id|nct_id|result_group_id|ctgov_group_code|title|period|description|count
8809198|NCT01496183|9861682|FG000|STARTED|Overall Study||9
8809199|NCT01496183|9861683|FG001|STARTED|Overall Study||15
8809200|NCT01496183|9861682|FG000|COMPLETED|Overall Study||6
8809201|NCT01496183|9861683|FG001|COMPLETED|Overall Study||13
8809202|NCT01496183|9861682|FG000|NOT COMPLETED|Overall Study||3
8809203|NCT01496183|9861683|FG001|NOT COMPLETED|Overall Study||2
8809204|NCT01496248|9861690|FG000|STARTED|Overall Study||35
8809205|NCT01496248|9861690|FG000|COMPLETED|Overall Study||25
8809206|NCT01496248|9861690|FG000|NOT COMPLETED|Overall Study||10
8809207|NCT01496274|9861696|FG000|STARTED|Overall Study||40
8809208|NCT01496274|9861697|FG001|STARTED|Overall Study||23
8809209|NCT01496274|9861696|FG000|COMPLETED|Overall Study||37
8809210|NCT01496274|9861697|FG001|COMPLETED|Overall Study||18
8809211|NCT01496274|9861696|FG000|NOT COMPLETED|Overall Study||3
8809212|NCT01496274|9861697|FG001|NOT COMPLETED|Overall Study||5
8809213|NCT01496287|9861718|FG000|STARTED|Overall Study||70
8809214|NCT01496287|9861718|FG000|COMPLETED|Overall Study||64
8809215|NCT01496287|9861718|FG000|NOT COMPLETED|Overall Study||6
8809216|NCT01496313|9861725|FG000|STARTED|Overall Study||40
8809217|NCT01496313|9861726|FG001|STARTED|Overall Study||41
8809218|NCT01496313|9861725|FG000|COMPLETED|Overall Study||35
8809219|NCT01496313|9861726|FG001|COMPLETED|Overall Study||26
8809220|NCT01496313|9861725|FG000|NOT COMPLETED|Overall Study||5
8809221|NCT01496313|9861726|FG001|NOT COMPLETED|Overall Study||15
8809222|NCT01496352|9861734|FG000|STARTED|Overall Study||24
8809223|NCT01496352|9861735|FG001|STARTED|Overall Study||6
8809224|NCT01496352|9861734|FG000|COMPLETED|Overall Study||24
8809225|NCT01496352|9861735|FG001|COMPLETED|Overall Study||6
8809226|NCT01496352|9861734|FG000|NOT COMPLETED|Overall Study||0
8809227|NCT01496352|9861735|FG001|NOT COMPLETED|Overall Study||0
8809228|NCT01496365|9861757|FG000|STARTED|Overall Study||112
8809229|NCT01496365|9861758|FG001|STARTED|Overall Study||56
8809230|NCT01496365|9861759|FG002|STARTED|Overall Study||57
8809231|NCT01496365|9861760|FG003|STARTED|Overall Study||57
8809232|NCT01496365|9861761|FG004|STARTED|Overall Study||57
8809233|NCT01496365|9861762|FG005|STARTED|Overall Study||56
8809234|NCT01496365|9861763|FG006|STARTED|Overall Study||57
8809235|NCT01496365|9861757|FG000|COMPLETED|Overall Study||97
8809236|NCT01496365|9861758|FG001|COMPLETED|Overall Study||41
8809237|NCT01496365|9861759|FG002|COMPLETED|Overall Study||51
8809238|NCT01496365|9861760|FG003|COMPLETED|Overall Study||53
8809239|NCT01496365|9861761|FG004|COMPLETED|Overall Study||44
8809240|NCT01496365|9861762|FG005|COMPLETED|Overall Study||46
8809241|NCT01496365|9861763|FG006|COMPLETED|Overall Study||51
8809242|NCT01496365|9861757|FG000|NOT COMPLETED|Overall Study||15
8809243|NCT01496365|9861758|FG001|NOT COMPLETED|Overall Study||15
8809244|NCT01496365|9861759|FG002|NOT COMPLETED|Overall Study||6
8809245|NCT01496365|9861760|FG003|NOT COMPLETED|Overall Study||4
8809246|NCT01496365|9861761|FG004|NOT COMPLETED|Overall Study||13
8809247|NCT01496365|9861762|FG005|NOT COMPLETED|Overall Study||10
8809248|NCT01496365|9861763|FG006|NOT COMPLETED|Overall Study||6
8809249|NCT01496430|9861782|FG000|STARTED|Overall Study||35
8809250|NCT01496430|9861783|FG001|STARTED|Overall Study||35
8809251|NCT01496430|9861784|FG002|STARTED|Overall Study||35
8809252|NCT01496430|9861782|FG000|COMPLETED|Overall Study||29
8809253|NCT01496430|9861783|FG001|COMPLETED|Overall Study||30
8809254|NCT01496430|9861784|FG002|COMPLETED|Overall Study||25
8809255|NCT01496430|9861782|FG000|NOT COMPLETED|Overall Study||6
8809256|NCT01496430|9861783|FG001|NOT COMPLETED|Overall Study||5
8809257|NCT01496430|9861784|FG002|NOT COMPLETED|Overall Study||10
8809258|NCT01496456|9861792|FG000|STARTED|Overall Study||17
8809259|NCT01496456|9861792|FG000|Baseline|Overall Study|Baseline group started with 16 patients.|16
8809260|NCT01496456|9861792|FG000|1-yr Recall|Overall Study||12
8809261|NCT01496456|9861792|FG000|2-yr Recall|Overall Study||10
8809262|NCT01496456|9861792|FG000|3-yr Final Recall|Overall Study||9
8809263|NCT01496456|9861792|FG000|COMPLETED|Overall Study||9
8809264|NCT01496456|9861792|FG000|NOT COMPLETED|Overall Study||8
8809265|NCT01496469|9861801|FG000|STARTED|Overall Study||60
8809266|NCT01496469|9861802|FG001|STARTED|Overall Study||61
8809267|NCT01496469|9861801|FG000|COMPLETED|Overall Study||50
8809268|NCT01496469|9861802|FG001|COMPLETED|Overall Study||53
8809269|NCT01496469|9861801|FG000|NOT COMPLETED|Overall Study||10
8809270|NCT01496469|9861802|FG001|NOT COMPLETED|Overall Study||8
8809271|NCT01496612|9861808|FG000|STARTED|1st Intervention||3
8809272|NCT01496612|9861809|FG001|STARTED|1st Intervention||4
8809273|NCT01496612|9861808|FG000|COMPLETED|1st Intervention||1
8809274|NCT01496612|9861809|FG001|COMPLETED|1st Intervention||4
8809275|NCT01496612|9861808|FG000|NOT COMPLETED|1st Intervention||2
8809276|NCT01496612|9861809|FG001|NOT COMPLETED|1st Intervention||0
8809277|NCT01496612|9861808|FG000|STARTED|2nd Intervention||1
8924224|NCT02247479|9985024|FG000|STARTED|Overall Study||305
8809278|NCT01496612|9861809|FG001|STARTED|2nd Intervention||4
8809279|NCT01496612|9861808|FG000|COMPLETED|2nd Intervention||1
8809280|NCT01496612|9861809|FG001|COMPLETED|2nd Intervention||4
8809281|NCT01496612|9861808|FG000|NOT COMPLETED|2nd Intervention||0
8809282|NCT01496612|9861809|FG001|NOT COMPLETED|2nd Intervention||0
8809283|NCT01496807|9861817|FG000|STARTED|Overall Study||31
8809284|NCT01496807|9861817|FG000|COMPLETED|Overall Study||1
8809285|NCT01496807|9861817|FG000|NOT COMPLETED|Overall Study||30
8809286|NCT01496846|9861827|FG000|STARTED|IANB Articaine (All Participants)||28
8809287|NCT01496846|9861828|FG001|STARTED|IANB Articaine (All Participants)||24
8809288|NCT01496846|9861829|FG002|STARTED|IANB Articaine (All Participants)||36
8809289|NCT01496846|9861830|FG003|STARTED|IANB Articaine (All Participants)||40
8809290|NCT01496846|9861831|FG004|STARTED|IANB Articaine (All Participants)||35
8809291|NCT01496846|9861832|FG005|STARTED|IANB Articaine (All Participants)||38
8809292|NCT01496846|9861827|FG000|COMPLETED|IANB Articaine (All Participants)||27
8809293|NCT01496846|9861828|FG001|COMPLETED|IANB Articaine (All Participants)||23
8809294|NCT01496846|9861829|FG002|COMPLETED|IANB Articaine (All Participants)||36
8809295|NCT01496846|9861830|FG003|COMPLETED|IANB Articaine (All Participants)||40
8809296|NCT01496846|9861831|FG004|COMPLETED|IANB Articaine (All Participants)||35
8809297|NCT01496846|9861832|FG005|COMPLETED|IANB Articaine (All Participants)||38
8809298|NCT01496846|9861827|FG000|NOT COMPLETED|IANB Articaine (All Participants)||1
8809299|NCT01496846|9861828|FG001|NOT COMPLETED|IANB Articaine (All Participants)||1
8809300|NCT01496846|9861829|FG002|NOT COMPLETED|IANB Articaine (All Participants)||0
8809301|NCT01496846|9861830|FG003|NOT COMPLETED|IANB Articaine (All Participants)||0
8809302|NCT01496846|9861831|FG004|NOT COMPLETED|IANB Articaine (All Participants)||0
8809303|NCT01496846|9861832|FG005|NOT COMPLETED|IANB Articaine (All Participants)||0
8809304|NCT01496846|9861827|FG000|STARTED|Supplemental Buccal Infiltration|No participants with successful IANB initially were brought forward to supplemental anesthetic|0
8809305|NCT01496846|9861828|FG001|STARTED|Supplemental Buccal Infiltration|No participants with successful IANB initially were brought forward to supplemental anesthetic|0
8809306|NCT01496846|9861829|FG002|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|36
8809307|NCT01496846|9861830|FG003|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|40
8809308|NCT01496846|9861831|FG004|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|35
8809309|NCT01496846|9861832|FG005|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|38
8809310|NCT01496846|9861827|FG000|COMPLETED|Supplemental Buccal Infiltration||0
8809311|NCT01496846|9861828|FG001|COMPLETED|Supplemental Buccal Infiltration||0
8809312|NCT01496846|9861829|FG002|COMPLETED|Supplemental Buccal Infiltration||36
8809313|NCT01496846|9861830|FG003|COMPLETED|Supplemental Buccal Infiltration||40
8809314|NCT01496846|9861831|FG004|COMPLETED|Supplemental Buccal Infiltration||35
8809315|NCT01496846|9861832|FG005|COMPLETED|Supplemental Buccal Infiltration||38
8809316|NCT01496846|9861827|FG000|NOT COMPLETED|Supplemental Buccal Infiltration||0
8809317|NCT01496846|9861828|FG001|NOT COMPLETED|Supplemental Buccal Infiltration||0
8809318|NCT01496846|9861829|FG002|NOT COMPLETED|Supplemental Buccal Infiltration||0
8809319|NCT01496846|9861830|FG003|NOT COMPLETED|Supplemental Buccal Infiltration||0
8809320|NCT01496846|9861831|FG004|NOT COMPLETED|Supplemental Buccal Infiltration||0
8809321|NCT01496846|9861832|FG005|NOT COMPLETED|Supplemental Buccal Infiltration||0
8809322|NCT01496885|9861843|FG000|STARTED|Overall Study||120
8809323|NCT01496885|9861843|FG000|COMPLETED|Overall Study||97
8809324|NCT01496885|9861843|FG000|NOT COMPLETED|Overall Study||23
8809325|NCT01497067|9861847|FG000|STARTED|Overall Study||657
8809326|NCT01497067|9861847|FG000|COMPLETED|Overall Study||575
8809327|NCT01497067|9861847|FG000|NOT COMPLETED|Overall Study||82
8809328|NCT01497197|9861854|FG000|STARTED|Overall Study||89
8809329|NCT01497197|9861855|FG001|STARTED|Overall Study||85
8809330|NCT01497197|9861854|FG000|COMPLETED|Overall Study||72
8809331|NCT01497197|9861855|FG001|COMPLETED|Overall Study||70
8809332|NCT01497197|9861854|FG000|NOT COMPLETED|Overall Study||17
8809333|NCT01497197|9861855|FG001|NOT COMPLETED|Overall Study||15
8809334|NCT01497262|9861861|FG000|STARTED|Overall Study||162
8809335|NCT01497262|9861861|FG000|COMPLETED|Overall Study||151
8809336|NCT01497262|9861861|FG000|NOT COMPLETED|Overall Study||11
8809337|NCT01497275|9861865|FG000|STARTED|Overall Study||5
8809338|NCT01497275|9861865|FG000|COMPLETED|Overall Study||3
8809339|NCT01497275|9861865|FG000|NOT COMPLETED|Overall Study||2
8809340|NCT01497366|9861871|FG000|STARTED|Overall Study||263
8809341|NCT01497366|9861872|FG001|STARTED|Overall Study||264
8809342|NCT01497366|9861871|FG000|Randomized But Not Treated|Overall Study||7
8809343|NCT01497366|9861872|FG001|Randomized But Not Treated|Overall Study||21
8809344|NCT01497366|9861871|FG000|COMPLETED|Overall Study||224
8809345|NCT01497366|9861872|FG001|COMPLETED|Overall Study||176
8924225|NCT02247479|9985025|FG001|STARTED|Overall Study||298
8924226|NCT02247479|9985026|FG002|STARTED|Overall Study||303
8924227|NCT02247479|9985024|FG000|COMPLETED|Overall Study||163
8924228|NCT02247479|9985025|FG001|COMPLETED|Overall Study||160
8924229|NCT02247479|9985026|FG002|COMPLETED|Overall Study||165
8924230|NCT02247479|9985024|FG000|NOT COMPLETED|Overall Study||142
8924231|NCT02247479|9985025|FG001|NOT COMPLETED|Overall Study||138
8924232|NCT02247479|9985026|FG002|NOT COMPLETED|Overall Study||138
9040024|NCT03345407|10100922|FG000|STARTED|Overall Study||276
9040025|NCT03345407|10100923|FG001|STARTED|Overall Study||22
9040026|NCT03345407|10100924|FG002|STARTED|Overall Study||91
9040027|NCT03345407|10100925|FG003|STARTED|Overall Study||92
9040028|NCT03345407|10100926|FG004|STARTED|Overall Study||90
8924233|NCT02247531|9985037|FG000|STARTED|Overall Study||321
8924234|NCT02247531|9985038|FG001|STARTED|Overall Study||330
8924235|NCT02247531|9985039|FG002|STARTED|Overall Study||324
8924236|NCT02247531|9985037|FG000|COMPLETED|Overall Study||215
8924237|NCT02247531|9985038|FG001|COMPLETED|Overall Study||205
8924238|NCT02247531|9985039|FG002|COMPLETED|Overall Study||214
8924239|NCT02247531|9985037|FG000|NOT COMPLETED|Overall Study||106
8924240|NCT02247531|9985038|FG001|NOT COMPLETED|Overall Study||125
8924241|NCT02247531|9985039|FG002|NOT COMPLETED|Overall Study||110
9040029|NCT03345407|10100927|FG005|STARTED|Overall Study||89
9040030|NCT03345407|10100928|FG006|STARTED|Overall Study||278
9040031|NCT03345407|10100922|FG000|COMPLETED|Overall Study||244
8809346|NCT01497366|9861871|FG000|NOT COMPLETED|Overall Study||39
8809347|NCT01497366|9861872|FG001|NOT COMPLETED|Overall Study||88
8809348|NCT01497496|9861879|FG000|STARTED|Overall Study||29
8809349|NCT01497496|9861879|FG000|COMPLETED|Overall Study||29
8809350|NCT01497496|9861879|FG000|NOT COMPLETED|Overall Study||0
8809351|NCT01497613|9861885|FG000|STARTED|Overall Study||150
8809352|NCT01497613|9861886|FG001|STARTED|Overall Study||150
8809353|NCT01497613|9861885|FG000|COMPLETED|Overall Study||113
8809354|NCT01497613|9861886|FG001|COMPLETED|Overall Study||131
8809355|NCT01497613|9861885|FG000|NOT COMPLETED|Overall Study||37
8809356|NCT01497613|9861886|FG001|NOT COMPLETED|Overall Study||19
8809357|NCT01497665|9861892|FG000|STARTED|Overall Study||16
8809358|NCT01497665|9861892|FG000|Completed Effifcacy Assessment|Overall Study|Number of patients who completed efficacy assessment with CNS lesions per Overall RECIST 1.1.|10
8809359|NCT01497665|9861892|FG000|COMPLETED|Overall Study||16
8809360|NCT01497665|9861892|FG000|NOT COMPLETED|Overall Study||0
8809361|NCT01497756|9861896|FG000|STARTED|Overall Study||10
8809362|NCT01497756|9861896|FG000|COMPLETED|Overall Study||10
8809363|NCT01497756|9861896|FG000|NOT COMPLETED|Overall Study||0
8849062|NCT01738594|9904286|FG007|COMPLETED|Registration and Treatment Start||0
8849063|NCT01738594|9904279|FG000|NOT COMPLETED|Registration and Treatment Start||0
8849064|NCT01738594|9904280|FG001|NOT COMPLETED|Registration and Treatment Start||1
8849065|NCT01738594|9904281|FG002|NOT COMPLETED|Registration and Treatment Start||0
8849066|NCT01738594|9904282|FG003|NOT COMPLETED|Registration and Treatment Start||0
8849067|NCT01738594|9904283|FG004|NOT COMPLETED|Registration and Treatment Start||0
8849068|NCT01738594|9904284|FG005|NOT COMPLETED|Registration and Treatment Start||0
8849069|NCT01738594|9904285|FG006|NOT COMPLETED|Registration and Treatment Start||0
8849070|NCT01738594|9904286|FG007|NOT COMPLETED|Registration and Treatment Start||0
8849071|NCT01738594|9904279|FG000|STARTED|Completed 2 Cycles/Reached 1st Response||0
8849072|NCT01738594|9904280|FG001|STARTED|Completed 2 Cycles/Reached 1st Response||2
8849073|NCT01738594|9904281|FG002|STARTED|Completed 2 Cycles/Reached 1st Response||0
8849074|NCT01738594|9904282|FG003|STARTED|Completed 2 Cycles/Reached 1st Response||0
8849075|NCT01738594|9904283|FG004|STARTED|Completed 2 Cycles/Reached 1st Response||1
8849076|NCT01738594|9904284|FG005|STARTED|Completed 2 Cycles/Reached 1st Response||3
8849077|NCT01738594|9904285|FG006|STARTED|Completed 2 Cycles/Reached 1st Response||0
8849078|NCT01738594|9904286|FG007|STARTED|Completed 2 Cycles/Reached 1st Response||0
8849079|NCT01738594|9904279|FG000|COMPLETED|Completed 2 Cycles/Reached 1st Response||0
8849080|NCT01738594|9904280|FG001|COMPLETED|Completed 2 Cycles/Reached 1st Response||2
8849081|NCT01738594|9904281|FG002|COMPLETED|Completed 2 Cycles/Reached 1st Response||0
8849082|NCT01738594|9904282|FG003|COMPLETED|Completed 2 Cycles/Reached 1st Response||0
8849083|NCT01738594|9904283|FG004|COMPLETED|Completed 2 Cycles/Reached 1st Response||1
8849084|NCT01738594|9904284|FG005|COMPLETED|Completed 2 Cycles/Reached 1st Response||2
8849085|NCT01738594|9904285|FG006|COMPLETED|Completed 2 Cycles/Reached 1st Response||0
8849086|NCT01738594|9904286|FG007|COMPLETED|Completed 2 Cycles/Reached 1st Response||0
8849087|NCT01738594|9904279|FG000|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
8849088|NCT01738594|9904280|FG001|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
8849089|NCT01738594|9904281|FG002|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
8849090|NCT01738594|9904282|FG003|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
8849091|NCT01738594|9904283|FG004|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
8849092|NCT01738594|9904284|FG005|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||1
8849093|NCT01738594|9904285|FG006|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
8849094|NCT01738594|9904286|FG007|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
8849095|NCT01738594|9904279|FG000|STARTED|Completed 4 Cycles of Treatment||0
8924242|NCT02247739|9985047|FG000|STARTED|Overall Study||5
8924243|NCT02247739|9985048|FG001|STARTED|Overall Study||6
8924244|NCT02247739|9985049|FG002|STARTED|Overall Study||5
8924245|NCT02247739|9985050|FG003|STARTED|Overall Study||5
8924246|NCT02247739|9985051|FG004|STARTED|Overall Study||6
8924247|NCT02247739|9985052|FG005|STARTED|Overall Study||5
8924248|NCT02247739|9985047|FG000|COMPLETED|Overall Study||5
8924249|NCT02247739|9985048|FG001|COMPLETED|Overall Study||3
8924250|NCT02247739|9985049|FG002|COMPLETED|Overall Study||4
8924251|NCT02247739|9985050|FG003|COMPLETED|Overall Study||5
8924252|NCT02247739|9985051|FG004|COMPLETED|Overall Study||5
8924253|NCT02247739|9985052|FG005|COMPLETED|Overall Study||4
8924254|NCT02247739|9985047|FG000|NOT COMPLETED|Overall Study||0
8924255|NCT02247739|9985048|FG001|NOT COMPLETED|Overall Study||3
8924256|NCT02247739|9985049|FG002|NOT COMPLETED|Overall Study||1
8924257|NCT02247739|9985050|FG003|NOT COMPLETED|Overall Study||0
8924258|NCT02247739|9985051|FG004|NOT COMPLETED|Overall Study||1
8924259|NCT02247739|9985052|FG005|NOT COMPLETED|Overall Study||1
8924260|NCT02247765|9985062|FG000|STARTED|Overall Study||18
8924261|NCT02247765|9985062|FG000|COMPLETED|Overall Study||18
8924262|NCT02247765|9985062|FG000|NOT COMPLETED|Overall Study||0
8924263|NCT02247804|9985069|FG000|STARTED|Treatment Period 1||198
8924264|NCT02247804|9985070|FG001|STARTED|Treatment Period 1||198
8924265|NCT02247804|9985071|FG002|STARTED|Treatment Period 1||198
8924266|NCT02247804|9985069|FG000|Received (Sham or Bimatoprost SR)|Treatment Period 1||193
8924267|NCT02247804|9985070|FG001|Received (Sham or Bimatoprost SR)|Treatment Period 1||197
8924268|NCT02247804|9985071|FG002|Received (Sham or Bimatoprost SR)|Treatment Period 1||197
8924269|NCT02247804|9985069|FG000|COMPLETED|Treatment Period 1||176
8924270|NCT02247804|9985070|FG001|COMPLETED|Treatment Period 1||194
8809364|NCT01497808|9861904|FG000|STARTED|Overall Study||6
8809365|NCT01497808|9861905|FG001|STARTED|Overall Study||4
8809366|NCT01497808|9861906|FG002|STARTED|Overall Study||6
8809367|NCT01497808|9861907|FG003|STARTED|Overall Study||6
8809368|NCT01497808|9861904|FG000|COMPLETED|Overall Study||6
8809369|NCT01497808|9861905|FG001|COMPLETED|Overall Study||4
8809370|NCT01497808|9861906|FG002|COMPLETED|Overall Study||6
8809371|NCT01497808|9861907|FG003|COMPLETED|Overall Study||6
8809372|NCT01497808|9861904|FG000|NOT COMPLETED|Overall Study||0
8809373|NCT01497808|9861905|FG001|NOT COMPLETED|Overall Study||0
8809374|NCT01497808|9861906|FG002|NOT COMPLETED|Overall Study||0
8809375|NCT01497808|9861907|FG003|NOT COMPLETED|Overall Study||0
8809376|NCT01497860|9861917|FG000|STARTED|Overall Study||12
8809377|NCT01497860|9861917|FG000|COMPLETED|Overall Study||12
8809378|NCT01497860|9861917|FG000|NOT COMPLETED|Overall Study||0
8809379|NCT01497899|9861925|FG000|STARTED|Double-Blind Phase||113
8809380|NCT01497899|9861926|FG001|STARTED|Double-Blind Phase||58
8809381|NCT01497899|9861927|FG002|STARTED|Double-Blind Phase||0
8809382|NCT01497899|9861928|FG003|STARTED|Double-Blind Phase||0
8809383|NCT01497899|9861925|FG000|COMPLETED|Double-Blind Phase||107
8809384|NCT01497899|9861926|FG001|COMPLETED|Double-Blind Phase||53
8809385|NCT01497899|9861927|FG002|COMPLETED|Double-Blind Phase||0
8809386|NCT01497899|9861928|FG003|COMPLETED|Double-Blind Phase||0
8809387|NCT01497899|9861925|FG000|NOT COMPLETED|Double-Blind Phase||6
8809388|NCT01497899|9861926|FG001|NOT COMPLETED|Double-Blind Phase||5
8809389|NCT01497899|9861927|FG002|NOT COMPLETED|Double-Blind Phase||0
8809390|NCT01497899|9861928|FG003|NOT COMPLETED|Double-Blind Phase||0
8809391|NCT01497899|9861925|FG000|STARTED|Open-Label Extension Phase|2 participants completed the Double-Blind Phase, but did not continue in the Open-Label Extension.|105
8809392|NCT01497899|9861926|FG001|STARTED|Open-Label Extension Phase||53
8809393|NCT01497899|9861927|FG002|STARTED|Open-Label Extension Phase|Participants enrolled from other Gilead-sponsored Study GS-US-299-0102.|70
8809394|NCT01497899|9861928|FG003|STARTED|Open-Label Extension Phase|Participants enrolled from other Gilead-sponsored Study GS-US-299-0102.|38
8809395|NCT01497899|9861925|FG000|COMPLETED|Open-Label Extension Phase||86
8809396|NCT01497899|9861926|FG001|COMPLETED|Open-Label Extension Phase||46
8809397|NCT01497899|9861927|FG002|COMPLETED|Open-Label Extension Phase||61
8809398|NCT01497899|9861928|FG003|COMPLETED|Open-Label Extension Phase||33
8809399|NCT01497899|9861925|FG000|NOT COMPLETED|Open-Label Extension Phase||19
8809400|NCT01497899|9861926|FG001|NOT COMPLETED|Open-Label Extension Phase||7
8809401|NCT01497899|9861927|FG002|NOT COMPLETED|Open-Label Extension Phase||9
8809402|NCT01497899|9861928|FG003|NOT COMPLETED|Open-Label Extension Phase||5
8809403|NCT01497938|9861937|FG000|STARTED|Overall Study||121
8809404|NCT01497938|9861938|FG001|STARTED|Overall Study||126
8809405|NCT01497938|9861937|FG000|COMPLETED|Overall Study||116
8809406|NCT01497938|9861938|FG001|COMPLETED|Overall Study||124
8809407|NCT01497938|9861937|FG000|NOT COMPLETED|Overall Study||5
8809408|NCT01497938|9861938|FG001|NOT COMPLETED|Overall Study||2
8809409|NCT01498068|9861946|FG000|STARTED|Overall Study||16
8809410|NCT01498068|9861947|FG001|STARTED|Overall Study||20
8809411|NCT01498068|9861946|FG000|COMPLETED|Overall Study||15
8809412|NCT01498068|9861947|FG001|COMPLETED|Overall Study||19
8809413|NCT01498068|9861946|FG000|NOT COMPLETED|Overall Study||1
8809414|NCT01498068|9861947|FG001|NOT COMPLETED|Overall Study||1
8809415|NCT01498120|9861953|FG000|STARTED|Overall Study||14
8809416|NCT01498120|9861953|FG000|COMPLETED|Overall Study||1
8809417|NCT01498120|9861953|FG000|NOT COMPLETED|Overall Study||13
8809418|NCT01498185|9861962|FG000|STARTED|Overall Study||13
8809419|NCT01498185|9861963|FG001|STARTED|Overall Study||13
8809420|NCT01498185|9861964|FG002|STARTED|Overall Study||15
8809421|NCT01498185|9861965|FG003|STARTED|Overall Study||14
8809422|NCT01498185|9861966|FG004|STARTED|Overall Study||15
8809423|NCT01498185|9861962|FG000|COMPLETED|Overall Study||12
8809424|NCT01498185|9861963|FG001|COMPLETED|Overall Study||12
8809425|NCT01498185|9861964|FG002|COMPLETED|Overall Study||15
8809426|NCT01498185|9861965|FG003|COMPLETED|Overall Study||11
8809427|NCT01498185|9861966|FG004|COMPLETED|Overall Study||12
8809428|NCT01498185|9861962|FG000|NOT COMPLETED|Overall Study||1
8809429|NCT01498185|9861963|FG001|NOT COMPLETED|Overall Study||1
8809430|NCT01498185|9861964|FG002|NOT COMPLETED|Overall Study||0
8924271|NCT02247804|9985071|FG002|COMPLETED|Treatment Period 1||190
8809431|NCT01498185|9861965|FG003|NOT COMPLETED|Overall Study||3
8809432|NCT01498185|9861966|FG004|NOT COMPLETED|Overall Study||3
8809433|NCT01498289|9861984|FG000|STARTED|Overall Study||98
8809434|NCT01498289|9861985|FG001|STARTED|Overall Study||104
8809435|NCT01498289|9861984|FG000|Participants Assessed for AEs|Overall Study||91
8809436|NCT01498289|9861985|FG001|Participants Assessed for AEs|Overall Study||98
8809437|NCT01498289|9861984|FG000|COMPLETED|Overall Study||0
8809438|NCT01498289|9861985|FG001|COMPLETED|Overall Study||0
8809439|NCT01498289|9861984|FG000|NOT COMPLETED|Overall Study||98
8809440|NCT01498289|9861985|FG001|NOT COMPLETED|Overall Study||104
8809441|NCT01498419|9861999|FG000|STARTED|Overall Study||60
8809442|NCT01498419|9862000|FG001|STARTED|Overall Study||62
8809443|NCT01498419|9862001|FG002|STARTED|Overall Study||59
8809444|NCT01498419|9862002|FG003|STARTED|Overall Study||26
8809445|NCT01498419|9861999|FG000|COMPLETED|Overall Study||42
8809446|NCT01498419|9862000|FG001|COMPLETED|Overall Study||39
8809447|NCT01498419|9862001|FG002|COMPLETED|Overall Study||41
8809448|NCT01498419|9862002|FG003|COMPLETED|Overall Study||7
8809449|NCT01498419|9861999|FG000|NOT COMPLETED|Overall Study||18
8809450|NCT01498419|9862000|FG001|NOT COMPLETED|Overall Study||23
8809451|NCT01498419|9862001|FG002|NOT COMPLETED|Overall Study||18
8809452|NCT01498419|9862002|FG003|NOT COMPLETED|Overall Study||19
8809453|NCT01498445|9862018|FG000|STARTED|Overall Study||4
8809454|NCT01498445|9862019|FG001|STARTED|Overall Study||3
8809455|NCT01498445|9862020|FG002|STARTED|Overall Study||8
8809456|NCT01498445|9862021|FG003|STARTED|Overall Study||8
8809457|NCT01498445|9862022|FG004|STARTED|Overall Study||4
8809458|NCT01498445|9862023|FG005|STARTED|Overall Study||5
8809459|NCT01498445|9862018|FG000|COMPLETED|Overall Study||4
8809460|NCT01498445|9862019|FG001|COMPLETED|Overall Study||3
8809461|NCT01498445|9862020|FG002|COMPLETED|Overall Study||7
8809462|NCT01498445|9862021|FG003|COMPLETED|Overall Study||6
8809463|NCT01498445|9862022|FG004|COMPLETED|Overall Study||3
8809464|NCT01498445|9862023|FG005|COMPLETED|Overall Study||4
8809465|NCT01498445|9862018|FG000|NOT COMPLETED|Overall Study||0
8809466|NCT01498445|9862019|FG001|NOT COMPLETED|Overall Study||0
8809467|NCT01498445|9862020|FG002|NOT COMPLETED|Overall Study||1
8809468|NCT01498445|9862021|FG003|NOT COMPLETED|Overall Study||2
8809469|NCT01498445|9862022|FG004|NOT COMPLETED|Overall Study||1
8809470|NCT01498445|9862023|FG005|NOT COMPLETED|Overall Study||1
8809471|NCT01498458|9862037|FG000|STARTED|Overall Study|9 patients took part in the study of which 8 received pazopanib.|8
8809472|NCT01498458|9862037|FG000|COMPLETED|Overall Study|only 1 patient was in the study at the end. 7 left due to Adverse Events or Investigators Decision.|1
8809473|NCT01498458|9862037|FG000|NOT COMPLETED|Overall Study||7
8924272|NCT02247804|9985069|FG000|NOT COMPLETED|Treatment Period 1||22
8924273|NCT02247804|9985070|FG001|NOT COMPLETED|Treatment Period 1||4
8924274|NCT02247804|9985071|FG002|NOT COMPLETED|Treatment Period 1||8
8924275|NCT02247804|9985069|FG000|STARTED|Treatment Period 2||172
8924276|NCT02247804|9985070|FG001|STARTED|Treatment Period 2||191
8924277|NCT02247804|9985071|FG002|STARTED|Treatment Period 2||187
8924278|NCT02247804|9985069|FG000|COMPLETED|Treatment Period 2||164
8924279|NCT02247804|9985070|FG001|COMPLETED|Treatment Period 2||186
8924280|NCT02247804|9985071|FG002|COMPLETED|Treatment Period 2||179
8924281|NCT02247804|9985069|FG000|NOT COMPLETED|Treatment Period 2||8
8924282|NCT02247804|9985070|FG001|NOT COMPLETED|Treatment Period 2||5
8924283|NCT02247804|9985071|FG002|NOT COMPLETED|Treatment Period 2||8
8924284|NCT02247804|9985069|FG000|STARTED|Treatment Period 3||158
8924285|NCT02247804|9985070|FG001|STARTED|Treatment Period 3||183
8924286|NCT02247804|9985071|FG002|STARTED|Treatment Period 3||177
8924287|NCT02247804|9985069|FG000|COMPLETED|Treatment Period 3||147
8924288|NCT02247804|9985070|FG001|COMPLETED|Treatment Period 3||173
8924289|NCT02247804|9985071|FG002|COMPLETED|Treatment Period 3||167
8924290|NCT02247804|9985069|FG000|NOT COMPLETED|Treatment Period 3||11
8924291|NCT02247804|9985070|FG001|NOT COMPLETED|Treatment Period 3||10
8924292|NCT02247804|9985071|FG002|NOT COMPLETED|Treatment Period 3||10
8924293|NCT02247960|9985081|FG000|STARTED|Patient Consent and Randomization||85
8924294|NCT02247960|9985082|FG001|STARTED|Patient Consent and Randomization||90
8924295|NCT02247960|9985081|FG000|COMPLETED|Patient Consent and Randomization||83
8924296|NCT02247960|9985082|FG001|COMPLETED|Patient Consent and Randomization||84
8924297|NCT02247960|9985081|FG000|NOT COMPLETED|Patient Consent and Randomization||2
8924298|NCT02247960|9985082|FG001|NOT COMPLETED|Patient Consent and Randomization||6
8924299|NCT02247960|9985081|FG000|STARTED|Catheter Removed||83
8924300|NCT02247960|9985082|FG001|STARTED|Catheter Removed||84
8924301|NCT02247960|9985081|FG000|COMPLETED|Catheter Removed||76
8924302|NCT02247960|9985082|FG001|COMPLETED|Catheter Removed||74
8924303|NCT02247960|9985081|FG000|NOT COMPLETED|Catheter Removed||7
8924304|NCT02247960|9985082|FG001|NOT COMPLETED|Catheter Removed||10
8924305|NCT02248103|9985090|FG000|STARTED|Overall Study||10
8924306|NCT02248103|9985091|FG001|STARTED|Overall Study||10
8924307|NCT02248103|9985090|FG000|COMPLETED|Overall Study||10
8924308|NCT02248103|9985091|FG001|COMPLETED|Overall Study||10
8924309|NCT02248103|9985090|FG000|NOT COMPLETED|Overall Study||0
8924310|NCT02248103|9985091|FG001|NOT COMPLETED|Overall Study||0
8924311|NCT02248246|9985097|FG000|STARTED|Overall Study||40
8924312|NCT02248246|9985097|FG000|COMPLETED|Overall Study||40
8924313|NCT02248246|9985097|FG000|NOT COMPLETED|Overall Study||0
8924314|NCT02248285|9985103|FG000|STARTED|Overall Study||687
8924315|NCT02248285|9985104|FG001|STARTED|Overall Study||858
8924316|NCT02248285|9985103|FG000|COMPLETED|Overall Study||586
8924317|NCT02248285|9985104|FG001|COMPLETED|Overall Study||571
8924318|NCT02248285|9985103|FG000|NOT COMPLETED|Overall Study||101
8924319|NCT02248285|9985104|FG001|NOT COMPLETED|Overall Study||287
8924320|NCT02248480|9985112|FG000|STARTED|Overall Study||178
8924321|NCT02248480|9985113|FG001|STARTED|Overall Study||176
8809474|NCT01498549|9862046|FG000|STARTED|Overall Study||39
8809475|NCT01498549|9862046|FG000|Atomoxetine 40 mg|Overall Study||39
8809476|NCT01498549|9862046|FG000|Atomoxetine 80 mg|Overall Study||37
8809477|NCT01498549|9862046|FG000|Sugar Pill 0 mg|Overall Study||36
8809478|NCT01498549|9862046|FG000|COMPLETED|Overall Study||35
8809479|NCT01498549|9862046|FG000|NOT COMPLETED|Overall Study||4
8809480|NCT01498575|9862057|FG000|STARTED|Overall Sample||610
8809481|NCT01498575|9862058|FG001|STARTED|Overall Sample||414
8809482|NCT01498575|9862057|FG000|COMPLETED|Overall Sample||550
8809483|NCT01498575|9862058|FG001|COMPLETED|Overall Sample||400
8809484|NCT01498575|9862057|FG000|NOT COMPLETED|Overall Sample||60
8809485|NCT01498575|9862058|FG001|NOT COMPLETED|Overall Sample||14
8924322|NCT02248480|9985112|FG000|Efficacy Population|Overall Study||177
8924323|NCT02248480|9985113|FG001|Efficacy Population|Overall Study||176
8924324|NCT02248480|9985112|FG000|COMPLETED|Overall Study||161
8924325|NCT02248480|9985113|FG001|COMPLETED|Overall Study||162
8809486|NCT01498575|9862057|FG000|STARTED|On the Road Driving Assessment (ODA)||128
8809487|NCT01498575|9862058|FG001|STARTED|On the Road Driving Assessment (ODA)||89
8809488|NCT01498575|9862057|FG000|COMPLETED|On the Road Driving Assessment (ODA)||86
8809489|NCT01498575|9862058|FG001|COMPLETED|On the Road Driving Assessment (ODA)||65
8809490|NCT01498575|9862057|FG000|NOT COMPLETED|On the Road Driving Assessment (ODA)||42
8809491|NCT01498575|9862058|FG001|NOT COMPLETED|On the Road Driving Assessment (ODA)||24
8809492|NCT01498588|9862064|FG000|STARTED|Overall Study||7
8809493|NCT01498588|9862064|FG000|COMPLETED|Overall Study||7
8809494|NCT01498588|9862064|FG000|NOT COMPLETED|Overall Study||0
8809495|NCT01498601|9862070|FG000|STARTED|Overall Study||51
8809496|NCT01498601|9862071|FG001|STARTED|Overall Study||32
8809497|NCT01498601|9862070|FG000|COMPLETED|Overall Study||51
8809498|NCT01498601|9862071|FG001|COMPLETED|Overall Study||32
8809499|NCT01498601|9862070|FG000|NOT COMPLETED|Overall Study||0
8809500|NCT01498601|9862071|FG001|NOT COMPLETED|Overall Study||0
8809501|NCT01498640|9862077|FG000|STARTED|Overall Study||52
8809502|NCT01498640|9862077|FG000|COMPLETED|Overall Study||47
8809503|NCT01498640|9862077|FG000|NOT COMPLETED|Overall Study||5
8809504|NCT01498653|9862087|FG000|STARTED|Overall Study||155
8809505|NCT01498653|9862088|FG001|STARTED|Overall Study||154
8809506|NCT01498653|9862087|FG000|COMPLETED|Overall Study||136
8809507|NCT01498653|9862088|FG001|COMPLETED|Overall Study||119
8809508|NCT01498653|9862087|FG000|NOT COMPLETED|Overall Study||19
8809509|NCT01498653|9862088|FG001|NOT COMPLETED|Overall Study||35
8809510|NCT01498679|9862096|FG000|STARTED|Overall Study||154
8809511|NCT01498679|9862097|FG001|STARTED|Overall Study||153
8809512|NCT01498679|9862096|FG000|COMPLETED|Overall Study||65
8809513|NCT01498679|9862097|FG001|COMPLETED|Overall Study||131
8809514|NCT01498679|9862096|FG000|NOT COMPLETED|Overall Study||89
8809515|NCT01498679|9862097|FG001|NOT COMPLETED|Overall Study||22
8809516|NCT01498692|9862103|FG000|STARTED|Overall Study||94
8809517|NCT01498692|9862103|FG000|COMPLETED|Overall Study||86
8809518|NCT01498692|9862103|FG000|NOT COMPLETED|Overall Study||8
8809519|NCT01498744|9862109|FG000|STARTED|Overall Study||22
8809520|NCT01498744|9862110|FG001|STARTED|Overall Study||31
8809521|NCT01498744|9862109|FG000|COMPLETED|Overall Study||22
8809522|NCT01498744|9862110|FG001|COMPLETED|Overall Study||31
8809523|NCT01498744|9862109|FG000|NOT COMPLETED|Overall Study||0
8809524|NCT01498744|9862110|FG001|NOT COMPLETED|Overall Study||0
8809525|NCT01498822|9862118|FG000|STARTED|Overall Study||175
8809526|NCT01498822|9862119|FG001|STARTED|Overall Study||178
8809527|NCT01498822|9862118|FG000|COMPLETED|Overall Study||121
8809528|NCT01498822|9862119|FG001|COMPLETED|Overall Study||122
8809529|NCT01498822|9862118|FG000|NOT COMPLETED|Overall Study||54
8809530|NCT01498822|9862119|FG001|NOT COMPLETED|Overall Study||56
8809531|NCT01498887|9862129|FG000|STARTED|Overall Study||200
8809532|NCT01498887|9862130|FG001|STARTED|Overall Study||147
8809533|NCT01498887|9862129|FG000|Safety Set|Overall Study||200
8809534|NCT01498887|9862130|FG001|Safety Set|Overall Study||147
8809535|NCT01498887|9862129|FG000|Intent-to-treat|Overall Study||185
8809536|NCT01498887|9862130|FG001|Intent-to-treat|Overall Study||135
8809537|NCT01498887|9862129|FG000|COMPLETED|Overall Study||184
8809538|NCT01498887|9862130|FG001|COMPLETED|Overall Study||136
8809539|NCT01498887|9862129|FG000|NOT COMPLETED|Overall Study||16
8809540|NCT01498887|9862130|FG001|NOT COMPLETED|Overall Study||11
8809541|NCT01498952|9862139|FG000|STARTED|Overall Study||3
8809542|NCT01498952|9862140|FG001|STARTED|Overall Study||3
8809543|NCT01498952|9862141|FG002|STARTED|Overall Study||0
8809544|NCT01498952|9862142|FG003|STARTED|Overall Study||0
8809545|NCT01498952|9862143|FG004|STARTED|Overall Study||0
8809546|NCT01498952|9862139|FG000|COMPLETED|Overall Study||1
8809547|NCT01498952|9862140|FG001|COMPLETED|Overall Study||1
8809548|NCT01498952|9862141|FG002|COMPLETED|Overall Study||0
8809549|NCT01498952|9862142|FG003|COMPLETED|Overall Study||0
8809550|NCT01498952|9862143|FG004|COMPLETED|Overall Study||0
8809551|NCT01498952|9862139|FG000|NOT COMPLETED|Overall Study||2
8809552|NCT01498952|9862140|FG001|NOT COMPLETED|Overall Study||2
8809553|NCT01498952|9862141|FG002|NOT COMPLETED|Overall Study||0
8809554|NCT01498952|9862142|FG003|NOT COMPLETED|Overall Study||0
8809555|NCT01498952|9862143|FG004|NOT COMPLETED|Overall Study||0
8809556|NCT01498978|9862156|FG000|STARTED|Overall Study||10
8809557|NCT01498978|9862156|FG000|COMPLETED|Overall Study||8
8809558|NCT01498978|9862156|FG000|NOT COMPLETED|Overall Study||2
8809559|NCT01499043|9862162|FG000|STARTED|Overall Study||6
8809560|NCT01499043|9862162|FG000|COMPLETED|Overall Study||0
8809561|NCT01499043|9862162|FG000|NOT COMPLETED|Overall Study||6
8809562|NCT01499134|9862173|FG000|STARTED|Overall Study||9
8809563|NCT01499134|9862174|FG001|STARTED|Overall Study||8
8809564|NCT01499134|9862173|FG000|COMPLETED|Overall Study||9
8809565|NCT01499134|9862174|FG001|COMPLETED|Overall Study||7
8809566|NCT01499134|9862173|FG000|NOT COMPLETED|Overall Study||0
8809567|NCT01499134|9862174|FG001|NOT COMPLETED|Overall Study||1
8809568|NCT01499147|9862182|FG000|STARTED|Overall Study||33
8809569|NCT01499147|9862183|FG001|STARTED|Overall Study||17
8809570|NCT01499147|9862182|FG000|COMPLETED|Overall Study||18
8809571|NCT01499147|9862183|FG001|COMPLETED|Overall Study||12
8809572|NCT01499147|9862182|FG000|NOT COMPLETED|Overall Study||15
8809573|NCT01499147|9862183|FG001|NOT COMPLETED|Overall Study||5
8809574|NCT01499173|9862193|FG000|STARTED|Overall Study||101
8809575|NCT01499173|9862193|FG000|COMPLETED|Overall Study||64
8809576|NCT01499173|9862193|FG000|NOT COMPLETED|Overall Study||37
8809577|NCT01499199|9862198|FG000|STARTED|Overall Study||13
8809578|NCT01499199|9862198|FG000|COMPLETED|Overall Study||11
8809579|NCT01499199|9862198|FG000|NOT COMPLETED|Overall Study||2
8809580|NCT01499277|9862204|FG000|STARTED|Overall Study||506
8809581|NCT01499277|9862205|FG001|STARTED|Overall Study||255
8809582|NCT01499277|9862204|FG000|COMPLETED|Overall Study||459
8809583|NCT01499277|9862205|FG001|COMPLETED|Overall Study||223
8809584|NCT01499277|9862204|FG000|NOT COMPLETED|Overall Study||47
8809585|NCT01499277|9862205|FG001|NOT COMPLETED|Overall Study||32
8809586|NCT01499290|9862213|FG000|STARTED|Overall Study|Patients dosed in pooled protocols D4280C00001/D4280C00005 (NCT01499290/NCT01500239) agreed with FDA|529
8809587|NCT01499290|9862214|FG001|STARTED|Overall Study|Patients dosed in pooled protocols D4280C00001/D4280C00005 (NCT01499290/NCT01500239) agreed with FDA|529
8809588|NCT01499290|9862213|FG000|COMPLETED|Overall Study|(Numbers indicate patients who completed treatment)|474
8809589|NCT01499290|9862214|FG001|COMPLETED|Overall Study|(Numbers indicate patients who completed treatment)|494
8809590|NCT01499290|9862213|FG000|NOT COMPLETED|Overall Study||55
8809591|NCT01499290|9862214|FG001|NOT COMPLETED|Overall Study||35
8809592|NCT01499303|9862241|FG000|STARTED|Overall Study||21
8809593|NCT01499303|9862242|FG001|STARTED|Overall Study||47
8809594|NCT01499303|9862241|FG000|COMPLETED|Overall Study||18
8809595|NCT01499303|9862242|FG001|COMPLETED|Overall Study||40
8809596|NCT01499303|9862241|FG000|NOT COMPLETED|Overall Study||3
8809597|NCT01499303|9862242|FG001|NOT COMPLETED|Overall Study||7
8809598|NCT01499355|9862248|FG000|STARTED|Run-In Period||276
8809599|NCT01499355|9862249|FG001|STARTED|Run-In Period||0
8809600|NCT01499355|9862250|FG002|STARTED|Run-In Period||0
8809601|NCT01499355|9862251|FG003|STARTED|Run-In Period||0
8809602|NCT01499355|9862248|FG000|COMPLETED|Run-In Period||245
8809603|NCT01499355|9862249|FG001|COMPLETED|Run-In Period||0
8809604|NCT01499355|9862250|FG002|COMPLETED|Run-In Period||0
8809605|NCT01499355|9862251|FG003|COMPLETED|Run-In Period||0
8809606|NCT01499355|9862248|FG000|NOT COMPLETED|Run-In Period||31
8809607|NCT01499355|9862249|FG001|NOT COMPLETED|Run-In Period||0
8809608|NCT01499355|9862250|FG002|NOT COMPLETED|Run-In Period||0
8809609|NCT01499355|9862251|FG003|NOT COMPLETED|Run-In Period||0
8809610|NCT01499355|9862248|FG000|STARTED|Double-Blind Period||0
8809611|NCT01499355|9862249|FG001|STARTED|Double-Blind Period||63
8809612|NCT01499355|9862250|FG002|STARTED|Double-Blind Period||63
8809613|NCT01499355|9862251|FG003|STARTED|Double-Blind Period||62
8809614|NCT01499355|9862248|FG000|COMPLETED|Double-Blind Period||0
8809615|NCT01499355|9862249|FG001|COMPLETED|Double-Blind Period||40
8809616|NCT01499355|9862250|FG002|COMPLETED|Double-Blind Period||38
8809617|NCT01499355|9862251|FG003|COMPLETED|Double-Blind Period||39
8809618|NCT01499355|9862248|FG000|NOT COMPLETED|Double-Blind Period||0
8809619|NCT01499355|9862249|FG001|NOT COMPLETED|Double-Blind Period||23
8809620|NCT01499355|9862250|FG002|NOT COMPLETED|Double-Blind Period||25
8809621|NCT01499355|9862251|FG003|NOT COMPLETED|Double-Blind Period||23
8924326|NCT02248480|9985112|FG000|NOT COMPLETED|Overall Study||17
8924327|NCT02248480|9985113|FG001|NOT COMPLETED|Overall Study||14
8924328|NCT02248558|9985122|FG000|STARTED|Overall Study||369
8924329|NCT02248558|9985123|FG001|STARTED|Overall Study||352
8924330|NCT02248558|9985122|FG000|COMPLETED|Overall Study||317
8924331|NCT02248558|9985123|FG001|COMPLETED|Overall Study||307
8924332|NCT02248558|9985122|FG000|NOT COMPLETED|Overall Study||52
8924333|NCT02248558|9985123|FG001|NOT COMPLETED|Overall Study||45
8924334|NCT02248636|9985133|FG000|STARTED|Overall Study||26
8924335|NCT02248636|9985134|FG001|STARTED|Overall Study||35
8924336|NCT02248636|9985133|FG000|COMPLETED|Overall Study||20
9040032|NCT03345407|10100923|FG001|COMPLETED|Overall Study||19
9040033|NCT03345407|10100924|FG002|COMPLETED|Overall Study||79
9040034|NCT03345407|10100925|FG003|COMPLETED|Overall Study||81
9040035|NCT03345407|10100926|FG004|COMPLETED|Overall Study||75
9040036|NCT03345407|10100927|FG005|COMPLETED|Overall Study||73
9040037|NCT03345407|10100928|FG006|COMPLETED|Overall Study||233
9040038|NCT03345407|10100922|FG000|NOT COMPLETED|Overall Study||32
9040039|NCT03345407|10100923|FG001|NOT COMPLETED|Overall Study||3
9040040|NCT03345407|10100924|FG002|NOT COMPLETED|Overall Study||12
9040041|NCT03345407|10100925|FG003|NOT COMPLETED|Overall Study||11
9040042|NCT03345407|10100926|FG004|NOT COMPLETED|Overall Study||15
9040043|NCT03345407|10100927|FG005|NOT COMPLETED|Overall Study||16
9040044|NCT03345407|10100928|FG006|NOT COMPLETED|Overall Study||45
9040045|NCT03345472|10100950|FG000|STARTED|Implant to 3 Months||103
9040046|NCT03345472|10100950|FG000|COMPLETED|Implant to 3 Months||99
9040047|NCT03345472|10100950|FG000|NOT COMPLETED|Implant to 3 Months||4
9040048|NCT03345472|10100950|FG000|STARTED|3 Months to 12 Months||99
9040049|NCT03345472|10100950|FG000|COMPLETED|3 Months to 12 Months||91
9040050|NCT03345472|10100950|FG000|NOT COMPLETED|3 Months to 12 Months||8
9040051|NCT03345914|10100957|FG000|STARTED|Overall Study||123
9040052|NCT03345914|10100958|FG001|STARTED|Overall Study||122
9040053|NCT03345914|10100959|FG002|STARTED|Overall Study||122
9040054|NCT03345914|10100957|FG000|Completed Week 16 Study Treatment|Overall Study||114
9040055|NCT03345914|10100958|FG001|Completed Week 16 Study Treatment|Overall Study||118
9040056|NCT03345914|10100959|FG002|Completed Week 16 Study Treatment|Overall Study||119
8809622|NCT01499368|9862264|FG000|STARTED|Overall Study||165
8809623|NCT01499368|9862265|FG001|STARTED|Overall Study||163
8809624|NCT01499368|9862266|FG002|STARTED|Overall Study||167
8809625|NCT01499368|9862264|FG000|COMPLETED|Overall Study||138
8809626|NCT01499368|9862265|FG001|COMPLETED|Overall Study||145
8809627|NCT01499368|9862266|FG002|COMPLETED|Overall Study||146
8809628|NCT01499368|9862264|FG000|NOT COMPLETED|Overall Study||27
9040057|NCT03345914|10100957|FG000|Completed Week 28 End of Study|Overall Study||0
9040058|NCT03345914|10100958|FG001|Completed Week 28 End of Study|Overall Study||0
9040059|NCT03345914|10100959|FG002|Completed Week 28 End of Study|Overall Study||0
9040060|NCT03345914|10100957|FG000|COMPLETED|Overall Study||0
9040061|NCT03345914|10100958|FG001|COMPLETED|Overall Study||0
9040062|NCT03345914|10100959|FG002|COMPLETED|Overall Study||0
9040063|NCT03345914|10100957|FG000|NOT COMPLETED|Overall Study||123
9040064|NCT03345914|10100958|FG001|NOT COMPLETED|Overall Study||122
9040065|NCT03345914|10100959|FG002|NOT COMPLETED|Overall Study||122
9040066|NCT03345979|10100969|FG000|STARTED|Overall Study||99
9040067|NCT03345979|10100970|FG001|STARTED|Overall Study||101
9040068|NCT03345979|10100969|FG000|COMPLETED|Overall Study||56
9040069|NCT03345979|10100970|FG001|COMPLETED|Overall Study||43
9040070|NCT03345979|10100969|FG000|NOT COMPLETED|Overall Study||43
8924337|NCT02248636|9985134|FG001|COMPLETED|Overall Study||32
8924338|NCT02248636|9985133|FG000|NOT COMPLETED|Overall Study||6
8924339|NCT02248636|9985134|FG001|NOT COMPLETED|Overall Study||3
8924340|NCT02248649|9985142|FG000|STARTED|Overall Study||80
8924341|NCT02248649|9985143|FG001|STARTED|Overall Study||80
8924342|NCT02248649|9985142|FG000|COMPLETED|Overall Study||59
8924343|NCT02248649|9985143|FG001|COMPLETED|Overall Study||59
8924344|NCT02248649|9985142|FG000|NOT COMPLETED|Overall Study||21
8924345|NCT02248649|9985143|FG001|NOT COMPLETED|Overall Study||21
9040071|NCT03345979|10100970|FG001|NOT COMPLETED|Overall Study||58
9040072|NCT03346057|10100980|FG000|STARTED|Overall Study||111
9040073|NCT03346057|10100981|FG001|STARTED|Overall Study||112
9040074|NCT03346057|10100982|FG002|STARTED|Overall Study||68
9040075|NCT03346057|10100983|FG003|STARTED|Overall Study||53
9040076|NCT03346057|10100980|FG000|Treated|Overall Study||105
9040077|NCT03346057|10100981|FG001|Treated|Overall Study||107
9040078|NCT03346057|10100982|FG002|Treated|Overall Study||68
9040079|NCT03346057|10100983|FG003|Treated|Overall Study||51
9040080|NCT03346057|10100980|FG000|COMPLETED|Overall Study||104
9040081|NCT03346057|10100981|FG001|COMPLETED|Overall Study||104
9040082|NCT03346057|10100982|FG002|COMPLETED|Overall Study||67
9040083|NCT03346057|10100983|FG003|COMPLETED|Overall Study||51
9040084|NCT03346057|10100980|FG000|NOT COMPLETED|Overall Study||7
9040085|NCT03346057|10100981|FG001|NOT COMPLETED|Overall Study||8
9040086|NCT03346057|10100982|FG002|NOT COMPLETED|Overall Study||1
9040087|NCT03346057|10100983|FG003|NOT COMPLETED|Overall Study||2
9040088|NCT03346070|10100998|FG000|STARTED|Overall Study||41
9040089|NCT03346070|10100999|FG001|STARTED|Overall Study||41
9040090|NCT03346070|10101000|FG002|STARTED|Overall Study||41
9040091|NCT03346070|10101001|FG003|STARTED|Overall Study||42
9040092|NCT03346070|10101002|FG004|STARTED|Overall Study||42
9040093|NCT03346070|10100998|FG000|Treated|Overall Study||38
9040094|NCT03346070|10100999|FG001|Treated|Overall Study||38
9040095|NCT03346070|10101000|FG002|Treated|Overall Study||38
9040096|NCT03346070|10101001|FG003|Treated|Overall Study||36
9040097|NCT03346070|10101002|FG004|Treated|Overall Study||38
8924346|NCT02248662|9985151|FG000|STARTED|Overall Study||5320
8924347|NCT02248662|9985152|FG001|STARTED|Overall Study||33194
8924348|NCT02248662|9985151|FG000|COMPLETED|Overall Study||757
8924349|NCT02248662|9985152|FG001|COMPLETED|Overall Study||2679
8924350|NCT02248662|9985151|FG000|NOT COMPLETED|Overall Study||4563
8924351|NCT02248662|9985152|FG001|NOT COMPLETED|Overall Study||30515
8924352|NCT02248675|9985164|FG000|STARTED|Overall Study||26
8924353|NCT02248675|9985165|FG001|STARTED|Overall Study||28
8924354|NCT02248675|9985164|FG000|COMPLETED|Overall Study||23
8924355|NCT02248675|9985165|FG001|COMPLETED|Overall Study||27
8924356|NCT02248675|9985164|FG000|NOT COMPLETED|Overall Study||3
8924357|NCT02248675|9985165|FG001|NOT COMPLETED|Overall Study||1
8924358|NCT02248714|9985173|FG000|STARTED|Overall Study||66
8924359|NCT02248714|9985174|FG001|STARTED|Overall Study||65
9040098|NCT03346070|10100998|FG000|COMPLETED|Overall Study||38
9040099|NCT03346070|10100999|FG001|COMPLETED|Overall Study||37
9040100|NCT03346070|10101000|FG002|COMPLETED|Overall Study||37
9040101|NCT03346070|10101001|FG003|COMPLETED|Overall Study||36
9040102|NCT03346070|10101002|FG004|COMPLETED|Overall Study||37
9040103|NCT03346070|10100998|FG000|NOT COMPLETED|Overall Study||3
9040104|NCT03346070|10100999|FG001|NOT COMPLETED|Overall Study||4
9040105|NCT03346070|10101000|FG002|NOT COMPLETED|Overall Study||4
9040106|NCT03346070|10101001|FG003|NOT COMPLETED|Overall Study||6
9040107|NCT03346070|10101002|FG004|NOT COMPLETED|Overall Study||5
9040108|NCT03346161|10101018|FG000|STARTED|Overall Study||60
8924360|NCT02248714|9985173|FG000|COMPLETED|Overall Study||62
8924361|NCT02248714|9985174|FG001|COMPLETED|Overall Study||61
8924362|NCT02248714|9985173|FG000|NOT COMPLETED|Overall Study||4
8924363|NCT02248714|9985174|FG001|NOT COMPLETED|Overall Study||4
8924364|NCT02248727|9985180|FG000|STARTED|Overall Study||30
8924365|NCT02248727|9985180|FG000|COMPLETED|Overall Study||30
8924366|NCT02248727|9985180|FG000|NOT COMPLETED|Overall Study||0
8924367|NCT02248766|9985187|FG000|STARTED|Overall Study||30
9040109|NCT03346161|10101019|FG001|STARTED|Overall Study||60
9040110|NCT03346161|10101018|FG000|COMPLETED|Overall Study||60
9040111|NCT03346161|10101019|FG001|COMPLETED|Overall Study||60
9040112|NCT03346161|10101018|FG000|NOT COMPLETED|Overall Study||0
9040113|NCT03346161|10101019|FG001|NOT COMPLETED|Overall Study||0
9040114|NCT03346759|10101027|FG000|STARTED|Enrollment to Baseline Data Collected||15
9040115|NCT03346759|10101028|FG001|STARTED|Enrollment to Baseline Data Collected||13
9040116|NCT03346759|10101027|FG000|COMPLETED|Enrollment to Baseline Data Collected|Participants assigned to the Tampon A First arm who provided at least one vaginal microbiota sample.|13
8924368|NCT02248766|9985187|FG000|COMPLETED|Overall Study||30
8924369|NCT02248766|9985187|FG000|NOT COMPLETED|Overall Study||0
8924370|NCT02248818|9985203|FG000|STARTED|Screening||0
8924371|NCT02248818|9985204|FG001|STARTED|Screening||0
8924372|NCT02248818|9985205|FG002|STARTED|Screening||0
8924373|NCT02248818|9985206|FG003|STARTED|Screening||0
8924374|NCT02248818|9985207|FG004|STARTED|Screening||0
8924375|NCT02248818|9985208|FG005|STARTED|Screening||0
8924376|NCT02248818|9985209|FG006|STARTED|Screening||0
8924377|NCT02248818|9985210|FG007|STARTED|Screening||0
8924378|NCT02248818|9985211|FG008|STARTED|Screening||155
8924379|NCT02248818|9985203|FG000|COMPLETED|Screening||0
8924380|NCT02248818|9985204|FG001|COMPLETED|Screening||0
8924381|NCT02248818|9985205|FG002|COMPLETED|Screening||0
8924382|NCT02248818|9985206|FG003|COMPLETED|Screening||0
8924383|NCT02248818|9985207|FG004|COMPLETED|Screening||0
9040117|NCT03346759|10101028|FG001|COMPLETED|Enrollment to Baseline Data Collected|Participants assigned to the Tampon B First arm who provided at least one vaginal microbiota sample.|10
9040118|NCT03346759|10101027|FG000|NOT COMPLETED|Enrollment to Baseline Data Collected||2
9040119|NCT03346759|10101028|FG001|NOT COMPLETED|Enrollment to Baseline Data Collected||3
9040120|NCT03346759|10101027|FG000|STARTED|First Menstrual Cycle||13
9040121|NCT03346759|10101028|FG001|STARTED|First Menstrual Cycle||10
9040122|NCT03346759|10101027|FG000|COMPLETED|First Menstrual Cycle||12
9040123|NCT03346759|10101028|FG001|COMPLETED|First Menstrual Cycle||10
9040124|NCT03346759|10101027|FG000|NOT COMPLETED|First Menstrual Cycle||1
9040125|NCT03346759|10101028|FG001|NOT COMPLETED|First Menstrual Cycle||0
9040126|NCT03346759|10101027|FG000|STARTED|Second Menstrual Cycle||12
9040127|NCT03346759|10101028|FG001|STARTED|Second Menstrual Cycle||10
9040128|NCT03346759|10101027|FG000|COMPLETED|Second Menstrual Cycle||11
9040129|NCT03346759|10101028|FG001|COMPLETED|Second Menstrual Cycle||10
9040130|NCT03346759|10101027|FG000|NOT COMPLETED|Second Menstrual Cycle||1
8809629|NCT01499368|9862265|FG001|NOT COMPLETED|Overall Study||18
8809630|NCT01499368|9862266|FG002|NOT COMPLETED|Overall Study||21
8809631|NCT01499498|9862274|FG000|STARTED|Overall Study||13
8809632|NCT01499498|9862274|FG000|COMPLETED|Overall Study||13
8809633|NCT01499498|9862274|FG000|NOT COMPLETED|Overall Study||0
8809634|NCT01499511|9862283|FG000|STARTED|Overall Study||885
8809635|NCT01499511|9862284|FG001|STARTED|Overall Study||833
8809636|NCT01499511|9862283|FG000|COMPLETED|Overall Study||884
8809637|NCT01499511|9862284|FG001|COMPLETED|Overall Study||833
8809638|NCT01499511|9862283|FG000|NOT COMPLETED|Overall Study||1
8809639|NCT01499511|9862284|FG001|NOT COMPLETED|Overall Study||0
8809640|NCT01499576|9862291|FG000|STARTED|Overall Study||126
8809641|NCT01499576|9862291|FG000|COMPLETED|Overall Study||105
8809642|NCT01499576|9862291|FG000|NOT COMPLETED|Overall Study||21
8809643|NCT01499654|9862296|FG000|STARTED|Overall Study||64
8809644|NCT01499654|9862296|FG000|COMPLETED|Overall Study||64
8809645|NCT01499654|9862296|FG000|NOT COMPLETED|Overall Study||0
8809646|NCT01499667|9862309|FG000|STARTED|Overall Study|"Started indicates randomized as well as safety population."|50
8809647|NCT01499667|9862310|FG001|STARTED|Overall Study||42
8809648|NCT01499667|9862311|FG002|STARTED|Overall Study||50
8809649|NCT01499667|9862309|FG000|Full Analysis Set (FAS)|Overall Study|One randomized patient did not receive natalizumub at screening, which was a requirement for FAS.|49
8809650|NCT01499667|9862310|FG001|Full Analysis Set (FAS)|Overall Study||42
8809651|NCT01499667|9862311|FG002|Full Analysis Set (FAS)|Overall Study||50
8809652|NCT01499667|9862309|FG000|Modified Full Analysis Set|Overall Study|mFAS included all FAS patients who completed 8 wks of fingolimod treatment with MRI scan|41
8809653|NCT01499667|9862310|FG001|Modified Full Analysis Set|Overall Study||29
8809654|NCT01499667|9862311|FG002|Modified Full Analysis Set|Overall Study||39
8809655|NCT01499667|9862309|FG000|COMPLETED|Overall Study||41
8809656|NCT01499667|9862310|FG001|COMPLETED|Overall Study||31
8809657|NCT01499667|9862311|FG002|COMPLETED|Overall Study||40
8809658|NCT01499667|9862309|FG000|NOT COMPLETED|Overall Study||9
8809659|NCT01499667|9862310|FG001|NOT COMPLETED|Overall Study||11
8809660|NCT01499667|9862311|FG002|NOT COMPLETED|Overall Study||10
8809661|NCT01499810|9862319|FG000|STARTED|Overall Study||53
8809662|NCT01499810|9862319|FG000|COMPLETED|Overall Study||41
8809663|NCT01499810|9862319|FG000|NOT COMPLETED|Overall Study||12
8809664|NCT01499849|9862326|FG000|STARTED|Overall Study|Number of randomized patients|266
8809665|NCT01499849|9862327|FG001|STARTED|Overall Study||266
8809666|NCT01499849|9862326|FG000|COMPLETED|Overall Study|Number of patients who completed 6 cycles|42
8809667|NCT01499849|9862327|FG001|COMPLETED|Overall Study||40
8809668|NCT01499849|9862326|FG000|NOT COMPLETED|Overall Study||224
8809669|NCT01499849|9862327|FG001|NOT COMPLETED|Overall Study||226
8809670|NCT01499862|9862333|FG000|STARTED|Overall Study||3
8809671|NCT01499862|9862333|FG000|COMPLETED|Overall Study||3
8809672|NCT01499862|9862333|FG000|NOT COMPLETED|Overall Study||0
8809673|NCT01499940|9862351|FG000|STARTED|Overall Study||9
8924384|NCT02248818|9985208|FG005|COMPLETED|Screening||0
8924385|NCT02248818|9985209|FG006|COMPLETED|Screening||0
8924386|NCT02248818|9985210|FG007|COMPLETED|Screening||0
8809674|NCT01499940|9862351|FG000|COMPLETED|Overall Study||0
8809675|NCT01499940|9862351|FG000|NOT COMPLETED|Overall Study||9
8809676|NCT01500031|9862355|FG000|STARTED|Overall Study||92
8809677|NCT01500031|9862355|FG000|COMPLETED|Overall Study||87
8809678|NCT01500031|9862355|FG000|NOT COMPLETED|Overall Study||5
8809679|NCT01500057|9862361|FG000|STARTED|Overall Study||31
8809680|NCT01500057|9862362|FG001|STARTED|Overall Study||35
8809681|NCT01500057|9862361|FG000|COMPLETED|Overall Study||25
8924387|NCT02248818|9985211|FG008|COMPLETED|Screening||48
9040131|NCT03346759|10101028|FG001|NOT COMPLETED|Second Menstrual Cycle||0
9040132|NCT03346759|10101027|FG000|STARTED|Third Menstrual Cycle||11
9040133|NCT03346759|10101028|FG001|STARTED|Third Menstrual Cycle||10
9040134|NCT03346759|10101027|FG000|COMPLETED|Third Menstrual Cycle||11
9040135|NCT03346759|10101028|FG001|COMPLETED|Third Menstrual Cycle||10
9040136|NCT03346759|10101027|FG000|NOT COMPLETED|Third Menstrual Cycle||0
9040137|NCT03346759|10101028|FG001|NOT COMPLETED|Third Menstrual Cycle||0
9040138|NCT03346850|10101037|FG000|STARTED|Overall Study||20
9040139|NCT03346850|10101038|FG001|STARTED|Overall Study||20
9040140|NCT03346850|10101037|FG000|COMPLETED|Overall Study||18
9040141|NCT03346850|10101038|FG001|COMPLETED|Overall Study||17
9040142|NCT03346850|10101037|FG000|NOT COMPLETED|Overall Study||2
9040143|NCT03346850|10101038|FG001|NOT COMPLETED|Overall Study||3
9040144|NCT03346902|10101046|FG000|STARTED|Overall Study||4
9040145|NCT03346902|10101047|FG001|STARTED|Overall Study||8
9040146|NCT03346902|10101046|FG000|COMPLETED|Overall Study||4
9040147|NCT03346902|10101047|FG001|COMPLETED|Overall Study||8
9040148|NCT03346902|10101046|FG000|NOT COMPLETED|Overall Study||0
9040149|NCT03346902|10101047|FG001|NOT COMPLETED|Overall Study||0
9040150|NCT03347188|10101055|FG000|STARTED|Double-blind (DB) Period (12 Weeks)||44
9040151|NCT03347188|10101056|FG001|STARTED|Double-blind (DB) Period (12 Weeks)||43
9040152|NCT03347188|10101055|FG000|Received at Least 1 Dose of Study Drug|Double-blind (DB) Period (12 Weeks)||43
9040153|NCT03347188|10101056|FG001|Received at Least 1 Dose of Study Drug|Double-blind (DB) Period (12 Weeks)||43
9040154|NCT03347188|10101055|FG000|Full Analysis Set (FAS)|Double-blind (DB) Period (12 Weeks)||42
8809682|NCT01500057|9862362|FG001|COMPLETED|Overall Study||31
8809683|NCT01500057|9862361|FG000|NOT COMPLETED|Overall Study||6
8809684|NCT01500057|9862362|FG001|NOT COMPLETED|Overall Study||4
8809685|NCT01500083|9862370|FG000|STARTED|Overall Study||16
8924388|NCT02248818|9985203|FG000|NOT COMPLETED|Screening||0
8924389|NCT02248818|9985204|FG001|NOT COMPLETED|Screening||0
8924390|NCT02248818|9985205|FG002|NOT COMPLETED|Screening||0
8924391|NCT02248818|9985206|FG003|NOT COMPLETED|Screening||0
8924392|NCT02248818|9985207|FG004|NOT COMPLETED|Screening||0
8924393|NCT02248818|9985208|FG005|NOT COMPLETED|Screening||0
8924394|NCT02248818|9985209|FG006|NOT COMPLETED|Screening||0
8924395|NCT02248818|9985210|FG007|NOT COMPLETED|Screening||0
8924396|NCT02248818|9985211|FG008|NOT COMPLETED|Screening||107
8924397|NCT02248818|9985203|FG000|STARTED|Randomised Study||6
8924398|NCT02248818|9985204|FG001|STARTED|Randomised Study||6
8924399|NCT02248818|9985205|FG002|STARTED|Randomised Study||6
8924400|NCT02248818|9985206|FG003|STARTED|Randomised Study||6
8924401|NCT02248818|9985207|FG004|STARTED|Randomised Study||6
8924402|NCT02248818|9985208|FG005|STARTED|Randomised Study||8
8924403|NCT02248818|9985209|FG006|STARTED|Randomised Study||6
8924404|NCT02248818|9985210|FG007|STARTED|Randomised Study||4
8924405|NCT02248818|9985211|FG008|STARTED|Randomised Study||0
8924406|NCT02248818|9985203|FG000|COMPLETED|Randomised Study||6
8924407|NCT02248818|9985204|FG001|COMPLETED|Randomised Study||6
8924408|NCT02248818|9985205|FG002|COMPLETED|Randomised Study||6
8924409|NCT02248818|9985206|FG003|COMPLETED|Randomised Study||6
8924410|NCT02248818|9985207|FG004|COMPLETED|Randomised Study||6
8924411|NCT02248818|9985208|FG005|COMPLETED|Randomised Study||0
8924412|NCT02248818|9985209|FG006|COMPLETED|Randomised Study||6
8924413|NCT02248818|9985210|FG007|COMPLETED|Randomised Study||4
8924414|NCT02248818|9985211|FG008|COMPLETED|Randomised Study||0
8924415|NCT02248818|9985203|FG000|NOT COMPLETED|Randomised Study||0
8924416|NCT02248818|9985204|FG001|NOT COMPLETED|Randomised Study||0
8924417|NCT02248818|9985205|FG002|NOT COMPLETED|Randomised Study||0
8924418|NCT02248818|9985206|FG003|NOT COMPLETED|Randomised Study||0
8924419|NCT02248818|9985207|FG004|NOT COMPLETED|Randomised Study||0
8924420|NCT02248818|9985208|FG005|NOT COMPLETED|Randomised Study||8
8924421|NCT02248818|9985209|FG006|NOT COMPLETED|Randomised Study||0
8924422|NCT02248818|9985210|FG007|NOT COMPLETED|Randomised Study||0
8924423|NCT02248818|9985211|FG008|NOT COMPLETED|Randomised Study||0
8924424|NCT02248857|9985232|FG000|STARTED|Baseline||157
8924425|NCT02248857|9985233|FG001|STARTED|Baseline||168
8924426|NCT02248857|9985234|FG002|STARTED|Baseline||127
8924427|NCT02248857|9985232|FG000|COMPLETED|Baseline||157
8924428|NCT02248857|9985233|FG001|COMPLETED|Baseline||168
8924429|NCT02248857|9985234|FG002|COMPLETED|Baseline||127
8924430|NCT02248857|9985232|FG000|NOT COMPLETED|Baseline||0
8924431|NCT02248857|9985233|FG001|NOT COMPLETED|Baseline||0
8924432|NCT02248857|9985234|FG002|NOT COMPLETED|Baseline||0
8924433|NCT02248857|9985232|FG000|STARTED|3 Month||157
8924434|NCT02248857|9985233|FG001|STARTED|3 Month||168
8924435|NCT02248857|9985234|FG002|STARTED|3 Month||127
8924436|NCT02248857|9985232|FG000|COMPLETED|3 Month||111
8924437|NCT02248857|9985233|FG001|COMPLETED|3 Month||134
8924438|NCT02248857|9985234|FG002|COMPLETED|3 Month||96
8924439|NCT02248857|9985232|FG000|NOT COMPLETED|3 Month||46
9040155|NCT03347188|10101056|FG001|Full Analysis Set (FAS)|Double-blind (DB) Period (12 Weeks)||43
8924440|NCT02248857|9985233|FG001|NOT COMPLETED|3 Month||34
8924441|NCT02248857|9985234|FG002|NOT COMPLETED|3 Month||31
8924442|NCT02248857|9985232|FG000|STARTED|6 Month|157 baseline - 9 who withdrew = 148|148
8924443|NCT02248857|9985233|FG001|STARTED|6 Month|168 baseline - 3 who withdrew = 165|165
8924444|NCT02248857|9985234|FG002|STARTED|6 Month|127 baseline - 4 who withdrew = 123|123
8924445|NCT02248857|9985232|FG000|COMPLETED|6 Month||120
9040156|NCT03347188|10101055|FG000|COMPLETED|Double-blind (DB) Period (12 Weeks)||29
9040157|NCT03347188|10101056|FG001|COMPLETED|Double-blind (DB) Period (12 Weeks)||26
8924446|NCT02248857|9985233|FG001|COMPLETED|6 Month||136
8924447|NCT02248857|9985234|FG002|COMPLETED|6 Month||106
8924448|NCT02248857|9985232|FG000|NOT COMPLETED|6 Month||28
8924449|NCT02248857|9985233|FG001|NOT COMPLETED|6 Month||29
8924450|NCT02248857|9985234|FG002|NOT COMPLETED|6 Month||17
8924451|NCT02248922|9985244|FG000|STARTED|Overall Study||5
8924452|NCT02248922|9985245|FG001|STARTED|Overall Study||12
8924453|NCT02248922|9985244|FG000|COMPLETED|Overall Study||5
8924454|NCT02248922|9985245|FG001|COMPLETED|Overall Study||12
8924455|NCT02248922|9985244|FG000|NOT COMPLETED|Overall Study||0
8924456|NCT02248922|9985245|FG001|NOT COMPLETED|Overall Study||0
8924457|NCT02248961|9985252|FG000|STARTED|Overall Study||89
8924458|NCT02248961|9985253|FG001|STARTED|Overall Study||90
8924459|NCT02248961|9985252|FG000|COMPLETED|Overall Study||86
8924460|NCT02248961|9985253|FG001|COMPLETED|Overall Study||88
8924461|NCT02248961|9985252|FG000|NOT COMPLETED|Overall Study||3
8924462|NCT02248961|9985253|FG001|NOT COMPLETED|Overall Study||2
8924463|NCT02248974|9985261|FG000|STARTED|Baseline||47
8924464|NCT02248974|9985262|FG001|STARTED|Baseline||51
8924465|NCT02248974|9985261|FG000|COMPLETED|Baseline||47
8924466|NCT02248974|9985262|FG001|COMPLETED|Baseline||51
8924467|NCT02248974|9985261|FG000|NOT COMPLETED|Baseline||0
8924468|NCT02248974|9985262|FG001|NOT COMPLETED|Baseline||0
8924469|NCT02248974|9985261|FG000|STARTED|1-Day Follow-Up||47
8924470|NCT02248974|9985262|FG001|STARTED|1-Day Follow-Up|"No DA group did not receive 1-Day Follow-up survey."|0
8924471|NCT02248974|9985261|FG000|COMPLETED|1-Day Follow-Up||37
8924472|NCT02248974|9985262|FG001|COMPLETED|1-Day Follow-Up|"No DA group did not receive 1-Day Follow-up survey."|0
8924473|NCT02248974|9985261|FG000|NOT COMPLETED|1-Day Follow-Up||10
8924474|NCT02248974|9985262|FG001|NOT COMPLETED|1-Day Follow-Up||0
9040158|NCT03347188|10101055|FG000|NOT COMPLETED|Double-blind (DB) Period (12 Weeks)||15
9040159|NCT03347188|10101056|FG001|NOT COMPLETED|Double-blind (DB) Period (12 Weeks)||17
9040160|NCT03347188|10101055|FG000|STARTED|Open-label (OL) Period (12 Weeks)||35
9040161|NCT03347188|10101056|FG001|STARTED|Open-label (OL) Period (12 Weeks)||35
9040162|NCT03347188|10101055|FG000|Entered in OL Period for Anti-drug Antibody (ADA) Only|Open-label (OL) Period (12 Weeks)||26
9040163|NCT03347188|10101056|FG001|Entered in OL Period for Anti-drug Antibody (ADA) Only|Open-label (OL) Period (12 Weeks)||28
9040164|NCT03347188|10101055|FG000|Received at Least 1 Dose of Study Drug|Open-label (OL) Period (12 Weeks)||9
9040165|NCT03347188|10101056|FG001|Received at Least 1 Dose of Study Drug|Open-label (OL) Period (12 Weeks)||7
9040166|NCT03347188|10101055|FG000|COMPLETED|Open-label (OL) Period (12 Weeks)||8
9040167|NCT03347188|10101056|FG001|COMPLETED|Open-label (OL) Period (12 Weeks)||6
9040168|NCT03347188|10101055|FG000|NOT COMPLETED|Open-label (OL) Period (12 Weeks)||27
9040169|NCT03347188|10101056|FG001|NOT COMPLETED|Open-label (OL) Period (12 Weeks)||29
9040170|NCT03347279|10101064|FG000|STARTED|Overall Study||529
9040171|NCT03347279|10101065|FG001|STARTED|Overall Study||532
9040172|NCT03347279|10101064|FG000|Received Treatment|Overall Study||528
9040173|NCT03347279|10101065|FG001|Received Treatment|Overall Study||531
9040174|NCT03347279|10101064|FG000|COMPLETED|Overall Study||513
9040175|NCT03347279|10101065|FG001|COMPLETED|Overall Study||509
9040176|NCT03347279|10101064|FG000|NOT COMPLETED|Overall Study||16
9040177|NCT03347279|10101065|FG001|NOT COMPLETED|Overall Study||23
9040178|NCT03347695|10101073|FG000|STARTED|Overall Study||20
9040179|NCT03347695|10101074|FG001|STARTED|Overall Study||120
9040180|NCT03347695|10101073|FG000|COMPLETED|Overall Study||20
9040181|NCT03347695|10101074|FG001|COMPLETED|Overall Study||115
9040182|NCT03347695|10101073|FG000|NOT COMPLETED|Overall Study||0
8809686|NCT01500083|9862371|FG001|STARTED|Overall Study||74
8809687|NCT01500083|9862370|FG000|COMPLETED|Overall Study||4
8809688|NCT01500083|9862371|FG001|COMPLETED|Overall Study||31
8809689|NCT01500083|9862370|FG000|NOT COMPLETED|Overall Study||12
8809690|NCT01500083|9862371|FG001|NOT COMPLETED|Overall Study||43
8809691|NCT01500096|9862381|FG000|STARTED|Overall Study||32
8809692|NCT01500096|9862382|FG001|STARTED|Overall Study||17
8809693|NCT01500096|9862383|FG002|STARTED|Overall Study||31
8809694|NCT01500096|9862384|FG003|STARTED|Overall Study||16
8809695|NCT01500096|9862381|FG000|COMPLETED|Overall Study||31
8809696|NCT01500096|9862382|FG001|COMPLETED|Overall Study||17
8809697|NCT01500096|9862383|FG002|COMPLETED|Overall Study||31
8809698|NCT01500096|9862384|FG003|COMPLETED|Overall Study||14
8809699|NCT01500096|9862381|FG000|NOT COMPLETED|Overall Study||1
8809700|NCT01500096|9862382|FG001|NOT COMPLETED|Overall Study||0
8809701|NCT01500096|9862383|FG002|NOT COMPLETED|Overall Study||0
8809702|NCT01500096|9862384|FG003|NOT COMPLETED|Overall Study||2
8809703|NCT01500135|9862396|FG000|STARTED|Overall Study||100
8809704|NCT01500135|9862397|FG001|STARTED|Overall Study||50
8809705|NCT01500135|9862396|FG000|COMPLETED|Overall Study||83
8809706|NCT01500135|9862397|FG001|COMPLETED|Overall Study||39
9040183|NCT03347695|10101074|FG001|NOT COMPLETED|Overall Study||5
9040184|NCT03348683|10101084|FG000|STARTED|Overall Study||121
8809707|NCT01500135|9862396|FG000|NOT COMPLETED|Overall Study||17
8809708|NCT01500135|9862397|FG001|NOT COMPLETED|Overall Study||11
8809709|NCT01500187|9862405|FG000|STARTED|Overall Study||23
8809710|NCT01500187|9862406|FG001|STARTED|Overall Study||15
8924475|NCT02248974|9985261|FG000|STARTED|1-Week Follow-Up||37
8924476|NCT02248974|9985262|FG001|STARTED|1-Week Follow-Up||51
8924477|NCT02248974|9985261|FG000|COMPLETED|1-Week Follow-Up||29
8924478|NCT02248974|9985262|FG001|COMPLETED|1-Week Follow-Up||34
8924479|NCT02248974|9985261|FG000|NOT COMPLETED|1-Week Follow-Up||8
8924480|NCT02248974|9985262|FG001|NOT COMPLETED|1-Week Follow-Up||17
8924481|NCT02248974|9985261|FG000|STARTED|1-Month Follow-Up||29
9040185|NCT03348683|10101085|FG001|STARTED|Overall Study||119
9040186|NCT03348683|10101084|FG000|COMPLETED|Overall Study||121
9040187|NCT03348683|10101085|FG001|COMPLETED|Overall Study||119
9040188|NCT03348683|10101084|FG000|NOT COMPLETED|Overall Study||0
9040189|NCT03348683|10101085|FG001|NOT COMPLETED|Overall Study||0
9040190|NCT03349034|10101093|FG000|STARTED|Overall Study||12
9040191|NCT03349034|10101094|FG001|STARTED|Overall Study||12
9040192|NCT03349034|10101093|FG000|COMPLETED|Overall Study||8
9040193|NCT03349034|10101094|FG001|COMPLETED|Overall Study||10
9040194|NCT03349034|10101093|FG000|NOT COMPLETED|Overall Study||4
9040195|NCT03349034|10101094|FG001|NOT COMPLETED|Overall Study||2
9040196|NCT03349060|10101105|FG000|STARTED|Overall Study||156
9040197|NCT03349060|10101106|FG001|STARTED|Overall Study||154
9040198|NCT03349060|10101107|FG002|STARTED|Overall Study||77
9040199|NCT03349060|10101105|FG000|COMPLETED|Overall Study||135
9040200|NCT03349060|10101106|FG001|COMPLETED|Overall Study||137
9040201|NCT03349060|10101107|FG002|COMPLETED|Overall Study||61
9040202|NCT03349060|10101105|FG000|NOT COMPLETED|Overall Study||21
9040203|NCT03349060|10101106|FG001|NOT COMPLETED|Overall Study||17
9040204|NCT03349060|10101107|FG002|NOT COMPLETED|Overall Study||16
9040205|NCT03349099|10101117|FG000|STARTED|Overall Study||48
9040206|NCT03349099|10101118|FG001|STARTED|Overall Study||47
9040207|NCT03349099|10101117|FG000|COMPLETED|Overall Study||44
9040208|NCT03349099|10101118|FG001|COMPLETED|Overall Study||43
9040209|NCT03349099|10101117|FG000|NOT COMPLETED|Overall Study||4
9040210|NCT03349099|10101118|FG001|NOT COMPLETED|Overall Study||4
9040211|NCT03349333|10101124|FG000|STARTED|Overall Study||71
9040212|NCT03349333|10101124|FG000|COMPLETED|Overall Study||0
9040213|NCT03349333|10101124|FG000|NOT COMPLETED|Overall Study||71
9040214|NCT03349437|10101128|FG000|STARTED|Screening||25
9040215|NCT03349437|10101129|FG001|STARTED|Screening||0
9040216|NCT03349437|10101130|FG002|STARTED|Screening||0
9040217|NCT03349437|10101128|FG000|COMPLETED|Screening||20
9040218|NCT03349437|10101129|FG001|COMPLETED|Screening||0
9040219|NCT03349437|10101130|FG002|COMPLETED|Screening||0
9040220|NCT03349437|10101128|FG000|NOT COMPLETED|Screening||5
9040221|NCT03349437|10101129|FG001|NOT COMPLETED|Screening||0
9040222|NCT03349437|10101130|FG002|NOT COMPLETED|Screening||0
9040223|NCT03349437|10101128|FG000|STARTED|Intervention||0
9040224|NCT03349437|10101129|FG001|STARTED|Intervention||10
9040225|NCT03349437|10101130|FG002|STARTED|Intervention||10
9040226|NCT03349437|10101128|FG000|COMPLETED|Intervention||0
9040227|NCT03349437|10101129|FG001|COMPLETED|Intervention||10
9040228|NCT03349437|10101130|FG002|COMPLETED|Intervention||10
9040229|NCT03349437|10101128|FG000|NOT COMPLETED|Intervention||0
9040230|NCT03349437|10101129|FG001|NOT COMPLETED|Intervention||0
9040231|NCT03349437|10101130|FG002|NOT COMPLETED|Intervention||0
9040232|NCT03349515|10101139|FG000|STARTED|Overall Study||55
9040233|NCT03349515|10101140|FG001|STARTED|Overall Study||51
9040234|NCT03349515|10101139|FG000|COMPLETED|Overall Study||50
9040235|NCT03349515|10101140|FG001|COMPLETED|Overall Study||50
9040236|NCT03349515|10101139|FG000|NOT COMPLETED|Overall Study||5
9040237|NCT03349515|10101140|FG001|NOT COMPLETED|Overall Study||1
9040238|NCT03349567|10101150|FG000|STARTED|Overall Study||2
9040239|NCT03349567|10101151|FG001|STARTED|Overall Study||2
9040240|NCT03349567|10101150|FG000|COMPLETED|Overall Study||2
9040241|NCT03349567|10101151|FG001|COMPLETED|Overall Study||2
9040242|NCT03349567|10101150|FG000|NOT COMPLETED|Overall Study||0
9040243|NCT03349567|10101151|FG001|NOT COMPLETED|Overall Study||0
9040244|NCT03349632|10101159|FG000|STARTED|Period 1, First Week of Wear||11
9040245|NCT03349632|10101160|FG001|STARTED|Period 1, First Week of Wear||11
9040246|NCT03349632|10101161|FG002|STARTED|Period 1, First Week of Wear||11
9040247|NCT03349632|10101162|FG003|STARTED|Period 1, First Week of Wear||11
9040248|NCT03349632|10101163|FG004|STARTED|Period 1, First Week of Wear||11
9040249|NCT03349632|10101164|FG005|STARTED|Period 1, First Week of Wear||11
9040250|NCT03349632|10101159|FG000|COMPLETED|Period 1, First Week of Wear||11
9040251|NCT03349632|10101160|FG001|COMPLETED|Period 1, First Week of Wear||11
9040252|NCT03349632|10101161|FG002|COMPLETED|Period 1, First Week of Wear||11
9040253|NCT03349632|10101162|FG003|COMPLETED|Period 1, First Week of Wear||11
9040254|NCT03349632|10101163|FG004|COMPLETED|Period 1, First Week of Wear||11
9040255|NCT03349632|10101164|FG005|COMPLETED|Period 1, First Week of Wear||11
9040256|NCT03349632|10101159|FG000|NOT COMPLETED|Period 1, First Week of Wear||0
9040257|NCT03349632|10101160|FG001|NOT COMPLETED|Period 1, First Week of Wear||0
9040258|NCT03349632|10101161|FG002|NOT COMPLETED|Period 1, First Week of Wear||0
9040259|NCT03349632|10101162|FG003|NOT COMPLETED|Period 1, First Week of Wear||0
9040260|NCT03349632|10101163|FG004|NOT COMPLETED|Period 1, First Week of Wear||0
9040261|NCT03349632|10101164|FG005|NOT COMPLETED|Period 1, First Week of Wear||0
9040262|NCT03349632|10101159|FG000|STARTED|Period 2, Second Week of Wear||11
9040263|NCT03349632|10101160|FG001|STARTED|Period 2, Second Week of Wear||11
9040264|NCT03349632|10101161|FG002|STARTED|Period 2, Second Week of Wear||11
9040265|NCT03349632|10101162|FG003|STARTED|Period 2, Second Week of Wear||11
9040266|NCT03349632|10101163|FG004|STARTED|Period 2, Second Week of Wear||11
9040267|NCT03349632|10101164|FG005|STARTED|Period 2, Second Week of Wear||11
9040268|NCT03349632|10101159|FG000|COMPLETED|Period 2, Second Week of Wear||11
9040269|NCT03349632|10101160|FG001|COMPLETED|Period 2, Second Week of Wear||11
9040270|NCT03349632|10101161|FG002|COMPLETED|Period 2, Second Week of Wear||11
9040271|NCT03349632|10101162|FG003|COMPLETED|Period 2, Second Week of Wear||11
9040272|NCT03349632|10101163|FG004|COMPLETED|Period 2, Second Week of Wear||11
9040273|NCT03349632|10101164|FG005|COMPLETED|Period 2, Second Week of Wear||11
9040274|NCT03349632|10101159|FG000|NOT COMPLETED|Period 2, Second Week of Wear||0
9040275|NCT03349632|10101160|FG001|NOT COMPLETED|Period 2, Second Week of Wear||0
9040276|NCT03349632|10101161|FG002|NOT COMPLETED|Period 2, Second Week of Wear||0
9040277|NCT03349632|10101162|FG003|NOT COMPLETED|Period 2, Second Week of Wear||0
9040278|NCT03349632|10101163|FG004|NOT COMPLETED|Period 2, Second Week of Wear||0
9040279|NCT03349632|10101164|FG005|NOT COMPLETED|Period 2, Second Week of Wear||0
9040280|NCT03349710|10101182|FG000|STARTED|Randomized||12
9040281|NCT03349710|10101183|FG001|STARTED|Randomized||10
9040282|NCT03349710|10101184|FG002|STARTED|Randomized||27
9040283|NCT03349710|10101185|FG003|STARTED|Randomized||25
9040284|NCT03349710|10101182|FG000|COMPLETED|Randomized||12
9040285|NCT03349710|10101183|FG001|COMPLETED|Randomized||10
9040286|NCT03349710|10101184|FG002|COMPLETED|Randomized||27
9040287|NCT03349710|10101185|FG003|COMPLETED|Randomized||24
9040288|NCT03349710|10101182|FG000|NOT COMPLETED|Randomized||0
9040289|NCT03349710|10101183|FG001|NOT COMPLETED|Randomized||0
9040290|NCT03349710|10101184|FG002|NOT COMPLETED|Randomized||0
9040291|NCT03349710|10101185|FG003|NOT COMPLETED|Randomized||1
9040292|NCT03349710|10101182|FG000|STARTED|Treatment Period||12
9040293|NCT03349710|10101183|FG001|STARTED|Treatment Period||10
9040294|NCT03349710|10101184|FG002|STARTED|Treatment Period||27
8578539|NCT00175019|9611624|FG000|STARTED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|606
8578540|NCT00175019|9611625|FG001|STARTED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|388
8578541|NCT00175019|9611626|FG002|STARTED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|92
8578542|NCT00175019|9611624|FG000|COMPLETED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|412
8578543|NCT00175019|9611625|FG001|COMPLETED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|217
8578544|NCT00175019|9611626|FG002|COMPLETED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|35
8578545|NCT00175019|9611624|FG000|NOT COMPLETED|Overall Study||194
8578546|NCT00175019|9611625|FG001|NOT COMPLETED|Overall Study||171
8578547|NCT00175019|9611626|FG002|NOT COMPLETED|Overall Study||57
8578548|NCT00175825|9611638|FG000|STARTED|Overall Study||54
8578549|NCT00175825|9611639|FG001|STARTED|Overall Study||50
8578550|NCT00175825|9611640|FG002|STARTED|Overall Study||52
9040295|NCT03349710|10101185|FG003|STARTED|Treatment Period||24
9040296|NCT03349710|10101182|FG000|COMPLETED|Treatment Period||0
9040297|NCT03349710|10101183|FG001|COMPLETED|Treatment Period||0
9040298|NCT03349710|10101184|FG002|COMPLETED|Treatment Period||0
8578551|NCT00175825|9611641|FG003|STARTED|Overall Study||52
8578552|NCT00175825|9611638|FG000|COMPLETED|Overall Study||49
8578553|NCT00175825|9611639|FG001|COMPLETED|Overall Study||46
8578554|NCT00175825|9611640|FG002|COMPLETED|Overall Study||51
8578555|NCT00175825|9611641|FG003|COMPLETED|Overall Study||51
8578556|NCT00175825|9611638|FG000|NOT COMPLETED|Overall Study||5
8578557|NCT00175825|9611639|FG001|NOT COMPLETED|Overall Study||4
8578558|NCT00175825|9611640|FG002|NOT COMPLETED|Overall Study||1
8578559|NCT00175825|9611641|FG003|NOT COMPLETED|Overall Study||1
8578560|NCT00175877|9611651|FG000|STARTED|Overall Study||846
8578561|NCT00175877|9611651|FG000|COMPLETED|Overall Study||497
8578562|NCT00175877|9611651|FG000|NOT COMPLETED|Overall Study||349
8578563|NCT00175916|9611655|FG000|STARTED|Overall Study||853
8578564|NCT00175916|9611655|FG000|COMPLETED|Overall Study||234
8578565|NCT00175916|9611655|FG000|NOT COMPLETED|Overall Study||619
8578566|NCT00176202|9611662|FG000|STARTED|Overall Study||32
8578567|NCT00176202|9611663|FG001|STARTED|Overall Study||33
8578568|NCT00176202|9611662|FG000|COMPLETED|Overall Study||27
8578569|NCT00176202|9611663|FG001|COMPLETED|Overall Study||17
8578570|NCT00176202|9611662|FG000|NOT COMPLETED|Overall Study||5
8578571|NCT00176202|9611663|FG001|NOT COMPLETED|Overall Study||16
8578572|NCT00176228|9611671|FG000|STARTED|Overall Study|When study began|48
8578573|NCT00176228|9611671|FG000|COMPLETED|Overall Study|Study ended|46
8578574|NCT00176228|9611671|FG000|NOT COMPLETED|Overall Study||2
8578575|NCT00176254|9611676|FG000|STARTED|Overall Study||40
8578576|NCT00176254|9611676|FG000|COMPLETED|Overall Study|1 patient only received 1 cycle and refused further induction, another progressed in neck nodes|39
8578577|NCT00176254|9611676|FG000|NOT COMPLETED|Overall Study||1
8578578|NCT00176306|9611680|FG000|STARTED|Overall Study||15
8578579|NCT00176306|9611680|FG000|COMPLETED|Overall Study||15
8578580|NCT00176306|9611680|FG000|NOT COMPLETED|Overall Study||0
8578581|NCT00176423|9611686|FG000|STARTED|Overall Study||42
8578582|NCT00176423|9611687|FG001|STARTED|Overall Study||44
8578583|NCT00176423|9611686|FG000|COMPLETED|Overall Study||35
8578584|NCT00176423|9611687|FG001|COMPLETED|Overall Study||38
8578585|NCT00176423|9611686|FG000|NOT COMPLETED|Overall Study||7
8578586|NCT00176423|9611687|FG001|NOT COMPLETED|Overall Study||6
8578587|NCT00176462|9611695|FG000|STARTED|Induction (4 Weeks)||21
8578588|NCT00176462|9611696|FG001|STARTED|Induction (4 Weeks)||39
8578589|NCT00176462|9611695|FG000|COMPLETED|Induction (4 Weeks)||20
8578590|NCT00176462|9611696|FG001|COMPLETED|Induction (4 Weeks)||34
8578591|NCT00176462|9611695|FG000|NOT COMPLETED|Induction (4 Weeks)||1
9040299|NCT03349710|10101185|FG003|COMPLETED|Treatment Period||0
8578592|NCT00176462|9611696|FG001|NOT COMPLETED|Induction (4 Weeks)||5
8578593|NCT00176462|9611695|FG000|STARTED|Consolidation (12 Weeks)||20
9040300|NCT03349710|10101182|FG000|NOT COMPLETED|Treatment Period||12
9040301|NCT03349710|10101183|FG001|NOT COMPLETED|Treatment Period||10
9040302|NCT03349710|10101184|FG002|NOT COMPLETED|Treatment Period||27
8578594|NCT00176462|9611696|FG001|STARTED|Consolidation (12 Weeks)||34
8578595|NCT00176462|9611695|FG000|COMPLETED|Consolidation (12 Weeks)||20
8578596|NCT00176462|9611696|FG001|COMPLETED|Consolidation (12 Weeks)||29
8578597|NCT00176462|9611695|FG000|NOT COMPLETED|Consolidation (12 Weeks)||0
8578598|NCT00176462|9611696|FG001|NOT COMPLETED|Consolidation (12 Weeks)||5
8578599|NCT00176462|9611695|FG000|STARTED|Delayed Intensification (8 Weeks)||20
8578600|NCT00176462|9611696|FG001|STARTED|Delayed Intensification (8 Weeks)||29
8578601|NCT00176462|9611695|FG000|COMPLETED|Delayed Intensification (8 Weeks)||20
8578602|NCT00176462|9611696|FG001|COMPLETED|Delayed Intensification (8 Weeks)||29
8578603|NCT00176462|9611695|FG000|NOT COMPLETED|Delayed Intensification (8 Weeks)||0
8578604|NCT00176462|9611696|FG001|NOT COMPLETED|Delayed Intensification (8 Weeks)||0
8578605|NCT00176462|9611695|FG000|STARTED|Intensive Continuation (8X8-week Cycles)||20
8578606|NCT00176462|9611696|FG001|STARTED|Intensive Continuation (8X8-week Cycles)||29
8578607|NCT00176462|9611695|FG000|COMPLETED|Intensive Continuation (8X8-week Cycles)||19
8578608|NCT00176462|9611696|FG001|COMPLETED|Intensive Continuation (8X8-week Cycles)||26
8578609|NCT00176462|9611695|FG000|NOT COMPLETED|Intensive Continuation (8X8-week Cycles)||1
8578610|NCT00176462|9611696|FG001|NOT COMPLETED|Intensive Continuation (8X8-week Cycles)||3
8578611|NCT00176462|9611695|FG000|STARTED|Continuation -up to 30mos Post Remission||19
8578612|NCT00176462|9611696|FG001|STARTED|Continuation -up to 30mos Post Remission||26
8578613|NCT00176462|9611695|FG000|COMPLETED|Continuation -up to 30mos Post Remission||19
8578614|NCT00176462|9611696|FG001|COMPLETED|Continuation -up to 30mos Post Remission||26
8578615|NCT00176462|9611695|FG000|NOT COMPLETED|Continuation -up to 30mos Post Remission||0
8578616|NCT00176462|9611696|FG001|NOT COMPLETED|Continuation -up to 30mos Post Remission||0
8578617|NCT00176592|9611705|FG000|STARTED|Overall Study||36
8578618|NCT00176592|9611706|FG001|STARTED|Overall Study||39
8578619|NCT00176592|9611705|FG000|Followed for 1 Year|Overall Study||35
8578620|NCT00176592|9611706|FG001|Followed for 1 Year|Overall Study||35
8578621|NCT00176592|9611705|FG000|Followed for 2 Years|Overall Study||29
8578622|NCT00176592|9611706|FG001|Followed for 2 Years|Overall Study||35
8578623|NCT00176592|9611705|FG000|COMPLETED|Overall Study||36
8578624|NCT00176592|9611706|FG001|COMPLETED|Overall Study||39
8578625|NCT00176592|9611705|FG000|NOT COMPLETED|Overall Study||0
8578626|NCT00176592|9611706|FG001|NOT COMPLETED|Overall Study||0
8578627|NCT00176605|9611712|FG000|STARTED|Overall Study||15
8578628|NCT00176605|9611712|FG000|COMPLETED|Overall Study||13
8578629|NCT00176605|9611712|FG000|NOT COMPLETED|Overall Study||2
8578630|NCT00176644|9611716|FG000|STARTED|Overall Study||23
8578631|NCT00176644|9611716|FG000|COMPLETED|Overall Study||22
8578632|NCT00176644|9611716|FG000|NOT COMPLETED|Overall Study||1
8578633|NCT00176800|9611720|FG000|STARTED|Overall Study||69
8578634|NCT00176800|9611720|FG000|COMPLETED|Overall Study||69
8578635|NCT00176800|9611720|FG000|NOT COMPLETED|Overall Study||0
8578636|NCT00176826|9611724|FG000|STARTED|Overall Study||22
8578637|NCT00176826|9611724|FG000|COMPLETED|Overall Study||22
8578638|NCT00176826|9611724|FG000|NOT COMPLETED|Overall Study||0
8578639|NCT00176839|9611728|FG000|STARTED|Overall Study||11
8578640|NCT00176839|9611728|FG000|COMPLETED|Overall Study||11
8578641|NCT00176839|9611728|FG000|NOT COMPLETED|Overall Study||0
8578642|NCT00176852|9611735|FG000|STARTED|Overall Study||3
8578643|NCT00176852|9611736|FG001|STARTED|Overall Study||5
8578644|NCT00176852|9611737|FG002|STARTED|Overall Study||14
8578645|NCT00176852|9611735|FG000|COMPLETED|Overall Study||3
8578646|NCT00176852|9611736|FG001|COMPLETED|Overall Study||5
8578647|NCT00176852|9611737|FG002|COMPLETED|Overall Study||14
8578648|NCT00176852|9611735|FG000|NOT COMPLETED|Overall Study||0
8578649|NCT00176852|9611736|FG001|NOT COMPLETED|Overall Study||0
8578650|NCT00176852|9611737|FG002|NOT COMPLETED|Overall Study||0
8578651|NCT00176865|9611748|FG000|STARTED|Overall Study||3
8578652|NCT00176865|9611749|FG001|STARTED|Overall Study||10
8578653|NCT00176865|9611750|FG002|STARTED|Overall Study||6
8578654|NCT00176865|9611748|FG000|COMPLETED|Overall Study||3
8578655|NCT00176865|9611749|FG001|COMPLETED|Overall Study||10
8578656|NCT00176865|9611750|FG002|COMPLETED|Overall Study||6
8578657|NCT00176865|9611748|FG000|NOT COMPLETED|Overall Study||0
8578658|NCT00176865|9611749|FG001|NOT COMPLETED|Overall Study||0
8578659|NCT00176865|9611750|FG002|NOT COMPLETED|Overall Study||0
8578660|NCT00176878|9611758|FG000|STARTED|Overall Study||10
8578661|NCT00176878|9611758|FG000|COMPLETED|Overall Study||10
8578662|NCT00176878|9611758|FG000|NOT COMPLETED|Overall Study||0
8578663|NCT00176891|9611762|FG000|STARTED|Overall Study||25
8578664|NCT00176891|9611762|FG000|COMPLETED|Overall Study||22
8578665|NCT00176891|9611762|FG000|NOT COMPLETED|Overall Study||3
8578666|NCT00176904|9611766|FG000|STARTED|Overall Study||135
8578667|NCT00176904|9611766|FG000|COMPLETED|Overall Study||135
8578668|NCT00176904|9611766|FG000|NOT COMPLETED|Overall Study||0
8578669|NCT00176917|9611770|FG000|STARTED|Overall Study||41
8578670|NCT00176917|9611770|FG000|COMPLETED|Overall Study||41
8578671|NCT00176917|9611770|FG000|NOT COMPLETED|Overall Study||0
8578672|NCT00176930|9611782|FG000|STARTED|Overall Study||12
8578673|NCT00176930|9611783|FG001|STARTED|Overall Study||13
8578674|NCT00176930|9611784|FG002|STARTED|Overall Study||1
8578675|NCT00176930|9611785|FG003|STARTED|Overall Study||1
8578676|NCT00176930|9611786|FG004|STARTED|Overall Study||213
8578677|NCT00176930|9611787|FG005|STARTED|Overall Study||85
8578678|NCT00176930|9611788|FG006|STARTED|Overall Study||2
8578679|NCT00176930|9611789|FG007|STARTED|Overall Study||2
8578680|NCT00176930|9611782|FG000|COMPLETED|Overall Study||12
8578681|NCT00176930|9611783|FG001|COMPLETED|Overall Study||13
8578682|NCT00176930|9611784|FG002|COMPLETED|Overall Study||1
8578683|NCT00176930|9611785|FG003|COMPLETED|Overall Study||1
8578684|NCT00176930|9611786|FG004|COMPLETED|Overall Study||213
8578685|NCT00176930|9611787|FG005|COMPLETED|Overall Study||85
8578686|NCT00176930|9611788|FG006|COMPLETED|Overall Study||2
8578687|NCT00176930|9611789|FG007|COMPLETED|Overall Study||2
8578688|NCT00176930|9611782|FG000|NOT COMPLETED|Overall Study||0
8578689|NCT00176930|9611783|FG001|NOT COMPLETED|Overall Study||0
8578690|NCT00176930|9611784|FG002|NOT COMPLETED|Overall Study||0
8578691|NCT00176930|9611785|FG003|NOT COMPLETED|Overall Study||0
8578692|NCT00176930|9611786|FG004|NOT COMPLETED|Overall Study||0
8578693|NCT00176930|9611787|FG005|NOT COMPLETED|Overall Study||0
8694277|NCT00870870|9739737|FG000|STARTED|Overall Study||4
8694278|NCT00870870|9739738|FG001|STARTED|Overall Study||6
8694279|NCT00870870|9739739|FG002|STARTED|Overall Study||29
8694280|NCT00870870|9739740|FG003|STARTED|Overall Study||25
8694281|NCT00870870|9739737|FG000|COMPLETED|Overall Study||4
8694282|NCT00870870|9739738|FG001|COMPLETED|Overall Study||5
8694283|NCT00870870|9739739|FG002|COMPLETED|Overall Study||26
8694284|NCT00870870|9739740|FG003|COMPLETED|Overall Study||20
8694285|NCT00870870|9739737|FG000|NOT COMPLETED|Overall Study||0
8694286|NCT00870870|9739738|FG001|NOT COMPLETED|Overall Study||1
8924482|NCT02248974|9985262|FG001|STARTED|1-Month Follow-Up||34
8924483|NCT02248974|9985261|FG000|COMPLETED|1-Month Follow-Up||27
8924484|NCT02248974|9985262|FG001|COMPLETED|1-Month Follow-Up||31
8924485|NCT02248974|9985261|FG000|NOT COMPLETED|1-Month Follow-Up||2
8924486|NCT02248974|9985262|FG001|NOT COMPLETED|1-Month Follow-Up||3
8924487|NCT02249052|9985268|FG000|STARTED|Overall Study||19
8924488|NCT02249052|9985268|FG000|COMPLETED|Overall Study||19
8924489|NCT02249052|9985268|FG000|NOT COMPLETED|Overall Study||0
8924490|NCT02249065|9985276|FG000|STARTED|Overall Study||205
8924491|NCT02249065|9985276|FG000|Treated|Overall Study||181
8924492|NCT02249065|9985276|FG000|COMPLETED|Overall Study||176
8924493|NCT02249065|9985276|FG000|NOT COMPLETED|Overall Study||29
8924494|NCT02249091|9985282|FG000|STARTED|Overall Study||27
8924495|NCT02249091|9985283|FG001|STARTED|Overall Study||15
8924496|NCT02249091|9985282|FG000|COMPLETED|Overall Study||7
8924497|NCT02249091|9985283|FG001|COMPLETED|Overall Study||2
8924498|NCT02249091|9985282|FG000|NOT COMPLETED|Overall Study||20
8924499|NCT02249091|9985283|FG001|NOT COMPLETED|Overall Study||13
8924500|NCT02249104|9985289|FG000|STARTED|Overall Study||28
8924501|NCT02249104|9985289|FG000|COMPLETED|Overall Study||25
8924502|NCT02249104|9985289|FG000|NOT COMPLETED|Overall Study||3
8924503|NCT02249143|9985295|FG000|STARTED|Overall Study||24
8924504|NCT02249143|9985296|FG001|STARTED|Overall Study|randomized|26
8924505|NCT02249143|9985295|FG000|COMPLETED|Overall Study|with technically acceptable pulmonary function tests in the neonatal intensive care unit|22
8924506|NCT02249143|9985296|FG001|COMPLETED|Overall Study|with technically acceptable pulmonary function tests in the neonatal intensive care unit|22
8924507|NCT02249143|9985295|FG000|NOT COMPLETED|Overall Study||2
8924508|NCT02249143|9985296|FG001|NOT COMPLETED|Overall Study||4
8924509|NCT02249182|9985307|FG000|STARTED|PK Lead-In Phase||10
8924510|NCT02249182|9985308|FG001|STARTED|PK Lead-In Phase||12
8924511|NCT02249182|9985309|FG002|STARTED|PK Lead-In Phase||0
8924512|NCT02249182|9985310|FG003|STARTED|PK Lead-In Phase||0
8924513|NCT02249182|9985311|FG004|STARTED|PK Lead-In Phase||17
8924514|NCT02249182|9985307|FG000|COMPLETED|PK Lead-In Phase||10
8924515|NCT02249182|9985308|FG001|COMPLETED|PK Lead-In Phase||12
8924516|NCT02249182|9985309|FG002|COMPLETED|PK Lead-In Phase||0
8924517|NCT02249182|9985310|FG003|COMPLETED|PK Lead-In Phase||0
8924518|NCT02249182|9985311|FG004|COMPLETED|PK Lead-In Phase||17
8924519|NCT02249182|9985307|FG000|NOT COMPLETED|PK Lead-In Phase||0
8924520|NCT02249182|9985308|FG001|NOT COMPLETED|PK Lead-In Phase||0
8924521|NCT02249182|9985309|FG002|NOT COMPLETED|PK Lead-In Phase||0
8924522|NCT02249182|9985310|FG003|NOT COMPLETED|PK Lead-In Phase||0
8694287|NCT00870870|9739739|FG002|NOT COMPLETED|Overall Study||3
8694288|NCT00870870|9739740|FG003|NOT COMPLETED|Overall Study||5
8694289|NCT00870896|9739755|FG000|STARTED|Overall Study||5
8694290|NCT00870896|9739755|FG000|COMPLETED|Overall Study||5
8694291|NCT00870896|9739755|FG000|NOT COMPLETED|Overall Study||0
8694292|NCT00871000|9739763|FG000|STARTED|Overall Study||151
8694293|NCT00871000|9739764|FG001|STARTED|Overall Study||152
8694294|NCT00871000|9739763|FG000|COMPLETED|Overall Study||150
8694295|NCT00871000|9739764|FG001|COMPLETED|Overall Study||152
8694296|NCT00871000|9739763|FG000|NOT COMPLETED|Overall Study||1
8694297|NCT00871000|9739764|FG001|NOT COMPLETED|Overall Study||0
8694298|NCT00871117|9739772|FG000|STARTED|Overall Study||239
8694299|NCT00871117|9739773|FG001|STARTED|Overall Study||237
8924523|NCT02249182|9985311|FG004|NOT COMPLETED|PK Lead-In Phase||0
8924524|NCT02249182|9985307|FG000|STARTED|Treatment Phase|90 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|100
8924525|NCT02249182|9985308|FG001|STARTED|Treatment Phase|77 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|89
8924526|NCT02249182|9985309|FG002|STARTED|Treatment Phase|1 participant enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|1
8924527|NCT02249182|9985310|FG003|STARTED|Treatment Phase|2 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|2
8948165|NCT02427737|10010506|FG001|COMPLETED|OSU Baseline Q4FY15||3230
8578694|NCT00176930|9611788|FG006|NOT COMPLETED|Overall Study||0
8578695|NCT00176930|9611789|FG007|NOT COMPLETED|Overall Study||0
8578696|NCT00177047|9611807|FG000|STARTED|Overall Study||363
8694300|NCT00871117|9739772|FG000|COMPLETED|Overall Study||234
8694301|NCT00871117|9739773|FG001|COMPLETED|Overall Study||227
8694302|NCT00871117|9739772|FG000|NOT COMPLETED|Overall Study||5
8694303|NCT00871117|9739773|FG001|NOT COMPLETED|Overall Study||10
8694304|NCT00871143|9739782|FG000|STARTED|Overall Study||21
8694305|NCT00871143|9739783|FG001|STARTED|Overall Study||25
8694306|NCT00871143|9739782|FG000|COMPLETED|Overall Study||21
8694307|NCT00871143|9739783|FG001|COMPLETED|Overall Study||25
8694308|NCT00871143|9739782|FG000|NOT COMPLETED|Overall Study||0
8694309|NCT00871143|9739783|FG001|NOT COMPLETED|Overall Study||0
8924528|NCT02249182|9985311|FG004|STARTED|Treatment Phase|17 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|34
8924529|NCT02249182|9985307|FG000|COMPLETED|Treatment Phase||96
8924530|NCT02249182|9985308|FG001|COMPLETED|Treatment Phase||89
8924531|NCT02249182|9985309|FG002|COMPLETED|Treatment Phase||1
8924532|NCT02249182|9985310|FG003|COMPLETED|Treatment Phase||2
8924533|NCT02249182|9985311|FG004|COMPLETED|Treatment Phase||34
8924534|NCT02249182|9985307|FG000|NOT COMPLETED|Treatment Phase||4
8924535|NCT02249182|9985308|FG001|NOT COMPLETED|Treatment Phase||0
8924536|NCT02249182|9985309|FG002|NOT COMPLETED|Treatment Phase||0
9040303|NCT03349710|10101185|FG003|NOT COMPLETED|Treatment Period||24
9040304|NCT03349892|10101195|FG000|STARTED|Overall Study||1
9040305|NCT03349892|10101195|FG000|COMPLETED|Overall Study||1
9040306|NCT03349892|10101195|FG000|NOT COMPLETED|Overall Study||0
9040307|NCT03350217|10101201|FG000|STARTED|Overall Study||79
9040308|NCT03350217|10101202|FG001|STARTED|Overall Study||81
9040309|NCT03350217|10101201|FG000|COMPLETED|Overall Study||77
9040310|NCT03350217|10101202|FG001|COMPLETED|Overall Study||81
9040311|NCT03350217|10101201|FG000|NOT COMPLETED|Overall Study||2
9040312|NCT03350217|10101202|FG001|NOT COMPLETED|Overall Study||0
9040313|NCT03350256|10101208|FG000|STARTED|Overall Study||60
9040314|NCT03350256|10101208|FG000|Spinal Cord Stimulation Trial|Overall Study|Subject that underwent SCS trial|50
9040315|NCT03350256|10101208|FG000|Permanent Implant|Overall Study|subjects that underwent permanent SCS implant|35
9040316|NCT03350256|10101208|FG000|1 Month Follow up|Overall Study||30
9040317|NCT03350256|10101208|FG000|3 Month Follow up|Overall Study||27
9040318|NCT03350256|10101208|FG000|6 Month Follow up|Overall Study||24
9040319|NCT03350256|10101208|FG000|COMPLETED|Overall Study||24
9040320|NCT03350256|10101208|FG000|NOT COMPLETED|Overall Study||36
9040321|NCT03350542|10101212|FG000|STARTED|Overall Study||100
9040322|NCT03350542|10101212|FG000|Completed 12-Month Clinical F/U|Overall Study||96
9040323|NCT03350542|10101212|FG000|Death With no 12-month F/U|Overall Study||4
9040324|NCT03350542|10101212|FG000|COMPLETED|Overall Study||96
9040325|NCT03350542|10101212|FG000|NOT COMPLETED|Overall Study||4
9040326|NCT03350672|10101219|FG000|STARTED|Overall Study||17
9040327|NCT03350672|10101220|FG001|STARTED|Overall Study||10
9040328|NCT03350672|10101221|FG002|STARTED|Overall Study||10
9040329|NCT03350672|10101219|FG000|COMPLETED|Overall Study||10
9040330|NCT03350672|10101220|FG001|COMPLETED|Overall Study||10
9040331|NCT03350672|10101221|FG002|COMPLETED|Overall Study||10
9040332|NCT03350672|10101219|FG000|NOT COMPLETED|Overall Study||7
9040333|NCT03350672|10101220|FG001|NOT COMPLETED|Overall Study||0
9040334|NCT03350672|10101221|FG002|NOT COMPLETED|Overall Study||0
9040335|NCT03350724|10101231|FG000|STARTED|Overall Study||17
9040336|NCT03350724|10101232|FG001|STARTED|Overall Study||17
9040337|NCT03350724|10101231|FG000|COMPLETED|Overall Study||17
9040338|NCT03350724|10101232|FG001|COMPLETED|Overall Study||17
9040339|NCT03350724|10101231|FG000|NOT COMPLETED|Overall Study||0
9040340|NCT03350724|10101232|FG001|NOT COMPLETED|Overall Study||0
9040341|NCT03350919|10101240|FG000|STARTED|Overall Study||25
9040342|NCT03350919|10101241|FG001|STARTED|Overall Study||23
9040343|NCT03350919|10101240|FG000|COMPLETED|Overall Study||23
9040344|NCT03350919|10101241|FG001|COMPLETED|Overall Study||23
9040345|NCT03350919|10101240|FG000|NOT COMPLETED|Overall Study||2
9040346|NCT03350919|10101241|FG001|NOT COMPLETED|Overall Study||0
9040347|NCT03351101|10101251|FG000|STARTED|Overall Study||136
9040348|NCT03351101|10101252|FG001|STARTED|Overall Study||132
9040349|NCT03351101|10101251|FG000|COMPLETED|Overall Study||135
9040350|NCT03351101|10101252|FG001|COMPLETED|Overall Study||129
9040351|NCT03351101|10101251|FG000|NOT COMPLETED|Overall Study||1
9040352|NCT03351101|10101252|FG001|NOT COMPLETED|Overall Study||3
9040353|NCT03351114|10101258|FG000|STARTED|Overall Study||8
9040354|NCT03351114|10101258|FG000|COMPLETED|Overall Study||7
9040355|NCT03351114|10101258|FG000|NOT COMPLETED|Overall Study||1
9040356|NCT03351231|10101262|FG000|STARTED|Combination Therapy Period|Started = initiated and completed monotherapy, then initiated combination therapy|5
9040357|NCT03351231|10101262|FG000|COMPLETED|Combination Therapy Period|Completed = finished combination therapy|0
9040358|NCT03351231|10101262|FG000|NOT COMPLETED|Combination Therapy Period||5
9040359|NCT03351231|10101262|FG000|STARTED|Safety Follow-Up Period|Started = Initiated Safety Follow-up|3
9040360|NCT03351231|10101262|FG000|COMPLETED|Safety Follow-Up Period|Completed = Finishing safety follow-up and continuing in study|0
9040361|NCT03351231|10101262|FG000|NOT COMPLETED|Safety Follow-Up Period||3
9040362|NCT03351335|10101269|FG000|STARTED|Overall Study||21
9040363|NCT03351335|10101270|FG001|STARTED|Overall Study||19
9040364|NCT03351335|10101271|FG002|STARTED|Overall Study||20
9040365|NCT03351335|10101269|FG000|COMPLETED|Overall Study||21
9040366|NCT03351335|10101270|FG001|COMPLETED|Overall Study||19
9040367|NCT03351335|10101271|FG002|COMPLETED|Overall Study||16
9040368|NCT03351335|10101269|FG000|NOT COMPLETED|Overall Study||0
8694310|NCT00871169|9739789|FG000|STARTED|Overall Study||61
8694311|NCT00871169|9739789|FG000|COMPLETED|Overall Study||58
8694312|NCT00871169|9739789|FG000|NOT COMPLETED|Overall Study||3
8694313|NCT00871234|9739793|FG000|STARTED|Overall Study||28
8694314|NCT00871234|9739793|FG000|COMPLETED|Overall Study||23
8694315|NCT00871234|9739793|FG000|NOT COMPLETED|Overall Study||5
8694316|NCT00871260|9739797|FG000|STARTED|Overall Study||20
8694317|NCT00871260|9739797|FG000|COMPLETED|Overall Study||20
8694318|NCT00871260|9739797|FG000|NOT COMPLETED|Overall Study||0
8694319|NCT00871286|9739803|FG000|STARTED|Overall Study||20
8694320|NCT00871286|9739804|FG001|STARTED|Overall Study||20
8924537|NCT02249182|9985310|FG003|NOT COMPLETED|Treatment Phase||0
8924538|NCT02249182|9985311|FG004|NOT COMPLETED|Treatment Phase||0
8924539|NCT02249585|9985339|FG000|STARTED|Overall Study||43
8924540|NCT02249585|9985340|FG001|STARTED|Overall Study||44
8924541|NCT02249585|9985341|FG002|STARTED|Overall Study||44
8924542|NCT02249585|9985339|FG000|COMPLETED|Overall Study||43
8924543|NCT02249585|9985340|FG001|COMPLETED|Overall Study||44
8924544|NCT02249585|9985341|FG002|COMPLETED|Overall Study||44
8924545|NCT02249585|9985339|FG000|NOT COMPLETED|Overall Study||0
8924546|NCT02249585|9985340|FG001|NOT COMPLETED|Overall Study||0
8924547|NCT02249585|9985341|FG002|NOT COMPLETED|Overall Study||0
8924548|NCT02249728|9985349|FG000|STARTED|Part One (4 Days)||6
8924549|NCT02249728|9985349|FG000|COMPLETED|Part One (4 Days)||6
8924550|NCT02249728|9985349|FG000|NOT COMPLETED|Part One (4 Days)||0
8924551|NCT02249728|9985349|FG000|STARTED|Part Two (up to 6 Days)||6
8924552|NCT02249728|9985349|FG000|COMPLETED|Part Two (up to 6 Days)||6
8924553|NCT02249728|9985349|FG000|NOT COMPLETED|Part Two (up to 6 Days)||0
8924554|NCT02249767|9985359|FG000|STARTED|Overall Study||230
8924555|NCT02249767|9985360|FG001|STARTED|Overall Study||229
8924556|NCT02249767|9985361|FG002|STARTED|Overall Study||115
8924557|NCT02249767|9985359|FG000|COMPLETED|Overall Study||222
8924558|NCT02249767|9985360|FG001|COMPLETED|Overall Study||220
8924559|NCT02249767|9985361|FG002|COMPLETED|Overall Study||107
8924560|NCT02249767|9985359|FG000|NOT COMPLETED|Overall Study||8
8924561|NCT02249767|9985360|FG001|NOT COMPLETED|Overall Study||9
8924562|NCT02249767|9985361|FG002|NOT COMPLETED|Overall Study||8
8924563|NCT02249793|9985369|FG000|STARTED|Session 1, 48-hours Healthy Volunteers||6
8924564|NCT02249793|9985369|FG000|COMPLETED|Session 1, 48-hours Healthy Volunteers||6
8924565|NCT02249793|9985369|FG000|NOT COMPLETED|Session 1, 48-hours Healthy Volunteers||0
8924566|NCT02249793|9985369|FG000|STARTED|Session 2, 48-Hours Healthy Volunteers||6
8924567|NCT02249793|9985369|FG000|COMPLETED|Session 2, 48-Hours Healthy Volunteers||6
8924568|NCT02249793|9985369|FG000|NOT COMPLETED|Session 2, 48-Hours Healthy Volunteers||0
8924569|NCT02249819|9985374|FG000|STARTED|Overall Study||8
8924570|NCT02249819|9985375|FG001|STARTED|Overall Study||7
8924571|NCT02249819|9985374|FG000|COMPLETED|Overall Study||8
8924572|NCT02249819|9985375|FG001|COMPLETED|Overall Study||7
8924573|NCT02249819|9985374|FG000|NOT COMPLETED|Overall Study||0
8924574|NCT02249819|9985375|FG001|NOT COMPLETED|Overall Study||0
8924575|NCT02249832|9985381|FG000|STARTED|Overall Study||55
8924576|NCT02249832|9985381|FG000|COMPLETED|Overall Study||42
8924577|NCT02249832|9985381|FG000|NOT COMPLETED|Overall Study||13
8924578|NCT02249949|9985390|FG000|STARTED|Overall Study||13
8924579|NCT02249949|9985390|FG000|COMPLETED|Overall Study||11
8924580|NCT02249949|9985390|FG000|NOT COMPLETED|Overall Study||2
8924581|NCT02250092|9985396|FG000|STARTED|Overall Study||10
8924582|NCT02250092|9985397|FG001|STARTED|Overall Study||10
8924583|NCT02250092|9985396|FG000|COMPLETED|Overall Study||10
8924584|NCT02250092|9985397|FG001|COMPLETED|Overall Study||10
8924585|NCT02250092|9985396|FG000|NOT COMPLETED|Overall Study||0
8924586|NCT02250092|9985397|FG001|NOT COMPLETED|Overall Study||0
8924587|NCT02250183|9985403|FG000|STARTED|Overall Study||21
8924588|NCT02250183|9985403|FG000|COMPLETED|Overall Study||13
8924589|NCT02250183|9985403|FG000|NOT COMPLETED|Overall Study||8
8924590|NCT02250274|9985412|FG000|STARTED|Overall Study||85
8924591|NCT02250274|9985413|FG001|STARTED|Overall Study||46
8924592|NCT02250274|9985412|FG000|COMPLETED|Overall Study||78
8924593|NCT02250274|9985413|FG001|COMPLETED|Overall Study||40
8924594|NCT02250274|9985412|FG000|NOT COMPLETED|Overall Study||7
8924595|NCT02250274|9985413|FG001|NOT COMPLETED|Overall Study||6
8924596|NCT02250417|9985425|FG000|STARTED|First Intervention (1 Night)||6
8924597|NCT02250417|9985426|FG001|STARTED|First Intervention (1 Night)||6
8924598|NCT02250417|9985425|FG000|COMPLETED|First Intervention (1 Night)||6
8924599|NCT02250417|9985426|FG001|COMPLETED|First Intervention (1 Night)||6
8924600|NCT02250417|9985425|FG000|NOT COMPLETED|First Intervention (1 Night)||0
8924601|NCT02250417|9985426|FG001|NOT COMPLETED|First Intervention (1 Night)||0
8924602|NCT02250417|9985425|FG000|STARTED|Second Intervention (1 Night)||6
8924603|NCT02250417|9985426|FG001|STARTED|Second Intervention (1 Night)||6
8924604|NCT02250417|9985425|FG000|COMPLETED|Second Intervention (1 Night)||6
8924605|NCT02250417|9985426|FG001|COMPLETED|Second Intervention (1 Night)||6
8924606|NCT02250417|9985425|FG000|NOT COMPLETED|Second Intervention (1 Night)||0
8694321|NCT00871286|9739803|FG000|COMPLETED|Overall Study||20
8694322|NCT00871286|9739804|FG001|COMPLETED|Overall Study||14
8694323|NCT00871286|9739803|FG000|NOT COMPLETED|Overall Study||0
8694324|NCT00871286|9739804|FG001|NOT COMPLETED|Overall Study||6
8694325|NCT00871338|9739812|FG000|STARTED|Prior to Booster||142
8924607|NCT02250417|9985426|FG001|NOT COMPLETED|Second Intervention (1 Night)||0
8924608|NCT02250443|9985435|FG000|STARTED|Overall Study||10
8924609|NCT02250443|9985435|FG000|COMPLETED|Overall Study||0
8924610|NCT02250443|9985435|FG000|NOT COMPLETED|Overall Study||10
8924611|NCT02250521|9985439|FG000|STARTED|Overall Study||100
8694326|NCT00871338|9739813|FG001|STARTED|Prior to Booster||142
8694327|NCT00871338|9739812|FG000|COMPLETED|Prior to Booster||140
8694328|NCT00871338|9739813|FG001|COMPLETED|Prior to Booster||139
8694329|NCT00871338|9739812|FG000|NOT COMPLETED|Prior to Booster||2
8694330|NCT00871338|9739813|FG001|NOT COMPLETED|Prior to Booster||3
8694331|NCT00871338|9739812|FG000|STARTED|After Booster||139
8694332|NCT00871338|9739813|FG001|STARTED|After Booster||135
8694333|NCT00871338|9739812|FG000|COMPLETED|After Booster||139
8694334|NCT00871338|9739813|FG001|COMPLETED|After Booster||135
8694335|NCT00871338|9739812|FG000|NOT COMPLETED|After Booster||0
8694336|NCT00871338|9739813|FG001|NOT COMPLETED|After Booster||0
8694337|NCT00871377|9739819|FG000|STARTED|First Intervention (10 Weeks)||3
8694338|NCT00871377|9739820|FG001|STARTED|First Intervention (10 Weeks)||4
8694339|NCT00871377|9739821|FG002|STARTED|First Intervention (10 Weeks)||4
8694340|NCT00871377|9739822|FG003|STARTED|First Intervention (10 Weeks)||4
8694341|NCT00871377|9739823|FG004|STARTED|First Intervention (10 Weeks)||4
8694342|NCT00871377|9739824|FG005|STARTED|First Intervention (10 Weeks)||5
8694343|NCT00871377|9739819|FG000|COMPLETED|First Intervention (10 Weeks)||3
8694344|NCT00871377|9739820|FG001|COMPLETED|First Intervention (10 Weeks)||4
8694345|NCT00871377|9739821|FG002|COMPLETED|First Intervention (10 Weeks)||3
8694346|NCT00871377|9739822|FG003|COMPLETED|First Intervention (10 Weeks)||4
8694347|NCT00871377|9739823|FG004|COMPLETED|First Intervention (10 Weeks)||4
8694348|NCT00871377|9739824|FG005|COMPLETED|First Intervention (10 Weeks)||4
8694349|NCT00871377|9739819|FG000|NOT COMPLETED|First Intervention (10 Weeks)||0
8694350|NCT00871377|9739820|FG001|NOT COMPLETED|First Intervention (10 Weeks)||0
8694351|NCT00871377|9739821|FG002|NOT COMPLETED|First Intervention (10 Weeks)||1
8694352|NCT00871377|9739822|FG003|NOT COMPLETED|First Intervention (10 Weeks)||0
8694353|NCT00871377|9739823|FG004|NOT COMPLETED|First Intervention (10 Weeks)||0
8924612|NCT02250521|9985439|FG000|COMPLETED|Overall Study||99
8924613|NCT02250521|9985439|FG000|NOT COMPLETED|Overall Study||1
8924614|NCT02250612|9985448|FG000|STARTED|Overall Study||37
8924615|NCT02250612|9985449|FG001|STARTED|Overall Study||40
8924616|NCT02250612|9985450|FG002|STARTED|Overall Study||37
8924617|NCT02250612|9985451|FG003|STARTED|Overall Study||33
8924618|NCT02250612|9985452|FG004|STARTED|Overall Study||37
8924619|NCT02250612|9985448|FG000|COMPLETED|Overall Study||36
8924620|NCT02250612|9985449|FG001|COMPLETED|Overall Study||38
8924621|NCT02250612|9985450|FG002|COMPLETED|Overall Study||35
8924622|NCT02250612|9985451|FG003|COMPLETED|Overall Study||33
8924623|NCT02250612|9985452|FG004|COMPLETED|Overall Study||36
8924624|NCT02250612|9985448|FG000|NOT COMPLETED|Overall Study||1
8924625|NCT02250612|9985449|FG001|NOT COMPLETED|Overall Study||2
8924626|NCT02250612|9985450|FG002|NOT COMPLETED|Overall Study||2
8924627|NCT02250612|9985451|FG003|NOT COMPLETED|Overall Study||0
8924628|NCT02250612|9985452|FG004|NOT COMPLETED|Overall Study||1
8924629|NCT02250651|9985474|FG000|STARTED|Treatment Period 1 (Day 1 to Week 15)||176
8924630|NCT02250651|9985475|FG001|STARTED|Treatment Period 1 (Day 1 to Week 15)||176
8924631|NCT02250651|9985476|FG002|STARTED|Treatment Period 1 (Day 1 to Week 15)||176
8924632|NCT02250651|9985474|FG000|Received Sham or Bimatoprost SR|Treatment Period 1 (Day 1 to Week 15)||176
8924633|NCT02250651|9985475|FG001|Received Sham or Bimatoprost SR|Treatment Period 1 (Day 1 to Week 15)||175
8924634|NCT02250651|9985476|FG002|Received Sham or Bimatoprost SR|Treatment Period 1 (Day 1 to Week 15)||173
8924635|NCT02250651|9985474|FG000|COMPLETED|Treatment Period 1 (Day 1 to Week 15)||172
8924636|NCT02250651|9985475|FG001|COMPLETED|Treatment Period 1 (Day 1 to Week 15)||170
8924637|NCT02250651|9985476|FG002|COMPLETED|Treatment Period 1 (Day 1 to Week 15)||165
8924638|NCT02250651|9985474|FG000|NOT COMPLETED|Treatment Period 1 (Day 1 to Week 15)||4
8924639|NCT02250651|9985475|FG001|NOT COMPLETED|Treatment Period 1 (Day 1 to Week 15)||6
8694354|NCT00871377|9739824|FG005|NOT COMPLETED|First Intervention (10 Weeks)||1
8694355|NCT00871377|9739819|FG000|STARTED|Washout (6 Weeks)||3
8694356|NCT00871377|9739820|FG001|STARTED|Washout (6 Weeks)||4
8924640|NCT02250651|9985476|FG002|NOT COMPLETED|Treatment Period 1 (Day 1 to Week 15)||11
8924641|NCT02250651|9985474|FG000|STARTED|Treatment Period 2 (Week 16 to Week 31)||165
8924642|NCT02250651|9985475|FG001|STARTED|Treatment Period 2 (Week 16 to Week 31)||168
8924643|NCT02250651|9985476|FG002|STARTED|Treatment Period 2 (Week 16 to Week 31)||165
8924644|NCT02250651|9985474|FG000|COMPLETED|Treatment Period 2 (Week 16 to Week 31)||159
8924645|NCT02250651|9985475|FG001|COMPLETED|Treatment Period 2 (Week 16 to Week 31)||162
8924646|NCT02250651|9985476|FG002|COMPLETED|Treatment Period 2 (Week 16 to Week 31)||160
8924647|NCT02250651|9985474|FG000|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 31)||6
8924648|NCT02250651|9985475|FG001|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 31)||6
8924649|NCT02250651|9985476|FG002|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 31)||5
8924650|NCT02250651|9985474|FG000|STARTED|Treatment Period 3 (Week 32 to Week 52)||147
8924651|NCT02250651|9985475|FG001|STARTED|Treatment Period 3 (Week 32 to Week 52)||156
8924652|NCT02250651|9985476|FG002|STARTED|Treatment Period 3 (Week 32 to Week 52)||159
8924653|NCT02250651|9985474|FG000|COMPLETED|Treatment Period 3 (Week 32 to Week 52)||138
8924654|NCT02250651|9985475|FG001|COMPLETED|Treatment Period 3 (Week 32 to Week 52)||152
8924655|NCT02250651|9985476|FG002|COMPLETED|Treatment Period 3 (Week 32 to Week 52)||154
8924656|NCT02250651|9985474|FG000|NOT COMPLETED|Treatment Period 3 (Week 32 to Week 52)||9
8924657|NCT02250651|9985475|FG001|NOT COMPLETED|Treatment Period 3 (Week 32 to Week 52)||4
8924658|NCT02250651|9985476|FG002|NOT COMPLETED|Treatment Period 3 (Week 32 to Week 52)||5
8694357|NCT00871377|9739821|FG002|STARTED|Washout (6 Weeks)||3
8694358|NCT00871377|9739822|FG003|STARTED|Washout (6 Weeks)||4
8694359|NCT00871377|9739823|FG004|STARTED|Washout (6 Weeks)||4
8694360|NCT00871377|9739824|FG005|STARTED|Washout (6 Weeks)||4
8694361|NCT00871377|9739819|FG000|COMPLETED|Washout (6 Weeks)||2
8694362|NCT00871377|9739820|FG001|COMPLETED|Washout (6 Weeks)||4
8694363|NCT00871377|9739821|FG002|COMPLETED|Washout (6 Weeks)||3
8694364|NCT00871377|9739822|FG003|COMPLETED|Washout (6 Weeks)||4
8694365|NCT00871377|9739823|FG004|COMPLETED|Washout (6 Weeks)||4
8694366|NCT00871377|9739824|FG005|COMPLETED|Washout (6 Weeks)||4
8694367|NCT00871377|9739819|FG000|NOT COMPLETED|Washout (6 Weeks)||1
8694368|NCT00871377|9739820|FG001|NOT COMPLETED|Washout (6 Weeks)||0
8694369|NCT00871377|9739821|FG002|NOT COMPLETED|Washout (6 Weeks)||0
8694370|NCT00871377|9739822|FG003|NOT COMPLETED|Washout (6 Weeks)||0
8694371|NCT00871377|9739823|FG004|NOT COMPLETED|Washout (6 Weeks)||0
8694372|NCT00871377|9739824|FG005|NOT COMPLETED|Washout (6 Weeks)||0
8694373|NCT00871377|9739819|FG000|STARTED|Second Intervention (10 Weeks)||2
8694374|NCT00871377|9739820|FG001|STARTED|Second Intervention (10 Weeks)||4
8694375|NCT00871377|9739821|FG002|STARTED|Second Intervention (10 Weeks)||3
8694376|NCT00871377|9739822|FG003|STARTED|Second Intervention (10 Weeks)||4
8694377|NCT00871377|9739823|FG004|STARTED|Second Intervention (10 Weeks)||4
8694378|NCT00871377|9739824|FG005|STARTED|Second Intervention (10 Weeks)||4
8694379|NCT00871377|9739819|FG000|COMPLETED|Second Intervention (10 Weeks)||2
8694380|NCT00871377|9739820|FG001|COMPLETED|Second Intervention (10 Weeks)||4
8694381|NCT00871377|9739821|FG002|COMPLETED|Second Intervention (10 Weeks)||3
8694382|NCT00871377|9739822|FG003|COMPLETED|Second Intervention (10 Weeks)||4
8694383|NCT00871377|9739823|FG004|COMPLETED|Second Intervention (10 Weeks)||4
8694384|NCT00871377|9739824|FG005|COMPLETED|Second Intervention (10 Weeks)||4
8694385|NCT00871377|9739819|FG000|NOT COMPLETED|Second Intervention (10 Weeks)||0
8694386|NCT00871377|9739820|FG001|NOT COMPLETED|Second Intervention (10 Weeks)||0
8694387|NCT00871377|9739821|FG002|NOT COMPLETED|Second Intervention (10 Weeks)||0
8694388|NCT00871377|9739822|FG003|NOT COMPLETED|Second Intervention (10 Weeks)||0
8694389|NCT00871377|9739823|FG004|NOT COMPLETED|Second Intervention (10 Weeks)||0
8694390|NCT00871377|9739824|FG005|NOT COMPLETED|Second Intervention (10 Weeks)||0
8694391|NCT00871377|9739819|FG000|STARTED|Washout (6 Weeks)||2
8694392|NCT00871377|9739820|FG001|STARTED|Washout (6 Weeks)||4
8694393|NCT00871377|9739821|FG002|STARTED|Washout (6 Weeks)||3
8694394|NCT00871377|9739822|FG003|STARTED|Washout (6 Weeks)||4
8694395|NCT00871377|9739823|FG004|STARTED|Washout (6 Weeks)||4
8694396|NCT00871377|9739824|FG005|STARTED|Washout (6 Weeks)||4
8694397|NCT00871377|9739819|FG000|COMPLETED|Washout (6 Weeks)||2
8694398|NCT00871377|9739820|FG001|COMPLETED|Washout (6 Weeks)||4
8694399|NCT00871377|9739821|FG002|COMPLETED|Washout (6 Weeks)||3
8694400|NCT00871377|9739822|FG003|COMPLETED|Washout (6 Weeks)||4
8694401|NCT00871377|9739823|FG004|COMPLETED|Washout (6 Weeks)||4
8694402|NCT00871377|9739824|FG005|COMPLETED|Washout (6 Weeks)||3
8694403|NCT00871377|9739819|FG000|NOT COMPLETED|Washout (6 Weeks)||0
8694404|NCT00871377|9739820|FG001|NOT COMPLETED|Washout (6 Weeks)||0
8694405|NCT00871377|9739821|FG002|NOT COMPLETED|Washout (6 Weeks)||0
8694406|NCT00871377|9739822|FG003|NOT COMPLETED|Washout (6 Weeks)||0
8924659|NCT02250703|9985486|FG000|STARTED|Overall Study||38
8924660|NCT02250703|9985487|FG001|STARTED|Overall Study||37
8924661|NCT02250703|9985486|FG000|COMPLETED|Overall Study||37
8924662|NCT02250703|9985487|FG001|COMPLETED|Overall Study||36
8924663|NCT02250703|9985486|FG000|NOT COMPLETED|Overall Study||1
8924664|NCT02250703|9985487|FG001|NOT COMPLETED|Overall Study||1
8924665|NCT02250807|9985493|FG000|STARTED|Overall Study||40
8924666|NCT02250807|9985493|FG000|COMPLETED|Overall Study||40
8924667|NCT02250807|9985493|FG000|NOT COMPLETED|Overall Study||0
8924668|NCT02251236|9985500|FG000|STARTED|Overall Study||9
8924669|NCT02251236|9985501|FG001|STARTED|Overall Study||5
8924670|NCT02251236|9985502|FG002|STARTED|Overall Study||0
8924671|NCT02251236|9985500|FG000|COMPLETED|Overall Study||9
8924672|NCT02251236|9985501|FG001|COMPLETED|Overall Study||5
8924673|NCT02251236|9985502|FG002|COMPLETED|Overall Study||0
8924674|NCT02251236|9985500|FG000|NOT COMPLETED|Overall Study||0
8924675|NCT02251236|9985501|FG001|NOT COMPLETED|Overall Study||0
8924676|NCT02251236|9985502|FG002|NOT COMPLETED|Overall Study||0
8924677|NCT02251275|9985515|FG000|STARTED|Overall Study||506
8924678|NCT02251275|9985516|FG001|STARTED|Overall Study||570
8924679|NCT02251275|9985517|FG002|STARTED|Overall Study||718
8924680|NCT02251275|9985518|FG003|STARTED|Overall Study|From trials 156-04-251 and 156-09-290|6
8924681|NCT02251275|9985519|FG004|STARTED|Overall Study|From trials 156-04-251 and 156-09-290|3
8924682|NCT02251275|9985515|FG000|Received at Least 1 Dose of Study Drug|Overall Study||505
8924683|NCT02251275|9985516|FG001|Received at Least 1 Dose of Study Drug|Overall Study||569
8924684|NCT02251275|9985517|FG002|Received at Least 1 Dose of Study Drug|Overall Study||717
8924685|NCT02251275|9985518|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
8924686|NCT02251275|9985519|FG004|Received at Least 1 Dose of Study Drug|Overall Study||3
8924687|NCT02251275|9985515|FG000|COMPLETED|Overall Study||434
8924688|NCT02251275|9985516|FG001|COMPLETED|Overall Study||423
8924689|NCT02251275|9985517|FG002|COMPLETED|Overall Study||624
8924690|NCT02251275|9985518|FG003|COMPLETED|Overall Study||5
8924691|NCT02251275|9985519|FG004|COMPLETED|Overall Study||2
8694407|NCT00871377|9739823|FG004|NOT COMPLETED|Washout (6 Weeks)||0
8694408|NCT00871377|9739824|FG005|NOT COMPLETED|Washout (6 Weeks)||1
8694409|NCT00871377|9739819|FG000|STARTED|Third Intervention (10 Weeks)||2
8694410|NCT00871377|9739820|FG001|STARTED|Third Intervention (10 Weeks)||4
8924692|NCT02251275|9985515|FG000|NOT COMPLETED|Overall Study||72
8924693|NCT02251275|9985516|FG001|NOT COMPLETED|Overall Study||147
8924694|NCT02251275|9985517|FG002|NOT COMPLETED|Overall Study||94
8694411|NCT00871377|9739821|FG002|STARTED|Third Intervention (10 Weeks)||3
8694412|NCT00871377|9739822|FG003|STARTED|Third Intervention (10 Weeks)||4
8694413|NCT00871377|9739823|FG004|STARTED|Third Intervention (10 Weeks)||4
8694414|NCT00871377|9739824|FG005|STARTED|Third Intervention (10 Weeks)||3
8694415|NCT00871377|9739819|FG000|COMPLETED|Third Intervention (10 Weeks)||2
8694416|NCT00871377|9739820|FG001|COMPLETED|Third Intervention (10 Weeks)||4
8694417|NCT00871377|9739821|FG002|COMPLETED|Third Intervention (10 Weeks)||3
8694418|NCT00871377|9739822|FG003|COMPLETED|Third Intervention (10 Weeks)||3
8694419|NCT00871377|9739823|FG004|COMPLETED|Third Intervention (10 Weeks)||4
8694420|NCT00871377|9739824|FG005|COMPLETED|Third Intervention (10 Weeks)||3
8694421|NCT00871377|9739819|FG000|NOT COMPLETED|Third Intervention (10 Weeks)||0
8694422|NCT00871377|9739820|FG001|NOT COMPLETED|Third Intervention (10 Weeks)||0
8694423|NCT00871377|9739821|FG002|NOT COMPLETED|Third Intervention (10 Weeks)||0
8694424|NCT00871377|9739822|FG003|NOT COMPLETED|Third Intervention (10 Weeks)||1
8694425|NCT00871377|9739823|FG004|NOT COMPLETED|Third Intervention (10 Weeks)||0
8694426|NCT00871377|9739824|FG005|NOT COMPLETED|Third Intervention (10 Weeks)||0
8694427|NCT00871403|9739835|FG000|STARTED|Combination Treatment Phase||9
8694428|NCT00871403|9739836|FG001|STARTED|Combination Treatment Phase||62
8694429|NCT00871403|9739837|FG002|STARTED|Combination Treatment Phase||35
8694430|NCT00871403|9739835|FG000|COMPLETED|Combination Treatment Phase|No particiapants completed Combination Treatement.|0
8694431|NCT00871403|9739836|FG001|COMPLETED|Combination Treatment Phase|These participants completed combination treatment|13
8694432|NCT00871403|9739837|FG002|COMPLETED|Combination Treatment Phase|These participants completed combination treatment|23
8694433|NCT00871403|9739835|FG000|NOT COMPLETED|Combination Treatment Phase||9
8694434|NCT00871403|9739836|FG001|NOT COMPLETED|Combination Treatment Phase||49
8694435|NCT00871403|9739837|FG002|NOT COMPLETED|Combination Treatment Phase||12
8694436|NCT00871403|9739835|FG000|STARTED|Monotherapy Treatment Phase||0
8694437|NCT00871403|9739836|FG001|STARTED|Monotherapy Treatment Phase||13
8694438|NCT00871403|9739837|FG002|STARTED|Monotherapy Treatment Phase||1
8694439|NCT00871403|9739835|FG000|COMPLETED|Monotherapy Treatment Phase||0
8694440|NCT00871403|9739836|FG001|COMPLETED|Monotherapy Treatment Phase||0
8694441|NCT00871403|9739837|FG002|COMPLETED|Monotherapy Treatment Phase||0
8694442|NCT00871403|9739835|FG000|NOT COMPLETED|Monotherapy Treatment Phase||0
8694443|NCT00871403|9739836|FG001|NOT COMPLETED|Monotherapy Treatment Phase||13
8694444|NCT00871403|9739837|FG002|NOT COMPLETED|Monotherapy Treatment Phase||1
8694445|NCT00871429|9739844|FG000|STARTED|Overall Study||99
8694446|NCT00871429|9739844|FG000|COMPLETED|Overall Study||75
8694447|NCT00871429|9739844|FG000|NOT COMPLETED|Overall Study||24
8694448|NCT00871494|9739852|FG000|STARTED|Overall Study||76
8694449|NCT00871494|9739852|FG000|COMPLETED|Overall Study||62
8694450|NCT00871494|9739852|FG000|NOT COMPLETED|Overall Study||14
8694451|NCT00871572|9739860|FG000|STARTED|Overall Study||10
8694452|NCT00871572|9739861|FG001|STARTED|Overall Study||17
8694453|NCT00871572|9739862|FG002|STARTED|Overall Study||34
8694454|NCT00871572|9739863|FG003|STARTED|Overall Study||26
8694455|NCT00871572|9739860|FG000|≥1 Post Baseline Value by Assigned Group|Overall Study||9
8694456|NCT00871572|9739861|FG001|≥1 Post Baseline Value by Assigned Group|Overall Study||17
8694457|NCT00871572|9739862|FG002|≥1 Post Baseline Value by Assigned Group|Overall Study||34
8694458|NCT00871572|9739863|FG003|≥1 Post Baseline Value by Assigned Group|Overall Study||25
8694459|NCT00871572|9739860|FG000|Received at Least 1 Dose of Study Drug|Overall Study||9
8694460|NCT00871572|9739861|FG001|Received at Least 1 Dose of Study Drug|Overall Study||17
8694461|NCT00871572|9739862|FG002|Received at Least 1 Dose of Study Drug|Overall Study||34
8694462|NCT00871572|9739863|FG003|Received at Least 1 Dose of Study Drug|Overall Study||25
8694463|NCT00871572|9739860|FG000|COMPLETED|Overall Study||8
8694464|NCT00871572|9739861|FG001|COMPLETED|Overall Study||11
8694465|NCT00871572|9739862|FG002|COMPLETED|Overall Study||30
8694466|NCT00871572|9739863|FG003|COMPLETED|Overall Study||19
8694467|NCT00871572|9739860|FG000|NOT COMPLETED|Overall Study||2
8694468|NCT00871572|9739861|FG001|NOT COMPLETED|Overall Study||6
8694469|NCT00871572|9739862|FG002|NOT COMPLETED|Overall Study||4
8694470|NCT00871572|9739863|FG003|NOT COMPLETED|Overall Study||7
8694471|NCT00871624|9739875|FG000|STARTED|Overall Study||18
8694472|NCT00871624|9739876|FG001|STARTED|Overall Study||18
8694473|NCT00871624|9739875|FG000|COMPLETED|Overall Study||16
8694474|NCT00871624|9739876|FG001|COMPLETED|Overall Study||17
8924695|NCT02251275|9985518|FG003|NOT COMPLETED|Overall Study||1
8694475|NCT00871624|9739875|FG000|NOT COMPLETED|Overall Study||2
8694476|NCT00871624|9739876|FG001|NOT COMPLETED|Overall Study||1
8724135|NCT01025843|9771504|FG005|STARTED|Period 2||2
8724136|NCT01025843|9771505|FG006|STARTED|Period 2||2
8724137|NCT01025843|9771506|FG007|STARTED|Period 2||2
8724138|NCT01025843|9771507|FG008|STARTED|Period 2||2
8724139|NCT01025843|9771508|FG009|STARTED|Period 2||2
8924696|NCT02251275|9985519|FG004|NOT COMPLETED|Overall Study||1
8724140|NCT01025843|9771499|FG000|COMPLETED|Period 2||2
8724141|NCT01025843|9771500|FG001|COMPLETED|Period 2||2
8724142|NCT01025843|9771501|FG002|COMPLETED|Period 2||2
8724143|NCT01025843|9771502|FG003|COMPLETED|Period 2||2
8724144|NCT01025843|9771503|FG004|COMPLETED|Period 2||2
8724145|NCT01025843|9771504|FG005|COMPLETED|Period 2||2
8724146|NCT01025843|9771505|FG006|COMPLETED|Period 2||2
8724147|NCT01025843|9771506|FG007|COMPLETED|Period 2||2
8724148|NCT01025843|9771507|FG008|COMPLETED|Period 2||2
8724149|NCT01025843|9771508|FG009|COMPLETED|Period 2||2
8948166|NCT02427737|10010505|FG000|NOT COMPLETED|OSU Baseline Q4FY15||218
8694477|NCT00871689|9739884|FG000|STARTED|Overall Study||2
8694478|NCT00871689|9739884|FG000|COMPLETED|Overall Study||2
8694479|NCT00871689|9739884|FG000|NOT COMPLETED|Overall Study||0
8694480|NCT00871715|9739891|FG000|STARTED|Overall Study||119
8694481|NCT00871715|9739892|FG001|STARTED|Overall Study||120
8694482|NCT00871715|9739893|FG002|STARTED|Overall Study||122
8694483|NCT00871715|9739891|FG000|Post-Intervention|Overall Study||112
8694484|NCT00871715|9739892|FG001|Post-Intervention|Overall Study||115
8694485|NCT00871715|9739893|FG002|Post-Intervention|Overall Study||115
8694486|NCT00871715|9739891|FG000|6-mo Follow-up|Overall Study||110
8694487|NCT00871715|9739892|FG001|6-mo Follow-up|Overall Study||113
8694488|NCT00871715|9739893|FG002|6-mo Follow-up|Overall Study||112
8694489|NCT00871715|9739891|FG000|COMPLETED|Overall Study|"Completed refers to participants who completed the primary outcome, Wolf Motor Function Test."|104
8924697|NCT02251379|9985533|FG000|STARTED|Overall Study||77
8924698|NCT02251379|9985534|FG001|STARTED|Overall Study||78
8924699|NCT02251379|9985533|FG000|COMPLETED|Overall Study||57
8924700|NCT02251379|9985534|FG001|COMPLETED|Overall Study||58
8924701|NCT02251379|9985533|FG000|NOT COMPLETED|Overall Study||20
8924702|NCT02251379|9985534|FG001|NOT COMPLETED|Overall Study||20
8924703|NCT02251496|9985542|FG000|STARTED|Overall Study||19
8924704|NCT02251496|9985543|FG001|STARTED|Overall Study||15
8924705|NCT02251496|9985542|FG000|COMPLETED|Overall Study||14
8924706|NCT02251496|9985543|FG001|COMPLETED|Overall Study||11
8924707|NCT02251496|9985542|FG000|NOT COMPLETED|Overall Study||5
8924708|NCT02251496|9985543|FG001|NOT COMPLETED|Overall Study||4
8924709|NCT02251561|9985549|FG000|STARTED|Overall Study||28
8924710|NCT02251561|9985549|FG000|COMPLETED|Overall Study||28
8924711|NCT02251561|9985549|FG000|NOT COMPLETED|Overall Study||0
8924712|NCT02251613|9985555|FG000|STARTED|Overall Study||50
8924713|NCT02251613|9985555|FG000|COMPLETED|Overall Study||50
8924714|NCT02251613|9985555|FG000|NOT COMPLETED|Overall Study||0
8924715|NCT02251652|9985561|FG000|STARTED|Overall Study||17
8924716|NCT02251652|9985561|FG000|COMPLETED|Overall Study||16
8924717|NCT02251652|9985561|FG000|NOT COMPLETED|Overall Study||1
8924718|NCT02251717|9985569|FG000|STARTED|Overall Study||57
8924719|NCT02251717|9985570|FG001|STARTED|Overall Study||57
8924720|NCT02251717|9985569|FG000|COMPLETED|Overall Study||56
8924721|NCT02251717|9985570|FG001|COMPLETED|Overall Study||56
8924722|NCT02251717|9985569|FG000|NOT COMPLETED|Overall Study||1
8924723|NCT02251717|9985570|FG001|NOT COMPLETED|Overall Study||1
8924724|NCT02251743|9985578|FG000|STARTED|Overall Study||85
8924725|NCT02251743|9985579|FG001|STARTED|Overall Study||59
8924726|NCT02251743|9985578|FG000|COMPLETED|Overall Study||84
8924727|NCT02251743|9985579|FG001|COMPLETED|Overall Study||58
8924728|NCT02251743|9985578|FG000|NOT COMPLETED|Overall Study||1
8924729|NCT02251743|9985579|FG001|NOT COMPLETED|Overall Study||1
8924730|NCT02251886|9985589|FG000|STARTED|Overall Study||48
8924731|NCT02251886|9985590|FG001|STARTED|Overall Study||54
8924732|NCT02251886|9985591|FG002|STARTED|Overall Study||44
8924733|NCT02251886|9985592|FG003|STARTED|Overall Study||54
8924734|NCT02251886|9985589|FG000|COMPLETED|Overall Study||48
8924735|NCT02251886|9985590|FG001|COMPLETED|Overall Study||54
8924736|NCT02251886|9985591|FG002|COMPLETED|Overall Study||44
8924737|NCT02251886|9985592|FG003|COMPLETED|Overall Study||54
8924738|NCT02251886|9985589|FG000|NOT COMPLETED|Overall Study||0
8924739|NCT02251886|9985590|FG001|NOT COMPLETED|Overall Study||0
8924740|NCT02251886|9985591|FG002|NOT COMPLETED|Overall Study||0
8924741|NCT02251886|9985592|FG003|NOT COMPLETED|Overall Study||0
8924742|NCT02251912|9985604|FG000|STARTED|Overall Study||12
8924743|NCT02251912|9985605|FG001|STARTED|Overall Study||10
8924744|NCT02251912|9985604|FG000|COMPLETED|Overall Study||10
8924745|NCT02251912|9985605|FG001|COMPLETED|Overall Study||5
8924746|NCT02251912|9985604|FG000|NOT COMPLETED|Overall Study||2
8924747|NCT02251912|9985605|FG001|NOT COMPLETED|Overall Study||5
8924748|NCT02251938|9985611|FG000|STARTED|Overall Study||60
8924749|NCT02251938|9985611|FG000|COMPLETED|Overall Study||43
8924750|NCT02251938|9985611|FG000|NOT COMPLETED|Overall Study||17
8924751|NCT02251990|9985617|FG000|STARTED|Period 1 (Double-blind [DB])||366
8924752|NCT02251990|9985618|FG001|STARTED|Period 1 (Double-blind [DB])||123
8924753|NCT02251990|9985617|FG000|Treated|Period 1 (Double-blind [DB])|Started Grazoprevir/Elbasvir|365
8924754|NCT02251990|9985618|FG001|Treated|Period 1 (Double-blind [DB])|Started Placebo|123
8924755|NCT02251990|9985617|FG000|COMPLETED|Period 1 (Double-blind [DB])|Completed 12 weeks of Grazoprevir/Elbasvir|358
8924756|NCT02251990|9985618|FG001|COMPLETED|Period 1 (Double-blind [DB])|Completed 12 weeks of Placebo|122
8924757|NCT02251990|9985617|FG000|NOT COMPLETED|Period 1 (Double-blind [DB])||8
8924758|NCT02251990|9985618|FG001|NOT COMPLETED|Period 1 (Double-blind [DB])||1
8924759|NCT02251990|9985617|FG000|STARTED|Period 2 (ITG Follow-up/DTG Open Label)|2 participants that did not complete Period 1 treatment were included in Follow-up.|360
8924760|NCT02251990|9985618|FG001|STARTED|Period 2 (ITG Follow-up/DTG Open Label)|1 participant completing Period 1 was not eligible for Period 2 and was not treated.|121
8924761|NCT02251990|9985617|FG000|COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)|Completed 24 weeks of follow-up|360
8924762|NCT02251990|9985618|FG001|COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)|Completed 12 weeks of Grazoprevir/Elbasvir|118
8924763|NCT02251990|9985617|FG000|NOT COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)||0
8924764|NCT02251990|9985618|FG001|NOT COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)||3
8924765|NCT02251990|9985617|FG000|STARTED|Period 3 (DTG Follow-up)|The ITG completed the study with Period 2|0
8924766|NCT02251990|9985618|FG001|STARTED|Period 3 (DTG Follow-up)|3 participants that discontinued treatment in Period 2 were included in Follow-up.|121
8694490|NCT00871715|9739892|FG001|COMPLETED|Overall Study|"Completed refers to participants who completed the primary outcome, Wolf Motor Function Test."|104
8694491|NCT00871715|9739893|FG002|COMPLETED|Overall Study|"Completed refers to participants who completed the primary outcome, Wolf Motor Function Test."|96
8694492|NCT00871715|9739891|FG000|NOT COMPLETED|Overall Study||15
8694493|NCT00871715|9739892|FG001|NOT COMPLETED|Overall Study||16
8694494|NCT00871715|9739893|FG002|NOT COMPLETED|Overall Study||26
8694495|NCT00871728|9739902|FG000|STARTED|Overall Study||132
8694496|NCT00871728|9739902|FG000|Treated|Overall Study||130
8924767|NCT02251990|9985617|FG000|COMPLETED|Period 3 (DTG Follow-up)||0
8924768|NCT02251990|9985618|FG001|COMPLETED|Period 3 (DTG Follow-up)|Completed 24 weeks of follow-up|121
8924769|NCT02251990|9985617|FG000|NOT COMPLETED|Period 3 (DTG Follow-up)||0
8924770|NCT02251990|9985618|FG001|NOT COMPLETED|Period 3 (DTG Follow-up)||0
8924771|NCT02252016|9985627|FG000|STARTED|Overall Study||107
8924772|NCT02252016|9985628|FG001|STARTED|Overall Study||52
8924773|NCT02252016|9985627|FG000|COMPLETED|Overall Study|Completed = completed 24 weeks of follow-up|104
8924774|NCT02252016|9985628|FG001|COMPLETED|Overall Study|Completed = completed 24 weeks of follow-up|49
8924775|NCT02252016|9985627|FG000|NOT COMPLETED|Overall Study||3
8924776|NCT02252016|9985628|FG001|NOT COMPLETED|Overall Study||3
8924777|NCT02252042|9985636|FG000|STARTED|Overall Study||247
8924778|NCT02252042|9985637|FG001|STARTED|Overall Study||248
8924779|NCT02252042|9985636|FG000|Treated|Overall Study|1 participant was randomized but did not receive study treatment.|246
8924780|NCT02252042|9985637|FG001|Treated|Overall Study|14 participants were randomized but did not receive study treatment.|234
9040369|NCT03351335|10101270|FG001|NOT COMPLETED|Overall Study||0
9040370|NCT03351335|10101271|FG002|NOT COMPLETED|Overall Study||4
9040371|NCT03351478|10101282|FG000|STARTED|Overall Study||307
9040372|NCT03351478|10101283|FG001|STARTED|Overall Study||309
9040373|NCT03351478|10101284|FG002|STARTED|Overall Study||154
9040374|NCT03351478|10101282|FG000|COMPLETED|Overall Study||293
9040375|NCT03351478|10101283|FG001|COMPLETED|Overall Study||292
9040376|NCT03351478|10101284|FG002|COMPLETED|Overall Study||147
9040377|NCT03351478|10101282|FG000|NOT COMPLETED|Overall Study||14
9040378|NCT03351478|10101283|FG001|NOT COMPLETED|Overall Study||17
9040379|NCT03351478|10101284|FG002|NOT COMPLETED|Overall Study||7
9040380|NCT03351608|10101297|FG000|STARTED|Overall Study||19
9040381|NCT03351608|10101298|FG001|STARTED|Overall Study||23
9040382|NCT03351608|10101299|FG002|STARTED|Overall Study||35
9040383|NCT03351608|10101300|FG003|STARTED|Overall Study||176
9040384|NCT03351608|10101301|FG004|STARTED|Overall Study||35
9040385|NCT03351608|10101297|FG000|Treated|Overall Study||18
9040386|NCT03351608|10101298|FG001|Treated|Overall Study||22
9040387|NCT03351608|10101299|FG002|Treated|Overall Study||33
9040388|NCT03351608|10101300|FG003|Treated|Overall Study||169
9040389|NCT03351608|10101301|FG004|Treated|Overall Study||34
9040390|NCT03351608|10101297|FG000|COMPLETED|Overall Study||18
9040391|NCT03351608|10101298|FG001|COMPLETED|Overall Study||21
9040392|NCT03351608|10101299|FG002|COMPLETED|Overall Study||32
9040393|NCT03351608|10101300|FG003|COMPLETED|Overall Study||168
9040394|NCT03351608|10101301|FG004|COMPLETED|Overall Study||33
9040395|NCT03351608|10101297|FG000|NOT COMPLETED|Overall Study||1
9040396|NCT03351608|10101298|FG001|NOT COMPLETED|Overall Study||2
9040397|NCT03351608|10101299|FG002|NOT COMPLETED|Overall Study||3
9040398|NCT03351608|10101300|FG003|NOT COMPLETED|Overall Study||8
9040399|NCT03351608|10101301|FG004|NOT COMPLETED|Overall Study||2
9040400|NCT03351699|10101329|FG000|STARTED|Overall Study||6
9040401|NCT03351699|10101330|FG001|STARTED|Overall Study||6
9040402|NCT03351699|10101331|FG002|STARTED|Overall Study||6
9040403|NCT03351699|10101332|FG003|STARTED|Overall Study||6
9040404|NCT03351699|10101333|FG004|STARTED|Overall Study|Panel F did not enroll, following evaluation of earlier Panel data.|0
9040405|NCT03351699|10101329|FG000|COMPLETED|Overall Study||6
9040406|NCT03351699|10101330|FG001|COMPLETED|Overall Study||6
9040407|NCT03351699|10101331|FG002|COMPLETED|Overall Study||6
9040408|NCT03351699|10101332|FG003|COMPLETED|Overall Study||6
9040409|NCT03351699|10101333|FG004|COMPLETED|Overall Study|Panel F did not enroll, following evaluation of earlier Panel data.|0
9040410|NCT03351699|10101329|FG000|NOT COMPLETED|Overall Study||0
9040411|NCT03351699|10101330|FG001|NOT COMPLETED|Overall Study||0
9040412|NCT03351699|10101331|FG002|NOT COMPLETED|Overall Study||0
9040413|NCT03351699|10101332|FG003|NOT COMPLETED|Overall Study||0
9040414|NCT03351699|10101333|FG004|NOT COMPLETED|Overall Study||0
9040415|NCT03351738|10101357|FG000|STARTED|Overall Study||23
9040416|NCT03351738|10101358|FG001|STARTED|Overall Study||20
9040417|NCT03351738|10101359|FG002|STARTED|Overall Study||24
9040418|NCT03351738|10101360|FG003|STARTED|Overall Study||22
9040419|NCT03351738|10101361|FG004|STARTED|Overall Study||21
9040420|NCT03351738|10101362|FG005|STARTED|Overall Study||22
9040421|NCT03351738|10101357|FG000|COMPLETED|Overall Study||23
9040422|NCT03351738|10101358|FG001|COMPLETED|Overall Study||19
9040423|NCT03351738|10101359|FG002|COMPLETED|Overall Study||24
9040424|NCT03351738|10101360|FG003|COMPLETED|Overall Study||21
8694497|NCT00871728|9739902|FG000|COMPLETED|Overall Study||112
8694498|NCT00871728|9739902|FG000|NOT COMPLETED|Overall Study||20
9040425|NCT03351738|10101361|FG004|COMPLETED|Overall Study||21
9040426|NCT03351738|10101362|FG005|COMPLETED|Overall Study||22
9040427|NCT03351738|10101357|FG000|NOT COMPLETED|Overall Study||0
9040428|NCT03351738|10101358|FG001|NOT COMPLETED|Overall Study||1
9040429|NCT03351738|10101359|FG002|NOT COMPLETED|Overall Study||0
9040430|NCT03351738|10101360|FG003|NOT COMPLETED|Overall Study||1
9040431|NCT03351738|10101361|FG004|NOT COMPLETED|Overall Study||0
8924781|NCT02252042|9985636|FG000|COMPLETED|Overall Study||0
8924782|NCT02252042|9985637|FG001|COMPLETED|Overall Study||0
8924783|NCT02252042|9985636|FG000|NOT COMPLETED|Overall Study||247
8694499|NCT00871741|9739908|FG000|STARTED|Overall Study||9
8694500|NCT00871741|9739909|FG001|STARTED|Overall Study||7
8694501|NCT00871741|9739908|FG000|COMPLETED|Overall Study||0
8694502|NCT00871741|9739909|FG001|COMPLETED|Overall Study||0
8694503|NCT00871741|9739908|FG000|NOT COMPLETED|Overall Study||9
8694504|NCT00871741|9739909|FG001|NOT COMPLETED|Overall Study||7
8694505|NCT00871780|9739915|FG000|STARTED|Overall Study|number enrolled|224
8694506|NCT00871780|9739915|FG000|Safety Analysis Population|Overall Study|participants who had ≥1 infusion of natalizumab during the study|218
8694507|NCT00871780|9739915|FG000|Efficacy Analysis Population|Overall Study|participants who had ≥1 infusion of natalizumab and completed at least 1 on-treatment evaluation|215
8694508|NCT00871780|9739915|FG000|COMPLETED|Overall Study||197
8694509|NCT00871780|9739915|FG000|NOT COMPLETED|Overall Study||27
8694510|NCT00871819|9739922|FG000|STARTED|Overall Study||20
8694511|NCT00871819|9739922|FG000|COMPLETED|Overall Study||20
8694512|NCT00871819|9739922|FG000|NOT COMPLETED|Overall Study||0
8694513|NCT00871845|9739928|FG000|STARTED|Overall Study||11
8694514|NCT00871845|9739929|FG001|STARTED|Overall Study||25
8694515|NCT00871845|9739928|FG000|COMPLETED|Overall Study||11
8694516|NCT00871845|9739929|FG001|COMPLETED|Overall Study||25
8694517|NCT00871845|9739928|FG000|NOT COMPLETED|Overall Study||0
8694518|NCT00871845|9739929|FG001|NOT COMPLETED|Overall Study||0
8694519|NCT00871858|9739941|FG000|STARTED|Overall Study||61
8694520|NCT00871858|9739942|FG001|STARTED|Overall Study||59
8694521|NCT00871858|9739941|FG000|Evaluable for Safety|Overall Study|1 patient refused to continue study and therefore did not received treatment.|60
8694522|NCT00871858|9739942|FG001|Evaluable for Safety|Overall Study|1 patient refused to continue study after randomization and therefore did not received treatment.|58
8694523|NCT00871858|9739941|FG000|COMPLETED|Overall Study||56
8694524|NCT00871858|9739942|FG001|COMPLETED|Overall Study||52
8694525|NCT00871858|9739941|FG000|NOT COMPLETED|Overall Study||5
8694526|NCT00871858|9739942|FG001|NOT COMPLETED|Overall Study||7
8694527|NCT00871871|9739950|FG000|STARTED|Part I||18
8694528|NCT00871871|9739951|FG001|STARTED|Part I||18
8694529|NCT00871871|9739952|FG002|STARTED|Part I||0
8694530|NCT00871871|9739953|FG003|STARTED|Part I||0
8694531|NCT00871871|9739950|FG000|COMPLETED|Part I||15
8694532|NCT00871871|9739951|FG001|COMPLETED|Part I||15
8694533|NCT00871871|9739952|FG002|COMPLETED|Part I||0
8694534|NCT00871871|9739953|FG003|COMPLETED|Part I||0
8694535|NCT00871871|9739950|FG000|NOT COMPLETED|Part I||3
8694536|NCT00871871|9739951|FG001|NOT COMPLETED|Part I||3
8694537|NCT00871871|9739952|FG002|NOT COMPLETED|Part I||0
8694538|NCT00871871|9739953|FG003|NOT COMPLETED|Part I||0
8694539|NCT00871871|9739950|FG000|STARTED|Part II||0
8694540|NCT00871871|9739951|FG001|STARTED|Part II||0
8694541|NCT00871871|9739952|FG002|STARTED|Part II||13
8694542|NCT00871871|9739953|FG003|STARTED|Part II||15
8694543|NCT00871871|9739950|FG000|COMPLETED|Part II||0
8694544|NCT00871871|9739951|FG001|COMPLETED|Part II||0
8694545|NCT00871871|9739952|FG002|COMPLETED|Part II||9
8694546|NCT00871871|9739953|FG003|COMPLETED|Part II||11
8694547|NCT00871871|9739950|FG000|NOT COMPLETED|Part II||0
8694548|NCT00871871|9739951|FG001|NOT COMPLETED|Part II||0
8924784|NCT02252042|9985637|FG001|NOT COMPLETED|Overall Study||248
8924785|NCT02252068|9985646|FG000|STARTED|Overall Study||5
8924786|NCT02252068|9985647|FG001|STARTED|Overall Study||13
8924787|NCT02252068|9985648|FG002|STARTED|Overall Study||13
8924788|NCT02252068|9985646|FG000|COMPLETED|Overall Study||3
8924789|NCT02252068|9985647|FG001|COMPLETED|Overall Study||13
8924790|NCT02252068|9985648|FG002|COMPLETED|Overall Study||13
8924791|NCT02252068|9985646|FG000|NOT COMPLETED|Overall Study||2
8924792|NCT02252068|9985647|FG001|NOT COMPLETED|Overall Study||0
8924793|NCT02252068|9985648|FG002|NOT COMPLETED|Overall Study||0
8924794|NCT02252081|9985658|FG000|STARTED|Overall Study||30
8924795|NCT02252081|9985659|FG001|STARTED|Overall Study||30
8924796|NCT02252081|9985658|FG000|COMPLETED|Overall Study||24
8924797|NCT02252081|9985659|FG001|COMPLETED|Overall Study||26
8924798|NCT02252081|9985658|FG000|NOT COMPLETED|Overall Study||6
8924799|NCT02252081|9985659|FG001|NOT COMPLETED|Overall Study||4
8924800|NCT02252133|9985670|FG000|STARTED|Period 1||23
8924801|NCT02252133|9985671|FG001|STARTED|Period 1||24
8924802|NCT02252133|9985670|FG000|COMPLETED|Period 1||23
8924803|NCT02252133|9985671|FG001|COMPLETED|Period 1||24
8924804|NCT02252133|9985670|FG000|NOT COMPLETED|Period 1||0
8924805|NCT02252133|9985671|FG001|NOT COMPLETED|Period 1||0
8924806|NCT02252133|9985670|FG000|STARTED|Period 2||23
8694549|NCT00871871|9739952|FG002|NOT COMPLETED|Part II||4
8694550|NCT00871871|9739953|FG003|NOT COMPLETED|Part II||4
8694551|NCT00871923|9739963|FG000|STARTED|Overall Study||44
8694552|NCT00871923|9739963|FG000|COMPLETED|Overall Study||42
8694553|NCT00871923|9739963|FG000|NOT COMPLETED|Overall Study||2
8694554|NCT00871975|9739967|FG000|STARTED|Overall Study||155
8694555|NCT00871975|9739967|FG000|COMPLETED|Overall Study||133
8694556|NCT00871975|9739967|FG000|NOT COMPLETED|Overall Study||22
8694557|NCT00872001|9739973|FG000|STARTED|Overall Study||1536
8694558|NCT00872001|9739974|FG001|STARTED|Overall Study||1544
8924807|NCT02252133|9985671|FG001|STARTED|Period 2||24
8924808|NCT02252133|9985670|FG000|COMPLETED|Period 2||23
8694559|NCT00872001|9739973|FG000|COMPLETED|Overall Study||1400
8694560|NCT00872001|9739974|FG001|COMPLETED|Overall Study||1413
8694561|NCT00872001|9739973|FG000|NOT COMPLETED|Overall Study||136
8924809|NCT02252133|9985671|FG001|COMPLETED|Period 2||24
8694562|NCT00872001|9739974|FG001|NOT COMPLETED|Overall Study||131
8694563|NCT00872027|9739984|FG000|STARTED|Overall Study||7
8694564|NCT00872027|9739985|FG001|STARTED|Overall Study||8
8694565|NCT00872027|9739984|FG000|COMPLETED|Overall Study||7
8694566|NCT00872027|9739985|FG001|COMPLETED|Overall Study||8
8694567|NCT00872027|9739984|FG000|NOT COMPLETED|Overall Study||0
8694568|NCT00872027|9739985|FG001|NOT COMPLETED|Overall Study||0
8694569|NCT00872079|9739991|FG000|STARTED|Overall Study||175
8694570|NCT00872079|9739991|FG000|COMPLETED|Overall Study||175
8694571|NCT00872079|9739991|FG000|NOT COMPLETED|Overall Study||0
8694572|NCT00872170|9739997|FG000|STARTED|Overall Study||14
8694573|NCT00872170|9739998|FG001|STARTED|Overall Study||13
8694574|NCT00872170|9739997|FG000|COMPLETED|Overall Study|One patient withdrew from study at week 2.|13
8694575|NCT00872170|9739998|FG001|COMPLETED|Overall Study||13
8694576|NCT00872170|9739997|FG000|NOT COMPLETED|Overall Study||1
8694577|NCT00872170|9739998|FG001|NOT COMPLETED|Overall Study||0
8694578|NCT00872339|9740006|FG000|STARTED|Overall Study||201
8694579|NCT00872339|9740007|FG001|STARTED|Overall Study||14
8694580|NCT00872339|9740008|FG002|STARTED|Overall Study||37
8694581|NCT00872339|9740006|FG000|COMPLETED|Overall Study||201
8694582|NCT00872339|9740007|FG001|COMPLETED|Overall Study||14
8694583|NCT00872339|9740008|FG002|COMPLETED|Overall Study||37
8694584|NCT00872339|9740006|FG000|NOT COMPLETED|Overall Study||0
8694585|NCT00872339|9740007|FG001|NOT COMPLETED|Overall Study||0
8694586|NCT00872339|9740008|FG002|NOT COMPLETED|Overall Study||0
8694587|NCT00872521|9740019|FG000|STARTED|Completed PAD Induction|Received allocated treatment|26
8694588|NCT00872521|9740020|FG001|STARTED|Completed PAD Induction|Received allocated treatment|72
8694589|NCT00872521|9740021|FG002|STARTED|Completed PAD Induction|Received allocated treatment|9
8694590|NCT00872521|9740019|FG000|COMPLETED|Completed PAD Induction|Completed PAD induction|21
8694591|NCT00872521|9740020|FG001|COMPLETED|Completed PAD Induction|Completed PAD induction|68
8694592|NCT00872521|9740021|FG002|COMPLETED|Completed PAD Induction|Completed PAD induction|9
8694593|NCT00872521|9740019|FG000|NOT COMPLETED|Completed PAD Induction||5
8694594|NCT00872521|9740020|FG001|NOT COMPLETED|Completed PAD Induction||4
8694595|NCT00872521|9740021|FG002|NOT COMPLETED|Completed PAD Induction||0
8694596|NCT00872521|9740019|FG000|STARTED|Primary Endpoint Analysis|Completed PAD induction|21
8694597|NCT00872521|9740020|FG001|STARTED|Primary Endpoint Analysis|Completed PAD induction|68
8694598|NCT00872521|9740021|FG002|STARTED|Primary Endpoint Analysis|Completed PAD induction|9
8694599|NCT00872521|9740019|FG000|COMPLETED|Primary Endpoint Analysis|participants analyzed|20
8694600|NCT00872521|9740020|FG001|COMPLETED|Primary Endpoint Analysis|participants analyzed|63
8694601|NCT00872521|9740021|FG002|COMPLETED|Primary Endpoint Analysis|participants analyzed|8
8694602|NCT00872521|9740019|FG000|NOT COMPLETED|Primary Endpoint Analysis||1
8694603|NCT00872521|9740020|FG001|NOT COMPLETED|Primary Endpoint Analysis||5
8694604|NCT00872521|9740021|FG002|NOT COMPLETED|Primary Endpoint Analysis||1
8694605|NCT00872521|9740019|FG000|STARTED|Completed 3-month Follow up|Participants analyzed for primary endpoint|20
8694606|NCT00872521|9740020|FG001|STARTED|Completed 3-month Follow up|Participants analyzed for primary endpoint|63
8694607|NCT00872521|9740021|FG002|STARTED|Completed 3-month Follow up|Participants analyzed for primary endpoint|8
8694608|NCT00872521|9740019|FG000|COMPLETED|Completed 3-month Follow up|Completed 3-month follow-up|20
8694609|NCT00872521|9740020|FG001|COMPLETED|Completed 3-month Follow up|Completed 3-month follow-up|60
8694610|NCT00872521|9740021|FG002|COMPLETED|Completed 3-month Follow up|Completed 3-month follow-up|8
8694611|NCT00872521|9740019|FG000|NOT COMPLETED|Completed 3-month Follow up||0
8694612|NCT00872521|9740020|FG001|NOT COMPLETED|Completed 3-month Follow up||3
8694613|NCT00872521|9740021|FG002|NOT COMPLETED|Completed 3-month Follow up||0
8694614|NCT00872521|9740019|FG000|STARTED|Secondary Endpoint Analysis|Completed 3-month follow-up|20
8694615|NCT00872521|9740020|FG001|STARTED|Secondary Endpoint Analysis|Completed 3-month follow-up|60
8694616|NCT00872521|9740021|FG002|STARTED|Secondary Endpoint Analysis|Completed 3-month follow-up|8
8694617|NCT00872521|9740019|FG000|COMPLETED|Secondary Endpoint Analysis|Participants analyzed for secondary endpoint|20
8694618|NCT00872521|9740020|FG001|COMPLETED|Secondary Endpoint Analysis|Participants analyzed for secondary endpoint|58
8694619|NCT00872521|9740021|FG002|COMPLETED|Secondary Endpoint Analysis|Participants analyzed for secondary endpoint|7
8694620|NCT00872521|9740019|FG000|NOT COMPLETED|Secondary Endpoint Analysis||0
8694621|NCT00872521|9740020|FG001|NOT COMPLETED|Secondary Endpoint Analysis||2
8694622|NCT00872521|9740021|FG002|NOT COMPLETED|Secondary Endpoint Analysis||1
8694623|NCT00872534|9740042|FG000|STARTED|Overall Study||100
8694624|NCT00872534|9740043|FG001|STARTED|Overall Study||104
8694625|NCT00872534|9740042|FG000|COMPLETED|Overall Study||97
8694626|NCT00872534|9740043|FG001|COMPLETED|Overall Study||101
8694627|NCT00872534|9740042|FG000|NOT COMPLETED|Overall Study||3
8694628|NCT00872534|9740043|FG001|NOT COMPLETED|Overall Study||3
8694629|NCT00872599|9740049|FG000|STARTED|First Washout Period After Low Salt||16
8694630|NCT00872599|9740050|FG001|STARTED|First Washout Period After Low Salt||17
8694631|NCT00872599|9740049|FG000|COMPLETED|First Washout Period After Low Salt||16
8694632|NCT00872599|9740050|FG001|COMPLETED|First Washout Period After Low Salt||17
8694633|NCT00872599|9740049|FG000|NOT COMPLETED|First Washout Period After Low Salt||0
8694634|NCT00872599|9740050|FG001|NOT COMPLETED|First Washout Period After Low Salt||0
8694635|NCT00872599|9740049|FG000|STARTED|First Drug During High Salt Intake||16
8694636|NCT00872599|9740050|FG001|STARTED|First Drug During High Salt Intake||17
8694637|NCT00872599|9740049|FG000|COMPLETED|First Drug During High Salt Intake||16
8694638|NCT00872599|9740050|FG001|COMPLETED|First Drug During High Salt Intake||17
8694639|NCT00872599|9740049|FG000|NOT COMPLETED|First Drug During High Salt Intake||0
8694640|NCT00872599|9740050|FG001|NOT COMPLETED|First Drug During High Salt Intake||0
8694641|NCT00872599|9740049|FG000|STARTED|Second Washout Period||16
8694642|NCT00872599|9740050|FG001|STARTED|Second Washout Period||17
8694643|NCT00872599|9740049|FG000|COMPLETED|Second Washout Period||15
8694644|NCT00872599|9740050|FG001|COMPLETED|Second Washout Period||16
8694645|NCT00872599|9740049|FG000|NOT COMPLETED|Second Washout Period||1
8694646|NCT00872599|9740050|FG001|NOT COMPLETED|Second Washout Period||1
8694647|NCT00872599|9740049|FG000|STARTED|Second Drug During High Salt Intake||15
8694648|NCT00872599|9740050|FG001|STARTED|Second Drug During High Salt Intake||16
8694649|NCT00872599|9740049|FG000|COMPLETED|Second Drug During High Salt Intake||15
8694650|NCT00872599|9740050|FG001|COMPLETED|Second Drug During High Salt Intake||16
8694651|NCT00872599|9740049|FG000|NOT COMPLETED|Second Drug During High Salt Intake||0
8694652|NCT00872599|9740050|FG001|NOT COMPLETED|Second Drug During High Salt Intake||0
8694653|NCT00872729|9740056|FG000|STARTED|Overall Study||9
8694654|NCT00872729|9740056|FG000|COMPLETED|Overall Study||9
8694655|NCT00872729|9740056|FG000|NOT COMPLETED|Overall Study||0
8694656|NCT00872833|9740082|FG000|STARTED|Overall Study||15
8694657|NCT00872833|9740083|FG001|STARTED|Overall Study||17
8694658|NCT00872833|9740082|FG000|COMPLETED|Overall Study||15
8694659|NCT00872833|9740083|FG001|COMPLETED|Overall Study||17
8694660|NCT00872833|9740082|FG000|NOT COMPLETED|Overall Study||0
8694661|NCT00872833|9740083|FG001|NOT COMPLETED|Overall Study||0
8694662|NCT00872898|9740095|FG000|STARTED|Part One - Open Label, Pharmacokinetics||0
8694663|NCT00872898|9740096|FG001|STARTED|Part One - Open Label, Pharmacokinetics||4
8694664|NCT00872898|9740095|FG000|COMPLETED|Part One - Open Label, Pharmacokinetics||0
8694665|NCT00872898|9740096|FG001|COMPLETED|Part One - Open Label, Pharmacokinetics||4
8694666|NCT00872898|9740095|FG000|NOT COMPLETED|Part One - Open Label, Pharmacokinetics||0
8694667|NCT00872898|9740096|FG001|NOT COMPLETED|Part One - Open Label, Pharmacokinetics||0
8694668|NCT00872898|9740095|FG000|STARTED|Part Two - Double Blind||61
8694669|NCT00872898|9740096|FG001|STARTED|Part Two - Double Blind||60
8694670|NCT00872898|9740095|FG000|COMPLETED|Part Two - Double Blind||50
8694671|NCT00872898|9740096|FG001|COMPLETED|Part Two - Double Blind||54
8694672|NCT00872898|9740095|FG000|NOT COMPLETED|Part Two - Double Blind||11
8694673|NCT00872898|9740096|FG001|NOT COMPLETED|Part Two - Double Blind||6
8694674|NCT00872989|9740107|FG000|STARTED|Overall Study||66
8694675|NCT00872989|9740108|FG001|STARTED|Overall Study||63
8694676|NCT00872989|9740107|FG000|COMPLETED|Overall Study||1
8694677|NCT00872989|9740108|FG001|COMPLETED|Overall Study||0
8694678|NCT00872989|9740107|FG000|NOT COMPLETED|Overall Study||65
8694679|NCT00872989|9740108|FG001|NOT COMPLETED|Overall Study||63
8694680|NCT00873015|9740124|FG000|STARTED|Overall Study||9
8694681|NCT00873015|9740125|FG001|STARTED|Overall Study||4
8694682|NCT00873015|9740126|FG002|STARTED|Overall Study||3
8694683|NCT00873015|9740127|FG003|STARTED|Overall Study||3
8694684|NCT00873015|9740124|FG000|COMPLETED|Overall Study||9
8694685|NCT00873015|9740125|FG001|COMPLETED|Overall Study||3
8694686|NCT00873015|9740126|FG002|COMPLETED|Overall Study||3
8694687|NCT00873015|9740127|FG003|COMPLETED|Overall Study||3
8694688|NCT00873015|9740124|FG000|NOT COMPLETED|Overall Study||0
8694689|NCT00873015|9740125|FG001|NOT COMPLETED|Overall Study||1
8694690|NCT00873015|9740126|FG002|NOT COMPLETED|Overall Study||0
8694691|NCT00873015|9740127|FG003|NOT COMPLETED|Overall Study||0
8694692|NCT00873041|9740139|FG000|STARTED|Core Study||55
8694693|NCT00873041|9740140|FG001|STARTED|Core Study||55
8694694|NCT00873041|9740141|FG002|STARTED|Core Study||56
8694695|NCT00873041|9740139|FG000|COMPLETED|Core Study||48
8694696|NCT00873041|9740140|FG001|COMPLETED|Core Study||49
8694697|NCT00873041|9740141|FG002|COMPLETED|Core Study||51
8694698|NCT00873041|9740139|FG000|NOT COMPLETED|Core Study||7
8694699|NCT00873041|9740140|FG001|NOT COMPLETED|Core Study||6
8694700|NCT00873041|9740141|FG002|NOT COMPLETED|Core Study||5
8694701|NCT00873041|9740139|FG000|STARTED|Extension Study||41
8694702|NCT00873041|9740140|FG001|STARTED|Extension Study||44
8694703|NCT00873041|9740141|FG002|STARTED|Extension Study||48
8694704|NCT00873041|9740139|FG000|COMPLETED|Extension Study||40
8694705|NCT00873041|9740140|FG001|COMPLETED|Extension Study||44
8694706|NCT00873041|9740141|FG002|COMPLETED|Extension Study||46
8694707|NCT00873041|9740139|FG000|NOT COMPLETED|Extension Study||1
8694708|NCT00873041|9740140|FG001|NOT COMPLETED|Extension Study||0
8694709|NCT00873041|9740141|FG002|NOT COMPLETED|Extension Study||2
8694710|NCT00873093|9740161|FG000|STARTED|Overall Study||4
8694711|NCT00873093|9740162|FG001|STARTED|Overall Study||62
8694712|NCT00873093|9740163|FG002|STARTED|Overall Study||49
8694713|NCT00873093|9740164|FG003|STARTED|Overall Study||23
8694714|NCT00873093|9740165|FG004|STARTED|Overall Study||10
8694715|NCT00873093|9740161|FG000|COMPLETED|Overall Study||3
8694716|NCT00873093|9740162|FG001|COMPLETED|Overall Study||35
8694717|NCT00873093|9740163|FG002|COMPLETED|Overall Study||33
8694718|NCT00873093|9740164|FG003|COMPLETED|Overall Study||12
8694719|NCT00873093|9740165|FG004|COMPLETED|Overall Study||8
8694720|NCT00873093|9740161|FG000|NOT COMPLETED|Overall Study||1
8694721|NCT00873093|9740162|FG001|NOT COMPLETED|Overall Study||27
8694722|NCT00873093|9740163|FG002|NOT COMPLETED|Overall Study||16
8694723|NCT00873093|9740164|FG003|NOT COMPLETED|Overall Study||11
8694724|NCT00873093|9740165|FG004|NOT COMPLETED|Overall Study||2
8694725|NCT00873119|9740189|FG000|STARTED|Overall Study||44
8694726|NCT00873119|9740190|FG001|STARTED|Overall Study||45
8724150|NCT01025843|9771499|FG000|NOT COMPLETED|Period 2||0
8694727|NCT00873119|9740189|FG000|COMPLETED|Overall Study|Of 42 patients treated with belinostat, 23 patients received 6 or more treatment cycles.|0
8694728|NCT00873119|9740190|FG001|COMPLETED|Overall Study||19
8694729|NCT00873119|9740189|FG000|NOT COMPLETED|Overall Study||44
8694730|NCT00873119|9740190|FG001|NOT COMPLETED|Overall Study||26
8694731|NCT00873327|9740196|FG000|STARTED|Overall Study||32
8694732|NCT00873327|9740196|FG000|COMPLETED|Overall Study||32
8694733|NCT00873327|9740196|FG000|NOT COMPLETED|Overall Study||0
8694734|NCT00873457|9740200|FG000|STARTED|Overall Study||16
8694735|NCT00873457|9740200|FG000|COMPLETED|Overall Study||16
8694736|NCT00873457|9740200|FG000|NOT COMPLETED|Overall Study||0
8694737|NCT00873730|9740206|FG000|STARTED|Overall Study||54
8694738|NCT00873730|9740207|FG001|STARTED|Overall Study||54
8694739|NCT00873730|9740206|FG000|COMPLETED|Overall Study||48
8694740|NCT00873730|9740207|FG001|COMPLETED|Overall Study||49
8694741|NCT00873730|9740206|FG000|NOT COMPLETED|Overall Study||6
8694742|NCT00873730|9740207|FG001|NOT COMPLETED|Overall Study||5
8694743|NCT00873782|9740213|FG000|STARTED|Overall Study||16
8694744|NCT00873782|9740213|FG000|COMPLETED|Overall Study||16
8694745|NCT00873782|9740213|FG000|NOT COMPLETED|Overall Study||0
8694746|NCT00873821|9740219|FG000|STARTED|Overall Study||22
8694747|NCT00873821|9740220|FG001|STARTED|Overall Study||22
8694748|NCT00873821|9740219|FG000|COMPLETED|Overall Study||22
8694749|NCT00873821|9740220|FG001|COMPLETED|Overall Study||22
8924810|NCT02252133|9985670|FG000|NOT COMPLETED|Period 2||0
8924811|NCT02252133|9985671|FG001|NOT COMPLETED|Period 2||0
8924812|NCT02252146|9985677|FG000|STARTED|Overall Study||6
8924813|NCT02252146|9985677|FG000|COMPLETED|Overall Study||0
8924814|NCT02252146|9985677|FG000|NOT COMPLETED|Overall Study||6
8924815|NCT02252211|9985683|FG000|STARTED|Overall Study||5
8924816|NCT02252211|9985684|FG001|STARTED|Overall Study||3
8924817|NCT02252211|9985685|FG002|STARTED|Overall Study||1
8924818|NCT02252211|9985683|FG000|Received Dose 1 (Day 1)|Overall Study||4
8924819|NCT02252211|9985684|FG001|Received Dose 1 (Day 1)|Overall Study||3
8924820|NCT02252211|9985685|FG002|Received Dose 1 (Day 1)|Overall Study||0
8924821|NCT02252211|9985683|FG000|Received Dose 2 (Day 8)|Overall Study||4
8924822|NCT02252211|9985684|FG001|Received Dose 2 (Day 8)|Overall Study||3
8924823|NCT02252211|9985685|FG002|Received Dose 2 (Day 8)|Overall Study||0
8924824|NCT02252211|9985683|FG000|Received Dose 3 (Day 22)|Overall Study||3
8924825|NCT02252211|9985684|FG001|Received Dose 3 (Day 22)|Overall Study||3
8924826|NCT02252211|9985685|FG002|Received Dose 3 (Day 22)|Overall Study||0
8924827|NCT02252211|9985683|FG000|Received Dose 4 (Day 36)|Overall Study||1
8924828|NCT02252211|9985684|FG001|Received Dose 4 (Day 36)|Overall Study||1
8924829|NCT02252211|9985685|FG002|Received Dose 4 (Day 36)|Overall Study||0
8924830|NCT02252211|9985683|FG000|Received Further Doses (Through Dose 24)|Overall Study||1
8924831|NCT02252211|9985684|FG001|Received Further Doses (Through Dose 24)|Overall Study||0
8924832|NCT02252211|9985685|FG002|Received Further Doses (Through Dose 24)|Overall Study||0
8924833|NCT02252211|9985683|FG000|COMPLETED|Overall Study||0
8924834|NCT02252211|9985684|FG001|COMPLETED|Overall Study||0
8924835|NCT02252211|9985685|FG002|COMPLETED|Overall Study||0
8924836|NCT02252211|9985683|FG000|NOT COMPLETED|Overall Study||5
8924837|NCT02252211|9985684|FG001|NOT COMPLETED|Overall Study||3
8924838|NCT02252211|9985685|FG002|NOT COMPLETED|Overall Study||1
8924839|NCT02252354|9985694|FG000|STARTED|Overall Study||6
8924840|NCT02252354|9985695|FG001|STARTED|Overall Study||6
8924841|NCT02252354|9985694|FG000|COMPLETED|Overall Study||6
8924842|NCT02252354|9985695|FG001|COMPLETED|Overall Study||6
8924843|NCT02252354|9985694|FG000|NOT COMPLETED|Overall Study||0
8924844|NCT02252354|9985695|FG001|NOT COMPLETED|Overall Study||0
8924845|NCT02252406|9985703|FG000|STARTED|Starting Dose Ranolazine 500 mg BID||16
8924846|NCT02252406|9985704|FG001|STARTED|Starting Dose Ranolazine 500 mg BID||17
8924847|NCT02252406|9985703|FG000|COMPLETED|Starting Dose Ranolazine 500 mg BID||12
8924848|NCT02252406|9985704|FG001|COMPLETED|Starting Dose Ranolazine 500 mg BID||14
8924849|NCT02252406|9985703|FG000|NOT COMPLETED|Starting Dose Ranolazine 500 mg BID||4
8924850|NCT02252406|9985704|FG001|NOT COMPLETED|Starting Dose Ranolazine 500 mg BID||3
8924851|NCT02252406|9985703|FG000|STARTED|Titrated to Ranolazine 1000mg BID||12
8924852|NCT02252406|9985704|FG001|STARTED|Titrated to Ranolazine 1000mg BID||14
8924853|NCT02252406|9985703|FG000|COMPLETED|Titrated to Ranolazine 1000mg BID||9
8924854|NCT02252406|9985704|FG001|COMPLETED|Titrated to Ranolazine 1000mg BID||13
8924855|NCT02252406|9985703|FG000|NOT COMPLETED|Titrated to Ranolazine 1000mg BID||3
8924856|NCT02252406|9985704|FG001|NOT COMPLETED|Titrated to Ranolazine 1000mg BID||1
8924857|NCT02252445|9985712|FG000|STARTED|Overall Study||41
8924858|NCT02252445|9985713|FG001|STARTED|Overall Study||41
8924859|NCT02252445|9985712|FG000|COMPLETED|Overall Study||41
8924860|NCT02252445|9985713|FG001|COMPLETED|Overall Study||41
8924861|NCT02252445|9985712|FG000|NOT COMPLETED|Overall Study||0
8694750|NCT00873821|9740219|FG000|NOT COMPLETED|Overall Study||0
8694751|NCT00873821|9740220|FG001|NOT COMPLETED|Overall Study||0
8694752|NCT00873860|9740230|FG000|STARTED|Overall Study||48
8694753|NCT00873860|9740231|FG001|STARTED|Overall Study||47
8694754|NCT00873860|9740232|FG002|STARTED|Overall Study||51
8694755|NCT00873860|9740233|FG003|STARTED|Overall Study||48
8694756|NCT00873860|9740230|FG000|Treated|Overall Study||47
8694757|NCT00873860|9740231|FG001|Treated|Overall Study||47
8694758|NCT00873860|9740232|FG002|Treated|Overall Study||51
8924862|NCT02252445|9985713|FG001|NOT COMPLETED|Overall Study||0
8694759|NCT00873860|9740233|FG003|Treated|Overall Study||48
8924863|NCT02252536|9985721|FG000|STARTED|Overall Study||173
8694760|NCT00873860|9740230|FG000|COMPLETED|Overall Study||44
8694761|NCT00873860|9740231|FG001|COMPLETED|Overall Study||47
8694762|NCT00873860|9740232|FG002|COMPLETED|Overall Study||48
8694763|NCT00873860|9740233|FG003|COMPLETED|Overall Study||47
8694764|NCT00873860|9740230|FG000|NOT COMPLETED|Overall Study||4
8694765|NCT00873860|9740231|FG001|NOT COMPLETED|Overall Study||0
8694766|NCT00873860|9740232|FG002|NOT COMPLETED|Overall Study||3
8694767|NCT00873860|9740233|FG003|NOT COMPLETED|Overall Study||1
8694768|NCT00873873|9740250|FG000|STARTED|Overall Study||20
8694769|NCT00873873|9740251|FG001|STARTED|Overall Study||8
8694770|NCT00873873|9740252|FG002|STARTED|Overall Study||9
8694771|NCT00873873|9740253|FG003|STARTED|Overall Study||18
8694772|NCT00873873|9740250|FG000|COMPLETED|Overall Study||20
8694773|NCT00873873|9740251|FG001|COMPLETED|Overall Study||8
8924864|NCT02252536|9985722|FG001|STARTED|Overall Study||173
8924865|NCT02252536|9985721|FG000|COMPLETED|Overall Study||168
8924866|NCT02252536|9985722|FG001|COMPLETED|Overall Study||170
8924867|NCT02252536|9985721|FG000|NOT COMPLETED|Overall Study||5
8924868|NCT02252536|9985722|FG001|NOT COMPLETED|Overall Study||3
8924869|NCT02252562|9985730|FG000|STARTED|Overall Study||1620
8924870|NCT02252562|9985731|FG001|STARTED|Overall Study||1636
8924871|NCT02252562|9985730|FG000|COMPLETED|Overall Study||1620
8924872|NCT02252562|9985731|FG001|COMPLETED|Overall Study||1636
8924873|NCT02252562|9985730|FG000|NOT COMPLETED|Overall Study||0
8924874|NCT02252562|9985731|FG001|NOT COMPLETED|Overall Study||0
8924875|NCT02252588|9985740|FG000|STARTED|Overall Study||24
8924876|NCT02252588|9985741|FG001|STARTED|Overall Study||20
8924877|NCT02252588|9985740|FG000|COMPLETED|Overall Study||20
8924878|NCT02252588|9985741|FG001|COMPLETED|Overall Study||20
8924879|NCT02252588|9985740|FG000|NOT COMPLETED|Overall Study||4
8924880|NCT02252588|9985741|FG001|NOT COMPLETED|Overall Study||0
8924881|NCT02252666|9985747|FG000|STARTED|Overall Study||6
8924882|NCT02252666|9985747|FG000|COMPLETED|Overall Study||6
8924883|NCT02252666|9985747|FG000|NOT COMPLETED|Overall Study||0
8924884|NCT02252718|9985751|FG000|STARTED|Overall Study||100
8924885|NCT02252718|9985751|FG000|COMPLETED|Overall Study||100
8924886|NCT02252718|9985751|FG000|NOT COMPLETED|Overall Study||0
8924887|NCT02252744|9985755|FG000|STARTED|Overall Study||286
8924888|NCT02252744|9985755|FG000|COMPLETED|Overall Study||286
8924889|NCT02252744|9985755|FG000|NOT COMPLETED|Overall Study||0
8924890|NCT02252939|9985759|FG000|STARTED|Overall Study||62
8924891|NCT02252939|9985759|FG000|COMPLETED|Overall Study||59
8924892|NCT02252939|9985759|FG000|NOT COMPLETED|Overall Study||3
8924893|NCT02252965|9985770|FG000|STARTED|Overall Study||267
8924894|NCT02252965|9985771|FG001|STARTED|Overall Study||265
8924895|NCT02252965|9985770|FG000|Safety Population|Overall Study|Out of 261, 12 subjects intolerant to the Metformin IR switched to Metformin XR group.|261
8924896|NCT02252965|9985771|FG001|Safety Population|Overall Study||264
8924897|NCT02252965|9985770|FG000|COMPLETED|Overall Study||227
8924898|NCT02252965|9985771|FG001|COMPLETED|Overall Study||222
8924899|NCT02252965|9985770|FG000|NOT COMPLETED|Overall Study||40
8924900|NCT02252965|9985771|FG001|NOT COMPLETED|Overall Study||43
8924901|NCT02253147|9985779|FG000|STARTED|Overall Study||118
8924902|NCT02253147|9985779|FG000|N Patients at W24 (Primary Outcome)|Overall Study||88
8924903|NCT02253147|9985779|FG000|N Patients at W36|Overall Study||86
8924904|NCT02253147|9985779|FG000|N Patients at W52|Overall Study||84
8924905|NCT02253147|9985779|FG000|COMPLETED|Overall Study||71
8924906|NCT02253147|9985779|FG000|NOT COMPLETED|Overall Study||47
8924907|NCT02253160|9985788|FG000|STARTED|Overall Study||1
8924908|NCT02253160|9985789|FG001|STARTED|Overall Study||12
8924909|NCT02253160|9985790|FG002|STARTED|Overall Study||10
8924910|NCT02253160|9985788|FG000|COMPLETED|Overall Study||1
8924911|NCT02253160|9985789|FG001|COMPLETED|Overall Study||12
8924912|NCT02253160|9985790|FG002|COMPLETED|Overall Study||10
8924913|NCT02253160|9985788|FG000|NOT COMPLETED|Overall Study||0
8924914|NCT02253160|9985789|FG001|NOT COMPLETED|Overall Study||0
8924915|NCT02253160|9985790|FG002|NOT COMPLETED|Overall Study||0
8924916|NCT02253173|9985804|FG000|STARTED|Overall Study||191
8924917|NCT02253173|9985805|FG001|STARTED|Overall Study||191
8924918|NCT02253173|9985806|FG002|STARTED|Overall Study||190
8924919|NCT02253173|9985807|FG003|STARTED|Overall Study||192
8924920|NCT02253173|9985804|FG000|COMPLETED|Overall Study||175
8924921|NCT02253173|9985805|FG001|COMPLETED|Overall Study||174
8924922|NCT02253173|9985806|FG002|COMPLETED|Overall Study||177
8924923|NCT02253173|9985807|FG003|COMPLETED|Overall Study||178
8924924|NCT02253173|9985804|FG000|NOT COMPLETED|Overall Study||16
8924925|NCT02253173|9985805|FG001|NOT COMPLETED|Overall Study||17
8924926|NCT02253173|9985806|FG002|NOT COMPLETED|Overall Study||13
8694774|NCT00873873|9740252|FG002|COMPLETED|Overall Study||9
8694775|NCT00873873|9740253|FG003|COMPLETED|Overall Study||18
8694776|NCT00873873|9740250|FG000|NOT COMPLETED|Overall Study||0
8924927|NCT02253173|9985807|FG003|NOT COMPLETED|Overall Study||14
8924928|NCT02253433|9985823|FG000|STARTED|Overall Study||130
8924929|NCT02253433|9985824|FG001|STARTED|Overall Study||134
8924930|NCT02253433|9985823|FG000|COMPLETED|Overall Study||114
8924931|NCT02253433|9985824|FG001|COMPLETED|Overall Study||79
8924932|NCT02253433|9985823|FG000|NOT COMPLETED|Overall Study||16
8924933|NCT02253433|9985824|FG001|NOT COMPLETED|Overall Study||55
8924934|NCT02253537|9985831|FG000|STARTED|Overall Study||15
8924935|NCT02253537|9985831|FG000|COMPLETED|Overall Study||15
8924936|NCT02253537|9985831|FG000|NOT COMPLETED|Overall Study||0
8924937|NCT02253654|9985837|FG000|STARTED|Overall Study||108
8694777|NCT00873873|9740251|FG001|NOT COMPLETED|Overall Study||0
8694778|NCT00873873|9740252|FG002|NOT COMPLETED|Overall Study||0
8694779|NCT00873873|9740253|FG003|NOT COMPLETED|Overall Study||0
8694780|NCT00873912|9740265|FG000|STARTED|Overall Study||240
8694781|NCT00873912|9740266|FG001|STARTED|Overall Study||60
8694782|NCT00873912|9740265|FG000|COMPLETED|Overall Study||237
8694783|NCT00873912|9740266|FG001|COMPLETED|Overall Study||60
8694784|NCT00873912|9740265|FG000|NOT COMPLETED|Overall Study||3
8694785|NCT00873912|9740266|FG001|NOT COMPLETED|Overall Study||0
8694786|NCT00874029|9740272|FG000|STARTED|Overall Study||137
8694787|NCT00874029|9740272|FG000|COMPLETED|Overall Study||116
8694788|NCT00874029|9740272|FG000|NOT COMPLETED|Overall Study||21
8924938|NCT02253654|9985838|FG001|STARTED|Overall Study||108
8924939|NCT02253654|9985837|FG000|Received Treatment|Overall Study||104
8924940|NCT02253654|9985838|FG001|Received Treatment|Overall Study||107
8924941|NCT02253654|9985837|FG000|COMPLETED|Overall Study||85
8924942|NCT02253654|9985838|FG001|COMPLETED|Overall Study||90
8924943|NCT02253654|9985837|FG000|NOT COMPLETED|Overall Study||23
8924944|NCT02253654|9985838|FG001|NOT COMPLETED|Overall Study||18
8924945|NCT02253992|9985847|FG000|STARTED|Overall Study||6
8924946|NCT02253992|9985848|FG001|STARTED|Overall Study||4
8924947|NCT02253992|9985849|FG002|STARTED|Overall Study||150
8924948|NCT02253992|9985847|FG000|COMPLETED|Overall Study||0
8924949|NCT02253992|9985848|FG001|COMPLETED|Overall Study||0
8924950|NCT02253992|9985849|FG002|COMPLETED|Overall Study||6
8924951|NCT02253992|9985847|FG000|NOT COMPLETED|Overall Study||6
8924952|NCT02253992|9985848|FG001|NOT COMPLETED|Overall Study||4
8924953|NCT02253992|9985849|FG002|NOT COMPLETED|Overall Study||144
8924954|NCT02254252|9985873|FG000|STARTED|Overall Study||27
8924955|NCT02254252|9985874|FG001|STARTED|Overall Study||27
8924956|NCT02254252|9985873|FG000|COMPLETED|Overall Study||24
8924957|NCT02254252|9985874|FG001|COMPLETED|Overall Study||25
8924958|NCT02254252|9985873|FG000|NOT COMPLETED|Overall Study||3
8924959|NCT02254252|9985874|FG001|NOT COMPLETED|Overall Study||2
8924960|NCT02254265|9985883|FG000|STARTED|Overall Study||151
8924961|NCT02254265|9985884|FG001|STARTED|Overall Study||152
8924962|NCT02254265|9985885|FG002|STARTED|Overall Study||152
8924963|NCT02254265|9985883|FG000|COMPLETED|Overall Study||142
8924964|NCT02254265|9985884|FG001|COMPLETED|Overall Study||140
8924965|NCT02254265|9985885|FG002|COMPLETED|Overall Study||144
8924966|NCT02254265|9985883|FG000|NOT COMPLETED|Overall Study||9
8924967|NCT02254265|9985884|FG001|NOT COMPLETED|Overall Study||12
8924968|NCT02254265|9985885|FG002|NOT COMPLETED|Overall Study||8
8924969|NCT02254291|9985896|FG000|STARTED|Overall Study||103
8924970|NCT02254291|9985897|FG001|STARTED|Overall Study||102
8924971|NCT02254291|9985898|FG002|STARTED|Overall Study||103
8924972|NCT02254291|9985896|FG000|Exposed|Overall Study||103
8924973|NCT02254291|9985897|FG001|Exposed|Overall Study||102
8924974|NCT02254291|9985898|FG002|Exposed|Overall Study||103
8924975|NCT02254291|9985896|FG000|COMPLETED|Overall Study||103
8924976|NCT02254291|9985897|FG001|COMPLETED|Overall Study||99
8924977|NCT02254291|9985898|FG002|COMPLETED|Overall Study||101
8924978|NCT02254291|9985896|FG000|NOT COMPLETED|Overall Study||0
8924979|NCT02254291|9985897|FG001|NOT COMPLETED|Overall Study||3
8924980|NCT02254291|9985898|FG002|NOT COMPLETED|Overall Study||2
8924981|NCT02254304|9985908|FG000|STARTED|Overall Study||89
8924982|NCT02254304|9985909|FG001|STARTED|Overall Study||17
8924983|NCT02254304|9985908|FG000|COMPLETED|Overall Study||75
8924984|NCT02254304|9985909|FG001|COMPLETED|Overall Study||13
8924985|NCT02254304|9985908|FG000|NOT COMPLETED|Overall Study||14
8924986|NCT02254304|9985909|FG001|NOT COMPLETED|Overall Study||4
8924987|NCT02254408|9985919|FG000|STARTED|Overall Study||96
8924988|NCT02254408|9985920|FG001|STARTED|Overall Study||93
9040432|NCT03351738|10101362|FG005|NOT COMPLETED|Overall Study||0
8694789|NCT00874094|9740286|FG000|STARTED|Overall Study||15
8694790|NCT00874094|9740286|FG000|COMPLETED|Overall Study||15
8694791|NCT00874094|9740286|FG000|NOT COMPLETED|Overall Study||0
8694792|NCT00874120|9740292|FG000|STARTED|First Intervention||58
8924989|NCT02254408|9985919|FG000|COMPLETED|Overall Study||88
8924990|NCT02254408|9985920|FG001|COMPLETED|Overall Study||83
8924991|NCT02254408|9985919|FG000|NOT COMPLETED|Overall Study||8
8924992|NCT02254408|9985920|FG001|NOT COMPLETED|Overall Study||10
8924993|NCT02254421|9985928|FG000|STARTED|Overall Study||31
8924994|NCT02254421|9985929|FG001|STARTED|Overall Study||29
8924995|NCT02254421|9985928|FG000|COMPLETED|Overall Study||29
8924996|NCT02254421|9985929|FG001|COMPLETED|Overall Study||26
8924997|NCT02254421|9985928|FG000|NOT COMPLETED|Overall Study||2
8924998|NCT02254421|9985929|FG001|NOT COMPLETED|Overall Study||3
8924999|NCT02254460|9985935|FG000|STARTED|Overall Study||13
8925000|NCT02254460|9985936|FG001|STARTED|Overall Study||12
8925001|NCT02254460|9985935|FG000|COMPLETED|Overall Study||12
8925002|NCT02254460|9985936|FG001|COMPLETED|Overall Study||12
8925003|NCT02254460|9985935|FG000|NOT COMPLETED|Overall Study||1
8925004|NCT02254460|9985936|FG001|NOT COMPLETED|Overall Study||0
8925005|NCT02254473|9985944|FG000|STARTED|Overall Study||9
8925006|NCT02254473|9985945|FG001|STARTED|Overall Study||3
8925007|NCT02254473|9985944|FG000|COMPLETED|Overall Study||7
8925008|NCT02254473|9985945|FG001|COMPLETED|Overall Study||2
8694793|NCT00874120|9740293|FG001|STARTED|First Intervention||58
8694794|NCT00874120|9740292|FG000|COMPLETED|First Intervention||52
8694795|NCT00874120|9740293|FG001|COMPLETED|First Intervention||56
8694796|NCT00874120|9740292|FG000|NOT COMPLETED|First Intervention||6
8925009|NCT02254473|9985944|FG000|NOT COMPLETED|Overall Study||2
8925010|NCT02254473|9985945|FG001|NOT COMPLETED|Overall Study||1
8694797|NCT00874120|9740293|FG001|NOT COMPLETED|First Intervention||2
8694798|NCT00874120|9740292|FG000|STARTED|Wash-out Period||52
8694799|NCT00874120|9740293|FG001|STARTED|Wash-out Period||56
8694800|NCT00874120|9740292|FG000|COMPLETED|Wash-out Period||52
8925011|NCT02254486|9985953|FG000|STARTED|Overall Study||311
8925012|NCT02254486|9985954|FG001|STARTED|Overall Study||310
8925013|NCT02254486|9985953|FG000|COMPLETED|Overall Study||261
8925014|NCT02254486|9985954|FG001|COMPLETED|Overall Study||255
8925015|NCT02254486|9985953|FG000|NOT COMPLETED|Overall Study||50
8925016|NCT02254486|9985954|FG001|NOT COMPLETED|Overall Study||55
8925017|NCT02254551|9985960|FG000|STARTED|Dose Escalation||7
8925018|NCT02254551|9985960|FG000|Cohort 1: LDE225 400mg|Dose Escalation|1 patient was found to be refractory to bortezomib and deemed ineligible.|7
8925019|NCT02254551|9985960|FG000|Cohort 2: LDE225 600mg|Dose Escalation||0
8925020|NCT02254551|9985960|FG000|Cohort 3: LDE225 800mg|Dose Escalation||0
8925021|NCT02254551|9985960|FG000|COMPLETED|Dose Escalation|Due to toxicity and lack of efficacy, no other dose levels were examined.|4
8925022|NCT02254551|9985960|FG000|NOT COMPLETED|Dose Escalation||3
8925023|NCT02254551|9985960|FG000|STARTED|Expansion||0
8925024|NCT02254551|9985960|FG000|COMPLETED|Expansion||0
8925025|NCT02254551|9985960|FG000|NOT COMPLETED|Expansion||0
8925026|NCT02254551|9985960|FG000|STARTED|Maintenance||0
8925027|NCT02254551|9985960|FG000|COMPLETED|Maintenance||0
8925028|NCT02254551|9985960|FG000|NOT COMPLETED|Maintenance||0
8925029|NCT02254681|9985967|FG000|STARTED|Overall Study||6
8925030|NCT02254681|9985967|FG000|COMPLETED|Overall Study||0
8925031|NCT02254681|9985967|FG000|NOT COMPLETED|Overall Study||6
8925032|NCT02254772|9985972|FG000|STARTED|Overall Study||9
8925033|NCT02254772|9985972|FG000|COMPLETED|Overall Study||7
8925034|NCT02254772|9985972|FG000|NOT COMPLETED|Overall Study||2
8925035|NCT02255032|9985978|FG000|STARTED|Overall Study||17
8925036|NCT02255032|9985979|FG001|STARTED|Overall Study||5
8925037|NCT02255032|9985978|FG000|COMPLETED|Overall Study||17
8925038|NCT02255032|9985979|FG001|COMPLETED|Overall Study||5
8925039|NCT02255032|9985978|FG000|NOT COMPLETED|Overall Study||0
8925040|NCT02255032|9985979|FG001|NOT COMPLETED|Overall Study||0
8925041|NCT02255097|9985985|FG000|STARTED|Overall Study||172
8925042|NCT02255097|9985985|FG000|Treated|Overall Study||171
8925043|NCT02255097|9985985|FG000|COMPLETED|Overall Study||0
8925044|NCT02255097|9985985|FG000|NOT COMPLETED|Overall Study||172
8925045|NCT02255110|9985989|FG000|STARTED|Overall Study||6
8925046|NCT02255110|9985989|FG000|COMPLETED|Overall Study||6
8925047|NCT02255110|9985989|FG000|NOT COMPLETED|Overall Study||0
8925048|NCT02255149|9985993|FG000|STARTED|Overall Study||10
8925049|NCT02255149|9985993|FG000|COMPLETED|Overall Study||5
8925050|NCT02255149|9985993|FG000|NOT COMPLETED|Overall Study||5
8925051|NCT02255175|9985999|FG000|STARTED|Overall Study||33
8925052|NCT02255175|9986000|FG001|STARTED|Overall Study||31
8925053|NCT02255175|9985999|FG000|COMPLETED|Overall Study||16
8925054|NCT02255175|9986000|FG001|COMPLETED|Overall Study||19
8925055|NCT02255175|9985999|FG000|NOT COMPLETED|Overall Study||17
8925056|NCT02255175|9986000|FG001|NOT COMPLETED|Overall Study||12
8925057|NCT02255279|9986012|FG000|STARTED|Overall Study||144
8925058|NCT02255279|9986013|FG001|STARTED|Overall Study||143
8925059|NCT02255279|9986012|FG000|COMPLETED|Overall Study||139
8925060|NCT02255279|9986013|FG001|COMPLETED|Overall Study||134
8925061|NCT02255279|9986012|FG000|NOT COMPLETED|Overall Study||5
8925062|NCT02255279|9986013|FG001|NOT COMPLETED|Overall Study||9
8925063|NCT02255357|9986035|FG000|STARTED|Overall Study||11
8925064|NCT02255357|9986036|FG001|STARTED|Overall Study||15
8925065|NCT02255357|9986035|FG000|COMPLETED|Overall Study||4
8925066|NCT02255357|9986036|FG001|COMPLETED|Overall Study||5
8925067|NCT02255357|9986035|FG000|NOT COMPLETED|Overall Study||7
8925068|NCT02255357|9986036|FG001|NOT COMPLETED|Overall Study||10
8925069|NCT02255422|9986049|FG000|STARTED|Overall Study||13
8925070|NCT02255422|9986050|FG001|STARTED|Overall Study||6
8694801|NCT00874120|9740293|FG001|COMPLETED|Wash-out Period||56
8694802|NCT00874120|9740292|FG000|NOT COMPLETED|Wash-out Period||0
8694803|NCT00874120|9740293|FG001|NOT COMPLETED|Wash-out Period||0
8694804|NCT00874120|9740292|FG000|STARTED|Second Intervention||52
8925071|NCT02255422|9986051|FG002|STARTED|Overall Study||6
8925072|NCT02255422|9986052|FG003|STARTED|Overall Study||6
8925073|NCT02255422|9986053|FG004|STARTED|Overall Study||6
8925074|NCT02255422|9986054|FG005|STARTED|Overall Study||6
8925075|NCT02255422|9986055|FG006|STARTED|Overall Study||10
8925076|NCT02255422|9986049|FG000|COMPLETED|Overall Study||13
8925077|NCT02255422|9986050|FG001|COMPLETED|Overall Study||6
8925078|NCT02255422|9986051|FG002|COMPLETED|Overall Study||5
8925079|NCT02255422|9986052|FG003|COMPLETED|Overall Study||6
8925080|NCT02255422|9986053|FG004|COMPLETED|Overall Study||6
8925081|NCT02255422|9986054|FG005|COMPLETED|Overall Study||6
8925082|NCT02255422|9986055|FG006|COMPLETED|Overall Study||8
8925083|NCT02255422|9986049|FG000|NOT COMPLETED|Overall Study||0
8925084|NCT02255422|9986050|FG001|NOT COMPLETED|Overall Study||0
8925085|NCT02255422|9986051|FG002|NOT COMPLETED|Overall Study||1
8925086|NCT02255422|9986052|FG003|NOT COMPLETED|Overall Study||0
8925087|NCT02255422|9986053|FG004|NOT COMPLETED|Overall Study||0
8925088|NCT02255422|9986054|FG005|NOT COMPLETED|Overall Study||0
8925089|NCT02255422|9986055|FG006|NOT COMPLETED|Overall Study||2
8925090|NCT02255461|9986076|FG000|STARTED|Overall Study||3
8925091|NCT02255461|9986077|FG001|STARTED|Overall Study||12
8925092|NCT02255461|9986078|FG002|STARTED|Overall Study||6
8925093|NCT02255461|9986079|FG003|STARTED|Overall Study||4
8694805|NCT00874120|9740293|FG001|STARTED|Second Intervention||56
8694806|NCT00874120|9740292|FG000|COMPLETED|Second Intervention||50
8694807|NCT00874120|9740293|FG001|COMPLETED|Second Intervention||56
8809711|NCT01500187|9862405|FG000|COMPLETED|Overall Study||17
8809712|NCT01500187|9862406|FG001|COMPLETED|Overall Study||15
8925094|NCT02255461|9986080|FG004|STARTED|Overall Study||10
8925095|NCT02255461|9986076|FG000|COMPLETED|Overall Study||3
8925096|NCT02255461|9986077|FG001|COMPLETED|Overall Study||10
8925097|NCT02255461|9986078|FG002|COMPLETED|Overall Study||5
8925098|NCT02255461|9986079|FG003|COMPLETED|Overall Study||4
8925099|NCT02255461|9986080|FG004|COMPLETED|Overall Study||8
8925100|NCT02255461|9986076|FG000|NOT COMPLETED|Overall Study||0
8925101|NCT02255461|9986077|FG001|NOT COMPLETED|Overall Study||2
8925102|NCT02255461|9986078|FG002|NOT COMPLETED|Overall Study||1
8694808|NCT00874120|9740292|FG000|NOT COMPLETED|Second Intervention||2
8694809|NCT00874120|9740293|FG001|NOT COMPLETED|Second Intervention||0
8694810|NCT00874237|9740299|FG000|STARTED|Overall Study||8
8694811|NCT00874237|9740300|FG001|STARTED|Overall Study||8
8694812|NCT00874237|9740301|FG002|STARTED|Overall Study||8
8694813|NCT00874237|9740302|FG003|STARTED|Overall Study||8
8694814|NCT00874237|9740303|FG004|STARTED|Overall Study||8
8694815|NCT00874237|9740304|FG005|STARTED|Overall Study||8
8694816|NCT00874237|9740299|FG000|COMPLETED|Overall Study||8
8694817|NCT00874237|9740300|FG001|COMPLETED|Overall Study||7
8694818|NCT00874237|9740301|FG002|COMPLETED|Overall Study||7
8694819|NCT00874237|9740302|FG003|COMPLETED|Overall Study||8
8694820|NCT00874237|9740303|FG004|COMPLETED|Overall Study||8
8694821|NCT00874237|9740304|FG005|COMPLETED|Overall Study||8
8694822|NCT00874237|9740299|FG000|NOT COMPLETED|Overall Study||0
8694823|NCT00874237|9740300|FG001|NOT COMPLETED|Overall Study||1
8694824|NCT00874237|9740301|FG002|NOT COMPLETED|Overall Study||1
8694825|NCT00874237|9740302|FG003|NOT COMPLETED|Overall Study||0
8694826|NCT00874237|9740303|FG004|NOT COMPLETED|Overall Study||0
8694827|NCT00874237|9740304|FG005|NOT COMPLETED|Overall Study||0
8694828|NCT00874250|9740314|FG000|STARTED|Overall Study||51
8694829|NCT00874250|9740314|FG000|COMPLETED|Overall Study||0
8694830|NCT00874250|9740314|FG000|NOT COMPLETED|Overall Study||51
8694831|NCT00874276|9740321|FG000|STARTED|Overall Study||6
8694832|NCT00874276|9740322|FG001|STARTED|Overall Study||8
8694833|NCT00874276|9740321|FG000|COMPLETED|Overall Study||5
8694834|NCT00874276|9740322|FG001|COMPLETED|Overall Study||7
8694835|NCT00874276|9740321|FG000|NOT COMPLETED|Overall Study||1
8694836|NCT00874276|9740322|FG001|NOT COMPLETED|Overall Study||1
8694837|NCT00874432|9740334|FG000|STARTED|Overall Study||8
8694838|NCT00874432|9740335|FG001|STARTED|Overall Study||4
8694839|NCT00874432|9740336|FG002|STARTED|Overall Study||17
8694840|NCT00874432|9740337|FG003|STARTED|Overall Study||14
8694841|NCT00874432|9740334|FG000|COMPLETED|Overall Study||5
8694842|NCT00874432|9740335|FG001|COMPLETED|Overall Study||2
8694843|NCT00874432|9740336|FG002|COMPLETED|Overall Study||9
8694844|NCT00874432|9740337|FG003|COMPLETED|Overall Study||11
8694845|NCT00874432|9740334|FG000|NOT COMPLETED|Overall Study||3
8694846|NCT00874432|9740335|FG001|NOT COMPLETED|Overall Study||2
8694847|NCT00874432|9740336|FG002|NOT COMPLETED|Overall Study||8
8694848|NCT00874432|9740337|FG003|NOT COMPLETED|Overall Study||3
8694849|NCT00874497|9740351|FG000|STARTED|Overall Study|This is the number of participants who were treated and were considered as safety population.|51
8694850|NCT00874497|9740352|FG001|STARTED|Overall Study|This is the number of participants who were treated and were considered as safety population.|33
8694851|NCT00874497|9740351|FG000|COMPLETED|Overall Study||23
8694852|NCT00874497|9740352|FG001|COMPLETED|Overall Study||15
8694853|NCT00874497|9740351|FG000|NOT COMPLETED|Overall Study||28
8694854|NCT00874497|9740352|FG001|NOT COMPLETED|Overall Study||18
8694855|NCT00874510|9740360|FG000|STARTED|Year 1||88
8694856|NCT00874510|9740361|FG001|STARTED|Year 1||85
8694857|NCT00874510|9740360|FG000|COMPLETED|Year 1||88
8694858|NCT00874510|9740361|FG001|COMPLETED|Year 1||85
8694859|NCT00874510|9740360|FG000|NOT COMPLETED|Year 1||0
8694860|NCT00874510|9740361|FG001|NOT COMPLETED|Year 1||0
8694861|NCT00874510|9740360|FG000|STARTED|Year 2||92
8694862|NCT00874510|9740361|FG001|STARTED|Year 2||87
8694863|NCT00874510|9740360|FG000|COMPLETED|Year 2||92
8694864|NCT00874510|9740361|FG001|COMPLETED|Year 2||87
8694865|NCT00874510|9740360|FG000|NOT COMPLETED|Year 2||0
8694866|NCT00874510|9740361|FG001|NOT COMPLETED|Year 2||0
8694867|NCT00874549|9740371|FG000|STARTED|Overall Study||51
8694868|NCT00874549|9740372|FG001|STARTED|Overall Study||56
8694869|NCT00874549|9740373|FG002|STARTED|Overall Study||51
8694870|NCT00874549|9740374|FG003|STARTED|Overall Study||58
8694871|NCT00874549|9740371|FG000|COMPLETED|Overall Study||50
8694872|NCT00874549|9740372|FG001|COMPLETED|Overall Study||55
8694873|NCT00874549|9740373|FG002|COMPLETED|Overall Study||47
8694874|NCT00874549|9740374|FG003|COMPLETED|Overall Study||56
8694875|NCT00874549|9740371|FG000|NOT COMPLETED|Overall Study||1
8694876|NCT00874549|9740372|FG001|NOT COMPLETED|Overall Study||1
8694877|NCT00874549|9740373|FG002|NOT COMPLETED|Overall Study||4
8925103|NCT02255461|9986079|FG003|NOT COMPLETED|Overall Study||0
8925104|NCT02255461|9986080|FG004|NOT COMPLETED|Overall Study||2
8925105|NCT02255474|9986100|FG000|STARTED|Overall Study||98
8925106|NCT02255474|9986101|FG001|STARTED|Overall Study||98
8925107|NCT02255474|9986102|FG002|STARTED|Overall Study||98
8925108|NCT02255474|9986100|FG000|COMPLETED|Overall Study||96
8925109|NCT02255474|9986101|FG001|COMPLETED|Overall Study||96
8925110|NCT02255474|9986102|FG002|COMPLETED|Overall Study||95
8925111|NCT02255474|9986100|FG000|NOT COMPLETED|Overall Study||2
8694878|NCT00874549|9740374|FG003|NOT COMPLETED|Overall Study||2
8694879|NCT00874614|9740384|FG000|STARTED|Overall Study||74
8694880|NCT00874614|9740384|FG000|Received at Least One Therapeutic Dose|Overall Study||68
8694881|NCT00874614|9740384|FG000|Received Two Therapeutic Doses|Overall Study||50
8694882|NCT00874614|9740384|FG000|COMPLETED|Overall Study|As of December 2017|16
8694883|NCT00874614|9740384|FG000|NOT COMPLETED|Overall Study||58
8694884|NCT00874731|9740390|FG000|STARTED|Part 1, Day 1: Placebo||23
8694885|NCT00874731|9740391|FG001|STARTED|Part 1, Day 1: Placebo||0
8694886|NCT00874731|9740392|FG002|STARTED|Part 1, Day 1: Placebo||0
8694887|NCT00874731|9740390|FG000|COMPLETED|Part 1, Day 1: Placebo||22
8694888|NCT00874731|9740391|FG001|COMPLETED|Part 1, Day 1: Placebo||0
8694889|NCT00874731|9740392|FG002|COMPLETED|Part 1, Day 1: Placebo||0
8694890|NCT00874731|9740390|FG000|NOT COMPLETED|Part 1, Day 1: Placebo||1
8694891|NCT00874731|9740391|FG001|NOT COMPLETED|Part 1, Day 1: Placebo||0
8694892|NCT00874731|9740392|FG002|NOT COMPLETED|Part 1, Day 1: Placebo||0
8694893|NCT00874731|9740390|FG000|STARTED|Part 1, Day 2: Ridaforolimus 100 mg|"Participants completing Pt 1, Day 1, enter into the Pt 1, Day 2. Ridaforolimus 100 mg arm."|0
8694894|NCT00874731|9740391|FG001|STARTED|Part 1, Day 2: Ridaforolimus 100 mg|"Participants completing Pt 1, Day 1, started this period in Pt 1, Day 2. Ridaforolimus 100 mg arm."|22
8694895|NCT00874731|9740392|FG002|STARTED|Part 1, Day 2: Ridaforolimus 100 mg||0
8694896|NCT00874731|9740390|FG000|COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0
8694897|NCT00874731|9740391|FG001|COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||22
8694898|NCT00874731|9740392|FG002|COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0
8694899|NCT00874731|9740390|FG000|NOT COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0
8694900|NCT00874731|9740391|FG001|NOT COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0
8694901|NCT00874731|9740392|FG002|NOT COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0
8694902|NCT00874731|9740390|FG000|STARTED|Washout Period||0
8694903|NCT00874731|9740391|FG001|STARTED|Washout Period||22
8694904|NCT00874731|9740392|FG002|STARTED|Washout Period||0
8694905|NCT00874731|9740390|FG000|COMPLETED|Washout Period||0
8694906|NCT00874731|9740391|FG001|COMPLETED|Washout Period||22
8694907|NCT00874731|9740392|FG002|COMPLETED|Washout Period||0
8694908|NCT00874731|9740390|FG000|NOT COMPLETED|Washout Period||0
8694909|NCT00874731|9740391|FG001|NOT COMPLETED|Washout Period||0
8694910|NCT00874731|9740392|FG002|NOT COMPLETED|Washout Period||0
8694911|NCT00874731|9740390|FG000|STARTED|Part 2: Ridaforolimus 40 mg||0
8694912|NCT00874731|9740391|FG001|STARTED|Part 2: Ridaforolimus 40 mg|"Participants completing Pt 1 and washout, enter into the Pt 2. Ridaforolimus 40 mg arm."|0
8694913|NCT00874731|9740392|FG002|STARTED|Part 2: Ridaforolimus 40 mg|"Participants completing Pt 1 and washout, started this period in Pt 2. Ridaforolimus 40 mg arm."|22
8694914|NCT00874731|9740390|FG000|COMPLETED|Part 2: Ridaforolimus 40 mg||0
8694915|NCT00874731|9740391|FG001|COMPLETED|Part 2: Ridaforolimus 40 mg||0
8694916|NCT00874731|9740392|FG002|COMPLETED|Part 2: Ridaforolimus 40 mg||0
8925112|NCT02255474|9986101|FG001|NOT COMPLETED|Overall Study||2
8925113|NCT02255474|9986102|FG002|NOT COMPLETED|Overall Study||3
8925114|NCT02255500|9986113|FG000|STARTED|Overall Study||16
8925115|NCT02255500|9986114|FG001|STARTED|Overall Study||7
8925116|NCT02255500|9986113|FG000|COMPLETED|Overall Study||15
8925117|NCT02255500|9986114|FG001|COMPLETED|Overall Study||7
8925118|NCT02255500|9986113|FG000|NOT COMPLETED|Overall Study||1
8578697|NCT00177047|9611807|FG000|COMPLETED|Overall Study||363
8578698|NCT00177047|9611807|FG000|NOT COMPLETED|Overall Study||0
8578699|NCT00177164|9611813|FG000|STARTED|Overall Study||23
8578700|NCT00177164|9611814|FG001|STARTED|Overall Study||25
8578701|NCT00177164|9611813|FG000|COMPLETED|Overall Study||14
8578702|NCT00177164|9611814|FG001|COMPLETED|Overall Study||9
8578703|NCT00177164|9611813|FG000|NOT COMPLETED|Overall Study||9
8578704|NCT00177164|9611814|FG001|NOT COMPLETED|Overall Study||16
8578705|NCT00177216|9611823|FG000|STARTED|Overall Study||26
8578706|NCT00177216|9611824|FG001|STARTED|Overall Study||23
8578707|NCT00177216|9611825|FG002|STARTED|Overall Study||20
8578708|NCT00177216|9611823|FG000|COMPLETED|Overall Study||20
8578709|NCT00177216|9611824|FG001|COMPLETED|Overall Study||20
8578710|NCT00177216|9611825|FG002|COMPLETED|Overall Study||19
8578711|NCT00177216|9611823|FG000|NOT COMPLETED|Overall Study||6
8578712|NCT00177216|9611824|FG001|NOT COMPLETED|Overall Study||3
8578713|NCT00177216|9611825|FG002|NOT COMPLETED|Overall Study||1
8578714|NCT00177255|9611837|FG000|STARTED|Overall Study||39
8578715|NCT00177255|9611837|FG000|COMPLETED|Overall Study||39
8578716|NCT00177255|9611837|FG000|NOT COMPLETED|Overall Study||0
8578717|NCT00177294|9611843|FG000|STARTED|Overall Study||60
8578718|NCT00177294|9611844|FG001|STARTED|Overall Study||64
8578719|NCT00177294|9611843|FG000|COMPLETED|Overall Study||53
8578720|NCT00177294|9611844|FG001|COMPLETED|Overall Study||59
8578721|NCT00177294|9611843|FG000|NOT COMPLETED|Overall Study||7
8578722|NCT00177294|9611844|FG001|NOT COMPLETED|Overall Study||5
8578723|NCT00177307|9611850|FG000|STARTED|Overall Study||40
8578724|NCT00177307|9611850|FG000|COMPLETED|Overall Study||39
8578725|NCT00177307|9611850|FG000|NOT COMPLETED|Overall Study||1
8578726|NCT00177671|9611856|FG000|STARTED|Overall Study||67
8578727|NCT00177671|9611857|FG001|STARTED|Overall Study||63
8578728|NCT00177671|9611856|FG000|Month 12|Overall Study||45
8578729|NCT00177671|9611857|FG001|Month 12|Overall Study||57
8578730|NCT00177671|9611856|FG000|Month 24|Overall Study||42
8578731|NCT00177671|9611857|FG001|Month 24|Overall Study||49
8578732|NCT00177671|9611856|FG000|COMPLETED|Overall Study||42
8578733|NCT00177671|9611857|FG001|COMPLETED|Overall Study||49
8694917|NCT00874731|9740390|FG000|NOT COMPLETED|Part 2: Ridaforolimus 40 mg||0
8694918|NCT00874731|9740391|FG001|NOT COMPLETED|Part 2: Ridaforolimus 40 mg||0
8694919|NCT00874731|9740392|FG002|NOT COMPLETED|Part 2: Ridaforolimus 40 mg||22
8694920|NCT00874770|9740404|FG000|STARTED|Overall Study||12
8694921|NCT00874770|9740405|FG001|STARTED|Overall Study||12
8694922|NCT00874770|9740406|FG002|STARTED|Overall Study||12
8694923|NCT00874770|9740407|FG003|STARTED|Overall Study||12
8694924|NCT00874770|9740404|FG000|COMPLETED|Overall Study||7
8694925|NCT00874770|9740405|FG001|COMPLETED|Overall Study||11
8694926|NCT00874770|9740406|FG002|COMPLETED|Overall Study||8
8694927|NCT00874770|9740407|FG003|COMPLETED|Overall Study||7
8694928|NCT00874770|9740404|FG000|NOT COMPLETED|Overall Study||5
8694929|NCT00874770|9740405|FG001|NOT COMPLETED|Overall Study||1
8694930|NCT00874770|9740406|FG002|NOT COMPLETED|Overall Study||4
8694931|NCT00874770|9740407|FG003|NOT COMPLETED|Overall Study||5
8925119|NCT02255500|9986114|FG001|NOT COMPLETED|Overall Study||0
8925120|NCT02255513|9986122|FG000|STARTED|Open-label, Treatment Optimization||43
8925121|NCT02255513|9986123|FG001|STARTED|Open-label, Treatment Optimization||0
8925122|NCT02255513|9986122|FG000|COMPLETED|Open-label, Treatment Optimization||43
8925123|NCT02255513|9986123|FG001|COMPLETED|Open-label, Treatment Optimization||0
8925124|NCT02255513|9986122|FG000|NOT COMPLETED|Open-label, Treatment Optimization||0
8925125|NCT02255513|9986123|FG001|NOT COMPLETED|Open-label, Treatment Optimization||0
8925126|NCT02255513|9986122|FG000|STARTED|Double Blind, Placebo-controlled||22
8925127|NCT02255513|9986123|FG001|STARTED|Double Blind, Placebo-controlled||21
8925128|NCT02255513|9986122|FG000|COMPLETED|Double Blind, Placebo-controlled||22
8925129|NCT02255513|9986123|FG001|COMPLETED|Double Blind, Placebo-controlled||21
8925130|NCT02255513|9986122|FG000|NOT COMPLETED|Double Blind, Placebo-controlled||0
8925131|NCT02255513|9986123|FG001|NOT COMPLETED|Double Blind, Placebo-controlled||0
8925132|NCT02255552|9986131|FG000|STARTED|Overall Study||79
8925133|NCT02255552|9986132|FG001|STARTED|Overall Study||30
8925134|NCT02255552|9986131|FG000|COMPLETED|Overall Study||78
8925135|NCT02255552|9986132|FG001|COMPLETED|Overall Study||15
8925136|NCT02255552|9986131|FG000|NOT COMPLETED|Overall Study||1
8925137|NCT02255552|9986132|FG001|NOT COMPLETED|Overall Study||15
8925138|NCT02255565|9986141|FG000|STARTED|Overall Study||9
8925139|NCT02255565|9986142|FG001|STARTED|Overall Study||9
8925140|NCT02255565|9986143|FG002|STARTED|Overall Study||9
8925141|NCT02255565|9986141|FG000|COMPLETED|Overall Study||9
8925142|NCT02255565|9986142|FG001|COMPLETED|Overall Study||8
8925143|NCT02255565|9986143|FG002|COMPLETED|Overall Study||9
8925144|NCT02255565|9986141|FG000|NOT COMPLETED|Overall Study||0
8925145|NCT02255565|9986142|FG001|NOT COMPLETED|Overall Study||1
8925146|NCT02255565|9986143|FG002|NOT COMPLETED|Overall Study||0
8925147|NCT02255604|9986187|FG000|STARTED|Overall Study||12
8925148|NCT02255604|9986188|FG001|STARTED|Overall Study||12
8925149|NCT02255604|9986189|FG002|STARTED|Overall Study||12
8925150|NCT02255604|9986187|FG000|COMPLETED|Overall Study||10
8925151|NCT02255604|9986188|FG001|COMPLETED|Overall Study||11
8925152|NCT02255604|9986189|FG002|COMPLETED|Overall Study||9
8925153|NCT02255604|9986187|FG000|NOT COMPLETED|Overall Study||2
8925154|NCT02255604|9986188|FG001|NOT COMPLETED|Overall Study||1
8925155|NCT02255604|9986189|FG002|NOT COMPLETED|Overall Study||3
8925156|NCT02255760|9986202|FG000|STARTED|Overall Study||14
8925157|NCT02255760|9986203|FG001|STARTED|Overall Study||3
8925158|NCT02255760|9986204|FG002|STARTED|Overall Study||15
8925159|NCT02255760|9986205|FG003|STARTED|Overall Study||15
8925160|NCT02255760|9986206|FG004|STARTED|Overall Study||9
8925161|NCT02255760|9986202|FG000|COMPLETED|Overall Study||14
8925162|NCT02255760|9986203|FG001|COMPLETED|Overall Study||2
8925163|NCT02255760|9986204|FG002|COMPLETED|Overall Study||15
8925164|NCT02255760|9986205|FG003|COMPLETED|Overall Study||15
8925165|NCT02255760|9986206|FG004|COMPLETED|Overall Study||9
8925166|NCT02255760|9986202|FG000|NOT COMPLETED|Overall Study||0
8925167|NCT02255760|9986203|FG001|NOT COMPLETED|Overall Study||1
8925168|NCT02255760|9986204|FG002|NOT COMPLETED|Overall Study||0
8925169|NCT02255760|9986205|FG003|NOT COMPLETED|Overall Study||0
8925170|NCT02255760|9986206|FG004|NOT COMPLETED|Overall Study||0
8925171|NCT02255981|9986222|FG000|STARTED|Overall Study|Both eyes of each patient were included except 2 that not were treatable|33
8925172|NCT02255981|9986222|FG000|COMPLETED|Overall Study|2 eyes of the final 29 subjects were excluded.|29
8694932|NCT00874822|9740427|FG000|STARTED|Overall Study||216
8694933|NCT00874822|9740427|FG000|COMPLETED|Overall Study||208
8694934|NCT00874822|9740427|FG000|NOT COMPLETED|Overall Study||8
8694935|NCT00874848|9740433|FG000|STARTED|Overall Study||59
8694936|NCT00874848|9740434|FG001|STARTED|Overall Study||29
8694937|NCT00874848|9740433|FG000|Discontinued|Overall Study||59
8694938|NCT00874848|9740434|FG001|Discontinued|Overall Study||28
8925173|NCT02255981|9986222|FG000|NOT COMPLETED|Overall Study||4
8925174|NCT02256072|9986234|FG000|STARTED|Overall Study||194
8925175|NCT02256072|9986235|FG001|STARTED|Overall Study||191
8925176|NCT02256072|9986234|FG000|Completed 1 Month Follow-Up|Overall Study|Completed the 1-month follow-up|167
8925177|NCT02256072|9986235|FG001|Completed 1 Month Follow-Up|Overall Study||179
8925178|NCT02256072|9986234|FG000|COMPLETED|Overall Study|Completed the 3-month follow-up|152
8925179|NCT02256072|9986235|FG001|COMPLETED|Overall Study||162
8925180|NCT02256072|9986234|FG000|NOT COMPLETED|Overall Study||42
8694939|NCT00874848|9740433|FG000|COMPLETED|Overall Study|Pts who completed 18 tx cycles without progressive disease were defined as completing treatment.|0
8724151|NCT01025843|9771500|FG001|NOT COMPLETED|Period 2||0
8694940|NCT00874848|9740434|FG001|COMPLETED|Overall Study|Pts who completed 18 tx cycles without progressive disease were defined as completing treatment.|1
8694941|NCT00874848|9740433|FG000|NOT COMPLETED|Overall Study||59
8694942|NCT00874848|9740434|FG001|NOT COMPLETED|Overall Study||28
8694943|NCT00874887|9740442|FG000|STARTED|Overall Study||32
8694944|NCT00874887|9740443|FG001|STARTED|Overall Study||34
8694945|NCT00874887|9740442|FG000|COMPLETED|Overall Study||32
8694946|NCT00874887|9740443|FG001|COMPLETED|Overall Study||34
8694947|NCT00874887|9740442|FG000|NOT COMPLETED|Overall Study||0
8694948|NCT00874887|9740443|FG001|NOT COMPLETED|Overall Study||0
8694949|NCT00875017|9740455|FG000|STARTED|First Intervention||5
8694950|NCT00875017|9740456|FG001|STARTED|First Intervention||5
8694951|NCT00875017|9740457|FG002|STARTED|First Intervention||5
8694952|NCT00875017|9740458|FG003|STARTED|First Intervention||6
8694953|NCT00875017|9740459|FG004|STARTED|First Intervention||5
8694954|NCT00875017|9740460|FG005|STARTED|First Intervention||5
8694955|NCT00875017|9740455|FG000|COMPLETED|First Intervention||3
8694956|NCT00875017|9740456|FG001|COMPLETED|First Intervention||5
8694957|NCT00875017|9740457|FG002|COMPLETED|First Intervention||4
8694958|NCT00875017|9740458|FG003|COMPLETED|First Intervention||5
8694959|NCT00875017|9740459|FG004|COMPLETED|First Intervention||4
8694960|NCT00875017|9740460|FG005|COMPLETED|First Intervention||5
8694961|NCT00875017|9740455|FG000|NOT COMPLETED|First Intervention||2
8694962|NCT00875017|9740456|FG001|NOT COMPLETED|First Intervention||0
8694963|NCT00875017|9740457|FG002|NOT COMPLETED|First Intervention||1
8694964|NCT00875017|9740458|FG003|NOT COMPLETED|First Intervention||1
8694965|NCT00875017|9740459|FG004|NOT COMPLETED|First Intervention||1
8694966|NCT00875017|9740460|FG005|NOT COMPLETED|First Intervention||0
8694967|NCT00875017|9740455|FG000|STARTED|Washout||3
8694968|NCT00875017|9740456|FG001|STARTED|Washout||5
8694969|NCT00875017|9740457|FG002|STARTED|Washout||4
8694970|NCT00875017|9740458|FG003|STARTED|Washout||5
8694971|NCT00875017|9740459|FG004|STARTED|Washout||4
8694972|NCT00875017|9740460|FG005|STARTED|Washout||5
8694973|NCT00875017|9740455|FG000|COMPLETED|Washout||3
8694974|NCT00875017|9740456|FG001|COMPLETED|Washout||5
8694975|NCT00875017|9740457|FG002|COMPLETED|Washout||3
8694976|NCT00875017|9740458|FG003|COMPLETED|Washout||5
8694977|NCT00875017|9740459|FG004|COMPLETED|Washout||4
8694978|NCT00875017|9740460|FG005|COMPLETED|Washout||5
8694979|NCT00875017|9740455|FG000|NOT COMPLETED|Washout||0
8694980|NCT00875017|9740456|FG001|NOT COMPLETED|Washout||0
8694981|NCT00875017|9740457|FG002|NOT COMPLETED|Washout||1
8694982|NCT00875017|9740458|FG003|NOT COMPLETED|Washout||0
8694983|NCT00875017|9740459|FG004|NOT COMPLETED|Washout||0
8694984|NCT00875017|9740460|FG005|NOT COMPLETED|Washout||0
8694985|NCT00875017|9740455|FG000|STARTED|Second Intervention||3
8694986|NCT00875017|9740456|FG001|STARTED|Second Intervention||5
8694987|NCT00875017|9740457|FG002|STARTED|Second Intervention||3
8694988|NCT00875017|9740458|FG003|STARTED|Second Intervention||5
8694989|NCT00875017|9740459|FG004|STARTED|Second Intervention||4
8694990|NCT00875017|9740460|FG005|STARTED|Second Intervention||5
8694991|NCT00875017|9740455|FG000|COMPLETED|Second Intervention||3
8694992|NCT00875017|9740456|FG001|COMPLETED|Second Intervention||5
8694993|NCT00875017|9740457|FG002|COMPLETED|Second Intervention||3
8694994|NCT00875017|9740458|FG003|COMPLETED|Second Intervention||4
8694995|NCT00875017|9740459|FG004|COMPLETED|Second Intervention||4
8694996|NCT00875017|9740460|FG005|COMPLETED|Second Intervention||5
8694997|NCT00875017|9740455|FG000|NOT COMPLETED|Second Intervention||0
8694998|NCT00875017|9740456|FG001|NOT COMPLETED|Second Intervention||0
8694999|NCT00875017|9740457|FG002|NOT COMPLETED|Second Intervention||0
8695000|NCT00875017|9740458|FG003|NOT COMPLETED|Second Intervention||1
8695001|NCT00875017|9740459|FG004|NOT COMPLETED|Second Intervention||0
8695002|NCT00875017|9740460|FG005|NOT COMPLETED|Second Intervention||0
8695003|NCT00875017|9740455|FG000|STARTED|Washout||3
8695004|NCT00875017|9740456|FG001|STARTED|Washout||5
8695005|NCT00875017|9740457|FG002|STARTED|Washout||3
8695006|NCT00875017|9740458|FG003|STARTED|Washout||4
8695007|NCT00875017|9740459|FG004|STARTED|Washout||4
8695008|NCT00875017|9740460|FG005|STARTED|Washout||5
8695009|NCT00875017|9740455|FG000|COMPLETED|Washout||3
8695010|NCT00875017|9740456|FG001|COMPLETED|Washout||4
8695011|NCT00875017|9740457|FG002|COMPLETED|Washout||3
8695012|NCT00875017|9740458|FG003|COMPLETED|Washout||4
8695013|NCT00875017|9740459|FG004|COMPLETED|Washout||4
8695014|NCT00875017|9740460|FG005|COMPLETED|Washout||5
8695015|NCT00875017|9740455|FG000|NOT COMPLETED|Washout||0
8695016|NCT00875017|9740456|FG001|NOT COMPLETED|Washout||1
8695017|NCT00875017|9740457|FG002|NOT COMPLETED|Washout||0
8695018|NCT00875017|9740458|FG003|NOT COMPLETED|Washout||0
8695019|NCT00875017|9740459|FG004|NOT COMPLETED|Washout||0
8695020|NCT00875017|9740460|FG005|NOT COMPLETED|Washout||0
8695021|NCT00875017|9740455|FG000|STARTED|Third Intervention||3
8695022|NCT00875017|9740456|FG001|STARTED|Third Intervention||4
8695023|NCT00875017|9740457|FG002|STARTED|Third Intervention||3
8695024|NCT00875017|9740458|FG003|STARTED|Third Intervention||4
8695025|NCT00875017|9740459|FG004|STARTED|Third Intervention||4
8695026|NCT00875017|9740460|FG005|STARTED|Third Intervention||5
8695027|NCT00875017|9740455|FG000|COMPLETED|Third Intervention||3
8695028|NCT00875017|9740456|FG001|COMPLETED|Third Intervention||3
8695029|NCT00875017|9740457|FG002|COMPLETED|Third Intervention||2
8695030|NCT00875017|9740458|FG003|COMPLETED|Third Intervention||4
8695031|NCT00875017|9740459|FG004|COMPLETED|Third Intervention||4
8695032|NCT00875017|9740460|FG005|COMPLETED|Third Intervention||5
8695033|NCT00875017|9740455|FG000|NOT COMPLETED|Third Intervention||0
8695034|NCT00875017|9740456|FG001|NOT COMPLETED|Third Intervention||1
8695035|NCT00875017|9740457|FG002|NOT COMPLETED|Third Intervention||1
8695036|NCT00875017|9740458|FG003|NOT COMPLETED|Third Intervention||0
8695037|NCT00875017|9740459|FG004|NOT COMPLETED|Third Intervention||0
8695038|NCT00875017|9740460|FG005|NOT COMPLETED|Third Intervention||0
8695039|NCT00875017|9740455|FG000|STARTED|Washout||3
8695040|NCT00875017|9740456|FG001|STARTED|Washout||3
8695041|NCT00875017|9740457|FG002|STARTED|Washout||2
8695042|NCT00875017|9740458|FG003|STARTED|Washout||4
8695043|NCT00875017|9740459|FG004|STARTED|Washout||4
8695044|NCT00875017|9740460|FG005|STARTED|Washout||5
8695045|NCT00875017|9740455|FG000|COMPLETED|Washout||3
8695046|NCT00875017|9740456|FG001|COMPLETED|Washout||3
8695047|NCT00875017|9740457|FG002|COMPLETED|Washout||2
8695048|NCT00875017|9740458|FG003|COMPLETED|Washout||4
8695049|NCT00875017|9740459|FG004|COMPLETED|Washout||3
8695050|NCT00875017|9740460|FG005|COMPLETED|Washout||5
8695051|NCT00875017|9740455|FG000|NOT COMPLETED|Washout||0
8695052|NCT00875017|9740456|FG001|NOT COMPLETED|Washout||0
8695053|NCT00875017|9740457|FG002|NOT COMPLETED|Washout||0
8695054|NCT00875017|9740458|FG003|NOT COMPLETED|Washout||0
8695055|NCT00875017|9740459|FG004|NOT COMPLETED|Washout||1
8695056|NCT00875017|9740460|FG005|NOT COMPLETED|Washout||0
8695057|NCT00875017|9740455|FG000|STARTED|Fourth Intervention||3
8695058|NCT00875017|9740456|FG001|STARTED|Fourth Intervention||3
8695059|NCT00875017|9740457|FG002|STARTED|Fourth Intervention||2
8695060|NCT00875017|9740458|FG003|STARTED|Fourth Intervention||4
8695061|NCT00875017|9740459|FG004|STARTED|Fourth Intervention||3
8695062|NCT00875017|9740460|FG005|STARTED|Fourth Intervention||5
8695063|NCT00875017|9740455|FG000|COMPLETED|Fourth Intervention||3
8695064|NCT00875017|9740456|FG001|COMPLETED|Fourth Intervention||3
8695065|NCT00875017|9740457|FG002|COMPLETED|Fourth Intervention||2
8695066|NCT00875017|9740458|FG003|COMPLETED|Fourth Intervention||4
8695067|NCT00875017|9740459|FG004|COMPLETED|Fourth Intervention||3
8925181|NCT02256072|9986235|FG001|NOT COMPLETED|Overall Study||29
8925182|NCT02256111|9986244|FG000|STARTED|Overall Study||13
8925183|NCT02256111|9986245|FG001|STARTED|Overall Study||13
8925184|NCT02256111|9986244|FG000|COMPLETED|Overall Study||13
8925185|NCT02256111|9986245|FG001|COMPLETED|Overall Study||13
8925186|NCT02256111|9986244|FG000|NOT COMPLETED|Overall Study||0
8925187|NCT02256111|9986245|FG001|NOT COMPLETED|Overall Study||0
8925188|NCT02256189|9986254|FG000|STARTED|Overall Study||15
8925189|NCT02256189|9986255|FG001|STARTED|Overall Study||13
8925190|NCT02256189|9986254|FG000|COMPLETED|Overall Study||15
8925191|NCT02256189|9986255|FG001|COMPLETED|Overall Study||13
8925192|NCT02256189|9986254|FG000|NOT COMPLETED|Overall Study||0
8925193|NCT02256189|9986255|FG001|NOT COMPLETED|Overall Study||0
8925194|NCT02256267|9986263|FG000|STARTED|Period 1 (Day 1; Day 2 to Day 9 Washout)||24
8925195|NCT02256267|9986263|FG000|Received at Least 1 Dose of LY2835219|Period 1 (Day 1; Day 2 to Day 9 Washout)||24
8925196|NCT02256267|9986263|FG000|COMPLETED|Period 1 (Day 1; Day 2 to Day 9 Washout)||23
8925197|NCT02256267|9986263|FG000|NOT COMPLETED|Period 1 (Day 1; Day 2 to Day 9 Washout)||1
8925198|NCT02256267|9986263|FG000|STARTED|Period 2 (Day 1 to Day 6)||23
8925199|NCT02256267|9986263|FG000|Received at Least 1 Dose of Rifampin|Period 2 (Day 1 to Day 6)||23
8925200|NCT02256267|9986263|FG000|COMPLETED|Period 2 (Day 1 to Day 6)||23
8925201|NCT02256267|9986263|FG000|NOT COMPLETED|Period 2 (Day 1 to Day 6)||0
8925202|NCT02256267|9986263|FG000|STARTED|Period 2 (Day 7 to Day 14)||23
8925203|NCT02256267|9986263|FG000|Received LY2835219 + Rifampin|Period 2 (Day 7 to Day 14)||23
8925204|NCT02256267|9986263|FG000|COMPLETED|Period 2 (Day 7 to Day 14)||22
8925205|NCT02256267|9986263|FG000|NOT COMPLETED|Period 2 (Day 7 to Day 14)||1
8925206|NCT02256345|9986272|FG000|STARTED|Overall Study||9
8925207|NCT02256345|9986273|FG001|STARTED|Overall Study||3
8925208|NCT02256345|9986272|FG000|COMPLETED|Overall Study||9
8925209|NCT02256345|9986273|FG001|COMPLETED|Overall Study||3
8925210|NCT02256345|9986272|FG000|NOT COMPLETED|Overall Study||0
8695068|NCT00875017|9740460|FG005|COMPLETED|Fourth Intervention||4
8695069|NCT00875017|9740455|FG000|NOT COMPLETED|Fourth Intervention||0
8695070|NCT00875017|9740456|FG001|NOT COMPLETED|Fourth Intervention||0
8695071|NCT00875017|9740457|FG002|NOT COMPLETED|Fourth Intervention||0
8695072|NCT00875017|9740458|FG003|NOT COMPLETED|Fourth Intervention||0
8695073|NCT00875017|9740459|FG004|NOT COMPLETED|Fourth Intervention||0
8695074|NCT00875017|9740460|FG005|NOT COMPLETED|Fourth Intervention||1
8695075|NCT00875056|9740476|FG000|STARTED|Overall Study||39
8695076|NCT00875056|9740477|FG001|STARTED|Overall Study||11
8695077|NCT00875056|9740478|FG002|STARTED|Overall Study||6
8695078|NCT00875056|9740476|FG000|COMPLETED|Overall Study||16
8925211|NCT02256345|9986273|FG001|NOT COMPLETED|Overall Study||0
8925212|NCT02256358|9986281|FG000|STARTED|Overall Study||34
8925213|NCT02256358|9986282|FG001|STARTED|Overall Study||34
8925214|NCT02256358|9986281|FG000|COMPLETED|Overall Study||34
8925215|NCT02256358|9986282|FG001|COMPLETED|Overall Study||33
8925216|NCT02256358|9986281|FG000|NOT COMPLETED|Overall Study||0
8925217|NCT02256358|9986282|FG001|NOT COMPLETED|Overall Study||1
8925218|NCT02256384|9986288|FG000|STARTED|Overall Study||76
8925219|NCT02256384|9986288|FG000|COMPLETED|Overall Study||62
8925220|NCT02256384|9986288|FG000|NOT COMPLETED|Overall Study||14
8695079|NCT00875056|9740477|FG001|COMPLETED|Overall Study||2
8695080|NCT00875056|9740478|FG002|COMPLETED|Overall Study||0
8695081|NCT00875056|9740476|FG000|NOT COMPLETED|Overall Study||23
8695082|NCT00875056|9740477|FG001|NOT COMPLETED|Overall Study||9
8695083|NCT00875056|9740478|FG002|NOT COMPLETED|Overall Study||6
8695084|NCT00875212|9740486|FG000|STARTED|Placebo Dentifrice||12
8695085|NCT00875212|9740486|FG000|COMPLETED|Placebo Dentifrice|all participants completed this group|12
8695086|NCT00875212|9740486|FG000|NOT COMPLETED|Placebo Dentifrice||0
8695087|NCT00875212|9740486|FG000|STARTED|CaGP Only Dentifrice||12
8695088|NCT00875212|9740486|FG000|COMPLETED|CaGP Only Dentifrice||12
8695089|NCT00875212|9740486|FG000|NOT COMPLETED|CaGP Only Dentifrice||0
8695090|NCT00875212|9740486|FG000|STARTED|Fluoride Only Dentifrice||12
8695091|NCT00875212|9740486|FG000|COMPLETED|Fluoride Only Dentifrice||12
8695092|NCT00875212|9740486|FG000|NOT COMPLETED|Fluoride Only Dentifrice||0
8695093|NCT00875212|9740486|FG000|STARTED|CaGP and Fluoride Dentifrice||12
8695094|NCT00875212|9740486|FG000|COMPLETED|CaGP and Fluoride Dentifrice||12
8695095|NCT00875212|9740486|FG000|NOT COMPLETED|CaGP and Fluoride Dentifrice||0
8695096|NCT00875277|9740497|FG000|STARTED|Overall Study||24
8695097|NCT00875277|9740497|FG000|COMPLETED|Overall Study||24
8695098|NCT00875277|9740497|FG000|NOT COMPLETED|Overall Study||0
8695099|NCT00875329|9740508|FG000|STARTED|Overall Study||97
8695100|NCT00875329|9740508|FG000|COMPLETED|Overall Study||97
8695101|NCT00875329|9740508|FG000|NOT COMPLETED|Overall Study||0
8695102|NCT00875342|9740514|FG000|STARTED|Overall Study||20
8695103|NCT00875342|9740515|FG001|STARTED|Overall Study||21
8695104|NCT00875342|9740514|FG000|COMPLETED|Overall Study||16
8695105|NCT00875342|9740515|FG001|COMPLETED|Overall Study||16
8695106|NCT00875342|9740514|FG000|NOT COMPLETED|Overall Study||4
8695107|NCT00875342|9740515|FG001|NOT COMPLETED|Overall Study||5
8695108|NCT00875420|9740526|FG000|STARTED|Overall Study||22
8695109|NCT00875420|9740527|FG001|STARTED|Overall Study||20
8695110|NCT00875420|9740528|FG002|STARTED|Overall Study||21
8695111|NCT00875420|9740529|FG003|STARTED|Overall Study||18
8695112|NCT00875420|9740530|FG004|STARTED|Overall Study||19
8695113|NCT00875420|9740526|FG000|COMPLETED|Overall Study||20
8695114|NCT00875420|9740527|FG001|COMPLETED|Overall Study||18
8695115|NCT00875420|9740528|FG002|COMPLETED|Overall Study||18
8695116|NCT00875420|9740529|FG003|COMPLETED|Overall Study||16
8695117|NCT00875420|9740530|FG004|COMPLETED|Overall Study||17
8695118|NCT00875420|9740526|FG000|NOT COMPLETED|Overall Study||2
8695119|NCT00875420|9740527|FG001|NOT COMPLETED|Overall Study||2
8695120|NCT00875420|9740528|FG002|NOT COMPLETED|Overall Study||3
8695121|NCT00875420|9740529|FG003|NOT COMPLETED|Overall Study||2
8695122|NCT00875420|9740530|FG004|NOT COMPLETED|Overall Study||2
8695123|NCT00875433|9740542|FG000|STARTED|Overall Study|Treated|60
8695124|NCT00875433|9740542|FG000|COMPLETED|Overall Study||0
8695125|NCT00875433|9740542|FG000|NOT COMPLETED|Overall Study||60
8695126|NCT00875485|9740548|FG000|STARTED|Year 11||99
8695127|NCT00875485|9740549|FG001|STARTED|Year 11||111
8695128|NCT00875485|9740548|FG000|COMPLETED|Year 11||99
8695129|NCT00875485|9740549|FG001|COMPLETED|Year 11||111
8695130|NCT00875485|9740548|FG000|NOT COMPLETED|Year 11||0
8695131|NCT00875485|9740549|FG001|NOT COMPLETED|Year 11||0
8695132|NCT00875485|9740548|FG000|STARTED|Year 12||101
8695133|NCT00875485|9740549|FG001|STARTED|Year 12||109
8695134|NCT00875485|9740548|FG000|COMPLETED|Year 12||101
8695135|NCT00875485|9740549|FG001|COMPLETED|Year 12||109
8695136|NCT00875485|9740548|FG000|NOT COMPLETED|Year 12||0
8695137|NCT00875485|9740549|FG001|NOT COMPLETED|Year 12||0
8695138|NCT00875485|9740548|FG000|STARTED|Year 13||102
8695139|NCT00875485|9740549|FG001|STARTED|Year 13||113
8695140|NCT00875485|9740548|FG000|COMPLETED|Year 13||102
8695141|NCT00875485|9740549|FG001|COMPLETED|Year 13||113
8695142|NCT00875485|9740548|FG000|NOT COMPLETED|Year 13||0
8695143|NCT00875485|9740549|FG001|NOT COMPLETED|Year 13||0
8695144|NCT00875485|9740548|FG000|STARTED|Year 14||100
8695145|NCT00875485|9740549|FG001|STARTED|Year 14||113
8695146|NCT00875485|9740548|FG000|COMPLETED|Year 14||100
8695147|NCT00875485|9740549|FG001|COMPLETED|Year 14||113
8925221|NCT02256436|9986298|FG000|STARTED|Overall Study||272
8925222|NCT02256436|9986299|FG001|STARTED|Overall Study||270
8925223|NCT02256436|9986298|FG000|Treated|Overall Study||255
8925224|NCT02256436|9986299|FG001|Treated|Overall Study||266
8925225|NCT02256436|9986298|FG000|Switched Over to Pembrolizumab|Overall Study||13
8695148|NCT00875485|9740548|FG000|NOT COMPLETED|Year 14||0
8695149|NCT00875485|9740549|FG001|NOT COMPLETED|Year 14||0
8695150|NCT00875485|9740548|FG000|STARTED|Year 15||98
8695151|NCT00875485|9740549|FG001|STARTED|Year 15||111
8695152|NCT00875485|9740548|FG000|COMPLETED|Year 15||98
8695153|NCT00875485|9740549|FG001|COMPLETED|Year 15||111
8695154|NCT00875485|9740548|FG000|NOT COMPLETED|Year 15||0
8695155|NCT00875485|9740549|FG001|NOT COMPLETED|Year 15||0
8695156|NCT00875485|9740548|FG000|STARTED|Challenge Dose Epoch||8
8695157|NCT00875485|9740549|FG001|STARTED|Challenge Dose Epoch||11
8695158|NCT00875485|9740548|FG000|COMPLETED|Challenge Dose Epoch||7
8695159|NCT00875485|9740549|FG001|COMPLETED|Challenge Dose Epoch||11
8695160|NCT00875485|9740548|FG000|NOT COMPLETED|Challenge Dose Epoch||1
8695161|NCT00875485|9740549|FG001|NOT COMPLETED|Challenge Dose Epoch||0
8925226|NCT02256436|9986299|FG001|Switched Over to Pembrolizumab|Overall Study||0
8925227|NCT02256436|9986298|FG000|COMPLETED|Overall Study||0
9040433|NCT03351933|10101381|FG000|STARTED|Overall Study||28
8695162|NCT00875550|9740557|FG000|STARTED|Overall Study||89
8695163|NCT00875550|9740558|FG001|STARTED|Overall Study||86
8695164|NCT00875550|9740557|FG000|COMPLETED|Overall Study||77
8695165|NCT00875550|9740558|FG001|COMPLETED|Overall Study||76
8695166|NCT00875550|9740557|FG000|NOT COMPLETED|Overall Study||12
8695167|NCT00875550|9740558|FG001|NOT COMPLETED|Overall Study||10
8695168|NCT00875563|9740566|FG000|STARTED|Overall Study||42
8695169|NCT00875563|9740566|FG000|COMPLETED|Overall Study||18
8695170|NCT00875563|9740566|FG000|NOT COMPLETED|Overall Study||24
8695171|NCT00875589|9740572|FG000|STARTED|Overall Study||15
8695172|NCT00875589|9740573|FG001|STARTED|Overall Study||11
8695173|NCT00875589|9740572|FG000|COMPLETED|Overall Study||15
8695174|NCT00875589|9740573|FG001|COMPLETED|Overall Study||11
8695175|NCT00875589|9740572|FG000|NOT COMPLETED|Overall Study||0
8695176|NCT00875589|9740573|FG001|NOT COMPLETED|Overall Study||0
8695177|NCT00875615|9740579|FG000|STARTED|Overall Study||11
8695178|NCT00875615|9740579|FG000|COMPLETED|Overall Study||10
8695179|NCT00875615|9740579|FG000|NOT COMPLETED|Overall Study||1
8695180|NCT00875641|9740586|FG000|STARTED|Overall Study||57931
8695181|NCT00875641|9740587|FG001|STARTED|Overall Study||173384
8925228|NCT02256436|9986299|FG001|COMPLETED|Overall Study||0
8925229|NCT02256436|9986298|FG000|NOT COMPLETED|Overall Study||272
8925230|NCT02256436|9986299|FG001|NOT COMPLETED|Overall Study||270
8925231|NCT02256488|9986310|FG000|STARTED|Overall Study||387
8925232|NCT02256488|9986311|FG001|STARTED|Overall Study||392
8925233|NCT02256488|9986312|FG002|STARTED|Overall Study||392
8925234|NCT02256488|9986313|FG003|STARTED|Overall Study||390
8925235|NCT02256488|9986310|FG000|COMPLETED|Overall Study||379
8925236|NCT02256488|9986311|FG001|COMPLETED|Overall Study||386
8925237|NCT02256488|9986312|FG002|COMPLETED|Overall Study||382
8925238|NCT02256488|9986313|FG003|COMPLETED|Overall Study||384
8925239|NCT02256488|9986310|FG000|NOT COMPLETED|Overall Study||8
8925240|NCT02256488|9986311|FG001|NOT COMPLETED|Overall Study||6
8925241|NCT02256488|9986312|FG002|NOT COMPLETED|Overall Study||10
8925242|NCT02256488|9986313|FG003|NOT COMPLETED|Overall Study||6
8925243|NCT02256540|9986324|FG000|STARTED|Overall Study||6
8925244|NCT02256540|9986325|FG001|STARTED|Overall Study||6
8925245|NCT02256540|9986326|FG002|STARTED|Overall Study||6
8925246|NCT02256540|9986324|FG000|COMPLETED|Overall Study||6
8925247|NCT02256540|9986325|FG001|COMPLETED|Overall Study||5
8925248|NCT02256540|9986326|FG002|COMPLETED|Overall Study||4
8925249|NCT02256540|9986324|FG000|NOT COMPLETED|Overall Study||0
8925250|NCT02256540|9986325|FG001|NOT COMPLETED|Overall Study||1
8925251|NCT02256540|9986326|FG002|NOT COMPLETED|Overall Study||2
8925252|NCT02256553|9986334|FG000|STARTED|Period I||102
8925253|NCT02256553|9986334|FG000|COMPLETED|Period I||96
8925254|NCT02256553|9986334|FG000|NOT COMPLETED|Period I||6
8925255|NCT02256553|9986334|FG000|STARTED|Period II||96
8925256|NCT02256553|9986334|FG000|COMPLETED|Period II||94
8925257|NCT02256553|9986334|FG000|NOT COMPLETED|Period II||2
8925258|NCT02256553|9986334|FG000|STARTED|Period III||94
8925259|NCT02256553|9986334|FG000|COMPLETED|Period III||91
8925260|NCT02256553|9986334|FG000|NOT COMPLETED|Period III||3
8925261|NCT02256839|9986342|FG000|STARTED|Overall Study||53
8925262|NCT02256839|9986343|FG001|STARTED|Overall Study||215
8925263|NCT02256839|9986342|FG000|COMPLETED|Overall Study||51
9040434|NCT03351933|10101381|FG000|COMPLETED|Overall Study||26
9040435|NCT03351933|10101381|FG000|NOT COMPLETED|Overall Study||2
9040436|NCT03352245|10101387|FG000|STARTED|Overall Study||20
9040437|NCT03352245|10101388|FG001|STARTED|Overall Study||20
9040438|NCT03352245|10101387|FG000|COMPLETED|Overall Study||20
9040439|NCT03352245|10101388|FG001|COMPLETED|Overall Study||19
9040440|NCT03352245|10101387|FG000|NOT COMPLETED|Overall Study||0
9040441|NCT03352245|10101388|FG001|NOT COMPLETED|Overall Study||1
9040442|NCT03352323|10101394|FG000|STARTED|Overall Study||50
9040443|NCT03352323|10101394|FG000|COMPLETED|Overall Study||49
9040444|NCT03352323|10101394|FG000|NOT COMPLETED|Overall Study||1
9040445|NCT03352414|10101400|FG000|STARTED|Overall Study||42
9040446|NCT03352414|10101401|FG001|STARTED|Overall Study||42
9040447|NCT03352414|10101400|FG000|Allocated|Overall Study||30
9040448|NCT03352414|10101401|FG001|Allocated|Overall Study||32
9040449|NCT03352414|10101400|FG000|COMPLETED|Overall Study||30
9040450|NCT03352414|10101401|FG001|COMPLETED|Overall Study||32
9040451|NCT03352414|10101400|FG000|NOT COMPLETED|Overall Study||12
9040452|NCT03352414|10101401|FG001|NOT COMPLETED|Overall Study||10
9040453|NCT03352453|10101411|FG000|STARTED|Overall Study||66
9040454|NCT03352453|10101412|FG001|STARTED|Overall Study||72
9040455|NCT03352453|10101411|FG000|COMPLETED|Overall Study||44
8695182|NCT00875641|9740588|FG002|STARTED|Overall Study||159344
8695183|NCT00875641|9740586|FG000|COMPLETED|Overall Study||57931
9040456|NCT03352453|10101412|FG001|COMPLETED|Overall Study||40
9040457|NCT03352453|10101411|FG000|NOT COMPLETED|Overall Study||22
9040458|NCT03352453|10101412|FG001|NOT COMPLETED|Overall Study||32
9040459|NCT03352609|10101420|FG000|STARTED|Overall Study||2
9040460|NCT03352609|10101421|FG001|STARTED|Overall Study||3
9040461|NCT03352609|10101420|FG000|COMPLETED|Overall Study||2
9040462|NCT03352609|10101421|FG001|COMPLETED|Overall Study||3
9040463|NCT03352609|10101420|FG000|NOT COMPLETED|Overall Study||0
9040464|NCT03352609|10101421|FG001|NOT COMPLETED|Overall Study||0
8695184|NCT00875641|9740587|FG001|COMPLETED|Overall Study||173384
8695185|NCT00875641|9740588|FG002|COMPLETED|Overall Study||159344
8695186|NCT00875641|9740586|FG000|NOT COMPLETED|Overall Study||0
8925264|NCT02256839|9986343|FG001|COMPLETED|Overall Study||212
8925265|NCT02256839|9986342|FG000|NOT COMPLETED|Overall Study||2
8925266|NCT02256839|9986343|FG001|NOT COMPLETED|Overall Study||3
8925267|NCT02256891|9986351|FG000|STARTED|Overall Study||55
8925268|NCT02256891|9986352|FG001|STARTED|Overall Study||42
8925269|NCT02256891|9986351|FG000|COMPLETED|Overall Study||43
8925270|NCT02256891|9986352|FG001|COMPLETED|Overall Study||29
9040465|NCT03352713|10101427|FG000|STARTED|Overall Study||185
9040466|NCT03352713|10101427|FG000|COMPLETED|Overall Study|Participants who completed at least 1 EMA for inclusion in data analysis|159
8695187|NCT00875641|9740587|FG001|NOT COMPLETED|Overall Study||0
8695188|NCT00875641|9740588|FG002|NOT COMPLETED|Overall Study||0
8695189|NCT00875667|9740598|FG000|STARTED|Overall Study||170
8695190|NCT00875667|9740599|FG001|STARTED|Overall Study||84
8695191|NCT00875667|9740598|FG000|Crossover From IC to Lenalidomide|Overall Study|NA = Participants in the IC arm were able to crossover to lenalidomide|0
8695192|NCT00875667|9740599|FG001|Crossover From IC to Lenalidomide|Overall Study|Upon disease progression, participants crossed over to lenalidomide|40
8695193|NCT00875667|9740598|FG000|Participants Treated|Overall Study||167
8695194|NCT00875667|9740599|FG001|Participants Treated|Overall Study||83
8695195|NCT00875667|9740598|FG000|COMPLETED|Overall Study||0
8695196|NCT00875667|9740599|FG001|COMPLETED|Overall Study|Participants completed 6 cycles of IC single agent cytarabine, fludarabine, or gemcitabine.|11
9040467|NCT03352713|10101427|FG000|NOT COMPLETED|Overall Study||26
9040468|NCT03353220|10101431|FG000|STARTED|First Intervention (7 Days) - Phase 1||14
9040469|NCT03353220|10101432|FG001|STARTED|First Intervention (7 Days) - Phase 1||16
9040470|NCT03353220|10101431|FG000|COMPLETED|First Intervention (7 Days) - Phase 1||14
9040471|NCT03353220|10101432|FG001|COMPLETED|First Intervention (7 Days) - Phase 1||16
9040472|NCT03353220|10101431|FG000|NOT COMPLETED|First Intervention (7 Days) - Phase 1||0
9040473|NCT03353220|10101432|FG001|NOT COMPLETED|First Intervention (7 Days) - Phase 1||0
9040474|NCT03353220|10101431|FG000|STARTED|Washout (3 Weeks) - Phase 1||14
9040475|NCT03353220|10101432|FG001|STARTED|Washout (3 Weeks) - Phase 1||16
9040476|NCT03353220|10101431|FG000|COMPLETED|Washout (3 Weeks) - Phase 1||14
9040477|NCT03353220|10101432|FG001|COMPLETED|Washout (3 Weeks) - Phase 1||16
9040478|NCT03353220|10101431|FG000|NOT COMPLETED|Washout (3 Weeks) - Phase 1||0
9040479|NCT03353220|10101432|FG001|NOT COMPLETED|Washout (3 Weeks) - Phase 1||0
9040480|NCT03353220|10101431|FG000|STARTED|Second Intervention (7 Days) - Phase 1||14
9040481|NCT03353220|10101432|FG001|STARTED|Second Intervention (7 Days) - Phase 1||16
9040482|NCT03353220|10101431|FG000|COMPLETED|Second Intervention (7 Days) - Phase 1||14
9040483|NCT03353220|10101432|FG001|COMPLETED|Second Intervention (7 Days) - Phase 1||16
9040484|NCT03353220|10101431|FG000|NOT COMPLETED|Second Intervention (7 Days) - Phase 1||0
9040485|NCT03353220|10101432|FG001|NOT COMPLETED|Second Intervention (7 Days) - Phase 1||0
9040486|NCT03353220|10101431|FG000|STARTED|Third Intervention (6 Months) - Phase 2||14
9040487|NCT03353220|10101432|FG001|STARTED|Third Intervention (6 Months) - Phase 2||16
9040488|NCT03353220|10101431|FG000|COMPLETED|Third Intervention (6 Months) - Phase 2||10
9040489|NCT03353220|10101432|FG001|COMPLETED|Third Intervention (6 Months) - Phase 2||9
9040490|NCT03353220|10101431|FG000|NOT COMPLETED|Third Intervention (6 Months) - Phase 2||4
9040491|NCT03353220|10101432|FG001|NOT COMPLETED|Third Intervention (6 Months) - Phase 2||7
9040492|NCT03353246|10101438|FG000|STARTED|Overall Study||500
9040493|NCT03353246|10101438|FG000|COMPLETED|Overall Study||500
9040494|NCT03353246|10101438|FG000|NOT COMPLETED|Overall Study||0
9040495|NCT03353740|10101442|FG000|STARTED|Overall Study||346
9040496|NCT03353740|10101442|FG000|COMPLETED|Overall Study||294
9040497|NCT03353740|10101442|FG000|NOT COMPLETED|Overall Study||52
9040498|NCT03353753|10101448|FG000|STARTED|Overall Study||85
9040499|NCT03353753|10101449|FG001|STARTED|Overall Study|1 patient was randomized but not dosed|44
9040500|NCT03353753|10101448|FG000|COMPLETED|Overall Study||46
9040501|NCT03353753|10101449|FG001|COMPLETED|Overall Study||35
9040502|NCT03353753|10101448|FG000|NOT COMPLETED|Overall Study||39
9040503|NCT03353753|10101449|FG001|NOT COMPLETED|Overall Study||9
9040504|NCT03354325|10101457|FG000|STARTED|Overall Study||151
9040505|NCT03354325|10101458|FG001|STARTED|Overall Study||153
9040506|NCT03354325|10101457|FG000|COMPLETED|Overall Study||131
9040507|NCT03354325|10101458|FG001|COMPLETED|Overall Study||138
9040508|NCT03354325|10101457|FG000|NOT COMPLETED|Overall Study||20
9040509|NCT03354325|10101458|FG001|NOT COMPLETED|Overall Study||15
9040510|NCT03354429|10101466|FG000|STARTED|Overall Study||5523
9040511|NCT03354429|10101467|FG001|STARTED|Overall Study||5493
9040512|NCT03354429|10101466|FG000|COMPLETED|Overall Study||5514
9040513|NCT03354429|10101467|FG001|COMPLETED|Overall Study||5486
9040514|NCT03354429|10101466|FG000|NOT COMPLETED|Overall Study||9
9040515|NCT03354429|10101467|FG001|NOT COMPLETED|Overall Study||7
9040516|NCT03354598|10101475|FG000|STARTED|Overall Study||835
9040517|NCT03354598|10101476|FG001|STARTED|Overall Study||836
9040518|NCT03354598|10101475|FG000|Microbiologic Modified Intent to Treat Resistant (Micro-MITTR) Participants|Overall Study||147
9040519|NCT03354598|10101476|FG001|Microbiologic Modified Intent to Treat Resistant (Micro-MITTR) Participants|Overall Study||139
9040520|NCT03354598|10101475|FG000|Microbiologic Modified Intent to Treat Susceptible (Micro-MITTS) Participants|Overall Study||370
9040521|NCT03354598|10101476|FG001|Microbiologic Modified Intent to Treat Susceptible (Micro-MITTS) Participants|Overall Study||415
9040522|NCT03354598|10101475|FG000|Microbiologic Modified Intent to Treat (Micro-MITT) Participants|Overall Study||517
9040523|NCT03354598|10101476|FG001|Microbiologic Modified Intent to Treat (Micro-MITT) Participants|Overall Study||554
9040524|NCT03354598|10101475|FG000|Modified Intent to Treat (MITT) Participants|Overall Study||785
9040525|NCT03354598|10101476|FG001|Modified Intent to Treat (MITT) Participants|Overall Study||794
9040526|NCT03354598|10101475|FG000|Intent to Treat (ITT) Participants|Overall Study||787
9040527|NCT03354598|10101476|FG001|Intent to Treat (ITT) Participants|Overall Study||803
9040528|NCT03354598|10101475|FG000|Safety Participants|Overall Study||833
9040529|NCT03354598|10101476|FG001|Safety Participants|Overall Study||827
8695197|NCT00875667|9740598|FG000|NOT COMPLETED|Overall Study||170
8695198|NCT00875667|9740599|FG001|NOT COMPLETED|Overall Study||73
8695199|NCT00875706|9740608|FG000|STARTED|Overall Study||8
8695200|NCT00875706|9740609|FG001|STARTED|Overall Study||24
8695201|NCT00875706|9740610|FG002|STARTED|Overall Study||13
8695202|NCT00875706|9740608|FG000|COMPLETED|Overall Study||7
8695203|NCT00875706|9740609|FG001|COMPLETED|Overall Study||24
8695204|NCT00875706|9740610|FG002|COMPLETED|Overall Study||13
8695205|NCT00875706|9740608|FG000|NOT COMPLETED|Overall Study||1
8695206|NCT00875706|9740609|FG001|NOT COMPLETED|Overall Study||0
8695207|NCT00875706|9740610|FG002|NOT COMPLETED|Overall Study||0
8695208|NCT00875797|9740620|FG000|STARTED|Overall Study||45
9040530|NCT03354598|10101475|FG000|COMPLETED|Overall Study||755
9040531|NCT03354598|10101476|FG001|COMPLETED|Overall Study||761
9040532|NCT03354598|10101475|FG000|NOT COMPLETED|Overall Study||80
9040533|NCT03354598|10101476|FG001|NOT COMPLETED|Overall Study||75
9040534|NCT03354637|10101485|FG000|STARTED|Double-blind Period||43
9040535|NCT03354637|10101486|FG001|STARTED|Double-blind Period||44
9040536|NCT03354637|10101487|FG002|STARTED|Double-blind Period||42
9040537|NCT03354637|10101485|FG000|COMPLETED|Double-blind Period||26
9040538|NCT03354637|10101486|FG001|COMPLETED|Double-blind Period||31
9040539|NCT03354637|10101487|FG002|COMPLETED|Double-blind Period||35
9040540|NCT03354637|10101485|FG000|NOT COMPLETED|Double-blind Period||17
9040541|NCT03354637|10101486|FG001|NOT COMPLETED|Double-blind Period||13
9040542|NCT03354637|10101487|FG002|NOT COMPLETED|Double-blind Period||7
9040543|NCT03354637|10101485|FG000|STARTED|Open Label Extension||0
9040544|NCT03354637|10101486|FG001|STARTED|Open Label Extension||0
9040545|NCT03354637|10101487|FG002|STARTED|Open Label Extension||61
9040546|NCT03354637|10101485|FG000|COMPLETED|Open Label Extension||0
9040547|NCT03354637|10101486|FG001|COMPLETED|Open Label Extension||0
9040548|NCT03354637|10101487|FG002|COMPLETED|Open Label Extension||33
9040549|NCT03354637|10101485|FG000|NOT COMPLETED|Open Label Extension||0
9040550|NCT03354637|10101486|FG001|NOT COMPLETED|Open Label Extension||0
9040551|NCT03354637|10101487|FG002|NOT COMPLETED|Open Label Extension||28
9040552|NCT03354663|10101496|FG000|STARTED|Enrollment to Catheter Insertion||156
9040553|NCT03354663|10101496|FG000|COMPLETED|Enrollment to Catheter Insertion||151
9040554|NCT03354663|10101496|FG000|NOT COMPLETED|Enrollment to Catheter Insertion||5
9040555|NCT03354663|10101496|FG000|STARTED|Completed 30-day Visit||151
9040556|NCT03354663|10101496|FG000|COMPLETED|Completed 30-day Visit||149
9040557|NCT03354663|10101496|FG000|NOT COMPLETED|Completed 30-day Visit||2
9040558|NCT03354754|10101506|FG000|STARTED|Overall Study||2
9040559|NCT03354754|10101507|FG001|STARTED|Overall Study||1
8695209|NCT00875797|9740621|FG001|STARTED|Overall Study||45
8695210|NCT00875797|9740620|FG000|COMPLETED|Overall Study||39
8695211|NCT00875797|9740621|FG001|COMPLETED|Overall Study||42
8695212|NCT00875797|9740620|FG000|NOT COMPLETED|Overall Study||6
8695213|NCT00875797|9740621|FG001|NOT COMPLETED|Overall Study||3
8695214|NCT00875810|9740630|FG000|STARTED|Overall Study||194
9040560|NCT03354754|10101506|FG000|COMPLETED|Overall Study||2
9040561|NCT03354754|10101507|FG001|COMPLETED|Overall Study||1
9040562|NCT03354754|10101506|FG000|NOT COMPLETED|Overall Study||0
9040563|NCT03354754|10101507|FG001|NOT COMPLETED|Overall Study||0
9040564|NCT03355326|10101515|FG000|STARTED|Overall Study||9
9040565|NCT03355326|10101516|FG001|STARTED|Overall Study||7
9040566|NCT03355326|10101515|FG000|COMPLETED|Overall Study||6
9040567|NCT03355326|10101516|FG001|COMPLETED|Overall Study||4
9040568|NCT03355326|10101515|FG000|NOT COMPLETED|Overall Study||3
9040569|NCT03355326|10101516|FG001|NOT COMPLETED|Overall Study||3
9040570|NCT03355742|10101522|FG000|STARTED|Overall Study||963
9040571|NCT03355742|10101522|FG000|COMPLETED|Overall Study||864
9040572|NCT03355742|10101522|FG000|NOT COMPLETED|Overall Study||99
9040573|NCT03355820|10101526|FG000|STARTED|Overall Study||227
9040574|NCT03355820|10101526|FG000|COMPLETED|Overall Study||227
9040575|NCT03355820|10101526|FG000|NOT COMPLETED|Overall Study||0
9040576|NCT03356145|10101532|FG000|STARTED|Overall Study||48
9040577|NCT03356145|10101533|FG001|STARTED|Overall Study||48
9040578|NCT03356145|10101532|FG000|Received Allocated Intervention|Overall Study||45
9040579|NCT03356145|10101533|FG001|Received Allocated Intervention|Overall Study||47
9040580|NCT03356145|10101532|FG000|COMPLETED|Overall Study||45
9040581|NCT03356145|10101533|FG001|COMPLETED|Overall Study||47
9040582|NCT03356145|10101532|FG000|NOT COMPLETED|Overall Study||3
9040583|NCT03356145|10101533|FG001|NOT COMPLETED|Overall Study||1
9040584|NCT03356977|10101539|FG000|STARTED|Overall Study||137
9040585|NCT03356977|10101539|FG000|COMPLETED|Overall Study||132
9040586|NCT03356977|10101539|FG000|NOT COMPLETED|Overall Study||5
9040587|NCT03357341|10101545|FG000|STARTED|Overall Study||96
9040588|NCT03357341|10101546|FG001|STARTED|Overall Study||98
9040589|NCT03357341|10101545|FG000|COMPLETED|Overall Study||89
9040590|NCT03357341|10101546|FG001|COMPLETED|Overall Study||86
9040591|NCT03357341|10101545|FG000|NOT COMPLETED|Overall Study||7
9040592|NCT03357341|10101546|FG001|NOT COMPLETED|Overall Study||12
9040593|NCT03357393|10101556|FG000|STARTED|Overall Study||50
9040594|NCT03357393|10101557|FG001|STARTED|Overall Study||50
9040595|NCT03357393|10101558|FG002|STARTED|Overall Study||50
9040596|NCT03357393|10101556|FG000|COMPLETED|Overall Study||50
9040597|NCT03357393|10101557|FG001|COMPLETED|Overall Study||50
9040598|NCT03357393|10101558|FG002|COMPLETED|Overall Study||50
8695215|NCT00875810|9740630|FG000|Implanted|Overall Study||190
8695216|NCT00875810|9740630|FG000|Discharged|Overall Study||177
9040599|NCT03357393|10101556|FG000|NOT COMPLETED|Overall Study||0
9040600|NCT03357393|10101557|FG001|NOT COMPLETED|Overall Study||0
8695217|NCT00875810|9740630|FG000|3 Months Follow up|Overall Study||175
9040601|NCT03357393|10101558|FG002|NOT COMPLETED|Overall Study||0
9040602|NCT03357471|10101568|FG000|STARTED|Overall Study||35
9040603|NCT03357471|10101569|FG001|STARTED|Overall Study||32
8695218|NCT00875810|9740630|FG000|6 Months Follow up|Overall Study||80
8695219|NCT00875810|9740630|FG000|12 Months Follow up|Overall Study||112
8695220|NCT00875810|9740630|FG000|24 Months Follow up|Overall Study||148
8695221|NCT00875810|9740630|FG000|COMPLETED|Overall Study||148
8695222|NCT00875810|9740630|FG000|NOT COMPLETED|Overall Study||46
8695223|NCT00875836|9740636|FG000|STARTED|Overall Study||88
8695224|NCT00875836|9740637|FG001|STARTED|Overall Study||87
8695225|NCT00875836|9740636|FG000|COMPLETED|Overall Study||45
8695226|NCT00875836|9740637|FG001|COMPLETED|Overall Study||47
8695227|NCT00875836|9740636|FG000|NOT COMPLETED|Overall Study||43
8695228|NCT00875836|9740637|FG001|NOT COMPLETED|Overall Study||40
8695229|NCT00875979|9740645|FG000|STARTED|Dose Escalation Phase - 3.0 mg/kg||3
8695230|NCT00875979|9740646|FG001|STARTED|Dose Escalation Phase - 3.0 mg/kg||0
8695231|NCT00875979|9740645|FG000|COMPLETED|Dose Escalation Phase - 3.0 mg/kg||0
8695232|NCT00875979|9740646|FG001|COMPLETED|Dose Escalation Phase - 3.0 mg/kg||0
8695233|NCT00875979|9740645|FG000|NOT COMPLETED|Dose Escalation Phase - 3.0 mg/kg||3
8695234|NCT00875979|9740646|FG001|NOT COMPLETED|Dose Escalation Phase - 3.0 mg/kg||0
8695235|NCT00875979|9740645|FG000|STARTED|Dose Escalation Phase - 3.6 mg/kg||0
8695236|NCT00875979|9740646|FG001|STARTED|Dose Escalation Phase - 3.6 mg/kg||6
9040604|NCT03357471|10101568|FG000|COMPLETED|Overall Study||33
9040605|NCT03357471|10101569|FG001|COMPLETED|Overall Study||32
9040606|NCT03357471|10101568|FG000|NOT COMPLETED|Overall Study||2
9040607|NCT03357471|10101569|FG001|NOT COMPLETED|Overall Study||0
9040608|NCT03357614|10101577|FG000|STARTED|Overall Study||697
9040609|NCT03357614|10101578|FG001|STARTED|Overall Study||698
9040610|NCT03357614|10101577|FG000|COMPLETED|Overall Study||672
9040611|NCT03357614|10101578|FG001|COMPLETED|Overall Study||670
9040612|NCT03357614|10101577|FG000|NOT COMPLETED|Overall Study||25
9040613|NCT03357614|10101578|FG001|NOT COMPLETED|Overall Study||28
8695237|NCT00875979|9740645|FG000|COMPLETED|Dose Escalation Phase - 3.6 mg/kg||0
8695238|NCT00875979|9740646|FG001|COMPLETED|Dose Escalation Phase - 3.6 mg/kg||0
8695239|NCT00875979|9740645|FG000|NOT COMPLETED|Dose Escalation Phase - 3.6 mg/kg||0
8695240|NCT00875979|9740646|FG001|NOT COMPLETED|Dose Escalation Phase - 3.6 mg/kg||6
8695241|NCT00875979|9740645|FG000|STARTED|Dose Expansion Phase - 3.6 mg/kg||0
8695242|NCT00875979|9740646|FG001|STARTED|Dose Expansion Phase - 3.6 mg/kg||58
8695243|NCT00875979|9740645|FG000|COMPLETED|Dose Expansion Phase - 3.6 mg/kg||0
8695244|NCT00875979|9740646|FG001|COMPLETED|Dose Expansion Phase - 3.6 mg/kg||11
8695245|NCT00875979|9740645|FG000|NOT COMPLETED|Dose Expansion Phase - 3.6 mg/kg||0
8695246|NCT00875979|9740646|FG001|NOT COMPLETED|Dose Expansion Phase - 3.6 mg/kg||47
8695247|NCT00876018|9740655|FG000|STARTED|Overall Study||100
8695248|NCT00876018|9740656|FG001|STARTED|Overall Study||100
8695249|NCT00876018|9740657|FG002|STARTED|Overall Study||100
8695250|NCT00876018|9740655|FG000|COMPLETED|Overall Study||95
8695251|NCT00876018|9740656|FG001|COMPLETED|Overall Study||95
8695252|NCT00876018|9740657|FG002|COMPLETED|Overall Study||97
8695253|NCT00876018|9740655|FG000|NOT COMPLETED|Overall Study||5
8695254|NCT00876018|9740656|FG001|NOT COMPLETED|Overall Study||5
8695255|NCT00876018|9740657|FG002|NOT COMPLETED|Overall Study||3
8695256|NCT00876187|9740672|FG000|STARTED|Overall Study||233
8695257|NCT00876187|9740673|FG001|STARTED|Overall Study||233
8695258|NCT00876187|9740674|FG002|STARTED|Overall Study||298
8695259|NCT00876187|9740675|FG003|STARTED|Overall Study||297
8695260|NCT00876187|9740676|FG004|STARTED|Overall Study||298
8695261|NCT00876187|9740672|FG000|Treated|Overall Study||230
8695262|NCT00876187|9740673|FG001|Treated|Overall Study||232
8695263|NCT00876187|9740674|FG002|Treated|Overall Study||295
8695264|NCT00876187|9740675|FG003|Treated|Overall Study||295
8695265|NCT00876187|9740676|FG004|Treated|Overall Study||295
8695266|NCT00876187|9740672|FG000|Completed Treatment|Overall Study|Participants who completed treatment at Week 16 visit.|128
8695267|NCT00876187|9740673|FG001|Completed Treatment|Overall Study|Participants who completed treatment at Week 16 visit.|146
8695268|NCT00876187|9740674|FG002|Completed Treatment|Overall Study|Participants who completed treatment at Week 16 visit.|193
8695269|NCT00876187|9740675|FG003|Completed Treatment|Overall Study|Participants who completed treatment at Week 16 visit.|188
8695270|NCT00876187|9740676|FG004|Completed Treatment|Overall Study|Participants who completed treatment at Week 16 visit.|185
9040614|NCT03357731|10101584|FG000|STARTED|Overall Study||8
9040615|NCT03357731|10101585|FG001|STARTED|Overall Study||7
9040616|NCT03357731|10101586|FG002|STARTED|Overall Study||7
9040617|NCT03357731|10101587|FG003|STARTED|Overall Study||7
9040618|NCT03357731|10101588|FG004|STARTED|Overall Study||8
9040619|NCT03357731|10101589|FG005|STARTED|Overall Study||8
9040620|NCT03357731|10101584|FG000|Completed Period 1 (P1)|Overall Study|1 withdrew post-P1 completion/prior to P2 therapy due to acute cholecystitis, but returned for P2/P3|8
9040621|NCT03357731|10101585|FG001|Completed Period 1 (P1)|Overall Study||7
9040622|NCT03357731|10101586|FG002|Completed Period 1 (P1)|Overall Study||7
9040623|NCT03357731|10101587|FG003|Completed Period 1 (P1)|Overall Study|1 discontinued P1 due to acute bradycardia and hypotension|6
9040624|NCT03357731|10101588|FG004|Completed Period 1 (P1)|Overall Study|1 discontinued P1 due to hypotension but resumed P2/P3|7
9040625|NCT03357731|10101589|FG005|Completed Period 1 (P1)|Overall Study||8
9040626|NCT03357731|10101584|FG000|Completed Period 2 (P2)|Overall Study||8
9040627|NCT03357731|10101585|FG001|Completed Period 2 (P2)|Overall Study||7
9040628|NCT03357731|10101586|FG002|Completed Period 2 (P2)|Overall Study||7
9040629|NCT03357731|10101587|FG003|Completed Period 2 (P2)|Overall Study|"1 completed P1, did not proceed to P2/P3 (lost to follow-up);~1 discontinued P2 due to hypotension"|4
9040630|NCT03357731|10101588|FG004|Completed Period 2 (P2)|Overall Study|1 only completed P1, did not continue to P2/P3 (withdrew consent due to personal reasons)|7
9040631|NCT03357731|10101589|FG005|Completed Period 2 (P2)|Overall Study|1 discontinued P2 due to an Adverse Event (AE)|7
9040632|NCT03357731|10101584|FG000|COMPLETED|Overall Study||8
9040633|NCT03357731|10101585|FG001|COMPLETED|Overall Study||7
9040634|NCT03357731|10101586|FG002|COMPLETED|Overall Study|1 discontinuation due to hypotension|6
9040635|NCT03357731|10101587|FG003|COMPLETED|Overall Study||4
9040636|NCT03357731|10101588|FG004|COMPLETED|Overall Study||7
9040637|NCT03357731|10101589|FG005|COMPLETED|Overall Study||7
9040638|NCT03357731|10101584|FG000|NOT COMPLETED|Overall Study||0
9040639|NCT03357731|10101585|FG001|NOT COMPLETED|Overall Study||0
9040640|NCT03357731|10101586|FG002|NOT COMPLETED|Overall Study||1
9040641|NCT03357731|10101587|FG003|NOT COMPLETED|Overall Study||3
9040642|NCT03357731|10101588|FG004|NOT COMPLETED|Overall Study||1
9040643|NCT03357731|10101589|FG005|NOT COMPLETED|Overall Study||1
9040644|NCT03358147|10101602|FG000|STARTED|Overall Study||235
9040645|NCT03358147|10101603|FG001|STARTED|Overall Study||240
9040646|NCT03358147|10101604|FG002|STARTED|Overall Study||240
9040647|NCT03358147|10101605|FG003|STARTED|Overall Study||237
9040648|NCT03358147|10101606|FG004|STARTED|Overall Study||119
9040649|NCT03358147|10101602|FG000|COMPLETED|Overall Study||201
9040650|NCT03358147|10101603|FG001|COMPLETED|Overall Study||201
9040651|NCT03358147|10101604|FG002|COMPLETED|Overall Study||206
9040652|NCT03358147|10101605|FG003|COMPLETED|Overall Study||201
9040653|NCT03358147|10101606|FG004|COMPLETED|Overall Study||105
9040654|NCT03358147|10101602|FG000|NOT COMPLETED|Overall Study||34
9040655|NCT03358147|10101603|FG001|NOT COMPLETED|Overall Study||39
9040656|NCT03358147|10101604|FG002|NOT COMPLETED|Overall Study||34
9040657|NCT03358147|10101605|FG003|NOT COMPLETED|Overall Study||36
9040658|NCT03358147|10101606|FG004|NOT COMPLETED|Overall Study||14
9040659|NCT03358238|10101620|FG000|STARTED|Overall Study||23
9040660|NCT03358238|10101621|FG001|STARTED|Overall Study||25
9040661|NCT03358238|10101620|FG000|COMPLETED|Overall Study||23
9040662|NCT03358238|10101621|FG001|COMPLETED|Overall Study||24
9040663|NCT03358238|10101620|FG000|NOT COMPLETED|Overall Study||0
9040664|NCT03358238|10101621|FG001|NOT COMPLETED|Overall Study||1
9040665|NCT03358251|10101631|FG000|STARTED|Overall Study||34
9040666|NCT03358251|10101631|FG000|COMPLETED|Overall Study||34
9040667|NCT03358251|10101631|FG000|NOT COMPLETED|Overall Study||0
9040668|NCT03358290|10101643|FG000|STARTED|Overall Study||2
9040669|NCT03358290|10101644|FG001|STARTED|Overall Study||3
8695271|NCT00876187|9740672|FG000|COMPLETED|Overall Study||23
8695272|NCT00876187|9740673|FG001|COMPLETED|Overall Study||18
8695273|NCT00876187|9740674|FG002|COMPLETED|Overall Study||19
8925271|NCT02256891|9986351|FG000|NOT COMPLETED|Overall Study||12
8925272|NCT02256891|9986352|FG001|NOT COMPLETED|Overall Study||13
9040670|NCT03358290|10101645|FG002|STARTED|Overall Study||3
9040671|NCT03358290|10101646|FG003|STARTED|Overall Study||3
9040672|NCT03358290|10101647|FG004|STARTED|Overall Study||2
9040673|NCT03358290|10101643|FG000|COMPLETED|Overall Study||2
9040674|NCT03358290|10101644|FG001|COMPLETED|Overall Study||2
9040675|NCT03358290|10101645|FG002|COMPLETED|Overall Study||1
9040676|NCT03358290|10101646|FG003|COMPLETED|Overall Study||1
9040677|NCT03358290|10101647|FG004|COMPLETED|Overall Study||1
9040678|NCT03358290|10101643|FG000|NOT COMPLETED|Overall Study||0
9040679|NCT03358290|10101644|FG001|NOT COMPLETED|Overall Study||1
9040680|NCT03358290|10101645|FG002|NOT COMPLETED|Overall Study||2
9040681|NCT03358290|10101646|FG003|NOT COMPLETED|Overall Study||2
9040682|NCT03358290|10101647|FG004|NOT COMPLETED|Overall Study||1
9040683|NCT03358329|10101659|FG000|STARTED|Overall Study||50
9040684|NCT03358329|10101659|FG000|COMPLETED|Overall Study||46
9040685|NCT03358329|10101659|FG000|NOT COMPLETED|Overall Study||4
9040686|NCT03358355|10101665|FG000|STARTED|Overall Study||9
9040687|NCT03358355|10101665|FG000|COMPLETED|Overall Study||9
9040688|NCT03358355|10101665|FG000|NOT COMPLETED|Overall Study||0
9040689|NCT03358407|10101684|FG000|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
9040690|NCT03358407|10101685|FG001|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
9040691|NCT03358407|10101686|FG002|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
9040692|NCT03358407|10101687|FG003|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
9040693|NCT03358407|10101688|FG004|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
9040694|NCT03358407|10101689|FG005|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
9040695|NCT03358407|10101690|FG006|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
9040696|NCT03358407|10101691|FG007|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
9040697|NCT03358407|10101692|FG008|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
9040698|NCT03358407|10101693|FG009|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
9040699|NCT03358407|10101684|FG000|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
9040700|NCT03358407|10101685|FG001|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
9040701|NCT03358407|10101686|FG002|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
9040702|NCT03358407|10101687|FG003|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
9040703|NCT03358407|10101688|FG004|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
9040704|NCT03358407|10101689|FG005|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
9040705|NCT03358407|10101690|FG006|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
9040706|NCT03358407|10101691|FG007|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
9040707|NCT03358407|10101692|FG008|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
9040708|NCT03358407|10101693|FG009|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
9040709|NCT03358407|10101684|FG000|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
9040710|NCT03358407|10101685|FG001|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
9040711|NCT03358407|10101686|FG002|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
9040712|NCT03358407|10101687|FG003|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
9040713|NCT03358407|10101688|FG004|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
9040714|NCT03358407|10101689|FG005|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
9040715|NCT03358407|10101690|FG006|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
9040716|NCT03358407|10101691|FG007|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
9040717|NCT03358407|10101692|FG008|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
9040718|NCT03358407|10101693|FG009|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
8925273|NCT02256917|9986360|FG000|STARTED|Pharmacokinetic (PK) Evaluation Phase||58
8925274|NCT02256917|9986360|FG000|COMPLETED|Pharmacokinetic (PK) Evaluation Phase||58
8925275|NCT02256917|9986360|FG000|NOT COMPLETED|Pharmacokinetic (PK) Evaluation Phase||0
8925276|NCT02256917|9986360|FG000|STARTED|Prophylactic Treatment Phase I||57
8925277|NCT02256917|9986360|FG000|COMPLETED|Prophylactic Treatment Phase I||56
8925278|NCT02256917|9986360|FG000|NOT COMPLETED|Prophylactic Treatment Phase I||1
8925279|NCT02256917|9986360|FG000|STARTED|Prophylactic Treatment Phase II||56
8925280|NCT02256917|9986360|FG000|COMPLETED|Prophylactic Treatment Phase II||52
8925281|NCT02256917|9986360|FG000|NOT COMPLETED|Prophylactic Treatment Phase II||4
8925282|NCT02256969|9986374|FG000|STARTED|Overall Study||15
8925283|NCT02256969|9986375|FG001|STARTED|Overall Study||15
8925284|NCT02256969|9986376|FG002|STARTED|Overall Study||15
8925285|NCT02256969|9986374|FG000|COMPLETED|Overall Study||13
8925286|NCT02256969|9986375|FG001|COMPLETED|Overall Study||14
8925287|NCT02256969|9986376|FG002|COMPLETED|Overall Study||14
8925288|NCT02256969|9986374|FG000|NOT COMPLETED|Overall Study||2
8925289|NCT02256969|9986375|FG001|NOT COMPLETED|Overall Study||1
8925290|NCT02256969|9986376|FG002|NOT COMPLETED|Overall Study||1
8925291|NCT02256982|9986386|FG000|STARTED|Overall Study||1
8925292|NCT02256982|9986387|FG001|STARTED|Overall Study||2
8925293|NCT02256982|9986386|FG000|COMPLETED|Overall Study||1
8925294|NCT02256982|9986387|FG001|COMPLETED|Overall Study||1
8925295|NCT02256982|9986386|FG000|NOT COMPLETED|Overall Study||0
8925296|NCT02256982|9986387|FG001|NOT COMPLETED|Overall Study||1
8925297|NCT02257099|9986393|FG000|STARTED|Overall Study||20
8695274|NCT00876187|9740675|FG003|COMPLETED|Overall Study||22
8925298|NCT02257099|9986393|FG000|COMPLETED|Overall Study||20
9040719|NCT03358407|10101684|FG000|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
9040720|NCT03358407|10101685|FG001|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
9040721|NCT03358407|10101686|FG002|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
8695275|NCT00876187|9740676|FG004|COMPLETED|Overall Study||27
8695276|NCT00876187|9740672|FG000|NOT COMPLETED|Overall Study||210
8695277|NCT00876187|9740673|FG001|NOT COMPLETED|Overall Study||215
8695278|NCT00876187|9740674|FG002|NOT COMPLETED|Overall Study||279
8695279|NCT00876187|9740675|FG003|NOT COMPLETED|Overall Study||275
8695280|NCT00876187|9740676|FG004|NOT COMPLETED|Overall Study||271
8695281|NCT00876200|9740693|FG000|STARTED|Overall Study||9
8695282|NCT00876200|9740694|FG001|STARTED|Overall Study||12
8695283|NCT00876200|9740693|FG000|COMPLETED|Overall Study||8
8695284|NCT00876200|9740694|FG001|COMPLETED|Overall Study||9
8695285|NCT00876200|9740693|FG000|NOT COMPLETED|Overall Study||1
8695286|NCT00876200|9740694|FG001|NOT COMPLETED|Overall Study||3
8695287|NCT00876265|9740700|FG000|STARTED|Overall Study||118
8695288|NCT00876265|9740700|FG000|COMPLETED|Overall Study||106
8695289|NCT00876265|9740700|FG000|NOT COMPLETED|Overall Study||12
8695290|NCT00876343|9740709|FG000|STARTED|Overall Study||194
8695291|NCT00876343|9740710|FG001|STARTED|Overall Study||197
8695292|NCT00876343|9740711|FG002|STARTED|Overall Study||195
8695293|NCT00876343|9740709|FG000|COMPLETED|Overall Study||177
8695294|NCT00876343|9740710|FG001|COMPLETED|Overall Study||180
8695295|NCT00876343|9740711|FG002|COMPLETED|Overall Study||183
8695296|NCT00876343|9740709|FG000|NOT COMPLETED|Overall Study||17
8695297|NCT00876343|9740710|FG001|NOT COMPLETED|Overall Study||17
8695298|NCT00876343|9740711|FG002|NOT COMPLETED|Overall Study||12
8695299|NCT00876395|9740721|FG000|STARTED|Overall Study||480
8695300|NCT00876395|9740722|FG001|STARTED|Overall Study||239
8695301|NCT00876395|9740721|FG000|Untreated|Overall Study||8
8695302|NCT00876395|9740722|FG001|Untreated|Overall Study||1
8695303|NCT00876395|9740721|FG000|COMPLETED|Overall Study||0
8695304|NCT00876395|9740722|FG001|COMPLETED|Overall Study||0
8695305|NCT00876395|9740721|FG000|NOT COMPLETED|Overall Study||480
8695306|NCT00876395|9740722|FG001|NOT COMPLETED|Overall Study||239
8695307|NCT00876447|9740735|FG000|STARTED|Overall Study||185
8695308|NCT00876447|9740736|FG001|STARTED|Overall Study||203
8695309|NCT00876447|9740735|FG000|COMPLETED|Overall Study||105
8695310|NCT00876447|9740736|FG001|COMPLETED|Overall Study||122
8695311|NCT00876447|9740735|FG000|NOT COMPLETED|Overall Study||80
8695312|NCT00876447|9740736|FG001|NOT COMPLETED|Overall Study||81
8695313|NCT00876460|9740774|FG000|STARTED|Combination Therapy Phase||3
8695314|NCT00876460|9740775|FG001|STARTED|Combination Therapy Phase||7
8695315|NCT00876460|9740776|FG002|STARTED|Combination Therapy Phase||3
8695316|NCT00876460|9740777|FG003|STARTED|Combination Therapy Phase||6
8695317|NCT00876460|9740778|FG004|STARTED|Combination Therapy Phase||7
8695318|NCT00876460|9740779|FG005|STARTED|Combination Therapy Phase||3
8695319|NCT00876460|9740780|FG006|STARTED|Combination Therapy Phase||8
8695320|NCT00876460|9740781|FG007|STARTED|Combination Therapy Phase||6
8695321|NCT00876460|9740774|FG000|COMPLETED|Combination Therapy Phase||0
8695322|NCT00876460|9740775|FG001|COMPLETED|Combination Therapy Phase||0
8695323|NCT00876460|9740776|FG002|COMPLETED|Combination Therapy Phase||0
8695324|NCT00876460|9740777|FG003|COMPLETED|Combination Therapy Phase||0
9040722|NCT03358407|10101687|FG003|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
9040723|NCT03358407|10101688|FG004|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
9040724|NCT03358407|10101689|FG005|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
9040725|NCT03358407|10101690|FG006|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
9040726|NCT03358407|10101691|FG007|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
9040727|NCT03358407|10101692|FG008|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
9040728|NCT03358407|10101693|FG009|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
9040729|NCT03358407|10101684|FG000|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
9040730|NCT03358407|10101685|FG001|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
9040731|NCT03358407|10101686|FG002|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||1
9040732|NCT03358407|10101687|FG003|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
9040733|NCT03358407|10101688|FG004|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
9040734|NCT03358407|10101689|FG005|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
9040735|NCT03358407|10101690|FG006|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
9040736|NCT03358407|10101691|FG007|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
9040737|NCT03358407|10101692|FG008|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
9040738|NCT03358407|10101693|FG009|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
9040739|NCT03358407|10101684|FG000|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
8695325|NCT00876460|9740778|FG004|COMPLETED|Combination Therapy Phase||0
8695326|NCT00876460|9740779|FG005|COMPLETED|Combination Therapy Phase||0
8695327|NCT00876460|9740780|FG006|COMPLETED|Combination Therapy Phase||0
8695328|NCT00876460|9740781|FG007|COMPLETED|Combination Therapy Phase||0
8695329|NCT00876460|9740774|FG000|NOT COMPLETED|Combination Therapy Phase||3
8695330|NCT00876460|9740775|FG001|NOT COMPLETED|Combination Therapy Phase||7
8695331|NCT00876460|9740776|FG002|NOT COMPLETED|Combination Therapy Phase||3
8695332|NCT00876460|9740777|FG003|NOT COMPLETED|Combination Therapy Phase||6
8695333|NCT00876460|9740778|FG004|NOT COMPLETED|Combination Therapy Phase||7
8695334|NCT00876460|9740779|FG005|NOT COMPLETED|Combination Therapy Phase||3
8695335|NCT00876460|9740780|FG006|NOT COMPLETED|Combination Therapy Phase||8
8695336|NCT00876460|9740781|FG007|NOT COMPLETED|Combination Therapy Phase||6
8695337|NCT00876460|9740774|FG000|STARTED|Mono Therapy Phase||0
8695338|NCT00876460|9740775|FG001|STARTED|Mono Therapy Phase|One patient started mono therapy phase after discontinued from combination therapy phase.|1
8695339|NCT00876460|9740776|FG002|STARTED|Mono Therapy Phase||0
8695340|NCT00876460|9740777|FG003|STARTED|Mono Therapy Phase|One patient started mono therapy phase after discontinued from combination therapy phase.|1
8695341|NCT00876460|9740778|FG004|STARTED|Mono Therapy Phase|Two patients started mono therapy phase after discontinued from combination therapy phase.|2
9040740|NCT03358407|10101685|FG001|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
9040741|NCT03358407|10101686|FG002|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||1
9040742|NCT03358407|10101687|FG003|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
9040743|NCT03358407|10101688|FG004|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
9040744|NCT03358407|10101689|FG005|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
9040745|NCT03358407|10101690|FG006|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
9040746|NCT03358407|10101691|FG007|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
9040747|NCT03358407|10101692|FG008|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
9040748|NCT03358407|10101693|FG009|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
9040749|NCT03358407|10101684|FG000|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
9040750|NCT03358407|10101685|FG001|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
9040751|NCT03358407|10101686|FG002|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)|1 participant was added to Part A-Cohort 1: GSK 2mg/GSK 4mg/Placebo/GSK 30mg/GSK 100mg arm|2
9040752|NCT03358407|10101687|FG003|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
9040753|NCT03358407|10101688|FG004|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
9040754|NCT03358407|10101689|FG005|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
9040755|NCT03358407|10101690|FG006|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
9040756|NCT03358407|10101691|FG007|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
9040757|NCT03358407|10101692|FG008|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
9040758|NCT03358407|10101693|FG009|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
9040759|NCT03358407|10101684|FG000|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
9040760|NCT03358407|10101685|FG001|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
9040761|NCT03358407|10101686|FG002|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
9040762|NCT03358407|10101687|FG003|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
9040763|NCT03358407|10101688|FG004|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
9040764|NCT03358407|10101689|FG005|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
9040765|NCT03358407|10101690|FG006|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
9040766|NCT03358407|10101691|FG007|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
9040767|NCT03358407|10101692|FG008|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
9040768|NCT03358407|10101693|FG009|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
9040769|NCT03358407|10101684|FG000|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
9040770|NCT03358407|10101685|FG001|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
9040771|NCT03358407|10101686|FG002|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
9040772|NCT03358407|10101687|FG003|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
9040773|NCT03358407|10101688|FG004|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
9040774|NCT03358407|10101689|FG005|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
9040775|NCT03358407|10101690|FG006|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
9040776|NCT03358407|10101691|FG007|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
9040777|NCT03358407|10101692|FG008|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
9040778|NCT03358407|10101693|FG009|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
9040779|NCT03358407|10101684|FG000|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
9040780|NCT03358407|10101685|FG001|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
9040781|NCT03358407|10101686|FG002|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
9040782|NCT03358407|10101687|FG003|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
9040783|NCT03358407|10101688|FG004|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
9040784|NCT03358407|10101689|FG005|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
9040785|NCT03358407|10101690|FG006|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
9040786|NCT03358407|10101691|FG007|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
9040787|NCT03358407|10101692|FG008|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
9040788|NCT03358407|10101693|FG009|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
9040789|NCT03358407|10101684|FG000|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
9040790|NCT03358407|10101685|FG001|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
9040791|NCT03358407|10101686|FG002|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
9040792|NCT03358407|10101687|FG003|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
9040793|NCT03358407|10101688|FG004|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||1
9040794|NCT03358407|10101689|FG005|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
9040795|NCT03358407|10101690|FG006|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
9040796|NCT03358407|10101691|FG007|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
9040797|NCT03358407|10101692|FG008|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
9040798|NCT03358407|10101693|FG009|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
9040799|NCT03358407|10101684|FG000|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
9040800|NCT03358407|10101685|FG001|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
9040801|NCT03358407|10101686|FG002|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
9040802|NCT03358407|10101687|FG003|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
8695342|NCT00876460|9740779|FG005|STARTED|Mono Therapy Phase||0
8695343|NCT00876460|9740780|FG006|STARTED|Mono Therapy Phase|One patient started mono therapy phase after discontinued from combination therapy phase.|1
8695344|NCT00876460|9740781|FG007|STARTED|Mono Therapy Phase|Three patients started mono therapy phase after discontinued from combination therapy phase.|3
8695345|NCT00876460|9740774|FG000|COMPLETED|Mono Therapy Phase||0
8695346|NCT00876460|9740775|FG001|COMPLETED|Mono Therapy Phase||0
8695347|NCT00876460|9740776|FG002|COMPLETED|Mono Therapy Phase||0
8695348|NCT00876460|9740777|FG003|COMPLETED|Mono Therapy Phase||0
8695349|NCT00876460|9740778|FG004|COMPLETED|Mono Therapy Phase||0
8695350|NCT00876460|9740779|FG005|COMPLETED|Mono Therapy Phase||0
8695351|NCT00876460|9740780|FG006|COMPLETED|Mono Therapy Phase||0
8925299|NCT02257099|9986393|FG000|NOT COMPLETED|Overall Study||0
8925300|NCT02257177|9986410|FG000|STARTED|Overall Study||4
8925301|NCT02257177|9986411|FG001|STARTED|Overall Study||4
8695352|NCT00876460|9740781|FG007|COMPLETED|Mono Therapy Phase||0
8695353|NCT00876460|9740774|FG000|NOT COMPLETED|Mono Therapy Phase||0
8695354|NCT00876460|9740775|FG001|NOT COMPLETED|Mono Therapy Phase||1
8695355|NCT00876460|9740776|FG002|NOT COMPLETED|Mono Therapy Phase||0
8695356|NCT00876460|9740777|FG003|NOT COMPLETED|Mono Therapy Phase||1
8695357|NCT00876460|9740778|FG004|NOT COMPLETED|Mono Therapy Phase||2
8695358|NCT00876460|9740779|FG005|NOT COMPLETED|Mono Therapy Phase||0
8695359|NCT00876460|9740780|FG006|NOT COMPLETED|Mono Therapy Phase||1
8695360|NCT00876460|9740781|FG007|NOT COMPLETED|Mono Therapy Phase||3
8695361|NCT00876694|9740813|FG000|STARTED|Overall Study||125
8695362|NCT00876694|9740814|FG001|STARTED|Overall Study||61
8695363|NCT00876694|9740813|FG000|COMPLETED|Overall Study||104
8695364|NCT00876694|9740814|FG001|COMPLETED|Overall Study||49
8695365|NCT00876694|9740813|FG000|NOT COMPLETED|Overall Study||21
8695366|NCT00876694|9740814|FG001|NOT COMPLETED|Overall Study||12
8695367|NCT00876733|9740824|FG000|STARTED|Overall Study||288
8695368|NCT00876733|9740825|FG001|STARTED|Overall Study||203
9040803|NCT03358407|10101688|FG004|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||1
9040804|NCT03358407|10101689|FG005|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
9040805|NCT03358407|10101690|FG006|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
9040806|NCT03358407|10101691|FG007|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
8695369|NCT00876733|9740826|FG002|STARTED|Overall Study||93
8695370|NCT00876733|9740827|FG003|STARTED|Overall Study||21
8695371|NCT00876733|9740824|FG000|COMPLETED|Overall Study||197
8695372|NCT00876733|9740825|FG001|COMPLETED|Overall Study||161
8695373|NCT00876733|9740826|FG002|COMPLETED|Overall Study||63
8695374|NCT00876733|9740827|FG003|COMPLETED|Overall Study||14
8695375|NCT00876733|9740824|FG000|NOT COMPLETED|Overall Study||91
8695376|NCT00876733|9740825|FG001|NOT COMPLETED|Overall Study||42
8695377|NCT00876733|9740826|FG002|NOT COMPLETED|Overall Study||30
8695378|NCT00876733|9740827|FG003|NOT COMPLETED|Overall Study||7
8695379|NCT00876915|9740840|FG000|STARTED|Overall Study||50
8695380|NCT00876915|9740841|FG001|STARTED|Overall Study||48
8695381|NCT00876915|9740842|FG002|STARTED|Overall Study||101
8695382|NCT00876915|9740840|FG000|Week 4|Overall Study||38
8695383|NCT00876915|9740841|FG001|Week 4|Overall Study||45
8695384|NCT00876915|9740842|FG002|Week 4|Overall Study||0
8695385|NCT00876915|9740840|FG000|Week 8|Overall Study||33
8695386|NCT00876915|9740841|FG001|Week 8|Overall Study||36
8695387|NCT00876915|9740842|FG002|Week 8|Overall Study||0
8695388|NCT00876915|9740840|FG000|COMPLETED|Overall Study||31
8695389|NCT00876915|9740841|FG001|COMPLETED|Overall Study||34
8695390|NCT00876915|9740842|FG002|COMPLETED|Overall Study||101
8695391|NCT00876915|9740840|FG000|NOT COMPLETED|Overall Study||19
8695392|NCT00876915|9740841|FG001|NOT COMPLETED|Overall Study||14
8695393|NCT00876915|9740842|FG002|NOT COMPLETED|Overall Study||0
8695394|NCT00876928|9740852|FG000|STARTED|Overall Study||56
8695395|NCT00876928|9740853|FG001|STARTED|Overall Study||61
8695396|NCT00876928|9740852|FG000|COMPLETED|Overall Study||53
8695397|NCT00876928|9740853|FG001|COMPLETED|Overall Study||56
8695398|NCT00876928|9740852|FG000|NOT COMPLETED|Overall Study||3
8695399|NCT00876928|9740853|FG001|NOT COMPLETED|Overall Study||5
8695400|NCT00876993|9740864|FG000|STARTED|Overall Study||5
8695401|NCT00876993|9740865|FG001|STARTED|Overall Study||6
8695402|NCT00876993|9740866|FG002|STARTED|Overall Study||5
8695403|NCT00876993|9740867|FG003|STARTED|Overall Study||5
8695404|NCT00876993|9740868|FG004|STARTED|Overall Study||5
8695405|NCT00876993|9740864|FG000|COMPLETED|Overall Study||4
8695406|NCT00876993|9740865|FG001|COMPLETED|Overall Study||6
8695407|NCT00876993|9740866|FG002|COMPLETED|Overall Study||3
8695408|NCT00876993|9740867|FG003|COMPLETED|Overall Study||5
8695409|NCT00876993|9740868|FG004|COMPLETED|Overall Study||3
8695410|NCT00876993|9740864|FG000|NOT COMPLETED|Overall Study||1
8695411|NCT00876993|9740865|FG001|NOT COMPLETED|Overall Study||0
8695412|NCT00876993|9740866|FG002|NOT COMPLETED|Overall Study||2
9040807|NCT03358407|10101692|FG008|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
8925302|NCT02257177|9986412|FG002|STARTED|Overall Study||4
8695413|NCT00876993|9740867|FG003|NOT COMPLETED|Overall Study||0
8695414|NCT00876993|9740868|FG004|NOT COMPLETED|Overall Study||2
8695415|NCT00877006|9740884|FG000|STARTED|Treatment Period||224
8695416|NCT00877006|9740885|FG001|STARTED|Treatment Period||223
8695417|NCT00877006|9740884|FG000|COMPLETED|Treatment Period||199
8695418|NCT00877006|9740885|FG001|COMPLETED|Treatment Period||196
8695419|NCT00877006|9740884|FG000|NOT COMPLETED|Treatment Period||25
8695420|NCT00877006|9740885|FG001|NOT COMPLETED|Treatment Period||27
8695421|NCT00877006|9740884|FG000|STARTED|Long-Term Follow-up Period||210
8695422|NCT00877006|9740885|FG001|STARTED|Long-Term Follow-up Period||209
8695423|NCT00877006|9740884|FG000|COMPLETED|Long-Term Follow-up Period||157
8695424|NCT00877006|9740885|FG001|COMPLETED|Long-Term Follow-up Period||154
8695425|NCT00877006|9740884|FG000|NOT COMPLETED|Long-Term Follow-up Period||53
8695426|NCT00877006|9740885|FG001|NOT COMPLETED|Long-Term Follow-up Period||55
8695427|NCT00877032|9740900|FG000|STARTED|Overall Study||6
8695428|NCT00877032|9740901|FG001|STARTED|Overall Study||6
8695429|NCT00877032|9740902|FG002|STARTED|Overall Study||6
8695430|NCT00877032|9740903|FG003|STARTED|Overall Study||7
8695431|NCT00877032|9740904|FG004|STARTED|Overall Study||6
8695432|NCT00877032|9740905|FG005|STARTED|Overall Study||6
8695433|NCT00877032|9740906|FG006|STARTED|Overall Study||20
8695434|NCT00877032|9740900|FG000|Treated|Overall Study||6
8695435|NCT00877032|9740901|FG001|Treated|Overall Study||6
8695436|NCT00877032|9740902|FG002|Treated|Overall Study||6
8695437|NCT00877032|9740903|FG003|Treated|Overall Study||6
8695438|NCT00877032|9740904|FG004|Treated|Overall Study||6
8695439|NCT00877032|9740905|FG005|Treated|Overall Study||6
8695440|NCT00877032|9740906|FG006|Treated|Overall Study||18
8695441|NCT00877032|9740900|FG000|COMPLETED|Overall Study||6
8695442|NCT00877032|9740901|FG001|COMPLETED|Overall Study||6
8695443|NCT00877032|9740902|FG002|COMPLETED|Overall Study||6
8695444|NCT00877032|9740903|FG003|COMPLETED|Overall Study||6
8695445|NCT00877032|9740904|FG004|COMPLETED|Overall Study||6
8695446|NCT00877032|9740905|FG005|COMPLETED|Overall Study||6
8695447|NCT00877032|9740906|FG006|COMPLETED|Overall Study||18
8695448|NCT00877032|9740900|FG000|NOT COMPLETED|Overall Study||0
8695449|NCT00877032|9740901|FG001|NOT COMPLETED|Overall Study||0
8695450|NCT00877032|9740902|FG002|NOT COMPLETED|Overall Study||0
8695451|NCT00877032|9740903|FG003|NOT COMPLETED|Overall Study||1
8695452|NCT00877032|9740904|FG004|NOT COMPLETED|Overall Study||0
8695453|NCT00877032|9740905|FG005|NOT COMPLETED|Overall Study||0
8695454|NCT00877032|9740906|FG006|NOT COMPLETED|Overall Study||2
8695455|NCT00877058|9740925|FG000|STARTED|Overall Study||174
8695456|NCT00877058|9740926|FG001|STARTED|Overall Study||171
8695457|NCT00877058|9740927|FG002|STARTED|Overall Study||114
8695458|NCT00877058|9740925|FG000|COMPLETED|Overall Study||137
8695459|NCT00877058|9740926|FG001|COMPLETED|Overall Study||131
8695460|NCT00877058|9740927|FG002|COMPLETED|Overall Study||75
8695461|NCT00877058|9740925|FG000|NOT COMPLETED|Overall Study||37
8695462|NCT00877058|9740926|FG001|NOT COMPLETED|Overall Study||40
8695463|NCT00877058|9740927|FG002|NOT COMPLETED|Overall Study||39
8695464|NCT00877370|9740935|FG000|STARTED|Overall Study||8
8695465|NCT00877370|9740935|FG000|COMPLETED|Overall Study||8
8695466|NCT00877370|9740935|FG000|NOT COMPLETED|Overall Study||0
8695467|NCT00877383|9740941|FG000|STARTED|Overall Study||572
9040808|NCT03358407|10101693|FG009|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
9040809|NCT03358407|10101684|FG000|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||2
9040810|NCT03358407|10101685|FG001|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||2
9040811|NCT03358407|10101686|FG002|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||2
9040812|NCT03358407|10101687|FG003|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||2
8556969|NCT02964039|9588762|FG000|COMPLETED|Overall Study||14
8556970|NCT02964039|9588763|FG001|COMPLETED|Overall Study||17
8695468|NCT00877383|9740942|FG001|STARTED|Overall Study||570
8695469|NCT00877383|9740941|FG000|COMPLETED|Overall Study||543
8695470|NCT00877383|9740942|FG001|COMPLETED|Overall Study||533
8556971|NCT02964039|9588764|FG002|COMPLETED|Overall Study||13
8695471|NCT00877383|9740941|FG000|NOT COMPLETED|Overall Study||29
8695472|NCT00877383|9740942|FG001|NOT COMPLETED|Overall Study||37
8695473|NCT00877448|9740955|FG000|STARTED|Overall Study||10
8695474|NCT00877448|9740956|FG001|STARTED|Overall Study||10
8695475|NCT00877448|9740957|FG002|STARTED|Overall Study||10
8695476|NCT00877448|9740958|FG003|STARTED|Overall Study||10
8695477|NCT00877448|9740959|FG004|STARTED|Overall Study||10
8695478|NCT00877448|9740960|FG005|STARTED|Overall Study||10
8695479|NCT00877448|9740961|FG006|STARTED|Overall Study||3
8695480|NCT00877448|9740955|FG000|COMPLETED|Overall Study||10
8695481|NCT00877448|9740956|FG001|COMPLETED|Overall Study||9
8556972|NCT02964039|9588762|FG000|NOT COMPLETED|Overall Study||4
8556973|NCT02964039|9588763|FG001|NOT COMPLETED|Overall Study||1
8556974|NCT02964039|9588764|FG002|NOT COMPLETED|Overall Study||5
8695482|NCT00877448|9740957|FG002|COMPLETED|Overall Study||10
8556975|NCT02930889|9588772|FG000|STARTED|Overall Study||21
8695483|NCT00877448|9740958|FG003|COMPLETED|Overall Study||9
8695484|NCT00877448|9740959|FG004|COMPLETED|Overall Study||10
8695485|NCT00877448|9740960|FG005|COMPLETED|Overall Study||9
8695486|NCT00877448|9740961|FG006|COMPLETED|Overall Study||3
8695487|NCT00877448|9740955|FG000|NOT COMPLETED|Overall Study||0
8695488|NCT00877448|9740956|FG001|NOT COMPLETED|Overall Study||1
8695489|NCT00877448|9740957|FG002|NOT COMPLETED|Overall Study||0
8695490|NCT00877448|9740958|FG003|NOT COMPLETED|Overall Study||1
8695491|NCT00877448|9740959|FG004|NOT COMPLETED|Overall Study||0
8695492|NCT00877448|9740960|FG005|NOT COMPLETED|Overall Study||1
8695493|NCT00877448|9740961|FG006|NOT COMPLETED|Overall Study||0
8695494|NCT00877487|9740977|FG000|STARTED|Open-label Treatment Phase||123
8695495|NCT00877487|9740978|FG001|STARTED|Open-label Treatment Phase||0
8695496|NCT00877487|9740977|FG000|COMPLETED|Open-label Treatment Phase||116
8695497|NCT00877487|9740978|FG001|COMPLETED|Open-label Treatment Phase||0
8695498|NCT00877487|9740977|FG000|NOT COMPLETED|Open-label Treatment Phase||7
8695499|NCT00877487|9740978|FG001|NOT COMPLETED|Open-label Treatment Phase||0
8695500|NCT00877487|9740977|FG000|STARTED|Double-blind Randomized Withdrawal Phase||56
8695501|NCT00877487|9740978|FG001|STARTED|Double-blind Randomized Withdrawal Phase||60
8695502|NCT00877487|9740977|FG000|COMPLETED|Double-blind Randomized Withdrawal Phase||50
8695503|NCT00877487|9740978|FG001|COMPLETED|Double-blind Randomized Withdrawal Phase||13
8695504|NCT00877487|9740977|FG000|NOT COMPLETED|Double-blind Randomized Withdrawal Phase||6
8695505|NCT00877487|9740978|FG001|NOT COMPLETED|Double-blind Randomized Withdrawal Phase||47
8695506|NCT00877604|9740986|FG000|STARTED|Overall Study||17
8695507|NCT00877604|9740987|FG001|STARTED|Overall Study||17
8695508|NCT00877604|9740986|FG000|COMPLETED|Overall Study||15
8695509|NCT00877604|9740987|FG001|COMPLETED|Overall Study||14
9040813|NCT03358407|10101688|FG004|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)|1 participant was added to Part A-Cohort 1: GSK 2mg/GSK 4mg/GSK 10mg/GSK 30mg/Placebo arm|2
9040814|NCT03358407|10101689|FG005|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||0
9040815|NCT03358407|10101690|FG006|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||0
9040816|NCT03358407|10101691|FG007|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||0
9040817|NCT03358407|10101692|FG008|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||0
9040818|NCT03358407|10101693|FG009|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||0
9040819|NCT03358407|10101684|FG000|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||2
9040820|NCT03358407|10101685|FG001|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||2
9040821|NCT03358407|10101686|FG002|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||2
9040822|NCT03358407|10101687|FG003|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||2
9040823|NCT03358407|10101688|FG004|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||2
9040824|NCT03358407|10101689|FG005|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
9040825|NCT03358407|10101690|FG006|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
9040826|NCT03358407|10101691|FG007|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
9040827|NCT03358407|10101692|FG008|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
9040828|NCT03358407|10101693|FG009|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
9040829|NCT03358407|10101684|FG000|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
9040830|NCT03358407|10101685|FG001|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
9040831|NCT03358407|10101686|FG002|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
9040832|NCT03358407|10101687|FG003|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
9040833|NCT03358407|10101688|FG004|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
9040834|NCT03358407|10101689|FG005|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
9040835|NCT03358407|10101690|FG006|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
9040836|NCT03358407|10101691|FG007|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
9040837|NCT03358407|10101692|FG008|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
9040838|NCT03358407|10101693|FG009|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
9040839|NCT03358407|10101684|FG000|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
9040840|NCT03358407|10101685|FG001|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
9040841|NCT03358407|10101686|FG002|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
9040842|NCT03358407|10101687|FG003|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
9040843|NCT03358407|10101688|FG004|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
9040844|NCT03358407|10101689|FG005|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||3
9040845|NCT03358407|10101690|FG006|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||3
9040846|NCT03358407|10101691|FG007|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||6
9040847|NCT03358407|10101692|FG008|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
9040848|NCT03358407|10101693|FG009|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
9040849|NCT03358407|10101684|FG000|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
9040850|NCT03358407|10101685|FG001|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
9040851|NCT03358407|10101686|FG002|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
9040852|NCT03358407|10101687|FG003|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
9040853|NCT03358407|10101688|FG004|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
9040854|NCT03358407|10101689|FG005|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
9040855|NCT03358407|10101690|FG006|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||2
9040856|NCT03358407|10101691|FG007|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||3
9040857|NCT03358407|10101692|FG008|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
9040858|NCT03358407|10101693|FG009|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
9040859|NCT03358407|10101684|FG000|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
9040860|NCT03358407|10101685|FG001|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
9040861|NCT03358407|10101686|FG002|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
9040862|NCT03358407|10101687|FG003|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
9040863|NCT03358407|10101688|FG004|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
9040864|NCT03358407|10101689|FG005|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||3
9040865|NCT03358407|10101690|FG006|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||1
9040866|NCT03358407|10101691|FG007|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||3
9040867|NCT03358407|10101692|FG008|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
9040868|NCT03358407|10101693|FG009|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
9040869|NCT03358407|10101684|FG000|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
9040870|NCT03358407|10101685|FG001|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
9040871|NCT03358407|10101686|FG002|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
9040872|NCT03358407|10101687|FG003|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
9040873|NCT03358407|10101688|FG004|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
8556976|NCT02930889|9588772|FG000|COMPLETED|Overall Study||5
8695510|NCT00877604|9740986|FG000|NOT COMPLETED|Overall Study||2
8695511|NCT00877604|9740987|FG001|NOT COMPLETED|Overall Study||3
8695512|NCT00877773|9740993|FG000|STARTED|Overall Study||44
8925303|NCT02257177|9986413|FG003|STARTED|Overall Study||4
9040874|NCT03358407|10101689|FG005|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)|3 participants were added to Part A-Cohort 2: Placebo/GSK 400mg arm|3
9040875|NCT03358407|10101690|FG006|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)|1 participant was added to Part A-Cohort 2: GSK 200mg/ Placebo arm|3
9040876|NCT03358407|10101691|FG007|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)|3 participants were added to Part A-Cohort 2: GSK 200mg/GSK 400mg arm|6
9040877|NCT03358407|10101692|FG008|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
9040878|NCT03358407|10101693|FG009|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
9040879|NCT03358407|10101684|FG000|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
9040880|NCT03358407|10101685|FG001|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
9040881|NCT03358407|10101686|FG002|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
9040882|NCT03358407|10101687|FG003|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
9040883|NCT03358407|10101688|FG004|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
9040884|NCT03358407|10101689|FG005|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
9040885|NCT03358407|10101690|FG006|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
9040886|NCT03358407|10101691|FG007|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
9040887|NCT03358407|10101692|FG008|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
9040888|NCT03358407|10101693|FG009|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
9040889|NCT03358407|10101684|FG000|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
9040890|NCT03358407|10101685|FG001|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
9040891|NCT03358407|10101686|FG002|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
9040892|NCT03358407|10101687|FG003|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
9040893|NCT03358407|10101688|FG004|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
9040894|NCT03358407|10101689|FG005|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||3
9040895|NCT03358407|10101690|FG006|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||3
9040896|NCT03358407|10101691|FG007|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||6
9040897|NCT03358407|10101692|FG008|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
9040898|NCT03358407|10101693|FG009|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
9040899|NCT03358407|10101684|FG000|STARTED|Part B: Overall Period (11 Weeks)||0
9040900|NCT03358407|10101685|FG001|STARTED|Part B: Overall Period (11 Weeks)||0
9040901|NCT03358407|10101686|FG002|STARTED|Part B: Overall Period (11 Weeks)||0
9040902|NCT03358407|10101687|FG003|STARTED|Part B: Overall Period (11 Weeks)||0
9040903|NCT03358407|10101688|FG004|STARTED|Part B: Overall Period (11 Weeks)||0
9040904|NCT03358407|10101689|FG005|STARTED|Part B: Overall Period (11 Weeks)||0
9040905|NCT03358407|10101690|FG006|STARTED|Part B: Overall Period (11 Weeks)||0
9040906|NCT03358407|10101691|FG007|STARTED|Part B: Overall Period (11 Weeks)||0
9040907|NCT03358407|10101692|FG008|STARTED|Part B: Overall Period (11 Weeks)||0
9040908|NCT03358407|10101693|FG009|STARTED|Part B: Overall Period (11 Weeks)||0
9040909|NCT03358407|10101684|FG000|COMPLETED|Part B: Overall Period (11 Weeks)||0
9040910|NCT03358407|10101685|FG001|COMPLETED|Part B: Overall Period (11 Weeks)||0
9040911|NCT03358407|10101686|FG002|COMPLETED|Part B: Overall Period (11 Weeks)||0
9040912|NCT03358407|10101687|FG003|COMPLETED|Part B: Overall Period (11 Weeks)||0
9040913|NCT03358407|10101688|FG004|COMPLETED|Part B: Overall Period (11 Weeks)||0
9040914|NCT03358407|10101689|FG005|COMPLETED|Part B: Overall Period (11 Weeks)||0
9040915|NCT03358407|10101690|FG006|COMPLETED|Part B: Overall Period (11 Weeks)||0
9040916|NCT03358407|10101691|FG007|COMPLETED|Part B: Overall Period (11 Weeks)||0
9040917|NCT03358407|10101692|FG008|COMPLETED|Part B: Overall Period (11 Weeks)||0
9040918|NCT03358407|10101693|FG009|COMPLETED|Part B: Overall Period (11 Weeks)||0
9040919|NCT03358407|10101684|FG000|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
9040920|NCT03358407|10101685|FG001|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
9040921|NCT03358407|10101686|FG002|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
9040922|NCT03358407|10101687|FG003|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
9040923|NCT03358407|10101688|FG004|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
9040924|NCT03358407|10101689|FG005|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
9040925|NCT03358407|10101690|FG006|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
9040926|NCT03358407|10101691|FG007|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
9040927|NCT03358407|10101692|FG008|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
8695513|NCT00877773|9740993|FG000|COMPLETED|Overall Study|No participant reached to first restaging.|0
8925304|NCT02257177|9986414|FG004|STARTED|Overall Study||4
8925305|NCT02257177|9986415|FG005|STARTED|Overall Study||4
8925306|NCT02257177|9986416|FG006|STARTED|Overall Study||12
8925307|NCT02257177|9986417|FG007|STARTED|Overall Study||5
8925308|NCT02257177|9986418|FG008|STARTED|Overall Study||5
8925309|NCT02257177|9986419|FG009|STARTED|Overall Study||5
8925310|NCT02257177|9986420|FG010|STARTED|Overall Study||9
8925311|NCT02257177|9986410|FG000|COMPLETED|Overall Study||4
8925312|NCT02257177|9986411|FG001|COMPLETED|Overall Study||4
8925313|NCT02257177|9986412|FG002|COMPLETED|Overall Study||4
8925314|NCT02257177|9986413|FG003|COMPLETED|Overall Study||4
8925315|NCT02257177|9986414|FG004|COMPLETED|Overall Study||4
8925316|NCT02257177|9986415|FG005|COMPLETED|Overall Study||4
8925317|NCT02257177|9986416|FG006|COMPLETED|Overall Study||12
8925318|NCT02257177|9986417|FG007|COMPLETED|Overall Study||5
8925319|NCT02257177|9986418|FG008|COMPLETED|Overall Study||5
8925320|NCT02257177|9986419|FG009|COMPLETED|Overall Study||4
8695514|NCT00877773|9740993|FG000|NOT COMPLETED|Overall Study||44
8695515|NCT00877799|9741002|FG000|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||25
8695516|NCT00877799|9741003|FG001|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||22
8695517|NCT00877799|9741004|FG002|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||21
8695518|NCT00877799|9741005|FG003|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||0
8695519|NCT00877799|9741006|FG004|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||0
8695520|NCT00877799|9741002|FG000|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||22
8695521|NCT00877799|9741003|FG001|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||17
8695522|NCT00877799|9741004|FG002|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||18
8695523|NCT00877799|9741005|FG003|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
8695524|NCT00877799|9741006|FG004|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
8695525|NCT00877799|9741002|FG000|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||3
8695526|NCT00877799|9741003|FG001|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||5
8695527|NCT00877799|9741004|FG002|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||3
8695528|NCT00877799|9741005|FG003|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
9040928|NCT03358407|10101693|FG009|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
9040929|NCT03358472|10101724|FG000|STARTED|Overall Study||35
9040930|NCT03358472|10101725|FG001|STARTED|Overall Study||19
9040931|NCT03358472|10101726|FG002|STARTED|Overall Study||35
9040932|NCT03358472|10101724|FG000|Intention-to-Treat (ITT)|Overall Study||35
9040933|NCT03358472|10101725|FG001|Intention-to-Treat (ITT)|Overall Study||19
9040934|NCT03358472|10101726|FG002|Intention-to-Treat (ITT)|Overall Study||35
9040935|NCT03358472|10101724|FG000|All Participants as Treated (APaT)|Overall Study||34
9040936|NCT03358472|10101725|FG001|All Participants as Treated (APaT)|Overall Study||19
9040937|NCT03358472|10101726|FG002|All Participants as Treated (APaT)|Overall Study||34
9040938|NCT03358472|10101724|FG000|COMPLETED|Overall Study||20
9040939|NCT03358472|10101725|FG001|COMPLETED|Overall Study||9
9040940|NCT03358472|10101726|FG002|COMPLETED|Overall Study||19
9040941|NCT03358472|10101724|FG000|NOT COMPLETED|Overall Study||15
9040942|NCT03358472|10101725|FG001|NOT COMPLETED|Overall Study||10
9040943|NCT03358472|10101726|FG002|NOT COMPLETED|Overall Study||16
9040944|NCT03358576|10101736|FG000|STARTED|Overall Study||338
9040945|NCT03358576|10101737|FG001|STARTED|Overall Study||336
9040946|NCT03358576|10101736|FG000|COMPLETED|Overall Study||312
9040947|NCT03358576|10101737|FG001|COMPLETED|Overall Study||311
9040948|NCT03358576|10101736|FG000|NOT COMPLETED|Overall Study||26
9040949|NCT03358576|10101737|FG001|NOT COMPLETED|Overall Study||25
9040950|NCT03359395|10101745|FG000|STARTED|First Intervention A / B||49
9040951|NCT03359395|10101746|FG001|STARTED|First Intervention A / B||50
9040952|NCT03359395|10101745|FG000|COMPLETED|First Intervention A / B||46
9040953|NCT03359395|10101746|FG001|COMPLETED|First Intervention A / B||47
9040954|NCT03359395|10101745|FG000|NOT COMPLETED|First Intervention A / B||3
9040955|NCT03359395|10101746|FG001|NOT COMPLETED|First Intervention A / B||3
9040956|NCT03359395|10101745|FG000|STARTED|Second Intervention B/A||46
9040957|NCT03359395|10101746|FG001|STARTED|Second Intervention B/A||47
9040958|NCT03359395|10101745|FG000|COMPLETED|Second Intervention B/A||43
9040959|NCT03359395|10101746|FG001|COMPLETED|Second Intervention B/A||44
9040960|NCT03359395|10101745|FG000|NOT COMPLETED|Second Intervention B/A||3
9040961|NCT03359395|10101746|FG001|NOT COMPLETED|Second Intervention B/A||3
9040962|NCT03359473|10101756|FG000|STARTED|Overall Study||23
9040963|NCT03359473|10101757|FG001|STARTED|Overall Study||24
9040964|NCT03359473|10101758|FG002|STARTED|Overall Study||24
9040965|NCT03359473|10101759|FG003|STARTED|Overall Study||25
9040966|NCT03359473|10101756|FG000|COMPLETED|Overall Study||21
9040967|NCT03359473|10101757|FG001|COMPLETED|Overall Study||18
9040968|NCT03359473|10101758|FG002|COMPLETED|Overall Study||18
9040969|NCT03359473|10101759|FG003|COMPLETED|Overall Study||20
9040970|NCT03359473|10101756|FG000|NOT COMPLETED|Overall Study||2
9040971|NCT03359473|10101757|FG001|NOT COMPLETED|Overall Study||6
9040972|NCT03359473|10101758|FG002|NOT COMPLETED|Overall Study||6
9040973|NCT03359473|10101759|FG003|NOT COMPLETED|Overall Study||5
9040974|NCT03359590|10101772|FG000|STARTED|First Intervention||10
9040975|NCT03359590|10101773|FG001|STARTED|First Intervention||10
9040976|NCT03359590|10101772|FG000|Exposed|First Intervention||9
9040977|NCT03359590|10101773|FG001|Exposed|First Intervention||10
9040978|NCT03359590|10101772|FG000|Discontinued|First Intervention||1
9040979|NCT03359590|10101773|FG001|Discontinued|First Intervention||2
9040980|NCT03359590|10101772|FG000|COMPLETED|First Intervention||9
9040981|NCT03359590|10101773|FG001|COMPLETED|First Intervention||8
9040982|NCT03359590|10101772|FG000|NOT COMPLETED|First Intervention||1
9040983|NCT03359590|10101773|FG001|NOT COMPLETED|First Intervention||2
9040984|NCT03359590|10101772|FG000|STARTED|Second Intervention||9
9040985|NCT03359590|10101773|FG001|STARTED|Second Intervention||8
9040986|NCT03359590|10101772|FG000|Exposed|Second Intervention||9
9040987|NCT03359590|10101773|FG001|Exposed|Second Intervention||8
9040988|NCT03359590|10101772|FG000|Discontinued|Second Intervention||0
9040989|NCT03359590|10101773|FG001|Discontinued|Second Intervention||0
9040990|NCT03359590|10101772|FG000|COMPLETED|Second Intervention||9
9040991|NCT03359590|10101773|FG001|COMPLETED|Second Intervention||8
9040992|NCT03359590|10101772|FG000|NOT COMPLETED|Second Intervention||0
9040993|NCT03359590|10101773|FG001|NOT COMPLETED|Second Intervention||0
9040994|NCT03359629|10101781|FG000|STARTED|Overall Study||200
9040995|NCT03359629|10101782|FG001|STARTED|Overall Study||10
9040996|NCT03359629|10101781|FG000|COMPLETED|Overall Study||200
9040997|NCT03359629|10101782|FG001|COMPLETED|Overall Study||10
8695529|NCT00877799|9741006|FG004|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
8695530|NCT00877799|9741002|FG000|STARTED|Cohort 2: Immediately Post-op (Day 0)||0
8695531|NCT00877799|9741003|FG001|STARTED|Cohort 2: Immediately Post-op (Day 0)||0
8695532|NCT00877799|9741004|FG002|STARTED|Cohort 2: Immediately Post-op (Day 0)||0
9040998|NCT03359629|10101781|FG000|NOT COMPLETED|Overall Study||0
9040999|NCT03359629|10101782|FG001|NOT COMPLETED|Overall Study||0
9041000|NCT03359850|10101790|FG000|STARTED|PK Phase (Up to Day 8)||9
9041001|NCT03359850|10101791|FG001|STARTED|PK Phase (Up to Day 8)||8
9041002|NCT03359850|10101790|FG000|COMPLETED|PK Phase (Up to Day 8)||8
9041003|NCT03359850|10101791|FG001|COMPLETED|PK Phase (Up to Day 8)||7
9041004|NCT03359850|10101790|FG000|NOT COMPLETED|PK Phase (Up to Day 8)||1
9041005|NCT03359850|10101791|FG001|NOT COMPLETED|PK Phase (Up to Day 8)||1
9041006|NCT03359850|10101790|FG000|STARTED|Extension Phase (Up to 28 Months)||8
9041007|NCT03359850|10101791|FG001|STARTED|Extension Phase (Up to 28 Months)||7
9041008|NCT03359850|10101790|FG000|COMPLETED|Extension Phase (Up to 28 Months)||0
9041009|NCT03359850|10101791|FG001|COMPLETED|Extension Phase (Up to 28 Months)||1
9041010|NCT03359850|10101790|FG000|NOT COMPLETED|Extension Phase (Up to 28 Months)||8
9041011|NCT03359850|10101791|FG001|NOT COMPLETED|Extension Phase (Up to 28 Months)||6
9041012|NCT03359889|10101799|FG000|STARTED|Overall Study||5
9041013|NCT03359889|10101799|FG000|COMPLETED|Overall Study||5
9041014|NCT03359889|10101799|FG000|NOT COMPLETED|Overall Study||0
9041015|NCT03360071|10101805|FG000|STARTED|Overall Study||17
9041016|NCT03360071|10101806|FG001|STARTED|Overall Study||14
9041017|NCT03360071|10101805|FG000|COMPLETED|Overall Study||16
9041018|NCT03360071|10101806|FG001|COMPLETED|Overall Study||14
9041019|NCT03360071|10101805|FG000|NOT COMPLETED|Overall Study||1
9041020|NCT03360071|10101806|FG001|NOT COMPLETED|Overall Study||0
9041021|NCT03360110|10101812|FG000|STARTED|First Intervention||27
9041022|NCT03360110|10101813|FG001|STARTED|First Intervention||26
9041023|NCT03360110|10101812|FG000|COMPLETED|First Intervention||27
9041024|NCT03360110|10101813|FG001|COMPLETED|First Intervention||26
9041025|NCT03360110|10101812|FG000|NOT COMPLETED|First Intervention||0
9041026|NCT03360110|10101813|FG001|NOT COMPLETED|First Intervention||0
9041027|NCT03360110|10101812|FG000|STARTED|Second Intervention||27
9041028|NCT03360110|10101813|FG001|STARTED|Second Intervention||26
9041029|NCT03360110|10101812|FG000|COMPLETED|Second Intervention||27
9041030|NCT03360110|10101813|FG001|COMPLETED|Second Intervention||26
9041031|NCT03360110|10101812|FG000|NOT COMPLETED|Second Intervention||0
9041032|NCT03360110|10101813|FG001|NOT COMPLETED|Second Intervention||0
9041033|NCT03360344|10101834|FG000|STARTED|Overall Study||15
9041034|NCT03360344|10101835|FG001|STARTED|Overall Study||16
9041035|NCT03360344|10101836|FG002|STARTED|Overall Study||13
9041036|NCT03360344|10101834|FG000|COMPLETED|Overall Study||15
9041037|NCT03360344|10101835|FG001|COMPLETED|Overall Study||15
9041038|NCT03360344|10101836|FG002|COMPLETED|Overall Study||12
9041039|NCT03360344|10101834|FG000|NOT COMPLETED|Overall Study||0
9041040|NCT03360344|10101835|FG001|NOT COMPLETED|Overall Study||1
9041041|NCT03360344|10101836|FG002|NOT COMPLETED|Overall Study||1
9041042|NCT03360747|10101844|FG000|STARTED|Overall Study||3
9041043|NCT03360747|10101844|FG000|COMPLETED|Overall Study||2
9041044|NCT03360747|10101844|FG000|NOT COMPLETED|Overall Study||1
9041045|NCT03361137|10101853|FG000|STARTED|Overall Study||1
9041046|NCT03361137|10101854|FG001|STARTED|Overall Study||9
9041047|NCT03361137|10101855|FG002|STARTED|Overall Study||1
9041048|NCT03361137|10101856|FG003|STARTED|Overall Study||2
9041049|NCT03361137|10101857|FG004|STARTED|Overall Study||1
9041050|NCT03361137|10101853|FG000|COMPLETED|Overall Study||0
9041051|NCT03361137|10101854|FG001|COMPLETED|Overall Study||9
9041052|NCT03361137|10101855|FG002|COMPLETED|Overall Study||1
9041053|NCT03361137|10101856|FG003|COMPLETED|Overall Study||2
9041054|NCT03361137|10101857|FG004|COMPLETED|Overall Study||1
9041055|NCT03361137|10101853|FG000|NOT COMPLETED|Overall Study||1
9041056|NCT03361137|10101854|FG001|NOT COMPLETED|Overall Study||0
9041057|NCT03361137|10101855|FG002|NOT COMPLETED|Overall Study||0
9041058|NCT03361137|10101856|FG003|NOT COMPLETED|Overall Study||0
9041059|NCT03361137|10101857|FG004|NOT COMPLETED|Overall Study||0
9041060|NCT03361176|10101873|FG000|STARTED|Overall Study||10
9041061|NCT03361176|10101874|FG001|STARTED|Overall Study||20
9041062|NCT03361176|10101873|FG000|COMPLETED|Overall Study||9
9041063|NCT03361176|10101874|FG001|COMPLETED|Overall Study||15
9041064|NCT03361176|10101873|FG000|NOT COMPLETED|Overall Study||1
9041065|NCT03361176|10101874|FG001|NOT COMPLETED|Overall Study||5
9041066|NCT03361293|10101882|FG000|STARTED|Overall Study||20
9041067|NCT03361293|10101883|FG001|STARTED|Overall Study||24
9041068|NCT03361293|10101882|FG000|COMPLETED|Overall Study||19
9041069|NCT03361293|10101883|FG001|COMPLETED|Overall Study||19
9041070|NCT03361293|10101882|FG000|NOT COMPLETED|Overall Study||1
9041071|NCT03361293|10101883|FG001|NOT COMPLETED|Overall Study||5
8809713|NCT01500187|9862405|FG000|NOT COMPLETED|Overall Study||6
9041072|NCT03361423|10101891|FG000|STARTED|Overall Study||126
9041073|NCT03361423|10101892|FG001|STARTED|Overall Study||126
9041074|NCT03361423|10101891|FG000|COMPLETED|Overall Study||99
9041075|NCT03361423|10101892|FG001|COMPLETED|Overall Study||103
9041076|NCT03361423|10101891|FG000|NOT COMPLETED|Overall Study||27
9041077|NCT03361423|10101892|FG001|NOT COMPLETED|Overall Study||23
9041078|NCT03361605|10101898|FG000|STARTED|Overall Study||29
9041079|NCT03361605|10101898|FG000|COMPLETED|Overall Study||26
9041080|NCT03361605|10101898|FG000|NOT COMPLETED|Overall Study||3
9041081|NCT03361917|10101904|FG000|STARTED|Overall Study||99
9041082|NCT03361917|10101905|FG001|STARTED|Overall Study||101
8695533|NCT00877799|9741005|FG003|STARTED|Cohort 2: Immediately Post-op (Day 0)||26
8695534|NCT00877799|9741006|FG004|STARTED|Cohort 2: Immediately Post-op (Day 0)||20
8695535|NCT00877799|9741002|FG000|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
8695536|NCT00877799|9741003|FG001|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
8695537|NCT00877799|9741004|FG002|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
8695538|NCT00877799|9741005|FG003|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||24
8695539|NCT00877799|9741006|FG004|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||19
8695540|NCT00877799|9741002|FG000|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
8695541|NCT00877799|9741003|FG001|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
8695542|NCT00877799|9741004|FG002|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
8695543|NCT00877799|9741005|FG003|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||2
8695544|NCT00877799|9741006|FG004|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||1
8695545|NCT00877877|9741017|FG000|STARTED|Year 5||397
8695546|NCT00877877|9741017|FG000|COMPLETED|Year 5||397
8695547|NCT00877877|9741017|FG000|NOT COMPLETED|Year 5||0
8695548|NCT00877877|9741017|FG000|STARTED|Year 6||529
8695549|NCT00877877|9741017|FG000|COMPLETED|Year 6||529
8695550|NCT00877877|9741017|FG000|NOT COMPLETED|Year 6||0
8695551|NCT00877877|9741017|FG000|STARTED|Year 7||523
9041083|NCT03361917|10101904|FG000|COMPLETED|Overall Study||99
9041084|NCT03361917|10101905|FG001|COMPLETED|Overall Study||101
9041085|NCT03361917|10101904|FG000|NOT COMPLETED|Overall Study||0
9041086|NCT03361917|10101905|FG001|NOT COMPLETED|Overall Study||0
9041087|NCT03362879|10101911|FG000|STARTED|Overall Study||409
9041088|NCT03362879|10101911|FG000|COMPLETED|Overall Study||409
9041089|NCT03362879|10101911|FG000|NOT COMPLETED|Overall Study||0
9041090|NCT03362944|10101916|FG000|STARTED|First Intervention||8
9041091|NCT03362944|10101917|FG001|STARTED|First Intervention||8
9041092|NCT03362944|10101916|FG000|COMPLETED|First Intervention||8
9041093|NCT03362944|10101917|FG001|COMPLETED|First Intervention||8
9041094|NCT03362944|10101916|FG000|NOT COMPLETED|First Intervention||0
9041095|NCT03362944|10101917|FG001|NOT COMPLETED|First Intervention||0
9041096|NCT03362944|10101916|FG000|STARTED|Single Week Washout Period||8
9041097|NCT03362944|10101917|FG001|STARTED|Single Week Washout Period||8
9041098|NCT03362944|10101916|FG000|COMPLETED|Single Week Washout Period||8
9041099|NCT03362944|10101917|FG001|COMPLETED|Single Week Washout Period||8
9041100|NCT03362944|10101916|FG000|NOT COMPLETED|Single Week Washout Period||0
9041101|NCT03362944|10101917|FG001|NOT COMPLETED|Single Week Washout Period||0
9041102|NCT03362944|10101916|FG000|STARTED|Second Intervention||8
9041103|NCT03362944|10101917|FG001|STARTED|Second Intervention||8
9041104|NCT03362944|10101916|FG000|COMPLETED|Second Intervention||8
9041105|NCT03362944|10101917|FG001|COMPLETED|Second Intervention||8
9041106|NCT03362944|10101916|FG000|NOT COMPLETED|Second Intervention||0
9041107|NCT03362944|10101917|FG001|NOT COMPLETED|Second Intervention||0
9041108|NCT03362957|10101925|FG000|STARTED|Overall Study||14
9041109|NCT03362957|10101926|FG001|STARTED|Overall Study||7
9041110|NCT03362957|10101925|FG000|Crossover to Receive GAE Procedure|Overall Study||0
9041111|NCT03362957|10101926|FG001|Crossover to Receive GAE Procedure|Overall Study||7
9041112|NCT03362957|10101925|FG000|COMPLETED|Overall Study||14
9041113|NCT03362957|10101926|FG001|COMPLETED|Overall Study||7
9041114|NCT03362957|10101925|FG000|NOT COMPLETED|Overall Study||0
9041115|NCT03362957|10101926|FG001|NOT COMPLETED|Overall Study||0
9041116|NCT03363321|10101939|FG000|STARTED|Overall Study||5
9041117|NCT03363321|10101940|FG001|STARTED|Overall Study||4
9041118|NCT03363321|10101941|FG002|STARTED|Overall Study||4
9041119|NCT03363321|10101942|FG003|STARTED|Overall Study||5
9041120|NCT03363321|10101943|FG004|STARTED|Overall Study||2
9041121|NCT03363321|10101939|FG000|COMPLETED|Overall Study||5
9041122|NCT03363321|10101940|FG001|COMPLETED|Overall Study||3
9041123|NCT03363321|10101941|FG002|COMPLETED|Overall Study||4
9041124|NCT03363321|10101942|FG003|COMPLETED|Overall Study||4
9041125|NCT03363321|10101943|FG004|COMPLETED|Overall Study||2
9041126|NCT03363321|10101939|FG000|NOT COMPLETED|Overall Study||0
9041127|NCT03363321|10101940|FG001|NOT COMPLETED|Overall Study||1
9041128|NCT03363321|10101941|FG002|NOT COMPLETED|Overall Study||0
9041129|NCT03363321|10101942|FG003|NOT COMPLETED|Overall Study||1
9041130|NCT03363321|10101943|FG004|NOT COMPLETED|Overall Study||0
9041131|NCT03363776|10101959|FG000|STARTED|Overall Study||4
9041132|NCT03363776|10101960|FG001|STARTED|Overall Study||3
9041133|NCT03363776|10101961|FG002|STARTED|Overall Study||3
9041134|NCT03363776|10101959|FG000|COMPLETED|Overall Study||1
9041135|NCT03363776|10101960|FG001|COMPLETED|Overall Study||0
9041136|NCT03363776|10101961|FG002|COMPLETED|Overall Study||1
9041137|NCT03363776|10101959|FG000|NOT COMPLETED|Overall Study||3
9041138|NCT03363776|10101960|FG001|NOT COMPLETED|Overall Study||3
9041139|NCT03363776|10101961|FG002|NOT COMPLETED|Overall Study||2
9041140|NCT03363854|10101971|FG000|STARTED|Initial Treatment Period||253
8695552|NCT00877877|9741017|FG000|COMPLETED|Year 7||523
8695553|NCT00877877|9741017|FG000|NOT COMPLETED|Year 7||0
8695554|NCT00877877|9741017|FG000|STARTED|Year 8||522
8695555|NCT00877877|9741017|FG000|COMPLETED|Year 8||522
8695556|NCT00877877|9741017|FG000|NOT COMPLETED|Year 8||0
8695557|NCT00877877|9741017|FG000|STARTED|Year 9||507
8695558|NCT00877877|9741017|FG000|COMPLETED|Year 9||507
8695559|NCT00877877|9741017|FG000|NOT COMPLETED|Year 9||0
8695560|NCT00877877|9741017|FG000|STARTED|Year 10||495
8695561|NCT00877877|9741017|FG000|COMPLETED|Year 10||495
9041141|NCT03363854|10101972|FG001|STARTED|Initial Treatment Period||127
8695562|NCT00877877|9741017|FG000|NOT COMPLETED|Year 10||0
8695563|NCT00877890|9741028|FG000|STARTED|Overall Study||129
8695564|NCT00877890|9741029|FG001|STARTED|Overall Study||125
9041142|NCT03363854|10101973|FG002|STARTED|Initial Treatment Period|This treatment group applies to the continuation treatment period (see below).|0
9041143|NCT03363854|10101974|FG003|STARTED|Initial Treatment Period|This treatment group applies to the continuation treatment period (see below).|0
9041144|NCT03363854|10101975|FG004|STARTED|Initial Treatment Period|This treatment group applies to the continuation treatment period (see below).|0
9041145|NCT03363854|10101976|FG005|STARTED|Initial Treatment Period|This treatment group applies to the continuation treatment period (see below).|0
9041146|NCT03363854|10101977|FG006|STARTED|Initial Treatment Period|This treatment group applies to the continuation treatment period (see below).|0
9041147|NCT03363854|10101978|FG007|STARTED|Initial Treatment Period|This treatment group applies to the safety follow-up period (see below).|0
9041148|NCT03363854|10101971|FG000|COMPLETED|Initial Treatment Period||235
9041149|NCT03363854|10101972|FG001|COMPLETED|Initial Treatment Period||120
9041150|NCT03363854|10101973|FG002|COMPLETED|Initial Treatment Period||0
9041151|NCT03363854|10101974|FG003|COMPLETED|Initial Treatment Period||0
9041152|NCT03363854|10101975|FG004|COMPLETED|Initial Treatment Period||0
9041153|NCT03363854|10101976|FG005|COMPLETED|Initial Treatment Period||0
9041154|NCT03363854|10101977|FG006|COMPLETED|Initial Treatment Period||0
9041155|NCT03363854|10101978|FG007|COMPLETED|Initial Treatment Period||0
9041156|NCT03363854|10101971|FG000|NOT COMPLETED|Initial Treatment Period||18
9041157|NCT03363854|10101972|FG001|NOT COMPLETED|Initial Treatment Period||7
9041158|NCT03363854|10101973|FG002|NOT COMPLETED|Initial Treatment Period||0
9041159|NCT03363854|10101974|FG003|NOT COMPLETED|Initial Treatment Period||0
9041160|NCT03363854|10101975|FG004|NOT COMPLETED|Initial Treatment Period||0
9041161|NCT03363854|10101976|FG005|NOT COMPLETED|Initial Treatment Period||0
9041162|NCT03363854|10101977|FG006|NOT COMPLETED|Initial Treatment Period||0
9041163|NCT03363854|10101978|FG007|NOT COMPLETED|Initial Treatment Period||0
9041164|NCT03363854|10101971|FG000|STARTED|Continuation Treatment Period|This treatment group applies to the initial treatment period (see above).|0
9041165|NCT03363854|10101972|FG001|STARTED|Continuation Treatment Period|This treatment group applies to the initial treatment period (see above).|0
9041166|NCT03363854|10101973|FG002|STARTED|Continuation Treatment Period||69
9041167|NCT03363854|10101974|FG003|STARTED|Continuation Treatment Period||69
9041168|NCT03363854|10101975|FG004|STARTED|Continuation Treatment Period||95
9041169|NCT03363854|10101976|FG005|STARTED|Continuation Treatment Period||79
9041170|NCT03363854|10101977|FG006|STARTED|Continuation Treatment Period||41
9041171|NCT03363854|10101978|FG007|STARTED|Continuation Treatment Period|This treatment group applies to the safety follow-up period (see below).|0
9041172|NCT03363854|10101971|FG000|COMPLETED|Continuation Treatment Period||0
9041173|NCT03363854|10101972|FG001|COMPLETED|Continuation Treatment Period||0
9041174|NCT03363854|10101973|FG002|COMPLETED|Continuation Treatment Period||68
9041175|NCT03363854|10101974|FG003|COMPLETED|Continuation Treatment Period||65
9041176|NCT03363854|10101975|FG004|COMPLETED|Continuation Treatment Period||87
9041177|NCT03363854|10101976|FG005|COMPLETED|Continuation Treatment Period||72
9041178|NCT03363854|10101977|FG006|COMPLETED|Continuation Treatment Period||38
9041179|NCT03363854|10101978|FG007|COMPLETED|Continuation Treatment Period||0
9041180|NCT03363854|10101971|FG000|NOT COMPLETED|Continuation Treatment Period||0
9041181|NCT03363854|10101972|FG001|NOT COMPLETED|Continuation Treatment Period||0
9041182|NCT03363854|10101973|FG002|NOT COMPLETED|Continuation Treatment Period||1
9041183|NCT03363854|10101974|FG003|NOT COMPLETED|Continuation Treatment Period||4
9041184|NCT03363854|10101975|FG004|NOT COMPLETED|Continuation Treatment Period||8
9041185|NCT03363854|10101976|FG005|NOT COMPLETED|Continuation Treatment Period||7
9041186|NCT03363854|10101977|FG006|NOT COMPLETED|Continuation Treatment Period||3
9041187|NCT03363854|10101978|FG007|NOT COMPLETED|Continuation Treatment Period||0
9041188|NCT03363854|10101971|FG000|STARTED|Safety Follow-up Period|This treatment group applies to the initial treatment period (see above).|0
9041189|NCT03363854|10101972|FG001|STARTED|Safety Follow-up Period|This treatment group applies to the initial treatment period (see above).|0
9041190|NCT03363854|10101973|FG002|STARTED|Safety Follow-up Period|This treatment group applies to the continuation treatment period (see above).|0
9041191|NCT03363854|10101974|FG003|STARTED|Safety Follow-up Period|This treatment group applies to the continuation treatment period (see above).|0
9041192|NCT03363854|10101975|FG004|STARTED|Safety Follow-up Period|This treatment group applies to the continuation treatment period (see above).|0
9041193|NCT03363854|10101976|FG005|STARTED|Safety Follow-up Period|This treatment group applies to the continuation treatment period (see above).|0
9041194|NCT03363854|10101977|FG006|STARTED|Safety Follow-up Period|This treatment group applies to the continuation treatment period (see above).|0
9041195|NCT03363854|10101978|FG007|STARTED|Safety Follow-up Period||278
9041196|NCT03363854|10101971|FG000|COMPLETED|Safety Follow-up Period||0
9041197|NCT03363854|10101972|FG001|COMPLETED|Safety Follow-up Period||0
9041198|NCT03363854|10101973|FG002|COMPLETED|Safety Follow-up Period||0
9041199|NCT03363854|10101974|FG003|COMPLETED|Safety Follow-up Period||0
9041200|NCT03363854|10101975|FG004|COMPLETED|Safety Follow-up Period||0
9041201|NCT03363854|10101976|FG005|COMPLETED|Safety Follow-up Period||0
9041202|NCT03363854|10101977|FG006|COMPLETED|Safety Follow-up Period||0
9041203|NCT03363854|10101978|FG007|COMPLETED|Safety Follow-up Period||62
9041204|NCT03363854|10101971|FG000|NOT COMPLETED|Safety Follow-up Period||0
9041205|NCT03363854|10101972|FG001|NOT COMPLETED|Safety Follow-up Period||0
9041206|NCT03363854|10101973|FG002|NOT COMPLETED|Safety Follow-up Period||0
9041207|NCT03363854|10101974|FG003|NOT COMPLETED|Safety Follow-up Period||0
8695565|NCT00877890|9741028|FG000|Intent to Treat (ITT)|Overall Study||129
8695566|NCT00877890|9741029|FG001|Intent to Treat (ITT)|Overall Study||123
8695567|NCT00877890|9741028|FG000|COMPLETED|Overall Study||109
8695568|NCT00877890|9741029|FG001|COMPLETED|Overall Study||95
8695569|NCT00877890|9741028|FG000|NOT COMPLETED|Overall Study||20
8695570|NCT00877890|9741029|FG001|NOT COMPLETED|Overall Study||30
8695571|NCT00877929|9741041|FG000|STARTED|Overall Study||352
8695572|NCT00877929|9741042|FG001|STARTED|Overall Study||354
8695573|NCT00877929|9741041|FG000|COMPLETED|Overall Study||332
8695574|NCT00877929|9741042|FG001|COMPLETED|Overall Study||319
8695575|NCT00877929|9741041|FG000|NOT COMPLETED|Overall Study||20
9041208|NCT03363854|10101975|FG004|NOT COMPLETED|Safety Follow-up Period||0
9041209|NCT03363854|10101976|FG005|NOT COMPLETED|Safety Follow-up Period||0
9041210|NCT03363854|10101977|FG006|NOT COMPLETED|Safety Follow-up Period||0
9041211|NCT03363854|10101978|FG007|NOT COMPLETED|Safety Follow-up Period||216
9041212|NCT03363906|10102001|FG000|STARTED|Period 1 (Reference or Test)||15
9041213|NCT03363906|10102002|FG001|STARTED|Period 1 (Reference or Test)||12
9041214|NCT03363906|10102001|FG000|Received at Least One Dose of Study Drug|Period 1 (Reference or Test)||15
9041215|NCT03363906|10102002|FG001|Received at Least One Dose of Study Drug|Period 1 (Reference or Test)||11
9041216|NCT03363906|10102001|FG000|COMPLETED|Period 1 (Reference or Test)||14
9041217|NCT03363906|10102002|FG001|COMPLETED|Period 1 (Reference or Test)||10
9041218|NCT03363906|10102001|FG000|NOT COMPLETED|Period 1 (Reference or Test)||1
9041219|NCT03363906|10102002|FG001|NOT COMPLETED|Period 1 (Reference or Test)||2
9041220|NCT03363906|10102001|FG000|STARTED|Period 2 (Test or Reference)||14
9041221|NCT03363906|10102002|FG001|STARTED|Period 2 (Test or Reference)||10
9041222|NCT03363906|10102001|FG000|Received at Least One Dose of Study Drug|Period 2 (Test or Reference)||12
9041223|NCT03363906|10102002|FG001|Received at Least One Dose of Study Drug|Period 2 (Test or Reference)||9
9041224|NCT03363906|10102001|FG000|COMPLETED|Period 2 (Test or Reference)||10
9041225|NCT03363906|10102002|FG001|COMPLETED|Period 2 (Test or Reference)||9
9041226|NCT03363906|10102001|FG000|NOT COMPLETED|Period 2 (Test or Reference)||4
9041227|NCT03363906|10102002|FG001|NOT COMPLETED|Period 2 (Test or Reference)||1
9041228|NCT03364023|10102008|FG000|STARTED|Overall Study||183
9041229|NCT03364023|10102008|FG000|COMPLETED|Overall Study||166
9041230|NCT03364023|10102008|FG000|NOT COMPLETED|Overall Study||17
9041231|NCT03364049|10102016|FG000|STARTED|Overall Study||6
9041232|NCT03364049|10102017|FG001|STARTED|Overall Study||6
9041233|NCT03364049|10102018|FG002|STARTED|Overall Study||6
9041234|NCT03364049|10102019|FG003|STARTED|Overall Study||15
9041235|NCT03364049|10102016|FG000|COMPLETED|Overall Study||0
9041236|NCT03364049|10102017|FG001|COMPLETED|Overall Study||0
9041237|NCT03364049|10102018|FG002|COMPLETED|Overall Study||0
9041238|NCT03364049|10102019|FG003|COMPLETED|Overall Study||0
9041239|NCT03364049|10102016|FG000|NOT COMPLETED|Overall Study||6
9041240|NCT03364049|10102017|FG001|NOT COMPLETED|Overall Study||6
9041241|NCT03364049|10102018|FG002|NOT COMPLETED|Overall Study||6
9041242|NCT03364049|10102019|FG003|NOT COMPLETED|Overall Study||15
9041243|NCT03364192|10102029|FG000|STARTED|Overall Study||28
9041244|NCT03364192|10102029|FG000|COMPLETED|Overall Study||12
9041245|NCT03364192|10102029|FG000|NOT COMPLETED|Overall Study||16
9041246|NCT03364309|10102037|FG000|STARTED|Induction Period||88
9041247|NCT03364309|10102038|FG001|STARTED|Induction Period||174
9041248|NCT03364309|10102039|FG002|STARTED|Induction Period||176
9041249|NCT03364309|10102040|FG003|STARTED|Induction Period||0
9041250|NCT03364309|10102041|FG004|STARTED|Induction Period||0
9041251|NCT03364309|10102042|FG005|STARTED|Induction Period||0
9041252|NCT03364309|10102043|FG006|STARTED|Induction Period||0
9041253|NCT03364309|10102044|FG007|STARTED|Induction Period||0
9041254|NCT03364309|10102045|FG008|STARTED|Induction Period||0
9041255|NCT03364309|10102046|FG009|STARTED|Induction Period||0
9041256|NCT03364309|10102047|FG010|STARTED|Induction Period||0
9041257|NCT03364309|10102048|FG011|STARTED|Induction Period||0
9041258|NCT03364309|10102049|FG012|STARTED|Induction Period||0
9041259|NCT03364309|10102050|FG013|STARTED|Induction Period||0
9041260|NCT03364309|10102051|FG014|STARTED|Induction Period||0
9041261|NCT03364309|10102052|FG015|STARTED|Induction Period||0
9041262|NCT03364309|10102053|FG016|STARTED|Induction Period||0
9041263|NCT03364309|10102054|FG017|STARTED|Induction Period||0
8556977|NCT02930889|9588772|FG000|NOT COMPLETED|Overall Study||16
8695576|NCT00877929|9741042|FG001|NOT COMPLETED|Overall Study||35
8695577|NCT00878072|9741052|FG000|STARTED|Overall Study||53
8695578|NCT00878072|9741052|FG000|COMPLETED|Overall Study||51
8695579|NCT00878072|9741052|FG000|NOT COMPLETED|Overall Study||2
9041264|NCT03364309|10102055|FG018|STARTED|Induction Period||0
9041265|NCT03364309|10102037|FG000|Received at Least One Dose of Study Drug|Induction Period||88
9041266|NCT03364309|10102038|FG001|Received at Least One Dose of Study Drug|Induction Period||174
9041267|NCT03364309|10102039|FG002|Received at Least One Dose of Study Drug|Induction Period||176
9041268|NCT03364309|10102040|FG003|Received at Least One Dose of Study Drug|Induction Period||0
9041269|NCT03364309|10102041|FG004|Received at Least One Dose of Study Drug|Induction Period||0
9041270|NCT03364309|10102042|FG005|Received at Least One Dose of Study Drug|Induction Period||0
9041271|NCT03364309|10102043|FG006|Received at Least One Dose of Study Drug|Induction Period||0
9041272|NCT03364309|10102044|FG007|Received at Least One Dose of Study Drug|Induction Period||0
9041273|NCT03364309|10102045|FG008|Received at Least One Dose of Study Drug|Induction Period||0
9041274|NCT03364309|10102046|FG009|Received at Least One Dose of Study Drug|Induction Period||0
9041275|NCT03364309|10102047|FG010|Received at Least One Dose of Study Drug|Induction Period||0
9041276|NCT03364309|10102048|FG011|Received at Least One Dose of Study Drug|Induction Period||0
8695580|NCT00878189|9741063|FG000|STARTED|Overall Study||3
8695581|NCT00878189|9741064|FG001|STARTED|Overall Study||3
8695582|NCT00878189|9741065|FG002|STARTED|Overall Study||4
8695583|NCT00878189|9741066|FG003|STARTED|Overall Study||8
8695584|NCT00878189|9741067|FG004|STARTED|Overall Study||4
8695585|NCT00878189|9741068|FG005|STARTED|Overall Study||23
8695586|NCT00878189|9741069|FG006|STARTED|Overall Study||16
8695587|NCT00878189|9741070|FG007|STARTED|Overall Study||3
8695588|NCT00878189|9741071|FG008|STARTED|Overall Study||8
8695589|NCT00878189|9741063|FG000|COMPLETED|Overall Study||0
8695590|NCT00878189|9741064|FG001|COMPLETED|Overall Study||0
8695591|NCT00878189|9741065|FG002|COMPLETED|Overall Study||0
8695592|NCT00878189|9741066|FG003|COMPLETED|Overall Study||0
8695593|NCT00878189|9741067|FG004|COMPLETED|Overall Study||0
8695594|NCT00878189|9741068|FG005|COMPLETED|Overall Study||0
8695595|NCT00878189|9741069|FG006|COMPLETED|Overall Study||0
8695596|NCT00878189|9741070|FG007|COMPLETED|Overall Study||0
8695597|NCT00878189|9741071|FG008|COMPLETED|Overall Study||0
8695598|NCT00878189|9741063|FG000|NOT COMPLETED|Overall Study||3
8695599|NCT00878189|9741064|FG001|NOT COMPLETED|Overall Study||3
8695600|NCT00878189|9741065|FG002|NOT COMPLETED|Overall Study||4
8695601|NCT00878189|9741066|FG003|NOT COMPLETED|Overall Study||8
8695602|NCT00878189|9741067|FG004|NOT COMPLETED|Overall Study||4
8695603|NCT00878189|9741068|FG005|NOT COMPLETED|Overall Study||23
8695604|NCT00878189|9741069|FG006|NOT COMPLETED|Overall Study||16
8695605|NCT00878189|9741070|FG007|NOT COMPLETED|Overall Study||3
8695606|NCT00878189|9741071|FG008|NOT COMPLETED|Overall Study||8
8695607|NCT00878215|9741109|FG000|STARTED|Overall Study||21
8695608|NCT00878215|9741110|FG001|STARTED|Overall Study||19
8695609|NCT00878215|9741111|FG002|STARTED|Overall Study|Phase 3 not performed because the liver imaging system became commercially available|0
8695610|NCT00878215|9741112|FG003|STARTED|Overall Study|Phase 4 not performed because the liver imaging system became commercially available|0
8695611|NCT00878215|9741109|FG000|COMPLETED|Overall Study||21
8695612|NCT00878215|9741110|FG001|COMPLETED|Overall Study||9
8695613|NCT00878215|9741111|FG002|COMPLETED|Overall Study||0
9041277|NCT03364309|10102049|FG012|Received at Least One Dose of Study Drug|Induction Period||0
9041278|NCT03364309|10102050|FG013|Received at Least One Dose of Study Drug|Induction Period||0
9041279|NCT03364309|10102051|FG014|Received at Least One Dose of Study Drug|Induction Period||0
9041280|NCT03364309|10102052|FG015|Received at Least One Dose of Study Drug|Induction Period||0
9041281|NCT03364309|10102053|FG016|Received at Least One Dose of Study Drug|Induction Period||0
9041282|NCT03364309|10102054|FG017|Received at Least One Dose of Study Drug|Induction Period||0
9041283|NCT03364309|10102055|FG018|Received at Least One Dose of Study Drug|Induction Period||0
9041284|NCT03364309|10102037|FG000|COMPLETED|Induction Period||82
9041285|NCT03364309|10102038|FG001|COMPLETED|Induction Period||170
9041286|NCT03364309|10102039|FG002|COMPLETED|Induction Period||175
9041287|NCT03364309|10102040|FG003|COMPLETED|Induction Period||0
9041288|NCT03364309|10102041|FG004|COMPLETED|Induction Period||0
9041289|NCT03364309|10102042|FG005|COMPLETED|Induction Period||0
9041290|NCT03364309|10102043|FG006|COMPLETED|Induction Period||0
9041291|NCT03364309|10102044|FG007|COMPLETED|Induction Period||0
9041292|NCT03364309|10102045|FG008|COMPLETED|Induction Period||0
9041293|NCT03364309|10102046|FG009|COMPLETED|Induction Period||0
9041294|NCT03364309|10102047|FG010|COMPLETED|Induction Period||0
9041295|NCT03364309|10102048|FG011|COMPLETED|Induction Period||0
9041296|NCT03364309|10102049|FG012|COMPLETED|Induction Period||0
9041297|NCT03364309|10102050|FG013|COMPLETED|Induction Period||0
9041298|NCT03364309|10102051|FG014|COMPLETED|Induction Period||0
9041299|NCT03364309|10102052|FG015|COMPLETED|Induction Period||0
9041300|NCT03364309|10102053|FG016|COMPLETED|Induction Period||0
9041301|NCT03364309|10102054|FG017|COMPLETED|Induction Period||0
9041302|NCT03364309|10102055|FG018|COMPLETED|Induction Period||0
9041303|NCT03364309|10102037|FG000|NOT COMPLETED|Induction Period||6
9041304|NCT03364309|10102038|FG001|NOT COMPLETED|Induction Period||4
9041305|NCT03364309|10102039|FG002|NOT COMPLETED|Induction Period||1
8695614|NCT00878215|9741112|FG003|COMPLETED|Overall Study||0
8695615|NCT00878215|9741109|FG000|NOT COMPLETED|Overall Study||0
8695616|NCT00878215|9741110|FG001|NOT COMPLETED|Overall Study||10
8695617|NCT00878215|9741111|FG002|NOT COMPLETED|Overall Study||0
8695618|NCT00878215|9741112|FG003|NOT COMPLETED|Overall Study||0
8724152|NCT01025843|9771501|FG002|NOT COMPLETED|Period 2||0
8724153|NCT01025843|9771502|FG003|NOT COMPLETED|Period 2||0
8724154|NCT01025843|9771503|FG004|NOT COMPLETED|Period 2||0
8724155|NCT01025843|9771504|FG005|NOT COMPLETED|Period 2||0
8724156|NCT01025843|9771505|FG006|NOT COMPLETED|Period 2||0
8724157|NCT01025843|9771506|FG007|NOT COMPLETED|Period 2||0
8724158|NCT01025843|9771507|FG008|NOT COMPLETED|Period 2||0
8724159|NCT01025843|9771508|FG009|NOT COMPLETED|Period 2||0
8724160|NCT01025843|9771499|FG000|STARTED|Washout 2||2
8724161|NCT01025843|9771500|FG001|STARTED|Washout 2||2
8724162|NCT01025843|9771501|FG002|STARTED|Washout 2||2
8724163|NCT01025843|9771502|FG003|STARTED|Washout 2||2
8724164|NCT01025843|9771503|FG004|STARTED|Washout 2||2
8724165|NCT01025843|9771504|FG005|STARTED|Washout 2||2
8724166|NCT01025843|9771505|FG006|STARTED|Washout 2||2
8724167|NCT01025843|9771506|FG007|STARTED|Washout 2||2
9041306|NCT03364309|10102040|FG003|NOT COMPLETED|Induction Period||0
9041307|NCT03364309|10102041|FG004|NOT COMPLETED|Induction Period||0
9041308|NCT03364309|10102042|FG005|NOT COMPLETED|Induction Period||0
9041309|NCT03364309|10102043|FG006|NOT COMPLETED|Induction Period||0
9041310|NCT03364309|10102044|FG007|NOT COMPLETED|Induction Period||0
9041311|NCT03364309|10102045|FG008|NOT COMPLETED|Induction Period||0
9041312|NCT03364309|10102046|FG009|NOT COMPLETED|Induction Period||0
9041313|NCT03364309|10102047|FG010|NOT COMPLETED|Induction Period||0
8695619|NCT00878228|9741124|FG000|STARTED|Overall Study||49
8695620|NCT00878228|9741125|FG001|STARTED|Overall Study||49
8695621|NCT00878228|9741124|FG000|COMPLETED|Overall Study||39
8695622|NCT00878228|9741125|FG001|COMPLETED|Overall Study||37
8695623|NCT00878228|9741124|FG000|NOT COMPLETED|Overall Study||10
8695624|NCT00878228|9741125|FG001|NOT COMPLETED|Overall Study||12
8695625|NCT00878436|9741133|FG000|STARTED|Overall Study||28
8695626|NCT00878436|9741134|FG001|STARTED|Overall Study||24
8695627|NCT00878436|9741133|FG000|Completed 2 Cycles|Overall Study||21
8695628|NCT00878436|9741134|FG001|Completed 2 Cycles|Overall Study||20
8695629|NCT00878436|9741133|FG000|6 Months|Overall Study||8
8695630|NCT00878436|9741134|FG001|6 Months|Overall Study||0
8695631|NCT00878436|9741133|FG000|COMPLETED|Overall Study||5
8695632|NCT00878436|9741134|FG001|COMPLETED|Overall Study||0
8695633|NCT00878436|9741133|FG000|NOT COMPLETED|Overall Study||23
8695634|NCT00878436|9741134|FG001|NOT COMPLETED|Overall Study||24
8695635|NCT00878501|9741143|FG000|STARTED|Overall Study|One of these patients did not receive study drug since incorrectly enrolled (mis-randomisation)|104
8695636|NCT00878501|9741144|FG001|STARTED|Overall Study||44
8695637|NCT00878501|9741145|FG002|STARTED|Overall Study||93
8695638|NCT00878501|9741143|FG000|Interim Analysis|Overall Study||83
8695639|NCT00878501|9741144|FG001|Interim Analysis|Overall Study||37
8695640|NCT00878501|9741145|FG002|Interim Analysis|Overall Study||81
8695641|NCT00878501|9741143|FG000|COMPLETED|Overall Study||87
8695642|NCT00878501|9741144|FG001|COMPLETED|Overall Study||37
8695643|NCT00878501|9741145|FG002|COMPLETED|Overall Study||85
8695644|NCT00878501|9741143|FG000|NOT COMPLETED|Overall Study||17
8695645|NCT00878501|9741144|FG001|NOT COMPLETED|Overall Study||7
8695646|NCT00878501|9741145|FG002|NOT COMPLETED|Overall Study||8
8695647|NCT00878553|9741157|FG000|STARTED|Sleep Study|This Intention to Treat population includes all randomized patients; one dropped prior to treatment.|67
8695648|NCT00878553|9741158|FG001|STARTED|Sleep Study||0
8695649|NCT00878553|9741159|FG002|STARTED|Sleep Study||0
8695650|NCT00878553|9741160|FG003|STARTED|Sleep Study||0
8695651|NCT00878553|9741161|FG004|STARTED|Sleep Study||0
8695652|NCT00878553|9741157|FG000|Number of Patients Receiving Placebo|Sleep Study||66
8695653|NCT00878553|9741158|FG001|Number of Patients Receiving Placebo|Sleep Study||0
8695654|NCT00878553|9741159|FG002|Number of Patients Receiving Placebo|Sleep Study||0
8695655|NCT00878553|9741160|FG003|Number of Patients Receiving Placebo|Sleep Study||0
8695656|NCT00878553|9741161|FG004|Number of Patients Receiving Placebo|Sleep Study||0
8695657|NCT00878553|9741157|FG000|Number of Patients Receiving 10mg|Sleep Study||65
8695658|NCT00878553|9741158|FG001|Number of Patients Receiving 10mg|Sleep Study||0
8695659|NCT00878553|9741159|FG002|Number of Patients Receiving 10mg|Sleep Study||0
8695660|NCT00878553|9741160|FG003|Number of Patients Receiving 10mg|Sleep Study||0
8695661|NCT00878553|9741161|FG004|Number of Patients Receiving 10mg|Sleep Study||0
8695662|NCT00878553|9741157|FG000|Number of Patients Receiving 15mg|Sleep Study||65
8695663|NCT00878553|9741158|FG001|Number of Patients Receiving 15mg|Sleep Study||0
8695664|NCT00878553|9741159|FG002|Number of Patients Receiving 15mg|Sleep Study||0
8695665|NCT00878553|9741160|FG003|Number of Patients Receiving 15mg|Sleep Study||0
8695666|NCT00878553|9741161|FG004|Number of Patients Receiving 15mg|Sleep Study||0
8695667|NCT00878553|9741157|FG000|Number of Patients Receiving 20mg|Sleep Study||65
8809714|NCT01500187|9862406|FG001|NOT COMPLETED|Overall Study||0
8809715|NCT01500200|9862415|FG000|STARTED|Stage 1||98
8809716|NCT01500200|9862416|FG001|STARTED|Stage 1||24
8809717|NCT01500200|9862417|FG002|STARTED|Stage 1||19
8809718|NCT01500200|9862418|FG003|STARTED|Stage 1||0
8809719|NCT01500200|9862419|FG004|STARTED|Stage 1||0
8809720|NCT01500200|9862420|FG005|STARTED|Stage 1||0
8809721|NCT01500200|9862415|FG000|COMPLETED|Stage 1||90
8809722|NCT01500200|9862416|FG001|COMPLETED|Stage 1||18
8809723|NCT01500200|9862417|FG002|COMPLETED|Stage 1||13
8809724|NCT01500200|9862418|FG003|COMPLETED|Stage 1||0
8809725|NCT01500200|9862419|FG004|COMPLETED|Stage 1||0
8809726|NCT01500200|9862420|FG005|COMPLETED|Stage 1||0
8809727|NCT01500200|9862415|FG000|NOT COMPLETED|Stage 1||8
8809728|NCT01500200|9862416|FG001|NOT COMPLETED|Stage 1||6
8809729|NCT01500200|9862417|FG002|NOT COMPLETED|Stage 1||6
8809730|NCT01500200|9862418|FG003|NOT COMPLETED|Stage 1||0
8809731|NCT01500200|9862419|FG004|NOT COMPLETED|Stage 1||0
8809732|NCT01500200|9862420|FG005|NOT COMPLETED|Stage 1||0
8809733|NCT01500200|9862415|FG000|STARTED|Stage 2||0
8809734|NCT01500200|9862416|FG001|STARTED|Stage 2||0
8809735|NCT01500200|9862417|FG002|STARTED|Stage 2||0
8809736|NCT01500200|9862418|FG003|STARTED|Stage 2||20
8809737|NCT01500200|9862419|FG004|STARTED|Stage 2||23
8809738|NCT01500200|9862420|FG005|STARTED|Stage 2||22
8809739|NCT01500200|9862415|FG000|COMPLETED|Stage 2||0
8809740|NCT01500200|9862416|FG001|COMPLETED|Stage 2||0
8809741|NCT01500200|9862417|FG002|COMPLETED|Stage 2||0
8809742|NCT01500200|9862418|FG003|COMPLETED|Stage 2||20
8556978|NCT02919618|9588776|FG000|STARTED|Overall Study||19
8809743|NCT01500200|9862419|FG004|COMPLETED|Stage 2||18
8809744|NCT01500200|9862420|FG005|COMPLETED|Stage 2||18
8809745|NCT01500200|9862415|FG000|NOT COMPLETED|Stage 2||0
8809746|NCT01500200|9862416|FG001|NOT COMPLETED|Stage 2||0
8809747|NCT01500200|9862417|FG002|NOT COMPLETED|Stage 2||0
8809748|NCT01500200|9862418|FG003|NOT COMPLETED|Stage 2||0
8809749|NCT01500200|9862419|FG004|NOT COMPLETED|Stage 2||5
8809750|NCT01500200|9862420|FG005|NOT COMPLETED|Stage 2||4
8809751|NCT01500213|9862436|FG000|STARTED|Overall Study|Number of randomized patients|278
8809752|NCT01500213|9862437|FG001|STARTED|Overall Study||277
8809753|NCT01500213|9862436|FG000|COMPLETED|Overall Study|Number of patients who completed 6 cycles|61
8809754|NCT01500213|9862437|FG001|COMPLETED|Overall Study||53
8809755|NCT01500213|9862436|FG000|NOT COMPLETED|Overall Study||217
8809756|NCT01500213|9862437|FG001|NOT COMPLETED|Overall Study||224
8809757|NCT01500226|9862445|FG000|STARTED|Overall Study|Number of randomized patients|684
8809758|NCT01500226|9862446|FG001|STARTED|Overall Study||685
8809759|NCT01500226|9862445|FG000|COMPLETED|Overall Study|Number of patients who completed 6 cycles|185
8809760|NCT01500226|9862446|FG001|COMPLETED|Overall Study||191
8809761|NCT01500226|9862445|FG000|NOT COMPLETED|Overall Study||499
8809762|NCT01500226|9862446|FG001|NOT COMPLETED|Overall Study||494
8809763|NCT01500252|9862454|FG000|STARTED|Overall Study||21
9041314|NCT03364309|10102048|FG011|NOT COMPLETED|Induction Period||0
9041315|NCT03364309|10102049|FG012|NOT COMPLETED|Induction Period||0
9041316|NCT03364309|10102050|FG013|NOT COMPLETED|Induction Period||0
9041317|NCT03364309|10102051|FG014|NOT COMPLETED|Induction Period||0
9041318|NCT03364309|10102052|FG015|NOT COMPLETED|Induction Period||0
9041319|NCT03364309|10102053|FG016|NOT COMPLETED|Induction Period||0
9041320|NCT03364309|10102054|FG017|NOT COMPLETED|Induction Period||0
9041321|NCT03364309|10102055|FG018|NOT COMPLETED|Induction Period||0
9041322|NCT03364309|10102037|FG000|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|0
9041323|NCT03364309|10102038|FG001|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|0
9041324|NCT03364309|10102039|FG002|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|0
9041325|NCT03364309|10102040|FG003|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|47
9041326|NCT03364309|10102041|FG004|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|92
9041327|NCT03364309|10102042|FG005|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|50
9041328|NCT03364309|10102043|FG006|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|100
9041329|NCT03364309|10102044|FG007|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|3
9041330|NCT03364309|10102045|FG008|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|79
9041331|NCT03364309|10102046|FG009|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|31
9041332|NCT03364309|10102047|FG010|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|23
9041333|NCT03364309|10102048|FG011|STARTED|Maintenance Period||0
9041334|NCT03364309|10102049|FG012|STARTED|Maintenance Period||0
9041335|NCT03364309|10102050|FG013|STARTED|Maintenance Period||0
9041336|NCT03364309|10102051|FG014|STARTED|Maintenance Period||0
9041337|NCT03364309|10102052|FG015|STARTED|Maintenance Period||0
9041338|NCT03364309|10102053|FG016|STARTED|Maintenance Period||0
9041339|NCT03364309|10102054|FG017|STARTED|Maintenance Period||0
9041340|NCT03364309|10102055|FG018|STARTED|Maintenance Period||0
9041341|NCT03364309|10102037|FG000|Received at Least One Dose of Study Drug|Maintenance Period||0
9041342|NCT03364309|10102038|FG001|Received at Least One Dose of Study Drug|Maintenance Period||0
9041343|NCT03364309|10102039|FG002|Received at Least One Dose of Study Drug|Maintenance Period||0
9041344|NCT03364309|10102040|FG003|Received at Least One Dose of Study Drug|Maintenance Period||47
9041345|NCT03364309|10102041|FG004|Received at Least One Dose of Study Drug|Maintenance Period||92
9041346|NCT03364309|10102042|FG005|Received at Least One Dose of Study Drug|Maintenance Period||50
9041347|NCT03364309|10102043|FG006|Received at Least One Dose of Study Drug|Maintenance Period||100
9041348|NCT03364309|10102044|FG007|Received at Least One Dose of Study Drug|Maintenance Period||3
9041349|NCT03364309|10102045|FG008|Received at Least One Dose of Study Drug|Maintenance Period||79
9041350|NCT03364309|10102046|FG009|Received at Least One Dose of Study Drug|Maintenance Period||31
9041351|NCT03364309|10102047|FG010|Received at Least One Dose of Study Drug|Maintenance Period||23
9041352|NCT03364309|10102048|FG011|Received at Least One Dose of Study Drug|Maintenance Period||0
9041353|NCT03364309|10102049|FG012|Received at Least One Dose of Study Drug|Maintenance Period||0
9041354|NCT03364309|10102050|FG013|Received at Least One Dose of Study Drug|Maintenance Period||0
9041355|NCT03364309|10102051|FG014|Received at Least One Dose of Study Drug|Maintenance Period||0
9041356|NCT03364309|10102052|FG015|Received at Least One Dose of Study Drug|Maintenance Period||0
9041357|NCT03364309|10102053|FG016|Received at Least One Dose of Study Drug|Maintenance Period||0
9041358|NCT03364309|10102054|FG017|Received at Least One Dose of Study Drug|Maintenance Period||0
9041359|NCT03364309|10102055|FG018|Received at Least One Dose of Study Drug|Maintenance Period||0
9041360|NCT03364309|10102037|FG000|COMPLETED|Maintenance Period||0
9041361|NCT03364309|10102038|FG001|COMPLETED|Maintenance Period||0
9041362|NCT03364309|10102039|FG002|COMPLETED|Maintenance Period||0
9041363|NCT03364309|10102040|FG003|COMPLETED|Maintenance Period||3
9041364|NCT03364309|10102041|FG004|COMPLETED|Maintenance Period||80
9041365|NCT03364309|10102042|FG005|COMPLETED|Maintenance Period||4
9041366|NCT03364309|10102043|FG006|COMPLETED|Maintenance Period||84
9041367|NCT03364309|10102044|FG007|COMPLETED|Maintenance Period||1
9041368|NCT03364309|10102045|FG008|COMPLETED|Maintenance Period||73
8809764|NCT01500252|9862455|FG001|STARTED|Overall Study||17
8809765|NCT01500252|9862454|FG000|One Years|Overall Study||20
9041369|NCT03364309|10102046|FG009|COMPLETED|Maintenance Period||27
9041370|NCT03364309|10102047|FG010|COMPLETED|Maintenance Period||17
9041371|NCT03364309|10102048|FG011|COMPLETED|Maintenance Period||0
9041372|NCT03364309|10102049|FG012|COMPLETED|Maintenance Period||0
8809766|NCT01500252|9862455|FG001|One Years|Overall Study||16
8809767|NCT01500252|9862454|FG000|Five Years|Overall Study||17
8809768|NCT01500252|9862455|FG001|Five Years|Overall Study||13
8809769|NCT01500252|9862454|FG000|Ten Years|Overall Study||12
8809770|NCT01500252|9862455|FG001|Ten Years|Overall Study||11
8809771|NCT01500252|9862454|FG000|COMPLETED|Overall Study|2 participants died within 5 years; 2 participants died between 5 & 10 years for a total of 4 deaths|12
8809772|NCT01500252|9862455|FG001|COMPLETED|Overall Study|2 participant deceased by 5 years; no further deaths between 5 & 10 years for a total of 2 deaths|11
8809773|NCT01500252|9862454|FG000|NOT COMPLETED|Overall Study||9
8809774|NCT01500252|9862455|FG001|NOT COMPLETED|Overall Study||6
8809775|NCT01500278|9862464|FG000|STARTED|Week 0 - Week 12||457
8809776|NCT01500278|9862465|FG001|STARTED|Week 0 - Week 12||458
8809777|NCT01500278|9862464|FG000|COMPLETED|Week 0 - Week 12||426
8809778|NCT01500278|9862465|FG001|COMPLETED|Week 0 - Week 12||428
8925321|NCT02257177|9986420|FG010|COMPLETED|Overall Study||9
8925322|NCT02257177|9986410|FG000|NOT COMPLETED|Overall Study||0
8925323|NCT02257177|9986411|FG001|NOT COMPLETED|Overall Study||0
8925324|NCT02257177|9986412|FG002|NOT COMPLETED|Overall Study||0
8925325|NCT02257177|9986413|FG003|NOT COMPLETED|Overall Study||0
8925326|NCT02257177|9986414|FG004|NOT COMPLETED|Overall Study||0
8925327|NCT02257177|9986415|FG005|NOT COMPLETED|Overall Study||0
8925328|NCT02257177|9986416|FG006|NOT COMPLETED|Overall Study||0
8925329|NCT02257177|9986417|FG007|NOT COMPLETED|Overall Study||0
8925330|NCT02257177|9986418|FG008|NOT COMPLETED|Overall Study||0
8925331|NCT02257177|9986419|FG009|NOT COMPLETED|Overall Study||1
8925332|NCT02257177|9986420|FG010|NOT COMPLETED|Overall Study||0
8925333|NCT02257372|9986446|FG000|STARTED|Overall Study||117
8925334|NCT02257372|9986447|FG001|STARTED|Overall Study||119
8925335|NCT02257372|9986446|FG000|COMPLETED|Overall Study||110
8925336|NCT02257372|9986447|FG001|COMPLETED|Overall Study||109
8925337|NCT02257372|9986446|FG000|NOT COMPLETED|Overall Study||7
8925338|NCT02257372|9986447|FG001|NOT COMPLETED|Overall Study||10
8925339|NCT02257385|9986455|FG000|STARTED|Overall Study||482
8925340|NCT02257385|9986456|FG001|STARTED|Overall Study||479
8925341|NCT02257385|9986455|FG000|COMPLETED|Overall Study||460
8925342|NCT02257385|9986456|FG001|COMPLETED|Overall Study||457
8925343|NCT02257385|9986455|FG000|NOT COMPLETED|Overall Study||22
8925344|NCT02257385|9986456|FG001|NOT COMPLETED|Overall Study||22
8925345|NCT02257489|9986471|FG000|STARTED|Overall Study||6
8925346|NCT02257489|9986472|FG001|STARTED|Overall Study||6
8925347|NCT02257489|9986473|FG002|STARTED|Overall Study||6
8925348|NCT02257489|9986474|FG003|STARTED|Overall Study||6
8925349|NCT02257489|9986475|FG004|STARTED|Overall Study||6
8925350|NCT02257489|9986476|FG005|STARTED|Overall Study||6
8925351|NCT02257489|9986477|FG006|STARTED|Overall Study||6
8925352|NCT02257489|9986478|FG007|STARTED|Overall Study||10
8925353|NCT02257489|9986479|FG008|STARTED|Overall Study||6
8925354|NCT02257489|9986471|FG000|COMPLETED|Overall Study||6
8925355|NCT02257489|9986472|FG001|COMPLETED|Overall Study||6
8925356|NCT02257489|9986473|FG002|COMPLETED|Overall Study||6
8925357|NCT02257489|9986474|FG003|COMPLETED|Overall Study||5
8925358|NCT02257489|9986475|FG004|COMPLETED|Overall Study||6
8925359|NCT02257489|9986476|FG005|COMPLETED|Overall Study||6
8925360|NCT02257489|9986477|FG006|COMPLETED|Overall Study||6
8925361|NCT02257489|9986478|FG007|COMPLETED|Overall Study||10
8925362|NCT02257489|9986479|FG008|COMPLETED|Overall Study||6
8925363|NCT02257489|9986471|FG000|NOT COMPLETED|Overall Study||0
8925364|NCT02257489|9986472|FG001|NOT COMPLETED|Overall Study||0
8925365|NCT02257489|9986473|FG002|NOT COMPLETED|Overall Study||0
8925366|NCT02257489|9986474|FG003|NOT COMPLETED|Overall Study||1
8925367|NCT02257489|9986475|FG004|NOT COMPLETED|Overall Study||0
8925368|NCT02257489|9986476|FG005|NOT COMPLETED|Overall Study||0
8925369|NCT02257489|9986477|FG006|NOT COMPLETED|Overall Study||0
8925370|NCT02257489|9986478|FG007|NOT COMPLETED|Overall Study||0
8925371|NCT02257489|9986479|FG008|NOT COMPLETED|Overall Study||0
8925372|NCT02257541|9986504|FG000|STARTED|Overall Study||3
8925373|NCT02257541|9986505|FG001|STARTED|Overall Study||8
8925374|NCT02257541|9986506|FG002|STARTED|Overall Study||1
8925375|NCT02257541|9986507|FG003|STARTED|Overall Study||3
8925376|NCT02257541|9986508|FG004|STARTED|Overall Study||1
8925377|NCT02257541|9986504|FG000|COMPLETED|Overall Study||3
8925378|NCT02257541|9986505|FG001|COMPLETED|Overall Study||8
8925379|NCT02257541|9986506|FG002|COMPLETED|Overall Study||1
8925380|NCT02257541|9986507|FG003|COMPLETED|Overall Study||3
8925381|NCT02257541|9986508|FG004|COMPLETED|Overall Study||1
8925382|NCT02257541|9986504|FG000|NOT COMPLETED|Overall Study||0
8925383|NCT02257541|9986505|FG001|NOT COMPLETED|Overall Study||0
8925384|NCT02257541|9986506|FG002|NOT COMPLETED|Overall Study||0
8925385|NCT02257541|9986507|FG003|NOT COMPLETED|Overall Study||0
8925386|NCT02257541|9986508|FG004|NOT COMPLETED|Overall Study||0
8925387|NCT02257632|9986521|FG000|STARTED|Overall Study||19
8925388|NCT02257632|9986522|FG001|STARTED|Overall Study||22
8925389|NCT02257632|9986521|FG000|Full Analysis Set (FAS)|Overall Study||19
8925390|NCT02257632|9986522|FG001|Full Analysis Set (FAS)|Overall Study||21
8925391|NCT02257632|9986521|FG000|Safety Set (SAF)|Overall Study||19
8925392|NCT02257632|9986522|FG001|Safety Set (SAF)|Overall Study||21
8925393|NCT02257632|9986521|FG000|Per-Protocol Set (PPS)|Overall Study||17
8925394|NCT02257632|9986522|FG001|Per-Protocol Set (PPS)|Overall Study||20
8925395|NCT02257632|9986521|FG000|COMPLETED|Overall Study||18
8925396|NCT02257632|9986522|FG001|COMPLETED|Overall Study||19
8925397|NCT02257632|9986521|FG000|NOT COMPLETED|Overall Study||1
8809779|NCT01500278|9862464|FG000|NOT COMPLETED|Week 0 - Week 12||31
8809780|NCT01500278|9862465|FG001|NOT COMPLETED|Week 0 - Week 12||30
8809781|NCT01500278|9862464|FG000|STARTED|Week 13 - Week 104||426
8809782|NCT01500278|9862465|FG001|STARTED|Week 13 - Week 104||428
8809783|NCT01500278|9862464|FG000|COMPLETED|Week 13 - Week 104||287
8809784|NCT01500278|9862465|FG001|COMPLETED|Week 13 - Week 104||302
8809785|NCT01500278|9862464|FG000|NOT COMPLETED|Week 13 - Week 104||139
8809786|NCT01500278|9862465|FG001|NOT COMPLETED|Week 13 - Week 104||126
8809787|NCT01500317|9862476|FG000|STARTED|Overall Study||13
8809788|NCT01500317|9862477|FG001|STARTED|Overall Study||12
8809789|NCT01500317|9862478|FG002|STARTED|Overall Study||13
8809790|NCT01500317|9862476|FG000|COMPLETED|Overall Study||10
8809791|NCT01500317|9862477|FG001|COMPLETED|Overall Study||10
9041373|NCT03364309|10102050|FG013|COMPLETED|Maintenance Period||0
9041374|NCT03364309|10102051|FG014|COMPLETED|Maintenance Period||0
9041375|NCT03364309|10102052|FG015|COMPLETED|Maintenance Period||0
9041376|NCT03364309|10102053|FG016|COMPLETED|Maintenance Period||0
9041377|NCT03364309|10102054|FG017|COMPLETED|Maintenance Period||0
9041378|NCT03364309|10102055|FG018|COMPLETED|Maintenance Period||0
9041379|NCT03364309|10102037|FG000|NOT COMPLETED|Maintenance Period||0
9041380|NCT03364309|10102038|FG001|NOT COMPLETED|Maintenance Period||0
9041381|NCT03364309|10102039|FG002|NOT COMPLETED|Maintenance Period||0
9041382|NCT03364309|10102040|FG003|NOT COMPLETED|Maintenance Period||44
9041383|NCT03364309|10102041|FG004|NOT COMPLETED|Maintenance Period||12
9041384|NCT03364309|10102042|FG005|NOT COMPLETED|Maintenance Period||46
9041385|NCT03364309|10102043|FG006|NOT COMPLETED|Maintenance Period||16
9041386|NCT03364309|10102044|FG007|NOT COMPLETED|Maintenance Period||2
9041387|NCT03364309|10102045|FG008|NOT COMPLETED|Maintenance Period||6
9041388|NCT03364309|10102046|FG009|NOT COMPLETED|Maintenance Period||4
9041389|NCT03364309|10102047|FG010|NOT COMPLETED|Maintenance Period||6
9041390|NCT03364309|10102048|FG011|NOT COMPLETED|Maintenance Period||0
9041391|NCT03364309|10102049|FG012|NOT COMPLETED|Maintenance Period||0
9041392|NCT03364309|10102050|FG013|NOT COMPLETED|Maintenance Period||0
9041393|NCT03364309|10102051|FG014|NOT COMPLETED|Maintenance Period||0
9041394|NCT03364309|10102052|FG015|NOT COMPLETED|Maintenance Period||0
9041395|NCT03364309|10102053|FG016|NOT COMPLETED|Maintenance Period||0
9041396|NCT03364309|10102054|FG017|NOT COMPLETED|Maintenance Period||0
9041397|NCT03364309|10102055|FG018|NOT COMPLETED|Maintenance Period||0
9041398|NCT03364309|10102037|FG000|STARTED|Re-treatment (Maintenance) Period||0
9041399|NCT03364309|10102038|FG001|STARTED|Re-treatment (Maintenance) Period||0
9041400|NCT03364309|10102039|FG002|STARTED|Re-treatment (Maintenance) Period||0
9041401|NCT03364309|10102040|FG003|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|0
9041402|NCT03364309|10102041|FG004|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|0
9041403|NCT03364309|10102042|FG005|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|0
9041404|NCT03364309|10102043|FG006|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|0
9041405|NCT03364309|10102044|FG007|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|0
9041406|NCT03364309|10102045|FG008|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|0
9041407|NCT03364309|10102046|FG009|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|0
9041408|NCT03364309|10102047|FG010|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|0
9041409|NCT03364309|10102048|FG011|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|2
9041410|NCT03364309|10102049|FG012|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|43
9041411|NCT03364309|10102050|FG013|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|7
9041412|NCT03364309|10102051|FG014|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|45
9041413|NCT03364309|10102052|FG015|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|10
9041414|NCT03364309|10102053|FG016|STARTED|Re-treatment (Maintenance) Period||0
9041415|NCT03364309|10102054|FG017|STARTED|Re-treatment (Maintenance) Period||0
9041416|NCT03364309|10102055|FG018|STARTED|Re-treatment (Maintenance) Period||0
9041417|NCT03364309|10102037|FG000|COMPLETED|Re-treatment (Maintenance) Period||0
9041418|NCT03364309|10102038|FG001|COMPLETED|Re-treatment (Maintenance) Period||0
9041419|NCT03364309|10102039|FG002|COMPLETED|Re-treatment (Maintenance) Period||0
9041420|NCT03364309|10102040|FG003|COMPLETED|Re-treatment (Maintenance) Period||0
9041421|NCT03364309|10102041|FG004|COMPLETED|Re-treatment (Maintenance) Period||0
9041422|NCT03364309|10102042|FG005|COMPLETED|Re-treatment (Maintenance) Period||0
9041423|NCT03364309|10102043|FG006|COMPLETED|Re-treatment (Maintenance) Period||0
9041424|NCT03364309|10102044|FG007|COMPLETED|Re-treatment (Maintenance) Period||0
9041425|NCT03364309|10102045|FG008|COMPLETED|Re-treatment (Maintenance) Period||0
9041426|NCT03364309|10102046|FG009|COMPLETED|Re-treatment (Maintenance) Period||0
9041427|NCT03364309|10102047|FG010|COMPLETED|Re-treatment (Maintenance) Period||0
9041428|NCT03364309|10102048|FG011|COMPLETED|Re-treatment (Maintenance) Period||2
9041429|NCT03364309|10102049|FG012|COMPLETED|Re-treatment (Maintenance) Period||42
9041430|NCT03364309|10102050|FG013|COMPLETED|Re-treatment (Maintenance) Period||6
9041431|NCT03364309|10102051|FG014|COMPLETED|Re-treatment (Maintenance) Period||43
8809792|NCT01500317|9862478|FG002|COMPLETED|Overall Study||13
8809793|NCT01500317|9862476|FG000|NOT COMPLETED|Overall Study||3
8809794|NCT01500317|9862477|FG001|NOT COMPLETED|Overall Study||2
8809795|NCT01500317|9862478|FG002|NOT COMPLETED|Overall Study||0
8809796|NCT01500382|9862490|FG000|STARTED|Treatment Period 1||1
8809797|NCT01500382|9862491|FG001|STARTED|Treatment Period 1||1
8809798|NCT01500382|9862492|FG002|STARTED|Treatment Period 1||1
8809799|NCT01500382|9862493|FG003|STARTED|Treatment Period 1||1
8809800|NCT01500382|9862490|FG000|COMPLETED|Treatment Period 1||1
8809801|NCT01500382|9862491|FG001|COMPLETED|Treatment Period 1||1
8809802|NCT01500382|9862492|FG002|COMPLETED|Treatment Period 1||1
8809803|NCT01500382|9862493|FG003|COMPLETED|Treatment Period 1||1
8809804|NCT01500382|9862490|FG000|NOT COMPLETED|Treatment Period 1||0
8809805|NCT01500382|9862491|FG001|NOT COMPLETED|Treatment Period 1||0
8809806|NCT01500382|9862492|FG002|NOT COMPLETED|Treatment Period 1||0
8809807|NCT01500382|9862493|FG003|NOT COMPLETED|Treatment Period 1||0
8809808|NCT01500382|9862490|FG000|STARTED|Washout Period||1
8809809|NCT01500382|9862491|FG001|STARTED|Washout Period||1
8809810|NCT01500382|9862492|FG002|STARTED|Washout Period||1
8809811|NCT01500382|9862493|FG003|STARTED|Washout Period||1
8809812|NCT01500382|9862490|FG000|COMPLETED|Washout Period||1
8809813|NCT01500382|9862491|FG001|COMPLETED|Washout Period||1
8809814|NCT01500382|9862492|FG002|COMPLETED|Washout Period||0
8809815|NCT01500382|9862493|FG003|COMPLETED|Washout Period||1
9041432|NCT03364309|10102052|FG015|COMPLETED|Re-treatment (Maintenance) Period||8
9041433|NCT03364309|10102053|FG016|COMPLETED|Re-treatment (Maintenance) Period||0
9041434|NCT03364309|10102054|FG017|COMPLETED|Re-treatment (Maintenance) Period||0
9041435|NCT03364309|10102055|FG018|COMPLETED|Re-treatment (Maintenance) Period||0
9041436|NCT03364309|10102037|FG000|NOT COMPLETED|Re-treatment (Maintenance) Period||0
9041437|NCT03364309|10102038|FG001|NOT COMPLETED|Re-treatment (Maintenance) Period||0
9041438|NCT03364309|10102039|FG002|NOT COMPLETED|Re-treatment (Maintenance) Period||0
9041439|NCT03364309|10102040|FG003|NOT COMPLETED|Re-treatment (Maintenance) Period||0
9041440|NCT03364309|10102041|FG004|NOT COMPLETED|Re-treatment (Maintenance) Period||0
9041441|NCT03364309|10102042|FG005|NOT COMPLETED|Re-treatment (Maintenance) Period||0
9041442|NCT03364309|10102043|FG006|NOT COMPLETED|Re-treatment (Maintenance) Period||0
9041443|NCT03364309|10102044|FG007|NOT COMPLETED|Re-treatment (Maintenance) Period||0
9041444|NCT03364309|10102045|FG008|NOT COMPLETED|Re-treatment (Maintenance) Period||0
9041445|NCT03364309|10102046|FG009|NOT COMPLETED|Re-treatment (Maintenance) Period||0
9041446|NCT03364309|10102047|FG010|NOT COMPLETED|Re-treatment (Maintenance) Period||0
9041447|NCT03364309|10102048|FG011|NOT COMPLETED|Re-treatment (Maintenance) Period||0
9041448|NCT03364309|10102049|FG012|NOT COMPLETED|Re-treatment (Maintenance) Period||1
9041449|NCT03364309|10102050|FG013|NOT COMPLETED|Re-treatment (Maintenance) Period||1
9041450|NCT03364309|10102051|FG014|NOT COMPLETED|Re-treatment (Maintenance) Period||2
9041451|NCT03364309|10102052|FG015|NOT COMPLETED|Re-treatment (Maintenance) Period||2
9041452|NCT03364309|10102053|FG016|NOT COMPLETED|Re-treatment (Maintenance) Period||0
9041453|NCT03364309|10102054|FG017|NOT COMPLETED|Re-treatment (Maintenance) Period||0
9041454|NCT03364309|10102055|FG018|NOT COMPLETED|Re-treatment (Maintenance) Period||0
9041455|NCT03364309|10102037|FG000|STARTED|Post-Treatment Followup Period||0
9041456|NCT03364309|10102038|FG001|STARTED|Post-Treatment Followup Period||0
9041457|NCT03364309|10102039|FG002|STARTED|Post-Treatment Followup Period||0
9041458|NCT03364309|10102040|FG003|STARTED|Post-Treatment Followup Period||0
9041459|NCT03364309|10102041|FG004|STARTED|Post-Treatment Followup Period||0
9041460|NCT03364309|10102042|FG005|STARTED|Post-Treatment Followup Period||0
9041461|NCT03364309|10102043|FG006|STARTED|Post-Treatment Followup Period||0
9041462|NCT03364309|10102044|FG007|STARTED|Post-Treatment Followup Period||0
9041463|NCT03364309|10102045|FG008|STARTED|Post-Treatment Followup Period||0
9041464|NCT03364309|10102046|FG009|STARTED|Post-Treatment Followup Period||0
9041465|NCT03364309|10102047|FG010|STARTED|Post-Treatment Followup Period||0
9041466|NCT03364309|10102048|FG011|STARTED|Post-Treatment Followup Period|This period is to report for Follow-up Period participants.|0
9041467|NCT03364309|10102049|FG012|STARTED|Post-Treatment Followup Period|This period is to report for Follow-up Period participants.|0
9041468|NCT03364309|10102050|FG013|STARTED|Post-Treatment Followup Period|This period is to report for Follow-up Period participants.|0
9041469|NCT03364309|10102051|FG014|STARTED|Post-Treatment Followup Period|This period is to report for Follow-up Period participants.|0
9041470|NCT03364309|10102052|FG015|STARTED|Post-Treatment Followup Period|This period is to report for Follow-up Period participants.|0
9041471|NCT03364309|10102053|FG016|STARTED|Post-Treatment Followup Period|This period is to report for Follow-up Period participants.|11
9041472|NCT03364309|10102054|FG017|STARTED|Post-Treatment Followup Period|This period is to report for Follow-up Period participants.|375
9041473|NCT03364309|10102055|FG018|STARTED|Post-Treatment Followup Period|This period is to report for Follow-up Period participants.|2
9041474|NCT03364309|10102037|FG000|COMPLETED|Post-Treatment Followup Period||0
9041475|NCT03364309|10102038|FG001|COMPLETED|Post-Treatment Followup Period||0
9041476|NCT03364309|10102039|FG002|COMPLETED|Post-Treatment Followup Period||0
9041477|NCT03364309|10102040|FG003|COMPLETED|Post-Treatment Followup Period||0
9041478|NCT03364309|10102041|FG004|COMPLETED|Post-Treatment Followup Period||0
9041479|NCT03364309|10102042|FG005|COMPLETED|Post-Treatment Followup Period||0
9041480|NCT03364309|10102043|FG006|COMPLETED|Post-Treatment Followup Period||0
8809816|NCT01500382|9862490|FG000|NOT COMPLETED|Washout Period||0
8809817|NCT01500382|9862491|FG001|NOT COMPLETED|Washout Period||0
8809818|NCT01500382|9862492|FG002|NOT COMPLETED|Washout Period||1
8809819|NCT01500382|9862493|FG003|NOT COMPLETED|Washout Period||0
8809820|NCT01500382|9862490|FG000|STARTED|Treatment Period 2||1
8809821|NCT01500382|9862491|FG001|STARTED|Treatment Period 2||1
8809822|NCT01500382|9862492|FG002|STARTED|Treatment Period 2||0
8809823|NCT01500382|9862493|FG003|STARTED|Treatment Period 2||1
8809824|NCT01500382|9862490|FG000|COMPLETED|Treatment Period 2||1
8809825|NCT01500382|9862491|FG001|COMPLETED|Treatment Period 2||1
8809826|NCT01500382|9862492|FG002|COMPLETED|Treatment Period 2||0
8809827|NCT01500382|9862493|FG003|COMPLETED|Treatment Period 2||1
8809828|NCT01500382|9862490|FG000|NOT COMPLETED|Treatment Period 2||0
8809829|NCT01500382|9862491|FG001|NOT COMPLETED|Treatment Period 2||0
8809830|NCT01500382|9862492|FG002|NOT COMPLETED|Treatment Period 2||0
8809831|NCT01500382|9862493|FG003|NOT COMPLETED|Treatment Period 2||0
8809832|NCT01500434|9862503|FG000|STARTED|Overall Study||102
8809833|NCT01500434|9862503|FG000|COMPLETED|Overall Study||95
8809834|NCT01500434|9862503|FG000|NOT COMPLETED|Overall Study||7
8809835|NCT01500525|9862509|FG000|STARTED|Overall Study||286
8809836|NCT01500525|9862510|FG001|STARTED|Overall Study||301
8809837|NCT01500525|9862509|FG000|COMPLETED|Overall Study||286
8809838|NCT01500525|9862510|FG001|COMPLETED|Overall Study||301
8809839|NCT01500525|9862509|FG000|NOT COMPLETED|Overall Study||0
8809840|NCT01500525|9862510|FG001|NOT COMPLETED|Overall Study||0
8809841|NCT01500629|9862518|FG000|STARTED|Period 1 (Single Dose)||11
8809842|NCT01500629|9862519|FG001|STARTED|Period 1 (Single Dose)||10
8809843|NCT01500629|9862518|FG000|COMPLETED|Period 1 (Single Dose)||11
8809844|NCT01500629|9862519|FG001|COMPLETED|Period 1 (Single Dose)||10
8809845|NCT01500629|9862518|FG000|NOT COMPLETED|Period 1 (Single Dose)||0
8809846|NCT01500629|9862519|FG001|NOT COMPLETED|Period 1 (Single Dose)||0
8809847|NCT01500629|9862518|FG000|STARTED|Washout Period of 14 to 30 Days||11
8809848|NCT01500629|9862519|FG001|STARTED|Washout Period of 14 to 30 Days||10
8809849|NCT01500629|9862518|FG000|COMPLETED|Washout Period of 14 to 30 Days||10
8809850|NCT01500629|9862519|FG001|COMPLETED|Washout Period of 14 to 30 Days||10
8809851|NCT01500629|9862518|FG000|NOT COMPLETED|Washout Period of 14 to 30 Days||1
8809852|NCT01500629|9862519|FG001|NOT COMPLETED|Washout Period of 14 to 30 Days||0
8809853|NCT01500629|9862518|FG000|STARTED|Period 2 (Single Dose)||10
8809854|NCT01500629|9862519|FG001|STARTED|Period 2 (Single Dose)||10
8809855|NCT01500629|9862518|FG000|COMPLETED|Period 2 (Single Dose)||10
8809856|NCT01500629|9862519|FG001|COMPLETED|Period 2 (Single Dose)||10
8809857|NCT01500629|9862518|FG000|NOT COMPLETED|Period 2 (Single Dose)||0
8809858|NCT01500629|9862519|FG001|NOT COMPLETED|Period 2 (Single Dose)||0
8809859|NCT01500694|9862534|FG000|STARTED|Overall Study||131
8809860|NCT01500694|9862535|FG001|STARTED|Overall Study|Participants who received treatment were reported as Started.|83
8809861|NCT01500694|9862534|FG000|COMPLETED|Overall Study||79
8809862|NCT01500694|9862535|FG001|COMPLETED|Overall Study||54
8809863|NCT01500694|9862534|FG000|NOT COMPLETED|Overall Study||52
8809864|NCT01500694|9862535|FG001|NOT COMPLETED|Overall Study||29
8849096|NCT01738594|9904280|FG001|STARTED|Completed 4 Cycles of Treatment||2
8849097|NCT01738594|9904281|FG002|STARTED|Completed 4 Cycles of Treatment||0
8849098|NCT01738594|9904282|FG003|STARTED|Completed 4 Cycles of Treatment||0
8849099|NCT01738594|9904283|FG004|STARTED|Completed 4 Cycles of Treatment||1
8849100|NCT01738594|9904284|FG005|STARTED|Completed 4 Cycles of Treatment||2
8849101|NCT01738594|9904285|FG006|STARTED|Completed 4 Cycles of Treatment||0
8849102|NCT01738594|9904286|FG007|STARTED|Completed 4 Cycles of Treatment||0
8849103|NCT01738594|9904279|FG000|COMPLETED|Completed 4 Cycles of Treatment||0
8849104|NCT01738594|9904280|FG001|COMPLETED|Completed 4 Cycles of Treatment||0
8849105|NCT01738594|9904281|FG002|COMPLETED|Completed 4 Cycles of Treatment||0
8849106|NCT01738594|9904282|FG003|COMPLETED|Completed 4 Cycles of Treatment||0
8849107|NCT01738594|9904283|FG004|COMPLETED|Completed 4 Cycles of Treatment||1
8849108|NCT01738594|9904284|FG005|COMPLETED|Completed 4 Cycles of Treatment||1
8849109|NCT01738594|9904285|FG006|COMPLETED|Completed 4 Cycles of Treatment||0
8849110|NCT01738594|9904286|FG007|COMPLETED|Completed 4 Cycles of Treatment||0
8849111|NCT01738594|9904279|FG000|NOT COMPLETED|Completed 4 Cycles of Treatment||0
8849112|NCT01738594|9904280|FG001|NOT COMPLETED|Completed 4 Cycles of Treatment||2
8849113|NCT01738594|9904281|FG002|NOT COMPLETED|Completed 4 Cycles of Treatment||0
8849114|NCT01738594|9904282|FG003|NOT COMPLETED|Completed 4 Cycles of Treatment||0
8849115|NCT01738594|9904283|FG004|NOT COMPLETED|Completed 4 Cycles of Treatment||0
8849116|NCT01738594|9904284|FG005|NOT COMPLETED|Completed 4 Cycles of Treatment||1
8849117|NCT01738594|9904285|FG006|NOT COMPLETED|Completed 4 Cycles of Treatment||0
8849118|NCT01738594|9904286|FG007|NOT COMPLETED|Completed 4 Cycles of Treatment||0
8849119|NCT01738594|9904279|FG000|STARTED|Went on to Continue Treatment Cycle 5||0
8849120|NCT01738594|9904280|FG001|STARTED|Went on to Continue Treatment Cycle 5||0
8849121|NCT01738594|9904281|FG002|STARTED|Went on to Continue Treatment Cycle 5||0
8849122|NCT01738594|9904282|FG003|STARTED|Went on to Continue Treatment Cycle 5||0
8849123|NCT01738594|9904283|FG004|STARTED|Went on to Continue Treatment Cycle 5||1
8849124|NCT01738594|9904284|FG005|STARTED|Went on to Continue Treatment Cycle 5||1
8849125|NCT01738594|9904285|FG006|STARTED|Went on to Continue Treatment Cycle 5||0
8849126|NCT01738594|9904286|FG007|STARTED|Went on to Continue Treatment Cycle 5||0
8849127|NCT01738594|9904279|FG000|COMPLETED|Went on to Continue Treatment Cycle 5||0
8849128|NCT01738594|9904280|FG001|COMPLETED|Went on to Continue Treatment Cycle 5||0
8849129|NCT01738594|9904281|FG002|COMPLETED|Went on to Continue Treatment Cycle 5||0
8849130|NCT01738594|9904282|FG003|COMPLETED|Went on to Continue Treatment Cycle 5||0
8849131|NCT01738594|9904283|FG004|COMPLETED|Went on to Continue Treatment Cycle 5||0
8849132|NCT01738594|9904284|FG005|COMPLETED|Went on to Continue Treatment Cycle 5||0
8849133|NCT01738594|9904285|FG006|COMPLETED|Went on to Continue Treatment Cycle 5||0
8849134|NCT01738594|9904286|FG007|COMPLETED|Went on to Continue Treatment Cycle 5||0
9041481|NCT03364309|10102044|FG007|COMPLETED|Post-Treatment Followup Period||0
9041482|NCT03364309|10102045|FG008|COMPLETED|Post-Treatment Followup Period||0
9041483|NCT03364309|10102046|FG009|COMPLETED|Post-Treatment Followup Period||0
9041484|NCT03364309|10102047|FG010|COMPLETED|Post-Treatment Followup Period||0
9041485|NCT03364309|10102048|FG011|COMPLETED|Post-Treatment Followup Period||0
9041486|NCT03364309|10102049|FG012|COMPLETED|Post-Treatment Followup Period||0
9041487|NCT03364309|10102050|FG013|COMPLETED|Post-Treatment Followup Period||0
9041488|NCT03364309|10102051|FG014|COMPLETED|Post-Treatment Followup Period||0
9041489|NCT03364309|10102052|FG015|COMPLETED|Post-Treatment Followup Period||0
9041490|NCT03364309|10102053|FG016|COMPLETED|Post-Treatment Followup Period||6
9041491|NCT03364309|10102054|FG017|COMPLETED|Post-Treatment Followup Period||344
9041492|NCT03364309|10102055|FG018|COMPLETED|Post-Treatment Followup Period||0
8695668|NCT00878553|9741158|FG001|Number of Patients Receiving 20mg|Sleep Study||0
8695669|NCT00878553|9741159|FG002|Number of Patients Receiving 20mg|Sleep Study||0
8695670|NCT00878553|9741160|FG003|Number of Patients Receiving 20mg|Sleep Study||0
8695671|NCT00878553|9741161|FG004|Number of Patients Receiving 20mg|Sleep Study||0
8695672|NCT00878553|9741157|FG000|COMPLETED|Sleep Study|5 patient withdraws result in greater than 5 lost patient data across groups due to CROSSOVER design|62
8695673|NCT00878553|9741158|FG001|COMPLETED|Sleep Study||0
8695674|NCT00878553|9741159|FG002|COMPLETED|Sleep Study||0
8695675|NCT00878553|9741160|FG003|COMPLETED|Sleep Study||0
8695676|NCT00878553|9741161|FG004|COMPLETED|Sleep Study||0
8695677|NCT00878553|9741157|FG000|NOT COMPLETED|Sleep Study||5
8695678|NCT00878553|9741158|FG001|NOT COMPLETED|Sleep Study||0
8695679|NCT00878553|9741159|FG002|NOT COMPLETED|Sleep Study||0
8695680|NCT00878553|9741160|FG003|NOT COMPLETED|Sleep Study||0
8695681|NCT00878553|9741161|FG004|NOT COMPLETED|Sleep Study||0
8724168|NCT01025843|9771507|FG008|STARTED|Washout 2||2
8724169|NCT01025843|9771508|FG009|STARTED|Washout 2||2
8724170|NCT01025843|9771499|FG000|COMPLETED|Washout 2||2
8724171|NCT01025843|9771500|FG001|COMPLETED|Washout 2||2
8724172|NCT01025843|9771501|FG002|COMPLETED|Washout 2||2
8724173|NCT01025843|9771502|FG003|COMPLETED|Washout 2||2
8724174|NCT01025843|9771503|FG004|COMPLETED|Washout 2||2
8724175|NCT01025843|9771504|FG005|COMPLETED|Washout 2||2
8724176|NCT01025843|9771505|FG006|COMPLETED|Washout 2||2
8724177|NCT01025843|9771506|FG007|COMPLETED|Washout 2||2
8724178|NCT01025843|9771507|FG008|COMPLETED|Washout 2||2
8724179|NCT01025843|9771508|FG009|COMPLETED|Washout 2||2
8724180|NCT01025843|9771499|FG000|NOT COMPLETED|Washout 2||0
8724181|NCT01025843|9771500|FG001|NOT COMPLETED|Washout 2||0
8724182|NCT01025843|9771501|FG002|NOT COMPLETED|Washout 2||0
8724183|NCT01025843|9771502|FG003|NOT COMPLETED|Washout 2||0
8724184|NCT01025843|9771503|FG004|NOT COMPLETED|Washout 2||0
8724185|NCT01025843|9771504|FG005|NOT COMPLETED|Washout 2||0
8724186|NCT01025843|9771505|FG006|NOT COMPLETED|Washout 2||0
8724187|NCT01025843|9771506|FG007|NOT COMPLETED|Washout 2||0
8724188|NCT01025843|9771507|FG008|NOT COMPLETED|Washout 2||0
8724189|NCT01025843|9771508|FG009|NOT COMPLETED|Washout 2||0
8724190|NCT01025843|9771499|FG000|STARTED|Period 3||2
8724191|NCT01025843|9771500|FG001|STARTED|Period 3||2
8724192|NCT01025843|9771501|FG002|STARTED|Period 3||2
8724193|NCT01025843|9771502|FG003|STARTED|Period 3||2
8724194|NCT01025843|9771503|FG004|STARTED|Period 3||2
8724195|NCT01025843|9771504|FG005|STARTED|Period 3||2
8724196|NCT01025843|9771505|FG006|STARTED|Period 3||2
8724197|NCT01025843|9771506|FG007|STARTED|Period 3||2
8724198|NCT01025843|9771507|FG008|STARTED|Period 3||2
8724199|NCT01025843|9771508|FG009|STARTED|Period 3||2
8724200|NCT01025843|9771499|FG000|COMPLETED|Period 3||2
8724201|NCT01025843|9771500|FG001|COMPLETED|Period 3||2
8724202|NCT01025843|9771501|FG002|COMPLETED|Period 3||2
8724203|NCT01025843|9771502|FG003|COMPLETED|Period 3||2
8724204|NCT01025843|9771503|FG004|COMPLETED|Period 3||2
8724205|NCT01025843|9771504|FG005|COMPLETED|Period 3||2
8724206|NCT01025843|9771505|FG006|COMPLETED|Period 3||2
8724207|NCT01025843|9771506|FG007|COMPLETED|Period 3||2
8724208|NCT01025843|9771507|FG008|COMPLETED|Period 3||2
8724209|NCT01025843|9771508|FG009|COMPLETED|Period 3||2
8724210|NCT01025843|9771499|FG000|NOT COMPLETED|Period 3||0
8724211|NCT01025843|9771500|FG001|NOT COMPLETED|Period 3||0
8724212|NCT01025843|9771501|FG002|NOT COMPLETED|Period 3||0
8724213|NCT01025843|9771502|FG003|NOT COMPLETED|Period 3||0
8724214|NCT01025843|9771503|FG004|NOT COMPLETED|Period 3||0
8724215|NCT01025843|9771504|FG005|NOT COMPLETED|Period 3||0
8724216|NCT01025843|9771505|FG006|NOT COMPLETED|Period 3||0
8724217|NCT01025843|9771506|FG007|NOT COMPLETED|Period 3||0
8724218|NCT01025843|9771507|FG008|NOT COMPLETED|Period 3||0
8724219|NCT01025843|9771508|FG009|NOT COMPLETED|Period 3||0
8724220|NCT01025843|9771499|FG000|STARTED|Washout 3||2
8724221|NCT01025843|9771500|FG001|STARTED|Washout 3||2
8724222|NCT01025843|9771501|FG002|STARTED|Washout 3||2
8724223|NCT01025843|9771502|FG003|STARTED|Washout 3||2
8724224|NCT01025843|9771503|FG004|STARTED|Washout 3||2
8724225|NCT01025843|9771504|FG005|STARTED|Washout 3||2
8724226|NCT01025843|9771505|FG006|STARTED|Washout 3||2
8724227|NCT01025843|9771506|FG007|STARTED|Washout 3||2
8724228|NCT01025843|9771507|FG008|STARTED|Washout 3||2
8724229|NCT01025843|9771508|FG009|STARTED|Washout 3||2
8724230|NCT01025843|9771499|FG000|COMPLETED|Washout 3||2
8724231|NCT01025843|9771500|FG001|COMPLETED|Washout 3||2
8809865|NCT01500720|9862543|FG000|STARTED|Overall Study|Randomized|90
8809866|NCT01500720|9862544|FG001|STARTED|Overall Study|Randomized|89
8809867|NCT01500720|9862543|FG000|Treated|Overall Study||89
8809868|NCT01500720|9862544|FG001|Treated|Overall Study||88
8809869|NCT01500720|9862543|FG000|COMPLETED|Overall Study|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|85
9041493|NCT03364309|10102037|FG000|NOT COMPLETED|Post-Treatment Followup Period||0
9041494|NCT03364309|10102038|FG001|NOT COMPLETED|Post-Treatment Followup Period||0
9041495|NCT03364309|10102039|FG002|NOT COMPLETED|Post-Treatment Followup Period||0
8809870|NCT01500720|9862544|FG001|COMPLETED|Overall Study|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|80
8809871|NCT01500720|9862543|FG000|NOT COMPLETED|Overall Study||5
8809872|NCT01500720|9862544|FG001|NOT COMPLETED|Overall Study||9
8809873|NCT01500746|9862552|FG000|STARTED|Overall Study||4
8809874|NCT01500746|9862553|FG001|STARTED|Overall Study||4
8809875|NCT01500746|9862552|FG000|COMPLETED|Overall Study||4
8809876|NCT01500746|9862553|FG001|COMPLETED|Overall Study||4
8809877|NCT01500746|9862552|FG000|NOT COMPLETED|Overall Study||0
8809878|NCT01500746|9862553|FG001|NOT COMPLETED|Overall Study||0
8809879|NCT01500759|9862561|FG000|STARTED|Overall Study||3686
8809880|NCT01500759|9862562|FG001|STARTED|Overall Study||3190
8809881|NCT01500759|9862561|FG000|COMPLETED|Overall Study||3686
8809882|NCT01500759|9862562|FG001|COMPLETED|Overall Study||3190
8809883|NCT01500759|9862561|FG000|NOT COMPLETED|Overall Study||0
8809884|NCT01500759|9862562|FG001|NOT COMPLETED|Overall Study||0
8809885|NCT01501110|9862579|FG000|STARTED|Overall Study||34
8809886|NCT01501110|9862580|FG001|STARTED|Overall Study||34
8809887|NCT01501110|9862579|FG000|COMPLETED|Overall Study||34
8809888|NCT01501110|9862580|FG001|COMPLETED|Overall Study||33
8809889|NCT01501110|9862579|FG000|NOT COMPLETED|Overall Study||0
8809890|NCT01501110|9862580|FG001|NOT COMPLETED|Overall Study||1
8809891|NCT01501162|9862588|FG000|STARTED|Overall Study||65
8809892|NCT01501162|9862589|FG001|STARTED|Overall Study||65
8809893|NCT01501162|9862588|FG000|COMPLETED|Overall Study||57
8809894|NCT01501162|9862589|FG001|COMPLETED|Overall Study||60
8809895|NCT01501162|9862588|FG000|NOT COMPLETED|Overall Study||8
8809896|NCT01501162|9862589|FG001|NOT COMPLETED|Overall Study||5
8809897|NCT01501929|9862595|FG000|STARTED|First Intervention||8
8809898|NCT01501929|9862596|FG001|STARTED|First Intervention||17
8809899|NCT01501929|9862595|FG000|COMPLETED|First Intervention||8
8809900|NCT01501929|9862596|FG001|COMPLETED|First Intervention||17
8809901|NCT01501929|9862595|FG000|NOT COMPLETED|First Intervention||0
8809902|NCT01501929|9862596|FG001|NOT COMPLETED|First Intervention||0
8809903|NCT01501929|9862595|FG000|STARTED|Second Intervention||8
8809904|NCT01501929|9862596|FG001|STARTED|Second Intervention||17
8809905|NCT01501929|9862595|FG000|COMPLETED|Second Intervention||8
8809906|NCT01501929|9862596|FG001|COMPLETED|Second Intervention||17
8809907|NCT01501929|9862595|FG000|NOT COMPLETED|Second Intervention||0
8809908|NCT01501929|9862596|FG001|NOT COMPLETED|Second Intervention||0
8809909|NCT01502033|9862602|FG000|STARTED|Overall Study|Milestone (10 participants) met.|10
8809910|NCT01502033|9862602|FG000|COMPLETED|Overall Study|Milestone (10 participants) met|7
8809911|NCT01502033|9862602|FG000|NOT COMPLETED|Overall Study||3
9041496|NCT03364309|10102040|FG003|NOT COMPLETED|Post-Treatment Followup Period||0
9041497|NCT03364309|10102041|FG004|NOT COMPLETED|Post-Treatment Followup Period||0
9041498|NCT03364309|10102042|FG005|NOT COMPLETED|Post-Treatment Followup Period||0
9041499|NCT03364309|10102043|FG006|NOT COMPLETED|Post-Treatment Followup Period||0
9041500|NCT03364309|10102044|FG007|NOT COMPLETED|Post-Treatment Followup Period||0
9041501|NCT03364309|10102045|FG008|NOT COMPLETED|Post-Treatment Followup Period||0
9041502|NCT03364309|10102046|FG009|NOT COMPLETED|Post-Treatment Followup Period||0
9041503|NCT03364309|10102047|FG010|NOT COMPLETED|Post-Treatment Followup Period||0
9041504|NCT03364309|10102048|FG011|NOT COMPLETED|Post-Treatment Followup Period||0
9041505|NCT03364309|10102049|FG012|NOT COMPLETED|Post-Treatment Followup Period||0
9041506|NCT03364309|10102050|FG013|NOT COMPLETED|Post-Treatment Followup Period||0
9041507|NCT03364309|10102051|FG014|NOT COMPLETED|Post-Treatment Followup Period||0
9041508|NCT03364309|10102052|FG015|NOT COMPLETED|Post-Treatment Followup Period||0
9041509|NCT03364309|10102053|FG016|NOT COMPLETED|Post-Treatment Followup Period||5
9041510|NCT03364309|10102054|FG017|NOT COMPLETED|Post-Treatment Followup Period||31
9041511|NCT03364309|10102055|FG018|NOT COMPLETED|Post-Treatment Followup Period||2
9041512|NCT03364335|10102084|FG000|STARTED|Overall Study||52
9041513|NCT03364335|10102085|FG001|STARTED|Overall Study||51
9041514|NCT03364335|10102086|FG002|STARTED|Overall Study||53
9041515|NCT03364335|10102087|FG003|STARTED|Overall Study||50
9041516|NCT03364335|10102088|FG004|STARTED|Overall Study||52
9041517|NCT03364335|10102084|FG000|COMPLETED|Overall Study||42
9041518|NCT03364335|10102085|FG001|COMPLETED|Overall Study||40
9041519|NCT03364335|10102086|FG002|COMPLETED|Overall Study||42
9041520|NCT03364335|10102087|FG003|COMPLETED|Overall Study||37
9041521|NCT03364335|10102088|FG004|COMPLETED|Overall Study||41
9041522|NCT03364335|10102084|FG000|NOT COMPLETED|Overall Study||10
9041523|NCT03364335|10102085|FG001|NOT COMPLETED|Overall Study||11
9041524|NCT03364335|10102086|FG002|NOT COMPLETED|Overall Study||11
9041525|NCT03364335|10102087|FG003|NOT COMPLETED|Overall Study||13
9041526|NCT03364335|10102088|FG004|NOT COMPLETED|Overall Study||11
9041527|NCT03364608|10102100|FG000|STARTED|Overall Study||86
8809912|NCT01502072|9862611|FG000|STARTED|Overall Study||14
8809913|NCT01502072|9862612|FG001|STARTED|Overall Study||10
8809914|NCT01502072|9862613|FG002|STARTED|Overall Study||20
8809915|NCT01502072|9862611|FG000|COMPLETED|Overall Study||13
8809916|NCT01502072|9862612|FG001|COMPLETED|Overall Study||9
8809917|NCT01502072|9862613|FG002|COMPLETED|Overall Study||20
8809918|NCT01502072|9862611|FG000|NOT COMPLETED|Overall Study||1
8809919|NCT01502072|9862612|FG001|NOT COMPLETED|Overall Study||1
8809920|NCT01502072|9862613|FG002|NOT COMPLETED|Overall Study||0
8809921|NCT01502228|9862621|FG000|STARTED|Overall Study||14
8809922|NCT01502228|9862621|FG000|COMPLETED|Overall Study||13
8809923|NCT01502228|9862621|FG000|NOT COMPLETED|Overall Study||1
8809924|NCT01502293|9862628|FG000|STARTED|Overall Study||30
8809925|NCT01502293|9862629|FG001|STARTED|Overall Study||17
8809926|NCT01502293|9862630|FG002|STARTED|Overall Study||4
9041528|NCT03364608|10102100|FG000|Placebo MDI|Overall Study||82
9041529|NCT03364608|10102100|FG000|AS MDI 90 µg|Overall Study||81
9041530|NCT03364608|10102100|FG000|AS MDI 180 µg|Overall Study||81
8809927|NCT01502293|9862628|FG000|COMPLETED|Overall Study||5
8809928|NCT01502293|9862629|FG001|COMPLETED|Overall Study||0
8809929|NCT01502293|9862630|FG002|COMPLETED|Overall Study||0
8809930|NCT01502293|9862628|FG000|NOT COMPLETED|Overall Study||25
8809931|NCT01502293|9862629|FG001|NOT COMPLETED|Overall Study||17
8809932|NCT01502293|9862630|FG002|NOT COMPLETED|Overall Study||4
8809933|NCT01502306|9862644|FG000|STARTED|Overall Study||1004
8809934|NCT01502306|9862645|FG001|STARTED|Overall Study||1405
8809935|NCT01502306|9862646|FG002|STARTED|Overall Study||1407
8809936|NCT01502306|9862644|FG000|COMPLETED|Overall Study||1004
8809937|NCT01502306|9862645|FG001|COMPLETED|Overall Study||1405
8809938|NCT01502306|9862646|FG002|COMPLETED|Overall Study||1407
8809939|NCT01502306|9862644|FG000|NOT COMPLETED|Overall Study||0
8809940|NCT01502306|9862645|FG001|NOT COMPLETED|Overall Study||0
8809941|NCT01502306|9862646|FG002|NOT COMPLETED|Overall Study||0
8809942|NCT01502332|9862656|FG000|STARTED|Overall Study||157
8809943|NCT01502332|9862657|FG001|STARTED|Overall Study||163
8809944|NCT01502332|9862656|FG000|COMPLETED|Overall Study||157
8809945|NCT01502332|9862657|FG001|COMPLETED|Overall Study||163
8809946|NCT01502332|9862656|FG000|NOT COMPLETED|Overall Study||0
8809947|NCT01502332|9862657|FG001|NOT COMPLETED|Overall Study||0
8809948|NCT01502410|9862667|FG000|STARTED|Overall Study||10
8809949|NCT01502410|9862668|FG001|STARTED|Overall Study||10
8809950|NCT01502410|9862669|FG002|STARTED|Overall Study||0
8809951|NCT01502410|9862670|FG003|STARTED|Overall Study||0
8809952|NCT01502410|9862667|FG000|COMPLETED|Overall Study||0
8809953|NCT01502410|9862668|FG001|COMPLETED|Overall Study||0
8809954|NCT01502410|9862669|FG002|COMPLETED|Overall Study||0
8809955|NCT01502410|9862670|FG003|COMPLETED|Overall Study||0
8809956|NCT01502410|9862667|FG000|NOT COMPLETED|Overall Study||10
8809957|NCT01502410|9862668|FG001|NOT COMPLETED|Overall Study||10
8809958|NCT01502410|9862669|FG002|NOT COMPLETED|Overall Study||0
8809959|NCT01502410|9862670|FG003|NOT COMPLETED|Overall Study||0
8809960|NCT01502423|9862681|FG000|STARTED|Overall Study||31
8809961|NCT01502423|9862682|FG001|STARTED|Overall Study||30
8809962|NCT01502423|9862681|FG000|COMPLETED|Overall Study||31
8809963|NCT01502423|9862682|FG001|COMPLETED|Overall Study||29
8809964|NCT01502423|9862681|FG000|NOT COMPLETED|Overall Study||0
9041531|NCT03364608|10102100|FG000|Proventil 90 µg|Overall Study||82
9041532|NCT03364608|10102100|FG000|Proventil 180 µg|Overall Study||79
9041533|NCT03364608|10102100|FG000|COMPLETED|Overall Study||78
9041534|NCT03364608|10102100|FG000|NOT COMPLETED|Overall Study||8
9041535|NCT03364673|10102112|FG000|STARTED|Overall Study||29
9041536|NCT03364673|10102112|FG000|COMPLETED|Overall Study||24
9041537|NCT03364673|10102112|FG000|NOT COMPLETED|Overall Study||5
9041538|NCT03364738|10102116|FG000|STARTED|Overall Study||22
9041539|NCT03364738|10102116|FG000|COMPLETED|Overall Study||14
9041540|NCT03364738|10102116|FG000|NOT COMPLETED|Overall Study||8
9041541|NCT03364751|10102125|FG000|STARTED|Overall Study||70
9041542|NCT03364751|10102126|FG001|STARTED|Overall Study||84
9041543|NCT03364751|10102127|FG002|STARTED|Overall Study||17
9041544|NCT03364751|10102128|FG003|STARTED|Overall Study||1
9041545|NCT03364751|10102125|FG000|COMPLETED|Overall Study||69
9041546|NCT03364751|10102126|FG001|COMPLETED|Overall Study||83
9041547|NCT03364751|10102127|FG002|COMPLETED|Overall Study||17
9041548|NCT03364751|10102128|FG003|COMPLETED|Overall Study||1
9041549|NCT03364751|10102125|FG000|NOT COMPLETED|Overall Study||1
8809965|NCT01502423|9862682|FG001|NOT COMPLETED|Overall Study||1
8809966|NCT01502631|9862690|FG000|STARTED|Overall Study||30
9041550|NCT03364751|10102126|FG001|NOT COMPLETED|Overall Study||1
9041551|NCT03364751|10102127|FG002|NOT COMPLETED|Overall Study||0
9041552|NCT03364751|10102128|FG003|NOT COMPLETED|Overall Study||0
9041553|NCT03365011|10102144|FG000|STARTED|Overall Study||20
9041554|NCT03365011|10102145|FG001|STARTED|Overall Study||20
8809967|NCT01502631|9862691|FG001|STARTED|Overall Study||31
8809968|NCT01502631|9862690|FG000|COMPLETED|Overall Study||10
9041555|NCT03365011|10102144|FG000|COMPLETED|Overall Study||19
8809969|NCT01502631|9862691|FG001|COMPLETED|Overall Study||11
9041556|NCT03365011|10102145|FG001|COMPLETED|Overall Study||18
9041557|NCT03365011|10102144|FG000|NOT COMPLETED|Overall Study||1
8809970|NCT01502631|9862690|FG000|NOT COMPLETED|Overall Study||20
8809971|NCT01502631|9862691|FG001|NOT COMPLETED|Overall Study||20
8809972|NCT01502644|9862700|FG000|STARTED|Enrolled at Visit 1 After Pre-screening||81
8809973|NCT01502644|9862701|FG001|STARTED|Enrolled at Visit 1 After Pre-screening||0
8809974|NCT01502644|9862702|FG002|STARTED|Enrolled at Visit 1 After Pre-screening||0
8809975|NCT01502644|9862703|FG003|STARTED|Enrolled at Visit 1 After Pre-screening||0
8850423|NCT01746368|9905625|FG001|NOT COMPLETED|Overall Study||1
8809976|NCT01502644|9862700|FG000|COMPLETED|Enrolled at Visit 1 After Pre-screening|Participants who completed Visit 1 were assigned to 1 of the 3 NA groups for remainder of the trial|72
9041558|NCT03365011|10102145|FG001|NOT COMPLETED|Overall Study||2
9041559|NCT03365154|10102151|FG000|STARTED|Overall Study||10
9041560|NCT03365154|10102151|FG000|COMPLETED|Overall Study||10
9041561|NCT03365154|10102151|FG000|NOT COMPLETED|Overall Study||0
9041562|NCT03365778|10102158|FG000|STARTED|Overall Study||16
9041563|NCT03365778|10102159|FG001|STARTED|Overall Study||17
9041564|NCT03365778|10102160|FG002|STARTED|Overall Study||53
9041565|NCT03365778|10102158|FG000|COMPLETED|Overall Study||16
9041566|NCT03365778|10102159|FG001|COMPLETED|Overall Study||17
9041567|NCT03365778|10102160|FG002|COMPLETED|Overall Study||53
9041568|NCT03365778|10102158|FG000|NOT COMPLETED|Overall Study||0
9041569|NCT03365778|10102159|FG001|NOT COMPLETED|Overall Study||0
9041570|NCT03365778|10102160|FG002|NOT COMPLETED|Overall Study||0
9041571|NCT03365934|10102168|FG000|STARTED|Overall Study||35
9041572|NCT03365934|10102168|FG000|COMPLETED|Overall Study||33
9041573|NCT03365934|10102168|FG000|NOT COMPLETED|Overall Study||2
9041574|NCT03366207|10102177|FG000|STARTED|Overall Study||250
9041575|NCT03366207|10102177|FG000|COMPLETED|Overall Study||242
9041576|NCT03366207|10102177|FG000|NOT COMPLETED|Overall Study||8
9041577|NCT03366298|10102181|FG000|STARTED|Overall Study||3
9041578|NCT03366298|10102182|FG001|STARTED|Overall Study||3
9041579|NCT03366298|10102183|FG002|STARTED|Overall Study||3
9041580|NCT03366298|10102184|FG003|STARTED|Overall Study||3
9041581|NCT03366298|10102181|FG000|COMPLETED|Overall Study||3
9041582|NCT03366298|10102182|FG001|COMPLETED|Overall Study||3
9041583|NCT03366298|10102183|FG002|COMPLETED|Overall Study||3
9041584|NCT03366298|10102184|FG003|COMPLETED|Overall Study||3
9041585|NCT03366298|10102181|FG000|NOT COMPLETED|Overall Study||0
9041586|NCT03366298|10102182|FG001|NOT COMPLETED|Overall Study||0
9041587|NCT03366298|10102183|FG002|NOT COMPLETED|Overall Study||0
9041588|NCT03366298|10102184|FG003|NOT COMPLETED|Overall Study||0
9041589|NCT03367793|10102198|FG000|STARTED|Initial Acuity at Dispense Visit (10min)||5
9041590|NCT03367793|10102199|FG001|STARTED|Initial Acuity at Dispense Visit (10min)||5
9041591|NCT03367793|10102200|FG002|STARTED|Initial Acuity at Dispense Visit (10min)||5
9041592|NCT03367793|10102201|FG003|STARTED|Initial Acuity at Dispense Visit (10min)||5
9041593|NCT03367793|10102202|FG004|STARTED|Initial Acuity at Dispense Visit (10min)||5
9041594|NCT03367793|10102203|FG005|STARTED|Initial Acuity at Dispense Visit (10min)||5
9041595|NCT03367793|10102198|FG000|COMPLETED|Initial Acuity at Dispense Visit (10min)||5
9041596|NCT03367793|10102199|FG001|COMPLETED|Initial Acuity at Dispense Visit (10min)||5
9041597|NCT03367793|10102200|FG002|COMPLETED|Initial Acuity at Dispense Visit (10min)||5
9041598|NCT03367793|10102201|FG003|COMPLETED|Initial Acuity at Dispense Visit (10min)||5
9041599|NCT03367793|10102202|FG004|COMPLETED|Initial Acuity at Dispense Visit (10min)||5
9041600|NCT03367793|10102203|FG005|COMPLETED|Initial Acuity at Dispense Visit (10min)||5
9041601|NCT03367793|10102198|FG000|NOT COMPLETED|Initial Acuity at Dispense Visit (10min)||0
9041602|NCT03367793|10102199|FG001|NOT COMPLETED|Initial Acuity at Dispense Visit (10min)||0
9041603|NCT03367793|10102200|FG002|NOT COMPLETED|Initial Acuity at Dispense Visit (10min)||0
9041604|NCT03367793|10102201|FG003|NOT COMPLETED|Initial Acuity at Dispense Visit (10min)||0
9041605|NCT03367793|10102202|FG004|NOT COMPLETED|Initial Acuity at Dispense Visit (10min)||0
9041606|NCT03367793|10102203|FG005|NOT COMPLETED|Initial Acuity at Dispense Visit (10min)||0
9041607|NCT03367793|10102198|FG000|STARTED|Treatment 1 Dispense to 2 Months Wear||5
9041608|NCT03367793|10102199|FG001|STARTED|Treatment 1 Dispense to 2 Months Wear||5
9041609|NCT03367793|10102200|FG002|STARTED|Treatment 1 Dispense to 2 Months Wear||5
9041610|NCT03367793|10102201|FG003|STARTED|Treatment 1 Dispense to 2 Months Wear||5
9041611|NCT03367793|10102202|FG004|STARTED|Treatment 1 Dispense to 2 Months Wear||5
9041612|NCT03367793|10102203|FG005|STARTED|Treatment 1 Dispense to 2 Months Wear||5
9041613|NCT03367793|10102198|FG000|COMPLETED|Treatment 1 Dispense to 2 Months Wear||5
9041614|NCT03367793|10102199|FG001|COMPLETED|Treatment 1 Dispense to 2 Months Wear||5
9041615|NCT03367793|10102200|FG002|COMPLETED|Treatment 1 Dispense to 2 Months Wear||5
9041616|NCT03367793|10102201|FG003|COMPLETED|Treatment 1 Dispense to 2 Months Wear||5
9041617|NCT03367793|10102202|FG004|COMPLETED|Treatment 1 Dispense to 2 Months Wear||5
9041618|NCT03367793|10102203|FG005|COMPLETED|Treatment 1 Dispense to 2 Months Wear||5
9041619|NCT03367793|10102198|FG000|NOT COMPLETED|Treatment 1 Dispense to 2 Months Wear||0
9041620|NCT03367793|10102199|FG001|NOT COMPLETED|Treatment 1 Dispense to 2 Months Wear||0
9041621|NCT03367793|10102200|FG002|NOT COMPLETED|Treatment 1 Dispense to 2 Months Wear||0
9041622|NCT03367793|10102201|FG003|NOT COMPLETED|Treatment 1 Dispense to 2 Months Wear||0
9041623|NCT03367793|10102202|FG004|NOT COMPLETED|Treatment 1 Dispense to 2 Months Wear||0
9041624|NCT03367793|10102203|FG005|NOT COMPLETED|Treatment 1 Dispense to 2 Months Wear||0
9041625|NCT03367793|10102198|FG000|STARTED|Treatment 2 Dispense to 2 Months Wear||5
9041626|NCT03367793|10102199|FG001|STARTED|Treatment 2 Dispense to 2 Months Wear||5
9041627|NCT03367793|10102200|FG002|STARTED|Treatment 2 Dispense to 2 Months Wear||5
9041628|NCT03367793|10102201|FG003|STARTED|Treatment 2 Dispense to 2 Months Wear||5
9041629|NCT03367793|10102202|FG004|STARTED|Treatment 2 Dispense to 2 Months Wear||5
9041630|NCT03367793|10102203|FG005|STARTED|Treatment 2 Dispense to 2 Months Wear||5
9041631|NCT03367793|10102198|FG000|COMPLETED|Treatment 2 Dispense to 2 Months Wear||5
9041632|NCT03367793|10102199|FG001|COMPLETED|Treatment 2 Dispense to 2 Months Wear||5
9041633|NCT03367793|10102200|FG002|COMPLETED|Treatment 2 Dispense to 2 Months Wear||4
9041634|NCT03367793|10102201|FG003|COMPLETED|Treatment 2 Dispense to 2 Months Wear||5
9041635|NCT03367793|10102202|FG004|COMPLETED|Treatment 2 Dispense to 2 Months Wear||5
9041636|NCT03367793|10102203|FG005|COMPLETED|Treatment 2 Dispense to 2 Months Wear||5
9041637|NCT03367793|10102198|FG000|NOT COMPLETED|Treatment 2 Dispense to 2 Months Wear||0
9041638|NCT03367793|10102199|FG001|NOT COMPLETED|Treatment 2 Dispense to 2 Months Wear||0
8809977|NCT01502644|9862701|FG001|COMPLETED|Enrolled at Visit 1 After Pre-screening||0
8809978|NCT01502644|9862702|FG002|COMPLETED|Enrolled at Visit 1 After Pre-screening||0
8809979|NCT01502644|9862703|FG003|COMPLETED|Enrolled at Visit 1 After Pre-screening||0
8809980|NCT01502644|9862700|FG000|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||9
8809981|NCT01502644|9862701|FG001|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||0
8809982|NCT01502644|9862702|FG002|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||0
8809983|NCT01502644|9862703|FG003|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||0
8809984|NCT01502644|9862700|FG000|STARTED|Assigned to NA Groups||0
8809985|NCT01502644|9862701|FG001|STARTED|Assigned to NA Groups||30
8809986|NCT01502644|9862702|FG002|STARTED|Assigned to NA Groups||10
8809987|NCT01502644|9862703|FG003|STARTED|Assigned to NA Groups||32
8809988|NCT01502644|9862700|FG000|COMPLETED|Assigned to NA Groups||0
8809989|NCT01502644|9862701|FG001|COMPLETED|Assigned to NA Groups|Completed = completed at least 50% of the opioid treatment period (at least 10 weeks of treatment)|24
8809990|NCT01502644|9862702|FG002|COMPLETED|Assigned to NA Groups|Completed = completed at least 50% of the opioid treatment period (at least 10 weeks of treatment)|7
8809991|NCT01502644|9862703|FG003|COMPLETED|Assigned to NA Groups|Completed = completed at least 50% of the opioid treatment period (at least 10 weeks of treatment)|24
8809992|NCT01502644|9862700|FG000|NOT COMPLETED|Assigned to NA Groups||0
8809993|NCT01502644|9862701|FG001|NOT COMPLETED|Assigned to NA Groups||6
8809994|NCT01502644|9862702|FG002|NOT COMPLETED|Assigned to NA Groups||3
8809995|NCT01502644|9862703|FG003|NOT COMPLETED|Assigned to NA Groups||8
8809996|NCT01502709|9862713|FG000|STARTED|Overall Study||5
8809997|NCT01502709|9862714|FG001|STARTED|Overall Study||0
8809998|NCT01502709|9862713|FG000|COMPLETED|Overall Study||1
8809999|NCT01502709|9862714|FG001|COMPLETED|Overall Study||0
8810000|NCT01502709|9862713|FG000|NOT COMPLETED|Overall Study||4
8810001|NCT01502709|9862714|FG001|NOT COMPLETED|Overall Study||0
8810002|NCT01502761|9862725|FG000|STARTED|Overall Study||4
8810003|NCT01502761|9862726|FG001|STARTED|Overall Study||0
8810004|NCT01502761|9862727|FG002|STARTED|Overall Study||0
8810005|NCT01502761|9862728|FG003|STARTED|Overall Study||0
8810006|NCT01502761|9862725|FG000|COMPLETED|Overall Study||4
8810007|NCT01502761|9862726|FG001|COMPLETED|Overall Study||0
8810008|NCT01502761|9862727|FG002|COMPLETED|Overall Study||0
8810009|NCT01502761|9862728|FG003|COMPLETED|Overall Study||0
8810010|NCT01502761|9862725|FG000|NOT COMPLETED|Overall Study||0
8810011|NCT01502761|9862726|FG001|NOT COMPLETED|Overall Study||0
8810012|NCT01502761|9862727|FG002|NOT COMPLETED|Overall Study||0
8810013|NCT01502761|9862728|FG003|NOT COMPLETED|Overall Study||0
8810014|NCT01502787|9862738|FG000|STARTED|Overall Study||11
8810015|NCT01502787|9862739|FG001|STARTED|Overall Study||10
8810016|NCT01502787|9862738|FG000|COMPLETED|Overall Study||11
8810017|NCT01502787|9862739|FG001|COMPLETED|Overall Study||10
8810018|NCT01502787|9862738|FG000|NOT COMPLETED|Overall Study||0
8810019|NCT01502787|9862739|FG001|NOT COMPLETED|Overall Study||0
8810020|NCT01502813|9862749|FG000|STARTED|Overall Study||40
8810021|NCT01502813|9862749|FG000|COMPLETED|Overall Study||40
8810022|NCT01502813|9862749|FG000|NOT COMPLETED|Overall Study||0
8810023|NCT01502956|9862755|FG000|STARTED|Overall Study||192
8810024|NCT01502956|9862756|FG001|STARTED|Overall Study||194
8810025|NCT01502956|9862755|FG000|COMPLETED|Overall Study||168
8810026|NCT01502956|9862756|FG001|COMPLETED|Overall Study||168
8810027|NCT01502956|9862755|FG000|NOT COMPLETED|Overall Study||24
8810028|NCT01502956|9862756|FG001|NOT COMPLETED|Overall Study||26
8810029|NCT01503021|9862764|FG000|STARTED|Overall Study||360
8810030|NCT01503021|9862765|FG001|STARTED|Overall Study||358
8810031|NCT01503021|9862764|FG000|Dosed|Overall Study||351
8810032|NCT01503021|9862765|FG001|Dosed|Overall Study||352
8810033|NCT01503021|9862764|FG000|Completed Treatment|Overall Study||333
8810034|NCT01503021|9862765|FG001|Completed Treatment|Overall Study|One patient completed the treatment period but discontinued prior to completing the follow-up visit.|333
8810035|NCT01503021|9862764|FG000|COMPLETED|Overall Study||333
8810036|NCT01503021|9862765|FG001|COMPLETED|Overall Study||332
8810037|NCT01503021|9862764|FG000|NOT COMPLETED|Overall Study||27
8810038|NCT01503021|9862765|FG001|NOT COMPLETED|Overall Study||26
8810039|NCT01503164|9862778|FG000|STARTED|Overall Study||55
8810040|NCT01503164|9862779|FG001|STARTED|Overall Study||56
8810041|NCT01503164|9862778|FG000|COMPLETED|Overall Study||53
8810042|NCT01503164|9862779|FG001|COMPLETED|Overall Study||55
8810043|NCT01503164|9862778|FG000|NOT COMPLETED|Overall Study||2
8810044|NCT01503164|9862779|FG001|NOT COMPLETED|Overall Study||1
8810045|NCT01503229|9862785|FG000|STARTED|Overall Study||30
8810046|NCT01503229|9862785|FG000|COMPLETED|Overall Study||29
8810047|NCT01503229|9862785|FG000|NOT COMPLETED|Overall Study||1
8810048|NCT01503333|9862791|FG000|STARTED|Overall Study||777
8810049|NCT01503333|9862792|FG001|STARTED|Overall Study||766
8810050|NCT01503333|9862791|FG000|Completed Baseline|Overall Study||766
8810051|NCT01503333|9862792|FG001|Completed Baseline|Overall Study||753
8810052|NCT01503333|9862791|FG000|Completed Post-intervention|Overall Study||680
8810053|NCT01503333|9862792|FG001|Completed Post-intervention|Overall Study||706
8810054|NCT01503333|9862791|FG000|COMPLETED|Overall Study||437
8810055|NCT01503333|9862792|FG001|COMPLETED|Overall Study||461
8810056|NCT01503333|9862791|FG000|NOT COMPLETED|Overall Study||340
8810057|NCT01503333|9862792|FG001|NOT COMPLETED|Overall Study||305
8810058|NCT01503749|9862809|FG000|STARTED|Overall Study||3
8810059|NCT01503749|9862810|FG001|STARTED|Overall Study||3
8810060|NCT01503749|9862811|FG002|STARTED|Overall Study||3
8810061|NCT01503749|9862809|FG000|COMPLETED|Overall Study||3
9041639|NCT03367793|10102200|FG002|NOT COMPLETED|Treatment 2 Dispense to 2 Months Wear||1
9041640|NCT03367793|10102201|FG003|NOT COMPLETED|Treatment 2 Dispense to 2 Months Wear||0
8695682|NCT00878553|9741157|FG000|STARTED|PK Study|A total of 62 randomized patients started this parallel group, single dose PK substudy.|0
8695683|NCT00878553|9741158|FG001|STARTED|PK Study|During the PK period, 16 randomized participants received one bedtime dose of SKP-1041 placebo.|16
8695684|NCT00878553|9741159|FG002|STARTED|PK Study|During the PK period, 17 randomized participants received one bedtime dose of 10mg SKP-1041.|17
8695685|NCT00878553|9741160|FG003|STARTED|PK Study|During the PK period, 14 participants were randomized to receive one bedtime dose of 15mg SKP-1041.|14
8695686|NCT00878553|9741161|FG004|STARTED|PK Study|During the PK period, 15 randomized participants received one bedtime dose of 20mg SKP-1041.|15
8695687|NCT00878553|9741157|FG000|COMPLETED|PK Study|A total of 61 randomized patients completed this parallel group, single dose PK substudy.|0
8695688|NCT00878553|9741158|FG001|COMPLETED|PK Study||16
8695689|NCT00878553|9741159|FG002|COMPLETED|PK Study||17
8695690|NCT00878553|9741160|FG003|COMPLETED|PK Study|One patient withdrew consent after completing the Sleep Substudy and prior to starting PK substudy.|13
8810062|NCT01503749|9862810|FG001|COMPLETED|Overall Study||3
8810063|NCT01503749|9862811|FG002|COMPLETED|Overall Study||3
9041641|NCT03367793|10102202|FG004|NOT COMPLETED|Treatment 2 Dispense to 2 Months Wear||0
9041642|NCT03367793|10102203|FG005|NOT COMPLETED|Treatment 2 Dispense to 2 Months Wear||0
9041643|NCT03367793|10102198|FG000|STARTED|Treatment 3 Dispense to 2 Months Wear||5
9041644|NCT03367793|10102199|FG001|STARTED|Treatment 3 Dispense to 2 Months Wear||5
9041645|NCT03367793|10102200|FG002|STARTED|Treatment 3 Dispense to 2 Months Wear||5
9041646|NCT03367793|10102201|FG003|STARTED|Treatment 3 Dispense to 2 Months Wear||5
9041647|NCT03367793|10102202|FG004|STARTED|Treatment 3 Dispense to 2 Months Wear||5
9041648|NCT03367793|10102203|FG005|STARTED|Treatment 3 Dispense to 2 Months Wear||5
9041649|NCT03367793|10102198|FG000|COMPLETED|Treatment 3 Dispense to 2 Months Wear||5
9041650|NCT03367793|10102199|FG001|COMPLETED|Treatment 3 Dispense to 2 Months Wear||5
9041651|NCT03367793|10102200|FG002|COMPLETED|Treatment 3 Dispense to 2 Months Wear||5
9041652|NCT03367793|10102201|FG003|COMPLETED|Treatment 3 Dispense to 2 Months Wear||5
9041653|NCT03367793|10102202|FG004|COMPLETED|Treatment 3 Dispense to 2 Months Wear||5
9041654|NCT03367793|10102203|FG005|COMPLETED|Treatment 3 Dispense to 2 Months Wear||5
9041655|NCT03367793|10102198|FG000|NOT COMPLETED|Treatment 3 Dispense to 2 Months Wear||0
9041656|NCT03367793|10102199|FG001|NOT COMPLETED|Treatment 3 Dispense to 2 Months Wear||0
9041657|NCT03367793|10102200|FG002|NOT COMPLETED|Treatment 3 Dispense to 2 Months Wear||0
9041658|NCT03367793|10102201|FG003|NOT COMPLETED|Treatment 3 Dispense to 2 Months Wear||0
9041659|NCT03367793|10102202|FG004|NOT COMPLETED|Treatment 3 Dispense to 2 Months Wear||0
9041660|NCT03367793|10102203|FG005|NOT COMPLETED|Treatment 3 Dispense to 2 Months Wear||0
9041661|NCT03368053|10102214|FG000|STARTED|Overall Study||36
9041662|NCT03368053|10102214|FG000|COMPLETED|Overall Study||36
9041663|NCT03368053|10102214|FG000|NOT COMPLETED|Overall Study||0
9041664|NCT03368235|10102220|FG000|STARTED|Overall Study||11
9041665|NCT03368235|10102221|FG001|STARTED|Overall Study||10
9041666|NCT03368235|10102220|FG000|COMPLETED|Overall Study||11
9041667|NCT03368235|10102221|FG001|COMPLETED|Overall Study||10
9041668|NCT03368235|10102220|FG000|NOT COMPLETED|Overall Study||0
9041669|NCT03368235|10102221|FG001|NOT COMPLETED|Overall Study||0
9041670|NCT03368807|10102227|FG000|STARTED|Period 1 (Blinded CGM)||79
9041671|NCT03368807|10102227|FG000|Received at Least 1 Dose of Study Drug|Period 1 (Blinded CGM)||78
9041672|NCT03368807|10102227|FG000|COMPLETED|Period 1 (Blinded CGM)||73
9041673|NCT03368807|10102227|FG000|NOT COMPLETED|Period 1 (Blinded CGM)||6
9041674|NCT03368807|10102227|FG000|STARTED|Period 2 (Unblinded CGM)||73
9041675|NCT03368807|10102227|FG000|COMPLETED|Period 2 (Unblinded CGM)||73
9041676|NCT03368807|10102227|FG000|NOT COMPLETED|Period 2 (Unblinded CGM)||0
9041677|NCT03368859|10102235|FG000|STARTED|Overall Study||36
9041678|NCT03368859|10102236|FG001|STARTED|Overall Study||34
9041679|NCT03368859|10102235|FG000|COMPLETED|Overall Study||0
9041680|NCT03368859|10102236|FG001|COMPLETED|Overall Study||0
9041681|NCT03368859|10102235|FG000|NOT COMPLETED|Overall Study||36
9041682|NCT03368859|10102236|FG001|NOT COMPLETED|Overall Study||34
9041683|NCT03368898|10102245|FG000|STARTED|Overall Study||37
9041684|NCT03368898|10102246|FG001|STARTED|Overall Study||33
9041685|NCT03368898|10102247|FG002|STARTED|Overall Study||34
9041686|NCT03368898|10102245|FG000|COMPLETED|Overall Study||37
9041687|NCT03368898|10102246|FG001|COMPLETED|Overall Study||33
9041688|NCT03368898|10102247|FG002|COMPLETED|Overall Study||34
9041689|NCT03368898|10102245|FG000|NOT COMPLETED|Overall Study||0
9041690|NCT03368898|10102246|FG001|NOT COMPLETED|Overall Study||0
9041691|NCT03368898|10102247|FG002|NOT COMPLETED|Overall Study||0
9041692|NCT03369158|10102257|FG000|STARTED|Overall Study||14
9041693|NCT03369158|10102258|FG001|STARTED|Overall Study||15
9041694|NCT03369158|10102257|FG000|COMPLETED|Overall Study||14
9041695|NCT03369158|10102258|FG001|COMPLETED|Overall Study||15
9041696|NCT03369158|10102257|FG000|NOT COMPLETED|Overall Study||0
9041697|NCT03369158|10102258|FG001|NOT COMPLETED|Overall Study||0
9041698|NCT03369236|10102266|FG000|STARTED|Double-blind Treatment Period||6
9041699|NCT03369236|10102267|FG001|STARTED|Double-blind Treatment Period||7
8695691|NCT00878553|9741161|FG004|COMPLETED|PK Study||15
8695692|NCT00878553|9741157|FG000|NOT COMPLETED|PK Study||0
8695693|NCT00878553|9741158|FG001|NOT COMPLETED|PK Study||0
8695694|NCT00878553|9741159|FG002|NOT COMPLETED|PK Study||0
9041700|NCT03369236|10102266|FG000|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||6
9041701|NCT03369236|10102267|FG001|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||7
9041702|NCT03369236|10102266|FG000|COMPLETED|Double-blind Treatment Period||6
9041703|NCT03369236|10102267|FG001|COMPLETED|Double-blind Treatment Period||6
9041704|NCT03369236|10102266|FG000|NOT COMPLETED|Double-blind Treatment Period||0
9041705|NCT03369236|10102267|FG001|NOT COMPLETED|Double-blind Treatment Period||1
9041706|NCT03369236|10102266|FG000|STARTED|Open-label Extension Period||6
9041707|NCT03369236|10102267|FG001|STARTED|Open-label Extension Period||6
9041708|NCT03369236|10102266|FG000|Received at Least 1 Dose of Study Drug|Open-label Extension Period|All participants received danicopan in the open-label extension period.|6
9041709|NCT03369236|10102267|FG001|Received at Least 1 Dose of Study Drug|Open-label Extension Period|All participants received danicopan in the open-label extension period.|6
9041710|NCT03369236|10102266|FG000|COMPLETED|Open-label Extension Period||1
9041711|NCT03369236|10102267|FG001|COMPLETED|Open-label Extension Period||0
9041712|NCT03369236|10102266|FG000|NOT COMPLETED|Open-label Extension Period||5
9041713|NCT03369236|10102267|FG001|NOT COMPLETED|Open-label Extension Period||6
9041714|NCT03369340|10102279|FG000|STARTED|Day 2||3
9041715|NCT03369340|10102280|FG001|STARTED|Day 2||3
9041716|NCT03369340|10102281|FG002|STARTED|Day 2||3
9041717|NCT03369340|10102282|FG003|STARTED|Day 2||3
9041718|NCT03369340|10102283|FG004|STARTED|Day 2||3
9041719|NCT03369340|10102284|FG005|STARTED|Day 2||3
9041720|NCT03369340|10102279|FG000|COMPLETED|Day 2||3
9041721|NCT03369340|10102280|FG001|COMPLETED|Day 2||3
9041722|NCT03369340|10102281|FG002|COMPLETED|Day 2||3
9041723|NCT03369340|10102282|FG003|COMPLETED|Day 2||3
9041724|NCT03369340|10102283|FG004|COMPLETED|Day 2||3
9041725|NCT03369340|10102284|FG005|COMPLETED|Day 2||3
9041726|NCT03369340|10102279|FG000|NOT COMPLETED|Day 2||0
9041727|NCT03369340|10102280|FG001|NOT COMPLETED|Day 2||0
9041728|NCT03369340|10102281|FG002|NOT COMPLETED|Day 2||0
9041729|NCT03369340|10102282|FG003|NOT COMPLETED|Day 2||0
9041730|NCT03369340|10102283|FG004|NOT COMPLETED|Day 2||0
9041731|NCT03369340|10102284|FG005|NOT COMPLETED|Day 2||0
9041732|NCT03369340|10102279|FG000|STARTED|Day 3||3
9041733|NCT03369340|10102280|FG001|STARTED|Day 3||3
9041734|NCT03369340|10102281|FG002|STARTED|Day 3||3
9041735|NCT03369340|10102282|FG003|STARTED|Day 3||3
9041736|NCT03369340|10102283|FG004|STARTED|Day 3||3
9041737|NCT03369340|10102284|FG005|STARTED|Day 3||3
9041738|NCT03369340|10102279|FG000|COMPLETED|Day 3||3
9041739|NCT03369340|10102280|FG001|COMPLETED|Day 3||3
9041740|NCT03369340|10102281|FG002|COMPLETED|Day 3||3
9041741|NCT03369340|10102282|FG003|COMPLETED|Day 3||3
9041742|NCT03369340|10102283|FG004|COMPLETED|Day 3||3
9041743|NCT03369340|10102284|FG005|COMPLETED|Day 3||3
9041744|NCT03369340|10102279|FG000|NOT COMPLETED|Day 3||0
9041745|NCT03369340|10102280|FG001|NOT COMPLETED|Day 3||0
9041746|NCT03369340|10102281|FG002|NOT COMPLETED|Day 3||0
9041747|NCT03369340|10102282|FG003|NOT COMPLETED|Day 3||0
9041748|NCT03369340|10102283|FG004|NOT COMPLETED|Day 3||0
9041749|NCT03369340|10102284|FG005|NOT COMPLETED|Day 3||0
9041750|NCT03369340|10102279|FG000|STARTED|Day 4||3
9041751|NCT03369340|10102280|FG001|STARTED|Day 4||3
9041752|NCT03369340|10102281|FG002|STARTED|Day 4||3
9041753|NCT03369340|10102282|FG003|STARTED|Day 4||3
9041754|NCT03369340|10102283|FG004|STARTED|Day 4||3
9041755|NCT03369340|10102284|FG005|STARTED|Day 4||3
9041756|NCT03369340|10102279|FG000|COMPLETED|Day 4||3
9041757|NCT03369340|10102280|FG001|COMPLETED|Day 4||3
9041758|NCT03369340|10102281|FG002|COMPLETED|Day 4||3
9041759|NCT03369340|10102282|FG003|COMPLETED|Day 4||3
9041760|NCT03369340|10102283|FG004|COMPLETED|Day 4||3
9041761|NCT03369340|10102284|FG005|COMPLETED|Day 4||3
9041762|NCT03369340|10102279|FG000|NOT COMPLETED|Day 4||0
9041763|NCT03369340|10102280|FG001|NOT COMPLETED|Day 4||0
9041764|NCT03369340|10102281|FG002|NOT COMPLETED|Day 4||0
9041765|NCT03369340|10102282|FG003|NOT COMPLETED|Day 4||0
9041766|NCT03369340|10102283|FG004|NOT COMPLETED|Day 4||0
9041767|NCT03369340|10102284|FG005|NOT COMPLETED|Day 4||0
9041768|NCT03369418|10102296|FG000|STARTED|Overall Study||16
9041769|NCT03369418|10102297|FG001|STARTED|Overall Study||14
9041770|NCT03369418|10102296|FG000|COMPLETED|Overall Study||13
9041771|NCT03369418|10102297|FG001|COMPLETED|Overall Study||11
9041772|NCT03369418|10102296|FG000|NOT COMPLETED|Overall Study||3
9041773|NCT03369418|10102297|FG001|NOT COMPLETED|Overall Study||3
9041774|NCT03369704|10102305|FG000|STARTED|Treatment Epoch||162
9041775|NCT03369704|10102306|FG001|STARTED|Treatment Epoch||175
9041776|NCT03369704|10102305|FG000|COMPLETED|Treatment Epoch||158
9041777|NCT03369704|10102306|FG001|COMPLETED|Treatment Epoch||172
8695695|NCT00878553|9741160|FG003|NOT COMPLETED|PK Study||1
9041778|NCT03369704|10102305|FG000|NOT COMPLETED|Treatment Epoch||4
9041779|NCT03369704|10102306|FG001|NOT COMPLETED|Treatment Epoch||3
9041780|NCT03369704|10102305|FG000|STARTED|Follow-up Epoch||161
9041781|NCT03369704|10102306|FG001|STARTED|Follow-up Epoch||174
9041782|NCT03369704|10102305|FG000|COMPLETED|Follow-up Epoch||160
9041783|NCT03369704|10102306|FG001|COMPLETED|Follow-up Epoch||174
9041784|NCT03369704|10102305|FG000|NOT COMPLETED|Follow-up Epoch||1
9041785|NCT03369704|10102306|FG001|NOT COMPLETED|Follow-up Epoch||0
9041786|NCT03369756|10102312|FG000|STARTED|Overall Study||43
8695696|NCT00878553|9741161|FG004|NOT COMPLETED|PK Study||0
8695697|NCT00878644|9741180|FG000|STARTED|Overall Study||155
8695698|NCT00878644|9741181|FG001|STARTED|Overall Study||140
8695699|NCT00878644|9741180|FG000|COMPLETED|Overall Study||151
8695700|NCT00878644|9741181|FG001|COMPLETED|Overall Study||136
8695701|NCT00878644|9741180|FG000|NOT COMPLETED|Overall Study||4
8695702|NCT00878644|9741181|FG001|NOT COMPLETED|Overall Study||4
8695703|NCT00878709|9741189|FG000|STARTED|Overall Study||1420
8695704|NCT00878709|9741190|FG001|STARTED|Overall Study||1420
8695705|NCT00878709|9741189|FG000|COMPLETED|Overall Study||1095
8695706|NCT00878709|9741190|FG001|COMPLETED|Overall Study||1183
8695707|NCT00878709|9741189|FG000|NOT COMPLETED|Overall Study||325
8695708|NCT00878709|9741190|FG001|NOT COMPLETED|Overall Study||237
8695709|NCT00878722|9741205|FG000|STARTED|Overall Study||3
8695710|NCT00878722|9741206|FG001|STARTED|Overall Study||3
8695711|NCT00878722|9741207|FG002|STARTED|Overall Study||3
8695712|NCT00878722|9741208|FG003|STARTED|Overall Study||9
9041787|NCT03369756|10102312|FG000|COMPLETED|Overall Study|36 completed 4 weeks of treatment; 40 were considered statistical completers|36
9041788|NCT03369756|10102312|FG000|NOT COMPLETED|Overall Study||7
9041789|NCT03369951|10102316|FG000|STARTED|Overall Study||58
9041790|NCT03369951|10102316|FG000|Received Study Drug|Overall Study||57
9041791|NCT03369951|10102316|FG000|COMPLETED|Overall Study||52
9041792|NCT03369951|10102316|FG000|NOT COMPLETED|Overall Study||6
9041793|NCT03370042|10102322|FG000|STARTED|Overall Study||10
9041794|NCT03370042|10102323|FG001|STARTED|Overall Study||10
9041795|NCT03370042|10102322|FG000|COMPLETED|Overall Study||10
9041796|NCT03370042|10102323|FG001|COMPLETED|Overall Study||10
9041797|NCT03370042|10102322|FG000|NOT COMPLETED|Overall Study||0
9041798|NCT03370042|10102323|FG001|NOT COMPLETED|Overall Study||0
9041799|NCT03370289|10102333|FG000|STARTED|Overall Study||55
9041800|NCT03370289|10102333|FG000|COMPLETED|Overall Study||50
9041801|NCT03370289|10102333|FG000|NOT COMPLETED|Overall Study||5
9041802|NCT03370302|10102343|FG000|STARTED|Dose Escalation Phase||3
9041803|NCT03370302|10102344|FG001|STARTED|Dose Escalation Phase||6
9041804|NCT03370302|10102345|FG002|STARTED|Dose Escalation Phase||7
9041805|NCT03370302|10102346|FG003|STARTED|Dose Escalation Phase||0
9041806|NCT03370302|10102347|FG004|STARTED|Dose Escalation Phase||3
9041807|NCT03370302|10102348|FG005|STARTED|Dose Escalation Phase||3
9041808|NCT03370302|10102343|FG000|COMPLETED|Dose Escalation Phase||0
9041809|NCT03370302|10102344|FG001|COMPLETED|Dose Escalation Phase||0
9041810|NCT03370302|10102345|FG002|COMPLETED|Dose Escalation Phase||0
9041811|NCT03370302|10102346|FG003|COMPLETED|Dose Escalation Phase||0
9041812|NCT03370302|10102347|FG004|COMPLETED|Dose Escalation Phase||0
9041813|NCT03370302|10102348|FG005|COMPLETED|Dose Escalation Phase||0
9041814|NCT03370302|10102343|FG000|NOT COMPLETED|Dose Escalation Phase||3
9041815|NCT03370302|10102344|FG001|NOT COMPLETED|Dose Escalation Phase||6
9041816|NCT03370302|10102345|FG002|NOT COMPLETED|Dose Escalation Phase||7
9041817|NCT03370302|10102346|FG003|NOT COMPLETED|Dose Escalation Phase||0
9041818|NCT03370302|10102347|FG004|NOT COMPLETED|Dose Escalation Phase||3
9041819|NCT03370302|10102348|FG005|NOT COMPLETED|Dose Escalation Phase||3
9041820|NCT03370302|10102343|FG000|STARTED|Dose Expansion Phase||0
9041821|NCT03370302|10102344|FG001|STARTED|Dose Expansion Phase||0
9041822|NCT03370302|10102345|FG002|STARTED|Dose Expansion Phase||0
9041823|NCT03370302|10102346|FG003|STARTED|Dose Expansion Phase||6
9041824|NCT03370302|10102347|FG004|STARTED|Dose Expansion Phase||0
9041825|NCT03370302|10102348|FG005|STARTED|Dose Expansion Phase||0
9041826|NCT03370302|10102343|FG000|COMPLETED|Dose Expansion Phase||0
9041827|NCT03370302|10102344|FG001|COMPLETED|Dose Expansion Phase||0
9041828|NCT03370302|10102345|FG002|COMPLETED|Dose Expansion Phase||0
9041829|NCT03370302|10102346|FG003|COMPLETED|Dose Expansion Phase||0
9041830|NCT03370302|10102347|FG004|COMPLETED|Dose Expansion Phase||0
9041831|NCT03370302|10102348|FG005|COMPLETED|Dose Expansion Phase||0
9041832|NCT03370302|10102343|FG000|NOT COMPLETED|Dose Expansion Phase||0
9041833|NCT03370302|10102344|FG001|NOT COMPLETED|Dose Expansion Phase||0
9041834|NCT03370302|10102345|FG002|NOT COMPLETED|Dose Expansion Phase||0
9041835|NCT03370302|10102346|FG003|NOT COMPLETED|Dose Expansion Phase||6
9041836|NCT03370302|10102347|FG004|NOT COMPLETED|Dose Expansion Phase||0
9041837|NCT03370302|10102348|FG005|NOT COMPLETED|Dose Expansion Phase||0
9041838|NCT03370419|10102366|FG000|STARTED|Overall Study||40
9041839|NCT03370419|10102366|FG000|COMPLETED|Overall Study||24
9041840|NCT03370419|10102366|FG000|NOT COMPLETED|Overall Study||16
9041841|NCT03370471|10102372|FG000|STARTED|Overall Study||23
9041842|NCT03370471|10102373|FG001|STARTED|Overall Study||5
9041843|NCT03370471|10102372|FG000|COMPLETED|Overall Study||16
9041844|NCT03370471|10102373|FG001|COMPLETED|Overall Study||3
9041845|NCT03370471|10102372|FG000|NOT COMPLETED|Overall Study||7
8695713|NCT00878722|9741209|FG004|STARTED|Overall Study||7
8695714|NCT00878722|9741210|FG005|STARTED|Overall Study||3
8695715|NCT00878722|9741211|FG006|STARTED|Overall Study||6
8695716|NCT00878722|9741212|FG007|STARTED|Overall Study||7
8695717|NCT00878722|9741205|FG000|COMPLETED|Overall Study||0
8695718|NCT00878722|9741206|FG001|COMPLETED|Overall Study||0
9041846|NCT03370471|10102373|FG001|NOT COMPLETED|Overall Study||2
9041847|NCT03370770|10102381|FG000|STARTED|Overall Study||204
9041848|NCT03370770|10102381|FG000|COMPLETED|Overall Study||98
9041849|NCT03370770|10102381|FG000|NOT COMPLETED|Overall Study||106
9041850|NCT03371355|10102389|FG000|STARTED|Overall Study||27
9041851|NCT03371355|10102390|FG001|STARTED|Overall Study||26
8695719|NCT00878722|9741207|FG002|COMPLETED|Overall Study||0
8695720|NCT00878722|9741208|FG003|COMPLETED|Overall Study||0
8695721|NCT00878722|9741209|FG004|COMPLETED|Overall Study||0
8695722|NCT00878722|9741210|FG005|COMPLETED|Overall Study||1
8925398|NCT02257632|9986522|FG001|NOT COMPLETED|Overall Study||3
8925399|NCT02257684|9986530|FG000|STARTED|Overall Study||4
8925400|NCT02257684|9986530|FG000|COMPLETED|Overall Study||0
8925401|NCT02257684|9986530|FG000|NOT COMPLETED|Overall Study||4
8925402|NCT02257957|9986536|FG000|STARTED|Overall Study||15
9041852|NCT03371355|10102391|FG002|STARTED|Overall Study||26
9041853|NCT03371355|10102392|FG003|STARTED|Overall Study||26
9041854|NCT03371355|10102389|FG000|COMPLETED|Overall Study||26
9041855|NCT03371355|10102390|FG001|COMPLETED|Overall Study||24
8925403|NCT02257957|9986537|FG001|STARTED|Overall Study||15
8925404|NCT02257957|9986536|FG000|COMPLETED|Overall Study||15
8925405|NCT02257957|9986537|FG001|COMPLETED|Overall Study||15
8925406|NCT02257957|9986536|FG000|NOT COMPLETED|Overall Study||0
8925407|NCT02257957|9986537|FG001|NOT COMPLETED|Overall Study||0
8925408|NCT02257970|9986547|FG000|STARTED|Part 1||50
8925409|NCT02257970|9986548|FG001|STARTED|Part 1||0
8925410|NCT02257970|9986549|FG002|STARTED|Part 1||0
8925411|NCT02257970|9986550|FG003|STARTED|Part 1||0
8925412|NCT02257970|9986547|FG000|COMPLETED|Part 1||50
8925413|NCT02257970|9986548|FG001|COMPLETED|Part 1||0
8925414|NCT02257970|9986549|FG002|COMPLETED|Part 1||0
8925415|NCT02257970|9986550|FG003|COMPLETED|Part 1||0
8925416|NCT02257970|9986547|FG000|NOT COMPLETED|Part 1||0
8925417|NCT02257970|9986548|FG001|NOT COMPLETED|Part 1||0
8925418|NCT02257970|9986549|FG002|NOT COMPLETED|Part 1||0
8925419|NCT02257970|9986550|FG003|NOT COMPLETED|Part 1||0
8925420|NCT02257970|9986547|FG000|STARTED|Part 2||0
8925421|NCT02257970|9986548|FG001|STARTED|Part 2||23
8925422|NCT02257970|9986549|FG002|STARTED|Part 2||0
8925423|NCT02257970|9986550|FG003|STARTED|Part 2||0
8925424|NCT02257970|9986547|FG000|COMPLETED|Part 2||0
8925425|NCT02257970|9986548|FG001|COMPLETED|Part 2||16
8925426|NCT02257970|9986549|FG002|COMPLETED|Part 2||0
8925427|NCT02257970|9986550|FG003|COMPLETED|Part 2||0
8925428|NCT02257970|9986547|FG000|NOT COMPLETED|Part 2||0
8925429|NCT02257970|9986548|FG001|NOT COMPLETED|Part 2||7
8925430|NCT02257970|9986549|FG002|NOT COMPLETED|Part 2||0
8925431|NCT02257970|9986550|FG003|NOT COMPLETED|Part 2||0
8925432|NCT02257970|9986547|FG000|STARTED|Part 3||0
8925433|NCT02257970|9986548|FG001|STARTED|Part 3||0
8925434|NCT02257970|9986549|FG002|STARTED|Part 3||23
8925435|NCT02257970|9986550|FG003|STARTED|Part 3||21
8925436|NCT02257970|9986547|FG000|COMPLETED|Part 3||0
8925437|NCT02257970|9986548|FG001|COMPLETED|Part 3||0
8925438|NCT02257970|9986549|FG002|COMPLETED|Part 3||16
8925439|NCT02257970|9986550|FG003|COMPLETED|Part 3||14
8925440|NCT02257970|9986547|FG000|NOT COMPLETED|Part 3||0
8925441|NCT02257970|9986548|FG001|NOT COMPLETED|Part 3||0
8925442|NCT02257970|9986549|FG002|NOT COMPLETED|Part 3||7
8925443|NCT02257970|9986550|FG003|NOT COMPLETED|Part 3||7
8925444|NCT02258074|9986573|FG000|STARTED|Overall Study||53
8925445|NCT02258074|9986574|FG001|STARTED|Overall Study||50
8925446|NCT02258074|9986575|FG002|STARTED|Overall Study||51
8925447|NCT02258074|9986576|FG003|STARTED|Overall Study||51
8925448|NCT02258074|9986573|FG000|COMPLETED|Overall Study||52
8925449|NCT02258074|9986574|FG001|COMPLETED|Overall Study||50
8925450|NCT02258074|9986575|FG002|COMPLETED|Overall Study||51
8925451|NCT02258074|9986576|FG003|COMPLETED|Overall Study||51
8925452|NCT02258074|9986573|FG000|NOT COMPLETED|Overall Study||1
8925453|NCT02258074|9986574|FG001|NOT COMPLETED|Overall Study||0
8925454|NCT02258074|9986575|FG002|NOT COMPLETED|Overall Study||0
8925455|NCT02258074|9986576|FG003|NOT COMPLETED|Overall Study||0
8925456|NCT02258139|9986586|FG000|STARTED|Overall Study||38
8925457|NCT02258139|9986586|FG000|COMPLETED|Overall Study||30
8925458|NCT02258139|9986586|FG000|NOT COMPLETED|Overall Study||8
8925459|NCT02258152|9986594|FG000|STARTED|Overall Study||44
8925460|NCT02258152|9986595|FG001|STARTED|Overall Study||38
8925461|NCT02258152|9986594|FG000|COMPLETED|Overall Study||38
8925462|NCT02258152|9986595|FG001|COMPLETED|Overall Study||34
8925463|NCT02258152|9986594|FG000|NOT COMPLETED|Overall Study||6
8925464|NCT02258152|9986595|FG001|NOT COMPLETED|Overall Study||4
8925465|NCT02258217|9986601|FG000|STARTED|Overall Study||30
8925466|NCT02258217|9986601|FG000|COMPLETED|Overall Study||30
8925467|NCT02258217|9986601|FG000|NOT COMPLETED|Overall Study||0
8925468|NCT02258256|9986605|FG000|STARTED|Overall Study||11
8925469|NCT02258256|9986605|FG000|COMPLETED|Overall Study||11
8925470|NCT02258256|9986605|FG000|NOT COMPLETED|Overall Study||0
8948167|NCT02427737|10010506|FG001|NOT COMPLETED|OSU Baseline Q4FY15||216
8948168|NCT02427737|10010505|FG000|STARTED|OSU Q1FY16 (First Post-Training Quarter)||4030
8948169|NCT02427737|10010506|FG001|STARTED|OSU Q1FY16 (First Post-Training Quarter)||3246
8948170|NCT02427737|10010505|FG000|COMPLETED|OSU Q1FY16 (First Post-Training Quarter)||3815
8948171|NCT02427737|10010506|FG001|COMPLETED|OSU Q1FY16 (First Post-Training Quarter)||3032
8948172|NCT02427737|10010505|FG000|NOT COMPLETED|OSU Q1FY16 (First Post-Training Quarter)||215
8948173|NCT02427737|10010506|FG001|NOT COMPLETED|OSU Q1FY16 (First Post-Training Quarter)||214
8948174|NCT02427737|10010505|FG000|STARTED|OSU Q2FY16(Second Post Training Quarter)||4121
8948175|NCT02427737|10010506|FG001|STARTED|OSU Q2FY16(Second Post Training Quarter)||3070
8948176|NCT02427737|10010505|FG000|COMPLETED|OSU Q2FY16(Second Post Training Quarter)||3907
8948177|NCT02427737|10010506|FG001|COMPLETED|OSU Q2FY16(Second Post Training Quarter)||2857
8695723|NCT00878722|9741211|FG006|COMPLETED|Overall Study||0
8695724|NCT00878722|9741212|FG007|COMPLETED|Overall Study||0
8948178|NCT02427737|10010505|FG000|NOT COMPLETED|OSU Q2FY16(Second Post Training Quarter)||214
8948179|NCT02427737|10010506|FG001|NOT COMPLETED|OSU Q2FY16(Second Post Training Quarter)||213
8810064|NCT01503749|9862809|FG000|NOT COMPLETED|Overall Study||0
8810065|NCT01503749|9862810|FG001|NOT COMPLETED|Overall Study||0
8810066|NCT01503749|9862811|FG002|NOT COMPLETED|Overall Study||0
8810067|NCT01504204|9862821|FG000|STARTED|Overall Study||10
8810068|NCT01504204|9862822|FG001|STARTED|Overall Study||10
8810069|NCT01504204|9862821|FG000|COMPLETED|Overall Study||9
8810070|NCT01504204|9862822|FG001|COMPLETED|Overall Study||9
8810071|NCT01504204|9862821|FG000|NOT COMPLETED|Overall Study||1
8810072|NCT01504204|9862822|FG001|NOT COMPLETED|Overall Study||1
8810073|NCT01504412|9862833|FG000|STARTED|Overall Study||89
8810074|NCT01504412|9862834|FG001|STARTED|Overall Study||87
8810075|NCT01504412|9862835|FG002|STARTED|Overall Study||90
8810076|NCT01504412|9862836|FG003|STARTED|Overall Study||94
8810077|NCT01504412|9862837|FG004|STARTED|Overall Study||90
8810078|NCT01504412|9862833|FG000|COMPLETED|Overall Study||84
8810079|NCT01504412|9862834|FG001|COMPLETED|Overall Study||75
8810080|NCT01504412|9862835|FG002|COMPLETED|Overall Study||86
8810081|NCT01504412|9862836|FG003|COMPLETED|Overall Study||75
8810082|NCT01504412|9862837|FG004|COMPLETED|Overall Study||77
8810083|NCT01504412|9862833|FG000|NOT COMPLETED|Overall Study||5
8810084|NCT01504412|9862834|FG001|NOT COMPLETED|Overall Study||12
8810085|NCT01504412|9862835|FG002|NOT COMPLETED|Overall Study||4
8810086|NCT01504412|9862836|FG003|NOT COMPLETED|Overall Study||19
8810087|NCT01504412|9862837|FG004|NOT COMPLETED|Overall Study||13
8810088|NCT01504477|9862849|FG000|STARTED|Overall Study||6
8810089|NCT01504477|9862849|FG000|COMPLETED|Overall Study||6
8810090|NCT01504477|9862849|FG000|NOT COMPLETED|Overall Study||0
8810091|NCT01504672|9862855|FG000|STARTED|Overall Study||230
8810092|NCT01504672|9862856|FG001|STARTED|Overall Study||230
8810093|NCT01504672|9862855|FG000|COMPLETED|Overall Study||212
9041856|NCT03371355|10102391|FG002|COMPLETED|Overall Study||22
9041857|NCT03371355|10102392|FG003|COMPLETED|Overall Study||19
9041858|NCT03371355|10102389|FG000|NOT COMPLETED|Overall Study||1
9041859|NCT03371355|10102390|FG001|NOT COMPLETED|Overall Study||2
9041860|NCT03371355|10102391|FG002|NOT COMPLETED|Overall Study||4
9041861|NCT03371355|10102392|FG003|NOT COMPLETED|Overall Study||7
9041862|NCT03371381|10102406|FG000|STARTED|Overall Study||12
9041863|NCT03371381|10102406|FG000|COMPLETED|Overall Study||0
9041864|NCT03371381|10102406|FG000|NOT COMPLETED|Overall Study||12
9041865|NCT03371459|10102410|FG000|STARTED|Period 1||23
9041866|NCT03371459|10102411|FG001|STARTED|Period 1||23
9041867|NCT03371459|10102410|FG000|COMPLETED|Period 1||23
9041868|NCT03371459|10102411|FG001|COMPLETED|Period 1||23
9041869|NCT03371459|10102410|FG000|NOT COMPLETED|Period 1||0
9041870|NCT03371459|10102411|FG001|NOT COMPLETED|Period 1||0
9041871|NCT03371459|10102410|FG000|STARTED|Washout||23
9041872|NCT03371459|10102411|FG001|STARTED|Washout||23
9041873|NCT03371459|10102410|FG000|COMPLETED|Washout||23
8810094|NCT01504672|9862856|FG001|COMPLETED|Overall Study||217
8810095|NCT01504672|9862855|FG000|NOT COMPLETED|Overall Study||18
8810096|NCT01504672|9862856|FG001|NOT COMPLETED|Overall Study||13
8810097|NCT01504711|9862864|FG000|STARTED|Overall Study||30
8810098|NCT01504711|9862864|FG000|COMPLETED|Overall Study||27
9041874|NCT03371459|10102411|FG001|COMPLETED|Washout||22
9041875|NCT03371459|10102410|FG000|NOT COMPLETED|Washout||0
9041876|NCT03371459|10102411|FG001|NOT COMPLETED|Washout||1
9041877|NCT03371459|10102410|FG000|STARTED|Period 2||23
9041878|NCT03371459|10102411|FG001|STARTED|Period 2||22
9041879|NCT03371459|10102410|FG000|COMPLETED|Period 2||23
9041880|NCT03371459|10102411|FG001|COMPLETED|Period 2||22
9041881|NCT03371459|10102410|FG000|NOT COMPLETED|Period 2||0
9041882|NCT03371459|10102411|FG001|NOT COMPLETED|Period 2||0
9041883|NCT03371732|10102419|FG000|STARTED|Overall Study||51
9041884|NCT03371732|10102420|FG001|STARTED|Overall Study||53
9041885|NCT03371732|10102419|FG000|COMPLETED|Overall Study||39
9041886|NCT03371732|10102420|FG001|COMPLETED|Overall Study||46
9041887|NCT03371732|10102419|FG000|NOT COMPLETED|Overall Study||12
9041888|NCT03371732|10102420|FG001|NOT COMPLETED|Overall Study||7
9041889|NCT03371836|10102428|FG000|STARTED|Overall Study||20
9041890|NCT03371836|10102428|FG000|COMPLETED|Overall Study||18
9041891|NCT03371836|10102428|FG000|NOT COMPLETED|Overall Study||2
9041892|NCT03372083|10102432|FG000|STARTED|Overall Study||44
9041893|NCT03372083|10102432|FG000|COMPLETED|Overall Study||39
9041894|NCT03372083|10102432|FG000|NOT COMPLETED|Overall Study||5
9041895|NCT03372096|10102436|FG000|STARTED|Overall Study||18
9041896|NCT03372096|10102436|FG000|Received Intervention|Overall Study||10
9041897|NCT03372096|10102436|FG000|COMPLETED|Overall Study||10
9041898|NCT03372096|10102436|FG000|NOT COMPLETED|Overall Study||8
9041899|NCT03372369|10102445|FG000|STARTED|Qualification Period||495
8810099|NCT01504711|9862864|FG000|NOT COMPLETED|Overall Study||3
8810100|NCT01504841|9862871|FG000|STARTED|Overall Study||20
8810101|NCT01504841|9862872|FG001|STARTED|Overall Study||6
8810102|NCT01504841|9862873|FG002|STARTED|Overall Study|No enrollments occurred into Cohort 3 during the study.|0
8810103|NCT01504841|9862871|FG000|COMPLETED|Overall Study||19
8810104|NCT01504841|9862872|FG001|COMPLETED|Overall Study||5
8810105|NCT01504841|9862873|FG002|COMPLETED|Overall Study||0
8810106|NCT01504841|9862871|FG000|NOT COMPLETED|Overall Study||1
8810107|NCT01504841|9862872|FG001|NOT COMPLETED|Overall Study||1
9041900|NCT03372369|10102446|FG001|STARTED|Qualification Period||495
9041901|NCT03372369|10102445|FG000|COMPLETED|Qualification Period||469
9041902|NCT03372369|10102446|FG001|COMPLETED|Qualification Period||473
9041903|NCT03372369|10102445|FG000|NOT COMPLETED|Qualification Period||26
9041904|NCT03372369|10102446|FG001|NOT COMPLETED|Qualification Period||22
8810108|NCT01504841|9862873|FG002|NOT COMPLETED|Overall Study||0
8810109|NCT01504854|9862882|FG000|STARTED|Overall Study||64
8810110|NCT01504854|9862883|FG001|STARTED|Overall Study||55
8810111|NCT01504854|9862882|FG000|COMPLETED|Overall Study||56
8810112|NCT01504854|9862883|FG001|COMPLETED|Overall Study||48
8810113|NCT01504854|9862882|FG000|NOT COMPLETED|Overall Study||8
8810114|NCT01504854|9862883|FG001|NOT COMPLETED|Overall Study||7
8810115|NCT01504867|9862891|FG000|STARTED|Overall Study||202
8810116|NCT01504867|9862892|FG001|STARTED|Overall Study||198
8810117|NCT01504867|9862891|FG000|COMPLETED|Overall Study||195
8810118|NCT01504867|9862892|FG001|COMPLETED|Overall Study||195
8810119|NCT01504867|9862891|FG000|NOT COMPLETED|Overall Study||7
8810120|NCT01504867|9862892|FG001|NOT COMPLETED|Overall Study||3
8810121|NCT01504958|9862901|FG000|STARTED|Overall Study|Baseline clinical, cognitive, and behavioral assessments: TMS-EMG measures, MRI scan, randomization.|10
8810122|NCT01504958|9862902|FG001|STARTED|Overall Study|Baseline clinical, cognitive, and behavioral assessments: TMS-EMG measures, MRI scan, randomization.|6
8810123|NCT01504958|9862903|FG002|STARTED|Overall Study|Baseline clinical, cognitive, and behavioral assessments: TMS-EMG measures, MRI scan, randomization.|6
8810124|NCT01504958|9862901|FG000|COMPLETED|Overall Study|1 Month Post-Treatment Follow Up|10
8810125|NCT01504958|9862902|FG001|COMPLETED|Overall Study|1 Month Post-Treatment Follow Up|6
8810126|NCT01504958|9862903|FG002|COMPLETED|Overall Study|1 Month Post-Treatment Follow Up|6
8810127|NCT01504958|9862901|FG000|NOT COMPLETED|Overall Study||0
8810128|NCT01504958|9862902|FG001|NOT COMPLETED|Overall Study||0
8810129|NCT01504958|9862903|FG002|NOT COMPLETED|Overall Study||0
8810130|NCT01504971|9862911|FG000|STARTED|Overall Study||95
8810131|NCT01504971|9862911|FG000|COMPLETED|Overall Study||82
8810132|NCT01504971|9862911|FG000|NOT COMPLETED|Overall Study||13
8810133|NCT01504997|9862919|FG000|STARTED|Overall Study||18
9041905|NCT03372369|10102445|FG000|STARTED|Intervention and Follow-Up Period||469
9041906|NCT03372369|10102446|FG001|STARTED|Intervention and Follow-Up Period||473
9041907|NCT03372369|10102445|FG000|COMPLETED|Intervention and Follow-Up Period||466
9041908|NCT03372369|10102446|FG001|COMPLETED|Intervention and Follow-Up Period||470
9041909|NCT03372369|10102445|FG000|NOT COMPLETED|Intervention and Follow-Up Period||3
9041910|NCT03372369|10102446|FG001|NOT COMPLETED|Intervention and Follow-Up Period||3
9041911|NCT03372382|10102454|FG000|STARTED|Overall Study||85
9041912|NCT03372382|10102455|FG001|STARTED|Overall Study||85
9041913|NCT03372382|10102454|FG000|COMPLETED|Overall Study||76
9041914|NCT03372382|10102455|FG001|COMPLETED|Overall Study||81
9041915|NCT03372382|10102454|FG000|NOT COMPLETED|Overall Study||9
9041916|NCT03372382|10102455|FG001|NOT COMPLETED|Overall Study||4
9041917|NCT03372434|10102466|FG000|STARTED|Overall Study||78
9041918|NCT03372434|10102467|FG001|STARTED|Overall Study||73
9041919|NCT03372434|10102468|FG002|STARTED|Overall Study||74
9041920|NCT03372434|10102466|FG000|1 Month Follow-up|Overall Study||76
9041921|NCT03372434|10102467|FG001|1 Month Follow-up|Overall Study||72
9041922|NCT03372434|10102468|FG002|1 Month Follow-up|Overall Study||73
9041923|NCT03372434|10102466|FG000|COMPLETED|Overall Study||76
9041924|NCT03372434|10102467|FG001|COMPLETED|Overall Study||70
9041925|NCT03372434|10102468|FG002|COMPLETED|Overall Study||72
9041926|NCT03372434|10102466|FG000|NOT COMPLETED|Overall Study||2
9041927|NCT03372434|10102467|FG001|NOT COMPLETED|Overall Study||3
9041928|NCT03372434|10102468|FG002|NOT COMPLETED|Overall Study||2
9041929|NCT03372551|10102476|FG000|STARTED|First Intervention (1 Week)||17
9041930|NCT03372551|10102477|FG001|STARTED|First Intervention (1 Week)||16
9041931|NCT03372551|10102476|FG000|COMPLETED|First Intervention (1 Week)||16
9041932|NCT03372551|10102477|FG001|COMPLETED|First Intervention (1 Week)||16
9041933|NCT03372551|10102476|FG000|NOT COMPLETED|First Intervention (1 Week)||1
9041934|NCT03372551|10102477|FG001|NOT COMPLETED|First Intervention (1 Week)||0
9041935|NCT03372551|10102476|FG000|STARTED|Second Intervention (1 Week)||16
9041936|NCT03372551|10102477|FG001|STARTED|Second Intervention (1 Week)||16
9041937|NCT03372551|10102476|FG000|COMPLETED|Second Intervention (1 Week)||16
9041938|NCT03372551|10102477|FG001|COMPLETED|Second Intervention (1 Week)||16
9041939|NCT03372551|10102476|FG000|NOT COMPLETED|Second Intervention (1 Week)||0
9041940|NCT03372551|10102477|FG001|NOT COMPLETED|Second Intervention (1 Week)||0
9041941|NCT03372603|10102490|FG000|STARTED|Treatment Period 1 (Up to 7 Days)||9
9041942|NCT03372603|10102491|FG001|STARTED|Treatment Period 1 (Up to 7 Days)||8
9041943|NCT03372603|10102490|FG000|COMPLETED|Treatment Period 1 (Up to 7 Days)||9
9041944|NCT03372603|10102491|FG001|COMPLETED|Treatment Period 1 (Up to 7 Days)||8
9041945|NCT03372603|10102490|FG000|NOT COMPLETED|Treatment Period 1 (Up to 7 Days)||0
9041946|NCT03372603|10102491|FG001|NOT COMPLETED|Treatment Period 1 (Up to 7 Days)||0
9041947|NCT03372603|10102490|FG000|STARTED|Wash-out Period (14-21 Days)||9
9041948|NCT03372603|10102491|FG001|STARTED|Wash-out Period (14-21 Days)||8
9041949|NCT03372603|10102490|FG000|COMPLETED|Wash-out Period (14-21 Days)||8
9041950|NCT03372603|10102491|FG001|COMPLETED|Wash-out Period (14-21 Days)||8
9041951|NCT03372603|10102490|FG000|NOT COMPLETED|Wash-out Period (14-21 Days)||1
9041952|NCT03372603|10102491|FG001|NOT COMPLETED|Wash-out Period (14-21 Days)||0
9041953|NCT03372603|10102490|FG000|STARTED|Treatment Period 2 (Up to 7 Days)||8
9041954|NCT03372603|10102491|FG001|STARTED|Treatment Period 2 (Up to 7 Days)||8
9041955|NCT03372603|10102490|FG000|COMPLETED|Treatment Period 2 (Up to 7 Days)||7
9041956|NCT03372603|10102491|FG001|COMPLETED|Treatment Period 2 (Up to 7 Days)||8
9041957|NCT03372603|10102490|FG000|NOT COMPLETED|Treatment Period 2 (Up to 7 Days)||1
9041958|NCT03372603|10102491|FG001|NOT COMPLETED|Treatment Period 2 (Up to 7 Days)||0
9041959|NCT03372928|10102497|FG000|STARTED|First Intervention (5 d Energy Deficit)||10
8810134|NCT01504997|9862919|FG000|COMPLETED|Overall Study||18
8810135|NCT01504997|9862919|FG000|NOT COMPLETED|Overall Study||0
8810136|NCT01505010|9862925|FG000|STARTED|Overall Study||9
8810137|NCT01505010|9862926|FG001|STARTED|Overall Study||8
8810138|NCT01505010|9862925|FG000|COMPLETED|Overall Study||9
8810139|NCT01505010|9862926|FG001|COMPLETED|Overall Study||6
8810140|NCT01505010|9862925|FG000|NOT COMPLETED|Overall Study||0
8810141|NCT01505010|9862926|FG001|NOT COMPLETED|Overall Study||2
8810142|NCT01505114|9862936|FG000|STARTED|Overall Study||148
8810143|NCT01505114|9862937|FG001|STARTED|Overall Study||148
8810144|NCT01505114|9862938|FG002|STARTED|Overall Study||147
8810145|NCT01505114|9862939|FG003|STARTED|Overall Study||151
8810146|NCT01505114|9862936|FG000|COMPLETED|Overall Study||123
9041960|NCT03372928|10102498|FG001|STARTED|First Intervention (5 d Energy Deficit)||10
9041961|NCT03372928|10102497|FG000|COMPLETED|First Intervention (5 d Energy Deficit)||10
9041962|NCT03372928|10102498|FG001|COMPLETED|First Intervention (5 d Energy Deficit)||10
9041963|NCT03372928|10102497|FG000|NOT COMPLETED|First Intervention (5 d Energy Deficit)||0
9041964|NCT03372928|10102498|FG001|NOT COMPLETED|First Intervention (5 d Energy Deficit)||0
9041965|NCT03372928|10102497|FG000|STARTED|Washout (14 d)||10
9041966|NCT03372928|10102498|FG001|STARTED|Washout (14 d)||10
9041967|NCT03372928|10102497|FG000|COMPLETED|Washout (14 d)||10
9041968|NCT03372928|10102498|FG001|COMPLETED|Washout (14 d)||9
9041969|NCT03372928|10102497|FG000|NOT COMPLETED|Washout (14 d)||0
9041970|NCT03372928|10102498|FG001|NOT COMPLETED|Washout (14 d)||1
9041971|NCT03372928|10102497|FG000|STARTED|Second Intervention (5 d Energy Deficit)||10
9041972|NCT03372928|10102498|FG001|STARTED|Second Intervention (5 d Energy Deficit)||9
9041973|NCT03372928|10102497|FG000|COMPLETED|Second Intervention (5 d Energy Deficit)||10
9041974|NCT03372928|10102498|FG001|COMPLETED|Second Intervention (5 d Energy Deficit)||9
9041975|NCT03372928|10102497|FG000|NOT COMPLETED|Second Intervention (5 d Energy Deficit)||0
9041976|NCT03372928|10102498|FG001|NOT COMPLETED|Second Intervention (5 d Energy Deficit)||0
9041977|NCT03373162|10102509|FG000|STARTED|Overall Study||10
9041978|NCT03373162|10102509|FG000|COMPLETED|Overall Study||10
9041979|NCT03373162|10102509|FG000|NOT COMPLETED|Overall Study||0
9041980|NCT03373240|10102516|FG000|STARTED|Overall Study||22
9041981|NCT03373240|10102517|FG001|STARTED|Overall Study||24
9041982|NCT03373240|10102516|FG000|4-week Post Treatment|Overall Study||14
9041983|NCT03373240|10102517|FG001|4-week Post Treatment|Overall Study||23
9041984|NCT03373240|10102516|FG000|COMPLETED|Overall Study|This is the 1-month post follow-up|11
9041985|NCT03373240|10102517|FG001|COMPLETED|Overall Study|This is the 1-month post follow-up|20
9041986|NCT03373240|10102516|FG000|NOT COMPLETED|Overall Study||11
9041987|NCT03373240|10102517|FG001|NOT COMPLETED|Overall Study||4
9041988|NCT03373383|10102528|FG000|STARTED|Treatment Period: Wk0-16||83
9041989|NCT03373383|10102529|FG001|STARTED|Treatment Period: Wk0-16||81
9041990|NCT03373383|10102530|FG002|STARTED|Treatment Period: Wk0-16||83
9041991|NCT03373383|10102531|FG003|STARTED|Treatment Period: Wk0-16||82
9041992|NCT03373383|10102532|FG004|STARTED|Treatment Period: Wk0-16||82
9041993|NCT03373383|10102528|FG000|Completed Titration and Stabilization|Treatment Period: Wk0-16||78
9041994|NCT03373383|10102529|FG001|Completed Titration and Stabilization|Treatment Period: Wk0-16||72
9041995|NCT03373383|10102530|FG002|Completed Titration and Stabilization|Treatment Period: Wk0-16||71
9041996|NCT03373383|10102531|FG003|Completed Titration and Stabilization|Treatment Period: Wk0-16||68
9041997|NCT03373383|10102532|FG004|Completed Titration and Stabilization|Treatment Period: Wk0-16||65
9041998|NCT03373383|10102528|FG000|Completed Maintenance Period|Treatment Period: Wk0-16||70
9041999|NCT03373383|10102529|FG001|Completed Maintenance Period|Treatment Period: Wk0-16||66
9042000|NCT03373383|10102530|FG002|Completed Maintenance Period|Treatment Period: Wk0-16||68
9042001|NCT03373383|10102531|FG003|Completed Maintenance Period|Treatment Period: Wk0-16||61
9042002|NCT03373383|10102532|FG004|Completed Maintenance Period|Treatment Period: Wk0-16||58
9042003|NCT03373383|10102528|FG000|Had Taper and Safety Follow-up|Treatment Period: Wk0-16||6
9042004|NCT03373383|10102529|FG001|Had Taper and Safety Follow-up|Treatment Period: Wk0-16||11
9042005|NCT03373383|10102530|FG002|Had Taper and Safety Follow-up|Treatment Period: Wk0-16||8
9042006|NCT03373383|10102531|FG003|Had Taper and Safety Follow-up|Treatment Period: Wk0-16||18
9042007|NCT03373383|10102532|FG004|Had Taper and Safety Follow-up|Treatment Period: Wk0-16||21
9042008|NCT03373383|10102528|FG000|COMPLETED|Treatment Period: Wk0-16||70
9042009|NCT03373383|10102529|FG001|COMPLETED|Treatment Period: Wk0-16||66
9042010|NCT03373383|10102530|FG002|COMPLETED|Treatment Period: Wk0-16||68
9042011|NCT03373383|10102531|FG003|COMPLETED|Treatment Period: Wk0-16||61
9042012|NCT03373383|10102532|FG004|COMPLETED|Treatment Period: Wk0-16||58
9042013|NCT03373383|10102528|FG000|NOT COMPLETED|Treatment Period: Wk0-16||13
9042014|NCT03373383|10102529|FG001|NOT COMPLETED|Treatment Period: Wk0-16||15
9042015|NCT03373383|10102530|FG002|NOT COMPLETED|Treatment Period: Wk0-16||15
9042016|NCT03373383|10102531|FG003|NOT COMPLETED|Treatment Period: Wk0-16||21
9042017|NCT03373383|10102532|FG004|NOT COMPLETED|Treatment Period: Wk0-16||24
9042018|NCT03373383|10102528|FG000|STARTED|Post-Treatment Period: Wk16-23||70
9042019|NCT03373383|10102529|FG001|STARTED|Post-Treatment Period: Wk16-23||66
9042020|NCT03373383|10102530|FG002|STARTED|Post-Treatment Period: Wk16-23||68
9042021|NCT03373383|10102531|FG003|STARTED|Post-Treatment Period: Wk16-23||61
8925471|NCT02258334|9986613|FG000|STARTED|Overall Study||50
9042022|NCT03373383|10102532|FG004|STARTED|Post-Treatment Period: Wk16-23||58
8810147|NCT01505114|9862937|FG001|COMPLETED|Overall Study||135
8810148|NCT01505114|9862938|FG002|COMPLETED|Overall Study||129
8810149|NCT01505114|9862939|FG003|COMPLETED|Overall Study||128
8810150|NCT01505114|9862936|FG000|NOT COMPLETED|Overall Study||25
8810151|NCT01505114|9862937|FG001|NOT COMPLETED|Overall Study||13
8810152|NCT01505114|9862938|FG002|NOT COMPLETED|Overall Study||18
8810153|NCT01505114|9862939|FG003|NOT COMPLETED|Overall Study||23
8810154|NCT01505166|9862952|FG000|STARTED|Overall Study||3
8810155|NCT01505166|9862953|FG001|STARTED|Overall Study||0
8810156|NCT01505166|9862954|FG002|STARTED|Overall Study||0
8810157|NCT01505166|9862952|FG000|COMPLETED|Overall Study|"Completed means subject had successful Vigil manufacturing and had been given all the doses."|3
8810158|NCT01505166|9862953|FG001|COMPLETED|Overall Study||0
8810159|NCT01505166|9862954|FG002|COMPLETED|Overall Study||0
8810160|NCT01505166|9862952|FG000|NOT COMPLETED|Overall Study||0
8810161|NCT01505166|9862953|FG001|NOT COMPLETED|Overall Study||0
8810162|NCT01505166|9862954|FG002|NOT COMPLETED|Overall Study||0
8810163|NCT01505179|9862966|FG000|STARTED|Overall Study||6
8810164|NCT01505179|9862967|FG001|STARTED|Overall Study||4
8810165|NCT01505179|9862966|FG000|COMPLETED|Overall Study||6
8810166|NCT01505179|9862967|FG001|COMPLETED|Overall Study||4
8810167|NCT01505179|9862966|FG000|NOT COMPLETED|Overall Study||0
8810168|NCT01505179|9862967|FG001|NOT COMPLETED|Overall Study||0
8810169|NCT01505374|9862973|FG000|STARTED|Overall Study||30
8810170|NCT01505374|9862974|FG001|STARTED|Overall Study||30
8810171|NCT01505374|9862973|FG000|COMPLETED|Overall Study||29
8810172|NCT01505374|9862974|FG001|COMPLETED|Overall Study||30
8810173|NCT01505374|9862973|FG000|NOT COMPLETED|Overall Study||1
8810174|NCT01505374|9862974|FG001|NOT COMPLETED|Overall Study||0
8810175|NCT01505387|9862983|FG000|STARTED|Overall Study||25
8810176|NCT01505387|9862984|FG001|STARTED|Overall Study||25
8810177|NCT01505387|9862983|FG000|Treated|Overall Study||24
8810178|NCT01505387|9862984|FG001|Treated|Overall Study||24
8810179|NCT01505387|9862983|FG000|COMPLETED|Overall Study|1 subject not included in intention to treat population as violated inclusion criteria|23
8810180|NCT01505387|9862984|FG001|COMPLETED|Overall Study||24
8810181|NCT01505387|9862983|FG000|NOT COMPLETED|Overall Study||2
8810182|NCT01505387|9862984|FG001|NOT COMPLETED|Overall Study||1
8810183|NCT01505491|9862993|FG000|STARTED|Overall Study||67
8810184|NCT01505491|9862994|FG001|STARTED|Overall Study||62
8810185|NCT01505491|9862995|FG002|STARTED|Overall Study||64
8810186|NCT01505491|9862993|FG000|COMPLETED|Overall Study||65
8810187|NCT01505491|9862994|FG001|COMPLETED|Overall Study||61
8810188|NCT01505491|9862995|FG002|COMPLETED|Overall Study||59
8810189|NCT01505491|9862993|FG000|NOT COMPLETED|Overall Study||2
8810190|NCT01505491|9862994|FG001|NOT COMPLETED|Overall Study||1
8810191|NCT01505491|9862995|FG002|NOT COMPLETED|Overall Study||5
8810192|NCT01505530|9863006|FG000|STARTED|Overall Study||41
8810193|NCT01505530|9863007|FG001|STARTED|Overall Study||43
8810194|NCT01505530|9863008|FG002|STARTED|Overall Study||41
8810195|NCT01505530|9863006|FG000|Received At Least One Dose of Study Drug|Overall Study||41
8810196|NCT01505530|9863007|FG001|Received At Least One Dose of Study Drug|Overall Study||42
8810197|NCT01505530|9863008|FG002|Received At Least One Dose of Study Drug|Overall Study||41
8810198|NCT01505530|9863006|FG000|Completed One Cycle of Study Drug|Overall Study||29
8810199|NCT01505530|9863007|FG001|Completed One Cycle of Study Drug|Overall Study||27
8810200|NCT01505530|9863008|FG002|Completed One Cycle of Study Drug|Overall Study||31
8810201|NCT01505530|9863006|FG000|COMPLETED|Overall Study||0
8810202|NCT01505530|9863007|FG001|COMPLETED|Overall Study||0
8810203|NCT01505530|9863008|FG002|COMPLETED|Overall Study||0
8810204|NCT01505530|9863006|FG000|NOT COMPLETED|Overall Study||41
8810205|NCT01505530|9863007|FG001|NOT COMPLETED|Overall Study||43
8810206|NCT01505530|9863008|FG002|NOT COMPLETED|Overall Study||41
8810207|NCT01505634|9863019|FG000|STARTED|Overall Study||101
8810208|NCT01505634|9863020|FG001|STARTED|Overall Study||101
8810209|NCT01505634|9863021|FG002|STARTED|Overall Study||100
8810210|NCT01505634|9863019|FG000|Treated|Overall Study||99
8810211|NCT01505634|9863020|FG001|Treated|Overall Study||99
8810212|NCT01505634|9863021|FG002|Treated|Overall Study||100
8810213|NCT01505634|9863019|FG000|COMPLETED|Overall Study||92
8810214|NCT01505634|9863020|FG001|COMPLETED|Overall Study||91
8810215|NCT01505634|9863021|FG002|COMPLETED|Overall Study||94
8810216|NCT01505634|9863019|FG000|NOT COMPLETED|Overall Study||9
8810217|NCT01505634|9863020|FG001|NOT COMPLETED|Overall Study||10
8810218|NCT01505634|9863021|FG002|NOT COMPLETED|Overall Study||6
8810219|NCT01505647|9863031|FG000|STARTED|Day 1 Through Day 42 Follow-up||332
8810220|NCT01505647|9863032|FG001|STARTED|Day 1 Through Day 42 Follow-up||166
8810221|NCT01505647|9863031|FG000|Vaccinated|Day 1 Through Day 42 Follow-up||331
8810222|NCT01505647|9863032|FG001|Vaccinated|Day 1 Through Day 42 Follow-up||166
8810223|NCT01505647|9863031|FG000|COMPLETED|Day 1 Through Day 42 Follow-up||329
8810224|NCT01505647|9863032|FG001|COMPLETED|Day 1 Through Day 42 Follow-up||166
8810225|NCT01505647|9863031|FG000|NOT COMPLETED|Day 1 Through Day 42 Follow-up||3
8810226|NCT01505647|9863032|FG001|NOT COMPLETED|Day 1 Through Day 42 Follow-up||0
8810227|NCT01505647|9863031|FG000|STARTED|Day 43 Through Day 182 Follow-up||329
8810228|NCT01505647|9863032|FG001|STARTED|Day 43 Through Day 182 Follow-up||166
8925472|NCT02258334|9986614|FG001|STARTED|Overall Study||54
8810229|NCT01505647|9863031|FG000|COMPLETED|Day 43 Through Day 182 Follow-up||328
8810230|NCT01505647|9863032|FG001|COMPLETED|Day 43 Through Day 182 Follow-up||163
8810231|NCT01505647|9863031|FG000|NOT COMPLETED|Day 43 Through Day 182 Follow-up||1
8810232|NCT01505647|9863032|FG001|NOT COMPLETED|Day 43 Through Day 182 Follow-up||3
8810233|NCT01505673|9863040|FG000|STARTED|Overall Study||35
8810234|NCT01505673|9863041|FG001|STARTED|Overall Study||36
8810235|NCT01505673|9863040|FG000|COMPLETED|Overall Study||32
8810236|NCT01505673|9863041|FG001|COMPLETED|Overall Study||34
8925473|NCT02258334|9986615|FG002|STARTED|Overall Study||52
9042023|NCT03373383|10102528|FG000|Started Conversion Period|Post-Treatment Period: Wk16-23||69
9042024|NCT03373383|10102529|FG001|Started Conversion Period|Post-Treatment Period: Wk16-23||64
9042025|NCT03373383|10102530|FG002|Started Conversion Period|Post-Treatment Period: Wk16-23||66
9042026|NCT03373383|10102531|FG003|Started Conversion Period|Post-Treatment Period: Wk16-23||55
9042027|NCT03373383|10102532|FG004|Started Conversion Period|Post-Treatment Period: Wk16-23||57
9042028|NCT03373383|10102528|FG000|Completed Conversion Period|Post-Treatment Period: Wk16-23||68
9042029|NCT03373383|10102529|FG001|Completed Conversion Period|Post-Treatment Period: Wk16-23||64
9042030|NCT03373383|10102530|FG002|Completed Conversion Period|Post-Treatment Period: Wk16-23||66
9042031|NCT03373383|10102531|FG003|Completed Conversion Period|Post-Treatment Period: Wk16-23||55
9042032|NCT03373383|10102532|FG004|Completed Conversion Period|Post-Treatment Period: Wk16-23||57
9042033|NCT03373383|10102528|FG000|Had Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||3
9042034|NCT03373383|10102529|FG001|Had Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||3
9042035|NCT03373383|10102530|FG002|Had Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||3
9042036|NCT03373383|10102531|FG003|Had Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||6
9042037|NCT03373383|10102532|FG004|Had Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||1
9042038|NCT03373383|10102528|FG000|Enrolled in EP0093|Post-Treatment Period: Wk16-23||67
9042039|NCT03373383|10102529|FG001|Enrolled in EP0093|Post-Treatment Period: Wk16-23||63
9042040|NCT03373383|10102530|FG002|Enrolled in EP0093|Post-Treatment Period: Wk16-23||65
9042041|NCT03373383|10102531|FG003|Enrolled in EP0093|Post-Treatment Period: Wk16-23||55
9042042|NCT03373383|10102532|FG004|Enrolled in EP0093|Post-Treatment Period: Wk16-23||57
9042043|NCT03373383|10102528|FG000|COMPLETED|Post-Treatment Period: Wk16-23||69
9042044|NCT03373383|10102529|FG001|COMPLETED|Post-Treatment Period: Wk16-23||66
9042045|NCT03373383|10102530|FG002|COMPLETED|Post-Treatment Period: Wk16-23||68
9042046|NCT03373383|10102531|FG003|COMPLETED|Post-Treatment Period: Wk16-23||61
9042047|NCT03373383|10102532|FG004|COMPLETED|Post-Treatment Period: Wk16-23||58
9042048|NCT03373383|10102528|FG000|NOT COMPLETED|Post-Treatment Period: Wk16-23||1
9042049|NCT03373383|10102529|FG001|NOT COMPLETED|Post-Treatment Period: Wk16-23||0
9042050|NCT03373383|10102530|FG002|NOT COMPLETED|Post-Treatment Period: Wk16-23||0
9042051|NCT03373383|10102531|FG003|NOT COMPLETED|Post-Treatment Period: Wk16-23||0
9042052|NCT03373383|10102532|FG004|NOT COMPLETED|Post-Treatment Period: Wk16-23||0
9042053|NCT03373591|10102562|FG000|STARTED|Overall Study||75
8925474|NCT02258334|9986616|FG003|STARTED|Overall Study||52
8925475|NCT02258334|9986613|FG000|COMPLETED|Overall Study||49
8925476|NCT02258334|9986614|FG001|COMPLETED|Overall Study||54
8925477|NCT02258334|9986615|FG002|COMPLETED|Overall Study||52
8925478|NCT02258334|9986616|FG003|COMPLETED|Overall Study||52
8925479|NCT02258334|9986613|FG000|NOT COMPLETED|Overall Study||1
8925480|NCT02258334|9986614|FG001|NOT COMPLETED|Overall Study||0
8925481|NCT02258334|9986615|FG002|NOT COMPLETED|Overall Study||0
8925482|NCT02258334|9986616|FG003|NOT COMPLETED|Overall Study||0
8925483|NCT02258373|9986630|FG000|STARTED|Overall Study||149
8925484|NCT02258373|9986631|FG001|STARTED|Overall Study||77
8925485|NCT02258373|9986630|FG000|COMPLETED|Overall Study||142
8925486|NCT02258373|9986631|FG001|COMPLETED|Overall Study||75
8925487|NCT02258373|9986630|FG000|NOT COMPLETED|Overall Study||7
8925488|NCT02258373|9986631|FG001|NOT COMPLETED|Overall Study||2
8925489|NCT02258412|9986640|FG000|STARTED|Overall Study||26
8925490|NCT02258412|9986641|FG001|STARTED|Overall Study||25
8925491|NCT02258412|9986642|FG002|STARTED|Overall Study||61
8925492|NCT02258412|9986640|FG000|COMPLETED|Overall Study||26
8925493|NCT02258412|9986641|FG001|COMPLETED|Overall Study||25
8925494|NCT02258412|9986642|FG002|COMPLETED|Overall Study||61
8925495|NCT02258412|9986640|FG000|NOT COMPLETED|Overall Study||0
8925496|NCT02258412|9986641|FG001|NOT COMPLETED|Overall Study||0
8925497|NCT02258412|9986642|FG002|NOT COMPLETED|Overall Study||0
8925498|NCT02258464|9986651|FG000|STARTED|Overall Study||49
8925499|NCT02258464|9986652|FG001|STARTED|Overall Study||50
8925500|NCT02258464|9986651|FG000|COMPLETED|Overall Study||32
8925501|NCT02258464|9986652|FG001|COMPLETED|Overall Study||25
8925502|NCT02258464|9986651|FG000|NOT COMPLETED|Overall Study||17
8925503|NCT02258464|9986652|FG001|NOT COMPLETED|Overall Study||25
8948180|NCT02427737|10010505|FG000|STARTED|OSU Q3FY16 (Third Post Training Quarter)||4148
8948181|NCT02427737|10010506|FG001|STARTED|OSU Q3FY16 (Third Post Training Quarter)||2931
8948182|NCT02427737|10010505|FG000|COMPLETED|OSU Q3FY16 (Third Post Training Quarter)||3928
8948183|NCT02427737|10010506|FG001|COMPLETED|OSU Q3FY16 (Third Post Training Quarter)||2716
8948184|NCT02427737|10010505|FG000|NOT COMPLETED|OSU Q3FY16 (Third Post Training Quarter)||220
8948185|NCT02427737|10010506|FG001|NOT COMPLETED|OSU Q3FY16 (Third Post Training Quarter)||215
8948186|NCT02427737|10010505|FG000|STARTED|Duke Pre- and Post-Training Groups|Note this is a pre-training to post-training comparison.|9658
8948187|NCT02427737|10010506|FG001|STARTED|Duke Pre- and Post-Training Groups|Note Control=Baseline|4446
8948188|NCT02427737|10010505|FG000|COMPLETED|Duke Pre- and Post-Training Groups||8879
8948189|NCT02427737|10010506|FG001|COMPLETED|Duke Pre- and Post-Training Groups||4051
8948190|NCT02427737|10010505|FG000|NOT COMPLETED|Duke Pre- and Post-Training Groups||779
8948191|NCT02427737|10010506|FG001|NOT COMPLETED|Duke Pre- and Post-Training Groups||395
8948192|NCT02427750|10010522|FG000|STARTED|Overall Study||63
8948193|NCT02427750|10010523|FG001|STARTED|Overall Study||63
8948194|NCT02427750|10010522|FG000|COMPLETED|Overall Study||63
8948195|NCT02427750|10010523|FG001|COMPLETED|Overall Study||63
8810237|NCT01505673|9863040|FG000|NOT COMPLETED|Overall Study||3
9042054|NCT03373591|10102563|FG001|STARTED|Overall Study||71
9042055|NCT03373591|10102564|FG002|STARTED|Overall Study||73
9042056|NCT03373591|10102562|FG000|COMPLETED|Overall Study||75
9042057|NCT03373591|10102563|FG001|COMPLETED|Overall Study||71
9042058|NCT03373591|10102564|FG002|COMPLETED|Overall Study||73
9042059|NCT03373591|10102562|FG000|NOT COMPLETED|Overall Study||0
9042060|NCT03373591|10102563|FG001|NOT COMPLETED|Overall Study||0
9042061|NCT03373591|10102564|FG002|NOT COMPLETED|Overall Study||0
9042062|NCT03373890|10102574|FG000|STARTED|Overall Study||6
9042063|NCT03373890|10102575|FG001|STARTED|Overall Study||6
9042064|NCT03373890|10102574|FG000|COMPLETED|Overall Study||6
9042065|NCT03373890|10102575|FG001|COMPLETED|Overall Study||6
9042066|NCT03373890|10102574|FG000|NOT COMPLETED|Overall Study||0
9042067|NCT03373890|10102575|FG001|NOT COMPLETED|Overall Study||0
9042068|NCT03374176|10102585|FG000|STARTED|Overall Study||21
9042069|NCT03374176|10102586|FG001|STARTED|Overall Study||21
9042070|NCT03374176|10102585|FG000|COMPLETED|Overall Study||21
9042071|NCT03374176|10102586|FG001|COMPLETED|Overall Study||21
9042072|NCT03374176|10102585|FG000|NOT COMPLETED|Overall Study||0
9042073|NCT03374176|10102586|FG001|NOT COMPLETED|Overall Study||0
9042074|NCT03374189|10102594|FG000|STARTED|Overall Study||40
9042075|NCT03374189|10102595|FG001|STARTED|Overall Study||39
9042076|NCT03374189|10102594|FG000|COMPLETED|Overall Study||39
9042077|NCT03374189|10102595|FG001|COMPLETED|Overall Study||39
9042078|NCT03374189|10102594|FG000|NOT COMPLETED|Overall Study||1
9042079|NCT03374189|10102595|FG001|NOT COMPLETED|Overall Study||0
9042080|NCT03374358|10102603|FG000|STARTED|Overall Study||24
9042081|NCT03374358|10102604|FG001|STARTED|Overall Study||21
9042082|NCT03374358|10102603|FG000|COMPLETED|Overall Study||24
9042083|NCT03374358|10102604|FG001|COMPLETED|Overall Study||19
9042084|NCT03374358|10102603|FG000|NOT COMPLETED|Overall Study||0
9042085|NCT03374358|10102604|FG001|NOT COMPLETED|Overall Study||2
9042086|NCT03374488|10102612|FG000|STARTED|Overall Study||42
9042087|NCT03374488|10102613|FG001|STARTED|Overall Study||42
9042088|NCT03374488|10102612|FG000|Intention-to-Treat (ITT)|Overall Study||42
9042089|NCT03374488|10102613|FG001|Intention-to-Treat (ITT)|Overall Study||42
9042090|NCT03374488|10102612|FG000|All Participants as Treated (APaT)|Overall Study||42
9042091|NCT03374488|10102613|FG001|All Participants as Treated (APaT)|Overall Study||41
9042092|NCT03374488|10102612|FG000|COMPLETED|Overall Study||23
9042093|NCT03374488|10102613|FG001|COMPLETED|Overall Study||28
9042094|NCT03374488|10102612|FG000|NOT COMPLETED|Overall Study||19
9042095|NCT03374488|10102613|FG001|NOT COMPLETED|Overall Study||14
9042096|NCT03374683|10102623|FG000|STARTED|Overall Study||148
9042097|NCT03374683|10102624|FG001|STARTED|Overall Study||150
9042098|NCT03374683|10102625|FG002|STARTED|Overall Study||153
9042099|NCT03374683|10102623|FG000|1-week Post-intervention|Overall Study||135
9042100|NCT03374683|10102624|FG001|1-week Post-intervention|Overall Study||113
9042101|NCT03374683|10102625|FG002|1-week Post-intervention|Overall Study||85
9042102|NCT03374683|10102623|FG000|COMPLETED|Overall Study||123
9042103|NCT03374683|10102624|FG001|COMPLETED|Overall Study||105
9042104|NCT03374683|10102625|FG002|COMPLETED|Overall Study||84
9042105|NCT03374683|10102623|FG000|NOT COMPLETED|Overall Study||25
9042106|NCT03374683|10102624|FG001|NOT COMPLETED|Overall Study||45
9042107|NCT03374683|10102625|FG002|NOT COMPLETED|Overall Study||69
9042108|NCT03374995|10102635|FG000|STARTED|Overall Study||13
9042109|NCT03374995|10102636|FG001|STARTED|Overall Study||12
9042110|NCT03374995|10102635|FG000|COMPLETED|Overall Study||13
9042111|NCT03374995|10102636|FG001|COMPLETED|Overall Study||11
9042112|NCT03374995|10102635|FG000|NOT COMPLETED|Overall Study||0
9042113|NCT03374995|10102636|FG001|NOT COMPLETED|Overall Study||1
9042114|NCT03375294|10102642|FG000|STARTED|Overall Study||3
9042115|NCT03375294|10102642|FG000|COMPLETED|Overall Study||3
9042116|NCT03375294|10102642|FG000|NOT COMPLETED|Overall Study||0
9042117|NCT03376061|10102648|FG000|STARTED|Overall Study||49
9042118|NCT03376061|10102649|FG001|STARTED|Overall Study||48
9042119|NCT03376061|10102648|FG000|COMPLETED|Overall Study||49
9042120|NCT03376061|10102649|FG001|COMPLETED|Overall Study||48
9042121|NCT03376061|10102648|FG000|NOT COMPLETED|Overall Study||0
9042122|NCT03376061|10102649|FG001|NOT COMPLETED|Overall Study||0
9042123|NCT03376256|10102658|FG000|STARTED|Overall Study||2
9042124|NCT03376256|10102659|FG001|STARTED|Overall Study||0
9042125|NCT03376256|10102658|FG000|COMPLETED|Overall Study||2
9042126|NCT03376256|10102659|FG001|COMPLETED|Overall Study||0
9042127|NCT03376256|10102658|FG000|NOT COMPLETED|Overall Study||0
9042128|NCT03376256|10102659|FG001|NOT COMPLETED|Overall Study||0
9042129|NCT03376295|10102667|FG000|STARTED|Overall Study||1977
9042130|NCT03376295|10102668|FG001|STARTED|Overall Study||1977
9042131|NCT03376295|10102667|FG000|COMPLETED|Overall Study||1977
9042132|NCT03376295|10102668|FG001|COMPLETED|Overall Study||1977
9042133|NCT03376295|10102667|FG000|NOT COMPLETED|Overall Study||0
9042134|NCT03376295|10102668|FG001|NOT COMPLETED|Overall Study||0
9042135|NCT03376321|10102676|FG000|STARTED|Overall Study||168
9042136|NCT03376321|10102677|FG001|STARTED|Overall Study||166
9042137|NCT03376321|10102676|FG000|Treated|Overall Study||163
8569411|NCT00096993|9601650|FG001|NOT COMPLETED|Overall Study||65
9042138|NCT03376321|10102677|FG001|Treated|Overall Study||163
9042139|NCT03376321|10102676|FG000|COMPLETED|Overall Study||145
9042140|NCT03376321|10102677|FG001|COMPLETED|Overall Study||141
9042141|NCT03376321|10102676|FG000|NOT COMPLETED|Overall Study||23
9042142|NCT03376321|10102677|FG001|NOT COMPLETED|Overall Study||25
9042143|NCT03376516|10102683|FG000|STARTED|Overall Study||11
8810238|NCT01505673|9863041|FG001|NOT COMPLETED|Overall Study||2
8810239|NCT01505764|9863049|FG000|STARTED|Overall Study||6
8810240|NCT01505764|9863050|FG001|STARTED|Overall Study||3
8810241|NCT01505764|9863049|FG000|COMPLETED|Overall Study||3
8810242|NCT01505764|9863050|FG001|COMPLETED|Overall Study||2
8810243|NCT01505764|9863049|FG000|NOT COMPLETED|Overall Study||3
8810244|NCT01505764|9863050|FG001|NOT COMPLETED|Overall Study||1
8810245|NCT01505868|9863062|FG000|STARTED|Overall Study||4
8810246|NCT01505868|9863063|FG001|STARTED|Overall Study||3
8810247|NCT01505868|9863064|FG002|STARTED|Overall Study||3
8810248|NCT01505868|9863065|FG003|STARTED|Overall Study||79
8810249|NCT01505868|9863066|FG004|STARTED|Overall Study||81
9042144|NCT03376516|10102683|FG000|Received Treatment|Overall Study||10
9042145|NCT03376516|10102683|FG000|SAF Population|Overall Study||10
9042146|NCT03376516|10102683|FG000|FAS Population|Overall Study||10
9042147|NCT03376516|10102683|FG000|PK Population|Overall Study||10
9042148|NCT03376516|10102683|FG000|PP Population|Overall Study||9
9042149|NCT03376516|10102683|FG000|SURG Population|Overall Study||2
9042150|NCT03376516|10102683|FG000|COMPLETED|Overall Study||9
9042151|NCT03376516|10102683|FG000|NOT COMPLETED|Overall Study||2
9042152|NCT03377127|10102700|FG000|STARTED|Overall Study||42
9042153|NCT03377127|10102701|FG001|STARTED|Overall Study||44
9042154|NCT03377127|10102700|FG000|COMPLETED|Overall Study||42
9042155|NCT03377127|10102701|FG001|COMPLETED|Overall Study||44
9042156|NCT03377127|10102700|FG000|NOT COMPLETED|Overall Study||0
9042157|NCT03377127|10102701|FG001|NOT COMPLETED|Overall Study||0
9042158|NCT03377244|10102710|FG000|STARTED|Baseline||19
9042159|NCT03377244|10102711|FG001|STARTED|Baseline||14
9042160|NCT03377244|10102712|FG002|STARTED|Baseline||69
9042161|NCT03377244|10102710|FG000|COMPLETED|Baseline||19
9042162|NCT03377244|10102711|FG001|COMPLETED|Baseline||14
9042163|NCT03377244|10102712|FG002|COMPLETED|Baseline||69
9042164|NCT03377244|10102710|FG000|NOT COMPLETED|Baseline||0
9042165|NCT03377244|10102711|FG001|NOT COMPLETED|Baseline||0
9042166|NCT03377244|10102712|FG002|NOT COMPLETED|Baseline||0
9042167|NCT03377244|10102710|FG000|STARTED|6 Months Post-intervention||19
9042168|NCT03377244|10102711|FG001|STARTED|6 Months Post-intervention||14
9042169|NCT03377244|10102712|FG002|STARTED|6 Months Post-intervention||69
9042170|NCT03377244|10102710|FG000|COMPLETED|6 Months Post-intervention||13
9042171|NCT03377244|10102711|FG001|COMPLETED|6 Months Post-intervention||7
9042172|NCT03377244|10102712|FG002|COMPLETED|6 Months Post-intervention||55
9042173|NCT03377244|10102710|FG000|NOT COMPLETED|6 Months Post-intervention||6
9042174|NCT03377244|10102711|FG001|NOT COMPLETED|6 Months Post-intervention||7
9042175|NCT03377244|10102712|FG002|NOT COMPLETED|6 Months Post-intervention||14
8810250|NCT01505868|9863062|FG000|COMPLETED|Overall Study||3
8810251|NCT01505868|9863063|FG001|COMPLETED|Overall Study||3
8810252|NCT01505868|9863064|FG002|COMPLETED|Overall Study||3
8810253|NCT01505868|9863065|FG003|COMPLETED|Overall Study||79
8810254|NCT01505868|9863066|FG004|COMPLETED|Overall Study||81
8810255|NCT01505868|9863062|FG000|NOT COMPLETED|Overall Study||1
8810256|NCT01505868|9863063|FG001|NOT COMPLETED|Overall Study||0
8810257|NCT01505868|9863064|FG002|NOT COMPLETED|Overall Study||0
8810258|NCT01505868|9863065|FG003|NOT COMPLETED|Overall Study||0
8810259|NCT01505868|9863066|FG004|NOT COMPLETED|Overall Study||0
8810260|NCT01505881|9863080|FG000|STARTED|Overall Study||99
8810261|NCT01505881|9863081|FG001|STARTED|Overall Study||59
8810262|NCT01505881|9863080|FG000|COMPLETED|Overall Study||95
8810263|NCT01505881|9863081|FG001|COMPLETED|Overall Study||58
8810264|NCT01505881|9863080|FG000|NOT COMPLETED|Overall Study||4
9042176|NCT03377556|10102720|FG000|STARTED|Overall Study||47
9042177|NCT03377556|10102720|FG000|Primary Analysis Population (HRRD-positive Per MDVN Criteria)|Overall Study||24
9042178|NCT03377556|10102720|FG000|COMPLETED|Overall Study||0
9042179|NCT03377556|10102720|FG000|NOT COMPLETED|Overall Study||47
8695725|NCT00878722|9741205|FG000|NOT COMPLETED|Overall Study||3
8695726|NCT00878722|9741206|FG001|NOT COMPLETED|Overall Study||3
8695727|NCT00878722|9741207|FG002|NOT COMPLETED|Overall Study||3
8695728|NCT00878722|9741208|FG003|NOT COMPLETED|Overall Study||9
8695729|NCT00878722|9741209|FG004|NOT COMPLETED|Overall Study||7
8695730|NCT00878722|9741210|FG005|NOT COMPLETED|Overall Study||2
8695731|NCT00878722|9741211|FG006|NOT COMPLETED|Overall Study||6
8810265|NCT01505881|9863081|FG001|NOT COMPLETED|Overall Study||1
8810266|NCT01505933|9863090|FG000|STARTED|Overall Study||10
8810267|NCT01505933|9863091|FG001|STARTED|Overall Study||14
8810268|NCT01505933|9863090|FG000|COMPLETED|Overall Study||10
8810269|NCT01505933|9863091|FG001|COMPLETED|Overall Study||14
8810270|NCT01505933|9863090|FG000|NOT COMPLETED|Overall Study||0
8810271|NCT01505933|9863091|FG001|NOT COMPLETED|Overall Study||0
8810272|NCT01506193|9863100|FG000|STARTED|Overall Study||351
8810273|NCT01506193|9863101|FG001|STARTED|Overall Study||183
8810274|NCT01506193|9863102|FG002|STARTED|Overall Study||182
8810275|NCT01506193|9863100|FG000|COMPLETED|Overall Study||337
8810276|NCT01506193|9863101|FG001|COMPLETED|Overall Study||179
8810277|NCT01506193|9863102|FG002|COMPLETED|Overall Study||168
8810278|NCT01506193|9863100|FG000|NOT COMPLETED|Overall Study||14
8810279|NCT01506193|9863101|FG001|NOT COMPLETED|Overall Study||4
8810280|NCT01506193|9863102|FG002|NOT COMPLETED|Overall Study||14
8810281|NCT01506271|9863114|FG000|STARTED|Overall Study||118
8810282|NCT01506271|9863115|FG001|STARTED|Overall Study||116
8810283|NCT01506271|9863116|FG002|STARTED|Overall Study||117
8810284|NCT01506271|9863114|FG000|Treated|Overall Study||117
8810285|NCT01506271|9863115|FG001|Treated|Overall Study||116
8810286|NCT01506271|9863116|FG002|Treated|Overall Study||114
8810287|NCT01506271|9863114|FG000|COMPLETED|Overall Study||114
8810288|NCT01506271|9863115|FG001|COMPLETED|Overall Study||109
8810289|NCT01506271|9863116|FG002|COMPLETED|Overall Study||114
8810290|NCT01506271|9863114|FG000|NOT COMPLETED|Overall Study||4
8810291|NCT01506271|9863115|FG001|NOT COMPLETED|Overall Study||7
8810292|NCT01506271|9863116|FG002|NOT COMPLETED|Overall Study||3
8810293|NCT01506323|9863126|FG000|STARTED|Overall Study||89
8810294|NCT01506323|9863127|FG001|STARTED|Overall Study||84
8810295|NCT01506323|9863126|FG000|Post-treatment Completers|Overall Study||69
8810296|NCT01506323|9863127|FG001|Post-treatment Completers|Overall Study||72
8810297|NCT01506323|9863126|FG000|Post-treatment Completed CAPS|Overall Study||68
8810298|NCT01506323|9863127|FG001|Post-treatment Completed CAPS|Overall Study||72
8810299|NCT01506323|9863126|FG000|COMPLETED|Overall Study||65
8810300|NCT01506323|9863127|FG001|COMPLETED|Overall Study||71
8810301|NCT01506323|9863126|FG000|NOT COMPLETED|Overall Study||24
8810302|NCT01506323|9863127|FG001|NOT COMPLETED|Overall Study||13
8810303|NCT01506362|9863138|FG000|STARTED|Overall Study||22
8810304|NCT01506362|9863138|FG000|COMPLETED|Overall Study||16
8810305|NCT01506362|9863138|FG000|NOT COMPLETED|Overall Study||6
8810306|NCT01506453|9863144|FG000|STARTED|Overall Study||25
8810307|NCT01506453|9863145|FG001|STARTED|Overall Study||26
8810308|NCT01506453|9863144|FG000|COMPLETED|Overall Study||25
8810309|NCT01506453|9863145|FG001|COMPLETED|Overall Study||24
8810310|NCT01506453|9863144|FG000|NOT COMPLETED|Overall Study||0
8810311|NCT01506453|9863145|FG001|NOT COMPLETED|Overall Study||2
8810312|NCT01506479|9863154|FG000|STARTED|Overall Study||40
8810313|NCT01506479|9863155|FG001|STARTED|Overall Study||43
8810314|NCT01506479|9863156|FG002|STARTED|Overall Study||45
8810315|NCT01506479|9863154|FG000|COMPLETED|Overall Study||37
8810316|NCT01506479|9863155|FG001|COMPLETED|Overall Study||38
8810317|NCT01506479|9863156|FG002|COMPLETED|Overall Study||42
8810318|NCT01506479|9863154|FG000|NOT COMPLETED|Overall Study||3
8810319|NCT01506479|9863155|FG001|NOT COMPLETED|Overall Study||5
8810320|NCT01506479|9863156|FG002|NOT COMPLETED|Overall Study||3
8810321|NCT01506596|9863166|FG000|STARTED|Overall Study||42
8810322|NCT01506596|9863166|FG000|COMPLETED|Overall Study|One enrolled patient had ineligible pathology after starting treatment; was removed from treatment.|41
8810323|NCT01506596|9863166|FG000|NOT COMPLETED|Overall Study||1
8810324|NCT01506609|9863176|FG000|STARTED|Overall Study||2
8810325|NCT01506609|9863177|FG001|STARTED|Overall Study||1
8810326|NCT01506609|9863178|FG002|STARTED|Overall Study||1
8810327|NCT01506609|9863179|FG003|STARTED|Overall Study||99
8810328|NCT01506609|9863180|FG004|STARTED|Overall Study||97
8810329|NCT01506609|9863181|FG005|STARTED|Overall Study||94
8810330|NCT01506609|9863176|FG000|COMPLETED|Overall Study||0
8810331|NCT01506609|9863177|FG001|COMPLETED|Overall Study||0
8810332|NCT01506609|9863178|FG002|COMPLETED|Overall Study||0
8810333|NCT01506609|9863179|FG003|COMPLETED|Overall Study||0
8810334|NCT01506609|9863180|FG004|COMPLETED|Overall Study||1
8810335|NCT01506609|9863181|FG005|COMPLETED|Overall Study||0
8810336|NCT01506609|9863176|FG000|NOT COMPLETED|Overall Study||2
8810337|NCT01506609|9863177|FG001|NOT COMPLETED|Overall Study||1
8810338|NCT01506609|9863178|FG002|NOT COMPLETED|Overall Study||1
8810339|NCT01506609|9863179|FG003|NOT COMPLETED|Overall Study||99
8810340|NCT01506609|9863180|FG004|NOT COMPLETED|Overall Study||96
8810341|NCT01506609|9863181|FG005|NOT COMPLETED|Overall Study||94
8810342|NCT01506726|9863194|FG000|STARTED|Overall Study||6
8810343|NCT01506726|9863195|FG001|STARTED|Overall Study||5
8810344|NCT01506726|9863194|FG000|COMPLETED|Overall Study||5
8810345|NCT01506726|9863195|FG001|COMPLETED|Overall Study||3
8810346|NCT01506726|9863194|FG000|NOT COMPLETED|Overall Study||1
8810347|NCT01506726|9863195|FG001|NOT COMPLETED|Overall Study||2
8810348|NCT01506882|9863203|FG000|STARTED|Overall Study||61
8810349|NCT01506882|9863204|FG001|STARTED|Overall Study||10
8810350|NCT01506882|9863203|FG000|COMPLETED|Overall Study||39
8810351|NCT01506882|9863204|FG001|COMPLETED|Overall Study||3
8810352|NCT01506882|9863203|FG000|NOT COMPLETED|Overall Study||22
8810353|NCT01506882|9863204|FG001|NOT COMPLETED|Overall Study||7
8810354|NCT01506908|9863214|FG000|STARTED|Overall Study||162
8810355|NCT01506908|9863215|FG001|STARTED|Overall Study||161
8810356|NCT01506908|9863214|FG000|COMPLETED|Overall Study||161
8810357|NCT01506908|9863215|FG001|COMPLETED|Overall Study||161
8810358|NCT01506908|9863214|FG000|NOT COMPLETED|Overall Study||1
8810359|NCT01506908|9863215|FG001|NOT COMPLETED|Overall Study||0
8810360|NCT01506947|9863223|FG000|STARTED|Overall Study||65
8810361|NCT01506947|9863223|FG000|COMPLETED|Overall Study||49
8810362|NCT01506947|9863223|FG000|NOT COMPLETED|Overall Study||16
8810363|NCT01506960|9863229|FG000|STARTED|Overall Study||64
8810364|NCT01506960|9863229|FG000|COMPLETED|Overall Study||17
8810365|NCT01506960|9863229|FG000|NOT COMPLETED|Overall Study||47
8810366|NCT01507051|9863239|FG000|STARTED|Overall Study||29
8810367|NCT01507051|9863240|FG001|STARTED|Overall Study||31
8810368|NCT01507051|9863241|FG002|STARTED|Overall Study||29
8810369|NCT01507051|9863242|FG003|STARTED|Overall Study||7
8810370|NCT01507051|9863239|FG000|Warfarin run-in Phase|Overall Study||28
8810371|NCT01507051|9863240|FG001|Warfarin run-in Phase|Overall Study||28
8810372|NCT01507051|9863241|FG002|Warfarin run-in Phase|Overall Study||0
8810373|NCT01507051|9863242|FG003|Warfarin run-in Phase|Overall Study|Safety Population: in RG4|7
8810374|NCT01507051|9863239|FG000|Received Placebo or Rivaroxaban|Overall Study|Safety Population: in RG1 and in RG4 (RG = Reporting Group for Safety Data)|28
8810375|NCT01507051|9863240|FG001|Received Placebo or Rivaroxaban|Overall Study|Safety Population: in RG2 and in RG4|28
8810376|NCT01507051|9863241|FG002|Received Placebo or Rivaroxaban|Overall Study|Safety Population: in RG3|28
8810377|NCT01507051|9863242|FG003|Received Placebo or Rivaroxaban|Overall Study||0
8810378|NCT01507051|9863239|FG000|COMPLETED|Overall Study||27
8810379|NCT01507051|9863240|FG001|COMPLETED|Overall Study||28
8810380|NCT01507051|9863241|FG002|COMPLETED|Overall Study||28
8810381|NCT01507051|9863242|FG003|COMPLETED|Overall Study||0
8810382|NCT01507051|9863239|FG000|NOT COMPLETED|Overall Study||2
8810383|NCT01507051|9863240|FG001|NOT COMPLETED|Overall Study||3
8810384|NCT01507051|9863241|FG002|NOT COMPLETED|Overall Study||1
8810385|NCT01507051|9863242|FG003|NOT COMPLETED|Overall Study||7
8810386|NCT01507090|9863252|FG000|STARTED|Overall Study||642
8810387|NCT01507090|9863252|FG000|COMPLETED|Overall Study||624
8810388|NCT01507090|9863252|FG000|NOT COMPLETED|Overall Study||18
8810389|NCT01507103|9863264|FG000|STARTED|Overall Study||41
8810390|NCT01507103|9863265|FG001|STARTED|Overall Study||41
8810391|NCT01507103|9863266|FG002|STARTED|Overall Study||42
8810392|NCT01507103|9863264|FG000|COMPLETED|Overall Study||41
8810393|NCT01507103|9863265|FG001|COMPLETED|Overall Study||41
8810394|NCT01507103|9863266|FG002|COMPLETED|Overall Study||42
8810395|NCT01507103|9863264|FG000|NOT COMPLETED|Overall Study||0
8810396|NCT01507103|9863265|FG001|NOT COMPLETED|Overall Study||0
8810397|NCT01507103|9863266|FG002|NOT COMPLETED|Overall Study||0
8810398|NCT01507155|9863274|FG000|STARTED|Overall Study||625
8810399|NCT01507155|9863275|FG001|STARTED|Overall Study||60
8810400|NCT01507155|9863274|FG000|COMPLETED|Overall Study||625
8810401|NCT01507155|9863275|FG001|COMPLETED|Overall Study||60
8810402|NCT01507155|9863274|FG000|NOT COMPLETED|Overall Study||0
8810403|NCT01507155|9863275|FG001|NOT COMPLETED|Overall Study||0
8810404|NCT01507181|9863282|FG000|STARTED|Overall Study||12
8810405|NCT01507181|9863283|FG001|STARTED|Overall Study||12
8810406|NCT01507181|9863282|FG000|COMPLETED|Overall Study||12
8810407|NCT01507181|9863283|FG001|COMPLETED|Overall Study||12
8810408|NCT01507181|9863282|FG000|NOT COMPLETED|Overall Study||0
8810409|NCT01507181|9863283|FG001|NOT COMPLETED|Overall Study||0
8810410|NCT01507220|9863291|FG000|STARTED|Overall Study||2
8810411|NCT01507220|9863292|FG001|STARTED|Overall Study||0
8810412|NCT01507220|9863291|FG000|COMPLETED|Overall Study||2
8810413|NCT01507220|9863292|FG001|COMPLETED|Overall Study||0
8810414|NCT01507220|9863291|FG000|NOT COMPLETED|Overall Study||0
8810415|NCT01507220|9863292|FG001|NOT COMPLETED|Overall Study||0
8810416|NCT01507246|9863300|FG000|STARTED|Overall Study||20
8810417|NCT01507246|9863301|FG001|STARTED|Overall Study||22
8810418|NCT01507246|9863300|FG000|COMPLETED|Overall Study||18
8810419|NCT01507246|9863301|FG001|COMPLETED|Overall Study||21
8810420|NCT01507246|9863300|FG000|NOT COMPLETED|Overall Study||2
8810421|NCT01507246|9863301|FG001|NOT COMPLETED|Overall Study||1
8810422|NCT01507298|9863312|FG000|STARTED|Overall Study||1
8810423|NCT01507298|9863313|FG001|STARTED|Overall Study||20
8810424|NCT01507298|9863312|FG000|COMPLETED|Overall Study||1
8810425|NCT01507298|9863313|FG001|COMPLETED|Overall Study||14
8810426|NCT01507298|9863312|FG000|NOT COMPLETED|Overall Study||0
8810427|NCT01507298|9863313|FG001|NOT COMPLETED|Overall Study||6
8810428|NCT01507350|9863320|FG000|STARTED|Overall Study||9
8810429|NCT01507350|9863320|FG000|COMPLETED|Overall Study||9
8810430|NCT01507350|9863320|FG000|NOT COMPLETED|Overall Study||0
8810431|NCT01507493|9863326|FG000|STARTED|Overall Study||22
8810432|NCT01507493|9863327|FG001|STARTED|Overall Study||178
8810433|NCT01507493|9863326|FG000|COMPLETED|Overall Study||22
8810434|NCT01507493|9863327|FG001|COMPLETED|Overall Study||178
8810435|NCT01507493|9863326|FG000|NOT COMPLETED|Overall Study||0
8810436|NCT01507493|9863327|FG001|NOT COMPLETED|Overall Study||0
8810437|NCT01507662|9863335|FG000|STARTED|Overall Study||3898
8810438|NCT01507662|9863336|FG001|STARTED|Overall Study||3851
8810439|NCT01507662|9863335|FG000|COMPLETED|Overall Study||3082
8810440|NCT01507662|9863336|FG001|COMPLETED|Overall Study||3020
8810441|NCT01507662|9863335|FG000|NOT COMPLETED|Overall Study||816
8810442|NCT01507662|9863336|FG001|NOT COMPLETED|Overall Study||831
8810443|NCT01507688|9863344|FG000|STARTED|Baseline to 6 Month Assessment||129
8810444|NCT01507688|9863345|FG001|STARTED|Baseline to 6 Month Assessment||129
8810445|NCT01507688|9863344|FG000|COMPLETED|Baseline to 6 Month Assessment||113
8810446|NCT01507688|9863345|FG001|COMPLETED|Baseline to 6 Month Assessment||119
8810447|NCT01507688|9863344|FG000|NOT COMPLETED|Baseline to 6 Month Assessment||16
8810448|NCT01507688|9863345|FG001|NOT COMPLETED|Baseline to 6 Month Assessment||10
8810449|NCT01507688|9863344|FG000|STARTED|6 Month to 12 Month Assessment||113
8810450|NCT01507688|9863345|FG001|STARTED|6 Month to 12 Month Assessment||119
8810451|NCT01507688|9863344|FG000|COMPLETED|6 Month to 12 Month Assessment||108
8810452|NCT01507688|9863345|FG001|COMPLETED|6 Month to 12 Month Assessment||116
8810453|NCT01507688|9863344|FG000|NOT COMPLETED|6 Month to 12 Month Assessment||5
8810454|NCT01507688|9863345|FG001|NOT COMPLETED|6 Month to 12 Month Assessment||3
8810455|NCT01507779|9863353|FG000|STARTED|Overall Study||23
8810456|NCT01507779|9863354|FG001|STARTED|Overall Study||25
8810457|NCT01507779|9863353|FG000|COMPLETED|Overall Study||23
8810458|NCT01507779|9863354|FG001|COMPLETED|Overall Study||25
8810459|NCT01507779|9863353|FG000|NOT COMPLETED|Overall Study||0
8810460|NCT01507779|9863354|FG001|NOT COMPLETED|Overall Study||0
8810461|NCT01507831|9863364|FG000|STARTED|Overall Study|Randomized|788
8810462|NCT01507831|9863365|FG001|STARTED|Overall Study|Randomized|1553
8810463|NCT01507831|9863364|FG000|Treated|Overall Study||788
8810464|NCT01507831|9863365|FG001|Treated|Overall Study||1550
8810465|NCT01507831|9863364|FG000|COMPLETED|Overall Study||595
8810466|NCT01507831|9863365|FG001|COMPLETED|Overall Study||1113
8810467|NCT01507831|9863364|FG000|NOT COMPLETED|Overall Study||193
8810468|NCT01507831|9863365|FG001|NOT COMPLETED|Overall Study||440
8810469|NCT01507896|9863371|FG000|STARTED|Overall Study|30 unique participants had 40 surgeries planned (participants could have multiple surgeries).|30
8810470|NCT01507896|9863371|FG000|COMPLETED|Overall Study|28 unique participants had 38 surgeries (participants could have multiple surgeries).|28
8810471|NCT01507896|9863371|FG000|NOT COMPLETED|Overall Study||2
8810472|NCT01507987|9863384|FG000|STARTED|Overall Study||982
8810473|NCT01507987|9863385|FG001|STARTED|Overall Study||670
8810474|NCT01507987|9863386|FG002|STARTED|Overall Study||458
8810475|NCT01507987|9863387|FG003|STARTED|Overall Study||737
8810476|NCT01507987|9863384|FG000|COMPLETED|Overall Study||618
8810477|NCT01507987|9863385|FG001|COMPLETED|Overall Study||335
8810478|NCT01507987|9863386|FG002|COMPLETED|Overall Study||252
8810479|NCT01507987|9863387|FG003|COMPLETED|Overall Study||480
8810480|NCT01507987|9863384|FG000|NOT COMPLETED|Overall Study||364
8810481|NCT01507987|9863385|FG001|NOT COMPLETED|Overall Study||335
8810482|NCT01507987|9863386|FG002|NOT COMPLETED|Overall Study||206
8810483|NCT01507987|9863387|FG003|NOT COMPLETED|Overall Study||257
8810484|NCT01508013|9863416|FG000|STARTED|Overall Study||214
8810485|NCT01508013|9863417|FG001|STARTED|Overall Study||229
8810486|NCT01508013|9863416|FG000|COMPLETED|Overall Study||182
8810487|NCT01508013|9863417|FG001|COMPLETED|Overall Study||206
8810488|NCT01508013|9863416|FG000|NOT COMPLETED|Overall Study||32
8810489|NCT01508013|9863417|FG001|NOT COMPLETED|Overall Study||23
8810490|NCT01508052|9863425|FG000|STARTED|Overall Study||20
8810491|NCT01508052|9863426|FG001|STARTED|Overall Study||20
8810492|NCT01508052|9863425|FG000|COMPLETED|Overall Study||20
8810493|NCT01508052|9863426|FG001|COMPLETED|Overall Study||20
8810494|NCT01508052|9863425|FG000|NOT COMPLETED|Overall Study||0
8810495|NCT01508052|9863426|FG001|NOT COMPLETED|Overall Study||0
8810496|NCT01508117|9863432|FG000|STARTED|Overall Study||1
8810497|NCT01508117|9863432|FG000|COMPLETED|Overall Study||1
8810498|NCT01508117|9863432|FG000|NOT COMPLETED|Overall Study||0
8810499|NCT01508130|9863438|FG000|STARTED|Overall Study||493
8810500|NCT01508130|9863439|FG001|STARTED|Overall Study||142
8810501|NCT01508130|9863438|FG000|mTRT|Overall Study||493
8810502|NCT01508130|9863439|FG001|mTRT|Overall Study||142
8810503|NCT01508130|9863438|FG000|COMPLETED|Overall Study||266
8810504|NCT01508130|9863439|FG001|COMPLETED|Overall Study||73
8810505|NCT01508130|9863438|FG000|NOT COMPLETED|Overall Study||227
8810506|NCT01508130|9863439|FG001|NOT COMPLETED|Overall Study||69
8810507|NCT01508169|9863449|FG000|STARTED|Overall Study||47
8810508|NCT01508169|9863450|FG001|STARTED|Overall Study||47
8810509|NCT01508169|9863449|FG000|COMPLETED|Overall Study||44
8810510|NCT01508169|9863450|FG001|COMPLETED|Overall Study||45
8810511|NCT01508169|9863449|FG000|NOT COMPLETED|Overall Study||3
8810512|NCT01508169|9863450|FG001|NOT COMPLETED|Overall Study||2
8810513|NCT01508325|9863464|FG000|STARTED|Overall Study||93
8810514|NCT01508325|9863465|FG001|STARTED|Overall Study||93
8810515|NCT01508325|9863464|FG000|COMPLETED|Overall Study||75
8810516|NCT01508325|9863465|FG001|COMPLETED|Overall Study||72
8810517|NCT01508325|9863464|FG000|NOT COMPLETED|Overall Study||18
8810518|NCT01508325|9863465|FG001|NOT COMPLETED|Overall Study||21
8810519|NCT01508455|9863471|FG000|STARTED|Overall Study||6
8810520|NCT01508455|9863471|FG000|COMPLETED|Overall Study||6
8810521|NCT01508455|9863471|FG000|NOT COMPLETED|Overall Study||0
8810522|NCT01508650|9863477|FG000|STARTED|Overall Study||12
8810523|NCT01508650|9863478|FG001|STARTED|Overall Study||15
8810524|NCT01508650|9863477|FG000|COMPLETED|Overall Study||12
8810525|NCT01508650|9863478|FG001|COMPLETED|Overall Study||12
8810526|NCT01508650|9863477|FG000|NOT COMPLETED|Overall Study||0
8810527|NCT01508650|9863478|FG001|NOT COMPLETED|Overall Study||3
8810528|NCT01508676|9863486|FG000|STARTED|Phase I (2 Weeks)||18
8810529|NCT01508676|9863487|FG001|STARTED|Phase I (2 Weeks)||17
8810530|NCT01508676|9863486|FG000|COMPLETED|Phase I (2 Weeks)||16
8810531|NCT01508676|9863487|FG001|COMPLETED|Phase I (2 Weeks)||14
8810532|NCT01508676|9863486|FG000|NOT COMPLETED|Phase I (2 Weeks)||2
8810533|NCT01508676|9863487|FG001|NOT COMPLETED|Phase I (2 Weeks)||3
8810534|NCT01508676|9863486|FG000|STARTED|Washout Period (1 Week)||16
8925504|NCT02258477|9986658|FG000|STARTED|First Intervention (1 Week)||10
8925505|NCT02258477|9986659|FG001|STARTED|First Intervention (1 Week)||9
8925506|NCT02258477|9986660|FG002|STARTED|First Intervention (1 Week)||9
8925507|NCT02258477|9986661|FG003|STARTED|First Intervention (1 Week)||9
8925508|NCT02258477|9986658|FG000|COMPLETED|First Intervention (1 Week)||9
8925509|NCT02258477|9986659|FG001|COMPLETED|First Intervention (1 Week)||8
8925510|NCT02258477|9986660|FG002|COMPLETED|First Intervention (1 Week)||9
8925511|NCT02258477|9986661|FG003|COMPLETED|First Intervention (1 Week)||9
8925512|NCT02258477|9986658|FG000|NOT COMPLETED|First Intervention (1 Week)||1
8925513|NCT02258477|9986659|FG001|NOT COMPLETED|First Intervention (1 Week)||1
8925514|NCT02258477|9986660|FG002|NOT COMPLETED|First Intervention (1 Week)||0
8925515|NCT02258477|9986661|FG003|NOT COMPLETED|First Intervention (1 Week)||0
8925516|NCT02258477|9986658|FG000|STARTED|Second Intervention (1 Week)||9
8810535|NCT01508676|9863487|FG001|STARTED|Washout Period (1 Week)||14
8925517|NCT02258477|9986659|FG001|STARTED|Second Intervention (1 Week)||8
8925518|NCT02258477|9986660|FG002|STARTED|Second Intervention (1 Week)||9
8925519|NCT02258477|9986661|FG003|STARTED|Second Intervention (1 Week)||9
8925520|NCT02258477|9986658|FG000|COMPLETED|Second Intervention (1 Week)||9
8925521|NCT02258477|9986659|FG001|COMPLETED|Second Intervention (1 Week)||8
8925522|NCT02258477|9986660|FG002|COMPLETED|Second Intervention (1 Week)||8
8925523|NCT02258477|9986661|FG003|COMPLETED|Second Intervention (1 Week)||8
8925524|NCT02258477|9986658|FG000|NOT COMPLETED|Second Intervention (1 Week)||0
8925525|NCT02258477|9986659|FG001|NOT COMPLETED|Second Intervention (1 Week)||0
8810536|NCT01508676|9863486|FG000|COMPLETED|Washout Period (1 Week)||16
8810537|NCT01508676|9863487|FG001|COMPLETED|Washout Period (1 Week)||14
8810538|NCT01508676|9863486|FG000|NOT COMPLETED|Washout Period (1 Week)||0
8810539|NCT01508676|9863487|FG001|NOT COMPLETED|Washout Period (1 Week)||0
8810540|NCT01508676|9863486|FG000|STARTED|Phase II (2 Weeks)||16
8810541|NCT01508676|9863487|FG001|STARTED|Phase II (2 Weeks)||14
8810542|NCT01508676|9863486|FG000|COMPLETED|Phase II (2 Weeks)||15
8810543|NCT01508676|9863487|FG001|COMPLETED|Phase II (2 Weeks)||13
8810544|NCT01508676|9863486|FG000|NOT COMPLETED|Phase II (2 Weeks)||1
8810545|NCT01508676|9863487|FG001|NOT COMPLETED|Phase II (2 Weeks)||1
8810546|NCT01508702|9863496|FG000|STARTED|Overall Study||107
8810547|NCT01508702|9863497|FG001|STARTED|Overall Study||107
8810548|NCT01508702|9863496|FG000|COMPLETED|Overall Study||84
8810549|NCT01508702|9863497|FG001|COMPLETED|Overall Study||94
8810550|NCT01508702|9863496|FG000|NOT COMPLETED|Overall Study||23
8810551|NCT01508702|9863497|FG001|NOT COMPLETED|Overall Study||13
8810552|NCT01508832|9863505|FG000|STARTED|Overall Study||6
8810553|NCT01508832|9863506|FG001|STARTED|Overall Study||6
8810554|NCT01508832|9863505|FG000|COMPLETED|Overall Study||6
8810555|NCT01508832|9863506|FG001|COMPLETED|Overall Study||6
8810556|NCT01508832|9863505|FG000|NOT COMPLETED|Overall Study||0
8810557|NCT01508832|9863506|FG001|NOT COMPLETED|Overall Study||0
8810558|NCT01508910|9863515|FG000|STARTED|Randomization||57
8810559|NCT01508910|9863516|FG001|STARTED|Randomization||27
8810560|NCT01508910|9863517|FG002|STARTED|Randomization||28
8810561|NCT01508910|9863518|FG003|STARTED|Randomization|Participants not randomized into Not Injected arm, but some were re-assigned here during treatment.|0
8810562|NCT01508910|9863515|FG000|COMPLETED|Randomization||57
8810563|NCT01508910|9863516|FG001|COMPLETED|Randomization||27
8810564|NCT01508910|9863517|FG002|COMPLETED|Randomization||28
8810565|NCT01508910|9863518|FG003|COMPLETED|Randomization||0
8810566|NCT01508910|9863515|FG000|NOT COMPLETED|Randomization||0
8810567|NCT01508910|9863516|FG001|NOT COMPLETED|Randomization||0
8810568|NCT01508910|9863517|FG002|NOT COMPLETED|Randomization||0
8810569|NCT01508910|9863518|FG003|NOT COMPLETED|Randomization||0
8810570|NCT01508910|9863515|FG000|STARTED|Treatment||50
8810571|NCT01508910|9863516|FG001|STARTED|Treatment||28
8810572|NCT01508910|9863517|FG002|STARTED|Treatment||28
8810573|NCT01508910|9863518|FG003|STARTED|Treatment|3 moved from Treatment (Tx) to Active Control (AC) Arm; 6 in Not injected Arm(4 from Tx ; 2 from AC)|6
8810574|NCT01508910|9863515|FG000|COMPLETED|Treatment||48
8810575|NCT01508910|9863516|FG001|COMPLETED|Treatment||24
8810576|NCT01508910|9863517|FG002|COMPLETED|Treatment||18
8810577|NCT01508910|9863518|FG003|COMPLETED|Treatment||3
8810578|NCT01508910|9863515|FG000|NOT COMPLETED|Treatment||2
8810579|NCT01508910|9863516|FG001|NOT COMPLETED|Treatment||4
8810580|NCT01508910|9863517|FG002|NOT COMPLETED|Treatment||10
8810581|NCT01508910|9863518|FG003|NOT COMPLETED|Treatment||3
8810582|NCT01508936|9863532|FG000|STARTED|Overall Study||102
8810583|NCT01508936|9863533|FG001|STARTED|Overall Study||409
8810584|NCT01508936|9863532|FG000|Randomized, Not Analyzed|Overall Study|Participants from two centers were omitted from all analyses.|4
8810585|NCT01508936|9863533|FG001|Randomized, Not Analyzed|Overall Study|Participants from two centers were omitted from all analyses.|11
8810586|NCT01508936|9863532|FG000|Randomized|Overall Study||98
8810587|NCT01508936|9863533|FG001|Randomized|Overall Study||398
8810588|NCT01508936|9863532|FG000|Randomized, Not Treated|Overall Study||1
8810589|NCT01508936|9863533|FG001|Randomized, Not Treated|Overall Study||3
8810590|NCT01508936|9863532|FG000|Safety Analysis Set|Overall Study||97
8810591|NCT01508936|9863533|FG001|Safety Analysis Set|Overall Study||395
8810592|NCT01508936|9863532|FG000|Full Analysis Set|Overall Study||97
8810593|NCT01508936|9863533|FG001|Full Analysis Set|Overall Study||395
8810594|NCT01508936|9863532|FG000|FEV1 Subpopulation Analysis Set|Overall Study||91
8810595|NCT01508936|9863533|FG001|FEV1 Subpopulation Analysis Set|Overall Study||346
8810596|NCT01508936|9863532|FG000|COMPLETED|Overall Study||79
8810597|NCT01508936|9863533|FG001|COMPLETED|Overall Study||330
8810598|NCT01508936|9863532|FG000|NOT COMPLETED|Overall Study||23
8810599|NCT01508936|9863533|FG001|NOT COMPLETED|Overall Study||79
8810600|NCT01509040|9863542|FG000|STARTED|Overall Study||0
8810601|NCT01509040|9863543|FG001|STARTED|Overall Study||2
8810602|NCT01509040|9863544|FG002|STARTED|Overall Study||0
8810603|NCT01509040|9863542|FG000|COMPLETED|Overall Study||0
8810604|NCT01509040|9863543|FG001|COMPLETED|Overall Study||1
8810605|NCT01509040|9863544|FG002|COMPLETED|Overall Study||0
8810606|NCT01509040|9863542|FG000|NOT COMPLETED|Overall Study||0
8810607|NCT01509040|9863543|FG001|NOT COMPLETED|Overall Study||1
8810608|NCT01509040|9863544|FG002|NOT COMPLETED|Overall Study||0
8810609|NCT01509079|9863561|FG000|STARTED|Overall Study||57
8810610|NCT01509079|9863562|FG001|STARTED|Overall Study||59
8810611|NCT01509079|9863561|FG000|COMPLETED|Overall Study||57
8810612|NCT01509079|9863562|FG001|COMPLETED|Overall Study||56
8810613|NCT01509079|9863561|FG000|NOT COMPLETED|Overall Study||0
8810614|NCT01509079|9863562|FG001|NOT COMPLETED|Overall Study||3
8810615|NCT01509105|9863568|FG000|STARTED|Overall Study||649
8810616|NCT01509105|9863568|FG000|COMPLETED|Overall Study||649
8810617|NCT01509105|9863568|FG000|NOT COMPLETED|Overall Study||0
8695732|NCT00878722|9741212|FG007|NOT COMPLETED|Overall Study||7
8695733|NCT00878800|9741238|FG000|STARTED|Overall Study||3
8695734|NCT00878800|9741239|FG001|STARTED|Overall Study||7
8695735|NCT00878800|9741240|FG002|STARTED|Overall Study||9
8695736|NCT00878800|9741241|FG003|STARTED|Overall Study||6
8695737|NCT00878800|9741242|FG004|STARTED|Overall Study||16
8695738|NCT00878800|9741238|FG000|COMPLETED|Overall Study|Mean number of cycles administered: 4.0|0
8695739|NCT00878800|9741239|FG001|COMPLETED|Overall Study|Mean number of cycles administered: 4.6|0
8695740|NCT00878800|9741240|FG002|COMPLETED|Overall Study|Mean number of cycles administered: 3.0|0
8695741|NCT00878800|9741241|FG003|COMPLETED|Overall Study|Mean number of cycles administered: 5.3|0
8695742|NCT00878800|9741242|FG004|COMPLETED|Overall Study|Mean number of cycles administered: 6.4|0
8695743|NCT00878800|9741238|FG000|NOT COMPLETED|Overall Study||3
8695744|NCT00878800|9741239|FG001|NOT COMPLETED|Overall Study||7
8695745|NCT00878800|9741240|FG002|NOT COMPLETED|Overall Study||9
8695746|NCT00878800|9741241|FG003|NOT COMPLETED|Overall Study||6
8695747|NCT00878800|9741242|FG004|NOT COMPLETED|Overall Study||16
8695748|NCT00878826|9741256|FG000|STARTED|Overall Study||3
8695749|NCT00878826|9741257|FG001|STARTED|Overall Study||6
8695750|NCT00878826|9741258|FG002|STARTED|Overall Study||2
8695751|NCT00878826|9741256|FG000|COMPLETED|Overall Study||3
8695752|NCT00878826|9741257|FG001|COMPLETED|Overall Study||6
8695753|NCT00878826|9741258|FG002|COMPLETED|Overall Study||2
8695754|NCT00878826|9741256|FG000|NOT COMPLETED|Overall Study||0
8695755|NCT00878826|9741257|FG001|NOT COMPLETED|Overall Study||0
8695756|NCT00878826|9741258|FG002|NOT COMPLETED|Overall Study||0
8695757|NCT00878878|9741268|FG000|STARTED|Overall Study||15
8695758|NCT00878878|9741269|FG001|STARTED|Overall Study||15
8695759|NCT00878878|9741268|FG000|COMPLETED|Overall Study||15
8695760|NCT00878878|9741269|FG001|COMPLETED|Overall Study||15
8695761|NCT00878878|9741268|FG000|NOT COMPLETED|Overall Study||0
8695762|NCT00878878|9741269|FG001|NOT COMPLETED|Overall Study||0
8695763|NCT00878995|9741279|FG000|STARTED|Baseline Study - Midpoint Study||12
8695764|NCT00878995|9741280|FG001|STARTED|Baseline Study - Midpoint Study||12
8695765|NCT00878995|9741279|FG000|Baseline Study|Baseline Study - Midpoint Study||12
8695766|NCT00878995|9741280|FG001|Baseline Study|Baseline Study - Midpoint Study||12
8695767|NCT00878995|9741279|FG000|COMPLETED|Baseline Study - Midpoint Study||12
8695768|NCT00878995|9741280|FG001|COMPLETED|Baseline Study - Midpoint Study|2 subjects dropped after the baseline study. They decided to seek treatment closer to home.|10
8695769|NCT00878995|9741279|FG000|NOT COMPLETED|Baseline Study - Midpoint Study||0
8695770|NCT00878995|9741280|FG001|NOT COMPLETED|Baseline Study - Midpoint Study||2
8695771|NCT00878995|9741279|FG000|STARTED|Midpoint Study - Post Study||12
8695772|NCT00878995|9741280|FG001|STARTED|Midpoint Study - Post Study||10
8695773|NCT00878995|9741279|FG000|COMPLETED|Midpoint Study - Post Study||12
8695774|NCT00878995|9741280|FG001|COMPLETED|Midpoint Study - Post Study||10
8695775|NCT00878995|9741279|FG000|NOT COMPLETED|Midpoint Study - Post Study||0
8695776|NCT00878995|9741280|FG001|NOT COMPLETED|Midpoint Study - Post Study||0
8695777|NCT00879034|9741286|FG000|STARTED|Overall Study||5
8810618|NCT01509183|9863574|FG000|STARTED|Overall Study||250
8810619|NCT01509183|9863575|FG001|STARTED|Overall Study||245
8810620|NCT01509183|9863574|FG000|COMPLETED|Overall Study||141
8695778|NCT00879034|9741286|FG000|Received Treatment|Overall Study||4
8695779|NCT00879034|9741286|FG000|COMPLETED|Overall Study||5
8695780|NCT00879034|9741286|FG000|NOT COMPLETED|Overall Study||0
8695781|NCT00879060|9741292|FG000|STARTED|Overall Study||26
8695782|NCT00879060|9741293|FG001|STARTED|Overall Study||27
8695783|NCT00879060|9741292|FG000|COMPLETED|Overall Study||26
8695784|NCT00879060|9741293|FG001|COMPLETED|Overall Study||27
8695785|NCT00879060|9741292|FG000|NOT COMPLETED|Overall Study||0
8695786|NCT00879060|9741293|FG001|NOT COMPLETED|Overall Study||0
8695787|NCT00879190|9741304|FG000|STARTED|Overall Study||43
8810621|NCT01509183|9863575|FG001|COMPLETED|Overall Study||134
8810622|NCT01509183|9863574|FG000|NOT COMPLETED|Overall Study||109
8810623|NCT01509183|9863575|FG001|NOT COMPLETED|Overall Study||111
8810624|NCT01509404|9863585|FG000|STARTED|Overall Study||20
8810625|NCT01509404|9863586|FG001|STARTED|Overall Study||20
8810626|NCT01509404|9863585|FG000|COMPLETED|Overall Study||20
8810627|NCT01509404|9863586|FG001|COMPLETED|Overall Study||20
8810628|NCT01509404|9863585|FG000|NOT COMPLETED|Overall Study||0
8810629|NCT01509404|9863586|FG001|NOT COMPLETED|Overall Study||0
8810630|NCT01509547|9863594|FG000|STARTED|Overall Study||77
8810631|NCT01509547|9863595|FG001|STARTED|Overall Study||80
8810632|NCT01509547|9863594|FG000|COMPLETED|Overall Study||42
8810633|NCT01509547|9863595|FG001|COMPLETED|Overall Study||41
8810634|NCT01509547|9863594|FG000|NOT COMPLETED|Overall Study||35
8810635|NCT01509547|9863595|FG001|NOT COMPLETED|Overall Study||39
8849135|NCT01738594|9904279|FG000|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
8849136|NCT01738594|9904280|FG001|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
8849137|NCT01738594|9904281|FG002|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
8849138|NCT01738594|9904282|FG003|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
8849139|NCT01738594|9904283|FG004|NOT COMPLETED|Went on to Continue Treatment Cycle 5||1
8849140|NCT01738594|9904284|FG005|NOT COMPLETED|Went on to Continue Treatment Cycle 5||1
8849141|NCT01738594|9904285|FG006|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
8849142|NCT01738594|9904286|FG007|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
8849143|NCT01738594|9904279|FG000|STARTED|Follow up for 1 Year||0
8849144|NCT01738594|9904280|FG001|STARTED|Follow up for 1 Year||2
8849145|NCT01738594|9904281|FG002|STARTED|Follow up for 1 Year||0
8849146|NCT01738594|9904282|FG003|STARTED|Follow up for 1 Year||0
8849147|NCT01738594|9904283|FG004|STARTED|Follow up for 1 Year||1
8849148|NCT01738594|9904284|FG005|STARTED|Follow up for 1 Year||3
8849149|NCT01738594|9904285|FG006|STARTED|Follow up for 1 Year||0
8849150|NCT01738594|9904286|FG007|STARTED|Follow up for 1 Year||0
8849151|NCT01738594|9904279|FG000|COMPLETED|Follow up for 1 Year||0
8849152|NCT01738594|9904280|FG001|COMPLETED|Follow up for 1 Year||2
8849153|NCT01738594|9904281|FG002|COMPLETED|Follow up for 1 Year||0
8849154|NCT01738594|9904282|FG003|COMPLETED|Follow up for 1 Year||0
8849155|NCT01738594|9904283|FG004|COMPLETED|Follow up for 1 Year||1
8849156|NCT01738594|9904284|FG005|COMPLETED|Follow up for 1 Year||0
8849157|NCT01738594|9904285|FG006|COMPLETED|Follow up for 1 Year||0
8849158|NCT01738594|9904286|FG007|COMPLETED|Follow up for 1 Year||0
8849159|NCT01738594|9904279|FG000|NOT COMPLETED|Follow up for 1 Year||0
8849160|NCT01738594|9904280|FG001|NOT COMPLETED|Follow up for 1 Year||0
8849161|NCT01738594|9904281|FG002|NOT COMPLETED|Follow up for 1 Year||0
8849162|NCT01738594|9904282|FG003|NOT COMPLETED|Follow up for 1 Year||0
8849163|NCT01738594|9904283|FG004|NOT COMPLETED|Follow up for 1 Year||0
8849164|NCT01738594|9904284|FG005|NOT COMPLETED|Follow up for 1 Year||3
8849165|NCT01738594|9904285|FG006|NOT COMPLETED|Follow up for 1 Year||0
8849166|NCT01738594|9904286|FG007|NOT COMPLETED|Follow up for 1 Year||0
8849167|NCT01738646|9904296|FG000|STARTED|Overall Study||40
8849168|NCT01738646|9904296|FG000|COMPLETED|Overall Study|Participants who discontinued study drug for any reason.|38
8849169|NCT01738646|9904296|FG000|NOT COMPLETED|Overall Study||2
8849170|NCT01738672|9904301|FG000|STARTED|Overall Study||16
8849171|NCT01738672|9904301|FG000|COMPLETED|Overall Study||11
8695788|NCT00879190|9741305|FG001|STARTED|Overall Study||49
8695789|NCT00879190|9741304|FG000|COMPLETED|Overall Study||43
8695790|NCT00879190|9741305|FG001|COMPLETED|Overall Study||49
8695791|NCT00879190|9741304|FG000|NOT COMPLETED|Overall Study||0
8695792|NCT00879190|9741305|FG001|NOT COMPLETED|Overall Study||0
8695793|NCT00879229|9741313|FG000|STARTED|Overall Study||25
8695794|NCT00879229|9741314|FG001|STARTED|Overall Study||15
8695795|NCT00879229|9741313|FG000|COMPLETED|Overall Study||3
8695796|NCT00879229|9741314|FG001|COMPLETED|Overall Study||1
8695797|NCT00879229|9741313|FG000|NOT COMPLETED|Overall Study||22
8695798|NCT00879229|9741314|FG001|NOT COMPLETED|Overall Study||14
8695799|NCT00879255|9741322|FG000|STARTED|Overall Study||61
8695800|NCT00879255|9741323|FG001|STARTED|Overall Study||64
8695801|NCT00879255|9741322|FG000|Received Allocated Intervention:|Overall Study||51
8695802|NCT00879255|9741323|FG001|Received Allocated Intervention:|Overall Study||56
8695803|NCT00879255|9741322|FG000|Completed Posttreatment Follow-up|Overall Study||50
8695804|NCT00879255|9741323|FG001|Completed Posttreatment Follow-up|Overall Study||55
8695805|NCT00879255|9741322|FG000|Completed 3-mo Follow-up|Overall Study||48
8695806|NCT00879255|9741323|FG001|Completed 3-mo Follow-up|Overall Study||49
8695807|NCT00879255|9741322|FG000|COMPLETED|Overall Study|Completed 6-mo follow-up|45
8695808|NCT00879255|9741323|FG001|COMPLETED|Overall Study|Completed 6-mo follow-up|45
8695809|NCT00879255|9741322|FG000|NOT COMPLETED|Overall Study||16
8695810|NCT00879255|9741323|FG001|NOT COMPLETED|Overall Study||19
8695811|NCT00879333|9741331|FG000|STARTED|Overall Study||439
8695812|NCT00879333|9741332|FG001|STARTED|Overall Study||217
8695813|NCT00879333|9741331|FG000|Discontinued Study Treatment|Overall Study||428
8695814|NCT00879333|9741332|FG001|Discontinued Study Treatment|Overall Study||217
8695815|NCT00879333|9741331|FG000|COMPLETED|Overall Study|Completed=Patients Still on Treatment; At data cutoff final analysis, 11 patients were on treatment|11
8695816|NCT00879333|9741332|FG001|COMPLETED|Overall Study||0
8695817|NCT00879333|9741331|FG000|NOT COMPLETED|Overall Study||428
8695818|NCT00879333|9741332|FG001|NOT COMPLETED|Overall Study||217
8849172|NCT01738672|9904301|FG000|NOT COMPLETED|Overall Study||5
8810636|NCT01509586|9863603|FG000|STARTED|Overall Study|Week 0|626
8810637|NCT01509586|9863604|FG001|STARTED|Overall Study|Week 0|610
8810638|NCT01509586|9863603|FG000|Week 3|Overall Study||574
8810639|NCT01509586|9863604|FG001|Week 3|Overall Study||585
8810640|NCT01509586|9863603|FG000|Week 6|Overall Study||551
8810641|NCT01509586|9863604|FG001|Week 6|Overall Study||585
8695819|NCT00879359|9741340|FG000|STARTED|Overall Study||15
8695820|NCT00879359|9741340|FG000|COMPLETED|Overall Study||15
8695821|NCT00879359|9741340|FG000|NOT COMPLETED|Overall Study||0
8810642|NCT01509586|9863603|FG000|Week 10|Overall Study||537
8810643|NCT01509586|9863604|FG001|Week 10|Overall Study||574
8925526|NCT02258477|9986660|FG002|NOT COMPLETED|Second Intervention (1 Week)||1
8925527|NCT02258477|9986661|FG003|NOT COMPLETED|Second Intervention (1 Week)||1
8925528|NCT02258477|9986658|FG000|STARTED|Third Intervention (1 Week)||9
8925529|NCT02258477|9986659|FG001|STARTED|Third Intervention (1 Week)||8
8925530|NCT02258477|9986660|FG002|STARTED|Third Intervention (1 Week)||8
8695822|NCT00879398|9741345|FG000|STARTED|Overall Study||3109
8695823|NCT00879398|9741345|FG000|COMPLETED|Overall Study||2434
8695824|NCT00879398|9741345|FG000|NOT COMPLETED|Overall Study||675
8695825|NCT00879411|9741349|FG000|STARTED|Overall Study||701
8695826|NCT00879411|9741349|FG000|COMPLETED|Overall Study||539
8695827|NCT00879411|9741349|FG000|NOT COMPLETED|Overall Study||162
8695828|NCT00879437|9741353|FG000|STARTED|Overall Study||20
8695829|NCT00879437|9741354|FG001|STARTED|Overall Study||18
8695830|NCT00879437|9741353|FG000|COMPLETED|Overall Study||19
8695831|NCT00879437|9741354|FG001|COMPLETED|Overall Study||17
8695832|NCT00879437|9741353|FG000|NOT COMPLETED|Overall Study||1
8695833|NCT00879437|9741354|FG001|NOT COMPLETED|Overall Study||1
8695834|NCT00879645|9741366|FG000|STARTED|Overall Study||9
8695835|NCT00879645|9741367|FG001|STARTED|Overall Study||6
8695836|NCT00879645|9741368|FG002|STARTED|Overall Study||6
8695837|NCT00879645|9741369|FG003|STARTED|Overall Study||7
8695838|NCT00879645|9741366|FG000|COMPLETED|Overall Study||8
8695839|NCT00879645|9741367|FG001|COMPLETED|Overall Study||6
8695840|NCT00879645|9741368|FG002|COMPLETED|Overall Study||6
8695841|NCT00879645|9741369|FG003|COMPLETED|Overall Study||7
8695842|NCT00879645|9741366|FG000|NOT COMPLETED|Overall Study||1
8695843|NCT00879645|9741367|FG001|NOT COMPLETED|Overall Study||0
8695844|NCT00879645|9741368|FG002|NOT COMPLETED|Overall Study||0
8695845|NCT00879645|9741369|FG003|NOT COMPLETED|Overall Study||0
8695846|NCT00879658|9741386|FG000|STARTED|Overall Study||50
8695847|NCT00879658|9741387|FG001|STARTED|Overall Study||49
8695848|NCT00879658|9741388|FG002|STARTED|Overall Study||43
8695849|NCT00879658|9741389|FG003|STARTED|Overall Study||46
8695850|NCT00879658|9741390|FG004|STARTED|Overall Study||42
8695851|NCT00879658|9741391|FG005|STARTED|Overall Study||51
8695852|NCT00879658|9741392|FG006|STARTED|Overall Study||16
8695853|NCT00879658|9741386|FG000|COMPLETED|Overall Study||35
8695854|NCT00879658|9741387|FG001|COMPLETED|Overall Study||44
8695855|NCT00879658|9741388|FG002|COMPLETED|Overall Study||36
8695856|NCT00879658|9741389|FG003|COMPLETED|Overall Study||42
8695857|NCT00879658|9741390|FG004|COMPLETED|Overall Study||40
8695858|NCT00879658|9741391|FG005|COMPLETED|Overall Study||50
8695859|NCT00879658|9741392|FG006|COMPLETED|Overall Study||16
8695860|NCT00879658|9741386|FG000|NOT COMPLETED|Overall Study||15
8695861|NCT00879658|9741387|FG001|NOT COMPLETED|Overall Study||5
8695862|NCT00879658|9741388|FG002|NOT COMPLETED|Overall Study||7
8695863|NCT00879658|9741389|FG003|NOT COMPLETED|Overall Study||4
8695864|NCT00879658|9741390|FG004|NOT COMPLETED|Overall Study||2
8695865|NCT00879658|9741391|FG005|NOT COMPLETED|Overall Study||1
8695866|NCT00879658|9741392|FG006|NOT COMPLETED|Overall Study||0
8695867|NCT00879684|9741414|FG000|STARTED|Stage 1: Dose Escalation||3
8695868|NCT00879684|9741415|FG001|STARTED|Stage 1: Dose Escalation||3
8695869|NCT00879684|9741416|FG002|STARTED|Stage 1: Dose Escalation||3
8695870|NCT00879684|9741417|FG003|STARTED|Stage 1: Dose Escalation||6
8695871|NCT00879684|9741418|FG004|STARTED|Stage 1: Dose Escalation||3
8695872|NCT00879684|9741419|FG005|STARTED|Stage 1: Dose Escalation||3
8695873|NCT00879684|9741420|FG006|STARTED|Stage 1: Dose Escalation||0
8695874|NCT00879684|9741414|FG000|COMPLETED|Stage 1: Dose Escalation||0
8695875|NCT00879684|9741415|FG001|COMPLETED|Stage 1: Dose Escalation||0
8695876|NCT00879684|9741416|FG002|COMPLETED|Stage 1: Dose Escalation||0
8695877|NCT00879684|9741417|FG003|COMPLETED|Stage 1: Dose Escalation||0
8695878|NCT00879684|9741418|FG004|COMPLETED|Stage 1: Dose Escalation||0
8695879|NCT00879684|9741419|FG005|COMPLETED|Stage 1: Dose Escalation||0
8695880|NCT00879684|9741420|FG006|COMPLETED|Stage 1: Dose Escalation||0
8695881|NCT00879684|9741414|FG000|NOT COMPLETED|Stage 1: Dose Escalation||3
8695882|NCT00879684|9741415|FG001|NOT COMPLETED|Stage 1: Dose Escalation||3
8695883|NCT00879684|9741416|FG002|NOT COMPLETED|Stage 1: Dose Escalation||3
8695884|NCT00879684|9741417|FG003|NOT COMPLETED|Stage 1: Dose Escalation||6
8695885|NCT00879684|9741418|FG004|NOT COMPLETED|Stage 1: Dose Escalation||3
8695886|NCT00879684|9741419|FG005|NOT COMPLETED|Stage 1: Dose Escalation||3
8695887|NCT00879684|9741420|FG006|NOT COMPLETED|Stage 1: Dose Escalation||0
8695888|NCT00879684|9741414|FG000|STARTED|Stage 2: Expanded Cohort||0
8695889|NCT00879684|9741415|FG001|STARTED|Stage 2: Expanded Cohort||0
8810644|NCT01509586|9863603|FG000|Week 14|Overall Study||528
8810645|NCT01509586|9863604|FG001|Week 14|Overall Study||566
8810646|NCT01509586|9863603|FG000|Week18|Overall Study||529
8810647|NCT01509586|9863604|FG001|Week18|Overall Study||555
8810648|NCT01509586|9863603|FG000|Week 32 (Month 6)|Overall Study||504
8810649|NCT01509586|9863604|FG001|Week 32 (Month 6)|Overall Study||523
8810650|NCT01509586|9863603|FG000|Week 46|Overall Study||483
8810651|NCT01509586|9863604|FG001|Week 46|Overall Study||494
8810652|NCT01509586|9863603|FG000|Week 58 (Month 12)|Overall Study||492
8810653|NCT01509586|9863604|FG001|Week 58 (Month 12)|Overall Study||499
8810654|NCT01509586|9863603|FG000|COMPLETED|Overall Study|final intent to treat sample|626
8810655|NCT01509586|9863604|FG001|COMPLETED|Overall Study|final intent to treat sample|610
8810656|NCT01509586|9863603|FG000|NOT COMPLETED|Overall Study||0
8810657|NCT01509586|9863604|FG001|NOT COMPLETED|Overall Study||0
8810658|NCT01509612|9863613|FG000|STARTED|Overall Study||47
8810659|NCT01509612|9863614|FG001|STARTED|Overall Study||51
8810660|NCT01509612|9863615|FG002|STARTED|Overall Study||52
8810661|NCT01509612|9863613|FG000|COMPLETED|Overall Study||47
8810662|NCT01509612|9863614|FG001|COMPLETED|Overall Study||51
8810663|NCT01509612|9863615|FG002|COMPLETED|Overall Study||52
8810664|NCT01509612|9863613|FG000|NOT COMPLETED|Overall Study||0
8810665|NCT01509612|9863614|FG001|NOT COMPLETED|Overall Study||0
8810666|NCT01509612|9863615|FG002|NOT COMPLETED|Overall Study||0
8810667|NCT01509625|9863626|FG000|STARTED|Overall Study||272
8810668|NCT01509625|9863626|FG000|COMPLETED|Overall Study||263
8810669|NCT01509625|9863626|FG000|NOT COMPLETED|Overall Study||9
8810670|NCT01509638|9863641|FG000|STARTED|Overall Study||23
8810671|NCT01509638|9863642|FG001|STARTED|Overall Study||26
8810672|NCT01509638|9863641|FG000|COMPLETED|Overall Study||20
8810673|NCT01509638|9863642|FG001|COMPLETED|Overall Study||24
8810674|NCT01509638|9863641|FG000|NOT COMPLETED|Overall Study||3
8810675|NCT01509638|9863642|FG001|NOT COMPLETED|Overall Study||2
8810676|NCT01509664|9863650|FG000|STARTED|Overall Study||49
8810677|NCT01509664|9863651|FG001|STARTED|Overall Study||49
8810678|NCT01509664|9863650|FG000|T2 Follow-up|Overall Study||45
8810679|NCT01509664|9863651|FG001|T2 Follow-up|Overall Study||38
8810680|NCT01509664|9863650|FG000|T3 Follow-up|Overall Study||40
8810681|NCT01509664|9863651|FG001|T3 Follow-up|Overall Study||33
8810682|NCT01509664|9863650|FG000|COMPLETED|Overall Study||34
8810683|NCT01509664|9863651|FG001|COMPLETED|Overall Study||28
8810684|NCT01509664|9863650|FG000|NOT COMPLETED|Overall Study||15
8810685|NCT01509664|9863651|FG001|NOT COMPLETED|Overall Study||21
8695890|NCT00879684|9741416|FG002|STARTED|Stage 2: Expanded Cohort||0
8695891|NCT00879684|9741417|FG003|STARTED|Stage 2: Expanded Cohort||0
8695892|NCT00879684|9741418|FG004|STARTED|Stage 2: Expanded Cohort||0
8810686|NCT01509677|9863659|FG000|STARTED|Overall Study||79
8810687|NCT01509677|9863660|FG001|STARTED|Overall Study||79
8810688|NCT01509677|9863659|FG000|COMPLETED|Overall Study||76
8810689|NCT01509677|9863660|FG001|COMPLETED|Overall Study||73
8810690|NCT01509677|9863659|FG000|NOT COMPLETED|Overall Study||3
8810691|NCT01509677|9863660|FG001|NOT COMPLETED|Overall Study||6
8810692|NCT01509807|9863668|FG000|STARTED|Overall Study||16
8810693|NCT01509807|9863669|FG001|STARTED|Overall Study||17
8695893|NCT00879684|9741419|FG005|STARTED|Stage 2: Expanded Cohort||0
8695894|NCT00879684|9741420|FG006|STARTED|Stage 2: Expanded Cohort||13
8695895|NCT00879684|9741414|FG000|COMPLETED|Stage 2: Expanded Cohort||0
8695896|NCT00879684|9741415|FG001|COMPLETED|Stage 2: Expanded Cohort||0
8695897|NCT00879684|9741416|FG002|COMPLETED|Stage 2: Expanded Cohort||0
8695898|NCT00879684|9741417|FG003|COMPLETED|Stage 2: Expanded Cohort||0
8695899|NCT00879684|9741418|FG004|COMPLETED|Stage 2: Expanded Cohort||0
8695900|NCT00879684|9741419|FG005|COMPLETED|Stage 2: Expanded Cohort||0
8695901|NCT00879684|9741420|FG006|COMPLETED|Stage 2: Expanded Cohort||0
8695902|NCT00879684|9741414|FG000|NOT COMPLETED|Stage 2: Expanded Cohort||0
8695903|NCT00879684|9741415|FG001|NOT COMPLETED|Stage 2: Expanded Cohort||0
8695904|NCT00879684|9741416|FG002|NOT COMPLETED|Stage 2: Expanded Cohort||0
8695905|NCT00879684|9741417|FG003|NOT COMPLETED|Stage 2: Expanded Cohort||0
8695906|NCT00879684|9741418|FG004|NOT COMPLETED|Stage 2: Expanded Cohort||0
8695907|NCT00879684|9741419|FG005|NOT COMPLETED|Stage 2: Expanded Cohort||0
8695908|NCT00879684|9741420|FG006|NOT COMPLETED|Stage 2: Expanded Cohort||13
8695909|NCT00879697|9741441|FG000|STARTED|Overall Study|Seventeen patients achieved inclusion and exclusion criteria|17
8695910|NCT00879697|9741442|FG001|STARTED|Overall Study|Seventeen patients achieved inclusion and exclusion criteria|17
8695911|NCT00879697|9741441|FG000|COMPLETED|Overall Study|Two patients did not finish the trial|15
8695912|NCT00879697|9741442|FG001|COMPLETED|Overall Study|Two patients did not finish the trial|15
8695913|NCT00879697|9741441|FG000|NOT COMPLETED|Overall Study||2
8695914|NCT00879697|9741442|FG001|NOT COMPLETED|Overall Study||2
8695915|NCT00879710|9741450|FG000|STARTED|Phase 1 - 6 Weeks|Started with simvastatin 40 mg as the starting drug|12
8695916|NCT00879710|9741451|FG001|STARTED|Phase 1 - 6 Weeks|Started with simvastatin 40 mg as the starting drug|17
8695917|NCT00879710|9741452|FG002|STARTED|Phase 1 - 6 Weeks|Started with ezetimibe 10 mg as the starting drug|11
8695918|NCT00879710|9741453|FG003|STARTED|Phase 1 - 6 Weeks|Started with ezetimibe 10 mg as the starting drug|17
8695919|NCT00879710|9741450|FG000|COMPLETED|Phase 1 - 6 Weeks||10
8695920|NCT00879710|9741451|FG001|COMPLETED|Phase 1 - 6 Weeks||14
8695921|NCT00879710|9741452|FG002|COMPLETED|Phase 1 - 6 Weeks||9
8695922|NCT00879710|9741453|FG003|COMPLETED|Phase 1 - 6 Weeks||13
8810694|NCT01509807|9863668|FG000|COMPLETED|Overall Study||15
8810695|NCT01509807|9863669|FG001|COMPLETED|Overall Study||16
8810696|NCT01509807|9863668|FG000|NOT COMPLETED|Overall Study||1
8810697|NCT01509807|9863669|FG001|NOT COMPLETED|Overall Study||1
8810698|NCT01509846|9863680|FG000|STARTED|Received Vaccination 1||5
8810699|NCT01509846|9863681|FG001|STARTED|Received Vaccination 1||20
8810700|NCT01509846|9863682|FG002|STARTED|Received Vaccination 1||20
8810701|NCT01509846|9863683|FG003|STARTED|Received Vaccination 1||20
8810702|NCT01509846|9863684|FG004|STARTED|Received Vaccination 1||17
8810703|NCT01509846|9863680|FG000|COMPLETED|Received Vaccination 1||5
8810704|NCT01509846|9863681|FG001|COMPLETED|Received Vaccination 1||20
8810705|NCT01509846|9863682|FG002|COMPLETED|Received Vaccination 1||20
8810706|NCT01509846|9863683|FG003|COMPLETED|Received Vaccination 1||20
8810707|NCT01509846|9863684|FG004|COMPLETED|Received Vaccination 1||17
8810708|NCT01509846|9863680|FG000|NOT COMPLETED|Received Vaccination 1||0
8810709|NCT01509846|9863681|FG001|NOT COMPLETED|Received Vaccination 1||0
8810710|NCT01509846|9863682|FG002|NOT COMPLETED|Received Vaccination 1||0
8810711|NCT01509846|9863683|FG003|NOT COMPLETED|Received Vaccination 1||0
8810712|NCT01509846|9863684|FG004|NOT COMPLETED|Received Vaccination 1||0
8810713|NCT01509846|9863680|FG000|STARTED|Received Vaccination 2||5
8810714|NCT01509846|9863681|FG001|STARTED|Received Vaccination 2||20
8695923|NCT00879710|9741450|FG000|NOT COMPLETED|Phase 1 - 6 Weeks||2
8695924|NCT00879710|9741451|FG001|NOT COMPLETED|Phase 1 - 6 Weeks||3
8695925|NCT00879710|9741452|FG002|NOT COMPLETED|Phase 1 - 6 Weeks||2
8810715|NCT01509846|9863682|FG002|STARTED|Received Vaccination 2||20
8810716|NCT01509846|9863683|FG003|STARTED|Received Vaccination 2||20
8810717|NCT01509846|9863684|FG004|STARTED|Received Vaccination 2||17
8810718|NCT01509846|9863680|FG000|COMPLETED|Received Vaccination 2||0
8810719|NCT01509846|9863681|FG001|COMPLETED|Received Vaccination 2||20
8810720|NCT01509846|9863682|FG002|COMPLETED|Received Vaccination 2||19
8810721|NCT01509846|9863683|FG003|COMPLETED|Received Vaccination 2||20
8810722|NCT01509846|9863684|FG004|COMPLETED|Received Vaccination 2||14
8810723|NCT01509846|9863680|FG000|NOT COMPLETED|Received Vaccination 2||5
8810724|NCT01509846|9863681|FG001|NOT COMPLETED|Received Vaccination 2||0
8810725|NCT01509846|9863682|FG002|NOT COMPLETED|Received Vaccination 2||1
8810726|NCT01509846|9863683|FG003|NOT COMPLETED|Received Vaccination 2||0
8810727|NCT01509846|9863684|FG004|NOT COMPLETED|Received Vaccination 2||3
8810728|NCT01509846|9863680|FG000|STARTED|Received Vaccination 3||0
8810729|NCT01509846|9863681|FG001|STARTED|Received Vaccination 3||20
8810730|NCT01509846|9863682|FG002|STARTED|Received Vaccination 3||19
8810731|NCT01509846|9863683|FG003|STARTED|Received Vaccination 3||20
8810732|NCT01509846|9863684|FG004|STARTED|Received Vaccination 3||14
8810733|NCT01509846|9863680|FG000|COMPLETED|Received Vaccination 3||0
8810734|NCT01509846|9863681|FG001|COMPLETED|Received Vaccination 3||19
8810735|NCT01509846|9863682|FG002|COMPLETED|Received Vaccination 3||18
8810736|NCT01509846|9863683|FG003|COMPLETED|Received Vaccination 3||19
8810737|NCT01509846|9863684|FG004|COMPLETED|Received Vaccination 3||14
8810738|NCT01509846|9863680|FG000|NOT COMPLETED|Received Vaccination 3||0
8810739|NCT01509846|9863681|FG001|NOT COMPLETED|Received Vaccination 3||1
8810740|NCT01509846|9863682|FG002|NOT COMPLETED|Received Vaccination 3||1
8810741|NCT01509846|9863683|FG003|NOT COMPLETED|Received Vaccination 3||1
8810742|NCT01509846|9863684|FG004|NOT COMPLETED|Received Vaccination 3||0
8810743|NCT01509872|9863705|FG000|STARTED|Overall Study||26
8810744|NCT01509872|9863706|FG001|STARTED|Overall Study||24
8810745|NCT01509872|9863705|FG000|Post-Intervention Assessment|Overall Study||26
8810746|NCT01509872|9863706|FG001|Post-Intervention Assessment|Overall Study||24
8810747|NCT01509872|9863705|FG000|COMPLETED|Overall Study||25
8810748|NCT01509872|9863706|FG001|COMPLETED|Overall Study||24
8810749|NCT01509872|9863705|FG000|NOT COMPLETED|Overall Study||1
8810750|NCT01509872|9863706|FG001|NOT COMPLETED|Overall Study||0
8810751|NCT01509950|9863716|FG000|STARTED|Overall Study||7
8810752|NCT01509950|9863717|FG001|STARTED|Overall Study||8
8810753|NCT01509950|9863718|FG002|STARTED|Overall Study||0
8810754|NCT01509950|9863716|FG000|COMPLETED|Overall Study||7
8810755|NCT01509950|9863717|FG001|COMPLETED|Overall Study||8
8810756|NCT01509950|9863718|FG002|COMPLETED|Overall Study||0
8810757|NCT01509950|9863716|FG000|NOT COMPLETED|Overall Study||0
8695926|NCT00879710|9741453|FG003|NOT COMPLETED|Phase 1 - 6 Weeks||4
8695927|NCT00879710|9741450|FG000|STARTED|Wash Out Period of 4 Weeks||10
8695928|NCT00879710|9741451|FG001|STARTED|Wash Out Period of 4 Weeks||14
8695929|NCT00879710|9741452|FG002|STARTED|Wash Out Period of 4 Weeks|The person who did not complete ezetimibe arm came back to complete simvastatin arm.|10
8695930|NCT00879710|9741453|FG003|STARTED|Wash Out Period of 4 Weeks||13
8695931|NCT00879710|9741450|FG000|COMPLETED|Wash Out Period of 4 Weeks||10
8695932|NCT00879710|9741451|FG001|COMPLETED|Wash Out Period of 4 Weeks||14
8695933|NCT00879710|9741452|FG002|COMPLETED|Wash Out Period of 4 Weeks||10
8695934|NCT00879710|9741453|FG003|COMPLETED|Wash Out Period of 4 Weeks||13
8695935|NCT00879710|9741450|FG000|NOT COMPLETED|Wash Out Period of 4 Weeks||0
8695936|NCT00879710|9741451|FG001|NOT COMPLETED|Wash Out Period of 4 Weeks||0
8695937|NCT00879710|9741452|FG002|NOT COMPLETED|Wash Out Period of 4 Weeks||0
8695938|NCT00879710|9741453|FG003|NOT COMPLETED|Wash Out Period of 4 Weeks||0
8695939|NCT00879710|9741450|FG000|STARTED|Phase 2 6 Weeks||10
8695940|NCT00879710|9741451|FG001|STARTED|Phase 2 6 Weeks||14
8695941|NCT00879710|9741452|FG002|STARTED|Phase 2 6 Weeks||10
8695942|NCT00879710|9741453|FG003|STARTED|Phase 2 6 Weeks||13
8695943|NCT00879710|9741450|FG000|COMPLETED|Phase 2 6 Weeks||10
8695944|NCT00879710|9741451|FG001|COMPLETED|Phase 2 6 Weeks||14
8695945|NCT00879710|9741452|FG002|COMPLETED|Phase 2 6 Weeks||10
8810758|NCT01509950|9863717|FG001|NOT COMPLETED|Overall Study||0
8810759|NCT01509950|9863718|FG002|NOT COMPLETED|Overall Study||0
8810760|NCT01510028|9863728|FG000|STARTED|Overall Study||6
8810761|NCT01510028|9863729|FG001|STARTED|Overall Study||6
8810762|NCT01510028|9863730|FG002|STARTED|Overall Study||6
8810763|NCT01510028|9863731|FG003|STARTED|Overall Study||6
8810764|NCT01510028|9863728|FG000|COMPLETED|Overall Study||5
8810765|NCT01510028|9863729|FG001|COMPLETED|Overall Study||6
8810766|NCT01510028|9863730|FG002|COMPLETED|Overall Study||6
8695946|NCT00879710|9741453|FG003|COMPLETED|Phase 2 6 Weeks||13
8695947|NCT00879710|9741450|FG000|NOT COMPLETED|Phase 2 6 Weeks||0
8695948|NCT00879710|9741451|FG001|NOT COMPLETED|Phase 2 6 Weeks||0
8695949|NCT00879710|9741452|FG002|NOT COMPLETED|Phase 2 6 Weeks||0
8695950|NCT00879710|9741453|FG003|NOT COMPLETED|Phase 2 6 Weeks||0
8695951|NCT00879775|9741463|FG000|STARTED|Overall Study||20
8695952|NCT00879775|9741464|FG001|STARTED|Overall Study||21
8695953|NCT00879775|9741463|FG000|COMPLETED|Overall Study||18
8695954|NCT00879775|9741464|FG001|COMPLETED|Overall Study||20
8695955|NCT00879775|9741463|FG000|NOT COMPLETED|Overall Study||2
8695956|NCT00879775|9741464|FG001|NOT COMPLETED|Overall Study||1
8695957|NCT00879814|9741474|FG000|STARTED|Overall Study||12
8695958|NCT00879814|9741475|FG001|STARTED|Overall Study||12
8695959|NCT00879814|9741476|FG002|STARTED|Overall Study||12
8695960|NCT00879814|9741477|FG003|STARTED|Overall Study||12
8695961|NCT00879814|9741474|FG000|COMPLETED|Overall Study||8
8695962|NCT00879814|9741475|FG001|COMPLETED|Overall Study||10
8695963|NCT00879814|9741476|FG002|COMPLETED|Overall Study||9
8695964|NCT00879814|9741477|FG003|COMPLETED|Overall Study||7
8695965|NCT00879814|9741474|FG000|NOT COMPLETED|Overall Study||4
8695966|NCT00879814|9741475|FG001|NOT COMPLETED|Overall Study||2
8695967|NCT00879814|9741476|FG002|NOT COMPLETED|Overall Study||3
8695968|NCT00879814|9741477|FG003|NOT COMPLETED|Overall Study||5
8695969|NCT00879879|9741487|FG000|STARTED|Overall Study||20
8695970|NCT00879879|9741487|FG000|COMPLETED|Overall Study||17
8695971|NCT00879879|9741487|FG000|NOT COMPLETED|Overall Study||3
8695972|NCT00879970|9741496|FG000|STARTED|Period 1 TZD Randomization||541
8695973|NCT00879970|9741497|FG001|STARTED|Period 1 TZD Randomization||392
8695974|NCT00879970|9741498|FG002|STARTED|Period 1 TZD Randomization||399
8695975|NCT00879970|9741499|FG003|STARTED|Period 1 TZD Randomization||0
8695976|NCT00879970|9741500|FG004|STARTED|Period 1 TZD Randomization||0
8695977|NCT00879970|9741496|FG000|COMPLETED|Period 1 TZD Randomization||533
8695978|NCT00879970|9741497|FG001|COMPLETED|Period 1 TZD Randomization||388
8695979|NCT00879970|9741498|FG002|COMPLETED|Period 1 TZD Randomization||393
8695980|NCT00879970|9741499|FG003|COMPLETED|Period 1 TZD Randomization||0
8695981|NCT00879970|9741500|FG004|COMPLETED|Period 1 TZD Randomization||0
8695982|NCT00879970|9741496|FG000|NOT COMPLETED|Period 1 TZD Randomization||8
8695983|NCT00879970|9741497|FG001|NOT COMPLETED|Period 1 TZD Randomization||4
8695984|NCT00879970|9741498|FG002|NOT COMPLETED|Period 1 TZD Randomization||6
8695985|NCT00879970|9741499|FG003|NOT COMPLETED|Period 1 TZD Randomization||0
8695986|NCT00879970|9741500|FG004|NOT COMPLETED|Period 1 TZD Randomization||0
8695987|NCT00879970|9741496|FG000|STARTED|Period 2 Vitamin D Randomization||0
8695988|NCT00879970|9741497|FG001|STARTED|Period 2 Vitamin D Randomization||0
8695989|NCT00879970|9741498|FG002|STARTED|Period 2 Vitamin D Randomization||0
8695990|NCT00879970|9741499|FG003|STARTED|Period 2 Vitamin D Randomization||614
8695991|NCT00879970|9741500|FG004|STARTED|Period 2 Vitamin D Randomization||607
8695992|NCT00879970|9741496|FG000|COMPLETED|Period 2 Vitamin D Randomization||0
8695993|NCT00879970|9741497|FG001|COMPLETED|Period 2 Vitamin D Randomization||0
8695994|NCT00879970|9741498|FG002|COMPLETED|Period 2 Vitamin D Randomization||0
8695995|NCT00879970|9741499|FG003|COMPLETED|Period 2 Vitamin D Randomization||610
8695996|NCT00879970|9741500|FG004|COMPLETED|Period 2 Vitamin D Randomization||600
8695997|NCT00879970|9741496|FG000|NOT COMPLETED|Period 2 Vitamin D Randomization||0
8695998|NCT00879970|9741497|FG001|NOT COMPLETED|Period 2 Vitamin D Randomization||0
8695999|NCT00879970|9741498|FG002|NOT COMPLETED|Period 2 Vitamin D Randomization||0
8696000|NCT00879970|9741499|FG003|NOT COMPLETED|Period 2 Vitamin D Randomization||4
8696001|NCT00879970|9741500|FG004|NOT COMPLETED|Period 2 Vitamin D Randomization||7
8696002|NCT00879996|9741520|FG000|STARTED|Overall Study||28
8696003|NCT00879996|9741521|FG001|STARTED|Overall Study||26
8696004|NCT00879996|9741520|FG000|COMPLETED|Overall Study||13
8696005|NCT00879996|9741521|FG001|COMPLETED|Overall Study||13
8696006|NCT00879996|9741520|FG000|NOT COMPLETED|Overall Study||15
8696007|NCT00879996|9741521|FG001|NOT COMPLETED|Overall Study||13
8696008|NCT00880009|9741529|FG000|STARTED|Overall Study||16
8696009|NCT00880009|9741529|FG000|COMPLETED|Overall Study||0
8696010|NCT00880009|9741529|FG000|NOT COMPLETED|Overall Study||16
8696011|NCT00880022|9741538|FG000|STARTED|Overall Study||23
8696012|NCT00880022|9741539|FG001|STARTED|Overall Study||24
8696013|NCT00880022|9741538|FG000|COMPLETED|Overall Study||21
8696014|NCT00880022|9741539|FG001|COMPLETED|Overall Study||21
8696015|NCT00880022|9741538|FG000|NOT COMPLETED|Overall Study||2
8696016|NCT00880022|9741539|FG001|NOT COMPLETED|Overall Study||3
8696017|NCT00880048|9741550|FG000|STARTED|Overall Study||116
8696018|NCT00880048|9741551|FG001|STARTED|Overall Study||115
8696019|NCT00880048|9741552|FG002|STARTED|Overall Study||112
8696020|NCT00880048|9741550|FG000|COMPLETED|Overall Study||88
8696021|NCT00880048|9741551|FG001|COMPLETED|Overall Study||82
8696022|NCT00880048|9741552|FG002|COMPLETED|Overall Study||77
8696023|NCT00880048|9741550|FG000|NOT COMPLETED|Overall Study||28
8696024|NCT00880048|9741551|FG001|NOT COMPLETED|Overall Study||33
8696025|NCT00880048|9741552|FG002|NOT COMPLETED|Overall Study||35
8810767|NCT01510028|9863731|FG003|COMPLETED|Overall Study||6
8810768|NCT01510028|9863728|FG000|NOT COMPLETED|Overall Study||1
8810769|NCT01510028|9863729|FG001|NOT COMPLETED|Overall Study||0
8810770|NCT01510028|9863730|FG002|NOT COMPLETED|Overall Study||0
8696026|NCT00880087|9741562|FG000|STARTED|Overall Study|Among the 166 Started, 161 received Therapeutic Hypothermia and 5 received no treatment.|166
8696027|NCT00880087|9741563|FG001|STARTED|Overall Study|Among the 163 Started, 160 received Therapeutic Normothermia and 3 received no treatment.|163
8696028|NCT00880087|9741562|FG000|COMPLETED|Overall Study|1-year vital status available for all 166 Started patients.|166
8696029|NCT00880087|9741563|FG001|COMPLETED|Overall Study|Of 161 with 1-year vital status, 158 had received Therapeutic Normothermia, 3 received no treatment.|161
8696030|NCT00880087|9741562|FG000|NOT COMPLETED|Overall Study||0
8696031|NCT00880087|9741563|FG001|NOT COMPLETED|Overall Study||2
8696032|NCT00880100|9741569|FG000|STARTED|Baseline Phase-Usual Pancreatic Enzymes||49
8696033|NCT00880100|9741569|FG000|COMPLETED|Baseline Phase-Usual Pancreatic Enzymes||48
8696034|NCT00880100|9741569|FG000|NOT COMPLETED|Baseline Phase-Usual Pancreatic Enzymes||1
8696035|NCT00880100|9741569|FG000|STARTED|Treatment Phase With Ultrase® MT12||48
8696036|NCT00880100|9741569|FG000|COMPLETED|Treatment Phase With Ultrase® MT12||45
8696037|NCT00880100|9741569|FG000|NOT COMPLETED|Treatment Phase With Ultrase® MT12||3
8696038|NCT00880165|9741575|FG000|STARTED|Overall Study||148
8696039|NCT00880165|9741576|FG001|STARTED|Overall Study||148
8696040|NCT00880165|9741575|FG000|COMPLETED|Overall Study||86
8696041|NCT00880165|9741576|FG001|COMPLETED|Overall Study||98
8696042|NCT00880165|9741575|FG000|NOT COMPLETED|Overall Study||62
8696043|NCT00880165|9741576|FG001|NOT COMPLETED|Overall Study||50
8696044|NCT00880191|9741584|FG000|STARTED|Overall Study||207
8696045|NCT00880191|9741585|FG001|STARTED|Overall Study||206
8696046|NCT00880191|9741584|FG000|Available for Primary Endpoint Analysis|Overall Study||207
8696047|NCT00880191|9741585|FG001|Available for Primary Endpoint Analysis|Overall Study||206
8696048|NCT00880191|9741584|FG000|COMPLETED|Overall Study||194
8696049|NCT00880191|9741585|FG001|COMPLETED|Overall Study||198
8696050|NCT00880191|9741584|FG000|NOT COMPLETED|Overall Study||13
8696051|NCT00880191|9741585|FG001|NOT COMPLETED|Overall Study||8
8696052|NCT00880230|9741591|FG000|STARTED|Overall Study||141
8696053|NCT00880230|9741591|FG000|COMPLETED|Overall Study||134
8696054|NCT00880230|9741591|FG000|NOT COMPLETED|Overall Study||7
8696055|NCT00880256|9741595|FG000|STARTED|Overall Study||93
8696056|NCT00880256|9741595|FG000|COMPLETED|Overall Study||65
8696057|NCT00880256|9741595|FG000|NOT COMPLETED|Overall Study||28
8696058|NCT00880269|9741601|FG000|STARTED|Overall Study||32
8696059|NCT00880269|9741602|FG001|STARTED|Overall Study||27
8696060|NCT00880269|9741601|FG000|Discontinued Treatment|Overall Study||32
8696061|NCT00880269|9741602|FG001|Discontinued Treatment|Overall Study||27
8696062|NCT00880269|9741601|FG000|COMPLETED|Overall Study||0
8696063|NCT00880269|9741602|FG001|COMPLETED|Overall Study||0
8696064|NCT00880269|9741601|FG000|NOT COMPLETED|Overall Study||32
8696065|NCT00880269|9741602|FG001|NOT COMPLETED|Overall Study||27
8696066|NCT00880334|9741610|FG000|STARTED|Randomized Phase||74
8696067|NCT00880334|9741611|FG001|STARTED|Randomized Phase||75
8696068|NCT00880334|9741610|FG000|Eligible & Treated|Randomized Phase||70
8696069|NCT00880334|9741611|FG001|Eligible & Treated|Randomized Phase||72
8696070|NCT00880334|9741610|FG000|COMPLETED|Randomized Phase||70
8696071|NCT00880334|9741611|FG001|COMPLETED|Randomized Phase||35
8696072|NCT00880334|9741610|FG000|NOT COMPLETED|Randomized Phase||4
8696073|NCT00880334|9741611|FG001|NOT COMPLETED|Randomized Phase||40
8696074|NCT00880334|9741610|FG000|STARTED|Crossover Phase||0
8696075|NCT00880334|9741611|FG001|STARTED|Crossover Phase|Only participants randomized to placebo and docetaxel potentially received crossover treatment.|37
8696076|NCT00880334|9741610|FG000|COMPLETED|Crossover Phase||0
8696077|NCT00880334|9741611|FG001|COMPLETED|Crossover Phase||37
8696078|NCT00880334|9741610|FG000|NOT COMPLETED|Crossover Phase||0
8696079|NCT00880334|9741611|FG001|NOT COMPLETED|Crossover Phase||0
8696080|NCT00880360|9741621|FG000|STARTED|Overall Study||19
8696081|NCT00880360|9741621|FG000|COMPLETED|Overall Study||19
8696082|NCT00880360|9741621|FG000|NOT COMPLETED|Overall Study||0
8696083|NCT00880399|9741629|FG000|STARTED|Overall Study||108
8696084|NCT00880399|9741630|FG001|STARTED|Overall Study||113
8696085|NCT00880399|9741631|FG002|STARTED|Overall Study||107
8696086|NCT00880399|9741629|FG000|COMPLETED|Overall Study||77
8696087|NCT00880399|9741630|FG001|COMPLETED|Overall Study||84
8696088|NCT00880399|9741631|FG002|COMPLETED|Overall Study||81
8696089|NCT00880399|9741629|FG000|NOT COMPLETED|Overall Study||31
8696090|NCT00880399|9741630|FG001|NOT COMPLETED|Overall Study||29
8696091|NCT00880399|9741631|FG002|NOT COMPLETED|Overall Study||26
8696092|NCT00880425|9741639|FG000|STARTED|Overall Study||18
8696093|NCT00880425|9741640|FG001|STARTED|Overall Study||27
8696094|NCT00880425|9741639|FG000|COMPLETED|Overall Study||18
8696095|NCT00880425|9741640|FG001|COMPLETED|Overall Study||27
8696096|NCT00880425|9741639|FG000|NOT COMPLETED|Overall Study||0
8696097|NCT00880425|9741640|FG001|NOT COMPLETED|Overall Study||0
8696098|NCT00880464|9741646|FG000|STARTED|Overall Study||7
8810771|NCT01510028|9863731|FG003|NOT COMPLETED|Overall Study||0
8696099|NCT00880464|9741646|FG000|COMPLETED|Overall Study||7
8696100|NCT00880464|9741646|FG000|NOT COMPLETED|Overall Study||0
8696101|NCT00880555|9741653|FG000|STARTED|Overall Study||23
8696102|NCT00880555|9741654|FG001|STARTED|Overall Study||40
8696103|NCT00880555|9741655|FG002|STARTED|Overall Study||11
8696104|NCT00880555|9741656|FG003|STARTED|Overall Study||2
8696105|NCT00880555|9741657|FG004|STARTED|Overall Study||1
8696106|NCT00880555|9741658|FG005|STARTED|Overall Study||1
8696107|NCT00880555|9741653|FG000|COMPLETED|Overall Study||13
8696108|NCT00880555|9741654|FG001|COMPLETED|Overall Study||23
8696109|NCT00880555|9741655|FG002|COMPLETED|Overall Study||6
8696110|NCT00880555|9741656|FG003|COMPLETED|Overall Study||0
8696111|NCT00880555|9741657|FG004|COMPLETED|Overall Study||0
8810772|NCT01510145|9863743|FG000|STARTED|Overall Study||191
8810773|NCT01510145|9863743|FG000|COMPLETED|Overall Study||173
8810774|NCT01510145|9863743|FG000|NOT COMPLETED|Overall Study||18
8810775|NCT01510158|9863750|FG000|STARTED|Overall Study||202
8810776|NCT01510158|9863751|FG001|STARTED|Overall Study||203
8810777|NCT01510158|9863752|FG002|STARTED|Overall Study||202
8810778|NCT01510158|9863750|FG000|COMPLETED|Overall Study||151
8810779|NCT01510158|9863751|FG001|COMPLETED|Overall Study||150
8810780|NCT01510158|9863752|FG002|COMPLETED|Overall Study||152
8696112|NCT00880555|9741658|FG005|COMPLETED|Overall Study||0
8696113|NCT00880555|9741653|FG000|NOT COMPLETED|Overall Study||10
8696114|NCT00880555|9741654|FG001|NOT COMPLETED|Overall Study||17
8696115|NCT00880555|9741655|FG002|NOT COMPLETED|Overall Study||5
8696116|NCT00880555|9741656|FG003|NOT COMPLETED|Overall Study||2
8696117|NCT00880555|9741657|FG004|NOT COMPLETED|Overall Study||1
8696118|NCT00880555|9741658|FG005|NOT COMPLETED|Overall Study||1
8696119|NCT00880568|9741678|FG000|STARTED|Overall Study||3
8696120|NCT00880568|9741679|FG001|STARTED|Overall Study||3
8696121|NCT00880568|9741680|FG002|STARTED|Overall Study||3
8696122|NCT00880568|9741681|FG003|STARTED|Overall Study||1
8696123|NCT00880568|9741682|FG004|STARTED|Overall Study||3
8696124|NCT00880568|9741683|FG005|STARTED|Overall Study||3
8696125|NCT00880568|9741684|FG006|STARTED|Overall Study||6
8696126|NCT00880568|9741685|FG007|STARTED|Overall Study||2
8696127|NCT00880568|9741686|FG008|STARTED|Overall Study||3
8696128|NCT00880568|9741678|FG000|COMPLETED|Overall Study||0
8696129|NCT00880568|9741679|FG001|COMPLETED|Overall Study||0
8696130|NCT00880568|9741680|FG002|COMPLETED|Overall Study||0
8696131|NCT00880568|9741681|FG003|COMPLETED|Overall Study||0
8696132|NCT00880568|9741682|FG004|COMPLETED|Overall Study||0
8696133|NCT00880568|9741683|FG005|COMPLETED|Overall Study||0
8696134|NCT00880568|9741684|FG006|COMPLETED|Overall Study||0
8696135|NCT00880568|9741685|FG007|COMPLETED|Overall Study||0
8696136|NCT00880568|9741686|FG008|COMPLETED|Overall Study||0
8696137|NCT00880568|9741678|FG000|NOT COMPLETED|Overall Study||3
8696138|NCT00880568|9741679|FG001|NOT COMPLETED|Overall Study||3
8696139|NCT00880568|9741680|FG002|NOT COMPLETED|Overall Study||3
8696140|NCT00880568|9741681|FG003|NOT COMPLETED|Overall Study||1
8696141|NCT00880568|9741682|FG004|NOT COMPLETED|Overall Study||3
8696142|NCT00880568|9741683|FG005|NOT COMPLETED|Overall Study||3
8696143|NCT00880568|9741684|FG006|NOT COMPLETED|Overall Study||6
8696144|NCT00880568|9741685|FG007|NOT COMPLETED|Overall Study||2
8696145|NCT00880568|9741686|FG008|NOT COMPLETED|Overall Study||3
8696146|NCT00880581|9741711|FG000|STARTED|Cycle 1||30
8696147|NCT00880581|9741711|FG000|COMPLETED|Cycle 1||30
8696148|NCT00880581|9741711|FG000|NOT COMPLETED|Cycle 1||0
8696149|NCT00880581|9741711|FG000|STARTED|Cycle 2 Re-treatment|6 subjects with progessive disease were not treated and evaluated in Cycle 2|24
8696150|NCT00880581|9741711|FG000|COMPLETED|Cycle 2 Re-treatment||24
8696151|NCT00880581|9741711|FG000|NOT COMPLETED|Cycle 2 Re-treatment||0
8696152|NCT00880607|9741717|FG000|STARTED|Overall Study||44
8696153|NCT00880607|9741718|FG001|STARTED|Overall Study||37
8696154|NCT00880607|9741717|FG000|Observation After Receiving Medication|Overall Study||42
8696155|NCT00880607|9741718|FG001|Observation After Receiving Medication|Overall Study||35
8696156|NCT00880607|9741717|FG000|COMPLETED|Overall Study||37
8696157|NCT00880607|9741718|FG001|COMPLETED|Overall Study||34
8696158|NCT00880607|9741717|FG000|NOT COMPLETED|Overall Study||7
8696159|NCT00880607|9741718|FG001|NOT COMPLETED|Overall Study||3
8696160|NCT00880620|9741730|FG000|STARTED|Overall Study||92
8696161|NCT00880620|9741731|FG001|STARTED|Overall Study||87
8696162|NCT00880620|9741732|FG002|STARTED|Overall Study||104
8696163|NCT00880620|9741733|FG003|STARTED|Overall Study||98
8696164|NCT00880620|9741730|FG000|Week 4|Overall Study||88
8696165|NCT00880620|9741731|FG001|Week 4|Overall Study||79
8696166|NCT00880620|9741732|FG002|Week 4|Overall Study||94
8696167|NCT00880620|9741733|FG003|Week 4|Overall Study||86
8696168|NCT00880620|9741730|FG000|Week 9|Overall Study||80
8696169|NCT00880620|9741731|FG001|Week 9|Overall Study||73
8696170|NCT00880620|9741732|FG002|Week 9|Overall Study||88
8696171|NCT00880620|9741733|FG003|Week 9|Overall Study||78
8696172|NCT00880620|9741730|FG000|Week 16|Overall Study||74
8696173|NCT00880620|9741731|FG001|Week 16|Overall Study||73
8696174|NCT00880620|9741732|FG002|Week 16|Overall Study||87
8696175|NCT00880620|9741733|FG003|Week 16|Overall Study||74
8696176|NCT00880620|9741730|FG000|Week 23|Overall Study||71
8696177|NCT00880620|9741731|FG001|Week 23|Overall Study||72
8696178|NCT00880620|9741732|FG002|Week 23|Overall Study||85
8696179|NCT00880620|9741733|FG003|Week 23|Overall Study||74
8696180|NCT00880620|9741730|FG000|COMPLETED|Overall Study||71
8810781|NCT01510158|9863750|FG000|NOT COMPLETED|Overall Study||51
8696181|NCT00880620|9741731|FG001|COMPLETED|Overall Study||72
8696182|NCT00880620|9741732|FG002|COMPLETED|Overall Study||83
8696183|NCT00880620|9741733|FG003|COMPLETED|Overall Study||74
8810782|NCT01510158|9863751|FG001|NOT COMPLETED|Overall Study||53
8696184|NCT00880620|9741730|FG000|NOT COMPLETED|Overall Study||21
8696185|NCT00880620|9741731|FG001|NOT COMPLETED|Overall Study||15
8696186|NCT00880620|9741732|FG002|NOT COMPLETED|Overall Study||21
8696187|NCT00880620|9741733|FG003|NOT COMPLETED|Overall Study||24
8696188|NCT00880685|9741747|FG000|STARTED|Memantine 10mg||12
8696189|NCT00880685|9741747|FG000|COMPLETED|Memantine 10mg||10
8810783|NCT01510158|9863752|FG002|NOT COMPLETED|Overall Study||50
8810784|NCT01510327|9863760|FG000|STARTED|Overall Study||22
8810785|NCT01510327|9863760|FG000|COMPLETED|Overall Study||22
8810786|NCT01510327|9863760|FG000|NOT COMPLETED|Overall Study||0
8810787|NCT01510379|9863772|FG000|STARTED|Overall Study||49
8810788|NCT01510379|9863773|FG001|STARTED|Overall Study||51
8810789|NCT01510379|9863772|FG000|COMPLETED|Overall Study||49
8810790|NCT01510379|9863773|FG001|COMPLETED|Overall Study||51
8810791|NCT01510379|9863772|FG000|NOT COMPLETED|Overall Study||0
8810792|NCT01510379|9863773|FG001|NOT COMPLETED|Overall Study||0
8810793|NCT01510457|9863781|FG000|STARTED|Overall Study||17
8810794|NCT01510457|9863782|FG001|STARTED|Overall Study||29
8810795|NCT01510457|9863781|FG000|COMPLETED|Overall Study||12
8810796|NCT01510457|9863782|FG001|COMPLETED|Overall Study||26
8810797|NCT01510457|9863781|FG000|NOT COMPLETED|Overall Study||5
8810798|NCT01510457|9863782|FG001|NOT COMPLETED|Overall Study||3
8810799|NCT01510652|9863792|FG000|STARTED|Overall Study||719
8810800|NCT01510652|9863793|FG001|STARTED|Overall Study||355
8810801|NCT01510652|9863792|FG000|Baseline|Overall Study||718
8810802|NCT01510652|9863793|FG001|Baseline|Overall Study||348
8810803|NCT01510652|9863792|FG000|COMPLETED|Overall Study||627
8810804|NCT01510652|9863793|FG001|COMPLETED|Overall Study||288
8810805|NCT01510652|9863792|FG000|NOT COMPLETED|Overall Study||92
8810806|NCT01510652|9863793|FG001|NOT COMPLETED|Overall Study||67
8810807|NCT01510704|9863803|FG000|STARTED|Overall Study||54
8810808|NCT01510704|9863804|FG001|STARTED|Overall Study||58
8810809|NCT01510704|9863805|FG002|STARTED|Overall Study||50
8810810|NCT01510704|9863806|FG003|STARTED|Overall Study||53
8810811|NCT01510704|9863803|FG000|COMPLETED|Overall Study||54
8810812|NCT01510704|9863804|FG001|COMPLETED|Overall Study||58
8810813|NCT01510704|9863805|FG002|COMPLETED|Overall Study||50
8810814|NCT01510704|9863806|FG003|COMPLETED|Overall Study||53
8810815|NCT01510704|9863803|FG000|NOT COMPLETED|Overall Study||0
8810816|NCT01510704|9863804|FG001|NOT COMPLETED|Overall Study||0
8810817|NCT01510704|9863805|FG002|NOT COMPLETED|Overall Study||0
8810818|NCT01510704|9863806|FG003|NOT COMPLETED|Overall Study||0
8810819|NCT01510717|9863818|FG000|STARTED|Overall Study||155
8810820|NCT01510717|9863819|FG001|STARTED|Overall Study||165
8810821|NCT01510717|9863818|FG000|COMPLETED|Overall Study||153
8810822|NCT01510717|9863819|FG001|COMPLETED|Overall Study||160
8810823|NCT01510717|9863818|FG000|NOT COMPLETED|Overall Study||2
8810824|NCT01510717|9863819|FG001|NOT COMPLETED|Overall Study||5
8810825|NCT01510769|9863829|FG000|STARTED|Overall Study||106
8810826|NCT01510769|9863830|FG001|STARTED|Overall Study||109
8810827|NCT01510769|9863831|FG002|STARTED|Overall Study||109
8810828|NCT01510769|9863829|FG000|COMPLETED|Overall Study||79
8810829|NCT01510769|9863830|FG001|COMPLETED|Overall Study||84
8810830|NCT01510769|9863831|FG002|COMPLETED|Overall Study||87
8810831|NCT01510769|9863829|FG000|NOT COMPLETED|Overall Study||27
8810832|NCT01510769|9863830|FG001|NOT COMPLETED|Overall Study||25
8810833|NCT01510769|9863831|FG002|NOT COMPLETED|Overall Study||22
8810834|NCT01510834|9863839|FG000|STARTED|Overall Study||90
8810835|NCT01510834|9863839|FG000|COMPLETED|Overall Study||57
8810836|NCT01510834|9863839|FG000|NOT COMPLETED|Overall Study||33
8810837|NCT01510912|9863846|FG000|STARTED|Overall Study||602
8810838|NCT01510912|9863846|FG000|COMPLETED|Overall Study||360
8810839|NCT01510912|9863846|FG000|NOT COMPLETED|Overall Study||242
8810840|NCT01511016|9863852|FG000|STARTED|Overall Study||8
8810841|NCT01511016|9863853|FG001|STARTED|Overall Study||9
8810842|NCT01511016|9863852|FG000|COMPLETED|Overall Study||6
8810843|NCT01511016|9863853|FG001|COMPLETED|Overall Study||7
8810844|NCT01511016|9863852|FG000|NOT COMPLETED|Overall Study||2
8810845|NCT01511016|9863853|FG001|NOT COMPLETED|Overall Study||2
8810846|NCT01511055|9863860|FG000|STARTED|Overall Study||27
8810847|NCT01511055|9863860|FG000|COMPLETED|Overall Study||21
8810848|NCT01511055|9863860|FG000|NOT COMPLETED|Overall Study||6
8810849|NCT01511068|9863864|FG000|STARTED|Overall Study||2
8810850|NCT01511068|9863864|FG000|COMPLETED|Overall Study||2
8810851|NCT01511068|9863864|FG000|NOT COMPLETED|Overall Study||0
8810852|NCT01511107|9863870|FG000|STARTED|Overall Study|Randomized to the treatment group.|260
8810853|NCT01511107|9863871|FG001|STARTED|Overall Study|Randomized to the treatment group.|260
8810854|NCT01511107|9863870|FG000|COMPLETED|Overall Study|Completed - Assessed at a final visit in Sep or at the end of the respiratory season in Apr or May.|238
8810855|NCT01511107|9863871|FG001|COMPLETED|Overall Study|Completed - Assessed at a final visit in Sep or at the end of the respiratory season in Apr or May.|219
8810856|NCT01511107|9863870|FG000|NOT COMPLETED|Overall Study||22
8810857|NCT01511107|9863871|FG001|NOT COMPLETED|Overall Study||41
8810858|NCT01511250|9863887|FG000|STARTED|Overall Study||24
8810859|NCT01511250|9863888|FG001|STARTED|Overall Study||14
8810860|NCT01511250|9863889|FG002|STARTED|Overall Study||22
8810861|NCT01511250|9863890|FG003|STARTED|Overall Study||14
8810862|NCT01511250|9863891|FG004|STARTED|Overall Study||21
8810863|NCT01511250|9863892|FG005|STARTED|Overall Study||17
8810864|NCT01511250|9863893|FG006|STARTED|Overall Study||23
8810865|NCT01511250|9863894|FG007|STARTED|Overall Study||13
8810866|NCT01511250|9863895|FG008|STARTED|Overall Study||159
8810867|NCT01511250|9863896|FG009|STARTED|Overall Study||53
8810868|NCT01511250|9863887|FG000|COMPLETED|Overall Study||15
8810869|NCT01511250|9863888|FG001|COMPLETED|Overall Study||9
8810870|NCT01511250|9863889|FG002|COMPLETED|Overall Study||18
8810871|NCT01511250|9863890|FG003|COMPLETED|Overall Study||11
8810872|NCT01511250|9863891|FG004|COMPLETED|Overall Study||21
8810873|NCT01511250|9863892|FG005|COMPLETED|Overall Study||17
8810874|NCT01511250|9863893|FG006|COMPLETED|Overall Study||21
8810875|NCT01511250|9863894|FG007|COMPLETED|Overall Study||9
8810876|NCT01511250|9863895|FG008|COMPLETED|Overall Study||145
8810877|NCT01511250|9863896|FG009|COMPLETED|Overall Study||48
8810878|NCT01511250|9863887|FG000|NOT COMPLETED|Overall Study||9
8810879|NCT01511250|9863888|FG001|NOT COMPLETED|Overall Study||5
8810880|NCT01511250|9863889|FG002|NOT COMPLETED|Overall Study||4
8810881|NCT01511250|9863890|FG003|NOT COMPLETED|Overall Study||3
8810882|NCT01511250|9863891|FG004|NOT COMPLETED|Overall Study||0
8810883|NCT01511250|9863892|FG005|NOT COMPLETED|Overall Study||0
8810884|NCT01511250|9863893|FG006|NOT COMPLETED|Overall Study||2
8810885|NCT01511250|9863894|FG007|NOT COMPLETED|Overall Study||4
8810886|NCT01511250|9863895|FG008|NOT COMPLETED|Overall Study||14
8810887|NCT01511250|9863896|FG009|NOT COMPLETED|Overall Study||5
8810888|NCT01511315|9863918|FG000|STARTED|Overall Study||36
8810889|NCT01511315|9863918|FG000|COMPLETED|Overall Study||32
8810890|NCT01511315|9863918|FG000|NOT COMPLETED|Overall Study||4
8810891|NCT01511419|9863924|FG000|STARTED|Dose 1||30
8810892|NCT01511419|9863925|FG001|STARTED|Dose 1||10
8810893|NCT01511419|9863924|FG000|COMPLETED|Dose 1||30
8810894|NCT01511419|9863925|FG001|COMPLETED|Dose 1||10
8810895|NCT01511419|9863924|FG000|NOT COMPLETED|Dose 1||0
8810896|NCT01511419|9863925|FG001|NOT COMPLETED|Dose 1||0
8810897|NCT01511419|9863924|FG000|STARTED|Dose 2||30
8810898|NCT01511419|9863925|FG001|STARTED|Dose 2||10
8810899|NCT01511419|9863924|FG000|COMPLETED|Dose 2||29
8810900|NCT01511419|9863925|FG001|COMPLETED|Dose 2||10
8810901|NCT01511419|9863924|FG000|NOT COMPLETED|Dose 2||1
8810902|NCT01511419|9863925|FG001|NOT COMPLETED|Dose 2||0
8696190|NCT00880685|9741747|FG000|NOT COMPLETED|Memantine 10mg||2
8696191|NCT00880685|9741747|FG000|STARTED|Memantine 20mg||10
8696192|NCT00880685|9741747|FG000|COMPLETED|Memantine 20mg||9
8696193|NCT00880685|9741747|FG000|NOT COMPLETED|Memantine 20mg||1
8696194|NCT00880685|9741747|FG000|STARTED|Memantine 30mg||9
8696195|NCT00880685|9741747|FG000|COMPLETED|Memantine 30mg||9
8696196|NCT00880685|9741747|FG000|NOT COMPLETED|Memantine 30mg||0
8696197|NCT00880698|9741758|FG000|STARTED|Overall Study||62
8696198|NCT00880698|9741759|FG001|STARTED|Overall Study||64
8696199|NCT00880698|9741760|FG002|STARTED|Overall Study||37
8696200|NCT00880698|9741761|FG003|STARTED|Overall Study||39
8696201|NCT00880698|9741758|FG000|COMPLETED|Overall Study||61
8696202|NCT00880698|9741759|FG001|COMPLETED|Overall Study||61
8696203|NCT00880698|9741760|FG002|COMPLETED|Overall Study||36
8696204|NCT00880698|9741761|FG003|COMPLETED|Overall Study||36
8696205|NCT00880698|9741758|FG000|NOT COMPLETED|Overall Study||1
8696206|NCT00880698|9741759|FG001|NOT COMPLETED|Overall Study||3
8696207|NCT00880698|9741760|FG002|NOT COMPLETED|Overall Study||1
8696208|NCT00880698|9741761|FG003|NOT COMPLETED|Overall Study||3
8696209|NCT00880750|9741775|FG000|STARTED|First Intervention||39
8696210|NCT00880750|9741776|FG001|STARTED|First Intervention||33
8696211|NCT00880750|9741775|FG000|COMPLETED|First Intervention||30
8696212|NCT00880750|9741776|FG001|COMPLETED|First Intervention||32
8696213|NCT00880750|9741775|FG000|NOT COMPLETED|First Intervention||9
8696214|NCT00880750|9741776|FG001|NOT COMPLETED|First Intervention||1
8696215|NCT00880750|9741775|FG000|STARTED|Washout Period||30
8696216|NCT00880750|9741776|FG001|STARTED|Washout Period||32
8696217|NCT00880750|9741775|FG000|COMPLETED|Washout Period||30
8696218|NCT00880750|9741776|FG001|COMPLETED|Washout Period||32
8696219|NCT00880750|9741775|FG000|NOT COMPLETED|Washout Period||0
8696220|NCT00880750|9741776|FG001|NOT COMPLETED|Washout Period||0
8696221|NCT00880750|9741775|FG000|STARTED|Second Intervention||30
8696222|NCT00880750|9741776|FG001|STARTED|Second Intervention||32
8696223|NCT00880750|9741775|FG000|COMPLETED|Second Intervention||26
8696224|NCT00880750|9741776|FG001|COMPLETED|Second Intervention||30
8810903|NCT01511445|9863957|FG000|STARTED|Overall Study|Patient enrollment started in December, 2011.|53
8810904|NCT01511445|9863958|FG001|STARTED|Overall Study|Patient enrollment started in December, 2011.|51
8810905|NCT01511445|9863957|FG000|Surgeries Completed|Overall Study|All surgeries were completed by October, 2013.|53
8810906|NCT01511445|9863958|FG001|Surgeries Completed|Overall Study|All surgeries were completed by October, 2013.|51
8810907|NCT01511445|9863957|FG000|Primary Completion October, 2014|Overall Study|1 was excluded Bechterew's disease. 1 protocol violation. 3 were lost to follow-up.|48
8810908|NCT01511445|9863958|FG001|Primary Completion October, 2014|Overall Study|3 protocol violations. 1 lost to follow-up.|47
8810909|NCT01511445|9863957|FG000|Follow-up Completion|Overall Study|Two year follow-up was completed in November, 2015|48
8810910|NCT01511445|9863958|FG001|Follow-up Completion|Overall Study|Two year follow-up was completed in November, 2015|47
8810911|NCT01511445|9863957|FG000|COMPLETED|Overall Study|Data analysis was completed in February, 2016|48
8810912|NCT01511445|9863958|FG001|COMPLETED|Overall Study|Data analysis was completed in February, 2016|47
8810913|NCT01511445|9863957|FG000|NOT COMPLETED|Overall Study||5
8810914|NCT01511445|9863958|FG001|NOT COMPLETED|Overall Study||4
8810915|NCT01511536|9863967|FG000|STARTED|Phase 1||3
8810916|NCT01511536|9863968|FG001|STARTED|Phase 1||7
8810917|NCT01511536|9863969|FG002|STARTED|Phase 1|Phase 1 and phase 2 are separate populations.|0
8810918|NCT01511536|9863967|FG000|COMPLETED|Phase 1|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|3
8810919|NCT01511536|9863968|FG001|COMPLETED|Phase 1|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|6
8810920|NCT01511536|9863969|FG002|COMPLETED|Phase 1||0
8810921|NCT01511536|9863967|FG000|NOT COMPLETED|Phase 1||0
8810922|NCT01511536|9863968|FG001|NOT COMPLETED|Phase 1||1
8810923|NCT01511536|9863969|FG002|NOT COMPLETED|Phase 1||0
8810924|NCT01511536|9863967|FG000|STARTED|Phase 2||0
8810925|NCT01511536|9863968|FG001|STARTED|Phase 2||0
8810926|NCT01511536|9863969|FG002|STARTED|Phase 2||27
8810927|NCT01511536|9863967|FG000|COMPLETED|Phase 2||0
8810928|NCT01511536|9863968|FG001|COMPLETED|Phase 2||0
8810929|NCT01511536|9863969|FG002|COMPLETED|Phase 2|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|18
8810930|NCT01511536|9863967|FG000|NOT COMPLETED|Phase 2||0
8810931|NCT01511536|9863968|FG001|NOT COMPLETED|Phase 2||0
8810932|NCT01511536|9863969|FG002|NOT COMPLETED|Phase 2||9
8810933|NCT01511640|9863981|FG000|STARTED|First Intervention (11-15 Days)||7
8810934|NCT01511640|9863982|FG001|STARTED|First Intervention (11-15 Days)||8
8810935|NCT01511640|9863983|FG002|STARTED|First Intervention (11-15 Days)||7
8810936|NCT01511640|9863984|FG003|STARTED|First Intervention (11-15 Days)||8
8810937|NCT01511640|9863981|FG000|COMPLETED|First Intervention (11-15 Days)||5
8810938|NCT01511640|9863982|FG001|COMPLETED|First Intervention (11-15 Days)||8
8810939|NCT01511640|9863983|FG002|COMPLETED|First Intervention (11-15 Days)||7
8810940|NCT01511640|9863984|FG003|COMPLETED|First Intervention (11-15 Days)||7
8810941|NCT01511640|9863981|FG000|NOT COMPLETED|First Intervention (11-15 Days)||2
8810942|NCT01511640|9863982|FG001|NOT COMPLETED|First Intervention (11-15 Days)||0
8810943|NCT01511640|9863983|FG002|NOT COMPLETED|First Intervention (11-15 Days)||0
8810944|NCT01511640|9863984|FG003|NOT COMPLETED|First Intervention (11-15 Days)||1
8810945|NCT01511640|9863981|FG000|STARTED|Washout (6-10 Days)||5
8810946|NCT01511640|9863982|FG001|STARTED|Washout (6-10 Days)||8
8810947|NCT01511640|9863983|FG002|STARTED|Washout (6-10 Days)||7
8810948|NCT01511640|9863984|FG003|STARTED|Washout (6-10 Days)||7
8810949|NCT01511640|9863981|FG000|COMPLETED|Washout (6-10 Days)||5
8810950|NCT01511640|9863982|FG001|COMPLETED|Washout (6-10 Days)||8
8810951|NCT01511640|9863983|FG002|COMPLETED|Washout (6-10 Days)||7
8810952|NCT01511640|9863984|FG003|COMPLETED|Washout (6-10 Days)||6
8810953|NCT01511640|9863981|FG000|NOT COMPLETED|Washout (6-10 Days)||0
8810954|NCT01511640|9863982|FG001|NOT COMPLETED|Washout (6-10 Days)||0
8810955|NCT01511640|9863983|FG002|NOT COMPLETED|Washout (6-10 Days)||0
8810956|NCT01511640|9863984|FG003|NOT COMPLETED|Washout (6-10 Days)||1
8810957|NCT01511640|9863981|FG000|STARTED|Third Intervention (11-15 Days)||5
8810958|NCT01511640|9863982|FG001|STARTED|Third Intervention (11-15 Days)||8
8810959|NCT01511640|9863983|FG002|STARTED|Third Intervention (11-15 Days)||7
8810960|NCT01511640|9863984|FG003|STARTED|Third Intervention (11-15 Days)||6
8810961|NCT01511640|9863981|FG000|COMPLETED|Third Intervention (11-15 Days)||4
8810962|NCT01511640|9863982|FG001|COMPLETED|Third Intervention (11-15 Days)||7
8810963|NCT01511640|9863983|FG002|COMPLETED|Third Intervention (11-15 Days)||7
8810964|NCT01511640|9863984|FG003|COMPLETED|Third Intervention (11-15 Days)||6
8810965|NCT01511640|9863981|FG000|NOT COMPLETED|Third Intervention (11-15 Days)||1
8810966|NCT01511640|9863982|FG001|NOT COMPLETED|Third Intervention (11-15 Days)||1
8810967|NCT01511640|9863983|FG002|NOT COMPLETED|Third Intervention (11-15 Days)||0
8810968|NCT01511640|9863984|FG003|NOT COMPLETED|Third Intervention (11-15 Days)||0
8810969|NCT01511809|9863996|FG000|STARTED|Overall Study||58
8810970|NCT01511809|9863997|FG001|STARTED|Overall Study||59
8810971|NCT01511809|9863996|FG000|COMPLETED|Overall Study||51
8810972|NCT01511809|9863997|FG001|COMPLETED|Overall Study||52
8810973|NCT01511809|9863996|FG000|NOT COMPLETED|Overall Study||7
8810974|NCT01511809|9863997|FG001|NOT COMPLETED|Overall Study||7
8810975|NCT01511939|9864006|FG000|STARTED|Overall Study|Includes 1 subject who was also taking aspirin.|9
8810976|NCT01511939|9864007|FG001|STARTED|Overall Study|Includes one patient who was also taking aspirin.|5
8810977|NCT01511939|9864008|FG002|STARTED|Overall Study||8
8810978|NCT01511939|9864006|FG000|COMPLETED|Overall Study||7
8810979|NCT01511939|9864007|FG001|COMPLETED|Overall Study||4
8810980|NCT01511939|9864008|FG002|COMPLETED|Overall Study||8
8810981|NCT01511939|9864006|FG000|NOT COMPLETED|Overall Study||2
8810982|NCT01511939|9864007|FG001|NOT COMPLETED|Overall Study||1
8810983|NCT01511939|9864008|FG002|NOT COMPLETED|Overall Study||0
8810984|NCT01511978|9864018|FG000|STARTED|Overall Study||14
8810985|NCT01511978|9864019|FG001|STARTED|Overall Study||18
8810986|NCT01511978|9864018|FG000|COMPLETED|Overall Study||14
8810987|NCT01511978|9864019|FG001|COMPLETED|Overall Study||18
8810988|NCT01511978|9864018|FG000|NOT COMPLETED|Overall Study||0
8810989|NCT01511978|9864019|FG001|NOT COMPLETED|Overall Study||0
8810990|NCT01512108|9864029|FG000|STARTED|Overall Study||243
8810991|NCT01512108|9864030|FG001|STARTED|Overall Study||120
8810992|NCT01512108|9864029|FG000|Exposed|Overall Study|3 subjects withdrew prior to exposure to trial drug|240
8810993|NCT01512108|9864030|FG001|Exposed|Overall Study||120
8810994|NCT01512108|9864029|FG000|COMPLETED|Overall Study||221
8810995|NCT01512108|9864030|FG001|COMPLETED|Overall Study||111
8810996|NCT01512108|9864029|FG000|NOT COMPLETED|Overall Study||22
8810997|NCT01512108|9864030|FG001|NOT COMPLETED|Overall Study||9
8810998|NCT01512160|9864040|FG000|STARTED|Overall Study||22
8810999|NCT01512160|9864041|FG001|STARTED|Overall Study||23
8811000|NCT01512160|9864042|FG002|STARTED|Overall Study||22
8811001|NCT01512160|9864043|FG003|STARTED|Overall Study||23
8811002|NCT01512160|9864040|FG000|COMPLETED|Overall Study||20
8811003|NCT01512160|9864041|FG001|COMPLETED|Overall Study||23
8696225|NCT00880750|9741775|FG000|NOT COMPLETED|Second Intervention||4
8696226|NCT00880750|9741776|FG001|NOT COMPLETED|Second Intervention||2
8811004|NCT01512160|9864042|FG002|COMPLETED|Overall Study||22
8811005|NCT01512160|9864043|FG003|COMPLETED|Overall Study||22
8811006|NCT01512160|9864040|FG000|NOT COMPLETED|Overall Study||2
8811007|NCT01512160|9864041|FG001|NOT COMPLETED|Overall Study||0
8811008|NCT01512160|9864042|FG002|NOT COMPLETED|Overall Study||0
8696227|NCT00880763|9741786|FG000|STARTED|Initial Treatment Period (Part 1)||23
8696228|NCT00880763|9741787|FG001|STARTED|Initial Treatment Period (Part 1)||22
8696229|NCT00880763|9741788|FG002|STARTED|Initial Treatment Period (Part 1)||23
8696230|NCT00880763|9741789|FG003|STARTED|Initial Treatment Period (Part 1)||22
8696231|NCT00880763|9741786|FG000|COMPLETED|Initial Treatment Period (Part 1)||23
8696232|NCT00880763|9741787|FG001|COMPLETED|Initial Treatment Period (Part 1)||22
8696233|NCT00880763|9741788|FG002|COMPLETED|Initial Treatment Period (Part 1)||23
8696234|NCT00880763|9741789|FG003|COMPLETED|Initial Treatment Period (Part 1)||22
8696235|NCT00880763|9741786|FG000|NOT COMPLETED|Initial Treatment Period (Part 1)||0
8696236|NCT00880763|9741787|FG001|NOT COMPLETED|Initial Treatment Period (Part 1)||0
8696237|NCT00880763|9741788|FG002|NOT COMPLETED|Initial Treatment Period (Part 1)||0
8696238|NCT00880763|9741789|FG003|NOT COMPLETED|Initial Treatment Period (Part 1)||0
8696239|NCT00880763|9741786|FG000|STARTED|Extension Period (Part 2)||23
8696240|NCT00880763|9741787|FG001|STARTED|Extension Period (Part 2)||22
8696241|NCT00880763|9741788|FG002|STARTED|Extension Period (Part 2)||23
8696242|NCT00880763|9741789|FG003|STARTED|Extension Period (Part 2)||22
8696243|NCT00880763|9741786|FG000|COMPLETED|Extension Period (Part 2)||23
8696244|NCT00880763|9741787|FG001|COMPLETED|Extension Period (Part 2)||19
8696245|NCT00880763|9741788|FG002|COMPLETED|Extension Period (Part 2)||20
8696246|NCT00880763|9741789|FG003|COMPLETED|Extension Period (Part 2)||19
8696247|NCT00880763|9741786|FG000|NOT COMPLETED|Extension Period (Part 2)||0
8696248|NCT00880763|9741787|FG001|NOT COMPLETED|Extension Period (Part 2)||3
8696249|NCT00880763|9741788|FG002|NOT COMPLETED|Extension Period (Part 2)||3
8696250|NCT00880763|9741789|FG003|NOT COMPLETED|Extension Period (Part 2)||3
8696251|NCT00880906|9741801|FG000|STARTED|Overall Study||29
8696252|NCT00880906|9741802|FG001|STARTED|Overall Study||21
8696253|NCT00880906|9741801|FG000|COMPLETED|Overall Study||17
8696254|NCT00880906|9741802|FG001|COMPLETED|Overall Study||14
8696255|NCT00880906|9741801|FG000|NOT COMPLETED|Overall Study||12
8696256|NCT00880906|9741802|FG001|NOT COMPLETED|Overall Study||7
8696257|NCT00880919|9741811|FG000|STARTED|Overall Study||33
8696258|NCT00880919|9741812|FG001|STARTED|Overall Study||33
8696259|NCT00880919|9741813|FG002|STARTED|Overall Study||29
8696260|NCT00880919|9741811|FG000|COMPLETED|Overall Study||18
8696261|NCT00880919|9741812|FG001|COMPLETED|Overall Study||19
8696262|NCT00880919|9741813|FG002|COMPLETED|Overall Study||23
8696263|NCT00880919|9741811|FG000|NOT COMPLETED|Overall Study||15
8696264|NCT00880919|9741812|FG001|NOT COMPLETED|Overall Study||14
8696265|NCT00880919|9741813|FG002|NOT COMPLETED|Overall Study||6
8696266|NCT00880997|9741827|FG000|STARTED|Overall Study||9
8696267|NCT00880997|9741828|FG001|STARTED|Overall Study||8
8696268|NCT00880997|9741829|FG002|STARTED|Overall Study||13
8696269|NCT00880997|9741827|FG000|COMPLETED|Overall Study||6
8696270|NCT00880997|9741828|FG001|COMPLETED|Overall Study||6
8696271|NCT00880997|9741829|FG002|COMPLETED|Overall Study||5
8696272|NCT00880997|9741827|FG000|NOT COMPLETED|Overall Study||3
8811009|NCT01512160|9864043|FG003|NOT COMPLETED|Overall Study||1
8811010|NCT01512225|9864056|FG000|STARTED|Overall Study||45
8811011|NCT01512225|9864057|FG001|STARTED|Overall Study||45
8811012|NCT01512225|9864056|FG000|Provided Day 14 Volume|Overall Study||45
8811013|NCT01512225|9864057|FG001|Provided Day 14 Volume|Overall Study||40
8811014|NCT01512225|9864056|FG000|COMPLETED|Overall Study||45
8696273|NCT00880997|9741828|FG001|NOT COMPLETED|Overall Study||2
8696274|NCT00880997|9741829|FG002|NOT COMPLETED|Overall Study||8
8696275|NCT00881335|9741839|FG000|STARTED|Overall Study||30
8696276|NCT00881335|9741840|FG001|STARTED|Overall Study||30
8696277|NCT00881335|9741839|FG000|COMPLETED|Overall Study|3 participants did not complete the period|27
8811015|NCT01512225|9864057|FG001|COMPLETED|Overall Study||45
8811016|NCT01512225|9864056|FG000|NOT COMPLETED|Overall Study||0
8811017|NCT01512225|9864057|FG001|NOT COMPLETED|Overall Study||0
8811018|NCT01512251|9864067|FG000|STARTED|Dose Level -1||3
8696278|NCT00881335|9741840|FG001|COMPLETED|Overall Study|2 participants did not complete the period|28
8696279|NCT00881335|9741839|FG000|NOT COMPLETED|Overall Study||3
8811019|NCT01512251|9864068|FG001|STARTED|Dose Level -1||5
8811020|NCT01512251|9864067|FG000|COMPLETED|Dose Level -1||3
8811021|NCT01512251|9864068|FG001|COMPLETED|Dose Level -1||5
8811022|NCT01512251|9864067|FG000|NOT COMPLETED|Dose Level -1||0
8811023|NCT01512251|9864068|FG001|NOT COMPLETED|Dose Level -1||0
8811024|NCT01512251|9864067|FG000|STARTED|Phase I, Dose 1||3
8811025|NCT01512251|9864068|FG001|STARTED|Phase I, Dose 1||5
8811026|NCT01512251|9864067|FG000|COMPLETED|Phase I, Dose 1||0
8811027|NCT01512251|9864068|FG001|COMPLETED|Phase I, Dose 1||0
8811028|NCT01512251|9864067|FG000|NOT COMPLETED|Phase I, Dose 1||3
8811029|NCT01512251|9864068|FG001|NOT COMPLETED|Phase I, Dose 1||5
8811030|NCT01512251|9864067|FG000|STARTED|Phase I, Dose 2||0
8811031|NCT01512251|9864068|FG001|STARTED|Phase I, Dose 2||0
8811032|NCT01512251|9864067|FG000|COMPLETED|Phase I, Dose 2||0
8811033|NCT01512251|9864068|FG001|COMPLETED|Phase I, Dose 2||0
8811034|NCT01512251|9864067|FG000|NOT COMPLETED|Phase I, Dose 2||0
8811035|NCT01512251|9864068|FG001|NOT COMPLETED|Phase I, Dose 2||0
8811036|NCT01512251|9864067|FG000|STARTED|Phase I, Dose 3||0
8811037|NCT01512251|9864068|FG001|STARTED|Phase I, Dose 3||0
8811038|NCT01512251|9864067|FG000|COMPLETED|Phase I, Dose 3||0
8811039|NCT01512251|9864068|FG001|COMPLETED|Phase I, Dose 3||0
8811040|NCT01512251|9864067|FG000|NOT COMPLETED|Phase I, Dose 3||0
8811041|NCT01512251|9864068|FG001|NOT COMPLETED|Phase I, Dose 3||0
8811042|NCT01512251|9864067|FG000|STARTED|Phase I, Dose 4||0
8811043|NCT01512251|9864068|FG001|STARTED|Phase I, Dose 4||0
8811044|NCT01512251|9864067|FG000|COMPLETED|Phase I, Dose 4||0
8811045|NCT01512251|9864068|FG001|COMPLETED|Phase I, Dose 4||0
8811046|NCT01512251|9864067|FG000|NOT COMPLETED|Phase I, Dose 4||0
8811047|NCT01512251|9864068|FG001|NOT COMPLETED|Phase I, Dose 4||0
8811048|NCT01512251|9864067|FG000|STARTED|Phase II||0
8811049|NCT01512251|9864068|FG001|STARTED|Phase II||0
8811050|NCT01512251|9864067|FG000|COMPLETED|Phase II||0
8811051|NCT01512251|9864068|FG001|COMPLETED|Phase II||0
8811052|NCT01512251|9864067|FG000|NOT COMPLETED|Phase II||0
8811053|NCT01512251|9864068|FG001|NOT COMPLETED|Phase II||0
8811054|NCT01512264|9864079|FG000|STARTED|Overall Study||7
8811055|NCT01512264|9864080|FG001|STARTED|Overall Study||7
8696280|NCT00881335|9741840|FG001|NOT COMPLETED|Overall Study||2
8696281|NCT00881361|9741848|FG000|STARTED|Overall Study||707
8696282|NCT00881361|9741849|FG001|STARTED|Overall Study||47
8696283|NCT00881361|9741850|FG002|STARTED|Overall Study||2
8696284|NCT00881361|9741848|FG000|COMPLETED|Overall Study||663
8696285|NCT00881361|9741849|FG001|COMPLETED|Overall Study||38
8696286|NCT00881361|9741850|FG002|COMPLETED|Overall Study||0
8696287|NCT00881361|9741848|FG000|NOT COMPLETED|Overall Study||44
8696288|NCT00881361|9741849|FG001|NOT COMPLETED|Overall Study||9
8696289|NCT00881361|9741850|FG002|NOT COMPLETED|Overall Study||2
8696290|NCT00881465|9741861|FG000|STARTED|Overall Study||16
8696291|NCT00881465|9741862|FG001|STARTED|Overall Study||15
8696292|NCT00881465|9741861|FG000|COMPLETED|Overall Study||14
8696293|NCT00881465|9741862|FG001|COMPLETED|Overall Study||15
8696294|NCT00881465|9741861|FG000|NOT COMPLETED|Overall Study||2
8696295|NCT00881465|9741862|FG001|NOT COMPLETED|Overall Study||0
8696296|NCT00881504|9741868|FG000|STARTED|Overall Study||9
8696297|NCT00881504|9741868|FG000|COMPLETED|Overall Study||8
8696298|NCT00881504|9741868|FG000|NOT COMPLETED|Overall Study||1
8696299|NCT00881530|9741878|FG000|STARTED|Overall Study||106
8696300|NCT00881530|9741879|FG001|STARTED|Overall Study||109
8696301|NCT00881530|9741880|FG002|STARTED|Overall Study||56
8696302|NCT00881530|9741881|FG003|STARTED|Overall Study||166
8696303|NCT00881530|9741882|FG004|STARTED|Overall Study||166
8696304|NCT00881530|9741883|FG005|STARTED|Overall Study||56
8696305|NCT00881530|9741878|FG000|COMPLETED|Overall Study||92
8696306|NCT00881530|9741879|FG001|COMPLETED|Overall Study||104
8696307|NCT00881530|9741880|FG002|COMPLETED|Overall Study||51
8696308|NCT00881530|9741881|FG003|COMPLETED|Overall Study||157
8696309|NCT00881530|9741882|FG004|COMPLETED|Overall Study||152
8696310|NCT00881530|9741883|FG005|COMPLETED|Overall Study||51
8696311|NCT00881530|9741878|FG000|NOT COMPLETED|Overall Study||14
8696312|NCT00881530|9741879|FG001|NOT COMPLETED|Overall Study||5
8696313|NCT00881530|9741880|FG002|NOT COMPLETED|Overall Study||5
8696314|NCT00881530|9741881|FG003|NOT COMPLETED|Overall Study||9
8696315|NCT00881530|9741882|FG004|NOT COMPLETED|Overall Study||14
8696316|NCT00881530|9741883|FG005|NOT COMPLETED|Overall Study||5
8696317|NCT00881569|9741899|FG000|STARTED|Overall Study||1
8696318|NCT00881569|9741900|FG001|STARTED|Overall Study||1
8696319|NCT00881569|9741899|FG000|COMPLETED|Overall Study||0
8696320|NCT00881569|9741900|FG001|COMPLETED|Overall Study||0
8696321|NCT00881569|9741899|FG000|NOT COMPLETED|Overall Study||1
8696322|NCT00881569|9741900|FG001|NOT COMPLETED|Overall Study||1
8696323|NCT00881621|9741906|FG000|STARTED|Overall Study||51
8696324|NCT00881621|9741906|FG000|COMPLETED|Overall Study||17
8696325|NCT00881621|9741906|FG000|NOT COMPLETED|Overall Study||34
8811056|NCT01512264|9864081|FG002|STARTED|Overall Study||7
8811057|NCT01512264|9864082|FG003|STARTED|Overall Study||7
8811058|NCT01512264|9864079|FG000|COMPLETED|Overall Study||7
8696326|NCT00881647|9741912|FG000|STARTED|Overall Study||29
8696327|NCT00881647|9741913|FG001|STARTED|Overall Study||16
8696328|NCT00881647|9741912|FG000|COMPLETED|Overall Study||27
8811059|NCT01512264|9864080|FG001|COMPLETED|Overall Study||7
8811060|NCT01512264|9864081|FG002|COMPLETED|Overall Study||7
8696329|NCT00881647|9741913|FG001|COMPLETED|Overall Study||15
8696330|NCT00881647|9741912|FG000|NOT COMPLETED|Overall Study||2
8811061|NCT01512264|9864082|FG003|COMPLETED|Overall Study||6
8811062|NCT01512264|9864079|FG000|NOT COMPLETED|Overall Study||0
8811063|NCT01512264|9864080|FG001|NOT COMPLETED|Overall Study||0
8811064|NCT01512264|9864081|FG002|NOT COMPLETED|Overall Study||0
8696331|NCT00881647|9741913|FG001|NOT COMPLETED|Overall Study||1
8696332|NCT00881712|9741922|FG000|STARTED|Overall Study||15
8696333|NCT00881712|9741923|FG001|STARTED|Overall Study|This arm was non-randomized and no enrolled patients fit the inclusion criteria for this group.|0
8696334|NCT00881712|9741924|FG002|STARTED|Overall Study|This arm was non-randomized and no enrolled patients fit the inclusion criteria for this group.|0
8696335|NCT00881712|9741922|FG000|COMPLETED|Overall Study||13
8696336|NCT00881712|9741923|FG001|COMPLETED|Overall Study||0
8696337|NCT00881712|9741924|FG002|COMPLETED|Overall Study||0
8696338|NCT00881712|9741922|FG000|NOT COMPLETED|Overall Study||2
8696339|NCT00881712|9741923|FG001|NOT COMPLETED|Overall Study||0
8696340|NCT00881712|9741924|FG002|NOT COMPLETED|Overall Study||0
8696341|NCT00881751|9741934|FG000|STARTED|Overall Study||47
8696342|NCT00881751|9741935|FG001|STARTED|Overall Study||48
8696343|NCT00881751|9741934|FG000|COMPLETED|Overall Study||47
8696344|NCT00881751|9741935|FG001|COMPLETED|Overall Study||43
8696345|NCT00881751|9741934|FG000|NOT COMPLETED|Overall Study||0
8696346|NCT00881751|9741935|FG001|NOT COMPLETED|Overall Study||5
8696347|NCT00881868|9741943|FG000|STARTED|Overall Study||41
8696348|NCT00881868|9741944|FG001|STARTED|Overall Study||40
8696349|NCT00881868|9741943|FG000|COMPLETED|Overall Study||33
8696350|NCT00881868|9741944|FG001|COMPLETED|Overall Study||38
8696351|NCT00881868|9741943|FG000|NOT COMPLETED|Overall Study||8
8696352|NCT00881868|9741944|FG001|NOT COMPLETED|Overall Study||2
8696353|NCT00881894|9741952|FG000|STARTED|Overall Study||26
8696354|NCT00881894|9741953|FG001|STARTED|Overall Study||26
8696355|NCT00881894|9741952|FG000|Pharmacokinetic Set (PKS)|Overall Study|Patients with an insufficient patch adhesiveness were excluded from the PKS.|23
8696356|NCT00881894|9741953|FG001|Pharmacokinetic Set (PKS)|Overall Study|Patients with an insufficient patch adhesiveness were excluded from the PKS.|21
8696357|NCT00881894|9741952|FG000|COMPLETED|Overall Study||25
8696358|NCT00881894|9741953|FG001|COMPLETED|Overall Study||23
8696359|NCT00881894|9741952|FG000|NOT COMPLETED|Overall Study||1
8696360|NCT00881894|9741953|FG001|NOT COMPLETED|Overall Study||3
8696361|NCT00881959|9741961|FG000|STARTED|Overall Study||38
8696362|NCT00881959|9741962|FG001|STARTED|Overall Study||42
8696363|NCT00881959|9741961|FG000|COMPLETED|Overall Study||36
8696364|NCT00881959|9741962|FG001|COMPLETED|Overall Study||38
8696365|NCT00881959|9741961|FG000|NOT COMPLETED|Overall Study||2
8696366|NCT00881959|9741962|FG001|NOT COMPLETED|Overall Study||4
8696367|NCT00882102|9741968|FG000|STARTED|Overall Study||40
8696368|NCT00882102|9741968|FG000|COMPLETED|Overall Study||40
8696369|NCT00882102|9741968|FG000|NOT COMPLETED|Overall Study||0
8696370|NCT00882115|9741972|FG000|STARTED|Overall Study||38
8696371|NCT00882115|9741972|FG000|COMPLETED|Overall Study||29
8696372|NCT00882115|9741972|FG000|NOT COMPLETED|Overall Study||9
8696373|NCT00882206|9741976|FG000|STARTED|Overall Study||13
8696374|NCT00882206|9741976|FG000|COMPLETED|Overall Study||13
8696375|NCT00882206|9741976|FG000|NOT COMPLETED|Overall Study||0
8696376|NCT00882362|9741983|FG000|STARTED|Overall Study||122
8696377|NCT00882362|9741984|FG001|STARTED|Overall Study||33
8696378|NCT00882362|9741983|FG000|COMPLETED|Overall Study||73
8696379|NCT00882362|9741984|FG001|COMPLETED|Overall Study||10
8696380|NCT00882362|9741983|FG000|NOT COMPLETED|Overall Study||49
8696381|NCT00882362|9741984|FG001|NOT COMPLETED|Overall Study||23
8696382|NCT00882518|9741992|FG000|STARTED|Overall Study||196
8696383|NCT00882518|9741993|FG001|STARTED|Overall Study||192
8696384|NCT00882518|9741992|FG000|COMPLETED|Overall Study||158
8696385|NCT00882518|9741993|FG001|COMPLETED|Overall Study||148
8696386|NCT00882518|9741992|FG000|NOT COMPLETED|Overall Study||38
8696387|NCT00882518|9741993|FG001|NOT COMPLETED|Overall Study||44
8696388|NCT00882557|9742001|FG000|STARTED|Overall Study||8
8696389|NCT00882557|9742002|FG001|STARTED|Overall Study||8
8696390|NCT00882557|9742001|FG000|Completed Dose 1|Overall Study||8
8696391|NCT00882557|9742002|FG001|Completed Dose 1|Overall Study||7
8696392|NCT00882557|9742001|FG000|Completed Dose 2|Overall Study||6
8696393|NCT00882557|9742002|FG001|Completed Dose 2|Overall Study||7
8696394|NCT00882557|9742001|FG000|COMPLETED|Overall Study||6
8696395|NCT00882557|9742002|FG001|COMPLETED|Overall Study||7
8696396|NCT00882557|9742001|FG000|NOT COMPLETED|Overall Study||2
8696397|NCT00882557|9742002|FG001|NOT COMPLETED|Overall Study||1
8696398|NCT00882583|9742010|FG000|STARTED|Overall Study||7
8696399|NCT00882583|9742011|FG001|STARTED|Overall Study||12
8696400|NCT00882583|9742010|FG000|COMPLETED|Overall Study||6
8696401|NCT00882583|9742011|FG001|COMPLETED|Overall Study||11
8696402|NCT00882583|9742010|FG000|NOT COMPLETED|Overall Study||1
8696403|NCT00882583|9742011|FG001|NOT COMPLETED|Overall Study||1
8696404|NCT00882661|9742020|FG000|STARTED|Investigational Training||89
8696405|NCT00882661|9742021|FG001|STARTED|Investigational Training||0
8696406|NCT00882661|9742020|FG000|COMPLETED|Investigational Training||79
8811065|NCT01512264|9864082|FG003|NOT COMPLETED|Overall Study||1
8696407|NCT00882661|9742021|FG001|COMPLETED|Investigational Training||0
8696408|NCT00882661|9742020|FG000|NOT COMPLETED|Investigational Training||10
8696409|NCT00882661|9742021|FG001|NOT COMPLETED|Investigational Training||0
8696410|NCT00882661|9742020|FG000|STARTED|Treatment||151
8696411|NCT00882661|9742021|FG001|STARTED|Treatment||140
8811066|NCT01512368|9864092|FG000|STARTED|Overall Study||63
8696412|NCT00882661|9742020|FG000|COMPLETED|Treatment||141
8696413|NCT00882661|9742021|FG001|COMPLETED|Treatment||114
8811067|NCT01512368|9864092|FG000|COMPLETED|Overall Study||60
8811068|NCT01512368|9864092|FG000|NOT COMPLETED|Overall Study||3
8811069|NCT01512446|9864098|FG000|STARTED|Overall Study||221
8811070|NCT01512446|9864099|FG001|STARTED|Overall Study||215
8811071|NCT01512446|9864098|FG000|Safety Analysis Set|Overall Study||197
8696414|NCT00882661|9742020|FG000|NOT COMPLETED|Treatment||10
8696415|NCT00882661|9742021|FG001|NOT COMPLETED|Treatment||26
8696416|NCT00882687|9742033|FG000|STARTED|Overall Study||15
8696417|NCT00882687|9742034|FG001|STARTED|Overall Study||15
8696418|NCT00882687|9742035|FG002|STARTED|Overall Study||15
8696419|NCT00882687|9742036|FG003|STARTED|Overall Study||15
8696420|NCT00882687|9742033|FG000|COMPLETED|Overall Study||13
8696421|NCT00882687|9742034|FG001|COMPLETED|Overall Study||13
8696422|NCT00882687|9742035|FG002|COMPLETED|Overall Study||12
8696423|NCT00882687|9742036|FG003|COMPLETED|Overall Study||13
8696424|NCT00882687|9742033|FG000|NOT COMPLETED|Overall Study||2
8696425|NCT00882687|9742034|FG001|NOT COMPLETED|Overall Study||2
8696426|NCT00882687|9742035|FG002|NOT COMPLETED|Overall Study||3
8696427|NCT00882687|9742036|FG003|NOT COMPLETED|Overall Study||2
8696428|NCT00882713|9742046|FG000|STARTED|Overall Study||194
8696429|NCT00882713|9742046|FG000|COMPLETED|Overall Study||172
8696430|NCT00882713|9742046|FG000|NOT COMPLETED|Overall Study||22
8696431|NCT00882778|9742051|FG000|STARTED|Overall Study||86
8696432|NCT00882778|9742051|FG000|COMPLETED|Overall Study||86
8696433|NCT00882778|9742051|FG000|NOT COMPLETED|Overall Study||0
8696434|NCT00882908|9742060|FG000|STARTED|Overall Study||78
8696435|NCT00882908|9742061|FG001|STARTED|Overall Study||75
8696436|NCT00882908|9742062|FG002|STARTED|Overall Study||77
8696437|NCT00882908|9742063|FG003|STARTED|Overall Study||79
8696438|NCT00882908|9742064|FG004|STARTED|Overall Study||77
8696439|NCT00882908|9742060|FG000|COMPLETED|Overall Study||75
8696440|NCT00882908|9742061|FG001|COMPLETED|Overall Study||69
8696441|NCT00882908|9742062|FG002|COMPLETED|Overall Study||70
8696442|NCT00882908|9742063|FG003|COMPLETED|Overall Study||72
8696443|NCT00882908|9742064|FG004|COMPLETED|Overall Study||71
8696444|NCT00882908|9742060|FG000|NOT COMPLETED|Overall Study||3
8696445|NCT00882908|9742061|FG001|NOT COMPLETED|Overall Study||6
8696446|NCT00882908|9742062|FG002|NOT COMPLETED|Overall Study||7
8696447|NCT00882908|9742063|FG003|NOT COMPLETED|Overall Study||7
8696448|NCT00882908|9742064|FG004|NOT COMPLETED|Overall Study||6
8696449|NCT00882921|9742077|FG000|STARTED|Overall Study||26
8696450|NCT00882921|9742077|FG000|COMPLETED|Overall Study||15
8696451|NCT00882921|9742077|FG000|NOT COMPLETED|Overall Study||11
8696452|NCT00882999|9742089|FG000|STARTED|Overall Study||35
8696453|NCT00882999|9742090|FG001|STARTED|Overall Study||34
8696454|NCT00882999|9742091|FG002|STARTED|Overall Study||34
8696455|NCT00882999|9742092|FG003|STARTED|Overall Study||36
8696456|NCT00882999|9742093|FG004|STARTED|Overall Study||36
8696457|NCT00882999|9742094|FG005|STARTED|Overall Study||35
8696458|NCT00882999|9742095|FG006|STARTED|Overall Study||35
8696459|NCT00882999|9742089|FG000|Received Any Amount of Study Drug|Overall Study||35
8696460|NCT00882999|9742090|FG001|Received Any Amount of Study Drug|Overall Study||34
8696461|NCT00882999|9742091|FG002|Received Any Amount of Study Drug|Overall Study||34
8696462|NCT00882999|9742092|FG003|Received Any Amount of Study Drug|Overall Study||36
8696463|NCT00882999|9742093|FG004|Received Any Amount of Study Drug|Overall Study||36
8696464|NCT00882999|9742094|FG005|Received Any Amount of Study Drug|Overall Study||35
8696465|NCT00882999|9742095|FG006|Received Any Amount of Study Drug|Overall Study||35
8696466|NCT00882999|9742089|FG000|Completed Study Treatment|Overall Study||29
8696467|NCT00882999|9742090|FG001|Completed Study Treatment|Overall Study||29
8696468|NCT00882999|9742091|FG002|Completed Study Treatment|Overall Study||31
8696469|NCT00882999|9742092|FG003|Completed Study Treatment|Overall Study||33
8696470|NCT00882999|9742093|FG004|Completed Study Treatment|Overall Study||29
8696471|NCT00882999|9742094|FG005|Completed Study Treatment|Overall Study||30
8696472|NCT00882999|9742095|FG006|Completed Study Treatment|Overall Study||31
8696473|NCT00882999|9742089|FG000|COMPLETED|Overall Study||27
8696474|NCT00882999|9742090|FG001|COMPLETED|Overall Study||26
8696475|NCT00882999|9742091|FG002|COMPLETED|Overall Study||30
8696476|NCT00882999|9742092|FG003|COMPLETED|Overall Study||31
8696477|NCT00882999|9742093|FG004|COMPLETED|Overall Study||28
8696478|NCT00882999|9742094|FG005|COMPLETED|Overall Study||28
8696479|NCT00882999|9742095|FG006|COMPLETED|Overall Study||27
8696480|NCT00882999|9742089|FG000|NOT COMPLETED|Overall Study||8
8811072|NCT01512446|9864099|FG001|Safety Analysis Set|Overall Study||188
8811073|NCT01512446|9864098|FG000|COMPLETED|Overall Study||0
8811074|NCT01512446|9864099|FG001|COMPLETED|Overall Study||0
8696481|NCT00882999|9742090|FG001|NOT COMPLETED|Overall Study||8
8696482|NCT00882999|9742091|FG002|NOT COMPLETED|Overall Study||4
8696483|NCT00882999|9742092|FG003|NOT COMPLETED|Overall Study||5
8696484|NCT00882999|9742093|FG004|NOT COMPLETED|Overall Study||8
8696485|NCT00882999|9742094|FG005|NOT COMPLETED|Overall Study||7
8696486|NCT00882999|9742095|FG006|NOT COMPLETED|Overall Study||8
8696487|NCT00883051|9742123|FG000|STARTED|Overall Study||106
8696488|NCT00883051|9742124|FG001|STARTED|Overall Study||104
8811075|NCT01512446|9864098|FG000|NOT COMPLETED|Overall Study||221
8696489|NCT00883051|9742125|FG002|STARTED|Overall Study||100
8696490|NCT00883051|9742126|FG003|STARTED|Overall Study||99
8696491|NCT00883051|9742127|FG004|STARTED|Overall Study||103
8696492|NCT00883051|9742123|FG000|No Study Medication Used|Overall Study||24
8696493|NCT00883051|9742124|FG001|No Study Medication Used|Overall Study||22
8811076|NCT01512446|9864099|FG001|NOT COMPLETED|Overall Study||215
8811077|NCT01512667|9864107|FG000|STARTED|Overall Study||13
8811078|NCT01512667|9864108|FG001|STARTED|Overall Study||12
8811079|NCT01512667|9864107|FG000|Matched Participants|Overall Study||12
8811080|NCT01512667|9864108|FG001|Matched Participants|Overall Study||12
8811081|NCT01512667|9864107|FG000|Unmatched Participants|Overall Study|Participant was not matched to a healthy control participant.|1
8811082|NCT01512667|9864108|FG001|Unmatched Participants|Overall Study||0
8811083|NCT01512667|9864107|FG000|COMPLETED|Overall Study||13
8811084|NCT01512667|9864108|FG001|COMPLETED|Overall Study||12
8811085|NCT01512667|9864107|FG000|NOT COMPLETED|Overall Study||0
8811086|NCT01512667|9864108|FG001|NOT COMPLETED|Overall Study||0
8811087|NCT01512693|9864116|FG000|STARTED|Overall Study||8
8811088|NCT01512693|9864117|FG001|STARTED|Overall Study||9
8811089|NCT01512693|9864116|FG000|COMPLETED|Overall Study||8
8811090|NCT01512693|9864117|FG001|COMPLETED|Overall Study||8
8811091|NCT01512693|9864116|FG000|NOT COMPLETED|Overall Study||0
8811092|NCT01512693|9864117|FG001|NOT COMPLETED|Overall Study||1
8811093|NCT01512745|9864125|FG000|STARTED|Overall Study||176
8811094|NCT01512745|9864126|FG001|STARTED|Overall Study||91
8811095|NCT01512745|9864125|FG000|COMPLETED|Overall Study||136
8811096|NCT01512745|9864126|FG001|COMPLETED|Overall Study||71
8811097|NCT01512745|9864125|FG000|NOT COMPLETED|Overall Study||40
8811098|NCT01512745|9864126|FG001|NOT COMPLETED|Overall Study||20
8811099|NCT01512758|9864134|FG000|STARTED|Overall Study||30
8811100|NCT01512758|9864135|FG001|STARTED|Overall Study||6
8811101|NCT01512758|9864134|FG000|COMPLETED|Overall Study|Completed=Completed protocol-specified dosing and PK assessment.|30
8811102|NCT01512758|9864135|FG001|COMPLETED|Overall Study||6
8811103|NCT01512758|9864134|FG000|NOT COMPLETED|Overall Study||0
8811104|NCT01512758|9864135|FG001|NOT COMPLETED|Overall Study||0
8811105|NCT01512797|9864144|FG000|STARTED|Overall Study||16
8811106|NCT01512797|9864145|FG001|STARTED|Overall Study||16
8811107|NCT01512797|9864144|FG000|COMPLETED|Overall Study||16
8811108|NCT01512797|9864145|FG001|COMPLETED|Overall Study||16
8811109|NCT01512797|9864144|FG000|NOT COMPLETED|Overall Study||0
8811110|NCT01512797|9864145|FG001|NOT COMPLETED|Overall Study||0
8811111|NCT01512849|9864153|FG000|STARTED|Crossover Period 1||6
8811112|NCT01512849|9864154|FG001|STARTED|Crossover Period 1||6
8811113|NCT01512849|9864155|FG002|STARTED|Crossover Period 1||6
8811114|NCT01512849|9864156|FG003|STARTED|Crossover Period 1||6
8811115|NCT01512849|9864153|FG000|COMPLETED|Crossover Period 1||6
8811116|NCT01512849|9864154|FG001|COMPLETED|Crossover Period 1||6
8811117|NCT01512849|9864155|FG002|COMPLETED|Crossover Period 1||6
8811118|NCT01512849|9864156|FG003|COMPLETED|Crossover Period 1||6
8811119|NCT01512849|9864153|FG000|NOT COMPLETED|Crossover Period 1||0
8811120|NCT01512849|9864154|FG001|NOT COMPLETED|Crossover Period 1||0
8811121|NCT01512849|9864155|FG002|NOT COMPLETED|Crossover Period 1||0
8811122|NCT01512849|9864156|FG003|NOT COMPLETED|Crossover Period 1||0
8811123|NCT01512849|9864153|FG000|STARTED|Crossover Period 2||6
8811124|NCT01512849|9864154|FG001|STARTED|Crossover Period 2||6
8811125|NCT01512849|9864155|FG002|STARTED|Crossover Period 2||6
8811126|NCT01512849|9864156|FG003|STARTED|Crossover Period 2||6
8811127|NCT01512849|9864153|FG000|COMPLETED|Crossover Period 2||6
8811128|NCT01512849|9864154|FG001|COMPLETED|Crossover Period 2||6
8696494|NCT00883051|9742125|FG002|No Study Medication Used|Overall Study||29
8696495|NCT00883051|9742126|FG003|No Study Medication Used|Overall Study||29
8696496|NCT00883051|9742127|FG004|No Study Medication Used|Overall Study||17
8811129|NCT01512849|9864155|FG002|COMPLETED|Crossover Period 2||6
8811130|NCT01512849|9864156|FG003|COMPLETED|Crossover Period 2||6
8811131|NCT01512849|9864153|FG000|NOT COMPLETED|Crossover Period 2||0
8696497|NCT00883051|9742123|FG000|Received at Least 1 Dose of Study Drug|Overall Study||82
8696498|NCT00883051|9742124|FG001|Received at Least 1 Dose of Study Drug|Overall Study||82
8811132|NCT01512849|9864154|FG001|NOT COMPLETED|Crossover Period 2||0
8811133|NCT01512849|9864155|FG002|NOT COMPLETED|Crossover Period 2||0
8811134|NCT01512849|9864156|FG003|NOT COMPLETED|Crossover Period 2||0
8811135|NCT01512979|9864168|FG000|STARTED|Overall Study|Randomised and treated|159
8811136|NCT01512979|9864169|FG001|STARTED|Overall Study|Randomised and treated|157
8811137|NCT01512979|9864168|FG000|COMPLETED|Overall Study||140
8811138|NCT01512979|9864169|FG001|COMPLETED|Overall Study||135
8811139|NCT01512979|9864168|FG000|NOT COMPLETED|Overall Study||19
8811140|NCT01512979|9864169|FG001|NOT COMPLETED|Overall Study||22
8811141|NCT01513122|9864177|FG000|STARTED|Overall Study||102
8811142|NCT01513122|9864178|FG001|STARTED|Overall Study||108
8925531|NCT02258477|9986661|FG003|STARTED|Third Intervention (1 Week)||8
8925532|NCT02258477|9986658|FG000|COMPLETED|Third Intervention (1 Week)||9
8696499|NCT00883051|9742125|FG002|Received at Least 1 Dose of Study Drug|Overall Study||71
8696500|NCT00883051|9742126|FG003|Received at Least 1 Dose of Study Drug|Overall Study||70
8696501|NCT00883051|9742127|FG004|Received at Least 1 Dose of Study Drug|Overall Study||86
8696502|NCT00883051|9742123|FG000|COMPLETED|Overall Study||82
8696503|NCT00883051|9742124|FG001|COMPLETED|Overall Study||82
8696504|NCT00883051|9742125|FG002|COMPLETED|Overall Study||71
8696505|NCT00883051|9742126|FG003|COMPLETED|Overall Study||70
8811143|NCT01513122|9864177|FG000|COMPLETED|Overall Study||91
8811144|NCT01513122|9864178|FG001|COMPLETED|Overall Study||105
8811145|NCT01513122|9864177|FG000|NOT COMPLETED|Overall Study||11
8811146|NCT01513122|9864178|FG001|NOT COMPLETED|Overall Study||3
8811147|NCT01513148|9864186|FG000|STARTED|Overall Study||16
8811148|NCT01513148|9864187|FG001|STARTED|Overall Study||16
8811149|NCT01513148|9864186|FG000|COMPLETED|Overall Study||14
8811150|NCT01513148|9864187|FG001|COMPLETED|Overall Study||14
8811151|NCT01513148|9864186|FG000|NOT COMPLETED|Overall Study||2
8811152|NCT01513148|9864187|FG001|NOT COMPLETED|Overall Study||2
8811153|NCT01513239|9864236|FG000|STARTED|Period 1: Main Phase|Randomized participants|397
8811154|NCT01513239|9864237|FG001|STARTED|Period 1: Main Phase|Randomized participants|407
8811155|NCT01513239|9864238|FG002|STARTED|Period 1: Main Phase|Randomized participants|399
8811156|NCT01513239|9864239|FG003|STARTED|Period 1: Main Phase||0
8811157|NCT01513239|9864240|FG004|STARTED|Period 1: Main Phase||0
8811158|NCT01513239|9864241|FG005|STARTED|Period 1: Main Phase||0
8811159|NCT01513239|9864236|FG000|Treated|Period 1: Main Phase|Treated participants|391
8811160|NCT01513239|9864237|FG001|Treated|Period 1: Main Phase|Treated participants|396
8811161|NCT01513239|9864238|FG002|Treated|Period 1: Main Phase|Treated participants|381
8811162|NCT01513239|9864239|FG003|Treated|Period 1: Main Phase||0
8811163|NCT01513239|9864240|FG004|Treated|Period 1: Main Phase||0
8811164|NCT01513239|9864241|FG005|Treated|Period 1: Main Phase||0
8811165|NCT01513239|9864236|FG000|All Participants as Treated|Period 1: Main Phase|One participant randomized to receive MK-3415A (MK-3415 plus MK-6072) received only MK-3415|390
8811166|NCT01513239|9864237|FG001|All Participants as Treated|Period 1: Main Phase|Treatment actually received|396
8811167|NCT01513239|9864238|FG002|All Participants as Treated|Period 1: Main Phase|Treatment actually received|381
8811168|NCT01513239|9864239|FG003|All Participants as Treated|Period 1: Main Phase||0
8811169|NCT01513239|9864240|FG004|All Participants as Treated|Period 1: Main Phase||0
8811170|NCT01513239|9864241|FG005|All Participants as Treated|Period 1: Main Phase||0
8811171|NCT01513239|9864236|FG000|COMPLETED|Period 1: Main Phase||322
8811172|NCT01513239|9864237|FG001|COMPLETED|Period 1: Main Phase||337
8811173|NCT01513239|9864238|FG002|COMPLETED|Period 1: Main Phase||311
8811174|NCT01513239|9864239|FG003|COMPLETED|Period 1: Main Phase||0
8811175|NCT01513239|9864240|FG004|COMPLETED|Period 1: Main Phase||0
8811176|NCT01513239|9864241|FG005|COMPLETED|Period 1: Main Phase||0
8811177|NCT01513239|9864236|FG000|NOT COMPLETED|Period 1: Main Phase||75
8811178|NCT01513239|9864237|FG001|NOT COMPLETED|Period 1: Main Phase||70
8811179|NCT01513239|9864238|FG002|NOT COMPLETED|Period 1: Main Phase||88
8811180|NCT01513239|9864239|FG003|NOT COMPLETED|Period 1: Main Phase||0
8811181|NCT01513239|9864240|FG004|NOT COMPLETED|Period 1: Main Phase||0
8811182|NCT01513239|9864241|FG005|NOT COMPLETED|Period 1: Main Phase||0
8811183|NCT01513239|9864236|FG000|STARTED|Period 2: 9 Month Extension Phase||0
8811184|NCT01513239|9864237|FG001|STARTED|Period 2: 9 Month Extension Phase||0
8811185|NCT01513239|9864238|FG002|STARTED|Period 2: 9 Month Extension Phase||0
8811186|NCT01513239|9864239|FG003|STARTED|Period 2: 9 Month Extension Phase||112
8811187|NCT01513239|9864240|FG004|STARTED|Period 2: 9 Month Extension Phase||100
8811188|NCT01513239|9864241|FG005|STARTED|Period 2: 9 Month Extension Phase||83
8811189|NCT01513239|9864236|FG000|COMPLETED|Period 2: 9 Month Extension Phase||0
8811190|NCT01513239|9864237|FG001|COMPLETED|Period 2: 9 Month Extension Phase||0
8811191|NCT01513239|9864238|FG002|COMPLETED|Period 2: 9 Month Extension Phase||0
8811192|NCT01513239|9864239|FG003|COMPLETED|Period 2: 9 Month Extension Phase||102
8811193|NCT01513239|9864240|FG004|COMPLETED|Period 2: 9 Month Extension Phase||90
8696506|NCT00883051|9742127|FG004|COMPLETED|Overall Study|One participant was lost to follow up and did not provide adverse event data.|85
8696507|NCT00883051|9742123|FG000|NOT COMPLETED|Overall Study||24
8696508|NCT00883051|9742124|FG001|NOT COMPLETED|Overall Study||22
8696509|NCT00883051|9742125|FG002|NOT COMPLETED|Overall Study||29
8696510|NCT00883051|9742126|FG003|NOT COMPLETED|Overall Study||29
8696511|NCT00883051|9742127|FG004|NOT COMPLETED|Overall Study||18
8811194|NCT01513239|9864241|FG005|COMPLETED|Period 2: 9 Month Extension Phase||78
8811195|NCT01513239|9864236|FG000|NOT COMPLETED|Period 2: 9 Month Extension Phase||0
8811196|NCT01513239|9864237|FG001|NOT COMPLETED|Period 2: 9 Month Extension Phase||0
8811197|NCT01513239|9864238|FG002|NOT COMPLETED|Period 2: 9 Month Extension Phase||0
8811198|NCT01513239|9864239|FG003|NOT COMPLETED|Period 2: 9 Month Extension Phase||10
8811199|NCT01513239|9864240|FG004|NOT COMPLETED|Period 2: 9 Month Extension Phase||10
8811200|NCT01513239|9864241|FG005|NOT COMPLETED|Period 2: 9 Month Extension Phase||5
8811201|NCT01513291|9864255|FG000|STARTED|Treatment Period||120
8811202|NCT01513291|9864256|FG001|STARTED|Treatment Period||117
8811203|NCT01513291|9864257|FG002|STARTED|Treatment Period||0
8811204|NCT01513291|9864258|FG003|STARTED|Treatment Period||0
8811205|NCT01513291|9864259|FG004|STARTED|Treatment Period||0
8811206|NCT01513291|9864255|FG000|Treated|Treatment Period||120
8811207|NCT01513291|9864256|FG001|Treated|Treatment Period||115
8811208|NCT01513291|9864257|FG002|Treated|Treatment Period||0
8811209|NCT01513291|9864258|FG003|Treated|Treatment Period||0
8811210|NCT01513291|9864259|FG004|Treated|Treatment Period||0
8811211|NCT01513291|9864255|FG000|COMPLETED|Treatment Period||97
8811212|NCT01513291|9864256|FG001|COMPLETED|Treatment Period||101
8811213|NCT01513291|9864257|FG002|COMPLETED|Treatment Period||0
8811214|NCT01513291|9864258|FG003|COMPLETED|Treatment Period||0
8811215|NCT01513291|9864259|FG004|COMPLETED|Treatment Period||0
8696512|NCT00883090|9742139|FG000|STARTED|Overall Study|Of the 15 participants started, 14 were administered FXIII|15
8811216|NCT01513291|9864255|FG000|NOT COMPLETED|Treatment Period||23
8811217|NCT01513291|9864256|FG001|NOT COMPLETED|Treatment Period||16
8811218|NCT01513291|9864257|FG002|NOT COMPLETED|Treatment Period||0
8696513|NCT00883090|9742139|FG000|COMPLETED|Overall Study||13
8696514|NCT00883090|9742139|FG000|NOT COMPLETED|Overall Study||2
8696515|NCT00883103|9742145|FG000|STARTED|Overall Study||69
8696516|NCT00883103|9742146|FG001|STARTED|Overall Study||68
8696517|NCT00883103|9742145|FG000|COMPLETED|Overall Study||69
8696518|NCT00883103|9742146|FG001|COMPLETED|Overall Study||68
8696519|NCT00883103|9742145|FG000|NOT COMPLETED|Overall Study||0
8696520|NCT00883103|9742146|FG001|NOT COMPLETED|Overall Study||0
8696521|NCT00883116|9742154|FG000|STARTED|Overall Study||248
8696522|NCT00883116|9742155|FG001|STARTED|Overall Study||248
8696523|NCT00883116|9742154|FG000|Received Treatment|Overall Study||248
8696524|NCT00883116|9742155|FG001|Received Treatment|Overall Study||239
8696525|NCT00883116|9742154|FG000|COMPLETED|Overall Study||39
8696526|NCT00883116|9742155|FG001|COMPLETED|Overall Study||29
8696527|NCT00883116|9742154|FG000|NOT COMPLETED|Overall Study||209
8696528|NCT00883116|9742155|FG001|NOT COMPLETED|Overall Study||219
8696529|NCT00883129|9742165|FG000|STARTED|Overall Study||69
8696530|NCT00883129|9742166|FG001|STARTED|Overall Study||73
8811219|NCT01513291|9864258|FG003|NOT COMPLETED|Treatment Period||0
8811220|NCT01513291|9864259|FG004|NOT COMPLETED|Treatment Period||0
8811221|NCT01513291|9864255|FG000|STARTED|Run-out Period||0
8811222|NCT01513291|9864256|FG001|STARTED|Run-out Period||0
8811223|NCT01513291|9864257|FG002|STARTED|Run-out Period|These participants were pre-randomized from participants in the Treatment Period: MK-6096 group|50
8811224|NCT01513291|9864258|FG003|STARTED|Run-out Period|These participants were pre-randomized from participants in the Treatment Period: MK-6096 group|47
8811225|NCT01513291|9864259|FG004|STARTED|Run-out Period|These participants were completers from the Treatment Period: Placebo group|101
8811226|NCT01513291|9864255|FG000|COMPLETED|Run-out Period||0
8811227|NCT01513291|9864256|FG001|COMPLETED|Run-out Period||0
8811228|NCT01513291|9864257|FG002|COMPLETED|Run-out Period||50
8811229|NCT01513291|9864258|FG003|COMPLETED|Run-out Period||45
8811230|NCT01513291|9864259|FG004|COMPLETED|Run-out Period||101
8811231|NCT01513291|9864255|FG000|NOT COMPLETED|Run-out Period||0
8811232|NCT01513291|9864256|FG001|NOT COMPLETED|Run-out Period||0
8811233|NCT01513291|9864257|FG002|NOT COMPLETED|Run-out Period||0
8811234|NCT01513291|9864258|FG003|NOT COMPLETED|Run-out Period||2
8811235|NCT01513291|9864259|FG004|NOT COMPLETED|Run-out Period||0
8811236|NCT01513317|9864273|FG000|STARTED|Overall Study||50
8811237|NCT01513317|9864274|FG001|STARTED|Overall Study||26
8811238|NCT01513317|9864273|FG000|COMPLETED|Overall Study||16
8811239|NCT01513317|9864274|FG001|COMPLETED|Overall Study||2
8811240|NCT01513317|9864273|FG000|NOT COMPLETED|Overall Study||34
8811241|NCT01513317|9864274|FG001|NOT COMPLETED|Overall Study||24
8811242|NCT01513330|9864280|FG000|STARTED|SenSura Mio First,||64
8811243|NCT01513330|9864281|FG001|STARTED|SenSura Mio First,||58
8811244|NCT01513330|9864280|FG000|COMPLETED|SenSura Mio First,||60
8811245|NCT01513330|9864281|FG001|COMPLETED|SenSura Mio First,||56
8811246|NCT01513330|9864280|FG000|NOT COMPLETED|SenSura Mio First,||4
8811247|NCT01513330|9864281|FG001|NOT COMPLETED|SenSura Mio First,||2
8811248|NCT01513330|9864280|FG000|STARTED|Standard Care First,||60
8811249|NCT01513330|9864281|FG001|STARTED|Standard Care First,||56
8811250|NCT01513330|9864280|FG000|COMPLETED|Standard Care First,||56
8811251|NCT01513330|9864281|FG001|COMPLETED|Standard Care First,||52
8696531|NCT00883129|9742165|FG000|COMPLETED|Overall Study|53 subjects provided a 24 month outcome, 4 of whom had prematurely withdrawn from drug treatment.|49
8811252|NCT01513330|9864280|FG000|NOT COMPLETED|Standard Care First,||4
8811253|NCT01513330|9864281|FG001|NOT COMPLETED|Standard Care First,||4
8811254|NCT01513447|9864289|FG000|STARTED|Overall Study||3
8811255|NCT01513447|9864290|FG001|STARTED|Overall Study||5
8811256|NCT01513447|9864289|FG000|COMPLETED|Overall Study||3
8811257|NCT01513447|9864290|FG001|COMPLETED|Overall Study||5
8811258|NCT01513447|9864289|FG000|NOT COMPLETED|Overall Study||0
8811259|NCT01513447|9864290|FG001|NOT COMPLETED|Overall Study||0
8811260|NCT01513460|9864299|FG000|STARTED|Overall Study||258
8811261|NCT01513460|9864300|FG001|STARTED|Overall Study||258
8811262|NCT01513460|9864301|FG002|STARTED|Overall Study||257
8811263|NCT01513460|9864299|FG000|Full Analysis Set|Overall Study||257
8811264|NCT01513460|9864300|FG001|Full Analysis Set|Overall Study||258
8811265|NCT01513460|9864301|FG002|Full Analysis Set|Overall Study||257
8811266|NCT01513460|9864299|FG000|Per-protocol Set|Overall Study||196
8811267|NCT01513460|9864300|FG001|Per-protocol Set|Overall Study||186
8811268|NCT01513460|9864301|FG002|Per-protocol Set|Overall Study||166
8811269|NCT01513460|9864299|FG000|COMPLETED|Overall Study||229
8811270|NCT01513460|9864300|FG001|COMPLETED|Overall Study||226
8811271|NCT01513460|9864301|FG002|COMPLETED|Overall Study||201
8811272|NCT01513460|9864299|FG000|NOT COMPLETED|Overall Study||29
8811273|NCT01513460|9864300|FG001|NOT COMPLETED|Overall Study||32
8811274|NCT01513460|9864301|FG002|NOT COMPLETED|Overall Study||56
8811275|NCT01513473|9864313|FG000|STARTED|Main Trial (26 Weeks)||174
8811276|NCT01513473|9864314|FG001|STARTED|Main Trial (26 Weeks)|1 subject was randomised but withdrew before the drug exposure.|176
8811277|NCT01513473|9864313|FG000|Exposed|Main Trial (26 Weeks)||174
8811278|NCT01513473|9864314|FG001|Exposed|Main Trial (26 Weeks)||175
8811279|NCT01513473|9864313|FG000|COMPLETED|Main Trial (26 Weeks)||170
8811280|NCT01513473|9864314|FG001|COMPLETED|Main Trial (26 Weeks)||165
8811281|NCT01513473|9864313|FG000|NOT COMPLETED|Main Trial (26 Weeks)||4
8811282|NCT01513473|9864314|FG001|NOT COMPLETED|Main Trial (26 Weeks)||11
8696532|NCT00883129|9742166|FG001|COMPLETED|Overall Study|53 subjects provided a 24 month outcome, 16 of whom had prematurely withdrawn from drug treatment.|37
8696533|NCT00883129|9742165|FG000|NOT COMPLETED|Overall Study||20
8696534|NCT00883129|9742166|FG001|NOT COMPLETED|Overall Study||36
8696535|NCT00883168|9742176|FG000|STARTED|Overall Study||448
8811283|NCT01513473|9864313|FG000|STARTED|Extension Trial (26 Weeks)|18 subjects did not consent to participate in the extension trial.|152
8811284|NCT01513473|9864314|FG001|STARTED|Extension Trial (26 Weeks)|37 subjects did not consent to participate in the extension trial.|128
8811285|NCT01513473|9864313|FG000|COMPLETED|Extension Trial (26 Weeks)||151
8811286|NCT01513473|9864314|FG001|COMPLETED|Extension Trial (26 Weeks)||122
8811287|NCT01513473|9864313|FG000|NOT COMPLETED|Extension Trial (26 Weeks)||1
8811288|NCT01513473|9864314|FG001|NOT COMPLETED|Extension Trial (26 Weeks)||6
8811289|NCT01513538|9864320|FG000|STARTED|Overall Study||578
8811290|NCT01513538|9864320|FG000|COMPLETED|Overall Study||573
8811291|NCT01513538|9864320|FG000|NOT COMPLETED|Overall Study||5
8811292|NCT01513551|9864327|FG000|STARTED|Overall Study||230
8811293|NCT01513551|9864328|FG001|STARTED|Overall Study||231
8811294|NCT01513551|9864329|FG002|STARTED|Overall Study||231
8811295|NCT01513551|9864327|FG000|Vaccinated|Overall Study||230
8811296|NCT01513551|9864328|FG001|Vaccinated|Overall Study||231
8811297|NCT01513551|9864329|FG002|Vaccinated|Overall Study||230
8811298|NCT01513551|9864327|FG000|COMPLETED|Overall Study||226
8811299|NCT01513551|9864328|FG001|COMPLETED|Overall Study||225
8811300|NCT01513551|9864329|FG002|COMPLETED|Overall Study||226
8811301|NCT01513551|9864327|FG000|NOT COMPLETED|Overall Study||4
8811302|NCT01513551|9864328|FG001|NOT COMPLETED|Overall Study||6
8811303|NCT01513551|9864329|FG002|NOT COMPLETED|Overall Study||5
8811304|NCT01513590|9864339|FG000|STARTED|Overall Study||197
8811305|NCT01513590|9864340|FG001|STARTED|Overall Study||197
8811306|NCT01513590|9864339|FG000|Exposed|Overall Study|"One (1) subject was withdrawn prior to exposure due to non fulfilment of inclusion criteria"|196
8811307|NCT01513590|9864340|FG001|Exposed|Overall Study|"Two (2) subjects were withdrawn prior to exposure due to withdrawal of consent"|195
8811308|NCT01513590|9864339|FG000|COMPLETED|Overall Study||187
8811309|NCT01513590|9864340|FG001|COMPLETED|Overall Study||184
8811310|NCT01513590|9864339|FG000|NOT COMPLETED|Overall Study||10
8811311|NCT01513590|9864340|FG001|NOT COMPLETED|Overall Study||13
8811312|NCT01513759|9864346|FG000|STARTED|Overall Study||150
8811313|NCT01513759|9864346|FG000|At Least One Device Successfully Placed|Overall Study||149
8811314|NCT01513759|9864346|FG000|COMPLETED|Overall Study||145
8811315|NCT01513759|9864346|FG000|NOT COMPLETED|Overall Study||5
8811316|NCT01513902|9864353|FG000|STARTED|Overall Study||8
8811317|NCT01513902|9864354|FG001|STARTED|Overall Study||9
8811318|NCT01513902|9864355|FG002|STARTED|Overall Study||9
8811319|NCT01513902|9864353|FG000|COMPLETED|Overall Study||8
8811320|NCT01513902|9864354|FG001|COMPLETED|Overall Study||9
8811321|NCT01513902|9864355|FG002|COMPLETED|Overall Study||9
8811322|NCT01513902|9864353|FG000|NOT COMPLETED|Overall Study||0
8811323|NCT01513902|9864354|FG001|NOT COMPLETED|Overall Study||0
8811324|NCT01513902|9864355|FG002|NOT COMPLETED|Overall Study||0
8811325|NCT01513967|9864371|FG000|STARTED|Overall Study||4
8811326|NCT01513967|9864372|FG001|STARTED|Overall Study||4
8811327|NCT01513967|9864373|FG002|STARTED|Overall Study||4
8811328|NCT01513967|9864374|FG003|STARTED|Overall Study||6
8811329|NCT01513967|9864375|FG004|STARTED|Overall Study||4
8811330|NCT01513967|9864376|FG005|STARTED|Overall Study||4
8811331|NCT01513967|9864377|FG006|STARTED|Overall Study||5
8811332|NCT01513967|9864378|FG007|STARTED|Overall Study||8
8811333|NCT01513967|9864371|FG000|COMPLETED|Overall Study||4
8811334|NCT01513967|9864372|FG001|COMPLETED|Overall Study||4
8811335|NCT01513967|9864373|FG002|COMPLETED|Overall Study||4
8811336|NCT01513967|9864374|FG003|COMPLETED|Overall Study||6
8925533|NCT02258477|9986659|FG001|COMPLETED|Third Intervention (1 Week)||8
8925534|NCT02258477|9986660|FG002|COMPLETED|Third Intervention (1 Week)||8
8925535|NCT02258477|9986661|FG003|COMPLETED|Third Intervention (1 Week)||8
8925536|NCT02258477|9986658|FG000|NOT COMPLETED|Third Intervention (1 Week)||0
8925537|NCT02258477|9986659|FG001|NOT COMPLETED|Third Intervention (1 Week)||0
8925538|NCT02258477|9986660|FG002|NOT COMPLETED|Third Intervention (1 Week)||0
8925539|NCT02258477|9986661|FG003|NOT COMPLETED|Third Intervention (1 Week)||0
8925540|NCT02258477|9986658|FG000|STARTED|Fourth Intervention (1 Week)||9
8925541|NCT02258477|9986659|FG001|STARTED|Fourth Intervention (1 Week)||8
8925542|NCT02258477|9986660|FG002|STARTED|Fourth Intervention (1 Week)||8
8925543|NCT02258477|9986661|FG003|STARTED|Fourth Intervention (1 Week)||8
8925544|NCT02258477|9986658|FG000|COMPLETED|Fourth Intervention (1 Week)||9
8925545|NCT02258477|9986659|FG001|COMPLETED|Fourth Intervention (1 Week)||8
8925546|NCT02258477|9986660|FG002|COMPLETED|Fourth Intervention (1 Week)||8
8925547|NCT02258477|9986661|FG003|COMPLETED|Fourth Intervention (1 Week)||8
8925548|NCT02258477|9986658|FG000|NOT COMPLETED|Fourth Intervention (1 Week)||0
8925549|NCT02258477|9986659|FG001|NOT COMPLETED|Fourth Intervention (1 Week)||0
8925550|NCT02258477|9986660|FG002|NOT COMPLETED|Fourth Intervention (1 Week)||0
8925551|NCT02258477|9986661|FG003|NOT COMPLETED|Fourth Intervention (1 Week)||0
8925552|NCT02258529|9986670|FG000|STARTED|Overall Study||10
8925553|NCT02258529|9986670|FG000|COMPLETED|Overall Study||0
8925554|NCT02258529|9986670|FG000|NOT COMPLETED|Overall Study||10
8925555|NCT02259010|9986674|FG000|STARTED|Overall Study||24
8925556|NCT02259010|9986674|FG000|COMPLETED|Overall Study|Completed=Completed protocol-specified dosing and PK assessment.|19
8925557|NCT02259010|9986674|FG000|NOT COMPLETED|Overall Study||5
8811337|NCT01513967|9864375|FG004|COMPLETED|Overall Study||4
8811338|NCT01513967|9864376|FG005|COMPLETED|Overall Study||3
8811339|NCT01513967|9864377|FG006|COMPLETED|Overall Study||3
8811340|NCT01513967|9864378|FG007|COMPLETED|Overall Study||6
8925558|NCT02259088|9986682|FG000|STARTED|Overall Study||307
8925559|NCT02259088|9986683|FG001|STARTED|Overall Study||77
8925560|NCT02259088|9986682|FG000|Full Analysis Set|Overall Study||307
8925561|NCT02259088|9986683|FG001|Full Analysis Set|Overall Study||77
8925562|NCT02259088|9986682|FG000|Treated (Safety Analysis Set)|Overall Study||307
8948196|NCT02427750|10010522|FG000|NOT COMPLETED|Overall Study||0
8811341|NCT01513967|9864371|FG000|NOT COMPLETED|Overall Study||0
8811342|NCT01513967|9864372|FG001|NOT COMPLETED|Overall Study||0
8811343|NCT01513967|9864373|FG002|NOT COMPLETED|Overall Study||0
8811344|NCT01513967|9864374|FG003|NOT COMPLETED|Overall Study||0
8696536|NCT00883168|9742177|FG001|STARTED|Overall Study||445
8696537|NCT00883168|9742178|FG002|STARTED|Overall Study||450
8696538|NCT00883168|9742179|FG003|STARTED|Overall Study||448
8811345|NCT01513967|9864375|FG004|NOT COMPLETED|Overall Study||0
8811346|NCT01513967|9864376|FG005|NOT COMPLETED|Overall Study||1
8811347|NCT01513967|9864377|FG006|NOT COMPLETED|Overall Study||2
8811348|NCT01513967|9864378|FG007|NOT COMPLETED|Overall Study||2
8811349|NCT01514136|9864398|FG000|STARTED|Test Period 1; Test A|26 subjects tested Test A|25
8811350|NCT01514136|9864399|FG001|STARTED|Test Period 1; Test A||0
8811351|NCT01514136|9864400|FG002|STARTED|Test Period 1; Test A||0
8811352|NCT01514136|9864401|FG003|STARTED|Test Period 1; Test A||0
8811353|NCT01514136|9864402|FG004|STARTED|Test Period 1; Test A||0
8811354|NCT01514136|9864403|FG005|STARTED|Test Period 1; Test A||0
8811355|NCT01514136|9864404|FG006|STARTED|Test Period 1; Test A||0
8811356|NCT01514136|9864405|FG007|STARTED|Test Period 1; Test A||0
8811357|NCT01514136|9864398|FG000|COMPLETED|Test Period 1; Test A||22
8811358|NCT01514136|9864399|FG001|COMPLETED|Test Period 1; Test A||0
8811359|NCT01514136|9864400|FG002|COMPLETED|Test Period 1; Test A||0
8811360|NCT01514136|9864401|FG003|COMPLETED|Test Period 1; Test A||0
8811361|NCT01514136|9864402|FG004|COMPLETED|Test Period 1; Test A||0
8811362|NCT01514136|9864403|FG005|COMPLETED|Test Period 1; Test A||0
8811363|NCT01514136|9864404|FG006|COMPLETED|Test Period 1; Test A||0
8811364|NCT01514136|9864405|FG007|COMPLETED|Test Period 1; Test A||0
8811365|NCT01514136|9864398|FG000|NOT COMPLETED|Test Period 1; Test A||3
8696539|NCT00883168|9742176|FG000|COMPLETED|Overall Study||434
8696540|NCT00883168|9742177|FG001|COMPLETED|Overall Study||430
8696541|NCT00883168|9742178|FG002|COMPLETED|Overall Study||431
8696542|NCT00883168|9742179|FG003|COMPLETED|Overall Study||433
8696543|NCT00883168|9742176|FG000|NOT COMPLETED|Overall Study||14
8696544|NCT00883168|9742177|FG001|NOT COMPLETED|Overall Study||15
8696545|NCT00883168|9742178|FG002|NOT COMPLETED|Overall Study||19
8696546|NCT00883168|9742179|FG003|NOT COMPLETED|Overall Study||15
8696547|NCT00883181|9742189|FG000|STARTED|Overall Study|Full analysis set|1347
8696548|NCT00883181|9742189|FG000|COMPLETED|Overall Study|Completed planned chemotherapy|1069
8696549|NCT00883181|9742189|FG000|NOT COMPLETED|Overall Study||278
8696550|NCT00883233|9742210|FG000|STARTED|Overall Study||32
8696551|NCT00883233|9742211|FG001|STARTED|Overall Study||32
8696552|NCT00883233|9742212|FG002|STARTED|Overall Study||29
8696553|NCT00883233|9742213|FG003|STARTED|Overall Study||30
8696554|NCT00883233|9742210|FG000|COMPLETED|Overall Study||27
8696555|NCT00883233|9742211|FG001|COMPLETED|Overall Study||28
8696556|NCT00883233|9742212|FG002|COMPLETED|Overall Study||25
8696557|NCT00883233|9742213|FG003|COMPLETED|Overall Study||25
8696558|NCT00883233|9742210|FG000|NOT COMPLETED|Overall Study||5
8696559|NCT00883233|9742211|FG001|NOT COMPLETED|Overall Study||4
8696560|NCT00883233|9742212|FG002|NOT COMPLETED|Overall Study||4
8696561|NCT00883233|9742213|FG003|NOT COMPLETED|Overall Study||5
8696562|NCT00883246|9742223|FG000|STARTED|Overall Study||799
8696563|NCT00883246|9742223|FG000|COMPLETED|Overall Study||626
8696564|NCT00883246|9742223|FG000|NOT COMPLETED|Overall Study||173
8696565|NCT00883337|9742236|FG000|STARTED|Core Treatment Period||109
8696566|NCT00883337|9742237|FG001|STARTED|Core Treatment Period||111
8696567|NCT00883337|9742238|FG002|STARTED|Core Treatment Period||104
8696568|NCT00883337|9742236|FG000|Treated|Core Treatment Period||109
8696569|NCT00883337|9742237|FG001|Treated|Core Treatment Period|One participant received teriflunomide 7 mg instead of teriflunomide 14 mg|111
8696570|NCT00883337|9742238|FG002|Treated|Core Treatment Period|3 participants refused treatment with Rebif®|101
8696571|NCT00883337|9742236|FG000|COMPLETED|Core Treatment Period||89
8696572|NCT00883337|9742237|FG001|COMPLETED|Core Treatment Period||89
8696573|NCT00883337|9742238|FG002|COMPLETED|Core Treatment Period||71
8696574|NCT00883337|9742236|FG000|NOT COMPLETED|Core Treatment Period||20
8696575|NCT00883337|9742237|FG001|NOT COMPLETED|Core Treatment Period||22
8696576|NCT00883337|9742238|FG002|NOT COMPLETED|Core Treatment Period||33
8696577|NCT00883337|9742236|FG000|STARTED|Extension Treatment Period||89
8696578|NCT00883337|9742237|FG001|STARTED|Extension Treatment Period||89
8696579|NCT00883337|9742238|FG002|STARTED|Extension Treatment Period|12 participants completed the core period but didn't enter the extension period.|59
8696580|NCT00883337|9742236|FG000|COMPLETED|Extension Treatment Period||61
8696581|NCT00883337|9742237|FG001|COMPLETED|Extension Treatment Period||66
8696582|NCT00883337|9742238|FG002|COMPLETED|Extension Treatment Period||40
8696583|NCT00883337|9742236|FG000|NOT COMPLETED|Extension Treatment Period||28
8696584|NCT00883337|9742237|FG001|NOT COMPLETED|Extension Treatment Period||23
8696585|NCT00883337|9742238|FG002|NOT COMPLETED|Extension Treatment Period||19
8696586|NCT00883389|9742252|FG000|STARTED|Overall Study||26
8696587|NCT00883389|9742252|FG000|COMPLETED|Overall Study||26
8696588|NCT00883389|9742252|FG000|NOT COMPLETED|Overall Study||0
8696589|NCT00883415|9742256|FG000|STARTED|Overall Study||20
8811366|NCT01514136|9864399|FG001|NOT COMPLETED|Test Period 1; Test A||0
8811367|NCT01514136|9864400|FG002|NOT COMPLETED|Test Period 1; Test A||0
8811368|NCT01514136|9864401|FG003|NOT COMPLETED|Test Period 1; Test A||0
8811369|NCT01514136|9864402|FG004|NOT COMPLETED|Test Period 1; Test A||0
8811370|NCT01514136|9864403|FG005|NOT COMPLETED|Test Period 1; Test A||0
8811371|NCT01514136|9864404|FG006|NOT COMPLETED|Test Period 1; Test A||0
8811372|NCT01514136|9864405|FG007|NOT COMPLETED|Test Period 1; Test A||0
8811373|NCT01514136|9864398|FG000|STARTED|Test Period 1; Test B||0
8811374|NCT01514136|9864399|FG001|STARTED|Test Period 1; Test B|2 new subjects were entered the investigation|24
8811375|NCT01514136|9864400|FG002|STARTED|Test Period 1; Test B||0
8811376|NCT01514136|9864401|FG003|STARTED|Test Period 1; Test B||0
8811377|NCT01514136|9864402|FG004|STARTED|Test Period 1; Test B||0
8811378|NCT01514136|9864403|FG005|STARTED|Test Period 1; Test B||0
8811379|NCT01514136|9864404|FG006|STARTED|Test Period 1; Test B||0
8811380|NCT01514136|9864405|FG007|STARTED|Test Period 1; Test B||0
8811381|NCT01514136|9864398|FG000|COMPLETED|Test Period 1; Test B||0
8811382|NCT01514136|9864399|FG001|COMPLETED|Test Period 1; Test B||23
8811383|NCT01514136|9864400|FG002|COMPLETED|Test Period 1; Test B||0
8811384|NCT01514136|9864401|FG003|COMPLETED|Test Period 1; Test B||0
8811385|NCT01514136|9864402|FG004|COMPLETED|Test Period 1; Test B||0
8811386|NCT01514136|9864403|FG005|COMPLETED|Test Period 1; Test B||0
8811387|NCT01514136|9864404|FG006|COMPLETED|Test Period 1; Test B||0
8811388|NCT01514136|9864405|FG007|COMPLETED|Test Period 1; Test B||0
8811389|NCT01514136|9864398|FG000|NOT COMPLETED|Test Period 1; Test B||0
8811390|NCT01514136|9864399|FG001|NOT COMPLETED|Test Period 1; Test B||1
8811391|NCT01514136|9864400|FG002|NOT COMPLETED|Test Period 1; Test B||0
8811392|NCT01514136|9864401|FG003|NOT COMPLETED|Test Period 1; Test B||0
8811393|NCT01514136|9864402|FG004|NOT COMPLETED|Test Period 1; Test B||0
8811394|NCT01514136|9864403|FG005|NOT COMPLETED|Test Period 1; Test B||0
8811395|NCT01514136|9864404|FG006|NOT COMPLETED|Test Period 1; Test B||0
8811396|NCT01514136|9864405|FG007|NOT COMPLETED|Test Period 1; Test B||0
8811397|NCT01514136|9864398|FG000|STARTED|Test Period 1; Test C||0
8811398|NCT01514136|9864399|FG001|STARTED|Test Period 1; Test C||0
8811399|NCT01514136|9864400|FG002|STARTED|Test Period 1; Test C|1 new subject was included in the investigation|24
8811400|NCT01514136|9864401|FG003|STARTED|Test Period 1; Test C||0
8811401|NCT01514136|9864402|FG004|STARTED|Test Period 1; Test C||0
8811402|NCT01514136|9864403|FG005|STARTED|Test Period 1; Test C||0
8811403|NCT01514136|9864404|FG006|STARTED|Test Period 1; Test C||0
8811404|NCT01514136|9864405|FG007|STARTED|Test Period 1; Test C||0
8811405|NCT01514136|9864398|FG000|COMPLETED|Test Period 1; Test C||0
8811406|NCT01514136|9864399|FG001|COMPLETED|Test Period 1; Test C||0
8811407|NCT01514136|9864400|FG002|COMPLETED|Test Period 1; Test C||24
8811408|NCT01514136|9864401|FG003|COMPLETED|Test Period 1; Test C||0
8811409|NCT01514136|9864402|FG004|COMPLETED|Test Period 1; Test C||0
8811410|NCT01514136|9864403|FG005|COMPLETED|Test Period 1; Test C||0
8811411|NCT01514136|9864404|FG006|COMPLETED|Test Period 1; Test C||0
8811412|NCT01514136|9864405|FG007|COMPLETED|Test Period 1; Test C||0
8811413|NCT01514136|9864398|FG000|NOT COMPLETED|Test Period 1; Test C||0
8811414|NCT01514136|9864399|FG001|NOT COMPLETED|Test Period 1; Test C||0
8696590|NCT00883415|9742256|FG000|COMPLETED|Overall Study||18
8696591|NCT00883415|9742256|FG000|NOT COMPLETED|Overall Study||2
8696592|NCT00883493|9742262|FG000|STARTED|Overall Study||212
8811415|NCT01514136|9864400|FG002|NOT COMPLETED|Test Period 1; Test C||0
8811416|NCT01514136|9864401|FG003|NOT COMPLETED|Test Period 1; Test C||0
8811417|NCT01514136|9864402|FG004|NOT COMPLETED|Test Period 1; Test C||0
8811418|NCT01514136|9864403|FG005|NOT COMPLETED|Test Period 1; Test C||0
8811419|NCT01514136|9864404|FG006|NOT COMPLETED|Test Period 1; Test C||0
8811420|NCT01514136|9864405|FG007|NOT COMPLETED|Test Period 1; Test C||0
8811421|NCT01514136|9864398|FG000|STARTED|Test Period 1; Test D||0
8811422|NCT01514136|9864399|FG001|STARTED|Test Period 1; Test D||0
8811423|NCT01514136|9864400|FG002|STARTED|Test Period 1; Test D||0
8811424|NCT01514136|9864401|FG003|STARTED|Test Period 1; Test D|The two subject that were on holiday after test A re-entered the investigation|26
8811425|NCT01514136|9864402|FG004|STARTED|Test Period 1; Test D||0
8811426|NCT01514136|9864403|FG005|STARTED|Test Period 1; Test D||0
8811427|NCT01514136|9864404|FG006|STARTED|Test Period 1; Test D||0
8811428|NCT01514136|9864405|FG007|STARTED|Test Period 1; Test D||0
8696593|NCT00883493|9742263|FG001|STARTED|Overall Study||209
8696594|NCT00883493|9742262|FG000|Intention To Treat Analysis Population|Overall Study||204
8696595|NCT00883493|9742263|FG001|Intention To Treat Analysis Population|Overall Study||195
8696596|NCT00883493|9742262|FG000|Per Protocol Analysis Population|Overall Study||162
8696597|NCT00883493|9742263|FG001|Per Protocol Analysis Population|Overall Study||155
8696598|NCT00883493|9742262|FG000|COMPLETED|Overall Study||166
8696599|NCT00883493|9742263|FG001|COMPLETED|Overall Study||159
8696600|NCT00883493|9742262|FG000|NOT COMPLETED|Overall Study||46
8696601|NCT00883493|9742263|FG001|NOT COMPLETED|Overall Study||50
8696602|NCT00883558|9742269|FG000|STARTED|Titration Period (Weeks 0 to 4)||48
8696603|NCT00883558|9742270|FG001|STARTED|Titration Period (Weeks 0 to 4)||0
8696604|NCT00883558|9742271|FG002|STARTED|Titration Period (Weeks 0 to 4)||0
8696605|NCT00883558|9742269|FG000|COMPLETED|Titration Period (Weeks 0 to 4)||46
8696606|NCT00883558|9742270|FG001|COMPLETED|Titration Period (Weeks 0 to 4)||0
8696607|NCT00883558|9742271|FG002|COMPLETED|Titration Period (Weeks 0 to 4)||0
8696608|NCT00883558|9742269|FG000|NOT COMPLETED|Titration Period (Weeks 0 to 4)||2
8811429|NCT01514136|9864398|FG000|COMPLETED|Test Period 1; Test D||0
8811430|NCT01514136|9864399|FG001|COMPLETED|Test Period 1; Test D||0
8811431|NCT01514136|9864400|FG002|COMPLETED|Test Period 1; Test D||0
8811432|NCT01514136|9864401|FG003|COMPLETED|Test Period 1; Test D||24
8811433|NCT01514136|9864402|FG004|COMPLETED|Test Period 1; Test D||0
8696609|NCT00883558|9742270|FG001|NOT COMPLETED|Titration Period (Weeks 0 to 4)||0
8696610|NCT00883558|9742271|FG002|NOT COMPLETED|Titration Period (Weeks 0 to 4)||0
8811434|NCT01514136|9864403|FG005|COMPLETED|Test Period 1; Test D||0
8811435|NCT01514136|9864404|FG006|COMPLETED|Test Period 1; Test D||0
8811436|NCT01514136|9864405|FG007|COMPLETED|Test Period 1; Test D||0
8696611|NCT00883558|9742269|FG000|STARTED|First Treatment Cycle (Weeks 4 to 16)||0
8696612|NCT00883558|9742270|FG001|STARTED|First Treatment Cycle (Weeks 4 to 16)||22
8696613|NCT00883558|9742271|FG002|STARTED|First Treatment Cycle (Weeks 4 to 16)||24
8696614|NCT00883558|9742269|FG000|Received at Least 1 Dose of Study Drug|First Treatment Cycle (Weeks 4 to 16)||0
8696615|NCT00883558|9742270|FG001|Received at Least 1 Dose of Study Drug|First Treatment Cycle (Weeks 4 to 16)||22
8696616|NCT00883558|9742271|FG002|Received at Least 1 Dose of Study Drug|First Treatment Cycle (Weeks 4 to 16)||24
8696617|NCT00883558|9742269|FG000|COMPLETED|First Treatment Cycle (Weeks 4 to 16)||0
8696618|NCT00883558|9742270|FG001|COMPLETED|First Treatment Cycle (Weeks 4 to 16)||19
8696619|NCT00883558|9742271|FG002|COMPLETED|First Treatment Cycle (Weeks 4 to 16)||23
8696620|NCT00883558|9742269|FG000|NOT COMPLETED|First Treatment Cycle (Weeks 4 to 16)||0
8696621|NCT00883558|9742270|FG001|NOT COMPLETED|First Treatment Cycle (Weeks 4 to 16)||3
8696622|NCT00883558|9742271|FG002|NOT COMPLETED|First Treatment Cycle (Weeks 4 to 16)||1
8696623|NCT00883558|9742269|FG000|STARTED|Second Treatment Cycle (Weeks 16 to 28)||0
8696624|NCT00883558|9742270|FG001|STARTED|Second Treatment Cycle (Weeks 16 to 28)||19
8696625|NCT00883558|9742271|FG002|STARTED|Second Treatment Cycle (Weeks 16 to 28)||23
8696626|NCT00883558|9742269|FG000|Received at Least 1 Dose of Study Drug|Second Treatment Cycle (Weeks 16 to 28)||0
8696627|NCT00883558|9742270|FG001|Received at Least 1 Dose of Study Drug|Second Treatment Cycle (Weeks 16 to 28)||19
8696628|NCT00883558|9742271|FG002|Received at Least 1 Dose of Study Drug|Second Treatment Cycle (Weeks 16 to 28)||23
8696629|NCT00883558|9742269|FG000|COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||0
8696630|NCT00883558|9742270|FG001|COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||19
8696631|NCT00883558|9742271|FG002|COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||22
8696632|NCT00883558|9742269|FG000|NOT COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||0
8696633|NCT00883558|9742270|FG001|NOT COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||0
8696634|NCT00883558|9742271|FG002|NOT COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||1
8696635|NCT00883675|9742277|FG000|STARTED|Overall Study||133
8696636|NCT00883675|9742277|FG000|COMPLETED|Overall Study||133
8696637|NCT00883675|9742277|FG000|NOT COMPLETED|Overall Study||0
8724232|NCT01025843|9771501|FG002|COMPLETED|Washout 3||2
8724233|NCT01025843|9771502|FG003|COMPLETED|Washout 3||2
8724234|NCT01025843|9771503|FG004|COMPLETED|Washout 3||2
8724235|NCT01025843|9771504|FG005|COMPLETED|Washout 3||2
8724236|NCT01025843|9771505|FG006|COMPLETED|Washout 3||2
8724237|NCT01025843|9771506|FG007|COMPLETED|Washout 3||2
8724238|NCT01025843|9771507|FG008|COMPLETED|Washout 3||2
8724239|NCT01025843|9771508|FG009|COMPLETED|Washout 3||2
8724240|NCT01025843|9771499|FG000|NOT COMPLETED|Washout 3||0
8724241|NCT01025843|9771500|FG001|NOT COMPLETED|Washout 3||0
8724242|NCT01025843|9771501|FG002|NOT COMPLETED|Washout 3||0
8724243|NCT01025843|9771502|FG003|NOT COMPLETED|Washout 3||0
8724244|NCT01025843|9771503|FG004|NOT COMPLETED|Washout 3||0
8724245|NCT01025843|9771504|FG005|NOT COMPLETED|Washout 3||0
8724246|NCT01025843|9771505|FG006|NOT COMPLETED|Washout 3||0
8724247|NCT01025843|9771506|FG007|NOT COMPLETED|Washout 3||0
8724248|NCT01025843|9771507|FG008|NOT COMPLETED|Washout 3||0
8724249|NCT01025843|9771508|FG009|NOT COMPLETED|Washout 3||0
8724250|NCT01025843|9771499|FG000|STARTED|Period 4||2
8724251|NCT01025843|9771500|FG001|STARTED|Period 4||2
8724252|NCT01025843|9771501|FG002|STARTED|Period 4||2
8724253|NCT01025843|9771502|FG003|STARTED|Period 4||2
8724254|NCT01025843|9771503|FG004|STARTED|Period 4||2
8724255|NCT01025843|9771504|FG005|STARTED|Period 4||2
8724256|NCT01025843|9771505|FG006|STARTED|Period 4||2
8724257|NCT01025843|9771506|FG007|STARTED|Period 4||2
8724258|NCT01025843|9771507|FG008|STARTED|Period 4||2
8724259|NCT01025843|9771508|FG009|STARTED|Period 4||2
8724260|NCT01025843|9771499|FG000|COMPLETED|Period 4||2
8724261|NCT01025843|9771500|FG001|COMPLETED|Period 4||2
8724262|NCT01025843|9771501|FG002|COMPLETED|Period 4||2
8724263|NCT01025843|9771502|FG003|COMPLETED|Period 4||2
8724264|NCT01025843|9771503|FG004|COMPLETED|Period 4||2
8724265|NCT01025843|9771504|FG005|COMPLETED|Period 4||2
8724266|NCT01025843|9771505|FG006|COMPLETED|Period 4||2
8724267|NCT01025843|9771506|FG007|COMPLETED|Period 4||2
8724268|NCT01025843|9771507|FG008|COMPLETED|Period 4||2
8724269|NCT01025843|9771508|FG009|COMPLETED|Period 4||2
8724270|NCT01025843|9771499|FG000|NOT COMPLETED|Period 4||0
8724271|NCT01025843|9771500|FG001|NOT COMPLETED|Period 4||0
8724272|NCT01025843|9771501|FG002|NOT COMPLETED|Period 4||0
8724273|NCT01025843|9771502|FG003|NOT COMPLETED|Period 4||0
8724274|NCT01025843|9771503|FG004|NOT COMPLETED|Period 4||0
8724275|NCT01025843|9771504|FG005|NOT COMPLETED|Period 4||0
8811437|NCT01514136|9864398|FG000|NOT COMPLETED|Test Period 1; Test D||0
8811438|NCT01514136|9864399|FG001|NOT COMPLETED|Test Period 1; Test D||0
8724276|NCT01025843|9771505|FG006|NOT COMPLETED|Period 4||0
8724277|NCT01025843|9771506|FG007|NOT COMPLETED|Period 4||0
8724278|NCT01025843|9771507|FG008|NOT COMPLETED|Period 4||0
8724279|NCT01025843|9771508|FG009|NOT COMPLETED|Period 4||0
8724280|NCT01025843|9771499|FG000|STARTED|Washout 4||2
8724281|NCT01025843|9771500|FG001|STARTED|Washout 4||2
8724282|NCT01025843|9771501|FG002|STARTED|Washout 4||2
8724283|NCT01025843|9771502|FG003|STARTED|Washout 4||2
8724284|NCT01025843|9771503|FG004|STARTED|Washout 4||2
8724285|NCT01025843|9771504|FG005|STARTED|Washout 4||2
8724286|NCT01025843|9771505|FG006|STARTED|Washout 4||2
8811439|NCT01514136|9864400|FG002|NOT COMPLETED|Test Period 1; Test D||0
8811440|NCT01514136|9864401|FG003|NOT COMPLETED|Test Period 1; Test D||2
8811441|NCT01514136|9864402|FG004|NOT COMPLETED|Test Period 1; Test D||0
8811442|NCT01514136|9864403|FG005|NOT COMPLETED|Test Period 1; Test D||0
8811443|NCT01514136|9864404|FG006|NOT COMPLETED|Test Period 1; Test D||0
8696638|NCT00883688|9742281|FG000|STARTED|Overall Study||24
8696639|NCT00883688|9742281|FG000|COMPLETED|Overall Study||22
8696640|NCT00883688|9742281|FG000|NOT COMPLETED|Overall Study||2
8696641|NCT00883740|9742285|FG000|STARTED|First Intervention||60
8696642|NCT00883740|9742286|FG001|STARTED|First Intervention||59
8696643|NCT00883740|9742285|FG000|COMPLETED|First Intervention|1 participant not crossed to period 2 but continued on period 1, sponsor terminated as noncompliance|53
8696644|NCT00883740|9742286|FG001|COMPLETED|First Intervention||51
8696645|NCT00883740|9742285|FG000|NOT COMPLETED|First Intervention||7
8696646|NCT00883740|9742286|FG001|NOT COMPLETED|First Intervention||8
8696647|NCT00883740|9742285|FG000|STARTED|Taper and Washout Period (2 Weeks)|1 participant not crossed to period 2 but continued on period 1, sponsor terminated as noncompliance|54
8696648|NCT00883740|9742286|FG001|STARTED|Taper and Washout Period (2 Weeks)||51
8696649|NCT00883740|9742285|FG000|COMPLETED|Taper and Washout Period (2 Weeks)||54
8696650|NCT00883740|9742286|FG001|COMPLETED|Taper and Washout Period (2 Weeks)||51
8696651|NCT00883740|9742285|FG000|NOT COMPLETED|Taper and Washout Period (2 Weeks)||0
8696652|NCT00883740|9742286|FG001|NOT COMPLETED|Taper and Washout Period (2 Weeks)||0
8696653|NCT00883740|9742285|FG000|STARTED|Second Intervention|1 participant not crossed to period 2 but continued on period 1, sponsor terminated as noncompliance|53
8696654|NCT00883740|9742286|FG001|STARTED|Second Intervention||51
8696655|NCT00883740|9742285|FG000|COMPLETED|Second Intervention||52
8696656|NCT00883740|9742286|FG001|COMPLETED|Second Intervention||50
8696657|NCT00883740|9742285|FG000|NOT COMPLETED|Second Intervention||1
8696658|NCT00883740|9742286|FG001|NOT COMPLETED|Second Intervention||1
8696659|NCT00883753|9742292|FG000|STARTED|Overall Study||934
8696660|NCT00883753|9742292|FG000|COMPLETED|Overall Study||827
8696661|NCT00883753|9742292|FG000|NOT COMPLETED|Overall Study||107
8696662|NCT00883779|9742301|FG000|STARTED|Primary Study Treatment Phase||225
8696663|NCT00883779|9742302|FG001|STARTED|Primary Study Treatment Phase||226
8696664|NCT00883779|9742301|FG000|COMPLETED|Primary Study Treatment Phase||120
8696665|NCT00883779|9742302|FG001|COMPLETED|Primary Study Treatment Phase||140
8696666|NCT00883779|9742301|FG000|NOT COMPLETED|Primary Study Treatment Phase||105
8696667|NCT00883779|9742302|FG001|NOT COMPLETED|Primary Study Treatment Phase||86
8696668|NCT00883779|9742301|FG000|STARTED|Post-Study Treatment Phase||112
8696669|NCT00883779|9742302|FG001|STARTED|Post-Study Treatment Phase||135
8696670|NCT00883779|9742301|FG000|COMPLETED|Post-Study Treatment Phase||0
8696671|NCT00883779|9742302|FG001|COMPLETED|Post-Study Treatment Phase||0
8696672|NCT00883779|9742301|FG000|NOT COMPLETED|Post-Study Treatment Phase||112
8696673|NCT00883779|9742302|FG001|NOT COMPLETED|Post-Study Treatment Phase||135
8696674|NCT00883779|9742301|FG000|STARTED|Off-study Phase||209
8696675|NCT00883779|9742302|FG001|STARTED|Off-study Phase||202
8696676|NCT00883779|9742301|FG000|COMPLETED|Off-study Phase||0
8696677|NCT00883779|9742302|FG001|COMPLETED|Off-study Phase||0
8696678|NCT00883779|9742301|FG000|NOT COMPLETED|Off-study Phase||209
8696679|NCT00883779|9742302|FG001|NOT COMPLETED|Off-study Phase||202
8696680|NCT00884039|9742310|FG000|STARTED|Overall Study||5
8696681|NCT00884039|9742311|FG001|STARTED|Overall Study||2
8696682|NCT00884039|9742310|FG000|COMPLETED|Overall Study||3
8696683|NCT00884039|9742311|FG001|COMPLETED|Overall Study||1
8696684|NCT00884039|9742310|FG000|NOT COMPLETED|Overall Study||2
8696685|NCT00884039|9742311|FG001|NOT COMPLETED|Overall Study||1
8696686|NCT00884052|9742317|FG000|STARTED|Overall Study||6
8696687|NCT00884052|9742318|FG001|STARTED|Overall Study||12
8696688|NCT00884052|9742317|FG000|COMPLETED|Overall Study||6
8696689|NCT00884052|9742318|FG001|COMPLETED|Overall Study||12
8696690|NCT00884052|9742317|FG000|NOT COMPLETED|Overall Study||0
8696691|NCT00884052|9742318|FG001|NOT COMPLETED|Overall Study||0
8696692|NCT00884065|9742326|FG000|STARTED|Overall Study||25
8696693|NCT00884065|9742327|FG001|STARTED|Overall Study||25
8696694|NCT00884065|9742326|FG000|COMPLETED|Overall Study||25
8696695|NCT00884065|9742327|FG001|COMPLETED|Overall Study||25
8696696|NCT00884065|9742326|FG000|NOT COMPLETED|Overall Study||0
8696697|NCT00884065|9742327|FG001|NOT COMPLETED|Overall Study||0
8696698|NCT00884117|9742333|FG000|STARTED|Overall Study||4561
8696699|NCT00884117|9742333|FG000|COMPLETED|Overall Study|Defined as Day 6 visit for those enrolled before Amendment D; thereafter defined as Day 10 visit.|4312
8696700|NCT00884117|9742333|FG000|NOT COMPLETED|Overall Study||249
8696701|NCT00884221|9742352|FG000|STARTED|Overall Study||374
8696702|NCT00884221|9742353|FG001|STARTED|Overall Study||375
8696703|NCT00884221|9742352|FG000|COMPLETED|Overall Study||340
8696704|NCT00884221|9742353|FG001|COMPLETED|Overall Study||343
8696705|NCT00884221|9742352|FG000|NOT COMPLETED|Overall Study||34
8696706|NCT00884221|9742353|FG001|NOT COMPLETED|Overall Study||32
8696707|NCT00884273|9742363|FG000|STARTED|Overall Study|Intention-to-treat (ITT) population.|84
8696708|NCT00884273|9742364|FG001|STARTED|Overall Study|ITT population.|98
8696709|NCT00884273|9742363|FG000|Full Analysis Set (FAS)|Overall Study|Two participants did not have any post-dose efficacy assessment and were excluded from the FAS.|82
8811444|NCT01514136|9864405|FG007|NOT COMPLETED|Test Period 1; Test D||0
8811445|NCT01514136|9864398|FG000|STARTED|Test Period 2; Test A*||0
8811446|NCT01514136|9864399|FG001|STARTED|Test Period 2; Test A*||0
8811447|NCT01514136|9864400|FG002|STARTED|Test Period 2; Test A*||0
8811448|NCT01514136|9864401|FG003|STARTED|Test Period 2; Test A*||0
8811449|NCT01514136|9864402|FG004|STARTED|Test Period 2; Test A*|4 new subjects were included in the investigation|28
8811450|NCT01514136|9864403|FG005|STARTED|Test Period 2; Test A*||0
8811451|NCT01514136|9864404|FG006|STARTED|Test Period 2; Test A*||0
8811452|NCT01514136|9864405|FG007|STARTED|Test Period 2; Test A*||0
8811453|NCT01514136|9864398|FG000|COMPLETED|Test Period 2; Test A*||0
8811454|NCT01514136|9864399|FG001|COMPLETED|Test Period 2; Test A*||0
8811455|NCT01514136|9864400|FG002|COMPLETED|Test Period 2; Test A*||0
8811456|NCT01514136|9864401|FG003|COMPLETED|Test Period 2; Test A*||0
8811457|NCT01514136|9864402|FG004|COMPLETED|Test Period 2; Test A*||26
8811458|NCT01514136|9864403|FG005|COMPLETED|Test Period 2; Test A*||0
8811459|NCT01514136|9864404|FG006|COMPLETED|Test Period 2; Test A*||0
8811460|NCT01514136|9864405|FG007|COMPLETED|Test Period 2; Test A*||0
8811461|NCT01514136|9864398|FG000|NOT COMPLETED|Test Period 2; Test A*||0
8811462|NCT01514136|9864399|FG001|NOT COMPLETED|Test Period 2; Test A*||0
8696710|NCT00884273|9742364|FG001|Full Analysis Set (FAS)|Overall Study|One participant did not have any post-dose efficacy assessment and was excluded from the FAS.|97
8696711|NCT00884273|9742363|FG000|Per Protocol (PP) Analysis Set|Overall Study||81
8696712|NCT00884273|9742364|FG001|Per Protocol (PP) Analysis Set|Overall Study||92
8696713|NCT00884273|9742363|FG000|Safety Analysis Set|Overall Study||84
8696714|NCT00884273|9742364|FG001|Safety Analysis Set|Overall Study||98
8696715|NCT00884273|9742363|FG000|COMPLETED|Overall Study||82
8696716|NCT00884273|9742364|FG001|COMPLETED|Overall Study||93
8696717|NCT00884273|9742363|FG000|NOT COMPLETED|Overall Study||2
8696718|NCT00884273|9742364|FG001|NOT COMPLETED|Overall Study||5
8696719|NCT00884286|9742372|FG000|STARTED|Overall Study||34
8696720|NCT00884286|9742373|FG001|STARTED|Overall Study||33
8696721|NCT00884286|9742372|FG000|COMPLETED|Overall Study||2
8696722|NCT00884286|9742373|FG001|COMPLETED|Overall Study||0
8696723|NCT00884286|9742372|FG000|NOT COMPLETED|Overall Study||32
8696724|NCT00884286|9742373|FG001|NOT COMPLETED|Overall Study||33
8696725|NCT00884312|9742382|FG000|STARTED|Overall Study||9
8696726|NCT00884312|9742383|FG001|STARTED|Overall Study||92
8696727|NCT00884312|9742382|FG000|Received Treatment|Overall Study||9
8696728|NCT00884312|9742383|FG001|Received Treatment|Overall Study||91
8696729|NCT00884312|9742382|FG000|COMPLETED|Overall Study||7
8696730|NCT00884312|9742383|FG001|COMPLETED|Overall Study||67
8696731|NCT00884312|9742382|FG000|NOT COMPLETED|Overall Study||2
8696732|NCT00884312|9742383|FG001|NOT COMPLETED|Overall Study||25
8696733|NCT00884325|9742391|FG000|STARTED|Overall Study||20
8696734|NCT00884325|9742392|FG001|STARTED|Overall Study||20
8696735|NCT00884325|9742391|FG000|COMPLETED|Overall Study||17
8696736|NCT00884325|9742392|FG001|COMPLETED|Overall Study||16
8696737|NCT00884325|9742391|FG000|NOT COMPLETED|Overall Study||3
8696738|NCT00884325|9742392|FG001|NOT COMPLETED|Overall Study||4
8696739|NCT00884377|9742400|FG000|STARTED|Overall Study|1 not treated because infecting parasite could not be confirmed as L. major on rapid PCR testing,|28
8696740|NCT00884377|9742401|FG001|STARTED|Overall Study|1 was not treated due to concerns arising from the location of cutaneous leishmaniasis lesion|28
8696741|NCT00884377|9742400|FG000|COMPLETED|Overall Study|1 received full course of therapy,withdrew consent before completion of the 12 month follow up|26
8696742|NCT00884377|9742401|FG001|COMPLETED|Overall Study||27
8696743|NCT00884377|9742400|FG000|NOT COMPLETED|Overall Study||2
8696744|NCT00884377|9742401|FG001|NOT COMPLETED|Overall Study||1
8696745|NCT00884390|9742415|FG000|STARTED|Overall Study||146
8696746|NCT00884390|9742416|FG001|STARTED|Overall Study||62
8696747|NCT00884390|9742415|FG000|COMPLETED|Overall Study||123
8696748|NCT00884390|9742416|FG001|COMPLETED|Overall Study||54
8696749|NCT00884390|9742415|FG000|NOT COMPLETED|Overall Study||23
8696750|NCT00884390|9742416|FG001|NOT COMPLETED|Overall Study||8
8696751|NCT00884585|9742432|FG000|STARTED|Double-Masked Phase (Day 1-Month 3)||89
8696752|NCT00884585|9742433|FG001|STARTED|Double-Masked Phase (Day 1-Month 3)||87
8696753|NCT00884585|9742432|FG000|COMPLETED|Double-Masked Phase (Day 1-Month 3)||79
8696754|NCT00884585|9742433|FG001|COMPLETED|Double-Masked Phase (Day 1-Month 3)|All placebo patients who completed the double-masked phase received COS in the open-label phase.|83
8696755|NCT00884585|9742432|FG000|NOT COMPLETED|Double-Masked Phase (Day 1-Month 3)||10
8696756|NCT00884585|9742433|FG001|NOT COMPLETED|Double-Masked Phase (Day 1-Month 3)||4
8696757|NCT00884585|9742432|FG000|STARTED|Open-Label Phase (Months 3-9)|All patients who completed the double-masked phase received COS in the open-label phase.|162
8696758|NCT00884585|9742433|FG001|STARTED|Open-Label Phase (Months 3-9)|All placebo patients who completed the double-masked phase received COS in the open-label phase.|0
8696759|NCT00884585|9742432|FG000|COMPLETED|Open-Label Phase (Months 3-9)||147
8696760|NCT00884585|9742433|FG001|COMPLETED|Open-Label Phase (Months 3-9)||0
8696761|NCT00884585|9742432|FG000|NOT COMPLETED|Open-Label Phase (Months 3-9)||15
8696762|NCT00884585|9742433|FG001|NOT COMPLETED|Open-Label Phase (Months 3-9)||0
8696763|NCT00884585|9742432|FG000|STARTED|Open-Label Maintenance (Months 9-12)||147
8696764|NCT00884585|9742433|FG001|STARTED|Open-Label Maintenance (Months 9-12)||0
8696765|NCT00884585|9742432|FG000|COMPLETED|Open-Label Maintenance (Months 9-12)||144
8696766|NCT00884585|9742433|FG001|COMPLETED|Open-Label Maintenance (Months 9-12)||0
8811463|NCT01514136|9864400|FG002|NOT COMPLETED|Test Period 2; Test A*||0
8811464|NCT01514136|9864401|FG003|NOT COMPLETED|Test Period 2; Test A*||0
8811465|NCT01514136|9864402|FG004|NOT COMPLETED|Test Period 2; Test A*||2
8811466|NCT01514136|9864403|FG005|NOT COMPLETED|Test Period 2; Test A*||0
8811467|NCT01514136|9864404|FG006|NOT COMPLETED|Test Period 2; Test A*||0
8811468|NCT01514136|9864405|FG007|NOT COMPLETED|Test Period 2; Test A*||0
8811469|NCT01514136|9864398|FG000|STARTED|Test Period 2; Test B*||0
8811470|NCT01514136|9864399|FG001|STARTED|Test Period 2; Test B*||0
8811471|NCT01514136|9864400|FG002|STARTED|Test Period 2; Test B*||0
8811472|NCT01514136|9864401|FG003|STARTED|Test Period 2; Test B*||0
8811473|NCT01514136|9864402|FG004|STARTED|Test Period 2; Test B*||0
8811474|NCT01514136|9864403|FG005|STARTED|Test Period 2; Test B*|Two subjects did not test test A*, but had a break and continued again on Test B*|28
8811475|NCT01514136|9864404|FG006|STARTED|Test Period 2; Test B*||0
8811476|NCT01514136|9864405|FG007|STARTED|Test Period 2; Test B*||0
8811477|NCT01514136|9864398|FG000|COMPLETED|Test Period 2; Test B*||0
8811478|NCT01514136|9864399|FG001|COMPLETED|Test Period 2; Test B*||0
8811479|NCT01514136|9864400|FG002|COMPLETED|Test Period 2; Test B*||0
8811480|NCT01514136|9864401|FG003|COMPLETED|Test Period 2; Test B*||0
8811481|NCT01514136|9864402|FG004|COMPLETED|Test Period 2; Test B*||0
8811482|NCT01514136|9864403|FG005|COMPLETED|Test Period 2; Test B*||26
8811483|NCT01514136|9864404|FG006|COMPLETED|Test Period 2; Test B*||0
8811484|NCT01514136|9864405|FG007|COMPLETED|Test Period 2; Test B*||0
8811485|NCT01514136|9864398|FG000|NOT COMPLETED|Test Period 2; Test B*||0
8811486|NCT01514136|9864399|FG001|NOT COMPLETED|Test Period 2; Test B*||0
8811487|NCT01514136|9864400|FG002|NOT COMPLETED|Test Period 2; Test B*||0
8811488|NCT01514136|9864401|FG003|NOT COMPLETED|Test Period 2; Test B*||0
8811489|NCT01514136|9864402|FG004|NOT COMPLETED|Test Period 2; Test B*||0
8811490|NCT01514136|9864403|FG005|NOT COMPLETED|Test Period 2; Test B*||2
8811491|NCT01514136|9864404|FG006|NOT COMPLETED|Test Period 2; Test B*||0
8811492|NCT01514136|9864405|FG007|NOT COMPLETED|Test Period 2; Test B*||0
8811493|NCT01514136|9864398|FG000|STARTED|Test Period 2; Test C*||0
8811494|NCT01514136|9864399|FG001|STARTED|Test Period 2; Test C*||0
8811495|NCT01514136|9864400|FG002|STARTED|Test Period 2; Test C*||0
8811496|NCT01514136|9864401|FG003|STARTED|Test Period 2; Test C*||0
8811497|NCT01514136|9864402|FG004|STARTED|Test Period 2; Test C*||0
8811498|NCT01514136|9864403|FG005|STARTED|Test Period 2; Test C*||0
8811499|NCT01514136|9864404|FG006|STARTED|Test Period 2; Test C*||26
8811500|NCT01514136|9864405|FG007|STARTED|Test Period 2; Test C*||0
8811501|NCT01514136|9864398|FG000|COMPLETED|Test Period 2; Test C*||0
8811502|NCT01514136|9864399|FG001|COMPLETED|Test Period 2; Test C*||0
8811503|NCT01514136|9864400|FG002|COMPLETED|Test Period 2; Test C*||0
8811504|NCT01514136|9864401|FG003|COMPLETED|Test Period 2; Test C*||0
8811505|NCT01514136|9864402|FG004|COMPLETED|Test Period 2; Test C*||0
8811506|NCT01514136|9864403|FG005|COMPLETED|Test Period 2; Test C*||0
8811507|NCT01514136|9864404|FG006|COMPLETED|Test Period 2; Test C*||23
8811508|NCT01514136|9864405|FG007|COMPLETED|Test Period 2; Test C*||0
8925563|NCT02259088|9986683|FG001|Treated (Safety Analysis Set)|Overall Study||75
8925564|NCT02259088|9986682|FG000|COMPLETED|Overall Study||279
8925565|NCT02259088|9986683|FG001|COMPLETED|Overall Study||63
8925566|NCT02259088|9986682|FG000|NOT COMPLETED|Overall Study||28
8925567|NCT02259088|9986683|FG001|NOT COMPLETED|Overall Study||14
8925568|NCT02259114|9986694|FG000|STARTED|Overall Study||21
8925569|NCT02259114|9986695|FG001|STARTED|Overall Study||4
8925570|NCT02259114|9986696|FG002|STARTED|Overall Study||13
8925571|NCT02259114|9986697|FG003|STARTED|Overall Study||3
8925572|NCT02259114|9986698|FG004|STARTED|Overall Study||6
8925573|NCT02259114|9986694|FG000|Treated|Overall Study|One participant was randomized but did not receive treatment due to a protocol violation.|20
8925574|NCT02259114|9986695|FG001|Treated|Overall Study||4
8925575|NCT02259114|9986696|FG002|Treated|Overall Study||13
8925576|NCT02259114|9986697|FG003|Treated|Overall Study||3
8925577|NCT02259114|9986698|FG004|Treated|Overall Study||6
8925578|NCT02259114|9986694|FG000|COMPLETED|Overall Study||0
8925579|NCT02259114|9986695|FG001|COMPLETED|Overall Study||0
8925580|NCT02259114|9986696|FG002|COMPLETED|Overall Study||0
8925581|NCT02259114|9986697|FG003|COMPLETED|Overall Study||0
8925582|NCT02259114|9986698|FG004|COMPLETED|Overall Study||0
8925583|NCT02259114|9986694|FG000|NOT COMPLETED|Overall Study||21
8925584|NCT02259114|9986695|FG001|NOT COMPLETED|Overall Study||4
8925585|NCT02259114|9986696|FG002|NOT COMPLETED|Overall Study||13
8925586|NCT02259114|9986697|FG003|NOT COMPLETED|Overall Study||3
8925587|NCT02259114|9986698|FG004|NOT COMPLETED|Overall Study||6
8925588|NCT02259231|9986717|FG000|STARTED|Overall Study||6
8696767|NCT00884585|9742432|FG000|NOT COMPLETED|Open-Label Maintenance (Months 9-12)||3
8696768|NCT00884585|9742433|FG001|NOT COMPLETED|Open-Label Maintenance (Months 9-12)||0
8925589|NCT02259231|9986718|FG001|STARTED|Overall Study||6
8925590|NCT02259231|9986719|FG002|STARTED|Overall Study||6
8925591|NCT02259231|9986720|FG003|STARTED|Overall Study||6
8925592|NCT02259231|9986721|FG004|STARTED|Overall Study||6
8925593|NCT02259231|9986722|FG005|STARTED|Overall Study||6
8925594|NCT02259231|9986723|FG006|STARTED|Overall Study||5
8925595|NCT02259231|9986717|FG000|COMPLETED|Overall Study||0
8925596|NCT02259231|9986718|FG001|COMPLETED|Overall Study||0
8925597|NCT02259231|9986719|FG002|COMPLETED|Overall Study||0
8925598|NCT02259231|9986720|FG003|COMPLETED|Overall Study||0
8925599|NCT02259231|9986721|FG004|COMPLETED|Overall Study||0
8925600|NCT02259231|9986722|FG005|COMPLETED|Overall Study||0
8811509|NCT01514136|9864398|FG000|NOT COMPLETED|Test Period 2; Test C*||0
8811510|NCT01514136|9864399|FG001|NOT COMPLETED|Test Period 2; Test C*||0
8925601|NCT02259231|9986723|FG006|COMPLETED|Overall Study||0
8925602|NCT02259231|9986717|FG000|NOT COMPLETED|Overall Study||6
8925603|NCT02259231|9986718|FG001|NOT COMPLETED|Overall Study||6
8925604|NCT02259231|9986719|FG002|NOT COMPLETED|Overall Study||6
8925605|NCT02259231|9986720|FG003|NOT COMPLETED|Overall Study||6
8811511|NCT01514136|9864400|FG002|NOT COMPLETED|Test Period 2; Test C*||0
8811512|NCT01514136|9864401|FG003|NOT COMPLETED|Test Period 2; Test C*||0
8811513|NCT01514136|9864402|FG004|NOT COMPLETED|Test Period 2; Test C*||0
8811514|NCT01514136|9864403|FG005|NOT COMPLETED|Test Period 2; Test C*||0
8811515|NCT01514136|9864404|FG006|NOT COMPLETED|Test Period 2; Test C*||3
8811516|NCT01514136|9864405|FG007|NOT COMPLETED|Test Period 2; Test C*||0
8811517|NCT01514136|9864398|FG000|STARTED|Test Period; Test D*||0
8811518|NCT01514136|9864399|FG001|STARTED|Test Period; Test D*||0
8811519|NCT01514136|9864400|FG002|STARTED|Test Period; Test D*||0
8811520|NCT01514136|9864401|FG003|STARTED|Test Period; Test D*||0
8811521|NCT01514136|9864402|FG004|STARTED|Test Period; Test D*||0
8811522|NCT01514136|9864403|FG005|STARTED|Test Period; Test D*||0
8811523|NCT01514136|9864404|FG006|STARTED|Test Period; Test D*||0
8811524|NCT01514136|9864405|FG007|STARTED|Test Period; Test D*||23
8811525|NCT01514136|9864398|FG000|COMPLETED|Test Period; Test D*||0
8811526|NCT01514136|9864399|FG001|COMPLETED|Test Period; Test D*||0
8811527|NCT01514136|9864400|FG002|COMPLETED|Test Period; Test D*||0
8811528|NCT01514136|9864401|FG003|COMPLETED|Test Period; Test D*||0
8811529|NCT01514136|9864402|FG004|COMPLETED|Test Period; Test D*||0
8811530|NCT01514136|9864403|FG005|COMPLETED|Test Period; Test D*||0
8811531|NCT01514136|9864404|FG006|COMPLETED|Test Period; Test D*||0
8811532|NCT01514136|9864405|FG007|COMPLETED|Test Period; Test D*||23
8811533|NCT01514136|9864398|FG000|NOT COMPLETED|Test Period; Test D*||0
8696769|NCT00884611|9742439|FG000|STARTED|Overall Study||20
8696770|NCT00884611|9742439|FG000|Enrolled, Not Treated|Overall Study||1
8696771|NCT00884611|9742439|FG000|COMPLETED|Overall Study||19
8696772|NCT00884611|9742439|FG000|NOT COMPLETED|Overall Study||1
8696773|NCT00884650|9742451|FG000|STARTED|Overall Study||25
8696774|NCT00884650|9742452|FG001|STARTED|Overall Study||29
8696775|NCT00884650|9742451|FG000|COMPLETED|Overall Study||16
8696776|NCT00884650|9742452|FG001|COMPLETED|Overall Study||21
8696777|NCT00884650|9742451|FG000|NOT COMPLETED|Overall Study||9
8696778|NCT00884650|9742452|FG001|NOT COMPLETED|Overall Study||8
8696779|NCT00884741|9742462|FG000|STARTED|Step 1 Registration: Tissue Screening||978
8696780|NCT00884741|9742463|FG001|STARTED|Step 1 Registration: Tissue Screening||0
8696781|NCT00884741|9742464|FG002|STARTED|Step 1 Registration: Tissue Screening||0
8696782|NCT00884741|9742465|FG003|STARTED|Step 1 Registration: Tissue Screening||0
8696783|NCT00884741|9742462|FG000|COMPLETED|Step 1 Registration: Tissue Screening||666
8696784|NCT00884741|9742463|FG001|COMPLETED|Step 1 Registration: Tissue Screening||0
8696785|NCT00884741|9742464|FG002|COMPLETED|Step 1 Registration: Tissue Screening||0
8696786|NCT00884741|9742465|FG003|COMPLETED|Step 1 Registration: Tissue Screening||0
8696787|NCT00884741|9742462|FG000|NOT COMPLETED|Step 1 Registration: Tissue Screening||312
8696788|NCT00884741|9742463|FG001|NOT COMPLETED|Step 1 Registration: Tissue Screening||0
8696789|NCT00884741|9742464|FG002|NOT COMPLETED|Step 1 Registration: Tissue Screening||0
8696790|NCT00884741|9742465|FG003|NOT COMPLETED|Step 1 Registration: Tissue Screening||0
8696791|NCT00884741|9742462|FG000|STARTED|Step 2 Registration: Tissue Analysis|Step 1 Registration Arm goes to Step 2 Registration Arm|0
8696792|NCT00884741|9742463|FG001|STARTED|Step 2 Registration: Tissue Analysis|These patients completed the previous period on the Step 1 Registration arm.|666
8696793|NCT00884741|9742464|FG002|STARTED|Step 2 Registration: Tissue Analysis||0
8696794|NCT00884741|9742465|FG003|STARTED|Step 2 Registration: Tissue Analysis||0
8696795|NCT00884741|9742462|FG000|COMPLETED|Step 2 Registration: Tissue Analysis||0
8696796|NCT00884741|9742463|FG001|COMPLETED|Step 2 Registration: Tissue Analysis||637
8696797|NCT00884741|9742464|FG002|COMPLETED|Step 2 Registration: Tissue Analysis||0
8696798|NCT00884741|9742465|FG003|COMPLETED|Step 2 Registration: Tissue Analysis||0
8696799|NCT00884741|9742462|FG000|NOT COMPLETED|Step 2 Registration: Tissue Analysis||0
8696800|NCT00884741|9742463|FG001|NOT COMPLETED|Step 2 Registration: Tissue Analysis||29
8696801|NCT00884741|9742464|FG002|NOT COMPLETED|Step 2 Registration: Tissue Analysis||0
8696802|NCT00884741|9742465|FG003|NOT COMPLETED|Step 2 Registration: Tissue Analysis||0
8696803|NCT00884741|9742462|FG000|STARTED|Randomization||0
8696804|NCT00884741|9742463|FG001|STARTED|Randomization|Step 2 Registration Arm goes to a randomized arm.|0
8696805|NCT00884741|9742464|FG002|STARTED|Randomization|These patients completed the previous period on the Step 2 Registration arm.|317
8696806|NCT00884741|9742465|FG003|STARTED|Randomization|These patients completed the previous period on the Step 2 Registration arm.|320
8696807|NCT00884741|9742462|FG000|COMPLETED|Randomization||0
8696808|NCT00884741|9742463|FG001|COMPLETED|Randomization||0
8696809|NCT00884741|9742464|FG002|COMPLETED|Randomization|Patients with data available for the primary analysis are considered to have completed the study.|309
8696810|NCT00884741|9742465|FG003|COMPLETED|Randomization|Patients with data available for the primary analysis are considered to have completed the study.|312
8696811|NCT00884741|9742462|FG000|NOT COMPLETED|Randomization||0
8696812|NCT00884741|9742463|FG001|NOT COMPLETED|Randomization||0
8696813|NCT00884741|9742464|FG002|NOT COMPLETED|Randomization||8
8696814|NCT00884741|9742465|FG003|NOT COMPLETED|Randomization||8
8696815|NCT00884754|9742474|FG000|STARTED|Overall Study||30
8696816|NCT00884754|9742475|FG001|STARTED|Overall Study||30
8696817|NCT00884754|9742474|FG000|COMPLETED|Overall Study||30
8696818|NCT00884754|9742475|FG001|COMPLETED|Overall Study||30
8811534|NCT01514136|9864399|FG001|NOT COMPLETED|Test Period; Test D*||0
8811535|NCT01514136|9864400|FG002|NOT COMPLETED|Test Period; Test D*||0
8811536|NCT01514136|9864401|FG003|NOT COMPLETED|Test Period; Test D*||0
8811537|NCT01514136|9864402|FG004|NOT COMPLETED|Test Period; Test D*||0
8811538|NCT01514136|9864403|FG005|NOT COMPLETED|Test Period; Test D*||0
8811539|NCT01514136|9864404|FG006|NOT COMPLETED|Test Period; Test D*||0
8811540|NCT01514136|9864405|FG007|NOT COMPLETED|Test Period; Test D*||0
8811541|NCT01514149|9864436|FG000|STARTED|Overall Study||15
8811542|NCT01514149|9864437|FG001|STARTED|Overall Study||15
8696819|NCT00884754|9742474|FG000|NOT COMPLETED|Overall Study||0
8696820|NCT00884754|9742475|FG001|NOT COMPLETED|Overall Study||0
8696821|NCT00884793|9742481|FG000|STARTED|Overall Study||8
8696822|NCT00884793|9742481|FG000|COMPLETED|Overall Study||7
8696823|NCT00884793|9742481|FG000|NOT COMPLETED|Overall Study||1
8696824|NCT00884806|9742485|FG000|STARTED|Overall Study||110
8696825|NCT00884806|9742485|FG000|COMPLETED|Overall Study||110
8696826|NCT00884806|9742485|FG000|NOT COMPLETED|Overall Study||0
8696827|NCT00884832|9742491|FG000|STARTED|Overall Study||22
8696828|NCT00884832|9742492|FG001|STARTED|Overall Study||22
8696829|NCT00884832|9742491|FG000|COMPLETED|Overall Study||22
8696830|NCT00884832|9742492|FG001|COMPLETED|Overall Study||21
8696831|NCT00884832|9742491|FG000|NOT COMPLETED|Overall Study||0
8696832|NCT00884832|9742492|FG001|NOT COMPLETED|Overall Study||1
8696833|NCT00884897|9742500|FG000|STARTED|Overall Study||13
8696834|NCT00884897|9742501|FG001|STARTED|Overall Study||15
8696835|NCT00884897|9742500|FG000|COMPLETED|Overall Study||13
8696836|NCT00884897|9742501|FG001|COMPLETED|Overall Study||15
8696837|NCT00884897|9742500|FG000|NOT COMPLETED|Overall Study||0
8696838|NCT00884897|9742501|FG001|NOT COMPLETED|Overall Study||0
8696839|NCT00884910|9742507|FG000|STARTED|Overall Study||33
8696840|NCT00884910|9742507|FG000|COMPLETED|Overall Study|patient diagnosed with primary pulmonary tumor during study|32
8696841|NCT00884910|9742507|FG000|NOT COMPLETED|Overall Study||1
8696842|NCT00884949|9742511|FG000|STARTED|Weeks 1-12: 0.1 mg/kg/Week||20
8696843|NCT00884949|9742511|FG000|COMPLETED|Weeks 1-12: 0.1 mg/kg/Week||18
8696844|NCT00884949|9742511|FG000|NOT COMPLETED|Weeks 1-12: 0.1 mg/kg/Week||2
8696845|NCT00884949|9742511|FG000|STARTED|Weeks 13-24: 1.0 mg/kg/Week||18
8696846|NCT00884949|9742511|FG000|COMPLETED|Weeks 13-24: 1.0 mg/kg/Week||18
8696847|NCT00884949|9742511|FG000|NOT COMPLETED|Weeks 13-24: 1.0 mg/kg/Week||0
8696848|NCT00884949|9742511|FG000|STARTED|Weeks 25-36: 2.0 mg/kg/Week||18
8696849|NCT00884949|9742511|FG000|COMPLETED|Weeks 25-36: 2.0 mg/kg/Week||18
8696850|NCT00884949|9742511|FG000|NOT COMPLETED|Weeks 25-36: 2.0 mg/kg/Week||0
8696851|NCT00884949|9742511|FG000|STARTED|Continuation Period||18
8696852|NCT00884949|9742511|FG000|COMPLETED|Continuation Period||18
8696853|NCT00884949|9742511|FG000|NOT COMPLETED|Continuation Period||0
8696854|NCT00885079|9742526|FG000|STARTED|Overall Study||93
8696855|NCT00885079|9742527|FG001|STARTED|Overall Study||95
8696856|NCT00885079|9742526|FG000|COMPLETED|Overall Study||91
8696857|NCT00885079|9742527|FG001|COMPLETED|Overall Study||91
8696858|NCT00885079|9742526|FG000|NOT COMPLETED|Overall Study||2
8696859|NCT00885079|9742527|FG001|NOT COMPLETED|Overall Study||4
8696860|NCT00885092|9742535|FG000|STARTED|Period 1, 7 Days||20
8696861|NCT00885092|9742536|FG001|STARTED|Period 1, 7 Days||20
8696862|NCT00885092|9742535|FG000|COMPLETED|Period 1, 7 Days||20
8696863|NCT00885092|9742536|FG001|COMPLETED|Period 1, 7 Days||20
8696864|NCT00885092|9742535|FG000|NOT COMPLETED|Period 1, 7 Days||0
8696865|NCT00885092|9742536|FG001|NOT COMPLETED|Period 1, 7 Days||0
8696866|NCT00885092|9742535|FG000|STARTED|Period 2, 7 Days||20
8696867|NCT00885092|9742536|FG001|STARTED|Period 2, 7 Days||20
8696868|NCT00885092|9742535|FG000|COMPLETED|Period 2, 7 Days||20
8696869|NCT00885092|9742536|FG001|COMPLETED|Period 2, 7 Days||20
8696870|NCT00885092|9742535|FG000|NOT COMPLETED|Period 2, 7 Days||0
8696871|NCT00885092|9742536|FG001|NOT COMPLETED|Period 2, 7 Days||0
8696872|NCT00885105|9742544|FG000|STARTED|Overall Study||112
8696873|NCT00885105|9742545|FG001|STARTED|Overall Study||130
8696874|NCT00885105|9742544|FG000|COMPLETED|Overall Study||111
8696875|NCT00885105|9742545|FG001|COMPLETED|Overall Study||120
8696876|NCT00885105|9742544|FG000|NOT COMPLETED|Overall Study||1
8696877|NCT00885105|9742545|FG001|NOT COMPLETED|Overall Study||10
8696878|NCT00885118|9742556|FG000|STARTED|Overall Study||21
8696879|NCT00885118|9742557|FG001|STARTED|Overall Study||19
8696880|NCT00885118|9742558|FG002|STARTED|Overall Study||21
8696881|NCT00885118|9742559|FG003|STARTED|Overall Study||20
8696882|NCT00885118|9742560|FG004|STARTED|Overall Study||19
8696883|NCT00885118|9742556|FG000|COMPLETED|Overall Study||20
8696884|NCT00885118|9742557|FG001|COMPLETED|Overall Study||19
8696885|NCT00885118|9742558|FG002|COMPLETED|Overall Study||20
8696886|NCT00885118|9742559|FG003|COMPLETED|Overall Study||20
8696887|NCT00885118|9742560|FG004|COMPLETED|Overall Study||18
8696888|NCT00885118|9742556|FG000|NOT COMPLETED|Overall Study||1
8696889|NCT00885118|9742557|FG001|NOT COMPLETED|Overall Study||0
8696890|NCT00885118|9742558|FG002|NOT COMPLETED|Overall Study||1
8696891|NCT00885118|9742559|FG003|NOT COMPLETED|Overall Study||0
8696892|NCT00885118|9742560|FG004|NOT COMPLETED|Overall Study||1
8696893|NCT00885170|9742578|FG000|STARTED|Overall Study||124
8696894|NCT00885170|9742579|FG001|STARTED|Overall Study||122
8696895|NCT00885170|9742578|FG000|Treated|Overall Study||122
8696896|NCT00885170|9742579|FG001|Treated|Overall Study||121
8696897|NCT00885170|9742578|FG000|COMPLETED|Overall Study||86
8696898|NCT00885170|9742579|FG001|COMPLETED|Overall Study||99
8696899|NCT00885170|9742578|FG000|NOT COMPLETED|Overall Study||38
8696900|NCT00885170|9742579|FG001|NOT COMPLETED|Overall Study||23
8696901|NCT00885352|9742587|FG000|STARTED|Overall Study||157
8696902|NCT00885352|9742588|FG001|STARTED|Overall Study||156
8696903|NCT00885352|9742587|FG000|COMPLETED|Overall Study||149
8811543|NCT01514149|9864438|FG002|STARTED|Overall Study||14
8811544|NCT01514149|9864439|FG003|STARTED|Overall Study||14
8811545|NCT01514149|9864440|FG004|STARTED|Overall Study||15
8811546|NCT01514149|9864436|FG000|COMPLETED|Overall Study||12
8811547|NCT01514149|9864437|FG001|COMPLETED|Overall Study||14
8811548|NCT01514149|9864438|FG002|COMPLETED|Overall Study||11
8811549|NCT01514149|9864439|FG003|COMPLETED|Overall Study||13
8696904|NCT00885352|9742588|FG001|COMPLETED|Overall Study||136
8696905|NCT00885352|9742587|FG000|NOT COMPLETED|Overall Study||8
8696906|NCT00885352|9742588|FG001|NOT COMPLETED|Overall Study||20
8696907|NCT00885365|9742596|FG000|STARTED|4 Weeks ON Treatment||159
8696908|NCT00885365|9742597|FG001|STARTED|4 Weeks ON Treatment||165
8696909|NCT00885365|9742596|FG000|Intent-to-Treat Population|4 Weeks ON Treatment|Participants who took 1 dose of study medication and had baseline and at least 1 post-treatment FEV1|158
8696910|NCT00885365|9742597|FG001|Intent-to-Treat Population|4 Weeks ON Treatment||163
8696911|NCT00885365|9742596|FG000|Safety Population|4 Weeks ON Treatment|Nine participants randomized to Bramitob were administered TOBI.|156
8696912|NCT00885365|9742597|FG001|Safety Population|4 Weeks ON Treatment|Six participants randomized to TOBI were administered Bramitob|168
8696913|NCT00885365|9742596|FG000|COMPLETED|4 Weeks ON Treatment||155
8811550|NCT01514149|9864440|FG004|COMPLETED|Overall Study||14
8811551|NCT01514149|9864436|FG000|NOT COMPLETED|Overall Study||3
8811552|NCT01514149|9864437|FG001|NOT COMPLETED|Overall Study||1
8696914|NCT00885365|9742597|FG001|COMPLETED|4 Weeks ON Treatment||159
8696915|NCT00885365|9742596|FG000|NOT COMPLETED|4 Weeks ON Treatment||4
8696916|NCT00885365|9742597|FG001|NOT COMPLETED|4 Weeks ON Treatment||6
8696917|NCT00885365|9742596|FG000|STARTED|4 Weeks OFF Treatment||155
8696918|NCT00885365|9742597|FG001|STARTED|4 Weeks OFF Treatment||159
8696919|NCT00885365|9742596|FG000|COMPLETED|4 Weeks OFF Treatment||155
8696920|NCT00885365|9742597|FG001|COMPLETED|4 Weeks OFF Treatment||159
8696921|NCT00885365|9742596|FG000|NOT COMPLETED|4 Weeks OFF Treatment||0
8696922|NCT00885365|9742597|FG001|NOT COMPLETED|4 Weeks OFF Treatment||0
8696923|NCT00885378|9742605|FG000|STARTED|Overall Study|Number randomized.|74
8696924|NCT00885378|9742606|FG001|STARTED|Overall Study|Number randomized.|86
8696925|NCT00885378|9742605|FG000|COMPLETED|Overall Study||66
8696926|NCT00885378|9742606|FG001|COMPLETED|Overall Study||78
8696927|NCT00885378|9742605|FG000|NOT COMPLETED|Overall Study||8
8696928|NCT00885378|9742606|FG001|NOT COMPLETED|Overall Study||8
8696929|NCT00885482|9742612|FG000|STARTED|Overall Study||40
8696930|NCT00885482|9742612|FG000|COMPLETED|Overall Study||36
8696931|NCT00885482|9742612|FG000|NOT COMPLETED|Overall Study||4
8696932|NCT00885534|9742616|FG000|STARTED|Overall Study||7
8696933|NCT00885534|9742616|FG000|COMPLETED|Overall Study||6
8696934|NCT00885534|9742616|FG000|NOT COMPLETED|Overall Study||1
8696935|NCT00885638|9742620|FG000|STARTED|Overall Study||6
8696936|NCT00885638|9742621|FG001|STARTED|Overall Study||6
8696937|NCT00885638|9742620|FG000|COMPLETED|Overall Study||6
8696938|NCT00885638|9742621|FG001|COMPLETED|Overall Study||6
8696939|NCT00885638|9742620|FG000|NOT COMPLETED|Overall Study||0
8696940|NCT00885638|9742621|FG001|NOT COMPLETED|Overall Study||0
8696941|NCT00885677|9742630|FG000|STARTED|Overall Study||462
8696942|NCT00885677|9742631|FG001|STARTED|Overall Study||455
8696943|NCT00885677|9742630|FG000|Intention To Treat|Overall Study||437
8696944|NCT00885677|9742631|FG001|Intention To Treat|Overall Study||428
8696945|NCT00885677|9742630|FG000|COMPLETED|Overall Study||279
8696946|NCT00885677|9742631|FG001|COMPLETED|Overall Study||277
8696947|NCT00885677|9742630|FG000|NOT COMPLETED|Overall Study||183
8696948|NCT00885677|9742631|FG001|NOT COMPLETED|Overall Study||178
8696949|NCT00885703|9742644|FG000|STARTED|Overall Study||22
8696950|NCT00885703|9742645|FG001|STARTED|Overall Study||26
8696951|NCT00885703|9742646|FG002|STARTED|Overall Study||24
8696952|NCT00885703|9742647|FG003|STARTED|Overall Study||24
8696953|NCT00885703|9742648|FG004|STARTED|Overall Study||24
8696954|NCT00885703|9742649|FG005|STARTED|Overall Study||24
8696955|NCT00885703|9742650|FG006|STARTED|Overall Study||24
8696956|NCT00885703|9742644|FG000|COMPLETED|Overall Study||12
8696957|NCT00885703|9742645|FG001|COMPLETED|Overall Study||16
8696958|NCT00885703|9742646|FG002|COMPLETED|Overall Study||13
8696959|NCT00885703|9742647|FG003|COMPLETED|Overall Study||15
8696960|NCT00885703|9742648|FG004|COMPLETED|Overall Study||12
8696961|NCT00885703|9742649|FG005|COMPLETED|Overall Study||11
8696962|NCT00885703|9742650|FG006|COMPLETED|Overall Study||18
8696963|NCT00885703|9742644|FG000|NOT COMPLETED|Overall Study||10
8696964|NCT00885703|9742645|FG001|NOT COMPLETED|Overall Study||10
8696965|NCT00885703|9742646|FG002|NOT COMPLETED|Overall Study||11
8696966|NCT00885703|9742647|FG003|NOT COMPLETED|Overall Study||9
8696967|NCT00885703|9742648|FG004|NOT COMPLETED|Overall Study||12
8696968|NCT00885703|9742649|FG005|NOT COMPLETED|Overall Study||13
8696969|NCT00885703|9742650|FG006|NOT COMPLETED|Overall Study||6
8696970|NCT00885742|9742670|FG000|STARTED|Overall Study||41
8696971|NCT00885742|9742670|FG000|COMPLETED|Overall Study||41
8696972|NCT00885742|9742670|FG000|NOT COMPLETED|Overall Study||0
8696973|NCT00885755|9742677|FG000|STARTED|Part I: Trastuzumab+Taxane||31
8696974|NCT00885755|9742678|FG001|STARTED|Part I: Trastuzumab+Taxane||1
8696975|NCT00885755|9742679|FG002|STARTED|Part I: Trastuzumab+Taxane||1
8696976|NCT00885755|9742677|FG000|COMPLETED|Part I: Trastuzumab+Taxane||13
8811553|NCT01514149|9864438|FG002|NOT COMPLETED|Overall Study||3
8811554|NCT01514149|9864439|FG003|NOT COMPLETED|Overall Study||1
8811555|NCT01514149|9864440|FG004|NOT COMPLETED|Overall Study||1
8811556|NCT01514162|9864452|FG000|STARTED|Overall Study||245
8811557|NCT01514162|9864452|FG000|COMPLETED|Overall Study||160
8811558|NCT01514162|9864452|FG000|NOT COMPLETED|Overall Study||85
8811559|NCT01514201|9864460|FG000|STARTED|PHASE I: Veliparib + Radiation Therapy||6
8811560|NCT01514201|9864461|FG001|STARTED|PHASE I: Veliparib + Radiation Therapy||6
8811561|NCT01514201|9864462|FG002|STARTED|PHASE I: Veliparib + Radiation Therapy||6
8811562|NCT01514201|9864463|FG003|STARTED|PHASE I: Veliparib + Radiation Therapy||0
8811563|NCT01514201|9864460|FG000|COMPLETED|PHASE I: Veliparib + Radiation Therapy||5
8811564|NCT01514201|9864461|FG001|COMPLETED|PHASE I: Veliparib + Radiation Therapy||6
8811565|NCT01514201|9864462|FG002|COMPLETED|PHASE I: Veliparib + Radiation Therapy||6
8811566|NCT01514201|9864463|FG003|COMPLETED|PHASE I: Veliparib + Radiation Therapy||0
8811567|NCT01514201|9864460|FG000|NOT COMPLETED|PHASE I: Veliparib + Radiation Therapy||1
8811568|NCT01514201|9864461|FG001|NOT COMPLETED|PHASE I: Veliparib + Radiation Therapy||0
8811569|NCT01514201|9864462|FG002|NOT COMPLETED|PHASE I: Veliparib + Radiation Therapy||0
8811570|NCT01514201|9864463|FG003|NOT COMPLETED|PHASE I: Veliparib + Radiation Therapy||0
8811571|NCT01514201|9864460|FG000|STARTED|PHASE I: Maintenance With Veliparib/TMZ||5
8811572|NCT01514201|9864461|FG001|STARTED|PHASE I: Maintenance With Veliparib/TMZ||6
8811573|NCT01514201|9864462|FG002|STARTED|PHASE I: Maintenance With Veliparib/TMZ||6
8811574|NCT01514201|9864463|FG003|STARTED|PHASE I: Maintenance With Veliparib/TMZ||0
8811575|NCT01514201|9864460|FG000|COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0
8811576|NCT01514201|9864461|FG001|COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0
8811577|NCT01514201|9864462|FG002|COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0
8811578|NCT01514201|9864463|FG003|COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0
8811579|NCT01514201|9864460|FG000|NOT COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||5
8811580|NCT01514201|9864461|FG001|NOT COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||6
8811581|NCT01514201|9864462|FG002|NOT COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||6
8811582|NCT01514201|9864463|FG003|NOT COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0
8811583|NCT01514201|9864460|FG000|STARTED|PHASE II: Veliparib + Radiation Therapy||0
8811584|NCT01514201|9864461|FG001|STARTED|PHASE II: Veliparib + Radiation Therapy||0
8811585|NCT01514201|9864462|FG002|STARTED|PHASE II: Veliparib + Radiation Therapy||0
8696977|NCT00885755|9742678|FG001|COMPLETED|Part I: Trastuzumab+Taxane||1
8696978|NCT00885755|9742679|FG002|COMPLETED|Part I: Trastuzumab+Taxane||0
8696979|NCT00885755|9742677|FG000|NOT COMPLETED|Part I: Trastuzumab+Taxane||18
8696980|NCT00885755|9742678|FG001|NOT COMPLETED|Part I: Trastuzumab+Taxane||0
8696981|NCT00885755|9742679|FG002|NOT COMPLETED|Part I: Trastuzumab+Taxane||1
8696982|NCT00885755|9742677|FG000|STARTED|Part II: Trastuzumab + Capecitabine.||13
8811586|NCT01514201|9864463|FG003|STARTED|PHASE II: Veliparib + Radiation Therapy||47
8811587|NCT01514201|9864460|FG000|COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
8811588|NCT01514201|9864461|FG001|COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
8811589|NCT01514201|9864462|FG002|COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
8811590|NCT01514201|9864463|FG003|COMPLETED|PHASE II: Veliparib + Radiation Therapy||35
8811591|NCT01514201|9864460|FG000|NOT COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
8811592|NCT01514201|9864461|FG001|NOT COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
8811593|NCT01514201|9864462|FG002|NOT COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
8811594|NCT01514201|9864463|FG003|NOT COMPLETED|PHASE II: Veliparib + Radiation Therapy||12
8811595|NCT01514201|9864460|FG000|STARTED|PHASE II: Maintenance With Veliparib/TMZ||0
8811596|NCT01514201|9864461|FG001|STARTED|PHASE II: Maintenance With Veliparib/TMZ||0
8811597|NCT01514201|9864462|FG002|STARTED|PHASE II: Maintenance With Veliparib/TMZ||0
8811598|NCT01514201|9864463|FG003|STARTED|PHASE II: Maintenance With Veliparib/TMZ||35
8811599|NCT01514201|9864460|FG000|COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
8811600|NCT01514201|9864461|FG001|COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
8811601|NCT01514201|9864462|FG002|COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
8811602|NCT01514201|9864463|FG003|COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||2
8811603|NCT01514201|9864460|FG000|NOT COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
8811604|NCT01514201|9864461|FG001|NOT COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
8811605|NCT01514201|9864462|FG002|NOT COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
8811606|NCT01514201|9864463|FG003|NOT COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||33
8811607|NCT01514240|9864485|FG000|STARTED|Overall Study||56
8811608|NCT01514240|9864486|FG001|STARTED|Overall Study||56
8811609|NCT01514240|9864485|FG000|COMPLETED|Overall Study||50
8811610|NCT01514240|9864486|FG001|COMPLETED|Overall Study||45
8811611|NCT01514240|9864485|FG000|NOT COMPLETED|Overall Study||6
8811612|NCT01514240|9864486|FG001|NOT COMPLETED|Overall Study||11
8811613|NCT01514279|9864495|FG000|STARTED|Overall Study||118
8811614|NCT01514279|9864496|FG001|STARTED|Overall Study||123
8811615|NCT01514279|9864497|FG002|STARTED|Overall Study||119
8811616|NCT01514279|9864495|FG000|COMPLETED|Overall Study||107
8811617|NCT01514279|9864496|FG001|COMPLETED|Overall Study||110
8811618|NCT01514279|9864497|FG002|COMPLETED|Overall Study||114
8811619|NCT01514279|9864495|FG000|NOT COMPLETED|Overall Study||11
8811620|NCT01514279|9864496|FG001|NOT COMPLETED|Overall Study||13
8811621|NCT01514279|9864497|FG002|NOT COMPLETED|Overall Study||5
8811622|NCT01514292|9864505|FG000|STARTED|Overall Study||72
8811623|NCT01514292|9864505|FG000|COMPLETED|Overall Study||72
8811624|NCT01514292|9864505|FG000|NOT COMPLETED|Overall Study||0
8811625|NCT01514318|9864509|FG000|STARTED|Overall Study||8
8811626|NCT01514318|9864509|FG000|COMPLETED|Overall Study||8
8811627|NCT01514318|9864509|FG000|NOT COMPLETED|Overall Study||0
8696983|NCT00885755|9742678|FG001|STARTED|Part II: Trastuzumab + Capecitabine.||1
8696984|NCT00885755|9742679|FG002|STARTED|Part II: Trastuzumab + Capecitabine.||0
8811628|NCT01514357|9864515|FG000|STARTED|Overall Study||12
8811629|NCT01514357|9864516|FG001|STARTED|Overall Study||0
8811630|NCT01514357|9864515|FG000|COMPLETED|Overall Study||8
8811631|NCT01514357|9864516|FG001|COMPLETED|Overall Study||0
8811632|NCT01514357|9864515|FG000|NOT COMPLETED|Overall Study||4
8811633|NCT01514357|9864516|FG001|NOT COMPLETED|Overall Study||0
8811634|NCT01514370|9864524|FG000|STARTED|Overall Study||40
8811635|NCT01514370|9864525|FG001|STARTED|Overall Study||40
8811636|NCT01514370|9864524|FG000|Safety Population|Overall Study|The Safety population consisted all randomized subjects who received at least 1 dose of study drug.|38
8811637|NCT01514370|9864525|FG001|Safety Population|Overall Study|The Safety population consisted all randomized subjects who received at least 1 dose of study drug.|40
8811638|NCT01514370|9864524|FG000|COMPLETED|Overall Study||29
8925606|NCT02259231|9986721|FG004|NOT COMPLETED|Overall Study||6
8925607|NCT02259231|9986722|FG005|NOT COMPLETED|Overall Study||6
8925608|NCT02259231|9986723|FG006|NOT COMPLETED|Overall Study||5
8925609|NCT02259348|9986739|FG000|STARTED|Overall Study||12
8925610|NCT02259348|9986739|FG000|One Year Post-transplant|Overall Study||2
8925611|NCT02259348|9986739|FG000|COMPLETED|Overall Study||2
8925612|NCT02259348|9986739|FG000|NOT COMPLETED|Overall Study||10
8925613|NCT02259400|9986745|FG000|STARTED|Overall Study||62
8925614|NCT02259400|9986746|FG001|STARTED|Overall Study||62
8925615|NCT02259400|9986745|FG000|COMPLETED|Overall Study||62
8925616|NCT02259400|9986746|FG001|COMPLETED|Overall Study||60
8925617|NCT02259400|9986745|FG000|NOT COMPLETED|Overall Study||0
8925618|NCT02259400|9986746|FG001|NOT COMPLETED|Overall Study||2
8925619|NCT02259582|9986755|FG000|STARTED|Overall Study||25
8925620|NCT02259582|9986756|FG001|STARTED|Overall Study||28
8925621|NCT02259582|9986757|FG002|STARTED|Overall Study||29
8925622|NCT02259582|9986755|FG000|COMPLETED|Overall Study||9
8925623|NCT02259582|9986756|FG001|COMPLETED|Overall Study||11
8925624|NCT02259582|9986757|FG002|COMPLETED|Overall Study||8
8925625|NCT02259582|9986755|FG000|NOT COMPLETED|Overall Study||16
8925626|NCT02259582|9986756|FG001|NOT COMPLETED|Overall Study||17
8925627|NCT02259582|9986757|FG002|NOT COMPLETED|Overall Study||21
8925628|NCT02259608|9986765|FG000|STARTED|Overall Study||15
8925629|NCT02259608|9986765|FG000|COMPLETED|Overall Study||15
8925630|NCT02259608|9986765|FG000|NOT COMPLETED|Overall Study||0
8925631|NCT02259699|9986771|FG000|STARTED|Overall Study||64
8925632|NCT02259699|9986772|FG001|STARTED|Overall Study||60
8925633|NCT02259699|9986771|FG000|COMPLETED|Overall Study||37
8925634|NCT02259699|9986772|FG001|COMPLETED|Overall Study||40
8925635|NCT02259699|9986771|FG000|NOT COMPLETED|Overall Study||27
8925636|NCT02259699|9986772|FG001|NOT COMPLETED|Overall Study||20
8925637|NCT02260154|9986778|FG000|STARTED|Overall Study||220
8925638|NCT02260154|9986778|FG000|COMPLETED|Overall Study||218
8925639|NCT02260154|9986778|FG000|NOT COMPLETED|Overall Study||2
8925640|NCT02260180|9986786|FG000|STARTED|Overall Study||39
8925641|NCT02260180|9986787|FG001|STARTED|Overall Study||39
8925642|NCT02260180|9986788|FG002|STARTED|Overall Study||41
8925643|NCT02260180|9986786|FG000|COMPLETED|Overall Study||37
8925644|NCT02260180|9986787|FG001|COMPLETED|Overall Study||39
8925645|NCT02260180|9986788|FG002|COMPLETED|Overall Study||40
8925646|NCT02260180|9986786|FG000|NOT COMPLETED|Overall Study||2
8925647|NCT02260180|9986787|FG001|NOT COMPLETED|Overall Study||0
8925648|NCT02260180|9986788|FG002|NOT COMPLETED|Overall Study||1
8925649|NCT02260258|9986798|FG000|STARTED|Overall Study||39
8925650|NCT02260258|9986799|FG001|STARTED|Overall Study||44
8925651|NCT02260258|9986798|FG000|COMPLETED|Overall Study||37
8925652|NCT02260258|9986799|FG001|COMPLETED|Overall Study||43
8925653|NCT02260258|9986798|FG000|NOT COMPLETED|Overall Study||2
8925654|NCT02260258|9986799|FG001|NOT COMPLETED|Overall Study||1
8925655|NCT02260388|9986810|FG000|STARTED|Overall Study||134
8925656|NCT02260388|9986811|FG001|STARTED|Overall Study||126
8925657|NCT02260388|9986812|FG002|STARTED|Overall Study||73
8925658|NCT02260388|9986813|FG003|STARTED|Overall Study||69
8925659|NCT02260388|9986810|FG000|COMPLETED|Overall Study||132
8925660|NCT02260388|9986811|FG001|COMPLETED|Overall Study||118
8925661|NCT02260388|9986812|FG002|COMPLETED|Overall Study||70
8925662|NCT02260388|9986813|FG003|COMPLETED|Overall Study||65
8925663|NCT02260388|9986810|FG000|NOT COMPLETED|Overall Study||2
8925664|NCT02260388|9986811|FG001|NOT COMPLETED|Overall Study||8
8925665|NCT02260388|9986812|FG002|NOT COMPLETED|Overall Study||3
8811639|NCT01514370|9864525|FG001|COMPLETED|Overall Study||24
8811640|NCT01514370|9864524|FG000|NOT COMPLETED|Overall Study||11
8811641|NCT01514370|9864525|FG001|NOT COMPLETED|Overall Study||16
8811642|NCT01514383|9864532|FG000|STARTED|Overall Study||34
8811643|NCT01514383|9864532|FG000|COMPLETED|Overall Study||34
8811644|NCT01514383|9864532|FG000|NOT COMPLETED|Overall Study||0
8925666|NCT02260388|9986813|FG003|NOT COMPLETED|Overall Study||4
8925667|NCT02260401|9986825|FG000|STARTED|Overall Study||80
8925668|NCT02260401|9986826|FG001|STARTED|Overall Study||85
8925669|NCT02260401|9986825|FG000|COMPLETED|Overall Study||75
8925670|NCT02260401|9986826|FG001|COMPLETED|Overall Study||73
8925671|NCT02260401|9986825|FG000|NOT COMPLETED|Overall Study||5
8925672|NCT02260401|9986826|FG001|NOT COMPLETED|Overall Study||12
8925673|NCT02260440|9986832|FG000|STARTED|Overall Study||31
8925674|NCT02260440|9986832|FG000|COMPLETED|Overall Study||31
8925675|NCT02260440|9986832|FG000|NOT COMPLETED|Overall Study||0
8925676|NCT02260492|9986839|FG000|STARTED|Overall Study||418
8925677|NCT02260492|9986840|FG001|STARTED|Overall Study||419
8925678|NCT02260492|9986841|FG002|STARTED|Overall Study||42
8925679|NCT02260492|9986839|FG000|Completed Day 1|Overall Study||418
8811645|NCT01514396|9864537|FG000|STARTED|Overall Study||8
8925680|NCT02260492|9986840|FG001|Completed Day 1|Overall Study||419
8925681|NCT02260492|9986841|FG002|Completed Day 1|Overall Study||42
8925682|NCT02260492|9986839|FG000|COMPLETED|Overall Study||395
8925683|NCT02260492|9986840|FG001|COMPLETED|Overall Study||406
8925684|NCT02260492|9986841|FG002|COMPLETED|Overall Study||37
8925685|NCT02260492|9986839|FG000|NOT COMPLETED|Overall Study||23
8925686|NCT02260492|9986840|FG001|NOT COMPLETED|Overall Study||13
8925687|NCT02260492|9986841|FG002|NOT COMPLETED|Overall Study||5
8925688|NCT02260531|9986852|FG000|STARTED|Overall Study||21
8925689|NCT02260531|9986853|FG001|STARTED|Overall Study||7
8925690|NCT02260531|9986854|FG002|STARTED|Overall Study||8
8925691|NCT02260531|9986852|FG000|COMPLETED|Overall Study||21
8925692|NCT02260531|9986853|FG001|COMPLETED|Overall Study||7
8925693|NCT02260531|9986854|FG002|COMPLETED|Overall Study||8
8925694|NCT02260531|9986852|FG000|NOT COMPLETED|Overall Study||0
8925695|NCT02260531|9986853|FG001|NOT COMPLETED|Overall Study||0
8925696|NCT02260531|9986854|FG002|NOT COMPLETED|Overall Study||0
8925697|NCT02260622|9986871|FG000|STARTED|Overall Study||11
8925698|NCT02260622|9986872|FG001|STARTED|Overall Study||9
8925699|NCT02260622|9986871|FG000|COMPLETED|Overall Study||11
8925700|NCT02260622|9986872|FG001|COMPLETED|Overall Study||9
8696985|NCT00885755|9742677|FG000|COMPLETED|Part II: Trastuzumab + Capecitabine.||8
8696986|NCT00885755|9742678|FG001|COMPLETED|Part II: Trastuzumab + Capecitabine.||1
8696987|NCT00885755|9742679|FG002|COMPLETED|Part II: Trastuzumab + Capecitabine.||0
8696988|NCT00885755|9742677|FG000|NOT COMPLETED|Part II: Trastuzumab + Capecitabine.||5
8696989|NCT00885755|9742678|FG001|NOT COMPLETED|Part II: Trastuzumab + Capecitabine.||0
8696990|NCT00885755|9742679|FG002|NOT COMPLETED|Part II: Trastuzumab + Capecitabine.||0
8696991|NCT00885768|9742687|FG000|STARTED|Overall Study|all patients with coronary artery stenosis on angiography entered the study|146
8696992|NCT00885768|9742687|FG000|COMPLETED|Overall Study|all patients with including criteria completed the study|146
8696993|NCT00885768|9742687|FG000|NOT COMPLETED|Overall Study||0
8696994|NCT00885846|9742694|FG000|STARTED|Overall Study|Cohort 1 = 5 Cohort 2 = 6|11
8696995|NCT00885846|9742695|FG001|STARTED|Overall Study|Cohort 1 = 6 Cohort 2 = 5|11
8696996|NCT00885846|9742696|FG002|STARTED|Overall Study|Cohort 1 = 4 Cohort 2 = 6|10
8696997|NCT00885846|9742694|FG000|COMPLETED|Overall Study|Cohort 1 = 3 Cohort 2 = 6|9
8696998|NCT00885846|9742695|FG001|COMPLETED|Overall Study|Cohort 1 = 1 Cohort 2 = 5|6
8696999|NCT00885846|9742696|FG002|COMPLETED|Overall Study|Cohort 1 = 4 Cohort 2 = 6|8
8697000|NCT00885846|9742694|FG000|NOT COMPLETED|Overall Study||2
8697001|NCT00885846|9742695|FG001|NOT COMPLETED|Overall Study||5
8697002|NCT00885846|9742696|FG002|NOT COMPLETED|Overall Study||2
8697003|NCT00886015|9742706|FG000|STARTED|Overall Study|1674 eyes; 960 participants|1674
8697004|NCT00886015|9742707|FG001|STARTED|Overall Study|1671 eyes; 957 participants|1671
8697005|NCT00886015|9742706|FG000|COMPLETED|Overall Study|1674 eyes; 960 participants|1674
8697006|NCT00886015|9742707|FG001|COMPLETED|Overall Study|1669 eyes; 956 participants|1669
8697007|NCT00886015|9742706|FG000|NOT COMPLETED|Overall Study||0
8697008|NCT00886015|9742707|FG001|NOT COMPLETED|Overall Study||2
8697009|NCT00886119|9742713|FG000|STARTED|Period 1||24
8697010|NCT00886119|9742714|FG001|STARTED|Period 1||22
8697011|NCT00886119|9742713|FG000|COMPLETED|Period 1||23
8697012|NCT00886119|9742714|FG001|COMPLETED|Period 1||22
8697013|NCT00886119|9742713|FG000|NOT COMPLETED|Period 1||1
8697014|NCT00886119|9742714|FG001|NOT COMPLETED|Period 1||0
8697015|NCT00886119|9742713|FG000|STARTED|Period 2||23
8697016|NCT00886119|9742714|FG001|STARTED|Period 2||22
8697017|NCT00886119|9742713|FG000|COMPLETED|Period 2||23
8697018|NCT00886119|9742714|FG001|COMPLETED|Period 2||22
8697019|NCT00886119|9742713|FG000|NOT COMPLETED|Period 2||0
8697020|NCT00886119|9742714|FG001|NOT COMPLETED|Period 2||0
8697021|NCT00886145|9742720|FG000|STARTED|Overall Study||1
8697022|NCT00886145|9742720|FG000|COMPLETED|Overall Study||1
8697023|NCT00886145|9742720|FG000|NOT COMPLETED|Overall Study||0
8697024|NCT00886236|9742729|FG000|STARTED|Overall Study||20
8697025|NCT00886236|9742730|FG001|STARTED|Overall Study||21
8697026|NCT00886236|9742731|FG002|STARTED|Overall Study||21
8697027|NCT00886236|9742729|FG000|COMPLETED|Overall Study||18
8697028|NCT00886236|9742730|FG001|COMPLETED|Overall Study||17
8697029|NCT00886236|9742731|FG002|COMPLETED|Overall Study||17
8697030|NCT00886236|9742729|FG000|NOT COMPLETED|Overall Study||2
8697031|NCT00886236|9742730|FG001|NOT COMPLETED|Overall Study||4
8697032|NCT00886236|9742731|FG002|NOT COMPLETED|Overall Study||4
8697033|NCT00886262|9742741|FG000|STARTED|Overall Study||8
8697034|NCT00886262|9742742|FG001|STARTED|Overall Study||10
8697035|NCT00886262|9742741|FG000|COMPLETED|Overall Study||8
8697036|NCT00886262|9742742|FG001|COMPLETED|Overall Study||7
8697037|NCT00886262|9742741|FG000|NOT COMPLETED|Overall Study||0
8811646|NCT01514396|9864537|FG000|COMPLETED|Overall Study||8
8811647|NCT01514396|9864537|FG000|NOT COMPLETED|Overall Study||0
8811648|NCT01514422|9864542|FG000|STARTED|Overall Study||20
8811649|NCT01514422|9864542|FG000|COMPLETED|Overall Study||19
8811650|NCT01514422|9864542|FG000|NOT COMPLETED|Overall Study||1
8811651|NCT01514448|9864548|FG000|STARTED|Overall Study||16
8811652|NCT01514448|9864549|FG001|STARTED|Overall Study||13
8925701|NCT02260622|9986871|FG000|NOT COMPLETED|Overall Study||0
8925702|NCT02260622|9986872|FG001|NOT COMPLETED|Overall Study||0
8925703|NCT02260635|9986880|FG000|STARTED|Double-Blind Treatment Period||27
8925704|NCT02260635|9986881|FG001|STARTED|Double-Blind Treatment Period||27
8925705|NCT02260635|9986880|FG000|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||27
8811653|NCT01514448|9864548|FG000|Full Analysis Set (FAS)|Overall Study||12
8811654|NCT01514448|9864549|FG001|Full Analysis Set (FAS)|Overall Study||13
8811655|NCT01514448|9864548|FG000|COMPLETED|Overall Study||4
8811656|NCT01514448|9864549|FG001|COMPLETED|Overall Study||5
8811657|NCT01514448|9864548|FG000|NOT COMPLETED|Overall Study||12
8811658|NCT01514448|9864549|FG001|NOT COMPLETED|Overall Study||8
8811659|NCT01514461|9864559|FG000|STARTED|Overall Study||15
8811660|NCT01514461|9864560|FG001|STARTED|Overall Study||15
8811661|NCT01514461|9864561|FG002|STARTED|Overall Study||15
8697038|NCT00886262|9742742|FG001|NOT COMPLETED|Overall Study||3
8697039|NCT00886288|9742750|FG000|STARTED|Overall Study|Baseline Population|2027
8697040|NCT00886288|9742751|FG001|STARTED|Overall Study|Baseline Population|684
8697041|NCT00886288|9742750|FG000|COMPLETED|Overall Study||1284
8697042|NCT00886288|9742751|FG001|COMPLETED|Overall Study||457
8697043|NCT00886288|9742750|FG000|NOT COMPLETED|Overall Study||743
8697044|NCT00886288|9742751|FG001|NOT COMPLETED|Overall Study||227
8697045|NCT00886340|9742761|FG000|STARTED|Overall Study||27
8697046|NCT00886340|9742762|FG001|STARTED|Overall Study||31
8697047|NCT00886340|9742761|FG000|COMPLETED|Overall Study||27
8697048|NCT00886340|9742762|FG001|COMPLETED|Overall Study||24
8697049|NCT00886340|9742761|FG000|NOT COMPLETED|Overall Study||0
8697050|NCT00886340|9742762|FG001|NOT COMPLETED|Overall Study||7
8697051|NCT00886379|9742773|FG000|STARTED|Overall Study||104
8697052|NCT00886379|9742774|FG001|STARTED|Overall Study||143
8697053|NCT00886379|9742775|FG002|STARTED|Overall Study||143
8697054|NCT00886379|9742776|FG003|STARTED|Overall Study||112
8697055|NCT00886379|9742777|FG004|STARTED|Overall Study||95
8697056|NCT00886379|9742773|FG000|COMPLETED|Overall Study||101
8697057|NCT00886379|9742774|FG001|COMPLETED|Overall Study||140
8697058|NCT00886379|9742775|FG002|COMPLETED|Overall Study||137
8697059|NCT00886379|9742776|FG003|COMPLETED|Overall Study||109
8697060|NCT00886379|9742777|FG004|COMPLETED|Overall Study||92
8697061|NCT00886379|9742773|FG000|NOT COMPLETED|Overall Study||3
8697062|NCT00886379|9742774|FG001|NOT COMPLETED|Overall Study||3
8697063|NCT00886379|9742775|FG002|NOT COMPLETED|Overall Study||6
8697064|NCT00886379|9742776|FG003|NOT COMPLETED|Overall Study||3
8697065|NCT00886379|9742777|FG004|NOT COMPLETED|Overall Study||3
8697066|NCT00886483|9742791|FG000|STARTED|Overall Study||26
8697067|NCT00886483|9742792|FG001|STARTED|Overall Study||13
8697068|NCT00886483|9742791|FG000|Completed 20 Treatments|Overall Study||25
8697069|NCT00886483|9742792|FG001|Completed 20 Treatments|Overall Study||11
8697070|NCT00886483|9742791|FG000|COMPLETED|Overall Study||24
8697071|NCT00886483|9742792|FG001|COMPLETED|Overall Study||10
8697072|NCT00886483|9742791|FG000|NOT COMPLETED|Overall Study||2
8697073|NCT00886483|9742792|FG001|NOT COMPLETED|Overall Study||3
8697074|NCT00886587|9742808|FG000|STARTED|Overall Study||41
8697075|NCT00886587|9742809|FG001|STARTED|Overall Study||41
8697076|NCT00886587|9742808|FG000|COMPLETED|Overall Study||37
8697077|NCT00886587|9742809|FG001|COMPLETED|Overall Study||39
8697078|NCT00886587|9742808|FG000|NOT COMPLETED|Overall Study||4
8697079|NCT00886587|9742809|FG001|NOT COMPLETED|Overall Study||2
8697080|NCT00886613|9742818|FG000|STARTED|Overall Study||41
8697081|NCT00886613|9742819|FG001|STARTED|Overall Study||39
8697082|NCT00886613|9742820|FG002|STARTED|Overall Study||40
8697083|NCT00886613|9742818|FG000|COMPLETED|Overall Study||39
8697084|NCT00886613|9742819|FG001|COMPLETED|Overall Study||39
8697085|NCT00886613|9742820|FG002|COMPLETED|Overall Study||37
8697086|NCT00886613|9742818|FG000|NOT COMPLETED|Overall Study||2
8697087|NCT00886613|9742819|FG001|NOT COMPLETED|Overall Study||0
8697088|NCT00886613|9742820|FG002|NOT COMPLETED|Overall Study||3
8697089|NCT00886626|9742831|FG000|STARTED|Period 1 (90 Days)||6
8697090|NCT00886626|9742832|FG001|STARTED|Period 1 (90 Days)||6
8697091|NCT00886626|9742831|FG000|COMPLETED|Period 1 (90 Days)||5
8697092|NCT00886626|9742832|FG001|COMPLETED|Period 1 (90 Days)||6
8697093|NCT00886626|9742831|FG000|NOT COMPLETED|Period 1 (90 Days)||1
8697094|NCT00886626|9742832|FG001|NOT COMPLETED|Period 1 (90 Days)||0
8697095|NCT00886626|9742831|FG000|STARTED|Period 2 (90 Days)||5
8697096|NCT00886626|9742832|FG001|STARTED|Period 2 (90 Days)||6
8697097|NCT00886626|9742831|FG000|COMPLETED|Period 2 (90 Days)||5
8697098|NCT00886626|9742832|FG001|COMPLETED|Period 2 (90 Days)||6
8697099|NCT00886626|9742831|FG000|NOT COMPLETED|Period 2 (90 Days)||0
8697100|NCT00886626|9742832|FG001|NOT COMPLETED|Period 2 (90 Days)||0
8697101|NCT00886639|9742838|FG000|STARTED|Overall Study||127
8697102|NCT00886639|9742838|FG000|COMPLETED|Overall Study||111
8697103|NCT00886639|9742838|FG000|NOT COMPLETED|Overall Study||16
8697104|NCT00886704|9742844|FG000|STARTED|Overall Study||40
8697105|NCT00886704|9742845|FG001|STARTED|Overall Study||10
8697106|NCT00886704|9742844|FG000|COMPLETED|Overall Study||40
8697107|NCT00886704|9742845|FG001|COMPLETED|Overall Study||10
8697108|NCT00886704|9742844|FG000|NOT COMPLETED|Overall Study||0
8697109|NCT00886704|9742845|FG001|NOT COMPLETED|Overall Study||0
8697110|NCT00886743|9742853|FG000|STARTED|Overall Study|Received treatment|19
8697111|NCT00886743|9742853|FG000|COMPLETED|Overall Study||15
8697112|NCT00886743|9742853|FG000|NOT COMPLETED|Overall Study||4
8697113|NCT00886769|9742859|FG000|STARTED|Overall Study||43
8697114|NCT00886769|9742860|FG001|STARTED|Overall Study||41
8697115|NCT00886769|9742859|FG000|COMPLETED|Overall Study||37
8697116|NCT00886769|9742860|FG001|COMPLETED|Overall Study||4
8697117|NCT00886769|9742859|FG000|NOT COMPLETED|Overall Study||6
8811662|NCT01514461|9864559|FG000|COMPLETED|Overall Study||10
8811663|NCT01514461|9864560|FG001|COMPLETED|Overall Study||12
8811664|NCT01514461|9864561|FG002|COMPLETED|Overall Study||11
8811665|NCT01514461|9864559|FG000|NOT COMPLETED|Overall Study||5
8811666|NCT01514461|9864560|FG001|NOT COMPLETED|Overall Study||3
8811667|NCT01514461|9864561|FG002|NOT COMPLETED|Overall Study||4
8811668|NCT01514513|9864574|FG000|STARTED|Overall Study||21
8811669|NCT01514513|9864575|FG001|STARTED|Overall Study||21
8811670|NCT01514513|9864574|FG000|COMPLETED|Overall Study||20
8811671|NCT01514513|9864575|FG001|COMPLETED|Overall Study||20
8811672|NCT01514513|9864574|FG000|NOT COMPLETED|Overall Study||1
8811673|NCT01514513|9864575|FG001|NOT COMPLETED|Overall Study||1
8811674|NCT01514630|9864581|FG000|STARTED|Overall Study||14
8811675|NCT01514630|9864581|FG000|COMPLETED|Overall Study||11
8811676|NCT01514630|9864581|FG000|NOT COMPLETED|Overall Study||3
8811677|NCT01514734|9864585|FG000|STARTED|Overall Study||9
8811678|NCT01514734|9864585|FG000|COMPLETED|Overall Study||9
8811679|NCT01514734|9864585|FG000|NOT COMPLETED|Overall Study||0
8811680|NCT01514760|9864589|FG000|STARTED|Overall Study||22
8811681|NCT01514760|9864589|FG000|COMPLETED|Overall Study||20
8811682|NCT01514760|9864589|FG000|NOT COMPLETED|Overall Study||2
8811683|NCT01514786|9864595|FG000|STARTED|Overall Study||286
8811684|NCT01514786|9864596|FG001|STARTED|Overall Study||284
8811685|NCT01514786|9864595|FG000|COMPLETED|Overall Study||286
8811686|NCT01514786|9864596|FG001|COMPLETED|Overall Study||284
8811687|NCT01514786|9864595|FG000|NOT COMPLETED|Overall Study||0
8811688|NCT01514786|9864596|FG001|NOT COMPLETED|Overall Study||0
8811689|NCT01514864|9864604|FG000|STARTED|Overall Study||9
8811690|NCT01514864|9864605|FG001|STARTED|Overall Study||5
8811691|NCT01514864|9864604|FG000|COMPLETED|Overall Study|Study was terminated; no patients completed study treatment|0
8811692|NCT01514864|9864605|FG001|COMPLETED|Overall Study||0
8811693|NCT01514864|9864604|FG000|NOT COMPLETED|Overall Study||9
8811694|NCT01514864|9864605|FG001|NOT COMPLETED|Overall Study||5
8811695|NCT01515046|9864612|FG000|STARTED|Overall Study||1
8811696|NCT01515046|9864612|FG000|COMPLETED|Overall Study||1
8811697|NCT01515046|9864612|FG000|NOT COMPLETED|Overall Study||0
8811698|NCT01515072|9864618|FG000|STARTED|Overall Study||166
8811699|NCT01515072|9864619|FG001|STARTED|Overall Study||155
8811700|NCT01515072|9864618|FG000|COMPLETED|Overall Study|There were 566 total organs transplanted and 248 kidneys transplanted in the No RIPC group.|166
8811701|NCT01515072|9864619|FG001|COMPLETED|Overall Study|There were 513 total organs transplanted and 235 kidneys transplanted in the RIPC group|155
8811702|NCT01515072|9864618|FG000|NOT COMPLETED|Overall Study||0
8697118|NCT00886769|9742860|FG001|NOT COMPLETED|Overall Study||37
8697119|NCT00886795|9742866|FG000|STARTED|Overall Study||4
8697120|NCT00886795|9742866|FG000|COMPLETED|Overall Study||3
8697121|NCT00886795|9742866|FG000|NOT COMPLETED|Overall Study||1
8697122|NCT00886821|9742885|FG000|STARTED|Stage 1||7
8697123|NCT00886821|9742886|FG001|STARTED|Stage 1||6
8697124|NCT00886821|9742887|FG002|STARTED|Stage 1||6
8697125|NCT00886821|9742888|FG003|STARTED|Stage 1||7
8697126|NCT00886821|9742889|FG004|STARTED|Stage 1||6
8697127|NCT00886821|9742890|FG005|STARTED|Stage 1||6
8697128|NCT00886821|9742891|FG006|STARTED|Stage 1||6
8697129|NCT00886821|9742892|FG007|STARTED|Stage 1||6
8697130|NCT00886821|9742893|FG008|STARTED|Stage 1||6
8697131|NCT00886821|9742894|FG009|STARTED|Stage 1||18
8697132|NCT00886821|9742895|FG010|STARTED|Stage 1||0
8697133|NCT00886821|9742896|FG011|STARTED|Stage 1||0
8697134|NCT00886821|9742897|FG012|STARTED|Stage 1||0
8697135|NCT00886821|9742898|FG013|STARTED|Stage 1||0
8697136|NCT00886821|9742885|FG000|COMPLETED|Stage 1||7
8697137|NCT00886821|9742886|FG001|COMPLETED|Stage 1||6
8697138|NCT00886821|9742887|FG002|COMPLETED|Stage 1||6
8811703|NCT01515072|9864619|FG001|NOT COMPLETED|Overall Study||0
8811704|NCT01515176|9864641|FG000|STARTED|Overall Study||4
8811705|NCT01515176|9864642|FG001|STARTED|Overall Study||32
8811706|NCT01515176|9864641|FG000|COMPLETED|Overall Study||4
8811707|NCT01515176|9864642|FG001|COMPLETED|Overall Study||32
8697139|NCT00886821|9742888|FG003|COMPLETED|Stage 1||7
8697140|NCT00886821|9742889|FG004|COMPLETED|Stage 1||6
8811708|NCT01515176|9864641|FG000|NOT COMPLETED|Overall Study||0
8811709|NCT01515176|9864642|FG001|NOT COMPLETED|Overall Study||0
8811710|NCT01515189|9864652|FG000|STARTED|Induction|Includes 1 subject who was randomized but not treated due to an Adverse Event before treatment|365
8811711|NCT01515189|9864653|FG001|STARTED|Induction||362
8811712|NCT01515189|9864652|FG000|COMPLETED|Induction||128
8811713|NCT01515189|9864653|FG001|COMPLETED|Induction||130
8811714|NCT01515189|9864652|FG000|NOT COMPLETED|Induction||237
8811715|NCT01515189|9864653|FG001|NOT COMPLETED|Induction||232
8811716|NCT01515189|9864652|FG000|STARTED|First Re-Induction Phase||23
8811717|NCT01515189|9864653|FG001|STARTED|First Re-Induction Phase||32
8811718|NCT01515189|9864652|FG000|COMPLETED|First Re-Induction Phase||9
8811719|NCT01515189|9864653|FG001|COMPLETED|First Re-Induction Phase||17
8811720|NCT01515189|9864652|FG000|NOT COMPLETED|First Re-Induction Phase||14
8811721|NCT01515189|9864653|FG001|NOT COMPLETED|First Re-Induction Phase||15
8811722|NCT01515319|9864669|FG000|STARTED|Overall Study||3
8811723|NCT01515319|9864670|FG001|STARTED|Overall Study||3
8811724|NCT01515319|9864671|FG002|STARTED|Overall Study||6
8811725|NCT01515319|9864672|FG003|STARTED|Overall Study||6
8697141|NCT00886821|9742890|FG005|COMPLETED|Stage 1||6
8697142|NCT00886821|9742891|FG006|COMPLETED|Stage 1||6
8697143|NCT00886821|9742892|FG007|COMPLETED|Stage 1||6
8697144|NCT00886821|9742893|FG008|COMPLETED|Stage 1||6
8697145|NCT00886821|9742894|FG009|COMPLETED|Stage 1||18
8697146|NCT00886821|9742895|FG010|COMPLETED|Stage 1||0
8697147|NCT00886821|9742896|FG011|COMPLETED|Stage 1||0
8697148|NCT00886821|9742897|FG012|COMPLETED|Stage 1||0
8697149|NCT00886821|9742898|FG013|COMPLETED|Stage 1||0
8697150|NCT00886821|9742885|FG000|NOT COMPLETED|Stage 1||0
8697151|NCT00886821|9742886|FG001|NOT COMPLETED|Stage 1||0
8697152|NCT00886821|9742887|FG002|NOT COMPLETED|Stage 1||0
8811726|NCT01515319|9864673|FG004|STARTED|Overall Study||6
8811727|NCT01515319|9864674|FG005|STARTED|Overall Study||6
8811728|NCT01515319|9864675|FG006|STARTED|Overall Study||10
8811729|NCT01515319|9864676|FG007|STARTED|Overall Study||6
8811730|NCT01515319|9864677|FG008|STARTED|Overall Study||14
8811731|NCT01515319|9864678|FG009|STARTED|Overall Study||8
8811732|NCT01515319|9864669|FG000|COMPLETED|Overall Study||3
8811733|NCT01515319|9864670|FG001|COMPLETED|Overall Study||3
8811734|NCT01515319|9864671|FG002|COMPLETED|Overall Study||6
8811735|NCT01515319|9864672|FG003|COMPLETED|Overall Study||6
8811736|NCT01515319|9864673|FG004|COMPLETED|Overall Study||6
8925706|NCT02260635|9986881|FG001|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||26
8925707|NCT02260635|9986880|FG000|COMPLETED|Double-Blind Treatment Period||26
8925708|NCT02260635|9986881|FG001|COMPLETED|Double-Blind Treatment Period||25
8925709|NCT02260635|9986880|FG000|NOT COMPLETED|Double-Blind Treatment Period||1
8925710|NCT02260635|9986881|FG001|NOT COMPLETED|Double-Blind Treatment Period||2
8925711|NCT02260635|9986880|FG000|STARTED|Open-Label Extension||26
8925712|NCT02260635|9986881|FG001|STARTED|Open-Label Extension||25
8925713|NCT02260635|9986880|FG000|Received at Least One Dose of Study Drug|Open-Label Extension||26
8925714|NCT02260635|9986881|FG001|Received at Least One Dose of Study Drug|Open-Label Extension||25
8925715|NCT02260635|9986880|FG000|COMPLETED|Open-Label Extension||0
8925716|NCT02260635|9986881|FG001|COMPLETED|Open-Label Extension||0
8925717|NCT02260635|9986880|FG000|NOT COMPLETED|Open-Label Extension||26
8925718|NCT02260635|9986881|FG001|NOT COMPLETED|Open-Label Extension||25
8925719|NCT02260648|9986892|FG000|STARTED|Overall Study||53
8925720|NCT02260648|9986893|FG001|STARTED|Overall Study||46
8925721|NCT02260648|9986894|FG002|STARTED|Overall Study||50
8925722|NCT02260648|9986892|FG000|Received at Least One Dose of Study Drug|Overall Study||53
8925723|NCT02260648|9986893|FG001|Received at Least One Dose of Study Drug|Overall Study||46
8925724|NCT02260648|9986894|FG002|Received at Least One Dose of Study Drug|Overall Study||50
8925725|NCT02260648|9986892|FG000|COMPLETED|Overall Study||35
8925726|NCT02260648|9986893|FG001|COMPLETED|Overall Study||33
8925727|NCT02260648|9986894|FG002|COMPLETED|Overall Study||42
8925728|NCT02260648|9986892|FG000|NOT COMPLETED|Overall Study||18
8925729|NCT02260648|9986893|FG001|NOT COMPLETED|Overall Study||13
8925730|NCT02260648|9986894|FG002|NOT COMPLETED|Overall Study||8
8925731|NCT02260791|9986904|FG000|STARTED|Overall Study||366
8925732|NCT02260791|9986905|FG001|STARTED|Overall Study||362
8925733|NCT02260791|9986904|FG000|COMPLETED|Overall Study||333
8925734|NCT02260791|9986905|FG001|COMPLETED|Overall Study||328
8925735|NCT02260791|9986904|FG000|NOT COMPLETED|Overall Study||33
8925736|NCT02260791|9986905|FG001|NOT COMPLETED|Overall Study||34
8925737|NCT02260804|9986913|FG000|STARTED|Induction Study Period||130
8925738|NCT02260804|9986914|FG001|STARTED|Induction Study Period||128
8925739|NCT02260804|9986913|FG000|COMPLETED|Induction Study Period||128
8925740|NCT02260804|9986914|FG001|COMPLETED|Induction Study Period||128
8925741|NCT02260804|9986913|FG000|NOT COMPLETED|Induction Study Period||2
8925742|NCT02260804|9986914|FG001|NOT COMPLETED|Induction Study Period||0
8925743|NCT02260804|9986913|FG000|STARTED|1st Year of the Maintenance Period (MP1)|Five subjects completed the induction period but did not initiate this period in the CT-P10 group.|123
8925744|NCT02260804|9986914|FG001|STARTED|1st Year of the Maintenance Period (MP1)|Eight subjects completed the induction period but did not initiate this period in the Rituxan group.|120
8925745|NCT02260804|9986913|FG000|COMPLETED|1st Year of the Maintenance Period (MP1)||111
8925746|NCT02260804|9986914|FG001|COMPLETED|1st Year of the Maintenance Period (MP1)||105
8925747|NCT02260804|9986913|FG000|NOT COMPLETED|1st Year of the Maintenance Period (MP1)||12
8925748|NCT02260804|9986914|FG001|NOT COMPLETED|1st Year of the Maintenance Period (MP1)||15
8925749|NCT02260804|9986913|FG000|STARTED|2nd Year of the Maintenance Period (MP2)|One subject completed the MP1 but did not initiate this period in the CT-P10 group.|110
8925750|NCT02260804|9986914|FG001|STARTED|2nd Year of the Maintenance Period (MP2)|Two subjects completed the MP1 but did not initiate this period in the Rituxan group.|103
8925751|NCT02260804|9986913|FG000|COMPLETED|2nd Year of the Maintenance Period (MP2)||101
8925752|NCT02260804|9986914|FG001|COMPLETED|2nd Year of the Maintenance Period (MP2)||97
8925753|NCT02260804|9986913|FG000|NOT COMPLETED|2nd Year of the Maintenance Period (MP2)||9
8925754|NCT02260804|9986914|FG001|NOT COMPLETED|2nd Year of the Maintenance Period (MP2)||6
8925755|NCT02260817|9986922|FG000|STARTED|Overall Study||14
8925756|NCT02260817|9986923|FG001|STARTED|Overall Study||95
8925757|NCT02260817|9986922|FG000|COMPLETED|Overall Study||14
8925758|NCT02260817|9986923|FG001|COMPLETED|Overall Study||58
8697153|NCT00886821|9742888|FG003|NOT COMPLETED|Stage 1||0
8697154|NCT00886821|9742889|FG004|NOT COMPLETED|Stage 1||0
8697155|NCT00886821|9742890|FG005|NOT COMPLETED|Stage 1||0
8697156|NCT00886821|9742891|FG006|NOT COMPLETED|Stage 1||0
8925759|NCT02260817|9986922|FG000|NOT COMPLETED|Overall Study||0
8925760|NCT02260817|9986923|FG001|NOT COMPLETED|Overall Study||37
8925761|NCT02260882|9986931|FG000|STARTED|Overall Study||161
8925762|NCT02260882|9986932|FG001|STARTED|Overall Study||82
8925763|NCT02260882|9986931|FG000|COMPLETED|Overall Study||161
8697157|NCT00886821|9742892|FG007|NOT COMPLETED|Stage 1||0
8697158|NCT00886821|9742893|FG008|NOT COMPLETED|Stage 1||0
8697159|NCT00886821|9742894|FG009|NOT COMPLETED|Stage 1||0
8811737|NCT01515319|9864674|FG005|COMPLETED|Overall Study||6
8811738|NCT01515319|9864675|FG006|COMPLETED|Overall Study||9
8925764|NCT02260882|9986932|FG001|COMPLETED|Overall Study||81
8925765|NCT02260882|9986931|FG000|NOT COMPLETED|Overall Study||0
8925766|NCT02260882|9986932|FG001|NOT COMPLETED|Overall Study||1
8925767|NCT02260921|9986941|FG000|STARTED|Overall Study||121
8925768|NCT02260921|9986942|FG001|STARTED|Overall Study||59
8925769|NCT02260921|9986941|FG000|Per-Protocol Population|Overall Study||112
8925770|NCT02260921|9986942|FG001|Per-Protocol Population|Overall Study||56
8925771|NCT02260921|9986941|FG000|COMPLETED|Overall Study||107
8925772|NCT02260921|9986942|FG001|COMPLETED|Overall Study||55
8925773|NCT02260921|9986941|FG000|NOT COMPLETED|Overall Study||14
8925774|NCT02260921|9986942|FG001|NOT COMPLETED|Overall Study||4
8925775|NCT02260934|9986950|FG000|STARTED|Overall Study||22
8925776|NCT02260934|9986951|FG001|STARTED|Overall Study||21
8925777|NCT02260934|9986950|FG000|COMPLETED|Overall Study|At primary outcome timepoint: Ten participants engaged in ongoing scheduled study visits.|19
8925778|NCT02260934|9986951|FG001|COMPLETED|Overall Study|At primary outcome timepoint: Eleven participants engaged in ongoing scheduled study visits.|17
8925779|NCT02260934|9986950|FG000|NOT COMPLETED|Overall Study||3
8925780|NCT02260934|9986951|FG001|NOT COMPLETED|Overall Study||4
8925781|NCT02260986|9986967|FG000|STARTED|Overall Study||315
8925782|NCT02260986|9986968|FG001|STARTED|Overall Study||106
8925783|NCT02260986|9986969|FG002|STARTED|Overall Study||319
8925784|NCT02260986|9986967|FG000|Safety Population|Overall Study||315
8925785|NCT02260986|9986968|FG001|Safety Population|Overall Study|4 participants from Dupilumab 300 mg qw arm analyzed in Dupilumab 300 mg q2w arm|110
8925786|NCT02260986|9986969|FG002|Safety Population|Overall Study|4 participants received fewer injections of Dupilumab 300 mg (analyzed in Dupilumab 300 mg q2w arm)|315
8925787|NCT02260986|9986967|FG000|COMPLETED|Overall Study||225
8925788|NCT02260986|9986968|FG001|COMPLETED|Overall Study||93
8925789|NCT02260986|9986969|FG002|COMPLETED|Overall Study||278
8925790|NCT02260986|9986967|FG000|NOT COMPLETED|Overall Study||90
8925791|NCT02260986|9986968|FG001|NOT COMPLETED|Overall Study||13
8925792|NCT02260986|9986969|FG002|NOT COMPLETED|Overall Study||41
8925793|NCT02261428|9986984|FG000|STARTED|Overall Study|Washout (30 minutes)|10
8925794|NCT02261428|9986985|FG001|STARTED|Overall Study|Washout (30 minutes)|10
8925795|NCT02261428|9986984|FG000|COMPLETED|Overall Study||10
8925796|NCT02261428|9986985|FG001|COMPLETED|Overall Study||10
8925797|NCT02261428|9986984|FG000|NOT COMPLETED|Overall Study||0
8925798|NCT02261428|9986985|FG001|NOT COMPLETED|Overall Study||0
8925799|NCT02261467|9987005|FG000|STARTED|Overall Study||101
8925800|NCT02261467|9987006|FG001|STARTED|Overall Study||290
8925801|NCT02261467|9987005|FG000|COMPLETED|Overall Study||80
8925802|NCT02261467|9987006|FG001|COMPLETED|Overall Study||253
8925803|NCT02261467|9987005|FG000|NOT COMPLETED|Overall Study||21
8925804|NCT02261467|9987006|FG001|NOT COMPLETED|Overall Study||37
8925805|NCT02261493|9987015|FG000|STARTED|Overall Study||156
8925806|NCT02261493|9987016|FG001|STARTED|Overall Study||318
8925807|NCT02261493|9987017|FG002|STARTED|Overall Study||313
8925808|NCT02261493|9987015|FG000|COMPLETED|Overall Study||126
8925809|NCT02261493|9987016|FG001|COMPLETED|Overall Study||271
8925810|NCT02261493|9987017|FG002|COMPLETED|Overall Study||287
8925811|NCT02261493|9987015|FG000|NOT COMPLETED|Overall Study||30
8925812|NCT02261493|9987016|FG001|NOT COMPLETED|Overall Study||47
8925813|NCT02261493|9987017|FG002|NOT COMPLETED|Overall Study||26
8925814|NCT02261597|9987027|FG000|STARTED|Overall Study||22
8697160|NCT00886821|9742895|FG010|NOT COMPLETED|Stage 1||0
8697161|NCT00886821|9742896|FG011|NOT COMPLETED|Stage 1||0
8697162|NCT00886821|9742897|FG012|NOT COMPLETED|Stage 1||0
8697163|NCT00886821|9742898|FG013|NOT COMPLETED|Stage 1||0
8697164|NCT00886821|9742885|FG000|STARTED|Stage 2||0
8697165|NCT00886821|9742886|FG001|STARTED|Stage 2||0
8697166|NCT00886821|9742887|FG002|STARTED|Stage 2||0
8697167|NCT00886821|9742888|FG003|STARTED|Stage 2||0
8697168|NCT00886821|9742889|FG004|STARTED|Stage 2||0
8697169|NCT00886821|9742890|FG005|STARTED|Stage 2||0
8697170|NCT00886821|9742891|FG006|STARTED|Stage 2||0
8697171|NCT00886821|9742892|FG007|STARTED|Stage 2||0
8697172|NCT00886821|9742893|FG008|STARTED|Stage 2||0
8697173|NCT00886821|9742894|FG009|STARTED|Stage 2||0
8697174|NCT00886821|9742895|FG010|STARTED|Stage 2||9
8697175|NCT00886821|9742896|FG011|STARTED|Stage 2||9
8697176|NCT00886821|9742897|FG012|STARTED|Stage 2||13
8811739|NCT01515319|9864676|FG007|COMPLETED|Overall Study||6
8811740|NCT01515319|9864677|FG008|COMPLETED|Overall Study||9
8811741|NCT01515319|9864678|FG009|COMPLETED|Overall Study||8
8811742|NCT01515319|9864669|FG000|NOT COMPLETED|Overall Study||0
8811743|NCT01515319|9864670|FG001|NOT COMPLETED|Overall Study||0
8811744|NCT01515319|9864671|FG002|NOT COMPLETED|Overall Study||0
8811745|NCT01515319|9864672|FG003|NOT COMPLETED|Overall Study||0
8811746|NCT01515319|9864673|FG004|NOT COMPLETED|Overall Study||0
8811747|NCT01515319|9864674|FG005|NOT COMPLETED|Overall Study||0
8811748|NCT01515319|9864675|FG006|NOT COMPLETED|Overall Study||1
8811749|NCT01515319|9864676|FG007|NOT COMPLETED|Overall Study||0
8811750|NCT01515319|9864677|FG008|NOT COMPLETED|Overall Study||5
8811751|NCT01515319|9864678|FG009|NOT COMPLETED|Overall Study||0
8811752|NCT01515345|9864702|FG000|STARTED|Overall Study||665
8811753|NCT01515345|9864703|FG001|STARTED|Overall Study||343
8697177|NCT00886821|9742898|FG013|STARTED|Stage 2||9
8697178|NCT00886821|9742885|FG000|COMPLETED|Stage 2||0
8811754|NCT01515345|9864702|FG000|COMPLETED|Overall Study||664
8811755|NCT01515345|9864703|FG001|COMPLETED|Overall Study||343
8811756|NCT01515345|9864702|FG000|NOT COMPLETED|Overall Study||1
8811757|NCT01515345|9864703|FG001|NOT COMPLETED|Overall Study||0
8925815|NCT02261597|9987028|FG001|STARTED|Overall Study||22
8925816|NCT02261597|9987027|FG000|COMPLETED|Overall Study||22
8925817|NCT02261597|9987028|FG001|COMPLETED|Overall Study||22
8925818|NCT02261597|9987027|FG000|NOT COMPLETED|Overall Study||0
8925819|NCT02261597|9987028|FG001|NOT COMPLETED|Overall Study||0
8925820|NCT02261714|9987034|FG000|STARTED|Overall Study||32
8925821|NCT02261714|9987034|FG000|COMPLETED|Overall Study||4
8925822|NCT02261714|9987034|FG000|NOT COMPLETED|Overall Study||28
8925823|NCT02261727|9987042|FG000|STARTED|Overall Study||568
8925824|NCT02261727|9987043|FG001|STARTED|Overall Study||554
8925825|NCT02261727|9987044|FG002|STARTED|Overall Study||548
8925826|NCT02261727|9987042|FG000|COMPLETED|Overall Study||411
8925827|NCT02261727|9987043|FG001|COMPLETED|Overall Study||408
8925828|NCT02261727|9987044|FG002|COMPLETED|Overall Study||423
8925829|NCT02261727|9987042|FG000|NOT COMPLETED|Overall Study||157
8925830|NCT02261727|9987043|FG001|NOT COMPLETED|Overall Study||146
8925831|NCT02261727|9987044|FG002|NOT COMPLETED|Overall Study||125
8925832|NCT02261805|9987052|FG000|STARTED|Overall Study||3
9042180|NCT03377634|10102726|FG000|STARTED|Intervention Usability Testing Period||5
9042181|NCT03377634|10102727|FG001|STARTED|Intervention Usability Testing Period||0
8697179|NCT00886821|9742886|FG001|COMPLETED|Stage 2||0
8925833|NCT02261805|9987053|FG001|STARTED|Overall Study||6
8925834|NCT02261805|9987054|FG002|STARTED|Overall Study||2
8925835|NCT02261805|9987052|FG000|COMPLETED|Overall Study||3
8925836|NCT02261805|9987053|FG001|COMPLETED|Overall Study||6
8925837|NCT02261805|9987054|FG002|COMPLETED|Overall Study||2
8925838|NCT02261805|9987052|FG000|NOT COMPLETED|Overall Study||0
8925839|NCT02261805|9987053|FG001|NOT COMPLETED|Overall Study||0
8925840|NCT02261805|9987054|FG002|NOT COMPLETED|Overall Study||0
8925841|NCT02261818|9987060|FG000|STARTED|Overall Study||30
8925842|NCT02261818|9987060|FG000|COMPLETED|Overall Study||27
8925843|NCT02261818|9987060|FG000|NOT COMPLETED|Overall Study||3
8925844|NCT02261948|9987066|FG000|STARTED|Overall Study||23
8925845|NCT02261948|9987067|FG001|STARTED|Overall Study||19
8925846|NCT02261948|9987066|FG000|COMPLETED|Overall Study||23
8925847|NCT02261948|9987067|FG001|COMPLETED|Overall Study||19
8925848|NCT02261948|9987066|FG000|NOT COMPLETED|Overall Study||0
8925849|NCT02261948|9987067|FG001|NOT COMPLETED|Overall Study||0
8925850|NCT02261961|9987075|FG000|STARTED|Overall Study||22
8925851|NCT02261961|9987076|FG001|STARTED|Overall Study||22
8925852|NCT02261961|9987075|FG000|COMPLETED|Overall Study||13
8697180|NCT00886821|9742887|FG002|COMPLETED|Stage 2||0
8697181|NCT00886821|9742888|FG003|COMPLETED|Stage 2||0
8697182|NCT00886821|9742889|FG004|COMPLETED|Stage 2||0
8697183|NCT00886821|9742890|FG005|COMPLETED|Stage 2||0
8697184|NCT00886821|9742891|FG006|COMPLETED|Stage 2||0
8697185|NCT00886821|9742892|FG007|COMPLETED|Stage 2||0
8697186|NCT00886821|9742893|FG008|COMPLETED|Stage 2||0
8697187|NCT00886821|9742894|FG009|COMPLETED|Stage 2||0
8697188|NCT00886821|9742895|FG010|COMPLETED|Stage 2||9
8697189|NCT00886821|9742896|FG011|COMPLETED|Stage 2||8
8811758|NCT01515410|9864709|FG000|STARTED|Overall Study||19
8925853|NCT02261961|9987076|FG001|COMPLETED|Overall Study|One subject listed as completed who withdrew but finished training phase and has usable data.|20
8925854|NCT02261961|9987075|FG000|NOT COMPLETED|Overall Study||9
8925855|NCT02261961|9987076|FG001|NOT COMPLETED|Overall Study||2
8925856|NCT02261974|9987095|FG000|STARTED|Overall Study||123
8925857|NCT02261974|9987096|FG001|STARTED|Overall Study||63
8925858|NCT02261974|9987095|FG000|Treated|Overall Study||117
8925859|NCT02261974|9987096|FG001|Treated|Overall Study||57
8925860|NCT02261974|9987095|FG000|COMPLETED|Overall Study||108
8925861|NCT02261974|9987096|FG001|COMPLETED|Overall Study||56
8925862|NCT02261974|9987095|FG000|NOT COMPLETED|Overall Study||15
8925863|NCT02261974|9987096|FG001|NOT COMPLETED|Overall Study||7
8925864|NCT02262039|9987104|FG000|STARTED|Overall Study||14
8925865|NCT02262039|9987105|FG001|STARTED|Overall Study||27
8925866|NCT02262039|9987104|FG000|COMPLETED|Overall Study||14
8925867|NCT02262039|9987105|FG001|COMPLETED|Overall Study||27
8925868|NCT02262039|9987104|FG000|NOT COMPLETED|Overall Study||0
8697190|NCT00886821|9742897|FG012|COMPLETED|Stage 2||8
8697191|NCT00886821|9742898|FG013|COMPLETED|Stage 2||8
8697192|NCT00886821|9742885|FG000|NOT COMPLETED|Stage 2||0
8697193|NCT00886821|9742886|FG001|NOT COMPLETED|Stage 2||0
8697194|NCT00886821|9742887|FG002|NOT COMPLETED|Stage 2||0
8697195|NCT00886821|9742888|FG003|NOT COMPLETED|Stage 2||0
8811759|NCT01515410|9864710|FG001|STARTED|Overall Study||15
8811760|NCT01515410|9864709|FG000|COMPLETED|Overall Study||19
8811761|NCT01515410|9864710|FG001|COMPLETED|Overall Study||15
8811762|NCT01515410|9864709|FG000|NOT COMPLETED|Overall Study||0
8811763|NCT01515410|9864710|FG001|NOT COMPLETED|Overall Study||0
8811764|NCT01515423|9864718|FG000|STARTED|Open Label Phase||1429
8811765|NCT01515423|9864719|FG001|STARTED|Open Label Phase||0
8811766|NCT01515423|9864720|FG002|STARTED|Open Label Phase||0
8811767|NCT01515423|9864718|FG000|COMPLETED|Open Label Phase||1016
8925869|NCT02262039|9987105|FG001|NOT COMPLETED|Overall Study||0
8925870|NCT02262078|9987113|FG000|STARTED|Overall Study||13
8925871|NCT02262078|9987114|FG001|STARTED|Overall Study||13
8925872|NCT02262078|9987113|FG000|COMPLETED|Overall Study||13
8925873|NCT02262078|9987114|FG001|COMPLETED|Overall Study||13
8697196|NCT00886821|9742889|FG004|NOT COMPLETED|Stage 2||0
8697197|NCT00886821|9742890|FG005|NOT COMPLETED|Stage 2||0
8811768|NCT01515423|9864719|FG001|COMPLETED|Open Label Phase||0
8811769|NCT01515423|9864720|FG002|COMPLETED|Open Label Phase||0
8811770|NCT01515423|9864718|FG000|NOT COMPLETED|Open Label Phase||413
8925874|NCT02262078|9987113|FG000|NOT COMPLETED|Overall Study||0
8925875|NCT02262078|9987114|FG001|NOT COMPLETED|Overall Study||0
8925876|NCT02262130|9987120|FG000|STARTED|Overall Study||10
8925877|NCT02262130|9987120|FG000|COMPLETED|Overall Study||10
8925878|NCT02262130|9987120|FG000|NOT COMPLETED|Overall Study||0
8925879|NCT02262260|9987126|FG000|STARTED|Overall Study||45
8925880|NCT02262260|9987127|FG001|STARTED|Overall Study||42
8925881|NCT02262260|9987126|FG000|COMPLETED|Overall Study||34
8925882|NCT02262260|9987127|FG001|COMPLETED|Overall Study||32
8925883|NCT02262260|9987126|FG000|NOT COMPLETED|Overall Study||11
9042182|NCT03377634|10102726|FG000|COMPLETED|Intervention Usability Testing Period||5
9042183|NCT03377634|10102727|FG001|COMPLETED|Intervention Usability Testing Period||0
9042184|NCT03377634|10102726|FG000|NOT COMPLETED|Intervention Usability Testing Period||0
9042185|NCT03377634|10102727|FG001|NOT COMPLETED|Intervention Usability Testing Period||0
9042186|NCT03377634|10102726|FG000|STARTED|Study Period||15
8697198|NCT00886821|9742891|FG006|NOT COMPLETED|Stage 2||0
8697199|NCT00886821|9742892|FG007|NOT COMPLETED|Stage 2||0
8697200|NCT00886821|9742893|FG008|NOT COMPLETED|Stage 2||0
8697201|NCT00886821|9742894|FG009|NOT COMPLETED|Stage 2||0
8697202|NCT00886821|9742895|FG010|NOT COMPLETED|Stage 2||0
8811771|NCT01515423|9864719|FG001|NOT COMPLETED|Open Label Phase||0
9042187|NCT03377634|10102727|FG001|STARTED|Study Period||13
9042188|NCT03377634|10102726|FG000|COMPLETED|Study Period||13
9042189|NCT03377634|10102727|FG001|COMPLETED|Study Period||13
9042190|NCT03377634|10102726|FG000|NOT COMPLETED|Study Period||2
9042191|NCT03377634|10102727|FG001|NOT COMPLETED|Study Period||0
9042192|NCT03378076|10102735|FG000|STARTED|Overall Study||12
9042193|NCT03378076|10102736|FG001|STARTED|Overall Study||12
9042194|NCT03378076|10102735|FG000|COMPLETED|Overall Study||12
9042195|NCT03378076|10102736|FG001|COMPLETED|Overall Study||12
9042196|NCT03378076|10102735|FG000|NOT COMPLETED|Overall Study||0
9042197|NCT03378076|10102736|FG001|NOT COMPLETED|Overall Study||0
9042198|NCT03378635|10102745|FG000|STARTED|Overall Study||84
9042199|NCT03378635|10102746|FG001|STARTED|Overall Study||43
9042200|NCT03378635|10102747|FG002|STARTED|Overall Study||43
9042201|NCT03378635|10102745|FG000|Randomized and Exposed to Treatment|Overall Study||82
9042202|NCT03378635|10102746|FG001|Randomized and Exposed to Treatment|Overall Study||43
9042203|NCT03378635|10102747|FG002|Randomized and Exposed to Treatment|Overall Study||43
9042204|NCT03378635|10102745|FG000|COMPLETED|Overall Study||82
9042205|NCT03378635|10102746|FG001|COMPLETED|Overall Study||43
9042206|NCT03378635|10102747|FG002|COMPLETED|Overall Study||43
9042207|NCT03378635|10102745|FG000|NOT COMPLETED|Overall Study||2
9042208|NCT03378635|10102746|FG001|NOT COMPLETED|Overall Study||0
9042209|NCT03378635|10102747|FG002|NOT COMPLETED|Overall Study||0
9042210|NCT03378921|10102758|FG000|STARTED|Overall Study||13
9042211|NCT03378921|10102759|FG001|STARTED|Overall Study||13
9042212|NCT03378921|10102758|FG000|COMPLETED|Overall Study||13
9042213|NCT03378921|10102759|FG001|COMPLETED|Overall Study||13
9042214|NCT03378921|10102758|FG000|NOT COMPLETED|Overall Study||0
9042215|NCT03378921|10102759|FG001|NOT COMPLETED|Overall Study||0
9042216|NCT03378973|10102767|FG000|STARTED|Overall Study||4
9042217|NCT03378973|10102768|FG001|STARTED|Overall Study||3
9042218|NCT03378973|10102767|FG000|COMPLETED|Overall Study||4
9042219|NCT03378973|10102768|FG001|COMPLETED|Overall Study||3
9042220|NCT03378973|10102767|FG000|NOT COMPLETED|Overall Study||0
9042221|NCT03378973|10102768|FG001|NOT COMPLETED|Overall Study||0
9042222|NCT03379259|10102780|FG000|STARTED|Overall Study||3
9042223|NCT03379259|10102781|FG001|STARTED|Overall Study||3
9042224|NCT03379259|10102782|FG002|STARTED|Overall Study||6
9042225|NCT03379259|10102783|FG003|STARTED|Overall Study||3
9042226|NCT03379259|10102784|FG004|STARTED|Overall Study||12
9042227|NCT03379259|10102785|FG005|STARTED|Overall Study||12
8697203|NCT00886821|9742896|FG011|NOT COMPLETED|Stage 2||1
8697204|NCT00886821|9742897|FG012|NOT COMPLETED|Stage 2||5
8811772|NCT01515423|9864720|FG002|NOT COMPLETED|Open Label Phase||0
8811773|NCT01515423|9864718|FG000|STARTED|DOUBLE BLIND||0
8811774|NCT01515423|9864719|FG001|STARTED|DOUBLE BLIND||504
8811775|NCT01515423|9864720|FG002|STARTED|DOUBLE BLIND||512
8811776|NCT01515423|9864718|FG000|COMPLETED|DOUBLE BLIND||0
8811777|NCT01515423|9864719|FG001|COMPLETED|DOUBLE BLIND||422
8811778|NCT01515423|9864720|FG002|COMPLETED|DOUBLE BLIND||420
8811779|NCT01515423|9864718|FG000|NOT COMPLETED|DOUBLE BLIND||0
8811780|NCT01515423|9864719|FG001|NOT COMPLETED|DOUBLE BLIND||82
8811781|NCT01515423|9864720|FG002|NOT COMPLETED|DOUBLE BLIND||92
8811782|NCT01515475|9864731|FG000|STARTED|Overall Study||61
8811783|NCT01515475|9864732|FG001|STARTED|Overall Study||58
8811784|NCT01515475|9864733|FG002|STARTED|Overall Study||65
8811785|NCT01515475|9864734|FG003|STARTED|Overall Study||65
8811786|NCT01515475|9864731|FG000|COMPLETED|Overall Study||41
8811787|NCT01515475|9864732|FG001|COMPLETED|Overall Study||43
8811788|NCT01515475|9864733|FG002|COMPLETED|Overall Study||53
8811789|NCT01515475|9864734|FG003|COMPLETED|Overall Study||53
8811790|NCT01515475|9864731|FG000|NOT COMPLETED|Overall Study||20
8811791|NCT01515475|9864732|FG001|NOT COMPLETED|Overall Study||15
8811792|NCT01515475|9864733|FG002|NOT COMPLETED|Overall Study||12
8811793|NCT01515475|9864734|FG003|NOT COMPLETED|Overall Study||12
8811794|NCT01515488|9864746|FG000|STARTED|Overall Study||200
8925884|NCT02262260|9987127|FG001|NOT COMPLETED|Overall Study||10
8925885|NCT02262364|9987133|FG000|STARTED|Study Enrollment||11
8925886|NCT02262364|9987133|FG000|COMPLETED|Study Enrollment||11
8925887|NCT02262364|9987133|FG000|NOT COMPLETED|Study Enrollment||0
8925888|NCT02262364|9987133|FG000|STARTED|Blood Draw for Device Processing||11
8925889|NCT02262364|9987133|FG000|COMPLETED|Blood Draw for Device Processing||10
8925890|NCT02262364|9987133|FG000|NOT COMPLETED|Blood Draw for Device Processing||1
8925891|NCT02262364|9987133|FG000|STARTED|Injection With APS||10
8925892|NCT02262364|9987133|FG000|COMPLETED|Injection With APS||10
8925893|NCT02262364|9987133|FG000|NOT COMPLETED|Injection With APS||0
8925894|NCT02262364|9987133|FG000|STARTED|Follow-Up Through 12 Months||10
8925895|NCT02262364|9987133|FG000|COMPLETED|Follow-Up Through 12 Months||10
8925896|NCT02262364|9987133|FG000|NOT COMPLETED|Follow-Up Through 12 Months||0
8925897|NCT02262377|9987139|FG000|STARTED|Overall Study||80
8925898|NCT02262377|9987140|FG001|STARTED|Overall Study||79
8925899|NCT02262377|9987139|FG000|COMPLETED|Overall Study||68
8925900|NCT02262377|9987140|FG001|COMPLETED|Overall Study||73
8925901|NCT02262377|9987139|FG000|NOT COMPLETED|Overall Study||12
8925902|NCT02262377|9987140|FG001|NOT COMPLETED|Overall Study||6
8925903|NCT02262507|9987147|FG000|STARTED|Overall Study||410
8925904|NCT02262507|9987147|FG000|COMPLETED|Overall Study||410
8925905|NCT02262507|9987147|FG000|NOT COMPLETED|Overall Study||0
8697205|NCT00886821|9742898|FG013|NOT COMPLETED|Stage 2||1
8697206|NCT00886834|9742944|FG000|STARTED|Overall Study||54
8697207|NCT00886834|9742945|FG001|STARTED|Overall Study||54
8697208|NCT00886834|9742944|FG000|COMPLETED|Overall Study||54
8697209|NCT00886834|9742945|FG001|COMPLETED|Overall Study||51
8697210|NCT00886834|9742944|FG000|NOT COMPLETED|Overall Study||0
8697211|NCT00886834|9742945|FG001|NOT COMPLETED|Overall Study||3
8697212|NCT00886899|9742951|FG000|STARTED|Overall Study||147
8697213|NCT00886899|9742951|FG000|COMPLETED|Overall Study||147
8697214|NCT00886899|9742951|FG000|NOT COMPLETED|Overall Study||0
8697215|NCT00886938|9742955|FG000|STARTED|Overall Study||12
8697216|NCT00886938|9742955|FG000|COMPLETED|Overall Study||10
8697217|NCT00886938|9742955|FG000|NOT COMPLETED|Overall Study||2
8697218|NCT00887068|9742961|FG000|STARTED|Overall Study||93
8697219|NCT00887068|9742962|FG001|STARTED|Overall Study||94
8697220|NCT00887068|9742961|FG000|COMPLETED|Overall Study||87
8697221|NCT00887068|9742962|FG001|COMPLETED|Overall Study||94
8697222|NCT00887068|9742961|FG000|NOT COMPLETED|Overall Study||6
8697223|NCT00887068|9742962|FG001|NOT COMPLETED|Overall Study||0
8697224|NCT00887159|9742971|FG000|STARTED|Overall Study||56
8697225|NCT00887159|9742972|FG001|STARTED|Overall Study||56
8697226|NCT00887159|9742973|FG002|STARTED|Overall Study||56
8697227|NCT00887159|9742971|FG000|Patients Who Started Assigned Treatment|Overall Study||53
8697228|NCT00887159|9742972|FG001|Patients Who Started Assigned Treatment|Overall Study||53
8697229|NCT00887159|9742973|FG002|Patients Who Started Assigned Treatment|Overall Study||52
8697230|NCT00887159|9742971|FG000|Eligible and Treated Patients|Overall Study||48
8697231|NCT00887159|9742972|FG001|Eligible and Treated Patients|Overall Study||52
8697232|NCT00887159|9742973|FG002|Eligible and Treated Patients|Overall Study||52
8697233|NCT00887159|9742971|FG000|Eligible/Treated Pts With CTCs Results|Overall Study||40
8811795|NCT01515488|9864747|FG001|STARTED|Overall Study||200
8811796|NCT01515488|9864746|FG000|COMPLETED|Overall Study||200
8811797|NCT01515488|9864747|FG001|COMPLETED|Overall Study||200
8811798|NCT01515488|9864746|FG000|NOT COMPLETED|Overall Study||0
8811799|NCT01515488|9864747|FG001|NOT COMPLETED|Overall Study||0
8811800|NCT01515540|9864755|FG000|STARTED|Overall Study||20
8811801|NCT01515540|9864756|FG001|STARTED|Overall Study||18
8811802|NCT01515540|9864755|FG000|COMPLETED|Overall Study||15
8811803|NCT01515540|9864756|FG001|COMPLETED|Overall Study||15
8811804|NCT01515540|9864755|FG000|NOT COMPLETED|Overall Study||5
8811805|NCT01515540|9864756|FG001|NOT COMPLETED|Overall Study||3
8811806|NCT01515566|9864764|FG000|STARTED|Overall Study||10
8811807|NCT01515566|9864765|FG001|STARTED|Overall Study||10
8811808|NCT01515566|9864764|FG000|COMPLETED|Overall Study||10
8811809|NCT01515566|9864765|FG001|COMPLETED|Overall Study||10
8811810|NCT01515566|9864764|FG000|NOT COMPLETED|Overall Study||0
8811811|NCT01515566|9864765|FG001|NOT COMPLETED|Overall Study||0
8811812|NCT01515657|9864771|FG000|STARTED|First Intervention||14
8811813|NCT01515657|9864772|FG001|STARTED|First Intervention||13
8811814|NCT01515657|9864773|FG002|STARTED|First Intervention||13
8811815|NCT01515657|9864771|FG000|COMPLETED|First Intervention||14
8811816|NCT01515657|9864772|FG001|COMPLETED|First Intervention||12
8811817|NCT01515657|9864773|FG002|COMPLETED|First Intervention||13
8811818|NCT01515657|9864771|FG000|NOT COMPLETED|First Intervention||0
8811819|NCT01515657|9864772|FG001|NOT COMPLETED|First Intervention||1
8811820|NCT01515657|9864773|FG002|NOT COMPLETED|First Intervention||0
8811821|NCT01515657|9864771|FG000|STARTED|Second Intervention||14
8811822|NCT01515657|9864772|FG001|STARTED|Second Intervention||12
8811823|NCT01515657|9864773|FG002|STARTED|Second Intervention||13
8811824|NCT01515657|9864771|FG000|COMPLETED|Second Intervention||14
8811825|NCT01515657|9864772|FG001|COMPLETED|Second Intervention||11
8925906|NCT02262728|9987154|FG000|STARTED|Treatment Period (12 Weeks)||19
8811826|NCT01515657|9864773|FG002|COMPLETED|Second Intervention||13
8811827|NCT01515657|9864771|FG000|NOT COMPLETED|Second Intervention||0
8811828|NCT01515657|9864772|FG001|NOT COMPLETED|Second Intervention||1
8697234|NCT00887159|9742972|FG001|Eligible/Treated Pts With CTCs Results|Overall Study||42
8697235|NCT00887159|9742973|FG002|Eligible/Treated Pts With CTCs Results|Overall Study||38
8811829|NCT01515657|9864773|FG002|NOT COMPLETED|Second Intervention||0
8925907|NCT02262728|9987155|FG001|STARTED|Treatment Period (12 Weeks)||21
8925908|NCT02262728|9987154|FG000|COMPLETED|Treatment Period (12 Weeks)|Participants who completed continued follow-up phase.|19
8925909|NCT02262728|9987155|FG001|COMPLETED|Treatment Period (12 Weeks)|Participants who completed continued follow-up phase.|21
8925910|NCT02262728|9987154|FG000|NOT COMPLETED|Treatment Period (12 Weeks)||0
8925911|NCT02262728|9987155|FG001|NOT COMPLETED|Treatment Period (12 Weeks)||0
8925912|NCT02262728|9987154|FG000|STARTED|Follow-up Phase (3 Years)||19
8925913|NCT02262728|9987155|FG001|STARTED|Follow-up Phase (3 Years)||21
8925914|NCT02262728|9987154|FG000|COMPLETED|Follow-up Phase (3 Years)||15
8925915|NCT02262728|9987155|FG001|COMPLETED|Follow-up Phase (3 Years)||18
8925916|NCT02262728|9987154|FG000|NOT COMPLETED|Follow-up Phase (3 Years)||4
8925917|NCT02262728|9987155|FG001|NOT COMPLETED|Follow-up Phase (3 Years)||3
8925918|NCT02262754|9987164|FG000|STARTED|Overall Study||74
8925919|NCT02262754|9987165|FG001|STARTED|Overall Study||74
8925920|NCT02262754|9987166|FG002|STARTED|Overall Study||74
8925921|NCT02262754|9987164|FG000|COMPLETED|Overall Study||58
8925922|NCT02262754|9987165|FG001|COMPLETED|Overall Study||65
8925923|NCT02262754|9987166|FG002|COMPLETED|Overall Study||65
8925924|NCT02262754|9987164|FG000|NOT COMPLETED|Overall Study||16
8925925|NCT02262754|9987165|FG001|NOT COMPLETED|Overall Study||9
8925926|NCT02262754|9987166|FG002|NOT COMPLETED|Overall Study||9
8925927|NCT02263014|9987178|FG000|STARTED|Overall Study||44
8925928|NCT02263014|9987179|FG001|STARTED|Overall Study||208
8925929|NCT02263014|9987178|FG000|COMPLETED|Overall Study||44
8925930|NCT02263014|9987179|FG001|COMPLETED|Overall Study||208
8925931|NCT02263014|9987178|FG000|NOT COMPLETED|Overall Study||0
8925932|NCT02263014|9987179|FG001|NOT COMPLETED|Overall Study||0
8925933|NCT02263040|9987189|FG000|STARTED|Overall Study||87
8925934|NCT02263040|9987190|FG001|STARTED|Overall Study||83
8925935|NCT02263040|9987189|FG000|COMPLETED|Overall Study||87
8925936|NCT02263040|9987190|FG001|COMPLETED|Overall Study||83
8925937|NCT02263040|9987189|FG000|NOT COMPLETED|Overall Study||0
8925938|NCT02263040|9987190|FG001|NOT COMPLETED|Overall Study||0
8925939|NCT02263079|9987203|FG000|STARTED|Overall Study||26
8925940|NCT02263079|9987204|FG001|STARTED|Overall Study||33
8697236|NCT00887159|9742971|FG000|COMPLETED|Overall Study||27
8697237|NCT00887159|9742972|FG001|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicity.|0
8697238|NCT00887159|9742973|FG002|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicity.|0
8697239|NCT00887159|9742971|FG000|NOT COMPLETED|Overall Study||29
8697240|NCT00887159|9742972|FG001|NOT COMPLETED|Overall Study||56
8697241|NCT00887159|9742973|FG002|NOT COMPLETED|Overall Study||56
8697242|NCT00887198|9742985|FG000|STARTED|Randomized Period||546
8697243|NCT00887198|9742986|FG001|STARTED|Randomized Period||542
8697244|NCT00887198|9742987|FG002|STARTED|Randomized Period||0
8697245|NCT00887198|9742985|FG000|Treated|Randomized Period||542
8697246|NCT00887198|9742986|FG001|Treated|Randomized Period||540
8697247|NCT00887198|9742987|FG002|Treated|Randomized Period||0
8697248|NCT00887198|9742985|FG000|COMPLETED|Randomized Period||0
8697249|NCT00887198|9742986|FG001|COMPLETED|Randomized Period||0
8697250|NCT00887198|9742987|FG002|COMPLETED|Randomized Period||0
8697251|NCT00887198|9742985|FG000|NOT COMPLETED|Randomized Period||546
8697252|NCT00887198|9742986|FG001|NOT COMPLETED|Randomized Period||542
8697253|NCT00887198|9742987|FG002|NOT COMPLETED|Randomized Period||0
8697254|NCT00887198|9742985|FG000|STARTED|Cross Over (Placebo to AA)||0
8697255|NCT00887198|9742986|FG001|STARTED|Cross Over (Placebo to AA)||0
8697256|NCT00887198|9742987|FG002|STARTED|Cross Over (Placebo to AA)|93= 51 participants(crossed over under amendment 3)+42 participants (crossed over under amendment 4)|93
8697257|NCT00887198|9742985|FG000|COMPLETED|Cross Over (Placebo to AA)||0
8697258|NCT00887198|9742986|FG001|COMPLETED|Cross Over (Placebo to AA)||0
8697259|NCT00887198|9742987|FG002|COMPLETED|Cross Over (Placebo to AA)||0
8697260|NCT00887198|9742985|FG000|NOT COMPLETED|Cross Over (Placebo to AA)||0
8697261|NCT00887198|9742986|FG001|NOT COMPLETED|Cross Over (Placebo to AA)||0
8697262|NCT00887198|9742987|FG002|NOT COMPLETED|Cross Over (Placebo to AA)||93
8697263|NCT00887224|9742998|FG000|STARTED|Open-label Response (OLR) Phase||874
8697264|NCT00887224|9742999|FG001|STARTED|Open-label Response (OLR) Phase||0
8697265|NCT00887224|9743000|FG002|STARTED|Open-label Response (OLR) Phase||0
8811830|NCT01515657|9864771|FG000|STARTED|Third Intervention||14
8811831|NCT01515657|9864772|FG001|STARTED|Third Intervention||11
8811832|NCT01515657|9864773|FG002|STARTED|Third Intervention||13
8811833|NCT01515657|9864771|FG000|COMPLETED|Third Intervention||13
8811834|NCT01515657|9864772|FG001|COMPLETED|Third Intervention||11
8811835|NCT01515657|9864773|FG002|COMPLETED|Third Intervention||13
8811836|NCT01515657|9864771|FG000|NOT COMPLETED|Third Intervention||1
8811837|NCT01515657|9864772|FG001|NOT COMPLETED|Third Intervention||0
8811838|NCT01515657|9864773|FG002|NOT COMPLETED|Third Intervention||0
8811839|NCT01515696|9864783|FG000|STARTED|Overall Study||47
8925941|NCT02263079|9987205|FG002|STARTED|Overall Study||3
8925942|NCT02263079|9987203|FG000|COMPLETED|Overall Study||23
8925943|NCT02263079|9987204|FG001|COMPLETED|Overall Study||25
8925944|NCT02263079|9987205|FG002|COMPLETED|Overall Study|Completed study but not included in the analysis|3
8925945|NCT02263079|9987203|FG000|NOT COMPLETED|Overall Study||3
8925946|NCT02263079|9987204|FG001|NOT COMPLETED|Overall Study||8
8925947|NCT02263079|9987205|FG002|NOT COMPLETED|Overall Study||0
8697266|NCT00887224|9742998|FG000|COMPLETED|Open-label Response (OLR) Phase||752
8697267|NCT00887224|9742999|FG001|COMPLETED|Open-label Response (OLR) Phase||0
8697268|NCT00887224|9743000|FG002|COMPLETED|Open-label Response (OLR) Phase||0
8811840|NCT01515696|9864784|FG001|STARTED|Overall Study||49
8697269|NCT00887224|9742998|FG000|NOT COMPLETED|Open-label Response (OLR) Phase||122
8811841|NCT01515696|9864783|FG000|COMPLETED|Overall Study||39
8925948|NCT02263118|9987217|FG000|STARTED|Overall Study||24
8925949|NCT02263118|9987218|FG001|STARTED|Overall Study||32
8925950|NCT02263118|9987219|FG002|STARTED|Overall Study||30
8697270|NCT00887224|9742999|FG001|NOT COMPLETED|Open-label Response (OLR) Phase||0
8697271|NCT00887224|9743000|FG002|NOT COMPLETED|Open-label Response (OLR) Phase||0
8925951|NCT02263118|9987220|FG003|STARTED|Overall Study||14
8925952|NCT02263118|9987217|FG000|COMPLETED|Overall Study||20
8925953|NCT02263118|9987218|FG001|COMPLETED|Overall Study||24
8925954|NCT02263118|9987219|FG002|COMPLETED|Overall Study||22
8925955|NCT02263118|9987220|FG003|COMPLETED|Overall Study||12
8925956|NCT02263118|9987217|FG000|NOT COMPLETED|Overall Study||4
8925957|NCT02263118|9987218|FG001|NOT COMPLETED|Overall Study||8
8925958|NCT02263118|9987219|FG002|NOT COMPLETED|Overall Study||8
8925959|NCT02263118|9987220|FG003|NOT COMPLETED|Overall Study||2
8925960|NCT02263131|9987234|FG000|STARTED|Overall Study||347
8925961|NCT02263131|9987235|FG001|STARTED|Overall Study||69
8925962|NCT02263131|9987234|FG000|COMPLETED|Overall Study||337
8925963|NCT02263131|9987235|FG001|COMPLETED|Overall Study||68
8925964|NCT02263131|9987234|FG000|NOT COMPLETED|Overall Study||10
8925965|NCT02263131|9987235|FG001|NOT COMPLETED|Overall Study||1
8925966|NCT02263326|9987243|FG000|STARTED|Overall Study||44
8925967|NCT02263326|9987244|FG001|STARTED|Overall Study||45
8925968|NCT02263326|9987243|FG000|COMPLETED|Overall Study||43
8925969|NCT02263326|9987244|FG001|COMPLETED|Overall Study||44
8925970|NCT02263326|9987243|FG000|NOT COMPLETED|Overall Study||1
8925971|NCT02263326|9987244|FG001|NOT COMPLETED|Overall Study||1
8925972|NCT02263547|9987250|FG000|STARTED|Overall Study||14
8925973|NCT02263547|9987250|FG000|COMPLETED|Overall Study||11
8925974|NCT02263547|9987250|FG000|NOT COMPLETED|Overall Study||3
8925975|NCT02263833|9987254|FG000|STARTED|Overall Study||742
8925976|NCT02263833|9987254|FG000|COMPLETED|Overall Study||742
8925977|NCT02263833|9987254|FG000|NOT COMPLETED|Overall Study||0
8925978|NCT02263911|9987258|FG000|STARTED|Period 1||4
8925979|NCT02263911|9987259|FG001|STARTED|Period 1||4
8925980|NCT02263911|9987260|FG002|STARTED|Period 1||4
8925981|NCT02263911|9987261|FG003|STARTED|Period 1||4
8925982|NCT02263911|9987258|FG000|COMPLETED|Period 1||4
8925983|NCT02263911|9987259|FG001|COMPLETED|Period 1||4
8925984|NCT02263911|9987260|FG002|COMPLETED|Period 1||4
8925985|NCT02263911|9987261|FG003|COMPLETED|Period 1||4
8925986|NCT02263911|9987258|FG000|NOT COMPLETED|Period 1||0
8925987|NCT02263911|9987259|FG001|NOT COMPLETED|Period 1||0
8925988|NCT02263911|9987260|FG002|NOT COMPLETED|Period 1||0
8925989|NCT02263911|9987261|FG003|NOT COMPLETED|Period 1||0
8925990|NCT02263911|9987258|FG000|STARTED|Period 1 Washout||4
8925991|NCT02263911|9987259|FG001|STARTED|Period 1 Washout||4
8925992|NCT02263911|9987260|FG002|STARTED|Period 1 Washout||4
8925993|NCT02263911|9987261|FG003|STARTED|Period 1 Washout||4
8925994|NCT02263911|9987258|FG000|COMPLETED|Period 1 Washout||4
8925995|NCT02263911|9987259|FG001|COMPLETED|Period 1 Washout||4
8925996|NCT02263911|9987260|FG002|COMPLETED|Period 1 Washout||4
8925997|NCT02263911|9987261|FG003|COMPLETED|Period 1 Washout||4
8925998|NCT02263911|9987258|FG000|NOT COMPLETED|Period 1 Washout||0
8925999|NCT02263911|9987259|FG001|NOT COMPLETED|Period 1 Washout||0
8926000|NCT02263911|9987260|FG002|NOT COMPLETED|Period 1 Washout||0
8926001|NCT02263911|9987261|FG003|NOT COMPLETED|Period 1 Washout||0
8926002|NCT02263911|9987258|FG000|STARTED|Period 2||4
8926003|NCT02263911|9987259|FG001|STARTED|Period 2||4
8926004|NCT02263911|9987260|FG002|STARTED|Period 2||4
8926005|NCT02263911|9987261|FG003|STARTED|Period 2||4
8926006|NCT02263911|9987258|FG000|COMPLETED|Period 2||4
8926007|NCT02263911|9987259|FG001|COMPLETED|Period 2||4
8926008|NCT02263911|9987260|FG002|COMPLETED|Period 2||4
8926009|NCT02263911|9987261|FG003|COMPLETED|Period 2||4
8926010|NCT02263911|9987258|FG000|NOT COMPLETED|Period 2||0
8926011|NCT02263911|9987259|FG001|NOT COMPLETED|Period 2||0
8926012|NCT02263911|9987260|FG002|NOT COMPLETED|Period 2||0
8926013|NCT02263911|9987261|FG003|NOT COMPLETED|Period 2||0
8926014|NCT02263911|9987258|FG000|STARTED|Period 2 Washout||4
8926015|NCT02263911|9987259|FG001|STARTED|Period 2 Washout||4
8926016|NCT02263911|9987260|FG002|STARTED|Period 2 Washout||4
8926017|NCT02263911|9987261|FG003|STARTED|Period 2 Washout||4
8926018|NCT02263911|9987258|FG000|COMPLETED|Period 2 Washout||4
8926019|NCT02263911|9987259|FG001|COMPLETED|Period 2 Washout||4
8926020|NCT02263911|9987260|FG002|COMPLETED|Period 2 Washout||4
8926021|NCT02263911|9987261|FG003|COMPLETED|Period 2 Washout||4
8926022|NCT02263911|9987258|FG000|NOT COMPLETED|Period 2 Washout||0
8926023|NCT02263911|9987259|FG001|NOT COMPLETED|Period 2 Washout||0
8926024|NCT02263911|9987260|FG002|NOT COMPLETED|Period 2 Washout||0
8926025|NCT02263911|9987261|FG003|NOT COMPLETED|Period 2 Washout||0
8926026|NCT02263911|9987258|FG000|STARTED|Period 3||4
8926027|NCT02263911|9987259|FG001|STARTED|Period 3||4
8926028|NCT02263911|9987260|FG002|STARTED|Period 3||4
8926029|NCT02263911|9987261|FG003|STARTED|Period 3||4
8926030|NCT02263911|9987258|FG000|COMPLETED|Period 3||4
8926031|NCT02263911|9987259|FG001|COMPLETED|Period 3||4
8926032|NCT02263911|9987260|FG002|COMPLETED|Period 3||4
8926033|NCT02263911|9987261|FG003|COMPLETED|Period 3||4
8926034|NCT02263911|9987258|FG000|NOT COMPLETED|Period 3||0
8926035|NCT02263911|9987259|FG001|NOT COMPLETED|Period 3||0
8926036|NCT02263911|9987260|FG002|NOT COMPLETED|Period 3||0
8926037|NCT02263911|9987261|FG003|NOT COMPLETED|Period 3||0
8926038|NCT02263911|9987258|FG000|STARTED|Period 3 Washout||4
8926039|NCT02263911|9987259|FG001|STARTED|Period 3 Washout||4
8926040|NCT02263911|9987260|FG002|STARTED|Period 3 Washout||4
8926041|NCT02263911|9987261|FG003|STARTED|Period 3 Washout||4
8926042|NCT02263911|9987258|FG000|COMPLETED|Period 3 Washout||4
8926043|NCT02263911|9987259|FG001|COMPLETED|Period 3 Washout||4
8926044|NCT02263911|9987260|FG002|COMPLETED|Period 3 Washout||4
8926045|NCT02263911|9987261|FG003|COMPLETED|Period 3 Washout||4
8926046|NCT02263911|9987258|FG000|NOT COMPLETED|Period 3 Washout||0
8926047|NCT02263911|9987259|FG001|NOT COMPLETED|Period 3 Washout||0
8926048|NCT02263911|9987260|FG002|NOT COMPLETED|Period 3 Washout||0
8926049|NCT02263911|9987261|FG003|NOT COMPLETED|Period 3 Washout||0
8926050|NCT02263911|9987258|FG000|STARTED|Period 4||4
8697272|NCT00887224|9742998|FG000|STARTED|Between OLR and OLS Phases||752
8697273|NCT00887224|9742999|FG001|STARTED|Between OLR and OLS Phases||0
8811842|NCT01515696|9864784|FG001|COMPLETED|Overall Study||39
8811843|NCT01515696|9864783|FG000|NOT COMPLETED|Overall Study||8
8811844|NCT01515696|9864784|FG001|NOT COMPLETED|Overall Study||10
8811845|NCT01515865|9864790|FG000|STARTED|Part A (Open-label)||98
8811846|NCT01515865|9864791|FG001|STARTED|Part A (Open-label)||0
8811847|NCT01515865|9864792|FG002|STARTED|Part A (Open-label)||0
8811848|NCT01515865|9864790|FG000|COMPLETED|Part A (Open-label)||95
8811849|NCT01515865|9864791|FG001|COMPLETED|Part A (Open-label)||0
8811850|NCT01515865|9864792|FG002|COMPLETED|Part A (Open-label)||0
8811851|NCT01515865|9864790|FG000|NOT COMPLETED|Part A (Open-label)||3
8811852|NCT01515865|9864791|FG001|NOT COMPLETED|Part A (Open-label)||0
8811853|NCT01515865|9864792|FG002|NOT COMPLETED|Part A (Open-label)||0
8811854|NCT01515865|9864790|FG000|STARTED|Part B (Open-label)|Twenty-four subjects from Part A did not meet the criteria required to be enrolled into Part B.|71
8811855|NCT01515865|9864791|FG001|STARTED|Part B (Open-label)||0
8811856|NCT01515865|9864792|FG002|STARTED|Part B (Open-label)||0
8811857|NCT01515865|9864790|FG000|COMPLETED|Part B (Open-label)||69
8811858|NCT01515865|9864791|FG001|COMPLETED|Part B (Open-label)||0
8811859|NCT01515865|9864792|FG002|COMPLETED|Part B (Open-label)||0
8811860|NCT01515865|9864790|FG000|NOT COMPLETED|Part B (Open-label)||2
8811861|NCT01515865|9864791|FG001|NOT COMPLETED|Part B (Open-label)||0
8811862|NCT01515865|9864792|FG002|NOT COMPLETED|Part B (Open-label)||0
8811863|NCT01515865|9864790|FG000|STARTED|Part C (Randomized)||0
8811864|NCT01515865|9864791|FG001|STARTED|Part C (Randomized)|A total of two subjects from Part B did not meet the criteria required to be enrolled into Part C.|33
8811865|NCT01515865|9864792|FG002|STARTED|Part C (Randomized)||34
8811866|NCT01515865|9864790|FG000|COMPLETED|Part C (Randomized)||0
8811867|NCT01515865|9864791|FG001|COMPLETED|Part C (Randomized)||33
8811868|NCT01515865|9864792|FG002|COMPLETED|Part C (Randomized)||34
8811869|NCT01515865|9864790|FG000|NOT COMPLETED|Part C (Randomized)||0
8811870|NCT01515865|9864791|FG001|NOT COMPLETED|Part C (Randomized)||0
8811871|NCT01515865|9864792|FG002|NOT COMPLETED|Part C (Randomized)||0
8849173|NCT01738737|9904310|FG000|STARTED|Overall Study||29
8849174|NCT01738737|9904311|FG001|STARTED|Overall Study||29
8849175|NCT01738737|9904312|FG002|STARTED|Overall Study||29
8849176|NCT01738737|9904313|FG003|STARTED|Overall Study||29
8849177|NCT01738737|9904314|FG004|STARTED|Overall Study||29
8849178|NCT01738737|9904310|FG000|COMPLETED|Overall Study||25
8849179|NCT01738737|9904311|FG001|COMPLETED|Overall Study||25
8849180|NCT01738737|9904312|FG002|COMPLETED|Overall Study||25
8849181|NCT01738737|9904313|FG003|COMPLETED|Overall Study||25
8849182|NCT01738737|9904314|FG004|COMPLETED|Overall Study||25
8849183|NCT01738737|9904310|FG000|NOT COMPLETED|Overall Study||4
8849184|NCT01738737|9904311|FG001|NOT COMPLETED|Overall Study||4
8849185|NCT01738737|9904312|FG002|NOT COMPLETED|Overall Study||4
8849186|NCT01738737|9904313|FG003|NOT COMPLETED|Overall Study||4
8849187|NCT01738737|9904314|FG004|NOT COMPLETED|Overall Study||4
8849188|NCT01738750|9904328|FG000|STARTED|Overall Study||49
8849189|NCT01738750|9904329|FG001|STARTED|Overall Study||51
8849190|NCT01738750|9904328|FG000|COMPLETED|Overall Study||49
8849191|NCT01738750|9904329|FG001|COMPLETED|Overall Study||51
8849192|NCT01738750|9904328|FG000|NOT COMPLETED|Overall Study||0
8849193|NCT01738750|9904329|FG001|NOT COMPLETED|Overall Study||0
8849194|NCT01738919|9904339|FG000|STARTED|Overall Study||15
8849195|NCT01738919|9904340|FG001|STARTED|Overall Study||17
8849196|NCT01738919|9904339|FG000|COMPLETED|Overall Study||14
8849197|NCT01738919|9904340|FG001|COMPLETED|Overall Study||14
8849198|NCT01738919|9904339|FG000|NOT COMPLETED|Overall Study||1
8849199|NCT01738919|9904340|FG001|NOT COMPLETED|Overall Study||3
8849200|NCT01738971|9904351|FG000|STARTED|Overall Study|54 participants recruited to this arm|54
8849201|NCT01738971|9904352|FG001|STARTED|Overall Study|58 participants recruited to this arm|58
8849202|NCT01738971|9904353|FG002|STARTED|Overall Study|56 participants recruited to this arm|56
8926051|NCT02263911|9987259|FG001|STARTED|Period 4||4
8926052|NCT02263911|9987260|FG002|STARTED|Period 4||4
8926053|NCT02263911|9987261|FG003|STARTED|Period 4||4
8697274|NCT00887224|9743000|FG002|STARTED|Between OLR and OLS Phases||0
8697275|NCT00887224|9742998|FG000|COMPLETED|Between OLR and OLS Phases||659
8697276|NCT00887224|9742999|FG001|COMPLETED|Between OLR and OLS Phases||0
8697277|NCT00887224|9743000|FG002|COMPLETED|Between OLR and OLS Phases||0
8697278|NCT00887224|9742998|FG000|NOT COMPLETED|Between OLR and OLS Phases||93
8697279|NCT00887224|9742999|FG001|NOT COMPLETED|Between OLR and OLS Phases||0
8697280|NCT00887224|9743000|FG002|NOT COMPLETED|Between OLR and OLS Phases||0
8849203|NCT01738971|9904351|FG000|COMPLETED|Overall Study|35 participants successfully contacted to complete telephone follow-up at 6-8 weeks.|35
8850424|NCT01746420|9905636|FG000|STARTED|Overall Study||20
8926054|NCT02263911|9987258|FG000|COMPLETED|Period 4||4
8926055|NCT02263911|9987259|FG001|COMPLETED|Period 4||4
8697281|NCT00887224|9742998|FG000|STARTED|Open-label Stability (OLS) Phase||659
8697282|NCT00887224|9742999|FG001|STARTED|Open-label Stability (OLS) Phase||0
8697283|NCT00887224|9743000|FG002|STARTED|Open-label Stability (OLS) Phase||0
8697284|NCT00887224|9742998|FG000|COMPLETED|Open-label Stability (OLS) Phase||576
8697285|NCT00887224|9742999|FG001|COMPLETED|Open-label Stability (OLS) Phase||0
8697286|NCT00887224|9743000|FG002|COMPLETED|Open-label Stability (OLS) Phase||0
8697287|NCT00887224|9742998|FG000|NOT COMPLETED|Open-label Stability (OLS) Phase||83
8697288|NCT00887224|9742999|FG001|NOT COMPLETED|Open-label Stability (OLS) Phase||0
8697289|NCT00887224|9743000|FG002|NOT COMPLETED|Open-label Stability (OLS) Phase||0
8697290|NCT00887224|9742998|FG000|STARTED|Between OLS and DB Phases||576
8697291|NCT00887224|9742999|FG001|STARTED|Between OLS and DB Phases||0
8811872|NCT01515891|9864800|FG000|STARTED|Overall Study||4
8811873|NCT01515891|9864800|FG000|COMPLETED|Overall Study||4
8811874|NCT01515891|9864800|FG000|NOT COMPLETED|Overall Study||0
8811875|NCT01515943|9864807|FG000|STARTED|Overall Study||75
8811876|NCT01515943|9864808|FG001|STARTED|Overall Study||85
8811877|NCT01515943|9864809|FG002|STARTED|Overall Study||44
8811878|NCT01515943|9864807|FG000|COMPLETED|Overall Study||69
8811879|NCT01515943|9864808|FG001|COMPLETED|Overall Study||69
8811880|NCT01515943|9864809|FG002|COMPLETED|Overall Study||31
8811881|NCT01515943|9864807|FG000|NOT COMPLETED|Overall Study||6
8811882|NCT01515943|9864808|FG001|NOT COMPLETED|Overall Study||16
8811883|NCT01515943|9864809|FG002|NOT COMPLETED|Overall Study||13
8811884|NCT01515956|9864819|FG000|STARTED|Overall Study||15
8811885|NCT01515956|9864819|FG000|COMPLETED|Overall Study||15
8811886|NCT01515956|9864819|FG000|NOT COMPLETED|Overall Study||0
8811887|NCT01515995|9864826|FG000|STARTED|Overall Study||25
8811888|NCT01515995|9864827|FG001|STARTED|Overall Study||25
8811889|NCT01515995|9864826|FG000|COMPLETED|Overall Study||22
8811890|NCT01515995|9864827|FG001|COMPLETED|Overall Study||21
8811891|NCT01515995|9864826|FG000|NOT COMPLETED|Overall Study||3
8811892|NCT01515995|9864827|FG001|NOT COMPLETED|Overall Study||4
8811893|NCT01516008|9864836|FG000|STARTED|Overall Study||114
8811894|NCT01516008|9864837|FG001|STARTED|Overall Study||121
8811895|NCT01516008|9864838|FG002|STARTED|Overall Study||117
8811896|NCT01516008|9864836|FG000|COMPLETED|Overall Study||69
8811897|NCT01516008|9864837|FG001|COMPLETED|Overall Study||105
8811898|NCT01516008|9864838|FG002|COMPLETED|Overall Study||99
8811899|NCT01516008|9864836|FG000|NOT COMPLETED|Overall Study||45
8811900|NCT01516008|9864837|FG001|NOT COMPLETED|Overall Study||16
8811901|NCT01516008|9864838|FG002|NOT COMPLETED|Overall Study||18
8811902|NCT01516268|9864848|FG000|STARTED|Overall Study||25
8811903|NCT01516268|9864849|FG001|STARTED|Overall Study||25
8811904|NCT01516268|9864848|FG000|COMPLETED|Overall Study||25
8811905|NCT01516268|9864849|FG001|COMPLETED|Overall Study||25
8811906|NCT01516268|9864848|FG000|NOT COMPLETED|Overall Study||0
8811907|NCT01516268|9864849|FG001|NOT COMPLETED|Overall Study||0
8811908|NCT01516424|9864857|FG000|STARTED|Overall Study|the patient number of randomization for Blonanserin Group|131
8811909|NCT01516424|9864858|FG001|STARTED|Overall Study|the patient number of randomization for Risperidone Group|136
8811910|NCT01516424|9864857|FG000|COMPLETED|Overall Study||96
8811911|NCT01516424|9864858|FG001|COMPLETED|Overall Study||114
8811912|NCT01516424|9864857|FG000|NOT COMPLETED|Overall Study||35
8811913|NCT01516424|9864858|FG001|NOT COMPLETED|Overall Study||22
8811914|NCT01516437|9864868|FG000|STARTED|Overall Study||24
8811915|NCT01516437|9864869|FG001|STARTED|Overall Study||24
8811916|NCT01516437|9864870|FG002|STARTED|Overall Study||15
8811917|NCT01516437|9864871|FG003|STARTED|Overall Study||7
8811918|NCT01516437|9864868|FG000|COMPLETED|Overall Study||24
8811919|NCT01516437|9864869|FG001|COMPLETED|Overall Study||24
8811920|NCT01516437|9864870|FG002|COMPLETED|Overall Study||14
8811921|NCT01516437|9864871|FG003|COMPLETED|Overall Study||6
8811922|NCT01516437|9864868|FG000|NOT COMPLETED|Overall Study||0
8811923|NCT01516437|9864869|FG001|NOT COMPLETED|Overall Study||0
8811924|NCT01516437|9864870|FG002|NOT COMPLETED|Overall Study||1
8811925|NCT01516437|9864871|FG003|NOT COMPLETED|Overall Study||1
8811926|NCT01516632|9864885|FG000|STARTED|Overall Study||101
8811927|NCT01516632|9864886|FG001|STARTED|Overall Study||63
8811928|NCT01516632|9864885|FG000|COMPLETED|Overall Study||77
8811929|NCT01516632|9864886|FG001|COMPLETED|Overall Study||48
8811930|NCT01516632|9864885|FG000|NOT COMPLETED|Overall Study||24
8811931|NCT01516632|9864886|FG001|NOT COMPLETED|Overall Study||15
8811932|NCT01516684|9864896|FG000|STARTED|Overall Study|"Overall number of units (trials) was used for measuring results with 170 trials.~Trials were randomized for each arm, not participants"|
8811933|NCT01516684|9864897|FG001|STARTED|Overall Study|"Overall number of units (trials) was used for measuring results with 170 trials.~Trials were randomized for each arm, not participants"|
8811934|NCT01516684|9864896|FG000|COMPLETED|Overall Study|Trials were randomized for each arm, not participants|
8811935|NCT01516684|9864897|FG001|COMPLETED|Overall Study|"Overall number of units (trials) completed was 152~Trials were randomized for each arm, not participants"|
8811936|NCT01516684|9864896|FG000|NOT COMPLETED|Overall Study||
8811937|NCT01516684|9864897|FG001|NOT COMPLETED|Overall Study||
8811938|NCT01516736|9864907|FG000|STARTED|Overall Study||155
8697292|NCT00887224|9743000|FG002|STARTED|Between OLS and DB Phases||0
8811939|NCT01516736|9864908|FG001|STARTED|Overall Study||153
8697293|NCT00887224|9742998|FG000|COMPLETED|Between OLS and DB Phases||548
8697294|NCT00887224|9742999|FG001|COMPLETED|Between OLS and DB Phases||0
8811940|NCT01516736|9864907|FG000|COMPLETED|Overall Study||135
8811941|NCT01516736|9864908|FG001|COMPLETED|Overall Study||140
8811942|NCT01516736|9864907|FG000|NOT COMPLETED|Overall Study||20
8697295|NCT00887224|9743000|FG002|COMPLETED|Between OLS and DB Phases||0
8697296|NCT00887224|9742998|FG000|NOT COMPLETED|Between OLS and DB Phases||28
8926056|NCT02263911|9987260|FG002|COMPLETED|Period 4||4
8926057|NCT02263911|9987261|FG003|COMPLETED|Period 4||4
8926058|NCT02263911|9987258|FG000|NOT COMPLETED|Period 4||0
8926059|NCT02263911|9987259|FG001|NOT COMPLETED|Period 4||0
8926060|NCT02263911|9987260|FG002|NOT COMPLETED|Period 4||0
8926061|NCT02263911|9987261|FG003|NOT COMPLETED|Period 4||0
8926062|NCT02263911|9987258|FG000|STARTED|Period 4 Washout||4
8926063|NCT02263911|9987259|FG001|STARTED|Period 4 Washout||4
8926064|NCT02263911|9987260|FG002|STARTED|Period 4 Washout||4
8926065|NCT02263911|9987261|FG003|STARTED|Period 4 Washout||4
8926066|NCT02263911|9987258|FG000|COMPLETED|Period 4 Washout||4
8926067|NCT02263911|9987259|FG001|COMPLETED|Period 4 Washout||4
8926068|NCT02263911|9987260|FG002|COMPLETED|Period 4 Washout||4
8926069|NCT02263911|9987261|FG003|COMPLETED|Period 4 Washout||4
8926070|NCT02263911|9987258|FG000|NOT COMPLETED|Period 4 Washout||0
8926071|NCT02263911|9987259|FG001|NOT COMPLETED|Period 4 Washout||0
8926072|NCT02263911|9987260|FG002|NOT COMPLETED|Period 4 Washout||0
8926073|NCT02263911|9987261|FG003|NOT COMPLETED|Period 4 Washout||0
8926074|NCT02263911|9987258|FG000|STARTED|Period 5||4
8926075|NCT02263911|9987259|FG001|STARTED|Period 5||4
8926076|NCT02263911|9987260|FG002|STARTED|Period 5||4
9042228|NCT03379259|10102780|FG000|COMPLETED|Overall Study||2
9042229|NCT03379259|10102781|FG001|COMPLETED|Overall Study||2
8697297|NCT00887224|9742999|FG001|NOT COMPLETED|Between OLS and DB Phases||0
8926077|NCT02263911|9987261|FG003|STARTED|Period 5||4
8926078|NCT02263911|9987258|FG000|COMPLETED|Period 5||4
8926079|NCT02263911|9987259|FG001|COMPLETED|Period 5||4
8926080|NCT02263911|9987260|FG002|COMPLETED|Period 5||4
8926081|NCT02263911|9987261|FG003|COMPLETED|Period 5||4
8926082|NCT02263911|9987258|FG000|NOT COMPLETED|Period 5||0
8926083|NCT02263911|9987259|FG001|NOT COMPLETED|Period 5||0
9042230|NCT03379259|10102782|FG002|COMPLETED|Overall Study||3
9042231|NCT03379259|10102783|FG003|COMPLETED|Overall Study||0
9042232|NCT03379259|10102784|FG004|COMPLETED|Overall Study||3
9042233|NCT03379259|10102785|FG005|COMPLETED|Overall Study||5
9042234|NCT03379259|10102780|FG000|NOT COMPLETED|Overall Study||1
8697298|NCT00887224|9743000|FG002|NOT COMPLETED|Between OLS and DB Phases||0
8697299|NCT00887224|9742998|FG000|STARTED|OL Taper Phase / OL Follow Up|Could have entered 7-day taper period at any time during either the OLR phase or OLS phase.|307
8697300|NCT00887224|9742999|FG001|STARTED|OL Taper Phase / OL Follow Up||0
8697301|NCT00887224|9743000|FG002|STARTED|OL Taper Phase / OL Follow Up||0
8724287|NCT01025843|9771506|FG007|STARTED|Washout 4||2
8724288|NCT01025843|9771507|FG008|STARTED|Washout 4||2
8724289|NCT01025843|9771508|FG009|STARTED|Washout 4||2
8724290|NCT01025843|9771499|FG000|COMPLETED|Washout 4||2
8724291|NCT01025843|9771500|FG001|COMPLETED|Washout 4||2
8724292|NCT01025843|9771501|FG002|COMPLETED|Washout 4||1
8724293|NCT01025843|9771502|FG003|COMPLETED|Washout 4||1
8724294|NCT01025843|9771503|FG004|COMPLETED|Washout 4||2
8724295|NCT01025843|9771504|FG005|COMPLETED|Washout 4||2
8724296|NCT01025843|9771505|FG006|COMPLETED|Washout 4||2
8724297|NCT01025843|9771506|FG007|COMPLETED|Washout 4||2
8724298|NCT01025843|9771507|FG008|COMPLETED|Washout 4||2
8724299|NCT01025843|9771508|FG009|COMPLETED|Washout 4||2
8724300|NCT01025843|9771499|FG000|NOT COMPLETED|Washout 4||0
8724301|NCT01025843|9771500|FG001|NOT COMPLETED|Washout 4||0
8724302|NCT01025843|9771501|FG002|NOT COMPLETED|Washout 4||1
8724303|NCT01025843|9771502|FG003|NOT COMPLETED|Washout 4||1
8724304|NCT01025843|9771503|FG004|NOT COMPLETED|Washout 4||0
8724305|NCT01025843|9771504|FG005|NOT COMPLETED|Washout 4||0
8724306|NCT01025843|9771505|FG006|NOT COMPLETED|Washout 4||0
8724307|NCT01025843|9771506|FG007|NOT COMPLETED|Washout 4||0
8724308|NCT01025843|9771507|FG008|NOT COMPLETED|Washout 4||0
8724309|NCT01025843|9771508|FG009|NOT COMPLETED|Washout 4||0
8724310|NCT01025843|9771499|FG000|STARTED|Period 5||2
8724311|NCT01025843|9771500|FG001|STARTED|Period 5||2
8724312|NCT01025843|9771501|FG002|STARTED|Period 5||1
8724313|NCT01025843|9771502|FG003|STARTED|Period 5||1
8724314|NCT01025843|9771503|FG004|STARTED|Period 5||2
8724315|NCT01025843|9771504|FG005|STARTED|Period 5||2
8724316|NCT01025843|9771505|FG006|STARTED|Period 5||2
8724317|NCT01025843|9771506|FG007|STARTED|Period 5||2
8724318|NCT01025843|9771507|FG008|STARTED|Period 5||2
8724319|NCT01025843|9771508|FG009|STARTED|Period 5||2
8724320|NCT01025843|9771499|FG000|COMPLETED|Period 5||2
8724321|NCT01025843|9771500|FG001|COMPLETED|Period 5||2
8724322|NCT01025843|9771501|FG002|COMPLETED|Period 5||1
8724323|NCT01025843|9771502|FG003|COMPLETED|Period 5||1
8724324|NCT01025843|9771503|FG004|COMPLETED|Period 5||2
8724325|NCT01025843|9771504|FG005|COMPLETED|Period 5||2
8724326|NCT01025843|9771505|FG006|COMPLETED|Period 5||2
8724327|NCT01025843|9771506|FG007|COMPLETED|Period 5||2
8724328|NCT01025843|9771507|FG008|COMPLETED|Period 5||2
8724329|NCT01025843|9771508|FG009|COMPLETED|Period 5||2
8724330|NCT01025843|9771499|FG000|NOT COMPLETED|Period 5||0
8724331|NCT01025843|9771500|FG001|NOT COMPLETED|Period 5||0
8724332|NCT01025843|9771501|FG002|NOT COMPLETED|Period 5||0
8724333|NCT01025843|9771502|FG003|NOT COMPLETED|Period 5||0
8724334|NCT01025843|9771503|FG004|NOT COMPLETED|Period 5||0
8724335|NCT01025843|9771504|FG005|NOT COMPLETED|Period 5||0
8724336|NCT01025843|9771505|FG006|NOT COMPLETED|Period 5||0
8926084|NCT02263911|9987260|FG002|NOT COMPLETED|Period 5||0
8926085|NCT02263911|9987261|FG003|NOT COMPLETED|Period 5||0
8697302|NCT00887224|9742998|FG000|Discontinued Open-label Taper|OL Taper Phase / OL Follow Up|Could have discontinued at any time during OL taper phase or OL Follow-up (7 days after last dose).|144
8697303|NCT00887224|9742999|FG001|Discontinued Open-label Taper|OL Taper Phase / OL Follow Up||0
8697304|NCT00887224|9743000|FG002|Discontinued Open-label Taper|OL Taper Phase / OL Follow Up||0
8697305|NCT00887224|9742998|FG000|COMPLETED|OL Taper Phase / OL Follow Up||163
8697306|NCT00887224|9742999|FG001|COMPLETED|OL Taper Phase / OL Follow Up||0
8697307|NCT00887224|9743000|FG002|COMPLETED|OL Taper Phase / OL Follow Up||0
8697308|NCT00887224|9742998|FG000|NOT COMPLETED|OL Taper Phase / OL Follow Up||144
8697309|NCT00887224|9742999|FG001|NOT COMPLETED|OL Taper Phase / OL Follow Up||0
8697310|NCT00887224|9743000|FG002|NOT COMPLETED|OL Taper Phase / OL Follow Up||0
8697311|NCT00887224|9742998|FG000|STARTED|Double-blind (DB) Phase||0
8697312|NCT00887224|9742999|FG001|STARTED|Double-blind (DB) Phase|2 participants randomized in error to DB, then entered OL Taper; counted in OL Taper and DB phases.|276
8697313|NCT00887224|9743000|FG002|STARTED|Double-blind (DB) Phase||272
8697314|NCT00887224|9742998|FG000|COMPLETED|Double-blind (DB) Phase||0
8697315|NCT00887224|9742999|FG001|COMPLETED|Double-blind (DB) Phase||176
8697316|NCT00887224|9743000|FG002|COMPLETED|Double-blind (DB) Phase||210
8697317|NCT00887224|9742998|FG000|NOT COMPLETED|Double-blind (DB) Phase||0
8697318|NCT00887224|9742999|FG001|NOT COMPLETED|Double-blind (DB) Phase||100
8697319|NCT00887224|9743000|FG002|NOT COMPLETED|Double-blind (DB) Phase||62
8697320|NCT00887224|9742998|FG000|STARTED|DB Taper Phase / Post Study Follow Up||0
8697321|NCT00887224|9742999|FG001|STARTED|DB Taper Phase / Post Study Follow Up|Double-blind participants (DBp) could have entered 7-day taper period at any time during DB phase.|267
8697322|NCT00887224|9743000|FG002|STARTED|DB Taper Phase / Post Study Follow Up||265
8697323|NCT00887224|9742998|FG000|Did Not Enter DB Taper|DB Taper Phase / Post Study Follow Up||0
8697324|NCT00887224|9742999|FG001|Did Not Enter DB Taper|DB Taper Phase / Post Study Follow Up||9
8697325|NCT00887224|9743000|FG002|Did Not Enter DB Taper|DB Taper Phase / Post Study Follow Up||7
8697326|NCT00887224|9742998|FG000|Discontinued DB Taper|DB Taper Phase / Post Study Follow Up||0
8697327|NCT00887224|9742999|FG001|Discontinued DB Taper|DB Taper Phase / Post Study Follow Up|DBp could have discontinued at anytime during DB taper period or Follow-up (7 days after last dose).|41
8697328|NCT00887224|9743000|FG002|Discontinued DB Taper|DB Taper Phase / Post Study Follow Up||30
8697329|NCT00887224|9742998|FG000|COMPLETED|DB Taper Phase / Post Study Follow Up||0
8697330|NCT00887224|9742999|FG001|COMPLETED|DB Taper Phase / Post Study Follow Up||226
8697331|NCT00887224|9743000|FG002|COMPLETED|DB Taper Phase / Post Study Follow Up||235
8697332|NCT00887224|9742998|FG000|NOT COMPLETED|DB Taper Phase / Post Study Follow Up||0
8697333|NCT00887224|9742999|FG001|NOT COMPLETED|DB Taper Phase / Post Study Follow Up||41
8697334|NCT00887224|9743000|FG002|NOT COMPLETED|DB Taper Phase / Post Study Follow Up||30
8697335|NCT00887289|9743012|FG000|STARTED|Overall Study||1504
8697336|NCT00887289|9743012|FG000|COMPLETED|Overall Study||1409
8697337|NCT00887289|9743012|FG000|NOT COMPLETED|Overall Study||95
8697338|NCT00887341|9743018|FG000|STARTED|Overall Study||37
8697339|NCT00887341|9743019|FG001|STARTED|Overall Study||39
8697340|NCT00887341|9743018|FG000|COMPLETED|Overall Study||35
8697341|NCT00887341|9743019|FG001|COMPLETED|Overall Study||36
8697342|NCT00887341|9743018|FG000|NOT COMPLETED|Overall Study||2
8697343|NCT00887341|9743019|FG001|NOT COMPLETED|Overall Study||3
8697344|NCT00887354|9743027|FG000|STARTED|Treatment Phase (Week 0 to Week 26)||111
8697345|NCT00887354|9743028|FG001|STARTED|Treatment Phase (Week 0 to Week 26)||113
8697346|NCT00887354|9743027|FG000|Received at Least 1 Dose of Study Drug|Treatment Phase (Week 0 to Week 26)||106
8697347|NCT00887354|9743028|FG001|Received at Least 1 Dose of Study Drug|Treatment Phase (Week 0 to Week 26)||110
8697348|NCT00887354|9743027|FG000|Included in Full Analysis Set|Treatment Phase (Week 0 to Week 26)||86
8697349|NCT00887354|9743028|FG001|Included in Full Analysis Set|Treatment Phase (Week 0 to Week 26)||85
8697350|NCT00887354|9743027|FG000|COMPLETED|Treatment Phase (Week 0 to Week 26)||60
8697351|NCT00887354|9743028|FG001|COMPLETED|Treatment Phase (Week 0 to Week 26)||65
8697352|NCT00887354|9743027|FG000|NOT COMPLETED|Treatment Phase (Week 0 to Week 26)||51
8697353|NCT00887354|9743028|FG001|NOT COMPLETED|Treatment Phase (Week 0 to Week 26)||48
8697354|NCT00887354|9743027|FG000|STARTED|Open Label Phase (Week 26 to Week 78)||60
8697355|NCT00887354|9743028|FG001|STARTED|Open Label Phase (Week 26 to Week 78)||65
8697356|NCT00887354|9743027|FG000|COMPLETED|Open Label Phase (Week 26 to Week 78)||57
8697357|NCT00887354|9743028|FG001|COMPLETED|Open Label Phase (Week 26 to Week 78)||59
8697358|NCT00887354|9743027|FG000|NOT COMPLETED|Open Label Phase (Week 26 to Week 78)||3
8811943|NCT01516736|9864908|FG001|NOT COMPLETED|Overall Study||13
8811944|NCT01516749|9864914|FG000|STARTED|Active Therapy||6
8811945|NCT01516749|9864914|FG000|COMPLETED|Active Therapy||5
8811946|NCT01516749|9864914|FG000|NOT COMPLETED|Active Therapy||1
8811947|NCT01516749|9864914|FG000|STARTED|Follow-up Off Therapy||5
8811948|NCT01516749|9864914|FG000|COMPLETED|Follow-up Off Therapy||4
8811949|NCT01516749|9864914|FG000|NOT COMPLETED|Follow-up Off Therapy||1
8697359|NCT00887354|9743028|FG001|NOT COMPLETED|Open Label Phase (Week 26 to Week 78)||6
8697360|NCT00887432|9743037|FG000|STARTED|Overall Study||58
8697361|NCT00887432|9743038|FG001|STARTED|Overall Study||74
8697362|NCT00887432|9743037|FG000|COMPLETED|Overall Study||43
8697363|NCT00887432|9743038|FG001|COMPLETED|Overall Study||60
8811950|NCT01516879|9864920|FG000|STARTED|Overall Study||303
8926086|NCT02264249|9987278|FG000|STARTED|Overall Study||21
8926087|NCT02264249|9987279|FG001|STARTED|Overall Study||187
8926088|NCT02264249|9987280|FG002|STARTED|Overall Study||241
8926089|NCT02264249|9987278|FG000|COMPLETED|Overall Study||21
8697364|NCT00887432|9743037|FG000|NOT COMPLETED|Overall Study||15
8697365|NCT00887432|9743038|FG001|NOT COMPLETED|Overall Study||14
8697366|NCT00887458|9743046|FG000|STARTED|Overall Study||17
8697367|NCT00887458|9743047|FG001|STARTED|Overall Study||29
8697368|NCT00887458|9743046|FG000|COMPLETED|Overall Study||17
8697369|NCT00887458|9743047|FG001|COMPLETED|Overall Study||25
8697370|NCT00887458|9743046|FG000|NOT COMPLETED|Overall Study||0
8697371|NCT00887458|9743047|FG001|NOT COMPLETED|Overall Study||4
8697372|NCT00887471|9743057|FG000|STARTED|Overall Study||15
8697373|NCT00887471|9743058|FG001|STARTED|Overall Study||15
8697374|NCT00887471|9743057|FG000|COMPLETED|Overall Study||15
8697375|NCT00887471|9743058|FG001|COMPLETED|Overall Study||15
8697376|NCT00887471|9743057|FG000|NOT COMPLETED|Overall Study||0
8697377|NCT00887471|9743058|FG001|NOT COMPLETED|Overall Study||0
8697378|NCT00887484|9743064|FG000|STARTED|Split Face Treatment (Weeks 1 and 2)||48
8697379|NCT00887484|9743064|FG000|COMPLETED|Split Face Treatment (Weeks 1 and 2)||48
8697380|NCT00887484|9743064|FG000|NOT COMPLETED|Split Face Treatment (Weeks 1 and 2)||0
8697381|NCT00887484|9743064|FG000|STARTED|Full Face Treatment (Weeks 5 and 8)||48
8697382|NCT00887484|9743064|FG000|COMPLETED|Full Face Treatment (Weeks 5 and 8)||45
8697383|NCT00887484|9743064|FG000|NOT COMPLETED|Full Face Treatment (Weeks 5 and 8)||3
8697384|NCT00887510|9743075|FG000|STARTED|Overall Study||12
8697385|NCT00887510|9743076|FG001|STARTED|Overall Study||12
8697386|NCT00887510|9743075|FG000|COMPLETED|Overall Study||12
8697387|NCT00887510|9743076|FG001|COMPLETED|Overall Study||12
8697388|NCT00887510|9743075|FG000|NOT COMPLETED|Overall Study||0
8697389|NCT00887510|9743076|FG001|NOT COMPLETED|Overall Study||0
8697390|NCT00887549|9743082|FG000|STARTED|Induction Therapy||70
8697391|NCT00887549|9743082|FG000|COMPLETED|Induction Therapy||43
8697392|NCT00887549|9743082|FG000|NOT COMPLETED|Induction Therapy||27
8697393|NCT00887549|9743082|FG000|STARTED|Maintenance Therapy||43
8697394|NCT00887549|9743082|FG000|COMPLETED|Maintenance Therapy||0
8697395|NCT00887549|9743082|FG000|NOT COMPLETED|Maintenance Therapy||43
8697396|NCT00887562|9743089|FG000|STARTED|Overall Study||10
8697397|NCT00887562|9743090|FG001|STARTED|Overall Study||9
8697398|NCT00887562|9743091|FG002|STARTED|Overall Study||8
8697399|NCT00887562|9743089|FG000|COMPLETED|Overall Study||7
8697400|NCT00887562|9743090|FG001|COMPLETED|Overall Study||7
8697401|NCT00887562|9743091|FG002|COMPLETED|Overall Study||7
8697402|NCT00887562|9743089|FG000|NOT COMPLETED|Overall Study||3
8697403|NCT00887562|9743090|FG001|NOT COMPLETED|Overall Study||2
8697404|NCT00887562|9743091|FG002|NOT COMPLETED|Overall Study||1
8697405|NCT00887575|9743101|FG000|STARTED|Phase I||6
8697406|NCT00887575|9743102|FG001|STARTED|Phase I||6
8697407|NCT00887575|9743103|FG002|STARTED|Phase I||3
8697408|NCT00887575|9743101|FG000|COMPLETED|Phase I||6
8697409|NCT00887575|9743102|FG001|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
8697410|NCT00887575|9743103|FG002|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
8697411|NCT00887575|9743101|FG000|NOT COMPLETED|Phase I||0
8697412|NCT00887575|9743102|FG001|NOT COMPLETED|Phase I||6
8697413|NCT00887575|9743103|FG002|NOT COMPLETED|Phase I||3
8697414|NCT00887575|9743101|FG000|STARTED|Phase II - Neoadjuvant Therapy|Includes patients treated at MTD during Phase I, 39 additional patients enrolled, 4 were not treated|41
8697415|NCT00887575|9743102|FG001|STARTED|Phase II - Neoadjuvant Therapy||0
8697416|NCT00887575|9743103|FG002|STARTED|Phase II - Neoadjuvant Therapy||0
8697417|NCT00887575|9743101|FG000|COMPLETED|Phase II - Neoadjuvant Therapy||16
8697418|NCT00887575|9743102|FG001|COMPLETED|Phase II - Neoadjuvant Therapy||0
8697419|NCT00887575|9743103|FG002|COMPLETED|Phase II - Neoadjuvant Therapy||0
8697420|NCT00887575|9743101|FG000|NOT COMPLETED|Phase II - Neoadjuvant Therapy||25
8697421|NCT00887575|9743102|FG001|NOT COMPLETED|Phase II - Neoadjuvant Therapy||0
8697422|NCT00887575|9743103|FG002|NOT COMPLETED|Phase II - Neoadjuvant Therapy||0
8697423|NCT00887575|9743101|FG000|STARTED|Phase II - Maintenance Therapy|Pts who completed 6 cycles of Neoadjuvant Therapy & underwent surgery were eligible for maintenance|8
8697424|NCT00887575|9743102|FG001|STARTED|Phase II - Maintenance Therapy||0
8697425|NCT00887575|9743103|FG002|STARTED|Phase II - Maintenance Therapy||0
8697426|NCT00887575|9743101|FG000|COMPLETED|Phase II - Maintenance Therapy||6
8697427|NCT00887575|9743102|FG001|COMPLETED|Phase II - Maintenance Therapy||0
8697428|NCT00887575|9743103|FG002|COMPLETED|Phase II - Maintenance Therapy||0
8697429|NCT00887575|9743101|FG000|NOT COMPLETED|Phase II - Maintenance Therapy||2
8697430|NCT00887575|9743102|FG001|NOT COMPLETED|Phase II - Maintenance Therapy||0
8697431|NCT00887575|9743103|FG002|NOT COMPLETED|Phase II - Maintenance Therapy||0
8697432|NCT00887588|9743110|FG000|STARTED|Core Period||149
8697433|NCT00887588|9743111|FG001|STARTED|Core Period||152
8697434|NCT00887588|9743110|FG000|Extension Efficacy Set|Core Period||127
8697435|NCT00887588|9743111|FG001|Extension Efficacy Set|Core Period||125
8811951|NCT01516879|9864921|FG001|STARTED|Overall Study||602
8811952|NCT01516879|9864920|FG000|Received Treatment|Overall Study||302
8811953|NCT01516879|9864921|FG001|Received Treatment|Overall Study||599
8811954|NCT01516879|9864920|FG000|COMPLETED|Overall Study||287
8811955|NCT01516879|9864921|FG001|COMPLETED|Overall Study||568
8811956|NCT01516879|9864920|FG000|NOT COMPLETED|Overall Study||16
8811957|NCT01516879|9864921|FG001|NOT COMPLETED|Overall Study||34
8697436|NCT00887588|9743110|FG000|Full Analysis Set|Core Period||148
8811958|NCT01516892|9864927|FG000|STARTED|Overall Study||716
8697437|NCT00887588|9743111|FG001|Full Analysis Set|Core Period||146
8811959|NCT01516892|9864927|FG000|COMPLETED|Overall Study||373
8926090|NCT02264249|9987279|FG001|COMPLETED|Overall Study||187
8926091|NCT02264249|9987280|FG002|COMPLETED|Overall Study||241
8926092|NCT02264249|9987278|FG000|NOT COMPLETED|Overall Study||0
8926093|NCT02264249|9987279|FG001|NOT COMPLETED|Overall Study||0
9042235|NCT03379259|10102781|FG001|NOT COMPLETED|Overall Study||1
9042236|NCT03379259|10102782|FG002|NOT COMPLETED|Overall Study||3
8697438|NCT00887588|9743110|FG000|Arterial Stiffness Set|Core Period||86
8697439|NCT00887588|9743111|FG001|Arterial Stiffness Set|Core Period||94
8697440|NCT00887588|9743110|FG000|COMPLETED|Core Period||130
8697441|NCT00887588|9743111|FG001|COMPLETED|Core Period||131
8697442|NCT00887588|9743110|FG000|NOT COMPLETED|Core Period||19
8697443|NCT00887588|9743111|FG001|NOT COMPLETED|Core Period||21
8697444|NCT00887588|9743110|FG000|STARTED|Extension Period||127
8697445|NCT00887588|9743111|FG001|STARTED|Extension Period||125
8697446|NCT00887588|9743110|FG000|Arterial Stiffness Set|Extension Period||86
8697447|NCT00887588|9743111|FG001|Arterial Stiffness Set|Extension Period||94
8697448|NCT00887588|9743110|FG000|COMPLETED|Extension Period||121
8697449|NCT00887588|9743111|FG001|COMPLETED|Extension Period||120
8697450|NCT00887588|9743110|FG000|NOT COMPLETED|Extension Period||6
8697451|NCT00887588|9743111|FG001|NOT COMPLETED|Extension Period||5
8697452|NCT00887640|9743117|FG000|STARTED|Overall Study||11
8697453|NCT00887640|9743117|FG000|COMPLETED|Overall Study||11
8697454|NCT00887640|9743117|FG000|NOT COMPLETED|Overall Study||0
8697455|NCT00887653|9743121|FG000|STARTED|Overall Study||20
8697456|NCT00887653|9743121|FG000|COMPLETED|Overall Study||20
8697457|NCT00887653|9743121|FG000|NOT COMPLETED|Overall Study||0
8697458|NCT00887679|9743125|FG000|STARTED|Overall Study||30
8697459|NCT00887679|9743125|FG000|COMPLETED|Overall Study|20 subjects completed the study.|20
8697460|NCT00887679|9743125|FG000|NOT COMPLETED|Overall Study||10
8697461|NCT00887744|9743130|FG000|STARTED|Overall Study|162 patients signed an informed consent but only 157 patients were treated with the Aperius.|162
8697462|NCT00887744|9743130|FG000|COMPLETED|Overall Study||128
8697463|NCT00887744|9743130|FG000|NOT COMPLETED|Overall Study||34
8697464|NCT00887809|9743136|FG000|STARTED|Overall Study||37
8697465|NCT00887809|9743137|FG001|STARTED|Overall Study||10
8697466|NCT00887809|9743136|FG000|COMPLETED|Overall Study||33
8697467|NCT00887809|9743137|FG001|COMPLETED|Overall Study||10
8697468|NCT00887809|9743136|FG000|NOT COMPLETED|Overall Study||4
8697469|NCT00887809|9743137|FG001|NOT COMPLETED|Overall Study||0
8697470|NCT00887822|9743145|FG000|STARTED|Overall Study||100
8697471|NCT00887822|9743146|FG001|STARTED|Overall Study||102
8697472|NCT00887822|9743145|FG000|Treated (Safety Population)|Overall Study||100
8697473|NCT00887822|9743146|FG001|Treated (Safety Population)|Overall Study||101
8697474|NCT00887822|9743145|FG000|COMPLETED|Overall Study||3
8697475|NCT00887822|9743146|FG001|COMPLETED|Overall Study||0
8697476|NCT00887822|9743145|FG000|NOT COMPLETED|Overall Study||97
8697477|NCT00887822|9743146|FG001|NOT COMPLETED|Overall Study||102
8697478|NCT00887913|9743152|FG000|STARTED|Overall Study||69
8697479|NCT00887913|9743152|FG000|COMPLETED|Overall Study||63
8697480|NCT00887913|9743152|FG000|NOT COMPLETED|Overall Study||6
8697481|NCT00887926|9743160|FG000|STARTED|Overall Study||3
8697482|NCT00887926|9743161|FG001|STARTED|Overall Study||14
8697483|NCT00887926|9743162|FG002|STARTED|Overall Study||3
8697484|NCT00887926|9743163|FG003|STARTED|Overall Study||5
8697485|NCT00887926|9743160|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
8697486|NCT00887926|9743161|FG001|Received at Least 1 Dose of Study Drug|Overall Study||13
8811960|NCT01516892|9864927|FG000|NOT COMPLETED|Overall Study||343
8811961|NCT01516957|9864934|FG000|STARTED|Placebo-controlled Phase||55
8811962|NCT01516957|9864935|FG001|STARTED|Placebo-controlled Phase||57
8811963|NCT01516957|9864936|FG002|STARTED|Placebo-controlled Phase||56
8811964|NCT01516957|9864937|FG003|STARTED|Placebo-controlled Phase||0
8811965|NCT01516957|9864934|FG000|COMPLETED|Placebo-controlled Phase||52
8811966|NCT01516957|9864935|FG001|COMPLETED|Placebo-controlled Phase||53
8811967|NCT01516957|9864936|FG002|COMPLETED|Placebo-controlled Phase||51
8811968|NCT01516957|9864937|FG003|COMPLETED|Placebo-controlled Phase||0
8811969|NCT01516957|9864934|FG000|NOT COMPLETED|Placebo-controlled Phase||3
8811970|NCT01516957|9864935|FG001|NOT COMPLETED|Placebo-controlled Phase||4
8811971|NCT01516957|9864936|FG002|NOT COMPLETED|Placebo-controlled Phase||5
8811972|NCT01516957|9864937|FG003|NOT COMPLETED|Placebo-controlled Phase||0
8811973|NCT01516957|9864934|FG000|STARTED|Open-label Phase||0
8811974|NCT01516957|9864935|FG001|STARTED|Open-label Phase||0
8811975|NCT01516957|9864936|FG002|STARTED|Open-label Phase||0
8811976|NCT01516957|9864937|FG003|STARTED|Open-label Phase||156
8811977|NCT01516957|9864934|FG000|COMPLETED|Open-label Phase||0
8811978|NCT01516957|9864935|FG001|COMPLETED|Open-label Phase||0
8811979|NCT01516957|9864936|FG002|COMPLETED|Open-label Phase||0
8811980|NCT01516957|9864937|FG003|COMPLETED|Open-label Phase||0
8811981|NCT01516957|9864934|FG000|NOT COMPLETED|Open-label Phase||0
8811982|NCT01516957|9864935|FG001|NOT COMPLETED|Open-label Phase||0
8811983|NCT01516957|9864936|FG002|NOT COMPLETED|Open-label Phase||0
9042237|NCT03379259|10102783|FG003|NOT COMPLETED|Overall Study||3
9042238|NCT03379259|10102784|FG004|NOT COMPLETED|Overall Study||9
8697487|NCT00887926|9743162|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
8697488|NCT00887926|9743163|FG003|Received at Least 1 Dose of Study Drug|Overall Study||5
8697489|NCT00887926|9743160|FG000|COMPLETED|Overall Study||3
8697490|NCT00887926|9743161|FG001|COMPLETED|Overall Study||13
8697491|NCT00887926|9743162|FG002|COMPLETED|Overall Study||3
8811984|NCT01516957|9864937|FG003|NOT COMPLETED|Open-label Phase||156
8926094|NCT02264249|9987280|FG002|NOT COMPLETED|Overall Study||0
8926095|NCT02264353|9987288|FG000|STARTED|Overall Study||20
8926096|NCT02264353|9987289|FG001|STARTED|Overall Study||24
8926097|NCT02264353|9987288|FG000|COMPLETED|Overall Study||17
8926098|NCT02264353|9987289|FG001|COMPLETED|Overall Study||24
8926099|NCT02264353|9987288|FG000|NOT COMPLETED|Overall Study||3
9042239|NCT03379259|10102785|FG005|NOT COMPLETED|Overall Study||7
8697492|NCT00887926|9743163|FG003|COMPLETED|Overall Study||5
8697493|NCT00887926|9743160|FG000|NOT COMPLETED|Overall Study||0
8697494|NCT00887926|9743161|FG001|NOT COMPLETED|Overall Study||1
8697495|NCT00887926|9743162|FG002|NOT COMPLETED|Overall Study||0
8697496|NCT00887926|9743163|FG003|NOT COMPLETED|Overall Study||0
8697497|NCT00887965|9743175|FG000|STARTED|Overall Study||15
8697498|NCT00887965|9743175|FG000|COMPLETED|Overall Study||15
8697499|NCT00887965|9743175|FG000|NOT COMPLETED|Overall Study||0
8697500|NCT00887978|9743181|FG000|STARTED|Overall Study||157
8697501|NCT00887978|9743182|FG001|STARTED|Overall Study||153
8697502|NCT00887978|9743181|FG000|COMPLETED|Overall Study||132
8697503|NCT00887978|9743182|FG001|COMPLETED|Overall Study||138
8697504|NCT00887978|9743181|FG000|NOT COMPLETED|Overall Study||25
8697505|NCT00887978|9743182|FG001|NOT COMPLETED|Overall Study||15
8697506|NCT00888134|9743188|FG000|STARTED|Treatment With Study Drug||28
8697507|NCT00888134|9743188|FG000|COMPLETED|Treatment With Study Drug|21 had progressive disease; 5 had unacceptable toxicity; 1 finished treatment|27
8697508|NCT00888134|9743188|FG000|NOT COMPLETED|Treatment With Study Drug||1
8697509|NCT00888134|9743188|FG000|STARTED|Follow-up||27
8697510|NCT00888134|9743188|FG000|COMPLETED|Follow-up|23 died; 3 were lost-to-follow-up|26
8697511|NCT00888134|9743188|FG000|NOT COMPLETED|Follow-up||1
8697512|NCT00888173|9743193|FG000|STARTED|Overall Study||45
8697513|NCT00888173|9743193|FG000|COMPLETED|Overall Study||43
8697514|NCT00888173|9743193|FG000|NOT COMPLETED|Overall Study||2
8697515|NCT00888238|9743197|FG000|STARTED|First Period of Treatment Intervention||4
8697516|NCT00888238|9743198|FG001|STARTED|First Period of Treatment Intervention||4
8697517|NCT00888238|9743199|FG002|STARTED|First Period of Treatment Intervention||4
8697518|NCT00888238|9743197|FG000|COMPLETED|First Period of Treatment Intervention||4
8697519|NCT00888238|9743198|FG001|COMPLETED|First Period of Treatment Intervention||4
8697520|NCT00888238|9743199|FG002|COMPLETED|First Period of Treatment Intervention||4
8697521|NCT00888238|9743197|FG000|NOT COMPLETED|First Period of Treatment Intervention||0
8697522|NCT00888238|9743198|FG001|NOT COMPLETED|First Period of Treatment Intervention||0
8697523|NCT00888238|9743199|FG002|NOT COMPLETED|First Period of Treatment Intervention||0
8697524|NCT00888238|9743197|FG000|STARTED|Washout Period After Period 1||4
8697525|NCT00888238|9743198|FG001|STARTED|Washout Period After Period 1||4
8697526|NCT00888238|9743199|FG002|STARTED|Washout Period After Period 1||4
8697527|NCT00888238|9743197|FG000|COMPLETED|Washout Period After Period 1||4
8697528|NCT00888238|9743198|FG001|COMPLETED|Washout Period After Period 1||4
8697529|NCT00888238|9743199|FG002|COMPLETED|Washout Period After Period 1||4
8697530|NCT00888238|9743197|FG000|NOT COMPLETED|Washout Period After Period 1||0
8697531|NCT00888238|9743198|FG001|NOT COMPLETED|Washout Period After Period 1||0
8697532|NCT00888238|9743199|FG002|NOT COMPLETED|Washout Period After Period 1||0
8697533|NCT00888238|9743197|FG000|STARTED|Second Period of Treatment Intervention||4
8697534|NCT00888238|9743198|FG001|STARTED|Second Period of Treatment Intervention||4
8697535|NCT00888238|9743199|FG002|STARTED|Second Period of Treatment Intervention||4
8697536|NCT00888238|9743197|FG000|COMPLETED|Second Period of Treatment Intervention||4
8697537|NCT00888238|9743198|FG001|COMPLETED|Second Period of Treatment Intervention||4
8697538|NCT00888238|9743199|FG002|COMPLETED|Second Period of Treatment Intervention||4
8697539|NCT00888238|9743197|FG000|NOT COMPLETED|Second Period of Treatment Intervention||0
8697540|NCT00888238|9743198|FG001|NOT COMPLETED|Second Period of Treatment Intervention||0
8697541|NCT00888238|9743199|FG002|NOT COMPLETED|Second Period of Treatment Intervention||0
8697542|NCT00888238|9743197|FG000|STARTED|Washout Period After Period 2||4
8697543|NCT00888238|9743198|FG001|STARTED|Washout Period After Period 2||4
8697544|NCT00888238|9743199|FG002|STARTED|Washout Period After Period 2||4
8697545|NCT00888238|9743197|FG000|COMPLETED|Washout Period After Period 2||4
8697546|NCT00888238|9743198|FG001|COMPLETED|Washout Period After Period 2||4
8697547|NCT00888238|9743199|FG002|COMPLETED|Washout Period After Period 2||3
8697548|NCT00888238|9743197|FG000|NOT COMPLETED|Washout Period After Period 2||0
8697549|NCT00888238|9743198|FG001|NOT COMPLETED|Washout Period After Period 2||0
8697550|NCT00888238|9743199|FG002|NOT COMPLETED|Washout Period After Period 2||1
8697551|NCT00888238|9743197|FG000|STARTED|Third Period of Treatment Intervention||4
8697552|NCT00888238|9743198|FG001|STARTED|Third Period of Treatment Intervention||4
8697553|NCT00888238|9743199|FG002|STARTED|Third Period of Treatment Intervention||3
8697554|NCT00888238|9743197|FG000|COMPLETED|Third Period of Treatment Intervention||4
8697555|NCT00888238|9743198|FG001|COMPLETED|Third Period of Treatment Intervention||4
8697556|NCT00888238|9743199|FG002|COMPLETED|Third Period of Treatment Intervention||3
8697557|NCT00888238|9743197|FG000|NOT COMPLETED|Third Period of Treatment Intervention||0
8697558|NCT00888238|9743198|FG001|NOT COMPLETED|Third Period of Treatment Intervention||0
8697559|NCT00888238|9743199|FG002|NOT COMPLETED|Third Period of Treatment Intervention||0
8697560|NCT00888329|9743207|FG000|STARTED|Overall Study||125
8926100|NCT02264353|9987289|FG001|NOT COMPLETED|Overall Study||0
8926101|NCT02264574|9987297|FG000|STARTED|Overall Study||113
8926102|NCT02264574|9987298|FG001|STARTED|Overall Study||116
8926103|NCT02264574|9987297|FG000|COMPLETED|Overall Study||84
9042240|NCT03379376|10102802|FG000|STARTED|Overall Study||10
8926104|NCT02264574|9987298|FG001|COMPLETED|Overall Study||86
8926105|NCT02264574|9987297|FG000|NOT COMPLETED|Overall Study||29
8926106|NCT02264574|9987298|FG001|NOT COMPLETED|Overall Study||30
8926107|NCT02264639|9987309|FG000|STARTED|Overall Study|Subjects in this arm participated in Cohort 1 only.|2
8926108|NCT02264639|9987310|FG001|STARTED|Overall Study|Subject in this arm participated in Cohort 2 only.|1
8926109|NCT02264639|9987311|FG002|STARTED|Overall Study|Subject in this arm participated in Cohorts 2, 3 and 4.|1
8926110|NCT02264639|9987312|FG003|STARTED|Overall Study|Subject in this arm participated in Cohorts 3 and 4; single-dose phase was not applicable.|1
8926111|NCT02264639|9987313|FG004|STARTED|Overall Study|Subjects in this arm participated in Cohort 4 only; single-dose phase was not applicable.|4
8926112|NCT02264639|9987309|FG000|COMPLETED|Overall Study||0
8926113|NCT02264639|9987310|FG001|COMPLETED|Overall Study||1
8926114|NCT02264639|9987311|FG002|COMPLETED|Overall Study||0
8926115|NCT02264639|9987312|FG003|COMPLETED|Overall Study||1
8926116|NCT02264639|9987313|FG004|COMPLETED|Overall Study||3
8926117|NCT02264639|9987309|FG000|NOT COMPLETED|Overall Study||2
8926118|NCT02264639|9987310|FG001|NOT COMPLETED|Overall Study||0
8926119|NCT02264639|9987311|FG002|NOT COMPLETED|Overall Study||1
8926120|NCT02264639|9987312|FG003|NOT COMPLETED|Overall Study||0
8926121|NCT02264639|9987313|FG004|NOT COMPLETED|Overall Study||1
8926122|NCT02264821|9987331|FG000|STARTED|Overall Study|Double Blind|64
8926123|NCT02264821|9987332|FG001|STARTED|Overall Study|Double Blind|64
8926124|NCT02264821|9987333|FG002|STARTED|Overall Study|Double Blind|64
8926125|NCT02264821|9987331|FG000|COMPLETED|Overall Study||63
8926126|NCT02264821|9987332|FG001|COMPLETED|Overall Study||61
8926127|NCT02264821|9987333|FG002|COMPLETED|Overall Study||58
8926128|NCT02264821|9987331|FG000|NOT COMPLETED|Overall Study||1
8926129|NCT02264821|9987332|FG001|NOT COMPLETED|Overall Study||3
8926130|NCT02264821|9987333|FG002|NOT COMPLETED|Overall Study||6
8926131|NCT02264990|9987343|FG000|STARTED|Overall Study||297
8926132|NCT02264990|9987344|FG001|STARTED|Overall Study||298
8926133|NCT02264990|9987343|FG000|Received Treatment|Overall Study||288
8926134|NCT02264990|9987344|FG001|Received Treatment|Overall Study||293
8926135|NCT02264990|9987343|FG000|Received Maintenance Therapy|Overall Study||148
8926136|NCT02264990|9987344|FG001|Received Maintenance Therapy|Overall Study||123
8926137|NCT02264990|9987343|FG000|COMPLETED|Overall Study||37
8926138|NCT02264990|9987344|FG001|COMPLETED|Overall Study||39
8926139|NCT02264990|9987343|FG000|NOT COMPLETED|Overall Study||260
8926140|NCT02264990|9987344|FG001|NOT COMPLETED|Overall Study||259
8926141|NCT02265224|9987351|FG000|STARTED|Overall Study||48
8926142|NCT02265224|9987351|FG000|COMPLETED|Overall Study||48
8926143|NCT02265224|9987351|FG000|NOT COMPLETED|Overall Study||0
8926144|NCT02265237|9987362|FG000|STARTED|As Enrolled (Overall Study)||59
8926145|NCT02265237|9987363|FG001|STARTED|As Enrolled (Overall Study)||61
8926146|NCT02265237|9987364|FG002|STARTED|As Enrolled (Overall Study)||61
8926147|NCT02265237|9987365|FG003|STARTED|As Enrolled (Overall Study)||3
8926148|NCT02265237|9987362|FG000|COMPLETED|As Enrolled (Overall Study)||54
8926149|NCT02265237|9987363|FG001|COMPLETED|As Enrolled (Overall Study)||58
8926150|NCT02265237|9987364|FG002|COMPLETED|As Enrolled (Overall Study)||51
8926151|NCT02265237|9987365|FG003|COMPLETED|As Enrolled (Overall Study)||2
8697561|NCT00888329|9743208|FG001|STARTED|Overall Study||131
8697562|NCT00888329|9743207|FG000|COMPLETED|Overall Study||119
8697563|NCT00888329|9743208|FG001|COMPLETED|Overall Study||122
8697564|NCT00888329|9743207|FG000|NOT COMPLETED|Overall Study||6
8697565|NCT00888329|9743208|FG001|NOT COMPLETED|Overall Study||9
8697566|NCT00888381|9743216|FG000|STARTED|Overall Study||60
8697567|NCT00888381|9743217|FG001|STARTED|Overall Study||60
8697568|NCT00888381|9743216|FG000|COMPLETED|Overall Study||60
8697569|NCT00888381|9743217|FG001|COMPLETED|Overall Study||59
8697570|NCT00888381|9743216|FG000|NOT COMPLETED|Overall Study||0
8697571|NCT00888381|9743217|FG001|NOT COMPLETED|Overall Study||1
8811985|NCT01516970|9864948|FG000|STARTED|Overall Study||159
8811986|NCT01516970|9864949|FG001|STARTED|Overall Study||153
8811987|NCT01516970|9864948|FG000|COMPLETED|Overall Study||141
8811988|NCT01516970|9864949|FG001|COMPLETED|Overall Study||132
8811989|NCT01516970|9864948|FG000|NOT COMPLETED|Overall Study||18
8811990|NCT01516970|9864949|FG001|NOT COMPLETED|Overall Study||21
8811991|NCT01517074|9864955|FG000|STARTED|Overall Study||5
8811992|NCT01517074|9864955|FG000|COMPLETED|Overall Study||5
8811993|NCT01517074|9864955|FG000|NOT COMPLETED|Overall Study||0
8811994|NCT01517178|9864964|FG000|STARTED|Period 1|One subject (who discontinued due to an adverse event) actually used New ostomy base plate.|16
8811995|NCT01517178|9864965|FG001|STARTED|Period 1||11
8811996|NCT01517178|9864964|FG000|COMPLETED|Period 1||12
8811997|NCT01517178|9864965|FG001|COMPLETED|Period 1||6
8811998|NCT01517178|9864964|FG000|NOT COMPLETED|Period 1||4
8811999|NCT01517178|9864965|FG001|NOT COMPLETED|Period 1||5
8812000|NCT01517178|9864964|FG000|STARTED|Period 2|One subject discontinued during run-in and did not start period 2.|11
8812001|NCT01517178|9864965|FG001|STARTED|Period 2||6
8812002|NCT01517178|9864964|FG000|COMPLETED|Period 2||5
8812003|NCT01517178|9864965|FG001|COMPLETED|Period 2||4
8926152|NCT02265237|9987362|FG000|NOT COMPLETED|As Enrolled (Overall Study)||5
8926153|NCT02265237|9987363|FG001|NOT COMPLETED|As Enrolled (Overall Study)||3
8697572|NCT00888433|9743225|FG000|STARTED|Overall Study||52
8697573|NCT00888433|9743226|FG001|STARTED|Overall Study||54
8812004|NCT01517178|9864964|FG000|NOT COMPLETED|Period 2||6
8697574|NCT00888433|9743225|FG000|COMPLETED|Overall Study||49
8812005|NCT01517178|9864965|FG001|NOT COMPLETED|Period 2||2
8697575|NCT00888433|9743226|FG001|COMPLETED|Overall Study||51
8926154|NCT02265237|9987364|FG002|NOT COMPLETED|As Enrolled (Overall Study)||10
8926155|NCT02265237|9987365|FG003|NOT COMPLETED|As Enrolled (Overall Study)||1
8926156|NCT02265237|9987362|FG000|STARTED|As Treated (Overall Study)|One arm B subject received the drug for the duration for arm A and was included in arm A for safety.|60
8926157|NCT02265237|9987363|FG001|STARTED|As Treated (Overall Study)|One arm B subject received the drug for the duration for arm A and was included in arm A for safety.|60
8926158|NCT02265237|9987364|FG002|STARTED|As Treated (Overall Study)||61
8926159|NCT02265237|9987365|FG003|STARTED|As Treated (Overall Study)||3
8926160|NCT02265237|9987362|FG000|COMPLETED|As Treated (Overall Study)||55
8926161|NCT02265237|9987363|FG001|COMPLETED|As Treated (Overall Study)||57
8926162|NCT02265237|9987364|FG002|COMPLETED|As Treated (Overall Study)||51
8926163|NCT02265237|9987365|FG003|COMPLETED|As Treated (Overall Study)||2
8926164|NCT02265237|9987362|FG000|NOT COMPLETED|As Treated (Overall Study)||5
8926165|NCT02265237|9987363|FG001|NOT COMPLETED|As Treated (Overall Study)||3
8926166|NCT02265237|9987364|FG002|NOT COMPLETED|As Treated (Overall Study)||10
8926167|NCT02265237|9987365|FG003|NOT COMPLETED|As Treated (Overall Study)||1
8926168|NCT02265341|9987376|FG000|STARTED|Overall Study||12
8926169|NCT02265341|9987376|FG000|COMPLETED|Overall Study||12
8926170|NCT02265341|9987376|FG000|NOT COMPLETED|Overall Study||0
8926171|NCT02265510|9987394|FG000|STARTED|Overall Study||3
8926172|NCT02265510|9987395|FG001|STARTED|Overall Study||3
8926173|NCT02265510|9987396|FG002|STARTED|Overall Study||6
8926174|NCT02265510|9987397|FG003|STARTED|Overall Study||4
8926175|NCT02265510|9987398|FG004|STARTED|Overall Study||3
8926176|NCT02265510|9987399|FG005|STARTED|Overall Study||6
8926177|NCT02265510|9987400|FG006|STARTED|Overall Study||3
8926178|NCT02265510|9987401|FG007|STARTED|Overall Study||4
8926179|NCT02265510|9987402|FG008|STARTED|Overall Study||4
8926180|NCT02265510|9987403|FG009|STARTED|Overall Study||7
8926181|NCT02265510|9987404|FG010|STARTED|Overall Study||5
8926182|NCT02265510|9987405|FG011|STARTED|Overall Study||16
8926183|NCT02265510|9987406|FG012|STARTED|Overall Study||9
8926184|NCT02265510|9987407|FG013|STARTED|Overall Study||10
8926185|NCT02265510|9987394|FG000|COMPLETED|Overall Study||0
8926186|NCT02265510|9987395|FG001|COMPLETED|Overall Study||0
8926187|NCT02265510|9987396|FG002|COMPLETED|Overall Study||0
8926188|NCT02265510|9987397|FG003|COMPLETED|Overall Study||0
8926189|NCT02265510|9987398|FG004|COMPLETED|Overall Study||0
8926190|NCT02265510|9987399|FG005|COMPLETED|Overall Study||0
8926191|NCT02265510|9987400|FG006|COMPLETED|Overall Study||0
8926192|NCT02265510|9987401|FG007|COMPLETED|Overall Study||0
8812006|NCT01517282|9864975|FG000|STARTED|Overall Study|One patient was randomized but did not receive study medication based on the investigator's decision|9
8812007|NCT01517282|9864976|FG001|STARTED|Overall Study||8
8812008|NCT01517282|9864977|FG002|STARTED|Overall Study|1 patient completed the trial, but received only 4 doses of medication and 2 MRIs due to pregnancy|9
8812009|NCT01517282|9864978|FG003|STARTED|Overall Study||6
8812010|NCT01517282|9864975|FG000|COMPLETED|Overall Study||8
8926193|NCT02265510|9987402|FG008|COMPLETED|Overall Study||0
8926194|NCT02265510|9987403|FG009|COMPLETED|Overall Study||0
8926195|NCT02265510|9987404|FG010|COMPLETED|Overall Study||0
8926196|NCT02265510|9987405|FG011|COMPLETED|Overall Study||0
8926197|NCT02265510|9987406|FG012|COMPLETED|Overall Study||0
8926198|NCT02265510|9987407|FG013|COMPLETED|Overall Study||0
8926199|NCT02265510|9987394|FG000|NOT COMPLETED|Overall Study||3
8926200|NCT02265510|9987395|FG001|NOT COMPLETED|Overall Study||3
8926201|NCT02265510|9987396|FG002|NOT COMPLETED|Overall Study||6
8926202|NCT02265510|9987397|FG003|NOT COMPLETED|Overall Study||4
8926203|NCT02265510|9987398|FG004|NOT COMPLETED|Overall Study||3
8926204|NCT02265510|9987399|FG005|NOT COMPLETED|Overall Study||6
8926205|NCT02265510|9987400|FG006|NOT COMPLETED|Overall Study||3
8926206|NCT02265510|9987401|FG007|NOT COMPLETED|Overall Study||4
8926207|NCT02265510|9987402|FG008|NOT COMPLETED|Overall Study||4
8926208|NCT02265510|9987403|FG009|NOT COMPLETED|Overall Study||7
8926209|NCT02265510|9987404|FG010|NOT COMPLETED|Overall Study||5
8926210|NCT02265510|9987405|FG011|NOT COMPLETED|Overall Study||16
8926211|NCT02265510|9987406|FG012|NOT COMPLETED|Overall Study||9
8812011|NCT01517282|9864976|FG001|COMPLETED|Overall Study||7
8812012|NCT01517282|9864977|FG002|COMPLETED|Overall Study||8
8812013|NCT01517282|9864978|FG003|COMPLETED|Overall Study||5
8812014|NCT01517282|9864975|FG000|NOT COMPLETED|Overall Study||1
8812015|NCT01517282|9864976|FG001|NOT COMPLETED|Overall Study||1
8812016|NCT01517282|9864977|FG002|NOT COMPLETED|Overall Study||1
8812017|NCT01517282|9864978|FG003|NOT COMPLETED|Overall Study||1
8812018|NCT01517295|9864990|FG000|STARTED|Overall Study||16
8812019|NCT01517295|9864991|FG001|STARTED|Overall Study||14
8812020|NCT01517295|9864990|FG000|COMPLETED|Overall Study||15
8812021|NCT01517295|9864991|FG001|COMPLETED|Overall Study||14
8812022|NCT01517295|9864990|FG000|NOT COMPLETED|Overall Study||1
8812023|NCT01517295|9864991|FG001|NOT COMPLETED|Overall Study||0
8812024|NCT01517373|9865002|FG000|STARTED|Run-in Period||361
8812025|NCT01517373|9865003|FG001|STARTED|Run-in Period||0
8812026|NCT01517373|9865004|FG002|STARTED|Run-in Period||0
8812027|NCT01517373|9865005|FG003|STARTED|Run-in Period||0
8812028|NCT01517373|9865006|FG004|STARTED|Run-in Period||0
8812029|NCT01517373|9865007|FG005|STARTED|Run-in Period||0
8812030|NCT01517373|9865002|FG000|COMPLETED|Run-in Period||304
8812031|NCT01517373|9865003|FG001|COMPLETED|Run-in Period||0
8812032|NCT01517373|9865004|FG002|COMPLETED|Run-in Period||0
8812033|NCT01517373|9865005|FG003|COMPLETED|Run-in Period||0
8926212|NCT02265510|9987407|FG013|NOT COMPLETED|Overall Study||10
8926213|NCT02265705|9987465|FG000|STARTED|Treatment Period Week 0-24||145
8926214|NCT02265705|9987466|FG001|STARTED|Treatment Period Week 0-24||145
8926215|NCT02265705|9987467|FG002|STARTED|Treatment Period Week 0-24||0
8926216|NCT02265705|9987468|FG003|STARTED|Treatment Period Week 0-24||0
8926217|NCT02265705|9987469|FG004|STARTED|Treatment Period Week 0-24||0
8926218|NCT02265705|9987470|FG005|STARTED|Treatment Period Week 0-24||0
8926219|NCT02265705|9987471|FG006|STARTED|Treatment Period Week 0-24||0
8926220|NCT02265705|9987465|FG000|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||145
8926221|NCT02265705|9987466|FG001|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||145
8926222|NCT02265705|9987467|FG002|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0
8926223|NCT02265705|9987468|FG003|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0
8926224|NCT02265705|9987469|FG004|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0
8926225|NCT02265705|9987470|FG005|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0
8926226|NCT02265705|9987471|FG006|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0
8926227|NCT02265705|9987465|FG000|Rescued|Treatment Period Week 0-24||59
8926228|NCT02265705|9987466|FG001|Rescued|Treatment Period Week 0-24||17
8926229|NCT02265705|9987467|FG002|Rescued|Treatment Period Week 0-24||0
8926230|NCT02265705|9987468|FG003|Rescued|Treatment Period Week 0-24||0
8926231|NCT02265705|9987469|FG004|Rescued|Treatment Period Week 0-24||0
8926232|NCT02265705|9987470|FG005|Rescued|Treatment Period Week 0-24||0
8926233|NCT02265705|9987471|FG006|Rescued|Treatment Period Week 0-24||0
8926234|NCT02265705|9987465|FG000|COMPLETED|Treatment Period Week 0-24|"Completers include rescued participants."|133
8926235|NCT02265705|9987466|FG001|COMPLETED|Treatment Period Week 0-24|"Completers include rescued participants."|136
8926236|NCT02265705|9987467|FG002|COMPLETED|Treatment Period Week 0-24||0
8926237|NCT02265705|9987468|FG003|COMPLETED|Treatment Period Week 0-24||0
8926238|NCT02265705|9987469|FG004|COMPLETED|Treatment Period Week 0-24||0
8926239|NCT02265705|9987470|FG005|COMPLETED|Treatment Period Week 0-24||0
8926240|NCT02265705|9987471|FG006|COMPLETED|Treatment Period Week 0-24||0
8926241|NCT02265705|9987465|FG000|NOT COMPLETED|Treatment Period Week 0-24||12
8926242|NCT02265705|9987466|FG001|NOT COMPLETED|Treatment Period Week 0-24||9
8926243|NCT02265705|9987467|FG002|NOT COMPLETED|Treatment Period Week 0-24||0
8926244|NCT02265705|9987468|FG003|NOT COMPLETED|Treatment Period Week 0-24||0
8926245|NCT02265705|9987469|FG004|NOT COMPLETED|Treatment Period Week 0-24||0
8926246|NCT02265705|9987470|FG005|NOT COMPLETED|Treatment Period Week 0-24||0
8926247|NCT02265705|9987471|FG006|NOT COMPLETED|Treatment Period Week 0-24||0
8926248|NCT02265705|9987465|FG000|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
8926249|NCT02265705|9987466|FG001|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
8926250|NCT02265705|9987467|FG002|STARTED|Rescue Period|Participants who were determined to be nonresponders based on tender/swollen joint count.|77
8926251|NCT02265705|9987468|FG003|STARTED|Rescue Period||0
8926252|NCT02265705|9987469|FG004|STARTED|Rescue Period||0
8926253|NCT02265705|9987470|FG005|STARTED|Rescue Period||0
8926254|NCT02265705|9987471|FG006|STARTED|Rescue Period||0
8926255|NCT02265705|9987465|FG000|COMPLETED|Rescue Period||0
8926256|NCT02265705|9987466|FG001|COMPLETED|Rescue Period||0
8926257|NCT02265705|9987467|FG002|COMPLETED|Rescue Period||74
8926258|NCT02265705|9987468|FG003|COMPLETED|Rescue Period||0
8926259|NCT02265705|9987469|FG004|COMPLETED|Rescue Period||0
8926260|NCT02265705|9987470|FG005|COMPLETED|Rescue Period||0
8926261|NCT02265705|9987471|FG006|COMPLETED|Rescue Period||0
8926262|NCT02265705|9987465|FG000|NOT COMPLETED|Rescue Period||0
8926263|NCT02265705|9987466|FG001|NOT COMPLETED|Rescue Period||0
8926264|NCT02265705|9987467|FG002|NOT COMPLETED|Rescue Period||3
8926265|NCT02265705|9987468|FG003|NOT COMPLETED|Rescue Period||0
8926266|NCT02265705|9987469|FG004|NOT COMPLETED|Rescue Period||0
8926267|NCT02265705|9987470|FG005|NOT COMPLETED|Rescue Period||0
8926268|NCT02265705|9987471|FG006|NOT COMPLETED|Rescue Period||0
8926269|NCT02265705|9987465|FG000|STARTED|Open Label Period||0
8926270|NCT02265705|9987466|FG001|STARTED|Open Label Period||0
8926271|NCT02265705|9987467|FG002|STARTED|Open Label Period||0
8926272|NCT02265705|9987468|FG003|STARTED|Open Label Period|Completed Wk 24 w/o rescue Tx, switched to or remained on active Tx, and entered Open Label Period.|74
8926273|NCT02265705|9987469|FG004|STARTED|Open Label Period|Completed Wk 24 w/o rescue Tx, switched to or remained on active Tx, and entered Open Label Period.|120
8926274|NCT02265705|9987470|FG005|STARTED|Open Label Period||0
8926275|NCT02265705|9987471|FG006|STARTED|Open Label Period||0
8926276|NCT02265705|9987465|FG000|COMPLETED|Open Label Period||0
8926277|NCT02265705|9987466|FG001|COMPLETED|Open Label Period||0
8926278|NCT02265705|9987467|FG002|COMPLETED|Open Label Period||0
8926279|NCT02265705|9987468|FG003|COMPLETED|Open Label Period||72
8926280|NCT02265705|9987469|FG004|COMPLETED|Open Label Period||115
8926281|NCT02265705|9987470|FG005|COMPLETED|Open Label Period||0
8926282|NCT02265705|9987471|FG006|COMPLETED|Open Label Period||0
8926283|NCT02265705|9987465|FG000|NOT COMPLETED|Open Label Period||0
8926284|NCT02265705|9987466|FG001|NOT COMPLETED|Open Label Period||0
8926285|NCT02265705|9987467|FG002|NOT COMPLETED|Open Label Period||0
8926286|NCT02265705|9987468|FG003|NOT COMPLETED|Open Label Period||2
8926287|NCT02265705|9987469|FG004|NOT COMPLETED|Open Label Period||5
8926288|NCT02265705|9987470|FG005|NOT COMPLETED|Open Label Period||0
8926289|NCT02265705|9987471|FG006|NOT COMPLETED|Open Label Period||0
8926290|NCT02265705|9987465|FG000|STARTED|Follow-up Period||0
8926291|NCT02265705|9987466|FG001|STARTED|Follow-up Period||0
8926292|NCT02265705|9987467|FG002|STARTED|Follow-up Period||0
8926293|NCT02265705|9987468|FG003|STARTED|Follow-up Period||0
8926294|NCT02265705|9987469|FG004|STARTED|Follow-up Period||0
8926295|NCT02265705|9987470|FG005|STARTED|Follow-up Period|Participants from placebo who never rescued or switched and entered post-treatment follow-up period.|2
8926296|NCT02265705|9987471|FG006|STARTED|Follow-up Period|Participants who ever took baricitinib and entered the post-treatment follow-up period.|58
8926297|NCT02265705|9987465|FG000|COMPLETED|Follow-up Period||0
8926298|NCT02265705|9987466|FG001|COMPLETED|Follow-up Period||0
8926299|NCT02265705|9987467|FG002|COMPLETED|Follow-up Period||0
8926300|NCT02265705|9987468|FG003|COMPLETED|Follow-up Period||0
8926301|NCT02265705|9987469|FG004|COMPLETED|Follow-up Period||0
8926302|NCT02265705|9987470|FG005|COMPLETED|Follow-up Period||1
8926303|NCT02265705|9987471|FG006|COMPLETED|Follow-up Period||47
8926304|NCT02265705|9987465|FG000|NOT COMPLETED|Follow-up Period||0
8926305|NCT02265705|9987466|FG001|NOT COMPLETED|Follow-up Period||0
8926306|NCT02265705|9987467|FG002|NOT COMPLETED|Follow-up Period||0
8926307|NCT02265705|9987468|FG003|NOT COMPLETED|Follow-up Period||0
8926308|NCT02265705|9987469|FG004|NOT COMPLETED|Follow-up Period||0
8926309|NCT02265705|9987470|FG005|NOT COMPLETED|Follow-up Period||1
8926310|NCT02265705|9987471|FG006|NOT COMPLETED|Follow-up Period||11
8926311|NCT02265744|9987487|FG000|STARTED|Overall Study||69
8926312|NCT02265744|9987488|FG001|STARTED|Overall Study||68
8926313|NCT02265744|9987489|FG002|STARTED|Overall Study||68
8926314|NCT02265744|9987490|FG003|STARTED|Overall Study||70
8926315|NCT02265744|9987491|FG004|STARTED|Overall Study||71
8926316|NCT02265744|9987487|FG000|COMPLETED|Overall Study||49
8926317|NCT02265744|9987488|FG001|COMPLETED|Overall Study||53
8697576|NCT00888433|9743225|FG000|NOT COMPLETED|Overall Study||3
8697577|NCT00888433|9743226|FG001|NOT COMPLETED|Overall Study||3
8697578|NCT00888459|9743234|FG000|STARTED|Overall Study||30
8697579|NCT00888459|9743235|FG001|STARTED|Overall Study||30
8697580|NCT00888459|9743234|FG000|COMPLETED|Overall Study||30
8697581|NCT00888459|9743235|FG001|COMPLETED|Overall Study||30
8697582|NCT00888459|9743234|FG000|NOT COMPLETED|Overall Study||0
8697583|NCT00888459|9743235|FG001|NOT COMPLETED|Overall Study||0
8697584|NCT00888511|9743241|FG000|STARTED|Overall Study||15
8926318|NCT02265744|9987489|FG002|COMPLETED|Overall Study||51
8926319|NCT02265744|9987490|FG003|COMPLETED|Overall Study||47
8926320|NCT02265744|9987491|FG004|COMPLETED|Overall Study||58
8926321|NCT02265744|9987487|FG000|NOT COMPLETED|Overall Study||20
8926322|NCT02265744|9987488|FG001|NOT COMPLETED|Overall Study||15
8926323|NCT02265744|9987489|FG002|NOT COMPLETED|Overall Study||17
8926324|NCT02265744|9987490|FG003|NOT COMPLETED|Overall Study||23
8926325|NCT02265744|9987491|FG004|NOT COMPLETED|Overall Study||13
8926326|NCT02265783|9987503|FG000|STARTED|Overall Study||20
8926327|NCT02265783|9987503|FG000|COMPLETED|Overall Study|All subjects completed, one excluded from the analysis due to an issue with the data collection|20
8926328|NCT02265783|9987503|FG000|NOT COMPLETED|Overall Study||0
8926329|NCT02265796|9987509|FG000|STARTED|Overall Study||25
8926330|NCT02265796|9987510|FG001|STARTED|Overall Study||25
8926331|NCT02265796|9987509|FG000|COMPLETED|Overall Study||22
8926332|NCT02265796|9987510|FG001|COMPLETED|Overall Study||24
8926333|NCT02265796|9987509|FG000|NOT COMPLETED|Overall Study||3
8926334|NCT02265796|9987510|FG001|NOT COMPLETED|Overall Study||1
8926335|NCT02265848|9987518|FG000|STARTED|Overall Study|First subject for this study was randomized on October 1st 2014|11
8926336|NCT02265848|9987519|FG001|STARTED|Overall Study||11
8926337|NCT02265848|9987518|FG000|COMPLETED|Overall Study||11
8926338|NCT02265848|9987519|FG001|COMPLETED|Overall Study|Last subject for this study completed the visit on December 24, 2014|11
8926339|NCT02265848|9987518|FG000|NOT COMPLETED|Overall Study||0
8926340|NCT02265848|9987519|FG001|NOT COMPLETED|Overall Study||0
8926341|NCT02265913|9987528|FG000|STARTED|Overall Study||1357
8926342|NCT02265913|9987529|FG001|STARTED|Overall Study||1361
8926343|NCT02265913|9987530|FG002|STARTED|Overall Study||1358
8926344|NCT02265913|9987528|FG000|COMPLETED|Overall Study||793
8926345|NCT02265913|9987529|FG001|COMPLETED|Overall Study||810
8926346|NCT02265913|9987530|FG002|COMPLETED|Overall Study||813
8926347|NCT02265913|9987528|FG000|NOT COMPLETED|Overall Study||564
8926348|NCT02265913|9987529|FG001|NOT COMPLETED|Overall Study||551
8926349|NCT02265913|9987530|FG002|NOT COMPLETED|Overall Study||545
8926350|NCT02265952|9987538|FG000|STARTED|Main Study Period||9
8697585|NCT00888511|9743241|FG000|COMPLETED|Overall Study||15
8697586|NCT00888511|9743241|FG000|NOT COMPLETED|Overall Study||0
8697587|NCT00888615|9743245|FG000|STARTED|Overall Study||58
8697588|NCT00888615|9743245|FG000|COMPLETED|Overall Study||56
8697589|NCT00888615|9743245|FG000|NOT COMPLETED|Overall Study||2
8697590|NCT00888628|9743249|FG000|STARTED|Overall Study||7
8697591|NCT00888628|9743249|FG000|Enrolled|Overall Study||7
8697592|NCT00888628|9743249|FG000|Screen Failure|Overall Study||2
8697593|NCT00888628|9743249|FG000|Withdrawn|Overall Study||1
8697594|NCT00888628|9743249|FG000|Transplanted|Overall Study||4
8697595|NCT00888628|9743249|FG000|COMPLETED|Overall Study||4
8697596|NCT00888628|9743249|FG000|NOT COMPLETED|Overall Study||3
8724337|NCT01025843|9771506|FG007|NOT COMPLETED|Period 5||0
8724338|NCT01025843|9771507|FG008|NOT COMPLETED|Period 5||0
8724339|NCT01025843|9771508|FG009|NOT COMPLETED|Period 5||0
8724340|NCT01026012|9771536|FG000|STARTED|Overall Study||40
8724341|NCT01026012|9771536|FG000|COMPLETED|Overall Study||40
8724342|NCT01026012|9771536|FG000|NOT COMPLETED|Overall Study||0
8926351|NCT02265952|9987539|FG001|STARTED|Main Study Period||0
8926352|NCT02265952|9987538|FG000|COMPLETED|Main Study Period||9
8926353|NCT02265952|9987539|FG001|COMPLETED|Main Study Period||0
8926354|NCT02265952|9987538|FG000|NOT COMPLETED|Main Study Period||0
8926355|NCT02265952|9987539|FG001|NOT COMPLETED|Main Study Period||0
8926356|NCT02265952|9987538|FG000|STARTED|Open Label Extension (OLE) Period||0
8926357|NCT02265952|9987539|FG001|STARTED|Open Label Extension (OLE) Period||8
8926358|NCT02265952|9987538|FG000|COMPLETED|Open Label Extension (OLE) Period||0
8926359|NCT02265952|9987539|FG001|COMPLETED|Open Label Extension (OLE) Period||0
8926360|NCT02265952|9987538|FG000|NOT COMPLETED|Open Label Extension (OLE) Period||0
8926361|NCT02265952|9987539|FG001|NOT COMPLETED|Open Label Extension (OLE) Period||8
8926362|NCT02265965|9987547|FG000|STARTED|Overall Study||7
8926363|NCT02265965|9987548|FG001|STARTED|Overall Study||11
8926364|NCT02265965|9987547|FG000|COMPLETED|Overall Study||7
8926365|NCT02265965|9987548|FG001|COMPLETED|Overall Study||11
8926366|NCT02265965|9987547|FG000|NOT COMPLETED|Overall Study||0
8926367|NCT02265965|9987548|FG001|NOT COMPLETED|Overall Study||0
9042241|NCT03379376|10102802|FG000|COMPLETED|Overall Study||5
9042242|NCT03379376|10102802|FG000|NOT COMPLETED|Overall Study||5
9042243|NCT03379506|10102810|FG000|STARTED|Overall Study||22
9042244|NCT03379506|10102811|FG001|STARTED|Overall Study||17
9042245|NCT03379506|10102812|FG002|STARTED|Overall Study||7
9042246|NCT03379506|10102813|FG003|STARTED|Overall Study||11
9042247|NCT03379506|10102810|FG000|COMPLETED|Overall Study||22
9042248|NCT03379506|10102811|FG001|COMPLETED|Overall Study||17
9042249|NCT03379506|10102812|FG002|COMPLETED|Overall Study||7
9042250|NCT03379506|10102813|FG003|COMPLETED|Overall Study||11
8697597|NCT00888654|9743253|FG000|STARTED|Overall Study||41
8697598|NCT00888654|9743253|FG000|COMPLETED|Overall Study||31
8812034|NCT01517373|9865006|FG004|COMPLETED|Run-in Period||0
8812035|NCT01517373|9865007|FG005|COMPLETED|Run-in Period||0
8812036|NCT01517373|9865002|FG000|NOT COMPLETED|Run-in Period||57
8812037|NCT01517373|9865003|FG001|NOT COMPLETED|Run-in Period||0
9042251|NCT03379506|10102810|FG000|NOT COMPLETED|Overall Study||0
9042252|NCT03379506|10102811|FG001|NOT COMPLETED|Overall Study||0
9042253|NCT03379506|10102812|FG002|NOT COMPLETED|Overall Study||0
9042254|NCT03379506|10102813|FG003|NOT COMPLETED|Overall Study||0
8697599|NCT00888654|9743253|FG000|NOT COMPLETED|Overall Study||10
8697600|NCT00888849|9743259|FG000|STARTED|Overall Study||142
8697601|NCT00888849|9743260|FG001|STARTED|Overall Study||138
8697602|NCT00888849|9743259|FG000|COMPLETED|Overall Study||137
8697603|NCT00888849|9743260|FG001|COMPLETED|Overall Study||129
8697604|NCT00888849|9743259|FG000|NOT COMPLETED|Overall Study||5
8697605|NCT00888849|9743260|FG001|NOT COMPLETED|Overall Study||9
8697606|NCT00888927|9743270|FG000|STARTED|Overall Study||3
8697607|NCT00888927|9743271|FG001|STARTED|Overall Study||3
8697608|NCT00888927|9743272|FG002|STARTED|Overall Study||3
8697609|NCT00888927|9743273|FG003|STARTED|Overall Study||33
8697610|NCT00888927|9743270|FG000|COMPLETED|Overall Study||3
8697611|NCT00888927|9743271|FG001|COMPLETED|Overall Study||3
8697612|NCT00888927|9743272|FG002|COMPLETED|Overall Study||3
8697613|NCT00888927|9743273|FG003|COMPLETED|Overall Study||31
8697614|NCT00888927|9743270|FG000|NOT COMPLETED|Overall Study||0
8697615|NCT00888927|9743271|FG001|NOT COMPLETED|Overall Study||0
8697616|NCT00888927|9743272|FG002|NOT COMPLETED|Overall Study||0
8697617|NCT00888927|9743273|FG003|NOT COMPLETED|Overall Study||2
8697618|NCT00888940|9743285|FG000|STARTED|Overall Study||120
8697619|NCT00888940|9743286|FG001|STARTED|Overall Study||122
8697620|NCT00888940|9743285|FG000|Completed Therapy|Overall Study||107
8697621|NCT00888940|9743286|FG001|Completed Therapy|Overall Study||106
8697622|NCT00888940|9743285|FG000|COMPLETED|Overall Study||92
8697623|NCT00888940|9743286|FG001|COMPLETED|Overall Study||101
8697624|NCT00888940|9743285|FG000|NOT COMPLETED|Overall Study||28
8697625|NCT00888940|9743286|FG001|NOT COMPLETED|Overall Study||21
8697626|NCT00888979|9743292|FG000|STARTED|Overall Study||10
8697627|NCT00888979|9743292|FG000|Received the Inhaler/Counseling|Overall Study||8
8697628|NCT00888979|9743292|FG000|COMPLETED|Overall Study||6
8697629|NCT00888979|9743292|FG000|NOT COMPLETED|Overall Study||4
8697630|NCT00889005|9743298|FG000|STARTED|Overall Study||65
8697631|NCT00889005|9743299|FG001|STARTED|Overall Study||74
8697632|NCT00889005|9743298|FG000|COMPLETED|Overall Study||57
8697633|NCT00889005|9743299|FG001|COMPLETED|Overall Study||72
8812038|NCT01517373|9865004|FG002|NOT COMPLETED|Run-in Period||0
8812039|NCT01517373|9865005|FG003|NOT COMPLETED|Run-in Period||0
8812040|NCT01517373|9865006|FG004|NOT COMPLETED|Run-in Period||0
8812041|NCT01517373|9865007|FG005|NOT COMPLETED|Run-in Period||0
8812042|NCT01517373|9865002|FG000|STARTED|Treatment Period||0
8812043|NCT01517373|9865003|FG001|STARTED|Treatment Period||61
8812044|NCT01517373|9865004|FG002|STARTED|Treatment Period||60
8812045|NCT01517373|9865005|FG003|STARTED|Treatment Period||61
8812046|NCT01517373|9865006|FG004|STARTED|Treatment Period||61
8812047|NCT01517373|9865007|FG005|STARTED|Treatment Period||61
8812048|NCT01517373|9865002|FG000|COMPLETED|Treatment Period||0
8812049|NCT01517373|9865003|FG001|COMPLETED|Treatment Period||57
8697634|NCT00889005|9743298|FG000|NOT COMPLETED|Overall Study||8
8697635|NCT00889005|9743299|FG001|NOT COMPLETED|Overall Study||2
8697636|NCT00889187|9743305|FG000|STARTED|Overall Study||3
8697637|NCT00889187|9743306|FG001|STARTED|Overall Study||3
8812050|NCT01517373|9865004|FG002|COMPLETED|Treatment Period||54
8812051|NCT01517373|9865005|FG003|COMPLETED|Treatment Period||54
8926368|NCT02266004|9987554|FG000|STARTED|Overall Study||9
8926369|NCT02266004|9987554|FG000|COMPLETED|Overall Study||7
8926370|NCT02266004|9987554|FG000|NOT COMPLETED|Overall Study||2
8926371|NCT02266108|9987560|FG000|STARTED|Overall Study||80
8926372|NCT02266108|9987561|FG001|STARTED|Overall Study||71
8926373|NCT02266108|9987560|FG000|COMPLETED|Overall Study||80
8926374|NCT02266108|9987561|FG001|COMPLETED|Overall Study||71
8926375|NCT02266108|9987560|FG000|NOT COMPLETED|Overall Study||0
8926376|NCT02266108|9987561|FG001|NOT COMPLETED|Overall Study||0
8926377|NCT02266147|9987571|FG000|STARTED|PART 1: Dose Escalation||3
8926378|NCT02266147|9987572|FG001|STARTED|PART 1: Dose Escalation||3
8926379|NCT02266147|9987573|FG002|STARTED|PART 1: Dose Escalation||3
8926380|NCT02266147|9987574|FG003|STARTED|PART 1: Dose Escalation||4
8926381|NCT02266147|9987571|FG000|COMPLETED|PART 1: Dose Escalation||2
8926382|NCT02266147|9987572|FG001|COMPLETED|PART 1: Dose Escalation||0
8926383|NCT02266147|9987573|FG002|COMPLETED|PART 1: Dose Escalation||0
8926384|NCT02266147|9987574|FG003|COMPLETED|PART 1: Dose Escalation||0
8926385|NCT02266147|9987571|FG000|NOT COMPLETED|PART 1: Dose Escalation||1
8926386|NCT02266147|9987572|FG001|NOT COMPLETED|PART 1: Dose Escalation||3
8926387|NCT02266147|9987573|FG002|NOT COMPLETED|PART 1: Dose Escalation||3
8926388|NCT02266147|9987574|FG003|NOT COMPLETED|PART 1: Dose Escalation||4
8926389|NCT02266147|9987571|FG000|STARTED|PART 2: Dose Expansion|Participants were enrolled separately from Part 1; sponsor terminated the trial early during Part 2.|7
8926390|NCT02266147|9987572|FG001|STARTED|PART 2: Dose Expansion|No new participants were enrolled and sponsor terminated the trial early during Part 2.|0
8926391|NCT02266147|9987573|FG002|STARTED|PART 2: Dose Expansion|No new participants were enrolled and sponsor terminated the trial early during Part 2.|0
8926392|NCT02266147|9987574|FG003|STARTED|PART 2: Dose Expansion|Participants were enrolled separately from Part 1; sponsor terminated the trial early during Part 2.|9
8926393|NCT02266147|9987571|FG000|COMPLETED|PART 2: Dose Expansion||0
8926394|NCT02266147|9987572|FG001|COMPLETED|PART 2: Dose Expansion||0
8926395|NCT02266147|9987573|FG002|COMPLETED|PART 2: Dose Expansion||0
8926396|NCT02266147|9987574|FG003|COMPLETED|PART 2: Dose Expansion||0
8812052|NCT01517373|9865006|FG004|COMPLETED|Treatment Period||55
8812053|NCT01517373|9865007|FG005|COMPLETED|Treatment Period||54
8812054|NCT01517373|9865002|FG000|NOT COMPLETED|Treatment Period||0
8812055|NCT01517373|9865003|FG001|NOT COMPLETED|Treatment Period||4
8812056|NCT01517373|9865004|FG002|NOT COMPLETED|Treatment Period||6
8812057|NCT01517373|9865005|FG003|NOT COMPLETED|Treatment Period||7
8812058|NCT01517373|9865006|FG004|NOT COMPLETED|Treatment Period||6
8812059|NCT01517373|9865007|FG005|NOT COMPLETED|Treatment Period||7
8812060|NCT01517412|9865022|FG000|STARTED|Overall Study||225
8812061|NCT01517412|9865023|FG001|STARTED|Overall Study||226
8812062|NCT01517412|9865022|FG000|COMPLETED|Overall Study||189
8812063|NCT01517412|9865023|FG001|COMPLETED|Overall Study||202
8812064|NCT01517412|9865022|FG000|NOT COMPLETED|Overall Study||36
8812065|NCT01517412|9865023|FG001|NOT COMPLETED|Overall Study||24
8812066|NCT01517529|9865029|FG000|STARTED|Overall Study||10
8812067|NCT01517529|9865029|FG000|COMPLETED|Overall Study||10
8812068|NCT01517529|9865029|FG000|NOT COMPLETED|Overall Study||0
8812069|NCT01517750|9865037|FG000|STARTED|Overall Study||21
8812070|NCT01517750|9865038|FG001|STARTED|Overall Study||19
8812071|NCT01517750|9865039|FG002|STARTED|Overall Study||21
8812072|NCT01517750|9865040|FG003|STARTED|Overall Study||19
8812073|NCT01517750|9865037|FG000|COMPLETED|Overall Study||20
8812074|NCT01517750|9865038|FG001|COMPLETED|Overall Study||17
8812075|NCT01517750|9865039|FG002|COMPLETED|Overall Study||17
8812076|NCT01517750|9865040|FG003|COMPLETED|Overall Study||18
8812077|NCT01517750|9865037|FG000|NOT COMPLETED|Overall Study||1
8812078|NCT01517750|9865038|FG001|NOT COMPLETED|Overall Study||2
8812079|NCT01517750|9865039|FG002|NOT COMPLETED|Overall Study||4
8812080|NCT01517750|9865040|FG003|NOT COMPLETED|Overall Study||1
8812081|NCT01517867|9865056|FG000|STARTED|Overall Study||81
8812082|NCT01517867|9865057|FG001|STARTED|Overall Study||80
8812083|NCT01517867|9865056|FG000|COMPLETED|Overall Study||18
8812084|NCT01517867|9865057|FG001|COMPLETED|Overall Study||15
8812085|NCT01517867|9865056|FG000|NOT COMPLETED|Overall Study||63
8812086|NCT01517867|9865057|FG001|NOT COMPLETED|Overall Study||65
8812087|NCT01517893|9865065|FG000|STARTED|Overall Study||8
8812088|NCT01517893|9865066|FG001|STARTED|Overall Study||7
8812089|NCT01517893|9865065|FG000|COMPLETED|Overall Study||5
8812090|NCT01517893|9865066|FG001|COMPLETED|Overall Study||7
8812091|NCT01517893|9865065|FG000|NOT COMPLETED|Overall Study||3
8812092|NCT01517893|9865066|FG001|NOT COMPLETED|Overall Study||0
8812093|NCT01517984|9865075|FG000|STARTED|Overall Study||5
8812094|NCT01517984|9865076|FG001|STARTED|Overall Study||26
8812095|NCT01517984|9865077|FG002|STARTED|Overall Study||14
8812096|NCT01517984|9865078|FG003|STARTED|Overall Study||7
8812097|NCT01517984|9865075|FG000|COMPLETED|Overall Study||0
8812098|NCT01517984|9865076|FG001|COMPLETED|Overall Study||3
8812099|NCT01517984|9865077|FG002|COMPLETED|Overall Study||10
8812100|NCT01517984|9865078|FG003|COMPLETED|Overall Study||6
8812101|NCT01517984|9865075|FG000|NOT COMPLETED|Overall Study||5
8812102|NCT01517984|9865076|FG001|NOT COMPLETED|Overall Study||23
8812103|NCT01517984|9865077|FG002|NOT COMPLETED|Overall Study||4
8812104|NCT01517984|9865078|FG003|NOT COMPLETED|Overall Study||1
8812105|NCT01518153|9865085|FG000|STARTED|Stem Cell Transplant||16
8812106|NCT01518153|9865086|FG001|STARTED|Stem Cell Transplant||0
8812107|NCT01518153|9865087|FG002|STARTED|Stem Cell Transplant||0
8812108|NCT01518153|9865085|FG000|COMPLETED|Stem Cell Transplant||7
8697638|NCT00889187|9743307|FG002|STARTED|Overall Study||4
8697639|NCT00889187|9743308|FG003|STARTED|Overall Study||0
8697640|NCT00889187|9743305|FG000|COMPLETED|Overall Study||3
8697641|NCT00889187|9743306|FG001|COMPLETED|Overall Study||3
8697642|NCT00889187|9743307|FG002|COMPLETED|Overall Study||4
8697643|NCT00889187|9743308|FG003|COMPLETED|Overall Study||0
8697644|NCT00889187|9743305|FG000|NOT COMPLETED|Overall Study||0
8697645|NCT00889187|9743306|FG001|NOT COMPLETED|Overall Study||0
8697646|NCT00889187|9743307|FG002|NOT COMPLETED|Overall Study||0
8697647|NCT00889187|9743308|FG003|NOT COMPLETED|Overall Study||0
8697648|NCT00889200|9743318|FG000|STARTED|Overall Study||12
8697649|NCT00889200|9743318|FG000|COMPLETED|Overall Study||12
8697650|NCT00889200|9743318|FG000|NOT COMPLETED|Overall Study||0
8697651|NCT00889226|9743324|FG000|STARTED|Overall Study||83
8697652|NCT00889226|9743325|FG001|STARTED|Overall Study||78
8697653|NCT00889226|9743324|FG000|COMPLETED|Overall Study||58
8697654|NCT00889226|9743325|FG001|COMPLETED|Overall Study||43
8697655|NCT00889226|9743324|FG000|NOT COMPLETED|Overall Study||25
8697656|NCT00889226|9743325|FG001|NOT COMPLETED|Overall Study||35
8697657|NCT00889252|9743333|FG000|STARTED|Overall Study||168
8697658|NCT00889252|9743334|FG001|STARTED|Overall Study||82
8697659|NCT00889252|9743333|FG000|COMPLETED|Overall Study||161
8697660|NCT00889252|9743334|FG001|COMPLETED|Overall Study||78
8697661|NCT00889252|9743333|FG000|NOT COMPLETED|Overall Study||7
8697662|NCT00889252|9743334|FG001|NOT COMPLETED|Overall Study||4
8697663|NCT00889265|9743340|FG000|STARTED|Overall Study|Date Enrollment Started: 07/21/2009 Date Enrollment Completed: 02/15/2011 Total enrolled: 51|51
8697664|NCT00889265|9743340|FG000|COMPLETED|Overall Study||44
8697665|NCT00889265|9743340|FG000|NOT COMPLETED|Overall Study||7
8697666|NCT00889330|9743346|FG000|STARTED|Overall Study||30
8697667|NCT00889330|9743347|FG001|STARTED|Overall Study||30
8697668|NCT00889330|9743346|FG000|COMPLETED|Overall Study||30
8697669|NCT00889330|9743347|FG001|COMPLETED|Overall Study||30
8697670|NCT00889330|9743346|FG000|NOT COMPLETED|Overall Study||0
8697671|NCT00889330|9743347|FG001|NOT COMPLETED|Overall Study||0
8697672|NCT00889512|9743355|FG000|STARTED|Overall Study||5
8697673|NCT00889512|9743356|FG001|STARTED|Overall Study||9
8697674|NCT00889512|9743355|FG000|COMPLETED|Overall Study||5
8697675|NCT00889512|9743356|FG001|COMPLETED|Overall Study||9
8697676|NCT00889512|9743355|FG000|NOT COMPLETED|Overall Study||0
8812109|NCT01518153|9865086|FG001|COMPLETED|Stem Cell Transplant||0
8812110|NCT01518153|9865087|FG002|COMPLETED|Stem Cell Transplant||0
8812111|NCT01518153|9865085|FG000|NOT COMPLETED|Stem Cell Transplant||9
8812112|NCT01518153|9865086|FG001|NOT COMPLETED|Stem Cell Transplant||0
8812113|NCT01518153|9865087|FG002|NOT COMPLETED|Stem Cell Transplant||0
8812114|NCT01518153|9865085|FG000|STARTED|Donor Lymphocyte Infusion||0
8812115|NCT01518153|9865086|FG001|STARTED|Donor Lymphocyte Infusion||3
8812116|NCT01518153|9865087|FG002|STARTED|Donor Lymphocyte Infusion||4
8812117|NCT01518153|9865085|FG000|COMPLETED|Donor Lymphocyte Infusion||0
8812118|NCT01518153|9865086|FG001|COMPLETED|Donor Lymphocyte Infusion||1
8812119|NCT01518153|9865087|FG002|COMPLETED|Donor Lymphocyte Infusion||3
8812120|NCT01518153|9865085|FG000|NOT COMPLETED|Donor Lymphocyte Infusion||0
8812121|NCT01518153|9865086|FG001|NOT COMPLETED|Donor Lymphocyte Infusion||2
8812122|NCT01518153|9865087|FG002|NOT COMPLETED|Donor Lymphocyte Infusion||1
8812123|NCT01518192|9865098|FG000|STARTED|Overall Study||145
8812124|NCT01518192|9865099|FG001|STARTED|Overall Study||140
8812125|NCT01518192|9865100|FG002|STARTED|Overall Study||259
8812126|NCT01518192|9865098|FG000|COMPLETED|Overall Study||116
8812127|NCT01518192|9865099|FG001|COMPLETED|Overall Study||114
8812128|NCT01518192|9865100|FG002|COMPLETED|Overall Study||224
8812129|NCT01518192|9865098|FG000|NOT COMPLETED|Overall Study||29
8812130|NCT01518192|9865099|FG001|NOT COMPLETED|Overall Study||26
8812131|NCT01518192|9865100|FG002|NOT COMPLETED|Overall Study||35
8812132|NCT01518244|9865114|FG000|STARTED|Overall Study||50
8812133|NCT01518244|9865114|FG000|COMPLETED|Overall Study||47
8812134|NCT01518244|9865114|FG000|NOT COMPLETED|Overall Study||3
8812135|NCT01518257|9865120|FG000|STARTED|Overall Study||61
8812136|NCT01518257|9865121|FG001|STARTED|Overall Study||60
8812137|NCT01518257|9865120|FG000|COMPLETED|Overall Study||59
8812138|NCT01518257|9865121|FG001|COMPLETED|Overall Study||60
8812139|NCT01518257|9865120|FG000|NOT COMPLETED|Overall Study||2
8812140|NCT01518257|9865121|FG001|NOT COMPLETED|Overall Study||0
8812141|NCT01518270|9865127|FG000|STARTED|Overall Study||179
8812142|NCT01518270|9865127|FG000|COMPLETED|Overall Study||179
8812143|NCT01518270|9865127|FG000|NOT COMPLETED|Overall Study||0
8812144|NCT01518309|9865131|FG000|STARTED|Overall Study||39
8812145|NCT01518309|9865131|FG000|COMPLETED|Overall Study||0
8697677|NCT00889512|9743356|FG001|NOT COMPLETED|Overall Study||0
8697678|NCT00889603|9743362|FG000|STARTED|Overall Study||370
8697679|NCT00889603|9743362|FG000|COMPLETED|Overall Study||333
8697680|NCT00889603|9743362|FG000|NOT COMPLETED|Overall Study||37
8697681|NCT00889681|9743366|FG000|STARTED|Overall Study||81
8812146|NCT01518309|9865131|FG000|NOT COMPLETED|Overall Study||39
8697682|NCT00889681|9743366|FG000|Received Treatment|Overall Study||78
8697683|NCT00889681|9743366|FG000|COMPLETED|Overall Study||78
8697684|NCT00889681|9743366|FG000|NOT COMPLETED|Overall Study||3
8697685|NCT00889707|9743372|FG000|STARTED|Overall Study||61
8697686|NCT00889707|9743373|FG001|STARTED|Overall Study||31
8697687|NCT00889707|9743372|FG000|COMPLETED|Overall Study||54
8697688|NCT00889707|9743373|FG001|COMPLETED|Overall Study||21
8812147|NCT01518322|9865135|FG000|STARTED|Overall Study||235
8812148|NCT01518322|9865135|FG000|COMPLETED|Overall Study||222
8812149|NCT01518322|9865135|FG000|NOT COMPLETED|Overall Study||13
8812150|NCT01518374|9865144|FG000|STARTED|Overall Study||1768
8812151|NCT01518374|9865144|FG000|COMPLETED|Overall Study||1761
8697689|NCT00889707|9743372|FG000|NOT COMPLETED|Overall Study||7
8697690|NCT00889707|9743373|FG001|NOT COMPLETED|Overall Study||10
8697691|NCT00889720|9743379|FG000|STARTED|Overall Study||16
8697692|NCT00889720|9743379|FG000|Surgical Population|Overall Study||12
8697693|NCT00889720|9743379|FG000|COMPLETED|Overall Study||8
8697694|NCT00889720|9743379|FG000|NOT COMPLETED|Overall Study||8
8697695|NCT00889824|9743383|FG000|STARTED|Overall Study||5
8697696|NCT00889824|9743383|FG000|COMPLETED|Overall Study||5
8697697|NCT00889824|9743383|FG000|NOT COMPLETED|Overall Study||0
8697698|NCT00889863|9743387|FG000|STARTED|Part I: Open Label||177
8697699|NCT00889863|9743388|FG001|STARTED|Part I: Open Label|No participants received placebo in Part I.|0
8697700|NCT00889863|9743387|FG000|Entered Part Ia|Part I: Open Label||145
8697701|NCT00889863|9743388|FG001|Entered Part Ia|Part I: Open Label||0
8697702|NCT00889863|9743387|FG000|Entered Part Ib|Part I: Open Label||142
8697703|NCT00889863|9743388|FG001|Entered Part Ib|Part I: Open Label||0
8697704|NCT00889863|9743387|FG000|Entered Part Ic|Part I: Open Label|Patients steroid free at study entry entered Part Id directly and did not participate in Part Ic.|92
8697705|NCT00889863|9743388|FG001|Entered Part Ic|Part I: Open Label||0
8697706|NCT00889863|9743387|FG000|Entered Part 1d|Part I: Open Label||103
8697707|NCT00889863|9743388|FG001|Entered Part 1d|Part I: Open Label||0
8697708|NCT00889863|9743387|FG000|COMPLETED|Part I: Open Label||100
8697709|NCT00889863|9743388|FG001|COMPLETED|Part I: Open Label||0
8697710|NCT00889863|9743387|FG000|NOT COMPLETED|Part I: Open Label||77
8697711|NCT00889863|9743388|FG001|NOT COMPLETED|Part I: Open Label||0
8697712|NCT00889863|9743387|FG000|STARTED|Part II: Randomized Double Blind||50
8697713|NCT00889863|9743388|FG001|STARTED|Part II: Randomized Double Blind||50
8697714|NCT00889863|9743387|FG000|COMPLETED|Part II: Randomized Double Blind||39
8697715|NCT00889863|9743388|FG001|COMPLETED|Part II: Randomized Double Blind||24
8697716|NCT00889863|9743387|FG000|NOT COMPLETED|Part II: Randomized Double Blind||11
8697717|NCT00889863|9743388|FG001|NOT COMPLETED|Part II: Randomized Double Blind||26
8697718|NCT00889915|9743400|FG000|STARTED|Overall Study||37
8697719|NCT00889915|9743401|FG001|STARTED|Overall Study||76
8697720|NCT00889915|9743402|FG002|STARTED|Overall Study||67
8697721|NCT00889915|9743403|FG003|STARTED|Overall Study||48
8697722|NCT00889915|9743400|FG000|COMPLETED|Overall Study||35
8697723|NCT00889915|9743401|FG001|COMPLETED|Overall Study||71
8697724|NCT00889915|9743402|FG002|COMPLETED|Overall Study||54
8697725|NCT00889915|9743403|FG003|COMPLETED|Overall Study||40
8697726|NCT00889915|9743400|FG000|NOT COMPLETED|Overall Study||2
8697727|NCT00889915|9743401|FG001|NOT COMPLETED|Overall Study||5
8697728|NCT00889915|9743402|FG002|NOT COMPLETED|Overall Study||13
8697729|NCT00889915|9743403|FG003|NOT COMPLETED|Overall Study||8
8697730|NCT00889928|9743413|FG000|STARTED|Overall Study||7
8697731|NCT00889928|9743413|FG000|COMPLETED|Overall Study||7
8697732|NCT00889928|9743413|FG000|NOT COMPLETED|Overall Study||0
8697733|NCT00890045|9743419|FG000|STARTED|Overall Study||20
8697734|NCT00890045|9743420|FG001|STARTED|Overall Study|Of the 52 subjects randomized to the HeRO Graft, two implants were abandoned.|52
8697735|NCT00890045|9743419|FG000|COMPLETED|Overall Study||15
8697736|NCT00890045|9743420|FG001|COMPLETED|Overall Study||42
8697737|NCT00890045|9743419|FG000|NOT COMPLETED|Overall Study||5
8697738|NCT00890045|9743420|FG001|NOT COMPLETED|Overall Study||10
8697739|NCT00890084|9743426|FG000|STARTED|Overall Study||2913
8697740|NCT00890084|9743426|FG000|COMPLETED|Overall Study||2771
8697741|NCT00890084|9743426|FG000|NOT COMPLETED|Overall Study||142
8697742|NCT00890097|9743433|FG000|STARTED|Overall Study||252
8697743|NCT00890097|9743434|FG001|STARTED|Overall Study||259
8697744|NCT00890097|9743435|FG002|STARTED|Overall Study||261
8697745|NCT00890097|9743433|FG000|COMPLETED|Overall Study||184
8697746|NCT00890097|9743434|FG001|COMPLETED|Overall Study||173
8697747|NCT00890097|9743435|FG002|COMPLETED|Overall Study||184
8697748|NCT00890097|9743433|FG000|NOT COMPLETED|Overall Study||68
8697749|NCT00890097|9743434|FG001|NOT COMPLETED|Overall Study||86
8697750|NCT00890097|9743435|FG002|NOT COMPLETED|Overall Study||77
8697751|NCT00890162|9743445|FG000|STARTED|Overall Study||8
8697752|NCT00890162|9743446|FG001|STARTED|Overall Study||8
8697753|NCT00890162|9743445|FG000|COMPLETED|Overall Study||6
8697754|NCT00890162|9743446|FG001|COMPLETED|Overall Study||7
8697755|NCT00890162|9743445|FG000|NOT COMPLETED|Overall Study||2
8697756|NCT00890162|9743446|FG001|NOT COMPLETED|Overall Study||1
8697757|NCT00890201|9743454|FG000|STARTED|Overall Study|5 patients with gastric cancer and gallstone disease|38
8697758|NCT00890201|9743455|FG001|STARTED|Overall Study|41 patients with acute cholecystitis and 15 patients with common bile duct stones|159
8697759|NCT00890201|9743454|FG000|COMPLETED|Overall Study|33 patients with gastric cancer and without gallstone disease|33
8697760|NCT00890201|9743455|FG001|COMPLETED|Overall Study|103 patients without acute cholecystitis or common bile duct stones|103
8697761|NCT00890201|9743454|FG000|NOT COMPLETED|Overall Study||5
8697762|NCT00890201|9743455|FG001|NOT COMPLETED|Overall Study||56
8697763|NCT00890396|9743463|FG000|STARTED|Overall Study||127
8697764|NCT00890396|9743464|FG001|STARTED|Overall Study||36
8697765|NCT00890396|9743463|FG000|COMPLETED|Overall Study||122
8697766|NCT00890396|9743464|FG001|COMPLETED|Overall Study||34
8697767|NCT00890396|9743463|FG000|NOT COMPLETED|Overall Study||5
8812152|NCT01518374|9865144|FG000|NOT COMPLETED|Overall Study||7
8697768|NCT00890396|9743464|FG001|NOT COMPLETED|Overall Study||2
8697769|NCT00890552|9743473|FG000|STARTED|Enrollment and Pre-treatment||25
8697770|NCT00890552|9743473|FG000|COMPLETED|Enrollment and Pre-treatment||24
8697771|NCT00890552|9743473|FG000|NOT COMPLETED|Enrollment and Pre-treatment||1
8697772|NCT00890552|9743473|FG000|STARTED|On-treatment||24
8697773|NCT00890552|9743473|FG000|COMPLETED|On-treatment||14
8697774|NCT00890552|9743473|FG000|NOT COMPLETED|On-treatment||10
8697775|NCT00890617|9743477|FG000|STARTED|Overall Study||9
8697776|NCT00890617|9743477|FG000|COMPLETED|Overall Study||9
8697777|NCT00890617|9743477|FG000|NOT COMPLETED|Overall Study||0
8697778|NCT00890656|9743481|FG000|STARTED|Overall Study||90
8697779|NCT00890656|9743481|FG000|COMPLETED|Overall Study||90
8697780|NCT00890656|9743481|FG000|NOT COMPLETED|Overall Study||0
8697781|NCT00890682|9743487|FG000|STARTED|Overall Study||97
8697782|NCT00890682|9743488|FG001|STARTED|Overall Study||96
8697783|NCT00890682|9743487|FG000|COMPLETED|Overall Study||93
8697784|NCT00890682|9743488|FG001|COMPLETED|Overall Study||94
8697785|NCT00890682|9743487|FG000|NOT COMPLETED|Overall Study||4
8697786|NCT00890682|9743488|FG001|NOT COMPLETED|Overall Study||2
8697787|NCT00890695|9743496|FG000|STARTED|Overall Study||32
8697788|NCT00890695|9743497|FG001|STARTED|Overall Study||33
8697789|NCT00890695|9743496|FG000|COMPLETED|Overall Study||31
8697790|NCT00890695|9743497|FG001|COMPLETED|Overall Study||33
8697791|NCT00890695|9743496|FG000|NOT COMPLETED|Overall Study||1
8697792|NCT00890695|9743497|FG001|NOT COMPLETED|Overall Study||0
8697793|NCT00890721|9743505|FG000|STARTED|Overall Study||95
8697794|NCT00890721|9743506|FG001|STARTED|Overall Study||94
8697795|NCT00890721|9743505|FG000|COMPLETED|Overall Study||94
8697796|NCT00890721|9743506|FG001|COMPLETED|Overall Study||93
8697797|NCT00890721|9743505|FG000|NOT COMPLETED|Overall Study||1
8697798|NCT00890721|9743506|FG001|NOT COMPLETED|Overall Study||1
8697799|NCT00890825|9743514|FG000|STARTED|Overall Study||44
8697800|NCT00890825|9743515|FG001|STARTED|Overall Study|A patient randomized to this arm was excluded from the safety population for not receiving treatment|43
8697801|NCT00890825|9743514|FG000|COMPLETED|Overall Study||30
8697802|NCT00890825|9743515|FG001|COMPLETED|Overall Study||29
8697803|NCT00890825|9743514|FG000|NOT COMPLETED|Overall Study||14
8697804|NCT00890825|9743515|FG001|NOT COMPLETED|Overall Study||14
8697805|NCT00890916|9743521|FG000|STARTED|"Rehab - Neuroprosthesis (NP) On"|First Implanted Stimulator-Telemeter (IST-12) Implant.|10
8697806|NCT00890916|9743521|FG000|"Grasp Release Pre-Test ON"|"Rehab - Neuroprosthesis (NP) On"||10
8697807|NCT00890916|9743521|FG000|COMPLETED|"Rehab - Neuroprosthesis (NP) On"||10
8697808|NCT00890916|9743521|FG000|NOT COMPLETED|"Rehab - Neuroprosthesis (NP) On"||0
8697809|NCT00890916|9743521|FG000|STARTED|"Rehab - NP Off"||10
8697810|NCT00890916|9743521|FG000|"Grasp Release Pre-Test OFF"|"Rehab - NP Off"||10
8697811|NCT00890916|9743521|FG000|COMPLETED|"Rehab - NP Off"||10
8697812|NCT00890916|9743521|FG000|NOT COMPLETED|"Rehab - NP Off"||0
8697813|NCT00890929|9743525|FG000|STARTED|Overall Study||45
8697814|NCT00890929|9743525|FG000|Consented & Enrolled|Overall Study||45
8697815|NCT00890929|9743525|FG000|Initiated Treatment|Overall Study||43
8697816|NCT00890929|9743525|FG000|COMPLETED|Overall Study||39
8697817|NCT00890929|9743525|FG000|NOT COMPLETED|Overall Study||6
8697818|NCT00890981|9743531|FG000|STARTED|Overall Study||39
8697819|NCT00890981|9743532|FG001|STARTED|Overall Study||40
8697820|NCT00890981|9743531|FG000|COMPLETED|Overall Study||39
8697821|NCT00890981|9743532|FG001|COMPLETED|Overall Study||40
8697822|NCT00890981|9743531|FG000|NOT COMPLETED|Overall Study||0
8697823|NCT00890981|9743532|FG001|NOT COMPLETED|Overall Study||0
8697824|NCT00891020|9743541|FG000|STARTED|24 Week Treatment Period||163
8697825|NCT00891020|9743542|FG001|STARTED|24 Week Treatment Period||363
8697826|NCT00891020|9743543|FG002|STARTED|24 Week Treatment Period||360
8697827|NCT00891020|9743541|FG000|Intent-to-Treat (ITT)|24 Week Treatment Period||163
8697828|NCT00891020|9743542|FG001|Intent-to-Treat (ITT)|24 Week Treatment Period||362
8697829|NCT00891020|9743543|FG002|Intent-to-Treat (ITT)|24 Week Treatment Period||358
8724343|NCT01026038|9771543|FG000|STARTED|Overall Study||130
8724344|NCT01026038|9771544|FG001|STARTED|Overall Study||65
8724345|NCT01026038|9771545|FG002|STARTED|Overall Study||67
8724346|NCT01026038|9771543|FG000|COMPLETED|Overall Study||129
8724347|NCT01026038|9771544|FG001|COMPLETED|Overall Study||64
8724348|NCT01026038|9771545|FG002|COMPLETED|Overall Study||67
8724349|NCT01026038|9771543|FG000|NOT COMPLETED|Overall Study||1
8724350|NCT01026038|9771544|FG001|NOT COMPLETED|Overall Study||1
8724351|NCT01026038|9771545|FG002|NOT COMPLETED|Overall Study||0
8724352|NCT01026103|9771553|FG000|STARTED|Overall Study||30
8724353|NCT01026103|9771553|FG000|Consented|Overall Study||30
8724354|NCT01026103|9771553|FG000|COMPLETED|Overall Study||28
8724355|NCT01026103|9771553|FG000|NOT COMPLETED|Overall Study||2
8724356|NCT01026142|9771559|FG000|STARTED|Overall Study||224
8724357|NCT01026142|9771560|FG001|STARTED|Overall Study||228
8724358|NCT01026142|9771559|FG000|COMPLETED|Overall Study||52
8724359|NCT01026142|9771560|FG001|COMPLETED|Overall Study||65
8724360|NCT01026142|9771559|FG000|NOT COMPLETED|Overall Study||172
8724361|NCT01026142|9771560|FG001|NOT COMPLETED|Overall Study||163
8724362|NCT01026181|9771569|FG000|STARTED|Overall Study||51
8724363|NCT01026181|9771570|FG001|STARTED|Overall Study||51
8724364|NCT01026181|9771571|FG002|STARTED|Overall Study||48
8724365|NCT01026181|9771569|FG000|COMPLETED|Overall Study||51
8724366|NCT01026181|9771570|FG001|COMPLETED|Overall Study||51
8724367|NCT01026181|9771571|FG002|COMPLETED|Overall Study||48
8724368|NCT01026181|9771569|FG000|NOT COMPLETED|Overall Study||0
8812153|NCT01518530|9865148|FG000|STARTED|Active Treatment Period||10
8812154|NCT01518530|9865148|FG000|COMPLETED|Active Treatment Period||9
8812155|NCT01518530|9865148|FG000|NOT COMPLETED|Active Treatment Period||1
8812156|NCT01518530|9865148|FG000|STARTED|Post-Treatment Follow-up||9
8812157|NCT01518530|9865148|FG000|COMPLETED|Post-Treatment Follow-up||9
8812158|NCT01518530|9865148|FG000|NOT COMPLETED|Post-Treatment Follow-up||0
8812159|NCT01518699|9865158|FG000|STARTED|Period 1||10
8812160|NCT01518699|9865159|FG001|STARTED|Period 1||9
8812161|NCT01518699|9865160|FG002|STARTED|Period 1||9
8812162|NCT01518699|9865161|FG003|STARTED|Period 1||10
8812163|NCT01518699|9865162|FG004|STARTED|Period 1||10
8812164|NCT01518699|9865163|FG005|STARTED|Period 1||9
8812165|NCT01518699|9865158|FG000|COMPLETED|Period 1||10
8812166|NCT01518699|9865159|FG001|COMPLETED|Period 1||9
8812167|NCT01518699|9865160|FG002|COMPLETED|Period 1||9
8812168|NCT01518699|9865161|FG003|COMPLETED|Period 1||10
8812169|NCT01518699|9865162|FG004|COMPLETED|Period 1||10
8812170|NCT01518699|9865163|FG005|COMPLETED|Period 1||9
8812171|NCT01518699|9865158|FG000|NOT COMPLETED|Period 1||0
8812172|NCT01518699|9865159|FG001|NOT COMPLETED|Period 1||0
8812173|NCT01518699|9865160|FG002|NOT COMPLETED|Period 1||0
8812174|NCT01518699|9865161|FG003|NOT COMPLETED|Period 1||0
8812175|NCT01518699|9865162|FG004|NOT COMPLETED|Period 1||0
8812176|NCT01518699|9865163|FG005|NOT COMPLETED|Period 1||0
8812177|NCT01518699|9865158|FG000|STARTED|Period 2||10
8812178|NCT01518699|9865159|FG001|STARTED|Period 2||9
8812179|NCT01518699|9865160|FG002|STARTED|Period 2||9
8697830|NCT00891020|9743541|FG000|Safety Set|24 Week Treatment Period|4 patients from 8 mg/kg +DMARD arm did not receive DMARD, included in Monotherapy arm for safety.|138
8697831|NCT00891020|9743542|FG001|Safety Set|24 Week Treatment Period|1 patient from Monotherapy arm and 1 from 8 mg/kg +DMARD, included in 4 mg/kg +DMARD arm for safety.|364
8697832|NCT00891020|9743543|FG002|Safety Set|24 Week Treatment Period|28 patients from Monotherapy arm received DMARD, included in 8 mg/kg +DMARD arm for safety.|381
8697833|NCT00891020|9743541|FG000|COMPLETED|24 Week Treatment Period||126
8697834|NCT00891020|9743542|FG001|COMPLETED|24 Week Treatment Period||303
8697835|NCT00891020|9743543|FG002|COMPLETED|24 Week Treatment Period||302
8697836|NCT00891020|9743541|FG000|NOT COMPLETED|24 Week Treatment Period||37
8697837|NCT00891020|9743542|FG001|NOT COMPLETED|24 Week Treatment Period||60
8697838|NCT00891020|9743543|FG002|NOT COMPLETED|24 Week Treatment Period||58
8697839|NCT00891020|9743541|FG000|STARTED|Long-term Extension Period||55
8697840|NCT00891020|9743542|FG001|STARTED|Long-term Extension Period||196
8697841|NCT00891020|9743543|FG002|STARTED|Long-term Extension Period||193
8697842|NCT00891020|9743541|FG000|COMPLETED|Long-term Extension Period||49
8697843|NCT00891020|9743542|FG001|COMPLETED|Long-term Extension Period||172
8697844|NCT00891020|9743543|FG002|COMPLETED|Long-term Extension Period||170
8697845|NCT00891020|9743541|FG000|NOT COMPLETED|Long-term Extension Period||6
8697846|NCT00891020|9743542|FG001|NOT COMPLETED|Long-term Extension Period||24
8697847|NCT00891020|9743543|FG002|NOT COMPLETED|Long-term Extension Period||23
8697848|NCT00891046|9743558|FG000|STARTED|Overall Study||33
8697849|NCT00891046|9743559|FG001|STARTED|Overall Study||63
8697850|NCT00891046|9743560|FG002|STARTED|Overall Study||40
8697851|NCT00891046|9743561|FG003|STARTED|Overall Study||11
8697852|NCT00891046|9743562|FG004|STARTED|Overall Study||123
8697853|NCT00891046|9743558|FG000|COMPLETED|Overall Study||21
8697854|NCT00891046|9743559|FG001|COMPLETED|Overall Study||54
8697855|NCT00891046|9743560|FG002|COMPLETED|Overall Study||17
8697856|NCT00891046|9743561|FG003|COMPLETED|Overall Study||8
8697857|NCT00891046|9743562|FG004|COMPLETED|Overall Study||84
8697858|NCT00891046|9743558|FG000|NOT COMPLETED|Overall Study||12
8697859|NCT00891046|9743559|FG001|NOT COMPLETED|Overall Study||9
8697860|NCT00891046|9743560|FG002|NOT COMPLETED|Overall Study||23
8697861|NCT00891046|9743561|FG003|NOT COMPLETED|Overall Study||3
8697862|NCT00891046|9743562|FG004|NOT COMPLETED|Overall Study||39
8697863|NCT00891176|9743593|FG000|STARTED|At 3 Years of Age||144
8697864|NCT00891176|9743594|FG001|STARTED|At 3 Years of Age||147
8697865|NCT00891176|9743595|FG002|STARTED|At 3 Years of Age||149
8697866|NCT00891176|9743596|FG003|STARTED|At 3 Years of Age||141
8812180|NCT01518699|9865161|FG003|STARTED|Period 2||10
8812181|NCT01518699|9865162|FG004|STARTED|Period 2||10
8812182|NCT01518699|9865163|FG005|STARTED|Period 2||9
8812183|NCT01518699|9865158|FG000|COMPLETED|Period 2||8
8812184|NCT01518699|9865159|FG001|COMPLETED|Period 2||7
8812185|NCT01518699|9865160|FG002|COMPLETED|Period 2||9
8812186|NCT01518699|9865161|FG003|COMPLETED|Period 2||10
8812187|NCT01518699|9865162|FG004|COMPLETED|Period 2||10
8812188|NCT01518699|9865163|FG005|COMPLETED|Period 2||9
8697867|NCT00891176|9743593|FG000|COMPLETED|At 3 Years of Age||144
8697868|NCT00891176|9743594|FG001|COMPLETED|At 3 Years of Age||147
8697869|NCT00891176|9743595|FG002|COMPLETED|At 3 Years of Age||149
8697870|NCT00891176|9743596|FG003|COMPLETED|At 3 Years of Age||141
8697871|NCT00891176|9743593|FG000|NOT COMPLETED|At 3 Years of Age||0
8697872|NCT00891176|9743594|FG001|NOT COMPLETED|At 3 Years of Age||0
8697873|NCT00891176|9743595|FG002|NOT COMPLETED|At 3 Years of Age||0
8812189|NCT01518699|9865158|FG000|NOT COMPLETED|Period 2||2
8812190|NCT01518699|9865159|FG001|NOT COMPLETED|Period 2||2
8812191|NCT01518699|9865160|FG002|NOT COMPLETED|Period 2||0
8812192|NCT01518699|9865161|FG003|NOT COMPLETED|Period 2||0
8812193|NCT01518699|9865162|FG004|NOT COMPLETED|Period 2||0
8812194|NCT01518699|9865163|FG005|NOT COMPLETED|Period 2||0
8812195|NCT01518699|9865158|FG000|STARTED|Period 3||8
8812196|NCT01518699|9865159|FG001|STARTED|Period 3||7
8812197|NCT01518699|9865160|FG002|STARTED|Period 3||9
8812198|NCT01518699|9865161|FG003|STARTED|Period 3||10
8812199|NCT01518699|9865162|FG004|STARTED|Period 3||10
8812200|NCT01518699|9865163|FG005|STARTED|Period 3||9
8812201|NCT01518699|9865158|FG000|COMPLETED|Period 3||8
8812202|NCT01518699|9865159|FG001|COMPLETED|Period 3||7
8812203|NCT01518699|9865160|FG002|COMPLETED|Period 3||9
8812204|NCT01518699|9865161|FG003|COMPLETED|Period 3||10
8697874|NCT00891176|9743596|FG003|NOT COMPLETED|At 3 Years of Age||0
8697875|NCT00891176|9743593|FG000|STARTED|At 4 Years of Age||140
8697876|NCT00891176|9743594|FG001|STARTED|At 4 Years of Age||142
8697877|NCT00891176|9743595|FG002|STARTED|At 4 Years of Age||142
8697878|NCT00891176|9743596|FG003|STARTED|At 4 Years of Age||137
8697879|NCT00891176|9743593|FG000|COMPLETED|At 4 Years of Age||140
8697880|NCT00891176|9743594|FG001|COMPLETED|At 4 Years of Age||142
8697881|NCT00891176|9743595|FG002|COMPLETED|At 4 Years of Age||142
8697882|NCT00891176|9743596|FG003|COMPLETED|At 4 Years of Age||137
8697883|NCT00891176|9743593|FG000|NOT COMPLETED|At 4 Years of Age||0
8697884|NCT00891176|9743594|FG001|NOT COMPLETED|At 4 Years of Age||0
8697885|NCT00891176|9743595|FG002|NOT COMPLETED|At 4 Years of Age||0
8697886|NCT00891176|9743596|FG003|NOT COMPLETED|At 4 Years of Age||0
8697887|NCT00891176|9743593|FG000|STARTED|At 6 Years of Age||131
8697888|NCT00891176|9743594|FG001|STARTED|At 6 Years of Age||138
8697889|NCT00891176|9743595|FG002|STARTED|At 6 Years of Age||135
8697890|NCT00891176|9743596|FG003|STARTED|At 6 Years of Age||135
8697891|NCT00891176|9743593|FG000|COMPLETED|At 6 Years of Age||131
8697892|NCT00891176|9743594|FG001|COMPLETED|At 6 Years of Age||138
8697893|NCT00891176|9743595|FG002|COMPLETED|At 6 Years of Age||135
8697894|NCT00891176|9743596|FG003|COMPLETED|At 6 Years of Age||135
8697895|NCT00891176|9743593|FG000|NOT COMPLETED|At 6 Years of Age||0
8697896|NCT00891176|9743594|FG001|NOT COMPLETED|At 6 Years of Age||0
8697897|NCT00891176|9743595|FG002|NOT COMPLETED|At 6 Years of Age||0
8697898|NCT00891176|9743596|FG003|NOT COMPLETED|At 6 Years of Age||0
8697899|NCT00891202|9743614|FG000|STARTED|PAP (Up To Week 39)||20
8697900|NCT00891202|9743615|FG001|STARTED|PAP (Up To Week 39)||20
8697901|NCT00891202|9743616|FG002|STARTED|PAP (Up To Week 39)||0
8697902|NCT00891202|9743617|FG003|STARTED|PAP (Up To Week 39)||0
8697903|NCT00891202|9743614|FG000|COMPLETED|PAP (Up To Week 39)||19
8697904|NCT00891202|9743615|FG001|COMPLETED|PAP (Up To Week 39)||20
8697905|NCT00891202|9743616|FG002|COMPLETED|PAP (Up To Week 39)||0
8697906|NCT00891202|9743617|FG003|COMPLETED|PAP (Up To Week 39)||0
8697907|NCT00891202|9743614|FG000|NOT COMPLETED|PAP (Up To Week 39)||1
8697908|NCT00891202|9743615|FG001|NOT COMPLETED|PAP (Up To Week 39)||0
8697909|NCT00891202|9743616|FG002|NOT COMPLETED|PAP (Up To Week 39)||0
8697910|NCT00891202|9743617|FG003|NOT COMPLETED|PAP (Up To Week 39)||0
8697911|NCT00891202|9743614|FG000|STARTED|LTTP (Post-Week 39 up to Week 312)||0
8697912|NCT00891202|9743615|FG001|STARTED|LTTP (Post-Week 39 up to Week 312)||0
8697913|NCT00891202|9743616|FG002|STARTED|LTTP (Post-Week 39 up to Week 312)||19
8697914|NCT00891202|9743617|FG003|STARTED|LTTP (Post-Week 39 up to Week 312)||20
8697915|NCT00891202|9743614|FG000|COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
8697916|NCT00891202|9743615|FG001|COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
8697917|NCT00891202|9743616|FG002|COMPLETED|LTTP (Post-Week 39 up to Week 312)||12
8697918|NCT00891202|9743617|FG003|COMPLETED|LTTP (Post-Week 39 up to Week 312)||15
8697919|NCT00891202|9743614|FG000|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
8697920|NCT00891202|9743615|FG001|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
8697921|NCT00891202|9743616|FG002|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||7
8697922|NCT00891202|9743617|FG003|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||5
8697923|NCT00891228|9743628|FG000|STARTED|Overall Study||32
8697924|NCT00891228|9743629|FG001|STARTED|Overall Study||33
8697925|NCT00891228|9743630|FG002|STARTED|Overall Study||34
8697926|NCT00891228|9743628|FG000|COMPLETED|Overall Study||21
8697927|NCT00891228|9743629|FG001|COMPLETED|Overall Study||20
8697928|NCT00891228|9743630|FG002|COMPLETED|Overall Study||19
8697929|NCT00891228|9743628|FG000|NOT COMPLETED|Overall Study||11
8697930|NCT00891228|9743629|FG001|NOT COMPLETED|Overall Study||13
8697931|NCT00891228|9743630|FG002|NOT COMPLETED|Overall Study||15
8697932|NCT00891293|9743638|FG000|STARTED|Overall Study|93 participants were enrolled; baseline data are provided for 89 participants (Safety Population).|93
8697933|NCT00891293|9743638|FG000|COMPLETED|Overall Study||9
8697934|NCT00891293|9743638|FG000|NOT COMPLETED|Overall Study||84
8697935|NCT00891319|9743644|FG000|STARTED|Overall Study||40
8697936|NCT00891319|9743645|FG001|STARTED|Overall Study||40
8697937|NCT00891319|9743644|FG000|COMPLETED|Overall Study||32
8697938|NCT00891319|9743645|FG001|COMPLETED|Overall Study||40
8697939|NCT00891319|9743644|FG000|NOT COMPLETED|Overall Study||8
8697940|NCT00891319|9743645|FG001|NOT COMPLETED|Overall Study||0
8697941|NCT00891371|9743651|FG000|STARTED|Pre-assignment||42
8697942|NCT00891371|9743651|FG000|COMPLETED|Pre-assignment||36
8697943|NCT00891371|9743651|FG000|NOT COMPLETED|Pre-assignment||6
8697944|NCT00891371|9743651|FG000|STARTED|Treatment||36
8697945|NCT00891371|9743651|FG000|COMPLETED|Treatment||27
8697946|NCT00891371|9743651|FG000|NOT COMPLETED|Treatment||9
8697947|NCT00891436|9743657|FG000|STARTED|Overall Study||10
8697948|NCT00891436|9743658|FG001|STARTED|Overall Study||10
8697949|NCT00891436|9743657|FG000|COMPLETED|Overall Study||10
8697950|NCT00891436|9743658|FG001|COMPLETED|Overall Study||10
8697951|NCT00891436|9743657|FG000|NOT COMPLETED|Overall Study||0
8697952|NCT00891436|9743658|FG001|NOT COMPLETED|Overall Study||0
8697953|NCT00891462|9743667|FG000|STARTED|Overall Study||186
8697954|NCT00891462|9743668|FG001|STARTED|Overall Study||185
8812205|NCT01518699|9865162|FG004|COMPLETED|Period 3||10
8812206|NCT01518699|9865163|FG005|COMPLETED|Period 3||9
8812207|NCT01518699|9865158|FG000|NOT COMPLETED|Period 3||0
8812208|NCT01518699|9865159|FG001|NOT COMPLETED|Period 3||0
8812209|NCT01518699|9865160|FG002|NOT COMPLETED|Period 3||0
8812210|NCT01518699|9865161|FG003|NOT COMPLETED|Period 3||0
8812211|NCT01518699|9865162|FG004|NOT COMPLETED|Period 3||0
8812212|NCT01518699|9865163|FG005|NOT COMPLETED|Period 3||0
8812213|NCT01518868|9865171|FG000|STARTED|Overall Study||63
8812214|NCT01518868|9865172|FG001|STARTED|Overall Study||63
8697955|NCT00891462|9743669|FG002|STARTED|Overall Study||190
8697956|NCT00891462|9743667|FG000|COMPLETED|Overall Study||149
8697957|NCT00891462|9743668|FG001|COMPLETED|Overall Study||152
8812215|NCT01518868|9865171|FG000|COMPLETED|Overall Study||59
8812216|NCT01518868|9865172|FG001|COMPLETED|Overall Study||59
8812217|NCT01518868|9865171|FG000|NOT COMPLETED|Overall Study||4
8812218|NCT01518868|9865172|FG001|NOT COMPLETED|Overall Study||4
8812219|NCT01518946|9865180|FG000|STARTED|Open-label Phase||24
8812220|NCT01518946|9865181|FG001|STARTED|Open-label Phase||0
8812221|NCT01518946|9865182|FG002|STARTED|Open-label Phase||0
8812222|NCT01518946|9865180|FG000|COMPLETED|Open-label Phase||20
8812223|NCT01518946|9865181|FG001|COMPLETED|Open-label Phase||0
8697958|NCT00891462|9743669|FG002|COMPLETED|Overall Study||166
8697959|NCT00891462|9743667|FG000|NOT COMPLETED|Overall Study||37
8697960|NCT00891462|9743668|FG001|NOT COMPLETED|Overall Study||33
8697961|NCT00891462|9743669|FG002|NOT COMPLETED|Overall Study||24
8697962|NCT00891527|9743679|FG000|STARTED|Overall Study||50
8697963|NCT00891527|9743679|FG000|COMPLETED|Overall Study||48
8697964|NCT00891527|9743679|FG000|NOT COMPLETED|Overall Study||2
8697965|NCT00891618|9743684|FG000|STARTED|Overall Study||21
8697966|NCT00891618|9743684|FG000|COMPLETED|Overall Study||20
8697967|NCT00891618|9743684|FG000|NOT COMPLETED|Overall Study||1
8697968|NCT00891657|9743690|FG000|STARTED|Overall Study||9
8697969|NCT00891657|9743691|FG001|STARTED|Overall Study||6
8697970|NCT00891657|9743690|FG000|COMPLETED|Overall Study||8
8697971|NCT00891657|9743691|FG001|COMPLETED|Overall Study||5
8697972|NCT00891657|9743690|FG000|NOT COMPLETED|Overall Study||1
8697973|NCT00891657|9743691|FG001|NOT COMPLETED|Overall Study||1
8697974|NCT00891735|9743701|FG000|STARTED|Overall Study||275
8697975|NCT00891735|9743702|FG001|STARTED|Overall Study||274
8697976|NCT00891735|9743703|FG002|STARTED|Overall Study||275
8697977|NCT00891735|9743704|FG003|STARTED|Overall Study||273
8697978|NCT00891735|9743701|FG000|COMPLETED|Overall Study||258
8697979|NCT00891735|9743702|FG001|COMPLETED|Overall Study||258
8697980|NCT00891735|9743703|FG002|COMPLETED|Overall Study||263
8697981|NCT00891735|9743704|FG003|COMPLETED|Overall Study||258
8697982|NCT00891735|9743701|FG000|NOT COMPLETED|Overall Study||17
8697983|NCT00891735|9743702|FG001|NOT COMPLETED|Overall Study||16
8697984|NCT00891735|9743703|FG002|NOT COMPLETED|Overall Study||12
8697985|NCT00891735|9743704|FG003|NOT COMPLETED|Overall Study||15
8697986|NCT00891774|9743714|FG000|STARTED|Overall Study||172
8697987|NCT00891774|9743714|FG000|COMPLETED|Overall Study||158
8697988|NCT00891774|9743714|FG000|NOT COMPLETED|Overall Study||14
8697989|NCT00891813|9743718|FG000|STARTED|Overall Study||100
8697990|NCT00891813|9743718|FG000|COMPLETED|Overall Study||88
8697991|NCT00891813|9743718|FG000|NOT COMPLETED|Overall Study||12
8697992|NCT00891839|9743722|FG000|STARTED|Overall Study||45
8697993|NCT00891839|9743722|FG000|COMPLETED|Overall Study|completed treatment|38
8697994|NCT00891839|9743722|FG000|NOT COMPLETED|Overall Study||7
8697995|NCT00891878|9743728|FG000|STARTED|Overall Study||6
8697996|NCT00891878|9743729|FG001|STARTED|Overall Study||6
8697997|NCT00891878|9743728|FG000|COMPLETED|Overall Study||6
8697998|NCT00891878|9743729|FG001|COMPLETED|Overall Study||6
8697999|NCT00891878|9743728|FG000|NOT COMPLETED|Overall Study||0
8698000|NCT00891878|9743729|FG001|NOT COMPLETED|Overall Study||0
8698001|NCT00891930|9743735|FG000|STARTED|Part 1: Panitumumab +Irinotecan||76
8698002|NCT00891930|9743735|FG000|Received Treatment|Part 1: Panitumumab +Irinotecan||74
8698003|NCT00891930|9743735|FG000|COMPLETED|Part 1: Panitumumab +Irinotecan||36
8698004|NCT00891930|9743735|FG000|NOT COMPLETED|Part 1: Panitumumab +Irinotecan||40
8698005|NCT00891930|9743735|FG000|STARTED|Part 2: Panitumumab + Ganitumab||36
8698006|NCT00891930|9743735|FG000|COMPLETED|Part 2: Panitumumab + Ganitumab||5
8698007|NCT00891930|9743735|FG000|NOT COMPLETED|Part 2: Panitumumab + Ganitumab||31
8698008|NCT00891982|9743745|FG000|STARTED|Overall Study||30
8698009|NCT00891982|9743746|FG001|STARTED|Overall Study||31
8698010|NCT00891982|9743745|FG000|COMPLETED|Overall Study||28
8698011|NCT00891982|9743746|FG001|COMPLETED|Overall Study||30
8698012|NCT00891982|9743745|FG000|NOT COMPLETED|Overall Study||2
8698013|NCT00891982|9743746|FG001|NOT COMPLETED|Overall Study||1
8698014|NCT00891995|9743754|FG000|STARTED|Overall Study||50
8698015|NCT00891995|9743755|FG001|STARTED|Overall Study||21
8698016|NCT00891995|9743754|FG000|COMPLETED|Overall Study||50
8812224|NCT01518946|9865182|FG002|COMPLETED|Open-label Phase||0
8812225|NCT01518946|9865180|FG000|NOT COMPLETED|Open-label Phase||4
8698017|NCT00891995|9743755|FG001|COMPLETED|Overall Study||21
8698018|NCT00891995|9743754|FG000|NOT COMPLETED|Overall Study||0
8698019|NCT00891995|9743755|FG001|NOT COMPLETED|Overall Study||0
8698020|NCT00892008|9743761|FG000|STARTED|Overall Study||2278
8812226|NCT01518946|9865181|FG001|NOT COMPLETED|Open-label Phase||0
8698021|NCT00892008|9743761|FG000|COMPLETED|Overall Study||1713
8698022|NCT00892008|9743761|FG000|NOT COMPLETED|Overall Study||565
8698023|NCT00892047|9743767|FG000|STARTED|Overall Study||91
8812227|NCT01518946|9865182|FG002|NOT COMPLETED|Open-label Phase||0
8812228|NCT01518946|9865180|FG000|STARTED|Randomized Phase (First Intervention)||0
8812229|NCT01518946|9865181|FG001|STARTED|Randomized Phase (First Intervention)||10
8812230|NCT01518946|9865182|FG002|STARTED|Randomized Phase (First Intervention)||10
8812231|NCT01518946|9865180|FG000|COMPLETED|Randomized Phase (First Intervention)||0
8812232|NCT01518946|9865181|FG001|COMPLETED|Randomized Phase (First Intervention)||9
8812233|NCT01518946|9865182|FG002|COMPLETED|Randomized Phase (First Intervention)||10
8812234|NCT01518946|9865180|FG000|NOT COMPLETED|Randomized Phase (First Intervention)||0
8812235|NCT01518946|9865181|FG001|NOT COMPLETED|Randomized Phase (First Intervention)||1
8812236|NCT01518946|9865182|FG002|NOT COMPLETED|Randomized Phase (First Intervention)||0
8812237|NCT01518946|9865180|FG000|STARTED|Randomized Phase (Second Intervention)||0
8812238|NCT01518946|9865181|FG001|STARTED|Randomized Phase (Second Intervention)||9
8812239|NCT01518946|9865182|FG002|STARTED|Randomized Phase (Second Intervention)||10
8812240|NCT01518946|9865180|FG000|COMPLETED|Randomized Phase (Second Intervention)||0
8812241|NCT01518946|9865181|FG001|COMPLETED|Randomized Phase (Second Intervention)||9
8926397|NCT02266147|9987571|FG000|NOT COMPLETED|PART 2: Dose Expansion||7
8926398|NCT02266147|9987572|FG001|NOT COMPLETED|PART 2: Dose Expansion||0
8926399|NCT02266147|9987573|FG002|NOT COMPLETED|PART 2: Dose Expansion||0
8926400|NCT02266147|9987574|FG003|NOT COMPLETED|PART 2: Dose Expansion||9
8926401|NCT02266225|9987586|FG000|STARTED|Overall Study||48
8926402|NCT02266225|9987586|FG000|Enrolled in Intervention|Overall Study||44
8926403|NCT02266225|9987586|FG000|COMPLETED|Overall Study||32
8926404|NCT02266225|9987586|FG000|NOT COMPLETED|Overall Study||16
8926405|NCT02266277|9987597|FG000|STARTED|Overall Study||5000
8926406|NCT02266277|9987598|FG001|STARTED|Overall Study||5000
8926407|NCT02266277|9987599|FG002|STARTED|Overall Study||5000
8926408|NCT02266277|9987600|FG003|STARTED|Overall Study||5000
8926409|NCT02266277|9987601|FG004|STARTED|Overall Study||5000
8926410|NCT02266277|9987602|FG005|STARTED|Overall Study||5000
8926411|NCT02266277|9987597|FG000|COMPLETED|Overall Study||5000
8926412|NCT02266277|9987598|FG001|COMPLETED|Overall Study||5000
8926413|NCT02266277|9987599|FG002|COMPLETED|Overall Study||5000
8926414|NCT02266277|9987600|FG003|COMPLETED|Overall Study||5000
8926415|NCT02266277|9987601|FG004|COMPLETED|Overall Study||5000
8926416|NCT02266277|9987602|FG005|COMPLETED|Overall Study||5000
8926417|NCT02266277|9987597|FG000|NOT COMPLETED|Overall Study||0
8926418|NCT02266277|9987598|FG001|NOT COMPLETED|Overall Study||0
8926419|NCT02266277|9987599|FG002|NOT COMPLETED|Overall Study||0
8926420|NCT02266277|9987600|FG003|NOT COMPLETED|Overall Study||0
8926421|NCT02266277|9987601|FG004|NOT COMPLETED|Overall Study||0
8926422|NCT02266277|9987602|FG005|NOT COMPLETED|Overall Study||0
8926423|NCT02266381|9987621|FG000|STARTED|Overall Study||150
8926424|NCT02266381|9987622|FG001|STARTED|Overall Study||150
8926425|NCT02266381|9987623|FG002|STARTED|Overall Study||150
8926426|NCT02266381|9987621|FG000|COMPLETED|Overall Study||147
8698024|NCT00892047|9743768|FG001|STARTED|Overall Study||90
8698025|NCT00892047|9743767|FG000|COMPLETED|Overall Study||87
8698026|NCT00892047|9743768|FG001|COMPLETED|Overall Study||83
8698027|NCT00892047|9743767|FG000|NOT COMPLETED|Overall Study||4
8698028|NCT00892047|9743768|FG001|NOT COMPLETED|Overall Study||7
8698029|NCT00892099|9743779|FG000|STARTED|Overall Study||36
8698030|NCT00892099|9743780|FG001|STARTED|Overall Study||33
8698031|NCT00892099|9743781|FG002|STARTED|Overall Study||36
8698032|NCT00892099|9743779|FG000|COMPLETED|Overall Study||31
8698033|NCT00892099|9743780|FG001|COMPLETED|Overall Study||32
8698034|NCT00892099|9743781|FG002|COMPLETED|Overall Study||29
8698035|NCT00892099|9743779|FG000|NOT COMPLETED|Overall Study||5
8698036|NCT00892099|9743780|FG001|NOT COMPLETED|Overall Study||1
8698037|NCT00892099|9743781|FG002|NOT COMPLETED|Overall Study||7
8698038|NCT00892151|9743789|FG000|STARTED|Overall Study||51
8698039|NCT00892151|9743789|FG000|COMPLETED|Overall Study||50
8698040|NCT00892151|9743789|FG000|NOT COMPLETED|Overall Study||1
8698041|NCT00892177|9743796|FG000|STARTED|Phase I: Dose Level 0||3
8698042|NCT00892177|9743797|FG001|STARTED|Phase I: Dose Level 0||0
8698043|NCT00892177|9743798|FG002|STARTED|Phase I: Dose Level 0||0
8698044|NCT00892177|9743799|FG003|STARTED|Phase I: Dose Level 0||0
8698045|NCT00892177|9743800|FG004|STARTED|Phase I: Dose Level 0||0
8698046|NCT00892177|9743801|FG005|STARTED|Phase I: Dose Level 0||0
8698047|NCT00892177|9743796|FG000|COMPLETED|Phase I: Dose Level 0||3
8698048|NCT00892177|9743797|FG001|COMPLETED|Phase I: Dose Level 0||0
8698049|NCT00892177|9743798|FG002|COMPLETED|Phase I: Dose Level 0||0
8926427|NCT02266381|9987622|FG001|COMPLETED|Overall Study||145
8926428|NCT02266381|9987623|FG002|COMPLETED|Overall Study||146
8926429|NCT02266381|9987621|FG000|NOT COMPLETED|Overall Study||3
8698050|NCT00892177|9743799|FG003|COMPLETED|Phase I: Dose Level 0||0
8698051|NCT00892177|9743800|FG004|COMPLETED|Phase I: Dose Level 0||0
8698052|NCT00892177|9743801|FG005|COMPLETED|Phase I: Dose Level 0||0
8698053|NCT00892177|9743796|FG000|NOT COMPLETED|Phase I: Dose Level 0||0
8698054|NCT00892177|9743797|FG001|NOT COMPLETED|Phase I: Dose Level 0||0
8698055|NCT00892177|9743798|FG002|NOT COMPLETED|Phase I: Dose Level 0||0
8698056|NCT00892177|9743799|FG003|NOT COMPLETED|Phase I: Dose Level 0||0
8698057|NCT00892177|9743800|FG004|NOT COMPLETED|Phase I: Dose Level 0||0
8698058|NCT00892177|9743801|FG005|NOT COMPLETED|Phase I: Dose Level 0||0
8812242|NCT01518946|9865182|FG002|COMPLETED|Randomized Phase (Second Intervention)||10
8698059|NCT00892177|9743796|FG000|STARTED|Phase I: Dose Level 1||0
8698060|NCT00892177|9743797|FG001|STARTED|Phase I: Dose Level 1||4
8698061|NCT00892177|9743798|FG002|STARTED|Phase I: Dose Level 1||0
8926430|NCT02266381|9987622|FG001|NOT COMPLETED|Overall Study||5
8926431|NCT02266381|9987623|FG002|NOT COMPLETED|Overall Study||4
8926432|NCT02266433|9987635|FG000|STARTED|Overall Study||127
8926433|NCT02266433|9987636|FG001|STARTED|Overall Study||118
8926434|NCT02266433|9987635|FG000|COMPLETED|Overall Study||68
8926435|NCT02266433|9987636|FG001|COMPLETED|Overall Study||65
8926436|NCT02266433|9987635|FG000|NOT COMPLETED|Overall Study||59
8926437|NCT02266433|9987636|FG001|NOT COMPLETED|Overall Study||53
8926438|NCT02266472|9987645|FG000|STARTED|Period 1+ Washout||15
8926439|NCT02266472|9987646|FG001|STARTED|Period 1+ Washout||15
8926440|NCT02266472|9987645|FG000|COMPLETED|Period 1+ Washout||15
8926441|NCT02266472|9987646|FG001|COMPLETED|Period 1+ Washout||15
8926442|NCT02266472|9987645|FG000|NOT COMPLETED|Period 1+ Washout||0
8926443|NCT02266472|9987646|FG001|NOT COMPLETED|Period 1+ Washout||0
8698062|NCT00892177|9743799|FG003|STARTED|Phase I: Dose Level 1||0
8698063|NCT00892177|9743800|FG004|STARTED|Phase I: Dose Level 1||0
8698064|NCT00892177|9743801|FG005|STARTED|Phase I: Dose Level 1||0
8698065|NCT00892177|9743796|FG000|COMPLETED|Phase I: Dose Level 1||0
8698066|NCT00892177|9743797|FG001|COMPLETED|Phase I: Dose Level 1||4
8698067|NCT00892177|9743798|FG002|COMPLETED|Phase I: Dose Level 1||0
8698068|NCT00892177|9743799|FG003|COMPLETED|Phase I: Dose Level 1||0
8698069|NCT00892177|9743800|FG004|COMPLETED|Phase I: Dose Level 1||0
8698070|NCT00892177|9743801|FG005|COMPLETED|Phase I: Dose Level 1||0
8698071|NCT00892177|9743796|FG000|NOT COMPLETED|Phase I: Dose Level 1||0
8698072|NCT00892177|9743797|FG001|NOT COMPLETED|Phase I: Dose Level 1||0
8698073|NCT00892177|9743798|FG002|NOT COMPLETED|Phase I: Dose Level 1||0
8698074|NCT00892177|9743799|FG003|NOT COMPLETED|Phase I: Dose Level 1||0
8698075|NCT00892177|9743800|FG004|NOT COMPLETED|Phase I: Dose Level 1||0
8698076|NCT00892177|9743801|FG005|NOT COMPLETED|Phase I: Dose Level 1||0
8698077|NCT00892177|9743796|FG000|STARTED|Phase I: Dose Level 2||0
8698078|NCT00892177|9743797|FG001|STARTED|Phase I: Dose Level 2||0
8698079|NCT00892177|9743798|FG002|STARTED|Phase I: Dose Level 2||3
8698080|NCT00892177|9743799|FG003|STARTED|Phase I: Dose Level 2||0
8698081|NCT00892177|9743800|FG004|STARTED|Phase I: Dose Level 2||0
8698082|NCT00892177|9743801|FG005|STARTED|Phase I: Dose Level 2||0
8698083|NCT00892177|9743796|FG000|COMPLETED|Phase I: Dose Level 2||0
8698084|NCT00892177|9743797|FG001|COMPLETED|Phase I: Dose Level 2||0
8698085|NCT00892177|9743798|FG002|COMPLETED|Phase I: Dose Level 2||3
8698086|NCT00892177|9743799|FG003|COMPLETED|Phase I: Dose Level 2||0
8698087|NCT00892177|9743800|FG004|COMPLETED|Phase I: Dose Level 2||0
8698088|NCT00892177|9743801|FG005|COMPLETED|Phase I: Dose Level 2||0
8698089|NCT00892177|9743796|FG000|NOT COMPLETED|Phase I: Dose Level 2||0
8698090|NCT00892177|9743797|FG001|NOT COMPLETED|Phase I: Dose Level 2||0
8698091|NCT00892177|9743798|FG002|NOT COMPLETED|Phase I: Dose Level 2||0
8698092|NCT00892177|9743799|FG003|NOT COMPLETED|Phase I: Dose Level 2||0
8698093|NCT00892177|9743800|FG004|NOT COMPLETED|Phase I: Dose Level 2||0
8698094|NCT00892177|9743801|FG005|NOT COMPLETED|Phase I: Dose Level 2||0
8698095|NCT00892177|9743796|FG000|STARTED|Phase I: Dose Level 3||0
8698096|NCT00892177|9743797|FG001|STARTED|Phase I: Dose Level 3||0
8698097|NCT00892177|9743798|FG002|STARTED|Phase I: Dose Level 3||0
8698098|NCT00892177|9743799|FG003|STARTED|Phase I: Dose Level 3||6
8698099|NCT00892177|9743800|FG004|STARTED|Phase I: Dose Level 3||0
8698100|NCT00892177|9743801|FG005|STARTED|Phase I: Dose Level 3||0
8698101|NCT00892177|9743796|FG000|COMPLETED|Phase I: Dose Level 3||0
8698102|NCT00892177|9743797|FG001|COMPLETED|Phase I: Dose Level 3||0
8698103|NCT00892177|9743798|FG002|COMPLETED|Phase I: Dose Level 3||0
8698104|NCT00892177|9743799|FG003|COMPLETED|Phase I: Dose Level 3||6
8698105|NCT00892177|9743800|FG004|COMPLETED|Phase I: Dose Level 3||0
8698106|NCT00892177|9743801|FG005|COMPLETED|Phase I: Dose Level 3||0
8698107|NCT00892177|9743796|FG000|NOT COMPLETED|Phase I: Dose Level 3||0
8698108|NCT00892177|9743797|FG001|NOT COMPLETED|Phase I: Dose Level 3||0
8698109|NCT00892177|9743798|FG002|NOT COMPLETED|Phase I: Dose Level 3||0
8698110|NCT00892177|9743799|FG003|NOT COMPLETED|Phase I: Dose Level 3||0
8698111|NCT00892177|9743800|FG004|NOT COMPLETED|Phase I: Dose Level 3||0
8698112|NCT00892177|9743801|FG005|NOT COMPLETED|Phase I: Dose Level 3||0
8698113|NCT00892177|9743796|FG000|STARTED|Phase II||0
8698114|NCT00892177|9743797|FG001|STARTED|Phase II||0
8698115|NCT00892177|9743798|FG002|STARTED|Phase II||0
8698116|NCT00892177|9743799|FG003|STARTED|Phase II||0
8698117|NCT00892177|9743800|FG004|STARTED|Phase II||88
8698118|NCT00892177|9743801|FG005|STARTED|Phase II||40
8698119|NCT00892177|9743796|FG000|COMPLETED|Phase II||0
8698120|NCT00892177|9743797|FG001|COMPLETED|Phase II||0
8698121|NCT00892177|9743798|FG002|COMPLETED|Phase II||0
8698122|NCT00892177|9743799|FG003|COMPLETED|Phase II||0
8698123|NCT00892177|9743800|FG004|COMPLETED|Phase II||83
8698124|NCT00892177|9743801|FG005|COMPLETED|Phase II||38
8698125|NCT00892177|9743796|FG000|NOT COMPLETED|Phase II||0
8698126|NCT00892177|9743797|FG001|NOT COMPLETED|Phase II||0
8698127|NCT00892177|9743798|FG002|NOT COMPLETED|Phase II||0
8698128|NCT00892177|9743799|FG003|NOT COMPLETED|Phase II||0
8926444|NCT02266472|9987645|FG000|STARTED|Period 2+ Washout||15
8926445|NCT02266472|9987646|FG001|STARTED|Period 2+ Washout||15
8926446|NCT02266472|9987645|FG000|COMPLETED|Period 2+ Washout||15
8698129|NCT00892177|9743800|FG004|NOT COMPLETED|Phase II||5
8698130|NCT00892177|9743801|FG005|NOT COMPLETED|Phase II||2
8698131|NCT00892281|9743818|FG000|STARTED|Overall Study||1197
8698132|NCT00892281|9743819|FG001|STARTED|Overall Study||224
8698133|NCT00892281|9743818|FG000|COMPLETED|Overall Study||930
8926447|NCT02266472|9987646|FG001|COMPLETED|Period 2+ Washout||15
8926448|NCT02266472|9987645|FG000|NOT COMPLETED|Period 2+ Washout||0
8926449|NCT02266472|9987646|FG001|NOT COMPLETED|Period 2+ Washout||0
8926450|NCT02266576|9987654|FG000|STARTED|Overall Study||102
8926451|NCT02266576|9987655|FG001|STARTED|Overall Study||105
8926452|NCT02266576|9987654|FG000|COMPLETED|Overall Study||85
8926453|NCT02266576|9987655|FG001|COMPLETED|Overall Study||90
8926454|NCT02266576|9987654|FG000|NOT COMPLETED|Overall Study||17
8926455|NCT02266576|9987655|FG001|NOT COMPLETED|Overall Study||15
8926456|NCT02266706|9987670|FG000|STARTED|Overall Study||6
8926457|NCT02266706|9987671|FG001|STARTED|Overall Study||7
8926458|NCT02266706|9987672|FG002|STARTED|Overall Study||4
8926459|NCT02266706|9987673|FG003|STARTED|Overall Study||4
8926460|NCT02266706|9987674|FG004|STARTED|Overall Study||1
8926461|NCT02266706|9987675|FG005|STARTED|Overall Study||7
8926462|NCT02266706|9987676|FG006|STARTED|Overall Study||8
8926463|NCT02266706|9987677|FG007|STARTED|Overall Study||2
8926464|NCT02266706|9987678|FG008|STARTED|Overall Study||4
8926465|NCT02266706|9987670|FG000|Treated|Overall Study||6
8698134|NCT00892281|9743819|FG001|COMPLETED|Overall Study||187
8698135|NCT00892281|9743818|FG000|NOT COMPLETED|Overall Study||267
8698136|NCT00892281|9743819|FG001|NOT COMPLETED|Overall Study||37
8698137|NCT00892437|9743827|FG000|STARTED|Randomized Phase||56
8698138|NCT00892437|9743828|FG001|STARTED|Randomized Phase||29
8698139|NCT00892437|9743827|FG000|Randomized and Treated|Randomized Phase||50
8698140|NCT00892437|9743828|FG001|Randomized and Treated|Randomized Phase||29
8698141|NCT00892437|9743827|FG000|COMPLETED|Randomized Phase||45
8698142|NCT00892437|9743828|FG001|COMPLETED|Randomized Phase||24
8698143|NCT00892437|9743827|FG000|NOT COMPLETED|Randomized Phase||11
8698144|NCT00892437|9743828|FG001|NOT COMPLETED|Randomized Phase||5
8698145|NCT00892437|9743827|FG000|STARTED|Open-Label Extension Phase|1 participant completed the randomized phase but did not enter the open-label extension phase.|44
8698146|NCT00892437|9743828|FG001|STARTED|Open-Label Extension Phase|5 participants completed the randomized phase but did not enter the open-label extension phase.|19
8698147|NCT00892437|9743827|FG000|COMPLETED|Open-Label Extension Phase||32
8698148|NCT00892437|9743828|FG001|COMPLETED|Open-Label Extension Phase||15
8698149|NCT00892437|9743827|FG000|NOT COMPLETED|Open-Label Extension Phase||12
8698150|NCT00892437|9743828|FG001|NOT COMPLETED|Open-Label Extension Phase||4
8698151|NCT00892606|9743837|FG000|STARTED|Overall Study||38
8698152|NCT00892606|9743838|FG001|STARTED|Overall Study||37
8698153|NCT00892606|9743837|FG000|COMPLETED|Overall Study||33
8698154|NCT00892606|9743838|FG001|COMPLETED|Overall Study||33
8698155|NCT00892606|9743837|FG000|NOT COMPLETED|Overall Study||5
8698156|NCT00892606|9743838|FG001|NOT COMPLETED|Overall Study||4
8698157|NCT00892697|9743844|FG000|STARTED|Overall Study||15
8698158|NCT00892697|9743844|FG000|COMPLETED|Overall Study||15
8698159|NCT00892697|9743844|FG000|NOT COMPLETED|Overall Study||0
8698160|NCT00892710|9743852|FG000|STARTED|Overall Study||48
8698161|NCT00892710|9743853|FG001|STARTED|Overall Study||59
8698162|NCT00892710|9743854|FG002|STARTED|Overall Study||55
8698163|NCT00892710|9743852|FG000|COMPLETED|Overall Study|Patients remained on study until disease progression or intolerable toxicity occurred|0
8698164|NCT00892710|9743853|FG001|COMPLETED|Overall Study|Patients remained on study until disease progression or intolerable toxicity occurred|0
8698165|NCT00892710|9743854|FG002|COMPLETED|Overall Study|Patients remained on study until disease progression or intolerable toxicity occurred|0
8698166|NCT00892710|9743852|FG000|NOT COMPLETED|Overall Study||48
8698167|NCT00892710|9743853|FG001|NOT COMPLETED|Overall Study||59
8698168|NCT00892710|9743854|FG002|NOT COMPLETED|Overall Study||55
8698169|NCT00892723|9743865|FG000|STARTED|Overall Study||21
8698170|NCT00892723|9743866|FG001|STARTED|Overall Study||19
8698171|NCT00892723|9743867|FG002|STARTED|Overall Study||19
8698172|NCT00892723|9743865|FG000|COMPLETED|Overall Study||19
8698173|NCT00892723|9743866|FG001|COMPLETED|Overall Study||15
8698174|NCT00892723|9743867|FG002|COMPLETED|Overall Study||17
8698175|NCT00892723|9743865|FG000|NOT COMPLETED|Overall Study||2
8926466|NCT02266706|9987671|FG001|Treated|Overall Study||6
8926467|NCT02266706|9987672|FG002|Treated|Overall Study||3
8926468|NCT02266706|9987673|FG003|Treated|Overall Study||3
8926469|NCT02266706|9987674|FG004|Treated|Overall Study||1
9042255|NCT03379545|10102823|FG000|STARTED|Overall Study||29
9042256|NCT03379545|10102823|FG000|COMPLETED|Overall Study||29
9042257|NCT03379545|10102823|FG000|NOT COMPLETED|Overall Study||0
9042258|NCT03379662|10102830|FG000|STARTED|Overall Study||21
9042259|NCT03379662|10102831|FG001|STARTED|Overall Study||19
9042260|NCT03379662|10102830|FG000|COMPLETED|Overall Study||21
9042261|NCT03379662|10102831|FG001|COMPLETED|Overall Study||19
9042262|NCT03379662|10102830|FG000|NOT COMPLETED|Overall Study||0
9042263|NCT03379662|10102831|FG001|NOT COMPLETED|Overall Study||0
9042264|NCT03379740|10102839|FG000|STARTED|Overall Study||8
9042265|NCT03379740|10102840|FG001|STARTED|Overall Study||7
9042266|NCT03379740|10102839|FG000|COMPLETED|Overall Study||8
9042267|NCT03379740|10102840|FG001|COMPLETED|Overall Study||7
9042268|NCT03379740|10102839|FG000|NOT COMPLETED|Overall Study||0
8698176|NCT00892723|9743866|FG001|NOT COMPLETED|Overall Study||4
8698177|NCT00892723|9743867|FG002|NOT COMPLETED|Overall Study||2
8698178|NCT00892775|9743910|FG000|STARTED|Overall Study||332
8698179|NCT00892775|9743911|FG001|STARTED|Overall Study||166
8698180|NCT00892775|9743910|FG000|COMPLETED|Overall Study||327
8698181|NCT00892775|9743911|FG001|COMPLETED|Overall Study||165
8698182|NCT00892775|9743910|FG000|NOT COMPLETED|Overall Study||5
8698183|NCT00892775|9743911|FG001|NOT COMPLETED|Overall Study||1
8926470|NCT02266706|9987675|FG005|Treated|Overall Study||5
8926471|NCT02266706|9987676|FG006|Treated|Overall Study||7
8926472|NCT02266706|9987677|FG007|Treated|Overall Study||2
8926473|NCT02266706|9987678|FG008|Treated|Overall Study||4
8926474|NCT02266706|9987670|FG000|COMPLETED|Overall Study||6
8926475|NCT02266706|9987671|FG001|COMPLETED|Overall Study||6
8926476|NCT02266706|9987672|FG002|COMPLETED|Overall Study||3
8698184|NCT00892957|9743919|FG000|STARTED|Intraoperative Day 0||70
8698185|NCT00892957|9743920|FG001|STARTED|Intraoperative Day 0||70
8698186|NCT00892957|9743919|FG000|COMPLETED|Intraoperative Day 0||70
8698187|NCT00892957|9743920|FG001|COMPLETED|Intraoperative Day 0||70
8698188|NCT00892957|9743919|FG000|NOT COMPLETED|Intraoperative Day 0||0
8698189|NCT00892957|9743920|FG001|NOT COMPLETED|Intraoperative Day 0||0
8698190|NCT00892957|9743919|FG000|STARTED|Postoperative Day 1 Assessment||70
8698191|NCT00892957|9743920|FG001|STARTED|Postoperative Day 1 Assessment||70
8698192|NCT00892957|9743919|FG000|COMPLETED|Postoperative Day 1 Assessment||70
8698193|NCT00892957|9743920|FG001|COMPLETED|Postoperative Day 1 Assessment||70
8698194|NCT00892957|9743919|FG000|NOT COMPLETED|Postoperative Day 1 Assessment||0
8698195|NCT00892957|9743920|FG001|NOT COMPLETED|Postoperative Day 1 Assessment||0
8698196|NCT00892957|9743919|FG000|STARTED|Between Postoperative Day 1 and Day 14||70
8698197|NCT00892957|9743920|FG001|STARTED|Between Postoperative Day 1 and Day 14||70
8698198|NCT00892957|9743919|FG000|COMPLETED|Between Postoperative Day 1 and Day 14||70
8698199|NCT00892957|9743920|FG001|COMPLETED|Between Postoperative Day 1 and Day 14||66
8698200|NCT00892957|9743919|FG000|NOT COMPLETED|Between Postoperative Day 1 and Day 14||0
8698201|NCT00892957|9743920|FG001|NOT COMPLETED|Between Postoperative Day 1 and Day 14||4
8698202|NCT00892957|9743919|FG000|STARTED|Postoperative Day 14 Assessment|Two participants missed postoperative Day 14 assessment, both returned for Day 30 postop assessment|68
8698203|NCT00892957|9743920|FG001|STARTED|Postoperative Day 14 Assessment||66
8698204|NCT00892957|9743919|FG000|COMPLETED|Postoperative Day 14 Assessment||68
8698205|NCT00892957|9743920|FG001|COMPLETED|Postoperative Day 14 Assessment||66
8698206|NCT00892957|9743919|FG000|NOT COMPLETED|Postoperative Day 14 Assessment||0
8698207|NCT00892957|9743920|FG001|NOT COMPLETED|Postoperative Day 14 Assessment||0
8698208|NCT00892957|9743919|FG000|STARTED|Postoperative Day 30 Assessment|Two participants missed postoperative Day 14 assessment, both returned for Day 30 postop assessment|70
8698209|NCT00892957|9743920|FG001|STARTED|Postoperative Day 30 Assessment||66
8698210|NCT00892957|9743919|FG000|COMPLETED|Postoperative Day 30 Assessment||70
8698211|NCT00892957|9743920|FG001|COMPLETED|Postoperative Day 30 Assessment||66
8698212|NCT00892957|9743919|FG000|NOT COMPLETED|Postoperative Day 30 Assessment||0
8698213|NCT00892957|9743920|FG001|NOT COMPLETED|Postoperative Day 30 Assessment||0
8698214|NCT00893074|9743940|FG000|STARTED|Overall Study||24
8698215|NCT00893074|9743940|FG000|COMPLETED|Overall Study||13
8698216|NCT00893074|9743940|FG000|NOT COMPLETED|Overall Study||11
8698217|NCT00893113|9743957|FG000|STARTED|Overall Study||36
8698218|NCT00893113|9743958|FG001|STARTED|Overall Study||38
8698219|NCT00893113|9743957|FG000|COMPLETED|Overall Study||23
8698220|NCT00893113|9743958|FG001|COMPLETED|Overall Study||22
8698221|NCT00893113|9743957|FG000|NOT COMPLETED|Overall Study||13
8698222|NCT00893113|9743958|FG001|NOT COMPLETED|Overall Study||16
8698223|NCT00893152|9743966|FG000|STARTED|Overall Study||47
8698224|NCT00893152|9743967|FG001|STARTED|Overall Study||36
8698225|NCT00893152|9743966|FG000|COMPLETED|Overall Study||47
8698226|NCT00893152|9743967|FG001|COMPLETED|Overall Study||36
8698227|NCT00893152|9743966|FG000|NOT COMPLETED|Overall Study||0
8698228|NCT00893152|9743967|FG001|NOT COMPLETED|Overall Study||0
8698229|NCT00893464|9743981|FG000|STARTED|Overall Study||1
8698230|NCT00893464|9743982|FG001|STARTED|Overall Study||1
8698231|NCT00893464|9743983|FG002|STARTED|Overall Study||1
8698232|NCT00893464|9743984|FG003|STARTED|Overall Study||1
8698233|NCT00893464|9743985|FG004|STARTED|Overall Study||4
8698234|NCT00893464|9743986|FG005|STARTED|Overall Study||7
8698235|NCT00893464|9743987|FG006|STARTED|Overall Study||10
8698236|NCT00893464|9743988|FG007|STARTED|Overall Study||5
8698237|NCT00893464|9743981|FG000|COMPLETED|Overall Study||1
8698238|NCT00893464|9743982|FG001|COMPLETED|Overall Study||1
8698239|NCT00893464|9743983|FG002|COMPLETED|Overall Study||1
8698240|NCT00893464|9743984|FG003|COMPLETED|Overall Study||1
8698241|NCT00893464|9743985|FG004|COMPLETED|Overall Study||4
8698242|NCT00893464|9743986|FG005|COMPLETED|Overall Study||7
8698243|NCT00893464|9743987|FG006|COMPLETED|Overall Study||8
8698244|NCT00893464|9743988|FG007|COMPLETED|Overall Study||3
8698245|NCT00893464|9743981|FG000|NOT COMPLETED|Overall Study||0
8698246|NCT00893464|9743982|FG001|NOT COMPLETED|Overall Study||0
8698247|NCT00893464|9743983|FG002|NOT COMPLETED|Overall Study||0
8698248|NCT00893464|9743984|FG003|NOT COMPLETED|Overall Study||0
8698249|NCT00893464|9743985|FG004|NOT COMPLETED|Overall Study||0
8698250|NCT00893464|9743986|FG005|NOT COMPLETED|Overall Study||0
8698251|NCT00893464|9743987|FG006|NOT COMPLETED|Overall Study||2
8698252|NCT00893464|9743988|FG007|NOT COMPLETED|Overall Study||2
8698253|NCT00893737|9744011|FG000|STARTED|Overall Study||147
8698254|NCT00893737|9744011|FG000|COMPLETED|Overall Study||135
8698255|NCT00893737|9744011|FG000|NOT COMPLETED|Overall Study||12
8698256|NCT00893763|9744017|FG000|STARTED|Overall Study||157
8698257|NCT00893763|9744018|FG001|STARTED|Overall Study||157
8698258|NCT00893763|9744017|FG000|COMPLETED|Overall Study||47
8698259|NCT00893763|9744018|FG001|COMPLETED|Overall Study||47
8698260|NCT00893763|9744017|FG000|NOT COMPLETED|Overall Study||110
8698261|NCT00893763|9744018|FG001|NOT COMPLETED|Overall Study||110
8926477|NCT02266706|9987673|FG003|COMPLETED|Overall Study||3
8698262|NCT00893971|9744026|FG000|STARTED|Overall Study||16
8698263|NCT00893971|9744026|FG000|Placebo + GP MDI (PT001)|Overall Study||15
8926478|NCT02266706|9987674|FG004|COMPLETED|Overall Study||1
8926479|NCT02266706|9987675|FG005|COMPLETED|Overall Study||5
8926480|NCT02266706|9987676|FG006|COMPLETED|Overall Study||7
8926481|NCT02266706|9987677|FG007|COMPLETED|Overall Study||2
8926482|NCT02266706|9987678|FG008|COMPLETED|Overall Study||4
8926483|NCT02266706|9987670|FG000|NOT COMPLETED|Overall Study||0
8926484|NCT02266706|9987671|FG001|NOT COMPLETED|Overall Study||1
8926485|NCT02266706|9987672|FG002|NOT COMPLETED|Overall Study||1
8698264|NCT00893971|9744026|FG000|Placebo + GFF MDI (PT003)|Overall Study||15
8698265|NCT00893971|9744026|FG000|Placebo + FF MDI (PT005)|Overall Study||13
8698266|NCT00893971|9744026|FG000|GP MDI (PT001) + FF MDI (PT005)|Overall Study||16
8698267|NCT00893971|9744026|FG000|COMPLETED|Overall Study||13
8698268|NCT00893971|9744026|FG000|NOT COMPLETED|Overall Study||3
8698269|NCT00893984|9744039|FG000|STARTED|Overall Study||6
8698270|NCT00893984|9744039|FG000|COMPLETED|Overall Study||0
8698271|NCT00893984|9744039|FG000|NOT COMPLETED|Overall Study||6
8698272|NCT00893997|9744043|FG000|STARTED|Overall Study||10
8698273|NCT00893997|9744043|FG000|COMPLETED|Overall Study||10
8698274|NCT00893997|9744043|FG000|NOT COMPLETED|Overall Study||0
8698275|NCT00894127|9744047|FG000|STARTED|Overall Study||128
8698276|NCT00894127|9744047|FG000|COMPLETED|Overall Study||128
8698277|NCT00894127|9744047|FG000|NOT COMPLETED|Overall Study||0
8698278|NCT00894166|9744059|FG000|STARTED|Overall Study||132
8698279|NCT00894166|9744060|FG001|STARTED|Overall Study||109
8698280|NCT00894166|9744061|FG002|STARTED|Overall Study||112
8698281|NCT00894166|9744062|FG003|STARTED|Overall Study||114
8698282|NCT00894166|9744063|FG004|STARTED|Overall Study||34
8698283|NCT00894166|9744064|FG005|STARTED|Overall Study||36
8698284|NCT00894166|9744065|FG006|STARTED|Overall Study||35
8698285|NCT00894166|9744066|FG007|STARTED|Overall Study||34
8698286|NCT00894166|9744059|FG000|COMPLETED|Overall Study||71
8698287|NCT00894166|9744060|FG001|COMPLETED|Overall Study||46
8698288|NCT00894166|9744061|FG002|COMPLETED|Overall Study||50
8698289|NCT00894166|9744062|FG003|COMPLETED|Overall Study||45
8698290|NCT00894166|9744063|FG004|COMPLETED|Overall Study||10
8698291|NCT00894166|9744064|FG005|COMPLETED|Overall Study||20
8698292|NCT00894166|9744065|FG006|COMPLETED|Overall Study||19
8698293|NCT00894166|9744066|FG007|COMPLETED|Overall Study||0
8698294|NCT00894166|9744059|FG000|NOT COMPLETED|Overall Study||61
8698295|NCT00894166|9744060|FG001|NOT COMPLETED|Overall Study||63
8698296|NCT00894166|9744061|FG002|NOT COMPLETED|Overall Study||62
8698297|NCT00894166|9744062|FG003|NOT COMPLETED|Overall Study||69
8698298|NCT00894166|9744063|FG004|NOT COMPLETED|Overall Study||24
8698299|NCT00894166|9744064|FG005|NOT COMPLETED|Overall Study||16
8698300|NCT00894166|9744065|FG006|NOT COMPLETED|Overall Study||16
8698301|NCT00894166|9744066|FG007|NOT COMPLETED|Overall Study||34
8698302|NCT00894322|9744092|FG000|STARTED|Overall Study||30
8698303|NCT00894322|9744093|FG001|STARTED|Overall Study||23
8698304|NCT00894322|9744094|FG002|STARTED|Overall Study||12
8698305|NCT00894322|9744092|FG000|COMPLETED|Overall Study||29
8698306|NCT00894322|9744093|FG001|COMPLETED|Overall Study||23
8698307|NCT00894322|9744094|FG002|COMPLETED|Overall Study||12
8698308|NCT00894322|9744092|FG000|NOT COMPLETED|Overall Study||1
8698309|NCT00894322|9744093|FG001|NOT COMPLETED|Overall Study||0
8698310|NCT00894322|9744094|FG002|NOT COMPLETED|Overall Study||0
8698311|NCT00894361|9744106|FG000|STARTED|Overall Study||200
8698312|NCT00894361|9744107|FG001|STARTED|Overall Study||200
8698313|NCT00894361|9744106|FG000|COMPLETED|Overall Study||176
8698314|NCT00894361|9744107|FG001|COMPLETED|Overall Study||136
8698315|NCT00894361|9744106|FG000|NOT COMPLETED|Overall Study||24
8698316|NCT00894361|9744107|FG001|NOT COMPLETED|Overall Study||64
8698317|NCT00894387|9744117|FG000|STARTED|Overall Study|"Started indicates all randomized patients"|821
8698318|NCT00894387|9744118|FG001|STARTED|Overall Study||818
8698319|NCT00894387|9744117|FG000|Safety Set|Overall Study||808
8698320|NCT00894387|9744118|FG001|Safety Set|Overall Study||810
8698321|NCT00894387|9744117|FG000|Full Analysis Set|Overall Study||808
8698322|NCT00894387|9744118|FG001|Full Analysis Set|Overall Study||807
8698323|NCT00894387|9744117|FG000|Completed Primary Efficacy Phase (6 m)|Overall Study||717
8698324|NCT00894387|9744118|FG001|Completed Primary Efficacy Phase (6 m)|Overall Study||707
8698325|NCT00894387|9744117|FG000|Completed Secondary Efficacy Phase (12m)|Overall Study||654
8698326|NCT00894387|9744118|FG001|Completed Secondary Efficacy Phase (12m)|Overall Study||640
8698327|NCT00894387|9744117|FG000|COMPLETED|Overall Study|"Completed indicates patients whose treatment duration completed as per protocol"|646
8698328|NCT00894387|9744118|FG001|COMPLETED|Overall Study||643
8698329|NCT00894387|9744117|FG000|NOT COMPLETED|Overall Study||175
8698330|NCT00894387|9744118|FG001|NOT COMPLETED|Overall Study||175
8698331|NCT00894413|9744126|FG000|STARTED|Overall Study||15
8698332|NCT00894413|9744127|FG001|STARTED|Overall Study||25
8698333|NCT00894413|9744126|FG000|COMPLETED|Overall Study||15
8698334|NCT00894413|9744127|FG001|COMPLETED|Overall Study||17
8698335|NCT00894413|9744126|FG000|NOT COMPLETED|Overall Study||0
8698336|NCT00894413|9744127|FG001|NOT COMPLETED|Overall Study||8
8698337|NCT00894465|9744135|FG000|STARTED|Overall Study||22
8698338|NCT00894465|9744136|FG001|STARTED|Overall Study||22
8698339|NCT00894465|9744135|FG000|COMPLETED|Overall Study||22
8698340|NCT00894465|9744136|FG001|COMPLETED|Overall Study||22
8698341|NCT00894465|9744135|FG000|NOT COMPLETED|Overall Study||0
8698342|NCT00894465|9744136|FG001|NOT COMPLETED|Overall Study||0
8698343|NCT00894504|9744144|FG000|STARTED|Overall Study||71
8698344|NCT00894504|9744144|FG000|COMPLETED|Overall Study||0
8698345|NCT00894504|9744144|FG000|NOT COMPLETED|Overall Study||71
8698346|NCT00894517|9744160|FG000|STARTED|Overall Study||30
8926486|NCT02266706|9987673|FG003|NOT COMPLETED|Overall Study||1
8926487|NCT02266706|9987674|FG004|NOT COMPLETED|Overall Study||0
8926488|NCT02266706|9987675|FG005|NOT COMPLETED|Overall Study||2
8926489|NCT02266706|9987676|FG006|NOT COMPLETED|Overall Study||1
8926490|NCT02266706|9987677|FG007|NOT COMPLETED|Overall Study||0
8698347|NCT00894517|9744161|FG001|STARTED|Overall Study||31
8698348|NCT00894517|9744160|FG000|COMPLETED|Overall Study||28
8698349|NCT00894517|9744161|FG001|COMPLETED|Overall Study||26
8698350|NCT00894517|9744160|FG000|NOT COMPLETED|Overall Study||2
8698351|NCT00894517|9744161|FG001|NOT COMPLETED|Overall Study||5
8698352|NCT00894543|9744169|FG000|STARTED|Baseline||104
8698353|NCT00894543|9744170|FG001|STARTED|Baseline||101
8698354|NCT00894543|9744169|FG000|COMPLETED|Baseline||104
8698355|NCT00894543|9744170|FG001|COMPLETED|Baseline||101
8698356|NCT00894543|9744169|FG000|NOT COMPLETED|Baseline||0
8698357|NCT00894543|9744170|FG001|NOT COMPLETED|Baseline||0
8698358|NCT00894543|9744169|FG000|STARTED|Baseline to Week 4||104
8698359|NCT00894543|9744170|FG001|STARTED|Baseline to Week 4||101
8698360|NCT00894543|9744169|FG000|COMPLETED|Baseline to Week 4||101
8698361|NCT00894543|9744170|FG001|COMPLETED|Baseline to Week 4||99
8698362|NCT00894543|9744169|FG000|NOT COMPLETED|Baseline to Week 4||3
8698363|NCT00894543|9744170|FG001|NOT COMPLETED|Baseline to Week 4||2
8698364|NCT00894543|9744169|FG000|STARTED|Week 4 to Week 8||101
8698365|NCT00894543|9744170|FG001|STARTED|Week 4 to Week 8||99
8698366|NCT00894543|9744169|FG000|COMPLETED|Week 4 to Week 8||97
8698367|NCT00894543|9744170|FG001|COMPLETED|Week 4 to Week 8||97
8698368|NCT00894543|9744169|FG000|NOT COMPLETED|Week 4 to Week 8||4
8698369|NCT00894543|9744170|FG001|NOT COMPLETED|Week 4 to Week 8||2
8698370|NCT00894647|9744178|FG000|STARTED|Overall Study||121
8698371|NCT00894647|9744179|FG001|STARTED|Overall Study||126
8698372|NCT00894647|9744178|FG000|COMPLETED|Overall Study||111
8698373|NCT00894647|9744179|FG001|COMPLETED|Overall Study||112
8698374|NCT00894647|9744178|FG000|NOT COMPLETED|Overall Study||10
8698375|NCT00894647|9744179|FG001|NOT COMPLETED|Overall Study||14
8698376|NCT00894686|9744185|FG000|STARTED|Overall Study||179
8698377|NCT00894686|9744185|FG000|COMPLETED|Overall Study||123
8698378|NCT00894686|9744185|FG000|NOT COMPLETED|Overall Study||56
8698379|NCT00894699|9744191|FG000|STARTED|Overall Study||21
8698380|NCT00894699|9744192|FG001|STARTED|Overall Study||19
8698381|NCT00894699|9744191|FG000|COMPLETED|Overall Study||21
8698382|NCT00894699|9744192|FG001|COMPLETED|Overall Study||19
8698383|NCT00894699|9744191|FG000|NOT COMPLETED|Overall Study||0
8698384|NCT00894699|9744192|FG001|NOT COMPLETED|Overall Study||0
8698385|NCT00894738|9744200|FG000|STARTED|Overall Study||25
8698386|NCT00894738|9744201|FG001|STARTED|Overall Study||19
8698387|NCT00894738|9744200|FG000|COMPLETED|Overall Study||25
8698388|NCT00894738|9744201|FG001|COMPLETED|Overall Study||19
8698389|NCT00894738|9744200|FG000|NOT COMPLETED|Overall Study||0
8698390|NCT00894738|9744201|FG001|NOT COMPLETED|Overall Study||0
8698391|NCT00894803|9744209|FG000|STARTED|Overall Study||101
8698392|NCT00894803|9744210|FG001|STARTED|Overall Study||25
8698393|NCT00894803|9744209|FG000|COMPLETED|Overall Study||81
8698394|NCT00894803|9744210|FG001|COMPLETED|Overall Study||20
8698395|NCT00894803|9744209|FG000|NOT COMPLETED|Overall Study||20
8698396|NCT00894803|9744210|FG001|NOT COMPLETED|Overall Study||5
8698397|NCT00894933|9744216|FG000|STARTED|Overall Study||33
8698398|NCT00894933|9744216|FG000|COMPLETED|Overall Study||29
8698399|NCT00894933|9744216|FG000|NOT COMPLETED|Overall Study||4
8698400|NCT00895011|9744223|FG000|STARTED|Overall Study||100
8698401|NCT00895011|9744224|FG001|STARTED|Overall Study||99
8698402|NCT00895011|9744225|FG002|STARTED|Overall Study||99
8698403|NCT00895011|9744223|FG000|COMPLETED|Overall Study||76
8698404|NCT00895011|9744224|FG001|COMPLETED|Overall Study||85
8698405|NCT00895011|9744225|FG002|COMPLETED|Overall Study||91
8698406|NCT00895011|9744223|FG000|NOT COMPLETED|Overall Study||24
8812243|NCT01518946|9865180|FG000|NOT COMPLETED|Randomized Phase (Second Intervention)||0
8812244|NCT01518946|9865181|FG001|NOT COMPLETED|Randomized Phase (Second Intervention)||0
8812245|NCT01518946|9865182|FG002|NOT COMPLETED|Randomized Phase (Second Intervention)||0
8812246|NCT01518972|9865191|FG000|STARTED|Overall Study||15
8812247|NCT01518972|9865192|FG001|STARTED|Overall Study||15
8812248|NCT01518972|9865191|FG000|COMPLETED|Overall Study||9
8812249|NCT01518972|9865192|FG001|COMPLETED|Overall Study||11
8812250|NCT01518972|9865191|FG000|NOT COMPLETED|Overall Study||6
8812251|NCT01518972|9865192|FG001|NOT COMPLETED|Overall Study||4
8812252|NCT01519063|9865200|FG000|STARTED|Overall Study||26
8812253|NCT01519063|9865201|FG001|STARTED|Overall Study||30
8812254|NCT01519063|9865200|FG000|COMPLETED|Overall Study||19
8812255|NCT01519063|9865201|FG001|COMPLETED|Overall Study||25
8926491|NCT02266706|9987678|FG008|NOT COMPLETED|Overall Study||0
8698407|NCT00895011|9744224|FG001|NOT COMPLETED|Overall Study||14
8698408|NCT00895011|9744225|FG002|NOT COMPLETED|Overall Study||8
8698409|NCT00895037|9744237|FG000|STARTED|Overall Study||22
8698410|NCT00895037|9744238|FG001|STARTED|Overall Study||77
8698411|NCT00895037|9744239|FG002|STARTED|Overall Study||2
8698412|NCT00895037|9744237|FG000|COMPLETED|Overall Study||22
8698413|NCT00895037|9744238|FG001|COMPLETED|Overall Study||75
8698414|NCT00895037|9744239|FG002|COMPLETED|Overall Study||1
8698415|NCT00895037|9744237|FG000|NOT COMPLETED|Overall Study||0
8698416|NCT00895037|9744238|FG001|NOT COMPLETED|Overall Study||2
8698417|NCT00895037|9744239|FG002|NOT COMPLETED|Overall Study||1
8698418|NCT00895154|9744249|FG000|STARTED|Overall Study||8
8698419|NCT00895154|9744250|FG001|STARTED|Overall Study||10
8698420|NCT00895154|9744249|FG000|Follow Up|Overall Study||7
8698421|NCT00895154|9744250|FG001|Follow Up|Overall Study||8
8698422|NCT00895154|9744249|FG000|COMPLETED|Overall Study||7
8698423|NCT00895154|9744250|FG001|COMPLETED|Overall Study||8
8698424|NCT00895154|9744249|FG000|NOT COMPLETED|Overall Study||1
8926492|NCT02266810|9987700|FG000|STARTED|Overall Study|sinus sides|80
8926493|NCT02266810|9987701|FG001|STARTED|Overall Study|sinus sides|80
8926494|NCT02266810|9987700|FG000|COMPLETED|Overall Study|sinus sides|79
8926495|NCT02266810|9987701|FG001|COMPLETED|Overall Study|sinus sides|79
8926496|NCT02266810|9987700|FG000|NOT COMPLETED|Overall Study||1
8926497|NCT02266810|9987701|FG001|NOT COMPLETED|Overall Study||1
8926498|NCT02266875|9987718|FG000|STARTED|Overall Study||40
8926499|NCT02266875|9987719|FG001|STARTED|Overall Study||30
8926500|NCT02266875|9987718|FG000|COMPLETED|Overall Study||29
8926501|NCT02266875|9987719|FG001|COMPLETED|Overall Study||30
8926502|NCT02266875|9987718|FG000|NOT COMPLETED|Overall Study||11
8926503|NCT02266875|9987719|FG001|NOT COMPLETED|Overall Study||0
8926504|NCT02266888|9987727|FG000|STARTED|Overall Study||15
8926505|NCT02266888|9987728|FG001|STARTED|Overall Study||12
8926506|NCT02266888|9987729|FG002|STARTED|Overall Study||11
8926507|NCT02266888|9987730|FG003|STARTED|Overall Study||7
8926508|NCT02266888|9987727|FG000|COMPLETED|Overall Study||8
8926509|NCT02266888|9987728|FG001|COMPLETED|Overall Study||8
8926510|NCT02266888|9987729|FG002|COMPLETED|Overall Study||0
8926511|NCT02266888|9987730|FG003|COMPLETED|Overall Study||0
8926512|NCT02266888|9987727|FG000|NOT COMPLETED|Overall Study||7
8926513|NCT02266888|9987728|FG001|NOT COMPLETED|Overall Study||4
8926514|NCT02266888|9987729|FG002|NOT COMPLETED|Overall Study||11
8926515|NCT02266888|9987730|FG003|NOT COMPLETED|Overall Study||7
8926516|NCT02267083|9987738|FG000|STARTED|Overall Study||22
8926517|NCT02267083|9987738|FG000|COMPLETED|Overall Study||3
8926518|NCT02267083|9987738|FG000|NOT COMPLETED|Overall Study||19
8926519|NCT02267135|9987744|FG000|STARTED|Period 1 (Randomized Set)||51
8926520|NCT02267135|9987745|FG001|STARTED|Period 1 (Randomized Set)||51
8926521|NCT02267135|9987744|FG000|COMPLETED|Period 1 (Randomized Set)||50
8926522|NCT02267135|9987745|FG001|COMPLETED|Period 1 (Randomized Set)||47
8926523|NCT02267135|9987744|FG000|NOT COMPLETED|Period 1 (Randomized Set)||1
8926524|NCT02267135|9987745|FG001|NOT COMPLETED|Period 1 (Randomized Set)||4
8926525|NCT02267135|9987744|FG000|STARTED|Period 2 (Randomized Set)||50
8926526|NCT02267135|9987745|FG001|STARTED|Period 2 (Randomized Set)||47
8926527|NCT02267135|9987744|FG000|COMPLETED|Period 2 (Randomized Set)||46
8926528|NCT02267135|9987745|FG001|COMPLETED|Period 2 (Randomized Set)||46
8926529|NCT02267135|9987744|FG000|NOT COMPLETED|Period 2 (Randomized Set)||4
8926530|NCT02267135|9987745|FG001|NOT COMPLETED|Period 2 (Randomized Set)||1
8926531|NCT02267187|9987754|FG000|STARTED|Overall Study||15
8926532|NCT02267187|9987754|FG000|COMPLETED|Overall Study||10
8926533|NCT02267187|9987754|FG000|NOT COMPLETED|Overall Study||5
8926534|NCT02267226|9987758|FG000|STARTED|Overall Study||25
8926535|NCT02267226|9987758|FG000|SAFETY Population|Overall Study||25
8926536|NCT02267226|9987758|FG000|FAS-Bleeding Population|Overall Study||24
8926537|NCT02267226|9987758|FG000|Surgical Prophylaxis Population|Overall Study||9
8926538|NCT02267226|9987758|FG000|COMPLETED|Overall Study||18
8926539|NCT02267226|9987758|FG000|NOT COMPLETED|Overall Study||7
8926540|NCT02267278|9987777|FG000|STARTED|Overall Study||25
8926541|NCT02267278|9987777|FG000|COMPLETED|Overall Study||20
8926542|NCT02267278|9987777|FG000|NOT COMPLETED|Overall Study||5
8926543|NCT02267317|9987784|FG000|STARTED|Infusion1||8
8926544|NCT02267317|9987785|FG001|STARTED|Infusion1||3
8926545|NCT02267317|9987786|FG002|STARTED|Infusion1||1
8926546|NCT02267317|9987787|FG003|STARTED|Infusion1||2
8926547|NCT02267317|9987788|FG004|STARTED|Infusion1||0
8926548|NCT02267317|9987789|FG005|STARTED|Infusion1||1
8926549|NCT02267317|9987784|FG000|COMPLETED|Infusion1||8
8926550|NCT02267317|9987785|FG001|COMPLETED|Infusion1||3
8926551|NCT02267317|9987786|FG002|COMPLETED|Infusion1||1
8926552|NCT02267317|9987787|FG003|COMPLETED|Infusion1||2
8926553|NCT02267317|9987788|FG004|COMPLETED|Infusion1||0
8926554|NCT02267317|9987789|FG005|COMPLETED|Infusion1||1
8926555|NCT02267317|9987784|FG000|NOT COMPLETED|Infusion1||0
8926556|NCT02267317|9987785|FG001|NOT COMPLETED|Infusion1||0
8926557|NCT02267317|9987786|FG002|NOT COMPLETED|Infusion1||0
8926558|NCT02267317|9987787|FG003|NOT COMPLETED|Infusion1||0
8926559|NCT02267317|9987788|FG004|NOT COMPLETED|Infusion1||0
8926560|NCT02267317|9987789|FG005|NOT COMPLETED|Infusion1||0
8926561|NCT02267317|9987784|FG000|STARTED|Washout (3-4weeks Between Infusions)||8
8926562|NCT02267317|9987785|FG001|STARTED|Washout (3-4weeks Between Infusions)||3
8926563|NCT02267317|9987786|FG002|STARTED|Washout (3-4weeks Between Infusions)||1
8926564|NCT02267317|9987787|FG003|STARTED|Washout (3-4weeks Between Infusions)||2
8926565|NCT02267317|9987788|FG004|STARTED|Washout (3-4weeks Between Infusions)||0
8926566|NCT02267317|9987789|FG005|STARTED|Washout (3-4weeks Between Infusions)||1
8698425|NCT00895154|9744250|FG001|NOT COMPLETED|Overall Study||2
8698426|NCT00895180|9744258|FG000|STARTED|Overall Study||40
8698427|NCT00895180|9744259|FG001|STARTED|Overall Study||40
8698428|NCT00895180|9744258|FG000|Received at Least 1 Dose of Study Drug|Overall Study||40
8724369|NCT01026181|9771570|FG001|NOT COMPLETED|Overall Study||0
8926567|NCT02267317|9987784|FG000|COMPLETED|Washout (3-4weeks Between Infusions)||6
8926568|NCT02267317|9987785|FG001|COMPLETED|Washout (3-4weeks Between Infusions)||3
8926569|NCT02267317|9987786|FG002|COMPLETED|Washout (3-4weeks Between Infusions)||1
8926570|NCT02267317|9987787|FG003|COMPLETED|Washout (3-4weeks Between Infusions)||2
8926571|NCT02267317|9987788|FG004|COMPLETED|Washout (3-4weeks Between Infusions)||0
9042269|NCT03379740|10102840|FG001|NOT COMPLETED|Overall Study||0
9042270|NCT03379753|10102855|FG000|STARTED|Overall Study||61
9042271|NCT03379753|10102856|FG001|STARTED|Overall Study||71
9042272|NCT03379753|10102855|FG000|COMPLETED|Overall Study||46
9042273|NCT03379753|10102856|FG001|COMPLETED|Overall Study||46
9042274|NCT03379753|10102855|FG000|NOT COMPLETED|Overall Study||15
9042275|NCT03379753|10102856|FG001|NOT COMPLETED|Overall Study||25
9042276|NCT03380000|10102862|FG000|STARTED|First Intervention (1day)||8
9042277|NCT03380000|10102863|FG001|STARTED|First Intervention (1day)||8
9042278|NCT03380000|10102862|FG000|COMPLETED|First Intervention (1day)||8
9042279|NCT03380000|10102863|FG001|COMPLETED|First Intervention (1day)||8
9042280|NCT03380000|10102862|FG000|NOT COMPLETED|First Intervention (1day)||0
9042281|NCT03380000|10102863|FG001|NOT COMPLETED|First Intervention (1day)||0
9042282|NCT03380000|10102862|FG000|STARTED|Washout (>7days)||8
9042283|NCT03380000|10102863|FG001|STARTED|Washout (>7days)||8
9042284|NCT03380000|10102862|FG000|COMPLETED|Washout (>7days)||8
9042285|NCT03380000|10102863|FG001|COMPLETED|Washout (>7days)||8
9042286|NCT03380000|10102862|FG000|NOT COMPLETED|Washout (>7days)||0
9042287|NCT03380000|10102863|FG001|NOT COMPLETED|Washout (>7days)||0
9042288|NCT03380000|10102862|FG000|STARTED|Second Intervention (1day)||8
9042289|NCT03380000|10102863|FG001|STARTED|Second Intervention (1day)||8
9042290|NCT03380000|10102862|FG000|COMPLETED|Second Intervention (1day)||8
9042291|NCT03380000|10102863|FG001|COMPLETED|Second Intervention (1day)||8
9042292|NCT03380000|10102862|FG000|NOT COMPLETED|Second Intervention (1day)||0
9042293|NCT03380000|10102863|FG001|NOT COMPLETED|Second Intervention (1day)||0
9042294|NCT03380026|10102869|FG000|STARTED|Overall Study||28
9042295|NCT03380026|10102869|FG000|Half of Body Assigned to Treatment With Valchlor Only|Overall Study||28
9042296|NCT03380026|10102869|FG000|Half of Body Assigned to Treatment With Valchlor and Triamcinolone Acetonide|Overall Study||28
9042297|NCT03380026|10102869|FG000|COMPLETED|Overall Study||25
9042298|NCT03380026|10102869|FG000|NOT COMPLETED|Overall Study||3
9042299|NCT03380091|10102878|FG000|STARTED|Overall Study||3
9042300|NCT03380091|10102879|FG001|STARTED|Overall Study||2
9042301|NCT03380091|10102878|FG000|Began Arm Treatment|Overall Study|1 participant withdrew after completing baseline measures and another withdrew just after enrolling.|1
9042302|NCT03380091|10102879|FG001|Began Arm Treatment|Overall Study|1 of the 2 participant assigned to Metformin withdrew from the study just after enrolling.|1
9042303|NCT03380091|10102878|FG000|COMPLETED|Overall Study||1
9042304|NCT03380091|10102879|FG001|COMPLETED|Overall Study||1
9042305|NCT03380091|10102878|FG000|NOT COMPLETED|Overall Study||2
9042306|NCT03380091|10102879|FG001|NOT COMPLETED|Overall Study||1
9042307|NCT03380390|10102887|FG000|STARTED|Overall Study||46
9042308|NCT03380390|10102887|FG000|COMPLETED|Overall Study||43
9042309|NCT03380390|10102887|FG000|NOT COMPLETED|Overall Study||3
9042310|NCT03380429|10102896|FG000|STARTED|Overall Study||87
9042311|NCT03380429|10102897|FG001|STARTED|Overall Study||88
9042312|NCT03380429|10102898|FG002|STARTED|Overall Study||88
9042313|NCT03380429|10102899|FG003|STARTED|Overall Study||88
9042314|NCT03380429|10102900|FG004|STARTED|Overall Study||86
9042315|NCT03380429|10102896|FG000|COMPLETED|Overall Study||82
9042316|NCT03380429|10102897|FG001|COMPLETED|Overall Study||81
9042317|NCT03380429|10102898|FG002|COMPLETED|Overall Study||77
9042318|NCT03380429|10102899|FG003|COMPLETED|Overall Study||78
9042319|NCT03380429|10102900|FG004|COMPLETED|Overall Study||81
9042320|NCT03380429|10102896|FG000|NOT COMPLETED|Overall Study||5
9042321|NCT03380429|10102897|FG001|NOT COMPLETED|Overall Study||7
9042322|NCT03380429|10102898|FG002|NOT COMPLETED|Overall Study||11
9042323|NCT03380429|10102899|FG003|NOT COMPLETED|Overall Study||10
9042324|NCT03380429|10102900|FG004|NOT COMPLETED|Overall Study||5
9042325|NCT03380572|10102919|FG000|STARTED|Overall Study||20
9042326|NCT03380572|10102920|FG001|STARTED|Overall Study||20
9042327|NCT03380572|10102919|FG000|COMPLETED|Overall Study||20
9042328|NCT03380572|10102920|FG001|COMPLETED|Overall Study||20
9042329|NCT03380572|10102919|FG000|NOT COMPLETED|Overall Study||0
9042330|NCT03380572|10102920|FG001|NOT COMPLETED|Overall Study||0
8926572|NCT02267317|9987789|FG005|COMPLETED|Washout (3-4weeks Between Infusions)||1
8926573|NCT02267317|9987784|FG000|NOT COMPLETED|Washout (3-4weeks Between Infusions)||2
8926574|NCT02267317|9987785|FG001|NOT COMPLETED|Washout (3-4weeks Between Infusions)||0
8926575|NCT02267317|9987786|FG002|NOT COMPLETED|Washout (3-4weeks Between Infusions)||0
8926576|NCT02267317|9987787|FG003|NOT COMPLETED|Washout (3-4weeks Between Infusions)||0
8926577|NCT02267317|9987788|FG004|NOT COMPLETED|Washout (3-4weeks Between Infusions)||0
8926578|NCT02267317|9987789|FG005|NOT COMPLETED|Washout (3-4weeks Between Infusions)||0
8926579|NCT02267317|9987784|FG000|STARTED|Infusion2||6
8926580|NCT02267317|9987785|FG001|STARTED|Infusion2||3
8926581|NCT02267317|9987786|FG002|STARTED|Infusion2||1
8926582|NCT02267317|9987787|FG003|STARTED|Infusion2||2
8926583|NCT02267317|9987788|FG004|STARTED|Infusion2||0
8926584|NCT02267317|9987789|FG005|STARTED|Infusion2||1
8926585|NCT02267317|9987784|FG000|COMPLETED|Infusion2||6
8926586|NCT02267317|9987785|FG001|COMPLETED|Infusion2||3
8926587|NCT02267317|9987786|FG002|COMPLETED|Infusion2||1
8926588|NCT02267317|9987787|FG003|COMPLETED|Infusion2||2
9042331|NCT03380624|10102926|FG000|STARTED|Overall Study||10
9042332|NCT03380624|10102927|FG001|STARTED|Overall Study||9
9042333|NCT03380624|10102926|FG000|COMPLETED|Overall Study||10
9042334|NCT03380624|10102927|FG001|COMPLETED|Overall Study||9
9042335|NCT03380624|10102926|FG000|NOT COMPLETED|Overall Study||0
8926589|NCT02267317|9987788|FG004|COMPLETED|Infusion2||0
8926590|NCT02267317|9987789|FG005|COMPLETED|Infusion2||1
8926591|NCT02267317|9987784|FG000|NOT COMPLETED|Infusion2||0
8926592|NCT02267317|9987785|FG001|NOT COMPLETED|Infusion2||0
8926593|NCT02267317|9987786|FG002|NOT COMPLETED|Infusion2||0
8926594|NCT02267317|9987787|FG003|NOT COMPLETED|Infusion2||0
8926595|NCT02267317|9987788|FG004|NOT COMPLETED|Infusion2||0
8926596|NCT02267317|9987789|FG005|NOT COMPLETED|Infusion2||0
8926597|NCT02267356|9987808|FG000|STARTED|Initial Study||53
8926598|NCT02267356|9987809|FG001|STARTED|Initial Study||53
8926599|NCT02267356|9987810|FG002|STARTED|Initial Study||52
8926600|NCT02267356|9987811|FG003|STARTED|Initial Study||54
8926601|NCT02267356|9987812|FG004|STARTED|Initial Study||47
8926602|NCT02267356|9987808|FG000|COMPLETED|Initial Study||47
8926603|NCT02267356|9987809|FG001|COMPLETED|Initial Study||48
8926604|NCT02267356|9987810|FG002|COMPLETED|Initial Study||42
8926605|NCT02267356|9987811|FG003|COMPLETED|Initial Study||43
8926606|NCT02267356|9987812|FG004|COMPLETED|Initial Study||42
8926607|NCT02267356|9987808|FG000|NOT COMPLETED|Initial Study||6
8926608|NCT02267356|9987809|FG001|NOT COMPLETED|Initial Study||5
8926609|NCT02267356|9987810|FG002|NOT COMPLETED|Initial Study||10
8926610|NCT02267356|9987811|FG003|NOT COMPLETED|Initial Study||11
8926611|NCT02267356|9987812|FG004|NOT COMPLETED|Initial Study||5
8926612|NCT02267356|9987808|FG000|STARTED|Study Extension||33
8926613|NCT02267356|9987809|FG001|STARTED|Study Extension||37
8926614|NCT02267356|9987810|FG002|STARTED|Study Extension||30
8926615|NCT02267356|9987811|FG003|STARTED|Study Extension||32
8926616|NCT02267356|9987812|FG004|STARTED|Study Extension||26
8926617|NCT02267356|9987808|FG000|COMPLETED|Study Extension||32
8926618|NCT02267356|9987809|FG001|COMPLETED|Study Extension||37
8926619|NCT02267356|9987810|FG002|COMPLETED|Study Extension||29
8926620|NCT02267356|9987811|FG003|COMPLETED|Study Extension||30
8926621|NCT02267356|9987812|FG004|COMPLETED|Study Extension||26
8926622|NCT02267356|9987808|FG000|NOT COMPLETED|Study Extension||1
8926623|NCT02267356|9987809|FG001|NOT COMPLETED|Study Extension||0
8926624|NCT02267356|9987810|FG002|NOT COMPLETED|Study Extension||1
8926625|NCT02267356|9987811|FG003|NOT COMPLETED|Study Extension||2
8926626|NCT02267356|9987812|FG004|NOT COMPLETED|Study Extension||0
8926627|NCT02267382|9987829|FG000|STARTED|Overall Study||42
8926628|NCT02267382|9987830|FG001|STARTED|Overall Study||43
8926629|NCT02267382|9987831|FG002|STARTED|Overall Study||43
8926630|NCT02267382|9987832|FG003|STARTED|Overall Study||41
8926631|NCT02267382|9987833|FG004|STARTED|Overall Study||46
8926632|NCT02267382|9987829|FG000|COMPLETED|Overall Study||35
8926633|NCT02267382|9987830|FG001|COMPLETED|Overall Study||33
8926634|NCT02267382|9987831|FG002|COMPLETED|Overall Study||34
8926635|NCT02267382|9987832|FG003|COMPLETED|Overall Study||35
8926636|NCT02267382|9987833|FG004|COMPLETED|Overall Study||39
8926637|NCT02267382|9987829|FG000|NOT COMPLETED|Overall Study||7
8926638|NCT02267382|9987830|FG001|NOT COMPLETED|Overall Study||10
8926639|NCT02267382|9987831|FG002|NOT COMPLETED|Overall Study||9
8926640|NCT02267382|9987832|FG003|NOT COMPLETED|Overall Study||6
8926641|NCT02267382|9987833|FG004|NOT COMPLETED|Overall Study||7
8926642|NCT02267447|9987847|FG000|STARTED|Overall Study||77251
8926643|NCT02267447|9987848|FG001|STARTED|Overall Study||26968
8926644|NCT02267447|9987847|FG000|COMPLETED|Overall Study||77251
8926645|NCT02267447|9987848|FG001|COMPLETED|Overall Study||26968
8926646|NCT02267447|9987847|FG000|NOT COMPLETED|Overall Study||0
8926647|NCT02267447|9987848|FG001|NOT COMPLETED|Overall Study||0
8926648|NCT02267538|9987857|FG000|STARTED|Overall Study||142
8926649|NCT02267538|9987858|FG001|STARTED|Overall Study||143
8926650|NCT02267538|9987857|FG000|COMPLETED|Overall Study||142
8926651|NCT02267538|9987858|FG001|COMPLETED|Overall Study||143
8926652|NCT02267538|9987857|FG000|NOT COMPLETED|Overall Study||0
8926653|NCT02267538|9987858|FG001|NOT COMPLETED|Overall Study||0
8926654|NCT02267577|9987864|FG000|STARTED|Overall Study||85
8926655|NCT02267577|9987864|FG000|COMPLETED|Overall Study||81
8926656|NCT02267577|9987864|FG000|NOT COMPLETED|Overall Study||4
8948197|NCT02427750|10010523|FG001|NOT COMPLETED|Overall Study||0
8948198|NCT02427802|10010533|FG000|STARTED|Overall Study||305
8948199|NCT02427802|10010534|FG001|STARTED|Overall Study||154
8948200|NCT02427802|10010535|FG002|STARTED|Overall Study||153
8948201|NCT02427802|10010533|FG000|COMPLETED|Overall Study||246
8948202|NCT02427802|10010534|FG001|COMPLETED|Overall Study||120
8948203|NCT02427802|10010535|FG002|COMPLETED|Overall Study||110
8948204|NCT02427802|10010533|FG000|NOT COMPLETED|Overall Study||59
8948205|NCT02427802|10010534|FG001|NOT COMPLETED|Overall Study||34
8948206|NCT02427802|10010535|FG002|NOT COMPLETED|Overall Study||43
8948207|NCT02427841|10010543|FG000|STARTED|Overall Study||19
8948208|NCT02427841|10010543|FG000|COMPLETED|Overall Study||11
8948209|NCT02427841|10010543|FG000|NOT COMPLETED|Overall Study||8
8948210|NCT02427984|10010550|FG000|STARTED|Overall Study||53
8948211|NCT02427984|10010551|FG001|STARTED|Overall Study||45
8948212|NCT02427984|10010552|FG002|STARTED|Overall Study||50
8948213|NCT02427984|10010550|FG000|COMPLETED|Overall Study||40
8948214|NCT02427984|10010551|FG001|COMPLETED|Overall Study||40
8948215|NCT02427984|10010552|FG002|COMPLETED|Overall Study||32
8948216|NCT02427984|10010550|FG000|NOT COMPLETED|Overall Study||13
8948217|NCT02427984|10010551|FG001|NOT COMPLETED|Overall Study||5
8948218|NCT02427984|10010552|FG002|NOT COMPLETED|Overall Study||18
8948219|NCT02428296|10010561|FG000|STARTED|Overall Study||39
8948220|NCT02428296|10010561|FG000|Treated|Overall Study||39
8948221|NCT02428296|10010561|FG000|COMPLETED|Overall Study|Number of participants who completed the full course of treatment.|30
8926657|NCT02267629|9987869|FG000|STARTED|Overall Study||7
8926658|NCT02267629|9987869|FG000|COMPLETED|Overall Study||7
8926659|NCT02267629|9987869|FG000|NOT COMPLETED|Overall Study||0
8926660|NCT02267746|9987876|FG000|STARTED|Overall Study||298
8926661|NCT02267746|9987877|FG001|STARTED|Overall Study||296
8926662|NCT02267746|9987878|FG002|STARTED|Overall Study||299
8926663|NCT02267746|9987876|FG000|COMPLETED|Overall Study||277
8926664|NCT02267746|9987877|FG001|COMPLETED|Overall Study||274
8926665|NCT02267746|9987878|FG002|COMPLETED|Overall Study||278
8926666|NCT02267746|9987876|FG000|NOT COMPLETED|Overall Study||21
8926667|NCT02267746|9987877|FG001|NOT COMPLETED|Overall Study||22
8926668|NCT02267746|9987878|FG002|NOT COMPLETED|Overall Study||21
8926669|NCT02267772|9987890|FG000|STARTED|Overall Study||50
8926670|NCT02267772|9987891|FG001|STARTED|Overall Study||52
8926671|NCT02267772|9987890|FG000|Randomized|Overall Study||50
8926672|NCT02267772|9987891|FG001|Randomized|Overall Study||52
8926673|NCT02267772|9987890|FG000|Received Study Drug|Overall Study||48
8926674|NCT02267772|9987891|FG001|Received Study Drug|Overall Study||52
8926675|NCT02267772|9987890|FG000|COMPLETED|Overall Study||48
8926676|NCT02267772|9987891|FG001|COMPLETED|Overall Study||52
8926677|NCT02267772|9987890|FG000|NOT COMPLETED|Overall Study||2
8926678|NCT02267772|9987891|FG001|NOT COMPLETED|Overall Study||0
8926679|NCT02267811|9987899|FG000|STARTED|Overall Study||16
8926680|NCT02267811|9987900|FG001|STARTED|Overall Study||17
8926681|NCT02267811|9987899|FG000|COMPLETED|Overall Study||15
8926682|NCT02267811|9987900|FG001|COMPLETED|Overall Study||15
8926683|NCT02267811|9987899|FG000|NOT COMPLETED|Overall Study||1
8926684|NCT02267811|9987900|FG001|NOT COMPLETED|Overall Study||2
8926685|NCT02267824|9987910|FG000|STARTED|Overall Study||83
8926686|NCT02267824|9987911|FG001|STARTED|Overall Study||18
8926687|NCT02267824|9987910|FG000|COMPLETED|Overall Study||73
8926688|NCT02267824|9987911|FG001|COMPLETED|Overall Study||17
8926689|NCT02267824|9987910|FG000|NOT COMPLETED|Overall Study||10
9042336|NCT03380624|10102927|FG001|NOT COMPLETED|Overall Study||0
9042337|NCT03380780|10102933|FG000|STARTED|Overall Study||16
9042338|NCT03380780|10102933|FG000|COMPLETED|Overall Study||16
9042339|NCT03380780|10102933|FG000|NOT COMPLETED|Overall Study||0
9042340|NCT03380845|10102937|FG000|STARTED|Overall Study|Participants got bilateral face treatments with Fraxel on one side of face; Fractora on the other.|4
9042341|NCT03380845|10102937|FG000|COMPLETED|Overall Study||4
9042342|NCT03380845|10102937|FG000|NOT COMPLETED|Overall Study||0
9042343|NCT03381196|10102945|FG000|STARTED|Overall Study||276
9042344|NCT03381196|10102946|FG001|STARTED|Overall Study||277
9042345|NCT03381196|10102945|FG000|Treated|Overall Study||273
9042346|NCT03381196|10102946|FG001|Treated|Overall Study||271
9042347|NCT03381196|10102945|FG000|COMPLETED|Overall Study||260
9042348|NCT03381196|10102946|FG001|COMPLETED|Overall Study||258
9042349|NCT03381196|10102945|FG000|NOT COMPLETED|Overall Study||16
9042350|NCT03381196|10102946|FG001|NOT COMPLETED|Overall Study||19
9042351|NCT03381248|10102954|FG000|STARTED|Overall Study||89
9042352|NCT03381248|10102955|FG001|STARTED|Overall Study||88
9042353|NCT03381248|10102954|FG000|COMPLETED|Overall Study||76
9042354|NCT03381248|10102955|FG001|COMPLETED|Overall Study||82
9042355|NCT03381248|10102954|FG000|NOT COMPLETED|Overall Study||13
9042356|NCT03381248|10102955|FG001|NOT COMPLETED|Overall Study||6
8698429|NCT00895180|9744259|FG001|Received at Least 1 Dose of Study Drug|Overall Study||40
8698430|NCT00895180|9744258|FG000|COMPLETED|Overall Study||40
8698431|NCT00895180|9744259|FG001|COMPLETED|Overall Study||40
8698432|NCT00895180|9744258|FG000|NOT COMPLETED|Overall Study||0
8698433|NCT00895180|9744259|FG001|NOT COMPLETED|Overall Study||0
8724370|NCT01026181|9771571|FG002|NOT COMPLETED|Overall Study||0
8724371|NCT01026194|9771581|FG000|STARTED|Period 1：Double Blind Period||101
8724372|NCT01026194|9771582|FG001|STARTED|Period 1：Double Blind Period||103
8724373|NCT01026194|9771581|FG000|COMPLETED|Period 1：Double Blind Period||98
8724374|NCT01026194|9771582|FG001|COMPLETED|Period 1：Double Blind Period||98
8724375|NCT01026194|9771581|FG000|NOT COMPLETED|Period 1：Double Blind Period||3
8724376|NCT01026194|9771582|FG001|NOT COMPLETED|Period 1：Double Blind Period||5
8926690|NCT02267824|9987911|FG001|NOT COMPLETED|Overall Study||1
8926691|NCT02267837|9987919|FG000|STARTED|Overall Study||11
8926692|NCT02267837|9987920|FG001|STARTED|Overall Study||9
8926693|NCT02267837|9987919|FG000|COMPLETED|Overall Study||11
8926694|NCT02267837|9987920|FG001|COMPLETED|Overall Study||9
8926695|NCT02267837|9987919|FG000|NOT COMPLETED|Overall Study||0
8926696|NCT02267837|9987920|FG001|NOT COMPLETED|Overall Study||0
9042357|NCT03381339|10102963|FG000|STARTED|Overall Study||27
9042358|NCT03381339|10102964|FG001|STARTED|Overall Study||28
9042359|NCT03381339|10102963|FG000|COMPLETED|Overall Study||23
9042360|NCT03381339|10102964|FG001|COMPLETED|Overall Study||24
8926697|NCT02267850|9987928|FG000|STARTED|Overall Study||15
8926698|NCT02267850|9987929|FG001|STARTED|Overall Study||14
8926699|NCT02267850|9987928|FG000|COMPLETED|Overall Study||14
8724377|NCT01026194|9771581|FG000|STARTED|Period 2：Open-label Period||98
8724378|NCT01026194|9771582|FG001|STARTED|Period 2：Open-label Period||98
8724379|NCT01026194|9771581|FG000|COMPLETED|Period 2：Open-label Period||91
8724380|NCT01026194|9771582|FG001|COMPLETED|Period 2：Open-label Period||88
8926700|NCT02267850|9987929|FG001|COMPLETED|Overall Study||12
8926701|NCT02267850|9987928|FG000|NOT COMPLETED|Overall Study||1
8926702|NCT02267850|9987929|FG001|NOT COMPLETED|Overall Study||2
8926703|NCT02268045|9987937|FG000|STARTED|Overall Study||136
8926704|NCT02268045|9987938|FG001|STARTED|Overall Study||136
9042361|NCT03381339|10102963|FG000|NOT COMPLETED|Overall Study||4
8926705|NCT02268045|9987937|FG000|COMPLETED|Overall Study||120
8926706|NCT02268045|9987938|FG001|COMPLETED|Overall Study||116
8926707|NCT02268045|9987937|FG000|NOT COMPLETED|Overall Study||16
8926708|NCT02268045|9987938|FG001|NOT COMPLETED|Overall Study||20
8926709|NCT02268058|9987950|FG000|STARTED|Overall Study||20
8926710|NCT02268058|9987951|FG001|STARTED|Overall Study||20
8926711|NCT02268058|9987952|FG002|STARTED|Overall Study||20
8926712|NCT02268058|9987953|FG003|STARTED|Overall Study||20
8926713|NCT02268058|9987950|FG000|COMPLETED|Overall Study||19
8926714|NCT02268058|9987951|FG001|COMPLETED|Overall Study||20
8926715|NCT02268058|9987952|FG002|COMPLETED|Overall Study||20
8926716|NCT02268058|9987953|FG003|COMPLETED|Overall Study||20
8926717|NCT02268058|9987950|FG000|NOT COMPLETED|Overall Study||1
8926718|NCT02268058|9987951|FG001|NOT COMPLETED|Overall Study||0
8926719|NCT02268058|9987952|FG002|NOT COMPLETED|Overall Study||0
8926720|NCT02268058|9987953|FG003|NOT COMPLETED|Overall Study||0
8926721|NCT02268084|9987965|FG000|STARTED|Overall Study||49
8926722|NCT02268084|9987966|FG001|STARTED|Overall Study||47
8926723|NCT02268084|9987965|FG000|COMPLETED|Overall Study||40
8926724|NCT02268084|9987966|FG001|COMPLETED|Overall Study||40
8926725|NCT02268084|9987965|FG000|NOT COMPLETED|Overall Study||9
8926726|NCT02268084|9987966|FG001|NOT COMPLETED|Overall Study||7
8926727|NCT02268214|9987981|FG000|STARTED|Overall Study||277
8926728|NCT02268214|9987982|FG001|STARTED|Overall Study||296
8926729|NCT02268214|9987983|FG002|STARTED|Overall Study||260
8926730|NCT02268214|9987981|FG000|COMPLETED 24 WEEK PERIOD|Overall Study||252
8926731|NCT02268214|9987982|FG001|COMPLETED 24 WEEK PERIOD|Overall Study||273
8926732|NCT02268214|9987983|FG002|COMPLETED 24 WEEK PERIOD|Overall Study||232
8926733|NCT02268214|9987981|FG000|COMPLETED|Overall Study||235
8926734|NCT02268214|9987982|FG001|COMPLETED|Overall Study||255
8926735|NCT02268214|9987983|FG002|COMPLETED|Overall Study||218
8926736|NCT02268214|9987981|FG000|NOT COMPLETED|Overall Study||42
8926737|NCT02268214|9987982|FG001|NOT COMPLETED|Overall Study||41
8926738|NCT02268214|9987983|FG002|NOT COMPLETED|Overall Study||42
8926739|NCT02268396|9987991|FG000|STARTED|Overall Study||138
8926740|NCT02268396|9987991|FG000|COMPLETED|Overall Study||126
8926741|NCT02268396|9987991|FG000|NOT COMPLETED|Overall Study||12
8926742|NCT02268500|9987997|FG000|STARTED|Overall Study||24
8926743|NCT02268500|9987998|FG001|STARTED|Overall Study||24
8926744|NCT02268500|9987997|FG000|COMPLETED|Overall Study||24
8926745|NCT02268500|9987998|FG001|COMPLETED|Overall Study||24
8926746|NCT02268500|9987997|FG000|NOT COMPLETED|Overall Study||0
8926747|NCT02268500|9987998|FG001|NOT COMPLETED|Overall Study||0
8926748|NCT02268526|9988007|FG000|STARTED|Overall Study||6
8698434|NCT00895193|9744271|FG000|STARTED|Overall Study||25
8698435|NCT00895193|9744272|FG001|STARTED|Overall Study||25
8698436|NCT00895193|9744273|FG002|STARTED|Overall Study||25
8698437|NCT00895193|9744274|FG003|STARTED|Overall Study||25
8698438|NCT00895193|9744271|FG000|COMPLETED|Overall Study||25
8698439|NCT00895193|9744272|FG001|COMPLETED|Overall Study||25
8698440|NCT00895193|9744273|FG002|COMPLETED|Overall Study||25
8698441|NCT00895193|9744274|FG003|COMPLETED|Overall Study||25
8698442|NCT00895193|9744271|FG000|NOT COMPLETED|Overall Study||0
8698443|NCT00895193|9744272|FG001|NOT COMPLETED|Overall Study||0
8698444|NCT00895193|9744273|FG002|NOT COMPLETED|Overall Study||0
8698445|NCT00895193|9744274|FG003|NOT COMPLETED|Overall Study||0
8698446|NCT00895232|9744287|FG000|STARTED|Overall Study||7
8698447|NCT00895232|9744288|FG001|STARTED|Overall Study||6
8698448|NCT00895232|9744289|FG002|STARTED|Overall Study||8
8698449|NCT00895232|9744287|FG000|COMPLETED|Overall Study||4
8698450|NCT00895232|9744288|FG001|COMPLETED|Overall Study||2
8698451|NCT00895232|9744289|FG002|COMPLETED|Overall Study||3
8698452|NCT00895232|9744287|FG000|NOT COMPLETED|Overall Study||3
8698453|NCT00895232|9744288|FG001|NOT COMPLETED|Overall Study||4
8698454|NCT00895232|9744289|FG002|NOT COMPLETED|Overall Study||5
8698455|NCT00895245|9744297|FG000|STARTED|Overall Study||6
8698456|NCT00895245|9744297|FG000|COMPLETED|Overall Study||0
8698457|NCT00895245|9744297|FG000|NOT COMPLETED|Overall Study||6
8698458|NCT00895310|9744301|FG000|STARTED|Overall Study||30
8698459|NCT00895310|9744301|FG000|COMPLETED|Overall Study||29
8698460|NCT00895310|9744301|FG000|NOT COMPLETED|Overall Study||1
8698461|NCT00895414|9744305|FG000|STARTED|First Intervention (14 Days)||9
8698462|NCT00895414|9744306|FG001|STARTED|First Intervention (14 Days)||10
8926749|NCT02268526|9988008|FG001|STARTED|Overall Study||59
8698463|NCT00895414|9744305|FG000|COMPLETED|First Intervention (14 Days)||8
8698464|NCT00895414|9744306|FG001|COMPLETED|First Intervention (14 Days)||9
8698465|NCT00895414|9744305|FG000|NOT COMPLETED|First Intervention (14 Days)||1
8926750|NCT02268526|9988009|FG002|STARTED|Overall Study||21
8926751|NCT02268526|9988007|FG000|PD Analysis Set (Cohort 2)|Overall Study||0
8926752|NCT02268526|9988008|FG001|PD Analysis Set (Cohort 2)|Overall Study||42
8926753|NCT02268526|9988009|FG002|PD Analysis Set (Cohort 2)|Overall Study||17
8926754|NCT02268526|9988007|FG000|COMPLETED|Overall Study||5
8926755|NCT02268526|9988008|FG001|COMPLETED|Overall Study||38
8926756|NCT02268526|9988009|FG002|COMPLETED|Overall Study||16
8926757|NCT02268526|9988007|FG000|NOT COMPLETED|Overall Study||1
8926758|NCT02268526|9988008|FG001|NOT COMPLETED|Overall Study||21
8926759|NCT02268526|9988009|FG002|NOT COMPLETED|Overall Study||5
8926760|NCT02268786|9988021|FG000|STARTED|Overall Study||330
8698466|NCT00895414|9744306|FG001|NOT COMPLETED|First Intervention (14 Days)||1
8698467|NCT00895414|9744305|FG000|STARTED|Second Intervention (14 Days)||8
8698468|NCT00895414|9744306|FG001|STARTED|Second Intervention (14 Days)||9
8926761|NCT02268786|9988022|FG001|STARTED|Overall Study||331
8926762|NCT02268786|9988021|FG000|COMPLETED|Overall Study||274
8926763|NCT02268786|9988022|FG001|COMPLETED|Overall Study||313
8926764|NCT02268786|9988021|FG000|NOT COMPLETED|Overall Study||56
8926765|NCT02268786|9988022|FG001|NOT COMPLETED|Overall Study||18
8926766|NCT02268812|9988032|FG000|STARTED|Overall Study||77
8926767|NCT02268812|9988033|FG001|STARTED|Overall Study||72
8926768|NCT02268812|9988034|FG002|STARTED|Overall Study||30
8926769|NCT02268812|9988035|FG003|STARTED|Overall Study||40
8926770|NCT02268812|9988032|FG000|COMPLETED|Overall Study||61
8926771|NCT02268812|9988033|FG001|COMPLETED|Overall Study||40
8926772|NCT02268812|9988034|FG002|COMPLETED|Overall Study||21
8926773|NCT02268812|9988035|FG003|COMPLETED|Overall Study||26
8926774|NCT02268812|9988032|FG000|NOT COMPLETED|Overall Study||16
8926775|NCT02268812|9988033|FG001|NOT COMPLETED|Overall Study||32
8926776|NCT02268812|9988034|FG002|NOT COMPLETED|Overall Study||9
8926777|NCT02268812|9988035|FG003|NOT COMPLETED|Overall Study||14
8926778|NCT02268851|9988051|FG000|STARTED|Overall Study||3
8926779|NCT02268851|9988052|FG001|STARTED|Overall Study||3
8926780|NCT02268851|9988053|FG002|STARTED|Overall Study||4
8926781|NCT02268851|9988054|FG003|STARTED|Overall Study||3
8926782|NCT02268851|9988055|FG004|STARTED|Overall Study||15
8926783|NCT02268851|9988056|FG005|STARTED|Overall Study||15
8926784|NCT02268851|9988051|FG000|COMPLETED|Overall Study||2
8926785|NCT02268851|9988052|FG001|COMPLETED|Overall Study||0
8926786|NCT02268851|9988053|FG002|COMPLETED|Overall Study||3
8926787|NCT02268851|9988054|FG003|COMPLETED|Overall Study||0
8926788|NCT02268851|9988055|FG004|COMPLETED|Overall Study||8
8926789|NCT02268851|9988056|FG005|COMPLETED|Overall Study||4
8926790|NCT02268851|9988051|FG000|NOT COMPLETED|Overall Study||1
8698469|NCT00895414|9744305|FG000|COMPLETED|Second Intervention (14 Days)||8
8698470|NCT00895414|9744306|FG001|COMPLETED|Second Intervention (14 Days)||9
8698471|NCT00895414|9744305|FG000|NOT COMPLETED|Second Intervention (14 Days)||0
8698472|NCT00895414|9744306|FG001|NOT COMPLETED|Second Intervention (14 Days)||0
8698473|NCT00895453|9744315|FG000|STARTED|Overall Study||48
8698474|NCT00895453|9744316|FG001|STARTED|Overall Study||50
8698475|NCT00895453|9744317|FG002|STARTED|Overall Study||46
8698476|NCT00895453|9744315|FG000|COMPLETED|Overall Study||23
8698477|NCT00895453|9744316|FG001|COMPLETED|Overall Study||25
8698478|NCT00895453|9744317|FG002|COMPLETED|Overall Study||23
8698479|NCT00895453|9744315|FG000|NOT COMPLETED|Overall Study||25
8698480|NCT00895453|9744316|FG001|NOT COMPLETED|Overall Study||25
8698481|NCT00895453|9744317|FG002|NOT COMPLETED|Overall Study||23
8698482|NCT00895531|9744327|FG000|STARTED|Overall Study||38
8698483|NCT00895531|9744328|FG001|STARTED|Overall Study||37
8698484|NCT00895531|9744327|FG000|COMPLETED|Overall Study||38
8698485|NCT00895531|9744328|FG001|COMPLETED|Overall Study||37
8698486|NCT00895531|9744327|FG000|NOT COMPLETED|Overall Study||0
8698487|NCT00895531|9744328|FG001|NOT COMPLETED|Overall Study||0
8698488|NCT00895583|9744336|FG000|STARTED|Overall Study||131
8698489|NCT00895583|9744337|FG001|STARTED|Overall Study||123
8698490|NCT00895583|9744336|FG000|COMPLETED|Overall Study||87
8698491|NCT00895583|9744337|FG001|COMPLETED|Overall Study||111
8698492|NCT00895583|9744336|FG000|NOT COMPLETED|Overall Study||44
8698493|NCT00895583|9744337|FG001|NOT COMPLETED|Overall Study||12
8698494|NCT00895622|9744346|FG000|STARTED|Overall Study||65
8698495|NCT00895622|9744347|FG001|STARTED|Overall Study||56
8698496|NCT00895622|9744348|FG002|STARTED|Overall Study||57
8698497|NCT00895622|9744346|FG000|COMPLETED|Overall Study||60
8698498|NCT00895622|9744347|FG001|COMPLETED|Overall Study||52
8698499|NCT00895622|9744348|FG002|COMPLETED|Overall Study||53
8698500|NCT00895622|9744346|FG000|NOT COMPLETED|Overall Study||5
8698501|NCT00895622|9744347|FG001|NOT COMPLETED|Overall Study||4
8698502|NCT00895622|9744348|FG002|NOT COMPLETED|Overall Study||4
8698503|NCT00895661|9744364|FG000|STARTED|Overall Study||40
8698504|NCT00895661|9744364|FG000|COMPLETED|Overall Study||37
8698505|NCT00895661|9744364|FG000|NOT COMPLETED|Overall Study||3
8698506|NCT00895752|9744368|FG000|STARTED|Overall Study||6
8698507|NCT00895752|9744368|FG000|COMPLETED|Overall Study||6
8698508|NCT00895752|9744368|FG000|NOT COMPLETED|Overall Study||0
8698509|NCT00895817|9744376|FG000|STARTED|Overall Study||21
8698510|NCT00895817|9744377|FG001|STARTED|Overall Study||21
8698511|NCT00895817|9744376|FG000|COMPLETED|Overall Study||21
8698512|NCT00895817|9744377|FG001|COMPLETED|Overall Study||21
8698513|NCT00895817|9744376|FG000|NOT COMPLETED|Overall Study||0
8698514|NCT00895817|9744377|FG001|NOT COMPLETED|Overall Study||0
8698515|NCT00895830|9744388|FG000|STARTED|Overall Study||51
8698516|NCT00895830|9744389|FG001|STARTED|Overall Study||50
8926791|NCT02268851|9988052|FG001|NOT COMPLETED|Overall Study||3
8926792|NCT02268851|9988053|FG002|NOT COMPLETED|Overall Study||1
8926793|NCT02268851|9988054|FG003|NOT COMPLETED|Overall Study||3
8926794|NCT02268851|9988055|FG004|NOT COMPLETED|Overall Study||7
8926795|NCT02268851|9988056|FG005|NOT COMPLETED|Overall Study||11
8926796|NCT02268864|9988073|FG000|STARTED|Overall Study||17
8698517|NCT00895830|9744390|FG002|STARTED|Overall Study||49
8698518|NCT00895830|9744391|FG003|STARTED|Overall Study||52
8698519|NCT00895830|9744392|FG004|STARTED|Overall Study||55
8926797|NCT02268864|9988074|FG001|STARTED|Overall Study||25
8926798|NCT02268864|9988075|FG002|STARTED|Overall Study||64
8926799|NCT02268864|9988073|FG000|COMPLETED|Overall Study||15
8926800|NCT02268864|9988074|FG001|COMPLETED|Overall Study||24
8926801|NCT02268864|9988075|FG002|COMPLETED|Overall Study||64
8926802|NCT02268864|9988073|FG000|NOT COMPLETED|Overall Study||2
8926803|NCT02268864|9988074|FG001|NOT COMPLETED|Overall Study||1
8926804|NCT02268864|9988075|FG002|NOT COMPLETED|Overall Study||0
8926805|NCT02268877|9988087|FG000|STARTED|Overall Study||122
8926806|NCT02268877|9988088|FG001|STARTED|Overall Study|111 patients were randomized to this arm.|111
8926807|NCT02268877|9988087|FG000|COMPLETED|Overall Study||118
8926808|NCT02268877|9988088|FG001|COMPLETED|Overall Study|106 patients received the intervention.|106
8926809|NCT02268877|9988087|FG000|NOT COMPLETED|Overall Study||4
8926810|NCT02268877|9988088|FG001|NOT COMPLETED|Overall Study||5
8926811|NCT02268942|9988094|FG000|STARTED|Overall Study||144
8926812|NCT02268942|9988094|FG000|COMPLETED|Overall Study||144
8926813|NCT02268942|9988094|FG000|NOT COMPLETED|Overall Study||0
8926814|NCT02268955|9988100|FG000|STARTED|Overall Study||11
8926815|NCT02268955|9988101|FG001|STARTED|Overall Study||11
8926816|NCT02268955|9988100|FG000|COMPLETED|Overall Study||9
8926817|NCT02268955|9988101|FG001|COMPLETED|Overall Study||9
8926818|NCT02268955|9988100|FG000|NOT COMPLETED|Overall Study||2
8926819|NCT02268955|9988101|FG001|NOT COMPLETED|Overall Study||2
8926820|NCT02268994|9988109|FG000|STARTED|Overall Study||117
8926821|NCT02268994|9988110|FG001|STARTED|Overall Study||116
8926822|NCT02268994|9988109|FG000|COMPLETED|Overall Study||86
8926823|NCT02268994|9988110|FG001|COMPLETED|Overall Study||81
8926824|NCT02268994|9988109|FG000|NOT COMPLETED|Overall Study||31
8926825|NCT02268994|9988110|FG001|NOT COMPLETED|Overall Study||35
8926826|NCT02269098|9988121|FG000|STARTED|Overall Study||51
8926827|NCT02269098|9988122|FG001|STARTED|Overall Study||50
8926828|NCT02269098|9988121|FG000|COMPLETED|Overall Study||37
8926829|NCT02269098|9988122|FG001|COMPLETED|Overall Study||41
8926830|NCT02269098|9988121|FG000|NOT COMPLETED|Overall Study||14
8926831|NCT02269098|9988122|FG001|NOT COMPLETED|Overall Study||9
8926832|NCT02269124|9988131|FG000|STARTED|Overall Study||21
8926833|NCT02269124|9988132|FG001|STARTED|Overall Study||16
8926834|NCT02269124|9988131|FG000|Completed Survey Round 1 (Arm 1, 0 Weeks)|Overall Study||20
8926835|NCT02269124|9988132|FG001|Completed Survey Round 1 (Arm 1, 0 Weeks)|Overall Study||14
8926836|NCT02269124|9988131|FG000|Completed Survey Round 2 (Arm 1, 6 Weeks)|Overall Study||17
8926837|NCT02269124|9988132|FG001|Completed Survey Round 2 (Arm 1, 6 Weeks)|Overall Study||13
8926838|NCT02269124|9988131|FG000|Completed Survey Round 3 (Arm 1, 12 Weeks)|Overall Study||17
8926839|NCT02269124|9988132|FG001|Completed Survey Round 3 (Arm 1, 12 Weeks)|Overall Study||11
8926840|NCT02269124|9988131|FG000|Completed Survey Round 4 (Arm 2, 12 Weeks)|Overall Study||11
8926841|NCT02269124|9988132|FG001|Completed Survey Round 4 (Arm 2, 12 Weeks)|Overall Study||8
8926842|NCT02269124|9988131|FG000|Completed Survey Round 5 (Arm 2, 18 Weeks)|Overall Study||16
8926843|NCT02269124|9988132|FG001|Completed Survey Round 5 (Arm 2, 18 Weeks)|Overall Study||10
8926844|NCT02269124|9988131|FG000|Completed Survey Round 6 (Arm 2, 24 Weeks)|Overall Study||14
8926845|NCT02269124|9988132|FG001|Completed Survey Round 6 (Arm 2, 24 Weeks)|Overall Study||10
8926846|NCT02269124|9988131|FG000|COMPLETED|Overall Study|One participant from the Conventional Measures Only First arm did not return any surveys, nor did their parent/guardian or teacher, and were deemed lost to follow-up.|20
8926847|NCT02269124|9988132|FG001|COMPLETED|Overall Study|Two participants from the Conventional measures + Hearing Aid First arm withdrew from the study prior to the second arm because they did not wish to stop using the hearing aid.|14
8926848|NCT02269124|9988131|FG000|NOT COMPLETED|Overall Study||1
8926849|NCT02269124|9988132|FG001|NOT COMPLETED|Overall Study||2
8926850|NCT02269163|9988141|FG000|STARTED|Overall Study||50
8926851|NCT02269163|9988142|FG001|STARTED|Overall Study||25
8926852|NCT02269163|9988141|FG000|COMPLETED|Overall Study||47
8926853|NCT02269163|9988142|FG001|COMPLETED|Overall Study||18
8926854|NCT02269163|9988141|FG000|NOT COMPLETED|Overall Study||3
8926855|NCT02269163|9988142|FG001|NOT COMPLETED|Overall Study||7
8926856|NCT02269241|9988150|FG000|STARTED|Overall Study||1552
8926857|NCT02269241|9988150|FG000|COMPLETED|Overall Study||352
8926858|NCT02269241|9988150|FG000|NOT COMPLETED|Overall Study||1200
8926859|NCT02269423|9988159|FG000|STARTED|Overall Study||10
8926860|NCT02269423|9988160|FG001|STARTED|Overall Study||10
8926861|NCT02269423|9988161|FG002|STARTED|Overall Study||10
8926862|NCT02269423|9988162|FG003|STARTED|Overall Study||9
8926863|NCT02269423|9988159|FG000|COMPLETED|Overall Study||10
8926864|NCT02269423|9988160|FG001|COMPLETED|Overall Study||9
8926865|NCT02269423|9988161|FG002|COMPLETED|Overall Study||10
8926866|NCT02269423|9988162|FG003|COMPLETED|Overall Study||8
8926867|NCT02269423|9988159|FG000|NOT COMPLETED|Overall Study||0
8926868|NCT02269423|9988160|FG001|NOT COMPLETED|Overall Study||1
8926869|NCT02269423|9988161|FG002|NOT COMPLETED|Overall Study||0
8926870|NCT02269423|9988162|FG003|NOT COMPLETED|Overall Study||1
8926871|NCT02269475|9988174|FG000|STARTED|Overall Study||868
8926872|NCT02269475|9988175|FG001|STARTED|Overall Study||433
8926873|NCT02269475|9988174|FG000|Received IP (Safety Population)|Overall Study||868
8926874|NCT02269475|9988175|FG001|Received IP (Safety Population)|Overall Study||433
8926875|NCT02269475|9988174|FG000|Per Protocol Population|Overall Study||849
8926876|NCT02269475|9988175|FG001|Per Protocol Population|Overall Study||430
8926877|NCT02269475|9988174|FG000|COMPLETED|Overall Study||865
8926878|NCT02269475|9988175|FG001|COMPLETED|Overall Study||432
8926879|NCT02269475|9988174|FG000|NOT COMPLETED|Overall Study||3
8926880|NCT02269475|9988175|FG001|NOT COMPLETED|Overall Study||1
8926881|NCT02269488|9988182|FG000|STARTED|Overall Study||100
8926882|NCT02269488|9988182|FG000|COMPLETED|Overall Study||100
8926883|NCT02269488|9988182|FG000|NOT COMPLETED|Overall Study||0
8926884|NCT02269631|9988188|FG000|STARTED|Overall Study||7
8926885|NCT02269631|9988189|FG001|STARTED|Overall Study||5
8926886|NCT02269631|9988188|FG000|COMPLETED|Overall Study||7
8926887|NCT02269631|9988189|FG001|COMPLETED|Overall Study||5
8698520|NCT00895830|9744388|FG000|COMPLETED|Overall Study||51
8698521|NCT00895830|9744389|FG001|COMPLETED|Overall Study||50
8698522|NCT00895830|9744390|FG002|COMPLETED|Overall Study||49
8698523|NCT00895830|9744391|FG003|COMPLETED|Overall Study||52
8698524|NCT00895830|9744392|FG004|COMPLETED|Overall Study||55
8698525|NCT00895830|9744388|FG000|NOT COMPLETED|Overall Study||0
8698526|NCT00895830|9744389|FG001|NOT COMPLETED|Overall Study||0
8698527|NCT00895830|9744390|FG002|NOT COMPLETED|Overall Study||0
8698528|NCT00895830|9744391|FG003|NOT COMPLETED|Overall Study||0
8698529|NCT00895830|9744392|FG004|NOT COMPLETED|Overall Study||0
8698530|NCT00895843|9744406|FG000|STARTED|Overall Study||60
8698531|NCT00895843|9744407|FG001|STARTED|Overall Study||62
8698532|NCT00895843|9744406|FG000|COMPLETED|Overall Study||48
8698533|NCT00895843|9744407|FG001|COMPLETED|Overall Study||50
8698534|NCT00895843|9744406|FG000|NOT COMPLETED|Overall Study||12
8698535|NCT00895843|9744407|FG001|NOT COMPLETED|Overall Study||12
8698536|NCT00895895|9744418|FG000|STARTED|Period 1||107
8698537|NCT00895895|9744419|FG001|STARTED|Period 1||105
8698538|NCT00895895|9744420|FG002|STARTED|Period 1||104
8698539|NCT00895895|9744421|FG003|STARTED|Period 1||104
8698540|NCT00895895|9744422|FG004|STARTED|Period 1||106
8698541|NCT00895895|9744418|FG000|Randomized But Not Treated|Period 1||1
8698542|NCT00895895|9744419|FG001|Randomized But Not Treated|Period 1||3
8698543|NCT00895895|9744420|FG002|Randomized But Not Treated|Period 1||1
8698544|NCT00895895|9744421|FG003|Randomized But Not Treated|Period 1||1
8698545|NCT00895895|9744422|FG004|Randomized But Not Treated|Period 1||2
8698546|NCT00895895|9744418|FG000|COMPLETED|Period 1||86
8698547|NCT00895895|9744419|FG001|COMPLETED|Period 1||84
8698548|NCT00895895|9744420|FG002|COMPLETED|Period 1||84
8698549|NCT00895895|9744421|FG003|COMPLETED|Period 1||91
8698550|NCT00895895|9744422|FG004|COMPLETED|Period 1||86
8698551|NCT00895895|9744418|FG000|NOT COMPLETED|Period 1||21
8698552|NCT00895895|9744419|FG001|NOT COMPLETED|Period 1||21
8698553|NCT00895895|9744420|FG002|NOT COMPLETED|Period 1||20
8698554|NCT00895895|9744421|FG003|NOT COMPLETED|Period 1||13
8698555|NCT00895895|9744422|FG004|NOT COMPLETED|Period 1||20
8698556|NCT00895895|9744418|FG000|STARTED|After Period 1, Prior to Period 2||86
8698557|NCT00895895|9744419|FG001|STARTED|After Period 1, Prior to Period 2||84
8698558|NCT00895895|9744420|FG002|STARTED|After Period 1, Prior to Period 2||84
8698559|NCT00895895|9744421|FG003|STARTED|After Period 1, Prior to Period 2||91
8698560|NCT00895895|9744422|FG004|STARTED|After Period 1, Prior to Period 2||86
8698561|NCT00895895|9744418|FG000|COMPLETED|After Period 1, Prior to Period 2||86
8698562|NCT00895895|9744419|FG001|COMPLETED|After Period 1, Prior to Period 2||84
8698563|NCT00895895|9744420|FG002|COMPLETED|After Period 1, Prior to Period 2||82
8698564|NCT00895895|9744421|FG003|COMPLETED|After Period 1, Prior to Period 2||91
8698565|NCT00895895|9744422|FG004|COMPLETED|After Period 1, Prior to Period 2||84
8698566|NCT00895895|9744418|FG000|NOT COMPLETED|After Period 1, Prior to Period 2||0
8698567|NCT00895895|9744419|FG001|NOT COMPLETED|After Period 1, Prior to Period 2||0
8698568|NCT00895895|9744420|FG002|NOT COMPLETED|After Period 1, Prior to Period 2||2
8698569|NCT00895895|9744421|FG003|NOT COMPLETED|After Period 1, Prior to Period 2||0
8698570|NCT00895895|9744422|FG004|NOT COMPLETED|After Period 1, Prior to Period 2||2
8698571|NCT00895895|9744418|FG000|STARTED|Period 2||86
8698572|NCT00895895|9744419|FG001|STARTED|Period 2||84
8698573|NCT00895895|9744420|FG002|STARTED|Period 2||82
8698574|NCT00895895|9744421|FG003|STARTED|Period 2||91
8812256|NCT01519063|9865200|FG000|NOT COMPLETED|Overall Study||7
8812257|NCT01519063|9865201|FG001|NOT COMPLETED|Overall Study||5
8698575|NCT00895895|9744422|FG004|STARTED|Period 2||84
8698576|NCT00895895|9744418|FG000|COMPLETED|Period 2||30
8698577|NCT00895895|9744419|FG001|COMPLETED|Period 2||31
8698578|NCT00895895|9744420|FG002|COMPLETED|Period 2||33
8698579|NCT00895895|9744421|FG003|COMPLETED|Period 2||37
8698580|NCT00895895|9744422|FG004|COMPLETED|Period 2||35
8698581|NCT00895895|9744418|FG000|NOT COMPLETED|Period 2||56
8698582|NCT00895895|9744419|FG001|NOT COMPLETED|Period 2||53
8698583|NCT00895895|9744420|FG002|NOT COMPLETED|Period 2||49
8698584|NCT00895895|9744421|FG003|NOT COMPLETED|Period 2||54
8698585|NCT00895895|9744422|FG004|NOT COMPLETED|Period 2||49
8698586|NCT00895921|9744442|FG000|STARTED|Overall Study||15
8698587|NCT00895921|9744443|FG001|STARTED|Overall Study||15
8698588|NCT00895921|9744442|FG000|COMPLETED|Overall Study||15
8698589|NCT00895921|9744443|FG001|COMPLETED|Overall Study||15
8698590|NCT00895921|9744442|FG000|NOT COMPLETED|Overall Study||0
8698591|NCT00895921|9744443|FG001|NOT COMPLETED|Overall Study||0
8698592|NCT00895934|9744451|FG000|STARTED|Dose Escalation||3
8698593|NCT00895934|9744452|FG001|STARTED|Dose Escalation||3
8698594|NCT00895934|9744453|FG002|STARTED|Dose Escalation||3
8698595|NCT00895934|9744454|FG003|STARTED|Dose Escalation||6
8698596|NCT00895934|9744451|FG000|COMPLETED|Dose Escalation||3
8698597|NCT00895934|9744452|FG001|COMPLETED|Dose Escalation||3
8698598|NCT00895934|9744453|FG002|COMPLETED|Dose Escalation||3
8698599|NCT00895934|9744454|FG003|COMPLETED|Dose Escalation||6
8698600|NCT00895934|9744451|FG000|NOT COMPLETED|Dose Escalation||0
8698601|NCT00895934|9744452|FG001|NOT COMPLETED|Dose Escalation||0
8698602|NCT00895934|9744453|FG002|NOT COMPLETED|Dose Escalation||0
8698603|NCT00895934|9744454|FG003|NOT COMPLETED|Dose Escalation||0
8698604|NCT00895934|9744451|FG000|STARTED|Efficacy of Most Tolerated Dose||0
8698605|NCT00895934|9744452|FG001|STARTED|Efficacy of Most Tolerated Dose||0
8926888|NCT02269631|9988188|FG000|NOT COMPLETED|Overall Study||0
8926889|NCT02269631|9988189|FG001|NOT COMPLETED|Overall Study||0
8926890|NCT02269657|9988195|FG000|STARTED|Overall Study||40
8926891|NCT02269657|9988195|FG000|COMPLETED|Overall Study||37
8926892|NCT02269657|9988195|FG000|NOT COMPLETED|Overall Study||3
8926893|NCT02269709|9988201|FG000|STARTED|Time of Enrollment||21
8926894|NCT02269709|9988201|FG000|COMPLETED|Time of Enrollment||18
8926895|NCT02269709|9988201|FG000|NOT COMPLETED|Time of Enrollment||3
8926896|NCT02269709|9988201|FG000|STARTED|Follow-up #1 (24-72 Hours Post-surgery)||18
8926897|NCT02269709|9988201|FG000|COMPLETED|Follow-up #1 (24-72 Hours Post-surgery)||17
8926898|NCT02269709|9988201|FG000|NOT COMPLETED|Follow-up #1 (24-72 Hours Post-surgery)||1
8926899|NCT02269709|9988201|FG000|STARTED|Prior to Hospital Discharge||17
8926900|NCT02269709|9988201|FG000|COMPLETED|Prior to Hospital Discharge||17
8926901|NCT02269709|9988201|FG000|NOT COMPLETED|Prior to Hospital Discharge||0
8698606|NCT00895934|9744453|FG002|STARTED|Efficacy of Most Tolerated Dose||0
8698607|NCT00895934|9744454|FG003|STARTED|Efficacy of Most Tolerated Dose||37
8698608|NCT00895934|9744451|FG000|COMPLETED|Efficacy of Most Tolerated Dose||0
8698609|NCT00895934|9744452|FG001|COMPLETED|Efficacy of Most Tolerated Dose||0
8698610|NCT00895934|9744453|FG002|COMPLETED|Efficacy of Most Tolerated Dose||0
8698611|NCT00895934|9744454|FG003|COMPLETED|Efficacy of Most Tolerated Dose||37
8698612|NCT00895934|9744451|FG000|NOT COMPLETED|Efficacy of Most Tolerated Dose||0
8698613|NCT00895934|9744452|FG001|NOT COMPLETED|Efficacy of Most Tolerated Dose||0
8698614|NCT00895934|9744453|FG002|NOT COMPLETED|Efficacy of Most Tolerated Dose||0
8698615|NCT00895934|9744454|FG003|NOT COMPLETED|Efficacy of Most Tolerated Dose||0
8698616|NCT00895947|9744467|FG000|STARTED|Overall Study||100
8698617|NCT00895947|9744468|FG001|STARTED|Overall Study||100
8698618|NCT00895947|9744467|FG000|COMPLETED|Overall Study||88
8698619|NCT00895947|9744468|FG001|COMPLETED|Overall Study||90
8698620|NCT00895947|9744467|FG000|NOT COMPLETED|Overall Study||12
8698621|NCT00895947|9744468|FG001|NOT COMPLETED|Overall Study||10
8698622|NCT00896012|9744476|FG000|STARTED|Overall Study||29
8698623|NCT00896012|9744477|FG001|STARTED|Overall Study||23
8698624|NCT00896012|9744476|FG000|COMPLETED|Overall Study||18
8698625|NCT00896012|9744477|FG001|COMPLETED|Overall Study||12
8698626|NCT00896012|9744476|FG000|NOT COMPLETED|Overall Study||11
8698627|NCT00896012|9744477|FG001|NOT COMPLETED|Overall Study||11
8698628|NCT00896038|9744485|FG000|STARTED|Overall Study||30
8698629|NCT00896038|9744486|FG001|STARTED|Overall Study||28
8698630|NCT00896038|9744485|FG000|COMPLETED|Overall Study||26
8698631|NCT00896038|9744486|FG001|COMPLETED|Overall Study||27
8698632|NCT00896038|9744485|FG000|NOT COMPLETED|Overall Study||4
8698633|NCT00896038|9744486|FG001|NOT COMPLETED|Overall Study||1
8698634|NCT00896051|9744494|FG000|STARTED|Overall Study||25
8698635|NCT00896051|9744495|FG001|STARTED|Overall Study||25
8698636|NCT00896051|9744494|FG000|COMPLETED|Overall Study||15
8698637|NCT00896051|9744495|FG001|COMPLETED|Overall Study||16
8698638|NCT00896051|9744494|FG000|NOT COMPLETED|Overall Study||10
8698639|NCT00896051|9744495|FG001|NOT COMPLETED|Overall Study||9
8698640|NCT00896064|9744512|FG000|STARTED|Overall Study||22
8698641|NCT00896064|9744513|FG001|STARTED|Overall Study||21
8698642|NCT00896064|9744512|FG000|COMPLETED|Overall Study||22
8698643|NCT00896064|9744513|FG001|COMPLETED|Overall Study||21
8698644|NCT00896064|9744512|FG000|NOT COMPLETED|Overall Study||0
8698645|NCT00896064|9744513|FG001|NOT COMPLETED|Overall Study||0
8698646|NCT00896168|9744521|FG000|STARTED|Overall Study||104
8698647|NCT00896168|9744522|FG001|STARTED|Overall Study||130
8698648|NCT00896168|9744521|FG000|COMPLETED|Overall Study||90
8698649|NCT00896168|9744522|FG001|COMPLETED|Overall Study||111
8698650|NCT00896168|9744521|FG000|NOT COMPLETED|Overall Study||14
8698651|NCT00896168|9744522|FG001|NOT COMPLETED|Overall Study||19
8698652|NCT00896181|9744528|FG000|STARTED|Overall Study||26
8698653|NCT00896181|9744528|FG000|COMPLETED|Overall Study||26
8698654|NCT00896181|9744528|FG000|NOT COMPLETED|Overall Study||0
8698655|NCT00896233|9744532|FG000|STARTED|Overall Study||10
8698656|NCT00896233|9744532|FG000|COMPLETED|Overall Study||9
8698657|NCT00896233|9744532|FG000|NOT COMPLETED|Overall Study||1
8698658|NCT00896298|9744539|FG000|STARTED|Overall Study||13
8698659|NCT00896298|9744540|FG001|STARTED|Overall Study||12
8698660|NCT00896298|9744539|FG000|COMPLETED|Overall Study||10
8698661|NCT00896298|9744540|FG001|COMPLETED|Overall Study||9
8698662|NCT00896298|9744539|FG000|NOT COMPLETED|Overall Study||3
8698663|NCT00896298|9744540|FG001|NOT COMPLETED|Overall Study||3
8698664|NCT00896337|9744546|FG000|STARTED|Overall Study||125
8698665|NCT00896337|9744546|FG000|COMPLETED|Overall Study||100
8698666|NCT00896337|9744546|FG000|NOT COMPLETED|Overall Study||25
8698667|NCT00896363|9744558|FG000|STARTED|Overall Study||31
8698668|NCT00896363|9744559|FG001|STARTED|Overall Study||36
8698669|NCT00896363|9744560|FG002|STARTED|Overall Study||32
8698670|NCT00896363|9744558|FG000|COMPLETED|Overall Study||25
8698671|NCT00896363|9744559|FG001|COMPLETED|Overall Study||25
8698672|NCT00896363|9744560|FG002|COMPLETED|Overall Study||24
8698673|NCT00896363|9744558|FG000|NOT COMPLETED|Overall Study||6
8698674|NCT00896363|9744559|FG001|NOT COMPLETED|Overall Study||11
8926902|NCT02269709|9988201|FG000|STARTED|Six Month Follow-up||17
8926903|NCT02269709|9988201|FG000|COMPLETED|Six Month Follow-up||5
8698675|NCT00896363|9744560|FG002|NOT COMPLETED|Overall Study||8
8698676|NCT00896441|9744573|FG000|STARTED|Overall Study||17
8698677|NCT00896441|9744574|FG001|STARTED|Overall Study||9
8698678|NCT00896441|9744573|FG000|COMPLETED|Overall Study||15
8698679|NCT00896441|9744574|FG001|COMPLETED|Overall Study||9
8698680|NCT00896441|9744573|FG000|NOT COMPLETED|Overall Study||2
8926904|NCT02269709|9988201|FG000|NOT COMPLETED|Six Month Follow-up||12
8926905|NCT02269787|9988208|FG000|STARTED|Overall Study||148
8926906|NCT02269787|9988209|FG001|STARTED|Overall Study||150
8926907|NCT02269787|9988208|FG000|COMPLETED|Overall Study||126
8926908|NCT02269787|9988209|FG001|COMPLETED|Overall Study||140
8926909|NCT02269787|9988208|FG000|NOT COMPLETED|Overall Study||22
8698681|NCT00896441|9744574|FG001|NOT COMPLETED|Overall Study||0
8698682|NCT00896454|9744579|FG000|STARTED|Overall Study||33
8698683|NCT00896454|9744579|FG000|COMPLETED|Overall Study||0
8698684|NCT00896454|9744579|FG000|NOT COMPLETED|Overall Study||33
8698685|NCT00896480|9744583|FG000|STARTED|Overall Study||24
8698686|NCT00896480|9744583|FG000|COMPLETED|Overall Study||3
8698687|NCT00896480|9744583|FG000|NOT COMPLETED|Overall Study||21
8698688|NCT00896532|9744598|FG000|STARTED|Months 1-24: Romosozumab Treatment Phase||52
8698689|NCT00896532|9744599|FG001|STARTED|Months 1-24: Romosozumab Treatment Phase||51
8698690|NCT00896532|9744600|FG002|STARTED|Months 1-24: Romosozumab Treatment Phase||55
8698691|NCT00896532|9744601|FG003|STARTED|Months 1-24: Romosozumab Treatment Phase||51
8698692|NCT00896532|9744602|FG004|STARTED|Months 1-24: Romosozumab Treatment Phase||54
8698693|NCT00896532|9744603|FG005|STARTED|Months 1-24: Romosozumab Treatment Phase||51
8698694|NCT00896532|9744604|FG006|STARTED|Months 1-24: Romosozumab Treatment Phase||53
8698695|NCT00896532|9744605|FG007|STARTED|Months 1-24: Romosozumab Treatment Phase||52
8698696|NCT00896532|9744606|FG008|STARTED|Months 1-24: Romosozumab Treatment Phase||0
8698697|NCT00896532|9744607|FG009|STARTED|Months 1-24: Romosozumab Treatment Phase||0
8698698|NCT00896532|9744608|FG010|STARTED|Months 1-24: Romosozumab Treatment Phase||0
8698699|NCT00896532|9744609|FG011|STARTED|Months 1-24: Romosozumab Treatment Phase||0
8698700|NCT00896532|9744610|FG012|STARTED|Months 1-24: Romosozumab Treatment Phase||0
8698701|NCT00896532|9744611|FG013|STARTED|Months 1-24: Romosozumab Treatment Phase||0
8698702|NCT00896532|9744612|FG014|STARTED|Months 1-24: Romosozumab Treatment Phase||0
8698703|NCT00896532|9744613|FG015|STARTED|Months 1-24: Romosozumab Treatment Phase||0
8698704|NCT00896532|9744614|FG016|STARTED|Months 1-24: Romosozumab Treatment Phase||0
8698705|NCT00896532|9744615|FG017|STARTED|Months 1-24: Romosozumab Treatment Phase||0
8698706|NCT00896532|9744616|FG018|STARTED|Months 1-24: Romosozumab Treatment Phase||0
8698707|NCT00896532|9744617|FG019|STARTED|Months 1-24: Romosozumab Treatment Phase||0
8698708|NCT00896532|9744618|FG020|STARTED|Months 1-24: Romosozumab Treatment Phase||0
8698709|NCT00896532|9744619|FG021|STARTED|Months 1-24: Romosozumab Treatment Phase||0
8698710|NCT00896532|9744620|FG022|STARTED|Months 1-24: Romosozumab Treatment Phase||0
8698711|NCT00896532|9744598|FG000|Received Treatment|Months 1-24: Romosozumab Treatment Phase|One participant received 1 dose of romosozumab 70 mg in error|51
8698712|NCT00896532|9744599|FG001|Received Treatment|Months 1-24: Romosozumab Treatment Phase||51
8698713|NCT00896532|9744600|FG002|Received Treatment|Months 1-24: Romosozumab Treatment Phase||54
8698714|NCT00896532|9744601|FG003|Received Treatment|Months 1-24: Romosozumab Treatment Phase||49
8698715|NCT00896532|9744602|FG004|Received Treatment|Months 1-24: Romosozumab Treatment Phase||53
8698716|NCT00896532|9744603|FG005|Received Treatment|Months 1-24: Romosozumab Treatment Phase||48
8698717|NCT00896532|9744604|FG006|Received Treatment|Months 1-24: Romosozumab Treatment Phase||53
8698718|NCT00896532|9744605|FG007|Received Treatment|Months 1-24: Romosozumab Treatment Phase||51
8698719|NCT00896532|9744606|FG008|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
8698720|NCT00896532|9744607|FG009|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
8698721|NCT00896532|9744608|FG010|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
8698722|NCT00896532|9744609|FG011|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
8698723|NCT00896532|9744610|FG012|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
8698724|NCT00896532|9744611|FG013|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
8698725|NCT00896532|9744612|FG014|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
8698726|NCT00896532|9744613|FG015|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
8698727|NCT00896532|9744614|FG016|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
8698728|NCT00896532|9744615|FG017|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
8698729|NCT00896532|9744616|FG018|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
8698730|NCT00896532|9744617|FG019|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
8698731|NCT00896532|9744618|FG020|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
8698732|NCT00896532|9744619|FG021|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
8698733|NCT00896532|9744620|FG022|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
8698734|NCT00896532|9744598|FG000|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||47
8698735|NCT00896532|9744599|FG001|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||49
8698736|NCT00896532|9744600|FG002|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||46
8698737|NCT00896532|9744601|FG003|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||45
8698738|NCT00896532|9744602|FG004|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||50
8698739|NCT00896532|9744603|FG005|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||46
8698740|NCT00896532|9744604|FG006|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||51
8698741|NCT00896532|9744605|FG007|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||49
8698742|NCT00896532|9744606|FG008|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
8926910|NCT02269787|9988209|FG001|NOT COMPLETED|Overall Study||10
8926911|NCT02269943|9988217|FG000|STARTED|Treatment Period||6
8926912|NCT02269943|9988218|FG001|STARTED|Treatment Period||30
8926913|NCT02269943|9988217|FG000|Investigational Product (IP) Stopped|Treatment Period||6
8926914|NCT02269943|9988218|FG001|Investigational Product (IP) Stopped|Treatment Period||30
8926915|NCT02269943|9988217|FG000|COMPLETED|Treatment Period|Not applicable according to the study design|0
8926916|NCT02269943|9988218|FG001|COMPLETED|Treatment Period|Not applicable according to the study design|0
8926917|NCT02269943|9988217|FG000|NOT COMPLETED|Treatment Period||6
8926918|NCT02269943|9988218|FG001|NOT COMPLETED|Treatment Period||30
8926919|NCT02269943|9988217|FG000|STARTED|Follow-Up Survival Period||5
8926920|NCT02269943|9988218|FG001|STARTED|Follow-Up Survival Period||26
8926921|NCT02269943|9988217|FG000|COMPLETED|Follow-Up Survival Period|Not applicable according to the study design.|0
8926922|NCT02269943|9988218|FG001|COMPLETED|Follow-Up Survival Period|Not applicable according to the study design.|0
8926923|NCT02269943|9988217|FG000|NOT COMPLETED|Follow-Up Survival Period||5
8926924|NCT02269943|9988218|FG001|NOT COMPLETED|Follow-Up Survival Period||26
8926925|NCT02270060|9988227|FG000|STARTED|Overall Study||20
8926926|NCT02270060|9988228|FG001|STARTED|Overall Study||20
8926927|NCT02270060|9988229|FG002|STARTED|Overall Study||20
8926928|NCT02270060|9988227|FG000|COMPLETED|Overall Study||20
8926929|NCT02270060|9988228|FG001|COMPLETED|Overall Study||20
8926930|NCT02270060|9988229|FG002|COMPLETED|Overall Study||20
8926931|NCT02270060|9988227|FG000|NOT COMPLETED|Overall Study||0
8926932|NCT02270060|9988228|FG001|NOT COMPLETED|Overall Study||0
8926933|NCT02270060|9988229|FG002|NOT COMPLETED|Overall Study||0
8926934|NCT02270242|9988239|FG000|STARTED|Overall Study||3555
8926935|NCT02270242|9988240|FG001|STARTED|Overall Study||3564
8926936|NCT02270242|9988239|FG000|COMPLETED|Overall Study||3496
8698743|NCT00896532|9744607|FG009|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
8698744|NCT00896532|9744608|FG010|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
8698745|NCT00896532|9744609|FG011|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
8698746|NCT00896532|9744610|FG012|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
8698747|NCT00896532|9744611|FG013|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
8698748|NCT00896532|9744612|FG014|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
8698749|NCT00896532|9744613|FG015|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
8698750|NCT00896532|9744614|FG016|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
8698751|NCT00896532|9744615|FG017|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
8698752|NCT00896532|9744616|FG018|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
8698753|NCT00896532|9744617|FG019|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
8698754|NCT00896532|9744618|FG020|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
8698755|NCT00896532|9744619|FG021|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
8698756|NCT00896532|9744620|FG022|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
8698757|NCT00896532|9744598|FG000|COMPLETED|Months 1-24: Romosozumab Treatment Phase||46
8698758|NCT00896532|9744599|FG001|COMPLETED|Months 1-24: Romosozumab Treatment Phase||45
8698759|NCT00896532|9744600|FG002|COMPLETED|Months 1-24: Romosozumab Treatment Phase||46
8698760|NCT00896532|9744601|FG003|COMPLETED|Months 1-24: Romosozumab Treatment Phase||39
8698761|NCT00896532|9744602|FG004|COMPLETED|Months 1-24: Romosozumab Treatment Phase||46
8698762|NCT00896532|9744603|FG005|COMPLETED|Months 1-24: Romosozumab Treatment Phase||43
8698763|NCT00896532|9744604|FG006|COMPLETED|Months 1-24: Romosozumab Treatment Phase||48
8698764|NCT00896532|9744605|FG007|COMPLETED|Months 1-24: Romosozumab Treatment Phase||48
8698765|NCT00896532|9744606|FG008|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8698766|NCT00896532|9744607|FG009|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8698767|NCT00896532|9744608|FG010|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8698768|NCT00896532|9744609|FG011|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8698769|NCT00896532|9744610|FG012|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8698770|NCT00896532|9744611|FG013|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8698771|NCT00896532|9744612|FG014|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8698772|NCT00896532|9744613|FG015|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8698773|NCT00896532|9744614|FG016|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8698774|NCT00896532|9744615|FG017|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8698775|NCT00896532|9744616|FG018|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8698776|NCT00896532|9744617|FG019|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8698777|NCT00896532|9744618|FG020|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8698778|NCT00896532|9744619|FG021|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8698779|NCT00896532|9744620|FG022|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8698780|NCT00896532|9744598|FG000|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||6
8698781|NCT00896532|9744599|FG001|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||6
8698782|NCT00896532|9744600|FG002|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||9
8698783|NCT00896532|9744601|FG003|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||12
8698784|NCT00896532|9744602|FG004|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||8
8698785|NCT00896532|9744603|FG005|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||8
8698786|NCT00896532|9744604|FG006|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||5
8698787|NCT00896532|9744605|FG007|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||4
8926937|NCT02270242|9988240|FG001|COMPLETED|Overall Study||3511
8926938|NCT02270242|9988239|FG000|NOT COMPLETED|Overall Study||59
8926939|NCT02270242|9988240|FG001|NOT COMPLETED|Overall Study||53
8926940|NCT02270255|9988248|FG000|STARTED|Overall Study||22
8926941|NCT02270255|9988249|FG001|STARTED|Overall Study||22
8926942|NCT02270255|9988248|FG000|Complete Data at Discharge PACU|Overall Study||22
8926943|NCT02270255|9988249|FG001|Complete Data at Discharge PACU|Overall Study||22
8926944|NCT02270255|9988248|FG000|Complete Data From Home Survey|Overall Study||21
8926945|NCT02270255|9988249|FG001|Complete Data From Home Survey|Overall Study||22
8926946|NCT02270255|9988248|FG000|COMPLETED|Overall Study||21
8926947|NCT02270255|9988249|FG001|COMPLETED|Overall Study||22
8926948|NCT02270255|9988248|FG000|NOT COMPLETED|Overall Study||1
8698788|NCT00896532|9744606|FG008|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8698789|NCT00896532|9744607|FG009|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8698790|NCT00896532|9744608|FG010|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8698791|NCT00896532|9744609|FG011|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8698792|NCT00896532|9744610|FG012|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8698793|NCT00896532|9744611|FG013|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8698794|NCT00896532|9744612|FG014|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8698795|NCT00896532|9744613|FG015|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8698796|NCT00896532|9744614|FG016|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8698797|NCT00896532|9744615|FG017|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8698798|NCT00896532|9744616|FG018|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8698799|NCT00896532|9744617|FG019|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8698800|NCT00896532|9744618|FG020|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8698801|NCT00896532|9744619|FG021|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8698802|NCT00896532|9744620|FG022|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8698803|NCT00896532|9744598|FG000|STARTED|Months 24-36: Denosumab Extension Phase||0
8698804|NCT00896532|9744599|FG001|STARTED|Months 24-36: Denosumab Extension Phase||0
8698805|NCT00896532|9744600|FG002|STARTED|Months 24-36: Denosumab Extension Phase||0
8698806|NCT00896532|9744601|FG003|STARTED|Months 24-36: Denosumab Extension Phase||0
8698807|NCT00896532|9744602|FG004|STARTED|Months 24-36: Denosumab Extension Phase||0
8698808|NCT00896532|9744603|FG005|STARTED|Months 24-36: Denosumab Extension Phase||0
8698809|NCT00896532|9744604|FG006|STARTED|Months 24-36: Denosumab Extension Phase||0
8698810|NCT00896532|9744605|FG007|STARTED|Months 24-36: Denosumab Extension Phase||0
8698811|NCT00896532|9744606|FG008|STARTED|Months 24-36: Denosumab Extension Phase||18
8698812|NCT00896532|9744607|FG009|STARTED|Months 24-36: Denosumab Extension Phase||18
8698813|NCT00896532|9744608|FG010|STARTED|Months 24-36: Denosumab Extension Phase||20
8698814|NCT00896532|9744609|FG011|STARTED|Months 24-36: Denosumab Extension Phase||21
8698815|NCT00896532|9744610|FG012|STARTED|Months 24-36: Denosumab Extension Phase||93
8698816|NCT00896532|9744611|FG013|STARTED|Months 24-36: Denosumab Extension Phase||90
8698817|NCT00896532|9744612|FG014|STARTED|Months 24-36: Denosumab Extension Phase||0
8698818|NCT00896532|9744613|FG015|STARTED|Months 24-36: Denosumab Extension Phase||0
8698819|NCT00896532|9744614|FG016|STARTED|Months 24-36: Denosumab Extension Phase||0
8698820|NCT00896532|9744615|FG017|STARTED|Months 24-36: Denosumab Extension Phase||0
8698821|NCT00896532|9744616|FG018|STARTED|Months 24-36: Denosumab Extension Phase||0
8698822|NCT00896532|9744617|FG019|STARTED|Months 24-36: Denosumab Extension Phase||0
8698823|NCT00896532|9744618|FG020|STARTED|Months 24-36: Denosumab Extension Phase||0
8698824|NCT00896532|9744619|FG021|STARTED|Months 24-36: Denosumab Extension Phase||0
8698825|NCT00896532|9744620|FG022|STARTED|Months 24-36: Denosumab Extension Phase||0
8698826|NCT00896532|9744598|FG000|Received Treatment|Months 24-36: Denosumab Extension Phase||0
8698827|NCT00896532|9744599|FG001|Received Treatment|Months 24-36: Denosumab Extension Phase||0
8698828|NCT00896532|9744600|FG002|Received Treatment|Months 24-36: Denosumab Extension Phase||0
8698829|NCT00896532|9744601|FG003|Received Treatment|Months 24-36: Denosumab Extension Phase||0
8698830|NCT00896532|9744602|FG004|Received Treatment|Months 24-36: Denosumab Extension Phase||0
8698831|NCT00896532|9744603|FG005|Received Treatment|Months 24-36: Denosumab Extension Phase||0
8698832|NCT00896532|9744604|FG006|Received Treatment|Months 24-36: Denosumab Extension Phase||0
8698833|NCT00896532|9744605|FG007|Received Treatment|Months 24-36: Denosumab Extension Phase||0
8698834|NCT00896532|9744606|FG008|Received Treatment|Months 24-36: Denosumab Extension Phase||18
8698835|NCT00896532|9744607|FG009|Received Treatment|Months 24-36: Denosumab Extension Phase|Includes one participant who received 1 dose of romosozumab 70 mg in error in first 12 months|18
8698836|NCT00896532|9744608|FG010|Received Treatment|Months 24-36: Denosumab Extension Phase||19
8698837|NCT00896532|9744609|FG011|Received Treatment|Months 24-36: Denosumab Extension Phase||19
8698838|NCT00896532|9744610|FG012|Received Treatment|Months 24-36: Denosumab Extension Phase||90
8698839|NCT00896532|9744611|FG013|Received Treatment|Months 24-36: Denosumab Extension Phase||88
8698840|NCT00896532|9744612|FG014|Received Treatment|Months 24-36: Denosumab Extension Phase||0
8698841|NCT00896532|9744613|FG015|Received Treatment|Months 24-36: Denosumab Extension Phase||0
8698842|NCT00896532|9744614|FG016|Received Treatment|Months 24-36: Denosumab Extension Phase||0
8698843|NCT00896532|9744615|FG017|Received Treatment|Months 24-36: Denosumab Extension Phase||0
8698844|NCT00896532|9744616|FG018|Received Treatment|Months 24-36: Denosumab Extension Phase||0
8725168|NCT01029691|9772358|FG000|STARTED|Continued APAP to Delivery||20
8926949|NCT02270255|9988249|FG001|NOT COMPLETED|Overall Study||0
8926950|NCT02270515|9988255|FG000|STARTED|Intervention Period 1: 0-6 Months||175
8926951|NCT02270515|9988255|FG000|COMPLETED|Intervention Period 1: 0-6 Months||159
8926952|NCT02270515|9988255|FG000|NOT COMPLETED|Intervention Period 1: 0-6 Months||16
8926953|NCT02270515|9988255|FG000|STARTED|Intervention Period 2: 6-12 Months||159
8926954|NCT02270515|9988255|FG000|COMPLETED|Intervention Period 2: 6-12 Months||127
8926955|NCT02270515|9988255|FG000|NOT COMPLETED|Intervention Period 2: 6-12 Months||32
8926956|NCT02270515|9988255|FG000|STARTED|Intervention Period 3: 12-18 Months||127
8926957|NCT02270515|9988255|FG000|COMPLETED|Intervention Period 3: 12-18 Months||103
8926958|NCT02270515|9988255|FG000|NOT COMPLETED|Intervention Period 3: 12-18 Months||24
8926959|NCT02270645|9988268|FG000|STARTED|Overall Study||8
8926960|NCT02270645|9988269|FG001|STARTED|Overall Study||4
8926961|NCT02270645|9988268|FG000|COMPLETED|Overall Study||6
8926962|NCT02270645|9988269|FG001|COMPLETED|Overall Study||4
8926963|NCT02270645|9988268|FG000|NOT COMPLETED|Overall Study||2
8926964|NCT02270645|9988269|FG001|NOT COMPLETED|Overall Study||0
8926965|NCT02270671|9988277|FG000|STARTED|Overall Study||64
8926966|NCT02270671|9988278|FG001|STARTED|Overall Study||66
8926967|NCT02270671|9988277|FG000|COMPLETED|Overall Study||59
8926968|NCT02270671|9988278|FG001|COMPLETED|Overall Study||61
8926969|NCT02270671|9988277|FG000|NOT COMPLETED|Overall Study||5
8926970|NCT02270671|9988278|FG001|NOT COMPLETED|Overall Study||5
8926971|NCT02270736|9988287|FG000|STARTED|Main Period (MP) (up to 16 Weeks)||72
8926972|NCT02270736|9988288|FG001|STARTED|Main Period (MP) (up to 16 Weeks)||148
8926973|NCT02270736|9988289|FG002|STARTED|Main Period (MP) (up to 16 Weeks)||36
8926974|NCT02270736|9988290|FG003|STARTED|Main Period (MP) (up to 16 Weeks)||0
8926975|NCT02270736|9988291|FG004|STARTED|Main Period (MP) (up to 16 Weeks)||0
8926976|NCT02270736|9988287|FG000|Treated|Main Period (MP) (up to 16 Weeks)||72
8926977|NCT02270736|9988288|FG001|Treated|Main Period (MP) (up to 16 Weeks)||148
8926978|NCT02270736|9988289|FG002|Treated|Main Period (MP) (up to 16 Weeks)||35
8926979|NCT02270736|9988290|FG003|Treated|Main Period (MP) (up to 16 Weeks)||0
8926980|NCT02270736|9988291|FG004|Treated|Main Period (MP) (up to 16 Weeks)||0
8926981|NCT02270736|9988287|FG000|COMPLETED|Main Period (MP) (up to 16 Weeks)||70
8926982|NCT02270736|9988288|FG001|COMPLETED|Main Period (MP) (up to 16 Weeks)||146
8698845|NCT00896532|9744617|FG019|Received Treatment|Months 24-36: Denosumab Extension Phase||0
8698846|NCT00896532|9744618|FG020|Received Treatment|Months 24-36: Denosumab Extension Phase||0
8698847|NCT00896532|9744619|FG021|Received Treatment|Months 24-36: Denosumab Extension Phase||0
8698848|NCT00896532|9744620|FG022|Received Treatment|Months 24-36: Denosumab Extension Phase||0
8698849|NCT00896532|9744598|FG000|COMPLETED|Months 24-36: Denosumab Extension Phase||0
8698850|NCT00896532|9744599|FG001|COMPLETED|Months 24-36: Denosumab Extension Phase||0
8698851|NCT00896532|9744600|FG002|COMPLETED|Months 24-36: Denosumab Extension Phase||0
8698852|NCT00896532|9744601|FG003|COMPLETED|Months 24-36: Denosumab Extension Phase||0
8698853|NCT00896532|9744602|FG004|COMPLETED|Months 24-36: Denosumab Extension Phase||0
8698854|NCT00896532|9744603|FG005|COMPLETED|Months 24-36: Denosumab Extension Phase||0
8698855|NCT00896532|9744604|FG006|COMPLETED|Months 24-36: Denosumab Extension Phase||0
8698856|NCT00896532|9744605|FG007|COMPLETED|Months 24-36: Denosumab Extension Phase||0
8698857|NCT00896532|9744606|FG008|COMPLETED|Months 24-36: Denosumab Extension Phase||17
8698858|NCT00896532|9744607|FG009|COMPLETED|Months 24-36: Denosumab Extension Phase||18
8698859|NCT00896532|9744608|FG010|COMPLETED|Months 24-36: Denosumab Extension Phase||18
8698860|NCT00896532|9744609|FG011|COMPLETED|Months 24-36: Denosumab Extension Phase||19
8698861|NCT00896532|9744610|FG012|COMPLETED|Months 24-36: Denosumab Extension Phase||88
8698862|NCT00896532|9744611|FG013|COMPLETED|Months 24-36: Denosumab Extension Phase||88
8698863|NCT00896532|9744612|FG014|COMPLETED|Months 24-36: Denosumab Extension Phase||0
8698864|NCT00896532|9744613|FG015|COMPLETED|Months 24-36: Denosumab Extension Phase||0
8698865|NCT00896532|9744614|FG016|COMPLETED|Months 24-36: Denosumab Extension Phase||0
8698866|NCT00896532|9744615|FG017|COMPLETED|Months 24-36: Denosumab Extension Phase||0
8698867|NCT00896532|9744616|FG018|COMPLETED|Months 24-36: Denosumab Extension Phase||0
8698868|NCT00896532|9744617|FG019|COMPLETED|Months 24-36: Denosumab Extension Phase||0
8698869|NCT00896532|9744618|FG020|COMPLETED|Months 24-36: Denosumab Extension Phase||0
8698870|NCT00896532|9744619|FG021|COMPLETED|Months 24-36: Denosumab Extension Phase||0
8698871|NCT00896532|9744620|FG022|COMPLETED|Months 24-36: Denosumab Extension Phase||0
8698872|NCT00896532|9744598|FG000|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
8698873|NCT00896532|9744599|FG001|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
8698874|NCT00896532|9744600|FG002|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
8698875|NCT00896532|9744601|FG003|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
8698876|NCT00896532|9744602|FG004|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
8698877|NCT00896532|9744603|FG005|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
8698878|NCT00896532|9744604|FG006|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
8698879|NCT00896532|9744605|FG007|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
8698880|NCT00896532|9744606|FG008|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||1
8698881|NCT00896532|9744607|FG009|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
8698882|NCT00896532|9744608|FG010|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||2
8698883|NCT00896532|9744609|FG011|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||2
8698884|NCT00896532|9744610|FG012|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||5
8698885|NCT00896532|9744611|FG013|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||2
8698886|NCT00896532|9744612|FG014|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
8698887|NCT00896532|9744613|FG015|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
8926983|NCT02270736|9988289|FG002|COMPLETED|Main Period (MP) (up to 16 Weeks)||34
8926984|NCT02270736|9988290|FG003|COMPLETED|Main Period (MP) (up to 16 Weeks)||0
8926985|NCT02270736|9988291|FG004|COMPLETED|Main Period (MP) (up to 16 Weeks)||0
8926986|NCT02270736|9988287|FG000|NOT COMPLETED|Main Period (MP) (up to 16 Weeks)||2
8926987|NCT02270736|9988288|FG001|NOT COMPLETED|Main Period (MP) (up to 16 Weeks)||2
8926988|NCT02270736|9988289|FG002|NOT COMPLETED|Main Period (MP) (up to 16 Weeks)||2
8926989|NCT02270736|9988290|FG003|NOT COMPLETED|Main Period (MP) (up to 16 Weeks)||0
8926990|NCT02270736|9988291|FG004|NOT COMPLETED|Main Period (MP) (up to 16 Weeks)||0
8926991|NCT02270736|9988287|FG000|STARTED|OLEX Period (up to 48 Weeks)||0
8926992|NCT02270736|9988288|FG001|STARTED|OLEX Period (up to 48 Weeks)||0
8926993|NCT02270736|9988289|FG002|STARTED|OLEX Period (up to 48 Weeks)||0
8926994|NCT02270736|9988290|FG003|STARTED|OLEX Period (up to 48 Weeks)|2 participants from MP did not enter OLEX due to withdrawal of consent.|214
8926995|NCT02270736|9988291|FG004|STARTED|OLEX Period (up to 48 Weeks)|1 participant from MP did not enter OLEX due to adverse event.|33
8926996|NCT02270736|9988287|FG000|COMPLETED|OLEX Period (up to 48 Weeks)||0
8926997|NCT02270736|9988288|FG001|COMPLETED|OLEX Period (up to 48 Weeks)||0
8926998|NCT02270736|9988289|FG002|COMPLETED|OLEX Period (up to 48 Weeks)||0
8926999|NCT02270736|9988290|FG003|COMPLETED|OLEX Period (up to 48 Weeks)||189
8927000|NCT02270736|9988291|FG004|COMPLETED|OLEX Period (up to 48 Weeks)||33
8927001|NCT02270736|9988287|FG000|NOT COMPLETED|OLEX Period (up to 48 Weeks)||0
8927002|NCT02270736|9988288|FG001|NOT COMPLETED|OLEX Period (up to 48 Weeks)||0
8927003|NCT02270736|9988289|FG002|NOT COMPLETED|OLEX Period (up to 48 Weeks)||0
8927004|NCT02270736|9988290|FG003|NOT COMPLETED|OLEX Period (up to 48 Weeks)||25
8927005|NCT02270736|9988291|FG004|NOT COMPLETED|OLEX Period (up to 48 Weeks)||0
8927006|NCT02270944|9988306|FG000|STARTED|Overall Study||529
8927007|NCT02270944|9988307|FG001|STARTED|Overall Study||521
8927008|NCT02270944|9988306|FG000|COMPLETED|Overall Study||518
8927009|NCT02270944|9988307|FG001|COMPLETED|Overall Study||516
8927010|NCT02270944|9988306|FG000|NOT COMPLETED|Overall Study||11
8927011|NCT02270944|9988307|FG001|NOT COMPLETED|Overall Study||5
8927012|NCT02270983|9988317|FG000|STARTED|Overall Study||79
8927013|NCT02270983|9988318|FG001|STARTED|Overall Study||87
8927014|NCT02270983|9988319|FG002|STARTED|Overall Study||88
8927015|NCT02270983|9988317|FG000|COMPLETED|Overall Study||70
8927016|NCT02270983|9988318|FG001|COMPLETED|Overall Study||80
8927017|NCT02270983|9988319|FG002|COMPLETED|Overall Study||76
8927018|NCT02270983|9988317|FG000|NOT COMPLETED|Overall Study||9
8927019|NCT02270983|9988318|FG001|NOT COMPLETED|Overall Study||7
8698888|NCT00896532|9744614|FG016|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
8698889|NCT00896532|9744615|FG017|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
8698890|NCT00896532|9744616|FG018|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
8698891|NCT00896532|9744617|FG019|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
8698892|NCT00896532|9744618|FG020|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
8698893|NCT00896532|9744619|FG021|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
8698894|NCT00896532|9744620|FG022|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
8698895|NCT00896532|9744598|FG000|STARTED|Months 36-48: Romosozumab Retreatment||0
8698896|NCT00896532|9744599|FG001|STARTED|Months 36-48: Romosozumab Retreatment||0
8698897|NCT00896532|9744600|FG002|STARTED|Months 36-48: Romosozumab Retreatment||0
8698898|NCT00896532|9744601|FG003|STARTED|Months 36-48: Romosozumab Retreatment||0
8698899|NCT00896532|9744602|FG004|STARTED|Months 36-48: Romosozumab Retreatment||0
8698900|NCT00896532|9744603|FG005|STARTED|Months 36-48: Romosozumab Retreatment||0
8698901|NCT00896532|9744604|FG006|STARTED|Months 36-48: Romosozumab Retreatment||0
8698902|NCT00896532|9744605|FG007|STARTED|Months 36-48: Romosozumab Retreatment||0
8698903|NCT00896532|9744606|FG008|STARTED|Months 36-48: Romosozumab Retreatment||0
8698904|NCT00896532|9744607|FG009|STARTED|Months 36-48: Romosozumab Retreatment||0
8698905|NCT00896532|9744608|FG010|STARTED|Months 36-48: Romosozumab Retreatment||0
8698906|NCT00896532|9744609|FG011|STARTED|Months 36-48: Romosozumab Retreatment||0
8698907|NCT00896532|9744610|FG012|STARTED|Months 36-48: Romosozumab Retreatment||0
8698908|NCT00896532|9744611|FG013|STARTED|Months 36-48: Romosozumab Retreatment||0
8698909|NCT00896532|9744612|FG014|STARTED|Months 36-48: Romosozumab Retreatment||12
8698910|NCT00896532|9744613|FG015|STARTED|Months 36-48: Romosozumab Retreatment||16
8698911|NCT00896532|9744614|FG016|STARTED|Months 36-48: Romosozumab Retreatment||72
8698912|NCT00896532|9744615|FG017|STARTED|Months 36-48: Romosozumab Retreatment||67
8698913|NCT00896532|9744616|FG018|STARTED|Months 36-48: Romosozumab Retreatment||0
8698914|NCT00896532|9744617|FG019|STARTED|Months 36-48: Romosozumab Retreatment||0
8698915|NCT00896532|9744618|FG020|STARTED|Months 36-48: Romosozumab Retreatment||0
8698916|NCT00896532|9744619|FG021|STARTED|Months 36-48: Romosozumab Retreatment||0
8698917|NCT00896532|9744620|FG022|STARTED|Months 36-48: Romosozumab Retreatment||0
8698918|NCT00896532|9744598|FG000|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
8698919|NCT00896532|9744599|FG001|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
8698920|NCT00896532|9744600|FG002|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
8698921|NCT00896532|9744601|FG003|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
8698922|NCT00896532|9744602|FG004|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
8698923|NCT00896532|9744603|FG005|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
8698924|NCT00896532|9744604|FG006|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
8698925|NCT00896532|9744605|FG007|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
8698926|NCT00896532|9744606|FG008|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
8698927|NCT00896532|9744607|FG009|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
8812258|NCT01519089|9865209|FG000|STARTED|Overall Study||47
8927020|NCT02270983|9988319|FG002|NOT COMPLETED|Overall Study||12
8927021|NCT02271217|9988330|FG000|STARTED|Overall Study||126
8927022|NCT02271217|9988331|FG001|STARTED|Overall Study||126
8927023|NCT02271217|9988332|FG002|STARTED|Overall Study||125
8927024|NCT02271217|9988330|FG000|COMPLETED|Overall Study||115
8927025|NCT02271217|9988331|FG001|COMPLETED|Overall Study||113
8927026|NCT02271217|9988332|FG002|COMPLETED|Overall Study||113
8927027|NCT02271217|9988330|FG000|NOT COMPLETED|Overall Study||11
8927028|NCT02271217|9988331|FG001|NOT COMPLETED|Overall Study||13
8927029|NCT02271217|9988332|FG002|NOT COMPLETED|Overall Study||12
8927030|NCT02271386|9988344|FG000|STARTED|Baseline Period- 8 Months||53
8927031|NCT02271386|9988345|FG001|STARTED|Baseline Period- 8 Months||52
8927032|NCT02271386|9988346|FG002|STARTED|Baseline Period- 8 Months||200
8927033|NCT02271386|9988347|FG003|STARTED|Baseline Period- 8 Months||191
8927034|NCT02271386|9988344|FG000|COMPLETED|Baseline Period- 8 Months||53
8927035|NCT02271386|9988345|FG001|COMPLETED|Baseline Period- 8 Months||52
8698928|NCT00896532|9744608|FG010|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
8698929|NCT00896532|9744609|FG011|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
8698930|NCT00896532|9744610|FG012|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
8927036|NCT02271386|9988346|FG002|COMPLETED|Baseline Period- 8 Months||200
8927037|NCT02271386|9988347|FG003|COMPLETED|Baseline Period- 8 Months||191
8927038|NCT02271386|9988344|FG000|NOT COMPLETED|Baseline Period- 8 Months||0
8927039|NCT02271386|9988345|FG001|NOT COMPLETED|Baseline Period- 8 Months||0
8927040|NCT02271386|9988346|FG002|NOT COMPLETED|Baseline Period- 8 Months||0
8927041|NCT02271386|9988347|FG003|NOT COMPLETED|Baseline Period- 8 Months||0
8927042|NCT02271386|9988344|FG000|STARTED|Intervention Period- 8 Months||53
8927043|NCT02271386|9988345|FG001|STARTED|Intervention Period- 8 Months||52
8927044|NCT02271386|9988346|FG002|STARTED|Intervention Period- 8 Months||202
8927045|NCT02271386|9988347|FG003|STARTED|Intervention Period- 8 Months||197
8927046|NCT02271386|9988344|FG000|COMPLETED|Intervention Period- 8 Months||53
8927047|NCT02271386|9988345|FG001|COMPLETED|Intervention Period- 8 Months||52
8927048|NCT02271386|9988346|FG002|COMPLETED|Intervention Period- 8 Months||202
8927049|NCT02271386|9988347|FG003|COMPLETED|Intervention Period- 8 Months||197
8927050|NCT02271386|9988344|FG000|NOT COMPLETED|Intervention Period- 8 Months||0
8927051|NCT02271386|9988345|FG001|NOT COMPLETED|Intervention Period- 8 Months||0
8927052|NCT02271386|9988346|FG002|NOT COMPLETED|Intervention Period- 8 Months||0
8927053|NCT02271386|9988347|FG003|NOT COMPLETED|Intervention Period- 8 Months||0
8927054|NCT02271425|9988361|FG000|STARTED|Overall Study||8
8927055|NCT02271425|9988361|FG000|COMPLETED|Overall Study||8
8927056|NCT02271425|9988361|FG000|NOT COMPLETED|Overall Study||0
8927057|NCT02271451|9988368|FG000|STARTED|Overall Study||7
8927058|NCT02271451|9988369|FG001|STARTED|Overall Study||8
8927059|NCT02271451|9988368|FG000|COMPLETED|Overall Study||7
8927060|NCT02271451|9988369|FG001|COMPLETED|Overall Study|one subject does not have MRI data due to braces|7
8927061|NCT02271451|9988368|FG000|NOT COMPLETED|Overall Study||0
8927062|NCT02271451|9988369|FG001|NOT COMPLETED|Overall Study||1
8927063|NCT02271477|9988377|FG000|STARTED|Overall Study||80
8927064|NCT02271477|9988378|FG001|STARTED|Overall Study||80
8927065|NCT02271477|9988377|FG000|COMPLETED|Overall Study||80
8927066|NCT02271477|9988378|FG001|COMPLETED|Overall Study||80
8927067|NCT02271477|9988377|FG000|NOT COMPLETED|Overall Study||0
8927068|NCT02271477|9988378|FG001|NOT COMPLETED|Overall Study||0
8927069|NCT02271529|9988385|FG000|STARTED|Overall Study||40
8927070|NCT02271529|9988385|FG000|COMPLETED|Overall Study||39
8927071|NCT02271529|9988385|FG000|NOT COMPLETED|Overall Study||1
8927072|NCT02271698|9988393|FG000|STARTED|Overall Study||11
8927073|NCT02271698|9988394|FG001|STARTED|Overall Study||10
8927074|NCT02271698|9988395|FG002|STARTED|Overall Study||10
8927075|NCT02271698|9988396|FG003|STARTED|Overall Study||11
8927076|NCT02271698|9988393|FG000|COMPLETED|Overall Study||11
9042362|NCT03381339|10102964|FG001|NOT COMPLETED|Overall Study||4
9042363|NCT03381742|10102974|FG000|STARTED|Overall Study||525
8698931|NCT00896532|9744611|FG013|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
8698932|NCT00896532|9744612|FG014|Received Romosozumab|Months 36-48: Romosozumab Retreatment||12
8698933|NCT00896532|9744613|FG015|Received Romosozumab|Months 36-48: Romosozumab Retreatment|Includes one participant who received 1 dose of romosozumab 70 mg in error in first 12 months|16
8698934|NCT00896532|9744614|FG016|Received Romosozumab|Months 36-48: Romosozumab Retreatment||72
8698935|NCT00896532|9744615|FG017|Received Romosozumab|Months 36-48: Romosozumab Retreatment||67
8698936|NCT00896532|9744616|FG018|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
8927077|NCT02271698|9988394|FG001|COMPLETED|Overall Study||10
8927078|NCT02271698|9988395|FG002|COMPLETED|Overall Study||10
8927079|NCT02271698|9988396|FG003|COMPLETED|Overall Study||11
8927080|NCT02271698|9988393|FG000|NOT COMPLETED|Overall Study||0
8927081|NCT02271698|9988394|FG001|NOT COMPLETED|Overall Study||0
8927082|NCT02271698|9988395|FG002|NOT COMPLETED|Overall Study||0
8927083|NCT02271698|9988396|FG003|NOT COMPLETED|Overall Study||0
8927084|NCT02271854|9988406|FG000|STARTED|Overall Study||102
8927085|NCT02271854|9988406|FG000|COMPLETED|Overall Study||98
8927086|NCT02271854|9988406|FG000|NOT COMPLETED|Overall Study||4
8927087|NCT02271880|9988413|FG000|STARTED|Overall Study||3
8927088|NCT02271880|9988414|FG001|STARTED|Overall Study||4
8927089|NCT02271880|9988413|FG000|COMPLETED|Overall Study||0
8927090|NCT02271880|9988414|FG001|COMPLETED|Overall Study||0
8927091|NCT02271880|9988413|FG000|NOT COMPLETED|Overall Study||3
8927092|NCT02271880|9988414|FG001|NOT COMPLETED|Overall Study||4
8927093|NCT02271906|9988422|FG000|STARTED|Overall Study||2
8698937|NCT00896532|9744617|FG019|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
8698938|NCT00896532|9744618|FG020|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
9042364|NCT03381742|10102975|FG001|STARTED|Overall Study||501
9042365|NCT03381742|10102976|FG002|STARTED|Overall Study||1511
9042366|NCT03381742|10102977|FG003|STARTED|Overall Study||506
9042367|NCT03381742|10102974|FG000|COMPLETED|Overall Study||525
9042368|NCT03381742|10102975|FG001|COMPLETED|Overall Study||501
9042369|NCT03381742|10102976|FG002|COMPLETED|Overall Study||1511
9042370|NCT03381742|10102977|FG003|COMPLETED|Overall Study||506
9042371|NCT03381742|10102974|FG000|NOT COMPLETED|Overall Study||0
9042372|NCT03381742|10102975|FG001|NOT COMPLETED|Overall Study||0
9042373|NCT03381742|10102976|FG002|NOT COMPLETED|Overall Study||0
9042374|NCT03381742|10102977|FG003|NOT COMPLETED|Overall Study||0
9042375|NCT03381989|10102987|FG000|STARTED|Overall Study||30
9042376|NCT03381989|10102987|FG000|COMPLETED|Overall Study||22
9042377|NCT03381989|10102987|FG000|NOT COMPLETED|Overall Study||8
9042378|NCT03382262|10102996|FG000|STARTED|Overall Study||12
8927094|NCT02271906|9988422|FG000|COMPLETED|Overall Study||2
8927095|NCT02271906|9988422|FG000|NOT COMPLETED|Overall Study||0
8927096|NCT02271945|9988428|FG000|STARTED|Overall Study||5
8927097|NCT02271945|9988429|FG001|STARTED|Overall Study||5
8927098|NCT02271945|9988428|FG000|COMPLETED|Overall Study||0
8927099|NCT02271945|9988429|FG001|COMPLETED|Overall Study||0
8927100|NCT02271945|9988428|FG000|NOT COMPLETED|Overall Study||5
8927101|NCT02271945|9988429|FG001|NOT COMPLETED|Overall Study||5
8927102|NCT02271984|9988435|FG000|STARTED|First Intervention Period (1 Day)||3
8927103|NCT02271984|9988436|FG001|STARTED|First Intervention Period (1 Day)||3
8927104|NCT02271984|9988437|FG002|STARTED|First Intervention Period (1 Day)||3
8927105|NCT02271984|9988438|FG003|STARTED|First Intervention Period (1 Day)||3
8927106|NCT02271984|9988439|FG004|STARTED|First Intervention Period (1 Day)||3
8927107|NCT02271984|9988440|FG005|STARTED|First Intervention Period (1 Day)||3
8927108|NCT02271984|9988441|FG006|STARTED|First Intervention Period (1 Day)||3
8927109|NCT02271984|9988442|FG007|STARTED|First Intervention Period (1 Day)||3
8927110|NCT02271984|9988443|FG008|STARTED|First Intervention Period (1 Day)||3
8927111|NCT02271984|9988444|FG009|STARTED|First Intervention Period (1 Day)||3
8927112|NCT02271984|9988445|FG010|STARTED|First Intervention Period (1 Day)||3
8927113|NCT02271984|9988446|FG011|STARTED|First Intervention Period (1 Day)||3
8927114|NCT02271984|9988435|FG000|COMPLETED|First Intervention Period (1 Day)||3
8698939|NCT00896532|9744619|FG021|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
8698940|NCT00896532|9744620|FG022|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
8698941|NCT00896532|9744598|FG000|COMPLETED|Months 36-48: Romosozumab Retreatment||0
8698942|NCT00896532|9744599|FG001|COMPLETED|Months 36-48: Romosozumab Retreatment||0
8698943|NCT00896532|9744600|FG002|COMPLETED|Months 36-48: Romosozumab Retreatment||0
8698944|NCT00896532|9744601|FG003|COMPLETED|Months 36-48: Romosozumab Retreatment||0
8927115|NCT02271984|9988436|FG001|COMPLETED|First Intervention Period (1 Day)||3
8927116|NCT02271984|9988437|FG002|COMPLETED|First Intervention Period (1 Day)||3
8927117|NCT02271984|9988438|FG003|COMPLETED|First Intervention Period (1 Day)||3
8927118|NCT02271984|9988439|FG004|COMPLETED|First Intervention Period (1 Day)||3
8927119|NCT02271984|9988440|FG005|COMPLETED|First Intervention Period (1 Day)||3
8927120|NCT02271984|9988441|FG006|COMPLETED|First Intervention Period (1 Day)||3
8927121|NCT02271984|9988442|FG007|COMPLETED|First Intervention Period (1 Day)||3
8927122|NCT02271984|9988443|FG008|COMPLETED|First Intervention Period (1 Day)||3
8927123|NCT02271984|9988444|FG009|COMPLETED|First Intervention Period (1 Day)||3
8927124|NCT02271984|9988445|FG010|COMPLETED|First Intervention Period (1 Day)||3
8927125|NCT02271984|9988446|FG011|COMPLETED|First Intervention Period (1 Day)||3
8927126|NCT02271984|9988435|FG000|NOT COMPLETED|First Intervention Period (1 Day)||0
8927127|NCT02271984|9988436|FG001|NOT COMPLETED|First Intervention Period (1 Day)||0
8927128|NCT02271984|9988437|FG002|NOT COMPLETED|First Intervention Period (1 Day)||0
8927129|NCT02271984|9988438|FG003|NOT COMPLETED|First Intervention Period (1 Day)||0
8927130|NCT02271984|9988439|FG004|NOT COMPLETED|First Intervention Period (1 Day)||0
8927131|NCT02271984|9988440|FG005|NOT COMPLETED|First Intervention Period (1 Day)||0
8927132|NCT02271984|9988441|FG006|NOT COMPLETED|First Intervention Period (1 Day)||0
8927133|NCT02271984|9988442|FG007|NOT COMPLETED|First Intervention Period (1 Day)||0
8927134|NCT02271984|9988443|FG008|NOT COMPLETED|First Intervention Period (1 Day)||0
8927135|NCT02271984|9988444|FG009|NOT COMPLETED|First Intervention Period (1 Day)||0
8927136|NCT02271984|9988445|FG010|NOT COMPLETED|First Intervention Period (1 Day)||0
8698945|NCT00896532|9744602|FG004|COMPLETED|Months 36-48: Romosozumab Retreatment||0
8698946|NCT00896532|9744603|FG005|COMPLETED|Months 36-48: Romosozumab Retreatment||0
8698947|NCT00896532|9744604|FG006|COMPLETED|Months 36-48: Romosozumab Retreatment||0
8698948|NCT00896532|9744605|FG007|COMPLETED|Months 36-48: Romosozumab Retreatment||0
8927137|NCT02271984|9988446|FG011|NOT COMPLETED|First Intervention Period (1 Day)||0
8927138|NCT02271984|9988435|FG000|STARTED|Washout Period 1 (7 Days)||3
8927139|NCT02271984|9988436|FG001|STARTED|Washout Period 1 (7 Days)||3
8927140|NCT02271984|9988437|FG002|STARTED|Washout Period 1 (7 Days)||3
8927141|NCT02271984|9988438|FG003|STARTED|Washout Period 1 (7 Days)||3
9042379|NCT03382262|10102997|FG001|STARTED|Overall Study||13
9042380|NCT03382262|10102998|FG002|STARTED|Overall Study||15
9042381|NCT03382262|10102999|FG003|STARTED|Overall Study||15
9042382|NCT03382262|10102996|FG000|COMPLETED|Overall Study||12
9042383|NCT03382262|10102997|FG001|COMPLETED|Overall Study||13
9042384|NCT03382262|10102998|FG002|COMPLETED|Overall Study||14
8927142|NCT02271984|9988439|FG004|STARTED|Washout Period 1 (7 Days)||3
8927143|NCT02271984|9988440|FG005|STARTED|Washout Period 1 (7 Days)||3
8927144|NCT02271984|9988441|FG006|STARTED|Washout Period 1 (7 Days)||3
8927145|NCT02271984|9988442|FG007|STARTED|Washout Period 1 (7 Days)||3
8927146|NCT02271984|9988443|FG008|STARTED|Washout Period 1 (7 Days)||3
8927147|NCT02271984|9988444|FG009|STARTED|Washout Period 1 (7 Days)||3
8927148|NCT02271984|9988445|FG010|STARTED|Washout Period 1 (7 Days)||3
8927149|NCT02271984|9988446|FG011|STARTED|Washout Period 1 (7 Days)||3
8927150|NCT02271984|9988435|FG000|COMPLETED|Washout Period 1 (7 Days)||3
8927151|NCT02271984|9988436|FG001|COMPLETED|Washout Period 1 (7 Days)||3
8927152|NCT02271984|9988437|FG002|COMPLETED|Washout Period 1 (7 Days)||3
8927153|NCT02271984|9988438|FG003|COMPLETED|Washout Period 1 (7 Days)||3
8927154|NCT02271984|9988439|FG004|COMPLETED|Washout Period 1 (7 Days)||3
8927155|NCT02271984|9988440|FG005|COMPLETED|Washout Period 1 (7 Days)||3
8927156|NCT02271984|9988441|FG006|COMPLETED|Washout Period 1 (7 Days)||3
8927157|NCT02271984|9988442|FG007|COMPLETED|Washout Period 1 (7 Days)||3
8927158|NCT02271984|9988443|FG008|COMPLETED|Washout Period 1 (7 Days)||3
8927159|NCT02271984|9988444|FG009|COMPLETED|Washout Period 1 (7 Days)||3
8927160|NCT02271984|9988445|FG010|COMPLETED|Washout Period 1 (7 Days)||3
8927161|NCT02271984|9988446|FG011|COMPLETED|Washout Period 1 (7 Days)||3
8927162|NCT02271984|9988435|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
8927163|NCT02271984|9988436|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
8927164|NCT02271984|9988437|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
8927165|NCT02271984|9988438|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
8927166|NCT02271984|9988439|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||0
8927167|NCT02271984|9988440|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||0
8927168|NCT02271984|9988441|FG006|NOT COMPLETED|Washout Period 1 (7 Days)||0
8927169|NCT02271984|9988442|FG007|NOT COMPLETED|Washout Period 1 (7 Days)||0
8927170|NCT02271984|9988443|FG008|NOT COMPLETED|Washout Period 1 (7 Days)||0
8927171|NCT02271984|9988444|FG009|NOT COMPLETED|Washout Period 1 (7 Days)||0
8927172|NCT02271984|9988445|FG010|NOT COMPLETED|Washout Period 1 (7 Days)||0
8927173|NCT02271984|9988446|FG011|NOT COMPLETED|Washout Period 1 (7 Days)||0
8927174|NCT02271984|9988435|FG000|STARTED|Second Intervention Period (1 Day)||3
8927175|NCT02271984|9988436|FG001|STARTED|Second Intervention Period (1 Day)||3
8927176|NCT02271984|9988437|FG002|STARTED|Second Intervention Period (1 Day)||3
8927177|NCT02271984|9988438|FG003|STARTED|Second Intervention Period (1 Day)||3
8927178|NCT02271984|9988439|FG004|STARTED|Second Intervention Period (1 Day)||3
8927179|NCT02271984|9988440|FG005|STARTED|Second Intervention Period (1 Day)||3
8927180|NCT02271984|9988441|FG006|STARTED|Second Intervention Period (1 Day)||3
8927181|NCT02271984|9988442|FG007|STARTED|Second Intervention Period (1 Day)||3
8927182|NCT02271984|9988443|FG008|STARTED|Second Intervention Period (1 Day)||3
8927183|NCT02271984|9988444|FG009|STARTED|Second Intervention Period (1 Day)||3
8927184|NCT02271984|9988445|FG010|STARTED|Second Intervention Period (1 Day)||3
8927185|NCT02271984|9988446|FG011|STARTED|Second Intervention Period (1 Day)||3
8927186|NCT02271984|9988435|FG000|COMPLETED|Second Intervention Period (1 Day)||3
8927187|NCT02271984|9988436|FG001|COMPLETED|Second Intervention Period (1 Day)||3
8927188|NCT02271984|9988437|FG002|COMPLETED|Second Intervention Period (1 Day)||3
8927189|NCT02271984|9988438|FG003|COMPLETED|Second Intervention Period (1 Day)||3
8927190|NCT02271984|9988439|FG004|COMPLETED|Second Intervention Period (1 Day)||3
8927191|NCT02271984|9988440|FG005|COMPLETED|Second Intervention Period (1 Day)||3
8927192|NCT02271984|9988441|FG006|COMPLETED|Second Intervention Period (1 Day)||3
8927193|NCT02271984|9988442|FG007|COMPLETED|Second Intervention Period (1 Day)||3
8927194|NCT02271984|9988443|FG008|COMPLETED|Second Intervention Period (1 Day)||3
8927195|NCT02271984|9988444|FG009|COMPLETED|Second Intervention Period (1 Day)||3
8927196|NCT02271984|9988445|FG010|COMPLETED|Second Intervention Period (1 Day)||3
8927197|NCT02271984|9988446|FG011|COMPLETED|Second Intervention Period (1 Day)||3
8927198|NCT02271984|9988435|FG000|NOT COMPLETED|Second Intervention Period (1 Day)||0
8927199|NCT02271984|9988436|FG001|NOT COMPLETED|Second Intervention Period (1 Day)||0
8927200|NCT02271984|9988437|FG002|NOT COMPLETED|Second Intervention Period (1 Day)||0
8927201|NCT02271984|9988438|FG003|NOT COMPLETED|Second Intervention Period (1 Day)||0
8927202|NCT02271984|9988439|FG004|NOT COMPLETED|Second Intervention Period (1 Day)||0
8927203|NCT02271984|9988440|FG005|NOT COMPLETED|Second Intervention Period (1 Day)||0
8927204|NCT02271984|9988441|FG006|NOT COMPLETED|Second Intervention Period (1 Day)||0
8927205|NCT02271984|9988442|FG007|NOT COMPLETED|Second Intervention Period (1 Day)||0
8927206|NCT02271984|9988443|FG008|NOT COMPLETED|Second Intervention Period (1 Day)||0
8927207|NCT02271984|9988444|FG009|NOT COMPLETED|Second Intervention Period (1 Day)||0
8927208|NCT02271984|9988445|FG010|NOT COMPLETED|Second Intervention Period (1 Day)||0
8927209|NCT02271984|9988446|FG011|NOT COMPLETED|Second Intervention Period (1 Day)||0
8927210|NCT02271984|9988435|FG000|STARTED|Washout Period 2 (7 Days)||3
8927211|NCT02271984|9988436|FG001|STARTED|Washout Period 2 (7 Days)||3
8927212|NCT02271984|9988437|FG002|STARTED|Washout Period 2 (7 Days)||3
8698949|NCT00896532|9744606|FG008|COMPLETED|Months 36-48: Romosozumab Retreatment||0
8698950|NCT00896532|9744607|FG009|COMPLETED|Months 36-48: Romosozumab Retreatment||0
8698951|NCT00896532|9744608|FG010|COMPLETED|Months 36-48: Romosozumab Retreatment||0
8698952|NCT00896532|9744609|FG011|COMPLETED|Months 36-48: Romosozumab Retreatment||0
8698953|NCT00896532|9744610|FG012|COMPLETED|Months 36-48: Romosozumab Retreatment||0
8698954|NCT00896532|9744611|FG013|COMPLETED|Months 36-48: Romosozumab Retreatment||0
8698955|NCT00896532|9744612|FG014|COMPLETED|Months 36-48: Romosozumab Retreatment||12
8698956|NCT00896532|9744613|FG015|COMPLETED|Months 36-48: Romosozumab Retreatment||14
8698957|NCT00896532|9744614|FG016|COMPLETED|Months 36-48: Romosozumab Retreatment||65
8698958|NCT00896532|9744615|FG017|COMPLETED|Months 36-48: Romosozumab Retreatment||64
8698959|NCT00896532|9744616|FG018|COMPLETED|Months 36-48: Romosozumab Retreatment||0
8698960|NCT00896532|9744617|FG019|COMPLETED|Months 36-48: Romosozumab Retreatment||0
8698961|NCT00896532|9744618|FG020|COMPLETED|Months 36-48: Romosozumab Retreatment||0
8698962|NCT00896532|9744619|FG021|COMPLETED|Months 36-48: Romosozumab Retreatment||0
8698963|NCT00896532|9744620|FG022|COMPLETED|Months 36-48: Romosozumab Retreatment||0
8698964|NCT00896532|9744598|FG000|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
8698965|NCT00896532|9744599|FG001|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
8698966|NCT00896532|9744600|FG002|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
8698967|NCT00896532|9744601|FG003|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
8698968|NCT00896532|9744602|FG004|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
8698969|NCT00896532|9744603|FG005|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
8698970|NCT00896532|9744604|FG006|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
8698971|NCT00896532|9744605|FG007|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
8698972|NCT00896532|9744606|FG008|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
8698973|NCT00896532|9744607|FG009|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
8698974|NCT00896532|9744608|FG010|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
8698975|NCT00896532|9744609|FG011|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
8927213|NCT02271984|9988438|FG003|STARTED|Washout Period 2 (7 Days)||3
8698976|NCT00896532|9744610|FG012|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
8698977|NCT00896532|9744611|FG013|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
8698978|NCT00896532|9744612|FG014|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
8698979|NCT00896532|9744613|FG015|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||2
8698980|NCT00896532|9744614|FG016|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||7
8698981|NCT00896532|9744615|FG017|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||3
8698982|NCT00896532|9744616|FG018|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
8698983|NCT00896532|9744617|FG019|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
8698984|NCT00896532|9744618|FG020|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
8698985|NCT00896532|9744619|FG021|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
8698986|NCT00896532|9744620|FG022|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
8698987|NCT00896532|9744598|FG000|STARTED|Months 48-72: Follow-on Phase||0
8698988|NCT00896532|9744599|FG001|STARTED|Months 48-72: Follow-on Phase||0
8698989|NCT00896532|9744600|FG002|STARTED|Months 48-72: Follow-on Phase||0
8698990|NCT00896532|9744601|FG003|STARTED|Months 48-72: Follow-on Phase||0
8698991|NCT00896532|9744602|FG004|STARTED|Months 48-72: Follow-on Phase||0
8698992|NCT00896532|9744603|FG005|STARTED|Months 48-72: Follow-on Phase||0
8698993|NCT00896532|9744604|FG006|STARTED|Months 48-72: Follow-on Phase||0
8698994|NCT00896532|9744605|FG007|STARTED|Months 48-72: Follow-on Phase||0
8698995|NCT00896532|9744606|FG008|STARTED|Months 48-72: Follow-on Phase||0
8698996|NCT00896532|9744607|FG009|STARTED|Months 48-72: Follow-on Phase||0
8698997|NCT00896532|9744608|FG010|STARTED|Months 48-72: Follow-on Phase||0
8698998|NCT00896532|9744609|FG011|STARTED|Months 48-72: Follow-on Phase||0
8698999|NCT00896532|9744610|FG012|STARTED|Months 48-72: Follow-on Phase||0
8699000|NCT00896532|9744611|FG013|STARTED|Months 48-72: Follow-on Phase||0
8699001|NCT00896532|9744612|FG014|STARTED|Months 48-72: Follow-on Phase||0
8699002|NCT00896532|9744613|FG015|STARTED|Months 48-72: Follow-on Phase||0
8699003|NCT00896532|9744614|FG016|STARTED|Months 48-72: Follow-on Phase||0
8699004|NCT00896532|9744615|FG017|STARTED|Months 48-72: Follow-on Phase||0
8699005|NCT00896532|9744616|FG018|STARTED|Months 48-72: Follow-on Phase||51
8699006|NCT00896532|9744617|FG019|STARTED|Months 48-72: Follow-on Phase||11
8699007|NCT00896532|9744618|FG020|STARTED|Months 48-72: Follow-on Phase||12
8699008|NCT00896532|9744619|FG021|STARTED|Months 48-72: Follow-on Phase||59
8699009|NCT00896532|9744620|FG022|STARTED|Months 48-72: Follow-on Phase||8
8699010|NCT00896532|9744598|FG000|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
8699011|NCT00896532|9744599|FG001|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
8699012|NCT00896532|9744600|FG002|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
8699013|NCT00896532|9744601|FG003|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
8699014|NCT00896532|9744602|FG004|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
8699015|NCT00896532|9744603|FG005|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
8699016|NCT00896532|9744604|FG006|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
8699017|NCT00896532|9744605|FG007|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
8699018|NCT00896532|9744606|FG008|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
8699019|NCT00896532|9744607|FG009|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
8699020|NCT00896532|9744608|FG010|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
8699021|NCT00896532|9744609|FG011|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
8699022|NCT00896532|9744610|FG012|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
8699023|NCT00896532|9744611|FG013|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
8699024|NCT00896532|9744612|FG014|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
8699025|NCT00896532|9744613|FG015|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
8699026|NCT00896532|9744614|FG016|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
8699027|NCT00896532|9744615|FG017|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
8927214|NCT02271984|9988439|FG004|STARTED|Washout Period 2 (7 Days)||3
8927215|NCT02271984|9988440|FG005|STARTED|Washout Period 2 (7 Days)||3
8927216|NCT02271984|9988441|FG006|STARTED|Washout Period 2 (7 Days)||3
8927217|NCT02271984|9988442|FG007|STARTED|Washout Period 2 (7 Days)||3
8927218|NCT02271984|9988443|FG008|STARTED|Washout Period 2 (7 Days)||3
8927219|NCT02271984|9988444|FG009|STARTED|Washout Period 2 (7 Days)||3
8927220|NCT02271984|9988445|FG010|STARTED|Washout Period 2 (7 Days)||3
8927221|NCT02271984|9988446|FG011|STARTED|Washout Period 2 (7 Days)||3
8927222|NCT02271984|9988435|FG000|COMPLETED|Washout Period 2 (7 Days)||3
8927223|NCT02271984|9988436|FG001|COMPLETED|Washout Period 2 (7 Days)||3
8927224|NCT02271984|9988437|FG002|COMPLETED|Washout Period 2 (7 Days)||3
8927225|NCT02271984|9988438|FG003|COMPLETED|Washout Period 2 (7 Days)||3
8927226|NCT02271984|9988439|FG004|COMPLETED|Washout Period 2 (7 Days)||3
8927227|NCT02271984|9988440|FG005|COMPLETED|Washout Period 2 (7 Days)||3
8927228|NCT02271984|9988441|FG006|COMPLETED|Washout Period 2 (7 Days)||3
8927229|NCT02271984|9988442|FG007|COMPLETED|Washout Period 2 (7 Days)||3
8927230|NCT02271984|9988443|FG008|COMPLETED|Washout Period 2 (7 Days)||3
8927231|NCT02271984|9988444|FG009|COMPLETED|Washout Period 2 (7 Days)||3
8927232|NCT02271984|9988445|FG010|COMPLETED|Washout Period 2 (7 Days)||3
8927233|NCT02271984|9988446|FG011|COMPLETED|Washout Period 2 (7 Days)||3
8927234|NCT02271984|9988435|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
8927235|NCT02271984|9988436|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
8927236|NCT02271984|9988437|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
8927237|NCT02271984|9988438|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
8927238|NCT02271984|9988439|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0
8927239|NCT02271984|9988440|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0
8927240|NCT02271984|9988441|FG006|NOT COMPLETED|Washout Period 2 (7 Days)||0
8927241|NCT02271984|9988442|FG007|NOT COMPLETED|Washout Period 2 (7 Days)||0
8927242|NCT02271984|9988443|FG008|NOT COMPLETED|Washout Period 2 (7 Days)||0
8927243|NCT02271984|9988444|FG009|NOT COMPLETED|Washout Period 2 (7 Days)||0
8927244|NCT02271984|9988445|FG010|NOT COMPLETED|Washout Period 2 (7 Days)||0
8927245|NCT02271984|9988446|FG011|NOT COMPLETED|Washout Period 2 (7 Days)||0
8927246|NCT02271984|9988435|FG000|STARTED|Third Intervention Period (1 Day)||3
8927247|NCT02271984|9988436|FG001|STARTED|Third Intervention Period (1 Day)||3
8927248|NCT02271984|9988437|FG002|STARTED|Third Intervention Period (1 Day)||3
8927249|NCT02271984|9988438|FG003|STARTED|Third Intervention Period (1 Day)||3
8927250|NCT02271984|9988439|FG004|STARTED|Third Intervention Period (1 Day)||3
8927251|NCT02271984|9988440|FG005|STARTED|Third Intervention Period (1 Day)||3
8927252|NCT02271984|9988441|FG006|STARTED|Third Intervention Period (1 Day)||3
8927253|NCT02271984|9988442|FG007|STARTED|Third Intervention Period (1 Day)||3
8927254|NCT02271984|9988443|FG008|STARTED|Third Intervention Period (1 Day)||3
8927255|NCT02271984|9988444|FG009|STARTED|Third Intervention Period (1 Day)||3
8927256|NCT02271984|9988445|FG010|STARTED|Third Intervention Period (1 Day)||3
8927257|NCT02271984|9988446|FG011|STARTED|Third Intervention Period (1 Day)||3
8927258|NCT02271984|9988435|FG000|COMPLETED|Third Intervention Period (1 Day)||3
8927259|NCT02271984|9988436|FG001|COMPLETED|Third Intervention Period (1 Day)||3
8927260|NCT02271984|9988437|FG002|COMPLETED|Third Intervention Period (1 Day)||3
8927261|NCT02271984|9988438|FG003|COMPLETED|Third Intervention Period (1 Day)||3
8927262|NCT02271984|9988439|FG004|COMPLETED|Third Intervention Period (1 Day)||3
8927263|NCT02271984|9988440|FG005|COMPLETED|Third Intervention Period (1 Day)||3
8927264|NCT02271984|9988441|FG006|COMPLETED|Third Intervention Period (1 Day)||3
8927265|NCT02271984|9988442|FG007|COMPLETED|Third Intervention Period (1 Day)||3
8927266|NCT02271984|9988443|FG008|COMPLETED|Third Intervention Period (1 Day)||3
8927267|NCT02271984|9988444|FG009|COMPLETED|Third Intervention Period (1 Day)||3
8927268|NCT02271984|9988445|FG010|COMPLETED|Third Intervention Period (1 Day)||3
8927269|NCT02271984|9988446|FG011|COMPLETED|Third Intervention Period (1 Day)||3
8927270|NCT02271984|9988435|FG000|NOT COMPLETED|Third Intervention Period (1 Day)||0
8927271|NCT02271984|9988436|FG001|NOT COMPLETED|Third Intervention Period (1 Day)||0
8927272|NCT02271984|9988437|FG002|NOT COMPLETED|Third Intervention Period (1 Day)||0
8927273|NCT02271984|9988438|FG003|NOT COMPLETED|Third Intervention Period (1 Day)||0
8927274|NCT02271984|9988439|FG004|NOT COMPLETED|Third Intervention Period (1 Day)||0
8927275|NCT02271984|9988440|FG005|NOT COMPLETED|Third Intervention Period (1 Day)||0
8927276|NCT02271984|9988441|FG006|NOT COMPLETED|Third Intervention Period (1 Day)||0
8927277|NCT02271984|9988442|FG007|NOT COMPLETED|Third Intervention Period (1 Day)||0
8927278|NCT02271984|9988443|FG008|NOT COMPLETED|Third Intervention Period (1 Day)||0
8927279|NCT02271984|9988444|FG009|NOT COMPLETED|Third Intervention Period (1 Day)||0
8927280|NCT02271984|9988445|FG010|NOT COMPLETED|Third Intervention Period (1 Day)||0
8927281|NCT02271984|9988446|FG011|NOT COMPLETED|Third Intervention Period (1 Day)||0
8927282|NCT02271984|9988435|FG000|STARTED|Washout Period 3 (7 Days)||3
8927283|NCT02271984|9988436|FG001|STARTED|Washout Period 3 (7 Days)||3
8927284|NCT02271984|9988437|FG002|STARTED|Washout Period 3 (7 Days)||3
8927285|NCT02271984|9988438|FG003|STARTED|Washout Period 3 (7 Days)||3
8927286|NCT02271984|9988439|FG004|STARTED|Washout Period 3 (7 Days)||3
8927287|NCT02271984|9988440|FG005|STARTED|Washout Period 3 (7 Days)||3
8927288|NCT02271984|9988441|FG006|STARTED|Washout Period 3 (7 Days)||3
8927289|NCT02271984|9988442|FG007|STARTED|Washout Period 3 (7 Days)||3
8927290|NCT02271984|9988443|FG008|STARTED|Washout Period 3 (7 Days)||3
8927291|NCT02271984|9988444|FG009|STARTED|Washout Period 3 (7 Days)||3
8927292|NCT02271984|9988445|FG010|STARTED|Washout Period 3 (7 Days)||3
8927293|NCT02271984|9988446|FG011|STARTED|Washout Period 3 (7 Days)||3
8927294|NCT02271984|9988435|FG000|COMPLETED|Washout Period 3 (7 Days)||3
8927295|NCT02271984|9988436|FG001|COMPLETED|Washout Period 3 (7 Days)||3
8927296|NCT02271984|9988437|FG002|COMPLETED|Washout Period 3 (7 Days)||3
8927297|NCT02271984|9988438|FG003|COMPLETED|Washout Period 3 (7 Days)||3
8927298|NCT02271984|9988439|FG004|COMPLETED|Washout Period 3 (7 Days)||3
8927299|NCT02271984|9988440|FG005|COMPLETED|Washout Period 3 (7 Days)||3
8927300|NCT02271984|9988441|FG006|COMPLETED|Washout Period 3 (7 Days)||3
8927301|NCT02271984|9988442|FG007|COMPLETED|Washout Period 3 (7 Days)||3
8927302|NCT02271984|9988443|FG008|COMPLETED|Washout Period 3 (7 Days)||3
8927303|NCT02271984|9988444|FG009|COMPLETED|Washout Period 3 (7 Days)||3
8927304|NCT02271984|9988445|FG010|COMPLETED|Washout Period 3 (7 Days)||3
8927305|NCT02271984|9988446|FG011|COMPLETED|Washout Period 3 (7 Days)||3
8927306|NCT02271984|9988435|FG000|NOT COMPLETED|Washout Period 3 (7 Days)||0
8927307|NCT02271984|9988436|FG001|NOT COMPLETED|Washout Period 3 (7 Days)||0
8927308|NCT02271984|9988437|FG002|NOT COMPLETED|Washout Period 3 (7 Days)||0
8927309|NCT02271984|9988438|FG003|NOT COMPLETED|Washout Period 3 (7 Days)||0
8927310|NCT02271984|9988439|FG004|NOT COMPLETED|Washout Period 3 (7 Days)||0
8927311|NCT02271984|9988440|FG005|NOT COMPLETED|Washout Period 3 (7 Days)||0
8927312|NCT02271984|9988441|FG006|NOT COMPLETED|Washout Period 3 (7 Days)||0
8927313|NCT02271984|9988442|FG007|NOT COMPLETED|Washout Period 3 (7 Days)||0
8927314|NCT02271984|9988443|FG008|NOT COMPLETED|Washout Period 3 (7 Days)||0
8927315|NCT02271984|9988444|FG009|NOT COMPLETED|Washout Period 3 (7 Days)||0
8927316|NCT02271984|9988445|FG010|NOT COMPLETED|Washout Period 3 (7 Days)||0
8927317|NCT02271984|9988446|FG011|NOT COMPLETED|Washout Period 3 (7 Days)||0
8927318|NCT02271984|9988435|FG000|STARTED|Fourth Intervention Period (Day 1)||3
8927319|NCT02271984|9988436|FG001|STARTED|Fourth Intervention Period (Day 1)||3
8927320|NCT02271984|9988437|FG002|STARTED|Fourth Intervention Period (Day 1)||3
8927321|NCT02271984|9988438|FG003|STARTED|Fourth Intervention Period (Day 1)||3
8927322|NCT02271984|9988439|FG004|STARTED|Fourth Intervention Period (Day 1)||3
8927323|NCT02271984|9988440|FG005|STARTED|Fourth Intervention Period (Day 1)||3
8927324|NCT02271984|9988441|FG006|STARTED|Fourth Intervention Period (Day 1)||3
8927325|NCT02271984|9988442|FG007|STARTED|Fourth Intervention Period (Day 1)||3
8927326|NCT02271984|9988443|FG008|STARTED|Fourth Intervention Period (Day 1)||3
8927327|NCT02271984|9988444|FG009|STARTED|Fourth Intervention Period (Day 1)||3
8927328|NCT02271984|9988445|FG010|STARTED|Fourth Intervention Period (Day 1)||3
8927329|NCT02271984|9988446|FG011|STARTED|Fourth Intervention Period (Day 1)||3
8927330|NCT02271984|9988435|FG000|COMPLETED|Fourth Intervention Period (Day 1)||3
8927331|NCT02271984|9988436|FG001|COMPLETED|Fourth Intervention Period (Day 1)||3
8927332|NCT02271984|9988437|FG002|COMPLETED|Fourth Intervention Period (Day 1)||3
8927333|NCT02271984|9988438|FG003|COMPLETED|Fourth Intervention Period (Day 1)||3
8927334|NCT02271984|9988439|FG004|COMPLETED|Fourth Intervention Period (Day 1)||3
8927335|NCT02271984|9988440|FG005|COMPLETED|Fourth Intervention Period (Day 1)||3
8927336|NCT02271984|9988441|FG006|COMPLETED|Fourth Intervention Period (Day 1)||3
8927337|NCT02271984|9988442|FG007|COMPLETED|Fourth Intervention Period (Day 1)||3
8927338|NCT02271984|9988443|FG008|COMPLETED|Fourth Intervention Period (Day 1)||3
8927339|NCT02271984|9988444|FG009|COMPLETED|Fourth Intervention Period (Day 1)||3
8927340|NCT02271984|9988445|FG010|COMPLETED|Fourth Intervention Period (Day 1)||3
8927341|NCT02271984|9988446|FG011|COMPLETED|Fourth Intervention Period (Day 1)||3
8927342|NCT02271984|9988435|FG000|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
8927343|NCT02271984|9988436|FG001|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
8927344|NCT02271984|9988437|FG002|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
8927345|NCT02271984|9988438|FG003|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
8927346|NCT02271984|9988439|FG004|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
8927347|NCT02271984|9988440|FG005|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
8927348|NCT02271984|9988441|FG006|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
8927349|NCT02271984|9988442|FG007|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
8927350|NCT02271984|9988443|FG008|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
8927351|NCT02271984|9988444|FG009|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
8927352|NCT02271984|9988445|FG010|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
8927353|NCT02271984|9988446|FG011|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
8927354|NCT02271984|9988435|FG000|STARTED|Washout Period 4 (7 Days)||3
8927355|NCT02271984|9988436|FG001|STARTED|Washout Period 4 (7 Days)||3
8927356|NCT02271984|9988437|FG002|STARTED|Washout Period 4 (7 Days)||3
8927357|NCT02271984|9988438|FG003|STARTED|Washout Period 4 (7 Days)||3
8927358|NCT02271984|9988439|FG004|STARTED|Washout Period 4 (7 Days)||3
8927359|NCT02271984|9988440|FG005|STARTED|Washout Period 4 (7 Days)||3
8927360|NCT02271984|9988441|FG006|STARTED|Washout Period 4 (7 Days)||3
8927361|NCT02271984|9988442|FG007|STARTED|Washout Period 4 (7 Days)||3
8927362|NCT02271984|9988443|FG008|STARTED|Washout Period 4 (7 Days)||3
8927363|NCT02271984|9988444|FG009|STARTED|Washout Period 4 (7 Days)||3
8927364|NCT02271984|9988445|FG010|STARTED|Washout Period 4 (7 Days)||3
8927365|NCT02271984|9988446|FG011|STARTED|Washout Period 4 (7 Days)||3
8927366|NCT02271984|9988435|FG000|COMPLETED|Washout Period 4 (7 Days)||3
8927367|NCT02271984|9988436|FG001|COMPLETED|Washout Period 4 (7 Days)||3
8927368|NCT02271984|9988437|FG002|COMPLETED|Washout Period 4 (7 Days)||3
8927369|NCT02271984|9988438|FG003|COMPLETED|Washout Period 4 (7 Days)||3
8927370|NCT02271984|9988439|FG004|COMPLETED|Washout Period 4 (7 Days)||3
8927371|NCT02271984|9988440|FG005|COMPLETED|Washout Period 4 (7 Days)||2
8927372|NCT02271984|9988441|FG006|COMPLETED|Washout Period 4 (7 Days)||3
8927373|NCT02271984|9988442|FG007|COMPLETED|Washout Period 4 (7 Days)||2
8927374|NCT02271984|9988443|FG008|COMPLETED|Washout Period 4 (7 Days)||3
8927375|NCT02271984|9988444|FG009|COMPLETED|Washout Period 4 (7 Days)||3
8927376|NCT02271984|9988445|FG010|COMPLETED|Washout Period 4 (7 Days)||3
8927377|NCT02271984|9988446|FG011|COMPLETED|Washout Period 4 (7 Days)||3
8927378|NCT02271984|9988435|FG000|NOT COMPLETED|Washout Period 4 (7 Days)||0
8927379|NCT02271984|9988436|FG001|NOT COMPLETED|Washout Period 4 (7 Days)||0
8927380|NCT02271984|9988437|FG002|NOT COMPLETED|Washout Period 4 (7 Days)||0
8927381|NCT02271984|9988438|FG003|NOT COMPLETED|Washout Period 4 (7 Days)||0
8927382|NCT02271984|9988439|FG004|NOT COMPLETED|Washout Period 4 (7 Days)||0
8927383|NCT02271984|9988440|FG005|NOT COMPLETED|Washout Period 4 (7 Days)||1
8927384|NCT02271984|9988441|FG006|NOT COMPLETED|Washout Period 4 (7 Days)||0
8927385|NCT02271984|9988442|FG007|NOT COMPLETED|Washout Period 4 (7 Days)||1
8927386|NCT02271984|9988443|FG008|NOT COMPLETED|Washout Period 4 (7 Days)||0
8927387|NCT02271984|9988444|FG009|NOT COMPLETED|Washout Period 4 (7 Days)||0
8927388|NCT02271984|9988445|FG010|NOT COMPLETED|Washout Period 4 (7 Days)||0
8927389|NCT02271984|9988446|FG011|NOT COMPLETED|Washout Period 4 (7 Days)||0
8927390|NCT02271984|9988435|FG000|STARTED|Fifth Intervention Period (1 Day)||3
8927391|NCT02271984|9988436|FG001|STARTED|Fifth Intervention Period (1 Day)||3
8927392|NCT02271984|9988437|FG002|STARTED|Fifth Intervention Period (1 Day)||3
8927393|NCT02271984|9988438|FG003|STARTED|Fifth Intervention Period (1 Day)||3
8927394|NCT02271984|9988439|FG004|STARTED|Fifth Intervention Period (1 Day)||3
8927395|NCT02271984|9988440|FG005|STARTED|Fifth Intervention Period (1 Day)||2
8927396|NCT02271984|9988441|FG006|STARTED|Fifth Intervention Period (1 Day)||3
8927397|NCT02271984|9988442|FG007|STARTED|Fifth Intervention Period (1 Day)||2
8927398|NCT02271984|9988443|FG008|STARTED|Fifth Intervention Period (1 Day)||3
8927399|NCT02271984|9988444|FG009|STARTED|Fifth Intervention Period (1 Day)||3
8927400|NCT02271984|9988445|FG010|STARTED|Fifth Intervention Period (1 Day)||3
8927401|NCT02271984|9988446|FG011|STARTED|Fifth Intervention Period (1 Day)||3
8927402|NCT02271984|9988435|FG000|COMPLETED|Fifth Intervention Period (1 Day)||3
8927403|NCT02271984|9988436|FG001|COMPLETED|Fifth Intervention Period (1 Day)||3
8927404|NCT02271984|9988437|FG002|COMPLETED|Fifth Intervention Period (1 Day)||3
8927405|NCT02271984|9988438|FG003|COMPLETED|Fifth Intervention Period (1 Day)||3
8927406|NCT02271984|9988439|FG004|COMPLETED|Fifth Intervention Period (1 Day)||3
8927407|NCT02271984|9988440|FG005|COMPLETED|Fifth Intervention Period (1 Day)||2
8927408|NCT02271984|9988441|FG006|COMPLETED|Fifth Intervention Period (1 Day)||3
8927409|NCT02271984|9988442|FG007|COMPLETED|Fifth Intervention Period (1 Day)||2
8927410|NCT02271984|9988443|FG008|COMPLETED|Fifth Intervention Period (1 Day)||3
8927411|NCT02271984|9988444|FG009|COMPLETED|Fifth Intervention Period (1 Day)||3
8927412|NCT02271984|9988445|FG010|COMPLETED|Fifth Intervention Period (1 Day)||3
8927413|NCT02271984|9988446|FG011|COMPLETED|Fifth Intervention Period (1 Day)||3
8927414|NCT02271984|9988435|FG000|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
8927415|NCT02271984|9988436|FG001|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
8927416|NCT02271984|9988437|FG002|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
8927417|NCT02271984|9988438|FG003|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
8927418|NCT02271984|9988439|FG004|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
8927419|NCT02271984|9988440|FG005|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
8927420|NCT02271984|9988441|FG006|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
8927421|NCT02271984|9988442|FG007|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
8927422|NCT02271984|9988443|FG008|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
8927423|NCT02271984|9988444|FG009|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
8927424|NCT02271984|9988445|FG010|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
8927425|NCT02271984|9988446|FG011|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
8927426|NCT02272244|9988463|FG000|STARTED|Overall Study||203
8927427|NCT02272244|9988464|FG001|STARTED|Overall Study||197
8927428|NCT02272244|9988463|FG000|COMPLETED|Overall Study||203
8927429|NCT02272244|9988464|FG001|COMPLETED|Overall Study||197
8927430|NCT02272244|9988463|FG000|NOT COMPLETED|Overall Study||0
8927431|NCT02272244|9988464|FG001|NOT COMPLETED|Overall Study||0
8927432|NCT02272413|9988472|FG000|STARTED|Randomized Through Treatment Start|Started for this period|338
8927433|NCT02272413|9988473|FG001|STARTED|Randomized Through Treatment Start|Started for this period|333
8927434|NCT02272413|9988472|FG000|Treated|Randomized Through Treatment Start||335
8927435|NCT02272413|9988473|FG001|Treated|Randomized Through Treatment Start||328
8927436|NCT02272413|9988472|FG000|COMPLETED|Randomized Through Treatment Start||335
8927437|NCT02272413|9988473|FG001|COMPLETED|Randomized Through Treatment Start||328
8699028|NCT00896532|9744616|FG018|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
8699029|NCT00896532|9744617|FG019|Received Zoledronic Acid|Months 48-72: Follow-on Phase||11
8699030|NCT00896532|9744618|FG020|Received Zoledronic Acid|Months 48-72: Follow-on Phase||12
8699031|NCT00896532|9744619|FG021|Received Zoledronic Acid|Months 48-72: Follow-on Phase||56
8699032|NCT00896532|9744620|FG022|Received Zoledronic Acid|Months 48-72: Follow-on Phase||8
8927438|NCT02272413|9988472|FG000|NOT COMPLETED|Randomized Through Treatment Start||3
8927439|NCT02272413|9988473|FG001|NOT COMPLETED|Randomized Through Treatment Start||5
8927440|NCT02272413|9988472|FG000|STARTED|Pre-switch Period|Started for this period|335
8927441|NCT02272413|9988473|FG001|STARTED|Pre-switch Period|Started for this period|328
8927442|NCT02272413|9988472|FG000|COMPLETED|Pre-switch Period||42
8927443|NCT02272413|9988473|FG001|COMPLETED|Pre-switch Period||46
8927444|NCT02272413|9988472|FG000|NOT COMPLETED|Pre-switch Period||293
8927445|NCT02272413|9988473|FG001|NOT COMPLETED|Pre-switch Period||282
8927446|NCT02272413|9988472|FG000|STARTED|Post-switch Period|Started for this period|42
8927447|NCT02272413|9988473|FG001|STARTED|Post-switch Period|Started for this period|46
8927448|NCT02272413|9988472|FG000|COMPLETED|Post-switch Period||0
8927449|NCT02272413|9988473|FG001|COMPLETED|Post-switch Period||0
8927450|NCT02272413|9988472|FG000|NOT COMPLETED|Post-switch Period||42
8927451|NCT02272413|9988473|FG001|NOT COMPLETED|Post-switch Period||46
8927452|NCT02272634|9988484|FG000|STARTED|Overall Study||20
8927453|NCT02272634|9988485|FG001|STARTED|Overall Study||21
8927454|NCT02272634|9988486|FG002|STARTED|Overall Study||20
8927455|NCT02272634|9988484|FG000|COMPLETED|Overall Study||19
8927456|NCT02272634|9988485|FG001|COMPLETED|Overall Study||20
8699033|NCT00896532|9744598|FG000|COMPLETED|Months 48-72: Follow-on Phase||0
8699034|NCT00896532|9744599|FG001|COMPLETED|Months 48-72: Follow-on Phase||0
8699035|NCT00896532|9744600|FG002|COMPLETED|Months 48-72: Follow-on Phase||0
8927457|NCT02272634|9988486|FG002|COMPLETED|Overall Study||19
8927458|NCT02272634|9988484|FG000|NOT COMPLETED|Overall Study||1
8927459|NCT02272634|9988485|FG001|NOT COMPLETED|Overall Study||1
8927460|NCT02272634|9988486|FG002|NOT COMPLETED|Overall Study||1
8927461|NCT02272686|9988497|FG000|STARTED|Overall Study||1
8927462|NCT02272686|9988497|FG000|COMPLETED|Overall Study||1
8927463|NCT02272686|9988497|FG000|NOT COMPLETED|Overall Study||0
8699036|NCT00896532|9744601|FG003|COMPLETED|Months 48-72: Follow-on Phase||0
8699037|NCT00896532|9744602|FG004|COMPLETED|Months 48-72: Follow-on Phase||0
8699038|NCT00896532|9744603|FG005|COMPLETED|Months 48-72: Follow-on Phase||0
8699039|NCT00896532|9744604|FG006|COMPLETED|Months 48-72: Follow-on Phase||0
8699040|NCT00896532|9744605|FG007|COMPLETED|Months 48-72: Follow-on Phase||0
8699041|NCT00896532|9744606|FG008|COMPLETED|Months 48-72: Follow-on Phase||0
8699042|NCT00896532|9744607|FG009|COMPLETED|Months 48-72: Follow-on Phase||0
8699043|NCT00896532|9744608|FG010|COMPLETED|Months 48-72: Follow-on Phase||0
8699044|NCT00896532|9744609|FG011|COMPLETED|Months 48-72: Follow-on Phase||0
8699045|NCT00896532|9744610|FG012|COMPLETED|Months 48-72: Follow-on Phase||0
8699046|NCT00896532|9744611|FG013|COMPLETED|Months 48-72: Follow-on Phase||0
8699047|NCT00896532|9744612|FG014|COMPLETED|Months 48-72: Follow-on Phase||0
8699048|NCT00896532|9744613|FG015|COMPLETED|Months 48-72: Follow-on Phase||0
8699049|NCT00896532|9744614|FG016|COMPLETED|Months 48-72: Follow-on Phase||0
8699050|NCT00896532|9744615|FG017|COMPLETED|Months 48-72: Follow-on Phase||0
8699051|NCT00896532|9744616|FG018|COMPLETED|Months 48-72: Follow-on Phase||50
8699052|NCT00896532|9744617|FG019|COMPLETED|Months 48-72: Follow-on Phase||11
8699053|NCT00896532|9744618|FG020|COMPLETED|Months 48-72: Follow-on Phase||12
8699054|NCT00896532|9744619|FG021|COMPLETED|Months 48-72: Follow-on Phase||57
8699055|NCT00896532|9744620|FG022|COMPLETED|Months 48-72: Follow-on Phase||8
8699056|NCT00896532|9744598|FG000|NOT COMPLETED|Months 48-72: Follow-on Phase||0
8699057|NCT00896532|9744599|FG001|NOT COMPLETED|Months 48-72: Follow-on Phase||0
8699058|NCT00896532|9744600|FG002|NOT COMPLETED|Months 48-72: Follow-on Phase||0
8699059|NCT00896532|9744601|FG003|NOT COMPLETED|Months 48-72: Follow-on Phase||0
8699060|NCT00896532|9744602|FG004|NOT COMPLETED|Months 48-72: Follow-on Phase||0
8699061|NCT00896532|9744603|FG005|NOT COMPLETED|Months 48-72: Follow-on Phase||0
8699062|NCT00896532|9744604|FG006|NOT COMPLETED|Months 48-72: Follow-on Phase||0
8699063|NCT00896532|9744605|FG007|NOT COMPLETED|Months 48-72: Follow-on Phase||0
8699064|NCT00896532|9744606|FG008|NOT COMPLETED|Months 48-72: Follow-on Phase||0
8699065|NCT00896532|9744607|FG009|NOT COMPLETED|Months 48-72: Follow-on Phase||0
8699066|NCT00896532|9744608|FG010|NOT COMPLETED|Months 48-72: Follow-on Phase||0
8699067|NCT00896532|9744609|FG011|NOT COMPLETED|Months 48-72: Follow-on Phase||0
8699068|NCT00896532|9744610|FG012|NOT COMPLETED|Months 48-72: Follow-on Phase||0
8699069|NCT00896532|9744611|FG013|NOT COMPLETED|Months 48-72: Follow-on Phase||0
8699070|NCT00896532|9744612|FG014|NOT COMPLETED|Months 48-72: Follow-on Phase||0
8699071|NCT00896532|9744613|FG015|NOT COMPLETED|Months 48-72: Follow-on Phase||0
8699072|NCT00896532|9744614|FG016|NOT COMPLETED|Months 48-72: Follow-on Phase||0
8699073|NCT00896532|9744615|FG017|NOT COMPLETED|Months 48-72: Follow-on Phase||0
8699074|NCT00896532|9744616|FG018|NOT COMPLETED|Months 48-72: Follow-on Phase||1
8699075|NCT00896532|9744617|FG019|NOT COMPLETED|Months 48-72: Follow-on Phase||0
8699076|NCT00896532|9744618|FG020|NOT COMPLETED|Months 48-72: Follow-on Phase||0
8699077|NCT00896532|9744619|FG021|NOT COMPLETED|Months 48-72: Follow-on Phase||2
8699078|NCT00896532|9744620|FG022|NOT COMPLETED|Months 48-72: Follow-on Phase||0
8699079|NCT00896649|9744667|FG000|STARTED|Overall Study||193
8699080|NCT00896649|9744667|FG000|COMPLETED|Overall Study||188
8699081|NCT00896649|9744667|FG000|NOT COMPLETED|Overall Study||5
8699082|NCT00896779|9744674|FG000|STARTED|Overall Study||8
8699083|NCT00896779|9744675|FG001|STARTED|Overall Study||12
8699084|NCT00896779|9744674|FG000|COMPLETED|Overall Study||8
8699085|NCT00896779|9744675|FG001|COMPLETED|Overall Study||11
8699086|NCT00896779|9744674|FG000|NOT COMPLETED|Overall Study||0
8699087|NCT00896779|9744675|FG001|NOT COMPLETED|Overall Study||1
8699088|NCT00897390|9744681|FG000|STARTED|Overall Study||24
8699089|NCT00897390|9744681|FG000|COMPLETED|Overall Study||18
8699090|NCT00897390|9744681|FG000|NOT COMPLETED|Overall Study||6
8699091|NCT00897676|9744692|FG000|STARTED|Intervention 1(6 Hours)||9
8927464|NCT02272725|9988503|FG000|STARTED|Overall Study||49
8927465|NCT02272725|9988504|FG001|STARTED|Overall Study||42
8927466|NCT02272725|9988503|FG000|COMPLETED|Overall Study||47
8927467|NCT02272725|9988504|FG001|COMPLETED|Overall Study||42
8927468|NCT02272725|9988503|FG000|NOT COMPLETED|Overall Study||2
8927469|NCT02272725|9988504|FG001|NOT COMPLETED|Overall Study||0
8927470|NCT02272777|9988512|FG000|STARTED|Overall Study||112
8927471|NCT02272777|9988513|FG001|STARTED|Overall Study||113
8927472|NCT02272777|9988512|FG000|COMPLETED|Overall Study||108
8927473|NCT02272777|9988513|FG001|COMPLETED|Overall Study||109
8927474|NCT02272777|9988512|FG000|NOT COMPLETED|Overall Study||4
8927475|NCT02272777|9988513|FG001|NOT COMPLETED|Overall Study||4
8927476|NCT02272816|9988519|FG000|STARTED|Overall Study||48
8927477|NCT02272816|9988519|FG000|COMPLETED|Overall Study||47
8927478|NCT02272816|9988519|FG000|NOT COMPLETED|Overall Study||1
8927479|NCT02272842|9988525|FG000|STARTED|Overall Study||300
8927480|NCT02272842|9988526|FG001|STARTED|Overall Study||300
8927481|NCT02272842|9988525|FG000|COMPLETED|Overall Study||284
8927482|NCT02272842|9988526|FG001|COMPLETED|Overall Study||290
8927483|NCT02272842|9988525|FG000|NOT COMPLETED|Overall Study||16
8927484|NCT02272842|9988526|FG001|NOT COMPLETED|Overall Study||10
8927485|NCT02272985|9988533|FG000|STARTED|Overall Study||15
8927486|NCT02272985|9988533|FG000|COMPLETED|Overall Study||12
8927487|NCT02272985|9988533|FG000|NOT COMPLETED|Overall Study||3
8927488|NCT02273037|9988540|FG000|STARTED|Overall Study||987
8927489|NCT02273037|9988541|FG001|STARTED|Overall Study||1000
8927490|NCT02273037|9988540|FG000|COMPLETED|Overall Study||979
8927491|NCT02273037|9988541|FG001|COMPLETED|Overall Study||992
8927492|NCT02273037|9988540|FG000|NOT COMPLETED|Overall Study||8
8927493|NCT02273037|9988541|FG001|NOT COMPLETED|Overall Study||8
8927494|NCT02273050|9988552|FG000|STARTED|Overall Study||210
8927495|NCT02273050|9988553|FG001|STARTED|Overall Study||216
8927496|NCT02273050|9988554|FG002|STARTED|Overall Study||214
8927497|NCT02273050|9988552|FG000|COMPLETED|Overall Study||186
8927498|NCT02273050|9988553|FG001|COMPLETED|Overall Study||194
8927499|NCT02273050|9988554|FG002|COMPLETED|Overall Study||185
8927500|NCT02273050|9988552|FG000|NOT COMPLETED|Overall Study||24
8927501|NCT02273050|9988553|FG001|NOT COMPLETED|Overall Study||22
8927502|NCT02273050|9988554|FG002|NOT COMPLETED|Overall Study||29
8927503|NCT02273063|9988562|FG000|STARTED|Overall Study||40
8927504|NCT02273063|9988562|FG000|COMPLETED|Overall Study||35
8927505|NCT02273063|9988562|FG000|NOT COMPLETED|Overall Study||5
8927506|NCT02273115|9988571|FG000|STARTED|Overall Study||94
8927507|NCT02273115|9988572|FG001|STARTED|Overall Study||90
8927508|NCT02273115|9988573|FG002|STARTED|Overall Study||67
8927509|NCT02273115|9988574|FG003|STARTED|Overall Study||72
8927510|NCT02273115|9988571|FG000|COMPLETED|Overall Study||94
8927511|NCT02273115|9988572|FG001|COMPLETED|Overall Study||90
8927512|NCT02273115|9988573|FG002|COMPLETED|Overall Study||67
8927513|NCT02273115|9988574|FG003|COMPLETED|Overall Study||71
8927514|NCT02273115|9988571|FG000|NOT COMPLETED|Overall Study||0
8927515|NCT02273115|9988572|FG001|NOT COMPLETED|Overall Study||0
8927516|NCT02273115|9988573|FG002|NOT COMPLETED|Overall Study||0
8699092|NCT00897676|9744693|FG001|STARTED|Intervention 1(6 Hours)||7
8699093|NCT00897676|9744692|FG000|COMPLETED|Intervention 1(6 Hours)||9
8699094|NCT00897676|9744693|FG001|COMPLETED|Intervention 1(6 Hours)||7
8699095|NCT00897676|9744692|FG000|NOT COMPLETED|Intervention 1(6 Hours)||0
8699096|NCT00897676|9744693|FG001|NOT COMPLETED|Intervention 1(6 Hours)||0
8699097|NCT00897676|9744692|FG000|STARTED|Intervention 2(6 Hours)||9
8699098|NCT00897676|9744693|FG001|STARTED|Intervention 2(6 Hours)||7
8699099|NCT00897676|9744692|FG000|COMPLETED|Intervention 2(6 Hours)||9
8699100|NCT00897676|9744693|FG001|COMPLETED|Intervention 2(6 Hours)||7
8699101|NCT00897676|9744692|FG000|NOT COMPLETED|Intervention 2(6 Hours)||0
8699102|NCT00897676|9744693|FG001|NOT COMPLETED|Intervention 2(6 Hours)||0
8699103|NCT00897715|9744708|FG000|STARTED|Overall Study||8
8699104|NCT00897715|9744709|FG001|STARTED|Overall Study||7
8699105|NCT00897715|9744708|FG000|COMPLETED|Overall Study||6
8699106|NCT00897715|9744709|FG001|COMPLETED|Overall Study||6
8699107|NCT00897715|9744708|FG000|NOT COMPLETED|Overall Study||2
8699108|NCT00897715|9744709|FG001|NOT COMPLETED|Overall Study||1
8927517|NCT02273115|9988574|FG003|NOT COMPLETED|Overall Study||1
8927518|NCT02273141|9988586|FG000|STARTED|Overall Study||257
8927519|NCT02273141|9988587|FG001|STARTED|Overall Study||258
8927520|NCT02273141|9988586|FG000|COMPLETED|Overall Study||240
8927521|NCT02273141|9988587|FG001|COMPLETED|Overall Study||233
8699109|NCT00897897|9744715|FG000|STARTED|Overall Study||33
8699110|NCT00897897|9744715|FG000|COMPLETED|Overall Study||33
8699111|NCT00897897|9744715|FG000|NOT COMPLETED|Overall Study||0
8699112|NCT00898222|9744719|FG000|STARTED|Overall Study||4
8699113|NCT00898222|9744719|FG000|COMPLETED|Overall Study||4
8699114|NCT00898222|9744719|FG000|NOT COMPLETED|Overall Study||0
8699115|NCT00898443|9744725|FG000|STARTED|Overall Study||10
8699116|NCT00898443|9744726|FG001|STARTED|Overall Study||8
8699117|NCT00898443|9744725|FG000|COMPLETED|Overall Study||9
8699118|NCT00898443|9744726|FG001|COMPLETED|Overall Study||8
8699119|NCT00898443|9744725|FG000|NOT COMPLETED|Overall Study||1
8699120|NCT00898443|9744726|FG001|NOT COMPLETED|Overall Study||0
8927522|NCT02273141|9988586|FG000|NOT COMPLETED|Overall Study||17
8927523|NCT02273141|9988587|FG001|NOT COMPLETED|Overall Study||25
8927524|NCT02273167|9988596|FG000|STARTED|Overall Study||283
8927525|NCT02273167|9988597|FG001|STARTED|Overall Study||283
8927526|NCT02273167|9988598|FG002|STARTED|Overall Study||283
8927527|NCT02273167|9988596|FG000|COMPLETED|Overall Study||259
8927528|NCT02273167|9988597|FG001|COMPLETED|Overall Study||260
8927529|NCT02273167|9988598|FG002|COMPLETED|Overall Study||262
8927530|NCT02273167|9988596|FG000|NOT COMPLETED|Overall Study||24
8927531|NCT02273167|9988597|FG001|NOT COMPLETED|Overall Study||23
8927532|NCT02273167|9988598|FG002|NOT COMPLETED|Overall Study||21
8927533|NCT02273180|9988609|FG000|STARTED|Overall Study||253
8927534|NCT02273180|9988610|FG001|STARTED|Overall Study||254
8927535|NCT02273180|9988609|FG000|Treated|Overall Study||252
8927536|NCT02273180|9988610|FG001|Treated|Overall Study||254
8927537|NCT02273180|9988609|FG000|COMPLETED|Overall Study||226
8927538|NCT02273180|9988610|FG001|COMPLETED|Overall Study||235
8927539|NCT02273180|9988609|FG000|NOT COMPLETED|Overall Study||27
8927540|NCT02273180|9988610|FG001|NOT COMPLETED|Overall Study||19
8927541|NCT02273206|9988618|FG000|STARTED|Overall Study||378
8927542|NCT02273206|9988619|FG001|STARTED|Overall Study||379
8699121|NCT00898560|9744732|FG000|STARTED|Overall Study||20
8699122|NCT00898560|9744732|FG000|COMPLETED|Overall Study||19
8699123|NCT00898560|9744732|FG000|NOT COMPLETED|Overall Study||1
8699124|NCT00898807|9744740|FG000|STARTED|Overall Study||94
8699125|NCT00898807|9744741|FG001|STARTED|Overall Study||92
8699126|NCT00898807|9744740|FG000|COMPLETED|Overall Study||86
8699127|NCT00898807|9744741|FG001|COMPLETED|Overall Study||83
8699128|NCT00898807|9744740|FG000|NOT COMPLETED|Overall Study||8
8699129|NCT00898807|9744741|FG001|NOT COMPLETED|Overall Study||9
8699130|NCT00898937|9744750|FG000|STARTED|Overall Study||25
8699131|NCT00898937|9744751|FG001|STARTED|Overall Study||21
8699132|NCT00898937|9744752|FG002|STARTED|Overall Study||9
8699133|NCT00898937|9744750|FG000|COMPLETED|Overall Study||25
8699134|NCT00898937|9744751|FG001|COMPLETED|Overall Study||21
8699135|NCT00898937|9744752|FG002|COMPLETED|Overall Study||9
8699136|NCT00898937|9744750|FG000|NOT COMPLETED|Overall Study||0
8699137|NCT00898937|9744751|FG001|NOT COMPLETED|Overall Study||0
8699138|NCT00898937|9744752|FG002|NOT COMPLETED|Overall Study||0
8699139|NCT00899353|9744760|FG000|STARTED|Overall Study||16
8699140|NCT00899353|9744760|FG000|COMPLETED|Overall Study||11
8699141|NCT00899353|9744760|FG000|NOT COMPLETED|Overall Study||5
8699142|NCT00899392|9744783|FG000|STARTED|Overall Study||68
8699143|NCT00899392|9744784|FG001|STARTED|Overall Study||74
8699144|NCT00899392|9744783|FG000|COMPLETED|Overall Study|Subjects:PerVariableStudied Consent:47-EAC 50-FBC Anxiety:60-EAC 3-FBC Satisfaction:63-EAC 67-FBC|47
8699145|NCT00899392|9744784|FG001|COMPLETED|Overall Study|Subjects:PerVariableStudied Consent:47-EAC 50-FBC Anxiety:60-EAC 3-FBC Satisfaction:63-EAC 67-FBC|50
8699146|NCT00899392|9744783|FG000|NOT COMPLETED|Overall Study||21
8699147|NCT00899392|9744784|FG001|NOT COMPLETED|Overall Study||24
8699148|NCT00899431|9744793|FG000|STARTED|Overall Study||22
8699149|NCT00899431|9744794|FG001|STARTED|Overall Study||8
8699150|NCT00899431|9744795|FG002|STARTED|Overall Study||9
8699151|NCT00899431|9744793|FG000|COMPLETED|Overall Study||21
8699152|NCT00899431|9744794|FG001|COMPLETED|Overall Study||8
8699153|NCT00899431|9744795|FG002|COMPLETED|Overall Study||9
8699154|NCT00899431|9744793|FG000|NOT COMPLETED|Overall Study||1
8699155|NCT00899431|9744794|FG001|NOT COMPLETED|Overall Study||0
8699156|NCT00899431|9744795|FG002|NOT COMPLETED|Overall Study||0
8699157|NCT00899470|9744806|FG000|STARTED|First Therapy||6
8699158|NCT00899470|9744807|FG001|STARTED|First Therapy||6
8699159|NCT00899470|9744808|FG002|STARTED|First Therapy||6
8699160|NCT00899470|9744809|FG003|STARTED|First Therapy||6
8699161|NCT00899470|9744806|FG000|COMPLETED|First Therapy||6
8699162|NCT00899470|9744807|FG001|COMPLETED|First Therapy||6
8699163|NCT00899470|9744808|FG002|COMPLETED|First Therapy||6
8699164|NCT00899470|9744809|FG003|COMPLETED|First Therapy||6
8699165|NCT00899470|9744806|FG000|NOT COMPLETED|First Therapy||0
8699166|NCT00899470|9744807|FG001|NOT COMPLETED|First Therapy||0
8699167|NCT00899470|9744808|FG002|NOT COMPLETED|First Therapy||0
8699168|NCT00899470|9744809|FG003|NOT COMPLETED|First Therapy||0
8699169|NCT00899470|9744806|FG000|STARTED|First Washout Period||6
8699170|NCT00899470|9744807|FG001|STARTED|First Washout Period||6
8699171|NCT00899470|9744808|FG002|STARTED|First Washout Period||6
8699172|NCT00899470|9744809|FG003|STARTED|First Washout Period||6
8699173|NCT00899470|9744806|FG000|COMPLETED|First Washout Period||6
8699174|NCT00899470|9744807|FG001|COMPLETED|First Washout Period||6
8699175|NCT00899470|9744808|FG002|COMPLETED|First Washout Period||6
8699176|NCT00899470|9744809|FG003|COMPLETED|First Washout Period||6
8699177|NCT00899470|9744806|FG000|NOT COMPLETED|First Washout Period||0
8699178|NCT00899470|9744807|FG001|NOT COMPLETED|First Washout Period||0
8699179|NCT00899470|9744808|FG002|NOT COMPLETED|First Washout Period||0
8699180|NCT00899470|9744809|FG003|NOT COMPLETED|First Washout Period||0
8699181|NCT00899470|9744806|FG000|STARTED|Second Therapy||6
8699182|NCT00899470|9744807|FG001|STARTED|Second Therapy||6
8699183|NCT00899470|9744808|FG002|STARTED|Second Therapy||6
8699184|NCT00899470|9744809|FG003|STARTED|Second Therapy||6
8699185|NCT00899470|9744806|FG000|COMPLETED|Second Therapy||6
8699186|NCT00899470|9744807|FG001|COMPLETED|Second Therapy||6
8699187|NCT00899470|9744808|FG002|COMPLETED|Second Therapy||6
8699188|NCT00899470|9744809|FG003|COMPLETED|Second Therapy||6
8699189|NCT00899470|9744806|FG000|NOT COMPLETED|Second Therapy||0
8699190|NCT00899470|9744807|FG001|NOT COMPLETED|Second Therapy||0
8927543|NCT02273206|9988618|FG000|COMPLETED|Overall Study||353
8927544|NCT02273206|9988619|FG001|COMPLETED|Overall Study||337
8699191|NCT00899470|9744808|FG002|NOT COMPLETED|Second Therapy||0
8927545|NCT02273206|9988618|FG000|NOT COMPLETED|Overall Study||25
8699192|NCT00899470|9744809|FG003|NOT COMPLETED|Second Therapy||0
8699193|NCT00899470|9744806|FG000|STARTED|Second Washout||6
8699194|NCT00899470|9744807|FG001|STARTED|Second Washout||6
8699195|NCT00899470|9744808|FG002|STARTED|Second Washout||6
8699196|NCT00899470|9744809|FG003|STARTED|Second Washout||6
8927546|NCT02273206|9988619|FG001|NOT COMPLETED|Overall Study||42
8927547|NCT02273310|9988627|FG000|STARTED|Overall Study||42
8927548|NCT02273310|9988628|FG001|STARTED|Overall Study||41
8927549|NCT02273310|9988627|FG000|COMPLETED|Overall Study||24
8927550|NCT02273310|9988628|FG001|COMPLETED|Overall Study||38
8927551|NCT02273310|9988627|FG000|NOT COMPLETED|Overall Study||18
8927552|NCT02273310|9988628|FG001|NOT COMPLETED|Overall Study||3
8927553|NCT02273323|9988635|FG000|STARTED|Overall Study||15
8927554|NCT02273323|9988636|FG001|STARTED|Overall Study||15
8927555|NCT02273323|9988635|FG000|COMPLETED|Overall Study||15
8927556|NCT02273323|9988636|FG001|COMPLETED|Overall Study||15
8927557|NCT02273323|9988635|FG000|NOT COMPLETED|Overall Study||0
8927558|NCT02273323|9988636|FG001|NOT COMPLETED|Overall Study||0
8927559|NCT02273596|9988642|FG000|STARTED|24-Week Treatment Period||29
8699197|NCT00899470|9744806|FG000|COMPLETED|Second Washout||6
8699198|NCT00899470|9744807|FG001|COMPLETED|Second Washout||6
8699199|NCT00899470|9744808|FG002|COMPLETED|Second Washout||6
8699200|NCT00899470|9744809|FG003|COMPLETED|Second Washout||6
8699201|NCT00899470|9744806|FG000|NOT COMPLETED|Second Washout||0
8699202|NCT00899470|9744807|FG001|NOT COMPLETED|Second Washout||0
8699203|NCT00899470|9744808|FG002|NOT COMPLETED|Second Washout||0
8699204|NCT00899470|9744809|FG003|NOT COMPLETED|Second Washout||0
8699205|NCT00899470|9744806|FG000|STARTED|Third Therapy||6
8699206|NCT00899470|9744807|FG001|STARTED|Third Therapy||6
8699207|NCT00899470|9744808|FG002|STARTED|Third Therapy||6
8699208|NCT00899470|9744809|FG003|STARTED|Third Therapy||6
8699209|NCT00899470|9744806|FG000|COMPLETED|Third Therapy||6
8699210|NCT00899470|9744807|FG001|COMPLETED|Third Therapy||6
8699211|NCT00899470|9744808|FG002|COMPLETED|Third Therapy||6
8699212|NCT00899470|9744809|FG003|COMPLETED|Third Therapy||6
8699213|NCT00899470|9744806|FG000|NOT COMPLETED|Third Therapy||0
8699214|NCT00899470|9744807|FG001|NOT COMPLETED|Third Therapy||0
8699215|NCT00899470|9744808|FG002|NOT COMPLETED|Third Therapy||0
8699216|NCT00899470|9744809|FG003|NOT COMPLETED|Third Therapy||0
8699217|NCT00899470|9744806|FG000|STARTED|Third Washout||6
8699218|NCT00899470|9744807|FG001|STARTED|Third Washout||6
8699219|NCT00899470|9744808|FG002|STARTED|Third Washout||6
8699220|NCT00899470|9744809|FG003|STARTED|Third Washout||6
8699221|NCT00899470|9744806|FG000|COMPLETED|Third Washout||6
8699222|NCT00899470|9744807|FG001|COMPLETED|Third Washout||6
8699223|NCT00899470|9744808|FG002|COMPLETED|Third Washout||6
8699224|NCT00899470|9744809|FG003|COMPLETED|Third Washout||6
8699225|NCT00899470|9744806|FG000|NOT COMPLETED|Third Washout||0
8699226|NCT00899470|9744807|FG001|NOT COMPLETED|Third Washout||0
8699227|NCT00899470|9744808|FG002|NOT COMPLETED|Third Washout||0
8699228|NCT00899470|9744809|FG003|NOT COMPLETED|Third Washout||0
8699229|NCT00899470|9744806|FG000|STARTED|Fourth Therapy||6
8699230|NCT00899470|9744807|FG001|STARTED|Fourth Therapy||6
8699231|NCT00899470|9744808|FG002|STARTED|Fourth Therapy||6
8699232|NCT00899470|9744809|FG003|STARTED|Fourth Therapy||6
8699233|NCT00899470|9744806|FG000|COMPLETED|Fourth Therapy||6
8699234|NCT00899470|9744807|FG001|COMPLETED|Fourth Therapy||6
8699235|NCT00899470|9744808|FG002|COMPLETED|Fourth Therapy||6
8699236|NCT00899470|9744809|FG003|COMPLETED|Fourth Therapy||6
8699237|NCT00899470|9744806|FG000|NOT COMPLETED|Fourth Therapy||0
8699238|NCT00899470|9744807|FG001|NOT COMPLETED|Fourth Therapy||0
8699239|NCT00899470|9744808|FG002|NOT COMPLETED|Fourth Therapy||0
8699240|NCT00899470|9744809|FG003|NOT COMPLETED|Fourth Therapy||0
8699241|NCT00899548|9744824|FG000|STARTED|Overall Study||182
8699242|NCT00899548|9744824|FG000|COMPLETED|Overall Study||179
8699243|NCT00899548|9744824|FG000|NOT COMPLETED|Overall Study||3
8699244|NCT00899574|9744832|FG000|STARTED|Overall Study||10
8699245|NCT00899574|9744832|FG000|COMPLETED|Overall Study||10
8699246|NCT00899574|9744832|FG000|NOT COMPLETED|Overall Study||0
8699247|NCT00899600|9744838|FG000|STARTED|Overall Study||50
8699248|NCT00899600|9744839|FG001|STARTED|Overall Study||52
8699249|NCT00899600|9744838|FG000|COMPLETED|Overall Study||50
8699250|NCT00899600|9744839|FG001|COMPLETED|Overall Study||52
8699251|NCT00899600|9744838|FG000|NOT COMPLETED|Overall Study||0
8699252|NCT00899600|9744839|FG001|NOT COMPLETED|Overall Study||0
8699253|NCT00899678|9744848|FG000|STARTED|Induction Period (Weeks 0 to 6)|Induction only includes subjects that discontinued before Maintenance Period.|27
8699254|NCT00899678|9744849|FG001|STARTED|Induction Period (Weeks 0 to 6)||37
8699255|NCT00899678|9744850|FG002|STARTED|Induction Period (Weeks 0 to 6)||35
8699256|NCT00899678|9744848|FG000|COMPLETED|Induction Period (Weeks 0 to 6)|2 subjects completed the Induction Phase, but discontinued prior to receiving any Maintenance doses.|2
8699257|NCT00899678|9744849|FG001|COMPLETED|Induction Period (Weeks 0 to 6)||37
8699258|NCT00899678|9744850|FG002|COMPLETED|Induction Period (Weeks 0 to 6)||35
8699259|NCT00899678|9744848|FG000|NOT COMPLETED|Induction Period (Weeks 0 to 6)||25
8699260|NCT00899678|9744849|FG001|NOT COMPLETED|Induction Period (Weeks 0 to 6)||0
8699261|NCT00899678|9744850|FG002|NOT COMPLETED|Induction Period (Weeks 0 to 6)||0
8699262|NCT00899678|9744848|FG000|STARTED|Maintenance Period (Weeks 8 to 62)|Induction only includes subjects that discontinued before Maintenance Period.|0
8699263|NCT00899678|9744849|FG001|STARTED|Maintenance Period (Weeks 8 to 62)||37
8699264|NCT00899678|9744850|FG002|STARTED|Maintenance Period (Weeks 8 to 62)||35
8699265|NCT00899678|9744848|FG000|COMPLETED|Maintenance Period (Weeks 8 to 62)||0
8699266|NCT00899678|9744849|FG001|COMPLETED|Maintenance Period (Weeks 8 to 62)||12
8699267|NCT00899678|9744850|FG002|COMPLETED|Maintenance Period (Weeks 8 to 62)||7
8699268|NCT00899678|9744848|FG000|NOT COMPLETED|Maintenance Period (Weeks 8 to 62)||0
8699269|NCT00899678|9744849|FG001|NOT COMPLETED|Maintenance Period (Weeks 8 to 62)||25
8699270|NCT00899678|9744850|FG002|NOT COMPLETED|Maintenance Period (Weeks 8 to 62)||28
8927560|NCT02273596|9988642|FG000|Received at Least 1 Dose of Study Drug|24-Week Treatment Period||28
8927561|NCT02273596|9988642|FG000|COMPLETED|24-Week Treatment Period||22
8927562|NCT02273596|9988642|FG000|NOT COMPLETED|24-Week Treatment Period||7
8927563|NCT02273596|9988642|FG000|STARTED|Extension Period||22
8927564|NCT02273596|9988642|FG000|Received at Least 1 Dose of Study Drug|Extension Period||22
8927565|NCT02273596|9988642|FG000|COMPLETED|Extension Period||0
8927566|NCT02273596|9988642|FG000|NOT COMPLETED|Extension Period||22
8927567|NCT02273726|9988654|FG000|STARTED|Overall Study||370
9042385|NCT03382262|10102999|FG003|COMPLETED|Overall Study||14
8699271|NCT00899717|9744860|FG000|STARTED|Overall Study||10
8699272|NCT00899717|9744861|FG001|STARTED|Overall Study||11
8699273|NCT00899717|9744860|FG000|COMPLETED|Overall Study||10
8699274|NCT00899717|9744861|FG001|COMPLETED|Overall Study||11
8699275|NCT00899717|9744860|FG000|NOT COMPLETED|Overall Study||0
8699276|NCT00899717|9744861|FG001|NOT COMPLETED|Overall Study||0
8699277|NCT00899847|9744873|FG000|STARTED|Overall Study||9
8699278|NCT00899847|9744873|FG000|COMPLETED|Overall Study||7
8699279|NCT00899847|9744873|FG000|NOT COMPLETED|Overall Study||2
8699280|NCT00900029|9744884|FG000|STARTED|Overall Study||38
8699281|NCT00900029|9744885|FG001|STARTED|Overall Study||41
8699282|NCT00900029|9744886|FG002|STARTED|Overall Study||41
8699283|NCT00900029|9744887|FG003|STARTED|Overall Study||42
8699284|NCT00900029|9744888|FG004|STARTED|Overall Study||44
8699285|NCT00900029|9744884|FG000|COMPLETED|Overall Study||35
8699286|NCT00900029|9744885|FG001|COMPLETED|Overall Study||37
8699287|NCT00900029|9744886|FG002|COMPLETED|Overall Study||38
8699288|NCT00900029|9744887|FG003|COMPLETED|Overall Study||35
8699289|NCT00900029|9744888|FG004|COMPLETED|Overall Study||38
8699290|NCT00900029|9744884|FG000|NOT COMPLETED|Overall Study||3
8699291|NCT00900029|9744885|FG001|NOT COMPLETED|Overall Study||4
8699292|NCT00900029|9744886|FG002|NOT COMPLETED|Overall Study||3
8699293|NCT00900029|9744887|FG003|NOT COMPLETED|Overall Study||7
8699294|NCT00900029|9744888|FG004|NOT COMPLETED|Overall Study||6
8699295|NCT00900146|9744905|FG000|STARTED|Dose Finding: Period II (4 Months)||93
8699296|NCT00900146|9744906|FG001|STARTED|Dose Finding: Period II (4 Months)||95
8699297|NCT00900146|9744907|FG002|STARTED|Dose Finding: Period II (4 Months)||92
8699298|NCT00900146|9744908|FG003|STARTED|Dose Finding: Period II (4 Months)||92
8699299|NCT00900146|9744909|FG004|STARTED|Dose Finding: Period II (4 Months)||179
8699300|NCT00900146|9744905|FG000|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||93
8699301|NCT00900146|9744906|FG001|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||95
8699302|NCT00900146|9744907|FG002|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||92
8699303|NCT00900146|9744908|FG003|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||92
8699304|NCT00900146|9744909|FG004|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||179
8699305|NCT00900146|9744905|FG000|COMPLETED|Dose Finding: Period II (4 Months)||88
8699306|NCT00900146|9744906|FG001|COMPLETED|Dose Finding: Period II (4 Months)||93
8699307|NCT00900146|9744907|FG002|COMPLETED|Dose Finding: Period II (4 Months)||87
8699308|NCT00900146|9744908|FG003|COMPLETED|Dose Finding: Period II (4 Months)||90
8699309|NCT00900146|9744909|FG004|COMPLETED|Dose Finding: Period II (4 Months)|Placebo also included 1 patient with no study completion page.|167
8699310|NCT00900146|9744905|FG000|NOT COMPLETED|Dose Finding: Period II (4 Months)||5
8699311|NCT00900146|9744906|FG001|NOT COMPLETED|Dose Finding: Period II (4 Months)||2
8699312|NCT00900146|9744907|FG002|NOT COMPLETED|Dose Finding: Period II (4 Months)||5
8699313|NCT00900146|9744908|FG003|NOT COMPLETED|Dose Finding: Period II (4 Months)||2
8699314|NCT00900146|9744909|FG004|NOT COMPLETED|Dose Finding: Period II (4 Months)||12
8699315|NCT00900146|9744905|FG000|STARTED|Intermediate: Period III||87
8699316|NCT00900146|9744906|FG001|STARTED|Intermediate: Period III||93
8699317|NCT00900146|9744907|FG002|STARTED|Intermediate: Period III||84
8699318|NCT00900146|9744908|FG003|STARTED|Intermediate: Period III||90
8699319|NCT00900146|9744909|FG004|STARTED|Intermediate: Period III||167
8699320|NCT00900146|9744905|FG000|Safety Set|Intermediate: Period III||86
8699321|NCT00900146|9744906|FG001|Safety Set|Intermediate: Period III||92
8699322|NCT00900146|9744907|FG002|Safety Set|Intermediate: Period III||84
8699323|NCT00900146|9744908|FG003|Safety Set|Intermediate: Period III||90
8699324|NCT00900146|9744909|FG004|Safety Set|Intermediate: Period III||166
8699325|NCT00900146|9744905|FG000|COMPLETED|Intermediate: Period III||0
8699326|NCT00900146|9744906|FG001|COMPLETED|Intermediate: Period III||0
8699327|NCT00900146|9744907|FG002|COMPLETED|Intermediate: Period III||0
8699328|NCT00900146|9744908|FG003|COMPLETED|Intermediate: Period III||0
8699329|NCT00900146|9744909|FG004|COMPLETED|Intermediate: Period III||0
8699330|NCT00900146|9744905|FG000|NOT COMPLETED|Intermediate: Period III||87
8699331|NCT00900146|9744906|FG001|NOT COMPLETED|Intermediate: Period III||93
8699332|NCT00900146|9744907|FG002|NOT COMPLETED|Intermediate: Period III||84
8699333|NCT00900146|9744908|FG003|NOT COMPLETED|Intermediate: Period III||90
8699334|NCT00900146|9744909|FG004|NOT COMPLETED|Intermediate: Period III||167
8699335|NCT00900159|9744923|FG000|STARTED|First Intervention||11
8699336|NCT00900159|9744924|FG001|STARTED|First Intervention||13
8699337|NCT00900159|9744923|FG000|COMPLETED|First Intervention||11
8699338|NCT00900159|9744924|FG001|COMPLETED|First Intervention||13
8699339|NCT00900159|9744923|FG000|NOT COMPLETED|First Intervention||0
8699340|NCT00900159|9744924|FG001|NOT COMPLETED|First Intervention||0
8927568|NCT02273726|9988655|FG001|STARTED|Overall Study||371
8927569|NCT02273726|9988654|FG000|Received at Least 1 Dose of Study Drug|Overall Study||370
8927570|NCT02273726|9988655|FG001|Received at Least 1 Dose of Study Drug|Overall Study||370
8927571|NCT02273726|9988654|FG000|COMPLETED|Overall Study||127
8927572|NCT02273726|9988655|FG001|COMPLETED|Overall Study||183
8927573|NCT02273726|9988654|FG000|NOT COMPLETED|Overall Study||243
8927574|NCT02273726|9988655|FG001|NOT COMPLETED|Overall Study||188
8927575|NCT02273739|9988665|FG000|STARTED|Overall Study||3
8927576|NCT02273739|9988666|FG001|STARTED|Overall Study||4
8927577|NCT02273739|9988667|FG002|STARTED|Overall Study||7
8927578|NCT02273739|9988668|FG003|STARTED|Overall Study||7
8927579|NCT02273739|9988665|FG000|COMPLETED|Overall Study||0
8927580|NCT02273739|9988666|FG001|COMPLETED|Overall Study||0
8927581|NCT02273739|9988667|FG002|COMPLETED|Overall Study||0
8927582|NCT02273739|9988668|FG003|COMPLETED|Overall Study||0
8927583|NCT02273739|9988665|FG000|NOT COMPLETED|Overall Study||3
8927584|NCT02273739|9988666|FG001|NOT COMPLETED|Overall Study||4
8927585|NCT02273739|9988667|FG002|NOT COMPLETED|Overall Study||7
8927586|NCT02273739|9988668|FG003|NOT COMPLETED|Overall Study||7
8927587|NCT02273908|9988685|FG000|STARTED|Overall Study||157
8927588|NCT02273908|9988686|FG001|STARTED|Overall Study||174
8927589|NCT02273908|9988685|FG000|COMPLETED|Overall Study||124
8927590|NCT02273908|9988686|FG001|COMPLETED|Overall Study||169
8927591|NCT02273908|9988685|FG000|NOT COMPLETED|Overall Study||33
8927592|NCT02273908|9988686|FG001|NOT COMPLETED|Overall Study||5
8927593|NCT02273960|9988700|FG000|STARTED|Short Term Period||5
8927594|NCT02273960|9988701|FG001|STARTED|Short Term Period||6
8927595|NCT02273960|9988702|FG002|STARTED|Short Term Period||5
8927596|NCT02273960|9988703|FG003|STARTED|Short Term Period||10
8927597|NCT02273960|9988700|FG000|COMPLETED|Short Term Period||0
8927598|NCT02273960|9988701|FG001|COMPLETED|Short Term Period||0
8927599|NCT02273960|9988702|FG002|COMPLETED|Short Term Period||1
8927600|NCT02273960|9988703|FG003|COMPLETED|Short Term Period||4
8927601|NCT02273960|9988700|FG000|NOT COMPLETED|Short Term Period||5
8927602|NCT02273960|9988701|FG001|NOT COMPLETED|Short Term Period||6
8927603|NCT02273960|9988702|FG002|NOT COMPLETED|Short Term Period||4
8699341|NCT00900159|9744923|FG000|STARTED|Washout||11
8699342|NCT00900159|9744924|FG001|STARTED|Washout||13
8699343|NCT00900159|9744923|FG000|COMPLETED|Washout||11
8699344|NCT00900159|9744924|FG001|COMPLETED|Washout||13
8699345|NCT00900159|9744923|FG000|NOT COMPLETED|Washout||0
8699346|NCT00900159|9744924|FG001|NOT COMPLETED|Washout||0
8699347|NCT00900159|9744923|FG000|STARTED|Second Intervention||11
8699348|NCT00900159|9744924|FG001|STARTED|Second Intervention||13
8699349|NCT00900159|9744923|FG000|COMPLETED|Second Intervention||10
8699350|NCT00900159|9744924|FG001|COMPLETED|Second Intervention||13
8699351|NCT00900159|9744923|FG000|NOT COMPLETED|Second Intervention||1
8699352|NCT00900159|9744924|FG001|NOT COMPLETED|Second Intervention||0
8699353|NCT00900237|9744932|FG000|STARTED|Overall Study||7
8699354|NCT00900237|9744933|FG001|STARTED|Overall Study||7
8699355|NCT00900237|9744932|FG000|COMPLETED|Overall Study||7
8699356|NCT00900237|9744933|FG001|COMPLETED|Overall Study||7
8699357|NCT00900237|9744932|FG000|NOT COMPLETED|Overall Study||0
8699358|NCT00900237|9744933|FG001|NOT COMPLETED|Overall Study||0
8699359|NCT00900562|9744941|FG000|STARTED|Overall Study||12
8699360|NCT00900562|9744942|FG001|STARTED|Overall Study||7
8699361|NCT00900562|9744941|FG000|COMPLETED|Overall Study||0
8699362|NCT00900562|9744942|FG001|COMPLETED|Overall Study||0
8699363|NCT00900562|9744941|FG000|NOT COMPLETED|Overall Study||12
8699364|NCT00900562|9744942|FG001|NOT COMPLETED|Overall Study||7
8699365|NCT00900601|9744949|FG000|STARTED|Overall Study||9
8699366|NCT00900601|9744949|FG000|COMPLETED|Overall Study||8
8699367|NCT00900601|9744949|FG000|NOT COMPLETED|Overall Study||1
8699368|NCT00900627|9744959|FG000|STARTED|Overall Study||6
8699369|NCT00900627|9744960|FG001|STARTED|Overall Study||2
8699370|NCT00900627|9744961|FG002|STARTED|Overall Study||6
8699371|NCT00900627|9744962|FG003|STARTED|Overall Study||6
8699372|NCT00900627|9744963|FG004|STARTED|Overall Study|The values under 'Not Completed' are based on the time of the primary analysis|94
8699373|NCT00900627|9744964|FG005|STARTED|Overall Study|The values under 'Not Completed' are based on the time of the primary analysis|96
8699374|NCT00900627|9744959|FG000|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
8699375|NCT00900627|9744960|FG001|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
8699376|NCT00900627|9744961|FG002|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
8699377|NCT00900627|9744962|FG003|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
8699378|NCT00900627|9744963|FG004|COMPLETED|Overall Study|No set completion, pts were to remain in study until withdrawn|65
8699379|NCT00900627|9744964|FG005|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|70
8699380|NCT00900627|9744959|FG000|NOT COMPLETED|Overall Study||6
8699381|NCT00900627|9744960|FG001|NOT COMPLETED|Overall Study||2
8699382|NCT00900627|9744961|FG002|NOT COMPLETED|Overall Study||6
8699383|NCT00900627|9744962|FG003|NOT COMPLETED|Overall Study||6
8699384|NCT00900627|9744963|FG004|NOT COMPLETED|Overall Study||29
8699385|NCT00900627|9744964|FG005|NOT COMPLETED|Overall Study||26
8699386|NCT00900666|9744980|FG000|STARTED|Overall Study||10
8699387|NCT00900666|9744981|FG001|STARTED|Overall Study||9
8699388|NCT00900666|9744980|FG000|COMPLETED|Overall Study||10
8927604|NCT02273960|9988703|FG003|NOT COMPLETED|Short Term Period||6
8927605|NCT02273960|9988700|FG000|STARTED|Long Term Extension||0
8927606|NCT02273960|9988701|FG001|STARTED|Long Term Extension||0
8927607|NCT02273960|9988702|FG002|STARTED|Long Term Extension||1
8927608|NCT02273960|9988703|FG003|STARTED|Long Term Extension||4
8927609|NCT02273960|9988700|FG000|COMPLETED|Long Term Extension||0
8927610|NCT02273960|9988701|FG001|COMPLETED|Long Term Extension||0
8927611|NCT02273960|9988702|FG002|COMPLETED|Long Term Extension||1
8927612|NCT02273960|9988703|FG003|COMPLETED|Long Term Extension||3
8927613|NCT02273960|9988700|FG000|NOT COMPLETED|Long Term Extension||0
8927614|NCT02273960|9988701|FG001|NOT COMPLETED|Long Term Extension||0
8927615|NCT02273960|9988702|FG002|NOT COMPLETED|Long Term Extension||0
8927616|NCT02273960|9988703|FG003|NOT COMPLETED|Long Term Extension||1
8927617|NCT02273973|9988715|FG000|STARTED|Overall Study||166
8927618|NCT02273973|9988716|FG001|STARTED|Overall Study||168
8927619|NCT02273973|9988715|FG000|COMPLETED|Overall Study||157
8927620|NCT02273973|9988716|FG001|COMPLETED|Overall Study||160
8927621|NCT02273973|9988715|FG000|NOT COMPLETED|Overall Study||9
8927622|NCT02273973|9988716|FG001|NOT COMPLETED|Overall Study||8
8927623|NCT02274038|9988722|FG000|STARTED|Overall Study||3
8927624|NCT02274038|9988722|FG000|COMPLETED|Overall Study||2
8927625|NCT02274038|9988722|FG000|NOT COMPLETED|Overall Study||1
8927626|NCT02274311|9988728|FG000|STARTED|Three Months of Clomiphene Treatment||16
8927627|NCT02274311|9988728|FG000|COMPLETED|Three Months of Clomiphene Treatment||16
8927628|NCT02274311|9988728|FG000|NOT COMPLETED|Three Months of Clomiphene Treatment||0
8927629|NCT02274311|9988728|FG000|STARTED|Three Months of Clomiphene Wash-out||16
8927630|NCT02274311|9988728|FG000|COMPLETED|Three Months of Clomiphene Wash-out||15
8927631|NCT02274311|9988728|FG000|NOT COMPLETED|Three Months of Clomiphene Wash-out||1
8699389|NCT00900666|9744981|FG001|COMPLETED|Overall Study||9
8699390|NCT00900666|9744980|FG000|NOT COMPLETED|Overall Study||0
8699391|NCT00900666|9744981|FG001|NOT COMPLETED|Overall Study||0
8699392|NCT00900731|9744989|FG000|STARTED|Overall Study|Randomized participants|797
8699393|NCT00900731|9744990|FG001|STARTED|Overall Study||801
8699394|NCT00900731|9744989|FG000|Safety Set: Received Study Drug|Overall Study||794
8699395|NCT00900731|9744990|FG001|Safety Set: Received Study Drug|Overall Study||799
8699396|NCT00900731|9744989|FG000|COMPLETED|Overall Study||737
8699397|NCT00900731|9744990|FG001|COMPLETED|Overall Study||740
8699398|NCT00900731|9744989|FG000|NOT COMPLETED|Overall Study||60
8699399|NCT00900731|9744990|FG001|NOT COMPLETED|Overall Study||61
8699400|NCT00900757|9744996|FG000|STARTED|Overall Study||57
8699401|NCT00900757|9744996|FG000|COMPLETED|Overall Study||38
8699402|NCT00900757|9744996|FG000|NOT COMPLETED|Overall Study||19
8699403|NCT00900796|9745000|FG000|STARTED|Phase 1||132
8699404|NCT00900796|9745000|FG000|COMPLETED|Phase 1||121
8699405|NCT00900796|9745000|FG000|NOT COMPLETED|Phase 1||11
8699406|NCT00900796|9745000|FG000|STARTED|Between Phase 1 and Phase 2||121
8699407|NCT00900796|9745000|FG000|COMPLETED|Between Phase 1 and Phase 2||11
8699408|NCT00900796|9745000|FG000|NOT COMPLETED|Between Phase 1 and Phase 2||110
8699409|NCT00900796|9745000|FG000|STARTED|Phase 2||11
8699410|NCT00900796|9745000|FG000|COMPLETED|Phase 2||6
8699411|NCT00900796|9745000|FG000|NOT COMPLETED|Phase 2||5
8699412|NCT00900822|9745005|FG000|STARTED|9 Months Histological Evaluation||11
8699413|NCT00900822|9745005|FG000|COMPLETED|9 Months Histological Evaluation||11
8699414|NCT00900822|9745005|FG000|NOT COMPLETED|9 Months Histological Evaluation||0
8699415|NCT00900822|9745005|FG000|STARTED|12 Months Clinical Evaluation||11
8699416|NCT00900822|9745005|FG000|COMPLETED|12 Months Clinical Evaluation||11
8699417|NCT00900822|9745005|FG000|NOT COMPLETED|12 Months Clinical Evaluation||0
8699418|NCT00901017|9745012|FG000|STARTED|Overall Study||14
8699419|NCT00901017|9745012|FG000|COMPLETED|Overall Study||14
8699420|NCT00901017|9745012|FG000|NOT COMPLETED|Overall Study||0
8699421|NCT00901186|9745021|FG000|STARTED|Overall Study||40
8699422|NCT00901186|9745022|FG001|STARTED|Overall Study||43
8699423|NCT00901186|9745021|FG000|Safety Set|Overall Study|One participant did not receive one intravitreal RFB002 injection.|39
8699424|NCT00901186|9745022|FG001|Safety Set|Overall Study||43
8699425|NCT00901186|9745021|FG000|Intent to Treat|Overall Study|Four treated participants did not have at least a baseline and one post-treatment BCVA.|35
8699426|NCT00901186|9745022|FG001|Intent to Treat|Overall Study|Five treated participants did not have at least a baseline and one post-treatment BCVA.|38
8699427|NCT00901186|9745021|FG000|COMPLETED|Overall Study||31
8699428|NCT00901186|9745022|FG001|COMPLETED|Overall Study||32
8699429|NCT00901186|9745021|FG000|NOT COMPLETED|Overall Study||9
8699430|NCT00901186|9745022|FG001|NOT COMPLETED|Overall Study||11
8699431|NCT00901199|9745028|FG000|STARTED|Overall Study||22
8699432|NCT00901199|9745028|FG000|COMPLETED|Overall Study||18
8699433|NCT00901199|9745028|FG000|NOT COMPLETED|Overall Study||4
8699434|NCT00901225|9745032|FG000|STARTED|Overall Study||21
8699435|NCT00901225|9745032|FG000|COMPLETED|Overall Study||20
8699436|NCT00901225|9745032|FG000|NOT COMPLETED|Overall Study||1
8699437|NCT00901316|9745038|FG000|STARTED|Overall Study||492
8699438|NCT00901316|9745039|FG001|STARTED|Overall Study||495
8699439|NCT00901316|9745038|FG000|COMPLETED|Overall Study||492
8699440|NCT00901316|9745039|FG001|COMPLETED|Overall Study||495
8927632|NCT02274493|9988734|FG000|STARTED|Overall Study||15
8927633|NCT02274493|9988734|FG000|COMPLETED|Overall Study||14
8699441|NCT00901316|9745038|FG000|NOT COMPLETED|Overall Study||0
8699442|NCT00901316|9745039|FG001|NOT COMPLETED|Overall Study||0
8699443|NCT00901342|9745045|FG000|STARTED|Overall Study||104
8699444|NCT00901342|9745045|FG000|Received at Least 1 Infusion|Overall Study||98
8699445|NCT00901342|9745045|FG000|COMPLETED|Overall Study|89 subjects completed the study completion visit|89
8699446|NCT00901342|9745045|FG000|NOT COMPLETED|Overall Study||15
8927634|NCT02274493|9988734|FG000|NOT COMPLETED|Overall Study||1
8927635|NCT02274558|9988741|FG000|STARTED|Overall Study||78
8927636|NCT02274558|9988742|FG001|STARTED|Overall Study||76
8927637|NCT02274558|9988743|FG002|STARTED|Overall Study||80
8927638|NCT02274558|9988741|FG000|Included in the Safety Analysis Set|Overall Study||76
8927639|NCT02274558|9988742|FG001|Included in the Safety Analysis Set|Overall Study||72
8927640|NCT02274558|9988743|FG002|Included in the Safety Analysis Set|Overall Study||79
8927641|NCT02274558|9988741|FG000|COMPLETED|Overall Study||71
8927642|NCT02274558|9988742|FG001|COMPLETED|Overall Study||63
8927643|NCT02274558|9988743|FG002|COMPLETED|Overall Study||71
8927644|NCT02274558|9988741|FG000|NOT COMPLETED|Overall Study||7
8927645|NCT02274558|9988742|FG001|NOT COMPLETED|Overall Study||13
8927646|NCT02274558|9988743|FG002|NOT COMPLETED|Overall Study||9
8927647|NCT02274649|9988755|FG000|STARTED|Overall Study||101
8927648|NCT02274649|9988756|FG001|STARTED|Overall Study||93
8927649|NCT02274649|9988755|FG000|COMPLETED|Overall Study||77
8927650|NCT02274649|9988756|FG001|COMPLETED|Overall Study||81
8927651|NCT02274649|9988755|FG000|NOT COMPLETED|Overall Study||24
8927652|NCT02274649|9988756|FG001|NOT COMPLETED|Overall Study||12
8927653|NCT02274675|9988762|FG000|STARTED|Overall Study||7
8927654|NCT02274675|9988762|FG000|COMPLETED|Overall Study||7
8927655|NCT02274675|9988762|FG000|NOT COMPLETED|Overall Study||0
8927656|NCT02274688|9988768|FG000|STARTED|Overall Study||86
8927657|NCT02274688|9988769|FG001|STARTED|Overall Study||85
8927658|NCT02274688|9988768|FG000|COMPLETED|Overall Study||72
8927659|NCT02274688|9988769|FG001|COMPLETED|Overall Study||72
8927660|NCT02274688|9988768|FG000|NOT COMPLETED|Overall Study||14
8927661|NCT02274688|9988769|FG001|NOT COMPLETED|Overall Study||13
8927662|NCT02274766|9988778|FG000|STARTED|Overall Study||39
8927663|NCT02274766|9988779|FG001|STARTED|Overall Study||38
8927664|NCT02274766|9988778|FG000|Received Study Drug|Overall Study||38
8927665|NCT02274766|9988779|FG001|Received Study Drug|Overall Study||37
8927666|NCT02274766|9988778|FG000|COMPLETED|Overall Study||35
8927667|NCT02274766|9988779|FG001|COMPLETED|Overall Study||29
8927668|NCT02274766|9988778|FG000|NOT COMPLETED|Overall Study||4
8927669|NCT02274766|9988779|FG001|NOT COMPLETED|Overall Study||9
8699447|NCT00901394|9745052|FG000|STARTED|Overall Study||21
8699448|NCT00901394|9745053|FG001|STARTED|Overall Study||20
8699449|NCT00901394|9745054|FG002|STARTED|Overall Study||22
8699450|NCT00901394|9745052|FG000|COMPLETED|Overall Study||20
8699451|NCT00901394|9745053|FG001|COMPLETED|Overall Study||19
8699452|NCT00901394|9745054|FG002|COMPLETED|Overall Study||20
8699453|NCT00901394|9745052|FG000|NOT COMPLETED|Overall Study||1
8699454|NCT00901394|9745053|FG001|NOT COMPLETED|Overall Study||1
8699455|NCT00901394|9745054|FG002|NOT COMPLETED|Overall Study||2
8699456|NCT00901459|9745062|FG000|STARTED|Overall Study||21
8699457|NCT00901459|9745062|FG000|COMPLETED|Overall Study||15
8699458|NCT00901459|9745062|FG000|NOT COMPLETED|Overall Study||6
8699459|NCT00901485|9745073|FG000|STARTED|Overall Study||10
8699460|NCT00901485|9745074|FG001|STARTED|Overall Study||13
8699461|NCT00901485|9745073|FG000|COMPLETED|Overall Study||9
8699462|NCT00901485|9745074|FG001|COMPLETED|Overall Study||9
8699463|NCT00901485|9745073|FG000|NOT COMPLETED|Overall Study||1
8699464|NCT00901485|9745074|FG001|NOT COMPLETED|Overall Study||4
8699465|NCT00901576|9745086|FG000|STARTED|First Intervention||6
8699466|NCT00901576|9745087|FG001|STARTED|First Intervention||7
8699467|NCT00901576|9745088|FG002|STARTED|First Intervention||7
8699468|NCT00901576|9745089|FG003|STARTED|First Intervention||6
8699469|NCT00901576|9745090|FG004|STARTED|First Intervention||6
8699470|NCT00901576|9745091|FG005|STARTED|First Intervention||6
8699471|NCT00901576|9745086|FG000|COMPLETED|First Intervention||6
8699472|NCT00901576|9745087|FG001|COMPLETED|First Intervention||7
8699473|NCT00901576|9745088|FG002|COMPLETED|First Intervention||7
8699474|NCT00901576|9745089|FG003|COMPLETED|First Intervention||6
8699475|NCT00901576|9745090|FG004|COMPLETED|First Intervention||6
8699476|NCT00901576|9745091|FG005|COMPLETED|First Intervention||6
8699477|NCT00901576|9745086|FG000|NOT COMPLETED|First Intervention||0
8699478|NCT00901576|9745087|FG001|NOT COMPLETED|First Intervention||0
8699479|NCT00901576|9745088|FG002|NOT COMPLETED|First Intervention||0
8699480|NCT00901576|9745089|FG003|NOT COMPLETED|First Intervention||0
8699481|NCT00901576|9745090|FG004|NOT COMPLETED|First Intervention||0
8699482|NCT00901576|9745091|FG005|NOT COMPLETED|First Intervention||0
8699483|NCT00901576|9745086|FG000|STARTED|Washout||6
8699484|NCT00901576|9745087|FG001|STARTED|Washout||7
8699485|NCT00901576|9745088|FG002|STARTED|Washout||7
8927670|NCT02274792|9988785|FG000|STARTED|Overall Study||132
8927671|NCT02274792|9988785|FG000|Received Treatment|Overall Study||131
8927672|NCT02274792|9988785|FG000|COMPLETED|Overall Study||107
8927673|NCT02274792|9988785|FG000|NOT COMPLETED|Overall Study||25
8699486|NCT00901576|9745089|FG003|STARTED|Washout||6
8699487|NCT00901576|9745090|FG004|STARTED|Washout||6
8699488|NCT00901576|9745091|FG005|STARTED|Washout||6
8927674|NCT02274844|9988791|FG000|STARTED|Overall Study||203
8699489|NCT00901576|9745086|FG000|COMPLETED|Washout||6
8699490|NCT00901576|9745087|FG001|COMPLETED|Washout||7
8699491|NCT00901576|9745088|FG002|COMPLETED|Washout||7
8699492|NCT00901576|9745089|FG003|COMPLETED|Washout||6
8699493|NCT00901576|9745090|FG004|COMPLETED|Washout||6
8927675|NCT02274844|9988792|FG001|STARTED|Overall Study||270
8699494|NCT00901576|9745091|FG005|COMPLETED|Washout||6
8699495|NCT00901576|9745086|FG000|NOT COMPLETED|Washout||0
8699496|NCT00901576|9745087|FG001|NOT COMPLETED|Washout||0
8699497|NCT00901576|9745088|FG002|NOT COMPLETED|Washout||0
8699498|NCT00901576|9745089|FG003|NOT COMPLETED|Washout||0
8699499|NCT00901576|9745090|FG004|NOT COMPLETED|Washout||0
8699500|NCT00901576|9745091|FG005|NOT COMPLETED|Washout||0
8927676|NCT02274844|9988791|FG000|COMPLETED|Overall Study||165
8927677|NCT02274844|9988792|FG001|COMPLETED|Overall Study||238
8927678|NCT02274844|9988791|FG000|NOT COMPLETED|Overall Study||38
8927679|NCT02274844|9988792|FG001|NOT COMPLETED|Overall Study||32
8927680|NCT02274857|9988800|FG000|STARTED|Overall Study||179
8927681|NCT02274857|9988801|FG001|STARTED|Overall Study||171
8927682|NCT02274857|9988800|FG000|Completed Per Protocol|Overall Study||102
8927683|NCT02274857|9988801|FG001|Completed Per Protocol|Overall Study||114
8927684|NCT02274857|9988800|FG000|COMPLETED|Overall Study||159
8927685|NCT02274857|9988801|FG001|COMPLETED|Overall Study||165
8927686|NCT02274857|9988800|FG000|NOT COMPLETED|Overall Study||20
8927687|NCT02274857|9988801|FG001|NOT COMPLETED|Overall Study||6
8927688|NCT02274870|9988810|FG000|STARTED|Overall Study||32
8927689|NCT02274870|9988811|FG001|STARTED|Overall Study||33
8699501|NCT00901576|9745086|FG000|STARTED|Second Intervention||6
8699502|NCT00901576|9745087|FG001|STARTED|Second Intervention||7
8699503|NCT00901576|9745088|FG002|STARTED|Second Intervention||7
8699504|NCT00901576|9745089|FG003|STARTED|Second Intervention||6
8699505|NCT00901576|9745090|FG004|STARTED|Second Intervention||6
8699506|NCT00901576|9745091|FG005|STARTED|Second Intervention||6
8699507|NCT00901576|9745086|FG000|COMPLETED|Second Intervention||5
8699508|NCT00901576|9745087|FG001|COMPLETED|Second Intervention||7
8699509|NCT00901576|9745088|FG002|COMPLETED|Second Intervention||7
8699510|NCT00901576|9745089|FG003|COMPLETED|Second Intervention||5
8699511|NCT00901576|9745090|FG004|COMPLETED|Second Intervention||6
8699512|NCT00901576|9745091|FG005|COMPLETED|Second Intervention||5
8699513|NCT00901576|9745086|FG000|NOT COMPLETED|Second Intervention||1
8699514|NCT00901576|9745087|FG001|NOT COMPLETED|Second Intervention||0
8699515|NCT00901576|9745088|FG002|NOT COMPLETED|Second Intervention||0
8699516|NCT00901576|9745089|FG003|NOT COMPLETED|Second Intervention||1
8699517|NCT00901576|9745090|FG004|NOT COMPLETED|Second Intervention||0
8699518|NCT00901576|9745091|FG005|NOT COMPLETED|Second Intervention||1
8699519|NCT00901576|9745086|FG000|STARTED|Washout||5
8699520|NCT00901576|9745087|FG001|STARTED|Washout||7
8699521|NCT00901576|9745088|FG002|STARTED|Washout||7
8699522|NCT00901576|9745089|FG003|STARTED|Washout||5
8699523|NCT00901576|9745090|FG004|STARTED|Washout||6
8699524|NCT00901576|9745091|FG005|STARTED|Washout||5
8699525|NCT00901576|9745086|FG000|COMPLETED|Washout||5
8699526|NCT00901576|9745087|FG001|COMPLETED|Washout||7
8699527|NCT00901576|9745088|FG002|COMPLETED|Washout||7
8699528|NCT00901576|9745089|FG003|COMPLETED|Washout||5
8699529|NCT00901576|9745090|FG004|COMPLETED|Washout||6
8699530|NCT00901576|9745091|FG005|COMPLETED|Washout||5
8699531|NCT00901576|9745086|FG000|NOT COMPLETED|Washout||0
8699532|NCT00901576|9745087|FG001|NOT COMPLETED|Washout||0
8699533|NCT00901576|9745088|FG002|NOT COMPLETED|Washout||0
8699534|NCT00901576|9745089|FG003|NOT COMPLETED|Washout||0
8699535|NCT00901576|9745090|FG004|NOT COMPLETED|Washout||0
8699536|NCT00901576|9745091|FG005|NOT COMPLETED|Washout||0
8699537|NCT00901576|9745086|FG000|STARTED|Third Intervention||5
8699538|NCT00901576|9745087|FG001|STARTED|Third Intervention||7
8699539|NCT00901576|9745088|FG002|STARTED|Third Intervention||7
8699540|NCT00901576|9745089|FG003|STARTED|Third Intervention||5
8699541|NCT00901576|9745090|FG004|STARTED|Third Intervention||6
8699542|NCT00901576|9745091|FG005|STARTED|Third Intervention||5
8699543|NCT00901576|9745086|FG000|COMPLETED|Third Intervention||5
8699544|NCT00901576|9745087|FG001|COMPLETED|Third Intervention||7
8699545|NCT00901576|9745088|FG002|COMPLETED|Third Intervention||7
8699546|NCT00901576|9745089|FG003|COMPLETED|Third Intervention||5
8699547|NCT00901576|9745090|FG004|COMPLETED|Third Intervention||6
8699548|NCT00901576|9745091|FG005|COMPLETED|Third Intervention||5
8699549|NCT00901576|9745086|FG000|NOT COMPLETED|Third Intervention||0
8699550|NCT00901576|9745087|FG001|NOT COMPLETED|Third Intervention||0
8699551|NCT00901576|9745088|FG002|NOT COMPLETED|Third Intervention||0
8699552|NCT00901576|9745089|FG003|NOT COMPLETED|Third Intervention||0
8699553|NCT00901576|9745090|FG004|NOT COMPLETED|Third Intervention||0
8699554|NCT00901576|9745091|FG005|NOT COMPLETED|Third Intervention||0
8699555|NCT00901628|9745101|FG000|STARTED|Overall Study||49
8699556|NCT00901628|9745102|FG001|STARTED|Overall Study||52
8699557|NCT00901628|9745101|FG000|COMPLETED|Overall Study||45
8699558|NCT00901628|9745102|FG001|COMPLETED|Overall Study||42
8699559|NCT00901628|9745101|FG000|NOT COMPLETED|Overall Study||4
8699560|NCT00901628|9745102|FG001|NOT COMPLETED|Overall Study||10
8699561|NCT00901901|9745110|FG000|STARTED|Treatment Period||362
8699562|NCT00901901|9745111|FG001|STARTED|Treatment Period||358
8699563|NCT00901901|9745110|FG000|Participants Received Treatment|Treatment Period||362
8699564|NCT00901901|9745111|FG001|Participants Received Treatment|Treatment Period||355
8699565|NCT00901901|9745110|FG000|COMPLETED|Treatment Period||193
8699566|NCT00901901|9745111|FG001|COMPLETED|Treatment Period||181
8699567|NCT00901901|9745110|FG000|NOT COMPLETED|Treatment Period||169
8699568|NCT00901901|9745111|FG001|NOT COMPLETED|Treatment Period||177
8699569|NCT00901901|9745110|FG000|STARTED|Follow-up Period||340
8699570|NCT00901901|9745111|FG001|STARTED|Follow-up Period||341
8699571|NCT00901901|9745110|FG000|COMPLETED|Follow-up Period||0
8699572|NCT00901901|9745111|FG001|COMPLETED|Follow-up Period||0
8699573|NCT00901901|9745110|FG000|NOT COMPLETED|Follow-up Period||340
8927690|NCT02274870|9988810|FG000|COMPLETED|Overall Study||32
8927691|NCT02274870|9988811|FG001|COMPLETED|Overall Study||33
8927692|NCT02274870|9988810|FG000|NOT COMPLETED|Overall Study||0
8699574|NCT00901901|9745111|FG001|NOT COMPLETED|Follow-up Period||341
8699575|NCT00901927|9745119|FG000|STARTED|Overall Study||14
8927693|NCT02274870|9988811|FG001|NOT COMPLETED|Overall Study||0
8927694|NCT02274948|9988822|FG000|STARTED|Overall Study||166
8927695|NCT02274948|9988823|FG001|STARTED|Overall Study||173
8927696|NCT02274948|9988822|FG000|COMPLETED|Overall Study||68
8927697|NCT02274948|9988823|FG001|COMPLETED|Overall Study||82
8927698|NCT02274948|9988822|FG000|NOT COMPLETED|Overall Study||98
8927699|NCT02274948|9988823|FG001|NOT COMPLETED|Overall Study||91
8927700|NCT02275026|9988830|FG000|STARTED|Overall Study||104
8927701|NCT02275026|9988830|FG000|COMPLETED|Overall Study||71
8927702|NCT02275026|9988830|FG000|NOT COMPLETED|Overall Study||33
8927703|NCT02275052|9988837|FG000|STARTED|Period 1: Treatment Period 1 (12 Weeks)||99
8927704|NCT02275052|9988838|FG001|STARTED|Period 1: Treatment Period 1 (12 Weeks)||99
8927705|NCT02275052|9988839|FG002|STARTED|Period 1: Treatment Period 1 (12 Weeks)||0
8927706|NCT02275052|9988840|FG003|STARTED|Period 1: Treatment Period 1 (12 Weeks)||0
8927707|NCT02275052|9988837|FG000|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||90
8927708|NCT02275052|9988838|FG001|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||93
8927709|NCT02275052|9988839|FG002|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
8927710|NCT02275052|9988840|FG003|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
8927711|NCT02275052|9988837|FG000|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||9
8927712|NCT02275052|9988838|FG001|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||6
8927713|NCT02275052|9988839|FG002|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
8927714|NCT02275052|9988840|FG003|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
8927715|NCT02275052|9988837|FG000|STARTED|Washout Period (12-17 Days)||90
8927716|NCT02275052|9988838|FG001|STARTED|Washout Period (12-17 Days)||93
8927717|NCT02275052|9988839|FG002|STARTED|Washout Period (12-17 Days)||0
8927718|NCT02275052|9988840|FG003|STARTED|Washout Period (12-17 Days)||0
8927719|NCT02275052|9988837|FG000|COMPLETED|Washout Period (12-17 Days)||86
8927720|NCT02275052|9988838|FG001|COMPLETED|Washout Period (12-17 Days)||93
8927721|NCT02275052|9988839|FG002|COMPLETED|Washout Period (12-17 Days)||0
8927722|NCT02275052|9988840|FG003|COMPLETED|Washout Period (12-17 Days)||0
8927723|NCT02275052|9988837|FG000|NOT COMPLETED|Washout Period (12-17 Days)||4
8927724|NCT02275052|9988838|FG001|NOT COMPLETED|Washout Period (12-17 Days)||0
8927725|NCT02275052|9988839|FG002|NOT COMPLETED|Washout Period (12-17 Days)||0
8927726|NCT02275052|9988840|FG003|NOT COMPLETED|Washout Period (12-17 Days)||0
8927727|NCT02275052|9988837|FG000|STARTED|Period 2: Treatment Period 2 (12 Weeks)||0
8927728|NCT02275052|9988838|FG001|STARTED|Period 2: Treatment Period 2 (12 Weeks)||0
8927729|NCT02275052|9988839|FG002|STARTED|Period 2: Treatment Period 2 (12 Weeks)||93
8927730|NCT02275052|9988840|FG003|STARTED|Period 2: Treatment Period 2 (12 Weeks)||86
8927731|NCT02275052|9988837|FG000|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
9042386|NCT03382262|10102996|FG000|NOT COMPLETED|Overall Study||0
9042387|NCT03382262|10102997|FG001|NOT COMPLETED|Overall Study||0
9042388|NCT03382262|10102998|FG002|NOT COMPLETED|Overall Study||1
8699576|NCT00901927|9745119|FG000|COMPLETED|Overall Study||8
8699577|NCT00901927|9745119|FG000|NOT COMPLETED|Overall Study||6
8699578|NCT00902018|9745126|FG000|STARTED|Overall Study||7
8699579|NCT00902018|9745127|FG001|STARTED|Overall Study||3
8699580|NCT00902018|9745128|FG002|STARTED|Overall Study||10
8699581|NCT00902018|9745126|FG000|COMPLETED|Overall Study||7
8699582|NCT00902018|9745127|FG001|COMPLETED|Overall Study||3
8699583|NCT00902018|9745128|FG002|COMPLETED|Overall Study||10
8699584|NCT00902018|9745126|FG000|NOT COMPLETED|Overall Study||0
8699585|NCT00902018|9745127|FG001|NOT COMPLETED|Overall Study||0
8699586|NCT00902018|9745128|FG002|NOT COMPLETED|Overall Study||0
8699587|NCT00902161|9745144|FG000|STARTED|Pre-study Washout/Propanolol Run-in||0
8699588|NCT00902161|9745145|FG001|STARTED|Pre-study Washout/Propanolol Run-in||0
8699589|NCT00902161|9745146|FG002|STARTED|Pre-study Washout/Propanolol Run-in||22
8699590|NCT00902161|9745144|FG000|COMPLETED|Pre-study Washout/Propanolol Run-in||0
8699591|NCT00902161|9745145|FG001|COMPLETED|Pre-study Washout/Propanolol Run-in||0
8699592|NCT00902161|9745146|FG002|COMPLETED|Pre-study Washout/Propanolol Run-in||22
8699593|NCT00902161|9745144|FG000|NOT COMPLETED|Pre-study Washout/Propanolol Run-in||0
8699594|NCT00902161|9745145|FG001|NOT COMPLETED|Pre-study Washout/Propanolol Run-in||0
8699595|NCT00902161|9745146|FG002|NOT COMPLETED|Pre-study Washout/Propanolol Run-in||0
8699596|NCT00902161|9745144|FG000|STARTED|Period 1||12
8699597|NCT00902161|9745145|FG001|STARTED|Period 1||10
8699598|NCT00902161|9745146|FG002|STARTED|Period 1||0
8699599|NCT00902161|9745144|FG000|COMPLETED|Period 1||12
8699600|NCT00902161|9745145|FG001|COMPLETED|Period 1||10
8699601|NCT00902161|9745146|FG002|COMPLETED|Period 1||0
8699602|NCT00902161|9745144|FG000|NOT COMPLETED|Period 1||0
8927732|NCT02275052|9988838|FG001|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
8927733|NCT02275052|9988839|FG002|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||88
8927734|NCT02275052|9988840|FG003|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||72
8927735|NCT02275052|9988837|FG000|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
8927736|NCT02275052|9988838|FG001|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
8699603|NCT00902161|9745145|FG001|NOT COMPLETED|Period 1||0
8699604|NCT00902161|9745146|FG002|NOT COMPLETED|Period 1||0
8699605|NCT00902161|9745144|FG000|STARTED|Post-clamp Washout||0
9042389|NCT03382262|10102999|FG003|NOT COMPLETED|Overall Study||1
8699606|NCT00902161|9745145|FG001|STARTED|Post-clamp Washout||0
8699607|NCT00902161|9745146|FG002|STARTED|Post-clamp Washout||22
8699608|NCT00902161|9745144|FG000|COMPLETED|Post-clamp Washout||0
8699609|NCT00902161|9745145|FG001|COMPLETED|Post-clamp Washout||0
8724381|NCT01026194|9771581|FG000|NOT COMPLETED|Period 2：Open-label Period||7
8927737|NCT02275052|9988839|FG002|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||5
9042390|NCT03382418|10103012|FG000|STARTED|Overall Study||25
9042391|NCT03382418|10103013|FG001|STARTED|Overall Study||15
9042392|NCT03382418|10103014|FG002|STARTED|Overall Study||5
9042393|NCT03382418|10103012|FG000|Month .5 Immunogenicity Cohort|Overall Study||25
9042394|NCT03382418|10103013|FG001|Month .5 Immunogenicity Cohort|Overall Study||14
9042395|NCT03382418|10103014|FG002|Month .5 Immunogenicity Cohort|Overall Study||5
9042396|NCT03382418|10103012|FG000|Month 6.5 Immunogenicity Cohort|Overall Study||21
9042397|NCT03382418|10103013|FG001|Month 6.5 Immunogenicity Cohort|Overall Study||13
9042398|NCT03382418|10103014|FG002|Month 6.5 Immunogenicity Cohort|Overall Study||5
9042399|NCT03382418|10103012|FG000|COMPLETED|Overall Study||22
9042400|NCT03382418|10103013|FG001|COMPLETED|Overall Study||12
9042401|NCT03382418|10103014|FG002|COMPLETED|Overall Study||5
9042402|NCT03382418|10103012|FG000|NOT COMPLETED|Overall Study||3
9042403|NCT03382418|10103013|FG001|NOT COMPLETED|Overall Study||3
9042404|NCT03382418|10103014|FG002|NOT COMPLETED|Overall Study||0
9042405|NCT03382509|10103025|FG000|STARTED|Overall Study||8
9042406|NCT03382509|10103026|FG001|STARTED|Overall Study||8
9042407|NCT03382509|10103025|FG000|COMPLETED|Overall Study||8
9042408|NCT03382509|10103026|FG001|COMPLETED|Overall Study||8
9042409|NCT03382509|10103025|FG000|NOT COMPLETED|Overall Study||0
9042410|NCT03382509|10103026|FG001|NOT COMPLETED|Overall Study||0
9042411|NCT03382665|10103033|FG000|STARTED|Overall Study||70
9042412|NCT03382665|10103033|FG000|Actual Enrollment|Overall Study||59
9042413|NCT03382665|10103033|FG000|5 Year Follow up|Overall Study||25
9042414|NCT03382665|10103033|FG000|COMPLETED|Overall Study||25
9042415|NCT03382665|10103033|FG000|NOT COMPLETED|Overall Study||45
9042416|NCT03382821|10103043|FG000|STARTED|Overall Study||60
9042417|NCT03382821|10103044|FG001|STARTED|Overall Study||60
9042418|NCT03382821|10103043|FG000|COMPLETED|Overall Study||60
9042419|NCT03382821|10103044|FG001|COMPLETED|Overall Study||57
9042420|NCT03382821|10103043|FG000|NOT COMPLETED|Overall Study||0
9042421|NCT03382821|10103044|FG001|NOT COMPLETED|Overall Study||3
9042422|NCT03382847|10103051|FG000|STARTED|Overall Study||25
9042423|NCT03382847|10103051|FG000|COMPLETED|Overall Study||25
9042424|NCT03382847|10103051|FG000|NOT COMPLETED|Overall Study||0
9042425|NCT03382899|10103057|FG000|STARTED|Overall Study||51
9042426|NCT03382899|10103058|FG001|STARTED|Overall Study||50
9042427|NCT03382899|10103057|FG000|Received at Least 1 Dose of Study Drug|Overall Study||50
9042428|NCT03382899|10103058|FG001|Received at Least 1 Dose of Study Drug|Overall Study||48
9042429|NCT03382899|10103057|FG000|COMPLETED|Overall Study||20
9042430|NCT03382899|10103058|FG001|COMPLETED|Overall Study||15
9042431|NCT03382899|10103057|FG000|NOT COMPLETED|Overall Study||31
9042432|NCT03382899|10103058|FG001|NOT COMPLETED|Overall Study||35
9042433|NCT03382912|10103066|FG000|STARTED|Overall Study||27
9042434|NCT03382912|10103067|FG001|STARTED|Overall Study||25
9042435|NCT03382912|10103066|FG000|Received at Least 1 Dose of Study Drug|Overall Study||27
9042436|NCT03382912|10103067|FG001|Received at Least 1 Dose of Study Drug|Overall Study||24
9042437|NCT03382912|10103066|FG000|COMPLETED|Overall Study||21
9042438|NCT03382912|10103067|FG001|COMPLETED|Overall Study||13
9042439|NCT03382912|10103066|FG000|NOT COMPLETED|Overall Study||6
9042440|NCT03382912|10103067|FG001|NOT COMPLETED|Overall Study||12
9042441|NCT03383146|10103075|FG000|STARTED|Overall Study||148
9042442|NCT03383146|10103076|FG001|STARTED|Overall Study||302
9042443|NCT03383146|10103075|FG000|Safety Population|Overall Study||145
9042444|NCT03383146|10103076|FG001|Safety Population|Overall Study||299
9042445|NCT03383146|10103075|FG000|Run-in Period|Overall Study||91
9042446|NCT03383146|10103076|FG001|Run-in Period|Overall Study||207
9042447|NCT03383146|10103075|FG000|COMPLETED|Overall Study||63
9042448|NCT03383146|10103076|FG001|COMPLETED|Overall Study||118
8699610|NCT00902161|9745146|FG002|COMPLETED|Post-clamp Washout|2 participants discontinued washout and were replaced; 1 due to an AE and 1 due to lack of efficacy|22
8699611|NCT00902161|9745144|FG000|NOT COMPLETED|Post-clamp Washout||0
8699612|NCT00902161|9745145|FG001|NOT COMPLETED|Post-clamp Washout||0
8699613|NCT00902161|9745146|FG002|NOT COMPLETED|Post-clamp Washout||0
8699614|NCT00902161|9745144|FG000|STARTED|Period 2||8
8699615|NCT00902161|9745145|FG001|STARTED|Period 2||9
8699616|NCT00902161|9745146|FG002|STARTED|Period 2||0
8724382|NCT01026194|9771582|FG001|NOT COMPLETED|Period 2：Open-label Period||10
8927738|NCT02275052|9988840|FG003|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||14
8927739|NCT02275065|9988851|FG000|STARTED|Overall Study||5
8927740|NCT02275065|9988852|FG001|STARTED|Overall Study||4
8927741|NCT02275065|9988853|FG002|STARTED|Overall Study||5
8927742|NCT02275065|9988854|FG003|STARTED|Overall Study||5
8927743|NCT02275065|9988855|FG004|STARTED|Overall Study||4
8927744|NCT02275065|9988851|FG000|COMPLETED|Overall Study||4
8927745|NCT02275065|9988852|FG001|COMPLETED|Overall Study||4
8927746|NCT02275065|9988853|FG002|COMPLETED|Overall Study||4
8927747|NCT02275065|9988854|FG003|COMPLETED|Overall Study||4
8927748|NCT02275065|9988855|FG004|COMPLETED|Overall Study||4
9042449|NCT03383146|10103075|FG000|NOT COMPLETED|Overall Study||85
9042450|NCT03383146|10103076|FG001|NOT COMPLETED|Overall Study||184
9042451|NCT03383198|10103085|FG000|STARTED|Overall Study||4
9042452|NCT03383198|10103086|FG001|STARTED|Overall Study||1
9042453|NCT03383198|10103085|FG000|COMPLETED|Overall Study||4
9042454|NCT03383198|10103086|FG001|COMPLETED|Overall Study||1
8927749|NCT02275065|9988851|FG000|NOT COMPLETED|Overall Study||1
8927750|NCT02275065|9988852|FG001|NOT COMPLETED|Overall Study||0
9042455|NCT03383198|10103085|FG000|NOT COMPLETED|Overall Study||0
8927751|NCT02275065|9988853|FG002|NOT COMPLETED|Overall Study||1
8927752|NCT02275065|9988854|FG003|NOT COMPLETED|Overall Study||1
8927753|NCT02275065|9988855|FG004|NOT COMPLETED|Overall Study||0
8927754|NCT02275117|9988872|FG000|STARTED|Overall Study||131
8927755|NCT02275117|9988873|FG001|STARTED|Overall Study||133
8927756|NCT02275117|9988874|FG002|STARTED|Overall Study||134
8927757|NCT02275117|9988875|FG003|STARTED|Overall Study||133
8927758|NCT02275117|9988876|FG004|STARTED|Overall Study||134
8927759|NCT02275117|9988872|FG000|Randomized and Treated|Overall Study||120
8927760|NCT02275117|9988873|FG001|Randomized and Treated|Overall Study||123
8927761|NCT02275117|9988874|FG002|Randomized and Treated|Overall Study||122
8927762|NCT02275117|9988875|FG003|Randomized and Treated|Overall Study||130
8927763|NCT02275117|9988876|FG004|Randomized and Treated|Overall Study||121
8927764|NCT02275117|9988872|FG000|COMPLETED|Overall Study||97
8927765|NCT02275117|9988873|FG001|COMPLETED|Overall Study||96
8927766|NCT02275117|9988874|FG002|COMPLETED|Overall Study||92
8927767|NCT02275117|9988875|FG003|COMPLETED|Overall Study||100
8927768|NCT02275117|9988876|FG004|COMPLETED|Overall Study||98
8927769|NCT02275117|9988872|FG000|NOT COMPLETED|Overall Study||34
8927770|NCT02275117|9988873|FG001|NOT COMPLETED|Overall Study||37
8927771|NCT02275117|9988874|FG002|NOT COMPLETED|Overall Study||42
8927772|NCT02275117|9988875|FG003|NOT COMPLETED|Overall Study||33
8927773|NCT02275117|9988876|FG004|NOT COMPLETED|Overall Study||36
8927774|NCT02275156|9988891|FG000|STARTED|Overall Study||6
8927775|NCT02275156|9988892|FG001|STARTED|Overall Study||6
8927776|NCT02275156|9988893|FG002|STARTED|Overall Study||6
8927777|NCT02275156|9988891|FG000|COMPLETED|Overall Study||6
8927778|NCT02275156|9988892|FG001|COMPLETED|Overall Study||6
8927779|NCT02275156|9988893|FG002|COMPLETED|Overall Study||6
8927780|NCT02275156|9988891|FG000|NOT COMPLETED|Overall Study||0
8927781|NCT02275156|9988892|FG001|NOT COMPLETED|Overall Study||0
8927782|NCT02275156|9988893|FG002|NOT COMPLETED|Overall Study||0
8927783|NCT02275338|9988902|FG000|STARTED|Overall Study||52
8927784|NCT02275338|9988902|FG000|Completed Phase 1|Overall Study||25
8927785|NCT02275338|9988902|FG000|Started Phase 2|Overall Study||21
8927786|NCT02275338|9988902|FG000|COMPLETED|Overall Study||19
8927787|NCT02275338|9988902|FG000|NOT COMPLETED|Overall Study||33
8927788|NCT02275364|9988907|FG000|STARTED|Period 1||14
8927789|NCT02275364|9988908|FG001|STARTED|Period 1||14
8927790|NCT02275364|9988907|FG000|COMPLETED|Period 1||12
8927791|NCT02275364|9988908|FG001|COMPLETED|Period 1||14
8927792|NCT02275364|9988907|FG000|NOT COMPLETED|Period 1||2
8927793|NCT02275364|9988908|FG001|NOT COMPLETED|Period 1||0
8927794|NCT02275364|9988907|FG000|STARTED|Washout Period 1||12
8927795|NCT02275364|9988908|FG001|STARTED|Washout Period 1||14
8927796|NCT02275364|9988907|FG000|COMPLETED|Washout Period 1||12
8927797|NCT02275364|9988908|FG001|COMPLETED|Washout Period 1||14
8927798|NCT02275364|9988907|FG000|NOT COMPLETED|Washout Period 1||0
8927799|NCT02275364|9988908|FG001|NOT COMPLETED|Washout Period 1||0
8927800|NCT02275364|9988907|FG000|STARTED|Period 2||12
8927801|NCT02275364|9988908|FG001|STARTED|Period 2||14
8927802|NCT02275364|9988907|FG000|COMPLETED|Period 2||12
8927803|NCT02275364|9988908|FG001|COMPLETED|Period 2||14
8927804|NCT02275364|9988907|FG000|NOT COMPLETED|Period 2||0
8927805|NCT02275364|9988908|FG001|NOT COMPLETED|Period 2||0
8927806|NCT02275364|9988907|FG000|STARTED|Washout Period 2||12
8927807|NCT02275364|9988908|FG001|STARTED|Washout Period 2||14
8927808|NCT02275364|9988907|FG000|COMPLETED|Washout Period 2||12
8927809|NCT02275364|9988908|FG001|COMPLETED|Washout Period 2||14
8927810|NCT02275364|9988907|FG000|NOT COMPLETED|Washout Period 2||0
8927811|NCT02275364|9988908|FG001|NOT COMPLETED|Washout Period 2||0
8927812|NCT02275364|9988907|FG000|STARTED|Period 3||12
8927813|NCT02275364|9988908|FG001|STARTED|Period 3||14
8927814|NCT02275364|9988907|FG000|COMPLETED|Period 3||12
8927815|NCT02275364|9988908|FG001|COMPLETED|Period 3||14
8927816|NCT02275364|9988907|FG000|NOT COMPLETED|Period 3||0
8927817|NCT02275364|9988908|FG001|NOT COMPLETED|Period 3||0
8927818|NCT02275364|9988907|FG000|STARTED|Period 4||12
8927819|NCT02275364|9988908|FG001|STARTED|Period 4||14
9042456|NCT03383198|10103086|FG001|NOT COMPLETED|Overall Study||0
9042457|NCT03383523|10103099|FG000|STARTED|Overall Study||11
9042458|NCT03383523|10103100|FG001|STARTED|Overall Study||11
9042459|NCT03383523|10103101|FG002|STARTED|Overall Study||10
9042460|NCT03383523|10103102|FG003|STARTED|Overall Study||12
9042461|NCT03383523|10103103|FG004|STARTED|Overall Study||11
9042462|NCT03383523|10103104|FG005|STARTED|Overall Study||12
9042463|NCT03383523|10103105|FG006|STARTED|Overall Study||10
9042464|NCT03383523|10103099|FG000|COMPLETED|Overall Study||10
9042465|NCT03383523|10103100|FG001|COMPLETED|Overall Study||11
9042466|NCT03383523|10103101|FG002|COMPLETED|Overall Study||9
9042467|NCT03383523|10103102|FG003|COMPLETED|Overall Study||12
9042468|NCT03383523|10103103|FG004|COMPLETED|Overall Study||11
8927820|NCT02275364|9988907|FG000|COMPLETED|Period 4||12
8927821|NCT02275364|9988908|FG001|COMPLETED|Period 4||14
8927822|NCT02275364|9988907|FG000|NOT COMPLETED|Period 4||0
8927823|NCT02275364|9988908|FG001|NOT COMPLETED|Period 4||0
8948222|NCT02428296|10010561|FG000|NOT COMPLETED|Overall Study||9
8948223|NCT02428309|10010568|FG000|STARTED|Overall Study||1
8948224|NCT02428309|10010568|FG000|COMPLETED|Overall Study|The enrolled participant completed treatment and was followed through week 152, per protocol.|1
8948225|NCT02428309|10010568|FG000|NOT COMPLETED|Overall Study||0
8948226|NCT02428413|10010575|FG000|STARTED|Overall Study||64
8948227|NCT02428413|10010576|FG001|STARTED|Overall Study||61
9042469|NCT03383523|10103104|FG005|COMPLETED|Overall Study||12
8927824|NCT02275611|9988929|FG000|STARTED|Inpatient Withdrawal||5
8927825|NCT02275611|9988930|FG001|STARTED|Inpatient Withdrawal||4
8927826|NCT02275611|9988931|FG002|STARTED|Inpatient Withdrawal||0
8927827|NCT02275611|9988932|FG003|STARTED|Inpatient Withdrawal||0
8699617|NCT00902161|9745144|FG000|COMPLETED|Period 2|2 participants discontinued and were replaced; 1 due to protocol deviation and 1 withdrew consent|8
8699618|NCT00902161|9745145|FG001|COMPLETED|Period 2||9
8699619|NCT00902161|9745146|FG002|COMPLETED|Period 2||0
8699620|NCT00902161|9745144|FG000|NOT COMPLETED|Period 2||0
8699621|NCT00902161|9745145|FG001|NOT COMPLETED|Period 2||0
8699622|NCT00902161|9745146|FG002|NOT COMPLETED|Period 2||0
8699623|NCT00902174|9745158|FG000|STARTED|Overall Study||103
8699624|NCT00902174|9745159|FG001|STARTED|Overall Study||99
8699625|NCT00902174|9745158|FG000|COMPLETED|Overall Study||69
8699626|NCT00902174|9745159|FG001|COMPLETED|Overall Study||81
8699627|NCT00902174|9745158|FG000|NOT COMPLETED|Overall Study||34
8699628|NCT00902174|9745159|FG001|NOT COMPLETED|Overall Study||18
8699629|NCT00902226|9745168|FG000|STARTED|Overall Study||30
8699630|NCT00902226|9745168|FG000|COMPLETED|Overall Study||30
8699631|NCT00902226|9745168|FG000|NOT COMPLETED|Overall Study||0
8699632|NCT00902265|9745172|FG000|STARTED|Overall Study||138
8699633|NCT00902265|9745172|FG000|Participants Who Received Treatment|Overall Study||137
8699634|NCT00902265|9745172|FG000|COMPLETED|Overall Study||132
8699635|NCT00902265|9745172|FG000|NOT COMPLETED|Overall Study||6
8699636|NCT00902278|9745181|FG000|STARTED|Overall Study||54
8699637|NCT00902278|9745182|FG001|STARTED|Overall Study||36
8699638|NCT00902278|9745183|FG002|STARTED|Overall Study||54
8699639|NCT00902278|9745184|FG003|STARTED|Overall Study||12
8699640|NCT00902278|9745185|FG004|STARTED|Overall Study||37
8699641|NCT00902278|9745181|FG000|COMPLETED|Overall Study||50
8699642|NCT00902278|9745182|FG001|COMPLETED|Overall Study||34
8699643|NCT00902278|9745183|FG002|COMPLETED|Overall Study||49
8699644|NCT00902278|9745184|FG003|COMPLETED|Overall Study||12
8699645|NCT00902278|9745185|FG004|COMPLETED|Overall Study||35
8699646|NCT00902278|9745181|FG000|NOT COMPLETED|Overall Study||4
8699647|NCT00902278|9745182|FG001|NOT COMPLETED|Overall Study||2
8699648|NCT00902278|9745183|FG002|NOT COMPLETED|Overall Study||5
8699649|NCT00902278|9745184|FG003|NOT COMPLETED|Overall Study||0
8699650|NCT00902278|9745185|FG004|NOT COMPLETED|Overall Study||2
8699651|NCT00902304|9745200|FG000|STARTED|Overall Study||524
8699652|NCT00902304|9745201|FG001|STARTED|Overall Study||360
8699653|NCT00902304|9745202|FG002|STARTED|Overall Study||678
8699654|NCT00902304|9745200|FG000|COMPLETED|Overall Study||466
8699655|NCT00902304|9745201|FG001|COMPLETED|Overall Study||289
8699656|NCT00902304|9745202|FG002|COMPLETED|Overall Study||568
8699657|NCT00902304|9745200|FG000|NOT COMPLETED|Overall Study||58
8699658|NCT00902304|9745201|FG001|NOT COMPLETED|Overall Study||71
8699659|NCT00902304|9745202|FG002|NOT COMPLETED|Overall Study||110
8699660|NCT00902330|9745213|FG000|STARTED|Overall Study||81
8699661|NCT00902330|9745214|FG001|STARTED|Overall Study||80
8699662|NCT00902330|9745213|FG000|COMPLETED|Overall Study||77
8699663|NCT00902330|9745214|FG001|COMPLETED|Overall Study||75
8699664|NCT00902330|9745213|FG000|NOT COMPLETED|Overall Study||4
8699665|NCT00902330|9745214|FG001|NOT COMPLETED|Overall Study||5
8699666|NCT00902486|9745227|FG000|STARTED|Treatment Period (Weeks 0 Through 12)||31
8699667|NCT00902486|9745228|FG001|STARTED|Treatment Period (Weeks 0 Through 12)||0
8699668|NCT00902486|9745229|FG002|STARTED|Treatment Period (Weeks 0 Through 12)||0
8699669|NCT00902486|9745230|FG003|STARTED|Treatment Period (Weeks 0 Through 12)||32
8699670|NCT00902486|9745231|FG004|STARTED|Treatment Period (Weeks 0 Through 12)||32
8699671|NCT00902486|9745232|FG005|STARTED|Treatment Period (Weeks 0 Through 12)||32
8699672|NCT00902486|9745227|FG000|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||31
8699673|NCT00902486|9745228|FG001|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||0
8699674|NCT00902486|9745229|FG002|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||0
8699675|NCT00902486|9745230|FG003|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||31
8699676|NCT00902486|9745231|FG004|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||32
8699677|NCT00902486|9745232|FG005|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||31
8699678|NCT00902486|9745227|FG000|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||31
8699679|NCT00902486|9745228|FG001|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||0
8699680|NCT00902486|9745229|FG002|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||0
8699681|NCT00902486|9745230|FG003|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||31
8699682|NCT00902486|9745231|FG004|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||32
8699683|NCT00902486|9745232|FG005|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||30
8699684|NCT00902486|9745227|FG000|COMPLETED|Treatment Period (Weeks 0 Through 12)||29
8699685|NCT00902486|9745228|FG001|COMPLETED|Treatment Period (Weeks 0 Through 12)||0
8699686|NCT00902486|9745229|FG002|COMPLETED|Treatment Period (Weeks 0 Through 12)||0
8699687|NCT00902486|9745230|FG003|COMPLETED|Treatment Period (Weeks 0 Through 12)||29
8699688|NCT00902486|9745231|FG004|COMPLETED|Treatment Period (Weeks 0 Through 12)||30
8699689|NCT00902486|9745232|FG005|COMPLETED|Treatment Period (Weeks 0 Through 12)||27
8699690|NCT00902486|9745227|FG000|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||2
8699691|NCT00902486|9745228|FG001|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||0
8927828|NCT02275611|9988929|FG000|COMPLETED|Inpatient Withdrawal||4
8927829|NCT02275611|9988930|FG001|COMPLETED|Inpatient Withdrawal||4
8927830|NCT02275611|9988931|FG002|COMPLETED|Inpatient Withdrawal||0
8927831|NCT02275611|9988932|FG003|COMPLETED|Inpatient Withdrawal||0
8927832|NCT02275611|9988929|FG000|NOT COMPLETED|Inpatient Withdrawal||1
8927833|NCT02275611|9988930|FG001|NOT COMPLETED|Inpatient Withdrawal||0
8927834|NCT02275611|9988931|FG002|NOT COMPLETED|Inpatient Withdrawal||0
8927835|NCT02275611|9988932|FG003|NOT COMPLETED|Inpatient Withdrawal||0
8927836|NCT02275611|9988929|FG000|STARTED|Outpatient Drinking||0
8927837|NCT02275611|9988930|FG001|STARTED|Outpatient Drinking||0
8927838|NCT02275611|9988931|FG002|STARTED|Outpatient Drinking||6
8927839|NCT02275611|9988932|FG003|STARTED|Outpatient Drinking||3
8927840|NCT02275611|9988929|FG000|COMPLETED|Outpatient Drinking||0
8927841|NCT02275611|9988930|FG001|COMPLETED|Outpatient Drinking||0
8927842|NCT02275611|9988931|FG002|COMPLETED|Outpatient Drinking||6
8927843|NCT02275611|9988932|FG003|COMPLETED|Outpatient Drinking||3
8927844|NCT02275611|9988929|FG000|NOT COMPLETED|Outpatient Drinking||0
8927845|NCT02275611|9988930|FG001|NOT COMPLETED|Outpatient Drinking||0
8927846|NCT02275611|9988931|FG002|NOT COMPLETED|Outpatient Drinking||0
8927847|NCT02275611|9988932|FG003|NOT COMPLETED|Outpatient Drinking||0
8927848|NCT02275767|9988947|FG000|STARTED|Overall Study||22
8927849|NCT02275767|9988948|FG001|STARTED|Overall Study||22
8927850|NCT02275767|9988949|FG002|STARTED|Overall Study||22
8927851|NCT02275767|9988947|FG000|COMPLETED|Overall Study||20
8927852|NCT02275767|9988948|FG001|COMPLETED|Overall Study||18
8927853|NCT02275767|9988949|FG002|COMPLETED|Overall Study||19
8927854|NCT02275767|9988947|FG000|NOT COMPLETED|Overall Study||2
8927855|NCT02275767|9988948|FG001|NOT COMPLETED|Overall Study||4
8927856|NCT02275767|9988949|FG002|NOT COMPLETED|Overall Study||3
8927857|NCT02275780|9988959|FG000|STARTED|Base Study: 96 Weeks||385
8927858|NCT02275780|9988960|FG001|STARTED|Base Study: 96 Weeks||384
8927859|NCT02275780|9988959|FG000|Treated|Base Study: 96 Weeks||383
8927860|NCT02275780|9988960|FG001|Treated|Base Study: 96 Weeks||383
8927861|NCT02275780|9988959|FG000|COMPLETED|Base Study: 96 Weeks||292
8927862|NCT02275780|9988960|FG001|COMPLETED|Base Study: 96 Weeks||273
8927863|NCT02275780|9988959|FG000|NOT COMPLETED|Base Study: 96 Weeks||93
8927864|NCT02275780|9988960|FG001|NOT COMPLETED|Base Study: 96 Weeks||111
8927865|NCT02275780|9988959|FG000|STARTED|Extension Study: up to 192 Weeks|The extension study is optional; not all eligible participants enrolled|260
8927866|NCT02275780|9988960|FG001|STARTED|Extension Study: up to 192 Weeks|The extension study is optional; not all eligible participants enrolled|233
8927867|NCT02275780|9988959|FG000|COMPLETED|Extension Study: up to 192 Weeks|The extension study is ongoing|0
8927868|NCT02275780|9988960|FG001|COMPLETED|Extension Study: up to 192 Weeks|The extension study is ongoing|0
8927869|NCT02275780|9988959|FG000|NOT COMPLETED|Extension Study: up to 192 Weeks||260
8927870|NCT02275780|9988960|FG001|NOT COMPLETED|Extension Study: up to 192 Weeks||233
8927871|NCT02275819|9988968|FG000|STARTED|Overall Study||5
8927872|NCT02275819|9988969|FG001|STARTED|Overall Study||6
8927873|NCT02275819|9988968|FG000|COMPLETED|Overall Study||5
8927874|NCT02275819|9988969|FG001|COMPLETED|Overall Study||5
8927875|NCT02275819|9988968|FG000|NOT COMPLETED|Overall Study||0
8927876|NCT02275819|9988969|FG001|NOT COMPLETED|Overall Study||1
8927877|NCT02275923|9988975|FG000|STARTED|Overall Study||9
8927878|NCT02275923|9988975|FG000|COMPLETED|Overall Study||7
8927879|NCT02275923|9988975|FG000|NOT COMPLETED|Overall Study||2
8927880|NCT02276027|9988983|FG000|STARTED|Overall Study||2
8927881|NCT02276027|9988984|FG001|STARTED|Overall Study||16
8927882|NCT02276027|9988985|FG002|STARTED|Overall Study||26
8927883|NCT02276027|9988986|FG003|STARTED|Overall Study||22
8927884|NCT02276027|9988983|FG000|COMPLETED|Overall Study||0
8927885|NCT02276027|9988984|FG001|COMPLETED|Overall Study||0
8927886|NCT02276027|9988985|FG002|COMPLETED|Overall Study||6
8699692|NCT00902486|9745229|FG002|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||0
8699693|NCT00902486|9745230|FG003|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||3
8699694|NCT00902486|9745231|FG004|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||2
8699695|NCT00902486|9745232|FG005|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||5
8699696|NCT00902486|9745227|FG000|STARTED|Extension Period (Weeks 12 Through 24)||0
8699697|NCT00902486|9745228|FG001|STARTED|Extension Period (Weeks 12 Through 24)||14
8699698|NCT00902486|9745229|FG002|STARTED|Extension Period (Weeks 12 Through 24)||15
8699699|NCT00902486|9745230|FG003|STARTED|Extension Period (Weeks 12 Through 24)||29
8699700|NCT00902486|9745231|FG004|STARTED|Extension Period (Weeks 12 Through 24)||30
8699701|NCT00902486|9745232|FG005|STARTED|Extension Period (Weeks 12 Through 24)||27
8699702|NCT00902486|9745227|FG000|COMPLETED|Extension Period (Weeks 12 Through 24)||0
8699703|NCT00902486|9745228|FG001|COMPLETED|Extension Period (Weeks 12 Through 24)||14
8699704|NCT00902486|9745229|FG002|COMPLETED|Extension Period (Weeks 12 Through 24)||13
8699705|NCT00902486|9745230|FG003|COMPLETED|Extension Period (Weeks 12 Through 24)||27
8699706|NCT00902486|9745231|FG004|COMPLETED|Extension Period (Weeks 12 Through 24)||29
8699707|NCT00902486|9745232|FG005|COMPLETED|Extension Period (Weeks 12 Through 24)||24
8699708|NCT00902486|9745227|FG000|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||0
8699709|NCT00902486|9745228|FG001|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||0
8927887|NCT02276027|9988986|FG003|COMPLETED|Overall Study||0
8927888|NCT02276027|9988983|FG000|NOT COMPLETED|Overall Study||2
8927889|NCT02276027|9988984|FG001|NOT COMPLETED|Overall Study||16
8927890|NCT02276027|9988985|FG002|NOT COMPLETED|Overall Study||20
8927891|NCT02276027|9988986|FG003|NOT COMPLETED|Overall Study||22
8927892|NCT02276040|9988996|FG000|STARTED|Overall Study||26
8927893|NCT02276040|9988996|FG000|COMPLETED|Overall Study||11
8927894|NCT02276040|9988996|FG000|NOT COMPLETED|Overall Study||15
8927895|NCT02276053|9989000|FG000|STARTED|Overall Study||93
9042470|NCT03383523|10103105|FG006|COMPLETED|Overall Study||10
9042471|NCT03383523|10103099|FG000|NOT COMPLETED|Overall Study||1
9042472|NCT03383523|10103100|FG001|NOT COMPLETED|Overall Study||0
9042473|NCT03383523|10103101|FG002|NOT COMPLETED|Overall Study||1
9042474|NCT03383523|10103102|FG003|NOT COMPLETED|Overall Study||0
9042475|NCT03383523|10103103|FG004|NOT COMPLETED|Overall Study||0
9042476|NCT03383523|10103104|FG005|NOT COMPLETED|Overall Study||0
9042477|NCT03383523|10103105|FG006|NOT COMPLETED|Overall Study||0
9042478|NCT03383588|10103124|FG000|STARTED|Overall Study||8
9042479|NCT03383588|10103125|FG001|STARTED|Overall Study||9
9042480|NCT03383588|10103126|FG002|STARTED|Overall Study||9
9042481|NCT03383588|10103124|FG000|COMPLETED|Overall Study||8
8699710|NCT00902486|9745229|FG002|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||2
8699711|NCT00902486|9745230|FG003|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||2
8699712|NCT00902486|9745231|FG004|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||1
8699713|NCT00902486|9745232|FG005|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||3
8699714|NCT00902486|9745227|FG000|STARTED|Follow-up (After Week 24)||0
8699715|NCT00902486|9745228|FG001|STARTED|Follow-up (After Week 24)||14
8699716|NCT00902486|9745229|FG002|STARTED|Follow-up (After Week 24)||13
8699717|NCT00902486|9745230|FG003|STARTED|Follow-up (After Week 24)||27
8699718|NCT00902486|9745231|FG004|STARTED|Follow-up (After Week 24)||29
8699719|NCT00902486|9745232|FG005|STARTED|Follow-up (After Week 24)||24
8927896|NCT02276053|9989000|FG000|COMPLETED|Overall Study||79
8927897|NCT02276053|9989000|FG000|NOT COMPLETED|Overall Study||14
8927898|NCT02276222|9989007|FG000|STARTED|Overall Study||621
8927899|NCT02276222|9989008|FG001|STARTED|Overall Study||466
8927900|NCT02276222|9989007|FG000|COMPLETED|Overall Study|one subject withdrew at randomization due to a pre-treatment event prior to being dosed|436
8927901|NCT02276222|9989008|FG001|COMPLETED|Overall Study||402
8927902|NCT02276222|9989007|FG000|NOT COMPLETED|Overall Study||185
8927903|NCT02276222|9989008|FG001|NOT COMPLETED|Overall Study||64
8927904|NCT02276274|9989016|FG000|STARTED|First Intervention Period||6
8927905|NCT02276274|9989017|FG001|STARTED|First Intervention Period||6
8927906|NCT02276274|9989016|FG000|COMPLETED|First Intervention Period||6
8927907|NCT02276274|9989017|FG001|COMPLETED|First Intervention Period||6
8927908|NCT02276274|9989016|FG000|NOT COMPLETED|First Intervention Period||0
8927909|NCT02276274|9989017|FG001|NOT COMPLETED|First Intervention Period||0
8927910|NCT02276274|9989016|FG000|STARTED|Washout Period (at Least 15 Days)||6
8927911|NCT02276274|9989017|FG001|STARTED|Washout Period (at Least 15 Days)||6
8927912|NCT02276274|9989016|FG000|COMPLETED|Washout Period (at Least 15 Days)||6
8927913|NCT02276274|9989017|FG001|COMPLETED|Washout Period (at Least 15 Days)||6
8927914|NCT02276274|9989016|FG000|NOT COMPLETED|Washout Period (at Least 15 Days)||0
8927915|NCT02276274|9989017|FG001|NOT COMPLETED|Washout Period (at Least 15 Days)||0
8927916|NCT02276274|9989016|FG000|STARTED|Second Intervention Period||6
8927917|NCT02276274|9989017|FG001|STARTED|Second Intervention Period||6
8927918|NCT02276274|9989016|FG000|COMPLETED|Second Intervention Period||6
8927919|NCT02276274|9989017|FG001|COMPLETED|Second Intervention Period||6
8927920|NCT02276274|9989016|FG000|NOT COMPLETED|Second Intervention Period||0
8927921|NCT02276274|9989017|FG001|NOT COMPLETED|Second Intervention Period||0
8927922|NCT02276482|9989025|FG000|STARTED|Overall Study||91
8927923|NCT02276482|9989026|FG001|STARTED|Overall Study||29
8927924|NCT02276482|9989025|FG000|COMPLETED|Overall Study||88
8927925|NCT02276482|9989026|FG001|COMPLETED|Overall Study||28
8927926|NCT02276482|9989025|FG000|NOT COMPLETED|Overall Study||3
8927927|NCT02276482|9989026|FG001|NOT COMPLETED|Overall Study||1
8927928|NCT02276612|9989034|FG000|STARTED|Overall Study||50
8927929|NCT02276612|9989035|FG001|STARTED|Overall Study||10
8927930|NCT02276612|9989034|FG000|COMPLETED|Overall Study||46
8927931|NCT02276612|9989035|FG001|COMPLETED|Overall Study||10
8927932|NCT02276612|9989034|FG000|NOT COMPLETED|Overall Study||4
8927933|NCT02276612|9989035|FG001|NOT COMPLETED|Overall Study||0
8927934|NCT02276638|9989044|FG000|STARTED|Overall Study||28
8927935|NCT02276638|9989045|FG001|STARTED|Overall Study||28
8927936|NCT02276638|9989046|FG002|STARTED|Overall Study||23
8927937|NCT02276638|9989044|FG000|COMPLETED|Overall Study||28
8927938|NCT02276638|9989045|FG001|COMPLETED|Overall Study||28
8927939|NCT02276638|9989046|FG002|COMPLETED|Overall Study||23
9042482|NCT03383588|10103125|FG001|COMPLETED|Overall Study||9
9042483|NCT03383588|10103126|FG002|COMPLETED|Overall Study||9
8927940|NCT02276638|9989044|FG000|NOT COMPLETED|Overall Study||0
8927941|NCT02276638|9989045|FG001|NOT COMPLETED|Overall Study||0
8927942|NCT02276638|9989046|FG002|NOT COMPLETED|Overall Study||0
8927943|NCT02276807|9989056|FG000|STARTED|Overall Study||68
8927944|NCT02276807|9989057|FG001|STARTED|Overall Study||72
8927945|NCT02276807|9989056|FG000|12-week Assessment|Overall Study||57
8927946|NCT02276807|9989057|FG001|12-week Assessment|Overall Study||63
8699720|NCT00902486|9745227|FG000|Safety Evaluable Participants|Follow-up (After Week 24)||0
8699721|NCT00902486|9745228|FG001|Safety Evaluable Participants|Follow-up (After Week 24)||14
8699722|NCT00902486|9745229|FG002|Safety Evaluable Participants|Follow-up (After Week 24)||15
8699723|NCT00902486|9745230|FG003|Safety Evaluable Participants|Follow-up (After Week 24)||29
8699724|NCT00902486|9745231|FG004|Safety Evaluable Participants|Follow-up (After Week 24)||30
8699725|NCT00902486|9745232|FG005|Safety Evaluable Participants|Follow-up (After Week 24)||27
8699726|NCT00902486|9745227|FG000|COMPLETED|Follow-up (After Week 24)||0
8699727|NCT00902486|9745228|FG001|COMPLETED|Follow-up (After Week 24)||14
8699728|NCT00902486|9745229|FG002|COMPLETED|Follow-up (After Week 24)||13
8699729|NCT00902486|9745230|FG003|COMPLETED|Follow-up (After Week 24)||26
8699730|NCT00902486|9745231|FG004|COMPLETED|Follow-up (After Week 24)||29
8699731|NCT00902486|9745232|FG005|COMPLETED|Follow-up (After Week 24)||24
8699732|NCT00902486|9745227|FG000|NOT COMPLETED|Follow-up (After Week 24)||0
8699733|NCT00902486|9745228|FG001|NOT COMPLETED|Follow-up (After Week 24)||0
8699734|NCT00902486|9745229|FG002|NOT COMPLETED|Follow-up (After Week 24)||0
8699735|NCT00902486|9745230|FG003|NOT COMPLETED|Follow-up (After Week 24)||1
8699736|NCT00902486|9745231|FG004|NOT COMPLETED|Follow-up (After Week 24)||0
8699737|NCT00902486|9745232|FG005|NOT COMPLETED|Follow-up (After Week 24)||0
8699738|NCT00902538|9745265|FG000|STARTED|1-Single-blind, Run-in, Single-Treatment||2204
8699739|NCT00902538|9745266|FG001|STARTED|1-Single-blind, Run-in, Single-Treatment||0
8699740|NCT00902538|9745267|FG002|STARTED|1-Single-blind, Run-in, Single-Treatment||0
8699741|NCT00902538|9745268|FG003|STARTED|1-Single-blind, Run-in, Single-Treatment||0
8699742|NCT00902538|9745269|FG004|STARTED|1-Single-blind, Run-in, Single-Treatment||0
8699743|NCT00902538|9745270|FG005|STARTED|1-Single-blind, Run-in, Single-Treatment||0
8699744|NCT00902538|9745265|FG000|COMPLETED|1-Single-blind, Run-in, Single-Treatment||2086
8699745|NCT00902538|9745266|FG001|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
8699746|NCT00902538|9745267|FG002|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
8699747|NCT00902538|9745268|FG003|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
8699748|NCT00902538|9745269|FG004|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
8699749|NCT00902538|9745270|FG005|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
8699750|NCT00902538|9745265|FG000|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||118
8699751|NCT00902538|9745266|FG001|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
8699752|NCT00902538|9745267|FG002|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
8699753|NCT00902538|9745268|FG003|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
8699754|NCT00902538|9745269|FG004|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
8699755|NCT00902538|9745270|FG005|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
8699756|NCT00902538|9745265|FG000|STARTED|2-Randomized Double-blind 3 Treatments|Only 808 began Period 2 because the others finishing Period 1 did not meet the entry criteria.|269
8699757|NCT00902538|9745266|FG001|STARTED|2-Randomized Double-blind 3 Treatments||269
8699758|NCT00902538|9745267|FG002|STARTED|2-Randomized Double-blind 3 Treatments||270
8699759|NCT00902538|9745268|FG003|STARTED|2-Randomized Double-blind 3 Treatments||0
8699760|NCT00902538|9745269|FG004|STARTED|2-Randomized Double-blind 3 Treatments||0
8812259|NCT01519089|9865210|FG001|STARTED|Overall Study||48
8812260|NCT01519089|9865209|FG000|Received Treatment|Overall Study||47
8812261|NCT01519089|9865210|FG001|Received Treatment|Overall Study||47
8812262|NCT01519089|9865209|FG000|COMPLETED|Overall Study||40
8812263|NCT01519089|9865210|FG001|COMPLETED|Overall Study||33
8812264|NCT01519089|9865209|FG000|NOT COMPLETED|Overall Study||7
8812265|NCT01519089|9865210|FG001|NOT COMPLETED|Overall Study||15
8812266|NCT01519167|9865220|FG000|STARTED|Overall Study||1
8812267|NCT01519167|9865221|FG001|STARTED|Overall Study||89
8812268|NCT01519167|9865220|FG000|COMPLETED|Overall Study||1
8812269|NCT01519167|9865221|FG001|COMPLETED|Overall Study||81
8812270|NCT01519167|9865220|FG000|NOT COMPLETED|Overall Study||0
8812271|NCT01519167|9865221|FG001|NOT COMPLETED|Overall Study||8
8812272|NCT01519206|9865227|FG000|STARTED|Overall Study||32
8812273|NCT01519206|9865227|FG000|COMPLETED|Overall Study||27
8812274|NCT01519206|9865227|FG000|NOT COMPLETED|Overall Study||5
8812275|NCT01519245|9865240|FG000|STARTED|Overall Study||24
8812276|NCT01519245|9865241|FG001|STARTED|Overall Study||20
8812277|NCT01519245|9865240|FG000|Received Pre-pump IV TXA|Overall Study|Two patients included in in the final analysis did not receive pre-pump IV TXA.|21
8812278|NCT01519245|9865241|FG001|Received Pre-pump IV TXA|Overall Study|All patients meeting inclusion criteria received appropriate dosing, as per protocol.|18
8812279|NCT01519245|9865240|FG000|Received Post-pump IV TXA|Overall Study|A break in protocol, dosing was given in the operating room at the surgeon's preference.|6
8812280|NCT01519245|9865241|FG001|Received Post-pump IV TXA|Overall Study|A break in protocol, dosing was given in the operating room at the surgeon's preference.|2
8812281|NCT01519245|9865240|FG000|COMPLETED|Overall Study||23
8812282|NCT01519245|9865241|FG001|COMPLETED|Overall Study||18
8812283|NCT01519245|9865240|FG000|NOT COMPLETED|Overall Study||1
8812284|NCT01519245|9865241|FG001|NOT COMPLETED|Overall Study||2
8927947|NCT02276807|9989056|FG000|COMPLETED|Overall Study||50
8927948|NCT02276807|9989057|FG001|COMPLETED|Overall Study||55
8927949|NCT02276807|9989056|FG000|NOT COMPLETED|Overall Study||18
8927950|NCT02276807|9989057|FG001|NOT COMPLETED|Overall Study||17
8927951|NCT02276872|9989066|FG000|STARTED|Overall Study||10
8927952|NCT02276872|9989067|FG001|STARTED|Overall Study||10
8927953|NCT02276872|9989068|FG002|STARTED|Overall Study||12
8927954|NCT02276872|9989066|FG000|COMPLETED|Overall Study||9
8927955|NCT02276872|9989067|FG001|COMPLETED|Overall Study||10
8927956|NCT02276872|9989068|FG002|COMPLETED|Overall Study||12
9042484|NCT03383588|10103124|FG000|NOT COMPLETED|Overall Study||0
9042485|NCT03383588|10103125|FG001|NOT COMPLETED|Overall Study||0
9042486|NCT03383588|10103126|FG002|NOT COMPLETED|Overall Study||0
9042487|NCT03383614|10103138|FG000|STARTED|Overall Study||6
9042488|NCT03383614|10103139|FG001|STARTED|Overall Study||6
8699761|NCT00902538|9745270|FG005|STARTED|2-Randomized Double-blind 3 Treatments||0
8699762|NCT00902538|9745265|FG000|COMPLETED|2-Randomized Double-blind 3 Treatments||260
8699763|NCT00902538|9745266|FG001|COMPLETED|2-Randomized Double-blind 3 Treatments||263
8699764|NCT00902538|9745267|FG002|COMPLETED|2-Randomized Double-blind 3 Treatments||262
8699765|NCT00902538|9745268|FG003|COMPLETED|2-Randomized Double-blind 3 Treatments||0
8699766|NCT00902538|9745269|FG004|COMPLETED|2-Randomized Double-blind 3 Treatments||0
8699767|NCT00902538|9745270|FG005|COMPLETED|2-Randomized Double-blind 3 Treatments||0
8699768|NCT00902538|9745265|FG000|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||9
8699769|NCT00902538|9745266|FG001|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||6
8699770|NCT00902538|9745267|FG002|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||8
8699771|NCT00902538|9745268|FG003|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||0
8699772|NCT00902538|9745269|FG004|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||0
8699773|NCT00902538|9745270|FG005|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||0
8699774|NCT00902538|9745265|FG000|STARTED|3-Single-blind, Single Treatment||0
8699775|NCT00902538|9745266|FG001|STARTED|3-Single-blind, Single Treatment|Number starting is < total completing previous arm since 3 subjects did not receive at least 1 dose.|782
8699776|NCT00902538|9745267|FG002|STARTED|3-Single-blind, Single Treatment||0
8699777|NCT00902538|9745268|FG003|STARTED|3-Single-blind, Single Treatment||0
8699778|NCT00902538|9745269|FG004|STARTED|3-Single-blind, Single Treatment||0
8699779|NCT00902538|9745270|FG005|STARTED|3-Single-blind, Single Treatment||0
8699780|NCT00902538|9745265|FG000|COMPLETED|3-Single-blind, Single Treatment||0
8699781|NCT00902538|9745266|FG001|COMPLETED|3-Single-blind, Single Treatment||767
8699782|NCT00902538|9745267|FG002|COMPLETED|3-Single-blind, Single Treatment||0
8699783|NCT00902538|9745268|FG003|COMPLETED|3-Single-blind, Single Treatment||0
8699784|NCT00902538|9745269|FG004|COMPLETED|3-Single-blind, Single Treatment||0
8699785|NCT00902538|9745270|FG005|COMPLETED|3-Single-blind, Single Treatment||0
8699786|NCT00902538|9745265|FG000|NOT COMPLETED|3-Single-blind, Single Treatment||0
8699787|NCT00902538|9745266|FG001|NOT COMPLETED|3-Single-blind, Single Treatment||15
8699788|NCT00902538|9745267|FG002|NOT COMPLETED|3-Single-blind, Single Treatment||0
8699789|NCT00902538|9745268|FG003|NOT COMPLETED|3-Single-blind, Single Treatment||0
8699790|NCT00902538|9745269|FG004|NOT COMPLETED|3-Single-blind, Single Treatment||0
8699791|NCT00902538|9745270|FG005|NOT COMPLETED|3-Single-blind, Single Treatment||0
8699792|NCT00902538|9745265|FG000|STARTED|4-Randomized Double-blind 2 Treatments||0
8699793|NCT00902538|9745266|FG001|STARTED|4-Randomized Double-blind 2 Treatments||0
8699794|NCT00902538|9745267|FG002|STARTED|4-Randomized Double-blind 2 Treatments||0
8699795|NCT00902538|9745268|FG003|STARTED|4-Randomized Double-blind 2 Treatments|Period 3 responders were continued on OLM 40-AML 10-HCTZ 12.5|467
8699796|NCT00902538|9745269|FG004|STARTED|4-Randomized Double-blind 2 Treatments|Period 3 non-responders were randomized to OLM 40-AML 10-HCTZ 12.5 or 25 in a 2:1 ratio|97
8699797|NCT00902538|9745270|FG005|STARTED|4-Randomized Double-blind 2 Treatments||197
8699798|NCT00902538|9745265|FG000|COMPLETED|4-Randomized Double-blind 2 Treatments||0
8699799|NCT00902538|9745266|FG001|COMPLETED|4-Randomized Double-blind 2 Treatments||0
8699800|NCT00902538|9745267|FG002|COMPLETED|4-Randomized Double-blind 2 Treatments||0
8699801|NCT00902538|9745268|FG003|COMPLETED|4-Randomized Double-blind 2 Treatments||458
8699802|NCT00902538|9745269|FG004|COMPLETED|4-Randomized Double-blind 2 Treatments||95
8699803|NCT00902538|9745270|FG005|COMPLETED|4-Randomized Double-blind 2 Treatments||196
8699804|NCT00902538|9745265|FG000|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||0
8699805|NCT00902538|9745266|FG001|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||0
8699806|NCT00902538|9745267|FG002|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||0
8699807|NCT00902538|9745268|FG003|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||9
8699808|NCT00902538|9745269|FG004|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||2
8699809|NCT00902538|9745270|FG005|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||1
8699810|NCT00902564|9745282|FG000|STARTED|Overall Study||30
8699811|NCT00902564|9745282|FG000|COMPLETED|Overall Study||28
8699812|NCT00902564|9745282|FG000|NOT COMPLETED|Overall Study||2
8699813|NCT00902577|9745286|FG000|STARTED|Overall Study||50
8699814|NCT00902577|9745286|FG000|FMISO/PET|Overall Study||38
8699815|NCT00902577|9745286|FG000|DCE MRI|Overall Study||31
8699816|NCT00902577|9745286|FG000|DSE MRI|Overall Study||37
8699817|NCT00902577|9745286|FG000|DWI MRI|Overall Study||39
8699818|NCT00902577|9745286|FG000|COMPLETED|Overall Study||42
8699819|NCT00902577|9745286|FG000|NOT COMPLETED|Overall Study||8
8699820|NCT00902746|9745309|FG000|STARTED|Overall Study||149
8927957|NCT02276872|9989066|FG000|NOT COMPLETED|Overall Study||1
8927958|NCT02276872|9989067|FG001|NOT COMPLETED|Overall Study||0
9042489|NCT03383614|10103140|FG002|STARTED|Overall Study||6
9042490|NCT03383614|10103141|FG003|STARTED|Overall Study||6
9042491|NCT03383614|10103138|FG000|COMPLETED|Overall Study||6
8699821|NCT00902746|9745309|FG000|Initiation of Study Drug Administration|Overall Study||148
8699822|NCT00902746|9745309|FG000|Transfer to Step 2|Overall Study||133
8699823|NCT00902746|9745309|FG000|COMPLETED|Overall Study||113
8699824|NCT00902746|9745309|FG000|NOT COMPLETED|Overall Study||36
8927959|NCT02276872|9989068|FG002|NOT COMPLETED|Overall Study||0
8927960|NCT02276963|9989081|FG000|STARTED|Overall Study||6
8927961|NCT02276963|9989081|FG000|COMPLETED|Overall Study||3
8927962|NCT02276963|9989081|FG000|NOT COMPLETED|Overall Study||3
8927963|NCT02277054|9989085|FG000|STARTED|Overall Study||5
8927964|NCT02277054|9989085|FG000|COMPLETED|Overall Study||5
8927965|NCT02277054|9989085|FG000|NOT COMPLETED|Overall Study||0
8927966|NCT02277093|9989090|FG000|STARTED|Overall Study||11
8927967|NCT02277093|9989090|FG000|COMPLETED|Overall Study||11
8927968|NCT02277093|9989090|FG000|NOT COMPLETED|Overall Study||0
8927969|NCT02277249|9989096|FG000|STARTED|Overall Study||30
8927970|NCT02277249|9989097|FG001|STARTED|Overall Study||30
8927971|NCT02277249|9989096|FG000|COMPLETED|Overall Study||30
8927972|NCT02277249|9989097|FG001|COMPLETED|Overall Study||30
8927973|NCT02277249|9989096|FG000|NOT COMPLETED|Overall Study||0
8927974|NCT02277249|9989097|FG001|NOT COMPLETED|Overall Study||0
8927975|NCT02277548|9989105|FG000|STARTED|Overall Study||9
8927976|NCT02277548|9989106|FG001|STARTED|Overall Study||11
8927977|NCT02277548|9989105|FG000|COMPLETED|Overall Study||9
8927978|NCT02277548|9989106|FG001|COMPLETED|Overall Study||9
8927979|NCT02277548|9989105|FG000|NOT COMPLETED|Overall Study||0
8927980|NCT02277548|9989106|FG001|NOT COMPLETED|Overall Study||2
8927981|NCT02277626|9989112|FG000|STARTED|Overall Study||6
8927982|NCT02277626|9989113|FG001|STARTED|Overall Study||9
8927983|NCT02277626|9989112|FG000|COMPLETED|Overall Study||6
8927984|NCT02277626|9989113|FG001|COMPLETED|Overall Study||9
8927985|NCT02277626|9989112|FG000|NOT COMPLETED|Overall Study||0
8927986|NCT02277626|9989113|FG001|NOT COMPLETED|Overall Study||0
8927987|NCT02277639|9989126|FG000|STARTED|Overall Study||0
8927988|NCT02277639|9989127|FG001|STARTED|Overall Study||2
8927989|NCT02277639|9989126|FG000|COMPLETED|Overall Study||0
8927990|NCT02277639|9989127|FG001|COMPLETED|Overall Study||2
8927991|NCT02277639|9989126|FG000|NOT COMPLETED|Overall Study||0
8927992|NCT02277639|9989127|FG001|NOT COMPLETED|Overall Study||0
8927993|NCT02277665|9989135|FG000|STARTED|Overall Study||33
8927994|NCT02277665|9989136|FG001|STARTED|Overall Study||34
8927995|NCT02277665|9989135|FG000|COMPLETED|Overall Study||33
8927996|NCT02277665|9989136|FG001|COMPLETED|Overall Study||34
8927997|NCT02277665|9989135|FG000|NOT COMPLETED|Overall Study||0
8927998|NCT02277665|9989136|FG001|NOT COMPLETED|Overall Study||0
8927999|NCT02277691|9989144|FG000|STARTED|Overall Study||341
8928000|NCT02277691|9989144|FG000|COMPLETED|Overall Study||295
8928001|NCT02277691|9989144|FG000|NOT COMPLETED|Overall Study||46
8928002|NCT02277743|9989151|FG000|STARTED|Overall Study||224
8928003|NCT02277743|9989152|FG001|STARTED|Overall Study||224
8928004|NCT02277743|9989153|FG002|STARTED|Overall Study||223
8928005|NCT02277743|9989151|FG000|Treated|Overall Study||223
8928006|NCT02277743|9989152|FG001|Treated|Overall Study||223
8928007|NCT02277743|9989153|FG002|Treated|Overall Study||223
9042492|NCT03383614|10103139|FG001|COMPLETED|Overall Study||5
9042493|NCT03383614|10103140|FG002|COMPLETED|Overall Study||6
9042494|NCT03383614|10103141|FG003|COMPLETED|Overall Study||6
9042495|NCT03383614|10103138|FG000|NOT COMPLETED|Overall Study||0
9042496|NCT03383614|10103139|FG001|NOT COMPLETED|Overall Study||1
9042497|NCT03383614|10103140|FG002|NOT COMPLETED|Overall Study||0
9042498|NCT03383614|10103141|FG003|NOT COMPLETED|Overall Study||0
9042499|NCT03383627|10103156|FG000|STARTED|Overall Study||80
9042500|NCT03383627|10103156|FG000|COMPLETED|Overall Study||80
9042501|NCT03383627|10103156|FG000|NOT COMPLETED|Overall Study||0
9042502|NCT03383757|10103160|FG000|STARTED|Overall Study||117
9042503|NCT03383757|10103160|FG000|TruSignal AllFit Sensor Subjects|Overall Study||56
9042504|NCT03383757|10103160|FG000|TruSignal Sensitive Sensor Subjects|Overall Study||59
9042505|NCT03383757|10103160|FG000|TruSignal AllFit Sensor Data Pairs|Overall Study||52
9042506|NCT03383757|10103160|FG000|TruSignal Sensitive Sensor Data Pairs|Overall Study||51
9042507|NCT03383757|10103160|FG000|COMPLETED|Overall Study||78
9042508|NCT03383757|10103160|FG000|NOT COMPLETED|Overall Study||39
9042509|NCT03383783|10103164|FG000|STARTED|Overall Study||27
9042510|NCT03383783|10103164|FG000|COMPLETED|Overall Study||25
8699825|NCT00902850|9745315|FG000|STARTED|Overall Study||14
8699826|NCT00902850|9745316|FG001|STARTED|Overall Study||14
8928008|NCT02277743|9989151|FG000|Safety Population|Overall Study|1 participant received at least 1 injection of Dupilumab 300mg(analyzed in Dupilumab 300 mg q2w arm)|222
8928009|NCT02277743|9989152|FG001|Safety Population|Overall Study|6 participants (1 [placebo] + 5 [Dupilumab 300 mg qw arm]) analyzed in Dupilumab 300 mg q2w arm|229
8928010|NCT02277743|9989153|FG002|Safety Population|Overall Study|5 participants received fewer injections of Dupilumab 300 mg (analyzed in Dupilumab 300 mg q2w arm)|218
8928011|NCT02277743|9989151|FG000|COMPLETED|Overall Study||184
8928012|NCT02277743|9989152|FG001|COMPLETED|Overall Study||208
8928013|NCT02277743|9989153|FG002|COMPLETED|Overall Study||197
8928014|NCT02277743|9989151|FG000|NOT COMPLETED|Overall Study||40
8928015|NCT02277743|9989152|FG001|NOT COMPLETED|Overall Study||16
8928016|NCT02277743|9989153|FG002|NOT COMPLETED|Overall Study||26
8928017|NCT02277769|9989164|FG000|STARTED|Overall Study||236
9042511|NCT03383783|10103164|FG000|NOT COMPLETED|Overall Study||2
9042512|NCT03383887|10103180|FG000|STARTED|Overall Study||5
9042513|NCT03383887|10103181|FG001|STARTED|Overall Study||6
9042514|NCT03383887|10103180|FG000|COMPLETED|Overall Study||5
9042515|NCT03383887|10103181|FG001|COMPLETED|Overall Study||5
9042516|NCT03383887|10103180|FG000|NOT COMPLETED|Overall Study||0
9042517|NCT03383887|10103181|FG001|NOT COMPLETED|Overall Study||1
8699827|NCT00902850|9745315|FG000|COMPLETED|Overall Study||12
8699828|NCT00902850|9745316|FG001|COMPLETED|Overall Study||12
8699829|NCT00902850|9745315|FG000|NOT COMPLETED|Overall Study||2
8699830|NCT00902850|9745316|FG001|NOT COMPLETED|Overall Study||2
8699831|NCT00903032|9745324|FG000|STARTED|Overall Study||129
9042518|NCT03384173|10103189|FG000|STARTED|Overall Study||35
9042519|NCT03384173|10103189|FG000|COMPLETED|Overall Study||35
9042520|NCT03384173|10103189|FG000|NOT COMPLETED|Overall Study||0
9042521|NCT03384316|10103201|FG000|STARTED|Overall Study||6
9042522|NCT03384316|10103202|FG001|STARTED|Overall Study||5
9042523|NCT03384316|10103201|FG000|COMPLETED|Overall Study||6
9042524|NCT03384316|10103202|FG001|COMPLETED|Overall Study||4
9042525|NCT03384316|10103201|FG000|NOT COMPLETED|Overall Study||0
9042526|NCT03384316|10103202|FG001|NOT COMPLETED|Overall Study||1
9042527|NCT03384329|10103212|FG000|STARTED|Overall Study||11
9042528|NCT03384329|10103213|FG001|STARTED|Overall Study||11
9042529|NCT03384329|10103212|FG000|COMPLETED|Overall Study||11
9042530|NCT03384329|10103213|FG001|COMPLETED|Overall Study||11
9042531|NCT03384329|10103212|FG000|NOT COMPLETED|Overall Study||0
9042532|NCT03384329|10103213|FG001|NOT COMPLETED|Overall Study||0
9042533|NCT03384693|10103219|FG000|STARTED|Overall Study||25
9042534|NCT03384693|10103219|FG000|COMPLETED|Overall Study||22
9042535|NCT03384693|10103219|FG000|NOT COMPLETED|Overall Study||3
9042536|NCT03384745|10103229|FG000|STARTED|Placebo Controlled Induction (W0 - W12)||52
9042537|NCT03384745|10103230|FG001|STARTED|Placebo Controlled Induction (W0 - W12)||52
9042538|NCT03384745|10103231|FG002|STARTED|Placebo Controlled Induction (W0 - W12)||53
9042539|NCT03384745|10103232|FG003|STARTED|Placebo Controlled Induction (W0 - W12)||51
8699832|NCT00903032|9745325|FG001|STARTED|Overall Study||124
8699833|NCT00903032|9745324|FG000|COMPLETED|Overall Study||122
8699834|NCT00903032|9745325|FG001|COMPLETED|Overall Study||119
8699835|NCT00903032|9745324|FG000|NOT COMPLETED|Overall Study||7
8699836|NCT00903032|9745325|FG001|NOT COMPLETED|Overall Study||5
8699837|NCT00903162|9745331|FG000|STARTED|Overall Study||16
8699838|NCT00903162|9745331|FG000|COMPLETED|Overall Study||12
8699839|NCT00903162|9745331|FG000|NOT COMPLETED|Overall Study||4
8699840|NCT00903175|9745337|FG000|STARTED|Period 1 - First Line||238
8699841|NCT00903175|9745338|FG001|STARTED|Period 1 - First Line||231
8699842|NCT00903175|9745337|FG000|COMPLETED|Period 1 - First Line|Completed = Disease progression (completed 1L)|161
8699843|NCT00903175|9745338|FG001|COMPLETED|Period 1 - First Line|Completed = Disease progression (completed 1L)|142
8699844|NCT00903175|9745337|FG000|NOT COMPLETED|Period 1 - First Line||77
8699845|NCT00903175|9745338|FG001|NOT COMPLETED|Period 1 - First Line||89
8699846|NCT00903175|9745337|FG000|STARTED|Period 2 - Second Line|139 from everolimus 1L planned to enter 2L period and cross over to sunitinib but only 128 did.|128
8699847|NCT00903175|9745338|FG001|STARTED|Period 2 - Second Line|130 from Sunitinib 1L planned to enter 2L period and cross over to everolimus but only 116 did.|116
8699848|NCT00903175|9745337|FG000|COMPLETED|Period 2 - Second Line|Completed = Disease progression - (completed 2L)|79
8699849|NCT00903175|9745338|FG001|COMPLETED|Period 2 - Second Line|Completed = Disease progression - (completed 2L)|80
8699850|NCT00903175|9745337|FG000|NOT COMPLETED|Period 2 - Second Line||49
8699851|NCT00903175|9745338|FG001|NOT COMPLETED|Period 2 - Second Line||36
8699852|NCT00903201|9745347|FG000|STARTED|Overall Study||61
8699853|NCT00903201|9745348|FG001|STARTED|Overall Study||44
8699854|NCT00903201|9745349|FG002|STARTED|Overall Study||41
8699855|NCT00903201|9745347|FG000|COMPLETED|Overall Study||56
8699856|NCT00903201|9745348|FG001|COMPLETED|Overall Study||38
8699857|NCT00903201|9745349|FG002|COMPLETED|Overall Study||39
8699858|NCT00903201|9745347|FG000|NOT COMPLETED|Overall Study||5
8699859|NCT00903201|9745348|FG001|NOT COMPLETED|Overall Study||6
8699860|NCT00903201|9745349|FG002|NOT COMPLETED|Overall Study||2
8699861|NCT00903331|9745361|FG000|STARTED|Overall Study||59
8699862|NCT00903331|9745362|FG001|STARTED|Overall Study||119
8699863|NCT00903331|9745361|FG000|COMPLETED|Overall Study||54
8699864|NCT00903331|9745362|FG001|COMPLETED|Overall Study||101
8699865|NCT00903331|9745361|FG000|NOT COMPLETED|Overall Study||5
8699866|NCT00903331|9745362|FG001|NOT COMPLETED|Overall Study||18
8699867|NCT00903344|9745370|FG000|STARTED|Overall Study||12
8699868|NCT00903344|9745371|FG001|STARTED|Overall Study||10
8699869|NCT00903344|9745370|FG000|3 Month Visit|Overall Study||10
8699870|NCT00903344|9745371|FG001|3 Month Visit|Overall Study||10
8699871|NCT00903344|9745370|FG000|6 Month Visit|Overall Study||9
9042540|NCT03384745|10103233|FG004|STARTED|Placebo Controlled Induction (W0 - W12)||52
9042541|NCT03384745|10103234|FG005|STARTED|Placebo Controlled Induction (W0 - W12)||53
9042542|NCT03384745|10103229|FG000|COMPLETED|Placebo Controlled Induction (W0 - W12)||52
9042543|NCT03384745|10103230|FG001|COMPLETED|Placebo Controlled Induction (W0 - W12)||51
9042544|NCT03384745|10103231|FG002|COMPLETED|Placebo Controlled Induction (W0 - W12)||50
9042545|NCT03384745|10103232|FG003|COMPLETED|Placebo Controlled Induction (W0 - W12)||49
9042546|NCT03384745|10103233|FG004|COMPLETED|Placebo Controlled Induction (W0 - W12)||49
9042547|NCT03384745|10103234|FG005|COMPLETED|Placebo Controlled Induction (W0 - W12)||51
9042548|NCT03384745|10103229|FG000|NOT COMPLETED|Placebo Controlled Induction (W0 - W12)||0
9042549|NCT03384745|10103230|FG001|NOT COMPLETED|Placebo Controlled Induction (W0 - W12)||1
9042550|NCT03384745|10103231|FG002|NOT COMPLETED|Placebo Controlled Induction (W0 - W12)||3
8699872|NCT00903344|9745371|FG001|6 Month Visit|Overall Study||10
9042551|NCT03384745|10103232|FG003|NOT COMPLETED|Placebo Controlled Induction (W0 - W12)||2
9042552|NCT03384745|10103233|FG004|NOT COMPLETED|Placebo Controlled Induction (W0 - W12)||3
9042553|NCT03384745|10103234|FG005|NOT COMPLETED|Placebo Controlled Induction (W0 - W12)||2
9042554|NCT03384745|10103229|FG000|STARTED|Maintenance/Escalation (W12-W24)||52
9042555|NCT03384745|10103230|FG001|STARTED|Maintenance/Escalation (W12-W24)||51
9042556|NCT03384745|10103231|FG002|STARTED|Maintenance/Escalation (W12-W24)||50
9042557|NCT03384745|10103232|FG003|STARTED|Maintenance/Escalation (W12-W24)||49
9042558|NCT03384745|10103233|FG004|STARTED|Maintenance/Escalation (W12-W24)||49
9042559|NCT03384745|10103234|FG005|STARTED|Maintenance/Escalation (W12-W24)||51
9042560|NCT03384745|10103229|FG000|COMPLETED|Maintenance/Escalation (W12-W24)||52
9042561|NCT03384745|10103230|FG001|COMPLETED|Maintenance/Escalation (W12-W24)||51
9042562|NCT03384745|10103231|FG002|COMPLETED|Maintenance/Escalation (W12-W24)||49
9042563|NCT03384745|10103232|FG003|COMPLETED|Maintenance/Escalation (W12-W24)||47
9042564|NCT03384745|10103233|FG004|COMPLETED|Maintenance/Escalation (W12-W24)||47
9042565|NCT03384745|10103234|FG005|COMPLETED|Maintenance/Escalation (W12-W24)||51
9042566|NCT03384745|10103229|FG000|NOT COMPLETED|Maintenance/Escalation (W12-W24)||0
9042567|NCT03384745|10103230|FG001|NOT COMPLETED|Maintenance/Escalation (W12-W24)||0
9042568|NCT03384745|10103231|FG002|NOT COMPLETED|Maintenance/Escalation (W12-W24)||1
9042569|NCT03384745|10103232|FG003|NOT COMPLETED|Maintenance/Escalation (W12-W24)||2
9042570|NCT03384745|10103233|FG004|NOT COMPLETED|Maintenance/Escalation (W12-W24)||2
9042571|NCT03384745|10103234|FG005|NOT COMPLETED|Maintenance/Escalation (W12-W24)||0
9042572|NCT03384745|10103229|FG000|STARTED|Response Assess/Dose Hold (W24-W48)||52
9042573|NCT03384745|10103230|FG001|STARTED|Response Assess/Dose Hold (W24-W48)||51
9042574|NCT03384745|10103231|FG002|STARTED|Response Assess/Dose Hold (W24-W48)||49
9042575|NCT03384745|10103232|FG003|STARTED|Response Assess/Dose Hold (W24-W48)||47
9042576|NCT03384745|10103233|FG004|STARTED|Response Assess/Dose Hold (W24-W48)||47
9042577|NCT03384745|10103234|FG005|STARTED|Response Assess/Dose Hold (W24-W48)||51
9042578|NCT03384745|10103229|FG000|COMPLETED|Response Assess/Dose Hold (W24-W48)||51
9042579|NCT03384745|10103230|FG001|COMPLETED|Response Assess/Dose Hold (W24-W48)||48
9042580|NCT03384745|10103231|FG002|COMPLETED|Response Assess/Dose Hold (W24-W48)||45
9042581|NCT03384745|10103232|FG003|COMPLETED|Response Assess/Dose Hold (W24-W48)||43
9042582|NCT03384745|10103233|FG004|COMPLETED|Response Assess/Dose Hold (W24-W48)||46
9042583|NCT03384745|10103234|FG005|COMPLETED|Response Assess/Dose Hold (W24-W48)||49
9042584|NCT03384745|10103229|FG000|NOT COMPLETED|Response Assess/Dose Hold (W24-W48)||1
9042585|NCT03384745|10103230|FG001|NOT COMPLETED|Response Assess/Dose Hold (W24-W48)||3
9042586|NCT03384745|10103231|FG002|NOT COMPLETED|Response Assess/Dose Hold (W24-W48)||4
9042587|NCT03384745|10103232|FG003|NOT COMPLETED|Response Assess/Dose Hold (W24-W48)||4
9042588|NCT03384745|10103233|FG004|NOT COMPLETED|Response Assess/Dose Hold (W24-W48)||1
9042589|NCT03384745|10103234|FG005|NOT COMPLETED|Response Assess/Dose Hold (W24-W48)||2
9042590|NCT03384940|10103257|FG000|STARTED|Overall Study||53
9042591|NCT03384940|10103258|FG001|STARTED|Overall Study||15
9042592|NCT03384940|10103259|FG002|STARTED|Overall Study||18
9042593|NCT03384940|10103257|FG000|COMPLETED|Overall Study||0
9042594|NCT03384940|10103258|FG001|COMPLETED|Overall Study||0
9042595|NCT03384940|10103259|FG002|COMPLETED|Overall Study||0
9042596|NCT03384940|10103257|FG000|NOT COMPLETED|Overall Study||53
9042597|NCT03384940|10103258|FG001|NOT COMPLETED|Overall Study||15
9042598|NCT03384940|10103259|FG002|NOT COMPLETED|Overall Study||18
9042599|NCT03384953|10103269|FG000|STARTED|Overall Study||91
9042600|NCT03384953|10103270|FG001|STARTED|Overall Study||12
9042601|NCT03384953|10103269|FG000|Completed Treatment|Overall Study||68
9042602|NCT03384953|10103270|FG001|Completed Treatment|Overall Study||6
9042603|NCT03384953|10103269|FG000|COMPLETED|Overall Study||51
9042604|NCT03384953|10103270|FG001|COMPLETED|Overall Study||4
9042605|NCT03384953|10103269|FG000|NOT COMPLETED|Overall Study||40
9042606|NCT03384953|10103270|FG001|NOT COMPLETED|Overall Study||8
9042607|NCT03384966|10103279|FG000|STARTED|Randomized at End of Screening Period||115
9042608|NCT03384966|10103280|FG001|STARTED|Randomized at End of Screening Period||115
9042609|NCT03384966|10103281|FG002|STARTED|Randomized at End of Screening Period||116
9042610|NCT03384966|10103279|FG000|COMPLETED|Randomized at End of Screening Period||114
9042611|NCT03384966|10103280|FG001|COMPLETED|Randomized at End of Screening Period||115
9042612|NCT03384966|10103281|FG002|COMPLETED|Randomized at End of Screening Period||116
9042613|NCT03384966|10103279|FG000|NOT COMPLETED|Randomized at End of Screening Period||1
9042614|NCT03384966|10103280|FG001|NOT COMPLETED|Randomized at End of Screening Period||0
9042615|NCT03384966|10103281|FG002|NOT COMPLETED|Randomized at End of Screening Period||0
9042616|NCT03384966|10103279|FG000|STARTED|Treatment Period||114
9042617|NCT03384966|10103280|FG001|STARTED|Treatment Period||115
9042618|NCT03384966|10103281|FG002|STARTED|Treatment Period||116
9042619|NCT03384966|10103279|FG000|Thigh Administration|Treatment Period||57
9042620|NCT03384966|10103280|FG001|Thigh Administration|Treatment Period||57
9042621|NCT03384966|10103281|FG002|Thigh Administration|Treatment Period||58
9042622|NCT03384966|10103279|FG000|Abdomen Administration|Treatment Period||57
9042623|NCT03384966|10103280|FG001|Abdomen Administration|Treatment Period||58
9042624|NCT03384966|10103281|FG002|Abdomen Administration|Treatment Period||58
9042625|NCT03384966|10103279|FG000|Per-protocol Analysis Set|Treatment Period||96
9042626|NCT03384966|10103280|FG001|Per-protocol Analysis Set|Treatment Period||90
9042627|NCT03384966|10103281|FG002|Per-protocol Analysis Set|Treatment Period||93
9042628|NCT03384966|10103279|FG000|Safety Analysis Set|Treatment Period||114
9042629|NCT03384966|10103280|FG001|Safety Analysis Set|Treatment Period||115
9042630|NCT03384966|10103281|FG002|Safety Analysis Set|Treatment Period||116
9042631|NCT03384966|10103279|FG000|Pharmacokinetic Analysis Set|Treatment Period||111
9042632|NCT03384966|10103280|FG001|Pharmacokinetic Analysis Set|Treatment Period||115
9042633|NCT03384966|10103281|FG002|Pharmacokinetic Analysis Set|Treatment Period||0
9042634|NCT03384966|10103279|FG000|COMPLETED|Treatment Period||114
9042635|NCT03384966|10103280|FG001|COMPLETED|Treatment Period||115
9042636|NCT03384966|10103281|FG002|COMPLETED|Treatment Period||116
9042637|NCT03384966|10103279|FG000|NOT COMPLETED|Treatment Period||0
9042638|NCT03384966|10103280|FG001|NOT COMPLETED|Treatment Period||0
9042639|NCT03384966|10103281|FG002|NOT COMPLETED|Treatment Period||0
9042640|NCT03384966|10103279|FG000|STARTED|Follow-up Period||114
9042641|NCT03384966|10103280|FG001|STARTED|Follow-up Period||115
9042642|NCT03384966|10103281|FG002|STARTED|Follow-up Period||116
9042643|NCT03384966|10103279|FG000|COMPLETED|Follow-up Period||113
9042644|NCT03384966|10103280|FG001|COMPLETED|Follow-up Period||115
9042645|NCT03384966|10103281|FG002|COMPLETED|Follow-up Period||116
8699873|NCT00903344|9745370|FG000|COMPLETED|Overall Study||7
8699874|NCT00903344|9745371|FG001|COMPLETED|Overall Study||7
8699875|NCT00903344|9745370|FG000|NOT COMPLETED|Overall Study||5
8699876|NCT00903344|9745371|FG001|NOT COMPLETED|Overall Study||3
8699877|NCT00903357|9745377|FG000|STARTED|First Intervention||27
8699878|NCT00903357|9745378|FG001|STARTED|First Intervention||27
8699879|NCT00903357|9745377|FG000|COMPLETED|First Intervention||22
8699880|NCT00903357|9745378|FG001|COMPLETED|First Intervention||23
8699881|NCT00903357|9745377|FG000|NOT COMPLETED|First Intervention||5
8699882|NCT00903357|9745378|FG001|NOT COMPLETED|First Intervention||4
8699883|NCT00903357|9745377|FG000|STARTED|Wash Out Period of 2 Weeks||22
8699884|NCT00903357|9745378|FG001|STARTED|Wash Out Period of 2 Weeks||23
8699885|NCT00903357|9745377|FG000|COMPLETED|Wash Out Period of 2 Weeks||22
8699886|NCT00903357|9745378|FG001|COMPLETED|Wash Out Period of 2 Weeks||22
8699887|NCT00903357|9745377|FG000|NOT COMPLETED|Wash Out Period of 2 Weeks||0
8699888|NCT00903357|9745378|FG001|NOT COMPLETED|Wash Out Period of 2 Weeks||1
8699889|NCT00903357|9745377|FG000|STARTED|Second Intervention||22
8699890|NCT00903357|9745378|FG001|STARTED|Second Intervention||22
8699891|NCT00903357|9745377|FG000|COMPLETED|Second Intervention||21
8699892|NCT00903357|9745378|FG001|COMPLETED|Second Intervention||22
8699893|NCT00903357|9745377|FG000|NOT COMPLETED|Second Intervention||1
8699894|NCT00903357|9745378|FG001|NOT COMPLETED|Second Intervention||0
8699895|NCT00903370|9745390|FG000|STARTED|Overall Study||127
8699896|NCT00903370|9745391|FG001|STARTED|Overall Study||133
8699897|NCT00903370|9745390|FG000|COMPLETED|Overall Study||99
8699898|NCT00903370|9745391|FG001|COMPLETED|Overall Study||109
8699899|NCT00903370|9745390|FG000|NOT COMPLETED|Overall Study||28
8699900|NCT00903370|9745391|FG001|NOT COMPLETED|Overall Study||24
8724383|NCT01026324|9771593|FG000|STARTED|Treatment Allocation||5
8724384|NCT01026324|9771594|FG001|STARTED|Treatment Allocation||3
8724385|NCT01026324|9771595|FG002|STARTED|Treatment Allocation||4
8724386|NCT01026324|9771593|FG000|Discontinued Intervention (Toxicity)|Treatment Allocation||1
8724387|NCT01026324|9771594|FG001|Discontinued Intervention (Toxicity)|Treatment Allocation||0
8724388|NCT01026324|9771595|FG002|Discontinued Intervention (Toxicity)|Treatment Allocation||0
9042646|NCT03384966|10103279|FG000|NOT COMPLETED|Follow-up Period||1
9042647|NCT03384966|10103280|FG001|NOT COMPLETED|Follow-up Period||0
9042648|NCT03384966|10103281|FG002|NOT COMPLETED|Follow-up Period||0
9042649|NCT03386032|10103301|FG000|STARTED|Overall Study||36
9042650|NCT03386032|10103302|FG001|STARTED|Overall Study||18
9042651|NCT03386032|10103303|FG002|STARTED|Overall Study||11
9042652|NCT03386032|10103301|FG000|COMPLETED|Overall Study||18
9042653|NCT03386032|10103302|FG001|COMPLETED|Overall Study||11
9042654|NCT03386032|10103303|FG002|COMPLETED|Overall Study||11
9042655|NCT03386032|10103301|FG000|NOT COMPLETED|Overall Study||18
9042656|NCT03386032|10103302|FG001|NOT COMPLETED|Overall Study||7
9042657|NCT03386032|10103303|FG002|NOT COMPLETED|Overall Study||0
9042658|NCT03386110|10103313|FG000|STARTED|Overall Study||56
9042659|NCT03386110|10103314|FG001|STARTED|Overall Study||44
9042660|NCT03386110|10103313|FG000|COMPLETED|Overall Study||41
9042661|NCT03386110|10103314|FG001|COMPLETED|Overall Study||38
8699901|NCT00903383|9745401|FG000|STARTED|Overall Study||55
8699902|NCT00903383|9745402|FG001|STARTED|Overall Study||54
8699903|NCT00903383|9745403|FG002|STARTED|Overall Study||50
9042662|NCT03386110|10103313|FG000|NOT COMPLETED|Overall Study||15
9042663|NCT03386110|10103314|FG001|NOT COMPLETED|Overall Study||6
9042664|NCT03386344|10103323|FG000|STARTED|Overall Study||126
9042665|NCT03386344|10103324|FG001|STARTED|Overall Study||125
9042666|NCT03386344|10103325|FG002|STARTED|Overall Study||125
9042667|NCT03386344|10103323|FG000|COMPLETED|Overall Study||9
9042668|NCT03386344|10103324|FG001|COMPLETED|Overall Study||9
9042669|NCT03386344|10103325|FG002|COMPLETED|Overall Study||9
9042670|NCT03386344|10103323|FG000|NOT COMPLETED|Overall Study||117
9042671|NCT03386344|10103324|FG001|NOT COMPLETED|Overall Study||116
9042672|NCT03386344|10103325|FG002|NOT COMPLETED|Overall Study||116
9042673|NCT03386435|10103335|FG000|STARTED|Overall Study||80
9042674|NCT03386435|10103336|FG001|STARTED|Overall Study||80
9042675|NCT03386435|10103335|FG000|COMPLETED|Overall Study||75
9042676|NCT03386435|10103336|FG001|COMPLETED|Overall Study||73
9042677|NCT03386435|10103335|FG000|NOT COMPLETED|Overall Study||5
9042678|NCT03386435|10103336|FG001|NOT COMPLETED|Overall Study||7
9042679|NCT03386448|10103344|FG000|STARTED|Overall Study||6
9042680|NCT03386448|10103345|FG001|STARTED|Overall Study||8
9042681|NCT03386448|10103344|FG000|COMPLETED|Overall Study||6
9042682|NCT03386448|10103345|FG001|COMPLETED|Overall Study||6
9042683|NCT03386448|10103344|FG000|NOT COMPLETED|Overall Study||0
9042684|NCT03386448|10103345|FG001|NOT COMPLETED|Overall Study||2
9042685|NCT03386474|10103353|FG000|STARTED|Overall Study||107
9042686|NCT03386474|10103354|FG001|STARTED|Overall Study||43
9042687|NCT03386474|10103353|FG000|COMPLETED|Overall Study||106
9042688|NCT03386474|10103354|FG001|COMPLETED|Overall Study||42
9042689|NCT03386474|10103353|FG000|NOT COMPLETED|Overall Study||1
9042690|NCT03386474|10103354|FG001|NOT COMPLETED|Overall Study||1
9042691|NCT03386994|10103368|FG000|STARTED|Overall Study||204
9042692|NCT03386994|10103368|FG000|COMPLETED|Overall Study||166
9042693|NCT03386994|10103368|FG000|NOT COMPLETED|Overall Study||38
9042694|NCT03387020|10103386|FG000|STARTED|Overall Study||13
8699904|NCT00903383|9745404|FG003|STARTED|Overall Study||49
8699905|NCT00903383|9745401|FG000|COMPLETED|Overall Study||48
8699906|NCT00903383|9745402|FG001|COMPLETED|Overall Study||48
8699907|NCT00903383|9745403|FG002|COMPLETED|Overall Study||47
8699908|NCT00903383|9745404|FG003|COMPLETED|Overall Study||44
8699909|NCT00903383|9745401|FG000|NOT COMPLETED|Overall Study||7
8699910|NCT00903383|9745402|FG001|NOT COMPLETED|Overall Study||6
8699911|NCT00903383|9745403|FG002|NOT COMPLETED|Overall Study||3
8699912|NCT00903383|9745404|FG003|NOT COMPLETED|Overall Study||5
9042695|NCT03387020|10103387|FG001|STARTED|Overall Study||3
9042696|NCT03387020|10103388|FG002|STARTED|Overall Study||5
9042697|NCT03387020|10103386|FG000|Received Treatment|Overall Study||12
9042698|NCT03387020|10103387|FG001|Received Treatment|Overall Study||3
9042699|NCT03387020|10103388|FG002|Received Treatment|Overall Study||5
9042700|NCT03387020|10103386|FG000|COMPLETED|Overall Study||11
9042701|NCT03387020|10103387|FG001|COMPLETED|Overall Study||1
9042702|NCT03387020|10103388|FG002|COMPLETED|Overall Study||5
9042703|NCT03387020|10103386|FG000|NOT COMPLETED|Overall Study||2
8699913|NCT00903409|9745416|FG000|STARTED|Overall Study||88
8699914|NCT00903409|9745417|FG001|STARTED|Overall Study||100
8699915|NCT00903409|9745416|FG000|COMPLETED|Overall Study||62
8699916|NCT00903409|9745417|FG001|COMPLETED|Overall Study||73
8699917|NCT00903409|9745416|FG000|NOT COMPLETED|Overall Study||26
8699918|NCT00903409|9745417|FG001|NOT COMPLETED|Overall Study||27
8699919|NCT00903448|9745425|FG000|STARTED|Period 1: 5 Days Then 10 Day Washout||20
8699920|NCT00903448|9745426|FG001|STARTED|Period 1: 5 Days Then 10 Day Washout||20
8699921|NCT00903448|9745425|FG000|COMPLETED|Period 1: 5 Days Then 10 Day Washout||20
9042704|NCT03387020|10103387|FG001|NOT COMPLETED|Overall Study||2
9042705|NCT03387020|10103388|FG002|NOT COMPLETED|Overall Study||0
9042706|NCT03387033|10103406|FG000|STARTED|Overall Study||20
9042707|NCT03387033|10103406|FG000|COMPLETED|Overall Study||20
9042708|NCT03387033|10103406|FG000|NOT COMPLETED|Overall Study||0
9042709|NCT03387046|10103412|FG000|STARTED|Overall Study||5
8699922|NCT00903448|9745426|FG001|COMPLETED|Period 1: 5 Days Then 10 Day Washout||20
8699923|NCT00903448|9745425|FG000|NOT COMPLETED|Period 1: 5 Days Then 10 Day Washout||0
8699924|NCT00903448|9745426|FG001|NOT COMPLETED|Period 1: 5 Days Then 10 Day Washout||0
9042710|NCT03387046|10103413|FG001|STARTED|Overall Study||2
9042711|NCT03387046|10103412|FG000|COMPLETED|Overall Study||4
9042712|NCT03387046|10103413|FG001|COMPLETED|Overall Study||1
9042713|NCT03387046|10103412|FG000|NOT COMPLETED|Overall Study||1
9042714|NCT03387046|10103413|FG001|NOT COMPLETED|Overall Study||1
9042715|NCT03387267|10103419|FG000|STARTED|Overall Study||452
9042716|NCT03387267|10103419|FG000|COMPLETED|Overall Study||438
9042717|NCT03387267|10103419|FG000|NOT COMPLETED|Overall Study||14
9042718|NCT03387319|10103426|FG000|STARTED|Overall Study||25
9042719|NCT03387319|10103427|FG001|STARTED|Overall Study||25
9042720|NCT03387319|10103426|FG000|COMPLETED|Overall Study||25
9042721|NCT03387319|10103427|FG001|COMPLETED|Overall Study||25
9042722|NCT03387319|10103426|FG000|NOT COMPLETED|Overall Study||0
9042723|NCT03387319|10103427|FG001|NOT COMPLETED|Overall Study||0
9042724|NCT03387462|10103433|FG000|STARTED|Overall Study||20
9042725|NCT03387462|10103433|FG000|4 Weeks|Overall Study||20
9042726|NCT03387462|10103433|FG000|8 Weeks|Overall Study||19
9042727|NCT03387462|10103433|FG000|COMPLETED|Overall Study||19
9042728|NCT03387462|10103433|FG000|NOT COMPLETED|Overall Study||1
9042729|NCT03387683|10103439|FG000|STARTED|Overall Study||27
9042730|NCT03387683|10103440|FG001|STARTED|Overall Study||26
9042731|NCT03387683|10103439|FG000|COMPLETED|Overall Study||25
9042732|NCT03387683|10103440|FG001|COMPLETED|Overall Study||26
9042733|NCT03387683|10103439|FG000|NOT COMPLETED|Overall Study||2
9042734|NCT03387683|10103440|FG001|NOT COMPLETED|Overall Study||0
8699925|NCT00903448|9745425|FG000|STARTED|Period 2: 5 Days Then 10 Day Washout||20
8699926|NCT00903448|9745426|FG001|STARTED|Period 2: 5 Days Then 10 Day Washout||20
8699927|NCT00903448|9745425|FG000|COMPLETED|Period 2: 5 Days Then 10 Day Washout||20
8699928|NCT00903448|9745426|FG001|COMPLETED|Period 2: 5 Days Then 10 Day Washout||20
8699929|NCT00903448|9745425|FG000|NOT COMPLETED|Period 2: 5 Days Then 10 Day Washout||0
8699930|NCT00903448|9745426|FG001|NOT COMPLETED|Period 2: 5 Days Then 10 Day Washout||0
8699931|NCT00903448|9745425|FG000|STARTED|Period 3: 5 Days||20
8699932|NCT00903448|9745426|FG001|STARTED|Period 3: 5 Days||20
8699933|NCT00903448|9745425|FG000|COMPLETED|Period 3: 5 Days||20
8699934|NCT00903448|9745426|FG001|COMPLETED|Period 3: 5 Days||20
8699935|NCT00903448|9745425|FG000|NOT COMPLETED|Period 3: 5 Days||0
8699936|NCT00903448|9745426|FG001|NOT COMPLETED|Period 3: 5 Days||0
8699937|NCT00903617|9745436|FG000|STARTED|Overall Study||19
8699938|NCT00903617|9745437|FG001|STARTED|Overall Study||20
8699939|NCT00903617|9745438|FG002|STARTED|Overall Study||20
8699940|NCT00903617|9745439|FG003|STARTED|Overall Study||21
8699941|NCT00903617|9745436|FG000|COMPLETED|Overall Study||16
8699942|NCT00903617|9745437|FG001|COMPLETED|Overall Study||15
8699943|NCT00903617|9745438|FG002|COMPLETED|Overall Study||15
8699944|NCT00903617|9745439|FG003|COMPLETED|Overall Study||20
8699945|NCT00903617|9745436|FG000|NOT COMPLETED|Overall Study||3
8699946|NCT00903617|9745437|FG001|NOT COMPLETED|Overall Study||5
8699947|NCT00903617|9745438|FG002|NOT COMPLETED|Overall Study||5
8699948|NCT00903617|9745439|FG003|NOT COMPLETED|Overall Study||1
8812285|NCT01519271|9865251|FG000|STARTED|Phase 1||14
8812286|NCT01519271|9865252|FG001|STARTED|Phase 1||14
8812287|NCT01519271|9865251|FG000|COMPLETED|Phase 1||14
8812288|NCT01519271|9865252|FG001|COMPLETED|Phase 1|1 participant discontinued participation in the middle of phase 1.|13
8812289|NCT01519271|9865251|FG000|NOT COMPLETED|Phase 1||0
8812290|NCT01519271|9865252|FG001|NOT COMPLETED|Phase 1||1
8812291|NCT01519271|9865251|FG000|STARTED|Phase 2|2 participants discontinued after Phase 1|12
8812292|NCT01519271|9865252|FG001|STARTED|Phase 2||14
8812293|NCT01519271|9865251|FG000|COMPLETED|Phase 2||12
8812294|NCT01519271|9865252|FG001|COMPLETED|Phase 2||14
8812295|NCT01519271|9865251|FG000|NOT COMPLETED|Phase 2||0
8812296|NCT01519271|9865252|FG001|NOT COMPLETED|Phase 2||0
8812297|NCT01519284|9865265|FG000|STARTED|Overall Study||16
8812298|NCT01519284|9865266|FG001|STARTED|Overall Study||16
8812299|NCT01519284|9865267|FG002|STARTED|Overall Study||18
8812300|NCT01519284|9865268|FG003|STARTED|Overall Study||16
8812301|NCT01519284|9865269|FG004|STARTED|Overall Study||16
8812302|NCT01519284|9865265|FG000|COMPLETED|Overall Study||16
8812303|NCT01519284|9865266|FG001|COMPLETED|Overall Study||16
8812304|NCT01519284|9865267|FG002|COMPLETED|Overall Study||16
8812305|NCT01519284|9865268|FG003|COMPLETED|Overall Study||16
8812306|NCT01519284|9865269|FG004|COMPLETED|Overall Study||16
8812307|NCT01519284|9865265|FG000|NOT COMPLETED|Overall Study||0
8812308|NCT01519284|9865266|FG001|NOT COMPLETED|Overall Study||0
8812309|NCT01519284|9865267|FG002|NOT COMPLETED|Overall Study||2
8812310|NCT01519284|9865268|FG003|NOT COMPLETED|Overall Study||0
8812311|NCT01519284|9865269|FG004|NOT COMPLETED|Overall Study||0
8812312|NCT01519323|9865281|FG000|STARTED|Overall Study||3
8812313|NCT01519323|9865282|FG001|STARTED|Overall Study||3
8812314|NCT01519323|9865281|FG000|COMPLETED|Overall Study||0
8812315|NCT01519323|9865282|FG001|COMPLETED|Overall Study||0
8812316|NCT01519323|9865281|FG000|NOT COMPLETED|Overall Study||3
8812317|NCT01519323|9865282|FG001|NOT COMPLETED|Overall Study||3
9042735|NCT03388008|10103448|FG000|STARTED|Overall Study||14
9042736|NCT03388008|10103449|FG001|STARTED|Overall Study||13
9042737|NCT03388008|10103448|FG000|COMPLETED|Overall Study||14
8699949|NCT00903630|9745453|FG000|STARTED|Phase l||6
8699950|NCT00903630|9745454|FG001|STARTED|Phase l||5
8699951|NCT00903630|9745455|FG002|STARTED|Phase l||0
8699952|NCT00903630|9745453|FG000|COMPLETED|Phase l||6
8812318|NCT01519414|9865290|FG000|STARTED|Pre Cross-over||52
8812319|NCT01519414|9865291|FG001|STARTED|Pre Cross-over||26
8812320|NCT01519414|9865292|FG002|STARTED|Pre Cross-over||0
8812321|NCT01519414|9865290|FG000|COMPLETED|Pre Cross-over||52
8699953|NCT00903630|9745454|FG001|COMPLETED|Phase l||5
8699954|NCT00903630|9745455|FG002|COMPLETED|Phase l||0
8699955|NCT00903630|9745453|FG000|NOT COMPLETED|Phase l||0
8812322|NCT01519414|9865291|FG001|COMPLETED|Pre Cross-over||26
9042738|NCT03388008|10103449|FG001|COMPLETED|Overall Study||13
9042739|NCT03388008|10103448|FG000|NOT COMPLETED|Overall Study||0
9042740|NCT03388008|10103449|FG001|NOT COMPLETED|Overall Study||0
9042741|NCT03388164|10103457|FG000|STARTED|Overall Study||10
9042742|NCT03388164|10103458|FG001|STARTED|Overall Study||10
9042743|NCT03388164|10103457|FG000|COMPLETED|Overall Study||7
9042744|NCT03388164|10103458|FG001|COMPLETED|Overall Study||9
9042745|NCT03388164|10103457|FG000|NOT COMPLETED|Overall Study||3
9042746|NCT03388164|10103458|FG001|NOT COMPLETED|Overall Study||1
9042747|NCT03388268|10103466|FG000|STARTED|Overall Study||8
8699956|NCT00903630|9745454|FG001|NOT COMPLETED|Phase l||0
8699957|NCT00903630|9745455|FG002|NOT COMPLETED|Phase l||0
8699958|NCT00903630|9745453|FG000|STARTED|Phase 2||6
8699959|NCT00903630|9745454|FG001|STARTED|Phase 2||0
8699960|NCT00903630|9745455|FG002|STARTED|Phase 2||4
8699961|NCT00903630|9745453|FG000|COMPLETED|Phase 2||6
8699962|NCT00903630|9745454|FG001|COMPLETED|Phase 2||0
8699963|NCT00903630|9745455|FG002|COMPLETED|Phase 2|One participant was removed from the study after 2 weeks of treatment due to skin toxicity.|3
8699964|NCT00903630|9745453|FG000|NOT COMPLETED|Phase 2||0
8699965|NCT00903630|9745454|FG001|NOT COMPLETED|Phase 2||0
8699966|NCT00903630|9745455|FG002|NOT COMPLETED|Phase 2||1
8699967|NCT00903682|9745467|FG000|STARTED|Overall Study||79
8699968|NCT00903682|9745468|FG001|STARTED|Overall Study||78
8699969|NCT00903682|9745467|FG000|COMPLETED|Overall Study||63
8699970|NCT00903682|9745468|FG001|COMPLETED|Overall Study||63
8699971|NCT00903682|9745467|FG000|NOT COMPLETED|Overall Study||16
8699972|NCT00903682|9745468|FG001|NOT COMPLETED|Overall Study||15
8699973|NCT00903695|9745476|FG000|STARTED|Overall Study||8
8699974|NCT00903695|9745477|FG001|STARTED|Overall Study||2
8699975|NCT00903695|9745476|FG000|COMPLETED|Overall Study||6
8699976|NCT00903695|9745477|FG001|COMPLETED|Overall Study||2
8699977|NCT00903695|9745476|FG000|NOT COMPLETED|Overall Study||2
8699978|NCT00903695|9745477|FG001|NOT COMPLETED|Overall Study||0
8699979|NCT00903760|9745487|FG000|STARTED|Overall Study||19
8699980|NCT00903760|9745488|FG001|STARTED|Overall Study||18
8699981|NCT00903760|9745487|FG000|COMPLETED|Overall Study|Completed all 24 courses|0
8699982|NCT00903760|9745488|FG001|COMPLETED|Overall Study|Completed all 24 courses|2
8699983|NCT00903760|9745487|FG000|NOT COMPLETED|Overall Study||19
8699984|NCT00903760|9745488|FG001|NOT COMPLETED|Overall Study||16
8699985|NCT00903786|9745494|FG000|STARTED|Overall Study||21
8699986|NCT00903786|9745494|FG000|COMPLETED|Overall Study||6
8699987|NCT00903786|9745494|FG000|NOT COMPLETED|Overall Study||15
8699988|NCT00903877|9745499|FG000|STARTED|Overall Study||51
8699989|NCT00903877|9745499|FG000|COMPLETED|Overall Study||8
8699990|NCT00903877|9745499|FG000|NOT COMPLETED|Overall Study||43
8699991|NCT00903929|9745503|FG000|STARTED|Overall Study||3
8699992|NCT00903929|9745504|FG001|STARTED|Overall Study||3
8699993|NCT00903929|9745505|FG002|STARTED|Overall Study|Participants who did not complete the study were replaced with additional participants.|4
8699994|NCT00903929|9745506|FG003|STARTED|Overall Study|Participants who did not complete the study were replaced with additional participants.|9
8699995|NCT00903929|9745503|FG000|COMPLETED|Overall Study||3
8699996|NCT00903929|9745504|FG001|COMPLETED|Overall Study||3
8699997|NCT00903929|9745505|FG002|COMPLETED|Overall Study||3
8699998|NCT00903929|9745506|FG003|COMPLETED|Overall Study||6
8699999|NCT00903929|9745503|FG000|NOT COMPLETED|Overall Study||0
8700000|NCT00903929|9745504|FG001|NOT COMPLETED|Overall Study||0
8700001|NCT00903929|9745505|FG002|NOT COMPLETED|Overall Study||1
8700002|NCT00903929|9745506|FG003|NOT COMPLETED|Overall Study||3
8700003|NCT00903968|9745513|FG000|STARTED|Overall Study||3
8700004|NCT00903968|9745514|FG001|STARTED|Overall Study||3
8700005|NCT00903968|9745515|FG002|STARTED|Overall Study||3
8700006|NCT00903968|9745516|FG003|STARTED|Overall Study||3
8700007|NCT00903968|9745517|FG004|STARTED|Overall Study||4
8700008|NCT00903968|9745518|FG005|STARTED|Overall Study||6
8700009|NCT00903968|9745519|FG006|STARTED|Overall Study||3
8700010|NCT00903968|9745520|FG007|STARTED|Overall Study||33
8700011|NCT00903968|9745513|FG000|COMPLETED|Overall Study||0
8700012|NCT00903968|9745514|FG001|COMPLETED|Overall Study||0
8700013|NCT00903968|9745515|FG002|COMPLETED|Overall Study||0
8700014|NCT00903968|9745516|FG003|COMPLETED|Overall Study||0
8700015|NCT00903968|9745517|FG004|COMPLETED|Overall Study||0
8700016|NCT00903968|9745518|FG005|COMPLETED|Overall Study||0
8700017|NCT00903968|9745519|FG006|COMPLETED|Overall Study||0
8700018|NCT00903968|9745520|FG007|COMPLETED|Overall Study||0
8700019|NCT00903968|9745513|FG000|NOT COMPLETED|Overall Study||3
8700020|NCT00903968|9745514|FG001|NOT COMPLETED|Overall Study||3
8700021|NCT00903968|9745515|FG002|NOT COMPLETED|Overall Study||3
8700022|NCT00903968|9745516|FG003|NOT COMPLETED|Overall Study||3
8700023|NCT00903968|9745517|FG004|NOT COMPLETED|Overall Study||4
8700024|NCT00903968|9745518|FG005|NOT COMPLETED|Overall Study||6
8700025|NCT00903968|9745519|FG006|NOT COMPLETED|Overall Study||3
8700026|NCT00903968|9745520|FG007|NOT COMPLETED|Overall Study||33
8700027|NCT00904007|9745543|FG000|STARTED|Overall Study||55
8700028|NCT00904007|9745544|FG001|STARTED|Overall Study||56
8700029|NCT00904007|9745543|FG000|COMPLETED|Overall Study||55
8700030|NCT00904007|9745544|FG001|COMPLETED|Overall Study||56
8700031|NCT00904007|9745543|FG000|NOT COMPLETED|Overall Study||0
8700032|NCT00904007|9745544|FG001|NOT COMPLETED|Overall Study||0
8700033|NCT00904033|9745556|FG000|STARTED|Overall Study||10
8700034|NCT00904033|9745557|FG001|STARTED|Overall Study||10
8700035|NCT00904033|9745558|FG002|STARTED|Overall Study||10
8700036|NCT00904033|9745559|FG003|STARTED|Overall Study||11
9042748|NCT03388268|10103467|FG001|STARTED|Overall Study||7
9042749|NCT03388268|10103466|FG000|COMPLETED|Overall Study||7
9042750|NCT03388268|10103467|FG001|COMPLETED|Overall Study||4
9042751|NCT03388268|10103466|FG000|NOT COMPLETED|Overall Study||1
9042752|NCT03388268|10103467|FG001|NOT COMPLETED|Overall Study||3
9042753|NCT03388294|10103475|FG000|STARTED|Overall Study||42
9042754|NCT03388294|10103476|FG001|STARTED|Overall Study||30
9042755|NCT03388294|10103475|FG000|Posttest 1|Overall Study||38
9042756|NCT03388294|10103476|FG001|Posttest 1|Overall Study||30
9042757|NCT03388294|10103475|FG000|Posttest 2|Overall Study||38
9042758|NCT03388294|10103476|FG001|Posttest 2|Overall Study||30
9042759|NCT03388294|10103475|FG000|COMPLETED|Overall Study||38
9042760|NCT03388294|10103476|FG001|COMPLETED|Overall Study||30
9042761|NCT03388294|10103475|FG000|NOT COMPLETED|Overall Study||4
9042762|NCT03388294|10103476|FG001|NOT COMPLETED|Overall Study||0
9042763|NCT03388645|10103484|FG000|STARTED|Low Dose RSV A2||4
9042764|NCT03388645|10103485|FG001|STARTED|Low Dose RSV A2||0
9042765|NCT03388645|10103484|FG000|COMPLETED|Low Dose RSV A2||4
9042766|NCT03388645|10103485|FG001|COMPLETED|Low Dose RSV A2||0
9042767|NCT03388645|10103484|FG000|NOT COMPLETED|Low Dose RSV A2||0
9042768|NCT03388645|10103485|FG001|NOT COMPLETED|Low Dose RSV A2||0
9042769|NCT03388645|10103484|FG000|STARTED|High Dose RSV A2||0
9042770|NCT03388645|10103485|FG001|STARTED|High Dose RSV A2||8
9042771|NCT03388645|10103484|FG000|COMPLETED|High Dose RSV A2||0
9042772|NCT03388645|10103485|FG001|COMPLETED|High Dose RSV A2||7
9042773|NCT03388645|10103484|FG000|NOT COMPLETED|High Dose RSV A2||0
9042774|NCT03388645|10103485|FG001|NOT COMPLETED|High Dose RSV A2||1
9042775|NCT03389308|10103491|FG000|STARTED|Overall Study||51
9042776|NCT03389308|10103491|FG000|COMPLETED|Overall Study||39
9042777|NCT03389308|10103491|FG000|NOT COMPLETED|Overall Study||12
9042778|NCT03389555|10103497|FG000|STARTED|Overall Study||103
9042779|NCT03389555|10103498|FG001|STARTED|Overall Study||102
9042780|NCT03389555|10103497|FG000|COMPLETED|Overall Study||101
9042781|NCT03389555|10103498|FG001|COMPLETED|Overall Study||99
9042782|NCT03389555|10103497|FG000|NOT COMPLETED|Overall Study||2
9042783|NCT03389555|10103498|FG001|NOT COMPLETED|Overall Study||3
9042784|NCT03389854|10103508|FG000|STARTED|Overall Study||28
9042785|NCT03389854|10103509|FG001|STARTED|Overall Study||27
8700037|NCT00904033|9745556|FG000|COMPLETED|Overall Study||9
8700038|NCT00904033|9745557|FG001|COMPLETED|Overall Study||9
8700039|NCT00904033|9745558|FG002|COMPLETED|Overall Study||9
8700040|NCT00904033|9745559|FG003|COMPLETED|Overall Study||9
8700041|NCT00904033|9745556|FG000|NOT COMPLETED|Overall Study||1
8700042|NCT00904033|9745557|FG001|NOT COMPLETED|Overall Study||1
8700043|NCT00904033|9745558|FG002|NOT COMPLETED|Overall Study||1
8700044|NCT00904033|9745559|FG003|NOT COMPLETED|Overall Study||2
8700045|NCT00904150|9745572|FG000|STARTED|Saliva Samples (DNA)||285
8700046|NCT00904150|9745573|FG001|STARTED|Saliva Samples (DNA)||300
8700047|NCT00904150|9745572|FG000|COMPLETED|Saliva Samples (DNA)||282
8700048|NCT00904150|9745573|FG001|COMPLETED|Saliva Samples (DNA)||155
8700049|NCT00904150|9745572|FG000|NOT COMPLETED|Saliva Samples (DNA)||3
8700050|NCT00904150|9745573|FG001|NOT COMPLETED|Saliva Samples (DNA)||145
8700051|NCT00904150|9745572|FG000|STARTED|Blood Samples (RNA): Follicular Phase||37
8700052|NCT00904150|9745573|FG001|STARTED|Blood Samples (RNA): Follicular Phase||32
8700053|NCT00904150|9745572|FG000|COMPLETED|Blood Samples (RNA): Follicular Phase||37
8700054|NCT00904150|9745573|FG001|COMPLETED|Blood Samples (RNA): Follicular Phase||32
8700055|NCT00904150|9745572|FG000|NOT COMPLETED|Blood Samples (RNA): Follicular Phase||0
8700056|NCT00904150|9745573|FG001|NOT COMPLETED|Blood Samples (RNA): Follicular Phase||0
8700057|NCT00904150|9745572|FG000|STARTED|Blood Samples (RNA): Luteal Phase||34
8700058|NCT00904150|9745573|FG001|STARTED|Blood Samples (RNA): Luteal Phase||30
8700059|NCT00904150|9745572|FG000|COMPLETED|Blood Samples (RNA): Luteal Phase||34
8700060|NCT00904150|9745573|FG001|COMPLETED|Blood Samples (RNA): Luteal Phase||30
8700061|NCT00904150|9745572|FG000|NOT COMPLETED|Blood Samples (RNA): Luteal Phase||0
8700062|NCT00904150|9745573|FG001|NOT COMPLETED|Blood Samples (RNA): Luteal Phase||0
8700063|NCT00904215|9745579|FG000|STARTED|Overall Study||1095
8700064|NCT00904215|9745579|FG000|COMPLETED|Overall Study||960
8700065|NCT00904215|9745579|FG000|NOT COMPLETED|Overall Study||135
8700066|NCT00904345|9745583|FG000|STARTED|Overall Study||21
8700067|NCT00904345|9745583|FG000|Stopped or Modified Treatment Due to Toxicity|Overall Study||3
8700068|NCT00904345|9745583|FG000|COMPLETED|Overall Study||18
8700069|NCT00904345|9745583|FG000|NOT COMPLETED|Overall Study||3
8700070|NCT00904371|9745587|FG000|STARTED|Overall Study||211
8700071|NCT00904371|9745587|FG000|COMPLETED|Overall Study||202
8700072|NCT00904371|9745587|FG000|NOT COMPLETED|Overall Study||9
9042786|NCT03389854|10103510|FG002|STARTED|Overall Study||28
9042787|NCT03389854|10103511|FG003|STARTED|Overall Study||27
9042788|NCT03389854|10103508|FG000|COMPLETED|Overall Study||27
9042789|NCT03389854|10103509|FG001|COMPLETED|Overall Study||21
9042790|NCT03389854|10103510|FG002|COMPLETED|Overall Study||23
9042791|NCT03389854|10103511|FG003|COMPLETED|Overall Study||19
9042792|NCT03389854|10103508|FG000|NOT COMPLETED|Overall Study||1
9042793|NCT03389854|10103509|FG001|NOT COMPLETED|Overall Study||6
9042794|NCT03389854|10103510|FG002|NOT COMPLETED|Overall Study||5
9042795|NCT03389854|10103511|FG003|NOT COMPLETED|Overall Study||8
9042796|NCT03389893|10103527|FG000|STARTED|Randomized Double Blind Period||46
9042797|NCT03389893|10103528|FG001|STARTED|Randomized Double Blind Period||26
9042798|NCT03389893|10103529|FG002|STARTED|Randomized Double Blind Period||0
9042799|NCT03389893|10103530|FG003|STARTED|Randomized Double Blind Period||0
9042800|NCT03389893|10103527|FG000|COMPLETED|Randomized Double Blind Period||45
9042801|NCT03389893|10103528|FG001|COMPLETED|Randomized Double Blind Period||26
9042802|NCT03389893|10103529|FG002|COMPLETED|Randomized Double Blind Period||0
9042803|NCT03389893|10103530|FG003|COMPLETED|Randomized Double Blind Period||0
9042804|NCT03389893|10103527|FG000|NOT COMPLETED|Randomized Double Blind Period||1
9042805|NCT03389893|10103528|FG001|NOT COMPLETED|Randomized Double Blind Period||0
9042806|NCT03389893|10103529|FG002|NOT COMPLETED|Randomized Double Blind Period||0
9042807|NCT03389893|10103530|FG003|NOT COMPLETED|Randomized Double Blind Period||0
9042808|NCT03389893|10103527|FG000|STARTED|Open Label Extension and Follow-Up||0
9042809|NCT03389893|10103528|FG001|STARTED|Open Label Extension and Follow-Up||0
9042810|NCT03389893|10103529|FG002|STARTED|Open Label Extension and Follow-Up||45
9042811|NCT03389893|10103530|FG003|STARTED|Open Label Extension and Follow-Up||26
9042812|NCT03389893|10103527|FG000|COMPLETED|Open Label Extension and Follow-Up||0
9042813|NCT03389893|10103528|FG001|COMPLETED|Open Label Extension and Follow-Up||0
9042814|NCT03389893|10103529|FG002|COMPLETED|Open Label Extension and Follow-Up||41
9042815|NCT03389893|10103530|FG003|COMPLETED|Open Label Extension and Follow-Up||25
9042816|NCT03389893|10103527|FG000|NOT COMPLETED|Open Label Extension and Follow-Up||0
8700073|NCT00904488|9745593|FG000|STARTED|Overall Study||5
8700074|NCT00904488|9745594|FG001|STARTED|Overall Study||6
8700075|NCT00904488|9745593|FG000|COMPLETED|Overall Study||5
8700076|NCT00904488|9745594|FG001|COMPLETED|Overall Study||6
8700077|NCT00904488|9745593|FG000|NOT COMPLETED|Overall Study||0
8700078|NCT00904488|9745594|FG001|NOT COMPLETED|Overall Study||0
8700079|NCT00904618|9745600|FG000|STARTED|Overall Study||48
8700080|NCT00904618|9745600|FG000|COMPLETED|Overall Study||48
8700081|NCT00904618|9745600|FG000|NOT COMPLETED|Overall Study||0
8700082|NCT00904670|9745607|FG000|STARTED|Open Label Phase||23
8700083|NCT00904670|9745608|FG001|STARTED|Open Label Phase||22
8700084|NCT00904670|9745607|FG000|COMPLETED|Open Label Phase||17
8700085|NCT00904670|9745608|FG001|COMPLETED|Open Label Phase||22
8700086|NCT00904670|9745607|FG000|NOT COMPLETED|Open Label Phase||6
8700087|NCT00904670|9745608|FG001|NOT COMPLETED|Open Label Phase||0
8700088|NCT00904670|9745607|FG000|STARTED|First Intervention Period||17
8700089|NCT00904670|9745608|FG001|STARTED|First Intervention Period||22
8700090|NCT00904670|9745607|FG000|COMPLETED|First Intervention Period||17
8700091|NCT00904670|9745608|FG001|COMPLETED|First Intervention Period||22
8700092|NCT00904670|9745607|FG000|NOT COMPLETED|First Intervention Period||0
8700093|NCT00904670|9745608|FG001|NOT COMPLETED|First Intervention Period||0
8700094|NCT00904670|9745607|FG000|STARTED|Second Intervention Period||17
8700095|NCT00904670|9745608|FG001|STARTED|Second Intervention Period||22
8700096|NCT00904670|9745607|FG000|COMPLETED|Second Intervention Period||17
8700097|NCT00904670|9745608|FG001|COMPLETED|Second Intervention Period||22
8700098|NCT00904670|9745607|FG000|NOT COMPLETED|Second Intervention Period||0
8700099|NCT00904670|9745608|FG001|NOT COMPLETED|Second Intervention Period||0
8700100|NCT00904722|9745616|FG000|STARTED|Overall Study||30
8700101|NCT00904722|9745616|FG000|COMPLETED|Overall Study||29
8700102|NCT00904722|9745616|FG000|NOT COMPLETED|Overall Study||1
8700103|NCT00904748|9745620|FG000|STARTED|Overall Study||8
8700104|NCT00904748|9745621|FG001|STARTED|Overall Study||8
8700105|NCT00904748|9745622|FG002|STARTED|Overall Study||8
8700106|NCT00904748|9745623|FG003|STARTED|Overall Study||8
8700107|NCT00904748|9745624|FG004|STARTED|Overall Study|1 participant randomized to this sequence discontinued prior to receipt of study medication.|8
8700108|NCT00904748|9745625|FG005|STARTED|Overall Study||8
8700109|NCT00904748|9745620|FG000|Received Treatment|Overall Study||8
8700110|NCT00904748|9745621|FG001|Received Treatment|Overall Study||8
8700111|NCT00904748|9745622|FG002|Received Treatment|Overall Study||8
8700112|NCT00904748|9745623|FG003|Received Treatment|Overall Study||8
8700113|NCT00904748|9745624|FG004|Received Treatment|Overall Study||7
8700114|NCT00904748|9745625|FG005|Received Treatment|Overall Study||8
8700115|NCT00904748|9745620|FG000|COMPLETED|Overall Study||7
8700116|NCT00904748|9745621|FG001|COMPLETED|Overall Study||7
8700117|NCT00904748|9745622|FG002|COMPLETED|Overall Study||7
8700118|NCT00904748|9745623|FG003|COMPLETED|Overall Study||6
8700119|NCT00904748|9745624|FG004|COMPLETED|Overall Study||7
8700120|NCT00904748|9745625|FG005|COMPLETED|Overall Study||8
8700121|NCT00904748|9745620|FG000|NOT COMPLETED|Overall Study||1
8700122|NCT00904748|9745621|FG001|NOT COMPLETED|Overall Study||1
8700123|NCT00904748|9745622|FG002|NOT COMPLETED|Overall Study||1
8700124|NCT00904748|9745623|FG003|NOT COMPLETED|Overall Study||2
8700125|NCT00904748|9745624|FG004|NOT COMPLETED|Overall Study||1
8700126|NCT00904748|9745625|FG005|NOT COMPLETED|Overall Study||0
8700127|NCT00904813|9745639|FG000|STARTED|Overall Study||129
8700128|NCT00904813|9745640|FG001|STARTED|Overall Study||128
8700129|NCT00904813|9745641|FG002|STARTED|Overall Study||128
8700130|NCT00904813|9745642|FG003|STARTED|Overall Study||228
8700131|NCT00904813|9745643|FG004|STARTED|Overall Study||227
8700132|NCT00904813|9745639|FG000|COMPLETED|Overall Study||129
8700133|NCT00904813|9745640|FG001|COMPLETED|Overall Study||128
9042817|NCT03389893|10103528|FG001|NOT COMPLETED|Open Label Extension and Follow-Up||0
8700134|NCT00904813|9745641|FG002|COMPLETED|Overall Study||128
8700135|NCT00904813|9745642|FG003|COMPLETED|Overall Study||228
8700136|NCT00904813|9745643|FG004|COMPLETED|Overall Study||227
9042818|NCT03389893|10103529|FG002|NOT COMPLETED|Open Label Extension and Follow-Up||4
9042819|NCT03389893|10103530|FG003|NOT COMPLETED|Open Label Extension and Follow-Up||1
8700137|NCT00904813|9745639|FG000|NOT COMPLETED|Overall Study||0
8700138|NCT00904813|9745640|FG001|NOT COMPLETED|Overall Study||0
8700139|NCT00904813|9745641|FG002|NOT COMPLETED|Overall Study||0
9042820|NCT03390101|10103539|FG000|STARTED|Weeks 0-12||85
9042821|NCT03390101|10103540|FG001|STARTED|Weeks 0-12||84
9042822|NCT03390101|10103541|FG002|STARTED|Weeks 0-12||44
9042823|NCT03390101|10103539|FG000|COMPLETED|Weeks 0-12||85
9042824|NCT03390101|10103540|FG001|COMPLETED|Weeks 0-12||82
9042825|NCT03390101|10103541|FG002|COMPLETED|Weeks 0-12||43
9042826|NCT03390101|10103539|FG000|NOT COMPLETED|Weeks 0-12||0
9042827|NCT03390101|10103540|FG001|NOT COMPLETED|Weeks 0-12||2
9042828|NCT03390101|10103541|FG002|NOT COMPLETED|Weeks 0-12||1
9042829|NCT03390101|10103539|FG000|STARTED|Weeks 12-54||85
9042830|NCT03390101|10103540|FG001|STARTED|Weeks 12-54||82
9042831|NCT03390101|10103541|FG002|STARTED|Weeks 12-54||43
9042832|NCT03390101|10103539|FG000|COMPLETED|Weeks 12-54||82
8700140|NCT00904813|9745642|FG003|NOT COMPLETED|Overall Study||0
8700141|NCT00904813|9745643|FG004|NOT COMPLETED|Overall Study||0
8700142|NCT00904826|9745666|FG000|STARTED|Overall Study||14
8700143|NCT00904826|9745666|FG000|COMPLETED|Overall Study||14
8700144|NCT00904826|9745666|FG000|NOT COMPLETED|Overall Study||0
8700145|NCT00904839|9745672|FG000|STARTED|Overall Study|All 4 patients were randomised to Maximum Tolerable Dose analysis set.|4
8700146|NCT00904839|9745673|FG001|STARTED|Overall Study|11 patients were randomised to Maximum Tolerable Dose analysis set.|82
8700147|NCT00904839|9745674|FG002|STARTED|Overall Study|Randomised|42
8700148|NCT00904839|9745672|FG000|COMPLETED|Overall Study||3
8700149|NCT00904839|9745673|FG001|COMPLETED|Overall Study||64
8700150|NCT00904839|9745674|FG002|COMPLETED|Overall Study||27
8700151|NCT00904839|9745672|FG000|NOT COMPLETED|Overall Study||1
8700152|NCT00904839|9745673|FG001|NOT COMPLETED|Overall Study||18
8700153|NCT00904839|9745674|FG002|NOT COMPLETED|Overall Study||15
8700154|NCT00904917|9745689|FG000|STARTED|Overall Study||7
8700155|NCT00904917|9745690|FG001|STARTED|Overall Study||11
8700156|NCT00904917|9745691|FG002|STARTED|Overall Study||8
8700157|NCT00904917|9745692|FG003|STARTED|Overall Study||8
8700158|NCT00904917|9745689|FG000|COMPLETED|Overall Study||5
8700159|NCT00904917|9745690|FG001|COMPLETED|Overall Study||9
8700160|NCT00904917|9745691|FG002|COMPLETED|Overall Study||6
8700161|NCT00904917|9745692|FG003|COMPLETED|Overall Study||6
8700162|NCT00904917|9745689|FG000|NOT COMPLETED|Overall Study||2
8700163|NCT00904917|9745690|FG001|NOT COMPLETED|Overall Study||2
8700164|NCT00904917|9745691|FG002|NOT COMPLETED|Overall Study||2
8700165|NCT00904917|9745692|FG003|NOT COMPLETED|Overall Study||2
8700166|NCT00904969|9745705|FG000|STARTED|Overall Study|Number of patients with an attempted implant; 1 subject with procedure aborted|50
8700167|NCT00904969|9745705|FG000|COMPLETED|Overall Study|# of Implanted Subjects Who Completed the Study|31
8700168|NCT00904969|9745705|FG000|NOT COMPLETED|Overall Study||19
8700169|NCT00904982|9745728|FG000|STARTED|Overall Study||68
8700170|NCT00904982|9745729|FG001|STARTED|Overall Study||67
8700171|NCT00904982|9745730|FG002|STARTED|Overall Study||67
8700172|NCT00904982|9745731|FG003|STARTED|Overall Study||68
8700173|NCT00904982|9745728|FG000|COMPLETED|Overall Study||66
8700174|NCT00904982|9745729|FG001|COMPLETED|Overall Study||67
8700175|NCT00904982|9745730|FG002|COMPLETED|Overall Study||67
8700176|NCT00904982|9745731|FG003|COMPLETED|Overall Study||68
8700177|NCT00904982|9745728|FG000|NOT COMPLETED|Overall Study||2
8700178|NCT00904982|9745729|FG001|NOT COMPLETED|Overall Study||0
8700179|NCT00904982|9745730|FG002|NOT COMPLETED|Overall Study||0
8700180|NCT00904982|9745731|FG003|NOT COMPLETED|Overall Study||0
8700181|NCT00904995|9745743|FG000|STARTED|Overall Study||10
8700182|NCT00904995|9745744|FG001|STARTED|Overall Study||11
8700183|NCT00904995|9745743|FG000|COMPLETED|Overall Study||10
8700184|NCT00904995|9745744|FG001|COMPLETED|Overall Study||11
8700185|NCT00904995|9745743|FG000|NOT COMPLETED|Overall Study||0
8700186|NCT00904995|9745744|FG001|NOT COMPLETED|Overall Study||0
8700187|NCT00905021|9745750|FG000|STARTED|Overall Study||4
8700188|NCT00905021|9745750|FG000|COMPLETED|Overall Study|2 patients were off study due to AE.|2
8700189|NCT00905021|9745750|FG000|NOT COMPLETED|Overall Study||2
8700190|NCT00905034|9745755|FG000|STARTED|Overall Study||37
8700191|NCT00905034|9745755|FG000|COMPLETED|Overall Study||36
8700192|NCT00905034|9745755|FG000|NOT COMPLETED|Overall Study||1
8700193|NCT00905060|9745759|FG000|STARTED|Surgical Resection||70
8700194|NCT00905060|9745759|FG000|COMPLETED|Surgical Resection||46
8700195|NCT00905060|9745759|FG000|NOT COMPLETED|Surgical Resection||24
8700196|NCT00905060|9745759|FG000|STARTED|Vaccination Treatment Period||46
8700197|NCT00905060|9745759|FG000|COMPLETED|Vaccination Treatment Period||46
8700198|NCT00905060|9745759|FG000|NOT COMPLETED|Vaccination Treatment Period||0
8700199|NCT00905125|9745765|FG000|STARTED|Overall Study||46
9042833|NCT03390101|10103540|FG001|COMPLETED|Weeks 12-54||78
9042834|NCT03390101|10103541|FG002|COMPLETED|Weeks 12-54||41
9042835|NCT03390101|10103539|FG000|NOT COMPLETED|Weeks 12-54||3
9042836|NCT03390101|10103540|FG001|NOT COMPLETED|Weeks 12-54||4
8700200|NCT00905125|9745766|FG001|STARTED|Overall Study||56
8700201|NCT00905125|9745765|FG000|COMPLETED|Overall Study||42
8700202|NCT00905125|9745766|FG001|COMPLETED|Overall Study||53
9042837|NCT03390101|10103541|FG002|NOT COMPLETED|Weeks 12-54||2
8700203|NCT00905125|9745765|FG000|NOT COMPLETED|Overall Study||4
8700204|NCT00905125|9745766|FG001|NOT COMPLETED|Overall Study||3
8700205|NCT00905151|9745772|FG000|STARTED|Overall Study||206
8700206|NCT00905151|9745772|FG000|COMPLETED|Overall Study||200
8700207|NCT00905151|9745772|FG000|NOT COMPLETED|Overall Study||6
8700208|NCT00905255|9745778|FG000|STARTED|Overall Study|Randomized.|33
8700209|NCT00905255|9745779|FG001|STARTED|Overall Study||36
8724389|NCT01026324|9771593|FG000|Discontinuted Intervention (Progression)|Treatment Allocation||3
8700210|NCT00905255|9745778|FG000|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|33
8700211|NCT00905255|9745779|FG001|Safety Population|Overall Study||36
8700212|NCT00905255|9745778|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|33
8700213|NCT00905255|9745779|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||36
8700214|NCT00905255|9745778|FG000|COMPLETED|Overall Study||20
8700215|NCT00905255|9745779|FG001|COMPLETED|Overall Study||27
8700216|NCT00905255|9745778|FG000|NOT COMPLETED|Overall Study||13
8700217|NCT00905255|9745779|FG001|NOT COMPLETED|Overall Study||9
8700218|NCT00905268|9745790|FG000|STARTED|Overall Study||57
8700219|NCT00905268|9745791|FG001|STARTED|Overall Study||57
8700220|NCT00905268|9745792|FG002|STARTED|Overall Study||59
8700221|NCT00905268|9745793|FG003|STARTED|Overall Study||59
8700222|NCT00905268|9745790|FG000|COMPLETED|Overall Study||53
8700223|NCT00905268|9745791|FG001|COMPLETED|Overall Study||56
8700224|NCT00905268|9745792|FG002|COMPLETED|Overall Study||59
8700225|NCT00905268|9745793|FG003|COMPLETED|Overall Study||57
8700226|NCT00905268|9745790|FG000|NOT COMPLETED|Overall Study||4
8700227|NCT00905268|9745791|FG001|NOT COMPLETED|Overall Study||1
8700228|NCT00905268|9745792|FG002|NOT COMPLETED|Overall Study||0
8700229|NCT00905268|9745793|FG003|NOT COMPLETED|Overall Study||2
8700230|NCT00905307|9745809|FG000|STARTED|Overall Study||42
8700231|NCT00905307|9745810|FG001|STARTED|Overall Study||89
8700232|NCT00905307|9745811|FG002|STARTED|Overall Study||90
8700233|NCT00905307|9745812|FG003|STARTED|Overall Study||93
8700234|NCT00905307|9745813|FG004|STARTED|Overall Study||50
8700235|NCT00905307|9745814|FG005|STARTED|Overall Study||95
8700236|NCT00905307|9745809|FG000|COMPLETED|Overall Study||20
8700237|NCT00905307|9745810|FG001|COMPLETED|Overall Study||52
8700238|NCT00905307|9745811|FG002|COMPLETED|Overall Study||53
8700239|NCT00905307|9745812|FG003|COMPLETED|Overall Study||56
8700240|NCT00905307|9745813|FG004|COMPLETED|Overall Study||34
8700241|NCT00905307|9745814|FG005|COMPLETED|Overall Study||53
8700242|NCT00905307|9745809|FG000|NOT COMPLETED|Overall Study||22
8700243|NCT00905307|9745810|FG001|NOT COMPLETED|Overall Study||37
8700244|NCT00905307|9745811|FG002|NOT COMPLETED|Overall Study||37
8700245|NCT00905307|9745812|FG003|NOT COMPLETED|Overall Study||37
8700246|NCT00905307|9745813|FG004|NOT COMPLETED|Overall Study||16
8812323|NCT01519414|9865292|FG002|COMPLETED|Pre Cross-over||0
8812324|NCT01519414|9865290|FG000|NOT COMPLETED|Pre Cross-over||0
8812325|NCT01519414|9865291|FG001|NOT COMPLETED|Pre Cross-over||0
8812326|NCT01519414|9865292|FG002|NOT COMPLETED|Pre Cross-over||0
8812327|NCT01519414|9865290|FG000|STARTED|Post Cross-over||52
8812328|NCT01519414|9865291|FG001|STARTED|Post Cross-over||14
8812329|NCT01519414|9865292|FG002|STARTED|Post Cross-over||12
8812330|NCT01519414|9865290|FG000|COMPLETED|Post Cross-over||52
8812331|NCT01519414|9865291|FG001|COMPLETED|Post Cross-over||14
8812332|NCT01519414|9865292|FG002|COMPLETED|Post Cross-over||12
8812333|NCT01519414|9865290|FG000|NOT COMPLETED|Post Cross-over||0
8812334|NCT01519414|9865291|FG001|NOT COMPLETED|Post Cross-over||0
8812335|NCT01519414|9865292|FG002|NOT COMPLETED|Post Cross-over||0
8812336|NCT01519427|9865303|FG000|STARTED|Overall Study||2
8812337|NCT01519427|9865303|FG000|COMPLETED|Overall Study||0
8812338|NCT01519427|9865303|FG000|NOT COMPLETED|Overall Study||2
8812339|NCT01519453|9865309|FG000|STARTED|Overall Study|Number of dyads (caregiver-child pairs) or 398 individuals|199
8812340|NCT01519453|9865310|FG001|STARTED|Overall Study|Number of dyads (caregiver-child pairs) or 398 individuals|199
8812341|NCT01519453|9865309|FG000|3 Month|Overall Study|Number of dyads (caregiver-child pairs) or 320 individuals|160
8812342|NCT01519453|9865310|FG001|3 Month|Overall Study|Number of dyads (caregiver-child pairs) or 362 individuals|181
8812343|NCT01519453|9865309|FG000|6 Month|Overall Study|Number of dyads (caregiver-child pairs) or 306 individuals|153
8812344|NCT01519453|9865310|FG001|6 Month|Overall Study|Number of dyads (caregiver-child pairs) or 350 individuals|175
8812345|NCT01519453|9865309|FG000|9 Month|Overall Study|Number of dyads (caregiver-child pairs) or 318 individuals|159
8812346|NCT01519453|9865310|FG001|9 Month|Overall Study|Number of dyads (caregiver-child pairs) or 332 individuals|166
8812347|NCT01519453|9865309|FG000|COMPLETED|Overall Study|Number of dyads (caregiver-child pairs) or 294 individuals|147
8812348|NCT01519453|9865310|FG001|COMPLETED|Overall Study|Number of dyads (caregiver-child pairs) or 326 individuals|163
8812349|NCT01519453|9865309|FG000|NOT COMPLETED|Overall Study||52
8812350|NCT01519453|9865310|FG001|NOT COMPLETED|Overall Study||36
8812351|NCT01519466|9865318|FG000|STARTED|Overall Study||33
8812352|NCT01519466|9865319|FG001|STARTED|Overall Study||16
8812353|NCT01519466|9865318|FG000|COMPLETED|Overall Study||33
8812354|NCT01519466|9865319|FG001|COMPLETED|Overall Study||16
8812355|NCT01519466|9865318|FG000|NOT COMPLETED|Overall Study||0
8812356|NCT01519466|9865319|FG001|NOT COMPLETED|Overall Study||0
8812357|NCT01519518|9865327|FG000|STARTED|Overall Study||914
8812358|NCT01519518|9865328|FG001|STARTED|Overall Study||915
8812359|NCT01519518|9865327|FG000|COMPLETED|Overall Study||907
8812360|NCT01519518|9865328|FG001|COMPLETED|Overall Study||905
8812361|NCT01519518|9865327|FG000|NOT COMPLETED|Overall Study||7
8812362|NCT01519518|9865328|FG001|NOT COMPLETED|Overall Study||10
8812363|NCT01519570|9865336|FG000|STARTED|Overall Study||500
8812364|NCT01519570|9865337|FG001|STARTED|Overall Study||2089
8812365|NCT01519570|9865336|FG000|COMPLETED|Overall Study||500
8700247|NCT00905307|9745814|FG005|NOT COMPLETED|Overall Study||42
8700248|NCT00905359|9745843|FG000|STARTED|Overall Study||82
8812366|NCT01519570|9865337|FG001|COMPLETED|Overall Study||2089
8700249|NCT00905359|9745844|FG001|STARTED|Overall Study||81
9042838|NCT03390114|10103551|FG000|STARTED|Overall Study||10
9042839|NCT03390114|10103552|FG001|STARTED|Overall Study||10
9042840|NCT03390114|10103551|FG000|COMPLETED|Overall Study||6
9042841|NCT03390114|10103552|FG001|COMPLETED|Overall Study||8
9042842|NCT03390114|10103551|FG000|NOT COMPLETED|Overall Study||4
9042843|NCT03390114|10103552|FG001|NOT COMPLETED|Overall Study||2
9042844|NCT03390166|10103560|FG000|STARTED|Overall Study||630
9042845|NCT03390166|10103561|FG001|STARTED|Overall Study||315
9042846|NCT03390166|10103560|FG000|COMPLETED|Overall Study||618
9042847|NCT03390166|10103561|FG001|COMPLETED|Overall Study||305
9042848|NCT03390166|10103560|FG000|NOT COMPLETED|Overall Study||12
9042849|NCT03390166|10103561|FG001|NOT COMPLETED|Overall Study||10
9042850|NCT03390257|10103567|FG000|STARTED|Overall Study||14
9042851|NCT03390257|10103567|FG000|COMPLETED|Overall Study||14
9042852|NCT03390257|10103567|FG000|NOT COMPLETED|Overall Study||0
8700250|NCT00905359|9745843|FG000|12 Months Follow up|Overall Study||68
8700251|NCT00905359|9745844|FG001|12 Months Follow up|Overall Study||72
8700252|NCT00905359|9745843|FG000|24 Months Follow up|Overall Study||58
8700253|NCT00905359|9745844|FG001|24 Months Follow up|Overall Study||65
8700254|NCT00905359|9745843|FG000|COMPLETED|Overall Study||58
8700255|NCT00905359|9745844|FG001|COMPLETED|Overall Study||65
8700256|NCT00905359|9745843|FG000|NOT COMPLETED|Overall Study||24
8700257|NCT00905359|9745844|FG001|NOT COMPLETED|Overall Study||16
8700258|NCT00905424|9745852|FG000|STARTED|Overall Study||89
8700259|NCT00905424|9745853|FG001|STARTED|Overall Study||88
8700260|NCT00905424|9745852|FG000|COMPLETED|Overall Study||78
8700261|NCT00905424|9745853|FG001|COMPLETED|Overall Study||79
8700262|NCT00905424|9745852|FG000|NOT COMPLETED|Overall Study||11
8700263|NCT00905424|9745853|FG001|NOT COMPLETED|Overall Study||9
8700264|NCT00905437|9745863|FG000|STARTED|Overall Study||35
8700265|NCT00905437|9745864|FG001|STARTED|Overall Study||37
8700266|NCT00905437|9745863|FG000|COMPLETED|Overall Study||27
8700267|NCT00905437|9745864|FG001|COMPLETED|Overall Study||27
8700268|NCT00905437|9745863|FG000|NOT COMPLETED|Overall Study||8
8700269|NCT00905437|9745864|FG001|NOT COMPLETED|Overall Study||10
8700270|NCT00905450|9745878|FG000|STARTED|Overall Study||60
8700271|NCT00905450|9745879|FG001|STARTED|Overall Study||28
8700272|NCT00905450|9745880|FG002|STARTED|Overall Study||28
8700273|NCT00905450|9745881|FG003|STARTED|Overall Study||60
8700274|NCT00905450|9745882|FG004|STARTED|Overall Study||59
8700275|NCT00905450|9745883|FG005|STARTED|Overall Study||60
8700276|NCT00905450|9745884|FG006|STARTED|Overall Study||60
8700277|NCT00905450|9745885|FG007|STARTED|Overall Study||60
8700278|NCT00905450|9745878|FG000|COMPLETED|Overall Study||59
8700279|NCT00905450|9745879|FG001|COMPLETED|Overall Study||27
8700280|NCT00905450|9745880|FG002|COMPLETED|Overall Study||28
8700281|NCT00905450|9745881|FG003|COMPLETED|Overall Study||60
8700282|NCT00905450|9745882|FG004|COMPLETED|Overall Study||59
8700283|NCT00905450|9745883|FG005|COMPLETED|Overall Study||58
8700284|NCT00905450|9745884|FG006|COMPLETED|Overall Study||58
8700285|NCT00905450|9745885|FG007|COMPLETED|Overall Study||59
8700286|NCT00905450|9745878|FG000|NOT COMPLETED|Overall Study||1
8700287|NCT00905450|9745879|FG001|NOT COMPLETED|Overall Study||1
8700288|NCT00905450|9745880|FG002|NOT COMPLETED|Overall Study||0
8700289|NCT00905450|9745881|FG003|NOT COMPLETED|Overall Study||0
8700290|NCT00905450|9745882|FG004|NOT COMPLETED|Overall Study||0
8700291|NCT00905450|9745883|FG005|NOT COMPLETED|Overall Study||2
8700292|NCT00905450|9745884|FG006|NOT COMPLETED|Overall Study||2
8700293|NCT00905450|9745885|FG007|NOT COMPLETED|Overall Study||1
8700294|NCT00905489|9745903|FG000|STARTED|Pharmaco-kinetic (PK) Phase||85
8700295|NCT00905489|9745903|FG000|COMPLETED|Pharmaco-kinetic (PK) Phase||80
8700296|NCT00905489|9745903|FG000|NOT COMPLETED|Pharmaco-kinetic (PK) Phase||5
8700297|NCT00905489|9745903|FG000|STARTED|Optional Extension Phase (OEP)|Includes only subjects who chose to continue trt with nevirapine XR after completing the PK phase.|40
8700298|NCT00905489|9745903|FG000|COMPLETED|Optional Extension Phase (OEP)||39
8700299|NCT00905489|9745903|FG000|NOT COMPLETED|Optional Extension Phase (OEP)||1
8700300|NCT00905515|9745915|FG000|STARTED|Overall Study||21
8700301|NCT00905515|9745916|FG001|STARTED|Overall Study||20
8700302|NCT00905515|9745917|FG002|STARTED|Overall Study||22
8700303|NCT00905515|9745915|FG000|COMPLETED|Overall Study||19
8700304|NCT00905515|9745916|FG001|COMPLETED|Overall Study||20
8700305|NCT00905515|9745917|FG002|COMPLETED|Overall Study||20
8700306|NCT00905515|9745915|FG000|NOT COMPLETED|Overall Study||2
8700307|NCT00905515|9745916|FG001|NOT COMPLETED|Overall Study||0
8700308|NCT00905515|9745917|FG002|NOT COMPLETED|Overall Study||2
8700309|NCT00905554|9745927|FG000|STARTED|Overall Study||116
8700310|NCT00905554|9745928|FG001|STARTED|Overall Study||114
9042853|NCT03390426|10103575|FG000|STARTED|Overall Study||15
9042854|NCT03390426|10103576|FG001|STARTED|Overall Study||16
9042855|NCT03390426|10103575|FG000|COMPLETED|Overall Study||15
9042856|NCT03390426|10103576|FG001|COMPLETED|Overall Study||15
9042857|NCT03390426|10103575|FG000|NOT COMPLETED|Overall Study||0
9042858|NCT03390426|10103576|FG001|NOT COMPLETED|Overall Study||1
8700311|NCT00905554|9745927|FG000|COMPLETED|Overall Study||116
8700312|NCT00905554|9745928|FG001|COMPLETED|Overall Study||114
8700313|NCT00905554|9745927|FG000|NOT COMPLETED|Overall Study||0
8700314|NCT00905554|9745928|FG001|NOT COMPLETED|Overall Study||0
8700315|NCT00905580|9745936|FG000|STARTED|Overall Study||49
8700316|NCT00905580|9745937|FG001|STARTED|Overall Study||50
9042859|NCT03390842|10103584|FG000|STARTED|Overall Study||114
9042860|NCT03390842|10103585|FG001|STARTED|Overall Study||82
9042861|NCT03390842|10103584|FG000|COMPLETED|Overall Study||111
9042862|NCT03390842|10103585|FG001|COMPLETED|Overall Study||74
9042863|NCT03390842|10103584|FG000|NOT COMPLETED|Overall Study||3
9042864|NCT03390842|10103585|FG001|NOT COMPLETED|Overall Study||8
9042865|NCT03390907|10103591|FG000|STARTED|Overall Study||40
9042866|NCT03390907|10103591|FG000|COMPLETED|Overall Study||40
9042867|NCT03390907|10103591|FG000|NOT COMPLETED|Overall Study||0
9042868|NCT03391115|10103598|FG000|STARTED|Overall Study||20
9042869|NCT03391115|10103599|FG001|STARTED|Overall Study||18
9042870|NCT03391115|10103598|FG000|COMPLETED|Overall Study||20
9042871|NCT03391115|10103599|FG001|COMPLETED|Overall Study|Two Nurse participants in the dyadic patient-nurse enrollment were not successfully recruited.|18
9042872|NCT03391115|10103598|FG000|NOT COMPLETED|Overall Study||0
9042873|NCT03391115|10103599|FG001|NOT COMPLETED|Overall Study||0
9042874|NCT03391765|10103609|FG000|STARTED|Overall Study||51
9042875|NCT03391765|10103610|FG001|STARTED|Overall Study||45
9042876|NCT03391765|10103611|FG002|STARTED|Overall Study||23
9042877|NCT03391765|10103612|FG003|STARTED|Overall Study||23
9042878|NCT03391765|10103609|FG000|COMPLETED|Overall Study||0
9042879|NCT03391765|10103610|FG001|COMPLETED|Overall Study||0
9042880|NCT03391765|10103611|FG002|COMPLETED|Overall Study||0
9042881|NCT03391765|10103612|FG003|COMPLETED|Overall Study||0
9042882|NCT03391765|10103609|FG000|NOT COMPLETED|Overall Study||51
9042883|NCT03391765|10103610|FG001|NOT COMPLETED|Overall Study||45
9042884|NCT03391765|10103611|FG002|NOT COMPLETED|Overall Study||23
9042885|NCT03391765|10103612|FG003|NOT COMPLETED|Overall Study||23
9042886|NCT03391986|10103625|FG000|STARTED|Overall Study||53
9042887|NCT03391986|10103626|FG001|STARTED|Overall Study||50
9042888|NCT03391986|10103627|FG002|STARTED|Overall Study||50
9042889|NCT03391986|10103625|FG000|COMPLETED|Overall Study||53
9042890|NCT03391986|10103626|FG001|COMPLETED|Overall Study||50
9042891|NCT03391986|10103627|FG002|COMPLETED|Overall Study||50
9042892|NCT03391986|10103625|FG000|NOT COMPLETED|Overall Study||0
9042893|NCT03391986|10103626|FG001|NOT COMPLETED|Overall Study||0
9042894|NCT03391986|10103627|FG002|NOT COMPLETED|Overall Study||0
9042895|NCT03392168|10103639|FG000|STARTED|Period 1: Cohort 1||8
9042896|NCT03392168|10103640|FG001|STARTED|Period 1: Cohort 1||0
9042897|NCT03392168|10103641|FG002|STARTED|Period 1: Cohort 1||0
9042898|NCT03392168|10103642|FG003|STARTED|Period 1: Cohort 1||0
9042899|NCT03392168|10103639|FG000|COMPLETED|Period 1: Cohort 1||8
9042900|NCT03392168|10103640|FG001|COMPLETED|Period 1: Cohort 1||0
9042901|NCT03392168|10103641|FG002|COMPLETED|Period 1: Cohort 1||0
9042902|NCT03392168|10103642|FG003|COMPLETED|Period 1: Cohort 1||0
9042903|NCT03392168|10103639|FG000|NOT COMPLETED|Period 1: Cohort 1||0
8700317|NCT00905580|9745936|FG000|COMPLETED|Overall Study||47
8700318|NCT00905580|9745937|FG001|COMPLETED|Overall Study||47
8700319|NCT00905580|9745936|FG000|NOT COMPLETED|Overall Study||2
8700320|NCT00905580|9745937|FG001|NOT COMPLETED|Overall Study||3
8700321|NCT00905632|9745950|FG000|STARTED|Overall Study||8
8700322|NCT00905632|9745951|FG001|STARTED|Overall Study||6
8700323|NCT00905632|9745952|FG002|STARTED|Overall Study||7
8700324|NCT00905632|9745953|FG003|STARTED|Overall Study||6
8700325|NCT00905632|9745954|FG004|STARTED|Overall Study||10
8700326|NCT00905632|9745955|FG005|STARTED|Overall Study||9
8700327|NCT00905632|9745956|FG006|STARTED|Overall Study||11
8700328|NCT00905632|9745950|FG000|COMPLETED|Overall Study||8
8700329|NCT00905632|9745951|FG001|COMPLETED|Overall Study||6
8700330|NCT00905632|9745952|FG002|COMPLETED|Overall Study||7
8700331|NCT00905632|9745953|FG003|COMPLETED|Overall Study||6
8700332|NCT00905632|9745954|FG004|COMPLETED|Overall Study||10
8700333|NCT00905632|9745955|FG005|COMPLETED|Overall Study||8
8700334|NCT00905632|9745956|FG006|COMPLETED|Overall Study||7
8700335|NCT00905632|9745950|FG000|NOT COMPLETED|Overall Study||0
8700336|NCT00905632|9745951|FG001|NOT COMPLETED|Overall Study||0
8700337|NCT00905632|9745952|FG002|NOT COMPLETED|Overall Study||0
8700338|NCT00905632|9745953|FG003|NOT COMPLETED|Overall Study||0
8700339|NCT00905632|9745954|FG004|NOT COMPLETED|Overall Study||0
8700340|NCT00905632|9745955|FG005|NOT COMPLETED|Overall Study||1
8700341|NCT00905632|9745956|FG006|NOT COMPLETED|Overall Study||4
8700342|NCT00905827|9745982|FG000|STARTED|Overall Study||70
8700343|NCT00905827|9745983|FG001|STARTED|Overall Study||69
8700344|NCT00905827|9745984|FG002|STARTED|Overall Study||73
8700345|NCT00905827|9745982|FG000|COMPLETED|Overall Study||70
8700346|NCT00905827|9745983|FG001|COMPLETED|Overall Study||69
8700347|NCT00905827|9745984|FG002|COMPLETED|Overall Study||73
8700348|NCT00905827|9745982|FG000|NOT COMPLETED|Overall Study||0
8700349|NCT00905827|9745983|FG001|NOT COMPLETED|Overall Study||0
8700350|NCT00905827|9745984|FG002|NOT COMPLETED|Overall Study||0
8700351|NCT00905840|9745992|FG000|STARTED|Overall Study||91
8700352|NCT00905840|9745992|FG000|COMPLETED|Overall Study||75
8700353|NCT00905840|9745992|FG000|NOT COMPLETED|Overall Study||16
8700354|NCT00906074|9746001|FG000|STARTED|Overall Study||90
8700355|NCT00906074|9746002|FG001|STARTED|Overall Study||90
8700356|NCT00906074|9746001|FG000|COMPLETED|Overall Study||90
8700357|NCT00906074|9746002|FG001|COMPLETED|Overall Study||90
8700358|NCT00906074|9746001|FG000|NOT COMPLETED|Overall Study||0
8700359|NCT00906074|9746002|FG001|NOT COMPLETED|Overall Study||0
9042904|NCT03392168|10103640|FG001|NOT COMPLETED|Period 1: Cohort 1||0
8700360|NCT00906087|9746008|FG000|STARTED|Initial Washout||14
8700361|NCT00906087|9746008|FG000|Completed Screening|Initial Washout||14
8700362|NCT00906087|9746008|FG000|Begin Washout|Initial Washout||13
8700363|NCT00906087|9746008|FG000|Completed Washout and Continue Protocol|Initial Washout||12
8700364|NCT00906087|9746008|FG000|COMPLETED|Initial Washout||12
8700365|NCT00906087|9746008|FG000|NOT COMPLETED|Initial Washout||2
8700366|NCT00906087|9746008|FG000|STARTED|Cosopt Treatment 6 Weeks||12
8700367|NCT00906087|9746008|FG000|COMPLETED|Cosopt Treatment 6 Weeks||12
8700368|NCT00906087|9746008|FG000|NOT COMPLETED|Cosopt Treatment 6 Weeks||0
8700369|NCT00906087|9746008|FG000|STARTED|Final Washout Period 4 Weeks||12
8700370|NCT00906087|9746008|FG000|COMPLETED|Final Washout Period 4 Weeks||12
8700371|NCT00906087|9746008|FG000|NOT COMPLETED|Final Washout Period 4 Weeks||0
8700372|NCT00906165|9746017|FG000|STARTED|Overall Study||14
8700373|NCT00906165|9746018|FG001|STARTED|Overall Study||14
8700374|NCT00906165|9746017|FG000|COMPLETED|Overall Study||10
8700375|NCT00906165|9746018|FG001|COMPLETED|Overall Study||14
8700376|NCT00906165|9746017|FG000|NOT COMPLETED|Overall Study||4
8700377|NCT00906165|9746018|FG001|NOT COMPLETED|Overall Study||0
8700378|NCT00906178|9746026|FG000|STARTED|Overall Study||183
8700379|NCT00906178|9746027|FG001|STARTED|Overall Study||183
8700380|NCT00906178|9746026|FG000|COMPLETED|Overall Study||168
8700381|NCT00906178|9746027|FG001|COMPLETED|Overall Study||167
8700382|NCT00906178|9746026|FG000|NOT COMPLETED|Overall Study||15
8700383|NCT00906178|9746027|FG001|NOT COMPLETED|Overall Study||16
8700384|NCT00906204|9746035|FG000|STARTED|Primary Endpoint (Early Safety)||45
8700385|NCT00906204|9746036|FG001|STARTED|Primary Endpoint (Early Safety)||52
8700386|NCT00906204|9746035|FG000|COMPLETED|Primary Endpoint (Early Safety)||43
8700387|NCT00906204|9746036|FG001|COMPLETED|Primary Endpoint (Early Safety)||51
8700388|NCT00906204|9746035|FG000|NOT COMPLETED|Primary Endpoint (Early Safety)||2
8700389|NCT00906204|9746036|FG001|NOT COMPLETED|Primary Endpoint (Early Safety)||1
8700390|NCT00906204|9746035|FG000|STARTED|Secondary Endpoints (Long-term Safety)||43
8700391|NCT00906204|9746036|FG001|STARTED|Secondary Endpoints (Long-term Safety)||51
8700392|NCT00906204|9746035|FG000|COMPLETED|Secondary Endpoints (Long-term Safety)||41
8700393|NCT00906204|9746036|FG001|COMPLETED|Secondary Endpoints (Long-term Safety)||48
8700394|NCT00906204|9746035|FG000|NOT COMPLETED|Secondary Endpoints (Long-term Safety)||2
8700395|NCT00906204|9746036|FG001|NOT COMPLETED|Secondary Endpoints (Long-term Safety)||3
8700396|NCT00906243|9746042|FG000|STARTED|Overall Study||6
8700397|NCT00906243|9746042|FG000|COMPLETED|Overall Study||6
8700398|NCT00906243|9746042|FG000|NOT COMPLETED|Overall Study||0
8700399|NCT00906282|9746046|FG000|STARTED|Preoperative Chemotherapy||46
8700400|NCT00906282|9746046|FG000|COMPLETED|Preoperative Chemotherapy|2 of 27 patients completed less than 4 cycles and were deemed surgical candidates.|27
8700401|NCT00906282|9746046|FG000|NOT COMPLETED|Preoperative Chemotherapy||19
8700402|NCT00906282|9746046|FG000|STARTED|Surgical Resection||27
8700403|NCT00906282|9746046|FG000|COMPLETED|Surgical Resection||27
8700404|NCT00906282|9746046|FG000|NOT COMPLETED|Surgical Resection||0
8700405|NCT00906347|9746053|FG000|STARTED|Randomized||176
8700406|NCT00906347|9746054|FG001|STARTED|Randomized||174
8700407|NCT00906347|9746053|FG000|COMPLETED|Randomized||176
8700408|NCT00906347|9746054|FG001|COMPLETED|Randomized||174
8700409|NCT00906347|9746053|FG000|NOT COMPLETED|Randomized||0
8700410|NCT00906347|9746054|FG001|NOT COMPLETED|Randomized||0
8700411|NCT00906347|9746053|FG000|STARTED|Received Study Drug||176
8700412|NCT00906347|9746054|FG001|STARTED|Received Study Drug||174
8700413|NCT00906347|9746053|FG000|COMPLETED|Received Study Drug||136
8700414|NCT00906347|9746054|FG001|COMPLETED|Received Study Drug||143
8700415|NCT00906347|9746053|FG000|NOT COMPLETED|Received Study Drug||40
8700416|NCT00906347|9746054|FG001|NOT COMPLETED|Received Study Drug||31
8700417|NCT00906373|9746062|FG000|STARTED|Overall Study||6
8700418|NCT00906373|9746063|FG001|STARTED|Overall Study||41
8700419|NCT00906373|9746062|FG000|Received Any Amount of Study Drug|Overall Study||6
8700420|NCT00906373|9746063|FG001|Received Any Amount of Study Drug|Overall Study||41
8700421|NCT00906373|9746062|FG000|COMPLETED|Overall Study||6
8700422|NCT00906373|9746063|FG001|COMPLETED|Overall Study||33
8700423|NCT00906373|9746062|FG000|NOT COMPLETED|Overall Study||0
8700424|NCT00906373|9746063|FG001|NOT COMPLETED|Overall Study||8
8700425|NCT00906399|9746073|FG000|STARTED|Year 1||500
8700426|NCT00906399|9746074|FG001|STARTED|Year 1||501
8700427|NCT00906399|9746075|FG002|STARTED|Year 1||515
8700428|NCT00906399|9746076|FG003|STARTED|Year 1||0
8700429|NCT00906399|9746077|FG004|STARTED|Year 1||0
8700430|NCT00906399|9746078|FG005|STARTED|Year 1||0
8700431|NCT00906399|9746079|FG006|STARTED|Year 1||0
8700432|NCT00906399|9746073|FG000|Completed Year 1 Study Treatment|Year 1||456
8700433|NCT00906399|9746074|FG001|Completed Year 1 Study Treatment|Year 1||438
8700434|NCT00906399|9746075|FG002|Completed Year 1 Study Treatment|Year 1||438
8700435|NCT00906399|9746076|FG003|Completed Year 1 Study Treatment|Year 1||0
8700436|NCT00906399|9746077|FG004|Completed Year 1 Study Treatment|Year 1||0
8700437|NCT00906399|9746078|FG005|Completed Year 1 Study Treatment|Year 1||0
8700438|NCT00906399|9746079|FG006|Completed Year 1 Study Treatment|Year 1||0
8700439|NCT00906399|9746073|FG000|COMPLETED|Year 1||456
8700440|NCT00906399|9746074|FG001|COMPLETED|Year 1||438
8700441|NCT00906399|9746075|FG002|COMPLETED|Year 1|1 participant discontinued treatment before end of study period but remained to complete follow-up.|439
8700442|NCT00906399|9746076|FG003|COMPLETED|Year 1||0
8700443|NCT00906399|9746077|FG004|COMPLETED|Year 1||0
8700444|NCT00906399|9746078|FG005|COMPLETED|Year 1||0
8700445|NCT00906399|9746079|FG006|COMPLETED|Year 1||0
8700446|NCT00906399|9746073|FG000|NOT COMPLETED|Year 1||44
8700447|NCT00906399|9746074|FG001|NOT COMPLETED|Year 1||63
8700448|NCT00906399|9746075|FG002|NOT COMPLETED|Year 1||76
8700449|NCT00906399|9746076|FG003|NOT COMPLETED|Year 1||0
8700450|NCT00906399|9746077|FG004|NOT COMPLETED|Year 1||0
8700451|NCT00906399|9746078|FG005|NOT COMPLETED|Year 1||0
9042905|NCT03392168|10103641|FG002|NOT COMPLETED|Period 1: Cohort 1||0
9042906|NCT03392168|10103642|FG003|NOT COMPLETED|Period 1: Cohort 1||0
9042907|NCT03392168|10103639|FG000|STARTED|Period 2: Cohort 2||0
9042908|NCT03392168|10103640|FG001|STARTED|Period 2: Cohort 2|Includes 2 participants from Cohort 1|30
9042909|NCT03392168|10103641|FG002|STARTED|Period 2: Cohort 2|Includes 2 participants from Cohort 1|28
8700452|NCT00906399|9746079|FG006|NOT COMPLETED|Year 1||0
8700453|NCT00906399|9746073|FG000|STARTED|Year 2||0
8700454|NCT00906399|9746074|FG001|STARTED|Year 2||0
8700455|NCT00906399|9746075|FG002|STARTED|Year 2||0
8700456|NCT00906399|9746076|FG003|STARTED|Year 2||228
8700457|NCT00906399|9746077|FG004|STARTED|Year 2||228
8700458|NCT00906399|9746078|FG005|STARTED|Year 2||438
8700459|NCT00906399|9746079|FG006|STARTED|Year 2||438
8700460|NCT00906399|9746073|FG000|Completed Year 2 Study Treatment|Year 2||0
8700461|NCT00906399|9746074|FG001|Completed Year 2 Study Treatment|Year 2||0
8700462|NCT00906399|9746075|FG002|Completed Year 2 Study Treatment|Year 2||0
8700463|NCT00906399|9746076|FG003|Completed Year 2 Study Treatment|Year 2||200
8700464|NCT00906399|9746077|FG004|Completed Year 2 Study Treatment|Year 2||196
8700465|NCT00906399|9746078|FG005|Completed Year 2 Study Treatment|Year 2||391
8700466|NCT00906399|9746079|FG006|Completed Year 2 Study Treatment|Year 2||411
8700467|NCT00906399|9746073|FG000|COMPLETED|Year 2||0
8700468|NCT00906399|9746074|FG001|COMPLETED|Year 2||0
8700469|NCT00906399|9746075|FG002|COMPLETED|Year 2||0
8700470|NCT00906399|9746076|FG003|COMPLETED|Year 2||198
8700471|NCT00906399|9746077|FG004|COMPLETED|Year 2||193
8700472|NCT00906399|9746078|FG005|COMPLETED|Year 2||391
8700473|NCT00906399|9746079|FG006|COMPLETED|Year 2||409
8700474|NCT00906399|9746073|FG000|NOT COMPLETED|Year 2||0
8700475|NCT00906399|9746074|FG001|NOT COMPLETED|Year 2||0
8700476|NCT00906399|9746075|FG002|NOT COMPLETED|Year 2||0
8700477|NCT00906399|9746076|FG003|NOT COMPLETED|Year 2||30
8700478|NCT00906399|9746077|FG004|NOT COMPLETED|Year 2||35
8700479|NCT00906399|9746078|FG005|NOT COMPLETED|Year 2||47
8700480|NCT00906399|9746079|FG006|NOT COMPLETED|Year 2||29
8700481|NCT00906425|9746093|FG000|STARTED|Overall Study||73
8700482|NCT00906425|9746094|FG001|STARTED|Overall Study||72
8700483|NCT00906425|9746093|FG000|6 Months|Overall Study|ITT population|69
8700484|NCT00906425|9746094|FG001|6 Months|Overall Study|ITT population|64
8700485|NCT00906425|9746093|FG000|1 Year|Overall Study|ITT population|67
8700486|NCT00906425|9746094|FG001|1 Year|Overall Study|ITT population|60
8700487|NCT00906425|9746093|FG000|2 Year|Overall Study|ITT population|62
8700488|NCT00906425|9746094|FG001|2 Year|Overall Study|ITT population|58
8700489|NCT00906425|9746093|FG000|COMPLETED|Overall Study|Clinical Trial expected to be completed in 2013|0
8700490|NCT00906425|9746094|FG001|COMPLETED|Overall Study|Clinical Trial expected to be completed in 2013|0
8700491|NCT00906425|9746093|FG000|NOT COMPLETED|Overall Study||73
8700492|NCT00906425|9746094|FG001|NOT COMPLETED|Overall Study||72
8700493|NCT00906503|9746100|FG000|STARTED|Overall Study||9
8700494|NCT00906503|9746100|FG000|COMPLETED|Overall Study||9
8700495|NCT00906503|9746100|FG000|NOT COMPLETED|Overall Study||0
8700496|NCT00906698|9746110|FG000|STARTED|Overall Study||3
8700497|NCT00906698|9746111|FG001|STARTED|Overall Study||19
8812367|NCT01519570|9865336|FG000|NOT COMPLETED|Overall Study||0
8812368|NCT01519570|9865337|FG001|NOT COMPLETED|Overall Study||0
8812369|NCT01519635|9865345|FG000|STARTED|Overall Study||12
8812370|NCT01519635|9865346|FG001|STARTED|Overall Study||12
8812371|NCT01519635|9865345|FG000|COMPLETED|Overall Study||11
8812372|NCT01519635|9865346|FG001|COMPLETED|Overall Study||9
8812373|NCT01519635|9865345|FG000|NOT COMPLETED|Overall Study||1
8812374|NCT01519635|9865346|FG001|NOT COMPLETED|Overall Study||3
8812375|NCT01519648|9865354|FG000|STARTED|Overall Study||502
8812376|NCT01519648|9865355|FG001|STARTED|Overall Study||306
8812377|NCT01519648|9865354|FG000|COMPLETED|Overall Study||502
8812378|NCT01519648|9865355|FG001|COMPLETED|Overall Study||306
8812379|NCT01519648|9865354|FG000|NOT COMPLETED|Overall Study||0
8812380|NCT01519648|9865355|FG001|NOT COMPLETED|Overall Study||0
8812381|NCT01519661|9865361|FG000|STARTED|Overall Study||157
8812382|NCT01519661|9865361|FG000|COMPLETED|Overall Study||96
8812383|NCT01519661|9865361|FG000|NOT COMPLETED|Overall Study||61
8812384|NCT01519674|9865369|FG000|STARTED|Overall Study||194
8812385|NCT01519674|9865370|FG001|STARTED|Overall Study||195
8812386|NCT01519674|9865371|FG002|STARTED|Overall Study||193
8812387|NCT01519674|9865369|FG000|Exposed|Overall Study||192
8812388|NCT01519674|9865370|FG001|Exposed|Overall Study||193
8812389|NCT01519674|9865371|FG002|Exposed|Overall Study||190
8812390|NCT01519674|9865369|FG000|COMPLETED|Overall Study||173
8812391|NCT01519674|9865370|FG001|COMPLETED|Overall Study||182
8812392|NCT01519674|9865371|FG002|COMPLETED|Overall Study||181
8812393|NCT01519674|9865369|FG000|NOT COMPLETED|Overall Study||21
8812394|NCT01519674|9865370|FG001|NOT COMPLETED|Overall Study||13
8700498|NCT00906698|9746112|FG002|STARTED|Overall Study||6
8700499|NCT00906698|9746113|FG003|STARTED|Overall Study||4
8700500|NCT00906698|9746114|FG004|STARTED|Overall Study||18
8812395|NCT01519674|9865371|FG002|NOT COMPLETED|Overall Study||12
8700501|NCT00906698|9746115|FG005|STARTED|Overall Study||5
8700502|NCT00906698|9746110|FG000|COMPLETED|Overall Study||0
8700503|NCT00906698|9746111|FG001|COMPLETED|Overall Study||0
8700504|NCT00906698|9746112|FG002|COMPLETED|Overall Study||0
8812396|NCT01519700|9865383|FG000|STARTED|Overall Study||54
8812397|NCT01519700|9865384|FG001|STARTED|Overall Study||55
8812398|NCT01519700|9865385|FG002|STARTED|Overall Study||55
8812399|NCT01519700|9865386|FG003|STARTED|Overall Study||54
9042910|NCT03392168|10103642|FG003|STARTED|Period 2: Cohort 2|Includes 2 participants from Cohort 1|31
9042911|NCT03392168|10103639|FG000|COMPLETED|Period 2: Cohort 2||0
9042912|NCT03392168|10103640|FG001|COMPLETED|Period 2: Cohort 2||28
9042913|NCT03392168|10103641|FG002|COMPLETED|Period 2: Cohort 2||27
9042914|NCT03392168|10103642|FG003|COMPLETED|Period 2: Cohort 2||30
9042915|NCT03392168|10103639|FG000|NOT COMPLETED|Period 2: Cohort 2||0
9042916|NCT03392168|10103640|FG001|NOT COMPLETED|Period 2: Cohort 2||2
9042917|NCT03392168|10103641|FG002|NOT COMPLETED|Period 2: Cohort 2||1
8700505|NCT00906698|9746113|FG003|COMPLETED|Overall Study||0
8700506|NCT00906698|9746114|FG004|COMPLETED|Overall Study||0
8700507|NCT00906698|9746115|FG005|COMPLETED|Overall Study||0
8700508|NCT00906698|9746110|FG000|NOT COMPLETED|Overall Study||3
8700509|NCT00906698|9746111|FG001|NOT COMPLETED|Overall Study||19
8700510|NCT00906698|9746112|FG002|NOT COMPLETED|Overall Study||6
8700511|NCT00906698|9746113|FG003|NOT COMPLETED|Overall Study||4
8700512|NCT00906698|9746114|FG004|NOT COMPLETED|Overall Study||18
8700513|NCT00906698|9746115|FG005|NOT COMPLETED|Overall Study||5
8700514|NCT00906776|9746149|FG000|STARTED|Overall Study||11
8700515|NCT00906776|9746150|FG001|STARTED|Overall Study||8
8700516|NCT00906776|9746149|FG000|COMPLETED|Overall Study||11
8700517|NCT00906776|9746150|FG001|COMPLETED|Overall Study||8
8700518|NCT00906776|9746149|FG000|NOT COMPLETED|Overall Study||0
8700519|NCT00906776|9746150|FG001|NOT COMPLETED|Overall Study||0
8700520|NCT00906789|9746156|FG000|STARTED|Overall Study|Radiologists served as own control. Total enrollment is 15 radiologists.|15
8700521|NCT00906789|9746156|FG000|COMPLETED|Overall Study||15
8700522|NCT00906789|9746156|FG000|NOT COMPLETED|Overall Study||0
8700523|NCT00906945|9746167|FG000|STARTED|Overall Study||3
8700524|NCT00906945|9746168|FG001|STARTED|Overall Study||3
8700525|NCT00906945|9746169|FG002|STARTED|Overall Study||3
8700526|NCT00906945|9746170|FG003|STARTED|Overall Study||7
8700527|NCT00906945|9746171|FG004|STARTED|Overall Study||7
8700528|NCT00906945|9746172|FG005|STARTED|Overall Study||16
8700529|NCT00906945|9746167|FG000|COMPLETED|Overall Study||3
8700530|NCT00906945|9746168|FG001|COMPLETED|Overall Study||3
8700531|NCT00906945|9746169|FG002|COMPLETED|Overall Study||3
8700532|NCT00906945|9746170|FG003|COMPLETED|Overall Study||6
8700533|NCT00906945|9746171|FG004|COMPLETED|Overall Study||6
8700534|NCT00906945|9746172|FG005|COMPLETED|Overall Study||14
8700535|NCT00906945|9746167|FG000|NOT COMPLETED|Overall Study||0
8700536|NCT00906945|9746168|FG001|NOT COMPLETED|Overall Study||0
8700537|NCT00906945|9746169|FG002|NOT COMPLETED|Overall Study||0
8700538|NCT00906945|9746170|FG003|NOT COMPLETED|Overall Study||1
8700539|NCT00906945|9746171|FG004|NOT COMPLETED|Overall Study||1
8700540|NCT00906945|9746172|FG005|NOT COMPLETED|Overall Study||2
8700541|NCT00906958|9746188|FG000|STARTED|Overall Study||10
8700542|NCT00906958|9746189|FG001|STARTED|Overall Study||10
8700543|NCT00906958|9746188|FG000|COMPLETED|Overall Study||10
8700544|NCT00906958|9746189|FG001|COMPLETED|Overall Study||10
8700545|NCT00906958|9746188|FG000|NOT COMPLETED|Overall Study||0
8700546|NCT00906958|9746189|FG001|NOT COMPLETED|Overall Study||0
8700547|NCT00906971|9746199|FG000|STARTED|Overall Study||36
8700548|NCT00906971|9746200|FG001|STARTED|Overall Study||36
8700549|NCT00906971|9746199|FG000|COMPLETED|Overall Study||28
8700550|NCT00906971|9746200|FG001|COMPLETED|Overall Study||33
8700551|NCT00906971|9746199|FG000|NOT COMPLETED|Overall Study||8
8700552|NCT00906971|9746200|FG001|NOT COMPLETED|Overall Study||3
8700553|NCT00907088|9746208|FG000|STARTED|Overall Study||122
8700554|NCT00907088|9746209|FG001|STARTED|Overall Study||129
8700555|NCT00907088|9746208|FG000|COMPLETED|Overall Study||102
8700556|NCT00907088|9746209|FG001|COMPLETED|Overall Study||99
8700557|NCT00907088|9746208|FG000|NOT COMPLETED|Overall Study||20
8700558|NCT00907088|9746209|FG001|NOT COMPLETED|Overall Study||30
8700559|NCT00907101|9746215|FG000|STARTED|Overall Study||30
8700560|NCT00907101|9746215|FG000|COMPLETED|Overall Study||30
8700561|NCT00907101|9746215|FG000|NOT COMPLETED|Overall Study||0
8700562|NCT00907153|9746221|FG000|STARTED|Overall Study||13
8700563|NCT00907153|9746222|FG001|STARTED|Overall Study||15
8700564|NCT00907153|9746221|FG000|COMPLETED|Overall Study||11
8700565|NCT00907153|9746222|FG001|COMPLETED|Overall Study||11
8700566|NCT00907153|9746221|FG000|NOT COMPLETED|Overall Study||2
8700567|NCT00907153|9746222|FG001|NOT COMPLETED|Overall Study||4
8700568|NCT00907257|9746230|FG000|STARTED|Overall Study||123
8700569|NCT00907257|9746231|FG001|STARTED|Overall Study||124
8700570|NCT00907257|9746230|FG000|COMPLETED|Overall Study||110
8700571|NCT00907257|9746231|FG001|COMPLETED|Overall Study||112
8700572|NCT00907257|9746230|FG000|NOT COMPLETED|Overall Study||13
8700573|NCT00907257|9746231|FG001|NOT COMPLETED|Overall Study||12
9042918|NCT03392168|10103642|FG003|NOT COMPLETED|Period 2: Cohort 2||1
8700574|NCT00907296|9746247|FG000|STARTED|Overall Study||103
8700575|NCT00907296|9746248|FG001|STARTED|Overall Study||34
8700576|NCT00907296|9746249|FG002|STARTED|Overall Study||34
8700577|NCT00907296|9746250|FG003|STARTED|Overall Study||33
8700578|NCT00907296|9746251|FG004|STARTED|Overall Study||33
8700579|NCT00907296|9746252|FG005|STARTED|Overall Study||33
8700580|NCT00907296|9746253|FG006|STARTED|Overall Study||33
8700581|NCT00907296|9746254|FG007|STARTED|Overall Study||33
8700582|NCT00907296|9746255|FG008|STARTED|Overall Study||31
8700583|NCT00907296|9746256|FG009|STARTED|Overall Study||35
8700584|NCT00907296|9746247|FG000|Received Treatment|Overall Study||100
8700585|NCT00907296|9746248|FG001|Received Treatment|Overall Study||34
8700586|NCT00907296|9746249|FG002|Received Treatment|Overall Study||34
8700587|NCT00907296|9746250|FG003|Received Treatment|Overall Study||32
9042919|NCT03392194|10103653|FG000|STARTED|Overall Study||16
9042920|NCT03392194|10103654|FG001|STARTED|Overall Study||17
9042921|NCT03392194|10103653|FG000|COMPLETED|Overall Study||14
9042922|NCT03392194|10103654|FG001|COMPLETED|Overall Study||15
9042923|NCT03392194|10103653|FG000|NOT COMPLETED|Overall Study||2
9042924|NCT03392194|10103654|FG001|NOT COMPLETED|Overall Study||2
9042925|NCT03392532|10103660|FG000|STARTED|Period 1, FIrst 30 Minutes of Wear||18
9042926|NCT03392532|10103661|FG001|STARTED|Period 1, FIrst 30 Minutes of Wear||18
9042927|NCT03392532|10103660|FG000|COMPLETED|Period 1, FIrst 30 Minutes of Wear||18
9042928|NCT03392532|10103661|FG001|COMPLETED|Period 1, FIrst 30 Minutes of Wear||18
9042929|NCT03392532|10103660|FG000|NOT COMPLETED|Period 1, FIrst 30 Minutes of Wear||0
9042930|NCT03392532|10103661|FG001|NOT COMPLETED|Period 1, FIrst 30 Minutes of Wear||0
8700588|NCT00907296|9746251|FG004|Received Treatment|Overall Study||33
8700589|NCT00907296|9746252|FG005|Received Treatment|Overall Study||32
8700590|NCT00907296|9746253|FG006|Received Treatment|Overall Study||31
8700591|NCT00907296|9746254|FG007|Received Treatment|Overall Study||32
8700592|NCT00907296|9746255|FG008|Received Treatment|Overall Study||30
8700593|NCT00907296|9746256|FG009|Received Treatment|Overall Study||35
8700594|NCT00907296|9746247|FG000|COMPLETED|Overall Study||83
8700595|NCT00907296|9746248|FG001|COMPLETED|Overall Study||29
8700596|NCT00907296|9746249|FG002|COMPLETED|Overall Study||32
8700597|NCT00907296|9746250|FG003|COMPLETED|Overall Study||29
8700598|NCT00907296|9746251|FG004|COMPLETED|Overall Study||32
8700599|NCT00907296|9746252|FG005|COMPLETED|Overall Study||24
8700600|NCT00907296|9746253|FG006|COMPLETED|Overall Study||27
8700601|NCT00907296|9746254|FG007|COMPLETED|Overall Study||26
8700602|NCT00907296|9746255|FG008|COMPLETED|Overall Study||27
8700603|NCT00907296|9746256|FG009|COMPLETED|Overall Study||28
8700604|NCT00907296|9746247|FG000|NOT COMPLETED|Overall Study||20
8700605|NCT00907296|9746248|FG001|NOT COMPLETED|Overall Study||5
8700606|NCT00907296|9746249|FG002|NOT COMPLETED|Overall Study||2
8700607|NCT00907296|9746250|FG003|NOT COMPLETED|Overall Study||4
8700608|NCT00907296|9746251|FG004|NOT COMPLETED|Overall Study||1
8700609|NCT00907296|9746252|FG005|NOT COMPLETED|Overall Study||9
8700610|NCT00907296|9746253|FG006|NOT COMPLETED|Overall Study||6
8700611|NCT00907296|9746254|FG007|NOT COMPLETED|Overall Study||7
8700612|NCT00907296|9746255|FG008|NOT COMPLETED|Overall Study||4
8700613|NCT00907296|9746256|FG009|NOT COMPLETED|Overall Study||7
8700614|NCT00907335|9746280|FG000|STARTED|Overall Study||55
8700615|NCT00907335|9746281|FG001|STARTED|Overall Study||55
8700616|NCT00907335|9746280|FG000|COMPLETED|Overall Study||47
8700617|NCT00907335|9746281|FG001|COMPLETED|Overall Study||54
8700618|NCT00907335|9746280|FG000|NOT COMPLETED|Overall Study||8
8700619|NCT00907335|9746281|FG001|NOT COMPLETED|Overall Study||1
8700620|NCT00907374|9746289|FG000|STARTED|Overall Study||14
8700621|NCT00907374|9746290|FG001|STARTED|Overall Study||13
8700622|NCT00907374|9746289|FG000|COMPLETED|Overall Study||12
8700623|NCT00907374|9746290|FG001|COMPLETED|Overall Study||11
8700624|NCT00907374|9746289|FG000|NOT COMPLETED|Overall Study||2
8700625|NCT00907374|9746290|FG001|NOT COMPLETED|Overall Study||2
8700626|NCT00907426|9746299|FG000|STARTED|Treatment Period 1 (0 to 6 Months)||215
8700627|NCT00907426|9746300|FG001|STARTED|Treatment Period 1 (0 to 6 Months)||60
8700628|NCT00907426|9746301|FG002|STARTED|Treatment Period 1 (0 to 6 Months)||93
8700629|NCT00907426|9746299|FG000|COMPLETED|Treatment Period 1 (0 to 6 Months)||195
8700630|NCT00907426|9746300|FG001|COMPLETED|Treatment Period 1 (0 to 6 Months)||55
8700631|NCT00907426|9746301|FG002|COMPLETED|Treatment Period 1 (0 to 6 Months)||84
8700632|NCT00907426|9746299|FG000|NOT COMPLETED|Treatment Period 1 (0 to 6 Months)||20
8700633|NCT00907426|9746300|FG001|NOT COMPLETED|Treatment Period 1 (0 to 6 Months)||5
8700634|NCT00907426|9746301|FG002|NOT COMPLETED|Treatment Period 1 (0 to 6 Months)||9
8700635|NCT00907426|9746299|FG000|STARTED|Treatment Period 2 (6 to 12 Months)||195
8700636|NCT00907426|9746300|FG001|STARTED|Treatment Period 2 (6 to 12 Months)||55
8700637|NCT00907426|9746301|FG002|STARTED|Treatment Period 2 (6 to 12 Months)||84
8700638|NCT00907426|9746299|FG000|COMPLETED|Treatment Period 2 (6 to 12 Months)||184
8700639|NCT00907426|9746300|FG001|COMPLETED|Treatment Period 2 (6 to 12 Months)||52
8700640|NCT00907426|9746301|FG002|COMPLETED|Treatment Period 2 (6 to 12 Months)||77
8700641|NCT00907426|9746299|FG000|NOT COMPLETED|Treatment Period 2 (6 to 12 Months)||11
8700642|NCT00907426|9746300|FG001|NOT COMPLETED|Treatment Period 2 (6 to 12 Months)||3
8700643|NCT00907426|9746301|FG002|NOT COMPLETED|Treatment Period 2 (6 to 12 Months)||7
8812400|NCT01519700|9865383|FG000|Treated Cycle 1 EP2006|Overall Study||53
8812401|NCT01519700|9865384|FG001|Treated Cycle 1 EP2006|Overall Study||54
8812402|NCT01519700|9865385|FG002|Treated Cycle 1 EP2006|Overall Study||0
8812403|NCT01519700|9865386|FG003|Treated Cycle 1 EP2006|Overall Study||0
8812404|NCT01519700|9865383|FG000|Treated Cycle 1 Neupogen|Overall Study||0
8812405|NCT01519700|9865384|FG001|Treated Cycle 1 Neupogen|Overall Study||0
8812406|NCT01519700|9865385|FG002|Treated Cycle 1 Neupogen|Overall Study||55
8812407|NCT01519700|9865386|FG003|Treated Cycle 1 Neupogen|Overall Study||52
8812408|NCT01519700|9865383|FG000|Treated Cycle 2 EP2006|Overall Study||52
8812409|NCT01519700|9865384|FG001|Treated Cycle 2 EP2006|Overall Study||0
8812410|NCT01519700|9865385|FG002|Treated Cycle 2 EP2006|Overall Study||55
9042931|NCT03392532|10103660|FG000|STARTED|Period 2, Second 30 Minutes of Wear||18
8700644|NCT00907478|9746311|FG000|STARTED|Overall Study||50
8700645|NCT00907478|9746312|FG001|STARTED|Overall Study||50
8812411|NCT01519700|9865386|FG003|Treated Cycle 2 EP2006|Overall Study||0
8812412|NCT01519700|9865383|FG000|Treated Cycle 2 Neupogen|Overall Study||0
9042932|NCT03392532|10103661|FG001|STARTED|Period 2, Second 30 Minutes of Wear||18
9042933|NCT03392532|10103660|FG000|COMPLETED|Period 2, Second 30 Minutes of Wear||18
9042934|NCT03392532|10103661|FG001|COMPLETED|Period 2, Second 30 Minutes of Wear||18
9042935|NCT03392532|10103660|FG000|NOT COMPLETED|Period 2, Second 30 Minutes of Wear||0
9042936|NCT03392532|10103661|FG001|NOT COMPLETED|Period 2, Second 30 Minutes of Wear||0
9042937|NCT03392935|10103667|FG000|STARTED|Overall Study||37
9042938|NCT03392935|10103667|FG000|COMPLETED|Overall Study||35
9042939|NCT03392935|10103667|FG000|NOT COMPLETED|Overall Study||2
9042940|NCT03392974|10103671|FG000|STARTED|Overall Study||1
9042941|NCT03392974|10103671|FG000|COMPLETED|Overall Study||1
9042942|NCT03392974|10103671|FG000|NOT COMPLETED|Overall Study||0
9042943|NCT03393000|10103676|FG000|STARTED|Overall Study|23 subjects screened|19
9042944|NCT03393000|10103676|FG000|COMPLETED|Overall Study|19 subjects treated|5
9042945|NCT03393000|10103676|FG000|NOT COMPLETED|Overall Study||14
9042946|NCT03393208|10103684|FG000|STARTED|Treatment Period 1 (Day 1-Day 3)||13
9042947|NCT03393208|10103685|FG001|STARTED|Treatment Period 1 (Day 1-Day 3)||13
9042948|NCT03393208|10103686|FG002|STARTED|Treatment Period 1 (Day 1-Day 3)||9
9042949|NCT03393208|10103687|FG003|STARTED|Treatment Period 1 (Day 1-Day 3)||9
9042950|NCT03393208|10103684|FG000|COMPLETED|Treatment Period 1 (Day 1-Day 3)||13
9042951|NCT03393208|10103685|FG001|COMPLETED|Treatment Period 1 (Day 1-Day 3)||13
9042952|NCT03393208|10103686|FG002|COMPLETED|Treatment Period 1 (Day 1-Day 3)||9
9042953|NCT03393208|10103687|FG003|COMPLETED|Treatment Period 1 (Day 1-Day 3)||9
9042954|NCT03393208|10103684|FG000|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
9042955|NCT03393208|10103685|FG001|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
9042956|NCT03393208|10103686|FG002|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
9042957|NCT03393208|10103687|FG003|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
9042958|NCT03393208|10103684|FG000|STARTED|Treatment Period 2 (Day 8- Day 10)||13
9042959|NCT03393208|10103685|FG001|STARTED|Treatment Period 2 (Day 8- Day 10)||13
9042960|NCT03393208|10103686|FG002|STARTED|Treatment Period 2 (Day 8- Day 10)||9
9042961|NCT03393208|10103687|FG003|STARTED|Treatment Period 2 (Day 8- Day 10)||9
9042962|NCT03393208|10103684|FG000|COMPLETED|Treatment Period 2 (Day 8- Day 10)||13
9042963|NCT03393208|10103685|FG001|COMPLETED|Treatment Period 2 (Day 8- Day 10)||13
9042964|NCT03393208|10103686|FG002|COMPLETED|Treatment Period 2 (Day 8- Day 10)||9
9042965|NCT03393208|10103687|FG003|COMPLETED|Treatment Period 2 (Day 8- Day 10)||9
9042966|NCT03393208|10103684|FG000|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
9042967|NCT03393208|10103685|FG001|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
9042968|NCT03393208|10103686|FG002|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
9042969|NCT03393208|10103687|FG003|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
9042970|NCT03393494|10103702|FG000|STARTED|Overall Study||329
9042971|NCT03393494|10103703|FG001|STARTED|Overall Study||331
9042972|NCT03393494|10103704|FG002|STARTED|Overall Study||165
9042973|NCT03393494|10103702|FG000|COMPLETED|Overall Study||261
9042974|NCT03393494|10103703|FG001|COMPLETED|Overall Study||256
9042975|NCT03393494|10103704|FG002|COMPLETED|Overall Study||140
9042976|NCT03393494|10103702|FG000|NOT COMPLETED|Overall Study||68
9042977|NCT03393494|10103703|FG001|NOT COMPLETED|Overall Study||75
9042978|NCT03393494|10103704|FG002|NOT COMPLETED|Overall Study||25
9042979|NCT03393754|10103714|FG000|STARTED|Overall Study||811
9042980|NCT03393754|10103715|FG001|STARTED|Overall Study||796
9042981|NCT03393754|10103714|FG000|COMPLETED|Overall Study||785
9042982|NCT03393754|10103715|FG001|COMPLETED|Overall Study||758
9042983|NCT03393754|10103714|FG000|NOT COMPLETED|Overall Study||26
9042984|NCT03393754|10103715|FG001|NOT COMPLETED|Overall Study||38
9042985|NCT03393806|10103723|FG000|STARTED|Overall Study||9
9042986|NCT03393806|10103724|FG001|STARTED|Overall Study||8
9042987|NCT03393806|10103723|FG000|COMPLETED|Overall Study||8
9042988|NCT03393806|10103724|FG001|COMPLETED|Overall Study||8
9042989|NCT03393806|10103723|FG000|NOT COMPLETED|Overall Study||1
9042990|NCT03393806|10103724|FG001|NOT COMPLETED|Overall Study||0
9042991|NCT03394391|10103733|FG000|STARTED|Overall Study||106
9042992|NCT03394391|10103734|FG001|STARTED|Overall Study||106
9042993|NCT03394391|10103733|FG000|COMPLETED|Overall Study||105
9042994|NCT03394391|10103734|FG001|COMPLETED|Overall Study||104
9042995|NCT03394391|10103733|FG000|NOT COMPLETED|Overall Study||1
9042996|NCT03394391|10103734|FG001|NOT COMPLETED|Overall Study||2
9042997|NCT03394508|10103742|FG000|STARTED|Overall Study||13
9042998|NCT03394508|10103743|FG001|STARTED|Overall Study||17
9042999|NCT03394508|10103742|FG000|COMPLETED|Overall Study||12
9043000|NCT03394508|10103743|FG001|COMPLETED|Overall Study||14
9043001|NCT03394508|10103742|FG000|NOT COMPLETED|Overall Study||1
9043002|NCT03394508|10103743|FG001|NOT COMPLETED|Overall Study||3
9043003|NCT03394768|10103753|FG000|STARTED|Overall Study||26
9043004|NCT03394768|10103753|FG000|COMPLETED|Overall Study||26
9043005|NCT03394768|10103753|FG000|NOT COMPLETED|Overall Study||0
9043006|NCT03394885|10103757|FG000|STARTED|Overall Study||18
9043007|NCT03394885|10103757|FG000|COMPLETED|Overall Study||3
9043008|NCT03394885|10103757|FG000|NOT COMPLETED|Overall Study||15
9043009|NCT03394924|10103764|FG000|STARTED|Overall Study||31
9043010|NCT03394924|10103765|FG001|STARTED|Overall Study||28
9043011|NCT03394924|10103766|FG002|STARTED|Overall Study||9
9043012|NCT03394924|10103764|FG000|COMPLETED|Overall Study||28
9043013|NCT03394924|10103765|FG001|COMPLETED|Overall Study||22
9043014|NCT03394924|10103766|FG002|COMPLETED|Overall Study||9
9043015|NCT03394924|10103764|FG000|NOT COMPLETED|Overall Study||3
9043016|NCT03394924|10103765|FG001|NOT COMPLETED|Overall Study||6
9043017|NCT03394924|10103766|FG002|NOT COMPLETED|Overall Study||0
9043018|NCT03395353|10103776|FG000|STARTED|Overall Study||151
9043019|NCT03395353|10103776|FG000|Received At Least 1 Dose of Study Drug|Overall Study||150
9043020|NCT03395353|10103776|FG000|COMPLETED|Overall Study||64
9043021|NCT03395353|10103776|FG000|NOT COMPLETED|Overall Study||87
8700646|NCT00907478|9746313|FG002|STARTED|Overall Study||69
8700647|NCT00907478|9746311|FG000|COMPLETED|Overall Study|Defined as participants who completed the full 3 years and completed the end of study visit.|23
8700648|NCT00907478|9746312|FG001|COMPLETED|Overall Study|Defined as participants who completed the full 3 years and completed the end of study visit.|33
8700649|NCT00907478|9746313|FG002|COMPLETED|Overall Study|Defined as participants who completed the full 3 years and completed the end of study visit.|47
8700650|NCT00907478|9746311|FG000|NOT COMPLETED|Overall Study||27
8700651|NCT00907478|9746312|FG001|NOT COMPLETED|Overall Study||17
8700652|NCT00907478|9746313|FG002|NOT COMPLETED|Overall Study||22
8700653|NCT00907517|9746328|FG000|STARTED|Overall Study||3
8700654|NCT00907517|9746329|FG001|STARTED|Overall Study||3
8700655|NCT00907517|9746330|FG002|STARTED|Overall Study||6
8700656|NCT00907517|9746331|FG003|STARTED|Overall Study||6
8700657|NCT00907517|9746332|FG004|STARTED|Overall Study||6
8700658|NCT00907517|9746328|FG000|COMPLETED|Overall Study||0
8700659|NCT00907517|9746329|FG001|COMPLETED|Overall Study||0
8700660|NCT00907517|9746330|FG002|COMPLETED|Overall Study||2
8700661|NCT00907517|9746331|FG003|COMPLETED|Overall Study||2
8700662|NCT00907517|9746332|FG004|COMPLETED|Overall Study||1
8700663|NCT00907517|9746328|FG000|NOT COMPLETED|Overall Study||3
8700664|NCT00907517|9746329|FG001|NOT COMPLETED|Overall Study||3
8700665|NCT00907517|9746330|FG002|NOT COMPLETED|Overall Study||4
8700666|NCT00907517|9746331|FG003|NOT COMPLETED|Overall Study||4
8700667|NCT00907517|9746332|FG004|NOT COMPLETED|Overall Study||5
8700668|NCT00907621|9746346|FG000|STARTED|Overall Study||45
8700669|NCT00907621|9746347|FG001|STARTED|Overall Study||45
8700670|NCT00907621|9746346|FG000|COMPLETED|Overall Study||38
8700671|NCT00907621|9746347|FG001|COMPLETED|Overall Study||41
8700672|NCT00907621|9746346|FG000|NOT COMPLETED|Overall Study||7
8700673|NCT00907621|9746347|FG001|NOT COMPLETED|Overall Study||4
8700674|NCT00907738|9746358|FG000|STARTED|Overall Study||13
8700675|NCT00907738|9746359|FG001|STARTED|Overall Study||1
8700676|NCT00907738|9746360|FG002|STARTED|Overall Study||7
8700677|NCT00907738|9746361|FG003|STARTED|Overall Study||4
8700678|NCT00907738|9746362|FG004|STARTED|Overall Study||2
8700679|NCT00907738|9746358|FG000|COMPLETED|Overall Study||0
8700680|NCT00907738|9746359|FG001|COMPLETED|Overall Study||0
8700681|NCT00907738|9746360|FG002|COMPLETED|Overall Study||0
8700682|NCT00907738|9746361|FG003|COMPLETED|Overall Study||0
8700683|NCT00907738|9746362|FG004|COMPLETED|Overall Study||0
8700684|NCT00907738|9746358|FG000|NOT COMPLETED|Overall Study||13
8700685|NCT00907738|9746359|FG001|NOT COMPLETED|Overall Study||1
8700686|NCT00907738|9746360|FG002|NOT COMPLETED|Overall Study||7
8700687|NCT00907738|9746361|FG003|NOT COMPLETED|Overall Study||4
8700688|NCT00907738|9746362|FG004|NOT COMPLETED|Overall Study||2
8700689|NCT00907777|9746380|FG000|STARTED|Overall Study||25
8700690|NCT00907777|9746381|FG001|STARTED|Overall Study||27
8700691|NCT00907777|9746380|FG000|COMPLETED|Overall Study||25
8700692|NCT00907777|9746381|FG001|COMPLETED|Overall Study||26
8700693|NCT00907777|9746380|FG000|NOT COMPLETED|Overall Study||0
8700694|NCT00907777|9746381|FG001|NOT COMPLETED|Overall Study||1
8700695|NCT00907803|9746390|FG000|STARTED|Overall Study||45
8700696|NCT00907803|9746391|FG001|STARTED|Overall Study||46
8700697|NCT00907803|9746392|FG002|STARTED|Overall Study||16
8700698|NCT00907803|9746390|FG000|COMPLETED|Overall Study||42
8700699|NCT00907803|9746391|FG001|COMPLETED|Overall Study||43
9043022|NCT03395808|10103784|FG000|STARTED|Overall Study||251
9043023|NCT03395808|10103784|FG000|COMPLETED|Overall Study||251
9043024|NCT03395808|10103784|FG000|NOT COMPLETED|Overall Study||0
9043025|NCT03395886|10103790|FG000|STARTED|Overall Study||52
9043026|NCT03395886|10103791|FG001|STARTED|Overall Study||38
9043027|NCT03395886|10103790|FG000|COMPLETED|Overall Study||0
9043028|NCT03395886|10103791|FG001|COMPLETED|Overall Study||0
9043029|NCT03395886|10103790|FG000|NOT COMPLETED|Overall Study||52
9043030|NCT03395886|10103791|FG001|NOT COMPLETED|Overall Study||38
9043031|NCT03395990|10103799|FG000|STARTED|Overall Study||8
9043032|NCT03395990|10103800|FG001|STARTED|Overall Study||8
9043033|NCT03395990|10103799|FG000|COMPLETED|Overall Study||8
9043034|NCT03395990|10103800|FG001|COMPLETED|Overall Study||8
9043035|NCT03395990|10103799|FG000|NOT COMPLETED|Overall Study||0
9043036|NCT03395990|10103800|FG001|NOT COMPLETED|Overall Study||0
9043037|NCT03396432|10103808|FG000|STARTED|Overall Study||283
9043038|NCT03396432|10103809|FG001|STARTED|Overall Study||283
9043039|NCT03396432|10103808|FG000|COMPLETED|Overall Study||274
9043040|NCT03396432|10103809|FG001|COMPLETED|Overall Study||277
9043041|NCT03396432|10103808|FG000|NOT COMPLETED|Overall Study||9
9043042|NCT03396432|10103809|FG001|NOT COMPLETED|Overall Study||6
9043043|NCT03396835|10103817|FG000|STARTED|Overall Study||16
9043044|NCT03396835|10103817|FG000|COMPLETED|Overall Study||14
9043045|NCT03396835|10103817|FG000|NOT COMPLETED|Overall Study||2
9043046|NCT03396913|10103823|FG000|STARTED|Overall Study||43
9043047|NCT03396913|10103824|FG001|STARTED|Overall Study||45
9043048|NCT03396913|10103823|FG000|COMPLETED|Overall Study||43
9043049|NCT03396913|10103824|FG001|COMPLETED|Overall Study||39
9043050|NCT03396913|10103823|FG000|NOT COMPLETED|Overall Study||0
9043051|NCT03396913|10103824|FG001|NOT COMPLETED|Overall Study||6
9043052|NCT03396952|10103830|FG000|STARTED|Overall Study||27
9043053|NCT03396952|10103830|FG000|COMPLETED|Overall Study||27
9043054|NCT03396952|10103830|FG000|NOT COMPLETED|Overall Study||0
9043055|NCT03397121|10103836|FG000|STARTED|Overall Study||242
9043056|NCT03397121|10103837|FG001|STARTED|Overall Study||240
9043057|NCT03397121|10103836|FG000|COMPLETED|Overall Study||235
9043058|NCT03397121|10103837|FG001|COMPLETED|Overall Study||231
9043059|NCT03397121|10103836|FG000|NOT COMPLETED|Overall Study||7
9043060|NCT03397121|10103837|FG001|NOT COMPLETED|Overall Study||9
9043061|NCT03397394|10103847|FG000|STARTED|Overall Study||47
9043062|NCT03397394|10103848|FG001|STARTED|Overall Study||30
9043063|NCT03397394|10103849|FG002|STARTED|Overall Study||20
9043064|NCT03397394|10103847|FG000|COMPLETED|Overall Study||47
9043065|NCT03397394|10103848|FG001|COMPLETED|Overall Study||30
9043066|NCT03397394|10103849|FG002|COMPLETED|Overall Study||20
9043067|NCT03397394|10103847|FG000|NOT COMPLETED|Overall Study||0
9043068|NCT03397394|10103848|FG001|NOT COMPLETED|Overall Study||0
9043069|NCT03397394|10103849|FG002|NOT COMPLETED|Overall Study||0
9043070|NCT03397771|10103861|FG000|STARTED|Overall Study||53
9043071|NCT03397771|10103862|FG001|STARTED|Overall Study||29
9043072|NCT03397771|10103861|FG000|COMPLETED|Overall Study||45
9043073|NCT03397771|10103862|FG001|COMPLETED|Overall Study||22
9043074|NCT03397771|10103861|FG000|NOT COMPLETED|Overall Study||8
9043075|NCT03397771|10103862|FG001|NOT COMPLETED|Overall Study||7
9043076|NCT03398213|10103871|FG000|STARTED|Overall Study||26
9043077|NCT03398213|10103872|FG001|STARTED|Overall Study||24
9043078|NCT03398213|10103873|FG002|STARTED|Overall Study||22
9043079|NCT03398213|10103871|FG000|COMPLETED|Overall Study||26
9043080|NCT03398213|10103872|FG001|COMPLETED|Overall Study||24
9043081|NCT03398213|10103873|FG002|COMPLETED|Overall Study||22
9043082|NCT03398213|10103871|FG000|NOT COMPLETED|Overall Study||0
9043083|NCT03398213|10103872|FG001|NOT COMPLETED|Overall Study||0
9043084|NCT03398213|10103873|FG002|NOT COMPLETED|Overall Study||0
9043085|NCT03398265|10103883|FG000|STARTED|Overall Study||7
9043086|NCT03398265|10103884|FG001|STARTED|Overall Study||8
9043087|NCT03398265|10103883|FG000|COMPLETED|Overall Study||7
9043088|NCT03398265|10103884|FG001|COMPLETED|Overall Study||8
9043089|NCT03398265|10103883|FG000|NOT COMPLETED|Overall Study||0
9043090|NCT03398265|10103884|FG001|NOT COMPLETED|Overall Study||0
9043091|NCT03398278|10103893|FG000|STARTED|Period 1||19
9043092|NCT03398278|10103894|FG001|STARTED|Period 1||19
9043093|NCT03398278|10103893|FG000|COMPLETED|Period 1||18
9043094|NCT03398278|10103894|FG001|COMPLETED|Period 1||19
9043095|NCT03398278|10103893|FG000|NOT COMPLETED|Period 1||1
9043096|NCT03398278|10103894|FG001|NOT COMPLETED|Period 1||0
8700700|NCT00907803|9746392|FG002|COMPLETED|Overall Study||16
8700701|NCT00907803|9746390|FG000|NOT COMPLETED|Overall Study||3
9043097|NCT03398278|10103893|FG000|STARTED|Period 2||18
9043098|NCT03398278|10103894|FG001|STARTED|Period 2||19
9043099|NCT03398278|10103893|FG000|COMPLETED|Period 2||16
9043100|NCT03398278|10103894|FG001|COMPLETED|Period 2||17
9043101|NCT03398278|10103893|FG000|NOT COMPLETED|Period 2||2
9043102|NCT03398278|10103894|FG001|NOT COMPLETED|Period 2||2
9043103|NCT03398330|10103916|FG000|STARTED|Period 1||21
8700702|NCT00907803|9746391|FG001|NOT COMPLETED|Overall Study||3
9043104|NCT03398330|10103917|FG001|STARTED|Period 1||21
9043105|NCT03398330|10103916|FG000|COMPLETED|Period 1||20
9043106|NCT03398330|10103917|FG001|COMPLETED|Period 1||17
9043107|NCT03398330|10103916|FG000|NOT COMPLETED|Period 1||1
9043108|NCT03398330|10103917|FG001|NOT COMPLETED|Period 1||4
9043109|NCT03398330|10103916|FG000|STARTED|Period 2||20
9043110|NCT03398330|10103917|FG001|STARTED|Period 2||17
9043111|NCT03398330|10103916|FG000|COMPLETED|Period 2||19
9043112|NCT03398330|10103917|FG001|COMPLETED|Period 2||17
9043113|NCT03398330|10103916|FG000|NOT COMPLETED|Period 2||1
9043114|NCT03398330|10103917|FG001|NOT COMPLETED|Period 2||0
9043115|NCT03398421|10103937|FG000|STARTED|Treatment Period 1 (Up to 6 Days)||20
9043116|NCT03398421|10103938|FG001|STARTED|Treatment Period 1 (Up to 6 Days)||0
9043117|NCT03398421|10103937|FG000|COMPLETED|Treatment Period 1 (Up to 6 Days)||20
9043118|NCT03398421|10103938|FG001|COMPLETED|Treatment Period 1 (Up to 6 Days)||0
9043119|NCT03398421|10103937|FG000|NOT COMPLETED|Treatment Period 1 (Up to 6 Days)||0
9043120|NCT03398421|10103938|FG001|NOT COMPLETED|Treatment Period 1 (Up to 6 Days)||0
9043121|NCT03398421|10103937|FG000|STARTED|Washout Period (Up to 14 Days)||20
9043122|NCT03398421|10103938|FG001|STARTED|Washout Period (Up to 14 Days)||0
9043123|NCT03398421|10103937|FG000|COMPLETED|Washout Period (Up to 14 Days)||20
9043124|NCT03398421|10103938|FG001|COMPLETED|Washout Period (Up to 14 Days)||0
9043125|NCT03398421|10103937|FG000|NOT COMPLETED|Washout Period (Up to 14 Days)||0
9043126|NCT03398421|10103938|FG001|NOT COMPLETED|Washout Period (Up to 14 Days)||0
9043127|NCT03398421|10103937|FG000|STARTED|Treatment Period 2 (Up to 11 Days)||0
9043128|NCT03398421|10103938|FG001|STARTED|Treatment Period 2 (Up to 11 Days)||20
9043129|NCT03398421|10103937|FG000|COMPLETED|Treatment Period 2 (Up to 11 Days)||0
9043130|NCT03398421|10103938|FG001|COMPLETED|Treatment Period 2 (Up to 11 Days)||20
9043131|NCT03398421|10103937|FG000|NOT COMPLETED|Treatment Period 2 (Up to 11 Days)||0
9043132|NCT03398421|10103938|FG001|NOT COMPLETED|Treatment Period 2 (Up to 11 Days)||0
9043133|NCT03398798|10103950|FG000|STARTED|Overall Study||9
9043134|NCT03398798|10103951|FG001|STARTED|Overall Study||9
9043135|NCT03398798|10103952|FG002|STARTED|Overall Study||9
9043136|NCT03398798|10103953|FG003|STARTED|Overall Study||9
9043137|NCT03398798|10103950|FG000|COMPLETED|Overall Study||9
9043138|NCT03398798|10103951|FG001|COMPLETED|Overall Study||9
9043139|NCT03398798|10103952|FG002|COMPLETED|Overall Study||9
9043140|NCT03398798|10103953|FG003|COMPLETED|Overall Study||9
9043141|NCT03398798|10103950|FG000|NOT COMPLETED|Overall Study||0
9043142|NCT03398798|10103951|FG001|NOT COMPLETED|Overall Study||0
9043143|NCT03398798|10103952|FG002|NOT COMPLETED|Overall Study||0
9043144|NCT03398798|10103953|FG003|NOT COMPLETED|Overall Study||0
9043145|NCT03398928|10103965|FG000|STARTED|Overall Study||50
9043146|NCT03398928|10103966|FG001|STARTED|Overall Study||31
9043147|NCT03398928|10103965|FG000|COMPLETED|Overall Study||50
9043148|NCT03398928|10103966|FG001|COMPLETED|Overall Study||31
9043149|NCT03398928|10103965|FG000|NOT COMPLETED|Overall Study||0
9043150|NCT03398928|10103966|FG001|NOT COMPLETED|Overall Study||0
9043151|NCT03399370|10103974|FG000|STARTED|Overall Study||781
9043152|NCT03399370|10103975|FG001|STARTED|Overall Study||780
9043153|NCT03399370|10103974|FG000|COMPLETED|Overall Study||721
9043154|NCT03399370|10103975|FG001|COMPLETED|Overall Study||694
9043155|NCT03399370|10103974|FG000|NOT COMPLETED|Overall Study||60
9043156|NCT03399370|10103975|FG001|NOT COMPLETED|Overall Study||86
9043157|NCT03399786|10103984|FG000|STARTED|Double-blind Treatment Period (DBTP)||22
9043158|NCT03399786|10103985|FG001|STARTED|Double-blind Treatment Period (DBTP)||43
9043159|NCT03399786|10103986|FG002|STARTED|Double-blind Treatment Period (DBTP)||0
9043160|NCT03399786|10103987|FG003|STARTED|Double-blind Treatment Period (DBTP)||0
9043161|NCT03399786|10103984|FG000|COMPLETED|Double-blind Treatment Period (DBTP)||21
9043162|NCT03399786|10103985|FG001|COMPLETED|Double-blind Treatment Period (DBTP)||43
9043163|NCT03399786|10103986|FG002|COMPLETED|Double-blind Treatment Period (DBTP)||0
9043164|NCT03399786|10103987|FG003|COMPLETED|Double-blind Treatment Period (DBTP)||0
9043165|NCT03399786|10103984|FG000|NOT COMPLETED|Double-blind Treatment Period (DBTP)||1
9043166|NCT03399786|10103985|FG001|NOT COMPLETED|Double-blind Treatment Period (DBTP)||0
9043167|NCT03399786|10103986|FG002|NOT COMPLETED|Double-blind Treatment Period (DBTP)||0
9043168|NCT03399786|10103987|FG003|NOT COMPLETED|Double-blind Treatment Period (DBTP)||0
9043169|NCT03399786|10103984|FG000|STARTED|Open-label Treatment Period (OLTP)||0
9043170|NCT03399786|10103985|FG001|STARTED|Open-label Treatment Period (OLTP)||0
9043171|NCT03399786|10103986|FG002|STARTED|Open-label Treatment Period (OLTP)|One participant from the placebo group received evinacumab during the DBTP|20
9043172|NCT03399786|10103987|FG003|STARTED|Open-label Treatment Period (OLTP)||44
9043173|NCT03399786|10103984|FG000|COMPLETED|Open-label Treatment Period (OLTP)||0
9043174|NCT03399786|10103985|FG001|COMPLETED|Open-label Treatment Period (OLTP)||0
9043175|NCT03399786|10103986|FG002|COMPLETED|Open-label Treatment Period (OLTP)||19
9043176|NCT03399786|10103987|FG003|COMPLETED|Open-label Treatment Period (OLTP)||43
9043177|NCT03399786|10103984|FG000|NOT COMPLETED|Open-label Treatment Period (OLTP)||0
9043178|NCT03399786|10103985|FG001|NOT COMPLETED|Open-label Treatment Period (OLTP)||0
9043179|NCT03399786|10103986|FG002|NOT COMPLETED|Open-label Treatment Period (OLTP)||1
9043180|NCT03399786|10103987|FG003|NOT COMPLETED|Open-label Treatment Period (OLTP)||1
9043181|NCT03400033|10103997|FG000|STARTED|Overall Study||270
9043182|NCT03400033|10103998|FG001|STARTED|Overall Study||137
9043183|NCT03400033|10103997|FG000|COMPLETED|Overall Study||269
9043184|NCT03400033|10103998|FG001|COMPLETED|Overall Study||135
9043185|NCT03400033|10103997|FG000|NOT COMPLETED|Overall Study||1
9043186|NCT03400033|10103998|FG001|NOT COMPLETED|Overall Study||2
9043187|NCT03400163|10104015|FG000|STARTED|Treatment Period||1
9043188|NCT03400163|10104016|FG001|STARTED|Treatment Period||2
9043189|NCT03400163|10104015|FG000|COMPLETED|Treatment Period||1
9043190|NCT03400163|10104016|FG001|COMPLETED|Treatment Period||2
9043191|NCT03400163|10104015|FG000|NOT COMPLETED|Treatment Period||0
9043192|NCT03400163|10104016|FG001|NOT COMPLETED|Treatment Period||0
9043193|NCT03400163|10104015|FG000|STARTED|Follow-up Period||1
9043194|NCT03400163|10104016|FG001|STARTED|Follow-up Period||2
9043195|NCT03400163|10104015|FG000|COMPLETED|Follow-up Period||1
9043196|NCT03400163|10104016|FG001|COMPLETED|Follow-up Period||2
9043197|NCT03400163|10104015|FG000|NOT COMPLETED|Follow-up Period||0
9043198|NCT03400163|10104016|FG001|NOT COMPLETED|Follow-up Period||0
9043199|NCT03400449|10104024|FG000|STARTED|Overall Study||121
9043200|NCT03400449|10104025|FG001|STARTED|Overall Study||119
9043201|NCT03400449|10104024|FG000|COMPLETED|Overall Study||120
9043202|NCT03400449|10104025|FG001|COMPLETED|Overall Study||119
9043203|NCT03400449|10104024|FG000|NOT COMPLETED|Overall Study||1
9043204|NCT03400449|10104025|FG001|NOT COMPLETED|Overall Study||0
9043205|NCT03400475|10104035|FG000|STARTED|Overall Study||24
9043206|NCT03400475|10104036|FG001|STARTED|Overall Study||22
9043207|NCT03400475|10104035|FG000|COMPLETED|Overall Study||24
9043208|NCT03400475|10104036|FG001|COMPLETED|Overall Study||22
9043209|NCT03400475|10104035|FG000|NOT COMPLETED|Overall Study||0
9043210|NCT03400475|10104036|FG001|NOT COMPLETED|Overall Study||0
9043211|NCT03400579|10104043|FG000|STARTED|Overall Study||10
9043212|NCT03400579|10104043|FG000|COMPLETED|Overall Study||10
9043213|NCT03400579|10104043|FG000|NOT COMPLETED|Overall Study||0
8700703|NCT00907803|9746392|FG002|NOT COMPLETED|Overall Study||0
8700704|NCT00907881|9746400|FG000|STARTED|Overall Study||1069
8700705|NCT00907881|9746400|FG000|COMPLETED|Overall Study||984
8700706|NCT00907881|9746400|FG000|NOT COMPLETED|Overall Study||85
8700707|NCT00908011|9746406|FG000|STARTED|Overall Study||23
8700708|NCT00908011|9746407|FG001|STARTED|Overall Study||20
8700709|NCT00908011|9746406|FG000|COMPLETED|Overall Study||21
8700710|NCT00908011|9746407|FG001|COMPLETED|Overall Study||18
8700711|NCT00908011|9746406|FG000|NOT COMPLETED|Overall Study||2
8700712|NCT00908011|9746407|FG001|NOT COMPLETED|Overall Study||2
8700713|NCT00908037|9746420|FG000|STARTED|Part1 (24 Week Dose-Finding Period)||5
8700714|NCT00908037|9746421|FG001|STARTED|Part1 (24 Week Dose-Finding Period)||5
8700715|NCT00908037|9746422|FG002|STARTED|Part1 (24 Week Dose-Finding Period)||5
8700716|NCT00908037|9746423|FG003|STARTED|Part1 (24 Week Dose-Finding Period)||0
8700717|NCT00908037|9746424|FG004|STARTED|Part1 (24 Week Dose-Finding Period)||0
8700718|NCT00908037|9746425|FG005|STARTED|Part1 (24 Week Dose-Finding Period)||0
8700719|NCT00908037|9746426|FG006|STARTED|Part1 (24 Week Dose-Finding Period)||0
8700720|NCT00908037|9746427|FG007|STARTED|Part1 (24 Week Dose-Finding Period)||0
8700721|NCT00908037|9746428|FG008|STARTED|Part1 (24 Week Dose-Finding Period)||0
8700722|NCT00908037|9746429|FG009|STARTED|Part1 (24 Week Dose-Finding Period)||0
8700723|NCT00908037|9746430|FG010|STARTED|Part1 (24 Week Dose-Finding Period)||0
8700724|NCT00908037|9746431|FG011|STARTED|Part1 (24 Week Dose-Finding Period)||0
8700725|NCT00908037|9746420|FG000|COMPLETED|Part1 (24 Week Dose-Finding Period)|Participants who completed Part 1 did not enroll in Parts 2 or 2/3|5
8700726|NCT00908037|9746421|FG001|COMPLETED|Part1 (24 Week Dose-Finding Period)|Participants who completed Part 1 did not enroll in Parts 2 or 2/3|5
8700727|NCT00908037|9746422|FG002|COMPLETED|Part1 (24 Week Dose-Finding Period)|Participants who completed Part 1 did not enroll in Parts 2 or 2/3|5
8700728|NCT00908037|9746423|FG003|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
8700729|NCT00908037|9746424|FG004|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
8700730|NCT00908037|9746425|FG005|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
8700731|NCT00908037|9746426|FG006|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
8700732|NCT00908037|9746427|FG007|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
8700733|NCT00908037|9746428|FG008|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
8700734|NCT00908037|9746429|FG009|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
8700735|NCT00908037|9746430|FG010|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
8700736|NCT00908037|9746431|FG011|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
8700737|NCT00908037|9746420|FG000|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
8700738|NCT00908037|9746421|FG001|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
8700739|NCT00908037|9746422|FG002|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
8700740|NCT00908037|9746423|FG003|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
8700741|NCT00908037|9746424|FG004|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
8700742|NCT00908037|9746425|FG005|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
8700743|NCT00908037|9746426|FG006|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
8700744|NCT00908037|9746427|FG007|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
8700745|NCT00908037|9746428|FG008|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
8700746|NCT00908037|9746429|FG009|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
8700747|NCT00908037|9746430|FG010|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
8700748|NCT00908037|9746431|FG011|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
8700749|NCT00908037|9746420|FG000|STARTED|Part 2 (7 Week Randomized Period)||0
8700750|NCT00908037|9746421|FG001|STARTED|Part 2 (7 Week Randomized Period)||0
8700751|NCT00908037|9746422|FG002|STARTED|Part 2 (7 Week Randomized Period)||0
8700752|NCT00908037|9746423|FG003|STARTED|Part 2 (7 Week Randomized Period)||8
8700753|NCT00908037|9746424|FG004|STARTED|Part 2 (7 Week Randomized Period)||16
8700754|NCT00908037|9746425|FG005|STARTED|Part 2 (7 Week Randomized Period)||9
8700755|NCT00908037|9746426|FG006|STARTED|Part 2 (7 Week Randomized Period)||19
9043214|NCT03400748|10104047|FG000|STARTED|Overall Study||6
9043215|NCT03400748|10104047|FG000|COMPLETED|Overall Study||6
9043216|NCT03400748|10104047|FG000|NOT COMPLETED|Overall Study||0
9043217|NCT03400787|10104053|FG000|STARTED|Overall Study||66
9043218|NCT03400787|10104054|FG001|STARTED|Overall Study||71
9043219|NCT03400787|10104053|FG000|3-Month Follow-up|Overall Study||64
9043220|NCT03400787|10104054|FG001|3-Month Follow-up|Overall Study||63
9043221|NCT03400787|10104053|FG000|COMPLETED|Overall Study||64
9043222|NCT03400787|10104054|FG001|COMPLETED|Overall Study||63
9043223|NCT03400787|10104053|FG000|NOT COMPLETED|Overall Study||2
9043224|NCT03400787|10104054|FG001|NOT COMPLETED|Overall Study||8
9043225|NCT03400800|10104062|FG000|STARTED|Overall Study||810
9043226|NCT03400800|10104063|FG001|STARTED|Overall Study||807
9043227|NCT03400800|10104062|FG000|COMPLETED|Overall Study||772
9043228|NCT03400800|10104063|FG001|COMPLETED|Overall Study||770
9043229|NCT03400800|10104062|FG000|NOT COMPLETED|Overall Study||38
9043230|NCT03400800|10104063|FG001|NOT COMPLETED|Overall Study||37
9043231|NCT03400852|10104071|FG000|STARTED|Blinded Treatment Period||29
9043232|NCT03400852|10104072|FG001|STARTED|Blinded Treatment Period||15
9043233|NCT03400852|10104073|FG002|STARTED|Blinded Treatment Period||0
9043234|NCT03400852|10104071|FG000|COMPLETED|Blinded Treatment Period||20
9043235|NCT03400852|10104072|FG001|COMPLETED|Blinded Treatment Period||9
9043236|NCT03400852|10104073|FG002|COMPLETED|Blinded Treatment Period||0
9043237|NCT03400852|10104071|FG000|NOT COMPLETED|Blinded Treatment Period||9
9043238|NCT03400852|10104072|FG001|NOT COMPLETED|Blinded Treatment Period||6
9043239|NCT03400852|10104073|FG002|NOT COMPLETED|Blinded Treatment Period||0
9043240|NCT03400852|10104071|FG000|STARTED|Open Label Period||0
9043241|NCT03400852|10104072|FG001|STARTED|Open Label Period||0
9043242|NCT03400852|10104073|FG002|STARTED|Open Label Period||24
9043243|NCT03400852|10104071|FG000|COMPLETED|Open Label Period||0
9043244|NCT03400852|10104072|FG001|COMPLETED|Open Label Period||0
8700756|NCT00908037|9746427|FG007|STARTED|Part 2 (7 Week Randomized Period)||5
8700757|NCT00908037|9746428|FG008|STARTED|Part 2 (7 Week Randomized Period)||10
8700758|NCT00908037|9746429|FG009|STARTED|Part 2 (7 Week Randomized Period)||0
8700759|NCT00908037|9746430|FG010|STARTED|Part 2 (7 Week Randomized Period)||0
8700760|NCT00908037|9746431|FG011|STARTED|Part 2 (7 Week Randomized Period)||0
8700761|NCT00908037|9746420|FG000|COMPLETED|Part 2 (7 Week Randomized Period)||0
8700762|NCT00908037|9746421|FG001|COMPLETED|Part 2 (7 Week Randomized Period)||0
8700763|NCT00908037|9746422|FG002|COMPLETED|Part 2 (7 Week Randomized Period)||0
8700764|NCT00908037|9746423|FG003|COMPLETED|Part 2 (7 Week Randomized Period)||7
8700765|NCT00908037|9746424|FG004|COMPLETED|Part 2 (7 Week Randomized Period)||13
8700766|NCT00908037|9746425|FG005|COMPLETED|Part 2 (7 Week Randomized Period)||9
8700767|NCT00908037|9746426|FG006|COMPLETED|Part 2 (7 Week Randomized Period)||15
8700768|NCT00908037|9746427|FG007|COMPLETED|Part 2 (7 Week Randomized Period)||5
8700769|NCT00908037|9746428|FG008|COMPLETED|Part 2 (7 Week Randomized Period)||5
8700770|NCT00908037|9746429|FG009|COMPLETED|Part 2 (7 Week Randomized Period)||0
8700771|NCT00908037|9746430|FG010|COMPLETED|Part 2 (7 Week Randomized Period)||0
8700772|NCT00908037|9746431|FG011|COMPLETED|Part 2 (7 Week Randomized Period)||0
8700773|NCT00908037|9746420|FG000|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
8700774|NCT00908037|9746421|FG001|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
8700775|NCT00908037|9746422|FG002|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
8700776|NCT00908037|9746423|FG003|NOT COMPLETED|Part 2 (7 Week Randomized Period)||1
8700777|NCT00908037|9746424|FG004|NOT COMPLETED|Part 2 (7 Week Randomized Period)||3
8700778|NCT00908037|9746425|FG005|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
8700779|NCT00908037|9746426|FG006|NOT COMPLETED|Part 2 (7 Week Randomized Period)||4
8700780|NCT00908037|9746427|FG007|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
8700781|NCT00908037|9746428|FG008|NOT COMPLETED|Part 2 (7 Week Randomized Period)||5
8700782|NCT00908037|9746429|FG009|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
8700783|NCT00908037|9746430|FG010|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
8700784|NCT00908037|9746431|FG011|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
8700785|NCT00908037|9746420|FG000|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
8700786|NCT00908037|9746421|FG001|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
8700787|NCT00908037|9746422|FG002|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
8700788|NCT00908037|9746423|FG003|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
8700789|NCT00908037|9746424|FG004|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
8700790|NCT00908037|9746425|FG005|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
8700791|NCT00908037|9746426|FG006|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
8700792|NCT00908037|9746427|FG007|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
8700793|NCT00908037|9746428|FG008|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
8700794|NCT00908037|9746429|FG009|STARTED|Part 2/3(Eltrombopag Open-Label Period)||24
8700795|NCT00908037|9746430|FG010|STARTED|Part 2/3(Eltrombopag Open-Label Period)|Two participants were randomized but did not receive treatment.|28
8700796|NCT00908037|9746431|FG011|STARTED|Part 2/3(Eltrombopag Open-Label Period)||15
8700797|NCT00908037|9746420|FG000|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
8700798|NCT00908037|9746421|FG001|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
8700799|NCT00908037|9746422|FG002|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
8700800|NCT00908037|9746423|FG003|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
8700801|NCT00908037|9746424|FG004|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
8700802|NCT00908037|9746425|FG005|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
8700803|NCT00908037|9746426|FG006|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
8700804|NCT00908037|9746427|FG007|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
8700805|NCT00908037|9746428|FG008|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
9043245|NCT03400852|10104073|FG002|COMPLETED|Open Label Period||2
9043246|NCT03400852|10104071|FG000|NOT COMPLETED|Open Label Period||0
9043247|NCT03400852|10104072|FG001|NOT COMPLETED|Open Label Period||0
9043248|NCT03400852|10104073|FG002|NOT COMPLETED|Open Label Period||22
8569412|NCT00097253|9601656|FG000|STARTED|Lavender||56
9043249|NCT03400956|10104084|FG000|STARTED|Treatment Period 1||35
9043250|NCT03400956|10104085|FG001|STARTED|Treatment Period 1||34
9043251|NCT03400956|10104086|FG002|STARTED|Treatment Period 1||34
8700806|NCT00908037|9746429|FG009|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||21
8700807|NCT00908037|9746430|FG010|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)|Two participants were randomized but did not receive treatment.|24
8700808|NCT00908037|9746431|FG011|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||12
8700809|NCT00908037|9746420|FG000|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
8700810|NCT00908037|9746421|FG001|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
8700811|NCT00908037|9746422|FG002|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
9043252|NCT03400956|10104084|FG000|Treated|Treatment Period 1||31
9043253|NCT03400956|10104085|FG001|Treated|Treatment Period 1||30
9043254|NCT03400956|10104086|FG002|Treated|Treatment Period 1||30
9043255|NCT03400956|10104084|FG000|COMPLETED|Treatment Period 1||31
9043256|NCT03400956|10104085|FG001|COMPLETED|Treatment Period 1||26
9043257|NCT03400956|10104086|FG002|COMPLETED|Treatment Period 1||25
9043258|NCT03400956|10104084|FG000|NOT COMPLETED|Treatment Period 1||4
9043259|NCT03400956|10104085|FG001|NOT COMPLETED|Treatment Period 1||8
9043260|NCT03400956|10104086|FG002|NOT COMPLETED|Treatment Period 1||9
9043261|NCT03400956|10104084|FG000|STARTED|Post-treatment Period 1||31
9043262|NCT03400956|10104085|FG001|STARTED|Post-treatment Period 1||26
9043263|NCT03400956|10104086|FG002|STARTED|Post-treatment Period 1||25
9043264|NCT03400956|10104084|FG000|COMPLETED|Post-treatment Period 1||9
9043265|NCT03400956|10104085|FG001|COMPLETED|Post-treatment Period 1||10
9043266|NCT03400956|10104086|FG002|COMPLETED|Post-treatment Period 1||9
9043267|NCT03400956|10104084|FG000|NOT COMPLETED|Post-treatment Period 1||22
9043268|NCT03400956|10104085|FG001|NOT COMPLETED|Post-treatment Period 1||16
9043269|NCT03400956|10104086|FG002|NOT COMPLETED|Post-treatment Period 1||16
9043270|NCT03400956|10104084|FG000|STARTED|Treatment Period 2||9
9043271|NCT03400956|10104085|FG001|STARTED|Treatment Period 2||10
9043272|NCT03400956|10104086|FG002|STARTED|Treatment Period 2||9
9043273|NCT03400956|10104084|FG000|COMPLETED|Treatment Period 2||5
9043274|NCT03400956|10104085|FG001|COMPLETED|Treatment Period 2||7
9043275|NCT03400956|10104086|FG002|COMPLETED|Treatment Period 2||5
9043276|NCT03400956|10104084|FG000|NOT COMPLETED|Treatment Period 2||4
9043277|NCT03400956|10104085|FG001|NOT COMPLETED|Treatment Period 2||3
9043278|NCT03400956|10104086|FG002|NOT COMPLETED|Treatment Period 2||4
9043279|NCT03400956|10104084|FG000|STARTED|Follow-up Period||6
9043280|NCT03400956|10104085|FG001|STARTED|Follow-up Period||9
9043281|NCT03400956|10104086|FG002|STARTED|Follow-up Period||7
9043282|NCT03400956|10104084|FG000|COMPLETED|Follow-up Period||6
9043283|NCT03400956|10104085|FG001|COMPLETED|Follow-up Period||9
9043284|NCT03400956|10104086|FG002|COMPLETED|Follow-up Period||5
9043285|NCT03400956|10104084|FG000|NOT COMPLETED|Follow-up Period||0
9043286|NCT03400956|10104085|FG001|NOT COMPLETED|Follow-up Period||0
9043287|NCT03400956|10104086|FG002|NOT COMPLETED|Follow-up Period||2
9043288|NCT03401229|10104099|FG000|STARTED|Overall Study||207
9043289|NCT03401229|10104100|FG001|STARTED|Overall Study||203
9043290|NCT03401229|10104099|FG000|COMPLETED|Overall Study||167
9043291|NCT03401229|10104100|FG001|COMPLETED|Overall Study||166
9043292|NCT03401229|10104099|FG000|NOT COMPLETED|Overall Study||40
9043293|NCT03401229|10104100|FG001|NOT COMPLETED|Overall Study||37
9043294|NCT03401450|10104108|FG000|STARTED|Overall Study||33
9043295|NCT03401450|10104109|FG001|STARTED|Overall Study||36
9043296|NCT03401450|10104108|FG000|COMPLETED|Overall Study||21
9043297|NCT03401450|10104109|FG001|COMPLETED|Overall Study||23
9043298|NCT03401450|10104108|FG000|NOT COMPLETED|Overall Study||12
9043299|NCT03401450|10104109|FG001|NOT COMPLETED|Overall Study||13
9043300|NCT03401671|10104117|FG000|STARTED|Overall Study||16
9043301|NCT03401671|10104118|FG001|STARTED|Overall Study||16
9043302|NCT03401671|10104117|FG000|COMPLETED|Overall Study||16
9043303|NCT03401671|10104118|FG001|COMPLETED|Overall Study||16
9043304|NCT03401671|10104117|FG000|NOT COMPLETED|Overall Study||0
9043305|NCT03401671|10104118|FG001|NOT COMPLETED|Overall Study||0
9043306|NCT03402126|10104124|FG000|STARTED|Overall Study||138
9043307|NCT03402126|10104124|FG000|COMPLETED|Overall Study||76
9043308|NCT03402126|10104124|FG000|NOT COMPLETED|Overall Study||62
9043309|NCT03402243|10104131|FG000|STARTED|Overall Study||16
9043310|NCT03402243|10104132|FG001|STARTED|Overall Study||15
9043311|NCT03402243|10104133|FG002|STARTED|Overall Study||16
9043312|NCT03402243|10104131|FG000|COMPLETED|Overall Study||13
9043313|NCT03402243|10104132|FG001|COMPLETED|Overall Study||12
9043314|NCT03402243|10104133|FG002|COMPLETED|Overall Study||14
9043315|NCT03402243|10104131|FG000|NOT COMPLETED|Overall Study||3
9043316|NCT03402243|10104132|FG001|NOT COMPLETED|Overall Study||3
9043317|NCT03402243|10104133|FG002|NOT COMPLETED|Overall Study||2
9043318|NCT03402386|10104141|FG000|STARTED|Overall Study||42
9043319|NCT03402386|10104141|FG000|Correction Group|Overall Study||2
9043320|NCT03402386|10104141|FG000|Conversion Group|Overall Study||40
9043321|NCT03402386|10104141|FG000|COMPLETED|Overall Study||36
9043322|NCT03402386|10104141|FG000|NOT COMPLETED|Overall Study||6
9043323|NCT03402555|10104145|FG000|STARTED|Overall Study||96
9043324|NCT03402555|10104145|FG000|COMPLETED|Overall Study||91
9043325|NCT03402555|10104145|FG000|NOT COMPLETED|Overall Study||5
9043326|NCT03402659|10104151|FG000|STARTED|Overall Study||83
9043327|NCT03402659|10104152|FG001|STARTED|Overall Study||78
9043328|NCT03402659|10104151|FG000|COMPLETED|Overall Study||78
9043329|NCT03402659|10104152|FG001|COMPLETED|Overall Study||73
9043330|NCT03402659|10104151|FG000|NOT COMPLETED|Overall Study||5
9043331|NCT03402659|10104152|FG001|NOT COMPLETED|Overall Study||5
9043332|NCT03402750|10104160|FG000|STARTED|Overall Study||20
9043333|NCT03402750|10104161|FG001|STARTED|Overall Study||20
9043334|NCT03402750|10104160|FG000|COMPLETED|Overall Study||18
9043335|NCT03402750|10104161|FG001|COMPLETED|Overall Study||19
9043336|NCT03402750|10104160|FG000|NOT COMPLETED|Overall Study||2
9043337|NCT03402750|10104161|FG001|NOT COMPLETED|Overall Study||1
9043338|NCT03402893|10104167|FG000|STARTED|Overall Study||21
9043339|NCT03402893|10104167|FG000|COMPLETED|Overall Study||20
9043340|NCT03402893|10104167|FG000|NOT COMPLETED|Overall Study||1
9043341|NCT03402932|10104176|FG000|STARTED|Overall Study||13
9043342|NCT03402932|10104177|FG001|STARTED|Overall Study||8
9043343|NCT03402932|10104178|FG002|STARTED|Overall Study||8
9043344|NCT03402932|10104179|FG003|STARTED|Overall Study||8
9043345|NCT03402932|10104176|FG000|COMPLETED|Overall Study||13
9043346|NCT03402932|10104177|FG001|COMPLETED|Overall Study||8
9043347|NCT03402932|10104178|FG002|COMPLETED|Overall Study||8
9043348|NCT03402932|10104179|FG003|COMPLETED|Overall Study||8
9043349|NCT03402932|10104176|FG000|NOT COMPLETED|Overall Study||0
9043350|NCT03402932|10104177|FG001|NOT COMPLETED|Overall Study||0
9043351|NCT03402932|10104178|FG002|NOT COMPLETED|Overall Study||0
8700812|NCT00908037|9746423|FG003|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
8700813|NCT00908037|9746424|FG004|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
8700814|NCT00908037|9746425|FG005|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
8700815|NCT00908037|9746426|FG006|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
8700816|NCT00908037|9746427|FG007|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
8700817|NCT00908037|9746428|FG008|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
8700818|NCT00908037|9746429|FG009|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||3
8700819|NCT00908037|9746430|FG010|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||4
8700820|NCT00908037|9746431|FG011|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||3
8700821|NCT00908076|9746485|FG000|STARTED|Overall Study||27
8700822|NCT00908076|9746486|FG001|STARTED|Overall Study||27
8700823|NCT00908076|9746485|FG000|COMPLETED|Overall Study||26
8700824|NCT00908076|9746486|FG001|COMPLETED|Overall Study||26
8700825|NCT00908076|9746485|FG000|NOT COMPLETED|Overall Study||1
8700826|NCT00908076|9746486|FG001|NOT COMPLETED|Overall Study||1
8700827|NCT00908115|9746492|FG000|STARTED|Overall Study||1258
8700828|NCT00908115|9746492|FG000|COMPLETED|Overall Study||1244
8700829|NCT00908115|9746492|FG000|NOT COMPLETED|Overall Study||14
8700830|NCT00908141|9746498|FG000|STARTED|Overall Study||8
8700831|NCT00908141|9746499|FG001|STARTED|Overall Study||9
8700832|NCT00908141|9746498|FG000|COMPLETED|Overall Study||8
8700833|NCT00908141|9746499|FG001|COMPLETED|Overall Study||8
8700834|NCT00908141|9746498|FG000|NOT COMPLETED|Overall Study||0
8700835|NCT00908141|9746499|FG001|NOT COMPLETED|Overall Study||1
8700836|NCT00908232|9746505|FG000|STARTED|Cycle 1 to 4|All participants started VD treatment for 4 cycles prior to local site response assessments|163
8700837|NCT00908232|9746506|FG001|STARTED|Cycle 1 to 4||0
8700838|NCT00908232|9746507|FG002|STARTED|Cycle 1 to 4||0
8700839|NCT00908232|9746508|FG003|STARTED|Cycle 1 to 4||0
8700840|NCT00908232|9746505|FG000|COMPLETED|Cycle 1 to 4|Of those completed, 120 subjects were assessed for response, 117 w/ Response or SD continued.|135
8700841|NCT00908232|9746506|FG001|COMPLETED|Cycle 1 to 4||0
8700842|NCT00908232|9746507|FG002|COMPLETED|Cycle 1 to 4||0
8700843|NCT00908232|9746508|FG003|COMPLETED|Cycle 1 to 4||0
8700844|NCT00908232|9746505|FG000|NOT COMPLETED|Cycle 1 to 4||28
8700845|NCT00908232|9746506|FG001|NOT COMPLETED|Cycle 1 to 4||0
8700846|NCT00908232|9746507|FG002|NOT COMPLETED|Cycle 1 to 4||0
8700847|NCT00908232|9746508|FG003|NOT COMPLETED|Cycle 1 to 4||0
8700848|NCT00908232|9746505|FG000|STARTED|Randomization (Cycle 5) to Cycle 8|Responding patients (not randomized) who received 4 more cycles of VD|98
8700849|NCT00908232|9746506|FG001|STARTED|Randomization (Cycle 5) to Cycle 8||7
8700850|NCT00908232|9746507|FG002|STARTED|Randomization (Cycle 5) to Cycle 8||8
9043352|NCT03402932|10104179|FG003|NOT COMPLETED|Overall Study||0
9043353|NCT03403036|10104193|FG000|STARTED|Overall Study||39
9043354|NCT03403036|10104193|FG000|COMPLETED|Overall Study||34
9043355|NCT03403036|10104193|FG000|NOT COMPLETED|Overall Study||5
9043356|NCT03403192|10104201|FG000|STARTED|Overall Study||41
9043357|NCT03403192|10104202|FG001|STARTED|Overall Study||40
9043358|NCT03403192|10104203|FG002|STARTED|Overall Study||40
9043359|NCT03403192|10104204|FG003|STARTED|Overall Study||42
9043360|NCT03403192|10104201|FG000|COMPLETED|Overall Study||37
9043361|NCT03403192|10104202|FG001|COMPLETED|Overall Study||36
9043362|NCT03403192|10104203|FG002|COMPLETED|Overall Study||37
9043363|NCT03403192|10104204|FG003|COMPLETED|Overall Study||36
9043364|NCT03403192|10104201|FG000|NOT COMPLETED|Overall Study||4
9043365|NCT03403192|10104202|FG001|NOT COMPLETED|Overall Study||4
9043366|NCT03403192|10104203|FG002|NOT COMPLETED|Overall Study||3
9043367|NCT03403192|10104204|FG003|NOT COMPLETED|Overall Study||6
9043368|NCT03403231|10104230|FG000|STARTED|Overall Study||9
9043369|NCT03403231|10104231|FG001|STARTED|Overall Study||9
9043370|NCT03403231|10104232|FG002|STARTED|Overall Study||9
9043371|NCT03403231|10104233|FG003|STARTED|Overall Study||9
9043372|NCT03403231|10104234|FG004|STARTED|Overall Study||9
9043373|NCT03403231|10104235|FG005|STARTED|Overall Study||9
9043374|NCT03403231|10104236|FG006|STARTED|Overall Study||9
9043375|NCT03403231|10104237|FG007|STARTED|Overall Study||9
9043376|NCT03403231|10104238|FG008|STARTED|Overall Study||9
9043377|NCT03403231|10104239|FG009|STARTED|Overall Study||9
9043378|NCT03403231|10104240|FG010|STARTED|Overall Study||9
9043379|NCT03403231|10104241|FG011|STARTED|Overall Study||9
9043380|NCT03403231|10104242|FG012|STARTED|Overall Study||9
9043381|NCT03403231|10104243|FG013|STARTED|Overall Study||9
9043382|NCT03403231|10104244|FG014|STARTED|Overall Study||9
9043383|NCT03403231|10104245|FG015|STARTED|Overall Study||9
9043384|NCT03403231|10104230|FG000|COMPLETED|Overall Study||9
9043385|NCT03403231|10104231|FG001|COMPLETED|Overall Study||9
9043386|NCT03403231|10104232|FG002|COMPLETED|Overall Study||9
9043387|NCT03403231|10104233|FG003|COMPLETED|Overall Study||9
9043388|NCT03403231|10104234|FG004|COMPLETED|Overall Study||9
9043389|NCT03403231|10104235|FG005|COMPLETED|Overall Study||9
9043390|NCT03403231|10104236|FG006|COMPLETED|Overall Study||9
9043391|NCT03403231|10104237|FG007|COMPLETED|Overall Study||9
9043392|NCT03403231|10104238|FG008|COMPLETED|Overall Study||9
9043393|NCT03403231|10104239|FG009|COMPLETED|Overall Study||9
9043394|NCT03403231|10104240|FG010|COMPLETED|Overall Study||9
9043395|NCT03403231|10104241|FG011|COMPLETED|Overall Study||9
9043396|NCT03403231|10104242|FG012|COMPLETED|Overall Study||9
9043397|NCT03403231|10104243|FG013|COMPLETED|Overall Study||9
9043398|NCT03403231|10104244|FG014|COMPLETED|Overall Study||9
9043399|NCT03403231|10104245|FG015|COMPLETED|Overall Study||9
9043400|NCT03403231|10104230|FG000|NOT COMPLETED|Overall Study||0
9043401|NCT03403231|10104231|FG001|NOT COMPLETED|Overall Study||0
8700851|NCT00908232|9746508|FG003|STARTED|Randomization (Cycle 5) to Cycle 8||4
8700852|NCT00908232|9746505|FG000|COMPLETED|Randomization (Cycle 5) to Cycle 8||63
8700853|NCT00908232|9746506|FG001|COMPLETED|Randomization (Cycle 5) to Cycle 8||4
8700854|NCT00908232|9746507|FG002|COMPLETED|Randomization (Cycle 5) to Cycle 8||7
8700855|NCT00908232|9746508|FG003|COMPLETED|Randomization (Cycle 5) to Cycle 8||4
8700856|NCT00908232|9746505|FG000|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||35
8700857|NCT00908232|9746506|FG001|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||3
8700858|NCT00908232|9746507|FG002|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||1
8700859|NCT00908232|9746508|FG003|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||0
8700860|NCT00908310|9746514|FG000|STARTED|Overall Study||213
8700861|NCT00908310|9746514|FG000|COMPLETED|Overall Study||153
8700862|NCT00908310|9746514|FG000|NOT COMPLETED|Overall Study||60
8700863|NCT00908349|9746518|FG000|STARTED|Overall Study||214
8700864|NCT00908349|9746518|FG000|COMPLETED|Overall Study||179
8700865|NCT00908349|9746518|FG000|NOT COMPLETED|Overall Study||35
8700866|NCT00908375|9746524|FG000|STARTED|Overall Study||20
8700867|NCT00908375|9746525|FG001|STARTED|Overall Study||19
8700868|NCT00908375|9746524|FG000|COMPLETED|Overall Study||10
8700869|NCT00908375|9746525|FG001|COMPLETED|Overall Study||9
8700870|NCT00908375|9746524|FG000|NOT COMPLETED|Overall Study||10
8700871|NCT00908375|9746525|FG001|NOT COMPLETED|Overall Study||10
8700872|NCT00908388|9746531|FG000|STARTED|Overall Study||50
8700873|NCT00908388|9746531|FG000|COMPLETED|Overall Study||40
8700874|NCT00908388|9746531|FG000|NOT COMPLETED|Overall Study||10
8700875|NCT00908466|9746537|FG000|STARTED|Overall Study||15
8700876|NCT00908466|9746538|FG001|STARTED|Overall Study||15
8700877|NCT00908466|9746537|FG000|COMPLETED|Overall Study||14
8700878|NCT00908466|9746538|FG001|COMPLETED|Overall Study||14
8700879|NCT00908466|9746537|FG000|NOT COMPLETED|Overall Study||1
8700880|NCT00908466|9746538|FG001|NOT COMPLETED|Overall Study||1
8700881|NCT00908544|9746546|FG000|STARTED|Overall Study||20
8700882|NCT00908544|9746547|FG001|STARTED|Overall Study||22
8700883|NCT00908544|9746546|FG000|COMPLETED|Overall Study||15
8700884|NCT00908544|9746547|FG001|COMPLETED|Overall Study||16
9043402|NCT03403231|10104232|FG002|NOT COMPLETED|Overall Study||0
9043403|NCT03403231|10104233|FG003|NOT COMPLETED|Overall Study||0
9043404|NCT03403231|10104234|FG004|NOT COMPLETED|Overall Study||0
9043405|NCT03403231|10104235|FG005|NOT COMPLETED|Overall Study||0
8700885|NCT00908544|9746546|FG000|NOT COMPLETED|Overall Study||5
8700886|NCT00908544|9746547|FG001|NOT COMPLETED|Overall Study||6
8700887|NCT00908583|9746553|FG000|STARTED|Phase 1||20
8700888|NCT00908583|9746553|FG000|COMPLETED|Phase 1||15
8700889|NCT00908583|9746553|FG000|NOT COMPLETED|Phase 1||5
8700890|NCT00908583|9746553|FG000|STARTED|Phase 2||12
9043406|NCT03403231|10104236|FG006|NOT COMPLETED|Overall Study||0
9043407|NCT03403231|10104237|FG007|NOT COMPLETED|Overall Study||0
9043408|NCT03403231|10104238|FG008|NOT COMPLETED|Overall Study||0
9043409|NCT03403231|10104239|FG009|NOT COMPLETED|Overall Study||0
9043410|NCT03403231|10104240|FG010|NOT COMPLETED|Overall Study||0
9043411|NCT03403231|10104241|FG011|NOT COMPLETED|Overall Study||0
9043412|NCT03403231|10104242|FG012|NOT COMPLETED|Overall Study||0
9043413|NCT03403231|10104243|FG013|NOT COMPLETED|Overall Study||0
9043414|NCT03403231|10104244|FG014|NOT COMPLETED|Overall Study||0
9043415|NCT03403231|10104245|FG015|NOT COMPLETED|Overall Study||0
9043416|NCT03403374|10104279|FG000|STARTED|Overall Study||30
9043417|NCT03403374|10104279|FG000|COMPLETED|Overall Study||29
9043418|NCT03403374|10104279|FG000|NOT COMPLETED|Overall Study||1
9043419|NCT03403400|10104286|FG000|STARTED|Overall Study||5
9043420|NCT03403400|10104287|FG001|STARTED|Overall Study||6
9043421|NCT03403400|10104288|FG002|STARTED|Overall Study||6
9043422|NCT03403400|10104286|FG000|COMPLETED|Overall Study||3
9043423|NCT03403400|10104287|FG001|COMPLETED|Overall Study||6
9043424|NCT03403400|10104288|FG002|COMPLETED|Overall Study||4
9043425|NCT03403400|10104286|FG000|NOT COMPLETED|Overall Study||2
9043426|NCT03403400|10104287|FG001|NOT COMPLETED|Overall Study||0
9043427|NCT03403400|10104288|FG002|NOT COMPLETED|Overall Study||2
9043428|NCT03403413|10104311|FG000|STARTED|Overall Study||5
9043429|NCT03403413|10104311|FG000|COMPLETED|Overall Study||3
9043430|NCT03403413|10104311|FG000|NOT COMPLETED|Overall Study||2
9043431|NCT03403426|10104317|FG000|STARTED|Overall Study||85
9043432|NCT03403426|10104317|FG000|COMPLETED|Overall Study||82
9043433|NCT03403426|10104317|FG000|NOT COMPLETED|Overall Study||3
9043434|NCT03403491|10104321|FG000|STARTED|Overall Study||20
9043435|NCT03403491|10104322|FG001|STARTED|Overall Study||23
9043436|NCT03403491|10104321|FG000|COMPLETED|Overall Study||17
9043437|NCT03403491|10104322|FG001|COMPLETED|Overall Study||18
9043438|NCT03403491|10104321|FG000|NOT COMPLETED|Overall Study||3
9043439|NCT03403491|10104322|FG001|NOT COMPLETED|Overall Study||5
9043440|NCT03403504|10104331|FG000|STARTED|Period 1||12
9043441|NCT03403504|10104332|FG001|STARTED|Period 1||12
9043442|NCT03403504|10104331|FG000|COMPLETED|Period 1||12
9043443|NCT03403504|10104332|FG001|COMPLETED|Period 1||11
9043444|NCT03403504|10104331|FG000|NOT COMPLETED|Period 1||0
9043445|NCT03403504|10104332|FG001|NOT COMPLETED|Period 1||1
9043446|NCT03403504|10104331|FG000|STARTED|Period 2||12
9043447|NCT03403504|10104332|FG001|STARTED|Period 2||11
9043448|NCT03403504|10104331|FG000|COMPLETED|Period 2||12
9043449|NCT03403504|10104332|FG001|COMPLETED|Period 2||11
9043450|NCT03403504|10104331|FG000|NOT COMPLETED|Period 2||0
9043451|NCT03403504|10104332|FG001|NOT COMPLETED|Period 2||0
9043452|NCT03403517|10104354|FG000|STARTED|Overall Study||88
9043453|NCT03403517|10104355|FG001|STARTED|Overall Study||86
8700891|NCT00908583|9746553|FG000|COMPLETED|Phase 2||10
8700892|NCT00908583|9746553|FG000|NOT COMPLETED|Phase 2||2
8700893|NCT00908583|9746553|FG000|STARTED|Phase 3||10
8700894|NCT00908583|9746553|FG000|COMPLETED|Phase 3||8
8700895|NCT00908583|9746553|FG000|NOT COMPLETED|Phase 3||2
8700896|NCT00908583|9746553|FG000|STARTED|Phase 4||5
8700897|NCT00908583|9746553|FG000|COMPLETED|Phase 4||3
8700898|NCT00908583|9746553|FG000|NOT COMPLETED|Phase 4||2
8700899|NCT00908583|9746553|FG000|STARTED|Phase 5||5
8700900|NCT00908583|9746553|FG000|COMPLETED|Phase 5||2
8700901|NCT00908583|9746553|FG000|NOT COMPLETED|Phase 5||3
8700902|NCT00908596|9746575|FG000|STARTED|Overall Study||47
8700903|NCT00908596|9746576|FG001|STARTED|Overall Study||32
8700904|NCT00908596|9746577|FG002|STARTED|Overall Study||193
8700905|NCT00908596|9746578|FG003|STARTED|Overall Study||85
8700906|NCT00908596|9746575|FG000|COMPLETED|Overall Study||0
8700907|NCT00908596|9746576|FG001|COMPLETED|Overall Study||19
8700908|NCT00908596|9746577|FG002|COMPLETED|Overall Study||119
8700909|NCT00908596|9746578|FG003|COMPLETED|Overall Study||48
8700910|NCT00908596|9746575|FG000|NOT COMPLETED|Overall Study||47
8700911|NCT00908596|9746576|FG001|NOT COMPLETED|Overall Study||13
8700912|NCT00908596|9746577|FG002|NOT COMPLETED|Overall Study||74
8700913|NCT00908596|9746578|FG003|NOT COMPLETED|Overall Study||37
8700914|NCT00908791|9746588|FG000|STARTED|Overall Study||24
8700915|NCT00908791|9746588|FG000|COMPLETED|Overall Study||24
8700916|NCT00908791|9746588|FG000|NOT COMPLETED|Overall Study||0
8700917|NCT00908830|9746603|FG000|STARTED|Overall Study||5
8700918|NCT00908830|9746604|FG001|STARTED|Overall Study||5
8700919|NCT00908830|9746603|FG000|COMPLETED|Overall Study||5
8700920|NCT00908830|9746604|FG001|COMPLETED|Overall Study||5
9043454|NCT03403517|10104354|FG000|COMPLETED|Overall Study||88
9043455|NCT03403517|10104355|FG001|COMPLETED|Overall Study||86
9043456|NCT03403517|10104354|FG000|NOT COMPLETED|Overall Study||0
9043457|NCT03403517|10104355|FG001|NOT COMPLETED|Overall Study||0
9043458|NCT03403712|10104363|FG000|STARTED|Overall Study||200
9043459|NCT03403712|10104364|FG001|STARTED|Overall Study||202
9043460|NCT03403712|10104363|FG000|COMPLETED|Overall Study||95
9043461|NCT03403712|10104364|FG001|COMPLETED|Overall Study||102
9043462|NCT03403712|10104363|FG000|NOT COMPLETED|Overall Study||105
9043463|NCT03403712|10104364|FG001|NOT COMPLETED|Overall Study||100
9043464|NCT03403725|10104381|FG000|STARTED|Overall Study||1
9043465|NCT03403725|10104382|FG001|STARTED|Overall Study||1
9043466|NCT03403725|10104383|FG002|STARTED|Overall Study||1
9043467|NCT03403725|10104384|FG003|STARTED|Overall Study||1
9043468|NCT03403725|10104385|FG004|STARTED|Overall Study||1
9043469|NCT03403725|10104386|FG005|STARTED|Overall Study||6
9043470|NCT03403725|10104387|FG006|STARTED|Overall Study||6
8700921|NCT00908830|9746603|FG000|NOT COMPLETED|Overall Study||0
8700922|NCT00908830|9746604|FG001|NOT COMPLETED|Overall Study||0
9043471|NCT03403725|10104388|FG007|STARTED|Overall Study||3
8700923|NCT00908882|9746612|FG000|STARTED|Overall Study||89
8700924|NCT00908882|9746613|FG001|STARTED|Overall Study||89
8700925|NCT00908882|9746612|FG000|COMPLETED|Overall Study||61
9043472|NCT03403725|10104389|FG008|STARTED|Overall Study||3
9043473|NCT03403725|10104390|FG009|STARTED|Overall Study||4
8700926|NCT00908882|9746613|FG001|COMPLETED|Overall Study||59
8700927|NCT00908882|9746612|FG000|NOT COMPLETED|Overall Study||28
8700928|NCT00908882|9746613|FG001|NOT COMPLETED|Overall Study||30
8700929|NCT00908895|9746621|FG000|STARTED|Overall Study||57
8700930|NCT00908895|9746622|FG001|STARTED|Overall Study||63
8700931|NCT00908895|9746621|FG000|COMPLETED|Overall Study||53
9043474|NCT03403725|10104391|FG010|STARTED|Overall Study||1
9043475|NCT03403725|10104381|FG000|COMPLETED|Overall Study||1
9043476|NCT03403725|10104382|FG001|COMPLETED|Overall Study||1
9043477|NCT03403725|10104383|FG002|COMPLETED|Overall Study||1
9043478|NCT03403725|10104384|FG003|COMPLETED|Overall Study||1
9043479|NCT03403725|10104385|FG004|COMPLETED|Overall Study||1
9043480|NCT03403725|10104386|FG005|COMPLETED|Overall Study||6
9043481|NCT03403725|10104387|FG006|COMPLETED|Overall Study||6
9043482|NCT03403725|10104388|FG007|COMPLETED|Overall Study||3
9043483|NCT03403725|10104389|FG008|COMPLETED|Overall Study||3
9043484|NCT03403725|10104390|FG009|COMPLETED|Overall Study||4
9043485|NCT03403725|10104391|FG010|COMPLETED|Overall Study||1
9043486|NCT03403725|10104381|FG000|NOT COMPLETED|Overall Study||0
9043487|NCT03403725|10104382|FG001|NOT COMPLETED|Overall Study||0
9043488|NCT03403725|10104383|FG002|NOT COMPLETED|Overall Study||0
9043489|NCT03403725|10104384|FG003|NOT COMPLETED|Overall Study||0
9043490|NCT03403725|10104385|FG004|NOT COMPLETED|Overall Study||0
9043491|NCT03403725|10104386|FG005|NOT COMPLETED|Overall Study||0
9043492|NCT03403725|10104387|FG006|NOT COMPLETED|Overall Study||0
9043493|NCT03403725|10104388|FG007|NOT COMPLETED|Overall Study||0
9043494|NCT03403725|10104389|FG008|NOT COMPLETED|Overall Study||0
9043495|NCT03403725|10104390|FG009|NOT COMPLETED|Overall Study||0
9043496|NCT03403725|10104391|FG010|NOT COMPLETED|Overall Study||0
9043497|NCT03403751|10104419|FG000|STARTED|Overall Study||28
9043498|NCT03403751|10104420|FG001|STARTED|Overall Study||30
9043499|NCT03403751|10104419|FG000|COMPLETED|Overall Study||21
9043500|NCT03403751|10104420|FG001|COMPLETED|Overall Study||22
8700932|NCT00908895|9746622|FG001|COMPLETED|Overall Study||57
8700933|NCT00908895|9746621|FG000|NOT COMPLETED|Overall Study||4
8700934|NCT00908895|9746622|FG001|NOT COMPLETED|Overall Study||6
8724390|NCT01026324|9771594|FG001|Discontinuted Intervention (Progression)|Treatment Allocation||3
8724391|NCT01026324|9771595|FG002|Discontinuted Intervention (Progression)|Treatment Allocation||4
8724392|NCT01026324|9771593|FG000|Discontinued Intervention (Withdrew)|Treatment Allocation||1
8724393|NCT01026324|9771594|FG001|Discontinued Intervention (Withdrew)|Treatment Allocation||0
8724394|NCT01026324|9771595|FG002|Discontinued Intervention (Withdrew)|Treatment Allocation||0
8724395|NCT01026324|9771593|FG000|COMPLETED|Treatment Allocation||5
8724396|NCT01026324|9771594|FG001|COMPLETED|Treatment Allocation||3
8724397|NCT01026324|9771595|FG002|COMPLETED|Treatment Allocation||4
8724398|NCT01026324|9771593|FG000|NOT COMPLETED|Treatment Allocation||0
8724399|NCT01026324|9771594|FG001|NOT COMPLETED|Treatment Allocation||0
8724400|NCT01026324|9771595|FG002|NOT COMPLETED|Treatment Allocation||0
8724401|NCT01026324|9771593|FG000|STARTED|Follow up/Survival||5
8724402|NCT01026324|9771594|FG001|STARTED|Follow up/Survival||3
8724403|NCT01026324|9771595|FG002|STARTED|Follow up/Survival||4
8724404|NCT01026324|9771593|FG000|Follow up Discontinuation (Death)|Follow up/Survival||4
8724405|NCT01026324|9771594|FG001|Follow up Discontinuation (Death)|Follow up/Survival||3
8724406|NCT01026324|9771595|FG002|Follow up Discontinuation (Death)|Follow up/Survival||4
8724407|NCT01026324|9771593|FG000|COMPLETED|Follow up/Survival||4
8724408|NCT01026324|9771594|FG001|COMPLETED|Follow up/Survival||3
8724409|NCT01026324|9771595|FG002|COMPLETED|Follow up/Survival||4
8724410|NCT01026324|9771593|FG000|NOT COMPLETED|Follow up/Survival||1
8724411|NCT01026324|9771594|FG001|NOT COMPLETED|Follow up/Survival||0
8724412|NCT01026324|9771595|FG002|NOT COMPLETED|Follow up/Survival||0
8724413|NCT01026389|9771606|FG000|STARTED|Overall Study||93
8724414|NCT01026389|9771607|FG001|STARTED|Overall Study||93
8724415|NCT01026389|9771606|FG000|COMPLETED|Overall Study||88
8724416|NCT01026389|9771607|FG001|COMPLETED|Overall Study||88
8724417|NCT01026389|9771606|FG000|NOT COMPLETED|Overall Study||5
8724418|NCT01026389|9771607|FG001|NOT COMPLETED|Overall Study||5
8724419|NCT01026402|9771630|FG000|STARTED|Overall Study||6
8724420|NCT01026402|9771631|FG001|STARTED|Overall Study||8
8724421|NCT01026402|9771632|FG002|STARTED|Overall Study||33
8724422|NCT01026402|9771633|FG003|STARTED|Overall Study||18
8724423|NCT01026402|9771634|FG004|STARTED|Overall Study||3
8724424|NCT01026402|9771635|FG005|STARTED|Overall Study||5
9043501|NCT03403751|10104419|FG000|NOT COMPLETED|Overall Study||7
9043502|NCT03403751|10104420|FG001|NOT COMPLETED|Overall Study||8
9043503|NCT03404167|10104428|FG000|STARTED|Overall Study||8
9043504|NCT03404167|10104428|FG000|COMPLETED|Overall Study||8
9043505|NCT03404167|10104428|FG000|NOT COMPLETED|Overall Study||0
9043506|NCT03404206|10104437|FG000|STARTED|Overall Study||166
9043507|NCT03404206|10104438|FG001|STARTED|Overall Study||166
9043508|NCT03404206|10104439|FG002|STARTED|Overall Study||55
9043509|NCT03404206|10104437|FG000|COMPLETED|Overall Study||162
9043510|NCT03404206|10104438|FG001|COMPLETED|Overall Study||164
8724425|NCT01026402|9771636|FG006|STARTED|Overall Study||8
8724426|NCT01026402|9771637|FG007|STARTED|Overall Study||3
8724427|NCT01026402|9771638|FG008|STARTED|Overall Study||7
8724428|NCT01026402|9771639|FG009|STARTED|Overall Study||3
8724429|NCT01026402|9771640|FG010|STARTED|Overall Study||7
9043511|NCT03404206|10104439|FG002|COMPLETED|Overall Study||55
9043512|NCT03404206|10104437|FG000|NOT COMPLETED|Overall Study||4
8724430|NCT01026402|9771641|FG011|STARTED|Overall Study||8
9043513|NCT03404206|10104438|FG001|NOT COMPLETED|Overall Study||2
9043514|NCT03404206|10104439|FG002|NOT COMPLETED|Overall Study||0
9043515|NCT03404219|10104447|FG000|STARTED|Overall Study||31
9043516|NCT03404219|10104447|FG000|COMPLETED|Overall Study||31
9043517|NCT03404219|10104447|FG000|NOT COMPLETED|Overall Study||0
9043518|NCT03404375|10104454|FG000|STARTED|Overall Study||70
9043519|NCT03404375|10104455|FG001|STARTED|Overall Study||172
9043520|NCT03404375|10104454|FG000|COMPLETED|Overall Study||70
9043521|NCT03404375|10104455|FG001|COMPLETED|Overall Study||172
9043522|NCT03404375|10104454|FG000|NOT COMPLETED|Overall Study||0
9043523|NCT03404375|10104455|FG001|NOT COMPLETED|Overall Study||0
9043524|NCT03404401|10104463|FG000|STARTED|Overall Study||281
9043525|NCT03404401|10104464|FG001|STARTED|Overall Study||271
9043526|NCT03404401|10104463|FG000|COMPLETED|Overall Study||263
9043527|NCT03404401|10104464|FG001|COMPLETED|Overall Study||252
9043528|NCT03404401|10104463|FG000|NOT COMPLETED|Overall Study||18
9043529|NCT03404401|10104464|FG001|NOT COMPLETED|Overall Study||19
9043530|NCT03404609|10104470|FG000|STARTED|Overall Study||7
9043531|NCT03404609|10104470|FG000|COMPLETED|Overall Study||7
9043532|NCT03404609|10104470|FG000|NOT COMPLETED|Overall Study||0
9043533|NCT03404648|10104474|FG000|STARTED|Overall Study||19
9043534|NCT03404648|10104474|FG000|COMPLETED|Overall Study||19
9043535|NCT03404648|10104474|FG000|NOT COMPLETED|Overall Study||0
9043536|NCT03404674|10104484|FG000|STARTED|Overall Study||5
9043537|NCT03404674|10104485|FG001|STARTED|Overall Study||5
9043538|NCT03404674|10104486|FG002|STARTED|Overall Study||10
9043539|NCT03404674|10104487|FG003|STARTED|Overall Study||10
9043540|NCT03404674|10104488|FG004|STARTED|Overall Study||10
9043541|NCT03404674|10104489|FG005|STARTED|Overall Study||10
9043542|NCT03404674|10104484|FG000|Received Dose 2|Overall Study||5
8700935|NCT00908908|9746628|FG000|STARTED|Overall Study||6
8700936|NCT00908908|9746628|FG000|Adverse Event|Overall Study||0
8700937|NCT00908908|9746628|FG000|Withdrawl by Subject|Overall Study||0
9043543|NCT03404674|10104485|FG001|Received Dose 2|Overall Study||4
9043544|NCT03404674|10104486|FG002|Received Dose 2|Overall Study||10
8700938|NCT00908908|9746628|FG000|Administrative/Other|Overall Study||0
8700939|NCT00908908|9746628|FG000|Physician Decision|Overall Study||0
8700940|NCT00908908|9746628|FG000|COMPLETED|Overall Study||6
8700941|NCT00908908|9746628|FG000|NOT COMPLETED|Overall Study||0
8700942|NCT00908947|9746632|FG000|STARTED|Overall Study||173
8700943|NCT00908947|9746632|FG000|COMPLETED|Overall Study||83
8700944|NCT00908947|9746632|FG000|NOT COMPLETED|Overall Study||90
8700945|NCT00908960|9746640|FG000|STARTED|Overall Study||24
8700946|NCT00908960|9746641|FG001|STARTED|Overall Study||12
8700947|NCT00908960|9746642|FG002|STARTED|Overall Study||34
8700948|NCT00908960|9746640|FG000|Evaluable|Overall Study||23
8700949|NCT00908960|9746641|FG001|Evaluable|Overall Study||11
8700950|NCT00908960|9746642|FG002|Evaluable|Overall Study||32
8700951|NCT00908960|9746640|FG000|COMPLETED|Overall Study||23
8700952|NCT00908960|9746641|FG001|COMPLETED|Overall Study||11
8700953|NCT00908960|9746642|FG002|COMPLETED|Overall Study||32
8700954|NCT00908960|9746640|FG000|NOT COMPLETED|Overall Study||1
8700955|NCT00908960|9746641|FG001|NOT COMPLETED|Overall Study||1
8700956|NCT00908960|9746642|FG002|NOT COMPLETED|Overall Study||2
8700957|NCT00909038|9746650|FG000|STARTED|Overall Study||2411
8700958|NCT00909038|9746650|FG000|COMPLETED|Overall Study||1994
8700959|NCT00909038|9746650|FG000|NOT COMPLETED|Overall Study||417
8700960|NCT00909064|9746654|FG000|STARTED|Overall Study||114
8700961|NCT00909064|9746654|FG000|COMPLETED|Overall Study||114
8700962|NCT00909064|9746654|FG000|NOT COMPLETED|Overall Study||0
8700963|NCT00909090|9746660|FG000|STARTED|Overall Study||53
8700964|NCT00909090|9746661|FG001|STARTED|Overall Study||56
8700965|NCT00909090|9746660|FG000|COMPLETED|Overall Study||36
8700966|NCT00909090|9746661|FG001|COMPLETED|Overall Study||39
8700967|NCT00909090|9746660|FG000|NOT COMPLETED|Overall Study||17
8700968|NCT00909090|9746661|FG001|NOT COMPLETED|Overall Study||17
8700969|NCT00909155|9746673|FG000|STARTED|Overall Study||15
8700970|NCT00909155|9746674|FG001|STARTED|Overall Study||14
8700971|NCT00909155|9746675|FG002|STARTED|Overall Study||21
8700972|NCT00909155|9746673|FG000|COMPLETED|Overall Study||12
9043545|NCT03404674|10104487|FG003|Received Dose 2|Overall Study||9
8700973|NCT00909155|9746674|FG001|COMPLETED|Overall Study||9
8700974|NCT00909155|9746675|FG002|COMPLETED|Overall Study||14
8700975|NCT00909155|9746673|FG000|NOT COMPLETED|Overall Study||3
8700976|NCT00909155|9746674|FG001|NOT COMPLETED|Overall Study||5
8700977|NCT00909155|9746675|FG002|NOT COMPLETED|Overall Study||7
8700978|NCT00909181|9746689|FG000|STARTED|Overall Study||210
8700979|NCT00909181|9746690|FG001|STARTED|Overall Study||214
8700980|NCT00909181|9746691|FG002|STARTED|Overall Study||202
9043546|NCT03404674|10104488|FG004|Received Dose 2|Overall Study||10
9043547|NCT03404674|10104489|FG005|Received Dose 2|Overall Study||10
9043548|NCT03404674|10104484|FG000|Received Dose 3|Overall Study||5
9043549|NCT03404674|10104485|FG001|Received Dose 3|Overall Study||4
9043550|NCT03404674|10104486|FG002|Received Dose 3|Overall Study||9
9043551|NCT03404674|10104487|FG003|Received Dose 3|Overall Study||9
9043552|NCT03404674|10104488|FG004|Received Dose 3|Overall Study||10
9043553|NCT03404674|10104489|FG005|Received Dose 3|Overall Study||9
9043554|NCT03404674|10104484|FG000|COMPLETED|Overall Study||5
9043555|NCT03404674|10104485|FG001|COMPLETED|Overall Study||4
8700981|NCT00909181|9746689|FG000|COMPLETED|Overall Study||171
8700982|NCT00909181|9746690|FG001|COMPLETED|Overall Study||196
8700983|NCT00909181|9746691|FG002|COMPLETED|Overall Study||169
9043556|NCT03404674|10104486|FG002|COMPLETED|Overall Study||8
9043557|NCT03404674|10104487|FG003|COMPLETED|Overall Study||9
8700984|NCT00909181|9746689|FG000|NOT COMPLETED|Overall Study||39
8700985|NCT00909181|9746690|FG001|NOT COMPLETED|Overall Study||18
8700986|NCT00909181|9746691|FG002|NOT COMPLETED|Overall Study||33
8700987|NCT00909220|9746701|FG000|STARTED|Overall Study|Started enrolling participants May 2009|41
8700988|NCT00909220|9746702|FG001|STARTED|Overall Study|Started enrolling participants May 2009|36
8700989|NCT00909220|9746701|FG000|Data Entry|Overall Study||41
8700990|NCT00909220|9746702|FG001|Data Entry|Overall Study||36
8700991|NCT00909220|9746701|FG000|Data Analyses|Overall Study||41
8700992|NCT00909220|9746702|FG001|Data Analyses|Overall Study||36
8700993|NCT00909220|9746701|FG000|Submission for Publication|Overall Study||41
8700994|NCT00909220|9746702|FG001|Submission for Publication|Overall Study||36
8700995|NCT00909220|9746701|FG000|COMPLETED|Overall Study||41
8700996|NCT00909220|9746702|FG001|COMPLETED|Overall Study||36
8700997|NCT00909220|9746701|FG000|NOT COMPLETED|Overall Study||0
8700998|NCT00909220|9746702|FG001|NOT COMPLETED|Overall Study||0
8700999|NCT00909324|9746712|FG000|STARTED|Overall Study||72
8701000|NCT00909324|9746713|FG001|STARTED|Overall Study||90
8701001|NCT00909324|9746712|FG000|COMPLETED|Overall Study||72
8701002|NCT00909324|9746713|FG001|COMPLETED|Overall Study||90
8701003|NCT00909324|9746712|FG000|NOT COMPLETED|Overall Study||0
8701004|NCT00909324|9746713|FG001|NOT COMPLETED|Overall Study||0
8701005|NCT00909363|9746722|FG000|STARTED|Overall Study||11
8701006|NCT00909363|9746723|FG001|STARTED|Overall Study||8
8701007|NCT00909363|9746724|FG002|STARTED|Overall Study||5
8701008|NCT00909363|9746722|FG000|COMPLETED|Overall Study|1 patient started bleeding 3 days after starting eltrombopag; he underwent bone marrow transplant|9
8701009|NCT00909363|9746723|FG001|COMPLETED|Overall Study||8
8701010|NCT00909363|9746724|FG002|COMPLETED|Overall Study||5
8701011|NCT00909363|9746722|FG000|NOT COMPLETED|Overall Study||2
8701012|NCT00909363|9746723|FG001|NOT COMPLETED|Overall Study||0
8701013|NCT00909363|9746724|FG002|NOT COMPLETED|Overall Study||0
8701014|NCT00909428|9746738|FG000|STARTED|Overall Study||18
8701015|NCT00909428|9746739|FG001|STARTED|Overall Study||15
8701016|NCT00909428|9746740|FG002|STARTED|Overall Study||9
8701017|NCT00909428|9746738|FG000|COMPLETED|Overall Study||5
8701018|NCT00909428|9746739|FG001|COMPLETED|Overall Study||5
8701019|NCT00909428|9746740|FG002|COMPLETED|Overall Study||0
8701020|NCT00909428|9746738|FG000|NOT COMPLETED|Overall Study||13
8701021|NCT00909428|9746739|FG001|NOT COMPLETED|Overall Study||10
8701022|NCT00909428|9746740|FG002|NOT COMPLETED|Overall Study||9
8701023|NCT00909480|9746749|FG000|STARTED|Overall Study||228
8701024|NCT00909480|9746750|FG001|STARTED|Overall Study||229
8701025|NCT00909480|9746749|FG000|Exposed|Overall Study|2 subjects withdrew before exposure to trial insulin|226
8701026|NCT00909480|9746750|FG001|Exposed|Overall Study|2 subjects withdrew before exposure to trial insulin|227
8701027|NCT00909480|9746749|FG000|COMPLETED|Overall Study||190
8701028|NCT00909480|9746750|FG001|COMPLETED|Overall Study||188
8701029|NCT00909480|9746749|FG000|NOT COMPLETED|Overall Study||38
8701030|NCT00909480|9746750|FG001|NOT COMPLETED|Overall Study||41
8812413|NCT01519700|9865384|FG001|Treated Cycle 2 Neupogen|Overall Study||52
8812414|NCT01519700|9865385|FG002|Treated Cycle 2 Neupogen|Overall Study||0
8812415|NCT01519700|9865386|FG003|Treated Cycle 2 Neupogen|Overall Study||51
8812416|NCT01519700|9865383|FG000|Treated Cycle 3 EP2006|Overall Study||51
8812417|NCT01519700|9865384|FG001|Treated Cycle 3 EP2006|Overall Study||51
8812418|NCT01519700|9865385|FG002|Treated Cycle 3 EP2006|Overall Study||0
8812419|NCT01519700|9865386|FG003|Treated Cycle 3 EP2006|Overall Study||0
8812420|NCT01519700|9865383|FG000|Treated Cycle 3 Neupogen|Overall Study||0
8812421|NCT01519700|9865384|FG001|Treated Cycle 3 Neupogen|Overall Study||0
8812422|NCT01519700|9865385|FG002|Treated Cycle 3 Neupogen|Overall Study||54
8812423|NCT01519700|9865386|FG003|Treated Cycle 3 Neupogen|Overall Study||51
8812424|NCT01519700|9865383|FG000|Treated Cycle 4 EP2006|Overall Study||51
8812425|NCT01519700|9865384|FG001|Treated Cycle 4 EP2006|Overall Study||0
8812426|NCT01519700|9865385|FG002|Treated Cycle 4 EP2006|Overall Study||50
8812427|NCT01519700|9865386|FG003|Treated Cycle 4 EP2006|Overall Study||0
8812428|NCT01519700|9865383|FG000|Treated Cycle 4 Neupogen|Overall Study||0
8812429|NCT01519700|9865384|FG001|Treated Cycle 4 Neupogen|Overall Study||51
8812430|NCT01519700|9865385|FG002|Treated Cycle 4 Neupogen|Overall Study||0
8812431|NCT01519700|9865386|FG003|Treated Cycle 4 Neupogen|Overall Study||50
8812432|NCT01519700|9865383|FG000|Treated Cycle 5 EP2006|Overall Study||46
8812433|NCT01519700|9865384|FG001|Treated Cycle 5 EP2006|Overall Study||49
8812434|NCT01519700|9865385|FG002|Treated Cycle 5 EP2006|Overall Study||0
8812435|NCT01519700|9865386|FG003|Treated Cycle 5 EP2006|Overall Study||0
8812436|NCT01519700|9865383|FG000|Treated Cycle 5 Neupogen|Overall Study||0
8812437|NCT01519700|9865384|FG001|Treated Cycle 5 Neupogen|Overall Study||0
8812438|NCT01519700|9865385|FG002|Treated Cycle 5 Neupogen|Overall Study||48
8812439|NCT01519700|9865386|FG003|Treated Cycle 5 Neupogen|Overall Study||50
8812440|NCT01519700|9865383|FG000|Treated Cycle 6 EP2006|Overall Study||45
8701031|NCT00909532|9746758|FG000|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (placebo).|78
8812441|NCT01519700|9865384|FG001|Treated Cycle 6 EP2006|Overall Study||0
8812442|NCT01519700|9865385|FG002|Treated Cycle 6 EP2006|Overall Study||48
8812443|NCT01519700|9865386|FG003|Treated Cycle 6 EP2006|Overall Study||0
8812444|NCT01519700|9865383|FG000|Treated Cycle 6 Neupogen|Overall Study||0
8812445|NCT01519700|9865384|FG001|Treated Cycle 6 Neupogen|Overall Study||49
8812446|NCT01519700|9865385|FG002|Treated Cycle 6 Neupogen|Overall Study||0
9043558|NCT03404674|10104488|FG004|COMPLETED|Overall Study||10
9043559|NCT03404674|10104489|FG005|COMPLETED|Overall Study||9
9043560|NCT03404674|10104484|FG000|NOT COMPLETED|Overall Study||0
9043561|NCT03404674|10104485|FG001|NOT COMPLETED|Overall Study||1
9043562|NCT03404674|10104486|FG002|NOT COMPLETED|Overall Study||2
9043563|NCT03404674|10104487|FG003|NOT COMPLETED|Overall Study||1
9043564|NCT03404674|10104488|FG004|NOT COMPLETED|Overall Study||0
9043565|NCT03404674|10104489|FG005|NOT COMPLETED|Overall Study||1
9043566|NCT03404843|10104506|FG000|STARTED|Overall Study||17
9043567|NCT03404843|10104507|FG001|STARTED|Overall Study||14
9043568|NCT03404843|10104506|FG000|COMPLETED|Overall Study||13
9043569|NCT03404843|10104507|FG001|COMPLETED|Overall Study||13
9043570|NCT03404843|10104506|FG000|NOT COMPLETED|Overall Study||4
9043571|NCT03404843|10104507|FG001|NOT COMPLETED|Overall Study||1
9043572|NCT03405259|10104519|FG000|STARTED|Overall Study||11
9043573|NCT03405259|10104520|FG001|STARTED|Overall Study||11
9043574|NCT03405259|10104519|FG000|COMPLETED|Overall Study||11
9043575|NCT03405259|10104520|FG001|COMPLETED|Overall Study||11
9043576|NCT03405259|10104519|FG000|NOT COMPLETED|Overall Study||0
9043577|NCT03405259|10104520|FG001|NOT COMPLETED|Overall Study||0
9043578|NCT03405363|10104528|FG000|STARTED|Overall Study||14239
9043579|NCT03405363|10104529|FG001|STARTED|Overall Study||51167
9043580|NCT03405363|10104528|FG000|COMPLETED|Overall Study||14239
9043581|NCT03405363|10104529|FG001|COMPLETED|Overall Study||51167
9043582|NCT03405363|10104528|FG000|NOT COMPLETED|Overall Study||0
9043583|NCT03405363|10104529|FG001|NOT COMPLETED|Overall Study||0
9043584|NCT03405818|10104535|FG000|STARTED|Overall Study||55
9043585|NCT03405818|10104535|FG000|COMPLETED|Overall Study||47
9043586|NCT03405818|10104535|FG000|NOT COMPLETED|Overall Study||8
9043587|NCT03405935|10104539|FG000|STARTED|Overall Study||86
9043588|NCT03405935|10104539|FG000|COMPLETED|Overall Study||78
9043589|NCT03405935|10104539|FG000|NOT COMPLETED|Overall Study||8
9043590|NCT03406260|10104549|FG000|STARTED|Period 1||6
9043591|NCT03406260|10104550|FG001|STARTED|Period 1||6
8701032|NCT00909532|9746759|FG001|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (ivacaftor).|83
8701033|NCT00909532|9746758|FG000|Completed Treatment Period, Week 24|Overall Study||71
8701034|NCT00909532|9746759|FG001|Completed Treatment Period, Week 24|Overall Study||80
8701035|NCT00909532|9746758|FG000|COMPLETED|Overall Study|Completed Treatment and Extension Periods (Through Week 48)|68
8701036|NCT00909532|9746759|FG001|COMPLETED|Overall Study|Completed Treatment and Extension Periods (Through Week 48)|77
8701037|NCT00909532|9746758|FG000|NOT COMPLETED|Overall Study||10
8701038|NCT00909532|9746759|FG001|NOT COMPLETED|Overall Study||6
8701039|NCT00909545|9746770|FG000|STARTED|Overall Study||26
8701040|NCT00909545|9746771|FG001|STARTED|Overall Study||23
8701041|NCT00909545|9746772|FG002|STARTED|Overall Study||26
8701042|NCT00909545|9746773|FG003|STARTED|Overall Study||24
8701043|NCT00909545|9746770|FG000|COMPLETED|Overall Study||25
8701044|NCT00909545|9746771|FG001|COMPLETED|Overall Study||22
8701045|NCT00909545|9746772|FG002|COMPLETED|Overall Study||25
8701046|NCT00909545|9746773|FG003|COMPLETED|Overall Study||19
8701047|NCT00909545|9746770|FG000|NOT COMPLETED|Overall Study||1
8701048|NCT00909545|9746771|FG001|NOT COMPLETED|Overall Study||1
8701049|NCT00909545|9746772|FG002|NOT COMPLETED|Overall Study||1
8701050|NCT00909545|9746773|FG003|NOT COMPLETED|Overall Study||5
8701051|NCT00909727|9746786|FG000|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (placebo)|26
8701052|NCT00909727|9746787|FG001|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (ivacaftor)|26
8701053|NCT00909727|9746786|FG000|Completed Treatment Period, Week 24|Overall Study||23
8701054|NCT00909727|9746787|FG001|Completed Treatment Period, Week 24|Overall Study||26
8701055|NCT00909727|9746786|FG000|COMPLETED|Overall Study|Completed Treatment and Extension Periods (through Week 48)|22
8701056|NCT00909727|9746787|FG001|COMPLETED|Overall Study|Completed Treatment and Extension Periods (through Week 48)|26
8701057|NCT00909727|9746786|FG000|NOT COMPLETED|Overall Study||4
8701058|NCT00909727|9746787|FG001|NOT COMPLETED|Overall Study||0
8701059|NCT00909779|9746795|FG000|STARTED|Overall Study||421
8701060|NCT00909779|9746796|FG001|STARTED|Overall Study||420
8701061|NCT00909779|9746795|FG000|COMPLETED|Overall Study|All subjects but 47 were followed for 12 months/until death (whichever was earlier).|211
8701062|NCT00909779|9746796|FG001|COMPLETED|Overall Study|All subjects but 42 were followed for 12 months/until death (whichever was earlier).|255
8701063|NCT00909779|9746795|FG000|NOT COMPLETED|Overall Study||210
8701064|NCT00909779|9746796|FG001|NOT COMPLETED|Overall Study||165
8701065|NCT00909792|9746804|FG000|STARTED|Period 1||130
8701066|NCT00909792|9746805|FG001|STARTED|Period 1||128
8701067|NCT00909792|9746804|FG000|COMPLETED|Period 1||130
8701068|NCT00909792|9746805|FG001|COMPLETED|Period 1||127
8701069|NCT00909792|9746804|FG000|NOT COMPLETED|Period 1||0
8701070|NCT00909792|9746805|FG001|NOT COMPLETED|Period 1||1
9043592|NCT03406260|10104551|FG002|STARTED|Period 1||6
9043593|NCT03406260|10104552|FG003|STARTED|Period 1||6
9043594|NCT03406260|10104553|FG004|STARTED|Period 1||6
9043595|NCT03406260|10104554|FG005|STARTED|Period 1||6
9043596|NCT03406260|10104549|FG000|Received at Least 1 Dose of Study Drug|Period 1||6
9043597|NCT03406260|10104550|FG001|Received at Least 1 Dose of Study Drug|Period 1||6
9043598|NCT03406260|10104551|FG002|Received at Least 1 Dose of Study Drug|Period 1||6
9043599|NCT03406260|10104552|FG003|Received at Least 1 Dose of Study Drug|Period 1||6
9043600|NCT03406260|10104553|FG004|Received at Least 1 Dose of Study Drug|Period 1||6
9043601|NCT03406260|10104554|FG005|Received at Least 1 Dose of Study Drug|Period 1||6
9043602|NCT03406260|10104549|FG000|COMPLETED|Period 1||6
9043603|NCT03406260|10104550|FG001|COMPLETED|Period 1||6
9043604|NCT03406260|10104551|FG002|COMPLETED|Period 1||6
9043605|NCT03406260|10104552|FG003|COMPLETED|Period 1||6
9043606|NCT03406260|10104553|FG004|COMPLETED|Period 1||5
9043607|NCT03406260|10104554|FG005|COMPLETED|Period 1||6
9043608|NCT03406260|10104549|FG000|NOT COMPLETED|Period 1||0
9043609|NCT03406260|10104550|FG001|NOT COMPLETED|Period 1||0
8701071|NCT00909792|9746804|FG000|STARTED|Period 2|One participant discontinued between Period 1 and Period 2 due to lack of efficacy.|129
8701072|NCT00909792|9746805|FG001|STARTED|Period 2|Two discontinuations between P1 & P2: 1 for fail inc/exc criteria; 1 for lack of efficacy.|125
8701073|NCT00909792|9746804|FG000|COMPLETED|Period 2||128
8701074|NCT00909792|9746805|FG001|COMPLETED|Period 2||124
8701075|NCT00909792|9746804|FG000|NOT COMPLETED|Period 2||1
8701076|NCT00909792|9746805|FG001|NOT COMPLETED|Period 2||1
8701077|NCT00909844|9746811|FG000|STARTED|Overall Study||35
8701078|NCT00909844|9746811|FG000|COMPLETED|Overall Study||31
8812447|NCT01519700|9865386|FG003|Treated Cycle 6 Neupogen|Overall Study||49
8812448|NCT01519700|9865383|FG000|COMPLETED|Overall Study||45
8812449|NCT01519700|9865384|FG001|COMPLETED|Overall Study||49
8812450|NCT01519700|9865385|FG002|COMPLETED|Overall Study||48
8812451|NCT01519700|9865386|FG003|COMPLETED|Overall Study||47
8812452|NCT01519700|9865383|FG000|NOT COMPLETED|Overall Study||9
8812453|NCT01519700|9865384|FG001|NOT COMPLETED|Overall Study||6
8812454|NCT01519700|9865385|FG002|NOT COMPLETED|Overall Study||7
8812455|NCT01519700|9865386|FG003|NOT COMPLETED|Overall Study||7
8812456|NCT01519713|9865405|FG000|STARTED|Overall Study||194
8812457|NCT01519713|9865406|FG001|STARTED|Overall Study||2
8812458|NCT01519713|9865407|FG002|STARTED|Overall Study||4
8812459|NCT01519713|9865405|FG000|COMPLETED|Overall Study||194
8812460|NCT01519713|9865406|FG001|COMPLETED|Overall Study||2
8812461|NCT01519713|9865407|FG002|COMPLETED|Overall Study||4
8812462|NCT01519713|9865405|FG000|NOT COMPLETED|Overall Study||0
8812463|NCT01519713|9865406|FG001|NOT COMPLETED|Overall Study||0
8812464|NCT01519713|9865407|FG002|NOT COMPLETED|Overall Study||0
8812465|NCT01519765|9865417|FG000|STARTED|Overall Study||37
8812466|NCT01519765|9865418|FG001|STARTED|Overall Study||36
8812467|NCT01519765|9865417|FG000|COMPLETED|Overall Study||34
8812468|NCT01519765|9865418|FG001|COMPLETED|Overall Study||34
8812469|NCT01519765|9865417|FG000|NOT COMPLETED|Overall Study||3
8812470|NCT01519765|9865418|FG001|NOT COMPLETED|Overall Study||2
8812471|NCT01519778|9865425|FG000|STARTED|Overall Study||200
8812472|NCT01519778|9865425|FG000|COMPLETED|Overall Study||186
8812473|NCT01519778|9865425|FG000|NOT COMPLETED|Overall Study||14
8812474|NCT01519791|9865431|FG000|STARTED|Overall Study||219
8812475|NCT01519791|9865432|FG001|STARTED|Overall Study||660
8812476|NCT01519791|9865431|FG000|Completed Week 52|Overall Study||143
8812477|NCT01519791|9865432|FG001|Completed Week 52|Overall Study||500
8812478|NCT01519791|9865431|FG000|COMPLETED|Overall Study||67
8812479|NCT01519791|9865432|FG001|COMPLETED|Overall Study||292
8812480|NCT01519791|9865431|FG000|NOT COMPLETED|Overall Study||152
8812481|NCT01519791|9865432|FG001|NOT COMPLETED|Overall Study||368
8812482|NCT01519817|9865440|FG000|STARTED|Overall Study||4
8812483|NCT01519817|9865441|FG001|STARTED|Overall Study||3
8812484|NCT01519817|9865442|FG002|STARTED|Overall Study||16
8812485|NCT01519817|9865443|FG003|STARTED|Overall Study||11
8701079|NCT00909844|9746811|FG000|NOT COMPLETED|Overall Study||4
8812486|NCT01519817|9865440|FG000|COMPLETED|Overall Study||3
8812487|NCT01519817|9865441|FG001|COMPLETED|Overall Study||3
8812488|NCT01519817|9865442|FG002|COMPLETED|Overall Study||16
8812489|NCT01519817|9865443|FG003|COMPLETED|Overall Study||10
8812490|NCT01519817|9865440|FG000|NOT COMPLETED|Overall Study||1
8812491|NCT01519817|9865441|FG001|NOT COMPLETED|Overall Study||0
8812492|NCT01519817|9865442|FG002|NOT COMPLETED|Overall Study||0
8812493|NCT01519817|9865443|FG003|NOT COMPLETED|Overall Study||1
8701080|NCT00909857|9746818|FG000|STARTED|Overall Study||253
8701081|NCT00909857|9746819|FG001|STARTED|Overall Study||254
8701082|NCT00909857|9746818|FG000|Treated|Overall Study||234
8701083|NCT00909857|9746819|FG001|Treated|Overall Study||230
8701084|NCT00909857|9746818|FG000|COMPLETED|Overall Study||217
8701085|NCT00909857|9746819|FG001|COMPLETED|Overall Study||209
8701086|NCT00909857|9746818|FG000|NOT COMPLETED|Overall Study||36
8701087|NCT00909857|9746819|FG001|NOT COMPLETED|Overall Study||45
8812494|NCT01519869|9865453|FG000|STARTED|Overall Study||28
8812495|NCT01519869|9865453|FG000|COMPLETED|Overall Study||27
8812496|NCT01519869|9865453|FG000|NOT COMPLETED|Overall Study||1
8812497|NCT01519882|9865459|FG000|STARTED|Overall Study||1
8812498|NCT01519882|9865460|FG001|STARTED|Overall Study||0
8812499|NCT01519882|9865459|FG000|COMPLETED|Overall Study||1
8812500|NCT01519882|9865460|FG001|COMPLETED|Overall Study||0
8812501|NCT01519882|9865459|FG000|NOT COMPLETED|Overall Study||0
8812502|NCT01519882|9865460|FG001|NOT COMPLETED|Overall Study||0
8812503|NCT01519921|9865468|FG000|STARTED|Overall Study||86
8812504|NCT01519921|9865469|FG001|STARTED|Overall Study||64
8812505|NCT01519921|9865468|FG000|COMPLETED|Overall Study||65
8812506|NCT01519921|9865469|FG001|COMPLETED|Overall Study||49
8812507|NCT01519921|9865468|FG000|NOT COMPLETED|Overall Study||21
8812508|NCT01519921|9865469|FG001|NOT COMPLETED|Overall Study||15
8812509|NCT01519934|9865475|FG000|STARTED|Overall Study||48
9043610|NCT03406260|10104551|FG002|NOT COMPLETED|Period 1||0
9043611|NCT03406260|10104552|FG003|NOT COMPLETED|Period 1||0
9043612|NCT03406260|10104553|FG004|NOT COMPLETED|Period 1||1
9043613|NCT03406260|10104554|FG005|NOT COMPLETED|Period 1||0
9043614|NCT03406260|10104549|FG000|STARTED|Period 2||6
9043615|NCT03406260|10104550|FG001|STARTED|Period 2||6
9043616|NCT03406260|10104551|FG002|STARTED|Period 2||6
9043617|NCT03406260|10104552|FG003|STARTED|Period 2||6
9043618|NCT03406260|10104553|FG004|STARTED|Period 2||5
9043619|NCT03406260|10104554|FG005|STARTED|Period 2||6
9043620|NCT03406260|10104549|FG000|COMPLETED|Period 2||6
9043621|NCT03406260|10104550|FG001|COMPLETED|Period 2||6
9043622|NCT03406260|10104551|FG002|COMPLETED|Period 2||6
9043623|NCT03406260|10104552|FG003|COMPLETED|Period 2||6
9043624|NCT03406260|10104553|FG004|COMPLETED|Period 2||5
8701088|NCT00909870|9746827|FG000|STARTED|Overall Study||274
8701089|NCT00909870|9746828|FG001|STARTED|Overall Study||263
8701090|NCT00909870|9746827|FG000|COMPLETED|Overall Study||251
8701091|NCT00909870|9746828|FG001|COMPLETED|Overall Study||236
8701092|NCT00909870|9746827|FG000|NOT COMPLETED|Overall Study||23
8701093|NCT00909870|9746828|FG001|NOT COMPLETED|Overall Study||27
8701094|NCT00910000|9746841|FG000|STARTED|Overall Study||3
8701095|NCT00910000|9746842|FG001|STARTED|Overall Study||3
8701096|NCT00910000|9746843|FG002|STARTED|Overall Study||3
8701097|NCT00910000|9746844|FG003|STARTED|Overall Study||2
8701098|NCT00910000|9746845|FG004|STARTED|Overall Study||3
8812510|NCT01519934|9865475|FG000|COMPLETED|Overall Study||45
8812511|NCT01519934|9865475|FG000|NOT COMPLETED|Overall Study||3
8812512|NCT01519947|9865483|FG000|STARTED|Overall Study||19
8812513|NCT01519947|9865484|FG001|STARTED|Overall Study||11
8812514|NCT01519947|9865485|FG002|STARTED|Overall Study||15
8812515|NCT01519947|9865486|FG003|STARTED|Overall Study||42
8812516|NCT01519947|9865483|FG000|COMPLETED|Overall Study||17
8812517|NCT01519947|9865484|FG001|COMPLETED|Overall Study||7
8812518|NCT01519947|9865485|FG002|COMPLETED|Overall Study||8
8812519|NCT01519947|9865486|FG003|COMPLETED|Overall Study||34
8812520|NCT01519947|9865483|FG000|NOT COMPLETED|Overall Study||2
8812521|NCT01519947|9865484|FG001|NOT COMPLETED|Overall Study||4
8812522|NCT01519947|9865485|FG002|NOT COMPLETED|Overall Study||7
8812523|NCT01519947|9865486|FG003|NOT COMPLETED|Overall Study||8
8812524|NCT01520038|9865496|FG000|STARTED|Overall Study||2
8812525|NCT01520038|9865496|FG000|COMPLETED|Overall Study||1
8812526|NCT01520038|9865496|FG000|NOT COMPLETED|Overall Study||1
8812527|NCT01520207|9865502|FG000|STARTED|Overall Study||27
8812528|NCT01520207|9865503|FG001|STARTED|Overall Study||25
8812529|NCT01520207|9865502|FG000|COMPLETED|Overall Study||25
8812530|NCT01520207|9865503|FG001|COMPLETED|Overall Study||25
8812531|NCT01520207|9865502|FG000|NOT COMPLETED|Overall Study||2
8812532|NCT01520207|9865503|FG001|NOT COMPLETED|Overall Study||0
8812533|NCT01520324|9865509|FG000|STARTED|Overall Study||53
8812534|NCT01520324|9865509|FG000|COMPLETED|Overall Study||52
8812535|NCT01520324|9865509|FG000|NOT COMPLETED|Overall Study||1
8812536|NCT01520363|9865515|FG000|STARTED|Overall Study||26
8812537|NCT01520363|9865516|FG001|STARTED|Overall Study||26
8812538|NCT01520363|9865515|FG000|COMPLETED|Overall Study||24
8812539|NCT01520363|9865516|FG001|COMPLETED|Overall Study||26
8812540|NCT01520363|9865515|FG000|NOT COMPLETED|Overall Study||2
8812541|NCT01520363|9865516|FG001|NOT COMPLETED|Overall Study||0
8812542|NCT01520402|9865546|FG000|STARTED|Overall Study||35
8812543|NCT01520402|9865546|FG000|COMPLETED|Overall Study||30
8812544|NCT01520402|9865546|FG000|NOT COMPLETED|Overall Study||5
8812545|NCT01520454|9865561|FG000|STARTED|Overall Study||9
8812546|NCT01520454|9865562|FG001|STARTED|Overall Study||6
8812547|NCT01520454|9865563|FG002|STARTED|Overall Study||5
8812548|NCT01520454|9865564|FG003|STARTED|Overall Study||6
8812549|NCT01520454|9865561|FG000|COMPLETED|Overall Study||9
8812550|NCT01520454|9865562|FG001|COMPLETED|Overall Study||6
8812551|NCT01520454|9865563|FG002|COMPLETED|Overall Study||5
8812552|NCT01520454|9865564|FG003|COMPLETED|Overall Study||6
8812553|NCT01520454|9865561|FG000|NOT COMPLETED|Overall Study||0
8812554|NCT01520454|9865562|FG001|NOT COMPLETED|Overall Study||0
8812555|NCT01520454|9865563|FG002|NOT COMPLETED|Overall Study||0
8812556|NCT01520454|9865564|FG003|NOT COMPLETED|Overall Study||0
8812557|NCT01520506|9865577|FG000|STARTED|Overall Study||50
8812558|NCT01520506|9865577|FG000|COMPLETED|Overall Study||44
8812559|NCT01520506|9865577|FG000|NOT COMPLETED|Overall Study||6
8812560|NCT01520519|9865581|FG000|STARTED|Overall Study||40
8812561|NCT01520519|9865581|FG000|COMPLETED|Overall Study||40
8812562|NCT01520519|9865581|FG000|NOT COMPLETED|Overall Study||0
8812563|NCT01520532|9865585|FG000|STARTED|Overall Study|Subjects who underwent an ablation and had post-procedure MRI|60
8812564|NCT01520532|9865585|FG000|COMPLETED|Overall Study||60
8812565|NCT01520532|9865585|FG000|NOT COMPLETED|Overall Study||0
8812566|NCT01520558|9865592|FG000|STARTED|Overall Study||3
8812567|NCT01520558|9865593|FG001|STARTED|Overall Study||3
8812568|NCT01520558|9865594|FG002|STARTED|Overall Study||6
8812569|NCT01520558|9865592|FG000|COMPLETED|Overall Study||1
8812570|NCT01520558|9865593|FG001|COMPLETED|Overall Study||1
9043625|NCT03406260|10104554|FG005|COMPLETED|Period 2||6
9043626|NCT03406260|10104549|FG000|NOT COMPLETED|Period 2||0
9043627|NCT03406260|10104550|FG001|NOT COMPLETED|Period 2||0
9043628|NCT03406260|10104551|FG002|NOT COMPLETED|Period 2||0
9043629|NCT03406260|10104552|FG003|NOT COMPLETED|Period 2||0
9043630|NCT03406260|10104553|FG004|NOT COMPLETED|Period 2||0
9043631|NCT03406260|10104554|FG005|NOT COMPLETED|Period 2||0
9043632|NCT03406260|10104549|FG000|STARTED|Period 3||6
9043633|NCT03406260|10104550|FG001|STARTED|Period 3||6
9043634|NCT03406260|10104551|FG002|STARTED|Period 3||6
9043635|NCT03406260|10104552|FG003|STARTED|Period 3||6
9043636|NCT03406260|10104553|FG004|STARTED|Period 3||5
9043637|NCT03406260|10104554|FG005|STARTED|Period 3||6
9043638|NCT03406260|10104549|FG000|COMPLETED|Period 3||6
9043639|NCT03406260|10104550|FG001|COMPLETED|Period 3||6
9043640|NCT03406260|10104551|FG002|COMPLETED|Period 3||6
9043641|NCT03406260|10104552|FG003|COMPLETED|Period 3||6
9043642|NCT03406260|10104553|FG004|COMPLETED|Period 3||5
9043643|NCT03406260|10104554|FG005|COMPLETED|Period 3||6
9043644|NCT03406260|10104549|FG000|NOT COMPLETED|Period 3||0
9043645|NCT03406260|10104550|FG001|NOT COMPLETED|Period 3||0
9043646|NCT03406260|10104551|FG002|NOT COMPLETED|Period 3||0
9043647|NCT03406260|10104552|FG003|NOT COMPLETED|Period 3||0
9043648|NCT03406260|10104553|FG004|NOT COMPLETED|Period 3||0
9043649|NCT03406260|10104554|FG005|NOT COMPLETED|Period 3||0
9043650|NCT03406325|10104572|FG000|STARTED|Overall Study||12
9043651|NCT03406325|10104573|FG001|STARTED|Overall Study||1
9043652|NCT03406325|10104574|FG002|STARTED|Overall Study||1
9043653|NCT03406325|10104575|FG003|STARTED|Overall Study||1
9043654|NCT03406325|10104576|FG004|STARTED|Overall Study||1
9043655|NCT03406325|10104577|FG005|STARTED|Overall Study||1
9043656|NCT03406325|10104578|FG006|STARTED|Overall Study||1
9043657|NCT03406325|10104579|FG007|STARTED|Overall Study||1
9043658|NCT03406325|10104572|FG000|COMPLETED|Overall Study||12
9043659|NCT03406325|10104573|FG001|COMPLETED|Overall Study||1
9043660|NCT03406325|10104574|FG002|COMPLETED|Overall Study||1
9043661|NCT03406325|10104575|FG003|COMPLETED|Overall Study||1
9043662|NCT03406325|10104576|FG004|COMPLETED|Overall Study||1
9043663|NCT03406325|10104577|FG005|COMPLETED|Overall Study||1
9043664|NCT03406325|10104578|FG006|COMPLETED|Overall Study||1
9043665|NCT03406325|10104579|FG007|COMPLETED|Overall Study||1
9043666|NCT03406325|10104572|FG000|NOT COMPLETED|Overall Study||0
9043667|NCT03406325|10104573|FG001|NOT COMPLETED|Overall Study||0
9043668|NCT03406325|10104574|FG002|NOT COMPLETED|Overall Study||0
9043669|NCT03406325|10104575|FG003|NOT COMPLETED|Overall Study||0
9043670|NCT03406325|10104576|FG004|NOT COMPLETED|Overall Study||0
9043671|NCT03406325|10104577|FG005|NOT COMPLETED|Overall Study||0
9043672|NCT03406325|10104578|FG006|NOT COMPLETED|Overall Study||0
9043673|NCT03406325|10104579|FG007|NOT COMPLETED|Overall Study||0
9043674|NCT03406377|10104613|FG000|STARTED|Overall Study||41
9043675|NCT03406377|10104614|FG001|STARTED|Overall Study||72
9043676|NCT03406377|10104613|FG000|COMPLETED|Overall Study||25
9043677|NCT03406377|10104614|FG001|COMPLETED|Overall Study||51
9043678|NCT03406377|10104613|FG000|NOT COMPLETED|Overall Study||16
9043679|NCT03406377|10104614|FG001|NOT COMPLETED|Overall Study||21
9043680|NCT03406962|10104620|FG000|STARTED|Overall Study||8
9043681|NCT03406962|10104620|FG000|COMPLETED|Overall Study||5
8701099|NCT00910000|9746846|FG005|STARTED|Overall Study||1
8701100|NCT00910000|9746841|FG000|COMPLETED|Overall Study||3
8701101|NCT00910000|9746842|FG001|COMPLETED|Overall Study||0
8701102|NCT00910000|9746843|FG002|COMPLETED|Overall Study||0
8701103|NCT00910000|9746844|FG003|COMPLETED|Overall Study||0
8701104|NCT00910000|9746845|FG004|COMPLETED|Overall Study||2
8701105|NCT00910000|9746846|FG005|COMPLETED|Overall Study||0
8701106|NCT00910000|9746841|FG000|NOT COMPLETED|Overall Study||0
8701107|NCT00910000|9746842|FG001|NOT COMPLETED|Overall Study||3
8701108|NCT00910000|9746843|FG002|NOT COMPLETED|Overall Study||3
8701109|NCT00910000|9746844|FG003|NOT COMPLETED|Overall Study||2
8701110|NCT00910000|9746845|FG004|NOT COMPLETED|Overall Study||1
8701111|NCT00910000|9746846|FG005|NOT COMPLETED|Overall Study||1
8701112|NCT00910039|9746856|FG000|STARTED|Overall Study||14
8701113|NCT00910039|9746856|FG000|COMPLETED|Overall Study||13
8701114|NCT00910039|9746856|FG000|NOT COMPLETED|Overall Study||1
8701115|NCT00910091|9746863|FG000|STARTED|Pre-assignment||36
8701116|NCT00910091|9746864|FG001|STARTED|Pre-assignment||37
8701117|NCT00910091|9746863|FG000|COMPLETED|Pre-assignment||36
8701118|NCT00910091|9746864|FG001|COMPLETED|Pre-assignment||35
8701119|NCT00910091|9746863|FG000|NOT COMPLETED|Pre-assignment||0
8701120|NCT00910091|9746864|FG001|NOT COMPLETED|Pre-assignment||2
8701121|NCT00910091|9746863|FG000|STARTED|Treatment and Survival||36
8701122|NCT00910091|9746864|FG001|STARTED|Treatment and Survival||35
8701123|NCT00910091|9746863|FG000|COMPLETED|Treatment and Survival||32
8701124|NCT00910091|9746864|FG001|COMPLETED|Treatment and Survival||31
8701125|NCT00910091|9746863|FG000|NOT COMPLETED|Treatment and Survival||4
8701126|NCT00910091|9746864|FG001|NOT COMPLETED|Treatment and Survival||4
8701127|NCT00910208|9746874|FG000|STARTED|Overall Study||69
8701128|NCT00910208|9746875|FG001|STARTED|Overall Study||72
8701129|NCT00910208|9746876|FG002|STARTED|Overall Study||70
8701130|NCT00910208|9746874|FG000|COMPLETED|Overall Study||67
8701131|NCT00910208|9746875|FG001|COMPLETED|Overall Study||70
8701132|NCT00910208|9746876|FG002|COMPLETED|Overall Study||69
8701133|NCT00910208|9746874|FG000|NOT COMPLETED|Overall Study||2
8701134|NCT00910208|9746875|FG001|NOT COMPLETED|Overall Study||2
8701135|NCT00910208|9746876|FG002|NOT COMPLETED|Overall Study||1
8701136|NCT00910247|9746884|FG000|STARTED|Overall Study||274
9043682|NCT03406962|10104620|FG000|NOT COMPLETED|Overall Study||3
9043683|NCT03407053|10104627|FG000|STARTED|Overall Study||10
8701137|NCT00910247|9746884|FG000|COMPLETED|Overall Study||205
8701138|NCT00910247|9746884|FG000|NOT COMPLETED|Overall Study||69
9043684|NCT03407053|10104628|FG001|STARTED|Overall Study||10
9043685|NCT03407053|10104627|FG000|COMPLETED|Overall Study||10
9043686|NCT03407053|10104628|FG001|COMPLETED|Overall Study||10
9043687|NCT03407053|10104627|FG000|NOT COMPLETED|Overall Study||0
9043688|NCT03407053|10104628|FG001|NOT COMPLETED|Overall Study||0
9043689|NCT03407118|10104634|FG000|STARTED|Period 1||14
9043690|NCT03407118|10104635|FG001|STARTED|Period 1||17
9043691|NCT03407118|10104634|FG000|Received at Least 1 Dose of Study Drug|Period 1||14
9043692|NCT03407118|10104635|FG001|Received at Least 1 Dose of Study Drug|Period 1||17
9043693|NCT03407118|10104634|FG000|COMPLETED|Period 1||14
8701139|NCT00910273|9746890|FG000|STARTED|Overall Study||18
8701140|NCT00910273|9746891|FG001|STARTED|Overall Study||16
8701141|NCT00910273|9746890|FG000|COMPLETED|Overall Study||0
8701142|NCT00910273|9746891|FG001|COMPLETED|Overall Study||3
8701143|NCT00910273|9746890|FG000|NOT COMPLETED|Overall Study||18
8701144|NCT00910273|9746891|FG001|NOT COMPLETED|Overall Study||13
8701145|NCT00910299|9746899|FG000|STARTED|Overall Study||212
8701146|NCT00910299|9746900|FG001|STARTED|Overall Study||211
8701147|NCT00910299|9746899|FG000|Received at Least 1 Dose of Study Drug|Overall Study||210
8701148|NCT00910299|9746900|FG001|Received at Least 1 Dose of Study Drug|Overall Study||210
8701149|NCT00910299|9746899|FG000|COMPLETED|Overall Study||136
8701150|NCT00910299|9746900|FG001|COMPLETED|Overall Study|"1 participant died of sepsis while on study drug and was considered a protocol completer."|137
8701151|NCT00910299|9746899|FG000|NOT COMPLETED|Overall Study||76
8701152|NCT00910299|9746900|FG001|NOT COMPLETED|Overall Study||74
8701153|NCT00910429|9746908|FG000|STARTED|Overall Study||155
8701154|NCT00910429|9746909|FG001|STARTED|Overall Study||82
8701155|NCT00910429|9746908|FG000|COMPLETED|Overall Study|Completed treatment|116
8701156|NCT00910429|9746909|FG001|COMPLETED|Overall Study|Completed treatment|61
8701157|NCT00910429|9746908|FG000|NOT COMPLETED|Overall Study||39
8701158|NCT00910429|9746909|FG001|NOT COMPLETED|Overall Study||21
8701159|NCT00910481|9746917|FG000|STARTED|Overall Study||151
8701160|NCT00910481|9746918|FG001|STARTED|Overall Study||150
8701161|NCT00910481|9746917|FG000|COMPLETED|Overall Study||151
8701162|NCT00910481|9746918|FG001|COMPLETED|Overall Study||150
8701163|NCT00910481|9746917|FG000|NOT COMPLETED|Overall Study||0
8701164|NCT00910481|9746918|FG001|NOT COMPLETED|Overall Study||0
8701165|NCT00910520|9746926|FG000|STARTED|Treatment Cycle 1||277
8701166|NCT00910520|9746927|FG001|STARTED|Treatment Cycle 1||271
8701167|NCT00910520|9746926|FG000|COMPLETED|Treatment Cycle 1||257
8701168|NCT00910520|9746927|FG001|COMPLETED|Treatment Cycle 1||247
8701169|NCT00910520|9746926|FG000|NOT COMPLETED|Treatment Cycle 1||20
8701170|NCT00910520|9746927|FG001|NOT COMPLETED|Treatment Cycle 1||24
8701171|NCT00910520|9746926|FG000|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|163
8701172|NCT00910520|9746927|FG001|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|223
8701173|NCT00910520|9746926|FG000|COMPLETED|Treatment Cycle 2||156
8701174|NCT00910520|9746927|FG001|COMPLETED|Treatment Cycle 2||215
8701175|NCT00910520|9746926|FG000|NOT COMPLETED|Treatment Cycle 2||7
8701176|NCT00910520|9746927|FG001|NOT COMPLETED|Treatment Cycle 2||8
8701177|NCT00910624|9746937|FG000|STARTED|Treatment Phase||52
8701178|NCT00910624|9746938|FG001|STARTED|Treatment Phase||85
8701179|NCT00910624|9746939|FG002|STARTED|Treatment Phase||29
8701180|NCT00910624|9746940|FG003|STARTED|Treatment Phase||2
8701181|NCT00910624|9746937|FG000|COMPLETED|Treatment Phase||22
8701182|NCT00910624|9746938|FG001|COMPLETED|Treatment Phase||64
8701183|NCT00910624|9746939|FG002|COMPLETED|Treatment Phase||20
8701184|NCT00910624|9746940|FG003|COMPLETED|Treatment Phase||2
8701185|NCT00910624|9746937|FG000|NOT COMPLETED|Treatment Phase||30
8812571|NCT01520558|9865594|FG002|COMPLETED|Overall Study||3
8812572|NCT01520558|9865592|FG000|NOT COMPLETED|Overall Study||2
8812573|NCT01520558|9865593|FG001|NOT COMPLETED|Overall Study||2
8812574|NCT01520558|9865594|FG002|NOT COMPLETED|Overall Study||3
8812575|NCT01520688|9865602|FG000|STARTED|Overall Study||4
8812576|NCT01520688|9865603|FG001|STARTED|Overall Study||4
8812577|NCT01520688|9865604|FG002|STARTED|Overall Study||4
8812578|NCT01520688|9865605|FG003|STARTED|Overall Study||5
8812579|NCT01520688|9865606|FG004|STARTED|Overall Study||5
8812580|NCT01520688|9865607|FG005|STARTED|Overall Study||5
8812581|NCT01520688|9865608|FG006|STARTED|Overall Study||5
8812582|NCT01520688|9865602|FG000|COMPLETED|Overall Study||4
8812583|NCT01520688|9865603|FG001|COMPLETED|Overall Study||2
8812584|NCT01520688|9865604|FG002|COMPLETED|Overall Study||4
8812585|NCT01520688|9865605|FG003|COMPLETED|Overall Study||4
8812586|NCT01520688|9865606|FG004|COMPLETED|Overall Study||4
8812587|NCT01520688|9865607|FG005|COMPLETED|Overall Study||5
8812588|NCT01520688|9865608|FG006|COMPLETED|Overall Study||0
8812589|NCT01520688|9865602|FG000|NOT COMPLETED|Overall Study||0
8812590|NCT01520688|9865603|FG001|NOT COMPLETED|Overall Study||2
8812591|NCT01520688|9865604|FG002|NOT COMPLETED|Overall Study||0
8812592|NCT01520688|9865605|FG003|NOT COMPLETED|Overall Study||1
8812593|NCT01520688|9865606|FG004|NOT COMPLETED|Overall Study||1
8812594|NCT01520688|9865607|FG005|NOT COMPLETED|Overall Study||0
8812595|NCT01520688|9865608|FG006|NOT COMPLETED|Overall Study||5
8812596|NCT01520727|9865625|FG000|STARTED|Overall Study||6
8812597|NCT01520727|9865626|FG001|STARTED|Overall Study||6
8812598|NCT01520727|9865627|FG002|STARTED|Overall Study||6
8812599|NCT01520727|9865628|FG003|STARTED|Overall Study||6
8812600|NCT01520727|9865629|FG004|STARTED|Overall Study||6
8812601|NCT01520727|9865630|FG005|STARTED|Overall Study||6
8812602|NCT01520727|9865631|FG006|STARTED|Overall Study||6
8812603|NCT01520727|9865632|FG007|STARTED|Overall Study||6
8812604|NCT01520727|9865633|FG008|STARTED|Overall Study||16
8812605|NCT01520727|9865625|FG000|COMPLETED|Overall Study||6
8812606|NCT01520727|9865626|FG001|COMPLETED|Overall Study||6
8812607|NCT01520727|9865627|FG002|COMPLETED|Overall Study||6
8812608|NCT01520727|9865628|FG003|COMPLETED|Overall Study||6
9043694|NCT03407118|10104635|FG001|COMPLETED|Period 1||17
9043695|NCT03407118|10104634|FG000|NOT COMPLETED|Period 1||0
9043696|NCT03407118|10104635|FG001|NOT COMPLETED|Period 1||0
9043697|NCT03407118|10104634|FG000|STARTED|Period 2||14
9043698|NCT03407118|10104635|FG001|STARTED|Period 2||17
9043699|NCT03407118|10104634|FG000|Received at Least 1 Dose of Study Drug|Period 2||13
9043700|NCT03407118|10104635|FG001|Received at Least 1 Dose of Study Drug|Period 2||17
9043701|NCT03407118|10104634|FG000|COMPLETED|Period 2||13
9043702|NCT03407118|10104635|FG001|COMPLETED|Period 2||17
9043703|NCT03407118|10104634|FG000|NOT COMPLETED|Period 2||1
8701186|NCT00910624|9746938|FG001|NOT COMPLETED|Treatment Phase||21
8701187|NCT00910624|9746939|FG002|NOT COMPLETED|Treatment Phase||9
8701188|NCT00910624|9746940|FG003|NOT COMPLETED|Treatment Phase||0
8701189|NCT00910624|9746937|FG000|STARTED|Follow-Up Phase||48
8701190|NCT00910624|9746938|FG001|STARTED|Follow-Up Phase||80
8701191|NCT00910624|9746939|FG002|STARTED|Follow-Up Phase||29
8701192|NCT00910624|9746940|FG003|STARTED|Follow-Up Phase||2
8701193|NCT00910624|9746937|FG000|COMPLETED|Follow-Up Phase||42
8701194|NCT00910624|9746938|FG001|COMPLETED|Follow-Up Phase||76
8701195|NCT00910624|9746939|FG002|COMPLETED|Follow-Up Phase||25
8701196|NCT00910624|9746940|FG003|COMPLETED|Follow-Up Phase||2
8701197|NCT00910624|9746937|FG000|NOT COMPLETED|Follow-Up Phase||6
8701198|NCT00910624|9746938|FG001|NOT COMPLETED|Follow-Up Phase||4
8701199|NCT00910624|9746939|FG002|NOT COMPLETED|Follow-Up Phase||4
8701200|NCT00910624|9746940|FG003|NOT COMPLETED|Follow-Up Phase||0
8701201|NCT00910663|9746950|FG000|STARTED|Period 1||30
8701202|NCT00910663|9746951|FG001|STARTED|Period 1||30
8701203|NCT00910663|9746950|FG000|COMPLETED|Period 1||30
8701204|NCT00910663|9746951|FG001|COMPLETED|Period 1||29
8701205|NCT00910663|9746950|FG000|NOT COMPLETED|Period 1||0
8701206|NCT00910663|9746951|FG001|NOT COMPLETED|Period 1||1
8701207|NCT00910663|9746950|FG000|STARTED|Period 2||30
8701208|NCT00910663|9746951|FG001|STARTED|Period 2||29
8701209|NCT00910663|9746950|FG000|COMPLETED|Period 2||30
8701210|NCT00910663|9746951|FG001|COMPLETED|Period 2||29
8701211|NCT00910663|9746950|FG000|NOT COMPLETED|Period 2||0
8701212|NCT00910663|9746951|FG001|NOT COMPLETED|Period 2||0
8701213|NCT00910689|9746961|FG000|STARTED|Month 1: Optimal Acute Therapy Run in||55
8701214|NCT00910689|9746962|FG001|STARTED|Month 1: Optimal Acute Therapy Run in||53
8701215|NCT00910689|9746963|FG002|STARTED|Month 1: Optimal Acute Therapy Run in||55
8701216|NCT00910689|9746964|FG003|STARTED|Month 1: Optimal Acute Therapy Run in||69
8701217|NCT00910689|9746961|FG000|COMPLETED|Month 1: Optimal Acute Therapy Run in||53
8701218|NCT00910689|9746962|FG001|COMPLETED|Month 1: Optimal Acute Therapy Run in||52
8701219|NCT00910689|9746963|FG002|COMPLETED|Month 1: Optimal Acute Therapy Run in||50
8701220|NCT00910689|9746964|FG003|COMPLETED|Month 1: Optimal Acute Therapy Run in||59
8701221|NCT00910689|9746961|FG000|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||2
8701222|NCT00910689|9746962|FG001|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||1
8701223|NCT00910689|9746963|FG002|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||5
8701224|NCT00910689|9746964|FG003|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||10
8701225|NCT00910689|9746961|FG000|STARTED|Month 2- 4: Treatment Period||53
8701226|NCT00910689|9746962|FG001|STARTED|Month 2- 4: Treatment Period||52
8701227|NCT00910689|9746963|FG002|STARTED|Month 2- 4: Treatment Period||50
8701228|NCT00910689|9746964|FG003|STARTED|Month 2- 4: Treatment Period||59
8701229|NCT00910689|9746961|FG000|COMPLETED|Month 2- 4: Treatment Period||44
8701230|NCT00910689|9746962|FG001|COMPLETED|Month 2- 4: Treatment Period||42
8701231|NCT00910689|9746963|FG002|COMPLETED|Month 2- 4: Treatment Period||42
8701232|NCT00910689|9746964|FG003|COMPLETED|Month 2- 4: Treatment Period||48
8701233|NCT00910689|9746961|FG000|NOT COMPLETED|Month 2- 4: Treatment Period||9
8701234|NCT00910689|9746962|FG001|NOT COMPLETED|Month 2- 4: Treatment Period||10
8701235|NCT00910689|9746963|FG002|NOT COMPLETED|Month 2- 4: Treatment Period||8
8701236|NCT00910689|9746964|FG003|NOT COMPLETED|Month 2- 4: Treatment Period||11
8701237|NCT00910689|9746961|FG000|STARTED|Months 5 - 10: Evaluation Period I||44
8701238|NCT00910689|9746962|FG001|STARTED|Months 5 - 10: Evaluation Period I||42
8701239|NCT00910689|9746963|FG002|STARTED|Months 5 - 10: Evaluation Period I||42
8701240|NCT00910689|9746964|FG003|STARTED|Months 5 - 10: Evaluation Period I||48
8701241|NCT00910689|9746961|FG000|COMPLETED|Months 5 - 10: Evaluation Period I||40
8701242|NCT00910689|9746962|FG001|COMPLETED|Months 5 - 10: Evaluation Period I||35
8701243|NCT00910689|9746963|FG002|COMPLETED|Months 5 - 10: Evaluation Period I||35
8701244|NCT00910689|9746964|FG003|COMPLETED|Months 5 - 10: Evaluation Period I||41
8701245|NCT00910689|9746961|FG000|NOT COMPLETED|Months 5 - 10: Evaluation Period I||4
8701246|NCT00910689|9746962|FG001|NOT COMPLETED|Months 5 - 10: Evaluation Period I||7
8701247|NCT00910689|9746963|FG002|NOT COMPLETED|Months 5 - 10: Evaluation Period I||7
8701248|NCT00910689|9746964|FG003|NOT COMPLETED|Months 5 - 10: Evaluation Period I||7
8701249|NCT00910689|9746961|FG000|STARTED|Months 11- 16: Evaluation Period II||40
8701250|NCT00910689|9746962|FG001|STARTED|Months 11- 16: Evaluation Period II||35
8701251|NCT00910689|9746963|FG002|STARTED|Months 11- 16: Evaluation Period II||35
8701252|NCT00910689|9746964|FG003|STARTED|Months 11- 16: Evaluation Period II||41
9043704|NCT03407118|10104635|FG001|NOT COMPLETED|Period 2||0
9043705|NCT03407170|10104641|FG000|STARTED|Overall Study||1
9043706|NCT03407170|10104641|FG000|COMPLETED|Overall Study||0
9043707|NCT03407170|10104641|FG000|NOT COMPLETED|Overall Study||1
9043708|NCT03407313|10104645|FG000|STARTED|Overall Study||68
8701253|NCT00910689|9746961|FG000|COMPLETED|Months 11- 16: Evaluation Period II||30
8701254|NCT00910689|9746962|FG001|COMPLETED|Months 11- 16: Evaluation Period II||25
9043709|NCT03407313|10104645|FG000|COMPLETED|Overall Study||66
9043710|NCT03407313|10104645|FG000|NOT COMPLETED|Overall Study||2
9043711|NCT03407430|10104651|FG000|STARTED|First Intervention||5
9043712|NCT03407430|10104652|FG001|STARTED|First Intervention||3
9043713|NCT03407430|10104651|FG000|COMPLETED|First Intervention||5
9043714|NCT03407430|10104652|FG001|COMPLETED|First Intervention||3
9043715|NCT03407430|10104651|FG000|NOT COMPLETED|First Intervention||0
8701255|NCT00910689|9746963|FG002|COMPLETED|Months 11- 16: Evaluation Period II||28
8701256|NCT00910689|9746964|FG003|COMPLETED|Months 11- 16: Evaluation Period II||35
8701257|NCT00910689|9746961|FG000|NOT COMPLETED|Months 11- 16: Evaluation Period II||10
8701258|NCT00910689|9746962|FG001|NOT COMPLETED|Months 11- 16: Evaluation Period II||10
8701259|NCT00910689|9746963|FG002|NOT COMPLETED|Months 11- 16: Evaluation Period II||7
8701260|NCT00910689|9746964|FG003|NOT COMPLETED|Months 11- 16: Evaluation Period II||6
8701261|NCT00910715|9746977|FG000|STARTED|Overall Study||108
8701262|NCT00910715|9746978|FG001|STARTED|Overall Study||117
8701263|NCT00910715|9746979|FG002|STARTED|Overall Study||81
8701264|NCT00910715|9746977|FG000|COMPLETED|Overall Study||86
8701265|NCT00910715|9746978|FG001|COMPLETED|Overall Study||91
8701266|NCT00910715|9746979|FG002|COMPLETED|Overall Study||81
8701267|NCT00910715|9746977|FG000|NOT COMPLETED|Overall Study||22
8701268|NCT00910715|9746978|FG001|NOT COMPLETED|Overall Study||26
8701269|NCT00910715|9746979|FG002|NOT COMPLETED|Overall Study||0
8701270|NCT00910728|9746998|FG000|STARTED|Overall Study||6
8701271|NCT00910728|9746999|FG001|STARTED|Overall Study||3
8701272|NCT00910728|9747000|FG002|STARTED|Overall Study||3
8701273|NCT00910728|9747001|FG003|STARTED|Overall Study||3
8701274|NCT00910728|9747002|FG004|STARTED|Overall Study||6
8701275|NCT00910728|9747003|FG005|STARTED|Overall Study||1
8701276|NCT00910728|9747004|FG006|STARTED|Overall Study||6
8701277|NCT00910728|9747005|FG007|STARTED|Overall Study||4
8701278|NCT00910728|9747006|FG008|STARTED|Overall Study||3
8701279|NCT00910728|9746998|FG000|COMPLETED|Overall Study||0
8701280|NCT00910728|9746999|FG001|COMPLETED|Overall Study||0
8701281|NCT00910728|9747000|FG002|COMPLETED|Overall Study||0
8701282|NCT00910728|9747001|FG003|COMPLETED|Overall Study||0
8701283|NCT00910728|9747002|FG004|COMPLETED|Overall Study||1
8701284|NCT00910728|9747003|FG005|COMPLETED|Overall Study||0
8701285|NCT00910728|9747004|FG006|COMPLETED|Overall Study||0
8701286|NCT00910728|9747005|FG007|COMPLETED|Overall Study||1
8701287|NCT00910728|9747006|FG008|COMPLETED|Overall Study||0
8701288|NCT00910728|9746998|FG000|NOT COMPLETED|Overall Study||6
8701289|NCT00910728|9746999|FG001|NOT COMPLETED|Overall Study||3
8701290|NCT00910728|9747000|FG002|NOT COMPLETED|Overall Study||3
8701291|NCT00910728|9747001|FG003|NOT COMPLETED|Overall Study||3
8701292|NCT00910728|9747002|FG004|NOT COMPLETED|Overall Study||5
8701293|NCT00910728|9747003|FG005|NOT COMPLETED|Overall Study||1
8701294|NCT00910728|9747004|FG006|NOT COMPLETED|Overall Study||6
8701295|NCT00910728|9747005|FG007|NOT COMPLETED|Overall Study||3
8701296|NCT00910728|9747006|FG008|NOT COMPLETED|Overall Study||3
8701297|NCT00910845|9747028|FG000|STARTED|Treatment Cycle 1||280
8701298|NCT00910845|9747029|FG001|STARTED|Treatment Cycle 1||277
8701299|NCT00910845|9747028|FG000|COMPLETED|Treatment Cycle 1||249
8701300|NCT00910845|9747029|FG001|COMPLETED|Treatment Cycle 1||243
8701301|NCT00910845|9747028|FG000|NOT COMPLETED|Treatment Cycle 1||31
8701302|NCT00910845|9747029|FG001|NOT COMPLETED|Treatment Cycle 1||34
8701303|NCT00910845|9747028|FG000|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|141
8701304|NCT00910845|9747029|FG001|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|212
8701305|NCT00910845|9747028|FG000|COMPLETED|Treatment Cycle 2||136
8701306|NCT00910845|9747029|FG001|COMPLETED|Treatment Cycle 2||203
8701307|NCT00910845|9747028|FG000|NOT COMPLETED|Treatment Cycle 2||5
8701308|NCT00910845|9747029|FG001|NOT COMPLETED|Treatment Cycle 2||9
8701309|NCT00910858|9747038|FG000|STARTED|Pharmacokinetic Phase||9
8701310|NCT00910858|9747039|FG001|STARTED|Pharmacokinetic Phase||0
8701311|NCT00910858|9747040|FG002|STARTED|Pharmacokinetic Phase||3
8701312|NCT00910858|9747038|FG000|COMPLETED|Pharmacokinetic Phase||8
8701313|NCT00910858|9747039|FG001|COMPLETED|Pharmacokinetic Phase||0
8701314|NCT00910858|9747040|FG002|COMPLETED|Pharmacokinetic Phase||3
8701315|NCT00910858|9747038|FG000|NOT COMPLETED|Pharmacokinetic Phase||1
8701316|NCT00910858|9747039|FG001|NOT COMPLETED|Pharmacokinetic Phase||0
8701317|NCT00910858|9747040|FG002|NOT COMPLETED|Pharmacokinetic Phase||0
8701318|NCT00910858|9747038|FG000|STARTED|Monotherapy Phase|Includes 8 participants from the PK Phase and 9 newly enrolled participants.|17
8701319|NCT00910858|9747039|FG001|STARTED|Monotherapy Phase|All 15 participants were newly enrolled into the Monotherapy Phase.|15
8701320|NCT00910858|9747040|FG002|STARTED|Monotherapy Phase|Includes 3 participants from the PK Phase and 4 newly enrolled participants.|7
9043716|NCT03407430|10104652|FG001|NOT COMPLETED|First Intervention||0
8701321|NCT00910858|9747038|FG000|Safety Population|Monotherapy Phase|All patients who took at least 1 dose of study drug during Monotherapy or Combined Treatment Phase.|17
8701322|NCT00910858|9747039|FG001|Safety Population|Monotherapy Phase|All patients who took at least 1 dose of study drug during Monotherapy or Combined Treatment Phase.|15
8701323|NCT00910858|9747040|FG002|Safety Population|Monotherapy Phase|All patients who took at least 1 dose of study drug during Monotherapy or Combined Treatment Phase.|7
8701324|NCT00910858|9747038|FG000|Pharmacokinetic Population|Monotherapy Phase||17
9043717|NCT03407430|10104651|FG000|STARTED|Washout||5
9043718|NCT03407430|10104652|FG001|STARTED|Washout||3
8701325|NCT00910858|9747039|FG001|Pharmacokinetic Population|Monotherapy Phase|Patients in the 15 mg Non-del 5q group were not included in the pharmacokinetic assessment.|0
9043719|NCT03407430|10104651|FG000|COMPLETED|Washout||4
9043720|NCT03407430|10104652|FG001|COMPLETED|Washout||3
9043721|NCT03407430|10104651|FG000|NOT COMPLETED|Washout||1
9043722|NCT03407430|10104652|FG001|NOT COMPLETED|Washout||0
9043723|NCT03407430|10104651|FG000|STARTED|Second Intervention||4
9043724|NCT03407430|10104652|FG001|STARTED|Second Intervention||3
9043725|NCT03407430|10104651|FG000|COMPLETED|Second Intervention||4
9043726|NCT03407430|10104652|FG001|COMPLETED|Second Intervention||3
9043727|NCT03407430|10104651|FG000|NOT COMPLETED|Second Intervention||0
9043728|NCT03407430|10104652|FG001|NOT COMPLETED|Second Intervention||0
9043729|NCT03407482|10104665|FG000|STARTED|Overall Study||160
9043730|NCT03407482|10104665|FG000|COMPLETED|Overall Study||29
9043731|NCT03407482|10104665|FG000|NOT COMPLETED|Overall Study||131
9043732|NCT03407612|10104671|FG000|STARTED|Overall Study||19
9043733|NCT03407612|10104672|FG001|STARTED|Overall Study||23
9043734|NCT03407612|10104671|FG000|COMPLETED|Overall Study||19
9043735|NCT03407612|10104672|FG001|COMPLETED|Overall Study||23
9043736|NCT03407612|10104671|FG000|NOT COMPLETED|Overall Study||0
9043737|NCT03407612|10104672|FG001|NOT COMPLETED|Overall Study||0
9043738|NCT03407625|10104680|FG000|STARTED|Overall Study||1117
9043739|NCT03407625|10104681|FG001|STARTED|Overall Study||1110
9043740|NCT03407625|10104680|FG000|COMPLETED|Overall Study||1117
9043741|NCT03407625|10104681|FG001|COMPLETED|Overall Study||1110
9043742|NCT03407625|10104680|FG000|NOT COMPLETED|Overall Study||0
9043743|NCT03407625|10104681|FG001|NOT COMPLETED|Overall Study||0
9043744|NCT03407651|10104687|FG000|STARTED|Period 1: Part 1a||11
9043745|NCT03407651|10104687|FG000|COMPLETED|Period 1: Part 1a||10
9043746|NCT03407651|10104687|FG000|NOT COMPLETED|Period 1: Part 1a||1
8701326|NCT00910858|9747040|FG002|Pharmacokinetic Population|Monotherapy Phase||7
8701327|NCT00910858|9747038|FG000|COMPLETED|Monotherapy Phase||0
8701328|NCT00910858|9747039|FG001|COMPLETED|Monotherapy Phase||0
8701329|NCT00910858|9747040|FG002|COMPLETED|Monotherapy Phase||0
8701330|NCT00910858|9747038|FG000|NOT COMPLETED|Monotherapy Phase||17
8701331|NCT00910858|9747039|FG001|NOT COMPLETED|Monotherapy Phase||15
8701332|NCT00910858|9747040|FG002|NOT COMPLETED|Monotherapy Phase||7
8701333|NCT00910858|9747038|FG000|STARTED|Combined Treatment Phase|Patients who discontinued the Monotherapy Phase due to erythroid non-response or erythroid relapse.|9
8701334|NCT00910858|9747039|FG001|STARTED|Combined Treatment Phase|Patients who discontinued the Monotherapy Phase due to erythroid non-response or erythroid relapse.|10
8701335|NCT00910858|9747040|FG002|STARTED|Combined Treatment Phase|Patients who discontinued the Monotherapy Phase due to erythroid non-response or erythroid relapse.|4
8701336|NCT00910858|9747038|FG000|COMPLETED|Combined Treatment Phase||0
8701337|NCT00910858|9747039|FG001|COMPLETED|Combined Treatment Phase||0
8701338|NCT00910858|9747040|FG002|COMPLETED|Combined Treatment Phase||0
8701339|NCT00910858|9747038|FG000|NOT COMPLETED|Combined Treatment Phase||9
8701340|NCT00910858|9747039|FG001|NOT COMPLETED|Combined Treatment Phase||10
8701341|NCT00910858|9747040|FG002|NOT COMPLETED|Combined Treatment Phase||4
8701342|NCT00910871|9747056|FG000|STARTED|Overall Study||233
8701343|NCT00910871|9747056|FG000|COMPLETED|Overall Study||179
8701344|NCT00910871|9747056|FG000|NOT COMPLETED|Overall Study||54
8701345|NCT00910910|9747062|FG000|STARTED|Overall Study||225
8701346|NCT00910910|9747063|FG001|STARTED|Overall Study||225
8701347|NCT00910910|9747062|FG000|Safety Population|Overall Study|All randomized participants who received at least 1 dose of the either lenalidomide or chlorambucil|224
8701348|NCT00910910|9747063|FG001|Safety Population|Overall Study|All randomized participants who received at least 1 dose of the either lenalidomide or chlorambucil|223
8701349|NCT00910910|9747062|FG000|COMPLETED|Overall Study|Completed includes participants who continued with ongoing treatment|0
8701350|NCT00910910|9747063|FG001|COMPLETED|Overall Study|Completed includes participants who continued with ongoing treatment|1
8701351|NCT00910910|9747062|FG000|NOT COMPLETED|Overall Study||225
8701352|NCT00910910|9747063|FG001|NOT COMPLETED|Overall Study||224
8701353|NCT00910962|9747072|FG000|STARTED|Overall Study||135
8701354|NCT00910962|9747073|FG001|STARTED|Overall Study||199
8701355|NCT00910962|9747074|FG002|STARTED|Overall Study||192
8701356|NCT00910962|9747072|FG000|COMPLETED|Overall Study||92
8701357|NCT00910962|9747073|FG001|COMPLETED|Overall Study||121
8701358|NCT00910962|9747074|FG002|COMPLETED|Overall Study||116
8701359|NCT00910962|9747072|FG000|NOT COMPLETED|Overall Study||43
8701360|NCT00910962|9747073|FG001|NOT COMPLETED|Overall Study||78
8701361|NCT00910962|9747074|FG002|NOT COMPLETED|Overall Study||76
8701362|NCT00910988|9747088|FG000|STARTED|Overall Study||16
8701363|NCT00910988|9747089|FG001|STARTED|Overall Study||16
8701364|NCT00910988|9747090|FG002|STARTED|Overall Study||8
8701365|NCT00910988|9747091|FG003|STARTED|Overall Study||6
8701366|NCT00910988|9747088|FG000|COMPLETED|Overall Study||14
8701367|NCT00910988|9747089|FG001|COMPLETED|Overall Study||12
8701368|NCT00910988|9747090|FG002|COMPLETED|Overall Study||5
8701369|NCT00910988|9747091|FG003|COMPLETED|Overall Study||6
8701370|NCT00910988|9747088|FG000|NOT COMPLETED|Overall Study||2
9043747|NCT03407651|10104687|FG000|STARTED|Period 2: Part 1b||9
9043748|NCT03407651|10104687|FG000|COMPLETED|Period 2: Part 1b||9
9043749|NCT03407651|10104687|FG000|NOT COMPLETED|Period 2: Part 1b||0
9043750|NCT03407651|10104687|FG000|STARTED|Period 3: Part 2|The subject who discontinued after 44 daily SC doses in Part 2 elected to participate in Period 3.|11
9043751|NCT03407651|10104687|FG000|COMPLETED|Period 3: Part 2||8
9043752|NCT03407651|10104687|FG000|NOT COMPLETED|Period 3: Part 2||3
9043753|NCT03408171|10104709|FG000|STARTED|Overall Study||20
9043754|NCT03408171|10104710|FG001|STARTED|Overall Study||20
9043755|NCT03408171|10104709|FG000|COMPLETED|Overall Study||20
9043756|NCT03408171|10104710|FG001|COMPLETED|Overall Study||20
9043757|NCT03408171|10104709|FG000|NOT COMPLETED|Overall Study||0
9043758|NCT03408171|10104710|FG001|NOT COMPLETED|Overall Study||0
9043759|NCT03408392|10104716|FG000|STARTED|Treatment Period 1 (16 Days)||14
9043760|NCT03408392|10104717|FG001|STARTED|Treatment Period 1 (16 Days)||14
8701371|NCT00910988|9747089|FG001|NOT COMPLETED|Overall Study||4
8701372|NCT00910988|9747090|FG002|NOT COMPLETED|Overall Study||3
8701373|NCT00910988|9747091|FG003|NOT COMPLETED|Overall Study||0
8701374|NCT00911144|9747119|FG000|STARTED|Overall Study||335
8701375|NCT00911144|9747120|FG001|STARTED|Overall Study||113
8701376|NCT00911144|9747119|FG000|COMPLETED|Overall Study||319
8701377|NCT00911144|9747120|FG001|COMPLETED|Overall Study||108
8701378|NCT00911144|9747119|FG000|NOT COMPLETED|Overall Study||16
8701379|NCT00911144|9747120|FG001|NOT COMPLETED|Overall Study||5
8701380|NCT00911157|9747128|FG000|STARTED|Overall Study||29
8701381|NCT00911157|9747129|FG001|STARTED|Overall Study||10
8701382|NCT00911157|9747128|FG000|COMPLETED|Overall Study||22
8701383|NCT00911157|9747129|FG001|COMPLETED|Overall Study||8
8701384|NCT00911157|9747128|FG000|NOT COMPLETED|Overall Study||7
8701385|NCT00911157|9747129|FG001|NOT COMPLETED|Overall Study||2
8701386|NCT00911170|9747137|FG000|STARTED|Treatment Period||424
8701387|NCT00911170|9747138|FG001|STARTED|Treatment Period||423
8701388|NCT00911170|9747137|FG000|Received Chemotherapy|Treatment Period|Primary Analysis Set|423
8701389|NCT00911170|9747138|FG001|Received Chemotherapy|Treatment Period|Primary Analysis Set|422
8701390|NCT00911170|9747137|FG000|Received Bevacizumab|Treatment Period||423
8701391|NCT00911170|9747138|FG001|Received Bevacizumab|Treatment Period||420
8724431|NCT01026402|9771642|FG012|STARTED|Overall Study||8
9043761|NCT03408392|10104716|FG000|COMPLETED|Treatment Period 1 (16 Days)||14
9043762|NCT03408392|10104717|FG001|COMPLETED|Treatment Period 1 (16 Days)||14
8724432|NCT01026402|9771643|FG013|STARTED|Overall Study||6
8724433|NCT01026402|9771644|FG014|STARTED|Overall Study||3
8724434|NCT01026402|9771645|FG015|STARTED|Overall Study||5
8724435|NCT01026402|9771646|FG016|STARTED|Overall Study||4
8724436|NCT01026402|9771630|FG000|COMPLETED|Overall Study||6
8724437|NCT01026402|9771631|FG001|COMPLETED|Overall Study||8
8724438|NCT01026402|9771632|FG002|COMPLETED|Overall Study||33
8724439|NCT01026402|9771633|FG003|COMPLETED|Overall Study||18
8724440|NCT01026402|9771634|FG004|COMPLETED|Overall Study||3
8724441|NCT01026402|9771635|FG005|COMPLETED|Overall Study||5
8724442|NCT01026402|9771636|FG006|COMPLETED|Overall Study||8
8724443|NCT01026402|9771637|FG007|COMPLETED|Overall Study||3
8724444|NCT01026402|9771638|FG008|COMPLETED|Overall Study||7
8724445|NCT01026402|9771639|FG009|COMPLETED|Overall Study||3
8724446|NCT01026402|9771640|FG010|COMPLETED|Overall Study||7
8724447|NCT01026402|9771641|FG011|COMPLETED|Overall Study||8
8724448|NCT01026402|9771642|FG012|COMPLETED|Overall Study||8
8724449|NCT01026402|9771643|FG013|COMPLETED|Overall Study||6
8724450|NCT01026402|9771644|FG014|COMPLETED|Overall Study||3
8724451|NCT01026402|9771645|FG015|COMPLETED|Overall Study||5
8724452|NCT01026402|9771646|FG016|COMPLETED|Overall Study||4
8724453|NCT01026402|9771630|FG000|NOT COMPLETED|Overall Study||0
8724454|NCT01026402|9771631|FG001|NOT COMPLETED|Overall Study||0
8724455|NCT01026402|9771632|FG002|NOT COMPLETED|Overall Study||0
8724456|NCT01026402|9771633|FG003|NOT COMPLETED|Overall Study||0
8724457|NCT01026402|9771634|FG004|NOT COMPLETED|Overall Study||0
8724458|NCT01026402|9771635|FG005|NOT COMPLETED|Overall Study||0
8724459|NCT01026402|9771636|FG006|NOT COMPLETED|Overall Study||0
8724460|NCT01026402|9771637|FG007|NOT COMPLETED|Overall Study||0
8724461|NCT01026402|9771638|FG008|NOT COMPLETED|Overall Study||0
8724462|NCT01026402|9771639|FG009|NOT COMPLETED|Overall Study||0
8724463|NCT01026402|9771640|FG010|NOT COMPLETED|Overall Study||0
8724464|NCT01026402|9771641|FG011|NOT COMPLETED|Overall Study||0
8724465|NCT01026402|9771642|FG012|NOT COMPLETED|Overall Study||0
8724466|NCT01026402|9771643|FG013|NOT COMPLETED|Overall Study||0
8724467|NCT01026402|9771644|FG014|NOT COMPLETED|Overall Study||0
8724468|NCT01026402|9771645|FG015|NOT COMPLETED|Overall Study||0
8724469|NCT01026402|9771646|FG016|NOT COMPLETED|Overall Study||0
8724470|NCT01026454|9771687|FG000|STARTED|First Intervention||18
8724471|NCT01026454|9771688|FG001|STARTED|First Intervention||14
8724472|NCT01026454|9771687|FG000|COMPLETED|First Intervention||18
8724473|NCT01026454|9771688|FG001|COMPLETED|First Intervention||14
8724474|NCT01026454|9771687|FG000|NOT COMPLETED|First Intervention||0
8724475|NCT01026454|9771688|FG001|NOT COMPLETED|First Intervention||0
8724476|NCT01026454|9771687|FG000|STARTED|Washout||18
8724477|NCT01026454|9771688|FG001|STARTED|Washout||14
8724478|NCT01026454|9771687|FG000|COMPLETED|Washout||18
8724479|NCT01026454|9771688|FG001|COMPLETED|Washout||14
8724480|NCT01026454|9771687|FG000|NOT COMPLETED|Washout||0
8724481|NCT01026454|9771688|FG001|NOT COMPLETED|Washout||0
8724482|NCT01026454|9771687|FG000|STARTED|Second Intervention||17
8724483|NCT01026454|9771688|FG001|STARTED|Second Intervention||14
8724484|NCT01026454|9771687|FG000|COMPLETED|Second Intervention||16
8724485|NCT01026454|9771688|FG001|COMPLETED|Second Intervention||13
8724486|NCT01026454|9771687|FG000|NOT COMPLETED|Second Intervention||1
8724487|NCT01026454|9771688|FG001|NOT COMPLETED|Second Intervention||1
8724488|NCT01026493|9771702|FG000|STARTED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|8
8724489|NCT01026493|9771703|FG001|STARTED|Overall Study||7
9043763|NCT03408392|10104716|FG000|NOT COMPLETED|Treatment Period 1 (16 Days)||0
9043764|NCT03408392|10104717|FG001|NOT COMPLETED|Treatment Period 1 (16 Days)||0
9043765|NCT03408392|10104716|FG000|STARTED|Wash-out Period (14 Days)||14
9043766|NCT03408392|10104717|FG001|STARTED|Wash-out Period (14 Days)||14
9043767|NCT03408392|10104716|FG000|COMPLETED|Wash-out Period (14 Days)||14
9043768|NCT03408392|10104717|FG001|COMPLETED|Wash-out Period (14 Days)||14
9043769|NCT03408392|10104716|FG000|NOT COMPLETED|Wash-out Period (14 Days)||0
9043770|NCT03408392|10104717|FG001|NOT COMPLETED|Wash-out Period (14 Days)||0
9043771|NCT03408392|10104716|FG000|STARTED|Treatment Period 2 (16 Days)||14
9043772|NCT03408392|10104717|FG001|STARTED|Treatment Period 2 (16 Days)||14
9043773|NCT03408392|10104716|FG000|COMPLETED|Treatment Period 2 (16 Days)||14
9043774|NCT03408392|10104717|FG001|COMPLETED|Treatment Period 2 (16 Days)||14
9043775|NCT03408392|10104716|FG000|NOT COMPLETED|Treatment Period 2 (16 Days)||0
9043776|NCT03408392|10104717|FG001|NOT COMPLETED|Treatment Period 2 (16 Days)||0
8701392|NCT00911170|9747137|FG000|Received Investigational Product|Treatment Period|Includes one participant who received pegfilgrastim in error.|422
8701393|NCT00911170|9747138|FG001|Received Investigational Product|Treatment Period||419
8701394|NCT00911170|9747137|FG000|COMPLETED|Treatment Period|Completed 4 cycles of treatment including chemotherapy, bevacizumab and investigational product.|397
8701395|NCT00911170|9747138|FG001|COMPLETED|Treatment Period|Completed 4 cycles of treatment including chemotherapy, bevacizumab and investigational product.|386
8701396|NCT00911170|9747137|FG000|NOT COMPLETED|Treatment Period||27
8701397|NCT00911170|9747138|FG001|NOT COMPLETED|Treatment Period||37
8701398|NCT00911170|9747137|FG000|STARTED|Long Term Follow-Up|Participants who received treatment in the Treatment Period|423
8701399|NCT00911170|9747138|FG001|STARTED|Long Term Follow-Up|Participants who received treatment in the Treatment Period|422
8701400|NCT00911170|9747137|FG000|COMPLETED|Long Term Follow-Up|As of the data cut-off date of 8 June 2012|0
8701401|NCT00911170|9747138|FG001|COMPLETED|Long Term Follow-Up|As of the data cut-off date of 8 June 2012|0
8701402|NCT00911170|9747137|FG000|NOT COMPLETED|Long Term Follow-Up||423
8701403|NCT00911170|9747138|FG001|NOT COMPLETED|Long Term Follow-Up||422
8701404|NCT00911300|9747146|FG000|STARTED|Overall Study||175
8701405|NCT00911300|9747147|FG001|STARTED|Overall Study||174
8701406|NCT00911300|9747146|FG000|COMPLETED|Overall Study||140
8701407|NCT00911300|9747147|FG001|COMPLETED|Overall Study||131
8701408|NCT00911300|9747146|FG000|NOT COMPLETED|Overall Study||35
8701409|NCT00911300|9747147|FG001|NOT COMPLETED|Overall Study||43
8701410|NCT00911326|9747154|FG000|STARTED|Overall Study||101
8701411|NCT00911326|9747154|FG000|COMPLETED|Overall Study||85
8701412|NCT00911326|9747154|FG000|NOT COMPLETED|Overall Study||16
8701413|NCT00911495|9747158|FG000|STARTED|Overall Study||15
8701414|NCT00911495|9747158|FG000|COMPLETED|Overall Study||14
8701415|NCT00911495|9747158|FG000|NOT COMPLETED|Overall Study||1
8701416|NCT00911508|9747164|FG000|STARTED|Overall Study||1108
8701417|NCT00911508|9747165|FG001|STARTED|Overall Study||1096
8701418|NCT00911508|9747164|FG000|COMPLETED|Overall Study||1002
8701419|NCT00911508|9747165|FG001|COMPLETED|Overall Study||966
8701420|NCT00911508|9747164|FG000|NOT COMPLETED|Overall Study||106
8701421|NCT00911508|9747165|FG001|NOT COMPLETED|Overall Study||130
8701422|NCT00911534|9747173|FG000|STARTED|Overall Study|Randomized (treated)|147
8701423|NCT00911534|9747174|FG001|STARTED|Overall Study|Randomized (treated)|153
8701424|NCT00911534|9747173|FG000|COMPLETED|Overall Study||132
8701425|NCT00911534|9747174|FG001|COMPLETED|Overall Study||137
8701426|NCT00911534|9747173|FG000|NOT COMPLETED|Overall Study||15
8701427|NCT00911534|9747174|FG001|NOT COMPLETED|Overall Study||16
8701428|NCT00911586|9747180|FG000|STARTED|Overall Study||15
8701429|NCT00911586|9747180|FG000|COMPLETED|Overall Study||15
8701430|NCT00911586|9747180|FG000|NOT COMPLETED|Overall Study||0
8701431|NCT00911612|9747187|FG000|STARTED|Overall Study||12
8701432|NCT00911612|9747188|FG001|STARTED|Overall Study||12
8701433|NCT00911612|9747187|FG000|COMPLETED|Overall Study||12
8701434|NCT00911612|9747188|FG001|COMPLETED|Overall Study||12
8701435|NCT00911612|9747187|FG000|NOT COMPLETED|Overall Study||0
8701436|NCT00911612|9747188|FG001|NOT COMPLETED|Overall Study||0
8701437|NCT00911625|9747196|FG000|STARTED|Overall Study||57
8701438|NCT00911625|9747197|FG001|STARTED|Overall Study||57
8701439|NCT00911625|9747196|FG000|COMPLETED|Overall Study||50
8701440|NCT00911625|9747197|FG001|COMPLETED|Overall Study||57
8701441|NCT00911625|9747196|FG000|NOT COMPLETED|Overall Study||7
8701442|NCT00911625|9747197|FG001|NOT COMPLETED|Overall Study||0
8701443|NCT00911742|9747205|FG000|STARTED|Treatment Phase I||13
8701444|NCT00911742|9747206|FG001|STARTED|Treatment Phase I||13
8701445|NCT00911742|9747205|FG000|COMPLETED|Treatment Phase I||13
8701446|NCT00911742|9747206|FG001|COMPLETED|Treatment Phase I||13
8701447|NCT00911742|9747205|FG000|NOT COMPLETED|Treatment Phase I||0
8701448|NCT00911742|9747206|FG001|NOT COMPLETED|Treatment Phase I||0
8701449|NCT00911742|9747205|FG000|STARTED|Treatment Phase II||13
8701450|NCT00911742|9747206|FG001|STARTED|Treatment Phase II||13
9043777|NCT03408483|10104725|FG000|STARTED|Overall Study||42
9043778|NCT03408483|10104726|FG001|STARTED|Overall Study||38
8701451|NCT00911742|9747205|FG000|COMPLETED|Treatment Phase II||13
8701452|NCT00911742|9747206|FG001|COMPLETED|Treatment Phase II||13
8701453|NCT00911742|9747205|FG000|NOT COMPLETED|Treatment Phase II||0
8701454|NCT00911742|9747206|FG001|NOT COMPLETED|Treatment Phase II||0
8701455|NCT00911768|9747214|FG000|STARTED|Overall Study||50
8701456|NCT00911768|9747215|FG001|STARTED|Overall Study||50
8701457|NCT00911768|9747214|FG000|COMPLETED|Overall Study||44
8701458|NCT00911768|9747215|FG001|COMPLETED|Overall Study||46
8701459|NCT00911768|9747214|FG000|NOT COMPLETED|Overall Study||6
9043779|NCT03408483|10104725|FG000|COMPLETED|Overall Study||36
9043780|NCT03408483|10104726|FG001|COMPLETED|Overall Study||35
9043781|NCT03408483|10104725|FG000|NOT COMPLETED|Overall Study||6
9043782|NCT03408483|10104726|FG001|NOT COMPLETED|Overall Study||3
9043783|NCT03408639|10104734|FG000|STARTED|Overall Study||78
9043784|NCT03408639|10104735|FG001|STARTED|Overall Study||78
9043785|NCT03408639|10104734|FG000|COMPLETED|Overall Study||67
9043786|NCT03408639|10104735|FG001|COMPLETED|Overall Study||56
8701460|NCT00911768|9747215|FG001|NOT COMPLETED|Overall Study||4
8701461|NCT00911807|9747224|FG000|STARTED|Overall Study||72
8701462|NCT00911807|9747225|FG001|STARTED|Overall Study||70
8701463|NCT00911807|9747226|FG002|STARTED|Overall Study||75
8701464|NCT00911807|9747224|FG000|COMPLETED|Overall Study||55
8701465|NCT00911807|9747225|FG001|COMPLETED|Overall Study||52
8701466|NCT00911807|9747226|FG002|COMPLETED|Overall Study||52
8701467|NCT00911807|9747224|FG000|NOT COMPLETED|Overall Study||17
8701468|NCT00911807|9747225|FG001|NOT COMPLETED|Overall Study||18
8701469|NCT00911807|9747226|FG002|NOT COMPLETED|Overall Study||23
8701470|NCT00911820|9747236|FG000|STARTED|Overall Study||45
8701471|NCT00911820|9747237|FG001|STARTED|Overall Study||43
8701472|NCT00911820|9747236|FG000|Treated|Overall Study|Randomized patients not treated: unable to confirm pathology (n=1)|44
8701473|NCT00911820|9747237|FG001|Treated|Overall Study|Randomized patients not treated: withdrew consent (n=2)|41
8701474|NCT00911820|9747236|FG000|COMPLETED|Overall Study||0
8701475|NCT00911820|9747237|FG001|COMPLETED|Overall Study||0
8701476|NCT00911820|9747236|FG000|NOT COMPLETED|Overall Study||45
8701477|NCT00911820|9747237|FG001|NOT COMPLETED|Overall Study||43
8701478|NCT00911859|9747246|FG000|STARTED|Treatment Period||12
8701479|NCT00911859|9747247|FG001|STARTED|Treatment Period||54
8701480|NCT00911859|9747248|FG002|STARTED|Treatment Period||52
8701481|NCT00911859|9747246|FG000|Received Treatment|Treatment Period||12
8701482|NCT00911859|9747247|FG001|Received Treatment|Treatment Period||53
8701483|NCT00911859|9747248|FG002|Received Treatment|Treatment Period||52
8701484|NCT00911859|9747246|FG000|COMPLETED|Treatment Period||4
8701485|NCT00911859|9747247|FG001|COMPLETED|Treatment Period||33
8701486|NCT00911859|9747248|FG002|COMPLETED|Treatment Period||27
8701487|NCT00911859|9747246|FG000|NOT COMPLETED|Treatment Period||8
8701488|NCT00911859|9747247|FG001|NOT COMPLETED|Treatment Period||21
8701489|NCT00911859|9747248|FG002|NOT COMPLETED|Treatment Period||25
8701490|NCT00911859|9747246|FG000|STARTED|Maintainance Period||0
8701491|NCT00911859|9747247|FG001|STARTED|Maintainance Period||0
8701492|NCT00911859|9747248|FG002|STARTED|Maintainance Period|Participants who received siltuximab only during the 18-month maintenance period|21
8701493|NCT00911859|9747246|FG000|COMPLETED|Maintainance Period||0
8701494|NCT00911859|9747247|FG001|COMPLETED|Maintainance Period||0
8701495|NCT00911859|9747248|FG002|COMPLETED|Maintainance Period||0
8701496|NCT00911859|9747246|FG000|NOT COMPLETED|Maintainance Period||0
8701497|NCT00911859|9747247|FG001|NOT COMPLETED|Maintainance Period||0
8701498|NCT00911859|9747248|FG002|NOT COMPLETED|Maintainance Period||21
8701499|NCT00911859|9747246|FG000|STARTED|Follow-up Period|Participants followed until death or 3.5 years after the last participant was assigned to treatment|12
8701500|NCT00911859|9747247|FG001|STARTED|Follow-up Period|Participants followed until death or 3.5 years after the last participant was assigned to treatment|53
8701501|NCT00911859|9747248|FG002|STARTED|Follow-up Period|Participants followed until death or 3.5 years after the last participant was assigned to treatment|52
8701502|NCT00911859|9747246|FG000|COMPLETED|Follow-up Period||1
8701503|NCT00911859|9747247|FG001|COMPLETED|Follow-up Period||7
8701504|NCT00911859|9747248|FG002|COMPLETED|Follow-up Period||11
8701505|NCT00911859|9747246|FG000|NOT COMPLETED|Follow-up Period||11
8701506|NCT00911859|9747247|FG001|NOT COMPLETED|Follow-up Period||46
8701507|NCT00911859|9747248|FG002|NOT COMPLETED|Follow-up Period||41
8701508|NCT00911898|9747256|FG000|STARTED|Overall Study||20
8701509|NCT00911898|9747256|FG000|COMPLETED|Overall Study||20
8701510|NCT00911898|9747256|FG000|NOT COMPLETED|Overall Study||0
8701511|NCT00911937|9747262|FG000|STARTED|Overall Study||487
8701512|NCT00911937|9747263|FG001|STARTED|Overall Study||476
8701513|NCT00911937|9747262|FG000|Treated|Overall Study||474
8701514|NCT00911937|9747263|FG001|Treated|Overall Study||463
8701515|NCT00911937|9747262|FG000|COMPLETED|Overall Study||400
8701516|NCT00911937|9747263|FG001|COMPLETED|Overall Study||381
8701517|NCT00911937|9747262|FG000|NOT COMPLETED|Overall Study||87
8701518|NCT00911937|9747263|FG001|NOT COMPLETED|Overall Study||95
8701519|NCT00911989|9747269|FG000|STARTED|Overall Study||4
8701520|NCT00911989|9747269|FG000|COMPLETED|Overall Study||3
8701521|NCT00911989|9747269|FG000|NOT COMPLETED|Overall Study||1
8701522|NCT00912002|9747273|FG000|STARTED|Overall Study||6
8701523|NCT00912002|9747273|FG000|COMPLETED|Overall Study||6
8701524|NCT00912002|9747273|FG000|NOT COMPLETED|Overall Study||0
8701525|NCT00912015|9747282|FG000|STARTED|Overall Study|Dose at which a patient spent the longest time.|141
8701526|NCT00912015|9747283|FG001|STARTED|Overall Study|Dose at which a patient spent the longest time.|70
8701527|NCT00912015|9747284|FG002|STARTED|Overall Study|Dose at which a patient spent the longest time.|25
8701528|NCT00912015|9747285|FG003|STARTED|Overall Study|Two patients took 100 mg against instructions in protocol that the minimum daily dose was 200 mg.|2
8701529|NCT00912015|9747282|FG000|COMPLETED|Overall Study||125
9043787|NCT03408639|10104734|FG000|NOT COMPLETED|Overall Study||11
8701530|NCT00912015|9747283|FG001|COMPLETED|Overall Study||62
8701531|NCT00912015|9747284|FG002|COMPLETED|Overall Study||22
9043788|NCT03408639|10104735|FG001|NOT COMPLETED|Overall Study||22
9043789|NCT03408730|10104745|FG000|STARTED|Overall Study||712
9043790|NCT03408730|10104746|FG001|STARTED|Overall Study||711
9043791|NCT03408730|10104747|FG002|STARTED|Overall Study||709
9043792|NCT03408730|10104748|FG003|STARTED|Overall Study||706
9043793|NCT03408730|10104745|FG000|COMPLETED|Overall Study||643
9043794|NCT03408730|10104746|FG001|COMPLETED|Overall Study||636
9043795|NCT03408730|10104747|FG002|COMPLETED|Overall Study||637
9043796|NCT03408730|10104748|FG003|COMPLETED|Overall Study||625
9043797|NCT03408730|10104745|FG000|NOT COMPLETED|Overall Study||69
9043798|NCT03408730|10104746|FG001|NOT COMPLETED|Overall Study||75
9043799|NCT03408730|10104747|FG002|NOT COMPLETED|Overall Study||72
9043800|NCT03408730|10104748|FG003|NOT COMPLETED|Overall Study||81
9043801|NCT03408808|10104764|FG000|STARTED|Overall Study||8
9043802|NCT03408808|10104765|FG001|STARTED|Overall Study||9
9043803|NCT03408808|10104764|FG000|COMPLETED|Overall Study||8
9043804|NCT03408808|10104765|FG001|COMPLETED|Overall Study||8
9043805|NCT03408808|10104764|FG000|NOT COMPLETED|Overall Study||0
9043806|NCT03408808|10104765|FG001|NOT COMPLETED|Overall Study||1
9043807|NCT03409107|10104773|FG000|STARTED|Overall Study||307
9043808|NCT03409107|10104774|FG001|STARTED|Overall Study||307
9043809|NCT03409107|10104773|FG000|COMPLETED|Overall Study||290
9043810|NCT03409107|10104774|FG001|COMPLETED|Overall Study||300
9043811|NCT03409107|10104773|FG000|NOT COMPLETED|Overall Study||17
9043812|NCT03409107|10104774|FG001|NOT COMPLETED|Overall Study||7
9043813|NCT03410056|10104784|FG000|STARTED|Overall Study||8
9043814|NCT03410056|10104785|FG001|STARTED|Overall Study||6
9043815|NCT03410056|10104786|FG002|STARTED|Overall Study||11
9043816|NCT03410056|10104787|FG003|STARTED|Overall Study||11
9043817|NCT03410056|10104788|FG004|STARTED|Overall Study||0
9043818|NCT03410056|10104789|FG005|STARTED|Overall Study||0
9043819|NCT03410056|10104790|FG006|STARTED|Overall Study||0
9043820|NCT03410056|10104784|FG000|Received Treatment|Overall Study||8
9043821|NCT03410056|10104785|FG001|Received Treatment|Overall Study||6
9043822|NCT03410056|10104786|FG002|Received Treatment|Overall Study||11
9043823|NCT03410056|10104787|FG003|Received Treatment|Overall Study||11
9043824|NCT03410056|10104788|FG004|Received Treatment|Overall Study||0
9043825|NCT03410056|10104789|FG005|Received Treatment|Overall Study||0
9043826|NCT03410056|10104790|FG006|Received Treatment|Overall Study||0
9043827|NCT03410056|10104784|FG000|COMPLETED|Overall Study||8
9043828|NCT03410056|10104785|FG001|COMPLETED|Overall Study||4
9043829|NCT03410056|10104786|FG002|COMPLETED|Overall Study||3
9043830|NCT03410056|10104787|FG003|COMPLETED|Overall Study||6
9043831|NCT03410056|10104788|FG004|COMPLETED|Overall Study||0
9043832|NCT03410056|10104789|FG005|COMPLETED|Overall Study||0
9043833|NCT03410056|10104790|FG006|COMPLETED|Overall Study||0
9043834|NCT03410056|10104784|FG000|NOT COMPLETED|Overall Study||0
9043835|NCT03410056|10104785|FG001|NOT COMPLETED|Overall Study||2
9043836|NCT03410056|10104786|FG002|NOT COMPLETED|Overall Study||8
9043837|NCT03410056|10104787|FG003|NOT COMPLETED|Overall Study||5
9043838|NCT03410056|10104788|FG004|NOT COMPLETED|Overall Study||0
9043839|NCT03410056|10104789|FG005|NOT COMPLETED|Overall Study||0
9043840|NCT03410056|10104790|FG006|NOT COMPLETED|Overall Study||0
9043841|NCT03410628|10104806|FG000|STARTED|Overall Study||21
9043842|NCT03410628|10104806|FG000|COMPLETED|Overall Study||15
9043843|NCT03410628|10104806|FG000|NOT COMPLETED|Overall Study||6
9043844|NCT03410797|10104810|FG000|STARTED|Overall Study||11
9043845|NCT03410797|10104810|FG000|COMPLETED|Overall Study||11
9043846|NCT03410797|10104810|FG000|NOT COMPLETED|Overall Study||0
9043847|NCT03410862|10104817|FG000|STARTED|Overall Study||43
9043848|NCT03410862|10104818|FG001|STARTED|Overall Study||44
9043849|NCT03410862|10104817|FG000|COMPLETED|Overall Study||41
9043850|NCT03410862|10104818|FG001|COMPLETED|Overall Study||42
9043851|NCT03410862|10104817|FG000|NOT COMPLETED|Overall Study||2
9043852|NCT03410862|10104818|FG001|NOT COMPLETED|Overall Study||2
9043853|NCT03410914|10104824|FG000|STARTED|Overall Study||52
9043854|NCT03410914|10104824|FG000|COMPLETED|Overall Study||52
9043855|NCT03410914|10104824|FG000|NOT COMPLETED|Overall Study||0
9043856|NCT03410953|10104828|FG000|STARTED|Overall Study|First patient recruited|67
9043857|NCT03410953|10104828|FG000|COMPLETED|Overall Study|67 participants were enrolled in the Clinical Trial and included the analyses|67
9043858|NCT03410953|10104828|FG000|NOT COMPLETED|Overall Study||0
9043859|NCT03411902|10104834|FG000|STARTED|Overall Study||11
9043860|NCT03411902|10104835|FG001|STARTED|Overall Study||13
9043861|NCT03411902|10104834|FG000|COMPLETED|Overall Study||8
9043862|NCT03411902|10104835|FG001|COMPLETED|Overall Study||13
9043863|NCT03411902|10104834|FG000|NOT COMPLETED|Overall Study||3
9043864|NCT03411902|10104835|FG001|NOT COMPLETED|Overall Study||0
9043865|NCT03412019|10104843|FG000|STARTED|Overall Study||11
9043866|NCT03412019|10104844|FG001|STARTED|Overall Study||11
9043867|NCT03412019|10104843|FG000|COMPLETED|Overall Study||10
9043868|NCT03412019|10104844|FG001|COMPLETED|Overall Study||10
9043869|NCT03412019|10104843|FG000|NOT COMPLETED|Overall Study||1
9043870|NCT03412019|10104844|FG001|NOT COMPLETED|Overall Study||1
9043871|NCT03412084|10104852|FG000|STARTED|Overall Study||48
9043872|NCT03412084|10104853|FG001|STARTED|Overall Study||36
9043873|NCT03412084|10104852|FG000|COMPLETED|Overall Study||44
9043874|NCT03412084|10104853|FG001|COMPLETED|Overall Study||35
9043875|NCT03412084|10104852|FG000|NOT COMPLETED|Overall Study||4
9043876|NCT03412084|10104853|FG001|NOT COMPLETED|Overall Study||1
9043877|NCT03412734|10104861|FG000|STARTED|Overall Study||47
9043878|NCT03412734|10104862|FG001|STARTED|Overall Study||41
9043879|NCT03412734|10104861|FG000|COMPLETED|Overall Study||44
9043880|NCT03412734|10104862|FG001|COMPLETED|Overall Study||41
9043881|NCT03412734|10104861|FG000|NOT COMPLETED|Overall Study||3
9043882|NCT03412734|10104862|FG001|NOT COMPLETED|Overall Study||0
9043883|NCT03412929|10104868|FG000|STARTED|Overall Study||8
9043884|NCT03412929|10104868|FG000|COMPLETED|Overall Study||5
9043885|NCT03412929|10104868|FG000|NOT COMPLETED|Overall Study||3
9043886|NCT03413618|10104874|FG000|STARTED|Overall Study||45
9043887|NCT03413618|10104875|FG001|STARTED|Overall Study||45
9043888|NCT03413618|10104874|FG000|COMPLETED|Overall Study||45
9043889|NCT03413618|10104875|FG001|COMPLETED|Overall Study||45
9043890|NCT03413618|10104874|FG000|NOT COMPLETED|Overall Study||0
9043891|NCT03413618|10104875|FG001|NOT COMPLETED|Overall Study||0
9043892|NCT03414047|10104885|FG000|STARTED|Overall Study||53
9043893|NCT03414047|10104886|FG001|STARTED|Overall Study||46
9043894|NCT03414047|10104887|FG002|STARTED|Overall Study||41
9043895|NCT03414047|10104888|FG003|STARTED|Overall Study||29
9043896|NCT03414047|10104885|FG000|Received at Least One Dose of Study Drug|Overall Study||53
9043897|NCT03414047|10104886|FG001|Received at Least One Dose of Study Drug|Overall Study||46
9043898|NCT03414047|10104887|FG002|Received at Least One Dose of Study Drug|Overall Study||41
9043899|NCT03414047|10104888|FG003|Received at Least One Dose of Study Drug|Overall Study||29
9043900|NCT03414047|10104885|FG000|COMPLETED|Overall Study||51
9043901|NCT03414047|10104886|FG001|COMPLETED|Overall Study||46
9043902|NCT03414047|10104887|FG002|COMPLETED|Overall Study||38
9043903|NCT03414047|10104888|FG003|COMPLETED|Overall Study||27
9043904|NCT03414047|10104885|FG000|NOT COMPLETED|Overall Study||2
9043905|NCT03414047|10104886|FG001|NOT COMPLETED|Overall Study||0
9043906|NCT03414047|10104887|FG002|NOT COMPLETED|Overall Study||3
9043907|NCT03414047|10104888|FG003|NOT COMPLETED|Overall Study||2
9043908|NCT03414359|10104901|FG000|STARTED|Overall Study||35
9043909|NCT03414359|10104902|FG001|STARTED|Overall Study||35
9043910|NCT03414359|10104901|FG000|COMPLETED|Overall Study||34
9043911|NCT03414359|10104902|FG001|COMPLETED|Overall Study||33
8701532|NCT00912015|9747285|FG003|COMPLETED|Overall Study||0
8701533|NCT00912015|9747282|FG000|NOT COMPLETED|Overall Study||16
8701534|NCT00912015|9747283|FG001|NOT COMPLETED|Overall Study||8
8701535|NCT00912015|9747284|FG002|NOT COMPLETED|Overall Study||3
8701536|NCT00912015|9747285|FG003|NOT COMPLETED|Overall Study||2
8701537|NCT00912028|9747298|FG000|STARTED|Overall Study||35
8701538|NCT00912028|9747299|FG001|STARTED|Overall Study||3
8701539|NCT00912028|9747300|FG002|STARTED|Overall Study||13
8701540|NCT00912028|9747301|FG003|STARTED|Overall Study||17
9043912|NCT03414359|10104901|FG000|NOT COMPLETED|Overall Study||1
9043913|NCT03414359|10104902|FG001|NOT COMPLETED|Overall Study||2
8701541|NCT00912028|9747302|FG004|STARTED|Overall Study||3
8701542|NCT00912028|9747298|FG000|COMPLETED|Overall Study||30
9043914|NCT03415152|10104908|FG000|STARTED|Overall Study||3000
9043915|NCT03415152|10104908|FG000|COMPLETED|Overall Study||1975
9043916|NCT03415152|10104908|FG000|NOT COMPLETED|Overall Study||1025
9043917|NCT03415178|10104917|FG000|STARTED|Parallel-Arm Period (up to Week 4)|Randomized|34
9043918|NCT03415178|10104918|FG001|STARTED|Parallel-Arm Period (up to Week 4)|Randomized|35
9043919|NCT03415178|10104917|FG000|Treated|Parallel-Arm Period (up to Week 4)||34
9043920|NCT03415178|10104918|FG001|Treated|Parallel-Arm Period (up to Week 4)||33
9043921|NCT03415178|10104917|FG000|COMPLETED|Parallel-Arm Period (up to Week 4)|33 participants entered in single arm period & 1 participant decided not to enter single arm period.|34
8701543|NCT00912028|9747299|FG001|COMPLETED|Overall Study||0
8701544|NCT00912028|9747300|FG002|COMPLETED|Overall Study||13
8701545|NCT00912028|9747301|FG003|COMPLETED|Overall Study||16
9043922|NCT03415178|10104918|FG001|COMPLETED|Parallel-Arm Period (up to Week 4)|32 participants entered in single arm period & 1 participant decided not to enter single arm period.|33
9043923|NCT03415178|10104917|FG000|NOT COMPLETED|Parallel-Arm Period (up to Week 4)||0
9043924|NCT03415178|10104918|FG001|NOT COMPLETED|Parallel-Arm Period (up to Week 4)||2
9043925|NCT03415178|10104917|FG000|STARTED|Single Arm Period (up to Week 16)|Out of 34 participants from AI group, 33 participants entered entered in single arm period.|0
9043926|NCT03415178|10104918|FG001|STARTED|Single Arm Period (up to Week 16)|65 (participants completed period 1) + 1 (randomized to SYDNEY arm but not treated in period 1).|66
9043927|NCT03415178|10104917|FG000|COMPLETED|Single Arm Period (up to Week 16)||0
9043928|NCT03415178|10104918|FG001|COMPLETED|Single Arm Period (up to Week 16)||65
9043929|NCT03415178|10104917|FG000|NOT COMPLETED|Single Arm Period (up to Week 16)||0
9043930|NCT03415178|10104918|FG001|NOT COMPLETED|Single Arm Period (up to Week 16)||1
9043931|NCT03415243|10104930|FG000|STARTED|Overall Study||14
9043932|NCT03415243|10104931|FG001|STARTED|Overall Study||14
9043933|NCT03415243|10104930|FG000|COMPLETED|Overall Study||14
9043934|NCT03415243|10104931|FG001|COMPLETED|Overall Study||14
9043935|NCT03415243|10104930|FG000|NOT COMPLETED|Overall Study||0
9043936|NCT03415243|10104931|FG001|NOT COMPLETED|Overall Study||0
9043937|NCT03415581|10104939|FG000|STARTED|Overall Study||7
9043938|NCT03415581|10104940|FG001|STARTED|Overall Study||6
9043939|NCT03415581|10104939|FG000|COMPLETED|Overall Study||1
9043940|NCT03415581|10104940|FG001|COMPLETED|Overall Study||1
9043941|NCT03415581|10104939|FG000|NOT COMPLETED|Overall Study||6
9043942|NCT03415581|10104940|FG001|NOT COMPLETED|Overall Study||5
9043943|NCT03416127|10104951|FG000|STARTED|Overall Study||12
9043944|NCT03416127|10104952|FG001|STARTED|Overall Study||12
8701546|NCT00912028|9747302|FG004|COMPLETED|Overall Study||0
8701547|NCT00912028|9747298|FG000|NOT COMPLETED|Overall Study||5
8701548|NCT00912028|9747299|FG001|NOT COMPLETED|Overall Study||3
8701549|NCT00912028|9747300|FG002|NOT COMPLETED|Overall Study||0
8701550|NCT00912028|9747301|FG003|NOT COMPLETED|Overall Study||1
8701551|NCT00912028|9747302|FG004|NOT COMPLETED|Overall Study||3
8701552|NCT00912093|9747317|FG000|STARTED|The Controlled Phase||43
8701553|NCT00912093|9747318|FG001|STARTED|The Controlled Phase||45
8701554|NCT00912093|9747319|FG002|STARTED|The Controlled Phase||3
8701555|NCT00912093|9747320|FG003|STARTED|The Controlled Phase||2
8701556|NCT00912093|9747321|FG004|STARTED|The Controlled Phase||5
8701557|NCT00912093|9747317|FG000|COMPLETED|The Controlled Phase||43
8701558|NCT00912093|9747318|FG001|COMPLETED|The Controlled Phase||43
8812609|NCT01520727|9865629|FG004|COMPLETED|Overall Study||6
8812610|NCT01520727|9865630|FG005|COMPLETED|Overall Study||6
8812611|NCT01520727|9865631|FG006|COMPLETED|Overall Study||6
8812612|NCT01520727|9865632|FG007|COMPLETED|Overall Study||6
8812613|NCT01520727|9865633|FG008|COMPLETED|Overall Study||16
8812614|NCT01520727|9865625|FG000|NOT COMPLETED|Overall Study||0
8812615|NCT01520727|9865626|FG001|NOT COMPLETED|Overall Study||0
8812616|NCT01520727|9865627|FG002|NOT COMPLETED|Overall Study||0
8812617|NCT01520727|9865628|FG003|NOT COMPLETED|Overall Study||0
8812618|NCT01520727|9865629|FG004|NOT COMPLETED|Overall Study||0
8812619|NCT01520727|9865630|FG005|NOT COMPLETED|Overall Study||0
8812620|NCT01520727|9865631|FG006|NOT COMPLETED|Overall Study||0
8812621|NCT01520727|9865632|FG007|NOT COMPLETED|Overall Study||0
8812622|NCT01520727|9865633|FG008|NOT COMPLETED|Overall Study||0
8812623|NCT01520870|9865653|FG000|STARTED|Overall Study||49
8812624|NCT01520870|9865653|FG000|COMPLETED|Overall Study||47
8812625|NCT01520870|9865653|FG000|NOT COMPLETED|Overall Study||2
8812626|NCT01520909|9865659|FG000|STARTED|Part 1 (Randomized Period)||29
8812627|NCT01520909|9865660|FG001|STARTED|Part 1 (Randomized Period)||63
8812628|NCT01520909|9865661|FG002|STARTED|Part 1 (Randomized Period)||0
8812629|NCT01520909|9865659|FG000|COMPLETED|Part 1 (Randomized Period)||28
8812630|NCT01520909|9865660|FG001|COMPLETED|Part 1 (Randomized Period)||61
8812631|NCT01520909|9865661|FG002|COMPLETED|Part 1 (Randomized Period)||0
8812632|NCT01520909|9865659|FG000|NOT COMPLETED|Part 1 (Randomized Period)||1
8812633|NCT01520909|9865660|FG001|NOT COMPLETED|Part 1 (Randomized Period)||2
8812634|NCT01520909|9865661|FG002|NOT COMPLETED|Part 1 (Randomized Period)||0
8812635|NCT01520909|9865659|FG000|STARTED|Part 2 (Open-Label Period)-Eltrombopag||0
8812636|NCT01520909|9865660|FG001|STARTED|Part 2 (Open-Label Period)-Eltrombopag||0
8812637|NCT01520909|9865661|FG002|STARTED|Part 2 (Open-Label Period)-Eltrombopag|Two participants that completed Part 1 did not start Part 2 because of lack of efficacy.|87
8812638|NCT01520909|9865659|FG000|COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
8812639|NCT01520909|9865660|FG001|COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
8701559|NCT00912093|9747319|FG002|COMPLETED|The Controlled Phase||3
8701560|NCT00912093|9747320|FG003|COMPLETED|The Controlled Phase||2
9043945|NCT03416127|10104953|FG002|STARTED|Overall Study||12
9043946|NCT03416127|10104951|FG000|COMPLETED|Overall Study||12
9043947|NCT03416127|10104952|FG001|COMPLETED|Overall Study||11
9043948|NCT03416127|10104953|FG002|COMPLETED|Overall Study||11
9043949|NCT03416127|10104951|FG000|NOT COMPLETED|Overall Study||0
9043950|NCT03416127|10104952|FG001|NOT COMPLETED|Overall Study||1
9043951|NCT03416127|10104953|FG002|NOT COMPLETED|Overall Study||1
9043952|NCT03416621|10104965|FG000|STARTED|Overall Study||13
9043953|NCT03416621|10104966|FG001|STARTED|Overall Study||12
9043954|NCT03416621|10104967|FG002|STARTED|Overall Study||6
9043955|NCT03416621|10104965|FG000|COMPLETED|Overall Study||13
9043956|NCT03416621|10104966|FG001|COMPLETED|Overall Study||11
9043957|NCT03416621|10104967|FG002|COMPLETED|Overall Study||1
9043958|NCT03416621|10104965|FG000|NOT COMPLETED|Overall Study||0
9043959|NCT03416621|10104966|FG001|NOT COMPLETED|Overall Study||1
9043960|NCT03416621|10104967|FG002|NOT COMPLETED|Overall Study||5
9043961|NCT03416946|10104979|FG000|STARTED|Overall Study||25
9043962|NCT03416946|10104980|FG001|STARTED|Overall Study||29
9043963|NCT03416946|10104979|FG000|COMPLETED|Overall Study||25
9043964|NCT03416946|10104980|FG001|COMPLETED|Overall Study||29
9043965|NCT03416946|10104979|FG000|NOT COMPLETED|Overall Study||0
9043966|NCT03416946|10104980|FG001|NOT COMPLETED|Overall Study||0
9043967|NCT03416985|10104989|FG000|STARTED|Overall Study||30
9043968|NCT03416985|10104990|FG001|STARTED|Overall Study||30
9043969|NCT03416985|10104991|FG002|STARTED|Overall Study||30
9043970|NCT03416985|10104989|FG000|COMPLETED|Overall Study||28
9043971|NCT03416985|10104990|FG001|COMPLETED|Overall Study||30
9043972|NCT03416985|10104991|FG002|COMPLETED|Overall Study||24
9043973|NCT03416985|10104989|FG000|NOT COMPLETED|Overall Study||2
9043974|NCT03416985|10104990|FG001|NOT COMPLETED|Overall Study||0
9043975|NCT03416985|10104991|FG002|NOT COMPLETED|Overall Study||6
9043976|NCT03417024|10105002|FG000|STARTED|Overall Study||13
9043977|NCT03417024|10105002|FG000|COMPLETED|Overall Study||0
9043978|NCT03417024|10105002|FG000|NOT COMPLETED|Overall Study||13
9043979|NCT03417141|10105006|FG000|STARTED|Overall Study||12
9043980|NCT03417141|10105006|FG000|COMPLETED|Overall Study||8
9043981|NCT03417141|10105006|FG000|NOT COMPLETED|Overall Study||4
9043982|NCT03417219|10105012|FG000|STARTED|Overall Study||8
9043983|NCT03417219|10105013|FG001|STARTED|Overall Study||8
9043984|NCT03417219|10105012|FG000|COMPLETED|Overall Study||8
9043985|NCT03417219|10105013|FG001|COMPLETED|Overall Study||5
9043986|NCT03417219|10105012|FG000|NOT COMPLETED|Overall Study||0
9043987|NCT03417219|10105013|FG001|NOT COMPLETED|Overall Study||3
9043988|NCT03417466|10105019|FG000|STARTED|Overall Study||66
9043989|NCT03417466|10105019|FG000|COMPLETED|Overall Study||66
9043990|NCT03417466|10105019|FG000|NOT COMPLETED|Overall Study||0
9043991|NCT03417505|10105023|FG000|STARTED|First Lens Type (30 Days)||9
9043992|NCT03417505|10105024|FG001|STARTED|First Lens Type (30 Days)||12
9043993|NCT03417505|10105023|FG000|COMPLETED|First Lens Type (30 Days)||8
9043994|NCT03417505|10105024|FG001|COMPLETED|First Lens Type (30 Days)||11
9043995|NCT03417505|10105023|FG000|NOT COMPLETED|First Lens Type (30 Days)||1
9043996|NCT03417505|10105024|FG001|NOT COMPLETED|First Lens Type (30 Days)||1
9043997|NCT03417505|10105023|FG000|STARTED|Washout Period (7 Days)||8
9043998|NCT03417505|10105024|FG001|STARTED|Washout Period (7 Days)||11
9043999|NCT03417505|10105023|FG000|COMPLETED|Washout Period (7 Days)||8
9044000|NCT03417505|10105024|FG001|COMPLETED|Washout Period (7 Days)||11
9044001|NCT03417505|10105023|FG000|NOT COMPLETED|Washout Period (7 Days)||0
9044002|NCT03417505|10105024|FG001|NOT COMPLETED|Washout Period (7 Days)||0
9044003|NCT03417505|10105023|FG000|STARTED|Second Lens Type (30 Days)||8
9044004|NCT03417505|10105024|FG001|STARTED|Second Lens Type (30 Days)||11
9044005|NCT03417505|10105023|FG000|COMPLETED|Second Lens Type (30 Days)||8
9044006|NCT03417505|10105024|FG001|COMPLETED|Second Lens Type (30 Days)||11
9044007|NCT03417505|10105023|FG000|NOT COMPLETED|Second Lens Type (30 Days)||0
9044008|NCT03417505|10105024|FG001|NOT COMPLETED|Second Lens Type (30 Days)||0
9044009|NCT03417557|10105030|FG000|STARTED|1st Intervention (3 Hours)||8
9044010|NCT03417557|10105031|FG001|STARTED|1st Intervention (3 Hours)||9
9044011|NCT03417557|10105030|FG000|COMPLETED|1st Intervention (3 Hours)||8
9044012|NCT03417557|10105031|FG001|COMPLETED|1st Intervention (3 Hours)||9
9044013|NCT03417557|10105030|FG000|NOT COMPLETED|1st Intervention (3 Hours)||0
9044014|NCT03417557|10105031|FG001|NOT COMPLETED|1st Intervention (3 Hours)||0
9044015|NCT03417557|10105030|FG000|STARTED|2nd Intervention (3 Hours)||9
9044016|NCT03417557|10105031|FG001|STARTED|2nd Intervention (3 Hours)||8
9044017|NCT03417557|10105030|FG000|COMPLETED|2nd Intervention (3 Hours)||9
9044018|NCT03417557|10105031|FG001|COMPLETED|2nd Intervention (3 Hours)||8
9044019|NCT03417557|10105030|FG000|NOT COMPLETED|2nd Intervention (3 Hours)||0
9044020|NCT03417557|10105031|FG001|NOT COMPLETED|2nd Intervention (3 Hours)||0
9044021|NCT03417713|10105037|FG000|STARTED|Overall Study||33
9044022|NCT03417713|10105037|FG000|COMPLETED|Overall Study||30
9044023|NCT03417713|10105037|FG000|NOT COMPLETED|Overall Study||3
9044024|NCT03417739|10105041|FG000|STARTED|Overall Study||13
9044025|NCT03417739|10105041|FG000|COMPLETED|Overall Study||13
9044026|NCT03417739|10105041|FG000|NOT COMPLETED|Overall Study||0
9044027|NCT03417752|10105048|FG000|STARTED|Overall Study||149
9044028|NCT03417752|10105049|FG001|STARTED|Overall Study||175
9044029|NCT03417752|10105050|FG002|STARTED|Overall Study||150
9044030|NCT03417752|10105048|FG000|COMPLETED|Overall Study||115
9044031|NCT03417752|10105049|FG001|COMPLETED|Overall Study||133
9044032|NCT03417752|10105050|FG002|COMPLETED|Overall Study||110
9044033|NCT03417752|10105048|FG000|NOT COMPLETED|Overall Study||34
9044034|NCT03417752|10105049|FG001|NOT COMPLETED|Overall Study||42
9044035|NCT03417752|10105050|FG002|NOT COMPLETED|Overall Study||40
9044036|NCT03417778|10105060|FG000|STARTED|Overall Study||10
9044037|NCT03417778|10105061|FG001|STARTED|Overall Study||10
9044038|NCT03417778|10105060|FG000|COMPLETED|Overall Study||10
9044039|NCT03417778|10105061|FG001|COMPLETED|Overall Study||10
9044040|NCT03417778|10105060|FG000|NOT COMPLETED|Overall Study||0
9044041|NCT03417778|10105061|FG001|NOT COMPLETED|Overall Study||0
9044042|NCT03417804|10105067|FG000|STARTED|Overall Study|at least 360 patients|366
9044043|NCT03417804|10105067|FG000|COMPLETED|Overall Study||366
9044044|NCT03417804|10105067|FG000|NOT COMPLETED|Overall Study||0
9044045|NCT03417830|10105074|FG000|STARTED|Part A (up to 26 Days)||2
9044046|NCT03417830|10105075|FG001|STARTED|Part A (up to 26 Days)||0
9044047|NCT03417830|10105074|FG000|COMPLETED|Part A (up to 26 Days)||1
9044048|NCT03417830|10105075|FG001|COMPLETED|Part A (up to 26 Days)||0
9044049|NCT03417830|10105074|FG000|NOT COMPLETED|Part A (up to 26 Days)||1
9044050|NCT03417830|10105075|FG001|NOT COMPLETED|Part A (up to 26 Days)||0
9044051|NCT03417830|10105074|FG000|STARTED|Part B (up to 26 Days)||0
9044052|NCT03417830|10105075|FG001|STARTED|Part B (up to 26 Days)||0
9044053|NCT03417830|10105074|FG000|COMPLETED|Part B (up to 26 Days)||0
9044054|NCT03417830|10105075|FG001|COMPLETED|Part B (up to 26 Days)||0
9044055|NCT03417830|10105074|FG000|NOT COMPLETED|Part B (up to 26 Days)||0
9044056|NCT03417830|10105075|FG001|NOT COMPLETED|Part B (up to 26 Days)||0
9044057|NCT03418051|10105085|FG000|STARTED|Overall Study||20
9044058|NCT03418051|10105086|FG001|STARTED|Overall Study||20
9044059|NCT03418051|10105087|FG002|STARTED|Overall Study||20
9044060|NCT03418051|10105085|FG000|COMPLETED|Overall Study||14
9044061|NCT03418051|10105086|FG001|COMPLETED|Overall Study||18
9044062|NCT03418051|10105087|FG002|COMPLETED|Overall Study||17
9044063|NCT03418051|10105085|FG000|NOT COMPLETED|Overall Study||6
9044064|NCT03418051|10105086|FG001|NOT COMPLETED|Overall Study||2
9044065|NCT03418051|10105087|FG002|NOT COMPLETED|Overall Study||3
9044066|NCT03418064|10105095|FG000|STARTED|First Intervention (1 Month)||21
9044067|NCT03418064|10105096|FG001|STARTED|First Intervention (1 Month)||21
9044068|NCT03418064|10105095|FG000|COMPLETED|First Intervention (1 Month)||21
9044069|NCT03418064|10105096|FG001|COMPLETED|First Intervention (1 Month)||21
9044070|NCT03418064|10105095|FG000|NOT COMPLETED|First Intervention (1 Month)||0
9044071|NCT03418064|10105096|FG001|NOT COMPLETED|First Intervention (1 Month)||0
9044072|NCT03418064|10105095|FG000|STARTED|Second Intervention (1 Month)||21
8701561|NCT00912093|9747321|FG004|COMPLETED|The Controlled Phase||4
8701562|NCT00912093|9747317|FG000|NOT COMPLETED|The Controlled Phase||0
8701563|NCT00912093|9747318|FG001|NOT COMPLETED|The Controlled Phase||2
8701564|NCT00912093|9747319|FG002|NOT COMPLETED|The Controlled Phase||0
8701565|NCT00912093|9747320|FG003|NOT COMPLETED|The Controlled Phase||0
8701566|NCT00912093|9747321|FG004|NOT COMPLETED|The Controlled Phase||1
8701567|NCT00912093|9747317|FG000|STARTED|The Open Label Extension (OLE) Phase||38
8701568|NCT00912093|9747318|FG001|STARTED|The Open Label Extension (OLE) Phase||35
8701569|NCT00912093|9747319|FG002|STARTED|The Open Label Extension (OLE) Phase||3
8701570|NCT00912093|9747320|FG003|STARTED|The Open Label Extension (OLE) Phase||2
8701571|NCT00912093|9747321|FG004|STARTED|The Open Label Extension (OLE) Phase||4
8701572|NCT00912093|9747317|FG000|COMPLETED|The Open Label Extension (OLE) Phase||38
8701573|NCT00912093|9747318|FG001|COMPLETED|The Open Label Extension (OLE) Phase||35
8701574|NCT00912093|9747319|FG002|COMPLETED|The Open Label Extension (OLE) Phase||3
8701575|NCT00912093|9747320|FG003|COMPLETED|The Open Label Extension (OLE) Phase||2
8701576|NCT00912093|9747321|FG004|COMPLETED|The Open Label Extension (OLE) Phase||4
8701577|NCT00912093|9747317|FG000|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
8701578|NCT00912093|9747318|FG001|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
9044073|NCT03418064|10105096|FG001|STARTED|Second Intervention (1 Month)||21
9044074|NCT03418064|10105095|FG000|COMPLETED|Second Intervention (1 Month)||21
9044075|NCT03418064|10105096|FG001|COMPLETED|Second Intervention (1 Month)||21
9044076|NCT03418064|10105095|FG000|NOT COMPLETED|Second Intervention (1 Month)||0
9044077|NCT03418064|10105096|FG001|NOT COMPLETED|Second Intervention (1 Month)||0
9044078|NCT03418324|10105112|FG000|STARTED|Overall Study||3
9044079|NCT03418324|10105113|FG001|STARTED|Overall Study||8
9044080|NCT03418324|10105112|FG000|COMPLETED|Overall Study||2
8701579|NCT00912093|9747319|FG002|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
8701580|NCT00912093|9747320|FG003|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
8701581|NCT00912093|9747321|FG004|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
8701582|NCT00912197|9747331|FG000|STARTED|Overall Study||15
8701583|NCT00912197|9747332|FG001|STARTED|Overall Study||13
8701584|NCT00912197|9747331|FG000|COMPLETED|Overall Study||12
8701585|NCT00912197|9747332|FG001|COMPLETED|Overall Study||10
8701586|NCT00912197|9747331|FG000|NOT COMPLETED|Overall Study||3
8701587|NCT00912197|9747332|FG001|NOT COMPLETED|Overall Study||3
8701588|NCT00912288|9747342|FG000|STARTED|Overall Study||44
8701589|NCT00912288|9747343|FG001|STARTED|Overall Study||42
8701590|NCT00912288|9747342|FG000|COMPLETED|Overall Study||3
9044081|NCT03418324|10105113|FG001|COMPLETED|Overall Study||6
9044082|NCT03418324|10105112|FG000|NOT COMPLETED|Overall Study||1
9044083|NCT03418324|10105113|FG001|NOT COMPLETED|Overall Study||2
9044084|NCT03418376|10105123|FG000|STARTED|Overall Study||12
9044085|NCT03418376|10105124|FG001|STARTED|Overall Study||11
9044086|NCT03418376|10105125|FG002|STARTED|Overall Study||11
8701591|NCT00912288|9747343|FG001|COMPLETED|Overall Study||2
9044087|NCT03418376|10105126|FG003|STARTED|Overall Study||11
9044088|NCT03418376|10105123|FG000|COMPLETED|Overall Study||11
9044089|NCT03418376|10105124|FG001|COMPLETED|Overall Study||6
9044090|NCT03418376|10105125|FG002|COMPLETED|Overall Study||8
9044091|NCT03418376|10105126|FG003|COMPLETED|Overall Study||10
9044092|NCT03418376|10105123|FG000|NOT COMPLETED|Overall Study||1
9044093|NCT03418376|10105124|FG001|NOT COMPLETED|Overall Study||5
9044094|NCT03418376|10105125|FG002|NOT COMPLETED|Overall Study||3
9044095|NCT03418376|10105126|FG003|NOT COMPLETED|Overall Study||1
9044096|NCT03418545|10105138|FG000|STARTED|Overall Study||35
9044097|NCT03418545|10105139|FG001|STARTED|Overall Study||105
9044098|NCT03418545|10105138|FG000|Safety Population|Overall Study||34
9044099|NCT03418545|10105139|FG001|Safety Population|Overall Study||105
9044100|NCT03418545|10105138|FG000|Received Optional or Repeat Treatment|Overall Study||29
9044101|NCT03418545|10105139|FG001|Received Optional or Repeat Treatment|Overall Study||37
9044102|NCT03418545|10105138|FG000|COMPLETED|Overall Study||30
9044103|NCT03418545|10105139|FG001|COMPLETED|Overall Study||94
9044104|NCT03418545|10105138|FG000|NOT COMPLETED|Overall Study||5
9044105|NCT03418545|10105139|FG001|NOT COMPLETED|Overall Study||11
9044106|NCT03418571|10105150|FG000|STARTED|Overall Study||12
9044107|NCT03418571|10105151|FG001|STARTED|Overall Study||3
9044108|NCT03418571|10105150|FG000|COMPLETED|Overall Study||11
9044109|NCT03418571|10105151|FG001|COMPLETED|Overall Study||3
9044110|NCT03418571|10105150|FG000|NOT COMPLETED|Overall Study||1
9044111|NCT03418571|10105151|FG001|NOT COMPLETED|Overall Study||0
9044112|NCT03418662|10105159|FG000|STARTED|Overall Study||287
9044113|NCT03418662|10105160|FG001|STARTED|Overall Study||282
9044114|NCT03418662|10105159|FG000|COMPLETED|Overall Study||284
9044115|NCT03418662|10105160|FG001|COMPLETED|Overall Study||278
9044116|NCT03418662|10105159|FG000|NOT COMPLETED|Overall Study||3
9044117|NCT03418662|10105160|FG001|NOT COMPLETED|Overall Study||4
9044118|NCT03418714|10105166|FG000|STARTED|Overall Study||13
9044119|NCT03418714|10105166|FG000|COMPLETED|Overall Study|One participant moved too much during the practice session and was therefore excluded from the scan.|12
9044120|NCT03418714|10105166|FG000|NOT COMPLETED|Overall Study||1
8701592|NCT00912288|9747342|FG000|NOT COMPLETED|Overall Study||41
8701593|NCT00912288|9747343|FG001|NOT COMPLETED|Overall Study||40
9044121|NCT03419078|10105173|FG000|STARTED|Overall Study||245
9044122|NCT03419078|10105174|FG001|STARTED|Overall Study||148
9044123|NCT03419078|10105175|FG002|STARTED|Overall Study||91
9044124|NCT03419078|10105173|FG000|COMPLETED|Overall Study||245
9044125|NCT03419078|10105174|FG001|COMPLETED|Overall Study||148
9044126|NCT03419078|10105175|FG002|COMPLETED|Overall Study||91
9044127|NCT03419078|10105173|FG000|NOT COMPLETED|Overall Study||0
9044128|NCT03419078|10105174|FG001|NOT COMPLETED|Overall Study||0
9044129|NCT03419078|10105175|FG002|NOT COMPLETED|Overall Study||0
9044130|NCT03419403|10105186|FG000|STARTED|Overall Study||14
9044131|NCT03419403|10105187|FG001|STARTED|Overall Study||12
9044132|NCT03419403|10105188|FG002|STARTED|Overall Study||12
9044133|NCT03419403|10105189|FG003|STARTED|Overall Study||2
9044134|NCT03419403|10105186|FG000|COMPLETED|Overall Study||2
9044135|NCT03419403|10105187|FG001|COMPLETED|Overall Study||3
9044136|NCT03419403|10105188|FG002|COMPLETED|Overall Study||0
9044137|NCT03419403|10105189|FG003|COMPLETED|Overall Study||0
9044138|NCT03419403|10105186|FG000|NOT COMPLETED|Overall Study||12
9044139|NCT03419403|10105187|FG001|NOT COMPLETED|Overall Study||9
9044140|NCT03419403|10105188|FG002|NOT COMPLETED|Overall Study||12
9044141|NCT03419403|10105189|FG003|NOT COMPLETED|Overall Study||2
9044142|NCT03419533|10105199|FG000|STARTED|Overall Study||4107
9044143|NCT03419533|10105200|FG001|STARTED|Overall Study||2695
9044144|NCT03419533|10105199|FG000|COMPLETED|Overall Study||4107
9044145|NCT03419533|10105200|FG001|COMPLETED|Overall Study||2695
9044146|NCT03419533|10105199|FG000|NOT COMPLETED|Overall Study||0
9044147|NCT03419533|10105200|FG001|NOT COMPLETED|Overall Study||0
9044148|NCT03419598|10105214|FG000|STARTED|Overall Study||30
9044149|NCT03419598|10105214|FG000|Subject Specific Tibia Models Created and Virtual Osteotomy Performed|Overall Study||28
9044150|NCT03419598|10105214|FG000|Virtual Cohort Duplicated Into A. Personalised and B. Generic Copies|Overall Study||28
9044151|NCT03419598|10105214|FG000|Finite Element (FE) Model Created for Cohort Copy Stabilised by Personalised HTO Plate|Overall Study||28
9044152|NCT03419598|10105214|FG000|FE Models Created for Cohort Copy Stabilised by Generic HTO Plate|Overall Study||28
9044153|NCT03419598|10105214|FG000|FE Models Solved for Personalised HTO Plate Stabilised Cohort Copy|Overall Study||28
9044154|NCT03419598|10105214|FG000|FE Models Solved for Generic HTO Plate Stabilised Cohort Copy|Overall Study||28
9044155|NCT03419598|10105214|FG000|COMPLETED|Overall Study||28
9044156|NCT03419598|10105214|FG000|NOT COMPLETED|Overall Study||2
9044157|NCT03419780|10105222|FG000|STARTED|Overall Study||33
9044158|NCT03419780|10105223|FG001|STARTED|Overall Study||33
9044159|NCT03419780|10105222|FG000|COMPLETED|Overall Study||33
9044160|NCT03419780|10105223|FG001|COMPLETED|Overall Study||33
9044161|NCT03419780|10105222|FG000|NOT COMPLETED|Overall Study||0
9044162|NCT03419780|10105223|FG001|NOT COMPLETED|Overall Study||0
9044163|NCT03419962|10105229|FG000|STARTED|Overall Study||1359
9044164|NCT03419962|10105229|FG000|COMPLETED|Overall Study||1322
9044165|NCT03419962|10105229|FG000|NOT COMPLETED|Overall Study||37
9044166|NCT03420300|10105233|FG000|STARTED|Overall Study||40
9044167|NCT03420300|10105233|FG000|COMPLETED|Overall Study||38
9044168|NCT03420300|10105233|FG000|NOT COMPLETED|Overall Study||2
9044169|NCT03420625|10105237|FG000|STARTED|Overall Study||10
9044170|NCT03420625|10105237|FG000|Baseline|Overall Study||10
9044171|NCT03420625|10105237|FG000|Foot IPC|Overall Study||10
9044172|NCT03420625|10105237|FG000|Rapid Calf IPC|Overall Study||10
9044173|NCT03420625|10105237|FG000|Slow Calf IPC|Overall Study||10
9044174|NCT03420625|10105237|FG000|Calf NMES|Overall Study||10
9044175|NCT03420625|10105237|FG000|COMPLETED|Overall Study||10
9044176|NCT03420625|10105237|FG000|NOT COMPLETED|Overall Study||0
9044177|NCT03421210|10105253|FG000|STARTED|Overall Study||88
9044178|NCT03421210|10105253|FG000|Received Functional Magnetic Resonance Imaging (fMRI)|Overall Study||42
9044179|NCT03421210|10105253|FG000|COMPLETED|Overall Study||35
9044180|NCT03421210|10105253|FG000|NOT COMPLETED|Overall Study||53
9044181|NCT03421379|10105259|FG000|STARTED|Period 1||34
9044182|NCT03421379|10105260|FG001|STARTED|Period 1||41
9044183|NCT03421379|10105259|FG000|Received at Least One Dose of Study Drug|Period 1||33
9044184|NCT03421379|10105260|FG001|Received at Least One Dose of Study Drug|Period 1||39
9044185|NCT03421379|10105259|FG000|COMPLETED|Period 1||32
9044186|NCT03421379|10105260|FG001|COMPLETED|Period 1||37
9044187|NCT03421379|10105259|FG000|NOT COMPLETED|Period 1||2
9044188|NCT03421379|10105260|FG001|NOT COMPLETED|Period 1||4
9044189|NCT03421379|10105259|FG000|STARTED|Washout Period (3 to 14 Days)||32
9044190|NCT03421379|10105260|FG001|STARTED|Washout Period (3 to 14 Days)||37
9044191|NCT03421379|10105259|FG000|COMPLETED|Washout Period (3 to 14 Days)||32
9044192|NCT03421379|10105260|FG001|COMPLETED|Washout Period (3 to 14 Days)||37
9044193|NCT03421379|10105259|FG000|NOT COMPLETED|Washout Period (3 to 14 Days)||0
9044194|NCT03421379|10105260|FG001|NOT COMPLETED|Washout Period (3 to 14 Days)||0
9044195|NCT03421379|10105259|FG000|STARTED|Period 2||32
9044196|NCT03421379|10105260|FG001|STARTED|Period 2||37
9044197|NCT03421379|10105259|FG000|COMPLETED|Period 2||32
9044198|NCT03421379|10105260|FG001|COMPLETED|Period 2||37
9044199|NCT03421379|10105259|FG000|NOT COMPLETED|Period 2||0
9044200|NCT03421379|10105260|FG001|NOT COMPLETED|Period 2||0
9044201|NCT03421431|10105269|FG000|STARTED|Overall Study||24
9044202|NCT03421431|10105270|FG001|STARTED|Overall Study||55
9044203|NCT03421431|10105271|FG002|STARTED|Overall Study||53
9044204|NCT03421431|10105269|FG000|COMPLETED|Overall Study||18
9044205|NCT03421431|10105270|FG001|COMPLETED|Overall Study||49
9044206|NCT03421431|10105271|FG002|COMPLETED|Overall Study||39
9044207|NCT03421431|10105269|FG000|NOT COMPLETED|Overall Study||6
9044208|NCT03421431|10105270|FG001|NOT COMPLETED|Overall Study||6
9044209|NCT03421431|10105271|FG002|NOT COMPLETED|Overall Study||14
9044210|NCT03421730|10105281|FG000|STARTED|First Intervention (Day 1, Visit 2)||1
9044211|NCT03421730|10105282|FG001|STARTED|First Intervention (Day 1, Visit 2)||3
9044212|NCT03421730|10105283|FG002|STARTED|First Intervention (Day 1, Visit 2)||1
9044213|NCT03421730|10105284|FG003|STARTED|First Intervention (Day 1, Visit 2)||1
9044214|NCT03421730|10105285|FG004|STARTED|First Intervention (Day 1, Visit 2)||3
9044215|NCT03421730|10105286|FG005|STARTED|First Intervention (Day 1, Visit 2)||1
9044216|NCT03421730|10105287|FG006|STARTED|First Intervention (Day 1, Visit 2)||1
9044217|NCT03421730|10105288|FG007|STARTED|First Intervention (Day 1, Visit 2)||1
9044218|NCT03421730|10105289|FG008|STARTED|First Intervention (Day 1, Visit 2)||1
9044219|NCT03421730|10105290|FG009|STARTED|First Intervention (Day 1, Visit 2)||2
9044220|NCT03421730|10105291|FG010|STARTED|First Intervention (Day 1, Visit 2)||1
9044221|NCT03421730|10105292|FG011|STARTED|First Intervention (Day 1, Visit 2)||1
9044222|NCT03421730|10105281|FG000|COMPLETED|First Intervention (Day 1, Visit 2)||1
9044223|NCT03421730|10105282|FG001|COMPLETED|First Intervention (Day 1, Visit 2)|Two subjects withdrew without receiving treatment with either A or C.|1
9044224|NCT03421730|10105283|FG002|COMPLETED|First Intervention (Day 1, Visit 2)||1
9044225|NCT03421730|10105284|FG003|COMPLETED|First Intervention (Day 1, Visit 2)||1
9044226|NCT03421730|10105285|FG004|COMPLETED|First Intervention (Day 1, Visit 2)||3
9044227|NCT03421730|10105286|FG005|COMPLETED|First Intervention (Day 1, Visit 2)||1
9044228|NCT03421730|10105287|FG006|COMPLETED|First Intervention (Day 1, Visit 2)||1
9044229|NCT03421730|10105288|FG007|COMPLETED|First Intervention (Day 1, Visit 2)||1
9044230|NCT03421730|10105289|FG008|COMPLETED|First Intervention (Day 1, Visit 2)||1
9044231|NCT03421730|10105290|FG009|COMPLETED|First Intervention (Day 1, Visit 2)||2
9044232|NCT03421730|10105291|FG010|COMPLETED|First Intervention (Day 1, Visit 2)||1
9044233|NCT03421730|10105292|FG011|COMPLETED|First Intervention (Day 1, Visit 2)||1
9044234|NCT03421730|10105281|FG000|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
8701594|NCT00912301|9747352|FG000|STARTED|Overall Study||11
8701595|NCT00912301|9747353|FG001|STARTED|Overall Study||12
8701596|NCT00912301|9747354|FG002|STARTED|Overall Study||13
8701597|NCT00912301|9747352|FG000|COMPLETED|Overall Study||11
8701598|NCT00912301|9747353|FG001|COMPLETED|Overall Study||12
8701599|NCT00912301|9747354|FG002|COMPLETED|Overall Study||13
8701600|NCT00912301|9747352|FG000|NOT COMPLETED|Overall Study||0
8701601|NCT00912301|9747353|FG001|NOT COMPLETED|Overall Study||0
8701602|NCT00912301|9747354|FG002|NOT COMPLETED|Overall Study||0
8701603|NCT00912340|9747365|FG000|STARTED|Overall Study||24
8701604|NCT00912340|9747366|FG001|STARTED|Overall Study||30
8701605|NCT00912340|9747367|FG002|STARTED|Overall Study||4
9044235|NCT03421730|10105282|FG001|NOT COMPLETED|First Intervention (Day 1, Visit 2)||2
8701606|NCT00912340|9747365|FG000|COMPLETED|Overall Study||22
8701607|NCT00912340|9747366|FG001|COMPLETED|Overall Study||26
8701608|NCT00912340|9747367|FG002|COMPLETED|Overall Study||0
8701609|NCT00912340|9747365|FG000|NOT COMPLETED|Overall Study||2
8701610|NCT00912340|9747366|FG001|NOT COMPLETED|Overall Study||4
8701611|NCT00912340|9747367|FG002|NOT COMPLETED|Overall Study||4
8701612|NCT00912405|9747375|FG000|STARTED|Overall Study||50
8701613|NCT00912405|9747375|FG000|COMPLETED|Overall Study||45
8701614|NCT00912405|9747375|FG000|NOT COMPLETED|Overall Study||5
9044236|NCT03421730|10105283|FG002|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
9044237|NCT03421730|10105284|FG003|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
9044238|NCT03421730|10105285|FG004|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
9044239|NCT03421730|10105286|FG005|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
9044240|NCT03421730|10105287|FG006|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
9044241|NCT03421730|10105288|FG007|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
9044242|NCT03421730|10105289|FG008|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
9044243|NCT03421730|10105290|FG009|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
9044244|NCT03421730|10105291|FG010|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
9044245|NCT03421730|10105292|FG011|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
9044246|NCT03421730|10105281|FG000|STARTED|Washout (Days 4 to 10)||1
9044247|NCT03421730|10105282|FG001|STARTED|Washout (Days 4 to 10)||1
9044248|NCT03421730|10105283|FG002|STARTED|Washout (Days 4 to 10)||1
9044249|NCT03421730|10105284|FG003|STARTED|Washout (Days 4 to 10)||1
9044250|NCT03421730|10105285|FG004|STARTED|Washout (Days 4 to 10)||3
9044251|NCT03421730|10105286|FG005|STARTED|Washout (Days 4 to 10)||1
9044252|NCT03421730|10105287|FG006|STARTED|Washout (Days 4 to 10)||1
9044253|NCT03421730|10105288|FG007|STARTED|Washout (Days 4 to 10)||1
9044254|NCT03421730|10105289|FG008|STARTED|Washout (Days 4 to 10)||1
9044255|NCT03421730|10105290|FG009|STARTED|Washout (Days 4 to 10)||2
9044256|NCT03421730|10105291|FG010|STARTED|Washout (Days 4 to 10)||1
9044257|NCT03421730|10105292|FG011|STARTED|Washout (Days 4 to 10)||1
9044258|NCT03421730|10105281|FG000|COMPLETED|Washout (Days 4 to 10)||1
9044259|NCT03421730|10105282|FG001|COMPLETED|Washout (Days 4 to 10)||1
9044260|NCT03421730|10105283|FG002|COMPLETED|Washout (Days 4 to 10)||1
9044261|NCT03421730|10105284|FG003|COMPLETED|Washout (Days 4 to 10)||1
9044262|NCT03421730|10105285|FG004|COMPLETED|Washout (Days 4 to 10)|Two subjects withdrew after receiving treatment with B but before receiving treatment with C.|1
9044263|NCT03421730|10105286|FG005|COMPLETED|Washout (Days 4 to 10)||1
9044264|NCT03421730|10105287|FG006|COMPLETED|Washout (Days 4 to 10)||1
9044265|NCT03421730|10105288|FG007|COMPLETED|Washout (Days 4 to 10)||1
9044266|NCT03421730|10105289|FG008|COMPLETED|Washout (Days 4 to 10)||1
9044267|NCT03421730|10105290|FG009|COMPLETED|Washout (Days 4 to 10)||2
9044268|NCT03421730|10105291|FG010|COMPLETED|Washout (Days 4 to 10)||1
9044269|NCT03421730|10105292|FG011|COMPLETED|Washout (Days 4 to 10)||1
9044270|NCT03421730|10105281|FG000|NOT COMPLETED|Washout (Days 4 to 10)||0
9044271|NCT03421730|10105282|FG001|NOT COMPLETED|Washout (Days 4 to 10)||0
9044272|NCT03421730|10105283|FG002|NOT COMPLETED|Washout (Days 4 to 10)||0
9044273|NCT03421730|10105284|FG003|NOT COMPLETED|Washout (Days 4 to 10)||0
9044274|NCT03421730|10105285|FG004|NOT COMPLETED|Washout (Days 4 to 10)||2
9044275|NCT03421730|10105286|FG005|NOT COMPLETED|Washout (Days 4 to 10)||0
9044276|NCT03421730|10105287|FG006|NOT COMPLETED|Washout (Days 4 to 10)||0
9044277|NCT03421730|10105288|FG007|NOT COMPLETED|Washout (Days 4 to 10)||0
9044278|NCT03421730|10105289|FG008|NOT COMPLETED|Washout (Days 4 to 10)||0
9044279|NCT03421730|10105290|FG009|NOT COMPLETED|Washout (Days 4 to 10)||0
9044280|NCT03421730|10105291|FG010|NOT COMPLETED|Washout (Days 4 to 10)||0
9044281|NCT03421730|10105292|FG011|NOT COMPLETED|Washout (Days 4 to 10)||0
9044282|NCT03421730|10105281|FG000|STARTED|Second Intervention (Day 8±3, Visit 3)||1
9044283|NCT03421730|10105282|FG001|STARTED|Second Intervention (Day 8±3, Visit 3)||1
9044284|NCT03421730|10105283|FG002|STARTED|Second Intervention (Day 8±3, Visit 3)||1
9044285|NCT03421730|10105284|FG003|STARTED|Second Intervention (Day 8±3, Visit 3)||1
9044286|NCT03421730|10105285|FG004|STARTED|Second Intervention (Day 8±3, Visit 3)||1
9044287|NCT03421730|10105286|FG005|STARTED|Second Intervention (Day 8±3, Visit 3)||1
9044288|NCT03421730|10105287|FG006|STARTED|Second Intervention (Day 8±3, Visit 3)||1
9044289|NCT03421730|10105288|FG007|STARTED|Second Intervention (Day 8±3, Visit 3)||1
9044290|NCT03421730|10105289|FG008|STARTED|Second Intervention (Day 8±3, Visit 3)||1
9044291|NCT03421730|10105290|FG009|STARTED|Second Intervention (Day 8±3, Visit 3)||2
9044292|NCT03421730|10105291|FG010|STARTED|Second Intervention (Day 8±3, Visit 3)||1
9044293|NCT03421730|10105292|FG011|STARTED|Second Intervention (Day 8±3, Visit 3)||1
9044294|NCT03421730|10105281|FG000|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
9044295|NCT03421730|10105282|FG001|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
9044296|NCT03421730|10105283|FG002|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
9044297|NCT03421730|10105284|FG003|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
9044298|NCT03421730|10105285|FG004|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
9044299|NCT03421730|10105286|FG005|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
9044300|NCT03421730|10105287|FG006|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
9044301|NCT03421730|10105288|FG007|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
9044302|NCT03421730|10105289|FG008|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
9044303|NCT03421730|10105290|FG009|COMPLETED|Second Intervention (Day 8±3, Visit 3)||2
9044304|NCT03421730|10105291|FG010|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
9044305|NCT03421730|10105292|FG011|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
9044306|NCT03421730|10105281|FG000|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
9044307|NCT03421730|10105282|FG001|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
9044308|NCT03421730|10105283|FG002|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
9044309|NCT03421730|10105284|FG003|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
9044310|NCT03421730|10105285|FG004|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
9044311|NCT03421730|10105286|FG005|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
9044312|NCT03421730|10105287|FG006|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
9044313|NCT03421730|10105288|FG007|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
9044314|NCT03421730|10105289|FG008|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
9044315|NCT03421730|10105290|FG009|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
9044316|NCT03421730|10105291|FG010|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
9044317|NCT03421730|10105292|FG011|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
9044318|NCT03421886|10105308|FG000|STARTED|Overall Study||30
9044319|NCT03421886|10105309|FG001|STARTED|Overall Study||15
9044320|NCT03421886|10105308|FG000|COMPLETED|Overall Study||23
9044321|NCT03421886|10105309|FG001|COMPLETED|Overall Study||13
9044322|NCT03421886|10105308|FG000|NOT COMPLETED|Overall Study||7
9044323|NCT03421886|10105309|FG001|NOT COMPLETED|Overall Study||2
9044324|NCT03422159|10105317|FG000|STARTED|Overall Study||70
9044325|NCT03422159|10105318|FG001|STARTED|Overall Study||70
9044326|NCT03422159|10105317|FG000|COMPLETED|Overall Study||68
9044327|NCT03422159|10105318|FG001|COMPLETED|Overall Study||69
9044328|NCT03422159|10105317|FG000|NOT COMPLETED|Overall Study||2
9044329|NCT03422159|10105318|FG001|NOT COMPLETED|Overall Study||1
9044330|NCT03422172|10105326|FG000|STARTED|Oral lead-in Phase (4 Weeks)||48
9044331|NCT03422172|10105326|FG000|COMPLETED|Oral lead-in Phase (4 Weeks)||47
9044332|NCT03422172|10105326|FG000|NOT COMPLETED|Oral lead-in Phase (4 Weeks)||1
9044333|NCT03422172|10105326|FG000|STARTED|Washout (7 Days)||47
9044334|NCT03422172|10105326|FG000|COMPLETED|Washout (7 Days)||47
9044335|NCT03422172|10105326|FG000|NOT COMPLETED|Washout (7 Days)||0
9044336|NCT03422172|10105326|FG000|STARTED|Injection Phase (Week 5 to Week 41)||47
9044337|NCT03422172|10105326|FG000|COMPLETED|Injection Phase (Week 5 to Week 41)||43
9044338|NCT03422172|10105326|FG000|NOT COMPLETED|Injection Phase (Week 5 to Week 41)||4
9044339|NCT03422172|10105326|FG000|STARTED|Long Term Follow-up Phase(Upto Week 89)||43
9044340|NCT03422172|10105326|FG000|COMPLETED|Long Term Follow-up Phase(Upto Week 89)||43
9044341|NCT03422172|10105326|FG000|NOT COMPLETED|Long Term Follow-up Phase(Upto Week 89)||0
9044342|NCT03422250|10105339|FG000|STARTED|Intervention||11
9044343|NCT03422250|10105340|FG001|STARTED|Intervention||11
9044344|NCT03422250|10105341|FG002|STARTED|Intervention||12
9044345|NCT03422250|10105342|FG003|STARTED|Intervention||11
9044346|NCT03422250|10105339|FG000|COMPLETED|Intervention||10
9044347|NCT03422250|10105340|FG001|COMPLETED|Intervention||10
9044348|NCT03422250|10105341|FG002|COMPLETED|Intervention||10
9044349|NCT03422250|10105342|FG003|COMPLETED|Intervention||10
9044350|NCT03422250|10105339|FG000|NOT COMPLETED|Intervention||1
9044351|NCT03422250|10105340|FG001|NOT COMPLETED|Intervention||1
9044352|NCT03422250|10105341|FG002|NOT COMPLETED|Intervention||2
9044353|NCT03422250|10105342|FG003|NOT COMPLETED|Intervention||1
9044354|NCT03422250|10105339|FG000|STARTED|Follow-up||10
9044355|NCT03422250|10105340|FG001|STARTED|Follow-up||10
9044356|NCT03422250|10105341|FG002|STARTED|Follow-up||10
9044357|NCT03422250|10105342|FG003|STARTED|Follow-up||10
9044358|NCT03422250|10105339|FG000|COMPLETED|Follow-up||10
8701615|NCT00912509|9747381|FG000|STARTED|Overall Study||20
9044359|NCT03422250|10105340|FG001|COMPLETED|Follow-up||10
9044360|NCT03422250|10105341|FG002|COMPLETED|Follow-up||10
9044361|NCT03422250|10105342|FG003|COMPLETED|Follow-up||8
9044362|NCT03422250|10105339|FG000|NOT COMPLETED|Follow-up||0
9044363|NCT03422250|10105340|FG001|NOT COMPLETED|Follow-up||0
9044364|NCT03422250|10105341|FG002|NOT COMPLETED|Follow-up||0
9044365|NCT03422250|10105342|FG003|NOT COMPLETED|Follow-up||2
9044366|NCT03423082|10105354|FG000|STARTED|Overall Study||1
9044367|NCT03423082|10105354|FG000|COMPLETED|Overall Study||1
9044368|NCT03423082|10105354|FG000|NOT COMPLETED|Overall Study||0
9044369|NCT03423173|10105362|FG000|STARTED|Overall Study||132
9044370|NCT03423173|10105363|FG001|STARTED|Overall Study||263
9044371|NCT03423173|10105364|FG002|STARTED|Overall Study||264
9044372|NCT03423173|10105365|FG003|STARTED|Overall Study||264
9044373|NCT03423173|10105362|FG000|Received at Least 1 Dose of the IP|Overall Study||131
9044374|NCT03423173|10105363|FG001|Received at Least 1 Dose of the IP|Overall Study||263
9044375|NCT03423173|10105364|FG002|Received at Least 1 Dose of the IP|Overall Study|1 participant of TDV Lot 2 received vaccine of Lot 1 and was included in TDV Lot 1 in Safety Set.|262
9044376|NCT03423173|10105365|FG003|Received at Least 1 Dose of the IP|Overall Study||263
9044377|NCT03423173|10105362|FG000|COMPLETED|Overall Study||113
9044378|NCT03423173|10105363|FG001|COMPLETED|Overall Study||228
9044379|NCT03423173|10105364|FG002|COMPLETED|Overall Study||237
9044380|NCT03423173|10105365|FG003|COMPLETED|Overall Study||234
9044381|NCT03423173|10105362|FG000|NOT COMPLETED|Overall Study||19
9044382|NCT03423173|10105363|FG001|NOT COMPLETED|Overall Study||35
9044383|NCT03423173|10105364|FG002|NOT COMPLETED|Overall Study||27
9044384|NCT03423173|10105365|FG003|NOT COMPLETED|Overall Study||30
9044385|NCT03423186|10105377|FG000|STARTED|Overall Study||3
9044386|NCT03423186|10105378|FG001|STARTED|Overall Study||3
9044387|NCT03423186|10105377|FG000|COMPLETED|Overall Study||3
9044388|NCT03423186|10105378|FG001|COMPLETED|Overall Study||3
8701616|NCT00912509|9747382|FG001|STARTED|Overall Study||10
9044389|NCT03423186|10105377|FG000|NOT COMPLETED|Overall Study||0
9044390|NCT03423186|10105378|FG001|NOT COMPLETED|Overall Study||0
9044391|NCT03423238|10105386|FG000|STARTED|Overall Study||19
9044392|NCT03423238|10105387|FG001|STARTED|Overall Study||19
9044393|NCT03423238|10105386|FG000|COMPLETED|Overall Study||17
9044394|NCT03423238|10105387|FG001|COMPLETED|Overall Study||19
9044395|NCT03423238|10105386|FG000|NOT COMPLETED|Overall Study||2
9044396|NCT03423238|10105387|FG001|NOT COMPLETED|Overall Study||0
9044397|NCT03423641|10105396|FG000|STARTED|Overall Study||15524
9044398|NCT03423641|10105397|FG001|STARTED|Overall Study||18284
9044399|NCT03423641|10105396|FG000|COMPLETED|Overall Study||15193
9044400|NCT03423641|10105397|FG001|COMPLETED|Overall Study||10210
9044401|NCT03423641|10105396|FG000|NOT COMPLETED|Overall Study||331
9044402|NCT03423641|10105397|FG001|NOT COMPLETED|Overall Study||8074
9044403|NCT03424044|10105403|FG000|STARTED|Dexcom Training Visit (1 Week)||4
9044404|NCT03424044|10105404|FG001|STARTED|Dexcom Training Visit (1 Week)||3
9044405|NCT03424044|10105405|FG002|STARTED|Dexcom Training Visit (1 Week)||3
9044406|NCT03424044|10105406|FG003|STARTED|Dexcom Training Visit (1 Week)||3
9044407|NCT03424044|10105407|FG004|STARTED|Dexcom Training Visit (1 Week)||3
9044408|NCT03424044|10105408|FG005|STARTED|Dexcom Training Visit (1 Week)||4
9044409|NCT03424044|10105409|FG006|STARTED|Dexcom Training Visit (1 Week)||1
9044410|NCT03424044|10105410|FG007|STARTED|Dexcom Training Visit (1 Week)||1
9044411|NCT03424044|10105411|FG008|STARTED|Dexcom Training Visit (1 Week)||1
9044412|NCT03424044|10105403|FG000|COMPLETED|Dexcom Training Visit (1 Week)||4
9044413|NCT03424044|10105404|FG001|COMPLETED|Dexcom Training Visit (1 Week)||3
9044414|NCT03424044|10105405|FG002|COMPLETED|Dexcom Training Visit (1 Week)||3
9044415|NCT03424044|10105406|FG003|COMPLETED|Dexcom Training Visit (1 Week)||3
9044416|NCT03424044|10105407|FG004|COMPLETED|Dexcom Training Visit (1 Week)||3
9044417|NCT03424044|10105408|FG005|COMPLETED|Dexcom Training Visit (1 Week)||4
9044418|NCT03424044|10105409|FG006|COMPLETED|Dexcom Training Visit (1 Week)||1
9044419|NCT03424044|10105410|FG007|COMPLETED|Dexcom Training Visit (1 Week)||1
9044420|NCT03424044|10105411|FG008|COMPLETED|Dexcom Training Visit (1 Week)||1
9044421|NCT03424044|10105403|FG000|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
8701617|NCT00912509|9747381|FG000|COMPLETED|Overall Study||15
8701618|NCT00912509|9747382|FG001|COMPLETED|Overall Study||7
8701619|NCT00912509|9747381|FG000|NOT COMPLETED|Overall Study||5
8701620|NCT00912509|9747382|FG001|NOT COMPLETED|Overall Study||3
8701621|NCT00912743|9747391|FG000|STARTED|Overall Study||13
8701622|NCT00912743|9747392|FG001|STARTED|Overall Study||20
8701623|NCT00912743|9747391|FG000|COMPLETED|Overall Study||0
8701624|NCT00912743|9747392|FG001|COMPLETED|Overall Study||0
8701625|NCT00912743|9747391|FG000|NOT COMPLETED|Overall Study||13
8701626|NCT00912743|9747392|FG001|NOT COMPLETED|Overall Study||20
8701627|NCT00912782|9747400|FG000|STARTED|Overall Study||27
8701628|NCT00912782|9747401|FG001|STARTED|Overall Study||25
8701629|NCT00912782|9747400|FG000|COMPLETED|Overall Study||24
8701630|NCT00912782|9747401|FG001|COMPLETED|Overall Study||20
8701631|NCT00912782|9747400|FG000|NOT COMPLETED|Overall Study||3
8701632|NCT00912782|9747401|FG001|NOT COMPLETED|Overall Study||5
8701633|NCT00912795|9747409|FG000|STARTED|Overall Study||76
8701634|NCT00912795|9747410|FG001|STARTED|Overall Study||75
8701635|NCT00912795|9747409|FG000|COMPLETED|Overall Study||29
8701636|NCT00912795|9747410|FG001|COMPLETED|Overall Study||17
8701637|NCT00912795|9747409|FG000|NOT COMPLETED|Overall Study||47
8701638|NCT00912795|9747410|FG001|NOT COMPLETED|Overall Study||58
8701639|NCT00912808|9747418|FG000|STARTED|First Intervention (6 Weeks)||11
8701640|NCT00912808|9747419|FG001|STARTED|First Intervention (6 Weeks)||12
8701641|NCT00912808|9747418|FG000|Received Intervention|First Intervention (6 Weeks)||11
8701642|NCT00912808|9747419|FG001|Received Intervention|First Intervention (6 Weeks)||12
8701643|NCT00912808|9747418|FG000|COMPLETED|First Intervention (6 Weeks)||9
8701644|NCT00912808|9747419|FG001|COMPLETED|First Intervention (6 Weeks)||11
8701645|NCT00912808|9747418|FG000|NOT COMPLETED|First Intervention (6 Weeks)||2
8701646|NCT00912808|9747419|FG001|NOT COMPLETED|First Intervention (6 Weeks)||1
8701647|NCT00912808|9747418|FG000|STARTED|Washout||9
8701648|NCT00912808|9747419|FG001|STARTED|Washout||11
8701649|NCT00912808|9747418|FG000|COMPLETED|Washout||9
8701650|NCT00912808|9747419|FG001|COMPLETED|Washout||10
8701651|NCT00912808|9747418|FG000|NOT COMPLETED|Washout||0
8701652|NCT00912808|9747419|FG001|NOT COMPLETED|Washout||1
8701653|NCT00912808|9747418|FG000|STARTED|Second Intervention (6 Weeks)||9
8701654|NCT00912808|9747419|FG001|STARTED|Second Intervention (6 Weeks)||10
8701655|NCT00912808|9747418|FG000|Received Intervention|Second Intervention (6 Weeks)||9
8701656|NCT00912808|9747419|FG001|Received Intervention|Second Intervention (6 Weeks)||10
8701657|NCT00912808|9747418|FG000|COMPLETED|Second Intervention (6 Weeks)||8
8701658|NCT00912808|9747419|FG001|COMPLETED|Second Intervention (6 Weeks)||9
8701659|NCT00912808|9747418|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||1
8701660|NCT00912808|9747419|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||1
8701661|NCT00912873|9747428|FG000|STARTED|Overall Study||26
8701662|NCT00912873|9747429|FG001|STARTED|Overall Study||24
8701663|NCT00912873|9747428|FG000|COMPLETED|Overall Study||26
8701664|NCT00912873|9747429|FG001|COMPLETED|Overall Study||24
8701665|NCT00912873|9747428|FG000|NOT COMPLETED|Overall Study||0
8701666|NCT00912873|9747429|FG001|NOT COMPLETED|Overall Study||0
8701667|NCT00912912|9747439|FG000|STARTED|Overall Study||5
8701668|NCT00912912|9747439|FG000|COMPLETED|Overall Study||1
8701669|NCT00912912|9747439|FG000|NOT COMPLETED|Overall Study||4
8701670|NCT00912925|9747445|FG000|STARTED|Overall Study||23
8701671|NCT00912925|9747446|FG001|STARTED|Overall Study||22
8701672|NCT00912925|9747445|FG000|COMPLETED|Overall Study||23
8701673|NCT00912925|9747446|FG001|COMPLETED|Overall Study||22
8701674|NCT00912925|9747445|FG000|NOT COMPLETED|Overall Study||0
8701675|NCT00912925|9747446|FG001|NOT COMPLETED|Overall Study||0
8701676|NCT00912964|9747455|FG000|STARTED|Overall Study||433
9044422|NCT03424044|10105404|FG001|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
9044423|NCT03424044|10105405|FG002|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
9044424|NCT03424044|10105406|FG003|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
9044425|NCT03424044|10105407|FG004|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
9044426|NCT03424044|10105408|FG005|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
9044427|NCT03424044|10105409|FG006|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
9044428|NCT03424044|10105410|FG007|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
9044429|NCT03424044|10105411|FG008|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
9044430|NCT03424044|10105403|FG000|STARTED|First Rest Period (1-12 Weeks)||4
9044431|NCT03424044|10105404|FG001|STARTED|First Rest Period (1-12 Weeks)||3
9044432|NCT03424044|10105405|FG002|STARTED|First Rest Period (1-12 Weeks)||3
9044433|NCT03424044|10105406|FG003|STARTED|First Rest Period (1-12 Weeks)||3
9044434|NCT03424044|10105407|FG004|STARTED|First Rest Period (1-12 Weeks)||3
9044435|NCT03424044|10105408|FG005|STARTED|First Rest Period (1-12 Weeks)||4
9044436|NCT03424044|10105409|FG006|STARTED|First Rest Period (1-12 Weeks)||1
9044437|NCT03424044|10105410|FG007|STARTED|First Rest Period (1-12 Weeks)||1
9044438|NCT03424044|10105411|FG008|STARTED|First Rest Period (1-12 Weeks)||1
9044439|NCT03424044|10105403|FG000|COMPLETED|First Rest Period (1-12 Weeks)||4
9044440|NCT03424044|10105404|FG001|COMPLETED|First Rest Period (1-12 Weeks)||3
9044441|NCT03424044|10105405|FG002|COMPLETED|First Rest Period (1-12 Weeks)||2
9044442|NCT03424044|10105406|FG003|COMPLETED|First Rest Period (1-12 Weeks)||3
9044443|NCT03424044|10105407|FG004|COMPLETED|First Rest Period (1-12 Weeks)||3
9044444|NCT03424044|10105408|FG005|COMPLETED|First Rest Period (1-12 Weeks)||4
9044445|NCT03424044|10105409|FG006|COMPLETED|First Rest Period (1-12 Weeks)||1
9044446|NCT03424044|10105410|FG007|COMPLETED|First Rest Period (1-12 Weeks)||1
9044447|NCT03424044|10105411|FG008|COMPLETED|First Rest Period (1-12 Weeks)||1
9044448|NCT03424044|10105403|FG000|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
9044449|NCT03424044|10105404|FG001|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
9044450|NCT03424044|10105405|FG002|NOT COMPLETED|First Rest Period (1-12 Weeks)||1
9044451|NCT03424044|10105406|FG003|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
9044452|NCT03424044|10105407|FG004|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
9044453|NCT03424044|10105408|FG005|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
9044454|NCT03424044|10105409|FG006|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
9044455|NCT03424044|10105410|FG007|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
9044456|NCT03424044|10105411|FG008|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
9044457|NCT03424044|10105403|FG000|STARTED|First Intervention (76 Hours)||4
9044458|NCT03424044|10105404|FG001|STARTED|First Intervention (76 Hours)||3
9044459|NCT03424044|10105405|FG002|STARTED|First Intervention (76 Hours)||2
9044460|NCT03424044|10105406|FG003|STARTED|First Intervention (76 Hours)||3
9044461|NCT03424044|10105407|FG004|STARTED|First Intervention (76 Hours)||3
9044462|NCT03424044|10105408|FG005|STARTED|First Intervention (76 Hours)||4
9044463|NCT03424044|10105409|FG006|STARTED|First Intervention (76 Hours)||1
9044464|NCT03424044|10105410|FG007|STARTED|First Intervention (76 Hours)||1
9044465|NCT03424044|10105411|FG008|STARTED|First Intervention (76 Hours)||1
9044466|NCT03424044|10105403|FG000|COMPLETED|First Intervention (76 Hours)||4
9044467|NCT03424044|10105404|FG001|COMPLETED|First Intervention (76 Hours)||3
9044468|NCT03424044|10105405|FG002|COMPLETED|First Intervention (76 Hours)||2
9044469|NCT03424044|10105406|FG003|COMPLETED|First Intervention (76 Hours)||3
9044470|NCT03424044|10105407|FG004|COMPLETED|First Intervention (76 Hours)||2
9044471|NCT03424044|10105408|FG005|COMPLETED|First Intervention (76 Hours)||4
9044472|NCT03424044|10105409|FG006|COMPLETED|First Intervention (76 Hours)||0
9044473|NCT03424044|10105410|FG007|COMPLETED|First Intervention (76 Hours)||0
9044474|NCT03424044|10105411|FG008|COMPLETED|First Intervention (76 Hours)||0
9044475|NCT03424044|10105403|FG000|NOT COMPLETED|First Intervention (76 Hours)||0
9044476|NCT03424044|10105404|FG001|NOT COMPLETED|First Intervention (76 Hours)||0
9044477|NCT03424044|10105405|FG002|NOT COMPLETED|First Intervention (76 Hours)||0
9044478|NCT03424044|10105406|FG003|NOT COMPLETED|First Intervention (76 Hours)||0
9044479|NCT03424044|10105407|FG004|NOT COMPLETED|First Intervention (76 Hours)||1
9044480|NCT03424044|10105408|FG005|NOT COMPLETED|First Intervention (76 Hours)||0
8701677|NCT00912964|9747456|FG001|STARTED|Overall Study||433
8701678|NCT00912964|9747457|FG002|STARTED|Overall Study||440
8701679|NCT00912964|9747455|FG000|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|433
8701680|NCT00912964|9747456|FG001|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|432
8701681|NCT00912964|9747457|FG002|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|440
8701682|NCT00912964|9747455|FG000|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 post-baseline micturition measurement.|415
8701683|NCT00912964|9747456|FG001|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 post-baseline micturition measurement.|410
9044481|NCT03424044|10105409|FG006|NOT COMPLETED|First Intervention (76 Hours)||1
9044482|NCT03424044|10105410|FG007|NOT COMPLETED|First Intervention (76 Hours)||1
9044483|NCT03424044|10105411|FG008|NOT COMPLETED|First Intervention (76 Hours)||1
9044484|NCT03424044|10105403|FG000|STARTED|Second Rest Period (7-45 Days)||4
9044485|NCT03424044|10105404|FG001|STARTED|Second Rest Period (7-45 Days)||3
9044486|NCT03424044|10105405|FG002|STARTED|Second Rest Period (7-45 Days)||2
9044487|NCT03424044|10105406|FG003|STARTED|Second Rest Period (7-45 Days)||3
9044488|NCT03424044|10105407|FG004|STARTED|Second Rest Period (7-45 Days)||2
9044489|NCT03424044|10105408|FG005|STARTED|Second Rest Period (7-45 Days)||4
9044490|NCT03424044|10105409|FG006|STARTED|Second Rest Period (7-45 Days)||1
9044491|NCT03424044|10105410|FG007|STARTED|Second Rest Period (7-45 Days)||1
9044492|NCT03424044|10105411|FG008|STARTED|Second Rest Period (7-45 Days)||1
9044493|NCT03424044|10105403|FG000|COMPLETED|Second Rest Period (7-45 Days)||4
9044494|NCT03424044|10105404|FG001|COMPLETED|Second Rest Period (7-45 Days)||3
9044495|NCT03424044|10105405|FG002|COMPLETED|Second Rest Period (7-45 Days)||2
9044496|NCT03424044|10105406|FG003|COMPLETED|Second Rest Period (7-45 Days)||3
9044497|NCT03424044|10105407|FG004|COMPLETED|Second Rest Period (7-45 Days)||2
9044498|NCT03424044|10105408|FG005|COMPLETED|Second Rest Period (7-45 Days)||4
9044499|NCT03424044|10105409|FG006|COMPLETED|Second Rest Period (7-45 Days)||1
9044500|NCT03424044|10105410|FG007|COMPLETED|Second Rest Period (7-45 Days)||1
9044501|NCT03424044|10105411|FG008|COMPLETED|Second Rest Period (7-45 Days)||1
9044502|NCT03424044|10105403|FG000|NOT COMPLETED|Second Rest Period (7-45 Days)||0
9044503|NCT03424044|10105404|FG001|NOT COMPLETED|Second Rest Period (7-45 Days)||0
9044504|NCT03424044|10105405|FG002|NOT COMPLETED|Second Rest Period (7-45 Days)||0
9044505|NCT03424044|10105406|FG003|NOT COMPLETED|Second Rest Period (7-45 Days)||0
9044506|NCT03424044|10105407|FG004|NOT COMPLETED|Second Rest Period (7-45 Days)||0
9044507|NCT03424044|10105408|FG005|NOT COMPLETED|Second Rest Period (7-45 Days)||0
9044508|NCT03424044|10105409|FG006|NOT COMPLETED|Second Rest Period (7-45 Days)||0
9044509|NCT03424044|10105410|FG007|NOT COMPLETED|Second Rest Period (7-45 Days)||0
9044510|NCT03424044|10105411|FG008|NOT COMPLETED|Second Rest Period (7-45 Days)||0
9044511|NCT03424044|10105403|FG000|STARTED|Second Intervention (76 Hours)||4
9044512|NCT03424044|10105404|FG001|STARTED|Second Intervention (76 Hours)||3
9044513|NCT03424044|10105405|FG002|STARTED|Second Intervention (76 Hours)||2
9044514|NCT03424044|10105406|FG003|STARTED|Second Intervention (76 Hours)||3
9044515|NCT03424044|10105407|FG004|STARTED|Second Intervention (76 Hours)||2
9044516|NCT03424044|10105408|FG005|STARTED|Second Intervention (76 Hours)||4
9044517|NCT03424044|10105409|FG006|STARTED|Second Intervention (76 Hours)||1
9044518|NCT03424044|10105410|FG007|STARTED|Second Intervention (76 Hours)||1
9044519|NCT03424044|10105411|FG008|STARTED|Second Intervention (76 Hours)||1
9044520|NCT03424044|10105403|FG000|COMPLETED|Second Intervention (76 Hours)||4
9044521|NCT03424044|10105404|FG001|COMPLETED|Second Intervention (76 Hours)||3
9044522|NCT03424044|10105405|FG002|COMPLETED|Second Intervention (76 Hours)||2
9044523|NCT03424044|10105406|FG003|COMPLETED|Second Intervention (76 Hours)||3
9044524|NCT03424044|10105407|FG004|COMPLETED|Second Intervention (76 Hours)||2
9044525|NCT03424044|10105408|FG005|COMPLETED|Second Intervention (76 Hours)||4
9044526|NCT03424044|10105409|FG006|COMPLETED|Second Intervention (76 Hours)||1
9044527|NCT03424044|10105410|FG007|COMPLETED|Second Intervention (76 Hours)||1
9044528|NCT03424044|10105411|FG008|COMPLETED|Second Intervention (76 Hours)||1
9044529|NCT03424044|10105403|FG000|NOT COMPLETED|Second Intervention (76 Hours)||0
9044530|NCT03424044|10105404|FG001|NOT COMPLETED|Second Intervention (76 Hours)||0
9044531|NCT03424044|10105405|FG002|NOT COMPLETED|Second Intervention (76 Hours)||0
9044532|NCT03424044|10105406|FG003|NOT COMPLETED|Second Intervention (76 Hours)||0
9044533|NCT03424044|10105407|FG004|NOT COMPLETED|Second Intervention (76 Hours)||0
9044534|NCT03424044|10105408|FG005|NOT COMPLETED|Second Intervention (76 Hours)||0
9044535|NCT03424044|10105409|FG006|NOT COMPLETED|Second Intervention (76 Hours)||0
9044536|NCT03424044|10105410|FG007|NOT COMPLETED|Second Intervention (76 Hours)||0
9044537|NCT03424044|10105411|FG008|NOT COMPLETED|Second Intervention (76 Hours)||0
9044538|NCT03424044|10105403|FG000|STARTED|Third Rest Period (7-45 Days)||4
9044539|NCT03424044|10105404|FG001|STARTED|Third Rest Period (7-45 Days)||3
9044540|NCT03424044|10105405|FG002|STARTED|Third Rest Period (7-45 Days)||2
9044541|NCT03424044|10105406|FG003|STARTED|Third Rest Period (7-45 Days)||3
9044542|NCT03424044|10105407|FG004|STARTED|Third Rest Period (7-45 Days)||2
9044543|NCT03424044|10105408|FG005|STARTED|Third Rest Period (7-45 Days)||4
9044544|NCT03424044|10105409|FG006|STARTED|Third Rest Period (7-45 Days)||1
9044545|NCT03424044|10105410|FG007|STARTED|Third Rest Period (7-45 Days)||1
9044546|NCT03424044|10105411|FG008|STARTED|Third Rest Period (7-45 Days)||1
9044547|NCT03424044|10105403|FG000|COMPLETED|Third Rest Period (7-45 Days)||4
9044548|NCT03424044|10105404|FG001|COMPLETED|Third Rest Period (7-45 Days)||3
9044549|NCT03424044|10105405|FG002|COMPLETED|Third Rest Period (7-45 Days)||2
9044550|NCT03424044|10105406|FG003|COMPLETED|Third Rest Period (7-45 Days)||3
9044551|NCT03424044|10105407|FG004|COMPLETED|Third Rest Period (7-45 Days)||2
9044552|NCT03424044|10105408|FG005|COMPLETED|Third Rest Period (7-45 Days)||4
9044553|NCT03424044|10105409|FG006|COMPLETED|Third Rest Period (7-45 Days)||1
9044554|NCT03424044|10105410|FG007|COMPLETED|Third Rest Period (7-45 Days)||1
9044555|NCT03424044|10105411|FG008|COMPLETED|Third Rest Period (7-45 Days)||1
9044556|NCT03424044|10105403|FG000|NOT COMPLETED|Third Rest Period (7-45 Days)||0
9044557|NCT03424044|10105404|FG001|NOT COMPLETED|Third Rest Period (7-45 Days)||0
9044558|NCT03424044|10105405|FG002|NOT COMPLETED|Third Rest Period (7-45 Days)||0
9044559|NCT03424044|10105406|FG003|NOT COMPLETED|Third Rest Period (7-45 Days)||0
9044560|NCT03424044|10105407|FG004|NOT COMPLETED|Third Rest Period (7-45 Days)||0
9044561|NCT03424044|10105408|FG005|NOT COMPLETED|Third Rest Period (7-45 Days)||0
9044562|NCT03424044|10105409|FG006|NOT COMPLETED|Third Rest Period (7-45 Days)||0
9044563|NCT03424044|10105410|FG007|NOT COMPLETED|Third Rest Period (7-45 Days)||0
9044564|NCT03424044|10105411|FG008|NOT COMPLETED|Third Rest Period (7-45 Days)||0
9044565|NCT03424044|10105403|FG000|STARTED|Third Intervention (76 Hours)||4
9044566|NCT03424044|10105404|FG001|STARTED|Third Intervention (76 Hours)||3
9044567|NCT03424044|10105405|FG002|STARTED|Third Intervention (76 Hours)||2
9044568|NCT03424044|10105406|FG003|STARTED|Third Intervention (76 Hours)||3
9044569|NCT03424044|10105407|FG004|STARTED|Third Intervention (76 Hours)||2
9044570|NCT03424044|10105408|FG005|STARTED|Third Intervention (76 Hours)||4
9044571|NCT03424044|10105409|FG006|STARTED|Third Intervention (76 Hours)||1
9044572|NCT03424044|10105410|FG007|STARTED|Third Intervention (76 Hours)||1
9044573|NCT03424044|10105411|FG008|STARTED|Third Intervention (76 Hours)||1
9044574|NCT03424044|10105403|FG000|COMPLETED|Third Intervention (76 Hours)||3
9044575|NCT03424044|10105404|FG001|COMPLETED|Third Intervention (76 Hours)||3
9044576|NCT03424044|10105405|FG002|COMPLETED|Third Intervention (76 Hours)||2
9044577|NCT03424044|10105406|FG003|COMPLETED|Third Intervention (76 Hours)||2
9044578|NCT03424044|10105407|FG004|COMPLETED|Third Intervention (76 Hours)||2
9044579|NCT03424044|10105408|FG005|COMPLETED|Third Intervention (76 Hours)||4
9044580|NCT03424044|10105409|FG006|COMPLETED|Third Intervention (76 Hours)||0
9044581|NCT03424044|10105410|FG007|COMPLETED|Third Intervention (76 Hours)||1
8701684|NCT00912964|9747457|FG002|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 post-baseline micturition measurement.|426
8701685|NCT00912964|9747455|FG000|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at Baseline.|262
8701686|NCT00912964|9747456|FG001|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at Baseline.|254
8701687|NCT00912964|9747457|FG002|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at Baseline.|257
8701688|NCT00912964|9747455|FG000|COMPLETED|Overall Study||367
8701689|NCT00912964|9747456|FG001|COMPLETED|Overall Study||387
8701690|NCT00912964|9747457|FG002|COMPLETED|Overall Study||386
8701691|NCT00912964|9747455|FG000|NOT COMPLETED|Overall Study||66
8701692|NCT00912964|9747456|FG001|NOT COMPLETED|Overall Study||46
8701693|NCT00912964|9747457|FG002|NOT COMPLETED|Overall Study||54
8701694|NCT00912990|9747467|FG000|STARTED|Overall Study||16
8701695|NCT00912990|9747468|FG001|STARTED|Overall Study||18
8701696|NCT00912990|9747467|FG000|COMPLETED|Overall Study||16
8701697|NCT00912990|9747468|FG001|COMPLETED|Overall Study||18
8701698|NCT00912990|9747467|FG000|NOT COMPLETED|Overall Study||0
8701699|NCT00912990|9747468|FG001|NOT COMPLETED|Overall Study||0
8701700|NCT00913003|9747476|FG000|STARTED|Overall Study||11
8701701|NCT00913003|9747477|FG001|STARTED|Overall Study||11
8701702|NCT00913003|9747476|FG000|COMPLETED|Overall Study||11
8701703|NCT00913003|9747477|FG001|COMPLETED|Overall Study||11
8701704|NCT00913003|9747476|FG000|NOT COMPLETED|Overall Study||0
8701705|NCT00913003|9747477|FG001|NOT COMPLETED|Overall Study||0
8701706|NCT00913068|9747485|FG000|STARTED|Overall Study||56
8701707|NCT00913068|9747486|FG001|STARTED|Overall Study||54
8701708|NCT00913068|9747485|FG000|COMPLETED|Overall Study||48
8701709|NCT00913068|9747486|FG001|COMPLETED|Overall Study||46
8701710|NCT00913068|9747485|FG000|NOT COMPLETED|Overall Study||8
8701711|NCT00913068|9747486|FG001|NOT COMPLETED|Overall Study||8
8701712|NCT00913081|9747492|FG000|STARTED|Quercetin 500 mg + Niacin 500 mg (1day)||17
8701713|NCT00913081|9747492|FG000|COMPLETED|Quercetin 500 mg + Niacin 500 mg (1day)||17
8701714|NCT00913081|9747492|FG000|NOT COMPLETED|Quercetin 500 mg + Niacin 500 mg (1day)||0
8701715|NCT00913081|9747492|FG000|STARTED|Washout #1 (7 Days)||17
8701716|NCT00913081|9747492|FG000|COMPLETED|Washout #1 (7 Days)||17
8701717|NCT00913081|9747492|FG000|NOT COMPLETED|Washout #1 (7 Days)||0
8701718|NCT00913081|9747492|FG000|STARTED|Quercetin 1000 mg + Niacin 500 mg (1day)||17
8701719|NCT00913081|9747492|FG000|COMPLETED|Quercetin 1000 mg + Niacin 500 mg (1day)||17
8701720|NCT00913081|9747492|FG000|NOT COMPLETED|Quercetin 1000 mg + Niacin 500 mg (1day)||0
8701721|NCT00913081|9747492|FG000|STARTED|Washout #2 (7 Days)||17
8701722|NCT00913081|9747492|FG000|COMPLETED|Washout #2 (7 Days)||17
8701723|NCT00913081|9747492|FG000|NOT COMPLETED|Washout #2 (7 Days)||0
8701724|NCT00913081|9747492|FG000|STARTED|Quercetin 2000 mg + Niacin 500 mg (1day)||17
8701725|NCT00913081|9747492|FG000|COMPLETED|Quercetin 2000 mg + Niacin 500 mg (1day)||17
8701726|NCT00913081|9747492|FG000|NOT COMPLETED|Quercetin 2000 mg + Niacin 500 mg (1day)||0
8701727|NCT00913081|9747492|FG000|STARTED|Washout #3 (7days)||17
8701728|NCT00913081|9747492|FG000|COMPLETED|Washout #3 (7days)||17
8701729|NCT00913081|9747492|FG000|NOT COMPLETED|Washout #3 (7days)||0
8701730|NCT00913081|9747492|FG000|STARTED|Placebo + Niacin 500 mg (1day)||17
8701731|NCT00913081|9747492|FG000|COMPLETED|Placebo + Niacin 500 mg (1day)||17
8701732|NCT00913081|9747492|FG000|NOT COMPLETED|Placebo + Niacin 500 mg (1day)||0
8701733|NCT00913133|9747502|FG000|STARTED|Overall Study||516
8701734|NCT00913133|9747502|FG000|COMPLETED|Overall Study||516
8701735|NCT00913133|9747502|FG000|NOT COMPLETED|Overall Study||0
8701736|NCT00913263|9747506|FG000|STARTED|Overall Study||24
8701737|NCT00913263|9747506|FG000|COMPLETED|Overall Study||24
8701738|NCT00913263|9747506|FG000|NOT COMPLETED|Overall Study||0
8701739|NCT00913380|9747516|FG000|STARTED|CT Examination||444
9044582|NCT03424044|10105411|FG008|COMPLETED|Third Intervention (76 Hours)||1
9044583|NCT03424044|10105403|FG000|NOT COMPLETED|Third Intervention (76 Hours)||1
9044584|NCT03424044|10105404|FG001|NOT COMPLETED|Third Intervention (76 Hours)||0
8701740|NCT00913380|9747517|FG001|STARTED|CT Examination||447
8701741|NCT00913380|9747516|FG000|COMPLETED|CT Examination||444
8701742|NCT00913380|9747517|FG001|COMPLETED|CT Examination||447
8701743|NCT00913380|9747516|FG000|NOT COMPLETED|CT Examination||0
8701744|NCT00913380|9747517|FG001|NOT COMPLETED|CT Examination||0
8701745|NCT00913380|9747516|FG000|STARTED|Clinical Outcomes||444
8701746|NCT00913380|9747517|FG001|STARTED|Clinical Outcomes||447
8701747|NCT00913380|9747516|FG000|COMPLETED|Clinical Outcomes||438
8701748|NCT00913380|9747517|FG001|COMPLETED|Clinical Outcomes||441
9044585|NCT03424044|10105405|FG002|NOT COMPLETED|Third Intervention (76 Hours)||0
9044586|NCT03424044|10105406|FG003|NOT COMPLETED|Third Intervention (76 Hours)||1
9044587|NCT03424044|10105407|FG004|NOT COMPLETED|Third Intervention (76 Hours)||0
9044588|NCT03424044|10105408|FG005|NOT COMPLETED|Third Intervention (76 Hours)||0
9044589|NCT03424044|10105409|FG006|NOT COMPLETED|Third Intervention (76 Hours)||1
9044590|NCT03424044|10105410|FG007|NOT COMPLETED|Third Intervention (76 Hours)||0
9044591|NCT03424044|10105411|FG008|NOT COMPLETED|Third Intervention (76 Hours)||0
9044592|NCT03424044|10105403|FG000|STARTED|Optional Fourth Rest Period (7-45 Days)||0
9044593|NCT03424044|10105404|FG001|STARTED|Optional Fourth Rest Period (7-45 Days)||0
9044594|NCT03424044|10105405|FG002|STARTED|Optional Fourth Rest Period (7-45 Days)||0
9044595|NCT03424044|10105406|FG003|STARTED|Optional Fourth Rest Period (7-45 Days)||0
9044596|NCT03424044|10105407|FG004|STARTED|Optional Fourth Rest Period (7-45 Days)||0
8701749|NCT00913380|9747516|FG000|NOT COMPLETED|Clinical Outcomes||6
8701750|NCT00913380|9747517|FG001|NOT COMPLETED|Clinical Outcomes||6
8701751|NCT00913458|9747523|FG000|STARTED|Phase 1||306
8701752|NCT00913458|9747524|FG001|STARTED|Phase 1|This arm is part of Phase 2 study|0
8701753|NCT00913458|9747525|FG002|STARTED|Phase 1|This arm is part of Phase 2 study|0
8701754|NCT00913458|9747526|FG003|STARTED|Phase 1|This arm is part of Phase 2 study|0
8701755|NCT00913458|9747527|FG004|STARTED|Phase 1|This arm is part of Phase 3 study|0
8701756|NCT00913458|9747528|FG005|STARTED|Phase 1|This arm is part of Phase 3 study|0
8701757|NCT00913458|9747529|FG006|STARTED|Phase 1|This arm is part of Phase 3 study|0
8701758|NCT00913458|9747523|FG000|COMPLETED|Phase 1|194 continued to Phase 2 but 1 was randomized in error leaving 193 in the phase 2 analysis.|194
8701759|NCT00913458|9747524|FG001|COMPLETED|Phase 1|This arm is part of Phase 2 study|0
8701760|NCT00913458|9747525|FG002|COMPLETED|Phase 1|This arm is part of Phase 2 study|0
8701761|NCT00913458|9747526|FG003|COMPLETED|Phase 1|This arm is part of Phase 2 study|0
8701762|NCT00913458|9747527|FG004|COMPLETED|Phase 1|This arm is part of Phase 3 study|0
8701763|NCT00913458|9747528|FG005|COMPLETED|Phase 1|This arm is part of Phase 3 study|0
8701764|NCT00913458|9747529|FG006|COMPLETED|Phase 1|This arm is part of Phase 3 study|0
8701765|NCT00913458|9747523|FG000|NOT COMPLETED|Phase 1||112
8701766|NCT00913458|9747524|FG001|NOT COMPLETED|Phase 1||0
8701767|NCT00913458|9747525|FG002|NOT COMPLETED|Phase 1||0
8701768|NCT00913458|9747526|FG003|NOT COMPLETED|Phase 1||0
8701769|NCT00913458|9747527|FG004|NOT COMPLETED|Phase 1||0
8701770|NCT00913458|9747528|FG005|NOT COMPLETED|Phase 1||0
8701771|NCT00913458|9747529|FG006|NOT COMPLETED|Phase 1||0
8701772|NCT00913458|9747523|FG000|STARTED|Phase 2|This arm is part of Phase 1 of the study.|0
8701773|NCT00913458|9747524|FG001|STARTED|Phase 2||63
8701774|NCT00913458|9747525|FG002|STARTED|Phase 2||65
8701775|NCT00913458|9747526|FG003|STARTED|Phase 2||65
8701776|NCT00913458|9747527|FG004|STARTED|Phase 2||0
8701777|NCT00913458|9747528|FG005|STARTED|Phase 2||0
8701778|NCT00913458|9747529|FG006|STARTED|Phase 2||0
8701779|NCT00913458|9747523|FG000|COMPLETED|Phase 2|This arm is part of Phase 1 of the study.|0
8701780|NCT00913458|9747524|FG001|COMPLETED|Phase 2|Participants randomized into Phase 3 of study.|53
8701781|NCT00913458|9747525|FG002|COMPLETED|Phase 2|Participants randomized into Phase 3 of study.|46
8701782|NCT00913458|9747526|FG003|COMPLETED|Phase 2|Participants randomized into Phase 3 of study.|32
8701783|NCT00913458|9747527|FG004|COMPLETED|Phase 2||0
8701784|NCT00913458|9747528|FG005|COMPLETED|Phase 2||0
8701785|NCT00913458|9747529|FG006|COMPLETED|Phase 2||0
8701786|NCT00913458|9747523|FG000|NOT COMPLETED|Phase 2||0
8701787|NCT00913458|9747524|FG001|NOT COMPLETED|Phase 2||10
8701788|NCT00913458|9747525|FG002|NOT COMPLETED|Phase 2||19
8701789|NCT00913458|9747526|FG003|NOT COMPLETED|Phase 2||33
8701790|NCT00913458|9747527|FG004|NOT COMPLETED|Phase 2||0
8701791|NCT00913458|9747528|FG005|NOT COMPLETED|Phase 2||0
8701792|NCT00913458|9747529|FG006|NOT COMPLETED|Phase 2||0
8701793|NCT00913458|9747523|FG000|STARTED|Phase 3|This arm is part of Phase 1 of the study.|0
8701794|NCT00913458|9747524|FG001|STARTED|Phase 3||0
8701795|NCT00913458|9747525|FG002|STARTED|Phase 3||0
8701796|NCT00913458|9747526|FG003|STARTED|Phase 3||0
8701797|NCT00913458|9747527|FG004|STARTED|Phase 3|Participants who completed Phase 2 study|53
8701798|NCT00913458|9747528|FG005|STARTED|Phase 3|Participants who completed Phase 2 study|46
8701799|NCT00913458|9747529|FG006|STARTED|Phase 3|Participants who completed Phase 2 study|32
8701800|NCT00913458|9747523|FG000|COMPLETED|Phase 3|This arm is part of Phase 1 of the study.|0
8701801|NCT00913458|9747524|FG001|COMPLETED|Phase 3||0
8701802|NCT00913458|9747525|FG002|COMPLETED|Phase 3||0
8701803|NCT00913458|9747526|FG003|COMPLETED|Phase 3||0
8701804|NCT00913458|9747527|FG004|COMPLETED|Phase 3||31
8701805|NCT00913458|9747528|FG005|COMPLETED|Phase 3||28
8701806|NCT00913458|9747529|FG006|COMPLETED|Phase 3||24
8701807|NCT00913458|9747523|FG000|NOT COMPLETED|Phase 3||0
8701808|NCT00913458|9747524|FG001|NOT COMPLETED|Phase 3||0
9044597|NCT03424044|10105408|FG005|STARTED|Optional Fourth Rest Period (7-45 Days)||0
8701809|NCT00913458|9747525|FG002|NOT COMPLETED|Phase 3||0
8701810|NCT00913458|9747526|FG003|NOT COMPLETED|Phase 3||0
8701811|NCT00913458|9747527|FG004|NOT COMPLETED|Phase 3||22
8701812|NCT00913458|9747528|FG005|NOT COMPLETED|Phase 3||18
8701813|NCT00913458|9747529|FG006|NOT COMPLETED|Phase 3||8
8701814|NCT00913510|9747548|FG000|STARTED|Overall Study||13
8701815|NCT00913510|9747549|FG001|STARTED|Overall Study||7
8701816|NCT00913510|9747548|FG000|COMPLETED|Overall Study||5
8701817|NCT00913510|9747549|FG001|COMPLETED|Overall Study||3
8701818|NCT00913510|9747548|FG000|NOT COMPLETED|Overall Study||8
8701819|NCT00913510|9747549|FG001|NOT COMPLETED|Overall Study||4
9044598|NCT03424044|10105409|FG006|STARTED|Optional Fourth Rest Period (7-45 Days)||0
9044599|NCT03424044|10105410|FG007|STARTED|Optional Fourth Rest Period (7-45 Days)||1
9044600|NCT03424044|10105411|FG008|STARTED|Optional Fourth Rest Period (7-45 Days)||1
9044601|NCT03424044|10105403|FG000|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
9044602|NCT03424044|10105404|FG001|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
9044603|NCT03424044|10105405|FG002|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
9044604|NCT03424044|10105406|FG003|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
9044605|NCT03424044|10105407|FG004|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
9044606|NCT03424044|10105408|FG005|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
9044607|NCT03424044|10105409|FG006|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
9044608|NCT03424044|10105410|FG007|COMPLETED|Optional Fourth Rest Period (7-45 Days)||1
9044609|NCT03424044|10105411|FG008|COMPLETED|Optional Fourth Rest Period (7-45 Days)||1
9044610|NCT03424044|10105403|FG000|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
9044611|NCT03424044|10105404|FG001|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
9044612|NCT03424044|10105405|FG002|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
9044613|NCT03424044|10105406|FG003|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
9044614|NCT03424044|10105407|FG004|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
9044615|NCT03424044|10105408|FG005|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
9044616|NCT03424044|10105409|FG006|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
9044617|NCT03424044|10105410|FG007|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
9044618|NCT03424044|10105411|FG008|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
9044619|NCT03424044|10105403|FG000|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
9044620|NCT03424044|10105404|FG001|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
9044621|NCT03424044|10105405|FG002|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
9044622|NCT03424044|10105406|FG003|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
9044623|NCT03424044|10105407|FG004|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
8701820|NCT00913523|9747558|FG000|STARTED|Overall Study||162
8701821|NCT00913523|9747559|FG001|STARTED|Overall Study||159
8701822|NCT00913523|9747560|FG002|STARTED|Overall Study||161
8701823|NCT00913523|9747558|FG000|COMPLETED|Overall Study||144
8701824|NCT00913523|9747559|FG001|COMPLETED|Overall Study||143
8701825|NCT00913523|9747560|FG002|COMPLETED|Overall Study||147
9044624|NCT03424044|10105408|FG005|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
9044625|NCT03424044|10105409|FG006|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
9044626|NCT03424044|10105410|FG007|STARTED|Fourth Intervention Repeat Visit (76 hr)||1
9044627|NCT03424044|10105411|FG008|STARTED|Fourth Intervention Repeat Visit (76 hr)||1
9044628|NCT03424044|10105403|FG000|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
9044629|NCT03424044|10105404|FG001|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
9044630|NCT03424044|10105405|FG002|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
8701826|NCT00913523|9747558|FG000|NOT COMPLETED|Overall Study||18
8701827|NCT00913523|9747559|FG001|NOT COMPLETED|Overall Study||16
8701828|NCT00913523|9747560|FG002|NOT COMPLETED|Overall Study||14
8701829|NCT00913627|9747572|FG000|STARTED|Overall Study||29
8701830|NCT00913627|9747573|FG001|STARTED|Overall Study||53
8701831|NCT00913627|9747574|FG002|STARTED|Overall Study||56
8701832|NCT00913627|9747575|FG003|STARTED|Overall Study||58
8701833|NCT00913627|9747572|FG000|COMPLETED|Overall Study||29
8701834|NCT00913627|9747573|FG001|COMPLETED|Overall Study||53
8701835|NCT00913627|9747574|FG002|COMPLETED|Overall Study||56
8701836|NCT00913627|9747575|FG003|COMPLETED|Overall Study||58
8701837|NCT00913627|9747572|FG000|NOT COMPLETED|Overall Study||0
8701838|NCT00913627|9747573|FG001|NOT COMPLETED|Overall Study||0
8701839|NCT00913627|9747574|FG002|NOT COMPLETED|Overall Study||0
8701840|NCT00913627|9747575|FG003|NOT COMPLETED|Overall Study||0
8701841|NCT00913744|9747587|FG000|STARTED|Overall Study||75
8701842|NCT00913744|9747588|FG001|STARTED|Overall Study||25
8701843|NCT00913744|9747587|FG000|COMPLETED|Overall Study||70
8701844|NCT00913744|9747588|FG001|COMPLETED|Overall Study||24
8701845|NCT00913744|9747587|FG000|NOT COMPLETED|Overall Study||5
8701846|NCT00913744|9747588|FG001|NOT COMPLETED|Overall Study||1
8701847|NCT00913770|9747597|FG000|STARTED|Overall Study||104
8701848|NCT00913770|9747598|FG001|STARTED|Overall Study||111
8701849|NCT00913770|9747599|FG002|STARTED|Overall Study||114
8701850|NCT00913770|9747597|FG000|COMPLETED|Overall Study||69
8701851|NCT00913770|9747598|FG001|COMPLETED|Overall Study||82
8701852|NCT00913770|9747599|FG002|COMPLETED|Overall Study||93
8701853|NCT00913770|9747597|FG000|NOT COMPLETED|Overall Study||35
8701854|NCT00913770|9747598|FG001|NOT COMPLETED|Overall Study||29
8701855|NCT00913770|9747599|FG002|NOT COMPLETED|Overall Study||21
8701856|NCT00913835|9747609|FG000|STARTED|Olara+Lip Dox and Lip Dox Monotherapy||63
8701857|NCT00913835|9747610|FG001|STARTED|Olara+Lip Dox and Lip Dox Monotherapy||62
8701858|NCT00913835|9747609|FG000|Received Any Study Drug|Olara+Lip Dox and Lip Dox Monotherapy||62
8701859|NCT00913835|9747610|FG001|Received Any Study Drug|Olara+Lip Dox and Lip Dox Monotherapy||61
8701860|NCT00913835|9747609|FG000|COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||55
8701861|NCT00913835|9747610|FG001|COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||55
8701862|NCT00913835|9747609|FG000|NOT COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||8
8701863|NCT00913835|9747610|FG001|NOT COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||7
8701864|NCT00913835|9747609|FG000|STARTED|Lip Dox: Olaratumab Monotherapy||0
8701865|NCT00913835|9747610|FG001|STARTED|Lip Dox: Olaratumab Monotherapy||28
8701866|NCT00913835|9747609|FG000|Received at Least 1 Dose of Study Drug|Lip Dox: Olaratumab Monotherapy||0
8701867|NCT00913835|9747610|FG001|Received at Least 1 Dose of Study Drug|Lip Dox: Olaratumab Monotherapy||28
8701868|NCT00913835|9747609|FG000|COMPLETED|Lip Dox: Olaratumab Monotherapy||0
8701869|NCT00913835|9747610|FG001|COMPLETED|Lip Dox: Olaratumab Monotherapy||25
8701870|NCT00913835|9747609|FG000|NOT COMPLETED|Lip Dox: Olaratumab Monotherapy||0
8701871|NCT00913835|9747610|FG001|NOT COMPLETED|Lip Dox: Olaratumab Monotherapy||3
8701872|NCT00913913|9747623|FG000|STARTED|Overall Study||8
8701873|NCT00913913|9747623|FG000|COMPLETED|Overall Study||0
8701874|NCT00913913|9747623|FG000|NOT COMPLETED|Overall Study||8
8701875|NCT00913978|9747629|FG000|STARTED|Overall Study||26
8701876|NCT00913978|9747630|FG001|STARTED|Overall Study||24
8701877|NCT00913978|9747629|FG000|COMPLETED|Overall Study||25
8701878|NCT00913978|9747630|FG001|COMPLETED|Overall Study||21
8701879|NCT00913978|9747629|FG000|NOT COMPLETED|Overall Study||1
8701880|NCT00913978|9747630|FG001|NOT COMPLETED|Overall Study||3
8701881|NCT00914069|9747638|FG000|STARTED|Overall Study||84
8701882|NCT00914069|9747639|FG001|STARTED|Overall Study||88
8701883|NCT00914069|9747638|FG000|COMPLETED|Overall Study||84
8701884|NCT00914069|9747639|FG001|COMPLETED|Overall Study||88
9044631|NCT03424044|10105406|FG003|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
9044632|NCT03424044|10105407|FG004|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
9044633|NCT03424044|10105408|FG005|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
8701885|NCT00914069|9747638|FG000|NOT COMPLETED|Overall Study||0
8701886|NCT00914069|9747639|FG001|NOT COMPLETED|Overall Study||0
8701887|NCT00914186|9747649|FG000|STARTED|Overall Study||31
8701888|NCT00914186|9747650|FG001|STARTED|Overall Study||30
8701889|NCT00914186|9747651|FG002|STARTED|Overall Study||31
8701890|NCT00914186|9747652|FG003|STARTED|Overall Study||30
8701891|NCT00914186|9747649|FG000|COMPLETED|Overall Study||28
8701892|NCT00914186|9747650|FG001|COMPLETED|Overall Study||28
8701893|NCT00914186|9747651|FG002|COMPLETED|Overall Study||29
8701894|NCT00914186|9747652|FG003|COMPLETED|Overall Study||20
8701895|NCT00914186|9747649|FG000|NOT COMPLETED|Overall Study||3
8701896|NCT00914186|9747650|FG001|NOT COMPLETED|Overall Study||2
8701897|NCT00914186|9747651|FG002|NOT COMPLETED|Overall Study||2
8701898|NCT00914186|9747652|FG003|NOT COMPLETED|Overall Study||10
8701899|NCT00914316|9747667|FG000|STARTED|Phase 1||7
8701900|NCT00914316|9747668|FG001|STARTED|Phase 1||6
8701901|NCT00914316|9747669|FG002|STARTED|Phase 1||8
8701902|NCT00914316|9747670|FG003|STARTED|Phase 1||8
8701903|NCT00914316|9747667|FG000|COMPLETED|Phase 1||2
8701904|NCT00914316|9747668|FG001|COMPLETED|Phase 1||4
8701905|NCT00914316|9747669|FG002|COMPLETED|Phase 1||3
8701906|NCT00914316|9747670|FG003|COMPLETED|Phase 1||6
8701907|NCT00914316|9747667|FG000|NOT COMPLETED|Phase 1||5
8701908|NCT00914316|9747668|FG001|NOT COMPLETED|Phase 1||2
8701909|NCT00914316|9747669|FG002|NOT COMPLETED|Phase 1||5
8701910|NCT00914316|9747670|FG003|NOT COMPLETED|Phase 1||2
8701911|NCT00914316|9747667|FG000|STARTED|Phase 2||2
8701912|NCT00914316|9747668|FG001|STARTED|Phase 2||4
8701913|NCT00914316|9747669|FG002|STARTED|Phase 2||3
8701914|NCT00914316|9747670|FG003|STARTED|Phase 2||6
8701915|NCT00914316|9747667|FG000|COMPLETED|Phase 2||1
8701916|NCT00914316|9747668|FG001|COMPLETED|Phase 2||4
8701917|NCT00914316|9747669|FG002|COMPLETED|Phase 2||2
8701918|NCT00914316|9747670|FG003|COMPLETED|Phase 2||6
8701919|NCT00914316|9747667|FG000|NOT COMPLETED|Phase 2||1
8701920|NCT00914316|9747668|FG001|NOT COMPLETED|Phase 2||0
8701921|NCT00914316|9747669|FG002|NOT COMPLETED|Phase 2||1
8701922|NCT00914316|9747670|FG003|NOT COMPLETED|Phase 2||0
8701923|NCT00914459|9747682|FG000|STARTED|Overall Study||18
8701924|NCT00914459|9747683|FG001|STARTED|Overall Study||19
8701925|NCT00914459|9747682|FG000|COMPLETED|Overall Study||17
8701926|NCT00914459|9747683|FG001|COMPLETED|Overall Study||18
8701927|NCT00914459|9747682|FG000|NOT COMPLETED|Overall Study||1
8701928|NCT00914459|9747683|FG001|NOT COMPLETED|Overall Study||1
8701929|NCT00914485|9747691|FG000|STARTED|Overall Study||369
8701930|NCT00914485|9747691|FG000|COMPLETED|Overall Study||369
8701931|NCT00914485|9747691|FG000|NOT COMPLETED|Overall Study||0
8724490|NCT01026493|9771704|FG002|STARTED|Overall Study||9
8724491|NCT01026493|9771705|FG003|STARTED|Overall Study||8
8724492|NCT01026493|9771706|FG004|STARTED|Overall Study||75
8724493|NCT01026493|9771707|FG005|STARTED|Overall Study||76
8724494|NCT01026493|9771708|FG006|STARTED|Overall Study||36
8724495|NCT01026493|9771709|FG007|STARTED|Overall Study||38
8724496|NCT01026493|9771702|FG000|COMPLETED|Overall Study||8
8724497|NCT01026493|9771703|FG001|COMPLETED|Overall Study||6
8724498|NCT01026493|9771704|FG002|COMPLETED|Overall Study||9
8724499|NCT01026493|9771705|FG003|COMPLETED|Overall Study||8
8724500|NCT01026493|9771706|FG004|COMPLETED|Overall Study||73
8724501|NCT01026493|9771707|FG005|COMPLETED|Overall Study||73
8724502|NCT01026493|9771708|FG006|COMPLETED|Overall Study||32
8724503|NCT01026493|9771709|FG007|COMPLETED|Overall Study||37
8724504|NCT01026493|9771702|FG000|NOT COMPLETED|Overall Study||0
8724505|NCT01026493|9771703|FG001|NOT COMPLETED|Overall Study||1
8724506|NCT01026493|9771704|FG002|NOT COMPLETED|Overall Study||0
8724507|NCT01026493|9771705|FG003|NOT COMPLETED|Overall Study||0
8724508|NCT01026493|9771706|FG004|NOT COMPLETED|Overall Study||2
8724509|NCT01026493|9771707|FG005|NOT COMPLETED|Overall Study||3
8724510|NCT01026493|9771708|FG006|NOT COMPLETED|Overall Study||4
8724511|NCT01026493|9771709|FG007|NOT COMPLETED|Overall Study||1
8724512|NCT01026623|9771730|FG000|STARTED|Overall Study||6
8724513|NCT01026623|9771731|FG001|STARTED|Overall Study||5
8724514|NCT01026623|9771732|FG002|STARTED|Overall Study||5
8724515|NCT01026623|9771730|FG000|COMPLETED|Overall Study||6
8724516|NCT01026623|9771731|FG001|COMPLETED|Overall Study||5
8724517|NCT01026623|9771732|FG002|COMPLETED|Overall Study||5
8724518|NCT01026623|9771730|FG000|NOT COMPLETED|Overall Study||0
8724519|NCT01026623|9771731|FG001|NOT COMPLETED|Overall Study||0
8724520|NCT01026623|9771732|FG002|NOT COMPLETED|Overall Study||0
8724521|NCT01026792|9771741|FG000|STARTED|Overall Study||38
8724522|NCT01026792|9771741|FG000|COMPLETED|Overall Study||37
8724523|NCT01026792|9771741|FG000|NOT COMPLETED|Overall Study||1
8724524|NCT01026805|9771745|FG000|STARTED|Overall Study||11
8724525|NCT01026805|9771745|FG000|COMPLETED|Overall Study||11
8724526|NCT01026805|9771745|FG000|NOT COMPLETED|Overall Study||0
8724527|NCT01026818|9771752|FG000|STARTED|Screening Period||583
8724528|NCT01026818|9771753|FG001|STARTED|Screening Period||0
8724529|NCT01026818|9771754|FG002|STARTED|Screening Period||0
8724530|NCT01026818|9771755|FG003|STARTED|Screening Period||0
8724531|NCT01026818|9771752|FG000|COMPLETED|Screening Period||423
8724532|NCT01026818|9771753|FG001|COMPLETED|Screening Period||0
8724533|NCT01026818|9771754|FG002|COMPLETED|Screening Period||0
8724534|NCT01026818|9771755|FG003|COMPLETED|Screening Period||0
9044634|NCT03424044|10105409|FG006|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
9044635|NCT03424044|10105410|FG007|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||1
9044636|NCT03424044|10105411|FG008|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||1
9044637|NCT03424044|10105403|FG000|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
9044638|NCT03424044|10105404|FG001|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
9044639|NCT03424044|10105405|FG002|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
9044640|NCT03424044|10105406|FG003|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
9044641|NCT03424044|10105407|FG004|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
9044642|NCT03424044|10105408|FG005|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
9044643|NCT03424044|10105409|FG006|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
9044644|NCT03424044|10105410|FG007|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
9044645|NCT03424044|10105411|FG008|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
9044646|NCT03424187|10105427|FG000|STARTED|Overall Study||2
9044647|NCT03424187|10105428|FG001|STARTED|Overall Study||3
9044648|NCT03424187|10105429|FG002|STARTED|Overall Study||2
9044649|NCT03424187|10105430|FG003|STARTED|Overall Study||3
9044650|NCT03424187|10105431|FG004|STARTED|Overall Study||2
9044651|NCT03424187|10105432|FG005|STARTED|Overall Study||3
9044652|NCT03424187|10105427|FG000|COMPLETED|Overall Study||2
9044653|NCT03424187|10105428|FG001|COMPLETED|Overall Study||3
9044654|NCT03424187|10105429|FG002|COMPLETED|Overall Study||2
9044655|NCT03424187|10105430|FG003|COMPLETED|Overall Study||3
9044656|NCT03424187|10105431|FG004|COMPLETED|Overall Study||2
9044657|NCT03424187|10105432|FG005|COMPLETED|Overall Study||3
9044658|NCT03424187|10105427|FG000|NOT COMPLETED|Overall Study||0
9044659|NCT03424187|10105428|FG001|NOT COMPLETED|Overall Study||0
9044660|NCT03424187|10105429|FG002|NOT COMPLETED|Overall Study||0
9044661|NCT03424187|10105430|FG003|NOT COMPLETED|Overall Study||0
9044662|NCT03424187|10105431|FG004|NOT COMPLETED|Overall Study||0
9044663|NCT03424187|10105432|FG005|NOT COMPLETED|Overall Study||0
9044664|NCT03424239|10105445|FG000|STARTED|Overall Study||6
9044665|NCT03424239|10105445|FG000|Baseline/Zoledronic Acid Administration|Overall Study||4
9044666|NCT03424239|10105445|FG000|2 Week Post-op|Overall Study||4
9044667|NCT03424239|10105445|FG000|12 Week Post-op|Overall Study||4
9044668|NCT03424239|10105445|FG000|24 Week Post-op|Overall Study||4
9044669|NCT03424239|10105445|FG000|COMPLETED|Overall Study||4
9044670|NCT03424239|10105445|FG000|NOT COMPLETED|Overall Study||2
9044671|NCT03424265|10105451|FG000|STARTED|Overall Study||29
9044672|NCT03424265|10105452|FG001|STARTED|Overall Study||34
9044673|NCT03424265|10105451|FG000|COMPLETED|Overall Study||28
9044674|NCT03424265|10105452|FG001|COMPLETED|Overall Study||32
9044675|NCT03424265|10105451|FG000|NOT COMPLETED|Overall Study||1
9044676|NCT03424265|10105452|FG001|NOT COMPLETED|Overall Study||2
9044677|NCT03424681|10105460|FG000|STARTED|Overall Study||6
9044678|NCT03424681|10105461|FG001|STARTED|Overall Study||6
9044679|NCT03424681|10105460|FG000|COMPLETED|Overall Study||6
8701932|NCT00914589|9747698|FG000|STARTED|Overall Study||128
8701933|NCT00914589|9747699|FG001|STARTED|Overall Study||143
8701934|NCT00914589|9747700|FG002|STARTED|Overall Study||138
8701935|NCT00914589|9747698|FG000|COMPLETED|Overall Study||103
8701936|NCT00914589|9747699|FG001|COMPLETED|Overall Study||127
8701937|NCT00914589|9747700|FG002|COMPLETED|Overall Study||126
8701938|NCT00914589|9747698|FG000|NOT COMPLETED|Overall Study||25
8701939|NCT00914589|9747699|FG001|NOT COMPLETED|Overall Study||16
8701940|NCT00914589|9747700|FG002|NOT COMPLETED|Overall Study||12
8701941|NCT00914628|9747710|FG000|STARTED|Overall Study|Referred to all randomized patient|64
8701942|NCT00914628|9747711|FG001|STARTED|Overall Study|Referred to all randomized patient|28
8701943|NCT00914628|9747710|FG000|COMPLETED|Overall Study|Early termination of the Study|0
8701944|NCT00914628|9747711|FG001|COMPLETED|Overall Study|Early termination of the Study|0
8701945|NCT00914628|9747710|FG000|NOT COMPLETED|Overall Study||64
8701946|NCT00914628|9747711|FG001|NOT COMPLETED|Overall Study||28
8701947|NCT00914732|9747724|FG000|STARTED|Overall Study||165
8701948|NCT00914732|9747725|FG001|STARTED|Overall Study||167
8701949|NCT00914732|9747726|FG002|STARTED|Overall Study||191
8701950|NCT00914732|9747724|FG000|Received Second Vaccination|Overall Study||150
8701951|NCT00914732|9747725|FG001|Received Second Vaccination|Overall Study||157
8701952|NCT00914732|9747726|FG002|Received Second Vaccination|Overall Study||153
8701953|NCT00914732|9747724|FG000|COMPLETED|Overall Study||155
8701954|NCT00914732|9747725|FG001|COMPLETED|Overall Study||160
8701955|NCT00914732|9747726|FG002|COMPLETED|Overall Study||180
8701956|NCT00914732|9747724|FG000|NOT COMPLETED|Overall Study||10
8701957|NCT00914732|9747725|FG001|NOT COMPLETED|Overall Study||7
8701958|NCT00914732|9747726|FG002|NOT COMPLETED|Overall Study||11
8701959|NCT00914810|9747737|FG000|STARTED|Overall Study||20
8701960|NCT00914810|9747738|FG001|STARTED|Overall Study||19
8701961|NCT00914810|9747737|FG000|COMPLETED|Overall Study||18
8701962|NCT00914810|9747738|FG001|COMPLETED|Overall Study||18
8701963|NCT00914810|9747737|FG000|NOT COMPLETED|Overall Study||2
8701964|NCT00914810|9747738|FG001|NOT COMPLETED|Overall Study||1
8701965|NCT00914849|9747746|FG000|STARTED|Overall Study||34
8701966|NCT00914849|9747747|FG001|STARTED|Overall Study||34
8701967|NCT00914849|9747746|FG000|COMPLETED|Overall Study||33
8701968|NCT00914849|9747747|FG001|COMPLETED|Overall Study||33
9044680|NCT03424681|10105461|FG001|COMPLETED|Overall Study||5
9044681|NCT03424681|10105460|FG000|NOT COMPLETED|Overall Study||0
9044682|NCT03424681|10105461|FG001|NOT COMPLETED|Overall Study||1
9044683|NCT03425019|10105467|FG000|STARTED|Overall Study||20
9044684|NCT03425019|10105467|FG000|COMPLETED|Overall Study||20
9044685|NCT03425019|10105467|FG000|NOT COMPLETED|Overall Study||0
9044686|NCT03425097|10105472|FG000|STARTED|Treatment Period 1 (2 Weeks)||6
9044687|NCT03425097|10105473|FG001|STARTED|Treatment Period 1 (2 Weeks)||5
9044688|NCT03425097|10105472|FG000|COMPLETED|Treatment Period 1 (2 Weeks)||6
9044689|NCT03425097|10105473|FG001|COMPLETED|Treatment Period 1 (2 Weeks)||5
9044690|NCT03425097|10105472|FG000|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
9044691|NCT03425097|10105473|FG001|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
9044692|NCT03425097|10105472|FG000|STARTED|Washout Period (1 Week)||6
9044693|NCT03425097|10105473|FG001|STARTED|Washout Period (1 Week)||5
9044694|NCT03425097|10105472|FG000|COMPLETED|Washout Period (1 Week)||6
9044695|NCT03425097|10105473|FG001|COMPLETED|Washout Period (1 Week)||5
9044696|NCT03425097|10105472|FG000|NOT COMPLETED|Washout Period (1 Week)||0
9044697|NCT03425097|10105473|FG001|NOT COMPLETED|Washout Period (1 Week)||0
9044698|NCT03425097|10105472|FG000|STARTED|Second Treatment Period (2 Weeks)||6
9044699|NCT03425097|10105473|FG001|STARTED|Second Treatment Period (2 Weeks)||5
9044700|NCT03425097|10105472|FG000|COMPLETED|Second Treatment Period (2 Weeks)||6
9044701|NCT03425097|10105473|FG001|COMPLETED|Second Treatment Period (2 Weeks)||5
9044702|NCT03425097|10105472|FG000|NOT COMPLETED|Second Treatment Period (2 Weeks)||0
9044703|NCT03425097|10105473|FG001|NOT COMPLETED|Second Treatment Period (2 Weeks)||0
9044704|NCT03425188|10105482|FG000|STARTED|Overall Study||53
9044705|NCT03425188|10105482|FG000|COMPLETED|Overall Study||52
9044706|NCT03425188|10105482|FG000|NOT COMPLETED|Overall Study||1
9044707|NCT03425253|10105487|FG000|STARTED|Overall Study||58
9044708|NCT03425253|10105487|FG000|Safety Analysis Set|Overall Study||53
9044709|NCT03425253|10105487|FG000|FAS|Overall Study||53
9044710|NCT03425253|10105487|FG000|Evaluable Set (ES)|Overall Study||42
9044711|NCT03425253|10105487|FG000|COMPLETED|Overall Study||42
9044712|NCT03425253|10105487|FG000|NOT COMPLETED|Overall Study||16
9044713|NCT03425396|10105497|FG000|STARTED|Overall Study||55
9044714|NCT03425396|10105498|FG001|STARTED|Overall Study||54
9044715|NCT03425396|10105499|FG002|STARTED|Overall Study||54
9044716|NCT03425396|10105500|FG003|STARTED|Overall Study||8
9044717|NCT03425396|10105501|FG004|STARTED|Overall Study||54
9044718|NCT03425396|10105497|FG000|Completed End of Treatment Visit|Overall Study||53
9044719|NCT03425396|10105498|FG001|Completed End of Treatment Visit|Overall Study||52
9044720|NCT03425396|10105499|FG002|Completed End of Treatment Visit|Overall Study||51
9044721|NCT03425396|10105500|FG003|Completed End of Treatment Visit|Overall Study||7
9044722|NCT03425396|10105501|FG004|Completed End of Treatment Visit|Overall Study||53
9044723|NCT03425396|10105497|FG000|Completed Post-therapy Evaluation Visit|Overall Study||53
9044724|NCT03425396|10105498|FG001|Completed Post-therapy Evaluation Visit|Overall Study||49
9044725|NCT03425396|10105499|FG002|Completed Post-therapy Evaluation Visit|Overall Study||51
9044726|NCT03425396|10105500|FG003|Completed Post-therapy Evaluation Visit|Overall Study||7
9044727|NCT03425396|10105501|FG004|Completed Post-therapy Evaluation Visit|Overall Study||54
9044728|NCT03425396|10105497|FG000|Completed Final Follow-up Visit|Overall Study||53
9044729|NCT03425396|10105498|FG001|Completed Final Follow-up Visit|Overall Study||47
9044730|NCT03425396|10105499|FG002|Completed Final Follow-up Visit|Overall Study||51
9044731|NCT03425396|10105500|FG003|Completed Final Follow-up Visit|Overall Study||7
9044732|NCT03425396|10105501|FG004|Completed Final Follow-up Visit|Overall Study||53
9044733|NCT03425396|10105497|FG000|COMPLETED|Overall Study||53
9044734|NCT03425396|10105498|FG001|COMPLETED|Overall Study||47
9044735|NCT03425396|10105499|FG002|COMPLETED|Overall Study||51
9044736|NCT03425396|10105500|FG003|COMPLETED|Overall Study||7
9044737|NCT03425396|10105501|FG004|COMPLETED|Overall Study||53
9044738|NCT03425396|10105497|FG000|NOT COMPLETED|Overall Study||2
9044739|NCT03425396|10105498|FG001|NOT COMPLETED|Overall Study||7
9044740|NCT03425396|10105499|FG002|NOT COMPLETED|Overall Study||3
9044741|NCT03425396|10105500|FG003|NOT COMPLETED|Overall Study||1
9044742|NCT03425396|10105501|FG004|NOT COMPLETED|Overall Study||1
9044743|NCT03426228|10105515|FG000|STARTED|Overall Study||158
9044744|NCT03426228|10105516|FG001|STARTED|Overall Study||191
9044745|NCT03426228|10105515|FG000|COMPLETED|Overall Study||117
9044746|NCT03426228|10105516|FG001|COMPLETED|Overall Study||158
9044747|NCT03426228|10105515|FG000|NOT COMPLETED|Overall Study||41
9044748|NCT03426228|10105516|FG001|NOT COMPLETED|Overall Study||33
9044749|NCT03426267|10105526|FG000|STARTED|Overall Study||163
9044750|NCT03426267|10105527|FG001|STARTED|Overall Study||162
9044751|NCT03426267|10105526|FG000|Modified Intent-to-Treat Population|Overall Study||154
9044752|NCT03426267|10105527|FG001|Modified Intent-to-Treat Population|Overall Study||144
9044753|NCT03426267|10105526|FG000|COMPLETED|Overall Study||142
9044754|NCT03426267|10105527|FG001|COMPLETED|Overall Study||90
9044755|NCT03426267|10105526|FG000|NOT COMPLETED|Overall Study||21
9044756|NCT03426267|10105527|FG001|NOT COMPLETED|Overall Study||72
9044757|NCT03426345|10105535|FG000|STARTED|Overall Study||155
9044758|NCT03426345|10105536|FG001|STARTED|Overall Study||156
9044759|NCT03426345|10105535|FG000|Safety Population|Overall Study||152
9044760|NCT03426345|10105536|FG001|Safety Population|Overall Study||155
9044761|NCT03426345|10105535|FG000|COMPLETED|Overall Study||137
9044762|NCT03426345|10105536|FG001|COMPLETED|Overall Study||139
9044763|NCT03426345|10105535|FG000|NOT COMPLETED|Overall Study||18
9044764|NCT03426345|10105536|FG001|NOT COMPLETED|Overall Study||17
9044765|NCT03426436|10105543|FG000|STARTED|Overall Study||314
9044766|NCT03426436|10105543|FG000|COMPLETED|Overall Study||295
9044767|NCT03426436|10105543|FG000|NOT COMPLETED|Overall Study||19
9044768|NCT03426631|10105547|FG000|STARTED|Overall Study||7
9044769|NCT03426631|10105548|FG001|STARTED|Overall Study||6
9044770|NCT03426631|10105547|FG000|COMPLETED|Overall Study||7
8701969|NCT00914849|9747746|FG000|NOT COMPLETED|Overall Study||1
8701970|NCT00914849|9747747|FG001|NOT COMPLETED|Overall Study||1
8701971|NCT00914862|9747758|FG000|STARTED|Overall Study||6
8701972|NCT00914862|9747759|FG001|STARTED|Overall Study||6
8701973|NCT00914862|9747760|FG002|STARTED|Overall Study||8
8701974|NCT00914862|9747761|FG003|STARTED|Overall Study||8
8701975|NCT00914862|9747762|FG004|STARTED|Overall Study||28
8701976|NCT00914862|9747758|FG000|COMPLETED|Overall Study||6
8701977|NCT00914862|9747759|FG001|COMPLETED|Overall Study||6
8701978|NCT00914862|9747760|FG002|COMPLETED|Overall Study||8
8701979|NCT00914862|9747761|FG003|COMPLETED|Overall Study||8
8701980|NCT00914862|9747762|FG004|COMPLETED|Overall Study||28
8701981|NCT00914862|9747758|FG000|NOT COMPLETED|Overall Study||0
8701982|NCT00914862|9747759|FG001|NOT COMPLETED|Overall Study||0
8701983|NCT00914862|9747760|FG002|NOT COMPLETED|Overall Study||0
8701984|NCT00914862|9747761|FG003|NOT COMPLETED|Overall Study||0
8701985|NCT00914862|9747762|FG004|NOT COMPLETED|Overall Study||0
8701986|NCT00914927|9747781|FG000|STARTED|Overall Study||18
8701987|NCT00914927|9747782|FG001|STARTED|Overall Study||16
8701988|NCT00914927|9747783|FG002|STARTED|Overall Study||17
8701989|NCT00914927|9747784|FG003|STARTED|Overall Study||16
8701990|NCT00914927|9747785|FG004|STARTED|Overall Study||21
8701991|NCT00914927|9747786|FG005|STARTED|Overall Study||21
8701992|NCT00914927|9747787|FG006|STARTED|Overall Study||21
8701993|NCT00914927|9747781|FG000|COMPLETED|Overall Study||16
8701994|NCT00914927|9747782|FG001|COMPLETED|Overall Study||14
8701995|NCT00914927|9747783|FG002|COMPLETED|Overall Study||17
8701996|NCT00914927|9747784|FG003|COMPLETED|Overall Study||14
8701997|NCT00914927|9747785|FG004|COMPLETED|Overall Study||19
8701998|NCT00914927|9747786|FG005|COMPLETED|Overall Study||21
8701999|NCT00914927|9747787|FG006|COMPLETED|Overall Study||21
8702000|NCT00914927|9747781|FG000|NOT COMPLETED|Overall Study||2
8702001|NCT00914927|9747782|FG001|NOT COMPLETED|Overall Study||2
8702002|NCT00914927|9747783|FG002|NOT COMPLETED|Overall Study||0
8702003|NCT00914927|9747784|FG003|NOT COMPLETED|Overall Study||2
8702004|NCT00914927|9747785|FG004|NOT COMPLETED|Overall Study||2
8702005|NCT00914927|9747786|FG005|NOT COMPLETED|Overall Study||0
8702006|NCT00914927|9747787|FG006|NOT COMPLETED|Overall Study||0
8702007|NCT00914940|9747812|FG000|STARTED|D0 to D100 Post-transplant||41
8702008|NCT00914940|9747812|FG000|COMPLETED|D0 to D100 Post-transplant||39
8702009|NCT00914940|9747812|FG000|NOT COMPLETED|D0 to D100 Post-transplant||2
8702010|NCT00914940|9747812|FG000|STARTED|D101 to 2 Years Post-transplant||39
8702011|NCT00914940|9747812|FG000|COMPLETED|D101 to 2 Years Post-transplant||31
8702012|NCT00914940|9747812|FG000|NOT COMPLETED|D101 to 2 Years Post-transplant||8
8702013|NCT00914940|9747812|FG000|STARTED|2 Years to 5 Years Post-transplant||31
8702014|NCT00914940|9747812|FG000|COMPLETED|2 Years to 5 Years Post-transplant||28
8702015|NCT00914940|9747812|FG000|NOT COMPLETED|2 Years to 5 Years Post-transplant||3
8702016|NCT00914966|9747816|FG000|STARTED|Step 1: 1500 Units||20
8702017|NCT00914966|9747816|FG000|COMPLETED|Step 1: 1500 Units|5/18 subjects completing Step 1 (1500 Units) entered the 3 month follow-up and did not dose escalate|18
8702018|NCT00914966|9747816|FG000|NOT COMPLETED|Step 1: 1500 Units||2
8702019|NCT00914966|9747816|FG000|STARTED|Step 2: 2000 Units||13
8702020|NCT00914966|9747816|FG000|COMPLETED|Step 2: 2000 Units||12
8702021|NCT00914966|9747816|FG000|NOT COMPLETED|Step 2: 2000 Units||1
8702022|NCT00914966|9747816|FG000|STARTED|Step 3: 2500 Units||12
8702023|NCT00914966|9747816|FG000|COMPLETED|Step 3: 2500 Units||12
8702024|NCT00914966|9747816|FG000|NOT COMPLETED|Step 3: 2500 Units||0
8702025|NCT00915005|9747827|FG000|STARTED|Overall Study||105
8702026|NCT00915005|9747828|FG001|STARTED|Overall Study||76
8702027|NCT00915005|9747827|FG000|COMPLETED|Overall Study||92
8702028|NCT00915005|9747828|FG001|COMPLETED|Overall Study||57
8702029|NCT00915005|9747827|FG000|NOT COMPLETED|Overall Study||13
8702030|NCT00915005|9747828|FG001|NOT COMPLETED|Overall Study||19
8702031|NCT00915018|9747836|FG000|STARTED|Overall Study||242
8702032|NCT00915018|9747837|FG001|STARTED|Overall Study||237
8702033|NCT00915018|9747836|FG000|Received Treatment|Overall Study||240
8702034|NCT00915018|9747837|FG001|Received Treatment|Overall Study||234
8702035|NCT00915018|9747836|FG000|COMPLETED|Overall Study||27
8702036|NCT00915018|9747837|FG001|COMPLETED|Overall Study||30
8702037|NCT00915018|9747836|FG000|NOT COMPLETED|Overall Study||215
8702038|NCT00915018|9747837|FG001|NOT COMPLETED|Overall Study||207
8702039|NCT00915031|9747845|FG000|STARTED|Overall Study||714
8702040|NCT00915031|9747846|FG001|STARTED|Overall Study||24
8702041|NCT00915031|9747845|FG000|COMPLETED|Overall Study||714
8702042|NCT00915031|9747846|FG001|COMPLETED|Overall Study||24
8702043|NCT00915031|9747845|FG000|NOT COMPLETED|Overall Study||0
8702044|NCT00915031|9747846|FG001|NOT COMPLETED|Overall Study||0
8702045|NCT00915148|9747851|FG000|STARTED|Overall Study|October 2009|110
8702046|NCT00915148|9747851|FG000|COMPLETED|Overall Study|August 2010|110
8702047|NCT00915148|9747851|FG000|NOT COMPLETED|Overall Study||0
8702048|NCT00915278|9747862|FG000|STARTED|Overall Study||8
8702049|NCT00915278|9747863|FG001|STARTED|Overall Study||5
8702050|NCT00915278|9747864|FG002|STARTED|Overall Study||3
8702051|NCT00915278|9747865|FG003|STARTED|Overall Study||5
8702052|NCT00915278|9747866|FG004|STARTED|Overall Study||3
8702053|NCT00915278|9747867|FG005|STARTED|Overall Study||9
8702054|NCT00915278|9747862|FG000|COMPLETED|Overall Study||3
8702055|NCT00915278|9747863|FG001|COMPLETED|Overall Study||2
9044771|NCT03426631|10105548|FG001|COMPLETED|Overall Study||5
9044772|NCT03426631|10105547|FG000|NOT COMPLETED|Overall Study||0
9044773|NCT03426631|10105548|FG001|NOT COMPLETED|Overall Study||1
9044774|NCT03426787|10105554|FG000|STARTED|Overall Study||70
9044775|NCT03426787|10105554|FG000|COMPLETED|Overall Study||56
9044776|NCT03426787|10105554|FG000|NOT COMPLETED|Overall Study||14
9044777|NCT03426995|10105583|FG000|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
9044778|NCT03426995|10105584|FG001|STARTED|Part A: Cohort 1-Period 1 (Day1)||2
9044779|NCT03426995|10105585|FG002|STARTED|Part A: Cohort 1-Period 1 (Day1)||1
8702056|NCT00915278|9747864|FG002|COMPLETED|Overall Study||2
8702057|NCT00915278|9747865|FG003|COMPLETED|Overall Study||2
8702058|NCT00915278|9747866|FG004|COMPLETED|Overall Study||1
8702059|NCT00915278|9747867|FG005|COMPLETED|Overall Study||1
8702060|NCT00915278|9747862|FG000|NOT COMPLETED|Overall Study||5
8702061|NCT00915278|9747863|FG001|NOT COMPLETED|Overall Study||3
8702062|NCT00915278|9747864|FG002|NOT COMPLETED|Overall Study||1
8702063|NCT00915278|9747865|FG003|NOT COMPLETED|Overall Study||3
8702064|NCT00915278|9747866|FG004|NOT COMPLETED|Overall Study||2
8702065|NCT00915278|9747867|FG005|NOT COMPLETED|Overall Study||8
8702066|NCT00915343|9747881|FG000|STARTED|Part A - First Intervention Period||32
8702067|NCT00915343|9747882|FG001|STARTED|Part A - First Intervention Period||32
8702068|NCT00915343|9747883|FG002|STARTED|Part A - First Intervention Period||0
8702069|NCT00915343|9747881|FG000|COMPLETED|Part A - First Intervention Period||32
8702070|NCT00915343|9747882|FG001|COMPLETED|Part A - First Intervention Period||32
8702071|NCT00915343|9747883|FG002|COMPLETED|Part A - First Intervention Period||0
8702072|NCT00915343|9747881|FG000|NOT COMPLETED|Part A - First Intervention Period||0
8702073|NCT00915343|9747882|FG001|NOT COMPLETED|Part A - First Intervention Period||0
8702074|NCT00915343|9747883|FG002|NOT COMPLETED|Part A - First Intervention Period||0
8702075|NCT00915343|9747881|FG000|STARTED|Part A - Second Intervention Period||32
8702076|NCT00915343|9747882|FG001|STARTED|Part A - Second Intervention Period||32
8702077|NCT00915343|9747883|FG002|STARTED|Part A - Second Intervention Period||0
8702078|NCT00915343|9747881|FG000|COMPLETED|Part A - Second Intervention Period||32
8702079|NCT00915343|9747882|FG001|COMPLETED|Part A - Second Intervention Period||32
8702080|NCT00915343|9747883|FG002|COMPLETED|Part A - Second Intervention Period||0
8702081|NCT00915343|9747881|FG000|NOT COMPLETED|Part A - Second Intervention Period||0
8702082|NCT00915343|9747882|FG001|NOT COMPLETED|Part A - Second Intervention Period||0
8702083|NCT00915343|9747883|FG002|NOT COMPLETED|Part A - Second Intervention Period||0
8702084|NCT00915343|9747881|FG000|STARTED|Part B - Open Label Period||0
8702085|NCT00915343|9747882|FG001|STARTED|Part B - Open Label Period||0
8702086|NCT00915343|9747883|FG002|STARTED|Part B - Open Label Period||59
8702087|NCT00915343|9747881|FG000|COMPLETED|Part B - Open Label Period||0
8702088|NCT00915343|9747882|FG001|COMPLETED|Part B - Open Label Period||0
8702089|NCT00915343|9747883|FG002|COMPLETED|Part B - Open Label Period||57
8702090|NCT00915343|9747881|FG000|NOT COMPLETED|Part B - Open Label Period||0
8702091|NCT00915343|9747882|FG001|NOT COMPLETED|Part B - Open Label Period||0
8702092|NCT00915343|9747883|FG002|NOT COMPLETED|Part B - Open Label Period||2
8702093|NCT00915356|9747900|FG000|STARTED|Overall Study||26
8702094|NCT00915356|9747901|FG001|STARTED|Overall Study||45
8702095|NCT00915356|9747902|FG002|STARTED|Overall Study||45
8702096|NCT00915356|9747903|FG003|STARTED|Overall Study||12
8702097|NCT00915356|9747904|FG004|STARTED|Overall Study||43
8702098|NCT00915356|9747900|FG000|COMPLETED|Overall Study||25
8702099|NCT00915356|9747901|FG001|COMPLETED|Overall Study||45
8702100|NCT00915356|9747902|FG002|COMPLETED|Overall Study||45
8702101|NCT00915356|9747903|FG003|COMPLETED|Overall Study||12
8702102|NCT00915356|9747904|FG004|COMPLETED|Overall Study||43
8702103|NCT00915356|9747900|FG000|NOT COMPLETED|Overall Study||1
8702104|NCT00915356|9747901|FG001|NOT COMPLETED|Overall Study||0
8702105|NCT00915356|9747902|FG002|NOT COMPLETED|Overall Study||0
8702106|NCT00915356|9747903|FG003|NOT COMPLETED|Overall Study||0
8702107|NCT00915356|9747904|FG004|NOT COMPLETED|Overall Study||0
8702108|NCT00915473|9747918|FG000|STARTED|Screening||35
8702109|NCT00915473|9747919|FG001|STARTED|Screening||35
8702110|NCT00915473|9747918|FG000|COMPLETED|Screening||34
8702111|NCT00915473|9747919|FG001|COMPLETED|Screening||35
8702112|NCT00915473|9747918|FG000|NOT COMPLETED|Screening||1
8702113|NCT00915473|9747919|FG001|NOT COMPLETED|Screening||0
8702114|NCT00915473|9747918|FG000|STARTED|Injection||34
8702115|NCT00915473|9747919|FG001|STARTED|Injection||35
8702116|NCT00915473|9747918|FG000|COMPLETED|Injection||34
8702117|NCT00915473|9747919|FG001|COMPLETED|Injection||35
8702118|NCT00915473|9747918|FG000|NOT COMPLETED|Injection||0
8702119|NCT00915473|9747919|FG001|NOT COMPLETED|Injection||0
8702120|NCT00915473|9747918|FG000|STARTED|4-week Follow Up||34
9044780|NCT03426995|10105586|FG003|STARTED|Part A: Cohort 1-Period 1 (Day1)||2
9044781|NCT03426995|10105587|FG004|STARTED|Part A: Cohort 1-Period 1 (Day1)||1
8702121|NCT00915473|9747919|FG001|STARTED|4-week Follow Up||35
8702122|NCT00915473|9747918|FG000|COMPLETED|4-week Follow Up||33
8702123|NCT00915473|9747919|FG001|COMPLETED|4-week Follow Up||30
8702124|NCT00915473|9747918|FG000|NOT COMPLETED|4-week Follow Up||1
8702125|NCT00915473|9747919|FG001|NOT COMPLETED|4-week Follow Up||5
8702126|NCT00915499|9747927|FG000|STARTED|Overall Study||33
8702127|NCT00915499|9747928|FG001|STARTED|Overall Study||33
8702128|NCT00915499|9747927|FG000|COMPLETED|Overall Study||29
8702129|NCT00915499|9747928|FG001|COMPLETED|Overall Study||31
8702130|NCT00915499|9747927|FG000|NOT COMPLETED|Overall Study||4
8702131|NCT00915499|9747928|FG001|NOT COMPLETED|Overall Study||2
8702132|NCT00915525|9747936|FG000|STARTED|Overall Study||543
8702133|NCT00915525|9747937|FG001|STARTED|Overall Study||286
8702134|NCT00915525|9747936|FG000|COMPLETED|Overall Study||278
8702135|NCT00915525|9747937|FG001|COMPLETED|Overall Study||151
8702136|NCT00915525|9747936|FG000|NOT COMPLETED|Overall Study||265
8702137|NCT00915525|9747937|FG001|NOT COMPLETED|Overall Study||135
8702138|NCT00915538|9747965|FG000|STARTED|Overall Study||8
8702139|NCT00915538|9747966|FG001|STARTED|Overall Study||8
8702140|NCT00915538|9747965|FG000|COMPLETED|Overall Study||8
8702141|NCT00915538|9747966|FG001|COMPLETED|Overall Study||8
8702142|NCT00915538|9747965|FG000|NOT COMPLETED|Overall Study||0
8702143|NCT00915538|9747966|FG001|NOT COMPLETED|Overall Study||0
8702144|NCT00915551|9747976|FG000|STARTED|Overall Study||142
8702145|NCT00915551|9747977|FG001|STARTED|Overall Study||136
8702146|NCT00915551|9747976|FG000|COMPLETED|Overall Study||142
8702147|NCT00915551|9747977|FG001|COMPLETED|Overall Study||135
8702148|NCT00915551|9747976|FG000|NOT COMPLETED|Overall Study||0
8702149|NCT00915551|9747977|FG001|NOT COMPLETED|Overall Study||1
8702150|NCT00915590|9747985|FG000|STARTED|Overall Study||5
8702151|NCT00915590|9747986|FG001|STARTED|Overall Study||5
8702152|NCT00915590|9747985|FG000|COMPLETED|Overall Study||3
8702153|NCT00915590|9747986|FG001|COMPLETED|Overall Study||4
8702154|NCT00915590|9747985|FG000|NOT COMPLETED|Overall Study||2
8702155|NCT00915590|9747986|FG001|NOT COMPLETED|Overall Study||1
8702156|NCT00915603|9747999|FG000|STARTED|Overall Study|One patient enrolled/randomized but did not start treatment|56
8702157|NCT00915603|9748000|FG001|STARTED|Overall Study|One patient enrolled/randomized but did not start treatment|55
8702158|NCT00915603|9747999|FG000|COMPLETED|Overall Study||0
8702159|NCT00915603|9748000|FG001|COMPLETED|Overall Study||0
8702160|NCT00915603|9747999|FG000|NOT COMPLETED|Overall Study||56
8702161|NCT00915603|9748000|FG001|NOT COMPLETED|Overall Study||55
8702162|NCT00915655|9748006|FG000|STARTED|Overall Study||12
8702163|NCT00915655|9748006|FG000|COMPLETED|Overall Study|'Completed' represents patients who have not discontinued at time of cut-off for Week 24 analysis|12
8702164|NCT00915655|9748006|FG000|NOT COMPLETED|Overall Study||0
8702165|NCT00915759|9748010|FG000|STARTED|Overall Study|number of participants|40
8702166|NCT00915759|9748010|FG000|COMPLETED|Overall Study|number of participants|40
8702167|NCT00915759|9748010|FG000|NOT COMPLETED|Overall Study||0
8702168|NCT00915772|9748023|FG000|STARTED|Overall Study||170
8702169|NCT00915772|9748024|FG001|STARTED|Overall Study||225
8702170|NCT00915772|9748025|FG002|STARTED|Overall Study||171
8702171|NCT00915772|9748023|FG000|COMPLETED|Overall Study||134
8702172|NCT00915772|9748024|FG001|COMPLETED|Overall Study||179
8702173|NCT00915772|9748025|FG002|COMPLETED|Overall Study||142
8702174|NCT00915772|9748023|FG000|NOT COMPLETED|Overall Study||36
8702175|NCT00915772|9748024|FG001|NOT COMPLETED|Overall Study||46
8702176|NCT00915772|9748025|FG002|NOT COMPLETED|Overall Study||29
8702177|NCT00915798|9748038|FG000|STARTED|Overall Study||19
8702178|NCT00915798|9748039|FG001|STARTED|Overall Study||21
8702179|NCT00915798|9748040|FG002|STARTED|Overall Study||23
8702180|NCT00915798|9748041|FG003|STARTED|Overall Study||26
8702181|NCT00915798|9748038|FG000|COMPLETED|Overall Study||19
8702182|NCT00915798|9748039|FG001|COMPLETED|Overall Study||21
8702183|NCT00915798|9748040|FG002|COMPLETED|Overall Study||23
8702184|NCT00915798|9748041|FG003|COMPLETED|Overall Study||26
8702185|NCT00915798|9748038|FG000|NOT COMPLETED|Overall Study||0
8702186|NCT00915798|9748039|FG001|NOT COMPLETED|Overall Study||0
8702187|NCT00915798|9748040|FG002|NOT COMPLETED|Overall Study||0
8702188|NCT00915798|9748041|FG003|NOT COMPLETED|Overall Study||0
8702189|NCT00915876|9748063|FG000|STARTED|Overall Study||20
8702190|NCT00915876|9748064|FG001|STARTED|Overall Study||21
8702191|NCT00915876|9748063|FG000|Moving Beyond First Dose|Overall Study||20
8702192|NCT00915876|9748064|FG001|Moving Beyond First Dose|Overall Study||20
8702193|NCT00915876|9748063|FG000|COMPLETED|Overall Study||20
8702194|NCT00915876|9748064|FG001|COMPLETED|Overall Study||20
8702195|NCT00915876|9748063|FG000|NOT COMPLETED|Overall Study||0
8702196|NCT00915876|9748064|FG001|NOT COMPLETED|Overall Study||1
8702197|NCT00915902|9748072|FG000|STARTED|1st Treatment Period||20
8702198|NCT00915902|9748073|FG001|STARTED|1st Treatment Period||22
8702199|NCT00915902|9748072|FG000|COMPLETED|1st Treatment Period||19
8702200|NCT00915902|9748073|FG001|COMPLETED|1st Treatment Period||22
8702201|NCT00915902|9748072|FG000|NOT COMPLETED|1st Treatment Period||1
8702202|NCT00915902|9748073|FG001|NOT COMPLETED|1st Treatment Period||0
8702203|NCT00915902|9748072|FG000|STARTED|Washout (4 Weeks)||19
8702204|NCT00915902|9748073|FG001|STARTED|Washout (4 Weeks)||22
8702205|NCT00915902|9748072|FG000|COMPLETED|Washout (4 Weeks)||19
8702206|NCT00915902|9748073|FG001|COMPLETED|Washout (4 Weeks)||21
8702207|NCT00915902|9748072|FG000|NOT COMPLETED|Washout (4 Weeks)||0
8702208|NCT00915902|9748073|FG001|NOT COMPLETED|Washout (4 Weeks)||1
8702209|NCT00915902|9748072|FG000|STARTED|2nd Treatment Period||19
8702210|NCT00915902|9748073|FG001|STARTED|2nd Treatment Period||21
8702211|NCT00915902|9748072|FG000|COMPLETED|2nd Treatment Period||19
8702212|NCT00915902|9748073|FG001|COMPLETED|2nd Treatment Period||20
8702213|NCT00915902|9748072|FG000|NOT COMPLETED|2nd Treatment Period||0
8702214|NCT00915902|9748073|FG001|NOT COMPLETED|2nd Treatment Period||1
8702215|NCT00915928|9748083|FG000|STARTED|Overall Study||25
8702216|NCT00915928|9748084|FG001|STARTED|Overall Study||22
8702217|NCT00915928|9748083|FG000|COMPLETED|Overall Study||25
8702218|NCT00915928|9748084|FG001|COMPLETED|Overall Study||22
8702219|NCT00915928|9748083|FG000|NOT COMPLETED|Overall Study||0
8702220|NCT00915928|9748084|FG001|NOT COMPLETED|Overall Study||0
8702221|NCT00915954|9748094|FG000|STARTED|Overall Study||10
9044782|NCT03426995|10105588|FG005|STARTED|Part A: Cohort 1-Period 1 (Day1)||1
9044783|NCT03426995|10105589|FG006|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
9044784|NCT03426995|10105590|FG007|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
9044785|NCT03426995|10105591|FG008|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
9044786|NCT03426995|10105592|FG009|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
9044787|NCT03426995|10105593|FG010|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
9044788|NCT03426995|10105594|FG011|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
9044789|NCT03426995|10105595|FG012|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
9044790|NCT03426995|10105596|FG013|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
9044791|NCT03426995|10105597|FG014|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
9044792|NCT03426995|10105598|FG015|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
9044793|NCT03426995|10105599|FG016|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
9044794|NCT03426995|10105600|FG017|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
9044795|NCT03426995|10105601|FG018|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
9044796|NCT03426995|10105583|FG000|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
9044797|NCT03426995|10105584|FG001|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||2
9044798|NCT03426995|10105585|FG002|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
9044799|NCT03426995|10105586|FG003|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||2
9044800|NCT03426995|10105587|FG004|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||1
9044801|NCT03426995|10105588|FG005|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||1
9044802|NCT03426995|10105589|FG006|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
9044803|NCT03426995|10105590|FG007|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
9044804|NCT03426995|10105591|FG008|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
9044805|NCT03426995|10105592|FG009|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
9044806|NCT03426995|10105593|FG010|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
9044807|NCT03426995|10105594|FG011|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
9044808|NCT03426995|10105595|FG012|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
9044809|NCT03426995|10105596|FG013|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
9044810|NCT03426995|10105597|FG014|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
9044811|NCT03426995|10105598|FG015|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
9044812|NCT03426995|10105599|FG016|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
9044813|NCT03426995|10105600|FG017|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
9044814|NCT03426995|10105601|FG018|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
9044815|NCT03426995|10105583|FG000|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
9044816|NCT03426995|10105584|FG001|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
9044817|NCT03426995|10105585|FG002|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||1
9044818|NCT03426995|10105586|FG003|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
9044819|NCT03426995|10105587|FG004|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
9044820|NCT03426995|10105588|FG005|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
9044821|NCT03426995|10105589|FG006|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
9044822|NCT03426995|10105590|FG007|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
9044823|NCT03426995|10105591|FG008|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
8702222|NCT00915954|9748095|FG001|STARTED|Overall Study||8
8702223|NCT00915954|9748096|FG002|STARTED|Overall Study||10
9044824|NCT03426995|10105592|FG009|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
9044825|NCT03426995|10105593|FG010|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
9044826|NCT03426995|10105594|FG011|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
9044827|NCT03426995|10105595|FG012|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
9044828|NCT03426995|10105596|FG013|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
9044829|NCT03426995|10105597|FG014|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
9044830|NCT03426995|10105598|FG015|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
9044831|NCT03426995|10105599|FG016|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
9044832|NCT03426995|10105600|FG017|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
9044833|NCT03426995|10105601|FG018|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
9044834|NCT03426995|10105583|FG000|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
9044835|NCT03426995|10105584|FG001|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||2
9044836|NCT03426995|10105585|FG002|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
9044837|NCT03426995|10105586|FG003|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||2
9044838|NCT03426995|10105587|FG004|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||1
9044839|NCT03426995|10105588|FG005|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||1
9044840|NCT03426995|10105589|FG006|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
9044841|NCT03426995|10105590|FG007|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
9044842|NCT03426995|10105591|FG008|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
9044843|NCT03426995|10105592|FG009|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
9044844|NCT03426995|10105593|FG010|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
9044845|NCT03426995|10105594|FG011|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
9044846|NCT03426995|10105595|FG012|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
9044847|NCT03426995|10105596|FG013|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
9044848|NCT03426995|10105597|FG014|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
9044849|NCT03426995|10105598|FG015|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
9044850|NCT03426995|10105599|FG016|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
9044851|NCT03426995|10105600|FG017|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
9044852|NCT03426995|10105601|FG018|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
9044853|NCT03426995|10105583|FG000|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
9044854|NCT03426995|10105584|FG001|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||2
8702224|NCT00915954|9748094|FG000|COMPLETED|Overall Study||10
9044855|NCT03426995|10105585|FG002|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
9044856|NCT03426995|10105586|FG003|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||2
9044857|NCT03426995|10105587|FG004|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||1
9044858|NCT03426995|10105588|FG005|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||1
9044859|NCT03426995|10105589|FG006|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
9044860|NCT03426995|10105590|FG007|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
9044861|NCT03426995|10105591|FG008|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
9044862|NCT03426995|10105592|FG009|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
9044863|NCT03426995|10105593|FG010|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
9044864|NCT03426995|10105594|FG011|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
9044865|NCT03426995|10105595|FG012|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
9044866|NCT03426995|10105596|FG013|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
9044867|NCT03426995|10105597|FG014|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
9044868|NCT03426995|10105598|FG015|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
9044869|NCT03426995|10105599|FG016|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
9044870|NCT03426995|10105600|FG017|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
9044871|NCT03426995|10105601|FG018|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
9044872|NCT03426995|10105583|FG000|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
9044873|NCT03426995|10105584|FG001|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
9044874|NCT03426995|10105585|FG002|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8702225|NCT00915954|9748095|FG001|COMPLETED|Overall Study||8
8702226|NCT00915954|9748096|FG002|COMPLETED|Overall Study||10
8702227|NCT00915954|9748094|FG000|NOT COMPLETED|Overall Study||0
8702228|NCT00915954|9748095|FG001|NOT COMPLETED|Overall Study||0
8702229|NCT00915954|9748096|FG002|NOT COMPLETED|Overall Study||0
8702230|NCT00915967|9748106|FG000|STARTED|Overall Study||98
8702231|NCT00915967|9748107|FG001|STARTED|Overall Study||100
8702232|NCT00915967|9748106|FG000|COMPLETED|Overall Study||97
8702233|NCT00915967|9748107|FG001|COMPLETED|Overall Study||98
8702234|NCT00915967|9748106|FG000|NOT COMPLETED|Overall Study||1
8702235|NCT00915967|9748107|FG001|NOT COMPLETED|Overall Study||2
8702236|NCT00916006|9748115|FG000|STARTED|Overall Study||135
8702237|NCT00916006|9748116|FG001|STARTED|Overall Study||134
8702238|NCT00916006|9748115|FG000|COMPLETED|Overall Study||132
8702239|NCT00916006|9748116|FG001|COMPLETED|Overall Study||127
8702240|NCT00916006|9748115|FG000|NOT COMPLETED|Overall Study||3
8702241|NCT00916006|9748116|FG001|NOT COMPLETED|Overall Study||7
8702242|NCT00916032|9748122|FG000|STARTED|Overall Study||12
8702243|NCT00916032|9748123|FG001|STARTED|Overall Study||11
8702244|NCT00916032|9748122|FG000|COMPLETED|Overall Study||12
8702245|NCT00916032|9748123|FG001|COMPLETED|Overall Study||11
8702246|NCT00916032|9748122|FG000|NOT COMPLETED|Overall Study||0
8702247|NCT00916032|9748123|FG001|NOT COMPLETED|Overall Study||0
8702248|NCT00916058|9748136|FG000|STARTED|Phase 1||3
8702249|NCT00916058|9748137|FG001|STARTED|Phase 1||6
8702250|NCT00916058|9748138|FG002|STARTED|Phase 1||3
8702251|NCT00916058|9748139|FG003|STARTED|Phase 1||3
8702252|NCT00916058|9748140|FG004|STARTED|Phase 1||3
8702253|NCT00916058|9748141|FG005|STARTED|Phase 1||8
8702254|NCT00916058|9748142|FG006|STARTED|Phase 1||0
8702255|NCT00916058|9748136|FG000|COMPLETED|Phase 1||3
8702256|NCT00916058|9748137|FG001|COMPLETED|Phase 1||6
8702257|NCT00916058|9748138|FG002|COMPLETED|Phase 1||3
8702258|NCT00916058|9748139|FG003|COMPLETED|Phase 1||3
8702259|NCT00916058|9748140|FG004|COMPLETED|Phase 1||3
8702260|NCT00916058|9748141|FG005|COMPLETED|Phase 1||7
8702261|NCT00916058|9748142|FG006|COMPLETED|Phase 1||0
9044875|NCT03426995|10105586|FG003|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
9044876|NCT03426995|10105587|FG004|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
9044877|NCT03426995|10105588|FG005|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
9044878|NCT03426995|10105589|FG006|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
9044879|NCT03426995|10105590|FG007|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
9044880|NCT03426995|10105591|FG008|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
9044881|NCT03426995|10105592|FG009|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
9044882|NCT03426995|10105593|FG010|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
9044883|NCT03426995|10105594|FG011|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
9044884|NCT03426995|10105595|FG012|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
9044885|NCT03426995|10105596|FG013|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
9044886|NCT03426995|10105597|FG014|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
9044887|NCT03426995|10105598|FG015|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8702262|NCT00916058|9748136|FG000|NOT COMPLETED|Phase 1||0
8702263|NCT00916058|9748137|FG001|NOT COMPLETED|Phase 1||0
8702264|NCT00916058|9748138|FG002|NOT COMPLETED|Phase 1||0
8702265|NCT00916058|9748139|FG003|NOT COMPLETED|Phase 1||0
8702266|NCT00916058|9748140|FG004|NOT COMPLETED|Phase 1||0
8702267|NCT00916058|9748141|FG005|NOT COMPLETED|Phase 1||1
8702268|NCT00916058|9748142|FG006|NOT COMPLETED|Phase 1||0
8702269|NCT00916058|9748136|FG000|STARTED|Phase 2||0
8702270|NCT00916058|9748137|FG001|STARTED|Phase 2||0
8702271|NCT00916058|9748138|FG002|STARTED|Phase 2||0
8702272|NCT00916058|9748139|FG003|STARTED|Phase 2||0
8702273|NCT00916058|9748140|FG004|STARTED|Phase 2||0
8702274|NCT00916058|9748141|FG005|STARTED|Phase 2||0
8702275|NCT00916058|9748142|FG006|STARTED|Phase 2||31
8702276|NCT00916058|9748136|FG000|COMPLETED|Phase 2||0
9044888|NCT03426995|10105599|FG016|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
9044889|NCT03426995|10105600|FG017|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
9044890|NCT03426995|10105601|FG018|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
9044891|NCT03426995|10105583|FG000|STARTED|Part A: Cohort 1-Period 2 (Day1)|New participant enrolled and dosed.|1
9044892|NCT03426995|10105584|FG001|STARTED|Part A: Cohort 1-Period 2 (Day1)||2
9044893|NCT03426995|10105585|FG002|STARTED|Part A: Cohort 1-Period 2 (Day1)|New participant enrolled and dosed.|1
9044894|NCT03426995|10105586|FG003|STARTED|Part A: Cohort 1-Period 2 (Day1)||2
9044895|NCT03426995|10105587|FG004|STARTED|Part A: Cohort 1-Period 2 (Day1)||1
9044896|NCT03426995|10105588|FG005|STARTED|Part A: Cohort 1-Period 2 (Day1)|Two additional participants were enrolled and dosed.|3
9044897|NCT03426995|10105589|FG006|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
9044898|NCT03426995|10105590|FG007|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
9044899|NCT03426995|10105591|FG008|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
9044900|NCT03426995|10105592|FG009|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
9044901|NCT03426995|10105593|FG010|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
9044902|NCT03426995|10105594|FG011|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
9044903|NCT03426995|10105595|FG012|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
9044904|NCT03426995|10105596|FG013|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
9044905|NCT03426995|10105597|FG014|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
9044906|NCT03426995|10105598|FG015|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
9044907|NCT03426995|10105599|FG016|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
9044908|NCT03426995|10105600|FG017|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
9044909|NCT03426995|10105601|FG018|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
9044910|NCT03426995|10105583|FG000|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||1
9044911|NCT03426995|10105584|FG001|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||2
8702277|NCT00916058|9748137|FG001|COMPLETED|Phase 2||0
8702278|NCT00916058|9748138|FG002|COMPLETED|Phase 2||0
9044912|NCT03426995|10105585|FG002|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||1
9044913|NCT03426995|10105586|FG003|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||2
9044914|NCT03426995|10105587|FG004|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
9044915|NCT03426995|10105588|FG005|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||1
9044916|NCT03426995|10105589|FG006|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
9044917|NCT03426995|10105590|FG007|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
9044918|NCT03426995|10105591|FG008|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
9044919|NCT03426995|10105592|FG009|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
9044920|NCT03426995|10105593|FG010|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
9044921|NCT03426995|10105594|FG011|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
9044922|NCT03426995|10105595|FG012|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
9044923|NCT03426995|10105596|FG013|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
9044924|NCT03426995|10105597|FG014|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
9044925|NCT03426995|10105598|FG015|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
9044926|NCT03426995|10105599|FG016|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
9044927|NCT03426995|10105600|FG017|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
9044928|NCT03426995|10105601|FG018|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
9044929|NCT03426995|10105583|FG000|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
9044930|NCT03426995|10105584|FG001|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
9044931|NCT03426995|10105585|FG002|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
9044932|NCT03426995|10105586|FG003|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
9044933|NCT03426995|10105587|FG004|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||1
9044934|NCT03426995|10105588|FG005|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||2
9044935|NCT03426995|10105589|FG006|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
9044936|NCT03426995|10105590|FG007|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
9044937|NCT03426995|10105591|FG008|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
9044938|NCT03426995|10105592|FG009|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
9044939|NCT03426995|10105593|FG010|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
9044940|NCT03426995|10105594|FG011|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
9044941|NCT03426995|10105595|FG012|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
9044942|NCT03426995|10105596|FG013|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
9044943|NCT03426995|10105597|FG014|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
9044944|NCT03426995|10105598|FG015|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
9044945|NCT03426995|10105599|FG016|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
9044946|NCT03426995|10105600|FG017|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
9044947|NCT03426995|10105601|FG018|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
9044948|NCT03426995|10105583|FG000|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||1
9044949|NCT03426995|10105584|FG001|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||2
9044950|NCT03426995|10105585|FG002|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||1
9044951|NCT03426995|10105586|FG003|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||2
9044952|NCT03426995|10105587|FG004|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
9044953|NCT03426995|10105588|FG005|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||1
9044954|NCT03426995|10105589|FG006|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
9044955|NCT03426995|10105590|FG007|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
9044956|NCT03426995|10105591|FG008|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
9044957|NCT03426995|10105592|FG009|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
9044958|NCT03426995|10105593|FG010|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8702279|NCT00916058|9748139|FG003|COMPLETED|Phase 2||0
8702280|NCT00916058|9748140|FG004|COMPLETED|Phase 2||0
9044959|NCT03426995|10105594|FG011|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
9044960|NCT03426995|10105595|FG012|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
9044961|NCT03426995|10105596|FG013|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
9044962|NCT03426995|10105597|FG014|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
9044963|NCT03426995|10105598|FG015|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8702281|NCT00916058|9748141|FG005|COMPLETED|Phase 2||0
8702282|NCT00916058|9748142|FG006|COMPLETED|Phase 2||28
8702283|NCT00916058|9748136|FG000|NOT COMPLETED|Phase 2||0
8702284|NCT00916058|9748137|FG001|NOT COMPLETED|Phase 2||0
8702285|NCT00916058|9748138|FG002|NOT COMPLETED|Phase 2||0
8702286|NCT00916058|9748139|FG003|NOT COMPLETED|Phase 2||0
8702287|NCT00916058|9748140|FG004|NOT COMPLETED|Phase 2||0
8702288|NCT00916058|9748141|FG005|NOT COMPLETED|Phase 2||0
8702289|NCT00916058|9748142|FG006|NOT COMPLETED|Phase 2||3
8702290|NCT00916136|9748162|FG000|STARTED|Overall Study||37
8702291|NCT00916136|9748163|FG001|STARTED|Overall Study||29
8702292|NCT00916136|9748162|FG000|COMPLETED|Overall Study||37
8702293|NCT00916136|9748163|FG001|COMPLETED|Overall Study||29
8702294|NCT00916136|9748162|FG000|NOT COMPLETED|Overall Study||0
8702295|NCT00916136|9748163|FG001|NOT COMPLETED|Overall Study||0
8702296|NCT00916149|9748172|FG000|STARTED|Overall Study||16
8702297|NCT00916149|9748173|FG001|STARTED|Overall Study||10
8702298|NCT00916149|9748174|FG002|STARTED|Overall Study||5
8702299|NCT00916149|9748172|FG000|COMPLETED|Overall Study||12
8702300|NCT00916149|9748173|FG001|COMPLETED|Overall Study||8
8812640|NCT01520909|9865661|FG002|COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||80
8812641|NCT01520909|9865659|FG000|NOT COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
8812642|NCT01520909|9865660|FG001|NOT COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
8812643|NCT01520909|9865661|FG002|NOT COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||7
8812644|NCT01520922|9865683|FG000|STARTED|Treatment Phase||44
8812645|NCT01520922|9865684|FG001|STARTED|Treatment Phase||53
8812646|NCT01520922|9865683|FG000|COMPLETED|Treatment Phase|Completed 6 Cycles of Study Treatment|39
8812647|NCT01520922|9865684|FG001|COMPLETED|Treatment Phase|Completed 6 Cycles of Study Treatment|45
8812648|NCT01520922|9865683|FG000|NOT COMPLETED|Treatment Phase||5
8812649|NCT01520922|9865684|FG001|NOT COMPLETED|Treatment Phase||8
8812650|NCT01520922|9865683|FG000|STARTED|Follow up||44
8812651|NCT01520922|9865684|FG001|STARTED|Follow up||45
8812652|NCT01520922|9865683|FG000|COMPLETED|Follow up||44
8812653|NCT01520922|9865684|FG001|COMPLETED|Follow up||44
8812654|NCT01520922|9865683|FG000|NOT COMPLETED|Follow up||0
8812655|NCT01520922|9865684|FG001|NOT COMPLETED|Follow up||1
8812656|NCT01520922|9865683|FG000|STARTED|Survival Follow-up||21
8812657|NCT01520922|9865684|FG001|STARTED|Survival Follow-up||40
8812658|NCT01520922|9865683|FG000|COMPLETED|Survival Follow-up||20
8812659|NCT01520922|9865684|FG001|COMPLETED|Survival Follow-up||40
8812660|NCT01520922|9865683|FG000|NOT COMPLETED|Survival Follow-up||1
8812661|NCT01520922|9865684|FG001|NOT COMPLETED|Survival Follow-up||0
8812662|NCT01520987|9865698|FG000|STARTED|Overall Study||13
8812663|NCT01520987|9865699|FG001|STARTED|Overall Study||12
8812664|NCT01520987|9865700|FG002|STARTED|Overall Study||11
8812665|NCT01520987|9865701|FG003|STARTED|Overall Study||15
8812666|NCT01520987|9865702|FG004|STARTED|Overall Study||14
8812667|NCT01520987|9865703|FG005|STARTED|Overall Study||14
8812668|NCT01520987|9865704|FG006|STARTED|Overall Study||12
8812669|NCT01520987|9865705|FG007|STARTED|Overall Study||14
8812670|NCT01520987|9865698|FG000|Dosed|Overall Study||13
8812671|NCT01520987|9865699|FG001|Dosed|Overall Study||12
8812672|NCT01520987|9865700|FG002|Dosed|Overall Study||11
8812673|NCT01520987|9865701|FG003|Dosed|Overall Study||15
8812674|NCT01520987|9865702|FG004|Dosed|Overall Study||14
8812675|NCT01520987|9865703|FG005|Dosed|Overall Study||14
8812676|NCT01520987|9865704|FG006|Dosed|Overall Study||12
8812677|NCT01520987|9865705|FG007|Dosed|Overall Study||14
8812678|NCT01520987|9865698|FG000|COMPLETED|Overall Study||12
8812679|NCT01520987|9865699|FG001|COMPLETED|Overall Study||12
8812680|NCT01520987|9865700|FG002|COMPLETED|Overall Study||11
8812681|NCT01520987|9865701|FG003|COMPLETED|Overall Study||15
8812682|NCT01520987|9865702|FG004|COMPLETED|Overall Study||14
8812683|NCT01520987|9865703|FG005|COMPLETED|Overall Study||13
8812684|NCT01520987|9865704|FG006|COMPLETED|Overall Study||12
8812685|NCT01520987|9865705|FG007|COMPLETED|Overall Study||14
8812686|NCT01520987|9865698|FG000|NOT COMPLETED|Overall Study||1
8812687|NCT01520987|9865699|FG001|NOT COMPLETED|Overall Study||0
8812688|NCT01520987|9865700|FG002|NOT COMPLETED|Overall Study||0
8812689|NCT01520987|9865701|FG003|NOT COMPLETED|Overall Study||0
9044964|NCT03426995|10105599|FG016|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
9044965|NCT03426995|10105600|FG017|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8702301|NCT00916149|9748174|FG002|COMPLETED|Overall Study||5
8702302|NCT00916149|9748172|FG000|NOT COMPLETED|Overall Study||4
8702303|NCT00916149|9748173|FG001|NOT COMPLETED|Overall Study||2
8702304|NCT00916149|9748174|FG002|NOT COMPLETED|Overall Study||0
8702305|NCT00916279|9748181|FG000|STARTED|Overall Study||41
8702306|NCT00916279|9748181|FG000|30 Days|Overall Study||41
8702307|NCT00916279|9748181|FG000|6 Months|Overall Study||41
8702308|NCT00916279|9748181|FG000|24 Months|Overall Study||37
8702309|NCT00916279|9748181|FG000|COMPLETED|Overall Study||37
8812690|NCT01520987|9865702|FG004|NOT COMPLETED|Overall Study||0
8812691|NCT01520987|9865703|FG005|NOT COMPLETED|Overall Study||1
8812692|NCT01520987|9865704|FG006|NOT COMPLETED|Overall Study||0
8812693|NCT01520987|9865705|FG007|NOT COMPLETED|Overall Study||0
9044966|NCT03426995|10105601|FG018|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
9044967|NCT03426995|10105583|FG000|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||1
9044968|NCT03426995|10105584|FG001|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||2
9044969|NCT03426995|10105585|FG002|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||1
9044970|NCT03426995|10105586|FG003|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||2
9044971|NCT03426995|10105587|FG004|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
9044972|NCT03426995|10105588|FG005|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||1
9044973|NCT03426995|10105589|FG006|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
9044974|NCT03426995|10105590|FG007|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
9044975|NCT03426995|10105591|FG008|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
9044976|NCT03426995|10105592|FG009|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
9044977|NCT03426995|10105593|FG010|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
9044978|NCT03426995|10105594|FG011|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
9044979|NCT03426995|10105595|FG012|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
9044980|NCT03426995|10105596|FG013|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
9044981|NCT03426995|10105597|FG014|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
9044982|NCT03426995|10105598|FG015|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
9044983|NCT03426995|10105599|FG016|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
9044984|NCT03426995|10105600|FG017|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
9044985|NCT03426995|10105601|FG018|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
9044986|NCT03426995|10105583|FG000|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
9044987|NCT03426995|10105584|FG001|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
9044988|NCT03426995|10105585|FG002|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
9044989|NCT03426995|10105586|FG003|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
9044990|NCT03426995|10105587|FG004|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
9044991|NCT03426995|10105588|FG005|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
9044992|NCT03426995|10105589|FG006|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
9044993|NCT03426995|10105590|FG007|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
9044994|NCT03426995|10105591|FG008|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
9044995|NCT03426995|10105592|FG009|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
9044996|NCT03426995|10105593|FG010|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
9044997|NCT03426995|10105594|FG011|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
9044998|NCT03426995|10105595|FG012|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
9044999|NCT03426995|10105596|FG013|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
9045000|NCT03426995|10105597|FG014|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
9045001|NCT03426995|10105598|FG015|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
9045002|NCT03426995|10105599|FG016|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
9045003|NCT03426995|10105600|FG017|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
9045004|NCT03426995|10105601|FG018|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
9045005|NCT03426995|10105583|FG000|STARTED|Part A: Cohort 1-Period 3 (Day1)||1
9045006|NCT03426995|10105584|FG001|STARTED|Part A: Cohort 1-Period 3 (Day1)||2
9045007|NCT03426995|10105585|FG002|STARTED|Part A: Cohort 1-Period 3 (Day1)||1
9045008|NCT03426995|10105586|FG003|STARTED|Part A: Cohort 1-Period 3 (Day1)||2
9045009|NCT03426995|10105587|FG004|STARTED|Part A: Cohort 1-Period 3 (Day1)|New participant enrolled and dosed.|1
9045010|NCT03426995|10105588|FG005|STARTED|Part A: Cohort 1-Period 3 (Day1)|New participant enrolled and dosed.|2
9045011|NCT03426995|10105589|FG006|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
9045012|NCT03426995|10105590|FG007|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
9045013|NCT03426995|10105591|FG008|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
9045014|NCT03426995|10105592|FG009|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
9045015|NCT03426995|10105593|FG010|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
9045016|NCT03426995|10105594|FG011|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
9045017|NCT03426995|10105595|FG012|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
9045018|NCT03426995|10105596|FG013|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
9045019|NCT03426995|10105597|FG014|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
9045020|NCT03426995|10105598|FG015|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
9045021|NCT03426995|10105599|FG016|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
9045022|NCT03426995|10105600|FG017|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
9045023|NCT03426995|10105601|FG018|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
9045024|NCT03426995|10105583|FG000|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||1
9045025|NCT03426995|10105584|FG001|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||2
9045026|NCT03426995|10105585|FG002|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||1
9045027|NCT03426995|10105586|FG003|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||2
9045028|NCT03426995|10105587|FG004|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||1
9045029|NCT03426995|10105588|FG005|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||2
9045030|NCT03426995|10105589|FG006|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
9045031|NCT03426995|10105590|FG007|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
9045032|NCT03426995|10105591|FG008|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
9045033|NCT03426995|10105592|FG009|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
9045034|NCT03426995|10105593|FG010|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
9045035|NCT03426995|10105594|FG011|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
9045036|NCT03426995|10105595|FG012|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
9045037|NCT03426995|10105596|FG013|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
9045038|NCT03426995|10105597|FG014|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
9045039|NCT03426995|10105598|FG015|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
9045040|NCT03426995|10105599|FG016|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
9045041|NCT03426995|10105600|FG017|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
9045042|NCT03426995|10105601|FG018|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
9045043|NCT03426995|10105583|FG000|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
9045044|NCT03426995|10105584|FG001|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
9045045|NCT03426995|10105585|FG002|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
9045046|NCT03426995|10105586|FG003|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
9045047|NCT03426995|10105587|FG004|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
9045048|NCT03426995|10105588|FG005|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
9045049|NCT03426995|10105589|FG006|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
9045050|NCT03426995|10105590|FG007|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
9045051|NCT03426995|10105591|FG008|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
9045052|NCT03426995|10105592|FG009|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
9045053|NCT03426995|10105593|FG010|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
9045054|NCT03426995|10105594|FG011|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
9045055|NCT03426995|10105595|FG012|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
9045056|NCT03426995|10105596|FG013|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
9045057|NCT03426995|10105597|FG014|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
9045058|NCT03426995|10105598|FG015|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
9045059|NCT03426995|10105599|FG016|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
9045060|NCT03426995|10105600|FG017|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
9045061|NCT03426995|10105601|FG018|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
9045062|NCT03426995|10105583|FG000|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||1
9045063|NCT03426995|10105584|FG001|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||2
9045064|NCT03426995|10105585|FG002|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||1
9045065|NCT03426995|10105586|FG003|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||2
9045066|NCT03426995|10105587|FG004|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||1
9045067|NCT03426995|10105588|FG005|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||2
9045068|NCT03426995|10105589|FG006|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
9045069|NCT03426995|10105590|FG007|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
9045070|NCT03426995|10105591|FG008|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
9045071|NCT03426995|10105592|FG009|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
9045072|NCT03426995|10105593|FG010|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
9045073|NCT03426995|10105594|FG011|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
9045074|NCT03426995|10105595|FG012|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
9045075|NCT03426995|10105596|FG013|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
9045076|NCT03426995|10105597|FG014|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
9045077|NCT03426995|10105598|FG015|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
9045078|NCT03426995|10105599|FG016|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
9045079|NCT03426995|10105600|FG017|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
9045080|NCT03426995|10105601|FG018|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
9045081|NCT03426995|10105583|FG000|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||1
9045082|NCT03426995|10105584|FG001|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||2
9045083|NCT03426995|10105585|FG002|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||1
9045084|NCT03426995|10105586|FG003|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||2
9045085|NCT03426995|10105587|FG004|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||1
9045086|NCT03426995|10105588|FG005|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||2
9045087|NCT03426995|10105589|FG006|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
9045088|NCT03426995|10105590|FG007|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
9045089|NCT03426995|10105591|FG008|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
9045090|NCT03426995|10105592|FG009|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
9045091|NCT03426995|10105593|FG010|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
9045092|NCT03426995|10105594|FG011|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
9045093|NCT03426995|10105595|FG012|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
9045094|NCT03426995|10105596|FG013|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
9045095|NCT03426995|10105597|FG014|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
9045096|NCT03426995|10105598|FG015|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
9045097|NCT03426995|10105599|FG016|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
9045098|NCT03426995|10105600|FG017|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
9045099|NCT03426995|10105601|FG018|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
9045100|NCT03426995|10105583|FG000|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
9045101|NCT03426995|10105584|FG001|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
9045102|NCT03426995|10105585|FG002|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
9045103|NCT03426995|10105586|FG003|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
9045104|NCT03426995|10105587|FG004|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
9045105|NCT03426995|10105588|FG005|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
9045106|NCT03426995|10105589|FG006|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
9045107|NCT03426995|10105590|FG007|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
9045108|NCT03426995|10105591|FG008|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
9045109|NCT03426995|10105592|FG009|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
9045110|NCT03426995|10105593|FG010|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
9045111|NCT03426995|10105594|FG011|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
9045112|NCT03426995|10105595|FG012|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
9045113|NCT03426995|10105596|FG013|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
9045114|NCT03426995|10105597|FG014|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
9045115|NCT03426995|10105598|FG015|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
9045116|NCT03426995|10105599|FG016|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
9045117|NCT03426995|10105600|FG017|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
9045118|NCT03426995|10105601|FG018|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
9045119|NCT03426995|10105583|FG000|STARTED|Part A: Cohort 1-Period 4 (Day1)||1
9045120|NCT03426995|10105584|FG001|STARTED|Part A: Cohort 1-Period 4 (Day1)||2
9045121|NCT03426995|10105585|FG002|STARTED|Part A: Cohort 1-Period 4 (Day1)||1
9045122|NCT03426995|10105586|FG003|STARTED|Part A: Cohort 1-Period 4 (Day1)||2
9045123|NCT03426995|10105587|FG004|STARTED|Part A: Cohort 1-Period 4 (Day1)||1
9045124|NCT03426995|10105588|FG005|STARTED|Part A: Cohort 1-Period 4 (Day1)||2
9045125|NCT03426995|10105589|FG006|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
9045126|NCT03426995|10105590|FG007|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
9045127|NCT03426995|10105591|FG008|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
9045128|NCT03426995|10105592|FG009|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
9045129|NCT03426995|10105593|FG010|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
9045130|NCT03426995|10105594|FG011|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
9045131|NCT03426995|10105595|FG012|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
9045132|NCT03426995|10105596|FG013|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
9045133|NCT03426995|10105597|FG014|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
9045134|NCT03426995|10105598|FG015|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
9045135|NCT03426995|10105599|FG016|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
9045136|NCT03426995|10105600|FG017|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
8702310|NCT00916279|9748181|FG000|NOT COMPLETED|Overall Study||4
8702311|NCT00916305|9748190|FG000|STARTED|Overall Study||28
8702312|NCT00916305|9748191|FG001|STARTED|Overall Study||37
8702313|NCT00916305|9748190|FG000|COMPLETED|Overall Study||7
8702314|NCT00916305|9748191|FG001|COMPLETED|Overall Study||9
8702315|NCT00916305|9748190|FG000|NOT COMPLETED|Overall Study||21
8702316|NCT00916305|9748191|FG001|NOT COMPLETED|Overall Study||28
9045137|NCT03426995|10105601|FG018|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
9045138|NCT03426995|10105583|FG000|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||1
9045139|NCT03426995|10105584|FG001|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||2
9045140|NCT03426995|10105585|FG002|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||1
9045141|NCT03426995|10105586|FG003|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||2
9045142|NCT03426995|10105587|FG004|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||1
9045143|NCT03426995|10105588|FG005|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||2
9045144|NCT03426995|10105589|FG006|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
9045145|NCT03426995|10105590|FG007|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
9045146|NCT03426995|10105591|FG008|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
9045147|NCT03426995|10105592|FG009|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
9045148|NCT03426995|10105593|FG010|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
9045149|NCT03426995|10105594|FG011|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
9045150|NCT03426995|10105595|FG012|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
9045151|NCT03426995|10105596|FG013|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
9045152|NCT03426995|10105597|FG014|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
9045153|NCT03426995|10105598|FG015|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
9045154|NCT03426995|10105599|FG016|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
9045155|NCT03426995|10105600|FG017|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
9045156|NCT03426995|10105601|FG018|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
9045157|NCT03426995|10105583|FG000|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
9045158|NCT03426995|10105584|FG001|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
9045159|NCT03426995|10105585|FG002|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
9045160|NCT03426995|10105586|FG003|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
9045161|NCT03426995|10105587|FG004|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
9045162|NCT03426995|10105588|FG005|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
9045163|NCT03426995|10105589|FG006|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
9045164|NCT03426995|10105590|FG007|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
9045165|NCT03426995|10105591|FG008|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
9045166|NCT03426995|10105592|FG009|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
9045167|NCT03426995|10105593|FG010|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
9045168|NCT03426995|10105594|FG011|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
9045169|NCT03426995|10105595|FG012|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
9045170|NCT03426995|10105596|FG013|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
9045171|NCT03426995|10105597|FG014|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
9045172|NCT03426995|10105598|FG015|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
9045173|NCT03426995|10105599|FG016|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
9045174|NCT03426995|10105600|FG017|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
9045175|NCT03426995|10105601|FG018|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
9045176|NCT03426995|10105583|FG000|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
8702317|NCT00916344|9748197|FG000|STARTED|Overall Study||175
8702318|NCT00916344|9748197|FG000|COMPLETED|Overall Study||167
8702319|NCT00916344|9748197|FG000|NOT COMPLETED|Overall Study||8
8702320|NCT00916357|9748201|FG000|STARTED|Period 1||4
8702321|NCT00916357|9748202|FG001|STARTED|Period 1||4
9045177|NCT03426995|10105584|FG001|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
9045178|NCT03426995|10105585|FG002|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
9045179|NCT03426995|10105586|FG003|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
9045180|NCT03426995|10105587|FG004|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
9045181|NCT03426995|10105588|FG005|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
9045182|NCT03426995|10105589|FG006|STARTED|Part A: Cohort 2-Period 1 (Day1)||1
9045183|NCT03426995|10105590|FG007|STARTED|Part A: Cohort 2-Period 1 (Day1)||2
9045184|NCT03426995|10105591|FG008|STARTED|Part A: Cohort 2-Period 1 (Day1)||1
9045185|NCT03426995|10105592|FG009|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
9045186|NCT03426995|10105593|FG010|STARTED|Part A: Cohort 2-Period 1 (Day1)||1
9045187|NCT03426995|10105594|FG011|STARTED|Part A: Cohort 2-Period 1 (Day1)||1
9045188|NCT03426995|10105595|FG012|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
9045189|NCT03426995|10105596|FG013|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
9045190|NCT03426995|10105597|FG014|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
9045191|NCT03426995|10105598|FG015|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
9045192|NCT03426995|10105599|FG016|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
9045193|NCT03426995|10105600|FG017|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
9045194|NCT03426995|10105601|FG018|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
9045195|NCT03426995|10105583|FG000|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
9045196|NCT03426995|10105584|FG001|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
9045197|NCT03426995|10105585|FG002|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
9045198|NCT03426995|10105586|FG003|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
9045199|NCT03426995|10105587|FG004|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
9045200|NCT03426995|10105588|FG005|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
9045201|NCT03426995|10105589|FG006|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||1
9045202|NCT03426995|10105590|FG007|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||2
9045203|NCT03426995|10105591|FG008|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||1
9045204|NCT03426995|10105592|FG009|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
9045205|NCT03426995|10105593|FG010|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||1
9045206|NCT03426995|10105594|FG011|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||1
9045207|NCT03426995|10105595|FG012|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
9045208|NCT03426995|10105596|FG013|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
9045209|NCT03426995|10105597|FG014|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
9045210|NCT03426995|10105598|FG015|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
9045211|NCT03426995|10105599|FG016|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
9045212|NCT03426995|10105600|FG017|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
8702322|NCT00916357|9748203|FG002|STARTED|Period 1||4
8702323|NCT00916357|9748204|FG003|STARTED|Period 1||4
8702324|NCT00916357|9748205|FG004|STARTED|Period 1||3
8702325|NCT00916357|9748206|FG005|STARTED|Period 1||4
8702326|NCT00916357|9748201|FG000|Received at Least 1 Dose of Study Drug|Period 1||4
8702327|NCT00916357|9748202|FG001|Received at Least 1 Dose of Study Drug|Period 1||4
8702328|NCT00916357|9748203|FG002|Received at Least 1 Dose of Study Drug|Period 1||4
8702329|NCT00916357|9748204|FG003|Received at Least 1 Dose of Study Drug|Period 1||4
8702330|NCT00916357|9748205|FG004|Received at Least 1 Dose of Study Drug|Period 1||3
8702331|NCT00916357|9748206|FG005|Received at Least 1 Dose of Study Drug|Period 1||4
8702332|NCT00916357|9748201|FG000|COMPLETED|Period 1||3
8702333|NCT00916357|9748202|FG001|COMPLETED|Period 1||4
8702334|NCT00916357|9748203|FG002|COMPLETED|Period 1||4
8702335|NCT00916357|9748204|FG003|COMPLETED|Period 1||4
8702336|NCT00916357|9748205|FG004|COMPLETED|Period 1||3
8702337|NCT00916357|9748206|FG005|COMPLETED|Period 1||4
8702338|NCT00916357|9748201|FG000|NOT COMPLETED|Period 1||1
8702339|NCT00916357|9748202|FG001|NOT COMPLETED|Period 1||0
8702340|NCT00916357|9748203|FG002|NOT COMPLETED|Period 1||0
8702341|NCT00916357|9748204|FG003|NOT COMPLETED|Period 1||0
8702342|NCT00916357|9748205|FG004|NOT COMPLETED|Period 1||0
8702343|NCT00916357|9748206|FG005|NOT COMPLETED|Period 1||0
8702344|NCT00916357|9748201|FG000|STARTED|Washout (3 to 14 Days)||3
8702345|NCT00916357|9748202|FG001|STARTED|Washout (3 to 14 Days)||4
8702346|NCT00916357|9748203|FG002|STARTED|Washout (3 to 14 Days)||4
8702347|NCT00916357|9748204|FG003|STARTED|Washout (3 to 14 Days)||4
8702348|NCT00916357|9748205|FG004|STARTED|Washout (3 to 14 Days)||3
8702349|NCT00916357|9748206|FG005|STARTED|Washout (3 to 14 Days)||4
8702350|NCT00916357|9748201|FG000|COMPLETED|Washout (3 to 14 Days)||3
8702351|NCT00916357|9748202|FG001|COMPLETED|Washout (3 to 14 Days)||4
8702352|NCT00916357|9748203|FG002|COMPLETED|Washout (3 to 14 Days)||4
8702353|NCT00916357|9748204|FG003|COMPLETED|Washout (3 to 14 Days)||4
8702354|NCT00916357|9748205|FG004|COMPLETED|Washout (3 to 14 Days)||3
8702355|NCT00916357|9748206|FG005|COMPLETED|Washout (3 to 14 Days)||4
8702356|NCT00916357|9748201|FG000|NOT COMPLETED|Washout (3 to 14 Days)||0
8702357|NCT00916357|9748202|FG001|NOT COMPLETED|Washout (3 to 14 Days)||0
8702358|NCT00916357|9748203|FG002|NOT COMPLETED|Washout (3 to 14 Days)||0
8702359|NCT00916357|9748204|FG003|NOT COMPLETED|Washout (3 to 14 Days)||0
8702360|NCT00916357|9748205|FG004|NOT COMPLETED|Washout (3 to 14 Days)||0
8702361|NCT00916357|9748206|FG005|NOT COMPLETED|Washout (3 to 14 Days)||0
8702362|NCT00916357|9748201|FG000|STARTED|Period 2||3
8702363|NCT00916357|9748202|FG001|STARTED|Period 2||4
8702364|NCT00916357|9748203|FG002|STARTED|Period 2||4
8702365|NCT00916357|9748204|FG003|STARTED|Period 2||4
8702366|NCT00916357|9748205|FG004|STARTED|Period 2||3
9045213|NCT03426995|10105601|FG018|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
9045214|NCT03426995|10105583|FG000|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
9045215|NCT03426995|10105584|FG001|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
9045216|NCT03426995|10105585|FG002|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
9045217|NCT03426995|10105586|FG003|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
9045218|NCT03426995|10105587|FG004|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
9045219|NCT03426995|10105588|FG005|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
9045220|NCT03426995|10105589|FG006|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
9045221|NCT03426995|10105590|FG007|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
9045222|NCT03426995|10105591|FG008|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
9045223|NCT03426995|10105592|FG009|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
9045224|NCT03426995|10105593|FG010|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
9045225|NCT03426995|10105594|FG011|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
9045226|NCT03426995|10105595|FG012|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
9045227|NCT03426995|10105596|FG013|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
9045228|NCT03426995|10105597|FG014|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
9045229|NCT03426995|10105598|FG015|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
9045230|NCT03426995|10105599|FG016|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
9045231|NCT03426995|10105600|FG017|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
9045232|NCT03426995|10105601|FG018|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
9045233|NCT03426995|10105583|FG000|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
9045234|NCT03426995|10105584|FG001|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
9045235|NCT03426995|10105585|FG002|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
9045236|NCT03426995|10105586|FG003|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
9045237|NCT03426995|10105587|FG004|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
9045238|NCT03426995|10105588|FG005|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
9045239|NCT03426995|10105589|FG006|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
9045240|NCT03426995|10105590|FG007|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||2
9045241|NCT03426995|10105591|FG008|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
9045242|NCT03426995|10105592|FG009|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
9045243|NCT03426995|10105593|FG010|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
9045244|NCT03426995|10105594|FG011|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
9045245|NCT03426995|10105595|FG012|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
9045246|NCT03426995|10105596|FG013|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
9045247|NCT03426995|10105597|FG014|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
9045248|NCT03426995|10105598|FG015|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
9045249|NCT03426995|10105599|FG016|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
9045250|NCT03426995|10105600|FG017|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
9045251|NCT03426995|10105601|FG018|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
9045252|NCT03426995|10105583|FG000|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
9045253|NCT03426995|10105584|FG001|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
9045254|NCT03426995|10105585|FG002|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
9045255|NCT03426995|10105586|FG003|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
9045256|NCT03426995|10105587|FG004|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
9045257|NCT03426995|10105588|FG005|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
9045258|NCT03426995|10105589|FG006|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
9045259|NCT03426995|10105590|FG007|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||2
9045260|NCT03426995|10105591|FG008|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
9045261|NCT03426995|10105592|FG009|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
9045262|NCT03426995|10105593|FG010|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
9045263|NCT03426995|10105594|FG011|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
9045264|NCT03426995|10105595|FG012|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
9045265|NCT03426995|10105596|FG013|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
9045266|NCT03426995|10105597|FG014|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
9045267|NCT03426995|10105598|FG015|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
9045268|NCT03426995|10105599|FG016|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
9045269|NCT03426995|10105600|FG017|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8702367|NCT00916357|9748206|FG005|STARTED|Period 2||4
8702368|NCT00916357|9748201|FG000|COMPLETED|Period 2||3
8702369|NCT00916357|9748202|FG001|COMPLETED|Period 2||4
8702370|NCT00916357|9748203|FG002|COMPLETED|Period 2||4
8702371|NCT00916357|9748204|FG003|COMPLETED|Period 2||3
8702372|NCT00916357|9748205|FG004|COMPLETED|Period 2||3
8702373|NCT00916357|9748206|FG005|COMPLETED|Period 2||4
8702374|NCT00916357|9748201|FG000|NOT COMPLETED|Period 2||0
8702375|NCT00916357|9748202|FG001|NOT COMPLETED|Period 2||0
8702376|NCT00916357|9748203|FG002|NOT COMPLETED|Period 2||0
8702377|NCT00916357|9748204|FG003|NOT COMPLETED|Period 2||1
8702378|NCT00916357|9748205|FG004|NOT COMPLETED|Period 2||0
8702379|NCT00916357|9748206|FG005|NOT COMPLETED|Period 2||0
8702380|NCT00916357|9748201|FG000|STARTED|Washout (3 to 14 Days)||3
8702381|NCT00916357|9748202|FG001|STARTED|Washout (3 to 14 Days)||4
8702382|NCT00916357|9748203|FG002|STARTED|Washout (3 to 14 Days)||4
8702383|NCT00916357|9748204|FG003|STARTED|Washout (3 to 14 Days)||3
8702384|NCT00916357|9748205|FG004|STARTED|Washout (3 to 14 Days)||3
8702385|NCT00916357|9748206|FG005|STARTED|Washout (3 to 14 Days)||4
8702386|NCT00916357|9748201|FG000|COMPLETED|Washout (3 to 14 Days)||3
9045270|NCT03426995|10105601|FG018|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
9045271|NCT03426995|10105583|FG000|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
9045272|NCT03426995|10105584|FG001|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
9045273|NCT03426995|10105585|FG002|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
9045274|NCT03426995|10105586|FG003|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
9045275|NCT03426995|10105587|FG004|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
9045276|NCT03426995|10105588|FG005|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
9045277|NCT03426995|10105589|FG006|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
9045278|NCT03426995|10105590|FG007|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
9045279|NCT03426995|10105591|FG008|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
9045280|NCT03426995|10105592|FG009|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
9045281|NCT03426995|10105593|FG010|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
9045282|NCT03426995|10105594|FG011|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
9045283|NCT03426995|10105595|FG012|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
9045284|NCT03426995|10105596|FG013|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
9045285|NCT03426995|10105597|FG014|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
9045286|NCT03426995|10105598|FG015|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
9045287|NCT03426995|10105599|FG016|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
9045288|NCT03426995|10105600|FG017|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
9045289|NCT03426995|10105601|FG018|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
9045290|NCT03426995|10105583|FG000|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
9045291|NCT03426995|10105584|FG001|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
9045292|NCT03426995|10105585|FG002|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
9045293|NCT03426995|10105586|FG003|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
9045294|NCT03426995|10105587|FG004|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
9045295|NCT03426995|10105588|FG005|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
9045296|NCT03426995|10105589|FG006|STARTED|Part A: Cohort 2-Period 2 (Day1)||1
9045297|NCT03426995|10105590|FG007|STARTED|Part A: Cohort 2-Period 2 (Day1)||2
9045298|NCT03426995|10105591|FG008|STARTED|Part A: Cohort 2-Period 2 (Day1)||1
9045299|NCT03426995|10105592|FG009|STARTED|Part A: Cohort 2-Period 2 (Day1)|Two additional participants were enrolled and dosed.|2
9045300|NCT03426995|10105593|FG010|STARTED|Part A: Cohort 2-Period 2 (Day1)||1
9045301|NCT03426995|10105594|FG011|STARTED|Part A: Cohort 2-Period 2 (Day1)|New participant enrolled and dosed.|2
9045302|NCT03426995|10105595|FG012|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
9045303|NCT03426995|10105596|FG013|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
9045304|NCT03426995|10105597|FG014|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
9045305|NCT03426995|10105598|FG015|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
8702387|NCT00916357|9748202|FG001|COMPLETED|Washout (3 to 14 Days)||4
8702388|NCT00916357|9748203|FG002|COMPLETED|Washout (3 to 14 Days)||4
8702389|NCT00916357|9748204|FG003|COMPLETED|Washout (3 to 14 Days)||3
8702390|NCT00916357|9748205|FG004|COMPLETED|Washout (3 to 14 Days)||3
8702391|NCT00916357|9748206|FG005|COMPLETED|Washout (3 to 14 Days)||4
8702392|NCT00916357|9748201|FG000|NOT COMPLETED|Washout (3 to 14 Days)||0
8702393|NCT00916357|9748202|FG001|NOT COMPLETED|Washout (3 to 14 Days)||0
8702394|NCT00916357|9748203|FG002|NOT COMPLETED|Washout (3 to 14 Days)||0
8702395|NCT00916357|9748204|FG003|NOT COMPLETED|Washout (3 to 14 Days)||0
8702396|NCT00916357|9748205|FG004|NOT COMPLETED|Washout (3 to 14 Days)||0
8702397|NCT00916357|9748206|FG005|NOT COMPLETED|Washout (3 to 14 Days)||0
8702398|NCT00916357|9748201|FG000|STARTED|Period 3||3
8702399|NCT00916357|9748202|FG001|STARTED|Period 3||4
8702400|NCT00916357|9748203|FG002|STARTED|Period 3||4
8702401|NCT00916357|9748204|FG003|STARTED|Period 3||3
8702402|NCT00916357|9748205|FG004|STARTED|Period 3||3
8702403|NCT00916357|9748206|FG005|STARTED|Period 3||4
8702404|NCT00916357|9748201|FG000|COMPLETED|Period 3||3
8702405|NCT00916357|9748202|FG001|COMPLETED|Period 3||4
8702406|NCT00916357|9748203|FG002|COMPLETED|Period 3||4
8702407|NCT00916357|9748204|FG003|COMPLETED|Period 3||3
8702408|NCT00916357|9748205|FG004|COMPLETED|Period 3||3
8702409|NCT00916357|9748206|FG005|COMPLETED|Period 3||4
8702410|NCT00916357|9748201|FG000|NOT COMPLETED|Period 3||0
8702411|NCT00916357|9748202|FG001|NOT COMPLETED|Period 3||0
8702412|NCT00916357|9748203|FG002|NOT COMPLETED|Period 3||0
8702413|NCT00916357|9748204|FG003|NOT COMPLETED|Period 3||0
8702414|NCT00916357|9748205|FG004|NOT COMPLETED|Period 3||0
8702415|NCT00916357|9748206|FG005|NOT COMPLETED|Period 3||0
8702416|NCT00916370|9748217|FG000|STARTED|Overall Study||401
8702417|NCT00916370|9748218|FG001|STARTED|Overall Study||104
8702418|NCT00916370|9748217|FG000|COMPLETED|Overall Study||396
8702419|NCT00916370|9748218|FG001|COMPLETED|Overall Study||102
8702420|NCT00916370|9748217|FG000|NOT COMPLETED|Overall Study||5
8702421|NCT00916370|9748218|FG001|NOT COMPLETED|Overall Study||2
8702422|NCT00916383|9748225|FG000|STARTED|Overall Study||49
8702423|NCT00916383|9748225|FG000|COMPLETED|Overall Study||46
8702424|NCT00916383|9748225|FG000|NOT COMPLETED|Overall Study||3
8702425|NCT00916539|9748235|FG000|STARTED|Overall Study||31
8702426|NCT00916539|9748236|FG001|STARTED|Overall Study||31
8702427|NCT00916539|9748235|FG000|COMPLETED|Overall Study||31
8702428|NCT00916539|9748236|FG001|COMPLETED|Overall Study||31
8702429|NCT00916539|9748235|FG000|NOT COMPLETED|Overall Study||0
8702430|NCT00916539|9748236|FG001|NOT COMPLETED|Overall Study||0
8702431|NCT00916578|9748242|FG000|STARTED|Overall Study||33
8702432|NCT00916578|9748242|FG000|COMPLETED|Overall Study||26
8702433|NCT00916578|9748242|FG000|NOT COMPLETED|Overall Study||7
9045306|NCT03426995|10105599|FG016|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
9045307|NCT03426995|10105600|FG017|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
9045308|NCT03426995|10105601|FG018|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
9045309|NCT03426995|10105583|FG000|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
9045310|NCT03426995|10105584|FG001|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
9045311|NCT03426995|10105585|FG002|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
9045312|NCT03426995|10105586|FG003|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
9045313|NCT03426995|10105587|FG004|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
9045314|NCT03426995|10105588|FG005|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
9045315|NCT03426995|10105589|FG006|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||1
9045316|NCT03426995|10105590|FG007|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||2
9045317|NCT03426995|10105591|FG008|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||1
9045318|NCT03426995|10105592|FG009|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||2
9045319|NCT03426995|10105593|FG010|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||1
9045320|NCT03426995|10105594|FG011|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||2
9045321|NCT03426995|10105595|FG012|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
9045322|NCT03426995|10105596|FG013|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
9045323|NCT03426995|10105597|FG014|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
9045324|NCT03426995|10105598|FG015|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
9045325|NCT03426995|10105599|FG016|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
9045326|NCT03426995|10105600|FG017|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
9045327|NCT03426995|10105601|FG018|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
9045328|NCT03426995|10105583|FG000|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
9045329|NCT03426995|10105584|FG001|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
9045330|NCT03426995|10105585|FG002|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
9045331|NCT03426995|10105586|FG003|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
8702434|NCT00916617|9748250|FG000|STARTED|Overall Study||24
8702435|NCT00916617|9748251|FG001|STARTED|Overall Study||21
8702436|NCT00916617|9748252|FG002|STARTED|Overall Study||10
8702437|NCT00916617|9748253|FG003|STARTED|Overall Study||7
8702438|NCT00916617|9748250|FG000|COMPLETED|Overall Study||1
8702439|NCT00916617|9748251|FG001|COMPLETED|Overall Study||0
8702440|NCT00916617|9748252|FG002|COMPLETED|Overall Study||0
8702441|NCT00916617|9748253|FG003|COMPLETED|Overall Study||0
8702442|NCT00916617|9748250|FG000|NOT COMPLETED|Overall Study||23
8702443|NCT00916617|9748251|FG001|NOT COMPLETED|Overall Study||21
8702444|NCT00916617|9748252|FG002|NOT COMPLETED|Overall Study||10
8702445|NCT00916617|9748253|FG003|NOT COMPLETED|Overall Study||7
8702446|NCT00916643|9748263|FG000|STARTED|Overall Study||113
8702447|NCT00916643|9748263|FG000|COMPLETED|Overall Study||113
8702448|NCT00916643|9748263|FG000|NOT COMPLETED|Overall Study||0
8702449|NCT00916721|9748269|FG000|STARTED|Overall Study||35
8702450|NCT00916721|9748270|FG001|STARTED|Overall Study||39
8702451|NCT00916721|9748269|FG000|COMPLETED|Overall Study||25
8702452|NCT00916721|9748270|FG001|COMPLETED|Overall Study||29
8702453|NCT00916721|9748269|FG000|NOT COMPLETED|Overall Study||10
8702454|NCT00916721|9748270|FG001|NOT COMPLETED|Overall Study||10
8702455|NCT00916929|9748278|FG000|STARTED|Overall Study||80
8702456|NCT00916929|9748279|FG001|STARTED|Overall Study||82
8702457|NCT00916929|9748278|FG000|COMPLETED|Overall Study||70
8702458|NCT00916929|9748279|FG001|COMPLETED|Overall Study||53
8702459|NCT00916929|9748278|FG000|NOT COMPLETED|Overall Study||10
8702460|NCT00916929|9748279|FG001|NOT COMPLETED|Overall Study||29
8702461|NCT00917124|9748289|FG000|STARTED|Overall Study||100
8702462|NCT00917124|9748290|FG001|STARTED|Overall Study||100
8702463|NCT00917124|9748289|FG000|COMPLETED|Overall Study||96
8702464|NCT00917124|9748290|FG001|COMPLETED|Overall Study||94
8702465|NCT00917124|9748289|FG000|NOT COMPLETED|Overall Study||4
8702466|NCT00917124|9748290|FG001|NOT COMPLETED|Overall Study||6
8702467|NCT00917150|9748300|FG000|STARTED|Overall Study||192
8702468|NCT00917150|9748301|FG001|STARTED|Overall Study||198
8702469|NCT00917150|9748302|FG002|STARTED|Overall Study||191
8702470|NCT00917150|9748303|FG003|STARTED|Overall Study||190
8702471|NCT00917150|9748300|FG000|COMPLETED|Overall Study||155
8702472|NCT00917150|9748301|FG001|COMPLETED|Overall Study||161
8702473|NCT00917150|9748302|FG002|COMPLETED|Overall Study||149
8702474|NCT00917150|9748303|FG003|COMPLETED|Overall Study||156
8702475|NCT00917150|9748300|FG000|NOT COMPLETED|Overall Study||37
8702476|NCT00917150|9748301|FG001|NOT COMPLETED|Overall Study||37
8702477|NCT00917150|9748302|FG002|NOT COMPLETED|Overall Study||42
8702478|NCT00917150|9748303|FG003|NOT COMPLETED|Overall Study||34
8702479|NCT00917267|9748315|FG000|STARTED|Overall Study||346
8702480|NCT00917267|9748316|FG001|STARTED|Overall Study||345
8702481|NCT00917267|9748315|FG000|Intent to Treat (ITT)|Overall Study||340
8812694|NCT01521026|9865723|FG000|STARTED|Overall Study||38
8702482|NCT00917267|9748316|FG001|Intent to Treat (ITT)|Overall Study||338
8702483|NCT00917267|9748315|FG000|COMPLETED|Overall Study||307
8702484|NCT00917267|9748316|FG001|COMPLETED|Overall Study||266
8702485|NCT00917267|9748315|FG000|NOT COMPLETED|Overall Study||39
8702486|NCT00917267|9748316|FG001|NOT COMPLETED|Overall Study||79
8702487|NCT00917384|9748328|FG000|STARTED|Overall Study||238
8702488|NCT00917384|9748329|FG001|STARTED|Overall Study||117
8702489|NCT00917384|9748328|FG000|Received at Least 1 Dose of Study Drug|Overall Study||236
8702490|NCT00917384|9748329|FG001|Received at Least 1 Dose of Study Drug|Overall Study||115
8702491|NCT00917384|9748328|FG000|COMPLETED|Overall Study||224
8702492|NCT00917384|9748329|FG001|COMPLETED|Overall Study||113
8702493|NCT00917384|9748328|FG000|NOT COMPLETED|Overall Study||14
9045332|NCT03426995|10105587|FG004|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
9045333|NCT03426995|10105588|FG005|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
9045334|NCT03426995|10105589|FG006|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
9045335|NCT03426995|10105590|FG007|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
9045336|NCT03426995|10105591|FG008|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
9045337|NCT03426995|10105592|FG009|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
9045338|NCT03426995|10105593|FG010|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
9045339|NCT03426995|10105594|FG011|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
9045340|NCT03426995|10105595|FG012|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
9045341|NCT03426995|10105596|FG013|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
9045342|NCT03426995|10105597|FG014|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
9045343|NCT03426995|10105598|FG015|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
9045344|NCT03426995|10105599|FG016|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
9045345|NCT03426995|10105600|FG017|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
9045346|NCT03426995|10105601|FG018|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
9045347|NCT03426995|10105583|FG000|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
9045348|NCT03426995|10105584|FG001|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
9045349|NCT03426995|10105585|FG002|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
9045350|NCT03426995|10105586|FG003|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
9045351|NCT03426995|10105587|FG004|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
9045352|NCT03426995|10105588|FG005|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
9045353|NCT03426995|10105589|FG006|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||1
9045354|NCT03426995|10105590|FG007|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||2
9045355|NCT03426995|10105591|FG008|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||1
9045356|NCT03426995|10105592|FG009|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||2
9045357|NCT03426995|10105593|FG010|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||1
9045358|NCT03426995|10105594|FG011|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||2
9045359|NCT03426995|10105595|FG012|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
9045360|NCT03426995|10105596|FG013|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
9045361|NCT03426995|10105597|FG014|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
9045362|NCT03426995|10105598|FG015|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8702494|NCT00917384|9748329|FG001|NOT COMPLETED|Overall Study||4
8702495|NCT00917462|9748335|FG000|STARTED|Overall Study||35
8702496|NCT00917462|9748335|FG000|COMPLETED|Overall Study||34
8702497|NCT00917462|9748335|FG000|NOT COMPLETED|Overall Study||1
8702498|NCT00917501|9748341|FG000|STARTED|Overall Study||29
8702499|NCT00917501|9748342|FG001|STARTED|Overall Study||26
8702500|NCT00917501|9748341|FG000|COMPLETED|Overall Study||21
8702501|NCT00917501|9748342|FG001|COMPLETED|Overall Study||21
8702502|NCT00917501|9748341|FG000|NOT COMPLETED|Overall Study||8
8702503|NCT00917501|9748342|FG001|NOT COMPLETED|Overall Study||5
8702504|NCT00917553|9748350|FG000|STARTED|Overall Study||17
8702505|NCT00917553|9748351|FG001|STARTED|Overall Study||16
8702506|NCT00917553|9748350|FG000|COMPLETED|Overall Study||15
8702507|NCT00917553|9748351|FG001|COMPLETED|Overall Study||15
8702508|NCT00917553|9748350|FG000|NOT COMPLETED|Overall Study||2
8702509|NCT00917553|9748351|FG001|NOT COMPLETED|Overall Study||1
8702510|NCT00917579|9748357|FG000|STARTED|Period 1: 1st Intervention||39
8702511|NCT00917579|9748358|FG001|STARTED|Period 1: 1st Intervention||37
8702512|NCT00917579|9748357|FG000|COMPLETED|Period 1: 1st Intervention||39
8702513|NCT00917579|9748358|FG001|COMPLETED|Period 1: 1st Intervention||37
8702514|NCT00917579|9748357|FG000|NOT COMPLETED|Period 1: 1st Intervention||0
8702515|NCT00917579|9748358|FG001|NOT COMPLETED|Period 1: 1st Intervention||0
8702516|NCT00917579|9748357|FG000|STARTED|Washout >= 2 Weeks||39
8702517|NCT00917579|9748358|FG001|STARTED|Washout >= 2 Weeks||37
8702518|NCT00917579|9748357|FG000|COMPLETED|Washout >= 2 Weeks||37
8702519|NCT00917579|9748358|FG001|COMPLETED|Washout >= 2 Weeks||37
8702520|NCT00917579|9748357|FG000|NOT COMPLETED|Washout >= 2 Weeks||2
8702521|NCT00917579|9748358|FG001|NOT COMPLETED|Washout >= 2 Weeks||0
8702522|NCT00917579|9748357|FG000|STARTED|Period 2: 2nd Intervention||37
8702523|NCT00917579|9748358|FG001|STARTED|Period 2: 2nd Intervention||37
8702524|NCT00917579|9748357|FG000|COMPLETED|Period 2: 2nd Intervention||37
8702525|NCT00917579|9748358|FG001|COMPLETED|Period 2: 2nd Intervention||37
8702526|NCT00917579|9748357|FG000|NOT COMPLETED|Period 2: 2nd Intervention||0
8702527|NCT00917579|9748358|FG001|NOT COMPLETED|Period 2: 2nd Intervention||0
8702528|NCT00917644|9748364|FG000|STARTED|Period 1: First Intervention||39
8702529|NCT00917644|9748365|FG001|STARTED|Period 1: First Intervention||37
8702530|NCT00917644|9748364|FG000|COMPLETED|Period 1: First Intervention||39
8702531|NCT00917644|9748365|FG001|COMPLETED|Period 1: First Intervention||37
8702532|NCT00917644|9748364|FG000|NOT COMPLETED|Period 1: First Intervention||0
8702533|NCT00917644|9748365|FG001|NOT COMPLETED|Period 1: First Intervention||0
8702534|NCT00917644|9748364|FG000|STARTED|Period: Washout Period of > = 2 Weeks||39
8702535|NCT00917644|9748365|FG001|STARTED|Period: Washout Period of > = 2 Weeks||37
8702536|NCT00917644|9748364|FG000|COMPLETED|Period: Washout Period of > = 2 Weeks||37
8702537|NCT00917644|9748365|FG001|COMPLETED|Period: Washout Period of > = 2 Weeks||37
9045363|NCT03426995|10105599|FG016|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
9045364|NCT03426995|10105600|FG017|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8702538|NCT00917644|9748364|FG000|NOT COMPLETED|Period: Washout Period of > = 2 Weeks||2
8702539|NCT00917644|9748365|FG001|NOT COMPLETED|Period: Washout Period of > = 2 Weeks||0
8724535|NCT01026818|9771752|FG000|NOT COMPLETED|Screening Period||160
9045365|NCT03426995|10105601|FG018|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
9045366|NCT03426995|10105583|FG000|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
9045367|NCT03426995|10105584|FG001|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
9045368|NCT03426995|10105585|FG002|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
9045369|NCT03426995|10105586|FG003|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
9045370|NCT03426995|10105587|FG004|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
9045371|NCT03426995|10105588|FG005|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
9045372|NCT03426995|10105589|FG006|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||1
9045373|NCT03426995|10105590|FG007|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||2
9045374|NCT03426995|10105591|FG008|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||1
9045375|NCT03426995|10105592|FG009|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||2
9045376|NCT03426995|10105593|FG010|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||1
9045377|NCT03426995|10105594|FG011|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||2
9045378|NCT03426995|10105595|FG012|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
9045379|NCT03426995|10105596|FG013|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
9045380|NCT03426995|10105597|FG014|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
9045381|NCT03426995|10105598|FG015|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
9045382|NCT03426995|10105599|FG016|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
9045383|NCT03426995|10105600|FG017|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
9045384|NCT03426995|10105601|FG018|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8702540|NCT00917644|9748364|FG000|STARTED|Period 2: Second Intervention|Washout: Test drug 1st, completed = 37; 2nd period: Test drug 2nd, completed = 37.|37
8702541|NCT00917644|9748365|FG001|STARTED|Period 2: Second Intervention|Washout: Reference drug (Ref) 1st, completed = 37; 2nd period: Ref drug 2nd, completed = 36.|37
8702542|NCT00917644|9748364|FG000|COMPLETED|Period 2: Second Intervention|Total number of subjects completed Test drug = 74.|36
8702543|NCT00917644|9748365|FG001|COMPLETED|Period 2: Second Intervention|Total number of subjects completed Ref drug = 73.|37
8702544|NCT00917644|9748364|FG000|NOT COMPLETED|Period 2: Second Intervention||1
8702545|NCT00917644|9748365|FG001|NOT COMPLETED|Period 2: Second Intervention||0
8702546|NCT00917735|9748373|FG000|STARTED|Overall Study||538
8702547|NCT00917735|9748374|FG001|STARTED|Overall Study||537
8702548|NCT00917735|9748373|FG000|COMPLETED|Overall Study||463
8702549|NCT00917735|9748374|FG001|COMPLETED|Overall Study||474
8702550|NCT00917735|9748373|FG000|NOT COMPLETED|Overall Study||75
8702551|NCT00917735|9748374|FG001|NOT COMPLETED|Overall Study||63
8702552|NCT00917852|9748380|FG000|STARTED|Overall Study||51
8702553|NCT00917852|9748380|FG000|COMPLETED|Overall Study||45
8702554|NCT00917852|9748380|FG000|NOT COMPLETED|Overall Study||6
8702555|NCT00917865|9748385|FG000|STARTED|Overall Study||11
8702556|NCT00917865|9748385|FG000|COMPLETED|Overall Study||11
8702557|NCT00917865|9748385|FG000|NOT COMPLETED|Overall Study||0
8702558|NCT00918125|9748398|FG000|STARTED|Overall Study||20
8702559|NCT00918125|9748399|FG001|STARTED|Overall Study||39
8702560|NCT00918125|9748398|FG000|COMPLETED|Overall Study||20
8702561|NCT00918125|9748399|FG001|COMPLETED|Overall Study||39
8702562|NCT00918125|9748398|FG000|NOT COMPLETED|Overall Study||0
8702563|NCT00918125|9748399|FG001|NOT COMPLETED|Overall Study||0
8702564|NCT00918138|9748410|FG000|STARTED|Overall Study||46
8702565|NCT00918138|9748411|FG001|STARTED|Overall Study||47
8702566|NCT00918138|9748410|FG000|COMPLETED|Overall Study||44
8702567|NCT00918138|9748411|FG001|COMPLETED|Overall Study||46
8702568|NCT00918138|9748410|FG000|NOT COMPLETED|Overall Study||2
8702569|NCT00918138|9748411|FG001|NOT COMPLETED|Overall Study||1
8702570|NCT00918203|9748419|FG000|STARTED|Treatment With or Without Olaratumab||70
8702571|NCT00918203|9748420|FG001|STARTED|Treatment With or Without Olaratumab||67
8702572|NCT00918203|9748421|FG002|STARTED|Treatment With or Without Olaratumab||0
8702573|NCT00918203|9748419|FG000|Received at Least 1 Dose of Study Drug|Treatment With or Without Olaratumab||67
8702574|NCT00918203|9748420|FG001|Received at Least 1 Dose of Study Drug|Treatment With or Without Olaratumab||64
8702575|NCT00918203|9748421|FG002|Received at Least 1 Dose of Study Drug|Treatment With or Without Olaratumab||0
8702576|NCT00918203|9748419|FG000|Death Due to Any Cause|Treatment With or Without Olaratumab||53
8702577|NCT00918203|9748420|FG001|Death Due to Any Cause|Treatment With or Without Olaratumab||47
8702578|NCT00918203|9748421|FG002|Death Due to Any Cause|Treatment With or Without Olaratumab||0
8702579|NCT00918203|9748419|FG000|Alive/On Study at End/Off Treatment|Treatment With or Without Olaratumab||11
8702580|NCT00918203|9748420|FG001|Alive/On Study at End/Off Treatment|Treatment With or Without Olaratumab||10
8702581|NCT00918203|9748421|FG002|Alive/On Study at End/Off Treatment|Treatment With or Without Olaratumab||0
8702582|NCT00918203|9748419|FG000|COMPLETED|Treatment With or Without Olaratumab||64
8702583|NCT00918203|9748420|FG001|COMPLETED|Treatment With or Without Olaratumab||57
8702584|NCT00918203|9748421|FG002|COMPLETED|Treatment With or Without Olaratumab||0
8702585|NCT00918203|9748419|FG000|NOT COMPLETED|Treatment With or Without Olaratumab||6
8702586|NCT00918203|9748420|FG001|NOT COMPLETED|Treatment With or Without Olaratumab||10
8702587|NCT00918203|9748421|FG002|NOT COMPLETED|Treatment With or Without Olaratumab||0
8702588|NCT00918203|9748419|FG000|STARTED|Crossover to Olaratumab Monotherapy||0
8702589|NCT00918203|9748420|FG001|STARTED|Crossover to Olaratumab Monotherapy||0
8702590|NCT00918203|9748421|FG002|STARTED|Crossover to Olaratumab Monotherapy|18 participants who had progressive disease crossed over to monotherapy.|18
8702591|NCT00918203|9748419|FG000|COMPLETED|Crossover to Olaratumab Monotherapy||0
9045385|NCT03426995|10105583|FG000|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
9045386|NCT03426995|10105584|FG001|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
9045387|NCT03426995|10105585|FG002|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
9045388|NCT03426995|10105586|FG003|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
9045389|NCT03426995|10105587|FG004|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
9045390|NCT03426995|10105588|FG005|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
9045391|NCT03426995|10105589|FG006|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
9045392|NCT03426995|10105590|FG007|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
9045393|NCT03426995|10105591|FG008|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
9045394|NCT03426995|10105592|FG009|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
9045395|NCT03426995|10105593|FG010|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
9045396|NCT03426995|10105594|FG011|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
9045397|NCT03426995|10105595|FG012|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
9045398|NCT03426995|10105596|FG013|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
9045399|NCT03426995|10105597|FG014|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
9045400|NCT03426995|10105598|FG015|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
9045401|NCT03426995|10105599|FG016|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
9045402|NCT03426995|10105600|FG017|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
9045403|NCT03426995|10105601|FG018|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
9045404|NCT03426995|10105583|FG000|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
9045405|NCT03426995|10105584|FG001|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
9045406|NCT03426995|10105585|FG002|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
9045407|NCT03426995|10105586|FG003|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
9045408|NCT03426995|10105587|FG004|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
9045409|NCT03426995|10105588|FG005|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
9045410|NCT03426995|10105589|FG006|STARTED|Part A: Cohort 2-Period 3 (Day1)||1
9045411|NCT03426995|10105590|FG007|STARTED|Part A: Cohort 2-Period 3 (Day1)||2
9045412|NCT03426995|10105591|FG008|STARTED|Part A: Cohort 2-Period 3 (Day1)||1
9045413|NCT03426995|10105592|FG009|STARTED|Part A: Cohort 2-Period 3 (Day1)||2
9045414|NCT03426995|10105593|FG010|STARTED|Part A: Cohort 2-Period 3 (Day1)||1
9045415|NCT03426995|10105594|FG011|STARTED|Part A: Cohort 2-Period 3 (Day1)||2
9045416|NCT03426995|10105595|FG012|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
9045417|NCT03426995|10105596|FG013|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
9045418|NCT03426995|10105597|FG014|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
9045419|NCT03426995|10105598|FG015|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
9045420|NCT03426995|10105599|FG016|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
9045421|NCT03426995|10105600|FG017|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
9045422|NCT03426995|10105601|FG018|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
9045423|NCT03426995|10105583|FG000|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
9045424|NCT03426995|10105584|FG001|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
9045425|NCT03426995|10105585|FG002|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
9045426|NCT03426995|10105586|FG003|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
8702592|NCT00918203|9748420|FG001|COMPLETED|Crossover to Olaratumab Monotherapy||0
8702593|NCT00918203|9748421|FG002|COMPLETED|Crossover to Olaratumab Monotherapy||18
8702594|NCT00918203|9748419|FG000|NOT COMPLETED|Crossover to Olaratumab Monotherapy||0
8702595|NCT00918203|9748420|FG001|NOT COMPLETED|Crossover to Olaratumab Monotherapy||0
8702596|NCT00918203|9748421|FG002|NOT COMPLETED|Crossover to Olaratumab Monotherapy||0
8702597|NCT00918229|9748433|FG000|STARTED|Overall Study||24
8702598|NCT00918229|9748433|FG000|COMPLETED|Overall Study||24
8702599|NCT00918229|9748433|FG000|NOT COMPLETED|Overall Study||0
8702600|NCT00918255|9748440|FG000|STARTED|Overall Study||51
8702601|NCT00918255|9748441|FG001|STARTED|Overall Study||52
8702602|NCT00918255|9748442|FG002|STARTED|Overall Study||51
8702603|NCT00918255|9748440|FG000|COMPLETED|Overall Study||45
8702604|NCT00918255|9748441|FG001|COMPLETED|Overall Study||52
8702605|NCT00918255|9748442|FG002|COMPLETED|Overall Study||46
8702606|NCT00918255|9748440|FG000|NOT COMPLETED|Overall Study||6
8702607|NCT00918255|9748441|FG001|NOT COMPLETED|Overall Study||0
8702608|NCT00918255|9748442|FG002|NOT COMPLETED|Overall Study||5
8702609|NCT00918281|9748450|FG000|STARTED|Overall Study||70
8702610|NCT00918281|9748450|FG000|COMPLETED|Overall Study||41
8702611|NCT00918281|9748450|FG000|NOT COMPLETED|Overall Study||29
8702612|NCT00918333|9748459|FG000|STARTED|Overall Study||26
8702613|NCT00918333|9748460|FG001|STARTED|Overall Study||98
9045427|NCT03426995|10105587|FG004|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
8702614|NCT00918333|9748459|FG000|COMPLETED|Overall Study||23
8702615|NCT00918333|9748460|FG001|COMPLETED|Overall Study||93
8702616|NCT00918333|9748459|FG000|NOT COMPLETED|Overall Study||3
8702617|NCT00918333|9748460|FG001|NOT COMPLETED|Overall Study||5
8702618|NCT00918346|9748469|FG000|STARTED|First Treatment Period (4 Weeks)||21
8702619|NCT00918346|9748470|FG001|STARTED|First Treatment Period (4 Weeks)||22
8702620|NCT00918346|9748469|FG000|COMPLETED|First Treatment Period (4 Weeks)||21
8702621|NCT00918346|9748470|FG001|COMPLETED|First Treatment Period (4 Weeks)|A patient completed the first treatment period but discontinued thereafter (did not start washout).|21
8702622|NCT00918346|9748469|FG000|NOT COMPLETED|First Treatment Period (4 Weeks)||0
8702623|NCT00918346|9748470|FG001|NOT COMPLETED|First Treatment Period (4 Weeks)||1
8702624|NCT00918346|9748469|FG000|STARTED|Washout (at Least 4 Weeks)||21
8702625|NCT00918346|9748470|FG001|STARTED|Washout (at Least 4 Weeks)||21
8702626|NCT00918346|9748469|FG000|COMPLETED|Washout (at Least 4 Weeks)||21
9045428|NCT03426995|10105588|FG005|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
9045429|NCT03426995|10105589|FG006|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||1
9045430|NCT03426995|10105590|FG007|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||2
9045431|NCT03426995|10105591|FG008|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||1
9045432|NCT03426995|10105592|FG009|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||2
9045433|NCT03426995|10105593|FG010|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||1
9045434|NCT03426995|10105594|FG011|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||2
9045435|NCT03426995|10105595|FG012|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
9045436|NCT03426995|10105596|FG013|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
9045437|NCT03426995|10105597|FG014|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
9045438|NCT03426995|10105598|FG015|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
9045439|NCT03426995|10105599|FG016|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
9045440|NCT03426995|10105600|FG017|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
9045441|NCT03426995|10105601|FG018|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
9045442|NCT03426995|10105583|FG000|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
8702627|NCT00918346|9748470|FG001|COMPLETED|Washout (at Least 4 Weeks)||21
8702628|NCT00918346|9748469|FG000|NOT COMPLETED|Washout (at Least 4 Weeks)||0
8702629|NCT00918346|9748470|FG001|NOT COMPLETED|Washout (at Least 4 Weeks)||0
8702630|NCT00918346|9748469|FG000|STARTED|Second Treatment Period (4 Weeks)||21
8702631|NCT00918346|9748470|FG001|STARTED|Second Treatment Period (4 Weeks)||21
8702632|NCT00918346|9748469|FG000|COMPLETED|Second Treatment Period (4 Weeks)||21
8702633|NCT00918346|9748470|FG001|COMPLETED|Second Treatment Period (4 Weeks)||21
8702634|NCT00918346|9748469|FG000|NOT COMPLETED|Second Treatment Period (4 Weeks)||0
8702635|NCT00918346|9748470|FG001|NOT COMPLETED|Second Treatment Period (4 Weeks)||0
8702636|NCT00918346|9748469|FG000|STARTED|Post Study Period||21
8702637|NCT00918346|9748470|FG001|STARTED|Post Study Period||21
8702638|NCT00918346|9748469|FG000|COMPLETED|Post Study Period||21
8702639|NCT00918346|9748470|FG001|COMPLETED|Post Study Period||21
8702640|NCT00918346|9748469|FG000|NOT COMPLETED|Post Study Period||0
8702641|NCT00918346|9748470|FG001|NOT COMPLETED|Post Study Period||0
8702642|NCT00918385|9748481|FG000|STARTED|Monotherapy||14
8702643|NCT00918385|9748482|FG001|STARTED|Monotherapy||17
8702644|NCT00918385|9748481|FG000|COMPLETED|Monotherapy|Completed = received treatment until first disease progression on single agent.|12
8702645|NCT00918385|9748482|FG001|COMPLETED|Monotherapy|Completed = received treatment until first disease progression on single agent.|11
8702646|NCT00918385|9748481|FG000|NOT COMPLETED|Monotherapy||2
8702647|NCT00918385|9748482|FG001|NOT COMPLETED|Monotherapy||6
8702648|NCT00918385|9748481|FG000|STARTED|Combination Nilutamide and Dasatinib||12
8702649|NCT00918385|9748482|FG001|STARTED|Combination Nilutamide and Dasatinib||11
8702650|NCT00918385|9748481|FG000|COMPLETED|Combination Nilutamide and Dasatinib||6
8702651|NCT00918385|9748482|FG001|COMPLETED|Combination Nilutamide and Dasatinib||3
8702652|NCT00918385|9748481|FG000|NOT COMPLETED|Combination Nilutamide and Dasatinib||6
8702653|NCT00918385|9748482|FG001|NOT COMPLETED|Combination Nilutamide and Dasatinib||8
8702654|NCT00918567|9748492|FG000|STARTED|Overall Study||29
8702655|NCT00918567|9748493|FG001|STARTED|Overall Study||27
8702656|NCT00918567|9748492|FG000|COMPLETED|Overall Study||24
8702657|NCT00918567|9748493|FG001|COMPLETED|Overall Study||25
8702658|NCT00918567|9748492|FG000|NOT COMPLETED|Overall Study||5
8702659|NCT00918567|9748493|FG001|NOT COMPLETED|Overall Study||2
8702660|NCT00918580|9748499|FG000|STARTED|Up to 6-month Follow-up(FU)||158
8702661|NCT00918580|9748499|FG000|Vaccinated Dose 1|Up to 6-month Follow-up(FU)||158
8702662|NCT00918580|9748499|FG000|Vaccinated Dose 2|Up to 6-month Follow-up(FU)||146
8702663|NCT00918580|9748499|FG000|COMPLETED|Up to 6-month Follow-up(FU)|Completed include 1 participant:withdrew before Dose 2 (protocol violation) but completed 6-month FU|147
8702664|NCT00918580|9748499|FG000|NOT COMPLETED|Up to 6-month Follow-up(FU)||11
8702665|NCT00918580|9748499|FG000|STARTED|After 6-month FU to 1-year FU||147
8702666|NCT00918580|9748499|FG000|Continued After 6-Month FU|After 6-month FU to 1-year FU||89
8702667|NCT00918580|9748499|FG000|COMPLETED|After 6-month FU to 1-year FU||87
8702668|NCT00918580|9748499|FG000|NOT COMPLETED|After 6-month FU to 1-year FU||60
8702669|NCT00918671|9748506|FG000|STARTED|Overall Study||60
8702670|NCT00918671|9748506|FG000|COMPLETED|Overall Study||60
8702671|NCT00918671|9748506|FG000|NOT COMPLETED|Overall Study||0
8702672|NCT00918684|9748510|FG000|STARTED|Two Week Drug Washout and Placebo Phase||106
8702673|NCT00918684|9748510|FG000|COMPLETED|Two Week Drug Washout and Placebo Phase||90
8702674|NCT00918684|9748510|FG000|NOT COMPLETED|Two Week Drug Washout and Placebo Phase||16
8702675|NCT00918684|9748510|FG000|STARTED|Treatment Phase||90
8702676|NCT00918684|9748510|FG000|COMPLETED|Treatment Phase||65
8702677|NCT00918684|9748510|FG000|NOT COMPLETED|Treatment Phase||25
8702678|NCT00918723|9748514|FG000|STARTED|Overall Study||40
8702679|NCT00918723|9748514|FG000|COMPLETED|Overall Study||40
8702680|NCT00918723|9748514|FG000|NOT COMPLETED|Overall Study||0
8702681|NCT00918736|9748520|FG000|STARTED|Overall Study|October, 2007|50
9045443|NCT03426995|10105584|FG001|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
9045444|NCT03426995|10105585|FG002|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
8702682|NCT00918736|9748520|FG000|COMPLETED|Overall Study|October, 2008|46
9045445|NCT03426995|10105586|FG003|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
8702683|NCT00918736|9748520|FG000|NOT COMPLETED|Overall Study||4
8702684|NCT00918749|9748527|FG000|STARTED|Overall Study||70
8702685|NCT00918749|9748528|FG001|STARTED|Overall Study||66
8702686|NCT00918749|9748529|FG002|STARTED|Overall Study||69
8724536|NCT01026818|9771753|FG001|NOT COMPLETED|Screening Period||0
9045446|NCT03426995|10105587|FG004|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
9045447|NCT03426995|10105588|FG005|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
9045448|NCT03426995|10105589|FG006|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
9045449|NCT03426995|10105590|FG007|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
9045450|NCT03426995|10105591|FG008|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
9045451|NCT03426995|10105592|FG009|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
9045452|NCT03426995|10105593|FG010|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
9045453|NCT03426995|10105594|FG011|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
9045454|NCT03426995|10105595|FG012|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
8702687|NCT00918749|9748527|FG000|ITT (Intent to Treat) Population|Overall Study|One subject took no study drug and was not included in ITT Population|69
8702688|NCT00918749|9748528|FG001|ITT (Intent to Treat) Population|Overall Study||66
8702689|NCT00918749|9748529|FG002|ITT (Intent to Treat) Population|Overall Study||69
8702690|NCT00918749|9748527|FG000|COMPLETED|Overall Study||63
8702691|NCT00918749|9748528|FG001|COMPLETED|Overall Study||63
8702692|NCT00918749|9748529|FG002|COMPLETED|Overall Study||62
9045455|NCT03426995|10105596|FG013|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
9045456|NCT03426995|10105597|FG014|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
9045457|NCT03426995|10105598|FG015|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
9045458|NCT03426995|10105599|FG016|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
9045459|NCT03426995|10105600|FG017|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
9045460|NCT03426995|10105601|FG018|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
8702693|NCT00918749|9748527|FG000|NOT COMPLETED|Overall Study||7
8702694|NCT00918749|9748528|FG001|NOT COMPLETED|Overall Study||3
8702695|NCT00918749|9748529|FG002|NOT COMPLETED|Overall Study||7
8702696|NCT00918866|9748539|FG000|STARTED|Overall Study||16
8702697|NCT00918866|9748540|FG001|STARTED|Overall Study||16
8702698|NCT00918866|9748539|FG000|COMPLETED|Overall Study||16
8702699|NCT00918866|9748540|FG001|COMPLETED|Overall Study||16
8702700|NCT00918866|9748539|FG000|NOT COMPLETED|Overall Study||0
8702701|NCT00918866|9748540|FG001|NOT COMPLETED|Overall Study||0
8702702|NCT00918879|9748548|FG000|STARTED|Overall Study|Randomized and treated|107
8702703|NCT00918879|9748549|FG001|STARTED|Overall Study|Randomized and treated|106
8702704|NCT00918879|9748548|FG000|COMPLETED|Overall Study|Completed 24 weeks of treatment|101
8702705|NCT00918879|9748549|FG001|COMPLETED|Overall Study|Completed 24 weeks of treatment|100
8702706|NCT00918879|9748548|FG000|NOT COMPLETED|Overall Study||6
8702707|NCT00918879|9748549|FG001|NOT COMPLETED|Overall Study||6
8702708|NCT00918931|9748555|FG000|STARTED|Overall Study||3
8702709|NCT00918931|9748555|FG000|COMPLETED|Overall Study||3
8702710|NCT00918931|9748555|FG000|NOT COMPLETED|Overall Study||0
8702711|NCT00918957|9748561|FG000|STARTED|Overall Study||32
8702712|NCT00918957|9748562|FG001|STARTED|Overall Study||30
8702713|NCT00918957|9748561|FG000|COMPLETED|Overall Study||29
8702714|NCT00918957|9748562|FG001|COMPLETED|Overall Study||30
8702715|NCT00918957|9748561|FG000|NOT COMPLETED|Overall Study||3
8702716|NCT00918957|9748562|FG001|NOT COMPLETED|Overall Study||0
8702717|NCT00919035|9748568|FG000|STARTED|Overall Study||21
8702718|NCT00919035|9748568|FG000|COMPLETED|Overall Study||21
8702719|NCT00919035|9748568|FG000|NOT COMPLETED|Overall Study||0
8702720|NCT00919061|9748572|FG000|STARTED|Overall Study||39
8702721|NCT00919061|9748572|FG000|COMPLETED|Overall Study||37
8702722|NCT00919061|9748572|FG000|NOT COMPLETED|Overall Study||2
8702723|NCT00919100|9748578|FG000|STARTED|Overall Study||40
8702724|NCT00919100|9748579|FG001|STARTED|Overall Study||41
8702725|NCT00919100|9748578|FG000|COMPLETED|Overall Study||40
8702726|NCT00919100|9748579|FG001|COMPLETED|Overall Study||41
8702727|NCT00919100|9748578|FG000|NOT COMPLETED|Overall Study||0
8702728|NCT00919100|9748579|FG001|NOT COMPLETED|Overall Study||0
8702729|NCT00919113|9748587|FG000|STARTED|Overall Study||50
8702730|NCT00919113|9748588|FG001|STARTED|Overall Study||48
8702731|NCT00919113|9748587|FG000|Received Uracyst|Overall Study|One subject was misrandomized. Actual treatment was used for Demographic and Safety analysis.|49
8702732|NCT00919113|9748588|FG001|Received Uracyst|Overall Study||0
8702733|NCT00919113|9748587|FG000|Received Placebo|Overall Study||0
8702734|NCT00919113|9748588|FG001|Received Placebo|Overall Study|One subject was misrandomized. Actual treatment was used for Demographic and Safety analysis.|49
8702735|NCT00919113|9748587|FG000|COMPLETED|Overall Study||41
8702736|NCT00919113|9748588|FG001|COMPLETED|Overall Study||40
8702737|NCT00919113|9748587|FG000|NOT COMPLETED|Overall Study||9
8702738|NCT00919113|9748588|FG001|NOT COMPLETED|Overall Study||8
8702739|NCT00919126|9748597|FG000|STARTED|Overall Study||32
8702740|NCT00919126|9748598|FG001|STARTED|Overall Study||37
8702741|NCT00919126|9748599|FG002|STARTED|Overall Study||33
9045461|NCT03426995|10105583|FG000|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
9045462|NCT03426995|10105584|FG001|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8702742|NCT00919126|9748597|FG000|COMPLETED|Overall Study||31
8702743|NCT00919126|9748598|FG001|COMPLETED|Overall Study||32
8702744|NCT00919126|9748599|FG002|COMPLETED|Overall Study||32
8702745|NCT00919126|9748597|FG000|NOT COMPLETED|Overall Study||1
8702746|NCT00919126|9748598|FG001|NOT COMPLETED|Overall Study||5
8702747|NCT00919126|9748599|FG002|NOT COMPLETED|Overall Study||1
8702748|NCT00919191|9748608|FG000|STARTED|Overall Study||26
8702749|NCT00919191|9748608|FG000|COMPLETED|Overall Study||26
8702750|NCT00919191|9748608|FG000|NOT COMPLETED|Overall Study||0
8702751|NCT00919503|9748616|FG000|STARTED|Overall Study||84
8702752|NCT00919503|9748617|FG001|STARTED|Overall Study||14
8702753|NCT00919503|9748616|FG000|COMPLETED|Overall Study||84
9045463|NCT03426995|10105585|FG002|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
9045464|NCT03426995|10105586|FG003|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
9045465|NCT03426995|10105587|FG004|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
9045466|NCT03426995|10105588|FG005|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
9045467|NCT03426995|10105589|FG006|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||1
9045468|NCT03426995|10105590|FG007|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||2
9045469|NCT03426995|10105591|FG008|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||1
9045470|NCT03426995|10105592|FG009|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||2
9045471|NCT03426995|10105593|FG010|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||1
9045472|NCT03426995|10105594|FG011|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||2
9045473|NCT03426995|10105595|FG012|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
9045474|NCT03426995|10105596|FG013|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
9045475|NCT03426995|10105597|FG014|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
9045476|NCT03426995|10105598|FG015|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
9045477|NCT03426995|10105599|FG016|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
9045478|NCT03426995|10105600|FG017|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
9045479|NCT03426995|10105601|FG018|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
9045480|NCT03426995|10105583|FG000|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
9045481|NCT03426995|10105584|FG001|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
9045482|NCT03426995|10105585|FG002|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
9045483|NCT03426995|10105586|FG003|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
9045484|NCT03426995|10105587|FG004|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
9045485|NCT03426995|10105588|FG005|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
9045486|NCT03426995|10105589|FG006|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||1
9045487|NCT03426995|10105590|FG007|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||2
9045488|NCT03426995|10105591|FG008|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||1
9045489|NCT03426995|10105592|FG009|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||2
9045490|NCT03426995|10105593|FG010|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||1
9045491|NCT03426995|10105594|FG011|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||2
9045492|NCT03426995|10105595|FG012|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
9045493|NCT03426995|10105596|FG013|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
9045494|NCT03426995|10105597|FG014|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
9045495|NCT03426995|10105598|FG015|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
9045496|NCT03426995|10105599|FG016|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
9045497|NCT03426995|10105600|FG017|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
9045498|NCT03426995|10105601|FG018|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
9045499|NCT03426995|10105583|FG000|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
9045500|NCT03426995|10105584|FG001|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
9045501|NCT03426995|10105585|FG002|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
9045502|NCT03426995|10105586|FG003|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
9045503|NCT03426995|10105587|FG004|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
9045504|NCT03426995|10105588|FG005|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
9045505|NCT03426995|10105589|FG006|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
9045506|NCT03426995|10105590|FG007|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
9045507|NCT03426995|10105591|FG008|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
9045508|NCT03426995|10105592|FG009|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
9045509|NCT03426995|10105593|FG010|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
9045510|NCT03426995|10105594|FG011|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
9045511|NCT03426995|10105595|FG012|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
9045512|NCT03426995|10105596|FG013|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
9045513|NCT03426995|10105597|FG014|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
9045514|NCT03426995|10105598|FG015|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
9045515|NCT03426995|10105599|FG016|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
9045516|NCT03426995|10105600|FG017|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
9045517|NCT03426995|10105601|FG018|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
9045518|NCT03426995|10105583|FG000|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
9045519|NCT03426995|10105584|FG001|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
9045520|NCT03426995|10105585|FG002|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
9045521|NCT03426995|10105586|FG003|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
9045522|NCT03426995|10105587|FG004|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
9045523|NCT03426995|10105588|FG005|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
9045524|NCT03426995|10105589|FG006|STARTED|Part A: Cohort 2-Period 4 (Day1)||1
9045525|NCT03426995|10105590|FG007|STARTED|Part A: Cohort 2-Period 4 (Day1)|New participant enrolled and dosed.|3
9045526|NCT03426995|10105591|FG008|STARTED|Part A: Cohort 2-Period 4 (Day1)||1
9045527|NCT03426995|10105592|FG009|STARTED|Part A: Cohort 2-Period 4 (Day1)||2
9045528|NCT03426995|10105593|FG010|STARTED|Part A: Cohort 2-Period 4 (Day1)||1
9045529|NCT03426995|10105594|FG011|STARTED|Part A: Cohort 2-Period 4 (Day1)||2
9045530|NCT03426995|10105595|FG012|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
9045531|NCT03426995|10105596|FG013|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
9045532|NCT03426995|10105597|FG014|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
9045533|NCT03426995|10105598|FG015|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
9045534|NCT03426995|10105599|FG016|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
8812695|NCT01521026|9865724|FG001|STARTED|Overall Study||31
9045535|NCT03426995|10105600|FG017|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
9045536|NCT03426995|10105601|FG018|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
9045537|NCT03426995|10105583|FG000|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
9045538|NCT03426995|10105584|FG001|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
9045539|NCT03426995|10105585|FG002|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
9045540|NCT03426995|10105586|FG003|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
9045541|NCT03426995|10105587|FG004|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
9045542|NCT03426995|10105588|FG005|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
9045543|NCT03426995|10105589|FG006|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||1
9045544|NCT03426995|10105590|FG007|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||2
9045545|NCT03426995|10105591|FG008|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||1
9045546|NCT03426995|10105592|FG009|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||2
9045547|NCT03426995|10105593|FG010|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
9045548|NCT03426995|10105594|FG011|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||2
9045549|NCT03426995|10105595|FG012|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
9045550|NCT03426995|10105596|FG013|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
9045551|NCT03426995|10105597|FG014|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
9045552|NCT03426995|10105598|FG015|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
9045553|NCT03426995|10105599|FG016|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
9045554|NCT03426995|10105600|FG017|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
9045555|NCT03426995|10105601|FG018|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
9045556|NCT03426995|10105583|FG000|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
9045557|NCT03426995|10105584|FG001|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
9045558|NCT03426995|10105585|FG002|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
9045559|NCT03426995|10105586|FG003|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
9045560|NCT03426995|10105587|FG004|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
9045561|NCT03426995|10105588|FG005|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
9045562|NCT03426995|10105589|FG006|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
9045563|NCT03426995|10105590|FG007|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||1
9045564|NCT03426995|10105591|FG008|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
9045565|NCT03426995|10105592|FG009|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
9045566|NCT03426995|10105593|FG010|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||1
9045567|NCT03426995|10105594|FG011|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
9045568|NCT03426995|10105595|FG012|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
9045569|NCT03426995|10105596|FG013|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
9045570|NCT03426995|10105597|FG014|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
9045571|NCT03426995|10105598|FG015|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
9045572|NCT03426995|10105599|FG016|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
9045573|NCT03426995|10105600|FG017|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
9045574|NCT03426995|10105601|FG018|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
9045575|NCT03426995|10105583|FG000|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
9045576|NCT03426995|10105584|FG001|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
9045577|NCT03426995|10105585|FG002|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
9045578|NCT03426995|10105586|FG003|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
9045579|NCT03426995|10105587|FG004|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
9045580|NCT03426995|10105588|FG005|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
9045581|NCT03426995|10105589|FG006|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
9045582|NCT03426995|10105590|FG007|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
9045583|NCT03426995|10105591|FG008|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
9045584|NCT03426995|10105592|FG009|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
9045585|NCT03426995|10105593|FG010|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
9045586|NCT03426995|10105594|FG011|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
9045587|NCT03426995|10105595|FG012|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
9045588|NCT03426995|10105596|FG013|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
9045589|NCT03426995|10105597|FG014|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
9045590|NCT03426995|10105598|FG015|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
9045591|NCT03426995|10105599|FG016|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
9045592|NCT03426995|10105600|FG017|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
9045593|NCT03426995|10105601|FG018|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
9045594|NCT03426995|10105583|FG000|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
9045595|NCT03426995|10105584|FG001|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
9045596|NCT03426995|10105585|FG002|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
9045597|NCT03426995|10105586|FG003|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
9045598|NCT03426995|10105587|FG004|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
9045599|NCT03426995|10105588|FG005|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
9045600|NCT03426995|10105589|FG006|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
9045601|NCT03426995|10105590|FG007|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
9045602|NCT03426995|10105591|FG008|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
9045603|NCT03426995|10105592|FG009|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
9045604|NCT03426995|10105593|FG010|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
9045605|NCT03426995|10105594|FG011|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
9045606|NCT03426995|10105595|FG012|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
9045607|NCT03426995|10105596|FG013|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8702754|NCT00919503|9748617|FG001|COMPLETED|Overall Study||14
8702755|NCT00919503|9748616|FG000|NOT COMPLETED|Overall Study||0
8702756|NCT00919503|9748617|FG001|NOT COMPLETED|Overall Study||0
8702757|NCT00919633|9748627|FG000|STARTED|Overall Study||28
8702758|NCT00919633|9748628|FG001|STARTED|Overall Study||25
8702759|NCT00919633|9748629|FG002|STARTED|Overall Study||27
8702760|NCT00919633|9748630|FG003|STARTED|Overall Study||26
8702761|NCT00919633|9748627|FG000|COMPLETED|Overall Study||6
8702762|NCT00919633|9748628|FG001|COMPLETED|Overall Study||10
8702763|NCT00919633|9748629|FG002|COMPLETED|Overall Study||4
8702764|NCT00919633|9748630|FG003|COMPLETED|Overall Study||5
8702765|NCT00919633|9748627|FG000|NOT COMPLETED|Overall Study||22
8702766|NCT00919633|9748628|FG001|NOT COMPLETED|Overall Study||15
8702767|NCT00919633|9748629|FG002|NOT COMPLETED|Overall Study||23
8702768|NCT00919633|9748630|FG003|NOT COMPLETED|Overall Study||21
8702769|NCT00919711|9748642|FG000|STARTED|Overall Study||435
8702770|NCT00919711|9748643|FG001|STARTED|Overall Study||435
8702771|NCT00919711|9748642|FG000|COMPLETED|Overall Study||402
8702772|NCT00919711|9748643|FG001|COMPLETED|Overall Study||422
8702773|NCT00919711|9748642|FG000|NOT COMPLETED|Overall Study||33
8702774|NCT00919711|9748643|FG001|NOT COMPLETED|Overall Study||13
8702775|NCT00919724|9748651|FG000|STARTED|Overall Study||45
8702776|NCT00919724|9748652|FG001|STARTED|Overall Study||44
8702777|NCT00919724|9748651|FG000|COMPLETED|Overall Study||45
8702778|NCT00919724|9748652|FG001|COMPLETED|Overall Study||44
8702779|NCT00919724|9748651|FG000|NOT COMPLETED|Overall Study||0
8702780|NCT00919724|9748652|FG001|NOT COMPLETED|Overall Study||0
8702781|NCT00919763|9748660|FG000|STARTED|Overall Study||53
8702782|NCT00919763|9748661|FG001|STARTED|Overall Study||49
8702783|NCT00919763|9748660|FG000|COMPLETED|Overall Study||41
8702784|NCT00919763|9748661|FG001|COMPLETED|Overall Study||45
8702785|NCT00919763|9748660|FG000|NOT COMPLETED|Overall Study||12
8702786|NCT00919763|9748661|FG001|NOT COMPLETED|Overall Study||4
8702787|NCT00919802|9748667|FG000|STARTED|First Intervention - (24 Hours)||12
8702788|NCT00919802|9748668|FG001|STARTED|First Intervention - (24 Hours)||13
8702789|NCT00919802|9748667|FG000|COMPLETED|First Intervention - (24 Hours)||12
8702790|NCT00919802|9748668|FG001|COMPLETED|First Intervention - (24 Hours)||13
8702791|NCT00919802|9748667|FG000|NOT COMPLETED|First Intervention - (24 Hours)||0
8702792|NCT00919802|9748668|FG001|NOT COMPLETED|First Intervention - (24 Hours)||0
8702793|NCT00919802|9748667|FG000|STARTED|Second Intervention - (24 Hours)||12
8702794|NCT00919802|9748668|FG001|STARTED|Second Intervention - (24 Hours)||13
8702795|NCT00919802|9748667|FG000|COMPLETED|Second Intervention - (24 Hours)||12
8702796|NCT00919802|9748668|FG001|COMPLETED|Second Intervention - (24 Hours)||13
8702797|NCT00919802|9748667|FG000|NOT COMPLETED|Second Intervention - (24 Hours)||0
8702798|NCT00919802|9748668|FG001|NOT COMPLETED|Second Intervention - (24 Hours)||0
8702799|NCT00919854|9748674|FG000|STARTED|Overall Study||21
8702800|NCT00919854|9748674|FG000|COMPLETED|Overall Study|'Completed' represents the patients that are ongoing at the time of cut-off for the Week 24 analysis|20
8702801|NCT00919854|9748674|FG000|NOT COMPLETED|Overall Study||1
8702802|NCT00919867|9748684|FG000|STARTED|First Intervention||7
8702803|NCT00919867|9748685|FG001|STARTED|First Intervention||7
8702804|NCT00919867|9748686|FG002|STARTED|First Intervention||7
8702805|NCT00919867|9748687|FG003|STARTED|First Intervention||7
8702806|NCT00919867|9748688|FG004|STARTED|First Intervention||7
8702807|NCT00919867|9748689|FG005|STARTED|First Intervention||7
8702808|NCT00919867|9748684|FG000|COMPLETED|First Intervention||7
8702809|NCT00919867|9748685|FG001|COMPLETED|First Intervention||7
8702810|NCT00919867|9748686|FG002|COMPLETED|First Intervention||6
8702811|NCT00919867|9748687|FG003|COMPLETED|First Intervention||7
8702812|NCT00919867|9748688|FG004|COMPLETED|First Intervention||7
8702813|NCT00919867|9748689|FG005|COMPLETED|First Intervention||6
8702814|NCT00919867|9748684|FG000|NOT COMPLETED|First Intervention||0
8702815|NCT00919867|9748685|FG001|NOT COMPLETED|First Intervention||0
8702816|NCT00919867|9748686|FG002|NOT COMPLETED|First Intervention||1
8702817|NCT00919867|9748687|FG003|NOT COMPLETED|First Intervention||0
9045608|NCT03426995|10105597|FG014|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
9045609|NCT03426995|10105598|FG015|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8702818|NCT00919867|9748688|FG004|NOT COMPLETED|First Intervention||0
8702819|NCT00919867|9748689|FG005|NOT COMPLETED|First Intervention||1
8702820|NCT00919867|9748684|FG000|STARTED|Washout||7
8702821|NCT00919867|9748685|FG001|STARTED|Washout||7
8702822|NCT00919867|9748686|FG002|STARTED|Washout||6
8702823|NCT00919867|9748687|FG003|STARTED|Washout||7
8702824|NCT00919867|9748688|FG004|STARTED|Washout||7
8702825|NCT00919867|9748689|FG005|STARTED|Washout||6
8702826|NCT00919867|9748684|FG000|COMPLETED|Washout||7
8702827|NCT00919867|9748685|FG001|COMPLETED|Washout||7
8702828|NCT00919867|9748686|FG002|COMPLETED|Washout||6
8702829|NCT00919867|9748687|FG003|COMPLETED|Washout||7
8702830|NCT00919867|9748688|FG004|COMPLETED|Washout||7
8702831|NCT00919867|9748689|FG005|COMPLETED|Washout||6
8702832|NCT00919867|9748684|FG000|NOT COMPLETED|Washout||0
9045610|NCT03426995|10105599|FG016|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
9045611|NCT03426995|10105600|FG017|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
9045612|NCT03426995|10105601|FG018|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
9045613|NCT03426995|10105583|FG000|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
9045614|NCT03426995|10105584|FG001|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
9045615|NCT03426995|10105585|FG002|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
9045616|NCT03426995|10105586|FG003|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
9045617|NCT03426995|10105587|FG004|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
9045618|NCT03426995|10105588|FG005|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
9045619|NCT03426995|10105589|FG006|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
9045620|NCT03426995|10105590|FG007|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
9045621|NCT03426995|10105591|FG008|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
9045622|NCT03426995|10105592|FG009|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
9045623|NCT03426995|10105593|FG010|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
9045624|NCT03426995|10105594|FG011|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
9045625|NCT03426995|10105595|FG012|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
9045626|NCT03426995|10105596|FG013|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
9045627|NCT03426995|10105597|FG014|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
9045628|NCT03426995|10105598|FG015|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
9045629|NCT03426995|10105599|FG016|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
9045630|NCT03426995|10105600|FG017|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
9045631|NCT03426995|10105601|FG018|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
9045632|NCT03426995|10105583|FG000|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
9045633|NCT03426995|10105584|FG001|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
9045634|NCT03426995|10105585|FG002|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
9045635|NCT03426995|10105586|FG003|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
9045636|NCT03426995|10105587|FG004|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
9045637|NCT03426995|10105588|FG005|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
9045638|NCT03426995|10105589|FG006|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
9045639|NCT03426995|10105590|FG007|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
9045640|NCT03426995|10105591|FG008|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
9045641|NCT03426995|10105592|FG009|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
9045642|NCT03426995|10105593|FG010|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
9045643|NCT03426995|10105594|FG011|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
9045644|NCT03426995|10105595|FG012|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
9045645|NCT03426995|10105596|FG013|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
9045646|NCT03426995|10105597|FG014|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
9045647|NCT03426995|10105598|FG015|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
9045648|NCT03426995|10105599|FG016|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
9045649|NCT03426995|10105600|FG017|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
9045650|NCT03426995|10105601|FG018|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
9045651|NCT03426995|10105583|FG000|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
9045652|NCT03426995|10105584|FG001|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
9045653|NCT03426995|10105585|FG002|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
9045654|NCT03426995|10105586|FG003|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
9045655|NCT03426995|10105587|FG004|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
9045656|NCT03426995|10105588|FG005|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
9045657|NCT03426995|10105589|FG006|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
9045658|NCT03426995|10105590|FG007|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8702833|NCT00919867|9748685|FG001|NOT COMPLETED|Washout||0
8702834|NCT00919867|9748686|FG002|NOT COMPLETED|Washout||0
8702835|NCT00919867|9748687|FG003|NOT COMPLETED|Washout||0
8702836|NCT00919867|9748688|FG004|NOT COMPLETED|Washout||0
8702837|NCT00919867|9748689|FG005|NOT COMPLETED|Washout||0
8702838|NCT00919867|9748684|FG000|STARTED|Second Intervention||7
8702839|NCT00919867|9748685|FG001|STARTED|Second Intervention||7
8702840|NCT00919867|9748686|FG002|STARTED|Second Intervention||6
8702841|NCT00919867|9748687|FG003|STARTED|Second Intervention||7
8702842|NCT00919867|9748688|FG004|STARTED|Second Intervention||7
8702843|NCT00919867|9748689|FG005|STARTED|Second Intervention||6
8702844|NCT00919867|9748684|FG000|COMPLETED|Second Intervention||7
8702845|NCT00919867|9748685|FG001|COMPLETED|Second Intervention||7
8702846|NCT00919867|9748686|FG002|COMPLETED|Second Intervention||6
8702847|NCT00919867|9748687|FG003|COMPLETED|Second Intervention||7
8702848|NCT00919867|9748688|FG004|COMPLETED|Second Intervention||7
8702849|NCT00919867|9748689|FG005|COMPLETED|Second Intervention||6
8702850|NCT00919867|9748684|FG000|NOT COMPLETED|Second Intervention||0
8702851|NCT00919867|9748685|FG001|NOT COMPLETED|Second Intervention||0
8702852|NCT00919867|9748686|FG002|NOT COMPLETED|Second Intervention||0
8702853|NCT00919867|9748687|FG003|NOT COMPLETED|Second Intervention||0
8702854|NCT00919867|9748688|FG004|NOT COMPLETED|Second Intervention||0
8702855|NCT00919867|9748689|FG005|NOT COMPLETED|Second Intervention||0
8702856|NCT00919867|9748684|FG000|STARTED|Washout||7
8702857|NCT00919867|9748685|FG001|STARTED|Washout||7
8702858|NCT00919867|9748686|FG002|STARTED|Washout||6
8702859|NCT00919867|9748687|FG003|STARTED|Washout||7
8702860|NCT00919867|9748688|FG004|STARTED|Washout||7
8702861|NCT00919867|9748689|FG005|STARTED|Washout||6
8702862|NCT00919867|9748684|FG000|COMPLETED|Washout||7
8702863|NCT00919867|9748685|FG001|COMPLETED|Washout||7
9045659|NCT03426995|10105591|FG008|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
9045660|NCT03426995|10105592|FG009|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
9045661|NCT03426995|10105593|FG010|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8702864|NCT00919867|9748686|FG002|COMPLETED|Washout||6
8702865|NCT00919867|9748687|FG003|COMPLETED|Washout||7
8702866|NCT00919867|9748688|FG004|COMPLETED|Washout||7
8702867|NCT00919867|9748689|FG005|COMPLETED|Washout||6
8702868|NCT00919867|9748684|FG000|NOT COMPLETED|Washout||0
8702869|NCT00919867|9748685|FG001|NOT COMPLETED|Washout||0
8702870|NCT00919867|9748686|FG002|NOT COMPLETED|Washout||0
8702871|NCT00919867|9748687|FG003|NOT COMPLETED|Washout||0
8702872|NCT00919867|9748688|FG004|NOT COMPLETED|Washout||0
8702873|NCT00919867|9748689|FG005|NOT COMPLETED|Washout||0
8702874|NCT00919867|9748684|FG000|STARTED|Third Intervention||7
8702875|NCT00919867|9748685|FG001|STARTED|Third Intervention||7
8702876|NCT00919867|9748686|FG002|STARTED|Third Intervention||6
8702877|NCT00919867|9748687|FG003|STARTED|Third Intervention||7
8702878|NCT00919867|9748688|FG004|STARTED|Third Intervention||7
8702879|NCT00919867|9748689|FG005|STARTED|Third Intervention||6
8702880|NCT00919867|9748684|FG000|COMPLETED|Third Intervention||7
8702881|NCT00919867|9748685|FG001|COMPLETED|Third Intervention||7
8702882|NCT00919867|9748686|FG002|COMPLETED|Third Intervention||6
8702883|NCT00919867|9748687|FG003|COMPLETED|Third Intervention||7
8702884|NCT00919867|9748688|FG004|COMPLETED|Third Intervention||7
8702885|NCT00919867|9748689|FG005|COMPLETED|Third Intervention||6
8702886|NCT00919867|9748684|FG000|NOT COMPLETED|Third Intervention||0
8702887|NCT00919867|9748685|FG001|NOT COMPLETED|Third Intervention||0
8702888|NCT00919867|9748686|FG002|NOT COMPLETED|Third Intervention||0
8702889|NCT00919867|9748687|FG003|NOT COMPLETED|Third Intervention||0
8702890|NCT00919867|9748688|FG004|NOT COMPLETED|Third Intervention||0
8702891|NCT00919867|9748689|FG005|NOT COMPLETED|Third Intervention||0
8702892|NCT00919932|9748699|FG000|STARTED|Overall Study||4
8702893|NCT00919932|9748700|FG001|STARTED|Overall Study||5
8702894|NCT00919932|9748699|FG000|COMPLETED|Overall Study||4
8702895|NCT00919932|9748700|FG001|COMPLETED|Overall Study||5
8702896|NCT00919932|9748699|FG000|NOT COMPLETED|Overall Study||0
8702897|NCT00919932|9748700|FG001|NOT COMPLETED|Overall Study||0
8702898|NCT00920023|9748706|FG000|STARTED|Overall Study||15
8702899|NCT00920023|9748706|FG000|COMPLETED|Overall Study||15
8702900|NCT00920023|9748706|FG000|NOT COMPLETED|Overall Study||0
8702901|NCT00920075|9748710|FG000|STARTED|Last Study, 25 Pts Invited,11 Responded||11
8702902|NCT00920075|9748710|FG000|COMPLETED|Last Study, 25 Pts Invited,11 Responded||11
8702903|NCT00920075|9748710|FG000|NOT COMPLETED|Last Study, 25 Pts Invited,11 Responded||0
8702904|NCT00920075|9748710|FG000|STARTED|Post Study, 11 Pts Responded||11
8702905|NCT00920075|9748710|FG000|COMPLETED|Post Study, 11 Pts Responded||11
8702906|NCT00920075|9748710|FG000|NOT COMPLETED|Post Study, 11 Pts Responded||0
8702907|NCT00920140|9748719|FG000|STARTED|Phase 1 (Dose Escalation)||5
8702908|NCT00920140|9748720|FG001|STARTED|Phase 1 (Dose Escalation)||9
8702909|NCT00920140|9748721|FG002|STARTED|Phase 1 (Dose Escalation)||0
8702910|NCT00920140|9748722|FG003|STARTED|Phase 1 (Dose Escalation)||0
8702911|NCT00920140|9748723|FG004|STARTED|Phase 1 (Dose Escalation)||0
8702912|NCT00920140|9748719|FG000|COMPLETED|Phase 1 (Dose Escalation)||0
8702913|NCT00920140|9748720|FG001|COMPLETED|Phase 1 (Dose Escalation)||0
8702914|NCT00920140|9748721|FG002|COMPLETED|Phase 1 (Dose Escalation)||0
8702915|NCT00920140|9748722|FG003|COMPLETED|Phase 1 (Dose Escalation)||0
8702916|NCT00920140|9748723|FG004|COMPLETED|Phase 1 (Dose Escalation)||0
8702917|NCT00920140|9748719|FG000|NOT COMPLETED|Phase 1 (Dose Escalation)||5
8702918|NCT00920140|9748720|FG001|NOT COMPLETED|Phase 1 (Dose Escalation)||9
8702919|NCT00920140|9748721|FG002|NOT COMPLETED|Phase 1 (Dose Escalation)||0
8702920|NCT00920140|9748722|FG003|NOT COMPLETED|Phase 1 (Dose Escalation)||0
8702921|NCT00920140|9748723|FG004|NOT COMPLETED|Phase 1 (Dose Escalation)||0
8702922|NCT00920140|9748719|FG000|STARTED|Phase 2||0
8702923|NCT00920140|9748720|FG001|STARTED|Phase 2||0
8702924|NCT00920140|9748721|FG002|STARTED|Phase 2||50
8702925|NCT00920140|9748722|FG003|STARTED|Phase 2||22
8702926|NCT00920140|9748723|FG004|STARTED|Phase 2||11
8702927|NCT00920140|9748719|FG000|COMPLETED|Phase 2||0
8702928|NCT00920140|9748720|FG001|COMPLETED|Phase 2||0
8702929|NCT00920140|9748721|FG002|COMPLETED|Phase 2||0
8702930|NCT00920140|9748722|FG003|COMPLETED|Phase 2||0
8702931|NCT00920140|9748723|FG004|COMPLETED|Phase 2||0
9045662|NCT03426995|10105594|FG011|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
9045663|NCT03426995|10105595|FG012|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
9045664|NCT03426995|10105596|FG013|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8702932|NCT00920140|9748719|FG000|NOT COMPLETED|Phase 2||0
8702933|NCT00920140|9748720|FG001|NOT COMPLETED|Phase 2||0
8702934|NCT00920140|9748721|FG002|NOT COMPLETED|Phase 2||50
8702935|NCT00920140|9748722|FG003|NOT COMPLETED|Phase 2||22
8702936|NCT00920140|9748723|FG004|NOT COMPLETED|Phase 2||11
8702937|NCT00920218|9748740|FG000|STARTED|Overall Study||30
8702938|NCT00920218|9748741|FG001|STARTED|Overall Study||29
8702939|NCT00920218|9748742|FG002|STARTED|Overall Study||31
8702940|NCT00920218|9748743|FG003|STARTED|Overall Study||30
8702941|NCT00920218|9748740|FG000|COMPLETED|Overall Study||28
8702942|NCT00920218|9748741|FG001|COMPLETED|Overall Study||24
8702943|NCT00920218|9748742|FG002|COMPLETED|Overall Study||23
8702944|NCT00920218|9748743|FG003|COMPLETED|Overall Study||23
8702945|NCT00920218|9748740|FG000|NOT COMPLETED|Overall Study||2
8702946|NCT00920218|9748741|FG001|NOT COMPLETED|Overall Study||5
9045665|NCT03426995|10105597|FG014|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
9045666|NCT03426995|10105598|FG015|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
9045667|NCT03426995|10105599|FG016|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
9045668|NCT03426995|10105600|FG017|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8702947|NCT00920218|9748742|FG002|NOT COMPLETED|Overall Study||8
8702948|NCT00920218|9748743|FG003|NOT COMPLETED|Overall Study||7
8724537|NCT01026818|9771754|FG002|NOT COMPLETED|Screening Period||0
8724538|NCT01026818|9771755|FG003|NOT COMPLETED|Screening Period||0
8724539|NCT01026818|9771752|FG000|STARTED|DB Treatment Period (Month 0 - 9)||0
8724540|NCT01026818|9771753|FG001|STARTED|DB Treatment Period (Month 0 - 9)||139
8724541|NCT01026818|9771754|FG002|STARTED|DB Treatment Period (Month 0 - 9)||143
8724542|NCT01026818|9771755|FG003|STARTED|DB Treatment Period (Month 0 - 9)||141
8724543|NCT01026818|9771752|FG000|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||0
8724544|NCT01026818|9771753|FG001|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||139
8724545|NCT01026818|9771754|FG002|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||143
8724546|NCT01026818|9771755|FG003|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||141
8724547|NCT01026818|9771752|FG000|COMPLETED|DB Treatment Period (Month 0 - 9)||0
8724548|NCT01026818|9771753|FG001|COMPLETED|DB Treatment Period (Month 0 - 9)||114
8724549|NCT01026818|9771754|FG002|COMPLETED|DB Treatment Period (Month 0 - 9)||122
8724550|NCT01026818|9771755|FG003|COMPLETED|DB Treatment Period (Month 0 - 9)||115
8724551|NCT01026818|9771752|FG000|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||0
8724552|NCT01026818|9771753|FG001|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||25
8724553|NCT01026818|9771754|FG002|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||21
8724554|NCT01026818|9771755|FG003|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||26
8724555|NCT01026818|9771752|FG000|STARTED|Drug-Free Washout Period (Month 9-10.5)||0
8724556|NCT01026818|9771753|FG001|STARTED|Drug-Free Washout Period (Month 9-10.5)||114
8724557|NCT01026818|9771754|FG002|STARTED|Drug-Free Washout Period (Month 9-10.5)||122
8724558|NCT01026818|9771755|FG003|STARTED|Drug-Free Washout Period (Month 9-10.5)||115
8724559|NCT01026818|9771752|FG000|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||0
8724560|NCT01026818|9771753|FG001|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||105
8724561|NCT01026818|9771754|FG002|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||117
8724562|NCT01026818|9771755|FG003|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||108
8724563|NCT01026818|9771752|FG000|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||0
8724564|NCT01026818|9771753|FG001|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||9
8724565|NCT01026818|9771754|FG002|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||5
8724566|NCT01026818|9771755|FG003|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||7
8724567|NCT01026818|9771752|FG000|STARTED|OL Period (Month 10.5 - 13.5)||0
8724568|NCT01026818|9771753|FG001|STARTED|OL Period (Month 10.5 - 13.5)||105
8724569|NCT01026818|9771754|FG002|STARTED|OL Period (Month 10.5 - 13.5)||117
8724570|NCT01026818|9771755|FG003|STARTED|OL Period (Month 10.5 - 13.5)||108
8724571|NCT01026818|9771752|FG000|COMPLETED|OL Period (Month 10.5 - 13.5)||0
8724572|NCT01026818|9771753|FG001|COMPLETED|OL Period (Month 10.5 - 13.5)||98
8724573|NCT01026818|9771754|FG002|COMPLETED|OL Period (Month 10.5 - 13.5)||112
8724574|NCT01026818|9771755|FG003|COMPLETED|OL Period (Month 10.5 - 13.5)||105
8724575|NCT01026818|9771752|FG000|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||0
8724576|NCT01026818|9771753|FG001|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||7
8724577|NCT01026818|9771754|FG002|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||5
8724578|NCT01026818|9771755|FG003|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||3
8724579|NCT01026831|9771769|FG000|STARTED|Overall Study|randomized|320
8724580|NCT01026831|9771770|FG001|STARTED|Overall Study|randomized|323
8724581|NCT01026831|9771769|FG000|COMPLETED|Overall Study||306
8724582|NCT01026831|9771770|FG001|COMPLETED|Overall Study||312
8724583|NCT01026831|9771769|FG000|NOT COMPLETED|Overall Study||14
8724584|NCT01026831|9771770|FG001|NOT COMPLETED|Overall Study||11
8724585|NCT01026844|9771778|FG000|STARTED|Overall Study||19
8724586|NCT01026844|9771779|FG001|STARTED|Overall Study||8
8724587|NCT01026844|9771778|FG000|COMPLETED|Overall Study||19
8724588|NCT01026844|9771779|FG001|COMPLETED|Overall Study||8
8724589|NCT01026844|9771778|FG000|NOT COMPLETED|Overall Study||0
8724590|NCT01026844|9771779|FG001|NOT COMPLETED|Overall Study||0
8724591|NCT01026909|9771787|FG000|STARTED|Overall Study||1
8724592|NCT01026909|9771788|FG001|STARTED|Overall Study||2
8724593|NCT01026909|9771787|FG000|COMPLETED|Overall Study||1
8724594|NCT01026909|9771788|FG001|COMPLETED|Overall Study||2
8724595|NCT01026909|9771787|FG000|NOT COMPLETED|Overall Study||0
8724596|NCT01026909|9771788|FG001|NOT COMPLETED|Overall Study||0
8725169|NCT01029691|9772359|FG001|STARTED|Continued APAP to Delivery||16
8725170|NCT01029691|9772360|FG002|STARTED|Continued APAP to Delivery||77
8725171|NCT01029691|9772358|FG000|COMPLETED|Continued APAP to Delivery||20
8725172|NCT01029691|9772359|FG001|COMPLETED|Continued APAP to Delivery||16
8725173|NCT01029691|9772360|FG002|COMPLETED|Continued APAP to Delivery||76
8725174|NCT01029691|9772358|FG000|NOT COMPLETED|Continued APAP to Delivery||0
8725175|NCT01029691|9772359|FG001|NOT COMPLETED|Continued APAP to Delivery||0
8725176|NCT01029691|9772360|FG002|NOT COMPLETED|Continued APAP to Delivery||1
8725177|NCT01029704|9772378|FG000|STARTED|Overall Study||5
8725178|NCT01029704|9772379|FG001|STARTED|Overall Study||5
8725179|NCT01029704|9772380|FG002|STARTED|Overall Study||5
8725180|NCT01029704|9772381|FG003|STARTED|Overall Study||5
8725181|NCT01029704|9772382|FG004|STARTED|Overall Study||28
8725182|NCT01029704|9772383|FG005|STARTED|Overall Study||24
9045669|NCT03426995|10105601|FG018|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
9045670|NCT03426995|10105583|FG000|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
9045671|NCT03426995|10105584|FG001|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
9045672|NCT03426995|10105585|FG002|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
9045673|NCT03426995|10105586|FG003|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
9045674|NCT03426995|10105587|FG004|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
9045675|NCT03426995|10105588|FG005|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
9045676|NCT03426995|10105589|FG006|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
9045677|NCT03426995|10105590|FG007|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
9045678|NCT03426995|10105591|FG008|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
9045679|NCT03426995|10105592|FG009|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
9045680|NCT03426995|10105593|FG010|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
9045681|NCT03426995|10105594|FG011|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
9045682|NCT03426995|10105595|FG012|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
9045683|NCT03426995|10105596|FG013|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
9045684|NCT03426995|10105597|FG014|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
9045685|NCT03426995|10105598|FG015|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
9045686|NCT03426995|10105599|FG016|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
9045687|NCT03426995|10105600|FG017|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
9045688|NCT03426995|10105601|FG018|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
9045689|NCT03426995|10105583|FG000|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
9045690|NCT03426995|10105584|FG001|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
9045691|NCT03426995|10105585|FG002|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
9045692|NCT03426995|10105586|FG003|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
9045693|NCT03426995|10105587|FG004|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
9045694|NCT03426995|10105588|FG005|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
9045695|NCT03426995|10105589|FG006|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
9045696|NCT03426995|10105590|FG007|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
9045697|NCT03426995|10105591|FG008|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
9045698|NCT03426995|10105592|FG009|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
9045699|NCT03426995|10105593|FG010|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
9045700|NCT03426995|10105594|FG011|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
9045701|NCT03426995|10105595|FG012|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
9045702|NCT03426995|10105596|FG013|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
9045703|NCT03426995|10105597|FG014|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
9045704|NCT03426995|10105598|FG015|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
9045705|NCT03426995|10105599|FG016|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
9045706|NCT03426995|10105600|FG017|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
9045707|NCT03426995|10105601|FG018|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
9045708|NCT03426995|10105583|FG000|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8702949|NCT00920231|9748759|FG000|STARTED|Overall Study||8
8702950|NCT00920231|9748760|FG001|STARTED|Overall Study||8
8702951|NCT00920231|9748759|FG000|COMPLETED|Overall Study||8
8702952|NCT00920231|9748760|FG001|COMPLETED|Overall Study||8
8702953|NCT00920231|9748759|FG000|NOT COMPLETED|Overall Study||0
8702954|NCT00920231|9748760|FG001|NOT COMPLETED|Overall Study||0
8702955|NCT00920374|9748770|FG000|STARTED|Overall Study||61
8702956|NCT00920374|9748771|FG001|STARTED|Overall Study||57
8702957|NCT00920374|9748770|FG000|COMPLETED|Overall Study||61
8702958|NCT00920374|9748771|FG001|COMPLETED|Overall Study||57
8702959|NCT00920374|9748770|FG000|NOT COMPLETED|Overall Study||0
8702960|NCT00920374|9748771|FG001|NOT COMPLETED|Overall Study||0
8702961|NCT00920426|9748780|FG000|STARTED|ITZ111451||8
8702962|NCT00920426|9748781|FG001|STARTED|ITZ111451||0
8702963|NCT00920426|9748782|FG002|STARTED|ITZ111451||0
8702964|NCT00920426|9748783|FG003|STARTED|ITZ111451||0
8702965|NCT00920426|9748780|FG000|COMPLETED|ITZ111451||7
8702966|NCT00920426|9748781|FG001|COMPLETED|ITZ111451||0
8702967|NCT00920426|9748782|FG002|COMPLETED|ITZ111451||0
8702968|NCT00920426|9748783|FG003|COMPLETED|ITZ111451||0
8702969|NCT00920426|9748780|FG000|NOT COMPLETED|ITZ111451||1
8702970|NCT00920426|9748781|FG001|NOT COMPLETED|ITZ111451||0
8702971|NCT00920426|9748782|FG002|NOT COMPLETED|ITZ111451||0
8702972|NCT00920426|9748783|FG003|NOT COMPLETED|ITZ111451||0
8702973|NCT00920426|9748780|FG000|STARTED|ITZ112929: Randomized Regimen||0
8702974|NCT00920426|9748781|FG001|STARTED|ITZ112929: Randomized Regimen||7
8702975|NCT00920426|9748782|FG002|STARTED|ITZ112929: Randomized Regimen||2
8702976|NCT00920426|9748783|FG003|STARTED|ITZ112929: Randomized Regimen||0
8702977|NCT00920426|9748780|FG000|COMPLETED|ITZ112929: Randomized Regimen||0
8702978|NCT00920426|9748781|FG001|COMPLETED|ITZ112929: Randomized Regimen||7
8702979|NCT00920426|9748782|FG002|COMPLETED|ITZ112929: Randomized Regimen||2
8702980|NCT00920426|9748783|FG003|COMPLETED|ITZ112929: Randomized Regimen||0
8702981|NCT00920426|9748780|FG000|NOT COMPLETED|ITZ112929: Randomized Regimen||0
8702982|NCT00920426|9748781|FG001|NOT COMPLETED|ITZ112929: Randomized Regimen||0
8702983|NCT00920426|9748782|FG002|NOT COMPLETED|ITZ112929: Randomized Regimen||0
8702984|NCT00920426|9748783|FG003|NOT COMPLETED|ITZ112929: Randomized Regimen||0
8702985|NCT00920426|9748780|FG000|STARTED|ITZ112929: Optimized Therapy (OT)||0
8702986|NCT00920426|9748781|FG001|STARTED|ITZ112929: Optimized Therapy (OT)||0
8702987|NCT00920426|9748782|FG002|STARTED|ITZ112929: Optimized Therapy (OT)||0
8724597|NCT01026948|9771794|FG000|STARTED|Overall Study||70
9045709|NCT03426995|10105584|FG001|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
9045710|NCT03426995|10105585|FG002|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
9045711|NCT03426995|10105586|FG003|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
9045712|NCT03426995|10105587|FG004|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
9045713|NCT03426995|10105588|FG005|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
9045714|NCT03426995|10105589|FG006|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
9045715|NCT03426995|10105590|FG007|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
9045716|NCT03426995|10105591|FG008|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
9045717|NCT03426995|10105592|FG009|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8702988|NCT00920426|9748783|FG003|STARTED|ITZ112929: Optimized Therapy (OT)|Out of 9 participants receiving randomized regimen, 8 participants continued to receive OT.|8
8702989|NCT00920426|9748780|FG000|COMPLETED|ITZ112929: Optimized Therapy (OT)||0
8702990|NCT00920426|9748781|FG001|COMPLETED|ITZ112929: Optimized Therapy (OT)||0
8702991|NCT00920426|9748782|FG002|COMPLETED|ITZ112929: Optimized Therapy (OT)||0
8702992|NCT00920426|9748783|FG003|COMPLETED|ITZ112929: Optimized Therapy (OT)||8
8702993|NCT00920426|9748780|FG000|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0
8702994|NCT00920426|9748781|FG001|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0
8702995|NCT00920426|9748782|FG002|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0
8702996|NCT00920426|9748783|FG003|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0
8702997|NCT00920439|9748795|FG000|STARTED|Overall Study||25
8702998|NCT00920439|9748795|FG000|COMPLETED|Overall Study||25
8702999|NCT00920439|9748795|FG000|NOT COMPLETED|Overall Study||0
8703000|NCT00920556|9748799|FG000|STARTED|Overall Study||24
8703001|NCT00920556|9748799|FG000|COMPLETED|Overall Study||0
8703002|NCT00920556|9748799|FG000|NOT COMPLETED|Overall Study||24
8703003|NCT00920647|9748811|FG000|STARTED|Overall Study||4
8703004|NCT00920647|9748812|FG001|STARTED|Overall Study||4
8703005|NCT00920647|9748813|FG002|STARTED|Overall Study||4
8703006|NCT00920647|9748814|FG003|STARTED|Overall Study||4
8703007|NCT00920647|9748811|FG000|COMPLETED|Overall Study||4
8703008|NCT00920647|9748812|FG001|COMPLETED|Overall Study||4
8703009|NCT00920647|9748813|FG002|COMPLETED|Overall Study||4
8703010|NCT00920647|9748814|FG003|COMPLETED|Overall Study||4
8703011|NCT00920647|9748811|FG000|NOT COMPLETED|Overall Study||0
8703012|NCT00920647|9748812|FG001|NOT COMPLETED|Overall Study||0
8703013|NCT00920647|9748813|FG002|NOT COMPLETED|Overall Study||0
8703014|NCT00920647|9748814|FG003|NOT COMPLETED|Overall Study||0
8703015|NCT00920686|9748837|FG000|STARTED|Overall Study||82
8703016|NCT00920686|9748838|FG001|STARTED|Overall Study||82
8703017|NCT00920686|9748839|FG002|STARTED|Overall Study||75
8703018|NCT00920686|9748837|FG000|COMPLETED|Overall Study||63
8703019|NCT00920686|9748838|FG001|COMPLETED|Overall Study||60
8703020|NCT00920686|9748839|FG002|COMPLETED|Overall Study||62
8703021|NCT00920686|9748837|FG000|NOT COMPLETED|Overall Study||19
8703022|NCT00920686|9748838|FG001|NOT COMPLETED|Overall Study||22
8703023|NCT00920686|9748839|FG002|NOT COMPLETED|Overall Study||13
8703024|NCT00920699|9748854|FG000|STARTED|Overall Study||29
8703025|NCT00920699|9748855|FG001|STARTED|Overall Study||30
8703026|NCT00920699|9748856|FG002|STARTED|Overall Study||32
8703027|NCT00920699|9748854|FG000|COMPLETED|Overall Study||27
8703028|NCT00920699|9748855|FG001|COMPLETED|Overall Study||29
8703029|NCT00920699|9748856|FG002|COMPLETED|Overall Study||28
8703030|NCT00920699|9748854|FG000|NOT COMPLETED|Overall Study||2
8703031|NCT00920699|9748855|FG001|NOT COMPLETED|Overall Study||1
8703032|NCT00920699|9748856|FG002|NOT COMPLETED|Overall Study||4
8703033|NCT00920790|9748864|FG000|STARTED|Overall Study||27
8703034|NCT00920790|9748864|FG000|COMPLETED|Overall Study||13
8703035|NCT00920790|9748864|FG000|NOT COMPLETED|Overall Study||14
8703036|NCT00920829|9748872|FG000|STARTED|Allocation||38
8703037|NCT00920829|9748873|FG001|STARTED|Allocation||39
8703038|NCT00920829|9748874|FG002|STARTED|Allocation||38
8703039|NCT00920829|9748875|FG003|STARTED|Allocation||37
8703040|NCT00920829|9748872|FG000|COMPLETED|Allocation||35
8703041|NCT00920829|9748873|FG001|COMPLETED|Allocation||38
8703042|NCT00920829|9748874|FG002|COMPLETED|Allocation||38
8703043|NCT00920829|9748875|FG003|COMPLETED|Allocation||35
8703044|NCT00920829|9748872|FG000|NOT COMPLETED|Allocation||3
8703045|NCT00920829|9748873|FG001|NOT COMPLETED|Allocation||1
8703046|NCT00920829|9748874|FG002|NOT COMPLETED|Allocation||0
8703047|NCT00920829|9748875|FG003|NOT COMPLETED|Allocation||2
8703048|NCT00920829|9748872|FG000|STARTED|Available for Analysis||35
8703049|NCT00920829|9748873|FG001|STARTED|Available for Analysis||38
8703050|NCT00920829|9748874|FG002|STARTED|Available for Analysis||38
8703051|NCT00920829|9748875|FG003|STARTED|Available for Analysis||35
8703052|NCT00920829|9748872|FG000|COMPLETED|Available for Analysis||27
8703053|NCT00920829|9748873|FG001|COMPLETED|Available for Analysis||27
8703054|NCT00920829|9748874|FG002|COMPLETED|Available for Analysis||28
8703055|NCT00920829|9748875|FG003|COMPLETED|Available for Analysis||24
8703056|NCT00920829|9748872|FG000|NOT COMPLETED|Available for Analysis||8
8703057|NCT00920829|9748873|FG001|NOT COMPLETED|Available for Analysis||11
8703058|NCT00920829|9748874|FG002|NOT COMPLETED|Available for Analysis||10
8703059|NCT00920829|9748875|FG003|NOT COMPLETED|Available for Analysis||11
8703060|NCT00920855|9748888|FG000|STARTED|Overall Study||5
8703061|NCT00920855|9748889|FG001|STARTED|Overall Study||4
8703062|NCT00920855|9748890|FG002|STARTED|Overall Study||31
8703063|NCT00920855|9748888|FG000|Safety and Efficacy Populations|Overall Study||5
8703064|NCT00920855|9748889|FG001|Safety and Efficacy Populations|Overall Study||4
8703065|NCT00920855|9748890|FG002|Safety and Efficacy Populations|Overall Study||31
9045718|NCT03426995|10105593|FG010|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
9045719|NCT03426995|10105594|FG011|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
9045720|NCT03426995|10105595|FG012|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
9045721|NCT03426995|10105596|FG013|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
9045722|NCT03426995|10105597|FG014|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8703066|NCT00920855|9748888|FG000|COMPLETED|Overall Study|completed eight cycles of treatment|0
8703067|NCT00920855|9748889|FG001|COMPLETED|Overall Study|completed eight cycles of treatment|1
8703068|NCT00920855|9748890|FG002|COMPLETED|Overall Study|completed eight cycles of treatment|9
8703069|NCT00920855|9748888|FG000|NOT COMPLETED|Overall Study||5
8703070|NCT00920855|9748889|FG001|NOT COMPLETED|Overall Study||3
8703071|NCT00920855|9748890|FG002|NOT COMPLETED|Overall Study||22
8703072|NCT00920907|9748901|FG000|STARTED|Induction Period||37
8703073|NCT00920907|9748902|FG001|STARTED|Induction Period||38
8703074|NCT00920907|9748901|FG000|COMPLETED|Induction Period||15
8703075|NCT00920907|9748902|FG001|COMPLETED|Induction Period||16
8703076|NCT00920907|9748901|FG000|NOT COMPLETED|Induction Period||22
8703077|NCT00920907|9748902|FG001|NOT COMPLETED|Induction Period||22
8703078|NCT00920907|9748901|FG000|STARTED|Maintenance Period||15
8703079|NCT00920907|9748902|FG001|STARTED|Maintenance Period|1 patient completed Induction phase but discontinued the study prior to start of maintenance phase.|15
8703080|NCT00920907|9748901|FG000|COMPLETED|Maintenance Period|All participants who entered Maintenance were treated with study drug.|3
8703081|NCT00920907|9748902|FG001|COMPLETED|Maintenance Period|2 participants who entered Maintenance Period did not receive study drug during the period.|2
8703082|NCT00920907|9748901|FG000|NOT COMPLETED|Maintenance Period||12
8703083|NCT00920907|9748902|FG001|NOT COMPLETED|Maintenance Period||13
8703084|NCT00921024|9748912|FG000|STARTED|Overall Study||85
8703085|NCT00921024|9748913|FG001|STARTED|Overall Study||42
8703086|NCT00921024|9748912|FG000|COMPLETED|Overall Study||81
8703087|NCT00921024|9748913|FG001|COMPLETED|Overall Study||39
8703088|NCT00921024|9748912|FG000|NOT COMPLETED|Overall Study||4
8703089|NCT00921024|9748913|FG001|NOT COMPLETED|Overall Study||3
8703090|NCT00921115|9748919|FG000|STARTED|Overall Study||42
8703091|NCT00921115|9748919|FG000|COMPLETED|Overall Study||42
8703092|NCT00921115|9748919|FG000|NOT COMPLETED|Overall Study||0
8703093|NCT00921310|9748925|FG000|STARTED|Overall Study||2
8703094|NCT00921310|9748926|FG001|STARTED|Overall Study||6
8703095|NCT00921310|9748927|FG002|STARTED|Overall Study||4
8703096|NCT00921310|9748925|FG000|COMPLETED|Overall Study||2
8703097|NCT00921310|9748926|FG001|COMPLETED|Overall Study||6
8703098|NCT00921310|9748927|FG002|COMPLETED|Overall Study||4
8703099|NCT00921310|9748925|FG000|NOT COMPLETED|Overall Study||0
8703100|NCT00921310|9748926|FG001|NOT COMPLETED|Overall Study||0
8703101|NCT00921310|9748927|FG002|NOT COMPLETED|Overall Study||0
8703102|NCT00921518|9748941|FG000|STARTED|Overall Study||48
8703103|NCT00921518|9748942|FG001|STARTED|Overall Study||44
8703104|NCT00921518|9748941|FG000|COMPLETED|Overall Study||48
8703105|NCT00921518|9748942|FG001|COMPLETED|Overall Study||44
8703106|NCT00921518|9748941|FG000|NOT COMPLETED|Overall Study||0
8703107|NCT00921518|9748942|FG001|NOT COMPLETED|Overall Study||0
8703108|NCT00921557|9748951|FG000|STARTED|Weeks 0-48 (on Study Treatment)||17
8703109|NCT00921557|9748952|FG001|STARTED|Weeks 0-48 (on Study Treatment)||17
8703110|NCT00921557|9748953|FG002|STARTED|Weeks 0-48 (on Study Treatment)||18
8703111|NCT00921557|9748951|FG000|COMPLETED|Weeks 0-48 (on Study Treatment)|Completed 48 weeks|15
8703112|NCT00921557|9748952|FG001|COMPLETED|Weeks 0-48 (on Study Treatment)|Completed 48 weeks|17
8703113|NCT00921557|9748953|FG002|COMPLETED|Weeks 0-48 (on Study Treatment)|Completed 48 weeks|18
8703114|NCT00921557|9748951|FG000|NOT COMPLETED|Weeks 0-48 (on Study Treatment)||2
8703115|NCT00921557|9748952|FG001|NOT COMPLETED|Weeks 0-48 (on Study Treatment)||0
8703116|NCT00921557|9748953|FG002|NOT COMPLETED|Weeks 0-48 (on Study Treatment)||0
8703117|NCT00921557|9748951|FG000|STARTED|Weeks 48-96 (on Study Treatment)||15
8703118|NCT00921557|9748952|FG001|STARTED|Weeks 48-96 (on Study Treatment)||17
8703119|NCT00921557|9748953|FG002|STARTED|Weeks 48-96 (on Study Treatment)||18
8703120|NCT00921557|9748951|FG000|COMPLETED|Weeks 48-96 (on Study Treatment)||15
8703121|NCT00921557|9748952|FG001|COMPLETED|Weeks 48-96 (on Study Treatment)||16
8703122|NCT00921557|9748953|FG002|COMPLETED|Weeks 48-96 (on Study Treatment)||17
8703123|NCT00921557|9748951|FG000|NOT COMPLETED|Weeks 48-96 (on Study Treatment)||0
8703124|NCT00921557|9748952|FG001|NOT COMPLETED|Weeks 48-96 (on Study Treatment)||1
8703125|NCT00921557|9748953|FG002|NOT COMPLETED|Weeks 48-96 (on Study Treatment)||1
8703126|NCT00921557|9748951|FG000|STARTED|Weeks 96-144 (Off Study Treatment)||15
8703127|NCT00921557|9748952|FG001|STARTED|Weeks 96-144 (Off Study Treatment)||16
8703128|NCT00921557|9748953|FG002|STARTED|Weeks 96-144 (Off Study Treatment)||17
8703129|NCT00921557|9748951|FG000|COMPLETED|Weeks 96-144 (Off Study Treatment)||12
8703130|NCT00921557|9748952|FG001|COMPLETED|Weeks 96-144 (Off Study Treatment)||15
8703131|NCT00921557|9748953|FG002|COMPLETED|Weeks 96-144 (Off Study Treatment)||16
8703132|NCT00921557|9748951|FG000|NOT COMPLETED|Weeks 96-144 (Off Study Treatment)||3
8703133|NCT00921557|9748952|FG001|NOT COMPLETED|Weeks 96-144 (Off Study Treatment)||1
8703134|NCT00921557|9748953|FG002|NOT COMPLETED|Weeks 96-144 (Off Study Treatment)||1
8703135|NCT00921687|9748968|FG000|STARTED|Overall Study|eligible patients seen in clinic between 1/1/09 and 1/1/10|418
8703136|NCT00921687|9748969|FG001|STARTED|Overall Study||363
8703137|NCT00921687|9748968|FG000|COMPLETED|Overall Study||418
9045723|NCT03426995|10105598|FG015|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
9045724|NCT03426995|10105599|FG016|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
9045725|NCT03426995|10105600|FG017|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
9045726|NCT03426995|10105601|FG018|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8703138|NCT00921687|9748969|FG001|COMPLETED|Overall Study||363
8703139|NCT00921687|9748968|FG000|NOT COMPLETED|Overall Study||0
8703140|NCT00921687|9748969|FG001|NOT COMPLETED|Overall Study||0
8703141|NCT00921843|9748979|FG000|STARTED|Overall Study||10
8703142|NCT00921843|9748980|FG001|STARTED|Overall Study||10
8703143|NCT00921843|9748981|FG002|STARTED|Overall Study||11
8703144|NCT00921843|9748982|FG003|STARTED|Overall Study||30
8703145|NCT00921843|9748979|FG000|COMPLETED|Overall Study||10
8703146|NCT00921843|9748980|FG001|COMPLETED|Overall Study||10
8703147|NCT00921843|9748981|FG002|COMPLETED|Overall Study||11
8703148|NCT00921843|9748982|FG003|COMPLETED|Overall Study||30
8703149|NCT00921843|9748979|FG000|NOT COMPLETED|Overall Study||0
8703150|NCT00921843|9748980|FG001|NOT COMPLETED|Overall Study||0
8703151|NCT00921843|9748981|FG002|NOT COMPLETED|Overall Study||0
8703152|NCT00921843|9748982|FG003|NOT COMPLETED|Overall Study||0
8703153|NCT00921895|9748992|FG000|STARTED|Overall Study||128
8703154|NCT00921895|9748992|FG000|COMPLETED|Overall Study||128
8703155|NCT00921895|9748992|FG000|NOT COMPLETED|Overall Study||0
8703156|NCT00921934|9748997|FG000|STARTED|Overall Study||68
8703157|NCT00921934|9748997|FG000|COMPLETED|Overall Study||68
8703158|NCT00921934|9748997|FG000|NOT COMPLETED|Overall Study||0
8703159|NCT00921947|9749003|FG000|STARTED|Day 0||30
8703160|NCT00921947|9749004|FG001|STARTED|Day 0||30
8703161|NCT00921947|9749003|FG000|COMPLETED|Day 0||30
8703162|NCT00921947|9749004|FG001|COMPLETED|Day 0||30
8703163|NCT00921947|9749003|FG000|NOT COMPLETED|Day 0||0
8703164|NCT00921947|9749004|FG001|NOT COMPLETED|Day 0||0
8703165|NCT00921947|9749003|FG000|STARTED|Day 28|2 subjects were lost to follow-up and did not receive the 2nd vaccination of 1.0 ug i.m.|28
8703166|NCT00921947|9749004|FG001|STARTED|Day 28||30
8703167|NCT00921947|9749003|FG000|COMPLETED|Day 28||28
8703168|NCT00921947|9749004|FG001|COMPLETED|Day 28||30
8703169|NCT00921947|9749003|FG000|NOT COMPLETED|Day 28||0
8703170|NCT00921947|9749004|FG001|NOT COMPLETED|Day 28||0
8703171|NCT00922116|9749010|FG000|STARTED|Overall Study||191
8703172|NCT00922116|9749010|FG000|COMPLETED|Overall Study||176
8703173|NCT00922116|9749010|FG000|NOT COMPLETED|Overall Study||15
8703174|NCT00922194|9749014|FG000|STARTED|Metformin in Maximum Tolerated Dose|February 2006|102
8703175|NCT00922194|9749014|FG000|COMPLETED|Metformin in Maximum Tolerated Dose|June 2009|102
8703176|NCT00922194|9749014|FG000|NOT COMPLETED|Metformin in Maximum Tolerated Dose||0
8703177|NCT00922194|9749014|FG000|STARTED|Metformin for 12 Months or More|Gradually increasing dose of Extended Release Metformin|102
8703178|NCT00922194|9749014|FG000|COMPLETED|Metformin for 12 Months or More||102
8703179|NCT00922194|9749014|FG000|NOT COMPLETED|Metformin for 12 Months or More||0
8703180|NCT00922207|9749021|FG000|STARTED|Overall Study||91
8703181|NCT00922207|9749022|FG001|STARTED|Overall Study||95
8703182|NCT00922207|9749023|FG002|STARTED|Overall Study||94
8703183|NCT00922207|9749021|FG000|COMPLETED|Overall Study||85
8703184|NCT00922207|9749022|FG001|COMPLETED|Overall Study||88
8703185|NCT00922207|9749023|FG002|COMPLETED|Overall Study||90
8703186|NCT00922207|9749021|FG000|NOT COMPLETED|Overall Study||6
8703187|NCT00922207|9749022|FG001|NOT COMPLETED|Overall Study||7
8703188|NCT00922207|9749023|FG002|NOT COMPLETED|Overall Study||4
8703189|NCT00922233|9749031|FG000|STARTED|Overall Study||72
8703190|NCT00922233|9749031|FG000|COMPLETED|Overall Study||68
8703191|NCT00922233|9749031|FG000|NOT COMPLETED|Overall Study||4
8703192|NCT00922272|9749036|FG000|STARTED|Open-label Phase||92
8703193|NCT00922272|9749037|FG001|STARTED|Open-label Phase||0
8703194|NCT00922272|9749036|FG000|COMPLETED|Open-label Phase||69
8703195|NCT00922272|9749037|FG001|COMPLETED|Open-label Phase||0
8703196|NCT00922272|9749036|FG000|NOT COMPLETED|Open-label Phase||23
8703197|NCT00922272|9749037|FG001|NOT COMPLETED|Open-label Phase||0
8703198|NCT00922272|9749036|FG000|STARTED|Double-blind Phase||34
8703199|NCT00922272|9749037|FG001|STARTED|Double-blind Phase||35
8703200|NCT00922272|9749036|FG000|COMPLETED|Double-blind Phase||27
8703201|NCT00922272|9749037|FG001|COMPLETED|Double-blind Phase||29
8703202|NCT00922272|9749036|FG000|NOT COMPLETED|Double-blind Phase||7
8703203|NCT00922272|9749037|FG001|NOT COMPLETED|Double-blind Phase||6
8703204|NCT00922428|9749045|FG000|STARTED|Overall Study|13 patients were completely not analysed, 2 not for demographic or efficacy but for safety|1389
8703205|NCT00922428|9749045|FG000|COMPLETED|Overall Study|for 11 participants no gender was given|1374
8703206|NCT00922428|9749045|FG000|NOT COMPLETED|Overall Study||15
8703207|NCT00922441|9749058|FG000|STARTED|Overall Study||30
8703208|NCT00922441|9749059|FG001|STARTED|Overall Study||30
8703209|NCT00922441|9749060|FG002|STARTED|Overall Study||32
8703210|NCT00922441|9749058|FG000|COMPLETED|Overall Study||30
8703211|NCT00922441|9749059|FG001|COMPLETED|Overall Study||30
8703212|NCT00922441|9749060|FG002|COMPLETED|Overall Study||29
8703213|NCT00922441|9749058|FG000|NOT COMPLETED|Overall Study||0
8703214|NCT00922441|9749059|FG001|NOT COMPLETED|Overall Study||0
8703215|NCT00922441|9749060|FG002|NOT COMPLETED|Overall Study||3
8703216|NCT00922480|9749070|FG000|STARTED|Main Study||250
8703217|NCT00922480|9749071|FG001|STARTED|Main Study||255
8703218|NCT00922480|9749070|FG000|COMPLETED|Main Study||213
8703219|NCT00922480|9749071|FG001|COMPLETED|Main Study||226
8703220|NCT00922480|9749070|FG000|NOT COMPLETED|Main Study||37
8703221|NCT00922480|9749071|FG001|NOT COMPLETED|Main Study||29
8703222|NCT00922480|9749070|FG000|STARTED|Extension Study||73
8703223|NCT00922480|9749071|FG001|STARTED|Extension Study||85
8703224|NCT00922480|9749070|FG000|COMPLETED|Extension Study||68
9045727|NCT03426995|10105583|FG000|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
9045728|NCT03426995|10105584|FG001|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
9045729|NCT03426995|10105585|FG002|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
9045730|NCT03426995|10105586|FG003|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
9045731|NCT03426995|10105587|FG004|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
9045732|NCT03426995|10105588|FG005|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
9045733|NCT03426995|10105589|FG006|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
9045734|NCT03426995|10105590|FG007|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
9045735|NCT03426995|10105591|FG008|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
9045736|NCT03426995|10105592|FG009|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
9045737|NCT03426995|10105593|FG010|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
9045738|NCT03426995|10105594|FG011|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
9045739|NCT03426995|10105595|FG012|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
9045740|NCT03426995|10105596|FG013|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
9045741|NCT03426995|10105597|FG014|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
9045742|NCT03426995|10105598|FG015|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
9045743|NCT03426995|10105599|FG016|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
9045744|NCT03426995|10105600|FG017|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
9045745|NCT03426995|10105601|FG018|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
9045746|NCT03426995|10105583|FG000|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
9045747|NCT03426995|10105584|FG001|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
9045748|NCT03426995|10105585|FG002|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
9045749|NCT03426995|10105586|FG003|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
9045750|NCT03426995|10105587|FG004|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
9045751|NCT03426995|10105588|FG005|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
9045752|NCT03426995|10105589|FG006|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
9045753|NCT03426995|10105590|FG007|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
9045754|NCT03426995|10105591|FG008|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
9045755|NCT03426995|10105592|FG009|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
9045756|NCT03426995|10105593|FG010|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
9045757|NCT03426995|10105594|FG011|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
9045758|NCT03426995|10105595|FG012|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
9045759|NCT03426995|10105596|FG013|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
9045760|NCT03426995|10105597|FG014|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||11
9045761|NCT03426995|10105598|FG015|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||14
9045762|NCT03426995|10105599|FG016|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
9045763|NCT03426995|10105600|FG017|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
9045764|NCT03426995|10105601|FG018|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
9045765|NCT03426995|10105583|FG000|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
9045766|NCT03426995|10105584|FG001|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
9045767|NCT03426995|10105585|FG002|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
9045768|NCT03426995|10105586|FG003|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
9045769|NCT03426995|10105587|FG004|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
9045770|NCT03426995|10105588|FG005|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
9045771|NCT03426995|10105589|FG006|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
9045772|NCT03426995|10105590|FG007|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
9045773|NCT03426995|10105591|FG008|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
9045774|NCT03426995|10105592|FG009|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
9045775|NCT03426995|10105593|FG010|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
9045776|NCT03426995|10105594|FG011|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
9045777|NCT03426995|10105595|FG012|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
9045778|NCT03426995|10105596|FG013|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
9045779|NCT03426995|10105597|FG014|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||2
9045780|NCT03426995|10105598|FG015|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||2
9045781|NCT03426995|10105599|FG016|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
9045782|NCT03426995|10105600|FG017|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
9045783|NCT03426995|10105601|FG018|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
9045784|NCT03426995|10105583|FG000|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
9045785|NCT03426995|10105584|FG001|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
9045786|NCT03426995|10105585|FG002|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
9045787|NCT03426995|10105586|FG003|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
9045788|NCT03426995|10105587|FG004|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
9045789|NCT03426995|10105588|FG005|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
9045790|NCT03426995|10105589|FG006|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
9045791|NCT03426995|10105590|FG007|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
9045792|NCT03426995|10105591|FG008|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
9045793|NCT03426995|10105592|FG009|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
9045794|NCT03426995|10105593|FG010|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
9045795|NCT03426995|10105594|FG011|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
9045796|NCT03426995|10105595|FG012|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
9045797|NCT03426995|10105596|FG013|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
9045798|NCT03426995|10105597|FG014|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||9
9045799|NCT03426995|10105598|FG015|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||12
9045800|NCT03426995|10105599|FG016|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
9045801|NCT03426995|10105600|FG017|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
9045802|NCT03426995|10105601|FG018|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
9045803|NCT03427073|10105656|FG000|STARTED|Overall Study||1
9045804|NCT03427073|10105657|FG001|STARTED|Overall Study||1
9045805|NCT03427073|10105658|FG002|STARTED|Overall Study||1
9045806|NCT03427073|10105659|FG003|STARTED|Overall Study||3
9045807|NCT03427073|10105660|FG004|STARTED|Overall Study||3
9045808|NCT03427073|10105661|FG005|STARTED|Overall Study||4
9045809|NCT03427073|10105662|FG006|STARTED|Overall Study||3
9045810|NCT03427073|10105663|FG007|STARTED|Overall Study||4
9045811|NCT03427073|10105656|FG000|COMPLETED|Overall Study||0
9045812|NCT03427073|10105657|FG001|COMPLETED|Overall Study||0
9045813|NCT03427073|10105658|FG002|COMPLETED|Overall Study||0
9045814|NCT03427073|10105659|FG003|COMPLETED|Overall Study||0
9045815|NCT03427073|10105660|FG004|COMPLETED|Overall Study||0
9045816|NCT03427073|10105661|FG005|COMPLETED|Overall Study||0
9045817|NCT03427073|10105662|FG006|COMPLETED|Overall Study||0
9045818|NCT03427073|10105663|FG007|COMPLETED|Overall Study||0
9045819|NCT03427073|10105656|FG000|NOT COMPLETED|Overall Study||1
9045820|NCT03427073|10105657|FG001|NOT COMPLETED|Overall Study||1
9045821|NCT03427073|10105658|FG002|NOT COMPLETED|Overall Study||1
9045822|NCT03427073|10105659|FG003|NOT COMPLETED|Overall Study||3
9045823|NCT03427073|10105660|FG004|NOT COMPLETED|Overall Study||3
9045824|NCT03427073|10105661|FG005|NOT COMPLETED|Overall Study||4
9045825|NCT03427073|10105662|FG006|NOT COMPLETED|Overall Study||3
9045826|NCT03427073|10105663|FG007|NOT COMPLETED|Overall Study||4
9045827|NCT03427177|10105683|FG000|STARTED|Overall Study||125
9045828|NCT03427177|10105684|FG001|STARTED|Overall Study||132
9045829|NCT03427177|10105683|FG000|COMPLETED|Overall Study||92
9045830|NCT03427177|10105684|FG001|COMPLETED|Overall Study||105
9045831|NCT03427177|10105683|FG000|NOT COMPLETED|Overall Study||33
9045832|NCT03427177|10105684|FG001|NOT COMPLETED|Overall Study||27
9045833|NCT03427268|10105690|FG000|STARTED|Overall Study||32
9045834|NCT03427268|10105690|FG000|COMPLETED|Overall Study||0
9045835|NCT03427268|10105690|FG000|NOT COMPLETED|Overall Study||32
9045836|NCT03427619|10105694|FG000|STARTED|Overall Study||275
9045837|NCT03427619|10105694|FG000|Safety Population|Overall Study||275
9045838|NCT03427619|10105694|FG000|Modified Intention to Treat Population|Overall Study||143
9045839|NCT03427619|10105694|FG000|COMPLETED|Overall Study||209
9045840|NCT03427619|10105694|FG000|NOT COMPLETED|Overall Study||66
9045841|NCT03427892|10105698|FG000|STARTED|Overall Study||21
9045842|NCT03427892|10105698|FG000|COMPLETED|Overall Study|Of the 21 recruited, 19 completed at least one post baseline visit, included in the analysis.|19
9045843|NCT03427892|10105698|FG000|NOT COMPLETED|Overall Study||2
9045844|NCT03427931|10105702|FG000|STARTED|Overall Study||7
9045845|NCT03427931|10105702|FG000|COMPLETED|Overall Study||5
9045846|NCT03427931|10105702|FG000|NOT COMPLETED|Overall Study||2
9045847|NCT03428100|10105710|FG000|STARTED|Overall Study||93
9045848|NCT03428100|10105711|FG001|STARTED|Overall Study||93
9045849|NCT03428100|10105712|FG002|STARTED|Overall Study||185
9045850|NCT03428100|10105713|FG003|STARTED|Overall Study||92
9045851|NCT03428100|10105710|FG000|Received at Least One Dose of Study Drug|Overall Study||93
9045852|NCT03428100|10105711|FG001|Received at Least One Dose of Study Drug|Overall Study||93
8703225|NCT00922480|9749071|FG001|COMPLETED|Extension Study||82
8703226|NCT00922480|9749070|FG000|NOT COMPLETED|Extension Study||5
8703227|NCT00922480|9749071|FG001|NOT COMPLETED|Extension Study||3
8703228|NCT00922623|9749079|FG000|STARTED|Overall Study||93
8703229|NCT00922623|9749079|FG000|COMPLETED|Overall Study||88
8703230|NCT00922623|9749079|FG000|NOT COMPLETED|Overall Study||5
8703231|NCT00922636|9749090|FG000|STARTED|Overall Study||36
8703232|NCT00922636|9749091|FG001|STARTED|Overall Study||78
8703233|NCT00922636|9749092|FG002|STARTED|Overall Study||76
8703234|NCT00922636|9749093|FG003|STARTED|Overall Study||75
8703235|NCT00922636|9749094|FG004|STARTED|Overall Study||75
8703236|NCT00922636|9749090|FG000|Entered Optional Taper Phase|Overall Study||4
8703237|NCT00922636|9749091|FG001|Entered Optional Taper Phase|Overall Study||10
8703238|NCT00922636|9749092|FG002|Entered Optional Taper Phase|Overall Study||15
8703239|NCT00922636|9749093|FG003|Entered Optional Taper Phase|Overall Study||7
8703240|NCT00922636|9749094|FG004|Entered Optional Taper Phase|Overall Study||12
8703241|NCT00922636|9749090|FG000|COMPLETED|Overall Study||29
8703242|NCT00922636|9749091|FG001|COMPLETED|Overall Study||62
8703243|NCT00922636|9749092|FG002|COMPLETED|Overall Study||56
8703244|NCT00922636|9749093|FG003|COMPLETED|Overall Study||58
8703245|NCT00922636|9749094|FG004|COMPLETED|Overall Study||59
8703246|NCT00922636|9749090|FG000|NOT COMPLETED|Overall Study||7
9045853|NCT03428100|10105712|FG002|Received at Least One Dose of Study Drug|Overall Study||184
9045854|NCT03428100|10105713|FG003|Received at Least One Dose of Study Drug|Overall Study||92
9045855|NCT03428100|10105710|FG000|COMPLETED|Overall Study||72
9045856|NCT03428100|10105711|FG001|COMPLETED|Overall Study||80
9045857|NCT03428100|10105712|FG002|COMPLETED|Overall Study||173
9045858|NCT03428100|10105713|FG003|COMPLETED|Overall Study||85
9045859|NCT03428100|10105710|FG000|NOT COMPLETED|Overall Study||21
9045860|NCT03428100|10105711|FG001|NOT COMPLETED|Overall Study||13
9045861|NCT03428100|10105712|FG002|NOT COMPLETED|Overall Study||12
9045862|NCT03428100|10105713|FG003|NOT COMPLETED|Overall Study||7
9045863|NCT03428152|10105735|FG000|STARTED|Overall Study||37
9045864|NCT03428152|10105736|FG001|STARTED|Overall Study||41
9045865|NCT03428152|10105735|FG000|COMPLETED|Overall Study||30
8703247|NCT00922636|9749091|FG001|NOT COMPLETED|Overall Study||16
8703248|NCT00922636|9749092|FG002|NOT COMPLETED|Overall Study||20
8703249|NCT00922636|9749093|FG003|NOT COMPLETED|Overall Study||17
8703250|NCT00922636|9749094|FG004|NOT COMPLETED|Overall Study||16
8703251|NCT00922701|9749111|FG000|STARTED|Overall Study||4
8703252|NCT00922701|9749111|FG000|COMPLETED|Overall Study||4
8703253|NCT00922701|9749111|FG000|NOT COMPLETED|Overall Study||0
8703254|NCT00922766|9749115|FG000|STARTED|Overall Study||617
8703255|NCT00922766|9749115|FG000|COMPLETED|Overall Study||610
9045866|NCT03428152|10105736|FG001|COMPLETED|Overall Study|exclusions: epidural / TAP / wound infiltration malignity retroperitone was opened age >65|30
9045867|NCT03428152|10105735|FG000|NOT COMPLETED|Overall Study||7
9045868|NCT03428152|10105736|FG001|NOT COMPLETED|Overall Study||11
9045869|NCT03428230|10105746|FG000|STARTED|Overall Study||15
9045870|NCT03428230|10105747|FG001|STARTED|Overall Study||15
9045871|NCT03428230|10105748|FG002|STARTED|Overall Study||15
9045872|NCT03428230|10105749|FG003|STARTED|Overall Study||15
9045873|NCT03428230|10105746|FG000|COMPLETED|Overall Study||15
9045874|NCT03428230|10105747|FG001|COMPLETED|Overall Study||15
9045875|NCT03428230|10105748|FG002|COMPLETED|Overall Study||15
9045876|NCT03428230|10105749|FG003|COMPLETED|Overall Study||15
9045877|NCT03428230|10105746|FG000|NOT COMPLETED|Overall Study||0
9045878|NCT03428230|10105747|FG001|NOT COMPLETED|Overall Study||0
9045879|NCT03428230|10105748|FG002|NOT COMPLETED|Overall Study||0
9045880|NCT03428230|10105749|FG003|NOT COMPLETED|Overall Study||0
9045881|NCT03428360|10105759|FG000|STARTED|Overall Study||130
9045882|NCT03428360|10105759|FG000|COMPLETED|Overall Study||90
9045883|NCT03428360|10105759|FG000|NOT COMPLETED|Overall Study||40
9045884|NCT03428750|10105769|FG000|STARTED|Overall Study||210
9045885|NCT03428750|10105770|FG001|STARTED|Overall Study||213
9045886|NCT03428750|10105769|FG000|COMPLETED|Overall Study||186
9045887|NCT03428750|10105770|FG001|COMPLETED|Overall Study||192
9045888|NCT03428750|10105769|FG000|NOT COMPLETED|Overall Study||24
9045889|NCT03428750|10105770|FG001|NOT COMPLETED|Overall Study||21
9045890|NCT03428815|10105801|FG000|STARTED|Overall Study||17
9045891|NCT03428815|10105802|FG001|STARTED|Overall Study||19
9045892|NCT03428815|10105801|FG000|COMPLETED|Overall Study||7
9045893|NCT03428815|10105802|FG001|COMPLETED|Overall Study||14
9045894|NCT03428815|10105801|FG000|NOT COMPLETED|Overall Study||10
9045895|NCT03428815|10105802|FG001|NOT COMPLETED|Overall Study||5
9045896|NCT03428997|10105808|FG000|STARTED|Overall Study||24
9045897|NCT03428997|10105808|FG000|COMPLETED|Overall Study||16
9045898|NCT03428997|10105808|FG000|NOT COMPLETED|Overall Study||8
9045899|NCT03429270|10105814|FG000|STARTED|Overall Study||28
9045900|NCT03429270|10105814|FG000|COMPLETED|Overall Study||28
9045901|NCT03429270|10105814|FG000|NOT COMPLETED|Overall Study||0
9045902|NCT03429348|10105820|FG000|STARTED|Overall Study|4 participants had no additional rehab & had no corresponding sauna rehab participant to compare to.|12
9045903|NCT03429348|10105821|FG001|STARTED|Overall Study||12
9045904|NCT03429348|10105820|FG000|COMPLETED|Overall Study||12
9045905|NCT03429348|10105821|FG001|COMPLETED|Overall Study||12
9045906|NCT03429348|10105820|FG000|NOT COMPLETED|Overall Study||0
9045907|NCT03429348|10105821|FG001|NOT COMPLETED|Overall Study||0
9045908|NCT03429556|10105833|FG000|STARTED|Overall Study||12
9045909|NCT03429556|10105834|FG001|STARTED|Overall Study||4
9045910|NCT03429556|10105835|FG002|STARTED|Overall Study||4
9045911|NCT03429556|10105836|FG003|STARTED|Overall Study||3
9045912|NCT03429556|10105833|FG000|COMPLETED|Overall Study||12
9045913|NCT03429556|10105834|FG001|COMPLETED|Overall Study||3
9045914|NCT03429556|10105835|FG002|COMPLETED|Overall Study||4
9045915|NCT03429556|10105836|FG003|COMPLETED|Overall Study||3
9045916|NCT03429556|10105833|FG000|NOT COMPLETED|Overall Study||0
9045917|NCT03429556|10105834|FG001|NOT COMPLETED|Overall Study||1
9045918|NCT03429556|10105835|FG002|NOT COMPLETED|Overall Study||0
9045919|NCT03429556|10105836|FG003|NOT COMPLETED|Overall Study||0
9045920|NCT03430050|10105848|FG000|STARTED|Overall Study||3
9045921|NCT03430050|10105849|FG001|STARTED|Overall Study||5
9045922|NCT03430050|10105848|FG000|COMPLETED|Overall Study||3
9045923|NCT03430050|10105849|FG001|COMPLETED|Overall Study||5
9045924|NCT03430050|10105848|FG000|NOT COMPLETED|Overall Study||0
9045925|NCT03430050|10105849|FG001|NOT COMPLETED|Overall Study||0
9045926|NCT03430206|10105857|FG000|STARTED|Overall Study||40
9045927|NCT03430206|10105858|FG001|STARTED|Overall Study||38
9045928|NCT03430206|10105857|FG000|COMPLETED|Overall Study||18
9045929|NCT03430206|10105858|FG001|COMPLETED|Overall Study||21
9045930|NCT03430206|10105857|FG000|NOT COMPLETED|Overall Study||22
9045931|NCT03430206|10105858|FG001|NOT COMPLETED|Overall Study||17
9045932|NCT03430245|10105864|FG000|STARTED|Overall Study||16
9045933|NCT03430245|10105864|FG000|COMPLETED|Overall Study|6 subjects withdrew from study due to lengthy treatment. Treatment protocol amended.|9
9045934|NCT03430245|10105864|FG000|NOT COMPLETED|Overall Study||7
9045935|NCT03430349|10105870|FG000|STARTED|Overall Study||15
9045936|NCT03430349|10105871|FG001|STARTED|Overall Study||15
9045937|NCT03430349|10105870|FG000|Received nOPV Vaccination|Overall Study||15
9045938|NCT03430349|10105871|FG001|Received nOPV Vaccination|Overall Study||15
9045939|NCT03430349|10105870|FG000|COMPLETED|Overall Study||15
9045940|NCT03430349|10105871|FG001|COMPLETED|Overall Study||15
9045941|NCT03430349|10105870|FG000|NOT COMPLETED|Overall Study||0
9045942|NCT03430349|10105871|FG001|NOT COMPLETED|Overall Study||0
9045943|NCT03430856|10105881|FG000|STARTED|Overall Study||31
8703256|NCT00922766|9749115|FG000|NOT COMPLETED|Overall Study||7
8703257|NCT00922779|9749119|FG000|STARTED|Overall Study||6661
8703258|NCT00922779|9749119|FG000|COMPLETED|Overall Study||4334
9045944|NCT03430856|10105882|FG001|STARTED|Overall Study||30
9045945|NCT03430856|10105883|FG002|STARTED|Overall Study||30
9045946|NCT03430856|10105881|FG000|Exposed|Overall Study||31
9045947|NCT03430856|10105882|FG001|Exposed|Overall Study||30
9045948|NCT03430856|10105883|FG002|Exposed|Overall Study||30
9045949|NCT03430856|10105881|FG000|COMPLETED|Overall Study||29
9045950|NCT03430856|10105882|FG001|COMPLETED|Overall Study||27
9045951|NCT03430856|10105883|FG002|COMPLETED|Overall Study||29
9045952|NCT03430856|10105881|FG000|NOT COMPLETED|Overall Study||2
9045953|NCT03430856|10105882|FG001|NOT COMPLETED|Overall Study||3
9045954|NCT03430856|10105883|FG002|NOT COMPLETED|Overall Study||1
9045955|NCT03430986|10105896|FG000|STARTED|24-week Control Period||42
9045956|NCT03430986|10105897|FG001|STARTED|24-week Control Period||122
9045957|NCT03430986|10105896|FG000|Treated as Randomized|24-week Control Period||42
9045958|NCT03430986|10105897|FG001|Treated as Randomized|24-week Control Period||120
9045959|NCT03430986|10105896|FG000|COMPLETED|24-week Control Period||34
9045960|NCT03430986|10105897|FG001|COMPLETED|24-week Control Period||118
9045961|NCT03430986|10105896|FG000|NOT COMPLETED|24-week Control Period||8
9045962|NCT03430986|10105897|FG001|NOT COMPLETED|24-week Control Period||4
9045963|NCT03430986|10105896|FG000|STARTED|24-week Post-Control Period|Not all participants received the Optional Treatment.|31
9045964|NCT03430986|10105897|FG001|STARTED|24-week Post-Control Period||118
9045965|NCT03430986|10105896|FG000|COMPLETED|24-week Post-Control Period||30
9045966|NCT03430986|10105897|FG001|COMPLETED|24-week Post-Control Period||116
9045967|NCT03430986|10105896|FG000|NOT COMPLETED|24-week Post-Control Period||1
9045968|NCT03430986|10105897|FG001|NOT COMPLETED|24-week Post-Control Period||2
9045969|NCT03431012|10105910|FG000|STARTED|Overall Study||47
9045970|NCT03431012|10105911|FG001|STARTED|Overall Study||60
9045971|NCT03431012|10105912|FG002|STARTED|Overall Study||56
9045972|NCT03431012|10105913|FG003|STARTED|Overall Study||53
9045973|NCT03431012|10105910|FG000|COMPLETED|Overall Study||47
9045974|NCT03431012|10105911|FG001|COMPLETED|Overall Study||60
9045975|NCT03431012|10105912|FG002|COMPLETED|Overall Study||56
9045976|NCT03431012|10105913|FG003|COMPLETED|Overall Study||53
9045977|NCT03431012|10105910|FG000|NOT COMPLETED|Overall Study||0
9045978|NCT03431012|10105911|FG001|NOT COMPLETED|Overall Study||0
9045979|NCT03431012|10105912|FG002|NOT COMPLETED|Overall Study||0
9045980|NCT03431012|10105913|FG003|NOT COMPLETED|Overall Study||0
9045981|NCT03431337|10105929|FG000|STARTED|Overall Study||78
9045982|NCT03431337|10105930|FG001|STARTED|Overall Study||79
9045983|NCT03431337|10105929|FG000|COMPLETED|Overall Study||49
9045984|NCT03431337|10105930|FG001|COMPLETED|Overall Study||57
9045985|NCT03431337|10105929|FG000|NOT COMPLETED|Overall Study||29
9045986|NCT03431337|10105930|FG001|NOT COMPLETED|Overall Study||22
9045987|NCT03431441|10105940|FG000|STARTED|Overall Study||24
9045988|NCT03431441|10105940|FG000|COMPLETED|Overall Study||19
9045989|NCT03431441|10105940|FG000|NOT COMPLETED|Overall Study||5
9045990|NCT03431857|10105944|FG000|STARTED|Overall Study||106
9045991|NCT03431857|10105944|FG000|COMPLETED|Overall Study|52 subjects have completed the study, and 50 had complete data (all pages of CRF visit are complete)|52
9045992|NCT03431857|10105944|FG000|NOT COMPLETED|Overall Study||54
9045993|NCT03432390|10105950|FG000|STARTED|Apnea Period||36
9045994|NCT03432390|10105951|FG001|STARTED|Apnea Period||36
9045995|NCT03432390|10105950|FG000|COMPLETED|Apnea Period||34
9045996|NCT03432390|10105951|FG001|COMPLETED|Apnea Period||34
9045997|NCT03432390|10105950|FG000|NOT COMPLETED|Apnea Period||2
9045998|NCT03432390|10105951|FG001|NOT COMPLETED|Apnea Period||2
9045999|NCT03432390|10105950|FG000|STARTED|Recovery Period||34
9046000|NCT03432390|10105951|FG001|STARTED|Recovery Period||34
9046001|NCT03432390|10105950|FG000|COMPLETED|Recovery Period||34
9046002|NCT03432390|10105951|FG001|COMPLETED|Recovery Period||34
9046003|NCT03432390|10105950|FG000|NOT COMPLETED|Recovery Period||0
9046004|NCT03432390|10105951|FG001|NOT COMPLETED|Recovery Period||0
9046005|NCT03432533|10105959|FG000|STARTED|Overall Study||141
9046006|NCT03432533|10105960|FG001|STARTED|Overall Study||142
9046007|NCT03432533|10105959|FG000|Completed 6-Month Treatment Period|Overall Study||136
9046008|NCT03432533|10105960|FG001|Completed 6-Month Treatment Period|Overall Study||137
9046009|NCT03432533|10105959|FG000|COMPLETED|Overall Study||126
9046010|NCT03432533|10105960|FG001|COMPLETED|Overall Study||131
9046011|NCT03432533|10105959|FG000|NOT COMPLETED|Overall Study||15
9046012|NCT03432533|10105960|FG001|NOT COMPLETED|Overall Study||11
9046013|NCT03432858|10105969|FG000|STARTED|Overall Study||12
9046014|NCT03432858|10105970|FG001|STARTED|Overall Study||83
9046015|NCT03432858|10105971|FG002|STARTED|Overall Study||89
9046016|NCT03432858|10105969|FG000|COMPLETED|Overall Study||10
9046017|NCT03432858|10105970|FG001|COMPLETED|Overall Study||72
9046018|NCT03432858|10105971|FG002|COMPLETED|Overall Study||72
9046019|NCT03432858|10105969|FG000|NOT COMPLETED|Overall Study||2
9046020|NCT03432858|10105970|FG001|NOT COMPLETED|Overall Study||11
9046021|NCT03432858|10105971|FG002|NOT COMPLETED|Overall Study||17
9046022|NCT03433482|10105983|FG000|STARTED|Overall Study||420
9046023|NCT03433482|10105984|FG001|STARTED|Overall Study||424
9046024|NCT03433482|10105985|FG002|STARTED|Overall Study||427
9046025|NCT03433482|10105986|FG003|STARTED|Overall Study||419
9046026|NCT03433482|10105983|FG000|COMPLETED|Overall Study||419
9046027|NCT03433482|10105984|FG001|COMPLETED|Overall Study||424
9046028|NCT03433482|10105985|FG002|COMPLETED|Overall Study||423
9046029|NCT03433482|10105986|FG003|COMPLETED|Overall Study||418
9046030|NCT03433482|10105983|FG000|NOT COMPLETED|Overall Study||1
9046031|NCT03433482|10105984|FG001|NOT COMPLETED|Overall Study||0
9046032|NCT03433482|10105985|FG002|NOT COMPLETED|Overall Study||4
9046033|NCT03433482|10105986|FG003|NOT COMPLETED|Overall Study||1
9046034|NCT03433677|10105998|FG000|STARTED|Period 1||24
9046035|NCT03433677|10105999|FG001|STARTED|Period 1||25
9046036|NCT03433677|10105998|FG000|Received at Least 1 Dose of Study Drug|Period 1||24
9046037|NCT03433677|10105999|FG001|Received at Least 1 Dose of Study Drug|Period 1||25
9046038|NCT03433677|10105998|FG000|COMPLETED|Period 1||23
9046039|NCT03433677|10105999|FG001|COMPLETED|Period 1||25
9046040|NCT03433677|10105998|FG000|NOT COMPLETED|Period 1||1
9046041|NCT03433677|10105999|FG001|NOT COMPLETED|Period 1||0
9046042|NCT03433677|10105998|FG000|STARTED|Period 2||23
9046043|NCT03433677|10105999|FG001|STARTED|Period 2||25
9046044|NCT03433677|10105998|FG000|Received at Least 1 Dose of Study Drug|Period 2||23
9046045|NCT03433677|10105999|FG001|Received at Least 1 Dose of Study Drug|Period 2||25
9046046|NCT03433677|10105998|FG000|COMPLETED|Period 2||22
8703259|NCT00922779|9749119|FG000|NOT COMPLETED|Overall Study||2327
8703260|NCT00922883|9749123|FG000|STARTED|Overall Study||43
8703261|NCT00922883|9749123|FG000|COMPLETED|Overall Study||43
8703262|NCT00922883|9749123|FG000|NOT COMPLETED|Overall Study||0
8703263|NCT00922935|9749130|FG000|STARTED|Overall Study||10
8703264|NCT00922935|9749131|FG001|STARTED|Overall Study||16
8703265|NCT00922935|9749132|FG002|STARTED|Overall Study||10
8703266|NCT00922935|9749130|FG000|COMPLETED|Overall Study||9
8703267|NCT00922935|9749131|FG001|COMPLETED|Overall Study||11
8703268|NCT00922935|9749132|FG002|COMPLETED|Overall Study||10
8703269|NCT00922935|9749130|FG000|NOT COMPLETED|Overall Study||1
8703270|NCT00922935|9749131|FG001|NOT COMPLETED|Overall Study||5
8703271|NCT00922935|9749132|FG002|NOT COMPLETED|Overall Study||0
8703272|NCT00922974|9749143|FG000|STARTED|Phase II Component||46
8703273|NCT00922974|9749144|FG001|STARTED|Phase II Component||0
8703274|NCT00922974|9749143|FG000|Eligible|Phase II Component||44
8703275|NCT00922974|9749144|FG001|Eligible|Phase II Component||0
8703276|NCT00922974|9749143|FG000|Eligible and Started Treatment|Phase II Component||39
8703277|NCT00922974|9749144|FG001|Eligible and Started Treatment|Phase II Component||0
8703278|NCT00922974|9749143|FG000|Eligible, Treated, Adverse Event Data|Phase II Component||34
8703279|NCT00922974|9749144|FG001|Eligible, Treated, Adverse Event Data|Phase II Component||0
8703280|NCT00922974|9749143|FG000|COMPLETED|Phase II Component|These subjects do not participate in the phase III component.|39
8703281|NCT00922974|9749144|FG001|COMPLETED|Phase II Component||0
8703282|NCT00922974|9749143|FG000|NOT COMPLETED|Phase II Component||7
8703283|NCT00922974|9749144|FG001|NOT COMPLETED|Phase II Component||0
8703284|NCT00922974|9749143|FG000|STARTED|Phase III Component|The phase III component accrues new subjects; these are not continuing phase II subjects.|217
8703285|NCT00922974|9749144|FG001|STARTED|Phase III Component||136
8703286|NCT00922974|9749143|FG000|Eligible|Phase III Component||209
8703287|NCT00922974|9749144|FG001|Eligible|Phase III Component||130
8703288|NCT00922974|9749143|FG000|Eligible With 3 mo. NRPS Data|Phase III Component||139
8703289|NCT00922974|9749144|FG001|Eligible With 3 mo. NRPS Data|Phase III Component||76
8703290|NCT00922974|9749143|FG000|Eligible With 3 mo. FACT-G Data|Phase III Component||87
8703291|NCT00922974|9749144|FG001|Eligible With 3 mo. FACT-G Data|Phase III Component||58
8703292|NCT00922974|9749143|FG000|Eligible With Adverse Event Data|Phase III Component||202
8703293|NCT00922974|9749144|FG001|Eligible With Adverse Event Data|Phase III Component||117
8703294|NCT00922974|9749143|FG000|Eligible, Treated, Adverse Event Data|Phase III Component||148
8703295|NCT00922974|9749144|FG001|Eligible, Treated, Adverse Event Data|Phase III Component||83
8703296|NCT00922974|9749143|FG000|Eligible and Consented to Quality of Life Participate in Quality of Life (QOL) Study Component|Phase III Component||152
8703297|NCT00922974|9749144|FG001|Eligible and Consented to Quality of Life Participate in Quality of Life (QOL) Study Component|Phase III Component||100
8703298|NCT00922974|9749143|FG000|COMPLETED|Phase III Component||209
8703299|NCT00922974|9749144|FG001|COMPLETED|Phase III Component||130
8703300|NCT00922974|9749143|FG000|NOT COMPLETED|Phase III Component||8
8703301|NCT00922974|9749144|FG001|NOT COMPLETED|Phase III Component||6
8703302|NCT00922987|9749152|FG000|STARTED|Overall Study||281
8703303|NCT00922987|9749152|FG000|COMPLETED|Overall Study||277
8703304|NCT00922987|9749152|FG000|NOT COMPLETED|Overall Study||4
9046047|NCT03433677|10105999|FG001|COMPLETED|Period 2||24
9046048|NCT03433677|10105998|FG000|NOT COMPLETED|Period 2||1
9046049|NCT03433677|10105999|FG001|NOT COMPLETED|Period 2||1
9046050|NCT03433703|10106006|FG000|STARTED|Overall Study||2
9046051|NCT03433703|10106006|FG000|COMPLETED|Overall Study||0
9046052|NCT03433703|10106006|FG000|NOT COMPLETED|Overall Study||2
9046053|NCT03433755|10106014|FG000|STARTED|Overall Study||42
9046054|NCT03433755|10106015|FG001|STARTED|Overall Study||41
9046055|NCT03433755|10106016|FG002|STARTED|Overall Study||79
9046056|NCT03433755|10106017|FG003|STARTED|Overall Study||80
9046057|NCT03433755|10106014|FG000|Randomized and Treated|Overall Study||41
9046058|NCT03433755|10106015|FG001|Randomized and Treated|Overall Study||41
9046059|NCT03433755|10106016|FG002|Randomized and Treated|Overall Study||79
9046060|NCT03433755|10106017|FG003|Randomized and Treated|Overall Study||80
8703305|NCT00923078|9749159|FG000|STARTED|First Intervention (Weeks 1-4)||20
8703306|NCT00923078|9749160|FG001|STARTED|First Intervention (Weeks 1-4)||20
8703307|NCT00923078|9749161|FG002|STARTED|First Intervention (Weeks 1-4)||20
9046061|NCT03433755|10106014|FG000|COMPLETED|Overall Study||40
9046062|NCT03433755|10106015|FG001|COMPLETED|Overall Study||41
9046063|NCT03433755|10106016|FG002|COMPLETED|Overall Study||79
9046064|NCT03433755|10106017|FG003|COMPLETED|Overall Study||80
9046065|NCT03433755|10106014|FG000|NOT COMPLETED|Overall Study||2
9046066|NCT03433755|10106015|FG001|NOT COMPLETED|Overall Study||0
9046067|NCT03433755|10106016|FG002|NOT COMPLETED|Overall Study||0
9046068|NCT03433755|10106017|FG003|NOT COMPLETED|Overall Study||0
9046069|NCT03433794|10106032|FG000|STARTED|Baseline||183
9046070|NCT03433794|10106033|FG001|STARTED|Baseline||173
9046071|NCT03433794|10106034|FG002|STARTED|Baseline||181
9046072|NCT03433794|10106032|FG000|COMPLETED|Baseline||183
9046073|NCT03433794|10106033|FG001|COMPLETED|Baseline||173
9046074|NCT03433794|10106034|FG002|COMPLETED|Baseline||181
9046075|NCT03433794|10106032|FG000|NOT COMPLETED|Baseline||0
9046076|NCT03433794|10106033|FG001|NOT COMPLETED|Baseline||0
9046077|NCT03433794|10106034|FG002|NOT COMPLETED|Baseline||0
9046078|NCT03433794|10106032|FG000|STARTED|2-Week Assessment||183
9046079|NCT03433794|10106033|FG001|STARTED|2-Week Assessment||173
9046080|NCT03433794|10106034|FG002|STARTED|2-Week Assessment||181
9046081|NCT03433794|10106032|FG000|COMPLETED|2-Week Assessment||117
9046082|NCT03433794|10106033|FG001|COMPLETED|2-Week Assessment||112
9046083|NCT03433794|10106034|FG002|COMPLETED|2-Week Assessment||109
9046084|NCT03433794|10106032|FG000|NOT COMPLETED|2-Week Assessment||66
9046085|NCT03433794|10106033|FG001|NOT COMPLETED|2-Week Assessment||61
9046086|NCT03433794|10106034|FG002|NOT COMPLETED|2-Week Assessment||72
9046087|NCT03433794|10106032|FG000|STARTED|4-Week Assessment||183
9046088|NCT03433794|10106033|FG001|STARTED|4-Week Assessment||173
9046089|NCT03433794|10106034|FG002|STARTED|4-Week Assessment||181
9046090|NCT03433794|10106032|FG000|COMPLETED|4-Week Assessment||98
9046091|NCT03433794|10106033|FG001|COMPLETED|4-Week Assessment||95
9046092|NCT03433794|10106034|FG002|COMPLETED|4-Week Assessment||91
9046093|NCT03433794|10106032|FG000|NOT COMPLETED|4-Week Assessment||85
9046094|NCT03433794|10106033|FG001|NOT COMPLETED|4-Week Assessment||78
9046095|NCT03433794|10106034|FG002|NOT COMPLETED|4-Week Assessment||90
9046096|NCT03433794|10106032|FG000|STARTED|6-Week Assessment||183
9046097|NCT03433794|10106033|FG001|STARTED|6-Week Assessment||173
9046098|NCT03433794|10106034|FG002|STARTED|6-Week Assessment||181
9046099|NCT03433794|10106032|FG000|COMPLETED|6-Week Assessment||94
9046100|NCT03433794|10106033|FG001|COMPLETED|6-Week Assessment||85
9046101|NCT03433794|10106034|FG002|COMPLETED|6-Week Assessment||80
9046102|NCT03433794|10106032|FG000|NOT COMPLETED|6-Week Assessment||89
9046103|NCT03433794|10106033|FG001|NOT COMPLETED|6-Week Assessment||88
9046104|NCT03433794|10106034|FG002|NOT COMPLETED|6-Week Assessment||101
9046105|NCT03433794|10106032|FG000|STARTED|3-Month Assessment||183
9046106|NCT03433794|10106033|FG001|STARTED|3-Month Assessment||173
9046107|NCT03433794|10106034|FG002|STARTED|3-Month Assessment||181
9046108|NCT03433794|10106032|FG000|COMPLETED|3-Month Assessment||69
9046109|NCT03433794|10106033|FG001|COMPLETED|3-Month Assessment||73
9046110|NCT03433794|10106034|FG002|COMPLETED|3-Month Assessment||71
9046111|NCT03433794|10106032|FG000|NOT COMPLETED|3-Month Assessment||114
9046112|NCT03433794|10106033|FG001|NOT COMPLETED|3-Month Assessment||100
9046113|NCT03433794|10106034|FG002|NOT COMPLETED|3-Month Assessment||110
9046114|NCT03433794|10106032|FG000|STARTED|6-Month Assessment||183
9046115|NCT03433794|10106033|FG001|STARTED|6-Month Assessment||173
9046116|NCT03433794|10106034|FG002|STARTED|6-Month Assessment||181
9046117|NCT03433794|10106032|FG000|COMPLETED|6-Month Assessment||65
9046118|NCT03433794|10106033|FG001|COMPLETED|6-Month Assessment||58
9046119|NCT03433794|10106034|FG002|COMPLETED|6-Month Assessment||50
9046120|NCT03433794|10106032|FG000|NOT COMPLETED|6-Month Assessment||118
8703308|NCT00923078|9749159|FG000|COMPLETED|First Intervention (Weeks 1-4)||19
8703309|NCT00923078|9749160|FG001|COMPLETED|First Intervention (Weeks 1-4)||19
9046121|NCT03433794|10106033|FG001|NOT COMPLETED|6-Month Assessment||115
8703310|NCT00923078|9749161|FG002|COMPLETED|First Intervention (Weeks 1-4)||0
9046122|NCT03433794|10106034|FG002|NOT COMPLETED|6-Month Assessment||131
9046123|NCT03433794|10106032|FG000|STARTED|9-Month Assessment||183
9046124|NCT03433794|10106033|FG001|STARTED|9-Month Assessment||173
9046125|NCT03433794|10106034|FG002|STARTED|9-Month Assessment||181
9046126|NCT03433794|10106032|FG000|COMPLETED|9-Month Assessment||49
9046127|NCT03433794|10106033|FG001|COMPLETED|9-Month Assessment||52
9046128|NCT03433794|10106034|FG002|COMPLETED|9-Month Assessment||39
9046129|NCT03433794|10106032|FG000|NOT COMPLETED|9-Month Assessment||134
9046130|NCT03433794|10106033|FG001|NOT COMPLETED|9-Month Assessment||121
9046131|NCT03433794|10106034|FG002|NOT COMPLETED|9-Month Assessment||142
9046132|NCT03434249|10106044|FG000|STARTED|Overall Study||40
9046133|NCT03434249|10106045|FG001|STARTED|Overall Study||40
9046134|NCT03434249|10106044|FG000|COMPLETED|Overall Study||35
9046135|NCT03434249|10106045|FG001|COMPLETED|Overall Study||37
9046136|NCT03434249|10106044|FG000|NOT COMPLETED|Overall Study||5
9046137|NCT03434249|10106045|FG001|NOT COMPLETED|Overall Study||3
9046138|NCT03434457|10106051|FG000|STARTED|Overall Study||630
9046139|NCT03434457|10106051|FG000|COMPLETED|Overall Study||630
9046140|NCT03434457|10106051|FG000|NOT COMPLETED|Overall Study||0
9046141|NCT03434834|10106055|FG000|STARTED|Overall Study||53
9046142|NCT03434834|10106055|FG000|COMPLETED|Overall Study||37
9046143|NCT03434834|10106055|FG000|NOT COMPLETED|Overall Study||16
9046144|NCT03434977|10106061|FG000|STARTED|Intervention Period 1 (6 Days)||6
9046145|NCT03434977|10106062|FG001|STARTED|Intervention Period 1 (6 Days)||6
9046146|NCT03434977|10106061|FG000|COMPLETED|Intervention Period 1 (6 Days)||6
9046147|NCT03434977|10106062|FG001|COMPLETED|Intervention Period 1 (6 Days)||6
9046148|NCT03434977|10106061|FG000|NOT COMPLETED|Intervention Period 1 (6 Days)||0
9046149|NCT03434977|10106062|FG001|NOT COMPLETED|Intervention Period 1 (6 Days)||0
9046150|NCT03434977|10106061|FG000|STARTED|Washout Period (at Least 6 Days)||6
9046151|NCT03434977|10106062|FG001|STARTED|Washout Period (at Least 6 Days)||6
9046152|NCT03434977|10106061|FG000|COMPLETED|Washout Period (at Least 6 Days)||6
9046153|NCT03434977|10106062|FG001|COMPLETED|Washout Period (at Least 6 Days)||5
9046154|NCT03434977|10106061|FG000|NOT COMPLETED|Washout Period (at Least 6 Days)||0
9046155|NCT03434977|10106062|FG001|NOT COMPLETED|Washout Period (at Least 6 Days)||1
9046156|NCT03434977|10106061|FG000|STARTED|Intervention Period 2 (6 Days)||6
9046157|NCT03434977|10106062|FG001|STARTED|Intervention Period 2 (6 Days)||5
9046158|NCT03434977|10106061|FG000|COMPLETED|Intervention Period 2 (6 Days)||6
9046159|NCT03434977|10106062|FG001|COMPLETED|Intervention Period 2 (6 Days)||5
9046160|NCT03434977|10106061|FG000|NOT COMPLETED|Intervention Period 2 (6 Days)||0
9046161|NCT03434977|10106062|FG001|NOT COMPLETED|Intervention Period 2 (6 Days)||0
9046162|NCT03435055|10106068|FG000|STARTED|Screening||21
9046163|NCT03435055|10106068|FG000|COMPLETED|Screening||19
9046164|NCT03435055|10106068|FG000|NOT COMPLETED|Screening||2
9046165|NCT03435055|10106068|FG000|STARTED|Received Intervention||19
9046166|NCT03435055|10106068|FG000|COMPLETED|Received Intervention||16
9046167|NCT03435055|10106068|FG000|NOT COMPLETED|Received Intervention||3
9046168|NCT03435081|10106082|FG000|STARTED|Overall Study||147
9046169|NCT03435081|10106083|FG001|STARTED|Overall Study||147
9046170|NCT03435081|10106084|FG002|STARTED|Overall Study||146
9046171|NCT03435081|10106082|FG000|Received at Least One Dose of Study Drug|Overall Study||147
9046172|NCT03435081|10106083|FG001|Received at Least One Dose of Study Drug|Overall Study||147
9046173|NCT03435081|10106084|FG002|Received at Least One Dose of Study Drug|Overall Study||146
9046174|NCT03435081|10106082|FG000|COMPLETED|Overall Study||126
9046175|NCT03435081|10106083|FG001|COMPLETED|Overall Study||131
9046176|NCT03435081|10106084|FG002|COMPLETED|Overall Study||127
9046177|NCT03435081|10106082|FG000|NOT COMPLETED|Overall Study||21
9046178|NCT03435081|10106083|FG001|NOT COMPLETED|Overall Study||16
9046179|NCT03435081|10106084|FG002|NOT COMPLETED|Overall Study||19
9046180|NCT03435211|10106093|FG000|STARTED|Overall Study||26
9046181|NCT03435211|10106093|FG000|COMPLETED|Overall Study||25
9046182|NCT03435211|10106093|FG000|NOT COMPLETED|Overall Study||1
9046183|NCT03435224|10106097|FG000|STARTED|Overall Study||29
9046184|NCT03435224|10106097|FG000|COMPLETED|Overall Study||25
9046185|NCT03435224|10106097|FG000|NOT COMPLETED|Overall Study||4
9046186|NCT03435497|10106103|FG000|STARTED|Overall Study||51
9046187|NCT03435497|10106104|FG001|STARTED|Overall Study||47
8703311|NCT00923078|9749159|FG000|NOT COMPLETED|First Intervention (Weeks 1-4)||1
8703312|NCT00923078|9749160|FG001|NOT COMPLETED|First Intervention (Weeks 1-4)||1
8703313|NCT00923078|9749161|FG002|NOT COMPLETED|First Intervention (Weeks 1-4)||20
8703314|NCT00923078|9749159|FG000|STARTED|Second Intervention (Weeks 5-8)||19
8703315|NCT00923078|9749160|FG001|STARTED|Second Intervention (Weeks 5-8)||19
8703316|NCT00923078|9749161|FG002|STARTED|Second Intervention (Weeks 5-8)|Healthy Comparison sample subjects completed only a single test session (baseline)|0
9046188|NCT03435497|10106103|FG000|COMPLETED|Overall Study||49
9046189|NCT03435497|10106104|FG001|COMPLETED|Overall Study||41
9046190|NCT03435497|10106103|FG000|NOT COMPLETED|Overall Study||2
9046191|NCT03435497|10106104|FG001|NOT COMPLETED|Overall Study||6
9046192|NCT03435562|10106110|FG000|STARTED|Overall Study||22
8703317|NCT00923078|9749159|FG000|COMPLETED|Second Intervention (Weeks 5-8)||19
8703318|NCT00923078|9749160|FG001|COMPLETED|Second Intervention (Weeks 5-8)||19
8703319|NCT00923078|9749161|FG002|COMPLETED|Second Intervention (Weeks 5-8)||0
8703320|NCT00923078|9749159|FG000|NOT COMPLETED|Second Intervention (Weeks 5-8)||0
8703321|NCT00923078|9749160|FG001|NOT COMPLETED|Second Intervention (Weeks 5-8)||0
8703322|NCT00923078|9749161|FG002|NOT COMPLETED|Second Intervention (Weeks 5-8)||0
8703323|NCT00923091|9749176|FG000|STARTED|PeriodI-II (Randomized, Double-Blind)||335
8703324|NCT00923091|9749177|FG001|STARTED|PeriodI-II (Randomized, Double-Blind)||336
8703325|NCT00923091|9749178|FG002|STARTED|PeriodI-II (Randomized, Double-Blind)||336
8703326|NCT00923091|9749179|FG003|STARTED|PeriodI-II (Randomized, Double-Blind)||336
8703327|NCT00923091|9749180|FG004|STARTED|PeriodI-II (Randomized, Double-Blind)||336
8703328|NCT00923091|9749181|FG005|STARTED|PeriodI-II (Randomized, Double-Blind)||337
9046193|NCT03435562|10106110|FG000|COMPLETED|Overall Study||18
9046194|NCT03435562|10106110|FG000|NOT COMPLETED|Overall Study||4
9046195|NCT03435614|10106123|FG000|STARTED|Overall Study||6
9046196|NCT03435614|10106124|FG001|STARTED|Overall Study||23
9046197|NCT03435614|10106123|FG000|COMPLETED|Overall Study||6
9046198|NCT03435614|10106124|FG001|COMPLETED|Overall Study||23
9046199|NCT03435614|10106123|FG000|NOT COMPLETED|Overall Study||0
9046200|NCT03435614|10106124|FG001|NOT COMPLETED|Overall Study||0
9046201|NCT03435692|10106134|FG000|STARTED|Overall Study||17
9046202|NCT03435692|10106135|FG001|STARTED|Overall Study||18
9046203|NCT03435692|10106136|FG002|STARTED|Overall Study||7
9046204|NCT03435692|10106134|FG000|COMPLETED|Overall Study|Discontinued intervention (n=2). 1) Lumbar Epidural Catheter (LEC) not working Post-Operative Day (POD) 0, Lumbar Epidural Catheter (LEC) removed and morphine infusion started - patient 1 year old. 2) Lumbar Epidural Catheter (LEC) not working Post-Operative Day (POD) 1, Lumbar Epidural Catheter (LEC) removed and Patient Controlled Analgesia (PCA) started.|15
9046205|NCT03435692|10106135|FG001|COMPLETED|Overall Study|Discontinued intervention (n=2). 1) Successful lumbar plexus injection, but unable to thread catheter, morphine infusion started (patient 1 year old). 2) Lumbar Plexus Catheter (LPC) catheter (10 cm) not long enough to reach lumbar plexus in patient weighing 136kg, Lumbar Epidural Catheter (LEC) placed instead.|16
9046206|NCT03435692|10106136|FG002|COMPLETED|Overall Study||7
9046207|NCT03435692|10106134|FG000|NOT COMPLETED|Overall Study||2
9046208|NCT03435692|10106135|FG001|NOT COMPLETED|Overall Study||2
9046209|NCT03435692|10106136|FG002|NOT COMPLETED|Overall Study||0
9046210|NCT03435783|10106150|FG000|STARTED|Overall Study||20
9046211|NCT03435783|10106151|FG001|STARTED|Overall Study||20
9046212|NCT03435783|10106150|FG000|COMPLETED|Overall Study||20
9046213|NCT03435783|10106151|FG001|COMPLETED|Overall Study||19
9046214|NCT03435783|10106150|FG000|NOT COMPLETED|Overall Study||0
9046215|NCT03435783|10106151|FG001|NOT COMPLETED|Overall Study||1
9046216|NCT03436082|10106159|FG000|STARTED|Overall Study||30
9046217|NCT03436082|10106160|FG001|STARTED|Overall Study||30
9046218|NCT03436082|10106159|FG000|COMPLETED|Overall Study|Had procedure|29
9046219|NCT03436082|10106160|FG001|COMPLETED|Overall Study|Had procedure|30
9046220|NCT03436082|10106159|FG000|NOT COMPLETED|Overall Study||1
9046221|NCT03436082|10106160|FG001|NOT COMPLETED|Overall Study||0
9046222|NCT03436147|10106168|FG000|STARTED|Overall Study||19
9046223|NCT03436147|10106169|FG001|STARTED|Overall Study||30
9046224|NCT03436147|10106168|FG000|COMPLETED|Overall Study||15
9046225|NCT03436147|10106169|FG001|COMPLETED|Overall Study||19
9046226|NCT03436147|10106168|FG000|NOT COMPLETED|Overall Study||4
9046227|NCT03436147|10106169|FG001|NOT COMPLETED|Overall Study||11
9046228|NCT03436420|10106177|FG000|STARTED|Overall Study||6
9046229|NCT03436420|10106177|FG000|COMPLETED|Overall Study||3
9046230|NCT03436420|10106177|FG000|NOT COMPLETED|Overall Study||3
9046231|NCT03436732|10106183|FG000|STARTED|Overall Study||4
9046232|NCT03436732|10106184|FG001|STARTED|Overall Study||1
9046233|NCT03436732|10106183|FG000|COMPLETED|Overall Study||0
9046234|NCT03436732|10106184|FG001|COMPLETED|Overall Study||0
9046235|NCT03436732|10106183|FG000|NOT COMPLETED|Overall Study||4
9046236|NCT03436732|10106184|FG001|NOT COMPLETED|Overall Study||1
9046237|NCT03436810|10106193|FG000|STARTED|Overall Study||20
9046238|NCT03436810|10106194|FG001|STARTED|Overall Study||20
9046239|NCT03436810|10106193|FG000|COMPLETED|Overall Study||20
9046240|NCT03436810|10106194|FG001|COMPLETED|Overall Study||20
9046241|NCT03436810|10106193|FG000|NOT COMPLETED|Overall Study||0
9046242|NCT03436810|10106194|FG001|NOT COMPLETED|Overall Study||0
9046243|NCT03437031|10106202|FG000|STARTED|Overall Study||19
9046244|NCT03437031|10106203|FG001|STARTED|Overall Study||21
9046245|NCT03437031|10106202|FG000|COMPLETED|Overall Study||19
9046246|NCT03437031|10106203|FG001|COMPLETED|Overall Study||21
9046247|NCT03437031|10106202|FG000|NOT COMPLETED|Overall Study||0
9046248|NCT03437031|10106203|FG001|NOT COMPLETED|Overall Study||0
9046249|NCT03437044|10106213|FG000|STARTED|Overall Study||20
9046250|NCT03437044|10106214|FG001|STARTED|Overall Study||20
9046251|NCT03437044|10106213|FG000|COMPLETED|Overall Study||17
9046252|NCT03437044|10106214|FG001|COMPLETED|Overall Study||18
9046253|NCT03437044|10106213|FG000|NOT COMPLETED|Overall Study||3
9046254|NCT03437044|10106214|FG001|NOT COMPLETED|Overall Study||2
9046255|NCT03437265|10106220|FG000|STARTED|Overall Study||19
9046256|NCT03437265|10106220|FG000|COMPLETED|Overall Study||13
9046257|NCT03437265|10106220|FG000|NOT COMPLETED|Overall Study||6
9046258|NCT03437447|10106227|FG000|STARTED|Treatment Period 1||20
9046259|NCT03437447|10106228|FG001|STARTED|Treatment Period 1||20
9046260|NCT03437447|10106229|FG002|STARTED|Treatment Period 1||20
9046261|NCT03437447|10106227|FG000|COMPLETED|Treatment Period 1||20
9046262|NCT03437447|10106228|FG001|COMPLETED|Treatment Period 1||20
9046263|NCT03437447|10106229|FG002|COMPLETED|Treatment Period 1||19
9046264|NCT03437447|10106227|FG000|NOT COMPLETED|Treatment Period 1||0
9046265|NCT03437447|10106228|FG001|NOT COMPLETED|Treatment Period 1||0
9046266|NCT03437447|10106229|FG002|NOT COMPLETED|Treatment Period 1||1
9046267|NCT03437447|10106227|FG000|STARTED|Treatment Period 2||20
9046268|NCT03437447|10106228|FG001|STARTED|Treatment Period 2||20
9046269|NCT03437447|10106229|FG002|STARTED|Treatment Period 2||19
9046270|NCT03437447|10106227|FG000|COMPLETED|Treatment Period 2||20
9046271|NCT03437447|10106228|FG001|COMPLETED|Treatment Period 2||20
9046272|NCT03437447|10106229|FG002|COMPLETED|Treatment Period 2||19
9046273|NCT03437447|10106227|FG000|NOT COMPLETED|Treatment Period 2||0
9046274|NCT03437447|10106228|FG001|NOT COMPLETED|Treatment Period 2||0
9046275|NCT03437447|10106229|FG002|NOT COMPLETED|Treatment Period 2||0
9046276|NCT03437447|10106227|FG000|STARTED|Treatment Period 3||20
9046277|NCT03437447|10106228|FG001|STARTED|Treatment Period 3||20
9046278|NCT03437447|10106229|FG002|STARTED|Treatment Period 3||19
9046279|NCT03437447|10106227|FG000|COMPLETED|Treatment Period 3||20
9046280|NCT03437447|10106228|FG001|COMPLETED|Treatment Period 3||20
9046281|NCT03437447|10106229|FG002|COMPLETED|Treatment Period 3||19
9046282|NCT03437447|10106227|FG000|NOT COMPLETED|Treatment Period 3||0
9046283|NCT03437447|10106228|FG001|NOT COMPLETED|Treatment Period 3||0
9046284|NCT03437447|10106229|FG002|NOT COMPLETED|Treatment Period 3||0
9046285|NCT03437512|10106239|FG000|STARTED|Randomized||12
9046286|NCT03437512|10106240|FG001|STARTED|Randomized||13
9046287|NCT03437512|10106239|FG000|COMPLETED|Randomized||12
9046288|NCT03437512|10106240|FG001|COMPLETED|Randomized||11
9046289|NCT03437512|10106239|FG000|NOT COMPLETED|Randomized||0
9046290|NCT03437512|10106240|FG001|NOT COMPLETED|Randomized||2
9046291|NCT03437512|10106239|FG000|STARTED|Received First tDCS Session||12
9046292|NCT03437512|10106240|FG001|STARTED|Received First tDCS Session||11
9046293|NCT03437512|10106239|FG000|COMPLETED|Received First tDCS Session||12
9046294|NCT03437512|10106240|FG001|COMPLETED|Received First tDCS Session||11
9046295|NCT03437512|10106239|FG000|NOT COMPLETED|Received First tDCS Session||0
9046296|NCT03437512|10106240|FG001|NOT COMPLETED|Received First tDCS Session||0
9046297|NCT03437512|10106239|FG000|STARTED|Received Final tDCS Session||12
9046298|NCT03437512|10106240|FG001|STARTED|Received Final tDCS Session||11
9046299|NCT03437512|10106239|FG000|COMPLETED|Received Final tDCS Session||12
9046300|NCT03437512|10106240|FG001|COMPLETED|Received Final tDCS Session||11
9046301|NCT03437512|10106239|FG000|NOT COMPLETED|Received Final tDCS Session||0
9046302|NCT03437512|10106240|FG001|NOT COMPLETED|Received Final tDCS Session||0
9046303|NCT03437512|10106239|FG000|STARTED|Completed Study Follow up||12
9046304|NCT03437512|10106240|FG001|STARTED|Completed Study Follow up||11
9046305|NCT03437512|10106239|FG000|COMPLETED|Completed Study Follow up||10
9046306|NCT03437512|10106240|FG001|COMPLETED|Completed Study Follow up||10
9046307|NCT03437512|10106239|FG000|NOT COMPLETED|Completed Study Follow up||2
9046308|NCT03437512|10106240|FG001|NOT COMPLETED|Completed Study Follow up||1
9046309|NCT03437564|10106248|FG000|STARTED|Overall Study||14
9046310|NCT03437564|10106249|FG001|STARTED|Overall Study||14
9046311|NCT03437564|10106248|FG000|COMPLETED|Overall Study||14
9046312|NCT03437564|10106249|FG001|COMPLETED|Overall Study||14
9046313|NCT03437564|10106248|FG000|NOT COMPLETED|Overall Study||0
9046314|NCT03437564|10106249|FG001|NOT COMPLETED|Overall Study||0
9046315|NCT03437577|10106258|FG000|STARTED|Pre-Randomization||0
9046316|NCT03437577|10106259|FG001|STARTED|Pre-Randomization||0
9046317|NCT03437577|10106260|FG002|STARTED|Pre-Randomization||10
9046318|NCT03437577|10106258|FG000|COMPLETED|Pre-Randomization||0
9046319|NCT03437577|10106259|FG001|COMPLETED|Pre-Randomization||0
9046320|NCT03437577|10106260|FG002|COMPLETED|Pre-Randomization||0
9046321|NCT03437577|10106258|FG000|NOT COMPLETED|Pre-Randomization||0
9046322|NCT03437577|10106259|FG001|NOT COMPLETED|Pre-Randomization||0
9046323|NCT03437577|10106260|FG002|NOT COMPLETED|Pre-Randomization||10
9046324|NCT03437577|10106258|FG000|STARTED|Post-Randomization||3
9046325|NCT03437577|10106259|FG001|STARTED|Post-Randomization||5
9046326|NCT03437577|10106260|FG002|STARTED|Post-Randomization||0
9046327|NCT03437577|10106258|FG000|COMPLETED|Post-Randomization||3
9046328|NCT03437577|10106259|FG001|COMPLETED|Post-Randomization||3
9046329|NCT03437577|10106260|FG002|COMPLETED|Post-Randomization||0
9046330|NCT03437577|10106258|FG000|NOT COMPLETED|Post-Randomization||0
9046331|NCT03437577|10106259|FG001|NOT COMPLETED|Post-Randomization||2
9046332|NCT03437577|10106260|FG002|NOT COMPLETED|Post-Randomization||0
9046333|NCT03437733|10106268|FG000|STARTED|Overall Study||8
9046334|NCT03437733|10106269|FG001|STARTED|Overall Study||90
9046335|NCT03437733|10106268|FG000|Safety|Overall Study||8
9046336|NCT03437733|10106269|FG001|Safety|Overall Study||87
9046337|NCT03437733|10106268|FG000|COMPLETED|Overall Study||8
9046338|NCT03437733|10106269|FG001|COMPLETED|Overall Study||87
9046339|NCT03437733|10106268|FG000|NOT COMPLETED|Overall Study||0
9046340|NCT03437733|10106269|FG001|NOT COMPLETED|Overall Study||3
9046341|NCT03437863|10106274|FG000|STARTED|Overall Study||12
9046342|NCT03437863|10106274|FG000|COMPLETED|Overall Study||12
9046343|NCT03437863|10106274|FG000|NOT COMPLETED|Overall Study||0
9046344|NCT03438006|10106278|FG000|STARTED|Overall Study||3013
9046345|NCT03438006|10106278|FG000|COMPLETED|Overall Study||2895
9046346|NCT03438006|10106278|FG000|NOT COMPLETED|Overall Study||118
9046347|NCT03438045|10106282|FG000|STARTED|Overall Study||75
9046348|NCT03438045|10106282|FG000|COMPLETED|Overall Study||75
9046349|NCT03438045|10106282|FG000|NOT COMPLETED|Overall Study||0
9046350|NCT03438266|10106286|FG000|STARTED|Overall Study||60
9046351|NCT03438266|10106286|FG000|COMPLETED|Overall Study||60
9046352|NCT03438266|10106286|FG000|NOT COMPLETED|Overall Study||0
9046353|NCT03438383|10106294|FG000|STARTED|Overall Study||23
9046354|NCT03438383|10106295|FG001|STARTED|Overall Study||24
9046355|NCT03438383|10106294|FG000|COMPLETED|Overall Study||14
9046356|NCT03438383|10106295|FG001|COMPLETED|Overall Study||21
9046357|NCT03438383|10106294|FG000|NOT COMPLETED|Overall Study||9
9046358|NCT03438383|10106295|FG001|NOT COMPLETED|Overall Study||3
9046359|NCT03438396|10106301|FG000|STARTED|Overall Study||102
9046360|NCT03438396|10106301|FG000|Treated|Overall Study||101
9046361|NCT03438396|10106301|FG000|COMPLETED|Overall Study||0
9046362|NCT03438396|10106301|FG000|NOT COMPLETED|Overall Study||102
9046363|NCT03438539|10106311|FG000|STARTED|Overall Study||76
9046364|NCT03438539|10106312|FG001|STARTED|Overall Study||72
9046365|NCT03438539|10106313|FG002|STARTED|Overall Study||76
9046366|NCT03438539|10106314|FG003|STARTED|Overall Study||73
9046367|NCT03438539|10106315|FG004|STARTED|Overall Study||73
9046368|NCT03438539|10106316|FG005|STARTED|Overall Study||74
9046369|NCT03438539|10106311|FG000|COMPLETED|Overall Study||68
9046370|NCT03438539|10106312|FG001|COMPLETED|Overall Study||68
9046371|NCT03438539|10106313|FG002|COMPLETED|Overall Study||66
9046372|NCT03438539|10106314|FG003|COMPLETED|Overall Study||64
9046373|NCT03438539|10106315|FG004|COMPLETED|Overall Study||70
8703329|NCT00923091|9749182|FG006|STARTED|PeriodI-II (Randomized, Double-Blind)||337
9046374|NCT03438539|10106316|FG005|COMPLETED|Overall Study||66
9046375|NCT03438539|10106311|FG000|NOT COMPLETED|Overall Study||8
9046376|NCT03438539|10106312|FG001|NOT COMPLETED|Overall Study||4
9046377|NCT03438539|10106313|FG002|NOT COMPLETED|Overall Study||10
9046378|NCT03438539|10106314|FG003|NOT COMPLETED|Overall Study||9
9046379|NCT03438539|10106315|FG004|NOT COMPLETED|Overall Study||3
9046380|NCT03438539|10106316|FG005|NOT COMPLETED|Overall Study||8
9046381|NCT03438578|10106332|FG000|STARTED|Overall Study||100
9046382|NCT03438578|10106333|FG001|STARTED|Overall Study||100
9046383|NCT03438578|10106332|FG000|COMPLETED|Overall Study||99
9046384|NCT03438578|10106333|FG001|COMPLETED|Overall Study||96
9046385|NCT03438578|10106332|FG000|NOT COMPLETED|Overall Study||1
9046386|NCT03438578|10106333|FG001|NOT COMPLETED|Overall Study||4
9046387|NCT03439072|10106339|FG000|STARTED|Overall Study||41
9046388|NCT03439072|10106340|FG001|STARTED|Overall Study||40
9046389|NCT03439072|10106339|FG000|COMPLETED|Overall Study|1 subject dropped before G-Pen; another after G-Pen (n=40 G-Pen; N=39 Lilly Glucagon)|39
9046390|NCT03439072|10106340|FG001|COMPLETED|Overall Study|1 subject dropped before Lilly Glucagon; 3 others after Lilly Glucagon (N=39 Lilly; N=36 G-Pen)|36
9046391|NCT03439072|10106339|FG000|NOT COMPLETED|Overall Study||2
9046392|NCT03439072|10106340|FG001|NOT COMPLETED|Overall Study||4
9046393|NCT03439137|10106348|FG000|STARTED|Overall Study||162
9046394|NCT03439137|10106349|FG001|STARTED|Overall Study||161
9046395|NCT03439137|10106348|FG000|COMPLETED|Overall Study||120
9046396|NCT03439137|10106349|FG001|COMPLETED|Overall Study||135
9046397|NCT03439137|10106348|FG000|NOT COMPLETED|Overall Study||42
8703330|NCT00923091|9749183|FG007|STARTED|PeriodI-II (Randomized, Double-Blind)||336
9046398|NCT03439137|10106349|FG001|NOT COMPLETED|Overall Study||26
9046399|NCT03439189|10106355|FG000|STARTED|Overall Study|Subjects performed at least one Methacetin Breath Test (MBT)|343
9046400|NCT03439189|10106355|FG000|COMPLETED|Overall Study||261
9046401|NCT03439189|10106355|FG000|NOT COMPLETED|Overall Study||82
9046402|NCT03440229|10106362|FG000|STARTED|Overall Study||9
9046403|NCT03440229|10106363|FG001|STARTED|Overall Study||7
9046404|NCT03440229|10106362|FG000|COMPLETED|Overall Study||9
9046405|NCT03440229|10106363|FG001|COMPLETED|Overall Study||7
9046406|NCT03440229|10106362|FG000|NOT COMPLETED|Overall Study||0
9046407|NCT03440229|10106363|FG001|NOT COMPLETED|Overall Study||0
9046408|NCT03440320|10106373|FG000|STARTED|Overall Study||18
9046409|NCT03440320|10106374|FG001|STARTED|Overall Study||14
9046410|NCT03440320|10106373|FG000|COMPLETED|Overall Study||18
9046411|NCT03440320|10106374|FG001|COMPLETED|Overall Study||13
9046412|NCT03440320|10106373|FG000|NOT COMPLETED|Overall Study||0
9046413|NCT03440320|10106374|FG001|NOT COMPLETED|Overall Study||1
9046414|NCT03440411|10106386|FG000|STARTED|Overall Study||3
9046415|NCT03440411|10106387|FG001|STARTED|Overall Study||1
9046416|NCT03440411|10106388|FG002|STARTED|Overall Study||2
9046417|NCT03440411|10106389|FG003|STARTED|Overall Study||2
9046418|NCT03440411|10106386|FG000|COMPLETED|Overall Study||0
9046419|NCT03440411|10106387|FG001|COMPLETED|Overall Study||0
9046420|NCT03440411|10106388|FG002|COMPLETED|Overall Study||0
9046421|NCT03440411|10106389|FG003|COMPLETED|Overall Study||0
9046422|NCT03440411|10106386|FG000|NOT COMPLETED|Overall Study||3
9046423|NCT03440411|10106387|FG001|NOT COMPLETED|Overall Study||1
9046424|NCT03440411|10106388|FG002|NOT COMPLETED|Overall Study||2
9046425|NCT03440411|10106389|FG003|NOT COMPLETED|Overall Study||2
9046426|NCT03440424|10106407|FG000|STARTED|Overall Study||8
9046427|NCT03440424|10106408|FG001|STARTED|Overall Study||8
9046428|NCT03440424|10106409|FG002|STARTED|Overall Study||8
9046429|NCT03440424|10106407|FG000|COMPLETED|Overall Study||8
9046430|NCT03440424|10106408|FG001|COMPLETED|Overall Study||8
9046431|NCT03440424|10106409|FG002|COMPLETED|Overall Study||8
9046432|NCT03440424|10106407|FG000|NOT COMPLETED|Overall Study||0
9046433|NCT03440424|10106408|FG001|NOT COMPLETED|Overall Study||0
9046434|NCT03440424|10106409|FG002|NOT COMPLETED|Overall Study||0
9046435|NCT03440619|10106417|FG000|STARTED|Overall Study||28
9046436|NCT03440619|10106417|FG000|COMPLETED|Overall Study||28
9046437|NCT03440619|10106417|FG000|NOT COMPLETED|Overall Study||0
9046438|NCT03440723|10106423|FG000|STARTED|Overall Study||21
9046439|NCT03440723|10106424|FG001|STARTED|Overall Study||21
9046440|NCT03440723|10106423|FG000|COMPLETED|Overall Study||21
9046441|NCT03440723|10106424|FG001|COMPLETED|Overall Study||21
9046442|NCT03440723|10106423|FG000|NOT COMPLETED|Overall Study||0
9046443|NCT03440723|10106424|FG001|NOT COMPLETED|Overall Study||0
9046444|NCT03440918|10106433|FG000|STARTED|Overall Study||133
9046445|NCT03440918|10106434|FG001|STARTED|Overall Study||138
9046446|NCT03440918|10106433|FG000|COMPLETED|Overall Study||133
8703331|NCT00923091|9749184|FG008|STARTED|PeriodI-II (Randomized, Double-Blind)||0
8703332|NCT00923091|9749185|FG009|STARTED|PeriodI-II (Randomized, Double-Blind)||0
9046447|NCT03440918|10106434|FG001|COMPLETED|Overall Study||122
9046448|NCT03440918|10106433|FG000|NOT COMPLETED|Overall Study||0
9046449|NCT03440918|10106434|FG001|NOT COMPLETED|Overall Study||16
9046450|NCT03440944|10106442|FG000|STARTED|Overall Study||9
9046451|NCT03440944|10106443|FG001|STARTED|Overall Study||9
9046452|NCT03440944|10106442|FG000|COMPLETED|Overall Study||8
9046453|NCT03440944|10106443|FG001|COMPLETED|Overall Study||8
9046454|NCT03440944|10106442|FG000|NOT COMPLETED|Overall Study||1
9046455|NCT03440944|10106443|FG001|NOT COMPLETED|Overall Study||1
9046456|NCT03441178|10106450|FG000|STARTED|Overall Study||36
9046457|NCT03441178|10106451|FG001|STARTED|Overall Study||44
9046458|NCT03441178|10106452|FG002|STARTED|Overall Study||21
9046459|NCT03441178|10106450|FG000|COMPLETED|Overall Study||36
9046460|NCT03441178|10106451|FG001|COMPLETED|Overall Study||43
9046461|NCT03441178|10106452|FG002|COMPLETED|Overall Study||20
9046462|NCT03441178|10106450|FG000|NOT COMPLETED|Overall Study||0
9046463|NCT03441178|10106451|FG001|NOT COMPLETED|Overall Study||1
9046464|NCT03441178|10106452|FG002|NOT COMPLETED|Overall Study||1
9046465|NCT03441269|10106465|FG000|STARTED|Overall Study||75
9046466|NCT03441269|10106466|FG001|STARTED|Overall Study||75
9046467|NCT03441269|10106467|FG002|STARTED|Overall Study||75
9046468|NCT03441269|10106465|FG000|COMPLETED|Overall Study||75
9046469|NCT03441269|10106466|FG001|COMPLETED|Overall Study||74
9046470|NCT03441269|10106467|FG002|COMPLETED|Overall Study||74
9046471|NCT03441269|10106465|FG000|NOT COMPLETED|Overall Study||0
9046472|NCT03441269|10106466|FG001|NOT COMPLETED|Overall Study||1
9046473|NCT03441269|10106467|FG002|NOT COMPLETED|Overall Study||1
9046474|NCT03441581|10106477|FG000|STARTED|Overall Study||12
9046475|NCT03441581|10106478|FG001|STARTED|Overall Study||12
9046476|NCT03441581|10106477|FG000|COMPLETED|Overall Study||12
9046477|NCT03441581|10106478|FG001|COMPLETED|Overall Study||12
9046478|NCT03441581|10106477|FG000|NOT COMPLETED|Overall Study||0
9046479|NCT03441581|10106478|FG001|NOT COMPLETED|Overall Study||0
9046480|NCT03441594|10106484|FG000|STARTED|Overall Study||56
9046481|NCT03441594|10106484|FG000|COMPLETED|Overall Study||56
8703333|NCT00923091|9749186|FG010|STARTED|PeriodI-II (Randomized, Double-Blind)||0
8703334|NCT00923091|9749187|FG011|STARTED|PeriodI-II (Randomized, Double-Blind)||0
8703335|NCT00923091|9749188|FG012|STARTED|PeriodI-II (Randomized, Double-Blind)||0
9046482|NCT03441594|10106484|FG000|NOT COMPLETED|Overall Study||0
9046483|NCT03441633|10106498|FG000|STARTED|Overall Study||4712
9046484|NCT03441633|10106499|FG001|STARTED|Overall Study||1423
9046485|NCT03441633|10106500|FG002|STARTED|Overall Study||32212
9046486|NCT03441633|10106501|FG003|STARTED|Overall Study||192
9046487|NCT03441633|10106502|FG004|STARTED|Overall Study||2286
9046488|NCT03441633|10106503|FG005|STARTED|Overall Study||363
8703336|NCT00923091|9749176|FG000|COMPLETED|PeriodI-II (Randomized, Double-Blind)||319
8703337|NCT00923091|9749177|FG001|COMPLETED|PeriodI-II (Randomized, Double-Blind)||325
8703338|NCT00923091|9749178|FG002|COMPLETED|PeriodI-II (Randomized, Double-Blind)||323
8703339|NCT00923091|9749179|FG003|COMPLETED|PeriodI-II (Randomized, Double-Blind)||309
8703340|NCT00923091|9749180|FG004|COMPLETED|PeriodI-II (Randomized, Double-Blind)||315
8703341|NCT00923091|9749181|FG005|COMPLETED|PeriodI-II (Randomized, Double-Blind)||322
8703342|NCT00923091|9749182|FG006|COMPLETED|PeriodI-II (Randomized, Double-Blind)||319
8703343|NCT00923091|9749183|FG007|COMPLETED|PeriodI-II (Randomized, Double-Blind)||311
8703344|NCT00923091|9749184|FG008|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
8703345|NCT00923091|9749185|FG009|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
8703346|NCT00923091|9749186|FG010|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
8703347|NCT00923091|9749187|FG011|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
8703348|NCT00923091|9749188|FG012|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
8703349|NCT00923091|9749176|FG000|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||16
8703350|NCT00923091|9749177|FG001|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||11
8703351|NCT00923091|9749178|FG002|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||13
8703352|NCT00923091|9749179|FG003|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||27
8703353|NCT00923091|9749180|FG004|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||21
8703354|NCT00923091|9749181|FG005|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||15
8703355|NCT00923091|9749182|FG006|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||18
8703356|NCT00923091|9749183|FG007|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||25
8703357|NCT00923091|9749184|FG008|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
8703358|NCT00923091|9749185|FG009|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
8703359|NCT00923091|9749186|FG010|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
8703360|NCT00923091|9749187|FG011|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
8703361|NCT00923091|9749188|FG012|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
9046489|NCT03441633|10106504|FG006|STARTED|Overall Study||2855
9046490|NCT03441633|10106505|FG007|STARTED|Overall Study||953
9046491|NCT03441633|10106506|FG008|STARTED|Overall Study||5132
9046492|NCT03441633|10106507|FG009|STARTED|Overall Study||1562
9046493|NCT03441633|10106498|FG000|COMPLETED|Overall Study||4712
9046494|NCT03441633|10106499|FG001|COMPLETED|Overall Study||1423
9046495|NCT03441633|10106500|FG002|COMPLETED|Overall Study||32212
9046496|NCT03441633|10106501|FG003|COMPLETED|Overall Study||192
9046497|NCT03441633|10106502|FG004|COMPLETED|Overall Study||2286
9046498|NCT03441633|10106503|FG005|COMPLETED|Overall Study||363
9046499|NCT03441633|10106504|FG006|COMPLETED|Overall Study||2855
9046500|NCT03441633|10106505|FG007|COMPLETED|Overall Study||953
9046501|NCT03441633|10106506|FG008|COMPLETED|Overall Study||5132
9046502|NCT03441633|10106507|FG009|COMPLETED|Overall Study||1562
9046503|NCT03441633|10106498|FG000|NOT COMPLETED|Overall Study||0
9046504|NCT03441633|10106499|FG001|NOT COMPLETED|Overall Study||0
9046505|NCT03441633|10106500|FG002|NOT COMPLETED|Overall Study||0
9046506|NCT03441633|10106501|FG003|NOT COMPLETED|Overall Study||0
9046507|NCT03441633|10106502|FG004|NOT COMPLETED|Overall Study||0
9046508|NCT03441633|10106503|FG005|NOT COMPLETED|Overall Study||0
9046509|NCT03441633|10106504|FG006|NOT COMPLETED|Overall Study||0
9046510|NCT03441633|10106505|FG007|NOT COMPLETED|Overall Study||0
9046511|NCT03441633|10106506|FG008|NOT COMPLETED|Overall Study||0
9046512|NCT03441633|10106507|FG009|NOT COMPLETED|Overall Study||0
9046513|NCT03441789|10106535|FG000|STARTED|Overall Study||14
9046514|NCT03441789|10106536|FG001|STARTED|Overall Study||14
9046515|NCT03441789|10106535|FG000|COMPLETED|Overall Study||13
9046516|NCT03441789|10106536|FG001|COMPLETED|Overall Study||10
9046517|NCT03441789|10106535|FG000|NOT COMPLETED|Overall Study||1
9046518|NCT03441789|10106536|FG001|NOT COMPLETED|Overall Study||4
9046519|NCT03441984|10106544|FG000|STARTED|Part 1: Period 1 (Up to Day 4)||3
9046520|NCT03441984|10106545|FG001|STARTED|Part 1: Period 1 (Up to Day 4)||3
9046521|NCT03441984|10106546|FG002|STARTED|Part 1: Period 1 (Up to Day 4)||3
9046522|NCT03441984|10106547|FG003|STARTED|Part 1: Period 1 (Up to Day 4)||3
9046523|NCT03441984|10106548|FG004|STARTED|Part 1: Period 1 (Up to Day 4)||3
9046524|NCT03441984|10106549|FG005|STARTED|Part 1: Period 1 (Up to Day 4)||3
9046525|NCT03441984|10106550|FG006|STARTED|Part 1: Period 1 (Up to Day 4)||0
9046526|NCT03441984|10106551|FG007|STARTED|Part 1: Period 1 (Up to Day 4)||0
9046527|NCT03441984|10106552|FG008|STARTED|Part 1: Period 1 (Up to Day 4)||0
9046528|NCT03441984|10106553|FG009|STARTED|Part 1: Period 1 (Up to Day 4)||0
9046529|NCT03441984|10106554|FG010|STARTED|Part 1: Period 1 (Up to Day 4)||0
9046530|NCT03441984|10106555|FG011|STARTED|Part 1: Period 1 (Up to Day 4)||0
9046531|NCT03441984|10106544|FG000|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
9046532|NCT03441984|10106545|FG001|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
9046533|NCT03441984|10106546|FG002|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
9046534|NCT03441984|10106547|FG003|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
9046535|NCT03441984|10106548|FG004|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
9046536|NCT03441984|10106549|FG005|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
9046537|NCT03441984|10106550|FG006|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
9046538|NCT03441984|10106551|FG007|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
9046539|NCT03441984|10106552|FG008|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
9046540|NCT03441984|10106553|FG009|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
9046541|NCT03441984|10106554|FG010|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
9046542|NCT03441984|10106555|FG011|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
9046543|NCT03441984|10106544|FG000|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
9046544|NCT03441984|10106545|FG001|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
9046545|NCT03441984|10106546|FG002|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
9046546|NCT03441984|10106547|FG003|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
9046547|NCT03441984|10106548|FG004|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
9046548|NCT03441984|10106549|FG005|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
9046549|NCT03441984|10106550|FG006|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
9046550|NCT03441984|10106551|FG007|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
9046551|NCT03441984|10106552|FG008|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
9046552|NCT03441984|10106553|FG009|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
9046553|NCT03441984|10106554|FG010|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
9046554|NCT03441984|10106555|FG011|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
9046555|NCT03441984|10106544|FG000|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
9046556|NCT03441984|10106545|FG001|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
9046557|NCT03441984|10106546|FG002|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
9046558|NCT03441984|10106547|FG003|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
9046559|NCT03441984|10106548|FG004|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
9046560|NCT03441984|10106549|FG005|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
9046561|NCT03441984|10106550|FG006|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
9046562|NCT03441984|10106551|FG007|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
9046563|NCT03441984|10106552|FG008|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
9046564|NCT03441984|10106553|FG009|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
9046565|NCT03441984|10106554|FG010|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
9046566|NCT03441984|10106555|FG011|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
9046567|NCT03441984|10106544|FG000|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
9046568|NCT03441984|10106545|FG001|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
9046569|NCT03441984|10106546|FG002|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
9046570|NCT03441984|10106547|FG003|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
9046571|NCT03441984|10106548|FG004|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
9046572|NCT03441984|10106549|FG005|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
9046573|NCT03441984|10106550|FG006|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
9046574|NCT03441984|10106551|FG007|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
9046575|NCT03441984|10106552|FG008|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
9046576|NCT03441984|10106553|FG009|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
9046577|NCT03441984|10106554|FG010|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
9046578|NCT03441984|10106555|FG011|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
9046579|NCT03441984|10106544|FG000|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
9046580|NCT03441984|10106545|FG001|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
9046581|NCT03441984|10106546|FG002|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
9046582|NCT03441984|10106547|FG003|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
9046583|NCT03441984|10106548|FG004|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
9046584|NCT03441984|10106549|FG005|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
9046585|NCT03441984|10106550|FG006|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
9046586|NCT03441984|10106551|FG007|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
9046587|NCT03441984|10106552|FG008|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
9046588|NCT03441984|10106553|FG009|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
9046589|NCT03441984|10106554|FG010|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
9046590|NCT03441984|10106555|FG011|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
9046591|NCT03441984|10106544|FG000|STARTED|Part 1: Period 2 (Up to Day 4 )||3
9046592|NCT03441984|10106545|FG001|STARTED|Part 1: Period 2 (Up to Day 4 )||3
9046593|NCT03441984|10106546|FG002|STARTED|Part 1: Period 2 (Up to Day 4 )||3
9046594|NCT03441984|10106547|FG003|STARTED|Part 1: Period 2 (Up to Day 4 )||3
9046595|NCT03441984|10106548|FG004|STARTED|Part 1: Period 2 (Up to Day 4 )||3
9046596|NCT03441984|10106549|FG005|STARTED|Part 1: Period 2 (Up to Day 4 )||3
9046597|NCT03441984|10106550|FG006|STARTED|Part 1: Period 2 (Up to Day 4 )||0
9046598|NCT03441984|10106551|FG007|STARTED|Part 1: Period 2 (Up to Day 4 )||0
9046599|NCT03441984|10106552|FG008|STARTED|Part 1: Period 2 (Up to Day 4 )||0
9046600|NCT03441984|10106553|FG009|STARTED|Part 1: Period 2 (Up to Day 4 )||0
9046601|NCT03441984|10106554|FG010|STARTED|Part 1: Period 2 (Up to Day 4 )||0
9046602|NCT03441984|10106555|FG011|STARTED|Part 1: Period 2 (Up to Day 4 )||0
9046603|NCT03441984|10106544|FG000|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3
9046604|NCT03441984|10106545|FG001|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3
9046605|NCT03441984|10106546|FG002|COMPLETED|Part 1: Period 2 (Up to Day 4 )||2
9046606|NCT03441984|10106547|FG003|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3
9046607|NCT03441984|10106548|FG004|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3
9046608|NCT03441984|10106549|FG005|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3
9046609|NCT03441984|10106550|FG006|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
9046610|NCT03441984|10106551|FG007|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
9046611|NCT03441984|10106552|FG008|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
9046612|NCT03441984|10106553|FG009|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
9046613|NCT03441984|10106554|FG010|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
9046614|NCT03441984|10106555|FG011|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
9046615|NCT03441984|10106544|FG000|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
9046616|NCT03441984|10106545|FG001|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
9046617|NCT03441984|10106546|FG002|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||1
9046618|NCT03441984|10106547|FG003|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
9046619|NCT03441984|10106548|FG004|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
9046620|NCT03441984|10106549|FG005|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
9046621|NCT03441984|10106550|FG006|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
9046622|NCT03441984|10106551|FG007|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
9046623|NCT03441984|10106552|FG008|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
9046624|NCT03441984|10106553|FG009|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
9046625|NCT03441984|10106554|FG010|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
9046626|NCT03441984|10106555|FG011|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
9046627|NCT03441984|10106544|FG000|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3
9046628|NCT03441984|10106545|FG001|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3
9046629|NCT03441984|10106546|FG002|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||2
9046630|NCT03441984|10106547|FG003|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3
9046631|NCT03441984|10106548|FG004|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3
9046632|NCT03441984|10106549|FG005|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3
9046633|NCT03441984|10106550|FG006|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
9046634|NCT03441984|10106551|FG007|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
9046635|NCT03441984|10106552|FG008|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
9046636|NCT03441984|10106553|FG009|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
9046637|NCT03441984|10106554|FG010|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
9046638|NCT03441984|10106555|FG011|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
9046639|NCT03441984|10106544|FG000|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3
9046640|NCT03441984|10106545|FG001|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3
9046641|NCT03441984|10106546|FG002|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||2
9046642|NCT03441984|10106547|FG003|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3
9046643|NCT03441984|10106548|FG004|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3
9046644|NCT03441984|10106549|FG005|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3
9046645|NCT03441984|10106550|FG006|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
9046646|NCT03441984|10106551|FG007|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
9046647|NCT03441984|10106552|FG008|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
9046648|NCT03441984|10106553|FG009|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
9046649|NCT03441984|10106554|FG010|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
9046650|NCT03441984|10106555|FG011|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
9046651|NCT03441984|10106544|FG000|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
9046652|NCT03441984|10106545|FG001|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
9046653|NCT03441984|10106546|FG002|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
9046654|NCT03441984|10106547|FG003|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
8724598|NCT01026948|9771794|FG000|COMPLETED|Overall Study|8 Women were recalled because of signal loss|62
9046655|NCT03441984|10106548|FG004|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
9046656|NCT03441984|10106549|FG005|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
9046657|NCT03441984|10106550|FG006|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
9046658|NCT03441984|10106551|FG007|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
9046659|NCT03441984|10106552|FG008|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
9046660|NCT03441984|10106553|FG009|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
9046661|NCT03441984|10106554|FG010|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
9046662|NCT03441984|10106555|FG011|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
9046663|NCT03441984|10106544|FG000|STARTED|Part 1: Period 3 (Up to Day 4 )||3
9046664|NCT03441984|10106545|FG001|STARTED|Part 1: Period 3 (Up to Day 4 )||3
9046665|NCT03441984|10106546|FG002|STARTED|Part 1: Period 3 (Up to Day 4 )||2
9046666|NCT03441984|10106547|FG003|STARTED|Part 1: Period 3 (Up to Day 4 )||3
9046667|NCT03441984|10106548|FG004|STARTED|Part 1: Period 3 (Up to Day 4 )||3
9046668|NCT03441984|10106549|FG005|STARTED|Part 1: Period 3 (Up to Day 4 )||3
9046669|NCT03441984|10106550|FG006|STARTED|Part 1: Period 3 (Up to Day 4 )||0
9046670|NCT03441984|10106551|FG007|STARTED|Part 1: Period 3 (Up to Day 4 )||0
9046671|NCT03441984|10106552|FG008|STARTED|Part 1: Period 3 (Up to Day 4 )||0
9046672|NCT03441984|10106553|FG009|STARTED|Part 1: Period 3 (Up to Day 4 )||0
8703362|NCT00923091|9749176|FG000|STARTED|Period III (Single-Blind)|2543 completed Period 2. Three decided not to continue in the study=2540.|2540
8703363|NCT00923091|9749177|FG001|STARTED|Period III (Single-Blind)||0
8703364|NCT00923091|9749178|FG002|STARTED|Period III (Single-Blind)||0
8703365|NCT00923091|9749179|FG003|STARTED|Period III (Single-Blind)||0
8703366|NCT00923091|9749180|FG004|STARTED|Period III (Single-Blind)||0
8703367|NCT00923091|9749181|FG005|STARTED|Period III (Single-Blind)||0
8703368|NCT00923091|9749182|FG006|STARTED|Period III (Single-Blind)||0
8703369|NCT00923091|9749183|FG007|STARTED|Period III (Single-Blind)||0
8703370|NCT00923091|9749184|FG008|STARTED|Period III (Single-Blind)||0
8703371|NCT00923091|9749185|FG009|STARTED|Period III (Single-Blind)||0
8703372|NCT00923091|9749186|FG010|STARTED|Period III (Single-Blind)||0
9046673|NCT03441984|10106554|FG010|STARTED|Part 1: Period 3 (Up to Day 4 )||0
9046674|NCT03441984|10106555|FG011|STARTED|Part 1: Period 3 (Up to Day 4 )||0
9046675|NCT03441984|10106544|FG000|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3
9046676|NCT03441984|10106545|FG001|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3
8703373|NCT00923091|9749187|FG011|STARTED|Period III (Single-Blind)||0
8703374|NCT00923091|9749188|FG012|STARTED|Period III (Single-Blind)||0
8703375|NCT00923091|9749176|FG000|COMPLETED|Period III (Single-Blind)||2520
9046677|NCT03441984|10106546|FG002|COMPLETED|Part 1: Period 3 (Up to Day 4 )||2
9046678|NCT03441984|10106547|FG003|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3
9046679|NCT03441984|10106548|FG004|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3
9046680|NCT03441984|10106549|FG005|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3
9046681|NCT03441984|10106550|FG006|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
9046682|NCT03441984|10106551|FG007|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
9046683|NCT03441984|10106552|FG008|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
9046684|NCT03441984|10106553|FG009|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
9046685|NCT03441984|10106554|FG010|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
9046686|NCT03441984|10106555|FG011|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
9046687|NCT03441984|10106544|FG000|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
9046688|NCT03441984|10106545|FG001|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
9046689|NCT03441984|10106546|FG002|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
9046690|NCT03441984|10106547|FG003|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
9046691|NCT03441984|10106548|FG004|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
8703376|NCT00923091|9749177|FG001|COMPLETED|Period III (Single-Blind)||0
8703377|NCT00923091|9749178|FG002|COMPLETED|Period III (Single-Blind)||0
8703378|NCT00923091|9749179|FG003|COMPLETED|Period III (Single-Blind)||0
8703379|NCT00923091|9749180|FG004|COMPLETED|Period III (Single-Blind)||0
8703380|NCT00923091|9749181|FG005|COMPLETED|Period III (Single-Blind)||0
8703381|NCT00923091|9749182|FG006|COMPLETED|Period III (Single-Blind)||0
8703382|NCT00923091|9749183|FG007|COMPLETED|Period III (Single-Blind)||0
8703383|NCT00923091|9749184|FG008|COMPLETED|Period III (Single-Blind)||0
8703384|NCT00923091|9749185|FG009|COMPLETED|Period III (Single-Blind)||0
8703385|NCT00923091|9749186|FG010|COMPLETED|Period III (Single-Blind)||0
8703386|NCT00923091|9749187|FG011|COMPLETED|Period III (Single-Blind)||0
9046692|NCT03441984|10106549|FG005|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
9046693|NCT03441984|10106550|FG006|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
9046694|NCT03441984|10106551|FG007|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
9046695|NCT03441984|10106552|FG008|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
9046696|NCT03441984|10106553|FG009|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
9046697|NCT03441984|10106554|FG010|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
9046698|NCT03441984|10106555|FG011|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
9046699|NCT03441984|10106544|FG000|STARTED|Part 2: Period 1(Up to Day 4)||0
9046700|NCT03441984|10106545|FG001|STARTED|Part 2: Period 1(Up to Day 4)||0
9046701|NCT03441984|10106546|FG002|STARTED|Part 2: Period 1(Up to Day 4)||0
9046702|NCT03441984|10106547|FG003|STARTED|Part 2: Period 1(Up to Day 4)||0
9046703|NCT03441984|10106548|FG004|STARTED|Part 2: Period 1(Up to Day 4)||0
8703387|NCT00923091|9749188|FG012|COMPLETED|Period III (Single-Blind)||0
8703388|NCT00923091|9749176|FG000|NOT COMPLETED|Period III (Single-Blind)||20
9046704|NCT03441984|10106549|FG005|STARTED|Part 2: Period 1(Up to Day 4)||0
9046705|NCT03441984|10106550|FG006|STARTED|Part 2: Period 1(Up to Day 4)||3
9046706|NCT03441984|10106551|FG007|STARTED|Part 2: Period 1(Up to Day 4)||3
9046707|NCT03441984|10106552|FG008|STARTED|Part 2: Period 1(Up to Day 4)||3
9046708|NCT03441984|10106553|FG009|STARTED|Part 2: Period 1(Up to Day 4)||3
9046709|NCT03441984|10106554|FG010|STARTED|Part 2: Period 1(Up to Day 4)||3
9046710|NCT03441984|10106555|FG011|STARTED|Part 2: Period 1(Up to Day 4)||3
9046711|NCT03441984|10106544|FG000|COMPLETED|Part 2: Period 1(Up to Day 4)||0
9046712|NCT03441984|10106545|FG001|COMPLETED|Part 2: Period 1(Up to Day 4)||0
9046713|NCT03441984|10106546|FG002|COMPLETED|Part 2: Period 1(Up to Day 4)||0
9046714|NCT03441984|10106547|FG003|COMPLETED|Part 2: Period 1(Up to Day 4)||0
9046715|NCT03441984|10106548|FG004|COMPLETED|Part 2: Period 1(Up to Day 4)||0
9046716|NCT03441984|10106549|FG005|COMPLETED|Part 2: Period 1(Up to Day 4)||0
9046717|NCT03441984|10106550|FG006|COMPLETED|Part 2: Period 1(Up to Day 4)||3
9046718|NCT03441984|10106551|FG007|COMPLETED|Part 2: Period 1(Up to Day 4)||3
9046719|NCT03441984|10106552|FG008|COMPLETED|Part 2: Period 1(Up to Day 4)||3
9046720|NCT03441984|10106553|FG009|COMPLETED|Part 2: Period 1(Up to Day 4)||3
9046721|NCT03441984|10106554|FG010|COMPLETED|Part 2: Period 1(Up to Day 4)||3
9046722|NCT03441984|10106555|FG011|COMPLETED|Part 2: Period 1(Up to Day 4)||3
9046723|NCT03441984|10106544|FG000|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
9046724|NCT03441984|10106545|FG001|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
9046725|NCT03441984|10106546|FG002|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
9046726|NCT03441984|10106547|FG003|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
9046727|NCT03441984|10106548|FG004|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
9046728|NCT03441984|10106549|FG005|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
9046729|NCT03441984|10106550|FG006|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
9046730|NCT03441984|10106551|FG007|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
9046731|NCT03441984|10106552|FG008|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
9046732|NCT03441984|10106553|FG009|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
9046733|NCT03441984|10106554|FG010|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
9046734|NCT03441984|10106555|FG011|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
9046735|NCT03441984|10106544|FG000|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
8703389|NCT00923091|9749177|FG001|NOT COMPLETED|Period III (Single-Blind)||0
8703390|NCT00923091|9749178|FG002|NOT COMPLETED|Period III (Single-Blind)||0
9046736|NCT03441984|10106545|FG001|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
9046737|NCT03441984|10106546|FG002|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
9046738|NCT03441984|10106547|FG003|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
9046739|NCT03441984|10106548|FG004|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
9046740|NCT03441984|10106549|FG005|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
9046741|NCT03441984|10106550|FG006|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
9046742|NCT03441984|10106551|FG007|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
9046743|NCT03441984|10106552|FG008|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
9046744|NCT03441984|10106553|FG009|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
9046745|NCT03441984|10106554|FG010|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
9046746|NCT03441984|10106555|FG011|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
9046747|NCT03441984|10106544|FG000|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
9046748|NCT03441984|10106545|FG001|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
9046749|NCT03441984|10106546|FG002|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
9046750|NCT03441984|10106547|FG003|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
9046751|NCT03441984|10106548|FG004|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
9046752|NCT03441984|10106549|FG005|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
9046753|NCT03441984|10106550|FG006|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
9046754|NCT03441984|10106551|FG007|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
9046755|NCT03441984|10106552|FG008|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
9046756|NCT03441984|10106553|FG009|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
9046757|NCT03441984|10106554|FG010|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
9046758|NCT03441984|10106555|FG011|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
9046759|NCT03441984|10106544|FG000|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
9046760|NCT03441984|10106545|FG001|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
9046761|NCT03441984|10106546|FG002|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
9046762|NCT03441984|10106547|FG003|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
9046763|NCT03441984|10106548|FG004|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
9046764|NCT03441984|10106549|FG005|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
9046765|NCT03441984|10106550|FG006|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
9046766|NCT03441984|10106551|FG007|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
9046767|NCT03441984|10106552|FG008|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
9046768|NCT03441984|10106553|FG009|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
9046769|NCT03441984|10106554|FG010|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
9046770|NCT03441984|10106555|FG011|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
9046771|NCT03441984|10106544|FG000|STARTED|Part 2: Period 2 (Up to Day 4)||0
9046772|NCT03441984|10106545|FG001|STARTED|Part 2: Period 2 (Up to Day 4)||0
9046773|NCT03441984|10106546|FG002|STARTED|Part 2: Period 2 (Up to Day 4)||0
9046774|NCT03441984|10106547|FG003|STARTED|Part 2: Period 2 (Up to Day 4)||0
9046775|NCT03441984|10106548|FG004|STARTED|Part 2: Period 2 (Up to Day 4)||0
9046776|NCT03441984|10106549|FG005|STARTED|Part 2: Period 2 (Up to Day 4)||0
9046777|NCT03441984|10106550|FG006|STARTED|Part 2: Period 2 (Up to Day 4)||3
9046778|NCT03441984|10106551|FG007|STARTED|Part 2: Period 2 (Up to Day 4)||3
9046779|NCT03441984|10106552|FG008|STARTED|Part 2: Period 2 (Up to Day 4)||3
9046780|NCT03441984|10106553|FG009|STARTED|Part 2: Period 2 (Up to Day 4)||3
9046781|NCT03441984|10106554|FG010|STARTED|Part 2: Period 2 (Up to Day 4)||3
9046782|NCT03441984|10106555|FG011|STARTED|Part 2: Period 2 (Up to Day 4)||3
9046783|NCT03441984|10106544|FG000|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
9046784|NCT03441984|10106545|FG001|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
9046785|NCT03441984|10106546|FG002|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
9046786|NCT03441984|10106547|FG003|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
9046787|NCT03441984|10106548|FG004|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
9046788|NCT03441984|10106549|FG005|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
9046789|NCT03441984|10106550|FG006|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
9046790|NCT03441984|10106551|FG007|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
9046791|NCT03441984|10106552|FG008|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
9046792|NCT03441984|10106553|FG009|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
9046793|NCT03441984|10106554|FG010|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
9046794|NCT03441984|10106555|FG011|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
9046795|NCT03441984|10106544|FG000|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
9046796|NCT03441984|10106545|FG001|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
9046797|NCT03441984|10106546|FG002|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
9046798|NCT03441984|10106547|FG003|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
9046799|NCT03441984|10106548|FG004|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
9046800|NCT03441984|10106549|FG005|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
9046801|NCT03441984|10106550|FG006|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
9046802|NCT03441984|10106551|FG007|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
9046803|NCT03441984|10106552|FG008|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
9046804|NCT03441984|10106553|FG009|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
9046805|NCT03441984|10106554|FG010|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
9046806|NCT03441984|10106555|FG011|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
9046807|NCT03441984|10106544|FG000|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
9046808|NCT03441984|10106545|FG001|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
9046809|NCT03441984|10106546|FG002|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
9046810|NCT03441984|10106547|FG003|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
9046811|NCT03441984|10106548|FG004|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
9046812|NCT03441984|10106549|FG005|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
9046813|NCT03441984|10106550|FG006|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
9046814|NCT03441984|10106551|FG007|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
9046815|NCT03441984|10106552|FG008|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
9046816|NCT03441984|10106553|FG009|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
9046817|NCT03441984|10106554|FG010|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
9046818|NCT03441984|10106555|FG011|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
9046819|NCT03441984|10106544|FG000|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
9046820|NCT03441984|10106545|FG001|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
9046821|NCT03441984|10106546|FG002|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
9046822|NCT03441984|10106547|FG003|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
9046823|NCT03441984|10106548|FG004|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
9046824|NCT03441984|10106549|FG005|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
9046825|NCT03441984|10106550|FG006|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
9046826|NCT03441984|10106551|FG007|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
9046827|NCT03441984|10106552|FG008|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
9046828|NCT03441984|10106553|FG009|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
9046829|NCT03441984|10106554|FG010|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
9046830|NCT03441984|10106555|FG011|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
9046831|NCT03441984|10106544|FG000|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
9046832|NCT03441984|10106545|FG001|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
9046833|NCT03441984|10106546|FG002|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
9046834|NCT03441984|10106547|FG003|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
9046835|NCT03441984|10106548|FG004|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
9046836|NCT03441984|10106549|FG005|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
9046837|NCT03441984|10106550|FG006|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
9046838|NCT03441984|10106551|FG007|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
9046839|NCT03441984|10106552|FG008|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
9046840|NCT03441984|10106553|FG009|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
9046841|NCT03441984|10106554|FG010|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
9046842|NCT03441984|10106555|FG011|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
9046843|NCT03441984|10106544|FG000|STARTED|Part 2: Period 3 (Up to Day 4)||0
9046844|NCT03441984|10106545|FG001|STARTED|Part 2: Period 3 (Up to Day 4)||0
9046845|NCT03441984|10106546|FG002|STARTED|Part 2: Period 3 (Up to Day 4)||0
9046846|NCT03441984|10106547|FG003|STARTED|Part 2: Period 3 (Up to Day 4)||0
9046847|NCT03441984|10106548|FG004|STARTED|Part 2: Period 3 (Up to Day 4)||0
9046848|NCT03441984|10106549|FG005|STARTED|Part 2: Period 3 (Up to Day 4)||0
9046849|NCT03441984|10106550|FG006|STARTED|Part 2: Period 3 (Up to Day 4)||3
9046850|NCT03441984|10106551|FG007|STARTED|Part 2: Period 3 (Up to Day 4)||3
9046851|NCT03441984|10106552|FG008|STARTED|Part 2: Period 3 (Up to Day 4)||3
9046852|NCT03441984|10106553|FG009|STARTED|Part 2: Period 3 (Up to Day 4)||3
9046853|NCT03441984|10106554|FG010|STARTED|Part 2: Period 3 (Up to Day 4)||3
9046854|NCT03441984|10106555|FG011|STARTED|Part 2: Period 3 (Up to Day 4)||3
9046855|NCT03441984|10106544|FG000|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
9046856|NCT03441984|10106545|FG001|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
9046857|NCT03441984|10106546|FG002|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
9046858|NCT03441984|10106547|FG003|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
9046859|NCT03441984|10106548|FG004|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
9046860|NCT03441984|10106549|FG005|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
9046861|NCT03441984|10106550|FG006|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
9046862|NCT03441984|10106551|FG007|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
9046863|NCT03441984|10106552|FG008|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
9046864|NCT03441984|10106553|FG009|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
9046865|NCT03441984|10106554|FG010|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
9046866|NCT03441984|10106555|FG011|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
9046867|NCT03441984|10106544|FG000|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
9046868|NCT03441984|10106545|FG001|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
9046869|NCT03441984|10106546|FG002|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
9046870|NCT03441984|10106547|FG003|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
9046871|NCT03441984|10106548|FG004|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
9046872|NCT03441984|10106549|FG005|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
9046873|NCT03441984|10106550|FG006|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
9046874|NCT03441984|10106551|FG007|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
9046875|NCT03441984|10106552|FG008|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
9046876|NCT03441984|10106553|FG009|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
9046877|NCT03441984|10106554|FG010|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
9046878|NCT03441984|10106555|FG011|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
9046879|NCT03442036|10106572|FG000|STARTED|Overall Study||35
9046880|NCT03442036|10106573|FG001|STARTED|Overall Study||35
9046881|NCT03442036|10106572|FG000|COMPLETED|Overall Study||35
9046882|NCT03442036|10106573|FG001|COMPLETED|Overall Study||35
9046883|NCT03442036|10106572|FG000|NOT COMPLETED|Overall Study||0
9046884|NCT03442036|10106573|FG001|NOT COMPLETED|Overall Study||0
9046885|NCT03442296|10106583|FG000|STARTED|3 Month Follow-up||78
9046886|NCT03442296|10106584|FG001|STARTED|3 Month Follow-up||73
9046887|NCT03442296|10106583|FG000|COMPLETED|3 Month Follow-up||73
9046888|NCT03442296|10106584|FG001|COMPLETED|3 Month Follow-up||70
9046889|NCT03442296|10106583|FG000|NOT COMPLETED|3 Month Follow-up||5
9046890|NCT03442296|10106584|FG001|NOT COMPLETED|3 Month Follow-up||3
9046891|NCT03442296|10106583|FG000|STARTED|12 Month Follow-up|15 participants in the immediate group did not start the 12month visit due to: death unrelated to study (3), loss to follow up (6), or withdrew consent (6)|58
9046892|NCT03442296|10106584|FG001|STARTED|12 Month Follow-up|18 participants in the delayed group did not start the 12month visit due to: death unrelated to study (3), loss to follow up (5), or withdrew consent (10)|52
9046893|NCT03442296|10106583|FG000|COMPLETED|12 Month Follow-up||57
9046894|NCT03442296|10106584|FG001|COMPLETED|12 Month Follow-up||51
9046895|NCT03442296|10106583|FG000|NOT COMPLETED|12 Month Follow-up||1
9046896|NCT03442296|10106584|FG001|NOT COMPLETED|12 Month Follow-up||1
9046897|NCT03442569|10106590|FG000|STARTED|Overall Study||56
9046898|NCT03442569|10106590|FG000|Started Treatment|Overall Study||55
9046899|NCT03442569|10106590|FG000|COMPLETED|Overall Study||55
9046900|NCT03442569|10106590|FG000|NOT COMPLETED|Overall Study||1
9046901|NCT03442595|10106596|FG000|STARTED|Overall Study||460
9046902|NCT03442595|10106597|FG001|STARTED|Overall Study||366
9046903|NCT03442595|10106596|FG000|COMPLETED|Overall Study||366
9046904|NCT03442595|10106597|FG001|COMPLETED|Overall Study||366
9046905|NCT03442595|10106596|FG000|NOT COMPLETED|Overall Study||94
9046906|NCT03442595|10106597|FG001|NOT COMPLETED|Overall Study||0
9046907|NCT03442699|10106602|FG000|STARTED|Overall Study||6
9046908|NCT03442699|10106602|FG000|COMPLETED|Overall Study||6
9046909|NCT03442699|10106602|FG000|NOT COMPLETED|Overall Study||0
9046910|NCT03442725|10106610|FG000|STARTED|Overall Study||8
9046911|NCT03442725|10106611|FG001|STARTED|Overall Study||8
9046912|NCT03442725|10106610|FG000|COMPLETED|Overall Study||8
9046913|NCT03442725|10106611|FG001|COMPLETED|Overall Study||8
9046914|NCT03442725|10106610|FG000|NOT COMPLETED|Overall Study||0
9046915|NCT03442725|10106611|FG001|NOT COMPLETED|Overall Study||0
9046916|NCT03442777|10106620|FG000|STARTED|Overall Study|All participants received at least 1 dressing|542
9046917|NCT03442777|10106621|FG001|STARTED|Overall Study|One participant received one Allevyn® Life dressing (wrong brand by mistake), besides 13 Mepilex® Border on sacrum, (0.2%) All participants received at least 1 dressing|545
9046918|NCT03442777|10106622|FG002|STARTED|Overall Study|No participants received dressings|546
9046919|NCT03442777|10106620|FG000|COMPLETED|Overall Study||534
9046920|NCT03442777|10106621|FG001|COMPLETED|Overall Study||532
9046921|NCT03442777|10106622|FG002|COMPLETED|Overall Study||539
9046922|NCT03442777|10106620|FG000|NOT COMPLETED|Overall Study||8
9046923|NCT03442777|10106621|FG001|NOT COMPLETED|Overall Study||13
9046924|NCT03442777|10106622|FG002|NOT COMPLETED|Overall Study||7
9046925|NCT03442829|10106630|FG000|STARTED|Overall Study||27
9046926|NCT03442829|10106631|FG001|STARTED|Overall Study||27
9046927|NCT03442829|10106630|FG000|COMPLETED|Overall Study||23
9046928|NCT03442829|10106631|FG001|COMPLETED|Overall Study||25
9046929|NCT03442829|10106630|FG000|NOT COMPLETED|Overall Study||4
9046930|NCT03442829|10106631|FG001|NOT COMPLETED|Overall Study||2
9046931|NCT03442868|10106637|FG000|STARTED|Overall Study||15
9046932|NCT03442868|10106637|FG000|COMPLETED|Overall Study||15
9046933|NCT03442868|10106637|FG000|NOT COMPLETED|Overall Study||0
9046934|NCT03442933|10106641|FG000|STARTED|Overall Study||20
9046935|NCT03442933|10106642|FG001|STARTED|Overall Study||20
9046936|NCT03442933|10106641|FG000|COMPLETED|Overall Study||20
9046937|NCT03442933|10106642|FG001|COMPLETED|Overall Study||20
9046938|NCT03442933|10106641|FG000|NOT COMPLETED|Overall Study||0
9046939|NCT03442933|10106642|FG001|NOT COMPLETED|Overall Study||0
9046940|NCT03443024|10106655|FG000|STARTED|Overall Study||73
9046941|NCT03443024|10106656|FG001|STARTED|Overall Study||80
9046942|NCT03443024|10106657|FG002|STARTED|Overall Study||75
9046943|NCT03443024|10106658|FG003|STARTED|Overall Study||52
9046944|NCT03443024|10106655|FG000|Received at Least One Dose of Study Drug|Overall Study||73
9046945|NCT03443024|10106656|FG001|Received at Least One Dose of Study Drug|Overall Study||80
9046946|NCT03443024|10106657|FG002|Received at Least One Dose of Study Drug|Overall Study||75
9046947|NCT03443024|10106658|FG003|Received at Least One Dose of Study Drug|Overall Study||52
9046948|NCT03443024|10106655|FG000|COMPLETED|Overall Study||52
9046949|NCT03443024|10106656|FG001|COMPLETED|Overall Study||49
9046950|NCT03443024|10106657|FG002|COMPLETED|Overall Study||56
9046951|NCT03443024|10106658|FG003|COMPLETED|Overall Study||20
9046952|NCT03443024|10106655|FG000|NOT COMPLETED|Overall Study||21
9046953|NCT03443024|10106656|FG001|NOT COMPLETED|Overall Study||31
9046954|NCT03443024|10106657|FG002|NOT COMPLETED|Overall Study||19
9046955|NCT03443024|10106658|FG003|NOT COMPLETED|Overall Study||32
9046956|NCT03443063|10106670|FG000|STARTED|Overall Study||8
9046957|NCT03443063|10106671|FG001|STARTED|Overall Study||8
9046958|NCT03443063|10106670|FG000|COMPLETED|Overall Study||8
9046959|NCT03443063|10106671|FG001|COMPLETED|Overall Study||8
9046960|NCT03443063|10106670|FG000|NOT COMPLETED|Overall Study||0
9046961|NCT03443063|10106671|FG001|NOT COMPLETED|Overall Study||0
9046962|NCT03443414|10106684|FG000|STARTED|Overall Study||82
9046963|NCT03443414|10106685|FG001|STARTED|Overall Study||81
9046964|NCT03443414|10106686|FG002|STARTED|Overall Study||82
9046965|NCT03443414|10106687|FG003|STARTED|Overall Study||80
9046966|NCT03443414|10106688|FG004|STARTED|Overall Study||80
9046967|NCT03443414|10106684|FG000|Received Treatment|Overall Study||81
9046968|NCT03443414|10106685|FG001|Received Treatment|Overall Study||81
9046969|NCT03443414|10106686|FG002|Received Treatment|Overall Study||82
9046970|NCT03443414|10106687|FG003|Received Treatment|Overall Study||80
9046971|NCT03443414|10106688|FG004|Received Treatment|Overall Study||79
9046972|NCT03443414|10106684|FG000|COMPLETED|Overall Study||71
9046973|NCT03443414|10106685|FG001|COMPLETED|Overall Study||78
9046974|NCT03443414|10106686|FG002|COMPLETED|Overall Study||76
9046975|NCT03443414|10106687|FG003|COMPLETED|Overall Study||75
9046976|NCT03443414|10106688|FG004|COMPLETED|Overall Study||75
9046977|NCT03443414|10106684|FG000|NOT COMPLETED|Overall Study||11
9046978|NCT03443414|10106685|FG001|NOT COMPLETED|Overall Study||3
9046979|NCT03443414|10106686|FG002|NOT COMPLETED|Overall Study||6
9046980|NCT03443414|10106687|FG003|NOT COMPLETED|Overall Study||5
9046981|NCT03443414|10106688|FG004|NOT COMPLETED|Overall Study||5
9046982|NCT03443427|10106702|FG000|STARTED|Overall Study||100
9046983|NCT03443427|10106703|FG001|STARTED|Overall Study||100
9046984|NCT03443427|10106702|FG000|COMPLETED|Overall Study||88
9046985|NCT03443427|10106703|FG001|COMPLETED|Overall Study||89
9046986|NCT03443427|10106702|FG000|NOT COMPLETED|Overall Study||12
9046987|NCT03443427|10106703|FG001|NOT COMPLETED|Overall Study||11
9046988|NCT03443713|10106712|FG000|STARTED|Start up Visit (2 Hours)||8
9046989|NCT03443713|10106713|FG001|STARTED|Start up Visit (2 Hours)||8
9046990|NCT03443713|10106714|FG002|STARTED|Start up Visit (2 Hours)||9
9046991|NCT03443713|10106712|FG000|COMPLETED|Start up Visit (2 Hours)||8
9046992|NCT03443713|10106713|FG001|COMPLETED|Start up Visit (2 Hours)||8
9046993|NCT03443713|10106714|FG002|COMPLETED|Start up Visit (2 Hours)||9
9046994|NCT03443713|10106712|FG000|NOT COMPLETED|Start up Visit (2 Hours)||0
9046995|NCT03443713|10106713|FG001|NOT COMPLETED|Start up Visit (2 Hours)||0
9046996|NCT03443713|10106714|FG002|NOT COMPLETED|Start up Visit (2 Hours)||0
9046997|NCT03443713|10106712|FG000|STARTED|First at Home Period (9-14 Days)||8
9046998|NCT03443713|10106713|FG001|STARTED|First at Home Period (9-14 Days)||8
9046999|NCT03443713|10106714|FG002|STARTED|First at Home Period (9-14 Days)||9
9047000|NCT03443713|10106712|FG000|COMPLETED|First at Home Period (9-14 Days)||8
9047001|NCT03443713|10106713|FG001|COMPLETED|First at Home Period (9-14 Days)||8
8703391|NCT00923091|9749179|FG003|NOT COMPLETED|Period III (Single-Blind)||0
8703392|NCT00923091|9749180|FG004|NOT COMPLETED|Period III (Single-Blind)||0
8703393|NCT00923091|9749181|FG005|NOT COMPLETED|Period III (Single-Blind)||0
9047002|NCT03443713|10106714|FG002|COMPLETED|First at Home Period (9-14 Days)||8
9047003|NCT03443713|10106712|FG000|NOT COMPLETED|First at Home Period (9-14 Days)||0
9047004|NCT03443713|10106713|FG001|NOT COMPLETED|First at Home Period (9-14 Days)||0
9047005|NCT03443713|10106714|FG002|NOT COMPLETED|First at Home Period (9-14 Days)||1
9047006|NCT03443713|10106712|FG000|STARTED|First Exercise Visit (1 Hour)||8
9047007|NCT03443713|10106713|FG001|STARTED|First Exercise Visit (1 Hour)||8
9047008|NCT03443713|10106714|FG002|STARTED|First Exercise Visit (1 Hour)||8
9047009|NCT03443713|10106712|FG000|COMPLETED|First Exercise Visit (1 Hour)||8
9047010|NCT03443713|10106713|FG001|COMPLETED|First Exercise Visit (1 Hour)||8
9047011|NCT03443713|10106714|FG002|COMPLETED|First Exercise Visit (1 Hour)||8
9047012|NCT03443713|10106712|FG000|NOT COMPLETED|First Exercise Visit (1 Hour)||0
9047013|NCT03443713|10106713|FG001|NOT COMPLETED|First Exercise Visit (1 Hour)||0
9047014|NCT03443713|10106714|FG002|NOT COMPLETED|First Exercise Visit (1 Hour)||0
9047015|NCT03443713|10106712|FG000|STARTED|Dexcom Insertion Visit (30 Minutes)||8
9047016|NCT03443713|10106713|FG001|STARTED|Dexcom Insertion Visit (30 Minutes)||8
9047017|NCT03443713|10106714|FG002|STARTED|Dexcom Insertion Visit (30 Minutes)||8
9047018|NCT03443713|10106712|FG000|COMPLETED|Dexcom Insertion Visit (30 Minutes)||8
9047019|NCT03443713|10106713|FG001|COMPLETED|Dexcom Insertion Visit (30 Minutes)||8
9047020|NCT03443713|10106714|FG002|COMPLETED|Dexcom Insertion Visit (30 Minutes)||8
9047021|NCT03443713|10106712|FG000|NOT COMPLETED|Dexcom Insertion Visit (30 Minutes)||0
9047022|NCT03443713|10106713|FG001|NOT COMPLETED|Dexcom Insertion Visit (30 Minutes)||0
9047023|NCT03443713|10106714|FG002|NOT COMPLETED|Dexcom Insertion Visit (30 Minutes)||0
9047024|NCT03443713|10106712|FG000|STARTED|Second at Home Period (2-11 Days)||8
9047025|NCT03443713|10106713|FG001|STARTED|Second at Home Period (2-11 Days)||8
9047026|NCT03443713|10106714|FG002|STARTED|Second at Home Period (2-11 Days)||8
9047027|NCT03443713|10106712|FG000|COMPLETED|Second at Home Period (2-11 Days)||8
9047028|NCT03443713|10106713|FG001|COMPLETED|Second at Home Period (2-11 Days)||8
9047029|NCT03443713|10106714|FG002|COMPLETED|Second at Home Period (2-11 Days)||8
9047030|NCT03443713|10106712|FG000|NOT COMPLETED|Second at Home Period (2-11 Days)||0
9047031|NCT03443713|10106713|FG001|NOT COMPLETED|Second at Home Period (2-11 Days)||0
9047032|NCT03443713|10106714|FG002|NOT COMPLETED|Second at Home Period (2-11 Days)||0
9047033|NCT03443713|10106712|FG000|STARTED|Second Exercise Visit (1 Hour)||8
9047034|NCT03443713|10106713|FG001|STARTED|Second Exercise Visit (1 Hour)||8
9047035|NCT03443713|10106714|FG002|STARTED|Second Exercise Visit (1 Hour)||8
8703394|NCT00923091|9749182|FG006|NOT COMPLETED|Period III (Single-Blind)||0
8703395|NCT00923091|9749183|FG007|NOT COMPLETED|Period III (Single-Blind)||0
9047036|NCT03443713|10106712|FG000|COMPLETED|Second Exercise Visit (1 Hour)||8
9047037|NCT03443713|10106713|FG001|COMPLETED|Second Exercise Visit (1 Hour)||8
9047038|NCT03443713|10106714|FG002|COMPLETED|Second Exercise Visit (1 Hour)||8
9047039|NCT03443713|10106712|FG000|NOT COMPLETED|Second Exercise Visit (1 Hour)||0
9047040|NCT03443713|10106713|FG001|NOT COMPLETED|Second Exercise Visit (1 Hour)||0
9047041|NCT03443713|10106714|FG002|NOT COMPLETED|Second Exercise Visit (1 Hour)||0
9047042|NCT03443713|10106712|FG000|STARTED|Third at Home Period (8-12 Days)||8
9047043|NCT03443713|10106713|FG001|STARTED|Third at Home Period (8-12 Days)||8
9047044|NCT03443713|10106714|FG002|STARTED|Third at Home Period (8-12 Days)||8
9047045|NCT03443713|10106712|FG000|COMPLETED|Third at Home Period (8-12 Days)||8
9047046|NCT03443713|10106713|FG001|COMPLETED|Third at Home Period (8-12 Days)||8
9047047|NCT03443713|10106714|FG002|COMPLETED|Third at Home Period (8-12 Days)||8
9047048|NCT03443713|10106712|FG000|NOT COMPLETED|Third at Home Period (8-12 Days)||0
9047049|NCT03443713|10106713|FG001|NOT COMPLETED|Third at Home Period (8-12 Days)||0
9047050|NCT03443713|10106714|FG002|NOT COMPLETED|Third at Home Period (8-12 Days)||0
9047051|NCT03443713|10106712|FG000|STARTED|Close-out Visit (30 Minutes)||8
9047052|NCT03443713|10106713|FG001|STARTED|Close-out Visit (30 Minutes)||8
9047053|NCT03443713|10106714|FG002|STARTED|Close-out Visit (30 Minutes)||8
9047054|NCT03443713|10106712|FG000|COMPLETED|Close-out Visit (30 Minutes)||8
9047055|NCT03443713|10106713|FG001|COMPLETED|Close-out Visit (30 Minutes)||8
9047056|NCT03443713|10106714|FG002|COMPLETED|Close-out Visit (30 Minutes)||8
9047057|NCT03443713|10106712|FG000|NOT COMPLETED|Close-out Visit (30 Minutes)||0
9047058|NCT03443713|10106713|FG001|NOT COMPLETED|Close-out Visit (30 Minutes)||0
9047059|NCT03443713|10106714|FG002|NOT COMPLETED|Close-out Visit (30 Minutes)||0
9047060|NCT03444090|10106728|FG000|STARTED|Overall Study||214
9047061|NCT03444090|10106729|FG001|STARTED|Overall Study||214
9047062|NCT03444090|10106728|FG000|COMPLETED|Overall Study||211
9047063|NCT03444090|10106729|FG001|COMPLETED|Overall Study||210
9047064|NCT03444090|10106728|FG000|NOT COMPLETED|Overall Study||3
9047065|NCT03444090|10106729|FG001|NOT COMPLETED|Overall Study||4
9047066|NCT03444155|10106737|FG000|STARTED|First Intervention (6 Weeks)||15
9047067|NCT03444155|10106738|FG001|STARTED|First Intervention (6 Weeks)||15
9047068|NCT03444155|10106737|FG000|COMPLETED|First Intervention (6 Weeks)||14
9047069|NCT03444155|10106738|FG001|COMPLETED|First Intervention (6 Weeks)||15
9047070|NCT03444155|10106737|FG000|NOT COMPLETED|First Intervention (6 Weeks)||1
9047071|NCT03444155|10106738|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0
9047072|NCT03444155|10106737|FG000|STARTED|Washout (2 Weeks)||14
9047073|NCT03444155|10106738|FG001|STARTED|Washout (2 Weeks)||15
9047074|NCT03444155|10106737|FG000|COMPLETED|Washout (2 Weeks)||14
9047075|NCT03444155|10106738|FG001|COMPLETED|Washout (2 Weeks)||15
9047076|NCT03444155|10106737|FG000|NOT COMPLETED|Washout (2 Weeks)||0
9047077|NCT03444155|10106738|FG001|NOT COMPLETED|Washout (2 Weeks)||0
9047078|NCT03444155|10106737|FG000|STARTED|Second Intervention (6 Weeks)||14
9047079|NCT03444155|10106738|FG001|STARTED|Second Intervention (6 Weeks)||15
9047080|NCT03444155|10106737|FG000|COMPLETED|Second Intervention (6 Weeks)||14
9047081|NCT03444155|10106738|FG001|COMPLETED|Second Intervention (6 Weeks)||15
9047082|NCT03444155|10106737|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
9047083|NCT03444155|10106738|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0
9047084|NCT03444584|10106746|FG000|STARTED|Overall Study||24
9047085|NCT03444584|10106747|FG001|STARTED|Overall Study||25
9047086|NCT03444584|10106746|FG000|COMPLETED|Overall Study||24
9047087|NCT03444584|10106747|FG001|COMPLETED|Overall Study||23
9047088|NCT03444584|10106746|FG000|NOT COMPLETED|Overall Study||0
9047089|NCT03444584|10106747|FG001|NOT COMPLETED|Overall Study||2
9047090|NCT03444766|10106754|FG000|STARTED|Overall Study||100
9047091|NCT03444766|10106754|FG000|COMPLETED|Overall Study||34
9047092|NCT03444766|10106754|FG000|NOT COMPLETED|Overall Study||66
9047093|NCT03444961|10106758|FG000|STARTED|Overall Study||4
9047094|NCT03444961|10106758|FG000|COMPLETED|Overall Study||4
9047095|NCT03444961|10106758|FG000|NOT COMPLETED|Overall Study||0
9047096|NCT03445065|10106770|FG000|STARTED|Overall Study||97
9047097|NCT03445065|10106771|FG001|STARTED|Overall Study||52
9047098|NCT03445065|10106772|FG002|STARTED|Overall Study||62
9047099|NCT03445065|10106773|FG003|STARTED|Overall Study||28
9047100|NCT03445065|10106770|FG000|COMPLETED|Overall Study||90
9047101|NCT03445065|10106771|FG001|COMPLETED|Overall Study||43
9047102|NCT03445065|10106772|FG002|COMPLETED|Overall Study||57
9047103|NCT03445065|10106773|FG003|COMPLETED|Overall Study||25
9047104|NCT03445065|10106770|FG000|NOT COMPLETED|Overall Study||7
9047105|NCT03445065|10106771|FG001|NOT COMPLETED|Overall Study||9
9047106|NCT03445065|10106772|FG002|NOT COMPLETED|Overall Study||5
9047107|NCT03445065|10106773|FG003|NOT COMPLETED|Overall Study||3
9047108|NCT03445156|10106798|FG000|STARTED|Pilot Study||20
9047109|NCT03445156|10106799|FG001|STARTED|Pilot Study||20
9047110|NCT03445156|10106800|FG002|STARTED|Pilot Study||0
9047111|NCT03445156|10106798|FG000|COMPLETED|Pilot Study||20
9047112|NCT03445156|10106799|FG001|COMPLETED|Pilot Study||20
9047113|NCT03445156|10106800|FG002|COMPLETED|Pilot Study||0
9047114|NCT03445156|10106798|FG000|NOT COMPLETED|Pilot Study||0
9047115|NCT03445156|10106799|FG001|NOT COMPLETED|Pilot Study||0
9047116|NCT03445156|10106800|FG002|NOT COMPLETED|Pilot Study||0
9047117|NCT03445156|10106798|FG000|STARTED|Experiment Proper||113
9047118|NCT03445156|10106799|FG001|STARTED|Experiment Proper||115
9047119|NCT03445156|10106800|FG002|STARTED|Experiment Proper||59
9047120|NCT03445156|10106798|FG000|COMPLETED|Experiment Proper||113
9047121|NCT03445156|10106799|FG001|COMPLETED|Experiment Proper||115
9047122|NCT03445156|10106800|FG002|COMPLETED|Experiment Proper||59
9047123|NCT03445156|10106798|FG000|NOT COMPLETED|Experiment Proper||0
9047124|NCT03445156|10106799|FG001|NOT COMPLETED|Experiment Proper||0
9047125|NCT03445156|10106800|FG002|NOT COMPLETED|Experiment Proper||0
9047126|NCT03445195|10106814|FG000|STARTED|Overall Study||53
9047127|NCT03445195|10106815|FG001|STARTED|Overall Study||27
9047128|NCT03445195|10106814|FG000|COMPLETED|Overall Study||51
9047129|NCT03445195|10106815|FG001|COMPLETED|Overall Study||27
9047130|NCT03445195|10106814|FG000|NOT COMPLETED|Overall Study||2
9047131|NCT03445195|10106815|FG001|NOT COMPLETED|Overall Study||0
9047132|NCT03445390|10106821|FG000|STARTED|First Intervention||14
9047133|NCT03445390|10106822|FG001|STARTED|First Intervention||13
9047134|NCT03445390|10106821|FG000|COMPLETED|First Intervention||12
9047135|NCT03445390|10106822|FG001|COMPLETED|First Intervention||11
9047136|NCT03445390|10106821|FG000|NOT COMPLETED|First Intervention||2
9047137|NCT03445390|10106822|FG001|NOT COMPLETED|First Intervention||2
9047138|NCT03445390|10106821|FG000|STARTED|Second Intervention||12
9047139|NCT03445390|10106822|FG001|STARTED|Second Intervention||11
9047140|NCT03445390|10106821|FG000|COMPLETED|Second Intervention||10
9047141|NCT03445390|10106822|FG001|COMPLETED|Second Intervention||10
9047142|NCT03445390|10106821|FG000|NOT COMPLETED|Second Intervention||2
9047143|NCT03445390|10106822|FG001|NOT COMPLETED|Second Intervention||1
9047144|NCT03445793|10106828|FG000|STARTED|Overall Study||5
9047145|NCT03445793|10106828|FG000|COMPLETED|Overall Study||5
9047146|NCT03445793|10106828|FG000|NOT COMPLETED|Overall Study||0
9047147|NCT03446053|10106837|FG000|STARTED|Overall Study||2
9047148|NCT03446053|10106838|FG001|STARTED|Overall Study||6
9047149|NCT03446053|10106839|FG002|STARTED|Overall Study||6
9047150|NCT03446053|10106840|FG003|STARTED|Overall Study||7
9047151|NCT03446053|10106841|FG004|STARTED|Overall Study||6
9047152|NCT03446053|10106842|FG005|STARTED|Overall Study||6
9047153|NCT03446053|10106837|FG000|Randomized Set|Overall Study||2
9047154|NCT03446053|10106838|FG001|Randomized Set|Overall Study||6
9047155|NCT03446053|10106839|FG002|Randomized Set|Overall Study||6
9047156|NCT03446053|10106840|FG003|Randomized Set|Overall Study||7
9047157|NCT03446053|10106841|FG004|Randomized Set|Overall Study||6
9047158|NCT03446053|10106842|FG005|Randomized Set|Overall Study||6
9047159|NCT03446053|10106837|FG000|Safety Analysis Set|Overall Study||2
9047160|NCT03446053|10106838|FG001|Safety Analysis Set|Overall Study||6
9047161|NCT03446053|10106839|FG002|Safety Analysis Set|Overall Study||6
9047162|NCT03446053|10106840|FG003|Safety Analysis Set|Overall Study||6
9047163|NCT03446053|10106841|FG004|Safety Analysis Set|Overall Study||6
9047164|NCT03446053|10106842|FG005|Safety Analysis Set|Overall Study||6
9047165|NCT03446053|10106837|FG000|PK/PD Analysis Set|Overall Study||2
9047166|NCT03446053|10106838|FG001|PK/PD Analysis Set|Overall Study||6
9047167|NCT03446053|10106839|FG002|PK/PD Analysis Set|Overall Study||6
9047168|NCT03446053|10106840|FG003|PK/PD Analysis Set|Overall Study||6
9047169|NCT03446053|10106841|FG004|PK/PD Analysis Set|Overall Study||6
9047170|NCT03446053|10106842|FG005|PK/PD Analysis Set|Overall Study||5
9047171|NCT03446053|10106837|FG000|COMPLETED|Overall Study||2
9047172|NCT03446053|10106838|FG001|COMPLETED|Overall Study||5
9047173|NCT03446053|10106839|FG002|COMPLETED|Overall Study||6
9047174|NCT03446053|10106840|FG003|COMPLETED|Overall Study||6
8703396|NCT00923091|9749184|FG008|NOT COMPLETED|Period III (Single-Blind)||0
8703397|NCT00923091|9749185|FG009|NOT COMPLETED|Period III (Single-Blind)||0
9047175|NCT03446053|10106841|FG004|COMPLETED|Overall Study||6
9047176|NCT03446053|10106842|FG005|COMPLETED|Overall Study||5
9047177|NCT03446053|10106837|FG000|NOT COMPLETED|Overall Study||0
9047178|NCT03446053|10106838|FG001|NOT COMPLETED|Overall Study||1
9047179|NCT03446053|10106839|FG002|NOT COMPLETED|Overall Study||0
9047180|NCT03446053|10106840|FG003|NOT COMPLETED|Overall Study||1
8703398|NCT00923091|9749186|FG010|NOT COMPLETED|Period III (Single-Blind)||0
8703399|NCT00923091|9749187|FG011|NOT COMPLETED|Period III (Single-Blind)||0
8703400|NCT00923091|9749188|FG012|NOT COMPLETED|Period III (Single-Blind)||0
9047181|NCT03446053|10106841|FG004|NOT COMPLETED|Overall Study||0
9047182|NCT03446053|10106842|FG005|NOT COMPLETED|Overall Study||1
9047183|NCT03446690|10106871|FG000|STARTED|Overall Study||33
9047184|NCT03446690|10106872|FG001|STARTED|Overall Study||29
9047185|NCT03446690|10106871|FG000|COMPLETED|Overall Study||26
9047186|NCT03446690|10106872|FG001|COMPLETED|Overall Study||29
9047187|NCT03446690|10106871|FG000|NOT COMPLETED|Overall Study||7
9047188|NCT03446690|10106872|FG001|NOT COMPLETED|Overall Study||0
9047189|NCT03446781|10106880|FG000|STARTED|Overall Study||214
9047190|NCT03446781|10106881|FG001|STARTED|Overall Study||208
9047191|NCT03446781|10106880|FG000|COMPLETED|Overall Study||186
9047192|NCT03446781|10106881|FG001|COMPLETED|Overall Study||191
9047193|NCT03446781|10106880|FG000|NOT COMPLETED|Overall Study||28
9047194|NCT03446781|10106881|FG001|NOT COMPLETED|Overall Study||17
9047195|NCT03446846|10106912|FG000|STARTED|Overall Study||90
9047196|NCT03446846|10106913|FG001|STARTED|Overall Study||92
9047197|NCT03446846|10106914|FG002|STARTED|Overall Study||178
9047198|NCT03446846|10106912|FG000|COMPLETED|Overall Study||83
9047199|NCT03446846|10106913|FG001|COMPLETED|Overall Study||87
9047200|NCT03446846|10106914|FG002|COMPLETED|Overall Study||162
9047201|NCT03446846|10106912|FG000|NOT COMPLETED|Overall Study||7
9047202|NCT03446846|10106913|FG001|NOT COMPLETED|Overall Study||5
9047203|NCT03446846|10106914|FG002|NOT COMPLETED|Overall Study||16
9047204|NCT03446885|10106922|FG000|STARTED|Overall Study||12
9047205|NCT03446885|10106923|FG001|STARTED|Overall Study||10
9047206|NCT03446885|10106922|FG000|COMPLETED|Overall Study||10
9047207|NCT03446885|10106923|FG001|COMPLETED|Overall Study||10
9047208|NCT03446885|10106922|FG000|NOT COMPLETED|Overall Study||2
9047209|NCT03446885|10106923|FG001|NOT COMPLETED|Overall Study||0
9047210|NCT03447015|10106933|FG000|STARTED|Overall Study||140
9047211|NCT03447015|10106934|FG001|STARTED|Overall Study||150
9047212|NCT03447015|10106933|FG000|COMPLETED|Overall Study||95
9047213|NCT03447015|10106934|FG001|COMPLETED|Overall Study||106
9047214|NCT03447015|10106933|FG000|NOT COMPLETED|Overall Study||45
9047215|NCT03447015|10106934|FG001|NOT COMPLETED|Overall Study||44
9047216|NCT03447249|10106942|FG000|STARTED|Overall Study||190
9047217|NCT03447249|10106943|FG001|STARTED|Overall Study||192
9047218|NCT03447249|10106942|FG000|Safety Set|Overall Study||189
9047219|NCT03447249|10106943|FG001|Safety Set|Overall Study||193
9047220|NCT03447249|10106942|FG000|COMPLETED|Overall Study||185
9047221|NCT03447249|10106943|FG001|COMPLETED|Overall Study||192
9047222|NCT03447249|10106942|FG000|NOT COMPLETED|Overall Study||5
9047223|NCT03447249|10106943|FG001|NOT COMPLETED|Overall Study||0
9047224|NCT03447353|10106951|FG000|STARTED|Overall Study||18
9047225|NCT03447353|10106951|FG000|COMPLETED|Overall Study||8
9047226|NCT03447353|10106951|FG000|NOT COMPLETED|Overall Study||10
9047227|NCT03447730|10106964|FG000|STARTED|Overall Study||6
9047228|NCT03447730|10106965|FG001|STARTED|Overall Study||9
9047229|NCT03447730|10106966|FG002|STARTED|Overall Study||8
9047230|NCT03447730|10106964|FG000|COMPLETED|Overall Study||6
9047231|NCT03447730|10106965|FG001|COMPLETED|Overall Study||7
9047232|NCT03447730|10106966|FG002|COMPLETED|Overall Study||8
9047233|NCT03447730|10106964|FG000|NOT COMPLETED|Overall Study||0
9047234|NCT03447730|10106965|FG001|NOT COMPLETED|Overall Study||2
9047235|NCT03447730|10106966|FG002|NOT COMPLETED|Overall Study||0
9047236|NCT03447821|10106977|FG000|STARTED|Overall Study||14
9047237|NCT03447821|10106978|FG001|STARTED|Overall Study||13
9047238|NCT03447821|10106979|FG002|STARTED|Overall Study||13
9047239|NCT03447821|10106977|FG000|COMPLETED|Overall Study||13
9047240|NCT03447821|10106978|FG001|COMPLETED|Overall Study||12
9047241|NCT03447821|10106979|FG002|COMPLETED|Overall Study||12
9047242|NCT03447821|10106977|FG000|NOT COMPLETED|Overall Study||1
9047243|NCT03447821|10106978|FG001|NOT COMPLETED|Overall Study||1
9047244|NCT03447821|10106979|FG002|NOT COMPLETED|Overall Study||1
9047245|NCT03448068|10106989|FG000|STARTED|Overall Study||17
9047246|NCT03448068|10106990|FG001|STARTED|Overall Study||17
9047247|NCT03448068|10106989|FG000|COMPLETED|Overall Study||17
9047248|NCT03448068|10106990|FG001|COMPLETED|Overall Study||17
9047249|NCT03448068|10106989|FG000|NOT COMPLETED|Overall Study||0
9047250|NCT03448068|10106990|FG001|NOT COMPLETED|Overall Study||0
9047251|NCT03448224|10106998|FG000|STARTED|Overall Study||28
9047252|NCT03448224|10106999|FG001|STARTED|Overall Study||26
9047253|NCT03448224|10106998|FG000|COMPLETED|Overall Study||27
9047254|NCT03448224|10106999|FG001|COMPLETED|Overall Study||26
9047255|NCT03448224|10106998|FG000|NOT COMPLETED|Overall Study||1
9047256|NCT03448224|10106999|FG001|NOT COMPLETED|Overall Study||0
9047257|NCT03448406|10107007|FG000|STARTED|Overall Study||158
9047258|NCT03448406|10107008|FG001|STARTED|Overall Study||157
9047259|NCT03448406|10107007|FG000|COMPLETED|Overall Study||147
8703401|NCT00923091|9749176|FG000|STARTED|Period IV (Double-Blind)|2 did not continue in the study and 1837 responders went directly to Period VI. 228+453+2+1837=2520|228
8703402|NCT00923091|9749177|FG001|STARTED|Period IV (Double-Blind)||453
8703403|NCT00923091|9749178|FG002|STARTED|Period IV (Double-Blind)||0
8703404|NCT00923091|9749179|FG003|STARTED|Period IV (Double-Blind)||0
9047260|NCT03448406|10107008|FG001|COMPLETED|Overall Study||144
9047261|NCT03448406|10107007|FG000|NOT COMPLETED|Overall Study||11
9047262|NCT03448406|10107008|FG001|NOT COMPLETED|Overall Study||13
9047263|NCT03448419|10107016|FG000|STARTED|Overall Study||156
9047264|NCT03448419|10107017|FG001|STARTED|Overall Study||156
9047265|NCT03448419|10107016|FG000|Treated|Overall Study||156
9047266|NCT03448419|10107017|FG001|Treated|Overall Study||155
9047267|NCT03448419|10107016|FG000|COMPLETED|Overall Study||143
9047268|NCT03448419|10107017|FG001|COMPLETED|Overall Study||140
9047269|NCT03448419|10107016|FG000|NOT COMPLETED|Overall Study||13
9047270|NCT03448419|10107017|FG001|NOT COMPLETED|Overall Study||16
9047271|NCT03448536|10107027|FG000|STARTED|Overall Study||100
9047272|NCT03448536|10107028|FG001|STARTED|Overall Study||101
9047273|NCT03448536|10107027|FG000|Completed First Intervention|Overall Study||83
9047274|NCT03448536|10107028|FG001|Completed First Intervention|Overall Study||78
9047275|NCT03448536|10107027|FG000|Completed First Intervention|Overall Study||95
9047276|NCT03448536|10107028|FG001|Completed First Intervention|Overall Study||97
9047277|NCT03448536|10107027|FG000|Completed Second Intervention|Overall Study||82
9047278|NCT03448536|10107028|FG001|Completed Second Intervention|Overall Study||87
9047279|NCT03448536|10107027|FG000|COMPLETED|Overall Study||88
9047280|NCT03448536|10107028|FG001|COMPLETED|Overall Study||97
8703405|NCT00923091|9749180|FG004|STARTED|Period IV (Double-Blind)||0
9047281|NCT03448536|10107027|FG000|NOT COMPLETED|Overall Study||12
9047282|NCT03448536|10107028|FG001|NOT COMPLETED|Overall Study||4
9047283|NCT03449030|10107044|FG000|STARTED|Overall Study||1
9047284|NCT03449030|10107045|FG001|STARTED|Overall Study||1
9047285|NCT03449030|10107046|FG002|STARTED|Overall Study||1
9047286|NCT03449030|10107047|FG003|STARTED|Overall Study||5
9047287|NCT03449030|10107048|FG004|STARTED|Overall Study||7
9047288|NCT03449030|10107049|FG005|STARTED|Overall Study||7
9047289|NCT03449030|10107050|FG006|STARTED|Overall Study||2
9047290|NCT03449030|10107051|FG007|STARTED|Overall Study||3
9047291|NCT03449030|10107052|FG008|STARTED|Overall Study||3
9047292|NCT03449030|10107053|FG009|STARTED|Overall Study||1
9047293|NCT03449030|10107044|FG000|COMPLETED|Overall Study||0
9047294|NCT03449030|10107045|FG001|COMPLETED|Overall Study||0
9047295|NCT03449030|10107046|FG002|COMPLETED|Overall Study||0
9047296|NCT03449030|10107047|FG003|COMPLETED|Overall Study||0
9047297|NCT03449030|10107048|FG004|COMPLETED|Overall Study||0
9047298|NCT03449030|10107049|FG005|COMPLETED|Overall Study||0
9047299|NCT03449030|10107050|FG006|COMPLETED|Overall Study||0
9047300|NCT03449030|10107051|FG007|COMPLETED|Overall Study||0
9047301|NCT03449030|10107052|FG008|COMPLETED|Overall Study||0
9047302|NCT03449030|10107053|FG009|COMPLETED|Overall Study||0
9047303|NCT03449030|10107044|FG000|NOT COMPLETED|Overall Study||1
9047304|NCT03449030|10107045|FG001|NOT COMPLETED|Overall Study||1
9047305|NCT03449030|10107046|FG002|NOT COMPLETED|Overall Study||1
9047306|NCT03449030|10107047|FG003|NOT COMPLETED|Overall Study||5
9047307|NCT03449030|10107048|FG004|NOT COMPLETED|Overall Study||7
9047308|NCT03449030|10107049|FG005|NOT COMPLETED|Overall Study||7
9047309|NCT03449030|10107050|FG006|NOT COMPLETED|Overall Study||2
9047310|NCT03449030|10107051|FG007|NOT COMPLETED|Overall Study||3
9047311|NCT03449030|10107052|FG008|NOT COMPLETED|Overall Study||3
9047312|NCT03449030|10107053|FG009|NOT COMPLETED|Overall Study||1
9047313|NCT03449134|10107079|FG000|STARTED|52-Week Treatment Period||244
9047314|NCT03449134|10107080|FG001|STARTED|52-Week Treatment Period||244
9047315|NCT03449134|10107081|FG002|STARTED|52-Week Treatment Period||244
9047316|NCT03449134|10107079|FG000|Treated|52-Week Treatment Period||243
9047317|NCT03449134|10107080|FG001|Treated|52-Week Treatment Period||244
9047318|NCT03449134|10107081|FG002|Treated|52-Week Treatment Period||243
9047319|NCT03449134|10107079|FG000|COMPLETED|52-Week Treatment Period||199
9047320|NCT03449134|10107080|FG001|COMPLETED|52-Week Treatment Period||200
9047321|NCT03449134|10107081|FG002|COMPLETED|52-Week Treatment Period||184
9047322|NCT03449134|10107079|FG000|NOT COMPLETED|52-Week Treatment Period||45
9047323|NCT03449134|10107080|FG001|NOT COMPLETED|52-Week Treatment Period||44
9047324|NCT03449134|10107081|FG002|NOT COMPLETED|52-Week Treatment Period||60
9047325|NCT03449134|10107079|FG000|STARTED|12-Week Off-Treatment Durability Period|Not all participants continued in the optional Off-Treatment Period.|10
9047326|NCT03449134|10107080|FG001|STARTED|12-Week Off-Treatment Durability Period|Not all participants continued in the optional Off-Treatment Period.|18
9047327|NCT03449134|10107081|FG002|STARTED|12-Week Off-Treatment Durability Period|Not all participants continued in the optional Off-Treatment Period.|13
9047328|NCT03449134|10107079|FG000|COMPLETED|12-Week Off-Treatment Durability Period||10
9047329|NCT03449134|10107080|FG001|COMPLETED|12-Week Off-Treatment Durability Period||18
9047330|NCT03449134|10107081|FG002|COMPLETED|12-Week Off-Treatment Durability Period||13
9047331|NCT03449134|10107079|FG000|NOT COMPLETED|12-Week Off-Treatment Durability Period||0
9047332|NCT03449134|10107080|FG001|NOT COMPLETED|12-Week Off-Treatment Durability Period||0
9047333|NCT03449134|10107081|FG002|NOT COMPLETED|12-Week Off-Treatment Durability Period||0
9047334|NCT03449147|10107095|FG000|STARTED|52-week Treatment Period||436
9047335|NCT03449147|10107096|FG001|STARTED|52-week Treatment Period||442
9047336|NCT03449147|10107097|FG002|STARTED|52-week Treatment Period||439
9047337|NCT03449147|10107095|FG000|COMPLETED|52-week Treatment Period||382
9047338|NCT03449147|10107096|FG001|COMPLETED|52-week Treatment Period||368
9047339|NCT03449147|10107097|FG002|COMPLETED|52-week Treatment Period||355
9047340|NCT03449147|10107095|FG000|NOT COMPLETED|52-week Treatment Period||54
9047341|NCT03449147|10107096|FG001|NOT COMPLETED|52-week Treatment Period||74
9047342|NCT03449147|10107097|FG002|NOT COMPLETED|52-week Treatment Period||84
9047343|NCT03449147|10107095|FG000|STARTED|12-Week Off-Treatment Durability Period|Not all participants continued in the optional Off-Treatment Period.|48
9047344|NCT03449147|10107096|FG001|STARTED|12-Week Off-Treatment Durability Period|Not all participants continued in the optional Off-Treatment Period.|37
9047345|NCT03449147|10107097|FG002|STARTED|12-Week Off-Treatment Durability Period|Not all participants continued in the optional Off-Treatment Period.|37
9047346|NCT03449147|10107095|FG000|COMPLETED|12-Week Off-Treatment Durability Period||47
9047347|NCT03449147|10107096|FG001|COMPLETED|12-Week Off-Treatment Durability Period||36
9047348|NCT03449147|10107097|FG002|COMPLETED|12-Week Off-Treatment Durability Period||37
9047349|NCT03449147|10107095|FG000|NOT COMPLETED|12-Week Off-Treatment Durability Period||1
9047350|NCT03449147|10107096|FG001|NOT COMPLETED|12-Week Off-Treatment Durability Period||1
9047351|NCT03449147|10107097|FG002|NOT COMPLETED|12-Week Off-Treatment Durability Period||0
9047352|NCT03449342|10107111|FG000|STARTED|Overall Study||10
9047353|NCT03449342|10107112|FG001|STARTED|Overall Study||50
9047354|NCT03449342|10107111|FG000|COMPLETED|Overall Study||10
9047355|NCT03449342|10107112|FG001|COMPLETED|Overall Study||50
9047356|NCT03449342|10107111|FG000|NOT COMPLETED|Overall Study||0
9047357|NCT03449342|10107112|FG001|NOT COMPLETED|Overall Study||0
9047358|NCT03449433|10107120|FG000|STARTED|Period 1||17
9047359|NCT03449433|10107121|FG001|STARTED|Period 1||16
9047360|NCT03449433|10107122|FG002|STARTED|Period 1||18
9047361|NCT03449433|10107123|FG003|STARTED|Period 1||17
9047362|NCT03449433|10107124|FG004|STARTED|Period 1||12
9047363|NCT03449433|10107120|FG000|Received at Least 1 Dose of Study Drug|Period 1||17
9047364|NCT03449433|10107121|FG001|Received at Least 1 Dose of Study Drug|Period 1||16
9047365|NCT03449433|10107122|FG002|Received at Least 1 Dose of Study Drug|Period 1||18
9047366|NCT03449433|10107123|FG003|Received at Least 1 Dose of Study Drug|Period 1||17
9047367|NCT03449433|10107124|FG004|Received at Least 1 Dose of Study Drug|Period 1||0
9047368|NCT03449433|10107120|FG000|COMPLETED|Period 1||17
9047369|NCT03449433|10107121|FG001|COMPLETED|Period 1||16
9047370|NCT03449433|10107122|FG002|COMPLETED|Period 1||18
9047371|NCT03449433|10107123|FG003|COMPLETED|Period 1||17
9047372|NCT03449433|10107124|FG004|COMPLETED|Period 1||12
9047373|NCT03449433|10107120|FG000|NOT COMPLETED|Period 1||0
9047374|NCT03449433|10107121|FG001|NOT COMPLETED|Period 1||0
9047375|NCT03449433|10107122|FG002|NOT COMPLETED|Period 1||0
9047376|NCT03449433|10107123|FG003|NOT COMPLETED|Period 1||0
9047377|NCT03449433|10107124|FG004|NOT COMPLETED|Period 1||0
9047378|NCT03449433|10107120|FG000|STARTED|Period 2||17
9047379|NCT03449433|10107121|FG001|STARTED|Period 2||16
9047380|NCT03449433|10107122|FG002|STARTED|Period 2||18
9047381|NCT03449433|10107123|FG003|STARTED|Period 2||17
9047382|NCT03449433|10107124|FG004|STARTED|Period 2||12
9047383|NCT03449433|10107120|FG000|Received at Least 1 Dose of Study Drug|Period 2||17
9047384|NCT03449433|10107121|FG001|Received at Least 1 Dose of Study Drug|Period 2||16
9047385|NCT03449433|10107122|FG002|Received at Least 1 Dose of Study Drug|Period 2||18
9047386|NCT03449433|10107123|FG003|Received at Least 1 Dose of Study Drug|Period 2||17
9047387|NCT03449433|10107124|FG004|Received at Least 1 Dose of Study Drug|Period 2||0
9047388|NCT03449433|10107120|FG000|COMPLETED|Period 2||17
9047389|NCT03449433|10107121|FG001|COMPLETED|Period 2||16
9047390|NCT03449433|10107122|FG002|COMPLETED|Period 2||18
9047391|NCT03449433|10107123|FG003|COMPLETED|Period 2||17
9047392|NCT03449433|10107124|FG004|COMPLETED|Period 2||12
9047393|NCT03449433|10107120|FG000|NOT COMPLETED|Period 2||0
9047394|NCT03449433|10107121|FG001|NOT COMPLETED|Period 2||0
9047395|NCT03449433|10107122|FG002|NOT COMPLETED|Period 2||0
9047396|NCT03449433|10107123|FG003|NOT COMPLETED|Period 2||0
9047397|NCT03449433|10107124|FG004|NOT COMPLETED|Period 2||0
9047398|NCT03449433|10107120|FG000|STARTED|Period 3||17
9047399|NCT03449433|10107121|FG001|STARTED|Period 3||16
9047400|NCT03449433|10107122|FG002|STARTED|Period 3||18
9047401|NCT03449433|10107123|FG003|STARTED|Period 3||17
9047402|NCT03449433|10107124|FG004|STARTED|Period 3||12
9047403|NCT03449433|10107120|FG000|Received at Least 1 Dose of Study Drug|Period 3||17
9047404|NCT03449433|10107121|FG001|Received at Least 1 Dose of Study Drug|Period 3||15
9047405|NCT03449433|10107122|FG002|Received at Least 1 Dose of Study Drug|Period 3||18
9047406|NCT03449433|10107123|FG003|Received at Least 1 Dose of Study Drug|Period 3||17
9047407|NCT03449433|10107124|FG004|Received at Least 1 Dose of Study Drug|Period 3||0
9047408|NCT03449433|10107120|FG000|COMPLETED|Period 3||17
9047409|NCT03449433|10107121|FG001|COMPLETED|Period 3||15
9047410|NCT03449433|10107122|FG002|COMPLETED|Period 3||18
9047411|NCT03449433|10107123|FG003|COMPLETED|Period 3||17
9047412|NCT03449433|10107124|FG004|COMPLETED|Period 3||12
9047413|NCT03449433|10107120|FG000|NOT COMPLETED|Period 3||0
9047414|NCT03449433|10107121|FG001|NOT COMPLETED|Period 3||1
9047415|NCT03449433|10107122|FG002|NOT COMPLETED|Period 3||0
9047416|NCT03449433|10107123|FG003|NOT COMPLETED|Period 3||0
9047417|NCT03449433|10107124|FG004|NOT COMPLETED|Period 3||0
9047418|NCT03449433|10107120|FG000|STARTED|Period 4||17
9047419|NCT03449433|10107121|FG001|STARTED|Period 4||15
9047420|NCT03449433|10107122|FG002|STARTED|Period 4||18
9047421|NCT03449433|10107123|FG003|STARTED|Period 4||17
9047422|NCT03449433|10107124|FG004|STARTED|Period 4||12
9047423|NCT03449433|10107120|FG000|Received at Least 1 Dose of Study Drug|Period 4||17
9047424|NCT03449433|10107121|FG001|Received at Least 1 Dose of Study Drug|Period 4||15
9047425|NCT03449433|10107122|FG002|Received at Least 1 Dose of Study Drug|Period 4||18
9047426|NCT03449433|10107123|FG003|Received at Least 1 Dose of Study Drug|Period 4||17
9047427|NCT03449433|10107124|FG004|Received at Least 1 Dose of Study Drug|Period 4||0
9047428|NCT03449433|10107120|FG000|COMPLETED|Period 4||17
9047429|NCT03449433|10107121|FG001|COMPLETED|Period 4||15
9047430|NCT03449433|10107122|FG002|COMPLETED|Period 4||18
9047431|NCT03449433|10107123|FG003|COMPLETED|Period 4||17
9047432|NCT03449433|10107124|FG004|COMPLETED|Period 4||12
9047433|NCT03449433|10107120|FG000|NOT COMPLETED|Period 4||0
9047434|NCT03449433|10107121|FG001|NOT COMPLETED|Period 4||0
9047435|NCT03449433|10107122|FG002|NOT COMPLETED|Period 4||0
9047436|NCT03449433|10107123|FG003|NOT COMPLETED|Period 4||0
9047437|NCT03449433|10107124|FG004|NOT COMPLETED|Period 4||0
9047438|NCT03449446|10107145|FG000|STARTED|Overall Study||39
9047439|NCT03449446|10107146|FG001|STARTED|Overall Study||40
9047440|NCT03449446|10107147|FG002|STARTED|Overall Study||41
9047441|NCT03449446|10107148|FG003|STARTED|Overall Study||80
9047442|NCT03449446|10107149|FG004|STARTED|Overall Study||78
9047443|NCT03449446|10107150|FG005|STARTED|Overall Study||78
9047444|NCT03449446|10107151|FG006|STARTED|Overall Study||39
9047445|NCT03449446|10107145|FG000|COMPLETED|Overall Study||3
9047446|NCT03449446|10107146|FG001|COMPLETED|Overall Study||33
9047447|NCT03449446|10107147|FG002|COMPLETED|Overall Study||34
9047448|NCT03449446|10107148|FG003|COMPLETED|Overall Study||71
9047449|NCT03449446|10107149|FG004|COMPLETED|Overall Study||66
9047450|NCT03449446|10107150|FG005|COMPLETED|Overall Study||69
9047451|NCT03449446|10107151|FG006|COMPLETED|Overall Study||38
9047452|NCT03449446|10107145|FG000|NOT COMPLETED|Overall Study||36
9047453|NCT03449446|10107146|FG001|NOT COMPLETED|Overall Study||7
9047454|NCT03449446|10107147|FG002|NOT COMPLETED|Overall Study||7
9047455|NCT03449446|10107148|FG003|NOT COMPLETED|Overall Study||9
9047456|NCT03449446|10107149|FG004|NOT COMPLETED|Overall Study||12
9047457|NCT03449446|10107150|FG005|NOT COMPLETED|Overall Study||9
9047458|NCT03449446|10107151|FG006|NOT COMPLETED|Overall Study||1
9047459|NCT03449979|10107171|FG000|STARTED|Overall Study||21
9047460|NCT03449979|10107172|FG001|STARTED|Overall Study||20
9047461|NCT03449979|10107173|FG002|STARTED|Overall Study||21
9047462|NCT03449979|10107174|FG003|STARTED|Overall Study||22
9047463|NCT03449979|10107171|FG000|COMPLETED|Overall Study||21
9047464|NCT03449979|10107172|FG001|COMPLETED|Overall Study||20
9047465|NCT03449979|10107173|FG002|COMPLETED|Overall Study||21
9047466|NCT03449979|10107174|FG003|COMPLETED|Overall Study||21
9047467|NCT03449979|10107171|FG000|NOT COMPLETED|Overall Study||0
9047468|NCT03449979|10107172|FG001|NOT COMPLETED|Overall Study||0
9047469|NCT03449979|10107173|FG002|NOT COMPLETED|Overall Study||0
9047470|NCT03449979|10107174|FG003|NOT COMPLETED|Overall Study||1
9047471|NCT03450070|10107184|FG000|STARTED|Overall Study||118
9047472|NCT03450070|10107184|FG000|COMPLETED|Overall Study||110
9047473|NCT03450070|10107184|FG000|NOT COMPLETED|Overall Study||8
8703406|NCT00923091|9749181|FG005|STARTED|Period IV (Double-Blind)||0
9047474|NCT03450083|10107190|FG000|STARTED|Overall Study||12
9047475|NCT03450083|10107191|FG001|STARTED|Overall Study||12
9047476|NCT03450083|10107190|FG000|COMPLETED|Overall Study||12
9047477|NCT03450083|10107191|FG001|COMPLETED|Overall Study||12
9047478|NCT03450083|10107190|FG000|NOT COMPLETED|Overall Study||0
9047479|NCT03450083|10107191|FG001|NOT COMPLETED|Overall Study||0
9047480|NCT03450369|10107199|FG000|STARTED|Overall Study||5
9047481|NCT03450369|10107200|FG001|STARTED|Overall Study||5
9047482|NCT03450369|10107199|FG000|COMPLETED|Overall Study||5
9047483|NCT03450369|10107200|FG001|COMPLETED|Overall Study||5
9047484|NCT03450369|10107199|FG000|NOT COMPLETED|Overall Study||0
9047485|NCT03450369|10107200|FG001|NOT COMPLETED|Overall Study||0
9047486|NCT03450915|10107208|FG000|STARTED|Overall Study||6230
9047487|NCT03450915|10107209|FG001|STARTED|Overall Study||6230
9047488|NCT03450915|10107208|FG000|COMPLETED|Overall Study||5827
9047489|NCT03450915|10107209|FG001|COMPLETED|Overall Study||5855
9047490|NCT03450915|10107208|FG000|NOT COMPLETED|Overall Study||403
9047491|NCT03450915|10107209|FG001|NOT COMPLETED|Overall Study||375
9047492|NCT03451071|10107215|FG000|STARTED|First Vaccine||56
8703407|NCT00923091|9749182|FG006|STARTED|Period IV (Double-Blind)||0
8703408|NCT00923091|9749183|FG007|STARTED|Period IV (Double-Blind)||0
8703409|NCT00923091|9749184|FG008|STARTED|Period IV (Double-Blind)||0
8703410|NCT00923091|9749185|FG009|STARTED|Period IV (Double-Blind)||0
8703411|NCT00923091|9749186|FG010|STARTED|Period IV (Double-Blind)||0
8703412|NCT00923091|9749187|FG011|STARTED|Period IV (Double-Blind)||0
9047493|NCT03451071|10107215|FG000|COMPLETED|First Vaccine||55
9047494|NCT03451071|10107215|FG000|NOT COMPLETED|First Vaccine||1
9047495|NCT03451071|10107215|FG000|STARTED|Second Vaccine||55
9047496|NCT03451071|10107215|FG000|COMPLETED|Second Vaccine||36
9047497|NCT03451071|10107215|FG000|NOT COMPLETED|Second Vaccine||19
9047498|NCT03451071|10107215|FG000|STARTED|Third Vaccine||36
8703413|NCT00923091|9749188|FG012|STARTED|Period IV (Double-Blind)||0
8703414|NCT00923091|9749176|FG000|COMPLETED|Period IV (Double-Blind)||226
8703415|NCT00923091|9749177|FG001|COMPLETED|Period IV (Double-Blind)||451
8703416|NCT00923091|9749178|FG002|COMPLETED|Period IV (Double-Blind)||0
8703417|NCT00923091|9749179|FG003|COMPLETED|Period IV (Double-Blind)||0
8703418|NCT00923091|9749180|FG004|COMPLETED|Period IV (Double-Blind)||0
8703419|NCT00923091|9749181|FG005|COMPLETED|Period IV (Double-Blind)||0
8703420|NCT00923091|9749182|FG006|COMPLETED|Period IV (Double-Blind)||0
8703421|NCT00923091|9749183|FG007|COMPLETED|Period IV (Double-Blind)||0
8703422|NCT00923091|9749184|FG008|COMPLETED|Period IV (Double-Blind)||0
8703423|NCT00923091|9749185|FG009|COMPLETED|Period IV (Double-Blind)||0
9047499|NCT03451071|10107215|FG000|COMPLETED|Third Vaccine||14
9047500|NCT03451071|10107215|FG000|NOT COMPLETED|Third Vaccine||22
9047501|NCT03451071|10107215|FG000|STARTED|Final Questionnaire and Blood Draw||14
9047502|NCT03451071|10107215|FG000|COMPLETED|Final Questionnaire and Blood Draw||10
9047503|NCT03451071|10107215|FG000|NOT COMPLETED|Final Questionnaire and Blood Draw||4
9047504|NCT03451084|10107223|FG000|STARTED|Overall Study||6
9047505|NCT03451084|10107224|FG001|STARTED|Overall Study||6
9047506|NCT03451084|10107225|FG002|STARTED|Overall Study||6
9047507|NCT03451084|10107226|FG003|STARTED|Overall Study||6
9047508|NCT03451084|10107223|FG000|COMPLETED|Overall Study||0
9047509|NCT03451084|10107224|FG001|COMPLETED|Overall Study||0
9047510|NCT03451084|10107225|FG002|COMPLETED|Overall Study||0
9047511|NCT03451084|10107226|FG003|COMPLETED|Overall Study||0
8703424|NCT00923091|9749186|FG010|COMPLETED|Period IV (Double-Blind)||0
8703425|NCT00923091|9749187|FG011|COMPLETED|Period IV (Double-Blind)||0
8703426|NCT00923091|9749188|FG012|COMPLETED|Period IV (Double-Blind)||0
8703427|NCT00923091|9749176|FG000|NOT COMPLETED|Period IV (Double-Blind)||2
8703428|NCT00923091|9749177|FG001|NOT COMPLETED|Period IV (Double-Blind)||2
9047512|NCT03451084|10107223|FG000|NOT COMPLETED|Overall Study||6
9047513|NCT03451084|10107224|FG001|NOT COMPLETED|Overall Study||6
9047514|NCT03451084|10107225|FG002|NOT COMPLETED|Overall Study||6
9047515|NCT03451084|10107226|FG003|NOT COMPLETED|Overall Study||6
9047516|NCT03451721|10107236|FG000|STARTED|Overall Study||20
9047517|NCT03451721|10107236|FG000|COMPLETED|Overall Study||19
9047518|NCT03451721|10107236|FG000|NOT COMPLETED|Overall Study||1
9047519|NCT03451773|10107242|FG000|STARTED|Overall Study||1
9047520|NCT03451773|10107243|FG001|STARTED|Overall Study||6
9047521|NCT03451773|10107242|FG000|COMPLETED|Overall Study||0
9047522|NCT03451773|10107243|FG001|COMPLETED|Overall Study||0
9047523|NCT03451773|10107242|FG000|NOT COMPLETED|Overall Study||1
9047524|NCT03451773|10107243|FG001|NOT COMPLETED|Overall Study||6
9047525|NCT03452033|10107254|FG000|STARTED|Overall Study||21
9047526|NCT03452033|10107255|FG001|STARTED|Overall Study||22
9047527|NCT03452033|10107256|FG002|STARTED|Overall Study||22
9047528|NCT03452033|10107257|FG003|STARTED|Overall Study||22
9047529|NCT03452033|10107254|FG000|COMPLETED|Overall Study||21
9047530|NCT03452033|10107255|FG001|COMPLETED|Overall Study||22
9047531|NCT03452033|10107256|FG002|COMPLETED|Overall Study||22
9047532|NCT03452033|10107257|FG003|COMPLETED|Overall Study||22
9047533|NCT03452033|10107254|FG000|NOT COMPLETED|Overall Study||0
9047534|NCT03452033|10107255|FG001|NOT COMPLETED|Overall Study||0
9047535|NCT03452033|10107256|FG002|NOT COMPLETED|Overall Study||0
9047536|NCT03452033|10107257|FG003|NOT COMPLETED|Overall Study||0
9047537|NCT03452176|10107272|FG000|STARTED|Overall Study||11
9047538|NCT03452176|10107273|FG001|STARTED|Overall Study||11
9047539|NCT03452176|10107272|FG000|COMPLETED|Overall Study||11
9047540|NCT03452176|10107273|FG001|COMPLETED|Overall Study||11
9047541|NCT03452176|10107272|FG000|NOT COMPLETED|Overall Study||0
9047542|NCT03452176|10107273|FG001|NOT COMPLETED|Overall Study||0
9047543|NCT03452189|10107287|FG000|STARTED|First Intervention (3 Months)||10
9047544|NCT03452189|10107288|FG001|STARTED|First Intervention (3 Months)||5
9047545|NCT03452189|10107287|FG000|COMPLETED|First Intervention (3 Months)||5
9047546|NCT03452189|10107288|FG001|COMPLETED|First Intervention (3 Months)||5
9047547|NCT03452189|10107287|FG000|NOT COMPLETED|First Intervention (3 Months)||5
9047548|NCT03452189|10107288|FG001|NOT COMPLETED|First Intervention (3 Months)||0
9047549|NCT03452189|10107287|FG000|STARTED|Intervention 2 (3 Months)||5
9047550|NCT03452189|10107288|FG001|STARTED|Intervention 2 (3 Months)||5
9047551|NCT03452189|10107287|FG000|COMPLETED|Intervention 2 (3 Months)||5
9047552|NCT03452189|10107288|FG001|COMPLETED|Intervention 2 (3 Months)||5
9047553|NCT03452189|10107287|FG000|NOT COMPLETED|Intervention 2 (3 Months)||0
9047554|NCT03452189|10107288|FG001|NOT COMPLETED|Intervention 2 (3 Months)||0
9047555|NCT03452371|10107296|FG000|STARTED|Overall Study||21
9047556|NCT03452371|10107297|FG001|STARTED|Overall Study||23
9047557|NCT03452371|10107296|FG000|COMPLETED|Overall Study||21
9047558|NCT03452371|10107297|FG001|COMPLETED|Overall Study||23
9047559|NCT03452371|10107296|FG000|NOT COMPLETED|Overall Study||0
9047560|NCT03452371|10107297|FG001|NOT COMPLETED|Overall Study||0
9047561|NCT03452527|10107305|FG000|STARTED|Overall Study||7
9047562|NCT03452527|10107306|FG001|STARTED|Overall Study||8
9047563|NCT03452527|10107305|FG000|COMPLETED|Overall Study||4
9047564|NCT03452527|10107306|FG001|COMPLETED|Overall Study||4
9047565|NCT03452527|10107305|FG000|NOT COMPLETED|Overall Study||3
9047566|NCT03452527|10107306|FG001|NOT COMPLETED|Overall Study||4
8928018|NCT02277769|9989165|FG001|STARTED|Overall Study||233
8928019|NCT02277769|9989166|FG002|STARTED|Overall Study||239
8928020|NCT02277769|9989164|FG000|Treated|Overall Study||235
8928021|NCT02277769|9989165|FG001|Treated|Overall Study||233
8928022|NCT02277769|9989166|FG002|Treated|Overall Study||239
8928023|NCT02277769|9989164|FG000|Safety Population|Overall Study|1 participant received at least 1 injection of Dupilumab 300mg(analyzed in Dupilumab 300 mg q2w arm)|234
8928024|NCT02277769|9989165|FG001|Safety Population|Overall Study|3 participants (1 [placebo] + 2 [Dupilumab 300 mg qw arm]) analyzed in Dupilumab 300 mg q2w arm|236
8928025|NCT02277769|9989166|FG002|Safety Population|Overall Study|2 participants received fewer injections of Dupilumab 300 mg (analyzed in Dupilumab 300 mg q2w arm)|237
8928026|NCT02277769|9989164|FG000|COMPLETED|Overall Study||190
8928027|NCT02277769|9989165|FG001|COMPLETED|Overall Study||220
8928028|NCT02277769|9989166|FG002|COMPLETED|Overall Study||221
8928029|NCT02277769|9989164|FG000|NOT COMPLETED|Overall Study||46
8928030|NCT02277769|9989165|FG001|NOT COMPLETED|Overall Study||13
9047567|NCT03452943|10107314|FG000|STARTED|Titration Period (7 Weeks)||59
9047568|NCT03452943|10107315|FG001|STARTED|Titration Period (7 Weeks)||60
9047569|NCT03452943|10107314|FG000|Safety Analysis Set|Titration Period (7 Weeks)||58
9047570|NCT03452943|10107315|FG001|Safety Analysis Set|Titration Period (7 Weeks)||59
9047571|NCT03452943|10107314|FG000|Modified ITT (mITT) Analysis Set|Titration Period (7 Weeks)||58
9047572|NCT03452943|10107315|FG001|Modified ITT (mITT) Analysis Set|Titration Period (7 Weeks)||59
9047573|NCT03452943|10107314|FG000|COMPLETED|Titration Period (7 Weeks)||54
9047574|NCT03452943|10107315|FG001|COMPLETED|Titration Period (7 Weeks)||56
9047575|NCT03452943|10107314|FG000|NOT COMPLETED|Titration Period (7 Weeks)||5
9047576|NCT03452943|10107315|FG001|NOT COMPLETED|Titration Period (7 Weeks)||4
9047577|NCT03452943|10107314|FG000|STARTED|Maintenance Period (5 Weeks)||54
9047578|NCT03452943|10107315|FG001|STARTED|Maintenance Period (5 Weeks)||56
9047579|NCT03452943|10107314|FG000|COMPLETED|Maintenance Period (5 Weeks)||51
9047580|NCT03452943|10107315|FG001|COMPLETED|Maintenance Period (5 Weeks)||56
9047581|NCT03452943|10107314|FG000|NOT COMPLETED|Maintenance Period (5 Weeks)||3
9047582|NCT03452943|10107315|FG001|NOT COMPLETED|Maintenance Period (5 Weeks)||0
9047583|NCT03453060|10107326|FG000|STARTED|Overall Study||4
9047584|NCT03453060|10107327|FG001|STARTED|Overall Study||4
9047585|NCT03453060|10107328|FG002|STARTED|Overall Study||4
9047586|NCT03453060|10107329|FG003|STARTED|Overall Study||4
9047587|NCT03453060|10107330|FG004|STARTED|Overall Study||5
9047588|NCT03453060|10107326|FG000|COMPLETED|Overall Study||4
9047589|NCT03453060|10107327|FG001|COMPLETED|Overall Study||4
9047590|NCT03453060|10107328|FG002|COMPLETED|Overall Study||4
9047591|NCT03453060|10107329|FG003|COMPLETED|Overall Study||4
9047592|NCT03453060|10107330|FG004|COMPLETED|Overall Study||5
9047593|NCT03453060|10107326|FG000|NOT COMPLETED|Overall Study||0
9047594|NCT03453060|10107327|FG001|NOT COMPLETED|Overall Study||0
9047595|NCT03453060|10107328|FG002|NOT COMPLETED|Overall Study||0
9047596|NCT03453060|10107329|FG003|NOT COMPLETED|Overall Study||0
9047597|NCT03453060|10107330|FG004|NOT COMPLETED|Overall Study||0
9047598|NCT03453151|10107342|FG000|STARTED|Overall Study||19
9047599|NCT03453151|10107342|FG000|COMPLETED|Overall Study||15
9047600|NCT03453151|10107342|FG000|NOT COMPLETED|Overall Study||4
9047601|NCT03453515|10107348|FG000|STARTED|Overall Study||113
9047602|NCT03453515|10107349|FG001|STARTED|Overall Study||113
9047603|NCT03453515|10107348|FG000|COMPLETED|Overall Study||107
9047604|NCT03453515|10107349|FG001|COMPLETED|Overall Study||100
9047605|NCT03453515|10107348|FG000|NOT COMPLETED|Overall Study||6
9047606|NCT03453515|10107349|FG001|NOT COMPLETED|Overall Study||13
9047607|NCT03454048|10107359|FG000|STARTED|Overall Study||6
9047608|NCT03454048|10107360|FG001|STARTED|Overall Study||6
9047609|NCT03454048|10107361|FG002|STARTED|Overall Study||6
9047610|NCT03454048|10107362|FG003|STARTED|Overall Study||6
9047611|NCT03454048|10107359|FG000|COMPLETED|Overall Study||6
9047612|NCT03454048|10107360|FG001|COMPLETED|Overall Study||6
9047613|NCT03454048|10107361|FG002|COMPLETED|Overall Study||6
9047614|NCT03454048|10107362|FG003|COMPLETED|Overall Study||6
9047615|NCT03454048|10107359|FG000|NOT COMPLETED|Overall Study||0
9047616|NCT03454048|10107360|FG001|NOT COMPLETED|Overall Study||0
9047617|NCT03454048|10107361|FG002|NOT COMPLETED|Overall Study||0
9047618|NCT03454048|10107362|FG003|NOT COMPLETED|Overall Study||0
9047619|NCT03454412|10107374|FG000|STARTED|Baseline Assesment||44
9047620|NCT03454412|10107374|FG000|COMPLETED|Baseline Assesment||32
9047621|NCT03454412|10107374|FG000|NOT COMPLETED|Baseline Assesment||12
9047622|NCT03454412|10107374|FG000|STARTED|Treatment Course||32
9047623|NCT03454412|10107374|FG000|COMPLETED|Treatment Course||32
9047624|NCT03454412|10107374|FG000|NOT COMPLETED|Treatment Course||0
9047625|NCT03454412|10107374|FG000|STARTED|Final Assesment||32
9047626|NCT03454412|10107374|FG000|COMPLETED|Final Assesment||32
9047627|NCT03454412|10107374|FG000|NOT COMPLETED|Final Assesment||0
9047628|NCT03454581|10107381|FG000|STARTED|Overall Study||18
9047629|NCT03454581|10107382|FG001|STARTED|Overall Study||16
9047630|NCT03454581|10107383|FG002|STARTED|Overall Study||17
9047631|NCT03454581|10107381|FG000|COMPLETED|Overall Study||14
9047632|NCT03454581|10107382|FG001|COMPLETED|Overall Study||13
9047633|NCT03454581|10107383|FG002|COMPLETED|Overall Study||14
9047634|NCT03454581|10107381|FG000|NOT COMPLETED|Overall Study||4
9047635|NCT03454581|10107382|FG001|NOT COMPLETED|Overall Study||3
9047636|NCT03454581|10107383|FG002|NOT COMPLETED|Overall Study||3
9047637|NCT03455218|10107394|FG000|STARTED|Overall Study||18
9047638|NCT03455218|10107395|FG001|STARTED|Overall Study||22
9047639|NCT03455218|10107394|FG000|COMPLETED|Overall Study||18
9047640|NCT03455218|10107395|FG001|COMPLETED|Overall Study||22
9047641|NCT03455218|10107394|FG000|NOT COMPLETED|Overall Study||0
9047642|NCT03455218|10107395|FG001|NOT COMPLETED|Overall Study||0
9047643|NCT03455491|10107404|FG000|STARTED|Overall Study||40
9047644|NCT03455491|10107405|FG001|STARTED|Overall Study||40
9047645|NCT03455491|10107406|FG002|STARTED|Overall Study||40
9047646|NCT03455491|10107404|FG000|COMPLETED|Overall Study||40
9047647|NCT03455491|10107405|FG001|COMPLETED|Overall Study||40
9047648|NCT03455491|10107406|FG002|COMPLETED|Overall Study||40
9047649|NCT03455491|10107404|FG000|NOT COMPLETED|Overall Study||0
9047650|NCT03455491|10107405|FG001|NOT COMPLETED|Overall Study||0
9047651|NCT03455491|10107406|FG002|NOT COMPLETED|Overall Study||0
9047652|NCT03455543|10107416|FG000|STARTED|Part A: Randomized Treatment (17 Weeks)||92
9047653|NCT03455543|10107417|FG001|STARTED|Part A: Randomized Treatment (17 Weeks)||90
9047654|NCT03455543|10107418|FG002|STARTED|Part A: Randomized Treatment (17 Weeks)||0
9047655|NCT03455543|10107416|FG000|COMPLETED|Part A: Randomized Treatment (17 Weeks)||81
9047656|NCT03455543|10107417|FG001|COMPLETED|Part A: Randomized Treatment (17 Weeks)||83
9047657|NCT03455543|10107418|FG002|COMPLETED|Part A: Randomized Treatment (17 Weeks)||0
9047658|NCT03455543|10107416|FG000|NOT COMPLETED|Part A: Randomized Treatment (17 Weeks)||11
9047659|NCT03455543|10107417|FG001|NOT COMPLETED|Part A: Randomized Treatment (17 Weeks)||7
9047660|NCT03455543|10107418|FG002|NOT COMPLETED|Part A: Randomized Treatment (17 Weeks)||0
8703429|NCT00923091|9749178|FG002|NOT COMPLETED|Period IV (Double-Blind)||0
8703430|NCT00923091|9749179|FG003|NOT COMPLETED|Period IV (Double-Blind)||0
9047661|NCT03455543|10107416|FG000|STARTED|Part B: Open-label Extension (24 Weeks)||0
9047662|NCT03455543|10107417|FG001|STARTED|Part B: Open-label Extension (24 Weeks)||0
9047663|NCT03455543|10107418|FG002|STARTED|Part B: Open-label Extension (24 Weeks)||152
9047664|NCT03455543|10107416|FG000|COMPLETED|Part B: Open-label Extension (24 Weeks)||0
9047665|NCT03455543|10107417|FG001|COMPLETED|Part B: Open-label Extension (24 Weeks)||0
9047666|NCT03455543|10107418|FG002|COMPLETED|Part B: Open-label Extension (24 Weeks)||115
9047667|NCT03455543|10107416|FG000|NOT COMPLETED|Part B: Open-label Extension (24 Weeks)||0
9047668|NCT03455543|10107417|FG001|NOT COMPLETED|Part B: Open-label Extension (24 Weeks)||0
9047669|NCT03455543|10107418|FG002|NOT COMPLETED|Part B: Open-label Extension (24 Weeks)||37
9047670|NCT03456245|10107426|FG000|STARTED|Overall Study||205
9047671|NCT03456245|10107426|FG000|COMPLETED|Overall Study||190
9047672|NCT03456245|10107426|FG000|NOT COMPLETED|Overall Study||15
9047673|NCT03456427|10107430|FG000|STARTED|Overall Study||36
9047674|NCT03456427|10107430|FG000|COMPLETED|Overall Study||33
9047675|NCT03456427|10107430|FG000|NOT COMPLETED|Overall Study||3
9047676|NCT03456856|10107435|FG000|STARTED|Overall Study||30
9047677|NCT03456856|10107435|FG000|COMPLETED|Overall Study||27
9047678|NCT03456856|10107435|FG000|NOT COMPLETED|Overall Study||3
9047679|NCT03456960|10107445|FG000|STARTED|Period 1 (1 Day)||12
9047680|NCT03456960|10107446|FG001|STARTED|Period 1 (1 Day)||12
9047681|NCT03456960|10107447|FG002|STARTED|Period 1 (1 Day)||120
9047682|NCT03456960|10107448|FG003|STARTED|Period 1 (1 Day)||120
9047683|NCT03456960|10107449|FG004|STARTED|Period 1 (1 Day)||6
9047684|NCT03456960|10107450|FG005|STARTED|Period 1 (1 Day)||6
9047685|NCT03456960|10107445|FG000|COMPLETED|Period 1 (1 Day)||12
9047686|NCT03456960|10107446|FG001|COMPLETED|Period 1 (1 Day)||12
9047687|NCT03456960|10107447|FG002|COMPLETED|Period 1 (1 Day)||120
9047688|NCT03456960|10107448|FG003|COMPLETED|Period 1 (1 Day)||120
9047689|NCT03456960|10107449|FG004|COMPLETED|Period 1 (1 Day)||6
9047690|NCT03456960|10107450|FG005|COMPLETED|Period 1 (1 Day)||6
9047691|NCT03456960|10107445|FG000|NOT COMPLETED|Period 1 (1 Day)||0
9047692|NCT03456960|10107446|FG001|NOT COMPLETED|Period 1 (1 Day)||0
9047693|NCT03456960|10107447|FG002|NOT COMPLETED|Period 1 (1 Day)||0
9047694|NCT03456960|10107448|FG003|NOT COMPLETED|Period 1 (1 Day)||0
9047695|NCT03456960|10107449|FG004|NOT COMPLETED|Period 1 (1 Day)||0
9047696|NCT03456960|10107450|FG005|NOT COMPLETED|Period 1 (1 Day)||0
9047697|NCT03456960|10107445|FG000|STARTED|Washout Period (at Least 14 Days)||12
9047698|NCT03456960|10107446|FG001|STARTED|Washout Period (at Least 14 Days)||12
9047699|NCT03456960|10107447|FG002|STARTED|Washout Period (at Least 14 Days)||120
9047700|NCT03456960|10107448|FG003|STARTED|Washout Period (at Least 14 Days)||120
9047701|NCT03456960|10107449|FG004|STARTED|Washout Period (at Least 14 Days)||6
9047702|NCT03456960|10107450|FG005|STARTED|Washout Period (at Least 14 Days)||6
9047703|NCT03456960|10107445|FG000|COMPLETED|Washout Period (at Least 14 Days)||12
9047704|NCT03456960|10107446|FG001|COMPLETED|Washout Period (at Least 14 Days)||12
9047705|NCT03456960|10107447|FG002|COMPLETED|Washout Period (at Least 14 Days)||119
9047706|NCT03456960|10107448|FG003|COMPLETED|Washout Period (at Least 14 Days)||118
9047707|NCT03456960|10107449|FG004|COMPLETED|Washout Period (at Least 14 Days)||6
9047708|NCT03456960|10107450|FG005|COMPLETED|Washout Period (at Least 14 Days)||6
9047709|NCT03456960|10107445|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
9047710|NCT03456960|10107446|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
9047711|NCT03456960|10107447|FG002|NOT COMPLETED|Washout Period (at Least 14 Days)||1
9047712|NCT03456960|10107448|FG003|NOT COMPLETED|Washout Period (at Least 14 Days)||2
9047713|NCT03456960|10107449|FG004|NOT COMPLETED|Washout Period (at Least 14 Days)||0
9047714|NCT03456960|10107450|FG005|NOT COMPLETED|Washout Period (at Least 14 Days)||0
9047715|NCT03456960|10107445|FG000|STARTED|Period 2 (1 Day)||12
9047716|NCT03456960|10107446|FG001|STARTED|Period 2 (1 Day)||12
9047717|NCT03456960|10107447|FG002|STARTED|Period 2 (1 Day)||119
9047718|NCT03456960|10107448|FG003|STARTED|Period 2 (1 Day)||118
9047719|NCT03456960|10107449|FG004|STARTED|Period 2 (1 Day)||6
9047720|NCT03456960|10107450|FG005|STARTED|Period 2 (1 Day)||6
9047721|NCT03456960|10107445|FG000|COMPLETED|Period 2 (1 Day)||11
9047722|NCT03456960|10107446|FG001|COMPLETED|Period 2 (1 Day)||12
9047723|NCT03456960|10107447|FG002|COMPLETED|Period 2 (1 Day)||119
9047724|NCT03456960|10107448|FG003|COMPLETED|Period 2 (1 Day)||117
9047725|NCT03456960|10107449|FG004|COMPLETED|Period 2 (1 Day)||6
9047726|NCT03456960|10107450|FG005|COMPLETED|Period 2 (1 Day)||6
8703431|NCT00923091|9749180|FG004|NOT COMPLETED|Period IV (Double-Blind)||0
8703432|NCT00923091|9749181|FG005|NOT COMPLETED|Period IV (Double-Blind)||0
9047727|NCT03456960|10107445|FG000|NOT COMPLETED|Period 2 (1 Day)||1
9047728|NCT03456960|10107446|FG001|NOT COMPLETED|Period 2 (1 Day)||0
9047729|NCT03456960|10107447|FG002|NOT COMPLETED|Period 2 (1 Day)||0
9047730|NCT03456960|10107448|FG003|NOT COMPLETED|Period 2 (1 Day)||1
9047731|NCT03456960|10107449|FG004|NOT COMPLETED|Period 2 (1 Day)||0
9047732|NCT03456960|10107450|FG005|NOT COMPLETED|Period 2 (1 Day)||0
9047733|NCT03457103|10107468|FG000|STARTED|Overall Study||22
9047734|NCT03457103|10107469|FG001|STARTED|Overall Study||9
9047735|NCT03457103|10107468|FG000|COMPLETED|Overall Study||14
9047736|NCT03457103|10107469|FG001|COMPLETED|Overall Study||3
9047737|NCT03457103|10107468|FG000|NOT COMPLETED|Overall Study||8
9047738|NCT03457103|10107469|FG001|NOT COMPLETED|Overall Study||6
9047739|NCT03457116|10107477|FG000|STARTED|Overall Study||41
9047740|NCT03457116|10107478|FG001|STARTED|Overall Study||29
9047741|NCT03457116|10107477|FG000|COMPLETED|Overall Study||41
9047742|NCT03457116|10107478|FG001|COMPLETED|Overall Study||29
9047743|NCT03457116|10107477|FG000|NOT COMPLETED|Overall Study||0
9047744|NCT03457116|10107478|FG001|NOT COMPLETED|Overall Study||0
9047745|NCT03457636|10107484|FG000|STARTED|Overall Study||22
9047746|NCT03457636|10107484|FG000|COMPLETED|Overall Study||20
9047747|NCT03457636|10107484|FG000|NOT COMPLETED|Overall Study||2
9047748|NCT03457727|10107492|FG000|STARTED|Part 1, Period 1 (1 Day)||8
9047749|NCT03457727|10107493|FG001|STARTED|Part 1, Period 1 (1 Day)||8
9047750|NCT03457727|10107494|FG002|STARTED|Part 1, Period 1 (1 Day)||0
9047751|NCT03457727|10107495|FG003|STARTED|Part 1, Period 1 (1 Day)||0
9047752|NCT03457727|10107492|FG000|COMPLETED|Part 1, Period 1 (1 Day)||8
9047753|NCT03457727|10107493|FG001|COMPLETED|Part 1, Period 1 (1 Day)||8
9047754|NCT03457727|10107494|FG002|COMPLETED|Part 1, Period 1 (1 Day)||0
9047755|NCT03457727|10107495|FG003|COMPLETED|Part 1, Period 1 (1 Day)||0
9047756|NCT03457727|10107492|FG000|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
9047757|NCT03457727|10107493|FG001|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
9047758|NCT03457727|10107494|FG002|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
9047759|NCT03457727|10107495|FG003|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
9047760|NCT03457727|10107492|FG000|STARTED|Part 1, Washout Period 1 (5 Days)||8
9047761|NCT03457727|10107493|FG001|STARTED|Part 1, Washout Period 1 (5 Days)||8
9047762|NCT03457727|10107494|FG002|STARTED|Part 1, Washout Period 1 (5 Days)||0
9047763|NCT03457727|10107495|FG003|STARTED|Part 1, Washout Period 1 (5 Days)||0
9047764|NCT03457727|10107492|FG000|COMPLETED|Part 1, Washout Period 1 (5 Days)||8
9047765|NCT03457727|10107493|FG001|COMPLETED|Part 1, Washout Period 1 (5 Days)||8
9047766|NCT03457727|10107494|FG002|COMPLETED|Part 1, Washout Period 1 (5 Days)||0
9047767|NCT03457727|10107495|FG003|COMPLETED|Part 1, Washout Period 1 (5 Days)||0
9047768|NCT03457727|10107492|FG000|NOT COMPLETED|Part 1, Washout Period 1 (5 Days)||0
9047769|NCT03457727|10107493|FG001|NOT COMPLETED|Part 1, Washout Period 1 (5 Days)||0
9047770|NCT03457727|10107494|FG002|NOT COMPLETED|Part 1, Washout Period 1 (5 Days)||0
9047771|NCT03457727|10107495|FG003|NOT COMPLETED|Part 1, Washout Period 1 (5 Days)||0
9047772|NCT03457727|10107492|FG000|STARTED|Part 1, Period 2 (1 Day)||8
9047773|NCT03457727|10107493|FG001|STARTED|Part 1, Period 2 (1 Day)||8
9047774|NCT03457727|10107494|FG002|STARTED|Part 1, Period 2 (1 Day)||0
9047775|NCT03457727|10107495|FG003|STARTED|Part 1, Period 2 (1 Day)||0
9047776|NCT03457727|10107492|FG000|COMPLETED|Part 1, Period 2 (1 Day)||8
9047777|NCT03457727|10107493|FG001|COMPLETED|Part 1, Period 2 (1 Day)||8
9047778|NCT03457727|10107494|FG002|COMPLETED|Part 1, Period 2 (1 Day)||0
9047779|NCT03457727|10107495|FG003|COMPLETED|Part 1, Period 2 (1 Day)||0
9047780|NCT03457727|10107492|FG000|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
9047781|NCT03457727|10107493|FG001|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
9047782|NCT03457727|10107494|FG002|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
9047783|NCT03457727|10107495|FG003|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
9047784|NCT03457727|10107492|FG000|STARTED|Part 1, Washout Period 2 (5 Days)||8
9047785|NCT03457727|10107493|FG001|STARTED|Part 1, Washout Period 2 (5 Days)||8
9047786|NCT03457727|10107494|FG002|STARTED|Part 1, Washout Period 2 (5 Days)||0
9047787|NCT03457727|10107495|FG003|STARTED|Part 1, Washout Period 2 (5 Days)||0
9047788|NCT03457727|10107492|FG000|COMPLETED|Part 1, Washout Period 2 (5 Days)||8
9047789|NCT03457727|10107493|FG001|COMPLETED|Part 1, Washout Period 2 (5 Days)||8
9047790|NCT03457727|10107494|FG002|COMPLETED|Part 1, Washout Period 2 (5 Days)||0
9047791|NCT03457727|10107495|FG003|COMPLETED|Part 1, Washout Period 2 (5 Days)||0
9047792|NCT03457727|10107492|FG000|NOT COMPLETED|Part 1, Washout Period 2 (5 Days)||0
9047793|NCT03457727|10107493|FG001|NOT COMPLETED|Part 1, Washout Period 2 (5 Days)||0
9047794|NCT03457727|10107494|FG002|NOT COMPLETED|Part 1, Washout Period 2 (5 Days)||0
9047795|NCT03457727|10107495|FG003|NOT COMPLETED|Part 1, Washout Period 2 (5 Days)||0
9047796|NCT03457727|10107492|FG000|STARTED|Part 1, Period 3 (1 Day)||8
9047797|NCT03457727|10107493|FG001|STARTED|Part 1, Period 3 (1 Day)||8
9047798|NCT03457727|10107494|FG002|STARTED|Part 1, Period 3 (1 Day)||0
9047799|NCT03457727|10107495|FG003|STARTED|Part 1, Period 3 (1 Day)||0
9047800|NCT03457727|10107492|FG000|COMPLETED|Part 1, Period 3 (1 Day)||8
9047801|NCT03457727|10107493|FG001|COMPLETED|Part 1, Period 3 (1 Day)||8
9047802|NCT03457727|10107494|FG002|COMPLETED|Part 1, Period 3 (1 Day)||0
9047803|NCT03457727|10107495|FG003|COMPLETED|Part 1, Period 3 (1 Day)||0
9047804|NCT03457727|10107492|FG000|NOT COMPLETED|Part 1, Period 3 (1 Day)||0
9047805|NCT03457727|10107493|FG001|NOT COMPLETED|Part 1, Period 3 (1 Day)||0
9047806|NCT03457727|10107494|FG002|NOT COMPLETED|Part 1, Period 3 (1 Day)||0
9047807|NCT03457727|10107495|FG003|NOT COMPLETED|Part 1, Period 3 (1 Day)||0
9047808|NCT03457727|10107492|FG000|STARTED|Part 1, Washout Period 3 (5 Days)||8
9047809|NCT03457727|10107493|FG001|STARTED|Part 1, Washout Period 3 (5 Days)||8
9047810|NCT03457727|10107494|FG002|STARTED|Part 1, Washout Period 3 (5 Days)||0
9047811|NCT03457727|10107495|FG003|STARTED|Part 1, Washout Period 3 (5 Days)||0
9047812|NCT03457727|10107492|FG000|COMPLETED|Part 1, Washout Period 3 (5 Days)||8
9047813|NCT03457727|10107493|FG001|COMPLETED|Part 1, Washout Period 3 (5 Days)||8
9047814|NCT03457727|10107494|FG002|COMPLETED|Part 1, Washout Period 3 (5 Days)||0
9047815|NCT03457727|10107495|FG003|COMPLETED|Part 1, Washout Period 3 (5 Days)||0
9047816|NCT03457727|10107492|FG000|NOT COMPLETED|Part 1, Washout Period 3 (5 Days)||0
9047817|NCT03457727|10107493|FG001|NOT COMPLETED|Part 1, Washout Period 3 (5 Days)||0
9047818|NCT03457727|10107494|FG002|NOT COMPLETED|Part 1, Washout Period 3 (5 Days)||0
9047819|NCT03457727|10107495|FG003|NOT COMPLETED|Part 1, Washout Period 3 (5 Days)||0
9047820|NCT03457727|10107492|FG000|STARTED|Part 1, Period 4 (1 Day)||8
9047821|NCT03457727|10107493|FG001|STARTED|Part 1, Period 4 (1 Day)||8
9047822|NCT03457727|10107494|FG002|STARTED|Part 1, Period 4 (1 Day)||0
9047823|NCT03457727|10107495|FG003|STARTED|Part 1, Period 4 (1 Day)||0
9047824|NCT03457727|10107492|FG000|COMPLETED|Part 1, Period 4 (1 Day)||8
9047825|NCT03457727|10107493|FG001|COMPLETED|Part 1, Period 4 (1 Day)||8
9047826|NCT03457727|10107494|FG002|COMPLETED|Part 1, Period 4 (1 Day)||0
9047827|NCT03457727|10107495|FG003|COMPLETED|Part 1, Period 4 (1 Day)||0
9047828|NCT03457727|10107492|FG000|NOT COMPLETED|Part 1, Period 4 (1 Day)||0
9047829|NCT03457727|10107493|FG001|NOT COMPLETED|Part 1, Period 4 (1 Day)||0
9047830|NCT03457727|10107494|FG002|NOT COMPLETED|Part 1, Period 4 (1 Day)||0
9047831|NCT03457727|10107495|FG003|NOT COMPLETED|Part 1, Period 4 (1 Day)||0
9047832|NCT03457727|10107492|FG000|STARTED|Part 2, Period 1 (1 Day)||0
9047833|NCT03457727|10107493|FG001|STARTED|Part 2, Period 1 (1 Day)||0
9047834|NCT03457727|10107494|FG002|STARTED|Part 2, Period 1 (1 Day)||12
9047835|NCT03457727|10107495|FG003|STARTED|Part 2, Period 1 (1 Day)||12
9047836|NCT03457727|10107492|FG000|COMPLETED|Part 2, Period 1 (1 Day)||0
9047837|NCT03457727|10107493|FG001|COMPLETED|Part 2, Period 1 (1 Day)||0
9047838|NCT03457727|10107494|FG002|COMPLETED|Part 2, Period 1 (1 Day)||12
9047839|NCT03457727|10107495|FG003|COMPLETED|Part 2, Period 1 (1 Day)||12
9047840|NCT03457727|10107492|FG000|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
9047841|NCT03457727|10107493|FG001|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
9047842|NCT03457727|10107494|FG002|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
9047843|NCT03457727|10107495|FG003|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
9047844|NCT03457727|10107492|FG000|STARTED|Part 2, Washout Period 1 (5 Days)||0
9047845|NCT03457727|10107493|FG001|STARTED|Part 2, Washout Period 1 (5 Days)||0
9047846|NCT03457727|10107494|FG002|STARTED|Part 2, Washout Period 1 (5 Days)||12
9047847|NCT03457727|10107495|FG003|STARTED|Part 2, Washout Period 1 (5 Days)||12
9047848|NCT03457727|10107492|FG000|COMPLETED|Part 2, Washout Period 1 (5 Days)||0
9047849|NCT03457727|10107493|FG001|COMPLETED|Part 2, Washout Period 1 (5 Days)||0
9047850|NCT03457727|10107494|FG002|COMPLETED|Part 2, Washout Period 1 (5 Days)||12
9047851|NCT03457727|10107495|FG003|COMPLETED|Part 2, Washout Period 1 (5 Days)||11
9047852|NCT03457727|10107492|FG000|NOT COMPLETED|Part 2, Washout Period 1 (5 Days)||0
9047853|NCT03457727|10107493|FG001|NOT COMPLETED|Part 2, Washout Period 1 (5 Days)||0
9047854|NCT03457727|10107494|FG002|NOT COMPLETED|Part 2, Washout Period 1 (5 Days)||0
9047855|NCT03457727|10107495|FG003|NOT COMPLETED|Part 2, Washout Period 1 (5 Days)||1
9047856|NCT03457727|10107492|FG000|STARTED|Part 2, Period 2 (1 Day)||0
9047857|NCT03457727|10107493|FG001|STARTED|Part 2, Period 2 (1 Day)||0
9047858|NCT03457727|10107494|FG002|STARTED|Part 2, Period 2 (1 Day)||12
9047859|NCT03457727|10107495|FG003|STARTED|Part 2, Period 2 (1 Day)||11
9047860|NCT03457727|10107492|FG000|COMPLETED|Part 2, Period 2 (1 Day)||0
9047861|NCT03457727|10107493|FG001|COMPLETED|Part 2, Period 2 (1 Day)||0
9047862|NCT03457727|10107494|FG002|COMPLETED|Part 2, Period 2 (1 Day)||12
9047863|NCT03457727|10107495|FG003|COMPLETED|Part 2, Period 2 (1 Day)||11
9047864|NCT03457727|10107492|FG000|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
9047865|NCT03457727|10107493|FG001|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
9047866|NCT03457727|10107494|FG002|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
9047867|NCT03457727|10107495|FG003|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
9047868|NCT03457727|10107492|FG000|STARTED|Part 2, Washout Period 2 (5 Days)||0
9047869|NCT03457727|10107493|FG001|STARTED|Part 2, Washout Period 2 (5 Days)||0
9047870|NCT03457727|10107494|FG002|STARTED|Part 2, Washout Period 2 (5 Days)||12
9047871|NCT03457727|10107495|FG003|STARTED|Part 2, Washout Period 2 (5 Days)||11
9047872|NCT03457727|10107492|FG000|COMPLETED|Part 2, Washout Period 2 (5 Days)||0
9047873|NCT03457727|10107493|FG001|COMPLETED|Part 2, Washout Period 2 (5 Days)||0
9047874|NCT03457727|10107494|FG002|COMPLETED|Part 2, Washout Period 2 (5 Days)||12
9047875|NCT03457727|10107495|FG003|COMPLETED|Part 2, Washout Period 2 (5 Days)||11
9047876|NCT03457727|10107492|FG000|NOT COMPLETED|Part 2, Washout Period 2 (5 Days)||0
9047877|NCT03457727|10107493|FG001|NOT COMPLETED|Part 2, Washout Period 2 (5 Days)||0
9047878|NCT03457727|10107494|FG002|NOT COMPLETED|Part 2, Washout Period 2 (5 Days)||0
9047879|NCT03457727|10107495|FG003|NOT COMPLETED|Part 2, Washout Period 2 (5 Days)||0
9047880|NCT03457727|10107492|FG000|STARTED|Part 2, Period 3 (1 Day)||0
9047881|NCT03457727|10107493|FG001|STARTED|Part 2, Period 3 (1 Day)||0
9047882|NCT03457727|10107494|FG002|STARTED|Part 2, Period 3 (1 Day)||12
9047883|NCT03457727|10107495|FG003|STARTED|Part 2, Period 3 (1 Day)||11
9047884|NCT03457727|10107492|FG000|COMPLETED|Part 2, Period 3 (1 Day)||0
9047885|NCT03457727|10107493|FG001|COMPLETED|Part 2, Period 3 (1 Day)||0
9047886|NCT03457727|10107494|FG002|COMPLETED|Part 2, Period 3 (1 Day)||12
9047887|NCT03457727|10107495|FG003|COMPLETED|Part 2, Period 3 (1 Day)||11
9047888|NCT03457727|10107492|FG000|NOT COMPLETED|Part 2, Period 3 (1 Day)||0
9047889|NCT03457727|10107493|FG001|NOT COMPLETED|Part 2, Period 3 (1 Day)||0
9047890|NCT03457727|10107494|FG002|NOT COMPLETED|Part 2, Period 3 (1 Day)||0
9047891|NCT03457727|10107495|FG003|NOT COMPLETED|Part 2, Period 3 (1 Day)||0
9047892|NCT03457727|10107492|FG000|STARTED|Part 2, Washout Period 3 (5 Days)||0
9047893|NCT03457727|10107493|FG001|STARTED|Part 2, Washout Period 3 (5 Days)||0
9047894|NCT03457727|10107494|FG002|STARTED|Part 2, Washout Period 3 (5 Days)||12
9047895|NCT03457727|10107495|FG003|STARTED|Part 2, Washout Period 3 (5 Days)||11
9047896|NCT03457727|10107492|FG000|COMPLETED|Part 2, Washout Period 3 (5 Days)||0
9047897|NCT03457727|10107493|FG001|COMPLETED|Part 2, Washout Period 3 (5 Days)||0
9047898|NCT03457727|10107494|FG002|COMPLETED|Part 2, Washout Period 3 (5 Days)||12
9047899|NCT03457727|10107495|FG003|COMPLETED|Part 2, Washout Period 3 (5 Days)||11
9047900|NCT03457727|10107492|FG000|NOT COMPLETED|Part 2, Washout Period 3 (5 Days)||0
9047901|NCT03457727|10107493|FG001|NOT COMPLETED|Part 2, Washout Period 3 (5 Days)||0
9047902|NCT03457727|10107494|FG002|NOT COMPLETED|Part 2, Washout Period 3 (5 Days)||0
9047903|NCT03457727|10107495|FG003|NOT COMPLETED|Part 2, Washout Period 3 (5 Days)||0
9047904|NCT03457727|10107492|FG000|STARTED|Part 2, Period 4 (1 Day)||0
9047905|NCT03457727|10107493|FG001|STARTED|Part 2, Period 4 (1 Day)||0
9047906|NCT03457727|10107494|FG002|STARTED|Part 2, Period 4 (1 Day)||12
9047907|NCT03457727|10107495|FG003|STARTED|Part 2, Period 4 (1 Day)||0
9047908|NCT03457727|10107492|FG000|COMPLETED|Part 2, Period 4 (1 Day)||0
9047909|NCT03457727|10107493|FG001|COMPLETED|Part 2, Period 4 (1 Day)||0
9047910|NCT03457727|10107494|FG002|COMPLETED|Part 2, Period 4 (1 Day)||12
9047911|NCT03457727|10107495|FG003|COMPLETED|Part 2, Period 4 (1 Day)||0
9047912|NCT03457727|10107492|FG000|NOT COMPLETED|Part 2, Period 4 (1 Day)||0
9047913|NCT03457727|10107493|FG001|NOT COMPLETED|Part 2, Period 4 (1 Day)||0
9047914|NCT03457727|10107494|FG002|NOT COMPLETED|Part 2, Period 4 (1 Day)||0
9047915|NCT03457727|10107495|FG003|NOT COMPLETED|Part 2, Period 4 (1 Day)||0
9047916|NCT03457909|10107527|FG000|STARTED|Overall Study||25
9047917|NCT03457909|10107527|FG000|COMPLETED|Overall Study||25
9047918|NCT03457909|10107527|FG000|NOT COMPLETED|Overall Study||0
9047919|NCT03458702|10107531|FG000|STARTED|Study Condition A (Yoga or Rest)||28
9047920|NCT03458702|10107532|FG001|STARTED|Study Condition A (Yoga or Rest)||28
9047921|NCT03458702|10107531|FG000|COMPLETED|Study Condition A (Yoga or Rest)||24
9047922|NCT03458702|10107532|FG001|COMPLETED|Study Condition A (Yoga or Rest)||22
9047923|NCT03458702|10107531|FG000|NOT COMPLETED|Study Condition A (Yoga or Rest)||4
9047924|NCT03458702|10107532|FG001|NOT COMPLETED|Study Condition A (Yoga or Rest)||6
9047925|NCT03458702|10107531|FG000|STARTED|Study Condition B (Yoga or Rest)||24
9047926|NCT03458702|10107532|FG001|STARTED|Study Condition B (Yoga or Rest)||22
9047927|NCT03458702|10107531|FG000|COMPLETED|Study Condition B (Yoga or Rest)||20
9047928|NCT03458702|10107532|FG001|COMPLETED|Study Condition B (Yoga or Rest)||20
9047929|NCT03458702|10107531|FG000|NOT COMPLETED|Study Condition B (Yoga or Rest)||4
9047930|NCT03458702|10107532|FG001|NOT COMPLETED|Study Condition B (Yoga or Rest)||2
9047931|NCT03458702|10107531|FG000|STARTED|Picture Rating/Body Composition||20
8703433|NCT00923091|9749182|FG006|NOT COMPLETED|Period IV (Double-Blind)||0
8703434|NCT00923091|9749183|FG007|NOT COMPLETED|Period IV (Double-Blind)||0
8703435|NCT00923091|9749184|FG008|NOT COMPLETED|Period IV (Double-Blind)||0
8703436|NCT00923091|9749185|FG009|NOT COMPLETED|Period IV (Double-Blind)||0
8703437|NCT00923091|9749186|FG010|NOT COMPLETED|Period IV (Double-Blind)||0
8703438|NCT00923091|9749187|FG011|NOT COMPLETED|Period IV (Double-Blind)||0
8703439|NCT00923091|9749188|FG012|NOT COMPLETED|Period IV (Double-Blind)||0
9047932|NCT03458702|10107532|FG001|STARTED|Picture Rating/Body Composition||20
9047933|NCT03458702|10107531|FG000|COMPLETED|Picture Rating/Body Composition||20
9047934|NCT03458702|10107532|FG001|COMPLETED|Picture Rating/Body Composition||20
9047935|NCT03458702|10107531|FG000|NOT COMPLETED|Picture Rating/Body Composition||0
9047936|NCT03458702|10107532|FG001|NOT COMPLETED|Picture Rating/Body Composition||0
9047937|NCT03458871|10107538|FG000|STARTED|Overall Study||16
9047938|NCT03458871|10107538|FG000|COMPLETED|Overall Study||16
9047939|NCT03458871|10107538|FG000|NOT COMPLETED|Overall Study||0
9047940|NCT03459040|10107542|FG000|STARTED|Overall Study||30
9047941|NCT03459040|10107542|FG000|COMPLETED|Overall Study||21
8703440|NCT00923091|9749176|FG000|STARTED|Period V (Double -Blind)|677 completed Period 4. 1 did not continue and 2 erroneously responders were not counted = 674|0
8703441|NCT00923091|9749177|FG001|STARTED|Period V (Double -Blind)||0
8703442|NCT00923091|9749178|FG002|STARTED|Period V (Double -Blind)||0
8703443|NCT00923091|9749179|FG003|STARTED|Period V (Double -Blind)||0
8703444|NCT00923091|9749180|FG004|STARTED|Period V (Double -Blind)||0
8703445|NCT00923091|9749181|FG005|STARTED|Period V (Double -Blind)||0
8703446|NCT00923091|9749182|FG006|STARTED|Period V (Double -Blind)||0
8703447|NCT00923091|9749183|FG007|STARTED|Period V (Double -Blind)||0
8703448|NCT00923091|9749184|FG008|STARTED|Period V (Double -Blind)||135
8812696|NCT01521026|9865723|FG000|COMPLETED|Overall Study||23
8812697|NCT01521026|9865724|FG001|COMPLETED|Overall Study||28
8812698|NCT01521026|9865723|FG000|NOT COMPLETED|Overall Study||15
8812699|NCT01521026|9865724|FG001|NOT COMPLETED|Overall Study||3
8812700|NCT01521117|9865730|FG000|STARTED|First Intervention (6 Weeks)||10
8812701|NCT01521117|9865731|FG001|STARTED|First Intervention (6 Weeks)||11
9047942|NCT03459040|10107542|FG000|NOT COMPLETED|Overall Study||9
9047943|NCT03459131|10107547|FG000|STARTED|Period 1, First 7 Days of Wear||7
9047944|NCT03459131|10107548|FG001|STARTED|Period 1, First 7 Days of Wear||8
9047945|NCT03459131|10107547|FG000|COMPLETED|Period 1, First 7 Days of Wear||7
9047946|NCT03459131|10107548|FG001|COMPLETED|Period 1, First 7 Days of Wear||8
9047947|NCT03459131|10107547|FG000|NOT COMPLETED|Period 1, First 7 Days of Wear||0
9047948|NCT03459131|10107548|FG001|NOT COMPLETED|Period 1, First 7 Days of Wear||0
9047949|NCT03459131|10107547|FG000|STARTED|Period 2, Second 7 Days of Wear||7
9047950|NCT03459131|10107548|FG001|STARTED|Period 2, Second 7 Days of Wear||8
9047951|NCT03459131|10107547|FG000|COMPLETED|Period 2, Second 7 Days of Wear||7
9047952|NCT03459131|10107548|FG001|COMPLETED|Period 2, Second 7 Days of Wear||8
9047953|NCT03459131|10107547|FG000|NOT COMPLETED|Period 2, Second 7 Days of Wear||0
9047954|NCT03459131|10107548|FG001|NOT COMPLETED|Period 2, Second 7 Days of Wear||0
9047955|NCT03459196|10107554|FG000|STARTED|Overall Study||54
9047956|NCT03459196|10107554|FG000|COMPLETED|Overall Study||52
9047957|NCT03459196|10107554|FG000|NOT COMPLETED|Overall Study||2
9047958|NCT03459612|10107562|FG000|STARTED|Period 1||17
9047959|NCT03459612|10107563|FG001|STARTED|Period 1||17
9047960|NCT03459612|10107564|FG002|STARTED|Period 1||17
9047961|NCT03459612|10107565|FG003|STARTED|Period 1||17
9047962|NCT03459612|10107562|FG000|Received at Least 1 Dose of Study Drug|Period 1||17
9047963|NCT03459612|10107563|FG001|Received at Least 1 Dose of Study Drug|Period 1||17
9047964|NCT03459612|10107564|FG002|Received at Least 1 Dose of Study Drug|Period 1||17
9047965|NCT03459612|10107565|FG003|Received at Least 1 Dose of Study Drug|Period 1||17
9047966|NCT03459612|10107562|FG000|COMPLETED|Period 1||17
9047967|NCT03459612|10107563|FG001|COMPLETED|Period 1||17
9047968|NCT03459612|10107564|FG002|COMPLETED|Period 1||17
9047969|NCT03459612|10107565|FG003|COMPLETED|Period 1||17
9047970|NCT03459612|10107562|FG000|NOT COMPLETED|Period 1||0
9047971|NCT03459612|10107563|FG001|NOT COMPLETED|Period 1||0
9047972|NCT03459612|10107564|FG002|NOT COMPLETED|Period 1||0
9047973|NCT03459612|10107565|FG003|NOT COMPLETED|Period 1||0
9047974|NCT03459612|10107562|FG000|STARTED|Period 2||17
9047975|NCT03459612|10107563|FG001|STARTED|Period 2||17
9047976|NCT03459612|10107564|FG002|STARTED|Period 2||17
9047977|NCT03459612|10107565|FG003|STARTED|Period 2||17
9047978|NCT03459612|10107562|FG000|Received at Least 1 Dose of Study Drug|Period 2||17
9047979|NCT03459612|10107563|FG001|Received at Least 1 Dose of Study Drug|Period 2||17
9047980|NCT03459612|10107564|FG002|Received at Least 1 Dose of Study Drug|Period 2||17
9047981|NCT03459612|10107565|FG003|Received at Least 1 Dose of Study Drug|Period 2||17
9047982|NCT03459612|10107562|FG000|COMPLETED|Period 2||17
9047983|NCT03459612|10107563|FG001|COMPLETED|Period 2||17
9047984|NCT03459612|10107564|FG002|COMPLETED|Period 2||17
9047985|NCT03459612|10107565|FG003|COMPLETED|Period 2||17
9047986|NCT03459612|10107562|FG000|NOT COMPLETED|Period 2||0
9047987|NCT03459612|10107563|FG001|NOT COMPLETED|Period 2||0
9047988|NCT03459612|10107564|FG002|NOT COMPLETED|Period 2||0
9047989|NCT03459612|10107565|FG003|NOT COMPLETED|Period 2||0
9047990|NCT03459612|10107562|FG000|STARTED|Period 3||17
9047991|NCT03459612|10107563|FG001|STARTED|Period 3||17
9047992|NCT03459612|10107564|FG002|STARTED|Period 3||17
9047993|NCT03459612|10107565|FG003|STARTED|Period 3||17
9047994|NCT03459612|10107562|FG000|Received at Least 1 Dose of Study Drug|Period 3||17
9047995|NCT03459612|10107563|FG001|Received at Least 1 Dose of Study Drug|Period 3||17
9047996|NCT03459612|10107564|FG002|Received at Least 1 Dose of Study Drug|Period 3||17
9047997|NCT03459612|10107565|FG003|Received at Least 1 Dose of Study Drug|Period 3||17
9047998|NCT03459612|10107562|FG000|COMPLETED|Period 3||17
9047999|NCT03459612|10107563|FG001|COMPLETED|Period 3||17
9048000|NCT03459612|10107564|FG002|COMPLETED|Period 3||17
9048001|NCT03459612|10107565|FG003|COMPLETED|Period 3||17
9048002|NCT03459612|10107562|FG000|NOT COMPLETED|Period 3||0
9048003|NCT03459612|10107563|FG001|NOT COMPLETED|Period 3||0
9048004|NCT03459612|10107564|FG002|NOT COMPLETED|Period 3||0
9048005|NCT03459612|10107565|FG003|NOT COMPLETED|Period 3||0
9048006|NCT03459612|10107562|FG000|STARTED|Period 4||17
9048007|NCT03459612|10107563|FG001|STARTED|Period 4||17
9048008|NCT03459612|10107564|FG002|STARTED|Period 4|One participant completed period 3 and withdrew for personal reasons prior to Period 4.|16
9048009|NCT03459612|10107565|FG003|STARTED|Period 4||17
8812702|NCT01521117|9865730|FG000|COMPLETED|First Intervention (6 Weeks)||5
8812703|NCT01521117|9865731|FG001|COMPLETED|First Intervention (6 Weeks)||8
9048010|NCT03459612|10107562|FG000|Received at Least 1 Dose of Study Drug|Period 4||17
9048011|NCT03459612|10107563|FG001|Received at Least 1 Dose of Study Drug|Period 4||17
9048012|NCT03459612|10107564|FG002|Received at Least 1 Dose of Study Drug|Period 4||16
9048013|NCT03459612|10107565|FG003|Received at Least 1 Dose of Study Drug|Period 4||17
9048014|NCT03459612|10107562|FG000|COMPLETED|Period 4||17
9048015|NCT03459612|10107563|FG001|COMPLETED|Period 4||17
9048016|NCT03459612|10107564|FG002|COMPLETED|Period 4||16
9048017|NCT03459612|10107565|FG003|COMPLETED|Period 4||17
9048018|NCT03459612|10107562|FG000|NOT COMPLETED|Period 4||0
9048019|NCT03459612|10107563|FG001|NOT COMPLETED|Period 4||0
9048020|NCT03459612|10107564|FG002|NOT COMPLETED|Period 4||0
9048021|NCT03459612|10107565|FG003|NOT COMPLETED|Period 4||0
9048022|NCT03459794|10107580|FG000|STARTED|Overall Study||8
9048023|NCT03459794|10107581|FG001|STARTED|Overall Study||4
9048024|NCT03459794|10107580|FG000|COMPLETED|Overall Study||8
9048025|NCT03459794|10107581|FG001|COMPLETED|Overall Study||4
9048026|NCT03459794|10107580|FG000|NOT COMPLETED|Overall Study||0
9048027|NCT03459794|10107581|FG001|NOT COMPLETED|Overall Study||0
9048028|NCT03460587|10107593|FG000|STARTED|Overall Study||13
9048029|NCT03460587|10107593|FG000|COMPLETED|Overall Study||13
9048030|NCT03460587|10107593|FG000|NOT COMPLETED|Overall Study||0
9048031|NCT03460652|10107597|FG000|STARTED|Overall Study||282
9048032|NCT03460652|10107597|FG000|Entered Treatment Phase|Overall Study||238
9048033|NCT03460652|10107597|FG000|COMPLETED|Overall Study||155
9048034|NCT03460652|10107597|FG000|NOT COMPLETED|Overall Study||127
9048035|NCT03460899|10107602|FG000|STARTED|Euglycaemic Clamp|First Euglycaemic Clamp completed: 05. March 2018|14
9048036|NCT03460899|10107602|FG000|COMPLETED|Euglycaemic Clamp|Last Euglycaemic clamp completed: 23. May 2018|14
9048037|NCT03460899|10107602|FG000|NOT COMPLETED|Euglycaemic Clamp||0
9048038|NCT03460899|10107602|FG000|STARTED|Hyperinsulinaemic/Hypoglycaemic Clamp|First Hyperinsulinaemic/Hypoglycaemic Clamp completed: 15. March 2018|14
9048039|NCT03460899|10107602|FG000|COMPLETED|Hyperinsulinaemic/Hypoglycaemic Clamp|Last Hyperinsulinaemic/Hypoglycaemic Clamp completed: 05. June 2018|14
9048040|NCT03460899|10107602|FG000|NOT COMPLETED|Hyperinsulinaemic/Hypoglycaemic Clamp||0
9048041|NCT03460990|10107608|FG000|STARTED|Overall Study||57
9048042|NCT03460990|10107609|FG001|STARTED|Overall Study||54
9048043|NCT03460990|10107608|FG000|COMPLETED|Overall Study||57
9048044|NCT03460990|10107609|FG001|COMPLETED|Overall Study||54
9048045|NCT03460990|10107608|FG000|NOT COMPLETED|Overall Study||0
9048046|NCT03460990|10107609|FG001|NOT COMPLETED|Overall Study||0
9048047|NCT03461146|10107615|FG000|STARTED|Overall Study||24
9048048|NCT03461146|10107615|FG000|COMPLETED|Overall Study||21
9048049|NCT03461146|10107615|FG000|NOT COMPLETED|Overall Study||3
9048050|NCT03461757|10107621|FG000|STARTED|Overall Study||732
9048051|NCT03461757|10107622|FG001|STARTED|Overall Study||734
9048052|NCT03461757|10107621|FG000|Treated|Overall Study||682
9048053|NCT03461757|10107622|FG001|Treated|Overall Study||693
9048054|NCT03461757|10107621|FG000|COMPLETED|Overall Study||679
9048055|NCT03461757|10107622|FG001|COMPLETED|Overall Study||689
9048056|NCT03461757|10107621|FG000|NOT COMPLETED|Overall Study||53
9048057|NCT03461757|10107622|FG001|NOT COMPLETED|Overall Study||45
9048058|NCT03461965|10107630|FG000|STARTED|Overall Study||42
9048059|NCT03461965|10107631|FG001|STARTED|Overall Study||40
9048060|NCT03461965|10107630|FG000|COMPLETED|Overall Study||42
9048061|NCT03461965|10107631|FG001|COMPLETED|Overall Study||40
9048062|NCT03461965|10107630|FG000|NOT COMPLETED|Overall Study||0
9048063|NCT03461965|10107631|FG001|NOT COMPLETED|Overall Study||0
9048064|NCT03462082|10107637|FG000|STARTED|Study Phase (Randomized, Blinded Period)||3
9048065|NCT03462082|10107638|FG001|STARTED|Study Phase (Randomized, Blinded Period)||4
9048066|NCT03462082|10107639|FG002|STARTED|Study Phase (Randomized, Blinded Period)||4
9048067|NCT03462082|10107640|FG003|STARTED|Study Phase (Randomized, Blinded Period)||3
9048068|NCT03462082|10107641|FG004|STARTED|Study Phase (Randomized, Blinded Period)||3
9048069|NCT03462082|10107642|FG005|STARTED|Study Phase (Randomized, Blinded Period)||5
9048070|NCT03462082|10107643|FG006|STARTED|Study Phase (Randomized, Blinded Period)||0
9048071|NCT03462082|10107644|FG007|STARTED|Study Phase (Randomized, Blinded Period)||0
9048072|NCT03462082|10107637|FG000|COMPLETED|Study Phase (Randomized, Blinded Period)||3
9048073|NCT03462082|10107638|FG001|COMPLETED|Study Phase (Randomized, Blinded Period)||4
9048074|NCT03462082|10107639|FG002|COMPLETED|Study Phase (Randomized, Blinded Period)||4
9048075|NCT03462082|10107640|FG003|COMPLETED|Study Phase (Randomized, Blinded Period)||3
9048076|NCT03462082|10107641|FG004|COMPLETED|Study Phase (Randomized, Blinded Period)||3
9048077|NCT03462082|10107642|FG005|COMPLETED|Study Phase (Randomized, Blinded Period)||5
9048078|NCT03462082|10107643|FG006|COMPLETED|Study Phase (Randomized, Blinded Period)||0
9048079|NCT03462082|10107644|FG007|COMPLETED|Study Phase (Randomized, Blinded Period)||0
9048080|NCT03462082|10107637|FG000|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0
9048081|NCT03462082|10107638|FG001|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0
9048082|NCT03462082|10107639|FG002|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0
9048083|NCT03462082|10107640|FG003|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0
8703449|NCT00923091|9749185|FG009|STARTED|Period V (Double -Blind)||119
8703450|NCT00923091|9749186|FG010|STARTED|Period V (Double -Blind)||194
9048084|NCT03462082|10107641|FG004|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0
9048085|NCT03462082|10107642|FG005|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0
9048086|NCT03462082|10107643|FG006|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0
9048087|NCT03462082|10107644|FG007|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0
8703451|NCT00923091|9749187|FG011|STARTED|Period V (Double -Blind)||151
8703452|NCT00923091|9749188|FG012|STARTED|Period V (Double -Blind)||75
9048088|NCT03462082|10107637|FG000|STARTED|Open Label Phase||0
9048089|NCT03462082|10107638|FG001|STARTED|Open Label Phase||0
9048090|NCT03462082|10107639|FG002|STARTED|Open Label Phase||0
9048091|NCT03462082|10107640|FG003|STARTED|Open Label Phase||0
9048092|NCT03462082|10107641|FG004|STARTED|Open Label Phase||0
9048093|NCT03462082|10107642|FG005|STARTED|Open Label Phase||0
9048094|NCT03462082|10107643|FG006|STARTED|Open Label Phase||7
9048095|NCT03462082|10107644|FG007|STARTED|Open Label Phase||10
9048096|NCT03462082|10107637|FG000|COMPLETED|Open Label Phase||0
9048097|NCT03462082|10107638|FG001|COMPLETED|Open Label Phase||0
9048098|NCT03462082|10107639|FG002|COMPLETED|Open Label Phase||0
9048099|NCT03462082|10107640|FG003|COMPLETED|Open Label Phase||0
9048100|NCT03462082|10107641|FG004|COMPLETED|Open Label Phase||0
9048101|NCT03462082|10107642|FG005|COMPLETED|Open Label Phase||0
9048102|NCT03462082|10107643|FG006|COMPLETED|Open Label Phase||6
9048103|NCT03462082|10107644|FG007|COMPLETED|Open Label Phase||8
9048104|NCT03462082|10107637|FG000|NOT COMPLETED|Open Label Phase||0
9048105|NCT03462082|10107638|FG001|NOT COMPLETED|Open Label Phase||0
9048106|NCT03462082|10107639|FG002|NOT COMPLETED|Open Label Phase||0
9048107|NCT03462082|10107640|FG003|NOT COMPLETED|Open Label Phase||0
9048108|NCT03462082|10107641|FG004|NOT COMPLETED|Open Label Phase||0
9048109|NCT03462082|10107642|FG005|NOT COMPLETED|Open Label Phase||0
9048110|NCT03462082|10107643|FG006|NOT COMPLETED|Open Label Phase||1
9048111|NCT03462082|10107644|FG007|NOT COMPLETED|Open Label Phase||2
9048112|NCT03462576|10107657|FG000|STARTED|Overall Study||46
9048113|NCT03462576|10107658|FG001|STARTED|Overall Study||48
9048114|NCT03462576|10107659|FG002|STARTED|Overall Study||45
9048115|NCT03462576|10107657|FG000|COMPLETED|Overall Study||41
9048116|NCT03462576|10107658|FG001|COMPLETED|Overall Study||37
9048117|NCT03462576|10107659|FG002|COMPLETED|Overall Study||37
9048118|NCT03462576|10107657|FG000|NOT COMPLETED|Overall Study||5
9048119|NCT03462576|10107658|FG001|NOT COMPLETED|Overall Study||11
9048120|NCT03462576|10107659|FG002|NOT COMPLETED|Overall Study||8
9048121|NCT03462680|10107669|FG000|STARTED|Overall Study||21
9048122|NCT03462680|10107670|FG001|STARTED|Overall Study||26
9048123|NCT03462680|10107669|FG000|COMPLETED|Overall Study||18
9048124|NCT03462680|10107670|FG001|COMPLETED|Overall Study||21
9048125|NCT03462680|10107669|FG000|NOT COMPLETED|Overall Study||3
9048126|NCT03462680|10107670|FG001|NOT COMPLETED|Overall Study||5
9048127|NCT03462745|10107678|FG000|STARTED|Overall Study||92
9048128|NCT03462745|10107679|FG001|STARTED|Overall Study||92
9048129|NCT03462745|10107678|FG000|COMPLETED|Overall Study||92
9048130|NCT03462745|10107679|FG001|COMPLETED|Overall Study||92
9048131|NCT03462745|10107678|FG000|NOT COMPLETED|Overall Study||0
9048132|NCT03462745|10107679|FG001|NOT COMPLETED|Overall Study||0
9048133|NCT03462927|10107687|FG000|STARTED|Overall Study||32
9048134|NCT03462927|10107688|FG001|STARTED|Overall Study||31
9048135|NCT03462927|10107687|FG000|COMPLETED|Overall Study||26
9048136|NCT03462927|10107688|FG001|COMPLETED|Overall Study||29
9048137|NCT03462927|10107687|FG000|NOT COMPLETED|Overall Study||6
9048138|NCT03462927|10107688|FG001|NOT COMPLETED|Overall Study||2
9048139|NCT03463031|10107698|FG000|STARTED|Overall Study||225
9048140|NCT03463031|10107699|FG001|STARTED|Overall Study||221
9048141|NCT03463031|10107698|FG000|COMPLETED|Overall Study||215
9048142|NCT03463031|10107699|FG001|COMPLETED|Overall Study||216
9048143|NCT03463031|10107698|FG000|NOT COMPLETED|Overall Study||10
9048144|NCT03463031|10107699|FG001|NOT COMPLETED|Overall Study||5
9048145|NCT03463161|10107705|FG000|STARTED|Overall Study||2
9048146|NCT03463161|10107705|FG000|COMPLETED|Overall Study||2
9048147|NCT03463161|10107705|FG000|NOT COMPLETED|Overall Study||0
9048148|NCT03463512|10107711|FG000|STARTED|Overall Study||62
9048149|NCT03463512|10107712|FG001|STARTED|Overall Study||62
8812704|NCT01521117|9865730|FG000|NOT COMPLETED|First Intervention (6 Weeks)||5
8812705|NCT01521117|9865731|FG001|NOT COMPLETED|First Intervention (6 Weeks)||3
8812706|NCT01521117|9865730|FG000|STARTED|Washout (4 Weeks)||5
8812707|NCT01521117|9865731|FG001|STARTED|Washout (4 Weeks)||8
9048150|NCT03463512|10107711|FG000|COMPLETED|Overall Study||62
9048151|NCT03463512|10107712|FG001|COMPLETED|Overall Study||62
9048152|NCT03463512|10107711|FG000|NOT COMPLETED|Overall Study||0
9048153|NCT03463512|10107712|FG001|NOT COMPLETED|Overall Study||0
9048154|NCT03463889|10107718|FG000|STARTED|Overall Study||12
9048155|NCT03463889|10107718|FG000|COMPLETED|Overall Study||12
9048156|NCT03463889|10107718|FG000|NOT COMPLETED|Overall Study||0
9048157|NCT03463915|10107724|FG000|STARTED|Overall Study||45
9048158|NCT03463915|10107725|FG001|STARTED|Overall Study||45
9048159|NCT03463915|10107724|FG000|COMPLETED|Overall Study||35
9048160|NCT03463915|10107725|FG001|COMPLETED|Overall Study||36
9048161|NCT03463915|10107724|FG000|NOT COMPLETED|Overall Study||10
9048162|NCT03463915|10107725|FG001|NOT COMPLETED|Overall Study||9
9048163|NCT03463941|10107733|FG000|STARTED|Overall Study||80
9048164|NCT03463941|10107733|FG000|COMPLETED|Overall Study||62
9048165|NCT03463941|10107733|FG000|NOT COMPLETED|Overall Study||18
9048166|NCT03464383|10107741|FG000|STARTED|Overall Study||3
9048167|NCT03464383|10107742|FG001|STARTED|Overall Study||3
9048168|NCT03464383|10107743|FG002|STARTED|Overall Study||63
9048169|NCT03464383|10107741|FG000|COMPLETED|Overall Study||2
9048170|NCT03464383|10107742|FG001|COMPLETED|Overall Study||2
8812708|NCT01521117|9865730|FG000|COMPLETED|Washout (4 Weeks)||5
9048171|NCT03464383|10107743|FG002|COMPLETED|Overall Study||63
9048172|NCT03464383|10107741|FG000|NOT COMPLETED|Overall Study||1
9048173|NCT03464383|10107742|FG001|NOT COMPLETED|Overall Study||1
9048174|NCT03464383|10107743|FG002|NOT COMPLETED|Overall Study||0
9048175|NCT03464422|10107752|FG000|STARTED|Overall Study||21
9048176|NCT03464422|10107752|FG000|COMPLETED|Overall Study||17
9048177|NCT03464422|10107752|FG000|NOT COMPLETED|Overall Study||4
9048178|NCT03465436|10107762|FG000|STARTED|Period 1||14
9048179|NCT03465436|10107763|FG001|STARTED|Period 1||14
9048180|NCT03465436|10107764|FG002|STARTED|Period 1||14
9048181|NCT03465436|10107765|FG003|STARTED|Period 1||14
9048182|NCT03465436|10107762|FG000|Received at Least 1 Dose of Study Drug|Period 1||14
9048183|NCT03465436|10107763|FG001|Received at Least 1 Dose of Study Drug|Period 1||14
9048184|NCT03465436|10107764|FG002|Received at Least 1 Dose of Study Drug|Period 1||14
9048185|NCT03465436|10107765|FG003|Received at Least 1 Dose of Study Drug|Period 1||14
9048186|NCT03465436|10107762|FG000|COMPLETED|Period 1||14
9048187|NCT03465436|10107763|FG001|COMPLETED|Period 1||14
9048188|NCT03465436|10107764|FG002|COMPLETED|Period 1||13
9048189|NCT03465436|10107765|FG003|COMPLETED|Period 1||14
9048190|NCT03465436|10107762|FG000|NOT COMPLETED|Period 1||0
9048191|NCT03465436|10107763|FG001|NOT COMPLETED|Period 1||0
9048192|NCT03465436|10107764|FG002|NOT COMPLETED|Period 1||1
9048193|NCT03465436|10107765|FG003|NOT COMPLETED|Period 1||0
9048194|NCT03465436|10107762|FG000|STARTED|Period 2||14
9048195|NCT03465436|10107763|FG001|STARTED|Period 2||14
9048196|NCT03465436|10107764|FG002|STARTED|Period 2||13
9048197|NCT03465436|10107765|FG003|STARTED|Period 2||14
9048198|NCT03465436|10107762|FG000|Received at Least 1 Dose of Study Drug|Period 2||14
9048199|NCT03465436|10107763|FG001|Received at Least 1 Dose of Study Drug|Period 2||13
9048200|NCT03465436|10107764|FG002|Received at Least 1 Dose of Study Drug|Period 2||13
9048201|NCT03465436|10107765|FG003|Received at Least 1 Dose of Study Drug|Period 2||14
9048202|NCT03465436|10107762|FG000|COMPLETED|Period 2||14
9048203|NCT03465436|10107763|FG001|COMPLETED|Period 2||13
9048204|NCT03465436|10107764|FG002|COMPLETED|Period 2||13
9048205|NCT03465436|10107765|FG003|COMPLETED|Period 2||14
9048206|NCT03465436|10107762|FG000|NOT COMPLETED|Period 2||0
9048207|NCT03465436|10107763|FG001|NOT COMPLETED|Period 2||1
9048208|NCT03465436|10107764|FG002|NOT COMPLETED|Period 2||0
9048209|NCT03465436|10107765|FG003|NOT COMPLETED|Period 2||0
9048210|NCT03465436|10107762|FG000|STARTED|Period 3||14
9048211|NCT03465436|10107763|FG001|STARTED|Period 3||13
9048212|NCT03465436|10107764|FG002|STARTED|Period 3||13
9048213|NCT03465436|10107765|FG003|STARTED|Period 3||14
9048214|NCT03465436|10107762|FG000|Received at Least One Dose of Study Drug|Period 3||13
9048215|NCT03465436|10107763|FG001|Received at Least One Dose of Study Drug|Period 3||12
9048216|NCT03465436|10107764|FG002|Received at Least One Dose of Study Drug|Period 3||13
9048217|NCT03465436|10107765|FG003|Received at Least One Dose of Study Drug|Period 3||14
9048218|NCT03465436|10107762|FG000|COMPLETED|Period 3||13
9048219|NCT03465436|10107763|FG001|COMPLETED|Period 3||12
9048220|NCT03465436|10107764|FG002|COMPLETED|Period 3||13
9048221|NCT03465436|10107765|FG003|COMPLETED|Period 3||14
9048222|NCT03465436|10107762|FG000|NOT COMPLETED|Period 3||1
9048223|NCT03465436|10107763|FG001|NOT COMPLETED|Period 3||1
9048224|NCT03465436|10107764|FG002|NOT COMPLETED|Period 3||0
9048225|NCT03465436|10107765|FG003|NOT COMPLETED|Period 3||0
9048226|NCT03465436|10107762|FG000|STARTED|Period 4||13
9048227|NCT03465436|10107763|FG001|STARTED|Period 4||12
9048228|NCT03465436|10107764|FG002|STARTED|Period 4||13
9048229|NCT03465436|10107765|FG003|STARTED|Period 4||14
9048230|NCT03465436|10107762|FG000|Received at Least 1 Dose of Study Drug|Period 4||13
9048231|NCT03465436|10107763|FG001|Received at Least 1 Dose of Study Drug|Period 4||12
9048232|NCT03465436|10107764|FG002|Received at Least 1 Dose of Study Drug|Period 4||13
9048233|NCT03465436|10107765|FG003|Received at Least 1 Dose of Study Drug|Period 4||14
9048234|NCT03465436|10107762|FG000|COMPLETED|Period 4||13
9048235|NCT03465436|10107763|FG001|COMPLETED|Period 4||12
9048236|NCT03465436|10107764|FG002|COMPLETED|Period 4||12
9048237|NCT03465436|10107765|FG003|COMPLETED|Period 4||14
9048238|NCT03465436|10107762|FG000|NOT COMPLETED|Period 4||0
9048239|NCT03465436|10107763|FG001|NOT COMPLETED|Period 4||0
9048240|NCT03465436|10107764|FG002|NOT COMPLETED|Period 4||1
9048241|NCT03465436|10107765|FG003|NOT COMPLETED|Period 4||0
9048242|NCT03465709|10107777|FG000|STARTED|Overall Study||17
9048243|NCT03465709|10107777|FG000|COMPLETED|Overall Study||0
9048244|NCT03465709|10107777|FG000|NOT COMPLETED|Overall Study||17
9048245|NCT03465722|10107785|FG000|STARTED|End of Treatment||240
9048246|NCT03465722|10107786|FG001|STARTED|End of Treatment||236
9048247|NCT03465722|10107785|FG000|COMPLETED|End of Treatment||0
9048248|NCT03465722|10107786|FG001|COMPLETED|End of Treatment||0
9048249|NCT03465722|10107785|FG000|NOT COMPLETED|End of Treatment||240
9048250|NCT03465722|10107786|FG001|NOT COMPLETED|End of Treatment||236
9048251|NCT03465722|10107785|FG000|STARTED|End of Study||240
9048252|NCT03465722|10107786|FG001|STARTED|End of Study||236
9048253|NCT03465722|10107785|FG000|COMPLETED|End of Study||0
9048254|NCT03465722|10107786|FG001|COMPLETED|End of Study||0
9048255|NCT03465722|10107785|FG000|NOT COMPLETED|End of Study||240
9048256|NCT03465722|10107786|FG001|NOT COMPLETED|End of Study||236
9048257|NCT03465878|10107794|FG000|STARTED|Period 1-Part A First Intervention Day 1||21
9048258|NCT03465878|10107795|FG001|STARTED|Period 1-Part A First Intervention Day 1||21
9048259|NCT03465878|10107796|FG002|STARTED|Period 1-Part A First Intervention Day 1||0
9048260|NCT03465878|10107797|FG003|STARTED|Period 1-Part A First Intervention Day 1||0
9048261|NCT03465878|10107794|FG000|Received at Least 1 Dose of Study Drug|Period 1-Part A First Intervention Day 1||21
9048262|NCT03465878|10107795|FG001|Received at Least 1 Dose of Study Drug|Period 1-Part A First Intervention Day 1||21
9048263|NCT03465878|10107796|FG002|Received at Least 1 Dose of Study Drug|Period 1-Part A First Intervention Day 1||0
9048264|NCT03465878|10107797|FG003|Received at Least 1 Dose of Study Drug|Period 1-Part A First Intervention Day 1||0
9048265|NCT03465878|10107794|FG000|Children (2-11 Years)|Period 1-Part A First Intervention Day 1||7
9048266|NCT03465878|10107795|FG001|Children (2-11 Years)|Period 1-Part A First Intervention Day 1||6
9048267|NCT03465878|10107796|FG002|Children (2-11 Years)|Period 1-Part A First Intervention Day 1||0
9048268|NCT03465878|10107797|FG003|Children (2-11 Years)|Period 1-Part A First Intervention Day 1||0
9048269|NCT03465878|10107794|FG000|Adolescents (12-17 Years)|Period 1-Part A First Intervention Day 1||7
9048270|NCT03465878|10107795|FG001|Adolescents (12-17 Years)|Period 1-Part A First Intervention Day 1||7
9048271|NCT03465878|10107796|FG002|Adolescents (12-17 Years)|Period 1-Part A First Intervention Day 1||0
9048272|NCT03465878|10107797|FG003|Adolescents (12-17 Years)|Period 1-Part A First Intervention Day 1||0
9048273|NCT03465878|10107794|FG000|Adults (18-64 Years)|Period 1-Part A First Intervention Day 1||7
9048274|NCT03465878|10107795|FG001|Adults (18-64 Years)|Period 1-Part A First Intervention Day 1||8
9048275|NCT03465878|10107796|FG002|Adults (18-64 Years)|Period 1-Part A First Intervention Day 1||0
9048276|NCT03465878|10107797|FG003|Adults (18-64 Years)|Period 1-Part A First Intervention Day 1||0
9048277|NCT03465878|10107794|FG000|COMPLETED|Period 1-Part A First Intervention Day 1||21
9048278|NCT03465878|10107795|FG001|COMPLETED|Period 1-Part A First Intervention Day 1||20
9048279|NCT03465878|10107796|FG002|COMPLETED|Period 1-Part A First Intervention Day 1||0
9048280|NCT03465878|10107797|FG003|COMPLETED|Period 1-Part A First Intervention Day 1||0
9048281|NCT03465878|10107794|FG000|NOT COMPLETED|Period 1-Part A First Intervention Day 1||0
9048282|NCT03465878|10107795|FG001|NOT COMPLETED|Period 1-Part A First Intervention Day 1||1
9048283|NCT03465878|10107796|FG002|NOT COMPLETED|Period 1-Part A First Intervention Day 1||0
9048284|NCT03465878|10107797|FG003|NOT COMPLETED|Period 1-Part A First Intervention Day 1||0
9048285|NCT03465878|10107794|FG000|STARTED|Period2-Part A Second Intervention Day 1||21
9048286|NCT03465878|10107795|FG001|STARTED|Period2-Part A Second Intervention Day 1||20
9048287|NCT03465878|10107796|FG002|STARTED|Period2-Part A Second Intervention Day 1||0
9048288|NCT03465878|10107797|FG003|STARTED|Period2-Part A Second Intervention Day 1||0
9048289|NCT03465878|10107794|FG000|Children (2-11 Years)|Period2-Part A Second Intervention Day 1||7
9048290|NCT03465878|10107795|FG001|Children (2-11 Years)|Period2-Part A Second Intervention Day 1||6
9048291|NCT03465878|10107796|FG002|Children (2-11 Years)|Period2-Part A Second Intervention Day 1||0
9048292|NCT03465878|10107797|FG003|Children (2-11 Years)|Period2-Part A Second Intervention Day 1||0
9048293|NCT03465878|10107794|FG000|Adolescents (12-17 Years)|Period2-Part A Second Intervention Day 1||7
9048294|NCT03465878|10107795|FG001|Adolescents (12-17 Years)|Period2-Part A Second Intervention Day 1||7
9048295|NCT03465878|10107796|FG002|Adolescents (12-17 Years)|Period2-Part A Second Intervention Day 1||0
9048296|NCT03465878|10107797|FG003|Adolescents (12-17 Years)|Period2-Part A Second Intervention Day 1||0
9048297|NCT03465878|10107794|FG000|Adults (18-64 Years)|Period2-Part A Second Intervention Day 1||7
9048298|NCT03465878|10107795|FG001|Adults (18-64 Years)|Period2-Part A Second Intervention Day 1||7
9048299|NCT03465878|10107796|FG002|Adults (18-64 Years)|Period2-Part A Second Intervention Day 1||0
9048300|NCT03465878|10107797|FG003|Adults (18-64 Years)|Period2-Part A Second Intervention Day 1||0
9048301|NCT03465878|10107794|FG000|COMPLETED|Period2-Part A Second Intervention Day 1||21
9048302|NCT03465878|10107795|FG001|COMPLETED|Period2-Part A Second Intervention Day 1||20
9048303|NCT03465878|10107796|FG002|COMPLETED|Period2-Part A Second Intervention Day 1||0
9048304|NCT03465878|10107797|FG003|COMPLETED|Period2-Part A Second Intervention Day 1||0
9048305|NCT03465878|10107794|FG000|NOT COMPLETED|Period2-Part A Second Intervention Day 1||0
9048306|NCT03465878|10107795|FG001|NOT COMPLETED|Period2-Part A Second Intervention Day 1||0
9048307|NCT03465878|10107796|FG002|NOT COMPLETED|Period2-Part A Second Intervention Day 1||0
9048308|NCT03465878|10107797|FG003|NOT COMPLETED|Period2-Part A Second Intervention Day 1||0
9048309|NCT03465878|10107794|FG000|STARTED|Period 1-Part B First Intervention Day 1|This period is for Part B group.|0
9048310|NCT03465878|10107795|FG001|STARTED|Period 1-Part B First Intervention Day 1|This period is for Part B group.|0
9048311|NCT03465878|10107796|FG002|STARTED|Period 1-Part B First Intervention Day 1|25 pts from Part A were re-randomized to Part B, 14 new pts were randomized in Part B.|20
9048312|NCT03465878|10107797|FG003|STARTED|Period 1-Part B First Intervention Day 1|25 pts from Part A were re-randomized to Part B, 14 new pts were randomized in Part B.|19
9048313|NCT03465878|10107794|FG000|Received at Least 1 Dose of Study Drug|Period 1-Part B First Intervention Day 1||0
9048314|NCT03465878|10107795|FG001|Received at Least 1 Dose of Study Drug|Period 1-Part B First Intervention Day 1||0
9048315|NCT03465878|10107796|FG002|Received at Least 1 Dose of Study Drug|Period 1-Part B First Intervention Day 1||20
9048316|NCT03465878|10107797|FG003|Received at Least 1 Dose of Study Drug|Period 1-Part B First Intervention Day 1||17
9048317|NCT03465878|10107794|FG000|Children (2-11 Years)|Period 1-Part B First Intervention Day 1||0
9048318|NCT03465878|10107795|FG001|Children (2-11 Years)|Period 1-Part B First Intervention Day 1||0
9048319|NCT03465878|10107796|FG002|Children (2-11 Years)|Period 1-Part B First Intervention Day 1||6
9048320|NCT03465878|10107797|FG003|Children (2-11 Years)|Period 1-Part B First Intervention Day 1||6
9048321|NCT03465878|10107794|FG000|Adolescents (12-17 Years)|Period 1-Part B First Intervention Day 1||0
9048322|NCT03465878|10107795|FG001|Adolescents (12-17 Years)|Period 1-Part B First Intervention Day 1||0
9048323|NCT03465878|10107796|FG002|Adolescents (12-17 Years)|Period 1-Part B First Intervention Day 1||7
9048324|NCT03465878|10107797|FG003|Adolescents (12-17 Years)|Period 1-Part B First Intervention Day 1||6
9048325|NCT03465878|10107794|FG000|Adults (18-64 Years)|Period 1-Part B First Intervention Day 1||0
9048326|NCT03465878|10107795|FG001|Adults (18-64 Years)|Period 1-Part B First Intervention Day 1||0
9048327|NCT03465878|10107796|FG002|Adults (18-64 Years)|Period 1-Part B First Intervention Day 1||7
9048328|NCT03465878|10107797|FG003|Adults (18-64 Years)|Period 1-Part B First Intervention Day 1||5
9048329|NCT03465878|10107794|FG000|COMPLETED|Period 1-Part B First Intervention Day 1||0
9048330|NCT03465878|10107795|FG001|COMPLETED|Period 1-Part B First Intervention Day 1||0
9048331|NCT03465878|10107796|FG002|COMPLETED|Period 1-Part B First Intervention Day 1||20
9048332|NCT03465878|10107797|FG003|COMPLETED|Period 1-Part B First Intervention Day 1||17
9048333|NCT03465878|10107794|FG000|NOT COMPLETED|Period 1-Part B First Intervention Day 1||0
9048334|NCT03465878|10107795|FG001|NOT COMPLETED|Period 1-Part B First Intervention Day 1||0
9048335|NCT03465878|10107796|FG002|NOT COMPLETED|Period 1-Part B First Intervention Day 1||0
9048336|NCT03465878|10107797|FG003|NOT COMPLETED|Period 1-Part B First Intervention Day 1||2
9048337|NCT03465878|10107794|FG000|STARTED|Period2-Part B Second Intervention Day 1||0
9048338|NCT03465878|10107795|FG001|STARTED|Period2-Part B Second Intervention Day 1||0
9048339|NCT03465878|10107796|FG002|STARTED|Period2-Part B Second Intervention Day 1||20
9048340|NCT03465878|10107797|FG003|STARTED|Period2-Part B Second Intervention Day 1||17
9048341|NCT03465878|10107794|FG000|Children (2-11 Years)|Period2-Part B Second Intervention Day 1||0
9048342|NCT03465878|10107795|FG001|Children (2-11 Years)|Period2-Part B Second Intervention Day 1||0
9048343|NCT03465878|10107796|FG002|Children (2-11 Years)|Period2-Part B Second Intervention Day 1||6
9048344|NCT03465878|10107797|FG003|Children (2-11 Years)|Period2-Part B Second Intervention Day 1||6
9048345|NCT03465878|10107794|FG000|Adolescents (12-17 Years)|Period2-Part B Second Intervention Day 1||0
9048346|NCT03465878|10107795|FG001|Adolescents (12-17 Years)|Period2-Part B Second Intervention Day 1||0
9048347|NCT03465878|10107796|FG002|Adolescents (12-17 Years)|Period2-Part B Second Intervention Day 1||7
9048348|NCT03465878|10107797|FG003|Adolescents (12-17 Years)|Period2-Part B Second Intervention Day 1||6
9048349|NCT03465878|10107794|FG000|Adults (18-64 Years)|Period2-Part B Second Intervention Day 1||0
9048350|NCT03465878|10107795|FG001|Adults (18-64 Years)|Period2-Part B Second Intervention Day 1||0
9048351|NCT03465878|10107796|FG002|Adults (18-64 Years)|Period2-Part B Second Intervention Day 1||7
9048352|NCT03465878|10107797|FG003|Adults (18-64 Years)|Period2-Part B Second Intervention Day 1||5
9048353|NCT03465878|10107794|FG000|COMPLETED|Period2-Part B Second Intervention Day 1||0
9048354|NCT03465878|10107795|FG001|COMPLETED|Period2-Part B Second Intervention Day 1||0
9048355|NCT03465878|10107796|FG002|COMPLETED|Period2-Part B Second Intervention Day 1||20
9048356|NCT03465878|10107797|FG003|COMPLETED|Period2-Part B Second Intervention Day 1||17
9048357|NCT03465878|10107794|FG000|NOT COMPLETED|Period2-Part B Second Intervention Day 1||0
9048358|NCT03465878|10107795|FG001|NOT COMPLETED|Period2-Part B Second Intervention Day 1||0
9048359|NCT03465878|10107796|FG002|NOT COMPLETED|Period2-Part B Second Intervention Day 1||0
9048360|NCT03465878|10107797|FG003|NOT COMPLETED|Period2-Part B Second Intervention Day 1||0
9048361|NCT03465904|10107825|FG000|STARTED|Overall Study||298
9048362|NCT03465904|10107826|FG001|STARTED|Overall Study||303
9048363|NCT03465904|10107825|FG000|COMPLETED|Overall Study||209
9048364|NCT03465904|10107826|FG001|COMPLETED|Overall Study||237
9048365|NCT03465904|10107825|FG000|NOT COMPLETED|Overall Study||89
9048366|NCT03465904|10107826|FG001|NOT COMPLETED|Overall Study||66
9048367|NCT03466047|10107832|FG000|STARTED|Protein Stomach (1day)|The same 8 patients were studied in all interventions|8
9048368|NCT03466047|10107832|FG000|COMPLETED|Protein Stomach (1day)|The same 8 patients were studied in all interventions|8
9048369|NCT03466047|10107832|FG000|NOT COMPLETED|Protein Stomach (1day)||0
9048370|NCT03466047|10107832|FG000|STARTED|Protein Small Intestine (1 Day)||8
9048371|NCT03466047|10107832|FG000|COMPLETED|Protein Small Intestine (1 Day)||8
9048372|NCT03466047|10107832|FG000|NOT COMPLETED|Protein Small Intestine (1 Day)||0
9048373|NCT03466047|10107832|FG000|STARTED|CHO Stomach (1 Day)||8
8703453|NCT00923091|9749176|FG000|COMPLETED|Period V (Double -Blind)||0
8703454|NCT00923091|9749177|FG001|COMPLETED|Period V (Double -Blind)||0
8703455|NCT00923091|9749178|FG002|COMPLETED|Period V (Double -Blind)||0
8703456|NCT00923091|9749179|FG003|COMPLETED|Period V (Double -Blind)||0
8703457|NCT00923091|9749180|FG004|COMPLETED|Period V (Double -Blind)||0
8703458|NCT00923091|9749181|FG005|COMPLETED|Period V (Double -Blind)||0
8703459|NCT00923091|9749182|FG006|COMPLETED|Period V (Double -Blind)||0
8703460|NCT00923091|9749183|FG007|COMPLETED|Period V (Double -Blind)||0
8703461|NCT00923091|9749184|FG008|COMPLETED|Period V (Double -Blind)||134
8703462|NCT00923091|9749185|FG009|COMPLETED|Period V (Double -Blind)||119
9048374|NCT03466047|10107832|FG000|COMPLETED|CHO Stomach (1 Day)||8
9048375|NCT03466047|10107832|FG000|NOT COMPLETED|CHO Stomach (1 Day)||0
9048376|NCT03466047|10107832|FG000|STARTED|CHO Small Intestine (1 Day)||8
9048377|NCT03466047|10107832|FG000|COMPLETED|CHO Small Intestine (1 Day)||8
9048378|NCT03466047|10107832|FG000|NOT COMPLETED|CHO Small Intestine (1 Day)||0
9048379|NCT03466047|10107832|FG000|STARTED|Fat Stomach (1 Day)||8
9048380|NCT03466047|10107832|FG000|COMPLETED|Fat Stomach (1 Day)||8
9048381|NCT03466047|10107832|FG000|NOT COMPLETED|Fat Stomach (1 Day)||0
9048382|NCT03466047|10107832|FG000|STARTED|Fat Small Intestine (1 Day)||8
9048383|NCT03466047|10107832|FG000|COMPLETED|Fat Small Intestine (1 Day)||8
9048384|NCT03466047|10107832|FG000|NOT COMPLETED|Fat Small Intestine (1 Day)||0
9048385|NCT03466060|10107861|FG000|STARTED|Period 1||19
9048386|NCT03466060|10107862|FG001|STARTED|Period 1||18
9048387|NCT03466060|10107863|FG002|STARTED|Period 1||20
9048388|NCT03466060|10107864|FG003|STARTED|Period 1||18
9048389|NCT03466060|10107865|FG004|STARTED|Period 1||20
9048390|NCT03466060|10107866|FG005|STARTED|Period 1||18
9048391|NCT03466060|10107861|FG000|COMPLETED|Period 1||19
9048392|NCT03466060|10107862|FG001|COMPLETED|Period 1||16
9048393|NCT03466060|10107863|FG002|COMPLETED|Period 1||17
9048394|NCT03466060|10107864|FG003|COMPLETED|Period 1||17
9048395|NCT03466060|10107865|FG004|COMPLETED|Period 1||20
9048396|NCT03466060|10107866|FG005|COMPLETED|Period 1||18
9048397|NCT03466060|10107861|FG000|NOT COMPLETED|Period 1||0
9048398|NCT03466060|10107862|FG001|NOT COMPLETED|Period 1||2
9048399|NCT03466060|10107863|FG002|NOT COMPLETED|Period 1||3
9048400|NCT03466060|10107864|FG003|NOT COMPLETED|Period 1||1
9048401|NCT03466060|10107865|FG004|NOT COMPLETED|Period 1||0
9048402|NCT03466060|10107866|FG005|NOT COMPLETED|Period 1||0
9048403|NCT03466060|10107861|FG000|STARTED|Period 2||19
9048404|NCT03466060|10107862|FG001|STARTED|Period 2||16
9048405|NCT03466060|10107863|FG002|STARTED|Period 2||17
9048406|NCT03466060|10107864|FG003|STARTED|Period 2||17
9048407|NCT03466060|10107865|FG004|STARTED|Period 2||20
9048408|NCT03466060|10107866|FG005|STARTED|Period 2||18
9048409|NCT03466060|10107861|FG000|COMPLETED|Period 2||19
9048410|NCT03466060|10107862|FG001|COMPLETED|Period 2||16
9048411|NCT03466060|10107863|FG002|COMPLETED|Period 2||16
9048412|NCT03466060|10107864|FG003|COMPLETED|Period 2||17
9048413|NCT03466060|10107865|FG004|COMPLETED|Period 2||20
9048414|NCT03466060|10107866|FG005|COMPLETED|Period 2||18
9048415|NCT03466060|10107861|FG000|NOT COMPLETED|Period 2||0
9048416|NCT03466060|10107862|FG001|NOT COMPLETED|Period 2||0
9048417|NCT03466060|10107863|FG002|NOT COMPLETED|Period 2||1
9048418|NCT03466060|10107864|FG003|NOT COMPLETED|Period 2||0
9048419|NCT03466060|10107865|FG004|NOT COMPLETED|Period 2||0
9048420|NCT03466060|10107866|FG005|NOT COMPLETED|Period 2||0
9048421|NCT03466073|10107886|FG000|STARTED|Overall Study||6
9048422|NCT03466073|10107887|FG001|STARTED|Overall Study||2
9048423|NCT03466073|10107888|FG002|STARTED|Overall Study||6
9048424|NCT03466073|10107889|FG003|STARTED|Overall Study||6
9048425|NCT03466073|10107890|FG004|STARTED|Overall Study||6
9048426|NCT03466073|10107891|FG005|STARTED|Overall Study||7
9048427|NCT03466073|10107886|FG000|COMPLETED|Overall Study||5
9048428|NCT03466073|10107887|FG001|COMPLETED|Overall Study||2
9048429|NCT03466073|10107888|FG002|COMPLETED|Overall Study||6
9048430|NCT03466073|10107889|FG003|COMPLETED|Overall Study||6
9048431|NCT03466073|10107890|FG004|COMPLETED|Overall Study||6
9048432|NCT03466073|10107891|FG005|COMPLETED|Overall Study||6
9048433|NCT03466073|10107886|FG000|NOT COMPLETED|Overall Study||1
9048434|NCT03466073|10107887|FG001|NOT COMPLETED|Overall Study||0
9048435|NCT03466073|10107888|FG002|NOT COMPLETED|Overall Study||0
9048436|NCT03466073|10107889|FG003|NOT COMPLETED|Overall Study||0
9048437|NCT03466073|10107890|FG004|NOT COMPLETED|Overall Study||0
9048438|NCT03466073|10107891|FG005|NOT COMPLETED|Overall Study||1
9048439|NCT03466086|10107912|FG000|STARTED|Period 1||28
9048440|NCT03466086|10107913|FG001|STARTED|Period 1||27
9048441|NCT03466086|10107912|FG000|COMPLETED|Period 1||26
9048442|NCT03466086|10107913|FG001|COMPLETED|Period 1||27
9048443|NCT03466086|10107912|FG000|NOT COMPLETED|Period 1||2
9048444|NCT03466086|10107913|FG001|NOT COMPLETED|Period 1||0
9048445|NCT03466086|10107912|FG000|STARTED|Period 2||26
9048446|NCT03466086|10107913|FG001|STARTED|Period 2||27
9048447|NCT03466086|10107912|FG000|COMPLETED|Period 2||26
9048448|NCT03466086|10107913|FG001|COMPLETED|Period 2||27
9048449|NCT03466086|10107912|FG000|NOT COMPLETED|Period 2||0
9048450|NCT03466086|10107913|FG001|NOT COMPLETED|Period 2||0
9048451|NCT03466099|10107922|FG000|STARTED|Overall Study||41
9048452|NCT03466099|10107923|FG001|STARTED|Overall Study||44
9048453|NCT03466099|10107924|FG002|STARTED|Overall Study|One study subject consented and was randomized, but withdrew prior to receiving any study treatments|45
9048454|NCT03466099|10107922|FG000|Treated|Overall Study||41
9048455|NCT03466099|10107923|FG001|Treated|Overall Study||44
9048456|NCT03466099|10107924|FG002|Treated|Overall Study||44
9048457|NCT03466099|10107922|FG000|COMPLETED|Overall Study||24
9048458|NCT03466099|10107923|FG001|COMPLETED|Overall Study||30
9048459|NCT03466099|10107924|FG002|COMPLETED|Overall Study||28
9048460|NCT03466099|10107922|FG000|NOT COMPLETED|Overall Study||17
9048461|NCT03466099|10107923|FG001|NOT COMPLETED|Overall Study||14
9048462|NCT03466099|10107924|FG002|NOT COMPLETED|Overall Study||17
9048463|NCT03466918|10107932|FG000|STARTED|Overall Study||58
9048464|NCT03466918|10107932|FG000|Analysis Population|Overall Study||50
9048465|NCT03466918|10107932|FG000|COMPLETED|Overall Study|All 58 patients completed the 30-day primary endpoint.|58
9048466|NCT03466918|10107932|FG000|NOT COMPLETED|Overall Study||0
9048467|NCT03467048|10107939|FG000|STARTED|Overall Study||66
9048468|NCT03467048|10107940|FG001|STARTED|Overall Study||64
9048469|NCT03467048|10107939|FG000|COMPLETED|Overall Study||66
9048470|NCT03467048|10107940|FG001|COMPLETED|Overall Study||63
9048471|NCT03467048|10107939|FG000|NOT COMPLETED|Overall Study||0
9048472|NCT03467048|10107940|FG001|NOT COMPLETED|Overall Study||1
9048473|NCT03467217|10107948|FG000|STARTED|Overall Study||43
9048474|NCT03467217|10107949|FG001|STARTED|Overall Study||40
9048475|NCT03467217|10107948|FG000|COMPLETED|Overall Study||33
9048476|NCT03467217|10107949|FG001|COMPLETED|Overall Study||34
9048477|NCT03467217|10107948|FG000|NOT COMPLETED|Overall Study||10
9048478|NCT03467217|10107949|FG001|NOT COMPLETED|Overall Study||6
9048479|NCT03467412|10107955|FG000|STARTED|Overall Study|Each unique subject will appear in 2 arms. Total sum of subjects is therefore120/2=60.|25
9048480|NCT03467412|10107956|FG001|STARTED|Overall Study|Each unique subject will appear in 2 arms. Total sum of subjects is therefore120/2=60.|25
9048481|NCT03467412|10107957|FG002|STARTED|Overall Study|Each unique subject will appear in 2 arms. Total sum of subjects is therefore120/2=60.|25
9048482|NCT03467412|10107958|FG003|STARTED|Overall Study|Each unique subject will appear in 2 arms. Total sum of subjects is therefore120/2=60.|25
9048483|NCT03467412|10107959|FG004|STARTED|Overall Study|Each unique subject will appear in 2 arms. Total sum of subjects is therefore120/2=60.|20
9048484|NCT03467412|10107955|FG000|COMPLETED|Overall Study||22
9048485|NCT03467412|10107956|FG001|COMPLETED|Overall Study||24
9048486|NCT03467412|10107957|FG002|COMPLETED|Overall Study||20
9048487|NCT03467412|10107958|FG003|COMPLETED|Overall Study||23
9048488|NCT03467412|10107959|FG004|COMPLETED|Overall Study||17
9048489|NCT03467412|10107955|FG000|NOT COMPLETED|Overall Study||3
9048490|NCT03467412|10107956|FG001|NOT COMPLETED|Overall Study||1
9048491|NCT03467412|10107957|FG002|NOT COMPLETED|Overall Study||5
9048492|NCT03467412|10107958|FG003|NOT COMPLETED|Overall Study||2
9048493|NCT03467412|10107959|FG004|NOT COMPLETED|Overall Study||3
9048494|NCT03467425|10107980|FG000|STARTED|Overall Study||1545
9048495|NCT03467425|10107981|FG001|STARTED|Overall Study||1547
9048496|NCT03467425|10107980|FG000|Randomized But Did Not Start IP|Overall Study||1
9048497|NCT03467425|10107981|FG001|Randomized But Did Not Start IP|Overall Study||0
9048498|NCT03467425|10107980|FG000|Completed IP|Overall Study||1256
9048499|NCT03467425|10107981|FG001|Completed IP|Overall Study||1359
9048500|NCT03467425|10107980|FG000|Not Completed IP|Overall Study||288
9048501|NCT03467425|10107981|FG001|Not Completed IP|Overall Study||188
9048502|NCT03467425|10107980|FG000|Withdrew IP (WIP): Lost to Follow-up|Overall Study||15
9048503|NCT03467425|10107981|FG001|Withdrew IP (WIP): Lost to Follow-up|Overall Study||24
9048504|NCT03467425|10107980|FG000|WIP: Protocol Deviation|Overall Study||0
9048505|NCT03467425|10107981|FG001|WIP: Protocol Deviation|Overall Study||2
9048506|NCT03467425|10107980|FG000|WIP: Adverse Event|Overall Study||112
9048507|NCT03467425|10107981|FG001|WIP: Adverse Event|Overall Study||29
9048508|NCT03467425|10107980|FG000|WIP: Lack of Efficacy|Overall Study||56
9048509|NCT03467425|10107981|FG001|WIP: Lack of Efficacy|Overall Study||28
9048510|NCT03467425|10107980|FG000|WIP: Physician Decision|Overall Study||14
8703463|NCT00923091|9749186|FG010|COMPLETED|Period V (Double -Blind)||193
8703464|NCT00923091|9749187|FG011|COMPLETED|Period V (Double -Blind)||151
8703465|NCT00923091|9749188|FG012|COMPLETED|Period V (Double -Blind)||73
8703466|NCT00923091|9749176|FG000|NOT COMPLETED|Period V (Double -Blind)||0
8703467|NCT00923091|9749177|FG001|NOT COMPLETED|Period V (Double -Blind)||0
8703468|NCT00923091|9749178|FG002|NOT COMPLETED|Period V (Double -Blind)||0
8703469|NCT00923091|9749179|FG003|NOT COMPLETED|Period V (Double -Blind)||0
8703470|NCT00923091|9749180|FG004|NOT COMPLETED|Period V (Double -Blind)||0
9048511|NCT03467425|10107981|FG001|WIP: Physician Decision|Overall Study||27
9048512|NCT03467425|10107980|FG000|WIP: Withdrawal by Participant|Overall Study||91
9048513|NCT03467425|10107981|FG001|WIP: Withdrawal by Participant|Overall Study||78
9048514|NCT03467425|10107980|FG000|COMPLETED|Overall Study||1498
9048515|NCT03467425|10107981|FG001|COMPLETED|Overall Study||1493
9048516|NCT03467425|10107980|FG000|NOT COMPLETED|Overall Study||47
9048517|NCT03467425|10107981|FG001|NOT COMPLETED|Overall Study||54
9048518|NCT03467477|10107987|FG000|STARTED|Overall Study||161
9048519|NCT03467477|10107987|FG000|COMPLETED|Overall Study||161
9048520|NCT03467477|10107987|FG000|NOT COMPLETED|Overall Study||0
9048521|NCT03467685|10107996|FG000|STARTED|Overall Study||52
9048522|NCT03467685|10107997|FG001|STARTED|Overall Study||49
9048523|NCT03467685|10107996|FG000|COMPLETED|Overall Study||52
9048524|NCT03467685|10107997|FG001|COMPLETED|Overall Study||49
9048525|NCT03467685|10107996|FG000|NOT COMPLETED|Overall Study||0
9048526|NCT03467685|10107997|FG001|NOT COMPLETED|Overall Study||0
9048527|NCT03467763|10108003|FG000|STARTED|Overall Study||13
9048528|NCT03467763|10108003|FG000|Weeks 1-2|Overall Study||13
9048529|NCT03467763|10108003|FG000|Weeks 3-4|Overall Study||10
9048530|NCT03467763|10108003|FG000|Weeks 5-6|Overall Study||8
9048531|NCT03467763|10108003|FG000|Weeks 7-8|Overall Study||7
9048532|NCT03467763|10108003|FG000|Weeks 9 - 10|Overall Study||6
9048533|NCT03467763|10108003|FG000|Week 11-12|Overall Study||6
9048534|NCT03467763|10108003|FG000|Weeks 13-14|Overall Study||2
9048535|NCT03467763|10108003|FG000|Weeks 15-16|Overall Study||2
9048536|NCT03467763|10108003|FG000|COMPLETED|Overall Study||10
9048537|NCT03467763|10108003|FG000|NOT COMPLETED|Overall Study||3
9048538|NCT03467945|10108013|FG000|STARTED|Treatment Period 1||10
9048539|NCT03467945|10108014|FG001|STARTED|Treatment Period 1||10
9048540|NCT03467945|10108015|FG002|STARTED|Treatment Period 1||10
8703471|NCT00923091|9749181|FG005|NOT COMPLETED|Period V (Double -Blind)||0
8703472|NCT00923091|9749182|FG006|NOT COMPLETED|Period V (Double -Blind)||0
9048541|NCT03467945|10108016|FG003|STARTED|Treatment Period 1||10
9048542|NCT03467945|10108013|FG000|COMPLETED|Treatment Period 1||10
9048543|NCT03467945|10108014|FG001|COMPLETED|Treatment Period 1||10
9048544|NCT03467945|10108015|FG002|COMPLETED|Treatment Period 1||10
9048545|NCT03467945|10108016|FG003|COMPLETED|Treatment Period 1||10
9048546|NCT03467945|10108013|FG000|NOT COMPLETED|Treatment Period 1||0
9048547|NCT03467945|10108014|FG001|NOT COMPLETED|Treatment Period 1||0
9048548|NCT03467945|10108015|FG002|NOT COMPLETED|Treatment Period 1||0
9048549|NCT03467945|10108016|FG003|NOT COMPLETED|Treatment Period 1||0
9048550|NCT03467945|10108013|FG000|STARTED|Treatment Period 2||10
9048551|NCT03467945|10108014|FG001|STARTED|Treatment Period 2||10
9048552|NCT03467945|10108015|FG002|STARTED|Treatment Period 2||10
9048553|NCT03467945|10108016|FG003|STARTED|Treatment Period 2||10
9048554|NCT03467945|10108013|FG000|COMPLETED|Treatment Period 2||10
9048555|NCT03467945|10108014|FG001|COMPLETED|Treatment Period 2||9
9048556|NCT03467945|10108015|FG002|COMPLETED|Treatment Period 2||10
9048557|NCT03467945|10108016|FG003|COMPLETED|Treatment Period 2||10
9048558|NCT03467945|10108013|FG000|NOT COMPLETED|Treatment Period 2||0
9048559|NCT03467945|10108014|FG001|NOT COMPLETED|Treatment Period 2||1
9048560|NCT03467945|10108015|FG002|NOT COMPLETED|Treatment Period 2||0
9048561|NCT03467945|10108016|FG003|NOT COMPLETED|Treatment Period 2||0
9048562|NCT03467945|10108013|FG000|STARTED|Treatment Period 3||10
9048563|NCT03467945|10108014|FG001|STARTED|Treatment Period 3||9
9048564|NCT03467945|10108015|FG002|STARTED|Treatment Period 3||10
9048565|NCT03467945|10108016|FG003|STARTED|Treatment Period 3||10
9048566|NCT03467945|10108013|FG000|COMPLETED|Treatment Period 3||9
9048567|NCT03467945|10108014|FG001|COMPLETED|Treatment Period 3||9
9048568|NCT03467945|10108015|FG002|COMPLETED|Treatment Period 3||8
9048569|NCT03467945|10108016|FG003|COMPLETED|Treatment Period 3||9
9048570|NCT03467945|10108013|FG000|NOT COMPLETED|Treatment Period 3||1
9048571|NCT03467945|10108014|FG001|NOT COMPLETED|Treatment Period 3||0
9048572|NCT03467945|10108015|FG002|NOT COMPLETED|Treatment Period 3||2
9048573|NCT03467945|10108016|FG003|NOT COMPLETED|Treatment Period 3||1
9048574|NCT03467945|10108013|FG000|STARTED|Treatment Period 4||9
9048575|NCT03467945|10108014|FG001|STARTED|Treatment Period 4||9
9048576|NCT03467945|10108015|FG002|STARTED|Treatment Period 4||8
9048577|NCT03467945|10108016|FG003|STARTED|Treatment Period 4||9
9048578|NCT03467945|10108013|FG000|COMPLETED|Treatment Period 4||9
9048579|NCT03467945|10108014|FG001|COMPLETED|Treatment Period 4||9
9048580|NCT03467945|10108015|FG002|COMPLETED|Treatment Period 4||8
9048581|NCT03467945|10108016|FG003|COMPLETED|Treatment Period 4||9
9048582|NCT03467945|10108013|FG000|NOT COMPLETED|Treatment Period 4||0
9048583|NCT03467945|10108014|FG001|NOT COMPLETED|Treatment Period 4||0
9048584|NCT03467945|10108015|FG002|NOT COMPLETED|Treatment Period 4||0
9048585|NCT03467945|10108016|FG003|NOT COMPLETED|Treatment Period 4||0
9048586|NCT03467971|10108029|FG000|STARTED|Treatment Period 1||10
9048587|NCT03467971|10108030|FG001|STARTED|Treatment Period 1||11
9048588|NCT03467971|10108029|FG000|COMPLETED|Treatment Period 1||10
9048589|NCT03467971|10108030|FG001|COMPLETED|Treatment Period 1||11
9048590|NCT03467971|10108029|FG000|NOT COMPLETED|Treatment Period 1||0
9048591|NCT03467971|10108030|FG001|NOT COMPLETED|Treatment Period 1||0
9048592|NCT03467971|10108029|FG000|STARTED|Treatment Period 2||10
9048593|NCT03467971|10108030|FG001|STARTED|Treatment Period 2||11
9048594|NCT03467971|10108029|FG000|COMPLETED|Treatment Period 2||10
9048595|NCT03467971|10108030|FG001|COMPLETED|Treatment Period 2||10
9048596|NCT03467971|10108029|FG000|NOT COMPLETED|Treatment Period 2||0
9048597|NCT03467971|10108030|FG001|NOT COMPLETED|Treatment Period 2||1
9048598|NCT03468075|10108037|FG000|STARTED|Overall Study||10
9048599|NCT03468075|10108037|FG000|COMPLETED|Overall Study||10
9048600|NCT03468075|10108037|FG000|NOT COMPLETED|Overall Study||0
9048601|NCT03468179|10108041|FG000|STARTED|Overall Study||10
9048602|NCT03468179|10108041|FG000|COMPLETED|Overall Study||10
9048603|NCT03468179|10108041|FG000|NOT COMPLETED|Overall Study||0
9048604|NCT03468543|10108048|FG000|STARTED|Overall Study||3
9048605|NCT03468543|10108048|FG000|COMPLETED|Overall Study||0
9048606|NCT03468543|10108048|FG000|NOT COMPLETED|Overall Study||3
9048607|NCT03468816|10108054|FG000|STARTED|Overall Study||2
9048608|NCT03468816|10108055|FG001|STARTED|Overall Study||3
9048609|NCT03468816|10108054|FG000|COMPLETED|Overall Study||2
9048610|NCT03468816|10108055|FG001|COMPLETED|Overall Study||3
9048611|NCT03468816|10108054|FG000|NOT COMPLETED|Overall Study||0
9048612|NCT03468816|10108055|FG001|NOT COMPLETED|Overall Study||0
9048613|NCT03468855|10108063|FG000|STARTED|Overall Study||34
9048614|NCT03468855|10108063|FG000|COMPLETED|Overall Study||23
9048615|NCT03468855|10108063|FG000|NOT COMPLETED|Overall Study||11
9048616|NCT03468920|10108069|FG000|STARTED|Overall Study||60
9048617|NCT03468920|10108070|FG001|STARTED|Overall Study||60
9048618|NCT03468920|10108069|FG000|COMPLETED|Overall Study||60
9048619|NCT03468920|10108070|FG001|COMPLETED|Overall Study||60
9048620|NCT03468920|10108069|FG000|NOT COMPLETED|Overall Study||0
9048621|NCT03468920|10108070|FG001|NOT COMPLETED|Overall Study||0
9048622|NCT03468933|10108078|FG000|STARTED|Overall Study||16
9048623|NCT03468933|10108079|FG001|STARTED|Overall Study||16
9048624|NCT03468933|10108078|FG000|COMPLETED|Overall Study||16
9048625|NCT03468933|10108079|FG001|COMPLETED|Overall Study||16
9048626|NCT03468933|10108078|FG000|NOT COMPLETED|Overall Study||0
9048627|NCT03468933|10108079|FG001|NOT COMPLETED|Overall Study||0
9048628|NCT03469336|10108085|FG000|STARTED|Overall Study||18
9048629|NCT03469336|10108085|FG000|COMPLETED|Overall Study||17
9048630|NCT03469336|10108085|FG000|NOT COMPLETED|Overall Study||1
9048631|NCT03469349|10108097|FG000|STARTED|Overall Study||182
9048632|NCT03469349|10108098|FG001|STARTED|Overall Study||184
9048633|NCT03469349|10108097|FG000|COMPLETED|Overall Study||177
9048634|NCT03469349|10108098|FG001|COMPLETED|Overall Study||174
9048635|NCT03469349|10108097|FG000|NOT COMPLETED|Overall Study||5
9048636|NCT03469349|10108098|FG001|NOT COMPLETED|Overall Study||10
8703473|NCT00923091|9749183|FG007|NOT COMPLETED|Period V (Double -Blind)||0
9048637|NCT03470012|10108104|FG000|STARTED|Overall Study||24
9048638|NCT03470012|10108104|FG000|COMPLETED|Overall Study||24
9048639|NCT03470012|10108104|FG000|NOT COMPLETED|Overall Study||0
9048640|NCT03470194|10108110|FG000|STARTED|Overall Study||49
9048641|NCT03470194|10108111|FG001|STARTED|Overall Study||57
9048642|NCT03470194|10108110|FG000|COMPLETED|Overall Study||38
9048643|NCT03470194|10108111|FG001|COMPLETED|Overall Study||40
9048644|NCT03470194|10108110|FG000|NOT COMPLETED|Overall Study||11
9048645|NCT03470194|10108111|FG001|NOT COMPLETED|Overall Study||17
9048646|NCT03470493|10108117|FG000|STARTED|Overall Study||130
9048647|NCT03470493|10108117|FG000|Met Primary Endpoint|Overall Study||80
9048648|NCT03470493|10108117|FG000|COMPLETED|Overall Study||130
9048649|NCT03470493|10108117|FG000|NOT COMPLETED|Overall Study||0
9048650|NCT03470545|10108123|FG000|STARTED|Overall Study||123
9048651|NCT03470545|10108124|FG001|STARTED|Overall Study||128
9048652|NCT03470545|10108123|FG000|COMPLETED|Overall Study||119
9048653|NCT03470545|10108124|FG001|COMPLETED|Overall Study||125
9048654|NCT03470545|10108123|FG000|NOT COMPLETED|Overall Study||4
9048655|NCT03470545|10108124|FG001|NOT COMPLETED|Overall Study||3
9048656|NCT03470740|10108133|FG000|STARTED|Overall Study||112
9048657|NCT03470740|10108134|FG001|STARTED|Overall Study||112
9048658|NCT03470740|10108133|FG000|COMPLETED|Overall Study||108
9048659|NCT03470740|10108134|FG001|COMPLETED|Overall Study||106
9048660|NCT03470740|10108133|FG000|NOT COMPLETED|Overall Study||4
9048661|NCT03470740|10108134|FG001|NOT COMPLETED|Overall Study||6
9048662|NCT03471065|10108141|FG000|STARTED|Overall Study||100
9048663|NCT03471065|10108141|FG000|COMPLETED|Overall Study||100
9048664|NCT03471065|10108141|FG000|NOT COMPLETED|Overall Study||0
9048665|NCT03471078|10108147|FG000|STARTED|Overall Study||82
9048666|NCT03471078|10108148|FG001|STARTED|Overall Study||40
9048667|NCT03471078|10108147|FG000|COMPLETED|Overall Study||61
8703474|NCT00923091|9749184|FG008|NOT COMPLETED|Period V (Double -Blind)||1
8703475|NCT00923091|9749185|FG009|NOT COMPLETED|Period V (Double -Blind)||0
8703476|NCT00923091|9749186|FG010|NOT COMPLETED|Period V (Double -Blind)||1
9048668|NCT03471078|10108148|FG001|COMPLETED|Overall Study||34
9048669|NCT03471078|10108147|FG000|NOT COMPLETED|Overall Study||21
9048670|NCT03471078|10108148|FG001|NOT COMPLETED|Overall Study||6
9048671|NCT03471832|10108154|FG000|STARTED|Overall Study||40
9048672|NCT03471832|10108155|FG001|STARTED|Overall Study||40
9048673|NCT03471832|10108154|FG000|COMPLETED|Overall Study||40
9048674|NCT03471832|10108155|FG001|COMPLETED|Overall Study||40
9048675|NCT03471832|10108154|FG000|NOT COMPLETED|Overall Study||0
9048676|NCT03471832|10108155|FG001|NOT COMPLETED|Overall Study||0
9048677|NCT03471871|10108165|FG000|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||6
9048678|NCT03471871|10108166|FG001|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||5
9048679|NCT03471871|10108167|FG002|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||6
9048680|NCT03471871|10108168|FG003|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||19
9048681|NCT03471871|10108169|FG004|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||20
9048682|NCT03471871|10108165|FG000|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||6
9048683|NCT03471871|10108166|FG001|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||5
9048684|NCT03471871|10108167|FG002|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||6
9048685|NCT03471871|10108168|FG003|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||18
9048686|NCT03471871|10108169|FG004|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||20
9048687|NCT03471871|10108165|FG000|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||6
9048688|NCT03471871|10108166|FG001|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||5
9048689|NCT03471871|10108167|FG002|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||5
9048690|NCT03471871|10108168|FG003|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||18
9048691|NCT03471871|10108169|FG004|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||19
9048692|NCT03471871|10108165|FG000|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||0
9048693|NCT03471871|10108166|FG001|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||0
9048694|NCT03471871|10108167|FG002|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||1
9048695|NCT03471871|10108168|FG003|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||1
9048696|NCT03471871|10108169|FG004|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||1
9048697|NCT03471871|10108165|FG000|STARTED|Washout Period 1 (14 Days)||6
9048698|NCT03471871|10108166|FG001|STARTED|Washout Period 1 (14 Days)||5
9048699|NCT03471871|10108167|FG002|STARTED|Washout Period 1 (14 Days)||5
9048700|NCT03471871|10108168|FG003|STARTED|Washout Period 1 (14 Days)||18
9048701|NCT03471871|10108169|FG004|STARTED|Washout Period 1 (14 Days)||19
9048702|NCT03471871|10108165|FG000|COMPLETED|Washout Period 1 (14 Days)||6
9048703|NCT03471871|10108166|FG001|COMPLETED|Washout Period 1 (14 Days)||5
9048704|NCT03471871|10108167|FG002|COMPLETED|Washout Period 1 (14 Days)||5
9048705|NCT03471871|10108168|FG003|COMPLETED|Washout Period 1 (14 Days)||18
9048706|NCT03471871|10108169|FG004|COMPLETED|Washout Period 1 (14 Days)||19
9048707|NCT03471871|10108165|FG000|NOT COMPLETED|Washout Period 1 (14 Days)||0
9048708|NCT03471871|10108166|FG001|NOT COMPLETED|Washout Period 1 (14 Days)||0
9048709|NCT03471871|10108167|FG002|NOT COMPLETED|Washout Period 1 (14 Days)||0
8703477|NCT00923091|9749187|FG011|NOT COMPLETED|Period V (Double -Blind)||0
9048710|NCT03471871|10108168|FG003|NOT COMPLETED|Washout Period 1 (14 Days)||0
9048711|NCT03471871|10108169|FG004|NOT COMPLETED|Washout Period 1 (14 Days)||0
9048712|NCT03471871|10108165|FG000|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||6
9048713|NCT03471871|10108166|FG001|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||5
9048714|NCT03471871|10108167|FG002|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||5
9048715|NCT03471871|10108168|FG003|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||18
9048716|NCT03471871|10108169|FG004|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||19
9048717|NCT03471871|10108165|FG000|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||6
9048718|NCT03471871|10108166|FG001|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||5
9048719|NCT03471871|10108167|FG002|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||5
9048720|NCT03471871|10108168|FG003|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||18
9048721|NCT03471871|10108169|FG004|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||18
9048722|NCT03471871|10108165|FG000|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||0
9048723|NCT03471871|10108166|FG001|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||0
9048724|NCT03471871|10108167|FG002|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||0
9048725|NCT03471871|10108168|FG003|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||0
9048726|NCT03471871|10108169|FG004|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||1
9048727|NCT03471871|10108165|FG000|STARTED|Washout Period 2 (14 Days)||6
9048728|NCT03471871|10108166|FG001|STARTED|Washout Period 2 (14 Days)||5
9048729|NCT03471871|10108167|FG002|STARTED|Washout Period 2 (14 Days)||5
9048730|NCT03471871|10108168|FG003|STARTED|Washout Period 2 (14 Days)|0=not applicable, as OSA cohort was treated till Treatment Period 2, then directly followed up.|0
9048731|NCT03471871|10108169|FG004|STARTED|Washout Period 2 (14 Days)|0=not applicable, as OSA cohort was treated till Treatment Period 2, then directly followed up.|0
9048732|NCT03471871|10108165|FG000|COMPLETED|Washout Period 2 (14 Days)||6
9048733|NCT03471871|10108166|FG001|COMPLETED|Washout Period 2 (14 Days)||5
9048734|NCT03471871|10108167|FG002|COMPLETED|Washout Period 2 (14 Days)||5
9048735|NCT03471871|10108168|FG003|COMPLETED|Washout Period 2 (14 Days)||0
9048736|NCT03471871|10108169|FG004|COMPLETED|Washout Period 2 (14 Days)||0
9048737|NCT03471871|10108165|FG000|NOT COMPLETED|Washout Period 2 (14 Days)||0
9048738|NCT03471871|10108166|FG001|NOT COMPLETED|Washout Period 2 (14 Days)||0
9048739|NCT03471871|10108167|FG002|NOT COMPLETED|Washout Period 2 (14 Days)||0
9048740|NCT03471871|10108168|FG003|NOT COMPLETED|Washout Period 2 (14 Days)||0
9048741|NCT03471871|10108169|FG004|NOT COMPLETED|Washout Period 2 (14 Days)||0
9048742|NCT03471871|10108165|FG000|STARTED|Treatment Period 3: ( HV:1 Day)||6
9048743|NCT03471871|10108166|FG001|STARTED|Treatment Period 3: ( HV:1 Day)||5
9048744|NCT03471871|10108167|FG002|STARTED|Treatment Period 3: ( HV:1 Day)||5
9048745|NCT03471871|10108168|FG003|STARTED|Treatment Period 3: ( HV:1 Day)||0
9048746|NCT03471871|10108169|FG004|STARTED|Treatment Period 3: ( HV:1 Day)||0
9048747|NCT03471871|10108165|FG000|COMPLETED|Treatment Period 3: ( HV:1 Day)||6
9048748|NCT03471871|10108166|FG001|COMPLETED|Treatment Period 3: ( HV:1 Day)||5
9048749|NCT03471871|10108167|FG002|COMPLETED|Treatment Period 3: ( HV:1 Day)||5
9048750|NCT03471871|10108168|FG003|COMPLETED|Treatment Period 3: ( HV:1 Day)||0
9048751|NCT03471871|10108169|FG004|COMPLETED|Treatment Period 3: ( HV:1 Day)||0
9048752|NCT03471871|10108165|FG000|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0
9048753|NCT03471871|10108166|FG001|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0
9048754|NCT03471871|10108167|FG002|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0
9048755|NCT03471871|10108168|FG003|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0
9048756|NCT03471871|10108169|FG004|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0
9048757|NCT03471871|10108165|FG000|STARTED|Follow Up (14 Days for Both HV and OSA)||6
9048758|NCT03471871|10108166|FG001|STARTED|Follow Up (14 Days for Both HV and OSA)||5
9048759|NCT03471871|10108167|FG002|STARTED|Follow Up (14 Days for Both HV and OSA)||5
9048760|NCT03471871|10108168|FG003|STARTED|Follow Up (14 Days for Both HV and OSA)|OSA cohort was treated till Treatment Period 2 only and then entered in follow up period.|18
9048761|NCT03471871|10108169|FG004|STARTED|Follow Up (14 Days for Both HV and OSA)|OSA cohort was treated till Treatment Period 2 only and then entered in follow up period.|18
9048762|NCT03471871|10108165|FG000|COMPLETED|Follow Up (14 Days for Both HV and OSA)||6
9048763|NCT03471871|10108166|FG001|COMPLETED|Follow Up (14 Days for Both HV and OSA)||5
9048764|NCT03471871|10108167|FG002|COMPLETED|Follow Up (14 Days for Both HV and OSA)||5
9048765|NCT03471871|10108168|FG003|COMPLETED|Follow Up (14 Days for Both HV and OSA)||17
9048766|NCT03471871|10108169|FG004|COMPLETED|Follow Up (14 Days for Both HV and OSA)||17
9048767|NCT03471871|10108165|FG000|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||0
9048768|NCT03471871|10108166|FG001|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||0
9048769|NCT03471871|10108167|FG002|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||0
9048770|NCT03471871|10108168|FG003|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||1
9048771|NCT03471871|10108169|FG004|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||1
9048772|NCT03471975|10108183|FG000|STARTED|Overall Study||17
9048773|NCT03471975|10108184|FG001|STARTED|Overall Study||20
9048774|NCT03471975|10108183|FG000|COMPLETED|Overall Study||17
9048775|NCT03471975|10108184|FG001|COMPLETED|Overall Study||20
9048776|NCT03471975|10108183|FG000|NOT COMPLETED|Overall Study||0
9048777|NCT03471975|10108184|FG001|NOT COMPLETED|Overall Study||0
9048778|NCT03472014|10108190|FG000|STARTED|Overall Study||22
9048779|NCT03472014|10108190|FG000|COMPLETED|Overall Study||18
9048780|NCT03472014|10108190|FG000|NOT COMPLETED|Overall Study||4
9048781|NCT03472287|10108196|FG000|STARTED|Overall Study||8
9048782|NCT03472287|10108197|FG001|STARTED|Overall Study||3
9048783|NCT03472287|10108196|FG000|COMPLETED|Overall Study||8
9048784|NCT03472287|10108197|FG001|COMPLETED|Overall Study||3
9048785|NCT03472287|10108196|FG000|NOT COMPLETED|Overall Study||0
9048786|NCT03472287|10108197|FG001|NOT COMPLETED|Overall Study||0
9048787|NCT03472326|10108205|FG000|STARTED|Part 1: GS-9131 Functional Monotherapy||11
9048788|NCT03472326|10108206|FG001|STARTED|Part 1: GS-9131 Functional Monotherapy||10
9048789|NCT03472326|10108207|FG002|STARTED|Part 1: GS-9131 Functional Monotherapy||0
9048790|NCT03472326|10108208|FG003|STARTED|Part 1: GS-9131 Functional Monotherapy||0
9048791|NCT03472326|10108205|FG000|COMPLETED|Part 1: GS-9131 Functional Monotherapy||11
9048792|NCT03472326|10108206|FG001|COMPLETED|Part 1: GS-9131 Functional Monotherapy||10
9048793|NCT03472326|10108207|FG002|COMPLETED|Part 1: GS-9131 Functional Monotherapy||0
9048794|NCT03472326|10108208|FG003|COMPLETED|Part 1: GS-9131 Functional Monotherapy||0
9048795|NCT03472326|10108205|FG000|NOT COMPLETED|Part 1: GS-9131 Functional Monotherapy||0
9048796|NCT03472326|10108206|FG001|NOT COMPLETED|Part 1: GS-9131 Functional Monotherapy||0
9048797|NCT03472326|10108207|FG002|NOT COMPLETED|Part 1: GS-9131 Functional Monotherapy||0
9048798|NCT03472326|10108208|FG003|NOT COMPLETED|Part 1: GS-9131 Functional Monotherapy||0
9048799|NCT03472326|10108205|FG000|STARTED|Part 2: Combination Therapy||0
9048800|NCT03472326|10108206|FG001|STARTED|Part 2: Combination Therapy||0
9048801|NCT03472326|10108207|FG002|STARTED|Part 2: Combination Therapy|Of the participants who completed Part 1, only 1 participant entered in Part 2.|1
9048802|NCT03472326|10108208|FG003|STARTED|Part 2: Combination Therapy|Of the participants who completed Part 1, only 3 participants entered in Part 2.|3
9048803|NCT03472326|10108205|FG000|COMPLETED|Part 2: Combination Therapy||0
9048804|NCT03472326|10108206|FG001|COMPLETED|Part 2: Combination Therapy||0
9048805|NCT03472326|10108207|FG002|COMPLETED|Part 2: Combination Therapy||0
9048806|NCT03472326|10108208|FG003|COMPLETED|Part 2: Combination Therapy||0
9048807|NCT03472326|10108205|FG000|NOT COMPLETED|Part 2: Combination Therapy||0
9048808|NCT03472326|10108206|FG001|NOT COMPLETED|Part 2: Combination Therapy||0
9048809|NCT03472326|10108207|FG002|NOT COMPLETED|Part 2: Combination Therapy||1
9048810|NCT03472326|10108208|FG003|NOT COMPLETED|Part 2: Combination Therapy||3
8703478|NCT00923091|9749188|FG012|NOT COMPLETED|Period V (Double -Blind)||2
8703479|NCT00923091|9749176|FG000|STARTED|Period VI (Open-Label)|1837 from Period III+2 from Period IV + 670 from Period 5 = 2509|1447
8703480|NCT00923091|9749177|FG001|STARTED|Period VI (Open-Label)||272
8703481|NCT00923091|9749178|FG002|STARTED|Period VI (Open-Label)||480
8703482|NCT00923091|9749179|FG003|STARTED|Period VI (Open-Label)||146
8703483|NCT00923091|9749180|FG004|STARTED|Period VI (Open-Label)||164
9048811|NCT03472469|10108219|FG000|STARTED|Overall Study||787
9048812|NCT03472469|10108220|FG001|STARTED|Overall Study||774
9048813|NCT03472469|10108219|FG000|COMPLETED|Overall Study||787
9048814|NCT03472469|10108220|FG001|COMPLETED|Overall Study||774
9048815|NCT03472469|10108219|FG000|NOT COMPLETED|Overall Study||0
9048816|NCT03472469|10108220|FG001|NOT COMPLETED|Overall Study||0
9048817|NCT03472534|10108226|FG000|STARTED|Overall Study|Each participant receives all 4 unit interventions.|46
9048818|NCT03472534|10108226|FG000|Diacerein 1% Ointment|Overall Study||46
9048819|NCT03472534|10108226|FG000|Vehicle Ointment|Overall Study||46
9048820|NCT03472534|10108226|FG000|0.2% Sodium Lauryl Sulfate (SLS)|Overall Study||46
9048821|NCT03472534|10108226|FG000|0.9% Saline|Overall Study||46
9048822|NCT03472534|10108226|FG000|COMPLETED|Overall Study||35
8703484|NCT00923091|9749181|FG005|STARTED|Period VI (Open-Label)||0
8703485|NCT00923091|9749182|FG006|STARTED|Period VI (Open-Label)||0
8703486|NCT00923091|9749183|FG007|STARTED|Period VI (Open-Label)||0
8703487|NCT00923091|9749184|FG008|STARTED|Period VI (Open-Label)||0
9048823|NCT03472534|10108226|FG000|NOT COMPLETED|Overall Study||11
9048824|NCT03472547|10108230|FG000|STARTED|Overall Study||234
9048825|NCT03472547|10108230|FG000|COMPLETED|Overall Study||204
9048826|NCT03472547|10108230|FG000|NOT COMPLETED|Overall Study||30
9048827|NCT03473171|10108234|FG000|STARTED|Overall Study||5
9048828|NCT03473171|10108234|FG000|COMPLETED|Overall Study||5
9048829|NCT03473171|10108234|FG000|NOT COMPLETED|Overall Study||0
9048830|NCT03473184|10108238|FG000|STARTED|Overall Study||34
9048831|NCT03473184|10108238|FG000|Diacerein 1% Ointment Irradiated|Overall Study||34
9048832|NCT03473184|10108238|FG000|Vehicle Ointment Irradiated|Overall Study||34
9048833|NCT03473184|10108238|FG000|Diacerein 1% Ointment Non-irradiated|Overall Study||34
9048834|NCT03473184|10108238|FG000|Vehicle Ointment Non-irradiated|Overall Study||34
9048835|NCT03473184|10108238|FG000|Untreated Irradiated|Overall Study||34
9048836|NCT03473184|10108238|FG000|COMPLETED|Overall Study||34
9048837|NCT03473184|10108238|FG000|NOT COMPLETED|Overall Study||0
9048838|NCT03473197|10108242|FG000|STARTED|Overall Study||61
9048839|NCT03473197|10108242|FG000|Diacerein 1% Ointment Irradiated|Overall Study||51
9048840|NCT03473197|10108242|FG000|Vehicle Ointment Irradiated|Overall Study||51
9048841|NCT03473197|10108242|FG000|Diacerein 1% Ointment Non-irradiated|Overall Study||51
9048842|NCT03473197|10108242|FG000|Vehicle Ointment Non-irradiated|Overall Study||51
9048843|NCT03473197|10108242|FG000|Untreated Irradiated|Overall Study||51
9048844|NCT03473197|10108242|FG000|COMPLETED|Overall Study||51
9048845|NCT03473197|10108242|FG000|NOT COMPLETED|Overall Study||10
9048846|NCT03473236|10108256|FG000|STARTED|Overall Study||10
9048847|NCT03473236|10108257|FG001|STARTED|Overall Study||6
9048848|NCT03473236|10108258|FG002|STARTED|Overall Study||6
9048849|NCT03473236|10108259|FG003|STARTED|Overall Study||6
9048850|NCT03473236|10108260|FG004|STARTED|Overall Study||6
9048851|NCT03473236|10108261|FG005|STARTED|Overall Study||7
9048852|NCT03473236|10108262|FG006|STARTED|Overall Study||6
9048853|NCT03473236|10108263|FG007|STARTED|Overall Study||6
9048854|NCT03473236|10108264|FG008|STARTED|Overall Study||7
9048855|NCT03473236|10108265|FG009|STARTED|Overall Study||6
9048856|NCT03473236|10108256|FG000|COMPLETED|Overall Study||10
9048857|NCT03473236|10108257|FG001|COMPLETED|Overall Study||6
9048858|NCT03473236|10108258|FG002|COMPLETED|Overall Study||6
9048859|NCT03473236|10108259|FG003|COMPLETED|Overall Study||6
9048860|NCT03473236|10108260|FG004|COMPLETED|Overall Study||6
9048861|NCT03473236|10108261|FG005|COMPLETED|Overall Study||6
9048862|NCT03473236|10108262|FG006|COMPLETED|Overall Study||6
9048863|NCT03473236|10108263|FG007|COMPLETED|Overall Study||6
9048864|NCT03473236|10108264|FG008|COMPLETED|Overall Study||6
9048865|NCT03473236|10108265|FG009|COMPLETED|Overall Study||6
9048866|NCT03473236|10108256|FG000|NOT COMPLETED|Overall Study||0
9048867|NCT03473236|10108257|FG001|NOT COMPLETED|Overall Study||0
9048868|NCT03473236|10108258|FG002|NOT COMPLETED|Overall Study||0
9048869|NCT03473236|10108259|FG003|NOT COMPLETED|Overall Study||0
9048870|NCT03473236|10108260|FG004|NOT COMPLETED|Overall Study||0
9048871|NCT03473236|10108261|FG005|NOT COMPLETED|Overall Study||1
9048872|NCT03473236|10108262|FG006|NOT COMPLETED|Overall Study||0
9048873|NCT03473236|10108263|FG007|NOT COMPLETED|Overall Study||0
9048874|NCT03473236|10108264|FG008|NOT COMPLETED|Overall Study||1
9048875|NCT03473236|10108265|FG009|NOT COMPLETED|Overall Study||0
9048876|NCT03473301|10108298|FG000|STARTED|Overall Study||31
9048877|NCT03473301|10108299|FG001|STARTED|Overall Study||29
9048878|NCT03473301|10108300|FG002|STARTED|Overall Study||31
9048879|NCT03473301|10108298|FG000|COMPLETED|Overall Study||20
9048880|NCT03473301|10108299|FG001|COMPLETED|Overall Study||23
9048881|NCT03473301|10108300|FG002|COMPLETED|Overall Study||25
9048882|NCT03473301|10108298|FG000|NOT COMPLETED|Overall Study||11
9048883|NCT03473301|10108299|FG001|NOT COMPLETED|Overall Study||6
9048884|NCT03473301|10108300|FG002|NOT COMPLETED|Overall Study||6
9048885|NCT03473665|10108310|FG000|STARTED|Overall Study||9
8703488|NCT00923091|9749185|FG009|STARTED|Period VI (Open-Label)||0
8703489|NCT00923091|9749186|FG010|STARTED|Period VI (Open-Label)||0
9048886|NCT03473665|10108310|FG000|COMPLETED|Overall Study||9
9048887|NCT03473665|10108310|FG000|NOT COMPLETED|Overall Study||0
9048888|NCT03473808|10108319|FG000|STARTED|Overall Study||5
9048889|NCT03473808|10108319|FG000|COMPLETED|Overall Study||4
9048890|NCT03473808|10108319|FG000|NOT COMPLETED|Overall Study||1
9048891|NCT03473886|10108323|FG000|STARTED|Overall Study||8
9048892|NCT03473886|10108323|FG000|COMPLETED|Overall Study||7
9048893|NCT03473886|10108323|FG000|NOT COMPLETED|Overall Study||1
9048894|NCT03474081|10108329|FG000|STARTED|Overall Study||400
9048895|NCT03474081|10108330|FG001|STARTED|Overall Study||400
9048896|NCT03474081|10108329|FG000|Received Study Treatment|Overall Study||400
9048897|NCT03474081|10108330|FG001|Received Study Treatment|Overall Study|One randomized participant withdrew consent and never received study treatment.|399
9048898|NCT03474081|10108329|FG000|COMPLETED|Overall Study||383
9048899|NCT03474081|10108330|FG001|COMPLETED|Overall Study||387
9048900|NCT03474081|10108329|FG000|NOT COMPLETED|Overall Study||17
9048901|NCT03474081|10108330|FG001|NOT COMPLETED|Overall Study||13
9048902|NCT03474172|10108338|FG000|STARTED|Overall Study||30
9048903|NCT03474172|10108339|FG001|STARTED|Overall Study||30
9048904|NCT03474172|10108338|FG000|COMPLETED|Overall Study||30
9048905|NCT03474172|10108339|FG001|COMPLETED|Overall Study||30
9048906|NCT03474172|10108338|FG000|NOT COMPLETED|Overall Study||0
9048907|NCT03474172|10108339|FG001|NOT COMPLETED|Overall Study||0
9048908|NCT03474406|10108348|FG000|STARTED|Overall Study||150
9048909|NCT03474406|10108348|FG000|COMPLETED|Overall Study||72
9048910|NCT03474406|10108348|FG000|NOT COMPLETED|Overall Study||78
9048911|NCT03474874|10108352|FG000|STARTED|Overall Study||68
9048912|NCT03474874|10108352|FG000|COMPLETED|Overall Study||54
9048913|NCT03474874|10108352|FG000|NOT COMPLETED|Overall Study||14
9048914|NCT03475056|10108360|FG000|STARTED|Overall Study||20
9048915|NCT03475056|10108361|FG001|STARTED|Overall Study||20
9048916|NCT03475056|10108360|FG000|Received Product Administration|Overall Study||20
9048917|NCT03475056|10108361|FG001|Received Product Administration|Overall Study||20
9048918|NCT03475056|10108360|FG000|COMPLETED|Overall Study||20
9048919|NCT03475056|10108361|FG001|COMPLETED|Overall Study||17
9048920|NCT03475056|10108360|FG000|NOT COMPLETED|Overall Study||0
9048921|NCT03475056|10108361|FG001|NOT COMPLETED|Overall Study||3
9048922|NCT03475316|10108370|FG000|STARTED|6 Month Intervention||13
9048923|NCT03475316|10108371|FG001|STARTED|6 Month Intervention||12
9048924|NCT03475316|10108370|FG000|COMPLETED|6 Month Intervention||8
9048925|NCT03475316|10108371|FG001|COMPLETED|6 Month Intervention||8
9048926|NCT03475316|10108370|FG000|NOT COMPLETED|6 Month Intervention||5
9048927|NCT03475316|10108371|FG001|NOT COMPLETED|6 Month Intervention||4
9048928|NCT03475316|10108370|FG000|STARTED|9 Months||8
9048929|NCT03475316|10108371|FG001|STARTED|9 Months||8
9048930|NCT03475316|10108370|FG000|COMPLETED|9 Months||5
9048931|NCT03475316|10108371|FG001|COMPLETED|9 Months||4
9048932|NCT03475316|10108370|FG000|NOT COMPLETED|9 Months||3
9048933|NCT03475316|10108371|FG001|NOT COMPLETED|9 Months||4
9048934|NCT03475875|10108377|FG000|STARTED|Period 1||46
9048935|NCT03475875|10108378|FG001|STARTED|Period 1||45
9048936|NCT03475875|10108377|FG000|COMPLETED|Period 1||43
9048937|NCT03475875|10108378|FG001|COMPLETED|Period 1||44
9048938|NCT03475875|10108377|FG000|NOT COMPLETED|Period 1||3
9048939|NCT03475875|10108378|FG001|NOT COMPLETED|Period 1||1
9048940|NCT03475875|10108377|FG000|STARTED|Period 2||43
9048941|NCT03475875|10108378|FG001|STARTED|Period 2||44
9048942|NCT03475875|10108377|FG000|COMPLETED|Period 2||40
9048943|NCT03475875|10108378|FG001|COMPLETED|Period 2||43
9048944|NCT03475875|10108377|FG000|NOT COMPLETED|Period 2||3
9048945|NCT03475875|10108378|FG001|NOT COMPLETED|Period 2||1
9048946|NCT03475875|10108377|FG000|STARTED|Period 3||40
9048947|NCT03475875|10108378|FG001|STARTED|Period 3||43
9048948|NCT03475875|10108377|FG000|COMPLETED|Period 3||40
9048949|NCT03475875|10108378|FG001|COMPLETED|Period 3||43
9048950|NCT03475875|10108377|FG000|NOT COMPLETED|Period 3||0
9048951|NCT03475875|10108378|FG001|NOT COMPLETED|Period 3||0
9048952|NCT03475992|10108387|FG000|STARTED|Overall Study||11
9048953|NCT03475992|10108388|FG001|STARTED|Overall Study||9
9048954|NCT03475992|10108389|FG002|STARTED|Overall Study||5
9048955|NCT03475992|10108387|FG000|COMPLETED|Overall Study||11
9048956|NCT03475992|10108388|FG001|COMPLETED|Overall Study||9
9048957|NCT03475992|10108389|FG002|COMPLETED|Overall Study||5
9048958|NCT03475992|10108387|FG000|NOT COMPLETED|Overall Study||0
9048959|NCT03475992|10108388|FG001|NOT COMPLETED|Overall Study||0
9048960|NCT03475992|10108389|FG002|NOT COMPLETED|Overall Study||0
9048961|NCT03476278|10108397|FG000|STARTED|Overall Study||300
9048962|NCT03476278|10108397|FG000|COMPLETED|Overall Study||300
9048963|NCT03476278|10108397|FG000|NOT COMPLETED|Overall Study||0
9048964|NCT03476798|10108411|FG000|STARTED|Overall Study||33
9048965|NCT03476798|10108411|FG000|COMPLETED|Overall Study||28
9048966|NCT03476798|10108411|FG000|NOT COMPLETED|Overall Study||5
9048967|NCT03476850|10108417|FG000|STARTED|Overall Study||24
9048968|NCT03476850|10108418|FG001|STARTED|Overall Study||24
9048969|NCT03476850|10108417|FG000|COMPLETED|Overall Study||24
9048970|NCT03476850|10108418|FG001|COMPLETED|Overall Study||24
9048971|NCT03476850|10108417|FG000|NOT COMPLETED|Overall Study||0
9048972|NCT03476850|10108418|FG001|NOT COMPLETED|Overall Study||0
9048973|NCT03477006|10108426|FG000|STARTED|Overall Study||40
9048974|NCT03477006|10108427|FG001|STARTED|Overall Study||46
9048975|NCT03477006|10108426|FG000|COMPLETED|Overall Study||40
9048976|NCT03477006|10108427|FG001|COMPLETED|Overall Study||46
9048977|NCT03477006|10108426|FG000|NOT COMPLETED|Overall Study||0
9048978|NCT03477006|10108427|FG001|NOT COMPLETED|Overall Study||0
9048979|NCT03477279|10108438|FG000|STARTED|Overall Study||250
9048980|NCT03477279|10108439|FG001|STARTED|Overall Study||250
9048981|NCT03477279|10108440|FG002|STARTED|Overall Study||98
9048982|NCT03477279|10108441|FG003|STARTED|Overall Study||168
9048983|NCT03477279|10108442|FG004|STARTED|Overall Study||350
9048984|NCT03477279|10108438|FG000|COMPLETED|Overall Study||203
9048985|NCT03477279|10108439|FG001|COMPLETED|Overall Study||202
9048986|NCT03477279|10108440|FG002|COMPLETED|Overall Study||98
9048987|NCT03477279|10108441|FG003|COMPLETED|Overall Study||136
9048988|NCT03477279|10108442|FG004|COMPLETED|Overall Study||349
9048989|NCT03477279|10108438|FG000|NOT COMPLETED|Overall Study||47
9048990|NCT03477279|10108439|FG001|NOT COMPLETED|Overall Study||48
9048991|NCT03477279|10108440|FG002|NOT COMPLETED|Overall Study||0
9048992|NCT03477279|10108441|FG003|NOT COMPLETED|Overall Study||32
9048993|NCT03477279|10108442|FG004|NOT COMPLETED|Overall Study||1
9048994|NCT03477838|10108455|FG000|STARTED|Overall Study||28
9048995|NCT03477838|10108455|FG000|COMPLETED|Overall Study||14
9048996|NCT03477838|10108455|FG000|NOT COMPLETED|Overall Study||14
9048997|NCT03478163|10108461|FG000|STARTED|Overall Study||5
9048998|NCT03478163|10108462|FG001|STARTED|Overall Study||6
9048999|NCT03478163|10108461|FG000|COMPLETED|Overall Study||5
9049000|NCT03478163|10108462|FG001|COMPLETED|Overall Study||6
9049001|NCT03478163|10108461|FG000|NOT COMPLETED|Overall Study||0
9049002|NCT03478163|10108462|FG001|NOT COMPLETED|Overall Study||0
9049003|NCT03478254|10108468|FG000|STARTED|Overall Study||300
9049004|NCT03478254|10108468|FG000|COMPLETED|Overall Study||300
9049005|NCT03478254|10108468|FG000|NOT COMPLETED|Overall Study||0
9049006|NCT03478371|10108473|FG000|STARTED|Overall Study||94
9049007|NCT03478371|10108473|FG000|Received Tampon D|Overall Study||91
9049008|NCT03478371|10108473|FG000|Received Tampon M|Overall Study||92
9049009|NCT03478371|10108473|FG000|Recived Tampon T|Overall Study||90
9049010|NCT03478371|10108473|FG000|Received Tampon V|Overall Study||91
9049011|NCT03478371|10108473|FG000|COMPLETED|Overall Study||89
9049012|NCT03478371|10108473|FG000|NOT COMPLETED|Overall Study||5
9049013|NCT03478644|10108485|FG000|STARTED|Phase 1|In Phase 1, only the wipe treatment was administered to eligible participants.|31
9049014|NCT03478644|10108486|FG001|STARTED|Phase 1||0
9049015|NCT03478644|10108485|FG000|COMPLETED|Phase 1|In Phase 1, only the wipe treatment was administered to eligible participants.|31
9049016|NCT03478644|10108486|FG001|COMPLETED|Phase 1||0
9049017|NCT03478644|10108485|FG000|NOT COMPLETED|Phase 1||0
9049018|NCT03478644|10108486|FG001|NOT COMPLETED|Phase 1||0
9049019|NCT03478644|10108485|FG000|STARTED|Phase 2||76
9049020|NCT03478644|10108486|FG001|STARTED|Phase 2||76
9049021|NCT03478644|10108485|FG000|COMPLETED|Phase 2||73
9049022|NCT03478644|10108486|FG001|COMPLETED|Phase 2||75
9049023|NCT03478644|10108485|FG000|NOT COMPLETED|Phase 2||3
9049024|NCT03478644|10108486|FG001|NOT COMPLETED|Phase 2||1
9049025|NCT03478657|10108494|FG000|STARTED|Overall Study||88
9049026|NCT03478657|10108495|FG001|STARTED|Overall Study||134
9049027|NCT03478657|10108494|FG000|COMPLETED|Overall Study||88
9049028|NCT03478657|10108495|FG001|COMPLETED|Overall Study||133
9049029|NCT03478657|10108494|FG000|NOT COMPLETED|Overall Study||0
9049030|NCT03478657|10108495|FG001|NOT COMPLETED|Overall Study||1
9049031|NCT03478683|10108503|FG000|STARTED|Overall Study||363
9049032|NCT03478683|10108504|FG001|STARTED|Overall Study||365
9049033|NCT03478683|10108503|FG000|COMPLETED|Overall Study||350
9049034|NCT03478683|10108504|FG001|COMPLETED|Overall Study||347
9049035|NCT03478683|10108503|FG000|NOT COMPLETED|Overall Study||13
9049036|NCT03478683|10108504|FG001|NOT COMPLETED|Overall Study||18
9049037|NCT03478696|10108512|FG000|STARTED|Overall Study||366
9049038|NCT03478696|10108513|FG001|STARTED|Overall Study||366
9049039|NCT03478696|10108512|FG000|COMPLETED|Overall Study||349
9049040|NCT03478696|10108513|FG001|COMPLETED|Overall Study||354
9049041|NCT03478696|10108512|FG000|NOT COMPLETED|Overall Study||17
9049042|NCT03478696|10108513|FG001|NOT COMPLETED|Overall Study||12
9049043|NCT03478787|10108521|FG000|STARTED|Overall Study||163
9049044|NCT03478787|10108522|FG001|STARTED|Overall Study||164
9049045|NCT03478787|10108521|FG000|COMPLETED|Overall Study||134
9049046|NCT03478787|10108522|FG001|COMPLETED|Overall Study||151
9049047|NCT03478787|10108521|FG000|NOT COMPLETED|Overall Study||29
9049048|NCT03478787|10108522|FG001|NOT COMPLETED|Overall Study||13
8556979|NCT02919618|9588776|FG000|Primary Safety Endpoint (</=90 Days)|Overall Study||19
9049049|NCT03478891|10108531|FG000|STARTED|Overall Study||3
9049050|NCT03478891|10108532|FG001|STARTED|Overall Study||5
9049051|NCT03478891|10108533|FG002|STARTED|Overall Study||11
9049052|NCT03478891|10108531|FG000|Received MAb114|Overall Study||3
9049053|NCT03478891|10108532|FG001|Received MAb114|Overall Study||5
9049054|NCT03478891|10108533|FG002|Received MAb114|Overall Study|One Group 3 subject discontinued prior to MAb114 infusion due to inadequate venous access|10
9049055|NCT03478891|10108531|FG000|COMPLETED|Overall Study||2
9049056|NCT03478891|10108532|FG001|COMPLETED|Overall Study||5
9049057|NCT03478891|10108533|FG002|COMPLETED|Overall Study||8
9049058|NCT03478891|10108531|FG000|NOT COMPLETED|Overall Study||1
9049059|NCT03478891|10108532|FG001|NOT COMPLETED|Overall Study||0
9049060|NCT03478891|10108533|FG002|NOT COMPLETED|Overall Study||3
9049061|NCT03478904|10108545|FG000|STARTED|Overall Study||1
9049062|NCT03478904|10108545|FG000|COMPLETED|Overall Study||1
9049063|NCT03478904|10108545|FG000|NOT COMPLETED|Overall Study||0
9049064|NCT03478969|10108559|FG000|STARTED|Overall Study||62
9049065|NCT03478969|10108560|FG001|STARTED|Overall Study||61
9049066|NCT03478969|10108561|FG002|STARTED|Overall Study||58
9049067|NCT03478969|10108559|FG000|Participants at End of Parallel Phase|Overall Study||55
9049068|NCT03478969|10108560|FG001|Participants at End of Parallel Phase|Overall Study||58
9049069|NCT03478969|10108561|FG002|Participants at End of Parallel Phase|Overall Study||52
9049070|NCT03478969|10108559|FG000|COMPLETED|Overall Study||53
9049071|NCT03478969|10108560|FG001|COMPLETED|Overall Study||49
9049072|NCT03478969|10108561|FG002|COMPLETED|Overall Study||40
9049073|NCT03478969|10108559|FG000|NOT COMPLETED|Overall Study||9
9049074|NCT03478969|10108560|FG001|NOT COMPLETED|Overall Study||12
9049075|NCT03478969|10108561|FG002|NOT COMPLETED|Overall Study||18
9049076|NCT03478982|10108575|FG000|STARTED|Overall Study||11
9049077|NCT03478982|10108576|FG001|STARTED|Overall Study||50
9049078|NCT03478982|10108577|FG002|STARTED|Overall Study||47
9049079|NCT03478982|10108578|FG003|STARTED|Overall Study||48
9049080|NCT03478982|10108575|FG000|Enrolled Participants But Not Treated|Overall Study||3
9049081|NCT03478982|10108576|FG001|Enrolled Participants But Not Treated|Overall Study||10
9049082|NCT03478982|10108577|FG002|Enrolled Participants But Not Treated|Overall Study||9
9049083|NCT03478982|10108578|FG003|Enrolled Participants But Not Treated|Overall Study||10
9049084|NCT03478982|10108575|FG000|Intent-to-treat (ITT) Population|Overall Study||8
9049085|NCT03478982|10108576|FG001|Intent-to-treat (ITT) Population|Overall Study||40
9049086|NCT03478982|10108577|FG002|Intent-to-treat (ITT) Population|Overall Study||38
9049087|NCT03478982|10108578|FG003|Intent-to-treat (ITT) Population|Overall Study||38
9049088|NCT03478982|10108575|FG000|COMPLETED|Overall Study||11
9049089|NCT03478982|10108576|FG001|COMPLETED|Overall Study||50
9049090|NCT03478982|10108577|FG002|COMPLETED|Overall Study||47
9049091|NCT03478982|10108578|FG003|COMPLETED|Overall Study||48
9049092|NCT03478982|10108575|FG000|NOT COMPLETED|Overall Study||0
9049093|NCT03478982|10108576|FG001|NOT COMPLETED|Overall Study||0
9049094|NCT03478982|10108577|FG002|NOT COMPLETED|Overall Study||0
9049095|NCT03478982|10108578|FG003|NOT COMPLETED|Overall Study||0
9049096|NCT03479216|10108590|FG000|STARTED|Overall Study||31
9049097|NCT03479216|10108591|FG001|STARTED|Overall Study||31
9049098|NCT03479216|10108590|FG000|COMPLETED|Overall Study||26
9049099|NCT03479216|10108591|FG001|COMPLETED|Overall Study||26
9049100|NCT03479216|10108590|FG000|NOT COMPLETED|Overall Study||5
9049101|NCT03479216|10108591|FG001|NOT COMPLETED|Overall Study||5
9049102|NCT03479944|10108597|FG000|STARTED|Overall Study||55
9049103|NCT03479944|10108597|FG000|FLACS|Overall Study||55
9049104|NCT03479944|10108597|FG000|Conventional|Overall Study||55
9049105|NCT03479944|10108597|FG000|Full Analysis Set|Overall Study||53
9049106|NCT03479944|10108597|FG000|COMPLETED|Overall Study||55
9049107|NCT03479944|10108597|FG000|NOT COMPLETED|Overall Study||0
9049108|NCT03480009|10108609|FG000|STARTED|Overall Study||62
9049109|NCT03480009|10108610|FG001|STARTED|Overall Study||62
9049110|NCT03480009|10108611|FG002|STARTED|Overall Study||16
9049111|NCT03480009|10108612|FG003|STARTED|Overall Study||16
9049112|NCT03480009|10108609|FG000|COMPLETED|Overall Study||58
9049113|NCT03480009|10108610|FG001|COMPLETED|Overall Study||57
9049114|NCT03480009|10108611|FG002|COMPLETED|Overall Study||12
9049115|NCT03480009|10108612|FG003|COMPLETED|Overall Study||16
9049116|NCT03480009|10108609|FG000|NOT COMPLETED|Overall Study||4
9049117|NCT03480009|10108610|FG001|NOT COMPLETED|Overall Study||5
9049118|NCT03480009|10108611|FG002|NOT COMPLETED|Overall Study||4
9049119|NCT03480009|10108612|FG003|NOT COMPLETED|Overall Study||0
9049120|NCT03480022|10108627|FG000|STARTED|Overall Study||55
9049121|NCT03480022|10108628|FG001|STARTED|Overall Study||27
9049122|NCT03480022|10108627|FG000|COMPLETED|Overall Study||44
9049123|NCT03480022|10108628|FG001|COMPLETED|Overall Study||23
9049124|NCT03480022|10108627|FG000|NOT COMPLETED|Overall Study||11
9049125|NCT03480022|10108628|FG001|NOT COMPLETED|Overall Study||4
9049126|NCT03480048|10108636|FG000|STARTED|Overall Study||28
9049127|NCT03480048|10108637|FG001|STARTED|Overall Study||25
9049128|NCT03480048|10108636|FG000|COMPLETED|Overall Study||18
9049129|NCT03480048|10108637|FG001|COMPLETED|Overall Study||17
9049130|NCT03480048|10108636|FG000|NOT COMPLETED|Overall Study||10
9049131|NCT03480048|10108637|FG001|NOT COMPLETED|Overall Study||8
9049132|NCT03480152|10108645|FG000|STARTED|Phase I||3
9049133|NCT03480152|10108646|FG001|STARTED|Phase I||2
9049134|NCT03480152|10108647|FG002|STARTED|Phase I||0
9049135|NCT03480152|10108645|FG000|Received Intervention|Phase I||2
9049136|NCT03480152|10108646|FG001|Received Intervention|Phase I||2
9049137|NCT03480152|10108647|FG002|Received Intervention|Phase I||0
9049138|NCT03480152|10108645|FG000|COMPLETED|Phase I||2
9049139|NCT03480152|10108646|FG001|COMPLETED|Phase I||2
9049140|NCT03480152|10108647|FG002|COMPLETED|Phase I||0
9049141|NCT03480152|10108645|FG000|NOT COMPLETED|Phase I||1
9049142|NCT03480152|10108646|FG001|NOT COMPLETED|Phase I||0
8703490|NCT00923091|9749187|FG011|STARTED|Period VI (Open-Label)||0
9049143|NCT03480152|10108647|FG002|NOT COMPLETED|Phase I||0
9049144|NCT03480152|10108645|FG000|STARTED|Phase II||0
9049145|NCT03480152|10108646|FG001|STARTED|Phase II||0
9049146|NCT03480152|10108647|FG002|STARTED|Phase II||0
9049147|NCT03480152|10108645|FG000|COMPLETED|Phase II||0
9049148|NCT03480152|10108646|FG001|COMPLETED|Phase II||0
9049149|NCT03480152|10108647|FG002|COMPLETED|Phase II||0
9049150|NCT03480152|10108645|FG000|NOT COMPLETED|Phase II||0
9049151|NCT03480152|10108646|FG001|NOT COMPLETED|Phase II||0
9049152|NCT03480152|10108647|FG002|NOT COMPLETED|Phase II||0
9049153|NCT03480243|10108655|FG000|STARTED|Padsevonil (Period 1)||28
9049154|NCT03480243|10108655|FG000|COMPLETED|Padsevonil (Period 1)||28
9049155|NCT03480243|10108655|FG000|NOT COMPLETED|Padsevonil (Period 1)||0
9049156|NCT03480243|10108655|FG000|STARTED|Padsevonil (Period 2)||28
9049157|NCT03480243|10108655|FG000|COMPLETED|Padsevonil (Period 2)||27
9049158|NCT03480243|10108655|FG000|NOT COMPLETED|Padsevonil (Period 2)||1
9049159|NCT03480243|10108655|FG000|STARTED|Erythromycin (Period 3a)||27
9049160|NCT03480243|10108655|FG000|COMPLETED|Erythromycin (Period 3a)||27
9049161|NCT03480243|10108655|FG000|NOT COMPLETED|Erythromycin (Period 3a)||0
9049162|NCT03480243|10108655|FG000|STARTED|Padsevonil and Erythromycin (Period 3b)||27
9049163|NCT03480243|10108655|FG000|COMPLETED|Padsevonil and Erythromycin (Period 3b)||26
9049164|NCT03480243|10108655|FG000|NOT COMPLETED|Padsevonil and Erythromycin (Period 3b)||1
9049165|NCT03480243|10108655|FG000|STARTED|Erythromycin (Period 3c)||26
9049166|NCT03480243|10108655|FG000|COMPLETED|Erythromycin (Period 3c)||26
9049167|NCT03480243|10108655|FG000|NOT COMPLETED|Erythromycin (Period 3c)||0
9049168|NCT03480425|10108668|FG000|STARTED|Overall Study||11
9049169|NCT03480425|10108668|FG000|COMPLETED|Overall Study||10
9049170|NCT03480425|10108668|FG000|NOT COMPLETED|Overall Study||1
9049171|NCT03480685|10108672|FG000|STARTED|Overall Study||12
9049172|NCT03480685|10108672|FG000|COMPLETED|Overall Study||12
9049173|NCT03480685|10108672|FG000|NOT COMPLETED|Overall Study||0
9049174|NCT03480750|10108684|FG000|STARTED|Overall Study||3
9049175|NCT03480750|10108685|FG001|STARTED|Overall Study||4
9049176|NCT03480750|10108686|FG002|STARTED|Overall Study||3
9049177|NCT03480750|10108687|FG003|STARTED|Overall Study||3
9049178|NCT03480750|10108688|FG004|STARTED|Overall Study||3
9049179|NCT03480750|10108689|FG005|STARTED|Overall Study||2
9049180|NCT03480750|10108684|FG000|COMPLETED|Overall Study||3
9049181|NCT03480750|10108685|FG001|COMPLETED|Overall Study||3
9049182|NCT03480750|10108686|FG002|COMPLETED|Overall Study||3
9049183|NCT03480750|10108687|FG003|COMPLETED|Overall Study||3
9049184|NCT03480750|10108688|FG004|COMPLETED|Overall Study||3
9049185|NCT03480750|10108689|FG005|COMPLETED|Overall Study||1
9049186|NCT03480750|10108684|FG000|NOT COMPLETED|Overall Study||0
9049187|NCT03480750|10108685|FG001|NOT COMPLETED|Overall Study||1
9049188|NCT03480750|10108686|FG002|NOT COMPLETED|Overall Study||0
9049189|NCT03480750|10108687|FG003|NOT COMPLETED|Overall Study||0
9049190|NCT03480750|10108688|FG004|NOT COMPLETED|Overall Study||0
9049191|NCT03480750|10108689|FG005|NOT COMPLETED|Overall Study||1
9049192|NCT03480763|10108714|FG000|STARTED|Overall Study||327
9049193|NCT03480763|10108715|FG001|STARTED|Overall Study||325
9049194|NCT03480763|10108714|FG000|Vaccination 1 - (V114 or Prevnar 13™, Day 1)|Overall Study||326
9049195|NCT03480763|10108715|FG001|Vaccination 1 - (V114 or Prevnar 13™, Day 1)|Overall Study||325
9049196|NCT03480763|10108714|FG000|Vaccination 2 - (PNEUMOVAX™23, Month 12)|Overall Study||298
9049197|NCT03480763|10108715|FG001|Vaccination 2 - (PNEUMOVAX™23, Month 12)|Overall Study||302
9049198|NCT03480763|10108714|FG000|COMPLETED|Overall Study||303
9049199|NCT03480763|10108715|FG001|COMPLETED|Overall Study||306
9049200|NCT03480763|10108714|FG000|NOT COMPLETED|Overall Study||24
9049201|NCT03480763|10108715|FG001|NOT COMPLETED|Overall Study||19
9049202|NCT03480841|10108727|FG000|STARTED|Overall Study||10
9049203|NCT03480841|10108727|FG000|Time 1 Data Collection (T1)|Overall Study||10
9049204|NCT03480841|10108727|FG000|LENA Baseline|Overall Study||10
9049205|NCT03480841|10108727|FG000|LENA Time 1|Overall Study||10
9049206|NCT03480841|10108727|FG000|LENA Time 2|Overall Study||10
9049207|NCT03480841|10108727|FG000|LENA Time 3|Overall Study||10
9049208|NCT03480841|10108727|FG000|LENA Time 4|Overall Study||9
9049209|NCT03480841|10108727|FG000|LENA Time 5|Overall Study||8
9049210|NCT03480841|10108727|FG000|Time 2 Data Collection (T2)|Overall Study||8
9049211|NCT03480841|10108727|FG000|COMPLETED|Overall Study||8
9049212|NCT03480841|10108727|FG000|NOT COMPLETED|Overall Study||2
9049213|NCT03480919|10108734|FG000|STARTED|Overall Study||1
9049214|NCT03480919|10108735|FG001|STARTED|Overall Study||2
9049215|NCT03480919|10108736|FG002|STARTED|Overall Study||1
9049216|NCT03480919|10108734|FG000|COMPLETED|Overall Study||1
9049217|NCT03480919|10108735|FG001|COMPLETED|Overall Study||2
9049218|NCT03480919|10108736|FG002|COMPLETED|Overall Study||1
9049219|NCT03480919|10108734|FG000|NOT COMPLETED|Overall Study||0
9049220|NCT03480919|10108735|FG001|NOT COMPLETED|Overall Study||0
9049221|NCT03480919|10108736|FG002|NOT COMPLETED|Overall Study||0
9049222|NCT03480932|10108747|FG000|STARTED|Overall Study||50
9049223|NCT03480932|10108748|FG001|STARTED|Overall Study||50
9049224|NCT03480932|10108749|FG002|STARTED|Overall Study||50
9049225|NCT03480932|10108747|FG000|COMPLETED|Overall Study||47
9049226|NCT03480932|10108748|FG001|COMPLETED|Overall Study||45
9049227|NCT03480932|10108749|FG002|COMPLETED|Overall Study||45
9049228|NCT03480932|10108747|FG000|NOT COMPLETED|Overall Study||3
9049229|NCT03480932|10108748|FG001|NOT COMPLETED|Overall Study||5
9049230|NCT03480932|10108749|FG002|NOT COMPLETED|Overall Study||5
9049231|NCT03481270|10108759|FG000|STARTED|Overall Study||324
9049232|NCT03481270|10108760|FG001|STARTED|Overall Study||313
9049233|NCT03481270|10108759|FG000|COMPLETED|Overall Study||324
9049234|NCT03481270|10108760|FG001|COMPLETED|Overall Study||313
9049235|NCT03481270|10108759|FG000|NOT COMPLETED|Overall Study||0
9049236|NCT03481270|10108760|FG001|NOT COMPLETED|Overall Study||0
9049237|NCT03481309|10108772|FG000|STARTED|First Intervention (1 Day)||4
9049238|NCT03481309|10108773|FG001|STARTED|First Intervention (1 Day)||3
9049239|NCT03481309|10108774|FG002|STARTED|First Intervention (1 Day)||3
9049240|NCT03481309|10108775|FG003|STARTED|First Intervention (1 Day)||3
9049241|NCT03481309|10108776|FG004|STARTED|First Intervention (1 Day)||3
9049242|NCT03481309|10108777|FG005|STARTED|First Intervention (1 Day)||3
9049243|NCT03481309|10108772|FG000|COMPLETED|First Intervention (1 Day)||4
9049244|NCT03481309|10108773|FG001|COMPLETED|First Intervention (1 Day)||3
9049245|NCT03481309|10108774|FG002|COMPLETED|First Intervention (1 Day)||3
9049246|NCT03481309|10108775|FG003|COMPLETED|First Intervention (1 Day)||3
9049247|NCT03481309|10108776|FG004|COMPLETED|First Intervention (1 Day)||3
9049248|NCT03481309|10108777|FG005|COMPLETED|First Intervention (1 Day)||3
9049249|NCT03481309|10108772|FG000|NOT COMPLETED|First Intervention (1 Day)||0
9049250|NCT03481309|10108773|FG001|NOT COMPLETED|First Intervention (1 Day)||0
9049251|NCT03481309|10108774|FG002|NOT COMPLETED|First Intervention (1 Day)||0
9049252|NCT03481309|10108775|FG003|NOT COMPLETED|First Intervention (1 Day)||0
9049253|NCT03481309|10108776|FG004|NOT COMPLETED|First Intervention (1 Day)||0
9049254|NCT03481309|10108777|FG005|NOT COMPLETED|First Intervention (1 Day)||0
9049255|NCT03481309|10108772|FG000|STARTED|Washout (at Least 3 Days)||4
9049256|NCT03481309|10108773|FG001|STARTED|Washout (at Least 3 Days)||3
9049257|NCT03481309|10108774|FG002|STARTED|Washout (at Least 3 Days)||3
9049258|NCT03481309|10108775|FG003|STARTED|Washout (at Least 3 Days)||3
9049259|NCT03481309|10108776|FG004|STARTED|Washout (at Least 3 Days)||3
9049260|NCT03481309|10108777|FG005|STARTED|Washout (at Least 3 Days)||3
9049261|NCT03481309|10108772|FG000|COMPLETED|Washout (at Least 3 Days)||3
9049262|NCT03481309|10108773|FG001|COMPLETED|Washout (at Least 3 Days)||3
9049263|NCT03481309|10108774|FG002|COMPLETED|Washout (at Least 3 Days)||3
9049264|NCT03481309|10108775|FG003|COMPLETED|Washout (at Least 3 Days)||3
9049265|NCT03481309|10108776|FG004|COMPLETED|Washout (at Least 3 Days)||3
9049266|NCT03481309|10108777|FG005|COMPLETED|Washout (at Least 3 Days)||3
9049267|NCT03481309|10108772|FG000|NOT COMPLETED|Washout (at Least 3 Days)||1
9049268|NCT03481309|10108773|FG001|NOT COMPLETED|Washout (at Least 3 Days)||0
9049269|NCT03481309|10108774|FG002|NOT COMPLETED|Washout (at Least 3 Days)||0
9049270|NCT03481309|10108775|FG003|NOT COMPLETED|Washout (at Least 3 Days)||0
9049271|NCT03481309|10108776|FG004|NOT COMPLETED|Washout (at Least 3 Days)||0
9049272|NCT03481309|10108777|FG005|NOT COMPLETED|Washout (at Least 3 Days)||0
9049273|NCT03481309|10108772|FG000|STARTED|Second Intervention (1 Day)||3
9049274|NCT03481309|10108773|FG001|STARTED|Second Intervention (1 Day)||3
9049275|NCT03481309|10108774|FG002|STARTED|Second Intervention (1 Day)||3
9049276|NCT03481309|10108775|FG003|STARTED|Second Intervention (1 Day)||3
9049277|NCT03481309|10108776|FG004|STARTED|Second Intervention (1 Day)||3
9049278|NCT03481309|10108777|FG005|STARTED|Second Intervention (1 Day)||3
9049279|NCT03481309|10108772|FG000|COMPLETED|Second Intervention (1 Day)||3
9049280|NCT03481309|10108773|FG001|COMPLETED|Second Intervention (1 Day)||3
9049281|NCT03481309|10108774|FG002|COMPLETED|Second Intervention (1 Day)||3
9049282|NCT03481309|10108775|FG003|COMPLETED|Second Intervention (1 Day)||3
9049283|NCT03481309|10108776|FG004|COMPLETED|Second Intervention (1 Day)||3
9049284|NCT03481309|10108777|FG005|COMPLETED|Second Intervention (1 Day)||3
9049285|NCT03481309|10108772|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
9049286|NCT03481309|10108773|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
8703491|NCT00923091|9749188|FG012|STARTED|Period VI (Open-Label)||0
8703492|NCT00923091|9749176|FG000|COMPLETED|Period VI (Open-Label)||1408
8703493|NCT00923091|9749177|FG001|COMPLETED|Period VI (Open-Label)||264
8703494|NCT00923091|9749178|FG002|COMPLETED|Period VI (Open-Label)||467
9049287|NCT03481309|10108774|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
9049288|NCT03481309|10108775|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
9049289|NCT03481309|10108776|FG004|NOT COMPLETED|Second Intervention (1 Day)||0
9049290|NCT03481309|10108777|FG005|NOT COMPLETED|Second Intervention (1 Day)||0
9049291|NCT03481309|10108772|FG000|STARTED|Washout (at Least 3 Days)||3
9049292|NCT03481309|10108773|FG001|STARTED|Washout (at Least 3 Days)||3
9049293|NCT03481309|10108774|FG002|STARTED|Washout (at Least 3 Days)||3
9049294|NCT03481309|10108775|FG003|STARTED|Washout (at Least 3 Days)||3
9049295|NCT03481309|10108776|FG004|STARTED|Washout (at Least 3 Days)||3
9049296|NCT03481309|10108777|FG005|STARTED|Washout (at Least 3 Days)||3
9049297|NCT03481309|10108772|FG000|COMPLETED|Washout (at Least 3 Days)||3
9049298|NCT03481309|10108773|FG001|COMPLETED|Washout (at Least 3 Days)||3
9049299|NCT03481309|10108774|FG002|COMPLETED|Washout (at Least 3 Days)||3
9049300|NCT03481309|10108775|FG003|COMPLETED|Washout (at Least 3 Days)||3
9049301|NCT03481309|10108776|FG004|COMPLETED|Washout (at Least 3 Days)||3
9049302|NCT03481309|10108777|FG005|COMPLETED|Washout (at Least 3 Days)||3
9049303|NCT03481309|10108772|FG000|NOT COMPLETED|Washout (at Least 3 Days)||0
9049304|NCT03481309|10108773|FG001|NOT COMPLETED|Washout (at Least 3 Days)||0
9049305|NCT03481309|10108774|FG002|NOT COMPLETED|Washout (at Least 3 Days)||0
9049306|NCT03481309|10108775|FG003|NOT COMPLETED|Washout (at Least 3 Days)||0
9049307|NCT03481309|10108776|FG004|NOT COMPLETED|Washout (at Least 3 Days)||0
9049308|NCT03481309|10108777|FG005|NOT COMPLETED|Washout (at Least 3 Days)||0
9049309|NCT03481309|10108772|FG000|STARTED|Third Intervention (1 Day)||3
9049310|NCT03481309|10108773|FG001|STARTED|Third Intervention (1 Day)||3
9049311|NCT03481309|10108774|FG002|STARTED|Third Intervention (1 Day)||3
9049312|NCT03481309|10108775|FG003|STARTED|Third Intervention (1 Day)||3
9049313|NCT03481309|10108776|FG004|STARTED|Third Intervention (1 Day)||3
9049314|NCT03481309|10108777|FG005|STARTED|Third Intervention (1 Day)||3
9049315|NCT03481309|10108772|FG000|COMPLETED|Third Intervention (1 Day)||3
9049316|NCT03481309|10108773|FG001|COMPLETED|Third Intervention (1 Day)||3
9049317|NCT03481309|10108774|FG002|COMPLETED|Third Intervention (1 Day)||3
9049318|NCT03481309|10108775|FG003|COMPLETED|Third Intervention (1 Day)||3
9049319|NCT03481309|10108776|FG004|COMPLETED|Third Intervention (1 Day)||3
9049320|NCT03481309|10108777|FG005|COMPLETED|Third Intervention (1 Day)||3
9049321|NCT03481309|10108772|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
9049322|NCT03481309|10108773|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
9049323|NCT03481309|10108774|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
9049324|NCT03481309|10108775|FG003|NOT COMPLETED|Third Intervention (1 Day)||0
9049325|NCT03481309|10108776|FG004|NOT COMPLETED|Third Intervention (1 Day)||0
9049326|NCT03481309|10108777|FG005|NOT COMPLETED|Third Intervention (1 Day)||0
9049327|NCT03481595|10108787|FG000|STARTED|Overall Study||146
9049328|NCT03481595|10108788|FG001|STARTED|Overall Study||148
9049329|NCT03481595|10108787|FG000|COMPLETED|Overall Study||143
9049330|NCT03481595|10108788|FG001|COMPLETED|Overall Study||127
9049331|NCT03481595|10108787|FG000|NOT COMPLETED|Overall Study||3
9049332|NCT03481595|10108788|FG001|NOT COMPLETED|Overall Study||21
9049333|NCT03481725|10108796|FG000|STARTED|Overall Study||31
9049334|NCT03481725|10108797|FG001|STARTED|Overall Study||34
9049335|NCT03481725|10108796|FG000|COMPLETED|Overall Study||30
9049336|NCT03481725|10108797|FG001|COMPLETED|Overall Study||34
9049337|NCT03481725|10108796|FG000|NOT COMPLETED|Overall Study||1
9049338|NCT03481725|10108797|FG001|NOT COMPLETED|Overall Study||0
9049339|NCT03481816|10108807|FG000|STARTED|Starting Dose||6
9049340|NCT03481816|10108808|FG001|STARTED|Starting Dose||0
9049341|NCT03481816|10108807|FG000|COMPLETED|Starting Dose||5
9049342|NCT03481816|10108808|FG001|COMPLETED|Starting Dose||0
9049343|NCT03481816|10108807|FG000|NOT COMPLETED|Starting Dose||1
9049344|NCT03481816|10108808|FG001|NOT COMPLETED|Starting Dose||0
9049345|NCT03481816|10108807|FG000|STARTED|Dose Expansion||0
9049346|NCT03481816|10108808|FG001|STARTED|Dose Expansion||12
9049347|NCT03481816|10108807|FG000|COMPLETED|Dose Expansion||0
9049348|NCT03481816|10108808|FG001|COMPLETED|Dose Expansion||0
9049349|NCT03481816|10108807|FG000|NOT COMPLETED|Dose Expansion||0
9049350|NCT03481816|10108808|FG001|NOT COMPLETED|Dose Expansion||12
9049351|NCT03482011|10108818|FG000|STARTED|Induction Period (16 Weeks)||107
9049352|NCT03482011|10108819|FG001|STARTED|Induction Period (16 Weeks)||423
9049353|NCT03482011|10108820|FG002|STARTED|Induction Period (16 Weeks)|Participants were assigned to this arm during maintenance period.|0
9049354|NCT03482011|10108821|FG003|STARTED|Induction Period (16 Weeks)|Participants were assigned to this arm during maintenance period.|0
9049355|NCT03482011|10108822|FG004|STARTED|Induction Period (16 Weeks)|Participants were assigned to this arm during maintenance period.|0
9049356|NCT03482011|10108823|FG005|STARTED|Induction Period (16 Weeks)|Participants were assigned to this arm during maintenance period.|0
9049357|NCT03482011|10108824|FG006|STARTED|Induction Period (16 Weeks)|Participants were assigned to this arm during maintenance period.|0
9049358|NCT03482011|10108825|FG007|STARTED|Induction Period (16 Weeks)|Participants were assigned to this arm during maintenance period.|0
9049359|NCT03482011|10108818|FG000|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||107
9049360|NCT03482011|10108819|FG001|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||422
9049361|NCT03482011|10108820|FG002|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
9049362|NCT03482011|10108821|FG003|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
9049363|NCT03482011|10108822|FG004|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
9049364|NCT03482011|10108823|FG005|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
9049365|NCT03482011|10108824|FG006|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
9049366|NCT03482011|10108825|FG007|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
9049367|NCT03482011|10108818|FG000|COMPLETED|Induction Period (16 Weeks)||101
9049368|NCT03482011|10108819|FG001|COMPLETED|Induction Period (16 Weeks)||412
9049369|NCT03482011|10108820|FG002|COMPLETED|Induction Period (16 Weeks)||0
9049370|NCT03482011|10108821|FG003|COMPLETED|Induction Period (16 Weeks)||0
9049371|NCT03482011|10108822|FG004|COMPLETED|Induction Period (16 Weeks)||0
9049372|NCT03482011|10108823|FG005|COMPLETED|Induction Period (16 Weeks)||0
9049373|NCT03482011|10108824|FG006|COMPLETED|Induction Period (16 Weeks)||0
9049374|NCT03482011|10108825|FG007|COMPLETED|Induction Period (16 Weeks)||0
9049375|NCT03482011|10108818|FG000|NOT COMPLETED|Induction Period (16 Weeks)||6
9049376|NCT03482011|10108819|FG001|NOT COMPLETED|Induction Period (16 Weeks)||11
9049377|NCT03482011|10108820|FG002|NOT COMPLETED|Induction Period (16 Weeks)||0
9049378|NCT03482011|10108821|FG003|NOT COMPLETED|Induction Period (16 Weeks)||0
9049379|NCT03482011|10108822|FG004|NOT COMPLETED|Induction Period (16 Weeks)||0
9049380|NCT03482011|10108823|FG005|NOT COMPLETED|Induction Period (16 Weeks)||0
9049381|NCT03482011|10108824|FG006|NOT COMPLETED|Induction Period (16 Weeks)||0
9049382|NCT03482011|10108825|FG007|NOT COMPLETED|Induction Period (16 Weeks)||0
9049383|NCT03482011|10108818|FG000|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during induction period.|0
9049384|NCT03482011|10108819|FG001|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during induction period.|0
9049385|NCT03482011|10108820|FG002|STARTED|Maintenance Period (36 Weeks)||7
9049386|NCT03482011|10108821|FG003|STARTED|Maintenance Period (36 Weeks)||94
9049387|NCT03482011|10108822|FG004|STARTED|Maintenance Period (36 Weeks)||91
9049388|NCT03482011|10108823|FG005|STARTED|Maintenance Period (36 Weeks)||90
9049389|NCT03482011|10108824|FG006|STARTED|Maintenance Period (36 Weeks)||91
9049390|NCT03482011|10108825|FG007|STARTED|Maintenance Period (36 Weeks)||140
9049391|NCT03482011|10108818|FG000|Relapse|Maintenance Period (36 Weeks)||0
9049392|NCT03482011|10108819|FG001|Relapse|Maintenance Period (36 Weeks)||0
9049393|NCT03482011|10108820|FG002|Relapse|Maintenance Period (36 Weeks)||1
9049394|NCT03482011|10108821|FG003|Relapse|Maintenance Period (36 Weeks)||0
9049395|NCT03482011|10108822|FG004|Relapse|Maintenance Period (36 Weeks)||41
9049396|NCT03482011|10108823|FG005|Relapse|Maintenance Period (36 Weeks)||3
9049397|NCT03482011|10108824|FG006|Relapse|Maintenance Period (36 Weeks)||2
9049398|NCT03482011|10108825|FG007|Relapse|Maintenance Period (36 Weeks)||0
9049399|NCT03482011|10108818|FG000|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||0
9049400|NCT03482011|10108819|FG001|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||0
9049401|NCT03482011|10108820|FG002|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||6
9049402|NCT03482011|10108821|FG003|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||88
9049403|NCT03482011|10108822|FG004|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||86
9049404|NCT03482011|10108823|FG005|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||85
9049405|NCT03482011|10108824|FG006|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||87
9049406|NCT03482011|10108825|FG007|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||121
9049407|NCT03482011|10108818|FG000|COMPLETED|Maintenance Period (36 Weeks)||0
9049408|NCT03482011|10108819|FG001|COMPLETED|Maintenance Period (36 Weeks)||0
9049409|NCT03482011|10108820|FG002|COMPLETED|Maintenance Period (36 Weeks)||6
9049410|NCT03482011|10108821|FG003|COMPLETED|Maintenance Period (36 Weeks)||90
9049411|NCT03482011|10108822|FG004|COMPLETED|Maintenance Period (36 Weeks)||86
9049412|NCT03482011|10108823|FG005|COMPLETED|Maintenance Period (36 Weeks)||86
9049413|NCT03482011|10108824|FG006|COMPLETED|Maintenance Period (36 Weeks)||87
9049414|NCT03482011|10108825|FG007|COMPLETED|Maintenance Period (36 Weeks)||123
9049415|NCT03482011|10108818|FG000|NOT COMPLETED|Maintenance Period (36 Weeks)||0
9049416|NCT03482011|10108819|FG001|NOT COMPLETED|Maintenance Period (36 Weeks)||0
9049417|NCT03482011|10108820|FG002|NOT COMPLETED|Maintenance Period (36 Weeks)||1
9049418|NCT03482011|10108821|FG003|NOT COMPLETED|Maintenance Period (36 Weeks)||4
9049419|NCT03482011|10108822|FG004|NOT COMPLETED|Maintenance Period (36 Weeks)||5
9049420|NCT03482011|10108823|FG005|NOT COMPLETED|Maintenance Period (36 Weeks)||4
9049421|NCT03482011|10108824|FG006|NOT COMPLETED|Maintenance Period (36 Weeks)||4
9049422|NCT03482011|10108825|FG007|NOT COMPLETED|Maintenance Period (36 Weeks)||17
9049423|NCT03482011|10108818|FG000|STARTED|Follow-up Period (12 Weeks)|Participants were assigned to this arm during induction period.|0
9049424|NCT03482011|10108819|FG001|STARTED|Follow-up Period (12 Weeks)|Participants were assigned to this arm during induction period.|0
9049425|NCT03482011|10108820|FG002|STARTED|Follow-up Period (12 Weeks)||1
9049426|NCT03482011|10108821|FG003|STARTED|Follow-up Period (12 Weeks)||10
9049427|NCT03482011|10108822|FG004|STARTED|Follow-up Period (12 Weeks)||2
9049428|NCT03482011|10108823|FG005|STARTED|Follow-up Period (12 Weeks)||4
9049429|NCT03482011|10108824|FG006|STARTED|Follow-up Period (12 Weeks)||4
9049430|NCT03482011|10108825|FG007|STARTED|Follow-up Period (12 Weeks)||21
9049431|NCT03482011|10108818|FG000|COMPLETED|Follow-up Period (12 Weeks)||0
9049432|NCT03482011|10108819|FG001|COMPLETED|Follow-up Period (12 Weeks)||0
9049433|NCT03482011|10108820|FG002|COMPLETED|Follow-up Period (12 Weeks)||0
9049434|NCT03482011|10108821|FG003|COMPLETED|Follow-up Period (12 Weeks)||5
9049435|NCT03482011|10108822|FG004|COMPLETED|Follow-up Period (12 Weeks)||2
9049436|NCT03482011|10108823|FG005|COMPLETED|Follow-up Period (12 Weeks)||3
9049437|NCT03482011|10108824|FG006|COMPLETED|Follow-up Period (12 Weeks)||2
9049438|NCT03482011|10108825|FG007|COMPLETED|Follow-up Period (12 Weeks)||4
9049439|NCT03482011|10108818|FG000|NOT COMPLETED|Follow-up Period (12 Weeks)||0
9049440|NCT03482011|10108819|FG001|NOT COMPLETED|Follow-up Period (12 Weeks)||0
9049441|NCT03482011|10108820|FG002|NOT COMPLETED|Follow-up Period (12 Weeks)||1
9049442|NCT03482011|10108821|FG003|NOT COMPLETED|Follow-up Period (12 Weeks)||5
9049443|NCT03482011|10108822|FG004|NOT COMPLETED|Follow-up Period (12 Weeks)||0
9049444|NCT03482011|10108823|FG005|NOT COMPLETED|Follow-up Period (12 Weeks)||1
9049445|NCT03482011|10108824|FG006|NOT COMPLETED|Follow-up Period (12 Weeks)||2
9049446|NCT03482011|10108825|FG007|NOT COMPLETED|Follow-up Period (12 Weeks)||17
9049447|NCT03482453|10108862|FG000|STARTED|Part 1 (1 Day)||10
9049448|NCT03482453|10108863|FG001|STARTED|Part 1 (1 Day)||6
9049449|NCT03482453|10108864|FG002|STARTED|Part 1 (1 Day)||6
9049450|NCT03482453|10108865|FG003|STARTED|Part 1 (1 Day)||6
9049451|NCT03482453|10108866|FG004|STARTED|Part 1 (1 Day)||6
9049452|NCT03482453|10108867|FG005|STARTED|Part 1 (1 Day)||6
9049453|NCT03482453|10108868|FG006|STARTED|Part 1 (1 Day)||0
9049454|NCT03482453|10108869|FG007|STARTED|Part 1 (1 Day)||0
9049455|NCT03482453|10108870|FG008|STARTED|Part 1 (1 Day)||0
9049456|NCT03482453|10108871|FG009|STARTED|Part 1 (1 Day)||0
9049457|NCT03482453|10108872|FG010|STARTED|Part 1 (1 Day)||0
9049458|NCT03482453|10108873|FG011|STARTED|Part 1 (1 Day)||0
9049459|NCT03482453|10108862|FG000|COMPLETED|Part 1 (1 Day)||10
9049460|NCT03482453|10108863|FG001|COMPLETED|Part 1 (1 Day)||6
9049461|NCT03482453|10108864|FG002|COMPLETED|Part 1 (1 Day)||6
9049462|NCT03482453|10108865|FG003|COMPLETED|Part 1 (1 Day)||6
9049463|NCT03482453|10108866|FG004|COMPLETED|Part 1 (1 Day)||6
9049464|NCT03482453|10108867|FG005|COMPLETED|Part 1 (1 Day)||6
9049465|NCT03482453|10108868|FG006|COMPLETED|Part 1 (1 Day)||0
9049466|NCT03482453|10108869|FG007|COMPLETED|Part 1 (1 Day)||0
9049467|NCT03482453|10108870|FG008|COMPLETED|Part 1 (1 Day)||0
9049468|NCT03482453|10108871|FG009|COMPLETED|Part 1 (1 Day)||0
9049469|NCT03482453|10108872|FG010|COMPLETED|Part 1 (1 Day)||0
9049470|NCT03482453|10108873|FG011|COMPLETED|Part 1 (1 Day)||0
9049471|NCT03482453|10108862|FG000|NOT COMPLETED|Part 1 (1 Day)||0
9049472|NCT03482453|10108863|FG001|NOT COMPLETED|Part 1 (1 Day)||0
9049473|NCT03482453|10108864|FG002|NOT COMPLETED|Part 1 (1 Day)||0
9049474|NCT03482453|10108865|FG003|NOT COMPLETED|Part 1 (1 Day)||0
9049475|NCT03482453|10108866|FG004|NOT COMPLETED|Part 1 (1 Day)||0
9049476|NCT03482453|10108867|FG005|NOT COMPLETED|Part 1 (1 Day)||0
9049477|NCT03482453|10108868|FG006|NOT COMPLETED|Part 1 (1 Day)||0
9049478|NCT03482453|10108869|FG007|NOT COMPLETED|Part 1 (1 Day)||0
9049479|NCT03482453|10108870|FG008|NOT COMPLETED|Part 1 (1 Day)||0
9049480|NCT03482453|10108871|FG009|NOT COMPLETED|Part 1 (1 Day)||0
9049481|NCT03482453|10108872|FG010|NOT COMPLETED|Part 1 (1 Day)||0
9049482|NCT03482453|10108873|FG011|NOT COMPLETED|Part 1 (1 Day)||0
9049483|NCT03482453|10108862|FG000|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
9049484|NCT03482453|10108863|FG001|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
9049485|NCT03482453|10108864|FG002|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
9049486|NCT03482453|10108865|FG003|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
9049487|NCT03482453|10108866|FG004|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
9049488|NCT03482453|10108867|FG005|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
9049489|NCT03482453|10108868|FG006|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||3
9049490|NCT03482453|10108869|FG007|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||3
9049491|NCT03482453|10108870|FG008|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||5
9049492|NCT03482453|10108871|FG009|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||5
9049493|NCT03482453|10108872|FG010|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||7
9049494|NCT03482453|10108873|FG011|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||6
9049495|NCT03482453|10108862|FG000|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
9049496|NCT03482453|10108863|FG001|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
9049497|NCT03482453|10108864|FG002|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
9049498|NCT03482453|10108865|FG003|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
9049499|NCT03482453|10108866|FG004|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
9049500|NCT03482453|10108867|FG005|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
9049501|NCT03482453|10108868|FG006|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||3
9049502|NCT03482453|10108869|FG007|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||3
9049503|NCT03482453|10108870|FG008|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||5
9049504|NCT03482453|10108871|FG009|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||5
9049505|NCT03482453|10108872|FG010|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||6
9049506|NCT03482453|10108873|FG011|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||6
9049507|NCT03482453|10108862|FG000|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
9049508|NCT03482453|10108863|FG001|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
9049509|NCT03482453|10108864|FG002|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
9049510|NCT03482453|10108865|FG003|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
9049511|NCT03482453|10108866|FG004|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
9049512|NCT03482453|10108867|FG005|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
9049513|NCT03482453|10108868|FG006|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
9049514|NCT03482453|10108869|FG007|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
9049515|NCT03482453|10108870|FG008|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
9049516|NCT03482453|10108871|FG009|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
9049517|NCT03482453|10108872|FG010|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||1
9049518|NCT03482453|10108873|FG011|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
9049519|NCT03482453|10108862|FG000|STARTED|Parts 2, 3 Washout Period (7 Days)||0
9049520|NCT03482453|10108863|FG001|STARTED|Parts 2, 3 Washout Period (7 Days)||0
9049521|NCT03482453|10108864|FG002|STARTED|Parts 2, 3 Washout Period (7 Days)||0
9049522|NCT03482453|10108865|FG003|STARTED|Parts 2, 3 Washout Period (7 Days)||0
9049523|NCT03482453|10108866|FG004|STARTED|Parts 2, 3 Washout Period (7 Days)||0
9049524|NCT03482453|10108867|FG005|STARTED|Parts 2, 3 Washout Period (7 Days)||0
9049525|NCT03482453|10108868|FG006|STARTED|Parts 2, 3 Washout Period (7 Days)||3
9049526|NCT03482453|10108869|FG007|STARTED|Parts 2, 3 Washout Period (7 Days)||3
9049527|NCT03482453|10108870|FG008|STARTED|Parts 2, 3 Washout Period (7 Days)||5
9049528|NCT03482453|10108871|FG009|STARTED|Parts 2, 3 Washout Period (7 Days)||5
9049529|NCT03482453|10108872|FG010|STARTED|Parts 2, 3 Washout Period (7 Days)||6
9049530|NCT03482453|10108873|FG011|STARTED|Parts 2, 3 Washout Period (7 Days)||6
9049531|NCT03482453|10108862|FG000|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
9049532|NCT03482453|10108863|FG001|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
9049533|NCT03482453|10108864|FG002|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
9049534|NCT03482453|10108865|FG003|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
9049535|NCT03482453|10108866|FG004|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
9049536|NCT03482453|10108867|FG005|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
9049537|NCT03482453|10108868|FG006|COMPLETED|Parts 2, 3 Washout Period (7 Days)||3
9049538|NCT03482453|10108869|FG007|COMPLETED|Parts 2, 3 Washout Period (7 Days)||3
9049539|NCT03482453|10108870|FG008|COMPLETED|Parts 2, 3 Washout Period (7 Days)||5
9049540|NCT03482453|10108871|FG009|COMPLETED|Parts 2, 3 Washout Period (7 Days)||5
9049541|NCT03482453|10108872|FG010|COMPLETED|Parts 2, 3 Washout Period (7 Days)||6
9049542|NCT03482453|10108873|FG011|COMPLETED|Parts 2, 3 Washout Period (7 Days)||6
9049543|NCT03482453|10108862|FG000|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
9049544|NCT03482453|10108863|FG001|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
9049545|NCT03482453|10108864|FG002|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
9049546|NCT03482453|10108865|FG003|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
9049547|NCT03482453|10108866|FG004|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
9049548|NCT03482453|10108867|FG005|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
9049549|NCT03482453|10108868|FG006|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
9049550|NCT03482453|10108869|FG007|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
9049551|NCT03482453|10108870|FG008|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
9049552|NCT03482453|10108871|FG009|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
9049553|NCT03482453|10108872|FG010|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
9049554|NCT03482453|10108873|FG011|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
9049555|NCT03482453|10108862|FG000|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
9049556|NCT03482453|10108863|FG001|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
9049557|NCT03482453|10108864|FG002|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
9049558|NCT03482453|10108865|FG003|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
9049559|NCT03482453|10108866|FG004|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
9049560|NCT03482453|10108867|FG005|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
9049561|NCT03482453|10108868|FG006|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||3
9049562|NCT03482453|10108869|FG007|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||3
9049563|NCT03482453|10108870|FG008|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||5
9049564|NCT03482453|10108871|FG009|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||5
9049565|NCT03482453|10108872|FG010|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||6
9049566|NCT03482453|10108873|FG011|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||6
9049567|NCT03482453|10108862|FG000|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
9049568|NCT03482453|10108863|FG001|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
9049569|NCT03482453|10108864|FG002|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
9049570|NCT03482453|10108865|FG003|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
9049571|NCT03482453|10108866|FG004|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
9049572|NCT03482453|10108867|FG005|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
9049573|NCT03482453|10108868|FG006|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||3
9049574|NCT03482453|10108869|FG007|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||3
9049575|NCT03482453|10108870|FG008|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||5
9049576|NCT03482453|10108871|FG009|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||5
9049577|NCT03482453|10108872|FG010|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||6
9049578|NCT03482453|10108873|FG011|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||6
9049579|NCT03482453|10108862|FG000|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
9049580|NCT03482453|10108863|FG001|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
9049581|NCT03482453|10108864|FG002|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
9049582|NCT03482453|10108865|FG003|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
9049583|NCT03482453|10108866|FG004|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
9049584|NCT03482453|10108867|FG005|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
9049585|NCT03482453|10108868|FG006|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
9049586|NCT03482453|10108869|FG007|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
9049587|NCT03482453|10108870|FG008|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
9049588|NCT03482453|10108871|FG009|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
9049589|NCT03482453|10108872|FG010|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
9049590|NCT03482453|10108873|FG011|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
9049591|NCT03482583|10108912|FG000|STARTED|Overall Study||37
9049592|NCT03482583|10108913|FG001|STARTED|Overall Study||14
9049593|NCT03482583|10108914|FG002|STARTED|Overall Study||39
9049594|NCT03482583|10108912|FG000|COMPLETED|Overall Study||12
9049595|NCT03482583|10108913|FG001|COMPLETED|Overall Study||5
9049596|NCT03482583|10108914|FG002|COMPLETED|Overall Study||18
9049597|NCT03482583|10108912|FG000|NOT COMPLETED|Overall Study||25
9049598|NCT03482583|10108913|FG001|NOT COMPLETED|Overall Study||9
9049599|NCT03482583|10108914|FG002|NOT COMPLETED|Overall Study||21
9049600|NCT03482635|10108927|FG000|STARTED|Overall Study||23
9049601|NCT03482635|10108928|FG001|STARTED|Overall Study||24
9049602|NCT03482635|10108929|FG002|STARTED|Overall Study||23
9049603|NCT03482635|10108930|FG003|STARTED|Overall Study||28
9049604|NCT03482635|10108927|FG000|Treated|Overall Study||23
9049605|NCT03482635|10108928|FG001|Treated|Overall Study||24
9049606|NCT03482635|10108929|FG002|Treated|Overall Study||23
9049607|NCT03482635|10108930|FG003|Treated|Overall Study||27
9049608|NCT03482635|10108927|FG000|COMPLETED|Overall Study||18
9049609|NCT03482635|10108928|FG001|COMPLETED|Overall Study||21
9049610|NCT03482635|10108929|FG002|COMPLETED|Overall Study||22
9049611|NCT03482635|10108930|FG003|COMPLETED|Overall Study||20
9049612|NCT03482635|10108927|FG000|NOT COMPLETED|Overall Study||5
9049613|NCT03482635|10108928|FG001|NOT COMPLETED|Overall Study||3
9049614|NCT03482635|10108929|FG002|NOT COMPLETED|Overall Study||1
9049615|NCT03482635|10108930|FG003|NOT COMPLETED|Overall Study||8
9049616|NCT03482713|10108942|FG000|STARTED|Overall Study||11
9049617|NCT03482713|10108943|FG001|STARTED|Overall Study||12
9049618|NCT03482713|10108942|FG000|COMPLETED|Overall Study||11
9049619|NCT03482713|10108943|FG001|COMPLETED|Overall Study||12
9049620|NCT03482713|10108942|FG000|NOT COMPLETED|Overall Study||0
9049621|NCT03482713|10108943|FG001|NOT COMPLETED|Overall Study||0
9049622|NCT03482882|10108949|FG000|STARTED|Overall Study||47
9049623|NCT03482882|10108949|FG000|COMPLETED|Overall Study||40
9049624|NCT03482882|10108949|FG000|NOT COMPLETED|Overall Study||7
9049625|NCT03482973|10108955|FG000|STARTED|Overall Study||40
9049626|NCT03482973|10108956|FG001|STARTED|Overall Study||40
9049627|NCT03482973|10108955|FG000|COMPLETED|Overall Study||40
9049628|NCT03482973|10108956|FG001|COMPLETED|Overall Study||40
9049629|NCT03482973|10108955|FG000|NOT COMPLETED|Overall Study||0
9049630|NCT03482973|10108956|FG001|NOT COMPLETED|Overall Study||0
9049631|NCT03483506|10108962|FG000|STARTED|Overall Study||12
9049632|NCT03483506|10108962|FG000|COMPLETED|Overall Study||12
9049633|NCT03483506|10108962|FG000|NOT COMPLETED|Overall Study||0
9049634|NCT03483623|10108968|FG000|STARTED|Overall Study||44
9049635|NCT03483623|10108968|FG000|Started NATO WELP|Overall Study||44
9049636|NCT03483623|10108968|FG000|Completeded NATO WELP|Overall Study|1 subject was withdrawn after the target of 43 complete sets was achieved|43
9049637|NCT03483623|10108968|FG000|Started NATO FIS|Overall Study||44
9049638|NCT03483623|10108968|FG000|Completed NATO FIS|Overall Study|1 subject was withdrawn after the target of 43 complete sets was achieved|43
9049639|NCT03483623|10108968|FG000|Started RAVEN WELP|Overall Study||44
9049640|NCT03483623|10108968|FG000|Completed RAVEN WELP|Overall Study|1 subject was withdrawn after the target of 43 complete sets was achieved|43
9049641|NCT03483623|10108968|FG000|Started RAVEN FIS|Overall Study||44
9049642|NCT03483623|10108968|FG000|Completed RAVEN FIS|Overall Study|1 subject was withdrawn after the target of 43 complete sets was achieved|43
9049643|NCT03483623|10108968|FG000|COMPLETED|Overall Study|1 subject was withdrawn after the target of 43 complete sets was achieved|43
9049644|NCT03483623|10108968|FG000|NOT COMPLETED|Overall Study||1
9049645|NCT03483675|10108974|FG000|STARTED|Overall Study||9
9049646|NCT03483675|10108975|FG001|STARTED|Overall Study||8
9049647|NCT03483675|10108974|FG000|COMPLETED|Overall Study||9
9049648|NCT03483675|10108975|FG001|COMPLETED|Overall Study||8
9049649|NCT03483675|10108974|FG000|NOT COMPLETED|Overall Study||0
9049650|NCT03483675|10108975|FG001|NOT COMPLETED|Overall Study||0
9049651|NCT03483896|10108984|FG000|STARTED|Overall Study||33
9049652|NCT03483896|10108985|FG001|STARTED|Overall Study||50
9049653|NCT03483896|10108984|FG000|COMPLETED|Overall Study||31
9049654|NCT03483896|10108985|FG001|COMPLETED|Overall Study||46
9049655|NCT03483896|10108984|FG000|NOT COMPLETED|Overall Study||2
9049656|NCT03483896|10108985|FG001|NOT COMPLETED|Overall Study||4
9049657|NCT03483935|10108993|FG000|STARTED|Stage 1: Dose Setting Study||7
9049658|NCT03483935|10108993|FG000|COMPLETED|Stage 1: Dose Setting Study||7
9049659|NCT03483935|10108993|FG000|NOT COMPLETED|Stage 1: Dose Setting Study||0
9049660|NCT03483935|10108993|FG000|STARTED|Stage 2: Randomised Controlled Trial|Participants were randomised to receiving treatment on the left or right side.|11
9049661|NCT03483935|10108993|FG000|AKs Treated|Stage 2: Randomised Controlled Trial||11
9049662|NCT03483935|10108993|FG000|AKs Not Treated|Stage 2: Randomised Controlled Trial||11
9049663|NCT03483935|10108993|FG000|COMPLETED|Stage 2: Randomised Controlled Trial||11
9049664|NCT03483935|10108993|FG000|NOT COMPLETED|Stage 2: Randomised Controlled Trial||0
9049665|NCT03483961|10109011|FG000|STARTED|Overall Study||53
9049666|NCT03483961|10109012|FG001|STARTED|Overall Study||52
9049667|NCT03483961|10109013|FG002|STARTED|Overall Study||51
9049668|NCT03483961|10109014|FG003|STARTED|Overall Study||50
9049669|NCT03483961|10109015|FG004|STARTED|Overall Study||53
9049670|NCT03483961|10109016|FG005|STARTED|Overall Study||53
9049671|NCT03483961|10109017|FG006|STARTED|Overall Study||51
9049672|NCT03483961|10109018|FG007|STARTED|Overall Study||52
9049673|NCT03483961|10109019|FG008|STARTED|Overall Study||20
9049674|NCT03483961|10109020|FG009|STARTED|Overall Study||10
9049675|NCT03483961|10109011|FG000|Exposed / Safety|Overall Study||53
9049676|NCT03483961|10109012|FG001|Exposed / Safety|Overall Study||52
9049677|NCT03483961|10109013|FG002|Exposed / Safety|Overall Study|One subject was randomized to Group 3 but treated in Group 4 due to a dispensing error.|50
9049678|NCT03483961|10109014|FG003|Exposed / Safety|Overall Study|One subject was randomized to Group 3 but treated in Group 4 due to a dispensing error.|51
9049679|NCT03483961|10109015|FG004|Exposed / Safety|Overall Study|One subject did not receive PXVX0317 but is in the Exposed / Safety population because of receipt of placebo.|53
9049680|NCT03483961|10109016|FG005|Exposed / Safety|Overall Study||53
9049681|NCT03483961|10109017|FG006|Exposed / Safety|Overall Study|One subject did not receive PXVX0317 but is in the Exposed / Safety population because of receipt of placebo.|51
9049682|NCT03483961|10109018|FG007|Exposed / Safety|Overall Study|Two subjects did not receive PXVX0317 but are in the Exposed / Safety population because of receipt of placebo.|52
9049683|NCT03483961|10109019|FG008|Exposed / Safety|Overall Study||20
9049684|NCT03483961|10109020|FG009|Exposed / Safety|Overall Study||10
9049685|NCT03483961|10109011|FG000|Immunogenicity-evaluable|Overall Study||47
9049686|NCT03483961|10109012|FG001|Immunogenicity-evaluable|Overall Study||44
9049687|NCT03483961|10109013|FG002|Immunogenicity-evaluable|Overall Study||44
9049688|NCT03483961|10109014|FG003|Immunogenicity-evaluable|Overall Study||45
9049689|NCT03483961|10109015|FG004|Immunogenicity-evaluable|Overall Study||48
9049690|NCT03483961|10109016|FG005|Immunogenicity-evaluable|Overall Study||48
9049691|NCT03483961|10109017|FG006|Immunogenicity-evaluable|Overall Study||47
9049692|NCT03483961|10109018|FG007|Immunogenicity-evaluable|Overall Study||50
9049693|NCT03483961|10109019|FG008|Immunogenicity-evaluable|Overall Study||20
9049694|NCT03483961|10109020|FG009|Immunogenicity-evaluable|Overall Study||10
9049695|NCT03483961|10109011|FG000|COMPLETED|Overall Study||42
9049696|NCT03483961|10109012|FG001|COMPLETED|Overall Study||42
9049697|NCT03483961|10109013|FG002|COMPLETED|Overall Study||39
9049698|NCT03483961|10109014|FG003|COMPLETED|Overall Study||41
9049699|NCT03483961|10109015|FG004|COMPLETED|Overall Study||43
9049700|NCT03483961|10109016|FG005|COMPLETED|Overall Study||47
9049701|NCT03483961|10109017|FG006|COMPLETED|Overall Study||46
9049702|NCT03483961|10109018|FG007|COMPLETED|Overall Study||39
9049703|NCT03483961|10109019|FG008|COMPLETED|Overall Study||18
9049704|NCT03483961|10109020|FG009|COMPLETED|Overall Study||10
9049705|NCT03483961|10109011|FG000|NOT COMPLETED|Overall Study||11
9049706|NCT03483961|10109012|FG001|NOT COMPLETED|Overall Study||10
9049707|NCT03483961|10109013|FG002|NOT COMPLETED|Overall Study||12
9049708|NCT03483961|10109014|FG003|NOT COMPLETED|Overall Study||9
9049709|NCT03483961|10109015|FG004|NOT COMPLETED|Overall Study||10
9049710|NCT03483961|10109016|FG005|NOT COMPLETED|Overall Study||6
9049711|NCT03483961|10109017|FG006|NOT COMPLETED|Overall Study||5
9049712|NCT03483961|10109018|FG007|NOT COMPLETED|Overall Study||13
9049713|NCT03483961|10109019|FG008|NOT COMPLETED|Overall Study||2
9049714|NCT03483961|10109020|FG009|NOT COMPLETED|Overall Study||0
9049715|NCT03484273|10109041|FG000|STARTED|Overall Study|This was a crossover trial. A total of 32 participants were enrolled in this study.|32
9049716|NCT03484273|10109041|FG000|COMPLETED|Overall Study|This was a crossover trial. A total of 30 participants completed all 4 arms.|30
9049717|NCT03484273|10109041|FG000|NOT COMPLETED|Overall Study||2
9049718|NCT03484429|10109055|FG000|STARTED|Overall Study||8
9049719|NCT03484429|10109056|FG001|STARTED|Overall Study||8
9049720|NCT03484429|10109055|FG000|Postamputation Week 1-4|Overall Study||8
9049721|NCT03484429|10109056|FG001|Postamputation Week 1-4|Overall Study||8
9049722|NCT03484429|10109055|FG000|Postamputation Week 5-8|Overall Study||5
9049723|NCT03484429|10109056|FG001|Postamputation Week 5-8|Overall Study||8
9049724|NCT03484429|10109055|FG000|Postamputation Month 3|Overall Study||5
9049725|NCT03484429|10109056|FG001|Postamputation Month 3|Overall Study||7
9049726|NCT03484429|10109055|FG000|COMPLETED|Overall Study||5
9049727|NCT03484429|10109056|FG001|COMPLETED|Overall Study||8
9049728|NCT03484429|10109055|FG000|NOT COMPLETED|Overall Study||3
9049729|NCT03484429|10109056|FG001|NOT COMPLETED|Overall Study||0
9049730|NCT03485222|10109064|FG000|STARTED|Overall Study||42
9049731|NCT03485222|10109065|FG001|STARTED|Overall Study||42
9049732|NCT03485222|10109064|FG000|COMPLETED|Overall Study||40
9049733|NCT03485222|10109065|FG001|COMPLETED|Overall Study||40
9049734|NCT03485222|10109064|FG000|NOT COMPLETED|Overall Study||2
9049735|NCT03485222|10109065|FG001|NOT COMPLETED|Overall Study||2
9049736|NCT03485495|10109073|FG000|STARTED|Overall Study||65
9049737|NCT03485495|10109074|FG001|STARTED|Overall Study||59
9049738|NCT03485495|10109073|FG000|COMPLETED|Overall Study||64
9049739|NCT03485495|10109074|FG001|COMPLETED|Overall Study||59
9049740|NCT03485495|10109073|FG000|NOT COMPLETED|Overall Study||1
9049741|NCT03485495|10109074|FG001|NOT COMPLETED|Overall Study||0
9049742|NCT03485976|10109080|FG000|STARTED|Overall Study||12
9049743|NCT03485976|10109080|FG000|COMPLETED|Overall Study||11
9049744|NCT03485976|10109080|FG000|NOT COMPLETED|Overall Study||1
9049745|NCT03486392|10109089|FG000|STARTED|Overall Study||60
9049746|NCT03486392|10109090|FG001|STARTED|Overall Study||59
9049747|NCT03486392|10109091|FG002|STARTED|Overall Study||118
9049748|NCT03486392|10109092|FG003|STARTED|Overall Study||118
9049749|NCT03486392|10109093|FG004|STARTED|Overall Study||119
9049750|NCT03486392|10109089|FG000|COMPLETED|Overall Study||57
9049751|NCT03486392|10109090|FG001|COMPLETED|Overall Study||59
9049752|NCT03486392|10109091|FG002|COMPLETED|Overall Study||104
9049753|NCT03486392|10109092|FG003|COMPLETED|Overall Study||109
9049754|NCT03486392|10109093|FG004|COMPLETED|Overall Study||115
9049755|NCT03486392|10109089|FG000|NOT COMPLETED|Overall Study||3
9049756|NCT03486392|10109090|FG001|NOT COMPLETED|Overall Study||0
9049757|NCT03486392|10109091|FG002|NOT COMPLETED|Overall Study||14
9049758|NCT03486392|10109092|FG003|NOT COMPLETED|Overall Study||9
9049759|NCT03486392|10109093|FG004|NOT COMPLETED|Overall Study||4
9049760|NCT03486834|10109108|FG000|STARTED|Overall Study||733
9049761|NCT03486834|10109109|FG001|STARTED|Overall Study||733
9049762|NCT03486834|10109110|FG002|STARTED|Overall Study||734
9049763|NCT03486834|10109108|FG000|Treatment 1|Overall Study||729
9049764|NCT03486834|10109109|FG001|Treatment 1|Overall Study||729
9049765|NCT03486834|10109110|FG002|Treatment 1|Overall Study||733
9049766|NCT03486834|10109108|FG000|Treatment 2|Overall Study||680
9049767|NCT03486834|10109109|FG001|Treatment 2|Overall Study||680
9049768|NCT03486834|10109110|FG002|Treatment 2|Overall Study||679
9049769|NCT03486834|10109108|FG000|Treatment 3|Overall Study||614
9049770|NCT03486834|10109109|FG001|Treatment 3|Overall Study||631
9049771|NCT03486834|10109110|FG002|Treatment 3|Overall Study||622
9049772|NCT03486834|10109108|FG000|COMPLETED|Overall Study||614
9049773|NCT03486834|10109109|FG001|COMPLETED|Overall Study||631
9049774|NCT03486834|10109110|FG002|COMPLETED|Overall Study||622
9049775|NCT03486834|10109108|FG000|NOT COMPLETED|Overall Study||119
9049776|NCT03486834|10109109|FG001|NOT COMPLETED|Overall Study||102
9049777|NCT03486834|10109110|FG002|NOT COMPLETED|Overall Study||112
9049778|NCT03486990|10109129|FG000|STARTED|Overall Study||2
9049779|NCT03486990|10109130|FG001|STARTED|Overall Study||2
9049780|NCT03486990|10109131|FG002|STARTED|Overall Study||3
9049781|NCT03486990|10109132|FG003|STARTED|Overall Study||3
9049782|NCT03486990|10109133|FG004|STARTED|Overall Study||3
9049783|NCT03486990|10109134|FG005|STARTED|Overall Study||4
9049784|NCT03486990|10109135|FG006|STARTED|Overall Study||2
9049785|NCT03486990|10109136|FG007|STARTED|Overall Study||2
9049786|NCT03486990|10109137|FG008|STARTED|Overall Study||2
9049787|NCT03486990|10109129|FG000|COMPLETED|Overall Study||2
9049788|NCT03486990|10109130|FG001|COMPLETED|Overall Study||2
9049789|NCT03486990|10109131|FG002|COMPLETED|Overall Study||3
9049790|NCT03486990|10109132|FG003|COMPLETED|Overall Study||3
9049791|NCT03486990|10109133|FG004|COMPLETED|Overall Study||3
9049792|NCT03486990|10109134|FG005|COMPLETED|Overall Study||4
9049793|NCT03486990|10109135|FG006|COMPLETED|Overall Study||2
9049794|NCT03486990|10109136|FG007|COMPLETED|Overall Study||2
9049795|NCT03486990|10109137|FG008|COMPLETED|Overall Study||2
9049796|NCT03486990|10109129|FG000|NOT COMPLETED|Overall Study||0
9049797|NCT03486990|10109130|FG001|NOT COMPLETED|Overall Study||0
9049798|NCT03486990|10109131|FG002|NOT COMPLETED|Overall Study||0
9049799|NCT03486990|10109132|FG003|NOT COMPLETED|Overall Study||0
9049800|NCT03486990|10109133|FG004|NOT COMPLETED|Overall Study||0
9049801|NCT03486990|10109134|FG005|NOT COMPLETED|Overall Study||0
9049802|NCT03486990|10109135|FG006|NOT COMPLETED|Overall Study||0
9049803|NCT03486990|10109136|FG007|NOT COMPLETED|Overall Study||0
9049804|NCT03486990|10109137|FG008|NOT COMPLETED|Overall Study||0
9049805|NCT03487276|10109178|FG000|STARTED|Main Period (16 Weeks)||37
9049806|NCT03487276|10109179|FG001|STARTED|Main Period (16 Weeks)||34
9049807|NCT03487276|10109180|FG002|STARTED|Main Period (16 Weeks)||36
9049808|NCT03487276|10109181|FG003|STARTED|Main Period (16 Weeks)||36
9049809|NCT03487276|10109182|FG004|STARTED|Main Period (16 Weeks)||36
9049810|NCT03487276|10109178|FG000|COMPLETED|Main Period (16 Weeks)||34
9049811|NCT03487276|10109179|FG001|COMPLETED|Main Period (16 Weeks)||30
9049812|NCT03487276|10109180|FG002|COMPLETED|Main Period (16 Weeks)||32
9049813|NCT03487276|10109181|FG003|COMPLETED|Main Period (16 Weeks)||30
9049814|NCT03487276|10109182|FG004|COMPLETED|Main Period (16 Weeks)|One patient completed the Main Period but was lost to follow-up afterwards and not treated in the Extension Period|31
9049815|NCT03487276|10109178|FG000|NOT COMPLETED|Main Period (16 Weeks)||3
9049816|NCT03487276|10109179|FG001|NOT COMPLETED|Main Period (16 Weeks)||4
9049817|NCT03487276|10109180|FG002|NOT COMPLETED|Main Period (16 Weeks)||4
9049818|NCT03487276|10109181|FG003|NOT COMPLETED|Main Period (16 Weeks)||6
9049819|NCT03487276|10109182|FG004|NOT COMPLETED|Main Period (16 Weeks)||5
9049820|NCT03487276|10109178|FG000|STARTED|Extension Period (28 Weeks)||0
9049821|NCT03487276|10109179|FG001|STARTED|Extension Period (28 Weeks)||0
9049822|NCT03487276|10109180|FG002|STARTED|Extension Period (28 Weeks)||72
9049823|NCT03487276|10109181|FG003|STARTED|Extension Period (28 Weeks)||84
9049824|NCT03487276|10109182|FG004|STARTED|Extension Period (28 Weeks)||0
9049825|NCT03487276|10109178|FG000|Number of Patients in Cohort 1 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
9049826|NCT03487276|10109179|FG001|Number of Patients in Cohort 1 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
9049827|NCT03487276|10109180|FG002|Number of Patients in Cohort 1 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||16
9049828|NCT03487276|10109181|FG003|Number of Patients in Cohort 1 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||18
9049829|NCT03487276|10109182|FG004|Number of Patients in Cohort 1 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
9049830|NCT03487276|10109178|FG000|Number of Patients in Cohort 2 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
9049831|NCT03487276|10109179|FG001|Number of Patients in Cohort 2 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
9049832|NCT03487276|10109180|FG002|Number of Patients in Cohort 2 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||12
9049833|NCT03487276|10109181|FG003|Number of Patients in Cohort 2 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||18
9049834|NCT03487276|10109182|FG004|Number of Patients in Cohort 2 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
9049835|NCT03487276|10109178|FG000|Number of Patients in Cohort 3 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
9049836|NCT03487276|10109179|FG001|Number of Patients in Cohort 3 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
9049837|NCT03487276|10109180|FG002|Number of Patients in Cohort 3 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||17
9049838|NCT03487276|10109181|FG003|Number of Patients in Cohort 3 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||15
9049839|NCT03487276|10109182|FG004|Number of Patients in Cohort 3 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
9049840|NCT03487276|10109178|FG000|Number of Patients in Cohort 4 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
9049841|NCT03487276|10109179|FG001|Number of Patients in Cohort 4 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
9049842|NCT03487276|10109180|FG002|Number of Patients in Cohort 4 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||12
9049843|NCT03487276|10109181|FG003|Number of Patients in Cohort 4 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||18
9049844|NCT03487276|10109182|FG004|Number of Patients in Cohort 4 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
9049845|NCT03487276|10109178|FG000|Number of Patients in Cohort 5 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
9049846|NCT03487276|10109179|FG001|Number of Patients in Cohort 5 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
9049847|NCT03487276|10109180|FG002|Number of Patients in Cohort 5 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||15
9049848|NCT03487276|10109181|FG003|Number of Patients in Cohort 5 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||16
9049849|NCT03487276|10109182|FG004|Number of Patients in Cohort 5 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
9049850|NCT03487276|10109178|FG000|COMPLETED|Extension Period (28 Weeks)||0
9049851|NCT03487276|10109179|FG001|COMPLETED|Extension Period (28 Weeks)||0
9049852|NCT03487276|10109180|FG002|COMPLETED|Extension Period (28 Weeks)||67
9049853|NCT03487276|10109181|FG003|COMPLETED|Extension Period (28 Weeks)||54
9049854|NCT03487276|10109182|FG004|COMPLETED|Extension Period (28 Weeks)||0
9049855|NCT03487276|10109178|FG000|NOT COMPLETED|Extension Period (28 Weeks)||0
9049856|NCT03487276|10109179|FG001|NOT COMPLETED|Extension Period (28 Weeks)||0
9049857|NCT03487276|10109180|FG002|NOT COMPLETED|Extension Period (28 Weeks)||5
9049858|NCT03487276|10109181|FG003|NOT COMPLETED|Extension Period (28 Weeks)||30
9049859|NCT03487276|10109182|FG004|NOT COMPLETED|Extension Period (28 Weeks)||0
9049860|NCT03487445|10109205|FG000|STARTED|Randomization||25
9049861|NCT03487445|10109206|FG001|STARTED|Randomization||23
9049862|NCT03487445|10109205|FG000|COMPLETED|Randomization||24
9049863|NCT03487445|10109206|FG001|COMPLETED|Randomization||23
9049864|NCT03487445|10109205|FG000|NOT COMPLETED|Randomization||1
9049865|NCT03487445|10109206|FG001|NOT COMPLETED|Randomization||0
9049866|NCT03487445|10109205|FG000|STARTED|Treatment Period||24
9049867|NCT03487445|10109206|FG001|STARTED|Treatment Period||23
9049868|NCT03487445|10109205|FG000|Modified Full Analysis Set (mFAS)|Treatment Period||23
9049869|NCT03487445|10109206|FG001|Modified Full Analysis Set (mFAS)|Treatment Period||22
9049870|NCT03487445|10109205|FG000|Per Protocol Set|Treatment Period||20
9049871|NCT03487445|10109206|FG001|Per Protocol Set|Treatment Period||20
9049872|NCT03487445|10109205|FG000|COMPLETED|Treatment Period||24
9049873|NCT03487445|10109206|FG001|COMPLETED|Treatment Period||23
9049874|NCT03487445|10109205|FG000|NOT COMPLETED|Treatment Period||0
9049875|NCT03487445|10109206|FG001|NOT COMPLETED|Treatment Period||0
9049876|NCT03487549|10109214|FG000|STARTED|Overall Study||21
9049877|NCT03487549|10109215|FG001|STARTED|Overall Study||35
9049878|NCT03487549|10109214|FG000|COMPLETED|Overall Study||17
9049879|NCT03487549|10109215|FG001|COMPLETED|Overall Study||33
9049880|NCT03487549|10109214|FG000|NOT COMPLETED|Overall Study||4
9049881|NCT03487549|10109215|FG001|NOT COMPLETED|Overall Study||2
9049882|NCT03487588|10109221|FG000|STARTED|Overall Study||41
9049883|NCT03487588|10109221|FG000|COMPLETED|Overall Study||41
9049884|NCT03487588|10109221|FG000|NOT COMPLETED|Overall Study||0
9049885|NCT03487718|10109227|FG000|STARTED|Overall Study||12
9049886|NCT03487718|10109228|FG001|STARTED|Overall Study||15
9049887|NCT03487718|10109227|FG000|COMPLETED|Overall Study||11
9049888|NCT03487718|10109228|FG001|COMPLETED|Overall Study||11
9049889|NCT03487718|10109227|FG000|NOT COMPLETED|Overall Study||1
9049890|NCT03487718|10109228|FG001|NOT COMPLETED|Overall Study||4
9049891|NCT03487848|10109234|FG000|STARTED|Overall Study||5
9049892|NCT03487848|10109234|FG000|COMPLETED|Overall Study||4
9049893|NCT03487848|10109234|FG000|NOT COMPLETED|Overall Study||1
9049894|NCT03488108|10109240|FG000|STARTED|First Intervention (12 Weeks)||10
9049895|NCT03488108|10109241|FG001|STARTED|First Intervention (12 Weeks)||10
9049896|NCT03488108|10109240|FG000|COMPLETED|First Intervention (12 Weeks)||10
9049897|NCT03488108|10109241|FG001|COMPLETED|First Intervention (12 Weeks)||9
9049898|NCT03488108|10109240|FG000|NOT COMPLETED|First Intervention (12 Weeks)||0
9049899|NCT03488108|10109241|FG001|NOT COMPLETED|First Intervention (12 Weeks)||1
9049900|NCT03488108|10109240|FG000|STARTED|Washout (2 Months)||10
9049901|NCT03488108|10109241|FG001|STARTED|Washout (2 Months)||9
9049902|NCT03488108|10109240|FG000|COMPLETED|Washout (2 Months)||10
9049903|NCT03488108|10109241|FG001|COMPLETED|Washout (2 Months)||9
9049904|NCT03488108|10109240|FG000|NOT COMPLETED|Washout (2 Months)||0
9049905|NCT03488108|10109241|FG001|NOT COMPLETED|Washout (2 Months)||0
9049906|NCT03488108|10109240|FG000|STARTED|Second Intervention (12 Weeks)||10
9049907|NCT03488108|10109241|FG001|STARTED|Second Intervention (12 Weeks)||9
9049908|NCT03488108|10109240|FG000|COMPLETED|Second Intervention (12 Weeks)||9
9049909|NCT03488108|10109241|FG001|COMPLETED|Second Intervention (12 Weeks)||9
9049910|NCT03488108|10109240|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||1
9049911|NCT03488108|10109241|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||0
9049912|NCT03488225|10109249|FG000|STARTED|Overall Study||4
9049913|NCT03488225|10109249|FG000|COMPLETED|Overall Study||0
9049914|NCT03488225|10109249|FG000|NOT COMPLETED|Overall Study||4
9049915|NCT03488238|10109253|FG000|STARTED|Overall Study||31
9049916|NCT03488238|10109253|FG000|COMPLETED|Overall Study||29
9049917|NCT03488238|10109253|FG000|NOT COMPLETED|Overall Study||2
9049918|NCT03488849|10109260|FG000|STARTED|Overall Study||10
9049919|NCT03488849|10109261|FG001|STARTED|Overall Study||8
9049920|NCT03488849|10109262|FG002|STARTED|Overall Study||6
9049921|NCT03488849|10109260|FG000|COMPLETED|Overall Study||10
9049922|NCT03488849|10109261|FG001|COMPLETED|Overall Study||8
9049923|NCT03488849|10109262|FG002|COMPLETED|Overall Study||6
9049924|NCT03488849|10109260|FG000|NOT COMPLETED|Overall Study||0
9049925|NCT03488849|10109261|FG001|NOT COMPLETED|Overall Study||0
9049926|NCT03488849|10109262|FG002|NOT COMPLETED|Overall Study||0
9049927|NCT03488927|10109273|FG000|STARTED|Overall Study||305
9049928|NCT03488927|10109274|FG001|STARTED|Overall Study||432
9049929|NCT03488927|10109275|FG002|STARTED|Overall Study||531
9049930|NCT03488927|10109273|FG000|COMPLETED|Overall Study||261
9049931|NCT03488927|10109274|FG001|COMPLETED|Overall Study||314
9049932|NCT03488927|10109275|FG002|COMPLETED|Overall Study||314
9049933|NCT03488927|10109273|FG000|NOT COMPLETED|Overall Study||44
9049934|NCT03488927|10109274|FG001|NOT COMPLETED|Overall Study||118
9049935|NCT03488927|10109275|FG002|NOT COMPLETED|Overall Study||217
9049936|NCT03489304|10109283|FG000|STARTED|Overall Study||20
9049937|NCT03489304|10109283|FG000|COMPLETED|Overall Study||16
9049938|NCT03489304|10109283|FG000|NOT COMPLETED|Overall Study||4
9049939|NCT03489343|10109294|FG000|STARTED|Overall Study||1
9049940|NCT03489343|10109295|FG001|STARTED|Overall Study||1
9049941|NCT03489343|10109296|FG002|STARTED|Overall Study||3
9049942|NCT03489343|10109297|FG003|STARTED|Overall Study||3
9049943|NCT03489343|10109298|FG004|STARTED|Overall Study||3
9049944|NCT03489343|10109299|FG005|STARTED|Overall Study||7
9049945|NCT03489343|10109300|FG006|STARTED|Overall Study||6
9049946|NCT03489343|10109294|FG000|COMPLETED|Overall Study||0
9049947|NCT03489343|10109295|FG001|COMPLETED|Overall Study||0
9049948|NCT03489343|10109296|FG002|COMPLETED|Overall Study||0
9049949|NCT03489343|10109297|FG003|COMPLETED|Overall Study||0
9049950|NCT03489343|10109298|FG004|COMPLETED|Overall Study||0
9049951|NCT03489343|10109299|FG005|COMPLETED|Overall Study||0
9049952|NCT03489343|10109300|FG006|COMPLETED|Overall Study||0
9049953|NCT03489343|10109294|FG000|NOT COMPLETED|Overall Study||1
9049954|NCT03489343|10109295|FG001|NOT COMPLETED|Overall Study||1
9049955|NCT03489343|10109296|FG002|NOT COMPLETED|Overall Study||3
9049956|NCT03489343|10109297|FG003|NOT COMPLETED|Overall Study||3
9049957|NCT03489343|10109298|FG004|NOT COMPLETED|Overall Study||3
9049958|NCT03489343|10109299|FG005|NOT COMPLETED|Overall Study||7
9049959|NCT03489343|10109300|FG006|NOT COMPLETED|Overall Study||6
9049960|NCT03489369|10109320|FG000|STARTED|Overall Study||3
9049961|NCT03489369|10109321|FG001|STARTED|Overall Study||3
9049962|NCT03489369|10109322|FG002|STARTED|Overall Study||3
9049963|NCT03489369|10109323|FG003|STARTED|Overall Study||6
9049964|NCT03489369|10109320|FG000|COMPLETED|Overall Study||0
9049965|NCT03489369|10109321|FG001|COMPLETED|Overall Study||0
9049966|NCT03489369|10109322|FG002|COMPLETED|Overall Study||0
9049967|NCT03489369|10109323|FG003|COMPLETED|Overall Study||0
9049968|NCT03489369|10109320|FG000|NOT COMPLETED|Overall Study||3
9049969|NCT03489369|10109321|FG001|NOT COMPLETED|Overall Study||3
9049970|NCT03489369|10109322|FG002|NOT COMPLETED|Overall Study||3
9049971|NCT03489369|10109323|FG003|NOT COMPLETED|Overall Study||6
9049972|NCT03489551|10109333|FG000|STARTED|Overall Study||17
9049973|NCT03489551|10109333|FG000|COMPLETED|Overall Study||15
9049974|NCT03489551|10109333|FG000|NOT COMPLETED|Overall Study||2
9049975|NCT03489720|10109339|FG000|STARTED|Overall Study||24
9049976|NCT03489720|10109340|FG001|STARTED|Overall Study||22
9049977|NCT03489720|10109339|FG000|COMPLETED|Overall Study||22
9049978|NCT03489720|10109340|FG001|COMPLETED|Overall Study||22
9049979|NCT03489720|10109339|FG000|NOT COMPLETED|Overall Study||2
9049980|NCT03489720|10109340|FG001|NOT COMPLETED|Overall Study||0
9049981|NCT03489850|10109352|FG000|STARTED|Overall Study||24
9049982|NCT03489850|10109353|FG001|STARTED|Overall Study||28
9049983|NCT03489850|10109352|FG000|COMPLETED|Overall Study||23
9049984|NCT03489850|10109353|FG001|COMPLETED|Overall Study||27
9049985|NCT03489850|10109352|FG000|NOT COMPLETED|Overall Study||1
9049986|NCT03489850|10109353|FG001|NOT COMPLETED|Overall Study||1
9049987|NCT03489863|10109361|FG000|STARTED|Overall Study||7
9049988|NCT03489863|10109362|FG001|STARTED|Overall Study||7
9049989|NCT03489863|10109361|FG000|COMPLETED|Overall Study||7
9049990|NCT03489863|10109362|FG001|COMPLETED|Overall Study||6
9049991|NCT03489863|10109361|FG000|NOT COMPLETED|Overall Study||0
9049992|NCT03489863|10109362|FG001|NOT COMPLETED|Overall Study||1
9049993|NCT03489941|10109368|FG000|STARTED|Overall Study||51
9049994|NCT03489941|10109369|FG001|STARTED|Overall Study||52
9049995|NCT03489941|10109370|FG002|STARTED|Overall Study||27
9049996|NCT03489941|10109368|FG000|COMPLETED|Overall Study||51
9049997|NCT03489941|10109369|FG001|COMPLETED|Overall Study||52
9049998|NCT03489941|10109370|FG002|COMPLETED|Overall Study||27
9049999|NCT03489941|10109368|FG000|NOT COMPLETED|Overall Study||0
9050000|NCT03489941|10109369|FG001|NOT COMPLETED|Overall Study||0
9050001|NCT03489941|10109370|FG002|NOT COMPLETED|Overall Study||0
9050002|NCT03490032|10109379|FG000|STARTED|Overall Study||6
9050003|NCT03490032|10109380|FG001|STARTED|Overall Study||12
9050004|NCT03490032|10109381|FG002|STARTED|Overall Study||12
9050005|NCT03490032|10109379|FG000|COMPLETED|Overall Study||5
9050006|NCT03490032|10109380|FG001|COMPLETED|Overall Study||12
9050007|NCT03490032|10109381|FG002|COMPLETED|Overall Study||12
9050008|NCT03490032|10109379|FG000|NOT COMPLETED|Overall Study||1
9050009|NCT03490032|10109380|FG001|NOT COMPLETED|Overall Study||0
9050010|NCT03490032|10109381|FG002|NOT COMPLETED|Overall Study||0
9050011|NCT03490110|10109392|FG000|STARTED|Overall Study||9
9050012|NCT03490110|10109393|FG001|STARTED|Overall Study||9
9050013|NCT03490110|10109392|FG000|COMPLETED|Overall Study||6
9050014|NCT03490110|10109393|FG001|COMPLETED|Overall Study||6
9050015|NCT03490110|10109392|FG000|NOT COMPLETED|Overall Study||3
9050016|NCT03490110|10109393|FG001|NOT COMPLETED|Overall Study||3
9050017|NCT03490942|10109402|FG000|STARTED|Overall Study||15
9050018|NCT03490942|10109403|FG001|STARTED|Overall Study||18
9050019|NCT03490942|10109404|FG002|STARTED|Overall Study||16
9050020|NCT03490942|10109402|FG000|COMPLETED|Overall Study||5
9050021|NCT03490942|10109403|FG001|COMPLETED|Overall Study||8
9050022|NCT03490942|10109404|FG002|COMPLETED|Overall Study||9
9050023|NCT03490942|10109402|FG000|NOT COMPLETED|Overall Study||10
9050024|NCT03490942|10109403|FG001|NOT COMPLETED|Overall Study||10
9050025|NCT03490942|10109404|FG002|NOT COMPLETED|Overall Study||7
9050026|NCT03490981|10109414|FG000|STARTED|Overall Study||15
9050027|NCT03490981|10109415|FG001|STARTED|Overall Study||15
9050028|NCT03490981|10109414|FG000|COMPLETED|Overall Study||14
9050029|NCT03490981|10109415|FG001|COMPLETED|Overall Study||13
9050030|NCT03490981|10109414|FG000|NOT COMPLETED|Overall Study||1
9050031|NCT03490981|10109415|FG001|NOT COMPLETED|Overall Study||2
8703495|NCT00923091|9749179|FG003|COMPLETED|Period VI (Open-Label)||143
8703496|NCT00923091|9749180|FG004|COMPLETED|Period VI (Open-Label)||157
8703497|NCT00923091|9749181|FG005|COMPLETED|Period VI (Open-Label)||0
8703498|NCT00923091|9749182|FG006|COMPLETED|Period VI (Open-Label)||0
9050032|NCT03491150|10109423|FG000|STARTED|Overall Study||76
9050033|NCT03491150|10109424|FG001|STARTED|Overall Study||73
9050034|NCT03491150|10109423|FG000|COMPLETED|Overall Study||0
9050035|NCT03491150|10109424|FG001|COMPLETED|Overall Study||0
9050036|NCT03491150|10109423|FG000|NOT COMPLETED|Overall Study||76
9050037|NCT03491150|10109424|FG001|NOT COMPLETED|Overall Study||73
9050038|NCT03491228|10109430|FG000|STARTED|Overall Study||107
9050039|NCT03491228|10109430|FG000|COMPLETED|Overall Study||107
9050040|NCT03491228|10109430|FG000|NOT COMPLETED|Overall Study||0
9050041|NCT03491553|10109440|FG000|STARTED|Main Study (Up to Week 48)||9
9050042|NCT03491553|10109441|FG001|STARTED|Main Study (Up to Week 48)||10
9050043|NCT03491553|10109442|FG002|STARTED|Main Study (Up to Week 48)||10
9050044|NCT03491553|10109443|FG003|STARTED|Main Study (Up to Week 48)||10
9050045|NCT03491553|10109444|FG004|STARTED|Main Study (Up to Week 48)||5
9050046|NCT03491553|10109445|FG005|STARTED|Main Study (Up to Week 48)||4
9050047|NCT03491553|10109440|FG000|COMPLETED|Main Study (Up to Week 48)||8
9050048|NCT03491553|10109441|FG001|COMPLETED|Main Study (Up to Week 48)||9
9050049|NCT03491553|10109442|FG002|COMPLETED|Main Study (Up to Week 48)||10
9050050|NCT03491553|10109443|FG003|COMPLETED|Main Study (Up to Week 48)||9
9050051|NCT03491553|10109444|FG004|COMPLETED|Main Study (Up to Week 48)||5
9050052|NCT03491553|10109445|FG005|COMPLETED|Main Study (Up to Week 48)||4
9050053|NCT03491553|10109440|FG000|NOT COMPLETED|Main Study (Up to Week 48)||1
9050054|NCT03491553|10109441|FG001|NOT COMPLETED|Main Study (Up to Week 48)||1
9050055|NCT03491553|10109442|FG002|NOT COMPLETED|Main Study (Up to Week 48)||0
9050056|NCT03491553|10109443|FG003|NOT COMPLETED|Main Study (Up to Week 48)||1
9050057|NCT03491553|10109444|FG004|NOT COMPLETED|Main Study (Up to Week 48)||0
9050058|NCT03491553|10109445|FG005|NOT COMPLETED|Main Study (Up to Week 48)||0
9050059|NCT03491553|10109440|FG000|STARTED|TFFU (Week 49 up to Additional 48 Weeks)|8 participants completed the study period up to Week 48 but did not continue in the TFFU phase.|0
9050060|NCT03491553|10109441|FG001|STARTED|TFFU (Week 49 up to Additional 48 Weeks)|9 participants completed the study period up to Week 48 but only 1 participant continued in the TFFU phase.|1
9050061|NCT03491553|10109442|FG002|STARTED|TFFU (Week 49 up to Additional 48 Weeks)|10 participants completed the study period up to Week 48 but did not continue in the TFFU phase.|0
9050062|NCT03491553|10109443|FG003|STARTED|TFFU (Week 49 up to Additional 48 Weeks)|9 participants completed the study period up to Week 48 but did not continue in the TFFU phase.|0
9050063|NCT03491553|10109444|FG004|STARTED|TFFU (Week 49 up to Additional 48 Weeks)|5 participants completed the study period up to Week 48 but did not continue in the TFFU phase.|0
9050064|NCT03491553|10109445|FG005|STARTED|TFFU (Week 49 up to Additional 48 Weeks)|4 participants completed the study period up to Week 48 but did not continue in the TFFU phase.|0
9050065|NCT03491553|10109440|FG000|COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
9050066|NCT03491553|10109441|FG001|COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||1
9050067|NCT03491553|10109442|FG002|COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
9050068|NCT03491553|10109443|FG003|COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
9050069|NCT03491553|10109444|FG004|COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
9050070|NCT03491553|10109445|FG005|COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
9050071|NCT03491553|10109440|FG000|NOT COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
9050072|NCT03491553|10109441|FG001|NOT COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
9050073|NCT03491553|10109442|FG002|NOT COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
9050074|NCT03491553|10109443|FG003|NOT COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
9050075|NCT03491553|10109444|FG004|NOT COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
9050076|NCT03491553|10109445|FG005|NOT COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
9050077|NCT03491800|10109464|FG000|STARTED|Overall Study||23
9050078|NCT03491800|10109465|FG001|STARTED|Overall Study||23
9050079|NCT03491800|10109466|FG002|STARTED|Overall Study||7
9050080|NCT03491800|10109464|FG000|COMPLETED|Overall Study||23
9050081|NCT03491800|10109465|FG001|COMPLETED|Overall Study||23
9050082|NCT03491800|10109466|FG002|COMPLETED|Overall Study||7
9050083|NCT03491800|10109464|FG000|NOT COMPLETED|Overall Study||0
9050084|NCT03491800|10109465|FG001|NOT COMPLETED|Overall Study||0
9050085|NCT03491800|10109466|FG002|NOT COMPLETED|Overall Study||0
9050086|NCT03491891|10109477|FG000|STARTED|Overall Study||6038
9050087|NCT03491891|10109478|FG001|STARTED|Overall Study||2438
9050088|NCT03491891|10109477|FG000|COMPLETED|Overall Study||5185
9050089|NCT03491891|10109478|FG001|COMPLETED|Overall Study||2058
9050090|NCT03491891|10109477|FG000|NOT COMPLETED|Overall Study||853
9050091|NCT03491891|10109478|FG001|NOT COMPLETED|Overall Study||380
9050092|NCT03491917|10109484|FG000|STARTED|First Reading Session||50
9050093|NCT03491917|10109485|FG001|STARTED|First Reading Session||50
9050094|NCT03491917|10109484|FG000|COMPLETED|First Reading Session||50
9050095|NCT03491917|10109485|FG001|COMPLETED|First Reading Session||50
9050096|NCT03491917|10109484|FG000|NOT COMPLETED|First Reading Session||0
9050097|NCT03491917|10109485|FG001|NOT COMPLETED|First Reading Session||0
9050098|NCT03491917|10109484|FG000|STARTED|4 Week Memory Washout Period||50
9050099|NCT03491917|10109485|FG001|STARTED|4 Week Memory Washout Period||50
9050100|NCT03491917|10109484|FG000|COMPLETED|4 Week Memory Washout Period||50
9050101|NCT03491917|10109485|FG001|COMPLETED|4 Week Memory Washout Period||50
9050102|NCT03491917|10109484|FG000|NOT COMPLETED|4 Week Memory Washout Period||0
9050103|NCT03491917|10109485|FG001|NOT COMPLETED|4 Week Memory Washout Period||0
9050104|NCT03491917|10109484|FG000|STARTED|Second Reading Session||50
9050105|NCT03491917|10109485|FG001|STARTED|Second Reading Session||50
9050106|NCT03491917|10109484|FG000|COMPLETED|Second Reading Session||50
9050107|NCT03491917|10109485|FG001|COMPLETED|Second Reading Session||50
9050108|NCT03491917|10109484|FG000|NOT COMPLETED|Second Reading Session||0
9050109|NCT03491917|10109485|FG001|NOT COMPLETED|Second Reading Session||0
9050110|NCT03492281|10109494|FG000|STARTED|Overall Study||540
9050111|NCT03492281|10109495|FG001|STARTED|Overall Study||547
9050112|NCT03492281|10109496|FG002|STARTED|Overall Study||431
9050113|NCT03492281|10109494|FG000|COMPLETED|Overall Study||486
9050114|NCT03492281|10109495|FG001|COMPLETED|Overall Study||502
9050115|NCT03492281|10109496|FG002|COMPLETED|Overall Study||385
9050116|NCT03492281|10109494|FG000|NOT COMPLETED|Overall Study||54
9050117|NCT03492281|10109495|FG001|NOT COMPLETED|Overall Study||45
9050118|NCT03492281|10109496|FG002|NOT COMPLETED|Overall Study||46
9050119|NCT03492398|10109516|FG000|STARTED|Overall Study||8
9050120|NCT03492398|10109517|FG001|STARTED|Overall Study||6
9050121|NCT03492398|10109518|FG002|STARTED|Overall Study||6
9050122|NCT03492398|10109519|FG003|STARTED|Overall Study||6
9050123|NCT03492398|10109520|FG004|STARTED|Overall Study||6
9050124|NCT03492398|10109521|FG005|STARTED|Overall Study||6
9050125|NCT03492398|10109522|FG006|STARTED|Overall Study||6
9050126|NCT03492398|10109523|FG007|STARTED|Overall Study||6
9050127|NCT03492398|10109524|FG008|STARTED|Overall Study||6
9050128|NCT03492398|10109516|FG000|COMPLETED|Overall Study||8
9050129|NCT03492398|10109517|FG001|COMPLETED|Overall Study||6
9050130|NCT03492398|10109518|FG002|COMPLETED|Overall Study||6
9050131|NCT03492398|10109519|FG003|COMPLETED|Overall Study||6
9050132|NCT03492398|10109520|FG004|COMPLETED|Overall Study||6
9050133|NCT03492398|10109521|FG005|COMPLETED|Overall Study||6
9050134|NCT03492398|10109522|FG006|COMPLETED|Overall Study||5
9050135|NCT03492398|10109523|FG007|COMPLETED|Overall Study||5
9050136|NCT03492398|10109524|FG008|COMPLETED|Overall Study||6
9050137|NCT03492398|10109516|FG000|NOT COMPLETED|Overall Study||0
9050138|NCT03492398|10109517|FG001|NOT COMPLETED|Overall Study||0
9050139|NCT03492398|10109518|FG002|NOT COMPLETED|Overall Study||0
9050140|NCT03492398|10109519|FG003|NOT COMPLETED|Overall Study||0
9050141|NCT03492398|10109520|FG004|NOT COMPLETED|Overall Study||0
9050142|NCT03492398|10109521|FG005|NOT COMPLETED|Overall Study||0
9050143|NCT03492398|10109522|FG006|NOT COMPLETED|Overall Study||1
9050144|NCT03492398|10109523|FG007|NOT COMPLETED|Overall Study||1
9050145|NCT03492398|10109524|FG008|NOT COMPLETED|Overall Study||0
9050146|NCT03492554|10109546|FG000|STARTED|Overall Study||301
9050147|NCT03492554|10109547|FG001|STARTED|Overall Study||301
9050148|NCT03492554|10109546|FG000|COMPLETED|Overall Study||301
9050149|NCT03492554|10109547|FG001|COMPLETED|Overall Study||287
9050150|NCT03492554|10109546|FG000|NOT COMPLETED|Overall Study||0
9050151|NCT03492554|10109547|FG001|NOT COMPLETED|Overall Study||14
9050152|NCT03493386|10109556|FG000|STARTED|Part 1, Intervention Period 1 (2 Days)||26
9050153|NCT03493386|10109557|FG001|STARTED|Part 1, Intervention Period 1 (2 Days)||26
9050154|NCT03493386|10109558|FG002|STARTED|Part 1, Intervention Period 1 (2 Days)||0
9050155|NCT03493386|10109559|FG003|STARTED|Part 1, Intervention Period 1 (2 Days)||0
9050156|NCT03493386|10109556|FG000|COMPLETED|Part 1, Intervention Period 1 (2 Days)||26
9050157|NCT03493386|10109557|FG001|COMPLETED|Part 1, Intervention Period 1 (2 Days)||26
9050158|NCT03493386|10109558|FG002|COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
9050159|NCT03493386|10109559|FG003|COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
9050160|NCT03493386|10109556|FG000|NOT COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
9050161|NCT03493386|10109557|FG001|NOT COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
9050162|NCT03493386|10109558|FG002|NOT COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
9050163|NCT03493386|10109559|FG003|NOT COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
9050164|NCT03493386|10109556|FG000|STARTED|Part 1, Washout Period (at Least 5 Days)||26
9050165|NCT03493386|10109557|FG001|STARTED|Part 1, Washout Period (at Least 5 Days)||26
9050166|NCT03493386|10109558|FG002|STARTED|Part 1, Washout Period (at Least 5 Days)||0
9050167|NCT03493386|10109559|FG003|STARTED|Part 1, Washout Period (at Least 5 Days)||0
9050168|NCT03493386|10109556|FG000|COMPLETED|Part 1, Washout Period (at Least 5 Days)||26
9050169|NCT03493386|10109557|FG001|COMPLETED|Part 1, Washout Period (at Least 5 Days)||25
9050170|NCT03493386|10109558|FG002|COMPLETED|Part 1, Washout Period (at Least 5 Days)||0
9050171|NCT03493386|10109559|FG003|COMPLETED|Part 1, Washout Period (at Least 5 Days)||0
9050172|NCT03493386|10109556|FG000|NOT COMPLETED|Part 1, Washout Period (at Least 5 Days)||0
9050173|NCT03493386|10109557|FG001|NOT COMPLETED|Part 1, Washout Period (at Least 5 Days)||1
9050174|NCT03493386|10109558|FG002|NOT COMPLETED|Part 1, Washout Period (at Least 5 Days)||0
9050175|NCT03493386|10109559|FG003|NOT COMPLETED|Part 1, Washout Period (at Least 5 Days)||0
9050176|NCT03493386|10109556|FG000|STARTED|Part 1, Intervention Period 2 (2 Days)||26
9050177|NCT03493386|10109557|FG001|STARTED|Part 1, Intervention Period 2 (2 Days)||25
9050178|NCT03493386|10109558|FG002|STARTED|Part 1, Intervention Period 2 (2 Days)||0
9050179|NCT03493386|10109559|FG003|STARTED|Part 1, Intervention Period 2 (2 Days)||0
9050180|NCT03493386|10109556|FG000|COMPLETED|Part 1, Intervention Period 2 (2 Days)||26
9050181|NCT03493386|10109557|FG001|COMPLETED|Part 1, Intervention Period 2 (2 Days)||25
9050182|NCT03493386|10109558|FG002|COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
9050183|NCT03493386|10109559|FG003|COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
9050184|NCT03493386|10109556|FG000|NOT COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
9050185|NCT03493386|10109557|FG001|NOT COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
9050186|NCT03493386|10109558|FG002|NOT COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
9050187|NCT03493386|10109559|FG003|NOT COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
9050188|NCT03493386|10109556|FG000|STARTED|Part 2, Intervention Period 1 (2 Days)||0
9050189|NCT03493386|10109557|FG001|STARTED|Part 2, Intervention Period 1 (2 Days)||0
9050190|NCT03493386|10109558|FG002|STARTED|Part 2, Intervention Period 1 (2 Days)||6
9050191|NCT03493386|10109559|FG003|STARTED|Part 2, Intervention Period 1 (2 Days)||6
9050192|NCT03493386|10109556|FG000|COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
9050193|NCT03493386|10109557|FG001|COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
9050194|NCT03493386|10109558|FG002|COMPLETED|Part 2, Intervention Period 1 (2 Days)||6
9050195|NCT03493386|10109559|FG003|COMPLETED|Part 2, Intervention Period 1 (2 Days)||6
9050196|NCT03493386|10109556|FG000|NOT COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
9050197|NCT03493386|10109557|FG001|NOT COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
9050198|NCT03493386|10109558|FG002|NOT COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
9050199|NCT03493386|10109559|FG003|NOT COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
9050200|NCT03493386|10109556|FG000|STARTED|Part 2, Washout Period (at Least 5 Days)||0
9050201|NCT03493386|10109557|FG001|STARTED|Part 2, Washout Period (at Least 5 Days)||0
9050202|NCT03493386|10109558|FG002|STARTED|Part 2, Washout Period (at Least 5 Days)||6
9050203|NCT03493386|10109559|FG003|STARTED|Part 2, Washout Period (at Least 5 Days)||6
9050204|NCT03493386|10109556|FG000|COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
9050205|NCT03493386|10109557|FG001|COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
9050206|NCT03493386|10109558|FG002|COMPLETED|Part 2, Washout Period (at Least 5 Days)||6
9050207|NCT03493386|10109559|FG003|COMPLETED|Part 2, Washout Period (at Least 5 Days)||6
9050208|NCT03493386|10109556|FG000|NOT COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
9050209|NCT03493386|10109557|FG001|NOT COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
9050210|NCT03493386|10109558|FG002|NOT COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
9050211|NCT03493386|10109559|FG003|NOT COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
9050212|NCT03493386|10109556|FG000|STARTED|Part 2, Intervention Period 2 (2 Days)||0
9050213|NCT03493386|10109557|FG001|STARTED|Part 2, Intervention Period 2 (2 Days)||0
9050214|NCT03493386|10109558|FG002|STARTED|Part 2, Intervention Period 2 (2 Days)||6
9050215|NCT03493386|10109559|FG003|STARTED|Part 2, Intervention Period 2 (2 Days)||6
9050216|NCT03493386|10109556|FG000|COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
9050217|NCT03493386|10109557|FG001|COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
9050218|NCT03493386|10109558|FG002|COMPLETED|Part 2, Intervention Period 2 (2 Days)||6
9050219|NCT03493386|10109559|FG003|COMPLETED|Part 2, Intervention Period 2 (2 Days)||6
9050220|NCT03493386|10109556|FG000|NOT COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
9050221|NCT03493386|10109557|FG001|NOT COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
9050222|NCT03493386|10109558|FG002|NOT COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
9050223|NCT03493386|10109559|FG003|NOT COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
9050224|NCT03493542|10109578|FG000|STARTED|Overall Study||383
9050225|NCT03493542|10109579|FG001|STARTED|Overall Study||383
9050226|NCT03493542|10109578|FG000|Vaccination 1|Overall Study||383
9050227|NCT03493542|10109579|FG001|Vaccination 1|Overall Study||383
9050228|NCT03493542|10109578|FG000|Vaccination 2|Overall Study||379
9050229|NCT03493542|10109579|FG001|Vaccination 2|Overall Study||378
9050230|NCT03493542|10109578|FG000|Vaccination 3|Overall Study||376
9050231|NCT03493542|10109579|FG001|Vaccination 3|Overall Study||374
9050232|NCT03493542|10109578|FG000|COMPLETED|Overall Study||376
9050233|NCT03493542|10109579|FG001|COMPLETED|Overall Study||374
9050234|NCT03493542|10109578|FG000|NOT COMPLETED|Overall Study||7
9050235|NCT03493542|10109579|FG001|NOT COMPLETED|Overall Study||9
9050236|NCT03493607|10109585|FG000|STARTED|Overall Study||6
9050237|NCT03493607|10109585|FG000|COMPLETED|Overall Study||6
9050238|NCT03493607|10109585|FG000|NOT COMPLETED|Overall Study||0
9050239|NCT03493698|10109589|FG000|STARTED|Treatment Period A||17
9050240|NCT03493698|10109589|FG000|COMPLETED|Treatment Period A||17
9050241|NCT03493698|10109589|FG000|NOT COMPLETED|Treatment Period A||0
8569413|NCT00097253|9601656|FG000|COMPLETED|Lavender||56
8812709|NCT01521117|9865731|FG001|COMPLETED|Washout (4 Weeks)||8
9050242|NCT03493698|10109589|FG000|STARTED|Treatment Period B||17
9050243|NCT03493698|10109589|FG000|COMPLETED|Treatment Period B||17
9050244|NCT03493698|10109589|FG000|NOT COMPLETED|Treatment Period B||0
8812710|NCT01521117|9865730|FG000|NOT COMPLETED|Washout (4 Weeks)||0
8812711|NCT01521117|9865731|FG001|NOT COMPLETED|Washout (4 Weeks)||0
8812712|NCT01521117|9865730|FG000|STARTED|Second Intervention (6 Weeks)||5
8812713|NCT01521117|9865731|FG001|STARTED|Second Intervention (6 Weeks)||8
8812714|NCT01521117|9865730|FG000|COMPLETED|Second Intervention (6 Weeks)||5
8812715|NCT01521117|9865731|FG001|COMPLETED|Second Intervention (6 Weeks)||5
9050245|NCT03493698|10109589|FG000|STARTED|Treatment Period C||17
9050246|NCT03493698|10109589|FG000|COMPLETED|Treatment Period C||15
9050247|NCT03493698|10109589|FG000|NOT COMPLETED|Treatment Period C||2
9050248|NCT03493698|10109589|FG000|STARTED|Treatment Period D||15
9050249|NCT03493698|10109589|FG000|COMPLETED|Treatment Period D||15
9050250|NCT03493698|10109589|FG000|NOT COMPLETED|Treatment Period D||0
9050251|NCT03493815|10109605|FG000|STARTED|Overall Study||42
9050252|NCT03493815|10109606|FG001|STARTED|Overall Study||43
9050253|NCT03493815|10109605|FG000|COMPLETED|Overall Study||33
9050254|NCT03493815|10109606|FG001|COMPLETED|Overall Study||32
9050255|NCT03493815|10109605|FG000|NOT COMPLETED|Overall Study||9
9050256|NCT03493815|10109606|FG001|NOT COMPLETED|Overall Study||11
9050257|NCT03493828|10109615|FG000|STARTED|Overall Study||20
9050258|NCT03493828|10109616|FG001|STARTED|Overall Study||20
9050259|NCT03493828|10109617|FG002|STARTED|Overall Study||20
8556980|NCT02919618|9588776|FG000|Primary Efficacy Endpoint (6 Months)|Overall Study||18
8556981|NCT02919618|9588776|FG000|COMPLETED|Overall Study||18
8556982|NCT02919618|9588776|FG000|NOT COMPLETED|Overall Study||1
8556983|NCT02844946|9588793|FG000|STARTED|Overall Study||27
8556984|NCT02844946|9588794|FG001|STARTED|Overall Study||12
8556985|NCT02844946|9588793|FG000|COMPLETED|Overall Study||20
8556986|NCT02844946|9588794|FG001|COMPLETED|Overall Study||12
8556987|NCT02844946|9588793|FG000|NOT COMPLETED|Overall Study||7
8556988|NCT02844946|9588794|FG001|NOT COMPLETED|Overall Study||0
8556989|NCT02675114|9588802|FG000|STARTED|Overall Study||497
8556990|NCT02675114|9588803|FG001|STARTED|Overall Study||503
8556991|NCT02675114|9588802|FG000|As Treated|Overall Study||454
8556992|NCT02675114|9588803|FG001|As Treated|Overall Study||496
8556993|NCT02675114|9588802|FG000|Valve Implant|Overall Study||453
8556994|NCT02675114|9588803|FG001|Valve Implant|Overall Study||495
8556995|NCT02675114|9588802|FG000|COMPLETED|Overall Study||424
8556996|NCT02675114|9588803|FG001|COMPLETED|Overall Study||490
8556997|NCT02675114|9588802|FG000|NOT COMPLETED|Overall Study||73
8556998|NCT02675114|9588803|FG001|NOT COMPLETED|Overall Study||13
8556999|NCT02564796|9588811|FG000|STARTED|Overall Study||2
8557000|NCT02564796|9588812|FG001|STARTED|Overall Study||2
8557001|NCT02564796|9588811|FG000|COMPLETED|Overall Study||0
8557002|NCT02564796|9588812|FG001|COMPLETED|Overall Study||0
8557003|NCT02564796|9588811|FG000|NOT COMPLETED|Overall Study||2
8557004|NCT02564796|9588812|FG001|NOT COMPLETED|Overall Study||2
8557005|NCT02562716|9588820|FG000|STARTED|Overall Study||55
8557006|NCT02562716|9588821|FG001|STARTED|Overall Study||47
8557007|NCT02562716|9588820|FG000|Participants Assessed for AEs|Overall Study||53
8557008|NCT02562716|9588821|FG001|Participants Assessed for AEs|Overall Study||45
8557009|NCT02562716|9588820|FG000|COMPLETED|Overall Study||27
8557010|NCT02562716|9588821|FG001|COMPLETED|Overall Study||19
8557011|NCT02562716|9588820|FG000|NOT COMPLETED|Overall Study||28
8557012|NCT02562716|9588821|FG001|NOT COMPLETED|Overall Study||28
8568743|NCT00093041|9600944|FG005|COMPLETED|Overall Study|Three discontinued during multiple dose period|4
8568744|NCT00093041|9600939|FG000|NOT COMPLETED|Overall Study||2
8568745|NCT00093041|9600940|FG001|NOT COMPLETED|Overall Study||3
9050260|NCT03493828|10109615|FG000|COMPLETED|Overall Study||20
9050261|NCT03493828|10109616|FG001|COMPLETED|Overall Study||20
9050262|NCT03493828|10109617|FG002|COMPLETED|Overall Study||20
9050263|NCT03493828|10109615|FG000|NOT COMPLETED|Overall Study||0
9050264|NCT03493828|10109616|FG001|NOT COMPLETED|Overall Study||0
9050265|NCT03493828|10109617|FG002|NOT COMPLETED|Overall Study||0
9050266|NCT03494725|10109627|FG000|STARTED|Overall Study||60
9050267|NCT03494725|10109628|FG001|STARTED|Overall Study||60
9050268|NCT03494725|10109627|FG000|Intervention (Post 2 Weeks run-in)|Overall Study||59
9050269|NCT03494725|10109628|FG001|Intervention (Post 2 Weeks run-in)|Overall Study||59
9050270|NCT03494725|10109627|FG000|COMPLETED|Overall Study||59
9050271|NCT03494725|10109628|FG001|COMPLETED|Overall Study||58
9050272|NCT03494725|10109627|FG000|NOT COMPLETED|Overall Study||1
9050273|NCT03494725|10109628|FG001|NOT COMPLETED|Overall Study||2
9050274|NCT03494816|10109640|FG000|STARTED|Overall Study||24
9050275|NCT03494816|10109640|FG000|COMPLETED|Overall Study||18
9050276|NCT03494816|10109640|FG000|NOT COMPLETED|Overall Study||6
9050277|NCT03494985|10109652|FG000|STARTED|Overall Study||101
9050278|NCT03494985|10109653|FG001|STARTED|Overall Study||98
9050279|NCT03494985|10109654|FG002|STARTED|Overall Study||98
9050280|NCT03494985|10109655|FG003|STARTED|Overall Study||99
9050281|NCT03494985|10109652|FG000|COMPLETED|Overall Study||96
9050282|NCT03494985|10109653|FG001|COMPLETED|Overall Study||92
9050283|NCT03494985|10109654|FG002|COMPLETED|Overall Study||92
9050284|NCT03494985|10109655|FG003|COMPLETED|Overall Study||94
9050285|NCT03494985|10109652|FG000|NOT COMPLETED|Overall Study||5
9050286|NCT03494985|10109653|FG001|NOT COMPLETED|Overall Study||6
9050287|NCT03494985|10109654|FG002|NOT COMPLETED|Overall Study||6
9050288|NCT03494985|10109655|FG003|NOT COMPLETED|Overall Study||5
9050289|NCT03495102|10109668|FG000|STARTED|Overall Study||612
9050290|NCT03495102|10109669|FG001|STARTED|Overall Study||616
9050291|NCT03495102|10109670|FG002|STARTED|Overall Study||614
9050292|NCT03495102|10109668|FG000|Received at Least One Dose of Study Drug|Overall Study||612
9050293|NCT03495102|10109669|FG001|Received at Least One Dose of Study Drug|Overall Study||616
9050294|NCT03495102|10109670|FG002|Received at Least One Dose of Study Drug|Overall Study||614
9050295|NCT03495102|10109668|FG000|COMPLETED|Overall Study||556
9050296|NCT03495102|10109669|FG001|COMPLETED|Overall Study||549
9050297|NCT03495102|10109670|FG002|COMPLETED|Overall Study||560
9050298|NCT03495102|10109668|FG000|NOT COMPLETED|Overall Study||56
9050299|NCT03495102|10109669|FG001|NOT COMPLETED|Overall Study||67
9050300|NCT03495102|10109670|FG002|NOT COMPLETED|Overall Study||54
9050301|NCT03495648|10109680|FG000|STARTED|Overall Study||60
9050302|NCT03495648|10109681|FG001|STARTED|Overall Study||61
9050303|NCT03495648|10109680|FG000|COMPLETED|Overall Study||60
9050304|NCT03495648|10109681|FG001|COMPLETED|Overall Study||61
9050305|NCT03495648|10109680|FG000|NOT COMPLETED|Overall Study||0
9050306|NCT03495648|10109681|FG001|NOT COMPLETED|Overall Study||0
9050307|NCT03495817|10109687|FG000|STARTED|26 Week Open Label||31
9050308|NCT03495817|10109687|FG000|COMPLETED|26 Week Open Label||23
9050309|NCT03495817|10109687|FG000|NOT COMPLETED|26 Week Open Label||8
9050310|NCT03495817|10109687|FG000|STARTED|26 Week Extension||19
9050311|NCT03495817|10109687|FG000|COMPLETED|26 Week Extension||17
9050312|NCT03495817|10109687|FG000|NOT COMPLETED|26 Week Extension||2
9050313|NCT03495856|10109691|FG000|STARTED|Overall Study||23
9050314|NCT03495856|10109691|FG000|COMPLETED|Overall Study||22
9050315|NCT03495856|10109691|FG000|NOT COMPLETED|Overall Study||1
9050316|NCT03495869|10109699|FG000|STARTED|Overall Study||54
9050317|NCT03495869|10109700|FG001|STARTED|Overall Study||124
9050318|NCT03495869|10109701|FG002|STARTED|Overall Study||61
9050319|NCT03495869|10109702|FG003|STARTED|Overall Study||129
9050320|NCT03495869|10109699|FG000|COMPLETED|Overall Study||50
9050321|NCT03495869|10109700|FG001|COMPLETED|Overall Study||97
9050322|NCT03495869|10109701|FG002|COMPLETED|Overall Study||51
9050323|NCT03495869|10109702|FG003|COMPLETED|Overall Study||108
9050324|NCT03495869|10109699|FG000|NOT COMPLETED|Overall Study||4
9050325|NCT03495869|10109700|FG001|NOT COMPLETED|Overall Study||27
9050326|NCT03495869|10109701|FG002|NOT COMPLETED|Overall Study||10
9050327|NCT03495869|10109702|FG003|NOT COMPLETED|Overall Study||21
9050328|NCT03495908|10109714|FG000|STARTED|Overall Study||69
9050329|NCT03495908|10109715|FG001|STARTED|Overall Study||67
9050330|NCT03495908|10109714|FG000|COMPLETED|Overall Study||59
9050331|NCT03495908|10109715|FG001|COMPLETED|Overall Study||54
9050332|NCT03495908|10109714|FG000|NOT COMPLETED|Overall Study||10
9050333|NCT03495908|10109715|FG001|NOT COMPLETED|Overall Study||13
9050334|NCT03496220|10109723|FG000|STARTED|First Intervention||15
9050335|NCT03496220|10109724|FG001|STARTED|First Intervention||4
9050336|NCT03496220|10109725|FG002|STARTED|First Intervention||10
9050337|NCT03496220|10109723|FG000|COMPLETED|First Intervention||15
9050338|NCT03496220|10109724|FG001|COMPLETED|First Intervention||4
9050339|NCT03496220|10109725|FG002|COMPLETED|First Intervention||10
9050340|NCT03496220|10109723|FG000|NOT COMPLETED|First Intervention||0
9050341|NCT03496220|10109724|FG001|NOT COMPLETED|First Intervention||0
9050342|NCT03496220|10109725|FG002|NOT COMPLETED|First Intervention||0
9050343|NCT03496220|10109723|FG000|STARTED|Second Intervention||17
9050344|NCT03496220|10109724|FG001|STARTED|Second Intervention||9
9050345|NCT03496220|10109725|FG002|STARTED|Second Intervention||11
9050346|NCT03496220|10109723|FG000|COMPLETED|Second Intervention||17
9050347|NCT03496220|10109724|FG001|COMPLETED|Second Intervention||9
9050348|NCT03496220|10109725|FG002|COMPLETED|Second Intervention||11
9050349|NCT03496220|10109723|FG000|NOT COMPLETED|Second Intervention||0
9050350|NCT03496220|10109724|FG001|NOT COMPLETED|Second Intervention||0
9050351|NCT03496220|10109725|FG002|NOT COMPLETED|Second Intervention||0
9050352|NCT03496220|10109723|FG000|STARTED|Third Intervention||11
9050353|NCT03496220|10109724|FG001|STARTED|Third Intervention||8
9050354|NCT03496220|10109725|FG002|STARTED|Third Intervention||5
9050355|NCT03496220|10109723|FG000|COMPLETED|Third Intervention||11
9050356|NCT03496220|10109724|FG001|COMPLETED|Third Intervention||8
9050357|NCT03496220|10109725|FG002|COMPLETED|Third Intervention||5
9050358|NCT03496220|10109723|FG000|NOT COMPLETED|Third Intervention||0
9050359|NCT03496220|10109724|FG001|NOT COMPLETED|Third Intervention||0
9050360|NCT03496220|10109725|FG002|NOT COMPLETED|Third Intervention||0
9050361|NCT03496298|10109734|FG000|STARTED|Overall Study||1359
9050362|NCT03496298|10109735|FG001|STARTED|Overall Study||1359
9050363|NCT03496298|10109736|FG002|STARTED|Overall Study||1358
9050364|NCT03496298|10109734|FG000|Randomized and Treated|Overall Study||1358
9050365|NCT03496298|10109735|FG001|Randomized and Treated|Overall Study||1358
9050366|NCT03496298|10109736|FG002|Randomized and Treated|Overall Study||1357
9050367|NCT03496298|10109734|FG000|Safety Population|Overall Study|2 participants of Placebo arm received Efpeglenatide 4 mg treatment and 1 participant received Efpeglenatide 6 mg treatment. Hence, they were counted in the respective arm for safety analysis.|1355
8703499|NCT00923091|9749183|FG007|COMPLETED|Period VI (Open-Label)||0
8703500|NCT00923091|9749184|FG008|COMPLETED|Period VI (Open-Label)||0
9050368|NCT03496298|10109735|FG001|Safety Population|Overall Study|2 participants of Placebo arm received Efpeglenatide 4 mg treatment and thus counted in the 4 mg treatment arm for safety analysis.|1360
9050369|NCT03496298|10109736|FG002|Safety Population|Overall Study|1 participant of Placebo arm received Efpeglenatide 6 mg treatment and thus counted in the 6 mg treatment arm for safety analysis.|1358
9050370|NCT03496298|10109734|FG000|COMPLETED|Overall Study||42
9050371|NCT03496298|10109735|FG001|COMPLETED|Overall Study||36
9050372|NCT03496298|10109736|FG002|COMPLETED|Overall Study||23
9050373|NCT03496298|10109734|FG000|NOT COMPLETED|Overall Study||1317
9050374|NCT03496298|10109735|FG001|NOT COMPLETED|Overall Study||1323
9050375|NCT03496298|10109736|FG002|NOT COMPLETED|Overall Study||1335
9050376|NCT03496324|10109743|FG000|STARTED|Period 1||6
9050377|NCT03496324|10109744|FG001|STARTED|Period 1||6
9050378|NCT03496324|10109745|FG002|STARTED|Period 1||6
9050379|NCT03496324|10109746|FG003|STARTED|Period 1||6
9050380|NCT03496324|10109743|FG000|COMPLETED|Period 1||6
9050381|NCT03496324|10109744|FG001|COMPLETED|Period 1||6
9050382|NCT03496324|10109745|FG002|COMPLETED|Period 1||6
9050383|NCT03496324|10109746|FG003|COMPLETED|Period 1||6
8703501|NCT00923091|9749185|FG009|COMPLETED|Period VI (Open-Label)||0
8703502|NCT00923091|9749186|FG010|COMPLETED|Period VI (Open-Label)||0
8703503|NCT00923091|9749187|FG011|COMPLETED|Period VI (Open-Label)||0
8703504|NCT00923091|9749188|FG012|COMPLETED|Period VI (Open-Label)||0
9050384|NCT03496324|10109743|FG000|NOT COMPLETED|Period 1||0
9050385|NCT03496324|10109744|FG001|NOT COMPLETED|Period 1||0
9050386|NCT03496324|10109745|FG002|NOT COMPLETED|Period 1||0
9050387|NCT03496324|10109746|FG003|NOT COMPLETED|Period 1||0
9050388|NCT03496324|10109743|FG000|STARTED|Period 1: Washout (3 to 7 Days)||6
9050389|NCT03496324|10109744|FG001|STARTED|Period 1: Washout (3 to 7 Days)||6
9050390|NCT03496324|10109745|FG002|STARTED|Period 1: Washout (3 to 7 Days)||6
9050391|NCT03496324|10109746|FG003|STARTED|Period 1: Washout (3 to 7 Days)||6
9050392|NCT03496324|10109743|FG000|COMPLETED|Period 1: Washout (3 to 7 Days)||6
9050393|NCT03496324|10109744|FG001|COMPLETED|Period 1: Washout (3 to 7 Days)||6
9050394|NCT03496324|10109745|FG002|COMPLETED|Period 1: Washout (3 to 7 Days)||6
9050395|NCT03496324|10109746|FG003|COMPLETED|Period 1: Washout (3 to 7 Days)||6
9050396|NCT03496324|10109743|FG000|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
8703505|NCT00923091|9749176|FG000|NOT COMPLETED|Period VI (Open-Label)||39
8703506|NCT00923091|9749177|FG001|NOT COMPLETED|Period VI (Open-Label)||8
8703507|NCT00923091|9749178|FG002|NOT COMPLETED|Period VI (Open-Label)||13
8703508|NCT00923091|9749179|FG003|NOT COMPLETED|Period VI (Open-Label)||3
8703509|NCT00923091|9749180|FG004|NOT COMPLETED|Period VI (Open-Label)||7
8703510|NCT00923091|9749181|FG005|NOT COMPLETED|Period VI (Open-Label)||0
8703511|NCT00923091|9749182|FG006|NOT COMPLETED|Period VI (Open-Label)||0
9050397|NCT03496324|10109744|FG001|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
9050398|NCT03496324|10109745|FG002|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
9050399|NCT03496324|10109746|FG003|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
9050400|NCT03496324|10109743|FG000|STARTED|Period 2||6
9050401|NCT03496324|10109744|FG001|STARTED|Period 2||6
9050402|NCT03496324|10109745|FG002|STARTED|Period 2||6
9050403|NCT03496324|10109746|FG003|STARTED|Period 2||6
9050404|NCT03496324|10109743|FG000|COMPLETED|Period 2||6
9050405|NCT03496324|10109744|FG001|COMPLETED|Period 2||6
9050406|NCT03496324|10109745|FG002|COMPLETED|Period 2||6
9050407|NCT03496324|10109746|FG003|COMPLETED|Period 2||6
9050408|NCT03496324|10109743|FG000|NOT COMPLETED|Period 2||0
9050409|NCT03496324|10109744|FG001|NOT COMPLETED|Period 2||0
9050410|NCT03496324|10109745|FG002|NOT COMPLETED|Period 2||0
9050411|NCT03496324|10109746|FG003|NOT COMPLETED|Period 2||0
9050412|NCT03496324|10109743|FG000|STARTED|Period 2: Washout (3 to 7 Days)||6
9050413|NCT03496324|10109744|FG001|STARTED|Period 2: Washout (3 to 7 Days)||6
9050414|NCT03496324|10109745|FG002|STARTED|Period 2: Washout (3 to 7 Days)||6
9050415|NCT03496324|10109746|FG003|STARTED|Period 2: Washout (3 to 7 Days)||6
9050416|NCT03496324|10109743|FG000|COMPLETED|Period 2: Washout (3 to 7 Days)||6
9050417|NCT03496324|10109744|FG001|COMPLETED|Period 2: Washout (3 to 7 Days)||6
9050418|NCT03496324|10109745|FG002|COMPLETED|Period 2: Washout (3 to 7 Days)||6
9050419|NCT03496324|10109746|FG003|COMPLETED|Period 2: Washout (3 to 7 Days)||6
9050420|NCT03496324|10109743|FG000|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
9050421|NCT03496324|10109744|FG001|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
9050422|NCT03496324|10109745|FG002|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
9050423|NCT03496324|10109746|FG003|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
9050424|NCT03496324|10109743|FG000|STARTED|Period 3||6
9050425|NCT03496324|10109744|FG001|STARTED|Period 3||6
9050426|NCT03496324|10109745|FG002|STARTED|Period 3||6
9050427|NCT03496324|10109746|FG003|STARTED|Period 3||6
9050428|NCT03496324|10109743|FG000|COMPLETED|Period 3||6
9050429|NCT03496324|10109744|FG001|COMPLETED|Period 3||6
9050430|NCT03496324|10109745|FG002|COMPLETED|Period 3||6
9050431|NCT03496324|10109746|FG003|COMPLETED|Period 3||6
9050432|NCT03496324|10109743|FG000|NOT COMPLETED|Period 3||0
9050433|NCT03496324|10109744|FG001|NOT COMPLETED|Period 3||0
9050434|NCT03496324|10109745|FG002|NOT COMPLETED|Period 3||0
9050435|NCT03496324|10109746|FG003|NOT COMPLETED|Period 3||0
9050436|NCT03496324|10109743|FG000|STARTED|Period 3: Washout (3 to 7 Days)||6
9050437|NCT03496324|10109744|FG001|STARTED|Period 3: Washout (3 to 7 Days)||6
9050438|NCT03496324|10109745|FG002|STARTED|Period 3: Washout (3 to 7 Days)||6
9050439|NCT03496324|10109746|FG003|STARTED|Period 3: Washout (3 to 7 Days)||6
9050440|NCT03496324|10109743|FG000|COMPLETED|Period 3: Washout (3 to 7 Days)||6
9050441|NCT03496324|10109744|FG001|COMPLETED|Period 3: Washout (3 to 7 Days)||6
9050442|NCT03496324|10109745|FG002|COMPLETED|Period 3: Washout (3 to 7 Days)||6
9050443|NCT03496324|10109746|FG003|COMPLETED|Period 3: Washout (3 to 7 Days)||6
9050444|NCT03496324|10109743|FG000|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
9050445|NCT03496324|10109744|FG001|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
9050446|NCT03496324|10109745|FG002|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
9050447|NCT03496324|10109746|FG003|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
9050448|NCT03496324|10109743|FG000|STARTED|Period 7: Period 4||6
9050449|NCT03496324|10109744|FG001|STARTED|Period 7: Period 4||6
9050450|NCT03496324|10109745|FG002|STARTED|Period 7: Period 4||6
9050451|NCT03496324|10109746|FG003|STARTED|Period 7: Period 4||6
9050452|NCT03496324|10109743|FG000|COMPLETED|Period 7: Period 4||6
9050453|NCT03496324|10109744|FG001|COMPLETED|Period 7: Period 4||6
9050454|NCT03496324|10109745|FG002|COMPLETED|Period 7: Period 4||6
9050455|NCT03496324|10109746|FG003|COMPLETED|Period 7: Period 4||6
9050456|NCT03496324|10109743|FG000|NOT COMPLETED|Period 7: Period 4||0
9050457|NCT03496324|10109744|FG001|NOT COMPLETED|Period 7: Period 4||0
9050458|NCT03496324|10109745|FG002|NOT COMPLETED|Period 7: Period 4||0
9050459|NCT03496324|10109746|FG003|NOT COMPLETED|Period 7: Period 4||0
9050460|NCT03496428|10109756|FG000|STARTED|Overall Study|304 locations distributed for the analyzed teeth 108 locations distributed for the implant spots|6
9050461|NCT03496428|10109756|FG000|COMPLETED|Overall Study|304 locations distributed for the analyzed teeth 108 locations distributed for the implant spots|6
9050462|NCT03496428|10109756|FG000|NOT COMPLETED|Overall Study||0
9050463|NCT03496467|10109762|FG000|STARTED|Overall Study||38
9050464|NCT03496467|10109763|FG001|STARTED|Overall Study||18
8703512|NCT00923091|9749183|FG007|NOT COMPLETED|Period VI (Open-Label)||0
9050465|NCT03496467|10109762|FG000|COMPLETED|Overall Study||34
9050466|NCT03496467|10109763|FG001|COMPLETED|Overall Study||14
9050467|NCT03496467|10109762|FG000|NOT COMPLETED|Overall Study||4
9050468|NCT03496467|10109763|FG001|NOT COMPLETED|Overall Study||4
9050469|NCT03496545|10109771|FG000|STARTED|Overall Study||21
9050470|NCT03496545|10109772|FG001|STARTED|Overall Study||26
9050471|NCT03496545|10109771|FG000|COMPLETED|Overall Study||20
9050472|NCT03496545|10109772|FG001|COMPLETED|Overall Study||24
8703513|NCT00923091|9749184|FG008|NOT COMPLETED|Period VI (Open-Label)||0
9050473|NCT03496545|10109771|FG000|NOT COMPLETED|Overall Study||1
9050474|NCT03496545|10109772|FG001|NOT COMPLETED|Overall Study||2
9050475|NCT03496701|10109778|FG000|STARTED|Overall Study||77
9050476|NCT03496701|10109778|FG000|COMPLETED|Overall Study||77
9050477|NCT03496701|10109778|FG000|NOT COMPLETED|Overall Study||0
9050478|NCT03496974|10109786|FG000|STARTED|Overall Study||10
9050479|NCT03496974|10109787|FG001|STARTED|Overall Study||28
9050480|NCT03496974|10109786|FG000|COMPLETED|Overall Study||9
9050481|NCT03496974|10109787|FG001|COMPLETED|Overall Study||20
9050482|NCT03496974|10109786|FG000|NOT COMPLETED|Overall Study||1
9050483|NCT03496974|10109787|FG001|NOT COMPLETED|Overall Study||8
8703514|NCT00923091|9749185|FG009|NOT COMPLETED|Period VI (Open-Label)||0
8703515|NCT00923091|9749186|FG010|NOT COMPLETED|Period VI (Open-Label)||0
8703516|NCT00923091|9749187|FG011|NOT COMPLETED|Period VI (Open-Label)||0
8703517|NCT00923091|9749188|FG012|NOT COMPLETED|Period VI (Open-Label)||0
8703518|NCT00923117|9749215|FG000|STARTED|Overall Study||44
8703519|NCT00923117|9749216|FG001|STARTED|Overall Study||43
9050484|NCT03496987|10109795|FG000|STARTED|Overall Study||49
9050485|NCT03496987|10109796|FG001|STARTED|Overall Study||51
9050486|NCT03496987|10109795|FG000|COMPLETED|Overall Study||49
9050487|NCT03496987|10109796|FG001|COMPLETED|Overall Study||51
9050488|NCT03496987|10109795|FG000|NOT COMPLETED|Overall Study||0
9050489|NCT03496987|10109796|FG001|NOT COMPLETED|Overall Study||0
9050490|NCT03497026|10109802|FG000|STARTED|Overall Study||4
9050491|NCT03497026|10109802|FG000|COMPLETED|Overall Study||4
9050492|NCT03497026|10109802|FG000|NOT COMPLETED|Overall Study||0
9050493|NCT03497039|10109808|FG000|STARTED|Overall Study||30
9050494|NCT03497039|10109809|FG001|STARTED|Overall Study||17
9050495|NCT03497039|10109808|FG000|Treated|Overall Study||29
9050496|NCT03497039|10109809|FG001|Treated|Overall Study||17
9050497|NCT03497039|10109808|FG000|COMPLETED|Overall Study||29
9050498|NCT03497039|10109809|FG001|COMPLETED|Overall Study||16
9050499|NCT03497039|10109808|FG000|NOT COMPLETED|Overall Study||1
9050500|NCT03497039|10109809|FG001|NOT COMPLETED|Overall Study||1
9050501|NCT03497130|10109817|FG000|STARTED|Overall Study||40
9050502|NCT03497130|10109818|FG001|STARTED|Overall Study||14
9050503|NCT03497130|10109817|FG000|COMPLETED|Overall Study||39
9050504|NCT03497130|10109818|FG001|COMPLETED|Overall Study||13
9050505|NCT03497130|10109817|FG000|NOT COMPLETED|Overall Study||1
9050506|NCT03497130|10109818|FG001|NOT COMPLETED|Overall Study||1
9050507|NCT03497429|10109826|FG000|STARTED|Overall Study||3
9050508|NCT03497429|10109827|FG001|STARTED|Overall Study||6
9050509|NCT03497429|10109826|FG000|Started|Overall Study||3
9050510|NCT03497429|10109827|FG001|Started|Overall Study||6
9050511|NCT03497429|10109826|FG000|Completed|Overall Study||0
8703520|NCT00923117|9749215|FG000|COMPLETED|Overall Study||44
8703521|NCT00923117|9749216|FG001|COMPLETED|Overall Study||43
8703522|NCT00923117|9749215|FG000|NOT COMPLETED|Overall Study||0
8703523|NCT00923117|9749216|FG001|NOT COMPLETED|Overall Study||0
8703524|NCT00923130|9749222|FG000|STARTED|Overall Study||30
8703525|NCT00923130|9749222|FG000|COMPLETED|Overall Study||5
8703526|NCT00923130|9749222|FG000|NOT COMPLETED|Overall Study||25
8703527|NCT00923156|9749229|FG000|STARTED|Overall Study|"Started indicates randomized, safety and pharmacodynamic population"|40
8703528|NCT00923156|9749230|FG001|STARTED|Overall Study||42
8703529|NCT00923156|9749231|FG002|STARTED|Overall Study||41
8703530|NCT00923156|9749229|FG000|COMPLETED|Overall Study||40
8703531|NCT00923156|9749230|FG001|COMPLETED|Overall Study||38
8703532|NCT00923156|9749231|FG002|COMPLETED|Overall Study||38
8703533|NCT00923156|9749229|FG000|NOT COMPLETED|Overall Study||0
8703534|NCT00923156|9749230|FG001|NOT COMPLETED|Overall Study||4
8703535|NCT00923156|9749231|FG002|NOT COMPLETED|Overall Study||3
8703536|NCT00923195|9749241|FG000|STARTED|Overall Study||2
8703537|NCT00923195|9749242|FG001|STARTED|Overall Study||2
8703538|NCT00923195|9749241|FG000|COMPLETED|Overall Study||2
9050512|NCT03497429|10109827|FG001|Completed|Overall Study||0
9050513|NCT03497429|10109826|FG000|COMPLETED|Overall Study||0
9050514|NCT03497429|10109827|FG001|COMPLETED|Overall Study||0
8703539|NCT00923195|9749242|FG001|COMPLETED|Overall Study||1
8703540|NCT00923195|9749241|FG000|NOT COMPLETED|Overall Study||0
8703541|NCT00923195|9749242|FG001|NOT COMPLETED|Overall Study||1
8703542|NCT00923260|9749250|FG000|STARTED|Overall Study||12
8703543|NCT00923260|9749251|FG001|STARTED|Overall Study||12
8703544|NCT00923260|9749250|FG000|COMPLETED|Overall Study|Patient didn't complete the follow-up period after surgery|11
9050515|NCT03497429|10109826|FG000|NOT COMPLETED|Overall Study||3
8703545|NCT00923260|9749251|FG001|COMPLETED|Overall Study|Patient didn't complete the follow-up period after surgery|11
8703546|NCT00923260|9749250|FG000|NOT COMPLETED|Overall Study||1
8703547|NCT00923260|9749251|FG001|NOT COMPLETED|Overall Study||1
9050516|NCT03497429|10109827|FG001|NOT COMPLETED|Overall Study||6
9050517|NCT03497585|10109833|FG000|STARTED|Overall Study|112 participants were recruited: 107 patients, plus 5 HCPs for the acceptability interviews.|112
8703548|NCT00923273|9749262|FG000|STARTED|Phase I Treatment Period|The phase I portion will establish the maximum tolerated dose. 4 subjects peme naive.|4
8703549|NCT00923273|9749263|FG001|STARTED|Phase I Treatment Period|3 subjects peme naive.|3
9050518|NCT03497585|10109833|FG000|COMPLETED|Overall Study||57
9050519|NCT03497585|10109833|FG000|NOT COMPLETED|Overall Study||55
9050520|NCT03497845|10109849|FG000|STARTED|Overall Study||60
9050521|NCT03497845|10109850|FG001|STARTED|Overall Study||58
9050522|NCT03497845|10109851|FG002|STARTED|Overall Study||61
9050523|NCT03497845|10109852|FG003|STARTED|Overall Study||60
9050524|NCT03497845|10109853|FG004|STARTED|Overall Study||59
9050525|NCT03497845|10109854|FG005|STARTED|Overall Study||62
9050526|NCT03497845|10109855|FG006|STARTED|Overall Study||59
9050527|NCT03497845|10109856|FG007|STARTED|Overall Study||60
9050528|NCT03497845|10109857|FG008|STARTED|Overall Study||61
9050529|NCT03497845|10109858|FG009|STARTED|Overall Study||59
9050530|NCT03497845|10109859|FG010|STARTED|Overall Study||61
9050531|NCT03497845|10109860|FG011|STARTED|Overall Study||60
9050532|NCT03497845|10109849|FG000|COMPLETED|Overall Study|Day 142|55
9050533|NCT03497845|10109850|FG001|COMPLETED|Overall Study|Day 142|45
9050534|NCT03497845|10109851|FG002|COMPLETED|Overall Study|Day 142|50
9050535|NCT03497845|10109852|FG003|COMPLETED|Overall Study|Day 142|50
9050536|NCT03497845|10109853|FG004|COMPLETED|Overall Study|Day 262|38
9050537|NCT03497845|10109854|FG005|COMPLETED|Overall Study|Day 262|44
9050538|NCT03497845|10109855|FG006|COMPLETED|Overall Study|Day 142|51
9050539|NCT03497845|10109856|FG007|COMPLETED|Overall Study|Day 142|50
9050540|NCT03497845|10109857|FG008|COMPLETED|Overall Study|Day 142|47
9050541|NCT03497845|10109858|FG009|COMPLETED|Overall Study|Day 142|53
9050542|NCT03497845|10109859|FG010|COMPLETED|Overall Study|Day 262|46
9050543|NCT03497845|10109860|FG011|COMPLETED|Overall Study|Day 262|38
9050544|NCT03497845|10109849|FG000|NOT COMPLETED|Overall Study||5
9050545|NCT03497845|10109850|FG001|NOT COMPLETED|Overall Study||13
9050546|NCT03497845|10109851|FG002|NOT COMPLETED|Overall Study||11
9050547|NCT03497845|10109852|FG003|NOT COMPLETED|Overall Study||10
9050548|NCT03497845|10109853|FG004|NOT COMPLETED|Overall Study||21
9050549|NCT03497845|10109854|FG005|NOT COMPLETED|Overall Study||18
9050550|NCT03497845|10109855|FG006|NOT COMPLETED|Overall Study||8
9050551|NCT03497845|10109856|FG007|NOT COMPLETED|Overall Study||10
9050552|NCT03497845|10109857|FG008|NOT COMPLETED|Overall Study||14
9050553|NCT03497845|10109858|FG009|NOT COMPLETED|Overall Study||6
9050554|NCT03497845|10109859|FG010|NOT COMPLETED|Overall Study||15
9050555|NCT03497845|10109860|FG011|NOT COMPLETED|Overall Study||22
9050556|NCT03498196|10109892|FG000|STARTED|Overall Study||1
9050557|NCT03498196|10109892|FG000|COMPLETED|Overall Study||1
9050558|NCT03498196|10109892|FG000|NOT COMPLETED|Overall Study||0
9050559|NCT03498287|10109898|FG000|STARTED|Overall Study||45
9050560|NCT03498287|10109899|FG001|STARTED|Overall Study||43
9050561|NCT03498287|10109898|FG000|COMPLETED|Overall Study||42
9050562|NCT03498287|10109899|FG001|COMPLETED|Overall Study||38
9050563|NCT03498287|10109898|FG000|NOT COMPLETED|Overall Study||3
9050564|NCT03498287|10109899|FG001|NOT COMPLETED|Overall Study||5
9050565|NCT03498300|10109907|FG000|STARTED|Overall Study||21
9050566|NCT03498300|10109908|FG001|STARTED|Overall Study||21
9050567|NCT03498300|10109907|FG000|COMPLETED|Overall Study||18
9050568|NCT03498300|10109908|FG001|COMPLETED|Overall Study||13
9050569|NCT03498300|10109907|FG000|NOT COMPLETED|Overall Study||3
9050570|NCT03498300|10109908|FG001|NOT COMPLETED|Overall Study||8
9050571|NCT03499028|10109917|FG000|STARTED|Overall Study||226
9050572|NCT03499028|10109918|FG001|STARTED|Overall Study||220
9050573|NCT03499028|10109917|FG000|COMPLETED|Overall Study||204
9050574|NCT03499028|10109918|FG001|COMPLETED|Overall Study||195
9050575|NCT03499028|10109917|FG000|NOT COMPLETED|Overall Study||22
9050576|NCT03499028|10109918|FG001|NOT COMPLETED|Overall Study||25
9050577|NCT03499067|10109926|FG000|STARTED|First Intervention||27
9050578|NCT03499067|10109927|FG001|STARTED|First Intervention||31
9050579|NCT03499067|10109926|FG000|COMPLETED|First Intervention||22
9050580|NCT03499067|10109927|FG001|COMPLETED|First Intervention||24
9050581|NCT03499067|10109926|FG000|NOT COMPLETED|First Intervention||5
9050582|NCT03499067|10109927|FG001|NOT COMPLETED|First Intervention||7
9050583|NCT03499067|10109926|FG000|STARTED|Second Intervention||22
9050584|NCT03499067|10109927|FG001|STARTED|Second Intervention||24
9050585|NCT03499067|10109926|FG000|COMPLETED|Second Intervention||22
9050586|NCT03499067|10109927|FG001|COMPLETED|Second Intervention||24
9050587|NCT03499067|10109926|FG000|NOT COMPLETED|Second Intervention||0
9050588|NCT03499067|10109927|FG001|NOT COMPLETED|Second Intervention||0
9050589|NCT03499353|10109933|FG000|STARTED|Treatment||61
9050590|NCT03499353|10109933|FG000|COMPLETED|Treatment||45
9050591|NCT03499353|10109933|FG000|NOT COMPLETED|Treatment||16
9050592|NCT03499353|10109933|FG000|STARTED|Safety Follow-up||49
9050593|NCT03499353|10109933|FG000|Received Treatment|Safety Follow-up||0
9050594|NCT03499353|10109933|FG000|COMPLETED|Safety Follow-up||49
9050595|NCT03499353|10109933|FG000|NOT COMPLETED|Safety Follow-up||0
9050596|NCT03499353|10109933|FG000|STARTED|Long-Term Follow-up||58
9050597|NCT03499353|10109933|FG000|Received Treatment|Long-Term Follow-up||0
9050598|NCT03499353|10109933|FG000|COMPLETED|Long-Term Follow-up||0
9050599|NCT03499353|10109933|FG000|NOT COMPLETED|Long-Term Follow-up||58
9050600|NCT03499873|10109940|FG000|STARTED|Overall Study||183
9050601|NCT03499873|10109941|FG001|STARTED|Overall Study||182
9050602|NCT03499873|10109942|FG002|STARTED|Overall Study||83
9050603|NCT03499873|10109940|FG000|Safety Population|Overall Study||175
9050604|NCT03499873|10109941|FG001|Safety Population|Overall Study||174
9050605|NCT03499873|10109942|FG002|Safety Population|Overall Study||80
9050606|NCT03499873|10109940|FG000|Per-Protocol Population|Overall Study||144
9050607|NCT03499873|10109941|FG001|Per-Protocol Population|Overall Study||143
9050608|NCT03499873|10109942|FG002|Per-Protocol Population|Overall Study||58
9050609|NCT03499873|10109940|FG000|Modified-Intent-to-Treat|Overall Study||170
9050610|NCT03499873|10109941|FG001|Modified-Intent-to-Treat|Overall Study||168
9050611|NCT03499873|10109942|FG002|Modified-Intent-to-Treat|Overall Study||77
9050612|NCT03499873|10109940|FG000|COMPLETED|Overall Study||163
9050613|NCT03499873|10109941|FG001|COMPLETED|Overall Study||162
9050614|NCT03499873|10109942|FG002|COMPLETED|Overall Study||56
9050615|NCT03499873|10109940|FG000|NOT COMPLETED|Overall Study||20
9050616|NCT03499873|10109941|FG001|NOT COMPLETED|Overall Study||20
9050617|NCT03499873|10109942|FG002|NOT COMPLETED|Overall Study||27
9050618|NCT03500094|10109950|FG000|STARTED|Overall Study||22
9050619|NCT03500094|10109950|FG000|Received At Least 1 Dose of Study Drug|Overall Study||21
9050620|NCT03500094|10109950|FG000|COMPLETED|Overall Study||19
9050621|NCT03500094|10109950|FG000|NOT COMPLETED|Overall Study||3
9050622|NCT03500198|10109958|FG000|STARTED|Overall Study||110
9050623|NCT03500198|10109959|FG001|STARTED|Overall Study||108
9050624|NCT03500198|10109958|FG000|First Eye|Overall Study||110
9050625|NCT03500198|10109959|FG001|First Eye|Overall Study||108
9050626|NCT03500198|10109958|FG000|Second Eye|Overall Study||109
9050627|NCT03500198|10109959|FG001|Second Eye|Overall Study||108
9050628|NCT03500198|10109958|FG000|COMPLETED|Overall Study||110
9050629|NCT03500198|10109959|FG001|COMPLETED|Overall Study||107
9050630|NCT03500198|10109958|FG000|NOT COMPLETED|Overall Study||0
9050631|NCT03500198|10109959|FG001|NOT COMPLETED|Overall Study||1
9050632|NCT03500211|10109969|FG000|STARTED|Overall Study||25
9050633|NCT03500211|10109970|FG001|STARTED|Overall Study||25
9050634|NCT03500211|10109969|FG000|COMPLETED|Overall Study||24
9050635|NCT03500211|10109970|FG001|COMPLETED|Overall Study||24
9050636|NCT03500211|10109969|FG000|NOT COMPLETED|Overall Study||1
9050637|NCT03500211|10109970|FG001|NOT COMPLETED|Overall Study||1
9050638|NCT03500224|10109976|FG000|STARTED|Overall Study||6
9050639|NCT03500224|10109976|FG000|COMPLETED|Overall Study||4
9050640|NCT03500224|10109976|FG000|NOT COMPLETED|Overall Study||2
9050641|NCT03500289|10109982|FG000|STARTED|Overall Study||12
9050642|NCT03500289|10109983|FG001|STARTED|Overall Study||6
9050643|NCT03500289|10109982|FG000|COMPLETED|Overall Study||12
9050644|NCT03500289|10109983|FG001|COMPLETED|Overall Study||6
9050645|NCT03500289|10109982|FG000|NOT COMPLETED|Overall Study||0
9050646|NCT03500289|10109983|FG001|NOT COMPLETED|Overall Study||0
9050647|NCT03500302|10109989|FG000|STARTED|Overall Study||19
9050648|NCT03500302|10109989|FG000|COMPLETED|Overall Study||19
9050649|NCT03500302|10109989|FG000|NOT COMPLETED|Overall Study||0
9050650|NCT03500419|10109995|FG000|STARTED|Overall Study||27
9050651|NCT03500419|10109996|FG001|STARTED|Overall Study||55
9050652|NCT03500419|10109995|FG000|COMPLETED|Overall Study||25
9050653|NCT03500419|10109996|FG001|COMPLETED|Overall Study||30
9050654|NCT03500419|10109995|FG000|NOT COMPLETED|Overall Study||2
9050655|NCT03500419|10109996|FG001|NOT COMPLETED|Overall Study||25
9050656|NCT03500679|10110004|FG000|STARTED|Overall Study||75
9050657|NCT03500679|10110005|FG001|STARTED|Overall Study||25
9050658|NCT03500679|10110004|FG000|COMPLETED|Overall Study||66
9050659|NCT03500679|10110005|FG001|COMPLETED|Overall Study||22
9050660|NCT03500679|10110004|FG000|NOT COMPLETED|Overall Study||9
9050661|NCT03500679|10110005|FG001|NOT COMPLETED|Overall Study||3
9050662|NCT03501043|10110011|FG000|STARTED|Overall Study||11
9050663|NCT03501043|10110011|FG000|COMPLETED|Overall Study||10
9050664|NCT03501043|10110011|FG000|NOT COMPLETED|Overall Study||1
9050665|NCT03501069|10110035|FG000|STARTED|Period A||2
9050666|NCT03501069|10110036|FG001|STARTED|Period A||4
9050667|NCT03501069|10110037|FG002|STARTED|Period A||2
9050668|NCT03501069|10110038|FG003|STARTED|Period A||5
9050669|NCT03501069|10110039|FG004|STARTED|Period A||1
9050670|NCT03501069|10110040|FG005|STARTED|Period A||6
9050671|NCT03501069|10110041|FG006|STARTED|Period A||6
9050672|NCT03501069|10110042|FG007|STARTED|Period A||3
9050673|NCT03501069|10110043|FG008|STARTED|Period A||3
9050674|NCT03501069|10110035|FG000|COMPLETED|Period A||2
9050675|NCT03501069|10110036|FG001|COMPLETED|Period A||4
9050676|NCT03501069|10110037|FG002|COMPLETED|Period A||2
9050677|NCT03501069|10110038|FG003|COMPLETED|Period A||5
9050678|NCT03501069|10110039|FG004|COMPLETED|Period A||1
9050679|NCT03501069|10110040|FG005|COMPLETED|Period A||6
9050680|NCT03501069|10110041|FG006|COMPLETED|Period A||6
9050681|NCT03501069|10110042|FG007|COMPLETED|Period A||3
9050682|NCT03501069|10110043|FG008|COMPLETED|Period A||3
9050683|NCT03501069|10110035|FG000|NOT COMPLETED|Period A||0
9050684|NCT03501069|10110036|FG001|NOT COMPLETED|Period A||0
9050685|NCT03501069|10110037|FG002|NOT COMPLETED|Period A||0
9050686|NCT03501069|10110038|FG003|NOT COMPLETED|Period A||0
9050687|NCT03501069|10110039|FG004|NOT COMPLETED|Period A||0
9050688|NCT03501069|10110040|FG005|NOT COMPLETED|Period A||0
9050689|NCT03501069|10110041|FG006|NOT COMPLETED|Period A||0
9050690|NCT03501069|10110042|FG007|NOT COMPLETED|Period A||0
9050691|NCT03501069|10110043|FG008|NOT COMPLETED|Period A||0
9050692|NCT03501069|10110035|FG000|STARTED|Washout Period (at Least 14 Days)||2
9050693|NCT03501069|10110036|FG001|STARTED|Washout Period (at Least 14 Days)||4
9050694|NCT03501069|10110037|FG002|STARTED|Washout Period (at Least 14 Days)||2
9050695|NCT03501069|10110038|FG003|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
9050696|NCT03501069|10110039|FG004|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
9050697|NCT03501069|10110040|FG005|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
9050698|NCT03501069|10110041|FG006|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
9050699|NCT03501069|10110042|FG007|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
9050700|NCT03501069|10110043|FG008|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
9050701|NCT03501069|10110035|FG000|COMPLETED|Washout Period (at Least 14 Days)||2
9050702|NCT03501069|10110036|FG001|COMPLETED|Washout Period (at Least 14 Days)||4
9050703|NCT03501069|10110037|FG002|COMPLETED|Washout Period (at Least 14 Days)||2
9050704|NCT03501069|10110038|FG003|COMPLETED|Washout Period (at Least 14 Days)||0
9050705|NCT03501069|10110039|FG004|COMPLETED|Washout Period (at Least 14 Days)||0
9050706|NCT03501069|10110040|FG005|COMPLETED|Washout Period (at Least 14 Days)||0
9050707|NCT03501069|10110041|FG006|COMPLETED|Washout Period (at Least 14 Days)||0
9050708|NCT03501069|10110042|FG007|COMPLETED|Washout Period (at Least 14 Days)||0
9050709|NCT03501069|10110043|FG008|COMPLETED|Washout Period (at Least 14 Days)||0
9050710|NCT03501069|10110035|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
9050711|NCT03501069|10110036|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
9050712|NCT03501069|10110037|FG002|NOT COMPLETED|Washout Period (at Least 14 Days)||0
9050713|NCT03501069|10110038|FG003|NOT COMPLETED|Washout Period (at Least 14 Days)||0
9050714|NCT03501069|10110039|FG004|NOT COMPLETED|Washout Period (at Least 14 Days)||0
9050715|NCT03501069|10110040|FG005|NOT COMPLETED|Washout Period (at Least 14 Days)||0
9050716|NCT03501069|10110041|FG006|NOT COMPLETED|Washout Period (at Least 14 Days)||0
9050717|NCT03501069|10110042|FG007|NOT COMPLETED|Washout Period (at Least 14 Days)||0
9050718|NCT03501069|10110043|FG008|NOT COMPLETED|Washout Period (at Least 14 Days)||0
9050719|NCT03501069|10110035|FG000|STARTED|Period B||2
9050720|NCT03501069|10110036|FG001|STARTED|Period B||4
9050721|NCT03501069|10110037|FG002|STARTED|Period B||2
9050722|NCT03501069|10110038|FG003|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
9050723|NCT03501069|10110039|FG004|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
9050724|NCT03501069|10110040|FG005|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
9050725|NCT03501069|10110041|FG006|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
9050726|NCT03501069|10110042|FG007|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
9050727|NCT03501069|10110043|FG008|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
9050728|NCT03501069|10110035|FG000|COMPLETED|Period B||2
9050729|NCT03501069|10110036|FG001|COMPLETED|Period B||4
9050730|NCT03501069|10110037|FG002|COMPLETED|Period B||2
9050731|NCT03501069|10110038|FG003|COMPLETED|Period B||0
9050732|NCT03501069|10110039|FG004|COMPLETED|Period B||0
9050733|NCT03501069|10110040|FG005|COMPLETED|Period B||0
9050734|NCT03501069|10110041|FG006|COMPLETED|Period B||0
9050735|NCT03501069|10110042|FG007|COMPLETED|Period B||0
9050736|NCT03501069|10110043|FG008|COMPLETED|Period B||0
9050737|NCT03501069|10110035|FG000|NOT COMPLETED|Period B||0
9050738|NCT03501069|10110036|FG001|NOT COMPLETED|Period B||0
9050739|NCT03501069|10110037|FG002|NOT COMPLETED|Period B||0
9050740|NCT03501069|10110038|FG003|NOT COMPLETED|Period B||0
9050741|NCT03501069|10110039|FG004|NOT COMPLETED|Period B||0
9050742|NCT03501069|10110040|FG005|NOT COMPLETED|Period B||0
9050743|NCT03501069|10110041|FG006|NOT COMPLETED|Period B||0
9050744|NCT03501069|10110042|FG007|NOT COMPLETED|Period B||0
9050745|NCT03501069|10110043|FG008|NOT COMPLETED|Period B||0
9050746|NCT03501264|10110073|FG000|STARTED|Overall Study||120
9050747|NCT03501264|10110074|FG001|STARTED|Overall Study||120
9050748|NCT03501264|10110073|FG000|COMPLETED|Overall Study||120
9050749|NCT03501264|10110074|FG001|COMPLETED|Overall Study||120
9050750|NCT03501264|10110073|FG000|NOT COMPLETED|Overall Study||0
9050751|NCT03501264|10110074|FG001|NOT COMPLETED|Overall Study||0
9050752|NCT03501277|10110084|FG000|STARTED|Intervention Period 1 (4 Days)||18
9050753|NCT03501277|10110085|FG001|STARTED|Intervention Period 1 (4 Days)||18
9050754|NCT03501277|10110086|FG002|STARTED|Intervention Period 1 (4 Days)||18
9050755|NCT03501277|10110087|FG003|STARTED|Intervention Period 1 (4 Days)||18
9050756|NCT03501277|10110084|FG000|Safety Analysis Set|Intervention Period 1 (4 Days)||18
9050757|NCT03501277|10110085|FG001|Safety Analysis Set|Intervention Period 1 (4 Days)||18
9050758|NCT03501277|10110086|FG002|Safety Analysis Set|Intervention Period 1 (4 Days)||17
9050759|NCT03501277|10110087|FG003|Safety Analysis Set|Intervention Period 1 (4 Days)||17
9050760|NCT03501277|10110084|FG000|COMPLETED|Intervention Period 1 (4 Days)||18
9050761|NCT03501277|10110085|FG001|COMPLETED|Intervention Period 1 (4 Days)||18
9050762|NCT03501277|10110086|FG002|COMPLETED|Intervention Period 1 (4 Days)||17
9050763|NCT03501277|10110087|FG003|COMPLETED|Intervention Period 1 (4 Days)||17
9050764|NCT03501277|10110084|FG000|NOT COMPLETED|Intervention Period 1 (4 Days)||0
9050765|NCT03501277|10110085|FG001|NOT COMPLETED|Intervention Period 1 (4 Days)||0
9050766|NCT03501277|10110086|FG002|NOT COMPLETED|Intervention Period 1 (4 Days)||1
9050767|NCT03501277|10110087|FG003|NOT COMPLETED|Intervention Period 1 (4 Days)||1
9050768|NCT03501277|10110084|FG000|STARTED|Washout Period 1 (7 Days)||18
9050769|NCT03501277|10110085|FG001|STARTED|Washout Period 1 (7 Days)||18
9050770|NCT03501277|10110086|FG002|STARTED|Washout Period 1 (7 Days)||17
9050771|NCT03501277|10110087|FG003|STARTED|Washout Period 1 (7 Days)||17
9050772|NCT03501277|10110084|FG000|COMPLETED|Washout Period 1 (7 Days)||18
9050773|NCT03501277|10110085|FG001|COMPLETED|Washout Period 1 (7 Days)||18
9050774|NCT03501277|10110086|FG002|COMPLETED|Washout Period 1 (7 Days)||17
9050775|NCT03501277|10110087|FG003|COMPLETED|Washout Period 1 (7 Days)||17
9050776|NCT03501277|10110084|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
9050777|NCT03501277|10110085|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
9050778|NCT03501277|10110086|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
9050779|NCT03501277|10110087|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
9050780|NCT03501277|10110084|FG000|STARTED|Intervention Period 2 (4 Days)||18
9050781|NCT03501277|10110085|FG001|STARTED|Intervention Period 2 (4 Days)||18
8703550|NCT00923273|9749264|FG002|STARTED|Phase I Treatment Period|3 subjects peme naive.|3
8703551|NCT00923273|9749265|FG003|STARTED|Phase I Treatment Period|3 subjects initially enrolled and 4 subjects added after dose level 5; peme naive.|7
8703552|NCT00923273|9749266|FG004|STARTED|Phase I Treatment Period|5 subjects peme naive.|5
8703553|NCT00923273|9749262|FG000|COMPLETED|Phase I Treatment Period||4
8703554|NCT00923273|9749263|FG001|COMPLETED|Phase I Treatment Period||3
9050782|NCT03501277|10110086|FG002|STARTED|Intervention Period 2 (4 Days)||17
9050783|NCT03501277|10110087|FG003|STARTED|Intervention Period 2 (4 Days)||17
9050784|NCT03501277|10110084|FG000|COMPLETED|Intervention Period 2 (4 Days)||18
9050785|NCT03501277|10110085|FG001|COMPLETED|Intervention Period 2 (4 Days)||18
9050786|NCT03501277|10110086|FG002|COMPLETED|Intervention Period 2 (4 Days)||17
9050787|NCT03501277|10110087|FG003|COMPLETED|Intervention Period 2 (4 Days)||16
9050788|NCT03501277|10110084|FG000|NOT COMPLETED|Intervention Period 2 (4 Days)||0
9050789|NCT03501277|10110085|FG001|NOT COMPLETED|Intervention Period 2 (4 Days)||0
9050790|NCT03501277|10110086|FG002|NOT COMPLETED|Intervention Period 2 (4 Days)||0
9050791|NCT03501277|10110087|FG003|NOT COMPLETED|Intervention Period 2 (4 Days)||1
9050792|NCT03501277|10110084|FG000|STARTED|Washout Period 2 (7 Days)||18
9050793|NCT03501277|10110085|FG001|STARTED|Washout Period 2 (7 Days)||18
9050794|NCT03501277|10110086|FG002|STARTED|Washout Period 2 (7 Days)||17
9050795|NCT03501277|10110087|FG003|STARTED|Washout Period 2 (7 Days)||16
9050796|NCT03501277|10110084|FG000|COMPLETED|Washout Period 2 (7 Days)||18
9050797|NCT03501277|10110085|FG001|COMPLETED|Washout Period 2 (7 Days)||18
9050798|NCT03501277|10110086|FG002|COMPLETED|Washout Period 2 (7 Days)||17
9050799|NCT03501277|10110087|FG003|COMPLETED|Washout Period 2 (7 Days)||16
9050800|NCT03501277|10110084|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
9050801|NCT03501277|10110085|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
9050802|NCT03501277|10110086|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
9050803|NCT03501277|10110087|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
9050804|NCT03501277|10110084|FG000|STARTED|Intervention Period 3 (4 Days)||18
9050805|NCT03501277|10110085|FG001|STARTED|Intervention Period 3 (4 Days)||18
9050806|NCT03501277|10110086|FG002|STARTED|Intervention Period 3 (4 Days)||17
9050807|NCT03501277|10110087|FG003|STARTED|Intervention Period 3 (4 Days)||16
9050808|NCT03501277|10110084|FG000|COMPLETED|Intervention Period 3 (4 Days)||18
9050809|NCT03501277|10110085|FG001|COMPLETED|Intervention Period 3 (4 Days)||18
9050810|NCT03501277|10110086|FG002|COMPLETED|Intervention Period 3 (4 Days)||17
9050811|NCT03501277|10110087|FG003|COMPLETED|Intervention Period 3 (4 Days)||15
9050812|NCT03501277|10110084|FG000|NOT COMPLETED|Intervention Period 3 (4 Days)||0
9050813|NCT03501277|10110085|FG001|NOT COMPLETED|Intervention Period 3 (4 Days)||0
9050814|NCT03501277|10110086|FG002|NOT COMPLETED|Intervention Period 3 (4 Days)||0
9050815|NCT03501277|10110087|FG003|NOT COMPLETED|Intervention Period 3 (4 Days)||1
9050816|NCT03501277|10110084|FG000|STARTED|Washout Period 3 (7 Days)||18
9050817|NCT03501277|10110085|FG001|STARTED|Washout Period 3 (7 Days)||18
9050818|NCT03501277|10110086|FG002|STARTED|Washout Period 3 (7 Days)||17
9050819|NCT03501277|10110087|FG003|STARTED|Washout Period 3 (7 Days)||15
9050820|NCT03501277|10110084|FG000|COMPLETED|Washout Period 3 (7 Days)||18
9050821|NCT03501277|10110085|FG001|COMPLETED|Washout Period 3 (7 Days)||18
9050822|NCT03501277|10110086|FG002|COMPLETED|Washout Period 3 (7 Days)||17
9050823|NCT03501277|10110087|FG003|COMPLETED|Washout Period 3 (7 Days)||15
9050824|NCT03501277|10110084|FG000|NOT COMPLETED|Washout Period 3 (7 Days)||0
9050825|NCT03501277|10110085|FG001|NOT COMPLETED|Washout Period 3 (7 Days)||0
9050826|NCT03501277|10110086|FG002|NOT COMPLETED|Washout Period 3 (7 Days)||0
9050827|NCT03501277|10110087|FG003|NOT COMPLETED|Washout Period 3 (7 Days)||0
9050828|NCT03501277|10110084|FG000|STARTED|Intervention Period 4 (4 Days)||18
9050829|NCT03501277|10110085|FG001|STARTED|Intervention Period 4 (4 Days)||18
8578734|NCT00177671|9611856|FG000|NOT COMPLETED|Overall Study||25
8578735|NCT00177671|9611857|FG001|NOT COMPLETED|Overall Study||14
8578736|NCT00178126|9611865|FG000|STARTED|Overall Study||119
8578737|NCT00178126|9611866|FG001|STARTED|Overall Study||113
8578738|NCT00178126|9611865|FG000|COMPLETED|Overall Study||94
8578739|NCT00178126|9611866|FG001|COMPLETED|Overall Study||86
8578740|NCT00178126|9611865|FG000|NOT COMPLETED|Overall Study||25
8578741|NCT00178126|9611866|FG001|NOT COMPLETED|Overall Study||27
8578742|NCT00178178|9611876|FG000|STARTED|Overall Study||24
9050830|NCT03501277|10110086|FG002|STARTED|Intervention Period 4 (4 Days)||17
9050831|NCT03501277|10110087|FG003|STARTED|Intervention Period 4 (4 Days)||15
9050832|NCT03501277|10110084|FG000|COMPLETED|Intervention Period 4 (4 Days)||18
9050833|NCT03501277|10110085|FG001|COMPLETED|Intervention Period 4 (4 Days)||18
9050834|NCT03501277|10110086|FG002|COMPLETED|Intervention Period 4 (4 Days)||17
9050835|NCT03501277|10110087|FG003|COMPLETED|Intervention Period 4 (4 Days)||15
9050836|NCT03501277|10110084|FG000|NOT COMPLETED|Intervention Period 4 (4 Days)||0
9050837|NCT03501277|10110085|FG001|NOT COMPLETED|Intervention Period 4 (4 Days)||0
9050838|NCT03501277|10110086|FG002|NOT COMPLETED|Intervention Period 4 (4 Days)||0
9050839|NCT03501277|10110087|FG003|NOT COMPLETED|Intervention Period 4 (4 Days)||0
9050840|NCT03501550|10110097|FG000|STARTED|Overall Study||12
9050841|NCT03501550|10110097|FG000|COMPLETED|Overall Study||12
9050842|NCT03501550|10110097|FG000|NOT COMPLETED|Overall Study||0
9050843|NCT03501693|10110101|FG000|STARTED|First Reading Session||75
9050844|NCT03501693|10110102|FG001|STARTED|First Reading Session||75
9050845|NCT03501693|10110101|FG000|COMPLETED|First Reading Session||75
9050846|NCT03501693|10110102|FG001|COMPLETED|First Reading Session||75
9050847|NCT03501693|10110101|FG000|NOT COMPLETED|First Reading Session||0
9050848|NCT03501693|10110102|FG001|NOT COMPLETED|First Reading Session||0
9050849|NCT03501693|10110101|FG000|STARTED|4 Week Memory Washout Period||75
9050850|NCT03501693|10110102|FG001|STARTED|4 Week Memory Washout Period||75
9050851|NCT03501693|10110101|FG000|COMPLETED|4 Week Memory Washout Period||75
9050852|NCT03501693|10110102|FG001|COMPLETED|4 Week Memory Washout Period||75
9050853|NCT03501693|10110101|FG000|NOT COMPLETED|4 Week Memory Washout Period||0
9050854|NCT03501693|10110102|FG001|NOT COMPLETED|4 Week Memory Washout Period||0
9050855|NCT03501693|10110101|FG000|STARTED|Second Reading Session||75
9050856|NCT03501693|10110102|FG001|STARTED|Second Reading Session||75
9050857|NCT03501693|10110101|FG000|COMPLETED|Second Reading Session||75
9050858|NCT03501693|10110102|FG001|COMPLETED|Second Reading Session||75
9050859|NCT03501693|10110101|FG000|NOT COMPLETED|Second Reading Session||0
9050860|NCT03501693|10110102|FG001|NOT COMPLETED|Second Reading Session||0
9050861|NCT03502265|10110108|FG000|STARTED|Overall Study||4
9050862|NCT03502265|10110108|FG000|COMPLETED|Overall Study||4
9050863|NCT03502265|10110108|FG000|NOT COMPLETED|Overall Study||0
9050864|NCT03502616|10110114|FG000|STARTED|Up to Week 16||134
9050865|NCT03502616|10110115|FG001|STARTED|Up to Week 16||136
9050866|NCT03502616|10110114|FG000|Treated|Up to Week 16||133
9050867|NCT03502616|10110115|FG001|Treated|Up to Week 16||136
9050868|NCT03502616|10110114|FG000|COMPLETED|Up to Week 16||132
9050869|NCT03502616|10110115|FG001|COMPLETED|Up to Week 16||133
9050870|NCT03502616|10110114|FG000|NOT COMPLETED|Up to Week 16||2
9050871|NCT03502616|10110115|FG001|NOT COMPLETED|Up to Week 16||3
9050872|NCT03502616|10110114|FG000|STARTED|Week 16 to Week 48||132
9050873|NCT03502616|10110115|FG001|STARTED|Week 16 to Week 48||133
9050874|NCT03502616|10110114|FG000|Treated|Week 16 to Week 48||132
9050875|NCT03502616|10110115|FG001|Treated|Week 16 to Week 48||133
9050876|NCT03502616|10110114|FG000|COMPLETED|Week 16 to Week 48||125
9050877|NCT03502616|10110115|FG001|COMPLETED|Week 16 to Week 48||127
9050878|NCT03502616|10110114|FG000|NOT COMPLETED|Week 16 to Week 48||7
9050879|NCT03502616|10110115|FG001|NOT COMPLETED|Week 16 to Week 48||6
9050880|NCT03502681|10110125|FG000|STARTED|Overall Study||3
9050881|NCT03502681|10110126|FG001|STARTED|Overall Study||3
9050882|NCT03502681|10110125|FG000|COMPLETED|Overall Study||0
9050883|NCT03502681|10110126|FG001|COMPLETED|Overall Study||1
9050884|NCT03502681|10110125|FG000|NOT COMPLETED|Overall Study||3
9050885|NCT03502681|10110126|FG001|NOT COMPLETED|Overall Study||2
9050886|NCT03502798|10110133|FG000|STARTED|Overall Study||5
9050887|NCT03502798|10110134|FG001|STARTED|Overall Study||40
9050888|NCT03502798|10110133|FG000|COMPLETED|Overall Study||5
9050889|NCT03502798|10110134|FG001|COMPLETED|Overall Study||33
9050890|NCT03502798|10110133|FG000|NOT COMPLETED|Overall Study||0
9050891|NCT03502798|10110134|FG001|NOT COMPLETED|Overall Study||7
9050892|NCT03502915|10110142|FG000|STARTED|Overall Study||24
9050893|NCT03502915|10110143|FG001|STARTED|Overall Study||24
9050894|NCT03502915|10110142|FG000|COMPLETED|Overall Study||24
9050895|NCT03502915|10110143|FG001|COMPLETED|Overall Study||24
9050896|NCT03502915|10110142|FG000|NOT COMPLETED|Overall Study||0
9050897|NCT03502915|10110143|FG001|NOT COMPLETED|Overall Study||0
9050898|NCT03502941|10110152|FG000|STARTED|Overall Study||3
9050899|NCT03502941|10110153|FG001|STARTED|Overall Study||5
9050900|NCT03502941|10110154|FG002|STARTED|Overall Study||8
9050901|NCT03502941|10110152|FG000|COMPLETED|Overall Study||3
9050902|NCT03502941|10110153|FG001|COMPLETED|Overall Study||5
9050903|NCT03502941|10110154|FG002|COMPLETED|Overall Study||8
9050904|NCT03502941|10110152|FG000|NOT COMPLETED|Overall Study||0
9050905|NCT03502941|10110153|FG001|NOT COMPLETED|Overall Study||0
9050906|NCT03502941|10110154|FG002|NOT COMPLETED|Overall Study||0
9050907|NCT03503162|10110162|FG000|STARTED|Overall Study||95
9050908|NCT03503162|10110162|FG000|COMPLETED|Overall Study||94
9050909|NCT03503162|10110162|FG000|NOT COMPLETED|Overall Study||1
9050910|NCT03503188|10110168|FG000|STARTED|Overall Study||128
9050911|NCT03503188|10110169|FG001|STARTED|Overall Study||146
9050912|NCT03503188|10110168|FG000|Entered in the Entire Study|Overall Study||128
9050913|NCT03503188|10110169|FG001|Entered in the Entire Study|Overall Study||145
9050914|NCT03503188|10110168|FG000|Main Study|Overall Study||99
9050915|NCT03503188|10110169|FG001|Main Study|Overall Study||101
9050916|NCT03503188|10110168|FG000|Sub-study|Overall Study||29
9050917|NCT03503188|10110169|FG001|Sub-study|Overall Study||44
9050918|NCT03503188|10110168|FG000|COMPLETED|Overall Study||128
9050919|NCT03503188|10110169|FG001|COMPLETED|Overall Study||145
9050920|NCT03503188|10110168|FG000|NOT COMPLETED|Overall Study||0
9050921|NCT03503188|10110169|FG001|NOT COMPLETED|Overall Study||1
9050922|NCT03503292|10110177|FG000|STARTED|Overall Study||2
9050923|NCT03503292|10110178|FG001|STARTED|Overall Study||90
9050924|NCT03503292|10110177|FG000|COMPLETED|Overall Study||2
9050925|NCT03503292|10110178|FG001|COMPLETED|Overall Study||90
9050926|NCT03503292|10110177|FG000|NOT COMPLETED|Overall Study||0
9050927|NCT03503292|10110178|FG001|NOT COMPLETED|Overall Study||0
9050928|NCT03503565|10110186|FG000|STARTED|Overall Study||59
9050929|NCT03503565|10110187|FG001|STARTED|Overall Study||58
9050930|NCT03503565|10110186|FG000|COMPLETED|Overall Study||59
9050931|NCT03503565|10110187|FG001|COMPLETED|Overall Study||58
9050932|NCT03503565|10110186|FG000|NOT COMPLETED|Overall Study||0
9050933|NCT03503565|10110187|FG001|NOT COMPLETED|Overall Study||0
9050934|NCT03503578|10110193|FG000|STARTED|Overall Study||12
9050935|NCT03503578|10110193|FG000|COMPLETED|Overall Study||12
9050936|NCT03503578|10110193|FG000|NOT COMPLETED|Overall Study||0
9050937|NCT03504189|10110197|FG000|STARTED|Overall Study||151
9050938|NCT03504189|10110197|FG000|COMPLETED|Overall Study||147
9050939|NCT03504189|10110197|FG000|NOT COMPLETED|Overall Study||4
9050940|NCT03504839|10110206|FG000|STARTED|Overall Study||53
9050941|NCT03504839|10110206|FG000|COMPLETED|Overall Study||49
9050942|NCT03504839|10110206|FG000|NOT COMPLETED|Overall Study||4
9050943|NCT03504852|10110213|FG000|STARTED|Overall Study||165
9050944|NCT03504852|10110214|FG001|STARTED|Overall Study||135
9050945|NCT03504852|10110215|FG002|STARTED|Overall Study||31
9050946|NCT03504852|10110213|FG000|COMPLETED|Overall Study||148
9050947|NCT03504852|10110214|FG001|COMPLETED|Overall Study||117
9050948|NCT03504852|10110215|FG002|COMPLETED|Overall Study||28
9050949|NCT03504852|10110213|FG000|NOT COMPLETED|Overall Study||17
9050950|NCT03504852|10110214|FG001|NOT COMPLETED|Overall Study||18
9050951|NCT03504852|10110215|FG002|NOT COMPLETED|Overall Study||3
9050952|NCT03504917|10110227|FG000|STARTED|Blinded Treatment Period||163
9050953|NCT03504917|10110228|FG001|STARTED|Blinded Treatment Period||158
9050954|NCT03504917|10110227|FG000|COMPLETED|Blinded Treatment Period||103
9050955|NCT03504917|10110228|FG001|COMPLETED|Blinded Treatment Period||102
9050956|NCT03504917|10110227|FG000|NOT COMPLETED|Blinded Treatment Period||60
9050957|NCT03504917|10110228|FG001|NOT COMPLETED|Blinded Treatment Period||56
8703555|NCT00923273|9749264|FG002|COMPLETED|Phase I Treatment Period||3
8703556|NCT00923273|9749265|FG003|COMPLETED|Phase I Treatment Period||7
8703557|NCT00923273|9749266|FG004|COMPLETED|Phase I Treatment Period||5
8703558|NCT00923273|9749262|FG000|NOT COMPLETED|Phase I Treatment Period||0
8703559|NCT00923273|9749263|FG001|NOT COMPLETED|Phase I Treatment Period||0
8703560|NCT00923273|9749264|FG002|NOT COMPLETED|Phase I Treatment Period||0
8703561|NCT00923273|9749265|FG003|NOT COMPLETED|Phase I Treatment Period||0
8703562|NCT00923273|9749266|FG004|NOT COMPLETED|Phase I Treatment Period||0
8703563|NCT00923273|9749262|FG000|STARTED|Phase II Treatment Period|The phase II portion will utilize the MTD from the phase I portion.|0
8703564|NCT00923273|9749263|FG001|STARTED|Phase II Treatment Period||0
8703565|NCT00923273|9749264|FG002|STARTED|Phase II Treatment Period||0
8703566|NCT00923273|9749265|FG003|STARTED|Phase II Treatment Period|Includes 8 subjects with prior peme;12 subjects who were peme naive; 7 subjects rolled over from phI|27
8703567|NCT00923273|9749266|FG004|STARTED|Phase II Treatment Period||0
9050958|NCT03504917|10110227|FG000|STARTED|Open Label Extension Treatment Period||100
9050959|NCT03504917|10110228|FG001|STARTED|Open Label Extension Treatment Period||97
9050960|NCT03504917|10110227|FG000|COMPLETED|Open Label Extension Treatment Period||0
9050961|NCT03504917|10110228|FG001|COMPLETED|Open Label Extension Treatment Period||0
9050962|NCT03504917|10110227|FG000|NOT COMPLETED|Open Label Extension Treatment Period||100
9050963|NCT03504917|10110228|FG001|NOT COMPLETED|Open Label Extension Treatment Period||97
9050964|NCT03505190|10110245|FG000|STARTED|Overall Study||9
9050965|NCT03505190|10110246|FG001|STARTED|Overall Study||8
9050966|NCT03505190|10110247|FG002|STARTED|Overall Study||8
9050967|NCT03505190|10110248|FG003|STARTED|Overall Study||8
9050968|NCT03505190|10110249|FG004|STARTED|Overall Study||8
9050969|NCT03505190|10110245|FG000|COMPLETED|Overall Study||9
9050970|NCT03505190|10110246|FG001|COMPLETED|Overall Study||8
9050971|NCT03505190|10110247|FG002|COMPLETED|Overall Study||8
9050972|NCT03505190|10110248|FG003|COMPLETED|Overall Study||8
9050973|NCT03505190|10110249|FG004|COMPLETED|Overall Study||8
9050974|NCT03505190|10110245|FG000|NOT COMPLETED|Overall Study||0
9050975|NCT03505190|10110246|FG001|NOT COMPLETED|Overall Study||0
9050976|NCT03505190|10110247|FG002|NOT COMPLETED|Overall Study||0
9050977|NCT03505190|10110248|FG003|NOT COMPLETED|Overall Study||0
9050978|NCT03505190|10110249|FG004|NOT COMPLETED|Overall Study||0
9050979|NCT03505593|10110261|FG000|STARTED|Overall Study||48
9050980|NCT03505593|10110261|FG000|COMPLETED|Overall Study||43
9050981|NCT03505593|10110261|FG000|NOT COMPLETED|Overall Study||5
9050982|NCT03506295|10110265|FG000|STARTED|Overall Study||10
9050983|NCT03506295|10110265|FG000|COMPLETED|Overall Study||10
9050984|NCT03506295|10110265|FG000|NOT COMPLETED|Overall Study||0
9050985|NCT03506347|10110273|FG000|STARTED|Overall Study||12
9050986|NCT03506347|10110274|FG001|STARTED|Overall Study||12
9050987|NCT03506347|10110273|FG000|COMPLETED|Overall Study||12
9050988|NCT03506347|10110274|FG001|COMPLETED|Overall Study||12
9050989|NCT03506347|10110273|FG000|NOT COMPLETED|Overall Study||0
9050990|NCT03506347|10110274|FG001|NOT COMPLETED|Overall Study||0
9050991|NCT03506386|10110280|FG000|STARTED|Overall Study||943
9050992|NCT03506386|10110280|FG000|COMPLETED|Overall Study||943
9050993|NCT03506386|10110280|FG000|NOT COMPLETED|Overall Study||0
9050994|NCT03506425|10110287|FG000|STARTED|Overall Study||5
9050995|NCT03506425|10110288|FG001|STARTED|Overall Study||5
9050996|NCT03506425|10110289|FG002|STARTED|Overall Study||5
9050997|NCT03506425|10110287|FG000|COMPLETED|Overall Study||3
9050998|NCT03506425|10110288|FG001|COMPLETED|Overall Study||2
9050999|NCT03506425|10110289|FG002|COMPLETED|Overall Study||4
9051000|NCT03506425|10110287|FG000|NOT COMPLETED|Overall Study||2
9051001|NCT03506425|10110288|FG001|NOT COMPLETED|Overall Study||3
9051002|NCT03506425|10110289|FG002|NOT COMPLETED|Overall Study||1
9051003|NCT03506477|10110300|FG000|STARTED|Overall Study||20
9051004|NCT03506477|10110301|FG001|STARTED|Overall Study||5
9051005|NCT03506477|10110300|FG000|COMPLETED|Overall Study||19
9051006|NCT03506477|10110301|FG001|COMPLETED|Overall Study||5
9051007|NCT03506477|10110300|FG000|NOT COMPLETED|Overall Study||1
9051008|NCT03506477|10110301|FG001|NOT COMPLETED|Overall Study||0
9051009|NCT03506724|10110309|FG000|STARTED|Overall Study||54
9051010|NCT03506724|10110310|FG001|STARTED|Overall Study||55
9051011|NCT03506724|10110309|FG000|COMPLETED|Overall Study||54
9051012|NCT03506724|10110310|FG001|COMPLETED|Overall Study||55
9051013|NCT03506724|10110309|FG000|NOT COMPLETED|Overall Study||0
9051014|NCT03506724|10110310|FG001|NOT COMPLETED|Overall Study||0
9051015|NCT03507036|10110316|FG000|STARTED|Overall Study||20
9051016|NCT03507036|10110316|FG000|COMPLETED|Overall Study||15
9051017|NCT03507036|10110316|FG000|NOT COMPLETED|Overall Study||5
9051018|NCT03507569|10110327|FG000|STARTED|Overall Study||2
9051019|NCT03507569|10110328|FG001|STARTED|Overall Study||1
9051020|NCT03507569|10110329|FG002|STARTED|Overall Study||2
9051021|NCT03507569|10110330|FG003|STARTED|Overall Study||1
9051022|NCT03507569|10110327|FG000|COMPLETED|Overall Study||2
9051023|NCT03507569|10110328|FG001|COMPLETED|Overall Study||1
9051024|NCT03507569|10110329|FG002|COMPLETED|Overall Study||2
9051025|NCT03507569|10110330|FG003|COMPLETED|Overall Study||1
9051026|NCT03507569|10110327|FG000|NOT COMPLETED|Overall Study||0
9051027|NCT03507569|10110328|FG001|NOT COMPLETED|Overall Study||0
9051028|NCT03507569|10110329|FG002|NOT COMPLETED|Overall Study||0
9051029|NCT03507569|10110330|FG003|NOT COMPLETED|Overall Study||0
9051030|NCT03508050|10110342|FG000|STARTED|Overall Study||20
9051031|NCT03508050|10110343|FG001|STARTED|Overall Study||17
9051032|NCT03508050|10110342|FG000|COMPLETED|Overall Study||15
9051033|NCT03508050|10110343|FG001|COMPLETED|Overall Study||15
9051034|NCT03508050|10110342|FG000|NOT COMPLETED|Overall Study||5
9051035|NCT03508050|10110343|FG001|NOT COMPLETED|Overall Study||2
9051036|NCT03508609|10110350|FG000|STARTED|Overall Study||20
9051037|NCT03508609|10110350|FG000|COMPLETED|Overall Study||19
9051038|NCT03508609|10110350|FG000|NOT COMPLETED|Overall Study||1
9051039|NCT03508661|10110354|FG000|STARTED|Overall Study||10
9051040|NCT03508661|10110354|FG000|COMPLETED|Overall Study||10
9051041|NCT03508661|10110354|FG000|NOT COMPLETED|Overall Study||0
9051042|NCT03508687|10110360|FG000|STARTED|Overall Study||2
9051043|NCT03508687|10110361|FG001|STARTED|Overall Study||3
9051044|NCT03508687|10110360|FG000|COMPLETED|Overall Study||2
9051045|NCT03508687|10110361|FG001|COMPLETED|Overall Study||3
9051046|NCT03508687|10110360|FG000|NOT COMPLETED|Overall Study||0
9051047|NCT03508687|10110361|FG001|NOT COMPLETED|Overall Study||0
9051048|NCT03508830|10110371|FG000|STARTED|Overall Study||46
9051049|NCT03508830|10110372|FG001|STARTED|Overall Study||45
9051050|NCT03508830|10110371|FG000|COMPLETED|Overall Study||41
9051051|NCT03508830|10110372|FG001|COMPLETED|Overall Study||39
9051052|NCT03508830|10110371|FG000|NOT COMPLETED|Overall Study||5
9051053|NCT03508830|10110372|FG001|NOT COMPLETED|Overall Study||6
9051054|NCT03508843|10110378|FG000|STARTED|Overall Study||150
9051055|NCT03508843|10110378|FG000|COMPLETED|Overall Study||147
9051056|NCT03508843|10110378|FG000|NOT COMPLETED|Overall Study||3
9051057|NCT03509350|10110384|FG000|STARTED|Overall Study||252
9051058|NCT03509350|10110385|FG001|STARTED|Overall Study||249
9051059|NCT03509350|10110384|FG000|COMPLETED|Overall Study||252
9051060|NCT03509350|10110385|FG001|COMPLETED|Overall Study||247
9051061|NCT03509350|10110384|FG000|NOT COMPLETED|Overall Study||0
9051062|NCT03509350|10110385|FG001|NOT COMPLETED|Overall Study||2
9051063|NCT03509675|10110393|FG000|STARTED|First Intervention (7 Days)||11
9051064|NCT03509675|10110394|FG001|STARTED|First Intervention (7 Days)||12
9051065|NCT03509675|10110393|FG000|COMPLETED|First Intervention (7 Days)||6
9051066|NCT03509675|10110394|FG001|COMPLETED|First Intervention (7 Days)||8
9051067|NCT03509675|10110393|FG000|NOT COMPLETED|First Intervention (7 Days)||5
9051068|NCT03509675|10110394|FG001|NOT COMPLETED|First Intervention (7 Days)||4
9051069|NCT03509675|10110393|FG000|STARTED|Washout Period (7 Days)||6
9051070|NCT03509675|10110394|FG001|STARTED|Washout Period (7 Days)||8
9051071|NCT03509675|10110393|FG000|COMPLETED|Washout Period (7 Days)||6
9051072|NCT03509675|10110394|FG001|COMPLETED|Washout Period (7 Days)||8
9051073|NCT03509675|10110393|FG000|NOT COMPLETED|Washout Period (7 Days)||0
9051074|NCT03509675|10110394|FG001|NOT COMPLETED|Washout Period (7 Days)||0
9051075|NCT03509675|10110393|FG000|STARTED|Second Intervention )7 Days)||6
9051076|NCT03509675|10110394|FG001|STARTED|Second Intervention )7 Days)||8
9051077|NCT03509675|10110393|FG000|COMPLETED|Second Intervention )7 Days)||4
9051078|NCT03509675|10110394|FG001|COMPLETED|Second Intervention )7 Days)||8
9051079|NCT03509675|10110393|FG000|NOT COMPLETED|Second Intervention )7 Days)||2
9051080|NCT03509675|10110394|FG001|NOT COMPLETED|Second Intervention )7 Days)||0
9051081|NCT03509766|10110400|FG000|STARTED|Overall Study||24
9051082|NCT03509766|10110400|FG000|COMPLETED|Overall Study||24
9051083|NCT03509766|10110400|FG000|NOT COMPLETED|Overall Study||0
9051084|NCT03509883|10110407|FG000|STARTED|Initial Treatment||15
9051085|NCT03509883|10110408|FG001|STARTED|Initial Treatment||15
9051086|NCT03509883|10110407|FG000|COMPLETED|Initial Treatment||15
9051087|NCT03509883|10110408|FG001|COMPLETED|Initial Treatment||15
9051088|NCT03509883|10110407|FG000|NOT COMPLETED|Initial Treatment||0
9051089|NCT03509883|10110408|FG001|NOT COMPLETED|Initial Treatment||0
9051090|NCT03509883|10110407|FG000|STARTED|Initial Treatment Washout||15
9051091|NCT03509883|10110408|FG001|STARTED|Initial Treatment Washout||15
9051092|NCT03509883|10110407|FG000|COMPLETED|Initial Treatment Washout||15
9051093|NCT03509883|10110408|FG001|COMPLETED|Initial Treatment Washout||15
9051094|NCT03509883|10110407|FG000|NOT COMPLETED|Initial Treatment Washout||0
9051095|NCT03509883|10110408|FG001|NOT COMPLETED|Initial Treatment Washout||0
9051096|NCT03509883|10110407|FG000|STARTED|Cross-over and Treatment||15
9051097|NCT03509883|10110408|FG001|STARTED|Cross-over and Treatment||15
9051098|NCT03509883|10110407|FG000|COMPLETED|Cross-over and Treatment||15
9051099|NCT03509883|10110408|FG001|COMPLETED|Cross-over and Treatment||15
9051100|NCT03509883|10110407|FG000|NOT COMPLETED|Cross-over and Treatment||0
9051101|NCT03509883|10110408|FG001|NOT COMPLETED|Cross-over and Treatment||0
9051102|NCT03509948|10110415|FG000|STARTED|Overall Study||6
9051103|NCT03509948|10110416|FG001|STARTED|Overall Study||7
9051104|NCT03509948|10110415|FG000|COMPLETED|Overall Study||6
9051105|NCT03509948|10110416|FG001|COMPLETED|Overall Study||6
9051106|NCT03509948|10110415|FG000|NOT COMPLETED|Overall Study||0
9051107|NCT03509948|10110416|FG001|NOT COMPLETED|Overall Study||1
9051108|NCT03509974|10110422|FG000|STARTED|Overall Study||14
9051109|NCT03509974|10110422|FG000|COMPLETED|Overall Study||14
9051110|NCT03509974|10110422|FG000|NOT COMPLETED|Overall Study||0
9051111|NCT03510182|10110426|FG000|STARTED|Overall Study||25
9051112|NCT03510182|10110426|FG000|COMPLETED|Overall Study||23
8703568|NCT00923273|9749262|FG000|COMPLETED|Phase II Treatment Period||0
8703569|NCT00923273|9749263|FG001|COMPLETED|Phase II Treatment Period||0
8703570|NCT00923273|9749264|FG002|COMPLETED|Phase II Treatment Period||0
8703571|NCT00923273|9749265|FG003|COMPLETED|Phase II Treatment Period||20
8703572|NCT00923273|9749266|FG004|COMPLETED|Phase II Treatment Period||0
8703573|NCT00923273|9749262|FG000|NOT COMPLETED|Phase II Treatment Period||0
8703574|NCT00923273|9749263|FG001|NOT COMPLETED|Phase II Treatment Period||0
8703575|NCT00923273|9749264|FG002|NOT COMPLETED|Phase II Treatment Period||0
8703576|NCT00923273|9749265|FG003|NOT COMPLETED|Phase II Treatment Period||7
8703577|NCT00923273|9749266|FG004|NOT COMPLETED|Phase II Treatment Period||0
9051113|NCT03510182|10110426|FG000|NOT COMPLETED|Overall Study||2
9051114|NCT03510195|10110430|FG000|STARTED|Overall Study||267
9051115|NCT03510195|10110430|FG000|COMPLETED|Overall Study||101
8703578|NCT00923351|9749286|FG000|STARTED|Overall Study||6
8703579|NCT00923351|9749287|FG001|STARTED|Overall Study||26
9051116|NCT03510195|10110430|FG000|NOT COMPLETED|Overall Study||166
9051117|NCT03510273|10110444|FG000|STARTED|Overall Study||319
9051118|NCT03510273|10110444|FG000|Treated With Thermal Coagulation|Overall Study||319
9051119|NCT03510273|10110444|FG000|Completed 1-mth Follow-up Visit & Exited|Overall Study||192
9051120|NCT03510273|10110444|FG000|Completed 1-mth Follow-up Visit & Cont'd|Overall Study||126
9051121|NCT03510273|10110444|FG000|Completed All One-year Follow up Visits|Overall Study||118
9051122|NCT03510273|10110444|FG000|COMPLETED|Overall Study||310
9051123|NCT03510273|10110444|FG000|NOT COMPLETED|Overall Study||9
8703580|NCT00923351|9749288|FG002|STARTED|Overall Study||12
9051124|NCT03510455|10110452|FG000|STARTED|Overall Study||4
9051125|NCT03510455|10110452|FG000|Treated|Overall Study||4
9051126|NCT03510455|10110452|FG000|Extension Phase|Overall Study||1
9051127|NCT03510455|10110452|FG000|Screening Failures|Overall Study||0
9051128|NCT03510455|10110452|FG000|COMPLETED|Overall Study|3 of 4 patients completed the 24 week treatment phase of the study|3
9051129|NCT03510455|10110452|FG000|NOT COMPLETED|Overall Study||1
9051130|NCT03510481|10110462|FG000|STARTED|Year 1||69
9051131|NCT03510481|10110463|FG001|STARTED|Year 1||70
9051132|NCT03510481|10110464|FG002|STARTED|Year 1||36
9051133|NCT03510481|10110465|FG003|STARTED|Year 1||35
9051134|NCT03510481|10110462|FG000|COMPLETED|Year 1||56
9051135|NCT03510481|10110463|FG001|COMPLETED|Year 1||61
9051136|NCT03510481|10110464|FG002|COMPLETED|Year 1||34
9051137|NCT03510481|10110465|FG003|COMPLETED|Year 1||31
9051138|NCT03510481|10110462|FG000|NOT COMPLETED|Year 1||13
9051139|NCT03510481|10110463|FG001|NOT COMPLETED|Year 1||9
9051140|NCT03510481|10110464|FG002|NOT COMPLETED|Year 1||2
9051141|NCT03510481|10110465|FG003|NOT COMPLETED|Year 1||4
9051142|NCT03510481|10110462|FG000|STARTED|Year 2 - Booster Dose|10 participants who completed Period 1 did not re-consent for Period 2.|46
9051143|NCT03510481|10110463|FG001|STARTED|Year 2 - Booster Dose|9 participants who completed Period 1 did not re-consent for Period 2.|52
9051144|NCT03510481|10110464|FG002|STARTED|Year 2 - Booster Dose|9 participants who completed Period 1 did not re-consent for Period 2.|25
9051145|NCT03510481|10110465|FG003|STARTED|Year 2 - Booster Dose|12 participants who completed Period 1 did not re-consent for Period 2.|19
9051146|NCT03510481|10110462|FG000|COMPLETED|Year 2 - Booster Dose||42
9051147|NCT03510481|10110463|FG001|COMPLETED|Year 2 - Booster Dose||49
9051148|NCT03510481|10110464|FG002|COMPLETED|Year 2 - Booster Dose||23
9051149|NCT03510481|10110465|FG003|COMPLETED|Year 2 - Booster Dose||18
9051150|NCT03510481|10110462|FG000|NOT COMPLETED|Year 2 - Booster Dose||4
9051151|NCT03510481|10110463|FG001|NOT COMPLETED|Year 2 - Booster Dose||3
9051152|NCT03510481|10110464|FG002|NOT COMPLETED|Year 2 - Booster Dose||2
9051153|NCT03510481|10110465|FG003|NOT COMPLETED|Year 2 - Booster Dose||1
9051154|NCT03510663|10110485|FG000|STARTED|Overall Study||6
9051155|NCT03510663|10110486|FG001|STARTED|Overall Study||6
9051156|NCT03510663|10110487|FG002|STARTED|Overall Study||6
9051157|NCT03510663|10110488|FG003|STARTED|Overall Study||6
9051158|NCT03510663|10110489|FG004|STARTED|Overall Study||6
9051159|NCT03510663|10110490|FG005|STARTED|Overall Study||6
9051160|NCT03510663|10110491|FG006|STARTED|Overall Study||6
9051161|NCT03510663|10110492|FG007|STARTED|Overall Study||6
9051162|NCT03510663|10110485|FG000|COMPLETED|Overall Study||6
9051163|NCT03510663|10110486|FG001|COMPLETED|Overall Study||5
9051164|NCT03510663|10110487|FG002|COMPLETED|Overall Study||6
9051165|NCT03510663|10110488|FG003|COMPLETED|Overall Study||6
9051166|NCT03510663|10110489|FG004|COMPLETED|Overall Study||6
9051167|NCT03510663|10110490|FG005|COMPLETED|Overall Study||6
9051168|NCT03510663|10110491|FG006|COMPLETED|Overall Study||6
9051169|NCT03510663|10110492|FG007|COMPLETED|Overall Study||6
9051170|NCT03510663|10110485|FG000|NOT COMPLETED|Overall Study||0
9051171|NCT03510663|10110486|FG001|NOT COMPLETED|Overall Study||1
9051172|NCT03510663|10110487|FG002|NOT COMPLETED|Overall Study||0
9051173|NCT03510663|10110488|FG003|NOT COMPLETED|Overall Study||0
9051174|NCT03510663|10110489|FG004|NOT COMPLETED|Overall Study||0
9051175|NCT03510663|10110490|FG005|NOT COMPLETED|Overall Study||0
9051176|NCT03510663|10110491|FG006|NOT COMPLETED|Overall Study||0
9051177|NCT03510663|10110492|FG007|NOT COMPLETED|Overall Study||0
9051178|NCT03510715|10110504|FG000|STARTED|Overall Study||9
9051179|NCT03510715|10110505|FG001|STARTED|Overall Study||9
9051180|NCT03510715|10110504|FG000|COMPLETED|Overall Study||8
9051181|NCT03510715|10110505|FG001|COMPLETED|Overall Study||9
9051182|NCT03510715|10110504|FG000|NOT COMPLETED|Overall Study||1
9051183|NCT03510715|10110505|FG001|NOT COMPLETED|Overall Study||0
9051184|NCT03510910|10110514|FG000|STARTED|Overall Study||42
9051185|NCT03510910|10110515|FG001|STARTED|Overall Study||43
9051186|NCT03510910|10110514|FG000|COMPLETED|Overall Study||40
9051187|NCT03510910|10110515|FG001|COMPLETED|Overall Study||40
9051188|NCT03510910|10110514|FG000|NOT COMPLETED|Overall Study||2
9051189|NCT03510910|10110515|FG001|NOT COMPLETED|Overall Study||3
9051190|NCT03511001|10110523|FG000|STARTED|Overall Study||126
9051191|NCT03511001|10110524|FG001|STARTED|Overall Study||61
9051192|NCT03511001|10110523|FG000|Completers Analyzed|Overall Study|1 participant was excluded post-randomization due to not meeting race/ethnicity inclusion criteria.|114
9051193|NCT03511001|10110524|FG001|Completers Analyzed|Overall Study||61
9051194|NCT03511001|10110523|FG000|COMPLETED|Overall Study||115
9051195|NCT03511001|10110524|FG001|COMPLETED|Overall Study||54
9051196|NCT03511001|10110523|FG000|NOT COMPLETED|Overall Study||11
9051197|NCT03511001|10110524|FG001|NOT COMPLETED|Overall Study||7
9051198|NCT03511053|10110530|FG000|STARTED|Overall Study||11
9051199|NCT03511053|10110530|FG000|COMPLETED|Overall Study||10
9051200|NCT03511053|10110530|FG000|NOT COMPLETED|Overall Study||1
9051201|NCT03511105|10110536|FG000|STARTED|Overall Study||25
9051202|NCT03511105|10110537|FG001|STARTED|Overall Study||22
9051203|NCT03511105|10110536|FG000|COMPLETED|Overall Study||23
9051204|NCT03511105|10110537|FG001|COMPLETED|Overall Study||22
9051205|NCT03511105|10110536|FG000|NOT COMPLETED|Overall Study||2
9051206|NCT03511105|10110537|FG001|NOT COMPLETED|Overall Study||0
9051207|NCT03511326|10110544|FG000|STARTED|Overall Study||50
9051208|NCT03511326|10110544|FG000|COMPLETED|Overall Study||49
9051209|NCT03511326|10110544|FG000|NOT COMPLETED|Overall Study||1
9051210|NCT03511378|10110550|FG000|STARTED|Overall Study||70
9051211|NCT03511378|10110551|FG001|STARTED|Overall Study||68
9051212|NCT03511378|10110550|FG000|COMPLETED|Overall Study||67
9051213|NCT03511378|10110551|FG001|COMPLETED|Overall Study||66
8703581|NCT00923351|9749286|FG000|COMPLETED|Overall Study||6
9051214|NCT03511378|10110550|FG000|NOT COMPLETED|Overall Study||3
9051215|NCT03511378|10110551|FG001|NOT COMPLETED|Overall Study||2
9051216|NCT03511521|10110559|FG000|STARTED|Overall Study||2
9051217|NCT03511521|10110560|FG001|STARTED|Overall Study||1
9051218|NCT03511521|10110559|FG000|COMPLETED|Overall Study||2
9051219|NCT03511521|10110560|FG001|COMPLETED|Overall Study||1
9051220|NCT03511521|10110559|FG000|NOT COMPLETED|Overall Study||0
9051221|NCT03511521|10110560|FG001|NOT COMPLETED|Overall Study||0
9051222|NCT03511638|10110568|FG000|STARTED|Overall Study||184
9051223|NCT03511638|10110569|FG001|STARTED|Overall Study||188
9051224|NCT03511638|10110568|FG000|COMPLETED|Overall Study||182
9051225|NCT03511638|10110569|FG001|COMPLETED|Overall Study||187
9051226|NCT03511638|10110568|FG000|NOT COMPLETED|Overall Study||2
9051227|NCT03511638|10110569|FG001|NOT COMPLETED|Overall Study||1
9051228|NCT03511937|10110577|FG000|STARTED|Overall Study||200
9051229|NCT03511937|10110578|FG001|STARTED|Overall Study||200
9051230|NCT03511937|10110577|FG000|COMPLETED|Overall Study||200
9051231|NCT03511937|10110578|FG001|COMPLETED|Overall Study||200
9051232|NCT03511937|10110577|FG000|NOT COMPLETED|Overall Study||0
9051233|NCT03511937|10110578|FG001|NOT COMPLETED|Overall Study||0
9051234|NCT03512028|10110588|FG000|STARTED|Overall Study||19
9051235|NCT03512028|10110589|FG001|STARTED|Overall Study||15
9051236|NCT03512028|10110588|FG000|COMPLETED|Overall Study||15
9051237|NCT03512028|10110589|FG001|COMPLETED|Overall Study||15
9051238|NCT03512028|10110588|FG000|NOT COMPLETED|Overall Study||4
9051239|NCT03512028|10110589|FG001|NOT COMPLETED|Overall Study||0
9051240|NCT03512041|10110599|FG000|STARTED|Overall Study||10
9051241|NCT03512041|10110600|FG001|STARTED|Overall Study||10
9051242|NCT03512041|10110601|FG002|STARTED|Overall Study||11
9051243|NCT03512041|10110602|FG003|STARTED|Overall Study||9
9051244|NCT03512041|10110599|FG000|COMPLETED|Overall Study||10
9051245|NCT03512041|10110600|FG001|COMPLETED|Overall Study||10
9051246|NCT03512041|10110601|FG002|COMPLETED|Overall Study||11
9051247|NCT03512041|10110602|FG003|COMPLETED|Overall Study||9
9051248|NCT03512041|10110599|FG000|NOT COMPLETED|Overall Study||0
9051249|NCT03512041|10110600|FG001|NOT COMPLETED|Overall Study||0
9051250|NCT03512041|10110601|FG002|NOT COMPLETED|Overall Study||0
9051251|NCT03512041|10110602|FG003|NOT COMPLETED|Overall Study||0
9051252|NCT03512067|10110612|FG000|STARTED|Overall Study||1
9051253|NCT03512067|10110612|FG000|COMPLETED|Overall Study||1
9051254|NCT03512067|10110612|FG000|NOT COMPLETED|Overall Study||0
9051255|NCT03512288|10110618|FG000|STARTED|Overall Study||232
9051256|NCT03512288|10110619|FG001|STARTED|Overall Study||228
9051257|NCT03512288|10110618|FG000|Vaccination 1|Overall Study||231
9051258|NCT03512288|10110619|FG001|Vaccination 1|Overall Study||227
9051259|NCT03512288|10110618|FG000|Vaccination 2|Overall Study||222
9051260|NCT03512288|10110619|FG001|Vaccination 2|Overall Study||213
9051261|NCT03512288|10110618|FG000|Vaccination 3|Overall Study||210
9051262|NCT03512288|10110619|FG001|Vaccination 3|Overall Study||206
9051263|NCT03512288|10110618|FG000|Vaccination 4|Overall Study||197
9051264|NCT03512288|10110619|FG001|Vaccination 4|Overall Study||194
9051265|NCT03512288|10110618|FG000|COMPLETED|Overall Study||191
9051266|NCT03512288|10110619|FG001|COMPLETED|Overall Study||185
9051267|NCT03512288|10110618|FG000|NOT COMPLETED|Overall Study||41
9051268|NCT03512288|10110619|FG001|NOT COMPLETED|Overall Study||43
9051269|NCT03512353|10110625|FG000|STARTED|Overall Study||7
9051270|NCT03512353|10110625|FG000|Received Treatment|Overall Study||6
9051271|NCT03512353|10110625|FG000|COMPLETED|Overall Study||3
9051272|NCT03512353|10110625|FG000|NOT COMPLETED|Overall Study||4
9051273|NCT03512457|10110633|FG000|STARTED|Overall Study||195
9051274|NCT03512457|10110634|FG001|STARTED|Overall Study||225
9051275|NCT03512457|10110633|FG000|COMPLETED|Overall Study||161
9051276|NCT03512457|10110634|FG001|COMPLETED|Overall Study||185
9051277|NCT03512457|10110633|FG000|NOT COMPLETED|Overall Study||34
9051278|NCT03512457|10110634|FG001|NOT COMPLETED|Overall Study||40
9051279|NCT03513588|10110645|FG000|STARTED|Overall Study||16
9051280|NCT03513588|10110646|FG001|STARTED|Overall Study||17
9051281|NCT03513588|10110647|FG002|STARTED|Overall Study||15
9051282|NCT03513588|10110645|FG000|COMPLETED|Overall Study||15
9051283|NCT03513588|10110646|FG001|COMPLETED|Overall Study||15
9051284|NCT03513588|10110647|FG002|COMPLETED|Overall Study||13
9051285|NCT03513588|10110645|FG000|NOT COMPLETED|Overall Study||1
9051286|NCT03513588|10110646|FG001|NOT COMPLETED|Overall Study||2
9051287|NCT03513588|10110647|FG002|NOT COMPLETED|Overall Study||2
9051288|NCT03513757|10110659|FG000|STARTED|Overall Study||22
9051289|NCT03513757|10110660|FG001|STARTED|Overall Study||18
9051290|NCT03513757|10110659|FG000|COMPLETED|Overall Study||22
9051291|NCT03513757|10110660|FG001|COMPLETED|Overall Study||18
9051292|NCT03513757|10110659|FG000|NOT COMPLETED|Overall Study||0
9051293|NCT03513757|10110660|FG001|NOT COMPLETED|Overall Study||0
9051294|NCT03513848|10110671|FG000|STARTED|Overall Study||9
9051295|NCT03513848|10110672|FG001|STARTED|Overall Study||6
9051296|NCT03513848|10110671|FG000|COMPLETED|Overall Study||9
9051297|NCT03513848|10110672|FG001|COMPLETED|Overall Study||6
9051298|NCT03513848|10110671|FG000|NOT COMPLETED|Overall Study||0
9051299|NCT03513848|10110672|FG001|NOT COMPLETED|Overall Study||0
9051300|NCT03514277|10110681|FG000|STARTED|Overall Study||11
9051301|NCT03514277|10110682|FG001|STARTED|Overall Study||4
9051302|NCT03514277|10110683|FG002|STARTED|Overall Study||4
9051303|NCT03514277|10110681|FG000|COMPLETED|Overall Study||11
9051304|NCT03514277|10110682|FG001|COMPLETED|Overall Study||4
9051305|NCT03514277|10110683|FG002|COMPLETED|Overall Study||4
9051306|NCT03514277|10110681|FG000|NOT COMPLETED|Overall Study||0
9051307|NCT03514277|10110682|FG001|NOT COMPLETED|Overall Study||0
9051308|NCT03514277|10110683|FG002|NOT COMPLETED|Overall Study||0
9051309|NCT03514420|10110691|FG000|STARTED|Overall Study||4
9051310|NCT03514420|10110691|FG000|COMPLETED|Overall Study||4
9051311|NCT03514420|10110691|FG000|NOT COMPLETED|Overall Study||0
9051312|NCT03514641|10110699|FG000|STARTED|603A: 0-12 Week Study Period||334
9051313|NCT03514641|10110700|FG001|STARTED|603A: 0-12 Week Study Period||339
9051314|NCT03514641|10110701|FG002|STARTED|603A: 0-12 Week Study Period||0
9051315|NCT03514641|10110702|FG003|STARTED|603A: 0-12 Week Study Period||0
9051316|NCT03514641|10110699|FG000|COMPLETED|603A: 0-12 Week Study Period||307
9051317|NCT03514641|10110700|FG001|COMPLETED|603A: 0-12 Week Study Period||319
9051318|NCT03514641|10110701|FG002|COMPLETED|603A: 0-12 Week Study Period||0
9051319|NCT03514641|10110702|FG003|COMPLETED|603A: 0-12 Week Study Period||0
9051320|NCT03514641|10110699|FG000|NOT COMPLETED|603A: 0-12 Week Study Period||27
9051321|NCT03514641|10110700|FG001|NOT COMPLETED|603A: 0-12 Week Study Period||20
9051322|NCT03514641|10110701|FG002|NOT COMPLETED|603A: 0-12 Week Study Period||0
9051323|NCT03514641|10110702|FG003|NOT COMPLETED|603A: 0-12 Week Study Period||0
9051324|NCT03514641|10110699|FG000|STARTED|603B: 24-36 Week Study Period|The second part of study only applies to subjects in 603B|0
9051325|NCT03514641|10110700|FG001|STARTED|603B: 24-36 Week Study Period|The second part of study only applies to subjects in 603B|0
9051326|NCT03514641|10110701|FG002|STARTED|603B: 24-36 Week Study Period|The subjects were re-randomized in 603B|281
9051327|NCT03514641|10110702|FG003|STARTED|603B: 24-36 Week Study Period|The subjects were re-randomized in 603B|281
9051328|NCT03514641|10110699|FG000|COMPLETED|603B: 24-36 Week Study Period||0
9051329|NCT03514641|10110700|FG001|COMPLETED|603B: 24-36 Week Study Period||0
9051330|NCT03514641|10110701|FG002|COMPLETED|603B: 24-36 Week Study Period||267
9051331|NCT03514641|10110702|FG003|COMPLETED|603B: 24-36 Week Study Period||266
9051332|NCT03514641|10110699|FG000|NOT COMPLETED|603B: 24-36 Week Study Period||0
9051333|NCT03514641|10110700|FG001|NOT COMPLETED|603B: 24-36 Week Study Period||0
9051334|NCT03514641|10110701|FG002|NOT COMPLETED|603B: 24-36 Week Study Period||14
9051335|NCT03514641|10110702|FG003|NOT COMPLETED|603B: 24-36 Week Study Period||15
9051336|NCT03514966|10110716|FG000|STARTED|Overall Study||40
9051337|NCT03514966|10110717|FG001|STARTED|Overall Study||43
9051338|NCT03514966|10110716|FG000|COMPLETED|Overall Study||40
9051339|NCT03514966|10110717|FG001|COMPLETED|Overall Study||43
9051340|NCT03514966|10110716|FG000|NOT COMPLETED|Overall Study||0
9051341|NCT03514966|10110717|FG001|NOT COMPLETED|Overall Study||0
9051342|NCT03515681|10110725|FG000|STARTED|Overall Study||70
9051343|NCT03515681|10110726|FG001|STARTED|Overall Study||70
9051344|NCT03515681|10110725|FG000|Randomized|Overall Study||70
9051345|NCT03515681|10110726|FG001|Randomized|Overall Study||70
9051346|NCT03515681|10110725|FG000|Completed at 6 Months|Overall Study||61
9051347|NCT03515681|10110726|FG001|Completed at 6 Months|Overall Study||62
9051348|NCT03515681|10110725|FG000|COMPLETED|Overall Study||37
9051349|NCT03515681|10110726|FG001|COMPLETED|Overall Study||25
9051350|NCT03515681|10110725|FG000|NOT COMPLETED|Overall Study||33
9051351|NCT03515681|10110726|FG001|NOT COMPLETED|Overall Study||45
9051352|NCT03515824|10110735|FG000|STARTED|Overall Study||3
9051353|NCT03515824|10110736|FG001|STARTED|Overall Study||4
9051354|NCT03515824|10110737|FG002|STARTED|Overall Study||15
9051355|NCT03515824|10110738|FG003|STARTED|Overall Study||0
9051356|NCT03515824|10110735|FG000|COMPLETED|Overall Study||0
9051357|NCT03515824|10110736|FG001|COMPLETED|Overall Study||0
9051358|NCT03515824|10110737|FG002|COMPLETED|Overall Study||0
9051359|NCT03515824|10110738|FG003|COMPLETED|Overall Study||0
9051360|NCT03515824|10110735|FG000|NOT COMPLETED|Overall Study||3
9051361|NCT03515824|10110736|FG001|NOT COMPLETED|Overall Study||4
9051362|NCT03515824|10110737|FG002|NOT COMPLETED|Overall Study||15
9051363|NCT03515824|10110738|FG003|NOT COMPLETED|Overall Study||0
9051364|NCT03515941|10110748|FG000|STARTED|Overall Study||4
9051365|NCT03515941|10110749|FG001|STARTED|Overall Study||2
9051366|NCT03515941|10110748|FG000|COMPLETED|Overall Study||3
9051367|NCT03515941|10110749|FG001|COMPLETED|Overall Study||2
9051368|NCT03515941|10110748|FG000|NOT COMPLETED|Overall Study||1
9051369|NCT03515941|10110749|FG001|NOT COMPLETED|Overall Study||0
9051370|NCT03516227|10110757|FG000|STARTED|Overall Study||20
9051371|NCT03516227|10110758|FG001|STARTED|Overall Study||20
9051372|NCT03516227|10110757|FG000|COMPLETED|Overall Study||19
9051373|NCT03516227|10110758|FG001|COMPLETED|Overall Study||16
9051374|NCT03516227|10110757|FG000|NOT COMPLETED|Overall Study||1
9051375|NCT03516227|10110758|FG001|NOT COMPLETED|Overall Study||4
9051376|NCT03517436|10110765|FG000|STARTED|Overall Study||101
9051377|NCT03517436|10110765|FG000|COMPLETED|Overall Study||93
9051378|NCT03517436|10110765|FG000|NOT COMPLETED|Overall Study||8
9051379|NCT03517566|10110774|FG000|STARTED|Overall Study||74
9051380|NCT03517566|10110775|FG001|STARTED|Overall Study||37
9051381|NCT03517566|10110776|FG002|STARTED|Overall Study||36
9051382|NCT03517566|10110777|FG003|STARTED|Overall Study||73
9051383|NCT03517566|10110778|FG004|STARTED|Overall Study||73
9051384|NCT03517566|10110774|FG000|COMPLETED|Overall Study||42
9051385|NCT03517566|10110775|FG001|COMPLETED|Overall Study||16
9051386|NCT03517566|10110776|FG002|COMPLETED|Overall Study||21
9051387|NCT03517566|10110777|FG003|COMPLETED|Overall Study||39
9051388|NCT03517566|10110778|FG004|COMPLETED|Overall Study||41
9051389|NCT03517566|10110774|FG000|NOT COMPLETED|Overall Study||32
9051390|NCT03517566|10110775|FG001|NOT COMPLETED|Overall Study||21
9051391|NCT03517566|10110776|FG002|NOT COMPLETED|Overall Study||15
9051392|NCT03517566|10110777|FG003|NOT COMPLETED|Overall Study||34
9051393|NCT03517566|10110778|FG004|NOT COMPLETED|Overall Study||32
9051394|NCT03518008|10110791|FG000|STARTED|Period 1, First Week of Wear||11
9051395|NCT03518008|10110792|FG001|STARTED|Period 1, First Week of Wear||11
9051396|NCT03518008|10110791|FG000|COMPLETED|Period 1, First Week of Wear||11
9051397|NCT03518008|10110792|FG001|COMPLETED|Period 1, First Week of Wear||11
9051398|NCT03518008|10110791|FG000|NOT COMPLETED|Period 1, First Week of Wear||0
9051399|NCT03518008|10110792|FG001|NOT COMPLETED|Period 1, First Week of Wear||0
9051400|NCT03518008|10110791|FG000|STARTED|Period 2, Second Week of Wear||11
9051401|NCT03518008|10110792|FG001|STARTED|Period 2, Second Week of Wear||11
9051402|NCT03518008|10110791|FG000|COMPLETED|Period 2, Second Week of Wear||11
9051403|NCT03518008|10110792|FG001|COMPLETED|Period 2, Second Week of Wear||10
9051404|NCT03518008|10110791|FG000|NOT COMPLETED|Period 2, Second Week of Wear||0
9051405|NCT03518008|10110792|FG001|NOT COMPLETED|Period 2, Second Week of Wear||1
9051406|NCT03518125|10110804|FG000|STARTED|Overall Study||50
9051407|NCT03518125|10110805|FG001|STARTED|Overall Study||50
9051408|NCT03518125|10110806|FG002|STARTED|Overall Study||49
9051409|NCT03518125|10110807|FG003|STARTED|Overall Study||52
9051410|NCT03518125|10110808|FG004|STARTED|Overall Study||52
9051411|NCT03518125|10110809|FG005|STARTED|Overall Study||52
9051412|NCT03518125|10110804|FG000|COMPLETED|Overall Study||48
9051413|NCT03518125|10110805|FG001|COMPLETED|Overall Study||46
9051414|NCT03518125|10110806|FG002|COMPLETED|Overall Study||49
9051415|NCT03518125|10110807|FG003|COMPLETED|Overall Study||51
9051416|NCT03518125|10110808|FG004|COMPLETED|Overall Study||48
9051417|NCT03518125|10110809|FG005|COMPLETED|Overall Study||44
9051418|NCT03518125|10110804|FG000|NOT COMPLETED|Overall Study||2
9051419|NCT03518125|10110805|FG001|NOT COMPLETED|Overall Study||4
9051420|NCT03518125|10110806|FG002|NOT COMPLETED|Overall Study||0
9051421|NCT03518125|10110807|FG003|NOT COMPLETED|Overall Study||1
9051422|NCT03518125|10110808|FG004|NOT COMPLETED|Overall Study||4
9051423|NCT03518125|10110809|FG005|NOT COMPLETED|Overall Study||8
9051424|NCT03518658|10110826|FG000|STARTED|Overall Study|Number of patients completing device pairing survey|257
9051425|NCT03518658|10110827|FG001|STARTED|Overall Study||128607
9051426|NCT03518658|10110826|FG000|COMPLETED|Overall Study|Number of patients completing annual survey|206
9051427|NCT03518658|10110827|FG001|COMPLETED|Overall Study||128607
9051428|NCT03518658|10110826|FG000|NOT COMPLETED|Overall Study||51
9051429|NCT03518658|10110827|FG001|NOT COMPLETED|Overall Study||0
9051430|NCT03518840|10110835|FG000|STARTED|Overall Study||63
9051431|NCT03518840|10110835|FG000|COMPLETED|Overall Study||57
9051432|NCT03518840|10110835|FG000|NOT COMPLETED|Overall Study||6
9051433|NCT03519087|10110844|FG000|STARTED|Clinic Evaluation||55
9051434|NCT03519087|10110845|FG001|STARTED|Clinic Evaluation||57
9051435|NCT03519087|10110846|FG002|STARTED|Clinic Evaluation||0
9051436|NCT03519087|10110847|FG003|STARTED|Clinic Evaluation||0
9051437|NCT03519087|10110848|FG004|STARTED|Clinic Evaluation||0
9051438|NCT03519087|10110844|FG000|Received Assigned Intervention|Clinic Evaluation||54
9051439|NCT03519087|10110845|FG001|Received Assigned Intervention|Clinic Evaluation||57
9051440|NCT03519087|10110846|FG002|Received Assigned Intervention|Clinic Evaluation||0
9051441|NCT03519087|10110847|FG003|Received Assigned Intervention|Clinic Evaluation||0
9051442|NCT03519087|10110848|FG004|Received Assigned Intervention|Clinic Evaluation||0
9051443|NCT03519087|10110844|FG000|Confirmed Diagnosis by Physician|Clinic Evaluation||39
9051444|NCT03519087|10110845|FG001|Confirmed Diagnosis by Physician|Clinic Evaluation||39
9051445|NCT03519087|10110846|FG002|Confirmed Diagnosis by Physician|Clinic Evaluation||0
9051446|NCT03519087|10110847|FG003|Confirmed Diagnosis by Physician|Clinic Evaluation||0
9051447|NCT03519087|10110848|FG004|Confirmed Diagnosis by Physician|Clinic Evaluation||0
9051448|NCT03519087|10110844|FG000|COMPLETED|Clinic Evaluation||39
9051449|NCT03519087|10110845|FG001|COMPLETED|Clinic Evaluation||39
9051450|NCT03519087|10110846|FG002|COMPLETED|Clinic Evaluation||0
9051451|NCT03519087|10110847|FG003|COMPLETED|Clinic Evaluation||0
9051452|NCT03519087|10110848|FG004|COMPLETED|Clinic Evaluation||0
9051453|NCT03519087|10110844|FG000|NOT COMPLETED|Clinic Evaluation||16
9051454|NCT03519087|10110845|FG001|NOT COMPLETED|Clinic Evaluation||18
9051455|NCT03519087|10110846|FG002|NOT COMPLETED|Clinic Evaluation||0
9051456|NCT03519087|10110847|FG003|NOT COMPLETED|Clinic Evaluation||0
9051457|NCT03519087|10110848|FG004|NOT COMPLETED|Clinic Evaluation||0
9051458|NCT03519087|10110844|FG000|STARTED|Re-randomization for Treatment||39
9051459|NCT03519087|10110845|FG001|STARTED|Re-randomization for Treatment||39
9051460|NCT03519087|10110846|FG002|STARTED|Re-randomization for Treatment||0
9051461|NCT03519087|10110847|FG003|STARTED|Re-randomization for Treatment||0
9051462|NCT03519087|10110848|FG004|STARTED|Re-randomization for Treatment||0
9051463|NCT03519087|10110844|FG000|COMPLETED|Re-randomization for Treatment||12
9051464|NCT03519087|10110845|FG001|COMPLETED|Re-randomization for Treatment||7
9051465|NCT03519087|10110846|FG002|COMPLETED|Re-randomization for Treatment||0
9051466|NCT03519087|10110847|FG003|COMPLETED|Re-randomization for Treatment||0
9051467|NCT03519087|10110848|FG004|COMPLETED|Re-randomization for Treatment||0
9051468|NCT03519087|10110844|FG000|NOT COMPLETED|Re-randomization for Treatment||27
9051469|NCT03519087|10110845|FG001|NOT COMPLETED|Re-randomization for Treatment||32
9051470|NCT03519087|10110846|FG002|NOT COMPLETED|Re-randomization for Treatment||0
9051471|NCT03519087|10110847|FG003|NOT COMPLETED|Re-randomization for Treatment||0
9051472|NCT03519087|10110848|FG004|NOT COMPLETED|Re-randomization for Treatment||0
9051473|NCT03519087|10110844|FG000|STARTED|Laboratory Testing||0
9051474|NCT03519087|10110845|FG001|STARTED|Laboratory Testing||0
9051475|NCT03519087|10110846|FG002|STARTED|Laboratory Testing|From interdisciplinary (4) or standard (2) evaluation from Period 1|6
9051476|NCT03519087|10110847|FG003|STARTED|Laboratory Testing|From interdisciplinary (4) or standard (2) evaluation from Period 1|6
9051477|NCT03519087|10110848|FG004|STARTED|Laboratory Testing|From interdisciplinary (4) or standard (3) evaluation from Period 1|7
9051478|NCT03519087|10110844|FG000|Baseline Lab Testing|Laboratory Testing||0
9051479|NCT03519087|10110845|FG001|Baseline Lab Testing|Laboratory Testing||0
9051480|NCT03519087|10110846|FG002|Baseline Lab Testing|Laboratory Testing||5
9051481|NCT03519087|10110847|FG003|Baseline Lab Testing|Laboratory Testing||4
9051482|NCT03519087|10110848|FG004|Baseline Lab Testing|Laboratory Testing||3
9051483|NCT03519087|10110844|FG000|COMPLETED|Laboratory Testing||0
9051484|NCT03519087|10110845|FG001|COMPLETED|Laboratory Testing||0
9051485|NCT03519087|10110846|FG002|COMPLETED|Laboratory Testing||4
9051486|NCT03519087|10110847|FG003|COMPLETED|Laboratory Testing||2
9051487|NCT03519087|10110848|FG004|COMPLETED|Laboratory Testing||1
9051488|NCT03519087|10110844|FG000|NOT COMPLETED|Laboratory Testing||0
9051489|NCT03519087|10110845|FG001|NOT COMPLETED|Laboratory Testing||0
9051490|NCT03519087|10110846|FG002|NOT COMPLETED|Laboratory Testing||2
9051491|NCT03519087|10110847|FG003|NOT COMPLETED|Laboratory Testing||4
9051492|NCT03519087|10110848|FG004|NOT COMPLETED|Laboratory Testing||6
9051493|NCT03519204|10110866|FG000|STARTED|Overall Study|3 control participants were treated in error; 29 participants received treatment after 3 months.|43
9051494|NCT03519204|10110867|FG001|STARTED|Overall Study||133
9051495|NCT03519204|10110866|FG000|mITT Population|Overall Study||33
9051496|NCT03519204|10110867|FG001|mITT Population|Overall Study||130
9051497|NCT03519204|10110866|FG000|Safety Population|Overall Study||40
9051498|NCT03519204|10110867|FG001|Safety Population|Overall Study||136
9051499|NCT03519204|10110866|FG000|COMPLETED|Overall Study||30
9051500|NCT03519204|10110867|FG001|COMPLETED|Overall Study||118
9051501|NCT03519204|10110866|FG000|NOT COMPLETED|Overall Study||13
9051502|NCT03519204|10110867|FG001|NOT COMPLETED|Overall Study||15
9051503|NCT03519243|10110880|FG000|STARTED|Overall Study||25
9051504|NCT03519243|10110881|FG001|STARTED|Overall Study||25
9051505|NCT03519243|10110882|FG002|STARTED|Overall Study|The dose level was not studied due to the dose level l.7 µg/kg demonstrated the sufficient PD effect|0
9051506|NCT03519243|10110883|FG003|STARTED|Overall Study||25
9051507|NCT03519243|10110880|FG000|COMPLETED|Overall Study||20
9051508|NCT03519243|10110881|FG001|COMPLETED|Overall Study||21
9051509|NCT03519243|10110882|FG002|COMPLETED|Overall Study||0
9051510|NCT03519243|10110883|FG003|COMPLETED|Overall Study||24
9051511|NCT03519243|10110880|FG000|NOT COMPLETED|Overall Study||5
9051512|NCT03519243|10110881|FG001|NOT COMPLETED|Overall Study||4
9051513|NCT03519243|10110882|FG002|NOT COMPLETED|Overall Study||0
9051514|NCT03519243|10110883|FG003|NOT COMPLETED|Overall Study||1
9051515|NCT03519282|10110891|FG000|STARTED|First Intervention||5
9051516|NCT03519282|10110892|FG001|STARTED|First Intervention||5
9051517|NCT03519282|10110891|FG000|COMPLETED|First Intervention||5
9051518|NCT03519282|10110892|FG001|COMPLETED|First Intervention||5
9051519|NCT03519282|10110891|FG000|NOT COMPLETED|First Intervention||0
9051520|NCT03519282|10110892|FG001|NOT COMPLETED|First Intervention||0
9051521|NCT03519282|10110891|FG000|STARTED|Second Intervention||5
9051522|NCT03519282|10110892|FG001|STARTED|Second Intervention||5
9051523|NCT03519282|10110891|FG000|COMPLETED|Second Intervention||5
9051524|NCT03519282|10110892|FG001|COMPLETED|Second Intervention||5
9051525|NCT03519282|10110891|FG000|NOT COMPLETED|Second Intervention||0
9051526|NCT03519282|10110892|FG001|NOT COMPLETED|Second Intervention||0
9051527|NCT03519516|10110900|FG000|STARTED|Overall Study||15
9051528|NCT03519516|10110901|FG001|STARTED|Overall Study||15
9051529|NCT03519516|10110900|FG000|COMPLETED|Overall Study||15
9051530|NCT03519516|10110901|FG001|COMPLETED|Overall Study||14
9051531|NCT03519516|10110900|FG000|NOT COMPLETED|Overall Study||0
9051532|NCT03519516|10110901|FG001|NOT COMPLETED|Overall Study||1
9051533|NCT03519854|10110925|FG000|STARTED|Overall Study|N=3 randomized to Arm A. An additional N=1 (randomized to Arm C) is counted as Started in Arm A|4
9051534|NCT03519854|10110926|FG001|STARTED|Overall Study||6
9051535|NCT03519854|10110927|FG002|STARTED|Overall Study||5
9051536|NCT03519854|10110928|FG003|STARTED|Overall Study||6
9051537|NCT03519854|10110929|FG004|STARTED|Overall Study||6
9051538|NCT03519854|10110930|FG005|STARTED|Overall Study||6
9051539|NCT03519854|10110931|FG006|STARTED|Overall Study||3
9051540|NCT03519854|10110932|FG007|STARTED|Overall Study||6
9051541|NCT03519854|10110933|FG008|STARTED|Overall Study||6
9051542|NCT03519854|10110934|FG009|STARTED|Overall Study||6
9051543|NCT03519854|10110935|FG010|STARTED|Overall Study||6
9051544|NCT03519854|10110936|FG011|STARTED|Overall Study||6
9051545|NCT03519854|10110937|FG012|STARTED|Overall Study||3
9051546|NCT03519854|10110938|FG013|STARTED|Overall Study||6
9051547|NCT03519854|10110939|FG014|STARTED|Overall Study||6
9051548|NCT03519854|10110940|FG015|STARTED|Overall Study||6
9051549|NCT03519854|10110941|FG016|STARTED|Overall Study||6
9051550|NCT03519854|10110942|FG017|STARTED|Overall Study||6
9051551|NCT03519854|10110925|FG000|Treated|Overall Study|N=1 (randomized to Arm C) received placebo, 3 min after 1.2 mg/kg Esmeron®|4
9051552|NCT03519854|10110926|FG001|Treated|Overall Study||6
9051553|NCT03519854|10110927|FG002|Treated|Overall Study||4
9051554|NCT03519854|10110928|FG003|Treated|Overall Study||6
9051555|NCT03519854|10110929|FG004|Treated|Overall Study||6
9051556|NCT03519854|10110930|FG005|Treated|Overall Study||6
9051557|NCT03519854|10110931|FG006|Treated|Overall Study||3
9051558|NCT03519854|10110932|FG007|Treated|Overall Study||6
9051559|NCT03519854|10110933|FG008|Treated|Overall Study||6
9051560|NCT03519854|10110934|FG009|Treated|Overall Study||6
9051561|NCT03519854|10110935|FG010|Treated|Overall Study||6
9051562|NCT03519854|10110936|FG011|Treated|Overall Study||6
9051563|NCT03519854|10110937|FG012|Treated|Overall Study||3
9051564|NCT03519854|10110938|FG013|Treated|Overall Study||6
9051565|NCT03519854|10110939|FG014|Treated|Overall Study||6
9051566|NCT03519854|10110940|FG015|Treated|Overall Study||6
9051567|NCT03519854|10110941|FG016|Treated|Overall Study||6
9051568|NCT03519854|10110942|FG017|Treated|Overall Study||6
9051569|NCT03519854|10110925|FG000|COMPLETED|Overall Study||4
9051570|NCT03519854|10110926|FG001|COMPLETED|Overall Study||6
9051571|NCT03519854|10110927|FG002|COMPLETED|Overall Study||4
9051572|NCT03519854|10110928|FG003|COMPLETED|Overall Study||6
9051573|NCT03519854|10110929|FG004|COMPLETED|Overall Study||6
9051574|NCT03519854|10110930|FG005|COMPLETED|Overall Study||6
9051575|NCT03519854|10110931|FG006|COMPLETED|Overall Study||3
9051576|NCT03519854|10110932|FG007|COMPLETED|Overall Study||6
9051577|NCT03519854|10110933|FG008|COMPLETED|Overall Study||6
9051578|NCT03519854|10110934|FG009|COMPLETED|Overall Study||6
9051579|NCT03519854|10110935|FG010|COMPLETED|Overall Study||6
9051580|NCT03519854|10110936|FG011|COMPLETED|Overall Study||6
9051581|NCT03519854|10110937|FG012|COMPLETED|Overall Study||3
9051582|NCT03519854|10110938|FG013|COMPLETED|Overall Study||6
9051583|NCT03519854|10110939|FG014|COMPLETED|Overall Study||6
9051584|NCT03519854|10110940|FG015|COMPLETED|Overall Study||6
9051585|NCT03519854|10110941|FG016|COMPLETED|Overall Study||6
9051586|NCT03519854|10110942|FG017|COMPLETED|Overall Study||6
9051587|NCT03519854|10110925|FG000|NOT COMPLETED|Overall Study||0
9051588|NCT03519854|10110926|FG001|NOT COMPLETED|Overall Study||0
9051589|NCT03519854|10110927|FG002|NOT COMPLETED|Overall Study||1
9051590|NCT03519854|10110928|FG003|NOT COMPLETED|Overall Study||0
9051591|NCT03519854|10110929|FG004|NOT COMPLETED|Overall Study||0
9051592|NCT03519854|10110930|FG005|NOT COMPLETED|Overall Study||0
9051593|NCT03519854|10110931|FG006|NOT COMPLETED|Overall Study||0
9051594|NCT03519854|10110932|FG007|NOT COMPLETED|Overall Study||0
9051595|NCT03519854|10110933|FG008|NOT COMPLETED|Overall Study||0
9051596|NCT03519854|10110934|FG009|NOT COMPLETED|Overall Study||0
9051597|NCT03519854|10110935|FG010|NOT COMPLETED|Overall Study||0
9051598|NCT03519854|10110936|FG011|NOT COMPLETED|Overall Study||0
9051599|NCT03519854|10110937|FG012|NOT COMPLETED|Overall Study||0
9051600|NCT03519854|10110938|FG013|NOT COMPLETED|Overall Study||0
9051601|NCT03519854|10110939|FG014|NOT COMPLETED|Overall Study||0
9051602|NCT03519854|10110940|FG015|NOT COMPLETED|Overall Study||0
8703582|NCT00923351|9749287|FG001|COMPLETED|Overall Study||26
8703583|NCT00923351|9749288|FG002|COMPLETED|Overall Study||0
8703584|NCT00923351|9749286|FG000|NOT COMPLETED|Overall Study||0
8703585|NCT00923351|9749287|FG001|NOT COMPLETED|Overall Study||0
9051603|NCT03519854|10110941|FG016|NOT COMPLETED|Overall Study||0
9051604|NCT03519854|10110942|FG017|NOT COMPLETED|Overall Study||0
9051605|NCT03519867|10110990|FG000|STARTED|Overall Study||6
9051606|NCT03519867|10110991|FG001|STARTED|Overall Study|One participant randomized to receive MK-8616 8.0 mg/kg received MK-8616 0.8 mg/kg.|7
9051607|NCT03519867|10110992|FG002|STARTED|Overall Study||6
9051608|NCT03519867|10110993|FG003|STARTED|Overall Study||4
9051609|NCT03519867|10110994|FG004|STARTED|Overall Study||5
9051610|NCT03519867|10110995|FG005|STARTED|Overall Study||5
9051611|NCT03519867|10110996|FG006|STARTED|Overall Study||4
9051612|NCT03519867|10110997|FG007|STARTED|Overall Study||5
9051613|NCT03519867|10110998|FG008|STARTED|Overall Study||4
9051614|NCT03519867|10110999|FG009|STARTED|Overall Study||4
9051615|NCT03519867|10110990|FG000|Treated|Overall Study||5
9051616|NCT03519867|10110991|FG001|Treated|Overall Study||6
9051617|NCT03519867|10110992|FG002|Treated|Overall Study||5
9051618|NCT03519867|10110993|FG003|Treated|Overall Study||3
9051619|NCT03519867|10110994|FG004|Treated|Overall Study||5
9051620|NCT03519867|10110995|FG005|Treated|Overall Study||4
9051621|NCT03519867|10110996|FG006|Treated|Overall Study||4
9051622|NCT03519867|10110997|FG007|Treated|Overall Study||4
9051623|NCT03519867|10110998|FG008|Treated|Overall Study||3
9051624|NCT03519867|10110999|FG009|Treated|Overall Study||4
9051625|NCT03519867|10110990|FG000|COMPLETED|Overall Study||3
9051626|NCT03519867|10110991|FG001|COMPLETED|Overall Study||4
9051627|NCT03519867|10110992|FG002|COMPLETED|Overall Study||5
9051628|NCT03519867|10110993|FG003|COMPLETED|Overall Study||3
9051629|NCT03519867|10110994|FG004|COMPLETED|Overall Study||5
9051630|NCT03519867|10110995|FG005|COMPLETED|Overall Study||2
9051631|NCT03519867|10110996|FG006|COMPLETED|Overall Study||3
9051632|NCT03519867|10110997|FG007|COMPLETED|Overall Study||4
9051633|NCT03519867|10110998|FG008|COMPLETED|Overall Study||3
9051634|NCT03519867|10110999|FG009|COMPLETED|Overall Study||4
9051635|NCT03519867|10110990|FG000|NOT COMPLETED|Overall Study||3
9051636|NCT03519867|10110991|FG001|NOT COMPLETED|Overall Study||3
9051637|NCT03519867|10110992|FG002|NOT COMPLETED|Overall Study||1
9051638|NCT03519867|10110993|FG003|NOT COMPLETED|Overall Study||1
9051639|NCT03519867|10110994|FG004|NOT COMPLETED|Overall Study||0
9051640|NCT03519867|10110995|FG005|NOT COMPLETED|Overall Study||3
9051641|NCT03519867|10110996|FG006|NOT COMPLETED|Overall Study||1
9051642|NCT03519867|10110997|FG007|NOT COMPLETED|Overall Study||1
9051643|NCT03519867|10110998|FG008|NOT COMPLETED|Overall Study||1
9051644|NCT03519867|10110999|FG009|NOT COMPLETED|Overall Study||0
9051645|NCT03519919|10111021|FG000|STARTED|Overall Study||51
9051646|NCT03519919|10111021|FG000|COMPLETED|Overall Study||48
9051647|NCT03519919|10111021|FG000|NOT COMPLETED|Overall Study||3
9051648|NCT03519932|10111051|FG000|STARTED|First Intervention||24
9051649|NCT03519932|10111052|FG001|STARTED|First Intervention||25
9051650|NCT03519932|10111051|FG000|COMPLETED|First Intervention|One subject had non-significant adverse event and data not included in the analysis|23
9051651|NCT03519932|10111052|FG001|COMPLETED|First Intervention|3 subjects had non-significant adverse events and data not included in analysis.|22
9051652|NCT03519932|10111051|FG000|NOT COMPLETED|First Intervention||1
9051653|NCT03519932|10111052|FG001|NOT COMPLETED|First Intervention||3
9051654|NCT03519932|10111051|FG000|STARTED|Second Intervention|Subjects who wore samfilcon A toric at 1st intervention wear comfilcon A toric at 2nd intervention|22
9051655|NCT03519932|10111052|FG001|STARTED|Second Intervention|Subjects who wore comfilcon A toric at 1st intervention wear Samfilcon A toric at 2nd intervention|23
9051656|NCT03519932|10111051|FG000|COMPLETED|Second Intervention||22
9051657|NCT03519932|10111052|FG001|COMPLETED|Second Intervention||23
9051658|NCT03519932|10111051|FG000|NOT COMPLETED|Second Intervention||0
9051659|NCT03519932|10111052|FG001|NOT COMPLETED|Second Intervention||0
9051660|NCT03520283|10111065|FG000|STARTED|Overall Study||24
9051661|NCT03520283|10111066|FG001|STARTED|Overall Study||42
9051662|NCT03520283|10111065|FG000|COMPLETED|Overall Study||24
9051663|NCT03520283|10111066|FG001|COMPLETED|Overall Study||42
9051664|NCT03520283|10111065|FG000|NOT COMPLETED|Overall Study||0
9051665|NCT03520283|10111066|FG001|NOT COMPLETED|Overall Study||0
9051666|NCT03520348|10111083|FG000|STARTED|Overall Study||12
9051667|NCT03520348|10111084|FG001|STARTED|Overall Study||12
9051668|NCT03520348|10111083|FG000|COMPLETED|Overall Study||12
9051669|NCT03520348|10111084|FG001|COMPLETED|Overall Study||12
9051670|NCT03520348|10111083|FG000|NOT COMPLETED|Overall Study||0
9051671|NCT03520348|10111084|FG001|NOT COMPLETED|Overall Study||0
9051672|NCT03520387|10111095|FG000|STARTED|Pre-Randomization||16
9051673|NCT03520387|10111096|FG001|STARTED|Pre-Randomization|Although participant flow is presented for each cell of the 2 x 2 contingency table in this factorial pilot trial, the primary analysis as originally planned focused on the main effects of (1) LRFA vs. simulated LRFA and (2) AcTIVE-CBT vs. TBSCE, unless there were indications of strong interactions between the two types of treatment. There are no participants in this group until the randomization period (until after the pre-randomization run-in period has ended).|0
9051674|NCT03520387|10111097|FG002|STARTED|Pre-Randomization|Although participant flow is presented for each cell of the 2 x 2 contingency table in this factorial pilot trial, the primary analysis as originally planned focused on the main effects of (1) LRFA vs. simulated LRFA and (2) AcTIVE-CBT vs. TBSCE, unless there were indications of strong interactions between the two types of treatment. There are no participants in this group until the randomization period (until after the pre-randomization run-in period has ended).|0
9051675|NCT03520387|10111098|FG003|STARTED|Pre-Randomization|Although participant flow is presented for each cell of the 2 x 2 contingency table in this factorial pilot trial, the primary analysis as originally planned focused on the main effects of (1) LRFA vs. simulated LRFA and (2) AcTIVE-CBT vs. TBSCE, unless there were indications of strong interactions between the two types of treatment. There are no participants in this group until the randomization period (until after the pre-randomization run-in period has ended).|0
9051676|NCT03520387|10111099|FG004|STARTED|Pre-Randomization|Although participant flow is presented for each cell of the 2 x 2 contingency table in this factorial pilot trial, the primary analysis as originally planned focused on the main effects of (1) LRFA vs. simulated LRFA and (2) AcTIVE-CBT vs. TBSCE, unless there were indications of strong interactions between the two types of treatment. There are no participants in this group until the randomization period (until after the pre-randomization run-in period has ended).|0
9051677|NCT03520387|10111095|FG000|COMPLETED|Pre-Randomization||13
9051678|NCT03520387|10111096|FG001|COMPLETED|Pre-Randomization||0
9051679|NCT03520387|10111097|FG002|COMPLETED|Pre-Randomization||0
9051680|NCT03520387|10111098|FG003|COMPLETED|Pre-Randomization||0
9051681|NCT03520387|10111099|FG004|COMPLETED|Pre-Randomization||0
9051682|NCT03520387|10111095|FG000|NOT COMPLETED|Pre-Randomization||3
9051683|NCT03520387|10111096|FG001|NOT COMPLETED|Pre-Randomization||0
9051684|NCT03520387|10111097|FG002|NOT COMPLETED|Pre-Randomization||0
9051685|NCT03520387|10111098|FG003|NOT COMPLETED|Pre-Randomization||0
9051686|NCT03520387|10111099|FG004|NOT COMPLETED|Pre-Randomization||0
9051687|NCT03520387|10111095|FG000|STARTED|Randomized|There are no participants in this group during this period, because the pre-randomization run-in period has ended.|0
9051688|NCT03520387|10111096|FG001|STARTED|Randomized|Although participant flow is presented for each cell of the 2 x 2 contingency table in this factorial pilot trial, the primary analysis as originally planned focused on the main effects of (1) LRFA vs. simulated LRFA and (2) AcTIVE-CBT vs. TBSCE, unless there were indications of strong interactions between the two types of treatment.|4
9051689|NCT03520387|10111097|FG002|STARTED|Randomized|Although participant flow is presented for each cell of the 2 x 2 contingency table in this factorial pilot trial, the primary analysis as originally planned focused on the main effects of (1) LRFA vs. simulated LRFA and (2) AcTIVE-CBT vs. TBSCE, unless there were indications of strong interactions between the two types of treatment.|3
9051690|NCT03520387|10111098|FG003|STARTED|Randomized|Although participant flow is presented for each cell of the 2 x 2 contingency table in this factorial pilot trial, the primary analysis as originally planned focused on the main effects of (1) LRFA vs. simulated LRFA and (2) AcTIVE-CBT vs. TBSCE, unless there were indications of strong interactions between the two types of treatment.|3
9051691|NCT03520387|10111099|FG004|STARTED|Randomized|Although participant flow is presented for each cell of the 2 x 2 contingency table in this factorial pilot trial, the primary analysis as originally planned focused on the main effects of (1) LRFA vs. simulated LRFA and (2) AcTIVE-CBT vs. TBSCE, unless there were indications of strong interactions between the two types of treatment.|3
9051692|NCT03520387|10111095|FG000|COMPLETED|Randomized||0
9051693|NCT03520387|10111096|FG001|COMPLETED|Randomized||4
8703586|NCT00923351|9749288|FG002|NOT COMPLETED|Overall Study||12
8703587|NCT00923364|9749294|FG000|STARTED|Overall Study||14
8703588|NCT00923364|9749295|FG001|STARTED|Overall Study||5
8703589|NCT00923364|9749294|FG000|COMPLETED|Overall Study||10
8703590|NCT00923364|9749295|FG001|COMPLETED|Overall Study||5
8703591|NCT00923364|9749294|FG000|NOT COMPLETED|Overall Study||4
8703592|NCT00923364|9749295|FG001|NOT COMPLETED|Overall Study||0
8703593|NCT00923481|9749300|FG000|STARTED|Overall Study||37
8703594|NCT00923481|9749300|FG000|COMPLETED|Overall Study||37
8703595|NCT00923481|9749300|FG000|NOT COMPLETED|Overall Study||0
8703596|NCT00923559|9749306|FG000|STARTED|Overall Study||40
8703597|NCT00923559|9749307|FG001|STARTED|Overall Study||40
8703598|NCT00923559|9749306|FG000|COMPLETED|Overall Study||38
8703599|NCT00923559|9749307|FG001|COMPLETED|Overall Study||37
8703600|NCT00923559|9749306|FG000|NOT COMPLETED|Overall Study||2
8703601|NCT00923559|9749307|FG001|NOT COMPLETED|Overall Study||3
9051694|NCT03520387|10111097|FG002|COMPLETED|Randomized||3
9051695|NCT03520387|10111098|FG003|COMPLETED|Randomized||3
9051696|NCT03520387|10111099|FG004|COMPLETED|Randomized||3
8703602|NCT00923598|9749317|FG000|STARTED|Overall Study||23
8703603|NCT00923598|9749318|FG001|STARTED|Overall Study||22
9051697|NCT03520387|10111095|FG000|NOT COMPLETED|Randomized||0
9051698|NCT03520387|10111096|FG001|NOT COMPLETED|Randomized||0
9051699|NCT03520387|10111097|FG002|NOT COMPLETED|Randomized||0
9051700|NCT03520387|10111098|FG003|NOT COMPLETED|Randomized||0
9051701|NCT03520387|10111099|FG004|NOT COMPLETED|Randomized||0
9051702|NCT03520400|10111112|FG000|STARTED|Overall Study||37
9051703|NCT03520400|10111113|FG001|STARTED|Overall Study||14
9051704|NCT03520400|10111112|FG000|COMPLETED|Overall Study||22
9051705|NCT03520400|10111113|FG001|COMPLETED|Overall Study||7
9051706|NCT03520400|10111112|FG000|NOT COMPLETED|Overall Study||15
9051707|NCT03520400|10111113|FG001|NOT COMPLETED|Overall Study||7
9051708|NCT03520920|10111122|FG000|STARTED|Overall Study||20
9051709|NCT03520920|10111123|FG001|STARTED|Overall Study||16
9051710|NCT03520920|10111124|FG002|STARTED|Overall Study||5
9051711|NCT03520920|10111122|FG000|Received at Least 1 Dose of Study Drug|Overall Study||20
9051712|NCT03520920|10111123|FG001|Received at Least 1 Dose of Study Drug|Overall Study||16
9051713|NCT03520920|10111124|FG002|Received at Least 1 Dose of Study Drug|Overall Study||5
9051714|NCT03520920|10111122|FG000|COMPLETED|Overall Study||0
9051715|NCT03520920|10111123|FG001|COMPLETED|Overall Study||0
9051716|NCT03520920|10111124|FG002|COMPLETED|Overall Study||0
9051717|NCT03520920|10111122|FG000|NOT COMPLETED|Overall Study||20
9051718|NCT03520920|10111123|FG001|NOT COMPLETED|Overall Study||16
9051719|NCT03520920|10111124|FG002|NOT COMPLETED|Overall Study||5
9051720|NCT03520959|10111140|FG000|STARTED|Overall Study||0
9051721|NCT03520959|10111141|FG001|STARTED|Overall Study||1
9051722|NCT03520959|10111140|FG000|COMPLETED|Overall Study||0
9051723|NCT03520959|10111141|FG001|COMPLETED|Overall Study||0
9051724|NCT03520959|10111140|FG000|NOT COMPLETED|Overall Study||0
9051725|NCT03520959|10111141|FG001|NOT COMPLETED|Overall Study||1
9051726|NCT03520998|10111149|FG000|STARTED|Overall Study||24
9051727|NCT03520998|10111150|FG001|STARTED|Overall Study||23
9051728|NCT03520998|10111149|FG000|COMPLETED|Overall Study||18
9051729|NCT03520998|10111150|FG001|COMPLETED|Overall Study||21
9051730|NCT03520998|10111149|FG000|NOT COMPLETED|Overall Study||6
9051731|NCT03520998|10111150|FG001|NOT COMPLETED|Overall Study||2
9051732|NCT03521089|10111158|FG000|STARTED|Overall Study||8
9051733|NCT03521089|10111159|FG001|STARTED|Overall Study||8
9051734|NCT03521089|10111158|FG000|COMPLETED|Overall Study||8
9051735|NCT03521089|10111159|FG001|COMPLETED|Overall Study||8
9051736|NCT03521089|10111158|FG000|NOT COMPLETED|Overall Study||0
9051737|NCT03521089|10111159|FG001|NOT COMPLETED|Overall Study||0
9051738|NCT03521115|10111167|FG000|STARTED|Time 0 Baseline Surveys||206
9051739|NCT03521115|10111168|FG001|STARTED|Time 0 Baseline Surveys||205
9051740|NCT03521115|10111167|FG000|COMPLETED|Time 0 Baseline Surveys||206
9051741|NCT03521115|10111168|FG001|COMPLETED|Time 0 Baseline Surveys||205
9051742|NCT03521115|10111167|FG000|NOT COMPLETED|Time 0 Baseline Surveys||0
9051743|NCT03521115|10111168|FG001|NOT COMPLETED|Time 0 Baseline Surveys||0
9051744|NCT03521115|10111167|FG000|STARTED|Time 1 Survey (6 Months Post Baseline)||206
9051745|NCT03521115|10111168|FG001|STARTED|Time 1 Survey (6 Months Post Baseline)||205
9051746|NCT03521115|10111167|FG000|COMPLETED|Time 1 Survey (6 Months Post Baseline)||150
9051747|NCT03521115|10111168|FG001|COMPLETED|Time 1 Survey (6 Months Post Baseline)||165
9051748|NCT03521115|10111167|FG000|NOT COMPLETED|Time 1 Survey (6 Months Post Baseline)||56
9051749|NCT03521115|10111168|FG001|NOT COMPLETED|Time 1 Survey (6 Months Post Baseline)||40
9051750|NCT03521115|10111167|FG000|STARTED|Time 2 Survey (12 Months Post Baseline)||150
9051751|NCT03521115|10111168|FG001|STARTED|Time 2 Survey (12 Months Post Baseline)||165
9051752|NCT03521115|10111167|FG000|COMPLETED|Time 2 Survey (12 Months Post Baseline)||147
9051753|NCT03521115|10111168|FG001|COMPLETED|Time 2 Survey (12 Months Post Baseline)||164
9051754|NCT03521115|10111167|FG000|NOT COMPLETED|Time 2 Survey (12 Months Post Baseline)||3
9051755|NCT03521115|10111168|FG001|NOT COMPLETED|Time 2 Survey (12 Months Post Baseline)||1
9051756|NCT03521115|10111167|FG000|STARTED|Time 3 Survey (18 Months Post Baseline)||147
9051757|NCT03521115|10111168|FG001|STARTED|Time 3 Survey (18 Months Post Baseline)||164
9051758|NCT03521115|10111167|FG000|COMPLETED|Time 3 Survey (18 Months Post Baseline)||145
9051759|NCT03521115|10111168|FG001|COMPLETED|Time 3 Survey (18 Months Post Baseline)||164
9051760|NCT03521115|10111167|FG000|NOT COMPLETED|Time 3 Survey (18 Months Post Baseline)||2
9051761|NCT03521115|10111168|FG001|NOT COMPLETED|Time 3 Survey (18 Months Post Baseline)||0
9051762|NCT03521141|10111183|FG000|STARTED|Overall Study||19
9051763|NCT03521141|10111184|FG001|STARTED|Overall Study||19
9051764|NCT03521141|10111185|FG002|STARTED|Overall Study||20
9051765|NCT03521141|10111183|FG000|COMPLETED|Overall Study||18
9051766|NCT03521141|10111184|FG001|COMPLETED|Overall Study||19
9051767|NCT03521141|10111185|FG002|COMPLETED|Overall Study||19
8703604|NCT00923598|9749317|FG000|COMPLETED|Overall Study||19
9051768|NCT03521141|10111183|FG000|NOT COMPLETED|Overall Study||1
9051769|NCT03521141|10111184|FG001|NOT COMPLETED|Overall Study||0
9051770|NCT03521141|10111185|FG002|NOT COMPLETED|Overall Study||1
9051771|NCT03521193|10111195|FG000|STARTED|Overall Study|enrolled on the PFO closure hospitalization|78
8703605|NCT00923598|9749318|FG001|COMPLETED|Overall Study||17
9051772|NCT03521193|10111196|FG001|STARTED|Overall Study||12
9051773|NCT03521193|10111195|FG000|COMPLETED|Overall Study|8 pts refused to continue the study; 8 patients were non compliant to ASA treatment|62
9051774|NCT03521193|10111196|FG001|COMPLETED|Overall Study||12
9051775|NCT03521193|10111195|FG000|NOT COMPLETED|Overall Study||16
9051776|NCT03521193|10111196|FG001|NOT COMPLETED|Overall Study||0
9051777|NCT03521479|10111207|FG000|STARTED|Overall Study||10
9051778|NCT03521479|10111208|FG001|STARTED|Overall Study||10
9051779|NCT03521479|10111209|FG002|STARTED|Overall Study||10
9051780|NCT03521479|10111210|FG003|STARTED|Overall Study||10
9051781|NCT03521479|10111207|FG000|COMPLETED|Overall Study||10
9051782|NCT03521479|10111208|FG001|COMPLETED|Overall Study||10
9051783|NCT03521479|10111209|FG002|COMPLETED|Overall Study||10
9051784|NCT03521479|10111210|FG003|COMPLETED|Overall Study||10
9051785|NCT03521479|10111207|FG000|NOT COMPLETED|Overall Study||0
9051786|NCT03521479|10111208|FG001|NOT COMPLETED|Overall Study||0
9051787|NCT03521479|10111209|FG002|NOT COMPLETED|Overall Study||0
9051788|NCT03521479|10111210|FG003|NOT COMPLETED|Overall Study||0
9051789|NCT03521505|10111222|FG000|STARTED|Overall Study||25
9051790|NCT03521505|10111223|FG001|STARTED|Overall Study||25
9051791|NCT03521505|10111222|FG000|COMPLETED|Overall Study||25
9051792|NCT03521505|10111223|FG001|COMPLETED|Overall Study||25
9051793|NCT03521505|10111222|FG000|NOT COMPLETED|Overall Study||0
9051794|NCT03521505|10111223|FG001|NOT COMPLETED|Overall Study||0
9051795|NCT03521635|10111231|FG000|STARTED|Overall Study||49
9051796|NCT03521635|10111232|FG001|STARTED|Overall Study||49
9051797|NCT03521635|10111231|FG000|COMPLETED|Overall Study||45
9051798|NCT03521635|10111232|FG001|COMPLETED|Overall Study||43
9051799|NCT03521635|10111231|FG000|NOT COMPLETED|Overall Study||4
9051800|NCT03521635|10111232|FG001|NOT COMPLETED|Overall Study||6
9051801|NCT03521791|10111240|FG000|STARTED|Overall Study||76
9051802|NCT03521791|10111241|FG001|STARTED|Overall Study||90
9051803|NCT03521791|10111240|FG000|COMPLETED|Overall Study||69
9051804|NCT03521791|10111241|FG001|COMPLETED|Overall Study||73
9051805|NCT03521791|10111240|FG000|NOT COMPLETED|Overall Study||7
9051806|NCT03521791|10111241|FG001|NOT COMPLETED|Overall Study||17
9051807|NCT03521817|10111249|FG000|STARTED|Overall Study||7
9051808|NCT03521817|10111250|FG001|STARTED|Overall Study||5
9051809|NCT03521817|10111249|FG000|COMPLETED|Overall Study||7
9051810|NCT03521817|10111250|FG001|COMPLETED|Overall Study|1 completer was non adherent based on weekly intervention body weight|4
9051811|NCT03521817|10111249|FG000|NOT COMPLETED|Overall Study||0
9051812|NCT03521817|10111250|FG001|NOT COMPLETED|Overall Study||1
9051813|NCT03522350|10111256|FG000|STARTED|Overall Study||18
9051814|NCT03522350|10111257|FG001|STARTED|Overall Study||18
9051815|NCT03522350|10111256|FG000|COMPLETED|Overall Study||18
9051816|NCT03522350|10111257|FG001|COMPLETED|Overall Study||18
9051817|NCT03522350|10111256|FG000|NOT COMPLETED|Overall Study||0
8703606|NCT00923598|9749317|FG000|NOT COMPLETED|Overall Study||4
8703607|NCT00923598|9749318|FG001|NOT COMPLETED|Overall Study||5
8703608|NCT00923845|9749326|FG000|STARTED|Donor Lymphocyte Harvest||13
8703609|NCT00923845|9749327|FG001|STARTED|Donor Lymphocyte Harvest||0
8703610|NCT00923845|9749326|FG000|COMPLETED|Donor Lymphocyte Harvest||13
8703611|NCT00923845|9749327|FG001|COMPLETED|Donor Lymphocyte Harvest||0
8703612|NCT00923845|9749326|FG000|NOT COMPLETED|Donor Lymphocyte Harvest||0
8703613|NCT00923845|9749327|FG001|NOT COMPLETED|Donor Lymphocyte Harvest||0
8703614|NCT00923845|9749326|FG000|STARTED|Donor Hematopoietic Stem Cell Harvest||13
8703615|NCT00923845|9749327|FG001|STARTED|Donor Hematopoietic Stem Cell Harvest||0
8703616|NCT00923845|9749326|FG000|COMPLETED|Donor Hematopoietic Stem Cell Harvest||13
8703617|NCT00923845|9749327|FG001|COMPLETED|Donor Hematopoietic Stem Cell Harvest||0
8703618|NCT00923845|9749326|FG000|NOT COMPLETED|Donor Hematopoietic Stem Cell Harvest||0
8703619|NCT00923845|9749327|FG001|NOT COMPLETED|Donor Hematopoietic Stem Cell Harvest||0
8703620|NCT00923845|9749326|FG000|STARTED|Induction Therapy||0
8703621|NCT00923845|9749327|FG001|STARTED|Induction Therapy||12
8703622|NCT00923845|9749326|FG000|COMPLETED|Induction Therapy||0
8703623|NCT00923845|9749327|FG001|COMPLETED|Induction Therapy||10
8703624|NCT00923845|9749326|FG000|NOT COMPLETED|Induction Therapy||0
9051818|NCT03522350|10111257|FG001|NOT COMPLETED|Overall Study||0
9051819|NCT03522441|10111265|FG000|STARTED|Overall Study||450
9051820|NCT03522441|10111266|FG001|STARTED|Overall Study||450
9051821|NCT03522441|10111267|FG002|STARTED|Overall Study||225
9051822|NCT03522441|10111265|FG000|COMPLETED|Overall Study||424
9051823|NCT03522441|10111266|FG001|COMPLETED|Overall Study||431
9051824|NCT03522441|10111267|FG002|COMPLETED|Overall Study||214
9051825|NCT03522441|10111265|FG000|NOT COMPLETED|Overall Study||26
9051826|NCT03522441|10111266|FG001|NOT COMPLETED|Overall Study||19
9051827|NCT03522441|10111267|FG002|NOT COMPLETED|Overall Study||11
9051828|NCT03522506|10111279|FG000|STARTED|Treatment Period 1 (2 Days)||5
9051829|NCT03522506|10111280|FG001|STARTED|Treatment Period 1 (2 Days)||5
9051830|NCT03522506|10111281|FG002|STARTED|Treatment Period 1 (2 Days)||5
9051831|NCT03522506|10111282|FG003|STARTED|Treatment Period 1 (2 Days)||5
9051832|NCT03522506|10111279|FG000|COMPLETED|Treatment Period 1 (2 Days)||5
9051833|NCT03522506|10111280|FG001|COMPLETED|Treatment Period 1 (2 Days)||5
9051834|NCT03522506|10111281|FG002|COMPLETED|Treatment Period 1 (2 Days)||5
9051835|NCT03522506|10111282|FG003|COMPLETED|Treatment Period 1 (2 Days)||5
8703625|NCT00923845|9749327|FG001|NOT COMPLETED|Induction Therapy||2
8703626|NCT00923845|9749326|FG000|STARTED|Allogeneic Stem Cell Therapy||0
8703627|NCT00923845|9749327|FG001|STARTED|Allogeneic Stem Cell Therapy||10
8703628|NCT00923845|9749326|FG000|Received Each of 3 Planned T-Rapa DLI|Allogeneic Stem Cell Therapy||0
8703629|NCT00923845|9749327|FG001|Received Each of 3 Planned T-Rapa DLI|Allogeneic Stem Cell Therapy||8
8703630|NCT00923845|9749326|FG000|Received More Unmanipulated DLI for PD|Allogeneic Stem Cell Therapy||0
8703631|NCT00923845|9749327|FG001|Received More Unmanipulated DLI for PD|Allogeneic Stem Cell Therapy||6
8703632|NCT00923845|9749326|FG000|COMPLETED|Allogeneic Stem Cell Therapy||0
8703633|NCT00923845|9749327|FG001|COMPLETED|Allogeneic Stem Cell Therapy||10
8703634|NCT00923845|9749326|FG000|NOT COMPLETED|Allogeneic Stem Cell Therapy||0
8703635|NCT00923845|9749327|FG001|NOT COMPLETED|Allogeneic Stem Cell Therapy||0
8703636|NCT00923910|9749336|FG000|STARTED|Period 1||5
9051836|NCT03522506|10111279|FG000|NOT COMPLETED|Treatment Period 1 (2 Days)||0
9051837|NCT03522506|10111280|FG001|NOT COMPLETED|Treatment Period 1 (2 Days)||0
9051838|NCT03522506|10111281|FG002|NOT COMPLETED|Treatment Period 1 (2 Days)||0
9051839|NCT03522506|10111282|FG003|NOT COMPLETED|Treatment Period 1 (2 Days)||0
9051840|NCT03522506|10111279|FG000|STARTED|Washout Period 1 (7 Days)||5
9051841|NCT03522506|10111280|FG001|STARTED|Washout Period 1 (7 Days)||5
9051842|NCT03522506|10111281|FG002|STARTED|Washout Period 1 (7 Days)||5
9051843|NCT03522506|10111282|FG003|STARTED|Washout Period 1 (7 Days)||5
9051844|NCT03522506|10111279|FG000|COMPLETED|Washout Period 1 (7 Days)||5
9051845|NCT03522506|10111280|FG001|COMPLETED|Washout Period 1 (7 Days)||5
9051846|NCT03522506|10111281|FG002|COMPLETED|Washout Period 1 (7 Days)||5
9051847|NCT03522506|10111282|FG003|COMPLETED|Washout Period 1 (7 Days)||4
9051848|NCT03522506|10111279|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
9051849|NCT03522506|10111280|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
9051850|NCT03522506|10111281|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
9051851|NCT03522506|10111282|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||1
9051852|NCT03522506|10111279|FG000|STARTED|Treatment Period 2 (2 Days)||5
9051853|NCT03522506|10111280|FG001|STARTED|Treatment Period 2 (2 Days)||5
9051854|NCT03522506|10111281|FG002|STARTED|Treatment Period 2 (2 Days)||5
9051855|NCT03522506|10111282|FG003|STARTED|Treatment Period 2 (2 Days)||4
9051856|NCT03522506|10111279|FG000|COMPLETED|Treatment Period 2 (2 Days)||5
9051857|NCT03522506|10111280|FG001|COMPLETED|Treatment Period 2 (2 Days)||5
9051858|NCT03522506|10111281|FG002|COMPLETED|Treatment Period 2 (2 Days)||5
9051859|NCT03522506|10111282|FG003|COMPLETED|Treatment Period 2 (2 Days)||4
9051860|NCT03522506|10111279|FG000|NOT COMPLETED|Treatment Period 2 (2 Days)||0
9051861|NCT03522506|10111280|FG001|NOT COMPLETED|Treatment Period 2 (2 Days)||0
9051862|NCT03522506|10111281|FG002|NOT COMPLETED|Treatment Period 2 (2 Days)||0
9051863|NCT03522506|10111282|FG003|NOT COMPLETED|Treatment Period 2 (2 Days)||0
9051864|NCT03522506|10111279|FG000|STARTED|Washout Period 2 (7 Days)||5
9051865|NCT03522506|10111280|FG001|STARTED|Washout Period 2 (7 Days)||5
9051866|NCT03522506|10111281|FG002|STARTED|Washout Period 2 (7 Days)||5
9051867|NCT03522506|10111282|FG003|STARTED|Washout Period 2 (7 Days)||4
9051868|NCT03522506|10111279|FG000|COMPLETED|Washout Period 2 (7 Days)||5
9051869|NCT03522506|10111280|FG001|COMPLETED|Washout Period 2 (7 Days)||5
9051870|NCT03522506|10111281|FG002|COMPLETED|Washout Period 2 (7 Days)||5
9051871|NCT03522506|10111282|FG003|COMPLETED|Washout Period 2 (7 Days)||3
9051872|NCT03522506|10111279|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
9051873|NCT03522506|10111280|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
9051874|NCT03522506|10111281|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
9051875|NCT03522506|10111282|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||1
9051876|NCT03522506|10111279|FG000|STARTED|Treatment Period 3 (2 Days)||5
9051877|NCT03522506|10111280|FG001|STARTED|Treatment Period 3 (2 Days)||5
9051878|NCT03522506|10111281|FG002|STARTED|Treatment Period 3 (2 Days)||5
9051879|NCT03522506|10111282|FG003|STARTED|Treatment Period 3 (2 Days)||3
9051880|NCT03522506|10111279|FG000|COMPLETED|Treatment Period 3 (2 Days)||5
9051881|NCT03522506|10111280|FG001|COMPLETED|Treatment Period 3 (2 Days)||5
9051882|NCT03522506|10111281|FG002|COMPLETED|Treatment Period 3 (2 Days)||5
9051883|NCT03522506|10111282|FG003|COMPLETED|Treatment Period 3 (2 Days)||3
9051884|NCT03522506|10111279|FG000|NOT COMPLETED|Treatment Period 3 (2 Days)||0
9051885|NCT03522506|10111280|FG001|NOT COMPLETED|Treatment Period 3 (2 Days)||0
9051886|NCT03522506|10111281|FG002|NOT COMPLETED|Treatment Period 3 (2 Days)||0
9051887|NCT03522506|10111282|FG003|NOT COMPLETED|Treatment Period 3 (2 Days)||0
9051888|NCT03522506|10111279|FG000|STARTED|Washout Period 3 (7 Days)||5
9051889|NCT03522506|10111280|FG001|STARTED|Washout Period 3 (7 Days)||5
9051890|NCT03522506|10111281|FG002|STARTED|Washout Period 3 (7 Days)||5
9051891|NCT03522506|10111282|FG003|STARTED|Washout Period 3 (7 Days)||3
9051892|NCT03522506|10111279|FG000|COMPLETED|Washout Period 3 (7 Days)||5
9051893|NCT03522506|10111280|FG001|COMPLETED|Washout Period 3 (7 Days)||5
9051894|NCT03522506|10111281|FG002|COMPLETED|Washout Period 3 (7 Days)||5
9051895|NCT03522506|10111282|FG003|COMPLETED|Washout Period 3 (7 Days)||3
9051896|NCT03522506|10111279|FG000|NOT COMPLETED|Washout Period 3 (7 Days)||0
9051897|NCT03522506|10111280|FG001|NOT COMPLETED|Washout Period 3 (7 Days)||0
9051898|NCT03522506|10111281|FG002|NOT COMPLETED|Washout Period 3 (7 Days)||0
9051899|NCT03522506|10111282|FG003|NOT COMPLETED|Washout Period 3 (7 Days)||0
9051900|NCT03522506|10111279|FG000|STARTED|Treatment Period 4 (2 Days)||5
9051901|NCT03522506|10111280|FG001|STARTED|Treatment Period 4 (2 Days)||5
9051902|NCT03522506|10111281|FG002|STARTED|Treatment Period 4 (2 Days)||5
8703637|NCT00923910|9749337|FG001|STARTED|Period 1||5
9051903|NCT03522506|10111282|FG003|STARTED|Treatment Period 4 (2 Days)||3
9051904|NCT03522506|10111279|FG000|COMPLETED|Treatment Period 4 (2 Days)||5
9051905|NCT03522506|10111280|FG001|COMPLETED|Treatment Period 4 (2 Days)||5
9051906|NCT03522506|10111281|FG002|COMPLETED|Treatment Period 4 (2 Days)||5
9051907|NCT03522506|10111282|FG003|COMPLETED|Treatment Period 4 (2 Days)||3
9051908|NCT03522506|10111279|FG000|NOT COMPLETED|Treatment Period 4 (2 Days)||0
9051909|NCT03522506|10111280|FG001|NOT COMPLETED|Treatment Period 4 (2 Days)||0
9051910|NCT03522506|10111281|FG002|NOT COMPLETED|Treatment Period 4 (2 Days)||0
9051911|NCT03522506|10111282|FG003|NOT COMPLETED|Treatment Period 4 (2 Days)||0
9051912|NCT03522675|10111296|FG000|STARTED|Overall Study||22
9051913|NCT03522675|10111296|FG000|COMPLETED|Overall Study||20
8703638|NCT00923910|9749336|FG000|COMPLETED|Period 1||5
8703639|NCT00923910|9749337|FG001|COMPLETED|Period 1||5
8703640|NCT00923910|9749336|FG000|NOT COMPLETED|Period 1||0
8703641|NCT00923910|9749337|FG001|NOT COMPLETED|Period 1||0
8703642|NCT00923910|9749336|FG000|STARTED|Period 2||5
8703643|NCT00923910|9749337|FG001|STARTED|Period 2||5
8703644|NCT00923910|9749336|FG000|COMPLETED|Period 2||5
9051914|NCT03522675|10111296|FG000|NOT COMPLETED|Overall Study||2
9051915|NCT03522948|10111304|FG000|STARTED|Overall Study||8
9051916|NCT03522948|10111304|FG000|COMPLETED|Overall Study||7
9051917|NCT03522948|10111304|FG000|NOT COMPLETED|Overall Study||1
9051918|NCT03523715|10111310|FG000|STARTED|Overall Study||38
9051919|NCT03523715|10111311|FG001|STARTED|Overall Study||39
9051920|NCT03523715|10111310|FG000|COMPLETED|Overall Study||26
9051921|NCT03523715|10111311|FG001|COMPLETED|Overall Study||23
9051922|NCT03523715|10111310|FG000|NOT COMPLETED|Overall Study||12
9051923|NCT03523715|10111311|FG001|NOT COMPLETED|Overall Study||16
9051924|NCT03523871|10111317|FG000|STARTED|Overall Study||20
9051925|NCT03523871|10111317|FG000|COMPLETED|Overall Study||19
9051926|NCT03523871|10111317|FG000|NOT COMPLETED|Overall Study||1
9051927|NCT03523988|10111324|FG000|STARTED|Overall Study||24
9051928|NCT03523988|10111325|FG001|STARTED|Overall Study||24
9051929|NCT03523988|10111326|FG002|STARTED|Overall Study||25
9051930|NCT03523988|10111324|FG000|COMPLETED|Overall Study||7
9051931|NCT03523988|10111325|FG001|COMPLETED|Overall Study||8
9051932|NCT03523988|10111326|FG002|COMPLETED|Overall Study||7
9051933|NCT03523988|10111324|FG000|NOT COMPLETED|Overall Study||17
9051934|NCT03523988|10111325|FG001|NOT COMPLETED|Overall Study||16
9051935|NCT03523988|10111326|FG002|NOT COMPLETED|Overall Study||18
9051936|NCT03524157|10111337|FG000|STARTED|Overall Study||10
9051937|NCT03524157|10111338|FG001|STARTED|Overall Study||10
9051938|NCT03524157|10111339|FG002|STARTED|Overall Study||10
9051939|NCT03524157|10111337|FG000|COMPLETED|Overall Study||10
9051940|NCT03524157|10111338|FG001|COMPLETED|Overall Study||10
9051941|NCT03524157|10111339|FG002|COMPLETED|Overall Study||9
9051942|NCT03524157|10111337|FG000|NOT COMPLETED|Overall Study||0
9051943|NCT03524157|10111338|FG001|NOT COMPLETED|Overall Study||0
9051944|NCT03524157|10111339|FG002|NOT COMPLETED|Overall Study||1
9051945|NCT03524339|10111349|FG000|STARTED|Overall Study||66
9051946|NCT03524339|10111350|FG001|STARTED|Overall Study||66
9051947|NCT03524339|10111349|FG000|COMPLETED|Overall Study||57
9051948|NCT03524339|10111350|FG001|COMPLETED|Overall Study||62
9051949|NCT03524339|10111349|FG000|NOT COMPLETED|Overall Study||9
9051950|NCT03524339|10111350|FG001|NOT COMPLETED|Overall Study||4
9051951|NCT03525119|10111359|FG000|STARTED|Overall Study||300
9051952|NCT03525119|10111360|FG001|STARTED|Overall Study||300
9051953|NCT03525119|10111361|FG002|STARTED|Overall Study||300
9051954|NCT03525119|10111359|FG000|Safety Population|Overall Study||299
9051955|NCT03525119|10111360|FG001|Safety Population|Overall Study||300
9051956|NCT03525119|10111361|FG002|Safety Population|Overall Study||298
9051957|NCT03525119|10111359|FG000|COMPLETED|Overall Study||260
9051958|NCT03525119|10111360|FG001|COMPLETED|Overall Study||261
9051959|NCT03525119|10111361|FG002|COMPLETED|Overall Study||257
9051960|NCT03525119|10111359|FG000|NOT COMPLETED|Overall Study||40
9051961|NCT03525119|10111360|FG001|NOT COMPLETED|Overall Study||39
9051962|NCT03525119|10111361|FG002|NOT COMPLETED|Overall Study||43
9051963|NCT03525210|10111371|FG000|STARTED|Overall Study||100
9051964|NCT03525210|10111372|FG001|STARTED|Overall Study||171
9051965|NCT03525210|10111371|FG000|COMPLETED|Overall Study||96
9051966|NCT03525210|10111372|FG001|COMPLETED|Overall Study||169
9051967|NCT03525210|10111371|FG000|NOT COMPLETED|Overall Study||4
9051968|NCT03525210|10111372|FG001|NOT COMPLETED|Overall Study||2
9051969|NCT03525444|10111382|FG000|STARTED|Overall Study||203
9051970|NCT03525444|10111383|FG001|STARTED|Overall Study||200
9051971|NCT03525444|10111382|FG000|Safety Set|Overall Study||201
9051972|NCT03525444|10111383|FG001|Safety Set|Overall Study||202
9051973|NCT03525444|10111382|FG000|COMPLETED|Overall Study||203
8703645|NCT00923910|9749337|FG001|COMPLETED|Period 2||5
9051974|NCT03525444|10111383|FG001|COMPLETED|Overall Study||197
9051975|NCT03525444|10111382|FG000|NOT COMPLETED|Overall Study||0
9051976|NCT03525444|10111383|FG001|NOT COMPLETED|Overall Study||3
9051977|NCT03525548|10111392|FG000|STARTED|Overall Study||52
9051978|NCT03525548|10111393|FG001|STARTED|Overall Study||55
9051979|NCT03525548|10111392|FG000|COMPLETED|Overall Study||52
9051980|NCT03525548|10111393|FG001|COMPLETED|Overall Study||55
9051981|NCT03525548|10111392|FG000|NOT COMPLETED|Overall Study||0
9051982|NCT03525548|10111393|FG001|NOT COMPLETED|Overall Study||0
9051983|NCT03525834|10111399|FG000|STARTED|Overall Study||40
9051984|NCT03525834|10111399|FG000|COMPLETED|Overall Study||39
9051985|NCT03525834|10111399|FG000|NOT COMPLETED|Overall Study||1
9051986|NCT03526055|10111403|FG000|STARTED|Initial Program||5
9051987|NCT03526055|10111404|FG001|STARTED|Initial Program||5
9051988|NCT03526055|10111403|FG000|COMPLETED|Initial Program||5
9051989|NCT03526055|10111404|FG001|COMPLETED|Initial Program||5
9051990|NCT03526055|10111403|FG000|NOT COMPLETED|Initial Program||0
9051991|NCT03526055|10111404|FG001|NOT COMPLETED|Initial Program||0
9051992|NCT03526055|10111403|FG000|STARTED|Second Program||5
9051993|NCT03526055|10111404|FG001|STARTED|Second Program||5
9051994|NCT03526055|10111403|FG000|COMPLETED|Second Program||5
9051995|NCT03526055|10111404|FG001|COMPLETED|Second Program||5
9051996|NCT03526055|10111403|FG000|NOT COMPLETED|Second Program||0
9051997|NCT03526055|10111404|FG001|NOT COMPLETED|Second Program||0
9051998|NCT03526458|10111413|FG000|STARTED|Overall Study||20
9051999|NCT03526458|10111414|FG001|STARTED|Overall Study||20
9052000|NCT03526458|10111413|FG000|COMPLETED|Overall Study||12
9052001|NCT03526458|10111414|FG001|COMPLETED|Overall Study||15
9052002|NCT03526458|10111413|FG000|NOT COMPLETED|Overall Study||8
9052003|NCT03526458|10111414|FG001|NOT COMPLETED|Overall Study||5
9052004|NCT03526861|10111423|FG000|STARTED|Initial Treatment Period||101
9052005|NCT03526861|10111424|FG001|STARTED|Initial Treatment Period||100
9052006|NCT03526861|10111425|FG002|STARTED|Initial Treatment Period||100
9052007|NCT03526861|10111426|FG003|STARTED|Initial Treatment Period||0
9052008|NCT03526861|10111427|FG004|STARTED|Initial Treatment Period||0
9052009|NCT03526861|10111428|FG005|STARTED|Initial Treatment Period||0
9052010|NCT03526861|10111429|FG006|STARTED|Initial Treatment Period||0
9052011|NCT03526861|10111430|FG007|STARTED|Initial Treatment Period||0
9052012|NCT03526861|10111431|FG008|STARTED|Initial Treatment Period||0
9052013|NCT03526861|10111423|FG000|COMPLETED|Initial Treatment Period||94
9052014|NCT03526861|10111424|FG001|COMPLETED|Initial Treatment Period||93
9052015|NCT03526861|10111425|FG002|COMPLETED|Initial Treatment Period||86
9052016|NCT03526861|10111426|FG003|COMPLETED|Initial Treatment Period||0
9052017|NCT03526861|10111427|FG004|COMPLETED|Initial Treatment Period||0
9052018|NCT03526861|10111428|FG005|COMPLETED|Initial Treatment Period||0
9052019|NCT03526861|10111429|FG006|COMPLETED|Initial Treatment Period||0
9052020|NCT03526861|10111430|FG007|COMPLETED|Initial Treatment Period||0
9052021|NCT03526861|10111431|FG008|COMPLETED|Initial Treatment Period||0
9052022|NCT03526861|10111423|FG000|NOT COMPLETED|Initial Treatment Period||7
9052023|NCT03526861|10111424|FG001|NOT COMPLETED|Initial Treatment Period||7
9052024|NCT03526861|10111425|FG002|NOT COMPLETED|Initial Treatment Period||14
9052025|NCT03526861|10111426|FG003|NOT COMPLETED|Initial Treatment Period||0
9052026|NCT03526861|10111427|FG004|NOT COMPLETED|Initial Treatment Period||0
9052027|NCT03526861|10111428|FG005|NOT COMPLETED|Initial Treatment Period||0
9052028|NCT03526861|10111429|FG006|NOT COMPLETED|Initial Treatment Period||0
9052029|NCT03526861|10111430|FG007|NOT COMPLETED|Initial Treatment Period||0
9052030|NCT03526861|10111431|FG008|NOT COMPLETED|Initial Treatment Period||0
9052031|NCT03526861|10111423|FG000|STARTED|Maintenance Treatment Period||0
9052032|NCT03526861|10111424|FG001|STARTED|Maintenance Treatment Period||0
9052033|NCT03526861|10111425|FG002|STARTED|Maintenance Treatment Period||0
9052034|NCT03526861|10111426|FG003|STARTED|Maintenance Treatment Period||13
9052035|NCT03526861|10111427|FG004|STARTED|Maintenance Treatment Period||14
9052036|NCT03526861|10111428|FG005|STARTED|Maintenance Treatment Period||12
9052037|NCT03526861|10111429|FG006|STARTED|Maintenance Treatment Period||14
9052038|NCT03526861|10111430|FG007|STARTED|Maintenance Treatment Period||6
9052039|NCT03526861|10111431|FG008|STARTED|Maintenance Treatment Period||0
9052040|NCT03526861|10111423|FG000|COMPLETED|Maintenance Treatment Period||0
9052041|NCT03526861|10111424|FG001|COMPLETED|Maintenance Treatment Period||0
9052042|NCT03526861|10111425|FG002|COMPLETED|Maintenance Treatment Period||0
9052043|NCT03526861|10111426|FG003|COMPLETED|Maintenance Treatment Period||5
9052044|NCT03526861|10111427|FG004|COMPLETED|Maintenance Treatment Period||8
9052045|NCT03526861|10111428|FG005|COMPLETED|Maintenance Treatment Period||8
9052046|NCT03526861|10111429|FG006|COMPLETED|Maintenance Treatment Period||8
9052047|NCT03526861|10111430|FG007|COMPLETED|Maintenance Treatment Period||4
9052048|NCT03526861|10111431|FG008|COMPLETED|Maintenance Treatment Period||0
9052049|NCT03526861|10111423|FG000|NOT COMPLETED|Maintenance Treatment Period||0
9052050|NCT03526861|10111424|FG001|NOT COMPLETED|Maintenance Treatment Period||0
9052051|NCT03526861|10111425|FG002|NOT COMPLETED|Maintenance Treatment Period||0
9052052|NCT03526861|10111426|FG003|NOT COMPLETED|Maintenance Treatment Period||8
9052053|NCT03526861|10111427|FG004|NOT COMPLETED|Maintenance Treatment Period||6
9052054|NCT03526861|10111428|FG005|NOT COMPLETED|Maintenance Treatment Period||4
9052055|NCT03526861|10111429|FG006|NOT COMPLETED|Maintenance Treatment Period||6
9052056|NCT03526861|10111430|FG007|NOT COMPLETED|Maintenance Treatment Period||2
9052057|NCT03526861|10111431|FG008|NOT COMPLETED|Maintenance Treatment Period||0
9052058|NCT03526861|10111423|FG000|STARTED|Open-label Treatment Period||0
9052059|NCT03526861|10111424|FG001|STARTED|Open-label Treatment Period||0
9052060|NCT03526861|10111425|FG002|STARTED|Open-label Treatment Period||0
9052061|NCT03526861|10111426|FG003|STARTED|Open-label Treatment Period||0
9052062|NCT03526861|10111427|FG004|STARTED|Open-label Treatment Period||0
9052063|NCT03526861|10111428|FG005|STARTED|Open-label Treatment Period||0
9052064|NCT03526861|10111429|FG006|STARTED|Open-label Treatment Period||0
9052065|NCT03526861|10111430|FG007|STARTED|Open-label Treatment Period||0
9052066|NCT03526861|10111431|FG008|STARTED|Open-label Treatment Period|226 subjects transferred to open-label treatment at Week 16. 24 subjects transferred to open-label treatment between Week 16 and Week 52.|242
9052067|NCT03526861|10111423|FG000|COMPLETED|Open-label Treatment Period||0
9052068|NCT03526861|10111424|FG001|COMPLETED|Open-label Treatment Period||0
9052069|NCT03526861|10111425|FG002|COMPLETED|Open-label Treatment Period||0
9052070|NCT03526861|10111426|FG003|COMPLETED|Open-label Treatment Period||0
9052071|NCT03526861|10111427|FG004|COMPLETED|Open-label Treatment Period||0
9052072|NCT03526861|10111428|FG005|COMPLETED|Open-label Treatment Period||0
9052073|NCT03526861|10111429|FG006|COMPLETED|Open-label Treatment Period||0
9052074|NCT03526861|10111430|FG007|COMPLETED|Open-label Treatment Period||0
9052075|NCT03526861|10111431|FG008|COMPLETED|Open-label Treatment Period||214
9052076|NCT03526861|10111423|FG000|NOT COMPLETED|Open-label Treatment Period||0
9052077|NCT03526861|10111424|FG001|NOT COMPLETED|Open-label Treatment Period||0
9052078|NCT03526861|10111425|FG002|NOT COMPLETED|Open-label Treatment Period||0
9052079|NCT03526861|10111426|FG003|NOT COMPLETED|Open-label Treatment Period||0
9052080|NCT03526861|10111427|FG004|NOT COMPLETED|Open-label Treatment Period||0
9052081|NCT03526861|10111428|FG005|NOT COMPLETED|Open-label Treatment Period||0
9052082|NCT03526861|10111429|FG006|NOT COMPLETED|Open-label Treatment Period||0
9052083|NCT03526861|10111430|FG007|NOT COMPLETED|Open-label Treatment Period||0
9052084|NCT03526861|10111431|FG008|NOT COMPLETED|Open-label Treatment Period||28
9052085|NCT03527160|10111453|FG000|STARTED|Overall Study||134
9052086|NCT03527160|10111453|FG000|COMPLETED|Overall Study||113
9052087|NCT03527160|10111453|FG000|NOT COMPLETED|Overall Study||21
9052088|NCT03527173|10111462|FG000|STARTED|Overall Study||36
9052089|NCT03527173|10111463|FG001|STARTED|Overall Study||35
9052090|NCT03527173|10111462|FG000|COMPLETED|Overall Study||29
9052091|NCT03527173|10111463|FG001|COMPLETED|Overall Study||28
9052092|NCT03527173|10111462|FG000|NOT COMPLETED|Overall Study||7
9052093|NCT03527173|10111463|FG001|NOT COMPLETED|Overall Study||7
9052094|NCT03527550|10111471|FG000|STARTED|Overall Study||24
9052095|NCT03527550|10111472|FG001|STARTED|Overall Study||22
9052096|NCT03527550|10111471|FG000|COMPLETED|Overall Study||15
9052097|NCT03527550|10111472|FG001|COMPLETED|Overall Study||19
9052098|NCT03527550|10111471|FG000|NOT COMPLETED|Overall Study||9
9052099|NCT03527550|10111472|FG001|NOT COMPLETED|Overall Study||3
9052100|NCT03527745|10111506|FG000|STARTED|Overall Study||27
9052101|NCT03527745|10111507|FG001|STARTED|Overall Study||27
9052102|NCT03527745|10111508|FG002|STARTED|Overall Study||30
9052103|NCT03527745|10111509|FG003|STARTED|Overall Study||27
9052104|NCT03527745|10111510|FG004|STARTED|Overall Study||46
9052105|NCT03527745|10111511|FG005|STARTED|Overall Study||45
9052106|NCT03527745|10111512|FG006|STARTED|Overall Study||46
9052107|NCT03527745|10111513|FG007|STARTED|Overall Study||43
9052108|NCT03527745|10111514|FG008|STARTED|Overall Study||10
9052109|NCT03527745|10111515|FG009|STARTED|Overall Study||11
9052110|NCT03527745|10111516|FG010|STARTED|Overall Study||9
9052111|NCT03527745|10111517|FG011|STARTED|Overall Study||12
9052112|NCT03527745|10111518|FG012|STARTED|Overall Study|During screening, the principal investigator decided to remove the this arm due to recruitment.|0
9052113|NCT03527745|10111519|FG013|STARTED|Overall Study||13
9052114|NCT03527745|10111520|FG014|STARTED|Overall Study||13
9052115|NCT03527745|10111521|FG015|STARTED|Overall Study||12
9052116|NCT03527745|10111522|FG016|STARTED|Overall Study||24
9052117|NCT03527745|10111523|FG017|STARTED|Overall Study||27
9052118|NCT03527745|10111524|FG018|STARTED|Overall Study||27
9052119|NCT03527745|10111525|FG019|STARTED|Overall Study||29
9052120|NCT03527745|10111526|FG020|STARTED|Overall Study||26
9052121|NCT03527745|10111527|FG021|STARTED|Overall Study||40
9052122|NCT03527745|10111528|FG022|STARTED|Overall Study||41
9052123|NCT03527745|10111529|FG023|STARTED|Overall Study||38
9052124|NCT03527745|10111530|FG024|STARTED|Overall Study||40
9052125|NCT03527745|10111531|FG025|STARTED|Overall Study||37
9052126|NCT03527745|10111506|FG000|COMPLETED|Overall Study||24
9052127|NCT03527745|10111507|FG001|COMPLETED|Overall Study||21
9052128|NCT03527745|10111508|FG002|COMPLETED|Overall Study||23
9052129|NCT03527745|10111509|FG003|COMPLETED|Overall Study||18
9052130|NCT03527745|10111510|FG004|COMPLETED|Overall Study||46
9052131|NCT03527745|10111511|FG005|COMPLETED|Overall Study||43
9052132|NCT03527745|10111512|FG006|COMPLETED|Overall Study||43
9052133|NCT03527745|10111513|FG007|COMPLETED|Overall Study||41
9052134|NCT03527745|10111514|FG008|COMPLETED|Overall Study||7
9052135|NCT03527745|10111515|FG009|COMPLETED|Overall Study||9
9052136|NCT03527745|10111516|FG010|COMPLETED|Overall Study||8
9052137|NCT03527745|10111517|FG011|COMPLETED|Overall Study||11
9052138|NCT03527745|10111518|FG012|COMPLETED|Overall Study||0
9052139|NCT03527745|10111519|FG013|COMPLETED|Overall Study||13
9052140|NCT03527745|10111520|FG014|COMPLETED|Overall Study||13
9052141|NCT03527745|10111521|FG015|COMPLETED|Overall Study||12
9052142|NCT03527745|10111522|FG016|COMPLETED|Overall Study||23
9052143|NCT03527745|10111523|FG017|COMPLETED|Overall Study||27
9052144|NCT03527745|10111524|FG018|COMPLETED|Overall Study||27
9052145|NCT03527745|10111525|FG019|COMPLETED|Overall Study||28
9052146|NCT03527745|10111526|FG020|COMPLETED|Overall Study||25
9052147|NCT03527745|10111527|FG021|COMPLETED|Overall Study||35
9052148|NCT03527745|10111528|FG022|COMPLETED|Overall Study||35
9052149|NCT03527745|10111529|FG023|COMPLETED|Overall Study||30
9052150|NCT03527745|10111530|FG024|COMPLETED|Overall Study||39
9052151|NCT03527745|10111531|FG025|COMPLETED|Overall Study||34
9052152|NCT03527745|10111506|FG000|NOT COMPLETED|Overall Study||3
9052153|NCT03527745|10111507|FG001|NOT COMPLETED|Overall Study||6
9052154|NCT03527745|10111508|FG002|NOT COMPLETED|Overall Study||7
9052155|NCT03527745|10111509|FG003|NOT COMPLETED|Overall Study||9
9052156|NCT03527745|10111510|FG004|NOT COMPLETED|Overall Study||0
9052157|NCT03527745|10111511|FG005|NOT COMPLETED|Overall Study||2
9052158|NCT03527745|10111512|FG006|NOT COMPLETED|Overall Study||3
9052159|NCT03527745|10111513|FG007|NOT COMPLETED|Overall Study||2
9052160|NCT03527745|10111514|FG008|NOT COMPLETED|Overall Study||3
9052161|NCT03527745|10111515|FG009|NOT COMPLETED|Overall Study||2
9052162|NCT03527745|10111516|FG010|NOT COMPLETED|Overall Study||1
9052163|NCT03527745|10111517|FG011|NOT COMPLETED|Overall Study||1
9052164|NCT03527745|10111518|FG012|NOT COMPLETED|Overall Study||0
9052165|NCT03527745|10111519|FG013|NOT COMPLETED|Overall Study||0
9052166|NCT03527745|10111520|FG014|NOT COMPLETED|Overall Study||0
9052167|NCT03527745|10111521|FG015|NOT COMPLETED|Overall Study||0
9052168|NCT03527745|10111522|FG016|NOT COMPLETED|Overall Study||1
9052169|NCT03527745|10111523|FG017|NOT COMPLETED|Overall Study||0
9052170|NCT03527745|10111524|FG018|NOT COMPLETED|Overall Study||0
9052171|NCT03527745|10111525|FG019|NOT COMPLETED|Overall Study||1
9052172|NCT03527745|10111526|FG020|NOT COMPLETED|Overall Study||1
9052173|NCT03527745|10111527|FG021|NOT COMPLETED|Overall Study||5
9052174|NCT03527745|10111528|FG022|NOT COMPLETED|Overall Study||6
9052175|NCT03527745|10111529|FG023|NOT COMPLETED|Overall Study||8
9052176|NCT03527745|10111530|FG024|NOT COMPLETED|Overall Study||1
9052177|NCT03527745|10111531|FG025|NOT COMPLETED|Overall Study||3
9052178|NCT03527966|10111589|FG000|STARTED|Overall Study||3
9052179|NCT03527966|10111590|FG001|STARTED|Overall Study||0
9052180|NCT03527966|10111589|FG000|COMPLETED|Overall Study||0
9052181|NCT03527966|10111590|FG001|COMPLETED|Overall Study||0
9052182|NCT03527966|10111589|FG000|NOT COMPLETED|Overall Study||3
9052183|NCT03527966|10111590|FG001|NOT COMPLETED|Overall Study||0
9052184|NCT03528174|10111596|FG000|STARTED|Overall Study||10
9052185|NCT03528174|10111596|FG000|COMPLETED|Overall Study||8
9052186|NCT03528174|10111596|FG000|NOT COMPLETED|Overall Study||2
9052187|NCT03528369|10111603|FG000|STARTED|Overall Study||40
9052188|NCT03528369|10111604|FG001|STARTED|Overall Study||42
9052189|NCT03528369|10111605|FG002|STARTED|Overall Study||40
9052190|NCT03528369|10111603|FG000|COMPLETED|Overall Study||37
9052191|NCT03528369|10111604|FG001|COMPLETED|Overall Study||41
9052192|NCT03528369|10111605|FG002|COMPLETED|Overall Study||40
9052193|NCT03528369|10111603|FG000|NOT COMPLETED|Overall Study||3
9052194|NCT03528369|10111604|FG001|NOT COMPLETED|Overall Study||1
9052195|NCT03528369|10111605|FG002|NOT COMPLETED|Overall Study||0
9052196|NCT03528512|10111615|FG000|STARTED|Overall Study||3
9052197|NCT03528512|10111616|FG001|STARTED|Overall Study||2
9052198|NCT03528512|10111615|FG000|COMPLETED|Overall Study||3
9052199|NCT03528512|10111616|FG001|COMPLETED|Overall Study||2
9052200|NCT03528512|10111615|FG000|NOT COMPLETED|Overall Study||0
9052201|NCT03528512|10111616|FG001|NOT COMPLETED|Overall Study||0
9052202|NCT03528551|10111625|FG000|STARTED|Overall Study||25
9052203|NCT03528551|10111626|FG001|STARTED|Overall Study||133
9052204|NCT03528551|10111627|FG002|STARTED|Overall Study||2
9052205|NCT03528551|10111625|FG000|COMPLETED|Overall Study||23
9052206|NCT03528551|10111626|FG001|COMPLETED|Overall Study||114
9052207|NCT03528551|10111627|FG002|COMPLETED|Overall Study||2
9052208|NCT03528551|10111625|FG000|NOT COMPLETED|Overall Study||2
9052209|NCT03528551|10111626|FG001|NOT COMPLETED|Overall Study||19
9052210|NCT03528551|10111627|FG002|NOT COMPLETED|Overall Study||0
9052211|NCT03528577|10111636|FG000|STARTED|Sequence 1||128
9052212|NCT03528577|10111636|FG000|COMPLETED|Sequence 1|Per report, 119 completed the trial, and all 119 received Treatment A, B, C and D.|126
9052213|NCT03528577|10111636|FG000|NOT COMPLETED|Sequence 1||2
9052214|NCT03528577|10111636|FG000|STARTED|Sequence 2||128
9052215|NCT03528577|10111636|FG000|COMPLETED|Sequence 2||125
9052216|NCT03528577|10111636|FG000|NOT COMPLETED|Sequence 2||3
9052217|NCT03528577|10111636|FG000|STARTED|Sequence 3||128
9052218|NCT03528577|10111636|FG000|COMPLETED|Sequence 3||127
9052219|NCT03528577|10111636|FG000|NOT COMPLETED|Sequence 3||1
9052220|NCT03528577|10111636|FG000|STARTED|Sequence 4||128
9052221|NCT03528577|10111636|FG000|COMPLETED|Sequence 4||125
9052222|NCT03528577|10111636|FG000|NOT COMPLETED|Sequence 4||3
9052223|NCT03529162|10111645|FG000|STARTED|Overall Study||2
9052224|NCT03529162|10111646|FG001|STARTED|Overall Study||2
9052225|NCT03529162|10111645|FG000|COMPLETED|Overall Study||0
9052226|NCT03529162|10111646|FG001|COMPLETED|Overall Study||0
9052227|NCT03529162|10111645|FG000|NOT COMPLETED|Overall Study||2
9052228|NCT03529162|10111646|FG001|NOT COMPLETED|Overall Study||2
9052229|NCT03529461|10111656|FG000|STARTED|Overall Study||28
9052230|NCT03529461|10111657|FG001|STARTED|Overall Study||28
9052231|NCT03529461|10111656|FG000|COMPLETED|Overall Study||28
9052232|NCT03529461|10111657|FG001|COMPLETED|Overall Study||28
9052233|NCT03529461|10111656|FG000|NOT COMPLETED|Overall Study||0
9052234|NCT03529461|10111657|FG001|NOT COMPLETED|Overall Study||0
9052235|NCT03530098|10111666|FG000|STARTED|Overall Study||939
9052236|NCT03530098|10111667|FG001|STARTED|Overall Study||964
9052237|NCT03530098|10111666|FG000|Ground-truth Labeled|Overall Study||741
9052238|NCT03530098|10111667|FG001|Ground-truth Labeled|Overall Study||794
9052239|NCT03530098|10111666|FG000|Primary Analysis Set|Overall Study||739
9052240|NCT03530098|10111667|FG001|Primary Analysis Set|Overall Study||792
9052241|NCT03530098|10111666|FG000|COMPLETED|Overall Study||939
9052242|NCT03530098|10111667|FG001|COMPLETED|Overall Study||964
9052243|NCT03530098|10111666|FG000|NOT COMPLETED|Overall Study||0
9052244|NCT03530098|10111667|FG001|NOT COMPLETED|Overall Study||0
9052245|NCT03530345|10111676|FG000|STARTED|Treatment Period A/Follow-up Period 1||28
9052246|NCT03530345|10111677|FG001|STARTED|Treatment Period A/Follow-up Period 1||29
9052247|NCT03530345|10111676|FG000|Treatment Period A Completers|Treatment Period A/Follow-up Period 1||26
9052248|NCT03530345|10111677|FG001|Treatment Period A Completers|Treatment Period A/Follow-up Period 1||27
9052249|NCT03530345|10111676|FG000|COMPLETED|Treatment Period A/Follow-up Period 1||7
9052250|NCT03530345|10111677|FG001|COMPLETED|Treatment Period A/Follow-up Period 1||7
9052251|NCT03530345|10111676|FG000|NOT COMPLETED|Treatment Period A/Follow-up Period 1||21
9052252|NCT03530345|10111677|FG001|NOT COMPLETED|Treatment Period A/Follow-up Period 1||22
9052253|NCT03530345|10111676|FG000|STARTED|Treatment Period B/Follow-up Period 2|2 participants completed Treatment Period A/Follow-up Period 1 but were not allocated in Period B.|5
9052254|NCT03530345|10111677|FG001|STARTED|Treatment Period B/Follow-up Period 2||7
9052255|NCT03530345|10111676|FG000|Treatment Period B Completers|Treatment Period B/Follow-up Period 2||4
9052256|NCT03530345|10111677|FG001|Treatment Period B Completers|Treatment Period B/Follow-up Period 2||6
9052257|NCT03530345|10111676|FG000|COMPLETED|Treatment Period B/Follow-up Period 2||0
9052258|NCT03530345|10111677|FG001|COMPLETED|Treatment Period B/Follow-up Period 2||0
9052259|NCT03530345|10111676|FG000|NOT COMPLETED|Treatment Period B/Follow-up Period 2||5
9052260|NCT03530345|10111677|FG001|NOT COMPLETED|Treatment Period B/Follow-up Period 2||7
9052261|NCT03530631|10111689|FG000|STARTED|Adderall/Truth||4
9052262|NCT03530631|10111689|FG000|COMPLETED|Adderall/Truth||4
9052263|NCT03530631|10111689|FG000|NOT COMPLETED|Adderall/Truth||0
9052264|NCT03530631|10111689|FG000|STARTED|Placebo/Truth||4
9052265|NCT03530631|10111689|FG000|COMPLETED|Placebo/Truth||4
9052266|NCT03530631|10111689|FG000|NOT COMPLETED|Placebo/Truth||0
9052267|NCT03530631|10111689|FG000|STARTED|Adderall/Deception||4
9052268|NCT03530631|10111689|FG000|COMPLETED|Adderall/Deception||4
9052269|NCT03530631|10111689|FG000|NOT COMPLETED|Adderall/Deception||0
9052270|NCT03530631|10111689|FG000|STARTED|Placebo/Deception||4
9052271|NCT03530631|10111689|FG000|COMPLETED|Placebo/Deception||4
9052272|NCT03530631|10111689|FG000|NOT COMPLETED|Placebo/Deception||0
9052273|NCT03530917|10111707|FG000|STARTED|Overall Study||8
9052274|NCT03530917|10111708|FG001|STARTED|Overall Study||8
9052275|NCT03530917|10111709|FG002|STARTED|Overall Study||8
9052276|NCT03530917|10111710|FG003|STARTED|Overall Study||8
9052277|NCT03530917|10111711|FG004|STARTED|Overall Study||8
9052278|NCT03530917|10111712|FG005|STARTED|Overall Study||6
9052279|NCT03530917|10111713|FG006|STARTED|Overall Study||8
9052280|NCT03530917|10111714|FG007|STARTED|Overall Study||16
9052281|NCT03530917|10111707|FG000|COMPLETED|Overall Study||8
9052282|NCT03530917|10111708|FG001|COMPLETED|Overall Study||8
9052283|NCT03530917|10111709|FG002|COMPLETED|Overall Study||8
9052284|NCT03530917|10111710|FG003|COMPLETED|Overall Study||8
9052285|NCT03530917|10111711|FG004|COMPLETED|Overall Study||8
9052286|NCT03530917|10111712|FG005|COMPLETED|Overall Study||6
9052287|NCT03530917|10111713|FG006|COMPLETED|Overall Study||8
9052288|NCT03530917|10111714|FG007|COMPLETED|Overall Study||16
9052289|NCT03530917|10111707|FG000|NOT COMPLETED|Overall Study||0
9052290|NCT03530917|10111708|FG001|NOT COMPLETED|Overall Study||0
9052291|NCT03530917|10111709|FG002|NOT COMPLETED|Overall Study||0
9052292|NCT03530917|10111710|FG003|NOT COMPLETED|Overall Study||0
9052293|NCT03530917|10111711|FG004|NOT COMPLETED|Overall Study||0
9052294|NCT03530917|10111712|FG005|NOT COMPLETED|Overall Study||0
9052295|NCT03530917|10111713|FG006|NOT COMPLETED|Overall Study||0
9052296|NCT03530917|10111714|FG007|NOT COMPLETED|Overall Study||0
9052297|NCT03531710|10111744|FG000|STARTED|Overall Study||10
9052298|NCT03531710|10111745|FG001|STARTED|Overall Study||2
9052299|NCT03531710|10111746|FG002|STARTED|Overall Study||7
9052300|NCT03531710|10111747|FG003|STARTED|Overall Study||5
9052301|NCT03531710|10111748|FG004|STARTED|Overall Study||8
9052302|NCT03531710|10111749|FG005|STARTED|Overall Study||2
9052303|NCT03531710|10111744|FG000|COMPLETED|Overall Study||8
9052304|NCT03531710|10111745|FG001|COMPLETED|Overall Study||2
9052305|NCT03531710|10111746|FG002|COMPLETED|Overall Study||7
9052306|NCT03531710|10111747|FG003|COMPLETED|Overall Study||5
9052307|NCT03531710|10111748|FG004|COMPLETED|Overall Study||8
9052308|NCT03531710|10111749|FG005|COMPLETED|Overall Study||2
9052309|NCT03531710|10111744|FG000|NOT COMPLETED|Overall Study||2
9052310|NCT03531710|10111745|FG001|NOT COMPLETED|Overall Study||0
9052311|NCT03531710|10111746|FG002|NOT COMPLETED|Overall Study||0
9052312|NCT03531710|10111747|FG003|NOT COMPLETED|Overall Study||0
9052313|NCT03531710|10111748|FG004|NOT COMPLETED|Overall Study||0
9052314|NCT03531710|10111749|FG005|NOT COMPLETED|Overall Study||0
9052315|NCT03531840|10111767|FG000|STARTED|Overall Study||5
9052316|NCT03531840|10111768|FG001|STARTED|Overall Study||6
9052317|NCT03531840|10111769|FG002|STARTED|Overall Study||8
9052318|NCT03531840|10111770|FG003|STARTED|Overall Study||4
9052319|NCT03531840|10111767|FG000|COMPLETED|Overall Study||0
9052320|NCT03531840|10111768|FG001|COMPLETED|Overall Study||1
9052321|NCT03531840|10111769|FG002|COMPLETED|Overall Study||3
9052322|NCT03531840|10111770|FG003|COMPLETED|Overall Study||1
9052323|NCT03531840|10111767|FG000|NOT COMPLETED|Overall Study||5
9052324|NCT03531840|10111768|FG001|NOT COMPLETED|Overall Study||5
9052325|NCT03531840|10111769|FG002|NOT COMPLETED|Overall Study||5
9052326|NCT03531840|10111770|FG003|NOT COMPLETED|Overall Study||3
9052327|NCT03531905|10111788|FG000|STARTED|Overall Study||81
9052328|NCT03531905|10111789|FG001|STARTED|Overall Study||81
9052329|NCT03531905|10111790|FG002|STARTED|Overall Study||80
9052330|NCT03531905|10111788|FG000|COMPLETED|Overall Study||74
9052331|NCT03531905|10111789|FG001|COMPLETED|Overall Study||76
9052332|NCT03531905|10111790|FG002|COMPLETED|Overall Study||77
9052333|NCT03531905|10111788|FG000|NOT COMPLETED|Overall Study||7
9052334|NCT03531905|10111789|FG001|NOT COMPLETED|Overall Study||5
9052335|NCT03531905|10111790|FG002|NOT COMPLETED|Overall Study||3
9052336|NCT03532009|10111802|FG000|STARTED|Overall Study||92
9052337|NCT03532009|10111803|FG001|STARTED|Overall Study||90
9052338|NCT03532009|10111802|FG000|Received Treatment|Overall Study||91
9052339|NCT03532009|10111803|FG001|Received Treatment|Overall Study||90
9052340|NCT03532009|10111802|FG000|COMPLETED|Overall Study||90
9052341|NCT03532009|10111803|FG001|COMPLETED|Overall Study||86
9052342|NCT03532009|10111802|FG000|NOT COMPLETED|Overall Study||2
9052343|NCT03532009|10111803|FG001|NOT COMPLETED|Overall Study||4
9052344|NCT03532048|10111811|FG000|STARTED|Overall Study|68 individuals (19 fathers, 31 children & 18 mothers)|68
9052345|NCT03532048|10111812|FG001|STARTED|Overall Study|67 individuals (17 fathers, 33 children & 17 mothers)|67
9052346|NCT03532048|10111811|FG000|COMPLETED|Overall Study|49 individuals (14 fathers, 22 children, 13 mothers). 1 father only took part in interview|49
9052347|NCT03532048|10111812|FG001|COMPLETED|Overall Study|50 individuals (13 fathers, 24 children & 13 mothers)|50
9052348|NCT03532048|10111811|FG000|NOT COMPLETED|Overall Study||19
9052349|NCT03532048|10111812|FG001|NOT COMPLETED|Overall Study||17
9052350|NCT03532308|10111820|FG000|STARTED|Overall Study||10
9052351|NCT03532308|10111821|FG001|STARTED|Overall Study||9
9052352|NCT03532308|10111820|FG000|Completed Assessments|Overall Study||9
9052353|NCT03532308|10111821|FG001|Completed Assessments|Overall Study||7
9052354|NCT03532308|10111820|FG000|COMPLETED|Overall Study||10
9052355|NCT03532308|10111821|FG001|COMPLETED|Overall Study||8
9052356|NCT03532308|10111820|FG000|NOT COMPLETED|Overall Study||0
9052357|NCT03532308|10111821|FG001|NOT COMPLETED|Overall Study||1
9052358|NCT03532776|10111830|FG000|STARTED|Overall Study||201
9052359|NCT03532776|10111831|FG001|STARTED|Overall Study||198
9052360|NCT03532776|10111832|FG002|STARTED|Overall Study||67
9052361|NCT03532776|10111830|FG000|COMPLETED|Overall Study||196
9052362|NCT03532776|10111831|FG001|COMPLETED|Overall Study||194
9052363|NCT03532776|10111832|FG002|COMPLETED|Overall Study||63
9052364|NCT03532776|10111830|FG000|NOT COMPLETED|Overall Study||5
9052365|NCT03532776|10111831|FG001|NOT COMPLETED|Overall Study||4
9052366|NCT03532776|10111832|FG002|NOT COMPLETED|Overall Study||4
9052367|NCT03533036|10111843|FG000|STARTED|Overall Study||15
9052368|NCT03533036|10111844|FG001|STARTED|Overall Study||15
9052369|NCT03533036|10111843|FG000|COMPLETED|Overall Study||15
9052370|NCT03533036|10111844|FG001|COMPLETED|Overall Study||15
9052371|NCT03533036|10111843|FG000|NOT COMPLETED|Overall Study||0
9052372|NCT03533036|10111844|FG001|NOT COMPLETED|Overall Study||0
9052373|NCT03533114|10111852|FG000|STARTED|Overall||88
9052374|NCT03533114|10111853|FG001|STARTED|Overall||66
9052375|NCT03533114|10111852|FG000|COMPLETED|Overall||57
9052376|NCT03533114|10111853|FG001|COMPLETED|Overall||38
9052377|NCT03533114|10111852|FG000|NOT COMPLETED|Overall||31
9052378|NCT03533114|10111853|FG001|NOT COMPLETED|Overall||28
9052379|NCT03533114|10111852|FG000|STARTED|Open Label Titration and Optimization||88
9052380|NCT03533114|10111853|FG001|STARTED|Open Label Titration and Optimization||66
9052381|NCT03533114|10111852|FG000|COMPLETED|Open Label Titration and Optimization||72
9052382|NCT03533114|10111853|FG001|COMPLETED|Open Label Titration and Optimization||53
9052383|NCT03533114|10111852|FG000|NOT COMPLETED|Open Label Titration and Optimization||16
9052384|NCT03533114|10111853|FG001|NOT COMPLETED|Open Label Titration and Optimization||13
9052385|NCT03533114|10111852|FG000|STARTED|Stable Dose||71
9052386|NCT03533114|10111853|FG001|STARTED|Stable Dose||52
9052387|NCT03533114|10111852|FG000|COMPLETED|Stable Dose||69
9052388|NCT03533114|10111853|FG001|COMPLETED|Stable Dose||50
9052389|NCT03533114|10111852|FG000|NOT COMPLETED|Stable Dose||2
9052390|NCT03533114|10111853|FG001|NOT COMPLETED|Stable Dose||2
9052391|NCT03533114|10111852|FG000|STARTED|Double Blind Randomized-Withdrawal||69
9052392|NCT03533114|10111853|FG001|STARTED|Double Blind Randomized-Withdrawal||47
9052393|NCT03533114|10111852|FG000|JZP-258|Double Blind Randomized-Withdrawal||57
8703646|NCT00923910|9749336|FG000|NOT COMPLETED|Period 2||0
8703647|NCT00923910|9749337|FG001|NOT COMPLETED|Period 2||0
8703648|NCT00923936|9749344|FG000|STARTED|Overall Study||10
8703649|NCT00923936|9749345|FG001|STARTED|Overall Study||6
8703650|NCT00923936|9749344|FG000|COMPLETED|Overall Study||2
8703651|NCT00923936|9749345|FG001|COMPLETED|Overall Study||3
8703652|NCT00923936|9749344|FG000|NOT COMPLETED|Overall Study||8
8703653|NCT00923936|9749345|FG001|NOT COMPLETED|Overall Study||3
8703654|NCT00923949|9749353|FG000|STARTED|Overall Study||1
8703655|NCT00923949|9749353|FG000|COMPLETED|Overall Study||1
8703656|NCT00923949|9749353|FG000|NOT COMPLETED|Overall Study||0
9052394|NCT03533114|10111853|FG001|JZP-258|Double Blind Randomized-Withdrawal||0
9052395|NCT03533114|10111852|FG000|Placebo|Double Blind Randomized-Withdrawal||0
9052396|NCT03533114|10111853|FG001|Placebo|Double Blind Randomized-Withdrawal||59
9052397|NCT03533114|10111852|FG000|COMPLETED|Double Blind Randomized-Withdrawal||67
9052398|NCT03533114|10111853|FG001|COMPLETED|Double Blind Randomized-Withdrawal||46
9052399|NCT03533114|10111852|FG000|NOT COMPLETED|Double Blind Randomized-Withdrawal||2
9052400|NCT03533114|10111853|FG001|NOT COMPLETED|Double Blind Randomized-Withdrawal||1
9052401|NCT03533114|10111852|FG000|STARTED|Open-Label Safety Extension||65
9052402|NCT03533114|10111853|FG001|STARTED|Open-Label Safety Extension||41
9052403|NCT03533114|10111852|FG000|COMPLETED|Open-Label Safety Extension||57
9052404|NCT03533114|10111853|FG001|COMPLETED|Open-Label Safety Extension||38
9052405|NCT03533114|10111852|FG000|NOT COMPLETED|Open-Label Safety Extension||8
9052406|NCT03533114|10111853|FG001|NOT COMPLETED|Open-Label Safety Extension||3
9052407|NCT03533244|10111864|FG000|STARTED|Overall Study||20
9052408|NCT03533244|10111865|FG001|STARTED|Overall Study||22
9052409|NCT03533244|10111866|FG002|STARTED|Overall Study||22
9052410|NCT03533244|10111864|FG000|COMPLETED|Overall Study||18
8703657|NCT00923975|9749357|FG000|STARTED|Overall Study||51
8703658|NCT00923975|9749357|FG000|COMPLETED|Overall Study|One subject did not meet inclusion criteria; the data was not used in analysis.|50
8703659|NCT00923975|9749357|FG000|NOT COMPLETED|Overall Study||1
9052411|NCT03533244|10111865|FG001|COMPLETED|Overall Study||21
8703660|NCT00924001|9749361|FG000|STARTED|Overall Study||1
8703661|NCT00924001|9749361|FG000|COMPLETED|Overall Study||1
8703662|NCT00924001|9749361|FG000|NOT COMPLETED|Overall Study||0
8703663|NCT00924040|9749365|FG000|STARTED|Overall Study||1
9052412|NCT03533244|10111866|FG002|COMPLETED|Overall Study||22
9052413|NCT03533244|10111864|FG000|NOT COMPLETED|Overall Study||2
9052414|NCT03533244|10111865|FG001|NOT COMPLETED|Overall Study||1
9052415|NCT03533244|10111866|FG002|NOT COMPLETED|Overall Study||0
9052416|NCT03533374|10111876|FG000|STARTED|Overall Study||54
9052417|NCT03533374|10111877|FG001|STARTED|Overall Study||46
9052418|NCT03533374|10111876|FG000|COMPLETED|Overall Study||54
9052419|NCT03533374|10111877|FG001|COMPLETED|Overall Study||46
9052420|NCT03533374|10111876|FG000|NOT COMPLETED|Overall Study||0
9052421|NCT03533374|10111877|FG001|NOT COMPLETED|Overall Study||0
9052422|NCT03533608|10111883|FG000|STARTED|Overall Study||39
9052423|NCT03533608|10111883|FG000|COMPLETED|Overall Study||34
9052424|NCT03533608|10111883|FG000|NOT COMPLETED|Overall Study||5
9052425|NCT03533829|10111891|FG000|STARTED|Overall Study||10
9052426|NCT03533829|10111892|FG001|STARTED|Overall Study||10
9052427|NCT03533829|10111893|FG002|STARTED|Overall Study||10
9052428|NCT03533829|10111891|FG000|COMPLETED|Overall Study||10
9052429|NCT03533829|10111892|FG001|COMPLETED|Overall Study||10
9052430|NCT03533829|10111893|FG002|COMPLETED|Overall Study||10
9052431|NCT03533829|10111891|FG000|NOT COMPLETED|Overall Study||0
9052432|NCT03533829|10111892|FG001|NOT COMPLETED|Overall Study||0
9052433|NCT03533829|10111893|FG002|NOT COMPLETED|Overall Study||0
9052434|NCT03534427|10111903|FG000|STARTED|Overall Study||20
9052435|NCT03534427|10111904|FG001|STARTED|Overall Study||20
9052436|NCT03534427|10111903|FG000|COMPLETED|Overall Study||20
9052437|NCT03534427|10111904|FG001|COMPLETED|Overall Study||20
9052438|NCT03534427|10111903|FG000|NOT COMPLETED|Overall Study||0
9052439|NCT03534427|10111904|FG001|NOT COMPLETED|Overall Study||0
9052440|NCT03534986|10111913|FG000|STARTED|Overall Study||10
9052441|NCT03534986|10111914|FG001|STARTED|Overall Study||10
9052442|NCT03534986|10111915|FG002|STARTED|Overall Study||12
9052443|NCT03534986|10111913|FG000|COMPLETED|Overall Study||10
9052444|NCT03534986|10111914|FG001|COMPLETED|Overall Study||10
9052445|NCT03534986|10111915|FG002|COMPLETED|Overall Study||10
9052446|NCT03534986|10111913|FG000|NOT COMPLETED|Overall Study||0
9052447|NCT03534986|10111914|FG001|NOT COMPLETED|Overall Study||0
9052448|NCT03534986|10111915|FG002|NOT COMPLETED|Overall Study||2
9052449|NCT03535194|10111928|FG000|STARTED|Induction Period||454
9052450|NCT03535194|10111929|FG001|STARTED|Induction Period||451
9052451|NCT03535194|10111930|FG002|STARTED|Induction Period||112
9052452|NCT03535194|10111931|FG003|STARTED|Induction Period||448
9052453|NCT03535194|10111932|FG004|STARTED|Induction Period|A plaque psoriasis participant was misrandomized by the site.|19
9052454|NCT03535194|10111928|FG000|Received at Least One Dose of Study Drug|Induction Period||454
9052455|NCT03535194|10111929|FG001|Received at Least One Dose of Study Drug|Induction Period||450
9052456|NCT03535194|10111930|FG002|Received at Least One Dose of Study Drug|Induction Period||112
9052457|NCT03535194|10111931|FG003|Received at Least One Dose of Study Drug|Induction Period||448
9052458|NCT03535194|10111932|FG004|Received at Least One Dose of Study Drug|Induction Period||19
9052459|NCT03535194|10111928|FG000|COMPLETED|Induction Period||443
9052460|NCT03535194|10111929|FG001|COMPLETED|Induction Period||434
9052461|NCT03535194|10111930|FG002|COMPLETED|Induction Period||104
9052462|NCT03535194|10111931|FG003|COMPLETED|Induction Period||437
9052463|NCT03535194|10111932|FG004|COMPLETED|Induction Period||19
9052464|NCT03535194|10111928|FG000|NOT COMPLETED|Induction Period||11
9052465|NCT03535194|10111929|FG001|NOT COMPLETED|Induction Period||17
9052466|NCT03535194|10111930|FG002|NOT COMPLETED|Induction Period||8
9052467|NCT03535194|10111931|FG003|NOT COMPLETED|Induction Period||11
9052468|NCT03535194|10111932|FG004|NOT COMPLETED|Induction Period||0
9052469|NCT03535194|10111928|FG000|STARTED|Maintenance Period||443
9052470|NCT03535194|10111929|FG001|STARTED|Maintenance Period||434
9052471|NCT03535194|10111930|FG002|STARTED|Maintenance Period||104
9052472|NCT03535194|10111931|FG003|STARTED|Maintenance Period||437
9052473|NCT03535194|10111932|FG004|STARTED|Maintenance Period||19
9052474|NCT03535194|10111928|FG000|COMPLETED|Maintenance Period||421
9052475|NCT03535194|10111929|FG001|COMPLETED|Maintenance Period||418
9052476|NCT03535194|10111930|FG002|COMPLETED|Maintenance Period||96
9052477|NCT03535194|10111931|FG003|COMPLETED|Maintenance Period||400
9052478|NCT03535194|10111932|FG004|COMPLETED|Maintenance Period||13
9052479|NCT03535194|10111928|FG000|NOT COMPLETED|Maintenance Period||22
9052480|NCT03535194|10111929|FG001|NOT COMPLETED|Maintenance Period||16
9052481|NCT03535194|10111930|FG002|NOT COMPLETED|Maintenance Period||8
9052482|NCT03535194|10111931|FG003|NOT COMPLETED|Maintenance Period||37
9052483|NCT03535194|10111932|FG004|NOT COMPLETED|Maintenance Period||6
9052484|NCT03535194|10111928|FG000|STARTED|Post-Treatment Followup Period|Participants who discontinued/completed Induction/Maintenance had option to enter post-treatment|38
9052485|NCT03535194|10111929|FG001|STARTED|Post-Treatment Followup Period|Participants who discontinued/completed Induction/Maintenance had option to enter post-treatment|35
9052486|NCT03535194|10111930|FG002|STARTED|Post-Treatment Followup Period|Participants who discontinued/completed Induction/Maintenance had option to enter post-treatment|18
9052487|NCT03535194|10111931|FG003|STARTED|Post-Treatment Followup Period|Participants who discontinued/completed Induction/Maintenance had option to enter post-treatment|47
9052488|NCT03535194|10111932|FG004|STARTED|Post-Treatment Followup Period|Participants who discontinued/completed Induction/Maintenance had option to enter post-treatment|8
9052489|NCT03535194|10111928|FG000|COMPLETED|Post-Treatment Followup Period||27
9052490|NCT03535194|10111929|FG001|COMPLETED|Post-Treatment Followup Period||21
9052491|NCT03535194|10111930|FG002|COMPLETED|Post-Treatment Followup Period||7
9052492|NCT03535194|10111931|FG003|COMPLETED|Post-Treatment Followup Period||23
9052493|NCT03535194|10111932|FG004|COMPLETED|Post-Treatment Followup Period||8
9052494|NCT03535194|10111928|FG000|NOT COMPLETED|Post-Treatment Followup Period||11
9052495|NCT03535194|10111929|FG001|NOT COMPLETED|Post-Treatment Followup Period||14
9052496|NCT03535194|10111930|FG002|NOT COMPLETED|Post-Treatment Followup Period||11
9052497|NCT03535194|10111931|FG003|NOT COMPLETED|Post-Treatment Followup Period||24
9052498|NCT03535194|10111932|FG004|NOT COMPLETED|Post-Treatment Followup Period||0
9052499|NCT03535571|10111956|FG000|STARTED|Overall Study||20
9052500|NCT03535571|10111956|FG000|COMPLETED|Overall Study||19
9052501|NCT03535571|10111956|FG000|NOT COMPLETED|Overall Study||1
9052502|NCT03535649|10111962|FG000|STARTED|Overall Study||105
9052503|NCT03535649|10111962|FG000|COMPLETED|Overall Study||105
9052504|NCT03535649|10111962|FG000|NOT COMPLETED|Overall Study||0
9052505|NCT03535844|10111968|FG000|STARTED|Overall Study||22
9052506|NCT03535844|10111969|FG001|STARTED|Overall Study||19
9052507|NCT03535844|10111968|FG000|COMPLETED|Overall Study||22
9052508|NCT03535844|10111969|FG001|COMPLETED|Overall Study||18
9052509|NCT03535844|10111968|FG000|NOT COMPLETED|Overall Study||0
9052510|NCT03535844|10111969|FG001|NOT COMPLETED|Overall Study||1
9052511|NCT03535974|10111978|FG000|STARTED|First Intervention Weeks 0-6 (V1-V2)||14
9052512|NCT03535974|10111979|FG001|STARTED|First Intervention Weeks 0-6 (V1-V2)||19
8703664|NCT00924040|9749365|FG000|COMPLETED|Overall Study||1
8703665|NCT00924040|9749365|FG000|NOT COMPLETED|Overall Study||0
8703666|NCT00924053|9749373|FG000|STARTED|Overall Study||6
8703667|NCT00924053|9749374|FG001|STARTED|Overall Study||6
8703668|NCT00924053|9749375|FG002|STARTED|Overall Study||6
9052513|NCT03535974|10111980|FG002|STARTED|First Intervention Weeks 0-6 (V1-V2)||5
9052514|NCT03535974|10111978|FG000|COMPLETED|First Intervention Weeks 0-6 (V1-V2)||12
9052515|NCT03535974|10111979|FG001|COMPLETED|First Intervention Weeks 0-6 (V1-V2)||17
9052516|NCT03535974|10111980|FG002|COMPLETED|First Intervention Weeks 0-6 (V1-V2)||5
9052517|NCT03535974|10111978|FG000|NOT COMPLETED|First Intervention Weeks 0-6 (V1-V2)||2
9052518|NCT03535974|10111979|FG001|NOT COMPLETED|First Intervention Weeks 0-6 (V1-V2)||2
9052519|NCT03535974|10111980|FG002|NOT COMPLETED|First Intervention Weeks 0-6 (V1-V2)||0
9052520|NCT03535974|10111978|FG000|STARTED|Second Intervention Weeks 6-12 (V2-V3)||12
9052521|NCT03535974|10111979|FG001|STARTED|Second Intervention Weeks 6-12 (V2-V3)||17
9052522|NCT03535974|10111980|FG002|STARTED|Second Intervention Weeks 6-12 (V2-V3)||5
9052523|NCT03535974|10111978|FG000|COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||12
9052524|NCT03535974|10111979|FG001|COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||17
9052525|NCT03535974|10111980|FG002|COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||5
9052526|NCT03535974|10111978|FG000|NOT COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||0
9052527|NCT03535974|10111979|FG001|NOT COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||0
9052528|NCT03535974|10111980|FG002|NOT COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||0
9052529|NCT03536663|10111988|FG000|STARTED|Optiflux||23
9052530|NCT03536663|10111988|FG000|COMPLETED|Optiflux||19
9052531|NCT03536663|10111988|FG000|NOT COMPLETED|Optiflux||4
9052532|NCT03536663|10111988|FG000|STARTED|Endexo|One subject completed the Optiflux period but missed Visit 13 and was withdrawn per protocol.|18
9052533|NCT03536663|10111988|FG000|COMPLETED|Endexo||17
9052534|NCT03536663|10111988|FG000|NOT COMPLETED|Endexo||1
9052535|NCT03536702|10111999|FG000|STARTED|Overall Study||40
9052536|NCT03536702|10112000|FG001|STARTED|Overall Study||20
9052537|NCT03536702|10111999|FG000|COMPLETED|Overall Study||26
9052538|NCT03536702|10112000|FG001|COMPLETED|Overall Study||8
9052539|NCT03536702|10111999|FG000|NOT COMPLETED|Overall Study||14
9052540|NCT03536702|10112000|FG001|NOT COMPLETED|Overall Study||12
9052541|NCT03536819|10112006|FG000|STARTED|Overall Study||20
9052542|NCT03536819|10112006|FG000|COMPLETED|Overall Study||15
9052543|NCT03536819|10112006|FG000|NOT COMPLETED|Overall Study||5
9052544|NCT03536923|10112010|FG000|STARTED|Overall Study||23
9052545|NCT03536923|10112010|FG000|COMPLETED|Overall Study||23
9052546|NCT03536923|10112010|FG000|NOT COMPLETED|Overall Study||0
9052547|NCT03536949|10112016|FG000|STARTED|Overall Study||157
9052548|NCT03536949|10112017|FG001|STARTED|Overall Study||77
9052549|NCT03536949|10112016|FG000|COMPLETED|Overall Study||143
9052550|NCT03536949|10112017|FG001|COMPLETED|Overall Study||75
9052551|NCT03536949|10112016|FG000|NOT COMPLETED|Overall Study||14
9052552|NCT03536949|10112017|FG001|NOT COMPLETED|Overall Study||2
9052553|NCT03537014|10112025|FG000|STARTED|Overall Study||46
9052554|NCT03537014|10112026|FG001|STARTED|Overall Study||45
9052555|NCT03537014|10112025|FG000|Withdrew Consent Before Dosing|Overall Study||0
9052556|NCT03537014|10112026|FG001|Withdrew Consent Before Dosing|Overall Study||1
9052557|NCT03537014|10112025|FG000|Completed First Experimental Session|Overall Study||46
9052558|NCT03537014|10112026|FG001|Completed First Experimental Session|Overall Study||44
9052559|NCT03537014|10112025|FG000|Completed Second Experimental Session|Overall Study||43
9052560|NCT03537014|10112026|FG001|Completed Second Experimental Session|Overall Study||41
9052561|NCT03537014|10112025|FG000|COMPLETED|Overall Study||42
9052562|NCT03537014|10112026|FG001|COMPLETED|Overall Study||40
9052563|NCT03537014|10112025|FG000|NOT COMPLETED|Overall Study||4
9052564|NCT03537014|10112026|FG001|NOT COMPLETED|Overall Study||5
9052565|NCT03537092|10112032|FG000|STARTED|Overall Study||64
9052566|NCT03537092|10112032|FG000|COMPLETED|Overall Study||64
9052567|NCT03537092|10112032|FG000|NOT COMPLETED|Overall Study||0
9052568|NCT03537261|10112038|FG000|STARTED|Overall Study||41
9052569|NCT03537261|10112039|FG001|STARTED|Overall Study||39
9052570|NCT03537261|10112038|FG000|Completed Baseline Assessment|Overall Study|One participant did not attend the CPI-Parent training but remained in the study.|35
9052571|NCT03537261|10112039|FG001|Completed Baseline Assessment|Overall Study||28
9052572|NCT03537261|10112038|FG000|COMPLETED|Overall Study|One participant did not attend the CPI-Parent training but remained in the study.|33
9052573|NCT03537261|10112039|FG001|COMPLETED|Overall Study||27
9052574|NCT03537261|10112038|FG000|NOT COMPLETED|Overall Study||8
9052575|NCT03537261|10112039|FG001|NOT COMPLETED|Overall Study||12
9052576|NCT03537274|10112049|FG000|STARTED|Overall Study||315
9052577|NCT03537274|10112050|FG001|STARTED|Overall Study||298
8703669|NCT00924053|9749376|FG003|STARTED|Overall Study||6
8703670|NCT00924053|9749373|FG000|COMPLETED|Overall Study||6
9052578|NCT03537274|10112051|FG002|STARTED|Overall Study||304
9052579|NCT03537274|10112052|FG003|STARTED|Overall Study||307
9052580|NCT03537274|10112049|FG000|Treated|Overall Study||315
9052581|NCT03537274|10112050|FG001|Treated|Overall Study||297
9052582|NCT03537274|10112051|FG002|Treated|Overall Study||304
9052583|NCT03537274|10112052|FG003|Treated|Overall Study||303
9052584|NCT03537274|10112049|FG000|COMPLETED|Overall Study||255
9052585|NCT03537274|10112050|FG001|COMPLETED|Overall Study||229
9052586|NCT03537274|10112051|FG002|COMPLETED|Overall Study||228
9052587|NCT03537274|10112052|FG003|COMPLETED|Overall Study||231
9052588|NCT03537274|10112049|FG000|NOT COMPLETED|Overall Study||60
9052589|NCT03537274|10112050|FG001|NOT COMPLETED|Overall Study||69
9052590|NCT03537274|10112051|FG002|NOT COMPLETED|Overall Study||76
9052591|NCT03537274|10112052|FG003|NOT COMPLETED|Overall Study||76
9052592|NCT03537404|10112065|FG000|STARTED|First Intervention (A or B or C)||18
9052593|NCT03537404|10112066|FG001|STARTED|First Intervention (A or B or C)||18
9052594|NCT03537404|10112065|FG000|COMPLETED|First Intervention (A or B or C)||18
9052595|NCT03537404|10112066|FG001|COMPLETED|First Intervention (A or B or C)||18
9052596|NCT03537404|10112065|FG000|NOT COMPLETED|First Intervention (A or B or C)||0
9052597|NCT03537404|10112066|FG001|NOT COMPLETED|First Intervention (A or B or C)||0
9052598|NCT03537404|10112065|FG000|STARTED|First Washout Period (8 Days)||18
9052599|NCT03537404|10112066|FG001|STARTED|First Washout Period (8 Days)||18
9052600|NCT03537404|10112065|FG000|COMPLETED|First Washout Period (8 Days)||18
9052601|NCT03537404|10112066|FG001|COMPLETED|First Washout Period (8 Days)||18
9052602|NCT03537404|10112065|FG000|NOT COMPLETED|First Washout Period (8 Days)||0
9052603|NCT03537404|10112066|FG001|NOT COMPLETED|First Washout Period (8 Days)||0
9052604|NCT03537404|10112065|FG000|STARTED|Second Intervention (A or B or C)||18
9052605|NCT03537404|10112066|FG001|STARTED|Second Intervention (A or B or C)||18
9052606|NCT03537404|10112065|FG000|COMPLETED|Second Intervention (A or B or C)||18
9052607|NCT03537404|10112066|FG001|COMPLETED|Second Intervention (A or B or C)||18
9052608|NCT03537404|10112065|FG000|NOT COMPLETED|Second Intervention (A or B or C)||0
9052609|NCT03537404|10112066|FG001|NOT COMPLETED|Second Intervention (A or B or C)||0
9052610|NCT03537404|10112065|FG000|STARTED|Second Washout Period (8 Days)||18
9052611|NCT03537404|10112066|FG001|STARTED|Second Washout Period (8 Days)||18
9052612|NCT03537404|10112065|FG000|COMPLETED|Second Washout Period (8 Days)||18
9052613|NCT03537404|10112066|FG001|COMPLETED|Second Washout Period (8 Days)||18
9052614|NCT03537404|10112065|FG000|NOT COMPLETED|Second Washout Period (8 Days)||0
9052615|NCT03537404|10112066|FG001|NOT COMPLETED|Second Washout Period (8 Days)||0
9052616|NCT03537404|10112065|FG000|STARTED|Third Intervention (A or B or C)||18
9052617|NCT03537404|10112066|FG001|STARTED|Third Intervention (A or B or C)||18
9052618|NCT03537404|10112065|FG000|COMPLETED|Third Intervention (A or B or C)||18
9052619|NCT03537404|10112066|FG001|COMPLETED|Third Intervention (A or B or C)||18
9052620|NCT03537404|10112065|FG000|NOT COMPLETED|Third Intervention (A or B or C)||0
9052621|NCT03537404|10112066|FG001|NOT COMPLETED|Third Intervention (A or B or C)||0
9052622|NCT03537651|10112090|FG000|STARTED|Overall Study||130
9052623|NCT03537651|10112090|FG000|113B/116 FAS|Overall Study||64
9052624|NCT03537651|10112090|FG000|113B/116 LCI FAS|Overall Study||30
9052625|NCT03537651|10112090|FG000|115/116 FAS|Overall Study||66
9052626|NCT03537651|10112090|FG000|115/116 FAS (TEZ/IVA Group)|Overall Study||53
9052627|NCT03537651|10112090|FG000|COMPLETED|Overall Study||69
9052628|NCT03537651|10112090|FG000|NOT COMPLETED|Overall Study||61
9052629|NCT03537664|10112097|FG000|STARTED|Overall Study||20
9052630|NCT03537664|10112098|FG001|STARTED|Overall Study||25
9052631|NCT03537664|10112097|FG000|Metabolic Activity of Bacteria|Overall Study|5 patients were excluded from metabolic activity analysis (lost of RNA)|15
9052632|NCT03537664|10112098|FG001|Metabolic Activity of Bacteria|Overall Study||25
9052633|NCT03537664|10112097|FG000|Bacterial Levels|Overall Study||20
9052634|NCT03537664|10112098|FG001|Bacterial Levels|Overall Study||25
9052635|NCT03537664|10112097|FG000|Bacterial Community Diversity|Overall Study||10
9052636|NCT03537664|10112098|FG001|Bacterial Community Diversity|Overall Study||0
9052637|NCT03537664|10112097|FG000|Endodontic Success|Overall Study||20
9052638|NCT03537664|10112098|FG001|Endodontic Success|Overall Study||10
9052639|NCT03537664|10112097|FG000|COMPLETED|Overall Study||20
9052640|NCT03537664|10112098|FG001|COMPLETED|Overall Study||25
9052641|NCT03537664|10112097|FG000|NOT COMPLETED|Overall Study||0
9052642|NCT03537664|10112098|FG001|NOT COMPLETED|Overall Study||0
9052643|NCT03538431|10112109|FG000|STARTED|Overall Study||13
9052644|NCT03538431|10112110|FG001|STARTED|Overall Study||13
9052645|NCT03538431|10112109|FG000|COMPLETED|Overall Study||12
9052646|NCT03538431|10112110|FG001|COMPLETED|Overall Study||12
9052647|NCT03538431|10112109|FG000|NOT COMPLETED|Overall Study||1
9052648|NCT03538431|10112110|FG001|NOT COMPLETED|Overall Study||1
9052649|NCT03538678|10112120|FG000|STARTED|Overall Study||20
9052650|NCT03538678|10112121|FG001|STARTED|Overall Study||20
9052651|NCT03538678|10112120|FG000|COMPLETED|Overall Study||5
9052652|NCT03538678|10112121|FG001|COMPLETED|Overall Study||9
9052653|NCT03538678|10112120|FG000|NOT COMPLETED|Overall Study||15
9052654|NCT03538678|10112121|FG001|NOT COMPLETED|Overall Study||11
9052655|NCT03538743|10112136|FG000|STARTED|Overall Study||25
9052656|NCT03538743|10112137|FG001|STARTED|Overall Study||9
9052657|NCT03538743|10112138|FG002|STARTED|Overall Study||9
9052658|NCT03538743|10112139|FG003|STARTED|Overall Study||10
9052659|NCT03538743|10112140|FG004|STARTED|Overall Study||9
9052660|NCT03538743|10112141|FG005|STARTED|Overall Study||9
9052661|NCT03538743|10112142|FG006|STARTED|Overall Study||9
9052662|NCT03538743|10112143|FG007|STARTED|Overall Study||8
9052663|NCT03538743|10112144|FG008|STARTED|Overall Study||10
9052664|NCT03538743|10112136|FG000|Received Treatment|Overall Study||25
9052665|NCT03538743|10112137|FG001|Received Treatment|Overall Study||9
9052666|NCT03538743|10112138|FG002|Received Treatment|Overall Study||9
9052667|NCT03538743|10112139|FG003|Received Treatment|Overall Study||10
9052668|NCT03538743|10112140|FG004|Received Treatment|Overall Study||9
9052669|NCT03538743|10112141|FG005|Received Treatment|Overall Study||9
9052670|NCT03538743|10112142|FG006|Received Treatment|Overall Study||9
9052671|NCT03538743|10112143|FG007|Received Treatment|Overall Study||8
9052672|NCT03538743|10112144|FG008|Received Treatment|Overall Study||10
9052673|NCT03538743|10112136|FG000|COMPLETED|Overall Study||25
9052674|NCT03538743|10112137|FG001|COMPLETED|Overall Study||9
9052675|NCT03538743|10112138|FG002|COMPLETED|Overall Study||8
9052676|NCT03538743|10112139|FG003|COMPLETED|Overall Study||8
9052677|NCT03538743|10112140|FG004|COMPLETED|Overall Study||9
9052678|NCT03538743|10112141|FG005|COMPLETED|Overall Study||9
9052679|NCT03538743|10112142|FG006|COMPLETED|Overall Study||9
9052680|NCT03538743|10112143|FG007|COMPLETED|Overall Study||8
9052681|NCT03538743|10112144|FG008|COMPLETED|Overall Study||7
9052682|NCT03538743|10112136|FG000|NOT COMPLETED|Overall Study||0
9052683|NCT03538743|10112137|FG001|NOT COMPLETED|Overall Study||0
9052684|NCT03538743|10112138|FG002|NOT COMPLETED|Overall Study||1
9052685|NCT03538743|10112139|FG003|NOT COMPLETED|Overall Study||2
9052686|NCT03538743|10112140|FG004|NOT COMPLETED|Overall Study||0
9052687|NCT03538743|10112141|FG005|NOT COMPLETED|Overall Study||0
9052688|NCT03538743|10112142|FG006|NOT COMPLETED|Overall Study||0
9052689|NCT03538743|10112143|FG007|NOT COMPLETED|Overall Study||0
9052690|NCT03538743|10112144|FG008|NOT COMPLETED|Overall Study||3
9052691|NCT03538795|10112172|FG000|STARTED|Overall Study||3
9052692|NCT03538795|10112172|FG000|COMPLETED|Overall Study||3
9052693|NCT03538795|10112172|FG000|NOT COMPLETED|Overall Study||0
9052694|NCT03538808|10112180|FG000|STARTED|Overall Study||20
9052695|NCT03538808|10112181|FG001|STARTED|Overall Study||20
9052696|NCT03538808|10112182|FG002|STARTED|Overall Study||20
9052697|NCT03538808|10112183|FG003|STARTED|Overall Study||20
9052698|NCT03538808|10112180|FG000|COMPLETED|Overall Study||18
9052699|NCT03538808|10112181|FG001|COMPLETED|Overall Study||20
9052700|NCT03538808|10112182|FG002|COMPLETED|Overall Study||16
9052701|NCT03538808|10112183|FG003|COMPLETED|Overall Study||18
9052702|NCT03538808|10112180|FG000|NOT COMPLETED|Overall Study||2
9052703|NCT03538808|10112181|FG001|NOT COMPLETED|Overall Study||0
9052704|NCT03538808|10112182|FG002|NOT COMPLETED|Overall Study||4
9052705|NCT03538808|10112183|FG003|NOT COMPLETED|Overall Study||2
9052706|NCT03539211|10112195|FG000|STARTED|Overall Study||16
9052707|NCT03539211|10112196|FG001|STARTED|Overall Study||15
9052708|NCT03539211|10112195|FG000|COMPLETED|Overall Study||16
9052709|NCT03539211|10112196|FG001|COMPLETED|Overall Study||15
9052710|NCT03539211|10112195|FG000|NOT COMPLETED|Overall Study||0
9052711|NCT03539211|10112196|FG001|NOT COMPLETED|Overall Study||0
9052712|NCT03539432|10112204|FG000|STARTED|Overall Study||2
9052713|NCT03539432|10112205|FG001|STARTED|Overall Study||1
9052714|NCT03539432|10112204|FG000|COMPLETED|Overall Study||2
9052715|NCT03539432|10112205|FG001|COMPLETED|Overall Study||0
9052716|NCT03539432|10112204|FG000|NOT COMPLETED|Overall Study||0
9052717|NCT03539432|10112205|FG001|NOT COMPLETED|Overall Study||1
9052718|NCT03539484|10112218|FG000|STARTED|Overall Study||1
9052719|NCT03539484|10112219|FG001|STARTED|Overall Study||1
9052720|NCT03539484|10112220|FG002|STARTED|Overall Study||1
9052721|NCT03539484|10112221|FG003|STARTED|Overall Study||3
9052722|NCT03539484|10112222|FG004|STARTED|Overall Study||13
9052723|NCT03539484|10112223|FG005|STARTED|Overall Study||5
9052724|NCT03539484|10112224|FG006|STARTED|Overall Study||2
9052725|NCT03539484|10112218|FG000|COMPLETED|Overall Study||0
9052726|NCT03539484|10112219|FG001|COMPLETED|Overall Study||0
9052727|NCT03539484|10112220|FG002|COMPLETED|Overall Study||0
9052728|NCT03539484|10112221|FG003|COMPLETED|Overall Study||0
9052729|NCT03539484|10112222|FG004|COMPLETED|Overall Study||0
9052730|NCT03539484|10112223|FG005|COMPLETED|Overall Study||0
9052731|NCT03539484|10112224|FG006|COMPLETED|Overall Study||0
9052732|NCT03539484|10112218|FG000|NOT COMPLETED|Overall Study||1
9052733|NCT03539484|10112219|FG001|NOT COMPLETED|Overall Study||1
9052734|NCT03539484|10112220|FG002|NOT COMPLETED|Overall Study||1
9052735|NCT03539484|10112221|FG003|NOT COMPLETED|Overall Study||3
9052736|NCT03539484|10112222|FG004|NOT COMPLETED|Overall Study||13
9052737|NCT03539484|10112223|FG005|NOT COMPLETED|Overall Study||5
9052738|NCT03539484|10112224|FG006|NOT COMPLETED|Overall Study||2
9052739|NCT03539549|10112245|FG000|STARTED|Overall Study||123
9052740|NCT03539549|10112245|FG000|COMPLETED|Overall Study||106
9052741|NCT03539549|10112245|FG000|NOT COMPLETED|Overall Study||17
9052742|NCT03540030|10112251|FG000|STARTED|Overall Study||48
9052743|NCT03540030|10112252|FG001|STARTED|Overall Study||38
9052744|NCT03540030|10112251|FG000|COMPLETED|Overall Study||30
9052745|NCT03540030|10112252|FG001|COMPLETED|Overall Study||35
9052746|NCT03540030|10112251|FG000|NOT COMPLETED|Overall Study||18
9052747|NCT03540030|10112252|FG001|NOT COMPLETED|Overall Study||3
9052748|NCT03540134|10112258|FG000|STARTED|Overall Study||4
9052749|NCT03540134|10112258|FG000|COMPLETED|Overall Study||4
9052750|NCT03540134|10112258|FG000|NOT COMPLETED|Overall Study||0
9052751|NCT03540147|10112262|FG000|STARTED|Overall Study||20
9052752|NCT03540147|10112262|FG000|COMPLETED|Overall Study||20
9052753|NCT03540147|10112262|FG000|NOT COMPLETED|Overall Study||0
9052754|NCT03540160|10112274|FG000|STARTED|Overall Study||558
9052755|NCT03540160|10112274|FG000|COMPLETED|Overall Study||179
9052756|NCT03540160|10112274|FG000|NOT COMPLETED|Overall Study||379
9052757|NCT03541044|10112278|FG000|STARTED|Study Period 1: Up to Day 1||23
9052758|NCT03541044|10112279|FG001|STARTED|Study Period 1: Up to Day 1||23
9052759|NCT03541044|10112278|FG000|COMPLETED|Study Period 1: Up to Day 1||23
9052760|NCT03541044|10112279|FG001|COMPLETED|Study Period 1: Up to Day 1||23
9052761|NCT03541044|10112278|FG000|NOT COMPLETED|Study Period 1: Up to Day 1||0
9052762|NCT03541044|10112279|FG001|NOT COMPLETED|Study Period 1: Up to Day 1||0
9052763|NCT03541044|10112278|FG000|STARTED|Washout Period: 5 to 7 Days||23
9052764|NCT03541044|10112279|FG001|STARTED|Washout Period: 5 to 7 Days||23
9052765|NCT03541044|10112278|FG000|COMPLETED|Washout Period: 5 to 7 Days||23
9052766|NCT03541044|10112279|FG001|COMPLETED|Washout Period: 5 to 7 Days||23
9052767|NCT03541044|10112278|FG000|NOT COMPLETED|Washout Period: 5 to 7 Days||0
9052768|NCT03541044|10112279|FG001|NOT COMPLETED|Washout Period: 5 to 7 Days||0
9052769|NCT03541044|10112278|FG000|STARTED|Study Period 2: Up to Day 8||23
9052770|NCT03541044|10112279|FG001|STARTED|Study Period 2: Up to Day 8||23
9052771|NCT03541044|10112278|FG000|COMPLETED|Study Period 2: Up to Day 8||21
9052772|NCT03541044|10112279|FG001|COMPLETED|Study Period 2: Up to Day 8||23
9052773|NCT03541044|10112278|FG000|NOT COMPLETED|Study Period 2: Up to Day 8||2
9052774|NCT03541044|10112279|FG001|NOT COMPLETED|Study Period 2: Up to Day 8||0
9052775|NCT03541356|10112292|FG000|STARTED|Overall Study||8
9052776|NCT03541356|10112293|FG001|STARTED|Overall Study||6
9052777|NCT03541356|10112294|FG002|STARTED|Overall Study||6
9052778|NCT03541356|10112295|FG003|STARTED|Overall Study||6
9052779|NCT03541356|10112296|FG004|STARTED|Overall Study||6
9052780|NCT03541356|10112292|FG000|COMPLETED|Overall Study||8
9052781|NCT03541356|10112293|FG001|COMPLETED|Overall Study||6
9052782|NCT03541356|10112294|FG002|COMPLETED|Overall Study||6
9052783|NCT03541356|10112295|FG003|COMPLETED|Overall Study||6
9052784|NCT03541356|10112296|FG004|COMPLETED|Overall Study||6
9052785|NCT03541356|10112292|FG000|NOT COMPLETED|Overall Study||0
9052786|NCT03541356|10112293|FG001|NOT COMPLETED|Overall Study||0
9052787|NCT03541356|10112294|FG002|NOT COMPLETED|Overall Study||0
9052788|NCT03541356|10112295|FG003|NOT COMPLETED|Overall Study||0
9052789|NCT03541356|10112296|FG004|NOT COMPLETED|Overall Study||0
9052790|NCT03541941|10112316|FG000|STARTED|Overall Study||57
9052791|NCT03541941|10112317|FG001|STARTED|Overall Study||55
9052792|NCT03541941|10112318|FG002|STARTED|Overall Study||52
9052793|NCT03541941|10112316|FG000|COMPLETED|Overall Study||57
9052794|NCT03541941|10112317|FG001|COMPLETED|Overall Study||55
9052795|NCT03541941|10112318|FG002|COMPLETED|Overall Study||52
9052796|NCT03541941|10112316|FG000|NOT COMPLETED|Overall Study||0
9052797|NCT03541941|10112317|FG001|NOT COMPLETED|Overall Study||0
9052798|NCT03541941|10112318|FG002|NOT COMPLETED|Overall Study||0
9052799|NCT03541980|10112328|FG000|STARTED|Overall Study||35
9052800|NCT03541980|10112329|FG001|STARTED|Overall Study||36
9052801|NCT03541980|10112328|FG000|COMPLETED|Overall Study||35
9052802|NCT03541980|10112329|FG001|COMPLETED|Overall Study||36
8557013|NCT01803854|9588829|FG000|STARTED|Overall Study||1275
9052803|NCT03541980|10112328|FG000|NOT COMPLETED|Overall Study||0
9052804|NCT03541980|10112329|FG001|NOT COMPLETED|Overall Study||0
9052805|NCT03542019|10112344|FG000|STARTED|Overall Study||20
9052806|NCT03542019|10112345|FG001|STARTED|Overall Study||20
9052807|NCT03542019|10112346|FG002|STARTED|Overall Study||20
9052808|NCT03542019|10112344|FG000|COMPLETED|Overall Study||19
9052809|NCT03542019|10112345|FG001|COMPLETED|Overall Study||17
9052810|NCT03542019|10112346|FG002|COMPLETED|Overall Study||19
9052811|NCT03542019|10112344|FG000|NOT COMPLETED|Overall Study||1
9052812|NCT03542019|10112345|FG001|NOT COMPLETED|Overall Study||3
9052813|NCT03542019|10112346|FG002|NOT COMPLETED|Overall Study||1
9052814|NCT03542305|10112358|FG000|STARTED|Overall Study||8
9052815|NCT03542305|10112359|FG001|STARTED|Overall Study||8
9052816|NCT03542305|10112360|FG002|STARTED|Overall Study||8
9052817|NCT03542305|10112361|FG003|STARTED|Overall Study||5
9052818|NCT03542305|10112358|FG000|COMPLETED|Overall Study||8
9052819|NCT03542305|10112359|FG001|COMPLETED|Overall Study||8
9052820|NCT03542305|10112360|FG002|COMPLETED|Overall Study||8
9052821|NCT03542305|10112361|FG003|COMPLETED|Overall Study||5
9052822|NCT03542305|10112358|FG000|NOT COMPLETED|Overall Study||0
9052823|NCT03542305|10112359|FG001|NOT COMPLETED|Overall Study||0
9052824|NCT03542305|10112360|FG002|NOT COMPLETED|Overall Study||0
9052825|NCT03542305|10112361|FG003|NOT COMPLETED|Overall Study||0
9052826|NCT03542474|10112371|FG000|STARTED|Overall Study||8
9052827|NCT03542474|10112371|FG000|COMPLETED|Overall Study||8
9052828|NCT03542474|10112371|FG000|NOT COMPLETED|Overall Study||0
9052829|NCT03543085|10112375|FG000|STARTED|Overall Study||10
9052830|NCT03543085|10112375|FG000|COMPLETED|Overall Study||10
9052831|NCT03543085|10112375|FG000|NOT COMPLETED|Overall Study||0
9052832|NCT03543137|10112379|FG000|STARTED|Study Period 1: Up to Day 1||18
9052833|NCT03543137|10112380|FG001|STARTED|Study Period 1: Up to Day 1||19
9052834|NCT03543137|10112379|FG000|COMPLETED|Study Period 1: Up to Day 1||18
9052835|NCT03543137|10112380|FG001|COMPLETED|Study Period 1: Up to Day 1||19
9052836|NCT03543137|10112379|FG000|NOT COMPLETED|Study Period 1: Up to Day 1||0
9052837|NCT03543137|10112380|FG001|NOT COMPLETED|Study Period 1: Up to Day 1||0
9052838|NCT03543137|10112379|FG000|STARTED|Washout Period: 5 to 7 Days||18
9052839|NCT03543137|10112380|FG001|STARTED|Washout Period: 5 to 7 Days||19
9052840|NCT03543137|10112379|FG000|COMPLETED|Washout Period: 5 to 7 Days||18
9052841|NCT03543137|10112380|FG001|COMPLETED|Washout Period: 5 to 7 Days||19
9052842|NCT03543137|10112379|FG000|NOT COMPLETED|Washout Period: 5 to 7 Days||0
9052843|NCT03543137|10112380|FG001|NOT COMPLETED|Washout Period: 5 to 7 Days||0
9052844|NCT03543137|10112379|FG000|STARTED|Study Period 2: Up to Day 8||18
9052845|NCT03543137|10112380|FG001|STARTED|Study Period 2: Up to Day 8||19
9052846|NCT03543137|10112379|FG000|Treated|Study Period 2: Up to Day 8||16
9052847|NCT03543137|10112380|FG001|Treated|Study Period 2: Up to Day 8||18
9052848|NCT03543137|10112379|FG000|COMPLETED|Study Period 2: Up to Day 8||16
9052849|NCT03543137|10112380|FG001|COMPLETED|Study Period 2: Up to Day 8||18
9052850|NCT03543137|10112379|FG000|NOT COMPLETED|Study Period 2: Up to Day 8||2
9052851|NCT03543137|10112380|FG001|NOT COMPLETED|Study Period 2: Up to Day 8||1
9052852|NCT03543176|10112390|FG000|STARTED|Overall Study||392
9052853|NCT03543176|10112391|FG001|STARTED|Overall Study||397
9052854|NCT03543176|10112390|FG000|COMPLETED|Overall Study||392
9052855|NCT03543176|10112391|FG001|COMPLETED|Overall Study||397
9052856|NCT03543176|10112390|FG000|NOT COMPLETED|Overall Study||0
9052857|NCT03543176|10112391|FG001|NOT COMPLETED|Overall Study||0
9052858|NCT03543878|10112399|FG000|STARTED|Overall Study||5
9052859|NCT03543878|10112400|FG001|STARTED|Overall Study||5
9052860|NCT03543878|10112399|FG000|COMPLETED|Overall Study||5
9052861|NCT03543878|10112400|FG001|COMPLETED|Overall Study||5
9052862|NCT03543878|10112399|FG000|NOT COMPLETED|Overall Study||0
9052863|NCT03543878|10112400|FG001|NOT COMPLETED|Overall Study||0
9052864|NCT03544216|10112409|FG000|STARTED|Overall Study||42
9052865|NCT03544216|10112410|FG001|STARTED|Overall Study||42
9052866|NCT03544216|10112409|FG000|COMPLETED|Overall Study||42
9052867|NCT03544216|10112410|FG001|COMPLETED|Overall Study||42
9052868|NCT03544216|10112409|FG000|NOT COMPLETED|Overall Study||0
9052869|NCT03544216|10112410|FG001|NOT COMPLETED|Overall Study||0
9052870|NCT03544307|10112419|FG000|STARTED|Overall Study||10
9052871|NCT03544307|10112420|FG001|STARTED|Overall Study||10
9052872|NCT03544307|10112419|FG000|COMPLETED|Overall Study||10
9052873|NCT03544307|10112420|FG001|COMPLETED|Overall Study||10
9052874|NCT03544307|10112419|FG000|NOT COMPLETED|Overall Study||0
9052875|NCT03544307|10112420|FG001|NOT COMPLETED|Overall Study||0
9052876|NCT03544333|10112428|FG000|STARTED|Overall Study||3
9052877|NCT03544333|10112429|FG001|STARTED|Overall Study||2
9052878|NCT03544333|10112428|FG000|COMPLETED|Overall Study||2
9052879|NCT03544333|10112429|FG001|COMPLETED|Overall Study||2
9052880|NCT03544333|10112428|FG000|NOT COMPLETED|Overall Study||1
9052881|NCT03544333|10112429|FG001|NOT COMPLETED|Overall Study||0
9052882|NCT03544879|10112437|FG000|STARTED|Overall Study||22
9052883|NCT03544879|10112438|FG001|STARTED|Overall Study||24
9052884|NCT03544879|10112437|FG000|Completed Follow-up Physical Assessment|Overall Study||20
9052885|NCT03544879|10112438|FG001|Completed Follow-up Physical Assessment|Overall Study||21
9052886|NCT03544879|10112437|FG000|COMPLETED|Overall Study||22
9052887|NCT03544879|10112438|FG001|COMPLETED|Overall Study||23
9052888|NCT03544879|10112437|FG000|NOT COMPLETED|Overall Study||0
9052889|NCT03544879|10112438|FG001|NOT COMPLETED|Overall Study||1
9052890|NCT03545165|10112446|FG000|STARTED|Overall Study||6
9052891|NCT03545165|10112446|FG000|COMPLETED|Overall Study||6
9052892|NCT03545165|10112446|FG000|NOT COMPLETED|Overall Study||0
9052893|NCT03545412|10112450|FG000|STARTED|Overall Study||25
9052894|NCT03545412|10112450|FG000|COMPLETED|Overall Study||25
9052895|NCT03545412|10112450|FG000|NOT COMPLETED|Overall Study||0
9052896|NCT03545503|10112456|FG000|STARTED|Overall Study||208
9052897|NCT03545503|10112457|FG001|STARTED|Overall Study||220
9052898|NCT03545503|10112456|FG000|COMPLETED|Overall Study||194
9052899|NCT03545503|10112457|FG001|COMPLETED|Overall Study||204
9052900|NCT03545503|10112456|FG000|NOT COMPLETED|Overall Study||14
9052901|NCT03545503|10112457|FG001|NOT COMPLETED|Overall Study||16
9052902|NCT03545893|10112465|FG000|STARTED|Overall Study||35
9052903|NCT03545893|10112466|FG001|STARTED|Overall Study||35
9052904|NCT03545893|10112465|FG000|COMPLETED|Overall Study||35
9052905|NCT03545893|10112466|FG001|COMPLETED|Overall Study||35
9052906|NCT03545893|10112465|FG000|NOT COMPLETED|Overall Study||0
9052907|NCT03545893|10112466|FG001|NOT COMPLETED|Overall Study||0
9052908|NCT03545984|10112474|FG000|STARTED|Overall Study||24
9052909|NCT03545984|10112475|FG001|STARTED|Overall Study||24
9052910|NCT03545984|10112474|FG000|COMPLETED|Overall Study||13
9052911|NCT03545984|10112475|FG001|COMPLETED|Overall Study||15
9052912|NCT03545984|10112474|FG000|NOT COMPLETED|Overall Study||11
9052913|NCT03545984|10112475|FG001|NOT COMPLETED|Overall Study||9
9052914|NCT03546270|10112483|FG000|STARTED|Overall Study||52
9052915|NCT03546270|10112484|FG001|STARTED|Overall Study||48
9052916|NCT03546270|10112483|FG000|COMPLETED|Overall Study||52
9052917|NCT03546270|10112484|FG001|COMPLETED|Overall Study||48
9052918|NCT03546270|10112483|FG000|NOT COMPLETED|Overall Study||0
9052919|NCT03546270|10112484|FG001|NOT COMPLETED|Overall Study||0
9052920|NCT03546491|10112490|FG000|STARTED|Overall Study||32
9052921|NCT03546491|10112490|FG000|Recieved Test Product 1|Overall Study||32
9052922|NCT03546491|10112490|FG000|Received Test Product 2|Overall Study||32
9052923|NCT03546491|10112490|FG000|COMPLETED|Overall Study||30
9052924|NCT03546491|10112490|FG000|NOT COMPLETED|Overall Study||2
9052925|NCT03546621|10112504|FG000|STARTED|Overall Study||28
9052926|NCT03546621|10112505|FG001|STARTED|Overall Study||32
9052927|NCT03546621|10112506|FG002|STARTED|Overall Study||30
9052928|NCT03546621|10112507|FG003|STARTED|Overall Study|2 patients from Tenofovir only group withdrew from the study before treatment.|28
9052929|NCT03546621|10112504|FG000|COMPLETED|Overall Study||28
9052930|NCT03546621|10112505|FG001|COMPLETED|Overall Study||29
9052931|NCT03546621|10112506|FG002|COMPLETED|Overall Study||28
9052932|NCT03546621|10112507|FG003|COMPLETED|Overall Study||25
9052933|NCT03546621|10112504|FG000|NOT COMPLETED|Overall Study||0
9052934|NCT03546621|10112505|FG001|NOT COMPLETED|Overall Study||3
9052935|NCT03546621|10112506|FG002|NOT COMPLETED|Overall Study||2
9052936|NCT03546621|10112507|FG003|NOT COMPLETED|Overall Study||3
9052937|NCT03546647|10112517|FG000|STARTED|Overall Study||18
9052938|NCT03546647|10112518|FG001|STARTED|Overall Study|34|17
9052939|NCT03546647|10112517|FG000|COMPLETED|Overall Study||17
9052940|NCT03546647|10112518|FG001|COMPLETED|Overall Study||17
8703671|NCT00924053|9749374|FG001|COMPLETED|Overall Study||6
8703672|NCT00924053|9749375|FG002|COMPLETED|Overall Study||6
8703673|NCT00924053|9749376|FG003|COMPLETED|Overall Study||6
9052941|NCT03546647|10112517|FG000|NOT COMPLETED|Overall Study||1
9052942|NCT03546647|10112518|FG001|NOT COMPLETED|Overall Study||0
9052943|NCT03546816|10112526|FG000|STARTED|Overall Study||142
9052944|NCT03546816|10112527|FG001|STARTED|Overall Study||143
9052945|NCT03546816|10112526|FG000|COMPLETED|Overall Study||121
9052946|NCT03546816|10112527|FG001|COMPLETED|Overall Study||124
9052947|NCT03546816|10112526|FG000|NOT COMPLETED|Overall Study||21
9052948|NCT03546816|10112527|FG001|NOT COMPLETED|Overall Study||19
9052949|NCT03546842|10112535|FG000|STARTED|Overall Study||201
9052950|NCT03546842|10112535|FG000|Vaccination 1|Overall Study||200
9052951|NCT03546842|10112535|FG000|Vaccination 2|Overall Study||200
9052952|NCT03546842|10112535|FG000|Vaccination 3|Overall Study||198
9052953|NCT03546842|10112535|FG000|COMPLETED|Overall Study||198
9052954|NCT03546842|10112535|FG000|NOT COMPLETED|Overall Study||3
9052955|NCT03547154|10112541|FG000|STARTED|Overall Study||173
9052956|NCT03547154|10112542|FG001|STARTED|Overall Study||171
9052957|NCT03547154|10112541|FG000|COMPLETED|Overall Study||50
9052958|NCT03547154|10112542|FG001|COMPLETED|Overall Study||55
8703674|NCT00924053|9749373|FG000|NOT COMPLETED|Overall Study||0
9052959|NCT03547154|10112541|FG000|NOT COMPLETED|Overall Study||123
9052960|NCT03547154|10112542|FG001|NOT COMPLETED|Overall Study||116
9052961|NCT03547167|10112550|FG000|STARTED|Overall Study||1135
9052962|NCT03547167|10112551|FG001|STARTED|Overall Study||380
9052963|NCT03547167|10112550|FG000|Vaccination 1 - (V114 or Prevnar 13™, Day 1)|Overall Study||1133
9052964|NCT03547167|10112551|FG001|Vaccination 1 - (V114 or Prevnar 13™, Day 1)|Overall Study||379
9052965|NCT03547167|10112550|FG000|Vaccination 2 - (PNEUMOVAX™23, Month 6)|Overall Study||1035
9052966|NCT03547167|10112551|FG001|Vaccination 2 - (PNEUMOVAX™23, Month 6)|Overall Study||346
9052967|NCT03547167|10112550|FG000|COMPLETED|Overall Study||1038
9052968|NCT03547167|10112551|FG001|COMPLETED|Overall Study||350
9052969|NCT03547167|10112550|FG000|NOT COMPLETED|Overall Study||97
9052970|NCT03547167|10112551|FG001|NOT COMPLETED|Overall Study||30
9052971|NCT03547531|10112563|FG000|STARTED|Overall Study||62
9052972|NCT03547531|10112564|FG001|STARTED|Overall Study||62
9052973|NCT03547531|10112563|FG000|COMPLETED|Overall Study||60
9052974|NCT03547531|10112564|FG001|COMPLETED|Overall Study||58
9052975|NCT03547531|10112563|FG000|NOT COMPLETED|Overall Study||2
9052976|NCT03547531|10112564|FG001|NOT COMPLETED|Overall Study||4
9052977|NCT03547583|10112573|FG000|STARTED|Overall Study||263
9052978|NCT03547583|10112574|FG001|STARTED|Overall Study||264
9052979|NCT03547583|10112575|FG002|STARTED|Overall Study||262
9052980|NCT03547583|10112573|FG000|Treated|Overall Study||262
9052981|NCT03547583|10112574|FG001|Treated|Overall Study||264
9052982|NCT03547583|10112575|FG002|Treated|Overall Study||262
9052983|NCT03547583|10112573|FG000|COMPLETED|Overall Study||218
9052984|NCT03547583|10112574|FG001|COMPLETED|Overall Study||224
9052985|NCT03547583|10112575|FG002|COMPLETED|Overall Study||230
9052986|NCT03547583|10112573|FG000|NOT COMPLETED|Overall Study||45
9052987|NCT03547583|10112574|FG001|NOT COMPLETED|Overall Study||40
9052988|NCT03547583|10112575|FG002|NOT COMPLETED|Overall Study||32
9052989|NCT03547635|10112589|FG000|STARTED|Overall Study||41
9052990|NCT03547635|10112590|FG001|STARTED|Overall Study||38
9052991|NCT03547635|10112591|FG002|STARTED|Overall Study||37
9052992|NCT03547635|10112589|FG000|COMPLETED|Overall Study||33
9052993|NCT03547635|10112590|FG001|COMPLETED|Overall Study||31
9052994|NCT03547635|10112591|FG002|COMPLETED|Overall Study||29
9052995|NCT03547635|10112589|FG000|NOT COMPLETED|Overall Study||8
9052996|NCT03547635|10112590|FG001|NOT COMPLETED|Overall Study||7
9052997|NCT03547635|10112591|FG002|NOT COMPLETED|Overall Study||8
9052998|NCT03547687|10112599|FG000|STARTED|Overall Study||9
9052999|NCT03547687|10112599|FG000|COMPLETED|Overall Study||7
9053000|NCT03547687|10112599|FG000|NOT COMPLETED|Overall Study||2
9053001|NCT03548337|10112605|FG000|STARTED|Infant Series||151
9053002|NCT03548337|10112606|FG001|STARTED|Infant Series||150
9053003|NCT03548337|10112605|FG000|Vaccination 1|Infant Series||150
9053004|NCT03548337|10112606|FG001|Vaccination 1|Infant Series||150
9053005|NCT03548337|10112605|FG000|Vaccination 2|Infant Series||144
9053006|NCT03548337|10112606|FG001|Vaccination 2|Infant Series||144
9053007|NCT03548337|10112605|FG000|Vaccination 3|Infant Series||144
9053008|NCT03548337|10112606|FG001|Vaccination 3|Infant Series||141
9053009|NCT03548337|10112605|FG000|COMPLETED|Infant Series||139
9053010|NCT03548337|10112606|FG001|COMPLETED|Infant Series||139
9053011|NCT03548337|10112605|FG000|NOT COMPLETED|Infant Series||12
9053012|NCT03548337|10112606|FG001|NOT COMPLETED|Infant Series||11
9053013|NCT03548337|10112605|FG000|STARTED|Toddler Dose||139
9053014|NCT03548337|10112606|FG001|STARTED|Toddler Dose||139
9053015|NCT03548337|10112605|FG000|Vaccination 4|Toddler Dose||139
9053016|NCT03548337|10112606|FG001|Vaccination 4|Toddler Dose||139
9053017|NCT03548337|10112605|FG000|COMPLETED|Toddler Dose||138
9053018|NCT03548337|10112606|FG001|COMPLETED|Toddler Dose||138
9053019|NCT03548337|10112605|FG000|NOT COMPLETED|Toddler Dose||1
9053020|NCT03548337|10112606|FG001|NOT COMPLETED|Toddler Dose||1
9053021|NCT03548935|10112620|FG000|STARTED|Overall Study||1306
9053022|NCT03548935|10112621|FG001|STARTED|Overall Study||655
9053023|NCT03548935|10112620|FG000|Full Analysis Set (FAS)|Overall Study||1306
9053024|NCT03548935|10112621|FG001|Full Analysis Set (FAS)|Overall Study||655
9053025|NCT03548935|10112620|FG000|Safety Analysis Set (SAS)|Overall Study||1306
9053026|NCT03548935|10112621|FG001|Safety Analysis Set (SAS)|Overall Study||655
9053027|NCT03548935|10112620|FG000|COMPLETED|Overall Study||1240
9053028|NCT03548935|10112621|FG001|COMPLETED|Overall Study||609
9053029|NCT03548935|10112620|FG000|NOT COMPLETED|Overall Study||66
9053030|NCT03548935|10112621|FG001|NOT COMPLETED|Overall Study||46
9053031|NCT03549117|10112629|FG000|STARTED|Overall Study||70
9053032|NCT03549117|10112630|FG001|STARTED|Overall Study||70
9053033|NCT03549117|10112629|FG000|COMPLETED|Overall Study||69
9053034|NCT03549117|10112630|FG001|COMPLETED|Overall Study||70
9053035|NCT03549117|10112629|FG000|NOT COMPLETED|Overall Study||1
9053036|NCT03549117|10112630|FG001|NOT COMPLETED|Overall Study||0
9053037|NCT03549130|10112638|FG000|STARTED|Overall Study||64
9053038|NCT03549130|10112639|FG001|STARTED|Overall Study||66
9053039|NCT03549130|10112638|FG000|COMPLETED|Overall Study||64
9053040|NCT03549130|10112639|FG001|COMPLETED|Overall Study||64
9053041|NCT03549130|10112638|FG000|NOT COMPLETED|Overall Study||0
9053042|NCT03549130|10112639|FG001|NOT COMPLETED|Overall Study||2
9053043|NCT03549234|10112649|FG000|STARTED|Overall Study||50
9053044|NCT03549234|10112650|FG001|STARTED|Overall Study||50
9053045|NCT03549234|10112649|FG000|COMPLETED|Overall Study||50
9053046|NCT03549234|10112650|FG001|COMPLETED|Overall Study||50
9053047|NCT03549234|10112649|FG000|NOT COMPLETED|Overall Study||0
9053048|NCT03549234|10112650|FG001|NOT COMPLETED|Overall Study||0
9053049|NCT03549338|10112659|FG000|STARTED|Overall Study||1
9053050|NCT03549338|10112660|FG001|STARTED|Overall Study||1
9053051|NCT03549338|10112661|FG002|STARTED|Overall Study||0
9053052|NCT03549338|10112659|FG000|COMPLETED|Overall Study||0
9053053|NCT03549338|10112660|FG001|COMPLETED|Overall Study|Patient crossed-over to Sym004 at the EOC1 per Sponsor decision following trial termination.|0
9053054|NCT03549338|10112661|FG002|COMPLETED|Overall Study||0
9053055|NCT03549338|10112659|FG000|NOT COMPLETED|Overall Study||1
9053056|NCT03549338|10112660|FG001|NOT COMPLETED|Overall Study||1
9053057|NCT03549338|10112661|FG002|NOT COMPLETED|Overall Study||0
9053058|NCT03549429|10112669|FG000|STARTED|Overall Study||81
9053059|NCT03549429|10112670|FG001|STARTED|Overall Study||78
9053060|NCT03549429|10112669|FG000|COMPLETED|Overall Study||76
9053061|NCT03549429|10112670|FG001|COMPLETED|Overall Study||75
9053062|NCT03549429|10112669|FG000|NOT COMPLETED|Overall Study||5
9053063|NCT03549429|10112670|FG001|NOT COMPLETED|Overall Study||3
9053064|NCT03549598|10112678|FG000|STARTED|Overall Study||15
9053065|NCT03549598|10112678|FG000|COMPLETED|Overall Study||15
9053066|NCT03549598|10112678|FG000|NOT COMPLETED|Overall Study||0
9053067|NCT03550066|10112686|FG000|STARTED|Overall Study||49
9053068|NCT03550066|10112687|FG001|STARTED|Overall Study||41
9053069|NCT03550066|10112686|FG000|COMPLETED|Overall Study||49
9053070|NCT03550066|10112687|FG001|COMPLETED|Overall Study||41
9053071|NCT03550066|10112686|FG000|NOT COMPLETED|Overall Study||0
9053072|NCT03550066|10112687|FG001|NOT COMPLETED|Overall Study||0
9053073|NCT03550209|10112697|FG000|STARTED|Overall Study||12
9053074|NCT03550209|10112698|FG001|STARTED|Overall Study||12
9053075|NCT03550209|10112699|FG002|STARTED|Overall Study||13
9053076|NCT03550209|10112700|FG003|STARTED|Overall Study||35
9053077|NCT03550209|10112697|FG000|COMPLETED|Overall Study||11
9053078|NCT03550209|10112698|FG001|COMPLETED|Overall Study||9
9053079|NCT03550209|10112699|FG002|COMPLETED|Overall Study||11
9053080|NCT03550209|10112700|FG003|COMPLETED|Overall Study||31
9053081|NCT03550209|10112697|FG000|NOT COMPLETED|Overall Study||1
9053082|NCT03550209|10112698|FG001|NOT COMPLETED|Overall Study||3
9053083|NCT03550209|10112699|FG002|NOT COMPLETED|Overall Study||2
9053084|NCT03550209|10112700|FG003|NOT COMPLETED|Overall Study||4
9053085|NCT03550313|10112713|FG000|STARTED|Overall Study||192
9053086|NCT03550313|10112714|FG001|STARTED|Overall Study||187
9053087|NCT03550313|10112715|FG002|STARTED|Overall Study||186
9053088|NCT03550313|10112713|FG000|Vaccinated for Dose 1|Overall Study||171
9053089|NCT03550313|10112714|FG001|Vaccinated for Dose 1|Overall Study||147
9053090|NCT03550313|10112715|FG002|Vaccinated for Dose 1|Overall Study||166
9053091|NCT03550313|10112713|FG000|Vaccinated for Dose 2|Overall Study||159
9053092|NCT03550313|10112714|FG001|Vaccinated for Dose 2|Overall Study||135
9053093|NCT03550313|10112715|FG002|Vaccinated for Dose 2|Overall Study||153
9053094|NCT03550313|10112713|FG000|Vaccinated for Dose 3|Overall Study||151
9053095|NCT03550313|10112714|FG001|Vaccinated for Dose 3|Overall Study||127
9053096|NCT03550313|10112715|FG002|Vaccinated for Dose 3|Overall Study||146
9053097|NCT03550313|10112713|FG000|COMPLETED|Overall Study||95
9053098|NCT03550313|10112714|FG001|COMPLETED|Overall Study||77
9053099|NCT03550313|10112715|FG002|COMPLETED|Overall Study||72
9053100|NCT03550313|10112713|FG000|NOT COMPLETED|Overall Study||97
9053101|NCT03550313|10112714|FG001|NOT COMPLETED|Overall Study||110
9053102|NCT03550313|10112715|FG002|NOT COMPLETED|Overall Study||114
9053103|NCT03550378|10112726|FG000|STARTED|Overall Study||20
9053104|NCT03550378|10112727|FG001|STARTED|Overall Study||21
9053105|NCT03550378|10112726|FG000|COMPLETED|Overall Study||20
9053106|NCT03550378|10112727|FG001|COMPLETED|Overall Study||20
9053107|NCT03550378|10112726|FG000|NOT COMPLETED|Overall Study||0
9053108|NCT03550378|10112727|FG001|NOT COMPLETED|Overall Study||1
9053109|NCT03550989|10112738|FG000|STARTED|Overall Study||190
9053110|NCT03550989|10112739|FG001|STARTED|Overall Study||74
9053111|NCT03550989|10112740|FG002|STARTED|Overall Study||77
9053112|NCT03550989|10112741|FG003|STARTED|Overall Study||60
9053113|NCT03550989|10112738|FG000|COMPLETED|Overall Study||188
9053114|NCT03550989|10112739|FG001|COMPLETED|Overall Study||73
9053115|NCT03550989|10112740|FG002|COMPLETED|Overall Study||76
9053116|NCT03550989|10112741|FG003|COMPLETED|Overall Study||60
9053117|NCT03550989|10112738|FG000|NOT COMPLETED|Overall Study||2
9053118|NCT03550989|10112739|FG001|NOT COMPLETED|Overall Study||1
9053119|NCT03550989|10112740|FG002|NOT COMPLETED|Overall Study||1
9053120|NCT03550989|10112741|FG003|NOT COMPLETED|Overall Study||0
9053121|NCT03551730|10112759|FG000|STARTED|Overall Study||9
9053122|NCT03551730|10112760|FG001|STARTED|Overall Study||6
9053123|NCT03551730|10112761|FG002|STARTED|Overall Study||6
9053124|NCT03551730|10112762|FG003|STARTED|Overall Study||6
9053125|NCT03551730|10112759|FG000|COMPLETED|Overall Study||8
9053126|NCT03551730|10112760|FG001|COMPLETED|Overall Study||6
9053127|NCT03551730|10112761|FG002|COMPLETED|Overall Study||6
9053128|NCT03551730|10112762|FG003|COMPLETED|Overall Study||6
9053129|NCT03551730|10112759|FG000|NOT COMPLETED|Overall Study||1
9053130|NCT03551730|10112760|FG001|NOT COMPLETED|Overall Study||0
9053131|NCT03551730|10112761|FG002|NOT COMPLETED|Overall Study||0
9053132|NCT03551730|10112762|FG003|NOT COMPLETED|Overall Study||0
9053133|NCT03551743|10112776|FG000|STARTED|Overall Study||10
9053134|NCT03551743|10112777|FG001|STARTED|Overall Study||6
9053135|NCT03551743|10112778|FG002|STARTED|Overall Study||6
9053136|NCT03551743|10112779|FG003|STARTED|Overall Study||6
9053137|NCT03551743|10112776|FG000|COMPLETED|Overall Study||8
9053138|NCT03551743|10112777|FG001|COMPLETED|Overall Study||6
9053139|NCT03551743|10112778|FG002|COMPLETED|Overall Study||6
9053140|NCT03551743|10112779|FG003|COMPLETED|Overall Study||6
9053141|NCT03551743|10112776|FG000|NOT COMPLETED|Overall Study||2
9053142|NCT03551743|10112777|FG001|NOT COMPLETED|Overall Study||0
9053143|NCT03551743|10112778|FG002|NOT COMPLETED|Overall Study||0
9053144|NCT03551743|10112779|FG003|NOT COMPLETED|Overall Study||0
9053145|NCT03551821|10112789|FG000|STARTED|Overall Study||1
9053146|NCT03551821|10112789|FG000|COMPLETED|Overall Study||1
9053147|NCT03551821|10112789|FG000|NOT COMPLETED|Overall Study||0
9053148|NCT03552198|10112797|FG000|STARTED|Overall Study||83
9053149|NCT03552198|10112798|FG001|STARTED|Overall Study||84
9053150|NCT03552198|10112799|FG002|STARTED|Overall Study||24
9053151|NCT03552198|10112800|FG003|STARTED|Overall Study||34
9053152|NCT03552198|10112797|FG000|Final Questionnaire 4 Weeks Follow-up|Overall Study||34
8703675|NCT00924053|9749374|FG001|NOT COMPLETED|Overall Study||0
8703676|NCT00924053|9749375|FG002|NOT COMPLETED|Overall Study||0
8703677|NCT00924053|9749376|FG003|NOT COMPLETED|Overall Study||0
8703678|NCT00924066|9749386|FG000|STARTED|Overall Study||41
9053153|NCT03552198|10112798|FG001|Final Questionnaire 4 Weeks Follow-up|Overall Study||29
9053154|NCT03552198|10112799|FG002|Final Questionnaire 4 Weeks Follow-up|Overall Study||7
9053155|NCT03552198|10112800|FG003|Final Questionnaire 4 Weeks Follow-up|Overall Study||12
9053156|NCT03552198|10112797|FG000|COMPLETED|Overall Study||34
9053157|NCT03552198|10112798|FG001|COMPLETED|Overall Study||29
9053158|NCT03552198|10112799|FG002|COMPLETED|Overall Study||7
9053159|NCT03552198|10112800|FG003|COMPLETED|Overall Study||12
9053160|NCT03552198|10112797|FG000|NOT COMPLETED|Overall Study||49
9053161|NCT03552198|10112798|FG001|NOT COMPLETED|Overall Study||55
9053162|NCT03552198|10112799|FG002|NOT COMPLETED|Overall Study||17
9053163|NCT03552198|10112800|FG003|NOT COMPLETED|Overall Study||22
9053164|NCT03552289|10112812|FG000|STARTED|Overall Study||102
9053165|NCT03552289|10112813|FG001|STARTED|Overall Study||109
9053166|NCT03552289|10112812|FG000|COMPLETED|Overall Study||101
9053167|NCT03552289|10112813|FG001|COMPLETED|Overall Study||106
9053168|NCT03552289|10112812|FG000|NOT COMPLETED|Overall Study||1
9053169|NCT03552289|10112813|FG001|NOT COMPLETED|Overall Study||3
9053170|NCT03552523|10112819|FG000|STARTED|Overall Study||5
9053171|NCT03552523|10112820|FG001|STARTED|Overall Study||2
9053172|NCT03552523|10112819|FG000|COMPLETED|Overall Study||4
9053173|NCT03552523|10112820|FG001|COMPLETED|Overall Study||1
9053174|NCT03552523|10112819|FG000|NOT COMPLETED|Overall Study||1
9053175|NCT03552523|10112820|FG001|NOT COMPLETED|Overall Study||1
9053176|NCT03552536|10112829|FG000|STARTED|Overall Study||5
9053177|NCT03552536|10112830|FG001|STARTED|Overall Study||0
9053178|NCT03552536|10112831|FG002|STARTED|Overall Study||0
9053179|NCT03552536|10112829|FG000|COMPLETED|Overall Study||5
9053180|NCT03552536|10112830|FG001|COMPLETED|Overall Study||0
8703679|NCT00924066|9749386|FG000|COMPLETED|Overall Study||41
8703680|NCT00924066|9749386|FG000|NOT COMPLETED|Overall Study||0
8703681|NCT00924118|9749393|FG000|STARTED|Overall Study||15
8703682|NCT00924118|9749394|FG001|STARTED|Overall Study||15
8703683|NCT00924118|9749393|FG000|COMPLETED|Overall Study||15
8703684|NCT00924118|9749394|FG001|COMPLETED|Overall Study||15
8703685|NCT00924118|9749393|FG000|NOT COMPLETED|Overall Study||0
8703686|NCT00924118|9749394|FG001|NOT COMPLETED|Overall Study||0
9053181|NCT03552536|10112831|FG002|COMPLETED|Overall Study||0
9053182|NCT03552536|10112829|FG000|NOT COMPLETED|Overall Study||0
9053183|NCT03552536|10112830|FG001|NOT COMPLETED|Overall Study||0
9053184|NCT03552536|10112831|FG002|NOT COMPLETED|Overall Study||0
9053185|NCT03552549|10112839|FG000|STARTED|Overall Study||63
9053186|NCT03552549|10112840|FG001|STARTED|Overall Study||63
9053187|NCT03552549|10112839|FG000|Treated|Overall Study||62
9053188|NCT03552549|10112840|FG001|Treated|Overall Study||62
9053189|NCT03552549|10112839|FG000|COMPLETED|Overall Study||10
9053190|NCT03552549|10112840|FG001|COMPLETED|Overall Study||11
9053191|NCT03552549|10112839|FG000|NOT COMPLETED|Overall Study||53
9053192|NCT03552549|10112840|FG001|NOT COMPLETED|Overall Study||52
9053193|NCT03552757|10112849|FG000|STARTED|Overall Study||403
9053194|NCT03552757|10112850|FG001|STARTED|Overall Study||404
9053195|NCT03552757|10112851|FG002|STARTED|Overall Study||403
9053196|NCT03552757|10112849|FG000|Exposed|Overall Study||402
9053197|NCT03552757|10112850|FG001|Exposed|Overall Study||403
9053198|NCT03552757|10112851|FG002|Exposed|Overall Study||402
9053199|NCT03552757|10112849|FG000|Full Analysis Set (FAS)|Overall Study||403
9053200|NCT03552757|10112850|FG001|Full Analysis Set (FAS)|Overall Study||404
9053201|NCT03552757|10112851|FG002|Full Analysis Set (FAS)|Overall Study||403
9053202|NCT03552757|10112849|FG000|Safety Analysis Set (SAS)|Overall Study||402
9053203|NCT03552757|10112850|FG001|Safety Analysis Set (SAS)|Overall Study||403
9053204|NCT03552757|10112851|FG002|Safety Analysis Set (SAS)|Overall Study||402
9053205|NCT03552757|10112849|FG000|COMPLETED|Overall Study||390
9053206|NCT03552757|10112850|FG001|COMPLETED|Overall Study||391
9053207|NCT03552757|10112851|FG002|COMPLETED|Overall Study||383
9053208|NCT03552757|10112849|FG000|NOT COMPLETED|Overall Study||13
9053209|NCT03552757|10112850|FG001|NOT COMPLETED|Overall Study||13
9053210|NCT03552757|10112851|FG002|NOT COMPLETED|Overall Study||20
9053211|NCT03553758|10112862|FG000|STARTED|Overall Study||16
9053212|NCT03553758|10112862|FG000|Completed Screening Visit|Overall Study||16
9053213|NCT03553758|10112862|FG000|COMPLETED|Overall Study||15
9053214|NCT03553758|10112862|FG000|NOT COMPLETED|Overall Study||1
9053215|NCT03553823|10112870|FG000|STARTED|Overall Study||20
9053216|NCT03553823|10112871|FG001|STARTED|Overall Study||20
9053217|NCT03553823|10112870|FG000|COMPLETED|Overall Study||20
9053218|NCT03553823|10112871|FG001|COMPLETED|Overall Study||19
9053219|NCT03553823|10112870|FG000|NOT COMPLETED|Overall Study||0
9053220|NCT03553823|10112871|FG001|NOT COMPLETED|Overall Study||1
9053221|NCT03553940|10112879|FG000|STARTED|Overall Study||22
9053222|NCT03553940|10112880|FG001|STARTED|Overall Study||21
9053223|NCT03553940|10112879|FG000|COMPLETED|Overall Study||22
9053224|NCT03553940|10112880|FG001|COMPLETED|Overall Study||21
9053225|NCT03553940|10112879|FG000|NOT COMPLETED|Overall Study||0
9053226|NCT03553940|10112880|FG001|NOT COMPLETED|Overall Study||0
9053227|NCT03554005|10112892|FG000|STARTED|Overall Study||1
9053228|NCT03554005|10112893|FG001|STARTED|Overall Study||2
9053229|NCT03554005|10112894|FG002|STARTED|Overall Study||2
9053230|NCT03554005|10112895|FG003|STARTED|Overall Study||2
9053231|NCT03554005|10112896|FG004|STARTED|Overall Study||11
9053232|NCT03554005|10112897|FG005|STARTED|Overall Study||11
9053233|NCT03554005|10112892|FG000|COMPLETED|Overall Study||0
9053234|NCT03554005|10112893|FG001|COMPLETED|Overall Study||1
9053235|NCT03554005|10112894|FG002|COMPLETED|Overall Study||1
9053236|NCT03554005|10112895|FG003|COMPLETED|Overall Study||1
9053237|NCT03554005|10112896|FG004|COMPLETED|Overall Study||5
9053238|NCT03554005|10112897|FG005|COMPLETED|Overall Study||0
9053239|NCT03554005|10112892|FG000|NOT COMPLETED|Overall Study||1
9053240|NCT03554005|10112893|FG001|NOT COMPLETED|Overall Study||1
9053241|NCT03554005|10112894|FG002|NOT COMPLETED|Overall Study||1
9053242|NCT03554005|10112895|FG003|NOT COMPLETED|Overall Study||1
9053243|NCT03554005|10112896|FG004|NOT COMPLETED|Overall Study||6
9053244|NCT03554005|10112897|FG005|NOT COMPLETED|Overall Study||11
9053245|NCT03554018|10112913|FG000|STARTED|Overall Study||60
9053246|NCT03554018|10112914|FG001|STARTED|Overall Study||60
9053247|NCT03554018|10112913|FG000|COMPLETED|Overall Study||57
9053248|NCT03554018|10112914|FG001|COMPLETED|Overall Study||53
9053249|NCT03554018|10112913|FG000|NOT COMPLETED|Overall Study||3
9053250|NCT03554018|10112914|FG001|NOT COMPLETED|Overall Study||7
9053251|NCT03554486|10112922|FG000|STARTED|Run-in Period (2 Weeks)||24
9053252|NCT03554486|10112923|FG001|STARTED|Run-in Period (2 Weeks)||0
9053253|NCT03554486|10112924|FG002|STARTED|Run-in Period (2 Weeks)||0
9053254|NCT03554486|10112922|FG000|COMPLETED|Run-in Period (2 Weeks)||21
9053255|NCT03554486|10112923|FG001|COMPLETED|Run-in Period (2 Weeks)||0
9053256|NCT03554486|10112924|FG002|COMPLETED|Run-in Period (2 Weeks)||0
9053257|NCT03554486|10112922|FG000|NOT COMPLETED|Run-in Period (2 Weeks)||3
9053258|NCT03554486|10112923|FG001|NOT COMPLETED|Run-in Period (2 Weeks)||0
9053259|NCT03554486|10112924|FG002|NOT COMPLETED|Run-in Period (2 Weeks)||0
9053260|NCT03554486|10112922|FG000|STARTED|Treatment Period 1 (2 Weeks)||0
9053261|NCT03554486|10112923|FG001|STARTED|Treatment Period 1 (2 Weeks)||11
9053262|NCT03554486|10112924|FG002|STARTED|Treatment Period 1 (2 Weeks)||10
9053263|NCT03554486|10112922|FG000|COMPLETED|Treatment Period 1 (2 Weeks)||0
9053264|NCT03554486|10112923|FG001|COMPLETED|Treatment Period 1 (2 Weeks)||10
9053265|NCT03554486|10112924|FG002|COMPLETED|Treatment Period 1 (2 Weeks)||9
9053266|NCT03554486|10112922|FG000|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
9053267|NCT03554486|10112923|FG001|NOT COMPLETED|Treatment Period 1 (2 Weeks)||1
9053268|NCT03554486|10112924|FG002|NOT COMPLETED|Treatment Period 1 (2 Weeks)||1
9053269|NCT03554486|10112922|FG000|STARTED|Treatment Period 2 (2 Weeks)||0
9053270|NCT03554486|10112923|FG001|STARTED|Treatment Period 2 (2 Weeks)||10
9053271|NCT03554486|10112924|FG002|STARTED|Treatment Period 2 (2 Weeks)||9
9053272|NCT03554486|10112922|FG000|COMPLETED|Treatment Period 2 (2 Weeks)||0
9053273|NCT03554486|10112923|FG001|COMPLETED|Treatment Period 2 (2 Weeks)||10
9053274|NCT03554486|10112924|FG002|COMPLETED|Treatment Period 2 (2 Weeks)||9
9053275|NCT03554486|10112922|FG000|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
9053276|NCT03554486|10112923|FG001|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
9053277|NCT03554486|10112924|FG002|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
9053278|NCT03554629|10112931|FG000|STARTED|Overall Study|8 filterlines per participant for four scripted activities with supplemental oxygen|29
9053279|NCT03554629|10112931|FG000|COMPLETED|Overall Study|8 filterlines (CCSF) per participate for four scripted activities with supplemental oxygen.|23
9053280|NCT03554629|10112931|FG000|NOT COMPLETED|Overall Study||6
9053281|NCT03554746|10112961|FG000|STARTED|Overall Study||24
9053282|NCT03554746|10112962|FG001|STARTED|Overall Study||24
9053283|NCT03554746|10112961|FG000|COMPLETED|Overall Study||24
9053284|NCT03554746|10112962|FG001|COMPLETED|Overall Study||24
9053285|NCT03554746|10112961|FG000|NOT COMPLETED|Overall Study||0
9053286|NCT03554746|10112962|FG001|NOT COMPLETED|Overall Study||0
9053287|NCT03554772|10112972|FG000|STARTED|Overall Study||30
9053288|NCT03554772|10112973|FG001|STARTED|Overall Study||30
9053289|NCT03554772|10112974|FG002|STARTED|Overall Study||29
9053290|NCT03554772|10112975|FG003|STARTED|Overall Study||31
9053291|NCT03554772|10112972|FG000|Completed Treatment Period (8 Hours Post Dose)|Overall Study||30
9053292|NCT03554772|10112973|FG001|Completed Treatment Period (8 Hours Post Dose)|Overall Study||30
9053293|NCT03554772|10112974|FG002|Completed Treatment Period (8 Hours Post Dose)|Overall Study||29
9053294|NCT03554772|10112975|FG003|Completed Treatment Period (8 Hours Post Dose)|Overall Study||31
9053295|NCT03554772|10112972|FG000|COMPLETED|Overall Study||30
9053296|NCT03554772|10112973|FG001|COMPLETED|Overall Study||30
9053297|NCT03554772|10112974|FG002|COMPLETED|Overall Study||29
9053298|NCT03554772|10112975|FG003|COMPLETED|Overall Study||29
8703687|NCT00924209|9749400|FG000|STARTED|Overall Study||7
9053299|NCT03554772|10112972|FG000|NOT COMPLETED|Overall Study||0
9053300|NCT03554772|10112973|FG001|NOT COMPLETED|Overall Study||0
9053301|NCT03554772|10112974|FG002|NOT COMPLETED|Overall Study||0
9053302|NCT03554772|10112975|FG003|NOT COMPLETED|Overall Study||2
9053303|NCT03554954|10112985|FG000|STARTED|Overall Study||108
9053304|NCT03554954|10112985|FG000|COMPLETED|Overall Study||108
9053305|NCT03554954|10112985|FG000|NOT COMPLETED|Overall Study||0
9053306|NCT03555266|10112995|FG000|STARTED|Overall Study||32
9053307|NCT03555266|10112996|FG001|STARTED|Overall Study||31
9053308|NCT03555266|10112995|FG000|COMPLETED|Overall Study||26
9053309|NCT03555266|10112996|FG001|COMPLETED|Overall Study||27
9053310|NCT03555266|10112995|FG000|NOT COMPLETED|Overall Study||6
9053311|NCT03555266|10112996|FG001|NOT COMPLETED|Overall Study||4
9053312|NCT03555305|10113002|FG000|STARTED|Period 1||29
9053313|NCT03555305|10113003|FG001|STARTED|Period 1||29
9053314|NCT03555305|10113002|FG000|Received at Least 1 Dose of Study Drug|Period 1||29
9053315|NCT03555305|10113003|FG001|Received at Least 1 Dose of Study Drug|Period 1||29
9053316|NCT03555305|10113002|FG000|COMPLETED|Period 1||29
9053317|NCT03555305|10113003|FG001|COMPLETED|Period 1||27
9053318|NCT03555305|10113002|FG000|NOT COMPLETED|Period 1||0
9053319|NCT03555305|10113003|FG001|NOT COMPLETED|Period 1||2
9053320|NCT03555305|10113002|FG000|STARTED|Period 2||29
9053321|NCT03555305|10113003|FG001|STARTED|Period 2||27
9053322|NCT03555305|10113002|FG000|COMPLETED|Period 2||29
9053323|NCT03555305|10113003|FG001|COMPLETED|Period 2||27
9053324|NCT03555305|10113002|FG000|NOT COMPLETED|Period 2||0
9053325|NCT03555305|10113003|FG001|NOT COMPLETED|Period 2||0
9053326|NCT03555435|10113012|FG000|STARTED|Overall Study||28
9053327|NCT03555435|10113013|FG001|STARTED|Overall Study||27
9053328|NCT03555435|10113014|FG002|STARTED|Overall Study||26
9053329|NCT03555435|10113012|FG000|COMPLETED|Overall Study||11
9053330|NCT03555435|10113013|FG001|COMPLETED|Overall Study||8
9053331|NCT03555435|10113014|FG002|COMPLETED|Overall Study||18
9053332|NCT03555435|10113012|FG000|NOT COMPLETED|Overall Study||17
9053333|NCT03555435|10113013|FG001|NOT COMPLETED|Overall Study||19
9053334|NCT03555435|10113014|FG002|NOT COMPLETED|Overall Study||8
9053335|NCT03555565|10113022|FG000|STARTED|Overall Study||1026
9053336|NCT03555565|10113022|FG000|COMPLETED|Overall Study||1011
8703688|NCT00924209|9749400|FG000|COMPLETED|Overall Study||7
8703689|NCT00924209|9749400|FG000|NOT COMPLETED|Overall Study||0
9053337|NCT03555565|10113022|FG000|NOT COMPLETED|Overall Study||15
9053338|NCT03555890|10113030|FG000|STARTED|Part 1:Treatment Period 1 (3 Days)||12
9053339|NCT03555890|10113031|FG001|STARTED|Part 1:Treatment Period 1 (3 Days)||12
9053340|NCT03555890|10113032|FG002|STARTED|Part 1:Treatment Period 1 (3 Days)||0
9053341|NCT03555890|10113033|FG003|STARTED|Part 1:Treatment Period 1 (3 Days)||0
9053342|NCT03555890|10113030|FG000|COMPLETED|Part 1:Treatment Period 1 (3 Days)||12
9053343|NCT03555890|10113031|FG001|COMPLETED|Part 1:Treatment Period 1 (3 Days)||12
9053344|NCT03555890|10113032|FG002|COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
9053345|NCT03555890|10113033|FG003|COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
9053346|NCT03555890|10113030|FG000|NOT COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
9053347|NCT03555890|10113031|FG001|NOT COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
9053348|NCT03555890|10113032|FG002|NOT COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
9053349|NCT03555890|10113033|FG003|NOT COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
9053350|NCT03555890|10113030|FG000|STARTED|Part 1:Washout Period (at Least 5 Days)||12
9053351|NCT03555890|10113031|FG001|STARTED|Part 1:Washout Period (at Least 5 Days)||12
9053352|NCT03555890|10113032|FG002|STARTED|Part 1:Washout Period (at Least 5 Days)||0
9053353|NCT03555890|10113033|FG003|STARTED|Part 1:Washout Period (at Least 5 Days)||0
9053354|NCT03555890|10113030|FG000|COMPLETED|Part 1:Washout Period (at Least 5 Days)||12
9053355|NCT03555890|10113031|FG001|COMPLETED|Part 1:Washout Period (at Least 5 Days)||12
9053356|NCT03555890|10113032|FG002|COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
9053357|NCT03555890|10113033|FG003|COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
9053358|NCT03555890|10113030|FG000|NOT COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
9053359|NCT03555890|10113031|FG001|NOT COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
9053360|NCT03555890|10113032|FG002|NOT COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
9053361|NCT03555890|10113033|FG003|NOT COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
9053362|NCT03555890|10113030|FG000|STARTED|Part 1:Treatment Period 2 (10 Days)||12
9053363|NCT03555890|10113031|FG001|STARTED|Part 1:Treatment Period 2 (10 Days)||12
9053364|NCT03555890|10113032|FG002|STARTED|Part 1:Treatment Period 2 (10 Days)||0
9053365|NCT03555890|10113033|FG003|STARTED|Part 1:Treatment Period 2 (10 Days)||0
9053366|NCT03555890|10113030|FG000|COMPLETED|Part 1:Treatment Period 2 (10 Days)||12
9053367|NCT03555890|10113031|FG001|COMPLETED|Part 1:Treatment Period 2 (10 Days)||12
9053368|NCT03555890|10113032|FG002|COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
9053369|NCT03555890|10113033|FG003|COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
9053370|NCT03555890|10113030|FG000|NOT COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
9053371|NCT03555890|10113031|FG001|NOT COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
9053372|NCT03555890|10113032|FG002|NOT COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
9053373|NCT03555890|10113033|FG003|NOT COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
9053374|NCT03555890|10113030|FG000|STARTED|Part 2:Treatment Period 1 (3 Days)||0
9053375|NCT03555890|10113031|FG001|STARTED|Part 2:Treatment Period 1 (3 Days)||0
9053376|NCT03555890|10113032|FG002|STARTED|Part 2:Treatment Period 1 (3 Days)||24
9053377|NCT03555890|10113033|FG003|STARTED|Part 2:Treatment Period 1 (3 Days)||24
9053378|NCT03555890|10113030|FG000|COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
9053379|NCT03555890|10113031|FG001|COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
9053380|NCT03555890|10113032|FG002|COMPLETED|Part 2:Treatment Period 1 (3 Days)||24
9053381|NCT03555890|10113033|FG003|COMPLETED|Part 2:Treatment Period 1 (3 Days)||24
9053382|NCT03555890|10113030|FG000|NOT COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
9053383|NCT03555890|10113031|FG001|NOT COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
9053384|NCT03555890|10113032|FG002|NOT COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
9053385|NCT03555890|10113033|FG003|NOT COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
9053386|NCT03555890|10113030|FG000|STARTED|Part 2:Washout Period (at Least 5 Days)||0
9053387|NCT03555890|10113031|FG001|STARTED|Part 2:Washout Period (at Least 5 Days)||0
9053388|NCT03555890|10113032|FG002|STARTED|Part 2:Washout Period (at Least 5 Days)||24
9053389|NCT03555890|10113033|FG003|STARTED|Part 2:Washout Period (at Least 5 Days)||24
9053390|NCT03555890|10113030|FG000|COMPLETED|Part 2:Washout Period (at Least 5 Days)||0
9053391|NCT03555890|10113031|FG001|COMPLETED|Part 2:Washout Period (at Least 5 Days)||0
8703690|NCT00924287|9749404|FG000|STARTED|Overall Study||1
8703691|NCT00924287|9749404|FG000|COMPLETED|Overall Study||0
8703692|NCT00924287|9749404|FG000|NOT COMPLETED|Overall Study||1
8703693|NCT00924313|9749408|FG000|STARTED|Overall Study||40
8703694|NCT00924313|9749408|FG000|COMPLETED|Overall Study||39
8703695|NCT00924313|9749408|FG000|NOT COMPLETED|Overall Study||1
9053392|NCT03555890|10113032|FG002|COMPLETED|Part 2:Washout Period (at Least 5 Days)||24
9053393|NCT03555890|10113033|FG003|COMPLETED|Part 2:Washout Period (at Least 5 Days)||23
9053394|NCT03555890|10113030|FG000|NOT COMPLETED|Part 2:Washout Period (at Least 5 Days)||0
9053395|NCT03555890|10113031|FG001|NOT COMPLETED|Part 2:Washout Period (at Least 5 Days)||0
9053396|NCT03555890|10113032|FG002|NOT COMPLETED|Part 2:Washout Period (at Least 5 Days)||0
9053397|NCT03555890|10113033|FG003|NOT COMPLETED|Part 2:Washout Period (at Least 5 Days)||1
8703696|NCT00924352|9749412|FG000|STARTED|Overall Study||12
8703697|NCT00924352|9749413|FG001|STARTED|Overall Study||44
8703698|NCT00924352|9749412|FG000|COMPLETED|Overall Study||12
8703699|NCT00924352|9749413|FG001|COMPLETED|Overall Study||44
8703700|NCT00924352|9749412|FG000|NOT COMPLETED|Overall Study||0
8703701|NCT00924352|9749413|FG001|NOT COMPLETED|Overall Study||0
8703702|NCT00924404|9749422|FG000|STARTED|Overall Study||27
8703703|NCT00924404|9749423|FG001|STARTED|Overall Study||26
8703704|NCT00924404|9749422|FG000|COMPLETED|Overall Study||21
8703705|NCT00924404|9749423|FG001|COMPLETED|Overall Study||22
9053398|NCT03555890|10113030|FG000|STARTED|Part 2:Treatment Period 2 (10 Days)||0
9053399|NCT03555890|10113031|FG001|STARTED|Part 2:Treatment Period 2 (10 Days)||0
9053400|NCT03555890|10113032|FG002|STARTED|Part 2:Treatment Period 2 (10 Days)||24
8703706|NCT00924404|9749422|FG000|NOT COMPLETED|Overall Study||6
8703707|NCT00924404|9749423|FG001|NOT COMPLETED|Overall Study||4
8703708|NCT00924443|9749429|FG000|STARTED|Overall Study||69
8703709|NCT00924443|9749429|FG000|Full Analysis Set (Received Study Drug)|Overall Study||66
9053401|NCT03555890|10113033|FG003|STARTED|Part 2:Treatment Period 2 (10 Days)||23
9053402|NCT03555890|10113030|FG000|COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
9053403|NCT03555890|10113031|FG001|COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
9053404|NCT03555890|10113032|FG002|COMPLETED|Part 2:Treatment Period 2 (10 Days)||24
9053405|NCT03555890|10113033|FG003|COMPLETED|Part 2:Treatment Period 2 (10 Days)||23
9053406|NCT03555890|10113030|FG000|NOT COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
9053407|NCT03555890|10113031|FG001|NOT COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
9053408|NCT03555890|10113032|FG002|NOT COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
9053409|NCT03555890|10113033|FG003|NOT COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
9053410|NCT03556579|10113043|FG000|STARTED|Visit 1||16
9053411|NCT03556579|10113044|FG001|STARTED|Visit 1||14
9053412|NCT03556579|10113045|FG002|STARTED|Visit 1||14
9053413|NCT03556579|10113046|FG003|STARTED|Visit 1||16
9053414|NCT03556579|10113043|FG000|COMPLETED|Visit 1||16
9053415|NCT03556579|10113044|FG001|COMPLETED|Visit 1||14
9053416|NCT03556579|10113045|FG002|COMPLETED|Visit 1||14
9053417|NCT03556579|10113046|FG003|COMPLETED|Visit 1||16
9053418|NCT03556579|10113043|FG000|NOT COMPLETED|Visit 1||0
9053419|NCT03556579|10113044|FG001|NOT COMPLETED|Visit 1||0
9053420|NCT03556579|10113045|FG002|NOT COMPLETED|Visit 1||0
9053421|NCT03556579|10113046|FG003|NOT COMPLETED|Visit 1||0
9053422|NCT03556579|10113043|FG000|STARTED|Visit 2||16
9053423|NCT03556579|10113044|FG001|STARTED|Visit 2||14
9053424|NCT03556579|10113045|FG002|STARTED|Visit 2||14
9053425|NCT03556579|10113046|FG003|STARTED|Visit 2||16
9053426|NCT03556579|10113043|FG000|COMPLETED|Visit 2||16
9053427|NCT03556579|10113044|FG001|COMPLETED|Visit 2||14
9053428|NCT03556579|10113045|FG002|COMPLETED|Visit 2||14
9053429|NCT03556579|10113046|FG003|COMPLETED|Visit 2||16
9053430|NCT03556579|10113043|FG000|NOT COMPLETED|Visit 2||0
9053431|NCT03556579|10113044|FG001|NOT COMPLETED|Visit 2||0
9053432|NCT03556579|10113045|FG002|NOT COMPLETED|Visit 2||0
9053433|NCT03556579|10113046|FG003|NOT COMPLETED|Visit 2||0
9053434|NCT03556761|10113058|FG000|STARTED|Overall Study||192
9053435|NCT03556761|10113059|FG001|STARTED|Overall Study||192
9053436|NCT03556761|10113058|FG000|COMPLETED|Overall Study||168
9053437|NCT03556761|10113059|FG001|COMPLETED|Overall Study||163
9053438|NCT03556761|10113058|FG000|NOT COMPLETED|Overall Study||24
9053439|NCT03556761|10113059|FG001|NOT COMPLETED|Overall Study||29
9053440|NCT03556891|10113065|FG000|STARTED|Overall Study||133
9053441|NCT03556891|10113065|FG000|COMPLETED|Overall Study||120
9053442|NCT03556891|10113065|FG000|NOT COMPLETED|Overall Study||13
9053443|NCT03557034|10113071|FG000|STARTED|Overall Study||49
9053444|NCT03557034|10113072|FG001|STARTED|Overall Study||51
9053445|NCT03557034|10113071|FG000|Randomization|Overall Study||49
9053446|NCT03557034|10113072|FG001|Randomization|Overall Study||51
9053447|NCT03557034|10113071|FG000|COMPLETED|Overall Study||48
9053448|NCT03557034|10113072|FG001|COMPLETED|Overall Study||51
9053449|NCT03557034|10113071|FG000|NOT COMPLETED|Overall Study||1
9053450|NCT03557034|10113072|FG001|NOT COMPLETED|Overall Study||0
9053451|NCT03557086|10113080|FG000|STARTED|Overall Study||26
9053452|NCT03557086|10113081|FG001|STARTED|Overall Study||24
9053453|NCT03557086|10113080|FG000|COMPLETED|Overall Study||26
9053454|NCT03557086|10113081|FG001|COMPLETED|Overall Study||24
9053455|NCT03557086|10113080|FG000|NOT COMPLETED|Overall Study||0
9053456|NCT03557086|10113081|FG001|NOT COMPLETED|Overall Study||0
9053457|NCT03557125|10113091|FG000|STARTED|Overall Study||22
9053458|NCT03557125|10113092|FG001|STARTED|Overall Study||24
9053459|NCT03557125|10113091|FG000|COMPLETED|Overall Study||22
9053460|NCT03557125|10113092|FG001|COMPLETED|Overall Study||24
9053461|NCT03557125|10113091|FG000|NOT COMPLETED|Overall Study||0
9053462|NCT03557125|10113092|FG001|NOT COMPLETED|Overall Study||0
9053463|NCT03557333|10113098|FG000|STARTED|Overall Study||354
9053464|NCT03557333|10113098|FG000|COMPLETED|Overall Study||262
9053465|NCT03557333|10113098|FG000|NOT COMPLETED|Overall Study||92
9053466|NCT03557372|10113104|FG000|STARTED|Overall Study||14
9053467|NCT03557372|10113104|FG000|COMPLETED|Overall Study||14
9053468|NCT03557372|10113104|FG000|NOT COMPLETED|Overall Study||0
9053469|NCT03557476|10113110|FG000|STARTED|Overall Study||13
9053470|NCT03557476|10113111|FG001|STARTED|Overall Study||13
9053471|NCT03557476|10113110|FG000|COMPLETED|Overall Study||13
9053472|NCT03557476|10113111|FG001|COMPLETED|Overall Study||13
9053473|NCT03557476|10113110|FG000|NOT COMPLETED|Overall Study||0
9053474|NCT03557476|10113111|FG001|NOT COMPLETED|Overall Study||0
9053475|NCT03557658|10113119|FG000|STARTED|Overall Study||8
9053476|NCT03557658|10113120|FG001|STARTED|Overall Study||8
9053477|NCT03557658|10113119|FG000|COMPLETED|Overall Study||8
9053478|NCT03557658|10113120|FG001|COMPLETED|Overall Study||8
9053479|NCT03557658|10113119|FG000|NOT COMPLETED|Overall Study||0
9053480|NCT03557658|10113120|FG001|NOT COMPLETED|Overall Study||0
9053481|NCT03557775|10113129|FG000|STARTED|Overall Study||5
9053482|NCT03557775|10113130|FG001|STARTED|Overall Study||7
9053483|NCT03557775|10113131|FG002|STARTED|Overall Study||8
9053484|NCT03557775|10113129|FG000|COMPLETED|Overall Study||4
9053485|NCT03557775|10113130|FG001|COMPLETED|Overall Study||4
9053486|NCT03557775|10113131|FG002|COMPLETED|Overall Study||4
9053487|NCT03557775|10113129|FG000|NOT COMPLETED|Overall Study||1
9053488|NCT03557775|10113130|FG001|NOT COMPLETED|Overall Study||3
9053489|NCT03557775|10113131|FG002|NOT COMPLETED|Overall Study||4
9053490|NCT03557801|10113142|FG000|STARTED|Overall Study||34
9053491|NCT03557801|10113143|FG001|STARTED|Overall Study||33
9053492|NCT03557801|10113144|FG002|STARTED|Overall Study||33
9053493|NCT03557801|10113142|FG000|COMPLETED|Overall Study||32
9053494|NCT03557801|10113143|FG001|COMPLETED|Overall Study||32
9053495|NCT03557801|10113144|FG002|COMPLETED|Overall Study||30
9053496|NCT03557801|10113142|FG000|NOT COMPLETED|Overall Study||2
9053497|NCT03557801|10113143|FG001|NOT COMPLETED|Overall Study||1
9053498|NCT03557801|10113144|FG002|NOT COMPLETED|Overall Study||3
9053499|NCT03558061|10113152|FG000|STARTED|Overall Study||30
9053500|NCT03558061|10113152|FG000|COMPLETED|Overall Study||29
9053501|NCT03558061|10113152|FG000|NOT COMPLETED|Overall Study||1
9053502|NCT03558074|10113156|FG000|STARTED|Overall Study||26
9053503|NCT03558074|10113156|FG000|COMPLETED|Overall Study||24
9053504|NCT03558074|10113156|FG000|NOT COMPLETED|Overall Study||2
9053505|NCT03558230|10113163|FG000|STARTED|Overall Study||7
9053506|NCT03558230|10113164|FG001|STARTED|Overall Study||6
9053507|NCT03558230|10113163|FG000|COMPLETED|Overall Study||7
9053508|NCT03558230|10113164|FG001|COMPLETED|Overall Study||6
9053509|NCT03558230|10113163|FG000|NOT COMPLETED|Overall Study||0
9053510|NCT03558230|10113164|FG001|NOT COMPLETED|Overall Study||0
9053511|NCT03558516|10113172|FG000|STARTED|Overall Study||40
9053512|NCT03558516|10113173|FG001|STARTED|Overall Study||40
9053513|NCT03558516|10113172|FG000|COMPLETED|Overall Study||38
9053514|NCT03558516|10113173|FG001|COMPLETED|Overall Study||38
9053515|NCT03558516|10113172|FG000|NOT COMPLETED|Overall Study||2
9053516|NCT03558516|10113173|FG001|NOT COMPLETED|Overall Study||2
9053517|NCT03558555|10113181|FG000|STARTED|Overall Study||58
9053518|NCT03558555|10113182|FG001|STARTED|Overall Study||45
9053519|NCT03558555|10113181|FG000|COMPLETED|Overall Study||56
9053520|NCT03558555|10113182|FG001|COMPLETED|Overall Study||44
9053521|NCT03558555|10113181|FG000|NOT COMPLETED|Overall Study||2
9053522|NCT03558555|10113182|FG001|NOT COMPLETED|Overall Study||1
9053523|NCT03558672|10113188|FG000|STARTED|Overall Study||18
9053524|NCT03558672|10113188|FG000|COMPLETED|Overall Study||8
9053525|NCT03558672|10113188|FG000|NOT COMPLETED|Overall Study||10
9053526|NCT03558997|10113196|FG000|STARTED|Overall Study||25
9053527|NCT03558997|10113197|FG001|STARTED|Overall Study||26
8703710|NCT00924443|9749429|FG000|COMPLETED|Overall Study||66
8703711|NCT00924443|9749429|FG000|NOT COMPLETED|Overall Study||3
8703712|NCT00924469|9749435|FG000|STARTED|Overall Study||30
8703713|NCT00924469|9749436|FG001|STARTED|Overall Study||28
8703714|NCT00924469|9749435|FG000|COMPLETED|Overall Study||28
8703715|NCT00924469|9749436|FG001|COMPLETED|Overall Study||26
8703716|NCT00924469|9749435|FG000|NOT COMPLETED|Overall Study||2
8703717|NCT00924469|9749436|FG001|NOT COMPLETED|Overall Study||2
8703718|NCT00924482|9749442|FG000|STARTED|Overall Study||261
9053528|NCT03558997|10113198|FG002|STARTED|Overall Study||26
9053529|NCT03558997|10113199|FG003|STARTED|Overall Study||26
9053530|NCT03558997|10113196|FG000|COMPLETED|Overall Study||24
9053531|NCT03558997|10113197|FG001|COMPLETED|Overall Study||24
9053532|NCT03558997|10113198|FG002|COMPLETED|Overall Study||18
9053533|NCT03558997|10113199|FG003|COMPLETED|Overall Study||24
9053534|NCT03558997|10113196|FG000|NOT COMPLETED|Overall Study||1
9053535|NCT03558997|10113197|FG001|NOT COMPLETED|Overall Study||2
9053536|NCT03558997|10113198|FG002|NOT COMPLETED|Overall Study||8
9053537|NCT03558997|10113199|FG003|NOT COMPLETED|Overall Study||2
9053538|NCT03559062|10113215|FG000|STARTED|Overall Study||10
9053539|NCT03559062|10113216|FG001|STARTED|Overall Study||54
9053540|NCT03559062|10113217|FG002|STARTED|Overall Study||3
9053541|NCT03559062|10113215|FG000|COMPLETED|Overall Study||10
9053542|NCT03559062|10113216|FG001|COMPLETED|Overall Study||53
9053543|NCT03559062|10113217|FG002|COMPLETED|Overall Study||3
9053544|NCT03559062|10113215|FG000|NOT COMPLETED|Overall Study||0
9053545|NCT03559062|10113216|FG001|NOT COMPLETED|Overall Study||1
9053546|NCT03559062|10113217|FG002|NOT COMPLETED|Overall Study||0
9053547|NCT03559179|10113229|FG000|STARTED|Overall Study||8
9053548|NCT03559179|10113230|FG001|STARTED|Overall Study||24
9053549|NCT03559179|10113231|FG002|STARTED|Overall Study||23
9053550|NCT03559179|10113229|FG000|COMPLETED|Overall Study||8
9053551|NCT03559179|10113230|FG001|COMPLETED|Overall Study||23
9053552|NCT03559179|10113231|FG002|COMPLETED|Overall Study||23
9053553|NCT03559179|10113229|FG000|NOT COMPLETED|Overall Study||0
9053554|NCT03559179|10113230|FG001|NOT COMPLETED|Overall Study||1
9053555|NCT03559179|10113231|FG002|NOT COMPLETED|Overall Study||0
9053556|NCT03559205|10113250|FG000|STARTED|Overall Study||177
9053557|NCT03559205|10113251|FG001|STARTED|Overall Study||144
9053558|NCT03559205|10113250|FG000|Baseline Data|Overall Study||141
9053559|NCT03559205|10113251|FG001|Baseline Data|Overall Study||132
9053560|NCT03559205|10113250|FG000|COMPLETED|Overall Study||65
9053561|NCT03559205|10113251|FG001|COMPLETED|Overall Study||57
9053562|NCT03559205|10113250|FG000|NOT COMPLETED|Overall Study||112
9053563|NCT03559205|10113251|FG001|NOT COMPLETED|Overall Study||87
9053564|NCT03559218|10113259|FG000|STARTED|Overall Study||12
9053565|NCT03559218|10113260|FG001|STARTED|Overall Study||13
9053566|NCT03559218|10113259|FG000|COMPLETED|Overall Study||11
9053567|NCT03559218|10113260|FG001|COMPLETED|Overall Study||13
9053568|NCT03559218|10113259|FG000|NOT COMPLETED|Overall Study||1
9053569|NCT03559218|10113260|FG001|NOT COMPLETED|Overall Study||0
9053570|NCT03559257|10113268|FG000|STARTED|Double Blind Treatment Period||230
9053571|NCT03559257|10113269|FG001|STARTED|Double Blind Treatment Period||233
9053572|NCT03559257|10113268|FG000|Received at Least One Dose of Study Drug|Double Blind Treatment Period||230
9053573|NCT03559257|10113269|FG001|Received at Least One Dose of Study Drug|Double Blind Treatment Period||232
9053574|NCT03559257|10113268|FG000|COMPLETED|Double Blind Treatment Period||226
9053575|NCT03559257|10113269|FG001|COMPLETED|Double Blind Treatment Period||225
9053576|NCT03559257|10113268|FG000|NOT COMPLETED|Double Blind Treatment Period||4
9053577|NCT03559257|10113269|FG001|NOT COMPLETED|Double Blind Treatment Period||8
9053578|NCT03559257|10113268|FG000|STARTED|Open-label Treatment Period|One participant who completed double blind period has withdrawn from the study.|225
9053579|NCT03559257|10113269|FG001|STARTED|Open-label Treatment Period|One participant who completed double blind period had discontinued due to adverse event.|224
9053580|NCT03559257|10113268|FG000|COMPLETED|Open-label Treatment Period||215
9053581|NCT03559257|10113269|FG001|COMPLETED|Open-label Treatment Period||217
9053582|NCT03559257|10113268|FG000|NOT COMPLETED|Open-label Treatment Period||10
9053583|NCT03559257|10113269|FG001|NOT COMPLETED|Open-label Treatment Period||7
9053584|NCT03559517|10113281|FG000|STARTED|Overall Study||8
9053585|NCT03559517|10113282|FG001|STARTED|Overall Study||9
9053586|NCT03559517|10113283|FG002|STARTED|Overall Study||12
9053587|NCT03559517|10113281|FG000|COMPLETED|Overall Study||7
9053588|NCT03559517|10113282|FG001|COMPLETED|Overall Study||9
9053589|NCT03559517|10113283|FG002|COMPLETED|Overall Study||12
9053590|NCT03559517|10113281|FG000|NOT COMPLETED|Overall Study||1
9053591|NCT03559517|10113282|FG001|NOT COMPLETED|Overall Study||0
9053592|NCT03559517|10113283|FG002|NOT COMPLETED|Overall Study||0
9053593|NCT03559530|10113291|FG000|STARTED|Overall Study||197
9053594|NCT03559530|10113292|FG001|STARTED|Overall Study||65
9053595|NCT03559530|10113291|FG000|COMPLETED|Overall Study||106
9053596|NCT03559530|10113292|FG001|COMPLETED|Overall Study||65
9053597|NCT03559530|10113291|FG000|NOT COMPLETED|Overall Study||91
9053598|NCT03559530|10113292|FG001|NOT COMPLETED|Overall Study||0
9053599|NCT03559829|10113297|FG000|STARTED|Overall Study||20
9053600|NCT03559829|10113297|FG000|COMPLETED|Overall Study||20
9053601|NCT03559829|10113297|FG000|NOT COMPLETED|Overall Study||0
9053602|NCT03559933|10113301|FG000|STARTED|Overall Study||12
9053603|NCT03559933|10113301|FG000|COMPLETED|Overall Study||12
9053604|NCT03559933|10113301|FG000|NOT COMPLETED|Overall Study||0
9053605|NCT03560102|10113306|FG000|STARTED|Overall Study||1
9053606|NCT03560102|10113306|FG000|COMPLETED|Overall Study||1
9053607|NCT03560102|10113306|FG000|NOT COMPLETED|Overall Study||0
9053608|NCT03560128|10113312|FG000|STARTED|Overall Study||306
9053609|NCT03560128|10113313|FG001|STARTED|Overall Study||306
9053610|NCT03560128|10113312|FG000|COMPLETED|Overall Study||294
9053611|NCT03560128|10113313|FG001|COMPLETED|Overall Study||298
9053612|NCT03560128|10113312|FG000|NOT COMPLETED|Overall Study||12
9053613|NCT03560128|10113313|FG001|NOT COMPLETED|Overall Study||8
9053614|NCT03560141|10113321|FG000|STARTED|Overall Study||6
9053615|NCT03560141|10113322|FG001|STARTED|Overall Study||5
9053616|NCT03560141|10113321|FG000|COMPLETED|Overall Study||6
9053617|NCT03560141|10113322|FG001|COMPLETED|Overall Study||5
9053618|NCT03560141|10113321|FG000|NOT COMPLETED|Overall Study||0
9053619|NCT03560141|10113322|FG001|NOT COMPLETED|Overall Study||0
9053620|NCT03560245|10113332|FG000|STARTED|Overall Study||53
9053621|NCT03560245|10113333|FG001|STARTED|Overall Study||55
9053622|NCT03560245|10113332|FG000|COMPLETED|Overall Study||48
9053623|NCT03560245|10113333|FG001|COMPLETED|Overall Study||48
9053624|NCT03560245|10113332|FG000|NOT COMPLETED|Overall Study||5
9053625|NCT03560245|10113333|FG001|NOT COMPLETED|Overall Study||7
9053626|NCT03560518|10113344|FG000|STARTED|Double Blind Treatment Period||147
9053627|NCT03560518|10113345|FG001|STARTED|Double Blind Treatment Period||145
9053628|NCT03560518|10113346|FG002|STARTED|Double Blind Treatment Period||147
9053629|NCT03560518|10113344|FG000|COMPLETED|Double Blind Treatment Period||122
9053630|NCT03560518|10113345|FG001|COMPLETED|Double Blind Treatment Period||116
9053631|NCT03560518|10113346|FG002|COMPLETED|Double Blind Treatment Period||124
9053632|NCT03560518|10113344|FG000|NOT COMPLETED|Double Blind Treatment Period||25
9053633|NCT03560518|10113345|FG001|NOT COMPLETED|Double Blind Treatment Period||29
9053634|NCT03560518|10113346|FG002|NOT COMPLETED|Double Blind Treatment Period||23
9053635|NCT03560518|10113344|FG000|STARTED|Safety Follow-Up Period||10
9053636|NCT03560518|10113345|FG001|STARTED|Safety Follow-Up Period||17
9053637|NCT03560518|10113346|FG002|STARTED|Safety Follow-Up Period||22
9053638|NCT03560518|10113344|FG000|COMPLETED|Safety Follow-Up Period||10
9053639|NCT03560518|10113345|FG001|COMPLETED|Safety Follow-Up Period||17
9053640|NCT03560518|10113346|FG002|COMPLETED|Safety Follow-Up Period||22
9053641|NCT03560518|10113344|FG000|NOT COMPLETED|Safety Follow-Up Period||0
9053642|NCT03560518|10113345|FG001|NOT COMPLETED|Safety Follow-Up Period||0
9053643|NCT03560518|10113346|FG002|NOT COMPLETED|Safety Follow-Up Period||0
9053644|NCT03560739|10113358|FG000|STARTED|Overall Study||128
9053645|NCT03560739|10113359|FG001|STARTED|Overall Study||130
9053646|NCT03560739|10113360|FG002|STARTED|Overall Study||13
9053647|NCT03560739|10113361|FG003|STARTED|Overall Study||13
9053648|NCT03560739|10113358|FG000|COMPLETED|Overall Study||128
9053649|NCT03560739|10113359|FG001|COMPLETED|Overall Study||129
9053650|NCT03560739|10113360|FG002|COMPLETED|Overall Study||13
9053651|NCT03560739|10113361|FG003|COMPLETED|Overall Study||13
9053652|NCT03560739|10113358|FG000|NOT COMPLETED|Overall Study||0
9053653|NCT03560739|10113359|FG001|NOT COMPLETED|Overall Study||1
9053654|NCT03560739|10113360|FG002|NOT COMPLETED|Overall Study||0
9053655|NCT03560739|10113361|FG003|NOT COMPLETED|Overall Study||0
9053656|NCT03560869|10113371|FG000|STARTED|Overall Study||14
9053657|NCT03560869|10113372|FG001|STARTED|Overall Study||21
9053658|NCT03560869|10113371|FG000|COMPLETED|Overall Study||7
9053659|NCT03560869|10113372|FG001|COMPLETED|Overall Study||12
9053660|NCT03560869|10113371|FG000|NOT COMPLETED|Overall Study||7
9053661|NCT03560869|10113372|FG001|NOT COMPLETED|Overall Study||9
9053662|NCT03560986|10113380|FG000|STARTED|Treatment Period A/Follow-up Period 1||48
9053663|NCT03560986|10113381|FG001|STARTED|Treatment Period A/Follow-up Period 1|One additional participant was allocated to placebo but not treated.|51
9053664|NCT03560986|10113380|FG000|Treatment Period A Completers|Treatment Period A/Follow-up Period 1||45
9053665|NCT03560986|10113381|FG001|Treatment Period A Completers|Treatment Period A/Follow-up Period 1||45
9053666|NCT03560986|10113380|FG000|COMPLETED|Treatment Period A/Follow-up Period 1||12
9053667|NCT03560986|10113381|FG001|COMPLETED|Treatment Period A/Follow-up Period 1||13
9053668|NCT03560986|10113380|FG000|NOT COMPLETED|Treatment Period A/Follow-up Period 1||36
9053669|NCT03560986|10113381|FG001|NOT COMPLETED|Treatment Period A/Follow-up Period 1||38
9053670|NCT03560986|10113380|FG000|STARTED|Treatment Period B/Follow-up Period 2|3 Participants completed Treatment Period A/Follow-up Period 1 but were not allocated in Period B.|9
9053671|NCT03560986|10113381|FG001|STARTED|Treatment Period B/Follow-up Period 2|5 Part. completed Placebo Treatment Period A/Follow-up Period 1 but were not allocated in Period B.|8
9053672|NCT03560986|10113380|FG000|Treatment Period B Completers|Treatment Period B/Follow-up Period 2||8
9053673|NCT03560986|10113381|FG001|Treatment Period B Completers|Treatment Period B/Follow-up Period 2||8
9053674|NCT03560986|10113380|FG000|COMPLETED|Treatment Period B/Follow-up Period 2||1
9053675|NCT03560986|10113381|FG001|COMPLETED|Treatment Period B/Follow-up Period 2||0
9053676|NCT03560986|10113380|FG000|NOT COMPLETED|Treatment Period B/Follow-up Period 2||8
9053677|NCT03560986|10113381|FG001|NOT COMPLETED|Treatment Period B/Follow-up Period 2||8
9053678|NCT03561090|10113395|FG000|STARTED|Overall Study||247
9053679|NCT03561090|10113396|FG001|STARTED|Overall Study||248
9053680|NCT03561090|10113395|FG000|Randomized and Treated|Overall Study||246
9053681|NCT03561090|10113396|FG001|Randomized and Treated|Overall Study||247
9053682|NCT03561090|10113395|FG000|COMPLETED|Overall Study||207
9053683|NCT03561090|10113396|FG001|COMPLETED|Overall Study||212
9053684|NCT03561090|10113395|FG000|NOT COMPLETED|Overall Study||40
9053685|NCT03561090|10113396|FG001|NOT COMPLETED|Overall Study||36
9053686|NCT03561883|10113406|FG000|STARTED|Overall Study||305
9053687|NCT03561883|10113407|FG001|STARTED|Overall Study||304
9053688|NCT03561883|10113406|FG000|COMPLETED|Overall Study||259
9053689|NCT03561883|10113407|FG001|COMPLETED|Overall Study||261
9053690|NCT03561883|10113406|FG000|NOT COMPLETED|Overall Study||46
9053691|NCT03561883|10113407|FG001|NOT COMPLETED|Overall Study||43
9053692|NCT03562117|10113416|FG000|STARTED|Part 1, Up to 3 Days||8
9053693|NCT03562117|10113417|FG001|STARTED|Part 1, Up to 3 Days||8
9053694|NCT03562117|10113418|FG002|STARTED|Part 1, Up to 3 Days||0
9053695|NCT03562117|10113416|FG000|COMPLETED|Part 1, Up to 3 Days||7
9053696|NCT03562117|10113417|FG001|COMPLETED|Part 1, Up to 3 Days||8
9053697|NCT03562117|10113418|FG002|COMPLETED|Part 1, Up to 3 Days||0
9053698|NCT03562117|10113416|FG000|NOT COMPLETED|Part 1, Up to 3 Days||1
9053699|NCT03562117|10113417|FG001|NOT COMPLETED|Part 1, Up to 3 Days||0
9053700|NCT03562117|10113418|FG002|NOT COMPLETED|Part 1, Up to 3 Days||0
9053701|NCT03562117|10113416|FG000|STARTED|Part 2, Up to 3 Days|Only 1 additional participant with normal hepatic function enrolled in Part 2 received dosing|8
9053702|NCT03562117|10113417|FG001|STARTED|Part 2, Up to 3 Days||0
9053703|NCT03562117|10113418|FG002|STARTED|Part 2, Up to 3 Days||8
9053704|NCT03562117|10113416|FG000|COMPLETED|Part 2, Up to 3 Days||8
9053705|NCT03562117|10113417|FG001|COMPLETED|Part 2, Up to 3 Days||0
9053706|NCT03562117|10113418|FG002|COMPLETED|Part 2, Up to 3 Days||8
9053707|NCT03562117|10113416|FG000|NOT COMPLETED|Part 2, Up to 3 Days||0
9053708|NCT03562117|10113417|FG001|NOT COMPLETED|Part 2, Up to 3 Days||0
9053709|NCT03562117|10113418|FG002|NOT COMPLETED|Part 2, Up to 3 Days||0
9053710|NCT03562377|10113428|FG000|STARTED|Treatment Period|Number of participants assigned to treatment|107
9053711|NCT03562377|10113429|FG001|STARTED|Treatment Period|Number of participants assigned to treatment|108
9053712|NCT03562377|10113428|FG000|Safety Analysis Set|Treatment Period||107
9053713|NCT03562377|10113429|FG001|Safety Analysis Set|Treatment Period||107
9053714|NCT03562377|10113428|FG000|Per Protocol Anaysis Set|Treatment Period||88
9053715|NCT03562377|10113429|FG001|Per Protocol Anaysis Set|Treatment Period||78
9053716|NCT03562377|10113428|FG000|Full Analysis Set|Treatment Period||106
9053717|NCT03562377|10113429|FG001|Full Analysis Set|Treatment Period||108
8928031|NCT02277769|9989166|FG002|NOT COMPLETED|Overall Study||18
8928032|NCT02277925|9989176|FG000|STARTED|Overall Study||102
8928033|NCT02277925|9989177|FG001|STARTED|Overall Study||102
9053718|NCT03562377|10113428|FG000|COMPLETED|Treatment Period|Number of participants attending the Week 16 visit (end of treatment visit)|100
9053719|NCT03562377|10113429|FG001|COMPLETED|Treatment Period|Number of participants attending the Week 16 visit (end of treatment visit)|89
9053720|NCT03562377|10113428|FG000|NOT COMPLETED|Treatment Period||7
9053721|NCT03562377|10113429|FG001|NOT COMPLETED|Treatment Period||19
9053722|NCT03562377|10113428|FG000|STARTED|Safety Follow-up Period|Last contact after exposure end. Main reason for not entering follow-up: transfer to extension trial|75
9053723|NCT03562377|10113429|FG001|STARTED|Safety Follow-up Period|Last contact after exposure end. Main reason for not entering follow-up: transfer to extension trial|75
8928034|NCT02277925|9989176|FG000|Surgery|Overall Study||99
8928035|NCT02277925|9989177|FG001|Surgery|Overall Study||101
8928036|NCT02277925|9989176|FG000|COMPLETED|Overall Study||95
9053724|NCT03562377|10113428|FG000|COMPLETED|Safety Follow-up Period|Attended Week 30 visit. Main reason for not attending was transfer to long-term extension trial.|16
9053725|NCT03562377|10113429|FG001|COMPLETED|Safety Follow-up Period|Attended Week 30 visit. Main reason for not attending was transfer to long-term extension trial.|18
9053726|NCT03562377|10113428|FG000|NOT COMPLETED|Safety Follow-up Period||59
9053727|NCT03562377|10113429|FG001|NOT COMPLETED|Safety Follow-up Period||57
9053728|NCT03562481|10113437|FG000|STARTED|First Intervention||12
9053729|NCT03562481|10113438|FG001|STARTED|First Intervention||14
9053730|NCT03562481|10113437|FG000|COMPLETED|First Intervention||11
9053731|NCT03562481|10113438|FG001|COMPLETED|First Intervention||14
8703719|NCT00924482|9749442|FG000|COMPLETED|Overall Study||261
8703720|NCT00924482|9749442|FG000|NOT COMPLETED|Overall Study||0
8703721|NCT00924508|9749447|FG000|STARTED|Overall Study||23
8703722|NCT00924508|9749447|FG000|COMPLETED|Overall Study||20
8703723|NCT00924508|9749447|FG000|NOT COMPLETED|Overall Study||3
9053732|NCT03562481|10113437|FG000|NOT COMPLETED|First Intervention||1
9053733|NCT03562481|10113438|FG001|NOT COMPLETED|First Intervention||0
9053734|NCT03562481|10113437|FG000|STARTED|Washout||11
9053735|NCT03562481|10113438|FG001|STARTED|Washout||14
9053736|NCT03562481|10113437|FG000|COMPLETED|Washout||11
9053737|NCT03562481|10113438|FG001|COMPLETED|Washout||14
9053738|NCT03562481|10113437|FG000|NOT COMPLETED|Washout||0
9053739|NCT03562481|10113438|FG001|NOT COMPLETED|Washout||0
9053740|NCT03562481|10113437|FG000|STARTED|Second Intervention||11
9053741|NCT03562481|10113438|FG001|STARTED|Second Intervention||14
9053742|NCT03562481|10113437|FG000|COMPLETED|Second Intervention||11
9053743|NCT03562481|10113438|FG001|COMPLETED|Second Intervention||14
9053744|NCT03562481|10113437|FG000|NOT COMPLETED|Second Intervention||0
9053745|NCT03562481|10113438|FG001|NOT COMPLETED|Second Intervention||0
9053746|NCT03562559|10113448|FG000|STARTED|Overall Study||40
9053747|NCT03562559|10113448|FG000|COMPLETED|Overall Study||40
9053748|NCT03562559|10113448|FG000|NOT COMPLETED|Overall Study||0
9053749|NCT03562663|10113454|FG000|STARTED|Overall Study||41
9053750|NCT03562663|10113455|FG001|STARTED|Overall Study||41
9053751|NCT03562663|10113454|FG000|COMPLETED|Overall Study||34
9053752|NCT03562663|10113455|FG001|COMPLETED|Overall Study||35
9053753|NCT03562663|10113454|FG000|NOT COMPLETED|Overall Study||7
9053754|NCT03562663|10113455|FG001|NOT COMPLETED|Overall Study||6
9053755|NCT03562988|10113461|FG000|STARTED|Overall Study||17
9053756|NCT03562988|10113462|FG001|STARTED|Overall Study||18
9053757|NCT03562988|10113461|FG000|COMPLETED|Overall Study||15
9053758|NCT03562988|10113462|FG001|COMPLETED|Overall Study||15
9053759|NCT03562988|10113461|FG000|NOT COMPLETED|Overall Study||2
9053760|NCT03562988|10113462|FG001|NOT COMPLETED|Overall Study||3
9053761|NCT03563027|10113475|FG000|STARTED|Overall Study||60
9053762|NCT03563027|10113476|FG001|STARTED|Overall Study||60
9053763|NCT03563027|10113477|FG002|STARTED|Overall Study||60
9053764|NCT03563027|10113475|FG000|COMPLETED|Overall Study||60
9053765|NCT03563027|10113476|FG001|COMPLETED|Overall Study||60
9053766|NCT03563027|10113477|FG002|COMPLETED|Overall Study||58
9053767|NCT03563027|10113475|FG000|NOT COMPLETED|Overall Study||0
9053768|NCT03563027|10113476|FG001|NOT COMPLETED|Overall Study||0
9053769|NCT03563027|10113477|FG002|NOT COMPLETED|Overall Study||2
9053770|NCT03563183|10113485|FG000|STARTED|Overall Study||26976
9053771|NCT03563183|10113485|FG000|COMPLETED|Overall Study||26976
9053772|NCT03563183|10113485|FG000|NOT COMPLETED|Overall Study||0
9053773|NCT03563209|10113504|FG000|STARTED|Overall Study||60
9053774|NCT03563209|10113504|FG000|COMPLETED|Overall Study||60
9053775|NCT03563209|10113504|FG000|NOT COMPLETED|Overall Study||0
9053776|NCT03563313|10113512|FG000|STARTED|Overall Study||112
9053777|NCT03563313|10113513|FG001|STARTED|Overall Study||56
9053778|NCT03563313|10113512|FG000|COMPLETED|Overall Study||112
9053779|NCT03563313|10113513|FG001|COMPLETED|Overall Study||56
9053780|NCT03563313|10113512|FG000|NOT COMPLETED|Overall Study||0
9053781|NCT03563313|10113513|FG001|NOT COMPLETED|Overall Study||0
9053782|NCT03564444|10113527|FG000|STARTED|Overall Study||60
8703724|NCT00924560|9749457|FG000|STARTED|Overall Study||458
8703725|NCT00924560|9749458|FG001|STARTED|Overall Study||448
8703726|NCT00924560|9749459|FG002|STARTED|Overall Study||455
9053783|NCT03564444|10113528|FG001|STARTED|Overall Study||240
9053784|NCT03564444|10113527|FG000|COMPLETED|Overall Study||60
8703727|NCT00924560|9749457|FG000|Received Treatment|Overall Study|Excludes 7 participants at 1 site that was closed. One participant received 28-day OC in error.|422
9053785|NCT03564444|10113528|FG001|COMPLETED|Overall Study||240
9053786|NCT03564444|10113527|FG000|NOT COMPLETED|Overall Study||0
9053787|NCT03564444|10113528|FG001|NOT COMPLETED|Overall Study||0
9053788|NCT03564886|10113536|FG000|STARTED|Overall Study||24
9053789|NCT03564886|10113537|FG001|STARTED|Overall Study||24
9053790|NCT03564886|10113536|FG000|COMPLETED|Overall Study||23
9053791|NCT03564886|10113537|FG001|COMPLETED|Overall Study||23
8703728|NCT00924560|9749458|FG001|Received Treatment|Overall Study|Excludes 9 participants from one site that was closed due to audit findings.|411
9053792|NCT03564886|10113536|FG000|NOT COMPLETED|Overall Study||1
9053793|NCT03564886|10113537|FG001|NOT COMPLETED|Overall Study||1
9053794|NCT03565068|10113552|FG000|STARTED|Overall Study||12
9053795|NCT03565068|10113553|FG001|STARTED|Overall Study||4
9053796|NCT03565068|10113554|FG002|STARTED|Overall Study||12
9053797|NCT03565068|10113555|FG003|STARTED|Overall Study||4
9053798|NCT03565068|10113556|FG004|STARTED|Overall Study||12
9053799|NCT03565068|10113557|FG005|STARTED|Overall Study||1
9053800|NCT03565068|10113558|FG006|STARTED|Overall Study||4
9053801|NCT03565068|10113559|FG007|STARTED|Overall Study||17
9053802|NCT03565068|10113560|FG008|STARTED|Overall Study||9
9053803|NCT03565068|10113552|FG000|COMPLETED|Overall Study||12
9053804|NCT03565068|10113553|FG001|COMPLETED|Overall Study||4
9053805|NCT03565068|10113554|FG002|COMPLETED|Overall Study||11
9053806|NCT03565068|10113555|FG003|COMPLETED|Overall Study||4
9053807|NCT03565068|10113556|FG004|COMPLETED|Overall Study||8
9053808|NCT03565068|10113557|FG005|COMPLETED|Overall Study||0
9053809|NCT03565068|10113558|FG006|COMPLETED|Overall Study||3
9053810|NCT03565068|10113559|FG007|COMPLETED|Overall Study||9
9053811|NCT03565068|10113560|FG008|COMPLETED|Overall Study||8
9053812|NCT03565068|10113552|FG000|NOT COMPLETED|Overall Study||0
9053813|NCT03565068|10113553|FG001|NOT COMPLETED|Overall Study||0
9053814|NCT03565068|10113554|FG002|NOT COMPLETED|Overall Study||1
9053815|NCT03565068|10113555|FG003|NOT COMPLETED|Overall Study||0
9053816|NCT03565068|10113556|FG004|NOT COMPLETED|Overall Study||4
9053817|NCT03565068|10113557|FG005|NOT COMPLETED|Overall Study||1
9053818|NCT03565068|10113558|FG006|NOT COMPLETED|Overall Study||1
9053819|NCT03565068|10113559|FG007|NOT COMPLETED|Overall Study||8
9053820|NCT03565068|10113560|FG008|NOT COMPLETED|Overall Study||1
9053821|NCT03565211|10113617|FG000|STARTED|Overall Study||254
9053822|NCT03565211|10113617|FG000|Modified Intention-to-treat (mITT)|Overall Study|Had successful oocyte retrieval, received >=1 dose of IMP, and completed fresh embryo transfer|243
9053823|NCT03565211|10113617|FG000|COMPLETED|Overall Study||206
9053824|NCT03565211|10113617|FG000|NOT COMPLETED|Overall Study||48
9053825|NCT03565315|10113625|FG000|STARTED|Overall Study||3
9053826|NCT03565315|10113626|FG001|STARTED|Overall Study||3
9053827|NCT03565315|10113627|FG002|STARTED|Overall Study||1
9053828|NCT03565315|10113628|FG003|STARTED|Overall Study||2
9053829|NCT03565315|10113625|FG000|Product Administration Completed|Overall Study||3
9053830|NCT03565315|10113626|FG001|Product Administration Completed|Overall Study||0
9053831|NCT03565315|10113627|FG002|Product Administration Completed|Overall Study||1
9053832|NCT03565315|10113628|FG003|Product Administration Completed|Overall Study||0
9053833|NCT03565315|10113625|FG000|Discontinued Product Administrations|Overall Study||0
9053834|NCT03565315|10113626|FG001|Discontinued Product Administrations|Overall Study||3
9053835|NCT03565315|10113627|FG002|Discontinued Product Administrations|Overall Study||0
9053836|NCT03565315|10113628|FG003|Discontinued Product Administrations|Overall Study|One Group 4 participant enrolled but did not receive product due to IND/PI voluntary study pause.|2
9053837|NCT03565315|10113625|FG000|COMPLETED|Overall Study||3
9053838|NCT03565315|10113626|FG001|COMPLETED|Overall Study||3
9053839|NCT03565315|10113627|FG002|COMPLETED|Overall Study||1
9053840|NCT03565315|10113628|FG003|COMPLETED|Overall Study||1
9053841|NCT03565315|10113625|FG000|NOT COMPLETED|Overall Study||0
9053842|NCT03565315|10113626|FG001|NOT COMPLETED|Overall Study||0
9053843|NCT03565315|10113627|FG002|NOT COMPLETED|Overall Study||0
9053844|NCT03565315|10113628|FG003|NOT COMPLETED|Overall Study||1
9053845|NCT03565666|10113651|FG000|STARTED|Overall Study||12
9053846|NCT03565666|10113652|FG001|STARTED|Overall Study||12
9053847|NCT03565666|10113653|FG002|STARTED|Overall Study||12
9053848|NCT03565666|10113651|FG000|COMPLETED|Overall Study||12
9053849|NCT03565666|10113652|FG001|COMPLETED|Overall Study||12
9053850|NCT03565666|10113653|FG002|COMPLETED|Overall Study||11
9053851|NCT03565666|10113651|FG000|NOT COMPLETED|Overall Study||0
9053852|NCT03565666|10113652|FG001|NOT COMPLETED|Overall Study||0
9053853|NCT03565666|10113653|FG002|NOT COMPLETED|Overall Study||1
9053854|NCT03565679|10113664|FG000|STARTED|Overall Study||10
9053855|NCT03565679|10113664|FG000|COMPLETED|Overall Study||10
9053856|NCT03565679|10113664|FG000|NOT COMPLETED|Overall Study||0
9053857|NCT03565874|10113671|FG000|STARTED|Overall Study||6
9053858|NCT03565874|10113671|FG000|COMPLETED|Overall Study||4
9053859|NCT03565874|10113671|FG000|NOT COMPLETED|Overall Study||2
9053860|NCT03565887|10113677|FG000|STARTED|Overall Study||109
9053861|NCT03565887|10113678|FG001|STARTED|Overall Study||55
9053862|NCT03565887|10113677|FG000|COMPLETED|Overall Study||108
9053863|NCT03565887|10113678|FG001|COMPLETED|Overall Study||53
9053864|NCT03565887|10113677|FG000|NOT COMPLETED|Overall Study||1
9053865|NCT03565887|10113678|FG001|NOT COMPLETED|Overall Study||2
9053866|NCT03566238|10113687|FG000|STARTED|Overall Study||23
9053867|NCT03566238|10113688|FG001|STARTED|Overall Study||19
9053868|NCT03566238|10113689|FG002|STARTED|Overall Study||20
9053869|NCT03566238|10113687|FG000|Received Treatment|Overall Study||23
9053870|NCT03566238|10113688|FG001|Received Treatment|Overall Study||19
9053871|NCT03566238|10113689|FG002|Received Treatment|Overall Study||20
9053872|NCT03566238|10113687|FG000|COMPLETED|Overall Study||18
9053873|NCT03566238|10113688|FG001|COMPLETED|Overall Study||16
9053874|NCT03566238|10113689|FG002|COMPLETED|Overall Study||15
9053875|NCT03566238|10113687|FG000|NOT COMPLETED|Overall Study||5
9053876|NCT03566238|10113688|FG001|NOT COMPLETED|Overall Study||3
9053877|NCT03566238|10113689|FG002|NOT COMPLETED|Overall Study||5
9053878|NCT03566485|10113699|FG000|STARTED|Overall Study||5
9053879|NCT03566485|10113700|FG001|STARTED|Overall Study|Dose level 1 (Idasanutlin 100mg PO)|7
9053880|NCT03566485|10113699|FG000|COMPLETED|Overall Study||0
9053881|NCT03566485|10113700|FG001|COMPLETED|Overall Study||0
9053882|NCT03566485|10113699|FG000|NOT COMPLETED|Overall Study||5
9053883|NCT03566485|10113700|FG001|NOT COMPLETED|Overall Study||7
9053884|NCT03566550|10113708|FG000|STARTED|Overall Study||12
9053885|NCT03566550|10113709|FG001|STARTED|Overall Study||13
9053886|NCT03566550|10113708|FG000|COMPLETED|Overall Study||12
9053887|NCT03566550|10113709|FG001|COMPLETED|Overall Study||12
9053888|NCT03566550|10113708|FG000|NOT COMPLETED|Overall Study||0
9053889|NCT03566550|10113709|FG001|NOT COMPLETED|Overall Study||1
9053890|NCT03566680|10113715|FG000|STARTED|Overall Study||46
9053891|NCT03566680|10113715|FG000|COMPLETED|Overall Study||29
9053892|NCT03566680|10113715|FG000|NOT COMPLETED|Overall Study||17
9053893|NCT03566810|10113723|FG000|STARTED|Treatment Period 1 (Day 1-Day 3)||19
9053894|NCT03566810|10113724|FG001|STARTED|Treatment Period 1 (Day 1-Day 3)||19
9053895|NCT03566810|10113725|FG002|STARTED|Treatment Period 1 (Day 1-Day 3)||8
9053896|NCT03566810|10113726|FG003|STARTED|Treatment Period 1 (Day 1-Day 3)||8
9053897|NCT03566810|10113723|FG000|Treated|Treatment Period 1 (Day 1-Day 3)||19
9053898|NCT03566810|10113724|FG001|Treated|Treatment Period 1 (Day 1-Day 3)||18
9053899|NCT03566810|10113725|FG002|Treated|Treatment Period 1 (Day 1-Day 3)||8
9053900|NCT03566810|10113726|FG003|Treated|Treatment Period 1 (Day 1-Day 3)||8
9053901|NCT03566810|10113723|FG000|COMPLETED|Treatment Period 1 (Day 1-Day 3)||19
9053902|NCT03566810|10113724|FG001|COMPLETED|Treatment Period 1 (Day 1-Day 3)||18
9053903|NCT03566810|10113725|FG002|COMPLETED|Treatment Period 1 (Day 1-Day 3)||8
9053904|NCT03566810|10113726|FG003|COMPLETED|Treatment Period 1 (Day 1-Day 3)||8
9053905|NCT03566810|10113723|FG000|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
9053906|NCT03566810|10113724|FG001|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||1
9053907|NCT03566810|10113725|FG002|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
9053908|NCT03566810|10113726|FG003|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
9053909|NCT03566810|10113723|FG000|STARTED|Treatment Period 2 (Day 8- Day 10)||19
9053910|NCT03566810|10113724|FG001|STARTED|Treatment Period 2 (Day 8- Day 10)||18
9053911|NCT03566810|10113725|FG002|STARTED|Treatment Period 2 (Day 8- Day 10)||8
9053912|NCT03566810|10113726|FG003|STARTED|Treatment Period 2 (Day 8- Day 10)||8
9053913|NCT03566810|10113723|FG000|COMPLETED|Treatment Period 2 (Day 8- Day 10)||19
9053914|NCT03566810|10113724|FG001|COMPLETED|Treatment Period 2 (Day 8- Day 10)||18
9053915|NCT03566810|10113725|FG002|COMPLETED|Treatment Period 2 (Day 8- Day 10)||8
9053916|NCT03566810|10113726|FG003|COMPLETED|Treatment Period 2 (Day 8- Day 10)||8
9053917|NCT03566810|10113723|FG000|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
9053918|NCT03566810|10113724|FG001|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
9053919|NCT03566810|10113725|FG002|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
9053920|NCT03566810|10113726|FG003|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
9053921|NCT03566823|10113739|FG000|STARTED|Overall Study||6
9053922|NCT03566823|10113740|FG001|STARTED|Overall Study||15
9053923|NCT03566823|10113741|FG002|STARTED|Overall Study||13
9053924|NCT03566823|10113739|FG000|COMPLETED|Overall Study||4
9053925|NCT03566823|10113740|FG001|COMPLETED|Overall Study||12
9053926|NCT03566823|10113741|FG002|COMPLETED|Overall Study||11
9053927|NCT03566823|10113739|FG000|NOT COMPLETED|Overall Study||2
9053928|NCT03566823|10113740|FG001|NOT COMPLETED|Overall Study||3
9053929|NCT03566823|10113741|FG002|NOT COMPLETED|Overall Study||2
9053930|NCT03566979|10113753|FG000|STARTED|Overall Study||58
9053931|NCT03566979|10113754|FG001|STARTED|Overall Study||152
9053932|NCT03566979|10113755|FG002|STARTED|Overall Study||142
9053933|NCT03566979|10113756|FG003|STARTED|Overall Study||149
9053934|NCT03566979|10113753|FG000|COMPLETED|Overall Study||53
9053935|NCT03566979|10113754|FG001|COMPLETED|Overall Study||145
9053936|NCT03566979|10113755|FG002|COMPLETED|Overall Study||132
9053937|NCT03566979|10113756|FG003|COMPLETED|Overall Study||143
9053938|NCT03566979|10113753|FG000|NOT COMPLETED|Overall Study||5
9053939|NCT03566979|10113754|FG001|NOT COMPLETED|Overall Study||7
9053940|NCT03566979|10113755|FG002|NOT COMPLETED|Overall Study||10
9053941|NCT03566979|10113756|FG003|NOT COMPLETED|Overall Study||6
9053942|NCT03567005|10113766|FG000|STARTED|Period 1, First 7 Days of Wear||29
9053943|NCT03567005|10113767|FG001|STARTED|Period 1, First 7 Days of Wear||31
9053944|NCT03567005|10113766|FG000|COMPLETED|Period 1, First 7 Days of Wear||29
9053945|NCT03567005|10113767|FG001|COMPLETED|Period 1, First 7 Days of Wear||31
8703729|NCT00924560|9749459|FG002|Received Treatment|Overall Study||0
9053946|NCT03567005|10113766|FG000|NOT COMPLETED|Period 1, First 7 Days of Wear||0
9053947|NCT03567005|10113767|FG001|NOT COMPLETED|Period 1, First 7 Days of Wear||0
9053948|NCT03567005|10113766|FG000|STARTED|Period 2, Second 7 Days of Wear||29
9053949|NCT03567005|10113767|FG001|STARTED|Period 2, Second 7 Days of Wear||31
9053950|NCT03567005|10113766|FG000|COMPLETED|Period 2, Second 7 Days of Wear||29
9053951|NCT03567005|10113767|FG001|COMPLETED|Period 2, Second 7 Days of Wear||31
9053952|NCT03567005|10113766|FG000|NOT COMPLETED|Period 2, Second 7 Days of Wear||0
9053953|NCT03567005|10113767|FG001|NOT COMPLETED|Period 2, Second 7 Days of Wear||0
9053954|NCT03567252|10113775|FG000|STARTED|Overall Study||48
9053955|NCT03567252|10113776|FG001|STARTED|Overall Study||19
9053956|NCT03567252|10113775|FG000|COMPLETED|Overall Study||48
9053957|NCT03567252|10113776|FG001|COMPLETED|Overall Study||19
9053958|NCT03567252|10113775|FG000|NOT COMPLETED|Overall Study||0
9053959|NCT03567252|10113776|FG001|NOT COMPLETED|Overall Study||0
8703730|NCT00924560|9749457|FG000|COMPLETED|Overall Study||247
8703731|NCT00924560|9749458|FG001|COMPLETED|Overall Study||240
8703732|NCT00924560|9749459|FG002|COMPLETED|Overall Study||372
8703733|NCT00924560|9749457|FG000|NOT COMPLETED|Overall Study||211
9053960|NCT03567291|10113782|FG000|STARTED|Period I||228
9053961|NCT03567291|10113783|FG001|STARTED|Period I||0
9053962|NCT03567291|10113784|FG002|STARTED|Period I||0
9053963|NCT03567291|10113785|FG003|STARTED|Period I||0
9053964|NCT03567291|10113782|FG000|Safety Set|Period I||227
9053965|NCT03567291|10113783|FG001|Safety Set|Period I||0
9053966|NCT03567291|10113784|FG002|Safety Set|Period I||0
9053967|NCT03567291|10113785|FG003|Safety Set|Period I||0
9053968|NCT03567291|10113782|FG000|Intent to Treat Set|Period I||228
9053969|NCT03567291|10113783|FG001|Intent to Treat Set|Period I||0
9053970|NCT03567291|10113784|FG002|Intent to Treat Set|Period I||0
9053971|NCT03567291|10113785|FG003|Intent to Treat Set|Period I||0
9053972|NCT03567291|10113782|FG000|COMPLETED|Period I||137
9053973|NCT03567291|10113783|FG001|COMPLETED|Period I||0
9053974|NCT03567291|10113784|FG002|COMPLETED|Period I||0
9053975|NCT03567291|10113785|FG003|COMPLETED|Period I||0
9053976|NCT03567291|10113782|FG000|NOT COMPLETED|Period I||91
9053977|NCT03567291|10113783|FG001|NOT COMPLETED|Period I||0
9053978|NCT03567291|10113784|FG002|NOT COMPLETED|Period I||0
8703734|NCT00924560|9749458|FG001|NOT COMPLETED|Overall Study||208
9053979|NCT03567291|10113785|FG003|NOT COMPLETED|Period I||0
9053980|NCT03567291|10113782|FG000|STARTED|Period II||0
9053981|NCT03567291|10113783|FG001|STARTED|Period II||91
9053982|NCT03567291|10113784|FG002|STARTED|Period II||46
9053983|NCT03567291|10113785|FG003|STARTED|Period II||0
9053984|NCT03567291|10113782|FG000|COMPLETED|Period II||0
9053985|NCT03567291|10113783|FG001|COMPLETED|Period II||88
8703735|NCT00924560|9749459|FG002|NOT COMPLETED|Overall Study||83
8703736|NCT00924612|9749469|FG000|STARTED|Overall Study||4
8703737|NCT00924612|9749470|FG001|STARTED|Overall Study||4
8703738|NCT00924612|9749471|FG002|STARTED|Overall Study||4
8703739|NCT00924612|9749472|FG003|STARTED|Overall Study||4
9053986|NCT03567291|10113784|FG002|COMPLETED|Period II||45
9053987|NCT03567291|10113785|FG003|COMPLETED|Period II||0
9053988|NCT03567291|10113782|FG000|NOT COMPLETED|Period II||0
9053989|NCT03567291|10113783|FG001|NOT COMPLETED|Period II||3
9053990|NCT03567291|10113784|FG002|NOT COMPLETED|Period II||1
9053991|NCT03567291|10113785|FG003|NOT COMPLETED|Period II||0
9053992|NCT03567291|10113782|FG000|STARTED|Period III||0
9053993|NCT03567291|10113783|FG001|STARTED|Period III||0
9053994|NCT03567291|10113784|FG002|STARTED|Period III||0
9053995|NCT03567291|10113785|FG003|STARTED|Period III||133
9053996|NCT03567291|10113782|FG000|COMPLETED|Period III||0
9053997|NCT03567291|10113783|FG001|COMPLETED|Period III||0
9053998|NCT03567291|10113784|FG002|COMPLETED|Period III||0
9053999|NCT03567291|10113785|FG003|COMPLETED|Period III||48
9054000|NCT03567291|10113782|FG000|NOT COMPLETED|Period III||0
9054001|NCT03567291|10113783|FG001|NOT COMPLETED|Period III||0
9054002|NCT03567291|10113784|FG002|NOT COMPLETED|Period III||0
9054003|NCT03567291|10113785|FG003|NOT COMPLETED|Period III||85
9054004|NCT03567382|10113793|FG000|STARTED|Overall Study||10
9054005|NCT03567382|10113794|FG001|STARTED|Overall Study||81
9054006|NCT03567382|10113795|FG002|STARTED|Overall Study||9
9054007|NCT03567382|10113796|FG003|STARTED|Overall Study||79
9054008|NCT03567382|10113793|FG000|Received Tenofovir|Overall Study||9
9054009|NCT03567382|10113794|FG001|Received Tenofovir|Overall Study||0
9054010|NCT03567382|10113795|FG002|Received Tenofovir|Overall Study||0
9054011|NCT03567382|10113796|FG003|Received Tenofovir|Overall Study||0
9054012|NCT03567382|10113793|FG000|COMPLETED|Overall Study||7
9054013|NCT03567382|10113794|FG001|COMPLETED|Overall Study||46
9054014|NCT03567382|10113795|FG002|COMPLETED|Overall Study||7
9054015|NCT03567382|10113796|FG003|COMPLETED|Overall Study||46
9054016|NCT03567382|10113793|FG000|NOT COMPLETED|Overall Study||3
9054017|NCT03567382|10113794|FG001|NOT COMPLETED|Overall Study||35
9054018|NCT03567382|10113795|FG002|NOT COMPLETED|Overall Study||2
9054019|NCT03567382|10113796|FG003|NOT COMPLETED|Overall Study||33
9054020|NCT03567616|10113809|FG000|STARTED|Overall Study||8
9054021|NCT03567616|10113809|FG000|COMPLETED|Overall Study||0
9054022|NCT03567616|10113809|FG000|NOT COMPLETED|Overall Study||8
9054023|NCT03567980|10113816|FG000|STARTED|Overall Study||30
9054024|NCT03567980|10113816|FG000|COMPLETED|Overall Study||29
9054025|NCT03567980|10113816|FG000|NOT COMPLETED|Overall Study||1
9054026|NCT03568500|10113823|FG000|STARTED|Overall Study||18
9054027|NCT03568500|10113824|FG001|STARTED|Overall Study||20
9054028|NCT03568500|10113825|FG002|STARTED|Overall Study||6
9054029|NCT03568500|10113823|FG000|Received At Least 1 Dose of Study Drug|Overall Study||18
9054030|NCT03568500|10113824|FG001|Received At Least 1 Dose of Study Drug|Overall Study||19
9054031|NCT03568500|10113825|FG002|Received At Least 1 Dose of Study Drug|Overall Study||6
9054032|NCT03568500|10113823|FG000|COMPLETED|Overall Study||8
9054033|NCT03568500|10113824|FG001|COMPLETED|Overall Study||14
9054034|NCT03568500|10113825|FG002|COMPLETED|Overall Study||2
9054035|NCT03568500|10113823|FG000|NOT COMPLETED|Overall Study||10
9054036|NCT03568500|10113824|FG001|NOT COMPLETED|Overall Study||6
9054037|NCT03568500|10113825|FG002|NOT COMPLETED|Overall Study||4
9054038|NCT03568539|10113840|FG000|STARTED|Overall Study||3
9054039|NCT03568539|10113841|FG001|STARTED|Overall Study||36
9054040|NCT03568539|10113840|FG000|COMPLETED|Overall Study||3
9054041|NCT03568539|10113841|FG001|COMPLETED|Overall Study||36
9054042|NCT03568539|10113840|FG000|NOT COMPLETED|Overall Study||0
9054043|NCT03568539|10113841|FG001|NOT COMPLETED|Overall Study||0
8703740|NCT00924612|9749469|FG000|COMPLETED|Overall Study||4
8703741|NCT00924612|9749470|FG001|COMPLETED|Overall Study||4
8703742|NCT00924612|9749471|FG002|COMPLETED|Overall Study||4
8703743|NCT00924612|9749472|FG003|COMPLETED|Overall Study||4
9054044|NCT03568942|10113848|FG000|STARTED|Overall Study||22
9054045|NCT03568942|10113848|FG000|COMPLETED|Overall Study||20
9054046|NCT03568942|10113848|FG000|NOT COMPLETED|Overall Study||2
8703744|NCT00924612|9749469|FG000|NOT COMPLETED|Overall Study||0
9054047|NCT03569020|10113854|FG000|STARTED|Period 1||22
9054048|NCT03569020|10113855|FG001|STARTED|Period 1||21
9054049|NCT03569020|10113854|FG000|COMPLETED|Period 1||22
9054050|NCT03569020|10113855|FG001|COMPLETED|Period 1||21
9054051|NCT03569020|10113854|FG000|NOT COMPLETED|Period 1||0
9054052|NCT03569020|10113855|FG001|NOT COMPLETED|Period 1||0
9054053|NCT03569020|10113854|FG000|STARTED|Period 2||22
9054054|NCT03569020|10113855|FG001|STARTED|Period 2||21
9054055|NCT03569020|10113854|FG000|COMPLETED|Period 2||22
9054056|NCT03569020|10113855|FG001|COMPLETED|Period 2||21
9054057|NCT03569020|10113854|FG000|NOT COMPLETED|Period 2||0
9054058|NCT03569020|10113855|FG001|NOT COMPLETED|Period 2||0
9054059|NCT03569033|10113867|FG000|STARTED|Overall Study||23
9054060|NCT03569033|10113868|FG001|STARTED|Overall Study||23
9054061|NCT03569033|10113867|FG000|COMPLETED|Overall Study||23
9054062|NCT03569033|10113868|FG001|COMPLETED|Overall Study||23
9054063|NCT03569033|10113867|FG000|NOT COMPLETED|Overall Study||0
9054064|NCT03569033|10113868|FG001|NOT COMPLETED|Overall Study||0
9054065|NCT03569098|10113877|FG000|STARTED|Double-Blind Treatment Cycle 1||63
9054066|NCT03569098|10113878|FG001|STARTED|Double-Blind Treatment Cycle 1||63
9054067|NCT03569098|10113879|FG002|STARTED|Double-Blind Treatment Cycle 1||60
9054068|NCT03569098|10113877|FG000|Received Study Medication|Double-Blind Treatment Cycle 1||61
9054069|NCT03569098|10113878|FG001|Received Study Medication|Double-Blind Treatment Cycle 1||63
9054070|NCT03569098|10113879|FG002|Received Study Medication|Double-Blind Treatment Cycle 1||56
9054071|NCT03569098|10113877|FG000|COMPLETED|Double-Blind Treatment Cycle 1||55
9054072|NCT03569098|10113878|FG001|COMPLETED|Double-Blind Treatment Cycle 1||53
9054073|NCT03569098|10113879|FG002|COMPLETED|Double-Blind Treatment Cycle 1||49
9054074|NCT03569098|10113877|FG000|NOT COMPLETED|Double-Blind Treatment Cycle 1||8
9054075|NCT03569098|10113878|FG001|NOT COMPLETED|Double-Blind Treatment Cycle 1||10
9054076|NCT03569098|10113879|FG002|NOT COMPLETED|Double-Blind Treatment Cycle 1||11
9054077|NCT03569098|10113877|FG000|STARTED|Open-Label Treatment Cycle 2|No participants were treated with placebo during the open-label treatment cycle 2.|0
9054078|NCT03569098|10113878|FG001|STARTED|Open-Label Treatment Cycle 2|All participants who met retreatment criteria were treated with Dysport 300 U during the open-label treatment cycle 2.|146
9054079|NCT03569098|10113879|FG002|STARTED|Open-Label Treatment Cycle 2|No participants were treated with Dysport 500 U during the open-label treatment cycle 2.|0
9054080|NCT03569098|10113877|FG000|COMPLETED|Open-Label Treatment Cycle 2||0
9054081|NCT03569098|10113878|FG001|COMPLETED|Open-Label Treatment Cycle 2||111
9054082|NCT03569098|10113879|FG002|COMPLETED|Open-Label Treatment Cycle 2||0
9054083|NCT03569098|10113877|FG000|NOT COMPLETED|Open-Label Treatment Cycle 2||0
9054084|NCT03569098|10113878|FG001|NOT COMPLETED|Open-Label Treatment Cycle 2||35
9054085|NCT03569098|10113879|FG002|NOT COMPLETED|Open-Label Treatment Cycle 2||0
9054086|NCT03569098|10113877|FG000|STARTED|Open-Label Treatment Cycle 3||0
9054087|NCT03569098|10113878|FG001|STARTED|Open-Label Treatment Cycle 3|Participants were treated with Dysport 300 U during open-label treatment cycle 3 based on investigator judgment following clinical evaluation of the participant at the time of retreatment.|8
9054088|NCT03569098|10113879|FG002|STARTED|Open-Label Treatment Cycle 3|Participants were treated with Dysport 500 U during open-label treatment cycle 3 based on investigator judgment following clinical evaluation of the participant at the time of retreatment.|56
9054089|NCT03569098|10113877|FG000|COMPLETED|Open-Label Treatment Cycle 3||0
9054090|NCT03569098|10113878|FG001|COMPLETED|Open-Label Treatment Cycle 3||7
9054091|NCT03569098|10113879|FG002|COMPLETED|Open-Label Treatment Cycle 3||50
9054092|NCT03569098|10113877|FG000|NOT COMPLETED|Open-Label Treatment Cycle 3||0
9054093|NCT03569098|10113878|FG001|NOT COMPLETED|Open-Label Treatment Cycle 3||1
9054094|NCT03569098|10113879|FG002|NOT COMPLETED|Open-Label Treatment Cycle 3||6
9054095|NCT03569202|10113892|FG000|STARTED|Part 1|Emulsion Eye Drops were used on one eye only.|3
9054096|NCT03569202|10113893|FG001|STARTED|Part 1|Control Eye Drops were not used for Part 1.|0
9054097|NCT03569202|10113892|FG000|COMPLETED|Part 1|No participant completing Part 1 was allowed to continue to Parts 2 or 3.|3
9054098|NCT03569202|10113893|FG001|COMPLETED|Part 1||0
9054099|NCT03569202|10113892|FG000|NOT COMPLETED|Part 1||0
9054100|NCT03569202|10113893|FG001|NOT COMPLETED|Part 1||0
9054101|NCT03569202|10113892|FG000|STARTED|Part 2|Emulsion Eye Drops were used on one randomized eye. Participants were different from Part 1.|9
9054102|NCT03569202|10113893|FG001|STARTED|Part 2|Control Eye Drops were used on contralateral eye. Participants were different from Part 1.|9
9054103|NCT03569202|10113892|FG000|COMPLETED|Part 2|No participant completing Part 2 was allowed to continue to Part 3.|9
9054104|NCT03569202|10113893|FG001|COMPLETED|Part 2|No participant completing Part 2 was allowed to continue to Part 3.|9
9054105|NCT03569202|10113892|FG000|NOT COMPLETED|Part 2||0
9054106|NCT03569202|10113893|FG001|NOT COMPLETED|Part 2||0
9054107|NCT03569202|10113892|FG000|STARTED|Part 3|Emulsion Eye Drops were used on both eyes. Participants were different from Parts 1 and 2.|26
9054108|NCT03569202|10113893|FG001|STARTED|Part 3|Control Eye Drops were used on both eyes. Participants were different from Parts 1 and 2.|26
9054109|NCT03569202|10113892|FG000|COMPLETED|Part 3|Per-protocol (PP) dataset. 'Not Completed' participants are included in safety and ITT datasets.|24
9054110|NCT03569202|10113893|FG001|COMPLETED|Part 3|Per-protocol (PP) dataset. 'Not Completed' participants are included in safety and ITT datasets.|25
9054111|NCT03569202|10113892|FG000|NOT COMPLETED|Part 3||2
9054112|NCT03569202|10113893|FG001|NOT COMPLETED|Part 3||1
9054113|NCT03569371|10113899|FG000|STARTED|Overall Study||10
9054114|NCT03569371|10113899|FG000|COMPLETED|Overall Study||7
9054115|NCT03569371|10113899|FG000|NOT COMPLETED|Overall Study||3
9054116|NCT03569397|10113905|FG000|STARTED|Overall Study||29
9054117|NCT03569397|10113906|FG001|STARTED|Overall Study||28
9054118|NCT03569397|10113905|FG000|COMPLETED|Overall Study||29
9054119|NCT03569397|10113906|FG001|COMPLETED|Overall Study||28
9054120|NCT03569397|10113905|FG000|NOT COMPLETED|Overall Study||0
9054121|NCT03569397|10113906|FG001|NOT COMPLETED|Overall Study||0
9054122|NCT03569618|10113913|FG000|STARTED|Overall Study||23
9054123|NCT03569618|10113914|FG001|STARTED|Overall Study||21
9054124|NCT03569618|10113913|FG000|COMPLETED|Overall Study||20
9054125|NCT03569618|10113914|FG001|COMPLETED|Overall Study||20
9054126|NCT03569618|10113913|FG000|NOT COMPLETED|Overall Study||3
9054127|NCT03569618|10113914|FG001|NOT COMPLETED|Overall Study||1
9054128|NCT03569748|10113923|FG000|STARTED|Overall Study||110
9054129|NCT03569748|10113924|FG001|STARTED|Overall Study||110
9054130|NCT03569748|10113923|FG000|COMPLETED|Overall Study||110
9054131|NCT03569748|10113924|FG001|COMPLETED|Overall Study||101
9054132|NCT03569748|10113923|FG000|NOT COMPLETED|Overall Study||0
9054133|NCT03569748|10113924|FG001|NOT COMPLETED|Overall Study||9
9054134|NCT03570047|10113941|FG000|STARTED|Overall Study||15902
9054135|NCT03570047|10113942|FG001|STARTED|Overall Study||22336
9054136|NCT03570047|10113943|FG002|STARTED|Overall Study||6925
8703745|NCT00924612|9749470|FG001|NOT COMPLETED|Overall Study||0
8703746|NCT00924612|9749471|FG002|NOT COMPLETED|Overall Study||0
8703747|NCT00924612|9749472|FG003|NOT COMPLETED|Overall Study||0
8703748|NCT00924638|9749486|FG000|STARTED|Overall Study|Randomized to Continuous Monitoring Arm|221
8703749|NCT00924638|9749487|FG001|STARTED|Overall Study|Randomized to Control Arm|220
8703750|NCT00924638|9749486|FG000|COMPLETED|Overall Study|Completed 6 months of follow-up|209
8703751|NCT00924638|9749487|FG001|COMPLETED|Overall Study|Completed 6 months of follow-up|207
8703752|NCT00924638|9749486|FG000|NOT COMPLETED|Overall Study||12
8703753|NCT00924638|9749487|FG001|NOT COMPLETED|Overall Study||13
8703754|NCT00924651|9749495|FG000|STARTED|Overall Study||356
9054137|NCT03570047|10113944|FG003|STARTED|Overall Study||16564
9054138|NCT03570047|10113945|FG004|STARTED|Overall Study||12262
9054139|NCT03570047|10113941|FG000|COMPLETED|Overall Study||15902
9054140|NCT03570047|10113942|FG001|COMPLETED|Overall Study||22336
9054141|NCT03570047|10113943|FG002|COMPLETED|Overall Study||6925
9054142|NCT03570047|10113944|FG003|COMPLETED|Overall Study||16564
9054143|NCT03570047|10113945|FG004|COMPLETED|Overall Study||12262
9054144|NCT03570047|10113941|FG000|NOT COMPLETED|Overall Study||0
9054145|NCT03570047|10113942|FG001|NOT COMPLETED|Overall Study||0
9054146|NCT03570047|10113943|FG002|NOT COMPLETED|Overall Study||0
9054147|NCT03570047|10113944|FG003|NOT COMPLETED|Overall Study||0
9054148|NCT03570047|10113945|FG004|NOT COMPLETED|Overall Study||0
9054149|NCT03570255|10113957|FG000|STARTED|Overall Study||28
9054150|NCT03570255|10113957|FG000|COMPLETED|Overall Study||28
9054151|NCT03570255|10113957|FG000|NOT COMPLETED|Overall Study||0
9054152|NCT03570476|10113961|FG000|STARTED|Overall Study||2
9054153|NCT03570476|10113961|FG000|COMPLETED|Overall Study||2
9054154|NCT03570476|10113961|FG000|NOT COMPLETED|Overall Study||0
9054155|NCT03570554|10113970|FG000|STARTED|Overall Study||10
9054156|NCT03570554|10113971|FG001|STARTED|Overall Study||10
9054157|NCT03570554|10113972|FG002|STARTED|Overall Study||11
9054158|NCT03570554|10113973|FG003|STARTED|Overall Study||10
9054159|NCT03570554|10113970|FG000|COMPLETED|Overall Study||10
9054160|NCT03570554|10113971|FG001|COMPLETED|Overall Study||10
9054161|NCT03570554|10113972|FG002|COMPLETED|Overall Study||10
9054162|NCT03570554|10113973|FG003|COMPLETED|Overall Study||9
9054163|NCT03570554|10113970|FG000|NOT COMPLETED|Overall Study||0
9054164|NCT03570554|10113971|FG001|NOT COMPLETED|Overall Study||0
9054165|NCT03570554|10113972|FG002|NOT COMPLETED|Overall Study||1
9054166|NCT03570554|10113973|FG003|NOT COMPLETED|Overall Study||1
9054167|NCT03570658|10113987|FG000|STARTED|Single Ascending Dose (SAD)||6
9054168|NCT03570658|10113988|FG001|STARTED|Single Ascending Dose (SAD)||2
9054169|NCT03570658|10113989|FG002|STARTED|Single Ascending Dose (SAD)||10
9054170|NCT03570658|10113990|FG003|STARTED|Single Ascending Dose (SAD)||10
9054171|NCT03570658|10113987|FG000|COMPLETED|Single Ascending Dose (SAD)||6
9054172|NCT03570658|10113988|FG001|COMPLETED|Single Ascending Dose (SAD)||2
9054173|NCT03570658|10113989|FG002|COMPLETED|Single Ascending Dose (SAD)||10
9054174|NCT03570658|10113990|FG003|COMPLETED|Single Ascending Dose (SAD)||10
9054175|NCT03570658|10113987|FG000|NOT COMPLETED|Single Ascending Dose (SAD)||0
9054176|NCT03570658|10113988|FG001|NOT COMPLETED|Single Ascending Dose (SAD)||0
9054177|NCT03570658|10113989|FG002|NOT COMPLETED|Single Ascending Dose (SAD)||0
9054178|NCT03570658|10113990|FG003|NOT COMPLETED|Single Ascending Dose (SAD)||0
9054179|NCT03570658|10113987|FG000|STARTED|Multiple Ascending Dose (MAD)||4
9054180|NCT03570658|10113988|FG001|STARTED|Multiple Ascending Dose (MAD)||0
9054181|NCT03570658|10113989|FG002|STARTED|Multiple Ascending Dose (MAD)||10
9054182|NCT03570658|10113990|FG003|STARTED|Multiple Ascending Dose (MAD)||10
9054183|NCT03570658|10113987|FG000|COMPLETED|Multiple Ascending Dose (MAD)||4
9054184|NCT03570658|10113988|FG001|COMPLETED|Multiple Ascending Dose (MAD)||0
9054185|NCT03570658|10113989|FG002|COMPLETED|Multiple Ascending Dose (MAD)||10
9054186|NCT03570658|10113990|FG003|COMPLETED|Multiple Ascending Dose (MAD)||10
9054187|NCT03570658|10113987|FG000|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
9054188|NCT03570658|10113988|FG001|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
9054189|NCT03570658|10113989|FG002|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
9054190|NCT03570658|10113990|FG003|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
9054191|NCT03571256|10114017|FG000|STARTED|Overall Study||52
9054192|NCT03571256|10114018|FG001|STARTED|Overall Study||54
9054193|NCT03571256|10114019|FG002|STARTED|Overall Study||52
9054194|NCT03571256|10114017|FG000|Safety Analysis Set|Overall Study||52
9054195|NCT03571256|10114018|FG001|Safety Analysis Set|Overall Study||54
9054196|NCT03571256|10114019|FG002|Safety Analysis Set|Overall Study||51
9054197|NCT03571256|10114017|FG000|Modified ITT (mITT) Analysis Set|Overall Study||49
9054198|NCT03571256|10114018|FG001|Modified ITT (mITT) Analysis Set|Overall Study||53
8703755|NCT00924651|9749496|FG001|STARTED|Overall Study||337
8703756|NCT00924651|9749495|FG000|COMPLETED|Overall Study||331
8703757|NCT00924651|9749496|FG001|COMPLETED|Overall Study||312
9054199|NCT03571256|10114019|FG002|Modified ITT (mITT) Analysis Set|Overall Study||51
9054200|NCT03571256|10114017|FG000|COMPLETED|Overall Study||46
9054201|NCT03571256|10114018|FG001|COMPLETED|Overall Study||51
9054202|NCT03571256|10114019|FG002|COMPLETED|Overall Study||48
9054203|NCT03571256|10114017|FG000|NOT COMPLETED|Overall Study||6
9054204|NCT03571256|10114018|FG001|NOT COMPLETED|Overall Study||3
9054205|NCT03571256|10114019|FG002|NOT COMPLETED|Overall Study||4
9054206|NCT03571516|10114031|FG000|STARTED|Overall Study||5
9054207|NCT03571516|10114032|FG001|STARTED|Overall Study||5
9054208|NCT03571516|10114031|FG000|COMPLETED|Overall Study||4
9054209|NCT03571516|10114032|FG001|COMPLETED|Overall Study||4
9054210|NCT03571516|10114031|FG000|NOT COMPLETED|Overall Study||1
9054211|NCT03571516|10114032|FG001|NOT COMPLETED|Overall Study||1
9054212|NCT03571555|10114040|FG000|STARTED|Overall Study||252
9054213|NCT03571555|10114041|FG001|STARTED|Overall Study||263
9054214|NCT03571555|10114040|FG000|COMPLETED|Overall Study||177
9054215|NCT03571555|10114041|FG001|COMPLETED|Overall Study||195
9054216|NCT03571555|10114040|FG000|NOT COMPLETED|Overall Study||75
9054217|NCT03571555|10114041|FG001|NOT COMPLETED|Overall Study||68
9054218|NCT03571607|10114049|FG000|STARTED|Overall Study||53
9054219|NCT03571607|10114050|FG001|STARTED|Overall Study||153
9054220|NCT03571607|10114049|FG000|Vaccinated|Overall Study||53
9054221|NCT03571607|10114050|FG001|Vaccinated|Overall Study||153
9054222|NCT03571607|10114049|FG000|COMPLETED|Overall Study||53
9054223|NCT03571607|10114050|FG001|COMPLETED|Overall Study||153
9054224|NCT03571607|10114049|FG000|NOT COMPLETED|Overall Study||0
9054225|NCT03571607|10114050|FG001|NOT COMPLETED|Overall Study||0
9054226|NCT03571672|10114058|FG000|STARTED|Overall Study||153
9054227|NCT03571672|10114058|FG000|COMPLETED|Overall Study||148
9054228|NCT03571672|10114058|FG000|NOT COMPLETED|Overall Study||5
9054229|NCT03571724|10114068|FG000|STARTED|Week -1 (Prior to Switching)||0
9054230|NCT03571724|10114069|FG001|STARTED|Week -1 (Prior to Switching)||0
9054231|NCT03571724|10114070|FG002|STARTED|Week -1 (Prior to Switching)||72
9054232|NCT03571724|10114071|FG003|STARTED|Week -1 (Prior to Switching)||70
9054233|NCT03571724|10114068|FG000|Topography|Week -1 (Prior to Switching)||0
9054234|NCT03571724|10114069|FG001|Topography|Week -1 (Prior to Switching)||0
9054235|NCT03571724|10114070|FG002|Topography|Week -1 (Prior to Switching)|These subjects switched into VLN arms.|18
9054236|NCT03571724|10114071|FG003|Topography|Week -1 (Prior to Switching)|These subjects switched into VLN arms.|18
9054237|NCT03571724|10114068|FG000|PK Nicotine|Week -1 (Prior to Switching)||0
9054238|NCT03571724|10114069|FG001|PK Nicotine|Week -1 (Prior to Switching)||0
9054239|NCT03571724|10114070|FG002|PK Nicotine|Week -1 (Prior to Switching)|These subjects switched into VLN arms.|12
9054240|NCT03571724|10114071|FG003|PK Nicotine|Week -1 (Prior to Switching)|These subjects switched into VLN arms.|12
9054241|NCT03571724|10114068|FG000|COMPLETED|Week -1 (Prior to Switching)||0
9054242|NCT03571724|10114069|FG001|COMPLETED|Week -1 (Prior to Switching)||0
9054243|NCT03571724|10114070|FG002|COMPLETED|Week -1 (Prior to Switching)||72
9054244|NCT03571724|10114071|FG003|COMPLETED|Week -1 (Prior to Switching)||70
9054245|NCT03571724|10114068|FG000|NOT COMPLETED|Week -1 (Prior to Switching)||0
9054246|NCT03571724|10114069|FG001|NOT COMPLETED|Week -1 (Prior to Switching)||0
9054247|NCT03571724|10114070|FG002|NOT COMPLETED|Week -1 (Prior to Switching)||0
9054248|NCT03571724|10114071|FG003|NOT COMPLETED|Week -1 (Prior to Switching)||0
9054249|NCT03571724|10114068|FG000|STARTED|Week 1-6|Non-menthol VLN subjects were assigned to this arm after randomization at week 1|50
9054250|NCT03571724|10114069|FG001|STARTED|Week 1-6|Menthol VLN subjects were assigned to this arm after randomization at week 1|50
9054251|NCT03571724|10114070|FG002|STARTED|Week 1-6||22
9054252|NCT03571724|10114071|FG003|STARTED|Week 1-6||20
9054253|NCT03571724|10114068|FG000|COMPLETED|Week 1-6||43
9054254|NCT03571724|10114069|FG001|COMPLETED|Week 1-6||42
9054255|NCT03571724|10114070|FG002|COMPLETED|Week 1-6||19
9054256|NCT03571724|10114071|FG003|COMPLETED|Week 1-6||20
9054257|NCT03571724|10114068|FG000|NOT COMPLETED|Week 1-6||7
9054258|NCT03571724|10114069|FG001|NOT COMPLETED|Week 1-6||8
9054259|NCT03571724|10114070|FG002|NOT COMPLETED|Week 1-6||3
9054260|NCT03571724|10114071|FG003|NOT COMPLETED|Week 1-6||0
9054261|NCT03572062|10114102|FG000|STARTED|Overall Study||32
9054262|NCT03572062|10114103|FG001|STARTED|Overall Study||32
9054263|NCT03572062|10114104|FG002|STARTED|Overall Study||32
9054264|NCT03572062|10114105|FG003|STARTED|Overall Study||31
9054265|NCT03572062|10114106|FG004|STARTED|Overall Study||32
9054266|NCT03572062|10114107|FG005|STARTED|Overall Study||32
9054267|NCT03572062|10114108|FG006|STARTED|Overall Study||32
9054268|NCT03572062|10114109|FG007|STARTED|Overall Study||31
9054269|NCT03572062|10114110|FG008|STARTED|Overall Study||32
9054270|NCT03572062|10114111|FG009|STARTED|Overall Study||31
9054271|NCT03572062|10114102|FG000|Treated|Overall Study||32
9054272|NCT03572062|10114103|FG001|Treated|Overall Study||32
9054273|NCT03572062|10114104|FG002|Treated|Overall Study||32
9054274|NCT03572062|10114105|FG003|Treated|Overall Study||31
9054275|NCT03572062|10114106|FG004|Treated|Overall Study||31
9054276|NCT03572062|10114107|FG005|Treated|Overall Study||30
9054277|NCT03572062|10114108|FG006|Treated|Overall Study||32
9054278|NCT03572062|10114109|FG007|Treated|Overall Study||30
9054279|NCT03572062|10114110|FG008|Treated|Overall Study||32
9054280|NCT03572062|10114111|FG009|Treated|Overall Study||31
9054281|NCT03572062|10114102|FG000|COMPLETED|Overall Study||32
9054282|NCT03572062|10114103|FG001|COMPLETED|Overall Study||32
9054283|NCT03572062|10114104|FG002|COMPLETED|Overall Study||32
9054284|NCT03572062|10114105|FG003|COMPLETED|Overall Study||31
9054285|NCT03572062|10114106|FG004|COMPLETED|Overall Study||31
9054286|NCT03572062|10114107|FG005|COMPLETED|Overall Study||28
9054287|NCT03572062|10114108|FG006|COMPLETED|Overall Study||31
9054288|NCT03572062|10114109|FG007|COMPLETED|Overall Study||30
9054289|NCT03572062|10114110|FG008|COMPLETED|Overall Study||0
9054290|NCT03572062|10114111|FG009|COMPLETED|Overall Study||0
9054291|NCT03572062|10114102|FG000|NOT COMPLETED|Overall Study||0
9054292|NCT03572062|10114103|FG001|NOT COMPLETED|Overall Study||0
9054293|NCT03572062|10114104|FG002|NOT COMPLETED|Overall Study||0
9054294|NCT03572062|10114105|FG003|NOT COMPLETED|Overall Study||0
9054295|NCT03572062|10114106|FG004|NOT COMPLETED|Overall Study||1
9054296|NCT03572062|10114107|FG005|NOT COMPLETED|Overall Study||4
9054297|NCT03572062|10114108|FG006|NOT COMPLETED|Overall Study||1
9054298|NCT03572062|10114109|FG007|NOT COMPLETED|Overall Study||1
9054299|NCT03572062|10114110|FG008|NOT COMPLETED|Overall Study||32
9054300|NCT03572062|10114111|FG009|NOT COMPLETED|Overall Study||31
9054301|NCT03572218|10114133|FG000|STARTED|Overall Study||36
9054302|NCT03572218|10114134|FG001|STARTED|Overall Study||36
9054303|NCT03572218|10114133|FG000|Week 12|Overall Study||30
9054304|NCT03572218|10114134|FG001|Week 12|Overall Study||31
9054305|NCT03572218|10114133|FG000|Week 26|Overall Study||30
9054306|NCT03572218|10114134|FG001|Week 26|Overall Study||31
9054307|NCT03572218|10114133|FG000|COMPLETED|Overall Study||30
9054308|NCT03572218|10114134|FG001|COMPLETED|Overall Study||31
9054309|NCT03572218|10114133|FG000|NOT COMPLETED|Overall Study||6
9054310|NCT03572218|10114134|FG001|NOT COMPLETED|Overall Study||5
9054311|NCT03572478|10114140|FG000|STARTED|Overall Study||12
9054312|NCT03572478|10114140|FG000|COMPLETED|Overall Study||12
9054313|NCT03572478|10114140|FG000|NOT COMPLETED|Overall Study||0
9054314|NCT03572972|10114149|FG000|STARTED|Overall Study||10548
9054315|NCT03572972|10114150|FG001|STARTED|Overall Study||11414
9054316|NCT03572972|10114151|FG002|STARTED|Overall Study||17779
9054317|NCT03572972|10114152|FG003|STARTED|Overall Study||8648
9054318|NCT03572972|10114153|FG004|STARTED|Overall Study||16295
9054319|NCT03572972|10114149|FG000|COMPLETED|Overall Study||10548
9054320|NCT03572972|10114150|FG001|COMPLETED|Overall Study||11414
9054321|NCT03572972|10114151|FG002|COMPLETED|Overall Study||17779
9054322|NCT03572972|10114152|FG003|COMPLETED|Overall Study||8648
9054323|NCT03572972|10114153|FG004|COMPLETED|Overall Study||16295
9054324|NCT03572972|10114149|FG000|NOT COMPLETED|Overall Study||0
9054325|NCT03572972|10114150|FG001|NOT COMPLETED|Overall Study||0
9054326|NCT03572972|10114151|FG002|NOT COMPLETED|Overall Study||0
9054327|NCT03572972|10114152|FG003|NOT COMPLETED|Overall Study||0
9054328|NCT03572972|10114153|FG004|NOT COMPLETED|Overall Study||0
9054329|NCT03573206|10114173|FG000|STARTED|Overall Study||168
9054330|NCT03573206|10114173|FG000|COMPLETED|Overall Study||168
9054331|NCT03573206|10114173|FG000|NOT COMPLETED|Overall Study||0
9054332|NCT03573323|10114179|FG000|STARTED|Blinded Treatment Period (Weeks 0-24)||520
9054333|NCT03573323|10114180|FG001|STARTED|Blinded Treatment Period (Weeks 0-24)||507
9054334|NCT03573323|10114179|FG000|Received at Least One Dose of Study Drug|Blinded Treatment Period (Weeks 0-24)||519
9054335|NCT03573323|10114180|FG001|Received at Least One Dose of Study Drug|Blinded Treatment Period (Weeks 0-24)||506
9054336|NCT03573323|10114179|FG000|COMPLETED|Blinded Treatment Period (Weeks 0-24)||465
9054337|NCT03573323|10114180|FG001|COMPLETED|Blinded Treatment Period (Weeks 0-24)||459
9054338|NCT03573323|10114179|FG000|NOT COMPLETED|Blinded Treatment Period (Weeks 0-24)||55
9054339|NCT03573323|10114180|FG001|NOT COMPLETED|Blinded Treatment Period (Weeks 0-24)||48
9054340|NCT03573323|10114179|FG000|STARTED|Post-Treatment Follow Up (Weeks 25-36)||465
9054341|NCT03573323|10114180|FG001|STARTED|Post-Treatment Follow Up (Weeks 25-36)|Excludes participants who completed treatment and did not enter the PTFU.|456
9054342|NCT03573323|10114179|FG000|COMPLETED|Post-Treatment Follow Up (Weeks 25-36)||406
9054343|NCT03573323|10114180|FG001|COMPLETED|Post-Treatment Follow Up (Weeks 25-36)||399
9054344|NCT03573323|10114179|FG000|NOT COMPLETED|Post-Treatment Follow Up (Weeks 25-36)||59
9054345|NCT03573323|10114180|FG001|NOT COMPLETED|Post-Treatment Follow Up (Weeks 25-36)||57
9054346|NCT03573505|10114192|FG000|STARTED|Overall Study||52
9054347|NCT03573505|10114193|FG001|STARTED|Overall Study||54
9054348|NCT03573505|10114192|FG000|COMPLETED|Overall Study||0
9054349|NCT03573505|10114193|FG001|COMPLETED|Overall Study||0
9054350|NCT03573505|10114192|FG000|NOT COMPLETED|Overall Study||52
9054351|NCT03573505|10114193|FG001|NOT COMPLETED|Overall Study||54
9054352|NCT03573804|10114200|FG000|STARTED|Overall Study||72
9054353|NCT03573804|10114200|FG000|COMPLETED|Overall Study||62
9054354|NCT03573804|10114200|FG000|NOT COMPLETED|Overall Study||10
9054355|NCT03573830|10114212|FG000|STARTED|Overall Study||364
9054356|NCT03573830|10114213|FG001|STARTED|Overall Study||367
9054357|NCT03573830|10114212|FG000|Reviewed Assigned Material|Overall Study|All participants assigned to this arm reviewed their assigned material.|364
9054358|NCT03573830|10114213|FG001|Reviewed Assigned Material|Overall Study|360 reviewed their assigned material:Transport Canada information plus the enhanced material.|360
9054359|NCT03573830|10114212|FG000|COMPLETED|Overall Study||360
9054360|NCT03573830|10114213|FG001|COMPLETED|Overall Study||360
9054361|NCT03573830|10114212|FG000|NOT COMPLETED|Overall Study||4
9054362|NCT03573830|10114213|FG001|NOT COMPLETED|Overall Study||7
9054363|NCT03573908|10114220|FG000|STARTED|Treatment Period||308
9054364|NCT03573908|10114221|FG001|STARTED|Treatment Period||306
9054365|NCT03573908|10114222|FG002|STARTED|Treatment Period||0
9054366|NCT03573908|10114223|FG003|STARTED|Treatment Period||0
9054367|NCT03573908|10114224|FG004|STARTED|Treatment Period||0
9054368|NCT03573908|10114220|FG000|COMPLETED|Treatment Period||284
9054369|NCT03573908|10114221|FG001|COMPLETED|Treatment Period||280
9054370|NCT03573908|10114222|FG002|COMPLETED|Treatment Period||0
9054371|NCT03573908|10114223|FG003|COMPLETED|Treatment Period||0
9054372|NCT03573908|10114224|FG004|COMPLETED|Treatment Period||0
9054373|NCT03573908|10114220|FG000|NOT COMPLETED|Treatment Period||24
9054374|NCT03573908|10114221|FG001|NOT COMPLETED|Treatment Period||26
9054375|NCT03573908|10114222|FG002|NOT COMPLETED|Treatment Period||0
9054376|NCT03573908|10114223|FG003|NOT COMPLETED|Treatment Period||0
9054377|NCT03573908|10114224|FG004|NOT COMPLETED|Treatment Period||0
9054378|NCT03573908|10114220|FG000|STARTED|Randomized Withdrawal Period||0
9054379|NCT03573908|10114221|FG001|STARTED|Randomized Withdrawal Period||0
9054380|NCT03573908|10114222|FG002|STARTED|Randomized Withdrawal Period||280
9054381|NCT03573908|10114223|FG003|STARTED|Randomized Withdrawal Period||138
9054382|NCT03573908|10114224|FG004|STARTED|Randomized Withdrawal Period||139
9054383|NCT03573908|10114220|FG000|COMPLETED|Randomized Withdrawal Period||0
9054384|NCT03573908|10114221|FG001|COMPLETED|Randomized Withdrawal Period||0
9054385|NCT03573908|10114222|FG002|COMPLETED|Randomized Withdrawal Period||272
9054386|NCT03573908|10114223|FG003|COMPLETED|Randomized Withdrawal Period||136
9054387|NCT03573908|10114224|FG004|COMPLETED|Randomized Withdrawal Period||137
9054388|NCT03573908|10114220|FG000|NOT COMPLETED|Randomized Withdrawal Period||0
9054389|NCT03573908|10114221|FG001|NOT COMPLETED|Randomized Withdrawal Period||0
9054390|NCT03573908|10114222|FG002|NOT COMPLETED|Randomized Withdrawal Period||8
9054391|NCT03573908|10114223|FG003|NOT COMPLETED|Randomized Withdrawal Period||2
9054392|NCT03573908|10114224|FG004|NOT COMPLETED|Randomized Withdrawal Period||2
9054393|NCT03574181|10114233|FG000|STARTED|Overall Study||9
9054394|NCT03574181|10114233|FG000|COMPLETED|Overall Study||0
9054395|NCT03574181|10114233|FG000|NOT COMPLETED|Overall Study||9
9054396|NCT03574441|10114240|FG000|STARTED|Overall Study||31
9054397|NCT03574441|10114241|FG001|STARTED|Overall Study||30
9054398|NCT03574441|10114242|FG002|STARTED|Overall Study||30
9054399|NCT03574441|10114240|FG000|COMPLETED|Overall Study||31
9054400|NCT03574441|10114241|FG001|COMPLETED|Overall Study||30
9054401|NCT03574441|10114242|FG002|COMPLETED|Overall Study||30
9054402|NCT03574441|10114240|FG000|NOT COMPLETED|Overall Study||0
9054403|NCT03574441|10114241|FG001|NOT COMPLETED|Overall Study||0
9054404|NCT03574441|10114242|FG002|NOT COMPLETED|Overall Study||0
9054405|NCT03574753|10114250|FG000|STARTED|Overall Study||23
9054406|NCT03574753|10114250|FG000|COMPLETED|Overall Study||0
9054407|NCT03574753|10114250|FG000|NOT COMPLETED|Overall Study||23
9054408|NCT03574818|10114255|FG000|STARTED|Overall Study||1
9054409|NCT03574818|10114255|FG000|COMPLETED|Overall Study||1
9054410|NCT03574818|10114255|FG000|NOT COMPLETED|Overall Study||0
9054411|NCT03575702|10114261|FG000|STARTED|Overall Study||149
9054412|NCT03575702|10114262|FG001|STARTED|Overall Study||150
9054413|NCT03575702|10114261|FG000|COMPLETED|Overall Study||143
9054414|NCT03575702|10114262|FG001|COMPLETED|Overall Study||146
9054415|NCT03575702|10114261|FG000|NOT COMPLETED|Overall Study||6
9054416|NCT03575702|10114262|FG001|NOT COMPLETED|Overall Study||4
8578743|NCT00178178|9611877|FG001|STARTED|Overall Study||24
8578744|NCT00178178|9611878|FG002|STARTED|Overall Study||24
8578745|NCT00178178|9611879|FG003|STARTED|Overall Study||24
9054417|NCT03575754|10114270|FG000|STARTED|Overall Study||25
9054418|NCT03575754|10114271|FG001|STARTED|Overall Study||25
9054419|NCT03575754|10114270|FG000|COMPLETED|Overall Study||25
9054420|NCT03575754|10114271|FG001|COMPLETED|Overall Study||25
9054421|NCT03575754|10114270|FG000|NOT COMPLETED|Overall Study||0
9054422|NCT03575754|10114271|FG001|NOT COMPLETED|Overall Study||0
9054423|NCT03575806|10114279|FG000|STARTED|Overall Study||25
9054424|NCT03575806|10114280|FG001|STARTED|Overall Study||27
9054425|NCT03575806|10114279|FG000|COMPLETED|Overall Study||25
9054426|NCT03575806|10114280|FG001|COMPLETED|Overall Study||23
9054427|NCT03575806|10114279|FG000|NOT COMPLETED|Overall Study||0
9054428|NCT03575806|10114280|FG001|NOT COMPLETED|Overall Study||4
9054429|NCT03575871|10114289|FG000|STARTED|Overall Study||158
9054430|NCT03575871|10114290|FG001|STARTED|Overall Study||155
8578746|NCT00178178|9611876|FG000|COMPLETED|Overall Study||24
9054431|NCT03575871|10114291|FG002|STARTED|Overall Study||78
9054432|NCT03575871|10114289|FG000|COMPLETED|Overall Study||137
9054433|NCT03575871|10114290|FG001|COMPLETED|Overall Study||141
9054434|NCT03575871|10114291|FG002|COMPLETED|Overall Study||52
9054435|NCT03575871|10114289|FG000|NOT COMPLETED|Overall Study||21
9054436|NCT03575871|10114290|FG001|NOT COMPLETED|Overall Study||14
9054437|NCT03575871|10114291|FG002|NOT COMPLETED|Overall Study||26
9054438|NCT03575962|10114299|FG000|STARTED|Treatment Period 1 (4 Days)||7
9054439|NCT03575962|10114300|FG001|STARTED|Treatment Period 1 (4 Days)||7
9054440|NCT03575962|10114299|FG000|COMPLETED|Treatment Period 1 (4 Days)||7
9054441|NCT03575962|10114300|FG001|COMPLETED|Treatment Period 1 (4 Days)||7
9054442|NCT03575962|10114299|FG000|NOT COMPLETED|Treatment Period 1 (4 Days)||0
9054443|NCT03575962|10114300|FG001|NOT COMPLETED|Treatment Period 1 (4 Days)||0
9054444|NCT03575962|10114299|FG000|STARTED|Washout Period (7 Days)||7
9054445|NCT03575962|10114300|FG001|STARTED|Washout Period (7 Days)||7
9054446|NCT03575962|10114299|FG000|COMPLETED|Washout Period (7 Days)||7
9054447|NCT03575962|10114300|FG001|COMPLETED|Washout Period (7 Days)||7
9054448|NCT03575962|10114299|FG000|NOT COMPLETED|Washout Period (7 Days)||0
9054449|NCT03575962|10114300|FG001|NOT COMPLETED|Washout Period (7 Days)||0
9054450|NCT03575962|10114299|FG000|STARTED|Treatment Period 2 (4 Days)||7
9054451|NCT03575962|10114300|FG001|STARTED|Treatment Period 2 (4 Days)||7
9054452|NCT03575962|10114299|FG000|COMPLETED|Treatment Period 2 (4 Days)||7
9054453|NCT03575962|10114300|FG001|COMPLETED|Treatment Period 2 (4 Days)||7
9054454|NCT03575962|10114299|FG000|NOT COMPLETED|Treatment Period 2 (4 Days)||0
9054455|NCT03575962|10114300|FG001|NOT COMPLETED|Treatment Period 2 (4 Days)||0
9054456|NCT03575975|10114309|FG000|STARTED|Overall Study||4
9054457|NCT03575975|10114310|FG001|STARTED|Overall Study||5
9054458|NCT03575975|10114311|FG002|STARTED|Overall Study||0
9054459|NCT03575975|10114309|FG000|COMPLETED|Overall Study||3
9054460|NCT03575975|10114310|FG001|COMPLETED|Overall Study||5
9054461|NCT03575975|10114311|FG002|COMPLETED|Overall Study||0
9054462|NCT03575975|10114309|FG000|NOT COMPLETED|Overall Study||1
9054463|NCT03575975|10114310|FG001|NOT COMPLETED|Overall Study||0
9054464|NCT03575975|10114311|FG002|NOT COMPLETED|Overall Study||0
9054465|NCT03576066|10114319|FG000|STARTED|Overall Study||45
9054466|NCT03576066|10114320|FG001|STARTED|Overall Study||28
9054467|NCT03576066|10114319|FG000|COMPLETED|Overall Study||45
9054468|NCT03576066|10114320|FG001|COMPLETED|Overall Study||27
9054469|NCT03576066|10114319|FG000|NOT COMPLETED|Overall Study||0
9054470|NCT03576066|10114320|FG001|NOT COMPLETED|Overall Study||1
9054471|NCT03576118|10114332|FG000|STARTED|Overall Study||37
9054472|NCT03576118|10114333|FG001|STARTED|Overall Study||37
9054473|NCT03576118|10114332|FG000|COMPLETED|Overall Study||34
9054474|NCT03576118|10114333|FG001|COMPLETED|Overall Study||33
9054475|NCT03576118|10114332|FG000|NOT COMPLETED|Overall Study||3
9054476|NCT03576118|10114333|FG001|NOT COMPLETED|Overall Study||4
9054477|NCT03576183|10114341|FG000|STARTED|Overall Study||17
9054478|NCT03576183|10114342|FG001|STARTED|Overall Study||17
9054479|NCT03576183|10114341|FG000|COMPLETED|Overall Study||15
9054480|NCT03576183|10114342|FG001|COMPLETED|Overall Study||16
9054481|NCT03576183|10114341|FG000|NOT COMPLETED|Overall Study||2
9054482|NCT03576183|10114342|FG001|NOT COMPLETED|Overall Study||1
9054483|NCT03576768|10114352|FG000|STARTED|Overall Study||13
9054484|NCT03576768|10114353|FG001|STARTED|Overall Study||12
9054485|NCT03576768|10114354|FG002|STARTED|Overall Study|The study was ended before recruitment into this arm started.|0
9054486|NCT03576768|10114355|FG003|STARTED|Overall Study|The study was ended before recruitment into this arm started.|0
9054487|NCT03576768|10114352|FG000|COMPLETED|Overall Study||10
9054488|NCT03576768|10114353|FG001|COMPLETED|Overall Study||9
9054489|NCT03576768|10114354|FG002|COMPLETED|Overall Study||0
9054490|NCT03576768|10114355|FG003|COMPLETED|Overall Study||0
9054491|NCT03576768|10114352|FG000|NOT COMPLETED|Overall Study||3
9054492|NCT03576768|10114353|FG001|NOT COMPLETED|Overall Study||3
9054493|NCT03576768|10114354|FG002|NOT COMPLETED|Overall Study||0
9054494|NCT03576768|10114355|FG003|NOT COMPLETED|Overall Study||0
9054495|NCT03577171|10114367|FG000|STARTED|Overall Study||13
9054496|NCT03577171|10114368|FG001|STARTED|Overall Study||12
9054497|NCT03577171|10114367|FG000|COMPLETED|Overall Study||13
9054498|NCT03577171|10114368|FG001|COMPLETED|Overall Study||12
9054499|NCT03577171|10114367|FG000|NOT COMPLETED|Overall Study||0
9054500|NCT03577171|10114368|FG001|NOT COMPLETED|Overall Study||0
9054501|NCT03577275|10114374|FG000|STARTED|Overall Study|All participants received all of the 4 interventions|32
9054502|NCT03577275|10114374|FG000|Placebo|Overall Study||32
9054503|NCT03577275|10114374|FG000|Moxifloxacin 400mg|Overall Study||32
9054504|NCT03577275|10114374|FG000|NST-4016 600mg|Overall Study||32
9054505|NCT03577275|10114374|FG000|NST-4016 2000mg|Overall Study||32
9054506|NCT03577275|10114374|FG000|COMPLETED|Overall Study||32
9054507|NCT03577275|10114374|FG000|NOT COMPLETED|Overall Study||0
9054508|NCT03577730|10114390|FG000|STARTED|Overall Study||34
9054509|NCT03577730|10114391|FG001|STARTED|Overall Study||31
9054510|NCT03577730|10114390|FG000|Received Treatment|Overall Study||33
9054511|NCT03577730|10114391|FG001|Received Treatment|Overall Study||31
9054512|NCT03577730|10114390|FG000|COMPLETED|Overall Study||30
9054513|NCT03577730|10114391|FG001|COMPLETED|Overall Study||30
9054514|NCT03577730|10114390|FG000|NOT COMPLETED|Overall Study||4
9054515|NCT03577730|10114391|FG001|NOT COMPLETED|Overall Study||1
9054516|NCT03578146|10114403|FG000|STARTED|Overall Study||16
9054517|NCT03578146|10114404|FG001|STARTED|Overall Study||6
9054518|NCT03578146|10114405|FG002|STARTED|Overall Study||6
9054519|NCT03578146|10114406|FG003|STARTED|Overall Study||6
9054520|NCT03578146|10114407|FG004|STARTED|Overall Study||6
9054521|NCT03578146|10114408|FG005|STARTED|Overall Study||8
9054522|NCT03578146|10114403|FG000|COMPLETED|Overall Study||15
9054523|NCT03578146|10114404|FG001|COMPLETED|Overall Study||5
9054524|NCT03578146|10114405|FG002|COMPLETED|Overall Study||5
9054525|NCT03578146|10114406|FG003|COMPLETED|Overall Study||6
9054526|NCT03578146|10114407|FG004|COMPLETED|Overall Study||6
9054527|NCT03578146|10114408|FG005|COMPLETED|Overall Study||5
9054528|NCT03578146|10114403|FG000|NOT COMPLETED|Overall Study||1
9054529|NCT03578146|10114404|FG001|NOT COMPLETED|Overall Study||1
9054530|NCT03578146|10114405|FG002|NOT COMPLETED|Overall Study||1
9054531|NCT03578146|10114406|FG003|NOT COMPLETED|Overall Study||0
9054532|NCT03578146|10114407|FG004|NOT COMPLETED|Overall Study||0
9054533|NCT03578146|10114408|FG005|NOT COMPLETED|Overall Study||3
9054534|NCT03578549|10114422|FG000|STARTED|Overall Study||30
9054535|NCT03578549|10114422|FG000|COMPLETED|Overall Study||29
9054536|NCT03578549|10114422|FG000|NOT COMPLETED|Overall Study||1
9054537|NCT03578926|10114426|FG000|STARTED|First Intervention||21
9054538|NCT03578926|10114427|FG001|STARTED|First Intervention||23
9054539|NCT03578926|10114426|FG000|COMPLETED|First Intervention||21
9054540|NCT03578926|10114427|FG001|COMPLETED|First Intervention||23
9054541|NCT03578926|10114426|FG000|NOT COMPLETED|First Intervention||0
9054542|NCT03578926|10114427|FG001|NOT COMPLETED|First Intervention||0
9054543|NCT03578926|10114426|FG000|STARTED|Second Intervention||23
9054544|NCT03578926|10114427|FG001|STARTED|Second Intervention||21
9054545|NCT03578926|10114426|FG000|COMPLETED|Second Intervention||23
9054546|NCT03578926|10114427|FG001|COMPLETED|Second Intervention||21
9054547|NCT03578926|10114426|FG000|NOT COMPLETED|Second Intervention||0
9054548|NCT03578926|10114427|FG001|NOT COMPLETED|Second Intervention||0
9054549|NCT03579290|10114435|FG000|STARTED|Overall Study||40
9054550|NCT03579290|10114435|FG000|COMPLETED|Overall Study||31
9054551|NCT03579290|10114435|FG000|NOT COMPLETED|Overall Study||9
9054552|NCT03579433|10114439|FG000|STARTED|Overall Study||104
9054553|NCT03579433|10114439|FG000|ORA With VerifEye+|Overall Study||96
9054554|NCT03579433|10114439|FG000|Barrett Calculator|Overall Study||102
9054555|NCT03579433|10114439|FG000|COMPLETED|Overall Study||98
9054556|NCT03579433|10114439|FG000|NOT COMPLETED|Overall Study||6
9054557|NCT03579719|10114447|FG000|STARTED|Overall Study||15
9054558|NCT03579719|10114447|FG000|COMPLETED|Overall Study||14
9054559|NCT03579719|10114447|FG000|NOT COMPLETED|Overall Study||1
9054560|NCT03579940|10114462|FG000|STARTED|Period 1||3
9054561|NCT03579940|10114463|FG001|STARTED|Period 1||2
9054562|NCT03579940|10114464|FG002|STARTED|Period 1||2
9054563|NCT03579940|10114465|FG003|STARTED|Period 1||2
9054564|NCT03579940|10114466|FG004|STARTED|Period 1||2
9054565|NCT03579940|10114467|FG005|STARTED|Period 1||2
9054566|NCT03579940|10114468|FG006|STARTED|Period 1||3
9054567|NCT03579940|10114469|FG007|STARTED|Period 1||3
9054568|NCT03579940|10114470|FG008|STARTED|Period 1||3
9054569|NCT03579940|10114471|FG009|STARTED|Period 1||2
9054570|NCT03579940|10114472|FG010|STARTED|Period 1||3
9054571|NCT03579940|10114462|FG000|Received at Least 1 Dose of Study Drug|Period 1||3
9054572|NCT03579940|10114463|FG001|Received at Least 1 Dose of Study Drug|Period 1||2
9054573|NCT03579940|10114464|FG002|Received at Least 1 Dose of Study Drug|Period 1||2
9054574|NCT03579940|10114465|FG003|Received at Least 1 Dose of Study Drug|Period 1||2
9054575|NCT03579940|10114466|FG004|Received at Least 1 Dose of Study Drug|Period 1||2
9054576|NCT03579940|10114467|FG005|Received at Least 1 Dose of Study Drug|Period 1||2
9054577|NCT03579940|10114468|FG006|Received at Least 1 Dose of Study Drug|Period 1||3
9054578|NCT03579940|10114469|FG007|Received at Least 1 Dose of Study Drug|Period 1||3
9054579|NCT03579940|10114470|FG008|Received at Least 1 Dose of Study Drug|Period 1||3
9054580|NCT03579940|10114471|FG009|Received at Least 1 Dose of Study Drug|Period 1||2
9054581|NCT03579940|10114472|FG010|Received at Least 1 Dose of Study Drug|Period 1||3
9054582|NCT03579940|10114462|FG000|COMPLETED|Period 1||3
9054583|NCT03579940|10114463|FG001|COMPLETED|Period 1||2
9054584|NCT03579940|10114464|FG002|COMPLETED|Period 1||2
9054585|NCT03579940|10114465|FG003|COMPLETED|Period 1||2
9054586|NCT03579940|10114466|FG004|COMPLETED|Period 1||2
9054587|NCT03579940|10114467|FG005|COMPLETED|Period 1||2
9054588|NCT03579940|10114468|FG006|COMPLETED|Period 1||3
9054589|NCT03579940|10114469|FG007|COMPLETED|Period 1||3
9054590|NCT03579940|10114470|FG008|COMPLETED|Period 1||3
9054591|NCT03579940|10114471|FG009|COMPLETED|Period 1||2
9054592|NCT03579940|10114472|FG010|COMPLETED|Period 1||3
9054593|NCT03579940|10114462|FG000|NOT COMPLETED|Period 1||0
9054594|NCT03579940|10114463|FG001|NOT COMPLETED|Period 1||0
9054595|NCT03579940|10114464|FG002|NOT COMPLETED|Period 1||0
9054596|NCT03579940|10114465|FG003|NOT COMPLETED|Period 1||0
9054597|NCT03579940|10114466|FG004|NOT COMPLETED|Period 1||0
9054598|NCT03579940|10114467|FG005|NOT COMPLETED|Period 1||0
9054599|NCT03579940|10114468|FG006|NOT COMPLETED|Period 1||0
9054600|NCT03579940|10114469|FG007|NOT COMPLETED|Period 1||0
9054601|NCT03579940|10114470|FG008|NOT COMPLETED|Period 1||0
9054602|NCT03579940|10114471|FG009|NOT COMPLETED|Period 1||0
9054603|NCT03579940|10114472|FG010|NOT COMPLETED|Period 1||0
9054604|NCT03579940|10114462|FG000|STARTED|Period 2||3
9054605|NCT03579940|10114463|FG001|STARTED|Period 2||2
9054606|NCT03579940|10114464|FG002|STARTED|Period 2||2
9054607|NCT03579940|10114465|FG003|STARTED|Period 2||2
9054608|NCT03579940|10114466|FG004|STARTED|Period 2||2
9054609|NCT03579940|10114467|FG005|STARTED|Period 2||2
9054610|NCT03579940|10114468|FG006|STARTED|Period 2||3
9054611|NCT03579940|10114469|FG007|STARTED|Period 2||3
9054612|NCT03579940|10114470|FG008|STARTED|Period 2||3
9054613|NCT03579940|10114471|FG009|STARTED|Period 2||2
9054614|NCT03579940|10114472|FG010|STARTED|Period 2||3
9054615|NCT03579940|10114462|FG000|COMPLETED|Period 2||3
9054616|NCT03579940|10114463|FG001|COMPLETED|Period 2||2
9054617|NCT03579940|10114464|FG002|COMPLETED|Period 2||1
9054618|NCT03579940|10114465|FG003|COMPLETED|Period 2||2
9054619|NCT03579940|10114466|FG004|COMPLETED|Period 2||2
9054620|NCT03579940|10114467|FG005|COMPLETED|Period 2||2
9054621|NCT03579940|10114468|FG006|COMPLETED|Period 2||3
9054622|NCT03579940|10114469|FG007|COMPLETED|Period 2||3
9054623|NCT03579940|10114470|FG008|COMPLETED|Period 2||3
9054624|NCT03579940|10114471|FG009|COMPLETED|Period 2||2
9054625|NCT03579940|10114472|FG010|COMPLETED|Period 2||3
9054626|NCT03579940|10114462|FG000|NOT COMPLETED|Period 2||0
9054627|NCT03579940|10114463|FG001|NOT COMPLETED|Period 2||0
9054628|NCT03579940|10114464|FG002|NOT COMPLETED|Period 2||1
9054629|NCT03579940|10114465|FG003|NOT COMPLETED|Period 2||0
9054630|NCT03579940|10114466|FG004|NOT COMPLETED|Period 2||0
9054631|NCT03579940|10114467|FG005|NOT COMPLETED|Period 2||0
9054632|NCT03579940|10114468|FG006|NOT COMPLETED|Period 2||0
9054633|NCT03579940|10114469|FG007|NOT COMPLETED|Period 2||0
9054634|NCT03579940|10114470|FG008|NOT COMPLETED|Period 2||0
9054635|NCT03579940|10114471|FG009|NOT COMPLETED|Period 2||0
9054636|NCT03579940|10114472|FG010|NOT COMPLETED|Period 2||0
9054637|NCT03579940|10114462|FG000|STARTED|Period 3||3
9054638|NCT03579940|10114463|FG001|STARTED|Period 3||2
9054639|NCT03579940|10114464|FG002|STARTED|Period 3||1
9054640|NCT03579940|10114465|FG003|STARTED|Period 3||2
9054641|NCT03579940|10114466|FG004|STARTED|Period 3||2
9054642|NCT03579940|10114467|FG005|STARTED|Period 3||2
9054643|NCT03579940|10114468|FG006|STARTED|Period 3||3
9054644|NCT03579940|10114469|FG007|STARTED|Period 3||3
9054645|NCT03579940|10114470|FG008|STARTED|Period 3||3
9054646|NCT03579940|10114471|FG009|STARTED|Period 3||2
9054647|NCT03579940|10114472|FG010|STARTED|Period 3||3
9054648|NCT03579940|10114462|FG000|COMPLETED|Period 3||3
9054649|NCT03579940|10114463|FG001|COMPLETED|Period 3||2
9054650|NCT03579940|10114464|FG002|COMPLETED|Period 3||1
9054651|NCT03579940|10114465|FG003|COMPLETED|Period 3||2
9054652|NCT03579940|10114466|FG004|COMPLETED|Period 3||2
9054653|NCT03579940|10114467|FG005|COMPLETED|Period 3||2
9054654|NCT03579940|10114468|FG006|COMPLETED|Period 3||3
9054655|NCT03579940|10114469|FG007|COMPLETED|Period 3||3
9054656|NCT03579940|10114470|FG008|COMPLETED|Period 3||3
9054657|NCT03579940|10114471|FG009|COMPLETED|Period 3||2
9054658|NCT03579940|10114472|FG010|COMPLETED|Period 3||3
9054659|NCT03579940|10114462|FG000|NOT COMPLETED|Period 3||0
9054660|NCT03579940|10114463|FG001|NOT COMPLETED|Period 3||0
9054661|NCT03579940|10114464|FG002|NOT COMPLETED|Period 3||0
9054662|NCT03579940|10114465|FG003|NOT COMPLETED|Period 3||0
9054663|NCT03579940|10114466|FG004|NOT COMPLETED|Period 3||0
9054664|NCT03579940|10114467|FG005|NOT COMPLETED|Period 3||0
9054665|NCT03579940|10114468|FG006|NOT COMPLETED|Period 3||0
9054666|NCT03579940|10114469|FG007|NOT COMPLETED|Period 3||0
9054667|NCT03579940|10114470|FG008|NOT COMPLETED|Period 3||0
9054668|NCT03579940|10114471|FG009|NOT COMPLETED|Period 3||0
9054669|NCT03579940|10114472|FG010|NOT COMPLETED|Period 3||0
9054670|NCT03580343|10114504|FG000|STARTED|Overall Study||5
9054671|NCT03580343|10114504|FG000|COMPLETED|Overall Study||4
9054672|NCT03580343|10114504|FG000|NOT COMPLETED|Overall Study||1
9054673|NCT03581084|10114508|FG000|STARTED|Overall Study||1
9054674|NCT03581084|10114508|FG000|COMPLETED|Overall Study||1
9054675|NCT03581084|10114508|FG000|NOT COMPLETED|Overall Study||0
9054676|NCT03581097|10114514|FG000|STARTED|Overall Study||46
9054677|NCT03581097|10114515|FG001|STARTED|Overall Study||47
9054678|NCT03581097|10114514|FG000|COMPLETED|Overall Study||46
9054679|NCT03581097|10114515|FG001|COMPLETED|Overall Study||47
9054680|NCT03581097|10114514|FG000|NOT COMPLETED|Overall Study||0
9054681|NCT03581097|10114515|FG001|NOT COMPLETED|Overall Study||0
9054682|NCT03581474|10114523|FG000|STARTED|Overall Study||12
9054683|NCT03581474|10114523|FG000|COMPLETED|Overall Study||12
9054684|NCT03581474|10114523|FG000|NOT COMPLETED|Overall Study||0
9054685|NCT03581825|10114527|FG000|STARTED|Period 1||31
9054686|NCT03581825|10114528|FG001|STARTED|Period 1||31
9054687|NCT03581825|10114527|FG000|COMPLETED|Period 1||30
9054688|NCT03581825|10114528|FG001|COMPLETED|Period 1||31
9054689|NCT03581825|10114527|FG000|NOT COMPLETED|Period 1||1
9054690|NCT03581825|10114528|FG001|NOT COMPLETED|Period 1||0
9054691|NCT03581825|10114527|FG000|STARTED|Period 2||30
9054692|NCT03581825|10114528|FG001|STARTED|Period 2||31
9054693|NCT03581825|10114527|FG000|COMPLETED|Period 2||30
9054694|NCT03581825|10114528|FG001|COMPLETED|Period 2||30
9054695|NCT03581825|10114527|FG000|NOT COMPLETED|Period 2||0
9054696|NCT03581825|10114528|FG001|NOT COMPLETED|Period 2||1
9054697|NCT03582215|10114542|FG000|STARTED|Overall Study||6
9054698|NCT03582215|10114543|FG001|STARTED|Overall Study||6
9054699|NCT03582215|10114544|FG002|STARTED|Overall Study||6
9054700|NCT03582215|10114545|FG003|STARTED|Overall Study||6
9054701|NCT03582215|10114546|FG004|STARTED|Overall Study||12
9054702|NCT03582215|10114547|FG005|STARTED|Overall Study||12
9054703|NCT03582215|10114548|FG006|STARTED|Overall Study||12
9054704|NCT03582215|10114549|FG007|STARTED|Overall Study||12
9054705|NCT03582215|10114542|FG000|COMPLETED|Overall Study||5
9054706|NCT03582215|10114543|FG001|COMPLETED|Overall Study||6
9054707|NCT03582215|10114544|FG002|COMPLETED|Overall Study||6
9054708|NCT03582215|10114545|FG003|COMPLETED|Overall Study||6
9054709|NCT03582215|10114546|FG004|COMPLETED|Overall Study||12
9054710|NCT03582215|10114547|FG005|COMPLETED|Overall Study||12
9054711|NCT03582215|10114548|FG006|COMPLETED|Overall Study||10
9054712|NCT03582215|10114549|FG007|COMPLETED|Overall Study||10
9054713|NCT03582215|10114542|FG000|NOT COMPLETED|Overall Study||1
9054714|NCT03582215|10114543|FG001|NOT COMPLETED|Overall Study||0
9054715|NCT03582215|10114544|FG002|NOT COMPLETED|Overall Study||0
9054716|NCT03582215|10114545|FG003|NOT COMPLETED|Overall Study||0
9054717|NCT03582215|10114546|FG004|NOT COMPLETED|Overall Study||0
9054718|NCT03582215|10114547|FG005|NOT COMPLETED|Overall Study||0
9054719|NCT03582215|10114548|FG006|NOT COMPLETED|Overall Study||2
9054720|NCT03582215|10114549|FG007|NOT COMPLETED|Overall Study||2
9054721|NCT03582553|10114584|FG000|STARTED|Intervention 1/Visit 1||3
9054722|NCT03582553|10114585|FG001|STARTED|Intervention 1/Visit 1||3
9054723|NCT03582553|10114586|FG002|STARTED|Intervention 1/Visit 1||3
9054724|NCT03582553|10114587|FG003|STARTED|Intervention 1/Visit 1||3
9054725|NCT03582553|10114588|FG004|STARTED|Intervention 1/Visit 1||3
9054726|NCT03582553|10114589|FG005|STARTED|Intervention 1/Visit 1||3
9054727|NCT03582553|10114584|FG000|COMPLETED|Intervention 1/Visit 1||3
9054728|NCT03582553|10114585|FG001|COMPLETED|Intervention 1/Visit 1||3
9054729|NCT03582553|10114586|FG002|COMPLETED|Intervention 1/Visit 1||3
9054730|NCT03582553|10114587|FG003|COMPLETED|Intervention 1/Visit 1||3
9054731|NCT03582553|10114588|FG004|COMPLETED|Intervention 1/Visit 1||3
9054732|NCT03582553|10114589|FG005|COMPLETED|Intervention 1/Visit 1||3
9054733|NCT03582553|10114584|FG000|NOT COMPLETED|Intervention 1/Visit 1||0
9054734|NCT03582553|10114585|FG001|NOT COMPLETED|Intervention 1/Visit 1||0
9054735|NCT03582553|10114586|FG002|NOT COMPLETED|Intervention 1/Visit 1||0
9054736|NCT03582553|10114587|FG003|NOT COMPLETED|Intervention 1/Visit 1||0
9054737|NCT03582553|10114588|FG004|NOT COMPLETED|Intervention 1/Visit 1||0
9054738|NCT03582553|10114589|FG005|NOT COMPLETED|Intervention 1/Visit 1||0
9054739|NCT03582553|10114584|FG000|STARTED|Washout Period ( At Least 1 Week)||3
9054740|NCT03582553|10114585|FG001|STARTED|Washout Period ( At Least 1 Week)||3
9054741|NCT03582553|10114586|FG002|STARTED|Washout Period ( At Least 1 Week)||3
9054742|NCT03582553|10114587|FG003|STARTED|Washout Period ( At Least 1 Week)||3
9054743|NCT03582553|10114588|FG004|STARTED|Washout Period ( At Least 1 Week)||3
9054744|NCT03582553|10114589|FG005|STARTED|Washout Period ( At Least 1 Week)||3
9054745|NCT03582553|10114584|FG000|COMPLETED|Washout Period ( At Least 1 Week)||3
9054746|NCT03582553|10114585|FG001|COMPLETED|Washout Period ( At Least 1 Week)||3
9054747|NCT03582553|10114586|FG002|COMPLETED|Washout Period ( At Least 1 Week)||3
9054748|NCT03582553|10114587|FG003|COMPLETED|Washout Period ( At Least 1 Week)||3
9054749|NCT03582553|10114588|FG004|COMPLETED|Washout Period ( At Least 1 Week)||3
9054750|NCT03582553|10114589|FG005|COMPLETED|Washout Period ( At Least 1 Week)||3
9054751|NCT03582553|10114584|FG000|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
9054752|NCT03582553|10114585|FG001|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
9054753|NCT03582553|10114586|FG002|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
9054754|NCT03582553|10114587|FG003|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
9054755|NCT03582553|10114588|FG004|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
9054756|NCT03582553|10114589|FG005|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
9054757|NCT03582553|10114584|FG000|STARTED|Intervention 2/Visit 2||3
9054758|NCT03582553|10114585|FG001|STARTED|Intervention 2/Visit 2||3
9054759|NCT03582553|10114586|FG002|STARTED|Intervention 2/Visit 2||3
9054760|NCT03582553|10114587|FG003|STARTED|Intervention 2/Visit 2||3
9054761|NCT03582553|10114588|FG004|STARTED|Intervention 2/Visit 2||3
9054762|NCT03582553|10114589|FG005|STARTED|Intervention 2/Visit 2||3
9054763|NCT03582553|10114584|FG000|COMPLETED|Intervention 2/Visit 2||3
9054764|NCT03582553|10114585|FG001|COMPLETED|Intervention 2/Visit 2||3
9054765|NCT03582553|10114586|FG002|COMPLETED|Intervention 2/Visit 2||3
9054766|NCT03582553|10114587|FG003|COMPLETED|Intervention 2/Visit 2||3
9054767|NCT03582553|10114588|FG004|COMPLETED|Intervention 2/Visit 2||3
9054768|NCT03582553|10114589|FG005|COMPLETED|Intervention 2/Visit 2||3
9054769|NCT03582553|10114584|FG000|NOT COMPLETED|Intervention 2/Visit 2||0
9054770|NCT03582553|10114585|FG001|NOT COMPLETED|Intervention 2/Visit 2||0
9054771|NCT03582553|10114586|FG002|NOT COMPLETED|Intervention 2/Visit 2||0
9054772|NCT03582553|10114587|FG003|NOT COMPLETED|Intervention 2/Visit 2||0
9054773|NCT03582553|10114588|FG004|NOT COMPLETED|Intervention 2/Visit 2||0
9054774|NCT03582553|10114589|FG005|NOT COMPLETED|Intervention 2/Visit 2||0
9054775|NCT03582553|10114584|FG000|STARTED|Washout Period (At Least 1 Week)||3
9054776|NCT03582553|10114585|FG001|STARTED|Washout Period (At Least 1 Week)||3
9054777|NCT03582553|10114586|FG002|STARTED|Washout Period (At Least 1 Week)||3
9054778|NCT03582553|10114587|FG003|STARTED|Washout Period (At Least 1 Week)||3
9054779|NCT03582553|10114588|FG004|STARTED|Washout Period (At Least 1 Week)||3
9054780|NCT03582553|10114589|FG005|STARTED|Washout Period (At Least 1 Week)||3
9054781|NCT03582553|10114584|FG000|COMPLETED|Washout Period (At Least 1 Week)||3
9054782|NCT03582553|10114585|FG001|COMPLETED|Washout Period (At Least 1 Week)||3
9054783|NCT03582553|10114586|FG002|COMPLETED|Washout Period (At Least 1 Week)||3
9054784|NCT03582553|10114587|FG003|COMPLETED|Washout Period (At Least 1 Week)||3
9054785|NCT03582553|10114588|FG004|COMPLETED|Washout Period (At Least 1 Week)||3
9054786|NCT03582553|10114589|FG005|COMPLETED|Washout Period (At Least 1 Week)||3
9054787|NCT03582553|10114584|FG000|NOT COMPLETED|Washout Period (At Least 1 Week)||0
9054788|NCT03582553|10114585|FG001|NOT COMPLETED|Washout Period (At Least 1 Week)||0
9054789|NCT03582553|10114586|FG002|NOT COMPLETED|Washout Period (At Least 1 Week)||0
9054790|NCT03582553|10114587|FG003|NOT COMPLETED|Washout Period (At Least 1 Week)||0
9054791|NCT03582553|10114588|FG004|NOT COMPLETED|Washout Period (At Least 1 Week)||0
9054792|NCT03582553|10114589|FG005|NOT COMPLETED|Washout Period (At Least 1 Week)||0
9054793|NCT03582553|10114584|FG000|STARTED|Intervention 3/Visit 3||3
9054794|NCT03582553|10114585|FG001|STARTED|Intervention 3/Visit 3||3
9054795|NCT03582553|10114586|FG002|STARTED|Intervention 3/Visit 3||3
9054796|NCT03582553|10114587|FG003|STARTED|Intervention 3/Visit 3||3
9054797|NCT03582553|10114588|FG004|STARTED|Intervention 3/Visit 3||3
9054798|NCT03582553|10114589|FG005|STARTED|Intervention 3/Visit 3||3
9054799|NCT03582553|10114584|FG000|COMPLETED|Intervention 3/Visit 3||3
9054800|NCT03582553|10114585|FG001|COMPLETED|Intervention 3/Visit 3||3
9054801|NCT03582553|10114586|FG002|COMPLETED|Intervention 3/Visit 3||3
9054802|NCT03582553|10114587|FG003|COMPLETED|Intervention 3/Visit 3||3
9054803|NCT03582553|10114588|FG004|COMPLETED|Intervention 3/Visit 3||3
9054804|NCT03582553|10114589|FG005|COMPLETED|Intervention 3/Visit 3||3
9054805|NCT03582553|10114584|FG000|NOT COMPLETED|Intervention 3/Visit 3||0
9054806|NCT03582553|10114585|FG001|NOT COMPLETED|Intervention 3/Visit 3||0
9054807|NCT03582553|10114586|FG002|NOT COMPLETED|Intervention 3/Visit 3||0
9054808|NCT03582553|10114587|FG003|NOT COMPLETED|Intervention 3/Visit 3||0
9054809|NCT03582553|10114588|FG004|NOT COMPLETED|Intervention 3/Visit 3||0
9054810|NCT03582553|10114589|FG005|NOT COMPLETED|Intervention 3/Visit 3||0
9054811|NCT03582813|10114609|FG000|STARTED|Overall Study||114
9054812|NCT03582813|10114610|FG001|STARTED|Overall Study||102
9054813|NCT03582813|10114609|FG000|COMPLETED|Overall Study||95
9054814|NCT03582813|10114610|FG001|COMPLETED|Overall Study||81
9054815|NCT03582813|10114609|FG000|NOT COMPLETED|Overall Study||19
9054816|NCT03582813|10114610|FG001|NOT COMPLETED|Overall Study||21
9054817|NCT03582826|10114618|FG000|STARTED|Overall Study||119
9054818|NCT03582826|10114619|FG001|STARTED|Overall Study||6
9054819|NCT03582826|10114618|FG000|COMPLETED|Overall Study||78
9054820|NCT03582826|10114619|FG001|COMPLETED|Overall Study||6
9054821|NCT03582826|10114618|FG000|NOT COMPLETED|Overall Study||41
9054822|NCT03582826|10114619|FG001|NOT COMPLETED|Overall Study||0
9054823|NCT03582943|10114636|FG000|STARTED|Allocated to Groups||42
9054824|NCT03582943|10114637|FG001|STARTED|Allocated to Groups||40
9054825|NCT03582943|10114636|FG000|COMPLETED|Allocated to Groups||41
9054826|NCT03582943|10114637|FG001|COMPLETED|Allocated to Groups||39
9054827|NCT03582943|10114636|FG000|NOT COMPLETED|Allocated to Groups||1
9054828|NCT03582943|10114637|FG001|NOT COMPLETED|Allocated to Groups||1
9054829|NCT03582943|10114636|FG000|STARTED|Intervention and Follow up||41
9054830|NCT03582943|10114637|FG001|STARTED|Intervention and Follow up||39
9054831|NCT03582943|10114636|FG000|COMPLETED|Intervention and Follow up||37
9054832|NCT03582943|10114637|FG001|COMPLETED|Intervention and Follow up||37
9054833|NCT03582943|10114636|FG000|NOT COMPLETED|Intervention and Follow up||4
9054834|NCT03582943|10114637|FG001|NOT COMPLETED|Intervention and Follow up||2
9054835|NCT03582943|10114636|FG000|STARTED|Analyzed||37
9054836|NCT03582943|10114637|FG001|STARTED|Analyzed||37
9054837|NCT03582943|10114636|FG000|COMPLETED|Analyzed||33
9054838|NCT03582943|10114637|FG001|COMPLETED|Analyzed||36
9054839|NCT03582943|10114636|FG000|NOT COMPLETED|Analyzed||4
9054840|NCT03582943|10114637|FG001|NOT COMPLETED|Analyzed||1
9054841|NCT03583372|10114647|FG000|STARTED|Overall Study||92
9054842|NCT03583372|10114648|FG001|STARTED|Overall Study||182
9054843|NCT03583372|10114649|FG002|STARTED|Overall Study||91
9054844|NCT03583372|10114650|FG003|STARTED|Overall Study||141
8703758|NCT00924651|9749495|FG000|NOT COMPLETED|Overall Study||25
9054845|NCT03583372|10114647|FG000|COMPLETED|Overall Study||79
9054846|NCT03583372|10114648|FG001|COMPLETED|Overall Study||156
9054847|NCT03583372|10114649|FG002|COMPLETED|Overall Study||72
9054848|NCT03583372|10114650|FG003|COMPLETED|Overall Study||123
9054849|NCT03583372|10114647|FG000|NOT COMPLETED|Overall Study||13
9054850|NCT03583372|10114648|FG001|NOT COMPLETED|Overall Study||26
9054851|NCT03583372|10114649|FG002|NOT COMPLETED|Overall Study||19
9054852|NCT03583372|10114650|FG003|NOT COMPLETED|Overall Study||18
9054853|NCT03583385|10114660|FG000|STARTED|Treatment Period 1||24
9054854|NCT03583385|10114661|FG001|STARTED|Treatment Period 1||24
9054855|NCT03583385|10114660|FG000|COMPLETED|Treatment Period 1||23
9054856|NCT03583385|10114661|FG001|COMPLETED|Treatment Period 1||23
9054857|NCT03583385|10114660|FG000|NOT COMPLETED|Treatment Period 1||1
9054858|NCT03583385|10114661|FG001|NOT COMPLETED|Treatment Period 1||1
9054859|NCT03583385|10114660|FG000|STARTED|Treatment Period 2|Of 46 participants who completed period 1, 45 entered period2 & 1 participant didn't attend period2.|22
9054860|NCT03583385|10114661|FG001|STARTED|Treatment Period 2||23
8703759|NCT00924651|9749496|FG001|NOT COMPLETED|Overall Study||25
8703760|NCT00924664|9749504|FG000|STARTED|Overall Study||322
8703761|NCT00924664|9749505|FG001|STARTED|Overall Study||527
8703762|NCT00924664|9749504|FG000|Treated|Overall Study||321
8703763|NCT00924664|9749505|FG001|Treated|Overall Study||527
8703764|NCT00924664|9749504|FG000|COMPLETED|Overall Study||0
8703765|NCT00924664|9749505|FG001|COMPLETED|Overall Study||0
8703766|NCT00924664|9749504|FG000|NOT COMPLETED|Overall Study||322
8703767|NCT00924664|9749505|FG001|NOT COMPLETED|Overall Study||527
8703768|NCT00924703|9749511|FG000|STARTED|Overall Study||68
8703769|NCT00924703|9749511|FG000|COMPLETED|Overall Study||46
8703770|NCT00924703|9749511|FG000|NOT COMPLETED|Overall Study||22
8703771|NCT00924729|9749517|FG000|STARTED|Overall Study||25
8703772|NCT00924729|9749518|FG001|STARTED|Overall Study||25
8703773|NCT00924729|9749517|FG000|COMPLETED|Overall Study||23
8703774|NCT00924729|9749518|FG001|COMPLETED|Overall Study||25
8703775|NCT00924729|9749517|FG000|NOT COMPLETED|Overall Study||2
8703776|NCT00924729|9749518|FG001|NOT COMPLETED|Overall Study||0
9054861|NCT03583385|10114660|FG000|COMPLETED|Treatment Period 2||21
9054862|NCT03583385|10114661|FG001|COMPLETED|Treatment Period 2||23
9054863|NCT03583385|10114660|FG000|NOT COMPLETED|Treatment Period 2||1
9054864|NCT03583385|10114661|FG001|NOT COMPLETED|Treatment Period 2||0
9054865|NCT03583450|10114669|FG000|STARTED|Overall Study||34
9054866|NCT03583450|10114670|FG001|STARTED|Overall Study||37
9054867|NCT03583450|10114669|FG000|COMPLETED|Overall Study||33
9054868|NCT03583450|10114670|FG001|COMPLETED|Overall Study||37
9054869|NCT03583450|10114669|FG000|NOT COMPLETED|Overall Study||1
9054870|NCT03583450|10114670|FG001|NOT COMPLETED|Overall Study||0
9054871|NCT03583606|10114681|FG000|STARTED|Overall Study||22
9054872|NCT03583606|10114682|FG001|STARTED|Overall Study||20
9054873|NCT03583606|10114683|FG002|STARTED|Overall Study||19
9054874|NCT03583606|10114681|FG000|COMPLETED|Overall Study||21
9054875|NCT03583606|10114682|FG001|COMPLETED|Overall Study||19
9054876|NCT03583606|10114683|FG002|COMPLETED|Overall Study||19
9054877|NCT03583606|10114681|FG000|NOT COMPLETED|Overall Study||1
9054878|NCT03583606|10114682|FG001|NOT COMPLETED|Overall Study||1
9054879|NCT03583606|10114683|FG002|NOT COMPLETED|Overall Study||0
9054880|NCT03584009|10114694|FG000|STARTED|Overall Study||51
9054881|NCT03584009|10114695|FG001|STARTED|Overall Study||52
9054882|NCT03584009|10114694|FG000|COMPLETED|Overall Study||0
9054883|NCT03584009|10114695|FG001|COMPLETED|Overall Study||0
9054884|NCT03584009|10114694|FG000|NOT COMPLETED|Overall Study||51
9054885|NCT03584009|10114695|FG001|NOT COMPLETED|Overall Study||52
9054886|NCT03584100|10114701|FG000|STARTED|Overall Study||12
9054887|NCT03584100|10114701|FG000|COMPLETED|Overall Study||12
9054888|NCT03584100|10114701|FG000|NOT COMPLETED|Overall Study||0
9054889|NCT03585244|10114708|FG000|STARTED|Overall Study||180
9054890|NCT03585244|10114708|FG000|COMPLETED|Overall Study||165
9054891|NCT03585244|10114708|FG000|NOT COMPLETED|Overall Study||15
9054892|NCT03585296|10114712|FG000|STARTED|Overall Study||22
9054893|NCT03585296|10114712|FG000|COMPLETED|Overall Study||17
9054894|NCT03585296|10114712|FG000|NOT COMPLETED|Overall Study||5
9054895|NCT03585504|10114718|FG000|STARTED|Overall Study||41
9054896|NCT03585504|10114719|FG001|STARTED|Overall Study||40
9054897|NCT03585504|10114718|FG000|COMPLETED|Overall Study||15
9054898|NCT03585504|10114719|FG001|COMPLETED|Overall Study||11
9054899|NCT03585504|10114718|FG000|NOT COMPLETED|Overall Study||26
9054900|NCT03585504|10114719|FG001|NOT COMPLETED|Overall Study||29
9054901|NCT03585543|10114725|FG000|STARTED|Overall Study||30
8703777|NCT00924781|9749530|FG000|STARTED|Overall Study||20
8703778|NCT00924781|9749531|FG001|STARTED|Overall Study||19
8703779|NCT00924781|9749530|FG000|COMPLETED|Overall Study||8
8703780|NCT00924781|9749531|FG001|COMPLETED|Overall Study||9
9054902|NCT03585543|10114725|FG000|Mid-intervention Assessment (6-weeks)|Overall Study||25
9054903|NCT03585543|10114725|FG000|End-of-intervention Assessment (12 Weeks|Overall Study||22
9054904|NCT03585543|10114725|FG000|3-month Post-intervention Follow-up (6 m|Overall Study||15
8703781|NCT00924781|9749530|FG000|NOT COMPLETED|Overall Study||12
8703782|NCT00924781|9749531|FG001|NOT COMPLETED|Overall Study||10
8703783|NCT00924820|9749547|FG000|STARTED|Overall Study||20
8703784|NCT00924820|9749547|FG000|COMPLETED|Overall Study||13
8703785|NCT00924820|9749547|FG000|NOT COMPLETED|Overall Study||7
8703786|NCT00924885|9749553|FG000|STARTED|Overall Study||129
8703787|NCT00924885|9749554|FG001|STARTED|Overall Study||128
8703788|NCT00924885|9749553|FG000|COMPLETED|Overall Study||126
8703789|NCT00924885|9749554|FG001|COMPLETED|Overall Study||124
8703790|NCT00924885|9749553|FG000|NOT COMPLETED|Overall Study||3
8703791|NCT00924885|9749554|FG001|NOT COMPLETED|Overall Study||4
8703792|NCT00924898|9749562|FG000|STARTED|Overall Study||92
8703793|NCT00924898|9749562|FG000|COMPLETED|Overall Study||90
8703794|NCT00924898|9749562|FG000|NOT COMPLETED|Overall Study||2
9054905|NCT03585543|10114725|FG000|COMPLETED|Overall Study||15
9054906|NCT03585543|10114725|FG000|NOT COMPLETED|Overall Study||15
9054907|NCT03585712|10114730|FG000|STARTED|Treatment Period 1||52
9054908|NCT03585712|10114731|FG001|STARTED|Treatment Period 1|Randomization in Treatment Period 2|0
9054909|NCT03585712|10114732|FG002|STARTED|Treatment Period 1|Randomization in Treatment Period 2|0
9054910|NCT03585712|10114730|FG000|COMPLETED|Treatment Period 1||51
9054911|NCT03585712|10114731|FG001|COMPLETED|Treatment Period 1||0
9054912|NCT03585712|10114732|FG002|COMPLETED|Treatment Period 1||0
9054913|NCT03585712|10114730|FG000|NOT COMPLETED|Treatment Period 1||1
9054914|NCT03585712|10114731|FG001|NOT COMPLETED|Treatment Period 1||0
9054915|NCT03585712|10114732|FG002|NOT COMPLETED|Treatment Period 1||0
9054916|NCT03585712|10114730|FG000|STARTED|Treatment Periods 2 and 3|Subjects having completed Treatment Period 1 randomized in Arm A or Arm B|0
9054917|NCT03585712|10114731|FG001|STARTED|Treatment Periods 2 and 3||26
9054918|NCT03585712|10114732|FG002|STARTED|Treatment Periods 2 and 3||25
9054919|NCT03585712|10114730|FG000|COMPLETED|Treatment Periods 2 and 3||0
9054920|NCT03585712|10114731|FG001|COMPLETED|Treatment Periods 2 and 3||23
9054921|NCT03585712|10114732|FG002|COMPLETED|Treatment Periods 2 and 3||22
9054922|NCT03585712|10114730|FG000|NOT COMPLETED|Treatment Periods 2 and 3||0
9054923|NCT03585712|10114731|FG001|NOT COMPLETED|Treatment Periods 2 and 3||3
9054924|NCT03585712|10114732|FG002|NOT COMPLETED|Treatment Periods 2 and 3||3
9054925|NCT03585790|10114751|FG000|STARTED|First Intervention (1 Week)||23
9054926|NCT03585790|10114752|FG001|STARTED|First Intervention (1 Week)||22
9054927|NCT03585790|10114751|FG000|COMPLETED|First Intervention (1 Week)||23
9054928|NCT03585790|10114752|FG001|COMPLETED|First Intervention (1 Week)||22
9054929|NCT03585790|10114751|FG000|NOT COMPLETED|First Intervention (1 Week)||0
9054930|NCT03585790|10114752|FG001|NOT COMPLETED|First Intervention (1 Week)||0
9054931|NCT03585790|10114751|FG000|STARTED|Second Intervention (1 Week)||23
9054932|NCT03585790|10114752|FG001|STARTED|Second Intervention (1 Week)||22
9054933|NCT03585790|10114751|FG000|COMPLETED|Second Intervention (1 Week)||23
9054934|NCT03585790|10114752|FG001|COMPLETED|Second Intervention (1 Week)||22
9054935|NCT03585790|10114751|FG000|NOT COMPLETED|Second Intervention (1 Week)||0
9054936|NCT03585790|10114752|FG001|NOT COMPLETED|Second Intervention (1 Week)||0
9054937|NCT03585959|10114759|FG000|STARTED|Overall Study||50
9054938|NCT03585959|10114759|FG000|COMPLETED|Overall Study||47
9054939|NCT03585959|10114759|FG000|NOT COMPLETED|Overall Study||3
9054940|NCT03586167|10114767|FG000|STARTED|Overall Study||58
9054941|NCT03586167|10114768|FG001|STARTED|Overall Study||28
9054942|NCT03586167|10114767|FG000|COMPLETED|Overall Study||57
9054943|NCT03586167|10114768|FG001|COMPLETED|Overall Study||28
9054944|NCT03586167|10114767|FG000|NOT COMPLETED|Overall Study||1
9054945|NCT03586167|10114768|FG001|NOT COMPLETED|Overall Study||0
9054946|NCT03586544|10114776|FG000|STARTED|First Intervention||6
9054947|NCT03586544|10114777|FG001|STARTED|First Intervention||12
9054948|NCT03586544|10114776|FG000|COMPLETED|First Intervention||6
9054949|NCT03586544|10114777|FG001|COMPLETED|First Intervention||11
9054950|NCT03586544|10114776|FG000|NOT COMPLETED|First Intervention||0
9054951|NCT03586544|10114777|FG001|NOT COMPLETED|First Intervention||1
9054952|NCT03586544|10114776|FG000|STARTED|Second Intervention||6
9054953|NCT03586544|10114777|FG001|STARTED|Second Intervention||11
9054954|NCT03586544|10114776|FG000|COMPLETED|Second Intervention||6
9054955|NCT03586544|10114777|FG001|COMPLETED|Second Intervention||10
9054956|NCT03586544|10114776|FG000|NOT COMPLETED|Second Intervention||0
9054957|NCT03586544|10114777|FG001|NOT COMPLETED|Second Intervention||1
8703795|NCT00924950|9749571|FG000|STARTED|Overall Study||30
8703796|NCT00924950|9749571|FG000|COMPLETED|Overall Study||28
9054958|NCT03586583|10114783|FG000|STARTED|Overall Study||600
9054959|NCT03586583|10114783|FG000|COMPLETED|Overall Study||600
9054960|NCT03586583|10114783|FG000|NOT COMPLETED|Overall Study||0
9054961|NCT03586648|10114788|FG000|STARTED|Period 1||36
9054962|NCT03586648|10114789|FG001|STARTED|Period 1||34
9054963|NCT03586648|10114788|FG000|COMPLETED|Period 1||32
9054964|NCT03586648|10114789|FG001|COMPLETED|Period 1||30
9054965|NCT03586648|10114788|FG000|NOT COMPLETED|Period 1||4
9054966|NCT03586648|10114789|FG001|NOT COMPLETED|Period 1||4
9054967|NCT03586648|10114788|FG000|STARTED|Period 2||32
9054968|NCT03586648|10114789|FG001|STARTED|Period 2||30
9054969|NCT03586648|10114788|FG000|COMPLETED|Period 2||31
9054970|NCT03586648|10114789|FG001|COMPLETED|Period 2||30
9054971|NCT03586648|10114788|FG000|NOT COMPLETED|Period 2||1
9054972|NCT03586648|10114789|FG001|NOT COMPLETED|Period 2||0
9054973|NCT03586726|10114795|FG000|STARTED|Overall Study||16
9054974|NCT03586726|10114795|FG000|COMPLETED|Overall Study||15
9054975|NCT03586726|10114795|FG000|NOT COMPLETED|Overall Study||1
9054976|NCT03586830|10114803|FG000|STARTED|Overall Study||50
9054977|NCT03586830|10114804|FG001|STARTED|Overall Study||48
9054978|NCT03586830|10114805|FG002|STARTED|Overall Study||49
9054979|NCT03586830|10114806|FG003|STARTED|Overall Study||49
9054980|NCT03586830|10114803|FG000|Treated|Overall Study||49
9054981|NCT03586830|10114804|FG001|Treated|Overall Study||48
9054982|NCT03586830|10114805|FG002|Treated|Overall Study||49
9054983|NCT03586830|10114806|FG003|Treated|Overall Study||49
9054984|NCT03586830|10114803|FG000|COMPLETED|Overall Study||48
9054985|NCT03586830|10114804|FG001|COMPLETED|Overall Study||42
9054986|NCT03586830|10114805|FG002|COMPLETED|Overall Study||41
9054987|NCT03586830|10114806|FG003|COMPLETED|Overall Study||44
9054988|NCT03586830|10114803|FG000|NOT COMPLETED|Overall Study||2
9054989|NCT03586830|10114804|FG001|NOT COMPLETED|Overall Study||6
9054990|NCT03586830|10114805|FG002|NOT COMPLETED|Overall Study||8
9054991|NCT03586830|10114806|FG003|NOT COMPLETED|Overall Study||5
9054992|NCT03587207|10114821|FG000|STARTED|Overall Study||100
9054993|NCT03587207|10114822|FG001|STARTED|Overall Study||104
9054994|NCT03587207|10114823|FG002|STARTED|Overall Study||100
9054995|NCT03587207|10114824|FG003|STARTED|Overall Study||94
9054996|NCT03587207|10114825|FG004|STARTED|Overall Study||102
9054997|NCT03587207|10114821|FG000|COMPLETED|Overall Study||100
9054998|NCT03587207|10114822|FG001|COMPLETED|Overall Study||104
9054999|NCT03587207|10114823|FG002|COMPLETED|Overall Study||100
9055000|NCT03587207|10114824|FG003|COMPLETED|Overall Study||94
9055001|NCT03587207|10114825|FG004|COMPLETED|Overall Study||102
9055002|NCT03587207|10114821|FG000|NOT COMPLETED|Overall Study||0
9055003|NCT03587207|10114822|FG001|NOT COMPLETED|Overall Study||0
9055004|NCT03587207|10114823|FG002|NOT COMPLETED|Overall Study||0
9055005|NCT03587207|10114824|FG003|NOT COMPLETED|Overall Study||0
9055006|NCT03587207|10114825|FG004|NOT COMPLETED|Overall Study||0
9055007|NCT03587428|10114837|FG000|STARTED|Period 1||3
9055008|NCT03587428|10114838|FG001|STARTED|Period 1||2
9055009|NCT03587428|10114839|FG002|STARTED|Period 1||3
9055010|NCT03587428|10114840|FG003|STARTED|Period 1||3
9055011|NCT03587428|10114841|FG004|STARTED|Period 1||2
9055012|NCT03587428|10114842|FG005|STARTED|Period 1||2
9055013|NCT03587428|10114837|FG000|COMPLETED|Period 1||3
9055014|NCT03587428|10114838|FG001|COMPLETED|Period 1||2
9055015|NCT03587428|10114839|FG002|COMPLETED|Period 1||3
9055016|NCT03587428|10114840|FG003|COMPLETED|Period 1||3
9055017|NCT03587428|10114841|FG004|COMPLETED|Period 1||2
9055018|NCT03587428|10114842|FG005|COMPLETED|Period 1||2
9055019|NCT03587428|10114837|FG000|NOT COMPLETED|Period 1||0
9055020|NCT03587428|10114838|FG001|NOT COMPLETED|Period 1||0
9055021|NCT03587428|10114839|FG002|NOT COMPLETED|Period 1||0
9055022|NCT03587428|10114840|FG003|NOT COMPLETED|Period 1||0
9055023|NCT03587428|10114841|FG004|NOT COMPLETED|Period 1||0
9055024|NCT03587428|10114842|FG005|NOT COMPLETED|Period 1||0
9055025|NCT03587428|10114837|FG000|STARTED|Period 2||3
9055026|NCT03587428|10114838|FG001|STARTED|Period 2||2
9055027|NCT03587428|10114839|FG002|STARTED|Period 2||3
9055028|NCT03587428|10114840|FG003|STARTED|Period 2||3
9055029|NCT03587428|10114841|FG004|STARTED|Period 2||2
9055030|NCT03587428|10114842|FG005|STARTED|Period 2||2
9055031|NCT03587428|10114837|FG000|COMPLETED|Period 2||3
9055032|NCT03587428|10114838|FG001|COMPLETED|Period 2||2
9055033|NCT03587428|10114839|FG002|COMPLETED|Period 2||3
9055034|NCT03587428|10114840|FG003|COMPLETED|Period 2||3
9055035|NCT03587428|10114841|FG004|COMPLETED|Period 2||2
9055036|NCT03587428|10114842|FG005|COMPLETED|Period 2||2
9055037|NCT03587428|10114837|FG000|NOT COMPLETED|Period 2||0
9055038|NCT03587428|10114838|FG001|NOT COMPLETED|Period 2||0
9055039|NCT03587428|10114839|FG002|NOT COMPLETED|Period 2||0
9055040|NCT03587428|10114840|FG003|NOT COMPLETED|Period 2||0
9055041|NCT03587428|10114841|FG004|NOT COMPLETED|Period 2||0
9055042|NCT03587428|10114842|FG005|NOT COMPLETED|Period 2||0
9055043|NCT03587428|10114837|FG000|STARTED|Period 3||3
9055044|NCT03587428|10114838|FG001|STARTED|Period 3||2
9055045|NCT03587428|10114839|FG002|STARTED|Period 3||3
9055046|NCT03587428|10114840|FG003|STARTED|Period 3||3
9055047|NCT03587428|10114841|FG004|STARTED|Period 3||2
9055048|NCT03587428|10114842|FG005|STARTED|Period 3||2
9055049|NCT03587428|10114837|FG000|COMPLETED|Period 3||3
9055050|NCT03587428|10114838|FG001|COMPLETED|Period 3||2
9055051|NCT03587428|10114839|FG002|COMPLETED|Period 3||3
9055052|NCT03587428|10114840|FG003|COMPLETED|Period 3||3
9055053|NCT03587428|10114841|FG004|COMPLETED|Period 3||2
9055054|NCT03587428|10114842|FG005|COMPLETED|Period 3||2
9055055|NCT03587428|10114837|FG000|NOT COMPLETED|Period 3||0
9055056|NCT03587428|10114838|FG001|NOT COMPLETED|Period 3||0
9055057|NCT03587428|10114839|FG002|NOT COMPLETED|Period 3||0
9055058|NCT03587428|10114840|FG003|NOT COMPLETED|Period 3||0
9055059|NCT03587428|10114841|FG004|NOT COMPLETED|Period 3||0
9055060|NCT03587428|10114842|FG005|NOT COMPLETED|Period 3||0
9055061|NCT03587974|10114852|FG000|STARTED|Overall Study||30
9055062|NCT03587974|10114853|FG001|STARTED|Overall Study||30
9055063|NCT03587974|10114852|FG000|COMPLETED|Overall Study||25
9055064|NCT03587974|10114853|FG001|COMPLETED|Overall Study||26
9055065|NCT03587974|10114852|FG000|NOT COMPLETED|Overall Study||5
9055066|NCT03587974|10114853|FG001|NOT COMPLETED|Overall Study||4
9055067|NCT03588572|10114861|FG000|STARTED|Visitation 1||22
9055068|NCT03588572|10114862|FG001|STARTED|Visitation 1||21
9055069|NCT03588572|10114861|FG000|COMPLETED|Visitation 1||21
9055070|NCT03588572|10114862|FG001|COMPLETED|Visitation 1||20
9055071|NCT03588572|10114861|FG000|NOT COMPLETED|Visitation 1||1
9055072|NCT03588572|10114862|FG001|NOT COMPLETED|Visitation 1||1
9055073|NCT03588572|10114861|FG000|STARTED|Visitation 2||21
9055074|NCT03588572|10114862|FG001|STARTED|Visitation 2||20
9055075|NCT03588572|10114861|FG000|COMPLETED|Visitation 2||19
9055076|NCT03588572|10114862|FG001|COMPLETED|Visitation 2||18
9055077|NCT03588572|10114861|FG000|NOT COMPLETED|Visitation 2||2
9055078|NCT03588572|10114862|FG001|NOT COMPLETED|Visitation 2||2
9055079|NCT03588572|10114861|FG000|STARTED|Visitation 3||19
9055080|NCT03588572|10114862|FG001|STARTED|Visitation 3||18
9055081|NCT03588572|10114861|FG000|COMPLETED|Visitation 3||16
9055082|NCT03588572|10114862|FG001|COMPLETED|Visitation 3||16
9055083|NCT03588572|10114861|FG000|NOT COMPLETED|Visitation 3||3
9055084|NCT03588572|10114862|FG001|NOT COMPLETED|Visitation 3||2
9055085|NCT03588741|10114868|FG000|STARTED|Overall Study||1
9055086|NCT03588741|10114868|FG000|COMPLETED|Overall Study||0
9055087|NCT03588741|10114868|FG000|NOT COMPLETED|Overall Study||1
9055088|NCT03588806|10114872|FG000|STARTED|Overall Study||11
9055089|NCT03588806|10114872|FG000|COMPLETED|Overall Study||11
9055090|NCT03588806|10114872|FG000|NOT COMPLETED|Overall Study||0
9055091|NCT03588910|10114878|FG000|STARTED|Overall Study||60
9055092|NCT03588910|10114879|FG001|STARTED|Overall Study||60
9055093|NCT03588910|10114878|FG000|Post Op Day 1 Survey|Overall Study||52
9055094|NCT03588910|10114879|FG001|Post Op Day 1 Survey|Overall Study||47
9055095|NCT03588910|10114878|FG000|COMPLETED|Overall Study||47
9055096|NCT03588910|10114879|FG001|COMPLETED|Overall Study||45
9055097|NCT03588910|10114878|FG000|NOT COMPLETED|Overall Study||13
9055098|NCT03588910|10114879|FG001|NOT COMPLETED|Overall Study||15
9055099|NCT03589807|10114891|FG000|STARTED|Overall Study||27
9055100|NCT03589807|10114892|FG001|STARTED|Overall Study||30
9055101|NCT03589807|10114893|FG002|STARTED|Overall Study||33
9055102|NCT03589807|10114894|FG003|STARTED|Overall Study||32
9055103|NCT03589807|10114895|FG004|STARTED|Overall Study||28
9055104|NCT03589807|10114896|FG005|STARTED|Overall Study||30
9055105|NCT03589807|10114891|FG000|COMPLETED|Overall Study||27
9055106|NCT03589807|10114892|FG001|COMPLETED|Overall Study||23
9055107|NCT03589807|10114893|FG002|COMPLETED|Overall Study||31
9055108|NCT03589807|10114894|FG003|COMPLETED|Overall Study||28
9055109|NCT03589807|10114895|FG004|COMPLETED|Overall Study||26
9055110|NCT03589807|10114896|FG005|COMPLETED|Overall Study||29
9055111|NCT03589807|10114891|FG000|NOT COMPLETED|Overall Study||0
9055112|NCT03589807|10114892|FG001|NOT COMPLETED|Overall Study||7
9055113|NCT03589807|10114893|FG002|NOT COMPLETED|Overall Study||2
9055114|NCT03589807|10114894|FG003|NOT COMPLETED|Overall Study||4
9055115|NCT03589807|10114895|FG004|NOT COMPLETED|Overall Study||2
8703797|NCT00924950|9749571|FG000|NOT COMPLETED|Overall Study||2
8703798|NCT00925002|9749581|FG000|STARTED|Overall Study||38
9055116|NCT03589807|10114896|FG005|NOT COMPLETED|Overall Study||1
9055117|NCT03589885|10114916|FG000|STARTED|Treatment Period 1-Randomized Set||41
9055118|NCT03589885|10114917|FG001|STARTED|Treatment Period 1-Randomized Set||41
9055119|NCT03589885|10114918|FG002|STARTED|Treatment Period 1-Randomized Set||40
9055120|NCT03589885|10114919|FG003|STARTED|Treatment Period 1-Randomized Set||0
9055121|NCT03589885|10114920|FG004|STARTED|Treatment Period 1-Randomized Set||0
9055122|NCT03589885|10114916|FG000|COMPLETED|Treatment Period 1-Randomized Set||41
9055123|NCT03589885|10114917|FG001|COMPLETED|Treatment Period 1-Randomized Set||39
9055124|NCT03589885|10114918|FG002|COMPLETED|Treatment Period 1-Randomized Set||37
9055125|NCT03589885|10114919|FG003|COMPLETED|Treatment Period 1-Randomized Set||0
9055126|NCT03589885|10114920|FG004|COMPLETED|Treatment Period 1-Randomized Set||0
9055127|NCT03589885|10114916|FG000|NOT COMPLETED|Treatment Period 1-Randomized Set||0
9055128|NCT03589885|10114917|FG001|NOT COMPLETED|Treatment Period 1-Randomized Set||2
9055129|NCT03589885|10114918|FG002|NOT COMPLETED|Treatment Period 1-Randomized Set||3
9055130|NCT03589885|10114919|FG003|NOT COMPLETED|Treatment Period 1-Randomized Set||0
9055131|NCT03589885|10114920|FG004|NOT COMPLETED|Treatment Period 1-Randomized Set||0
9055132|NCT03589885|10114916|FG000|STARTED|Treatment Period 2-Randomized Set||41
8703799|NCT00925002|9749582|FG001|STARTED|Overall Study||37
8703800|NCT00925002|9749583|FG002|STARTED|Overall Study||18
9055133|NCT03589885|10114917|FG001|STARTED|Treatment Period 2-Randomized Set||39
9055134|NCT03589885|10114918|FG002|STARTED|Treatment Period 2-Randomized Set||4
9055135|NCT03589885|10114919|FG003|STARTED|Treatment Period 2-Randomized Set||16
9055136|NCT03589885|10114920|FG004|STARTED|Treatment Period 2-Randomized Set||17
9055137|NCT03589885|10114916|FG000|COMPLETED|Treatment Period 2-Randomized Set||40
9055138|NCT03589885|10114917|FG001|COMPLETED|Treatment Period 2-Randomized Set||34
9055139|NCT03589885|10114918|FG002|COMPLETED|Treatment Period 2-Randomized Set||3
9055140|NCT03589885|10114919|FG003|COMPLETED|Treatment Period 2-Randomized Set||16
9055141|NCT03589885|10114920|FG004|COMPLETED|Treatment Period 2-Randomized Set||16
9055142|NCT03589885|10114916|FG000|NOT COMPLETED|Treatment Period 2-Randomized Set||1
9055143|NCT03589885|10114917|FG001|NOT COMPLETED|Treatment Period 2-Randomized Set||5
9055144|NCT03589885|10114918|FG002|NOT COMPLETED|Treatment Period 2-Randomized Set||1
9055145|NCT03589885|10114919|FG003|NOT COMPLETED|Treatment Period 2-Randomized Set||0
9055146|NCT03589885|10114920|FG004|NOT COMPLETED|Treatment Period 2-Randomized Set||1
9055147|NCT03590613|10114938|FG000|STARTED|Period 1, 4 Days||3
9055148|NCT03590613|10114939|FG001|STARTED|Period 1, 4 Days||3
9055149|NCT03590613|10114940|FG002|STARTED|Period 1, 4 Days||3
9055150|NCT03590613|10114941|FG003|STARTED|Period 1, 4 Days||3
9055151|NCT03590613|10114938|FG000|COMPLETED|Period 1, 4 Days||3
9055152|NCT03590613|10114939|FG001|COMPLETED|Period 1, 4 Days||3
9055153|NCT03590613|10114940|FG002|COMPLETED|Period 1, 4 Days||3
9055154|NCT03590613|10114941|FG003|COMPLETED|Period 1, 4 Days||3
9055155|NCT03590613|10114938|FG000|NOT COMPLETED|Period 1, 4 Days||0
9055156|NCT03590613|10114939|FG001|NOT COMPLETED|Period 1, 4 Days||0
9055157|NCT03590613|10114940|FG002|NOT COMPLETED|Period 1, 4 Days||0
9055158|NCT03590613|10114941|FG003|NOT COMPLETED|Period 1, 4 Days||0
9055159|NCT03590613|10114938|FG000|STARTED|Period 1, Wash-out, at Least 3 Days||3
9055160|NCT03590613|10114939|FG001|STARTED|Period 1, Wash-out, at Least 3 Days||3
9055161|NCT03590613|10114940|FG002|STARTED|Period 1, Wash-out, at Least 3 Days||3
9055162|NCT03590613|10114941|FG003|STARTED|Period 1, Wash-out, at Least 3 Days||3
9055163|NCT03590613|10114938|FG000|COMPLETED|Period 1, Wash-out, at Least 3 Days||3
9055164|NCT03590613|10114939|FG001|COMPLETED|Period 1, Wash-out, at Least 3 Days||3
9055165|NCT03590613|10114940|FG002|COMPLETED|Period 1, Wash-out, at Least 3 Days||3
9055166|NCT03590613|10114941|FG003|COMPLETED|Period 1, Wash-out, at Least 3 Days||3
9055167|NCT03590613|10114938|FG000|NOT COMPLETED|Period 1, Wash-out, at Least 3 Days||0
9055168|NCT03590613|10114939|FG001|NOT COMPLETED|Period 1, Wash-out, at Least 3 Days||0
9055169|NCT03590613|10114940|FG002|NOT COMPLETED|Period 1, Wash-out, at Least 3 Days||0
9055170|NCT03590613|10114941|FG003|NOT COMPLETED|Period 1, Wash-out, at Least 3 Days||0
9055171|NCT03590613|10114938|FG000|STARTED|Period 2, 4 Days||3
9055172|NCT03590613|10114939|FG001|STARTED|Period 2, 4 Days||3
9055173|NCT03590613|10114940|FG002|STARTED|Period 2, 4 Days||3
9055174|NCT03590613|10114941|FG003|STARTED|Period 2, 4 Days|One additional participant was enrolled in Period 2.|4
9055175|NCT03590613|10114938|FG000|COMPLETED|Period 2, 4 Days||3
9055176|NCT03590613|10114939|FG001|COMPLETED|Period 2, 4 Days||3
9055177|NCT03590613|10114940|FG002|COMPLETED|Period 2, 4 Days||3
9055178|NCT03590613|10114941|FG003|COMPLETED|Period 2, 4 Days||3
9055179|NCT03590613|10114938|FG000|NOT COMPLETED|Period 2, 4 Days||0
9055180|NCT03590613|10114939|FG001|NOT COMPLETED|Period 2, 4 Days||0
9055181|NCT03590613|10114940|FG002|NOT COMPLETED|Period 2, 4 Days||0
9055182|NCT03590613|10114941|FG003|NOT COMPLETED|Period 2, 4 Days||1
9055183|NCT03590613|10114938|FG000|STARTED|Period 2, Wash-out, at Least 3 Days||3
9055184|NCT03590613|10114939|FG001|STARTED|Period 2, Wash-out, at Least 3 Days||3
9055185|NCT03590613|10114940|FG002|STARTED|Period 2, Wash-out, at Least 3 Days||3
9055186|NCT03590613|10114941|FG003|STARTED|Period 2, Wash-out, at Least 3 Days||3
9055187|NCT03590613|10114938|FG000|COMPLETED|Period 2, Wash-out, at Least 3 Days||3
9055188|NCT03590613|10114939|FG001|COMPLETED|Period 2, Wash-out, at Least 3 Days||3
9055189|NCT03590613|10114940|FG002|COMPLETED|Period 2, Wash-out, at Least 3 Days||3
9055190|NCT03590613|10114941|FG003|COMPLETED|Period 2, Wash-out, at Least 3 Days||3
9055191|NCT03590613|10114938|FG000|NOT COMPLETED|Period 2, Wash-out, at Least 3 Days||0
9055192|NCT03590613|10114939|FG001|NOT COMPLETED|Period 2, Wash-out, at Least 3 Days||0
9055193|NCT03590613|10114940|FG002|NOT COMPLETED|Period 2, Wash-out, at Least 3 Days||0
9055194|NCT03590613|10114941|FG003|NOT COMPLETED|Period 2, Wash-out, at Least 3 Days||0
9055195|NCT03590613|10114938|FG000|STARTED|Period 3, 4 Days||3
9055196|NCT03590613|10114939|FG001|STARTED|Period 3, 4 Days||3
9055197|NCT03590613|10114940|FG002|STARTED|Period 3, 4 Days||3
9055198|NCT03590613|10114941|FG003|STARTED|Period 3, 4 Days||3
9055199|NCT03590613|10114938|FG000|COMPLETED|Period 3, 4 Days||3
9055200|NCT03590613|10114939|FG001|COMPLETED|Period 3, 4 Days||3
9055201|NCT03590613|10114940|FG002|COMPLETED|Period 3, 4 Days||3
9055202|NCT03590613|10114941|FG003|COMPLETED|Period 3, 4 Days||3
9055203|NCT03590613|10114938|FG000|NOT COMPLETED|Period 3, 4 Days||0
9055204|NCT03590613|10114939|FG001|NOT COMPLETED|Period 3, 4 Days||0
9055205|NCT03590613|10114940|FG002|NOT COMPLETED|Period 3, 4 Days||0
9055206|NCT03590613|10114941|FG003|NOT COMPLETED|Period 3, 4 Days||0
9055207|NCT03590613|10114938|FG000|STARTED|Period 3,Wash-out, at Least 3 Days||3
9055208|NCT03590613|10114939|FG001|STARTED|Period 3,Wash-out, at Least 3 Days||3
9055209|NCT03590613|10114940|FG002|STARTED|Period 3,Wash-out, at Least 3 Days||3
9055210|NCT03590613|10114941|FG003|STARTED|Period 3,Wash-out, at Least 3 Days||3
9055211|NCT03590613|10114938|FG000|COMPLETED|Period 3,Wash-out, at Least 3 Days||3
9055212|NCT03590613|10114939|FG001|COMPLETED|Period 3,Wash-out, at Least 3 Days||3
9055213|NCT03590613|10114940|FG002|COMPLETED|Period 3,Wash-out, at Least 3 Days||3
9055214|NCT03590613|10114941|FG003|COMPLETED|Period 3,Wash-out, at Least 3 Days||3
9055215|NCT03590613|10114938|FG000|NOT COMPLETED|Period 3,Wash-out, at Least 3 Days||0
9055216|NCT03590613|10114939|FG001|NOT COMPLETED|Period 3,Wash-out, at Least 3 Days||0
9055217|NCT03590613|10114940|FG002|NOT COMPLETED|Period 3,Wash-out, at Least 3 Days||0
9055218|NCT03590613|10114941|FG003|NOT COMPLETED|Period 3,Wash-out, at Least 3 Days||0
9055219|NCT03590613|10114938|FG000|STARTED|Period 4, 4 Days||3
9055220|NCT03590613|10114939|FG001|STARTED|Period 4, 4 Days||3
9055221|NCT03590613|10114940|FG002|STARTED|Period 4, 4 Days||3
9055222|NCT03590613|10114941|FG003|STARTED|Period 4, 4 Days||3
9055223|NCT03590613|10114938|FG000|COMPLETED|Period 4, 4 Days||3
9055224|NCT03590613|10114939|FG001|COMPLETED|Period 4, 4 Days||3
9055225|NCT03590613|10114940|FG002|COMPLETED|Period 4, 4 Days||3
9055226|NCT03590613|10114941|FG003|COMPLETED|Period 4, 4 Days||3
9055227|NCT03590613|10114938|FG000|NOT COMPLETED|Period 4, 4 Days||0
9055228|NCT03590613|10114939|FG001|NOT COMPLETED|Period 4, 4 Days||0
9055229|NCT03590613|10114940|FG002|NOT COMPLETED|Period 4, 4 Days||0
9055230|NCT03590613|10114941|FG003|NOT COMPLETED|Period 4, 4 Days||0
9055231|NCT03591068|10114954|FG000|STARTED|Overall Study||11
9055232|NCT03591068|10114954|FG000|COMPLETED|Overall Study||9
9055233|NCT03591068|10114954|FG000|NOT COMPLETED|Overall Study||2
9055234|NCT03591146|10114965|FG000|STARTED|TLC590 190mg and Naropin 150mg||12
9055235|NCT03591146|10114966|FG001|STARTED|TLC590 190mg and Naropin 150mg||0
9055236|NCT03591146|10114967|FG002|STARTED|TLC590 190mg and Naropin 150mg||0
9055237|NCT03591146|10114968|FG003|STARTED|TLC590 190mg and Naropin 150mg||0
9055238|NCT03591146|10114969|FG004|STARTED|TLC590 190mg and Naropin 150mg||4
8703801|NCT00925002|9749581|FG000|Treated|Overall Study||38
8703802|NCT00925002|9749582|FG001|Treated|Overall Study||37
8703803|NCT00925002|9749583|FG002|Treated|Overall Study||18
8703804|NCT00925002|9749581|FG000|COMPLETED|Overall Study||32
8703805|NCT00925002|9749582|FG001|COMPLETED|Overall Study||28
8703806|NCT00925002|9749583|FG002|COMPLETED|Overall Study||8
8703807|NCT00925002|9749581|FG000|NOT COMPLETED|Overall Study||6
8703808|NCT00925002|9749582|FG001|NOT COMPLETED|Overall Study||9
8703809|NCT00925002|9749583|FG002|NOT COMPLETED|Overall Study||10
8703810|NCT00925015|9749595|FG000|STARTED|Overall Study||8
8703811|NCT00925015|9749596|FG001|STARTED|Overall Study||6
8703812|NCT00925015|9749597|FG002|STARTED|Overall Study||6
8703813|NCT00925015|9749595|FG000|COMPLETED|Overall Study||0
8703814|NCT00925015|9749596|FG001|COMPLETED|Overall Study||0
8703815|NCT00925015|9749597|FG002|COMPLETED|Overall Study||0
9055239|NCT03591146|10114965|FG000|COMPLETED|TLC590 190mg and Naropin 150mg||12
8703816|NCT00925015|9749595|FG000|NOT COMPLETED|Overall Study||8
8703817|NCT00925015|9749596|FG001|NOT COMPLETED|Overall Study||6
9055240|NCT03591146|10114966|FG001|COMPLETED|TLC590 190mg and Naropin 150mg||0
9055241|NCT03591146|10114967|FG002|COMPLETED|TLC590 190mg and Naropin 150mg||0
8703818|NCT00925015|9749597|FG002|NOT COMPLETED|Overall Study||6
8703819|NCT00925054|9749614|FG000|STARTED|Overall Study||7
8703820|NCT00925054|9749615|FG001|STARTED|Overall Study||9
8703821|NCT00925054|9749616|FG002|STARTED|Overall Study||13
8703822|NCT00925054|9749617|FG003|STARTED|Overall Study||1
9055242|NCT03591146|10114968|FG003|COMPLETED|TLC590 190mg and Naropin 150mg||0
9055243|NCT03591146|10114969|FG004|COMPLETED|TLC590 190mg and Naropin 150mg||3
9055244|NCT03591146|10114965|FG000|NOT COMPLETED|TLC590 190mg and Naropin 150mg||0
9055245|NCT03591146|10114966|FG001|NOT COMPLETED|TLC590 190mg and Naropin 150mg||0
9055246|NCT03591146|10114967|FG002|NOT COMPLETED|TLC590 190mg and Naropin 150mg||0
9055247|NCT03591146|10114968|FG003|NOT COMPLETED|TLC590 190mg and Naropin 150mg||0
9055248|NCT03591146|10114969|FG004|NOT COMPLETED|TLC590 190mg and Naropin 150mg||1
9055249|NCT03591146|10114965|FG000|STARTED|TLC590 380mg and Naropin 150mg||0
9055250|NCT03591146|10114966|FG001|STARTED|TLC590 380mg and Naropin 150mg||12
9055251|NCT03591146|10114967|FG002|STARTED|TLC590 380mg and Naropin 150mg||0
9055252|NCT03591146|10114968|FG003|STARTED|TLC590 380mg and Naropin 150mg||0
9055253|NCT03591146|10114969|FG004|STARTED|TLC590 380mg and Naropin 150mg||5
9055254|NCT03591146|10114965|FG000|COMPLETED|TLC590 380mg and Naropin 150mg||0
9055255|NCT03591146|10114966|FG001|COMPLETED|TLC590 380mg and Naropin 150mg||11
9055256|NCT03591146|10114967|FG002|COMPLETED|TLC590 380mg and Naropin 150mg||0
9055257|NCT03591146|10114968|FG003|COMPLETED|TLC590 380mg and Naropin 150mg||0
9055258|NCT03591146|10114969|FG004|COMPLETED|TLC590 380mg and Naropin 150mg||4
9055259|NCT03591146|10114965|FG000|NOT COMPLETED|TLC590 380mg and Naropin 150mg||0
9055260|NCT03591146|10114966|FG001|NOT COMPLETED|TLC590 380mg and Naropin 150mg||1
9055261|NCT03591146|10114967|FG002|NOT COMPLETED|TLC590 380mg and Naropin 150mg||0
9055262|NCT03591146|10114968|FG003|NOT COMPLETED|TLC590 380mg and Naropin 150mg||0
9055263|NCT03591146|10114969|FG004|NOT COMPLETED|TLC590 380mg and Naropin 150mg||1
9055264|NCT03591146|10114965|FG000|STARTED|TLC590 570mg and Naropin 150mg||0
9055265|NCT03591146|10114966|FG001|STARTED|TLC590 570mg and Naropin 150mg||0
9055266|NCT03591146|10114967|FG002|STARTED|TLC590 570mg and Naropin 150mg||12
9055267|NCT03591146|10114968|FG003|STARTED|TLC590 570mg and Naropin 150mg||0
9055268|NCT03591146|10114969|FG004|STARTED|TLC590 570mg and Naropin 150mg||4
9055269|NCT03591146|10114965|FG000|COMPLETED|TLC590 570mg and Naropin 150mg||0
9055270|NCT03591146|10114966|FG001|COMPLETED|TLC590 570mg and Naropin 150mg||0
9055271|NCT03591146|10114967|FG002|COMPLETED|TLC590 570mg and Naropin 150mg||11
9055272|NCT03591146|10114968|FG003|COMPLETED|TLC590 570mg and Naropin 150mg||0
9055273|NCT03591146|10114969|FG004|COMPLETED|TLC590 570mg and Naropin 150mg||3
9055274|NCT03591146|10114965|FG000|NOT COMPLETED|TLC590 570mg and Naropin 150mg||0
9055275|NCT03591146|10114966|FG001|NOT COMPLETED|TLC590 570mg and Naropin 150mg||0
9055276|NCT03591146|10114967|FG002|NOT COMPLETED|TLC590 570mg and Naropin 150mg||1
9055277|NCT03591146|10114968|FG003|NOT COMPLETED|TLC590 570mg and Naropin 150mg||0
9055278|NCT03591146|10114969|FG004|NOT COMPLETED|TLC590 570mg and Naropin 150mg||1
9055279|NCT03591146|10114965|FG000|STARTED|TLC590 475mg and Naropin 150mg||0
9055280|NCT03591146|10114966|FG001|STARTED|TLC590 475mg and Naropin 150mg||0
9055281|NCT03591146|10114967|FG002|STARTED|TLC590 475mg and Naropin 150mg||0
9055282|NCT03591146|10114968|FG003|STARTED|TLC590 475mg and Naropin 150mg||12
9055283|NCT03591146|10114969|FG004|STARTED|TLC590 475mg and Naropin 150mg||4
9055284|NCT03591146|10114965|FG000|COMPLETED|TLC590 475mg and Naropin 150mg||0
9055285|NCT03591146|10114966|FG001|COMPLETED|TLC590 475mg and Naropin 150mg||0
9055286|NCT03591146|10114967|FG002|COMPLETED|TLC590 475mg and Naropin 150mg||0
9055287|NCT03591146|10114968|FG003|COMPLETED|TLC590 475mg and Naropin 150mg||12
9055288|NCT03591146|10114969|FG004|COMPLETED|TLC590 475mg and Naropin 150mg||4
9055289|NCT03591146|10114965|FG000|NOT COMPLETED|TLC590 475mg and Naropin 150mg||0
9055290|NCT03591146|10114966|FG001|NOT COMPLETED|TLC590 475mg and Naropin 150mg||0
9055291|NCT03591146|10114967|FG002|NOT COMPLETED|TLC590 475mg and Naropin 150mg||0
9055292|NCT03591146|10114968|FG003|NOT COMPLETED|TLC590 475mg and Naropin 150mg||0
9055293|NCT03591146|10114969|FG004|NOT COMPLETED|TLC590 475mg and Naropin 150mg||0
9055294|NCT03591406|10114983|FG000|STARTED|Overall Study||188
9055295|NCT03591406|10114984|FG001|STARTED|Overall Study||183
9055296|NCT03591406|10114983|FG000|COMPLETED|Overall Study||181
9055297|NCT03591406|10114984|FG001|COMPLETED|Overall Study||174
9055298|NCT03591406|10114983|FG000|NOT COMPLETED|Overall Study||7
9055299|NCT03591406|10114984|FG001|NOT COMPLETED|Overall Study||9
9055300|NCT03592121|10114992|FG000|STARTED|Overall Study||3
9055301|NCT03592121|10114993|FG001|STARTED|Overall Study||0
9055302|NCT03592121|10114992|FG000|COMPLETED|Overall Study||3
9055303|NCT03592121|10114993|FG001|COMPLETED|Overall Study||0
9055304|NCT03592121|10114992|FG000|NOT COMPLETED|Overall Study||0
9055305|NCT03592121|10114993|FG001|NOT COMPLETED|Overall Study||0
9055306|NCT03592745|10115001|FG000|STARTED|Overall Study||18
9055307|NCT03592745|10115002|FG001|STARTED|Overall Study||18
9055308|NCT03592745|10115001|FG000|COMPLETED|Overall Study||15
9055309|NCT03592745|10115002|FG001|COMPLETED|Overall Study||15
9055310|NCT03592745|10115001|FG000|NOT COMPLETED|Overall Study||3
9055311|NCT03592745|10115002|FG001|NOT COMPLETED|Overall Study||3
9055312|NCT03593200|10115008|FG000|STARTED|Overall Study||4
9055313|NCT03593200|10115008|FG000|COMPLETED|Overall Study||4
9055314|NCT03593200|10115008|FG000|NOT COMPLETED|Overall Study||0
9055315|NCT03593538|10115015|FG000|STARTED|Overall Study||26
9055316|NCT03593538|10115016|FG001|STARTED|Overall Study||21
9055317|NCT03593538|10115017|FG002|STARTED|Overall Study||22
9055318|NCT03593538|10115015|FG000|COMPLETED|Overall Study||15
9055319|NCT03593538|10115016|FG001|COMPLETED|Overall Study||15
9055320|NCT03593538|10115017|FG002|COMPLETED|Overall Study||11
9055321|NCT03593538|10115015|FG000|NOT COMPLETED|Overall Study||11
9055322|NCT03593538|10115016|FG001|NOT COMPLETED|Overall Study||6
9055323|NCT03593538|10115017|FG002|NOT COMPLETED|Overall Study||11
9055324|NCT03593681|10115025|FG000|STARTED|Overall Study||150
9055325|NCT03593681|10115025|FG000|COMPLETED|Overall Study||115
9055326|NCT03593681|10115025|FG000|NOT COMPLETED|Overall Study||35
9055327|NCT03593876|10115046|FG000|STARTED|Overall Study||16
9055328|NCT03593876|10115046|FG000|COMPLETED|Overall Study||13
9055329|NCT03593876|10115046|FG000|NOT COMPLETED|Overall Study||3
9055330|NCT03593902|10115050|FG000|STARTED|Overall Study||9
9055331|NCT03593902|10115050|FG000|COMPLETED|Overall Study||9
9055332|NCT03593902|10115050|FG000|NOT COMPLETED|Overall Study||0
9055333|NCT03594045|10115056|FG000|STARTED|Overall Study||0
9055334|NCT03594045|10115057|FG001|STARTED|Overall Study||5
8812716|NCT01521117|9865730|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
8812717|NCT01521117|9865731|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||3
8812718|NCT01521260|9865739|FG000|STARTED|Overall Study||15
8812719|NCT01521260|9865740|FG001|STARTED|Overall Study||15
8812720|NCT01521260|9865739|FG000|COMPLETED|Overall Study||15
8812721|NCT01521260|9865740|FG001|COMPLETED|Overall Study||15
8812722|NCT01521260|9865739|FG000|NOT COMPLETED|Overall Study||0
8812723|NCT01521260|9865740|FG001|NOT COMPLETED|Overall Study||0
8812724|NCT01521364|9865746|FG000|STARTED|Linezolid Without Clarithromycin (1 wk)||7
8812725|NCT01521364|9865746|FG000|COMPLETED|Linezolid Without Clarithromycin (1 wk)||7
8812726|NCT01521364|9865746|FG000|NOT COMPLETED|Linezolid Without Clarithromycin (1 wk)||0
8703823|NCT00925054|9749618|FG004|STARTED|Overall Study||10
8703824|NCT00925054|9749614|FG000|COMPLETED|Overall Study||7
8812727|NCT01521364|9865746|FG000|STARTED|Linezolid + 250mg Claritromycin (wk 2&3)||7
8812728|NCT01521364|9865746|FG000|COMPLETED|Linezolid + 250mg Claritromycin (wk 2&3)||6
8812729|NCT01521364|9865746|FG000|NOT COMPLETED|Linezolid + 250mg Claritromycin (wk 2&3)||1
8812730|NCT01521364|9865746|FG000|STARTED|Linezolid + 500mg Claritromycin (wk 4&5)||6
9055335|NCT03594045|10115056|FG000|COMPLETED|Overall Study||0
9055336|NCT03594045|10115057|FG001|COMPLETED|Overall Study||5
9055337|NCT03594045|10115056|FG000|NOT COMPLETED|Overall Study||0
9055338|NCT03594045|10115057|FG001|NOT COMPLETED|Overall Study||0
9055339|NCT03594071|10115063|FG000|STARTED|Overall Study||294
9055340|NCT03594071|10115063|FG000|COMPLETED|Overall Study||289
9055341|NCT03594071|10115063|FG000|NOT COMPLETED|Overall Study||5
9055342|NCT03594227|10115071|FG000|STARTED|Overall Study||23
9055343|NCT03594227|10115072|FG001|STARTED|Overall Study||23
9055344|NCT03594227|10115073|FG002|STARTED|Overall Study||22
9055345|NCT03594227|10115074|FG003|STARTED|Overall Study||19
9055346|NCT03594227|10115071|FG000|COMPLETED|Overall Study||18
9055347|NCT03594227|10115072|FG001|COMPLETED|Overall Study||19
9055348|NCT03594227|10115073|FG002|COMPLETED|Overall Study||19
9055349|NCT03594227|10115074|FG003|COMPLETED|Overall Study||14
9055350|NCT03594227|10115071|FG000|NOT COMPLETED|Overall Study||5
9055351|NCT03594227|10115072|FG001|NOT COMPLETED|Overall Study||4
9055352|NCT03594227|10115073|FG002|NOT COMPLETED|Overall Study||3
9055353|NCT03594227|10115074|FG003|NOT COMPLETED|Overall Study||5
9055354|NCT03594500|10115097|FG000|STARTED|Overall Study||66
9055355|NCT03594500|10115098|FG001|STARTED|Overall Study||67
9055356|NCT03594500|10115097|FG000|COMPLETED|Overall Study||60
9055357|NCT03594500|10115098|FG001|COMPLETED|Overall Study||63
9055358|NCT03594500|10115097|FG000|NOT COMPLETED|Overall Study||6
9055359|NCT03594500|10115098|FG001|NOT COMPLETED|Overall Study||4
9055360|NCT03595176|10115109|FG000|STARTED|Overall Study||47
9055361|NCT03595176|10115110|FG001|STARTED|Overall Study||384
9055362|NCT03595176|10115109|FG000|COMPLETED|Overall Study||47
8703825|NCT00925054|9749615|FG001|COMPLETED|Overall Study||8
8703826|NCT00925054|9749616|FG002|COMPLETED|Overall Study||12
8703827|NCT00925054|9749617|FG003|COMPLETED|Overall Study||0
8703828|NCT00925054|9749618|FG004|COMPLETED|Overall Study||10
8703829|NCT00925054|9749614|FG000|NOT COMPLETED|Overall Study||0
8703830|NCT00925054|9749615|FG001|NOT COMPLETED|Overall Study||1
8703831|NCT00925054|9749616|FG002|NOT COMPLETED|Overall Study||1
8703832|NCT00925054|9749617|FG003|NOT COMPLETED|Overall Study||1
8703833|NCT00925054|9749618|FG004|NOT COMPLETED|Overall Study||0
8703834|NCT00925119|9749631|FG000|STARTED|Overall Study||31
8703835|NCT00925119|9749631|FG000|COMPLETED|Overall Study||19
8703836|NCT00925119|9749631|FG000|NOT COMPLETED|Overall Study||12
8812731|NCT01521364|9865746|FG000|COMPLETED|Linezolid + 500mg Claritromycin (wk 4&5)||5
8812732|NCT01521364|9865746|FG000|NOT COMPLETED|Linezolid + 500mg Claritromycin (wk 4&5)||1
9055363|NCT03595176|10115110|FG001|COMPLETED|Overall Study||381
9055364|NCT03595176|10115109|FG000|NOT COMPLETED|Overall Study||0
9055365|NCT03595176|10115110|FG001|NOT COMPLETED|Overall Study||3
9055366|NCT03595215|10115115|FG000|STARTED|Overall Study||18
9055367|NCT03595215|10115115|FG000|COMPLETED|Overall Study||10
9055368|NCT03595215|10115115|FG000|NOT COMPLETED|Overall Study||8
9055369|NCT03595280|10115122|FG000|STARTED|Overall Study||119
9055370|NCT03595280|10115123|FG001|STARTED|Overall Study||117
9055371|NCT03595280|10115124|FG002|STARTED|Overall Study||113
9055372|NCT03595280|10115122|FG000|COMPLETED|Overall Study||113
9055373|NCT03595280|10115123|FG001|COMPLETED|Overall Study||108
9055374|NCT03595280|10115124|FG002|COMPLETED|Overall Study||98
9055375|NCT03595280|10115122|FG000|NOT COMPLETED|Overall Study||6
9055376|NCT03595280|10115123|FG001|NOT COMPLETED|Overall Study||9
9055377|NCT03595280|10115124|FG002|NOT COMPLETED|Overall Study||15
9055378|NCT03595449|10115134|FG000|STARTED|Overall Study||118
9055379|NCT03595449|10115135|FG001|STARTED|Overall Study||115
9055380|NCT03595449|10115134|FG000|COMPLETED|Overall Study||118
9055381|NCT03595449|10115135|FG001|COMPLETED|Overall Study||115
9055382|NCT03595449|10115134|FG000|NOT COMPLETED|Overall Study||0
9055383|NCT03595449|10115135|FG001|NOT COMPLETED|Overall Study||0
9055384|NCT03595579|10115143|FG000|STARTED|Overall Study||48
9055385|NCT03595579|10115144|FG001|STARTED|Overall Study||49
9055386|NCT03595579|10115143|FG000|mITT Population|Overall Study||43
9055387|NCT03595579|10115144|FG001|mITT Population|Overall Study||37
9055388|NCT03595579|10115143|FG000|Safety Population|Overall Study||48
9055389|NCT03595579|10115144|FG001|Safety Population|Overall Study||48
9055390|NCT03595579|10115143|FG000|COMPLETED|Overall Study||38
9055391|NCT03595579|10115144|FG001|COMPLETED|Overall Study||35
9055392|NCT03595579|10115143|FG000|NOT COMPLETED|Overall Study||10
9055393|NCT03595579|10115144|FG001|NOT COMPLETED|Overall Study||14
9055394|NCT03595618|10115154|FG000|STARTED|Overall Study||234
9055395|NCT03595618|10115155|FG001|STARTED|Overall Study||231
9055396|NCT03595618|10115156|FG002|STARTED|Overall Study||233
9055397|NCT03595618|10115157|FG003|STARTED|Overall Study||234
9055398|NCT03595618|10115154|FG000|Treated|Overall Study||234
9055399|NCT03595618|10115155|FG001|Treated|Overall Study||231
9055400|NCT03595618|10115156|FG002|Treated|Overall Study||232
9055401|NCT03595618|10115157|FG003|Treated|Overall Study||234
9055402|NCT03595618|10115154|FG000|COMPLETED|Overall Study||191
9055403|NCT03595618|10115155|FG001|COMPLETED|Overall Study||191
9055404|NCT03595618|10115156|FG002|COMPLETED|Overall Study||177
9055405|NCT03595618|10115157|FG003|COMPLETED|Overall Study||200
9055406|NCT03595618|10115154|FG000|NOT COMPLETED|Overall Study||43
9055407|NCT03595618|10115155|FG001|NOT COMPLETED|Overall Study||40
9055408|NCT03595618|10115156|FG002|NOT COMPLETED|Overall Study||56
9055409|NCT03595618|10115157|FG003|NOT COMPLETED|Overall Study||34
9055410|NCT03595904|10115169|FG000|STARTED|Overall Study||39
9055411|NCT03595904|10115170|FG001|STARTED|Overall Study||39
9055412|NCT03595904|10115169|FG000|COMPLETED|Overall Study||29
9055413|NCT03595904|10115170|FG001|COMPLETED|Overall Study||34
9055414|NCT03595904|10115169|FG000|NOT COMPLETED|Overall Study||10
9055415|NCT03595904|10115170|FG001|NOT COMPLETED|Overall Study||5
9055416|NCT03596151|10115176|FG000|STARTED|Overall Study||295
9055417|NCT03596151|10115176|FG000|COMPLETED|Overall Study||294
9055418|NCT03596151|10115176|FG000|NOT COMPLETED|Overall Study||1
9055419|NCT03596177|10115182|FG000|STARTED|Single Blind Period||9
9055420|NCT03596177|10115183|FG001|STARTED|Single Blind Period||19
9055421|NCT03596177|10115182|FG000|COMPLETED|Single Blind Period||7
9055422|NCT03596177|10115183|FG001|COMPLETED|Single Blind Period||18
9055423|NCT03596177|10115182|FG000|NOT COMPLETED|Single Blind Period||2
9055424|NCT03596177|10115183|FG001|NOT COMPLETED|Single Blind Period||1
9055425|NCT03596177|10115182|FG000|STARTED|Double Blind Period||7
9055426|NCT03596177|10115183|FG001|STARTED|Double Blind Period||18
9055427|NCT03596177|10115182|FG000|COMPLETED|Double Blind Period||7
9055428|NCT03596177|10115183|FG001|COMPLETED|Double Blind Period||12
9055429|NCT03596177|10115182|FG000|NOT COMPLETED|Double Blind Period||0
9055430|NCT03596177|10115183|FG001|NOT COMPLETED|Double Blind Period||6
9055431|NCT03596723|10115191|FG000|STARTED|Overall Study||1
9055432|NCT03596723|10115192|FG001|STARTED|Overall Study||1
9055433|NCT03596723|10115191|FG000|COMPLETED|Overall Study||1
9055434|NCT03596723|10115192|FG001|COMPLETED|Overall Study||1
9055435|NCT03596723|10115191|FG000|NOT COMPLETED|Overall Study||0
9055436|NCT03596723|10115192|FG001|NOT COMPLETED|Overall Study||0
9055437|NCT03597009|10115198|FG000|STARTED|Overall Study||1
9055438|NCT03597009|10115198|FG000|COMPLETED|Overall Study||1
9055439|NCT03597009|10115198|FG000|NOT COMPLETED|Overall Study||0
9055440|NCT03597022|10115205|FG000|STARTED|Overall Study||8
9055441|NCT03597022|10115206|FG001|STARTED|Overall Study||8
9055442|NCT03597022|10115207|FG002|STARTED|Overall Study||8
9055443|NCT03597022|10115205|FG000|COMPLETED|Overall Study||0
9055444|NCT03597022|10115206|FG001|COMPLETED|Overall Study||0
9055445|NCT03597022|10115207|FG002|COMPLETED|Overall Study||0
9055446|NCT03597022|10115205|FG000|NOT COMPLETED|Overall Study||8
9055447|NCT03597022|10115206|FG001|NOT COMPLETED|Overall Study||8
9055448|NCT03597022|10115207|FG002|NOT COMPLETED|Overall Study||8
8703837|NCT00925132|9749635|FG000|STARTED|Overall Study||5
8703838|NCT00925132|9749636|FG001|STARTED|Overall Study||4
8703839|NCT00925132|9749637|FG002|STARTED|Overall Study||4
8703840|NCT00925132|9749638|FG003|STARTED|Overall Study||4
8703841|NCT00925132|9749639|FG004|STARTED|Overall Study||22
8703842|NCT00925132|9749635|FG000|COMPLETED|Overall Study||3
8703843|NCT00925132|9749636|FG001|COMPLETED|Overall Study||4
8703844|NCT00925132|9749637|FG002|COMPLETED|Overall Study||4
8703845|NCT00925132|9749638|FG003|COMPLETED|Overall Study||4
8703846|NCT00925132|9749639|FG004|COMPLETED|Overall Study||17
9055449|NCT03597061|10115217|FG000|STARTED|Overall Study||17
9055450|NCT03597061|10115218|FG001|STARTED|Overall Study||17
9055451|NCT03597061|10115217|FG000|COMPLETED|Overall Study||16
9055452|NCT03597061|10115218|FG001|COMPLETED|Overall Study||16
9055453|NCT03597061|10115217|FG000|NOT COMPLETED|Overall Study||1
9055454|NCT03597061|10115218|FG001|NOT COMPLETED|Overall Study||1
9055455|NCT03597139|10115226|FG000|STARTED|Overall Study||51
9055456|NCT03597139|10115227|FG001|STARTED|Overall Study||49
9055457|NCT03597139|10115226|FG000|COMPLETED|Overall Study||47
9055458|NCT03597139|10115227|FG001|COMPLETED|Overall Study||49
9055459|NCT03597139|10115226|FG000|NOT COMPLETED|Overall Study||4
9055460|NCT03597139|10115227|FG001|NOT COMPLETED|Overall Study||0
9055461|NCT03597178|10115233|FG000|STARTED|Overall Study||14
9055462|NCT03597178|10115233|FG000|COMPLETED|Overall Study||14
9055463|NCT03597178|10115233|FG000|NOT COMPLETED|Overall Study||0
9055464|NCT03597347|10115240|FG000|STARTED|Overall Study||7
9055465|NCT03597347|10115241|FG001|STARTED|Overall Study||3
9055466|NCT03597347|10115242|FG002|STARTED|Overall Study||4
9055467|NCT03597347|10115240|FG000|COMPLETED|Overall Study||0
9055468|NCT03597347|10115241|FG001|COMPLETED|Overall Study||0
9055469|NCT03597347|10115242|FG002|COMPLETED|Overall Study||0
9055470|NCT03597347|10115240|FG000|NOT COMPLETED|Overall Study||7
9055471|NCT03597347|10115241|FG001|NOT COMPLETED|Overall Study||3
9055472|NCT03597347|10115242|FG002|NOT COMPLETED|Overall Study||4
9055473|NCT03597529|10115252|FG000|STARTED|Overall Study||42
9055474|NCT03597529|10115253|FG001|STARTED|Overall Study||42
9055475|NCT03597529|10115252|FG000|Follow-up|Overall Study||22
9055476|NCT03597529|10115253|FG001|Follow-up|Overall Study||24
9055477|NCT03597529|10115252|FG000|COMPLETED|Overall Study||22
9055478|NCT03597529|10115253|FG001|COMPLETED|Overall Study||24
9055479|NCT03597529|10115252|FG000|NOT COMPLETED|Overall Study||20
9055480|NCT03597529|10115253|FG001|NOT COMPLETED|Overall Study||18
9055481|NCT03597789|10115259|FG000|STARTED|Overall Study||45
9055482|NCT03597789|10115259|FG000|COMPLETED|Overall Study||10
9055483|NCT03597789|10115259|FG000|NOT COMPLETED|Overall Study||35
9055484|NCT03598647|10115265|FG000|STARTED|Exercisers vs. Non-exercisers||30
9055485|NCT03598647|10115266|FG001|STARTED|Exercisers vs. Non-exercisers||30
9055486|NCT03598647|10115267|FG002|STARTED|Exercisers vs. Non-exercisers||0
9055487|NCT03598647|10115268|FG003|STARTED|Exercisers vs. Non-exercisers||0
9055488|NCT03598647|10115265|FG000|COMPLETED|Exercisers vs. Non-exercisers||29
9055489|NCT03598647|10115266|FG001|COMPLETED|Exercisers vs. Non-exercisers||30
9055490|NCT03598647|10115267|FG002|COMPLETED|Exercisers vs. Non-exercisers||0
9055491|NCT03598647|10115268|FG003|COMPLETED|Exercisers vs. Non-exercisers||0
9055492|NCT03598647|10115265|FG000|NOT COMPLETED|Exercisers vs. Non-exercisers||1
9055493|NCT03598647|10115266|FG001|NOT COMPLETED|Exercisers vs. Non-exercisers||0
9055494|NCT03598647|10115267|FG002|NOT COMPLETED|Exercisers vs. Non-exercisers||0
9055495|NCT03598647|10115268|FG003|NOT COMPLETED|Exercisers vs. Non-exercisers||0
9055496|NCT03598647|10115265|FG000|STARTED|Interventions for Non-exercisers||0
9055497|NCT03598647|10115266|FG001|STARTED|Interventions for Non-exercisers||0
9055498|NCT03598647|10115267|FG002|STARTED|Interventions for Non-exercisers||14
9055499|NCT03598647|10115268|FG003|STARTED|Interventions for Non-exercisers||16
9055500|NCT03598647|10115265|FG000|COMPLETED|Interventions for Non-exercisers||0
9055501|NCT03598647|10115266|FG001|COMPLETED|Interventions for Non-exercisers||0
9055502|NCT03598647|10115267|FG002|COMPLETED|Interventions for Non-exercisers||14
9055503|NCT03598647|10115268|FG003|COMPLETED|Interventions for Non-exercisers||16
9055504|NCT03598647|10115265|FG000|NOT COMPLETED|Interventions for Non-exercisers||0
9055505|NCT03598647|10115266|FG001|NOT COMPLETED|Interventions for Non-exercisers||0
9055506|NCT03598647|10115267|FG002|NOT COMPLETED|Interventions for Non-exercisers||0
9055507|NCT03598647|10115268|FG003|NOT COMPLETED|Interventions for Non-exercisers||0
9055508|NCT03599089|10115282|FG000|STARTED|Overall Study||36
9055509|NCT03599089|10115283|FG001|STARTED|Overall Study||36
9055510|NCT03599089|10115284|FG002|STARTED|Overall Study||38
9055511|NCT03599089|10115285|FG003|STARTED|Overall Study||37
9055512|NCT03599089|10115282|FG000|COMPLETED|Overall Study||33
9055513|NCT03599089|10115283|FG001|COMPLETED|Overall Study||35
9055514|NCT03599089|10115284|FG002|COMPLETED|Overall Study||37
9055515|NCT03599089|10115285|FG003|COMPLETED|Overall Study||35
9055516|NCT03599089|10115282|FG000|NOT COMPLETED|Overall Study||3
9055517|NCT03599089|10115283|FG001|NOT COMPLETED|Overall Study||1
9055518|NCT03599089|10115284|FG002|NOT COMPLETED|Overall Study||1
9055519|NCT03599089|10115285|FG003|NOT COMPLETED|Overall Study||2
9055520|NCT03599193|10115297|FG000|STARTED|Overall Study||34
9055521|NCT03599193|10115298|FG001|STARTED|Overall Study||24
9055522|NCT03599193|10115297|FG000|COMPLETED|Overall Study||32
9055523|NCT03599193|10115298|FG001|COMPLETED|Overall Study||21
9055524|NCT03599193|10115297|FG000|NOT COMPLETED|Overall Study||2
9055525|NCT03599193|10115298|FG001|NOT COMPLETED|Overall Study||3
9055526|NCT03599271|10115307|FG000|STARTED|Overall Study||70
9055527|NCT03599271|10115308|FG001|STARTED|Overall Study||5
9055528|NCT03599271|10115307|FG000|Drug-Coated Device|Overall Study||70
9055529|NCT03599271|10115308|FG001|Drug-Coated Device|Overall Study||5
9055530|NCT03599271|10115307|FG000|Control Device|Overall Study||70
9055531|NCT03599271|10115308|FG001|Control Device|Overall Study||0
9055532|NCT03599271|10115307|FG000|COMPLETED|Overall Study||70
9055533|NCT03599271|10115308|FG001|COMPLETED|Overall Study||5
9055534|NCT03599271|10115307|FG000|NOT COMPLETED|Overall Study||0
9055535|NCT03599271|10115308|FG001|NOT COMPLETED|Overall Study||0
9055536|NCT03599349|10115316|FG000|STARTED|Overall Study||20
9055537|NCT03599349|10115316|FG000|Treated|Overall Study||20
9055538|NCT03599349|10115316|FG000|COMPLETED|Overall Study||19
9055539|NCT03599349|10115316|FG000|NOT COMPLETED|Overall Study||1
9055540|NCT03599362|10115320|FG000|STARTED|Overall Study||7
9055541|NCT03599362|10115320|FG000|COMPLETED|Overall Study||4
9055542|NCT03599362|10115320|FG000|NOT COMPLETED|Overall Study||3
9055543|NCT03599687|10115326|FG000|STARTED|Overall Study||82
9055544|NCT03599687|10115327|FG001|STARTED|Overall Study||82
9055545|NCT03599687|10115326|FG000|COMPLETED|Overall Study||82
9055546|NCT03599687|10115327|FG001|COMPLETED|Overall Study||82
9055547|NCT03599687|10115326|FG000|NOT COMPLETED|Overall Study||0
9055548|NCT03599687|10115327|FG001|NOT COMPLETED|Overall Study||0
9055549|NCT03599986|10115333|FG000|STARTED|Overall Study||398
9055550|NCT03599986|10115333|FG000|COMPLETED|Overall Study||366
9055551|NCT03599986|10115333|FG000|NOT COMPLETED|Overall Study||32
9055552|NCT03600194|10115338|FG000|STARTED|Screening||38
9055553|NCT03600194|10115339|FG001|STARTED|Screening||0
9055554|NCT03600194|10115340|FG002|STARTED|Screening||0
9055555|NCT03600194|10115338|FG000|COMPLETED|Screening||11
9055556|NCT03600194|10115339|FG001|COMPLETED|Screening||0
9055557|NCT03600194|10115340|FG002|COMPLETED|Screening||0
9055558|NCT03600194|10115338|FG000|NOT COMPLETED|Screening||27
9055559|NCT03600194|10115339|FG001|NOT COMPLETED|Screening||0
9055560|NCT03600194|10115340|FG002|NOT COMPLETED|Screening||0
9055561|NCT03600194|10115338|FG000|STARTED|In Lab Phase||0
9055562|NCT03600194|10115339|FG001|STARTED|In Lab Phase||5
9055563|NCT03600194|10115340|FG002|STARTED|In Lab Phase||6
9055564|NCT03600194|10115338|FG000|COMPLETED|In Lab Phase||0
9055565|NCT03600194|10115339|FG001|COMPLETED|In Lab Phase||5
9055566|NCT03600194|10115340|FG002|COMPLETED|In Lab Phase||6
9055567|NCT03600194|10115338|FG000|NOT COMPLETED|In Lab Phase||0
9055568|NCT03600194|10115339|FG001|NOT COMPLETED|In Lab Phase||0
9055569|NCT03600194|10115340|FG002|NOT COMPLETED|In Lab Phase||0
9055570|NCT03600376|10115353|FG000|STARTED|Overall Study||9
9055571|NCT03600376|10115354|FG001|STARTED|Overall Study||8
9055572|NCT03600376|10115353|FG000|COMPLETED|Overall Study||7
9055573|NCT03600376|10115354|FG001|COMPLETED|Overall Study||2
9055574|NCT03600376|10115353|FG000|NOT COMPLETED|Overall Study||2
9055575|NCT03600376|10115354|FG001|NOT COMPLETED|Overall Study||6
9055576|NCT03600428|10115362|FG000|STARTED|Overall Study||79
9055577|NCT03600428|10115363|FG001|STARTED|Overall Study||73
9055578|NCT03600428|10115362|FG000|15-day Follow-up|Overall Study||76
9055579|NCT03600428|10115363|FG001|15-day Follow-up|Overall Study||70
9055580|NCT03600428|10115362|FG000|43-day Follow-up|Overall Study||74
9055581|NCT03600428|10115363|FG001|43-day Follow-up|Overall Study||68
9055582|NCT03600428|10115362|FG000|COMPLETED|Overall Study||74
9055583|NCT03600428|10115363|FG001|COMPLETED|Overall Study||68
9055584|NCT03600428|10115362|FG000|NOT COMPLETED|Overall Study||5
9055585|NCT03600428|10115363|FG001|NOT COMPLETED|Overall Study||5
9055586|NCT03601052|10115369|FG000|STARTED|Overall Study||14
9055587|NCT03601052|10115369|FG000|COMPLETED|Overall Study||12
9055588|NCT03601052|10115369|FG000|NOT COMPLETED|Overall Study||2
9055589|NCT03601715|10115381|FG000|STARTED|First Intervention||7
9055590|NCT03601715|10115382|FG001|STARTED|First Intervention||7
9055591|NCT03601715|10115383|FG002|STARTED|First Intervention||6
9055592|NCT03601715|10115381|FG000|COMPLETED|First Intervention||7
9055593|NCT03601715|10115382|FG001|COMPLETED|First Intervention||7
9055594|NCT03601715|10115383|FG002|COMPLETED|First Intervention||6
9055595|NCT03601715|10115381|FG000|NOT COMPLETED|First Intervention||0
9055596|NCT03601715|10115382|FG001|NOT COMPLETED|First Intervention||0
9055597|NCT03601715|10115383|FG002|NOT COMPLETED|First Intervention||0
9055598|NCT03601715|10115381|FG000|STARTED|Washout 1 (at Least 24 Hours)||7
9055599|NCT03601715|10115382|FG001|STARTED|Washout 1 (at Least 24 Hours)||7
9055600|NCT03601715|10115383|FG002|STARTED|Washout 1 (at Least 24 Hours)||6
9055601|NCT03601715|10115381|FG000|COMPLETED|Washout 1 (at Least 24 Hours)||7
9055602|NCT03601715|10115382|FG001|COMPLETED|Washout 1 (at Least 24 Hours)||7
9055603|NCT03601715|10115383|FG002|COMPLETED|Washout 1 (at Least 24 Hours)||6
9055604|NCT03601715|10115381|FG000|NOT COMPLETED|Washout 1 (at Least 24 Hours)||0
9055605|NCT03601715|10115382|FG001|NOT COMPLETED|Washout 1 (at Least 24 Hours)||0
9055606|NCT03601715|10115383|FG002|NOT COMPLETED|Washout 1 (at Least 24 Hours)||0
9055607|NCT03601715|10115381|FG000|STARTED|Second Intervention||7
9055608|NCT03601715|10115382|FG001|STARTED|Second Intervention||7
9055609|NCT03601715|10115383|FG002|STARTED|Second Intervention||6
9055610|NCT03601715|10115381|FG000|COMPLETED|Second Intervention||6
9055611|NCT03601715|10115382|FG001|COMPLETED|Second Intervention||6
9055612|NCT03601715|10115383|FG002|COMPLETED|Second Intervention||6
9055613|NCT03601715|10115381|FG000|NOT COMPLETED|Second Intervention||1
9055614|NCT03601715|10115382|FG001|NOT COMPLETED|Second Intervention||1
9055615|NCT03601715|10115383|FG002|NOT COMPLETED|Second Intervention||0
9055616|NCT03601715|10115381|FG000|STARTED|Wash Out 2 (at Least 24 Hours)||6
9055617|NCT03601715|10115382|FG001|STARTED|Wash Out 2 (at Least 24 Hours)||6
9055618|NCT03601715|10115383|FG002|STARTED|Wash Out 2 (at Least 24 Hours)||6
9055619|NCT03601715|10115381|FG000|COMPLETED|Wash Out 2 (at Least 24 Hours)||6
9055620|NCT03601715|10115382|FG001|COMPLETED|Wash Out 2 (at Least 24 Hours)||6
9055621|NCT03601715|10115383|FG002|COMPLETED|Wash Out 2 (at Least 24 Hours)||6
9055622|NCT03601715|10115381|FG000|NOT COMPLETED|Wash Out 2 (at Least 24 Hours)||0
9055623|NCT03601715|10115382|FG001|NOT COMPLETED|Wash Out 2 (at Least 24 Hours)||0
9055624|NCT03601715|10115383|FG002|NOT COMPLETED|Wash Out 2 (at Least 24 Hours)||0
9055625|NCT03601715|10115381|FG000|STARTED|Third Intervention||6
9055626|NCT03601715|10115382|FG001|STARTED|Third Intervention||6
9055627|NCT03601715|10115383|FG002|STARTED|Third Intervention||6
9055628|NCT03601715|10115381|FG000|COMPLETED|Third Intervention||6
9055629|NCT03601715|10115382|FG001|COMPLETED|Third Intervention||6
9055630|NCT03601715|10115383|FG002|COMPLETED|Third Intervention||6
9055631|NCT03601715|10115381|FG000|NOT COMPLETED|Third Intervention||0
9055632|NCT03601715|10115382|FG001|NOT COMPLETED|Third Intervention||0
9055633|NCT03601715|10115383|FG002|NOT COMPLETED|Third Intervention||0
9055634|NCT03602053|10115394|FG000|STARTED|Overall Study||150
9055635|NCT03602053|10115395|FG001|STARTED|Overall Study||150
9055636|NCT03602053|10115396|FG002|STARTED|Overall Study||150
9055637|NCT03602053|10115394|FG000|COMPLETED|Overall Study||131
9055638|NCT03602053|10115395|FG001|COMPLETED|Overall Study||132
9055639|NCT03602053|10115396|FG002|COMPLETED|Overall Study||139
9055640|NCT03602053|10115394|FG000|NOT COMPLETED|Overall Study||19
9055641|NCT03602053|10115395|FG001|NOT COMPLETED|Overall Study||18
9055642|NCT03602053|10115396|FG002|NOT COMPLETED|Overall Study||11
9055643|NCT03602339|10115408|FG000|STARTED|Overall Study||157
9055644|NCT03602339|10115408|FG000|Completed Period 1 (Gadoterate)|Overall Study||155
9055645|NCT03602339|10115408|FG000|Started Period 2 (Gadobutrol)|Overall Study||142
9055646|NCT03602339|10115408|FG000|COMPLETED|Overall Study||142
9055647|NCT03602339|10115408|FG000|NOT COMPLETED|Overall Study||15
9055648|NCT03602482|10115417|FG000|STARTED|Overall Study||50
9055649|NCT03602482|10115418|FG001|STARTED|Overall Study||50
9055650|NCT03602482|10115419|FG002|STARTED|Overall Study||20
9055651|NCT03602482|10115420|FG003|STARTED|Overall Study||19
9055652|NCT03602482|10115417|FG000|COMPLETED|Overall Study||44
9055653|NCT03602482|10115418|FG001|COMPLETED|Overall Study||43
9055654|NCT03602482|10115419|FG002|COMPLETED|Overall Study||20
9055655|NCT03602482|10115420|FG003|COMPLETED|Overall Study||19
9055656|NCT03602482|10115417|FG000|NOT COMPLETED|Overall Study||6
9055657|NCT03602482|10115418|FG001|NOT COMPLETED|Overall Study||7
9055658|NCT03602482|10115419|FG002|NOT COMPLETED|Overall Study||0
9055659|NCT03602482|10115420|FG003|NOT COMPLETED|Overall Study||0
9055660|NCT03603028|10115433|FG000|STARTED|Overall Study||13
9055661|NCT03603028|10115433|FG000|COMPLETED|Overall Study||12
9055662|NCT03603028|10115433|FG000|NOT COMPLETED|Overall Study||1
9055663|NCT03603106|10115448|FG000|STARTED|Overall Study||6
9055664|NCT03603106|10115449|FG001|STARTED|Overall Study||6
9055665|NCT03603106|10115450|FG002|STARTED|Overall Study||6
9055666|NCT03603106|10115451|FG003|STARTED|Overall Study||6
9055667|NCT03603106|10115452|FG004|STARTED|Overall Study||6
9055668|NCT03603106|10115453|FG005|STARTED|Overall Study||6
9055669|NCT03603106|10115454|FG006|STARTED|Overall Study||18
9055670|NCT03603106|10115455|FG007|STARTED|Overall Study||3
9055671|NCT03603106|10115456|FG008|STARTED|Overall Study||3
9055672|NCT03603106|10115457|FG009|STARTED|Overall Study||3
9055673|NCT03603106|10115458|FG010|STARTED|Overall Study||3
9055674|NCT03603106|10115448|FG000|COMPLETED|Overall Study||6
9055675|NCT03603106|10115449|FG001|COMPLETED|Overall Study||6
9055676|NCT03603106|10115450|FG002|COMPLETED|Overall Study||6
9055677|NCT03603106|10115451|FG003|COMPLETED|Overall Study||6
9055678|NCT03603106|10115452|FG004|COMPLETED|Overall Study||6
9055679|NCT03603106|10115453|FG005|COMPLETED|Overall Study||6
9055680|NCT03603106|10115454|FG006|COMPLETED|Overall Study||18
9055681|NCT03603106|10115455|FG007|COMPLETED|Overall Study||3
9055682|NCT03603106|10115456|FG008|COMPLETED|Overall Study||3
9055683|NCT03603106|10115457|FG009|COMPLETED|Overall Study||3
9055684|NCT03603106|10115458|FG010|COMPLETED|Overall Study||3
9055685|NCT03603106|10115448|FG000|NOT COMPLETED|Overall Study||0
9055686|NCT03603106|10115449|FG001|NOT COMPLETED|Overall Study||0
9055687|NCT03603106|10115450|FG002|NOT COMPLETED|Overall Study||0
9055688|NCT03603106|10115451|FG003|NOT COMPLETED|Overall Study||0
9055689|NCT03603106|10115452|FG004|NOT COMPLETED|Overall Study||0
9055690|NCT03603106|10115453|FG005|NOT COMPLETED|Overall Study||0
9055691|NCT03603106|10115454|FG006|NOT COMPLETED|Overall Study||0
9055692|NCT03603106|10115455|FG007|NOT COMPLETED|Overall Study||0
9055693|NCT03603106|10115456|FG008|NOT COMPLETED|Overall Study||0
9055694|NCT03603106|10115457|FG009|NOT COMPLETED|Overall Study||0
9055695|NCT03603106|10115458|FG010|NOT COMPLETED|Overall Study||0
9055696|NCT03603652|10115491|FG000|STARTED|Overall Study||10
9055697|NCT03603652|10115491|FG000|COMPLETED|Overall Study||8
9055698|NCT03603652|10115491|FG000|NOT COMPLETED|Overall Study||2
9055699|NCT03604263|10115495|FG000|STARTED|Overall Study||17
9055700|NCT03604263|10115495|FG000|COMPLETED|Overall Study||15
9055701|NCT03604263|10115495|FG000|NOT COMPLETED|Overall Study||2
9055702|NCT03604341|10115501|FG000|STARTED|Overall Study||35
9055703|NCT03604341|10115502|FG001|STARTED|Overall Study||35
9055704|NCT03604341|10115501|FG000|COMPLETED|Overall Study||33
9055705|NCT03604341|10115502|FG001|COMPLETED|Overall Study||33
9055706|NCT03604341|10115501|FG000|NOT COMPLETED|Overall Study||2
9055707|NCT03604341|10115502|FG001|NOT COMPLETED|Overall Study||2
8703847|NCT00925132|9749635|FG000|NOT COMPLETED|Overall Study||2
8703848|NCT00925132|9749636|FG001|NOT COMPLETED|Overall Study||0
8703849|NCT00925132|9749637|FG002|NOT COMPLETED|Overall Study||0
8703850|NCT00925132|9749638|FG003|NOT COMPLETED|Overall Study||0
8703851|NCT00925132|9749639|FG004|NOT COMPLETED|Overall Study||5
8703852|NCT00925288|9749647|FG000|STARTED|Overall Study||100
8703853|NCT00925288|9749648|FG001|STARTED|Overall Study||100
8703854|NCT00925288|9749647|FG000|COMPLETED|Overall Study||91
9055708|NCT03604497|10115508|FG000|STARTED|Overall Study||437
9055709|NCT03604497|10115508|FG000|COMPLETED|Overall Study||385
9055710|NCT03604497|10115508|FG000|NOT COMPLETED|Overall Study||52
9055711|NCT03604523|10115518|FG000|STARTED|Overall Study||5
9055712|NCT03604523|10115519|FG001|STARTED|Overall Study||5
9055713|NCT03604523|10115518|FG000|COMPLETED|Overall Study||4
9055714|NCT03604523|10115519|FG001|COMPLETED|Overall Study||5
9055715|NCT03604523|10115518|FG000|NOT COMPLETED|Overall Study||1
8703855|NCT00925288|9749648|FG001|COMPLETED|Overall Study||93
8703856|NCT00925288|9749647|FG000|NOT COMPLETED|Overall Study||9
9055716|NCT03604523|10115519|FG001|NOT COMPLETED|Overall Study||0
9055717|NCT03604705|10115525|FG000|STARTED|Overall Study||21
9055718|NCT03604705|10115525|FG000|COMPLETED|Overall Study||20
9055719|NCT03604705|10115525|FG000|NOT COMPLETED|Overall Study||1
9055720|NCT03605212|10115542|FG000|STARTED|Baseline Period||3
9055721|NCT03605212|10115543|FG001|STARTED|Baseline Period||0
9055722|NCT03605212|10115544|FG002|STARTED|Baseline Period||3
9055723|NCT03605212|10115545|FG003|STARTED|Baseline Period||0
9055724|NCT03605212|10115546|FG004|STARTED|Baseline Period||24
9055725|NCT03605212|10115542|FG000|COMPLETED|Baseline Period||3
9055726|NCT03605212|10115543|FG001|COMPLETED|Baseline Period||0
9055727|NCT03605212|10115544|FG002|COMPLETED|Baseline Period||3
9055728|NCT03605212|10115545|FG003|COMPLETED|Baseline Period||0
9055729|NCT03605212|10115546|FG004|COMPLETED|Baseline Period||24
9055730|NCT03605212|10115542|FG000|NOT COMPLETED|Baseline Period||0
9055731|NCT03605212|10115543|FG001|NOT COMPLETED|Baseline Period||0
9055732|NCT03605212|10115544|FG002|NOT COMPLETED|Baseline Period||0
9055733|NCT03605212|10115545|FG003|NOT COMPLETED|Baseline Period||0
9055734|NCT03605212|10115546|FG004|NOT COMPLETED|Baseline Period||0
9055735|NCT03605212|10115542|FG000|STARTED|Treatment Period||3
9055736|NCT03605212|10115543|FG001|STARTED|Treatment Period||0
9055737|NCT03605212|10115544|FG002|STARTED|Treatment Period||3
9055738|NCT03605212|10115545|FG003|STARTED|Treatment Period||0
9055739|NCT03605212|10115546|FG004|STARTED|Treatment Period||24
9055740|NCT03605212|10115542|FG000|COMPLETED|Treatment Period||2
9055741|NCT03605212|10115543|FG001|COMPLETED|Treatment Period||0
9055742|NCT03605212|10115544|FG002|COMPLETED|Treatment Period||3
9055743|NCT03605212|10115545|FG003|COMPLETED|Treatment Period||0
9055744|NCT03605212|10115546|FG004|COMPLETED|Treatment Period||23
9055745|NCT03605212|10115542|FG000|NOT COMPLETED|Treatment Period||1
9055746|NCT03605212|10115543|FG001|NOT COMPLETED|Treatment Period||0
9055747|NCT03605212|10115544|FG002|NOT COMPLETED|Treatment Period||0
9055748|NCT03605212|10115545|FG003|NOT COMPLETED|Treatment Period||0
9055749|NCT03605212|10115546|FG004|NOT COMPLETED|Treatment Period||1
9055750|NCT03605693|10115561|FG000|STARTED|Overall Study||5
9055751|NCT03605693|10115562|FG001|STARTED|Overall Study||5
9055752|NCT03605693|10115561|FG000|COMPLETED|Overall Study||0
9055753|NCT03605693|10115562|FG001|COMPLETED|Overall Study||5
9055754|NCT03605693|10115561|FG000|NOT COMPLETED|Overall Study||5
9055755|NCT03605693|10115562|FG001|NOT COMPLETED|Overall Study||0
9055756|NCT03605745|10115568|FG000|STARTED|Overall Study||47
9055757|NCT03605745|10115568|FG000|2 Weeks|Overall Study||47
9055758|NCT03605745|10115568|FG000|6 Weeks|Overall Study||47
9055759|NCT03605745|10115568|FG000|3 Months|Overall Study||47
9055760|NCT03605745|10115568|FG000|6 Months|Overall Study||47
9055761|NCT03605745|10115568|FG000|12 Months|Overall Study||40
9055762|NCT03605745|10115568|FG000|24 Months|Overall Study||1
8703857|NCT00925288|9749648|FG001|NOT COMPLETED|Overall Study||7
8703858|NCT00925301|9749658|FG000|STARTED|6-Month Double-blind (Stage 1)||34
8703859|NCT00925301|9749659|FG001|STARTED|6-Month Double-blind (Stage 1)||33
9055763|NCT03605745|10115568|FG000|COMPLETED|Overall Study||0
9055764|NCT03605745|10115568|FG000|NOT COMPLETED|Overall Study||47
9055765|NCT03605836|10115576|FG000|STARTED|OL Placebo Run-in Period [1 Week]||590
9055766|NCT03605836|10115577|FG001|STARTED|OL Placebo Run-in Period [1 Week]||0
9055767|NCT03605836|10115578|FG002|STARTED|OL Placebo Run-in Period [1 Week]||0
9055768|NCT03605836|10115579|FG003|STARTED|OL Placebo Run-in Period [1 Week]||0
8724599|NCT01026948|9771794|FG000|NOT COMPLETED|Overall Study||8
9055769|NCT03605836|10115576|FG000|Treated|OL Placebo Run-in Period [1 Week]||579
9055770|NCT03605836|10115577|FG001|Treated|OL Placebo Run-in Period [1 Week]||0
9055771|NCT03605836|10115578|FG002|Treated|OL Placebo Run-in Period [1 Week]||0
9055772|NCT03605836|10115579|FG003|Treated|OL Placebo Run-in Period [1 Week]||0
9055773|NCT03605836|10115576|FG000|COMPLETED|OL Placebo Run-in Period [1 Week]||440
9055774|NCT03605836|10115577|FG001|COMPLETED|OL Placebo Run-in Period [1 Week]||0
9055775|NCT03605836|10115578|FG002|COMPLETED|OL Placebo Run-in Period [1 Week]||0
9055776|NCT03605836|10115579|FG003|COMPLETED|OL Placebo Run-in Period [1 Week]||0
9055777|NCT03605836|10115576|FG000|NOT COMPLETED|OL Placebo Run-in Period [1 Week]||150
9055778|NCT03605836|10115577|FG001|NOT COMPLETED|OL Placebo Run-in Period [1 Week]||0
9055779|NCT03605836|10115578|FG002|NOT COMPLETED|OL Placebo Run-in Period [1 Week]||0
9055780|NCT03605836|10115579|FG003|NOT COMPLETED|OL Placebo Run-in Period [1 Week]||0
9055781|NCT03605836|10115576|FG000|STARTED|Double-blind Treatment Period [6 Weeks]||0
9055782|NCT03605836|10115577|FG001|STARTED|Double-blind Treatment Period [6 Weeks]||147
9055783|NCT03605836|10115578|FG002|STARTED|Double-blind Treatment Period [6 Weeks]||147
9055784|NCT03605836|10115579|FG003|STARTED|Double-blind Treatment Period [6 Weeks]||146
9055785|NCT03605836|10115576|FG000|Treated|Double-blind Treatment Period [6 Weeks]||0
9055786|NCT03605836|10115577|FG001|Treated|Double-blind Treatment Period [6 Weeks]||145
9055787|NCT03605836|10115578|FG002|Treated|Double-blind Treatment Period [6 Weeks]||143
9055788|NCT03605836|10115579|FG003|Treated|Double-blind Treatment Period [6 Weeks]||142
9055789|NCT03605836|10115576|FG000|COMPLETED|Double-blind Treatment Period [6 Weeks]||0
9055790|NCT03605836|10115577|FG001|COMPLETED|Double-blind Treatment Period [6 Weeks]||111
9055791|NCT03605836|10115578|FG002|COMPLETED|Double-blind Treatment Period [6 Weeks]||102
9055792|NCT03605836|10115579|FG003|COMPLETED|Double-blind Treatment Period [6 Weeks]||123
9055793|NCT03605836|10115576|FG000|NOT COMPLETED|Double-blind Treatment Period [6 Weeks]||0
9055794|NCT03605836|10115577|FG001|NOT COMPLETED|Double-blind Treatment Period [6 Weeks]||36
9055795|NCT03605836|10115578|FG002|NOT COMPLETED|Double-blind Treatment Period [6 Weeks]||45
9055796|NCT03605836|10115579|FG003|NOT COMPLETED|Double-blind Treatment Period [6 Weeks]||23
9055797|NCT03605914|10115590|FG000|STARTED|Overall Study||57
9055798|NCT03605914|10115591|FG001|STARTED|Overall Study||43
9055799|NCT03605914|10115590|FG000|Completed Day 1 Assessment|Overall Study||31
9055800|NCT03605914|10115591|FG001|Completed Day 1 Assessment|Overall Study||26
9055801|NCT03605914|10115590|FG000|Completed Day 2 Assessment|Overall Study||32
9055802|NCT03605914|10115591|FG001|Completed Day 2 Assessment|Overall Study||27
9055803|NCT03605914|10115590|FG000|Completed Day 3 Assessment|Overall Study||31
9055804|NCT03605914|10115591|FG001|Completed Day 3 Assessment|Overall Study||28
9055805|NCT03605914|10115590|FG000|Completed Day 5 Assessment|Overall Study||30
9055806|NCT03605914|10115591|FG001|Completed Day 5 Assessment|Overall Study||24
9055807|NCT03605914|10115590|FG000|COMPLETED|Overall Study||30
9055808|NCT03605914|10115591|FG001|COMPLETED|Overall Study||24
9055809|NCT03605914|10115590|FG000|NOT COMPLETED|Overall Study||27
9055810|NCT03605914|10115591|FG001|NOT COMPLETED|Overall Study||19
9055811|NCT03606187|10115599|FG000|STARTED|Overall Study||67
9055812|NCT03606187|10115600|FG001|STARTED|Overall Study||61
9055813|NCT03606187|10115599|FG000|COMPLETED|Overall Study||67
9055814|NCT03606187|10115600|FG001|COMPLETED|Overall Study||61
9055815|NCT03606187|10115599|FG000|NOT COMPLETED|Overall Study||0
9055816|NCT03606187|10115600|FG001|NOT COMPLETED|Overall Study||0
9055817|NCT03606343|10115606|FG000|STARTED|Overall Study||21
9055818|NCT03606343|10115606|FG000|COMPLETED|Overall Study||21
9055819|NCT03606343|10115606|FG000|NOT COMPLETED|Overall Study||0
9055820|NCT03606460|10115612|FG000|STARTED|Overall Study||95
9055821|NCT03606460|10115613|FG001|STARTED|Overall Study||46
9055822|NCT03606460|10115612|FG000|COMPLETED|Overall Study||94
9055823|NCT03606460|10115613|FG001|COMPLETED|Overall Study||38
9055824|NCT03606460|10115612|FG000|NOT COMPLETED|Overall Study||1
9055825|NCT03606460|10115613|FG001|NOT COMPLETED|Overall Study||8
9055826|NCT03607539|10115622|FG000|STARTED|Overall Study||266
9055827|NCT03607539|10115623|FG001|STARTED|Overall Study||131
9055828|NCT03607539|10115622|FG000|COMPLETED|Overall Study||0
9055829|NCT03607539|10115623|FG001|COMPLETED|Overall Study||0
9055830|NCT03607539|10115622|FG000|NOT COMPLETED|Overall Study||266
9055831|NCT03607539|10115623|FG001|NOT COMPLETED|Overall Study||131
9055832|NCT03607682|10115629|FG000|STARTED|Overall Study||2
9055833|NCT03607682|10115629|FG000|COMPLETED|Overall Study||0
9055834|NCT03607682|10115629|FG000|NOT COMPLETED|Overall Study||2
9055835|NCT03607695|10115633|FG000|STARTED|2 Week||19
9055836|NCT03607695|10115633|FG000|COMPLETED|2 Week||19
9055837|NCT03607695|10115633|FG000|NOT COMPLETED|2 Week||0
9055838|NCT03607695|10115633|FG000|STARTED|10 Week||19
9055839|NCT03607695|10115633|FG000|COMPLETED|10 Week||18
9055840|NCT03607695|10115633|FG000|NOT COMPLETED|10 Week||1
9055841|NCT03607695|10115633|FG000|STARTED|16 Week||18
9055842|NCT03607695|10115633|FG000|COMPLETED|16 Week||16
9055843|NCT03607695|10115633|FG000|NOT COMPLETED|16 Week||2
9055844|NCT03608488|10115641|FG000|STARTED|Overall Study||22
9055845|NCT03608488|10115642|FG001|STARTED|Overall Study||21
9055846|NCT03608488|10115643|FG002|STARTED|Overall Study||22
9055847|NCT03608488|10115644|FG003|STARTED|Overall Study||45
9055848|NCT03608488|10115641|FG000|COMPLETED|Overall Study||21
9055849|NCT03608488|10115642|FG001|COMPLETED|Overall Study||18
9055850|NCT03608488|10115643|FG002|COMPLETED|Overall Study||20
9055851|NCT03608488|10115644|FG003|COMPLETED|Overall Study||40
9055852|NCT03608488|10115641|FG000|NOT COMPLETED|Overall Study||1
9055853|NCT03608488|10115642|FG001|NOT COMPLETED|Overall Study||3
9055854|NCT03608488|10115643|FG002|NOT COMPLETED|Overall Study||2
9055855|NCT03608488|10115644|FG003|NOT COMPLETED|Overall Study||5
9055856|NCT03608774|10115656|FG000|STARTED|Overall Study||89
9055857|NCT03608774|10115657|FG001|STARTED|Overall Study||88
9055858|NCT03608774|10115656|FG000|COMPLETED|Overall Study||82
9055859|NCT03608774|10115657|FG001|COMPLETED|Overall Study||81
9055860|NCT03608774|10115656|FG000|NOT COMPLETED|Overall Study||7
9055861|NCT03608774|10115657|FG001|NOT COMPLETED|Overall Study||7
9055862|NCT03608839|10115666|FG000|STARTED|Overall Study||9
9055863|NCT03608839|10115667|FG001|STARTED|Overall Study||9
9055864|NCT03608839|10115668|FG002|STARTED|Overall Study||9
9055865|NCT03608839|10115666|FG000|COMPLETED|Overall Study||9
9055866|NCT03608839|10115667|FG001|COMPLETED|Overall Study||9
9055867|NCT03608839|10115668|FG002|COMPLETED|Overall Study||9
9055868|NCT03608839|10115666|FG000|NOT COMPLETED|Overall Study||0
9055869|NCT03608839|10115667|FG001|NOT COMPLETED|Overall Study||0
9055870|NCT03608839|10115668|FG002|NOT COMPLETED|Overall Study||0
9055871|NCT03609619|10115678|FG000|STARTED|Overall Study||54
9055872|NCT03609619|10115679|FG001|STARTED|Overall Study||55
9055873|NCT03609619|10115678|FG000|COMPLETED|Overall Study||44
9055874|NCT03609619|10115679|FG001|COMPLETED|Overall Study||49
9055875|NCT03609619|10115678|FG000|NOT COMPLETED|Overall Study||10
9055876|NCT03609619|10115679|FG001|NOT COMPLETED|Overall Study||6
9055877|NCT03609658|10115687|FG000|STARTED|Overall Study||379
9055878|NCT03609658|10115688|FG001|STARTED|Overall Study||380
9055879|NCT03609658|10115687|FG000|COMPLETED|Overall Study||379
9055880|NCT03609658|10115688|FG001|COMPLETED|Overall Study||380
9055881|NCT03609658|10115687|FG000|NOT COMPLETED|Overall Study||0
9055882|NCT03609658|10115688|FG001|NOT COMPLETED|Overall Study||0
9055883|NCT03610048|10115694|FG000|STARTED|Overall Study||175
9055884|NCT03610048|10115694|FG000|Completed Treatment|Overall Study||15
9055885|NCT03610048|10115694|FG000|COMPLETED|Overall Study||14
9055886|NCT03610048|10115694|FG000|NOT COMPLETED|Overall Study||161
9055887|NCT03610165|10115700|FG000|STARTED|Overall Study||108
9055888|NCT03610165|10115701|FG001|STARTED|Overall Study||106
9055889|NCT03610165|10115700|FG000|COMPLETED|Overall Study||108
9055890|NCT03610165|10115701|FG001|COMPLETED|Overall Study||105
9055891|NCT03610165|10115700|FG000|NOT COMPLETED|Overall Study||0
9055892|NCT03610165|10115701|FG001|NOT COMPLETED|Overall Study||1
9055893|NCT03610269|10115707|FG000|STARTED|Overall Study||143
9055894|NCT03610269|10115707|FG000|COMPLETED|Overall Study||127
9055895|NCT03610269|10115707|FG000|NOT COMPLETED|Overall Study||16
9055896|NCT03610399|10115714|FG000|STARTED|Overall Study||63
9055897|NCT03610399|10115715|FG001|STARTED|Overall Study||96
9055898|NCT03610399|10115716|FG002|STARTED|Overall Study||95
9055899|NCT03610399|10115714|FG000|COMPLETED|Overall Study||53
9055900|NCT03610399|10115715|FG001|COMPLETED|Overall Study||78
8578747|NCT00178178|9611877|FG001|COMPLETED|Overall Study||24
8578748|NCT00178178|9611878|FG002|COMPLETED|Overall Study||24
8578749|NCT00178178|9611879|FG003|COMPLETED|Overall Study||24
8578750|NCT00178178|9611876|FG000|NOT COMPLETED|Overall Study||0
8578751|NCT00178178|9611877|FG001|NOT COMPLETED|Overall Study||0
8578752|NCT00178178|9611878|FG002|NOT COMPLETED|Overall Study||0
8578753|NCT00178178|9611879|FG003|NOT COMPLETED|Overall Study||0
8578754|NCT00178191|9611892|FG000|STARTED|Overall Study||11
8578755|NCT00178191|9611893|FG001|STARTED|Overall Study||10
8578756|NCT00178191|9611894|FG002|STARTED|Overall Study||7
8578757|NCT00178191|9611892|FG000|COMPLETED|Overall Study||11
8578758|NCT00178191|9611893|FG001|COMPLETED|Overall Study||10
8578759|NCT00178191|9611894|FG002|COMPLETED|Overall Study||7
8578760|NCT00178191|9611892|FG000|NOT COMPLETED|Overall Study||0
8578761|NCT00178191|9611893|FG001|NOT COMPLETED|Overall Study||0
8578762|NCT00178191|9611894|FG002|NOT COMPLETED|Overall Study||0
8578763|NCT00178256|9611902|FG000|STARTED|Overall Study||10
8578764|NCT00178256|9611903|FG001|STARTED|Overall Study||7
8578765|NCT00178256|9611904|FG002|STARTED|Overall Study||6
8578766|NCT00178256|9611905|FG003|STARTED|Overall Study||18
8578767|NCT00178256|9611902|FG000|COMPLETED|Overall Study||6
9055901|NCT03610399|10115716|FG002|COMPLETED|Overall Study||79
9055902|NCT03610399|10115714|FG000|NOT COMPLETED|Overall Study||10
9055903|NCT03610399|10115715|FG001|NOT COMPLETED|Overall Study||18
9055904|NCT03610399|10115716|FG002|NOT COMPLETED|Overall Study||16
9055905|NCT03610464|10115724|FG000|STARTED|Overall Study||5
9055906|NCT03610464|10115724|FG000|COMPLETED|Overall Study||5
9055907|NCT03610464|10115724|FG000|NOT COMPLETED|Overall Study||0
9055908|NCT03610581|10115731|FG000|STARTED|Overall Study||5
9055909|NCT03610581|10115732|FG001|STARTED|Overall Study||4
9055910|NCT03610581|10115731|FG000|Vaccinated|Overall Study||4
9055911|NCT03610581|10115732|FG001|Vaccinated|Overall Study||4
9055912|NCT03610581|10115731|FG000|COMPLETED|Overall Study||2
8703860|NCT00925301|9749660|FG002|STARTED|6-Month Double-blind (Stage 1)|Zero participants noted because participants did not start Stage 2 yet.|0
9055913|NCT03610581|10115732|FG001|COMPLETED|Overall Study||3
9055914|NCT03610581|10115731|FG000|NOT COMPLETED|Overall Study||3
9055915|NCT03610581|10115732|FG001|NOT COMPLETED|Overall Study||1
9055916|NCT03610633|10115740|FG000|STARTED|Overall Study||5
9055917|NCT03610633|10115741|FG001|STARTED|Overall Study||6
9055918|NCT03610633|10115740|FG000|COMPLETED|Overall Study||5
9055919|NCT03610633|10115741|FG001|COMPLETED|Overall Study||5
9055920|NCT03610633|10115740|FG000|NOT COMPLETED|Overall Study||0
9055921|NCT03610633|10115741|FG001|NOT COMPLETED|Overall Study||1
9055922|NCT03611062|10115749|FG000|STARTED|Overall Study||14
9055923|NCT03611062|10115750|FG001|STARTED|Overall Study||13
9055924|NCT03611062|10115749|FG000|COMPLETED|Overall Study||13
9055925|NCT03611062|10115750|FG001|COMPLETED|Overall Study||12
9055926|NCT03611062|10115749|FG000|NOT COMPLETED|Overall Study||1
9055927|NCT03611062|10115750|FG001|NOT COMPLETED|Overall Study||1
9055928|NCT03611075|10115765|FG000|STARTED|Overall Study||16
9055929|NCT03611075|10115766|FG001|STARTED|Overall Study||15
9055930|NCT03611075|10115767|FG002|STARTED|Overall Study||16
9055931|NCT03611075|10115768|FG003|STARTED|Overall Study||17
9055932|NCT03611075|10115769|FG004|STARTED|Overall Study||13
9055933|NCT03611075|10115770|FG005|STARTED|Overall Study||18
9055934|NCT03611075|10115771|FG006|STARTED|Overall Study||15
9055935|NCT03611075|10115772|FG007|STARTED|Overall Study||17
9055936|NCT03611075|10115773|FG008|STARTED|Overall Study||17
9055937|NCT03611075|10115765|FG000|COMPLETED|Overall Study||15
9055938|NCT03611075|10115766|FG001|COMPLETED|Overall Study||13
9055939|NCT03611075|10115767|FG002|COMPLETED|Overall Study||14
9055940|NCT03611075|10115768|FG003|COMPLETED|Overall Study||13
9055941|NCT03611075|10115769|FG004|COMPLETED|Overall Study||13
9055942|NCT03611075|10115770|FG005|COMPLETED|Overall Study||18
9055943|NCT03611075|10115771|FG006|COMPLETED|Overall Study||13
9055944|NCT03611075|10115772|FG007|COMPLETED|Overall Study||17
9055945|NCT03611075|10115773|FG008|COMPLETED|Overall Study||17
9055946|NCT03611075|10115765|FG000|NOT COMPLETED|Overall Study||1
9055947|NCT03611075|10115766|FG001|NOT COMPLETED|Overall Study||2
9055948|NCT03611075|10115767|FG002|NOT COMPLETED|Overall Study||2
9055949|NCT03611075|10115768|FG003|NOT COMPLETED|Overall Study||4
9055950|NCT03611075|10115769|FG004|NOT COMPLETED|Overall Study||0
9055951|NCT03611075|10115770|FG005|NOT COMPLETED|Overall Study||0
9055952|NCT03611075|10115771|FG006|NOT COMPLETED|Overall Study||2
9055953|NCT03611075|10115772|FG007|NOT COMPLETED|Overall Study||0
9055954|NCT03611075|10115773|FG008|NOT COMPLETED|Overall Study||0
9055955|NCT03611582|10115818|FG000|STARTED|Overall Study||407
9055956|NCT03611582|10115819|FG001|STARTED|Overall Study||204
9055957|NCT03611582|10115818|FG000|Full Analysis Set (FAS)|Overall Study||407
9055958|NCT03611582|10115819|FG001|Full Analysis Set (FAS)|Overall Study||204
9055959|NCT03611582|10115818|FG000|Safety Analysis Set (SAS)|Overall Study||407
9055960|NCT03611582|10115819|FG001|Safety Analysis Set (SAS)|Overall Study||204
9055961|NCT03611582|10115818|FG000|COMPLETED|Overall Study||339
9055962|NCT03611582|10115819|FG001|COMPLETED|Overall Study||166
9055963|NCT03611582|10115818|FG000|NOT COMPLETED|Overall Study||68
9055964|NCT03611582|10115819|FG001|NOT COMPLETED|Overall Study||38
9055965|NCT03611777|10115827|FG000|STARTED|Overall Study||432
9055966|NCT03611777|10115828|FG001|STARTED|Overall Study||469
9055967|NCT03611777|10115827|FG000|COMPLETED|Overall Study||432
9055968|NCT03611777|10115828|FG001|COMPLETED|Overall Study||469
9055969|NCT03611777|10115827|FG000|NOT COMPLETED|Overall Study||0
9055970|NCT03611777|10115828|FG001|NOT COMPLETED|Overall Study||0
9055971|NCT03611829|10115839|FG000|STARTED|Overall Study||43
9055972|NCT03611829|10115840|FG001|STARTED|Overall Study||44
9055973|NCT03611829|10115839|FG000|COMPLETED|Overall Study||21
9055974|NCT03611829|10115840|FG001|COMPLETED|Overall Study||19
9055975|NCT03611829|10115839|FG000|NOT COMPLETED|Overall Study||22
9055976|NCT03611829|10115840|FG001|NOT COMPLETED|Overall Study||25
9055977|NCT03613129|10115851|FG000|STARTED|Pre-treatment Assessment||3
9055978|NCT03613129|10115852|FG001|STARTED|Pre-treatment Assessment||3
9055979|NCT03613129|10115853|FG002|STARTED|Pre-treatment Assessment||7
9055980|NCT03613129|10115854|FG003|STARTED|Pre-treatment Assessment||2
9055981|NCT03613129|10115855|FG004|STARTED|Pre-treatment Assessment||2
9055982|NCT03613129|10115851|FG000|COMPLETED|Pre-treatment Assessment||0
9055983|NCT03613129|10115852|FG001|COMPLETED|Pre-treatment Assessment||3
9055984|NCT03613129|10115853|FG002|COMPLETED|Pre-treatment Assessment||7
9055985|NCT03613129|10115854|FG003|COMPLETED|Pre-treatment Assessment||2
9055986|NCT03613129|10115855|FG004|COMPLETED|Pre-treatment Assessment||2
9055987|NCT03613129|10115851|FG000|NOT COMPLETED|Pre-treatment Assessment||3
9055988|NCT03613129|10115852|FG001|NOT COMPLETED|Pre-treatment Assessment||0
9055989|NCT03613129|10115853|FG002|NOT COMPLETED|Pre-treatment Assessment||0
9055990|NCT03613129|10115854|FG003|NOT COMPLETED|Pre-treatment Assessment||0
9055991|NCT03613129|10115855|FG004|NOT COMPLETED|Pre-treatment Assessment||0
9055992|NCT03613129|10115851|FG000|STARTED|Treatment||0
9055993|NCT03613129|10115852|FG001|STARTED|Treatment||3
9055994|NCT03613129|10115853|FG002|STARTED|Treatment||7
9055995|NCT03613129|10115854|FG003|STARTED|Treatment||2
9055996|NCT03613129|10115855|FG004|STARTED|Treatment||2
9055997|NCT03613129|10115851|FG000|COMPLETED|Treatment||0
9055998|NCT03613129|10115852|FG001|COMPLETED|Treatment|ID35 received only 1 infusion (due to symptom worsening)|3
9055999|NCT03613129|10115853|FG002|COMPLETED|Treatment||7
9056000|NCT03613129|10115854|FG003|COMPLETED|Treatment|ID34 did not receive 3rd infusion (for lack of venous access)|2
9056001|NCT03613129|10115855|FG004|COMPLETED|Treatment||2
9056002|NCT03613129|10115851|FG000|NOT COMPLETED|Treatment||0
9056003|NCT03613129|10115852|FG001|NOT COMPLETED|Treatment||0
9056004|NCT03613129|10115853|FG002|NOT COMPLETED|Treatment||0
9056005|NCT03613129|10115854|FG003|NOT COMPLETED|Treatment||0
9056006|NCT03613129|10115855|FG004|NOT COMPLETED|Treatment||0
9056007|NCT03613129|10115851|FG000|STARTED|Post-treatment Assessment||0
9056008|NCT03613129|10115852|FG001|STARTED|Post-treatment Assessment||3
9056009|NCT03613129|10115853|FG002|STARTED|Post-treatment Assessment||7
9056010|NCT03613129|10115854|FG003|STARTED|Post-treatment Assessment||2
9056011|NCT03613129|10115855|FG004|STARTED|Post-treatment Assessment||2
9056012|NCT03613129|10115851|FG000|COMPLETED|Post-treatment Assessment||0
9056013|NCT03613129|10115852|FG001|COMPLETED|Post-treatment Assessment||3
9056014|NCT03613129|10115853|FG002|COMPLETED|Post-treatment Assessment||7
9056015|NCT03613129|10115854|FG003|COMPLETED|Post-treatment Assessment||2
9056016|NCT03613129|10115855|FG004|COMPLETED|Post-treatment Assessment||2
9056017|NCT03613129|10115851|FG000|NOT COMPLETED|Post-treatment Assessment||0
9056018|NCT03613129|10115852|FG001|NOT COMPLETED|Post-treatment Assessment||0
9056019|NCT03613129|10115853|FG002|NOT COMPLETED|Post-treatment Assessment||0
9056020|NCT03613129|10115854|FG003|NOT COMPLETED|Post-treatment Assessment||0
9056021|NCT03613129|10115855|FG004|NOT COMPLETED|Post-treatment Assessment||0
9056022|NCT03613454|10115869|FG000|STARTED|Overall Study||24
9056023|NCT03613454|10115870|FG001|STARTED|Overall Study||24
9056024|NCT03613454|10115869|FG000|COMPLETED|Overall Study||23
9056025|NCT03613454|10115870|FG001|COMPLETED|Overall Study||23
9056026|NCT03613454|10115869|FG000|NOT COMPLETED|Overall Study||1
9056027|NCT03613454|10115870|FG001|NOT COMPLETED|Overall Study||1
9056028|NCT03613493|10115880|FG000|STARTED|Overall Study||10
9056029|NCT03613493|10115881|FG001|STARTED|Overall Study||75
9056030|NCT03613493|10115882|FG002|STARTED|Overall Study||0
9056031|NCT03613493|10115883|FG003|STARTED|Overall Study||90
9056032|NCT03613493|10115880|FG000|Enrollment Criteria Met|Overall Study||10
9056033|NCT03613493|10115881|FG001|Enrollment Criteria Met|Overall Study||74
9056034|NCT03613493|10115882|FG002|Enrollment Criteria Met|Overall Study||0
9056035|NCT03613493|10115883|FG003|Enrollment Criteria Met|Overall Study||89
9056036|NCT03613493|10115880|FG000|COMPLETED|Overall Study||10
9056037|NCT03613493|10115881|FG001|COMPLETED|Overall Study||73
9056038|NCT03613493|10115882|FG002|COMPLETED|Overall Study||0
9056039|NCT03613493|10115883|FG003|COMPLETED|Overall Study||83
9056040|NCT03613493|10115880|FG000|NOT COMPLETED|Overall Study||0
9056041|NCT03613493|10115881|FG001|NOT COMPLETED|Overall Study||2
9056042|NCT03613493|10115882|FG002|NOT COMPLETED|Overall Study||0
9056043|NCT03613493|10115883|FG003|NOT COMPLETED|Overall Study||7
9056044|NCT03613649|10115904|FG000|STARTED|First Treatment||6
9056045|NCT03613649|10115905|FG001|STARTED|First Treatment||6
9056046|NCT03613649|10115906|FG002|STARTED|First Treatment||6
9056047|NCT03613649|10115907|FG003|STARTED|First Treatment||6
9056048|NCT03613649|10115908|FG004|STARTED|First Treatment||6
9056049|NCT03613649|10115909|FG005|STARTED|First Treatment||6
9056050|NCT03613649|10115910|FG006|STARTED|First Treatment||6
9056051|NCT03613649|10115911|FG007|STARTED|First Treatment||6
9056052|NCT03613649|10115912|FG008|STARTED|First Treatment||6
9056053|NCT03613649|10115913|FG009|STARTED|First Treatment||6
9056054|NCT03613649|10115914|FG010|STARTED|First Treatment||6
9056055|NCT03613649|10115915|FG011|STARTED|First Treatment||6
9056056|NCT03613649|10115904|FG000|Received Treatment|First Treatment||6
9056057|NCT03613649|10115905|FG001|Received Treatment|First Treatment||6
9056058|NCT03613649|10115906|FG002|Received Treatment|First Treatment||6
9056059|NCT03613649|10115907|FG003|Received Treatment|First Treatment||6
9056060|NCT03613649|10115908|FG004|Received Treatment|First Treatment||6
9056061|NCT03613649|10115909|FG005|Received Treatment|First Treatment||6
9056062|NCT03613649|10115910|FG006|Received Treatment|First Treatment||6
9056063|NCT03613649|10115911|FG007|Received Treatment|First Treatment||6
9056064|NCT03613649|10115912|FG008|Received Treatment|First Treatment||6
9056065|NCT03613649|10115913|FG009|Received Treatment|First Treatment||6
9056066|NCT03613649|10115914|FG010|Received Treatment|First Treatment||6
9056067|NCT03613649|10115915|FG011|Received Treatment|First Treatment||6
9056068|NCT03613649|10115904|FG000|COMPLETED|First Treatment||6
9056069|NCT03613649|10115905|FG001|COMPLETED|First Treatment||6
9056070|NCT03613649|10115906|FG002|COMPLETED|First Treatment||6
9056071|NCT03613649|10115907|FG003|COMPLETED|First Treatment||6
9056072|NCT03613649|10115908|FG004|COMPLETED|First Treatment||6
9056073|NCT03613649|10115909|FG005|COMPLETED|First Treatment||6
9056074|NCT03613649|10115910|FG006|COMPLETED|First Treatment||6
9056075|NCT03613649|10115911|FG007|COMPLETED|First Treatment||6
9056076|NCT03613649|10115912|FG008|COMPLETED|First Treatment||6
9056077|NCT03613649|10115913|FG009|COMPLETED|First Treatment||6
9056078|NCT03613649|10115914|FG010|COMPLETED|First Treatment||6
9056079|NCT03613649|10115915|FG011|COMPLETED|First Treatment||6
9056080|NCT03613649|10115904|FG000|NOT COMPLETED|First Treatment||0
9056081|NCT03613649|10115905|FG001|NOT COMPLETED|First Treatment||0
9056082|NCT03613649|10115906|FG002|NOT COMPLETED|First Treatment||0
9056083|NCT03613649|10115907|FG003|NOT COMPLETED|First Treatment||0
9056084|NCT03613649|10115908|FG004|NOT COMPLETED|First Treatment||0
9056085|NCT03613649|10115909|FG005|NOT COMPLETED|First Treatment||0
9056086|NCT03613649|10115910|FG006|NOT COMPLETED|First Treatment||0
9056087|NCT03613649|10115911|FG007|NOT COMPLETED|First Treatment||0
9056088|NCT03613649|10115912|FG008|NOT COMPLETED|First Treatment||0
9056089|NCT03613649|10115913|FG009|NOT COMPLETED|First Treatment||0
9056090|NCT03613649|10115914|FG010|NOT COMPLETED|First Treatment||0
9056091|NCT03613649|10115915|FG011|NOT COMPLETED|First Treatment||0
9056092|NCT03613649|10115904|FG000|STARTED|Second Treatment||6
9056093|NCT03613649|10115905|FG001|STARTED|Second Treatment||6
9056094|NCT03613649|10115906|FG002|STARTED|Second Treatment||6
9056095|NCT03613649|10115907|FG003|STARTED|Second Treatment||6
9056096|NCT03613649|10115908|FG004|STARTED|Second Treatment||6
9056097|NCT03613649|10115909|FG005|STARTED|Second Treatment||6
9056098|NCT03613649|10115910|FG006|STARTED|Second Treatment||6
9056099|NCT03613649|10115911|FG007|STARTED|Second Treatment||6
9056100|NCT03613649|10115912|FG008|STARTED|Second Treatment||6
9056101|NCT03613649|10115913|FG009|STARTED|Second Treatment||6
9056102|NCT03613649|10115914|FG010|STARTED|Second Treatment||6
9056103|NCT03613649|10115915|FG011|STARTED|Second Treatment||6
9056104|NCT03613649|10115904|FG000|Received Treatment|Second Treatment||6
9056105|NCT03613649|10115905|FG001|Received Treatment|Second Treatment||6
9056106|NCT03613649|10115906|FG002|Received Treatment|Second Treatment||6
9056107|NCT03613649|10115907|FG003|Received Treatment|Second Treatment||6
9056108|NCT03613649|10115908|FG004|Received Treatment|Second Treatment||6
9056109|NCT03613649|10115909|FG005|Received Treatment|Second Treatment||6
9056110|NCT03613649|10115910|FG006|Received Treatment|Second Treatment||6
9056111|NCT03613649|10115911|FG007|Received Treatment|Second Treatment||6
9056112|NCT03613649|10115912|FG008|Received Treatment|Second Treatment||6
9056113|NCT03613649|10115913|FG009|Received Treatment|Second Treatment||6
9056114|NCT03613649|10115914|FG010|Received Treatment|Second Treatment||6
9056115|NCT03613649|10115915|FG011|Received Treatment|Second Treatment||6
9056116|NCT03613649|10115904|FG000|COMPLETED|Second Treatment||6
9056117|NCT03613649|10115905|FG001|COMPLETED|Second Treatment||6
9056118|NCT03613649|10115906|FG002|COMPLETED|Second Treatment||5
9056119|NCT03613649|10115907|FG003|COMPLETED|Second Treatment||6
9056120|NCT03613649|10115908|FG004|COMPLETED|Second Treatment||5
9056121|NCT03613649|10115909|FG005|COMPLETED|Second Treatment||6
9056122|NCT03613649|10115910|FG006|COMPLETED|Second Treatment||6
9056123|NCT03613649|10115911|FG007|COMPLETED|Second Treatment||6
9056124|NCT03613649|10115912|FG008|COMPLETED|Second Treatment||6
9056125|NCT03613649|10115913|FG009|COMPLETED|Second Treatment||6
9056126|NCT03613649|10115914|FG010|COMPLETED|Second Treatment||6
9056127|NCT03613649|10115915|FG011|COMPLETED|Second Treatment||6
9056128|NCT03613649|10115904|FG000|NOT COMPLETED|Second Treatment||0
9056129|NCT03613649|10115905|FG001|NOT COMPLETED|Second Treatment||0
9056130|NCT03613649|10115906|FG002|NOT COMPLETED|Second Treatment||1
9056131|NCT03613649|10115907|FG003|NOT COMPLETED|Second Treatment||0
9056132|NCT03613649|10115908|FG004|NOT COMPLETED|Second Treatment||1
9056133|NCT03613649|10115909|FG005|NOT COMPLETED|Second Treatment||0
9056134|NCT03613649|10115910|FG006|NOT COMPLETED|Second Treatment||0
9056135|NCT03613649|10115911|FG007|NOT COMPLETED|Second Treatment||0
9056136|NCT03613649|10115912|FG008|NOT COMPLETED|Second Treatment||0
9056137|NCT03613649|10115913|FG009|NOT COMPLETED|Second Treatment||0
9056138|NCT03613649|10115914|FG010|NOT COMPLETED|Second Treatment||0
9056139|NCT03613649|10115915|FG011|NOT COMPLETED|Second Treatment||0
9056140|NCT03613649|10115904|FG000|STARTED|Third Treatment||6
9056141|NCT03613649|10115905|FG001|STARTED|Third Treatment||6
9056142|NCT03613649|10115906|FG002|STARTED|Third Treatment||5
9056143|NCT03613649|10115907|FG003|STARTED|Third Treatment||6
9056144|NCT03613649|10115908|FG004|STARTED|Third Treatment||5
9056145|NCT03613649|10115909|FG005|STARTED|Third Treatment||6
9056146|NCT03613649|10115910|FG006|STARTED|Third Treatment||6
9056147|NCT03613649|10115911|FG007|STARTED|Third Treatment||6
9056148|NCT03613649|10115912|FG008|STARTED|Third Treatment||6
9056149|NCT03613649|10115913|FG009|STARTED|Third Treatment||6
9056150|NCT03613649|10115914|FG010|STARTED|Third Treatment||6
8703861|NCT00925301|9749661|FG003|STARTED|6-Month Double-blind (Stage 1)|Zero participants noted because participants did not start the OLE yet.|0
9056151|NCT03613649|10115915|FG011|STARTED|Third Treatment||6
9056152|NCT03613649|10115904|FG000|Received Treatment|Third Treatment||6
9056153|NCT03613649|10115905|FG001|Received Treatment|Third Treatment||6
9056154|NCT03613649|10115906|FG002|Received Treatment|Third Treatment||5
9056155|NCT03613649|10115907|FG003|Received Treatment|Third Treatment||6
9056156|NCT03613649|10115908|FG004|Received Treatment|Third Treatment||5
9056157|NCT03613649|10115909|FG005|Received Treatment|Third Treatment||6
9056158|NCT03613649|10115910|FG006|Received Treatment|Third Treatment||5
9056159|NCT03613649|10115911|FG007|Received Treatment|Third Treatment||6
9056160|NCT03613649|10115912|FG008|Received Treatment|Third Treatment||6
9056161|NCT03613649|10115913|FG009|Received Treatment|Third Treatment||6
9056162|NCT03613649|10115914|FG010|Received Treatment|Third Treatment||6
9056163|NCT03613649|10115915|FG011|Received Treatment|Third Treatment||6
9056164|NCT03613649|10115904|FG000|COMPLETED|Third Treatment||6
9056165|NCT03613649|10115905|FG001|COMPLETED|Third Treatment||6
9056166|NCT03613649|10115906|FG002|COMPLETED|Third Treatment||5
9056167|NCT03613649|10115907|FG003|COMPLETED|Third Treatment||6
9056168|NCT03613649|10115908|FG004|COMPLETED|Third Treatment||4
9056169|NCT03613649|10115909|FG005|COMPLETED|Third Treatment||6
9056170|NCT03613649|10115910|FG006|COMPLETED|Third Treatment||5
9056171|NCT03613649|10115911|FG007|COMPLETED|Third Treatment||6
9056172|NCT03613649|10115912|FG008|COMPLETED|Third Treatment||6
9056173|NCT03613649|10115913|FG009|COMPLETED|Third Treatment||6
9056174|NCT03613649|10115914|FG010|COMPLETED|Third Treatment||6
9056175|NCT03613649|10115915|FG011|COMPLETED|Third Treatment||4
9056176|NCT03613649|10115904|FG000|NOT COMPLETED|Third Treatment||0
9056177|NCT03613649|10115905|FG001|NOT COMPLETED|Third Treatment||0
9056178|NCT03613649|10115906|FG002|NOT COMPLETED|Third Treatment||0
9056179|NCT03613649|10115907|FG003|NOT COMPLETED|Third Treatment||0
9056180|NCT03613649|10115908|FG004|NOT COMPLETED|Third Treatment||1
9056181|NCT03613649|10115909|FG005|NOT COMPLETED|Third Treatment||0
9056182|NCT03613649|10115910|FG006|NOT COMPLETED|Third Treatment||1
9056183|NCT03613649|10115911|FG007|NOT COMPLETED|Third Treatment||0
9056184|NCT03613649|10115912|FG008|NOT COMPLETED|Third Treatment||0
9056185|NCT03613649|10115913|FG009|NOT COMPLETED|Third Treatment||0
9056186|NCT03613649|10115914|FG010|NOT COMPLETED|Third Treatment||0
9056187|NCT03613649|10115915|FG011|NOT COMPLETED|Third Treatment||2
9056188|NCT03613649|10115904|FG000|STARTED|Fourth Treatment||6
9056189|NCT03613649|10115905|FG001|STARTED|Fourth Treatment||6
9056190|NCT03613649|10115906|FG002|STARTED|Fourth Treatment||5
9056191|NCT03613649|10115907|FG003|STARTED|Fourth Treatment||6
9056192|NCT03613649|10115908|FG004|STARTED|Fourth Treatment||4
9056193|NCT03613649|10115909|FG005|STARTED|Fourth Treatment||6
9056194|NCT03613649|10115910|FG006|STARTED|Fourth Treatment||5
9056195|NCT03613649|10115911|FG007|STARTED|Fourth Treatment||6
9056196|NCT03613649|10115912|FG008|STARTED|Fourth Treatment||6
9056197|NCT03613649|10115913|FG009|STARTED|Fourth Treatment||6
9056198|NCT03613649|10115914|FG010|STARTED|Fourth Treatment||6
9056199|NCT03613649|10115915|FG011|STARTED|Fourth Treatment||4
9056200|NCT03613649|10115904|FG000|Received Treatment|Fourth Treatment||5
9056201|NCT03613649|10115905|FG001|Received Treatment|Fourth Treatment||6
9056202|NCT03613649|10115906|FG002|Received Treatment|Fourth Treatment||5
9056203|NCT03613649|10115907|FG003|Received Treatment|Fourth Treatment||6
9056204|NCT03613649|10115908|FG004|Received Treatment|Fourth Treatment||4
9056205|NCT03613649|10115909|FG005|Received Treatment|Fourth Treatment||6
9056206|NCT03613649|10115910|FG006|Received Treatment|Fourth Treatment||4
9056207|NCT03613649|10115911|FG007|Received Treatment|Fourth Treatment||6
9056208|NCT03613649|10115912|FG008|Received Treatment|Fourth Treatment||6
9056209|NCT03613649|10115913|FG009|Received Treatment|Fourth Treatment||6
9056210|NCT03613649|10115914|FG010|Received Treatment|Fourth Treatment||6
9056211|NCT03613649|10115915|FG011|Received Treatment|Fourth Treatment||4
9056212|NCT03613649|10115904|FG000|COMPLETED|Fourth Treatment||5
9056213|NCT03613649|10115905|FG001|COMPLETED|Fourth Treatment||6
9056214|NCT03613649|10115906|FG002|COMPLETED|Fourth Treatment||5
9056215|NCT03613649|10115907|FG003|COMPLETED|Fourth Treatment||6
9056216|NCT03613649|10115908|FG004|COMPLETED|Fourth Treatment||3
9056217|NCT03613649|10115909|FG005|COMPLETED|Fourth Treatment||6
9056218|NCT03613649|10115910|FG006|COMPLETED|Fourth Treatment||4
9056219|NCT03613649|10115911|FG007|COMPLETED|Fourth Treatment||6
9056220|NCT03613649|10115912|FG008|COMPLETED|Fourth Treatment||6
9056221|NCT03613649|10115913|FG009|COMPLETED|Fourth Treatment||6
9056222|NCT03613649|10115914|FG010|COMPLETED|Fourth Treatment||6
9056223|NCT03613649|10115915|FG011|COMPLETED|Fourth Treatment||4
9056224|NCT03613649|10115904|FG000|NOT COMPLETED|Fourth Treatment||1
9056225|NCT03613649|10115905|FG001|NOT COMPLETED|Fourth Treatment||0
9056226|NCT03613649|10115906|FG002|NOT COMPLETED|Fourth Treatment||0
9056227|NCT03613649|10115907|FG003|NOT COMPLETED|Fourth Treatment||0
9056228|NCT03613649|10115908|FG004|NOT COMPLETED|Fourth Treatment||1
9056229|NCT03613649|10115909|FG005|NOT COMPLETED|Fourth Treatment||0
9056230|NCT03613649|10115910|FG006|NOT COMPLETED|Fourth Treatment||1
9056231|NCT03613649|10115911|FG007|NOT COMPLETED|Fourth Treatment||0
9056232|NCT03613649|10115912|FG008|NOT COMPLETED|Fourth Treatment||0
9056233|NCT03613649|10115913|FG009|NOT COMPLETED|Fourth Treatment||0
9056234|NCT03613649|10115914|FG010|NOT COMPLETED|Fourth Treatment||0
9056235|NCT03613649|10115915|FG011|NOT COMPLETED|Fourth Treatment||0
9056236|NCT03613818|10115935|FG000|STARTED|Overall Study||174
9056237|NCT03613818|10115936|FG001|STARTED|Overall Study||137
9056238|NCT03613818|10115935|FG000|COMPLETED|Overall Study||137
9056239|NCT03613818|10115936|FG001|COMPLETED|Overall Study||110
9056240|NCT03613818|10115935|FG000|NOT COMPLETED|Overall Study||37
9056241|NCT03613818|10115936|FG001|NOT COMPLETED|Overall Study||27
9056242|NCT03614078|10115945|FG000|STARTED|Overall Study||31
9056243|NCT03614078|10115946|FG001|STARTED|Overall Study||30
9056244|NCT03614078|10115947|FG002|STARTED|Overall Study||31
9056245|NCT03614078|10115945|FG000|COMPLETED|Overall Study||28
9056246|NCT03614078|10115946|FG001|COMPLETED|Overall Study||23
9056247|NCT03614078|10115947|FG002|COMPLETED|Overall Study||26
9056248|NCT03614078|10115945|FG000|NOT COMPLETED|Overall Study||3
9056249|NCT03614078|10115946|FG001|NOT COMPLETED|Overall Study||7
9056250|NCT03614078|10115947|FG002|NOT COMPLETED|Overall Study||5
9056251|NCT03614130|10115957|FG000|STARTED|Overall Study||10
9056252|NCT03614130|10115958|FG001|STARTED|Overall Study||12
9056253|NCT03614130|10115957|FG000|COMPLETED|Overall Study||10
9056254|NCT03614130|10115958|FG001|COMPLETED|Overall Study||12
9056255|NCT03614130|10115957|FG000|NOT COMPLETED|Overall Study||0
9056256|NCT03614130|10115958|FG001|NOT COMPLETED|Overall Study||0
9056257|NCT03614156|10115969|FG000|STARTED|Open-Label Treatment Period||363
9056258|NCT03614156|10115970|FG001|STARTED|Open-Label Treatment Period||0
9056259|NCT03614156|10115971|FG002|STARTED|Open-Label Treatment Period||0
9056260|NCT03614156|10115972|FG003|STARTED|Open-Label Treatment Period||0
9056261|NCT03614156|10115969|FG000|COMPLETED|Open-Label Treatment Period||209
9056262|NCT03614156|10115970|FG001|COMPLETED|Open-Label Treatment Period||0
9056263|NCT03614156|10115971|FG002|COMPLETED|Open-Label Treatment Period||0
9056264|NCT03614156|10115972|FG003|COMPLETED|Open-Label Treatment Period||0
9056265|NCT03614156|10115969|FG000|NOT COMPLETED|Open-Label Treatment Period||154
9056266|NCT03614156|10115970|FG001|NOT COMPLETED|Open-Label Treatment Period||0
9056267|NCT03614156|10115971|FG002|NOT COMPLETED|Open-Label Treatment Period||0
9056268|NCT03614156|10115972|FG003|NOT COMPLETED|Open-Label Treatment Period||0
9056269|NCT03614156|10115969|FG000|STARTED|Double-Blind Treatment Period (DBTP)||0
9056270|NCT03614156|10115970|FG001|STARTED|Double-Blind Treatment Period (DBTP)||40
9056271|NCT03614156|10115971|FG002|STARTED|Double-Blind Treatment Period (DBTP)||42
9056272|NCT03614156|10115972|FG003|STARTED|Double-Blind Treatment Period (DBTP)||55
8703862|NCT00925301|9749658|FG000|Received at Least 1 Dose of Study Drug|6-Month Double-blind (Stage 1)||34
8703863|NCT00925301|9749659|FG001|Received at Least 1 Dose of Study Drug|6-Month Double-blind (Stage 1)||33
8703864|NCT00925301|9749660|FG002|Received at Least 1 Dose of Study Drug|6-Month Double-blind (Stage 1)||0
8703865|NCT00925301|9749661|FG003|Received at Least 1 Dose of Study Drug|6-Month Double-blind (Stage 1)||0
8703866|NCT00925301|9749658|FG000|Intent-to-Treat (ITT)|6-Month Double-blind (Stage 1)||34
8703867|NCT00925301|9749659|FG001|Intent-to-Treat (ITT)|6-Month Double-blind (Stage 1)||33
8703868|NCT00925301|9749660|FG002|Intent-to-Treat (ITT)|6-Month Double-blind (Stage 1)||0
8703869|NCT00925301|9749661|FG003|Intent-to-Treat (ITT)|6-Month Double-blind (Stage 1)||0
8724600|NCT01026974|9771803|FG000|STARTED|Overall Study||16
9056273|NCT03614156|10115969|FG000|COMPLETED|Double-Blind Treatment Period (DBTP)||0
9056274|NCT03614156|10115970|FG001|COMPLETED|Double-Blind Treatment Period (DBTP)||10
9056275|NCT03614156|10115971|FG002|COMPLETED|Double-Blind Treatment Period (DBTP)||11
9056276|NCT03614156|10115972|FG003|COMPLETED|Double-Blind Treatment Period (DBTP)||10
9056277|NCT03614156|10115969|FG000|NOT COMPLETED|Double-Blind Treatment Period (DBTP)||0
9056278|NCT03614156|10115970|FG001|NOT COMPLETED|Double-Blind Treatment Period (DBTP)||30
9056279|NCT03614156|10115971|FG002|NOT COMPLETED|Double-Blind Treatment Period (DBTP)||31
9056280|NCT03614156|10115972|FG003|NOT COMPLETED|Double-Blind Treatment Period (DBTP)||45
9056281|NCT03614156|10115969|FG000|STARTED|Safety Follow-Up Period||165
9056282|NCT03614156|10115970|FG001|STARTED|Safety Follow-Up Period||26
9056283|NCT03614156|10115971|FG002|STARTED|Safety Follow-Up Period||30
9056284|NCT03614156|10115972|FG003|STARTED|Safety Follow-Up Period||35
9056285|NCT03614156|10115969|FG000|COMPLETED|Safety Follow-Up Period||162
9056286|NCT03614156|10115970|FG001|COMPLETED|Safety Follow-Up Period||26
9056287|NCT03614156|10115971|FG002|COMPLETED|Safety Follow-Up Period||29
9056288|NCT03614156|10115972|FG003|COMPLETED|Safety Follow-Up Period||34
9056289|NCT03614156|10115969|FG000|NOT COMPLETED|Safety Follow-Up Period||3
9056290|NCT03614156|10115970|FG001|NOT COMPLETED|Safety Follow-Up Period||0
9056291|NCT03614156|10115971|FG002|NOT COMPLETED|Safety Follow-Up Period||1
9056292|NCT03614156|10115972|FG003|NOT COMPLETED|Safety Follow-Up Period||1
9056293|NCT03614416|10115981|FG000|STARTED|Overall Study||13
9056294|NCT03614416|10115981|FG000|COMPLETED|Overall Study||13
9056295|NCT03614416|10115981|FG000|NOT COMPLETED|Overall Study||0
9056296|NCT03614975|10115989|FG000|STARTED|Overall Study||85
9056297|NCT03614975|10115990|FG001|STARTED|Overall Study||81
9056298|NCT03614975|10115989|FG000|COMPLETED|Overall Study||75
9056299|NCT03614975|10115990|FG001|COMPLETED|Overall Study||73
9056300|NCT03614975|10115989|FG000|NOT COMPLETED|Overall Study||10
9056301|NCT03614975|10115990|FG001|NOT COMPLETED|Overall Study||8
9056302|NCT03615001|10115996|FG000|STARTED|Overall Study||20
9056303|NCT03615001|10115996|FG000|COMPLETED|Overall Study||20
9056304|NCT03615001|10115996|FG000|NOT COMPLETED|Overall Study||0
9056305|NCT03615079|10116000|FG000|STARTED|Overall Study||28
9056306|NCT03615079|10116000|FG000|COMPLETED|Overall Study||11
9056307|NCT03615079|10116000|FG000|NOT COMPLETED|Overall Study||17
9056308|NCT03615183|10116009|FG000|STARTED|Overall Study||6
9056309|NCT03615183|10116010|FG001|STARTED|Overall Study||6
9056310|NCT03615183|10116011|FG002|STARTED|Overall Study||5
9056311|NCT03615183|10116012|FG003|STARTED|Overall Study|Panel D was not conducted as the scientific study objectives were met in the conducted panels.|0
9056312|NCT03615183|10116013|FG004|STARTED|Overall Study|Panel E was not conducted as the scientific study objectives were met in the conducted panels.|0
9056313|NCT03615183|10116009|FG000|COMPLETED|Overall Study||6
9056314|NCT03615183|10116010|FG001|COMPLETED|Overall Study||6
9056315|NCT03615183|10116011|FG002|COMPLETED|Overall Study||5
9056316|NCT03615183|10116012|FG003|COMPLETED|Overall Study||0
9056317|NCT03615183|10116013|FG004|COMPLETED|Overall Study||0
9056318|NCT03615183|10116009|FG000|NOT COMPLETED|Overall Study||0
9056319|NCT03615183|10116010|FG001|NOT COMPLETED|Overall Study||0
9056320|NCT03615183|10116011|FG002|NOT COMPLETED|Overall Study||0
9056321|NCT03615183|10116012|FG003|NOT COMPLETED|Overall Study||0
9056322|NCT03615183|10116013|FG004|NOT COMPLETED|Overall Study||0
9056323|NCT03615404|10116021|FG000|STARTED|Overall Study||11
9056324|NCT03615404|10116021|FG000|COMPLETED|Overall Study||9
9056325|NCT03615404|10116021|FG000|NOT COMPLETED|Overall Study||2
9056326|NCT03615482|10116027|FG000|STARTED|Overall Study||600
9056327|NCT03615482|10116028|FG001|STARTED|Overall Study||600
9056328|NCT03615482|10116027|FG000|Vaccinated|Overall Study||599
9056329|NCT03615482|10116028|FG001|Vaccinated|Overall Study||598
9056330|NCT03615482|10116027|FG000|COMPLETED|Overall Study||583
9056331|NCT03615482|10116028|FG001|COMPLETED|Overall Study||583
9056332|NCT03615482|10116027|FG000|NOT COMPLETED|Overall Study||17
9056333|NCT03615482|10116028|FG001|NOT COMPLETED|Overall Study||17
9056334|NCT03615534|10116038|FG000|STARTED|Overall Study||14
9056335|NCT03615534|10116039|FG001|STARTED|Overall Study||15
9056336|NCT03615534|10116040|FG002|STARTED|Overall Study||14
9056337|NCT03615534|10116041|FG003|STARTED|Overall Study||14
9056338|NCT03615534|10116038|FG000|COMPLETED|Overall Study||12
9056339|NCT03615534|10116039|FG001|COMPLETED|Overall Study||15
9056340|NCT03615534|10116040|FG002|COMPLETED|Overall Study||14
9056341|NCT03615534|10116041|FG003|COMPLETED|Overall Study||13
9056342|NCT03615534|10116038|FG000|NOT COMPLETED|Overall Study||2
9056343|NCT03615534|10116039|FG001|NOT COMPLETED|Overall Study||0
9056344|NCT03615534|10116040|FG002|NOT COMPLETED|Overall Study||0
9056345|NCT03615534|10116041|FG003|NOT COMPLETED|Overall Study||1
9056346|NCT03615807|10116053|FG000|STARTED|Overall Study||91
9056347|NCT03615807|10116054|FG001|STARTED|Overall Study||91
9056348|NCT03615807|10116053|FG000|COMPLETED|Overall Study||79
9056349|NCT03615807|10116054|FG001|COMPLETED|Overall Study||80
9056350|NCT03615807|10116053|FG000|NOT COMPLETED|Overall Study||12
9056351|NCT03615807|10116054|FG001|NOT COMPLETED|Overall Study||11
9056352|NCT03615911|10116062|FG000|STARTED|Overall Study||14
9056353|NCT03615911|10116063|FG001|STARTED|Overall Study||12
9056354|NCT03615911|10116062|FG000|Received Late Booster Immunization|Overall Study||3
9056355|NCT03615911|10116063|FG001|Received Late Booster Immunization|Overall Study||7
9056356|NCT03615911|10116062|FG000|COMPLETED|Overall Study|A subgroup received an additional booster of 1x10^8 PFU MVA-MERS-S 12 (+/-4) months after prime.|12
9056357|NCT03615911|10116063|FG001|COMPLETED|Overall Study|A subgroup received an additional booster of 1x10^8 PFU MVA-MERS-S 12 (+/-4) months after prime.|11
9056358|NCT03615911|10116062|FG000|NOT COMPLETED|Overall Study||2
9056359|NCT03615911|10116063|FG001|NOT COMPLETED|Overall Study||1
9056360|NCT03615924|10116073|FG000|STARTED|Overall Study||101
9056361|NCT03615924|10116074|FG001|STARTED|Overall Study||92
9056362|NCT03615924|10116073|FG000|Received Treatment|Overall Study||101
9056363|NCT03615924|10116074|FG001|Received Treatment|Overall Study||92
9056364|NCT03615924|10116073|FG000|COMPLETED|Overall Study||0
9056365|NCT03615924|10116074|FG001|COMPLETED|Overall Study||0
9056366|NCT03615924|10116073|FG000|NOT COMPLETED|Overall Study||101
9056367|NCT03615924|10116074|FG001|NOT COMPLETED|Overall Study||92
9056368|NCT03616106|10116082|FG000|STARTED|Overall Study||56
9056369|NCT03616106|10116083|FG001|STARTED|Overall Study||3
9056370|NCT03616106|10116082|FG000|COMPLETED|Overall Study||42
9056371|NCT03616106|10116083|FG001|COMPLETED|Overall Study||2
9056372|NCT03616106|10116082|FG000|NOT COMPLETED|Overall Study||14
9056373|NCT03616106|10116083|FG001|NOT COMPLETED|Overall Study||1
9056374|NCT03616171|10116090|FG000|STARTED|Overall Study||4
9056375|NCT03616171|10116091|FG001|STARTED|Overall Study||2
9056376|NCT03616171|10116090|FG000|COMPLETED|Overall Study||4
9056377|NCT03616171|10116091|FG001|COMPLETED|Overall Study||2
9056378|NCT03616171|10116090|FG000|NOT COMPLETED|Overall Study||0
9056379|NCT03616171|10116091|FG001|NOT COMPLETED|Overall Study||0
9056380|NCT03616600|10116100|FG000|STARTED|Overall Study||16
9056381|NCT03616600|10116101|FG001|STARTED|Overall Study||15
9056382|NCT03616600|10116100|FG000|COMPLETED|Overall Study||15
9056383|NCT03616600|10116101|FG001|COMPLETED|Overall Study||15
9056384|NCT03616600|10116100|FG000|NOT COMPLETED|Overall Study||1
9056385|NCT03616600|10116101|FG001|NOT COMPLETED|Overall Study||0
9056386|NCT03616899|10116110|FG000|STARTED|Overall Study||447
9056387|NCT03616899|10116111|FG001|STARTED|Overall Study||454
9056388|NCT03616899|10116110|FG000|COMPLETED|Overall Study||437
9056389|NCT03616899|10116111|FG001|COMPLETED|Overall Study||453
9056390|NCT03616899|10116110|FG000|NOT COMPLETED|Overall Study||10
9056391|NCT03616899|10116111|FG001|NOT COMPLETED|Overall Study||1
9056392|NCT03616977|10116117|FG000|STARTED|Period 1||34
9056393|NCT03616977|10116118|FG001|STARTED|Period 1||35
9056394|NCT03616977|10116117|FG000|Received at Least One Dose of Study Drug|Period 1||34
9056395|NCT03616977|10116118|FG001|Received at Least One Dose of Study Drug|Period 1||34
9056396|NCT03616977|10116117|FG000|COMPLETED|Period 1||34
9056397|NCT03616977|10116118|FG001|COMPLETED|Period 1||34
9056398|NCT03616977|10116117|FG000|NOT COMPLETED|Period 1||0
9056399|NCT03616977|10116118|FG001|NOT COMPLETED|Period 1||1
9056400|NCT03616977|10116117|FG000|STARTED|Period 2||34
9056401|NCT03616977|10116118|FG001|STARTED|Period 2||34
9056402|NCT03616977|10116117|FG000|COMPLETED|Period 2||34
9056403|NCT03616977|10116118|FG001|COMPLETED|Period 2||34
9056404|NCT03616977|10116117|FG000|NOT COMPLETED|Period 2||0
9056405|NCT03616977|10116118|FG001|NOT COMPLETED|Period 2||0
9056406|NCT03616977|10116117|FG000|STARTED|Period 3||34
9056407|NCT03616977|10116118|FG001|STARTED|Period 3|Participant completed Period 2 and withdrew from the study.|33
9056408|NCT03616977|10116117|FG000|Received Study Drug|Period 3|Participant not dosed due to adverse event.|33
9056409|NCT03616977|10116118|FG001|Received Study Drug|Period 3|Participant not dosed due to adverse event.|32
9056410|NCT03616977|10116117|FG000|COMPLETED|Period 3||33
9056411|NCT03616977|10116118|FG001|COMPLETED|Period 3||32
9056412|NCT03616977|10116117|FG000|NOT COMPLETED|Period 3||1
9056413|NCT03616977|10116118|FG001|NOT COMPLETED|Period 3||1
9056414|NCT03616977|10116117|FG000|STARTED|Period 4||33
9056415|NCT03616977|10116118|FG001|STARTED|Period 4||32
9056416|NCT03616977|10116117|FG000|COMPLETED|Period 4||33
9056417|NCT03616977|10116118|FG001|COMPLETED|Period 4||32
9056418|NCT03616977|10116117|FG000|NOT COMPLETED|Period 4||0
9056419|NCT03616977|10116118|FG001|NOT COMPLETED|Period 4||0
9056420|NCT03617419|10116125|FG000|STARTED|Part 1||2
9056421|NCT03617419|10116125|FG000|COMPLETED|Part 1||2
9056422|NCT03617419|10116125|FG000|NOT COMPLETED|Part 1||0
9056423|NCT03617419|10116125|FG000|STARTED|Part 2||14
9056424|NCT03617419|10116125|FG000|COMPLETED|Part 2||14
9056425|NCT03617419|10116125|FG000|NOT COMPLETED|Part 2||0
9056426|NCT03617588|10116131|FG000|STARTED|Overall Study||20
9056427|NCT03617588|10116132|FG001|STARTED|Overall Study||29
9056428|NCT03617588|10116131|FG000|COMPLETED|Overall Study||19
9056429|NCT03617588|10116132|FG001|COMPLETED|Overall Study||29
9056430|NCT03617588|10116131|FG000|NOT COMPLETED|Overall Study||1
9056431|NCT03617588|10116132|FG001|NOT COMPLETED|Overall Study||0
9056432|NCT03617770|10116144|FG000|STARTED|Overall Study|9|9
9056433|NCT03617770|10116145|FG001|STARTED|Overall Study|5|5
9056434|NCT03617770|10116144|FG000|COMPLETED|Overall Study|8|8
9056435|NCT03617770|10116145|FG001|COMPLETED|Overall Study||5
9056436|NCT03617770|10116144|FG000|NOT COMPLETED|Overall Study||1
9056437|NCT03617770|10116145|FG001|NOT COMPLETED|Overall Study||0
9056438|NCT03617861|10116153|FG000|STARTED|First Intervention (1 Day)||5
9056439|NCT03617861|10116154|FG001|STARTED|First Intervention (1 Day)||5
9056440|NCT03617861|10116155|FG002|STARTED|First Intervention (1 Day)||5
9056441|NCT03617861|10116156|FG003|STARTED|First Intervention (1 Day)||5
9056442|NCT03617861|10116153|FG000|COMPLETED|First Intervention (1 Day)||5
9056443|NCT03617861|10116154|FG001|COMPLETED|First Intervention (1 Day)||5
9056444|NCT03617861|10116155|FG002|COMPLETED|First Intervention (1 Day)||5
9056445|NCT03617861|10116156|FG003|COMPLETED|First Intervention (1 Day)||5
9056446|NCT03617861|10116153|FG000|NOT COMPLETED|First Intervention (1 Day)||0
9056447|NCT03617861|10116154|FG001|NOT COMPLETED|First Intervention (1 Day)||0
9056448|NCT03617861|10116155|FG002|NOT COMPLETED|First Intervention (1 Day)||0
9056449|NCT03617861|10116156|FG003|NOT COMPLETED|First Intervention (1 Day)||0
9056450|NCT03617861|10116153|FG000|STARTED|Washout (1 to 4 Weeks)||5
9056451|NCT03617861|10116154|FG001|STARTED|Washout (1 to 4 Weeks)||5
9056452|NCT03617861|10116155|FG002|STARTED|Washout (1 to 4 Weeks)||5
9056453|NCT03617861|10116156|FG003|STARTED|Washout (1 to 4 Weeks)||5
9056454|NCT03617861|10116153|FG000|COMPLETED|Washout (1 to 4 Weeks)||5
9056455|NCT03617861|10116154|FG001|COMPLETED|Washout (1 to 4 Weeks)||5
9056456|NCT03617861|10116155|FG002|COMPLETED|Washout (1 to 4 Weeks)||5
9056457|NCT03617861|10116156|FG003|COMPLETED|Washout (1 to 4 Weeks)||5
9056458|NCT03617861|10116153|FG000|NOT COMPLETED|Washout (1 to 4 Weeks)||0
9056459|NCT03617861|10116154|FG001|NOT COMPLETED|Washout (1 to 4 Weeks)||0
9056460|NCT03617861|10116155|FG002|NOT COMPLETED|Washout (1 to 4 Weeks)||0
9056461|NCT03617861|10116156|FG003|NOT COMPLETED|Washout (1 to 4 Weeks)||0
9056462|NCT03617861|10116153|FG000|STARTED|Second Intervention (1 Day)||5
9056463|NCT03617861|10116154|FG001|STARTED|Second Intervention (1 Day)||5
9056464|NCT03617861|10116155|FG002|STARTED|Second Intervention (1 Day)||5
9056465|NCT03617861|10116156|FG003|STARTED|Second Intervention (1 Day)||5
9056466|NCT03617861|10116153|FG000|COMPLETED|Second Intervention (1 Day)||5
9056467|NCT03617861|10116154|FG001|COMPLETED|Second Intervention (1 Day)||5
9056468|NCT03617861|10116155|FG002|COMPLETED|Second Intervention (1 Day)||4
9056469|NCT03617861|10116156|FG003|COMPLETED|Second Intervention (1 Day)||5
9056470|NCT03617861|10116153|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
9056471|NCT03617861|10116154|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
9056472|NCT03617861|10116155|FG002|NOT COMPLETED|Second Intervention (1 Day)||1
9056473|NCT03617861|10116156|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
9056474|NCT03617913|10116166|FG000|STARTED|Overall Study||2
9056475|NCT03617913|10116166|FG000|COMPLETED|Overall Study||2
9056476|NCT03617913|10116166|FG000|NOT COMPLETED|Overall Study||0
9056477|NCT03618017|10116172|FG000|STARTED|Overall Study||33
9056478|NCT03618017|10116173|FG001|STARTED|Overall Study||33
9056479|NCT03618017|10116172|FG000|COMPLETED|Overall Study||26
9056480|NCT03618017|10116173|FG001|COMPLETED|Overall Study||28
9056481|NCT03618017|10116172|FG000|NOT COMPLETED|Overall Study||7
9056482|NCT03618017|10116173|FG001|NOT COMPLETED|Overall Study||5
9056483|NCT03618030|10116183|FG000|STARTED|Overall Study||15
9056484|NCT03618030|10116184|FG001|STARTED|Overall Study||14
9056485|NCT03618030|10116185|FG002|STARTED|Overall Study||21
9056486|NCT03618030|10116186|FG003|STARTED|Overall Study||39
9056487|NCT03618030|10116187|FG004|STARTED|Overall Study||36
9056488|NCT03618030|10116188|FG005|STARTED|Overall Study||27
9056489|NCT03618030|10116189|FG006|STARTED|Overall Study||18
9056490|NCT03618030|10116190|FG007|STARTED|Overall Study||118
9056491|NCT03618030|10116183|FG000|COMPLETED|Overall Study||3
9056492|NCT03618030|10116184|FG001|COMPLETED|Overall Study||3
9056493|NCT03618030|10116185|FG002|COMPLETED|Overall Study||13
9056494|NCT03618030|10116186|FG003|COMPLETED|Overall Study||30
9056495|NCT03618030|10116187|FG004|COMPLETED|Overall Study||29
9056496|NCT03618030|10116188|FG005|COMPLETED|Overall Study||21
9056497|NCT03618030|10116189|FG006|COMPLETED|Overall Study||14
9056498|NCT03618030|10116190|FG007|COMPLETED|Overall Study||108
9056499|NCT03618030|10116183|FG000|NOT COMPLETED|Overall Study||12
9056500|NCT03618030|10116184|FG001|NOT COMPLETED|Overall Study||11
9056501|NCT03618030|10116185|FG002|NOT COMPLETED|Overall Study||8
9056502|NCT03618030|10116186|FG003|NOT COMPLETED|Overall Study||9
9056503|NCT03618030|10116187|FG004|NOT COMPLETED|Overall Study||7
9056504|NCT03618030|10116188|FG005|NOT COMPLETED|Overall Study||6
9056505|NCT03618030|10116189|FG006|NOT COMPLETED|Overall Study||4
9056506|NCT03618030|10116190|FG007|NOT COMPLETED|Overall Study||10
9056507|NCT03618147|10116203|FG000|STARTED|Overall Study||314
9056508|NCT03618147|10116203|FG000|COMPLETED|Overall Study||314
9056509|NCT03618147|10116203|FG000|NOT COMPLETED|Overall Study||0
9056510|NCT03618628|10116208|FG000|STARTED|Overall Study||3
9056511|NCT03618628|10116208|FG000|COMPLETED|Overall Study||1
9056512|NCT03618628|10116208|FG000|NOT COMPLETED|Overall Study||2
9056513|NCT03618823|10116214|FG000|STARTED|Overall Study||132
9056514|NCT03618823|10116215|FG001|STARTED|Overall Study||136
9056515|NCT03618823|10116214|FG000|COMPLETED|Overall Study||69
9056516|NCT03618823|10116215|FG001|COMPLETED|Overall Study||75
9056517|NCT03618823|10116214|FG000|NOT COMPLETED|Overall Study||63
9056518|NCT03618823|10116215|FG001|NOT COMPLETED|Overall Study||61
9056519|NCT03619135|10116226|FG000|STARTED|Overall Study||50
9056520|NCT03619135|10116227|FG001|STARTED|Overall Study||50
9056521|NCT03619135|10116226|FG000|COMPLETED|Overall Study||50
9056522|NCT03619135|10116227|FG001|COMPLETED|Overall Study||50
9056523|NCT03619135|10116226|FG000|NOT COMPLETED|Overall Study||0
9056524|NCT03619135|10116227|FG001|NOT COMPLETED|Overall Study||0
9056525|NCT03619590|10116233|FG000|STARTED|Overall Study||103
9056526|NCT03619590|10116233|FG000|COMPLETED|Overall Study||103
9056527|NCT03619590|10116233|FG000|NOT COMPLETED|Overall Study||0
9056528|NCT03619811|10116237|FG000|STARTED|Overall Study||43
9056529|NCT03619811|10116237|FG000|COMPLETED|Overall Study||31
9056530|NCT03619811|10116237|FG000|NOT COMPLETED|Overall Study||12
9056531|NCT03619837|10116241|FG000|STARTED|Screening||122
9056532|NCT03619837|10116241|FG000|COMPLETED|Screening||24
9056533|NCT03619837|10116241|FG000|NOT COMPLETED|Screening||98
9056534|NCT03619837|10116241|FG000|STARTED|Main Study||24
9056535|NCT03619837|10116241|FG000|COMPLETED|Main Study||24
9056536|NCT03619837|10116241|FG000|NOT COMPLETED|Main Study||0
9056537|NCT03619889|10116247|FG000|STARTED|Overall Study||37
9056538|NCT03619889|10116248|FG001|STARTED|Overall Study||37
9056539|NCT03619889|10116247|FG000|COMPLETED|Overall Study||35
9056540|NCT03619889|10116248|FG001|COMPLETED|Overall Study||37
9056541|NCT03619889|10116247|FG000|NOT COMPLETED|Overall Study||2
9056542|NCT03619889|10116248|FG001|NOT COMPLETED|Overall Study||0
9056543|NCT03620162|10116259|FG000|STARTED|Overall Study||179
9056544|NCT03620162|10116260|FG001|STARTED|Overall Study||181
9056545|NCT03620162|10116261|FG002|STARTED|Overall Study||180
9056546|NCT03620162|10116262|FG003|STARTED|Overall Study||180
9056547|NCT03620162|10116263|FG004|STARTED|Overall Study||180
9056548|NCT03620162|10116259|FG000|Vaccination 1 (V114 or Prevnar 13™)|Overall Study||179
9056549|NCT03620162|10116260|FG001|Vaccination 1 (V114 or Prevnar 13™)|Overall Study||181
9056550|NCT03620162|10116261|FG002|Vaccination 1 (V114 or Prevnar 13™)|Overall Study||178
9056551|NCT03620162|10116262|FG003|Vaccination 1 (V114 or Prevnar 13™)|Overall Study||179
9056552|NCT03620162|10116263|FG004|Vaccination 1 (V114 or Prevnar 13™)|Overall Study||179
9056553|NCT03620162|10116259|FG000|Vaccination 2 (V114 or Prevnar 13™)|Overall Study||176
9056554|NCT03620162|10116260|FG001|Vaccination 2 (V114 or Prevnar 13™)|Overall Study||175
9056555|NCT03620162|10116261|FG002|Vaccination 2 (V114 or Prevnar 13™)|Overall Study||166
9056556|NCT03620162|10116262|FG003|Vaccination 2 (V114 or Prevnar 13™)|Overall Study||169
9056557|NCT03620162|10116263|FG004|Vaccination 2 (V114 or Prevnar 13™)|Overall Study||173
9056558|NCT03620162|10116259|FG000|Vaccination 3 (V114 or Prevnar 13™)|Overall Study||175
9056559|NCT03620162|10116260|FG001|Vaccination 3 (V114 or Prevnar 13™)|Overall Study||174
9056560|NCT03620162|10116261|FG002|Vaccination 3 (V114 or Prevnar 13™)|Overall Study||161
9056561|NCT03620162|10116262|FG003|Vaccination 3 (V114 or Prevnar 13™)|Overall Study||167
9056562|NCT03620162|10116263|FG004|Vaccination 3 (V114 or Prevnar 13™)|Overall Study||173
9056563|NCT03620162|10116259|FG000|Vaccination 4 (V114 or Prevnar 13™)|Overall Study||165
9056564|NCT03620162|10116260|FG001|Vaccination 4 (V114 or Prevnar 13™)|Overall Study||168
9056565|NCT03620162|10116261|FG002|Vaccination 4 (V114 or Prevnar 13™)|Overall Study||150
9056566|NCT03620162|10116262|FG003|Vaccination 4 (V114 or Prevnar 13™)|Overall Study||162
9056567|NCT03620162|10116263|FG004|Vaccination 4 (V114 or Prevnar 13™)|Overall Study||168
9056568|NCT03620162|10116259|FG000|COMPLETED|Overall Study||164
9056569|NCT03620162|10116260|FG001|COMPLETED|Overall Study||167
9056570|NCT03620162|10116261|FG002|COMPLETED|Overall Study||147
9056571|NCT03620162|10116262|FG003|COMPLETED|Overall Study||160
9056572|NCT03620162|10116263|FG004|COMPLETED|Overall Study||167
9056573|NCT03620162|10116259|FG000|NOT COMPLETED|Overall Study||15
9056574|NCT03620162|10116260|FG001|NOT COMPLETED|Overall Study||14
9056575|NCT03620162|10116261|FG002|NOT COMPLETED|Overall Study||33
9056576|NCT03620162|10116262|FG003|NOT COMPLETED|Overall Study||20
9056577|NCT03620162|10116263|FG004|NOT COMPLETED|Overall Study||13
9056578|NCT03620383|10116279|FG000|STARTED|Overall Study||30
9056579|NCT03620383|10116280|FG001|STARTED|Overall Study||15
9056580|NCT03620383|10116279|FG000|COMPLETED|Overall Study||30
9056581|NCT03620383|10116280|FG001|COMPLETED|Overall Study||15
9056582|NCT03620383|10116279|FG000|NOT COMPLETED|Overall Study||0
9056583|NCT03620383|10116280|FG001|NOT COMPLETED|Overall Study||0
9056584|NCT03620708|10116289|FG000|STARTED|Overall Study||19
9056585|NCT03620708|10116290|FG001|STARTED|Overall Study||19
8703870|NCT00925301|9749658|FG000|Modified Intent-to-Treat (mITT)|6-Month Double-blind (Stage 1)||30
9056586|NCT03620708|10116291|FG002|STARTED|Overall Study||20
9056587|NCT03620708|10116289|FG000|COMPLETED|Overall Study||18
9056588|NCT03620708|10116290|FG001|COMPLETED|Overall Study||18
9056589|NCT03620708|10116291|FG002|COMPLETED|Overall Study||17
9056590|NCT03620708|10116289|FG000|NOT COMPLETED|Overall Study||1
9056591|NCT03620708|10116290|FG001|NOT COMPLETED|Overall Study||1
9056592|NCT03620708|10116291|FG002|NOT COMPLETED|Overall Study||3
9056593|NCT03620890|10116301|FG000|STARTED|Overall Study||57
9056594|NCT03620890|10116302|FG001|STARTED|Overall Study||51
9056595|NCT03620890|10116301|FG000|First Trimester Miscarriage|Overall Study||2
9056596|NCT03620890|10116302|FG001|First Trimester Miscarriage|Overall Study||1
9056597|NCT03620890|10116301|FG000|Major Fetal Anomalies (Hypoplastic Left Heart and Sacral Agenesis) With 2nd Trimester Stillbirth|Overall Study||1
9056598|NCT03620890|10116302|FG001|Major Fetal Anomalies (Hypoplastic Left Heart and Sacral Agenesis) With 2nd Trimester Stillbirth|Overall Study||0
9056599|NCT03620890|10116301|FG000|Major Fetal Anomaly (Holoprosencephaly) With 2nd Trimester Pregnancy Termination|Overall Study||1
9056600|NCT03620890|10116302|FG001|Major Fetal Anomaly (Holoprosencephaly) With 2nd Trimester Pregnancy Termination|Overall Study||0
9056601|NCT03620890|10116301|FG000|COMPLETED|Overall Study||53
9056602|NCT03620890|10116302|FG001|COMPLETED|Overall Study||50
9056603|NCT03620890|10116301|FG000|NOT COMPLETED|Overall Study||4
9056604|NCT03620890|10116302|FG001|NOT COMPLETED|Overall Study||1
9056605|NCT03621085|10116308|FG000|STARTED|Enrollment||22
9056606|NCT03621085|10116309|FG001|STARTED|Enrollment||21
9056607|NCT03621085|10116308|FG000|COMPLETED|Enrollment||16
9056608|NCT03621085|10116309|FG001|COMPLETED|Enrollment||14
9056609|NCT03621085|10116308|FG000|NOT COMPLETED|Enrollment||6
9056610|NCT03621085|10116309|FG001|NOT COMPLETED|Enrollment||7
9056611|NCT03621085|10116308|FG000|STARTED|First Visit||16
9056612|NCT03621085|10116309|FG001|STARTED|First Visit||14
9056613|NCT03621085|10116308|FG000|COMPLETED|First Visit||16
9056614|NCT03621085|10116309|FG001|COMPLETED|First Visit||14
9056615|NCT03621085|10116308|FG000|NOT COMPLETED|First Visit||0
9056616|NCT03621085|10116309|FG001|NOT COMPLETED|First Visit||0
9056617|NCT03621085|10116308|FG000|STARTED|Washout (at Least 48 Hours)||16
9056618|NCT03621085|10116309|FG001|STARTED|Washout (at Least 48 Hours)||14
9056619|NCT03621085|10116308|FG000|COMPLETED|Washout (at Least 48 Hours)||16
9056620|NCT03621085|10116309|FG001|COMPLETED|Washout (at Least 48 Hours)||14
9056621|NCT03621085|10116308|FG000|NOT COMPLETED|Washout (at Least 48 Hours)||0
9056622|NCT03621085|10116309|FG001|NOT COMPLETED|Washout (at Least 48 Hours)||0
9056623|NCT03621085|10116308|FG000|STARTED|Second Visit||16
9056624|NCT03621085|10116309|FG001|STARTED|Second Visit||14
9056625|NCT03621085|10116308|FG000|COMPLETED|Second Visit||16
9056626|NCT03621085|10116309|FG001|COMPLETED|Second Visit||14
9056627|NCT03621085|10116308|FG000|NOT COMPLETED|Second Visit||0
9056628|NCT03621085|10116309|FG001|NOT COMPLETED|Second Visit||0
9056629|NCT03621189|10116317|FG000|STARTED|Overall Study||40
9056630|NCT03621189|10116318|FG001|STARTED|Overall Study||40
9056631|NCT03621189|10116317|FG000|COMPLETED|Overall Study||40
9056632|NCT03621189|10116318|FG001|COMPLETED|Overall Study||35
9056633|NCT03621189|10116317|FG000|NOT COMPLETED|Overall Study||0
9056634|NCT03621189|10116318|FG001|NOT COMPLETED|Overall Study||5
9056635|NCT03621202|10116325|FG000|STARTED|Overall Study||66
9056636|NCT03621202|10116325|FG000|COMPLETED|Overall Study||60
9056637|NCT03621202|10116325|FG000|NOT COMPLETED|Overall Study||6
9056638|NCT03621787|10116329|FG000|STARTED|Overall Study||9
9056639|NCT03621787|10116329|FG000|COMPLETED|Overall Study||9
9056640|NCT03621787|10116329|FG000|NOT COMPLETED|Overall Study||0
9056641|NCT03621878|10116336|FG000|STARTED|Overall Study||17
9056642|NCT03621878|10116337|FG001|STARTED|Overall Study||17
9056643|NCT03621878|10116338|FG002|STARTED|Overall Study||17
9056644|NCT03621878|10116336|FG000|COMPLETED|Overall Study||17
9056645|NCT03621878|10116337|FG001|COMPLETED|Overall Study||17
9056646|NCT03621878|10116338|FG002|COMPLETED|Overall Study||17
9056647|NCT03621878|10116336|FG000|NOT COMPLETED|Overall Study||0
9056648|NCT03621878|10116337|FG001|NOT COMPLETED|Overall Study||0
9056649|NCT03621878|10116338|FG002|NOT COMPLETED|Overall Study||0
9056650|NCT03622112|10116353|FG000|STARTED|Overall Study||110
9056651|NCT03622112|10116354|FG001|STARTED|Overall Study||112
9056652|NCT03622112|10116355|FG002|STARTED|Overall Study||111
9056653|NCT03622112|10116356|FG003|STARTED|Overall Study||113
9056654|NCT03622112|10116357|FG004|STARTED|Overall Study||134
9056655|NCT03622112|10116358|FG005|STARTED|Overall Study||113
9056656|NCT03622112|10116359|FG006|STARTED|Overall Study||112
9056657|NCT03622112|10116353|FG000|COMPLETED|Overall Study||85
9056658|NCT03622112|10116354|FG001|COMPLETED|Overall Study||92
9056659|NCT03622112|10116355|FG002|COMPLETED|Overall Study||95
9056660|NCT03622112|10116356|FG003|COMPLETED|Overall Study||91
9056661|NCT03622112|10116357|FG004|COMPLETED|Overall Study||124
9056662|NCT03622112|10116358|FG005|COMPLETED|Overall Study||71
9056663|NCT03622112|10116359|FG006|COMPLETED|Overall Study||103
9056664|NCT03622112|10116353|FG000|NOT COMPLETED|Overall Study||25
9056665|NCT03622112|10116354|FG001|NOT COMPLETED|Overall Study||20
9056666|NCT03622112|10116355|FG002|NOT COMPLETED|Overall Study||16
9056667|NCT03622112|10116356|FG003|NOT COMPLETED|Overall Study||22
9056668|NCT03622112|10116357|FG004|NOT COMPLETED|Overall Study||10
9056669|NCT03622112|10116358|FG005|NOT COMPLETED|Overall Study||42
9056670|NCT03622112|10116359|FG006|NOT COMPLETED|Overall Study||9
9056671|NCT03622619|10116377|FG000|STARTED|Overall Study||23
9056672|NCT03622619|10116378|FG001|STARTED|Overall Study||23
9056673|NCT03622619|10116377|FG000|COMPLETED|Overall Study||21
9056674|NCT03622619|10116378|FG001|COMPLETED|Overall Study||21
9056675|NCT03622619|10116377|FG000|NOT COMPLETED|Overall Study||2
9056676|NCT03622619|10116378|FG001|NOT COMPLETED|Overall Study||2
9056677|NCT03623035|10116384|FG000|STARTED|Overall Study||10
9056678|NCT03623035|10116384|FG000|COMPLETED|Overall Study||10
9056679|NCT03623035|10116384|FG000|NOT COMPLETED|Overall Study||0
9056680|NCT03623334|10116391|FG000|STARTED|Overall Study||15
9056681|NCT03623334|10116392|FG001|STARTED|Overall Study||21
9056682|NCT03623334|10116393|FG002|STARTED|Overall Study||19
9056683|NCT03623334|10116391|FG000|COMPLETED|Overall Study||15
9056684|NCT03623334|10116392|FG001|COMPLETED|Overall Study||21
9056685|NCT03623334|10116393|FG002|COMPLETED|Overall Study||19
9056686|NCT03623334|10116391|FG000|NOT COMPLETED|Overall Study||0
9056687|NCT03623334|10116392|FG001|NOT COMPLETED|Overall Study||0
9056688|NCT03623334|10116393|FG002|NOT COMPLETED|Overall Study||0
9056689|NCT03623698|10116401|FG000|STARTED|Overall Study||24
9056690|NCT03623698|10116401|FG000|COMPLETED|Overall Study||24
9056691|NCT03623698|10116401|FG000|NOT COMPLETED|Overall Study||0
9056692|NCT03624192|10116412|FG000|STARTED|Overall Study||3
9056693|NCT03624192|10116413|FG001|STARTED|Overall Study||3
9056694|NCT03624192|10116412|FG000|COMPLETED|Overall Study||2
9056695|NCT03624192|10116413|FG001|COMPLETED|Overall Study||2
9056696|NCT03624192|10116412|FG000|NOT COMPLETED|Overall Study||1
9056697|NCT03624192|10116413|FG001|NOT COMPLETED|Overall Study||1
9056698|NCT03624504|10116421|FG000|STARTED|Overall Study||82
9056699|NCT03624504|10116421|FG000|COMPLETED|Overall Study||81
9056700|NCT03624504|10116421|FG000|NOT COMPLETED|Overall Study||1
9056701|NCT03624920|10116431|FG000|STARTED|Overall Study||14
9056702|NCT03624920|10116432|FG001|STARTED|Overall Study||14
9056703|NCT03624920|10116433|FG002|STARTED|Overall Study||13
9056704|NCT03624920|10116434|FG003|STARTED|Overall Study||13
9056705|NCT03624920|10116435|FG004|STARTED|Overall Study||11
9056706|NCT03624920|10116436|FG005|STARTED|Overall Study||12
9056707|NCT03624920|10116431|FG000|COMPLETED|Overall Study||13
9056708|NCT03624920|10116432|FG001|COMPLETED|Overall Study||12
9056709|NCT03624920|10116433|FG002|COMPLETED|Overall Study||12
9056710|NCT03624920|10116434|FG003|COMPLETED|Overall Study||12
9056711|NCT03624920|10116435|FG004|COMPLETED|Overall Study||7
9056712|NCT03624920|10116436|FG005|COMPLETED|Overall Study||11
9056713|NCT03624920|10116431|FG000|NOT COMPLETED|Overall Study||1
9056714|NCT03624920|10116432|FG001|NOT COMPLETED|Overall Study||2
9056715|NCT03624920|10116433|FG002|NOT COMPLETED|Overall Study||1
9056716|NCT03624920|10116434|FG003|NOT COMPLETED|Overall Study||1
9056717|NCT03624920|10116435|FG004|NOT COMPLETED|Overall Study||4
9056718|NCT03624920|10116436|FG005|NOT COMPLETED|Overall Study||1
9056719|NCT03624946|10116446|FG000|STARTED|Overall Study||19
9056720|NCT03624946|10116447|FG001|STARTED|Overall Study||11
9056721|NCT03624946|10116446|FG000|COMPLETED|Overall Study||19
9056722|NCT03624946|10116447|FG001|COMPLETED|Overall Study||10
9056723|NCT03624946|10116446|FG000|NOT COMPLETED|Overall Study||0
9056724|NCT03624946|10116447|FG001|NOT COMPLETED|Overall Study||1
9056725|NCT03624972|10116460|FG000|STARTED|Overall Study||71
9056726|NCT03624972|10116461|FG001|STARTED|Overall Study||73
9056727|NCT03624972|10116462|FG002|STARTED|Overall Study||9
9056728|NCT03624972|10116460|FG000|COMPLETED|Overall Study||69
9056729|NCT03624972|10116461|FG001|COMPLETED|Overall Study||71
9056730|NCT03624972|10116462|FG002|COMPLETED|Overall Study||9
9056731|NCT03624972|10116460|FG000|NOT COMPLETED|Overall Study||2
9056732|NCT03624972|10116461|FG001|NOT COMPLETED|Overall Study||2
9056733|NCT03624972|10116462|FG002|NOT COMPLETED|Overall Study||0
9056734|NCT03626415|10116474|FG000|STARTED|Overall Study||8
9056735|NCT03626415|10116475|FG001|STARTED|Overall Study||8
9056736|NCT03626415|10116476|FG002|STARTED|Overall Study||8
9056737|NCT03626415|10116474|FG000|COMPLETED|Overall Study||8
9056738|NCT03626415|10116475|FG001|COMPLETED|Overall Study||8
9056739|NCT03626415|10116476|FG002|COMPLETED|Overall Study||8
9056740|NCT03626415|10116474|FG000|NOT COMPLETED|Overall Study||0
9056741|NCT03626415|10116475|FG001|NOT COMPLETED|Overall Study||0
9056742|NCT03626415|10116476|FG002|NOT COMPLETED|Overall Study||0
9056743|NCT03626623|10116486|FG000|STARTED|Overall Study||5
9056744|NCT03626623|10116487|FG001|STARTED|Overall Study||10
9056745|NCT03626623|10116486|FG000|COMPLETED|Overall Study||0
9056746|NCT03626623|10116487|FG001|COMPLETED|Overall Study||0
9056747|NCT03626623|10116486|FG000|NOT COMPLETED|Overall Study||5
9056748|NCT03626623|10116487|FG001|NOT COMPLETED|Overall Study||10
9056749|NCT03626714|10116493|FG000|STARTED|Overall Study||8
9056750|NCT03626714|10116493|FG000|COMPLETED|Overall Study||8
9056751|NCT03626714|10116493|FG000|NOT COMPLETED|Overall Study||0
9056752|NCT03627065|10116497|FG000|STARTED|Overall Study||10
9056753|NCT03627065|10116497|FG000|COMPLETED|Overall Study||7
9056754|NCT03627065|10116497|FG000|NOT COMPLETED|Overall Study||3
9056755|NCT03627195|10116507|FG000|STARTED|Overall Study||6
9056756|NCT03627195|10116508|FG001|STARTED|Overall Study||6
9056757|NCT03627195|10116509|FG002|STARTED|Overall Study||6
9056758|NCT03627195|10116510|FG003|STARTED|Overall Study||6
9056759|NCT03627195|10116511|FG004|STARTED|Overall Study||6
9056760|NCT03627195|10116512|FG005|STARTED|Overall Study||10
9056761|NCT03627195|10116507|FG000|COMPLETED|Overall Study||5
9056762|NCT03627195|10116508|FG001|COMPLETED|Overall Study||6
9056763|NCT03627195|10116509|FG002|COMPLETED|Overall Study||6
9056764|NCT03627195|10116510|FG003|COMPLETED|Overall Study||6
9056765|NCT03627195|10116511|FG004|COMPLETED|Overall Study||6
9056766|NCT03627195|10116512|FG005|COMPLETED|Overall Study||10
9056767|NCT03627195|10116507|FG000|NOT COMPLETED|Overall Study||1
9056768|NCT03627195|10116508|FG001|NOT COMPLETED|Overall Study||0
9056769|NCT03627195|10116509|FG002|NOT COMPLETED|Overall Study||0
9056770|NCT03627195|10116510|FG003|NOT COMPLETED|Overall Study||0
9056771|NCT03627195|10116511|FG004|NOT COMPLETED|Overall Study||0
9056772|NCT03627195|10116512|FG005|NOT COMPLETED|Overall Study||0
9056773|NCT03627299|10116526|FG000|STARTED|Overall Study||10
9056774|NCT03627299|10116526|FG000|COMPLETED|Overall Study||10
9056775|NCT03627299|10116526|FG000|NOT COMPLETED|Overall Study||0
9056776|NCT03627416|10116532|FG000|STARTED|Overall Study||8
9056777|NCT03627416|10116533|FG001|STARTED|Overall Study||7
9056778|NCT03627416|10116532|FG000|COMPLETED|Overall Study||8
9056779|NCT03627416|10116533|FG001|COMPLETED|Overall Study||6
9056780|NCT03627416|10116532|FG000|NOT COMPLETED|Overall Study||0
9056781|NCT03627416|10116533|FG001|NOT COMPLETED|Overall Study||1
9056782|NCT03627494|10116551|FG000|STARTED|Part A Period 1 (4 Days)||3
9056783|NCT03627494|10116552|FG001|STARTED|Part A Period 1 (4 Days)||3
9056784|NCT03627494|10116553|FG002|STARTED|Part A Period 1 (4 Days)||3
9056785|NCT03627494|10116554|FG003|STARTED|Part A Period 1 (4 Days)||3
9056786|NCT03627494|10116555|FG004|STARTED|Part A Period 1 (4 Days)||3
9056787|NCT03627494|10116556|FG005|STARTED|Part A Period 1 (4 Days)||3
9056788|NCT03627494|10116557|FG006|STARTED|Part A Period 1 (4 Days)||0
9056789|NCT03627494|10116558|FG007|STARTED|Part A Period 1 (4 Days)||0
9056790|NCT03627494|10116559|FG008|STARTED|Part A Period 1 (4 Days)||0
9056791|NCT03627494|10116560|FG009|STARTED|Part A Period 1 (4 Days)||0
9056792|NCT03627494|10116561|FG010|STARTED|Part A Period 1 (4 Days)||0
9056793|NCT03627494|10116562|FG011|STARTED|Part A Period 1 (4 Days)||0
9056794|NCT03627494|10116551|FG000|COMPLETED|Part A Period 1 (4 Days)||3
9056795|NCT03627494|10116552|FG001|COMPLETED|Part A Period 1 (4 Days)||3
9056796|NCT03627494|10116553|FG002|COMPLETED|Part A Period 1 (4 Days)||3
9056797|NCT03627494|10116554|FG003|COMPLETED|Part A Period 1 (4 Days)||3
9056798|NCT03627494|10116555|FG004|COMPLETED|Part A Period 1 (4 Days)||3
9056799|NCT03627494|10116556|FG005|COMPLETED|Part A Period 1 (4 Days)||3
9056800|NCT03627494|10116557|FG006|COMPLETED|Part A Period 1 (4 Days)||0
9056801|NCT03627494|10116558|FG007|COMPLETED|Part A Period 1 (4 Days)||0
9056802|NCT03627494|10116559|FG008|COMPLETED|Part A Period 1 (4 Days)||0
9056803|NCT03627494|10116560|FG009|COMPLETED|Part A Period 1 (4 Days)||0
9056804|NCT03627494|10116561|FG010|COMPLETED|Part A Period 1 (4 Days)||0
9056805|NCT03627494|10116562|FG011|COMPLETED|Part A Period 1 (4 Days)||0
9056806|NCT03627494|10116551|FG000|NOT COMPLETED|Part A Period 1 (4 Days)||0
9056807|NCT03627494|10116552|FG001|NOT COMPLETED|Part A Period 1 (4 Days)||0
9056808|NCT03627494|10116553|FG002|NOT COMPLETED|Part A Period 1 (4 Days)||0
9056809|NCT03627494|10116554|FG003|NOT COMPLETED|Part A Period 1 (4 Days)||0
9056810|NCT03627494|10116555|FG004|NOT COMPLETED|Part A Period 1 (4 Days)||0
9056811|NCT03627494|10116556|FG005|NOT COMPLETED|Part A Period 1 (4 Days)||0
9056812|NCT03627494|10116557|FG006|NOT COMPLETED|Part A Period 1 (4 Days)||0
9056813|NCT03627494|10116558|FG007|NOT COMPLETED|Part A Period 1 (4 Days)||0
9056814|NCT03627494|10116559|FG008|NOT COMPLETED|Part A Period 1 (4 Days)||0
9056815|NCT03627494|10116560|FG009|NOT COMPLETED|Part A Period 1 (4 Days)||0
9056816|NCT03627494|10116561|FG010|NOT COMPLETED|Part A Period 1 (4 Days)||0
9056817|NCT03627494|10116562|FG011|NOT COMPLETED|Part A Period 1 (4 Days)||0
9056818|NCT03627494|10116551|FG000|STARTED|Part A Washout 1 (7 Days)||3
9056819|NCT03627494|10116552|FG001|STARTED|Part A Washout 1 (7 Days)||3
9056820|NCT03627494|10116553|FG002|STARTED|Part A Washout 1 (7 Days)||3
9056821|NCT03627494|10116554|FG003|STARTED|Part A Washout 1 (7 Days)||3
9056822|NCT03627494|10116555|FG004|STARTED|Part A Washout 1 (7 Days)||3
9056823|NCT03627494|10116556|FG005|STARTED|Part A Washout 1 (7 Days)||3
9056824|NCT03627494|10116557|FG006|STARTED|Part A Washout 1 (7 Days)||0
9056825|NCT03627494|10116558|FG007|STARTED|Part A Washout 1 (7 Days)||0
9056826|NCT03627494|10116559|FG008|STARTED|Part A Washout 1 (7 Days)||0
9056827|NCT03627494|10116560|FG009|STARTED|Part A Washout 1 (7 Days)||0
9056828|NCT03627494|10116561|FG010|STARTED|Part A Washout 1 (7 Days)||0
9056829|NCT03627494|10116562|FG011|STARTED|Part A Washout 1 (7 Days)||0
9056830|NCT03627494|10116551|FG000|COMPLETED|Part A Washout 1 (7 Days)||3
9056831|NCT03627494|10116552|FG001|COMPLETED|Part A Washout 1 (7 Days)||3
9056832|NCT03627494|10116553|FG002|COMPLETED|Part A Washout 1 (7 Days)||3
9056833|NCT03627494|10116554|FG003|COMPLETED|Part A Washout 1 (7 Days)||3
9056834|NCT03627494|10116555|FG004|COMPLETED|Part A Washout 1 (7 Days)||3
9056835|NCT03627494|10116556|FG005|COMPLETED|Part A Washout 1 (7 Days)||3
9056836|NCT03627494|10116557|FG006|COMPLETED|Part A Washout 1 (7 Days)||0
9056837|NCT03627494|10116558|FG007|COMPLETED|Part A Washout 1 (7 Days)||0
9056838|NCT03627494|10116559|FG008|COMPLETED|Part A Washout 1 (7 Days)||0
9056839|NCT03627494|10116560|FG009|COMPLETED|Part A Washout 1 (7 Days)||0
9056840|NCT03627494|10116561|FG010|COMPLETED|Part A Washout 1 (7 Days)||0
9056841|NCT03627494|10116562|FG011|COMPLETED|Part A Washout 1 (7 Days)||0
9056842|NCT03627494|10116551|FG000|NOT COMPLETED|Part A Washout 1 (7 Days)||0
9056843|NCT03627494|10116552|FG001|NOT COMPLETED|Part A Washout 1 (7 Days)||0
9056844|NCT03627494|10116553|FG002|NOT COMPLETED|Part A Washout 1 (7 Days)||0
9056845|NCT03627494|10116554|FG003|NOT COMPLETED|Part A Washout 1 (7 Days)||0
9056846|NCT03627494|10116555|FG004|NOT COMPLETED|Part A Washout 1 (7 Days)||0
9056847|NCT03627494|10116556|FG005|NOT COMPLETED|Part A Washout 1 (7 Days)||0
9056848|NCT03627494|10116557|FG006|NOT COMPLETED|Part A Washout 1 (7 Days)||0
9056849|NCT03627494|10116558|FG007|NOT COMPLETED|Part A Washout 1 (7 Days)||0
9056850|NCT03627494|10116559|FG008|NOT COMPLETED|Part A Washout 1 (7 Days)||0
9056851|NCT03627494|10116560|FG009|NOT COMPLETED|Part A Washout 1 (7 Days)||0
9056852|NCT03627494|10116561|FG010|NOT COMPLETED|Part A Washout 1 (7 Days)||0
9056853|NCT03627494|10116562|FG011|NOT COMPLETED|Part A Washout 1 (7 Days)||0
9056854|NCT03627494|10116551|FG000|STARTED|Part A Period 2 (4 Days)||3
8703871|NCT00925301|9749659|FG001|Modified Intent-to-Treat (mITT)|6-Month Double-blind (Stage 1)||30
8703872|NCT00925301|9749660|FG002|Modified Intent-to-Treat (mITT)|6-Month Double-blind (Stage 1)||0
8703873|NCT00925301|9749661|FG003|Modified Intent-to-Treat (mITT)|6-Month Double-blind (Stage 1)||0
8703874|NCT00925301|9749658|FG000|COMPLETED|6-Month Double-blind (Stage 1)||34
8703875|NCT00925301|9749659|FG001|COMPLETED|6-Month Double-blind (Stage 1)||30
9056855|NCT03627494|10116552|FG001|STARTED|Part A Period 2 (4 Days)||3
9056856|NCT03627494|10116553|FG002|STARTED|Part A Period 2 (4 Days)||3
9056857|NCT03627494|10116554|FG003|STARTED|Part A Period 2 (4 Days)||3
9056858|NCT03627494|10116555|FG004|STARTED|Part A Period 2 (4 Days)||3
9056859|NCT03627494|10116556|FG005|STARTED|Part A Period 2 (4 Days)||3
9056860|NCT03627494|10116557|FG006|STARTED|Part A Period 2 (4 Days)||0
9056861|NCT03627494|10116558|FG007|STARTED|Part A Period 2 (4 Days)||0
9056862|NCT03627494|10116559|FG008|STARTED|Part A Period 2 (4 Days)||0
9056863|NCT03627494|10116560|FG009|STARTED|Part A Period 2 (4 Days)||0
9056864|NCT03627494|10116561|FG010|STARTED|Part A Period 2 (4 Days)||0
9056865|NCT03627494|10116562|FG011|STARTED|Part A Period 2 (4 Days)||0
9056866|NCT03627494|10116551|FG000|COMPLETED|Part A Period 2 (4 Days)||3
9056867|NCT03627494|10116552|FG001|COMPLETED|Part A Period 2 (4 Days)||3
9056868|NCT03627494|10116553|FG002|COMPLETED|Part A Period 2 (4 Days)||3
9056869|NCT03627494|10116554|FG003|COMPLETED|Part A Period 2 (4 Days)||3
9056870|NCT03627494|10116555|FG004|COMPLETED|Part A Period 2 (4 Days)||3
9056871|NCT03627494|10116556|FG005|COMPLETED|Part A Period 2 (4 Days)||3
9056872|NCT03627494|10116557|FG006|COMPLETED|Part A Period 2 (4 Days)||0
9056873|NCT03627494|10116558|FG007|COMPLETED|Part A Period 2 (4 Days)||0
9056874|NCT03627494|10116559|FG008|COMPLETED|Part A Period 2 (4 Days)||0
9056875|NCT03627494|10116560|FG009|COMPLETED|Part A Period 2 (4 Days)||0
9056876|NCT03627494|10116561|FG010|COMPLETED|Part A Period 2 (4 Days)||0
9056877|NCT03627494|10116562|FG011|COMPLETED|Part A Period 2 (4 Days)||0
9056878|NCT03627494|10116551|FG000|NOT COMPLETED|Part A Period 2 (4 Days)||0
9056879|NCT03627494|10116552|FG001|NOT COMPLETED|Part A Period 2 (4 Days)||0
9056880|NCT03627494|10116553|FG002|NOT COMPLETED|Part A Period 2 (4 Days)||0
9056881|NCT03627494|10116554|FG003|NOT COMPLETED|Part A Period 2 (4 Days)||0
9056882|NCT03627494|10116555|FG004|NOT COMPLETED|Part A Period 2 (4 Days)||0
9056883|NCT03627494|10116556|FG005|NOT COMPLETED|Part A Period 2 (4 Days)||0
9056884|NCT03627494|10116557|FG006|NOT COMPLETED|Part A Period 2 (4 Days)||0
9056885|NCT03627494|10116558|FG007|NOT COMPLETED|Part A Period 2 (4 Days)||0
9056886|NCT03627494|10116559|FG008|NOT COMPLETED|Part A Period 2 (4 Days)||0
9056887|NCT03627494|10116560|FG009|NOT COMPLETED|Part A Period 2 (4 Days)||0
9056888|NCT03627494|10116561|FG010|NOT COMPLETED|Part A Period 2 (4 Days)||0
9056889|NCT03627494|10116562|FG011|NOT COMPLETED|Part A Period 2 (4 Days)||0
9056890|NCT03627494|10116551|FG000|STARTED|Part A Washout 2 (7 Days)||3
9056891|NCT03627494|10116552|FG001|STARTED|Part A Washout 2 (7 Days)||3
9056892|NCT03627494|10116553|FG002|STARTED|Part A Washout 2 (7 Days)||3
8703876|NCT00925301|9749660|FG002|COMPLETED|6-Month Double-blind (Stage 1)||0
8703877|NCT00925301|9749661|FG003|COMPLETED|6-Month Double-blind (Stage 1)||0
8703878|NCT00925301|9749658|FG000|NOT COMPLETED|6-Month Double-blind (Stage 1)||0
8703879|NCT00925301|9749659|FG001|NOT COMPLETED|6-Month Double-blind (Stage 1)||3
8703880|NCT00925301|9749660|FG002|NOT COMPLETED|6-Month Double-blind (Stage 1)||0
8703881|NCT00925301|9749661|FG003|NOT COMPLETED|6-Month Double-blind (Stage 1)||0
8703882|NCT00925301|9749658|FG000|STARTED|6-Month Open-label (Stage 2)|Zero participants noted because participants had completed Stage 1.|0
9056893|NCT03627494|10116554|FG003|STARTED|Part A Washout 2 (7 Days)||3
9056894|NCT03627494|10116555|FG004|STARTED|Part A Washout 2 (7 Days)||3
9056895|NCT03627494|10116556|FG005|STARTED|Part A Washout 2 (7 Days)||3
8703883|NCT00925301|9749659|FG001|STARTED|6-Month Open-label (Stage 2)|Zero participants noted because participants had completed Stage 1.|0
9056896|NCT03627494|10116557|FG006|STARTED|Part A Washout 2 (7 Days)||0
9056897|NCT03627494|10116558|FG007|STARTED|Part A Washout 2 (7 Days)||0
9056898|NCT03627494|10116559|FG008|STARTED|Part A Washout 2 (7 Days)||0
9056899|NCT03627494|10116560|FG009|STARTED|Part A Washout 2 (7 Days)||0
9056900|NCT03627494|10116561|FG010|STARTED|Part A Washout 2 (7 Days)||0
9056901|NCT03627494|10116562|FG011|STARTED|Part A Washout 2 (7 Days)||0
9056902|NCT03627494|10116551|FG000|COMPLETED|Part A Washout 2 (7 Days)||2
9056903|NCT03627494|10116552|FG001|COMPLETED|Part A Washout 2 (7 Days)||3
9056904|NCT03627494|10116553|FG002|COMPLETED|Part A Washout 2 (7 Days)||2
9056905|NCT03627494|10116554|FG003|COMPLETED|Part A Washout 2 (7 Days)||3
9056906|NCT03627494|10116555|FG004|COMPLETED|Part A Washout 2 (7 Days)||3
9056907|NCT03627494|10116556|FG005|COMPLETED|Part A Washout 2 (7 Days)||3
9056908|NCT03627494|10116557|FG006|COMPLETED|Part A Washout 2 (7 Days)||0
9056909|NCT03627494|10116558|FG007|COMPLETED|Part A Washout 2 (7 Days)||0
9056910|NCT03627494|10116559|FG008|COMPLETED|Part A Washout 2 (7 Days)||0
9056911|NCT03627494|10116560|FG009|COMPLETED|Part A Washout 2 (7 Days)||0
9056912|NCT03627494|10116561|FG010|COMPLETED|Part A Washout 2 (7 Days)||0
9056913|NCT03627494|10116562|FG011|COMPLETED|Part A Washout 2 (7 Days)||0
9056914|NCT03627494|10116551|FG000|NOT COMPLETED|Part A Washout 2 (7 Days)||1
9056915|NCT03627494|10116552|FG001|NOT COMPLETED|Part A Washout 2 (7 Days)||0
9056916|NCT03627494|10116553|FG002|NOT COMPLETED|Part A Washout 2 (7 Days)||1
9056917|NCT03627494|10116554|FG003|NOT COMPLETED|Part A Washout 2 (7 Days)||0
9056918|NCT03627494|10116555|FG004|NOT COMPLETED|Part A Washout 2 (7 Days)||0
9056919|NCT03627494|10116556|FG005|NOT COMPLETED|Part A Washout 2 (7 Days)||0
9056920|NCT03627494|10116557|FG006|NOT COMPLETED|Part A Washout 2 (7 Days)||0
9056921|NCT03627494|10116558|FG007|NOT COMPLETED|Part A Washout 2 (7 Days)||0
9056922|NCT03627494|10116559|FG008|NOT COMPLETED|Part A Washout 2 (7 Days)||0
9056923|NCT03627494|10116560|FG009|NOT COMPLETED|Part A Washout 2 (7 Days)||0
9056924|NCT03627494|10116561|FG010|NOT COMPLETED|Part A Washout 2 (7 Days)||0
9056925|NCT03627494|10116562|FG011|NOT COMPLETED|Part A Washout 2 (7 Days)||0
9056926|NCT03627494|10116551|FG000|STARTED|Part A Period3(4days)+Follow-up(14days)||2
9056927|NCT03627494|10116552|FG001|STARTED|Part A Period3(4days)+Follow-up(14days)||3
9056928|NCT03627494|10116553|FG002|STARTED|Part A Period3(4days)+Follow-up(14days)||2
9056929|NCT03627494|10116554|FG003|STARTED|Part A Period3(4days)+Follow-up(14days)||3
9056930|NCT03627494|10116555|FG004|STARTED|Part A Period3(4days)+Follow-up(14days)||3
9056931|NCT03627494|10116556|FG005|STARTED|Part A Period3(4days)+Follow-up(14days)||3
9056932|NCT03627494|10116557|FG006|STARTED|Part A Period3(4days)+Follow-up(14days)||0
9056933|NCT03627494|10116558|FG007|STARTED|Part A Period3(4days)+Follow-up(14days)||0
9056934|NCT03627494|10116559|FG008|STARTED|Part A Period3(4days)+Follow-up(14days)||0
8703884|NCT00925301|9749660|FG002|STARTED|6-Month Open-label (Stage 2)|One participant (Migalastat [0-6 Months]) withdrew consent after completing Month 6.|63
9056935|NCT03627494|10116560|FG009|STARTED|Part A Period3(4days)+Follow-up(14days)||0
9056936|NCT03627494|10116561|FG010|STARTED|Part A Period3(4days)+Follow-up(14days)||0
9056937|NCT03627494|10116562|FG011|STARTED|Part A Period3(4days)+Follow-up(14days)||0
9056938|NCT03627494|10116551|FG000|COMPLETED|Part A Period3(4days)+Follow-up(14days)||2
9056939|NCT03627494|10116552|FG001|COMPLETED|Part A Period3(4days)+Follow-up(14days)||3
9056940|NCT03627494|10116553|FG002|COMPLETED|Part A Period3(4days)+Follow-up(14days)||2
9056941|NCT03627494|10116554|FG003|COMPLETED|Part A Period3(4days)+Follow-up(14days)||3
9056942|NCT03627494|10116555|FG004|COMPLETED|Part A Period3(4days)+Follow-up(14days)||3
9056943|NCT03627494|10116556|FG005|COMPLETED|Part A Period3(4days)+Follow-up(14days)||3
9056944|NCT03627494|10116557|FG006|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
9056945|NCT03627494|10116558|FG007|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
9056946|NCT03627494|10116559|FG008|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
9056947|NCT03627494|10116560|FG009|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
9056948|NCT03627494|10116561|FG010|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
9056949|NCT03627494|10116562|FG011|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
9056950|NCT03627494|10116551|FG000|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
9056951|NCT03627494|10116552|FG001|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
9056952|NCT03627494|10116553|FG002|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
9056953|NCT03627494|10116554|FG003|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
9056954|NCT03627494|10116555|FG004|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
9056955|NCT03627494|10116556|FG005|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
9056956|NCT03627494|10116557|FG006|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
9056957|NCT03627494|10116558|FG007|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
9056958|NCT03627494|10116559|FG008|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
9056959|NCT03627494|10116560|FG009|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
9056960|NCT03627494|10116561|FG010|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
9056961|NCT03627494|10116562|FG011|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
9056962|NCT03627494|10116551|FG000|STARTED|Part B (Maximum of 34 Days)||0
9056963|NCT03627494|10116552|FG001|STARTED|Part B (Maximum of 34 Days)||0
9056964|NCT03627494|10116553|FG002|STARTED|Part B (Maximum of 34 Days)||0
9056965|NCT03627494|10116554|FG003|STARTED|Part B (Maximum of 34 Days)||0
9056966|NCT03627494|10116555|FG004|STARTED|Part B (Maximum of 34 Days)||0
9056967|NCT03627494|10116556|FG005|STARTED|Part B (Maximum of 34 Days)||0
9056968|NCT03627494|10116557|FG006|STARTED|Part B (Maximum of 34 Days)||9
9056969|NCT03627494|10116558|FG007|STARTED|Part B (Maximum of 34 Days)||9
9056970|NCT03627494|10116559|FG008|STARTED|Part B (Maximum of 34 Days)||9
9056971|NCT03627494|10116560|FG009|STARTED|Part B (Maximum of 34 Days)||9
9056972|NCT03627494|10116561|FG010|STARTED|Part B (Maximum of 34 Days)||0
9056973|NCT03627494|10116562|FG011|STARTED|Part B (Maximum of 34 Days)||0
9056974|NCT03627494|10116551|FG000|COMPLETED|Part B (Maximum of 34 Days)||0
9056975|NCT03627494|10116552|FG001|COMPLETED|Part B (Maximum of 34 Days)||0
9056976|NCT03627494|10116553|FG002|COMPLETED|Part B (Maximum of 34 Days)||0
9056977|NCT03627494|10116554|FG003|COMPLETED|Part B (Maximum of 34 Days)||0
9056978|NCT03627494|10116555|FG004|COMPLETED|Part B (Maximum of 34 Days)||0
9056979|NCT03627494|10116556|FG005|COMPLETED|Part B (Maximum of 34 Days)||0
9056980|NCT03627494|10116557|FG006|COMPLETED|Part B (Maximum of 34 Days)||9
9056981|NCT03627494|10116558|FG007|COMPLETED|Part B (Maximum of 34 Days)||9
9056982|NCT03627494|10116559|FG008|COMPLETED|Part B (Maximum of 34 Days)||7
9056983|NCT03627494|10116560|FG009|COMPLETED|Part B (Maximum of 34 Days)||9
9056984|NCT03627494|10116561|FG010|COMPLETED|Part B (Maximum of 34 Days)||0
9056985|NCT03627494|10116562|FG011|COMPLETED|Part B (Maximum of 34 Days)||0
9056986|NCT03627494|10116551|FG000|NOT COMPLETED|Part B (Maximum of 34 Days)||0
9056987|NCT03627494|10116552|FG001|NOT COMPLETED|Part B (Maximum of 34 Days)||0
9056988|NCT03627494|10116553|FG002|NOT COMPLETED|Part B (Maximum of 34 Days)||0
9056989|NCT03627494|10116554|FG003|NOT COMPLETED|Part B (Maximum of 34 Days)||0
9056990|NCT03627494|10116555|FG004|NOT COMPLETED|Part B (Maximum of 34 Days)||0
9056991|NCT03627494|10116556|FG005|NOT COMPLETED|Part B (Maximum of 34 Days)||0
9056992|NCT03627494|10116557|FG006|NOT COMPLETED|Part B (Maximum of 34 Days)||0
9056993|NCT03627494|10116558|FG007|NOT COMPLETED|Part B (Maximum of 34 Days)||0
9056994|NCT03627494|10116559|FG008|NOT COMPLETED|Part B (Maximum of 34 Days)||2
9056995|NCT03627494|10116560|FG009|NOT COMPLETED|Part B (Maximum of 34 Days)||0
9056996|NCT03627494|10116561|FG010|NOT COMPLETED|Part B (Maximum of 34 Days)||0
9056997|NCT03627494|10116562|FG011|NOT COMPLETED|Part B (Maximum of 34 Days)||0
9056998|NCT03627494|10116551|FG000|STARTED|Part C Period 1 (4 Days)||0
9056999|NCT03627494|10116552|FG001|STARTED|Part C Period 1 (4 Days)||0
9057000|NCT03627494|10116553|FG002|STARTED|Part C Period 1 (4 Days)||0
9057001|NCT03627494|10116554|FG003|STARTED|Part C Period 1 (4 Days)||0
9057002|NCT03627494|10116555|FG004|STARTED|Part C Period 1 (4 Days)||0
9057003|NCT03627494|10116556|FG005|STARTED|Part C Period 1 (4 Days)||0
8703885|NCT00925301|9749661|FG003|STARTED|6-Month Open-label (Stage 2)|Zero participants noted because participants did not start the OLE yet.|0
9057004|NCT03627494|10116557|FG006|STARTED|Part C Period 1 (4 Days)||0
9057005|NCT03627494|10116558|FG007|STARTED|Part C Period 1 (4 Days)||0
9057006|NCT03627494|10116559|FG008|STARTED|Part C Period 1 (4 Days)||0
9057007|NCT03627494|10116560|FG009|STARTED|Part C Period 1 (4 Days)||0
9057008|NCT03627494|10116561|FG010|STARTED|Part C Period 1 (4 Days)||6
9057009|NCT03627494|10116562|FG011|STARTED|Part C Period 1 (4 Days)||6
9057010|NCT03627494|10116551|FG000|COMPLETED|Part C Period 1 (4 Days)||0
9057011|NCT03627494|10116552|FG001|COMPLETED|Part C Period 1 (4 Days)||0
9057012|NCT03627494|10116553|FG002|COMPLETED|Part C Period 1 (4 Days)||0
9057013|NCT03627494|10116554|FG003|COMPLETED|Part C Period 1 (4 Days)||0
9057014|NCT03627494|10116555|FG004|COMPLETED|Part C Period 1 (4 Days)||0
9057015|NCT03627494|10116556|FG005|COMPLETED|Part C Period 1 (4 Days)||0
9057016|NCT03627494|10116557|FG006|COMPLETED|Part C Period 1 (4 Days)||0
9057017|NCT03627494|10116558|FG007|COMPLETED|Part C Period 1 (4 Days)||0
9057018|NCT03627494|10116559|FG008|COMPLETED|Part C Period 1 (4 Days)||0
9057019|NCT03627494|10116560|FG009|COMPLETED|Part C Period 1 (4 Days)||0
9057020|NCT03627494|10116561|FG010|COMPLETED|Part C Period 1 (4 Days)||6
9057021|NCT03627494|10116562|FG011|COMPLETED|Part C Period 1 (4 Days)||6
9057022|NCT03627494|10116551|FG000|NOT COMPLETED|Part C Period 1 (4 Days)||0
9057023|NCT03627494|10116552|FG001|NOT COMPLETED|Part C Period 1 (4 Days)||0
9057024|NCT03627494|10116553|FG002|NOT COMPLETED|Part C Period 1 (4 Days)||0
9057025|NCT03627494|10116554|FG003|NOT COMPLETED|Part C Period 1 (4 Days)||0
9057026|NCT03627494|10116555|FG004|NOT COMPLETED|Part C Period 1 (4 Days)||0
9057027|NCT03627494|10116556|FG005|NOT COMPLETED|Part C Period 1 (4 Days)||0
9057028|NCT03627494|10116557|FG006|NOT COMPLETED|Part C Period 1 (4 Days)||0
9057029|NCT03627494|10116558|FG007|NOT COMPLETED|Part C Period 1 (4 Days)||0
9057030|NCT03627494|10116559|FG008|NOT COMPLETED|Part C Period 1 (4 Days)||0
9057031|NCT03627494|10116560|FG009|NOT COMPLETED|Part C Period 1 (4 Days)||0
9057032|NCT03627494|10116561|FG010|NOT COMPLETED|Part C Period 1 (4 Days)||0
9057033|NCT03627494|10116562|FG011|NOT COMPLETED|Part C Period 1 (4 Days)||0
9057034|NCT03627494|10116551|FG000|STARTED|Part C Washout 1 (7 Days)||0
9057035|NCT03627494|10116552|FG001|STARTED|Part C Washout 1 (7 Days)||0
9057036|NCT03627494|10116553|FG002|STARTED|Part C Washout 1 (7 Days)||0
9057037|NCT03627494|10116554|FG003|STARTED|Part C Washout 1 (7 Days)||0
9057038|NCT03627494|10116555|FG004|STARTED|Part C Washout 1 (7 Days)||0
9057039|NCT03627494|10116556|FG005|STARTED|Part C Washout 1 (7 Days)||0
9057040|NCT03627494|10116557|FG006|STARTED|Part C Washout 1 (7 Days)||0
9057041|NCT03627494|10116558|FG007|STARTED|Part C Washout 1 (7 Days)||0
9057042|NCT03627494|10116559|FG008|STARTED|Part C Washout 1 (7 Days)||0
9057043|NCT03627494|10116560|FG009|STARTED|Part C Washout 1 (7 Days)||0
9057044|NCT03627494|10116561|FG010|STARTED|Part C Washout 1 (7 Days)||6
8703886|NCT00925301|9749658|FG000|ITT-amenable|6-Month Open-label (Stage 2)||0
9057045|NCT03627494|10116562|FG011|STARTED|Part C Washout 1 (7 Days)||6
9057046|NCT03627494|10116551|FG000|COMPLETED|Part C Washout 1 (7 Days)||0
9057047|NCT03627494|10116552|FG001|COMPLETED|Part C Washout 1 (7 Days)||0
9057048|NCT03627494|10116553|FG002|COMPLETED|Part C Washout 1 (7 Days)||0
9057049|NCT03627494|10116554|FG003|COMPLETED|Part C Washout 1 (7 Days)||0
9057050|NCT03627494|10116555|FG004|COMPLETED|Part C Washout 1 (7 Days)||0
9057051|NCT03627494|10116556|FG005|COMPLETED|Part C Washout 1 (7 Days)||0
9057052|NCT03627494|10116557|FG006|COMPLETED|Part C Washout 1 (7 Days)||0
9057053|NCT03627494|10116558|FG007|COMPLETED|Part C Washout 1 (7 Days)||0
9057054|NCT03627494|10116559|FG008|COMPLETED|Part C Washout 1 (7 Days)||0
9057055|NCT03627494|10116560|FG009|COMPLETED|Part C Washout 1 (7 Days)||0
9057056|NCT03627494|10116561|FG010|COMPLETED|Part C Washout 1 (7 Days)||5
9057057|NCT03627494|10116562|FG011|COMPLETED|Part C Washout 1 (7 Days)||5
9057058|NCT03627494|10116551|FG000|NOT COMPLETED|Part C Washout 1 (7 Days)||0
9057059|NCT03627494|10116552|FG001|NOT COMPLETED|Part C Washout 1 (7 Days)||0
9057060|NCT03627494|10116553|FG002|NOT COMPLETED|Part C Washout 1 (7 Days)||0
9057061|NCT03627494|10116554|FG003|NOT COMPLETED|Part C Washout 1 (7 Days)||0
9057062|NCT03627494|10116555|FG004|NOT COMPLETED|Part C Washout 1 (7 Days)||0
9057063|NCT03627494|10116556|FG005|NOT COMPLETED|Part C Washout 1 (7 Days)||0
9057064|NCT03627494|10116557|FG006|NOT COMPLETED|Part C Washout 1 (7 Days)||0
9057065|NCT03627494|10116558|FG007|NOT COMPLETED|Part C Washout 1 (7 Days)||0
9057066|NCT03627494|10116559|FG008|NOT COMPLETED|Part C Washout 1 (7 Days)||0
9057067|NCT03627494|10116560|FG009|NOT COMPLETED|Part C Washout 1 (7 Days)||0
9057068|NCT03627494|10116561|FG010|NOT COMPLETED|Part C Washout 1 (7 Days)||1
9057069|NCT03627494|10116562|FG011|NOT COMPLETED|Part C Washout 1 (7 Days)||1
9057070|NCT03627494|10116551|FG000|STARTED|Part C Period2(4days)+Follow-up(14days)||0
9057071|NCT03627494|10116552|FG001|STARTED|Part C Period2(4days)+Follow-up(14days)||0
9057072|NCT03627494|10116553|FG002|STARTED|Part C Period2(4days)+Follow-up(14days)||0
9057073|NCT03627494|10116554|FG003|STARTED|Part C Period2(4days)+Follow-up(14days)||0
9057074|NCT03627494|10116555|FG004|STARTED|Part C Period2(4days)+Follow-up(14days)||0
9057075|NCT03627494|10116556|FG005|STARTED|Part C Period2(4days)+Follow-up(14days)||0
9057076|NCT03627494|10116557|FG006|STARTED|Part C Period2(4days)+Follow-up(14days)||0
9057077|NCT03627494|10116558|FG007|STARTED|Part C Period2(4days)+Follow-up(14days)||0
9057078|NCT03627494|10116559|FG008|STARTED|Part C Period2(4days)+Follow-up(14days)||0
9057079|NCT03627494|10116560|FG009|STARTED|Part C Period2(4days)+Follow-up(14days)||0
9057080|NCT03627494|10116561|FG010|STARTED|Part C Period2(4days)+Follow-up(14days)||5
9057081|NCT03627494|10116562|FG011|STARTED|Part C Period2(4days)+Follow-up(14days)||5
9057082|NCT03627494|10116551|FG000|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
9057083|NCT03627494|10116552|FG001|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
9057084|NCT03627494|10116553|FG002|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
9057085|NCT03627494|10116554|FG003|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
9057086|NCT03627494|10116555|FG004|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
9057087|NCT03627494|10116556|FG005|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
9057088|NCT03627494|10116557|FG006|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
9057089|NCT03627494|10116558|FG007|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
9057090|NCT03627494|10116559|FG008|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
9057091|NCT03627494|10116560|FG009|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
9057092|NCT03627494|10116561|FG010|COMPLETED|Part C Period2(4days)+Follow-up(14days)||5
9057093|NCT03627494|10116562|FG011|COMPLETED|Part C Period2(4days)+Follow-up(14days)||5
9057094|NCT03627494|10116551|FG000|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
9057095|NCT03627494|10116552|FG001|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
9057096|NCT03627494|10116553|FG002|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
9057097|NCT03627494|10116554|FG003|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
9057098|NCT03627494|10116555|FG004|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
9057099|NCT03627494|10116556|FG005|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
9057100|NCT03627494|10116557|FG006|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
9057101|NCT03627494|10116558|FG007|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
9057102|NCT03627494|10116559|FG008|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
9057103|NCT03627494|10116560|FG009|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
9057104|NCT03627494|10116561|FG010|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
9057105|NCT03627494|10116562|FG011|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
9057106|NCT03627767|10116604|FG000|STARTED|Open-label (OL) Run-in Period (12 Weeks)||1235
9057107|NCT03627767|10116605|FG001|STARTED|Open-label (OL) Run-in Period (12 Weeks)||0
9057108|NCT03627767|10116606|FG002|STARTED|Open-label (OL) Run-in Period (12 Weeks)||0
9057109|NCT03627767|10116607|FG003|STARTED|Open-label (OL) Run-in Period (12 Weeks)||0
9057110|NCT03627767|10116608|FG004|STARTED|Open-label (OL) Run-in Period (12 Weeks)||0
9057111|NCT03627767|10116604|FG000|Treated|Open-label (OL) Run-in Period (12 Weeks)||1233
9057112|NCT03627767|10116605|FG001|Treated|Open-label (OL) Run-in Period (12 Weeks)||0
9057113|NCT03627767|10116606|FG002|Treated|Open-label (OL) Run-in Period (12 Weeks)||0
9057114|NCT03627767|10116607|FG003|Treated|Open-label (OL) Run-in Period (12 Weeks)||0
9057115|NCT03627767|10116608|FG004|Treated|Open-label (OL) Run-in Period (12 Weeks)||0
9057116|NCT03627767|10116604|FG000|COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||798
9057117|NCT03627767|10116605|FG001|COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||0
9057118|NCT03627767|10116606|FG002|COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||0
9057119|NCT03627767|10116607|FG003|COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||0
9057120|NCT03627767|10116608|FG004|COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||0
9057121|NCT03627767|10116604|FG000|NOT COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||437
9057122|NCT03627767|10116605|FG001|NOT COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||0
9057123|NCT03627767|10116606|FG002|NOT COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||0
9057124|NCT03627767|10116607|FG003|NOT COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||0
9057125|NCT03627767|10116608|FG004|NOT COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||0
9057126|NCT03627767|10116604|FG000|STARTED|Double-blind Treatment Period (40 Weeks)|Participants did not enter into the DB period.|0
9057127|NCT03627767|10116605|FG001|STARTED|Double-blind Treatment Period (40 Weeks)|Participants who met the pre-defined criteria for DB.|267
9057128|NCT03627767|10116606|FG002|STARTED|Double-blind Treatment Period (40 Weeks)|Participants who met the pre-defined criteria for DB.|265
9057129|NCT03627767|10116607|FG003|STARTED|Double-blind Treatment Period (40 Weeks)|Participants who met the pre-defined criteria for DB.|266
8703887|NCT00925301|9749659|FG001|ITT-amenable|6-Month Open-label (Stage 2)||0
8703888|NCT00925301|9749660|FG002|ITT-amenable|6-Month Open-label (Stage 2)||47
8703889|NCT00925301|9749661|FG003|ITT-amenable|6-Month Open-label (Stage 2)||0
8703890|NCT00925301|9749658|FG000|COMPLETED|6-Month Open-label (Stage 2)||0
8703891|NCT00925301|9749659|FG001|COMPLETED|6-Month Open-label (Stage 2)||0
8703892|NCT00925301|9749660|FG002|COMPLETED|6-Month Open-label (Stage 2)||60
8703893|NCT00925301|9749661|FG003|COMPLETED|6-Month Open-label (Stage 2)||0
8703894|NCT00925301|9749658|FG000|NOT COMPLETED|6-Month Open-label (Stage 2)||0
8703895|NCT00925301|9749659|FG001|NOT COMPLETED|6-Month Open-label (Stage 2)||0
8703896|NCT00925301|9749660|FG002|NOT COMPLETED|6-Month Open-label (Stage 2)||3
8703897|NCT00925301|9749661|FG003|NOT COMPLETED|6-Month Open-label (Stage 2)||0
8703898|NCT00925301|9749658|FG000|STARTED|12-Month Open-label Extension (Optional)|Zero participants noted because participants had completed Stage 1.|0
8703899|NCT00925301|9749659|FG001|STARTED|12-Month Open-label Extension (Optional)|Zero participants noted because participants had completed Stage 1.|0
8703900|NCT00925301|9749660|FG002|STARTED|12-Month Open-label Extension (Optional)|Zero participants noted because participants had completed Stage 2.|0
8703901|NCT00925301|9749661|FG003|STARTED|12-Month Open-label Extension (Optional)|The OLE was optional for those who completed Stage 2. Reasons for not entering were not recorded.|57
9057130|NCT03627767|10116608|FG004|STARTED|Double-blind Treatment Period (40 Weeks)||0
9057131|NCT03627767|10116604|FG000|Participants Entered Rescue Period|Double-blind Treatment Period (40 Weeks)||0
9057132|NCT03627767|10116605|FG001|Participants Entered Rescue Period|Double-blind Treatment Period (40 Weeks)||208
9057133|NCT03627767|10116606|FG002|Participants Entered Rescue Period|Double-blind Treatment Period (40 Weeks)||109
9057134|NCT03627767|10116607|FG003|Participants Entered Rescue Period|Double-blind Treatment Period (40 Weeks)||44
9057135|NCT03627767|10116608|FG004|Participants Entered Rescue Period|Double-blind Treatment Period (40 Weeks)||0
9057136|NCT03627767|10116604|FG000|Completed After Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||0
9057137|NCT03627767|10116605|FG001|Completed After Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||201
9057138|NCT03627767|10116606|FG002|Completed After Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||99
9057139|NCT03627767|10116607|FG003|Completed After Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||41
9057140|NCT03627767|10116608|FG004|Completed After Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||0
9057141|NCT03627767|10116604|FG000|Completed Without Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||0
9057142|NCT03627767|10116605|FG001|Completed Without Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||43
9057143|NCT03627767|10116606|FG002|Completed Without Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||134
9057144|NCT03627767|10116607|FG003|Completed Without Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||187
9057145|NCT03627767|10116608|FG004|Completed Without Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||0
9057146|NCT03627767|10116604|FG000|COMPLETED|Double-blind Treatment Period (40 Weeks)||0
9057147|NCT03627767|10116605|FG001|COMPLETED|Double-blind Treatment Period (40 Weeks)|208 entered RP+43 completed study in DB period|251
9057148|NCT03627767|10116606|FG002|COMPLETED|Double-blind Treatment Period (40 Weeks)|109 entered RP+134 completed study in DB period|243
9057149|NCT03627767|10116607|FG003|COMPLETED|Double-blind Treatment Period (40 Weeks)|44 entered RP+187 completed study in DB period|231
9057150|NCT03627767|10116608|FG004|COMPLETED|Double-blind Treatment Period (40 Weeks)||0
9057151|NCT03627767|10116604|FG000|NOT COMPLETED|Double-blind Treatment Period (40 Weeks)||0
9057152|NCT03627767|10116605|FG001|NOT COMPLETED|Double-blind Treatment Period (40 Weeks)||16
9057153|NCT03627767|10116606|FG002|NOT COMPLETED|Double-blind Treatment Period (40 Weeks)||22
9057154|NCT03627767|10116607|FG003|NOT COMPLETED|Double-blind Treatment Period (40 Weeks)||35
9057155|NCT03627767|10116608|FG004|NOT COMPLETED|Double-blind Treatment Period (40 Weeks)||0
9057156|NCT03627767|10116604|FG000|STARTED|Open-label Rescue Period (12 Weeks)||0
9057157|NCT03627767|10116605|FG001|STARTED|Open-label Rescue Period (12 Weeks)|Participants did not enter into the OL- Rescue Period.|0
9057158|NCT03627767|10116606|FG002|STARTED|Open-label Rescue Period (12 Weeks)|Participants did not enter into the OL- Rescue Period.|0
9057159|NCT03627767|10116607|FG003|STARTED|Open-label Rescue Period (12 Weeks)|Participants did not enter into the OL- Rescue Period.|0
8578768|NCT00178256|9611903|FG001|COMPLETED|Overall Study||6
8578769|NCT00178256|9611904|FG002|COMPLETED|Overall Study||6
8578770|NCT00178256|9611905|FG003|COMPLETED|Overall Study||16
9057160|NCT03627767|10116608|FG004|STARTED|Open-label Rescue Period (12 Weeks)|Participants who met the pre-defined criteria for OL- Rescue Period.|361
9057161|NCT03627767|10116604|FG000|Met Protocol-defined Flare Criteria|Open-label Rescue Period (12 Weeks)||0
9057162|NCT03627767|10116605|FG001|Met Protocol-defined Flare Criteria|Open-label Rescue Period (12 Weeks)||0
9057163|NCT03627767|10116606|FG002|Met Protocol-defined Flare Criteria|Open-label Rescue Period (12 Weeks)||0
9057164|NCT03627767|10116607|FG003|Met Protocol-defined Flare Criteria|Open-label Rescue Period (12 Weeks)||0
9057165|NCT03627767|10116608|FG004|Met Protocol-defined Flare Criteria|Open-label Rescue Period (12 Weeks)||351
9057166|NCT03627767|10116604|FG000|COMPLETED|Open-label Rescue Period (12 Weeks)||0
9057167|NCT03627767|10116605|FG001|COMPLETED|Open-label Rescue Period (12 Weeks)||0
9057168|NCT03627767|10116606|FG002|COMPLETED|Open-label Rescue Period (12 Weeks)||0
9057169|NCT03627767|10116607|FG003|COMPLETED|Open-label Rescue Period (12 Weeks)||0
9057170|NCT03627767|10116608|FG004|COMPLETED|Open-label Rescue Period (12 Weeks)||341
9057171|NCT03627767|10116604|FG000|NOT COMPLETED|Open-label Rescue Period (12 Weeks)||0
9057172|NCT03627767|10116605|FG001|NOT COMPLETED|Open-label Rescue Period (12 Weeks)||0
9057173|NCT03627767|10116606|FG002|NOT COMPLETED|Open-label Rescue Period (12 Weeks)||0
9057174|NCT03627767|10116607|FG003|NOT COMPLETED|Open-label Rescue Period (12 Weeks)||0
9057175|NCT03627767|10116608|FG004|NOT COMPLETED|Open-label Rescue Period (12 Weeks)||20
9057176|NCT03627832|10116621|FG000|STARTED|Overall Study||28
9057177|NCT03627832|10116622|FG001|STARTED|Overall Study||28
9057178|NCT03627832|10116621|FG000|COMPLETED|Overall Study||18
9057179|NCT03627832|10116622|FG001|COMPLETED|Overall Study||27
9057180|NCT03627832|10116621|FG000|NOT COMPLETED|Overall Study||10
9057181|NCT03627832|10116622|FG001|NOT COMPLETED|Overall Study||1
9057182|NCT03628417|10116628|FG000|STARTED|Overall Study||7
9057183|NCT03628417|10116629|FG001|STARTED|Overall Study||7
9057184|NCT03628417|10116628|FG000|Day 0|Overall Study||7
9057185|NCT03628417|10116629|FG001|Day 0|Overall Study||7
9057186|NCT03628417|10116628|FG000|Day 7|Overall Study||7
9057187|NCT03628417|10116629|FG001|Day 7|Overall Study||7
9057188|NCT03628417|10116628|FG000|Day 15|Overall Study||7
9057189|NCT03628417|10116629|FG001|Day 15|Overall Study||7
9057190|NCT03628417|10116628|FG000|Day 30|Overall Study||7
9057191|NCT03628417|10116629|FG001|Day 30|Overall Study||7
9057192|NCT03628417|10116628|FG000|Day 60|Overall Study||7
9057193|NCT03628417|10116629|FG001|Day 60|Overall Study||7
9057194|NCT03628417|10116628|FG000|Day 90|Overall Study||7
9057195|NCT03628417|10116629|FG001|Day 90|Overall Study||7
9057196|NCT03628417|10116628|FG000|Day 180|Overall Study||7
9057197|NCT03628417|10116629|FG001|Day 180|Overall Study||7
9057198|NCT03628417|10116628|FG000|COMPLETED|Overall Study|One patient died and 3 more Ca electroporated lesions were removed before the one-year closing visit|6
9057199|NCT03628417|10116629|FG001|COMPLETED|Overall Study|One patient died before the one-year closing visit,this is why decreased the number of metastases|6
9057200|NCT03628417|10116628|FG000|NOT COMPLETED|Overall Study||1
9057201|NCT03628417|10116629|FG001|NOT COMPLETED|Overall Study||1
9057202|NCT03628456|10116639|FG000|STARTED|Overall Study||10
9057203|NCT03628456|10116639|FG000|COMPLETED|Overall Study||10
9057204|NCT03628456|10116639|FG000|NOT COMPLETED|Overall Study||0
9057205|NCT03628508|10116647|FG000|STARTED|Overall Study||40
9057206|NCT03628508|10116647|FG000|COMPLETED|Overall Study||39
9057207|NCT03628508|10116647|FG000|NOT COMPLETED|Overall Study||1
9057208|NCT03628599|10116653|FG000|STARTED|Overall Study||18
9057209|NCT03628599|10116654|FG001|STARTED|Overall Study||19
9057210|NCT03628599|10116653|FG000|COMPLETED|Overall Study||18
9057211|NCT03628599|10116654|FG001|COMPLETED|Overall Study||18
9057212|NCT03628599|10116653|FG000|NOT COMPLETED|Overall Study||0
9057213|NCT03628599|10116654|FG001|NOT COMPLETED|Overall Study||1
9057214|NCT03628885|10116667|FG000|STARTED|Overall Study||306
9057215|NCT03628885|10116668|FG001|STARTED|Overall Study||299
9057216|NCT03628885|10116669|FG002|STARTED|Overall Study||303
9057217|NCT03628885|10116667|FG000|COMPLETED|Overall Study||267
9057218|NCT03628885|10116668|FG001|COMPLETED|Overall Study||252
9057219|NCT03628885|10116669|FG002|COMPLETED|Overall Study||243
9057220|NCT03628885|10116667|FG000|NOT COMPLETED|Overall Study||39
9057221|NCT03628885|10116668|FG001|NOT COMPLETED|Overall Study||47
9057222|NCT03628885|10116669|FG002|NOT COMPLETED|Overall Study||60
9057223|NCT03628898|10116677|FG000|STARTED|Overall Study||27
9057224|NCT03628898|10116677|FG000|COMPLETED|Overall Study||26
9057225|NCT03628898|10116677|FG000|NOT COMPLETED|Overall Study||1
8703902|NCT00925301|9749658|FG000|ITT-amenable|12-Month Open-label Extension (Optional)||0
8703903|NCT00925301|9749659|FG001|ITT-amenable|12-Month Open-label Extension (Optional)||0
8703904|NCT00925301|9749660|FG002|ITT-amenable|12-Month Open-label Extension (Optional)||0
8703905|NCT00925301|9749661|FG003|ITT-amenable|12-Month Open-label Extension (Optional)||42
8703906|NCT00925301|9749658|FG000|COMPLETED|12-Month Open-label Extension (Optional)||0
8703907|NCT00925301|9749659|FG001|COMPLETED|12-Month Open-label Extension (Optional)||0
8703908|NCT00925301|9749660|FG002|COMPLETED|12-Month Open-label Extension (Optional)||0
8703909|NCT00925301|9749661|FG003|COMPLETED|12-Month Open-label Extension (Optional)||54
8703910|NCT00925301|9749658|FG000|NOT COMPLETED|12-Month Open-label Extension (Optional)||0
8703911|NCT00925301|9749659|FG001|NOT COMPLETED|12-Month Open-label Extension (Optional)||0
8703912|NCT00925301|9749660|FG002|NOT COMPLETED|12-Month Open-label Extension (Optional)||0
8703913|NCT00925301|9749661|FG003|NOT COMPLETED|12-Month Open-label Extension (Optional)||3
8703914|NCT00925353|9749672|FG000|STARTED|Overall Study||13
8703915|NCT00925353|9749672|FG000|COMPLETED|Overall Study||10
8703916|NCT00925353|9749672|FG000|NOT COMPLETED|Overall Study||3
8703917|NCT00925522|9749676|FG000|STARTED|Overall Study||20
8703918|NCT00925522|9749676|FG000|COMPLETED|Overall Study||0
8703919|NCT00925522|9749676|FG000|NOT COMPLETED|Overall Study||20
8703920|NCT00925587|9749682|FG000|STARTED|Overall Study||178
8703921|NCT00925587|9749683|FG001|STARTED|Overall Study||180
8703922|NCT00925587|9749682|FG000|COMPLETED|Overall Study||142
8703923|NCT00925587|9749683|FG001|COMPLETED|Overall Study||155
8703924|NCT00925587|9749682|FG000|NOT COMPLETED|Overall Study||36
8703925|NCT00925587|9749683|FG001|NOT COMPLETED|Overall Study||25
8703926|NCT00925600|9749691|FG000|STARTED|Overall Study||386
8703927|NCT00925600|9749692|FG001|STARTED|Overall Study||383
8703928|NCT00925600|9749691|FG000|Received Treatment|Overall Study|Three participants received at least 1 dose of denosumab in error|383
8703929|NCT00925600|9749692|FG001|Received Treatment|Overall Study||382
8703930|NCT00925600|9749691|FG000|COMPLETED|Overall Study||354
8703931|NCT00925600|9749692|FG001|COMPLETED|Overall Study||355
8703932|NCT00925600|9749691|FG000|NOT COMPLETED|Overall Study||32
9057226|NCT03628924|10116684|FG000|STARTED|Placebo Controlled Period (Week 0 - 16)||62
9057227|NCT03628924|10116685|FG001|STARTED|Placebo Controlled Period (Week 0 - 16)||59
9057228|NCT03628924|10116686|FG002|STARTED|Placebo Controlled Period (Week 0 - 16)||60
9057229|NCT03628924|10116687|FG003|STARTED|Placebo Controlled Period (Week 0 - 16)||0
9057230|NCT03628924|10116688|FG004|STARTED|Placebo Controlled Period (Week 0 - 16)||0
9057231|NCT03628924|10116689|FG005|STARTED|Placebo Controlled Period (Week 0 - 16)||0
8703933|NCT00925600|9749692|FG001|NOT COMPLETED|Overall Study||28
8703934|NCT00925704|9749708|FG000|STARTED|First Intervention||6
8812733|NCT01521494|9865762|FG000|STARTED|Overall Study||39
9057232|NCT03628924|10116690|FG006|STARTED|Placebo Controlled Period (Week 0 - 16)||0
9057233|NCT03628924|10116684|FG000|COMPLETED|Placebo Controlled Period (Week 0 - 16)||56
9057234|NCT03628924|10116685|FG001|COMPLETED|Placebo Controlled Period (Week 0 - 16)||56
9057235|NCT03628924|10116686|FG002|COMPLETED|Placebo Controlled Period (Week 0 - 16)||57
9057236|NCT03628924|10116687|FG003|COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
9057237|NCT03628924|10116688|FG004|COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
9057238|NCT03628924|10116689|FG005|COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
9057239|NCT03628924|10116690|FG006|COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
9057240|NCT03628924|10116684|FG000|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||6
9057241|NCT03628924|10116685|FG001|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||3
9057242|NCT03628924|10116686|FG002|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||3
9057243|NCT03628924|10116687|FG003|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
9057244|NCT03628924|10116688|FG004|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
9057245|NCT03628924|10116689|FG005|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
9057246|NCT03628924|10116690|FG006|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
9057247|NCT03628924|10116684|FG000|STARTED|Active Treatment Period (Week 16-48)||0
9057248|NCT03628924|10116685|FG001|STARTED|Active Treatment Period (Week 16-48)||0
9057249|NCT03628924|10116686|FG002|STARTED|Active Treatment Period (Week 16-48)||0
9057250|NCT03628924|10116687|FG003|STARTED|Active Treatment Period (Week 16-48)||28
9057251|NCT03628924|10116688|FG004|STARTED|Active Treatment Period (Week 16-48)||28
9057252|NCT03628924|10116689|FG005|STARTED|Active Treatment Period (Week 16-48)||56
9057253|NCT03628924|10116690|FG006|STARTED|Active Treatment Period (Week 16-48)||57
9057254|NCT03628924|10116684|FG000|COMPLETED|Active Treatment Period (Week 16-48)||0
9057255|NCT03628924|10116685|FG001|COMPLETED|Active Treatment Period (Week 16-48)||0
9057256|NCT03628924|10116686|FG002|COMPLETED|Active Treatment Period (Week 16-48)||0
9057257|NCT03628924|10116687|FG003|COMPLETED|Active Treatment Period (Week 16-48)||20
9057258|NCT03628924|10116688|FG004|COMPLETED|Active Treatment Period (Week 16-48)||24
9057259|NCT03628924|10116689|FG005|COMPLETED|Active Treatment Period (Week 16-48)||43
9057260|NCT03628924|10116690|FG006|COMPLETED|Active Treatment Period (Week 16-48)||46
9057261|NCT03628924|10116684|FG000|NOT COMPLETED|Active Treatment Period (Week 16-48)||0
9057262|NCT03628924|10116685|FG001|NOT COMPLETED|Active Treatment Period (Week 16-48)||0
9057263|NCT03628924|10116686|FG002|NOT COMPLETED|Active Treatment Period (Week 16-48)||0
9057264|NCT03628924|10116687|FG003|NOT COMPLETED|Active Treatment Period (Week 16-48)||8
9057265|NCT03628924|10116688|FG004|NOT COMPLETED|Active Treatment Period (Week 16-48)||4
9057266|NCT03628924|10116689|FG005|NOT COMPLETED|Active Treatment Period (Week 16-48)||13
9057267|NCT03628924|10116690|FG006|NOT COMPLETED|Active Treatment Period (Week 16-48)||11
9057268|NCT03629028|10116704|FG000|STARTED|Overall Study||141
9057269|NCT03629028|10116705|FG001|STARTED|Overall Study||141
9057270|NCT03629028|10116704|FG000|COMPLETED|Overall Study||109
9057271|NCT03629028|10116705|FG001|COMPLETED|Overall Study||116
9057272|NCT03629028|10116704|FG000|NOT COMPLETED|Overall Study||32
9057273|NCT03629028|10116705|FG001|NOT COMPLETED|Overall Study||25
9057274|NCT03629041|10116721|FG000|STARTED|Visit 1||4
9057275|NCT03629041|10116722|FG001|STARTED|Visit 1||4
9057276|NCT03629041|10116723|FG002|STARTED|Visit 1||4
9057277|NCT03629041|10116724|FG003|STARTED|Visit 1||4
9057278|NCT03629041|10116721|FG000|COMPLETED|Visit 1||4
9057279|NCT03629041|10116722|FG001|COMPLETED|Visit 1||4
9057280|NCT03629041|10116723|FG002|COMPLETED|Visit 1||4
9057281|NCT03629041|10116724|FG003|COMPLETED|Visit 1||4
9057282|NCT03629041|10116721|FG000|NOT COMPLETED|Visit 1||0
9057283|NCT03629041|10116722|FG001|NOT COMPLETED|Visit 1||0
9057284|NCT03629041|10116723|FG002|NOT COMPLETED|Visit 1||0
9057285|NCT03629041|10116724|FG003|NOT COMPLETED|Visit 1||0
9057286|NCT03629041|10116721|FG000|STARTED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
9057287|NCT03629041|10116722|FG001|STARTED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
9057288|NCT03629041|10116723|FG002|STARTED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
9057289|NCT03629041|10116724|FG003|STARTED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
9057290|NCT03629041|10116721|FG000|COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
9057291|NCT03629041|10116722|FG001|COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||3
9057292|NCT03629041|10116723|FG002|COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
9057293|NCT03629041|10116724|FG003|COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
9057294|NCT03629041|10116721|FG000|NOT COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||0
9057295|NCT03629041|10116722|FG001|NOT COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||1
9057296|NCT03629041|10116723|FG002|NOT COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||0
9057297|NCT03629041|10116724|FG003|NOT COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||0
9057298|NCT03629054|10116744|FG000|STARTED|Period 1 (4 Days)|Started this period|15
9057299|NCT03629054|10116745|FG001|STARTED|Period 1 (4 Days)|Started this period|15
9057300|NCT03629054|10116744|FG000|COMPLETED|Period 1 (4 Days)||15
9057301|NCT03629054|10116745|FG001|COMPLETED|Period 1 (4 Days)||15
9057302|NCT03629054|10116744|FG000|NOT COMPLETED|Period 1 (4 Days)||0
9057303|NCT03629054|10116745|FG001|NOT COMPLETED|Period 1 (4 Days)||0
9057304|NCT03629054|10116744|FG000|STARTED|Wasout Period (35 Days)|Started this period|15
9057305|NCT03629054|10116745|FG001|STARTED|Wasout Period (35 Days)|Started this period|15
9057306|NCT03629054|10116744|FG000|COMPLETED|Wasout Period (35 Days)||15
9057307|NCT03629054|10116745|FG001|COMPLETED|Wasout Period (35 Days)||15
9057308|NCT03629054|10116744|FG000|NOT COMPLETED|Wasout Period (35 Days)||0
9057309|NCT03629054|10116745|FG001|NOT COMPLETED|Wasout Period (35 Days)||0
9057310|NCT03629054|10116744|FG000|STARTED|Period 2 (4 Days)|Started this period|15
9057311|NCT03629054|10116745|FG001|STARTED|Period 2 (4 Days)|Started this period|15
9057312|NCT03629054|10116744|FG000|Treated|Period 2 (4 Days)||15
9057313|NCT03629054|10116745|FG001|Treated|Period 2 (4 Days)||14
9057314|NCT03629054|10116744|FG000|COMPLETED|Period 2 (4 Days)||15
9057315|NCT03629054|10116745|FG001|COMPLETED|Period 2 (4 Days)||14
9057316|NCT03629054|10116744|FG000|NOT COMPLETED|Period 2 (4 Days)||0
9057317|NCT03629054|10116745|FG001|NOT COMPLETED|Period 2 (4 Days)||1
9057318|NCT03629184|10116753|FG000|STARTED|Overall Study||115
9057319|NCT03629184|10116754|FG001|STARTED|Overall Study||58
9057320|NCT03629184|10116753|FG000|COMPLETED|Overall Study||112
9057321|NCT03629184|10116754|FG001|COMPLETED|Overall Study||57
9057322|NCT03629184|10116753|FG000|NOT COMPLETED|Overall Study||3
9057323|NCT03629184|10116754|FG001|NOT COMPLETED|Overall Study||1
9057324|NCT03629249|10116763|FG000|STARTED|Overall Study||201
9057325|NCT03629249|10116764|FG001|STARTED|Overall Study||201
9057326|NCT03629249|10116765|FG002|STARTED|Overall Study||202
9057327|NCT03629249|10116763|FG000|Full Analysis Set (FAS)|Overall Study||201
9057328|NCT03629249|10116764|FG001|Full Analysis Set (FAS)|Overall Study||200
9057329|NCT03629249|10116765|FG002|Full Analysis Set (FAS)|Overall Study||201
9057330|NCT03629249|10116763|FG000|Safety Set (SAF)|Overall Study||201
9057331|NCT03629249|10116764|FG001|Safety Set (SAF)|Overall Study||200
9057332|NCT03629249|10116765|FG002|Safety Set (SAF)|Overall Study||201
9057333|NCT03629249|10116763|FG000|COMPLETED|Overall Study||0
9057334|NCT03629249|10116764|FG001|COMPLETED|Overall Study||0
9057335|NCT03629249|10116765|FG002|COMPLETED|Overall Study||0
9057336|NCT03629249|10116763|FG000|NOT COMPLETED|Overall Study||201
9057337|NCT03629249|10116764|FG001|NOT COMPLETED|Overall Study||201
9057338|NCT03629249|10116765|FG002|NOT COMPLETED|Overall Study||202
9057339|NCT03629535|10116773|FG000|STARTED|Overall Study||8
9057340|NCT03629535|10116773|FG000|COMPLETED|Overall Study||8
9057341|NCT03629535|10116773|FG000|NOT COMPLETED|Overall Study||0
9057342|NCT03629886|10116779|FG000|STARTED|Overall Study||1671
9057343|NCT03629886|10116780|FG001|STARTED|Overall Study||1866
9057344|NCT03629886|10116779|FG000|COMPLETED|Overall Study||1671
9057345|NCT03629886|10116780|FG001|COMPLETED|Overall Study||1686
9057346|NCT03629886|10116779|FG000|NOT COMPLETED|Overall Study||0
9057347|NCT03629886|10116780|FG001|NOT COMPLETED|Overall Study||180
9057348|NCT03629925|10116789|FG000|STARTED|Overall Study||179
9057349|NCT03629925|10116790|FG001|STARTED|Overall Study||178
9057350|NCT03629925|10116789|FG000|COMPLETED|Overall Study||0
9057351|NCT03629925|10116790|FG001|COMPLETED|Overall Study||0
9057352|NCT03629925|10116789|FG000|NOT COMPLETED|Overall Study||179
9057353|NCT03629925|10116790|FG001|NOT COMPLETED|Overall Study||178
9057354|NCT03630016|10116796|FG000|STARTED|Overall Study||11
9057355|NCT03630016|10116796|FG000|COMPLETED|Overall Study||10
9057356|NCT03630016|10116796|FG000|NOT COMPLETED|Overall Study||1
9057357|NCT03630185|10116802|FG000|STARTED|Overall Study||4
9057358|NCT03630185|10116803|FG001|STARTED|Overall Study||4
9057359|NCT03630185|10116802|FG000|30 Day Follow up|Overall Study||1
9057360|NCT03630185|10116803|FG001|30 Day Follow up|Overall Study||1
9057361|NCT03630185|10116802|FG000|90 Day Follow up|Overall Study||0
9057362|NCT03630185|10116803|FG001|90 Day Follow up|Overall Study||1
9057363|NCT03630185|10116802|FG000|6 Month Follow up|Overall Study||0
9057364|NCT03630185|10116803|FG001|6 Month Follow up|Overall Study||0
9057365|NCT03630185|10116802|FG000|COMPLETED|Overall Study||0
9057366|NCT03630185|10116803|FG001|COMPLETED|Overall Study||0
9057367|NCT03630185|10116802|FG000|NOT COMPLETED|Overall Study||4
9057368|NCT03630185|10116803|FG001|NOT COMPLETED|Overall Study||4
9057369|NCT03630198|10116811|FG000|STARTED|Overall Study||13
9057370|NCT03630198|10116812|FG001|STARTED|Overall Study||18
9057371|NCT03630198|10116811|FG000|COMPLETED|Overall Study||13
9057372|NCT03630198|10116812|FG001|COMPLETED|Overall Study||18
9057373|NCT03630198|10116811|FG000|NOT COMPLETED|Overall Study||0
9057374|NCT03630198|10116812|FG001|NOT COMPLETED|Overall Study||0
9057375|NCT03630302|10116818|FG000|STARTED|Surgery||10
9057376|NCT03630302|10116818|FG000|COMPLETED|Surgery||9
9057377|NCT03630302|10116818|FG000|NOT COMPLETED|Surgery||1
9057378|NCT03630302|10116818|FG000|STARTED|3 Month Visit||9
9057379|NCT03630302|10116818|FG000|COMPLETED|3 Month Visit||7
9057380|NCT03630302|10116818|FG000|NOT COMPLETED|3 Month Visit||2
9057381|NCT03630302|10116818|FG000|STARTED|Data Post Analyses||7
9057382|NCT03630302|10116818|FG000|COMPLETED|Data Post Analyses||5
9057383|NCT03630302|10116818|FG000|NOT COMPLETED|Data Post Analyses||2
9057384|NCT03630679|10116824|FG000|STARTED|Overall Study||20
9057385|NCT03630679|10116825|FG001|STARTED|Overall Study||25
9057386|NCT03630679|10116824|FG000|COMPLETED|Overall Study||13
9057387|NCT03630679|10116825|FG001|COMPLETED|Overall Study||13
9057388|NCT03630679|10116824|FG000|NOT COMPLETED|Overall Study||7
9057389|NCT03630679|10116825|FG001|NOT COMPLETED|Overall Study||12
9057390|NCT03631355|10116833|FG000|STARTED|Overall Study||55
9057391|NCT03631355|10116834|FG001|STARTED|Overall Study||55
9057392|NCT03631355|10116833|FG000|COMPLETED|Overall Study||54
9057393|NCT03631355|10116834|FG001|COMPLETED|Overall Study||53
9057394|NCT03631355|10116833|FG000|NOT COMPLETED|Overall Study||1
9057395|NCT03631355|10116834|FG001|NOT COMPLETED|Overall Study||2
9057396|NCT03631433|10116842|FG000|STARTED|Overall Study||49
9057397|NCT03631433|10116843|FG001|STARTED|Overall Study||53
9057398|NCT03631433|10116842|FG000|COMPLETED|Overall Study||49
9057399|NCT03631433|10116843|FG001|COMPLETED|Overall Study||53
9057400|NCT03631433|10116842|FG000|NOT COMPLETED|Overall Study||0
9057401|NCT03631433|10116843|FG001|NOT COMPLETED|Overall Study||0
9057402|NCT03631732|10116851|FG000|STARTED|Randomized Phase Up to Week 24||331
9057403|NCT03631732|10116852|FG001|STARTED|Randomized Phase Up to Week 24||165
9057404|NCT03631732|10116851|FG000|COMPLETED|Randomized Phase Up to Week 24||324
9057405|NCT03631732|10116852|FG001|COMPLETED|Randomized Phase Up to Week 24||163
9057406|NCT03631732|10116851|FG000|NOT COMPLETED|Randomized Phase Up to Week 24||7
9057407|NCT03631732|10116852|FG001|NOT COMPLETED|Randomized Phase Up to Week 24||2
9057408|NCT03631732|10116851|FG000|STARTED|B/F/TAF Treatment Phase (After Week 24)|5 participants completed 24 weeks of the study, but did not receive study treatment after Week 24.|319
9057409|NCT03631732|10116852|FG001|STARTED|B/F/TAF Treatment Phase (After Week 24)||163
9057410|NCT03631732|10116851|FG000|COMPLETED|B/F/TAF Treatment Phase (After Week 24)||303
9057411|NCT03631732|10116852|FG001|COMPLETED|B/F/TAF Treatment Phase (After Week 24)||158
9057412|NCT03631732|10116851|FG000|NOT COMPLETED|B/F/TAF Treatment Phase (After Week 24)||16
9057413|NCT03631732|10116852|FG001|NOT COMPLETED|B/F/TAF Treatment Phase (After Week 24)||5
9057414|NCT03631927|10116862|FG000|STARTED|Overall Study||5094
9057415|NCT03631927|10116862|FG000|COMPLETED|Overall Study||4669
9057416|NCT03631927|10116862|FG000|NOT COMPLETED|Overall Study||425
9057417|NCT03632083|10116866|FG000|STARTED|First Intervention||5
9057418|NCT03632083|10116867|FG001|STARTED|First Intervention||5
9057419|NCT03632083|10116868|FG002|STARTED|First Intervention||7
9057420|NCT03632083|10116869|FG003|STARTED|First Intervention||7
9057421|NCT03632083|10116870|FG004|STARTED|First Intervention||9
9057422|NCT03632083|10116871|FG005|STARTED|First Intervention||9
9057423|NCT03632083|10116872|FG006|STARTED|First Intervention||7
9057424|NCT03632083|10116873|FG007|STARTED|First Intervention||7
9057425|NCT03632083|10116866|FG000|COMPLETED|First Intervention||5
9057426|NCT03632083|10116867|FG001|COMPLETED|First Intervention||5
9057427|NCT03632083|10116868|FG002|COMPLETED|First Intervention||7
9057428|NCT03632083|10116869|FG003|COMPLETED|First Intervention||7
9057429|NCT03632083|10116870|FG004|COMPLETED|First Intervention||9
9057430|NCT03632083|10116871|FG005|COMPLETED|First Intervention||9
9057431|NCT03632083|10116872|FG006|COMPLETED|First Intervention||7
9057432|NCT03632083|10116873|FG007|COMPLETED|First Intervention||7
9057433|NCT03632083|10116866|FG000|NOT COMPLETED|First Intervention||0
9057434|NCT03632083|10116867|FG001|NOT COMPLETED|First Intervention||0
9057435|NCT03632083|10116868|FG002|NOT COMPLETED|First Intervention||0
9057436|NCT03632083|10116869|FG003|NOT COMPLETED|First Intervention||0
9057437|NCT03632083|10116870|FG004|NOT COMPLETED|First Intervention||0
9057438|NCT03632083|10116871|FG005|NOT COMPLETED|First Intervention||0
9057439|NCT03632083|10116872|FG006|NOT COMPLETED|First Intervention||0
9057440|NCT03632083|10116873|FG007|NOT COMPLETED|First Intervention||0
9057441|NCT03632083|10116866|FG000|STARTED|Second Intervention||5
9057442|NCT03632083|10116867|FG001|STARTED|Second Intervention||5
9057443|NCT03632083|10116868|FG002|STARTED|Second Intervention||7
9057444|NCT03632083|10116869|FG003|STARTED|Second Intervention||7
9057445|NCT03632083|10116870|FG004|STARTED|Second Intervention||9
9057446|NCT03632083|10116871|FG005|STARTED|Second Intervention||9
9057447|NCT03632083|10116872|FG006|STARTED|Second Intervention||7
9057448|NCT03632083|10116873|FG007|STARTED|Second Intervention||7
9057449|NCT03632083|10116866|FG000|COMPLETED|Second Intervention||5
9057450|NCT03632083|10116867|FG001|COMPLETED|Second Intervention||5
9057451|NCT03632083|10116868|FG002|COMPLETED|Second Intervention||7
9057452|NCT03632083|10116869|FG003|COMPLETED|Second Intervention||7
9057453|NCT03632083|10116870|FG004|COMPLETED|Second Intervention||9
9057454|NCT03632083|10116871|FG005|COMPLETED|Second Intervention||9
9057455|NCT03632083|10116872|FG006|COMPLETED|Second Intervention||7
9057456|NCT03632083|10116873|FG007|COMPLETED|Second Intervention||5
9057457|NCT03632083|10116866|FG000|NOT COMPLETED|Second Intervention||0
9057458|NCT03632083|10116867|FG001|NOT COMPLETED|Second Intervention||0
9057459|NCT03632083|10116868|FG002|NOT COMPLETED|Second Intervention||0
9057460|NCT03632083|10116869|FG003|NOT COMPLETED|Second Intervention||0
9057461|NCT03632083|10116870|FG004|NOT COMPLETED|Second Intervention||0
9057462|NCT03632083|10116871|FG005|NOT COMPLETED|Second Intervention||0
9057463|NCT03632083|10116872|FG006|NOT COMPLETED|Second Intervention||0
9057464|NCT03632083|10116873|FG007|NOT COMPLETED|Second Intervention||2
9057465|NCT03632109|10116885|FG000|STARTED|Overall Study||13
9057466|NCT03632109|10116885|FG000|COMPLETED|Overall Study||13
9057467|NCT03632109|10116885|FG000|NOT COMPLETED|Overall Study||0
9057468|NCT03632954|10116891|FG000|STARTED|Overall Study||37
9057469|NCT03632954|10116891|FG000|COMPLETED|Overall Study||3
9057470|NCT03632954|10116891|FG000|NOT COMPLETED|Overall Study||34
9057471|NCT03633084|10116898|FG000|STARTED|Overall Study||3
9057472|NCT03633084|10116899|FG001|STARTED|Overall Study||3
9057473|NCT03633084|10116900|FG002|STARTED|Overall Study||3
9057474|NCT03633084|10116898|FG000|COMPLETED|Overall Study||3
9057475|NCT03633084|10116899|FG001|COMPLETED|Overall Study||3
9057476|NCT03633084|10116900|FG002|COMPLETED|Overall Study||3
9057477|NCT03633084|10116898|FG000|NOT COMPLETED|Overall Study||0
9057478|NCT03633084|10116899|FG001|NOT COMPLETED|Overall Study||0
9057479|NCT03633084|10116900|FG002|NOT COMPLETED|Overall Study||0
9057480|NCT03633331|10116909|FG000|STARTED|Overall Study||93
9057481|NCT03633331|10116909|FG000|COMPLETED|Overall Study||92
9057482|NCT03633331|10116909|FG000|NOT COMPLETED|Overall Study||1
9057483|NCT03633344|10116915|FG000|STARTED|Overall Study||120
9057484|NCT03633344|10116916|FG001|STARTED|Overall Study||24
9057485|NCT03633344|10116915|FG000|COMPLETED|Overall Study||120
9057486|NCT03633344|10116916|FG001|COMPLETED|Overall Study||24
9057487|NCT03633344|10116915|FG000|NOT COMPLETED|Overall Study||0
9057488|NCT03633344|10116916|FG001|NOT COMPLETED|Overall Study||0
9057489|NCT03633448|10116926|FG000|STARTED|Period 1 (1 Day)||12
9057490|NCT03633448|10116927|FG001|STARTED|Period 1 (1 Day)||12
9057491|NCT03633448|10116926|FG000|COMPLETED|Period 1 (1 Day)||12
9057492|NCT03633448|10116927|FG001|COMPLETED|Period 1 (1 Day)||12
9057493|NCT03633448|10116926|FG000|NOT COMPLETED|Period 1 (1 Day)||0
9057494|NCT03633448|10116927|FG001|NOT COMPLETED|Period 1 (1 Day)||0
9057495|NCT03633448|10116926|FG000|STARTED|Washout (7 Days)||12
9057496|NCT03633448|10116927|FG001|STARTED|Washout (7 Days)||12
9057497|NCT03633448|10116926|FG000|COMPLETED|Washout (7 Days)||12
9057498|NCT03633448|10116927|FG001|COMPLETED|Washout (7 Days)||12
9057499|NCT03633448|10116926|FG000|NOT COMPLETED|Washout (7 Days)||0
9057500|NCT03633448|10116927|FG001|NOT COMPLETED|Washout (7 Days)||0
9057501|NCT03633448|10116926|FG000|STARTED|Period 2 (1 Day)||12
9057502|NCT03633448|10116927|FG001|STARTED|Period 2 (1 Day)||12
9057503|NCT03633448|10116926|FG000|COMPLETED|Period 2 (1 Day)||12
9057504|NCT03633448|10116927|FG001|COMPLETED|Period 2 (1 Day)||12
9057505|NCT03633448|10116926|FG000|NOT COMPLETED|Period 2 (1 Day)||0
9057506|NCT03633448|10116927|FG001|NOT COMPLETED|Period 2 (1 Day)||0
9057507|NCT03633487|10116937|FG000|STARTED|Overall Study||24
9057508|NCT03633487|10116937|FG000|COMPLETED|Overall Study||24
9057509|NCT03633487|10116937|FG000|NOT COMPLETED|Overall Study||0
9057510|NCT03633526|10116941|FG000|STARTED|Overall Study||16
9057511|NCT03633526|10116941|FG000|COMPLETED|Overall Study||16
9057512|NCT03633526|10116941|FG000|NOT COMPLETED|Overall Study||0
9057513|NCT03633825|10116947|FG000|STARTED|Enrollment||19838
9057514|NCT03633825|10116948|FG001|STARTED|Enrollment||19612
9057515|NCT03633825|10116947|FG000|COMPLETED|Enrollment||805
9057516|NCT03633825|10116948|FG001|COMPLETED|Enrollment||775
9057517|NCT03633825|10116947|FG000|NOT COMPLETED|Enrollment||19033
9057518|NCT03633825|10116948|FG001|NOT COMPLETED|Enrollment||18837
9057519|NCT03633825|10116947|FG000|STARTED|Allocation||805
9057520|NCT03633825|10116948|FG001|STARTED|Allocation||775
9057521|NCT03633825|10116947|FG000|COMPLETED|Allocation||805
9057522|NCT03633825|10116948|FG001|COMPLETED|Allocation||775
9057523|NCT03633825|10116947|FG000|NOT COMPLETED|Allocation||0
9057524|NCT03633825|10116948|FG001|NOT COMPLETED|Allocation||0
9057525|NCT03633825|10116947|FG000|STARTED|Follow up||805
9057526|NCT03633825|10116948|FG001|STARTED|Follow up||775
9057527|NCT03633825|10116947|FG000|COMPLETED|Follow up||327
9057528|NCT03633825|10116948|FG001|COMPLETED|Follow up||325
9057529|NCT03633825|10116947|FG000|NOT COMPLETED|Follow up||478
9057530|NCT03633825|10116948|FG001|NOT COMPLETED|Follow up||450
9057531|NCT03633825|10116947|FG000|STARTED|Analysis||327
9057532|NCT03633825|10116948|FG001|STARTED|Analysis||325
9057533|NCT03633825|10116947|FG000|COMPLETED|Analysis||327
9057534|NCT03633825|10116948|FG001|COMPLETED|Analysis||325
9057535|NCT03633825|10116947|FG000|NOT COMPLETED|Analysis||0
9057536|NCT03633825|10116948|FG001|NOT COMPLETED|Analysis||0
9057537|NCT03633903|10116956|FG000|STARTED|Overall Study||22
9057538|NCT03633903|10116957|FG001|STARTED|Overall Study||18
9057539|NCT03633903|10116956|FG000|Intent to Treat|Overall Study||0
9057540|NCT03633903|10116957|FG001|Intent to Treat|Overall Study||18
9057541|NCT03633903|10116956|FG000|COMPLETED|Overall Study||16
9057542|NCT03633903|10116957|FG001|COMPLETED|Overall Study||11
9057543|NCT03633903|10116956|FG000|NOT COMPLETED|Overall Study||6
9057544|NCT03633903|10116957|FG001|NOT COMPLETED|Overall Study||7
9057545|NCT03633929|10116963|FG000|STARTED|Overall Study||19
9057546|NCT03633929|10116963|FG000|COMPLETED|Overall Study||15
9057547|NCT03633929|10116963|FG000|NOT COMPLETED|Overall Study||4
9057548|NCT03634085|10116969|FG000|STARTED|Overall Study||8
9057549|NCT03634085|10116970|FG001|STARTED|Overall Study||8
9057550|NCT03634085|10116969|FG000|Period 1|Overall Study|8 subjects started BDM2-50 mg and 8 subjects completed BDM2-50 mg including matching placebo.|8
9057551|NCT03634085|10116970|FG001|Period 1|Overall Study|8 subjects started BDM2 - 150mg and 8 subjects completed BDM2 - 150 mg including matching placebo|8
9057552|NCT03634085|10116969|FG000|Period 2|Overall Study|8 subjects started BDM2 - 450 mg and 7 subjects completed BDM2 - 450 mg (drop out; 1 active)|8
9057553|NCT03634085|10116970|FG001|Period 2|Overall Study|8 subjects started BDM2 - 900 mg fasted and 8 subjects completed BDM2 - 900 mg fasted|8
9057554|NCT03634085|10116969|FG000|Period 3|Overall Study|8 subjects started BDM2 - 1800 mg and 7 subjects completed BDM2 - 1800 mg (drop out; 1 active)|8
9057555|NCT03634085|10116970|FG001|Period 3|Overall Study|8 subjects started and 6 subjects completed BDM2 - 900 mg fed (dropout; 1 active 1 placebo)|8
9057556|NCT03634085|10116969|FG000|Period 4|Overall Study|8 subjects started BDM2 - 3100 mg and 7 subjects completed BDM2 - 3100 mg (drop out; 1 active)|8
9057557|NCT03634085|10116970|FG001|Period 4|Overall Study|this period is not applicable for Cohort B|0
9057558|NCT03634085|10116969|FG000|COMPLETED|Overall Study|1 subject dropped out due to car accident|7
9057559|NCT03634085|10116970|FG001|COMPLETED|Overall Study|"1 subject dropped out due to personal emergency~1 subject dropped out due to personal circumstances"|6
9057560|NCT03634085|10116969|FG000|NOT COMPLETED|Overall Study||1
9057561|NCT03634085|10116970|FG001|NOT COMPLETED|Overall Study||2
9057562|NCT03634306|10116986|FG000|STARTED|Overall Study||15
9057563|NCT03634306|10116987|FG001|STARTED|Overall Study||15
9057564|NCT03634306|10116988|FG002|STARTED|Overall Study||5
9057565|NCT03634306|10116986|FG000|COMPLETED|Overall Study||15
9057566|NCT03634306|10116987|FG001|COMPLETED|Overall Study||15
9057567|NCT03634306|10116988|FG002|COMPLETED|Overall Study||5
9057568|NCT03634306|10116986|FG000|NOT COMPLETED|Overall Study||0
9057569|NCT03634306|10116987|FG001|NOT COMPLETED|Overall Study||0
9057570|NCT03634306|10116988|FG002|NOT COMPLETED|Overall Study||0
9057571|NCT03634579|10116996|FG000|STARTED|Overall Study||9
9057572|NCT03634579|10116996|FG000|COMPLETED|Overall Study||0
9057573|NCT03634579|10116996|FG000|NOT COMPLETED|Overall Study||9
9057574|NCT03634800|10117000|FG000|STARTED|Overall Study||6
9057575|NCT03634800|10117000|FG000|COMPLETED|Overall Study||0
9057576|NCT03634800|10117000|FG000|NOT COMPLETED|Overall Study||6
9057577|NCT03634813|10117006|FG000|STARTED|Overall Study||49
9057578|NCT03634813|10117007|FG001|STARTED|Overall Study||51
9057579|NCT03634813|10117006|FG000|COMPLETED|Overall Study||49
9057580|NCT03634813|10117007|FG001|COMPLETED|Overall Study||51
9057581|NCT03634813|10117006|FG000|NOT COMPLETED|Overall Study||0
9057582|NCT03634813|10117007|FG001|NOT COMPLETED|Overall Study||0
9057583|NCT03635086|10117019|FG000|STARTED|Overall Study||12
9057584|NCT03635086|10117020|FG001|STARTED|Overall Study||12
9057585|NCT03635086|10117021|FG002|STARTED|Overall Study||12
9057586|NCT03635086|10117022|FG003|STARTED|Overall Study||12
9057587|NCT03635086|10117023|FG004|STARTED|Overall Study||12
9057588|NCT03635086|10117019|FG000|COMPLETED|Overall Study||11
9057589|NCT03635086|10117020|FG001|COMPLETED|Overall Study||11
9057590|NCT03635086|10117021|FG002|COMPLETED|Overall Study||11
9057591|NCT03635086|10117022|FG003|COMPLETED|Overall Study||12
9057592|NCT03635086|10117023|FG004|COMPLETED|Overall Study||12
9057593|NCT03635086|10117019|FG000|NOT COMPLETED|Overall Study||1
9057594|NCT03635086|10117020|FG001|NOT COMPLETED|Overall Study||1
9057595|NCT03635086|10117021|FG002|NOT COMPLETED|Overall Study||1
9057596|NCT03635086|10117022|FG003|NOT COMPLETED|Overall Study||0
9057597|NCT03635086|10117023|FG004|NOT COMPLETED|Overall Study||0
9057598|NCT03635320|10117038|FG000|STARTED|Overall Study||94
9057599|NCT03635320|10117039|FG001|STARTED|Overall Study||94
9057600|NCT03635320|10117038|FG000|FAS|Overall Study|1 subject was not implanted the device|93
9057601|NCT03635320|10117039|FG001|FAS|Overall Study|2 subjects were not implant the device|92
9057602|NCT03635320|10117038|FG000|PPS|Overall Study|11 subjects early discontinued and didn't complete the trial which were excluded from PPS, 1 subject had a risk of unblinding, which was excluded from the PPS.|81
9057603|NCT03635320|10117039|FG001|PPS|Overall Study|6 subjects early discontinued and didn't complete the trial which were excluded from PPS, 1 subject didn't undergo the evaluation or laboratory examination required by the clinical trial, 1 subject violated the inclusion/exclusion criteria and 1 subject used the device beyond the scope of the specifications, which were excluded from the PPS.|83
9057604|NCT03635320|10117038|FG000|COMPLETED|Overall Study||82
9057605|NCT03635320|10117039|FG001|COMPLETED|Overall Study||86
9057606|NCT03635320|10117038|FG000|NOT COMPLETED|Overall Study||12
9057607|NCT03635320|10117039|FG001|NOT COMPLETED|Overall Study||8
9057608|NCT03635775|10117049|FG000|STARTED|Overall Study||5
9057609|NCT03635775|10117050|FG001|STARTED|Overall Study||0
9057610|NCT03635775|10117051|FG002|STARTED|Overall Study||5
9057611|NCT03635775|10117052|FG003|STARTED|Overall Study||10
9057612|NCT03635775|10117049|FG000|COMPLETED|Overall Study||5
9057613|NCT03635775|10117050|FG001|COMPLETED|Overall Study||0
9057614|NCT03635775|10117051|FG002|COMPLETED|Overall Study||5
9057615|NCT03635775|10117052|FG003|COMPLETED|Overall Study||9
9057616|NCT03635775|10117049|FG000|NOT COMPLETED|Overall Study||0
9057617|NCT03635775|10117050|FG001|NOT COMPLETED|Overall Study||0
9057618|NCT03635775|10117051|FG002|NOT COMPLETED|Overall Study||0
9057619|NCT03635775|10117052|FG003|NOT COMPLETED|Overall Study||1
9057620|NCT03635957|10117062|FG000|STARTED|Run-In Period||15
9057621|NCT03635957|10117062|FG000|COMPLETED|Run-In Period||14
9057622|NCT03635957|10117062|FG000|NOT COMPLETED|Run-In Period||1
9057623|NCT03635957|10117062|FG000|STARTED|Pegloticase + IMM Period||14
9057624|NCT03635957|10117062|FG000|Completed Study at 24 Weeks-Amendment 1|Pegloticase + IMM Period||1
9057625|NCT03635957|10117062|FG000|Completed Study at 52 Weeks-Amendment 2|Pegloticase + IMM Period||10
9057626|NCT03635957|10117062|FG000|Discontinued Study Treatment Early|Pegloticase + IMM Period||5
9057627|NCT03635957|10117062|FG000|Had 3-Month Follow-up|Pegloticase + IMM Period||7
9057628|NCT03635957|10117062|FG000|Had 6-Month Follow-up|Pegloticase + IMM Period||6
9057629|NCT03635957|10117062|FG000|COMPLETED|Pegloticase + IMM Period||11
9057630|NCT03635957|10117062|FG000|NOT COMPLETED|Pegloticase + IMM Period||3
9057631|NCT03636061|10117071|FG000|STARTED|Overall Study||47
9057632|NCT03636061|10117072|FG001|STARTED|Overall Study||48
9057633|NCT03636061|10117073|FG002|STARTED|Overall Study||44
9057634|NCT03636061|10117074|FG003|STARTED|Overall Study||43
9057635|NCT03636061|10117071|FG000|COMPLETED|Overall Study||47
9057636|NCT03636061|10117072|FG001|COMPLETED|Overall Study||46
9057637|NCT03636061|10117073|FG002|COMPLETED|Overall Study||40
9057638|NCT03636061|10117074|FG003|COMPLETED|Overall Study||43
9057639|NCT03636061|10117071|FG000|NOT COMPLETED|Overall Study||0
9057640|NCT03636061|10117072|FG001|NOT COMPLETED|Overall Study||2
9057641|NCT03636061|10117073|FG002|NOT COMPLETED|Overall Study||4
9057642|NCT03636061|10117074|FG003|NOT COMPLETED|Overall Study||0
9057643|NCT03636386|10117089|FG000|STARTED|Overall Study||24
9057644|NCT03636386|10117090|FG001|STARTED|Overall Study||24
9057645|NCT03636386|10117089|FG000|COMPLETED|Overall Study||24
9057646|NCT03636386|10117090|FG001|COMPLETED|Overall Study||24
9057647|NCT03636386|10117089|FG000|NOT COMPLETED|Overall Study||0
9057648|NCT03636386|10117090|FG001|NOT COMPLETED|Overall Study||0
9057649|NCT03636893|10117098|FG000|STARTED|Overall Study||40
9057650|NCT03636893|10117099|FG001|STARTED|Overall Study||34
9057651|NCT03636893|10117098|FG000|COMPLETED|Overall Study||31
9057652|NCT03636893|10117099|FG001|COMPLETED|Overall Study||24
9057653|NCT03636893|10117098|FG000|NOT COMPLETED|Overall Study||9
9057654|NCT03636893|10117099|FG001|NOT COMPLETED|Overall Study||10
9057655|NCT03637296|10117107|FG000|STARTED|Overall Study||10
9057656|NCT03637296|10117108|FG001|STARTED|Overall Study||5
9057657|NCT03637296|10117107|FG000|COMPLETED|Overall Study||10
9057658|NCT03637296|10117108|FG001|COMPLETED|Overall Study||5
9057659|NCT03637296|10117107|FG000|NOT COMPLETED|Overall Study||0
9057660|NCT03637296|10117108|FG001|NOT COMPLETED|Overall Study||0
9057661|NCT03637348|10117114|FG000|STARTED|Overall Study||45
9057662|NCT03637348|10117114|FG000|COMPLETED|Overall Study||45
9057663|NCT03637348|10117114|FG000|NOT COMPLETED|Overall Study||0
9057664|NCT03637517|10117122|FG000|STARTED|Overall Study||14
9057665|NCT03637517|10117123|FG001|STARTED|Overall Study||14
9057666|NCT03637517|10117124|FG002|STARTED|Overall Study||14
9057667|NCT03637517|10117122|FG000|COMPLETED|Overall Study||14
9057668|NCT03637517|10117123|FG001|COMPLETED|Overall Study||14
9057669|NCT03637517|10117124|FG002|COMPLETED|Overall Study||14
9057670|NCT03637517|10117122|FG000|NOT COMPLETED|Overall Study||0
9057671|NCT03637517|10117123|FG001|NOT COMPLETED|Overall Study||0
9057672|NCT03637517|10117124|FG002|NOT COMPLETED|Overall Study||0
9057673|NCT03637699|10117134|FG000|STARTED|Overall Study||15
9057674|NCT03637699|10117135|FG001|STARTED|Overall Study||15
9057675|NCT03637699|10117134|FG000|COMPLETED|Overall Study||14
9057676|NCT03637699|10117135|FG001|COMPLETED|Overall Study||14
9057677|NCT03637699|10117134|FG000|NOT COMPLETED|Overall Study||1
9057678|NCT03637699|10117135|FG001|NOT COMPLETED|Overall Study||1
9057679|NCT03637842|10117144|FG000|STARTED|Overall Study||2
9057680|NCT03637842|10117145|FG001|STARTED|Overall Study||2
9057681|NCT03637842|10117144|FG000|COMPLETED|Overall Study||2
9057682|NCT03637842|10117145|FG001|COMPLETED|Overall Study||2
9057683|NCT03637842|10117144|FG000|NOT COMPLETED|Overall Study||0
9057684|NCT03637842|10117145|FG001|NOT COMPLETED|Overall Study||0
9057685|NCT03638011|10117153|FG000|STARTED|Overall Study||38
9057686|NCT03638011|10117154|FG001|STARTED|Overall Study||33
9057687|NCT03638011|10117153|FG000|COMPLETED|Overall Study||38
9057688|NCT03638011|10117154|FG001|COMPLETED|Overall Study||33
9057689|NCT03638011|10117153|FG000|NOT COMPLETED|Overall Study||0
9057690|NCT03638011|10117154|FG001|NOT COMPLETED|Overall Study||0
9057691|NCT03638323|10117162|FG000|STARTED|Overall Study||38
9057692|NCT03638323|10117162|FG000|COMPLETED|Overall Study||37
9057693|NCT03638323|10117162|FG000|NOT COMPLETED|Overall Study||1
9057694|NCT03638622|10117169|FG000|STARTED|Overall Study||30
9057695|NCT03638622|10117169|FG000|COMPLETED|Overall Study||29
9057696|NCT03638622|10117169|FG000|NOT COMPLETED|Overall Study||1
9057697|NCT03638635|10117175|FG000|STARTED|Initial Hospitalization||39
9057698|NCT03638635|10117176|FG001|STARTED|Initial Hospitalization||24
9057699|NCT03638635|10117175|FG000|COMPLETED|Initial Hospitalization||39
9057700|NCT03638635|10117176|FG001|COMPLETED|Initial Hospitalization||22
9057701|NCT03638635|10117175|FG000|NOT COMPLETED|Initial Hospitalization||0
9057702|NCT03638635|10117176|FG001|NOT COMPLETED|Initial Hospitalization||2
9057703|NCT03638635|10117175|FG000|STARTED|Follow-Up (30 Days After Discharge)||39
9057704|NCT03638635|10117176|FG001|STARTED|Follow-Up (30 Days After Discharge)||22
9057705|NCT03638635|10117175|FG000|COMPLETED|Follow-Up (30 Days After Discharge)||0
9057706|NCT03638635|10117176|FG001|COMPLETED|Follow-Up (30 Days After Discharge)||0
9057707|NCT03638635|10117175|FG000|NOT COMPLETED|Follow-Up (30 Days After Discharge)||39
9057708|NCT03638635|10117176|FG001|NOT COMPLETED|Follow-Up (30 Days After Discharge)||22
9057709|NCT03638908|10117182|FG000|STARTED|Overall Study||8
9057710|NCT03638908|10117182|FG000|COMPLETED|Overall Study||7
9057711|NCT03638908|10117182|FG000|NOT COMPLETED|Overall Study||1
9057712|NCT03639675|10117190|FG000|STARTED|Overall Study||16
9057713|NCT03639675|10117190|FG000|Received Treatment|Overall Study||16
9057714|NCT03639675|10117190|FG000|COMPLETED|Overall Study||15
9057715|NCT03639675|10117190|FG000|NOT COMPLETED|Overall Study||1
9057716|NCT03639766|10117194|FG000|STARTED|Overall Study||3
9057717|NCT03639766|10117194|FG000|COMPLETED|Overall Study||3
9057718|NCT03639766|10117194|FG000|NOT COMPLETED|Overall Study||0
9057719|NCT03639779|10117200|FG000|STARTED|Overall Study||5
9057720|NCT03639779|10117200|FG000|Baseline|Overall Study||5
9057721|NCT03639779|10117200|FG000|Month 1|Overall Study||5
9057722|NCT03639779|10117200|FG000|Month 2|Overall Study||4
9057723|NCT03639779|10117200|FG000|Month 3|Overall Study||4
9057724|NCT03639779|10117200|FG000|COMPLETED|Overall Study||4
9057725|NCT03639779|10117200|FG000|NOT COMPLETED|Overall Study||1
9057726|NCT03639857|10117206|FG000|STARTED|Overall Study||1
9057727|NCT03639857|10117207|FG001|STARTED|Overall Study||3
9057728|NCT03639857|10117208|FG002|STARTED|Overall Study||3
9057729|NCT03639857|10117206|FG000|COMPLETED|Overall Study||1
9057730|NCT03639857|10117207|FG001|COMPLETED|Overall Study||3
9057731|NCT03639857|10117208|FG002|COMPLETED|Overall Study||3
9057732|NCT03639857|10117206|FG000|NOT COMPLETED|Overall Study||0
9057733|NCT03639857|10117207|FG001|NOT COMPLETED|Overall Study||0
9057734|NCT03639857|10117208|FG002|NOT COMPLETED|Overall Study||0
9057735|NCT03639987|10117218|FG000|STARTED|Overall Study||26
9057736|NCT03639987|10117219|FG001|STARTED|Overall Study||26
9057737|NCT03639987|10117218|FG000|COMPLETED|Overall Study||0
9057738|NCT03639987|10117219|FG001|COMPLETED|Overall Study||0
9057739|NCT03639987|10117218|FG000|NOT COMPLETED|Overall Study||26
9057740|NCT03639987|10117219|FG001|NOT COMPLETED|Overall Study||26
9057741|NCT03640052|10117225|FG000|STARTED|Overall Study||2
9057742|NCT03640052|10117226|FG001|STARTED|Overall Study||1
9057743|NCT03640052|10117227|FG002|STARTED|Overall Study||1
9057744|NCT03640052|10117228|FG003|STARTED|Overall Study||1
9057745|NCT03640052|10117229|FG004|STARTED|Overall Study||1
9057746|NCT03640052|10117225|FG000|COMPLETED|Overall Study||2
9057747|NCT03640052|10117226|FG001|COMPLETED|Overall Study|the patient performed 4 out of 5 nights|0
9057748|NCT03640052|10117227|FG002|COMPLETED|Overall Study||1
9057749|NCT03640052|10117228|FG003|COMPLETED|Overall Study||1
9057750|NCT03640052|10117229|FG004|COMPLETED|Overall Study||1
9057751|NCT03640052|10117225|FG000|NOT COMPLETED|Overall Study||0
9057752|NCT03640052|10117226|FG001|NOT COMPLETED|Overall Study||1
9057753|NCT03640052|10117227|FG002|NOT COMPLETED|Overall Study||0
9057754|NCT03640052|10117228|FG003|NOT COMPLETED|Overall Study||0
9057755|NCT03640052|10117229|FG004|NOT COMPLETED|Overall Study||0
9057756|NCT03640507|10117244|FG000|STARTED|Overall Study||10
9057757|NCT03640507|10117245|FG001|STARTED|Overall Study||9
9057758|NCT03640507|10117246|FG002|STARTED|Overall Study||11
9057759|NCT03640507|10117244|FG000|COMPLETED|Overall Study||10
9057760|NCT03640507|10117245|FG001|COMPLETED|Overall Study||9
9057761|NCT03640507|10117246|FG002|COMPLETED|Overall Study||10
9057762|NCT03640507|10117244|FG000|NOT COMPLETED|Overall Study||0
9057763|NCT03640507|10117245|FG001|NOT COMPLETED|Overall Study||0
9057764|NCT03640507|10117246|FG002|NOT COMPLETED|Overall Study||1
9057765|NCT03640559|10117256|FG000|STARTED|Overall Study||25
9057766|NCT03640559|10117257|FG001|STARTED|Overall Study||25
9057767|NCT03640559|10117256|FG000|COMPLETED|Overall Study||23
9057768|NCT03640559|10117257|FG001|COMPLETED|Overall Study||24
9057769|NCT03640559|10117256|FG000|NOT COMPLETED|Overall Study||2
9057770|NCT03640559|10117257|FG001|NOT COMPLETED|Overall Study||1
9057771|NCT03640832|10117265|FG000|STARTED|Overall Study||44
9057772|NCT03640832|10117266|FG001|STARTED|Overall Study||46
9057773|NCT03640832|10117265|FG000|COMPLETED|Overall Study||44
9057774|NCT03640832|10117266|FG001|COMPLETED|Overall Study||46
9057775|NCT03640832|10117265|FG000|NOT COMPLETED|Overall Study||0
9057776|NCT03640832|10117266|FG001|NOT COMPLETED|Overall Study||0
9057777|NCT03641508|10117274|FG000|STARTED|First Injection||37
9057778|NCT03641508|10117275|FG001|STARTED|First Injection||32
9057779|NCT03641508|10117274|FG000|COMPLETED|First Injection||35
9057780|NCT03641508|10117275|FG001|COMPLETED|First Injection||32
9057781|NCT03641508|10117274|FG000|NOT COMPLETED|First Injection||2
9057782|NCT03641508|10117275|FG001|NOT COMPLETED|First Injection||0
9057783|NCT03641508|10117274|FG000|STARTED|Follow-up/Second Injection||2
9057784|NCT03641508|10117275|FG001|STARTED|Follow-up/Second Injection|Only those who had symptoms at the six-week follow-up received the second injection|10
9057785|NCT03641508|10117274|FG000|COMPLETED|Follow-up/Second Injection|Only those who had symptoms at the six-week follow-up received the second injection|2
9057786|NCT03641508|10117275|FG001|COMPLETED|Follow-up/Second Injection|Only those who had symptoms at the six-week follow-up received the second injection|10
8703935|NCT00925704|9749709|FG001|STARTED|First Intervention||7
9057787|NCT03641508|10117274|FG000|NOT COMPLETED|Follow-up/Second Injection||0
9057788|NCT03641508|10117275|FG001|NOT COMPLETED|Follow-up/Second Injection||0
9057789|NCT03641716|10117281|FG000|STARTED|Overall Study||20
9057790|NCT03641716|10117281|FG000|COMPLETED|Overall Study||15
9057791|NCT03641716|10117281|FG000|NOT COMPLETED|Overall Study||5
9057792|NCT03642262|10117285|FG000|STARTED|Period 1||12
9057793|NCT03642262|10117286|FG001|STARTED|Period 1||18
9057794|NCT03642262|10117285|FG000|COMPLETED|Period 1||11
9057795|NCT03642262|10117286|FG001|COMPLETED|Period 1||16
9057796|NCT03642262|10117285|FG000|NOT COMPLETED|Period 1||1
9057797|NCT03642262|10117286|FG001|NOT COMPLETED|Period 1||2
9057798|NCT03642262|10117285|FG000|STARTED|Washout: 7 Days||11
9057799|NCT03642262|10117286|FG001|STARTED|Washout: 7 Days||16
9057800|NCT03642262|10117285|FG000|COMPLETED|Washout: 7 Days||11
9057801|NCT03642262|10117286|FG001|COMPLETED|Washout: 7 Days||16
9057802|NCT03642262|10117285|FG000|NOT COMPLETED|Washout: 7 Days||0
9057803|NCT03642262|10117286|FG001|NOT COMPLETED|Washout: 7 Days||0
9057804|NCT03642262|10117285|FG000|STARTED|Period 2||11
9057805|NCT03642262|10117286|FG001|STARTED|Period 2||16
9057806|NCT03642262|10117285|FG000|COMPLETED|Period 2||11
9057807|NCT03642262|10117286|FG001|COMPLETED|Period 2||16
9057808|NCT03642262|10117285|FG000|NOT COMPLETED|Period 2||0
9057809|NCT03642262|10117286|FG001|NOT COMPLETED|Period 2||0
9057810|NCT03642457|10117295|FG000|STARTED|Overall Study||35
9057811|NCT03642457|10117296|FG001|STARTED|Overall Study||30
9057812|NCT03642457|10117295|FG000|COMPLETED|Overall Study||35
9057813|NCT03642457|10117296|FG001|COMPLETED|Overall Study||30
9057814|NCT03642457|10117295|FG000|NOT COMPLETED|Overall Study||0
9057815|NCT03642457|10117296|FG001|NOT COMPLETED|Overall Study||0
9057816|NCT03642717|10117302|FG000|STARTED|Overall Study||658
9057817|NCT03642717|10117302|FG000|COMPLETED|Overall Study||620
9057818|NCT03642717|10117302|FG000|NOT COMPLETED|Overall Study||38
9057819|NCT03642873|10117307|FG000|STARTED|First Intervention (1 Day)||4
9057820|NCT03642873|10117308|FG001|STARTED|First Intervention (1 Day)||4
9057821|NCT03642873|10117309|FG002|STARTED|First Intervention (1 Day)||4
9057822|NCT03642873|10117310|FG003|STARTED|First Intervention (1 Day)||4
9057823|NCT03642873|10117311|FG004|STARTED|First Intervention (1 Day)||4
9057824|NCT03642873|10117312|FG005|STARTED|First Intervention (1 Day)||4
9057825|NCT03642873|10117307|FG000|COMPLETED|First Intervention (1 Day)||4
8703936|NCT00925704|9749710|FG002|STARTED|First Intervention||7
8703937|NCT00925704|9749711|FG003|STARTED|First Intervention||7
8703938|NCT00925704|9749712|FG004|STARTED|First Intervention||7
8703939|NCT00925704|9749713|FG005|STARTED|First Intervention||7
8703940|NCT00925704|9749708|FG000|COMPLETED|First Intervention||6
8703941|NCT00925704|9749709|FG001|COMPLETED|First Intervention||7
8703942|NCT00925704|9749710|FG002|COMPLETED|First Intervention||7
8703943|NCT00925704|9749711|FG003|COMPLETED|First Intervention||6
8703944|NCT00925704|9749712|FG004|COMPLETED|First Intervention||6
8703945|NCT00925704|9749713|FG005|COMPLETED|First Intervention||7
8703946|NCT00925704|9749708|FG000|NOT COMPLETED|First Intervention||0
8703947|NCT00925704|9749709|FG001|NOT COMPLETED|First Intervention||0
8703948|NCT00925704|9749710|FG002|NOT COMPLETED|First Intervention||0
8703949|NCT00925704|9749711|FG003|NOT COMPLETED|First Intervention||1
8703950|NCT00925704|9749712|FG004|NOT COMPLETED|First Intervention||1
8703951|NCT00925704|9749713|FG005|NOT COMPLETED|First Intervention||0
8703952|NCT00925704|9749708|FG000|STARTED|Washout||6
8703953|NCT00925704|9749709|FG001|STARTED|Washout||7
8703954|NCT00925704|9749710|FG002|STARTED|Washout||7
8703955|NCT00925704|9749711|FG003|STARTED|Washout||6
8703956|NCT00925704|9749712|FG004|STARTED|Washout||6
8703957|NCT00925704|9749713|FG005|STARTED|Washout||7
8703958|NCT00925704|9749708|FG000|COMPLETED|Washout||6
8703959|NCT00925704|9749709|FG001|COMPLETED|Washout||7
8703960|NCT00925704|9749710|FG002|COMPLETED|Washout||7
8703961|NCT00925704|9749711|FG003|COMPLETED|Washout||6
8703962|NCT00925704|9749712|FG004|COMPLETED|Washout||6
8703963|NCT00925704|9749713|FG005|COMPLETED|Washout||7
8703964|NCT00925704|9749708|FG000|NOT COMPLETED|Washout||0
8703965|NCT00925704|9749709|FG001|NOT COMPLETED|Washout||0
8703966|NCT00925704|9749710|FG002|NOT COMPLETED|Washout||0
9057826|NCT03642873|10117308|FG001|COMPLETED|First Intervention (1 Day)||4
9057827|NCT03642873|10117309|FG002|COMPLETED|First Intervention (1 Day)||4
9057828|NCT03642873|10117310|FG003|COMPLETED|First Intervention (1 Day)||4
9057829|NCT03642873|10117311|FG004|COMPLETED|First Intervention (1 Day)||4
9057830|NCT03642873|10117312|FG005|COMPLETED|First Intervention (1 Day)||4
9057831|NCT03642873|10117307|FG000|NOT COMPLETED|First Intervention (1 Day)||0
9057832|NCT03642873|10117308|FG001|NOT COMPLETED|First Intervention (1 Day)||0
9057833|NCT03642873|10117309|FG002|NOT COMPLETED|First Intervention (1 Day)||0
9057834|NCT03642873|10117310|FG003|NOT COMPLETED|First Intervention (1 Day)||0
9057835|NCT03642873|10117311|FG004|NOT COMPLETED|First Intervention (1 Day)||0
9057836|NCT03642873|10117312|FG005|NOT COMPLETED|First Intervention (1 Day)||0
9057837|NCT03642873|10117307|FG000|STARTED|Washout (7 Days)||4
9057838|NCT03642873|10117308|FG001|STARTED|Washout (7 Days)||4
9057839|NCT03642873|10117309|FG002|STARTED|Washout (7 Days)||4
9057840|NCT03642873|10117310|FG003|STARTED|Washout (7 Days)||4
9057841|NCT03642873|10117311|FG004|STARTED|Washout (7 Days)||4
9057842|NCT03642873|10117312|FG005|STARTED|Washout (7 Days)||4
9057843|NCT03642873|10117307|FG000|COMPLETED|Washout (7 Days)||4
9057844|NCT03642873|10117308|FG001|COMPLETED|Washout (7 Days)||4
9057845|NCT03642873|10117309|FG002|COMPLETED|Washout (7 Days)||4
9057846|NCT03642873|10117310|FG003|COMPLETED|Washout (7 Days)||4
9057847|NCT03642873|10117311|FG004|COMPLETED|Washout (7 Days)||4
9057848|NCT03642873|10117312|FG005|COMPLETED|Washout (7 Days)||4
9057849|NCT03642873|10117307|FG000|NOT COMPLETED|Washout (7 Days)||0
9057850|NCT03642873|10117308|FG001|NOT COMPLETED|Washout (7 Days)||0
9057851|NCT03642873|10117309|FG002|NOT COMPLETED|Washout (7 Days)||0
8703967|NCT00925704|9749711|FG003|NOT COMPLETED|Washout||0
8703968|NCT00925704|9749712|FG004|NOT COMPLETED|Washout||0
8703969|NCT00925704|9749713|FG005|NOT COMPLETED|Washout||0
8703970|NCT00925704|9749708|FG000|STARTED|Second Intervention||6
8703971|NCT00925704|9749709|FG001|STARTED|Second Intervention||7
8703972|NCT00925704|9749710|FG002|STARTED|Second Intervention||7
9057852|NCT03642873|10117310|FG003|NOT COMPLETED|Washout (7 Days)||0
9057853|NCT03642873|10117311|FG004|NOT COMPLETED|Washout (7 Days)||0
9057854|NCT03642873|10117312|FG005|NOT COMPLETED|Washout (7 Days)||0
9057855|NCT03642873|10117307|FG000|STARTED|Second Intervention (1 Day)||4
9057856|NCT03642873|10117308|FG001|STARTED|Second Intervention (1 Day)||4
9057857|NCT03642873|10117309|FG002|STARTED|Second Intervention (1 Day)||4
9057858|NCT03642873|10117310|FG003|STARTED|Second Intervention (1 Day)||4
9057859|NCT03642873|10117311|FG004|STARTED|Second Intervention (1 Day)||4
9057860|NCT03642873|10117312|FG005|STARTED|Second Intervention (1 Day)||4
9057861|NCT03642873|10117307|FG000|COMPLETED|Second Intervention (1 Day)||4
9057862|NCT03642873|10117308|FG001|COMPLETED|Second Intervention (1 Day)||4
9057863|NCT03642873|10117309|FG002|COMPLETED|Second Intervention (1 Day)||4
9057864|NCT03642873|10117310|FG003|COMPLETED|Second Intervention (1 Day)||4
9057865|NCT03642873|10117311|FG004|COMPLETED|Second Intervention (1 Day)||4
9057866|NCT03642873|10117312|FG005|COMPLETED|Second Intervention (1 Day)||4
9057867|NCT03642873|10117307|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
9057868|NCT03642873|10117308|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
9057869|NCT03642873|10117309|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
9057870|NCT03642873|10117310|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
9057871|NCT03642873|10117311|FG004|NOT COMPLETED|Second Intervention (1 Day)||0
9057872|NCT03642873|10117312|FG005|NOT COMPLETED|Second Intervention (1 Day)||0
9057873|NCT03642873|10117307|FG000|STARTED|Washout (7 Days)||4
8703973|NCT00925704|9749711|FG003|STARTED|Second Intervention||6
8703974|NCT00925704|9749712|FG004|STARTED|Second Intervention||6
8703975|NCT00925704|9749713|FG005|STARTED|Second Intervention||7
8703976|NCT00925704|9749708|FG000|COMPLETED|Second Intervention||5
9057874|NCT03642873|10117308|FG001|STARTED|Washout (7 Days)||4
9057875|NCT03642873|10117309|FG002|STARTED|Washout (7 Days)||4
9057876|NCT03642873|10117310|FG003|STARTED|Washout (7 Days)||4
9057877|NCT03642873|10117311|FG004|STARTED|Washout (7 Days)||4
9057878|NCT03642873|10117312|FG005|STARTED|Washout (7 Days)||4
9057879|NCT03642873|10117307|FG000|COMPLETED|Washout (7 Days)||4
9057880|NCT03642873|10117308|FG001|COMPLETED|Washout (7 Days)||4
9057881|NCT03642873|10117309|FG002|COMPLETED|Washout (7 Days)||4
9057882|NCT03642873|10117310|FG003|COMPLETED|Washout (7 Days)||4
9057883|NCT03642873|10117311|FG004|COMPLETED|Washout (7 Days)||4
9057884|NCT03642873|10117312|FG005|COMPLETED|Washout (7 Days)||4
9057885|NCT03642873|10117307|FG000|NOT COMPLETED|Washout (7 Days)||0
9057886|NCT03642873|10117308|FG001|NOT COMPLETED|Washout (7 Days)||0
9057887|NCT03642873|10117309|FG002|NOT COMPLETED|Washout (7 Days)||0
9057888|NCT03642873|10117310|FG003|NOT COMPLETED|Washout (7 Days)||0
9057889|NCT03642873|10117311|FG004|NOT COMPLETED|Washout (7 Days)||0
9057890|NCT03642873|10117312|FG005|NOT COMPLETED|Washout (7 Days)||0
9057891|NCT03642873|10117307|FG000|STARTED|Third Intervention (1 Day)||4
9057892|NCT03642873|10117308|FG001|STARTED|Third Intervention (1 Day)||4
9057893|NCT03642873|10117309|FG002|STARTED|Third Intervention (1 Day)||4
9057894|NCT03642873|10117310|FG003|STARTED|Third Intervention (1 Day)||4
9057895|NCT03642873|10117311|FG004|STARTED|Third Intervention (1 Day)||4
9057896|NCT03642873|10117312|FG005|STARTED|Third Intervention (1 Day)||4
9057897|NCT03642873|10117307|FG000|COMPLETED|Third Intervention (1 Day)||4
9057898|NCT03642873|10117308|FG001|COMPLETED|Third Intervention (1 Day)||4
9057899|NCT03642873|10117309|FG002|COMPLETED|Third Intervention (1 Day)||4
9057900|NCT03642873|10117310|FG003|COMPLETED|Third Intervention (1 Day)||4
9057901|NCT03642873|10117311|FG004|COMPLETED|Third Intervention (1 Day)||3
9057902|NCT03642873|10117312|FG005|COMPLETED|Third Intervention (1 Day)||4
9057903|NCT03642873|10117307|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
9057904|NCT03642873|10117308|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
9057905|NCT03642873|10117309|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
9057906|NCT03642873|10117310|FG003|NOT COMPLETED|Third Intervention (1 Day)||0
9057907|NCT03642873|10117311|FG004|NOT COMPLETED|Third Intervention (1 Day)||1
9057908|NCT03642873|10117312|FG005|NOT COMPLETED|Third Intervention (1 Day)||0
9057909|NCT03643432|10117326|FG000|STARTED|Overall Study||27
9057910|NCT03643432|10117327|FG001|STARTED|Overall Study||21
9057911|NCT03643432|10117326|FG000|COMPLETED|Overall Study||26
9057912|NCT03643432|10117327|FG001|COMPLETED|Overall Study||21
9057913|NCT03643432|10117326|FG000|NOT COMPLETED|Overall Study||1
9057914|NCT03643432|10117327|FG001|NOT COMPLETED|Overall Study||0
9057915|NCT03643575|10117333|FG000|STARTED|Period 1||5
9057916|NCT03643575|10117334|FG001|STARTED|Period 1||5
9057917|NCT03643575|10117335|FG002|STARTED|Period 1||5
9057918|NCT03643575|10117336|FG003|STARTED|Period 1||5
9057919|NCT03643575|10117337|FG004|STARTED|Period 1||5
9057920|NCT03643575|10117338|FG005|STARTED|Period 1||5
9057921|NCT03643575|10117333|FG000|COMPLETED|Period 1||5
9057922|NCT03643575|10117334|FG001|COMPLETED|Period 1||5
9057923|NCT03643575|10117335|FG002|COMPLETED|Period 1||5
9057924|NCT03643575|10117336|FG003|COMPLETED|Period 1||5
9057925|NCT03643575|10117337|FG004|COMPLETED|Period 1||5
9057926|NCT03643575|10117338|FG005|COMPLETED|Period 1||5
9057927|NCT03643575|10117333|FG000|NOT COMPLETED|Period 1||0
9057928|NCT03643575|10117334|FG001|NOT COMPLETED|Period 1||0
9057929|NCT03643575|10117335|FG002|NOT COMPLETED|Period 1||0
9057930|NCT03643575|10117336|FG003|NOT COMPLETED|Period 1||0
9057931|NCT03643575|10117337|FG004|NOT COMPLETED|Period 1||0
9057932|NCT03643575|10117338|FG005|NOT COMPLETED|Period 1||0
9057933|NCT03643575|10117333|FG000|STARTED|Washout: 7 Days||5
9057934|NCT03643575|10117334|FG001|STARTED|Washout: 7 Days||5
9057935|NCT03643575|10117335|FG002|STARTED|Washout: 7 Days||5
9057936|NCT03643575|10117336|FG003|STARTED|Washout: 7 Days||5
9057937|NCT03643575|10117337|FG004|STARTED|Washout: 7 Days||5
9057938|NCT03643575|10117338|FG005|STARTED|Washout: 7 Days||5
9057939|NCT03643575|10117333|FG000|COMPLETED|Washout: 7 Days||4
9057940|NCT03643575|10117334|FG001|COMPLETED|Washout: 7 Days||5
9057941|NCT03643575|10117335|FG002|COMPLETED|Washout: 7 Days||5
9057942|NCT03643575|10117336|FG003|COMPLETED|Washout: 7 Days||4
9057943|NCT03643575|10117337|FG004|COMPLETED|Washout: 7 Days||5
9057944|NCT03643575|10117338|FG005|COMPLETED|Washout: 7 Days||5
9057945|NCT03643575|10117333|FG000|NOT COMPLETED|Washout: 7 Days||1
9057946|NCT03643575|10117334|FG001|NOT COMPLETED|Washout: 7 Days||0
9057947|NCT03643575|10117335|FG002|NOT COMPLETED|Washout: 7 Days||0
9057948|NCT03643575|10117336|FG003|NOT COMPLETED|Washout: 7 Days||1
9057949|NCT03643575|10117337|FG004|NOT COMPLETED|Washout: 7 Days||0
9057950|NCT03643575|10117338|FG005|NOT COMPLETED|Washout: 7 Days||0
9057951|NCT03643575|10117333|FG000|STARTED|Period 2||4
9057952|NCT03643575|10117334|FG001|STARTED|Period 2||5
9057953|NCT03643575|10117335|FG002|STARTED|Period 2||5
9057954|NCT03643575|10117336|FG003|STARTED|Period 2||4
9057955|NCT03643575|10117337|FG004|STARTED|Period 2||5
9057956|NCT03643575|10117338|FG005|STARTED|Period 2||5
9057957|NCT03643575|10117333|FG000|COMPLETED|Period 2||4
9057958|NCT03643575|10117334|FG001|COMPLETED|Period 2||5
9057959|NCT03643575|10117335|FG002|COMPLETED|Period 2||5
8703977|NCT00925704|9749709|FG001|COMPLETED|Second Intervention||7
8703978|NCT00925704|9749710|FG002|COMPLETED|Second Intervention||7
8703979|NCT00925704|9749711|FG003|COMPLETED|Second Intervention||6
8703980|NCT00925704|9749712|FG004|COMPLETED|Second Intervention||5
9057960|NCT03643575|10117336|FG003|COMPLETED|Period 2||4
9057961|NCT03643575|10117337|FG004|COMPLETED|Period 2||5
9057962|NCT03643575|10117338|FG005|COMPLETED|Period 2||5
9057963|NCT03643575|10117333|FG000|NOT COMPLETED|Period 2||0
9057964|NCT03643575|10117334|FG001|NOT COMPLETED|Period 2||0
9057965|NCT03643575|10117335|FG002|NOT COMPLETED|Period 2||0
9057966|NCT03643575|10117336|FG003|NOT COMPLETED|Period 2||0
9057967|NCT03643575|10117337|FG004|NOT COMPLETED|Period 2||0
9057968|NCT03643575|10117338|FG005|NOT COMPLETED|Period 2||0
9057969|NCT03643575|10117333|FG000|STARTED|Washout: 7 Days||4
9057970|NCT03643575|10117334|FG001|STARTED|Washout: 7 Days||5
9057971|NCT03643575|10117335|FG002|STARTED|Washout: 7 Days||5
9057972|NCT03643575|10117336|FG003|STARTED|Washout: 7 Days||4
9057973|NCT03643575|10117337|FG004|STARTED|Washout: 7 Days||5
9057974|NCT03643575|10117338|FG005|STARTED|Washout: 7 Days||5
9057975|NCT03643575|10117333|FG000|COMPLETED|Washout: 7 Days||4
9057976|NCT03643575|10117334|FG001|COMPLETED|Washout: 7 Days||4
9057977|NCT03643575|10117335|FG002|COMPLETED|Washout: 7 Days||5
8703981|NCT00925704|9749713|FG005|COMPLETED|Second Intervention||7
9057978|NCT03643575|10117336|FG003|COMPLETED|Washout: 7 Days||4
9057979|NCT03643575|10117337|FG004|COMPLETED|Washout: 7 Days||5
9057980|NCT03643575|10117338|FG005|COMPLETED|Washout: 7 Days||5
9057981|NCT03643575|10117333|FG000|NOT COMPLETED|Washout: 7 Days||0
9057982|NCT03643575|10117334|FG001|NOT COMPLETED|Washout: 7 Days||1
9057983|NCT03643575|10117335|FG002|NOT COMPLETED|Washout: 7 Days||0
9057984|NCT03643575|10117336|FG003|NOT COMPLETED|Washout: 7 Days||0
9057985|NCT03643575|10117337|FG004|NOT COMPLETED|Washout: 7 Days||0
9057986|NCT03643575|10117338|FG005|NOT COMPLETED|Washout: 7 Days||0
9057987|NCT03643575|10117333|FG000|STARTED|Period 3||4
9057988|NCT03643575|10117334|FG001|STARTED|Period 3||4
9057989|NCT03643575|10117335|FG002|STARTED|Period 3||5
9057990|NCT03643575|10117336|FG003|STARTED|Period 3||4
9057991|NCT03643575|10117337|FG004|STARTED|Period 3||5
9057992|NCT03643575|10117338|FG005|STARTED|Period 3||5
9057993|NCT03643575|10117333|FG000|COMPLETED|Period 3||4
9057994|NCT03643575|10117334|FG001|COMPLETED|Period 3||4
9057995|NCT03643575|10117335|FG002|COMPLETED|Period 3||5
9057996|NCT03643575|10117336|FG003|COMPLETED|Period 3||4
9057997|NCT03643575|10117337|FG004|COMPLETED|Period 3||5
9057998|NCT03643575|10117338|FG005|COMPLETED|Period 3||5
9057999|NCT03643575|10117333|FG000|NOT COMPLETED|Period 3||0
9058000|NCT03643575|10117334|FG001|NOT COMPLETED|Period 3||0
9058001|NCT03643575|10117335|FG002|NOT COMPLETED|Period 3||0
9058002|NCT03643575|10117336|FG003|NOT COMPLETED|Period 3||0
9058003|NCT03643575|10117337|FG004|NOT COMPLETED|Period 3||0
9058004|NCT03643575|10117338|FG005|NOT COMPLETED|Period 3||0
9058005|NCT03643692|10117346|FG000|STARTED|Overall Study||12
9058006|NCT03643692|10117346|FG000|COMPLETED|Overall Study||12
9058007|NCT03643692|10117346|FG000|NOT COMPLETED|Overall Study||0
9058008|NCT03643952|10117350|FG000|STARTED|Overall Study||18
9058009|NCT03643952|10117350|FG000|COMPLETED|Overall Study||17
9058010|NCT03643952|10117350|FG000|NOT COMPLETED|Overall Study||1
9058011|NCT03644095|10117362|FG000|STARTED|Period 1||15
9058012|NCT03644095|10117363|FG001|STARTED|Period 1||15
9058013|NCT03644095|10117362|FG000|COMPLETED|Period 1||15
9058014|NCT03644095|10117363|FG001|COMPLETED|Period 1||15
9058015|NCT03644095|10117362|FG000|NOT COMPLETED|Period 1||0
9058016|NCT03644095|10117363|FG001|NOT COMPLETED|Period 1||0
9058017|NCT03644095|10117362|FG000|STARTED|Washout (7 Days)||15
9058018|NCT03644095|10117363|FG001|STARTED|Washout (7 Days)||15
9058019|NCT03644095|10117362|FG000|COMPLETED|Washout (7 Days)||15
9058020|NCT03644095|10117363|FG001|COMPLETED|Washout (7 Days)||15
9058021|NCT03644095|10117362|FG000|NOT COMPLETED|Washout (7 Days)||0
9058022|NCT03644095|10117363|FG001|NOT COMPLETED|Washout (7 Days)||0
9058023|NCT03644095|10117362|FG000|STARTED|Period 2||15
9058024|NCT03644095|10117363|FG001|STARTED|Period 2||15
9058025|NCT03644095|10117362|FG000|COMPLETED|Period 2||15
9058026|NCT03644095|10117363|FG001|COMPLETED|Period 2||15
9058027|NCT03644095|10117362|FG000|NOT COMPLETED|Period 2||0
9058028|NCT03644095|10117363|FG001|NOT COMPLETED|Period 2||0
8703982|NCT00925704|9749708|FG000|NOT COMPLETED|Second Intervention||1
8703983|NCT00925704|9749709|FG001|NOT COMPLETED|Second Intervention||0
8703984|NCT00925704|9749710|FG002|NOT COMPLETED|Second Intervention||0
8703985|NCT00925704|9749711|FG003|NOT COMPLETED|Second Intervention||0
8703986|NCT00925704|9749712|FG004|NOT COMPLETED|Second Intervention||1
8703987|NCT00925704|9749713|FG005|NOT COMPLETED|Second Intervention||0
8703988|NCT00925704|9749708|FG000|STARTED|Washout||5
8703989|NCT00925704|9749709|FG001|STARTED|Washout||7
8703990|NCT00925704|9749710|FG002|STARTED|Washout||7
8703991|NCT00925704|9749711|FG003|STARTED|Washout||6
8703992|NCT00925704|9749712|FG004|STARTED|Washout||5
8703993|NCT00925704|9749713|FG005|STARTED|Washout||7
8703994|NCT00925704|9749708|FG000|COMPLETED|Washout||5
8703995|NCT00925704|9749709|FG001|COMPLETED|Washout||7
8703996|NCT00925704|9749710|FG002|COMPLETED|Washout||7
8703997|NCT00925704|9749711|FG003|COMPLETED|Washout||6
8703998|NCT00925704|9749712|FG004|COMPLETED|Washout||5
8703999|NCT00925704|9749713|FG005|COMPLETED|Washout||7
8704000|NCT00925704|9749708|FG000|NOT COMPLETED|Washout||0
8704001|NCT00925704|9749709|FG001|NOT COMPLETED|Washout||0
8704002|NCT00925704|9749710|FG002|NOT COMPLETED|Washout||0
8704003|NCT00925704|9749711|FG003|NOT COMPLETED|Washout||0
8704004|NCT00925704|9749712|FG004|NOT COMPLETED|Washout||0
8704005|NCT00925704|9749713|FG005|NOT COMPLETED|Washout||0
9058029|NCT03644108|10117369|FG000|STARTED|Overall Study||30
9058030|NCT03644108|10117369|FG000|COMPLETED|Overall Study||30
9058031|NCT03644108|10117369|FG000|NOT COMPLETED|Overall Study||0
8704006|NCT00925704|9749708|FG000|STARTED|Third Intervention||5
8704007|NCT00925704|9749709|FG001|STARTED|Third Intervention||7
8704008|NCT00925704|9749710|FG002|STARTED|Third Intervention||7
8704009|NCT00925704|9749711|FG003|STARTED|Third Intervention||6
8704010|NCT00925704|9749712|FG004|STARTED|Third Intervention||5
8704011|NCT00925704|9749713|FG005|STARTED|Third Intervention||7
9058032|NCT03644173|10117373|FG000|STARTED|Participants at Last Visit (Pre-surveys)||37
9058033|NCT03644173|10117373|FG000|COMPLETED|Participants at Last Visit (Pre-surveys)||16
8704012|NCT00925704|9749708|FG000|COMPLETED|Third Intervention||5
8704013|NCT00925704|9749709|FG001|COMPLETED|Third Intervention||7
8704014|NCT00925704|9749710|FG002|COMPLETED|Third Intervention||7
9058034|NCT03644173|10117373|FG000|NOT COMPLETED|Participants at Last Visit (Pre-surveys)||21
9058035|NCT03644173|10117373|FG000|STARTED|Participants at the 1-month Follow up||16
9058036|NCT03644173|10117373|FG000|COMPLETED|Participants at the 1-month Follow up||12
9058037|NCT03644173|10117373|FG000|NOT COMPLETED|Participants at the 1-month Follow up||4
8704015|NCT00925704|9749711|FG003|COMPLETED|Third Intervention||6
9058038|NCT03644173|10117373|FG000|STARTED|Participants at the 3-month Follow up||12
9058039|NCT03644173|10117373|FG000|COMPLETED|Participants at the 3-month Follow up||10
9058040|NCT03644173|10117373|FG000|NOT COMPLETED|Participants at the 3-month Follow up||2
9058041|NCT03644212|10117380|FG000|STARTED|Overall Study||63
9058042|NCT03644212|10117381|FG001|STARTED|Overall Study||16
9058043|NCT03644212|10117380|FG000|COMPLETED|Overall Study||63
9058044|NCT03644212|10117381|FG001|COMPLETED|Overall Study||16
9058045|NCT03644212|10117380|FG000|NOT COMPLETED|Overall Study||0
9058046|NCT03644212|10117381|FG001|NOT COMPLETED|Overall Study||0
9058047|NCT03645421|10117391|FG000|STARTED|Overall Study||16
9058048|NCT03645421|10117392|FG001|STARTED|Overall Study||15
9058049|NCT03645421|10117393|FG002|STARTED|Overall Study||15
9058050|NCT03645421|10117394|FG003|STARTED|Overall Study||15
9058051|NCT03645421|10117391|FG000|Received Investigational Product (IP)|Overall Study||16
9058052|NCT03645421|10117392|FG001|Received Investigational Product (IP)|Overall Study||15
9058053|NCT03645421|10117393|FG002|Received Investigational Product (IP)|Overall Study||15
9058054|NCT03645421|10117394|FG003|Received Investigational Product (IP)|Overall Study||15
9058055|NCT03645421|10117391|FG000|COMPLETED|Overall Study||16
9058056|NCT03645421|10117392|FG001|COMPLETED|Overall Study||15
9058057|NCT03645421|10117393|FG002|COMPLETED|Overall Study||10
9058058|NCT03645421|10117394|FG003|COMPLETED|Overall Study||11
9058059|NCT03645421|10117391|FG000|NOT COMPLETED|Overall Study||0
9058060|NCT03645421|10117392|FG001|NOT COMPLETED|Overall Study||0
9058061|NCT03645421|10117393|FG002|NOT COMPLETED|Overall Study||5
9058062|NCT03645421|10117394|FG003|NOT COMPLETED|Overall Study||4
9058063|NCT03645434|10117407|FG000|STARTED|Period 1||12
9058064|NCT03645434|10117408|FG001|STARTED|Period 1||13
9058065|NCT03645434|10117409|FG002|STARTED|Period 1||13
9058066|NCT03645434|10117410|FG003|STARTED|Period 1||11
9058067|NCT03645434|10117411|FG004|STARTED|Period 1||12
9058068|NCT03645434|10117412|FG005|STARTED|Period 1||12
9058069|NCT03645434|10117407|FG000|COMPLETED|Period 1||12
9058070|NCT03645434|10117408|FG001|COMPLETED|Period 1||13
9058071|NCT03645434|10117409|FG002|COMPLETED|Period 1||13
9058072|NCT03645434|10117410|FG003|COMPLETED|Period 1||10
9058073|NCT03645434|10117411|FG004|COMPLETED|Period 1||11
9058074|NCT03645434|10117412|FG005|COMPLETED|Period 1||12
9058075|NCT03645434|10117407|FG000|NOT COMPLETED|Period 1||0
9058076|NCT03645434|10117408|FG001|NOT COMPLETED|Period 1||0
9058077|NCT03645434|10117409|FG002|NOT COMPLETED|Period 1||0
9058078|NCT03645434|10117410|FG003|NOT COMPLETED|Period 1||1
9058079|NCT03645434|10117411|FG004|NOT COMPLETED|Period 1||1
9058080|NCT03645434|10117412|FG005|NOT COMPLETED|Period 1||0
9058081|NCT03645434|10117407|FG000|STARTED|Period 2|2 subject discontinued as they did not meet stability or FEV1 variability.|10
9058082|NCT03645434|10117408|FG001|STARTED|Period 2||13
9058083|NCT03645434|10117409|FG002|STARTED|Period 2||13
9058084|NCT03645434|10117410|FG003|STARTED|Period 2||10
9058085|NCT03645434|10117411|FG004|STARTED|Period 2||11
9058086|NCT03645434|10117412|FG005|STARTED|Period 2|1 subject completed Period 1 but not allowed to enter Period 2 due to physician decision.|11
9058087|NCT03645434|10117407|FG000|COMPLETED|Period 2||10
9058088|NCT03645434|10117408|FG001|COMPLETED|Period 2||13
9058089|NCT03645434|10117409|FG002|COMPLETED|Period 2||13
9058090|NCT03645434|10117410|FG003|COMPLETED|Period 2||10
9058091|NCT03645434|10117411|FG004|COMPLETED|Period 2||11
9058092|NCT03645434|10117412|FG005|COMPLETED|Period 2||11
9058093|NCT03645434|10117407|FG000|NOT COMPLETED|Period 2||0
9058094|NCT03645434|10117408|FG001|NOT COMPLETED|Period 2||0
9058095|NCT03645434|10117409|FG002|NOT COMPLETED|Period 2||0
9058096|NCT03645434|10117410|FG003|NOT COMPLETED|Period 2||0
9058097|NCT03645434|10117411|FG004|NOT COMPLETED|Period 2||0
9058098|NCT03645434|10117412|FG005|NOT COMPLETED|Period 2||0
9058099|NCT03645434|10117407|FG000|STARTED|Period 3||10
9058100|NCT03645434|10117408|FG001|STARTED|Period 3||13
9058101|NCT03645434|10117409|FG002|STARTED|Period 3|2 subjects discontinued as they did not meet FEV1 stability criteria or pfts variability criteria.|11
9058102|NCT03645434|10117410|FG003|STARTED|Period 3||10
9058103|NCT03645434|10117411|FG004|STARTED|Period 3||11
9058104|NCT03645434|10117412|FG005|STARTED|Period 3||11
9058105|NCT03645434|10117407|FG000|COMPLETED|Period 3||10
9058106|NCT03645434|10117408|FG001|COMPLETED|Period 3||13
9058107|NCT03645434|10117409|FG002|COMPLETED|Period 3||11
9058108|NCT03645434|10117410|FG003|COMPLETED|Period 3||10
9058109|NCT03645434|10117411|FG004|COMPLETED|Period 3||11
9058110|NCT03645434|10117412|FG005|COMPLETED|Period 3||11
9058111|NCT03645434|10117407|FG000|NOT COMPLETED|Period 3||0
9058112|NCT03645434|10117408|FG001|NOT COMPLETED|Period 3||0
9058113|NCT03645434|10117409|FG002|NOT COMPLETED|Period 3||0
9058114|NCT03645434|10117410|FG003|NOT COMPLETED|Period 3||0
9058115|NCT03645434|10117411|FG004|NOT COMPLETED|Period 3||0
9058116|NCT03645434|10117412|FG005|NOT COMPLETED|Period 3||0
9058117|NCT03645785|10117420|FG000|STARTED|Day 1 (Normal Fluid Intake and Diet)||23
9058118|NCT03645785|10117420|FG000|COMPLETED|Day 1 (Normal Fluid Intake and Diet)||23
9058119|NCT03645785|10117420|FG000|NOT COMPLETED|Day 1 (Normal Fluid Intake and Diet)||0
9058120|NCT03645785|10117420|FG000|STARTED|Day 2-4 (Double Fluid and Add Citrate)||23
9058121|NCT03645785|10117420|FG000|COMPLETED|Day 2-4 (Double Fluid and Add Citrate)||23
9058122|NCT03645785|10117420|FG000|NOT COMPLETED|Day 2-4 (Double Fluid and Add Citrate)||0
9058123|NCT03645811|10117439|FG000|STARTED|Overall Study||32
9058124|NCT03645811|10117440|FG001|STARTED|Overall Study||32
9058125|NCT03645811|10117441|FG002|STARTED|Overall Study||32
8704016|NCT00925704|9749712|FG004|COMPLETED|Third Intervention||5
9058126|NCT03645811|10117439|FG000|COMPLETED|Overall Study||30
9058127|NCT03645811|10117440|FG001|COMPLETED|Overall Study||30
9058128|NCT03645811|10117441|FG002|COMPLETED|Overall Study||30
9058129|NCT03645811|10117439|FG000|NOT COMPLETED|Overall Study||2
9058130|NCT03645811|10117440|FG001|NOT COMPLETED|Overall Study||2
9058131|NCT03645811|10117441|FG002|NOT COMPLETED|Overall Study||2
9058132|NCT03645954|10117451|FG000|STARTED|Overall Study||40
9058133|NCT03645954|10117452|FG001|STARTED|Overall Study||40
9058134|NCT03645954|10117451|FG000|COMPLETED|Overall Study||37
9058135|NCT03645954|10117452|FG001|COMPLETED|Overall Study||40
9058136|NCT03645954|10117451|FG000|NOT COMPLETED|Overall Study||3
9058137|NCT03645954|10117452|FG001|NOT COMPLETED|Overall Study||0
9058138|NCT03646305|10117462|FG000|STARTED|Overall Study||32
9058139|NCT03646305|10117463|FG001|STARTED|Overall Study||35
9058140|NCT03646305|10117464|FG002|STARTED|Overall Study||33
9058141|NCT03646305|10117465|FG003|STARTED|Overall Study||33
9058142|NCT03646305|10117462|FG000|Received Treatment|Overall Study||31
9058143|NCT03646305|10117463|FG001|Received Treatment|Overall Study||35
9058144|NCT03646305|10117464|FG002|Received Treatment|Overall Study||32
9058145|NCT03646305|10117465|FG003|Received Treatment|Overall Study||32
9058146|NCT03646305|10117462|FG000|No Treatment Recieved|Overall Study||1
9058147|NCT03646305|10117463|FG001|No Treatment Recieved|Overall Study||0
9058148|NCT03646305|10117464|FG002|No Treatment Recieved|Overall Study||1
9058149|NCT03646305|10117465|FG003|No Treatment Recieved|Overall Study||1
9058150|NCT03646305|10117462|FG000|COMPLETED|Overall Study||27
9058151|NCT03646305|10117463|FG001|COMPLETED|Overall Study||33
9058152|NCT03646305|10117464|FG002|COMPLETED|Overall Study||31
9058153|NCT03646305|10117465|FG003|COMPLETED|Overall Study||31
9058154|NCT03646305|10117462|FG000|NOT COMPLETED|Overall Study||5
9058155|NCT03646305|10117463|FG001|NOT COMPLETED|Overall Study||2
9058156|NCT03646305|10117464|FG002|NOT COMPLETED|Overall Study||2
9058157|NCT03646305|10117465|FG003|NOT COMPLETED|Overall Study||2
9058158|NCT03646656|10117481|FG000|STARTED|Overall Study||12
9058159|NCT03646656|10117482|FG001|STARTED|Overall Study||3
9058160|NCT03646656|10117481|FG000|Attended 1st Group Session|Overall Study||10
9058161|NCT03646656|10117482|FG001|Attended 1st Group Session|Overall Study||3
9058162|NCT03646656|10117481|FG000|COMPLETED|Overall Study||9
9058163|NCT03646656|10117482|FG001|COMPLETED|Overall Study||3
9058164|NCT03646656|10117481|FG000|NOT COMPLETED|Overall Study||3
9058165|NCT03646656|10117482|FG001|NOT COMPLETED|Overall Study||0
9058166|NCT03647033|10117494|FG000|STARTED|Overall Study||16
9058167|NCT03647033|10117495|FG001|STARTED|Overall Study||16
9058168|NCT03647033|10117494|FG000|COMPLETED|Overall Study||16
9058169|NCT03647033|10117495|FG001|COMPLETED|Overall Study||16
9058170|NCT03647033|10117494|FG000|NOT COMPLETED|Overall Study||0
9058171|NCT03647033|10117495|FG001|NOT COMPLETED|Overall Study||0
9058172|NCT03647046|10117501|FG000|STARTED|Overall Study||12
9058173|NCT03647046|10117501|FG000|COMPLETED|Overall Study||8
9058174|NCT03647046|10117501|FG000|NOT COMPLETED|Overall Study||4
9058175|NCT03647267|10117507|FG000|STARTED|Overall Study||24
9058176|NCT03647267|10117508|FG001|STARTED|Overall Study||22
9058177|NCT03647267|10117507|FG000|COMPLETED|Overall Study||23
9058178|NCT03647267|10117508|FG001|COMPLETED|Overall Study||22
9058179|NCT03647267|10117507|FG000|NOT COMPLETED|Overall Study||1
9058180|NCT03647267|10117508|FG001|NOT COMPLETED|Overall Study||0
9058181|NCT03647475|10117516|FG000|STARTED|Overall Study||752
9058182|NCT03647475|10117516|FG000|NCT03647475 - Included in One Month Clear Analysis Population|Overall Study||601
9058183|NCT03647475|10117516|FG000|NCT03344653- Included in One Month Clear Analysis Population|Overall Study||905
9058184|NCT03647475|10117516|FG000|COMPLETED|Overall Study||75
9058185|NCT03647475|10117516|FG000|NOT COMPLETED|Overall Study||677
9058186|NCT03647709|10117520|FG000|STARTED|Overall Study||400
9058187|NCT03647709|10117520|FG000|COMPLETED|Overall Study||386
9058188|NCT03647709|10117520|FG000|NOT COMPLETED|Overall Study||14
9058189|NCT03648853|10117526|FG000|STARTED|Overall Study||12
9058190|NCT03648853|10117526|FG000|COMPLETED|Overall Study||12
9058191|NCT03648853|10117526|FG000|NOT COMPLETED|Overall Study||0
9058192|NCT03648879|10117530|FG000|STARTED|Overall Study||37
9058193|NCT03648879|10117530|FG000|COMPLETED|Overall Study||36
9058194|NCT03648879|10117530|FG000|NOT COMPLETED|Overall Study||1
9058195|NCT03649412|10117536|FG000|STARTED|Part A, Period 1 (4 Days)||16
9058196|NCT03649412|10117537|FG001|STARTED|Part A, Period 1 (4 Days)||0
9058197|NCT03649412|10117536|FG000|COMPLETED|Part A, Period 1 (4 Days)||16
9058198|NCT03649412|10117537|FG001|COMPLETED|Part A, Period 1 (4 Days)||0
9058199|NCT03649412|10117536|FG000|NOT COMPLETED|Part A, Period 1 (4 Days)||0
9058200|NCT03649412|10117537|FG001|NOT COMPLETED|Part A, Period 1 (4 Days)||0
9058201|NCT03649412|10117536|FG000|STARTED|Part A, Washout Period 1 (7 Days)||16
9058202|NCT03649412|10117537|FG001|STARTED|Part A, Washout Period 1 (7 Days)||0
9058203|NCT03649412|10117536|FG000|COMPLETED|Part A, Washout Period 1 (7 Days)||15
9058204|NCT03649412|10117537|FG001|COMPLETED|Part A, Washout Period 1 (7 Days)||0
9058205|NCT03649412|10117536|FG000|NOT COMPLETED|Part A, Washout Period 1 (7 Days)||1
9058206|NCT03649412|10117537|FG001|NOT COMPLETED|Part A, Washout Period 1 (7 Days)||0
9058207|NCT03649412|10117536|FG000|STARTED|Part A, Period 2 (3 Days)|1 Replacement par. was enrolled & dosed|16
9058208|NCT03649412|10117537|FG001|STARTED|Part A, Period 2 (3 Days)||0
9058209|NCT03649412|10117536|FG000|COMPLETED|Part A, Period 2 (3 Days)||16
9058210|NCT03649412|10117537|FG001|COMPLETED|Part A, Period 2 (3 Days)||0
9058211|NCT03649412|10117536|FG000|NOT COMPLETED|Part A, Period 2 (3 Days)||0
9058212|NCT03649412|10117537|FG001|NOT COMPLETED|Part A, Period 2 (3 Days)||0
9058213|NCT03649412|10117536|FG000|STARTED|Part A, Washout Period 2 (7 Days)||16
9058214|NCT03649412|10117537|FG001|STARTED|Part A, Washout Period 2 (7 Days)||0
9058215|NCT03649412|10117536|FG000|COMPLETED|Part A, Washout Period 2 (7 Days)||16
9058216|NCT03649412|10117537|FG001|COMPLETED|Part A, Washout Period 2 (7 Days)||0
9058217|NCT03649412|10117536|FG000|NOT COMPLETED|Part A, Washout Period 2 (7 Days)||0
9058218|NCT03649412|10117537|FG001|NOT COMPLETED|Part A, Washout Period 2 (7 Days)||0
9058219|NCT03649412|10117536|FG000|STARTED|Part A, Period 3 (4 Days)||16
9058220|NCT03649412|10117537|FG001|STARTED|Part A, Period 3 (4 Days)||0
9058221|NCT03649412|10117536|FG000|COMPLETED|Part A, Period 3 (4 Days)||16
9058222|NCT03649412|10117537|FG001|COMPLETED|Part A, Period 3 (4 Days)||0
9058223|NCT03649412|10117536|FG000|NOT COMPLETED|Part A, Period 3 (4 Days)||0
9058224|NCT03649412|10117537|FG001|NOT COMPLETED|Part A, Period 3 (4 Days)||0
9058225|NCT03649412|10117536|FG000|STARTED|Part A, Washout Period 3 (7 Days)||16
9058226|NCT03649412|10117537|FG001|STARTED|Part A, Washout Period 3 (7 Days)||0
9058227|NCT03649412|10117536|FG000|COMPLETED|Part A, Washout Period 3 (7 Days)||16
9058228|NCT03649412|10117537|FG001|COMPLETED|Part A, Washout Period 3 (7 Days)||0
9058229|NCT03649412|10117536|FG000|NOT COMPLETED|Part A, Washout Period 3 (7 Days)||0
9058230|NCT03649412|10117537|FG001|NOT COMPLETED|Part A, Washout Period 3 (7 Days)||0
9058231|NCT03649412|10117536|FG000|STARTED|Part A, Period 4 (4 Days)||16
9058232|NCT03649412|10117537|FG001|STARTED|Part A, Period 4 (4 Days)||0
9058233|NCT03649412|10117536|FG000|COMPLETED|Part A, Period 4 (4 Days)||16
9058234|NCT03649412|10117537|FG001|COMPLETED|Part A, Period 4 (4 Days)||0
9058235|NCT03649412|10117536|FG000|NOT COMPLETED|Part A, Period 4 (4 Days)||0
9058236|NCT03649412|10117537|FG001|NOT COMPLETED|Part A, Period 4 (4 Days)||0
9058237|NCT03649412|10117536|FG000|STARTED|Part A, Washout Period 4 (7 Days)||16
9058238|NCT03649412|10117537|FG001|STARTED|Part A, Washout Period 4 (7 Days)||0
9058239|NCT03649412|10117536|FG000|COMPLETED|Part A, Washout Period 4 (7 Days)||14
9058240|NCT03649412|10117537|FG001|COMPLETED|Part A, Washout Period 4 (7 Days)||0
9058241|NCT03649412|10117536|FG000|NOT COMPLETED|Part A, Washout Period 4 (7 Days)||2
9058242|NCT03649412|10117537|FG001|NOT COMPLETED|Part A, Washout Period 4 (7 Days)||0
9058243|NCT03649412|10117536|FG000|STARTED|Part A, Period 5 (4 Days)|Two participant did not start in Period 5|12
9058244|NCT03649412|10117537|FG001|STARTED|Part A, Period 5 (4 Days)||0
9058245|NCT03649412|10117536|FG000|COMPLETED|Part A, Period 5 (4 Days)||12
9058246|NCT03649412|10117537|FG001|COMPLETED|Part A, Period 5 (4 Days)||0
9058247|NCT03649412|10117536|FG000|NOT COMPLETED|Part A, Period 5 (4 Days)||0
9058248|NCT03649412|10117537|FG001|NOT COMPLETED|Part A, Period 5 (4 Days)||0
9058249|NCT03649412|10117536|FG000|STARTED|Part A, Washout Period 5 (7 Days)||12
9058250|NCT03649412|10117537|FG001|STARTED|Part A, Washout Period 5 (7 Days)||0
9058251|NCT03649412|10117536|FG000|COMPLETED|Part A, Washout Period 5 (7 Days)||11
9058252|NCT03649412|10117537|FG001|COMPLETED|Part A, Washout Period 5 (7 Days)||0
9058253|NCT03649412|10117536|FG000|NOT COMPLETED|Part A, Washout Period 5 (7 Days)||1
9058254|NCT03649412|10117537|FG001|NOT COMPLETED|Part A, Washout Period 5 (7 Days)||0
9058255|NCT03649412|10117536|FG000|STARTED|Part A, Period 6 (4 Days)|1 of the participant who did not start Period 5 directly joined into Period 6|12
9058256|NCT03649412|10117537|FG001|STARTED|Part A, Period 6 (4 Days)||0
9058257|NCT03649412|10117536|FG000|COMPLETED|Part A, Period 6 (4 Days)||12
9058258|NCT03649412|10117537|FG001|COMPLETED|Part A, Period 6 (4 Days)||0
9058259|NCT03649412|10117536|FG000|NOT COMPLETED|Part A, Period 6 (4 Days)||0
9058260|NCT03649412|10117537|FG001|NOT COMPLETED|Part A, Period 6 (4 Days)||0
9058261|NCT03649412|10117536|FG000|STARTED|Part B, Period 1 (4 Days)|Participants in Part A did not enter Part B|0
9058262|NCT03649412|10117537|FG001|STARTED|Part B, Period 1 (4 Days)|16 new participants enrolled in Part B|16
9058263|NCT03649412|10117536|FG000|COMPLETED|Part B, Period 1 (4 Days)||0
9058264|NCT03649412|10117537|FG001|COMPLETED|Part B, Period 1 (4 Days)||16
9058265|NCT03649412|10117536|FG000|NOT COMPLETED|Part B, Period 1 (4 Days)||0
9058266|NCT03649412|10117537|FG001|NOT COMPLETED|Part B, Period 1 (4 Days)||0
9058267|NCT03649412|10117536|FG000|STARTED|Part B, Washout Period 1 (7 Days)||0
9058268|NCT03649412|10117537|FG001|STARTED|Part B, Washout Period 1 (7 Days)||16
9058269|NCT03649412|10117536|FG000|COMPLETED|Part B, Washout Period 1 (7 Days)||0
9058270|NCT03649412|10117537|FG001|COMPLETED|Part B, Washout Period 1 (7 Days)||15
9058271|NCT03649412|10117536|FG000|NOT COMPLETED|Part B, Washout Period 1 (7 Days)||0
9058272|NCT03649412|10117537|FG001|NOT COMPLETED|Part B, Washout Period 1 (7 Days)||1
9058273|NCT03649412|10117536|FG000|STARTED|Part B, Period 2 (4 Days)||0
9058274|NCT03649412|10117537|FG001|STARTED|Part B, Period 2 (4 Days)||15
9058275|NCT03649412|10117536|FG000|COMPLETED|Part B, Period 2 (4 Days)||0
9058276|NCT03649412|10117537|FG001|COMPLETED|Part B, Period 2 (4 Days)||15
9058277|NCT03649412|10117536|FG000|NOT COMPLETED|Part B, Period 2 (4 Days)||0
9058278|NCT03649412|10117537|FG001|NOT COMPLETED|Part B, Period 2 (4 Days)||0
9058279|NCT03649412|10117536|FG000|STARTED|Part B, Washout Period 2 (7 Days)||0
9058280|NCT03649412|10117537|FG001|STARTED|Part B, Washout Period 2 (7 Days)||15
9058281|NCT03649412|10117536|FG000|COMPLETED|Part B, Washout Period 2 (7 Days)||0
9058282|NCT03649412|10117537|FG001|COMPLETED|Part B, Washout Period 2 (7 Days)||15
9058283|NCT03649412|10117536|FG000|NOT COMPLETED|Part B, Washout Period 2 (7 Days)||0
9058284|NCT03649412|10117537|FG001|NOT COMPLETED|Part B, Washout Period 2 (7 Days)||0
9058285|NCT03649412|10117536|FG000|STARTED|Part B, Period 3 (4 Days)||0
9058286|NCT03649412|10117537|FG001|STARTED|Part B, Period 3 (4 Days)||15
9058287|NCT03649412|10117536|FG000|COMPLETED|Part B, Period 3 (4 Days)||0
9058288|NCT03649412|10117537|FG001|COMPLETED|Part B, Period 3 (4 Days)||15
9058289|NCT03649412|10117536|FG000|NOT COMPLETED|Part B, Period 3 (4 Days)||0
9058290|NCT03649412|10117537|FG001|NOT COMPLETED|Part B, Period 3 (4 Days)||0
9058291|NCT03649412|10117536|FG000|STARTED|Part B, Washout Period 3 (7 Days)||0
9058292|NCT03649412|10117537|FG001|STARTED|Part B, Washout Period 3 (7 Days)||15
9058293|NCT03649412|10117536|FG000|COMPLETED|Part B, Washout Period 3 (7 Days)||0
9058294|NCT03649412|10117537|FG001|COMPLETED|Part B, Washout Period 3 (7 Days)||15
9058295|NCT03649412|10117536|FG000|NOT COMPLETED|Part B, Washout Period 3 (7 Days)||0
9058296|NCT03649412|10117537|FG001|NOT COMPLETED|Part B, Washout Period 3 (7 Days)||0
9058297|NCT03649412|10117536|FG000|STARTED|Part B, Period 4 (4 Days)||0
9058298|NCT03649412|10117537|FG001|STARTED|Part B, Period 4 (4 Days)||15
9058299|NCT03649412|10117536|FG000|COMPLETED|Part B, Period 4 (4 Days)||0
9058300|NCT03649412|10117537|FG001|COMPLETED|Part B, Period 4 (4 Days)||15
9058301|NCT03649412|10117536|FG000|NOT COMPLETED|Part B, Period 4 (4 Days)||0
9058302|NCT03649412|10117537|FG001|NOT COMPLETED|Part B, Period 4 (4 Days)||0
9058303|NCT03649412|10117536|FG000|STARTED|Part B, Washout Period 4 (7 Days)||0
9058304|NCT03649412|10117537|FG001|STARTED|Part B, Washout Period 4 (7 Days)||15
9058305|NCT03649412|10117536|FG000|COMPLETED|Part B, Washout Period 4 (7 Days)||0
9058306|NCT03649412|10117537|FG001|COMPLETED|Part B, Washout Period 4 (7 Days)||15
9058307|NCT03649412|10117536|FG000|NOT COMPLETED|Part B, Washout Period 4 (7 Days)||0
9058308|NCT03649412|10117537|FG001|NOT COMPLETED|Part B, Washout Period 4 (7 Days)||0
9058309|NCT03649412|10117536|FG000|STARTED|Part B, Period 5 (4 Days)||0
9058310|NCT03649412|10117537|FG001|STARTED|Part B, Period 5 (4 Days)|One participant did not start in Period 5|14
9058311|NCT03649412|10117536|FG000|COMPLETED|Part B, Period 5 (4 Days)||0
9058312|NCT03649412|10117537|FG001|COMPLETED|Part B, Period 5 (4 Days)||14
9058313|NCT03649412|10117536|FG000|NOT COMPLETED|Part B, Period 5 (4 Days)||0
9058314|NCT03649412|10117537|FG001|NOT COMPLETED|Part B, Period 5 (4 Days)||0
9058315|NCT03649412|10117536|FG000|STARTED|Part B, Washout Period 5 (7 Days)||0
9058316|NCT03649412|10117537|FG001|STARTED|Part B, Washout Period 5 (7 Days)||14
9058317|NCT03649412|10117536|FG000|COMPLETED|Part B, Washout Period 5 (7 Days)||0
9058318|NCT03649412|10117537|FG001|COMPLETED|Part B, Washout Period 5 (7 Days)||13
9058319|NCT03649412|10117536|FG000|NOT COMPLETED|Part B, Washout Period 5 (7 Days)||0
9058320|NCT03649412|10117537|FG001|NOT COMPLETED|Part B, Washout Period 5 (7 Days)||1
9058321|NCT03649412|10117536|FG000|STARTED|Part B, Period 6 (4days)||0
9058322|NCT03649412|10117537|FG001|STARTED|Part B, Period 6 (4days)|Participant who did not start Period 5 directly joined into Period 6|14
9058323|NCT03649412|10117536|FG000|COMPLETED|Part B, Period 6 (4days)||0
9058324|NCT03649412|10117537|FG001|COMPLETED|Part B, Period 6 (4days)||14
9058325|NCT03649412|10117536|FG000|NOT COMPLETED|Part B, Period 6 (4days)||0
9058326|NCT03649412|10117537|FG001|NOT COMPLETED|Part B, Period 6 (4days)||0
9058327|NCT03649477|10117583|FG000|STARTED|Overall Study||44
9058328|NCT03649477|10117584|FG001|STARTED|Overall Study||43
9058329|NCT03649477|10117585|FG002|STARTED|Overall Study||43
9058330|NCT03649477|10117583|FG000|COMPLETED|Overall Study||42
9058331|NCT03649477|10117584|FG001|COMPLETED|Overall Study||43
9058332|NCT03649477|10117585|FG002|COMPLETED|Overall Study||43
9058333|NCT03649477|10117583|FG000|NOT COMPLETED|Overall Study||2
9058334|NCT03649477|10117584|FG001|NOT COMPLETED|Overall Study||0
9058335|NCT03649477|10117585|FG002|NOT COMPLETED|Overall Study||0
9058336|NCT03649646|10117593|FG000|STARTED|Overall Study||4542
9058337|NCT03649646|10117593|FG000|COMPLETED|Overall Study||4075
9058338|NCT03649646|10117593|FG000|NOT COMPLETED|Overall Study||467
9058339|NCT03649750|10117597|FG000|STARTED|Period 1||12
9058340|NCT03649750|10117598|FG001|STARTED|Period 1||24
9058341|NCT03649750|10117597|FG000|COMPLETED|Period 1||12
9058342|NCT03649750|10117598|FG001|COMPLETED|Period 1||24
9058343|NCT03649750|10117597|FG000|NOT COMPLETED|Period 1||0
9058344|NCT03649750|10117598|FG001|NOT COMPLETED|Period 1||0
9058345|NCT03649750|10117597|FG000|STARTED|Washout: 7 Days||12
9058346|NCT03649750|10117598|FG001|STARTED|Washout: 7 Days||24
9058347|NCT03649750|10117597|FG000|COMPLETED|Washout: 7 Days||12
9058348|NCT03649750|10117598|FG001|COMPLETED|Washout: 7 Days||24
9058349|NCT03649750|10117597|FG000|NOT COMPLETED|Washout: 7 Days||0
9058350|NCT03649750|10117598|FG001|NOT COMPLETED|Washout: 7 Days||0
9058351|NCT03649750|10117597|FG000|STARTED|Period 2||12
9058352|NCT03649750|10117598|FG001|STARTED|Period 2||24
9058353|NCT03649750|10117597|FG000|COMPLETED|Period 2||12
9058354|NCT03649750|10117598|FG001|COMPLETED|Period 2||24
9058355|NCT03649750|10117597|FG000|NOT COMPLETED|Period 2||0
9058356|NCT03649750|10117598|FG001|NOT COMPLETED|Period 2||0
9058357|NCT03649815|10117605|FG000|STARTED|Overall Study||38
9058358|NCT03649815|10117605|FG000|COMPLETED|Overall Study||38
9058359|NCT03649815|10117605|FG000|NOT COMPLETED|Overall Study||0
9058360|NCT03649867|10117609|FG000|STARTED|Overall Study||13
9058361|NCT03649867|10117609|FG000|COMPLETED|Overall Study||13
9058362|NCT03649867|10117609|FG000|NOT COMPLETED|Overall Study||0
9058363|NCT03649932|10117616|FG000|STARTED|Overall Study||14
9058364|NCT03649932|10117617|FG001|STARTED|Overall Study||14
9058365|NCT03649932|10117618|FG002|STARTED|Overall Study||14
9058366|NCT03649932|10117616|FG000|COMPLETED|Overall Study||14
9058367|NCT03649932|10117617|FG001|COMPLETED|Overall Study||13
9058368|NCT03649932|10117618|FG002|COMPLETED|Overall Study||13
9058369|NCT03649932|10117616|FG000|NOT COMPLETED|Overall Study||0
9058370|NCT03649932|10117617|FG001|NOT COMPLETED|Overall Study||1
9058371|NCT03649932|10117618|FG002|NOT COMPLETED|Overall Study||1
9058372|NCT03650192|10117626|FG000|STARTED|Overall Study||40
9058373|NCT03650192|10117626|FG000|COMPLETED|Overall Study||40
9058374|NCT03650192|10117626|FG000|NOT COMPLETED|Overall Study||0
9058375|NCT03650387|10117630|FG000|STARTED|Overall Study||207
9058376|NCT03650387|10117630|FG000|COMPLETED|Overall Study||173
9058377|NCT03650387|10117630|FG000|NOT COMPLETED|Overall Study||34
9058378|NCT03650400|10117645|FG000|STARTED|Overall Study||6
9058379|NCT03650400|10117646|FG001|STARTED|Overall Study||5
9058380|NCT03650400|10117645|FG000|COMPLETED|Overall Study||6
9058381|NCT03650400|10117646|FG001|COMPLETED|Overall Study||0
9058382|NCT03650400|10117645|FG000|NOT COMPLETED|Overall Study||0
9058383|NCT03650400|10117646|FG001|NOT COMPLETED|Overall Study||5
9058384|NCT03650452|10117654|FG000|STARTED|Overall Study||70
9058385|NCT03650452|10117655|FG001|STARTED|Overall Study||71
9058386|NCT03650452|10117654|FG000|COMPLETED|Overall Study||60
9058387|NCT03650452|10117655|FG001|COMPLETED|Overall Study||66
9058388|NCT03650452|10117654|FG000|NOT COMPLETED|Overall Study||10
9058389|NCT03650452|10117655|FG001|NOT COMPLETED|Overall Study||5
9058390|NCT03650842|10117661|FG000|STARTED|Overall Study||25
9058391|NCT03650842|10117661|FG000|COMPLETED|Overall Study||25
9058392|NCT03650842|10117661|FG000|NOT COMPLETED|Overall Study||0
9058393|NCT03651479|10117667|FG000|STARTED|Overall Study||20
9058394|NCT03651479|10117668|FG001|STARTED|Overall Study||20
9058395|NCT03651479|10117667|FG000|COMPLETED|Overall Study||20
9058396|NCT03651479|10117668|FG001|COMPLETED|Overall Study||20
9058397|NCT03651479|10117667|FG000|NOT COMPLETED|Overall Study||0
9058398|NCT03651479|10117668|FG001|NOT COMPLETED|Overall Study||0
9058399|NCT03651856|10117674|FG000|STARTED|Overall Study||10
9058400|NCT03651856|10117674|FG000|COMPLETED|Overall Study||10
9058401|NCT03651856|10117674|FG000|NOT COMPLETED|Overall Study||0
9058402|NCT03652610|10117680|FG000|STARTED|Overall Study||490
9058403|NCT03652610|10117681|FG001|STARTED|Overall Study||489
9058404|NCT03652610|10117680|FG000|COMPLETED|Overall Study||486
9058405|NCT03652610|10117681|FG001|COMPLETED|Overall Study||484
9058406|NCT03652610|10117680|FG000|NOT COMPLETED|Overall Study||4
9058407|NCT03652610|10117681|FG001|NOT COMPLETED|Overall Study||5
9058408|NCT03652662|10117689|FG000|STARTED|Overall Study||18
9058409|NCT03652662|10117690|FG001|STARTED|Overall Study||16
9058410|NCT03652662|10117689|FG000|COMPLETED|Overall Study||15
9058411|NCT03652662|10117690|FG001|COMPLETED|Overall Study||15
9058412|NCT03652662|10117689|FG000|NOT COMPLETED|Overall Study||3
9058413|NCT03652662|10117690|FG001|NOT COMPLETED|Overall Study||1
9058414|NCT03652675|10117698|FG000|STARTED|Overall Study||16
9058415|NCT03652675|10117699|FG001|STARTED|Overall Study||15
9058416|NCT03652675|10117698|FG000|COMPLETED|Overall Study||12
9058417|NCT03652675|10117699|FG001|COMPLETED|Overall Study||11
9058418|NCT03652675|10117698|FG000|NOT COMPLETED|Overall Study||4
9058419|NCT03652675|10117699|FG001|NOT COMPLETED|Overall Study||4
9058420|NCT03652818|10117710|FG000|STARTED|Overall Study||24
9058421|NCT03652818|10117711|FG001|STARTED|Overall Study||23
9058422|NCT03652818|10117712|FG002|STARTED|Overall Study||22
9058423|NCT03652818|10117713|FG003|STARTED|Overall Study||23
9058424|NCT03652818|10117714|FG004|STARTED|Overall Study||23
9058425|NCT03652818|10117710|FG000|COMPLETED|Overall Study||22
9058426|NCT03652818|10117711|FG001|COMPLETED|Overall Study||22
9058427|NCT03652818|10117712|FG002|COMPLETED|Overall Study||20
9058428|NCT03652818|10117713|FG003|COMPLETED|Overall Study||22
9058429|NCT03652818|10117714|FG004|COMPLETED|Overall Study||22
9058430|NCT03652818|10117710|FG000|NOT COMPLETED|Overall Study||2
9058431|NCT03652818|10117711|FG001|NOT COMPLETED|Overall Study||1
9058432|NCT03652818|10117712|FG002|NOT COMPLETED|Overall Study||2
9058433|NCT03652818|10117713|FG003|NOT COMPLETED|Overall Study||1
9058434|NCT03652818|10117714|FG004|NOT COMPLETED|Overall Study||1
9058435|NCT03653208|10117735|FG000|STARTED|Overall Study||3
9058436|NCT03653208|10117736|FG001|STARTED|Overall Study||3
9058437|NCT03653208|10117737|FG002|STARTED|Overall Study||6
9058438|NCT03653208|10117738|FG003|STARTED|Overall Study||6
9058439|NCT03653208|10117739|FG004|STARTED|Overall Study||6
9058440|NCT03653208|10117740|FG005|STARTED|Overall Study||6
9058441|NCT03653208|10117741|FG006|STARTED|Overall Study||6
9058442|NCT03653208|10117742|FG007|STARTED|Overall Study||6
9058443|NCT03653208|10117743|FG008|STARTED|Overall Study||14
9058444|NCT03653208|10117735|FG000|COMPLETED|Overall Study||3
9058445|NCT03653208|10117736|FG001|COMPLETED|Overall Study||3
9058446|NCT03653208|10117737|FG002|COMPLETED|Overall Study||6
9058447|NCT03653208|10117738|FG003|COMPLETED|Overall Study||6
9058448|NCT03653208|10117739|FG004|COMPLETED|Overall Study||5
9058449|NCT03653208|10117740|FG005|COMPLETED|Overall Study||6
9058450|NCT03653208|10117741|FG006|COMPLETED|Overall Study||6
9058451|NCT03653208|10117742|FG007|COMPLETED|Overall Study||5
9058452|NCT03653208|10117743|FG008|COMPLETED|Overall Study||13
9058453|NCT03653208|10117735|FG000|NOT COMPLETED|Overall Study||0
9058454|NCT03653208|10117736|FG001|NOT COMPLETED|Overall Study||0
9058455|NCT03653208|10117737|FG002|NOT COMPLETED|Overall Study||0
9058456|NCT03653208|10117738|FG003|NOT COMPLETED|Overall Study||0
9058457|NCT03653208|10117739|FG004|NOT COMPLETED|Overall Study||1
9058458|NCT03653208|10117740|FG005|NOT COMPLETED|Overall Study||0
9058459|NCT03653208|10117741|FG006|NOT COMPLETED|Overall Study||0
9058460|NCT03653208|10117742|FG007|NOT COMPLETED|Overall Study||1
9058461|NCT03653208|10117743|FG008|NOT COMPLETED|Overall Study||1
9058462|NCT03653351|10117765|FG000|STARTED|Overall Study||14
9058463|NCT03653351|10117766|FG001|STARTED|Overall Study||12
9058464|NCT03653351|10117765|FG000|COMPLETED|Overall Study||13
9058465|NCT03653351|10117766|FG001|COMPLETED|Overall Study||10
9058466|NCT03653351|10117765|FG000|NOT COMPLETED|Overall Study||1
9058467|NCT03653351|10117766|FG001|NOT COMPLETED|Overall Study||2
9058468|NCT03653416|10117774|FG000|STARTED|Overall Study||52
9058469|NCT03653416|10117775|FG001|STARTED|Overall Study||47
9058470|NCT03653416|10117774|FG000|COMPLETED|Overall Study||46
9058471|NCT03653416|10117775|FG001|COMPLETED|Overall Study||46
9058472|NCT03653416|10117774|FG000|NOT COMPLETED|Overall Study||6
9058473|NCT03653416|10117775|FG001|NOT COMPLETED|Overall Study||1
9058474|NCT03653429|10117783|FG000|STARTED|Overall Study||49
9058475|NCT03653429|10117784|FG001|STARTED|Overall Study||51
9058476|NCT03653429|10117783|FG000|COMPLETED|Overall Study||45
9058477|NCT03653429|10117784|FG001|COMPLETED|Overall Study||41
9058478|NCT03653429|10117783|FG000|NOT COMPLETED|Overall Study||4
9058479|NCT03653429|10117784|FG001|NOT COMPLETED|Overall Study||10
9058480|NCT03654326|10117792|FG000|STARTED|Overall Study||94
9058481|NCT03654326|10117793|FG001|STARTED|Overall Study||93
9058482|NCT03654326|10117792|FG000|COMPLETED|Overall Study||88
9058483|NCT03654326|10117793|FG001|COMPLETED|Overall Study||87
9058484|NCT03654326|10117792|FG000|NOT COMPLETED|Overall Study||6
9058485|NCT03654326|10117793|FG001|NOT COMPLETED|Overall Study||6
9058486|NCT03654417|10117801|FG000|STARTED|Overall Study||19
9058487|NCT03654417|10117802|FG001|STARTED|Overall Study||18
9058488|NCT03654417|10117801|FG000|COMPLETED|Overall Study||19
9058489|NCT03654417|10117802|FG001|COMPLETED|Overall Study||18
9058490|NCT03654417|10117801|FG000|NOT COMPLETED|Overall Study||0
9058491|NCT03654417|10117802|FG001|NOT COMPLETED|Overall Study||0
9058492|NCT03654560|10117810|FG000|STARTED|Overall Study||118
9058493|NCT03654560|10117811|FG001|STARTED|Overall Study||118
9058494|NCT03654560|10117810|FG000|COMPLETED|Overall Study||114
9058495|NCT03654560|10117811|FG001|COMPLETED|Overall Study||117
9058496|NCT03654560|10117810|FG000|NOT COMPLETED|Overall Study||4
9058497|NCT03654560|10117811|FG001|NOT COMPLETED|Overall Study||1
9058498|NCT03655080|10117817|FG000|STARTED|Overall Study||2
9058499|NCT03655080|10117817|FG000|COMPLETED|Overall Study||2
9058500|NCT03655080|10117817|FG000|NOT COMPLETED|Overall Study||0
9058501|NCT03655106|10117823|FG000|STARTED|Overall Study||135
9058502|NCT03655106|10117824|FG001|STARTED|Overall Study||135
9058503|NCT03655106|10117823|FG000|COMPLETED|Overall Study||126
9058504|NCT03655106|10117824|FG001|COMPLETED|Overall Study||131
9058505|NCT03655106|10117823|FG000|NOT COMPLETED|Overall Study||9
9058506|NCT03655106|10117824|FG001|NOT COMPLETED|Overall Study||4
9058507|NCT03655301|10117830|FG000|STARTED|Overall Study||13
9058508|NCT03655301|10117830|FG000|COMPLETED|Overall Study||13
9058509|NCT03655301|10117830|FG000|NOT COMPLETED|Overall Study||0
9058510|NCT03655405|10117836|FG000|STARTED|Overall Study||32
9058511|NCT03655405|10117837|FG001|STARTED|Overall Study||30
9058512|NCT03655405|10117836|FG000|COMPLETED|Overall Study||27
9058513|NCT03655405|10117837|FG001|COMPLETED|Overall Study||25
9058514|NCT03655405|10117836|FG000|NOT COMPLETED|Overall Study||5
9058515|NCT03655405|10117837|FG001|NOT COMPLETED|Overall Study||5
9058516|NCT03655444|10117845|FG000|STARTED|Overall Study||3
9058517|NCT03655444|10117846|FG001|STARTED|Overall Study||3
9058518|NCT03655444|10117845|FG000|COMPLETED|Overall Study||3
9058519|NCT03655444|10117846|FG001|COMPLETED|Overall Study||3
9058520|NCT03655444|10117845|FG000|NOT COMPLETED|Overall Study||0
9058521|NCT03655444|10117846|FG001|NOT COMPLETED|Overall Study||0
9058522|NCT03655951|10117854|FG000|STARTED|Overall Study||358
9058523|NCT03655951|10117855|FG001|STARTED|Overall Study||372
9058524|NCT03655951|10117854|FG000|Completed Pretest|Overall Study||344
9058525|NCT03655951|10117855|FG001|Completed Pretest|Overall Study||366
9058526|NCT03655951|10117854|FG000|COMPLETED|Overall Study||319
9058527|NCT03655951|10117855|FG001|COMPLETED|Overall Study||351
9058528|NCT03655951|10117854|FG000|NOT COMPLETED|Overall Study||39
9058529|NCT03655951|10117855|FG001|NOT COMPLETED|Overall Study||21
9058530|NCT03656939|10117861|FG000|STARTED|Overall Study||21240
9058531|NCT03656939|10117861|FG000|Main Study Cohort|Overall Study||21240
9058532|NCT03656939|10117861|FG000|Main Study Cohort: Participants Who Received Dose 1|Overall Study||20318
9058533|NCT03656939|10117861|FG000|Main Study Cohort: Participants Who Received Dose 2|Overall Study||19387
9058534|NCT03656939|10117861|FG000|Main Study Cohort: Participants Who Received Dose 3|Overall Study||18415
9058535|NCT03656939|10117861|FG000|Main Study Cohort: Participants Who Received Dose 4|Overall Study||12944
9058536|NCT03656939|10117861|FG000|Prospective Study Cohort|Overall Study||2300
9058537|NCT03656939|10117861|FG000|Prospective Study Cohort: Participants Who Received Dose 1|Overall Study||2300
9058538|NCT03656939|10117861|FG000|Prospective Study Cohort: Participants Who Received Dose 2|Overall Study||2203
9058539|NCT03656939|10117861|FG000|Prospective Study Cohort: Participants Who Received Dose 3|Overall Study||2047
9058540|NCT03656939|10117861|FG000|Prospective Study Cohort: Participants Who Received Dose 4|Overall Study||1291
9058541|NCT03656939|10117861|FG000|COMPLETED|Overall Study||21240
9058542|NCT03656939|10117861|FG000|NOT COMPLETED|Overall Study||0
9058543|NCT03657095|10117869|FG000|STARTED|Overall Study||59
9058544|NCT03657095|10117870|FG001|STARTED|Overall Study||53
9058545|NCT03657095|10117869|FG000|Received at Least 1 Dose of Study Drug|Overall Study||59
9058546|NCT03657095|10117870|FG001|Received at Least 1 Dose of Study Drug|Overall Study||53
9058547|NCT03657095|10117869|FG000|COMPLETED|Overall Study||0
9058548|NCT03657095|10117870|FG001|COMPLETED|Overall Study||0
9058549|NCT03657095|10117869|FG000|NOT COMPLETED|Overall Study||59
9058550|NCT03657095|10117870|FG001|NOT COMPLETED|Overall Study||53
9058551|NCT03657134|10117876|FG000|STARTED|Overall Study||20
9058552|NCT03657134|10117876|FG000|COMPLETED|Overall Study||20
9058553|NCT03657134|10117876|FG000|NOT COMPLETED|Overall Study||0
9058554|NCT03657264|10117885|FG000|STARTED|Overall Study||12
9058555|NCT03657264|10117886|FG001|STARTED|Overall Study||12
9058556|NCT03657264|10117887|FG002|STARTED|Overall Study||12
9058557|NCT03657264|10117888|FG003|STARTED|Overall Study||12
9058558|NCT03657264|10117885|FG000|COMPLETED|Overall Study||12
9058559|NCT03657264|10117886|FG001|COMPLETED|Overall Study||12
9058560|NCT03657264|10117887|FG002|COMPLETED|Overall Study||12
9058561|NCT03657264|10117888|FG003|COMPLETED|Overall Study||12
9058562|NCT03657264|10117885|FG000|NOT COMPLETED|Overall Study||0
9058563|NCT03657264|10117886|FG001|NOT COMPLETED|Overall Study||0
9058564|NCT03657264|10117887|FG002|NOT COMPLETED|Overall Study||0
9058565|NCT03657264|10117888|FG003|NOT COMPLETED|Overall Study||0
9058566|NCT03657277|10117899|FG000|STARTED|Overall Study||46
9058567|NCT03657277|10117899|FG000|COMPLETED|Overall Study||35
9058568|NCT03657277|10117899|FG000|NOT COMPLETED|Overall Study||11
9058569|NCT03657407|10117905|FG000|STARTED|Overall Study||29
9058570|NCT03657407|10117906|FG001|STARTED|Overall Study||27
9058571|NCT03657407|10117905|FG000|COMPLETED|Overall Study||29
9058572|NCT03657407|10117906|FG001|COMPLETED|Overall Study||27
9058573|NCT03657407|10117905|FG000|NOT COMPLETED|Overall Study||0
9058574|NCT03657407|10117906|FG001|NOT COMPLETED|Overall Study||0
9058575|NCT03658811|10117912|FG000|STARTED|Overall Study||19
9058576|NCT03658811|10117912|FG000|COMPLETED|Overall Study||16
9058577|NCT03658811|10117912|FG000|NOT COMPLETED|Overall Study||3
9058578|NCT03658876|10117918|FG000|STARTED|Overall Study||88
9058579|NCT03658876|10117919|FG001|STARTED|Overall Study||96
9058580|NCT03658876|10117918|FG000|COMPLETED|Overall Study||76
9058581|NCT03658876|10117919|FG001|COMPLETED|Overall Study||84
9058582|NCT03658876|10117918|FG000|NOT COMPLETED|Overall Study||12
9058583|NCT03658876|10117919|FG001|NOT COMPLETED|Overall Study||12
9058584|NCT03658889|10117927|FG000|STARTED|Overall Study|Enrolled population|308
9058585|NCT03658889|10117928|FG001|STARTED|Overall Study||69
9058586|NCT03658889|10117927|FG000|COMPLETED|Overall Study|Analysis population|306
9058587|NCT03658889|10117928|FG001|COMPLETED|Overall Study||69
9058588|NCT03658889|10117927|FG000|NOT COMPLETED|Overall Study||2
9058589|NCT03658889|10117928|FG001|NOT COMPLETED|Overall Study||0
9058590|NCT03660787|10117937|FG000|STARTED|Overall Study||26
9058591|NCT03660787|10117938|FG001|STARTED|Overall Study||26
9058592|NCT03660787|10117939|FG002|STARTED|Overall Study||26
9058593|NCT03660787|10117940|FG003|STARTED|Overall Study||26
9058594|NCT03660787|10117937|FG000|COMPLETED|Overall Study||25
9058595|NCT03660787|10117938|FG001|COMPLETED|Overall Study||25
9058596|NCT03660787|10117939|FG002|COMPLETED|Overall Study||25
9058597|NCT03660787|10117940|FG003|COMPLETED|Overall Study||26
9058598|NCT03660787|10117937|FG000|NOT COMPLETED|Overall Study||1
9058599|NCT03660787|10117938|FG001|NOT COMPLETED|Overall Study||1
9058600|NCT03660787|10117939|FG002|NOT COMPLETED|Overall Study||1
9058601|NCT03660787|10117940|FG003|NOT COMPLETED|Overall Study||0
9058602|NCT03661346|10117952|FG000|STARTED|Overall Study|Esmolol administration|13
9058603|NCT03661346|10117953|FG001|STARTED|Overall Study||15
9058604|NCT03661346|10117952|FG000|COMPLETED|Overall Study||13
9058605|NCT03661346|10117953|FG001|COMPLETED|Overall Study||15
9058606|NCT03661346|10117952|FG000|NOT COMPLETED|Overall Study||0
9058607|NCT03661346|10117953|FG001|NOT COMPLETED|Overall Study||0
9058608|NCT03661541|10117962|FG000|STARTED|Overall Study||12
9058609|NCT03661541|10117963|FG001|STARTED|Overall Study||12
9058610|NCT03661541|10117964|FG002|STARTED|Overall Study||12
9058611|NCT03661541|10117962|FG000|COMPLETED|Overall Study||10
9058612|NCT03661541|10117963|FG001|COMPLETED|Overall Study||10
9058613|NCT03661541|10117964|FG002|COMPLETED|Overall Study||10
9058614|NCT03661541|10117962|FG000|NOT COMPLETED|Overall Study||2
9058615|NCT03661541|10117963|FG001|NOT COMPLETED|Overall Study||2
9058616|NCT03661541|10117964|FG002|NOT COMPLETED|Overall Study||2
9058617|NCT03661697|10117978|FG000|STARTED|Overall Study||7
9058618|NCT03661697|10117979|FG001|STARTED|Overall Study||7
9058619|NCT03661697|10117978|FG000|COMPLETED|Overall Study||7
9058620|NCT03661697|10117979|FG001|COMPLETED|Overall Study||7
9058621|NCT03661697|10117978|FG000|NOT COMPLETED|Overall Study||0
9058622|NCT03661697|10117979|FG001|NOT COMPLETED|Overall Study||0
9058623|NCT03661762|10117985|FG000|STARTED|Overall Study||18
9058624|NCT03661762|10117985|FG000|COMPLETED|Overall Study||10
9058625|NCT03661762|10117985|FG000|NOT COMPLETED|Overall Study||8
9058626|NCT03661814|10117992|FG000|STARTED|Overall Study||2
9058627|NCT03661814|10117993|FG001|STARTED|Overall Study||5
9058628|NCT03661814|10117992|FG000|COMPLETED|Overall Study||2
9058629|NCT03661814|10117993|FG001|COMPLETED|Overall Study||5
9058630|NCT03661814|10117992|FG000|NOT COMPLETED|Overall Study||0
9058631|NCT03661814|10117993|FG001|NOT COMPLETED|Overall Study||0
9058632|NCT03661983|10117999|FG000|STARTED|Open Label Stabilization Phase||36
9058633|NCT03661983|10118000|FG001|STARTED|Open Label Stabilization Phase||0
9058634|NCT03661983|10118001|FG002|STARTED|Open Label Stabilization Phase||0
9058635|NCT03661983|10118002|FG003|STARTED|Open Label Stabilization Phase||0
9058636|NCT03661983|10117999|FG000|COMPLETED|Open Label Stabilization Phase||25
9058637|NCT03661983|10118000|FG001|COMPLETED|Open Label Stabilization Phase||0
9058638|NCT03661983|10118001|FG002|COMPLETED|Open Label Stabilization Phase||0
9058639|NCT03661983|10118002|FG003|COMPLETED|Open Label Stabilization Phase||0
9058640|NCT03661983|10117999|FG000|NOT COMPLETED|Open Label Stabilization Phase||11
9058641|NCT03661983|10118000|FG001|NOT COMPLETED|Open Label Stabilization Phase||0
9058642|NCT03661983|10118001|FG002|NOT COMPLETED|Open Label Stabilization Phase||0
9058643|NCT03661983|10118002|FG003|NOT COMPLETED|Open Label Stabilization Phase||0
9058644|NCT03661983|10117999|FG000|STARTED|Double-blind Randomized Phase||0
9058645|NCT03661983|10118000|FG001|STARTED|Double-blind Randomized Phase||9
9058646|NCT03661983|10118001|FG002|STARTED|Double-blind Randomized Phase||8
9058647|NCT03661983|10118002|FG003|STARTED|Double-blind Randomized Phase||8
9058648|NCT03661983|10117999|FG000|COMPLETED|Double-blind Randomized Phase||0
9058649|NCT03661983|10118000|FG001|COMPLETED|Double-blind Randomized Phase||7
9058650|NCT03661983|10118001|FG002|COMPLETED|Double-blind Randomized Phase||7
9058651|NCT03661983|10118002|FG003|COMPLETED|Double-blind Randomized Phase||0
9058652|NCT03661983|10117999|FG000|NOT COMPLETED|Double-blind Randomized Phase||0
9058653|NCT03661983|10118000|FG001|NOT COMPLETED|Double-blind Randomized Phase||2
9058654|NCT03661983|10118001|FG002|NOT COMPLETED|Double-blind Randomized Phase||1
9058655|NCT03661983|10118002|FG003|NOT COMPLETED|Double-blind Randomized Phase||8
9058656|NCT03662074|10118011|FG000|STARTED|Overall Study||14
9058657|NCT03662074|10118011|FG000|COMPLETED|Overall Study||14
9058658|NCT03662074|10118011|FG000|NOT COMPLETED|Overall Study||0
9058659|NCT03662139|10118017|FG000|STARTED|Overall Study||16
9058660|NCT03662139|10118018|FG001|STARTED|Overall Study||16
9058661|NCT03662139|10118017|FG000|COMPLETED|Overall Study||16
9058662|NCT03662139|10118018|FG001|COMPLETED|Overall Study||16
9058663|NCT03662139|10118017|FG000|NOT COMPLETED|Overall Study||0
9058664|NCT03662139|10118018|FG001|NOT COMPLETED|Overall Study||0
9058665|NCT03662282|10118026|FG000|STARTED|Overall Study||2
9058666|NCT03662282|10118026|FG000|COMPLETED|Overall Study||2
9058667|NCT03662282|10118026|FG000|NOT COMPLETED|Overall Study||0
9058668|NCT03662334|10118032|FG000|STARTED|Part 1: Treatment Period 1||0
9058669|NCT03662334|10118033|FG001|STARTED|Part 1: Treatment Period 1||0
9058670|NCT03662334|10118032|FG000|COMPLETED|Part 1: Treatment Period 1||0
9058671|NCT03662334|10118033|FG001|COMPLETED|Part 1: Treatment Period 1||0
9058672|NCT03662334|10118032|FG000|NOT COMPLETED|Part 1: Treatment Period 1||0
9058673|NCT03662334|10118033|FG001|NOT COMPLETED|Part 1: Treatment Period 1||0
9058674|NCT03662334|10118032|FG000|STARTED|Part 1: Treatment Period 2||0
9058675|NCT03662334|10118033|FG001|STARTED|Part 1: Treatment Period 2||0
9058676|NCT03662334|10118032|FG000|COMPLETED|Part 1: Treatment Period 2||0
9058677|NCT03662334|10118033|FG001|COMPLETED|Part 1: Treatment Period 2||0
9058678|NCT03662334|10118032|FG000|NOT COMPLETED|Part 1: Treatment Period 2||0
9058679|NCT03662334|10118033|FG001|NOT COMPLETED|Part 1: Treatment Period 2||0
9058680|NCT03662334|10118032|FG000|STARTED|Part 2: Treatment Period 1 (2 Days)|Part 1 of the study was not conducted. Participants were enrolled starting with Part 2.|7
9058681|NCT03662334|10118033|FG001|STARTED|Part 2: Treatment Period 1 (2 Days)|Part 1 of the study was not conducted. Participants were enrolled starting with Part 2.|7
9058682|NCT03662334|10118032|FG000|COMPLETED|Part 2: Treatment Period 1 (2 Days)||7
9058683|NCT03662334|10118033|FG001|COMPLETED|Part 2: Treatment Period 1 (2 Days)||7
9058684|NCT03662334|10118032|FG000|NOT COMPLETED|Part 2: Treatment Period 1 (2 Days)||0
9058685|NCT03662334|10118033|FG001|NOT COMPLETED|Part 2: Treatment Period 1 (2 Days)||0
9058686|NCT03662334|10118032|FG000|STARTED|Part 2: Treatment Period 2 (2 Days)||7
9058687|NCT03662334|10118033|FG001|STARTED|Part 2: Treatment Period 2 (2 Days)||7
9058688|NCT03662334|10118032|FG000|COMPLETED|Part 2: Treatment Period 2 (2 Days)||6
9058689|NCT03662334|10118033|FG001|COMPLETED|Part 2: Treatment Period 2 (2 Days)||7
9058690|NCT03662334|10118032|FG000|NOT COMPLETED|Part 2: Treatment Period 2 (2 Days)||1
9058691|NCT03662334|10118033|FG001|NOT COMPLETED|Part 2: Treatment Period 2 (2 Days)||0
9058692|NCT03662334|10118032|FG000|STARTED|Part 3: Treatment Period 1|Part 3 of the study was not conducted. No participants were enrolled in this part of the study.|0
9058693|NCT03662334|10118033|FG001|STARTED|Part 3: Treatment Period 1|Part 3 of the study was not conducted. No participants were enrolled in this part of the study.|0
9058694|NCT03662334|10118032|FG000|COMPLETED|Part 3: Treatment Period 1||0
9058695|NCT03662334|10118033|FG001|COMPLETED|Part 3: Treatment Period 1||0
9058696|NCT03662334|10118032|FG000|NOT COMPLETED|Part 3: Treatment Period 1||0
9058697|NCT03662334|10118033|FG001|NOT COMPLETED|Part 3: Treatment Period 1||0
9058698|NCT03662334|10118032|FG000|STARTED|Part 3: Treatment Period 2||0
9058699|NCT03662334|10118033|FG001|STARTED|Part 3: Treatment Period 2||0
9058700|NCT03662334|10118032|FG000|COMPLETED|Part 3: Treatment Period 2||0
9058701|NCT03662334|10118033|FG001|COMPLETED|Part 3: Treatment Period 2||0
9058702|NCT03662334|10118032|FG000|NOT COMPLETED|Part 3: Treatment Period 2||0
9058703|NCT03662334|10118033|FG001|NOT COMPLETED|Part 3: Treatment Period 2||0
9058704|NCT03662360|10118041|FG000|STARTED|Overall Study||16
9058705|NCT03662360|10118042|FG001|STARTED|Overall Study||16
9058706|NCT03662360|10118041|FG000|COMPLETED|Overall Study||16
9058707|NCT03662360|10118042|FG001|COMPLETED|Overall Study||14
9058708|NCT03662360|10118041|FG000|NOT COMPLETED|Overall Study||0
9058709|NCT03662360|10118042|FG001|NOT COMPLETED|Overall Study||2
9058710|NCT03662750|10118049|FG000|STARTED|Overall Study||3
9058711|NCT03662750|10118049|FG000|COMPLETED|Overall Study||2
9058712|NCT03662750|10118049|FG000|NOT COMPLETED|Overall Study||1
9058713|NCT03662789|10118055|FG000|STARTED|Overall Study|Baseline|52
9058714|NCT03662789|10118056|FG001|STARTED|Overall Study|Baseline|50
9058715|NCT03662789|10118055|FG000|COMPLETED|Overall Study|Follow-up at 6 months|47
9058716|NCT03662789|10118056|FG001|COMPLETED|Overall Study|Follow-up at 6 months|43
9058717|NCT03662789|10118055|FG000|NOT COMPLETED|Overall Study||5
9058718|NCT03662789|10118056|FG001|NOT COMPLETED|Overall Study||7
9058719|NCT03662997|10118066|FG000|STARTED|Overall Study||11
9058720|NCT03662997|10118067|FG001|STARTED|Overall Study||10
9058721|NCT03662997|10118068|FG002|STARTED|Overall Study||11
9058722|NCT03662997|10118069|FG003|STARTED|Overall Study||8
9058723|NCT03662997|10118066|FG000|COMPLETED|Overall Study||11
9058724|NCT03662997|10118067|FG001|COMPLETED|Overall Study||8
9058725|NCT03662997|10118068|FG002|COMPLETED|Overall Study||11
9058726|NCT03662997|10118069|FG003|COMPLETED|Overall Study||8
9058727|NCT03662997|10118066|FG000|NOT COMPLETED|Overall Study||0
9058728|NCT03662997|10118067|FG001|NOT COMPLETED|Overall Study||2
9058729|NCT03662997|10118068|FG002|NOT COMPLETED|Overall Study||0
9058730|NCT03662997|10118069|FG003|NOT COMPLETED|Overall Study||0
9058731|NCT03663101|10118085|FG000|STARTED|Overall Study||4
9058732|NCT03663101|10118086|FG001|STARTED|Overall Study||3
9058733|NCT03663101|10118087|FG002|STARTED|Overall Study||5
9058734|NCT03663101|10118088|FG003|STARTED|Overall Study||4
9058735|NCT03663101|10118085|FG000|COMPLETED|Overall Study||4
9058736|NCT03663101|10118086|FG001|COMPLETED|Overall Study||3
9058737|NCT03663101|10118087|FG002|COMPLETED|Overall Study||5
9058738|NCT03663101|10118088|FG003|COMPLETED|Overall Study||4
9058739|NCT03663101|10118085|FG000|NOT COMPLETED|Overall Study||0
9058740|NCT03663101|10118086|FG001|NOT COMPLETED|Overall Study||0
9058741|NCT03663101|10118087|FG002|NOT COMPLETED|Overall Study||0
9058742|NCT03663101|10118088|FG003|NOT COMPLETED|Overall Study||0
9058743|NCT03663179|10118100|FG000|STARTED|Overall Study||18
9058744|NCT03663179|10118101|FG001|STARTED|Overall Study||14
9058745|NCT03663179|10118100|FG000|COMPLETED|Overall Study||14
9058746|NCT03663179|10118101|FG001|COMPLETED|Overall Study||13
9058747|NCT03663179|10118100|FG000|NOT COMPLETED|Overall Study||4
9058748|NCT03663179|10118101|FG001|NOT COMPLETED|Overall Study||1
9058749|NCT03663231|10118109|FG000|STARTED|First Intervention||16
9058750|NCT03663231|10118110|FG001|STARTED|First Intervention||13
9058751|NCT03663231|10118109|FG000|COMPLETED|First Intervention||14
9058752|NCT03663231|10118110|FG001|COMPLETED|First Intervention||12
9058753|NCT03663231|10118109|FG000|NOT COMPLETED|First Intervention||2
9058754|NCT03663231|10118110|FG001|NOT COMPLETED|First Intervention||1
9058755|NCT03663231|10118109|FG000|STARTED|Washout||14
9058756|NCT03663231|10118110|FG001|STARTED|Washout||12
9058757|NCT03663231|10118109|FG000|COMPLETED|Washout||14
9058758|NCT03663231|10118110|FG001|COMPLETED|Washout||12
9058759|NCT03663231|10118109|FG000|NOT COMPLETED|Washout||0
9058760|NCT03663231|10118110|FG001|NOT COMPLETED|Washout||0
9058761|NCT03663231|10118109|FG000|STARTED|Second Intervention||14
9058762|NCT03663231|10118110|FG001|STARTED|Second Intervention||12
9058763|NCT03663231|10118109|FG000|COMPLETED|Second Intervention||14
9058764|NCT03663231|10118110|FG001|COMPLETED|Second Intervention||12
9058765|NCT03663231|10118109|FG000|NOT COMPLETED|Second Intervention||0
9058766|NCT03663231|10118110|FG001|NOT COMPLETED|Second Intervention||0
9058767|NCT03663283|10118118|FG000|STARTED|Overall Study||52
9058768|NCT03663283|10118119|FG001|STARTED|Overall Study||52
9058769|NCT03663283|10118118|FG000|COMPLETED|Overall Study||52
9058770|NCT03663283|10118119|FG001|COMPLETED|Overall Study||52
9058771|NCT03663283|10118118|FG000|NOT COMPLETED|Overall Study||0
9058772|NCT03663283|10118119|FG001|NOT COMPLETED|Overall Study||0
9058773|NCT03663569|10118125|FG000|STARTED|Overall Study||4819
9058774|NCT03663569|10118125|FG000|COMPLETED|Overall Study||4756
9058775|NCT03663569|10118125|FG000|NOT COMPLETED|Overall Study||63
9058776|NCT03663582|10118129|FG000|STARTED|Overall Study||7
9058777|NCT03663582|10118129|FG000|COMPLETED|Overall Study||6
9058778|NCT03663582|10118129|FG000|NOT COMPLETED|Overall Study||1
9058779|NCT03663816|10118133|FG000|STARTED|Overall Study||15
9058780|NCT03663816|10118133|FG000|COMPLETED|Overall Study||15
9058781|NCT03663816|10118133|FG000|NOT COMPLETED|Overall Study||0
9058782|NCT03664193|10118137|FG000|STARTED|Overall Study||30
9058783|NCT03664193|10118137|FG000|COMPLETED|Overall Study||30
9058784|NCT03664193|10118137|FG000|NOT COMPLETED|Overall Study||0
9058785|NCT03664544|10118143|FG000|STARTED|Overall Study||6
9058786|NCT03664544|10118144|FG001|STARTED|Overall Study||6
9058787|NCT03664544|10118143|FG000|COMPLETED|Overall Study||6
9058788|NCT03664544|10118144|FG001|COMPLETED|Overall Study||6
9058789|NCT03664544|10118143|FG000|NOT COMPLETED|Overall Study||0
9058790|NCT03664544|10118144|FG001|NOT COMPLETED|Overall Study||0
9058791|NCT03665155|10118153|FG000|STARTED|Overall Study||3
9058792|NCT03665155|10118154|FG001|STARTED|Overall Study||7
9058793|NCT03665155|10118155|FG002|STARTED|Overall Study||1
9058794|NCT03665155|10118153|FG000|COMPLETED|Overall Study||3
9058795|NCT03665155|10118154|FG001|COMPLETED|Overall Study||7
9058796|NCT03665155|10118155|FG002|COMPLETED|Overall Study||1
9058797|NCT03665155|10118153|FG000|NOT COMPLETED|Overall Study||0
9058798|NCT03665155|10118154|FG001|NOT COMPLETED|Overall Study||0
9058799|NCT03665155|10118155|FG002|NOT COMPLETED|Overall Study||0
9058800|NCT03666026|10118165|FG000|STARTED|Overall Study||41070
9058801|NCT03666026|10118166|FG001|STARTED|Overall Study||41055
9058802|NCT03666026|10118167|FG002|STARTED|Overall Study||41046
9058803|NCT03666026|10118168|FG003|STARTED|Overall Study||41034
9058804|NCT03666026|10118165|FG000|COMPLETED|Overall Study||41070
9058805|NCT03666026|10118166|FG001|COMPLETED|Overall Study||41055
9058806|NCT03666026|10118167|FG002|COMPLETED|Overall Study||41046
9058807|NCT03666026|10118168|FG003|COMPLETED|Overall Study||41034
9058808|NCT03666026|10118165|FG000|NOT COMPLETED|Overall Study||0
9058809|NCT03666026|10118166|FG001|NOT COMPLETED|Overall Study||0
9058810|NCT03666026|10118167|FG002|NOT COMPLETED|Overall Study||0
9058811|NCT03666026|10118168|FG003|NOT COMPLETED|Overall Study||0
9058812|NCT03666663|10118182|FG000|STARTED|Overall Study||3
9058813|NCT03666663|10118183|FG001|STARTED|Overall Study||1
9058814|NCT03666663|10118184|FG002|STARTED|Overall Study||3
9058815|NCT03666663|10118185|FG003|STARTED|Overall Study||3
9058816|NCT03666663|10118182|FG000|COMPLETED|Overall Study||3
9058817|NCT03666663|10118183|FG001|COMPLETED|Overall Study||1
9058818|NCT03666663|10118184|FG002|COMPLETED|Overall Study||1
9058819|NCT03666663|10118185|FG003|COMPLETED|Overall Study||1
9058820|NCT03666663|10118182|FG000|NOT COMPLETED|Overall Study||0
9058821|NCT03666663|10118183|FG001|NOT COMPLETED|Overall Study||0
9058822|NCT03666663|10118184|FG002|NOT COMPLETED|Overall Study||2
9058823|NCT03666663|10118185|FG003|NOT COMPLETED|Overall Study||2
9058824|NCT03666858|10118195|FG000|STARTED|Cohort 1|All participants with TTH who had reported at least one headache and Neosaldina intake.|216
9058825|NCT03666858|10118196|FG001|STARTED|Cohort 1||0
9058826|NCT03666858|10118195|FG000|COMPLETED|Cohort 1||215
9058827|NCT03666858|10118196|FG001|COMPLETED|Cohort 1||0
9058828|NCT03666858|10118195|FG000|NOT COMPLETED|Cohort 1||1
9058829|NCT03666858|10118196|FG001|NOT COMPLETED|Cohort 1||0
9058830|NCT03666858|10118195|FG000|STARTED|Cohort 2||0
9058831|NCT03666858|10118196|FG001|STARTED|Cohort 2|Cohort 1 participants with pain intensity at 0,120minutes after Neosaldina/0 pain before 120minutes.|138
9058832|NCT03666858|10118195|FG000|COMPLETED|Cohort 2||0
9058833|NCT03666858|10118196|FG001|COMPLETED|Cohort 2||137
9058834|NCT03666858|10118195|FG000|NOT COMPLETED|Cohort 2||0
9058835|NCT03666858|10118196|FG001|NOT COMPLETED|Cohort 2||1
9058836|NCT03667053|10118205|FG000|STARTED|Overall Study||21
9058837|NCT03667053|10118206|FG001|STARTED|Overall Study||11
9058838|NCT03667053|10118207|FG002|STARTED|Overall Study||10
9058839|NCT03667053|10118205|FG000|Randomized and Treated|Overall Study||20
9058840|NCT03667053|10118206|FG001|Randomized and Treated|Overall Study||11
9058841|NCT03667053|10118207|FG002|Randomized and Treated|Overall Study||10
9058842|NCT03667053|10118205|FG000|COMPLETED|Overall Study||20
9058843|NCT03667053|10118206|FG001|COMPLETED|Overall Study||11
9058844|NCT03667053|10118207|FG002|COMPLETED|Overall Study||10
9058845|NCT03667053|10118205|FG000|NOT COMPLETED|Overall Study||1
9058846|NCT03667053|10118206|FG001|NOT COMPLETED|Overall Study||0
9058847|NCT03667053|10118207|FG002|NOT COMPLETED|Overall Study||0
9058848|NCT03667547|10118222|FG000|STARTED|Overall Study||12
9058849|NCT03667547|10118222|FG000|COMPLETED|Overall Study||12
9058850|NCT03667547|10118222|FG000|NOT COMPLETED|Overall Study||0
9058851|NCT03668600|10118226|FG000|STARTED|Overall Study||230
9058852|NCT03668600|10118226|FG000|COMPLETED|Overall Study||0
9058853|NCT03668600|10118226|FG000|NOT COMPLETED|Overall Study||230
9058854|NCT03668613|10118232|FG000|STARTED|Overall Study||42
9058855|NCT03668613|10118233|FG001|STARTED|Overall Study||42
9058856|NCT03668613|10118232|FG000|COMPLETED|Overall Study||42
9058857|NCT03668613|10118233|FG001|COMPLETED|Overall Study||39
9058858|NCT03668613|10118232|FG000|NOT COMPLETED|Overall Study||0
9058859|NCT03668613|10118233|FG001|NOT COMPLETED|Overall Study||3
9058860|NCT03669081|10118242|FG000|STARTED|Overall Study||34
9058861|NCT03669081|10118243|FG001|STARTED|Overall Study||30
9058862|NCT03669081|10118242|FG000|COMPLETED|Overall Study||33
9058863|NCT03669081|10118243|FG001|COMPLETED|Overall Study||29
9058864|NCT03669081|10118242|FG000|NOT COMPLETED|Overall Study||1
9058865|NCT03669081|10118243|FG001|NOT COMPLETED|Overall Study||1
9058866|NCT03669354|10118253|FG000|STARTED|Overall Study||73
9058867|NCT03669354|10118254|FG001|STARTED|Overall Study||22
9058868|NCT03669354|10118255|FG002|STARTED|Overall Study||47
9058869|NCT03669354|10118256|FG003|STARTED|Overall Study||53
9058870|NCT03669354|10118253|FG000|COMPLETED|Overall Study||73
9058871|NCT03669354|10118254|FG001|COMPLETED|Overall Study||22
9058872|NCT03669354|10118255|FG002|COMPLETED|Overall Study||47
9058873|NCT03669354|10118256|FG003|COMPLETED|Overall Study||53
9058874|NCT03669354|10118253|FG000|NOT COMPLETED|Overall Study||0
9058875|NCT03669354|10118254|FG001|NOT COMPLETED|Overall Study||0
9058876|NCT03669354|10118255|FG002|NOT COMPLETED|Overall Study||0
9058877|NCT03669354|10118256|FG003|NOT COMPLETED|Overall Study||0
9058878|NCT03669549|10118267|FG000|STARTED|Overall Study||15
9058879|NCT03669549|10118267|FG000|COMPLETED|Overall Study||9
9058880|NCT03669549|10118267|FG000|NOT COMPLETED|Overall Study||6
9058881|NCT03669861|10118275|FG000|STARTED|Overall Study||10
9058882|NCT03669861|10118275|FG000|COMPLETED|Overall Study||3
9058883|NCT03669861|10118275|FG000|NOT COMPLETED|Overall Study||7
9058884|NCT03670017|10118279|FG000|STARTED|Overall Study||68
9058885|NCT03670017|10118279|FG000|COMPLETED|Overall Study||50
9058886|NCT03670017|10118279|FG000|NOT COMPLETED|Overall Study||18
9058887|NCT03670030|10118283|FG000|STARTED|Overall Study||5
9058888|NCT03670030|10118283|FG000|COMPLETED|Overall Study||5
9058889|NCT03670030|10118283|FG000|NOT COMPLETED|Overall Study||0
9058890|NCT03670160|10118289|FG000|STARTED|Overall Study||11
9058891|NCT03670160|10118290|FG001|STARTED|Overall Study||14
9058892|NCT03670160|10118289|FG000|COMPLETED|Overall Study||11
9058893|NCT03670160|10118290|FG001|COMPLETED|Overall Study||14
9058894|NCT03670160|10118289|FG000|NOT COMPLETED|Overall Study||0
9058895|NCT03670160|10118290|FG001|NOT COMPLETED|Overall Study||0
9058896|NCT03670264|10118299|FG000|STARTED|Overall Study||5
9058897|NCT03670264|10118300|FG001|STARTED|Overall Study||5
9058898|NCT03670264|10118301|FG002|STARTED|Overall Study||5
9058899|NCT03670264|10118299|FG000|COMPLETED|Overall Study||5
9058900|NCT03670264|10118300|FG001|COMPLETED|Overall Study||5
9058901|NCT03670264|10118301|FG002|COMPLETED|Overall Study||5
9058902|NCT03670264|10118299|FG000|NOT COMPLETED|Overall Study||0
9058903|NCT03670264|10118300|FG001|NOT COMPLETED|Overall Study||0
9058904|NCT03670264|10118301|FG002|NOT COMPLETED|Overall Study||0
9058905|NCT03670537|10118309|FG000|STARTED|Overall Study||102
9058906|NCT03670537|10118309|FG000|COMPLETED|Overall Study||101
9058907|NCT03670537|10118309|FG000|NOT COMPLETED|Overall Study||1
9058908|NCT03670641|10118313|FG000|STARTED|Overall Study||10
9058909|NCT03670641|10118313|FG000|COMPLETED|Overall Study|3 participants were lost to follow up by 12 months|7
9058910|NCT03670641|10118313|FG000|NOT COMPLETED|Overall Study||3
9058911|NCT03670810|10118323|FG000|STARTED|Overall Study||485
9058912|NCT03670810|10118324|FG001|STARTED|Overall Study||486
9058913|NCT03670810|10118325|FG002|STARTED|Overall Study||249
9058914|NCT03670810|10118326|FG003|STARTED|Overall Study||251
9058915|NCT03670810|10118323|FG000|Treated at Least One Migraine Attack|Overall Study||485
9058916|NCT03670810|10118324|FG001|Treated at Least One Migraine Attack|Overall Study||486
9058917|NCT03670810|10118325|FG002|Treated at Least One Migraine Attack|Overall Study||249
9058918|NCT03670810|10118326|FG003|Treated at Least One Migraine Attack|Overall Study||251
9058919|NCT03670810|10118323|FG000|COMPLETED|Overall Study||381
9058920|NCT03670810|10118324|FG001|COMPLETED|Overall Study||369
9058921|NCT03670810|10118325|FG002|COMPLETED|Overall Study||208
9058922|NCT03670810|10118326|FG003|COMPLETED|Overall Study||213
9058923|NCT03670810|10118323|FG000|NOT COMPLETED|Overall Study||104
9058924|NCT03670810|10118324|FG001|NOT COMPLETED|Overall Study||117
9058925|NCT03670810|10118325|FG002|NOT COMPLETED|Overall Study||41
9058926|NCT03670810|10118326|FG003|NOT COMPLETED|Overall Study||38
9058927|NCT03672006|10118338|FG000|STARTED|Overall Study||10
9058928|NCT03672006|10118339|FG001|STARTED|Overall Study||10
9058929|NCT03672006|10118338|FG000|COMPLETED|Overall Study||10
9058930|NCT03672006|10118339|FG001|COMPLETED|Overall Study||9
9058931|NCT03672006|10118338|FG000|NOT COMPLETED|Overall Study||0
9058932|NCT03672006|10118339|FG001|NOT COMPLETED|Overall Study||1
9058933|NCT03672032|10118349|FG000|STARTED|Overall Study||67
9058934|NCT03672032|10118350|FG001|STARTED|Overall Study||67
9058935|NCT03672032|10118349|FG000|COMPLETED|Overall Study||67
9058936|NCT03672032|10118350|FG001|COMPLETED|Overall Study||67
9058937|NCT03672032|10118349|FG000|NOT COMPLETED|Overall Study||0
9058938|NCT03672032|10118350|FG001|NOT COMPLETED|Overall Study||0
9058939|NCT03672097|10118356|FG000|STARTED|Period 1||204
9058940|NCT03672097|10118356|FG000|COMPLETED|Period 1||200
9058941|NCT03672097|10118356|FG000|NOT COMPLETED|Period 1||4
9058942|NCT03672097|10118356|FG000|STARTED|Period 2||200
9058943|NCT03672097|10118356|FG000|COMPLETED|Period 2||196
9058944|NCT03672097|10118356|FG000|NOT COMPLETED|Period 2||4
9058945|NCT03672370|10118360|FG000|STARTED|Overall Study|11 hips did not receive the study devices acc. to the protocol and therefore had to be excluded.|89
9058946|NCT03672370|10118360|FG000|COMPLETED|Overall Study||42
9058947|NCT03672370|10118360|FG000|NOT COMPLETED|Overall Study||47
9058948|NCT03672396|10118364|FG000|STARTED|Overall Study||22
9058949|NCT03672396|10118364|FG000|COMPLETED|Overall Study||16
9058950|NCT03672396|10118364|FG000|NOT COMPLETED|Overall Study||6
9058951|NCT03673670|10118374|FG000|STARTED|Treatment Period 1 (3 Days)||14
9058952|NCT03673670|10118375|FG001|STARTED|Treatment Period 1 (3 Days)||14
9058953|NCT03673670|10118376|FG002|STARTED|Treatment Period 1 (3 Days)||13
9058954|NCT03673670|10118377|FG003|STARTED|Treatment Period 1 (3 Days)||12
9058955|NCT03673670|10118378|FG004|STARTED|Treatment Period 1 (3 Days)||13
9058956|NCT03673670|10118379|FG005|STARTED|Treatment Period 1 (3 Days)||13
9058957|NCT03673670|10118374|FG000|COMPLETED|Treatment Period 1 (3 Days)||13
9058958|NCT03673670|10118375|FG001|COMPLETED|Treatment Period 1 (3 Days)||14
9058959|NCT03673670|10118376|FG002|COMPLETED|Treatment Period 1 (3 Days)||12
9058960|NCT03673670|10118377|FG003|COMPLETED|Treatment Period 1 (3 Days)||12
9058961|NCT03673670|10118378|FG004|COMPLETED|Treatment Period 1 (3 Days)||13
9058962|NCT03673670|10118379|FG005|COMPLETED|Treatment Period 1 (3 Days)||11
9058963|NCT03673670|10118374|FG000|NOT COMPLETED|Treatment Period 1 (3 Days)||1
9058964|NCT03673670|10118375|FG001|NOT COMPLETED|Treatment Period 1 (3 Days)||0
9058965|NCT03673670|10118376|FG002|NOT COMPLETED|Treatment Period 1 (3 Days)||1
9058966|NCT03673670|10118377|FG003|NOT COMPLETED|Treatment Period 1 (3 Days)||0
9058967|NCT03673670|10118378|FG004|NOT COMPLETED|Treatment Period 1 (3 Days)||0
9058968|NCT03673670|10118379|FG005|NOT COMPLETED|Treatment Period 1 (3 Days)||2
9058969|NCT03673670|10118374|FG000|STARTED|Washout Period 1 (7-14 Days)||13
9058970|NCT03673670|10118375|FG001|STARTED|Washout Period 1 (7-14 Days)||14
9058971|NCT03673670|10118376|FG002|STARTED|Washout Period 1 (7-14 Days)||12
9058972|NCT03673670|10118377|FG003|STARTED|Washout Period 1 (7-14 Days)||12
9058973|NCT03673670|10118378|FG004|STARTED|Washout Period 1 (7-14 Days)||13
9058974|NCT03673670|10118379|FG005|STARTED|Washout Period 1 (7-14 Days)||11
9058975|NCT03673670|10118374|FG000|COMPLETED|Washout Period 1 (7-14 Days)||13
9058976|NCT03673670|10118375|FG001|COMPLETED|Washout Period 1 (7-14 Days)||14
9058977|NCT03673670|10118376|FG002|COMPLETED|Washout Period 1 (7-14 Days)||12
9058978|NCT03673670|10118377|FG003|COMPLETED|Washout Period 1 (7-14 Days)||12
9058979|NCT03673670|10118378|FG004|COMPLETED|Washout Period 1 (7-14 Days)||13
9058980|NCT03673670|10118379|FG005|COMPLETED|Washout Period 1 (7-14 Days)||11
9058981|NCT03673670|10118374|FG000|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
9058982|NCT03673670|10118375|FG001|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
9058983|NCT03673670|10118376|FG002|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
9058984|NCT03673670|10118377|FG003|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
9058985|NCT03673670|10118378|FG004|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
9058986|NCT03673670|10118379|FG005|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
9058987|NCT03673670|10118374|FG000|STARTED|Treatment Period 2 (3 Days)||13
9058988|NCT03673670|10118375|FG001|STARTED|Treatment Period 2 (3 Days)||14
9058989|NCT03673670|10118376|FG002|STARTED|Treatment Period 2 (3 Days)||12
9058990|NCT03673670|10118377|FG003|STARTED|Treatment Period 2 (3 Days)||12
9058991|NCT03673670|10118378|FG004|STARTED|Treatment Period 2 (3 Days)||13
9058992|NCT03673670|10118379|FG005|STARTED|Treatment Period 2 (3 Days)||11
9058993|NCT03673670|10118374|FG000|COMPLETED|Treatment Period 2 (3 Days)||13
9058994|NCT03673670|10118375|FG001|COMPLETED|Treatment Period 2 (3 Days)||14
9058995|NCT03673670|10118376|FG002|COMPLETED|Treatment Period 2 (3 Days)||11
9058996|NCT03673670|10118377|FG003|COMPLETED|Treatment Period 2 (3 Days)||12
9058997|NCT03673670|10118378|FG004|COMPLETED|Treatment Period 2 (3 Days)||12
9058998|NCT03673670|10118379|FG005|COMPLETED|Treatment Period 2 (3 Days)||11
9058999|NCT03673670|10118374|FG000|NOT COMPLETED|Treatment Period 2 (3 Days)||0
9059000|NCT03673670|10118375|FG001|NOT COMPLETED|Treatment Period 2 (3 Days)||0
9059001|NCT03673670|10118376|FG002|NOT COMPLETED|Treatment Period 2 (3 Days)||1
9059002|NCT03673670|10118377|FG003|NOT COMPLETED|Treatment Period 2 (3 Days)||0
9059003|NCT03673670|10118378|FG004|NOT COMPLETED|Treatment Period 2 (3 Days)||1
9059004|NCT03673670|10118379|FG005|NOT COMPLETED|Treatment Period 2 (3 Days)||0
9059005|NCT03673670|10118374|FG000|STARTED|Washout Period 2 (7-14 Days)||13
9059006|NCT03673670|10118375|FG001|STARTED|Washout Period 2 (7-14 Days)||14
9059007|NCT03673670|10118376|FG002|STARTED|Washout Period 2 (7-14 Days)||11
9059008|NCT03673670|10118377|FG003|STARTED|Washout Period 2 (7-14 Days)||12
9059009|NCT03673670|10118378|FG004|STARTED|Washout Period 2 (7-14 Days)||12
9059010|NCT03673670|10118379|FG005|STARTED|Washout Period 2 (7-14 Days)||11
9059011|NCT03673670|10118374|FG000|COMPLETED|Washout Period 2 (7-14 Days)||13
9059012|NCT03673670|10118375|FG001|COMPLETED|Washout Period 2 (7-14 Days)||14
9059013|NCT03673670|10118376|FG002|COMPLETED|Washout Period 2 (7-14 Days)||11
9059014|NCT03673670|10118377|FG003|COMPLETED|Washout Period 2 (7-14 Days)||12
9059015|NCT03673670|10118378|FG004|COMPLETED|Washout Period 2 (7-14 Days)||11
9059016|NCT03673670|10118379|FG005|COMPLETED|Washout Period 2 (7-14 Days)||11
9059017|NCT03673670|10118374|FG000|NOT COMPLETED|Washout Period 2 (7-14 Days)||0
9059018|NCT03673670|10118375|FG001|NOT COMPLETED|Washout Period 2 (7-14 Days)||0
9059019|NCT03673670|10118376|FG002|NOT COMPLETED|Washout Period 2 (7-14 Days)||0
9059020|NCT03673670|10118377|FG003|NOT COMPLETED|Washout Period 2 (7-14 Days)||0
9059021|NCT03673670|10118378|FG004|NOT COMPLETED|Washout Period 2 (7-14 Days)||1
9059022|NCT03673670|10118379|FG005|NOT COMPLETED|Washout Period 2 (7-14 Days)||0
9059023|NCT03673670|10118374|FG000|STARTED|Treatment Period 3 (3 Days)||13
9059024|NCT03673670|10118375|FG001|STARTED|Treatment Period 3 (3 Days)||14
9059025|NCT03673670|10118376|FG002|STARTED|Treatment Period 3 (3 Days)||11
9059026|NCT03673670|10118377|FG003|STARTED|Treatment Period 3 (3 Days)||12
9059027|NCT03673670|10118378|FG004|STARTED|Treatment Period 3 (3 Days)||11
9059028|NCT03673670|10118379|FG005|STARTED|Treatment Period 3 (3 Days)||11
9059029|NCT03673670|10118374|FG000|COMPLETED|Treatment Period 3 (3 Days)||13
9059030|NCT03673670|10118375|FG001|COMPLETED|Treatment Period 3 (3 Days)||14
9059031|NCT03673670|10118376|FG002|COMPLETED|Treatment Period 3 (3 Days)||11
9059032|NCT03673670|10118377|FG003|COMPLETED|Treatment Period 3 (3 Days)||12
9059033|NCT03673670|10118378|FG004|COMPLETED|Treatment Period 3 (3 Days)||10
9059034|NCT03673670|10118379|FG005|COMPLETED|Treatment Period 3 (3 Days)||11
9059035|NCT03673670|10118374|FG000|NOT COMPLETED|Treatment Period 3 (3 Days)||0
9059036|NCT03673670|10118375|FG001|NOT COMPLETED|Treatment Period 3 (3 Days)||0
9059037|NCT03673670|10118376|FG002|NOT COMPLETED|Treatment Period 3 (3 Days)||0
9059038|NCT03673670|10118377|FG003|NOT COMPLETED|Treatment Period 3 (3 Days)||0
9059039|NCT03673670|10118378|FG004|NOT COMPLETED|Treatment Period 3 (3 Days)||1
9059040|NCT03673670|10118379|FG005|NOT COMPLETED|Treatment Period 3 (3 Days)||0
9059041|NCT03674177|10118400|FG000|STARTED|Overall Study||124
9059042|NCT03674177|10118401|FG001|STARTED|Overall Study||126
9059043|NCT03674177|10118402|FG002|STARTED|Overall Study||126
9059044|NCT03674177|10118403|FG003|STARTED|Overall Study||126
9059045|NCT03674177|10118400|FG000|COMPLETED|Overall Study||122
9059046|NCT03674177|10118401|FG001|COMPLETED|Overall Study||125
9059047|NCT03674177|10118402|FG002|COMPLETED|Overall Study||126
9059048|NCT03674177|10118403|FG003|COMPLETED|Overall Study||124
9059049|NCT03674177|10118400|FG000|NOT COMPLETED|Overall Study||2
9059050|NCT03674177|10118401|FG001|NOT COMPLETED|Overall Study||1
9059051|NCT03674177|10118402|FG002|NOT COMPLETED|Overall Study||0
9059052|NCT03674177|10118403|FG003|NOT COMPLETED|Overall Study||2
9059053|NCT03674281|10118416|FG000|STARTED|Overall Study||18
9059054|NCT03674281|10118417|FG001|STARTED|Overall Study||16
9059055|NCT03674281|10118418|FG002|STARTED|Overall Study||16
9059056|NCT03674281|10118416|FG000|COMPLETED|Overall Study||15
9059057|NCT03674281|10118417|FG001|COMPLETED|Overall Study||13
9059058|NCT03674281|10118418|FG002|COMPLETED|Overall Study||13
9059059|NCT03674281|10118416|FG000|NOT COMPLETED|Overall Study||3
9059060|NCT03674281|10118417|FG001|NOT COMPLETED|Overall Study||3
9059061|NCT03674281|10118418|FG002|NOT COMPLETED|Overall Study||3
9059062|NCT03674970|10118437|FG000|STARTED|Overall Study||15
9059063|NCT03674970|10118438|FG001|STARTED|Overall Study||15
9059064|NCT03674970|10118439|FG002|STARTED|Overall Study||15
9059065|NCT03674970|10118437|FG000|COMPLETED|Overall Study||12
9059066|NCT03674970|10118438|FG001|COMPLETED|Overall Study||8
9059067|NCT03674970|10118439|FG002|COMPLETED|Overall Study||12
9059068|NCT03674970|10118437|FG000|NOT COMPLETED|Overall Study||3
9059069|NCT03674970|10118438|FG001|NOT COMPLETED|Overall Study||7
9059070|NCT03674970|10118439|FG002|NOT COMPLETED|Overall Study||3
9059071|NCT03675451|10118447|FG000|STARTED|Overall Study||20
9059072|NCT03675451|10118447|FG000|COMPLETED|Overall Study||20
9059073|NCT03675451|10118447|FG000|NOT COMPLETED|Overall Study||0
9059074|NCT03675581|10118458|FG000|STARTED|Period 1: Microgynon Alone||17
9059075|NCT03675581|10118458|FG000|COMPLETED|Period 1: Microgynon Alone||17
9059076|NCT03675581|10118458|FG000|NOT COMPLETED|Period 1: Microgynon Alone||0
9059077|NCT03675581|10118458|FG000|STARTED|Period 2: Microgynon + Nintedanib||17
9059078|NCT03675581|10118458|FG000|COMPLETED|Period 2: Microgynon + Nintedanib||17
9059079|NCT03675581|10118458|FG000|NOT COMPLETED|Period 2: Microgynon + Nintedanib||0
9059080|NCT03675685|10118466|FG000|STARTED|Overall Study||12
9059081|NCT03675685|10118466|FG000|COMPLETED|Overall Study||12
9059082|NCT03675685|10118466|FG000|NOT COMPLETED|Overall Study||0
9059083|NCT03675776|10118477|FG000|STARTED|Double Blind Treatment Period||15
9059084|NCT03675776|10118478|FG001|STARTED|Double Blind Treatment Period||17
9059085|NCT03675776|10118479|FG002|STARTED|Double Blind Treatment Period||18
9059086|NCT03675776|10118477|FG000|COMPLETED|Double Blind Treatment Period||9
9059087|NCT03675776|10118478|FG001|COMPLETED|Double Blind Treatment Period||11
9059088|NCT03675776|10118479|FG002|COMPLETED|Double Blind Treatment Period||10
9059089|NCT03675776|10118477|FG000|NOT COMPLETED|Double Blind Treatment Period||6
9059090|NCT03675776|10118478|FG001|NOT COMPLETED|Double Blind Treatment Period||6
9059091|NCT03675776|10118479|FG002|NOT COMPLETED|Double Blind Treatment Period||8
9059092|NCT03675776|10118477|FG000|STARTED|Safety Follow-up Period||6
9059093|NCT03675776|10118478|FG001|STARTED|Safety Follow-up Period||8
9059094|NCT03675776|10118479|FG002|STARTED|Safety Follow-up Period||7
9059095|NCT03675776|10118477|FG000|COMPLETED|Safety Follow-up Period||6
9059096|NCT03675776|10118478|FG001|COMPLETED|Safety Follow-up Period||8
9059097|NCT03675776|10118479|FG002|COMPLETED|Safety Follow-up Period||7
9059098|NCT03675776|10118477|FG000|NOT COMPLETED|Safety Follow-up Period||0
9059099|NCT03675776|10118478|FG001|NOT COMPLETED|Safety Follow-up Period||0
9059100|NCT03675776|10118479|FG002|NOT COMPLETED|Safety Follow-up Period||0
9059101|NCT03676270|10118487|FG000|STARTED|Overall Study||6915
9059102|NCT03676270|10118487|FG000|COMPLETED|Overall Study||6915
9059103|NCT03676270|10118487|FG000|NOT COMPLETED|Overall Study||0
9059104|NCT03676634|10118491|FG000|STARTED|Overall Study||32
9059105|NCT03676634|10118491|FG000|Screening|Overall Study||32
9059106|NCT03676634|10118491|FG000|Participants Received rBV A/B Injection|Overall Study||32
9059107|NCT03676634|10118491|FG000|Participants Included in the Plasma-donating Population|Overall Study||32
9059108|NCT03676634|10118491|FG000|Participants Completed Follow up|Overall Study||32
9059109|NCT03676634|10118491|FG000|COMPLETED|Overall Study||29
9059110|NCT03676634|10118491|FG000|NOT COMPLETED|Overall Study||3
9059111|NCT03676725|10118501|FG000|STARTED|Overall Study||23
9059112|NCT03676725|10118502|FG001|STARTED|Overall Study||14
9059113|NCT03676725|10118503|FG002|STARTED|Overall Study||22
9059114|NCT03676725|10118504|FG003|STARTED|Overall Study||5
9059115|NCT03676725|10118505|FG004|STARTED|Overall Study||15
9059116|NCT03676725|10118506|FG005|STARTED|Overall Study||11
9059117|NCT03676725|10118501|FG000|COMPLETED|Overall Study||23
9059118|NCT03676725|10118502|FG001|COMPLETED|Overall Study||14
9059119|NCT03676725|10118503|FG002|COMPLETED|Overall Study||22
9059120|NCT03676725|10118504|FG003|COMPLETED|Overall Study||5
9059121|NCT03676725|10118505|FG004|COMPLETED|Overall Study||15
9059122|NCT03676725|10118506|FG005|COMPLETED|Overall Study||11
9059123|NCT03676725|10118501|FG000|NOT COMPLETED|Overall Study||0
9059124|NCT03676725|10118502|FG001|NOT COMPLETED|Overall Study||0
9059125|NCT03676725|10118503|FG002|NOT COMPLETED|Overall Study||0
9059126|NCT03676725|10118504|FG003|NOT COMPLETED|Overall Study||0
9059127|NCT03676725|10118505|FG004|NOT COMPLETED|Overall Study||0
9059128|NCT03676725|10118506|FG005|NOT COMPLETED|Overall Study||0
9059129|NCT03676803|10118517|FG000|STARTED|Overall Study||15
9059130|NCT03676803|10118518|FG001|STARTED|Overall Study||16
9059131|NCT03676803|10118517|FG000|COMPLETED|Overall Study||15
9059132|NCT03676803|10118518|FG001|COMPLETED|Overall Study||16
9059133|NCT03676803|10118517|FG000|NOT COMPLETED|Overall Study||0
9059134|NCT03676803|10118518|FG001|NOT COMPLETED|Overall Study||0
9059135|NCT03676972|10118526|FG000|STARTED|Overall Study||60
9059136|NCT03676972|10118526|FG000|COMPLETED|Overall Study||58
9059137|NCT03676972|10118526|FG000|NOT COMPLETED|Overall Study||2
9059138|NCT03677089|10118530|FG000|STARTED|Overall Study||148
9059139|NCT03677089|10118530|FG000|Baseline/Pre-Intervention|Overall Study||137
9059140|NCT03677089|10118530|FG000|Mid-Intervention|Overall Study||120
9059141|NCT03677089|10118530|FG000|Post-Intervention|Overall Study||117
9059142|NCT03677089|10118530|FG000|Follow-Up|Overall Study||114
9059143|NCT03677089|10118530|FG000|COMPLETED|Overall Study||114
9059144|NCT03677089|10118530|FG000|NOT COMPLETED|Overall Study||34
9059145|NCT03677245|10118538|FG000|STARTED|Overall Study||8
9059146|NCT03677245|10118538|FG000|COMPLETED|Overall Study||8
9059147|NCT03677245|10118538|FG000|NOT COMPLETED|Overall Study||0
9059148|NCT03677375|10118543|FG000|STARTED|Overall Study||93
9059149|NCT03677375|10118543|FG000|COMPLETED|Overall Study||81
9059150|NCT03677375|10118543|FG000|NOT COMPLETED|Overall Study||12
9059151|NCT03677401|10118549|FG000|STARTED|Overall Study||148
9059152|NCT03677401|10118550|FG001|STARTED|Overall Study||147
9059153|NCT03677401|10118549|FG000|COMPLETED|Overall Study||138
9059154|NCT03677401|10118550|FG001|COMPLETED|Overall Study||129
9059155|NCT03677401|10118549|FG000|NOT COMPLETED|Overall Study||10
9059156|NCT03677401|10118550|FG001|NOT COMPLETED|Overall Study||18
9059157|NCT03677869|10118556|FG000|STARTED|Overall Study||35
9059158|NCT03677869|10118556|FG000|COMPLETED|Overall Study||34
9059159|NCT03677869|10118556|FG000|NOT COMPLETED|Overall Study||1
9059160|NCT03678103|10118560|FG000|STARTED|Overall Study||30
9059161|NCT03678103|10118560|FG000|COMPLETED|Overall Study||26
9059162|NCT03678103|10118560|FG000|NOT COMPLETED|Overall Study||4
9059163|NCT03678285|10118564|FG000|STARTED|Overall Study||42
9059164|NCT03678285|10118564|FG000|Started Workout|Overall Study||40
9059165|NCT03678285|10118564|FG000|COMPLETED|Overall Study||38
9059166|NCT03678285|10118564|FG000|NOT COMPLETED|Overall Study||4
9059167|NCT03678311|10118568|FG000|STARTED|Overall Study||9
9059168|NCT03678311|10118568|FG000|COMPLETED|Overall Study||9
9059169|NCT03678311|10118568|FG000|NOT COMPLETED|Overall Study||0
9059170|NCT03678870|10118574|FG000|STARTED|Overall Study||97
9059171|NCT03678870|10118575|FG001|STARTED|Overall Study||99
9059172|NCT03678870|10118574|FG000|COMPLETED|Overall Study||84
9059173|NCT03678870|10118575|FG001|COMPLETED|Overall Study||91
9059174|NCT03678870|10118574|FG000|NOT COMPLETED|Overall Study||13
9059175|NCT03678870|10118575|FG001|NOT COMPLETED|Overall Study||8
9059176|NCT03679494|10118583|FG000|STARTED|Overall Study||67
9059177|NCT03679494|10118584|FG001|STARTED|Overall Study||63
9059178|NCT03679494|10118583|FG000|COMPLETED|Overall Study||67
9059179|NCT03679494|10118584|FG001|COMPLETED|Overall Study||63
9059180|NCT03679494|10118583|FG000|NOT COMPLETED|Overall Study||0
9059181|NCT03679494|10118584|FG001|NOT COMPLETED|Overall Study||0
9059182|NCT03679741|10118590|FG000|STARTED|Period 1||59
9059183|NCT03679741|10118591|FG001|STARTED|Period 1||61
9059184|NCT03679741|10118590|FG000|COMPLETED|Period 1||57
9059185|NCT03679741|10118591|FG001|COMPLETED|Period 1||58
9059186|NCT03679741|10118590|FG000|NOT COMPLETED|Period 1||2
9059187|NCT03679741|10118591|FG001|NOT COMPLETED|Period 1||3
9059188|NCT03679741|10118590|FG000|STARTED|Period 2||57
9059189|NCT03679741|10118591|FG001|STARTED|Period 2||58
9059190|NCT03679741|10118590|FG000|COMPLETED|Period 2||54
9059191|NCT03679741|10118591|FG001|COMPLETED|Period 2||56
9059192|NCT03679741|10118590|FG000|NOT COMPLETED|Period 2||3
9059193|NCT03679741|10118591|FG001|NOT COMPLETED|Period 2||2
9059194|NCT03679741|10118590|FG000|STARTED|Period 3||54
9059195|NCT03679741|10118591|FG001|STARTED|Period 3||56
9059196|NCT03679741|10118590|FG000|COMPLETED|Period 3||54
9059197|NCT03679741|10118591|FG001|COMPLETED|Period 3||56
9059198|NCT03679741|10118590|FG000|NOT COMPLETED|Period 3||0
9059199|NCT03679741|10118591|FG001|NOT COMPLETED|Period 3||0
9059200|NCT03679975|10118597|FG000|STARTED|Overall Study||9
9059201|NCT03679975|10118597|FG000|COMPLETED|Overall Study||9
9059202|NCT03679975|10118597|FG000|NOT COMPLETED|Overall Study||0
9059203|NCT03680105|10118610|FG000|STARTED|Overall Study||8
9059204|NCT03680105|10118611|FG001|STARTED|Overall Study||8
9059205|NCT03680105|10118612|FG002|STARTED|Overall Study||8
9059206|NCT03680105|10118613|FG003|STARTED|Overall Study||8
9059207|NCT03680105|10118614|FG004|STARTED|Overall Study||8
9059208|NCT03680105|10118615|FG005|STARTED|Overall Study||12
9059209|NCT03680105|10118616|FG006|STARTED|Overall Study||8
9059210|NCT03680105|10118617|FG007|STARTED|Overall Study||8
9059211|NCT03680105|10118618|FG008|STARTED|Overall Study||8
9059212|NCT03680105|10118610|FG000|COMPLETED|Overall Study||8
9059213|NCT03680105|10118611|FG001|COMPLETED|Overall Study||8
9059214|NCT03680105|10118612|FG002|COMPLETED|Overall Study||8
9059215|NCT03680105|10118613|FG003|COMPLETED|Overall Study||8
9059216|NCT03680105|10118614|FG004|COMPLETED|Overall Study||8
9059217|NCT03680105|10118615|FG005|COMPLETED|Overall Study||12
9059218|NCT03680105|10118616|FG006|COMPLETED|Overall Study||8
9059219|NCT03680105|10118617|FG007|COMPLETED|Overall Study||8
9059220|NCT03680105|10118618|FG008|COMPLETED|Overall Study||8
9059221|NCT03680105|10118610|FG000|NOT COMPLETED|Overall Study||0
9059222|NCT03680105|10118611|FG001|NOT COMPLETED|Overall Study||0
9059223|NCT03680105|10118612|FG002|NOT COMPLETED|Overall Study||0
9059224|NCT03680105|10118613|FG003|NOT COMPLETED|Overall Study||0
9059225|NCT03680105|10118614|FG004|NOT COMPLETED|Overall Study||0
9059226|NCT03680105|10118615|FG005|NOT COMPLETED|Overall Study||0
9059227|NCT03680105|10118616|FG006|NOT COMPLETED|Overall Study||0
9059228|NCT03680105|10118617|FG007|NOT COMPLETED|Overall Study||0
9059229|NCT03680105|10118618|FG008|NOT COMPLETED|Overall Study||0
9059230|NCT03680521|10118644|FG000|STARTED|Overall Study||7
9059231|NCT03680521|10118645|FG001|STARTED|Overall Study||13
9059232|NCT03680521|10118644|FG000|COMPLETED|Overall Study||0
9059233|NCT03680521|10118645|FG001|COMPLETED|Overall Study||2
9059234|NCT03680521|10118644|FG000|NOT COMPLETED|Overall Study||7
9059235|NCT03680521|10118645|FG001|NOT COMPLETED|Overall Study||11
9059236|NCT03680742|10118654|FG000|STARTED|Overall Study||34
9059237|NCT03680742|10118654|FG000|COMPLETED|Overall Study||32
9059238|NCT03680742|10118654|FG000|NOT COMPLETED|Overall Study||2
9059239|NCT03681093|10118661|FG000|STARTED|Overall Study||32
9059240|NCT03681093|10118662|FG001|STARTED|Overall Study||34
9059241|NCT03681093|10118663|FG002|STARTED|Overall Study||32
9059242|NCT03681093|10118661|FG000|Full Analysis Set (FAS)|Overall Study||31
9059243|NCT03681093|10118662|FG001|Full Analysis Set (FAS)|Overall Study||32
9059244|NCT03681093|10118663|FG002|Full Analysis Set (FAS)|Overall Study||28
9059245|NCT03681093|10118661|FG000|Safety Analysis Set (SAF)|Overall Study||32
9059246|NCT03681093|10118662|FG001|Safety Analysis Set (SAF)|Overall Study||34
9059247|NCT03681093|10118663|FG002|Safety Analysis Set (SAF)|Overall Study||32
9059248|NCT03681093|10118661|FG000|COMPLETED|Overall Study||32
9059249|NCT03681093|10118662|FG001|COMPLETED|Overall Study||32
9059250|NCT03681093|10118663|FG002|COMPLETED|Overall Study||31
9059251|NCT03681093|10118661|FG000|NOT COMPLETED|Overall Study||0
9059252|NCT03681093|10118662|FG001|NOT COMPLETED|Overall Study||2
9059253|NCT03681093|10118663|FG002|NOT COMPLETED|Overall Study||1
9059254|NCT03681119|10118673|FG000|STARTED|Overall Study||72
9059255|NCT03681119|10118674|FG001|STARTED|Overall Study||11
9059256|NCT03681119|10118673|FG000|COMPLETED|Overall Study||66
9059257|NCT03681119|10118674|FG001|COMPLETED|Overall Study||11
9059258|NCT03681119|10118673|FG000|NOT COMPLETED|Overall Study||6
9059259|NCT03681119|10118674|FG001|NOT COMPLETED|Overall Study||0
9059260|NCT03681353|10118678|FG000|STARTED|Overall Study||25
9059261|NCT03681353|10118678|FG000|COMPLETED|Overall Study||18
9059262|NCT03681353|10118678|FG000|NOT COMPLETED|Overall Study||7
9059263|NCT03681405|10118684|FG000|STARTED|Overall Study||14
9059264|NCT03681405|10118685|FG001|STARTED|Overall Study||17
9059265|NCT03681405|10118684|FG000|COMPLETED|Overall Study||13
9059266|NCT03681405|10118685|FG001|COMPLETED|Overall Study||17
9059267|NCT03681405|10118684|FG000|NOT COMPLETED|Overall Study||1
9059268|NCT03681405|10118685|FG001|NOT COMPLETED|Overall Study||0
9059269|NCT03681808|10118695|FG000|STARTED|Overall Study||123
9059270|NCT03681808|10118696|FG001|STARTED|Overall Study||119
9059271|NCT03681808|10118695|FG000|COMPLETED|Overall Study||109
9059272|NCT03681808|10118696|FG001|COMPLETED|Overall Study||102
9059273|NCT03681808|10118695|FG000|NOT COMPLETED|Overall Study||14
9059274|NCT03681808|10118696|FG001|NOT COMPLETED|Overall Study||17
9059275|NCT03681886|10118702|FG000|STARTED|Overall Study||78
9059276|NCT03681886|10118702|FG000|Successful Implantation|Overall Study||76
9059277|NCT03681886|10118702|FG000|Failed Implantation|Overall Study||2
9059278|NCT03681886|10118702|FG000|Underwent Optic Exchange|Overall Study||4
9059279|NCT03681886|10118702|FG000|COMPLETED|Overall Study||76
9059280|NCT03681886|10118702|FG000|NOT COMPLETED|Overall Study||2
9059281|NCT03681951|10118731|FG000|STARTED|Part1: Monotherapy DE (Up to Day 95)||8
9059282|NCT03681951|10118732|FG001|STARTED|Part1: Monotherapy DE (Up to Day 95)|"No participant was enrolled in this arm as study was terminated during cohort GSK3145095 50mg BID"|0
9059283|NCT03681951|10118733|FG002|STARTED|Part1: Monotherapy DE (Up to Day 95)|"No participant was enrolled in this arm as study was terminated during cohort GSK3145095 50mg BID."|0
9059284|NCT03681951|10118734|FG003|STARTED|Part1: Monotherapy DE (Up to Day 95)|"No participant was enrolled in this arm as study was terminated during cohort GSK3145095 50mg BID"|0
9059285|NCT03681951|10118735|FG004|STARTED|Part1: Monotherapy DE (Up to Day 95)|"No participant was enrolled in this arm as study was terminated during cohort GSK3145095 50mg BID"|0
9059286|NCT03681951|10118736|FG005|STARTED|Part1: Monotherapy DE (Up to Day 95)|Part 2 was not initiated as this study was terminated during Part 1|0
9059287|NCT03681951|10118737|FG006|STARTED|Part1: Monotherapy DE (Up to Day 95)|Part 3 was not initiated as this study was terminated during Part 1|0
9059288|NCT03681951|10118738|FG007|STARTED|Part1: Monotherapy DE (Up to Day 95)|Part 4 was not initiated as this study was terminated during Part 1|0
9059289|NCT03681951|10118731|FG000|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
9059290|NCT03681951|10118732|FG001|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
9059291|NCT03681951|10118733|FG002|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
9059292|NCT03681951|10118734|FG003|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
9059293|NCT03681951|10118735|FG004|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
9059294|NCT03681951|10118736|FG005|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
9059295|NCT03681951|10118737|FG006|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
9059296|NCT03681951|10118738|FG007|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
9059297|NCT03681951|10118731|FG000|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||8
9059298|NCT03681951|10118732|FG001|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
9059299|NCT03681951|10118733|FG002|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
9059300|NCT03681951|10118734|FG003|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
9059301|NCT03681951|10118735|FG004|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
9059302|NCT03681951|10118736|FG005|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
9059303|NCT03681951|10118737|FG006|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
9059304|NCT03681951|10118738|FG007|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
9059305|NCT03681951|10118731|FG000|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
9059306|NCT03681951|10118732|FG001|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
9059307|NCT03681951|10118733|FG002|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
9059308|NCT03681951|10118734|FG003|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
9059309|NCT03681951|10118735|FG004|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
9059310|NCT03681951|10118736|FG005|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
9059311|NCT03681951|10118737|FG006|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
9059312|NCT03681951|10118738|FG007|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
9059313|NCT03681951|10118731|FG000|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
9059314|NCT03681951|10118732|FG001|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
9059315|NCT03681951|10118733|FG002|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
9059316|NCT03681951|10118734|FG003|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
9059317|NCT03681951|10118735|FG004|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
9059318|NCT03681951|10118736|FG005|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
9059319|NCT03681951|10118737|FG006|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
9059320|NCT03681951|10118738|FG007|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
9059321|NCT03681951|10118731|FG000|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
9059322|NCT03681951|10118732|FG001|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
9059323|NCT03681951|10118733|FG002|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
9059324|NCT03681951|10118734|FG003|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
9059325|NCT03681951|10118735|FG004|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
9059326|NCT03681951|10118736|FG005|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
9059327|NCT03681951|10118737|FG006|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
9059328|NCT03681951|10118738|FG007|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
9059329|NCT03681951|10118731|FG000|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
9059330|NCT03681951|10118732|FG001|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
9059331|NCT03681951|10118733|FG002|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
9059332|NCT03681951|10118734|FG003|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
9059333|NCT03681951|10118735|FG004|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
9059334|NCT03681951|10118736|FG005|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
9059335|NCT03681951|10118737|FG006|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
9059336|NCT03681951|10118738|FG007|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
9059337|NCT03681951|10118731|FG000|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
9059338|NCT03681951|10118732|FG001|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
9059339|NCT03681951|10118733|FG002|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
9059340|NCT03681951|10118734|FG003|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
9059341|NCT03681951|10118735|FG004|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
9059342|NCT03681951|10118736|FG005|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
9059343|NCT03681951|10118737|FG006|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
9059344|NCT03681951|10118738|FG007|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
9059345|NCT03681951|10118731|FG000|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
9059346|NCT03681951|10118732|FG001|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
9059347|NCT03681951|10118733|FG002|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
9059348|NCT03681951|10118734|FG003|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
9059349|NCT03681951|10118735|FG004|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
9059350|NCT03681951|10118736|FG005|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
9059351|NCT03681951|10118737|FG006|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
9059352|NCT03681951|10118738|FG007|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
9059353|NCT03681951|10118731|FG000|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
9059354|NCT03681951|10118732|FG001|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
9059355|NCT03681951|10118733|FG002|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
9059356|NCT03681951|10118734|FG003|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
9059357|NCT03681951|10118735|FG004|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
9059358|NCT03681951|10118736|FG005|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
9059359|NCT03681951|10118737|FG006|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
9059360|NCT03681951|10118738|FG007|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
9059361|NCT03681951|10118731|FG000|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
9059362|NCT03681951|10118732|FG001|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
9059363|NCT03681951|10118733|FG002|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
9059364|NCT03681951|10118734|FG003|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
9059365|NCT03681951|10118735|FG004|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
9059366|NCT03681951|10118736|FG005|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
9059367|NCT03681951|10118737|FG006|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
9059368|NCT03681951|10118738|FG007|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
9059369|NCT03681951|10118731|FG000|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
9059370|NCT03681951|10118732|FG001|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
9059371|NCT03681951|10118733|FG002|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
9059372|NCT03681951|10118734|FG003|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
9059373|NCT03681951|10118735|FG004|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
9059374|NCT03681951|10118736|FG005|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
9059375|NCT03681951|10118737|FG006|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
9059376|NCT03681951|10118738|FG007|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
9059377|NCT03682107|10118766|FG000|STARTED|Overall Study||10
9059378|NCT03682107|10118767|FG001|STARTED|Overall Study||10
9059379|NCT03682107|10118768|FG002|STARTED|Overall Study||10
9059380|NCT03682107|10118769|FG003|STARTED|Overall Study||10
9059381|NCT03682107|10118770|FG004|STARTED|Overall Study||8
9059382|NCT03682107|10118766|FG000|COMPLETED|Overall Study||10
9059383|NCT03682107|10118767|FG001|COMPLETED|Overall Study||9
9059384|NCT03682107|10118768|FG002|COMPLETED|Overall Study||10
9059385|NCT03682107|10118769|FG003|COMPLETED|Overall Study||10
9059386|NCT03682107|10118770|FG004|COMPLETED|Overall Study||8
9059387|NCT03682107|10118766|FG000|NOT COMPLETED|Overall Study||0
9059388|NCT03682107|10118767|FG001|NOT COMPLETED|Overall Study||1
9059389|NCT03682107|10118768|FG002|NOT COMPLETED|Overall Study||0
9059390|NCT03682107|10118769|FG003|NOT COMPLETED|Overall Study||0
9059391|NCT03682107|10118770|FG004|NOT COMPLETED|Overall Study||0
9059392|NCT03682120|10118786|FG000|STARTED|Overall Study||105
9059393|NCT03682120|10118787|FG001|STARTED|Overall Study||105
9059394|NCT03682120|10118788|FG002|STARTED|Overall Study||105
9059395|NCT03682120|10118789|FG003|STARTED|Overall Study||57
9059396|NCT03682120|10118786|FG000|COMPLETED|Overall Study||92
9059397|NCT03682120|10118787|FG001|COMPLETED|Overall Study||97
9059398|NCT03682120|10118788|FG002|COMPLETED|Overall Study||97
9059399|NCT03682120|10118789|FG003|COMPLETED|Overall Study||55
9059400|NCT03682120|10118786|FG000|NOT COMPLETED|Overall Study||13
9059401|NCT03682120|10118787|FG001|NOT COMPLETED|Overall Study||8
9059402|NCT03682120|10118788|FG002|NOT COMPLETED|Overall Study||8
9059403|NCT03682120|10118789|FG003|NOT COMPLETED|Overall Study||2
9059404|NCT03682302|10118805|FG000|STARTED|Overall Study||31
9059405|NCT03682302|10118806|FG001|STARTED|Overall Study||30
9059406|NCT03682302|10118807|FG002|STARTED|Overall Study|1 subject enrolled in Group 2, not treated, and surgery type unknown. Subject is not counted here.|6
9059407|NCT03682302|10118808|FG003|STARTED|Overall Study|1 subject enrolled in Group 2, not treated, and surgery type unknown. Subject is not counted here.|30
9059408|NCT03682302|10118805|FG000|COMPLETED|Overall Study||30
9059409|NCT03682302|10118806|FG001|COMPLETED|Overall Study||28
9059410|NCT03682302|10118807|FG002|COMPLETED|Overall Study||5
9059411|NCT03682302|10118808|FG003|COMPLETED|Overall Study||28
9059412|NCT03682302|10118805|FG000|NOT COMPLETED|Overall Study||1
9059413|NCT03682302|10118806|FG001|NOT COMPLETED|Overall Study||2
9059414|NCT03682302|10118807|FG002|NOT COMPLETED|Overall Study||1
9059415|NCT03682302|10118808|FG003|NOT COMPLETED|Overall Study||2
9059416|NCT03682705|10118824|FG000|STARTED|Overall Study||19
9059417|NCT03682705|10118825|FG001|STARTED|Overall Study||62
9059418|NCT03682705|10118826|FG002|STARTED|Overall Study||41
9059419|NCT03682705|10118827|FG003|STARTED|Overall Study||39
9059420|NCT03682705|10118828|FG004|STARTED|Overall Study||41
9059421|NCT03682705|10118829|FG005|STARTED|Overall Study||40
9059422|NCT03682705|10118824|FG000|COMPLETED|Overall Study||17
9059423|NCT03682705|10118825|FG001|COMPLETED|Overall Study||58
9059424|NCT03682705|10118826|FG002|COMPLETED|Overall Study||38
9059425|NCT03682705|10118827|FG003|COMPLETED|Overall Study||34
9059426|NCT03682705|10118828|FG004|COMPLETED|Overall Study||35
9059427|NCT03682705|10118829|FG005|COMPLETED|Overall Study||38
9059428|NCT03682705|10118824|FG000|NOT COMPLETED|Overall Study||2
9059429|NCT03682705|10118825|FG001|NOT COMPLETED|Overall Study||4
9059430|NCT03682705|10118826|FG002|NOT COMPLETED|Overall Study||3
9059431|NCT03682705|10118827|FG003|NOT COMPLETED|Overall Study||5
9059432|NCT03682705|10118828|FG004|NOT COMPLETED|Overall Study||6
9059433|NCT03682705|10118829|FG005|NOT COMPLETED|Overall Study||2
9059434|NCT03682809|10118845|FG000|STARTED|Overall Study||22
9059435|NCT03682809|10118846|FG001|STARTED|Overall Study||24
9059436|NCT03682809|10118845|FG000|COMPLETED|Overall Study||22
9059437|NCT03682809|10118846|FG001|COMPLETED|Overall Study||24
9059438|NCT03682809|10118845|FG000|NOT COMPLETED|Overall Study||0
9059439|NCT03682809|10118846|FG001|NOT COMPLETED|Overall Study||0
9059440|NCT03682965|10118854|FG000|STARTED|Overall Study||11
9059441|NCT03682965|10118855|FG001|STARTED|Overall Study||10
9059442|NCT03682965|10118854|FG000|COMPLETED|Overall Study||11
9059443|NCT03682965|10118855|FG001|COMPLETED|Overall Study||10
9059444|NCT03682965|10118854|FG000|NOT COMPLETED|Overall Study||0
9059445|NCT03682965|10118855|FG001|NOT COMPLETED|Overall Study||0
9059446|NCT03683576|10118865|FG000|STARTED|Overall Study||120
9059447|NCT03683576|10118866|FG001|STARTED|Overall Study||120
9059448|NCT03683576|10118867|FG002|STARTED|Overall Study||118
9059449|NCT03683576|10118868|FG003|STARTED|Overall Study||122
9059450|NCT03683576|10118865|FG000|COMPLETED|Overall Study||114
9059451|NCT03683576|10118866|FG001|COMPLETED|Overall Study||116
9059452|NCT03683576|10118867|FG002|COMPLETED|Overall Study||106
9059453|NCT03683576|10118868|FG003|COMPLETED|Overall Study||114
9059454|NCT03683576|10118865|FG000|NOT COMPLETED|Overall Study||6
9059455|NCT03683576|10118866|FG001|NOT COMPLETED|Overall Study||4
9059456|NCT03683576|10118867|FG002|NOT COMPLETED|Overall Study||12
9059457|NCT03683576|10118868|FG003|NOT COMPLETED|Overall Study||8
9059458|NCT03683719|10118883|FG000|STARTED|Overall Study||52
9059459|NCT03683719|10118884|FG001|STARTED|Overall Study||51
9059460|NCT03683719|10118885|FG002|STARTED|Overall Study||52
9059461|NCT03683719|10118886|FG003|STARTED|Overall Study||53
9059462|NCT03683719|10118887|FG004|STARTED|Overall Study||50
9059463|NCT03683719|10118883|FG000|COMPLETED|Overall Study||40
9059464|NCT03683719|10118884|FG001|COMPLETED|Overall Study||38
9059465|NCT03683719|10118885|FG002|COMPLETED|Overall Study||44
9059466|NCT03683719|10118886|FG003|COMPLETED|Overall Study||46
9059467|NCT03683719|10118887|FG004|COMPLETED|Overall Study||36
9059468|NCT03683719|10118883|FG000|NOT COMPLETED|Overall Study||12
9059469|NCT03683719|10118884|FG001|NOT COMPLETED|Overall Study||13
9059470|NCT03683719|10118885|FG002|NOT COMPLETED|Overall Study||8
9059471|NCT03683719|10118886|FG003|NOT COMPLETED|Overall Study||7
9059472|NCT03683719|10118887|FG004|NOT COMPLETED|Overall Study||14
9059473|NCT03683758|10118901|FG000|STARTED|Overall Study||11
9059474|NCT03683758|10118902|FG001|STARTED|Overall Study||10
9059475|NCT03683758|10118901|FG000|COMPLETED|Overall Study||8
9059476|NCT03683758|10118902|FG001|COMPLETED|Overall Study||7
9059477|NCT03683758|10118901|FG000|NOT COMPLETED|Overall Study||3
9059478|NCT03683758|10118902|FG001|NOT COMPLETED|Overall Study||3
9059479|NCT03683901|10118908|FG000|STARTED|Overall Study||10
9059480|NCT03683901|10118908|FG000|COMPLETED|Overall Study||10
9059481|NCT03683901|10118908|FG000|NOT COMPLETED|Overall Study||0
9059482|NCT03684044|10118916|FG000|STARTED|Overall Study||239
9059483|NCT03684044|10118917|FG001|STARTED|Overall Study||124
9059484|NCT03684044|10118916|FG000|COMPLETED|Overall Study||217
9059485|NCT03684044|10118917|FG001|COMPLETED|Overall Study||104
9059486|NCT03684044|10118916|FG000|NOT COMPLETED|Overall Study||22
9059487|NCT03684044|10118917|FG001|NOT COMPLETED|Overall Study||20
9059488|NCT03684265|10118925|FG000|STARTED|Treatment Period 1||13
9059489|NCT03684265|10118926|FG001|STARTED|Treatment Period 1||13
9059490|NCT03684265|10118925|FG000|COMPLETED|Treatment Period 1||13
9059491|NCT03684265|10118926|FG001|COMPLETED|Treatment Period 1||13
9059492|NCT03684265|10118925|FG000|NOT COMPLETED|Treatment Period 1||0
9059493|NCT03684265|10118926|FG001|NOT COMPLETED|Treatment Period 1||0
9059494|NCT03684265|10118925|FG000|STARTED|Washout Period of 1 Week||13
9059495|NCT03684265|10118926|FG001|STARTED|Washout Period of 1 Week||13
9059496|NCT03684265|10118925|FG000|COMPLETED|Washout Period of 1 Week||13
9059497|NCT03684265|10118926|FG001|COMPLETED|Washout Period of 1 Week||13
9059498|NCT03684265|10118925|FG000|NOT COMPLETED|Washout Period of 1 Week||0
9059499|NCT03684265|10118926|FG001|NOT COMPLETED|Washout Period of 1 Week||0
9059500|NCT03684265|10118925|FG000|STARTED|Treatment Period 2||13
9059501|NCT03684265|10118926|FG001|STARTED|Treatment Period 2||13
9059502|NCT03684265|10118925|FG000|COMPLETED|Treatment Period 2||13
9059503|NCT03684265|10118926|FG001|COMPLETED|Treatment Period 2||13
9059504|NCT03684265|10118925|FG000|NOT COMPLETED|Treatment Period 2||0
9059505|NCT03684265|10118926|FG001|NOT COMPLETED|Treatment Period 2||0
9059506|NCT03684642|10118935|FG000|STARTED|Overall Study||303
9059507|NCT03684642|10118936|FG001|STARTED|Overall Study||302
9059508|NCT03684642|10118937|FG002|STARTED|Overall Study||303
9059509|NCT03684642|10118935|FG000|Treated|Overall Study||303
9059510|NCT03684642|10118936|FG001|Treated|Overall Study||302
9059511|NCT03684642|10118937|FG002|Treated|Overall Study||302
9059512|NCT03684642|10118935|FG000|Safety Population|Overall Study|For safety analysis participants are included in the treatment group that they are exposed for longer duration. 10 participants randomized to Efpeglenatide 6 mg received 4 mg dose for longer duration, and considered in the Efpeglenatide 4 mg group for safety analysis.|313
9059513|NCT03684642|10118936|FG001|Safety Population|Overall Study||292
9059514|NCT03684642|10118937|FG002|Safety Population|Overall Study||302
9059515|NCT03684642|10118935|FG000|COMPLETED|Overall Study||200
9059516|NCT03684642|10118936|FG001|COMPLETED|Overall Study||169
9059517|NCT03684642|10118937|FG002|COMPLETED|Overall Study||197
9059518|NCT03684642|10118935|FG000|NOT COMPLETED|Overall Study||103
9059519|NCT03684642|10118936|FG001|NOT COMPLETED|Overall Study||133
9059520|NCT03684642|10118937|FG002|NOT COMPLETED|Overall Study||106
9059521|NCT03684928|10118945|FG000|STARTED|First Intervention||23
9059522|NCT03684928|10118946|FG001|STARTED|First Intervention||22
9059523|NCT03684928|10118945|FG000|COMPLETED|First Intervention||23
9059524|NCT03684928|10118946|FG001|COMPLETED|First Intervention||19
9059525|NCT03684928|10118945|FG000|NOT COMPLETED|First Intervention||0
9059526|NCT03684928|10118946|FG001|NOT COMPLETED|First Intervention||3
9059527|NCT03684928|10118945|FG000|STARTED|Second Intervention|Two participants discontinued between the first intervention and second intervention.|21
9059528|NCT03684928|10118946|FG001|STARTED|Second Intervention||19
9059529|NCT03684928|10118945|FG000|COMPLETED|Second Intervention||20
9059530|NCT03684928|10118946|FG001|COMPLETED|Second Intervention||19
9059531|NCT03684928|10118945|FG000|NOT COMPLETED|Second Intervention||1
9059532|NCT03684928|10118946|FG001|NOT COMPLETED|Second Intervention||0
9059533|NCT03685344|10118956|FG000|STARTED|Overall Study||3
9059534|NCT03685344|10118957|FG001|STARTED|Overall Study||3
9059535|NCT03685344|10118958|FG002|STARTED|Overall Study||7
8704017|NCT00925704|9749713|FG005|COMPLETED|Third Intervention||6
8704018|NCT00925704|9749708|FG000|NOT COMPLETED|Third Intervention||0
8704019|NCT00925704|9749709|FG001|NOT COMPLETED|Third Intervention||0
8704020|NCT00925704|9749710|FG002|NOT COMPLETED|Third Intervention||0
8704021|NCT00925704|9749711|FG003|NOT COMPLETED|Third Intervention||0
9059536|NCT03685344|10118959|FG003|STARTED|Overall Study||0
9059537|NCT03685344|10118956|FG000|Received Treatment|Overall Study||3
9059538|NCT03685344|10118957|FG001|Received Treatment|Overall Study||3
9059539|NCT03685344|10118958|FG002|Received Treatment|Overall Study||7
9059540|NCT03685344|10118959|FG003|Received Treatment|Overall Study||0
9059541|NCT03685344|10118956|FG000|COMPLETED|Overall Study||0
9059542|NCT03685344|10118957|FG001|COMPLETED|Overall Study||0
9059543|NCT03685344|10118958|FG002|COMPLETED|Overall Study||0
9059544|NCT03685344|10118959|FG003|COMPLETED|Overall Study||0
9059545|NCT03685344|10118956|FG000|NOT COMPLETED|Overall Study||3
9059546|NCT03685344|10118957|FG001|NOT COMPLETED|Overall Study||3
9059547|NCT03685344|10118958|FG002|NOT COMPLETED|Overall Study||7
9059548|NCT03685344|10118959|FG003|NOT COMPLETED|Overall Study||0
9059549|NCT03685396|10118971|FG000|STARTED|Overall Study||21
9059550|NCT03685396|10118972|FG001|STARTED|Overall Study||21
9059551|NCT03685396|10118971|FG000|COMPLETED|Overall Study||21
9059552|NCT03685396|10118972|FG001|COMPLETED|Overall Study||21
9059553|NCT03685396|10118971|FG000|NOT COMPLETED|Overall Study||0
9059554|NCT03685396|10118972|FG001|NOT COMPLETED|Overall Study||0
9059555|NCT03685643|10118980|FG000|STARTED|Overall Study||290
9059556|NCT03685643|10118981|FG001|STARTED|Overall Study||288
9059557|NCT03685643|10118980|FG000|COMPLETED|Overall Study||276
9059558|NCT03685643|10118981|FG001|COMPLETED|Overall Study||266
9059559|NCT03685643|10118980|FG000|NOT COMPLETED|Overall Study||14
9059560|NCT03685643|10118981|FG001|NOT COMPLETED|Overall Study||22
9059561|NCT03685968|10118990|FG000|STARTED|Overall Study||75
9059562|NCT03685968|10118991|FG001|STARTED|Overall Study||75
9059563|NCT03685968|10118992|FG002|STARTED|Overall Study||75
9059564|NCT03685968|10118990|FG000|COMPLETED|Overall Study||75
9059565|NCT03685968|10118991|FG001|COMPLETED|Overall Study||75
9059566|NCT03685968|10118992|FG002|COMPLETED|Overall Study||75
9059567|NCT03685968|10118990|FG000|NOT COMPLETED|Overall Study||0
9059568|NCT03685968|10118991|FG001|NOT COMPLETED|Overall Study||0
9059569|NCT03685968|10118992|FG002|NOT COMPLETED|Overall Study||0
9059570|NCT03686033|10119000|FG000|STARTED|Treatment Period 1 (1 Day)||1
9059571|NCT03686033|10119001|FG001|STARTED|Treatment Period 1 (1 Day)||1
9059572|NCT03686033|10119002|FG002|STARTED|Treatment Period 1 (1 Day)||1
9059573|NCT03686033|10119003|FG003|STARTED|Treatment Period 1 (1 Day)||1
9059574|NCT03686033|10119004|FG004|STARTED|Treatment Period 1 (1 Day)||1
9059575|NCT03686033|10119005|FG005|STARTED|Treatment Period 1 (1 Day)||0
9059576|NCT03686033|10119000|FG000|COMPLETED|Treatment Period 1 (1 Day)||1
9059577|NCT03686033|10119001|FG001|COMPLETED|Treatment Period 1 (1 Day)||1
9059578|NCT03686033|10119002|FG002|COMPLETED|Treatment Period 1 (1 Day)||1
9059579|NCT03686033|10119003|FG003|COMPLETED|Treatment Period 1 (1 Day)||1
9059580|NCT03686033|10119004|FG004|COMPLETED|Treatment Period 1 (1 Day)||1
9059581|NCT03686033|10119005|FG005|COMPLETED|Treatment Period 1 (1 Day)||0
9059582|NCT03686033|10119000|FG000|NOT COMPLETED|Treatment Period 1 (1 Day)||0
9059583|NCT03686033|10119001|FG001|NOT COMPLETED|Treatment Period 1 (1 Day)||0
9059584|NCT03686033|10119002|FG002|NOT COMPLETED|Treatment Period 1 (1 Day)||0
9059585|NCT03686033|10119003|FG003|NOT COMPLETED|Treatment Period 1 (1 Day)||0
9059586|NCT03686033|10119004|FG004|NOT COMPLETED|Treatment Period 1 (1 Day)||0
9059587|NCT03686033|10119005|FG005|NOT COMPLETED|Treatment Period 1 (1 Day)||0
9059588|NCT03686033|10119000|FG000|STARTED|Washout Phase (at Least 2 Weeks)||1
9059589|NCT03686033|10119001|FG001|STARTED|Washout Phase (at Least 2 Weeks)||1
9059590|NCT03686033|10119002|FG002|STARTED|Washout Phase (at Least 2 Weeks)||1
9059591|NCT03686033|10119003|FG003|STARTED|Washout Phase (at Least 2 Weeks)||1
9059592|NCT03686033|10119004|FG004|STARTED|Washout Phase (at Least 2 Weeks)||1
9059593|NCT03686033|10119005|FG005|STARTED|Washout Phase (at Least 2 Weeks)||0
9059594|NCT03686033|10119000|FG000|COMPLETED|Washout Phase (at Least 2 Weeks)||1
9059595|NCT03686033|10119001|FG001|COMPLETED|Washout Phase (at Least 2 Weeks)||1
9059596|NCT03686033|10119002|FG002|COMPLETED|Washout Phase (at Least 2 Weeks)||1
9059597|NCT03686033|10119003|FG003|COMPLETED|Washout Phase (at Least 2 Weeks)||1
9059598|NCT03686033|10119004|FG004|COMPLETED|Washout Phase (at Least 2 Weeks)||1
9059599|NCT03686033|10119005|FG005|COMPLETED|Washout Phase (at Least 2 Weeks)||0
9059600|NCT03686033|10119000|FG000|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
9059601|NCT03686033|10119001|FG001|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
9059602|NCT03686033|10119002|FG002|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
9059603|NCT03686033|10119003|FG003|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
9059604|NCT03686033|10119004|FG004|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
9059605|NCT03686033|10119005|FG005|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
9059606|NCT03686033|10119000|FG000|STARTED|Treatment Period 2 (1 Day)||1
9059607|NCT03686033|10119001|FG001|STARTED|Treatment Period 2 (1 Day)||1
9059608|NCT03686033|10119002|FG002|STARTED|Treatment Period 2 (1 Day)||1
9059609|NCT03686033|10119003|FG003|STARTED|Treatment Period 2 (1 Day)||1
9059610|NCT03686033|10119004|FG004|STARTED|Treatment Period 2 (1 Day)||1
9059611|NCT03686033|10119005|FG005|STARTED|Treatment Period 2 (1 Day)||0
9059612|NCT03686033|10119000|FG000|COMPLETED|Treatment Period 2 (1 Day)||1
9059613|NCT03686033|10119001|FG001|COMPLETED|Treatment Period 2 (1 Day)||1
9059614|NCT03686033|10119002|FG002|COMPLETED|Treatment Period 2 (1 Day)||1
9059615|NCT03686033|10119003|FG003|COMPLETED|Treatment Period 2 (1 Day)||1
9059616|NCT03686033|10119004|FG004|COMPLETED|Treatment Period 2 (1 Day)||0
9059617|NCT03686033|10119005|FG005|COMPLETED|Treatment Period 2 (1 Day)||0
9059618|NCT03686033|10119000|FG000|NOT COMPLETED|Treatment Period 2 (1 Day)||0
9059619|NCT03686033|10119001|FG001|NOT COMPLETED|Treatment Period 2 (1 Day)||0
9059620|NCT03686033|10119002|FG002|NOT COMPLETED|Treatment Period 2 (1 Day)||0
9059621|NCT03686033|10119003|FG003|NOT COMPLETED|Treatment Period 2 (1 Day)||0
9059622|NCT03686033|10119004|FG004|NOT COMPLETED|Treatment Period 2 (1 Day)||1
9059623|NCT03686033|10119005|FG005|NOT COMPLETED|Treatment Period 2 (1 Day)||0
9059624|NCT03686033|10119000|FG000|STARTED|Washout Phase (at Least 2 Weeks)||1
9059625|NCT03686033|10119001|FG001|STARTED|Washout Phase (at Least 2 Weeks)||1
9059626|NCT03686033|10119002|FG002|STARTED|Washout Phase (at Least 2 Weeks)||1
9059627|NCT03686033|10119003|FG003|STARTED|Washout Phase (at Least 2 Weeks)||1
9059628|NCT03686033|10119004|FG004|STARTED|Washout Phase (at Least 2 Weeks)||0
9059629|NCT03686033|10119005|FG005|STARTED|Washout Phase (at Least 2 Weeks)||0
9059630|NCT03686033|10119000|FG000|COMPLETED|Washout Phase (at Least 2 Weeks)||1
9059631|NCT03686033|10119001|FG001|COMPLETED|Washout Phase (at Least 2 Weeks)||1
9059632|NCT03686033|10119002|FG002|COMPLETED|Washout Phase (at Least 2 Weeks)||1
9059633|NCT03686033|10119003|FG003|COMPLETED|Washout Phase (at Least 2 Weeks)||1
9059634|NCT03686033|10119004|FG004|COMPLETED|Washout Phase (at Least 2 Weeks)||0
9059635|NCT03686033|10119005|FG005|COMPLETED|Washout Phase (at Least 2 Weeks)||0
9059636|NCT03686033|10119000|FG000|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
9059637|NCT03686033|10119001|FG001|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
9059638|NCT03686033|10119002|FG002|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
9059639|NCT03686033|10119003|FG003|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
9059640|NCT03686033|10119004|FG004|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
9059641|NCT03686033|10119005|FG005|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
9059642|NCT03686033|10119000|FG000|STARTED|Treatment Period 3 (1 Day)||1
9059643|NCT03686033|10119001|FG001|STARTED|Treatment Period 3 (1 Day)||1
9059644|NCT03686033|10119002|FG002|STARTED|Treatment Period 3 (1 Day)||1
9059645|NCT03686033|10119003|FG003|STARTED|Treatment Period 3 (1 Day)||1
9059646|NCT03686033|10119004|FG004|STARTED|Treatment Period 3 (1 Day)||0
9059647|NCT03686033|10119005|FG005|STARTED|Treatment Period 3 (1 Day)||0
9059648|NCT03686033|10119000|FG000|COMPLETED|Treatment Period 3 (1 Day)||1
9059649|NCT03686033|10119001|FG001|COMPLETED|Treatment Period 3 (1 Day)||1
9059650|NCT03686033|10119002|FG002|COMPLETED|Treatment Period 3 (1 Day)||1
9059651|NCT03686033|10119003|FG003|COMPLETED|Treatment Period 3 (1 Day)||1
9059652|NCT03686033|10119004|FG004|COMPLETED|Treatment Period 3 (1 Day)||0
9059653|NCT03686033|10119005|FG005|COMPLETED|Treatment Period 3 (1 Day)||0
9059654|NCT03686033|10119000|FG000|NOT COMPLETED|Treatment Period 3 (1 Day)||0
9059655|NCT03686033|10119001|FG001|NOT COMPLETED|Treatment Period 3 (1 Day)||0
9059656|NCT03686033|10119002|FG002|NOT COMPLETED|Treatment Period 3 (1 Day)||0
9059657|NCT03686033|10119003|FG003|NOT COMPLETED|Treatment Period 3 (1 Day)||0
9059658|NCT03686033|10119004|FG004|NOT COMPLETED|Treatment Period 3 (1 Day)||0
9059659|NCT03686033|10119005|FG005|NOT COMPLETED|Treatment Period 3 (1 Day)||0
9059660|NCT03686033|10119000|FG000|STARTED|Washout Phase (at Least 2 Weeks)||1
9059661|NCT03686033|10119001|FG001|STARTED|Washout Phase (at Least 2 Weeks)||1
9059662|NCT03686033|10119002|FG002|STARTED|Washout Phase (at Least 2 Weeks)||1
9059663|NCT03686033|10119003|FG003|STARTED|Washout Phase (at Least 2 Weeks)||1
9059664|NCT03686033|10119004|FG004|STARTED|Washout Phase (at Least 2 Weeks)||0
9059665|NCT03686033|10119005|FG005|STARTED|Washout Phase (at Least 2 Weeks)||0
9059666|NCT03686033|10119000|FG000|COMPLETED|Washout Phase (at Least 2 Weeks)||1
9059667|NCT03686033|10119001|FG001|COMPLETED|Washout Phase (at Least 2 Weeks)||1
9059668|NCT03686033|10119002|FG002|COMPLETED|Washout Phase (at Least 2 Weeks)||1
9059669|NCT03686033|10119003|FG003|COMPLETED|Washout Phase (at Least 2 Weeks)||1
9059670|NCT03686033|10119004|FG004|COMPLETED|Washout Phase (at Least 2 Weeks)||0
9059671|NCT03686033|10119005|FG005|COMPLETED|Washout Phase (at Least 2 Weeks)||0
9059672|NCT03686033|10119000|FG000|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
9059673|NCT03686033|10119001|FG001|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
9059674|NCT03686033|10119002|FG002|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
9059675|NCT03686033|10119003|FG003|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
9059676|NCT03686033|10119004|FG004|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
9059677|NCT03686033|10119005|FG005|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
9059678|NCT03686033|10119000|FG000|STARTED|Treatment Period 4 (1 Day)||1
9059679|NCT03686033|10119001|FG001|STARTED|Treatment Period 4 (1 Day)||1
9059680|NCT03686033|10119002|FG002|STARTED|Treatment Period 4 (1 Day)||1
9059681|NCT03686033|10119003|FG003|STARTED|Treatment Period 4 (1 Day)||1
9059682|NCT03686033|10119004|FG004|STARTED|Treatment Period 4 (1 Day)||0
9059683|NCT03686033|10119005|FG005|STARTED|Treatment Period 4 (1 Day)||0
9059684|NCT03686033|10119000|FG000|COMPLETED|Treatment Period 4 (1 Day)||1
9059685|NCT03686033|10119001|FG001|COMPLETED|Treatment Period 4 (1 Day)||1
9059686|NCT03686033|10119002|FG002|COMPLETED|Treatment Period 4 (1 Day)||1
9059687|NCT03686033|10119003|FG003|COMPLETED|Treatment Period 4 (1 Day)||1
9059688|NCT03686033|10119004|FG004|COMPLETED|Treatment Period 4 (1 Day)||0
9059689|NCT03686033|10119005|FG005|COMPLETED|Treatment Period 4 (1 Day)||0
9059690|NCT03686033|10119000|FG000|NOT COMPLETED|Treatment Period 4 (1 Day)||0
9059691|NCT03686033|10119001|FG001|NOT COMPLETED|Treatment Period 4 (1 Day)||0
9059692|NCT03686033|10119002|FG002|NOT COMPLETED|Treatment Period 4 (1 Day)||0
9059693|NCT03686033|10119003|FG003|NOT COMPLETED|Treatment Period 4 (1 Day)||0
9059694|NCT03686033|10119004|FG004|NOT COMPLETED|Treatment Period 4 (1 Day)||0
9059695|NCT03686033|10119005|FG005|NOT COMPLETED|Treatment Period 4 (1 Day)||0
8704022|NCT00925704|9749712|FG004|NOT COMPLETED|Third Intervention||0
8704023|NCT00925704|9749713|FG005|NOT COMPLETED|Third Intervention||1
8704024|NCT00925756|9749724|FG000|STARTED|Overall Study||32
8704025|NCT00925756|9749724|FG000|COMPLETED|Overall Study||32
8704026|NCT00925756|9749724|FG000|NOT COMPLETED|Overall Study||0
8704027|NCT00925769|9749728|FG000|STARTED|Overall Study||6
9059696|NCT03686176|10119022|FG000|STARTED|Overall Study||19
9059697|NCT03686176|10119023|FG001|STARTED|Overall Study||25
9059698|NCT03686176|10119024|FG002|STARTED|Overall Study||20
9059699|NCT03686176|10119022|FG000|COMPLETED|Overall Study||17
9059700|NCT03686176|10119023|FG001|COMPLETED|Overall Study||25
9059701|NCT03686176|10119024|FG002|COMPLETED|Overall Study||20
9059702|NCT03686176|10119022|FG000|NOT COMPLETED|Overall Study||2
9059703|NCT03686176|10119023|FG001|NOT COMPLETED|Overall Study||0
9059704|NCT03686176|10119024|FG002|NOT COMPLETED|Overall Study||0
9059705|NCT03687125|10119034|FG000|STARTED|Overall Study||3
9059706|NCT03687125|10119035|FG001|STARTED|Overall Study||3
9059707|NCT03687125|10119034|FG000|COMPLETED|Overall Study||0
9059708|NCT03687125|10119035|FG001|COMPLETED|Overall Study||2
9059709|NCT03687125|10119034|FG000|NOT COMPLETED|Overall Study||3
9059710|NCT03687125|10119035|FG001|NOT COMPLETED|Overall Study||1
8704028|NCT00925769|9749729|FG001|STARTED|Overall Study||6
8704029|NCT00925769|9749730|FG002|STARTED|Overall Study||6
8812734|NCT01521494|9865763|FG001|STARTED|Overall Study||36
8812735|NCT01521494|9865764|FG002|STARTED|Overall Study||35
9059711|NCT03687372|10119045|FG000|STARTED|Overall Study||254
9059712|NCT03687372|10119046|FG001|STARTED|Overall Study||249
9059713|NCT03687372|10119045|FG000|COMPLETED|Overall Study||237
9059714|NCT03687372|10119046|FG001|COMPLETED|Overall Study||210
9059715|NCT03687372|10119045|FG000|NOT COMPLETED|Overall Study||17
9059716|NCT03687372|10119046|FG001|NOT COMPLETED|Overall Study||39
9059717|NCT03687450|10119056|FG000|STARTED|Overall Study||38
9059718|NCT03687450|10119057|FG001|STARTED|Overall Study||18
9059719|NCT03687450|10119056|FG000|Post-Program Follow-Up|Overall Study|1 withdrew, 9 lost to follow-up|28
9059720|NCT03687450|10119057|FG001|Post-Program Follow-Up|Overall Study|3 lost to follow-up|15
9059721|NCT03687450|10119056|FG000|Two-month Follow-up|Overall Study|2 lost to follow-up|26
9059722|NCT03687450|10119057|FG001|Two-month Follow-up|Overall Study|2 lost to follow-up (N.B. 1 participant completed 2-month follow-up but not post-program follow-up)|16
9059723|NCT03687450|10119056|FG000|COMPLETED|Overall Study||26
9059724|NCT03687450|10119057|FG001|COMPLETED|Overall Study||16
9059725|NCT03687450|10119056|FG000|NOT COMPLETED|Overall Study||12
9059726|NCT03687450|10119057|FG001|NOT COMPLETED|Overall Study||2
9059727|NCT03687684|10119072|FG000|STARTED|Overall Study||4
9059728|NCT03687684|10119073|FG001|STARTED|Overall Study||2
9059729|NCT03687684|10119074|FG002|STARTED|Overall Study||2
8812736|NCT01521494|9865765|FG003|STARTED|Overall Study||36
9059730|NCT03687684|10119075|FG003|STARTED|Overall Study||6
9059731|NCT03687684|10119076|FG004|STARTED|Overall Study||6
9059732|NCT03687684|10119077|FG005|STARTED|Overall Study||6
9059733|NCT03687684|10119078|FG006|STARTED|Overall Study||6
8704030|NCT00925769|9749731|FG003|STARTED|Overall Study||6
8704031|NCT00925769|9749732|FG004|STARTED|Overall Study||3
9059734|NCT03687684|10119079|FG007|STARTED|Overall Study||2
9059735|NCT03687684|10119080|FG008|STARTED|Overall Study||6
9059736|NCT03687684|10119072|FG000|COMPLETED|Overall Study||4
9059737|NCT03687684|10119073|FG001|COMPLETED|Overall Study||2
9059738|NCT03687684|10119074|FG002|COMPLETED|Overall Study||2
9059739|NCT03687684|10119075|FG003|COMPLETED|Overall Study||6
9059740|NCT03687684|10119076|FG004|COMPLETED|Overall Study||6
9059741|NCT03687684|10119077|FG005|COMPLETED|Overall Study||6
9059742|NCT03687684|10119078|FG006|COMPLETED|Overall Study||6
9059743|NCT03687684|10119079|FG007|COMPLETED|Overall Study||2
9059744|NCT03687684|10119080|FG008|COMPLETED|Overall Study||6
9059745|NCT03687684|10119072|FG000|NOT COMPLETED|Overall Study||0
9059746|NCT03687684|10119073|FG001|NOT COMPLETED|Overall Study||0
9059747|NCT03687684|10119074|FG002|NOT COMPLETED|Overall Study||0
9059748|NCT03687684|10119075|FG003|NOT COMPLETED|Overall Study||0
9059749|NCT03687684|10119076|FG004|NOT COMPLETED|Overall Study||0
9059750|NCT03687684|10119077|FG005|NOT COMPLETED|Overall Study||0
9059751|NCT03687684|10119078|FG006|NOT COMPLETED|Overall Study||0
9059752|NCT03687684|10119079|FG007|NOT COMPLETED|Overall Study||0
9059753|NCT03687684|10119080|FG008|NOT COMPLETED|Overall Study||0
9059754|NCT03687736|10119110|FG000|STARTED|Overall Study||120
9059755|NCT03687736|10119110|FG000|COMPLETED|Overall Study||110
9059756|NCT03687736|10119110|FG000|NOT COMPLETED|Overall Study||10
9059757|NCT03687827|10119116|FG000|STARTED|Treatment Period 1||249
9059758|NCT03687827|10119117|FG001|STARTED|Treatment Period 1||249
9059759|NCT03687827|10119116|FG000|Full Analysis Set (FAS)|Treatment Period 1||249
9059760|NCT03687827|10119117|FG001|Full Analysis Set (FAS)|Treatment Period 1||249
9059761|NCT03687827|10119116|FG000|Safety Analysis Set (SAS)|Treatment Period 1||249
9059762|NCT03687827|10119117|FG001|Safety Analysis Set (SAS)|Treatment Period 1||249
9059763|NCT03687827|10119116|FG000|Per Protocol Set|Treatment Period 1||219
9059764|NCT03687827|10119117|FG001|Per Protocol Set|Treatment Period 1||229
9059765|NCT03687827|10119116|FG000|COMPLETED|Treatment Period 1||235
9059766|NCT03687827|10119117|FG001|COMPLETED|Treatment Period 1||241
9059767|NCT03687827|10119116|FG000|NOT COMPLETED|Treatment Period 1||14
9059768|NCT03687827|10119117|FG001|NOT COMPLETED|Treatment Period 1||8
9059769|NCT03687827|10119116|FG000|STARTED|Treatment Period 2||235
9059770|NCT03687827|10119117|FG001|STARTED|Treatment Period 2||241
9059771|NCT03687827|10119116|FG000|COMPLETED|Treatment Period 2||230
9059772|NCT03687827|10119117|FG001|COMPLETED|Treatment Period 2||238
9059773|NCT03687827|10119116|FG000|NOT COMPLETED|Treatment Period 2||5
9059774|NCT03687827|10119117|FG001|NOT COMPLETED|Treatment Period 2||3
9059775|NCT03687970|10119125|FG000|STARTED|Overall Study||22
9059776|NCT03687970|10119126|FG001|STARTED|Overall Study||20
9059777|NCT03687970|10119125|FG000|COMPLETED|Overall Study||20
9059778|NCT03687970|10119126|FG001|COMPLETED|Overall Study||20
9059779|NCT03687970|10119125|FG000|NOT COMPLETED|Overall Study||2
9059780|NCT03687970|10119126|FG001|NOT COMPLETED|Overall Study||0
9059781|NCT03688282|10119134|FG000|STARTED|Sham Treatment for 30 Minutes||18
9059782|NCT03688282|10119134|FG000|COMPLETED|Sham Treatment for 30 Minutes||17
9059783|NCT03688282|10119134|FG000|NOT COMPLETED|Sham Treatment for 30 Minutes||1
9059784|NCT03688282|10119134|FG000|STARTED|Washout (7 Days)||17
9059785|NCT03688282|10119134|FG000|COMPLETED|Washout (7 Days)||17
9059786|NCT03688282|10119134|FG000|NOT COMPLETED|Washout (7 Days)||0
9059787|NCT03688282|10119134|FG000|STARTED|Active Treatment for 30 Minutes||17
9059788|NCT03688282|10119134|FG000|COMPLETED|Active Treatment for 30 Minutes||17
9059789|NCT03688282|10119134|FG000|NOT COMPLETED|Active Treatment for 30 Minutes||0
9059790|NCT03688542|10119142|FG000|STARTED|Overall Study|No individual participants were recruited, only nursing homes.|
9059791|NCT03688542|10119143|FG001|STARTED|Overall Study|No individual participants were recruited, only nursing homes.|
9059792|NCT03688542|10119142|FG000|COMPLETED|Overall Study|No individual participants were recruited, only nursing homes.|
9059793|NCT03688542|10119143|FG001|COMPLETED|Overall Study|"1 nursing home withdrew from the study.~No individual participants were recruited, only nursing homes."|
9059794|NCT03688542|10119142|FG000|NOT COMPLETED|Overall Study||
9059795|NCT03688542|10119143|FG001|NOT COMPLETED|Overall Study||
9059796|NCT03688620|10119152|FG000|STARTED|Overall Study||329
9059797|NCT03688620|10119153|FG001|STARTED|Overall Study||278
9059798|NCT03688620|10119154|FG002|STARTED|Overall Study||453
9059799|NCT03688620|10119152|FG000|COMPLETED|Overall Study||313
9059800|NCT03688620|10119153|FG001|COMPLETED|Overall Study||277
9059801|NCT03688620|10119154|FG002|COMPLETED|Overall Study||445
9059802|NCT03688620|10119152|FG000|NOT COMPLETED|Overall Study||16
9059803|NCT03688620|10119153|FG001|NOT COMPLETED|Overall Study||1
9059804|NCT03688620|10119154|FG002|NOT COMPLETED|Overall Study||8
9059805|NCT03688685|10119164|FG000|STARTED|Overall Study||25
9059806|NCT03688685|10119164|FG000|COMPLETED|Overall Study||21
9059807|NCT03688685|10119164|FG000|NOT COMPLETED|Overall Study||4
9059808|NCT03688711|10119170|FG000|STARTED|Overall Study||34
9059809|NCT03688711|10119171|FG001|STARTED|Overall Study||11
9059810|NCT03688711|10119170|FG000|COMPLETED|Overall Study||34
9059811|NCT03688711|10119171|FG001|COMPLETED|Overall Study||10
9059812|NCT03688711|10119170|FG000|NOT COMPLETED|Overall Study||0
9059813|NCT03688711|10119171|FG001|NOT COMPLETED|Overall Study||1
9059814|NCT03688880|10119179|FG000|STARTED|Overall Study||29
9059815|NCT03688880|10119180|FG001|STARTED|Overall Study||60
9059816|NCT03688880|10119179|FG000|COMPLETED|Overall Study||15
9059817|NCT03688880|10119180|FG001|COMPLETED|Overall Study||29
9059818|NCT03688880|10119179|FG000|NOT COMPLETED|Overall Study||14
9059819|NCT03688880|10119180|FG001|NOT COMPLETED|Overall Study||31
9059820|NCT03689452|10119188|FG000|STARTED|Overall Study||15
9059821|NCT03689452|10119189|FG001|STARTED|Overall Study||15
9059822|NCT03689452|10119188|FG000|COMPLETED|Overall Study||14
9059823|NCT03689452|10119189|FG001|COMPLETED|Overall Study||14
9059824|NCT03689452|10119188|FG000|NOT COMPLETED|Overall Study||1
9059825|NCT03689452|10119189|FG001|NOT COMPLETED|Overall Study||1
9059826|NCT03689504|10119197|FG000|STARTED|Overall Study||70
9059827|NCT03689504|10119198|FG001|STARTED|Overall Study||70
9059828|NCT03689504|10119197|FG000|COMPLETED|Overall Study||65
9059829|NCT03689504|10119198|FG001|COMPLETED|Overall Study||70
9059830|NCT03689504|10119197|FG000|NOT COMPLETED|Overall Study||5
9059831|NCT03689504|10119198|FG001|NOT COMPLETED|Overall Study||0
9059832|NCT03690375|10119206|FG000|STARTED|Overall Study||10
9059833|NCT03690375|10119207|FG001|STARTED|Overall Study||10
9059834|NCT03690375|10119206|FG000|COMPLETED|Overall Study||10
9059835|NCT03690375|10119207|FG001|COMPLETED|Overall Study||10
9059836|NCT03690375|10119206|FG000|NOT COMPLETED|Overall Study||0
9059837|NCT03690375|10119207|FG001|NOT COMPLETED|Overall Study||0
9059838|NCT03691779|10119216|FG000|STARTED|Part A (15 Days)||16
9059839|NCT03691779|10119217|FG001|STARTED|Part A (15 Days)||0
9059840|NCT03691779|10119216|FG000|COMPLETED|Part A (15 Days)||16
9059841|NCT03691779|10119217|FG001|COMPLETED|Part A (15 Days)||0
9059842|NCT03691779|10119216|FG000|NOT COMPLETED|Part A (15 Days)||0
9059843|NCT03691779|10119217|FG001|NOT COMPLETED|Part A (15 Days)||0
9059844|NCT03691779|10119216|FG000|STARTED|Part B (24 Weeks)||0
9059845|NCT03691779|10119217|FG001|STARTED|Part B (24 Weeks)|Out of the 16 participants from Part A, 11 participants also participated in Part B of the study.|66
9059846|NCT03691779|10119216|FG000|COMPLETED|Part B (24 Weeks)||0
9059847|NCT03691779|10119217|FG001|COMPLETED|Part B (24 Weeks)||64
9059848|NCT03691779|10119216|FG000|NOT COMPLETED|Part B (24 Weeks)||0
9059849|NCT03691779|10119217|FG001|NOT COMPLETED|Part B (24 Weeks)||2
9059850|NCT03691831|10119226|FG000|STARTED|Overall Study||251
9059851|NCT03691831|10119227|FG001|STARTED|Overall Study||251
9059852|NCT03691831|10119226|FG000|COMPLETED|Overall Study||224
9059853|NCT03691831|10119227|FG001|COMPLETED|Overall Study||220
9059854|NCT03691831|10119226|FG000|NOT COMPLETED|Overall Study||27
9059855|NCT03691831|10119227|FG001|NOT COMPLETED|Overall Study||31
9059856|NCT03691844|10119237|FG000|STARTED|Overall Study||121
9059857|NCT03691844|10119238|FG001|STARTED|Overall Study||121
9059858|NCT03691844|10119239|FG002|STARTED|Overall Study||121
9059859|NCT03691844|10119240|FG003|STARTED|Overall Study||81
9059860|NCT03691844|10119237|FG000|COMPLETED|Overall Study||114
9059861|NCT03691844|10119238|FG001|COMPLETED|Overall Study||109
9059862|NCT03691844|10119239|FG002|COMPLETED|Overall Study||108
9059863|NCT03691844|10119240|FG003|COMPLETED|Overall Study||70
9059864|NCT03691844|10119237|FG000|NOT COMPLETED|Overall Study||7
9059865|NCT03691844|10119238|FG001|NOT COMPLETED|Overall Study||12
9059866|NCT03691844|10119239|FG002|NOT COMPLETED|Overall Study||13
9059867|NCT03691844|10119240|FG003|NOT COMPLETED|Overall Study||11
9059868|NCT03691948|10119254|FG000|STARTED|Overall Study||27
9059869|NCT03691948|10119255|FG001|STARTED|Overall Study||33
9059870|NCT03691948|10119254|FG000|COMPLETED|Overall Study||26
9059871|NCT03691948|10119255|FG001|COMPLETED|Overall Study||30
9059872|NCT03691948|10119254|FG000|NOT COMPLETED|Overall Study||1
9059873|NCT03691948|10119255|FG001|NOT COMPLETED|Overall Study||3
9059874|NCT03692676|10119266|FG000|STARTED|Overall Study||10365
9059875|NCT03692676|10119267|FG001|STARTED|Overall Study||51142
9059876|NCT03692676|10119268|FG002|STARTED|Overall Study||49479
9059877|NCT03692676|10119269|FG003|STARTED|Overall Study||5147
9059878|NCT03692676|10119266|FG000|COMPLETED|Overall Study||940
9059879|NCT03692676|10119267|FG001|COMPLETED|Overall Study||3704
9059880|NCT03692676|10119268|FG002|COMPLETED|Overall Study||11135
9059881|NCT03692676|10119269|FG003|COMPLETED|Overall Study||1561
9059882|NCT03692676|10119266|FG000|NOT COMPLETED|Overall Study||9425
9059883|NCT03692676|10119267|FG001|NOT COMPLETED|Overall Study||47438
9059884|NCT03692676|10119268|FG002|NOT COMPLETED|Overall Study||38344
9059885|NCT03692676|10119269|FG003|NOT COMPLETED|Overall Study||3586
9059886|NCT03693625|10119281|FG000|STARTED|Overall Study||23
9059887|NCT03693625|10119282|FG001|STARTED|Overall Study||8
9059888|NCT03693625|10119281|FG000|COMPLETED|Overall Study||0
9059889|NCT03693625|10119282|FG001|COMPLETED|Overall Study||0
9059890|NCT03693625|10119281|FG000|NOT COMPLETED|Overall Study||23
9059891|NCT03693625|10119282|FG001|NOT COMPLETED|Overall Study||8
9059892|NCT03693742|10119290|FG000|STARTED|Overall Study||7
9059893|NCT03693742|10119291|FG001|STARTED|Overall Study||3
9059894|NCT03693742|10119290|FG000|COMPLETED|Overall Study||7
9059895|NCT03693742|10119291|FG001|COMPLETED|Overall Study||3
9059896|NCT03693742|10119290|FG000|NOT COMPLETED|Overall Study||0
9059897|NCT03693742|10119291|FG001|NOT COMPLETED|Overall Study||0
9059898|NCT03693937|10119299|FG000|STARTED|Overall Study||776
9059899|NCT03693937|10119299|FG000|COMPLETED|Overall Study||776
9059900|NCT03693937|10119299|FG000|NOT COMPLETED|Overall Study||0
9059901|NCT03693950|10119305|FG000|STARTED|Overall Study||29
9059902|NCT03693950|10119306|FG001|STARTED|Overall Study||28
9059903|NCT03693950|10119305|FG000|COMPLETED|Overall Study||28
9059904|NCT03693950|10119306|FG001|COMPLETED|Overall Study||28
9059905|NCT03693950|10119305|FG000|NOT COMPLETED|Overall Study||1
9059906|NCT03693950|10119306|FG001|NOT COMPLETED|Overall Study||0
9059907|NCT03693989|10119314|FG000|STARTED|Overall Study||88
9059908|NCT03693989|10119315|FG001|STARTED|Overall Study||90
9059909|NCT03693989|10119314|FG000|COMPLETED|Overall Study||85
9059910|NCT03693989|10119315|FG001|COMPLETED|Overall Study||86
9059911|NCT03693989|10119314|FG000|NOT COMPLETED|Overall Study||3
9059912|NCT03693989|10119315|FG001|NOT COMPLETED|Overall Study||4
9059913|NCT03694197|10119321|FG000|STARTED|Overall Study||1385
9059914|NCT03694197|10119321|FG000|COMPLETED|Overall Study||0
9059915|NCT03694197|10119321|FG000|NOT COMPLETED|Overall Study||1385
9059916|NCT03694210|10119325|FG000|STARTED|Overall Study||37
9059917|NCT03694210|10119325|FG000|COMPLETED|Overall Study||29
9059918|NCT03694210|10119325|FG000|NOT COMPLETED|Overall Study||8
9059919|NCT03694548|10119333|FG000|STARTED|Part A Survey||18
9059920|NCT03694548|10119334|FG001|STARTED|Part A Survey||17
9059921|NCT03694548|10119335|FG002|STARTED|Part A Survey||0
9059922|NCT03694548|10119333|FG000|COMPLETED|Part A Survey||15
9059923|NCT03694548|10119334|FG001|COMPLETED|Part A Survey||14
9059924|NCT03694548|10119335|FG002|COMPLETED|Part A Survey||0
9059925|NCT03694548|10119333|FG000|NOT COMPLETED|Part A Survey||3
9059926|NCT03694548|10119334|FG001|NOT COMPLETED|Part A Survey||3
9059927|NCT03694548|10119335|FG002|NOT COMPLETED|Part A Survey||0
9059928|NCT03694548|10119333|FG000|STARTED|Part B Yoga Program||0
9059929|NCT03694548|10119334|FG001|STARTED|Part B Yoga Program||0
9059930|NCT03694548|10119335|FG002|STARTED|Part B Yoga Program||12
9059931|NCT03694548|10119333|FG000|COMPLETED|Part B Yoga Program||0
9059932|NCT03694548|10119334|FG001|COMPLETED|Part B Yoga Program||0
9059933|NCT03694548|10119335|FG002|COMPLETED|Part B Yoga Program||1
9059934|NCT03694548|10119333|FG000|NOT COMPLETED|Part B Yoga Program||0
9059935|NCT03694548|10119334|FG001|NOT COMPLETED|Part B Yoga Program||0
9059936|NCT03694548|10119335|FG002|NOT COMPLETED|Part B Yoga Program||11
9059937|NCT03694613|10119345|FG000|STARTED|Overall Study||65
9059938|NCT03694613|10119345|FG000|COMPLETED|Overall Study|65 samples were collected and analyzed. at least 3 ml were collected.|65
9059939|NCT03694613|10119345|FG000|NOT COMPLETED|Overall Study||0
9059940|NCT03694925|10119361|FG000|STARTED|Overall Study||30
9059941|NCT03694925|10119362|FG001|STARTED|Overall Study||73
9059942|NCT03694925|10119363|FG002|STARTED|Overall Study||53
9059943|NCT03694925|10119361|FG000|COMPLETED|Overall Study||30
9059944|NCT03694925|10119362|FG001|COMPLETED|Overall Study||70
9059945|NCT03694925|10119363|FG002|COMPLETED|Overall Study||53
9059946|NCT03694925|10119361|FG000|NOT COMPLETED|Overall Study||0
9059947|NCT03694925|10119362|FG001|NOT COMPLETED|Overall Study||3
9059948|NCT03694925|10119363|FG002|NOT COMPLETED|Overall Study||0
9059949|NCT03695094|10119375|FG000|STARTED|Overall Study||16
9059950|NCT03695094|10119376|FG001|STARTED|Overall Study||15
9059951|NCT03695094|10119375|FG000|COMPLETED|Overall Study||14
9059952|NCT03695094|10119376|FG001|COMPLETED|Overall Study||14
9059953|NCT03695094|10119375|FG000|NOT COMPLETED|Overall Study||2
9059954|NCT03695094|10119376|FG001|NOT COMPLETED|Overall Study||1
9059955|NCT03695367|10119386|FG000|STARTED|Overall Study||33
9059956|NCT03695367|10119387|FG001|STARTED|Overall Study||30
9059957|NCT03695367|10119386|FG000|COMPLETED|Overall Study||32
9059958|NCT03695367|10119387|FG001|COMPLETED|Overall Study||26
9059959|NCT03695367|10119386|FG000|NOT COMPLETED|Overall Study||1
9059960|NCT03695367|10119387|FG001|NOT COMPLETED|Overall Study||4
9059961|NCT03695393|10119395|FG000|STARTED|Overall Study||67
9059962|NCT03695393|10119396|FG001|STARTED|Overall Study||33
9059963|NCT03695393|10119395|FG000|1-month|Overall Study||66
9059964|NCT03695393|10119396|FG001|1-month|Overall Study||32
9059965|NCT03695393|10119395|FG000|6-month|Overall Study||64
9059966|NCT03695393|10119396|FG001|6-month|Overall Study||31
9059967|NCT03695393|10119395|FG000|COMPLETED|Overall Study||64
9059968|NCT03695393|10119396|FG001|COMPLETED|Overall Study||31
9059969|NCT03695393|10119395|FG000|NOT COMPLETED|Overall Study||3
9059970|NCT03695393|10119396|FG001|NOT COMPLETED|Overall Study||2
9059971|NCT03695913|10119402|FG000|STARTED|Overall Study||15
9059972|NCT03695913|10119402|FG000|COMPLETED|Overall Study||15
9059973|NCT03695913|10119402|FG000|NOT COMPLETED|Overall Study||0
9059974|NCT03696108|10119408|FG000|STARTED|Overall Study||84
9059975|NCT03696108|10119409|FG001|STARTED|Overall Study||85
9059976|NCT03696108|10119408|FG000|COMPLETED|Overall Study||80
9059977|NCT03696108|10119409|FG001|COMPLETED|Overall Study||79
9059978|NCT03696108|10119408|FG000|NOT COMPLETED|Overall Study||4
9059979|NCT03696108|10119409|FG001|NOT COMPLETED|Overall Study||6
9059980|NCT03696342|10119417|FG000|STARTED|Overall Study||23
9059981|NCT03696342|10119418|FG001|STARTED|Overall Study||23
9059982|NCT03696342|10119417|FG000|COMPLETED|Overall Study||22
9059983|NCT03696342|10119418|FG001|COMPLETED|Overall Study||23
9059984|NCT03696342|10119417|FG000|NOT COMPLETED|Overall Study||1
9059985|NCT03696342|10119418|FG001|NOT COMPLETED|Overall Study||0
9059986|NCT03696576|10119426|FG000|STARTED|Overall Study||13
9059987|NCT03696576|10119427|FG001|STARTED|Overall Study||11
9059988|NCT03696576|10119426|FG000|COMPLETED|Overall Study||10
9059989|NCT03696576|10119427|FG001|COMPLETED|Overall Study||6
9059990|NCT03696576|10119426|FG000|NOT COMPLETED|Overall Study||3
9059991|NCT03696576|10119427|FG001|NOT COMPLETED|Overall Study||5
9059992|NCT03696589|10119433|FG000|STARTED|Overall Study||13
9059993|NCT03696589|10119433|FG000|COMPLETED|Overall Study||12
9059994|NCT03696589|10119433|FG000|NOT COMPLETED|Overall Study||1
9059995|NCT03696758|10119446|FG000|STARTED|First Intervention||3
9059996|NCT03696758|10119447|FG001|STARTED|First Intervention||6
9059997|NCT03696758|10119446|FG000|COMPLETED|First Intervention||3
9059998|NCT03696758|10119447|FG001|COMPLETED|First Intervention||6
9059999|NCT03696758|10119446|FG000|NOT COMPLETED|First Intervention||0
9060000|NCT03696758|10119447|FG001|NOT COMPLETED|First Intervention||0
9060001|NCT03696758|10119446|FG000|STARTED|Wash Out>12 Hours||3
9060002|NCT03696758|10119447|FG001|STARTED|Wash Out>12 Hours||6
9060003|NCT03696758|10119446|FG000|COMPLETED|Wash Out>12 Hours||3
9060004|NCT03696758|10119447|FG001|COMPLETED|Wash Out>12 Hours||6
9060005|NCT03696758|10119446|FG000|NOT COMPLETED|Wash Out>12 Hours||0
9060006|NCT03696758|10119447|FG001|NOT COMPLETED|Wash Out>12 Hours||0
9060007|NCT03696758|10119446|FG000|STARTED|Second Intervention||3
9060008|NCT03696758|10119447|FG001|STARTED|Second Intervention||6
9060009|NCT03696758|10119446|FG000|COMPLETED|Second Intervention||3
9060010|NCT03696758|10119447|FG001|COMPLETED|Second Intervention||6
9060011|NCT03696758|10119446|FG000|NOT COMPLETED|Second Intervention||0
9060012|NCT03696758|10119447|FG001|NOT COMPLETED|Second Intervention||0
9060013|NCT03697083|10119456|FG000|STARTED|Overall Study||262
9060014|NCT03697083|10119457|FG001|STARTED|Overall Study||260
9060015|NCT03697083|10119458|FG002|STARTED|Overall Study||255
9060016|NCT03697083|10119456|FG000|COMPLETED|Overall Study||262
9060017|NCT03697083|10119457|FG001|COMPLETED|Overall Study||250
9060018|NCT03697083|10119458|FG002|COMPLETED|Overall Study||255
9060019|NCT03697083|10119456|FG000|NOT COMPLETED|Overall Study||0
9060020|NCT03697083|10119457|FG001|NOT COMPLETED|Overall Study||10
9060021|NCT03697083|10119458|FG002|NOT COMPLETED|Overall Study||0
9060022|NCT03697122|10119466|FG000|STARTED|Overall Study||14
9060023|NCT03697122|10119466|FG000|COMPLETED|Overall Study||14
9060024|NCT03697122|10119466|FG000|NOT COMPLETED|Overall Study||0
9060025|NCT03697252|10119472|FG000|STARTED|Overall Study||90
9060026|NCT03697252|10119473|FG001|STARTED|Overall Study||92
9060027|NCT03697252|10119472|FG000|COMPLETED|Overall Study||72
9060028|NCT03697252|10119473|FG001|COMPLETED|Overall Study||73
9060029|NCT03697252|10119472|FG000|NOT COMPLETED|Overall Study||18
9060030|NCT03697252|10119473|FG001|NOT COMPLETED|Overall Study||19
9060031|NCT03697460|10119479|FG000|STARTED|Overall Study||12
9060032|NCT03697460|10119479|FG000|COMPLETED|Overall Study||9
9060033|NCT03697460|10119479|FG000|NOT COMPLETED|Overall Study||3
9060034|NCT03697993|10119485|FG000|STARTED|Overall Study||32
9060035|NCT03697993|10119486|FG001|STARTED|Overall Study||30
9060036|NCT03697993|10119485|FG000|Initiated Treatment|Overall Study||30
9060037|NCT03697993|10119486|FG001|Initiated Treatment|Overall Study||28
9060038|NCT03697993|10119485|FG000|Switched Treatment|Overall Study||0
9060039|NCT03697993|10119486|FG001|Switched Treatment|Overall Study|Five (5) participants switched to Fosfomycin; 1 participant switched to Cefixime.|6
9060040|NCT03697993|10119485|FG000|Treated With at Least Two Dose of Fosfomycin|Overall Study||27
9060041|NCT03697993|10119486|FG001|Treated With at Least Two Dose of Fosfomycin|Overall Study||4
9060042|NCT03697993|10119485|FG000|COMPLETED|Overall Study||22
9060043|NCT03697993|10119486|FG001|COMPLETED|Overall Study||25
9060044|NCT03697993|10119485|FG000|NOT COMPLETED|Overall Study||10
9060045|NCT03697993|10119486|FG001|NOT COMPLETED|Overall Study||5
9060046|NCT03698331|10119495|FG000|STARTED|Overall Study||44
9060047|NCT03698331|10119496|FG001|STARTED|Overall Study||45
9060048|NCT03698331|10119495|FG000|Entered Withdrawal Period|Overall Study||42
9060049|NCT03698331|10119496|FG001|Entered Withdrawal Period|Overall Study||39
9060050|NCT03698331|10119495|FG000|COMPLETED|Overall Study||40
9060051|NCT03698331|10119496|FG001|COMPLETED|Overall Study||39
9060052|NCT03698331|10119495|FG000|NOT COMPLETED|Overall Study||4
9060053|NCT03698331|10119496|FG001|NOT COMPLETED|Overall Study||6
9060054|NCT03698591|10119504|FG000|STARTED|Overall Study||20
9060055|NCT03698591|10119505|FG001|STARTED|Overall Study||20
9060056|NCT03698591|10119504|FG000|COMPLETED|Overall Study||15
9060057|NCT03698591|10119505|FG001|COMPLETED|Overall Study||15
9060058|NCT03698591|10119504|FG000|NOT COMPLETED|Overall Study||5
9060059|NCT03698591|10119505|FG001|NOT COMPLETED|Overall Study||5
9060060|NCT03699124|10119514|FG000|STARTED|Overall Study||377
9060061|NCT03699124|10119515|FG001|STARTED|Overall Study||375
9060062|NCT03699124|10119516|FG002|STARTED|Overall Study||377
9060063|NCT03699124|10119514|FG000|COMPLETED|Overall Study||332
9060064|NCT03699124|10119515|FG001|COMPLETED|Overall Study||335
9060065|NCT03699124|10119516|FG002|COMPLETED|Overall Study||337
9060066|NCT03699124|10119514|FG000|NOT COMPLETED|Overall Study||45
9060067|NCT03699124|10119515|FG001|NOT COMPLETED|Overall Study||40
8557014|NCT01803854|9588829|FG000|COMPLETED|Overall Study||1275
8557015|NCT01803854|9588829|FG000|NOT COMPLETED|Overall Study||0
8557016|NCT01472081|9588840|FG000|STARTED|Overall Study||7
8557017|NCT01472081|9588841|FG001|STARTED|Overall Study||26
8557018|NCT01472081|9588842|FG002|STARTED|Overall Study||20
8557019|NCT01472081|9588843|FG003|STARTED|Overall Study||47
8557020|NCT01472081|9588844|FG004|STARTED|Overall Study||47
8557021|NCT01472081|9588845|FG005|STARTED|Overall Study||6
8557022|NCT01472081|9588840|FG000|COMPLETED|Overall Study||0
8557023|NCT01472081|9588841|FG001|COMPLETED|Overall Study||0
8557024|NCT01472081|9588842|FG002|COMPLETED|Overall Study||0
8557025|NCT01472081|9588843|FG003|COMPLETED|Overall Study||1
8557026|NCT01472081|9588844|FG004|COMPLETED|Overall Study||0
8557027|NCT01472081|9588845|FG005|COMPLETED|Overall Study||0
8557028|NCT01472081|9588840|FG000|NOT COMPLETED|Overall Study||7
8557029|NCT01472081|9588841|FG001|NOT COMPLETED|Overall Study||26
8557030|NCT01472081|9588842|FG002|NOT COMPLETED|Overall Study||20
8557031|NCT01472081|9588843|FG003|NOT COMPLETED|Overall Study||46
8557032|NCT01472081|9588844|FG004|NOT COMPLETED|Overall Study||47
8557033|NCT01472081|9588845|FG005|NOT COMPLETED|Overall Study||6
8557034|NCT01309672|9588858|FG000|STARTED|Overall Study||41
8557035|NCT01309672|9588858|FG000|Received Protocol Treatment|Overall Study||40
8557036|NCT01309672|9588858|FG000|COMPLETED|Overall Study||4
8557037|NCT01309672|9588858|FG000|NOT COMPLETED|Overall Study||37
8557038|NCT01131169|9588865|FG000|STARTED|Overall Study||47
8557039|NCT01131169|9588866|FG001|STARTED|Overall Study||19
8557040|NCT01131169|9588865|FG000|COMPLETED|Overall Study||47
8557041|NCT01131169|9588866|FG001|COMPLETED|Overall Study||19
8557042|NCT01131169|9588865|FG000|NOT COMPLETED|Overall Study||0
8557043|NCT01131169|9588866|FG001|NOT COMPLETED|Overall Study||0
8557044|NCT00774345|9588875|FG000|STARTED|Pre-treatment||160
8557045|NCT00774345|9588876|FG001|STARTED|Pre-treatment||157
8557046|NCT00774345|9588875|FG000|COMPLETED|Pre-treatment||158
8557047|NCT00774345|9588876|FG001|COMPLETED|Pre-treatment||157
8557048|NCT00774345|9588875|FG000|NOT COMPLETED|Pre-treatment||2
8557049|NCT00774345|9588876|FG001|NOT COMPLETED|Pre-treatment||0
8557050|NCT00774345|9588875|FG000|STARTED|Treatment||158
8557051|NCT00774345|9588876|FG001|STARTED|Treatment||157
8557052|NCT00774345|9588875|FG000|Participants Escalated to 5mg|Treatment||129
8557053|NCT00774345|9588876|FG001|Participants Escalated to 5mg|Treatment||149
8557054|NCT00774345|9588875|FG000|Participants Escalated to 10mg|Treatment||68
8557055|NCT00774345|9588876|FG001|Participants Escalated to 10mg|Treatment||88
8557056|NCT00774345|9588875|FG000|COMPLETED|Treatment||0
8557057|NCT00774345|9588876|FG001|COMPLETED|Treatment||0
8557058|NCT00774345|9588875|FG000|NOT COMPLETED|Treatment||158
8557059|NCT00774345|9588876|FG001|NOT COMPLETED|Treatment||157
8704032|NCT00925769|9749733|FG005|STARTED|Overall Study||3
8704033|NCT00925769|9749728|FG000|COMPLETED|Overall Study||0
8704034|NCT00925769|9749729|FG001|COMPLETED|Overall Study||0
8704035|NCT00925769|9749730|FG002|COMPLETED|Overall Study||0
8704036|NCT00925769|9749731|FG003|COMPLETED|Overall Study||0
9060068|NCT03699124|10119516|FG002|NOT COMPLETED|Overall Study||40
8557060|NCT00457951|9588885|FG000|STARTED|Overall Study||13
8557061|NCT00457951|9588886|FG001|STARTED|Overall Study||66
8557062|NCT00457951|9588887|FG002|STARTED|Overall Study||72
8557063|NCT00457951|9588885|FG000|COMPLETED|Overall Study||13
8557064|NCT00457951|9588886|FG001|COMPLETED|Overall Study||50
8557065|NCT00457951|9588887|FG002|COMPLETED|Overall Study||60
8557066|NCT00457951|9588885|FG000|NOT COMPLETED|Overall Study||0
8557067|NCT00457951|9588886|FG001|NOT COMPLETED|Overall Study||16
8557068|NCT00457951|9588887|FG002|NOT COMPLETED|Overall Study||12
8557069|NCT00345943|9588896|FG000|STARTED|Overall Study||38
8557070|NCT00345943|9588897|FG001|STARTED|Overall Study||33
8557071|NCT00345943|9588896|FG000|COMPLETED|Overall Study||33
8557072|NCT00345943|9588897|FG001|COMPLETED|Overall Study||28
8557073|NCT00345943|9588896|FG000|NOT COMPLETED|Overall Study||5
8704037|NCT00925769|9749732|FG004|COMPLETED|Overall Study||0
8704038|NCT00925769|9749733|FG005|COMPLETED|Overall Study||0
8704039|NCT00925769|9749728|FG000|NOT COMPLETED|Overall Study||6
8704040|NCT00925769|9749729|FG001|NOT COMPLETED|Overall Study||6
9060069|NCT03700320|10119526|FG000|STARTED|Overall Study||198
9060070|NCT03700320|10119527|FG001|STARTED|Overall Study||546
9060071|NCT03700320|10119526|FG000|Safety Population; Received Treatment|Overall Study||196
9060072|NCT03700320|10119527|FG001|Safety Population; Received Treatment|Overall Study||543
9060073|NCT03700320|10119526|FG000|Entered Safety Follow-up|Overall Study||159
9060074|NCT03700320|10119527|FG001|Entered Safety Follow-up|Overall Study||472
9060075|NCT03700320|10119526|FG000|COMPLETED|Overall Study||136
9060076|NCT03700320|10119527|FG001|COMPLETED|Overall Study||373
9060077|NCT03700320|10119526|FG000|NOT COMPLETED|Overall Study||62
9060078|NCT03700320|10119527|FG001|NOT COMPLETED|Overall Study||173
8557074|NCT00345943|9588897|FG001|NOT COMPLETED|Overall Study||5
8557075|NCT00258427|9588907|FG000|STARTED|Overall Study||3
8557076|NCT00258427|9588908|FG001|STARTED|Overall Study||8
8704041|NCT00925769|9749730|FG002|NOT COMPLETED|Overall Study||6
8557077|NCT00258427|9588909|FG002|STARTED|Overall Study||2
8557078|NCT00258427|9588910|FG003|STARTED|Overall Study||1
8557079|NCT00258427|9588907|FG000|COMPLETED|Overall Study||3
8557080|NCT00258427|9588908|FG001|COMPLETED|Overall Study||8
9060079|NCT03700372|10119533|FG000|STARTED|Overall Study||7
9060080|NCT03700372|10119533|FG000|COMPLETED|Overall Study||7
9060081|NCT03700372|10119533|FG000|NOT COMPLETED|Overall Study||0
9060082|NCT03700385|10119537|FG000|STARTED|Overall Study||40
9060083|NCT03700385|10119537|FG000|COMPLETED|Overall Study||39
9060084|NCT03700385|10119537|FG000|NOT COMPLETED|Overall Study||1
9060085|NCT03700671|10119543|FG000|STARTED|Overall Study||21
9060086|NCT03700671|10119544|FG001|STARTED|Overall Study||21
9060087|NCT03700671|10119543|FG000|COMPLETED|Overall Study||20
9060088|NCT03700671|10119544|FG001|COMPLETED|Overall Study||19
9060089|NCT03700671|10119543|FG000|NOT COMPLETED|Overall Study||1
9060090|NCT03700671|10119544|FG001|NOT COMPLETED|Overall Study||2
9060091|NCT03700736|10119554|FG000|STARTED|Overall Study||30
9060092|NCT03700736|10119555|FG001|STARTED|Overall Study||32
9060093|NCT03700736|10119554|FG000|COMPLETED|Overall Study||27
9060094|NCT03700736|10119555|FG001|COMPLETED|Overall Study||25
9060095|NCT03700736|10119554|FG000|NOT COMPLETED|Overall Study||3
9060096|NCT03700736|10119555|FG001|NOT COMPLETED|Overall Study||7
9060097|NCT03700892|10119566|FG000|STARTED|Baseline||15
9060098|NCT03700892|10119567|FG001|STARTED|Baseline||0
8704042|NCT00925769|9749731|FG003|NOT COMPLETED|Overall Study||6
8704043|NCT00925769|9749732|FG004|NOT COMPLETED|Overall Study||3
8704044|NCT00925769|9749733|FG005|NOT COMPLETED|Overall Study||3
8704045|NCT00925782|9749749|FG000|STARTED|Pretreatment (Day -30 to Day -3)||12
8704046|NCT00925782|9749750|FG001|STARTED|Pretreatment (Day -30 to Day -3)||12
8704047|NCT00925782|9749749|FG000|COMPLETED|Pretreatment (Day -30 to Day -3)||12
8704048|NCT00925782|9749750|FG001|COMPLETED|Pretreatment (Day -30 to Day -3)||12
8704049|NCT00925782|9749749|FG000|NOT COMPLETED|Pretreatment (Day -30 to Day -3)||0
8704050|NCT00925782|9749750|FG001|NOT COMPLETED|Pretreatment (Day -30 to Day -3)||0
8704051|NCT00925782|9749749|FG000|STARTED|Study Period (Day -3 to Day 0)||12
8704052|NCT00925782|9749750|FG001|STARTED|Study Period (Day -3 to Day 0)||12
9060099|NCT03700892|10119568|FG002|STARTED|Baseline||4
9060100|NCT03700892|10119566|FG000|COMPLETED|Baseline||15
9060101|NCT03700892|10119567|FG001|COMPLETED|Baseline||0
9060102|NCT03700892|10119568|FG002|COMPLETED|Baseline||4
9060103|NCT03700892|10119566|FG000|NOT COMPLETED|Baseline||0
9060104|NCT03700892|10119567|FG001|NOT COMPLETED|Baseline||0
9060105|NCT03700892|10119568|FG002|NOT COMPLETED|Baseline||0
9060106|NCT03700892|10119566|FG000|STARTED|First Intervention (Single 1-Day Visit)||1
9060107|NCT03700892|10119567|FG001|STARTED|First Intervention (Single 1-Day Visit)||4
9060108|NCT03700892|10119568|FG002|STARTED|First Intervention (Single 1-Day Visit)||0
9060109|NCT03700892|10119566|FG000|COMPLETED|First Intervention (Single 1-Day Visit)||1
9060110|NCT03700892|10119567|FG001|COMPLETED|First Intervention (Single 1-Day Visit)||4
9060111|NCT03700892|10119568|FG002|COMPLETED|First Intervention (Single 1-Day Visit)||0
9060112|NCT03700892|10119566|FG000|NOT COMPLETED|First Intervention (Single 1-Day Visit)||0
9060113|NCT03700892|10119567|FG001|NOT COMPLETED|First Intervention (Single 1-Day Visit)||0
9060114|NCT03700892|10119568|FG002|NOT COMPLETED|First Intervention (Single 1-Day Visit)||0
9060115|NCT03700892|10119566|FG000|STARTED|Washout (2-3 Weeks)||1
9060116|NCT03700892|10119567|FG001|STARTED|Washout (2-3 Weeks)||4
9060117|NCT03700892|10119568|FG002|STARTED|Washout (2-3 Weeks)||0
9060118|NCT03700892|10119566|FG000|COMPLETED|Washout (2-3 Weeks)||1
9060119|NCT03700892|10119567|FG001|COMPLETED|Washout (2-3 Weeks)||4
9060120|NCT03700892|10119568|FG002|COMPLETED|Washout (2-3 Weeks)||0
9060121|NCT03700892|10119566|FG000|NOT COMPLETED|Washout (2-3 Weeks)||0
9060122|NCT03700892|10119567|FG001|NOT COMPLETED|Washout (2-3 Weeks)||0
9060123|NCT03700892|10119568|FG002|NOT COMPLETED|Washout (2-3 Weeks)||0
9060124|NCT03700892|10119566|FG000|STARTED|Second Intervention (Single 1-Day Visit)||1
9060125|NCT03700892|10119567|FG001|STARTED|Second Intervention (Single 1-Day Visit)||4
9060126|NCT03700892|10119568|FG002|STARTED|Second Intervention (Single 1-Day Visit)||0
9060127|NCT03700892|10119566|FG000|Received Intervention|Second Intervention (Single 1-Day Visit)||1
9060128|NCT03700892|10119567|FG001|Received Intervention|Second Intervention (Single 1-Day Visit)||3
9060129|NCT03700892|10119568|FG002|Received Intervention|Second Intervention (Single 1-Day Visit)||0
9060130|NCT03700892|10119566|FG000|COMPLETED|Second Intervention (Single 1-Day Visit)||1
9060131|NCT03700892|10119567|FG001|COMPLETED|Second Intervention (Single 1-Day Visit)||3
9060132|NCT03700892|10119568|FG002|COMPLETED|Second Intervention (Single 1-Day Visit)||0
9060133|NCT03700892|10119566|FG000|NOT COMPLETED|Second Intervention (Single 1-Day Visit)||0
9060134|NCT03700892|10119567|FG001|NOT COMPLETED|Second Intervention (Single 1-Day Visit)||1
9060135|NCT03700892|10119568|FG002|NOT COMPLETED|Second Intervention (Single 1-Day Visit)||0
9060136|NCT03701061|10119579|FG000|STARTED|Overall Study||9
9060137|NCT03701061|10119580|FG001|STARTED|Overall Study||3
9060138|NCT03701061|10119579|FG000|COMPLETED|Overall Study||9
9060139|NCT03701061|10119580|FG001|COMPLETED|Overall Study||3
9060140|NCT03701061|10119579|FG000|NOT COMPLETED|Overall Study||0
9060141|NCT03701061|10119580|FG001|NOT COMPLETED|Overall Study||0
9060142|NCT03701074|10119588|FG000|STARTED|Overall Study||1
9060143|NCT03701074|10119589|FG001|STARTED|Overall Study||0
9060144|NCT03701074|10119588|FG000|COMPLETED|Overall Study|Treatment was withdrawn after the 10th dose of oral medication (acetaminophen), on day 3 of treatment, as the infant developed mild abdominal distension which was as per the study protocol|0
9060145|NCT03701074|10119589|FG001|COMPLETED|Overall Study||0
9060146|NCT03701074|10119588|FG000|NOT COMPLETED|Overall Study||1
9060147|NCT03701074|10119589|FG001|NOT COMPLETED|Overall Study||0
9060148|NCT03702010|10119597|FG000|STARTED|First Stimulation (5 Days)||13
8704053|NCT00925782|9749749|FG000|COMPLETED|Study Period (Day -3 to Day 0)||12
9060149|NCT03702010|10119598|FG001|STARTED|First Stimulation (5 Days)||14
9060150|NCT03702010|10119597|FG000|COMPLETED|First Stimulation (5 Days)||13
9060151|NCT03702010|10119598|FG001|COMPLETED|First Stimulation (5 Days)||14
9060152|NCT03702010|10119597|FG000|NOT COMPLETED|First Stimulation (5 Days)||0
9060153|NCT03702010|10119598|FG001|NOT COMPLETED|First Stimulation (5 Days)||0
9060154|NCT03702010|10119597|FG000|STARTED|Washout + Second Stimulation (2+5days)||13
9060155|NCT03702010|10119598|FG001|STARTED|Washout + Second Stimulation (2+5days)||14
9060156|NCT03702010|10119597|FG000|COMPLETED|Washout + Second Stimulation (2+5days)||13
9060157|NCT03702010|10119598|FG001|COMPLETED|Washout + Second Stimulation (2+5days)||14
9060158|NCT03702010|10119597|FG000|NOT COMPLETED|Washout + Second Stimulation (2+5days)||0
8704054|NCT00925782|9749750|FG001|COMPLETED|Study Period (Day -3 to Day 0)||12
8704055|NCT00925782|9749749|FG000|NOT COMPLETED|Study Period (Day -3 to Day 0)||0
8704056|NCT00925782|9749750|FG001|NOT COMPLETED|Study Period (Day -3 to Day 0)||0
9060159|NCT03702010|10119598|FG001|NOT COMPLETED|Washout + Second Stimulation (2+5days)||0
9060160|NCT03702010|10119597|FG000|STARTED|Follow-up (30days)||13
9060161|NCT03702010|10119598|FG001|STARTED|Follow-up (30days)||14
9060162|NCT03702010|10119597|FG000|COMPLETED|Follow-up (30days)||11
9060163|NCT03702010|10119598|FG001|COMPLETED|Follow-up (30days)||12
9060164|NCT03702010|10119597|FG000|NOT COMPLETED|Follow-up (30days)||2
9060165|NCT03702010|10119598|FG001|NOT COMPLETED|Follow-up (30days)||2
9060166|NCT03702166|10119610|FG000|STARTED|Overall Study||10
9060167|NCT03702166|10119610|FG000|COMPLETED|Overall Study||8
9060168|NCT03702166|10119610|FG000|NOT COMPLETED|Overall Study||2
9060169|NCT03702608|10119615|FG000|STARTED|Overall Study||50
9060170|NCT03702608|10119615|FG000|COMPLETED|Overall Study||50
9060171|NCT03702608|10119615|FG000|NOT COMPLETED|Overall Study||0
9060172|NCT03703336|10119621|FG000|STARTED|Overall Study||552
9060173|NCT03703336|10119622|FG001|STARTED|Overall Study||273
9060174|NCT03703336|10119621|FG000|Received Dose 1|Overall Study||552
9060175|NCT03703336|10119622|FG001|Received Dose 1|Overall Study||273
9060176|NCT03703336|10119621|FG000|Received Dose 2|Overall Study||518
9060177|NCT03703336|10119622|FG001|Received Dose 2|Overall Study||263
9060178|NCT03703336|10119621|FG000|Safety Population|Overall Study||551
9060179|NCT03703336|10119622|FG001|Safety Population|Overall Study||274
9060180|NCT03703336|10119621|FG000|COMPLETED|Overall Study||514
9060181|NCT03703336|10119622|FG001|COMPLETED|Overall Study||259
9060182|NCT03703336|10119621|FG000|NOT COMPLETED|Overall Study||38
9060183|NCT03703336|10119622|FG001|NOT COMPLETED|Overall Study||14
9060184|NCT03703466|10119631|FG000|STARTED|Overall Study||24
8704057|NCT00925782|9749749|FG000|STARTED|Follow-up(Day +1 to Date of Engraftment)||12
9060185|NCT03703466|10119632|FG001|STARTED|Overall Study||24
9060186|NCT03703466|10119633|FG002|STARTED|Overall Study||24
9060187|NCT03703466|10119631|FG000|Received at Least One Dose of Study Drug|Overall Study||24
9060188|NCT03703466|10119632|FG001|Received at Least One Dose of Study Drug|Overall Study||23
9060189|NCT03703466|10119633|FG002|Received at Least One Dose of Study Drug|Overall Study||24
9060190|NCT03703466|10119631|FG000|COMPLETED|Overall Study||20
9060191|NCT03703466|10119632|FG001|COMPLETED|Overall Study||18
9060192|NCT03703466|10119633|FG002|COMPLETED|Overall Study||22
9060193|NCT03703466|10119631|FG000|NOT COMPLETED|Overall Study||4
9060194|NCT03703466|10119632|FG001|NOT COMPLETED|Overall Study||6
9060195|NCT03703466|10119633|FG002|NOT COMPLETED|Overall Study||2
9060196|NCT03703817|10119644|FG000|STARTED|Overall Study||288
9060197|NCT03703817|10119645|FG001|STARTED|Overall Study||133
9060198|NCT03703817|10119644|FG000|COMPLETED|Overall Study||281
9060199|NCT03703817|10119645|FG001|COMPLETED|Overall Study||129
9060200|NCT03703817|10119644|FG000|NOT COMPLETED|Overall Study||7
9060201|NCT03703817|10119645|FG001|NOT COMPLETED|Overall Study||4
9060202|NCT03704194|10119653|FG000|STARTED|Overall Study||8
9060203|NCT03704194|10119654|FG001|STARTED|Overall Study||9
9060204|NCT03704194|10119653|FG000|COMPLETED|Overall Study||8
9060205|NCT03704194|10119654|FG001|COMPLETED|Overall Study||8
9060206|NCT03704194|10119653|FG000|NOT COMPLETED|Overall Study||0
9060207|NCT03704194|10119654|FG001|NOT COMPLETED|Overall Study||1
9060208|NCT03704376|10119664|FG000|STARTED|Overall Study||42
8812737|NCT01521494|9865766|FG004|STARTED|Overall Study||37
8812738|NCT01521494|9865762|FG000|COMPLETED|Overall Study||37
8812739|NCT01521494|9865763|FG001|COMPLETED|Overall Study||31
9060209|NCT03704376|10119665|FG001|STARTED|Overall Study||44
9060210|NCT03704376|10119664|FG000|COMPLETED|Overall Study||38
9060211|NCT03704376|10119665|FG001|COMPLETED|Overall Study||40
9060212|NCT03704376|10119664|FG000|NOT COMPLETED|Overall Study||4
9060213|NCT03704376|10119665|FG001|NOT COMPLETED|Overall Study||4
9060214|NCT03704467|10119671|FG000|STARTED|Overall Study||3
9060215|NCT03704467|10119671|FG000|COMPLETED|Overall Study||3
9060216|NCT03704467|10119671|FG000|NOT COMPLETED|Overall Study||0
9060217|NCT03705273|10119677|FG000|STARTED|Overall Study|Planned enrollment of 110 participants in the arm was not achieved due to lack of study personnel.|20
9060218|NCT03705273|10119678|FG001|STARTED|Overall Study|Planned enrollment of 110 participants in the arm was not achieved due to lack of study personnel.|20
9060219|NCT03705273|10119677|FG000|COMPLETED|Overall Study||20
9060220|NCT03705273|10119678|FG001|COMPLETED|Overall Study||20
9060221|NCT03705273|10119677|FG000|NOT COMPLETED|Overall Study||0
9060222|NCT03705273|10119678|FG001|NOT COMPLETED|Overall Study||0
9060223|NCT03705481|10119684|FG000|STARTED|Overall Study||5
9060224|NCT03705481|10119684|FG000|COMPLETED|Overall Study||5
9060225|NCT03705481|10119684|FG000|NOT COMPLETED|Overall Study||0
9060226|NCT03705494|10119693|FG000|STARTED|Overall Study||10
9060227|NCT03705494|10119694|FG001|STARTED|Overall Study||10
9060228|NCT03705494|10119693|FG000|COMPLETED|Overall Study||3
9060229|NCT03705494|10119694|FG001|COMPLETED|Overall Study||7
9060230|NCT03705494|10119693|FG000|NOT COMPLETED|Overall Study||7
9060231|NCT03705494|10119694|FG001|NOT COMPLETED|Overall Study||3
9060232|NCT03705793|10119702|FG000|STARTED|Overall Study||27
9060233|NCT03705793|10119703|FG001|STARTED|Overall Study||26
9060234|NCT03705793|10119702|FG000|COMPLETED|Overall Study||22
9060235|NCT03705793|10119703|FG001|COMPLETED|Overall Study||21
9060236|NCT03705793|10119702|FG000|NOT COMPLETED|Overall Study||5
9060237|NCT03705793|10119703|FG001|NOT COMPLETED|Overall Study||5
9060238|NCT03706040|10119712|FG000|STARTED|Period A (Week 0 to Week 16)||34
9060239|NCT03706040|10119713|FG001|STARTED|Period A (Week 0 to Week 16)||69
9060240|NCT03706040|10119714|FG002|STARTED|Period A (Week 0 to Week 16)||69
9060241|NCT03706040|10119715|FG003|STARTED|Period A (Week 0 to Week 16)||0
9060242|NCT03706040|10119716|FG004|STARTED|Period A (Week 0 to Week 16)||0
9060243|NCT03706040|10119717|FG005|STARTED|Period A (Week 0 to Week 16)||0
9060244|NCT03706040|10119718|FG006|STARTED|Period A (Week 0 to Week 16)||0
9060245|NCT03706040|10119712|FG000|Received Study Drug|Period A (Week 0 to Week 16)||34
9060246|NCT03706040|10119713|FG001|Received Study Drug|Period A (Week 0 to Week 16)||69
9060247|NCT03706040|10119714|FG002|Received Study Drug|Period A (Week 0 to Week 16)||69
9060248|NCT03706040|10119715|FG003|Received Study Drug|Period A (Week 0 to Week 16)||0
9060249|NCT03706040|10119716|FG004|Received Study Drug|Period A (Week 0 to Week 16)||0
9060250|NCT03706040|10119717|FG005|Received Study Drug|Period A (Week 0 to Week 16)||0
9060251|NCT03706040|10119718|FG006|Received Study Drug|Period A (Week 0 to Week 16)||0
9060252|NCT03706040|10119712|FG000|COMPLETED|Period A (Week 0 to Week 16)||25
9060253|NCT03706040|10119713|FG001|COMPLETED|Period A (Week 0 to Week 16)||61
9060254|NCT03706040|10119714|FG002|COMPLETED|Period A (Week 0 to Week 16)||58
9060255|NCT03706040|10119715|FG003|COMPLETED|Period A (Week 0 to Week 16)||0
9060256|NCT03706040|10119716|FG004|COMPLETED|Period A (Week 0 to Week 16)||0
9060257|NCT03706040|10119717|FG005|COMPLETED|Period A (Week 0 to Week 16)||0
9060258|NCT03706040|10119718|FG006|COMPLETED|Period A (Week 0 to Week 16)||0
9060259|NCT03706040|10119712|FG000|NOT COMPLETED|Period A (Week 0 to Week 16)||9
9060260|NCT03706040|10119713|FG001|NOT COMPLETED|Period A (Week 0 to Week 16)||8
9060261|NCT03706040|10119714|FG002|NOT COMPLETED|Period A (Week 0 to Week 16)||11
9060262|NCT03706040|10119715|FG003|NOT COMPLETED|Period A (Week 0 to Week 16)||0
9060263|NCT03706040|10119716|FG004|NOT COMPLETED|Period A (Week 0 to Week 16)||0
9060264|NCT03706040|10119717|FG005|NOT COMPLETED|Period A (Week 0 to Week 16)||0
8812740|NCT01521494|9865764|FG002|COMPLETED|Overall Study||23
8812741|NCT01521494|9865765|FG003|COMPLETED|Overall Study||15
9060265|NCT03706040|10119718|FG006|NOT COMPLETED|Period A (Week 0 to Week 16)||0
9060266|NCT03706040|10119712|FG000|STARTED|Period B (Week 16 to Week 52)||0
9060267|NCT03706040|10119713|FG001|STARTED|Period B (Week 16 to Week 52)||0
9060268|NCT03706040|10119714|FG002|STARTED|Period B (Week 16 to Week 52)||0
9060269|NCT03706040|10119715|FG003|STARTED|Period B (Week 16 to Week 52)||13
9060270|NCT03706040|10119716|FG004|STARTED|Period B (Week 16 to Week 52)||12
9060271|NCT03706040|10119717|FG005|STARTED|Period B (Week 16 to Week 52)||61
9060272|NCT03706040|10119718|FG006|STARTED|Period B (Week 16 to Week 52)||58
9060273|NCT03706040|10119712|FG000|Received Study Drug|Period B (Week 16 to Week 52)||0
9060274|NCT03706040|10119713|FG001|Received Study Drug|Period B (Week 16 to Week 52)||0
9060275|NCT03706040|10119714|FG002|Received Study Drug|Period B (Week 16 to Week 52)||0
9060276|NCT03706040|10119715|FG003|Received Study Drug|Period B (Week 16 to Week 52)||13
9060277|NCT03706040|10119716|FG004|Received Study Drug|Period B (Week 16 to Week 52)||11
9060278|NCT03706040|10119717|FG005|Received Study Drug|Period B (Week 16 to Week 52)||61
9060279|NCT03706040|10119718|FG006|Received Study Drug|Period B (Week 16 to Week 52)||57
9060280|NCT03706040|10119712|FG000|COMPLETED|Period B (Week 16 to Week 52)||0
9060281|NCT03706040|10119713|FG001|COMPLETED|Period B (Week 16 to Week 52)||0
9060282|NCT03706040|10119714|FG002|COMPLETED|Period B (Week 16 to Week 52)||0
9060283|NCT03706040|10119715|FG003|COMPLETED|Period B (Week 16 to Week 52)||5
9060284|NCT03706040|10119716|FG004|COMPLETED|Period B (Week 16 to Week 52)||3
9060285|NCT03706040|10119717|FG005|COMPLETED|Period B (Week 16 to Week 52)||33
9060286|NCT03706040|10119718|FG006|COMPLETED|Period B (Week 16 to Week 52)||30
9060287|NCT03706040|10119712|FG000|NOT COMPLETED|Period B (Week 16 to Week 52)||0
9060288|NCT03706040|10119713|FG001|NOT COMPLETED|Period B (Week 16 to Week 52)||0
9060289|NCT03706040|10119714|FG002|NOT COMPLETED|Period B (Week 16 to Week 52)||0
9060290|NCT03706040|10119715|FG003|NOT COMPLETED|Period B (Week 16 to Week 52)||8
9060291|NCT03706040|10119716|FG004|NOT COMPLETED|Period B (Week 16 to Week 52)||9
9060292|NCT03706040|10119717|FG005|NOT COMPLETED|Period B (Week 16 to Week 52)||28
9060293|NCT03706040|10119718|FG006|NOT COMPLETED|Period B (Week 16 to Week 52)||28
9060294|NCT03706313|10119736|FG000|STARTED|Overall Study||20
9060295|NCT03706313|10119737|FG001|STARTED|Overall Study||20
9060296|NCT03706313|10119736|FG000|COMPLETED|Overall Study||20
9060297|NCT03706313|10119737|FG001|COMPLETED|Overall Study||20
9060298|NCT03706313|10119736|FG000|NOT COMPLETED|Overall Study||0
9060299|NCT03706313|10119737|FG001|NOT COMPLETED|Overall Study||0
9060300|NCT03706456|10119743|FG000|STARTED|Overall Study||22
9060301|NCT03706456|10119743|FG000|Started|Overall Study||22
9060302|NCT03706456|10119743|FG000|Completed|Overall Study||0
9060303|NCT03706456|10119743|FG000|COMPLETED|Overall Study||0
9060304|NCT03706456|10119743|FG000|NOT COMPLETED|Overall Study||22
9060305|NCT03706469|10119751|FG000|STARTED|Overall Study||4
9060306|NCT03706469|10119752|FG001|STARTED|Overall Study||4
9060307|NCT03706469|10119753|FG002|STARTED|Overall Study||4
9060308|NCT03706469|10119754|FG003|STARTED|Overall Study||4
9060309|NCT03706469|10119751|FG000|COMPLETED|Overall Study||4
9060310|NCT03706469|10119752|FG001|COMPLETED|Overall Study||4
9060311|NCT03706469|10119753|FG002|COMPLETED|Overall Study||4
9060312|NCT03706469|10119754|FG003|COMPLETED|Overall Study||4
9060313|NCT03706469|10119751|FG000|NOT COMPLETED|Overall Study||0
9060314|NCT03706469|10119752|FG001|NOT COMPLETED|Overall Study||0
9060315|NCT03706469|10119753|FG002|NOT COMPLETED|Overall Study||0
9060316|NCT03706469|10119754|FG003|NOT COMPLETED|Overall Study||0
9060317|NCT03707041|10119771|FG000|STARTED|Overall Study||6
9060318|NCT03707041|10119772|FG001|STARTED|Overall Study||2
9060319|NCT03707041|10119773|FG002|STARTED|Overall Study||9
9060320|NCT03707041|10119774|FG003|STARTED|Overall Study||3
9060321|NCT03707041|10119775|FG004|STARTED|Overall Study||9
9060322|NCT03707041|10119776|FG005|STARTED|Overall Study||3
9060323|NCT03707041|10119771|FG000|COMPLETED|Overall Study||6
9060324|NCT03707041|10119772|FG001|COMPLETED|Overall Study||2
9060325|NCT03707041|10119773|FG002|COMPLETED|Overall Study||9
9060326|NCT03707041|10119774|FG003|COMPLETED|Overall Study||3
9060327|NCT03707041|10119775|FG004|COMPLETED|Overall Study||9
9060328|NCT03707041|10119776|FG005|COMPLETED|Overall Study||3
9060329|NCT03707041|10119771|FG000|NOT COMPLETED|Overall Study||0
9060330|NCT03707041|10119772|FG001|NOT COMPLETED|Overall Study||0
9060331|NCT03707041|10119773|FG002|NOT COMPLETED|Overall Study||0
9060332|NCT03707041|10119774|FG003|NOT COMPLETED|Overall Study||0
9060333|NCT03707041|10119775|FG004|NOT COMPLETED|Overall Study||0
9060334|NCT03707041|10119776|FG005|NOT COMPLETED|Overall Study||0
9060335|NCT03707522|10119795|FG000|STARTED|Overall Study||31
9060336|NCT03707522|10119796|FG001|STARTED|Overall Study||36
9060337|NCT03707522|10119797|FG002|STARTED|Overall Study||52
9060338|NCT03707522|10119798|FG003|STARTED|Overall Study||43
9060339|NCT03707522|10119795|FG000|COMPLETED|Overall Study||7
9060340|NCT03707522|10119796|FG001|COMPLETED|Overall Study||9
9060341|NCT03707522|10119797|FG002|COMPLETED|Overall Study||11
9060342|NCT03707522|10119798|FG003|COMPLETED|Overall Study||7
9060343|NCT03707522|10119795|FG000|NOT COMPLETED|Overall Study||24
9060344|NCT03707522|10119796|FG001|NOT COMPLETED|Overall Study||27
9060345|NCT03707522|10119797|FG002|NOT COMPLETED|Overall Study||41
9060346|NCT03707522|10119798|FG003|NOT COMPLETED|Overall Study||36
9060347|NCT03707587|10119810|FG000|STARTED|Overall Study||7
9060348|NCT03707587|10119811|FG001|STARTED|Overall Study||2
9060349|NCT03707587|10119810|FG000|COMPLETED|Overall Study||7
9060350|NCT03707587|10119811|FG001|COMPLETED|Overall Study||1
9060351|NCT03707587|10119810|FG000|NOT COMPLETED|Overall Study||0
9060352|NCT03707587|10119811|FG001|NOT COMPLETED|Overall Study||1
9060353|NCT03707821|10119819|FG000|STARTED|Overall Study||125
9060354|NCT03707821|10119820|FG001|STARTED|Overall Study||126
9060355|NCT03707821|10119819|FG000|COMPLETED|Overall Study||123
9060356|NCT03707821|10119820|FG001|COMPLETED|Overall Study||125
9060357|NCT03707821|10119819|FG000|NOT COMPLETED|Overall Study||2
9060358|NCT03707821|10119820|FG001|NOT COMPLETED|Overall Study||1
9060359|NCT03707912|10119828|FG000|STARTED|Overall Study||104
9060360|NCT03707912|10119829|FG001|STARTED|Overall Study||100
9060361|NCT03707912|10119828|FG000|COMPLETED|Overall Study||103
9060362|NCT03707912|10119829|FG001|COMPLETED|Overall Study||100
9060363|NCT03707912|10119828|FG000|NOT COMPLETED|Overall Study||1
9060364|NCT03707912|10119829|FG001|NOT COMPLETED|Overall Study||0
9060365|NCT03708211|10119837|FG000|STARTED|Overall Study||12
9060366|NCT03708211|10119838|FG001|STARTED|Overall Study||8
9060367|NCT03708211|10119837|FG000|COMPLETED|Overall Study||0
9060368|NCT03708211|10119838|FG001|COMPLETED|Overall Study||0
9060369|NCT03708211|10119837|FG000|NOT COMPLETED|Overall Study||12
9060370|NCT03708211|10119838|FG001|NOT COMPLETED|Overall Study||8
9060371|NCT03708367|10119848|FG000|STARTED|Overall Study||59
9060372|NCT03708367|10119849|FG001|STARTED|Overall Study||58
9060373|NCT03708367|10119848|FG000|COMPLETED|Overall Study||58
9060374|NCT03708367|10119849|FG001|COMPLETED|Overall Study||57
9060375|NCT03708367|10119848|FG000|NOT COMPLETED|Overall Study||1
9060376|NCT03708367|10119849|FG001|NOT COMPLETED|Overall Study||1
9060377|NCT03708393|10119856|FG000|STARTED|Overall Study||155
9060378|NCT03708393|10119856|FG000|COMPLETED|Overall Study||155
9060379|NCT03708393|10119856|FG000|NOT COMPLETED|Overall Study||0
9060380|NCT03708562|10119865|FG000|STARTED|Overall Study||24
9060381|NCT03708562|10119865|FG000|COMPLETED|Overall Study||12
9060382|NCT03708562|10119865|FG000|NOT COMPLETED|Overall Study||12
9060383|NCT03708744|10119869|FG000|STARTED|Overall Study||7
9060384|NCT03708744|10119870|FG001|STARTED|Overall Study||6
9060385|NCT03708744|10119871|FG002|STARTED|Overall Study||5
9060386|NCT03708744|10119872|FG003|STARTED|Overall Study||6
9060387|NCT03708744|10119869|FG000|COMPLETED|Overall Study||7
9060388|NCT03708744|10119870|FG001|COMPLETED|Overall Study||6
8704058|NCT00925782|9749750|FG001|STARTED|Follow-up(Day +1 to Date of Engraftment)||12
8704059|NCT00925782|9749749|FG000|COMPLETED|Follow-up(Day +1 to Date of Engraftment)||12
8704060|NCT00925782|9749750|FG001|COMPLETED|Follow-up(Day +1 to Date of Engraftment)||12
8704061|NCT00925782|9749749|FG000|NOT COMPLETED|Follow-up(Day +1 to Date of Engraftment)||0
9060389|NCT03708744|10119871|FG002|COMPLETED|Overall Study||4
9060390|NCT03708744|10119872|FG003|COMPLETED|Overall Study||6
9060391|NCT03708744|10119869|FG000|NOT COMPLETED|Overall Study||0
9060392|NCT03708744|10119870|FG001|NOT COMPLETED|Overall Study||0
9060393|NCT03708744|10119871|FG002|NOT COMPLETED|Overall Study||1
9060394|NCT03708744|10119872|FG003|NOT COMPLETED|Overall Study||0
9060395|NCT03708770|10119882|FG000|STARTED|Overall Study||32
9060396|NCT03708770|10119882|FG000|COMPLETED|Overall Study||22
9060397|NCT03708770|10119882|FG000|NOT COMPLETED|Overall Study||10
9060398|NCT03709602|10119889|FG000|STARTED|Overall Study|Adolescents recruited for qualitative interviews.|16
9060399|NCT03709602|10119890|FG001|STARTED|Overall Study|Parents recruited for qualitative interviews.|16
9060400|NCT03709602|10119891|FG002|STARTED|Overall Study|Cohort of adolescents created from the EHR data for the quantitative portion of the study.|3044
9060401|NCT03709602|10119889|FG000|COMPLETED|Overall Study|Adolescents recruited for qualitative interviews.|16
9060402|NCT03709602|10119890|FG001|COMPLETED|Overall Study|Parents recruited for qualitative interviews.|16
9060403|NCT03709602|10119891|FG002|COMPLETED|Overall Study|Cohort of adolescents created from the EHR data for the quantitative portion of the study.|3044
9060404|NCT03709602|10119889|FG000|NOT COMPLETED|Overall Study||0
9060405|NCT03709602|10119890|FG001|NOT COMPLETED|Overall Study||0
9060406|NCT03709602|10119891|FG002|NOT COMPLETED|Overall Study||0
9060407|NCT03709654|10119899|FG000|STARTED|Overall Study||23
9060408|NCT03709654|10119900|FG001|STARTED|Overall Study||13
9060409|NCT03709654|10119899|FG000|COMPLETED|Overall Study||20
9060410|NCT03709654|10119900|FG001|COMPLETED|Overall Study||11
9060411|NCT03709654|10119899|FG000|NOT COMPLETED|Overall Study||3
9060412|NCT03709654|10119900|FG001|NOT COMPLETED|Overall Study||2
9060413|NCT03709810|10119906|FG000|STARTED|Treatment Period 1 (Visit 2)||24
9060414|NCT03709810|10119907|FG001|STARTED|Treatment Period 1 (Visit 2)||24
9060415|NCT03709810|10119906|FG000|COMPLETED|Treatment Period 1 (Visit 2)||24
9060416|NCT03709810|10119907|FG001|COMPLETED|Treatment Period 1 (Visit 2)||24
9060417|NCT03709810|10119906|FG000|NOT COMPLETED|Treatment Period 1 (Visit 2)||0
9060418|NCT03709810|10119907|FG001|NOT COMPLETED|Treatment Period 1 (Visit 2)||0
9060419|NCT03709810|10119906|FG000|STARTED|Treatment Period 2 (Visit 3)||24
9060420|NCT03709810|10119907|FG001|STARTED|Treatment Period 2 (Visit 3)||24
9060421|NCT03709810|10119906|FG000|COMPLETED|Treatment Period 2 (Visit 3)||24
9060422|NCT03709810|10119907|FG001|COMPLETED|Treatment Period 2 (Visit 3)||24
9060423|NCT03709810|10119906|FG000|NOT COMPLETED|Treatment Period 2 (Visit 3)||0
9060424|NCT03709810|10119907|FG001|NOT COMPLETED|Treatment Period 2 (Visit 3)||0
9060425|NCT03709823|10119919|FG000|STARTED|Overall Study||51
9060426|NCT03709823|10119920|FG001|STARTED|Overall Study||50
9060427|NCT03709823|10119921|FG002|STARTED|Overall Study||25
9060428|NCT03709823|10119922|FG003|STARTED|Overall Study||52
9060429|NCT03709823|10119923|FG004|STARTED|Overall Study||50
9060430|NCT03709823|10119924|FG005|STARTED|Overall Study||26
9060431|NCT03709823|10119919|FG000|COMPLETED|Overall Study||48
9060432|NCT03709823|10119920|FG001|COMPLETED|Overall Study||45
9060433|NCT03709823|10119921|FG002|COMPLETED|Overall Study||22
9060434|NCT03709823|10119922|FG003|COMPLETED|Overall Study||50
9060435|NCT03709823|10119923|FG004|COMPLETED|Overall Study||49
9060436|NCT03709823|10119924|FG005|COMPLETED|Overall Study||26
9060437|NCT03709823|10119919|FG000|NOT COMPLETED|Overall Study||3
9060438|NCT03709823|10119920|FG001|NOT COMPLETED|Overall Study||5
9060439|NCT03709823|10119921|FG002|NOT COMPLETED|Overall Study||3
9060440|NCT03709823|10119922|FG003|NOT COMPLETED|Overall Study||2
9060441|NCT03709823|10119923|FG004|NOT COMPLETED|Overall Study||1
9060442|NCT03709823|10119924|FG005|NOT COMPLETED|Overall Study||0
9060443|NCT03710083|10119941|FG000|STARTED|Overall Study||66
9060444|NCT03710083|10119941|FG000|COMPLETED|Overall Study||63
9060445|NCT03710083|10119941|FG000|NOT COMPLETED|Overall Study||3
9060446|NCT03710161|10119947|FG000|STARTED|Overall Study||3
9060447|NCT03710161|10119948|FG001|STARTED|Overall Study||2
9060448|NCT03710161|10119947|FG000|COMPLETED|Overall Study|Study halted due to COVID pandemic|0
9060449|NCT03710161|10119948|FG001|COMPLETED|Overall Study|Study halted due to COVID pandemic|0
9060450|NCT03710161|10119947|FG000|NOT COMPLETED|Overall Study||3
9060451|NCT03710161|10119948|FG001|NOT COMPLETED|Overall Study||2
9060452|NCT03710187|10119956|FG000|STARTED|Overall Study||41
9060453|NCT03710187|10119957|FG001|STARTED|Overall Study||43
9060454|NCT03710187|10119956|FG000|COMPLETED|Overall Study||41
9060455|NCT03710187|10119957|FG001|COMPLETED|Overall Study||43
9060456|NCT03710187|10119956|FG000|NOT COMPLETED|Overall Study||0
9060457|NCT03710187|10119957|FG001|NOT COMPLETED|Overall Study||0
9060458|NCT03710577|10119965|FG000|STARTED|First Intervention||8
9060459|NCT03710577|10119966|FG001|STARTED|First Intervention||4
9060460|NCT03710577|10119965|FG000|COMPLETED|First Intervention||8
9060461|NCT03710577|10119966|FG001|COMPLETED|First Intervention||4
9060462|NCT03710577|10119965|FG000|NOT COMPLETED|First Intervention||0
9060463|NCT03710577|10119966|FG001|NOT COMPLETED|First Intervention||0
9060464|NCT03710577|10119965|FG000|STARTED|Time Between Sessions (2-5 Days)||8
9060465|NCT03710577|10119966|FG001|STARTED|Time Between Sessions (2-5 Days)||4
9060466|NCT03710577|10119965|FG000|COMPLETED|Time Between Sessions (2-5 Days)||8
9060467|NCT03710577|10119966|FG001|COMPLETED|Time Between Sessions (2-5 Days)||4
9060468|NCT03710577|10119965|FG000|NOT COMPLETED|Time Between Sessions (2-5 Days)||0
9060469|NCT03710577|10119966|FG001|NOT COMPLETED|Time Between Sessions (2-5 Days)||0
9060470|NCT03710577|10119965|FG000|STARTED|Second Intervention||8
9060471|NCT03710577|10119966|FG001|STARTED|Second Intervention||4
9060472|NCT03710577|10119965|FG000|COMPLETED|Second Intervention||8
9060473|NCT03710577|10119966|FG001|COMPLETED|Second Intervention||4
9060474|NCT03710577|10119965|FG000|NOT COMPLETED|Second Intervention||0
9060475|NCT03710577|10119966|FG001|NOT COMPLETED|Second Intervention||0
9060476|NCT03710590|10119974|FG000|STARTED|Overall Study||22
9060477|NCT03710590|10119975|FG001|STARTED|Overall Study||23
9060478|NCT03710590|10119974|FG000|Session 1: ECIG Lab Session 15 Watts, 10 mg Nicotine|Overall Study||12
9060479|NCT03710590|10119975|FG001|Session 1: ECIG Lab Session 15 Watts, 10 mg Nicotine|Overall Study||15
9060480|NCT03710590|10119974|FG000|Session 2: ECIG Lab Session 15 Watts, 15 mg Nicotine|Overall Study||12
9060481|NCT03710590|10119975|FG001|Session 2: ECIG Lab Session 15 Watts, 15 mg Nicotine|Overall Study||15
9060482|NCT03710590|10119974|FG000|Session 3: ECIG Lab Session 15 Watts, 30 mg Nicotine|Overall Study||12
9060483|NCT03710590|10119975|FG001|Session 3: ECIG Lab Session 15 Watts, 30 mg Nicotine|Overall Study||15
9060484|NCT03710590|10119974|FG000|Session 4: ECIG Lab Session 30 Watts, 10 mg Nicotine|Overall Study||12
9060485|NCT03710590|10119975|FG001|Session 4: ECIG Lab Session 30 Watts, 10 mg Nicotine|Overall Study||15
9060486|NCT03710590|10119974|FG000|Session 5: ECIG Lab Session 30 Watts, 15 mg Nicotine|Overall Study||12
9060487|NCT03710590|10119975|FG001|Session 5: ECIG Lab Session 30 Watts, 15 mg Nicotine|Overall Study||15
9060488|NCT03710590|10119974|FG000|Session 6: ECIG Lab Session 30 Watts, 30 mg Nicotine|Overall Study||12
9060489|NCT03710590|10119975|FG001|Session 6: ECIG Lab Session 30 Watts, 30 mg Nicotine|Overall Study||15
9060490|NCT03710590|10119974|FG000|COMPLETED|Overall Study||12
9060491|NCT03710590|10119975|FG001|COMPLETED|Overall Study||15
9060492|NCT03710590|10119974|FG000|NOT COMPLETED|Overall Study||10
9060493|NCT03710590|10119975|FG001|NOT COMPLETED|Overall Study||8
9060494|NCT03710889|10119981|FG000|STARTED|Overall Study||23
9060495|NCT03710889|10119981|FG000|Received at Least 1 Dose of Study Drug|Overall Study||23
9060496|NCT03710889|10119981|FG000|Bone-Biopsy Population|Overall Study||19
9060497|NCT03710889|10119981|FG000|COMPLETED|Overall Study||20
9060498|NCT03710889|10119981|FG000|NOT COMPLETED|Overall Study||3
9060499|NCT03711396|10119985|FG000|STARTED|Overall Study||13
9060500|NCT03711396|10119986|FG001|STARTED|Overall Study||13
9060501|NCT03711396|10119985|FG000|COMPLETED|Overall Study||13
9060502|NCT03711396|10119986|FG001|COMPLETED|Overall Study||13
9060503|NCT03711396|10119985|FG000|NOT COMPLETED|Overall Study||0
9060504|NCT03711396|10119986|FG001|NOT COMPLETED|Overall Study||0
9060505|NCT03711578|10119993|FG000|STARTED|Overall Study||20
9060506|NCT03711578|10119993|FG000|COMPLETED|Overall Study||20
9060507|NCT03711578|10119993|FG000|NOT COMPLETED|Overall Study||0
9060508|NCT03712189|10119999|FG000|STARTED|Overall Study||15
9060509|NCT03712189|10120000|FG001|STARTED|Overall Study||15
9060510|NCT03712189|10119999|FG000|COMPLETED|Overall Study||15
9060511|NCT03712189|10120000|FG001|COMPLETED|Overall Study||15
9060512|NCT03712189|10119999|FG000|NOT COMPLETED|Overall Study||0
9060513|NCT03712189|10120000|FG001|NOT COMPLETED|Overall Study||0
9060514|NCT03712280|10120010|FG000|STARTED|Overall Study||12
9060515|NCT03712280|10120011|FG001|STARTED|Overall Study||12
9060516|NCT03712280|10120012|FG002|STARTED|Overall Study||13
9060517|NCT03712280|10120013|FG003|STARTED|Overall Study||13
8704062|NCT00925782|9749750|FG001|NOT COMPLETED|Follow-up(Day +1 to Date of Engraftment)||0
8704063|NCT00925899|9749759|FG000|STARTED|Part 1||34
8704064|NCT00925899|9749760|FG001|STARTED|Part 1||38
9060518|NCT03712280|10120010|FG000|Safety Population|Overall Study||12
9060519|NCT03712280|10120011|FG001|Safety Population|Overall Study||11
9060520|NCT03712280|10120012|FG002|Safety Population|Overall Study||13
9060521|NCT03712280|10120013|FG003|Safety Population|Overall Study||12
9060522|NCT03712280|10120010|FG000|Modified Intent to Treat Population|Overall Study||12
9060523|NCT03712280|10120011|FG001|Modified Intent to Treat Population|Overall Study||11
9060524|NCT03712280|10120012|FG002|Modified Intent to Treat Population|Overall Study||13
9060525|NCT03712280|10120013|FG003|Modified Intent to Treat Population|Overall Study||12
9060526|NCT03712280|10120010|FG000|Completed 5 Day Treatment|Overall Study||11
9060527|NCT03712280|10120011|FG001|Completed 5 Day Treatment|Overall Study||11
9060528|NCT03712280|10120012|FG002|Completed 5 Day Treatment|Overall Study||12
9060529|NCT03712280|10120013|FG003|Completed 5 Day Treatment|Overall Study||12
9060530|NCT03712280|10120010|FG000|COMPLETED|Overall Study||11
9060531|NCT03712280|10120011|FG001|COMPLETED|Overall Study||11
9060532|NCT03712280|10120012|FG002|COMPLETED|Overall Study||12
9060533|NCT03712280|10120013|FG003|COMPLETED|Overall Study||12
9060534|NCT03712280|10120010|FG000|NOT COMPLETED|Overall Study||1
9060535|NCT03712280|10120011|FG001|NOT COMPLETED|Overall Study||1
9060536|NCT03712280|10120012|FG002|NOT COMPLETED|Overall Study||1
9060537|NCT03712280|10120013|FG003|NOT COMPLETED|Overall Study||1
9060538|NCT03712449|10120025|FG000|STARTED|Overall Study||13
9060539|NCT03712449|10120026|FG001|STARTED|Overall Study||46
9060540|NCT03712449|10120025|FG000|Full Analysis Population|Overall Study||13
8704065|NCT00925899|9749759|FG000|COMPLETED|Part 1||23
8704066|NCT00925899|9749760|FG001|COMPLETED|Part 1||27
8704067|NCT00925899|9749759|FG000|NOT COMPLETED|Part 1||11
8704068|NCT00925899|9749760|FG001|NOT COMPLETED|Part 1||11
8704069|NCT00925899|9749759|FG000|STARTED|Part 2|All patients received the same intervention in the second part of the study (20 mg melatonin)|15
8704070|NCT00925899|9749760|FG001|STARTED|Part 2|Nine patients withdrew because they did not wish to continue in the study|21
9060541|NCT03712449|10120026|FG001|Full Analysis Population|Overall Study||45
9060542|NCT03712449|10120025|FG000|COMPLETED|Overall Study||13
9060543|NCT03712449|10120026|FG001|COMPLETED|Overall Study||45
9060544|NCT03712449|10120025|FG000|NOT COMPLETED|Overall Study||0
9060545|NCT03712449|10120026|FG001|NOT COMPLETED|Overall Study||1
9060546|NCT03712852|10120035|FG000|STARTED|Overall Study||20
8704071|NCT00925899|9749759|FG000|COMPLETED|Part 2||9
8704072|NCT00925899|9749760|FG001|COMPLETED|Part 2||9
8704073|NCT00925899|9749759|FG000|NOT COMPLETED|Part 2||6
8704074|NCT00925899|9749760|FG001|NOT COMPLETED|Part 2||12
8704075|NCT00925938|9749770|FG000|STARTED|Overall Study||9
8704076|NCT00925938|9749771|FG001|STARTED|Overall Study||25
9060547|NCT03712852|10120036|FG001|STARTED|Overall Study||20
9060548|NCT03712852|10120037|FG002|STARTED|Overall Study||20
9060549|NCT03712852|10120035|FG000|COMPLETED|Overall Study||20
9060550|NCT03712852|10120036|FG001|COMPLETED|Overall Study||20
9060551|NCT03712852|10120037|FG002|COMPLETED|Overall Study||20
9060552|NCT03712852|10120035|FG000|NOT COMPLETED|Overall Study||0
9060553|NCT03712852|10120036|FG001|NOT COMPLETED|Overall Study||0
9060554|NCT03712852|10120037|FG002|NOT COMPLETED|Overall Study||0
9060555|NCT03712917|10120048|FG000|STARTED|Overall Study||40
9060556|NCT03712917|10120049|FG001|STARTED|Overall Study||40
9060557|NCT03712917|10120050|FG002|STARTED|Overall Study||40
9060558|NCT03712917|10120048|FG000|COMPLETED|Overall Study||31
9060559|NCT03712917|10120049|FG001|COMPLETED|Overall Study||32
9060560|NCT03712917|10120050|FG002|COMPLETED|Overall Study||31
9060561|NCT03712917|10120048|FG000|NOT COMPLETED|Overall Study||9
9060562|NCT03712917|10120049|FG001|NOT COMPLETED|Overall Study||8
9060563|NCT03712917|10120050|FG002|NOT COMPLETED|Overall Study||9
9060564|NCT03712930|10120058|FG000|STARTED|Overall Study||13
9060565|NCT03712930|10120058|FG000|COMPLETED|Overall Study||0
9060566|NCT03712930|10120058|FG000|NOT COMPLETED|Overall Study||13
9060567|NCT03713398|10120064|FG000|STARTED|Overall Study||50
9060568|NCT03713398|10120065|FG001|STARTED|Overall Study||50
9060569|NCT03713398|10120064|FG000|COMPLETED|Overall Study||24
9060570|NCT03713398|10120065|FG001|COMPLETED|Overall Study||23
9060571|NCT03713398|10120064|FG000|NOT COMPLETED|Overall Study||26
9060572|NCT03713398|10120065|FG001|NOT COMPLETED|Overall Study||27
9060573|NCT03714022|10120073|FG000|STARTED|Overall Study||70
9060574|NCT03714022|10120074|FG001|STARTED|Overall Study||70
8704077|NCT00925938|9749772|FG002|STARTED|Overall Study||17
8704078|NCT00925938|9749770|FG000|COMPLETED|Overall Study||9
8704079|NCT00925938|9749771|FG001|COMPLETED|Overall Study||25
8704080|NCT00925938|9749772|FG002|COMPLETED|Overall Study||17
8704081|NCT00925938|9749770|FG000|NOT COMPLETED|Overall Study||0
9060575|NCT03714022|10120073|FG000|COMPLETED|Overall Study||66
9060576|NCT03714022|10120074|FG001|COMPLETED|Overall Study||67
8704082|NCT00925938|9749771|FG001|NOT COMPLETED|Overall Study||0
9060577|NCT03714022|10120073|FG000|NOT COMPLETED|Overall Study||4
9060578|NCT03714022|10120074|FG001|NOT COMPLETED|Overall Study||3
9060579|NCT03714256|10120082|FG000|STARTED|Overall Study||14
9060580|NCT03714256|10120083|FG001|STARTED|Overall Study||19
9060581|NCT03714256|10120082|FG000|COMPLETED|Overall Study||14
9060582|NCT03714256|10120083|FG001|COMPLETED|Overall Study||19
8704083|NCT00925938|9749772|FG002|NOT COMPLETED|Overall Study||0
8724601|NCT01026974|9771804|FG001|STARTED|Overall Study||14
8704084|NCT00925990|9749782|FG000|STARTED|Overall Study||35
8704085|NCT00925990|9749783|FG001|STARTED|Overall Study||35
8704086|NCT00925990|9749782|FG000|COMPLETED|Overall Study||30
8704087|NCT00925990|9749783|FG001|COMPLETED|Overall Study||24
8704088|NCT00925990|9749782|FG000|NOT COMPLETED|Overall Study||5
8704089|NCT00925990|9749783|FG001|NOT COMPLETED|Overall Study||11
8704090|NCT00926003|9749792|FG000|STARTED|Baseline||53
8704091|NCT00926003|9749793|FG001|STARTED|Baseline||54
8704092|NCT00926003|9749794|FG002|STARTED|Baseline||52
8704093|NCT00926003|9749792|FG000|COMPLETED|Baseline||53
8704094|NCT00926003|9749793|FG001|COMPLETED|Baseline||54
8704095|NCT00926003|9749794|FG002|COMPLETED|Baseline||52
8704096|NCT00926003|9749792|FG000|NOT COMPLETED|Baseline||0
8704097|NCT00926003|9749793|FG001|NOT COMPLETED|Baseline||0
8704098|NCT00926003|9749794|FG002|NOT COMPLETED|Baseline||0
8704099|NCT00926003|9749792|FG000|STARTED|Post-Training Evaluation||53
8704100|NCT00926003|9749793|FG001|STARTED|Post-Training Evaluation||54
8704101|NCT00926003|9749794|FG002|STARTED|Post-Training Evaluation||52
8704102|NCT00926003|9749792|FG000|COMPLETED|Post-Training Evaluation||52
8704103|NCT00926003|9749793|FG001|COMPLETED|Post-Training Evaluation||54
8704104|NCT00926003|9749794|FG002|COMPLETED|Post-Training Evaluation||52
9060583|NCT03714256|10120082|FG000|NOT COMPLETED|Overall Study||0
9060584|NCT03714256|10120083|FG001|NOT COMPLETED|Overall Study||0
9060585|NCT03714659|10120089|FG000|STARTED|Overall Study||20
9060586|NCT03714659|10120089|FG000|COMPLETED|Overall Study||19
9060587|NCT03714659|10120089|FG000|NOT COMPLETED|Overall Study||1
9060588|NCT03714672|10120097|FG000|STARTED|Overall Study||209
9060589|NCT03714672|10120098|FG001|STARTED|Overall Study||206
9060590|NCT03714672|10120099|FG002|STARTED|Overall Study||206
9060591|NCT03714672|10120100|FG003|STARTED|Overall Study||208
9060592|NCT03714672|10120097|FG000|Safety Set|Overall Study||208
9060593|NCT03714672|10120098|FG001|Safety Set|Overall Study||205
9060594|NCT03714672|10120099|FG002|Safety Set|Overall Study||206
9060595|NCT03714672|10120100|FG003|Safety Set|Overall Study||207
9060596|NCT03714672|10120097|FG000|COMPLETED|Overall Study||207
9060597|NCT03714672|10120098|FG001|COMPLETED|Overall Study||202
9060598|NCT03714672|10120099|FG002|COMPLETED|Overall Study||202
9060599|NCT03714672|10120100|FG003|COMPLETED|Overall Study||207
9060600|NCT03714672|10120097|FG000|NOT COMPLETED|Overall Study||2
9060601|NCT03714672|10120098|FG001|NOT COMPLETED|Overall Study||4
9060602|NCT03714672|10120099|FG002|NOT COMPLETED|Overall Study||4
9060603|NCT03714672|10120100|FG003|NOT COMPLETED|Overall Study||1
9060604|NCT03714919|10120111|FG000|STARTED|Overall Study||10
9060605|NCT03714919|10120111|FG000|COMPLETED|Overall Study||10
9060606|NCT03714919|10120111|FG000|NOT COMPLETED|Overall Study||0
9060607|NCT03715426|10120117|FG000|STARTED|Overall Study||133
9060608|NCT03715426|10120118|FG001|STARTED|Overall Study||117
9060609|NCT03715426|10120117|FG000|1-Month Follow-Up Survey|Overall Study||113
9060610|NCT03715426|10120118|FG001|1-Month Follow-Up Survey|Overall Study||97
9060611|NCT03715426|10120117|FG000|4-Month Follow-Up Survey|Overall Study||112
9060612|NCT03715426|10120118|FG001|4-Month Follow-Up Survey|Overall Study||92
9060613|NCT03715426|10120117|FG000|COMPLETED|Overall Study||112
9060614|NCT03715426|10120118|FG001|COMPLETED|Overall Study||92
9060615|NCT03715426|10120117|FG000|NOT COMPLETED|Overall Study||21
9060616|NCT03715426|10120118|FG001|NOT COMPLETED|Overall Study||25
9060617|NCT03715452|10120124|FG000|STARTED|Overall Study||114
9060618|NCT03715452|10120124|FG000|COMPLETED|Overall Study||114
9060619|NCT03715452|10120124|FG000|NOT COMPLETED|Overall Study||0
9060620|NCT03715530|10120131|FG000|STARTED|Overall Study||33
9060621|NCT03715530|10120132|FG001|STARTED|Overall Study||42
9060622|NCT03715530|10120133|FG002|STARTED|Overall Study||87
9060623|NCT03715530|10120131|FG000|COMPLETED|Overall Study||30
9060624|NCT03715530|10120132|FG001|COMPLETED|Overall Study||41
9060625|NCT03715530|10120133|FG002|COMPLETED|Overall Study||85
9060626|NCT03715530|10120131|FG000|NOT COMPLETED|Overall Study||3
9060627|NCT03715530|10120132|FG001|NOT COMPLETED|Overall Study||1
9060628|NCT03715530|10120133|FG002|NOT COMPLETED|Overall Study||2
9060629|NCT03715803|10120143|FG000|STARTED|Overall Study||91
9060630|NCT03715803|10120144|FG001|STARTED|Overall Study||126
9060631|NCT03715803|10120143|FG000|COMPLETED|Overall Study||91
9060632|NCT03715803|10120144|FG001|COMPLETED|Overall Study||126
9060633|NCT03715803|10120143|FG000|NOT COMPLETED|Overall Study||0
9060634|NCT03715803|10120144|FG001|NOT COMPLETED|Overall Study||0
9060635|NCT03716024|10120152|FG000|STARTED|Overall Study||118
9060636|NCT03716024|10120153|FG001|STARTED|Overall Study||116
9060637|NCT03716024|10120152|FG000|COMPLETED|Overall Study||107
9060638|NCT03716024|10120153|FG001|COMPLETED|Overall Study||98
9060639|NCT03716024|10120152|FG000|NOT COMPLETED|Overall Study||11
9060640|NCT03716024|10120153|FG001|NOT COMPLETED|Overall Study||18
9060641|NCT03716050|10120167|FG000|STARTED|Overall Study||2
9060642|NCT03716050|10120168|FG001|STARTED|Overall Study||4
9060643|NCT03716050|10120169|FG002|STARTED|Overall Study||1
8704105|NCT00926003|9749792|FG000|NOT COMPLETED|Post-Training Evaluation||1
9060644|NCT03716050|10120170|FG003|STARTED|Overall Study||3
9060645|NCT03716050|10120171|FG004|STARTED|Overall Study||1
9060646|NCT03716050|10120172|FG005|STARTED|Overall Study||0
9060647|NCT03716050|10120173|FG006|STARTED|Overall Study||4
9060648|NCT03716050|10120174|FG007|STARTED|Overall Study||2
9060649|NCT03716050|10120167|FG000|COMPLETED|Overall Study||2
8704106|NCT00926003|9749793|FG001|NOT COMPLETED|Post-Training Evaluation||0
8704107|NCT00926003|9749794|FG002|NOT COMPLETED|Post-Training Evaluation||0
9060650|NCT03716050|10120168|FG001|COMPLETED|Overall Study||4
9060651|NCT03716050|10120169|FG002|COMPLETED|Overall Study||0
9060652|NCT03716050|10120170|FG003|COMPLETED|Overall Study||1
9060653|NCT03716050|10120171|FG004|COMPLETED|Overall Study||1
9060654|NCT03716050|10120172|FG005|COMPLETED|Overall Study||0
9060655|NCT03716050|10120173|FG006|COMPLETED|Overall Study||4
9060656|NCT03716050|10120174|FG007|COMPLETED|Overall Study||0
9060657|NCT03716050|10120167|FG000|NOT COMPLETED|Overall Study||0
9060658|NCT03716050|10120168|FG001|NOT COMPLETED|Overall Study||0
9060659|NCT03716050|10120169|FG002|NOT COMPLETED|Overall Study||1
9060660|NCT03716050|10120170|FG003|NOT COMPLETED|Overall Study||2
9060661|NCT03716050|10120171|FG004|NOT COMPLETED|Overall Study||0
9060662|NCT03716050|10120172|FG005|NOT COMPLETED|Overall Study||0
9060663|NCT03716050|10120173|FG006|NOT COMPLETED|Overall Study||0
9060664|NCT03716050|10120174|FG007|NOT COMPLETED|Overall Study||2
9060665|NCT03716076|10120193|FG000|STARTED|Overall Study||25
9060666|NCT03716076|10120194|FG001|STARTED|Overall Study||25
9060667|NCT03716076|10120193|FG000|COMPLETED|Overall Study||22
9060668|NCT03716076|10120194|FG001|COMPLETED|Overall Study||19
9060669|NCT03716076|10120193|FG000|NOT COMPLETED|Overall Study||3
9060670|NCT03716076|10120194|FG001|NOT COMPLETED|Overall Study||6
9060671|NCT03717012|10120202|FG000|STARTED|Overall Study||9
9060672|NCT03717012|10120203|FG001|STARTED|Overall Study||10
9060673|NCT03717012|10120202|FG000|COMPLETED|Overall Study||8
9060674|NCT03717012|10120203|FG001|COMPLETED|Overall Study||4
9060675|NCT03717012|10120202|FG000|NOT COMPLETED|Overall Study||1
9060676|NCT03717012|10120203|FG001|NOT COMPLETED|Overall Study||6
9060677|NCT03717051|10120211|FG000|STARTED|Overall Study||352
9060678|NCT03717051|10120212|FG001|STARTED|Overall Study||482
9060679|NCT03717051|10120211|FG000|COMPLETED|Overall Study||352
9060680|NCT03717051|10120212|FG001|COMPLETED|Overall Study||482
9060681|NCT03717051|10120211|FG000|NOT COMPLETED|Overall Study||0
9060682|NCT03717051|10120212|FG001|NOT COMPLETED|Overall Study||0
9060683|NCT03717064|10120218|FG000|STARTED|Period 1||18
9060684|NCT03717064|10120218|FG000|COMPLETED|Period 1||18
9060685|NCT03717064|10120218|FG000|NOT COMPLETED|Period 1||0
9060686|NCT03717064|10120218|FG000|STARTED|Period 2||18
9060687|NCT03717064|10120218|FG000|COMPLETED|Period 2||17
9060688|NCT03717064|10120218|FG000|NOT COMPLETED|Period 2||1
9060689|NCT03717155|10120222|FG000|STARTED|Overall Study||43
9060690|NCT03717155|10120222|FG000|COMPLETED|Overall Study||43
9060691|NCT03717155|10120222|FG000|NOT COMPLETED|Overall Study||0
9060692|NCT03717506|10120229|FG000|STARTED|Overall Study||496
9060693|NCT03717506|10120230|FG001|STARTED|Overall Study||491
9060694|NCT03717506|10120231|FG002|STARTED|Overall Study||249
9060695|NCT03717506|10120229|FG000|COMPLETED|Overall Study||447
9060696|NCT03717506|10120230|FG001|COMPLETED|Overall Study||441
9060697|NCT03717506|10120231|FG002|COMPLETED|Overall Study||222
9060698|NCT03717506|10120229|FG000|NOT COMPLETED|Overall Study||49
9060699|NCT03717506|10120230|FG001|NOT COMPLETED|Overall Study||50
9060700|NCT03717506|10120231|FG002|NOT COMPLETED|Overall Study||27
9060701|NCT03718000|10120241|FG000|STARTED|Overall Study||55
9060702|NCT03718000|10120242|FG001|STARTED|Overall Study||56
9060703|NCT03718000|10120241|FG000|COMPLETED|Overall Study||53
9060704|NCT03718000|10120242|FG001|COMPLETED|Overall Study||51
9060705|NCT03718000|10120241|FG000|NOT COMPLETED|Overall Study||2
9060706|NCT03718000|10120242|FG001|NOT COMPLETED|Overall Study||5
9060707|NCT03718871|10120251|FG000|STARTED|Overall Study||250
9060708|NCT03718871|10120252|FG001|STARTED|Overall Study||250
9060709|NCT03718871|10120251|FG000|COMPLETED|Overall Study||250
9060710|NCT03718871|10120252|FG001|COMPLETED|Overall Study||250
9060711|NCT03718871|10120251|FG000|NOT COMPLETED|Overall Study||0
9060712|NCT03718871|10120252|FG001|NOT COMPLETED|Overall Study||0
9060713|NCT03719300|10120259|FG000|STARTED|Overall Study||32
9060714|NCT03719300|10120259|FG000|COMPLETED|Overall Study||32
9060715|NCT03719300|10120259|FG000|NOT COMPLETED|Overall Study||0
9060716|NCT03719378|10120265|FG000|STARTED|Overall Study||75
9060717|NCT03719378|10120266|FG001|STARTED|Overall Study||75
9060718|NCT03719378|10120265|FG000|COMPLETED|Overall Study||65
9060719|NCT03719378|10120266|FG001|COMPLETED|Overall Study||65
9060720|NCT03719378|10120265|FG000|NOT COMPLETED|Overall Study||10
9060721|NCT03719378|10120266|FG001|NOT COMPLETED|Overall Study||10
9060722|NCT03719586|10120276|FG000|STARTED|Overall Study||177
9060723|NCT03719586|10120277|FG001|STARTED|Overall Study||176
9060724|NCT03719586|10120278|FG002|STARTED|Overall Study|The REGN-EB3 arm was added in 1/2019 after the trial had initially begun in November 2018.|158
9060725|NCT03719586|10120279|FG003|STARTED|Overall Study||169
9060726|NCT03719586|10120276|FG000|COMPLETED|Overall Study|in 8/2019 the DSMB recommended further randomization only occur to the MAb114 and REGN-EB3 arms.|169
9060727|NCT03719586|10120277|FG001|COMPLETED|Overall Study|in 8/2019 the DSMB recommended further randomization only occur to the MAb114 and REGN-EB3 arms.|169
9060728|NCT03719586|10120278|FG002|COMPLETED|Overall Study|in 8/2019 the DSMB recommended further randomization only occur to the MAb114 and REGN-EB3 arms.|154
9060729|NCT03719586|10120279|FG003|COMPLETED|Overall Study|in 8/2019 the DSMB recommended further randomization only occur to the MAb114 and REGN-EB3 arms.|169
9060730|NCT03719586|10120276|FG000|NOT COMPLETED|Overall Study||8
9060731|NCT03719586|10120277|FG001|NOT COMPLETED|Overall Study||7
9060732|NCT03719586|10120278|FG002|NOT COMPLETED|Overall Study||4
9060733|NCT03719586|10120279|FG003|NOT COMPLETED|Overall Study||0
9060734|NCT03719612|10120289|FG000|STARTED|Overall Study||160
9060735|NCT03719612|10120289|FG000|COMPLETED|Overall Study||148
9060736|NCT03719612|10120289|FG000|NOT COMPLETED|Overall Study||12
9060737|NCT03719677|10120295|FG000|STARTED|Overall Study||7
9060738|NCT03719677|10120295|FG000|COMPLETED|Overall Study||7
9060739|NCT03719677|10120295|FG000|NOT COMPLETED|Overall Study||0
9060740|NCT03719885|10120299|FG000|STARTED|Overall Study||55
9060741|NCT03719885|10120299|FG000|COMPLETED|Overall Study||35
9060742|NCT03719885|10120299|FG000|NOT COMPLETED|Overall Study||20
9060743|NCT03720119|10120305|FG000|STARTED|Overall Study||78
9060744|NCT03720119|10120305|FG000|COMPLETED|Overall Study||69
9060745|NCT03720119|10120305|FG000|NOT COMPLETED|Overall Study||9
9060746|NCT03720470|10120313|FG000|STARTED|Treatment Period: First Part 16 Weeks||131
9060747|NCT03720470|10120314|FG001|STARTED|Treatment Period: First Part 16 Weeks||0
9060748|NCT03720470|10120315|FG002|STARTED|Treatment Period: First Part 16 Weeks||0
9060749|NCT03720470|10120316|FG003|STARTED|Treatment Period: First Part 16 Weeks||238
9060750|NCT03720470|10120317|FG004|STARTED|Treatment Period: First Part 16 Weeks||226
9060751|NCT03720470|10120318|FG005|STARTED|Treatment Period: First Part 16 Weeks||243
9060752|NCT03720470|10120313|FG000|Treated/ Safety Analysis Set|Treatment Period: First Part 16 Weeks||131
9060753|NCT03720470|10120314|FG001|Treated/ Safety Analysis Set|Treatment Period: First Part 16 Weeks||0
9060754|NCT03720470|10120315|FG002|Treated/ Safety Analysis Set|Treatment Period: First Part 16 Weeks||0
9060755|NCT03720470|10120316|FG003|Treated/ Safety Analysis Set|Treatment Period: First Part 16 Weeks||238
9060756|NCT03720470|10120317|FG004|Treated/ Safety Analysis Set|Treatment Period: First Part 16 Weeks||226
9060757|NCT03720470|10120318|FG005|Treated/ Safety Analysis Set|Treatment Period: First Part 16 Weeks||242
9060758|NCT03720470|10120313|FG000|Full Analysis Set|Treatment Period: First Part 16 Weeks||131
9060759|NCT03720470|10120314|FG001|Full Analysis Set|Treatment Period: First Part 16 Weeks||0
9060760|NCT03720470|10120315|FG002|Full Analysis Set|Treatment Period: First Part 16 Weeks||0
9060761|NCT03720470|10120316|FG003|Full Analysis Set|Treatment Period: First Part 16 Weeks||238
9060762|NCT03720470|10120317|FG004|Full Analysis Set|Treatment Period: First Part 16 Weeks||226
9060763|NCT03720470|10120318|FG005|Full Analysis Set|Treatment Period: First Part 16 Weeks||242
9060764|NCT03720470|10120313|FG000|COMPLETED|Treatment Period: First Part 16 Weeks||117
9060765|NCT03720470|10120314|FG001|COMPLETED|Treatment Period: First Part 16 Weeks||0
9060766|NCT03720470|10120315|FG002|COMPLETED|Treatment Period: First Part 16 Weeks||0
9060767|NCT03720470|10120316|FG003|COMPLETED|Treatment Period: First Part 16 Weeks||217
9060768|NCT03720470|10120317|FG004|COMPLETED|Treatment Period: First Part 16 Weeks||208
9060769|NCT03720470|10120318|FG005|COMPLETED|Treatment Period: First Part 16 Weeks||223
9060770|NCT03720470|10120313|FG000|NOT COMPLETED|Treatment Period: First Part 16 Weeks||14
9060771|NCT03720470|10120314|FG001|NOT COMPLETED|Treatment Period: First Part 16 Weeks||0
9060772|NCT03720470|10120315|FG002|NOT COMPLETED|Treatment Period: First Part 16 Weeks||0
9060773|NCT03720470|10120316|FG003|NOT COMPLETED|Treatment Period: First Part 16 Weeks||21
9060774|NCT03720470|10120317|FG004|NOT COMPLETED|Treatment Period: First Part 16 Weeks||18
9060775|NCT03720470|10120318|FG005|NOT COMPLETED|Treatment Period: First Part 16 Weeks||20
9060776|NCT03720470|10120313|FG000|STARTED|Treatment Period: Final 4 Weeks|Participants received placebo till Week 16 then allocated to receive PF-04965842 post Week 16.|0
9060777|NCT03720470|10120314|FG001|STARTED|Treatment Period: Final 4 Weeks|Participants received placebo till Week 16 then allocated to receive PF-04965842 post Week 16.|60
9060778|NCT03720470|10120315|FG002|STARTED|Treatment Period: Final 4 Weeks|Participants received placebo till Week 16 then allocated to receive PF-04965842 post Week 16.|57
9060779|NCT03720470|10120316|FG003|STARTED|Treatment Period: Final 4 Weeks||217
9060780|NCT03720470|10120317|FG004|STARTED|Treatment Period: Final 4 Weeks||208
9060781|NCT03720470|10120318|FG005|STARTED|Treatment Period: Final 4 Weeks||223
9060782|NCT03720470|10120313|FG000|Treated/ Safety Analysis Set|Treatment Period: Final 4 Weeks||0
9060783|NCT03720470|10120314|FG001|Treated/ Safety Analysis Set|Treatment Period: Final 4 Weeks||60
9060784|NCT03720470|10120315|FG002|Treated/ Safety Analysis Set|Treatment Period: Final 4 Weeks||57
9060785|NCT03720470|10120316|FG003|Treated/ Safety Analysis Set|Treatment Period: Final 4 Weeks||217
9060786|NCT03720470|10120317|FG004|Treated/ Safety Analysis Set|Treatment Period: Final 4 Weeks||208
8704108|NCT00926003|9749792|FG000|STARTED|Post-Training 3-month Follow-up||52
8704109|NCT00926003|9749793|FG001|STARTED|Post-Training 3-month Follow-up||54
8704110|NCT00926003|9749794|FG002|STARTED|Post-Training 3-month Follow-up||52
8704111|NCT00926003|9749792|FG000|COMPLETED|Post-Training 3-month Follow-up||51
8704112|NCT00926003|9749793|FG001|COMPLETED|Post-Training 3-month Follow-up||54
8704113|NCT00926003|9749794|FG002|COMPLETED|Post-Training 3-month Follow-up||52
8704114|NCT00926003|9749792|FG000|NOT COMPLETED|Post-Training 3-month Follow-up||1
8704115|NCT00926003|9749793|FG001|NOT COMPLETED|Post-Training 3-month Follow-up||0
8704116|NCT00926003|9749794|FG002|NOT COMPLETED|Post-Training 3-month Follow-up||0
8704117|NCT00926029|9749805|FG000|STARTED|Overall Study||34
8704118|NCT00926029|9749806|FG001|STARTED|Overall Study||34
8704119|NCT00926029|9749807|FG002|STARTED|Overall Study||34
8704120|NCT00926029|9749805|FG000|COMPLETED|Overall Study||32
8704121|NCT00926029|9749806|FG001|COMPLETED|Overall Study||33
8704122|NCT00926029|9749807|FG002|COMPLETED|Overall Study||33
8704123|NCT00926029|9749805|FG000|NOT COMPLETED|Overall Study||2
8704124|NCT00926029|9749806|FG001|NOT COMPLETED|Overall Study||1
8704125|NCT00926029|9749807|FG002|NOT COMPLETED|Overall Study||1
8704126|NCT00926185|9749821|FG000|STARTED|Overall Study||57
8704127|NCT00926185|9749822|FG001|STARTED|Overall Study||57
8704128|NCT00926185|9749823|FG002|STARTED|Overall Study||58
8704129|NCT00926185|9749824|FG003|STARTED|Overall Study||58
8704130|NCT00926185|9749821|FG000|COMPLETED|Overall Study||54
8704131|NCT00926185|9749822|FG001|COMPLETED|Overall Study||51
8704132|NCT00926185|9749823|FG002|COMPLETED|Overall Study||48
8704133|NCT00926185|9749824|FG003|COMPLETED|Overall Study||48
8704134|NCT00926185|9749821|FG000|NOT COMPLETED|Overall Study||3
8704135|NCT00926185|9749822|FG001|NOT COMPLETED|Overall Study||6
8704136|NCT00926185|9749823|FG002|NOT COMPLETED|Overall Study||10
8704137|NCT00926185|9749824|FG003|NOT COMPLETED|Overall Study||10
8704138|NCT00926211|9749834|FG000|STARTED|Overall Study|One additional subject was not randomized and did not receive the treatment procedure.|36
8704139|NCT00926211|9749834|FG000|COMPLETED|Overall Study||35
8704140|NCT00926211|9749834|FG000|NOT COMPLETED|Overall Study||1
8704141|NCT00926237|9749839|FG000|STARTED|Overall Study|Two subjects withdrew after receiving sham rTMS but before receiving active rTMS.|19
9060787|NCT03720470|10120318|FG005|Treated/ Safety Analysis Set|Treatment Period: Final 4 Weeks||223
9060788|NCT03720470|10120313|FG000|Full Analysis Set|Treatment Period: Final 4 Weeks||0
9060789|NCT03720470|10120314|FG001|Full Analysis Set|Treatment Period: Final 4 Weeks||60
9060790|NCT03720470|10120315|FG002|Full Analysis Set|Treatment Period: Final 4 Weeks||57
9060791|NCT03720470|10120316|FG003|Full Analysis Set|Treatment Period: Final 4 Weeks||217
9060792|NCT03720470|10120317|FG004|Full Analysis Set|Treatment Period: Final 4 Weeks||208
9060793|NCT03720470|10120318|FG005|Full Analysis Set|Treatment Period: Final 4 Weeks||223
9060794|NCT03720470|10120313|FG000|COMPLETED|Treatment Period: Final 4 Weeks||0
9060795|NCT03720470|10120314|FG001|COMPLETED|Treatment Period: Final 4 Weeks||58
9060796|NCT03720470|10120315|FG002|COMPLETED|Treatment Period: Final 4 Weeks||55
9060797|NCT03720470|10120316|FG003|COMPLETED|Treatment Period: Final 4 Weeks||210
9060798|NCT03720470|10120317|FG004|COMPLETED|Treatment Period: Final 4 Weeks||204
9060799|NCT03720470|10120318|FG005|COMPLETED|Treatment Period: Final 4 Weeks||218
9060800|NCT03720470|10120313|FG000|NOT COMPLETED|Treatment Period: Final 4 Weeks||0
9060801|NCT03720470|10120314|FG001|NOT COMPLETED|Treatment Period: Final 4 Weeks||2
9060802|NCT03720470|10120315|FG002|NOT COMPLETED|Treatment Period: Final 4 Weeks||2
9060803|NCT03720470|10120316|FG003|NOT COMPLETED|Treatment Period: Final 4 Weeks||7
9060804|NCT03720470|10120317|FG004|NOT COMPLETED|Treatment Period: Final 4 Weeks||4
9060805|NCT03720470|10120318|FG005|NOT COMPLETED|Treatment Period: Final 4 Weeks||5
9060806|NCT03720652|10120340|FG000|STARTED|Overall Study||12
9060807|NCT03720652|10120341|FG001|STARTED|Overall Study||27
9060808|NCT03720652|10120340|FG000|Baseline Interview|Overall Study||12
9060809|NCT03720652|10120341|FG001|Baseline Interview|Overall Study||22
9060810|NCT03720652|10120340|FG000|Start Intervention|Overall Study||11
9060811|NCT03720652|10120341|FG001|Start Intervention|Overall Study||21
9060812|NCT03720652|10120340|FG000|Complete Intervention|Overall Study||10
9060813|NCT03720652|10120341|FG001|Complete Intervention|Overall Study||20
9060814|NCT03720652|10120340|FG000|3-Month Follow Up Interview|Overall Study||10
9060815|NCT03720652|10120341|FG001|3-Month Follow Up Interview|Overall Study||19
9060816|NCT03720652|10120340|FG000|6-Month Follow Up Interview|Overall Study||10
9060817|NCT03720652|10120341|FG001|6-Month Follow Up Interview|Overall Study||16
9060818|NCT03720652|10120340|FG000|COMPLETED|Overall Study||10
9060819|NCT03720652|10120341|FG001|COMPLETED|Overall Study||16
9060820|NCT03720652|10120340|FG000|NOT COMPLETED|Overall Study||2
9060821|NCT03720652|10120341|FG001|NOT COMPLETED|Overall Study||11
9060822|NCT03720847|10120349|FG000|STARTED|Condition 1||15
9060823|NCT03720847|10120350|FG001|STARTED|Condition 1||15
9060824|NCT03720847|10120349|FG000|COMPLETED|Condition 1||15
9060825|NCT03720847|10120350|FG001|COMPLETED|Condition 1||15
9060826|NCT03720847|10120349|FG000|NOT COMPLETED|Condition 1||0
9060827|NCT03720847|10120350|FG001|NOT COMPLETED|Condition 1||0
9060828|NCT03720847|10120349|FG000|STARTED|Washout||15
9060829|NCT03720847|10120350|FG001|STARTED|Washout||15
9060830|NCT03720847|10120349|FG000|COMPLETED|Washout||14
9060831|NCT03720847|10120350|FG001|COMPLETED|Washout||13
9060832|NCT03720847|10120349|FG000|NOT COMPLETED|Washout||1
9060833|NCT03720847|10120350|FG001|NOT COMPLETED|Washout||2
9060834|NCT03720847|10120349|FG000|STARTED|Condition 2||14
9060835|NCT03720847|10120350|FG001|STARTED|Condition 2||13
9060836|NCT03720847|10120349|FG000|COMPLETED|Condition 2||14
9060837|NCT03720847|10120350|FG001|COMPLETED|Condition 2||13
9060838|NCT03720847|10120349|FG000|NOT COMPLETED|Condition 2||0
9060839|NCT03720847|10120350|FG001|NOT COMPLETED|Condition 2||0
9060840|NCT03720938|10120359|FG000|STARTED|Overall Study||242
9060841|NCT03720938|10120360|FG001|STARTED|Overall Study||676
9060842|NCT03720938|10120359|FG000|COMPLETED|Overall Study||53
9060843|NCT03720938|10120360|FG001|COMPLETED|Overall Study||53
9060844|NCT03720938|10120359|FG000|NOT COMPLETED|Overall Study||189
9060845|NCT03720938|10120360|FG001|NOT COMPLETED|Overall Study||623
9060846|NCT03721172|10120379|FG000|STARTED|Placebo-controlled Phase||298
9060847|NCT03721172|10120380|FG001|STARTED|Placebo-controlled Phase||297
9060848|NCT03721172|10120381|FG002|STARTED|Placebo-controlled Phase|This arm was not included in the placebo-controlled phase.|0
9060849|NCT03721172|10120379|FG000|Received at Least 1 Dose of Treatment|Placebo-controlled Phase||297
9060850|NCT03721172|10120380|FG001|Received at Least 1 Dose of Treatment|Placebo-controlled Phase||297
9060851|NCT03721172|10120381|FG002|Received at Least 1 Dose of Treatment|Placebo-controlled Phase|This arm was not included in the placebo-controlled phase.|0
9060852|NCT03721172|10120379|FG000|COMPLETED|Placebo-controlled Phase||246
9060853|NCT03721172|10120380|FG001|COMPLETED|Placebo-controlled Phase||258
8724602|NCT01026974|9771805|FG002|STARTED|Overall Study||41
8724603|NCT01026974|9771806|FG003|STARTED|Overall Study||49
8724604|NCT01026974|9771803|FG000|COMPLETED|Overall Study||15
8724605|NCT01026974|9771804|FG001|COMPLETED|Overall Study||12
8724606|NCT01026974|9771805|FG002|COMPLETED|Overall Study||29
8724607|NCT01026974|9771806|FG003|COMPLETED|Overall Study||46
8724608|NCT01026974|9771803|FG000|NOT COMPLETED|Overall Study||1
8724609|NCT01026974|9771804|FG001|NOT COMPLETED|Overall Study||2
8724610|NCT01026974|9771805|FG002|NOT COMPLETED|Overall Study||12
9060854|NCT03721172|10120381|FG002|COMPLETED|Placebo-controlled Phase|This arm was not included in the placebo-controlled phase.|0
9060855|NCT03721172|10120379|FG000|NOT COMPLETED|Placebo-controlled Phase||52
9060856|NCT03721172|10120380|FG001|NOT COMPLETED|Placebo-controlled Phase||39
9060857|NCT03721172|10120381|FG002|NOT COMPLETED|Placebo-controlled Phase||0
9060858|NCT03721172|10120379|FG000|STARTED|Apremilast Extension Phase|This arm was not included in the extension phase.|0
9060859|NCT03721172|10120380|FG001|STARTED|Apremilast Extension Phase|This arm was not included in the extension phase.|0
9060860|NCT03721172|10120381|FG002|STARTED|Apremilast Extension Phase|1 participant did not enter the extension phase due to physician decision.|503
9060861|NCT03721172|10120379|FG000|Received at Least 1 Dose|Apremilast Extension Phase|This arm was not included in the extension phase.|0
9060862|NCT03721172|10120380|FG001|Received at Least 1 Dose|Apremilast Extension Phase|This arm was not included in the extension phase.|0
9060863|NCT03721172|10120381|FG002|Received at Least 1 Dose|Apremilast Extension Phase||503
9060864|NCT03721172|10120379|FG000|COMPLETED|Apremilast Extension Phase|This arm was not included in the extension phase.|0
9060865|NCT03721172|10120380|FG001|COMPLETED|Apremilast Extension Phase|This arm was not included in the extension phase.|0
9060866|NCT03721172|10120381|FG002|COMPLETED|Apremilast Extension Phase||437
9060867|NCT03721172|10120379|FG000|NOT COMPLETED|Apremilast Extension Phase||0
9060868|NCT03721172|10120380|FG001|NOT COMPLETED|Apremilast Extension Phase||0
9060869|NCT03721172|10120381|FG002|NOT COMPLETED|Apremilast Extension Phase||66
9060870|NCT03721549|10120391|FG000|STARTED|Overall Study||8
9060871|NCT03721549|10120392|FG001|STARTED|Overall Study||8
9060872|NCT03721549|10120391|FG000|COMPLETED|Overall Study||7
9060873|NCT03721549|10120392|FG001|COMPLETED|Overall Study||8
9060874|NCT03721549|10120391|FG000|NOT COMPLETED|Overall Study||1
9060875|NCT03721549|10120392|FG001|NOT COMPLETED|Overall Study||0
9060876|NCT03722030|10120400|FG000|STARTED|Overall Study||20
9060877|NCT03722030|10120401|FG001|STARTED|Overall Study||20
9060878|NCT03722030|10120400|FG000|COMPLETED|Overall Study||19
9060879|NCT03722030|10120401|FG001|COMPLETED|Overall Study||20
9060880|NCT03722030|10120400|FG000|NOT COMPLETED|Overall Study||1
9060881|NCT03722030|10120401|FG001|NOT COMPLETED|Overall Study||0
9060882|NCT03722238|10120410|FG000|STARTED|Overall Study||608
9060883|NCT03722238|10120411|FG001|STARTED|Overall Study||5
9060884|NCT03722238|10120410|FG000|Safety Set|Overall Study||198
9060885|NCT03722238|10120411|FG001|Safety Set|Overall Study||5
9060886|NCT03722238|10120410|FG000|Actual Drug Users|Overall Study||179
9060887|NCT03722238|10120411|FG001|Actual Drug Users|Overall Study||5
9060888|NCT03722238|10120410|FG000|COMPLETED|Overall Study||143
9060889|NCT03722238|10120411|FG001|COMPLETED|Overall Study||4
9060890|NCT03722238|10120410|FG000|NOT COMPLETED|Overall Study||465
9060891|NCT03722238|10120411|FG001|NOT COMPLETED|Overall Study||1
9060892|NCT03722264|10120417|FG000|STARTED|Overall Study||12
9060893|NCT03722264|10120417|FG000|COMPLETED|Overall Study||9
9060894|NCT03722264|10120417|FG000|NOT COMPLETED|Overall Study||3
9060895|NCT03722446|10120425|FG000|STARTED|Overall Study||135
9060896|NCT03722446|10120426|FG001|STARTED|Overall Study||122
9060897|NCT03722446|10120425|FG000|COMPLETED|Overall Study||120
9060898|NCT03722446|10120426|FG001|COMPLETED|Overall Study||120
9060899|NCT03722446|10120425|FG000|NOT COMPLETED|Overall Study||15
9060900|NCT03722446|10120426|FG001|NOT COMPLETED|Overall Study||2
9060901|NCT03722524|10120432|FG000|STARTED|Overall Study||1247
9060902|NCT03722524|10120432|FG000|COMPLETED|Overall Study||1148
9060903|NCT03722524|10120432|FG000|NOT COMPLETED|Overall Study||99
9060904|NCT03722576|10120436|FG000|STARTED|Overall Study||18
9060905|NCT03722576|10120436|FG000|COMPLETED|Overall Study||11
9060906|NCT03722576|10120436|FG000|NOT COMPLETED|Overall Study||7
9060907|NCT03722784|10120442|FG000|STARTED|Overall Study||58
9060908|NCT03722784|10120443|FG001|STARTED|Overall Study||30
9060909|NCT03722784|10120442|FG000|COMPLETED|Overall Study||56
9060910|NCT03722784|10120443|FG001|COMPLETED|Overall Study||28
9060911|NCT03722784|10120442|FG000|NOT COMPLETED|Overall Study||2
9060912|NCT03722784|10120443|FG001|NOT COMPLETED|Overall Study||2
9060913|NCT03723915|10120450|FG000|STARTED|Screening||17
9060914|NCT03723915|10120450|FG000|COMPLETED|Screening||15
9060915|NCT03723915|10120450|FG000|NOT COMPLETED|Screening||2
9060916|NCT03723915|10120450|FG000|STARTED|On Treatment||15
9060917|NCT03723915|10120450|FG000|Registered on Study|On Treatment||15
9060918|NCT03723915|10120450|FG000|Received First Dose of Study Drugs|On Treatment||13
9060919|NCT03723915|10120450|FG000|COMPLETED|On Treatment||13
9060920|NCT03723915|10120450|FG000|NOT COMPLETED|On Treatment||2
9060921|NCT03723915|10120450|FG000|STARTED|Survival Follow-up||13
9060922|NCT03723915|10120450|FG000|COMPLETED|Survival Follow-up||13
9060923|NCT03723915|10120450|FG000|NOT COMPLETED|Survival Follow-up||0
9060924|NCT03724812|10120454|FG000|STARTED|Overall Study||46
9060925|NCT03724812|10120454|FG000|Discharge|Overall Study||46
9060926|NCT03724812|10120454|FG000|30 Day Follow-Up|Overall Study||45
9060927|NCT03724812|10120454|FG000|6 Month Follow-Up|Overall Study||42
9060928|NCT03724812|10120454|FG000|12-Month Follow-Up|Overall Study||42
9060929|NCT03724812|10120454|FG000|COMPLETED|Overall Study||42
9060930|NCT03724812|10120454|FG000|NOT COMPLETED|Overall Study||4
9060931|NCT03725982|10120461|FG000|STARTED|First Intervention||20
9060932|NCT03725982|10120462|FG001|STARTED|First Intervention||19
9060933|NCT03725982|10120461|FG000|COMPLETED|First Intervention||19
9060934|NCT03725982|10120462|FG001|COMPLETED|First Intervention||17
9060935|NCT03725982|10120461|FG000|NOT COMPLETED|First Intervention||1
9060936|NCT03725982|10120462|FG001|NOT COMPLETED|First Intervention||2
9060937|NCT03725982|10120461|FG000|STARTED|Second Intervention||19
9060938|NCT03725982|10120462|FG001|STARTED|Second Intervention||17
9060939|NCT03725982|10120461|FG000|COMPLETED|Second Intervention||19
9060940|NCT03725982|10120462|FG001|COMPLETED|Second Intervention||17
9060941|NCT03725982|10120461|FG000|NOT COMPLETED|Second Intervention||0
9060942|NCT03725982|10120462|FG001|NOT COMPLETED|Second Intervention||0
9060943|NCT03727841|10120476|FG000|STARTED|Overall Study||3
9060944|NCT03727841|10120477|FG001|STARTED|Overall Study||1
9060945|NCT03727841|10120476|FG000|COMPLETED|Overall Study||1
9060946|NCT03727841|10120477|FG001|COMPLETED|Overall Study||0
9060947|NCT03727841|10120476|FG000|NOT COMPLETED|Overall Study||2
9060948|NCT03727841|10120477|FG001|NOT COMPLETED|Overall Study||1
9060949|NCT03736967|10120487|FG000|STARTED|Overall Study||51
9060950|NCT03736967|10120488|FG001|STARTED|Overall Study||52
9060951|NCT03736967|10120489|FG002|STARTED|Overall Study||51
9060952|NCT03736967|10120490|FG003|STARTED|Overall Study||52
9060953|NCT03736967|10120487|FG000|Treated|Overall Study||50
9060954|NCT03736967|10120488|FG001|Treated|Overall Study||52
9060955|NCT03736967|10120489|FG002|Treated|Overall Study||51
9060956|NCT03736967|10120490|FG003|Treated|Overall Study||52
9060957|NCT03736967|10120487|FG000|COMPLETED|Overall Study||20
9060958|NCT03736967|10120488|FG001|COMPLETED|Overall Study||24
9060959|NCT03736967|10120489|FG002|COMPLETED|Overall Study||27
9060960|NCT03736967|10120490|FG003|COMPLETED|Overall Study||22
9060961|NCT03736967|10120487|FG000|NOT COMPLETED|Overall Study||31
9060962|NCT03736967|10120488|FG001|NOT COMPLETED|Overall Study||28
9060963|NCT03736967|10120489|FG002|NOT COMPLETED|Overall Study||24
9060964|NCT03736967|10120490|FG003|NOT COMPLETED|Overall Study||30
9060965|NCT03739840|10120507|FG000|STARTED|Treatment Period: Wk0-16||56
9060966|NCT03739840|10120508|FG001|STARTED|Treatment Period: Wk0-16||60
9060967|NCT03739840|10120509|FG002|STARTED|Treatment Period: Wk0-16||57
9060968|NCT03739840|10120510|FG003|STARTED|Treatment Period: Wk0-16||59
9060969|NCT03739840|10120507|FG000|Completed Titration and Stabilization|Treatment Period: Wk0-16||54
9060970|NCT03739840|10120508|FG001|Completed Titration and Stabilization|Treatment Period: Wk0-16||58
9060971|NCT03739840|10120509|FG002|Completed Titration and Stabilization|Treatment Period: Wk0-16||51
9060972|NCT03739840|10120510|FG003|Completed Titration and Stabilization|Treatment Period: Wk0-16||54
9060973|NCT03739840|10120507|FG000|Completed Maintenance Period|Treatment Period: Wk0-16||46
9060974|NCT03739840|10120508|FG001|Completed Maintenance Period|Treatment Period: Wk0-16||44
9060975|NCT03739840|10120509|FG002|Completed Maintenance Period|Treatment Period: Wk0-16||44
9060976|NCT03739840|10120510|FG003|Completed Maintenance Period|Treatment Period: Wk0-16||36
9060977|NCT03739840|10120507|FG000|COMPLETED|Treatment Period: Wk0-16||46
9060978|NCT03739840|10120508|FG001|COMPLETED|Treatment Period: Wk0-16||44
9060979|NCT03739840|10120509|FG002|COMPLETED|Treatment Period: Wk0-16||44
9060980|NCT03739840|10120510|FG003|COMPLETED|Treatment Period: Wk0-16||36
9060981|NCT03739840|10120507|FG000|NOT COMPLETED|Treatment Period: Wk0-16||10
9060982|NCT03739840|10120508|FG001|NOT COMPLETED|Treatment Period: Wk0-16||16
9060983|NCT03739840|10120509|FG002|NOT COMPLETED|Treatment Period: Wk0-16||13
9060984|NCT03739840|10120510|FG003|NOT COMPLETED|Treatment Period: Wk0-16||23
9060985|NCT03739840|10120507|FG000|STARTED|Post-Treatment Period: Wk16-23||46
9060986|NCT03739840|10120508|FG001|STARTED|Post-Treatment Period: Wk16-23||44
9060987|NCT03739840|10120509|FG002|STARTED|Post-Treatment Period: Wk16-23||44
9060988|NCT03739840|10120510|FG003|STARTED|Post-Treatment Period: Wk16-23||36
9060989|NCT03739840|10120507|FG000|Started Conversion Period|Post-Treatment Period: Wk16-23||33
9060990|NCT03739840|10120508|FG001|Started Conversion Period|Post-Treatment Period: Wk16-23||31
9060991|NCT03739840|10120509|FG002|Started Conversion Period|Post-Treatment Period: Wk16-23||29
9060992|NCT03739840|10120510|FG003|Started Conversion Period|Post-Treatment Period: Wk16-23||28
9060993|NCT03739840|10120507|FG000|Completed Conversion Period|Post-Treatment Period: Wk16-23||33
9060994|NCT03739840|10120508|FG001|Completed Conversion Period|Post-Treatment Period: Wk16-23||31
9060995|NCT03739840|10120509|FG002|Completed Conversion Period|Post-Treatment Period: Wk16-23||29
9060996|NCT03739840|10120510|FG003|Completed Conversion Period|Post-Treatment Period: Wk16-23||28
9060997|NCT03739840|10120507|FG000|Started Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||19
9060998|NCT03739840|10120508|FG001|Started Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||18
9060999|NCT03739840|10120509|FG002|Started Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||21
9061000|NCT03739840|10120510|FG003|Started Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||13
9061001|NCT03739840|10120507|FG000|Completed Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||15
9061002|NCT03739840|10120508|FG001|Completed Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||16
9061003|NCT03739840|10120509|FG002|Completed Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||18
9061004|NCT03739840|10120510|FG003|Completed Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||12
9061005|NCT03739840|10120507|FG000|Enrolled in EP0093|Post-Treatment Period: Wk16-23||27
9061006|NCT03739840|10120508|FG001|Enrolled in EP0093|Post-Treatment Period: Wk16-23||26
9061007|NCT03739840|10120509|FG002|Enrolled in EP0093|Post-Treatment Period: Wk16-23||23
9061008|NCT03739840|10120510|FG003|Enrolled in EP0093|Post-Treatment Period: Wk16-23||23
9061009|NCT03739840|10120507|FG000|COMPLETED|Post-Treatment Period: Wk16-23||42
9061010|NCT03739840|10120508|FG001|COMPLETED|Post-Treatment Period: Wk16-23||42
9061011|NCT03739840|10120509|FG002|COMPLETED|Post-Treatment Period: Wk16-23||41
9061012|NCT03739840|10120510|FG003|COMPLETED|Post-Treatment Period: Wk16-23||35
9061013|NCT03739840|10120507|FG000|NOT COMPLETED|Post-Treatment Period: Wk16-23||4
9061014|NCT03739840|10120508|FG001|NOT COMPLETED|Post-Treatment Period: Wk16-23||2
9061015|NCT03739840|10120509|FG002|NOT COMPLETED|Post-Treatment Period: Wk16-23||3
9061016|NCT03739840|10120510|FG003|NOT COMPLETED|Post-Treatment Period: Wk16-23||1
9061017|NCT03739983|10120532|FG000|STARTED|Overall Study||2
9061018|NCT03739983|10120532|FG000|COMPLETED|Overall Study||2
9061019|NCT03739983|10120532|FG000|NOT COMPLETED|Overall Study||0
9061020|NCT03746002|10120538|FG000|STARTED|Overall Study||1
9061021|NCT03746002|10120539|FG001|STARTED|Overall Study||2
9061022|NCT03746002|10120538|FG000|COMPLETED|Overall Study||1
9061023|NCT03746002|10120539|FG001|COMPLETED|Overall Study||2
9061024|NCT03746002|10120538|FG000|NOT COMPLETED|Overall Study||0
9061025|NCT03746002|10120539|FG001|NOT COMPLETED|Overall Study||0
9061026|NCT03748771|10120545|FG000|STARTED|Overall Study||20
9061027|NCT03748771|10120545|FG000|COMPLETED|Overall Study||20
9061028|NCT03748771|10120545|FG000|NOT COMPLETED|Overall Study||0
9061029|NCT03752177|10120553|FG000|STARTED|Overall Study||3
9061030|NCT03752177|10120554|FG001|STARTED|Overall Study||3
9061031|NCT03752177|10120555|FG002|STARTED|Overall Study||3
9061032|NCT03752177|10120556|FG003|STARTED|Overall Study||3
9061033|NCT03752177|10120553|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
9061034|NCT03752177|10120554|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
9061035|NCT03752177|10120555|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
9061036|NCT03752177|10120556|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
9061037|NCT03752177|10120553|FG000|COMPLETED|Overall Study||3
9061038|NCT03752177|10120554|FG001|COMPLETED|Overall Study||3
9061039|NCT03752177|10120555|FG002|COMPLETED|Overall Study||3
9061040|NCT03752177|10120556|FG003|COMPLETED|Overall Study||3
9061041|NCT03752177|10120553|FG000|NOT COMPLETED|Overall Study||0
9061042|NCT03752177|10120554|FG001|NOT COMPLETED|Overall Study||0
9061043|NCT03752177|10120555|FG002|NOT COMPLETED|Overall Study||0
9061044|NCT03752177|10120556|FG003|NOT COMPLETED|Overall Study||0
9061045|NCT03753763|10120569|FG000|STARTED|Overall Study||32
9061046|NCT03753763|10120570|FG001|STARTED|Overall Study||17
9061047|NCT03753763|10120569|FG000|COMPLETED|Overall Study||26
9061048|NCT03753763|10120570|FG001|COMPLETED|Overall Study||16
9061049|NCT03753763|10120569|FG000|NOT COMPLETED|Overall Study||6
9061050|NCT03753763|10120570|FG001|NOT COMPLETED|Overall Study||1
9061051|NCT03756571|10120578|FG000|STARTED|Overall Study||10
9061052|NCT03756571|10120579|FG001|STARTED|Overall Study||11
9061053|NCT03756571|10120578|FG000|COMPLETED|Overall Study||9
9061054|NCT03756571|10120579|FG001|COMPLETED|Overall Study||10
9061055|NCT03756571|10120578|FG000|NOT COMPLETED|Overall Study||1
9061056|NCT03756571|10120579|FG001|NOT COMPLETED|Overall Study||1
9061057|NCT03761537|10120587|FG000|STARTED|Overall Study||140
9061058|NCT03761537|10120588|FG001|STARTED|Overall Study||137
9061059|NCT03761537|10120587|FG000|COMPLETED|Overall Study||125
9061060|NCT03761537|10120588|FG001|COMPLETED|Overall Study||120
9061061|NCT03761537|10120587|FG000|NOT COMPLETED|Overall Study||15
9061062|NCT03761537|10120588|FG001|NOT COMPLETED|Overall Study||17
9061063|NCT03763877|10120606|FG000|STARTED|Overall Study||31
9061064|NCT03763877|10120607|FG001|STARTED|Overall Study||30
9061065|NCT03763877|10120608|FG002|STARTED|Overall Study||31
9061066|NCT03763877|10120609|FG003|STARTED|Overall Study||29
9061067|NCT03763877|10120606|FG000|Received at Least 1 Dose of Double-blind Study Treatment|Overall Study||31
9061068|NCT03763877|10120607|FG001|Received at Least 1 Dose of Double-blind Study Treatment|Overall Study||30
9061069|NCT03763877|10120608|FG002|Received at Least 1 Dose of Double-blind Study Treatment|Overall Study||30
9061070|NCT03763877|10120609|FG003|Received at Least 1 Dose of Double-blind Study Treatment|Overall Study||29
9061071|NCT03763877|10120606|FG000|Completed the Double-blind Period|Overall Study||27
9061072|NCT03763877|10120607|FG001|Completed the Double-blind Period|Overall Study||26
9061073|NCT03763877|10120608|FG002|Completed the Double-blind Period|Overall Study||25
9061074|NCT03763877|10120609|FG003|Completed the Double-blind Period|Overall Study||24
9061075|NCT03763877|10120606|FG000|COMPLETED|Overall Study||26
9061076|NCT03763877|10120607|FG001|COMPLETED|Overall Study||26
9061077|NCT03763877|10120608|FG002|COMPLETED|Overall Study||24
9061078|NCT03763877|10120609|FG003|COMPLETED|Overall Study||24
9061079|NCT03763877|10120606|FG000|NOT COMPLETED|Overall Study||5
9061080|NCT03763877|10120607|FG001|NOT COMPLETED|Overall Study||4
9061081|NCT03763877|10120608|FG002|NOT COMPLETED|Overall Study||7
9061082|NCT03763877|10120609|FG003|NOT COMPLETED|Overall Study||5
9061083|NCT03764007|10120623|FG000|STARTED|Overall Study||98
9061084|NCT03764007|10120623|FG000|Imaging Completed|Overall Study||98
9061085|NCT03764007|10120623|FG000|Underwent Parathyroidectomy Surgery|Overall Study||77
9061086|NCT03764007|10120623|FG000|COMPLETED|Overall Study||77
9061087|NCT03764007|10120623|FG000|NOT COMPLETED|Overall Study||21
9061088|NCT03772587|10120632|FG000|STARTED|Overall Study||14
9061089|NCT03772587|10120633|FG001|STARTED|Overall Study||14
9061090|NCT03772587|10120634|FG002|STARTED|Overall Study||13
9061091|NCT03772587|10120635|FG003|STARTED|Overall Study||13
9061092|NCT03772587|10120636|FG004|STARTED|Overall Study||14
9061093|NCT03772587|10120632|FG000|COMPLETED|Overall Study||13
9061094|NCT03772587|10120633|FG001|COMPLETED|Overall Study||14
9061095|NCT03772587|10120634|FG002|COMPLETED|Overall Study||12
9061096|NCT03772587|10120635|FG003|COMPLETED|Overall Study||12
9061097|NCT03772587|10120636|FG004|COMPLETED|Overall Study||14
9061098|NCT03772587|10120632|FG000|NOT COMPLETED|Overall Study||1
9061099|NCT03772587|10120633|FG001|NOT COMPLETED|Overall Study||0
9061100|NCT03772587|10120634|FG002|NOT COMPLETED|Overall Study||1
9061101|NCT03772587|10120635|FG003|NOT COMPLETED|Overall Study||1
9061102|NCT03772587|10120636|FG004|NOT COMPLETED|Overall Study||0
9061103|NCT03789292|10120660|FG000|STARTED|Treatment Period I (Week 0 to Week 26)||324
9061104|NCT03789292|10120661|FG001|STARTED|Treatment Period I (Week 0 to Week 26)||324
9061105|NCT03789292|10120662|FG002|STARTED|Treatment Period I (Week 0 to Week 26)||0
9061106|NCT03789292|10120660|FG000|COMPLETED|Treatment Period I (Week 0 to Week 26)||303
9061107|NCT03789292|10120661|FG001|COMPLETED|Treatment Period I (Week 0 to Week 26)||305
9061108|NCT03789292|10120662|FG002|COMPLETED|Treatment Period I (Week 0 to Week 26)||0
9061109|NCT03789292|10120660|FG000|NOT COMPLETED|Treatment Period I (Week 0 to Week 26)||21
9061110|NCT03789292|10120661|FG001|NOT COMPLETED|Treatment Period I (Week 0 to Week 26)||19
9061111|NCT03789292|10120662|FG002|NOT COMPLETED|Treatment Period I (Week 0 to Week 26)||0
9061112|NCT03789292|10120660|FG000|STARTED|Treatment Period II (Week 26 to Week 52)||303
9061113|NCT03789292|10120661|FG001|STARTED|Treatment Period II (Week 26 to Week 52)|Patients who had administrated Humira SC during Treatment Period 1 has been devided into 2 groups - maintaining Humira SC and switched to CT-P17.|153
9061114|NCT03789292|10120662|FG002|STARTED|Treatment Period II (Week 26 to Week 52)|Patients who had administrated Humira SC during Treatment Period 1 has been devided into 2 groups - maintaining Humira SC and switched to CT-P17.|152
9061115|NCT03789292|10120660|FG000|COMPLETED|Treatment Period II (Week 26 to Week 52)||287
9061116|NCT03789292|10120661|FG001|COMPLETED|Treatment Period II (Week 26 to Week 52)||147
9061117|NCT03789292|10120662|FG002|COMPLETED|Treatment Period II (Week 26 to Week 52)||143
9061118|NCT03789292|10120660|FG000|NOT COMPLETED|Treatment Period II (Week 26 to Week 52)||16
9061119|NCT03789292|10120661|FG001|NOT COMPLETED|Treatment Period II (Week 26 to Week 52)||6
9061120|NCT03789292|10120662|FG002|NOT COMPLETED|Treatment Period II (Week 26 to Week 52)||9
9061121|NCT03799289|10120678|FG000|STARTED|Initial Weight Loss Program (Weeks 1-12)||30
9061122|NCT03799289|10120679|FG001|STARTED|Initial Weight Loss Program (Weeks 1-12)||30
9061123|NCT03799289|10120678|FG000|COMPLETED|Initial Weight Loss Program (Weeks 1-12)||24
9061124|NCT03799289|10120679|FG001|COMPLETED|Initial Weight Loss Program (Weeks 1-12)||27
9061125|NCT03799289|10120678|FG000|NOT COMPLETED|Initial Weight Loss Program (Weeks 1-12)||6
9061126|NCT03799289|10120679|FG001|NOT COMPLETED|Initial Weight Loss Program (Weeks 1-12)||3
9061127|NCT03799289|10120678|FG000|STARTED|Maintenance Intervention (Weeks 13-24)||24
9061128|NCT03799289|10120679|FG001|STARTED|Maintenance Intervention (Weeks 13-24)||27
9061129|NCT03799289|10120678|FG000|COMPLETED|Maintenance Intervention (Weeks 13-24)||24
9061130|NCT03799289|10120679|FG001|COMPLETED|Maintenance Intervention (Weeks 13-24)||27
9061131|NCT03799289|10120678|FG000|NOT COMPLETED|Maintenance Intervention (Weeks 13-24)||0
9061132|NCT03799289|10120679|FG001|NOT COMPLETED|Maintenance Intervention (Weeks 13-24)||0
9061133|NCT03801408|10120685|FG000|STARTED|Overall Study||145
9061134|NCT03801408|10120685|FG000|COMPLETED|Overall Study||145
9061135|NCT03801408|10120685|FG000|NOT COMPLETED|Overall Study||0
9061136|NCT03805438|10120689|FG000|STARTED|Overall Study||47
9061137|NCT03805438|10120689|FG000|COMPLETED|Overall Study||45
9061138|NCT03805438|10120689|FG000|NOT COMPLETED|Overall Study||2
9061139|NCT03808948|10120693|FG000|STARTED|Overall Study||50
9061140|NCT03808948|10120693|FG000|COMPLETED|Overall Study||50
9061141|NCT03808948|10120693|FG000|NOT COMPLETED|Overall Study||0
9061142|NCT03810053|10120697|FG000|STARTED|Overall Study||290
9061143|NCT03810053|10120697|FG000|COMPLETED|Overall Study||290
9061144|NCT03810053|10120697|FG000|NOT COMPLETED|Overall Study||0
9061145|NCT03817528|10120701|FG000|STARTED|Overall Study||4
9061146|NCT03817528|10120701|FG000|COMPLETED|Overall Study||1
9061147|NCT03817528|10120701|FG000|NOT COMPLETED|Overall Study||3
9061148|NCT03817580|10120708|FG000|STARTED|Overall Study||57
9061149|NCT03817580|10120709|FG001|STARTED|Overall Study||56
9061150|NCT03817580|10120710|FG002|STARTED|Overall Study||57
9061151|NCT03817580|10120708|FG000|COMPLETED|Overall Study||57
9061152|NCT03817580|10120709|FG001|COMPLETED|Overall Study||56
9061153|NCT03817580|10120710|FG002|COMPLETED|Overall Study||57
9061154|NCT03817580|10120708|FG000|NOT COMPLETED|Overall Study||0
9061155|NCT03817580|10120709|FG001|NOT COMPLETED|Overall Study||0
9061156|NCT03817580|10120710|FG002|NOT COMPLETED|Overall Study||0
9061157|NCT03828422|10120720|FG000|STARTED|Overall Study||40
9061158|NCT03828422|10120721|FG001|STARTED|Overall Study||42
9061159|NCT03828422|10120720|FG000|COMPLETED|Overall Study||36
9061160|NCT03828422|10120721|FG001|COMPLETED|Overall Study||38
9061161|NCT03828422|10120720|FG000|NOT COMPLETED|Overall Study||4
9061162|NCT03828422|10120721|FG001|NOT COMPLETED|Overall Study||4
9061163|NCT03829228|10120728|FG000|STARTED|Overall Study||30
9061164|NCT03829228|10120728|FG000|COMPLETED|Overall Study||29
9061165|NCT03829228|10120728|FG000|NOT COMPLETED|Overall Study||1
9061166|NCT03829618|10120735|FG000|STARTED|Overall Study||15
9061167|NCT03829618|10120736|FG001|STARTED|Overall Study||7
9061168|NCT03829618|10120737|FG002|STARTED|Overall Study||7
9061169|NCT03829618|10120735|FG000|COMPLETED|Overall Study||15
9061170|NCT03829618|10120736|FG001|COMPLETED|Overall Study||7
9061171|NCT03829618|10120737|FG002|COMPLETED|Overall Study||7
9061172|NCT03829618|10120735|FG000|NOT COMPLETED|Overall Study||0
9061173|NCT03829618|10120736|FG001|NOT COMPLETED|Overall Study||0
9061174|NCT03829618|10120737|FG002|NOT COMPLETED|Overall Study||0
9061175|NCT03830333|10120747|FG000|STARTED|Overall Study||134
9061176|NCT03830333|10120748|FG001|STARTED|Overall Study||134
9061177|NCT03830333|10120747|FG000|Clinically Evaluable Population|Overall Study||105
9061178|NCT03830333|10120748|FG001|Clinically Evaluable Population|Overall Study||116
9061179|NCT03830333|10120747|FG000|COMPLETED|Overall Study||126
9061180|NCT03830333|10120748|FG001|COMPLETED|Overall Study||130
9061181|NCT03830333|10120747|FG000|NOT COMPLETED|Overall Study||8
9061182|NCT03830333|10120748|FG001|NOT COMPLETED|Overall Study||4
9061183|NCT03831880|10120756|FG000|STARTED|Period 1 (12 Weeks)||43
9061184|NCT03831880|10120757|FG001|STARTED|Period 1 (12 Weeks)||44
9061185|NCT03831880|10120756|FG000|COMPLETED|Period 1 (12 Weeks)||43
9061186|NCT03831880|10120757|FG001|COMPLETED|Period 1 (12 Weeks)||43
9061187|NCT03831880|10120756|FG000|NOT COMPLETED|Period 1 (12 Weeks)||0
9061188|NCT03831880|10120757|FG001|NOT COMPLETED|Period 1 (12 Weeks)||1
9061189|NCT03831880|10120756|FG000|STARTED|Period 2 (12 Weeks)||43
9061190|NCT03831880|10120757|FG001|STARTED|Period 2 (12 Weeks)||43
9061191|NCT03831880|10120756|FG000|COMPLETED|Period 2 (12 Weeks)||43
9061192|NCT03831880|10120757|FG001|COMPLETED|Period 2 (12 Weeks)||42
9061193|NCT03831880|10120756|FG000|NOT COMPLETED|Period 2 (12 Weeks)||0
9061194|NCT03831880|10120757|FG001|NOT COMPLETED|Period 2 (12 Weeks)||1
9061195|NCT03831880|10120756|FG000|STARTED|Follow-up (5 Weeks)||43
9061196|NCT03831880|10120757|FG001|STARTED|Follow-up (5 Weeks)|1 participant who discontinued from Period 1 completed follow-up visit.|43
9061197|NCT03831880|10120756|FG000|COMPLETED|Follow-up (5 Weeks)||43
9061198|NCT03831880|10120757|FG001|COMPLETED|Follow-up (5 Weeks)||43
9061199|NCT03831880|10120756|FG000|NOT COMPLETED|Follow-up (5 Weeks)||0
9061200|NCT03831880|10120757|FG001|NOT COMPLETED|Follow-up (5 Weeks)||0
9061201|NCT03831945|10120767|FG000|STARTED|Overall Study||10
9061202|NCT03831945|10120768|FG001|STARTED|Overall Study||10
9061203|NCT03831945|10120767|FG000|COMPLETED|Overall Study||3
9061204|NCT03831945|10120768|FG001|COMPLETED|Overall Study||4
9061205|NCT03831945|10120767|FG000|NOT COMPLETED|Overall Study||7
9061206|NCT03831945|10120768|FG001|NOT COMPLETED|Overall Study||6
9061207|NCT03835728|10120776|FG000|STARTED|Overall Study||2
9061208|NCT03835728|10120777|FG001|STARTED|Overall Study||1
9061209|NCT03835728|10120776|FG000|COMPLETED|Overall Study||2
9061210|NCT03835728|10120777|FG001|COMPLETED|Overall Study||1
9061211|NCT03835728|10120776|FG000|NOT COMPLETED|Overall Study||0
9061212|NCT03835728|10120777|FG001|NOT COMPLETED|Overall Study||0
9061213|NCT03840174|10120787|FG000|STARTED|Overall Study||6
9061214|NCT03840174|10120788|FG001|STARTED|Overall Study||6
9061215|NCT03840174|10120789|FG002|STARTED|Overall Study||3
9061216|NCT03840174|10120790|FG003|STARTED|Overall Study||3
9061217|NCT03840174|10120787|FG000|Vaccination 1|Overall Study||6
9061218|NCT03840174|10120788|FG001|Vaccination 1|Overall Study||6
9061219|NCT03840174|10120789|FG002|Vaccination 1|Overall Study||3
9061220|NCT03840174|10120790|FG003|Vaccination 1|Overall Study||3
9061221|NCT03840174|10120787|FG000|Vaccination 2|Overall Study||5
9061222|NCT03840174|10120788|FG001|Vaccination 2|Overall Study||6
9061223|NCT03840174|10120789|FG002|Vaccination 2|Overall Study||3
9061224|NCT03840174|10120790|FG003|Vaccination 2|Overall Study||3
9061225|NCT03840174|10120787|FG000|Vaccination 3|Overall Study||5
9061226|NCT03840174|10120788|FG001|Vaccination 3|Overall Study||6
9061227|NCT03840174|10120789|FG002|Vaccination 3|Overall Study||3
9061228|NCT03840174|10120790|FG003|Vaccination 3|Overall Study||3
9061229|NCT03840174|10120787|FG000|COMPLETED|Overall Study||5
9061230|NCT03840174|10120788|FG001|COMPLETED|Overall Study||6
9061231|NCT03840174|10120789|FG002|COMPLETED|Overall Study||3
9061232|NCT03840174|10120790|FG003|COMPLETED|Overall Study||3
9061233|NCT03840174|10120787|FG000|NOT COMPLETED|Overall Study||1
9061234|NCT03840174|10120788|FG001|NOT COMPLETED|Overall Study||0
9061235|NCT03840174|10120789|FG002|NOT COMPLETED|Overall Study||0
9061236|NCT03840174|10120790|FG003|NOT COMPLETED|Overall Study||0
9061237|NCT03848910|10120801|FG000|STARTED|Overall Study||11
9061238|NCT03848910|10120801|FG000|COMPLETED|Overall Study||11
9061239|NCT03848910|10120801|FG000|NOT COMPLETED|Overall Study||0
9061240|NCT03852524|10120808|FG000|STARTED|Overall Study||41
9061241|NCT03852524|10120809|FG001|STARTED|Overall Study||41
9061242|NCT03852524|10120808|FG000|COMPLETED|Overall Study||41
9061243|NCT03852524|10120809|FG001|COMPLETED|Overall Study||41
9061244|NCT03852524|10120808|FG000|NOT COMPLETED|Overall Study||0
9061245|NCT03852524|10120809|FG001|NOT COMPLETED|Overall Study||0
9061246|NCT03857841|10120819|FG000|STARTED|Overall Study||2
9061247|NCT03857841|10120820|FG001|STARTED|Overall Study||0
9061248|NCT03857841|10120821|FG002|STARTED|Overall Study||0
9061249|NCT03857841|10120822|FG003|STARTED|Overall Study||1
9061250|NCT03857841|10120819|FG000|COMPLETED|Overall Study||0
9061251|NCT03857841|10120820|FG001|COMPLETED|Overall Study||0
9061252|NCT03857841|10120821|FG002|COMPLETED|Overall Study||0
9061253|NCT03857841|10120822|FG003|COMPLETED|Overall Study||1
9061254|NCT03857841|10120819|FG000|NOT COMPLETED|Overall Study||2
9061255|NCT03857841|10120820|FG001|NOT COMPLETED|Overall Study||0
9061256|NCT03857841|10120821|FG002|NOT COMPLETED|Overall Study||0
9061257|NCT03857841|10120822|FG003|NOT COMPLETED|Overall Study||0
9061258|NCT03861780|10120835|FG000|STARTED|Overall Study||51
9061259|NCT03861780|10120836|FG001|STARTED|Overall Study||50
9061260|NCT03861780|10120837|FG002|STARTED|Overall Study||51
9061261|NCT03861780|10120835|FG000|COMPLETED|Overall Study||51
9061262|NCT03861780|10120836|FG001|COMPLETED|Overall Study||50
9061263|NCT03861780|10120837|FG002|COMPLETED|Overall Study||51
9061264|NCT03861780|10120835|FG000|NOT COMPLETED|Overall Study||0
9061265|NCT03861780|10120836|FG001|NOT COMPLETED|Overall Study||0
9061266|NCT03861780|10120837|FG002|NOT COMPLETED|Overall Study||0
9061267|NCT03862625|10120847|FG000|STARTED|Overall Study||15
9061268|NCT03862625|10120848|FG001|STARTED|Overall Study||15
9061269|NCT03862625|10120847|FG000|COMPLETED|Overall Study||15
9061270|NCT03862625|10120848|FG001|COMPLETED|Overall Study||14
9061271|NCT03862625|10120847|FG000|NOT COMPLETED|Overall Study||0
9061272|NCT03862625|10120848|FG001|NOT COMPLETED|Overall Study||1
9061273|NCT03862755|10120854|FG000|STARTED|Overall Study||581
9061274|NCT03862755|10120854|FG000|COMPLETED|Overall Study||581
9061275|NCT03862755|10120854|FG000|NOT COMPLETED|Overall Study||0
9061276|NCT03869541|10120861|FG000|STARTED|Overall Study||40
9061277|NCT03869541|10120862|FG001|STARTED|Overall Study||50
9061278|NCT03869541|10120863|FG002|STARTED|Overall Study||10
9061279|NCT03869541|10120861|FG000|COMPLETED|Overall Study||40
9061280|NCT03869541|10120862|FG001|COMPLETED|Overall Study||50
9061281|NCT03869541|10120863|FG002|COMPLETED|Overall Study||10
9061282|NCT03869541|10120861|FG000|NOT COMPLETED|Overall Study||0
9061283|NCT03869541|10120862|FG001|NOT COMPLETED|Overall Study||0
9061284|NCT03869541|10120863|FG002|NOT COMPLETED|Overall Study||0
9061285|NCT03877224|10120876|FG000|STARTED|Overall Study||253
9061286|NCT03877224|10120877|FG001|STARTED|Overall Study||251
9061287|NCT03877224|10120876|FG000|Treated|Overall Study||252
9061288|NCT03877224|10120877|FG001|Treated|Overall Study||249
9061289|NCT03877224|10120876|FG000|COMPLETED|Overall Study||248
9061290|NCT03877224|10120877|FG001|COMPLETED|Overall Study||243
9061291|NCT03877224|10120876|FG000|NOT COMPLETED|Overall Study||5
9061292|NCT03877224|10120877|FG001|NOT COMPLETED|Overall Study||8
9061293|NCT03883607|10120885|FG000|STARTED|Overall Study||5
9061294|NCT03883607|10120886|FG001|STARTED|Overall Study||5
9061295|NCT03883607|10120885|FG000|COMPLETED|Overall Study||5
9061296|NCT03883607|10120886|FG001|COMPLETED|Overall Study||5
9061297|NCT03883607|10120885|FG000|NOT COMPLETED|Overall Study||0
9061298|NCT03883607|10120886|FG001|NOT COMPLETED|Overall Study||0
9061299|NCT03885596|10120896|FG000|STARTED|Overall Study||9
9061300|NCT03885596|10120897|FG001|STARTED|Overall Study||9
9061301|NCT03885596|10120898|FG002|STARTED|Overall Study||9
9061302|NCT03885596|10120899|FG003|STARTED|Overall Study||9
9061303|NCT03885596|10120896|FG000|COMPLETED|Overall Study||7
9061304|NCT03885596|10120897|FG001|COMPLETED|Overall Study||8
9061305|NCT03885596|10120898|FG002|COMPLETED|Overall Study||9
9061306|NCT03885596|10120899|FG003|COMPLETED|Overall Study||9
9061307|NCT03885596|10120896|FG000|NOT COMPLETED|Overall Study||2
9061308|NCT03885596|10120897|FG001|NOT COMPLETED|Overall Study||1
9061309|NCT03885596|10120898|FG002|NOT COMPLETED|Overall Study||0
9061310|NCT03885596|10120899|FG003|NOT COMPLETED|Overall Study||0
9061311|NCT03885661|10120914|FG000|STARTED|Overall Study||12
9061312|NCT03885661|10120915|FG001|STARTED|Overall Study||8
9061313|NCT03885661|10120914|FG000|Baseline|Overall Study||12
9061314|NCT03885661|10120915|FG001|Baseline|Overall Study||8
9061315|NCT03885661|10120914|FG000|Treatment Visit (12 Week)|Overall Study||11
9061316|NCT03885661|10120915|FG001|Treatment Visit (12 Week)|Overall Study||7
9061317|NCT03885661|10120914|FG000|COMPLETED|Overall Study||11
9061318|NCT03885661|10120915|FG001|COMPLETED|Overall Study||7
9061319|NCT03885661|10120914|FG000|NOT COMPLETED|Overall Study||1
9061320|NCT03885661|10120915|FG001|NOT COMPLETED|Overall Study||1
9061321|NCT03886493|10120921|FG000|STARTED|Overall Study||7
9061322|NCT03886493|10120921|FG000|COMPLETED|Overall Study||6
9061323|NCT03886493|10120921|FG000|NOT COMPLETED|Overall Study||1
9061324|NCT03888235|10120928|FG000|STARTED|Overall Study|1 Participant dropped out after the first visit and was replaced.|21
9061325|NCT03888235|10120929|FG001|STARTED|Overall Study|1 participants dropped out after the first visit and was replaced|21
9061326|NCT03888235|10120930|FG002|STARTED|Overall Study||20
9061327|NCT03888235|10120928|FG000|COMPLETED|Overall Study||20
9061328|NCT03888235|10120929|FG001|COMPLETED|Overall Study||20
9061329|NCT03888235|10120930|FG002|COMPLETED|Overall Study||20
9061330|NCT03888235|10120928|FG000|NOT COMPLETED|Overall Study||1
9061331|NCT03888235|10120929|FG001|NOT COMPLETED|Overall Study||1
9061332|NCT03888235|10120930|FG002|NOT COMPLETED|Overall Study||0
9061333|NCT03889158|10120963|FG000|STARTED|Overall Study||20
9061334|NCT03889158|10120964|FG001|STARTED|Overall Study||15
9061335|NCT03889158|10120963|FG000|COMPLETED|Overall Study||16
9061336|NCT03889158|10120964|FG001|COMPLETED|Overall Study||9
9061337|NCT03889158|10120963|FG000|NOT COMPLETED|Overall Study||4
9061338|NCT03889158|10120964|FG001|NOT COMPLETED|Overall Study||6
9061339|NCT03890419|10120974|FG000|STARTED|Overall Study||34
9061340|NCT03890419|10120975|FG001|STARTED|Overall Study||30
9061341|NCT03890419|10120976|FG002|STARTED|Overall Study||30
9061342|NCT03890419|10120974|FG000|COMPLETED|Overall Study||27
9061343|NCT03890419|10120975|FG001|COMPLETED|Overall Study||27
9061344|NCT03890419|10120976|FG002|COMPLETED|Overall Study||25
9061345|NCT03890419|10120974|FG000|NOT COMPLETED|Overall Study||7
9061346|NCT03890419|10120975|FG001|NOT COMPLETED|Overall Study||3
9061347|NCT03890419|10120976|FG002|NOT COMPLETED|Overall Study||5
9061348|NCT03897348|10120988|FG000|STARTED|ADP Session 1||1
9061349|NCT03897348|10120989|FG001|STARTED|ADP Session 1||1
9061350|NCT03897348|10120990|FG002|STARTED|ADP Session 1||1
9061351|NCT03897348|10120991|FG003|STARTED|ADP Session 1||1
9061352|NCT03897348|10120988|FG000|COMPLETED|ADP Session 1||1
9061353|NCT03897348|10120989|FG001|COMPLETED|ADP Session 1||1
9061354|NCT03897348|10120990|FG002|COMPLETED|ADP Session 1||1
9061355|NCT03897348|10120991|FG003|COMPLETED|ADP Session 1||1
9061356|NCT03897348|10120988|FG000|NOT COMPLETED|ADP Session 1||0
9061357|NCT03897348|10120989|FG001|NOT COMPLETED|ADP Session 1||0
9061358|NCT03897348|10120990|FG002|NOT COMPLETED|ADP Session 1||0
9061359|NCT03897348|10120991|FG003|NOT COMPLETED|ADP Session 1||0
9061360|NCT03897348|10120988|FG000|STARTED|ADP Session 2||1
9061361|NCT03897348|10120989|FG001|STARTED|ADP Session 2||1
9061362|NCT03897348|10120990|FG002|STARTED|ADP Session 2||1
9061363|NCT03897348|10120991|FG003|STARTED|ADP Session 2||1
9061364|NCT03897348|10120988|FG000|COMPLETED|ADP Session 2||1
9061365|NCT03897348|10120989|FG001|COMPLETED|ADP Session 2||1
9061366|NCT03897348|10120990|FG002|COMPLETED|ADP Session 2||1
9061367|NCT03897348|10120991|FG003|COMPLETED|ADP Session 2||1
9061368|NCT03897348|10120988|FG000|NOT COMPLETED|ADP Session 2||0
9061369|NCT03897348|10120989|FG001|NOT COMPLETED|ADP Session 2||0
9061370|NCT03897348|10120990|FG002|NOT COMPLETED|ADP Session 2||0
9061371|NCT03897348|10120991|FG003|NOT COMPLETED|ADP Session 2||0
9061372|NCT03897348|10120988|FG000|STARTED|ADP Session 3||1
9061373|NCT03897348|10120989|FG001|STARTED|ADP Session 3||1
9061374|NCT03897348|10120990|FG002|STARTED|ADP Session 3||0
9061375|NCT03897348|10120991|FG003|STARTED|ADP Session 3||1
9061376|NCT03897348|10120988|FG000|COMPLETED|ADP Session 3||1
9061377|NCT03897348|10120989|FG001|COMPLETED|ADP Session 3||1
9061378|NCT03897348|10120990|FG002|COMPLETED|ADP Session 3||0
9061379|NCT03897348|10120991|FG003|COMPLETED|ADP Session 3||1
9061380|NCT03897348|10120988|FG000|NOT COMPLETED|ADP Session 3||0
9061381|NCT03897348|10120989|FG001|NOT COMPLETED|ADP Session 3||0
9061382|NCT03897348|10120990|FG002|NOT COMPLETED|ADP Session 3||0
9061383|NCT03897348|10120991|FG003|NOT COMPLETED|ADP Session 3||0
9061384|NCT03900416|10121002|FG000|STARTED|Baseline||72
9061385|NCT03900416|10121003|FG001|STARTED|Baseline||80
9061386|NCT03900416|10121002|FG000|COMPLETED|Baseline||72
9061387|NCT03900416|10121003|FG001|COMPLETED|Baseline||80
9061388|NCT03900416|10121002|FG000|NOT COMPLETED|Baseline||0
9061389|NCT03900416|10121003|FG001|NOT COMPLETED|Baseline||0
9061390|NCT03900416|10121002|FG000|STARTED|Post||72
9061391|NCT03900416|10121003|FG001|STARTED|Post||80
9061392|NCT03900416|10121002|FG000|COMPLETED|Post||72
9061393|NCT03900416|10121003|FG001|COMPLETED|Post||80
9061394|NCT03900416|10121002|FG000|NOT COMPLETED|Post||0
9061395|NCT03900416|10121003|FG001|NOT COMPLETED|Post||0
9061396|NCT03900416|10121002|FG000|STARTED|Six Week Follow-up||72
9061397|NCT03900416|10121003|FG001|STARTED|Six Week Follow-up||80
9061398|NCT03900416|10121002|FG000|COMPLETED|Six Week Follow-up||70
9061399|NCT03900416|10121003|FG001|COMPLETED|Six Week Follow-up||80
9061400|NCT03900416|10121002|FG000|NOT COMPLETED|Six Week Follow-up||2
9061401|NCT03900416|10121003|FG001|NOT COMPLETED|Six Week Follow-up||0
9061402|NCT03900416|10121002|FG000|STARTED|Twelve Week Follow-up||70
9061403|NCT03900416|10121003|FG001|STARTED|Twelve Week Follow-up||80
9061404|NCT03900416|10121002|FG000|COMPLETED|Twelve Week Follow-up||69
9061405|NCT03900416|10121003|FG001|COMPLETED|Twelve Week Follow-up||76
9061406|NCT03900416|10121002|FG000|NOT COMPLETED|Twelve Week Follow-up||1
9061407|NCT03900416|10121003|FG001|NOT COMPLETED|Twelve Week Follow-up||4
9061408|NCT03900416|10121002|FG000|STARTED|Six Month Follow-up||69
9061409|NCT03900416|10121003|FG001|STARTED|Six Month Follow-up||76
9061410|NCT03900416|10121002|FG000|COMPLETED|Six Month Follow-up||64
9061411|NCT03900416|10121003|FG001|COMPLETED|Six Month Follow-up||72
9061412|NCT03900416|10121002|FG000|NOT COMPLETED|Six Month Follow-up||5
9061413|NCT03900416|10121003|FG001|NOT COMPLETED|Six Month Follow-up||4
9061414|NCT03905863|10121011|FG000|STARTED|Overall Study||64
9061415|NCT03905863|10121012|FG001|STARTED|Overall Study||81
9061416|NCT03905863|10121011|FG000|COMPLETED|Overall Study||59
9061417|NCT03905863|10121012|FG001|COMPLETED|Overall Study||69
9061418|NCT03905863|10121011|FG000|NOT COMPLETED|Overall Study||5
9061419|NCT03905863|10121012|FG001|NOT COMPLETED|Overall Study||12
9061420|NCT03907033|10121020|FG000|STARTED|Overall Study||14
9061421|NCT03907033|10121021|FG001|STARTED|Overall Study||14
9061422|NCT03907033|10121020|FG000|COMPLETED|Overall Study||14
9061423|NCT03907033|10121021|FG001|COMPLETED|Overall Study||14
9061424|NCT03907033|10121020|FG000|NOT COMPLETED|Overall Study||0
9061425|NCT03907033|10121021|FG001|NOT COMPLETED|Overall Study||0
9061426|NCT03909971|10121029|FG000|STARTED|Overall Study||67
9061427|NCT03909971|10121030|FG001|STARTED|Overall Study||42
9061428|NCT03909971|10121029|FG000|COMPLETED|Overall Study||57
9061429|NCT03909971|10121030|FG001|COMPLETED|Overall Study||20
9061430|NCT03909971|10121029|FG000|NOT COMPLETED|Overall Study||10
9061431|NCT03909971|10121030|FG001|NOT COMPLETED|Overall Study||22
9061432|NCT03920215|10121041|FG000|STARTED|Overall Study||26
9061433|NCT03920215|10121042|FG001|STARTED|Overall Study||29
9061434|NCT03920215|10121043|FG002|STARTED|Overall Study||23
9061435|NCT03920215|10121044|FG003|STARTED|Overall Study||23
9061436|NCT03920215|10121041|FG000|COMPLETED|Overall Study||25
9061437|NCT03920215|10121042|FG001|COMPLETED|Overall Study||27
9061438|NCT03920215|10121043|FG002|COMPLETED|Overall Study||23
9061439|NCT03920215|10121044|FG003|COMPLETED|Overall Study||22
9061440|NCT03920215|10121041|FG000|NOT COMPLETED|Overall Study||1
9061441|NCT03920215|10121042|FG001|NOT COMPLETED|Overall Study||2
9061442|NCT03920215|10121043|FG002|NOT COMPLETED|Overall Study||0
9061443|NCT03920215|10121044|FG003|NOT COMPLETED|Overall Study||1
9061444|NCT03921151|10121056|FG000|STARTED|Overall Study||46
9061445|NCT03921151|10121057|FG001|STARTED|Overall Study||44
9061446|NCT03921151|10121056|FG000|COMPLETED|Overall Study||35
9061447|NCT03921151|10121057|FG001|COMPLETED|Overall Study||28
9061448|NCT03921151|10121056|FG000|NOT COMPLETED|Overall Study||11
9061449|NCT03921151|10121057|FG001|NOT COMPLETED|Overall Study||16
9061450|NCT03926039|10121065|FG000|STARTED|Overall Study||35
9061451|NCT03926039|10121066|FG001|STARTED|Overall Study||35
9061452|NCT03926039|10121065|FG000|COMPLETED|Overall Study||35
9061453|NCT03926039|10121066|FG001|COMPLETED|Overall Study||34
9061454|NCT03926039|10121065|FG000|NOT COMPLETED|Overall Study||0
9061455|NCT03926039|10121066|FG001|NOT COMPLETED|Overall Study||1
9061456|NCT03927911|10121078|FG000|STARTED|Overall Study||0
9061457|NCT03927911|10121079|FG001|STARTED|Overall Study||17
9061458|NCT03927911|10121080|FG002|STARTED|Overall Study||0
9061459|NCT03927911|10121081|FG003|STARTED|Overall Study||3
9061460|NCT03927911|10121082|FG004|STARTED|Overall Study||13
9061461|NCT03927911|10121083|FG005|STARTED|Overall Study||32
9061462|NCT03927911|10121078|FG000|COMPLETED|Overall Study||0
9061463|NCT03927911|10121079|FG001|COMPLETED|Overall Study||15
9061464|NCT03927911|10121080|FG002|COMPLETED|Overall Study||0
9061465|NCT03927911|10121081|FG003|COMPLETED|Overall Study||1
9061466|NCT03927911|10121082|FG004|COMPLETED|Overall Study||13
9061467|NCT03927911|10121083|FG005|COMPLETED|Overall Study||25
9061468|NCT03927911|10121078|FG000|NOT COMPLETED|Overall Study||0
9061469|NCT03927911|10121079|FG001|NOT COMPLETED|Overall Study||2
9061470|NCT03927911|10121080|FG002|NOT COMPLETED|Overall Study||0
9061471|NCT03927911|10121081|FG003|NOT COMPLETED|Overall Study||2
9061472|NCT03927911|10121082|FG004|NOT COMPLETED|Overall Study||0
9061473|NCT03927911|10121083|FG005|NOT COMPLETED|Overall Study||7
9061474|NCT03937570|10121099|FG000|STARTED|Overall Study||13
9061475|NCT03937570|10121100|FG001|STARTED|Overall Study||14
9061476|NCT03937570|10121099|FG000|COMPLETED|Overall Study||13
9061477|NCT03937570|10121100|FG001|COMPLETED|Overall Study||14
9061478|NCT03937570|10121099|FG000|NOT COMPLETED|Overall Study||0
9061479|NCT03937570|10121100|FG001|NOT COMPLETED|Overall Study||0
9061480|NCT03938857|10121110|FG000|STARTED|Overall Study||6
9061481|NCT03938857|10121111|FG001|STARTED|Overall Study||12
9061482|NCT03938857|10121112|FG002|STARTED|Overall Study||12
9061483|NCT03938857|10121113|FG003|STARTED|Overall Study||0
9061484|NCT03938857|10121110|FG000|COMPLETED|Overall Study||5
9061485|NCT03938857|10121111|FG001|COMPLETED|Overall Study||12
9061486|NCT03938857|10121112|FG002|COMPLETED|Overall Study||12
9061487|NCT03938857|10121113|FG003|COMPLETED|Overall Study||0
9061488|NCT03938857|10121110|FG000|NOT COMPLETED|Overall Study||1
9061489|NCT03938857|10121111|FG001|NOT COMPLETED|Overall Study||0
9061490|NCT03938857|10121112|FG002|NOT COMPLETED|Overall Study||0
9061491|NCT03938857|10121113|FG003|NOT COMPLETED|Overall Study||0
9061492|NCT03941912|10121123|FG000|STARTED|Overall Study||44
9061493|NCT03941912|10121123|FG000|COMPLETED|Overall Study||44
9061494|NCT03941912|10121123|FG000|NOT COMPLETED|Overall Study||0
9061495|NCT03945981|10121127|FG000|STARTED|Overall Study||131
9061496|NCT03945981|10121127|FG000|COMPLETED|Overall Study||108
9061497|NCT03945981|10121127|FG000|NOT COMPLETED|Overall Study||23
9061498|NCT03950167|10121133|FG000|STARTED|Overall Study||25
9061499|NCT03950167|10121134|FG001|STARTED|Overall Study||25
9061500|NCT03950167|10121133|FG000|COMPLETED|Overall Study||24
9061501|NCT03950167|10121134|FG001|COMPLETED|Overall Study||22
9061502|NCT03950167|10121133|FG000|NOT COMPLETED|Overall Study||1
9061503|NCT03950167|10121134|FG001|NOT COMPLETED|Overall Study||3
9061504|NCT03954834|10121144|FG000|STARTED|Overall Study||121
9061505|NCT03954834|10121145|FG001|STARTED|Overall Study||121
9061506|NCT03954834|10121146|FG002|STARTED|Overall Study||121
9061507|NCT03954834|10121147|FG003|STARTED|Overall Study||115
9061508|NCT03954834|10121144|FG000|Received at Least One Dose of Study Drug|Overall Study||121
9061509|NCT03954834|10121145|FG001|Received at Least One Dose of Study Drug|Overall Study||121
9061510|NCT03954834|10121146|FG002|Received at Least One Dose of Study Drug|Overall Study||121
9061511|NCT03954834|10121147|FG003|Received at Least One Dose of Study Drug|Overall Study||115
9061512|NCT03954834|10121144|FG000|COMPLETED|Overall Study||114
9061513|NCT03954834|10121145|FG001|COMPLETED|Overall Study||112
9061514|NCT03954834|10121146|FG002|COMPLETED|Overall Study||103
9061515|NCT03954834|10121147|FG003|COMPLETED|Overall Study||99
9061516|NCT03954834|10121144|FG000|NOT COMPLETED|Overall Study||7
9061517|NCT03954834|10121145|FG001|NOT COMPLETED|Overall Study||9
9061518|NCT03954834|10121146|FG002|NOT COMPLETED|Overall Study||18
9061519|NCT03954834|10121147|FG003|NOT COMPLETED|Overall Study||16
9061520|NCT03958071|10121160|FG000|STARTED|Overall Study||347
9061521|NCT03958071|10121161|FG001|STARTED|Overall Study||423
9061522|NCT03958071|10121162|FG002|STARTED|Overall Study||12494
9061523|NCT03958071|10121160|FG000|COMPLETED|Overall Study||347
9061524|NCT03958071|10121161|FG001|COMPLETED|Overall Study||423
9061525|NCT03958071|10121162|FG002|COMPLETED|Overall Study||12494
9061526|NCT03958071|10121160|FG000|NOT COMPLETED|Overall Study||0
9061527|NCT03958071|10121161|FG001|NOT COMPLETED|Overall Study||0
9061528|NCT03958071|10121162|FG002|NOT COMPLETED|Overall Study||0
9061529|NCT03961529|10121174|FG000|STARTED|Overall Study||166
9061530|NCT03961529|10121175|FG001|STARTED|Overall Study||144
9061531|NCT03961529|10121176|FG002|STARTED|Overall Study||56
9061532|NCT03961529|10121174|FG000|COMPLETED|Overall Study||124
9061533|NCT03961529|10121175|FG001|COMPLETED|Overall Study||127
9061534|NCT03961529|10121176|FG002|COMPLETED|Overall Study||51
9061535|NCT03961529|10121174|FG000|NOT COMPLETED|Overall Study||42
9061536|NCT03961529|10121175|FG001|NOT COMPLETED|Overall Study||17
9061537|NCT03961529|10121176|FG002|NOT COMPLETED|Overall Study||5
9061538|NCT03968159|10121186|FG000|STARTED|Overall Study||148
9061539|NCT03968159|10121187|FG001|STARTED|Overall Study||150
9061540|NCT03968159|10121186|FG000|COMPLETED|Overall Study||135
9061541|NCT03968159|10121187|FG001|COMPLETED|Overall Study||135
9061542|NCT03968159|10121186|FG000|NOT COMPLETED|Overall Study||13
9061543|NCT03968159|10121187|FG001|NOT COMPLETED|Overall Study||15
9061544|NCT03968965|10121195|FG000|STARTED|Overall Study||32
9061545|NCT03968965|10121196|FG001|STARTED|Overall Study||32
9061546|NCT03968965|10121195|FG000|COMPLETED|Overall Study||32
9061547|NCT03968965|10121196|FG001|COMPLETED|Overall Study||30
9061548|NCT03968965|10121195|FG000|NOT COMPLETED|Overall Study||0
9061549|NCT03968965|10121196|FG001|NOT COMPLETED|Overall Study||2
9061550|NCT03970824|10121205|FG000|STARTED|Overall Study||103
9061551|NCT03970824|10121206|FG001|STARTED|Overall Study||103
9061552|NCT03970824|10121207|FG002|STARTED|Overall Study||106
9061553|NCT03970824|10121205|FG000|COMPLETED|Overall Study||101
9061554|NCT03970824|10121206|FG001|COMPLETED|Overall Study||100
9061555|NCT03970824|10121207|FG002|COMPLETED|Overall Study||102
9061556|NCT03970824|10121205|FG000|NOT COMPLETED|Overall Study||2
9061557|NCT03970824|10121206|FG001|NOT COMPLETED|Overall Study||3
9061558|NCT03970824|10121207|FG002|NOT COMPLETED|Overall Study||4
9061559|NCT03978403|10121219|FG000|STARTED|Overall Study||6
9061560|NCT03978403|10121220|FG001|STARTED|Overall Study||6
9061561|NCT03978403|10121221|FG002|STARTED|Overall Study||6
9061562|NCT03978403|10121222|FG003|STARTED|Overall Study||6
9061563|NCT03978403|10121219|FG000|COMPLETED|Overall Study||6
9061564|NCT03978403|10121220|FG001|COMPLETED|Overall Study||6
9061565|NCT03978403|10121221|FG002|COMPLETED|Overall Study||6
9061566|NCT03978403|10121222|FG003|COMPLETED|Overall Study||6
9061567|NCT03978403|10121219|FG000|NOT COMPLETED|Overall Study||0
9061568|NCT03978403|10121220|FG001|NOT COMPLETED|Overall Study||0
9061569|NCT03978403|10121221|FG002|NOT COMPLETED|Overall Study||0
9061570|NCT03978403|10121222|FG003|NOT COMPLETED|Overall Study||0
9061571|NCT03979807|10121235|FG000|STARTED|Overall Study||3876
9061572|NCT03979807|10121236|FG001|STARTED|Overall Study||7420
9061573|NCT03979807|10121235|FG000|COMPLETED|Overall Study||3876
9061574|NCT03979807|10121236|FG001|COMPLETED|Overall Study||7420
9061575|NCT03979807|10121235|FG000|NOT COMPLETED|Overall Study||0
9061576|NCT03979807|10121236|FG001|NOT COMPLETED|Overall Study||0
9061577|NCT03980470|10121242|FG000|STARTED|Overall Study||50
9061578|NCT03980470|10121242|FG000|COMPLETED|Overall Study||50
9061579|NCT03980470|10121242|FG000|NOT COMPLETED|Overall Study||0
9061580|NCT03982069|10121253|FG000|STARTED|Overall Study||108
9061581|NCT03982069|10121254|FG001|STARTED|Overall Study||110
9061582|NCT03982069|10121255|FG002|STARTED|Overall Study||127
9061583|NCT03982069|10121256|FG003|STARTED|Overall Study||120
9061584|NCT03982069|10121253|FG000|COMPLETED|Overall Study||98
9061585|NCT03982069|10121254|FG001|COMPLETED|Overall Study||100
9061586|NCT03982069|10121255|FG002|COMPLETED|Overall Study||118
9061587|NCT03982069|10121256|FG003|COMPLETED|Overall Study||112
9061588|NCT03982069|10121253|FG000|NOT COMPLETED|Overall Study||10
9061589|NCT03982069|10121254|FG001|NOT COMPLETED|Overall Study||10
9061590|NCT03982069|10121255|FG002|NOT COMPLETED|Overall Study||9
9061591|NCT03982069|10121256|FG003|NOT COMPLETED|Overall Study||8
9061592|NCT03984812|10121275|FG000|STARTED|Part 1 (Up to Day 28)||6
9061593|NCT03984812|10121276|FG001|STARTED|Part 1 (Up to Day 28)||6
9061594|NCT03984812|10121277|FG002|STARTED|Part 1 (Up to Day 28)||6
9061595|NCT03984812|10121278|FG003|STARTED|Part 1 (Up to Day 28)||6
9061596|NCT03984812|10121279|FG004|STARTED|Part 1 (Up to Day 28)|No participants were enrolled in this arm as the study was terminated due to non-safety reasons.|0
9061597|NCT03984812|10121280|FG005|STARTED|Part 1 (Up to Day 28)|No participants were enrolled in this arm as the study was terminated due to non-safety reasons.|0
9061598|NCT03984812|10121281|FG006|STARTED|Part 1 (Up to Day 28)|No participants were enrolled in this arm as the study was terminated due to non-safety reasons.|0
9061599|NCT03984812|10121282|FG007|STARTED|Part 1 (Up to Day 28)||0
9061600|NCT03984812|10121283|FG008|STARTED|Part 1 (Up to Day 28)||0
9061601|NCT03984812|10121284|FG009|STARTED|Part 1 (Up to Day 28)||0
9061602|NCT03984812|10121285|FG010|STARTED|Part 1 (Up to Day 28)||0
9061603|NCT03984812|10121275|FG000|COMPLETED|Part 1 (Up to Day 28)||6
9061604|NCT03984812|10121276|FG001|COMPLETED|Part 1 (Up to Day 28)||6
9061605|NCT03984812|10121277|FG002|COMPLETED|Part 1 (Up to Day 28)||5
9061606|NCT03984812|10121278|FG003|COMPLETED|Part 1 (Up to Day 28)||6
9061607|NCT03984812|10121279|FG004|COMPLETED|Part 1 (Up to Day 28)||0
9061608|NCT03984812|10121280|FG005|COMPLETED|Part 1 (Up to Day 28)||0
9061609|NCT03984812|10121281|FG006|COMPLETED|Part 1 (Up to Day 28)||0
9061610|NCT03984812|10121282|FG007|COMPLETED|Part 1 (Up to Day 28)||0
9061611|NCT03984812|10121283|FG008|COMPLETED|Part 1 (Up to Day 28)||0
9061612|NCT03984812|10121284|FG009|COMPLETED|Part 1 (Up to Day 28)||0
9061613|NCT03984812|10121285|FG010|COMPLETED|Part 1 (Up to Day 28)||0
9061614|NCT03984812|10121275|FG000|NOT COMPLETED|Part 1 (Up to Day 28)||0
9061615|NCT03984812|10121276|FG001|NOT COMPLETED|Part 1 (Up to Day 28)||0
9061616|NCT03984812|10121277|FG002|NOT COMPLETED|Part 1 (Up to Day 28)||1
9061617|NCT03984812|10121278|FG003|NOT COMPLETED|Part 1 (Up to Day 28)||0
9061618|NCT03984812|10121279|FG004|NOT COMPLETED|Part 1 (Up to Day 28)||0
9061619|NCT03984812|10121280|FG005|NOT COMPLETED|Part 1 (Up to Day 28)||0
9061620|NCT03984812|10121281|FG006|NOT COMPLETED|Part 1 (Up to Day 28)||0
9061621|NCT03984812|10121282|FG007|NOT COMPLETED|Part 1 (Up to Day 28)||0
9061622|NCT03984812|10121283|FG008|NOT COMPLETED|Part 1 (Up to Day 28)||0
9061623|NCT03984812|10121284|FG009|NOT COMPLETED|Part 1 (Up to Day 28)||0
9061624|NCT03984812|10121285|FG010|NOT COMPLETED|Part 1 (Up to Day 28)||0
9061625|NCT03984812|10121275|FG000|STARTED|Part 2 (Up to Day 49)||0
9061626|NCT03984812|10121276|FG001|STARTED|Part 2 (Up to Day 49)||0
9061627|NCT03984812|10121277|FG002|STARTED|Part 2 (Up to Day 49)||0
9061628|NCT03984812|10121278|FG003|STARTED|Part 2 (Up to Day 49)||0
9061629|NCT03984812|10121279|FG004|STARTED|Part 2 (Up to Day 49)||0
9061630|NCT03984812|10121280|FG005|STARTED|Part 2 (Up to Day 49)||0
9061631|NCT03984812|10121281|FG006|STARTED|Part 2 (Up to Day 49)||0
9061632|NCT03984812|10121282|FG007|STARTED|Part 2 (Up to Day 49)|No participants were enrolled in Part 2 as the study was terminated due to non-safety reasons.|0
9061633|NCT03984812|10121283|FG008|STARTED|Part 2 (Up to Day 49)|No participants were enrolled in Part 2 as the study was terminated due to non-safety reasons.|0
8928037|NCT02277925|9989177|FG001|COMPLETED|Overall Study||87
8928038|NCT02277925|9989176|FG000|NOT COMPLETED|Overall Study||7
8928039|NCT02277925|9989177|FG001|NOT COMPLETED|Overall Study||15
8928040|NCT02277990|9989187|FG000|STARTED|Overall Study||3495
8928041|NCT02277990|9989188|FG001|STARTED|Overall Study||3488
8928042|NCT02277990|9989187|FG000|COMPLETED|Overall Study||3129
8928043|NCT02277990|9989188|FG001|COMPLETED|Overall Study||3112
8928044|NCT02277990|9989187|FG000|NOT COMPLETED|Overall Study||366
8928045|NCT02277990|9989188|FG001|NOT COMPLETED|Overall Study||376
8928046|NCT02278003|9989196|FG000|STARTED|Overall Study||49
9061634|NCT03984812|10121284|FG009|STARTED|Part 2 (Up to Day 49)|No participants were enrolled in Part 2 as the study was terminated due to non-safety reasons.|0
9061635|NCT03984812|10121285|FG010|STARTED|Part 2 (Up to Day 49)|No participants were enrolled in Part 2 as the study was terminated due to non-safety reasons.|0
9061636|NCT03984812|10121275|FG000|COMPLETED|Part 2 (Up to Day 49)||0
9061637|NCT03984812|10121276|FG001|COMPLETED|Part 2 (Up to Day 49)||0
9061638|NCT03984812|10121277|FG002|COMPLETED|Part 2 (Up to Day 49)||0
9061639|NCT03984812|10121278|FG003|COMPLETED|Part 2 (Up to Day 49)||0
9061640|NCT03984812|10121279|FG004|COMPLETED|Part 2 (Up to Day 49)||0
9061641|NCT03984812|10121280|FG005|COMPLETED|Part 2 (Up to Day 49)||0
9061642|NCT03984812|10121281|FG006|COMPLETED|Part 2 (Up to Day 49)||0
9061643|NCT03984812|10121282|FG007|COMPLETED|Part 2 (Up to Day 49)||0
9061644|NCT03984812|10121283|FG008|COMPLETED|Part 2 (Up to Day 49)||0
9061645|NCT03984812|10121284|FG009|COMPLETED|Part 2 (Up to Day 49)||0
9061646|NCT03984812|10121285|FG010|COMPLETED|Part 2 (Up to Day 49)||0
9061647|NCT03984812|10121275|FG000|NOT COMPLETED|Part 2 (Up to Day 49)||0
9061648|NCT03984812|10121276|FG001|NOT COMPLETED|Part 2 (Up to Day 49)||0
9061649|NCT03984812|10121277|FG002|NOT COMPLETED|Part 2 (Up to Day 49)||0
9061650|NCT03984812|10121278|FG003|NOT COMPLETED|Part 2 (Up to Day 49)||0
9061651|NCT03984812|10121279|FG004|NOT COMPLETED|Part 2 (Up to Day 49)||0
9061652|NCT03984812|10121280|FG005|NOT COMPLETED|Part 2 (Up to Day 49)||0
9061653|NCT03984812|10121281|FG006|NOT COMPLETED|Part 2 (Up to Day 49)||0
9061654|NCT03984812|10121282|FG007|NOT COMPLETED|Part 2 (Up to Day 49)||0
9061655|NCT03984812|10121283|FG008|NOT COMPLETED|Part 2 (Up to Day 49)||0
9061656|NCT03984812|10121284|FG009|NOT COMPLETED|Part 2 (Up to Day 49)||0
9061657|NCT03984812|10121285|FG010|NOT COMPLETED|Part 2 (Up to Day 49)||0
9061658|NCT03985813|10121314|FG000|STARTED|Overall Study||27
9061659|NCT03985813|10121315|FG001|STARTED|Overall Study||26
9061660|NCT03985813|10121314|FG000|COMPLETED|Overall Study||27
9061661|NCT03985813|10121315|FG001|COMPLETED|Overall Study||26
9061662|NCT03985813|10121314|FG000|NOT COMPLETED|Overall Study||0
9061663|NCT03985813|10121315|FG001|NOT COMPLETED|Overall Study||0
9061664|NCT03998163|10121321|FG000|STARTED|Overall Study||222
9061665|NCT03998163|10121321|FG000|COMPLETED|Overall Study||197
9061666|NCT03998163|10121321|FG000|NOT COMPLETED|Overall Study||25
9061667|NCT04000373|10121325|FG000|STARTED|Overall Study||5
9061668|NCT04000373|10121325|FG000|COMPLETED|Overall Study||5
9061669|NCT04000373|10121325|FG000|NOT COMPLETED|Overall Study||0
9061670|NCT04001517|10121332|FG000|STARTED|Overall Study||20
9061671|NCT04001517|10121333|FG001|STARTED|Overall Study||26
9061672|NCT04001517|10121334|FG002|STARTED|Overall Study||27
9061673|NCT04001517|10121335|FG003|STARTED|Overall Study||18
9061674|NCT04001517|10121332|FG000|COMPLETED|Overall Study||20
9061675|NCT04001517|10121333|FG001|COMPLETED|Overall Study||20
9061676|NCT04001517|10121334|FG002|COMPLETED|Overall Study||26
9061677|NCT04001517|10121335|FG003|COMPLETED|Overall Study||15
9061678|NCT04001517|10121332|FG000|NOT COMPLETED|Overall Study||0
9061679|NCT04001517|10121333|FG001|NOT COMPLETED|Overall Study||6
9061680|NCT04001517|10121334|FG002|NOT COMPLETED|Overall Study||1
9061681|NCT04001517|10121335|FG003|NOT COMPLETED|Overall Study||3
9061682|NCT04006171|10121348|FG000|STARTED|Overall Study||48
9061683|NCT04006171|10121349|FG001|STARTED|Overall Study||42
9061684|NCT04006171|10121348|FG000|COMPLETED|Overall Study||36
9061685|NCT04006171|10121349|FG001|COMPLETED|Overall Study||30
9061686|NCT04006171|10121348|FG000|NOT COMPLETED|Overall Study||12
9061687|NCT04006171|10121349|FG001|NOT COMPLETED|Overall Study||12
9061688|NCT04011436|10121358|FG000|STARTED|Overall Study||20
9061689|NCT04011436|10121359|FG001|STARTED|Overall Study||20
9061690|NCT04011436|10121358|FG000|COMPLETED|Overall Study||19
9061691|NCT04011436|10121359|FG001|COMPLETED|Overall Study||19
9061692|NCT04011436|10121358|FG000|NOT COMPLETED|Overall Study||1
9061693|NCT04011436|10121359|FG001|NOT COMPLETED|Overall Study||1
9061694|NCT04011592|10121367|FG000|STARTED|Overall Study||1
9061695|NCT04011592|10121368|FG001|STARTED|Overall Study||0
9061696|NCT04011592|10121367|FG000|COMPLETED|Overall Study||1
9061697|NCT04011592|10121368|FG001|COMPLETED|Overall Study||0
9061698|NCT04011592|10121367|FG000|NOT COMPLETED|Overall Study||0
9061699|NCT04011592|10121368|FG001|NOT COMPLETED|Overall Study||0
9061700|NCT04013529|10121376|FG000|STARTED|Overall Study||20
9061701|NCT04013529|10121377|FG001|STARTED|Overall Study||20
9061702|NCT04013529|10121376|FG000|COMPLETED|Overall Study||19
9061703|NCT04013529|10121377|FG001|COMPLETED|Overall Study||19
9061704|NCT04013529|10121376|FG000|NOT COMPLETED|Overall Study||1
9061705|NCT04013529|10121377|FG001|NOT COMPLETED|Overall Study||1
9061706|NCT04016324|10121383|FG000|STARTED|Overall Study||110
9061707|NCT04016324|10121383|FG000|COMPLETED|Overall Study||107
9061708|NCT04016324|10121383|FG000|NOT COMPLETED|Overall Study||3
9061709|NCT04017910|10121388|FG000|STARTED|Overall Study||17
9061710|NCT04017910|10121388|FG000|COMPLETED|Overall Study||17
9061711|NCT04017910|10121388|FG000|NOT COMPLETED|Overall Study||0
9061712|NCT04018066|10121392|FG000|STARTED|Overall Study|34 participants were enrolled in the study|34
9061713|NCT04018066|10121392|FG000|COMPLETED|Overall Study|30 participants completed the study protocol.|30
9061714|NCT04018066|10121392|FG000|NOT COMPLETED|Overall Study||4
8928047|NCT02278003|9989197|FG001|STARTED|Overall Study||20
9061715|NCT04018794|10121397|FG000|STARTED|Overall Study|N=15 students participants completed the open trial of usability/feasibility of the intervention and completed quantitative ratings of usability before and after using the program.|15
9061716|NCT04018794|10121397|FG000|COMPLETED|Overall Study|N=15 students participants completed the open trial of usability/feasibility of the intervention and completed quantitative ratings of usability before and after using the program.|15
9061717|NCT04018794|10121397|FG000|NOT COMPLETED|Overall Study||0
9061718|NCT04032327|10121403|FG000|STARTED|Overall Study||60
9061719|NCT04032327|10121404|FG001|STARTED|Overall Study||60
9061720|NCT04032327|10121403|FG000|COMPLETED|Overall Study||60
9061721|NCT04032327|10121404|FG001|COMPLETED|Overall Study||60
9061722|NCT04032327|10121403|FG000|NOT COMPLETED|Overall Study||0
9061723|NCT04032327|10121404|FG001|NOT COMPLETED|Overall Study||0
9061724|NCT04033640|10121412|FG000|STARTED|Overall Study||1736
9061725|NCT04033640|10121413|FG001|STARTED|Overall Study||18
9061726|NCT04033640|10121412|FG000|COMPLETED|Overall Study||1736
9061727|NCT04033640|10121413|FG001|COMPLETED|Overall Study||18
9061728|NCT04033640|10121412|FG000|NOT COMPLETED|Overall Study||0
9061729|NCT04033640|10121413|FG001|NOT COMPLETED|Overall Study||0
9061730|NCT04036292|10121422|FG000|STARTED|Overall Study||260
9061731|NCT04036292|10121423|FG001|STARTED|Overall Study||246
9061732|NCT04036292|10121424|FG002|STARTED|Overall Study||252
9061733|NCT04036292|10121422|FG000|COMPLETED|Overall Study||239
9061734|NCT04036292|10121423|FG001|COMPLETED|Overall Study||212
9061735|NCT04036292|10121424|FG002|COMPLETED|Overall Study||228
9061736|NCT04036292|10121422|FG000|NOT COMPLETED|Overall Study||21
9061737|NCT04036292|10121423|FG001|NOT COMPLETED|Overall Study||34
9061738|NCT04036292|10121424|FG002|NOT COMPLETED|Overall Study||24
9061739|NCT04041440|10121437|FG000|STARTED|Overall Study||12
9061740|NCT04041440|10121438|FG001|STARTED|Overall Study||22
9061741|NCT04041440|10121437|FG000|COMPLETED|Overall Study||12
9061742|NCT04041440|10121438|FG001|COMPLETED|Overall Study||20
9061743|NCT04041440|10121437|FG000|NOT COMPLETED|Overall Study||0
9061744|NCT04041440|10121438|FG001|NOT COMPLETED|Overall Study||2
9061745|NCT04041570|10121447|FG000|STARTED|Overall Study||20
9061746|NCT04041570|10121448|FG001|STARTED|Overall Study||20
9061747|NCT04041570|10121447|FG000|COMPLETED|Overall Study||20
9061748|NCT04041570|10121448|FG001|COMPLETED|Overall Study||18
9061749|NCT04041570|10121447|FG000|NOT COMPLETED|Overall Study||0
9061750|NCT04041570|10121448|FG001|NOT COMPLETED|Overall Study||2
9061751|NCT04043143|10121457|FG000|STARTED|Overall Study||29
9061752|NCT04043143|10121458|FG001|STARTED|Overall Study||27
9061753|NCT04043143|10121457|FG000|COMPLETED|Overall Study||23
9061754|NCT04043143|10121458|FG001|COMPLETED|Overall Study||22
9061755|NCT04043143|10121457|FG000|NOT COMPLETED|Overall Study||6
9061756|NCT04043143|10121458|FG001|NOT COMPLETED|Overall Study||5
9061757|NCT04049123|10121464|FG000|STARTED|Period 1||5
9061758|NCT04049123|10121465|FG001|STARTED|Period 1||5
9061759|NCT04049123|10121466|FG002|STARTED|Period 1||5
9061760|NCT04049123|10121464|FG000|Received at Least One Dose of Study Drug|Period 1||5
9061761|NCT04049123|10121465|FG001|Received at Least One Dose of Study Drug|Period 1||5
9061762|NCT04049123|10121466|FG002|Received at Least One Dose of Study Drug|Period 1||5
9061763|NCT04049123|10121464|FG000|COMPLETED|Period 1||5
9061764|NCT04049123|10121465|FG001|COMPLETED|Period 1||5
9061765|NCT04049123|10121466|FG002|COMPLETED|Period 1||5
9061766|NCT04049123|10121464|FG000|NOT COMPLETED|Period 1||0
9061767|NCT04049123|10121465|FG001|NOT COMPLETED|Period 1||0
9061768|NCT04049123|10121466|FG002|NOT COMPLETED|Period 1||0
9061769|NCT04049123|10121464|FG000|STARTED|Period 2||5
9061770|NCT04049123|10121465|FG001|STARTED|Period 2||5
9061771|NCT04049123|10121466|FG002|STARTED|Period 2||5
9061772|NCT04049123|10121464|FG000|COMPLETED|Period 2||5
9061773|NCT04049123|10121465|FG001|COMPLETED|Period 2||5
9061774|NCT04049123|10121466|FG002|COMPLETED|Period 2||5
9061775|NCT04049123|10121464|FG000|NOT COMPLETED|Period 2||0
9061776|NCT04049123|10121465|FG001|NOT COMPLETED|Period 2||0
9061777|NCT04049123|10121466|FG002|NOT COMPLETED|Period 2||0
9061778|NCT04049123|10121464|FG000|STARTED|Period 3||5
9061779|NCT04049123|10121465|FG001|STARTED|Period 3||5
9061780|NCT04049123|10121466|FG002|STARTED|Period 3||5
9061781|NCT04049123|10121464|FG000|COMPLETED|Period 3||5
9061782|NCT04049123|10121465|FG001|COMPLETED|Period 3||5
9061783|NCT04049123|10121466|FG002|COMPLETED|Period 3||5
9061784|NCT04049123|10121464|FG000|NOT COMPLETED|Period 3||0
9061785|NCT04049123|10121465|FG001|NOT COMPLETED|Period 3||0
9061786|NCT04049123|10121466|FG002|NOT COMPLETED|Period 3||0
9061787|NCT04051463|10121476|FG000|STARTED|Overall Study||15
9061788|NCT04051463|10121477|FG001|STARTED|Overall Study||14
9061789|NCT04051463|10121476|FG000|COMPLETED|Overall Study||13
9061790|NCT04051463|10121477|FG001|COMPLETED|Overall Study||13
9061791|NCT04051463|10121476|FG000|NOT COMPLETED|Overall Study||2
9061792|NCT04051463|10121477|FG001|NOT COMPLETED|Overall Study||1
9061793|NCT04052204|10121483|FG000|STARTED|Overall Study||3
9061794|NCT04052204|10121484|FG001|STARTED|Overall Study|Arm was not tested due to study termination.|0
9061795|NCT04052204|10121485|FG002|STARTED|Overall Study|Arm was not tested due to study termination.|0
9061796|NCT04052204|10121483|FG000|COMPLETED|Overall Study||0
9061797|NCT04052204|10121484|FG001|COMPLETED|Overall Study||0
9061798|NCT04052204|10121485|FG002|COMPLETED|Overall Study||0
9061799|NCT04052204|10121483|FG000|NOT COMPLETED|Overall Study||3
9061800|NCT04052204|10121484|FG001|NOT COMPLETED|Overall Study||0
9061801|NCT04052204|10121485|FG002|NOT COMPLETED|Overall Study||0
9061802|NCT04054661|10121489|FG000|STARTED|Overall Study||229
9061803|NCT04054661|10121489|FG000|Enrolled in Repeatability Sub-study|Overall Study||15
9061804|NCT04054661|10121489|FG000|Enrolled in Sample Stability Sub-study|Overall Study||3
9061805|NCT04054661|10121489|FG000|COMPLETED|Overall Study||229
9061806|NCT04054661|10121489|FG000|NOT COMPLETED|Overall Study||0
9061807|NCT04067011|10121505|FG000|STARTED|Overall Study||70
9061808|NCT04067011|10121506|FG001|STARTED|Overall Study||71
9061809|NCT04067011|10121507|FG002|STARTED|Overall Study||69
9061810|NCT04067011|10121505|FG000|COMPLETED|Overall Study||51
9061811|NCT04067011|10121506|FG001|COMPLETED|Overall Study||58
9061812|NCT04067011|10121507|FG002|COMPLETED|Overall Study||61
9061813|NCT04067011|10121505|FG000|NOT COMPLETED|Overall Study||19
9061814|NCT04067011|10121506|FG001|NOT COMPLETED|Overall Study||13
9061815|NCT04067011|10121507|FG002|NOT COMPLETED|Overall Study||8
9061816|NCT04072159|10121519|FG000|STARTED|Overall Study||16
9061817|NCT04072159|10121520|FG001|STARTED|Overall Study||17
9061818|NCT04072159|10121519|FG000|COMPLETED|Overall Study||8
9061819|NCT04072159|10121520|FG001|COMPLETED|Overall Study||11
9061820|NCT04072159|10121519|FG000|NOT COMPLETED|Overall Study||8
9061821|NCT04072159|10121520|FG001|NOT COMPLETED|Overall Study||6
9061822|NCT04085341|10121530|FG000|STARTED|Overall Study||10
9061823|NCT04085341|10121531|FG001|STARTED|Overall Study||11
9061824|NCT04085341|10121530|FG000|COMPLETED|Overall Study||10
9061825|NCT04085341|10121531|FG001|COMPLETED|Overall Study||11
9061826|NCT04085341|10121530|FG000|NOT COMPLETED|Overall Study||0
9061827|NCT04085341|10121531|FG001|NOT COMPLETED|Overall Study||0
9061828|NCT04094870|10121539|FG000|STARTED|Overall Study||40
9061829|NCT04094870|10121540|FG001|STARTED|Overall Study||40
9061830|NCT04094870|10121539|FG000|COMPLETED|Overall Study||39
9061831|NCT04094870|10121540|FG001|COMPLETED|Overall Study||39
9061832|NCT04094870|10121539|FG000|NOT COMPLETED|Overall Study||1
9061833|NCT04094870|10121540|FG001|NOT COMPLETED|Overall Study||1
9061834|NCT04096482|10121553|FG000|STARTED|Overall Study||6
9061835|NCT04096482|10121553|FG000|COMPLETED|Overall Study||6
9061836|NCT04096482|10121553|FG000|NOT COMPLETED|Overall Study||0
9061837|NCT04098172|10121559|FG000|STARTED|Overall Study||39
9061838|NCT04098172|10121559|FG000|COMPLETED|Overall Study||39
9061839|NCT04098172|10121559|FG000|NOT COMPLETED|Overall Study||0
9061840|NCT04103515|10121566|FG000|STARTED|Overall Study||25
9061841|NCT04103515|10121567|FG001|STARTED|Overall Study||25
9061842|NCT04103515|10121566|FG000|COMPLETED|Overall Study||25
9061843|NCT04103515|10121567|FG001|COMPLETED|Overall Study||25
9061844|NCT04103515|10121566|FG000|NOT COMPLETED|Overall Study||0
9061845|NCT04103515|10121567|FG001|NOT COMPLETED|Overall Study||0
9061846|NCT04111276|10121573|FG000|STARTED|Overall Study||23
9061847|NCT04111276|10121573|FG000|COMPLETED|Overall Study||20
9061848|NCT04111276|10121573|FG000|NOT COMPLETED|Overall Study||3
9061849|NCT04123405|10121581|FG000|STARTED|Overall Study||235
9061850|NCT04123405|10121582|FG001|STARTED|Overall Study||238
9061851|NCT04123405|10121583|FG002|STARTED|Overall Study||238
9061852|NCT04123405|10121584|FG003|STARTED|Overall Study||233
9061853|NCT04123405|10121581|FG000|Full Analysis Set|Overall Study||235
9061854|NCT04123405|10121582|FG001|Full Analysis Set|Overall Study||236
9061855|NCT04123405|10121583|FG002|Full Analysis Set|Overall Study||238
9061856|NCT04123405|10121584|FG003|Full Analysis Set|Overall Study||230
9061857|NCT04123405|10121581|FG000|Per-protocol Set|Overall Study||213
9061858|NCT04123405|10121582|FG001|Per-protocol Set|Overall Study||215
9061859|NCT04123405|10121583|FG002|Per-protocol Set|Overall Study||212
9061860|NCT04123405|10121584|FG003|Per-protocol Set|Overall Study||207
9061861|NCT04123405|10121581|FG000|Safety Set|Overall Study||235
9061862|NCT04123405|10121582|FG001|Safety Set|Overall Study||238
9061863|NCT04123405|10121583|FG002|Safety Set|Overall Study||238
9061864|NCT04123405|10121584|FG003|Safety Set|Overall Study||233
9061865|NCT04123405|10121581|FG000|COMPLETED|Overall Study||231
9061866|NCT04123405|10121582|FG001|COMPLETED|Overall Study||231
9061867|NCT04123405|10121583|FG002|COMPLETED|Overall Study||235
9061868|NCT04123405|10121584|FG003|COMPLETED|Overall Study||225
9061869|NCT04123405|10121581|FG000|NOT COMPLETED|Overall Study||4
9061870|NCT04123405|10121582|FG001|NOT COMPLETED|Overall Study||7
9061871|NCT04123405|10121583|FG002|NOT COMPLETED|Overall Study||3
9061872|NCT04123405|10121584|FG003|NOT COMPLETED|Overall Study||8
9061873|NCT04128527|10121594|FG000|STARTED|Overall Study||16
9061874|NCT04128527|10121594|FG000|COMPLETED|Overall Study||16
9061875|NCT04128527|10121594|FG000|NOT COMPLETED|Overall Study||0
9061876|NCT04132973|10121598|FG000|STARTED|Overall Study||34
9061877|NCT04132973|10121598|FG000|Completed Intervention|Overall Study||11
9061878|NCT04132973|10121598|FG000|COMPLETED|Overall Study||8
9061879|NCT04132973|10121598|FG000|NOT COMPLETED|Overall Study||26
9061880|NCT04133415|10121602|FG000|STARTED|Overall Study||20
9061881|NCT04133415|10121602|FG000|COMPLETED|Overall Study||20
9061882|NCT04133415|10121602|FG000|NOT COMPLETED|Overall Study||0
9061883|NCT04138758|10121608|FG000|STARTED|Overall Study||2600
9061884|NCT04138758|10121609|FG001|STARTED|Overall Study||40353
9061885|NCT04138758|10121608|FG000|COMPLETED|Overall Study||2600
9061886|NCT04138758|10121609|FG001|COMPLETED|Overall Study||40353
9061887|NCT04138758|10121608|FG000|NOT COMPLETED|Overall Study||0
9061888|NCT04138758|10121609|FG001|NOT COMPLETED|Overall Study||0
9061889|NCT04147715|10121627|FG000|STARTED|Overall Study||12
9061890|NCT04147715|10121628|FG001|STARTED|Overall Study||6
9061891|NCT04147715|10121629|FG002|STARTED|Overall Study||6
9061892|NCT04147715|10121630|FG003|STARTED|Overall Study||8
9061893|NCT04147715|10121631|FG004|STARTED|Overall Study||6
9061894|NCT04147715|10121632|FG005|STARTED|Overall Study||6
9061895|NCT04147715|10121633|FG006|STARTED|Overall Study||6
9061896|NCT04147715|10121634|FG007|STARTED|Overall Study||4
9061897|NCT04147715|10121635|FG008|STARTED|Overall Study||8
9061898|NCT04147715|10121636|FG009|STARTED|Overall Study||8
9061899|NCT04147715|10121637|FG010|STARTED|Overall Study||14
9061900|NCT04147715|10121638|FG011|STARTED|Overall Study||14
9061901|NCT04147715|10121627|FG000|COMPLETED|Overall Study||12
9061902|NCT04147715|10121628|FG001|COMPLETED|Overall Study||6
9061903|NCT04147715|10121629|FG002|COMPLETED|Overall Study||6
9061904|NCT04147715|10121630|FG003|COMPLETED|Overall Study||8
9061905|NCT04147715|10121631|FG004|COMPLETED|Overall Study||6
9061906|NCT04147715|10121632|FG005|COMPLETED|Overall Study||6
9061907|NCT04147715|10121633|FG006|COMPLETED|Overall Study||6
9061908|NCT04147715|10121634|FG007|COMPLETED|Overall Study||2
9061909|NCT04147715|10121635|FG008|COMPLETED|Overall Study||7
9061910|NCT04147715|10121636|FG009|COMPLETED|Overall Study||8
9061911|NCT04147715|10121637|FG010|COMPLETED|Overall Study||14
9061912|NCT04147715|10121638|FG011|COMPLETED|Overall Study||14
9061913|NCT04147715|10121627|FG000|NOT COMPLETED|Overall Study||0
9061914|NCT04147715|10121628|FG001|NOT COMPLETED|Overall Study||0
9061915|NCT04147715|10121629|FG002|NOT COMPLETED|Overall Study||0
9061916|NCT04147715|10121630|FG003|NOT COMPLETED|Overall Study||0
9061917|NCT04147715|10121631|FG004|NOT COMPLETED|Overall Study||0
9061918|NCT04147715|10121632|FG005|NOT COMPLETED|Overall Study||0
9061919|NCT04147715|10121633|FG006|NOT COMPLETED|Overall Study||0
9061920|NCT04147715|10121634|FG007|NOT COMPLETED|Overall Study||2
9061921|NCT04147715|10121635|FG008|NOT COMPLETED|Overall Study||1
9061922|NCT04147715|10121636|FG009|NOT COMPLETED|Overall Study||0
9061923|NCT04147715|10121637|FG010|NOT COMPLETED|Overall Study||0
9061924|NCT04147715|10121638|FG011|NOT COMPLETED|Overall Study||0
9061925|NCT04154605|10121712|FG000|STARTED|Overall Study||68
9061926|NCT04154605|10121713|FG001|STARTED|Overall Study||65
9061927|NCT04154605|10121712|FG000|COMPLETED|Overall Study||65
9061928|NCT04154605|10121713|FG001|COMPLETED|Overall Study||63
9061929|NCT04154605|10121712|FG000|NOT COMPLETED|Overall Study||3
9061930|NCT04154605|10121713|FG001|NOT COMPLETED|Overall Study||2
9061931|NCT04160091|10121723|FG000|STARTED|Overall Study||7
9061932|NCT04160091|10121724|FG001|STARTED|Overall Study||3
9061933|NCT04160091|10121725|FG002|STARTED|Overall Study||5
9061934|NCT04160091|10121726|FG003|STARTED|Overall Study||4
9061935|NCT04160091|10121723|FG000|COMPLETED|Overall Study||0
9061936|NCT04160091|10121724|FG001|COMPLETED|Overall Study||0
9061937|NCT04160091|10121725|FG002|COMPLETED|Overall Study||0
9061938|NCT04160091|10121726|FG003|COMPLETED|Overall Study||0
9061939|NCT04160091|10121723|FG000|NOT COMPLETED|Overall Study||7
9061940|NCT04160091|10121724|FG001|NOT COMPLETED|Overall Study||3
9061941|NCT04160091|10121725|FG002|NOT COMPLETED|Overall Study||5
9061942|NCT04160091|10121726|FG003|NOT COMPLETED|Overall Study||4
9061943|NCT04160260|10121736|FG000|STARTED|Overall Study||18
9061944|NCT04160260|10121736|FG000|COMPLETED|Overall Study||18
9061945|NCT04160260|10121736|FG000|NOT COMPLETED|Overall Study||0
9061946|NCT04164758|10121743|FG000|STARTED|Overall Study||4
9061947|NCT04164758|10121744|FG001|STARTED|Overall Study||4
9061948|NCT04164758|10121745|FG002|STARTED|Overall Study||3
9061949|NCT04164758|10121743|FG000|COMPLETED|Overall Study||3
9061950|NCT04164758|10121744|FG001|COMPLETED|Overall Study||3
9061951|NCT04164758|10121745|FG002|COMPLETED|Overall Study||3
9061952|NCT04164758|10121743|FG000|NOT COMPLETED|Overall Study||1
9061953|NCT04164758|10121744|FG001|NOT COMPLETED|Overall Study||1
9061954|NCT04164758|10121745|FG002|NOT COMPLETED|Overall Study||0
9061955|NCT04165031|10121759|FG000|STARTED|Overall Study||2
9061956|NCT04165031|10121760|FG001|STARTED|Overall Study||1
9061957|NCT04165031|10121761|FG002|STARTED|Overall Study||2
9061958|NCT04165031|10121762|FG003|STARTED|Overall Study||0
9061959|NCT04165031|10121763|FG004|STARTED|Overall Study||0
9061960|NCT04165031|10121764|FG005|STARTED|Overall Study||0
9061961|NCT04165031|10121759|FG000|Received at Least One Dose of Study Drug|Overall Study||2
9061962|NCT04165031|10121760|FG001|Received at Least One Dose of Study Drug|Overall Study||1
9061963|NCT04165031|10121761|FG002|Received at Least One Dose of Study Drug|Overall Study||2
9061964|NCT04165031|10121762|FG003|Received at Least One Dose of Study Drug|Overall Study||0
9061965|NCT04165031|10121763|FG004|Received at Least One Dose of Study Drug|Overall Study||0
9061966|NCT04165031|10121764|FG005|Received at Least One Dose of Study Drug|Overall Study||0
9061967|NCT04165031|10121759|FG000|COMPLETED|Overall Study||1
9061968|NCT04165031|10121760|FG001|COMPLETED|Overall Study||0
9061969|NCT04165031|10121761|FG002|COMPLETED|Overall Study||1
9061970|NCT04165031|10121762|FG003|COMPLETED|Overall Study||0
9061971|NCT04165031|10121763|FG004|COMPLETED|Overall Study||0
9061972|NCT04165031|10121764|FG005|COMPLETED|Overall Study||0
9061973|NCT04165031|10121759|FG000|NOT COMPLETED|Overall Study||1
9061974|NCT04165031|10121760|FG001|NOT COMPLETED|Overall Study||1
9061975|NCT04165031|10121761|FG002|NOT COMPLETED|Overall Study||1
9061976|NCT04165031|10121762|FG003|NOT COMPLETED|Overall Study||0
9061977|NCT04165031|10121763|FG004|NOT COMPLETED|Overall Study||0
9061978|NCT04165031|10121764|FG005|NOT COMPLETED|Overall Study||0
9061979|NCT04166032|10121779|FG000|STARTED|Overall Study||15
9061980|NCT04166032|10121779|FG000|COMPLETED|Overall Study||14
9061981|NCT04166032|10121779|FG000|NOT COMPLETED|Overall Study||1
9061982|NCT04171414|10121783|FG000|STARTED|Overall Study||62
9061983|NCT04171414|10121783|FG000|COMPLETED|Overall Study||60
9061984|NCT04171414|10121783|FG000|NOT COMPLETED|Overall Study||2
9061985|NCT04175808|10121787|FG000|STARTED|Part A||70
9061986|NCT04175808|10121788|FG001|STARTED|Part A||0
9061987|NCT04175808|10121789|FG002|STARTED|Part A||0
9061988|NCT04175808|10121790|FG003|STARTED|Part A||0
9061989|NCT04175808|10121791|FG004|STARTED|Part A||0
9061990|NCT04175808|10121792|FG005|STARTED|Part A||0
9061991|NCT04175808|10121793|FG006|STARTED|Part A||0
9061992|NCT04175808|10121787|FG000|COMPLETED|Part A||68
9061993|NCT04175808|10121788|FG001|COMPLETED|Part A||0
9061994|NCT04175808|10121789|FG002|COMPLETED|Part A||0
9061995|NCT04175808|10121790|FG003|COMPLETED|Part A||0
9061996|NCT04175808|10121791|FG004|COMPLETED|Part A||0
9061997|NCT04175808|10121792|FG005|COMPLETED|Part A||0
9061998|NCT04175808|10121793|FG006|COMPLETED|Part A||0
9061999|NCT04175808|10121787|FG000|NOT COMPLETED|Part A||2
9062000|NCT04175808|10121788|FG001|NOT COMPLETED|Part A||0
9062001|NCT04175808|10121789|FG002|NOT COMPLETED|Part A||0
9062002|NCT04175808|10121790|FG003|NOT COMPLETED|Part A||0
9062003|NCT04175808|10121791|FG004|NOT COMPLETED|Part A||0
9062004|NCT04175808|10121792|FG005|NOT COMPLETED|Part A||0
9062005|NCT04175808|10121793|FG006|NOT COMPLETED|Part A||0
9062006|NCT04175808|10121787|FG000|STARTED|Part B||0
9062007|NCT04175808|10121788|FG001|STARTED|Part B||10
9062008|NCT04175808|10121789|FG002|STARTED|Part B||10
9062009|NCT04175808|10121790|FG003|STARTED|Part B||10
9062010|NCT04175808|10121791|FG004|STARTED|Part B||10
9062011|NCT04175808|10121792|FG005|STARTED|Part B||10
9062012|NCT04175808|10121793|FG006|STARTED|Part B||10
9062013|NCT04175808|10121787|FG000|COMPLETED|Part B||0
9062014|NCT04175808|10121788|FG001|COMPLETED|Part B||10
9062015|NCT04175808|10121789|FG002|COMPLETED|Part B||10
9062016|NCT04175808|10121790|FG003|COMPLETED|Part B||10
9062017|NCT04175808|10121791|FG004|COMPLETED|Part B||10
9062018|NCT04175808|10121792|FG005|COMPLETED|Part B||10
9062019|NCT04175808|10121793|FG006|COMPLETED|Part B||10
9062020|NCT04175808|10121787|FG000|NOT COMPLETED|Part B||0
9062021|NCT04175808|10121788|FG001|NOT COMPLETED|Part B||0
9062022|NCT04175808|10121789|FG002|NOT COMPLETED|Part B||0
9062023|NCT04175808|10121790|FG003|NOT COMPLETED|Part B||0
9062024|NCT04175808|10121791|FG004|NOT COMPLETED|Part B||0
9062025|NCT04175808|10121792|FG005|NOT COMPLETED|Part B||0
9062026|NCT04175808|10121793|FG006|NOT COMPLETED|Part B||0
9062027|NCT04178720|10121811|FG000|STARTED|Overall Study||40
9062028|NCT04178720|10121812|FG001|STARTED|Overall Study||78
9062029|NCT04178720|10121811|FG000|COMPLETED|Overall Study||38
9062030|NCT04178720|10121812|FG001|COMPLETED|Overall Study||77
9062031|NCT04178720|10121811|FG000|NOT COMPLETED|Overall Study||2
9062032|NCT04178720|10121812|FG001|NOT COMPLETED|Overall Study||1
9062033|NCT04184297|10121823|FG000|STARTED|Overall Study||2864
9062034|NCT04184297|10121824|FG001|STARTED|Overall Study||24326
9062035|NCT04184297|10121823|FG000|COMPLETED|Overall Study||2864
9062036|NCT04184297|10121824|FG001|COMPLETED|Overall Study||24326
9062037|NCT04184297|10121823|FG000|NOT COMPLETED|Overall Study||0
9062038|NCT04184297|10121824|FG001|NOT COMPLETED|Overall Study||0
9062039|NCT04189848|10121830|FG000|STARTED|Treatment Period 1 (Day 1)||26
9062040|NCT04189848|10121831|FG001|STARTED|Treatment Period 1 (Day 1)||26
9062041|NCT04189848|10121832|FG002|STARTED|Treatment Period 1 (Day 1)||25
9062042|NCT04189848|10121833|FG003|STARTED|Treatment Period 1 (Day 1)||27
9062043|NCT04189848|10121830|FG000|COMPLETED|Treatment Period 1 (Day 1)||26
9062044|NCT04189848|10121831|FG001|COMPLETED|Treatment Period 1 (Day 1)||26
9062045|NCT04189848|10121832|FG002|COMPLETED|Treatment Period 1 (Day 1)||25
9062046|NCT04189848|10121833|FG003|COMPLETED|Treatment Period 1 (Day 1)||27
9062047|NCT04189848|10121830|FG000|NOT COMPLETED|Treatment Period 1 (Day 1)||0
9062048|NCT04189848|10121831|FG001|NOT COMPLETED|Treatment Period 1 (Day 1)||0
9062049|NCT04189848|10121832|FG002|NOT COMPLETED|Treatment Period 1 (Day 1)||0
9062050|NCT04189848|10121833|FG003|NOT COMPLETED|Treatment Period 1 (Day 1)||0
9062051|NCT04189848|10121830|FG000|STARTED|Treatment Period 2 (Day 1)||26
9062052|NCT04189848|10121831|FG001|STARTED|Treatment Period 2 (Day 1)||26
9062053|NCT04189848|10121832|FG002|STARTED|Treatment Period 2 (Day 1)||25
9062054|NCT04189848|10121833|FG003|STARTED|Treatment Period 2 (Day 1)||27
9062055|NCT04189848|10121830|FG000|COMPLETED|Treatment Period 2 (Day 1)||26
9062056|NCT04189848|10121831|FG001|COMPLETED|Treatment Period 2 (Day 1)||26
9062057|NCT04189848|10121832|FG002|COMPLETED|Treatment Period 2 (Day 1)||25
9062058|NCT04189848|10121833|FG003|COMPLETED|Treatment Period 2 (Day 1)||27
9062059|NCT04189848|10121830|FG000|NOT COMPLETED|Treatment Period 2 (Day 1)||0
9062060|NCT04189848|10121831|FG001|NOT COMPLETED|Treatment Period 2 (Day 1)||0
9062061|NCT04189848|10121832|FG002|NOT COMPLETED|Treatment Period 2 (Day 1)||0
9062062|NCT04189848|10121833|FG003|NOT COMPLETED|Treatment Period 2 (Day 1)||0
9062063|NCT04210232|10121838|FG000|STARTED|Overall Study||54
9062064|NCT04210232|10121838|FG000|COMPLETED|Overall Study||54
9062065|NCT04210232|10121838|FG000|NOT COMPLETED|Overall Study||0
9062066|NCT04211909|10121844|FG000|STARTED|Overall Study||54
9062067|NCT04211909|10121845|FG001|STARTED|Overall Study||33
9062068|NCT04211909|10121844|FG000|COMPLETED|Overall Study||54
9062069|NCT04211909|10121845|FG001|COMPLETED|Overall Study||33
9062070|NCT04211909|10121844|FG000|NOT COMPLETED|Overall Study||0
9062071|NCT04211909|10121845|FG001|NOT COMPLETED|Overall Study||0
9062072|NCT04218110|10121855|FG000|STARTED|Overall Study||82
9062073|NCT04218110|10121856|FG001|STARTED|Overall Study||81
9062074|NCT04218110|10121857|FG002|STARTED|Overall Study||83
9062075|NCT04218110|10121858|FG003|STARTED|Overall Study||83
9062076|NCT04218110|10121855|FG000|Received Treatment|Overall Study||82
9062077|NCT04218110|10121856|FG001|Received Treatment|Overall Study||81
9062078|NCT04218110|10121857|FG002|Received Treatment|Overall Study||83
9062079|NCT04218110|10121858|FG003|Received Treatment|Overall Study||82
9062080|NCT04218110|10121855|FG000|COMPLETED|Overall Study||82
9062081|NCT04218110|10121856|FG001|COMPLETED|Overall Study||81
9062082|NCT04218110|10121857|FG002|COMPLETED|Overall Study||83
9062083|NCT04218110|10121858|FG003|COMPLETED|Overall Study||82
9062084|NCT04218110|10121855|FG000|NOT COMPLETED|Overall Study||0
9062085|NCT04218110|10121856|FG001|NOT COMPLETED|Overall Study||0
9062086|NCT04218110|10121857|FG002|NOT COMPLETED|Overall Study||0
9062087|NCT04218110|10121858|FG003|NOT COMPLETED|Overall Study||1
9062088|NCT04222725|10121872|FG000|STARTED|Overall Study||8
9062089|NCT04222725|10121873|FG001|STARTED|Overall Study||10
9062090|NCT04222725|10121874|FG002|STARTED|Overall Study||9
9062091|NCT04222725|10121875|FG003|STARTED|Overall Study||10
9062092|NCT04222725|10121872|FG000|COMPLETED|Overall Study||8
9062093|NCT04222725|10121873|FG001|COMPLETED|Overall Study||9
9062094|NCT04222725|10121874|FG002|COMPLETED|Overall Study||9
9062095|NCT04222725|10121875|FG003|COMPLETED|Overall Study||10
9062096|NCT04222725|10121872|FG000|NOT COMPLETED|Overall Study||0
9062097|NCT04222725|10121873|FG001|NOT COMPLETED|Overall Study||1
9062098|NCT04222725|10121874|FG002|NOT COMPLETED|Overall Study||0
9062099|NCT04222725|10121875|FG003|NOT COMPLETED|Overall Study||0
9062100|NCT04223843|10121889|FG000|STARTED|Overall Study||55
9062101|NCT04223843|10121890|FG001|STARTED|Overall Study||55
9062102|NCT04223843|10121891|FG002|STARTED|Overall Study||51
9062103|NCT04223843|10121892|FG003|STARTED|Overall Study||52
9062104|NCT04223843|10121889|FG000|COMPLETED|Overall Study||55
9062105|NCT04223843|10121890|FG001|COMPLETED|Overall Study||55
9062106|NCT04223843|10121891|FG002|COMPLETED|Overall Study||51
9062107|NCT04223843|10121892|FG003|COMPLETED|Overall Study||52
8812742|NCT01521494|9865766|FG004|COMPLETED|Overall Study||30
8812743|NCT01521494|9865762|FG000|NOT COMPLETED|Overall Study||2
8812744|NCT01521494|9865763|FG001|NOT COMPLETED|Overall Study||5
8812745|NCT01521494|9865764|FG002|NOT COMPLETED|Overall Study||12
8812746|NCT01521494|9865765|FG003|NOT COMPLETED|Overall Study||21
9062108|NCT04223843|10121889|FG000|NOT COMPLETED|Overall Study||0
9062109|NCT04223843|10121890|FG001|NOT COMPLETED|Overall Study||0
9062110|NCT04223843|10121891|FG002|NOT COMPLETED|Overall Study||0
9062111|NCT04223843|10121892|FG003|NOT COMPLETED|Overall Study||0
9062112|NCT04229303|10121909|FG000|STARTED|Overall Study||6
9062113|NCT04229303|10121910|FG001|STARTED|Overall Study||6
9062114|NCT04229303|10121911|FG002|STARTED|Overall Study||6
9062115|NCT04229303|10121912|FG003|STARTED|Overall Study||6
9062116|NCT04229303|10121913|FG004|STARTED|Overall Study||6
9062117|NCT04229303|10121914|FG005|STARTED|Overall Study||6
9062118|NCT04229303|10121915|FG006|STARTED|Overall Study||6
9062119|NCT04229303|10121916|FG007|STARTED|Overall Study||8
9062120|NCT04229303|10121917|FG008|STARTED|Overall Study||8
9062121|NCT04229303|10121909|FG000|COMPLETED|Overall Study||6
9062122|NCT04229303|10121910|FG001|COMPLETED|Overall Study||6
9062123|NCT04229303|10121911|FG002|COMPLETED|Overall Study||6
9062124|NCT04229303|10121912|FG003|COMPLETED|Overall Study||6
9062125|NCT04229303|10121913|FG004|COMPLETED|Overall Study||6
9062126|NCT04229303|10121914|FG005|COMPLETED|Overall Study||6
9062127|NCT04229303|10121915|FG006|COMPLETED|Overall Study||6
9062128|NCT04229303|10121916|FG007|COMPLETED|Overall Study||8
9062129|NCT04229303|10121917|FG008|COMPLETED|Overall Study||8
9062130|NCT04229303|10121909|FG000|NOT COMPLETED|Overall Study||0
9062131|NCT04229303|10121910|FG001|NOT COMPLETED|Overall Study||0
9062132|NCT04229303|10121911|FG002|NOT COMPLETED|Overall Study||0
9062133|NCT04229303|10121912|FG003|NOT COMPLETED|Overall Study||0
9062134|NCT04229303|10121913|FG004|NOT COMPLETED|Overall Study||0
9062135|NCT04229303|10121914|FG005|NOT COMPLETED|Overall Study||0
9062136|NCT04229303|10121915|FG006|NOT COMPLETED|Overall Study||0
9062137|NCT04229303|10121916|FG007|NOT COMPLETED|Overall Study||0
9062138|NCT04229303|10121917|FG008|NOT COMPLETED|Overall Study||0
9062139|NCT04243421|10121945|FG000|STARTED|Overall Study||30
9062140|NCT04243421|10121945|FG000|COMPLETED|Overall Study||30
9062141|NCT04243421|10121945|FG000|NOT COMPLETED|Overall Study||0
9062142|NCT04256603|10121952|FG000|STARTED|Overall Study||21
9062143|NCT04256603|10121953|FG001|STARTED|Overall Study||6
9062144|NCT04256603|10121952|FG000|COMPLETED|Overall Study||21
9062145|NCT04256603|10121953|FG001|COMPLETED|Overall Study||6
9062146|NCT04256603|10121952|FG000|NOT COMPLETED|Overall Study||0
9062147|NCT04256603|10121953|FG001|NOT COMPLETED|Overall Study||0
9062148|NCT04258995|10121961|FG000|STARTED|Overall Study||76
9062149|NCT04258995|10121962|FG001|STARTED|Overall Study||75
9062150|NCT04258995|10121961|FG000|Vaccinated|Overall Study||76
9062151|NCT04258995|10121962|FG001|Vaccinated|Overall Study||75
9062152|NCT04258995|10121961|FG000|COMPLETED|Overall Study||75
9062153|NCT04258995|10121962|FG001|COMPLETED|Overall Study||74
9062154|NCT04258995|10121961|FG000|NOT COMPLETED|Overall Study||1
9062155|NCT04258995|10121962|FG001|NOT COMPLETED|Overall Study||1
9062156|NCT04280445|10121968|FG000|STARTED|Overall Study||3
9062157|NCT04280445|10121968|FG000|COMPLETED|Overall Study||3
9062158|NCT04280445|10121968|FG000|NOT COMPLETED|Overall Study||0
9062159|NCT04285489|10121972|FG000|STARTED|Overall Study||130
8812747|NCT01521494|9865766|FG004|NOT COMPLETED|Overall Study||7
9062160|NCT04285489|10121972|FG000|COMPLETED|Overall Study|all subjects finished the study before Jul 1, 2020.|130
9062161|NCT04285489|10121972|FG000|NOT COMPLETED|Overall Study||0
9062162|NCT04290494|10121979|FG000|STARTED|Overall Study||10968
9062163|NCT04290494|10121980|FG001|STARTED|Overall Study||17823
9062164|NCT04290494|10121981|FG002|STARTED|Overall Study||13397
9062165|NCT04290494|10121979|FG000|COMPLETED|Overall Study||10968
9062166|NCT04290494|10121980|FG001|COMPLETED|Overall Study||17823
9062167|NCT04290494|10121981|FG002|COMPLETED|Overall Study||13397
9062168|NCT04290494|10121979|FG000|NOT COMPLETED|Overall Study||0
9062169|NCT04290494|10121980|FG001|NOT COMPLETED|Overall Study||0
9062170|NCT04290494|10121981|FG002|NOT COMPLETED|Overall Study||0
9062171|NCT04303156|10121991|FG000|STARTED|Overall Study||6
9062172|NCT04303156|10121992|FG001|STARTED|Overall Study||6
9062173|NCT04303156|10121991|FG000|COMPLETED|Overall Study||6
9062174|NCT04303156|10121992|FG001|COMPLETED|Overall Study||6
9062175|NCT04303156|10121991|FG000|NOT COMPLETED|Overall Study||0
9062176|NCT04303156|10121992|FG001|NOT COMPLETED|Overall Study||0
9062177|NCT04317040|10122001|FG000|STARTED|Overall Study||116
9062178|NCT04317040|10122002|FG001|STARTED|Overall Study||118
9062179|NCT04317040|10122001|FG000|Treated|Overall Study||114
9062180|NCT04317040|10122002|FG001|Treated|Overall Study||115
9062181|NCT04317040|10122001|FG000|COMPLETED|Overall Study||98
9062182|NCT04317040|10122002|FG001|COMPLETED|Overall Study||98
9062183|NCT04317040|10122001|FG000|NOT COMPLETED|Overall Study||18
9062184|NCT04317040|10122002|FG001|NOT COMPLETED|Overall Study||20
9062185|NCT04317313|10122010|FG000|STARTED|Overall Study||100
9062186|NCT04317313|10122011|FG001|STARTED|Overall Study||52
9062187|NCT04317313|10122010|FG000|COMPLETED|Overall Study||100
9062188|NCT04317313|10122011|FG001|COMPLETED|Overall Study||52
9062189|NCT04317313|10122010|FG000|NOT COMPLETED|Overall Study||0
9062190|NCT04317313|10122011|FG001|NOT COMPLETED|Overall Study||0
9062191|NCT04319159|10122019|FG000|STARTED|Overall Study||48
9062192|NCT04319159|10122019|FG000|COMPLETED|Overall Study||32
9062193|NCT04319159|10122019|FG000|NOT COMPLETED|Overall Study||16
9062194|NCT04321239|10122027|FG000|STARTED|Overall Study||25
9062195|NCT04321239|10122028|FG001|STARTED|Overall Study||26
9062196|NCT04321239|10122027|FG000|COMPLETED|Overall Study||22
9062197|NCT04321239|10122028|FG001|COMPLETED|Overall Study||24
9062198|NCT04321239|10122027|FG000|NOT COMPLETED|Overall Study||3
9062199|NCT04321239|10122028|FG001|NOT COMPLETED|Overall Study||2
9062200|NCT04323852|10122036|FG000|STARTED|Overall Study||35
9062201|NCT04323852|10122037|FG001|STARTED|Overall Study||35
9062202|NCT04323852|10122036|FG000|COMPLETED|Overall Study||35
9062203|NCT04323852|10122037|FG001|COMPLETED|Overall Study||35
9062204|NCT04323852|10122036|FG000|NOT COMPLETED|Overall Study||0
9062205|NCT04323852|10122037|FG001|NOT COMPLETED|Overall Study||0
9062206|NCT04327843|10122043|FG000|STARTED|Baseline Assessment||19
9062207|NCT04327843|10122043|FG000|COMPLETED|Baseline Assessment||19
9062208|NCT04327843|10122043|FG000|NOT COMPLETED|Baseline Assessment||0
9062209|NCT04327843|10122043|FG000|STARTED|Week 13 Assessment||19
9062210|NCT04327843|10122043|FG000|COMPLETED|Week 13 Assessment||19
9062211|NCT04327843|10122043|FG000|NOT COMPLETED|Week 13 Assessment||0
9062212|NCT04327843|10122043|FG000|STARTED|Week 25 Assessment||19
9062213|NCT04327843|10122043|FG000|COMPLETED|Week 25 Assessment||18
9062214|NCT04327843|10122043|FG000|NOT COMPLETED|Week 25 Assessment||1
9062215|NCT04331899|10122049|FG000|STARTED|Trial Period (28 Days)||60
9062216|NCT04331899|10122050|FG001|STARTED|Trial Period (28 Days)||60
9062217|NCT04331899|10122049|FG000|COMPLETED|Trial Period (28 Days)||58
9062218|NCT04331899|10122050|FG001|COMPLETED|Trial Period (28 Days)||58
9062219|NCT04331899|10122049|FG000|NOT COMPLETED|Trial Period (28 Days)||2
9062220|NCT04331899|10122050|FG001|NOT COMPLETED|Trial Period (28 Days)||2
9062221|NCT04331899|10122049|FG000|STARTED|Follow-up Period (10 Months)|16 participants who completed the trial period did not continue in the follow-up period.|42
9062222|NCT04331899|10122050|FG001|STARTED|Follow-up Period (10 Months)|15 participants who completed the trial period did not continue in the follow-up period.|43
9062223|NCT04331899|10122049|FG000|COMPLETED|Follow-up Period (10 Months)||42
9062224|NCT04331899|10122050|FG001|COMPLETED|Follow-up Period (10 Months)||43
9062225|NCT04331899|10122049|FG000|NOT COMPLETED|Follow-up Period (10 Months)||0
9062226|NCT04331899|10122050|FG001|NOT COMPLETED|Follow-up Period (10 Months)||0
9062227|NCT04334148|10122058|FG000|STARTED|Overall Study||683
9062228|NCT04334148|10122059|FG001|STARTED|Overall Study||677
9062229|NCT04334148|10122058|FG000|COMPLETED|Overall Study||683
9062230|NCT04334148|10122059|FG001|COMPLETED|Overall Study||676
9062231|NCT04334148|10122058|FG000|NOT COMPLETED|Overall Study||0
9062232|NCT04334148|10122059|FG001|NOT COMPLETED|Overall Study||1
9062233|NCT04343287|10122067|FG000|STARTED|Overall Study||108
9062234|NCT04343287|10122068|FG001|STARTED|Overall Study||112
9062235|NCT04343287|10122067|FG000|COMPLETED|Overall Study||108
9062236|NCT04343287|10122068|FG001|COMPLETED|Overall Study||111
9062237|NCT04343287|10122067|FG000|NOT COMPLETED|Overall Study||0
9062238|NCT04343287|10122068|FG001|NOT COMPLETED|Overall Study||1
9062239|NCT04347954|10122079|FG000|STARTED|Overall Study||15
9062240|NCT04347954|10122080|FG001|STARTED|Overall Study||15
9062241|NCT04347954|10122081|FG002|STARTED|Overall Study||17
9062242|NCT04347954|10122079|FG000|Received Allocated Intervention|Overall Study||12
9062243|NCT04347954|10122080|FG001|Received Allocated Intervention|Overall Study||15
9062244|NCT04347954|10122081|FG002|Received Allocated Intervention|Overall Study||14
9062245|NCT04347954|10122079|FG000|Negative PCR Swab at Baseline|Overall Study||1
9062246|NCT04347954|10122080|FG001|Negative PCR Swab at Baseline|Overall Study||3
9062247|NCT04347954|10122081|FG002|Negative PCR Swab at Baseline|Overall Study||1
9062248|NCT04347954|10122079|FG000|COMPLETED|Overall Study||12
9062249|NCT04347954|10122080|FG001|COMPLETED|Overall Study||14
9062250|NCT04347954|10122081|FG002|COMPLETED|Overall Study||14
9062251|NCT04347954|10122079|FG000|NOT COMPLETED|Overall Study||3
9062252|NCT04347954|10122080|FG001|NOT COMPLETED|Overall Study||1
9062253|NCT04347954|10122081|FG002|NOT COMPLETED|Overall Study||3
9062254|NCT04349098|10122091|FG000|STARTED|Overall Study||103
9062255|NCT04349098|10122092|FG001|STARTED|Overall Study||87
9062256|NCT04349098|10122091|FG000|Treated|Overall Study||102
9062257|NCT04349098|10122092|FG001|Treated|Overall Study||86
9062258|NCT04349098|10122091|FG000|COMPLETED|Overall Study||65
9062259|NCT04349098|10122092|FG001|COMPLETED|Overall Study||61
9062260|NCT04349098|10122091|FG000|NOT COMPLETED|Overall Study||38
9062261|NCT04349098|10122092|FG001|NOT COMPLETED|Overall Study||26
9062262|NCT04353037|10122102|FG000|STARTED|Overall Study||6
9062263|NCT04353037|10122103|FG001|STARTED|Overall Study||3
9062264|NCT04353037|10122104|FG002|STARTED|Overall Study||13
9062265|NCT04353037|10122105|FG003|STARTED|Overall Study||17
9062266|NCT04353037|10122102|FG000|COMPLETED|Overall Study||6
9062267|NCT04353037|10122103|FG001|COMPLETED|Overall Study||0
9062268|NCT04353037|10122104|FG002|COMPLETED|Overall Study||6
9062269|NCT04353037|10122105|FG003|COMPLETED|Overall Study||7
9062270|NCT04353037|10122102|FG000|NOT COMPLETED|Overall Study||0
9062271|NCT04353037|10122103|FG001|NOT COMPLETED|Overall Study||3
9062272|NCT04353037|10122104|FG002|NOT COMPLETED|Overall Study||7
9062273|NCT04353037|10122105|FG003|NOT COMPLETED|Overall Study||10
9062274|NCT04355117|10122117|FG000|STARTED|Overall Study||71
9062275|NCT04355117|10122117|FG000|COMPLETED|Overall Study||71
9062276|NCT04355117|10122117|FG000|NOT COMPLETED|Overall Study||0
9062277|NCT04355767|10122125|FG000|STARTED|Overall Study||257
9062278|NCT04355767|10122126|FG001|STARTED|Overall Study||254
9062279|NCT04355767|10122125|FG000|Intention-to-treat Population|Overall Study||257
9062280|NCT04355767|10122126|FG001|Intention-to-treat Population|Overall Study||254
9062281|NCT04355767|10122125|FG000|Had Data for 15-day Outcome|Overall Study||257
9062282|NCT04355767|10122126|FG001|Had Data for 15-day Outcome|Overall Study||254
9062283|NCT04355767|10122125|FG000|COMPLETED|Overall Study||250
9062284|NCT04355767|10122126|FG001|COMPLETED|Overall Study||251
9062285|NCT04355767|10122125|FG000|NOT COMPLETED|Overall Study||7
9062286|NCT04355767|10122126|FG001|NOT COMPLETED|Overall Study||3
9062287|NCT04356573|10122134|FG000|STARTED|Overall Study||7
9062288|NCT04356573|10122135|FG001|STARTED|Overall Study||6
9062289|NCT04356573|10122134|FG000|COMPLETED|Overall Study||6
9062290|NCT04356573|10122135|FG001|COMPLETED|Overall Study||6
9062291|NCT04356573|10122134|FG000|NOT COMPLETED|Overall Study||1
9062292|NCT04356573|10122135|FG001|NOT COMPLETED|Overall Study||0
9062293|NCT04357379|10122141|FG000|STARTED|Overall Study||10
9062294|NCT04357379|10122141|FG000|COMPLETED|Overall Study||10
9062295|NCT04357379|10122141|FG000|NOT COMPLETED|Overall Study||0
9062296|NCT04358068|10122147|FG000|STARTED|Overall Study||9
9062297|NCT04358068|10122148|FG001|STARTED|Overall Study||11
9062298|NCT04358068|10122147|FG000|COMPLETED|Overall Study||7
9062299|NCT04358068|10122148|FG001|COMPLETED|Overall Study||9
9062300|NCT04358068|10122147|FG000|NOT COMPLETED|Overall Study||2
9062301|NCT04358068|10122148|FG001|NOT COMPLETED|Overall Study||2
9062302|NCT04366349|10122160|FG000|STARTED|Overall Study||13
9062303|NCT04366349|10122161|FG001|STARTED|Overall Study||18
9062304|NCT04366349|10122162|FG002|STARTED|Overall Study||18
9062305|NCT04366349|10122163|FG003|STARTED|Overall Study||4
9062306|NCT04366349|10122164|FG004|STARTED|Overall Study||6
9062307|NCT04366349|10122165|FG005|STARTED|Overall Study||6
9062308|NCT04366349|10122160|FG000|COMPLETED|Overall Study||12
9062309|NCT04366349|10122161|FG001|COMPLETED|Overall Study||18
9062310|NCT04366349|10122162|FG002|COMPLETED|Overall Study||18
9062311|NCT04366349|10122163|FG003|COMPLETED|Overall Study||4
9062312|NCT04366349|10122164|FG004|COMPLETED|Overall Study||6
9062313|NCT04366349|10122165|FG005|COMPLETED|Overall Study||6
9062314|NCT04366349|10122160|FG000|NOT COMPLETED|Overall Study||1
9062315|NCT04366349|10122161|FG001|NOT COMPLETED|Overall Study||0
9062316|NCT04366349|10122162|FG002|NOT COMPLETED|Overall Study||0
9062317|NCT04366349|10122163|FG003|NOT COMPLETED|Overall Study||0
9062318|NCT04366349|10122164|FG004|NOT COMPLETED|Overall Study||0
9062319|NCT04366349|10122165|FG005|NOT COMPLETED|Overall Study||0
9062320|NCT04369885|10122183|FG000|STARTED|Overall Study||12
9062321|NCT04369885|10122183|FG000|COMPLETED|Overall Study||10
9062322|NCT04369885|10122183|FG000|NOT COMPLETED|Overall Study||2
9062323|NCT04373421|10122190|FG000|STARTED|Overall Study||30
9062324|NCT04373421|10122191|FG001|STARTED|Overall Study||30
9062325|NCT04373421|10122192|FG002|STARTED|Overall Study||30
9062326|NCT04373421|10122190|FG000|COMPLETED|Overall Study||26
9062327|NCT04373421|10122191|FG001|COMPLETED|Overall Study||26
9062328|NCT04373421|10122192|FG002|COMPLETED|Overall Study||29
9062329|NCT04373421|10122190|FG000|NOT COMPLETED|Overall Study||4
9062330|NCT04373421|10122191|FG001|NOT COMPLETED|Overall Study||4
9062331|NCT04373421|10122192|FG002|NOT COMPLETED|Overall Study||1
9062332|NCT04381728|10122203|FG000|STARTED|Overall Study||23
9062333|NCT04381728|10122203|FG000|COMPLETED|Overall Study||23
9062334|NCT04381728|10122203|FG000|NOT COMPLETED|Overall Study||0
9062335|NCT04388826|10122209|FG000|STARTED|Overall Study||19
9062336|NCT04388826|10122210|FG001|STARTED|Overall Study||20
9062337|NCT04388826|10122209|FG000|COMPLETED|Overall Study||15
9062338|NCT04388826|10122210|FG001|COMPLETED|Overall Study||18
9062339|NCT04388826|10122209|FG000|NOT COMPLETED|Overall Study||4
9062340|NCT04388826|10122210|FG001|NOT COMPLETED|Overall Study||2
9062341|NCT04394845|10122216|FG000|STARTED|Overall Study||6
9062342|NCT04394845|10122216|FG000|COMPLETED|Overall Study||6
9062343|NCT04394845|10122216|FG000|NOT COMPLETED|Overall Study||0
9062344|NCT04398732|10122222|FG000|STARTED|Overall Study||486
9062345|NCT04398732|10122222|FG000|COMPLETED|Overall Study||436
9062346|NCT04398732|10122222|FG000|NOT COMPLETED|Overall Study||50
9062347|NCT04401293|10122230|FG000|STARTED|Overall Study||130
9062348|NCT04401293|10122231|FG001|STARTED|Overall Study||127
9062349|NCT04401293|10122230|FG000|COMPLETED|Overall Study||129
9062350|NCT04401293|10122231|FG001|COMPLETED|Overall Study||124
9062351|NCT04401293|10122230|FG000|NOT COMPLETED|Overall Study||1
9062352|NCT04401293|10122231|FG001|NOT COMPLETED|Overall Study||3
9062353|NCT04411628|10122241|FG000|STARTED|Overall Study||7
9062354|NCT04411628|10122242|FG001|STARTED|Overall Study||6
9062355|NCT04411628|10122243|FG002|STARTED|Overall Study||7
9062356|NCT04411628|10122244|FG003|STARTED|Overall Study||6
9062357|NCT04411628|10122241|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
9062358|NCT04411628|10122242|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
9062359|NCT04411628|10122243|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
9062360|NCT04411628|10122244|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
9062361|NCT04411628|10122241|FG000|COMPLETED|Overall Study||6
9062362|NCT04411628|10122242|FG001|COMPLETED|Overall Study||4
9062363|NCT04411628|10122243|FG002|COMPLETED|Overall Study||5
9062364|NCT04411628|10122244|FG003|COMPLETED|Overall Study||6
9062365|NCT04411628|10122241|FG000|NOT COMPLETED|Overall Study||1
9062366|NCT04411628|10122242|FG001|NOT COMPLETED|Overall Study||2
9062367|NCT04411628|10122243|FG002|NOT COMPLETED|Overall Study||2
9062368|NCT04411628|10122244|FG003|NOT COMPLETED|Overall Study||0
9062369|NCT04418947|10122262|FG000|STARTED|Overall Study||1108
9062370|NCT04418947|10122263|FG001|STARTED|Overall Study||1351
9062371|NCT04418947|10122264|FG002|STARTED|Overall Study||1351
9062372|NCT04418947|10122265|FG003|STARTED|Overall Study||3655
9062373|NCT04418947|10122266|FG004|STARTED|Overall Study||3655
9062374|NCT04418947|10122262|FG000|COMPLETED|Overall Study||1108
9062375|NCT04418947|10122263|FG001|COMPLETED|Overall Study||1351
9062376|NCT04418947|10122264|FG002|COMPLETED|Overall Study||1351
9062377|NCT04418947|10122265|FG003|COMPLETED|Overall Study||3655
9062378|NCT04418947|10122266|FG004|COMPLETED|Overall Study||3655
9062379|NCT04418947|10122262|FG000|NOT COMPLETED|Overall Study||0
9062380|NCT04418947|10122263|FG001|NOT COMPLETED|Overall Study||0
9062381|NCT04418947|10122264|FG002|NOT COMPLETED|Overall Study||0
9062382|NCT04418947|10122265|FG003|NOT COMPLETED|Overall Study||0
9062383|NCT04418947|10122266|FG004|NOT COMPLETED|Overall Study||0
9062384|NCT04420273|10122280|FG000|STARTED|Overall Study||501
9062385|NCT04420273|10122281|FG001|STARTED|Overall Study||499
9062386|NCT04420273|10122280|FG000|COMPLETED|Overall Study||390
9062387|NCT04420273|10122281|FG001|COMPLETED|Overall Study||414
9062388|NCT04420273|10122280|FG000|NOT COMPLETED|Overall Study||111
9062389|NCT04420273|10122281|FG001|NOT COMPLETED|Overall Study||85
9062390|NCT04420572|10122289|FG000|STARTED|Overall Study||33
9062391|NCT04420572|10122290|FG001|STARTED|Overall Study||30
9062392|NCT04420572|10122289|FG000|COMPLETED|Overall Study||33
9062393|NCT04420572|10122290|FG001|COMPLETED|Overall Study||30
9062394|NCT04420572|10122289|FG000|NOT COMPLETED|Overall Study||0
9062395|NCT04420572|10122290|FG001|NOT COMPLETED|Overall Study||0
9062396|NCT04428411|10122296|FG000|STARTED|Overall Study||486
9062397|NCT04428411|10122296|FG000|Participants With Difficult to Treat Sites|Overall Study||397
9062398|NCT04428411|10122296|FG000|Participants Without Difficulty to Treat Sites|Overall Study||89
9062399|NCT04428411|10122296|FG000|Participants Adherent to Treatment|Overall Study||417
9062400|NCT04428411|10122296|FG000|Participants Not Adherent to Treatment|Overall Study||69
9062401|NCT04428411|10122296|FG000|COMPLETED|Overall Study||372
9062402|NCT04428411|10122296|FG000|NOT COMPLETED|Overall Study||114
9062403|NCT04435184|10122305|FG000|STARTED|Overall Study||25
9062404|NCT04435184|10122306|FG001|STARTED|Overall Study||25
9062405|NCT04435184|10122305|FG000|COMPLETED|Overall Study||22
9062406|NCT04435184|10122306|FG001|COMPLETED|Overall Study||20
9062407|NCT04435184|10122305|FG000|NOT COMPLETED|Overall Study||3
9062408|NCT04435184|10122306|FG001|NOT COMPLETED|Overall Study||5
9062409|NCT04476784|10122314|FG000|STARTED|First Wear Period (30 Days ± 2 Days)||31
9062410|NCT04476784|10122315|FG001|STARTED|First Wear Period (30 Days ± 2 Days)||35
9062411|NCT04476784|10122314|FG000|COMPLETED|First Wear Period (30 Days ± 2 Days)||30
9062412|NCT04476784|10122315|FG001|COMPLETED|First Wear Period (30 Days ± 2 Days)||35
9062413|NCT04476784|10122314|FG000|NOT COMPLETED|First Wear Period (30 Days ± 2 Days)||1
9062414|NCT04476784|10122315|FG001|NOT COMPLETED|First Wear Period (30 Days ± 2 Days)||0
9062415|NCT04476784|10122314|FG000|STARTED|Second Wear Period (30 Days ± 2 Days)||30
9062416|NCT04476784|10122315|FG001|STARTED|Second Wear Period (30 Days ± 2 Days)||35
9062417|NCT04476784|10122314|FG000|COMPLETED|Second Wear Period (30 Days ± 2 Days)||30
9062418|NCT04476784|10122315|FG001|COMPLETED|Second Wear Period (30 Days ± 2 Days)||35
9062419|NCT04476784|10122314|FG000|NOT COMPLETED|Second Wear Period (30 Days ± 2 Days)||0
9062420|NCT04476784|10122315|FG001|NOT COMPLETED|Second Wear Period (30 Days ± 2 Days)||0
9062421|NCT04484207|10122327|FG000|STARTED|Overall Study||86
9062422|NCT04484207|10122328|FG001|STARTED|Overall Study||44
9062423|NCT04484207|10122329|FG002|STARTED|Overall Study||42
9062424|NCT04484207|10122327|FG000|14-Day Follow-Up|Overall Study||69
9062425|NCT04484207|10122328|FG001|14-Day Follow-Up|Overall Study||40
9062426|NCT04484207|10122329|FG002|14-Day Follow-Up|Overall Study||33
9062427|NCT04484207|10122327|FG000|30-Day Follow-Up|Overall Study||65
9062428|NCT04484207|10122328|FG001|30-Day Follow-Up|Overall Study||34
9062429|NCT04484207|10122329|FG002|30-Day Follow-Up|Overall Study||31
9062430|NCT04484207|10122327|FG000|COMPLETED|Overall Study||65
9062431|NCT04484207|10122328|FG001|COMPLETED|Overall Study||34
9062432|NCT04484207|10122329|FG002|COMPLETED|Overall Study||31
9062433|NCT04484207|10122327|FG000|NOT COMPLETED|Overall Study||21
9062434|NCT04484207|10122328|FG001|NOT COMPLETED|Overall Study||10
9062435|NCT04484207|10122329|FG002|NOT COMPLETED|Overall Study||11
9062436|NCT04485455|10122340|FG000|STARTED|Overall Study||5
9062437|NCT04485455|10122340|FG000|COMPLETED|Overall Study||5
9062438|NCT04485455|10122340|FG000|NOT COMPLETED|Overall Study||0
9062439|NCT04495283|10122347|FG000|STARTED|Overall Study||35
9062440|NCT04495283|10122348|FG001|STARTED|Overall Study||35
9062441|NCT04495283|10122349|FG002|STARTED|Overall Study||17
9062442|NCT04495283|10122347|FG000|COMPLETED|Overall Study||34
9062443|NCT04495283|10122348|FG001|COMPLETED|Overall Study||34
9062444|NCT04495283|10122349|FG002|COMPLETED|Overall Study||14
9062445|NCT04495283|10122347|FG000|NOT COMPLETED|Overall Study||1
9062446|NCT04495283|10122348|FG001|NOT COMPLETED|Overall Study||1
9062447|NCT04495283|10122349|FG002|NOT COMPLETED|Overall Study||3
9062448|NCT04497948|10122360|FG000|STARTED|Overall Study||9
9062449|NCT04497948|10122360|FG000|COMPLETED|Overall Study||7
9062450|NCT04497948|10122360|FG000|NOT COMPLETED|Overall Study||2
9062451|NCT04501640|10122372|FG000|STARTED|Period 1 (5 Days)||6
9062452|NCT04501640|10122373|FG001|STARTED|Period 1 (5 Days)||6
9062453|NCT04501640|10122374|FG002|STARTED|Period 1 (5 Days)||6
9062454|NCT04501640|10122375|FG003|STARTED|Period 1 (5 Days)||6
9062455|NCT04501640|10122372|FG000|COMPLETED|Period 1 (5 Days)||6
9062456|NCT04501640|10122373|FG001|COMPLETED|Period 1 (5 Days)||6
9062457|NCT04501640|10122374|FG002|COMPLETED|Period 1 (5 Days)||6
9062458|NCT04501640|10122375|FG003|COMPLETED|Period 1 (5 Days)||6
9062459|NCT04501640|10122372|FG000|NOT COMPLETED|Period 1 (5 Days)||0
9062460|NCT04501640|10122373|FG001|NOT COMPLETED|Period 1 (5 Days)||0
9062461|NCT04501640|10122374|FG002|NOT COMPLETED|Period 1 (5 Days)||0
9062462|NCT04501640|10122375|FG003|NOT COMPLETED|Period 1 (5 Days)||0
9062463|NCT04501640|10122372|FG000|STARTED|Washout Period (10 Days)||6
9062464|NCT04501640|10122373|FG001|STARTED|Washout Period (10 Days)||6
9062465|NCT04501640|10122374|FG002|STARTED|Washout Period (10 Days)||6
9062466|NCT04501640|10122375|FG003|STARTED|Washout Period (10 Days)||6
9062467|NCT04501640|10122372|FG000|COMPLETED|Washout Period (10 Days)||6
9062468|NCT04501640|10122373|FG001|COMPLETED|Washout Period (10 Days)||6
9062469|NCT04501640|10122374|FG002|COMPLETED|Washout Period (10 Days)||6
9062470|NCT04501640|10122375|FG003|COMPLETED|Washout Period (10 Days)||6
9062471|NCT04501640|10122372|FG000|NOT COMPLETED|Washout Period (10 Days)||0
9062472|NCT04501640|10122373|FG001|NOT COMPLETED|Washout Period (10 Days)||0
9062473|NCT04501640|10122374|FG002|NOT COMPLETED|Washout Period (10 Days)||0
9062474|NCT04501640|10122375|FG003|NOT COMPLETED|Washout Period (10 Days)||0
9062475|NCT04501640|10122372|FG000|STARTED|Period 2 (5 Days)||6
9062476|NCT04501640|10122373|FG001|STARTED|Period 2 (5 Days)||6
9062477|NCT04501640|10122374|FG002|STARTED|Period 2 (5 Days)||6
9062478|NCT04501640|10122375|FG003|STARTED|Period 2 (5 Days)||6
9062479|NCT04501640|10122372|FG000|COMPLETED|Period 2 (5 Days)||6
9062480|NCT04501640|10122373|FG001|COMPLETED|Period 2 (5 Days)||6
9062481|NCT04501640|10122374|FG002|COMPLETED|Period 2 (5 Days)||6
9062482|NCT04501640|10122375|FG003|COMPLETED|Period 2 (5 Days)||6
9062483|NCT04501640|10122372|FG000|NOT COMPLETED|Period 2 (5 Days)||0
9062484|NCT04501640|10122373|FG001|NOT COMPLETED|Period 2 (5 Days)||0
9062485|NCT04501640|10122374|FG002|NOT COMPLETED|Period 2 (5 Days)||0
9062486|NCT04501640|10122375|FG003|NOT COMPLETED|Period 2 (5 Days)||0
9062487|NCT04501952|10122387|FG000|STARTED|Overall Study||292
9062488|NCT04501952|10122388|FG001|STARTED|Overall Study||292
9062489|NCT04501952|10122387|FG000|COMPLETED|Overall Study||266
9062490|NCT04501952|10122388|FG001|COMPLETED|Overall Study||272
9062491|NCT04501952|10122387|FG000|NOT COMPLETED|Overall Study||26
9062492|NCT04501952|10122388|FG001|NOT COMPLETED|Overall Study||20
9062493|NCT04504032|10122397|FG000|STARTED|Overall Study||246
9062494|NCT04504032|10122398|FG001|STARTED|Overall Study||251
9062495|NCT04504032|10122397|FG000|COMPLETED|Overall Study||210
9062496|NCT04504032|10122398|FG001|COMPLETED|Overall Study||223
9062497|NCT04504032|10122397|FG000|NOT COMPLETED|Overall Study||36
9062498|NCT04504032|10122398|FG001|NOT COMPLETED|Overall Study||28
9062499|NCT04507763|10122404|FG000|STARTED|Overall Study||763
9062500|NCT04507763|10122404|FG000|COMPLETED|Overall Study||562
9062501|NCT04507763|10122404|FG000|NOT COMPLETED|Overall Study||201
9062502|NCT04507867|10122413|FG000|STARTED|Overall Study||40
9062503|NCT04507867|10122414|FG001|STARTED|Overall Study||40
9062504|NCT04507867|10122413|FG000|COMPLETED|Overall Study||33
9062505|NCT04507867|10122414|FG001|COMPLETED|Overall Study||39
9062506|NCT04507867|10122413|FG000|NOT COMPLETED|Overall Study||7
9062507|NCT04507867|10122414|FG001|NOT COMPLETED|Overall Study||1
9062508|NCT04525079|10122441|FG000|STARTED|Overall Study||6
9062509|NCT04525079|10122442|FG001|STARTED|Overall Study||6
9062510|NCT04525079|10122443|FG002|STARTED|Overall Study||6
9062511|NCT04525079|10122444|FG003|STARTED|Overall Study||6
9062512|NCT04525079|10122445|FG004|STARTED|Overall Study||8
9062513|NCT04525079|10122441|FG000|COMPLETED|Overall Study||6
9062514|NCT04525079|10122442|FG001|COMPLETED|Overall Study||6
9062515|NCT04525079|10122443|FG002|COMPLETED|Overall Study||6
9062516|NCT04525079|10122444|FG003|COMPLETED|Overall Study||6
9062517|NCT04525079|10122445|FG004|COMPLETED|Overall Study||8
9062518|NCT04525079|10122441|FG000|NOT COMPLETED|Overall Study||0
9062519|NCT04525079|10122442|FG001|NOT COMPLETED|Overall Study||0
9062520|NCT04525079|10122443|FG002|NOT COMPLETED|Overall Study||0
9062521|NCT04525079|10122444|FG003|NOT COMPLETED|Overall Study||0
9062522|NCT04525079|10122445|FG004|NOT COMPLETED|Overall Study||0
9062523|NCT04527978|10122459|FG000|STARTED|First Wear Period (8 -0/+3 Days)||27
9062524|NCT04527978|10122460|FG001|STARTED|First Wear Period (8 -0/+3 Days)||28
9062525|NCT04527978|10122459|FG000|COMPLETED|First Wear Period (8 -0/+3 Days)||26
9062526|NCT04527978|10122460|FG001|COMPLETED|First Wear Period (8 -0/+3 Days)||28
9062527|NCT04527978|10122459|FG000|NOT COMPLETED|First Wear Period (8 -0/+3 Days)||1
9062528|NCT04527978|10122460|FG001|NOT COMPLETED|First Wear Period (8 -0/+3 Days)||0
9062529|NCT04527978|10122459|FG000|STARTED|Second Wear Period (8 -0/+3 Days)||26
9062530|NCT04527978|10122460|FG001|STARTED|Second Wear Period (8 -0/+3 Days)||28
9062531|NCT04527978|10122459|FG000|COMPLETED|Second Wear Period (8 -0/+3 Days)||26
9062532|NCT04527978|10122460|FG001|COMPLETED|Second Wear Period (8 -0/+3 Days)||28
9062533|NCT04527978|10122459|FG000|NOT COMPLETED|Second Wear Period (8 -0/+3 Days)||0
9062534|NCT04527978|10122460|FG001|NOT COMPLETED|Second Wear Period (8 -0/+3 Days)||0
9062535|NCT04528017|10122471|FG000|STARTED|First Wear Period (8 -0/+3 Days)||27
9062536|NCT04528017|10122472|FG001|STARTED|First Wear Period (8 -0/+3 Days)||28
9062537|NCT04528017|10122471|FG000|COMPLETED|First Wear Period (8 -0/+3 Days)||27
9062538|NCT04528017|10122472|FG001|COMPLETED|First Wear Period (8 -0/+3 Days)||28
9062539|NCT04528017|10122471|FG000|NOT COMPLETED|First Wear Period (8 -0/+3 Days)||0
9062540|NCT04528017|10122472|FG001|NOT COMPLETED|First Wear Period (8 -0/+3 Days)||0
9062541|NCT04528017|10122471|FG000|STARTED|Second Wear Period (8 -0/+3 Days)||27
9062542|NCT04528017|10122472|FG001|STARTED|Second Wear Period (8 -0/+3 Days)||28
9062543|NCT04528017|10122471|FG000|COMPLETED|Second Wear Period (8 -0/+3 Days)||27
9062544|NCT04528017|10122472|FG001|COMPLETED|Second Wear Period (8 -0/+3 Days)||28
9062545|NCT04528017|10122471|FG000|NOT COMPLETED|Second Wear Period (8 -0/+3 Days)||0
9062546|NCT04528017|10122472|FG001|NOT COMPLETED|Second Wear Period (8 -0/+3 Days)||0
9062547|NCT04529109|10122481|FG000|STARTED|Period 1||27
9062548|NCT04529109|10122482|FG001|STARTED|Period 1||29
9062549|NCT04529109|10122481|FG000|COMPLETED|Period 1||27
9062550|NCT04529109|10122482|FG001|COMPLETED|Period 1||28
9062551|NCT04529109|10122481|FG000|NOT COMPLETED|Period 1||0
9062552|NCT04529109|10122482|FG001|NOT COMPLETED|Period 1||1
9062553|NCT04529109|10122481|FG000|STARTED|Period 2||27
9062554|NCT04529109|10122482|FG001|STARTED|Period 2||28
9062555|NCT04529109|10122481|FG000|COMPLETED|Period 2||27
9062556|NCT04529109|10122482|FG001|COMPLETED|Period 2||28
9062557|NCT04529109|10122481|FG000|NOT COMPLETED|Period 2||0
9062558|NCT04529109|10122482|FG001|NOT COMPLETED|Period 2||0
9062559|NCT04536571|10122488|FG000|STARTED|First Intervention||11
9062560|NCT04536571|10122489|FG001|STARTED|First Intervention||16
9062561|NCT04536571|10122488|FG000|COMPLETED|First Intervention||11
9062562|NCT04536571|10122489|FG001|COMPLETED|First Intervention||16
9062563|NCT04536571|10122488|FG000|NOT COMPLETED|First Intervention||0
9062564|NCT04536571|10122489|FG001|NOT COMPLETED|First Intervention||0
9062565|NCT04536571|10122488|FG000|STARTED|Second Intervention||11
9062566|NCT04536571|10122489|FG001|STARTED|Second Intervention||16
9062567|NCT04536571|10122488|FG000|COMPLETED|Second Intervention||11
9062568|NCT04536571|10122489|FG001|COMPLETED|Second Intervention||16
9062569|NCT04536571|10122488|FG000|NOT COMPLETED|Second Intervention||0
9062570|NCT04536571|10122489|FG001|NOT COMPLETED|Second Intervention||0
9062571|NCT04544787|10122506|FG000|STARTED|Overall Study||50
9062572|NCT04544787|10122507|FG001|STARTED|Overall Study||50
9062573|NCT04544787|10122508|FG002|STARTED|Overall Study||50
9062574|NCT04544787|10122509|FG003|STARTED|Overall Study||50
9062575|NCT04544787|10122510|FG004|STARTED|Overall Study||17
9062576|NCT04544787|10122511|FG005|STARTED|Overall Study||16
9062577|NCT04544787|10122512|FG006|STARTED|Overall Study||17
9062578|NCT04544787|10122506|FG000|Received First Dose of Vaccine|Overall Study||50
9062579|NCT04544787|10122507|FG001|Received First Dose of Vaccine|Overall Study||50
9062580|NCT04544787|10122508|FG002|Received First Dose of Vaccine|Overall Study||50
9062581|NCT04544787|10122509|FG003|Received First Dose of Vaccine|Overall Study||50
9062582|NCT04544787|10122510|FG004|Received First Dose of Vaccine|Overall Study||17
9062583|NCT04544787|10122511|FG005|Received First Dose of Vaccine|Overall Study||16
9062584|NCT04544787|10122512|FG006|Received First Dose of Vaccine|Overall Study||17
9062585|NCT04544787|10122506|FG000|Received Second Dose of Vaccine|Overall Study||0
9062586|NCT04544787|10122507|FG001|Received Second Dose of Vaccine|Overall Study||49
9062587|NCT04544787|10122508|FG002|Received Second Dose of Vaccine|Overall Study||0
9062588|NCT04544787|10122509|FG003|Received Second Dose of Vaccine|Overall Study||49
9062589|NCT04544787|10122510|FG004|Received Second Dose of Vaccine|Overall Study||17
9062590|NCT04544787|10122511|FG005|Received Second Dose of Vaccine|Overall Study||15
9062591|NCT04544787|10122512|FG006|Received Second Dose of Vaccine|Overall Study||16
9062592|NCT04544787|10122506|FG000|COMPLETED|Overall Study||50
9062593|NCT04544787|10122507|FG001|COMPLETED|Overall Study||50
9062594|NCT04544787|10122508|FG002|COMPLETED|Overall Study||50
9062595|NCT04544787|10122509|FG003|COMPLETED|Overall Study||50
9062596|NCT04544787|10122510|FG004|COMPLETED|Overall Study||17
9062597|NCT04544787|10122511|FG005|COMPLETED|Overall Study||16
9062598|NCT04544787|10122512|FG006|COMPLETED|Overall Study||17
9062599|NCT04544787|10122506|FG000|NOT COMPLETED|Overall Study||0
9062600|NCT04544787|10122507|FG001|NOT COMPLETED|Overall Study||0
9062601|NCT04544787|10122508|FG002|NOT COMPLETED|Overall Study||0
9062602|NCT04544787|10122509|FG003|NOT COMPLETED|Overall Study||0
9062603|NCT04544787|10122510|FG004|NOT COMPLETED|Overall Study||0
9062604|NCT04544787|10122511|FG005|NOT COMPLETED|Overall Study||0
9062605|NCT04544787|10122512|FG006|NOT COMPLETED|Overall Study||0
9062606|NCT04555031|10122551|FG000|STARTED|Overall Study||10
9062607|NCT04555031|10122551|FG000|COMPLETED|Overall Study||10
9062608|NCT04555031|10122551|FG000|NOT COMPLETED|Overall Study||0
9062609|NCT04559282|10122558|FG000|STARTED|Intervention 1 (Day 0)||8
9062610|NCT04559282|10122559|FG001|STARTED|Intervention 1 (Day 0)||8
9062611|NCT04559282|10122558|FG000|COMPLETED|Intervention 1 (Day 0)||8
9062612|NCT04559282|10122559|FG001|COMPLETED|Intervention 1 (Day 0)||8
9062613|NCT04559282|10122558|FG000|NOT COMPLETED|Intervention 1 (Day 0)||0
9062614|NCT04559282|10122559|FG001|NOT COMPLETED|Intervention 1 (Day 0)||0
9062615|NCT04559282|10122558|FG000|STARTED|Intervention 2 (Day 7)||8
9062616|NCT04559282|10122559|FG001|STARTED|Intervention 2 (Day 7)||8
9062617|NCT04559282|10122558|FG000|COMPLETED|Intervention 2 (Day 7)||8
9062618|NCT04559282|10122559|FG001|COMPLETED|Intervention 2 (Day 7)||8
9062619|NCT04559282|10122558|FG000|NOT COMPLETED|Intervention 2 (Day 7)||0
9062620|NCT04559282|10122559|FG001|NOT COMPLETED|Intervention 2 (Day 7)||0
9062621|NCT04559282|10122558|FG000|STARTED|Intervention 3 (Day 14)||8
9062622|NCT04559282|10122559|FG001|STARTED|Intervention 3 (Day 14)||8
9062623|NCT04559282|10122558|FG000|COMPLETED|Intervention 3 (Day 14)||8
9062624|NCT04559282|10122559|FG001|COMPLETED|Intervention 3 (Day 14)||8
9062625|NCT04559282|10122558|FG000|NOT COMPLETED|Intervention 3 (Day 14)||0
9062626|NCT04559282|10122559|FG001|NOT COMPLETED|Intervention 3 (Day 14)||0
9062627|NCT04574297|10122572|FG000|STARTED|Overall Study||180
9062628|NCT04574297|10122573|FG001|STARTED|Overall Study||263
9062629|NCT04574297|10122574|FG002|STARTED|Overall Study||230
9062630|NCT04574297|10122575|FG003|STARTED|Overall Study||125
9062631|NCT04574297|10122572|FG000|COMPLETED|Overall Study||180
9062632|NCT04574297|10122573|FG001|COMPLETED|Overall Study||263
9062633|NCT04574297|10122574|FG002|COMPLETED|Overall Study||230
9062634|NCT04574297|10122575|FG003|COMPLETED|Overall Study||125
9062635|NCT04574297|10122572|FG000|NOT COMPLETED|Overall Study||0
9062636|NCT04574297|10122573|FG001|NOT COMPLETED|Overall Study||0
9062637|NCT04574297|10122574|FG002|NOT COMPLETED|Overall Study||0
9062638|NCT04574297|10122575|FG003|NOT COMPLETED|Overall Study||0
9062639|NCT04580290|10122587|FG000|STARTED|Overall Study||88
9062640|NCT04580290|10122588|FG001|STARTED|Overall Study||32
9062641|NCT04580290|10122587|FG000|COMPLETED|Overall Study||88
9062642|NCT04580290|10122588|FG001|COMPLETED|Overall Study||32
9062643|NCT04580290|10122587|FG000|NOT COMPLETED|Overall Study||0
9062644|NCT04580290|10122588|FG001|NOT COMPLETED|Overall Study||0
9062645|NCT04601103|10122597|FG000|STARTED|Overall Study||18
9062646|NCT04601103|10122598|FG001|STARTED|Overall Study||18
9062647|NCT04601103|10122599|FG002|STARTED|Overall Study||17
9062648|NCT04601103|10122597|FG000|COMPLETED|Overall Study||0
9062649|NCT04601103|10122598|FG001|COMPLETED|Overall Study||0
9062650|NCT04601103|10122599|FG002|COMPLETED|Overall Study||0
9062651|NCT04601103|10122597|FG000|NOT COMPLETED|Overall Study||18
9062652|NCT04601103|10122598|FG001|NOT COMPLETED|Overall Study||18
9062653|NCT04601103|10122599|FG002|NOT COMPLETED|Overall Study||17
9062654|NCT04617574|10122609|FG000|STARTED|Overall Study||30
9062655|NCT04617574|10122610|FG001|STARTED|Overall Study||30
9062656|NCT04617574|10122609|FG000|COMPLETED|Overall Study||30
9062657|NCT04617574|10122610|FG001|COMPLETED|Overall Study||30
9062658|NCT04617574|10122609|FG000|NOT COMPLETED|Overall Study||0
9062659|NCT04617574|10122610|FG001|NOT COMPLETED|Overall Study||0
9062660|NCT04658797|10122618|FG000|STARTED|Overall Study||15
9062661|NCT04658797|10122619|FG001|STARTED|Overall Study||15
9062662|NCT04658797|10122618|FG000|COMPLETED|Overall Study||15
9062663|NCT04658797|10122619|FG001|COMPLETED|Overall Study||15
9062664|NCT04658797|10122618|FG000|NOT COMPLETED|Overall Study||0
9062665|NCT04658797|10122619|FG001|NOT COMPLETED|Overall Study||0
9062666|NCT04664855|10122627|FG000|STARTED|Overall Study||23
9062667|NCT04664855|10122628|FG001|STARTED|Overall Study||24
9062668|NCT04664855|10122627|FG000|COMPLETED|Overall Study||23
9062669|NCT04664855|10122628|FG001|COMPLETED|Overall Study||22
9062670|NCT04664855|10122627|FG000|NOT COMPLETED|Overall Study||0
9062671|NCT04664855|10122628|FG001|NOT COMPLETED|Overall Study||2
9062672|NCT04701658|10122634|FG000|STARTED|Overall Study||109
9062673|NCT04701658|10122634|FG000|Received Single Dose of Bamlanivimab|Overall Study||109
9062674|NCT04701658|10122634|FG000|COMPLETED|Overall Study||103
9062675|NCT04701658|10122634|FG000|NOT COMPLETED|Overall Study||6
9062676|NCT04706416|10122640|FG000|STARTED|Overall Study||50
9062677|NCT04706416|10122641|FG001|STARTED|Overall Study||100
9062678|NCT04706416|10122640|FG000|COMPLETED|Overall Study||48
9062679|NCT04706416|10122641|FG001|COMPLETED|Overall Study||100
9062680|NCT04706416|10122640|FG000|NOT COMPLETED|Overall Study||2
9062681|NCT04706416|10122641|FG001|NOT COMPLETED|Overall Study||0
9062682|NCT04709484|10122652|FG000|STARTED|Overall Study||34
9062683|NCT04709484|10122653|FG001|STARTED|Overall Study||32
9062684|NCT04709484|10122652|FG000|COMPLETED|Overall Study||34
9062685|NCT04709484|10122653|FG001|COMPLETED|Overall Study||32
9062686|NCT04709484|10122652|FG000|NOT COMPLETED|Overall Study||0
9062687|NCT04709484|10122653|FG001|NOT COMPLETED|Overall Study||0
9062688|NCT04727749|10122661|FG000|STARTED|Overall Study||107
9062689|NCT04727749|10122662|FG001|STARTED|Overall Study||104
9062690|NCT04727749|10122661|FG000|COMPLETED|Overall Study||97
9062691|NCT04727749|10122662|FG001|COMPLETED|Overall Study||101
9062692|NCT04727749|10122661|FG000|NOT COMPLETED|Overall Study||10
9062693|NCT04727749|10122662|FG001|NOT COMPLETED|Overall Study||3
9062694|NCT04777214|10122672|FG000|STARTED|Initial Randomization||5
9062695|NCT04777214|10122673|FG001|STARTED|Initial Randomization||5
9062696|NCT04777214|10122672|FG000|COMPLETED|Initial Randomization||5
9062697|NCT04777214|10122673|FG001|COMPLETED|Initial Randomization||5
9062698|NCT04777214|10122672|FG000|NOT COMPLETED|Initial Randomization||0
9062699|NCT04777214|10122673|FG001|NOT COMPLETED|Initial Randomization||0
9062700|NCT04777214|10122672|FG000|STARTED|Sham Crossover to Active TMS Arm||0
9062701|NCT04777214|10122673|FG001|STARTED|Sham Crossover to Active TMS Arm||5
9062702|NCT04777214|10122672|FG000|COMPLETED|Sham Crossover to Active TMS Arm||0
9062703|NCT04777214|10122673|FG001|COMPLETED|Sham Crossover to Active TMS Arm||5
9062704|NCT04777214|10122672|FG000|NOT COMPLETED|Sham Crossover to Active TMS Arm||0
9062705|NCT04777214|10122673|FG001|NOT COMPLETED|Sham Crossover to Active TMS Arm||0
9062706|NCT04854707|10122684|FG000|STARTED|Overall Study||2625
9062707|NCT04854707|10122685|FG001|STARTED|Overall Study||2183
9062708|NCT04854707|10122686|FG002|STARTED|Overall Study||676
9062709|NCT04854707|10122684|FG000|COMPLETED|Overall Study||2547
9062710|NCT04854707|10122685|FG001|COMPLETED|Overall Study||2124
9062711|NCT04854707|10122686|FG002|COMPLETED|Overall Study||646
9062712|NCT04854707|10122684|FG000|NOT COMPLETED|Overall Study||78
9062713|NCT04854707|10122685|FG001|NOT COMPLETED|Overall Study||59
9062714|NCT04854707|10122686|FG002|NOT COMPLETED|Overall Study||30
9062715|NCT04898166|10122700|FG000|STARTED|Overall Study||220
9062716|NCT04898166|10122701|FG001|STARTED|Overall Study||80
9062717|NCT04898166|10122700|FG000|COMPLETED|Overall Study||220
9062718|NCT04898166|10122701|FG001|COMPLETED|Overall Study||80
9062719|NCT04898166|10122700|FG000|NOT COMPLETED|Overall Study||0
9062720|NCT04898166|10122701|FG001|NOT COMPLETED|Overall Study||0
9062721|NCT04926233|10122721|FG000|STARTED|Overall Study||1280486
9062722|NCT04926233|10122722|FG001|STARTED|Overall Study||90660
9062723|NCT04926233|10122721|FG000|COMPLETED|Overall Study||1280486
9062724|NCT04926233|10122722|FG001|COMPLETED|Overall Study||90660
9062725|NCT04926233|10122721|FG000|NOT COMPLETED|Overall Study||0
9062726|NCT04926233|10122722|FG001|NOT COMPLETED|Overall Study||0
9062727|NCT04943159|10122774|FG000|STARTED|Overall Study||3
9062728|NCT04943159|10122774|FG000|COMPLETED|Overall Study||3
9062729|NCT04943159|10122774|FG000|NOT COMPLETED|Overall Study||0
9062730|NCT04947436|10122781|FG000|STARTED|Overall Study||7
9062731|NCT04947436|10122782|FG001|STARTED|Overall Study||10
9062732|NCT04947436|10122783|FG002|STARTED|Overall Study||11
9062733|NCT04947436|10122781|FG000|COMPLETED|Overall Study||3
9062734|NCT04947436|10122782|FG001|COMPLETED|Overall Study||2
9062735|NCT04947436|10122783|FG002|COMPLETED|Overall Study||5
9062736|NCT04947436|10122781|FG000|NOT COMPLETED|Overall Study||4
9062737|NCT04947436|10122782|FG001|NOT COMPLETED|Overall Study||8
9062738|NCT04947436|10122783|FG002|NOT COMPLETED|Overall Study||6
9062739|NCT05002972|10122791|FG000|STARTED|Overall Study||63
9062740|NCT05002972|10122791|FG000|COMPLETED|Overall Study||61
9062741|NCT05002972|10122791|FG000|NOT COMPLETED|Overall Study||2
9062742|NCT05002985|10122795|FG000|STARTED|Overall Study||49
9062743|NCT05002985|10122795|FG000|COMPLETED|Overall Study||48
9062744|NCT05002985|10122795|FG000|NOT COMPLETED|Overall Study||1
9062745|NCT04512482|10122801|FG000|STARTED|First Intervention (1 Day)||24
9062746|NCT04512482|10122802|FG001|STARTED|First Intervention (1 Day)||21
9062747|NCT04512482|10122801|FG000|Baseline Plaque Assessment|First Intervention (1 Day)||24
9062748|NCT04512482|10122802|FG001|Baseline Plaque Assessment|First Intervention (1 Day)||21
9062749|NCT04512482|10122801|FG000|Baseline Photographs|First Intervention (1 Day)||24
9062750|NCT04512482|10122802|FG001|Baseline Photographs|First Intervention (1 Day)||21
9062751|NCT04512482|10122801|FG000|Received Rinse Intervention|First Intervention (1 Day)||24
9062752|NCT04512482|10122802|FG001|Received Rinse Intervention|First Intervention (1 Day)||21
9062753|NCT04512482|10122801|FG000|Post-rinse Photographs|First Intervention (1 Day)||24
9062754|NCT04512482|10122802|FG001|Post-rinse Photographs|First Intervention (1 Day)||21
9062755|NCT04512482|10122801|FG000|Toothbrush Utilization|First Intervention (1 Day)||24
9062756|NCT04512482|10122802|FG001|Toothbrush Utilization|First Intervention (1 Day)||21
9062757|NCT04512482|10122801|FG000|Post-toothbrush Photographs|First Intervention (1 Day)||24
9062758|NCT04512482|10122802|FG001|Post-toothbrush Photographs|First Intervention (1 Day)||21
9062759|NCT04512482|10122801|FG000|Waterpik Utilization|First Intervention (1 Day)||24
9062760|NCT04512482|10122802|FG001|Waterpik Utilization|First Intervention (1 Day)||21
9062761|NCT04512482|10122801|FG000|Post-Waterpik Photographs|First Intervention (1 Day)||24
9062762|NCT04512482|10122802|FG001|Post-Waterpik Photographs|First Intervention (1 Day)||21
9062763|NCT04512482|10122801|FG000|COMPLETED|First Intervention (1 Day)||24
9062764|NCT04512482|10122802|FG001|COMPLETED|First Intervention (1 Day)||21
9062765|NCT04512482|10122801|FG000|NOT COMPLETED|First Intervention (1 Day)||0
9062766|NCT04512482|10122802|FG001|NOT COMPLETED|First Intervention (1 Day)||0
9062767|NCT04512482|10122801|FG000|STARTED|Washout (1 Week)||24
9062768|NCT04512482|10122802|FG001|STARTED|Washout (1 Week)||21
9062769|NCT04512482|10122801|FG000|COMPLETED|Washout (1 Week)||24
9062770|NCT04512482|10122802|FG001|COMPLETED|Washout (1 Week)||21
9062771|NCT04512482|10122801|FG000|NOT COMPLETED|Washout (1 Week)||0
9062772|NCT04512482|10122802|FG001|NOT COMPLETED|Washout (1 Week)||0
9062773|NCT04512482|10122801|FG000|STARTED|Second Intervention (1 Day)||24
9062774|NCT04512482|10122802|FG001|STARTED|Second Intervention (1 Day)||21
9062775|NCT04512482|10122801|FG000|Baseline Plaque Assessment|Second Intervention (1 Day)||22
9062776|NCT04512482|10122802|FG001|Baseline Plaque Assessment|Second Intervention (1 Day)||20
9062777|NCT04512482|10122801|FG000|Baseline Photographs|Second Intervention (1 Day)||22
9062778|NCT04512482|10122802|FG001|Baseline Photographs|Second Intervention (1 Day)||20
9062779|NCT04512482|10122801|FG000|Received Intervention|Second Intervention (1 Day)||22
9062780|NCT04512482|10122802|FG001|Received Intervention|Second Intervention (1 Day)||20
9062781|NCT04512482|10122801|FG000|Post-rinse Photographs|Second Intervention (1 Day)||22
9062782|NCT04512482|10122802|FG001|Post-rinse Photographs|Second Intervention (1 Day)||20
9062783|NCT04512482|10122801|FG000|Toothbrush Utilization|Second Intervention (1 Day)||22
9062784|NCT04512482|10122802|FG001|Toothbrush Utilization|Second Intervention (1 Day)||20
9062785|NCT04512482|10122801|FG000|Post-toothbrush Photographs|Second Intervention (1 Day)||22
9062786|NCT04512482|10122802|FG001|Post-toothbrush Photographs|Second Intervention (1 Day)||20
9062787|NCT04512482|10122801|FG000|Waterpik Utilization|Second Intervention (1 Day)||22
9062788|NCT04512482|10122802|FG001|Waterpik Utilization|Second Intervention (1 Day)||20
9062789|NCT04512482|10122801|FG000|Post-Waterpik Photographs|Second Intervention (1 Day)||22
9062790|NCT04512482|10122802|FG001|Post-Waterpik Photographs|Second Intervention (1 Day)||20
9062791|NCT04512482|10122801|FG000|COMPLETED|Second Intervention (1 Day)||22
9062792|NCT04512482|10122802|FG001|COMPLETED|Second Intervention (1 Day)||20
9062793|NCT04512482|10122801|FG000|NOT COMPLETED|Second Intervention (1 Day)||2
9062794|NCT04512482|10122802|FG001|NOT COMPLETED|Second Intervention (1 Day)||1
9062795|NCT04499599|10122811|FG000|STARTED|Overall Study||35
9062796|NCT04499599|10122812|FG001|STARTED|Overall Study||35
9062797|NCT04499599|10122813|FG002|STARTED|Overall Study||35
9062798|NCT04499599|10122811|FG000|COMPLETED|Overall Study||35
9062799|NCT04499599|10122812|FG001|COMPLETED|Overall Study||35
9062800|NCT04499599|10122813|FG002|COMPLETED|Overall Study||35
9062801|NCT04499599|10122811|FG000|NOT COMPLETED|Overall Study||0
9062802|NCT04499599|10122812|FG001|NOT COMPLETED|Overall Study||0
9062803|NCT04499599|10122813|FG002|NOT COMPLETED|Overall Study||0
9062804|NCT04525157|10122821|FG000|STARTED|Overall Study||18
9062805|NCT04525157|10122821|FG000|COMPLETED|Overall Study||15
9062806|NCT04525157|10122821|FG000|NOT COMPLETED|Overall Study||3
9062807|NCT04523831|10122827|FG000|STARTED|Overall Study||200
9062808|NCT04523831|10122828|FG001|STARTED|Overall Study||200
9062809|NCT04523831|10122827|FG000|COMPLETED|Overall Study||183
9062810|NCT04523831|10122828|FG001|COMPLETED|Overall Study||180
9062811|NCT04523831|10122827|FG000|NOT COMPLETED|Overall Study||17
9062812|NCT04523831|10122828|FG001|NOT COMPLETED|Overall Study||20
9062813|NCT04521777|10122837|FG000|STARTED|Overall Study||24
9062814|NCT04521777|10122837|FG000|COMPLETED|Overall Study||20
9062815|NCT04521777|10122837|FG000|NOT COMPLETED|Overall Study||4
9062816|NCT04512703|10122843|FG000|STARTED|Within 7 Days From Start of Device Wear||6
9062817|NCT04512703|10122844|FG001|STARTED|Within 7 Days From Start of Device Wear||45
9062818|NCT04512703|10122843|FG000|Wore Front Position|Within 7 Days From Start of Device Wear||6
9062819|NCT04512703|10122844|FG001|Wore Front Position|Within 7 Days From Start of Device Wear||45
9062820|NCT04512703|10122843|FG000|Wore Side Position|Within 7 Days From Start of Device Wear||6
9062821|NCT04512703|10122844|FG001|Wore Side Position|Within 7 Days From Start of Device Wear||45
9062822|NCT04512703|10122843|FG000|COMPLETED|Within 7 Days From Start of Device Wear||6
9062823|NCT04512703|10122844|FG001|COMPLETED|Within 7 Days From Start of Device Wear||45
9062824|NCT04512703|10122843|FG000|NOT COMPLETED|Within 7 Days From Start of Device Wear||0
9062825|NCT04512703|10122844|FG001|NOT COMPLETED|Within 7 Days From Start of Device Wear||0
9062826|NCT04512703|10122843|FG000|STARTED|Between 7th and 90th Day of Device Wear||6
9062827|NCT04512703|10122844|FG001|STARTED|Between 7th and 90th Day of Device Wear||45
9062828|NCT04512703|10122843|FG000|Wore Side Position Device|Between 7th and 90th Day of Device Wear||3
9062829|NCT04512703|10122844|FG001|Wore Side Position Device|Between 7th and 90th Day of Device Wear||23
9062830|NCT04512703|10122843|FG000|Wore Front Position Device|Between 7th and 90th Day of Device Wear||3
9062831|NCT04512703|10122844|FG001|Wore Front Position Device|Between 7th and 90th Day of Device Wear||22
9062832|NCT04512703|10122843|FG000|COMPLETED|Between 7th and 90th Day of Device Wear||6
9062833|NCT04512703|10122844|FG001|COMPLETED|Between 7th and 90th Day of Device Wear||45
9062834|NCT04512703|10122843|FG000|NOT COMPLETED|Between 7th and 90th Day of Device Wear||0
9062835|NCT04512703|10122844|FG001|NOT COMPLETED|Between 7th and 90th Day of Device Wear||0
9062836|NCT04511520|10122856|FG000|STARTED|Overall Study||24
9062837|NCT04511520|10122857|FG001|STARTED|Overall Study||24
9062838|NCT04511520|10122858|FG002|STARTED|Overall Study||24
9062839|NCT04511520|10122856|FG000|COMPLETED|Overall Study||24
9062840|NCT04511520|10122857|FG001|COMPLETED|Overall Study||24
9062841|NCT04511520|10122858|FG002|COMPLETED|Overall Study||24
9062842|NCT04511520|10122856|FG000|NOT COMPLETED|Overall Study||0
9062843|NCT04511520|10122857|FG001|NOT COMPLETED|Overall Study||0
9062844|NCT04511520|10122858|FG002|NOT COMPLETED|Overall Study||0
9062845|NCT04507776|10122867|FG000|STARTED|Overall Study||763
9062846|NCT04507776|10122867|FG000|COMPLETED|Overall Study||562
9062847|NCT04507776|10122867|FG000|NOT COMPLETED|Overall Study||201
9062848|NCT04502979|10122878|FG000|STARTED|Overall Study||37
9062849|NCT04502979|10122879|FG001|STARTED|Overall Study||34
9062850|NCT04502979|10122878|FG000|COMPLETED|Overall Study||34
9062851|NCT04502979|10122879|FG001|COMPLETED|Overall Study||30
9062852|NCT04502979|10122878|FG000|NOT COMPLETED|Overall Study||3
9062853|NCT04502979|10122879|FG001|NOT COMPLETED|Overall Study||4
9062854|NCT04502056|10122887|FG000|STARTED|Overall Study||2046
9062855|NCT04502056|10122888|FG001|STARTED|Overall Study||2044
9062856|NCT04502056|10122889|FG002|STARTED|Overall Study||2045
9062857|NCT04502056|10122890|FG003|STARTED|Overall Study||2046
9062858|NCT04502056|10122891|FG004|STARTED|Overall Study||2044
9062859|NCT04502056|10122892|FG005|STARTED|Overall Study||2052
9062860|NCT04502056|10122893|FG006|STARTED|Overall Study||2046
9062861|NCT04502056|10122894|FG007|STARTED|Overall Study||2043
9062862|NCT04502056|10122895|FG008|STARTED|Overall Study||1026
9062863|NCT04502056|10122896|FG009|STARTED|Overall Study||1025
9062864|NCT04502056|10122897|FG010|STARTED|Overall Study||1023
9062865|NCT04502056|10122898|FG011|STARTED|Overall Study||1020
9062866|NCT04502056|10122887|FG000|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1859
9062867|NCT04502056|10122888|FG001|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1881
9062868|NCT04502056|10122889|FG002|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1879
9062869|NCT04502056|10122890|FG003|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1886
9062870|NCT04502056|10122891|FG004|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1846
9062871|NCT04502056|10122892|FG005|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1877
9062872|NCT04502056|10122893|FG006|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1888
9062873|NCT04502056|10122894|FG007|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1883
9062874|NCT04502056|10122895|FG008|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||947
9062875|NCT04502056|10122896|FG009|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||942
9062876|NCT04502056|10122897|FG010|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||946
9062877|NCT04502056|10122898|FG011|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||928
9062878|NCT04502056|10122887|FG000|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1799
9062879|NCT04502056|10122888|FG001|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1828
9062880|NCT04502056|10122889|FG002|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1830
9062881|NCT04502056|10122890|FG003|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1835
9062882|NCT04502056|10122891|FG004|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1792
9062883|NCT04502056|10122892|FG005|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1820
9062884|NCT04502056|10122893|FG006|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1821
9062885|NCT04502056|10122894|FG007|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1844
9062886|NCT04502056|10122895|FG008|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||914
9062887|NCT04502056|10122896|FG009|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||912
9062888|NCT04502056|10122897|FG010|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||928
9062889|NCT04502056|10122898|FG011|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||900
9062890|NCT04502056|10122887|FG000|Completed the Follow-up Survey|Overall Study||608
9062891|NCT04502056|10122888|FG001|Completed the Follow-up Survey|Overall Study||607
9062892|NCT04502056|10122889|FG002|Completed the Follow-up Survey|Overall Study||591
9062893|NCT04502056|10122890|FG003|Completed the Follow-up Survey|Overall Study||601
9062894|NCT04502056|10122891|FG004|Completed the Follow-up Survey|Overall Study||631
9062895|NCT04502056|10122892|FG005|Completed the Follow-up Survey|Overall Study||598
9062896|NCT04502056|10122893|FG006|Completed the Follow-up Survey|Overall Study||607
9062897|NCT04502056|10122894|FG007|Completed the Follow-up Survey|Overall Study||607
9062898|NCT04502056|10122895|FG008|Completed the Follow-up Survey|Overall Study||301
9062899|NCT04502056|10122896|FG009|Completed the Follow-up Survey|Overall Study||313
9062900|NCT04502056|10122897|FG010|Completed the Follow-up Survey|Overall Study||291
9062901|NCT04502056|10122898|FG011|Completed the Follow-up Survey|Overall Study||316
9062902|NCT04502056|10122887|FG000|COMPLETED|Overall Study||604
9062903|NCT04502056|10122888|FG001|COMPLETED|Overall Study||602
9062904|NCT04502056|10122889|FG002|COMPLETED|Overall Study||586
9062905|NCT04502056|10122890|FG003|COMPLETED|Overall Study||597
9062906|NCT04502056|10122891|FG004|COMPLETED|Overall Study||626
9062907|NCT04502056|10122892|FG005|COMPLETED|Overall Study||596
9062908|NCT04502056|10122893|FG006|COMPLETED|Overall Study||605
9062909|NCT04502056|10122894|FG007|COMPLETED|Overall Study||603
9062910|NCT04502056|10122895|FG008|COMPLETED|Overall Study||298
9062911|NCT04502056|10122896|FG009|COMPLETED|Overall Study||311
9062912|NCT04502056|10122897|FG010|COMPLETED|Overall Study||288
9062913|NCT04502056|10122898|FG011|COMPLETED|Overall Study||614
9062914|NCT04502056|10122887|FG000|NOT COMPLETED|Overall Study||1442
9062915|NCT04502056|10122888|FG001|NOT COMPLETED|Overall Study||1442
9062916|NCT04502056|10122889|FG002|NOT COMPLETED|Overall Study||1459
9062917|NCT04502056|10122890|FG003|NOT COMPLETED|Overall Study||1449
9062918|NCT04502056|10122891|FG004|NOT COMPLETED|Overall Study||1418
9062919|NCT04502056|10122892|FG005|NOT COMPLETED|Overall Study||1456
9062920|NCT04502056|10122893|FG006|NOT COMPLETED|Overall Study||1441
9062921|NCT04502056|10122894|FG007|NOT COMPLETED|Overall Study||1440
9062922|NCT04502056|10122895|FG008|NOT COMPLETED|Overall Study||728
9062923|NCT04502056|10122896|FG009|NOT COMPLETED|Overall Study||714
9062924|NCT04502056|10122897|FG010|NOT COMPLETED|Overall Study||735
9062925|NCT04502056|10122898|FG011|NOT COMPLETED|Overall Study||406
9062926|NCT04498403|10122922|FG000|STARTED|Overall Study||30
9062927|NCT04498403|10122923|FG001|STARTED|Overall Study||10
9062928|NCT04498403|10122922|FG000|Completed Follow up|Overall Study||30
9062929|NCT04498403|10122923|FG001|Completed Follow up|Overall Study||10
9062930|NCT04498403|10122922|FG000|COMPLETED|Overall Study||0
9062931|NCT04498403|10122923|FG001|COMPLETED|Overall Study||0
9062932|NCT04498403|10122922|FG000|NOT COMPLETED|Overall Study||30
9062933|NCT04498403|10122923|FG001|NOT COMPLETED|Overall Study||10
9062934|NCT04495374|10122931|FG000|STARTED|Overall Study||30
9062935|NCT04495374|10122932|FG001|STARTED|Overall Study||28
9062936|NCT04495374|10122931|FG000|COMPLETED|Overall Study||28
9062937|NCT04495374|10122932|FG001|COMPLETED|Overall Study||27
9062938|NCT04495374|10122931|FG000|NOT COMPLETED|Overall Study||2
9062939|NCT04495374|10122932|FG001|NOT COMPLETED|Overall Study||1
9062940|NCT04495712|10122940|FG000|STARTED|Overall Study||44
9062941|NCT04495712|10122941|FG001|STARTED|Overall Study||46
9062942|NCT04495712|10122940|FG000|COMPLETED|Overall Study||44
9062943|NCT04495712|10122941|FG001|COMPLETED|Overall Study||46
9062944|NCT04495712|10122940|FG000|NOT COMPLETED|Overall Study||0
9062945|NCT04495712|10122941|FG001|NOT COMPLETED|Overall Study||0
9062946|NCT04492397|10122947|FG000|STARTED|First Intervention||17
9062947|NCT04492397|10122948|FG001|STARTED|First Intervention||18
9062948|NCT04492397|10122947|FG000|COMPLETED|First Intervention||17
9062949|NCT04492397|10122948|FG001|COMPLETED|First Intervention||18
9062950|NCT04492397|10122947|FG000|NOT COMPLETED|First Intervention||0
9062951|NCT04492397|10122948|FG001|NOT COMPLETED|First Intervention||0
9062952|NCT04492397|10122947|FG000|STARTED|Second Intervention||17
9062953|NCT04492397|10122948|FG001|STARTED|Second Intervention||18
9062954|NCT04492397|10122947|FG000|COMPLETED|Second Intervention||17
9062955|NCT04492397|10122948|FG001|COMPLETED|Second Intervention||18
9062956|NCT04492397|10122947|FG000|NOT COMPLETED|Second Intervention||0
9062957|NCT04492397|10122948|FG001|NOT COMPLETED|Second Intervention||0
9062958|NCT04491994|10122956|FG000|STARTED|Overall Study||180
9062959|NCT04491994|10122957|FG001|STARTED|Overall Study||360
9062960|NCT04491994|10122956|FG000|COMPLETED|Overall Study||151
9062961|NCT04491994|10122957|FG001|COMPLETED|Overall Study||349
9062962|NCT04491994|10122956|FG000|NOT COMPLETED|Overall Study||29
9062963|NCT04491994|10122957|FG001|NOT COMPLETED|Overall Study||11
9062964|NCT04491240|10122966|FG000|STARTED|Overall Study||10
9062965|NCT04491240|10122967|FG001|STARTED|Overall Study||10
9062966|NCT04491240|10122968|FG002|STARTED|Overall Study||10
9062967|NCT04491240|10122966|FG000|COMPLETED|Overall Study||10
9062968|NCT04491240|10122967|FG001|COMPLETED|Overall Study||10
9062969|NCT04491240|10122968|FG002|COMPLETED|Overall Study||10
9062970|NCT04491240|10122966|FG000|NOT COMPLETED|Overall Study||0
9062971|NCT04491240|10122967|FG001|NOT COMPLETED|Overall Study||0
8812748|NCT01521507|9865780|FG000|STARTED|Stage 1: Randomized Design||101
8812749|NCT01521507|9865781|FG001|STARTED|Stage 1: Randomized Design||99
8812750|NCT01521507|9865780|FG000|Received Initial Treatment (Tx)|Stage 1: Randomized Design||99
9062972|NCT04491240|10122968|FG002|NOT COMPLETED|Overall Study||0
9062973|NCT04490863|10122976|FG000|STARTED|Overall Study||26
9062974|NCT04490863|10122976|FG000|COMPLETED|Overall Study||26
9062975|NCT04490863|10122976|FG000|NOT COMPLETED|Overall Study||0
9062976|NCT04490499|10122980|FG000|STARTED|Overall Study||207
9062977|NCT04490499|10122980|FG000|Vaccinated|Overall Study||205
9062978|NCT04490499|10122980|FG000|COMPLETED|Overall Study||205
9062979|NCT04490499|10122980|FG000|NOT COMPLETED|Overall Study||2
9062980|NCT04490239|10122984|FG000|STARTED|1000 U Acute (One Dose, Day 1)||6
9062981|NCT04490239|10122984|FG000|COMPLETED|1000 U Acute (One Dose, Day 1)||6
9062982|NCT04490239|10122984|FG000|NOT COMPLETED|1000 U Acute (One Dose, Day 1)||0
9062983|NCT04490239|10122984|FG000|STARTED|2000 U Acute (One Dose, Day 3)||6
9062984|NCT04490239|10122984|FG000|COMPLETED|2000 U Acute (One Dose, Day 3)||6
9062985|NCT04490239|10122984|FG000|NOT COMPLETED|2000 U Acute (One Dose, Day 3)||0
8812751|NCT01521507|9865781|FG001|Received Initial Treatment (Tx)|Stage 1: Randomized Design||98
8812752|NCT01521507|9865780|FG000|COMPLETED|Stage 1: Randomized Design||98
9062986|NCT04490239|10122984|FG000|STARTED|2000 U Chronic (Daily, 14 Days)||6
9062987|NCT04490239|10122984|FG000|COMPLETED|2000 U Chronic (Daily, 14 Days)||6
9062988|NCT04490239|10122984|FG000|NOT COMPLETED|2000 U Chronic (Daily, 14 Days)||0
9062989|NCT04486235|10122990|FG000|STARTED|Overall Study||32
9062990|NCT04486235|10122991|FG001|STARTED|Overall Study||30
9062991|NCT04486235|10122990|FG000|Analysis|Overall Study||30
9062992|NCT04486235|10122991|FG001|Analysis|Overall Study||30
9062993|NCT04486235|10122990|FG000|COMPLETED|Overall Study||30
9062994|NCT04486235|10122991|FG001|COMPLETED|Overall Study||30
9062995|NCT04486235|10122990|FG000|NOT COMPLETED|Overall Study||2
9062996|NCT04486235|10122991|FG001|NOT COMPLETED|Overall Study||0
9062997|NCT04483011|10123000|FG000|STARTED|Intervention Period 1 (8 Days)||9
9062998|NCT04483011|10123001|FG001|STARTED|Intervention Period 1 (8 Days)||9
9062999|NCT04483011|10123000|FG000|COMPLETED|Intervention Period 1 (8 Days)||9
9063000|NCT04483011|10123001|FG001|COMPLETED|Intervention Period 1 (8 Days)||9
9063001|NCT04483011|10123000|FG000|NOT COMPLETED|Intervention Period 1 (8 Days)||0
9063002|NCT04483011|10123001|FG001|NOT COMPLETED|Intervention Period 1 (8 Days)||0
9063003|NCT04483011|10123000|FG000|STARTED|Washout (7 Days)||9
9063004|NCT04483011|10123001|FG001|STARTED|Washout (7 Days)||9
9063005|NCT04483011|10123000|FG000|COMPLETED|Washout (7 Days)||9
9063006|NCT04483011|10123001|FG001|COMPLETED|Washout (7 Days)||8
9063007|NCT04483011|10123000|FG000|NOT COMPLETED|Washout (7 Days)||0
9063008|NCT04483011|10123001|FG001|NOT COMPLETED|Washout (7 Days)||1
9063009|NCT04483011|10123000|FG000|STARTED|Intervention Period 2 (8 Days)||9
9063010|NCT04483011|10123001|FG001|STARTED|Intervention Period 2 (8 Days)||8
9063011|NCT04483011|10123000|FG000|COMPLETED|Intervention Period 2 (8 Days)||9
9063012|NCT04483011|10123001|FG001|COMPLETED|Intervention Period 2 (8 Days)||8
9063013|NCT04483011|10123000|FG000|NOT COMPLETED|Intervention Period 2 (8 Days)||0
9063014|NCT04483011|10123001|FG001|NOT COMPLETED|Intervention Period 2 (8 Days)||0
9063015|NCT04475588|10123011|FG000|STARTED|Overall Study|Stated in protocol apriori, patient not completing 1st infusion were not evaluable & were replaced.|22
9063016|NCT04475588|10123012|FG001|STARTED|Overall Study||10
9063017|NCT04475588|10123011|FG000|COMPLETED|Overall Study||20
9063018|NCT04475588|10123012|FG001|COMPLETED|Overall Study||10
9063019|NCT04475588|10123011|FG000|NOT COMPLETED|Overall Study||2
9063020|NCT04475588|10123012|FG001|NOT COMPLETED|Overall Study||0
9063021|NCT04474496|10123019|FG000|STARTED|Overall Study||120
9063022|NCT04474496|10123019|FG000|COMPLETED|Overall Study|120 individuals were deemed eligible based on inclusion criteria, completed at least 10 survey items, and were included in the final analytical sample|120
9063023|NCT04474496|10123019|FG000|NOT COMPLETED|Overall Study||0
9063024|NCT04448210|10123025|FG000|STARTED|Overall Study||22
9063025|NCT04448210|10123026|FG001|STARTED|Overall Study||20
9063026|NCT04448210|10123025|FG000|COMPLETED|Overall Study||22
9063027|NCT04448210|10123026|FG001|COMPLETED|Overall Study||20
9063028|NCT04448210|10123025|FG000|NOT COMPLETED|Overall Study||0
9063029|NCT04448210|10123026|FG001|NOT COMPLETED|Overall Study||0
9063030|NCT04474405|10123038|FG000|STARTED|Overall Study||4
9063031|NCT04474405|10123039|FG001|STARTED|Overall Study||3
9063032|NCT04474405|10123040|FG002|STARTED|Overall Study||5
9063033|NCT04474405|10123041|FG003|STARTED|Overall Study||4
9063034|NCT04474405|10123042|FG004|STARTED|Overall Study||13
9063035|NCT04474405|10123043|FG005|STARTED|Overall Study||7
9063036|NCT04474405|10123038|FG000|Flortaucipir PET Scan|Overall Study||4
9063037|NCT04474405|10123039|FG001|Flortaucipir PET Scan|Overall Study||3
9063038|NCT04474405|10123040|FG002|Flortaucipir PET Scan|Overall Study||4
9063039|NCT04474405|10123041|FG003|Flortaucipir PET Scan|Overall Study||4
9063040|NCT04474405|10123042|FG004|Flortaucipir PET Scan|Overall Study||9
9063041|NCT04474405|10123043|FG005|Flortaucipir PET Scan|Overall Study||0
9063042|NCT04474405|10123038|FG000|Florbetapir PET Scan|Overall Study||4
9063043|NCT04474405|10123039|FG001|Florbetapir PET Scan|Overall Study||3
9063044|NCT04474405|10123040|FG002|Florbetapir PET Scan|Overall Study||0
9063045|NCT04474405|10123041|FG003|Florbetapir PET Scan|Overall Study||4
9063046|NCT04474405|10123042|FG004|Florbetapir PET Scan|Overall Study||0
9063047|NCT04474405|10123043|FG005|Florbetapir PET Scan|Overall Study||4
9063048|NCT04474405|10123038|FG000|COMPLETED|Overall Study||4
9063049|NCT04474405|10123039|FG001|COMPLETED|Overall Study||3
9063050|NCT04474405|10123040|FG002|COMPLETED|Overall Study||4
9063051|NCT04474405|10123041|FG003|COMPLETED|Overall Study||4
9063052|NCT04474405|10123042|FG004|COMPLETED|Overall Study||9
9063053|NCT04474405|10123043|FG005|COMPLETED|Overall Study||7
9063054|NCT04474405|10123038|FG000|NOT COMPLETED|Overall Study||0
9063055|NCT04474405|10123039|FG001|NOT COMPLETED|Overall Study||0
9063056|NCT04474405|10123040|FG002|NOT COMPLETED|Overall Study||1
9063057|NCT04474405|10123041|FG003|NOT COMPLETED|Overall Study||0
9063058|NCT04474405|10123042|FG004|NOT COMPLETED|Overall Study||4
9063059|NCT04474405|10123043|FG005|NOT COMPLETED|Overall Study||0
9063060|NCT04470375|10123057|FG000|STARTED|Overall Study||20
9063061|NCT04470375|10123057|FG000|COMPLETED|Overall Study||20
9063062|NCT04470375|10123057|FG000|NOT COMPLETED|Overall Study||0
9063063|NCT04468347|10123065|FG000|STARTED|Overall Study||6
9063064|NCT04468347|10123066|FG001|STARTED|Overall Study||11
9063065|NCT04468347|10123067|FG002|STARTED|Overall Study||47
9063066|NCT04468347|10123068|FG003|STARTED|Overall Study||25
9063067|NCT04468347|10123065|FG000|Baseline Flortacuipir PET Scan|Overall Study||5
9063068|NCT04468347|10123066|FG001|Baseline Flortacuipir PET Scan|Overall Study||11
9063069|NCT04468347|10123067|FG002|Baseline Flortacuipir PET Scan|Overall Study||45
9063070|NCT04468347|10123068|FG003|Baseline Flortacuipir PET Scan|Overall Study||25
9063071|NCT04468347|10123065|FG000|COMPLETED|Overall Study||4
9063072|NCT04468347|10123066|FG001|COMPLETED|Overall Study||10
9063073|NCT04468347|10123067|FG002|COMPLETED|Overall Study||41
9063074|NCT04468347|10123068|FG003|COMPLETED|Overall Study||21
9063075|NCT04468347|10123065|FG000|NOT COMPLETED|Overall Study||2
9063076|NCT04468347|10123066|FG001|NOT COMPLETED|Overall Study||1
9063077|NCT04468347|10123067|FG002|NOT COMPLETED|Overall Study||6
9063078|NCT04468347|10123068|FG003|NOT COMPLETED|Overall Study||4
9063079|NCT04467424|10123084|FG000|STARTED|Overall Study||100
9063080|NCT04467424|10123085|FG001|STARTED|Overall Study||100
9063081|NCT04467424|10123084|FG000|COMPLETED|Overall Study||100
9063082|NCT04467424|10123085|FG001|COMPLETED|Overall Study||100
9063083|NCT04467424|10123084|FG000|NOT COMPLETED|Overall Study||0
9063084|NCT04467424|10123085|FG001|NOT COMPLETED|Overall Study||0
9063085|NCT04465422|10123093|FG000|STARTED|Overall Study||17
9063086|NCT04465422|10123094|FG001|STARTED|Overall Study||16
9063087|NCT04465422|10123093|FG000|COMPLETED|Overall Study||17
9063088|NCT04465422|10123094|FG001|COMPLETED|Overall Study||14
9063089|NCT04465422|10123093|FG000|NOT COMPLETED|Overall Study||0
9063090|NCT04465422|10123094|FG001|NOT COMPLETED|Overall Study||2
9063091|NCT04463004|10123104|FG000|STARTED|Overall Study||1
9063092|NCT04463004|10123105|FG001|STARTED|Overall Study||1
9063093|NCT04463004|10123104|FG000|COMPLETED|Overall Study||1
9063094|NCT04463004|10123105|FG001|COMPLETED|Overall Study||1
9063095|NCT04463004|10123104|FG000|NOT COMPLETED|Overall Study||0
9063096|NCT04463004|10123105|FG001|NOT COMPLETED|Overall Study||0
9063097|NCT04448561|10123113|FG000|STARTED|Overall Study||16
9063098|NCT04448561|10123114|FG001|STARTED|Overall Study||8
9063099|NCT04448561|10123113|FG000|COMPLETED|Overall Study||15
9063100|NCT04448561|10123114|FG001|COMPLETED|Overall Study||8
9063101|NCT04448561|10123113|FG000|NOT COMPLETED|Overall Study||1
9063102|NCT04448561|10123114|FG001|NOT COMPLETED|Overall Study||0
9063103|NCT04462731|10123130|FG000|STARTED|Overall Study||97
9063104|NCT04462731|10123131|FG001|STARTED|Overall Study||97
9063105|NCT04462731|10123130|FG000|COMPLETED|Overall Study||41
9063106|NCT04462731|10123131|FG001|COMPLETED|Overall Study||51
9063107|NCT04462731|10123130|FG000|NOT COMPLETED|Overall Study||56
9063108|NCT04462731|10123131|FG001|NOT COMPLETED|Overall Study||46
9063109|NCT04459585|10123137|FG000|STARTED|Period 1 (Day 1 to Day 5)||20
9063110|NCT04459585|10123137|FG000|COMPLETED|Period 1 (Day 1 to Day 5)||20
9063111|NCT04459585|10123137|FG000|NOT COMPLETED|Period 1 (Day 1 to Day 5)||0
9063112|NCT04459585|10123137|FG000|STARTED|Period 2 (Day 5 to Day 12)||20
9063113|NCT04459585|10123137|FG000|COMPLETED|Period 2 (Day 5 to Day 12)||20
9063114|NCT04459585|10123137|FG000|NOT COMPLETED|Period 2 (Day 5 to Day 12)||0
9063115|NCT04458818|10123144|FG000|STARTED|Overall Study|May 01 2020|39
9063116|NCT04458818|10123144|FG000|COMPLETED|Overall Study|Jan 30 2021|39
9063117|NCT04458818|10123144|FG000|NOT COMPLETED|Overall Study||0
9063118|NCT04456634|10123150|FG000|STARTED|Overall Study||6
9063119|NCT04456634|10123151|FG001|STARTED|Overall Study||2
9063120|NCT04456634|10123150|FG000|COMPLETED|Overall Study||5
9063121|NCT04456634|10123151|FG001|COMPLETED|Overall Study||2
8704142|NCT00926237|9749840|FG001|STARTED|Overall Study|One subjects withdrew after receiving sham rTMS but before receiving active rTMS.|20
8704143|NCT00926237|9749839|FG000|COMPLETED|Overall Study||17
8704144|NCT00926237|9749840|FG001|COMPLETED|Overall Study||19
8704145|NCT00926237|9749839|FG000|NOT COMPLETED|Overall Study||2
8704146|NCT00926237|9749840|FG001|NOT COMPLETED|Overall Study||1
8704147|NCT00926263|9749852|FG000|STARTED|Overall Study||16
8704148|NCT00926263|9749853|FG001|STARTED|Overall Study||12
8704149|NCT00926263|9749852|FG000|COMPLETED|Overall Study||16
8704150|NCT00926263|9749853|FG001|COMPLETED|Overall Study||12
8704151|NCT00926263|9749852|FG000|NOT COMPLETED|Overall Study||0
8704152|NCT00926263|9749853|FG001|NOT COMPLETED|Overall Study||0
8704153|NCT00926289|9749862|FG000|STARTED|Overall Study|Number of treated patients|294
8704154|NCT00926289|9749863|FG001|STARTED|Overall Study|Number of treated patients|594
8704155|NCT00926289|9749862|FG000|COMPLETED|Overall Study||269
9063122|NCT04456634|10123150|FG000|NOT COMPLETED|Overall Study||1
9063123|NCT04456634|10123151|FG001|NOT COMPLETED|Overall Study||0
9063124|NCT04454138|10123159|FG000|STARTED|Overall Study||65
9063125|NCT04454138|10123160|FG001|STARTED|Overall Study||77
9063126|NCT04454138|10123159|FG000|COMPLETED|Overall Study||65
9063127|NCT04454138|10123160|FG001|COMPLETED|Overall Study||77
9063128|NCT04454138|10123159|FG000|NOT COMPLETED|Overall Study||0
9063129|NCT04454138|10123160|FG001|NOT COMPLETED|Overall Study||0
9063130|NCT04452435|10123168|FG000|STARTED|Screening||51
9063131|NCT04452435|10123169|FG001|STARTED|Screening||55
9063132|NCT04452435|10123168|FG000|COMPLETED|Screening||51
9063133|NCT04452435|10123169|FG001|COMPLETED|Screening||55
9063134|NCT04452435|10123168|FG000|NOT COMPLETED|Screening||0
9063135|NCT04452435|10123169|FG001|NOT COMPLETED|Screening||0
9063136|NCT04452435|10123168|FG000|STARTED|Treatment Period||51
9063137|NCT04452435|10123169|FG001|STARTED|Treatment Period||55
8704156|NCT00926289|9749863|FG001|COMPLETED|Overall Study||558
8704157|NCT00926289|9749862|FG000|NOT COMPLETED|Overall Study||25
8704158|NCT00926289|9749863|FG001|NOT COMPLETED|Overall Study||36
8704159|NCT00926328|9749871|FG000|STARTED|Overall Study||60
8704160|NCT00926328|9749872|FG001|STARTED|Overall Study||60
8704161|NCT00926328|9749871|FG000|COMPLETED|Overall Study||48
9063138|NCT04452435|10123168|FG000|COMPLETED|Treatment Period||45
9063139|NCT04452435|10123169|FG001|COMPLETED|Treatment Period||43
9063140|NCT04452435|10123168|FG000|NOT COMPLETED|Treatment Period||6
9063141|NCT04452435|10123169|FG001|NOT COMPLETED|Treatment Period||12
9063142|NCT04452435|10123168|FG000|STARTED|Follow-up||45
9063143|NCT04452435|10123169|FG001|STARTED|Follow-up||43
9063144|NCT04452435|10123168|FG000|COMPLETED|Follow-up||45
9063145|NCT04452435|10123169|FG001|COMPLETED|Follow-up||42
9063146|NCT04452435|10123168|FG000|NOT COMPLETED|Follow-up||0
9063147|NCT04452435|10123169|FG001|NOT COMPLETED|Follow-up||1
8704162|NCT00926328|9749872|FG001|COMPLETED|Overall Study||46
8704163|NCT00926328|9749871|FG000|NOT COMPLETED|Overall Study||12
8704164|NCT00926328|9749872|FG001|NOT COMPLETED|Overall Study||14
9063148|NCT04451707|10123176|FG000|STARTED|Overall Study||67
9063149|NCT04451707|10123176|FG000|COMPLETED|Overall Study||67
9063150|NCT04451707|10123176|FG000|NOT COMPLETED|Overall Study||0
9063151|NCT04449263|10123180|FG000|STARTED|First Intervention||29
9063152|NCT04449263|10123181|FG001|STARTED|First Intervention||30
9063153|NCT04449263|10123180|FG000|COMPLETED|First Intervention||29
9063154|NCT04449263|10123181|FG001|COMPLETED|First Intervention||30
9063155|NCT04449263|10123180|FG000|NOT COMPLETED|First Intervention||0
9063156|NCT04449263|10123181|FG001|NOT COMPLETED|First Intervention||0
9063157|NCT04449263|10123180|FG000|STARTED|Second Intervention||29
9063158|NCT04449263|10123181|FG001|STARTED|Second Intervention||30
9063159|NCT04449263|10123180|FG000|COMPLETED|Second Intervention||29
9063160|NCT04449263|10123181|FG001|COMPLETED|Second Intervention||30
9063161|NCT04449263|10123180|FG000|NOT COMPLETED|Second Intervention||0
8704165|NCT00926367|9749880|FG000|STARTED|Overall Study||25
8704166|NCT00926367|9749881|FG001|STARTED|Overall Study||27
9063162|NCT04449263|10123181|FG001|NOT COMPLETED|Second Intervention||0
9063163|NCT04449263|10123180|FG000|STARTED|Third Intervention||29
9063164|NCT04449263|10123181|FG001|STARTED|Third Intervention||30
9063165|NCT04449263|10123180|FG000|COMPLETED|Third Intervention||29
9063166|NCT04449263|10123181|FG001|COMPLETED|Third Intervention||30
9063167|NCT04449263|10123180|FG000|NOT COMPLETED|Third Intervention||0
9063168|NCT04449263|10123181|FG001|NOT COMPLETED|Third Intervention||0
9063169|NCT04450381|10123189|FG000|STARTED|Overall Study||131
9063170|NCT04450381|10123189|FG000|COMPLETED|Overall Study||125
9063171|NCT04450381|10123189|FG000|NOT COMPLETED|Overall Study||6
9063172|NCT04449341|10123195|FG000|STARTED|Overall Study||31
9063173|NCT04449341|10123196|FG001|STARTED|Overall Study||28
9063174|NCT04449341|10123195|FG000|COMPLETED|Overall Study||30
9063175|NCT04449341|10123196|FG001|COMPLETED|Overall Study||28
9063176|NCT04449341|10123195|FG000|NOT COMPLETED|Overall Study||1
9063177|NCT04449341|10123196|FG001|NOT COMPLETED|Overall Study||0
9063178|NCT04441255|10123204|FG000|STARTED|Period 1 (1 Day)||7
9063179|NCT04441255|10123205|FG001|STARTED|Period 1 (1 Day)||7
9063180|NCT04441255|10123204|FG000|COMPLETED|Period 1 (1 Day)||7
9063181|NCT04441255|10123205|FG001|COMPLETED|Period 1 (1 Day)||7
9063182|NCT04441255|10123204|FG000|NOT COMPLETED|Period 1 (1 Day)||0
9063183|NCT04441255|10123205|FG001|NOT COMPLETED|Period 1 (1 Day)||0
9063184|NCT04441255|10123204|FG000|STARTED|Washout Period (10 Days)||7
9063185|NCT04441255|10123205|FG001|STARTED|Washout Period (10 Days)||7
9063186|NCT04441255|10123204|FG000|COMPLETED|Washout Period (10 Days)||7
9063187|NCT04441255|10123205|FG001|COMPLETED|Washout Period (10 Days)||7
9063188|NCT04441255|10123204|FG000|NOT COMPLETED|Washout Period (10 Days)||0
9063189|NCT04441255|10123205|FG001|NOT COMPLETED|Washout Period (10 Days)||0
9063190|NCT04441255|10123204|FG000|STARTED|Period 2 (1 Day)||7
9063191|NCT04441255|10123205|FG001|STARTED|Period 2 (1 Day)||7
9063192|NCT04441255|10123204|FG000|COMPLETED|Period 2 (1 Day)||7
9063193|NCT04441255|10123205|FG001|COMPLETED|Period 2 (1 Day)||7
9063194|NCT04441255|10123204|FG000|NOT COMPLETED|Period 2 (1 Day)||0
9063195|NCT04441255|10123205|FG001|NOT COMPLETED|Period 2 (1 Day)||0
9063196|NCT04439214|10123211|FG000|STARTED|Overall Study||47
9063197|NCT04439214|10123211|FG000|Eligible|Overall Study||42
9063198|NCT04439214|10123211|FG000|Treated|Overall Study||47
9063199|NCT04439214|10123211|FG000|Treated and Reported Adverse Event Data|Overall Study|One patient experienced disease progression in cycle 1 and an AE form was not submitted.|46
9063200|NCT04439214|10123211|FG000|Eligible and Treated|Overall Study||42
9063201|NCT04439214|10123211|FG000|COMPLETED|Overall Study||0
9063202|NCT04439214|10123211|FG000|NOT COMPLETED|Overall Study||47
9063203|NCT04439240|10123215|FG000|STARTED|Overall Study||52
9063204|NCT04439240|10123215|FG000|Started Protocol Therapy|Overall Study||50
9063205|NCT04439240|10123215|FG000|Eligible|Overall Study||49
9063206|NCT04439240|10123215|FG000|Eligible and Started Protocol Therapy|Overall Study||48
9063207|NCT04439240|10123215|FG000|Reported Adverse Events Data|Overall Study||49
9063208|NCT04439240|10123215|FG000|COMPLETED|Overall Study||0
9063209|NCT04439240|10123215|FG000|NOT COMPLETED|Overall Study||52
9063210|NCT04438785|10123221|FG000|STARTED|Overall Study||20
9063211|NCT04438785|10123222|FG001|STARTED|Overall Study||20
9063212|NCT04438785|10123221|FG000|COMPLETED|Overall Study||18
9063213|NCT04438785|10123222|FG001|COMPLETED|Overall Study||10
9063214|NCT04438785|10123221|FG000|NOT COMPLETED|Overall Study||2
9063215|NCT04438785|10123222|FG001|NOT COMPLETED|Overall Study||10
9063216|NCT04431908|10123230|FG000|STARTED|Overall Study||1042
9063217|NCT04431908|10123231|FG001|STARTED|Overall Study||278
9063218|NCT04431908|10123230|FG000|COMPLETED|Overall Study||1042
9063219|NCT04431908|10123231|FG001|COMPLETED|Overall Study||278
9063220|NCT04431908|10123230|FG000|NOT COMPLETED|Overall Study||0
9063221|NCT04431908|10123231|FG001|NOT COMPLETED|Overall Study||0
9063222|NCT04413929|10123238|FG000|STARTED|Overall Study||8411
9063223|NCT04413929|10123238|FG000|COMPLETED|Overall Study||8411
9063224|NCT04413929|10123238|FG000|NOT COMPLETED|Overall Study||0
9063225|NCT04430634|10123251|FG000|STARTED|Overall Study||5
9063226|NCT04430634|10123252|FG001|STARTED|Overall Study||5
9063227|NCT04430634|10123253|FG002|STARTED|Overall Study||5
9063228|NCT04430634|10123254|FG003|STARTED|Overall Study||5
9063229|NCT04430634|10123255|FG004|STARTED|Overall Study||5
9063230|NCT04430634|10123256|FG005|STARTED|Overall Study||5
9063231|NCT04430634|10123257|FG006|STARTED|Overall Study||5
9063232|NCT04430634|10123258|FG007|STARTED|Overall Study||5
9063233|NCT04430634|10123251|FG000|COMPLETED|Overall Study||5
9063234|NCT04430634|10123252|FG001|COMPLETED|Overall Study||5
9063235|NCT04430634|10123253|FG002|COMPLETED|Overall Study||5
9063236|NCT04430634|10123254|FG003|COMPLETED|Overall Study||4
9063237|NCT04430634|10123255|FG004|COMPLETED|Overall Study||5
9063238|NCT04430634|10123256|FG005|COMPLETED|Overall Study||5
9063239|NCT04430634|10123257|FG006|COMPLETED|Overall Study||4
9063240|NCT04430634|10123258|FG007|COMPLETED|Overall Study||5
9063241|NCT04430634|10123251|FG000|NOT COMPLETED|Overall Study||0
9063242|NCT04430634|10123252|FG001|NOT COMPLETED|Overall Study||0
9063243|NCT04430634|10123253|FG002|NOT COMPLETED|Overall Study||0
9063244|NCT04430634|10123254|FG003|NOT COMPLETED|Overall Study||1
9063245|NCT04430634|10123255|FG004|NOT COMPLETED|Overall Study||0
9063246|NCT04430634|10123256|FG005|NOT COMPLETED|Overall Study||0
9063247|NCT04430634|10123257|FG006|NOT COMPLETED|Overall Study||1
9063248|NCT04430634|10123258|FG007|NOT COMPLETED|Overall Study||0
9063249|NCT04429932|10123285|FG000|STARTED|Overall Study||4
9063250|NCT04429932|10123286|FG001|STARTED|Overall Study||5
9063251|NCT04429932|10123287|FG002|STARTED|Overall Study||5
9063252|NCT04429932|10123288|FG003|STARTED|Overall Study||5
9063253|NCT04429932|10123289|FG004|STARTED|Overall Study||5
9063254|NCT04429932|10123290|FG005|STARTED|Overall Study||5
9063255|NCT04429932|10123291|FG006|STARTED|Overall Study||5
9063256|NCT04429932|10123292|FG007|STARTED|Overall Study||5
9063257|NCT04429932|10123285|FG000|COMPLETED|Overall Study||3
9063258|NCT04429932|10123286|FG001|COMPLETED|Overall Study||5
9063259|NCT04429932|10123287|FG002|COMPLETED|Overall Study||5
9063260|NCT04429932|10123288|FG003|COMPLETED|Overall Study||2
9063261|NCT04429932|10123289|FG004|COMPLETED|Overall Study||5
9063262|NCT04429932|10123290|FG005|COMPLETED|Overall Study||5
9063263|NCT04429932|10123291|FG006|COMPLETED|Overall Study||5
9063264|NCT04429932|10123292|FG007|COMPLETED|Overall Study||5
9063265|NCT04429932|10123285|FG000|NOT COMPLETED|Overall Study||1
9063266|NCT04429932|10123286|FG001|NOT COMPLETED|Overall Study||0
9063267|NCT04429932|10123287|FG002|NOT COMPLETED|Overall Study||0
9063268|NCT04429932|10123288|FG003|NOT COMPLETED|Overall Study||3
9063269|NCT04429932|10123289|FG004|NOT COMPLETED|Overall Study||0
9063270|NCT04429932|10123290|FG005|NOT COMPLETED|Overall Study||0
9063271|NCT04429932|10123291|FG006|NOT COMPLETED|Overall Study||0
9063272|NCT04429932|10123292|FG007|NOT COMPLETED|Overall Study||0
9063273|NCT04428502|10123311|FG000|STARTED|Overall Study||127
9063274|NCT04428502|10123311|FG000|COMPLETED|Overall Study||113
9063275|NCT04428502|10123311|FG000|NOT COMPLETED|Overall Study||14
9063276|NCT04428424|10123316|FG000|STARTED|Overall Study||1493
9063277|NCT04428424|10123316|FG000|COMPLETED|Overall Study||1246
9063278|NCT04428424|10123316|FG000|NOT COMPLETED|Overall Study||247
9063279|NCT04428359|10123322|FG000|STARTED|Overall Study||33
9063280|NCT04428359|10123323|FG001|STARTED|Overall Study||33
9063281|NCT04428359|10123322|FG000|COMPLETED|Overall Study||31
9063282|NCT04428359|10123323|FG001|COMPLETED|Overall Study||30
9063283|NCT04428359|10123322|FG000|NOT COMPLETED|Overall Study||2
9063284|NCT04428359|10123323|FG001|NOT COMPLETED|Overall Study||3
9063285|NCT04410159|10123333|FG000|STARTED|Overall Study||5
9063286|NCT04410159|10123334|FG001|STARTED|Overall Study||5
9063287|NCT04410159|10123335|FG002|STARTED|Overall Study||5
9063288|NCT04410159|10123336|FG003|STARTED|Overall Study||5
9063289|NCT04410159|10123333|FG000|COMPLETED|Overall Study||5
9063290|NCT04410159|10123334|FG001|COMPLETED|Overall Study||5
9063291|NCT04410159|10123335|FG002|COMPLETED|Overall Study||5
9063292|NCT04410159|10123336|FG003|COMPLETED|Overall Study||5
9063293|NCT04410159|10123333|FG000|NOT COMPLETED|Overall Study||0
9063294|NCT04410159|10123334|FG001|NOT COMPLETED|Overall Study||0
9063295|NCT04410159|10123335|FG002|NOT COMPLETED|Overall Study||0
9063296|NCT04410159|10123336|FG003|NOT COMPLETED|Overall Study||0
9063297|NCT04425850|10123348|FG000|STARTED|Overall Study|Standard prophylactic measures and PPE + iota carrageenan (nasal and buccal) and ivermectin (buccal)|131
9063298|NCT04425850|10123349|FG001|STARTED|Overall Study|Standard prophylactic measures and PPE only|98
9063299|NCT04425850|10123348|FG000|COMPLETED|Overall Study||131
9063300|NCT04425850|10123349|FG001|COMPLETED|Overall Study||98
9063301|NCT04425850|10123348|FG000|NOT COMPLETED|Overall Study||0
9063302|NCT04425850|10123349|FG001|NOT COMPLETED|Overall Study||0
9063303|NCT04425863|10123360|FG000|STARTED|Overall Study||135
9063304|NCT04425863|10123361|FG001|STARTED|Overall Study||12
9063305|NCT04425863|10123362|FG002|STARTED|Overall Study||20
9063306|NCT04425863|10123360|FG000|COMPLETED|Overall Study||135
9063307|NCT04425863|10123361|FG001|COMPLETED|Overall Study||12
9063308|NCT04425863|10123362|FG002|COMPLETED|Overall Study||19
9063309|NCT04425863|10123360|FG000|NOT COMPLETED|Overall Study||0
9063310|NCT04425863|10123361|FG001|NOT COMPLETED|Overall Study||0
9063311|NCT04425863|10123362|FG002|NOT COMPLETED|Overall Study||1
9063312|NCT04425746|10123384|FG000|STARTED|Overall Study||9
9063313|NCT04425746|10123385|FG001|STARTED|Overall Study||7
9063314|NCT04425746|10123384|FG000|COMPLETED|Overall Study||9
9063315|NCT04425746|10123385|FG001|COMPLETED|Overall Study||6
9063316|NCT04425746|10123384|FG000|NOT COMPLETED|Overall Study||0
9063317|NCT04425746|10123385|FG001|NOT COMPLETED|Overall Study||1
9063318|NCT04422561|10123395|FG000|STARTED|Overall Study||228
9063319|NCT04422561|10123396|FG001|STARTED|Overall Study||112
9063320|NCT04422561|10123395|FG000|COMPLETED|Overall Study||203
9063321|NCT04422561|10123396|FG001|COMPLETED|Overall Study||101
9063322|NCT04422561|10123395|FG000|NOT COMPLETED|Overall Study||25
9063323|NCT04422561|10123396|FG001|NOT COMPLETED|Overall Study||11
9063324|NCT04421404|10123404|FG000|STARTED|Overall Study||16
9063325|NCT04421404|10123405|FG001|STARTED|Overall Study||18
9063326|NCT04421404|10123404|FG000|COMPLETED|Overall Study||16
9063327|NCT04421404|10123405|FG001|COMPLETED|Overall Study||18
9063328|NCT04421404|10123404|FG000|NOT COMPLETED|Overall Study||0
9063329|NCT04421404|10123405|FG001|NOT COMPLETED|Overall Study||0
9063330|NCT04419311|10123413|FG000|STARTED|Overall Study||33
9063331|NCT04419311|10123414|FG001|STARTED|Overall Study||33
9063332|NCT04419311|10123413|FG000|COMPLETED|Overall Study||32
9063333|NCT04419311|10123414|FG001|COMPLETED|Overall Study||33
9063334|NCT04419311|10123413|FG000|NOT COMPLETED|Overall Study||1
9063335|NCT04419311|10123414|FG001|NOT COMPLETED|Overall Study||0
9063336|NCT04415489|10123424|FG000|STARTED|Overall Study||50
9063337|NCT04415489|10123425|FG001|STARTED|Overall Study||50
9063338|NCT04415489|10123424|FG000|COMPLETED|Overall Study||50
9063339|NCT04415489|10123425|FG001|COMPLETED|Overall Study||50
9063340|NCT04415489|10123424|FG000|NOT COMPLETED|Overall Study||0
9063341|NCT04415489|10123425|FG001|NOT COMPLETED|Overall Study||0
9063342|NCT04411667|10123434|FG000|STARTED|Overall Study||17
9063343|NCT04411667|10123435|FG001|STARTED|Overall Study||17
9063344|NCT04411667|10123434|FG000|COMPLETED|Overall Study||16
9063345|NCT04411667|10123435|FG001|COMPLETED|Overall Study||17
9063346|NCT04411667|10123434|FG000|NOT COMPLETED|Overall Study||1
9063347|NCT04411667|10123435|FG001|NOT COMPLETED|Overall Study||0
9063348|NCT04409886|10123441|FG000|STARTED|Overall Study||1
9063349|NCT04409886|10123441|FG000|COMPLETED|Overall Study||1
9063350|NCT04409886|10123441|FG000|NOT COMPLETED|Overall Study||0
9063351|NCT04407507|10123447|FG000|STARTED|Overall Study||33
9063352|NCT04407507|10123448|FG001|STARTED|Overall Study||33
9063353|NCT04407507|10123447|FG000|COMPLETED|Overall Study||33
9063354|NCT04407507|10123448|FG001|COMPLETED|Overall Study||32
9063355|NCT04407507|10123447|FG000|NOT COMPLETED|Overall Study||0
9063356|NCT04407507|10123448|FG001|NOT COMPLETED|Overall Study||1
9063357|NCT04406194|10123456|FG000|STARTED|Period 1||15
9063358|NCT04406194|10123457|FG001|STARTED|Period 1||15
9063359|NCT04406194|10123456|FG000|COMPLETED|Period 1||15
9063360|NCT04406194|10123457|FG001|COMPLETED|Period 1||14
9063361|NCT04406194|10123456|FG000|NOT COMPLETED|Period 1||0
9063362|NCT04406194|10123457|FG001|NOT COMPLETED|Period 1||1
9063363|NCT04406194|10123456|FG000|STARTED|Period 2||15
9063364|NCT04406194|10123457|FG001|STARTED|Period 2||14
9063365|NCT04406194|10123456|FG000|COMPLETED|Period 2||15
9063366|NCT04406194|10123457|FG001|COMPLETED|Period 2||14
9063367|NCT04406194|10123456|FG000|NOT COMPLETED|Period 2||0
9063368|NCT04406194|10123457|FG001|NOT COMPLETED|Period 2||0
9063369|NCT04404907|10123468|FG000|STARTED|Overall Study||442
9063370|NCT04404907|10123469|FG001|STARTED|Overall Study||95
9063371|NCT04404907|10123468|FG000|Occasional Tan|Overall Study||0
9063372|NCT04404907|10123469|FG001|Occasional Tan|Overall Study||88
9063373|NCT04404907|10123468|FG000|Frequent Tan|Overall Study||0
9063374|NCT04404907|10123469|FG001|Frequent Tan|Overall Study||7
9063375|NCT04404907|10123468|FG000|COMPLETED|Overall Study||442
9063376|NCT04404907|10123469|FG001|COMPLETED|Overall Study||95
9063377|NCT04404907|10123468|FG000|NOT COMPLETED|Overall Study||0
9063378|NCT04404907|10123469|FG001|NOT COMPLETED|Overall Study||0
9063379|NCT04404010|10123477|FG000|STARTED|Overall Study|1 participant was mistakenly consented, enrolled and randomized as part of study. After randomization, but prior to study testing we realized the participant was not eligible (they were not a PGY4 or 5), therefore they were excluded prior to any further study procedures commenced. Therefore, only 9 participants completed all study procedures/were followed for purposes of study.|10
9063380|NCT04404010|10123478|FG001|STARTED|Overall Study||9
9063381|NCT04404010|10123477|FG000|COMPLETED|Overall Study||9
9063382|NCT04404010|10123478|FG001|COMPLETED|Overall Study||9
9063383|NCT04404010|10123477|FG000|NOT COMPLETED|Overall Study||1
9063384|NCT04404010|10123478|FG001|NOT COMPLETED|Overall Study||0
9063385|NCT04403399|10123488|FG000|STARTED|Period 1||18
9063386|NCT04403399|10123489|FG001|STARTED|Period 1||16
9063387|NCT04403399|10123488|FG000|COMPLETED|Period 1||18
9063388|NCT04403399|10123489|FG001|COMPLETED|Period 1||16
9063389|NCT04403399|10123488|FG000|NOT COMPLETED|Period 1||0
9063390|NCT04403399|10123489|FG001|NOT COMPLETED|Period 1||0
9063391|NCT04403399|10123488|FG000|STARTED|Period 2||18
9063392|NCT04403399|10123489|FG001|STARTED|Period 2||16
9063393|NCT04403399|10123488|FG000|COMPLETED|Period 2||18
9063394|NCT04403399|10123489|FG001|COMPLETED|Period 2||15
9063395|NCT04403399|10123488|FG000|NOT COMPLETED|Period 2||0
9063396|NCT04403399|10123489|FG001|NOT COMPLETED|Period 2||1
9063397|NCT04402970|10123497|FG000|STARTED|Overall Study||10
9063398|NCT04402970|10123498|FG001|STARTED|Overall Study||20
9063399|NCT04402970|10123497|FG000|COMPLETED|Overall Study||10
9063400|NCT04402970|10123498|FG001|COMPLETED|Overall Study||20
9063401|NCT04402970|10123497|FG000|NOT COMPLETED|Overall Study||0
9063402|NCT04402970|10123498|FG001|NOT COMPLETED|Overall Study||0
9063403|NCT04403113|10123506|FG000|STARTED|Overall Study||20
9063404|NCT04403113|10123507|FG001|STARTED|Overall Study||20
9063405|NCT04403113|10123506|FG000|COMPLETED|Overall Study||20
9063406|NCT04403113|10123507|FG001|COMPLETED|Overall Study||20
9063407|NCT04403113|10123506|FG000|NOT COMPLETED|Overall Study||0
9063408|NCT04403113|10123507|FG001|NOT COMPLETED|Overall Study||0
9063409|NCT04401202|10123519|FG000|STARTED|Overall Study||92
9063410|NCT04401202|10123520|FG001|STARTED|Overall Study||91
9063411|NCT04401202|10123519|FG000|COMPLETED|Overall Study||86
9063412|NCT04401202|10123520|FG001|COMPLETED|Overall Study||87
9063413|NCT04401202|10123519|FG000|NOT COMPLETED|Overall Study||6
9063414|NCT04401202|10123520|FG001|NOT COMPLETED|Overall Study||4
9063415|NCT04400682|10123529|FG000|STARTED|Period 1||15
9063416|NCT04400682|10123530|FG001|STARTED|Period 1||15
9063417|NCT04400682|10123529|FG000|COMPLETED|Period 1||14
9063418|NCT04400682|10123530|FG001|COMPLETED|Period 1||11
9063419|NCT04400682|10123529|FG000|NOT COMPLETED|Period 1||1
9063420|NCT04400682|10123530|FG001|NOT COMPLETED|Period 1||4
9063421|NCT04400682|10123529|FG000|STARTED|Period 2||14
9063422|NCT04400682|10123530|FG001|STARTED|Period 2||11
9063423|NCT04400682|10123529|FG000|COMPLETED|Period 2||14
9063424|NCT04400682|10123530|FG001|COMPLETED|Period 2||11
9063425|NCT04400682|10123529|FG000|NOT COMPLETED|Period 2||0
9063426|NCT04400682|10123530|FG001|NOT COMPLETED|Period 2||0
9063427|NCT04399161|10123539|FG000|STARTED|Overall Study||20
9063428|NCT04399161|10123540|FG001|STARTED|Overall Study||20
9063429|NCT04399161|10123541|FG002|STARTED|Overall Study||20
9063430|NCT04399161|10123539|FG000|COMPLETED|Overall Study||18
9063431|NCT04399161|10123540|FG001|COMPLETED|Overall Study||18
9063432|NCT04399161|10123541|FG002|COMPLETED|Overall Study||18
9063433|NCT04399161|10123539|FG000|NOT COMPLETED|Overall Study||2
9063434|NCT04399161|10123540|FG001|NOT COMPLETED|Overall Study||2
9063435|NCT04399161|10123541|FG002|NOT COMPLETED|Overall Study||2
9063436|NCT04399980|10123551|FG000|STARTED|Overall Study||21
9063437|NCT04399980|10123552|FG001|STARTED|Overall Study||19
9063438|NCT04399980|10123551|FG000|COMPLETED|Overall Study||21
9063439|NCT04399980|10123552|FG001|COMPLETED|Overall Study||19
9063440|NCT04399980|10123551|FG000|NOT COMPLETED|Overall Study||0
9063441|NCT04399980|10123552|FG001|NOT COMPLETED|Overall Study||0
9063442|NCT04399122|10123560|FG000|STARTED|Overall Study||100
9063443|NCT04399122|10123561|FG001|STARTED|Overall Study||100
9063444|NCT04399122|10123560|FG000|COMPLETED|Overall Study||97
9063445|NCT04399122|10123561|FG001|COMPLETED|Overall Study||100
9063446|NCT04399122|10123560|FG000|NOT COMPLETED|Overall Study||3
9063447|NCT04399122|10123561|FG001|NOT COMPLETED|Overall Study||0
9063448|NCT04397445|10123567|FG000|STARTED|Overall Study||5
9063449|NCT04397445|10123568|FG001|STARTED|Overall Study||5
9063450|NCT04397445|10123569|FG002|STARTED|Overall Study||4
9063451|NCT04397445|10123570|FG003|STARTED|Overall Study||4
9063452|NCT04397445|10123567|FG000|COMPLETED|Overall Study||4
9063453|NCT04397445|10123568|FG001|COMPLETED|Overall Study||5
9063454|NCT04397445|10123569|FG002|COMPLETED|Overall Study||4
9063455|NCT04397445|10123570|FG003|COMPLETED|Overall Study||4
9063456|NCT04397445|10123567|FG000|NOT COMPLETED|Overall Study||1
9063457|NCT04397445|10123568|FG001|NOT COMPLETED|Overall Study||0
9063458|NCT04397445|10123569|FG002|NOT COMPLETED|Overall Study||0
9063459|NCT04397445|10123570|FG003|NOT COMPLETED|Overall Study||0
9063460|NCT04397094|10123587|FG000|STARTED|Overall Study||30
9063461|NCT04397094|10123588|FG001|STARTED|Overall Study||30
9063462|NCT04397094|10123587|FG000|COMPLETED|Overall Study||30
9063463|NCT04397094|10123588|FG001|COMPLETED|Overall Study||30
9063464|NCT04397094|10123587|FG000|NOT COMPLETED|Overall Study||0
9063465|NCT04397094|10123588|FG001|NOT COMPLETED|Overall Study||0
9063466|NCT04396639|10123596|FG000|STARTED|Overall Study||50
9063467|NCT04396639|10123596|FG000|Completed Follow up|Overall Study||48
9063468|NCT04396639|10123596|FG000|COMPLETED|Overall Study||48
9063469|NCT04396639|10123596|FG000|NOT COMPLETED|Overall Study||2
9063470|NCT04396665|10123602|FG000|STARTED|Overall Study||134
9063471|NCT04396665|10123603|FG001|STARTED|Overall Study||90
9063472|NCT04396665|10123602|FG000|COMPLETED|Overall Study||99
9063473|NCT04396665|10123603|FG001|COMPLETED|Overall Study||83
9063474|NCT04396665|10123602|FG000|NOT COMPLETED|Overall Study||35
9063475|NCT04396665|10123603|FG001|NOT COMPLETED|Overall Study||7
9063476|NCT04393493|10123615|FG000|STARTED|Follow up||40
9063477|NCT04393493|10123616|FG001|STARTED|Follow up||40
9063478|NCT04393493|10123615|FG000|COMPLETED|Follow up||40
9063479|NCT04393493|10123616|FG001|COMPLETED|Follow up||40
9063480|NCT04393493|10123615|FG000|NOT COMPLETED|Follow up||0
9063481|NCT04393493|10123616|FG001|NOT COMPLETED|Follow up||0
9063482|NCT04393493|10123615|FG000|STARTED|First 4 Days of Intervention||40
9063483|NCT04393493|10123616|FG001|STARTED|First 4 Days of Intervention||40
9063484|NCT04393493|10123615|FG000|COMPLETED|First 4 Days of Intervention||35
9063485|NCT04393493|10123616|FG001|COMPLETED|First 4 Days of Intervention||33
9063486|NCT04393493|10123615|FG000|NOT COMPLETED|First 4 Days of Intervention||5
9063487|NCT04393493|10123616|FG001|NOT COMPLETED|First 4 Days of Intervention||7
9063488|NCT04392362|10123626|FG000|STARTED|Overall Study||23
9063489|NCT04392362|10123627|FG001|STARTED|Overall Study||7
9063490|NCT04392362|10123626|FG000|COMPLETED|Overall Study||23
9063491|NCT04392362|10123627|FG001|COMPLETED|Overall Study||7
9063492|NCT04392362|10123626|FG000|NOT COMPLETED|Overall Study||0
9063493|NCT04392362|10123627|FG001|NOT COMPLETED|Overall Study||0
9063494|NCT04392141|10123635|FG000|STARTED|Overall Study||60
9063495|NCT04392141|10123636|FG001|STARTED|Overall Study||60
9063496|NCT04392141|10123635|FG000|COMPLETED|Overall Study||60
9063497|NCT04392141|10123636|FG001|COMPLETED|Overall Study||60
9063498|NCT04392141|10123635|FG000|NOT COMPLETED|Overall Study||0
9063499|NCT04392141|10123636|FG001|NOT COMPLETED|Overall Study||0
9063500|NCT04392219|10123660|FG000|STARTED|Overall Study||16
9063501|NCT04392219|10123661|FG001|STARTED|Overall Study||6
9063502|NCT04392219|10123662|FG002|STARTED|Overall Study||6
9063503|NCT04392219|10123663|FG003|STARTED|Overall Study||6
9063504|NCT04392219|10123664|FG004|STARTED|Overall Study||6
9063505|NCT04392219|10123665|FG005|STARTED|Overall Study||6
9063506|NCT04392219|10123666|FG006|STARTED|Overall Study||6
9063507|NCT04392219|10123667|FG007|STARTED|Overall Study||6
9063508|NCT04392219|10123668|FG008|STARTED|Overall Study||6
9063509|NCT04392219|10123669|FG009|STARTED|Overall Study||10
9063510|NCT04392219|10123670|FG010|STARTED|Overall Study||14
9063511|NCT04392219|10123671|FG011|STARTED|Overall Study||6
9063512|NCT04392219|10123672|FG012|STARTED|Overall Study||6
9063513|NCT04392219|10123673|FG013|STARTED|Overall Study||6
9063514|NCT04392219|10123674|FG014|STARTED|Overall Study||6
9063515|NCT04392219|10123675|FG015|STARTED|Overall Study||6
9063516|NCT04392219|10123676|FG016|STARTED|Overall Study||6
9063517|NCT04392219|10123677|FG017|STARTED|Overall Study||6
9063518|NCT04392219|10123660|FG000|COMPLETED|Overall Study||16
9063519|NCT04392219|10123661|FG001|COMPLETED|Overall Study||6
9063520|NCT04392219|10123662|FG002|COMPLETED|Overall Study||6
9063521|NCT04392219|10123663|FG003|COMPLETED|Overall Study||6
9063522|NCT04392219|10123664|FG004|COMPLETED|Overall Study||6
9063523|NCT04392219|10123665|FG005|COMPLETED|Overall Study||6
9063524|NCT04392219|10123666|FG006|COMPLETED|Overall Study||6
9063525|NCT04392219|10123667|FG007|COMPLETED|Overall Study||6
9063526|NCT04392219|10123668|FG008|COMPLETED|Overall Study||6
9063527|NCT04392219|10123669|FG009|COMPLETED|Overall Study||10
9063528|NCT04392219|10123670|FG010|COMPLETED|Overall Study||14
9063529|NCT04392219|10123671|FG011|COMPLETED|Overall Study||6
9063530|NCT04392219|10123672|FG012|COMPLETED|Overall Study||6
9063531|NCT04392219|10123673|FG013|COMPLETED|Overall Study||6
9063532|NCT04392219|10123674|FG014|COMPLETED|Overall Study||6
9063533|NCT04392219|10123675|FG015|COMPLETED|Overall Study||6
9063534|NCT04392219|10123676|FG016|COMPLETED|Overall Study||6
9063535|NCT04392219|10123677|FG017|COMPLETED|Overall Study||6
9063536|NCT04392219|10123660|FG000|NOT COMPLETED|Overall Study||0
9063537|NCT04392219|10123661|FG001|NOT COMPLETED|Overall Study||0
9063538|NCT04392219|10123662|FG002|NOT COMPLETED|Overall Study||0
9063539|NCT04392219|10123663|FG003|NOT COMPLETED|Overall Study||0
9063540|NCT04392219|10123664|FG004|NOT COMPLETED|Overall Study||0
9063541|NCT04392219|10123665|FG005|NOT COMPLETED|Overall Study||0
9063542|NCT04392219|10123666|FG006|NOT COMPLETED|Overall Study||0
9063543|NCT04392219|10123667|FG007|NOT COMPLETED|Overall Study||0
9063544|NCT04392219|10123668|FG008|NOT COMPLETED|Overall Study||0
9063545|NCT04392219|10123669|FG009|NOT COMPLETED|Overall Study||0
9063546|NCT04392219|10123670|FG010|NOT COMPLETED|Overall Study||0
9063547|NCT04392219|10123671|FG011|NOT COMPLETED|Overall Study||0
9063548|NCT04392219|10123672|FG012|NOT COMPLETED|Overall Study||0
9063549|NCT04392219|10123673|FG013|NOT COMPLETED|Overall Study||0
9063550|NCT04392219|10123674|FG014|NOT COMPLETED|Overall Study||0
9063551|NCT04392219|10123675|FG015|NOT COMPLETED|Overall Study||0
9063552|NCT04392219|10123676|FG016|NOT COMPLETED|Overall Study||0
9063553|NCT04392219|10123677|FG017|NOT COMPLETED|Overall Study||0
9063554|NCT04391842|10123715|FG000|STARTED|Overall Study||34
9063555|NCT04391842|10123715|FG000|COMPLETED|Overall Study||32
9063556|NCT04391842|10123715|FG000|NOT COMPLETED|Overall Study||2
9063557|NCT04390022|10123721|FG000|STARTED|Overall Study||12
9063558|NCT04390022|10123722|FG001|STARTED|Overall Study||12
9063559|NCT04390022|10123721|FG000|COMPLETED|Overall Study||12
9063560|NCT04390022|10123722|FG001|COMPLETED|Overall Study||12
9063561|NCT04390022|10123721|FG000|NOT COMPLETED|Overall Study||0
9063562|NCT04390022|10123722|FG001|NOT COMPLETED|Overall Study||0
9063563|NCT04386902|10123728|FG000|STARTED|Overall Study||60
9063564|NCT04386902|10123728|FG000|COMPLETED|Overall Study||50
9063565|NCT04386902|10123728|FG000|NOT COMPLETED|Overall Study||10
9063566|NCT04385238|10123734|FG000|STARTED|Overall Study||5712
9063567|NCT04385238|10123735|FG001|STARTED|Overall Study||1182
9063568|NCT04385238|10123734|FG000|COMPLETED|Overall Study||5712
9063569|NCT04385238|10123735|FG001|COMPLETED|Overall Study||1182
9063570|NCT04385238|10123734|FG000|NOT COMPLETED|Overall Study||0
9063571|NCT04385238|10123735|FG001|NOT COMPLETED|Overall Study||0
9063572|NCT04384523|10123747|FG000|STARTED|Overall Study||10
9063573|NCT04384523|10123748|FG001|STARTED|Overall Study||6
9063574|NCT04384523|10123749|FG002|STARTED|Overall Study||6
9063575|NCT04384523|10123750|FG003|STARTED|Overall Study||6
9063576|NCT04384523|10123751|FG004|STARTED|Overall Study||7
9063577|NCT04384523|10123752|FG005|STARTED|Overall Study||6
9063578|NCT04384523|10123747|FG000|COMPLETED|Overall Study||9
9063579|NCT04384523|10123748|FG001|COMPLETED|Overall Study||5
9063580|NCT04384523|10123749|FG002|COMPLETED|Overall Study||6
9063581|NCT04384523|10123750|FG003|COMPLETED|Overall Study||6
9063582|NCT04384523|10123751|FG004|COMPLETED|Overall Study||7
9063583|NCT04384523|10123752|FG005|COMPLETED|Overall Study||5
9063584|NCT04384523|10123747|FG000|NOT COMPLETED|Overall Study||1
9063585|NCT04384523|10123748|FG001|NOT COMPLETED|Overall Study||1
9063586|NCT04384523|10123749|FG002|NOT COMPLETED|Overall Study||0
9063587|NCT04384523|10123750|FG003|NOT COMPLETED|Overall Study||0
9063588|NCT04384523|10123751|FG004|NOT COMPLETED|Overall Study||0
9063589|NCT04384523|10123752|FG005|NOT COMPLETED|Overall Study||1
9063590|NCT04383665|10123772|FG000|STARTED|Overall Study||2
9063591|NCT04383665|10123773|FG001|STARTED|Overall Study||2
9063592|NCT04383665|10123774|FG002|STARTED|Overall Study||2
9063593|NCT04383665|10123775|FG003|STARTED|Overall Study||2
9063594|NCT04383665|10123776|FG004|STARTED|Overall Study||2
9063595|NCT04383665|10123777|FG005|STARTED|Overall Study||2
9063596|NCT04383665|10123772|FG000|COMPLETED|Overall Study||2
9063597|NCT04383665|10123773|FG001|COMPLETED|Overall Study||2
9063598|NCT04383665|10123774|FG002|COMPLETED|Overall Study||2
9063599|NCT04383665|10123775|FG003|COMPLETED|Overall Study||2
9063600|NCT04383665|10123776|FG004|COMPLETED|Overall Study||2
9063601|NCT04383665|10123777|FG005|COMPLETED|Overall Study||2
9063602|NCT04383665|10123772|FG000|NOT COMPLETED|Overall Study||0
9063603|NCT04383665|10123773|FG001|NOT COMPLETED|Overall Study||0
9063604|NCT04383665|10123774|FG002|NOT COMPLETED|Overall Study||0
9063605|NCT04383665|10123775|FG003|NOT COMPLETED|Overall Study||0
9063606|NCT04383665|10123776|FG004|NOT COMPLETED|Overall Study||0
9063607|NCT04383665|10123777|FG005|NOT COMPLETED|Overall Study||0
9063608|NCT04383132|10123787|FG000|STARTED|Overall Study||173
9063609|NCT04383132|10123788|FG001|STARTED|Overall Study||173
9063610|NCT04383132|10123787|FG000|COMPLETED|Overall Study||173
9063611|NCT04383132|10123788|FG001|COMPLETED|Overall Study||173
9063612|NCT04383132|10123787|FG000|NOT COMPLETED|Overall Study||0
9063613|NCT04383132|10123788|FG001|NOT COMPLETED|Overall Study||0
9063614|NCT04382066|10123797|FG000|STARTED|Overall Study||15
9063615|NCT04382066|10123798|FG001|STARTED|Overall Study||15
9063616|NCT04382066|10123799|FG002|STARTED|Overall Study||15
9063617|NCT04382066|10123797|FG000|Completed 3-day Treatment|Overall Study||14
9063618|NCT04382066|10123798|FG001|Completed 3-day Treatment|Overall Study||15
9063619|NCT04382066|10123799|FG002|Completed 3-day Treatment|Overall Study||15
9063620|NCT04382066|10123797|FG000|COMPLETED|Overall Study||13
9063621|NCT04382066|10123798|FG001|COMPLETED|Overall Study||15
9063622|NCT04382066|10123799|FG002|COMPLETED|Overall Study||14
9063623|NCT04382066|10123797|FG000|NOT COMPLETED|Overall Study||2
9063624|NCT04382066|10123798|FG001|NOT COMPLETED|Overall Study||0
9063625|NCT04382066|10123799|FG002|NOT COMPLETED|Overall Study||1
9063626|NCT04381481|10123821|FG000|STARTED|Overall Study||200
9063627|NCT04381481|10123822|FG001|STARTED|Overall Study||205
9063628|NCT04381481|10123823|FG002|STARTED|Overall Study||199
9063629|NCT04381481|10123824|FG003|STARTED|Overall Study||197
9063630|NCT04381481|10123825|FG004|STARTED|Overall Study||199
9063631|NCT04381481|10123826|FG005|STARTED|Overall Study||195
9063632|NCT04381481|10123827|FG006|STARTED|Overall Study||194
9063633|NCT04381481|10123828|FG007|STARTED|Overall Study||193
9063634|NCT04381481|10123829|FG008|STARTED|Overall Study||214
9063635|NCT04381481|10123830|FG009|STARTED|Overall Study||198
9063636|NCT04381481|10123831|FG010|STARTED|Overall Study||192
9063637|NCT04381481|10123832|FG011|STARTED|Overall Study||188
9063638|NCT04381481|10123821|FG000|COMPLETED|Overall Study||185
9063639|NCT04381481|10123822|FG001|COMPLETED|Overall Study||190
9063640|NCT04381481|10123823|FG002|COMPLETED|Overall Study||190
9063641|NCT04381481|10123824|FG003|COMPLETED|Overall Study||183
9063642|NCT04381481|10123825|FG004|COMPLETED|Overall Study||191
9063643|NCT04381481|10123826|FG005|COMPLETED|Overall Study||180
9063644|NCT04381481|10123827|FG006|COMPLETED|Overall Study||184
9063645|NCT04381481|10123828|FG007|COMPLETED|Overall Study||177
9063646|NCT04381481|10123829|FG008|COMPLETED|Overall Study||195
9063647|NCT04381481|10123830|FG009|COMPLETED|Overall Study||188
9063648|NCT04381481|10123831|FG010|COMPLETED|Overall Study||183
9063649|NCT04381481|10123832|FG011|COMPLETED|Overall Study||173
9063650|NCT04381481|10123821|FG000|NOT COMPLETED|Overall Study||15
9063651|NCT04381481|10123822|FG001|NOT COMPLETED|Overall Study||15
9063652|NCT04381481|10123823|FG002|NOT COMPLETED|Overall Study||9
9063653|NCT04381481|10123824|FG003|NOT COMPLETED|Overall Study||14
9063654|NCT04381481|10123825|FG004|NOT COMPLETED|Overall Study||8
9063655|NCT04381481|10123826|FG005|NOT COMPLETED|Overall Study||15
9063656|NCT04381481|10123827|FG006|NOT COMPLETED|Overall Study||10
9063657|NCT04381481|10123828|FG007|NOT COMPLETED|Overall Study||16
9063658|NCT04381481|10123829|FG008|NOT COMPLETED|Overall Study||19
9063659|NCT04381481|10123830|FG009|NOT COMPLETED|Overall Study||10
9063660|NCT04381481|10123831|FG010|NOT COMPLETED|Overall Study||9
9063661|NCT04381481|10123832|FG011|NOT COMPLETED|Overall Study||15
9063662|NCT04380688|10123860|FG000|STARTED|Overall Study||31
9063663|NCT04380688|10123861|FG001|STARTED|Overall Study||31
9063664|NCT04380688|10123860|FG000|COMPLETED|Overall Study||24
9063665|NCT04380688|10123861|FG001|COMPLETED|Overall Study||22
9063666|NCT04380688|10123860|FG000|NOT COMPLETED|Overall Study||7
9063667|NCT04380688|10123861|FG001|NOT COMPLETED|Overall Study||9
9063668|NCT04376060|10123867|FG000|STARTED|Overall Study||15
9063669|NCT04376060|10123867|FG000|COMPLETED|Overall Study||14
9063670|NCT04376060|10123867|FG000|NOT COMPLETED|Overall Study||1
9063671|NCT04374500|10123871|FG000|STARTED|Overall Study||10
9063672|NCT04374500|10123872|FG001|STARTED|Overall Study||10
9063673|NCT04374500|10123873|FG002|STARTED|Overall Study||83
9063674|NCT04374500|10123871|FG000|COMPLETED|Overall Study||10
9063675|NCT04374500|10123872|FG001|COMPLETED|Overall Study||10
9063676|NCT04374500|10123873|FG002|COMPLETED|Overall Study||83
9063677|NCT04374500|10123871|FG000|NOT COMPLETED|Overall Study||0
9063678|NCT04374500|10123872|FG001|NOT COMPLETED|Overall Study||0
9063679|NCT04374500|10123873|FG002|NOT COMPLETED|Overall Study||0
9063680|NCT04372186|10123886|FG000|STARTED|Overall Study||249
9063681|NCT04372186|10123887|FG001|STARTED|Overall Study||128
9063682|NCT04372186|10123886|FG000|COMPLETED|Overall Study||225
9063683|NCT04372186|10123887|FG001|COMPLETED|Overall Study||115
9063684|NCT04372186|10123886|FG000|NOT COMPLETED|Overall Study||24
9063685|NCT04372186|10123887|FG001|NOT COMPLETED|Overall Study||13
8704167|NCT00926367|9749880|FG000|COMPLETED|Overall Study||23
8704168|NCT00926367|9749881|FG001|COMPLETED|Overall Study||24
8704169|NCT00926367|9749880|FG000|NOT COMPLETED|Overall Study||2
8704170|NCT00926367|9749881|FG001|NOT COMPLETED|Overall Study||3
8704171|NCT00926380|9749892|FG000|STARTED|Year 1||33
8704172|NCT00926380|9749893|FG001|STARTED|Year 1||31
8704173|NCT00926380|9749894|FG002|STARTED|Year 1||30
8704174|NCT00926380|9749892|FG000|COMPLETED|Year 1||33
8704175|NCT00926380|9749893|FG001|COMPLETED|Year 1||30
8704176|NCT00926380|9749894|FG002|COMPLETED|Year 1||29
8704177|NCT00926380|9749892|FG000|NOT COMPLETED|Year 1||0
9063686|NCT04371419|10123895|FG000|STARTED|Overall Study||784
9063687|NCT04371419|10123896|FG001|STARTED|Overall Study||791
9063688|NCT04371419|10123897|FG002|STARTED|Overall Study||780
9063689|NCT04371419|10123898|FG003|STARTED|Overall Study||778
9063690|NCT04371419|10123899|FG004|STARTED|Overall Study||777
9063691|NCT04371419|10123900|FG005|STARTED|Overall Study||788
9063692|NCT04371419|10123901|FG006|STARTED|Overall Study||783
9063693|NCT04371419|10123902|FG007|STARTED|Overall Study||788
9063694|NCT04371419|10123903|FG008|STARTED|Overall Study||779
9063695|NCT04371419|10123904|FG009|STARTED|Overall Study||780
9063696|NCT04371419|10123905|FG010|STARTED|Overall Study||782
9063697|NCT04371419|10123906|FG011|STARTED|Overall Study||790
9063698|NCT04371419|10123907|FG012|STARTED|Overall Study||779
9063699|NCT04371419|10123908|FG013|STARTED|Overall Study||786
9063700|NCT04371419|10123909|FG014|STARTED|Overall Study||781
9063701|NCT04371419|10123910|FG015|STARTED|Overall Study||781
9063702|NCT04371419|10123911|FG016|STARTED|Overall Study||1617
9063703|NCT04371419|10123895|FG000|Completed the Knowledge Questions|Overall Study||663
9063704|NCT04371419|10123896|FG001|Completed the Knowledge Questions|Overall Study||669
9063705|NCT04371419|10123897|FG002|Completed the Knowledge Questions|Overall Study||673
9063706|NCT04371419|10123898|FG003|Completed the Knowledge Questions|Overall Study||664
9063707|NCT04371419|10123899|FG004|Completed the Knowledge Questions|Overall Study||666
9063708|NCT04371419|10123900|FG005|Completed the Knowledge Questions|Overall Study||683
9063709|NCT04371419|10123901|FG006|Completed the Knowledge Questions|Overall Study||664
9063710|NCT04371419|10123902|FG007|Completed the Knowledge Questions|Overall Study||679
9063711|NCT04371419|10123903|FG008|Completed the Knowledge Questions|Overall Study||670
9063712|NCT04371419|10123904|FG009|Completed the Knowledge Questions|Overall Study||655
9063713|NCT04371419|10123905|FG010|Completed the Knowledge Questions|Overall Study||656
9063714|NCT04371419|10123906|FG011|Completed the Knowledge Questions|Overall Study||692
9063715|NCT04371419|10123907|FG012|Completed the Knowledge Questions|Overall Study||664
9063716|NCT04371419|10123908|FG013|Completed the Knowledge Questions|Overall Study||687
9063717|NCT04371419|10123909|FG014|Completed the Knowledge Questions|Overall Study||652
9063718|NCT04371419|10123910|FG015|Completed the Knowledge Questions|Overall Study||652
9063719|NCT04371419|10123911|FG016|Completed the Knowledge Questions|Overall Study||1526
9063720|NCT04371419|10123895|FG000|COMPLETED|Overall Study||641
9063721|NCT04371419|10123896|FG001|COMPLETED|Overall Study||636
9063722|NCT04371419|10123897|FG002|COMPLETED|Overall Study||639
9063723|NCT04371419|10123898|FG003|COMPLETED|Overall Study||631
9063724|NCT04371419|10123899|FG004|COMPLETED|Overall Study||644
9063725|NCT04371419|10123900|FG005|COMPLETED|Overall Study||654
9063726|NCT04371419|10123901|FG006|COMPLETED|Overall Study||639
9063727|NCT04371419|10123902|FG007|COMPLETED|Overall Study||658
9063728|NCT04371419|10123903|FG008|COMPLETED|Overall Study||649
9063729|NCT04371419|10123904|FG009|COMPLETED|Overall Study||621
9063730|NCT04371419|10123905|FG010|COMPLETED|Overall Study||626
9063731|NCT04371419|10123906|FG011|COMPLETED|Overall Study||662
9063732|NCT04371419|10123907|FG012|COMPLETED|Overall Study||633
9063733|NCT04371419|10123908|FG013|COMPLETED|Overall Study||660
9063734|NCT04371419|10123909|FG014|COMPLETED|Overall Study||626
9063735|NCT04371419|10123910|FG015|COMPLETED|Overall Study||625
9063736|NCT04371419|10123911|FG016|COMPLETED|Overall Study||1450
9063737|NCT04371419|10123895|FG000|NOT COMPLETED|Overall Study||143
9063738|NCT04371419|10123896|FG001|NOT COMPLETED|Overall Study||155
9063739|NCT04371419|10123897|FG002|NOT COMPLETED|Overall Study||141
9063740|NCT04371419|10123898|FG003|NOT COMPLETED|Overall Study||147
9063741|NCT04371419|10123899|FG004|NOT COMPLETED|Overall Study||133
9063742|NCT04371419|10123900|FG005|NOT COMPLETED|Overall Study||134
9063743|NCT04371419|10123901|FG006|NOT COMPLETED|Overall Study||144
9063744|NCT04371419|10123902|FG007|NOT COMPLETED|Overall Study||130
9063745|NCT04371419|10123903|FG008|NOT COMPLETED|Overall Study||130
9063746|NCT04371419|10123904|FG009|NOT COMPLETED|Overall Study||159
9063747|NCT04371419|10123905|FG010|NOT COMPLETED|Overall Study||156
9063748|NCT04371419|10123906|FG011|NOT COMPLETED|Overall Study||128
9063749|NCT04371419|10123907|FG012|NOT COMPLETED|Overall Study||146
9063750|NCT04371419|10123908|FG013|NOT COMPLETED|Overall Study||126
9063751|NCT04371419|10123909|FG014|NOT COMPLETED|Overall Study||155
9063752|NCT04371419|10123910|FG015|NOT COMPLETED|Overall Study||156
9063753|NCT04371419|10123911|FG016|NOT COMPLETED|Overall Study||167
9063754|NCT04370834|10123942|FG000|STARTED|Overall Study||1
9063755|NCT04370834|10123942|FG000|COMPLETED|Overall Study||1
9063756|NCT04370834|10123942|FG000|NOT COMPLETED|Overall Study||0
9063757|NCT04370548|10123954|FG000|STARTED|Overall Study||204
9063758|NCT04370548|10123955|FG001|STARTED|Overall Study||103
9063759|NCT04370548|10123954|FG000|COMPLETED|Overall Study||190
9063760|NCT04370548|10123955|FG001|COMPLETED|Overall Study||100
9063761|NCT04370548|10123954|FG000|NOT COMPLETED|Overall Study||14
8704178|NCT00926380|9749893|FG001|NOT COMPLETED|Year 1||1
8704179|NCT00926380|9749894|FG002|NOT COMPLETED|Year 1||1
9063762|NCT04370548|10123955|FG001|NOT COMPLETED|Overall Study||3
9063763|NCT04370028|10123961|FG000|STARTED|Overall Study||2583
9063764|NCT04370028|10123961|FG000|COMPLETED|Overall Study||1876
8704180|NCT00926380|9749892|FG000|STARTED|Year 2||33
8704181|NCT00926380|9749893|FG001|STARTED|Year 2||30
8704182|NCT00926380|9749894|FG002|STARTED|Year 2||29
9063765|NCT04370028|10123961|FG000|NOT COMPLETED|Overall Study||707
9063766|NCT04363736|10123974|FG000|STARTED|Overall Study||49
9063767|NCT04363736|10123975|FG001|STARTED|Overall Study||48
9063768|NCT04363736|10123974|FG000|COMPLETED|Overall Study||30
9063769|NCT04363736|10123975|FG001|COMPLETED|Overall Study||35
9063770|NCT04363736|10123974|FG000|NOT COMPLETED|Overall Study||19
9063771|NCT04363736|10123975|FG001|NOT COMPLETED|Overall Study||13
9063772|NCT04366583|10123983|FG000|STARTED|Overall Study||82
9063773|NCT04366583|10123984|FG001|STARTED|Overall Study||84
9063774|NCT04366583|10123983|FG000|COMPLETED|Overall Study||82
9063775|NCT04366583|10123984|FG001|COMPLETED|Overall Study||84
9063776|NCT04366583|10123983|FG000|NOT COMPLETED|Overall Study||0
9063777|NCT04366583|10123984|FG001|NOT COMPLETED|Overall Study||0
9063778|NCT04365699|10123993|FG000|STARTED|Overall Study||10
9063779|NCT04365699|10123994|FG001|STARTED|Overall Study||16
9063780|NCT04365699|10123995|FG002|STARTED|Overall Study||55
9063781|NCT04365699|10123993|FG000|COMPLETED|Overall Study||8
9063782|NCT04365699|10123994|FG001|COMPLETED|Overall Study||11
9063783|NCT04365699|10123995|FG002|COMPLETED|Overall Study||40
9063784|NCT04365699|10123993|FG000|NOT COMPLETED|Overall Study||2
9063785|NCT04365699|10123994|FG001|NOT COMPLETED|Overall Study||5
9063786|NCT04365699|10123995|FG002|NOT COMPLETED|Overall Study||15
9063787|NCT04365153|10124006|FG000|STARTED|Overall Study||15
9063788|NCT04365153|10124007|FG001|STARTED|Overall Study||14
9063789|NCT04365153|10124008|FG002|STARTED|Overall Study||16
9063790|NCT04365153|10124006|FG000|COMPLETED|Overall Study||15
9063791|NCT04365153|10124007|FG001|COMPLETED|Overall Study||14
9063792|NCT04365153|10124008|FG002|COMPLETED|Overall Study||16
9063793|NCT04365153|10124006|FG000|NOT COMPLETED|Overall Study||0
9063794|NCT04365153|10124007|FG001|NOT COMPLETED|Overall Study||0
9063795|NCT04365153|10124008|FG002|NOT COMPLETED|Overall Study||0
9063796|NCT04363879|10124019|FG000|STARTED|Overall Study||78
9063797|NCT04363879|10124020|FG001|STARTED|Overall Study||92
9063798|NCT04363879|10124019|FG000|COMPLETED|Overall Study||78
9063799|NCT04363879|10124020|FG001|COMPLETED|Overall Study||92
9063800|NCT04363879|10124019|FG000|NOT COMPLETED|Overall Study||0
9063801|NCT04363879|10124020|FG001|NOT COMPLETED|Overall Study||0
9063802|NCT04362137|10124028|FG000|STARTED|Overall Study||287
9063803|NCT04362137|10124029|FG001|STARTED|Overall Study||145
9063804|NCT04362137|10124028|FG000|Safety Set|Overall Study||281
9063805|NCT04362137|10124029|FG001|Safety Set|Overall Study||143
9063806|NCT04362137|10124028|FG000|COMPLETED|Overall Study||269
9063807|NCT04362137|10124029|FG001|COMPLETED|Overall Study||139
9063808|NCT04362137|10124028|FG000|NOT COMPLETED|Overall Study||18
9063809|NCT04362137|10124029|FG001|NOT COMPLETED|Overall Study||6
9063810|NCT04359771|10124037|FG000|STARTED|Overall Study|Right eye of every participant was assigned to the diode MPL group|15
9063811|NCT04359771|10124038|FG001|STARTED|Overall Study|Left eye of every participant was assigned to the diode MPL group|15
9063812|NCT04359771|10124037|FG000|COMPLETED|Overall Study|The right eye of each participant was assigned to the diode MPL group|13
9063813|NCT04359771|10124038|FG001|COMPLETED|Overall Study|The left eye of every participant was assigned to the diode MPL group|13
9063814|NCT04359771|10124037|FG000|NOT COMPLETED|Overall Study||2
9063815|NCT04359771|10124038|FG001|NOT COMPLETED|Overall Study||2
9063816|NCT04358991|10124044|FG000|STARTED|Overall Study||20
9063817|NCT04358991|10124044|FG000|COMPLETED|Overall Study||20
9063818|NCT04358991|10124044|FG000|NOT COMPLETED|Overall Study||0
9063819|NCT04358081|10124051|FG000|STARTED|Treatment Phase of Study||7
9063820|NCT04358081|10124052|FG001|STARTED|Treatment Phase of Study||7
9063821|NCT04358081|10124053|FG002|STARTED|Treatment Phase of Study||5
9063822|NCT04358081|10124051|FG000|COMPLETED|Treatment Phase of Study||3
9063823|NCT04358081|10124052|FG001|COMPLETED|Treatment Phase of Study||6
9063824|NCT04358081|10124053|FG002|COMPLETED|Treatment Phase of Study||2
9063825|NCT04358081|10124051|FG000|NOT COMPLETED|Treatment Phase of Study||4
9063826|NCT04358081|10124052|FG001|NOT COMPLETED|Treatment Phase of Study||1
9063827|NCT04358081|10124053|FG002|NOT COMPLETED|Treatment Phase of Study||3
9063828|NCT04358081|10124051|FG000|STARTED|Study Completion Phase||7
9063829|NCT04358081|10124052|FG001|STARTED|Study Completion Phase||7
9063830|NCT04358081|10124053|FG002|STARTED|Study Completion Phase||5
9063831|NCT04358081|10124051|FG000|COMPLETED|Study Completion Phase||6
9063832|NCT04358081|10124052|FG001|COMPLETED|Study Completion Phase||7
9063833|NCT04358081|10124053|FG002|COMPLETED|Study Completion Phase||3
9063834|NCT04358081|10124051|FG000|NOT COMPLETED|Study Completion Phase||1
9063835|NCT04358081|10124052|FG001|NOT COMPLETED|Study Completion Phase||0
9063836|NCT04358081|10124053|FG002|NOT COMPLETED|Study Completion Phase||2
9063837|NCT04356937|10124065|FG000|STARTED|Randomization (Safety Population)||161
9063838|NCT04356937|10124066|FG001|STARTED|Randomization (Safety Population)||82
9063839|NCT04356937|10124065|FG000|COMPLETED|Randomization (Safety Population)||161
9063840|NCT04356937|10124066|FG001|COMPLETED|Randomization (Safety Population)||82
9063841|NCT04356937|10124065|FG000|NOT COMPLETED|Randomization (Safety Population)||0
9063842|NCT04356937|10124066|FG001|NOT COMPLETED|Randomization (Safety Population)||0
9063843|NCT04356937|10124065|FG000|STARTED|Treatment (mITT Population)||161
9063844|NCT04356937|10124066|FG001|STARTED|Treatment (mITT Population)||82
9063845|NCT04356937|10124065|FG000|COMPLETED|Treatment (mITT Population)||161
9063846|NCT04356937|10124066|FG001|COMPLETED|Treatment (mITT Population)||81
9063847|NCT04356937|10124065|FG000|NOT COMPLETED|Treatment (mITT Population)||0
9063848|NCT04356937|10124066|FG001|NOT COMPLETED|Treatment (mITT Population)||1
9063849|NCT04355663|10124075|FG000|STARTED|Overall Study||42
9063850|NCT04355663|10124076|FG001|STARTED|Overall Study||29
9063851|NCT04355663|10124077|FG002|STARTED|Overall Study||21
9063852|NCT04355663|10124075|FG000|COMPLETED|Overall Study||40
9063853|NCT04355663|10124076|FG001|COMPLETED|Overall Study||14
9063854|NCT04355663|10124077|FG002|COMPLETED|Overall Study||17
9063855|NCT04355663|10124075|FG000|NOT COMPLETED|Overall Study||2
9063856|NCT04355663|10124076|FG001|NOT COMPLETED|Overall Study||15
9063857|NCT04355663|10124077|FG002|NOT COMPLETED|Overall Study||4
9063858|NCT04354870|10124087|FG000|STARTED|Overall Study||83
9063859|NCT04354870|10124088|FG001|STARTED|Overall Study||47
9063860|NCT04354870|10124087|FG000|COMPLETED|Overall Study||35
9063861|NCT04354870|10124088|FG001|COMPLETED|Overall Study||14
9063862|NCT04354870|10124087|FG000|NOT COMPLETED|Overall Study||48
9063863|NCT04354870|10124088|FG001|NOT COMPLETED|Overall Study||33
9063864|NCT04350307|10124096|FG000|STARTED|Overall Study||84
9063865|NCT04350307|10124097|FG001|STARTED|Overall Study||78
9063866|NCT04350307|10124096|FG000|COMPLETED|Overall Study||84
9063867|NCT04350307|10124097|FG001|COMPLETED|Overall Study||78
9063868|NCT04350307|10124096|FG000|NOT COMPLETED|Overall Study||0
9063869|NCT04350307|10124097|FG001|NOT COMPLETED|Overall Study||0
9063870|NCT04352660|10124105|FG000|STARTED|Overall Study||50
9063871|NCT04352660|10124106|FG001|STARTED|Overall Study||50
9063872|NCT04352660|10124105|FG000|COMPLETED|Overall Study||36
9063873|NCT04352660|10124106|FG001|COMPLETED|Overall Study||40
9063874|NCT04352660|10124105|FG000|NOT COMPLETED|Overall Study||14
9063875|NCT04352660|10124106|FG001|NOT COMPLETED|Overall Study||10
9063876|NCT04350788|10124114|FG000|STARTED|Overall Study||62
9063877|NCT04350788|10124115|FG001|STARTED|Overall Study||62
9063878|NCT04350788|10124114|FG000|COMPLETED|Overall Study||50
9063879|NCT04350788|10124115|FG001|COMPLETED|Overall Study||56
9063880|NCT04350788|10124114|FG000|NOT COMPLETED|Overall Study||12
9063881|NCT04350788|10124115|FG001|NOT COMPLETED|Overall Study||6
9063882|NCT04349917|10124128|FG000|STARTED|First Intervention (2-4 Hours)||19
9063883|NCT04349917|10124129|FG001|STARTED|First Intervention (2-4 Hours)||18
9063884|NCT04349917|10124128|FG000|Received Intervention|First Intervention (2-4 Hours)||19
9063885|NCT04349917|10124129|FG001|Received Intervention|First Intervention (2-4 Hours)||17
9063886|NCT04349917|10124128|FG000|COMPLETED|First Intervention (2-4 Hours)||19
9063887|NCT04349917|10124129|FG001|COMPLETED|First Intervention (2-4 Hours)||16
9063888|NCT04349917|10124128|FG000|NOT COMPLETED|First Intervention (2-4 Hours)||0
9063889|NCT04349917|10124129|FG001|NOT COMPLETED|First Intervention (2-4 Hours)||2
9063890|NCT04349917|10124128|FG000|STARTED|Washout Period (4-20 Days)||19
9063891|NCT04349917|10124129|FG001|STARTED|Washout Period (4-20 Days)||16
9063892|NCT04349917|10124128|FG000|COMPLETED|Washout Period (4-20 Days)||19
9063893|NCT04349917|10124129|FG001|COMPLETED|Washout Period (4-20 Days)||16
9063894|NCT04349917|10124128|FG000|NOT COMPLETED|Washout Period (4-20 Days)||0
9063895|NCT04349917|10124129|FG001|NOT COMPLETED|Washout Period (4-20 Days)||0
9063896|NCT04349917|10124128|FG000|STARTED|Second Intervention (2-4 Hours)||19
9063897|NCT04349917|10124129|FG001|STARTED|Second Intervention (2-4 Hours)||16
9063898|NCT04349917|10124128|FG000|Received Intervention|Second Intervention (2-4 Hours)||19
9063899|NCT04349917|10124129|FG001|Received Intervention|Second Intervention (2-4 Hours)||16
9063900|NCT04349917|10124128|FG000|COMPLETED|Second Intervention (2-4 Hours)||19
9063901|NCT04349917|10124129|FG001|COMPLETED|Second Intervention (2-4 Hours)||16
9063902|NCT04349917|10124128|FG000|NOT COMPLETED|Second Intervention (2-4 Hours)||0
9063903|NCT04349917|10124129|FG001|NOT COMPLETED|Second Intervention (2-4 Hours)||0
9063904|NCT04348851|10124140|FG000|STARTED|Post-Test 1||13
9063905|NCT04348851|10124141|FG001|STARTED|Post-Test 1||13
9063906|NCT04348851|10124142|FG002|STARTED|Post-Test 1||13
9063907|NCT04348851|10124143|FG003|STARTED|Post-Test 1||14
9063908|NCT04348851|10124140|FG000|COMPLETED|Post-Test 1||13
9063909|NCT04348851|10124141|FG001|COMPLETED|Post-Test 1||11
9063910|NCT04348851|10124142|FG002|COMPLETED|Post-Test 1||13
9063911|NCT04348851|10124143|FG003|COMPLETED|Post-Test 1||14
9063912|NCT04348851|10124140|FG000|NOT COMPLETED|Post-Test 1||0
9063913|NCT04348851|10124141|FG001|NOT COMPLETED|Post-Test 1||2
9063914|NCT04348851|10124142|FG002|NOT COMPLETED|Post-Test 1||0
9063915|NCT04348851|10124143|FG003|NOT COMPLETED|Post-Test 1||0
9063916|NCT04348851|10124140|FG000|STARTED|Post-Test 2||13
9063917|NCT04348851|10124141|FG001|STARTED|Post-Test 2||11
9063918|NCT04348851|10124142|FG002|STARTED|Post-Test 2||13
9063919|NCT04348851|10124143|FG003|STARTED|Post-Test 2||14
9063920|NCT04348851|10124140|FG000|COMPLETED|Post-Test 2||13
9063921|NCT04348851|10124141|FG001|COMPLETED|Post-Test 2||10
9063922|NCT04348851|10124142|FG002|COMPLETED|Post-Test 2||13
9063923|NCT04348851|10124143|FG003|COMPLETED|Post-Test 2||13
9063924|NCT04348851|10124140|FG000|NOT COMPLETED|Post-Test 2||0
9063925|NCT04348851|10124141|FG001|NOT COMPLETED|Post-Test 2||1
9063926|NCT04348851|10124142|FG002|NOT COMPLETED|Post-Test 2||0
9063927|NCT04348851|10124143|FG003|NOT COMPLETED|Post-Test 2||1
9063928|NCT04348357|10124155|FG000|STARTED|Overall Study||25
9063929|NCT04348357|10124156|FG001|STARTED|Overall Study||28
9063930|NCT04348357|10124155|FG000|COMPLETED|Overall Study||25
9063931|NCT04348357|10124156|FG001|COMPLETED|Overall Study||16
9063932|NCT04348357|10124155|FG000|NOT COMPLETED|Overall Study||0
9063933|NCT04348357|10124156|FG001|NOT COMPLETED|Overall Study||12
9063934|NCT04346199|10124164|FG000|STARTED|Overall Study||89
9063935|NCT04346199|10124165|FG001|STARTED|Overall Study||88
9063936|NCT04346199|10124164|FG000|COMPLETED|Overall Study||74
9063937|NCT04346199|10124165|FG001|COMPLETED|Overall Study||77
9063938|NCT04346199|10124164|FG000|NOT COMPLETED|Overall Study||15
9063939|NCT04346199|10124165|FG001|NOT COMPLETED|Overall Study||11
9063940|NCT04345653|10124171|FG000|STARTED|Overall Study||48
9063941|NCT04345653|10124171|FG000|COMPLETED|Overall Study||46
9063942|NCT04345653|10124171|FG000|NOT COMPLETED|Overall Study||2
9063943|NCT04343261|10124176|FG000|STARTED|Overall Study||48
9063944|NCT04343261|10124176|FG000|COMPLETED|Overall Study||40
9063945|NCT04343261|10124176|FG000|NOT COMPLETED|Overall Study||8
9063946|NCT04343222|10124183|FG000|STARTED|Overall Study||16
9063947|NCT04343222|10124184|FG001|STARTED|Overall Study||15
9063948|NCT04343222|10124185|FG002|STARTED|Overall Study||15
9063949|NCT04343222|10124183|FG000|COMPLETED|Overall Study||16
9063950|NCT04343222|10124184|FG001|COMPLETED|Overall Study||15
9063951|NCT04343222|10124185|FG002|COMPLETED|Overall Study||15
9063952|NCT04343222|10124183|FG000|NOT COMPLETED|Overall Study||0
9063953|NCT04343222|10124184|FG001|NOT COMPLETED|Overall Study||0
9063954|NCT04343222|10124185|FG002|NOT COMPLETED|Overall Study||0
9063955|NCT04343092|10124193|FG000|STARTED|Overall Study||16
9063956|NCT04343092|10124193|FG000|COMPLETED|Overall Study||16
9063957|NCT04343092|10124193|FG000|NOT COMPLETED|Overall Study||0
9063958|NCT04342663|10124199|FG000|STARTED|Overall Study||80
9063959|NCT04342663|10124200|FG001|STARTED|Overall Study||72
9063960|NCT04342663|10124199|FG000|COMPLETED|Overall Study||62
9063961|NCT04342663|10124200|FG001|COMPLETED|Overall Study||53
9063962|NCT04342663|10124199|FG000|NOT COMPLETED|Overall Study||18
9063963|NCT04342663|10124200|FG001|NOT COMPLETED|Overall Study||19
9063964|NCT04342897|10124208|FG000|STARTED|Overall Study||47
9063965|NCT04342897|10124209|FG001|STARTED|Overall Study||48
9063966|NCT04342897|10124208|FG000|Received at Least One Dose of Study Drug|Overall Study||47
9063967|NCT04342897|10124209|FG001|Received at Least One Dose of Study Drug|Overall Study||48
9063968|NCT04342897|10124208|FG000|COMPLETED|Overall Study||33
9063969|NCT04342897|10124209|FG001|COMPLETED|Overall Study||36
9063970|NCT04342897|10124208|FG000|NOT COMPLETED|Overall Study||14
9063971|NCT04342897|10124209|FG001|NOT COMPLETED|Overall Study||12
9063972|NCT04342130|10124215|FG000|STARTED|Overall Study||10
9063973|NCT04342130|10124215|FG000|COMPLETED|Overall Study||10
9063974|NCT04342130|10124215|FG000|NOT COMPLETED|Overall Study||0
9063975|NCT04340557|10124221|FG000|STARTED|Overall Study||16
9063976|NCT04340557|10124222|FG001|STARTED|Overall Study||15
9063977|NCT04340557|10124221|FG000|COMPLETED|Overall Study||15
9063978|NCT04340557|10124222|FG001|COMPLETED|Overall Study||13
9063979|NCT04340557|10124221|FG000|NOT COMPLETED|Overall Study||1
9063980|NCT04340557|10124222|FG001|NOT COMPLETED|Overall Study||2
9063981|NCT04339972|10124230|FG000|STARTED|Overall Study||15
9063982|NCT04339972|10124231|FG001|STARTED|Overall Study||14
9063983|NCT04339972|10124230|FG000|COMPLETED|Overall Study||10
9063984|NCT04339972|10124231|FG001|COMPLETED|Overall Study||9
9063985|NCT04339972|10124230|FG000|NOT COMPLETED|Overall Study||5
9063986|NCT04339972|10124231|FG001|NOT COMPLETED|Overall Study||5
9063987|NCT04339296|10124239|FG000|STARTED|Overall Study||24
9063988|NCT04339296|10124240|FG001|STARTED|Overall Study||26
9063989|NCT04339296|10124239|FG000|Completed Baseline|Overall Study||23
9063990|NCT04339296|10124240|FG001|Completed Baseline|Overall Study||25
9063991|NCT04339296|10124239|FG000|Received Allocated Intervention|Overall Study||21
9063992|NCT04339296|10124240|FG001|Received Allocated Intervention|Overall Study||24
9063993|NCT04339296|10124239|FG000|COMPLETED|Overall Study||16
9063994|NCT04339296|10124240|FG001|COMPLETED|Overall Study||17
9063995|NCT04339296|10124239|FG000|NOT COMPLETED|Overall Study||8
9063996|NCT04339296|10124240|FG001|NOT COMPLETED|Overall Study||9
9063997|NCT04338009|10124248|FG000|STARTED|Overall Study||77
9063998|NCT04338009|10124249|FG001|STARTED|Overall Study||75
9063999|NCT04338009|10124248|FG000|COMPLETED|Overall Study||77
9064000|NCT04338009|10124249|FG001|COMPLETED|Overall Study||75
9064001|NCT04338009|10124248|FG000|NOT COMPLETED|Overall Study||0
9064002|NCT04338009|10124249|FG001|NOT COMPLETED|Overall Study||0
9064003|NCT04338074|10124257|FG000|STARTED|Overall Study||3
9064004|NCT04338074|10124258|FG001|STARTED|Overall Study||2
9064005|NCT04338074|10124257|FG000|COMPLETED|Overall Study||3
9064006|NCT04338074|10124258|FG001|COMPLETED|Overall Study||2
9064007|NCT04338074|10124257|FG000|NOT COMPLETED|Overall Study||0
9064008|NCT04338074|10124258|FG001|NOT COMPLETED|Overall Study||0
9064009|NCT04337138|10124264|FG000|STARTED|Overall Study||32
9064010|NCT04337138|10124264|FG000|COMPLETED|Overall Study||32
9064011|NCT04337138|10124264|FG000|NOT COMPLETED|Overall Study||0
9064012|NCT04336475|10124270|FG000|STARTED|Overall Study||30
9064013|NCT04336475|10124271|FG001|STARTED|Overall Study||30
9064014|NCT04336475|10124270|FG000|COMPLETED|Overall Study||28
9064015|NCT04336475|10124271|FG001|COMPLETED|Overall Study||28
9064016|NCT04336475|10124270|FG000|NOT COMPLETED|Overall Study||2
9064017|NCT04336475|10124271|FG001|NOT COMPLETED|Overall Study||2
9064018|NCT04335929|10124277|FG000|STARTED|Overall Study||32
9064019|NCT04335929|10124277|FG000|COMPLETED|Overall Study||22
9064020|NCT04335929|10124277|FG000|NOT COMPLETED|Overall Study||10
9064021|NCT04335812|10124283|FG000|STARTED|Overall Study||63
9064022|NCT04335812|10124284|FG001|STARTED|Overall Study||63
9064023|NCT04335812|10124283|FG000|COMPLETED|Overall Study||28
9064024|NCT04335812|10124284|FG001|COMPLETED|Overall Study||30
9064025|NCT04335812|10124283|FG000|NOT COMPLETED|Overall Study||35
9064026|NCT04335812|10124284|FG001|NOT COMPLETED|Overall Study||33
9064027|NCT04335136|10124292|FG000|STARTED|Overall Study||91
9064028|NCT04335136|10124293|FG001|STARTED|Overall Study||90
9064029|NCT04335136|10124292|FG000|Treated|Overall Study||88
9064030|NCT04335136|10124293|FG001|Treated|Overall Study||90
9064031|NCT04335136|10124292|FG000|COMPLETED|Overall Study||77
9064032|NCT04335136|10124293|FG001|COMPLETED|Overall Study||83
9064033|NCT04335136|10124292|FG000|NOT COMPLETED|Overall Study||14
9064034|NCT04335136|10124293|FG001|NOT COMPLETED|Overall Study||7
9064035|NCT04335552|10124303|FG000|STARTED|Overall Study||2
9064036|NCT04335552|10124304|FG001|STARTED|Overall Study||4
9064037|NCT04335552|10124305|FG002|STARTED|Overall Study||3
9064038|NCT04335552|10124306|FG003|STARTED|Overall Study||2
9064039|NCT04335552|10124303|FG000|COMPLETED|Overall Study||1
9064040|NCT04335552|10124304|FG001|COMPLETED|Overall Study||4
9064041|NCT04335552|10124305|FG002|COMPLETED|Overall Study||3
9064042|NCT04335552|10124306|FG003|COMPLETED|Overall Study||2
9064043|NCT04335552|10124303|FG000|NOT COMPLETED|Overall Study||1
9064044|NCT04335552|10124304|FG001|NOT COMPLETED|Overall Study||0
9064045|NCT04335552|10124305|FG002|NOT COMPLETED|Overall Study||0
9064046|NCT04335552|10124306|FG003|NOT COMPLETED|Overall Study||0
9064047|NCT04334876|10124316|FG000|STARTED|Overall Study||571
9064048|NCT04334876|10124316|FG000|COMPLETED|Overall Study||500
9064049|NCT04334876|10124316|FG000|NOT COMPLETED|Overall Study||71
9064050|NCT04334681|10124322|FG000|STARTED|Overall Study||135
9064051|NCT04334681|10124323|FG001|STARTED|Overall Study||143
9064052|NCT04334681|10124322|FG000|COMPLETED|Overall Study||135
9064053|NCT04334681|10124323|FG001|COMPLETED|Overall Study||143
9064054|NCT04334681|10124322|FG000|NOT COMPLETED|Overall Study||0
9064055|NCT04334681|10124323|FG001|NOT COMPLETED|Overall Study||0
9064056|NCT04333225|10124333|FG000|STARTED|Overall Study||101
9064057|NCT04333225|10124334|FG001|STARTED|Overall Study||120
9064058|NCT04333225|10124333|FG000|COMPLETED|Overall Study||98
9064059|NCT04333225|10124334|FG001|COMPLETED|Overall Study||115
9064060|NCT04333225|10124333|FG000|NOT COMPLETED|Overall Study||3
9064061|NCT04333225|10124334|FG001|NOT COMPLETED|Overall Study||5
9064062|NCT04333199|10124343|FG000|STARTED|Evaluated Patients||1669
9064063|NCT04333199|10124344|FG001|STARTED|Evaluated Patients||1672
9064064|NCT04333199|10124345|FG002|STARTED|Evaluated Patients||1671
9064065|NCT04333199|10124343|FG000|COMPLETED|Evaluated Patients||1669
9064066|NCT04333199|10124344|FG001|COMPLETED|Evaluated Patients||1671
9064067|NCT04333199|10124345|FG002|COMPLETED|Evaluated Patients||1669
9064068|NCT04333199|10124343|FG000|NOT COMPLETED|Evaluated Patients||0
9064069|NCT04333199|10124344|FG001|NOT COMPLETED|Evaluated Patients||1
9064070|NCT04333199|10124345|FG002|NOT COMPLETED|Evaluated Patients||2
9064071|NCT04333199|10124343|FG000|STARTED|Emailed Patients|Patients in this group were not emailed|0
9064072|NCT04333199|10124344|FG001|STARTED|Emailed Patients||1671
9064073|NCT04333199|10124345|FG002|STARTED|Emailed Patients||1669
9064074|NCT04333199|10124343|FG000|Valid Email Address|Emailed Patients|Patients in this group were not emailed|0
9064075|NCT04333199|10124344|FG001|Valid Email Address|Emailed Patients||1495
9064076|NCT04333199|10124345|FG002|Valid Email Address|Emailed Patients||1441
9064077|NCT04333199|10124343|FG000|COMPLETED|Emailed Patients|Patients in this group were not emailed|0
9064078|NCT04333199|10124344|FG001|COMPLETED|Emailed Patients||1399
9064079|NCT04333199|10124345|FG002|COMPLETED|Emailed Patients||1351
9064080|NCT04333199|10124343|FG000|NOT COMPLETED|Emailed Patients||0
9064081|NCT04333199|10124344|FG001|NOT COMPLETED|Emailed Patients||272
9064082|NCT04333199|10124345|FG002|NOT COMPLETED|Emailed Patients||318
9064083|NCT04332991|10124356|FG000|STARTED|Overall Study||242
9064084|NCT04332991|10124357|FG001|STARTED|Overall Study||237
9064085|NCT04332991|10124356|FG000|COMPLETED|Overall Study||242
9064086|NCT04332991|10124357|FG001|COMPLETED|Overall Study||237
9064087|NCT04332991|10124356|FG000|NOT COMPLETED|Overall Study||0
9064088|NCT04332991|10124357|FG001|NOT COMPLETED|Overall Study||0
9064089|NCT04332614|10124369|FG000|STARTED|~1 Week After Study Launch||2350
9064090|NCT04332614|10124370|FG001|STARTED|~1 Week After Study Launch||2350
9064091|NCT04332614|10124371|FG002|STARTED|~1 Week After Study Launch||2350
9064092|NCT04332614|10124372|FG003|STARTED|~1 Week After Study Launch||2350
9064093|NCT04332614|10124373|FG004|STARTED|~1 Week After Study Launch||2350
9064094|NCT04332614|10124374|FG005|STARTED|~1 Week After Study Launch||2349
9064095|NCT04332614|10124369|FG000|Data in EHR|~1 Week After Study Launch||2245
9064096|NCT04332614|10124370|FG001|Data in EHR|~1 Week After Study Launch||2273
9064097|NCT04332614|10124371|FG002|Data in EHR|~1 Week After Study Launch||2251
9064098|NCT04332614|10124372|FG003|Data in EHR|~1 Week After Study Launch||2254
9064099|NCT04332614|10124373|FG004|Data in EHR|~1 Week After Study Launch||2251
9064100|NCT04332614|10124374|FG005|Data in EHR|~1 Week After Study Launch||2249
9064101|NCT04332614|10124369|FG000|COMPLETED|~1 Week After Study Launch||2117
9064102|NCT04332614|10124370|FG001|COMPLETED|~1 Week After Study Launch||2129
9064103|NCT04332614|10124371|FG002|COMPLETED|~1 Week After Study Launch||2124
9064104|NCT04332614|10124372|FG003|COMPLETED|~1 Week After Study Launch||2131
9064105|NCT04332614|10124373|FG004|COMPLETED|~1 Week After Study Launch||2127
9064106|NCT04332614|10124374|FG005|COMPLETED|~1 Week After Study Launch||2115
9064107|NCT04332614|10124369|FG000|NOT COMPLETED|~1 Week After Study Launch||233
9064108|NCT04332614|10124370|FG001|NOT COMPLETED|~1 Week After Study Launch||221
9064109|NCT04332614|10124371|FG002|NOT COMPLETED|~1 Week After Study Launch||226
9064110|NCT04332614|10124372|FG003|NOT COMPLETED|~1 Week After Study Launch||219
9064111|NCT04332614|10124373|FG004|NOT COMPLETED|~1 Week After Study Launch||223
9064112|NCT04332614|10124374|FG005|NOT COMPLETED|~1 Week After Study Launch||234
9064113|NCT04332614|10124369|FG000|STARTED|~1 Month After Study Launch||2117
9064114|NCT04332614|10124370|FG001|STARTED|~1 Month After Study Launch||2129
9064115|NCT04332614|10124371|FG002|STARTED|~1 Month After Study Launch||2124
9064116|NCT04332614|10124372|FG003|STARTED|~1 Month After Study Launch||2131
9064117|NCT04332614|10124373|FG004|STARTED|~1 Month After Study Launch||2127
9064118|NCT04332614|10124374|FG005|STARTED|~1 Month After Study Launch||2115
9064119|NCT04332614|10124369|FG000|COMPLETED|~1 Month After Study Launch||2095
9064120|NCT04332614|10124370|FG001|COMPLETED|~1 Month After Study Launch||2107
9064121|NCT04332614|10124371|FG002|COMPLETED|~1 Month After Study Launch||2094
9064122|NCT04332614|10124372|FG003|COMPLETED|~1 Month After Study Launch||2107
9064123|NCT04332614|10124373|FG004|COMPLETED|~1 Month After Study Launch||2107
9064124|NCT04332614|10124374|FG005|COMPLETED|~1 Month After Study Launch||2096
9064125|NCT04332614|10124369|FG000|NOT COMPLETED|~1 Month After Study Launch||22
9064126|NCT04332614|10124370|FG001|NOT COMPLETED|~1 Month After Study Launch||22
8704183|NCT00926380|9749892|FG000|COMPLETED|Year 2||31
8704184|NCT00926380|9749893|FG001|COMPLETED|Year 2||28
8704185|NCT00926380|9749894|FG002|COMPLETED|Year 2||24
8704186|NCT00926380|9749892|FG000|NOT COMPLETED|Year 2||2
8704187|NCT00926380|9749893|FG001|NOT COMPLETED|Year 2||2
8704188|NCT00926380|9749894|FG002|NOT COMPLETED|Year 2||5
8704189|NCT00926393|9749904|FG000|STARTED|Overall Study||69
8557081|NCT00258427|9588909|FG002|COMPLETED|Overall Study||2
8557082|NCT00258427|9588910|FG003|COMPLETED|Overall Study||1
8557083|NCT00258427|9588907|FG000|NOT COMPLETED|Overall Study||0
8557084|NCT00258427|9588908|FG001|NOT COMPLETED|Overall Study||0
8557085|NCT00258427|9588909|FG002|NOT COMPLETED|Overall Study||0
8557086|NCT00258427|9588910|FG003|NOT COMPLETED|Overall Study||0
8557087|NCT03722810|9588922|FG000|STARTED|Overall Study||157
8557088|NCT03722810|9588923|FG001|STARTED|Overall Study||160
8557089|NCT03722810|9588922|FG000|COMPLETED|Overall Study||150
8557090|NCT03722810|9588923|FG001|COMPLETED|Overall Study||156
8557091|NCT03722810|9588922|FG000|NOT COMPLETED|Overall Study||7
8557092|NCT03722810|9588923|FG001|NOT COMPLETED|Overall Study||4
8557093|NCT00000125|9588938|FG000|STARTED|Overall Study||819
8557094|NCT00000125|9588939|FG001|STARTED|Overall Study||817
8557095|NCT00000125|9588938|FG000|Completed OHTS Phase I, June 2002|Overall Study||706
8557096|NCT00000125|9588939|FG001|Completed OHTS Phase I, June 2002|Overall Study||702
8557097|NCT00000125|9588938|FG000|COMPLETED|Overall Study|Completed OHTS Phase 2, through March 2009|580
8557098|NCT00000125|9588939|FG001|COMPLETED|Overall Study|Completed OHTS Phase 2, through March 2009|579
8557099|NCT00000125|9588938|FG000|NOT COMPLETED|Overall Study||239
8557100|NCT00000125|9588939|FG001|NOT COMPLETED|Overall Study||238
8557101|NCT00000134|9588948|FG000|STARTED|Overall Study||89
8557102|NCT00000134|9588949|FG001|STARTED|Overall Study||94
8557103|NCT00000134|9588950|FG002|STARTED|Overall Study||96
8557104|NCT00000134|9588948|FG000|COMPLETED|Overall Study||89
8557105|NCT00000134|9588949|FG001|COMPLETED|Overall Study||94
8557106|NCT00000134|9588950|FG002|COMPLETED|Overall Study||96
8557107|NCT00000134|9588948|FG000|NOT COMPLETED|Overall Study||0
8557108|NCT00000134|9588949|FG001|NOT COMPLETED|Overall Study||0
8557109|NCT00000134|9588950|FG002|NOT COMPLETED|Overall Study||0
8557110|NCT00000135|9588960|FG000|STARTED|Overall Study||104
8557111|NCT00000135|9588961|FG001|STARTED|Overall Study||105
8557112|NCT00000135|9588960|FG000|COMPLETED|Overall Study||77
8557113|NCT00000135|9588961|FG001|COMPLETED|Overall Study||91
8557114|NCT00000135|9588960|FG000|NOT COMPLETED|Overall Study||27
8557115|NCT00000135|9588961|FG001|NOT COMPLETED|Overall Study||14
8557116|NCT00000136|9588969|FG000|STARTED|Overall Study||107
8557117|NCT00000136|9588970|FG001|STARTED|Overall Study||127
8557118|NCT00000136|9588969|FG000|COMPLETED|Overall Study||107
8557119|NCT00000136|9588970|FG001|COMPLETED|Overall Study||127
8557120|NCT00000136|9588969|FG000|NOT COMPLETED|Overall Study||0
8557121|NCT00000136|9588970|FG001|NOT COMPLETED|Overall Study||0
8557122|NCT00000142|9588979|FG000|STARTED|Overall Study||26
8557123|NCT00000142|9588980|FG001|STARTED|Overall Study||26
8557124|NCT00000142|9588981|FG002|STARTED|Overall Study||12
8557125|NCT00000142|9588979|FG000|COMPLETED|Overall Study||26
8557126|NCT00000142|9588980|FG001|COMPLETED|Overall Study||26
8557127|NCT00000142|9588981|FG002|COMPLETED|Overall Study||12
8557128|NCT00000142|9588979|FG000|NOT COMPLETED|Overall Study||0
8557129|NCT00000142|9588980|FG001|NOT COMPLETED|Overall Study||0
8557130|NCT00000142|9588981|FG002|NOT COMPLETED|Overall Study||0
8557131|NCT00000143|9588991|FG000|STARTED|Overall Study||31
8557132|NCT00000143|9588992|FG001|STARTED|Overall Study||30
8557133|NCT00000143|9588991|FG000|COMPLETED|Overall Study||31
8557134|NCT00000143|9588992|FG001|COMPLETED|Overall Study||30
8557135|NCT00000143|9588991|FG000|NOT COMPLETED|Overall Study||0
8557136|NCT00000143|9588992|FG001|NOT COMPLETED|Overall Study||0
8557137|NCT00000371|9589000|FG000|STARTED|Overall Study||27
8557138|NCT00000371|9589001|FG001|STARTED|Overall Study||28
8557139|NCT00000371|9589000|FG000|COMPLETED|Overall Study||14
8557140|NCT00000371|9589001|FG001|COMPLETED|Overall Study||12
8557141|NCT00000371|9589000|FG000|NOT COMPLETED|Overall Study||13
8557142|NCT00000371|9589001|FG001|NOT COMPLETED|Overall Study||16
8557143|NCT00000378|9589009|FG000|STARTED|Overall Study||58
8557144|NCT00000378|9589010|FG001|STARTED|Overall Study||52
8557145|NCT00000378|9589009|FG000|COMPLETED|Overall Study||42
8557146|NCT00000378|9589010|FG001|COMPLETED|Overall Study||38
8557147|NCT00000378|9589009|FG000|NOT COMPLETED|Overall Study||16
8557148|NCT00000378|9589010|FG001|NOT COMPLETED|Overall Study||14
8812753|NCT01521507|9865781|FG001|COMPLETED|Stage 1: Randomized Design||94
8812754|NCT01521507|9865780|FG000|NOT COMPLETED|Stage 1: Randomized Design||3
8812755|NCT01521507|9865781|FG001|NOT COMPLETED|Stage 1: Randomized Design||5
8812756|NCT01521507|9865780|FG000|STARTED|Stage 2: Observational Design||98
8812757|NCT01521507|9865781|FG001|STARTED|Stage 2: Observational Design||94
8812758|NCT01521507|9865780|FG000|Received Crossover LipiFlow Tx|Stage 2: Observational Design||0
8812759|NCT01521507|9865781|FG001|Received Crossover LipiFlow Tx|Stage 2: Observational Design||93
8812760|NCT01521507|9865780|FG000|Received Only One LipiFlow Tx at 12 Mo|Stage 2: Observational Design||81
8812761|NCT01521507|9865781|FG001|Received Only One LipiFlow Tx at 12 Mo|Stage 2: Observational Design||82
8812762|NCT01521507|9865780|FG000|Received Other MGD Treatment at 12 Mo|Stage 2: Observational Design||11
8812763|NCT01521507|9865781|FG001|Received Other MGD Treatment at 12 Mo|Stage 2: Observational Design||9
8812764|NCT01521507|9865780|FG000|Received 2nd LipiFlow Tx at 12 Mo|Stage 2: Observational Design||2
8812765|NCT01521507|9865781|FG001|Received 2nd LipiFlow Tx at 12 Mo|Stage 2: Observational Design||1
8812766|NCT01521507|9865780|FG000|COMPLETED|Stage 2: Observational Design||94
8812767|NCT01521507|9865781|FG001|COMPLETED|Stage 2: Observational Design||92
8812768|NCT01521507|9865780|FG000|NOT COMPLETED|Stage 2: Observational Design||4
8812769|NCT01521507|9865781|FG001|NOT COMPLETED|Stage 2: Observational Design||2
8812770|NCT01521546|9865796|FG000|STARTED|Overall Study||22
8812771|NCT01521546|9865797|FG001|STARTED|Overall Study||20
8812772|NCT01521546|9865796|FG000|COMPLETED|Overall Study||20
8812773|NCT01521546|9865797|FG001|COMPLETED|Overall Study||20
8812774|NCT01521546|9865796|FG000|NOT COMPLETED|Overall Study||2
8812775|NCT01521546|9865797|FG001|NOT COMPLETED|Overall Study||0
8812776|NCT01521559|9865805|FG000|STARTED|Overall Study||92
8812777|NCT01521559|9865806|FG001|STARTED|Overall Study||91
8812778|NCT01521559|9865805|FG000|Completed Week 24|Overall Study||83
8812779|NCT01521559|9865806|FG001|Completed Week 24|Overall Study||85
8812780|NCT01521559|9865805|FG000|Completed Week 52|Overall Study||77
8812781|NCT01521559|9865806|FG001|Completed Week 52|Overall Study||73
8812782|NCT01521559|9865805|FG000|COMPLETED|Overall Study||77
8812783|NCT01521559|9865806|FG001|COMPLETED|Overall Study||73
8812784|NCT01521559|9865805|FG000|NOT COMPLETED|Overall Study||15
8812785|NCT01521559|9865806|FG001|NOT COMPLETED|Overall Study||18
8812786|NCT01521780|9865813|FG000|STARTED|Overall Study||9
8812787|NCT01521780|9865814|FG001|STARTED|Overall Study||1
8812788|NCT01521780|9865815|FG002|STARTED|Overall Study||2
8812789|NCT01521780|9865813|FG000|COMPLETED|Overall Study||9
8812790|NCT01521780|9865814|FG001|COMPLETED|Overall Study||1
8812791|NCT01521780|9865815|FG002|COMPLETED|Overall Study||2
8812792|NCT01521780|9865813|FG000|NOT COMPLETED|Overall Study||0
8812793|NCT01521780|9865814|FG001|NOT COMPLETED|Overall Study||0
8812794|NCT01521780|9865815|FG002|NOT COMPLETED|Overall Study||0
8812795|NCT01521845|9865826|FG000|STARTED|Overall Study||52
8812796|NCT01521845|9865827|FG001|STARTED|Overall Study||52
8812797|NCT01521845|9865826|FG000|COMPLETED|Overall Study||43
8812798|NCT01521845|9865827|FG001|COMPLETED|Overall Study||47
8812799|NCT01521845|9865826|FG000|NOT COMPLETED|Overall Study||9
8557149|NCT00000392|9589018|FG000|STARTED|Overall Study||106
8812800|NCT01521845|9865827|FG001|NOT COMPLETED|Overall Study||5
8812801|NCT01521871|9865835|FG000|STARTED|Overall Study||32
8812802|NCT01521871|9865836|FG001|STARTED|Overall Study||32
8812803|NCT01521871|9865835|FG000|COMPLETED|Overall Study||32
8812804|NCT01521871|9865836|FG001|COMPLETED|Overall Study||32
8812805|NCT01521871|9865835|FG000|NOT COMPLETED|Overall Study||0
8812806|NCT01521871|9865836|FG001|NOT COMPLETED|Overall Study||0
8704190|NCT00926393|9749905|FG001|STARTED|Overall Study||70
8704191|NCT00926393|9749904|FG000|COMPLETED|Overall Study||67
8704192|NCT00926393|9749905|FG001|COMPLETED|Overall Study||67
8704193|NCT00926393|9749904|FG000|NOT COMPLETED|Overall Study||2
8704194|NCT00926393|9749905|FG001|NOT COMPLETED|Overall Study||3
8704195|NCT00926497|9749913|FG000|STARTED|Overall Study||60
8704196|NCT00926497|9749914|FG001|STARTED|Overall Study||61
8704197|NCT00926497|9749913|FG000|COMPLETED|Overall Study||60
8704198|NCT00926497|9749914|FG001|COMPLETED|Overall Study||61
8704199|NCT00926497|9749913|FG000|NOT COMPLETED|Overall Study||0
8704200|NCT00926497|9749914|FG001|NOT COMPLETED|Overall Study||0
8704201|NCT00926536|9749922|FG000|STARTED|Overall Study||44
9064127|NCT04332614|10124371|FG002|NOT COMPLETED|~1 Month After Study Launch||30
9064128|NCT04332614|10124372|FG003|NOT COMPLETED|~1 Month After Study Launch||24
9064129|NCT04332614|10124373|FG004|NOT COMPLETED|~1 Month After Study Launch||20
9064130|NCT04332614|10124374|FG005|NOT COMPLETED|~1 Month After Study Launch||19
9064131|NCT04322968|10124393|FG000|STARTED|Overall Study||11
9064132|NCT04322968|10124394|FG001|STARTED|Overall Study||10
9064133|NCT04322968|10124395|FG002|STARTED|Overall Study||10
9064134|NCT04322968|10124396|FG003|STARTED|Overall Study||10
9064135|NCT04322968|10124393|FG000|COMPLETED|Overall Study||10
9064136|NCT04322968|10124394|FG001|COMPLETED|Overall Study||9
9064137|NCT04322968|10124395|FG002|COMPLETED|Overall Study||10
9064138|NCT04322968|10124396|FG003|COMPLETED|Overall Study||10
9064139|NCT04322968|10124393|FG000|NOT COMPLETED|Overall Study||1
9064140|NCT04322968|10124394|FG001|NOT COMPLETED|Overall Study||1
9064141|NCT04322968|10124395|FG002|NOT COMPLETED|Overall Study||0
8704202|NCT00926536|9749923|FG001|STARTED|Overall Study||43
8704203|NCT00926536|9749922|FG000|COMPLETED|Overall Study||43
8704204|NCT00926536|9749923|FG001|COMPLETED|Overall Study||41
8704205|NCT00926536|9749922|FG000|NOT COMPLETED|Overall Study||1
8704206|NCT00926536|9749923|FG001|NOT COMPLETED|Overall Study||2
8704207|NCT00926588|9749931|FG000|STARTED|Overall Study||124
8704208|NCT00926588|9749932|FG001|STARTED|Overall Study||126
8704209|NCT00926588|9749931|FG000|COMPLETED|Overall Study||116
8704210|NCT00926588|9749932|FG001|COMPLETED|Overall Study||122
8704211|NCT00926588|9749931|FG000|NOT COMPLETED|Overall Study||8
8704212|NCT00926588|9749932|FG001|NOT COMPLETED|Overall Study||4
8704213|NCT00926783|9749940|FG000|STARTED|Overall Study||42
8704214|NCT00926783|9749941|FG001|STARTED|Overall Study||41
8704215|NCT00926783|9749940|FG000|COMPLETED|Overall Study||39
8704216|NCT00926783|9749941|FG001|COMPLETED|Overall Study||38
8704217|NCT00926783|9749940|FG000|NOT COMPLETED|Overall Study||3
8704218|NCT00926783|9749941|FG001|NOT COMPLETED|Overall Study||3
8557150|NCT00000392|9589019|FG001|STARTED|Overall Study||109
8557151|NCT00000392|9589018|FG000|COMPLETED|Overall Study|provided complete NP outcome data constituted the sample for the primary efficacy analyses|66
8557152|NCT00000392|9589019|FG001|COMPLETED|Overall Study|provided complete NP outcome data constituted the sample for the primary efficacy analyses|77
8557153|NCT00000392|9589018|FG000|NOT COMPLETED|Overall Study||40
8557154|NCT00000392|9589019|FG001|NOT COMPLETED|Overall Study||32
8557155|NCT00000479|9589029|FG000|STARTED|Overall Study||9968
8557156|NCT00000479|9589030|FG001|STARTED|Overall Study||9971
8557157|NCT00000479|9589031|FG002|STARTED|Overall Study||9966
8557158|NCT00000479|9589032|FG003|STARTED|Overall Study||9971
8557159|NCT00000479|9589029|FG000|COMPLETED|Overall Study||9968
8557160|NCT00000479|9589030|FG001|COMPLETED|Overall Study||9971
8557161|NCT00000479|9589031|FG002|COMPLETED|Overall Study||9966
8557162|NCT00000479|9589032|FG003|COMPLETED|Overall Study||9971
8557163|NCT00000479|9589029|FG000|NOT COMPLETED|Overall Study||0
8557164|NCT00000479|9589030|FG001|NOT COMPLETED|Overall Study||0
8557165|NCT00000479|9589031|FG002|NOT COMPLETED|Overall Study||0
8557166|NCT00000479|9589032|FG003|NOT COMPLETED|Overall Study||0
8557167|NCT00000575|9589045|FG000|STARTED|Overall Study||311
8557168|NCT00000575|9589046|FG001|STARTED|Overall Study||312
8557169|NCT00000575|9589047|FG002|STARTED|Overall Study||418
8557170|NCT00000575|9589045|FG000|COMPLETED|Overall Study||311
8557171|NCT00000575|9589046|FG001|COMPLETED|Overall Study||312
8557172|NCT00000575|9589047|FG002|COMPLETED|Overall Study||418
8557173|NCT00000575|9589045|FG000|NOT COMPLETED|Overall Study||0
8557174|NCT00000575|9589046|FG001|NOT COMPLETED|Overall Study||0
8557175|NCT00000575|9589047|FG002|NOT COMPLETED|Overall Study||0
8557176|NCT00000620|9589057|FG000|STARTED|Overall Study||1178
8557177|NCT00000620|9589058|FG001|STARTED|Overall Study||1193
8557178|NCT00000620|9589059|FG002|STARTED|Overall Study||1374
8557179|NCT00000620|9589060|FG003|STARTED|Overall Study||1383
8557180|NCT00000620|9589061|FG004|STARTED|Overall Study||1184
8557181|NCT00000620|9589062|FG005|STARTED|Overall Study||1178
8557182|NCT00000620|9589063|FG006|STARTED|Overall Study||1391
8557183|NCT00000620|9589064|FG007|STARTED|Overall Study||1370
8557184|NCT00000620|9589057|FG000|COMPLETED|Overall Study||1016
8557185|NCT00000620|9589058|FG001|COMPLETED|Overall Study||1057
8557186|NCT00000620|9589059|FG002|COMPLETED|Overall Study||1204
8557187|NCT00000620|9589060|FG003|COMPLETED|Overall Study||1205
8557188|NCT00000620|9589061|FG004|COMPLETED|Overall Study||1049
8557189|NCT00000620|9589062|FG005|COMPLETED|Overall Study||1026
8557190|NCT00000620|9589063|FG006|COMPLETED|Overall Study||1242
8557191|NCT00000620|9589064|FG007|COMPLETED|Overall Study||1224
8557192|NCT00000620|9589057|FG000|NOT COMPLETED|Overall Study||162
8557193|NCT00000620|9589058|FG001|NOT COMPLETED|Overall Study||136
8557194|NCT00000620|9589059|FG002|NOT COMPLETED|Overall Study||170
8557195|NCT00000620|9589060|FG003|NOT COMPLETED|Overall Study||178
8557196|NCT00000620|9589061|FG004|NOT COMPLETED|Overall Study||135
8557197|NCT00000620|9589062|FG005|NOT COMPLETED|Overall Study||152
8557198|NCT00000620|9589063|FG006|NOT COMPLETED|Overall Study||149
8557199|NCT00000620|9589064|FG007|NOT COMPLETED|Overall Study||146
8557200|NCT00001151|9589076|FG000|STARTED|Overall Study||6
8557201|NCT00001151|9589076|FG000|COMPLETED|Overall Study||1
8557202|NCT00001151|9589076|FG000|NOT COMPLETED|Overall Study||5
8557203|NCT00001213|9589080|FG000|STARTED|Overall Study||328
8557204|NCT00001213|9589080|FG000|COMPLETED|Overall Study||310
8557205|NCT00001213|9589080|FG000|NOT COMPLETED|Overall Study||18
8557206|NCT00001262|9589087|FG000|STARTED|Overall Study||35
8557207|NCT00001262|9589088|FG001|STARTED|Overall Study||22
8557208|NCT00001262|9589089|FG002|STARTED|Overall Study||3
8557209|NCT00001262|9589087|FG000|COMPLETED|Overall Study||25
8557210|NCT00001262|9589088|FG001|COMPLETED|Overall Study||8
8557211|NCT00001262|9589089|FG002|COMPLETED|Overall Study||3
8557212|NCT00001262|9589087|FG000|NOT COMPLETED|Overall Study||10
8557213|NCT00001262|9589088|FG001|NOT COMPLETED|Overall Study||14
8557214|NCT00001262|9589089|FG002|NOT COMPLETED|Overall Study||0
8557215|NCT00001304|9589099|FG000|STARTED|Overall Study||13
8557216|NCT00001304|9589100|FG001|STARTED|Overall Study||14
8557217|NCT00001304|9589099|FG000|COMPLETED|Overall Study||13
8557218|NCT00001304|9589100|FG001|COMPLETED|Overall Study||14
8557219|NCT00001304|9589099|FG000|NOT COMPLETED|Overall Study||0
8557220|NCT00001304|9589100|FG001|NOT COMPLETED|Overall Study||0
8557221|NCT00001305|9589106|FG000|STARTED|Overall Study||42
8557222|NCT00001305|9589106|FG000|COMPLETED|Overall Study||42
8557223|NCT00001305|9589106|FG000|NOT COMPLETED|Overall Study||0
8557224|NCT00001566|9589110|FG000|STARTED|Overall Study||42
8557225|NCT00001566|9589110|FG000|Completed Immunotherapy|Overall Study||23
8557226|NCT00001566|9589110|FG000|COMPLETED|Overall Study||23
8557227|NCT00001566|9589110|FG000|NOT COMPLETED|Overall Study||19
8557228|NCT00001575|9589114|FG000|STARTED|Overall Study||87
8557229|NCT00001575|9589114|FG000|Treated|Overall Study||65
8557230|NCT00001575|9589114|FG000|COMPLETED|Overall Study||42
8557231|NCT00001575|9589114|FG000|NOT COMPLETED|Overall Study||45
8557232|NCT00001586|9589120|FG000|STARTED|Overall Study||49
8557233|NCT00001586|9589121|FG001|STARTED|Overall Study||56
8557234|NCT00001586|9589120|FG000|COMPLETED|Overall Study||49
8557235|NCT00001586|9589121|FG001|COMPLETED|Overall Study||56
8557236|NCT00001586|9589120|FG000|NOT COMPLETED|Overall Study||0
8557237|NCT00001586|9589121|FG001|NOT COMPLETED|Overall Study||0
8557238|NCT00001596|9589129|FG000|STARTED|Overall Study||23
8557239|NCT00001596|9589130|FG001|STARTED|Overall Study||12
8557240|NCT00001596|9589129|FG000|COMPLETED|Overall Study||6
8557241|NCT00001596|9589130|FG001|COMPLETED|Overall Study||2
8557242|NCT00001596|9589129|FG000|NOT COMPLETED|Overall Study||17
8557243|NCT00001596|9589130|FG001|NOT COMPLETED|Overall Study||10
8704219|NCT00926796|9749949|FG000|STARTED|Overall Study|Number randomized|309
8704220|NCT00926796|9749950|FG001|STARTED|Overall Study|Number randomized|305
8704221|NCT00926796|9749949|FG000|COMPLETED|Overall Study|Number eligible and in the full analysis set|202
8704222|NCT00926796|9749950|FG001|COMPLETED|Overall Study|Number eligible and in the full analysis set|199
8704223|NCT00926796|9749949|FG000|NOT COMPLETED|Overall Study||107
8704224|NCT00926796|9749950|FG001|NOT COMPLETED|Overall Study||106
8704225|NCT00926848|9749960|FG000|STARTED|Overall Study||34
8704226|NCT00926848|9749961|FG001|STARTED|Overall Study||34
8704227|NCT00926848|9749960|FG000|COMPLETED|Overall Study||34
8704228|NCT00926848|9749961|FG001|COMPLETED|Overall Study||34
8704229|NCT00926848|9749960|FG000|NOT COMPLETED|Overall Study||0
8704230|NCT00926848|9749961|FG001|NOT COMPLETED|Overall Study||0
8704231|NCT00926887|9749979|FG000|STARTED|Overall Study||54
8704232|NCT00926887|9749980|FG001|STARTED|Overall Study||50
8704233|NCT00926887|9749979|FG000|COMPLETED|Overall Study||54
8704234|NCT00926887|9749980|FG001|COMPLETED|Overall Study||50
8704235|NCT00926887|9749979|FG000|NOT COMPLETED|Overall Study||0
8704236|NCT00926887|9749980|FG001|NOT COMPLETED|Overall Study||0
8704237|NCT00926952|9749986|FG000|STARTED|Overall Study||20
8704238|NCT00926952|9749986|FG000|COMPLETED|Overall Study||20
8704239|NCT00926952|9749986|FG000|NOT COMPLETED|Overall Study||0
8704240|NCT00927069|9749992|FG000|STARTED|Week 0 to Week 12||50
8704241|NCT00927069|9749993|FG001|STARTED|Week 0 to Week 12||35
8704242|NCT00927069|9749994|FG002|STARTED|Week 0 to Week 12||0
8704243|NCT00927069|9749995|FG003|STARTED|Week 0 to Week 12||0
8704244|NCT00927069|9749992|FG000|COMPLETED|Week 0 to Week 12||49
8704245|NCT00927069|9749993|FG001|COMPLETED|Week 0 to Week 12||34
8704246|NCT00927069|9749994|FG002|COMPLETED|Week 0 to Week 12||0
8704247|NCT00927069|9749995|FG003|COMPLETED|Week 0 to Week 12||0
8704248|NCT00927069|9749992|FG000|NOT COMPLETED|Week 0 to Week 12||1
8704249|NCT00927069|9749993|FG001|NOT COMPLETED|Week 0 to Week 12||1
8704250|NCT00927069|9749994|FG002|NOT COMPLETED|Week 0 to Week 12||0
8704251|NCT00927069|9749995|FG003|NOT COMPLETED|Week 0 to Week 12||0
8704252|NCT00927069|9749992|FG000|STARTED|Week 12 to Week 24|17 patients stayed at the same dose. One patient withdrew at Week 12 and also had no dose increase|18
8704253|NCT00927069|9749993|FG001|STARTED|Week 12 to Week 24|11 patients stayed at the same dose of 40 mg Adalimumab every other week|11
8704254|NCT00927069|9749994|FG002|STARTED|Week 12 to Week 24|31 Pts. from Group A had a dose incr. since they did not respond to 40mg adalimumab every other week|31
8704255|NCT00927069|9749995|FG003|STARTED|Week 12 to Week 24|23 Pts. from Group B had a dose incr. since they did not respond to 40mg adalimumab every other week|23
8704256|NCT00927069|9749992|FG000|COMPLETED|Week 12 to Week 24||16
8704257|NCT00927069|9749993|FG001|COMPLETED|Week 12 to Week 24||11
8704258|NCT00927069|9749994|FG002|COMPLETED|Week 12 to Week 24||28
8704259|NCT00927069|9749995|FG003|COMPLETED|Week 12 to Week 24||20
8704260|NCT00927069|9749992|FG000|NOT COMPLETED|Week 12 to Week 24||2
8704261|NCT00927069|9749993|FG001|NOT COMPLETED|Week 12 to Week 24||0
8704262|NCT00927069|9749994|FG002|NOT COMPLETED|Week 12 to Week 24||3
8704263|NCT00927069|9749995|FG003|NOT COMPLETED|Week 12 to Week 24||3
8704264|NCT00927082|9750009|FG000|STARTED|Overall Study||91
8704265|NCT00927082|9750010|FG001|STARTED|Overall Study||87
8704266|NCT00927082|9750011|FG002|STARTED|Overall Study||108
8704267|NCT00927082|9750012|FG003|STARTED|Overall Study||97
8704268|NCT00927082|9750009|FG000|COMPLETED|Overall Study||79
8704269|NCT00927082|9750010|FG001|COMPLETED|Overall Study||77
8704270|NCT00927082|9750011|FG002|COMPLETED|Overall Study||86
8704271|NCT00927082|9750012|FG003|COMPLETED|Overall Study||78
8704272|NCT00927082|9750009|FG000|NOT COMPLETED|Overall Study||12
8704273|NCT00927082|9750010|FG001|NOT COMPLETED|Overall Study||10
8704274|NCT00927082|9750011|FG002|NOT COMPLETED|Overall Study||22
8704275|NCT00927082|9750012|FG003|NOT COMPLETED|Overall Study||19
8704276|NCT00927095|9750029|FG000|STARTED|Overall Study||22
8704277|NCT00927095|9750030|FG001|STARTED|Overall Study||21
8704278|NCT00927095|9750031|FG002|STARTED|Overall Study||24
8704279|NCT00927095|9750029|FG000|COMPLETED|Overall Study||16
8704280|NCT00927095|9750030|FG001|COMPLETED|Overall Study||17
8704281|NCT00927095|9750031|FG002|COMPLETED|Overall Study||22
8704282|NCT00927095|9750029|FG000|NOT COMPLETED|Overall Study||6
8704283|NCT00927095|9750030|FG001|NOT COMPLETED|Overall Study||4
8704284|NCT00927095|9750031|FG002|NOT COMPLETED|Overall Study||2
8704285|NCT00927160|9750041|FG000|STARTED|Overall Study||173
8704286|NCT00927160|9750042|FG001|STARTED|Overall Study||173
8704287|NCT00927160|9750041|FG000|COMPLETED|Overall Study||173
8704288|NCT00927160|9750042|FG001|COMPLETED|Overall Study||173
8704289|NCT00927160|9750041|FG000|NOT COMPLETED|Overall Study||0
8704290|NCT00927160|9750042|FG001|NOT COMPLETED|Overall Study||0
8704291|NCT00927186|9750050|FG000|STARTED|12 Months Primary Study||34
8704292|NCT00927186|9750051|FG001|STARTED|12 Months Primary Study||35
8704293|NCT00927186|9750050|FG000|Completed 6 Months Double Blind Phase|12 Months Primary Study||28
8704294|NCT00927186|9750051|FG001|Completed 6 Months Double Blind Phase|12 Months Primary Study||31
8704295|NCT00927186|9750050|FG000|COMPLETED|12 Months Primary Study||27
8704296|NCT00927186|9750051|FG001|COMPLETED|12 Months Primary Study||31
8704297|NCT00927186|9750050|FG000|NOT COMPLETED|12 Months Primary Study||7
8704298|NCT00927186|9750051|FG001|NOT COMPLETED|12 Months Primary Study||4
8704299|NCT00927186|9750050|FG000|STARTED|12 - 24 Months Extension Treatment|Not all participants who completed 12 months of primary study chose to enter 12-month extension.|10
8704300|NCT00927186|9750051|FG001|STARTED|12 - 24 Months Extension Treatment|Not all participants who completed 12 months of primary study chose to enter 12-month extension.|11
8704301|NCT00927186|9750050|FG000|COMPLETED|12 - 24 Months Extension Treatment||10
8704302|NCT00927186|9750051|FG001|COMPLETED|12 - 24 Months Extension Treatment||11
8704303|NCT00927186|9750050|FG000|NOT COMPLETED|12 - 24 Months Extension Treatment||0
8704304|NCT00927186|9750051|FG001|NOT COMPLETED|12 - 24 Months Extension Treatment||0
8704305|NCT00927251|9750060|FG000|STARTED|Overall Study||90
8704306|NCT00927251|9750060|FG000|COMPLETED|Overall Study||82
8704307|NCT00927251|9750060|FG000|NOT COMPLETED|Overall Study||8
8704308|NCT00927264|9750066|FG000|STARTED|Overall Study||165
8704309|NCT00927264|9750067|FG001|STARTED|Overall Study||165
8704310|NCT00927264|9750066|FG000|COMPLETED|Overall Study||109
8704311|NCT00927264|9750067|FG001|COMPLETED|Overall Study||140
8704312|NCT00927264|9750066|FG000|NOT COMPLETED|Overall Study||56
8704313|NCT00927264|9750067|FG001|NOT COMPLETED|Overall Study||25
8704314|NCT00927355|9750077|FG000|STARTED|Overall Study||5
8704315|NCT00927355|9750078|FG001|STARTED|Overall Study||5
8704316|NCT00927355|9750077|FG000|COMPLETED|Overall Study||4
8704317|NCT00927355|9750078|FG001|COMPLETED|Overall Study||4
8704318|NCT00927355|9750077|FG000|NOT COMPLETED|Overall Study||1
8704319|NCT00927355|9750078|FG001|NOT COMPLETED|Overall Study||1
8704320|NCT00927368|9750099|FG000|STARTED|Overall Study||153
8704321|NCT00927368|9750100|FG001|STARTED|Overall Study||157
8704322|NCT00927368|9750101|FG002|STARTED|Overall Study||143
8704323|NCT00927368|9750099|FG000|COMPLETED|Overall Study||147
8704324|NCT00927368|9750100|FG001|COMPLETED|Overall Study||152
8704325|NCT00927368|9750101|FG002|COMPLETED|Overall Study||138
8704326|NCT00927368|9750099|FG000|NOT COMPLETED|Overall Study||6
8704327|NCT00927368|9750100|FG001|NOT COMPLETED|Overall Study||5
8704328|NCT00927368|9750101|FG002|NOT COMPLETED|Overall Study||5
8704329|NCT00927394|9750111|FG000|STARTED|Overall Study||575
8704330|NCT00927394|9750112|FG001|STARTED|Overall Study|One patient was randomized in error and was discontinued by site.|568
8704331|NCT00927394|9750111|FG000|Cohort 1 (Randomized)|Overall Study|Cohort 1 includes patients with specific eligibility criteria mentioned in protocol section|157
8704332|NCT00927394|9750112|FG001|Cohort 1 (Randomized)|Overall Study||165
8704333|NCT00927394|9750111|FG000|Cohort 2 (Randomized)|Overall Study|Cohort 2 includes patients with specific eligibility criteria mentioned in protocol section|418
8704334|NCT00927394|9750112|FG001|Cohort 2 (Randomized)|Overall Study||403
8704335|NCT00927394|9750111|FG000|Combined Safety Set (Cohort 1 and 2)|Overall Study||574
8704336|NCT00927394|9750112|FG001|Combined Safety Set (Cohort 1 and 2)|Overall Study||565
8704337|NCT00927394|9750111|FG000|Cohort 1: Full Analysis Set 1 (FAS 1)|Overall Study|FAS 1 includes all patients in Cohort 1 to whom study treatments were given through randomization.|157
8704338|NCT00927394|9750112|FG001|Cohort 1: Full Analysis Set 1 (FAS 1)|Overall Study||164
8704339|NCT00927394|9750111|FG000|Cohort 2: Full Analysis Set 2 (FAS 2)|Overall Study|FAS 2= all patients randomized to Cohort 2 and who had a valid baseline assessment of 24 hours ABPM.|417
8704340|NCT00927394|9750112|FG001|Cohort 2: Full Analysis Set 2 (FAS 2)|Overall Study||398
8704341|NCT00927394|9750111|FG000|FAS 2 :Ambulatory Blood Pressure Monitor|Overall Study|consists of all patients in FAS 2 who had both valid baseline and post-baseline ABPM assessments.|342
8704342|NCT00927394|9750112|FG001|FAS 2 :Ambulatory Blood Pressure Monitor|Overall Study||323
8704343|NCT00927394|9750111|FG000|Combined Full Analysis Set (FAS 1+FAS 2)|Overall Study||574
8704344|NCT00927394|9750112|FG001|Combined Full Analysis Set (FAS 1+FAS 2)|Overall Study||562
8704345|NCT00927394|9750111|FG000|COMPLETED|Overall Study||498
8704346|NCT00927394|9750112|FG001|COMPLETED|Overall Study||483
8704347|NCT00927394|9750111|FG000|NOT COMPLETED|Overall Study||77
8704348|NCT00927394|9750112|FG001|NOT COMPLETED|Overall Study||85
8704349|NCT00927472|9750121|FG000|STARTED|Overall Study||126
8704350|NCT00927472|9750122|FG001|STARTED|Overall Study||128
8704351|NCT00927472|9750121|FG000|COMPLETED|Overall Study||115
8704352|NCT00927472|9750122|FG001|COMPLETED|Overall Study||106
8704353|NCT00927472|9750121|FG000|NOT COMPLETED|Overall Study||11
8704354|NCT00927472|9750122|FG001|NOT COMPLETED|Overall Study||22
8704355|NCT00927485|9750130|FG000|STARTED|Overall Study||21
8704356|NCT00927485|9750131|FG001|STARTED|Overall Study||23
8704357|NCT00927485|9750130|FG000|COMPLETED|Overall Study||15
8704358|NCT00927485|9750131|FG001|COMPLETED|Overall Study||19
8704359|NCT00927485|9750130|FG000|NOT COMPLETED|Overall Study||6
8704360|NCT00927485|9750131|FG001|NOT COMPLETED|Overall Study||4
8704361|NCT00927563|9750137|FG000|STARTED|Overall Study||24
8704362|NCT00927563|9750137|FG000|COMPLETED|Overall Study||22
8704363|NCT00927563|9750137|FG000|NOT COMPLETED|Overall Study||2
8704364|NCT00927576|9750143|FG000|STARTED|Overall Study||237
8704365|NCT00927576|9750144|FG001|STARTED|Overall Study||28
8704366|NCT00927576|9750143|FG000|Cognitive Testing|Overall Study||237
8704367|NCT00927576|9750144|FG001|Cognitive Testing|Overall Study||28
8704368|NCT00927576|9750143|FG000|COMPLETED|Overall Study||237
8704369|NCT00927576|9750144|FG001|COMPLETED|Overall Study||28
8704370|NCT00927576|9750143|FG000|NOT COMPLETED|Overall Study||0
8704371|NCT00927576|9750144|FG001|NOT COMPLETED|Overall Study||0
8704372|NCT00927589|9750149|FG000|STARTED|Overall Study||59
8704373|NCT00927589|9750149|FG000|COMPLETED|Overall Study|Participants were considered to have completed the study after receiving 3 cycles of treatment.|43
8704374|NCT00927589|9750149|FG000|NOT COMPLETED|Overall Study||16
8724611|NCT01026974|9771806|FG003|NOT COMPLETED|Overall Study||3
8724612|NCT01027000|9771821|FG000|STARTED|Overall Study||68
8724613|NCT01027000|9771821|FG000|COMPLETED|Overall Study||68
8724614|NCT01027000|9771821|FG000|NOT COMPLETED|Overall Study||0
8724615|NCT01027195|9771827|FG000|STARTED|Overall Study||71
8724616|NCT01027195|9771828|FG001|STARTED|Overall Study||69
8724617|NCT01027195|9771827|FG000|COMPLETED|Overall Study||71
8724618|NCT01027195|9771828|FG001|COMPLETED|Overall Study||69
8724619|NCT01027195|9771827|FG000|NOT COMPLETED|Overall Study||0
8724620|NCT01027195|9771828|FG001|NOT COMPLETED|Overall Study||0
8724621|NCT01027273|9771836|FG000|STARTED|Overall Study||301
8724622|NCT01027273|9771837|FG001|STARTED|Overall Study||299
8724623|NCT01027273|9771836|FG000|COMPLETED|Overall Study||242
8724624|NCT01027273|9771837|FG001|COMPLETED|Overall Study||266
8724625|NCT01027273|9771836|FG000|NOT COMPLETED|Overall Study||59
8724626|NCT01027273|9771837|FG001|NOT COMPLETED|Overall Study||33
8724627|NCT01027286|9771845|FG000|STARTED|Overall Study||50
8724628|NCT01027286|9771846|FG001|STARTED|Overall Study||50
8724629|NCT01027286|9771845|FG000|Preoperative|Overall Study||50
8724630|NCT01027286|9771846|FG001|Preoperative|Overall Study||50
8724631|NCT01027286|9771845|FG000|Day of Surgery|Overall Study||50
8724632|NCT01027286|9771846|FG001|Day of Surgery|Overall Study||50
8724633|NCT01027286|9771845|FG000|4 Week Postoperative|Overall Study||49
8724634|NCT01027286|9771846|FG001|4 Week Postoperative|Overall Study||50
8724635|NCT01027286|9771845|FG000|12 Week Postoperative|Overall Study||49
8704375|NCT00927758|9750153|FG000|STARTED|Treatment Cycle 1 (Day 1 - Day 7)|"Started  indicates randomized as well as safety set."|4
8704376|NCT00927758|9750154|FG001|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||4
8704377|NCT00927758|9750155|FG002|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||4
8704378|NCT00927758|9750156|FG003|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||3
8704379|NCT00927758|9750157|FG004|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||3
8704380|NCT00927758|9750158|FG005|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||4
8704381|NCT00927758|9750153|FG000|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||4
8704382|NCT00927758|9750154|FG001|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||4
8704383|NCT00927758|9750155|FG002|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||4
8704384|NCT00927758|9750156|FG003|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||2
8704385|NCT00927758|9750157|FG004|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||3
8704386|NCT00927758|9750158|FG005|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||3
8704387|NCT00927758|9750153|FG000|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||4
8704388|NCT00927758|9750154|FG001|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||4
8704389|NCT00927758|9750155|FG002|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||4
8704390|NCT00927758|9750156|FG003|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||2
8704391|NCT00927758|9750157|FG004|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||3
8704392|NCT00927758|9750158|FG005|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||3
8704393|NCT00927758|9750153|FG000|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
8704394|NCT00927758|9750154|FG001|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
8704395|NCT00927758|9750155|FG002|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
8704396|NCT00927758|9750156|FG003|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||1
8704397|NCT00927758|9750157|FG004|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
8704398|NCT00927758|9750158|FG005|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||1
8704399|NCT00927758|9750153|FG000|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||4
8704400|NCT00927758|9750154|FG001|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||4
8704401|NCT00927758|9750155|FG002|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||4
8704402|NCT00927758|9750156|FG003|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||2
8704403|NCT00927758|9750157|FG004|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||3
8704404|NCT00927758|9750158|FG005|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||3
8704405|NCT00927758|9750153|FG000|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||4
8704406|NCT00927758|9750154|FG001|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||4
8704407|NCT00927758|9750155|FG002|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||3
8704408|NCT00927758|9750156|FG003|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||1
8704409|NCT00927758|9750157|FG004|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||3
8704410|NCT00927758|9750158|FG005|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||2
8704411|NCT00927758|9750153|FG000|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||4
8704412|NCT00927758|9750154|FG001|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||4
8704413|NCT00927758|9750155|FG002|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||3
8704414|NCT00927758|9750156|FG003|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
8704415|NCT00927758|9750157|FG004|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||3
8704416|NCT00927758|9750158|FG005|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||2
8704417|NCT00927758|9750153|FG000|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||0
8704418|NCT00927758|9750154|FG001|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||0
8704419|NCT00927758|9750155|FG002|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
8704420|NCT00927758|9750156|FG003|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
8704421|NCT00927758|9750157|FG004|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||0
8704422|NCT00927758|9750158|FG005|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
8704423|NCT00927758|9750153|FG000|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||4
8704424|NCT00927758|9750154|FG001|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||4
8704425|NCT00927758|9750155|FG002|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||3
8704426|NCT00927758|9750156|FG003|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||1
8704427|NCT00927758|9750157|FG004|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||3
8704428|NCT00927758|9750158|FG005|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||2
8704429|NCT00927758|9750153|FG000|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||4
8704430|NCT00927758|9750154|FG001|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||4
8704431|NCT00927758|9750155|FG002|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||3
8704432|NCT00927758|9750156|FG003|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||1
8704433|NCT00927758|9750157|FG004|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||3
8704434|NCT00927758|9750158|FG005|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||2
8704435|NCT00927758|9750153|FG000|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
8704436|NCT00927758|9750154|FG001|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
8704437|NCT00927758|9750155|FG002|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
8704438|NCT00927758|9750156|FG003|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
8704439|NCT00927758|9750157|FG004|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
8704440|NCT00927758|9750158|FG005|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
8704441|NCT00927784|9750168|FG000|STARTED|Overall Study||8
8704442|NCT00927784|9750169|FG001|STARTED|Overall Study||2
8704443|NCT00927784|9750168|FG000|COMPLETED|Overall Study||6
8704444|NCT00927784|9750169|FG001|COMPLETED|Overall Study||2
8704445|NCT00927784|9750168|FG000|NOT COMPLETED|Overall Study||2
8704446|NCT00927784|9750169|FG001|NOT COMPLETED|Overall Study||0
8704447|NCT00927810|9750179|FG000|STARTED|Overall Study||75
8704448|NCT00927810|9750180|FG001|STARTED|Overall Study||181
8704449|NCT00927810|9750181|FG002|STARTED|Overall Study||25
8704450|NCT00927810|9750182|FG003|STARTED|Overall Study||60
8704451|NCT00927810|9750179|FG000|COMPLETED|Overall Study||75
8704452|NCT00927810|9750180|FG001|COMPLETED|Overall Study||173
8704453|NCT00927810|9750181|FG002|COMPLETED|Overall Study||24
8704454|NCT00927810|9750182|FG003|COMPLETED|Overall Study||58
8704455|NCT00927810|9750179|FG000|NOT COMPLETED|Overall Study||0
8704456|NCT00927810|9750180|FG001|NOT COMPLETED|Overall Study||8
8704457|NCT00927810|9750181|FG002|NOT COMPLETED|Overall Study||1
8704458|NCT00927810|9750182|FG003|NOT COMPLETED|Overall Study||2
8704459|NCT00927823|9750200|FG000|STARTED|Lead-In Period||3
8704460|NCT00927823|9750201|FG001|STARTED|Lead-In Period||3
8704461|NCT00927823|9750202|FG002|STARTED|Lead-In Period||26
8704462|NCT00927823|9750203|FG003|STARTED|Lead-In Period||5
8704463|NCT00927823|9750200|FG000|COMPLETED|Lead-In Period||3
8704464|NCT00927823|9750201|FG001|COMPLETED|Lead-In Period||3
8704465|NCT00927823|9750202|FG002|COMPLETED|Lead-In Period||26
8704466|NCT00927823|9750203|FG003|COMPLETED|Lead-In Period||5
8704467|NCT00927823|9750200|FG000|NOT COMPLETED|Lead-In Period||0
8704468|NCT00927823|9750201|FG001|NOT COMPLETED|Lead-In Period||0
8704469|NCT00927823|9750202|FG002|NOT COMPLETED|Lead-In Period||0
8704470|NCT00927823|9750203|FG003|NOT COMPLETED|Lead-In Period||0
8704471|NCT00927823|9750200|FG000|STARTED|Continuous Dosing Period||3
8704472|NCT00927823|9750201|FG001|STARTED|Continuous Dosing Period||3
8704473|NCT00927823|9750202|FG002|STARTED|Continuous Dosing Period||26
8704474|NCT00927823|9750203|FG003|STARTED|Continuous Dosing Period||5
8704475|NCT00927823|9750200|FG000|Treated|Continuous Dosing Period||3
8704476|NCT00927823|9750201|FG001|Treated|Continuous Dosing Period||3
8704477|NCT00927823|9750202|FG002|Treated|Continuous Dosing Period||23
8704478|NCT00927823|9750203|FG003|Treated|Continuous Dosing Period||5
8704479|NCT00927823|9750200|FG000|COMPLETED|Continuous Dosing Period||0
8704480|NCT00927823|9750201|FG001|COMPLETED|Continuous Dosing Period||0
8704481|NCT00927823|9750202|FG002|COMPLETED|Continuous Dosing Period||0
8704482|NCT00927823|9750203|FG003|COMPLETED|Continuous Dosing Period||0
8704483|NCT00927823|9750200|FG000|NOT COMPLETED|Continuous Dosing Period||3
8704484|NCT00927823|9750201|FG001|NOT COMPLETED|Continuous Dosing Period||3
8704485|NCT00927823|9750202|FG002|NOT COMPLETED|Continuous Dosing Period||26
8704486|NCT00927823|9750203|FG003|NOT COMPLETED|Continuous Dosing Period||5
8704487|NCT00927849|9750223|FG000|STARTED|Overall Study||21
8704488|NCT00927849|9750224|FG001|STARTED|Overall Study||21
8704489|NCT00927849|9750225|FG002|STARTED|Overall Study||21
8704490|NCT00927849|9750223|FG000|COMPLETED|Overall Study||21
8704491|NCT00927849|9750224|FG001|COMPLETED|Overall Study||21
8704492|NCT00927849|9750225|FG002|COMPLETED|Overall Study||21
8704493|NCT00927849|9750223|FG000|NOT COMPLETED|Overall Study||0
8704494|NCT00927849|9750224|FG001|NOT COMPLETED|Overall Study||0
8704495|NCT00927849|9750225|FG002|NOT COMPLETED|Overall Study||0
8704496|NCT00927862|9750235|FG000|STARTED|Overall Study||504
8704497|NCT00927862|9750236|FG001|STARTED|Overall Study||1911
8704498|NCT00927862|9750235|FG000|COMPLETED|Overall Study|477 patients evaluated in primary analyses and 488 evaluated in secondary analyses.|477
8704499|NCT00927862|9750236|FG001|COMPLETED|Overall Study||1866
8704500|NCT00927862|9750235|FG000|NOT COMPLETED|Overall Study||27
8704501|NCT00927862|9750236|FG001|NOT COMPLETED|Overall Study||45
8704502|NCT00927888|9750246|FG000|STARTED|Overall Study||29
8704503|NCT00927888|9750247|FG001|STARTED|Overall Study||27
8704504|NCT00927888|9750246|FG000|COMPLETED|Overall Study||29
8704505|NCT00927888|9750247|FG001|COMPLETED|Overall Study||27
8704506|NCT00927888|9750246|FG000|NOT COMPLETED|Overall Study||0
8704507|NCT00927888|9750247|FG001|NOT COMPLETED|Overall Study||0
8704508|NCT00927901|9750255|FG000|STARTED|Treatment Period 1||7
8704509|NCT00927901|9750256|FG001|STARTED|Treatment Period 1||7
8704510|NCT00927901|9750257|FG002|STARTED|Treatment Period 1||7
8704511|NCT00927901|9750258|FG003|STARTED|Treatment Period 1||9
8704512|NCT00927901|9750255|FG000|COMPLETED|Treatment Period 1||7
8704513|NCT00927901|9750256|FG001|COMPLETED|Treatment Period 1||7
8704514|NCT00927901|9750257|FG002|COMPLETED|Treatment Period 1||6
8704515|NCT00927901|9750258|FG003|COMPLETED|Treatment Period 1||9
8704516|NCT00927901|9750255|FG000|NOT COMPLETED|Treatment Period 1||0
8704517|NCT00927901|9750256|FG001|NOT COMPLETED|Treatment Period 1||0
8704518|NCT00927901|9750257|FG002|NOT COMPLETED|Treatment Period 1||1
8704519|NCT00927901|9750258|FG003|NOT COMPLETED|Treatment Period 1||0
8704520|NCT00927901|9750255|FG000|STARTED|Treatment Period 2||7
8704521|NCT00927901|9750256|FG001|STARTED|Treatment Period 2||7
8704522|NCT00927901|9750257|FG002|STARTED|Treatment Period 2||6
8704523|NCT00927901|9750258|FG003|STARTED|Treatment Period 2||9
8704524|NCT00927901|9750255|FG000|COMPLETED|Treatment Period 2||7
8704525|NCT00927901|9750256|FG001|COMPLETED|Treatment Period 2||7
8704526|NCT00927901|9750257|FG002|COMPLETED|Treatment Period 2||6
8704527|NCT00927901|9750258|FG003|COMPLETED|Treatment Period 2||9
8704528|NCT00927901|9750255|FG000|NOT COMPLETED|Treatment Period 2||0
8704529|NCT00927901|9750256|FG001|NOT COMPLETED|Treatment Period 2||0
8704530|NCT00927901|9750257|FG002|NOT COMPLETED|Treatment Period 2||0
8704531|NCT00927901|9750258|FG003|NOT COMPLETED|Treatment Period 2||0
8704532|NCT00927901|9750255|FG000|STARTED|Treatment Period 3||7
8704533|NCT00927901|9750256|FG001|STARTED|Treatment Period 3||7
8704534|NCT00927901|9750257|FG002|STARTED|Treatment Period 3||6
8704535|NCT00927901|9750258|FG003|STARTED|Treatment Period 3||9
8704536|NCT00927901|9750255|FG000|COMPLETED|Treatment Period 3||7
8812807|NCT01521884|9865842|FG000|STARTED|Overall Study||62
8812808|NCT01521884|9865842|FG000|COMPLETED|Overall Study||35
8812809|NCT01521884|9865842|FG000|NOT COMPLETED|Overall Study||27
8812810|NCT01521897|9865846|FG000|STARTED|Overall Study||1143
8812811|NCT01521897|9865846|FG000|COMPLETED|Overall Study||1120
8812812|NCT01521897|9865846|FG000|NOT COMPLETED|Overall Study||23
8812813|NCT01521923|9865854|FG000|STARTED|Overall Study||66
8812814|NCT01521923|9865855|FG001|STARTED|Overall Study||81
8812815|NCT01521923|9865856|FG002|STARTED|Overall Study||127
8812816|NCT01521923|9865857|FG003|STARTED|Overall Study||83
8812817|NCT01521923|9865854|FG000|COMPLETED|Overall Study||59
8812818|NCT01521923|9865855|FG001|COMPLETED|Overall Study||72
8812819|NCT01521923|9865856|FG002|COMPLETED|Overall Study||112
8812820|NCT01521923|9865857|FG003|COMPLETED|Overall Study||70
8704537|NCT00927901|9750256|FG001|COMPLETED|Treatment Period 3||7
8704538|NCT00927901|9750257|FG002|COMPLETED|Treatment Period 3||6
8704539|NCT00927901|9750258|FG003|COMPLETED|Treatment Period 3||9
8704540|NCT00927901|9750255|FG000|NOT COMPLETED|Treatment Period 3||0
8704541|NCT00927901|9750256|FG001|NOT COMPLETED|Treatment Period 3||0
8704542|NCT00927901|9750257|FG002|NOT COMPLETED|Treatment Period 3||0
8704543|NCT00927901|9750258|FG003|NOT COMPLETED|Treatment Period 3||0
8704544|NCT00927901|9750255|FG000|STARTED|Treatment Period 4||7
8704545|NCT00927901|9750256|FG001|STARTED|Treatment Period 4||7
8557244|NCT00001656|9589138|FG000|STARTED|Overall Study||13
8557245|NCT00001656|9589139|FG001|STARTED|Overall Study||12
8704546|NCT00927901|9750257|FG002|STARTED|Treatment Period 4||6
8704547|NCT00927901|9750258|FG003|STARTED|Treatment Period 4||9
8704548|NCT00927901|9750255|FG000|COMPLETED|Treatment Period 4||7
8557246|NCT00001656|9589138|FG000|COMPLETED|Overall Study||12
8557247|NCT00001656|9589139|FG001|COMPLETED|Overall Study||12
8557248|NCT00001656|9589138|FG000|NOT COMPLETED|Overall Study||1
8557249|NCT00001656|9589139|FG001|NOT COMPLETED|Overall Study||0
8557250|NCT00001703|9589145|FG000|STARTED|Overall Study||6
8557251|NCT00001703|9589145|FG000|Peptide Stock Completed|Overall Study|off therapy reason for 3 patients|3
8557252|NCT00001703|9589145|FG000|COMPLETED|Overall Study||1
8557253|NCT00001703|9589145|FG000|NOT COMPLETED|Overall Study||5
8557254|NCT00001723|9589151|FG000|STARTED|Overall Study||100
8557255|NCT00001723|9589152|FG001|STARTED|Overall Study||100
8557256|NCT00001723|9589151|FG000|COMPLETED|Overall Study||87
8557257|NCT00001723|9589152|FG001|COMPLETED|Overall Study||84
8557258|NCT00001723|9589151|FG000|NOT COMPLETED|Overall Study||13
8557259|NCT00001723|9589152|FG001|NOT COMPLETED|Overall Study||16
8557260|NCT00001832|9589176|FG000|STARTED|Apheresis Period||170
8557261|NCT00001832|9589177|FG001|STARTED|Apheresis Period||0
8557262|NCT00001832|9589178|FG002|STARTED|Apheresis Period||0
8557263|NCT00001832|9589179|FG003|STARTED|Apheresis Period||0
8557264|NCT00001832|9589180|FG004|STARTED|Apheresis Period||0
8557265|NCT00001832|9589181|FG005|STARTED|Apheresis Period||0
8557266|NCT00001832|9589182|FG006|STARTED|Apheresis Period||0
8557267|NCT00001832|9589183|FG007|STARTED|Apheresis Period||0
8557268|NCT00001832|9589184|FG008|STARTED|Apheresis Period||0
8557269|NCT00001832|9589185|FG009|STARTED|Apheresis Period||0
8557270|NCT00001832|9589186|FG010|STARTED|Apheresis Period||0
8557271|NCT00001832|9589187|FG011|STARTED|Apheresis Period||0
8557272|NCT00001832|9589188|FG012|STARTED|Apheresis Period||0
8557273|NCT00001832|9589189|FG013|STARTED|Apheresis Period||0
8557274|NCT00001832|9589190|FG014|STARTED|Apheresis Period||0
8557275|NCT00001832|9589176|FG000|COMPLETED|Apheresis Period||110
8557276|NCT00001832|9589177|FG001|COMPLETED|Apheresis Period||0
8557277|NCT00001832|9589178|FG002|COMPLETED|Apheresis Period||0
8557278|NCT00001832|9589179|FG003|COMPLETED|Apheresis Period||0
8557279|NCT00001832|9589180|FG004|COMPLETED|Apheresis Period||0
8557280|NCT00001832|9589181|FG005|COMPLETED|Apheresis Period||0
8557281|NCT00001832|9589182|FG006|COMPLETED|Apheresis Period||0
8557282|NCT00001832|9589183|FG007|COMPLETED|Apheresis Period||0
8557283|NCT00001832|9589184|FG008|COMPLETED|Apheresis Period||0
8557284|NCT00001832|9589185|FG009|COMPLETED|Apheresis Period||0
8557285|NCT00001832|9589186|FG010|COMPLETED|Apheresis Period||0
8557286|NCT00001832|9589187|FG011|COMPLETED|Apheresis Period||0
8557287|NCT00001832|9589188|FG012|COMPLETED|Apheresis Period||0
8557288|NCT00001832|9589189|FG013|COMPLETED|Apheresis Period||0
8557289|NCT00001832|9589190|FG014|COMPLETED|Apheresis Period||0
8557290|NCT00001832|9589176|FG000|NOT COMPLETED|Apheresis Period||60
8557291|NCT00001832|9589177|FG001|NOT COMPLETED|Apheresis Period||0
8557292|NCT00001832|9589178|FG002|NOT COMPLETED|Apheresis Period||0
8557293|NCT00001832|9589179|FG003|NOT COMPLETED|Apheresis Period||0
8557294|NCT00001832|9589180|FG004|NOT COMPLETED|Apheresis Period||0
8557295|NCT00001832|9589181|FG005|NOT COMPLETED|Apheresis Period||0
8557296|NCT00001832|9589182|FG006|NOT COMPLETED|Apheresis Period||0
8557297|NCT00001832|9589183|FG007|NOT COMPLETED|Apheresis Period||0
8557298|NCT00001832|9589184|FG008|NOT COMPLETED|Apheresis Period||0
8557299|NCT00001832|9589185|FG009|NOT COMPLETED|Apheresis Period||0
8557300|NCT00001832|9589186|FG010|NOT COMPLETED|Apheresis Period||0
8557301|NCT00001832|9589187|FG011|NOT COMPLETED|Apheresis Period||0
8557302|NCT00001832|9589188|FG012|NOT COMPLETED|Apheresis Period||0
8557303|NCT00001832|9589189|FG013|NOT COMPLETED|Apheresis Period||0
8557304|NCT00001832|9589190|FG014|NOT COMPLETED|Apheresis Period||0
8557305|NCT00001832|9589176|FG000|STARTED|Treatment Period||0
8557306|NCT00001832|9589177|FG001|STARTED|Treatment Period||3
8557307|NCT00001832|9589178|FG002|STARTED|Treatment Period||3
8557308|NCT00001832|9589179|FG003|STARTED|Treatment Period||3
8557309|NCT00001832|9589180|FG004|STARTED|Treatment Period||6
8557310|NCT00001832|9589181|FG005|STARTED|Treatment Period||51
8704549|NCT00927901|9750256|FG001|COMPLETED|Treatment Period 4||7
8704550|NCT00927901|9750257|FG002|COMPLETED|Treatment Period 4||5
8704551|NCT00927901|9750258|FG003|COMPLETED|Treatment Period 4||8
8704552|NCT00927901|9750255|FG000|NOT COMPLETED|Treatment Period 4||0
8704553|NCT00927901|9750256|FG001|NOT COMPLETED|Treatment Period 4||0
8704554|NCT00927901|9750257|FG002|NOT COMPLETED|Treatment Period 4||1
8704555|NCT00927901|9750258|FG003|NOT COMPLETED|Treatment Period 4||1
8704556|NCT00927927|9750286|FG000|STARTED|Overall Study||3
8704557|NCT00927927|9750287|FG001|STARTED|Overall Study||3
8704558|NCT00927927|9750288|FG002|STARTED|Overall Study||3
8704559|NCT00927927|9750289|FG003|STARTED|Overall Study||3
8704560|NCT00927927|9750290|FG004|STARTED|Overall Study||3
8704561|NCT00927927|9750291|FG005|STARTED|Overall Study||3
8704562|NCT00927927|9750292|FG006|STARTED|Overall Study||3
8704563|NCT00927927|9750293|FG007|STARTED|Overall Study||3
8704564|NCT00927927|9750294|FG008|STARTED|Overall Study||8
8704565|NCT00927927|9750295|FG009|STARTED|Overall Study||3
8704566|NCT00927927|9750296|FG010|STARTED|Overall Study||5
8704567|NCT00927927|9750297|FG011|STARTED|Overall Study||6
8704568|NCT00927927|9750298|FG012|STARTED|Overall Study||5
8704569|NCT00927927|9750299|FG013|STARTED|Overall Study||5
8704570|NCT00927927|9750300|FG014|STARTED|Overall Study||9
8704571|NCT00927927|9750286|FG000|Exposed|Overall Study||3
8704572|NCT00927927|9750287|FG001|Exposed|Overall Study||3
8704573|NCT00927927|9750288|FG002|Exposed|Overall Study||3
8704574|NCT00927927|9750289|FG003|Exposed|Overall Study||3
8704575|NCT00927927|9750290|FG004|Exposed|Overall Study||3
8704576|NCT00927927|9750291|FG005|Exposed|Overall Study||3
8704577|NCT00927927|9750292|FG006|Exposed|Overall Study||3
8704578|NCT00927927|9750293|FG007|Exposed|Overall Study||3
8704579|NCT00927927|9750294|FG008|Exposed|Overall Study||8
8704580|NCT00927927|9750295|FG009|Exposed|Overall Study||3
8704581|NCT00927927|9750296|FG010|Exposed|Overall Study||5
8704582|NCT00927927|9750297|FG011|Exposed|Overall Study||5
8704583|NCT00927927|9750298|FG012|Exposed|Overall Study||5
8704584|NCT00927927|9750299|FG013|Exposed|Overall Study||5
8704585|NCT00927927|9750300|FG014|Exposed|Overall Study||9
8704586|NCT00927927|9750286|FG000|COMPLETED|Overall Study||3
8704587|NCT00927927|9750287|FG001|COMPLETED|Overall Study||3
8704588|NCT00927927|9750288|FG002|COMPLETED|Overall Study||3
8704589|NCT00927927|9750289|FG003|COMPLETED|Overall Study||3
8704590|NCT00927927|9750290|FG004|COMPLETED|Overall Study||3
8704591|NCT00927927|9750291|FG005|COMPLETED|Overall Study||3
8704592|NCT00927927|9750292|FG006|COMPLETED|Overall Study||3
8704593|NCT00927927|9750293|FG007|COMPLETED|Overall Study||1
8704594|NCT00927927|9750294|FG008|COMPLETED|Overall Study||8
8704595|NCT00927927|9750295|FG009|COMPLETED|Overall Study||3
8704596|NCT00927927|9750296|FG010|COMPLETED|Overall Study||5
8704597|NCT00927927|9750297|FG011|COMPLETED|Overall Study|One subject withdrew consent after being randomised but before receiving any trial product.|4
8704598|NCT00927927|9750298|FG012|COMPLETED|Overall Study||5
8557311|NCT00001832|9589182|FG006|STARTED|Treatment Period||4
8557312|NCT00001832|9589183|FG007|STARTED|Treatment Period||7
8557313|NCT00001832|9589184|FG008|STARTED|Treatment Period||8
8557314|NCT00001832|9589185|FG009|STARTED|Treatment Period||6
8557315|NCT00001832|9589186|FG010|STARTED|Treatment Period||1
8557316|NCT00001832|9589187|FG011|STARTED|Treatment Period||7
8557317|NCT00001832|9589188|FG012|STARTED|Treatment Period||6
8557318|NCT00001832|9589189|FG013|STARTED|Treatment Period||3
8557319|NCT00001832|9589190|FG014|STARTED|Treatment Period||2
8557320|NCT00001832|9589176|FG000|COMPLETED|Treatment Period||0
8557321|NCT00001832|9589177|FG001|COMPLETED|Treatment Period||3
8557322|NCT00001832|9589178|FG002|COMPLETED|Treatment Period||3
8557323|NCT00001832|9589179|FG003|COMPLETED|Treatment Period||3
8557324|NCT00001832|9589180|FG004|COMPLETED|Treatment Period||6
8557325|NCT00001832|9589181|FG005|COMPLETED|Treatment Period||50
8557326|NCT00001832|9589182|FG006|COMPLETED|Treatment Period||4
8557327|NCT00001832|9589183|FG007|COMPLETED|Treatment Period||6
8557328|NCT00001832|9589184|FG008|COMPLETED|Treatment Period||8
8557329|NCT00001832|9589185|FG009|COMPLETED|Treatment Period||6
8557330|NCT00001832|9589186|FG010|COMPLETED|Treatment Period||1
8557331|NCT00001832|9589187|FG011|COMPLETED|Treatment Period||7
8557332|NCT00001832|9589188|FG012|COMPLETED|Treatment Period||6
8557333|NCT00001832|9589189|FG013|COMPLETED|Treatment Period||3
8557334|NCT00001832|9589190|FG014|COMPLETED|Treatment Period||2
8557335|NCT00001832|9589176|FG000|NOT COMPLETED|Treatment Period||0
8557336|NCT00001832|9589177|FG001|NOT COMPLETED|Treatment Period||0
8557337|NCT00001832|9589178|FG002|NOT COMPLETED|Treatment Period||0
8557338|NCT00001832|9589179|FG003|NOT COMPLETED|Treatment Period||0
8557339|NCT00001832|9589180|FG004|NOT COMPLETED|Treatment Period||0
8557340|NCT00001832|9589181|FG005|NOT COMPLETED|Treatment Period||1
8557341|NCT00001832|9589182|FG006|NOT COMPLETED|Treatment Period||0
8557342|NCT00001832|9589183|FG007|NOT COMPLETED|Treatment Period||1
8557343|NCT00001832|9589184|FG008|NOT COMPLETED|Treatment Period||0
8557344|NCT00001832|9589185|FG009|NOT COMPLETED|Treatment Period||0
8557345|NCT00001832|9589186|FG010|NOT COMPLETED|Treatment Period||0
8557346|NCT00001832|9589187|FG011|NOT COMPLETED|Treatment Period||0
8557347|NCT00001832|9589188|FG012|NOT COMPLETED|Treatment Period||0
8557348|NCT00001832|9589189|FG013|NOT COMPLETED|Treatment Period||0
8704599|NCT00927927|9750299|FG013|COMPLETED|Overall Study||5
8704600|NCT00927927|9750300|FG014|COMPLETED|Overall Study||9
8704601|NCT00927927|9750286|FG000|NOT COMPLETED|Overall Study||0
8704602|NCT00927927|9750287|FG001|NOT COMPLETED|Overall Study||0
8704603|NCT00927927|9750288|FG002|NOT COMPLETED|Overall Study||0
8704604|NCT00927927|9750289|FG003|NOT COMPLETED|Overall Study||0
8704605|NCT00927927|9750290|FG004|NOT COMPLETED|Overall Study||0
8704606|NCT00927927|9750291|FG005|NOT COMPLETED|Overall Study||0
8704607|NCT00927927|9750292|FG006|NOT COMPLETED|Overall Study||0
8704608|NCT00927927|9750293|FG007|NOT COMPLETED|Overall Study||2
8704609|NCT00927927|9750294|FG008|NOT COMPLETED|Overall Study||0
8704610|NCT00927927|9750295|FG009|NOT COMPLETED|Overall Study||0
8704611|NCT00927927|9750296|FG010|NOT COMPLETED|Overall Study||0
8704612|NCT00927927|9750297|FG011|NOT COMPLETED|Overall Study||2
8704613|NCT00927927|9750298|FG012|NOT COMPLETED|Overall Study||0
8704614|NCT00927927|9750299|FG013|NOT COMPLETED|Overall Study||0
8704615|NCT00927927|9750300|FG014|NOT COMPLETED|Overall Study||0
8812821|NCT01521923|9865854|FG000|NOT COMPLETED|Overall Study||7
8812822|NCT01521923|9865855|FG001|NOT COMPLETED|Overall Study||9
8812823|NCT01521923|9865856|FG002|NOT COMPLETED|Overall Study||15
8704616|NCT00927940|9750332|FG000|STARTED|Overall Study||100
8704617|NCT00927940|9750332|FG000|COMPLETED|Overall Study|A patient died before 30 days follow up. This pasitent is excluded from primary analysis.|99
8812824|NCT01521923|9865857|FG003|NOT COMPLETED|Overall Study||13
8557349|NCT00001832|9589190|FG014|NOT COMPLETED|Treatment Period||0
8704618|NCT00927940|9750332|FG000|NOT COMPLETED|Overall Study||1
8704619|NCT00927992|9750337|FG000|STARTED|Overall Study||11
8704620|NCT00927992|9750337|FG000|COMPLETED|Overall Study||11
8704621|NCT00927992|9750337|FG000|NOT COMPLETED|Overall Study||0
8704622|NCT00928018|9750343|FG000|STARTED|Overall Study|One Arm A patient withdrew consent, treated as Arm B, but analyzed on Arm A based on intent-to-treat|66
8704623|NCT00928018|9750344|FG001|STARTED|Overall Study||73
8704624|NCT00928018|9750343|FG000|COMPLETED|Overall Study||65
8704625|NCT00928018|9750344|FG001|COMPLETED|Overall Study||73
8704626|NCT00928018|9750343|FG000|NOT COMPLETED|Overall Study||1
8704627|NCT00928018|9750344|FG001|NOT COMPLETED|Overall Study||0
8704628|NCT00928057|9750356|FG000|STARTED|Overall Study||84
8704629|NCT00928057|9750357|FG001|STARTED|Overall Study||89
8704630|NCT00928057|9750356|FG000|COMPLETED|Overall Study||82
8704631|NCT00928057|9750357|FG001|COMPLETED|Overall Study||85
8704632|NCT00928057|9750356|FG000|NOT COMPLETED|Overall Study||2
8704633|NCT00928057|9750357|FG001|NOT COMPLETED|Overall Study||4
8704634|NCT00928070|9750375|FG000|STARTED|Overall Study||283
8704635|NCT00928070|9750376|FG001|STARTED|Overall Study||283
8704636|NCT00928070|9750375|FG000|Treated|Overall Study||281
8704637|NCT00928070|9750376|FG001|Treated|Overall Study||281
8704638|NCT00928070|9750375|FG000|COMPLETED|Overall Study||220
8704639|NCT00928070|9750376|FG001|COMPLETED|Overall Study||226
8704640|NCT00928070|9750375|FG000|NOT COMPLETED|Overall Study||63
8704641|NCT00928070|9750376|FG001|NOT COMPLETED|Overall Study||57
8704642|NCT00928083|9750385|FG000|STARTED|Overall Study||10
8704643|NCT00928083|9750386|FG001|STARTED|Overall Study||8
8704644|NCT00928083|9750387|FG002|STARTED|Overall Study||8
8704645|NCT00928083|9750388|FG003|STARTED|Overall Study||6
8704646|NCT00928083|9750389|FG004|STARTED|Overall Study||7
8704647|NCT00928083|9750390|FG005|STARTED|Overall Study||6
8704648|NCT00928083|9750391|FG006|STARTED|Overall Study||6
8704649|NCT00928083|9750392|FG007|STARTED|Overall Study||6
8704650|NCT00928083|9750393|FG008|STARTED|Overall Study||6
8704651|NCT00928083|9750385|FG000|COMPLETED|Overall Study||6
8704652|NCT00928083|9750386|FG001|COMPLETED|Overall Study||8
8704653|NCT00928083|9750387|FG002|COMPLETED|Overall Study||8
8704654|NCT00928083|9750388|FG003|COMPLETED|Overall Study||5
8704655|NCT00928083|9750389|FG004|COMPLETED|Overall Study||6
8704656|NCT00928083|9750390|FG005|COMPLETED|Overall Study||6
8704657|NCT00928083|9750391|FG006|COMPLETED|Overall Study||6
8704658|NCT00928083|9750392|FG007|COMPLETED|Overall Study||6
8704659|NCT00928083|9750393|FG008|COMPLETED|Overall Study||6
8704660|NCT00928083|9750385|FG000|NOT COMPLETED|Overall Study||4
8704661|NCT00928083|9750386|FG001|NOT COMPLETED|Overall Study||0
8704662|NCT00928083|9750387|FG002|NOT COMPLETED|Overall Study||0
8704663|NCT00928083|9750388|FG003|NOT COMPLETED|Overall Study||1
8704664|NCT00928083|9750389|FG004|NOT COMPLETED|Overall Study||1
8704665|NCT00928083|9750390|FG005|NOT COMPLETED|Overall Study||0
8704666|NCT00928083|9750391|FG006|NOT COMPLETED|Overall Study||0
8704667|NCT00928083|9750392|FG007|NOT COMPLETED|Overall Study||0
8704668|NCT00928083|9750393|FG008|NOT COMPLETED|Overall Study||0
8704669|NCT00928135|9750444|FG000|STARTED|Overall Study||30
8704670|NCT00928135|9750445|FG001|STARTED|Overall Study||30
8704671|NCT00928135|9750444|FG000|COMPLETED|Overall Study||29
8704672|NCT00928135|9750445|FG001|COMPLETED|Overall Study||30
8704673|NCT00928135|9750444|FG000|NOT COMPLETED|Overall Study||1
8704674|NCT00928135|9750445|FG001|NOT COMPLETED|Overall Study||0
8704675|NCT00928174|9750451|FG000|STARTED|Overall Study||27
8704676|NCT00928174|9750451|FG000|COMPLETED|Overall Study|3 withdrawn before start of participation|22
8704677|NCT00928174|9750451|FG000|NOT COMPLETED|Overall Study||5
8704678|NCT00928187|9750458|FG000|STARTED|Overall Study||152
8557350|NCT00001849|9589220|FG000|STARTED|Overall Study||68
8704679|NCT00928187|9750459|FG001|STARTED|Overall Study||147
8704680|NCT00928187|9750460|FG002|STARTED|Overall Study||155
8704681|NCT00928187|9750458|FG000|Analysed|Overall Study||152
8704682|NCT00928187|9750459|FG001|Analysed|Overall Study||145
8704683|NCT00928187|9750460|FG002|Analysed|Overall Study||154
8704684|NCT00928187|9750458|FG000|COMPLETED|Overall Study||150
8704685|NCT00928187|9750459|FG001|COMPLETED|Overall Study||141
8704686|NCT00928187|9750460|FG002|COMPLETED|Overall Study||150
8704687|NCT00928187|9750458|FG000|NOT COMPLETED|Overall Study||2
8704688|NCT00928187|9750459|FG001|NOT COMPLETED|Overall Study||6
8704689|NCT00928187|9750460|FG002|NOT COMPLETED|Overall Study||5
8704690|NCT00928200|9750468|FG000|STARTED|Overall Study||1
8704691|NCT00928200|9750468|FG000|COMPLETED|Overall Study||1
8704692|NCT00928200|9750468|FG000|NOT COMPLETED|Overall Study||0
8704693|NCT00928252|9750472|FG000|STARTED|Overall Study||45
8704694|NCT00928252|9750472|FG000|COMPLETED|Overall Study||42
8704695|NCT00928252|9750472|FG000|NOT COMPLETED|Overall Study||3
8704696|NCT00928304|9750478|FG000|STARTED|Overall Study||39
8704697|NCT00928304|9750479|FG001|STARTED|Overall Study||70
8704698|NCT00928304|9750478|FG000|COMPLETED|Overall Study||39
8704699|NCT00928304|9750479|FG001|COMPLETED|Overall Study||70
8704700|NCT00928304|9750478|FG000|NOT COMPLETED|Overall Study||0
8704701|NCT00928304|9750479|FG001|NOT COMPLETED|Overall Study||0
8704702|NCT00928395|9750491|FG000|STARTED|Overall Study||50
8704703|NCT00928395|9750491|FG000|COMPLETED|Overall Study||29
8704704|NCT00928395|9750491|FG000|NOT COMPLETED|Overall Study||21
8704705|NCT00928408|9750495|FG000|STARTED|Overall Study|Number Enrolled|305
8704706|NCT00928408|9750495|FG000|Full Analysis Set|Overall Study|All enrolled participants who fulfilled the study inclusion/exclusion criteria|303
8704707|NCT00928408|9750495|FG000|COMPLETED|Overall Study||282
8704708|NCT00928408|9750495|FG000|NOT COMPLETED|Overall Study||23
8704709|NCT00928421|9750499|FG000|STARTED|Overall Study||16
8704710|NCT00928421|9750499|FG000|Treated With Study Drug|Overall Study||16
8704711|NCT00928421|9750499|FG000|COMPLETED|Overall Study||16
8704712|NCT00928421|9750499|FG000|NOT COMPLETED|Overall Study||0
8704713|NCT00928434|9750506|FG000|STARTED|Overall Study|Full Analysis Set Patients|175
8704714|NCT00928434|9750507|FG001|STARTED|Overall Study|Full Analysis Set Patients|50
8704715|NCT00928434|9750508|FG002|STARTED|Overall Study|Full Analysis Set Patients|178
8704716|NCT00928434|9750506|FG000|Full Phase B Analysis Set|Overall Study|Patients completing 7 months treatment with PSA<2 ng/mL, and having one primary efficacy assessment.|137
8704717|NCT00928434|9750507|FG001|Full Phase B Analysis Set|Overall Study|Patients completing 7 months treatment with PSA<2 ng/mL, and having one primary efficacy assessment.|41
8704718|NCT00928434|9750508|FG002|Full Phase B Analysis Set|Overall Study|Patients completing 7 months treatment with PSA<2 ng/mL, and having one primary efficacy assessment.|150
8704719|NCT00928434|9750506|FG000|COMPLETED|Overall Study||131
8704720|NCT00928434|9750507|FG001|COMPLETED|Overall Study||36
8704721|NCT00928434|9750508|FG002|COMPLETED|Overall Study||134
8704722|NCT00928434|9750506|FG000|NOT COMPLETED|Overall Study||44
8704723|NCT00928434|9750507|FG001|NOT COMPLETED|Overall Study||14
8704724|NCT00928434|9750508|FG002|NOT COMPLETED|Overall Study||44
8704725|NCT00928486|9750524|FG000|STARTED|Overall Study||25
8704726|NCT00928486|9750524|FG000|Efficacy Evaluable (EE)|Overall Study|EE population = given at least 1 dose of study drug, evaluated for efficacy and met eligibility|24
8704727|NCT00928486|9750524|FG000|COMPLETED|Overall Study|Completed = those who continued responding to treatment; upon marketing approval, given lenalidomide|15
8704728|NCT00928486|9750524|FG000|NOT COMPLETED|Overall Study||10
8704729|NCT00928512|9750533|FG000|STARTED|Overall Study||41
8704730|NCT00928512|9750534|FG001|STARTED|Overall Study||43
8704731|NCT00928512|9750535|FG002|STARTED|Overall Study||49
8557351|NCT00001849|9589220|FG000|COMPLETED|Overall Study|Patients completed when an ectopic ACTH-secreting tumor was identified|54
8557352|NCT00001849|9589220|FG000|NOT COMPLETED|Overall Study||14
8557353|NCT00001880|9589233|FG000|STARTED|Overall Study||42
8557354|NCT00001880|9589233|FG000|COMPLETED|Overall Study||28
8557355|NCT00001880|9589233|FG000|NOT COMPLETED|Overall Study||14
8557356|NCT00001941|9589237|FG000|STARTED|Overall Study||3
8557357|NCT00001941|9589238|FG001|STARTED|Overall Study||5
8557358|NCT00001941|9589239|FG002|STARTED|Overall Study||3
8557359|NCT00001941|9589240|FG003|STARTED|Overall Study||3
8557360|NCT00001941|9589241|FG004|STARTED|Overall Study||20
8557361|NCT00001941|9589237|FG000|COMPLETED|Overall Study||3
8557362|NCT00001941|9589238|FG001|COMPLETED|Overall Study||5
8557363|NCT00001941|9589239|FG002|COMPLETED|Overall Study||3
8557364|NCT00001941|9589240|FG003|COMPLETED|Overall Study||3
8557365|NCT00001941|9589241|FG004|COMPLETED|Overall Study||19
8557366|NCT00001941|9589237|FG000|NOT COMPLETED|Overall Study||0
8557367|NCT00001941|9589238|FG001|NOT COMPLETED|Overall Study||0
8557368|NCT00001941|9589239|FG002|NOT COMPLETED|Overall Study||0
8557369|NCT00001941|9589240|FG003|NOT COMPLETED|Overall Study||0
8557370|NCT00001941|9589241|FG004|NOT COMPLETED|Overall Study||1
8557371|NCT00001959|9589246|FG000|STARTED|Overall Study||21
8557372|NCT00001959|9589246|FG000|COMPLETED|Overall Study||18
8557373|NCT00001959|9589246|FG000|NOT COMPLETED|Overall Study||3
8557374|NCT00001962|9589250|FG000|STARTED|Overall Study||100
8557375|NCT00001962|9589250|FG000|COMPLETED|Overall Study||72
8557376|NCT00001962|9589250|FG000|NOT COMPLETED|Overall Study||28
8557377|NCT00001984|9589254|FG000|STARTED|Overall Study||5
8557378|NCT00001984|9589254|FG000|COMPLETED|Overall Study||5
8557379|NCT00001984|9589254|FG000|NOT COMPLETED|Overall Study||0
8557380|NCT00002525|9589260|FG000|STARTED|Overall Study|859 patients were enrolled to the study, but 4 patients were not randomized to any treatment arm|427
8557381|NCT00002525|9589261|FG001|STARTED|Overall Study||428
8557382|NCT00002525|9589260|FG000|Treated|Overall Study||419
8704732|NCT00928512|9750536|FG003|STARTED|Overall Study||54
8704733|NCT00928512|9750537|FG004|STARTED|Overall Study||50
8704734|NCT00928512|9750533|FG000|Discontinued Prior to Week 16|Overall Study||3
8704735|NCT00928512|9750534|FG001|Discontinued Prior to Week 16|Overall Study||0
8704736|NCT00928512|9750535|FG002|Discontinued Prior to Week 16|Overall Study||2
8704737|NCT00928512|9750536|FG003|Discontinued Prior to Week 16|Overall Study||6
8704738|NCT00928512|9750537|FG004|Discontinued Prior to Week 16|Overall Study||5
8704739|NCT00928512|9750533|FG000|Reassigned at Week 20 (Non-responders)|Overall Study|All patients in the 300 mg group at Week 20 remained at this dose in this group.|0
8704740|NCT00928512|9750534|FG001|Reassigned at Week 20 (Non-responders)|Overall Study|Non-responders in the AIN457 150 mg group were reassigned treatment to the 300 mg group.|23
8704741|NCT00928512|9750535|FG002|Reassigned at Week 20 (Non-responders)|Overall Study|Non-responders in the AIN457 75 mg group were reassigned treatment to the 150 mg group.|23
8704742|NCT00928512|9750536|FG003|Reassigned at Week 20 (Non-responders)|Overall Study|Non-responders in the AIN457 25 mg group were reassigned treatment to the 150 mg group.|27
8704743|NCT00928512|9750537|FG004|Reassigned at Week 20 (Non-responders)|Overall Study|All placebo patients (responders & non-responders) were reassigned treatment to the 150 mg group.|45
8704744|NCT00928512|9750533|FG000|Not Reassigned at Week 20 (Responders)|Overall Study||37
8704745|NCT00928512|9750534|FG001|Not Reassigned at Week 20 (Responders)|Overall Study||20
8704746|NCT00928512|9750535|FG002|Not Reassigned at Week 20 (Responders)|Overall Study||23
8704747|NCT00928512|9750536|FG003|Not Reassigned at Week 20 (Responders)|Overall Study||18
8704748|NCT00928512|9750537|FG004|Not Reassigned at Week 20 (Responders)|Overall Study||0
8704749|NCT00928512|9750533|FG000|New Groups After Reassignment|Overall Study|1 patient in this group continued at Week 16 but did not receive any study drug at Week 20.|60
8704750|NCT00928512|9750534|FG001|New Groups After Reassignment|Overall Study||115
8704751|NCT00928512|9750535|FG002|New Groups After Reassignment|Overall Study|1 patient in this group continued at Week 16 but did not receive any study drug at Week 20.|23
8704752|NCT00928512|9750536|FG003|New Groups After Reassignment|Overall Study|2 patients in this group continued at Week 16 but did not receive any study drug at Week 20|18
8704753|NCT00928512|9750537|FG004|New Groups After Reassignment|Overall Study||0
8704754|NCT00928512|9750533|FG000|Completed Week 16|Overall Study||38
8704755|NCT00928512|9750534|FG001|Completed Week 16|Overall Study||43
8704756|NCT00928512|9750535|FG002|Completed Week 16|Overall Study||47
8704757|NCT00928512|9750536|FG003|Completed Week 16|Overall Study||48
8704758|NCT00928512|9750537|FG004|Completed Week 16|Overall Study||45
8704759|NCT00928512|9750533|FG000|Entered/Continued to Week 20 (All)|Overall Study||37
8704760|NCT00928512|9750534|FG001|Entered/Continued to Week 20 (All)|Overall Study||43
8704761|NCT00928512|9750535|FG002|Entered/Continued to Week 20 (All)|Overall Study||46
8704762|NCT00928512|9750536|FG003|Entered/Continued to Week 20 (All)|Overall Study||45
8704763|NCT00928512|9750537|FG004|Entered/Continued to Week 20 (All)|Overall Study||45
8704764|NCT00928512|9750533|FG000|COMPLETED|Overall Study||31
8704765|NCT00928512|9750534|FG001|COMPLETED|Overall Study||37
8704766|NCT00928512|9750535|FG002|COMPLETED|Overall Study||38
8704767|NCT00928512|9750536|FG003|COMPLETED|Overall Study||33
8704768|NCT00928512|9750537|FG004|COMPLETED|Overall Study||35
8704769|NCT00928512|9750533|FG000|NOT COMPLETED|Overall Study||10
8704770|NCT00928512|9750534|FG001|NOT COMPLETED|Overall Study||6
8704771|NCT00928512|9750535|FG002|NOT COMPLETED|Overall Study||11
8704772|NCT00928512|9750536|FG003|NOT COMPLETED|Overall Study||21
8704773|NCT00928512|9750537|FG004|NOT COMPLETED|Overall Study||15
8704774|NCT00928564|9750555|FG000|STARTED|Overall Study||28
8704775|NCT00928564|9750556|FG001|STARTED|Overall Study||12
8704776|NCT00928564|9750555|FG000|COMPLETED|Overall Study||22
8704777|NCT00928564|9750556|FG001|COMPLETED|Overall Study||12
8704778|NCT00928564|9750555|FG000|NOT COMPLETED|Overall Study||6
8704779|NCT00928564|9750556|FG001|NOT COMPLETED|Overall Study||0
8704780|NCT00928642|9750562|FG000|STARTED|Overall Study||8
8704781|NCT00928642|9750562|FG000|COMPLETED|Overall Study|1 subject withdrew after 1st cycle but before disease assessment. 7 of 8 are evaluable for response|8
8704782|NCT00928642|9750562|FG000|NOT COMPLETED|Overall Study||0
8704783|NCT00928668|9750569|FG000|STARTED|Overall Study||7
8704784|NCT00928668|9750570|FG001|STARTED|Overall Study||7
8704785|NCT00928668|9750571|FG002|STARTED|Overall Study||7
8704786|NCT00928668|9750572|FG003|STARTED|Overall Study||4
8704787|NCT00928668|9750573|FG004|STARTED|Overall Study||6
8704788|NCT00928668|9750569|FG000|COMPLETED|Overall Study||6
8704789|NCT00928668|9750570|FG001|COMPLETED|Overall Study||6
8704790|NCT00928668|9750571|FG002|COMPLETED|Overall Study||6
8704791|NCT00928668|9750572|FG003|COMPLETED|Overall Study||3
8704792|NCT00928668|9750573|FG004|COMPLETED|Overall Study||5
8704793|NCT00928668|9750569|FG000|NOT COMPLETED|Overall Study||1
8704794|NCT00928668|9750570|FG001|NOT COMPLETED|Overall Study||1
8704795|NCT00928668|9750571|FG002|NOT COMPLETED|Overall Study||1
8704796|NCT00928668|9750572|FG003|NOT COMPLETED|Overall Study||1
8704797|NCT00928668|9750573|FG004|NOT COMPLETED|Overall Study||1
8704798|NCT00928694|9750590|FG000|STARTED|First Intervention||7
8704799|NCT00928694|9750591|FG001|STARTED|First Intervention||7
8704800|NCT00928694|9750590|FG000|COMPLETED|First Intervention||7
8704801|NCT00928694|9750591|FG001|COMPLETED|First Intervention||7
8704802|NCT00928694|9750590|FG000|NOT COMPLETED|First Intervention||0
8704803|NCT00928694|9750591|FG001|NOT COMPLETED|First Intervention||0
8704804|NCT00928694|9750590|FG000|STARTED|Second Intervention||7
8704805|NCT00928694|9750591|FG001|STARTED|Second Intervention||7
8704806|NCT00928694|9750590|FG000|COMPLETED|Second Intervention||7
8704807|NCT00928694|9750591|FG001|COMPLETED|Second Intervention||7
8704808|NCT00928694|9750590|FG000|NOT COMPLETED|Second Intervention||0
8704809|NCT00928694|9750591|FG001|NOT COMPLETED|Second Intervention||0
8704810|NCT00928707|9750599|FG000|STARTED|Overall Study||23
8704811|NCT00928707|9750600|FG001|STARTED|Overall Study||22
8704812|NCT00928707|9750599|FG000|COMPLETED|Overall Study||22
8704813|NCT00928707|9750600|FG001|COMPLETED|Overall Study||22
8704814|NCT00928707|9750599|FG000|NOT COMPLETED|Overall Study||1
8704815|NCT00928707|9750600|FG001|NOT COMPLETED|Overall Study||0
8704816|NCT00928720|9750609|FG000|STARTED|Overall Study||19
8704817|NCT00928720|9750610|FG001|STARTED|Overall Study||20
8704818|NCT00928720|9750611|FG002|STARTED|Overall Study||18
8704819|NCT00928720|9750609|FG000|COMPLETED|Overall Study||17
8704820|NCT00928720|9750610|FG001|COMPLETED|Overall Study||14
8704821|NCT00928720|9750611|FG002|COMPLETED|Overall Study||15
8704822|NCT00928720|9750609|FG000|NOT COMPLETED|Overall Study||2
8704823|NCT00928720|9750610|FG001|NOT COMPLETED|Overall Study||6
8704824|NCT00928720|9750611|FG002|NOT COMPLETED|Overall Study||3
8704825|NCT00928746|9750622|FG000|STARTED|Overall Study||142
8704826|NCT00928746|9750622|FG000|COMPLETED|Overall Study||136
8704827|NCT00928746|9750622|FG000|NOT COMPLETED|Overall Study||6
8704828|NCT00928772|9750631|FG000|STARTED|Overall Study||39
8704829|NCT00928772|9750632|FG001|STARTED|Overall Study||38
8704830|NCT00928772|9750633|FG002|STARTED|Overall Study||38
8704831|NCT00928772|9750631|FG000|COMPLETED|Overall Study||39
8704832|NCT00928772|9750632|FG001|COMPLETED|Overall Study||38
8704833|NCT00928772|9750633|FG002|COMPLETED|Overall Study||38
8704834|NCT00928772|9750631|FG000|NOT COMPLETED|Overall Study||0
8704835|NCT00928772|9750632|FG001|NOT COMPLETED|Overall Study||0
8704836|NCT00928772|9750633|FG002|NOT COMPLETED|Overall Study||0
8704837|NCT00928889|9750643|FG000|STARTED|Overall Study||80
8704838|NCT00928889|9750644|FG001|STARTED|Overall Study||80
8928048|NCT02278003|9989196|FG000|COMPLETED|Overall Study||30
8928049|NCT02278003|9989197|FG001|COMPLETED|Overall Study||20
8928050|NCT02278003|9989196|FG000|NOT COMPLETED|Overall Study||19
8928051|NCT02278003|9989197|FG001|NOT COMPLETED|Overall Study||0
8928052|NCT02278146|9989205|FG000|STARTED|Overall Study||6
8928053|NCT02278146|9989206|FG001|STARTED|Overall Study||10
8928054|NCT02278146|9989205|FG000|COMPLETED|Overall Study||6
8928055|NCT02278146|9989206|FG001|COMPLETED|Overall Study||8
8928056|NCT02278146|9989205|FG000|NOT COMPLETED|Overall Study||0
8928057|NCT02278146|9989206|FG001|NOT COMPLETED|Overall Study||2
8928058|NCT02278237|9989212|FG000|STARTED|Overall Study||90
8928059|NCT02278237|9989212|FG000|COMPLETED|Overall Study||83
8928060|NCT02278237|9989212|FG000|NOT COMPLETED|Overall Study||7
8928061|NCT02278263|9989219|FG000|STARTED|Overall Study||30
8928062|NCT02278263|9989220|FG001|STARTED|Overall Study||60
8928063|NCT02278263|9989221|FG002|STARTED|Overall Study||60
8928064|NCT02278263|9989219|FG000|COMPLETED|Overall Study||23
8928065|NCT02278263|9989220|FG001|COMPLETED|Overall Study|Correction|60
8928066|NCT02278263|9989221|FG002|COMPLETED|Overall Study||51
8928067|NCT02278263|9989219|FG000|NOT COMPLETED|Overall Study||7
8928068|NCT02278263|9989220|FG001|NOT COMPLETED|Overall Study||0
8928069|NCT02278263|9989221|FG002|NOT COMPLETED|Overall Study||9
8928070|NCT02278289|9989234|FG000|STARTED|Overall Study||30
8704839|NCT00928889|9750643|FG000|COMPLETED|Overall Study||75
8704840|NCT00928889|9750644|FG001|COMPLETED|Overall Study||78
8704841|NCT00928889|9750643|FG000|NOT COMPLETED|Overall Study||5
8704842|NCT00928889|9750644|FG001|NOT COMPLETED|Overall Study||2
8704843|NCT00928954|9750650|FG000|STARTED|Overall Study||4
8568746|NCT00093041|9600941|FG002|NOT COMPLETED|Overall Study||2
8704844|NCT00928954|9750651|FG001|STARTED|Overall Study||6
8704845|NCT00928954|9750650|FG000|COMPLETED|Overall Study||4
8704846|NCT00928954|9750651|FG001|COMPLETED|Overall Study||6
8704847|NCT00928954|9750650|FG000|NOT COMPLETED|Overall Study||0
8704848|NCT00928954|9750651|FG001|NOT COMPLETED|Overall Study||0
8704849|NCT00929071|9750657|FG000|STARTED|Overall Study||10
8704850|NCT00929071|9750657|FG000|COMPLETED|Overall Study||10
8704851|NCT00929071|9750657|FG000|NOT COMPLETED|Overall Study||0
8704852|NCT00929110|9750667|FG000|STARTED|Overall Study||529
8704853|NCT00929110|9750668|FG001|STARTED|Overall Study||269
8704854|NCT00929110|9750669|FG002|STARTED|Overall Study||268
8704855|NCT00929110|9750667|FG000|COMPLETED|Overall Study||411
8704856|NCT00929110|9750668|FG001|COMPLETED|Overall Study||193
8928071|NCT02278289|9989235|FG001|STARTED|Overall Study||30
8928072|NCT02278289|9989234|FG000|COMPLETED|Overall Study||24
8928073|NCT02278289|9989235|FG001|COMPLETED|Overall Study||23
8928074|NCT02278289|9989234|FG000|NOT COMPLETED|Overall Study||6
8928075|NCT02278289|9989235|FG001|NOT COMPLETED|Overall Study||7
8928076|NCT02278328|9989241|FG000|STARTED|Neuropsych Screening||10
8928077|NCT02278328|9989242|FG001|STARTED|Neuropsych Screening||7
8704857|NCT00929110|9750669|FG002|COMPLETED|Overall Study||206
8704858|NCT00929110|9750667|FG000|NOT COMPLETED|Overall Study||118
8704859|NCT00929110|9750668|FG001|NOT COMPLETED|Overall Study||76
8704860|NCT00929110|9750669|FG002|NOT COMPLETED|Overall Study||62
8704861|NCT00929162|9750679|FG000|STARTED|Overall Study||59
8704862|NCT00929162|9750680|FG001|STARTED|Overall Study||61
8704863|NCT00929162|9750679|FG000|Patients Who Received Treatment|Overall Study||58
8704864|NCT00929162|9750680|FG001|Patients Who Received Treatment|Overall Study||58
8704865|NCT00929162|9750679|FG000|COMPLETED|Overall Study||11
8704866|NCT00929162|9750680|FG001|COMPLETED|Overall Study||19
8704867|NCT00929162|9750679|FG000|NOT COMPLETED|Overall Study||48
8704868|NCT00929162|9750680|FG001|NOT COMPLETED|Overall Study||42
8704869|NCT00929201|9750686|FG000|STARTED|Period 1||30
8704870|NCT00929201|9750687|FG001|STARTED|Period 1||31
8704871|NCT00929201|9750686|FG000|COMPLETED|Period 1||30
8704872|NCT00929201|9750687|FG001|COMPLETED|Period 1||30
8704873|NCT00929201|9750686|FG000|NOT COMPLETED|Period 1||0
8704874|NCT00929201|9750687|FG001|NOT COMPLETED|Period 1||1
8704875|NCT00929201|9750686|FG000|STARTED|7-day Washout||30
8704876|NCT00929201|9750687|FG001|STARTED|7-day Washout||30
8704877|NCT00929201|9750686|FG000|COMPLETED|7-day Washout||30
8704878|NCT00929201|9750687|FG001|COMPLETED|7-day Washout||30
8704879|NCT00929201|9750686|FG000|NOT COMPLETED|7-day Washout||0
8704880|NCT00929201|9750687|FG001|NOT COMPLETED|7-day Washout||0
8704881|NCT00929201|9750686|FG000|STARTED|Period 2||30
8704882|NCT00929201|9750687|FG001|STARTED|Period 2||30
8704883|NCT00929201|9750686|FG000|COMPLETED|Period 2||30
8704884|NCT00929201|9750687|FG001|COMPLETED|Period 2||30
8704885|NCT00929201|9750686|FG000|NOT COMPLETED|Period 2||0
8704886|NCT00929201|9750687|FG001|NOT COMPLETED|Period 2||0
8704887|NCT00929240|9750694|FG000|STARTED|Initial Treatment Phase|Includes only the participants that received Initial Phase Treatment.|284
8704888|NCT00929240|9750695|FG001|STARTED|Initial Treatment Phase|Participants were randomized to 1 of 2 treatment groups at the end of the initial treatment phase.|0
8704889|NCT00929240|9750696|FG002|STARTED|Initial Treatment Phase||0
8704890|NCT00929240|9750694|FG000|COMPLETED|Initial Treatment Phase|Participants were randomized to 1 of 2 treatment groups at the end of the initial treatment phase.|185
8704891|NCT00929240|9750695|FG001|COMPLETED|Initial Treatment Phase||0
8704892|NCT00929240|9750696|FG002|COMPLETED|Initial Treatment Phase||0
8704893|NCT00929240|9750694|FG000|NOT COMPLETED|Initial Treatment Phase||99
8704894|NCT00929240|9750695|FG001|NOT COMPLETED|Initial Treatment Phase||0
8704895|NCT00929240|9750696|FG002|NOT COMPLETED|Initial Treatment Phase||0
8704896|NCT00929240|9750694|FG000|STARTED|Maintenance Phase|Participants were randomized to 1 of 2 treatment groups at the end of the initial treatment phase.|0
8704897|NCT00929240|9750695|FG001|STARTED|Maintenance Phase||94
8704898|NCT00929240|9750696|FG002|STARTED|Maintenance Phase||91
8704899|NCT00929240|9750694|FG000|COMPLETED|Maintenance Phase||0
8704900|NCT00929240|9750695|FG001|COMPLETED|Maintenance Phase||0
8704901|NCT00929240|9750696|FG002|COMPLETED|Maintenance Phase||0
8704902|NCT00929240|9750694|FG000|NOT COMPLETED|Maintenance Phase||0
8704903|NCT00929240|9750695|FG001|NOT COMPLETED|Maintenance Phase||94
8704904|NCT00929240|9750696|FG002|NOT COMPLETED|Maintenance Phase||91
8704905|NCT00929305|9750707|FG000|STARTED|Overall Study||43
8704906|NCT00929305|9750708|FG001|STARTED|Overall Study||43
8704907|NCT00929305|9750707|FG000|COMPLETED|Overall Study||43
8704908|NCT00929305|9750708|FG001|COMPLETED|Overall Study||43
8704909|NCT00929305|9750707|FG000|NOT COMPLETED|Overall Study||0
8704910|NCT00929305|9750708|FG001|NOT COMPLETED|Overall Study||0
8704911|NCT00929331|9750717|FG000|STARTED|Overall Study||55
8704912|NCT00929331|9750718|FG001|STARTED|Overall Study||55
8704913|NCT00929331|9750717|FG000|COMPLETED|Overall Study||55
8704914|NCT00929331|9750718|FG001|COMPLETED|Overall Study||55
8704915|NCT00929331|9750717|FG000|NOT COMPLETED|Overall Study||0
8704916|NCT00929331|9750718|FG001|NOT COMPLETED|Overall Study||0
8704917|NCT00929344|9750727|FG000|STARTED|Overall Study||50
8704918|NCT00929344|9750728|FG001|STARTED|Overall Study||50
8704919|NCT00929344|9750729|FG002|STARTED|Overall Study||50
8704920|NCT00929344|9750727|FG000|COMPLETED|Overall Study||28
8704921|NCT00929344|9750728|FG001|COMPLETED|Overall Study||37
8704922|NCT00929344|9750729|FG002|COMPLETED|Overall Study||29
8704923|NCT00929344|9750727|FG000|NOT COMPLETED|Overall Study||22
8704924|NCT00929344|9750728|FG001|NOT COMPLETED|Overall Study||13
8704925|NCT00929344|9750729|FG002|NOT COMPLETED|Overall Study||21
8704926|NCT00929357|9750739|FG000|STARTED|Overall Study||92
8704927|NCT00929357|9750740|FG001|STARTED|Overall Study||64
8704928|NCT00929357|9750739|FG000|COMPLETED|Overall Study||92
8704929|NCT00929357|9750740|FG001|COMPLETED|Overall Study||64
8704930|NCT00929357|9750739|FG000|NOT COMPLETED|Overall Study||0
8704931|NCT00929357|9750740|FG001|NOT COMPLETED|Overall Study||0
8704932|NCT00929383|9750746|FG000|STARTED|Overall Study||82
8704933|NCT00929383|9750746|FG000|COMPLETED|Overall Study||67
8704934|NCT00929383|9750746|FG000|NOT COMPLETED|Overall Study||15
8704935|NCT00929500|9750752|FG000|STARTED|Overall Study||8
8704936|NCT00929500|9750753|FG001|STARTED|Overall Study||4
8704937|NCT00929500|9750752|FG000|COMPLETED|Overall Study||4
8704938|NCT00929500|9750753|FG001|COMPLETED|Overall Study||4
8704939|NCT00929500|9750752|FG000|NOT COMPLETED|Overall Study||4
8704940|NCT00929500|9750753|FG001|NOT COMPLETED|Overall Study||0
8704941|NCT00929526|9750761|FG000|STARTED|Overall Study||375
8704942|NCT00929526|9750762|FG001|STARTED|Overall Study||377
8704943|NCT00929526|9750761|FG000|COMPLETED|Overall Study||358
8704944|NCT00929526|9750762|FG001|COMPLETED|Overall Study||348
8704945|NCT00929526|9750761|FG000|NOT COMPLETED|Overall Study||17
8704946|NCT00929526|9750762|FG001|NOT COMPLETED|Overall Study||29
8704947|NCT00929578|9750768|FG000|STARTED|Overall Study||15
8704948|NCT00929578|9750768|FG000|COMPLETED|Overall Study||15
8704949|NCT00929578|9750768|FG000|NOT COMPLETED|Overall Study||0
8704950|NCT00929643|9750777|FG000|STARTED|Overall Study||203
8704951|NCT00929643|9750777|FG000|COMPLETED|Overall Study||201
8704952|NCT00929643|9750777|FG000|NOT COMPLETED|Overall Study||2
8704953|NCT00929656|9750783|FG000|STARTED|Overall Study||13
8704954|NCT00929656|9750784|FG001|STARTED|Overall Study||9
8704955|NCT00929656|9750783|FG000|COMPLETED|Overall Study||13
8704956|NCT00929656|9750784|FG001|COMPLETED|Overall Study||8
8704957|NCT00929656|9750783|FG000|NOT COMPLETED|Overall Study||0
8704958|NCT00929656|9750784|FG001|NOT COMPLETED|Overall Study||1
8704959|NCT00929669|9750790|FG000|STARTED|Overall Study||2
8704960|NCT00929669|9750790|FG000|COMPLETED|Overall Study||1
8704961|NCT00929669|9750790|FG000|NOT COMPLETED|Overall Study||1
8704962|NCT00929695|9750796|FG000|STARTED|Overall Study||81
8704963|NCT00929695|9750797|FG001|STARTED|Overall Study||83
8704964|NCT00929695|9750796|FG000|COMPLETED|Overall Study||73
8704965|NCT00929695|9750797|FG001|COMPLETED|Overall Study||77
8704966|NCT00929695|9750796|FG000|NOT COMPLETED|Overall Study||8
8704967|NCT00929695|9750797|FG001|NOT COMPLETED|Overall Study||6
8704968|NCT00929708|9750813|FG000|STARTED|Overall Study||65
8704969|NCT00929708|9750814|FG001|STARTED|Overall Study||69
8704970|NCT00929708|9750815|FG002|STARTED|Overall Study||65
8704971|NCT00929708|9750816|FG003|STARTED|Overall Study||67
8704972|NCT00929708|9750817|FG004|STARTED|Overall Study||63
8704973|NCT00929708|9750813|FG000|COMPLETED|Overall Study||61
8704974|NCT00929708|9750814|FG001|COMPLETED|Overall Study||66
8704975|NCT00929708|9750815|FG002|COMPLETED|Overall Study||62
8704976|NCT00929708|9750816|FG003|COMPLETED|Overall Study||61
8704977|NCT00929708|9750817|FG004|COMPLETED|Overall Study||57
8704978|NCT00929708|9750813|FG000|NOT COMPLETED|Overall Study||4
8704979|NCT00929708|9750814|FG001|NOT COMPLETED|Overall Study||3
8704980|NCT00929708|9750815|FG002|NOT COMPLETED|Overall Study||3
8704981|NCT00929708|9750816|FG003|NOT COMPLETED|Overall Study||6
8704982|NCT00929708|9750817|FG004|NOT COMPLETED|Overall Study||6
8704983|NCT00929734|9750831|FG000|STARTED|Overall Study||49
8704984|NCT00929734|9750832|FG001|STARTED|Overall Study||50
8704985|NCT00929734|9750831|FG000|COMPLETED|Overall Study||47
8704986|NCT00929734|9750832|FG001|COMPLETED|Overall Study||47
8704987|NCT00929734|9750831|FG000|NOT COMPLETED|Overall Study||2
8704988|NCT00929734|9750832|FG001|NOT COMPLETED|Overall Study||3
8704989|NCT00929773|9750840|FG000|STARTED|Overall Study||50
8704990|NCT00929773|9750841|FG001|STARTED|Overall Study||50
8704991|NCT00929773|9750840|FG000|COMPLETED|Overall Study||50
8704992|NCT00929773|9750841|FG001|COMPLETED|Overall Study||50
8704993|NCT00929773|9750840|FG000|NOT COMPLETED|Overall Study||0
8704994|NCT00929773|9750841|FG001|NOT COMPLETED|Overall Study||0
8704995|NCT00929838|9750852|FG000|STARTED|Overall Study||63
8704996|NCT00929838|9750853|FG001|STARTED|Overall Study||65
8704997|NCT00929838|9750854|FG002|STARTED|Overall Study||63
8704998|NCT00929838|9750855|FG003|STARTED|Overall Study||64
8704999|NCT00929838|9750852|FG000|COMPLETED|Overall Study||53
8705000|NCT00929838|9750853|FG001|COMPLETED|Overall Study||56
8705001|NCT00929838|9750854|FG002|COMPLETED|Overall Study||53
8705002|NCT00929838|9750855|FG003|COMPLETED|Overall Study||55
8705003|NCT00929838|9750852|FG000|NOT COMPLETED|Overall Study||10
8705004|NCT00929838|9750853|FG001|NOT COMPLETED|Overall Study||9
8705005|NCT00929838|9750854|FG002|NOT COMPLETED|Overall Study||10
8705006|NCT00929838|9750855|FG003|NOT COMPLETED|Overall Study||9
8705007|NCT00929864|9750867|FG000|STARTED|Overall Study||318
8705008|NCT00929864|9750868|FG001|STARTED|Overall Study||328
8705009|NCT00929864|9750867|FG000|COMPLETED|Overall Study||252
8705010|NCT00929864|9750868|FG001|COMPLETED|Overall Study||245
8705011|NCT00929864|9750867|FG000|NOT COMPLETED|Overall Study||66
8705012|NCT00929864|9750868|FG001|NOT COMPLETED|Overall Study||83
8705013|NCT00929981|9750874|FG000|STARTED|Overall Study||80
8705014|NCT00929981|9750874|FG000|COMPLETED|Overall Study||80
8705015|NCT00929981|9750874|FG000|NOT COMPLETED|Overall Study||0
8705016|NCT00929994|9750878|FG000|STARTED|Overall Study||20
8705017|NCT00929994|9750878|FG000|COMPLETED|Overall Study||14
8705018|NCT00929994|9750878|FG000|NOT COMPLETED|Overall Study||6
8705019|NCT00930046|9750887|FG000|STARTED|Overall Study||8
8705020|NCT00930046|9750888|FG001|STARTED|Overall Study||7
8705021|NCT00930046|9750887|FG000|COMPLETED|Overall Study||7
8705022|NCT00930046|9750888|FG001|COMPLETED|Overall Study||5
8705023|NCT00930046|9750887|FG000|NOT COMPLETED|Overall Study||1
8705024|NCT00930046|9750888|FG001|NOT COMPLETED|Overall Study||2
8705025|NCT00930059|9750896|FG000|STARTED|Overall Study||100
8705026|NCT00930059|9750897|FG001|STARTED|Overall Study||91
8705027|NCT00930059|9750896|FG000|COMPLETED|Overall Study||92
8705028|NCT00930059|9750897|FG001|COMPLETED|Overall Study||79
8705029|NCT00930059|9750896|FG000|NOT COMPLETED|Overall Study||8
8705030|NCT00930059|9750897|FG001|NOT COMPLETED|Overall Study||12
8705031|NCT00930176|9750903|FG000|STARTED|Overall Study||16
8705032|NCT00930176|9750903|FG000|COMPLETED|Overall Study||15
8705033|NCT00930176|9750903|FG000|NOT COMPLETED|Overall Study||1
8705034|NCT00930293|9750909|FG000|STARTED|Overall Study||24
8705035|NCT00930293|9750910|FG001|STARTED|Overall Study||26
8705036|NCT00930293|9750909|FG000|COMPLETED|Overall Study||17
8705037|NCT00930293|9750910|FG001|COMPLETED|Overall Study||19
8705038|NCT00930293|9750909|FG000|NOT COMPLETED|Overall Study||7
8705039|NCT00930293|9750910|FG001|NOT COMPLETED|Overall Study||7
8724636|NCT01027286|9771846|FG001|12 Week Postoperative|Overall Study||49
8724637|NCT01027286|9771845|FG000|COMPLETED|Overall Study||49
8724638|NCT01027286|9771846|FG001|COMPLETED|Overall Study||49
8724639|NCT01027286|9771845|FG000|NOT COMPLETED|Overall Study||1
8724640|NCT01027286|9771846|FG001|NOT COMPLETED|Overall Study||1
8724641|NCT01027351|9771858|FG000|STARTED|Overall Study||29
8724642|NCT01027351|9771859|FG001|STARTED|Overall Study||19
8724643|NCT01027351|9771860|FG002|STARTED|Overall Study||14
8724644|NCT01027351|9771861|FG003|STARTED|Overall Study||8
8724645|NCT01027351|9771862|FG004|STARTED|Overall Study||43
8724646|NCT01027351|9771863|FG005|STARTED|Overall Study||50
8724647|NCT01027351|9771858|FG000|COMPLETED|Overall Study||26
8724648|NCT01027351|9771859|FG001|COMPLETED|Overall Study||18
8724649|NCT01027351|9771860|FG002|COMPLETED|Overall Study||13
8724650|NCT01027351|9771861|FG003|COMPLETED|Overall Study||6
8724651|NCT01027351|9771862|FG004|COMPLETED|Overall Study||32
8724652|NCT01027351|9771863|FG005|COMPLETED|Overall Study||45
8724653|NCT01027351|9771858|FG000|NOT COMPLETED|Overall Study||3
8724654|NCT01027351|9771859|FG001|NOT COMPLETED|Overall Study||1
8724655|NCT01027351|9771860|FG002|NOT COMPLETED|Overall Study||1
8724656|NCT01027351|9771861|FG003|NOT COMPLETED|Overall Study||2
8724657|NCT01027351|9771862|FG004|NOT COMPLETED|Overall Study||11
8724658|NCT01027351|9771863|FG005|NOT COMPLETED|Overall Study||5
8724659|NCT01027364|9771888|FG000|STARTED|Overall Study||63
8724660|NCT01027364|9771889|FG001|STARTED|Overall Study||29
8724661|NCT01027364|9771890|FG002|STARTED|Overall Study||27
8724662|NCT01027364|9771891|FG003|STARTED|Overall Study|12 total participants in Arm 4 (6 started in Arm 4; 5 joined from Arm 1; 1 joined from Arm 3)|4
8724663|NCT01027364|9771888|FG000|Enrolled in Sequential PK Subgroup|Overall Study||22
8724664|NCT01027364|9771889|FG001|Enrolled in Sequential PK Subgroup|Overall Study||0
8724665|NCT01027364|9771890|FG002|Enrolled in Sequential PK Subgroup|Overall Study||0
8724666|NCT01027364|9771891|FG003|Enrolled in Sequential PK Subgroup|Overall Study||0
8724667|NCT01027364|9771888|FG000|Joined Arm 4 for Surgery Then Returned|Overall Study||5
8724668|NCT01027364|9771889|FG001|Joined Arm 4 for Surgery Then Returned|Overall Study||0
8724669|NCT01027364|9771890|FG002|Joined Arm 4 for Surgery Then Returned|Overall Study||1
8724670|NCT01027364|9771891|FG003|Joined Arm 4 for Surgery Then Returned|Overall Study||0
8724671|NCT01027364|9771888|FG000|Started Arm 4 Then Joined Another Arm|Overall Study||2
8724672|NCT01027364|9771889|FG001|Started Arm 4 Then Joined Another Arm|Overall Study||0
8724673|NCT01027364|9771890|FG002|Started Arm 4 Then Joined Another Arm|Overall Study||0
8724674|NCT01027364|9771891|FG003|Started Arm 4 Then Joined Another Arm|Overall Study||0
8724675|NCT01027364|9771888|FG000|COMPLETED|Overall Study||59
8724676|NCT01027364|9771889|FG001|COMPLETED|Overall Study||27
8724677|NCT01027364|9771890|FG002|COMPLETED|Overall Study||26
8705040|NCT00930553|9750916|FG000|STARTED|Overall Study||1314
8705041|NCT00930553|9750916|FG000|Participants Entered From CAMMS223|Overall Study||141
8705042|NCT00930553|9750916|FG000|Participants Entered From CAMMS323|Overall Study||488
8705043|NCT00930553|9750916|FG000|Participants Entered From CAMMS324|Overall Study||685
8705044|NCT00930553|9750916|FG000|COMPLETED|Overall Study||1091
8705045|NCT00930553|9750916|FG000|NOT COMPLETED|Overall Study||223
8705046|NCT00930644|9750938|FG000|STARTED|Overall Study||88
8705047|NCT00930644|9750938|FG000|COMPLETED|Overall Study||65
8705048|NCT00930644|9750938|FG000|NOT COMPLETED|Overall Study||23
8705049|NCT00930761|9750947|FG000|STARTED|Overall Study||50
8705050|NCT00930761|9750948|FG001|STARTED|Overall Study||51
8705051|NCT00930761|9750947|FG000|COMPLETED|Overall Study||46
8705052|NCT00930761|9750948|FG001|COMPLETED|Overall Study||48
8705053|NCT00930761|9750947|FG000|NOT COMPLETED|Overall Study||4
8705054|NCT00930761|9750948|FG001|NOT COMPLETED|Overall Study||3
8705055|NCT00930774|9750958|FG000|STARTED|Overall Study||25
8705056|NCT00930774|9750959|FG001|STARTED|Overall Study||25
8705057|NCT00930774|9750960|FG002|STARTED|Overall Study||24
8705058|NCT00930774|9750961|FG003|STARTED|Overall Study||25
8705059|NCT00930774|9750958|FG000|COMPLETED|Overall Study||24
8705060|NCT00930774|9750959|FG001|COMPLETED|Overall Study||16
8705061|NCT00930774|9750960|FG002|COMPLETED|Overall Study||22
8705062|NCT00930774|9750961|FG003|COMPLETED|Overall Study||25
8705063|NCT00930774|9750958|FG000|NOT COMPLETED|Overall Study||1
8705064|NCT00930774|9750959|FG001|NOT COMPLETED|Overall Study||9
8705065|NCT00930774|9750960|FG002|NOT COMPLETED|Overall Study||2
8705066|NCT00930774|9750961|FG003|NOT COMPLETED|Overall Study||0
8705067|NCT00930813|9750974|FG000|STARTED|Overall Study||49
8705068|NCT00930813|9750975|FG001|STARTED|Overall Study||52
8705069|NCT00930813|9750974|FG000|COMPLETED|Overall Study||41
8705070|NCT00930813|9750975|FG001|COMPLETED|Overall Study||38
8705071|NCT00930813|9750974|FG000|NOT COMPLETED|Overall Study||8
8705072|NCT00930813|9750975|FG001|NOT COMPLETED|Overall Study||14
8705073|NCT00930930|9750985|FG000|STARTED|Overall Study||96
8705074|NCT00930930|9750986|FG001|STARTED|Overall Study||49
8705075|NCT00930930|9750985|FG000|COMPLETED|Overall Study||75
8705076|NCT00930930|9750986|FG001|COMPLETED|Overall Study||40
8705077|NCT00930930|9750985|FG000|NOT COMPLETED|Overall Study||21
8705078|NCT00930930|9750986|FG001|NOT COMPLETED|Overall Study||9
8705079|NCT00930969|9750992|FG000|STARTED|Overall Study||175
8705080|NCT00930969|9750992|FG000|COMPLETED|Overall Study||137
8557383|NCT00002525|9589261|FG001|Treated|Overall Study|"Patients on No perioperative 5-FU arm received no perioperative chemotherapy"|0
8557384|NCT00002525|9589260|FG000|Dukes' B3 or C Stage|Overall Study|"Primary population: pts with Duke's B3, C disease. 158 such pts on No perioperative 5-FU arm"|156
8557385|NCT00002525|9589261|FG001|Dukes' B3 or C Stage|Overall Study||158
8557386|NCT00002525|9589260|FG000|Dukes' B2 Stage|Overall Study||150
8557387|NCT00002525|9589261|FG001|Dukes' B2 Stage|Overall Study||139
8557388|NCT00002525|9589260|FG000|COMPLETED|Overall Study||241
8557389|NCT00002525|9589261|FG001|COMPLETED|Overall Study|"Patients on No perioperative 5-FU arm received no perioperative chemotherapy"|428
8557390|NCT00002525|9589260|FG000|NOT COMPLETED|Overall Study||186
8557391|NCT00002525|9589261|FG001|NOT COMPLETED|Overall Study||0
8557392|NCT00002540|9589271|FG000|STARTED|Overall Study||38345
8557393|NCT00002540|9589272|FG001|STARTED|Overall Study||38340
8557394|NCT00002540|9589271|FG000|COMPLETED|Overall Study||37544
8557395|NCT00002540|9589272|FG001|COMPLETED|Overall Study||35876
8557396|NCT00002540|9589271|FG000|NOT COMPLETED|Overall Study||801
8705081|NCT00930969|9750992|FG000|NOT COMPLETED|Overall Study||38
8705082|NCT00930982|9750998|FG000|STARTED|Overall Study||60
8705083|NCT00930982|9750999|FG001|STARTED|Overall Study||64
8705084|NCT00930982|9750998|FG000|COMPLETED|Overall Study||39
8705085|NCT00930982|9750999|FG001|COMPLETED|Overall Study||35
8705086|NCT00930982|9750998|FG000|NOT COMPLETED|Overall Study||21
8705087|NCT00930982|9750999|FG001|NOT COMPLETED|Overall Study||29
8705088|NCT00931164|9751005|FG000|STARTED|Overall Study||6
8705089|NCT00931164|9751005|FG000|COMPLETED|Overall Study||6
8705090|NCT00931164|9751005|FG000|NOT COMPLETED|Overall Study||0
8705091|NCT00931242|9751011|FG000|STARTED|Overall Study||10
8705092|NCT00931242|9751012|FG001|STARTED|Overall Study||2
8705093|NCT00931242|9751011|FG000|COMPLETED|Overall Study||5
8705094|NCT00931242|9751012|FG001|COMPLETED|Overall Study||0
8705095|NCT00931242|9751011|FG000|NOT COMPLETED|Overall Study||5
8705096|NCT00931242|9751012|FG001|NOT COMPLETED|Overall Study||2
8705097|NCT00931268|9751016|FG000|STARTED|Overall Study||10
8705098|NCT00931268|9751016|FG000|COMPLETED|Overall Study||4
8705099|NCT00931268|9751016|FG000|NOT COMPLETED|Overall Study||6
8705100|NCT00931307|9751020|FG000|STARTED|Overall Study||22
8705101|NCT00931307|9751020|FG000|COMPLETED|Overall Study||9
8705102|NCT00931307|9751020|FG000|NOT COMPLETED|Overall Study||13
8705103|NCT00931359|9751026|FG000|STARTED|Overall Study||39
8705104|NCT00931359|9751027|FG001|STARTED|Overall Study||81
8705105|NCT00931359|9751026|FG000|COMPLETED|Overall Study||33
8705106|NCT00931359|9751027|FG001|COMPLETED|Overall Study||68
8705107|NCT00931359|9751026|FG000|NOT COMPLETED|Overall Study||6
8705108|NCT00931359|9751027|FG001|NOT COMPLETED|Overall Study||13
8705109|NCT00931385|9751033|FG000|STARTED|Overall Study||25
8705110|NCT00931385|9751034|FG001|STARTED|Overall Study||23
8705111|NCT00931385|9751035|FG002|STARTED|Overall Study||25
8705112|NCT00931385|9751036|FG003|STARTED|Overall Study||26
8705113|NCT00931385|9751033|FG000|COMPLETED|Overall Study||23
8705114|NCT00931385|9751034|FG001|COMPLETED|Overall Study||21
8705115|NCT00931385|9751035|FG002|COMPLETED|Overall Study||24
8705116|NCT00931385|9751036|FG003|COMPLETED|Overall Study||21
8705117|NCT00931385|9751033|FG000|NOT COMPLETED|Overall Study||2
8705118|NCT00931385|9751034|FG001|NOT COMPLETED|Overall Study||2
8705119|NCT00931385|9751035|FG002|NOT COMPLETED|Overall Study||1
8705120|NCT00931385|9751036|FG003|NOT COMPLETED|Overall Study||5
8705121|NCT00931411|9751052|FG000|STARTED|First Intervention - 42 Days||35
8705122|NCT00931411|9751053|FG001|STARTED|First Intervention - 42 Days||38
8705123|NCT00931411|9751052|FG000|COMPLETED|First Intervention - 42 Days||31
8705124|NCT00931411|9751053|FG001|COMPLETED|First Intervention - 42 Days||35
8705125|NCT00931411|9751052|FG000|NOT COMPLETED|First Intervention - 42 Days||4
8705126|NCT00931411|9751053|FG001|NOT COMPLETED|First Intervention - 42 Days||3
8705127|NCT00931411|9751052|FG000|STARTED|After Crossover - 14 Days (up to Day 56)||31
8705128|NCT00931411|9751053|FG001|STARTED|After Crossover - 14 Days (up to Day 56)||35
8705129|NCT00931411|9751052|FG000|COMPLETED|After Crossover - 14 Days (up to Day 56)||31
8705130|NCT00931411|9751053|FG001|COMPLETED|After Crossover - 14 Days (up to Day 56)||34
8705131|NCT00931411|9751052|FG000|NOT COMPLETED|After Crossover - 14 Days (up to Day 56)||0
8705132|NCT00931411|9751053|FG001|NOT COMPLETED|After Crossover - 14 Days (up to Day 56)||1
8705133|NCT00931463|9751065|FG000|STARTED|Overall Study||271
8705134|NCT00931463|9751066|FG001|STARTED|Overall Study||270
8705135|NCT00931463|9751065|FG000|COMPLETED|Overall Study||254
8705136|NCT00931463|9751066|FG001|COMPLETED|Overall Study||265
8705137|NCT00931463|9751065|FG000|NOT COMPLETED|Overall Study||17
8705138|NCT00931463|9751066|FG001|NOT COMPLETED|Overall Study||5
8705139|NCT00931489|9751077|FG000|STARTED|Overall Study||40
8705140|NCT00931489|9751078|FG001|STARTED|Overall Study||40
8705141|NCT00931489|9751079|FG002|STARTED|Overall Study||5
8705142|NCT00931489|9751080|FG003|STARTED|Overall Study||39
8705143|NCT00931489|9751081|FG004|STARTED|Overall Study||7
8705144|NCT00931489|9751077|FG000|COMPLETED|Overall Study||40
8705145|NCT00931489|9751078|FG001|COMPLETED|Overall Study||40
8705146|NCT00931489|9751079|FG002|COMPLETED|Overall Study|3 subjects enrolled in Group 1 (responders) were moved to Group 3 (non-responders)|5
8705147|NCT00931489|9751080|FG003|COMPLETED|Overall Study||39
8705148|NCT00931489|9751081|FG004|COMPLETED|Overall Study||7
8705149|NCT00931489|9751077|FG000|NOT COMPLETED|Overall Study||0
8705150|NCT00931489|9751078|FG001|NOT COMPLETED|Overall Study||0
8705151|NCT00931489|9751079|FG002|NOT COMPLETED|Overall Study||0
8705152|NCT00931489|9751080|FG003|NOT COMPLETED|Overall Study||0
8705153|NCT00931489|9751081|FG004|NOT COMPLETED|Overall Study||0
8705154|NCT00931515|9751094|FG000|STARTED|Overall Study||15
8705155|NCT00931515|9751095|FG001|STARTED|Overall Study||15
8705156|NCT00931515|9751094|FG000|COMPLETED|Overall Study||13
8705157|NCT00931515|9751095|FG001|COMPLETED|Overall Study||10
8705158|NCT00931515|9751094|FG000|NOT COMPLETED|Overall Study||2
8705159|NCT00931515|9751095|FG001|NOT COMPLETED|Overall Study||5
8705160|NCT00931528|9751103|FG000|STARTED|Overall Study||121
8705161|NCT00931528|9751104|FG001|STARTED|Overall Study||121
8705162|NCT00931528|9751103|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|80
8705163|NCT00931528|9751104|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|61
8705164|NCT00931528|9751103|FG000|NOT COMPLETED|Overall Study||41
8705165|NCT00931528|9751104|FG001|NOT COMPLETED|Overall Study||60
8705166|NCT00931632|9751113|FG000|STARTED|Overall Study|Randomized|229
8705167|NCT00931632|9751114|FG001|STARTED|Overall Study|Randomized|222
8705168|NCT00931632|9751113|FG000|COMPLETED|Overall Study|Completed at 36 weeks Postmenstrual Age (PMA)|208
8705169|NCT00931632|9751114|FG001|COMPLETED|Overall Study|Completed at 36 weeks Postmenstrual Age (PMA)|204
8705170|NCT00931632|9751113|FG000|NOT COMPLETED|Overall Study||21
8705171|NCT00931632|9751114|FG001|NOT COMPLETED|Overall Study||18
8705172|NCT00931710|9751122|FG000|STARTED|Overall Study||241
8705173|NCT00931710|9751123|FG001|STARTED|Overall Study||247
8705174|NCT00931710|9751122|FG000|COMPLETED|Overall Study||207
8705175|NCT00931710|9751123|FG001|COMPLETED|Overall Study||209
8705176|NCT00931710|9751122|FG000|NOT COMPLETED|Overall Study||34
8705177|NCT00931710|9751123|FG001|NOT COMPLETED|Overall Study||38
8705178|NCT00931723|9751131|FG000|STARTED|Overall Study||173
8705179|NCT00931723|9751132|FG001|STARTED|Overall Study||183
8705180|NCT00931723|9751131|FG000|COMPLETED|Overall Study||147
8705181|NCT00931723|9751132|FG001|COMPLETED|Overall Study||144
8705182|NCT00931723|9751131|FG000|NOT COMPLETED|Overall Study||26
8705183|NCT00931723|9751132|FG001|NOT COMPLETED|Overall Study||39
8705184|NCT00931762|9751138|FG000|STARTED|Overall Study||35
8705185|NCT00931762|9751138|FG000|COMPLETED|Overall Study||0
8705186|NCT00931762|9751138|FG000|NOT COMPLETED|Overall Study||35
8705187|NCT00931801|9751145|FG000|STARTED|Overall Study||14
8705188|NCT00931801|9751146|FG001|STARTED|Overall Study||15
8705189|NCT00931801|9751147|FG002|STARTED|Overall Study||14
8705190|NCT00931801|9751145|FG000|COMPLETED|Overall Study||13
8812825|NCT01521949|9865870|FG000|STARTED|Overall Study||21
8812826|NCT01521949|9865870|FG000|COMPLETED|Overall Study||21
8705191|NCT00931801|9751146|FG001|COMPLETED|Overall Study||14
8812827|NCT01521949|9865870|FG000|NOT COMPLETED|Overall Study||0
8850425|NCT01746420|9905637|FG001|STARTED|Overall Study||20
8705192|NCT00931801|9751147|FG002|COMPLETED|Overall Study||10
8705193|NCT00931801|9751145|FG000|NOT COMPLETED|Overall Study||1
8705194|NCT00931801|9751146|FG001|NOT COMPLETED|Overall Study||1
8705195|NCT00931801|9751147|FG002|NOT COMPLETED|Overall Study||4
8705196|NCT00931879|9751161|FG000|STARTED|Overall Study||22
8705197|NCT00931879|9751162|FG001|STARTED|Overall Study||22
8705198|NCT00931879|9751161|FG000|COMPLETED|Overall Study||19
8705199|NCT00931879|9751162|FG001|COMPLETED|Overall Study||19
8705200|NCT00931879|9751161|FG000|NOT COMPLETED|Overall Study||3
8705201|NCT00931879|9751162|FG001|NOT COMPLETED|Overall Study||3
8705202|NCT00931892|9751171|FG000|STARTED|Completed Gluten Challenge||10
8705203|NCT00931892|9751172|FG001|STARTED|Completed Gluten Challenge||10
8705204|NCT00931892|9751171|FG000|COMPLETED|Completed Gluten Challenge||10
8705205|NCT00931892|9751172|FG001|COMPLETED|Completed Gluten Challenge||10
8705206|NCT00931892|9751171|FG000|NOT COMPLETED|Completed Gluten Challenge||0
8705207|NCT00931892|9751172|FG001|NOT COMPLETED|Completed Gluten Challenge||0
8812828|NCT01522131|9865876|FG000|STARTED|Overall Study||16
8812829|NCT01522131|9865877|FG001|STARTED|Overall Study||17
8812830|NCT01522131|9865876|FG000|COMPLETED|Overall Study||14
8812831|NCT01522131|9865877|FG001|COMPLETED|Overall Study||17
8812832|NCT01522131|9865876|FG000|NOT COMPLETED|Overall Study||2
8812833|NCT01522131|9865877|FG001|NOT COMPLETED|Overall Study||0
8812834|NCT01522235|9865885|FG000|STARTED|Overall Study||3
8812835|NCT01522235|9865886|FG001|STARTED|Overall Study||3
8812836|NCT01522235|9865885|FG000|Randomized|Overall Study||2
8812837|NCT01522235|9865886|FG001|Randomized|Overall Study||3
8812838|NCT01522235|9865885|FG000|COMPLETED|Overall Study||2
8812839|NCT01522235|9865886|FG001|COMPLETED|Overall Study||2
8812840|NCT01522235|9865885|FG000|NOT COMPLETED|Overall Study||1
8812841|NCT01522235|9865886|FG001|NOT COMPLETED|Overall Study||1
8812842|NCT01522248|9865898|FG000|STARTED|Overall Study||10
8812843|NCT01522248|9865899|FG001|STARTED|Overall Study||10
8812844|NCT01522248|9865898|FG000|COMPLETED|Overall Study||9
8812845|NCT01522248|9865899|FG001|COMPLETED|Overall Study||10
8812846|NCT01522248|9865898|FG000|NOT COMPLETED|Overall Study||1
8812847|NCT01522248|9865899|FG001|NOT COMPLETED|Overall Study||0
8812848|NCT01522339|9865910|FG000|STARTED|Overall Study||15
8812849|NCT01522339|9865910|FG000|COMPLETED|Overall Study||15
8812850|NCT01522339|9865910|FG000|NOT COMPLETED|Overall Study||0
8812851|NCT01522391|9865917|FG000|STARTED|Overall Study||20
8812852|NCT01522391|9865918|FG001|STARTED|Overall Study||21
8812853|NCT01522391|9865917|FG000|COMPLETED|Overall Study||19
8812854|NCT01522391|9865918|FG001|COMPLETED|Overall Study||20
8812855|NCT01522391|9865917|FG000|NOT COMPLETED|Overall Study||1
8812856|NCT01522391|9865918|FG001|NOT COMPLETED|Overall Study||1
8812857|NCT01522404|9865926|FG000|STARTED|First Intervention (up to Week 29)||20
8812858|NCT01522404|9865927|FG001|STARTED|First Intervention (up to Week 29)||19
8812859|NCT01522404|9865926|FG000|COMPLETED|First Intervention (up to Week 29)||18
8812860|NCT01522404|9865927|FG001|COMPLETED|First Intervention (up to Week 29)||19
8812861|NCT01522404|9865926|FG000|NOT COMPLETED|First Intervention (up to Week 29)||2
8812862|NCT01522404|9865927|FG001|NOT COMPLETED|First Intervention (up to Week 29)||0
8812863|NCT01522404|9865926|FG000|STARTED|Second Intervention (up to Week 58)||18
8705208|NCT00931892|9751171|FG000|STARTED|Completed Endoscopies||10
8705209|NCT00931892|9751172|FG001|STARTED|Completed Endoscopies||10
8812864|NCT01522404|9865927|FG001|STARTED|Second Intervention (up to Week 58)||19
8812865|NCT01522404|9865926|FG000|COMPLETED|Second Intervention (up to Week 58)||17
8705210|NCT00931892|9751171|FG000|First Endoscopy|Completed Endoscopies||10
8812866|NCT01522404|9865927|FG001|COMPLETED|Second Intervention (up to Week 58)||19
8705211|NCT00931892|9751172|FG001|First Endoscopy|Completed Endoscopies||10
8705212|NCT00931892|9751171|FG000|Second Endoscopy|Completed Endoscopies||10
8705213|NCT00931892|9751172|FG001|Second Endoscopy|Completed Endoscopies||10
8705214|NCT00931892|9751171|FG000|Third Endoscopy|Completed Endoscopies||10
8705215|NCT00931892|9751172|FG001|Third Endoscopy|Completed Endoscopies||9
8705216|NCT00931892|9751171|FG000|COMPLETED|Completed Endoscopies||10
8705217|NCT00931892|9751172|FG001|COMPLETED|Completed Endoscopies||9
8705218|NCT00931892|9751171|FG000|NOT COMPLETED|Completed Endoscopies||0
8705219|NCT00931892|9751172|FG001|NOT COMPLETED|Completed Endoscopies||1
8705220|NCT00931918|9751220|FG000|STARTED|Overall Study||103
8705221|NCT00931918|9751221|FG001|STARTED|Overall Study||103
8705222|NCT00931918|9751220|FG000|Safety Population: Received Study Drug|Overall Study||100
8705223|NCT00931918|9751221|FG001|Safety Population: Received Study Drug|Overall Study||101
8705224|NCT00931918|9751220|FG000|COMPLETED|Overall Study|Completed the maximum of 6 cycles.|86
8705225|NCT00931918|9751221|FG001|COMPLETED|Overall Study|Completed the maximum of 6 cycles.|86
8705226|NCT00931918|9751220|FG000|NOT COMPLETED|Overall Study||17
8705227|NCT00931918|9751221|FG001|NOT COMPLETED|Overall Study||17
8705228|NCT00931944|9751227|FG000|STARTED|Overall Study||74
8705229|NCT00931944|9751227|FG000|COMPLETED|Overall Study||19
8705230|NCT00931944|9751227|FG000|NOT COMPLETED|Overall Study||55
8705231|NCT00931996|9751231|FG000|STARTED|Overall Study||12
8705232|NCT00931996|9751231|FG000|COMPLETED|Overall Study||5
8705233|NCT00931996|9751231|FG000|NOT COMPLETED|Overall Study||7
8705234|NCT00932022|9751237|FG000|STARTED|Overall Study||64
8705235|NCT00932022|9751238|FG001|STARTED|Overall Study||63
8705236|NCT00932022|9751237|FG000|COMPLETED|Overall Study||59
8705237|NCT00932022|9751238|FG001|COMPLETED|Overall Study||59
8705238|NCT00932022|9751237|FG000|NOT COMPLETED|Overall Study||5
8705239|NCT00932022|9751238|FG001|NOT COMPLETED|Overall Study||4
8705240|NCT00932035|9751246|FG000|STARTED|Overall Study||18
8705241|NCT00932035|9751247|FG001|STARTED|Overall Study||21
8705242|NCT00932035|9751246|FG000|COMPLETED|Overall Study||18
8705243|NCT00932035|9751247|FG001|COMPLETED|Overall Study||21
8705244|NCT00932035|9751246|FG000|NOT COMPLETED|Overall Study||0
8705245|NCT00932035|9751247|FG001|NOT COMPLETED|Overall Study||0
8705246|NCT00932113|9751255|FG000|STARTED|Overall Study||15
8705247|NCT00932113|9751256|FG001|STARTED|Overall Study||15
8705248|NCT00932113|9751255|FG000|COMPLETED|Overall Study||14
8705249|NCT00932113|9751256|FG001|COMPLETED|Overall Study||15
8705250|NCT00932113|9751255|FG000|NOT COMPLETED|Overall Study||1
8705251|NCT00932113|9751256|FG001|NOT COMPLETED|Overall Study||0
8705252|NCT00932126|9751262|FG000|STARTED|Overall Study||3
8705253|NCT00932126|9751263|FG001|STARTED|Overall Study||3
8705254|NCT00932126|9751264|FG002|STARTED|Overall Study||3
8705255|NCT00932126|9751265|FG003|STARTED|Overall Study||3
8705256|NCT00932126|9751266|FG004|STARTED|Overall Study||5
8705257|NCT00932126|9751267|FG005|STARTED|Overall Study||3
8705258|NCT00932126|9751268|FG006|STARTED|Overall Study||5
8705259|NCT00932126|9751269|FG007|STARTED|Overall Study||10
8705260|NCT00932126|9751262|FG000|COMPLETED|Overall Study||0
8705261|NCT00932126|9751263|FG001|COMPLETED|Overall Study||0
8705262|NCT00932126|9751264|FG002|COMPLETED|Overall Study||0
8705263|NCT00932126|9751265|FG003|COMPLETED|Overall Study||0
8705264|NCT00932126|9751266|FG004|COMPLETED|Overall Study||0
8705265|NCT00932126|9751267|FG005|COMPLETED|Overall Study||0
8705266|NCT00932126|9751268|FG006|COMPLETED|Overall Study||0
8705267|NCT00932126|9751269|FG007|COMPLETED|Overall Study||0
8705268|NCT00932126|9751262|FG000|NOT COMPLETED|Overall Study||3
8705269|NCT00932126|9751263|FG001|NOT COMPLETED|Overall Study||3
8705270|NCT00932126|9751264|FG002|NOT COMPLETED|Overall Study||3
8705271|NCT00932126|9751265|FG003|NOT COMPLETED|Overall Study||3
8705272|NCT00932126|9751266|FG004|NOT COMPLETED|Overall Study||5
8705273|NCT00932126|9751267|FG005|NOT COMPLETED|Overall Study||3
8705274|NCT00932126|9751268|FG006|NOT COMPLETED|Overall Study||5
8705275|NCT00932126|9751269|FG007|NOT COMPLETED|Overall Study||10
8705276|NCT00932165|9751289|FG000|STARTED|Overall Study||451
8705277|NCT00932165|9751289|FG000|COMPLETED|Overall Study||450
8705278|NCT00932165|9751289|FG000|NOT COMPLETED|Overall Study||1
8705279|NCT00932282|9751296|FG000|STARTED|Pre-OIT Anti-IgE Therapy Phase||7
8705280|NCT00932282|9751297|FG001|STARTED|Pre-OIT Anti-IgE Therapy Phase||6
8705281|NCT00932282|9751296|FG000|COMPLETED|Pre-OIT Anti-IgE Therapy Phase||6
8705282|NCT00932282|9751297|FG001|COMPLETED|Pre-OIT Anti-IgE Therapy Phase||5
8705283|NCT00932282|9751296|FG000|NOT COMPLETED|Pre-OIT Anti-IgE Therapy Phase||1
8705284|NCT00932282|9751297|FG001|NOT COMPLETED|Pre-OIT Anti-IgE Therapy Phase||1
8705285|NCT00932282|9751296|FG000|STARTED|Modified OIT Rush Desensitization Phase||6
8705286|NCT00932282|9751297|FG001|STARTED|Modified OIT Rush Desensitization Phase||5
8705287|NCT00932282|9751296|FG000|COMPLETED|Modified OIT Rush Desensitization Phase||6
8705288|NCT00932282|9751297|FG001|COMPLETED|Modified OIT Rush Desensitization Phase||5
8705289|NCT00932282|9751296|FG000|NOT COMPLETED|Modified OIT Rush Desensitization Phase||0
8705290|NCT00932282|9751297|FG001|NOT COMPLETED|Modified OIT Rush Desensitization Phase||0
8705291|NCT00932282|9751296|FG000|STARTED|Biweekly OIT Buildup Phase||6
8705292|NCT00932282|9751297|FG001|STARTED|Biweekly OIT Buildup Phase||5
8705293|NCT00932282|9751296|FG000|COMPLETED|Biweekly OIT Buildup Phase||5
8705294|NCT00932282|9751297|FG001|COMPLETED|Biweekly OIT Buildup Phase||4
8705295|NCT00932282|9751296|FG000|NOT COMPLETED|Biweekly OIT Buildup Phase||1
8705296|NCT00932282|9751297|FG001|NOT COMPLETED|Biweekly OIT Buildup Phase||1
8705297|NCT00932282|9751296|FG000|STARTED|OIT Maintenance Phase||5
8705298|NCT00932282|9751297|FG001|STARTED|OIT Maintenance Phase||4
8705299|NCT00932282|9751296|FG000|COMPLETED|OIT Maintenance Phase||4
8705300|NCT00932282|9751297|FG001|COMPLETED|OIT Maintenance Phase||2
8705301|NCT00932282|9751296|FG000|NOT COMPLETED|OIT Maintenance Phase||1
8705302|NCT00932282|9751297|FG001|NOT COMPLETED|OIT Maintenance Phase||2
8705303|NCT00932321|9751305|FG000|STARTED|Overall Study||751
8705304|NCT00932321|9751306|FG001|STARTED|Overall Study||187
8705305|NCT00932321|9751305|FG000|MITT Population|Overall Study||705
8705306|NCT00932321|9751306|FG001|MITT Population|Overall Study||181
8705307|NCT00932321|9751305|FG000|COMPLETED|Overall Study||580
8705308|NCT00932321|9751306|FG001|COMPLETED|Overall Study||141
8705309|NCT00932321|9751305|FG000|NOT COMPLETED|Overall Study||171
8705310|NCT00932321|9751306|FG001|NOT COMPLETED|Overall Study||46
8705311|NCT00932360|9751312|FG000|STARTED|1: Visit 1/Week1||10
8705312|NCT00932360|9751313|FG001|STARTED|1: Visit 1/Week1||6
8705313|NCT00932360|9751314|FG002|STARTED|1: Visit 1/Week1||3
8705314|NCT00932360|9751315|FG003|STARTED|1: Visit 1/Week1||13
8705315|NCT00932360|9751316|FG004|STARTED|1: Visit 1/Week1||4
8705316|NCT00932360|9751317|FG005|STARTED|1: Visit 1/Week1||7
8705317|NCT00932360|9751312|FG000|COMPLETED|1: Visit 1/Week1||10
8705318|NCT00932360|9751313|FG001|COMPLETED|1: Visit 1/Week1||6
8705319|NCT00932360|9751314|FG002|COMPLETED|1: Visit 1/Week1||3
8705320|NCT00932360|9751315|FG003|COMPLETED|1: Visit 1/Week1||13
8705321|NCT00932360|9751316|FG004|COMPLETED|1: Visit 1/Week1||4
8705322|NCT00932360|9751317|FG005|COMPLETED|1: Visit 1/Week1||7
8705323|NCT00932360|9751312|FG000|NOT COMPLETED|1: Visit 1/Week1||0
8705324|NCT00932360|9751313|FG001|NOT COMPLETED|1: Visit 1/Week1||0
8705325|NCT00932360|9751314|FG002|NOT COMPLETED|1: Visit 1/Week1||0
8705326|NCT00932360|9751315|FG003|NOT COMPLETED|1: Visit 1/Week1||0
8705327|NCT00932360|9751316|FG004|NOT COMPLETED|1: Visit 1/Week1||0
8705328|NCT00932360|9751317|FG005|NOT COMPLETED|1: Visit 1/Week1||0
8705329|NCT00932360|9751312|FG000|STARTED|Washout (One Week)||10
8705330|NCT00932360|9751313|FG001|STARTED|Washout (One Week)||6
8705331|NCT00932360|9751314|FG002|STARTED|Washout (One Week)||3
8705332|NCT00932360|9751315|FG003|STARTED|Washout (One Week)||13
8705333|NCT00932360|9751316|FG004|STARTED|Washout (One Week)||4
8705334|NCT00932360|9751317|FG005|STARTED|Washout (One Week)||7
8705335|NCT00932360|9751312|FG000|COMPLETED|Washout (One Week)||10
8705336|NCT00932360|9751313|FG001|COMPLETED|Washout (One Week)||6
8705337|NCT00932360|9751314|FG002|COMPLETED|Washout (One Week)||3
8705338|NCT00932360|9751315|FG003|COMPLETED|Washout (One Week)||13
8705339|NCT00932360|9751316|FG004|COMPLETED|Washout (One Week)||2
8705340|NCT00932360|9751317|FG005|COMPLETED|Washout (One Week)||7
8705341|NCT00932360|9751312|FG000|NOT COMPLETED|Washout (One Week)||0
8705342|NCT00932360|9751313|FG001|NOT COMPLETED|Washout (One Week)||0
8705343|NCT00932360|9751314|FG002|NOT COMPLETED|Washout (One Week)||0
8705344|NCT00932360|9751315|FG003|NOT COMPLETED|Washout (One Week)||0
8705345|NCT00932360|9751316|FG004|NOT COMPLETED|Washout (One Week)||2
8705346|NCT00932360|9751317|FG005|NOT COMPLETED|Washout (One Week)||0
8705347|NCT00932360|9751312|FG000|STARTED|Visit 2/Week 2||10
8705348|NCT00932360|9751313|FG001|STARTED|Visit 2/Week 2||6
8705349|NCT00932360|9751314|FG002|STARTED|Visit 2/Week 2||3
8705350|NCT00932360|9751315|FG003|STARTED|Visit 2/Week 2||13
8705351|NCT00932360|9751316|FG004|STARTED|Visit 2/Week 2||2
8705352|NCT00932360|9751317|FG005|STARTED|Visit 2/Week 2||7
8705353|NCT00932360|9751312|FG000|COMPLETED|Visit 2/Week 2||10
8705354|NCT00932360|9751313|FG001|COMPLETED|Visit 2/Week 2||6
8705355|NCT00932360|9751314|FG002|COMPLETED|Visit 2/Week 2||3
8705356|NCT00932360|9751315|FG003|COMPLETED|Visit 2/Week 2||13
8705357|NCT00932360|9751316|FG004|COMPLETED|Visit 2/Week 2||2
8705358|NCT00932360|9751317|FG005|COMPLETED|Visit 2/Week 2||7
8705359|NCT00932360|9751312|FG000|NOT COMPLETED|Visit 2/Week 2||0
8705360|NCT00932360|9751313|FG001|NOT COMPLETED|Visit 2/Week 2||0
8705361|NCT00932360|9751314|FG002|NOT COMPLETED|Visit 2/Week 2||0
8705362|NCT00932360|9751315|FG003|NOT COMPLETED|Visit 2/Week 2||0
8705363|NCT00932360|9751316|FG004|NOT COMPLETED|Visit 2/Week 2||0
8705364|NCT00932360|9751317|FG005|NOT COMPLETED|Visit 2/Week 2||0
8705365|NCT00932360|9751312|FG000|STARTED|Washout (One Week)||10
8705366|NCT00932360|9751313|FG001|STARTED|Washout (One Week)||6
8705367|NCT00932360|9751314|FG002|STARTED|Washout (One Week)||3
8705368|NCT00932360|9751315|FG003|STARTED|Washout (One Week)||13
8705369|NCT00932360|9751316|FG004|STARTED|Washout (One Week)||2
8705370|NCT00932360|9751317|FG005|STARTED|Washout (One Week)||7
8705371|NCT00932360|9751312|FG000|COMPLETED|Washout (One Week)||10
8705372|NCT00932360|9751313|FG001|COMPLETED|Washout (One Week)||6
8705373|NCT00932360|9751314|FG002|COMPLETED|Washout (One Week)||3
8705374|NCT00932360|9751315|FG003|COMPLETED|Washout (One Week)||13
8705375|NCT00932360|9751316|FG004|COMPLETED|Washout (One Week)||2
8705376|NCT00932360|9751317|FG005|COMPLETED|Washout (One Week)||7
8705377|NCT00932360|9751312|FG000|NOT COMPLETED|Washout (One Week)||0
8705378|NCT00932360|9751313|FG001|NOT COMPLETED|Washout (One Week)||0
8705379|NCT00932360|9751314|FG002|NOT COMPLETED|Washout (One Week)||0
8705380|NCT00932360|9751315|FG003|NOT COMPLETED|Washout (One Week)||0
8705381|NCT00932360|9751316|FG004|NOT COMPLETED|Washout (One Week)||0
8705382|NCT00932360|9751317|FG005|NOT COMPLETED|Washout (One Week)||0
8705383|NCT00932360|9751312|FG000|STARTED|Visit 3/Week 3||10
8705384|NCT00932360|9751313|FG001|STARTED|Visit 3/Week 3||6
8705385|NCT00932360|9751314|FG002|STARTED|Visit 3/Week 3||3
8705386|NCT00932360|9751315|FG003|STARTED|Visit 3/Week 3||13
8705387|NCT00932360|9751316|FG004|STARTED|Visit 3/Week 3||2
8705388|NCT00932360|9751317|FG005|STARTED|Visit 3/Week 3||7
8705389|NCT00932360|9751312|FG000|COMPLETED|Visit 3/Week 3||10
8705390|NCT00932360|9751313|FG001|COMPLETED|Visit 3/Week 3||6
8705391|NCT00932360|9751314|FG002|COMPLETED|Visit 3/Week 3||3
8705392|NCT00932360|9751315|FG003|COMPLETED|Visit 3/Week 3||13
8705393|NCT00932360|9751316|FG004|COMPLETED|Visit 3/Week 3||2
8705394|NCT00932360|9751317|FG005|COMPLETED|Visit 3/Week 3||7
8705395|NCT00932360|9751312|FG000|NOT COMPLETED|Visit 3/Week 3||0
8705396|NCT00932360|9751313|FG001|NOT COMPLETED|Visit 3/Week 3||0
8705397|NCT00932360|9751314|FG002|NOT COMPLETED|Visit 3/Week 3||0
8705398|NCT00932360|9751315|FG003|NOT COMPLETED|Visit 3/Week 3||0
8705399|NCT00932360|9751316|FG004|NOT COMPLETED|Visit 3/Week 3||0
8705400|NCT00932360|9751317|FG005|NOT COMPLETED|Visit 3/Week 3||0
8705401|NCT00932373|9751342|FG000|STARTED|Overall Study||3
8705402|NCT00932373|9751343|FG001|STARTED|Overall Study||1
8705403|NCT00932373|9751344|FG002|STARTED|Overall Study||1
8705404|NCT00932373|9751345|FG003|STARTED|Overall Study||1
8705405|NCT00932373|9751346|FG004|STARTED|Overall Study||15
8705406|NCT00932373|9751347|FG005|STARTED|Overall Study||3
8705407|NCT00932373|9751348|FG006|STARTED|Overall Study||3
8705408|NCT00932373|9751349|FG007|STARTED|Overall Study||3
8705409|NCT00932373|9751350|FG008|STARTED|Overall Study||3
8705410|NCT00932373|9751351|FG009|STARTED|Overall Study||16
8705411|NCT00932373|9751352|FG010|STARTED|Overall Study||3
8705412|NCT00932373|9751342|FG000|COMPLETED|Overall Study||0
8705413|NCT00932373|9751343|FG001|COMPLETED|Overall Study||0
8705414|NCT00932373|9751344|FG002|COMPLETED|Overall Study||0
8705415|NCT00932373|9751345|FG003|COMPLETED|Overall Study||1
8705416|NCT00932373|9751346|FG004|COMPLETED|Overall Study||1
8705417|NCT00932373|9751347|FG005|COMPLETED|Overall Study||0
8705418|NCT00932373|9751348|FG006|COMPLETED|Overall Study||2
8705419|NCT00932373|9751349|FG007|COMPLETED|Overall Study||0
8705420|NCT00932373|9751350|FG008|COMPLETED|Overall Study||1
8705421|NCT00932373|9751351|FG009|COMPLETED|Overall Study||3
8705422|NCT00932373|9751352|FG010|COMPLETED|Overall Study||0
8705423|NCT00932373|9751342|FG000|NOT COMPLETED|Overall Study||3
8705424|NCT00932373|9751343|FG001|NOT COMPLETED|Overall Study||1
8705425|NCT00932373|9751344|FG002|NOT COMPLETED|Overall Study||1
8705426|NCT00932373|9751345|FG003|NOT COMPLETED|Overall Study||0
8705427|NCT00932373|9751346|FG004|NOT COMPLETED|Overall Study||14
8705428|NCT00932373|9751347|FG005|NOT COMPLETED|Overall Study||3
8705429|NCT00932373|9751348|FG006|NOT COMPLETED|Overall Study||1
8705430|NCT00932373|9751349|FG007|NOT COMPLETED|Overall Study||3
8705431|NCT00932373|9751350|FG008|NOT COMPLETED|Overall Study||2
8705432|NCT00932373|9751351|FG009|NOT COMPLETED|Overall Study||13
8705433|NCT00932373|9751352|FG010|NOT COMPLETED|Overall Study||3
8705434|NCT00932399|9751386|FG000|STARTED|Overall Study||759
8705435|NCT00932399|9751387|FG001|STARTED|Overall Study||3790
8705436|NCT00932399|9751386|FG000|COMPLETED|Overall Study||759
8705437|NCT00932399|9751387|FG001|COMPLETED|Overall Study||3790
8705438|NCT00932399|9751386|FG000|NOT COMPLETED|Overall Study||0
8705439|NCT00932399|9751387|FG001|NOT COMPLETED|Overall Study||0
8705440|NCT00932425|9751395|FG000|STARTED|Overall Study||20
8705441|NCT00932425|9751396|FG001|STARTED|Overall Study||20
8705442|NCT00932425|9751395|FG000|COMPLETED|Overall Study||20
8705443|NCT00932425|9751396|FG001|COMPLETED|Overall Study||18
8705444|NCT00932425|9751395|FG000|NOT COMPLETED|Overall Study||0
8705445|NCT00932425|9751396|FG001|NOT COMPLETED|Overall Study||2
8705446|NCT00932438|9751404|FG000|STARTED|Overall Study||40
8705447|NCT00932438|9751405|FG001|STARTED|Overall Study||30
8705448|NCT00932438|9751404|FG000|COMPLETED|Overall Study||39
8705449|NCT00932438|9751405|FG001|COMPLETED|Overall Study||30
8705450|NCT00932438|9751404|FG000|NOT COMPLETED|Overall Study||1
8705451|NCT00932438|9751405|FG001|NOT COMPLETED|Overall Study||0
8705452|NCT00932451|9751413|FG000|STARTED|Overall Study||1066
8705453|NCT00932451|9751413|FG000|COMPLETED|Overall Study||244
8705454|NCT00932451|9751413|FG000|NOT COMPLETED|Overall Study||822
8705455|NCT00932477|9751421|FG000|STARTED|Treatment 1||7
8705456|NCT00932477|9751422|FG001|STARTED|Treatment 1||8
8705457|NCT00932477|9751423|FG002|STARTED|Treatment 1||9
8705458|NCT00932477|9751424|FG003|STARTED|Treatment 1||7
8705459|NCT00932477|9751425|FG004|STARTED|Treatment 1||8
8705460|NCT00932477|9751426|FG005|STARTED|Treatment 1||8
8705461|NCT00932477|9751421|FG000|COMPLETED|Treatment 1||7
8705462|NCT00932477|9751422|FG001|COMPLETED|Treatment 1||8
8705463|NCT00932477|9751423|FG002|COMPLETED|Treatment 1||9
8705464|NCT00932477|9751424|FG003|COMPLETED|Treatment 1||7
8705465|NCT00932477|9751425|FG004|COMPLETED|Treatment 1||8
8705466|NCT00932477|9751426|FG005|COMPLETED|Treatment 1||8
8705467|NCT00932477|9751421|FG000|NOT COMPLETED|Treatment 1||0
8705468|NCT00932477|9751422|FG001|NOT COMPLETED|Treatment 1||0
8812867|NCT01522404|9865926|FG000|NOT COMPLETED|Second Intervention (up to Week 58)||1
8705469|NCT00932477|9751423|FG002|NOT COMPLETED|Treatment 1||0
8705470|NCT00932477|9751424|FG003|NOT COMPLETED|Treatment 1||0
8705471|NCT00932477|9751425|FG004|NOT COMPLETED|Treatment 1||0
8705472|NCT00932477|9751426|FG005|NOT COMPLETED|Treatment 1||0
8705473|NCT00932477|9751421|FG000|STARTED|Treatment 2||7
8705474|NCT00932477|9751422|FG001|STARTED|Treatment 2||8
8705475|NCT00932477|9751423|FG002|STARTED|Treatment 2||9
8705476|NCT00932477|9751424|FG003|STARTED|Treatment 2||7
8705477|NCT00932477|9751425|FG004|STARTED|Treatment 2||8
8705478|NCT00932477|9751426|FG005|STARTED|Treatment 2||8
8705479|NCT00932477|9751421|FG000|COMPLETED|Treatment 2||7
8705480|NCT00932477|9751422|FG001|COMPLETED|Treatment 2||8
8705481|NCT00932477|9751423|FG002|COMPLETED|Treatment 2||9
8705482|NCT00932477|9751424|FG003|COMPLETED|Treatment 2||7
8705483|NCT00932477|9751425|FG004|COMPLETED|Treatment 2||8
8705484|NCT00932477|9751426|FG005|COMPLETED|Treatment 2||8
8705485|NCT00932477|9751421|FG000|NOT COMPLETED|Treatment 2||0
8705486|NCT00932477|9751422|FG001|NOT COMPLETED|Treatment 2||0
8705487|NCT00932477|9751423|FG002|NOT COMPLETED|Treatment 2||0
8705488|NCT00932477|9751424|FG003|NOT COMPLETED|Treatment 2||0
8705489|NCT00932477|9751425|FG004|NOT COMPLETED|Treatment 2||0
8705490|NCT00932477|9751426|FG005|NOT COMPLETED|Treatment 2||0
8705491|NCT00932477|9751421|FG000|STARTED|Treatment 3||7
8705492|NCT00932477|9751422|FG001|STARTED|Treatment 3||8
8705493|NCT00932477|9751423|FG002|STARTED|Treatment 3||9
8705494|NCT00932477|9751424|FG003|STARTED|Treatment 3||7
8705495|NCT00932477|9751425|FG004|STARTED|Treatment 3||8
8705496|NCT00932477|9751426|FG005|STARTED|Treatment 3||8
8705497|NCT00932477|9751421|FG000|COMPLETED|Treatment 3||7
8705498|NCT00932477|9751422|FG001|COMPLETED|Treatment 3||8
8705499|NCT00932477|9751423|FG002|COMPLETED|Treatment 3||9
8705500|NCT00932477|9751424|FG003|COMPLETED|Treatment 3||7
8705501|NCT00932477|9751425|FG004|COMPLETED|Treatment 3||8
8705502|NCT00932477|9751426|FG005|COMPLETED|Treatment 3||8
8705503|NCT00932477|9751421|FG000|NOT COMPLETED|Treatment 3||0
8705504|NCT00932477|9751422|FG001|NOT COMPLETED|Treatment 3||0
8705505|NCT00932477|9751423|FG002|NOT COMPLETED|Treatment 3||0
8705506|NCT00932477|9751424|FG003|NOT COMPLETED|Treatment 3||0
8705507|NCT00932477|9751425|FG004|NOT COMPLETED|Treatment 3||0
8705508|NCT00932477|9751426|FG005|NOT COMPLETED|Treatment 3||0
8705509|NCT00932620|9751436|FG000|STARTED|Overall Study||50
8705510|NCT00932620|9751437|FG001|STARTED|Overall Study||50
8705511|NCT00932620|9751436|FG000|COMPLETED|Overall Study||50
8705512|NCT00932620|9751437|FG001|COMPLETED|Overall Study||50
8705513|NCT00932620|9751436|FG000|NOT COMPLETED|Overall Study||0
8705514|NCT00932620|9751437|FG001|NOT COMPLETED|Overall Study||0
8705515|NCT00932646|9751445|FG000|STARTED|Overall Study||25
8705516|NCT00932646|9751446|FG001|STARTED|Overall Study||25
8705517|NCT00932646|9751447|FG002|STARTED|Overall Study||25
8705518|NCT00932646|9751448|FG003|STARTED|Overall Study||25
8705519|NCT00932646|9751445|FG000|COMPLETED|Overall Study||20
8705520|NCT00932646|9751446|FG001|COMPLETED|Overall Study||22
8705521|NCT00932646|9751447|FG002|COMPLETED|Overall Study||21
8705522|NCT00932646|9751448|FG003|COMPLETED|Overall Study||24
8705523|NCT00932646|9751445|FG000|NOT COMPLETED|Overall Study||5
8705524|NCT00932646|9751446|FG001|NOT COMPLETED|Overall Study||3
8705525|NCT00932646|9751447|FG002|NOT COMPLETED|Overall Study||4
8705526|NCT00932646|9751448|FG003|NOT COMPLETED|Overall Study||1
8705527|NCT00932659|9751462|FG000|STARTED|Overall Study||8
8705528|NCT00932659|9751462|FG000|COMPLETED|Overall Study||8
8705529|NCT00932659|9751462|FG000|NOT COMPLETED|Overall Study||0
8705530|NCT00932698|9751477|FG000|STARTED|Part 1 (Dose Escalation)||3
8705531|NCT00932698|9751478|FG001|STARTED|Part 1 (Dose Escalation)||3
8705532|NCT00932698|9751479|FG002|STARTED|Part 1 (Dose Escalation)||3
8705533|NCT00932698|9751480|FG003|STARTED|Part 1 (Dose Escalation)||3
8705534|NCT00932698|9751481|FG004|STARTED|Part 1 (Dose Escalation)||3
8705535|NCT00932698|9751482|FG005|STARTED|Part 1 (Dose Escalation)||7
8705536|NCT00932698|9751483|FG006|STARTED|Part 1 (Dose Escalation)||4
8705537|NCT00932698|9751484|FG007|STARTED|Part 1 (Dose Escalation)||0
8705538|NCT00932698|9751485|FG008|STARTED|Part 1 (Dose Escalation)||0
8705539|NCT00932698|9751486|FG009|STARTED|Part 1 (Dose Escalation)||0
8705540|NCT00932698|9751487|FG010|STARTED|Part 1 (Dose Escalation)||0
8705541|NCT00932698|9751477|FG000|COMPLETED|Part 1 (Dose Escalation)||0
8705542|NCT00932698|9751478|FG001|COMPLETED|Part 1 (Dose Escalation)||0
8705543|NCT00932698|9751479|FG002|COMPLETED|Part 1 (Dose Escalation)||0
8705544|NCT00932698|9751480|FG003|COMPLETED|Part 1 (Dose Escalation)||0
8705545|NCT00932698|9751481|FG004|COMPLETED|Part 1 (Dose Escalation)||0
8705546|NCT00932698|9751482|FG005|COMPLETED|Part 1 (Dose Escalation)|6 participants from 2.0 mg/m^2 dose cohort transitioned to dose expansion cohort: 5 in RR, 1 in VR.|0
8705547|NCT00932698|9751483|FG006|COMPLETED|Part 1 (Dose Escalation)||0
8705548|NCT00932698|9751484|FG007|COMPLETED|Part 1 (Dose Escalation)||0
8705549|NCT00932698|9751485|FG008|COMPLETED|Part 1 (Dose Escalation)||0
8705550|NCT00932698|9751486|FG009|COMPLETED|Part 1 (Dose Escalation)||0
8705551|NCT00932698|9751487|FG010|COMPLETED|Part 1 (Dose Escalation)||0
8705552|NCT00932698|9751477|FG000|NOT COMPLETED|Part 1 (Dose Escalation)||3
8705553|NCT00932698|9751478|FG001|NOT COMPLETED|Part 1 (Dose Escalation)||3
8705554|NCT00932698|9751479|FG002|NOT COMPLETED|Part 1 (Dose Escalation)||3
8705555|NCT00932698|9751480|FG003|NOT COMPLETED|Part 1 (Dose Escalation)||3
8705556|NCT00932698|9751481|FG004|NOT COMPLETED|Part 1 (Dose Escalation)||3
8705557|NCT00932698|9751482|FG005|NOT COMPLETED|Part 1 (Dose Escalation)||7
8705558|NCT00932698|9751483|FG006|NOT COMPLETED|Part 1 (Dose Escalation)||4
8705559|NCT00932698|9751484|FG007|NOT COMPLETED|Part 1 (Dose Escalation)||0
8705560|NCT00932698|9751485|FG008|NOT COMPLETED|Part 1 (Dose Escalation)||0
8705561|NCT00932698|9751486|FG009|NOT COMPLETED|Part 1 (Dose Escalation)||0
8705562|NCT00932698|9751487|FG010|NOT COMPLETED|Part 1 (Dose Escalation)||0
8705563|NCT00932698|9751477|FG000|STARTED|Part 2 (Dose Expansion)||0
8705564|NCT00932698|9751478|FG001|STARTED|Part 2 (Dose Expansion)||0
8705565|NCT00932698|9751479|FG002|STARTED|Part 2 (Dose Expansion)||0
8705566|NCT00932698|9751480|FG003|STARTED|Part 2 (Dose Expansion)||0
8705567|NCT00932698|9751481|FG004|STARTED|Part 2 (Dose Expansion)||0
8705568|NCT00932698|9751482|FG005|STARTED|Part 2 (Dose Expansion)||0
8705569|NCT00932698|9751483|FG006|STARTED|Part 2 (Dose Expansion)||0
8705570|NCT00932698|9751484|FG007|STARTED|Part 2 (Dose Expansion)||20
8705571|NCT00932698|9751485|FG008|STARTED|Part 2 (Dose Expansion)||12
8705572|NCT00932698|9751486|FG009|STARTED|Part 2 (Dose Expansion)||6
8705573|NCT00932698|9751487|FG010|STARTED|Part 2 (Dose Expansion)||2
8705574|NCT00932698|9751477|FG000|COMPLETED|Part 2 (Dose Expansion)||0
8705575|NCT00932698|9751478|FG001|COMPLETED|Part 2 (Dose Expansion)||0
8705576|NCT00932698|9751479|FG002|COMPLETED|Part 2 (Dose Expansion)||0
8705577|NCT00932698|9751480|FG003|COMPLETED|Part 2 (Dose Expansion)||0
8705578|NCT00932698|9751481|FG004|COMPLETED|Part 2 (Dose Expansion)||0
8557397|NCT00002540|9589272|FG001|NOT COMPLETED|Overall Study||2464
8557398|NCT00002558|9589280|FG000|STARTED|Overall Study||92
8557399|NCT00002558|9589281|FG001|STARTED|Overall Study||16
8557400|NCT00002558|9589280|FG000|COMPLETED|Overall Study||92
8557401|NCT00002558|9589281|FG001|COMPLETED|Overall Study||15
8557402|NCT00002558|9589280|FG000|NOT COMPLETED|Overall Study||0
8557403|NCT00002558|9589281|FG001|NOT COMPLETED|Overall Study||1
8557404|NCT00002597|9589289|FG000|STARTED|Overall Study||1013
8557405|NCT00002597|9589290|FG001|STARTED|Overall Study||1015
8557406|NCT00002597|9589289|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|987
8557407|NCT00002597|9589290|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|992
8705579|NCT00932698|9751482|FG005|COMPLETED|Part 2 (Dose Expansion)||0
8705580|NCT00932698|9751483|FG006|COMPLETED|Part 2 (Dose Expansion)||0
8705581|NCT00932698|9751484|FG007|COMPLETED|Part 2 (Dose Expansion)||0
8705582|NCT00932698|9751485|FG008|COMPLETED|Part 2 (Dose Expansion)||0
8705583|NCT00932698|9751486|FG009|COMPLETED|Part 2 (Dose Expansion)||0
8705584|NCT00932698|9751487|FG010|COMPLETED|Part 2 (Dose Expansion)||0
8705585|NCT00932698|9751477|FG000|NOT COMPLETED|Part 2 (Dose Expansion)||0
8705586|NCT00932698|9751478|FG001|NOT COMPLETED|Part 2 (Dose Expansion)||0
8705587|NCT00932698|9751479|FG002|NOT COMPLETED|Part 2 (Dose Expansion)||0
8705588|NCT00932698|9751480|FG003|NOT COMPLETED|Part 2 (Dose Expansion)||0
8705589|NCT00932698|9751481|FG004|NOT COMPLETED|Part 2 (Dose Expansion)||0
8705590|NCT00932698|9751482|FG005|NOT COMPLETED|Part 2 (Dose Expansion)||0
8705591|NCT00932698|9751483|FG006|NOT COMPLETED|Part 2 (Dose Expansion)||0
8705592|NCT00932698|9751484|FG007|NOT COMPLETED|Part 2 (Dose Expansion)||20
8705593|NCT00932698|9751485|FG008|NOT COMPLETED|Part 2 (Dose Expansion)||12
8705594|NCT00932698|9751486|FG009|NOT COMPLETED|Part 2 (Dose Expansion)||6
8705595|NCT00932698|9751487|FG010|NOT COMPLETED|Part 2 (Dose Expansion)||2
8705596|NCT00932828|9751513|FG000|STARTED|Overall Study||37
8705597|NCT00932828|9751513|FG000|COMPLETED|Overall Study|5 subjects who did not complete the protocol were considered in an ITT analysis.|32
8705598|NCT00932828|9751513|FG000|NOT COMPLETED|Overall Study||5
8705599|NCT00932893|9751519|FG000|STARTED|Overall Study||173
8705600|NCT00932893|9751520|FG001|STARTED|Overall Study||174
8705601|NCT00932893|9751519|FG000|Treated|Overall Study||172
8705602|NCT00932893|9751520|FG001|Treated|Overall Study||171
8705603|NCT00932893|9751519|FG000|COMPLETED|Overall Study||40
8705604|NCT00932893|9751520|FG001|COMPLETED|Overall Study||4
8705605|NCT00932893|9751519|FG000|NOT COMPLETED|Overall Study||133
8705606|NCT00932893|9751520|FG001|NOT COMPLETED|Overall Study||170
8705607|NCT00933166|9751527|FG000|STARTED|Overall Study||169
8705608|NCT00933166|9751527|FG000|COMPLETED|Overall Study||151
8705609|NCT00933166|9751527|FG000|NOT COMPLETED|Overall Study||18
8705610|NCT00933244|9751534|FG000|STARTED|Overall Study||79
8705611|NCT00933244|9751535|FG001|STARTED|Overall Study||75
8705612|NCT00933244|9751536|FG002|STARTED|Overall Study||76
8705613|NCT00933244|9751534|FG000|COMPLETED|Overall Study||74
8705614|NCT00933244|9751535|FG001|COMPLETED|Overall Study||74
8705615|NCT00933244|9751536|FG002|COMPLETED|Overall Study||73
8705616|NCT00933244|9751534|FG000|NOT COMPLETED|Overall Study||5
8705617|NCT00933244|9751535|FG001|NOT COMPLETED|Overall Study||1
8705618|NCT00933244|9751536|FG002|NOT COMPLETED|Overall Study||3
8705619|NCT00933270|9751544|FG000|STARTED|Overall Study|ITT population|264
8705620|NCT00933270|9751544|FG000|COMPLETED|Overall Study||177
8705621|NCT00933270|9751544|FG000|NOT COMPLETED|Overall Study||87
8705622|NCT00933335|9751551|FG000|STARTED|Overall Study||2
8705623|NCT00933335|9751552|FG001|STARTED|Overall Study|35/36 participants who received 3 cycles of fludarabine later received a DD and TD of TST/I 131 TST.|36
8705624|NCT00933335|9751551|FG000|COMPLETED|Overall Study||0
8705625|NCT00933335|9751552|FG001|COMPLETED|Overall Study||20
8705626|NCT00933335|9751551|FG000|NOT COMPLETED|Overall Study||2
8705627|NCT00933335|9751552|FG001|NOT COMPLETED|Overall Study||16
8705628|NCT00933491|9751566|FG000|STARTED|Overall Study||14
8705629|NCT00933491|9751567|FG001|STARTED|Overall Study||18
8705630|NCT00933491|9751566|FG000|COMPLETED|Overall Study||14
8705631|NCT00933491|9751567|FG001|COMPLETED|Overall Study||18
8705632|NCT00933491|9751566|FG000|NOT COMPLETED|Overall Study||0
8705633|NCT00933491|9751567|FG001|NOT COMPLETED|Overall Study||0
8705634|NCT00933543|9751575|FG000|STARTED|Overall Study||54
8705635|NCT00933543|9751576|FG001|STARTED|Overall Study||53
8705636|NCT00933543|9751575|FG000|COMPLETED|Overall Study||51
8705637|NCT00933543|9751576|FG001|COMPLETED|Overall Study||46
8705638|NCT00933543|9751575|FG000|NOT COMPLETED|Overall Study||3
8705639|NCT00933543|9751576|FG001|NOT COMPLETED|Overall Study||7
8705640|NCT00933608|9751584|FG000|STARTED|Overall Study||7
8705641|NCT00933608|9751585|FG001|STARTED|Overall Study||10
8705642|NCT00933608|9751584|FG000|COMPLETED|Overall Study||2
8705643|NCT00933608|9751585|FG001|COMPLETED|Overall Study||8
8705644|NCT00933608|9751584|FG000|NOT COMPLETED|Overall Study||5
8705645|NCT00933608|9751585|FG001|NOT COMPLETED|Overall Study||2
8705646|NCT00933686|9751593|FG000|STARTED|Overall Study||55
8705647|NCT00933686|9751594|FG001|STARTED|Overall Study||58
8705648|NCT00933686|9751593|FG000|COMPLETED|Overall Study||45
8705649|NCT00933686|9751594|FG001|COMPLETED|Overall Study||47
8705650|NCT00933686|9751593|FG000|NOT COMPLETED|Overall Study||10
8705651|NCT00933686|9751594|FG001|NOT COMPLETED|Overall Study||11
8705652|NCT00933933|9751605|FG000|STARTED|General Population From 16 to 89 Years||6164
8705653|NCT00933933|9751606|FG001|STARTED|General Population From 16 to 89 Years||1287
8705654|NCT00933933|9751607|FG002|STARTED|General Population From 16 to 89 Years||1206
8705655|NCT00933933|9751605|FG000|COMPLETED|General Population From 16 to 89 Years||6164
8705656|NCT00933933|9751606|FG001|COMPLETED|General Population From 16 to 89 Years||1267
8705657|NCT00933933|9751607|FG002|COMPLETED|General Population From 16 to 89 Years||1206
8705658|NCT00933933|9751605|FG000|NOT COMPLETED|General Population From 16 to 89 Years||0
8705659|NCT00933933|9751606|FG001|NOT COMPLETED|General Population From 16 to 89 Years||20
8725183|NCT01029704|9772384|FG006|STARTED|Overall Study||23
8705660|NCT00933933|9751607|FG002|NOT COMPLETED|General Population From 16 to 89 Years||0
8705661|NCT00933933|9751605|FG000|STARTED|Pregnant Females Between 16-44 Years||448
8705662|NCT00933933|9751606|FG001|STARTED|Pregnant Females Between 16-44 Years||67
8705663|NCT00933933|9751607|FG002|STARTED|Pregnant Females Between 16-44 Years||203
8705664|NCT00933933|9751605|FG000|COMPLETED|Pregnant Females Between 16-44 Years||448
8705665|NCT00933933|9751606|FG001|COMPLETED|Pregnant Females Between 16-44 Years||65
8705666|NCT00933933|9751607|FG002|COMPLETED|Pregnant Females Between 16-44 Years||203
8705667|NCT00933933|9751605|FG000|NOT COMPLETED|Pregnant Females Between 16-44 Years||0
8705668|NCT00933933|9751606|FG001|NOT COMPLETED|Pregnant Females Between 16-44 Years||2
8705669|NCT00933933|9751607|FG002|NOT COMPLETED|Pregnant Females Between 16-44 Years||0
8705670|NCT00933933|9751605|FG000|STARTED|Pediatric From 2 to 21 Years||588
8705671|NCT00933933|9751606|FG001|STARTED|Pediatric From 2 to 21 Years||64
8705672|NCT00933933|9751607|FG002|STARTED|Pediatric From 2 to 21 Years|Specimens from individuals 16-21 years included reactivity for general population or pregnant women.|0
8705673|NCT00933933|9751605|FG000|COMPLETED|Pediatric From 2 to 21 Years||588
8705674|NCT00933933|9751606|FG001|COMPLETED|Pediatric From 2 to 21 Years||64
8705675|NCT00933933|9751607|FG002|COMPLETED|Pediatric From 2 to 21 Years|Specimens from individuals 16-21 years included reactivity for general population or pregnant women|0
8705676|NCT00933933|9751605|FG000|NOT COMPLETED|Pediatric From 2 to 21 Years||0
8705677|NCT00933933|9751606|FG001|NOT COMPLETED|Pediatric From 2 to 21 Years||0
8705678|NCT00933933|9751607|FG002|NOT COMPLETED|Pediatric From 2 to 21 Years||0
8705679|NCT00934024|9751625|FG000|STARTED|Overall Study||10
8705680|NCT00934024|9751626|FG001|STARTED|Overall Study||11
8705681|NCT00934024|9751625|FG000|COMPLETED|Overall Study||10
8705682|NCT00934024|9751626|FG001|COMPLETED|Overall Study||6
8705683|NCT00934024|9751625|FG000|NOT COMPLETED|Overall Study||0
8705684|NCT00934024|9751626|FG001|NOT COMPLETED|Overall Study||5
8705685|NCT00934050|9751637|FG000|STARTED|Enrolled Prior to 15 Dec 2009||12
8705686|NCT00934050|9751638|FG001|STARTED|Enrolled Prior to 15 Dec 2009||12
8705687|NCT00934050|9751639|FG002|STARTED|Enrolled Prior to 15 Dec 2009||12
8705688|NCT00934050|9751640|FG003|STARTED|Enrolled Prior to 15 Dec 2009||14
8705689|NCT00934050|9751641|FG004|STARTED|Enrolled Prior to 15 Dec 2009||0
8705690|NCT00934050|9751642|FG005|STARTED|Enrolled Prior to 15 Dec 2009||0
8705691|NCT00934050|9751637|FG000|COMPLETED|Enrolled Prior to 15 Dec 2009||0
8705692|NCT00934050|9751638|FG001|COMPLETED|Enrolled Prior to 15 Dec 2009||0
8705693|NCT00934050|9751639|FG002|COMPLETED|Enrolled Prior to 15 Dec 2009||0
8705694|NCT00934050|9751640|FG003|COMPLETED|Enrolled Prior to 15 Dec 2009||0
8705695|NCT00934050|9751641|FG004|COMPLETED|Enrolled Prior to 15 Dec 2009||0
8705696|NCT00934050|9751642|FG005|COMPLETED|Enrolled Prior to 15 Dec 2009||0
8705697|NCT00934050|9751637|FG000|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||12
8705698|NCT00934050|9751638|FG001|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||12
8705699|NCT00934050|9751639|FG002|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||12
8705700|NCT00934050|9751640|FG003|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||14
8705701|NCT00934050|9751641|FG004|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||0
8705702|NCT00934050|9751642|FG005|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||0
8705703|NCT00934050|9751637|FG000|STARTED|Enrolled After 15 Dec 2009||0
8705704|NCT00934050|9751638|FG001|STARTED|Enrolled After 15 Dec 2009||0
8705705|NCT00934050|9751639|FG002|STARTED|Enrolled After 15 Dec 2009||0
8705706|NCT00934050|9751640|FG003|STARTED|Enrolled After 15 Dec 2009||0
8705707|NCT00934050|9751641|FG004|STARTED|Enrolled After 15 Dec 2009||26
8705708|NCT00934050|9751642|FG005|STARTED|Enrolled After 15 Dec 2009||27
8705709|NCT00934050|9751637|FG000|COMPLETED|Enrolled After 15 Dec 2009||0
8705710|NCT00934050|9751638|FG001|COMPLETED|Enrolled After 15 Dec 2009||0
8705711|NCT00934050|9751639|FG002|COMPLETED|Enrolled After 15 Dec 2009||0
8705712|NCT00934050|9751640|FG003|COMPLETED|Enrolled After 15 Dec 2009||0
8705713|NCT00934050|9751641|FG004|COMPLETED|Enrolled After 15 Dec 2009||19
8705714|NCT00934050|9751642|FG005|COMPLETED|Enrolled After 15 Dec 2009||23
8705715|NCT00934050|9751637|FG000|NOT COMPLETED|Enrolled After 15 Dec 2009||0
8705716|NCT00934050|9751638|FG001|NOT COMPLETED|Enrolled After 15 Dec 2009||0
8705717|NCT00934050|9751639|FG002|NOT COMPLETED|Enrolled After 15 Dec 2009||0
8705718|NCT00934050|9751640|FG003|NOT COMPLETED|Enrolled After 15 Dec 2009||0
8705719|NCT00934050|9751641|FG004|NOT COMPLETED|Enrolled After 15 Dec 2009||7
8705720|NCT00934050|9751642|FG005|NOT COMPLETED|Enrolled After 15 Dec 2009||4
8705721|NCT00934089|9751654|FG000|STARTED|First Intervention Period (14 Days)||15
8705722|NCT00934089|9751655|FG001|STARTED|First Intervention Period (14 Days)||16
8705723|NCT00934089|9751654|FG000|Treated|First Intervention Period (14 Days)||14
8705724|NCT00934089|9751655|FG001|Treated|First Intervention Period (14 Days)||16
8705725|NCT00934089|9751654|FG000|COMPLETED|First Intervention Period (14 Days)||13
8705726|NCT00934089|9751655|FG001|COMPLETED|First Intervention Period (14 Days)||16
8705727|NCT00934089|9751654|FG000|NOT COMPLETED|First Intervention Period (14 Days)||2
8705728|NCT00934089|9751655|FG001|NOT COMPLETED|First Intervention Period (14 Days)||0
8705729|NCT00934089|9751654|FG000|STARTED|Washout Period (28 Days)||13
8705730|NCT00934089|9751655|FG001|STARTED|Washout Period (28 Days)||16
8705731|NCT00934089|9751654|FG000|COMPLETED|Washout Period (28 Days)||13
8705732|NCT00934089|9751655|FG001|COMPLETED|Washout Period (28 Days)||16
8705733|NCT00934089|9751654|FG000|NOT COMPLETED|Washout Period (28 Days)||0
8705734|NCT00934089|9751655|FG001|NOT COMPLETED|Washout Period (28 Days)||0
8705735|NCT00934089|9751654|FG000|STARTED|Second Intervention Period (14 Days)||13
8705736|NCT00934089|9751655|FG001|STARTED|Second Intervention Period (14 Days)||16
8705737|NCT00934089|9751654|FG000|COMPLETED|Second Intervention Period (14 Days)||13
8705738|NCT00934089|9751655|FG001|COMPLETED|Second Intervention Period (14 Days)||16
8705739|NCT00934089|9751654|FG000|NOT COMPLETED|Second Intervention Period (14 Days)||0
8705740|NCT00934089|9751655|FG001|NOT COMPLETED|Second Intervention Period (14 Days)||0
8705741|NCT00934102|9751661|FG000|STARTED|Period 1, One Night of Wear||16
8705742|NCT00934102|9751662|FG001|STARTED|Period 1, One Night of Wear||15
8705743|NCT00934102|9751663|FG002|STARTED|Period 1, One Night of Wear||15
8705744|NCT00934102|9751661|FG000|COMPLETED|Period 1, One Night of Wear||15
8705745|NCT00934102|9751662|FG001|COMPLETED|Period 1, One Night of Wear||15
8705746|NCT00934102|9751663|FG002|COMPLETED|Period 1, One Night of Wear||15
8705747|NCT00934102|9751661|FG000|NOT COMPLETED|Period 1, One Night of Wear||1
8705748|NCT00934102|9751662|FG001|NOT COMPLETED|Period 1, One Night of Wear||0
8705749|NCT00934102|9751663|FG002|NOT COMPLETED|Period 1, One Night of Wear||0
8705750|NCT00934102|9751661|FG000|STARTED|Period 2, 7 Days/6 Nights of Wear||15
8705751|NCT00934102|9751662|FG001|STARTED|Period 2, 7 Days/6 Nights of Wear||15
8705752|NCT00934102|9751663|FG002|STARTED|Period 2, 7 Days/6 Nights of Wear||15
8705753|NCT00934102|9751661|FG000|COMPLETED|Period 2, 7 Days/6 Nights of Wear||15
8705754|NCT00934102|9751662|FG001|COMPLETED|Period 2, 7 Days/6 Nights of Wear||15
8705755|NCT00934102|9751663|FG002|COMPLETED|Period 2, 7 Days/6 Nights of Wear||15
8705756|NCT00934102|9751661|FG000|NOT COMPLETED|Period 2, 7 Days/6 Nights of Wear||0
8705757|NCT00934102|9751662|FG001|NOT COMPLETED|Period 2, 7 Days/6 Nights of Wear||0
8705758|NCT00934102|9751663|FG002|NOT COMPLETED|Period 2, 7 Days/6 Nights of Wear||0
8705759|NCT00934128|9751673|FG000|STARTED|First Intervention (2 Hours)||15
8705760|NCT00934128|9751674|FG001|STARTED|First Intervention (2 Hours)||15
8705761|NCT00934128|9751673|FG000|COMPLETED|First Intervention (2 Hours)||10
8705762|NCT00934128|9751674|FG001|COMPLETED|First Intervention (2 Hours)||13
8705763|NCT00934128|9751673|FG000|NOT COMPLETED|First Intervention (2 Hours)||5
8705764|NCT00934128|9751674|FG001|NOT COMPLETED|First Intervention (2 Hours)||2
8705765|NCT00934128|9751673|FG000|STARTED|Washout Period (1 Hour)||10
8705766|NCT00934128|9751674|FG001|STARTED|Washout Period (1 Hour)||13
8705767|NCT00934128|9751673|FG000|COMPLETED|Washout Period (1 Hour)||3
8705768|NCT00934128|9751674|FG001|COMPLETED|Washout Period (1 Hour)||8
8705769|NCT00934128|9751673|FG000|NOT COMPLETED|Washout Period (1 Hour)||7
8705770|NCT00934128|9751674|FG001|NOT COMPLETED|Washout Period (1 Hour)||5
8705771|NCT00934128|9751673|FG000|STARTED|Second Intervention (2 Hours)||3
8705772|NCT00934128|9751674|FG001|STARTED|Second Intervention (2 Hours)||8
8705773|NCT00934128|9751673|FG000|COMPLETED|Second Intervention (2 Hours)||3
8705774|NCT00934128|9751674|FG001|COMPLETED|Second Intervention (2 Hours)||5
8705775|NCT00934128|9751673|FG000|NOT COMPLETED|Second Intervention (2 Hours)||0
8705776|NCT00934128|9751674|FG001|NOT COMPLETED|Second Intervention (2 Hours)||3
8705777|NCT00934141|9751684|FG000|STARTED|Overall Study||49
8705778|NCT00934141|9751685|FG001|STARTED|Overall Study||50
8705779|NCT00934141|9751686|FG002|STARTED|Overall Study||48
8705780|NCT00934141|9751687|FG003|STARTED|Overall Study||54
8705781|NCT00934141|9751684|FG000|COMPLETED|Overall Study||45
8705782|NCT00934141|9751685|FG001|COMPLETED|Overall Study||47
8705783|NCT00934141|9751686|FG002|COMPLETED|Overall Study||48
8705784|NCT00934141|9751687|FG003|COMPLETED|Overall Study||51
8705785|NCT00934141|9751684|FG000|NOT COMPLETED|Overall Study||4
8705786|NCT00934141|9751685|FG001|NOT COMPLETED|Overall Study||3
8705787|NCT00934141|9751686|FG002|NOT COMPLETED|Overall Study||0
8705788|NCT00934141|9751687|FG003|NOT COMPLETED|Overall Study||3
8705789|NCT00934362|9751701|FG000|STARTED|Overall Study||8
8705790|NCT00934362|9751702|FG001|STARTED|Overall Study||8
8705791|NCT00934362|9751701|FG000|COMPLETED|Overall Study||7
8705792|NCT00934362|9751702|FG001|COMPLETED|Overall Study||8
8705793|NCT00934362|9751701|FG000|NOT COMPLETED|Overall Study||1
8705794|NCT00934362|9751702|FG001|NOT COMPLETED|Overall Study||0
8705795|NCT00934375|9751710|FG000|STARTED|Overall Study||68
8705796|NCT00934375|9751711|FG001|STARTED|Overall Study||77
8705797|NCT00934375|9751710|FG000|COMPLETED|Overall Study||55
8705798|NCT00934375|9751711|FG001|COMPLETED|Overall Study||55
8705799|NCT00934375|9751710|FG000|NOT COMPLETED|Overall Study||13
8705800|NCT00934375|9751711|FG001|NOT COMPLETED|Overall Study||22
8705801|NCT00934440|9751717|FG000|STARTED|Overall Study||11
8705802|NCT00934440|9751717|FG000|COMPLETED|Overall Study||10
8705803|NCT00934440|9751717|FG000|NOT COMPLETED|Overall Study||1
8705804|NCT00934544|9751724|FG000|STARTED|Primary Endpoint Analysis (Interim)||146
8705805|NCT00934544|9751725|FG001|STARTED|Primary Endpoint Analysis (Interim)||73
8705806|NCT00934544|9751726|FG002|STARTED|Primary Endpoint Analysis (Interim)||0
8705807|NCT00934544|9751724|FG000|COMPLETED|Primary Endpoint Analysis (Interim)||91
8705808|NCT00934544|9751725|FG001|COMPLETED|Primary Endpoint Analysis (Interim)||31
8705809|NCT00934544|9751726|FG002|COMPLETED|Primary Endpoint Analysis (Interim)||0
8705810|NCT00934544|9751724|FG000|NOT COMPLETED|Primary Endpoint Analysis (Interim)||55
8705811|NCT00934544|9751725|FG001|NOT COMPLETED|Primary Endpoint Analysis (Interim)||42
8705812|NCT00934544|9751726|FG002|NOT COMPLETED|Primary Endpoint Analysis (Interim)||0
8928078|NCT02278328|9989243|FG002|STARTED|Neuropsych Screening||8
8928079|NCT02278328|9989241|FG000|COMPLETED|Neuropsych Screening||9
8928080|NCT02278328|9989242|FG001|COMPLETED|Neuropsych Screening||6
8928081|NCT02278328|9989243|FG002|COMPLETED|Neuropsych Screening||6
8705813|NCT00934544|9751724|FG000|STARTED|Overall Disposition at 5 Year Follow-up||146
8705814|NCT00934544|9751725|FG001|STARTED|Overall Disposition at 5 Year Follow-up||28
8705815|NCT00934544|9751726|FG002|STARTED|Overall Disposition at 5 Year Follow-up||45
8705816|NCT00934544|9751724|FG000|Crossed Over After Qualifying Event|Overall Disposition at 5 Year Follow-up||0
8705817|NCT00934544|9751725|FG001|Crossed Over After Qualifying Event|Overall Disposition at 5 Year Follow-up||0
8705818|NCT00934544|9751726|FG002|Crossed Over After Qualifying Event|Overall Disposition at 5 Year Follow-up||27
8705819|NCT00934544|9751724|FG000|Crossed Over After AMEND 5|Overall Disposition at 5 Year Follow-up||0
8705820|NCT00934544|9751725|FG001|Crossed Over After AMEND 5|Overall Disposition at 5 Year Follow-up||0
8705821|NCT00934544|9751726|FG002|Crossed Over After AMEND 5|Overall Disposition at 5 Year Follow-up||12
8705822|NCT00934544|9751724|FG000|Crossed Over: Other|Overall Disposition at 5 Year Follow-up||0
8705823|NCT00934544|9751725|FG001|Crossed Over: Other|Overall Disposition at 5 Year Follow-up||0
8705824|NCT00934544|9751726|FG002|Crossed Over: Other|Overall Disposition at 5 Year Follow-up||6
8705825|NCT00934544|9751724|FG000|COMPLETED|Overall Disposition at 5 Year Follow-up||39
8705826|NCT00934544|9751725|FG001|COMPLETED|Overall Disposition at 5 Year Follow-up||0
8705827|NCT00934544|9751726|FG002|COMPLETED|Overall Disposition at 5 Year Follow-up||11
8705828|NCT00934544|9751724|FG000|NOT COMPLETED|Overall Disposition at 5 Year Follow-up||107
8705829|NCT00934544|9751725|FG001|NOT COMPLETED|Overall Disposition at 5 Year Follow-up||28
8705830|NCT00934544|9751726|FG002|NOT COMPLETED|Overall Disposition at 5 Year Follow-up||34
8705831|NCT00934596|9751745|FG000|STARTED|Overall Study|Twenty patients were prospectively randomly assigned to the two arms|10
8705832|NCT00934596|9751746|FG001|STARTED|Overall Study||10
8705833|NCT00934596|9751745|FG000|COMPLETED|Overall Study||10
8705834|NCT00934596|9751746|FG001|COMPLETED|Overall Study||10
8705835|NCT00934596|9751745|FG000|NOT COMPLETED|Overall Study||0
8705836|NCT00934596|9751746|FG001|NOT COMPLETED|Overall Study||0
8705837|NCT00934622|9751756|FG000|STARTED|Overall Study||76
8705838|NCT00934622|9751756|FG000|COMPLETED|Overall Study||68
8705839|NCT00934622|9751756|FG000|NOT COMPLETED|Overall Study||8
8705840|NCT00934635|9751769|FG000|STARTED|Overall Study||0
8705841|NCT00934635|9751770|FG001|STARTED|Overall Study||1
8705842|NCT00934635|9751771|FG002|STARTED|Overall Study||0
8705843|NCT00934635|9751772|FG003|STARTED|Overall Study||0
8705844|NCT00934635|9751773|FG004|STARTED|Overall Study||0
8705845|NCT00934635|9751774|FG005|STARTED|Overall Study||0
8705846|NCT00934635|9751775|FG006|STARTED|Overall Study||0
8705847|NCT00934635|9751776|FG007|STARTED|Overall Study||0
8705848|NCT00934635|9751777|FG008|STARTED|Overall Study||1
8705849|NCT00934635|9751769|FG000|COMPLETED|Overall Study||0
8705850|NCT00934635|9751770|FG001|COMPLETED|Overall Study||1
8705851|NCT00934635|9751771|FG002|COMPLETED|Overall Study||0
8705852|NCT00934635|9751772|FG003|COMPLETED|Overall Study||0
8705853|NCT00934635|9751773|FG004|COMPLETED|Overall Study||0
8705854|NCT00934635|9751774|FG005|COMPLETED|Overall Study||0
8705855|NCT00934635|9751775|FG006|COMPLETED|Overall Study||0
8705856|NCT00934635|9751776|FG007|COMPLETED|Overall Study||0
8705857|NCT00934635|9751777|FG008|COMPLETED|Overall Study||1
8705858|NCT00934635|9751769|FG000|NOT COMPLETED|Overall Study||0
8705859|NCT00934635|9751770|FG001|NOT COMPLETED|Overall Study||0
8705860|NCT00934635|9751771|FG002|NOT COMPLETED|Overall Study||0
8705861|NCT00934635|9751772|FG003|NOT COMPLETED|Overall Study||0
8705862|NCT00934635|9751773|FG004|NOT COMPLETED|Overall Study||0
8705863|NCT00934635|9751774|FG005|NOT COMPLETED|Overall Study||0
8705864|NCT00934635|9751775|FG006|NOT COMPLETED|Overall Study||0
8705865|NCT00934635|9751776|FG007|NOT COMPLETED|Overall Study||0
8705866|NCT00934635|9751777|FG008|NOT COMPLETED|Overall Study||0
8705867|NCT00934648|9751797|FG000|STARTED|Overall Study||15
8705868|NCT00934648|9751797|FG000|COMPLETED|Overall Study||6
8705869|NCT00934648|9751797|FG000|NOT COMPLETED|Overall Study||9
8705870|NCT00934661|9751803|FG000|STARTED|Overall Study||20
8705871|NCT00934661|9751804|FG001|STARTED|Overall Study||20
8705872|NCT00934661|9751803|FG000|COMPLETED|Overall Study||19
8705873|NCT00934661|9751804|FG001|COMPLETED|Overall Study||20
8705874|NCT00934661|9751803|FG000|NOT COMPLETED|Overall Study||1
8705875|NCT00934661|9751804|FG001|NOT COMPLETED|Overall Study||0
8705876|NCT00934843|9751812|FG000|STARTED|Overall Study||37
8705877|NCT00934843|9751813|FG001|STARTED|Overall Study||40
8705878|NCT00934843|9751812|FG000|COMPLETED|Overall Study||37
8705879|NCT00934843|9751813|FG001|COMPLETED|Overall Study|1 subject discontinued intervention, surgery plan changed and did not require CPB|39
8705880|NCT00934843|9751812|FG000|NOT COMPLETED|Overall Study||0
8705881|NCT00934843|9751813|FG001|NOT COMPLETED|Overall Study||1
8705882|NCT00934856|9751825|FG000|STARTED|Feasibility Part||6
8705883|NCT00934856|9751826|FG001|STARTED|Feasibility Part||6
8705884|NCT00934856|9751827|FG002|STARTED|Feasibility Part||3
8705885|NCT00934856|9751828|FG003|STARTED|Feasibility Part||6
8705886|NCT00934856|9751829|FG004|STARTED|Feasibility Part||12
8705887|NCT00934856|9751830|FG005|STARTED|Feasibility Part||9
8705888|NCT00934856|9751825|FG000|COMPLETED|Feasibility Part||1
8705889|NCT00934856|9751826|FG001|COMPLETED|Feasibility Part||1
8705890|NCT00934856|9751827|FG002|COMPLETED|Feasibility Part||0
8705891|NCT00934856|9751828|FG003|COMPLETED|Feasibility Part||1
8557408|NCT00002597|9589289|FG000|NOT COMPLETED|Overall Study||26
8557409|NCT00002597|9589290|FG001|NOT COMPLETED|Overall Study||23
8557410|NCT00002601|9589296|FG000|STARTED|Overall Study||13
8557411|NCT00002601|9589296|FG000|COMPLETED|Overall Study||13
8705892|NCT00934856|9751829|FG004|COMPLETED|Feasibility Part||12
8705893|NCT00934856|9751830|FG005|COMPLETED|Feasibility Part||6
8705894|NCT00934856|9751825|FG000|NOT COMPLETED|Feasibility Part||5
8705895|NCT00934856|9751826|FG001|NOT COMPLETED|Feasibility Part||5
8705896|NCT00934856|9751827|FG002|NOT COMPLETED|Feasibility Part||3
8705897|NCT00934856|9751828|FG003|NOT COMPLETED|Feasibility Part||5
8705898|NCT00934856|9751829|FG004|NOT COMPLETED|Feasibility Part||0
8705899|NCT00934856|9751830|FG005|NOT COMPLETED|Feasibility Part||3
8705900|NCT00934856|9751825|FG000|STARTED|Extension Part||0
8705901|NCT00934856|9751826|FG001|STARTED|Extension Part||0
8705902|NCT00934856|9751827|FG002|STARTED|Extension Part||0
8705903|NCT00934856|9751828|FG003|STARTED|Extension Part|New participants were enrolled in the extension part.|4
8705904|NCT00934856|9751829|FG004|STARTED|Extension Part|New participants were enrolled in the extension part.|28
8705905|NCT00934856|9751830|FG005|STARTED|Extension Part|New participants were enrolled in the extension part.|24
8705906|NCT00934856|9751825|FG000|COMPLETED|Extension Part||0
8705907|NCT00934856|9751826|FG001|COMPLETED|Extension Part||0
8705908|NCT00934856|9751827|FG002|COMPLETED|Extension Part||0
8705909|NCT00934856|9751828|FG003|COMPLETED|Extension Part||2
8705910|NCT00934856|9751829|FG004|COMPLETED|Extension Part||24
8705911|NCT00934856|9751830|FG005|COMPLETED|Extension Part||19
8705912|NCT00934856|9751825|FG000|NOT COMPLETED|Extension Part||0
8705913|NCT00934856|9751826|FG001|NOT COMPLETED|Extension Part||0
8705914|NCT00934856|9751827|FG002|NOT COMPLETED|Extension Part||0
8705915|NCT00934856|9751828|FG003|NOT COMPLETED|Extension Part||2
8705916|NCT00934856|9751829|FG004|NOT COMPLETED|Extension Part||4
8705917|NCT00934856|9751830|FG005|NOT COMPLETED|Extension Part||5
8705918|NCT00934934|9751864|FG000|STARTED|Overall Study||30
8705919|NCT00934934|9751865|FG001|STARTED|Overall Study||31
8705920|NCT00934934|9751864|FG000|COMPLETED|Overall Study||29
8705921|NCT00934934|9751865|FG001|COMPLETED|Overall Study||31
8705922|NCT00934934|9751864|FG000|NOT COMPLETED|Overall Study||1
8705923|NCT00934934|9751865|FG001|NOT COMPLETED|Overall Study||0
8705924|NCT00934947|9751876|FG000|STARTED|Overall Study||23
8705925|NCT00934947|9751877|FG001|STARTED|Overall Study||22
8705926|NCT00934947|9751876|FG000|COMPLETED|Overall Study||23
8705927|NCT00934947|9751877|FG001|COMPLETED|Overall Study||20
8705928|NCT00934947|9751876|FG000|NOT COMPLETED|Overall Study||0
8705929|NCT00934947|9751877|FG001|NOT COMPLETED|Overall Study||2
8705930|NCT00935012|9751885|FG000|STARTED|Overall Study||31
8705931|NCT00935012|9751885|FG000|COMPLETED|Overall Study||2
8705932|NCT00935012|9751885|FG000|NOT COMPLETED|Overall Study||29
8705933|NCT00935064|9751891|FG000|STARTED|Overall Study||30
8705934|NCT00935064|9751892|FG001|STARTED|Overall Study||30
8705935|NCT00935064|9751891|FG000|COMPLETED|Overall Study||30
8705936|NCT00935064|9751892|FG001|COMPLETED|Overall Study||30
8705937|NCT00935064|9751891|FG000|NOT COMPLETED|Overall Study||0
8705938|NCT00935064|9751892|FG001|NOT COMPLETED|Overall Study||0
8705939|NCT00935220|9751898|FG000|STARTED|Overall Study||41
8705940|NCT00935220|9751898|FG000|COMPLETED|Overall Study||39
8705941|NCT00935220|9751898|FG000|NOT COMPLETED|Overall Study||2
8705942|NCT00935259|9751902|FG000|STARTED|Period 1||16
8705943|NCT00935259|9751903|FG001|STARTED|Period 1||15
8705944|NCT00935259|9751902|FG000|COMPLETED|Period 1||15
8705945|NCT00935259|9751903|FG001|COMPLETED|Period 1||14
8705946|NCT00935259|9751902|FG000|NOT COMPLETED|Period 1||1
8705947|NCT00935259|9751903|FG001|NOT COMPLETED|Period 1||1
8705948|NCT00935259|9751902|FG000|STARTED|Period 2||15
8705949|NCT00935259|9751903|FG001|STARTED|Period 2||14
8705950|NCT00935259|9751902|FG000|COMPLETED|Period 2||15
8705951|NCT00935259|9751903|FG001|COMPLETED|Period 2||14
8705952|NCT00935259|9751902|FG000|NOT COMPLETED|Period 2||0
8705953|NCT00935259|9751903|FG001|NOT COMPLETED|Period 2||0
8705954|NCT00935272|9751913|FG000|STARTED|Overall Study||135
8705955|NCT00935272|9751914|FG001|STARTED|Overall Study||45
8705956|NCT00935272|9751913|FG000|COMPLETED|Overall Study||116
8705957|NCT00935272|9751914|FG001|COMPLETED|Overall Study||39
8705958|NCT00935272|9751913|FG000|NOT COMPLETED|Overall Study||19
8705959|NCT00935272|9751914|FG001|NOT COMPLETED|Overall Study||6
8705960|NCT00935311|9751924|FG000|STARTED|Overall Study||43
8705961|NCT00935311|9751925|FG001|STARTED|Overall Study||39
8705962|NCT00935311|9751926|FG002|STARTED|Overall Study||40
8705963|NCT00935311|9751924|FG000|COMPLETED|Overall Study||43
8705964|NCT00935311|9751925|FG001|COMPLETED|Overall Study||39
8705965|NCT00935311|9751926|FG002|COMPLETED|Overall Study||40
8705966|NCT00935311|9751924|FG000|NOT COMPLETED|Overall Study||0
8705967|NCT00935311|9751925|FG001|NOT COMPLETED|Overall Study||0
8705968|NCT00935311|9751926|FG002|NOT COMPLETED|Overall Study||0
8705969|NCT00935428|9751934|FG000|STARTED|Overall Study||231
8705970|NCT00935428|9751934|FG000|COMPLETED|Overall Study||231
8705971|NCT00935428|9751934|FG000|NOT COMPLETED|Overall Study||0
8705972|NCT00935493|9751947|FG000|STARTED|Overall Study||41
8705973|NCT00935493|9751948|FG001|STARTED|Overall Study||41
8705974|NCT00935493|9751949|FG002|STARTED|Overall Study||41
8705975|NCT00935493|9751947|FG000|COMPLETED|Overall Study||40
8705976|NCT00935493|9751948|FG001|COMPLETED|Overall Study||39
8705977|NCT00935493|9751949|FG002|COMPLETED|Overall Study||40
8705978|NCT00935493|9751947|FG000|NOT COMPLETED|Overall Study||1
8705979|NCT00935493|9751948|FG001|NOT COMPLETED|Overall Study||2
8705980|NCT00935493|9751949|FG002|NOT COMPLETED|Overall Study||1
8705981|NCT00935532|9751959|FG000|STARTED|Overall Study||215
8705982|NCT00935532|9751960|FG001|STARTED|Overall Study||212
8705983|NCT00935532|9751959|FG000|COMPLETED|Overall Study||193
8705984|NCT00935532|9751960|FG001|COMPLETED|Overall Study||201
8705985|NCT00935532|9751959|FG000|NOT COMPLETED|Overall Study||22
8705986|NCT00935532|9751960|FG001|NOT COMPLETED|Overall Study||11
8705987|NCT00935584|9751968|FG000|STARTED|Overall Study|Out of 128 participants consented, 2 patients had no data collected, as the clinic was cancelled.|126
8705988|NCT00935584|9751969|FG001|STARTED|Overall Study||23
8705989|NCT00935584|9751968|FG000|COMPLETED|Overall Study||77
8705990|NCT00935584|9751969|FG001|COMPLETED|Overall Study||19
8705991|NCT00935584|9751968|FG000|NOT COMPLETED|Overall Study||49
8705992|NCT00935584|9751969|FG001|NOT COMPLETED|Overall Study||4
8705993|NCT00935701|9751973|FG000|STARTED|Overall Study||10
8705994|NCT00935701|9751973|FG000|Transition Acupressure to Acupuncture|Overall Study||9
8705995|NCT00935701|9751973|FG000|COMPLETED|Overall Study||9
8705996|NCT00935701|9751973|FG000|NOT COMPLETED|Overall Study||1
8705997|NCT00935766|9751980|FG000|STARTED|Overall Study||42
8705998|NCT00935766|9751981|FG001|STARTED|Overall Study||34
8705999|NCT00935766|9751980|FG000|COMPLETED|Overall Study||35
8706000|NCT00935766|9751981|FG001|COMPLETED|Overall Study||27
8706001|NCT00935766|9751980|FG000|NOT COMPLETED|Overall Study||7
8706002|NCT00935766|9751981|FG001|NOT COMPLETED|Overall Study||7
8706003|NCT00935792|9751990|FG000|STARTED|Overall Study||7
8706004|NCT00935792|9751991|FG001|STARTED|Overall Study||9
8706005|NCT00935792|9751992|FG002|STARTED|Overall Study||12
8706006|NCT00935792|9751990|FG000|COMPLETED|Overall Study||6
8706007|NCT00935792|9751991|FG001|COMPLETED|Overall Study||6
8706008|NCT00935792|9751992|FG002|COMPLETED|Overall Study||12
8706009|NCT00935792|9751990|FG000|NOT COMPLETED|Overall Study||1
8706010|NCT00935792|9751991|FG001|NOT COMPLETED|Overall Study||3
8706011|NCT00935792|9751992|FG002|NOT COMPLETED|Overall Study||0
8706012|NCT00935818|9752004|FG000|STARTED|Overall Study||249
8706013|NCT00935818|9752005|FG001|STARTED|Overall Study||257
8706014|NCT00935818|9752004|FG000|End of Medication Phase|Overall Study||182
8706015|NCT00935818|9752005|FG001|End of Medication Phase|Overall Study||184
8706016|NCT00935818|9752004|FG000|COMPLETED|Overall Study||158
8706017|NCT00935818|9752005|FG001|COMPLETED|Overall Study||157
8706018|NCT00935818|9752004|FG000|NOT COMPLETED|Overall Study||91
8706019|NCT00935818|9752005|FG001|NOT COMPLETED|Overall Study||100
8706020|NCT00935857|9752013|FG000|STARTED|Overall Study||14
8706021|NCT00935857|9752014|FG001|STARTED|Overall Study||16
8706022|NCT00935857|9752013|FG000|COMPLETED|Overall Study||14
8706023|NCT00935857|9752014|FG001|COMPLETED|Overall Study||16
8706024|NCT00935857|9752013|FG000|NOT COMPLETED|Overall Study||0
8706025|NCT00935857|9752014|FG001|NOT COMPLETED|Overall Study||0
8706026|NCT00935883|9752022|FG000|STARTED|Treatment Period||20
8706027|NCT00935883|9752023|FG001|STARTED|Treatment Period||40
8706028|NCT00935883|9752022|FG000|COMPLETED|Treatment Period||19
8706029|NCT00935883|9752023|FG001|COMPLETED|Treatment Period||38
8706030|NCT00935883|9752022|FG000|NOT COMPLETED|Treatment Period||1
8706031|NCT00935883|9752023|FG001|NOT COMPLETED|Treatment Period||2
8706032|NCT00935883|9752022|FG000|STARTED|Follow-Up Period||19
8706033|NCT00935883|9752023|FG001|STARTED|Follow-Up Period||38
8706034|NCT00935883|9752022|FG000|COMPLETED|Follow-Up Period||19
8706035|NCT00935883|9752023|FG001|COMPLETED|Follow-Up Period||38
8706036|NCT00935883|9752022|FG000|NOT COMPLETED|Follow-Up Period||0
8706037|NCT00935883|9752023|FG001|NOT COMPLETED|Follow-Up Period||0
8706038|NCT00936065|9752032|FG000|STARTED|Overall Study||21
8706039|NCT00936065|9752033|FG001|STARTED|Overall Study||20
8706040|NCT00936065|9752034|FG002|STARTED|Overall Study||19
8706041|NCT00936065|9752032|FG000|Received Treatment|Overall Study||21
8706042|NCT00936065|9752033|FG001|Received Treatment|Overall Study||20
8706043|NCT00936065|9752034|FG002|Received Treatment|Overall Study||18
8706044|NCT00936065|9752032|FG000|Study Assessments Performed|Overall Study||21
8557412|NCT00002601|9589296|FG000|NOT COMPLETED|Overall Study||0
8557413|NCT00002651|9589304|FG000|STARTED|Induction||3040
8557414|NCT00002651|9589305|FG001|STARTED|Induction||0
8557415|NCT00002651|9589306|FG002|STARTED|Induction||0
8557416|NCT00002651|9589304|FG000|Eligible|Induction||2950
8557417|NCT00002651|9589305|FG001|Eligible|Induction||0
8557418|NCT00002651|9589306|FG002|Eligible|Induction||0
8557419|NCT00002651|9589304|FG000|Eligible and Began Protocol Therapy|Induction||2950
8557420|NCT00002651|9589305|FG001|Eligible and Began Protocol Therapy|Induction||0
8557421|NCT00002651|9589306|FG002|Eligible and Began Protocol Therapy|Induction||0
8557422|NCT00002651|9589304|FG000|COMPLETED|Induction||1697
8557423|NCT00002651|9589305|FG001|COMPLETED|Induction||0
8557424|NCT00002651|9589306|FG002|COMPLETED|Induction||0
8557425|NCT00002651|9589304|FG000|NOT COMPLETED|Induction||1343
8557426|NCT00002651|9589305|FG001|NOT COMPLETED|Induction||0
8557427|NCT00002651|9589306|FG002|NOT COMPLETED|Induction||0
8557428|NCT00002651|9589304|FG000|STARTED|Consolidation and Randomization||0
8557429|NCT00002651|9589305|FG001|STARTED|Consolidation and Randomization|After induction,patients with stable or declining PSA (≤ 4.0 ng/mL) were eligible for randomization|867
8557430|NCT00002651|9589306|FG002|STARTED|Consolidation and Randomization|After induction,patients with stable or declining PSA (≤ 4.0 ng/mL) were eligible for randomization|882
8557431|NCT00002651|9589304|FG000|Eligible|Consolidation and Randomization||0
8557432|NCT00002651|9589305|FG001|Eligible|Consolidation and Randomization||765
8557433|NCT00002651|9589306|FG002|Eligible|Consolidation and Randomization||770
8557434|NCT00002651|9589304|FG000|Assessable for Toxicity|Consolidation and Randomization||0
8557435|NCT00002651|9589305|FG001|Assessable for Toxicity|Consolidation and Randomization||732
8557436|NCT00002651|9589306|FG002|Assessable for Toxicity|Consolidation and Randomization||702
8557437|NCT00002651|9589304|FG000|COMPLETED|Consolidation and Randomization||0
8557438|NCT00002651|9589305|FG001|COMPLETED|Consolidation and Randomization||29
8557439|NCT00002651|9589306|FG002|COMPLETED|Consolidation and Randomization||22
8557440|NCT00002651|9589304|FG000|NOT COMPLETED|Consolidation and Randomization||0
8557441|NCT00002651|9589305|FG001|NOT COMPLETED|Consolidation and Randomization||838
8557442|NCT00002651|9589306|FG002|NOT COMPLETED|Consolidation and Randomization||860
8557443|NCT00002766|9589316|FG000|STARTED|Overall Study||81
8557444|NCT00002766|9589317|FG001|STARTED|Overall Study||89
8557445|NCT00002766|9589316|FG000|COMPLETED|Overall Study||78
8557446|NCT00002766|9589317|FG001|COMPLETED|Overall Study||85
8928082|NCT02278328|9989241|FG000|NOT COMPLETED|Neuropsych Screening||1
8928083|NCT02278328|9989242|FG001|NOT COMPLETED|Neuropsych Screening||1
8928084|NCT02278328|9989243|FG002|NOT COMPLETED|Neuropsych Screening||2
8928085|NCT02278328|9989241|FG000|STARTED|First Intervention (1 Day)||9
8928086|NCT02278328|9989242|FG001|STARTED|First Intervention (1 Day)||6
8928087|NCT02278328|9989243|FG002|STARTED|First Intervention (1 Day)||6
8557447|NCT00002766|9589316|FG000|NOT COMPLETED|Overall Study||3
8557448|NCT00002766|9589317|FG001|NOT COMPLETED|Overall Study||4
8706045|NCT00936065|9752033|FG001|Study Assessments Performed|Overall Study||19
8706046|NCT00936065|9752034|FG002|Study Assessments Performed|Overall Study||18
8706047|NCT00936065|9752032|FG000|COMPLETED|Overall Study||17
8706048|NCT00936065|9752033|FG001|COMPLETED|Overall Study||16
8706049|NCT00936065|9752034|FG002|COMPLETED|Overall Study||12
8928088|NCT02278328|9989241|FG000|COMPLETED|First Intervention (1 Day)||9
8557449|NCT00002842|9589323|FG000|STARTED|Overall Study||49
8557450|NCT00002842|9589323|FG000|COMPLETED|Overall Study||22
8557451|NCT00002842|9589323|FG000|NOT COMPLETED|Overall Study||27
8557452|NCT00002850|9589330|FG000|STARTED|Overall Study||69
8557453|NCT00002850|9589331|FG001|STARTED|Overall Study||76
8557454|NCT00002850|9589332|FG002|STARTED|Overall Study||67
8557455|NCT00002850|9589330|FG000|COMPLETED|Overall Study||64
8557456|NCT00002850|9589331|FG001|COMPLETED|Overall Study||74
8557457|NCT00002850|9589332|FG002|COMPLETED|Overall Study||63
8557458|NCT00002850|9589330|FG000|NOT COMPLETED|Overall Study||5
8557459|NCT00002850|9589331|FG001|NOT COMPLETED|Overall Study||2
8557460|NCT00002850|9589332|FG002|NOT COMPLETED|Overall Study||4
8568747|NCT00093041|9600942|FG003|NOT COMPLETED|Overall Study||1
8568748|NCT00093041|9600943|FG004|NOT COMPLETED|Overall Study||1
8568749|NCT00093041|9600944|FG005|NOT COMPLETED|Overall Study||3
8568750|NCT00093145|9600958|FG000|STARTED|Overall Study||32
8706050|NCT00936065|9752032|FG000|NOT COMPLETED|Overall Study||4
8706051|NCT00936065|9752033|FG001|NOT COMPLETED|Overall Study||4
8706052|NCT00936065|9752034|FG002|NOT COMPLETED|Overall Study||7
8706053|NCT00936117|9752042|FG000|STARTED|Overall Study||20
8706054|NCT00936117|9752042|FG000|COMPLETED|Overall Study|Completed 42 days on study drug|10
8706055|NCT00936117|9752042|FG000|NOT COMPLETED|Overall Study||10
8706056|NCT00936208|9752049|FG000|STARTED|Overall Study||1499
8706057|NCT00936208|9752050|FG001|STARTED|Overall Study||1596
8706058|NCT00936208|9752049|FG000|COMPLETED|Overall Study||1462
8706059|NCT00936208|9752050|FG001|COMPLETED|Overall Study||1574
8706060|NCT00936208|9752049|FG000|NOT COMPLETED|Overall Study||37
8706061|NCT00936208|9752050|FG001|NOT COMPLETED|Overall Study||22
8706062|NCT00936221|9752058|FG000|STARTED|Overall Study||45
8706063|NCT00936221|9752059|FG001|STARTED|Overall Study||46
8706064|NCT00936221|9752058|FG000|Received Treatment|Overall Study||44
8706065|NCT00936221|9752059|FG001|Received Treatment|Overall Study||45
8706066|NCT00936221|9752058|FG000|COMPLETED|Overall Study|13 patients ongoing cutoff + 31 patients who had died.|44
8706067|NCT00936221|9752059|FG001|COMPLETED|Overall Study|10 patients ongoing at data cutoff + 35 patients who had died.|45
8706068|NCT00936221|9752058|FG000|NOT COMPLETED|Overall Study||1
8706069|NCT00936221|9752059|FG001|NOT COMPLETED|Overall Study||1
8706070|NCT00936299|9752067|FG000|STARTED|Overall Study||53
8706071|NCT00936299|9752068|FG001|STARTED|Overall Study||52
8706072|NCT00936299|9752067|FG000|COMPLETED|Overall Study||40
8706073|NCT00936299|9752068|FG001|COMPLETED|Overall Study||40
8706074|NCT00936299|9752067|FG000|NOT COMPLETED|Overall Study||13
8706075|NCT00936299|9752068|FG001|NOT COMPLETED|Overall Study||12
8706076|NCT00936351|9752078|FG000|STARTED|Overall Study||18
8706077|NCT00936351|9752079|FG001|STARTED|Overall Study||16
8706078|NCT00936351|9752078|FG000|COMPLETED|Overall Study||15
8706079|NCT00936351|9752079|FG001|COMPLETED|Overall Study||14
8706080|NCT00936351|9752078|FG000|NOT COMPLETED|Overall Study||3
8706081|NCT00936351|9752079|FG001|NOT COMPLETED|Overall Study||2
8706082|NCT00936377|9752088|FG000|STARTED|Overall Study||8
8706083|NCT00936377|9752089|FG001|STARTED|Overall Study||8
8706084|NCT00936377|9752090|FG002|STARTED|Overall Study||8
8706085|NCT00936377|9752088|FG000|COMPLETED|Overall Study||8
8706086|NCT00936377|9752089|FG001|COMPLETED|Overall Study||8
8706087|NCT00936377|9752090|FG002|COMPLETED|Overall Study||8
8706088|NCT00936377|9752088|FG000|NOT COMPLETED|Overall Study||0
8706089|NCT00936377|9752089|FG001|NOT COMPLETED|Overall Study||0
8706090|NCT00936377|9752090|FG002|NOT COMPLETED|Overall Study||0
8724678|NCT01027364|9771891|FG003|COMPLETED|Overall Study|11 participants total completed Arm 4 (3: compl. Arm 4 only; 7: cont. to Arm 1; 1: cont. to Arm 3)|3
8724679|NCT01027364|9771888|FG000|NOT COMPLETED|Overall Study||4
8724680|NCT01027364|9771889|FG001|NOT COMPLETED|Overall Study||2
8724681|NCT01027364|9771890|FG002|NOT COMPLETED|Overall Study||1
8724682|NCT01027364|9771891|FG003|NOT COMPLETED|Overall Study||1
8724683|NCT01027416|9771919|FG000|STARTED|Overall Study||31
8724684|NCT01027416|9771920|FG001|STARTED|Overall Study||28
8724685|NCT01027416|9771919|FG000|COMPLETED|Overall Study||30
8724686|NCT01027416|9771920|FG001|COMPLETED|Overall Study||23
8724687|NCT01027416|9771919|FG000|NOT COMPLETED|Overall Study||1
8724688|NCT01027416|9771920|FG001|NOT COMPLETED|Overall Study||5
8724689|NCT01027468|9771926|FG000|STARTED|Overall Study||160
8724690|NCT01027468|9771926|FG000|COMPLETED|Overall Study||160
8724691|NCT01027468|9771926|FG000|NOT COMPLETED|Overall Study||0
8724692|NCT01027559|9771933|FG000|STARTED|Overall Study||26
8724693|NCT01027559|9771934|FG001|STARTED|Overall Study||34
8724694|NCT01027559|9771935|FG002|STARTED|Overall Study||31
8724695|NCT01027559|9771933|FG000|COMPLETED|Overall Study||20
8724696|NCT01027559|9771934|FG001|COMPLETED|Overall Study||26
8724697|NCT01027559|9771935|FG002|COMPLETED|Overall Study||22
8724698|NCT01027559|9771933|FG000|NOT COMPLETED|Overall Study||6
8724699|NCT01027559|9771934|FG001|NOT COMPLETED|Overall Study||8
8724700|NCT01027559|9771935|FG002|NOT COMPLETED|Overall Study||9
8724701|NCT01027598|9771946|FG000|STARTED|Overall Study|One patient was enrolled but not treated|134
8724702|NCT01027598|9771947|FG001|STARTED|Overall Study||67
8724703|NCT01027598|9771946|FG000|COMPLETED|Overall Study|Patients remained on treatment until coming off for progression, toxicity or any other reason|0
8724704|NCT01027598|9771947|FG001|COMPLETED|Overall Study|Patients remained on treatment until coming off for progression, toxicity or any other reason|0
8724705|NCT01027598|9771946|FG000|NOT COMPLETED|Overall Study||134
8724706|NCT01027598|9771947|FG001|NOT COMPLETED|Overall Study||67
8724707|NCT01027650|9771961|FG000|STARTED|Overall Study||6
8724708|NCT01027650|9771962|FG001|STARTED|Overall Study||6
8724709|NCT01027650|9771963|FG002|STARTED|Overall Study||6
8724710|NCT01027650|9771964|FG003|STARTED|Overall Study||3
8724711|NCT01027650|9771965|FG004|STARTED|Overall Study||25
8724712|NCT01027650|9771966|FG005|STARTED|Overall Study||26
8812868|NCT01522404|9865927|FG001|NOT COMPLETED|Second Intervention (up to Week 58)||0
8706091|NCT00936455|9752100|FG000|STARTED|Overall Study||37
8706092|NCT00936455|9752101|FG001|STARTED|Overall Study||38
8706093|NCT00936455|9752100|FG000|COMPLETED|Overall Study||37
8706094|NCT00936455|9752101|FG001|COMPLETED|Overall Study||38
8706095|NCT00936455|9752100|FG000|NOT COMPLETED|Overall Study||0
8706096|NCT00936455|9752101|FG001|NOT COMPLETED|Overall Study||0
8706097|NCT00936481|9752115|FG000|STARTED|Overall Study||17
8706098|NCT00936481|9752116|FG001|STARTED|Overall Study||17
8706099|NCT00936481|9752115|FG000|COMPLETED|Overall Study||17
8706100|NCT00936481|9752116|FG001|COMPLETED|Overall Study||17
8706101|NCT00936481|9752115|FG000|NOT COMPLETED|Overall Study||0
8706102|NCT00936481|9752116|FG001|NOT COMPLETED|Overall Study||0
8706103|NCT00936611|9752122|FG000|STARTED|Overall Study||39
8706104|NCT00936611|9752122|FG000|Treated|Overall Study||36
8706105|NCT00936611|9752122|FG000|Starting Dose Reduction: 30 mg to 25 mg|Overall Study||12
8706106|NCT00936611|9752122|FG000|COMPLETED|Overall Study||0
8706107|NCT00936611|9752122|FG000|NOT COMPLETED|Overall Study||39
8706108|NCT00936663|9752128|FG000|STARTED|Overall Study||1
8706109|NCT00936663|9752129|FG001|STARTED|Overall Study||2
8706110|NCT00936663|9752128|FG000|COMPLETED|Overall Study||1
8706111|NCT00936663|9752129|FG001|COMPLETED|Overall Study||2
8706112|NCT00936663|9752128|FG000|NOT COMPLETED|Overall Study||0
8706113|NCT00936663|9752129|FG001|NOT COMPLETED|Overall Study||0
8706114|NCT00936702|9752135|FG000|STARTED|Overall Study||46
8706115|NCT00936702|9752135|FG000|COMPLETED|Overall Study||0
8706116|NCT00936702|9752135|FG000|NOT COMPLETED|Overall Study||46
8706117|NCT00936715|9752139|FG000|STARTED|Overall Study||24
8706118|NCT00936715|9752139|FG000|COMPLETED|Overall Study||18
8706119|NCT00936715|9752139|FG000|NOT COMPLETED|Overall Study||6
8706120|NCT00936741|9752143|FG000|STARTED|Overall Study||30
8706121|NCT00936741|9752143|FG000|COMPLETED|Overall Study||21
8706122|NCT00936741|9752143|FG000|NOT COMPLETED|Overall Study||9
8706123|NCT00936858|9752147|FG000|STARTED|Overall Study||50
8706124|NCT00936858|9752147|FG000|Participants With Medullary Thyroid Cancer|Overall Study||10
8706125|NCT00936858|9752147|FG000|COMPLETED|Overall Study||0
8706126|NCT00936858|9752147|FG000|NOT COMPLETED|Overall Study||50
8706127|NCT00936884|9752154|FG000|STARTED|Double-blind|Twenty-five subjects received MNTX, and 24 had ≥ 1 post baseline diary assessment.|25
8706128|NCT00936884|9752155|FG001|STARTED|Double-blind|Twenty-four subjects received placebo, and 23 had ≥ 1 post baseline diary assessment.|25
8706129|NCT00936884|9752156|FG002|STARTED|Double-blind|Thirteen subjects from the MNTX group and 18 from the placebo group entered the 12-week extension.|0
8706130|NCT00936884|9752154|FG000|COMPLETED|Double-blind||13
8706131|NCT00936884|9752155|FG001|COMPLETED|Double-blind||18
8706132|NCT00936884|9752156|FG002|COMPLETED|Double-blind||0
8706133|NCT00936884|9752154|FG000|NOT COMPLETED|Double-blind||12
8706134|NCT00936884|9752155|FG001|NOT COMPLETED|Double-blind||7
8706135|NCT00936884|9752156|FG002|NOT COMPLETED|Double-blind||0
8706136|NCT00936884|9752154|FG000|STARTED|Open-label||0
8706137|NCT00936884|9752155|FG001|STARTED|Open-label||0
8706138|NCT00936884|9752156|FG002|STARTED|Open-label||31
8706139|NCT00936884|9752154|FG000|COMPLETED|Open-label||0
8706140|NCT00936884|9752155|FG001|COMPLETED|Open-label||0
8706141|NCT00936884|9752156|FG002|COMPLETED|Open-label||12
8706142|NCT00936884|9752154|FG000|NOT COMPLETED|Open-label||0
8706143|NCT00936884|9752155|FG001|NOT COMPLETED|Open-label||0
8706144|NCT00936884|9752156|FG002|NOT COMPLETED|Open-label||19
8706145|NCT00936897|9752165|FG000|STARTED|Overall Study|Randomized|417
8706146|NCT00936897|9752166|FG001|STARTED|Overall Study|Randomized|416
8706147|NCT00936897|9752165|FG000|COMPLETED|Overall Study||398
8706148|NCT00936897|9752166|FG001|COMPLETED|Overall Study||356
8706149|NCT00936897|9752165|FG000|NOT COMPLETED|Overall Study||19
8706150|NCT00936897|9752166|FG001|NOT COMPLETED|Overall Study||60
8706151|NCT00936910|9752172|FG000|STARTED|Overall Study||13
8706152|NCT00936910|9752172|FG000|COMPLETED|Overall Study|The primary endpt. of 2 (-) cultures within 5 d of lock therapy was met for 10 patients|10
8706153|NCT00936910|9752172|FG000|NOT COMPLETED|Overall Study||3
8706154|NCT00936975|9752177|FG000|STARTED|Overall Study||18
8706155|NCT00936975|9752177|FG000|COMPLETED|Overall Study||12
8706156|NCT00936975|9752177|FG000|NOT COMPLETED|Overall Study||6
8706157|NCT00937040|9752184|FG000|STARTED|Overall Study||179
8706158|NCT00937040|9752185|FG001|STARTED|Overall Study||178
8706159|NCT00937040|9752184|FG000|COMPLETED|Overall Study||138
8706160|NCT00937040|9752185|FG001|COMPLETED|Overall Study||141
8706161|NCT00937040|9752184|FG000|NOT COMPLETED|Overall Study||41
8706162|NCT00937040|9752185|FG001|NOT COMPLETED|Overall Study||37
8706163|NCT00937105|9752193|FG000|STARTED|Overall Study||109
8706164|NCT00937105|9752194|FG001|STARTED|Overall Study||109
8706165|NCT00937105|9752193|FG000|COMPLETED|Overall Study||69
8706166|NCT00937105|9752194|FG001|COMPLETED|Overall Study||70
8706167|NCT00937105|9752193|FG000|NOT COMPLETED|Overall Study||40
8706168|NCT00937105|9752194|FG001|NOT COMPLETED|Overall Study||39
8706169|NCT00937118|9752209|FG000|STARTED|Overall Study||41
8706170|NCT00937118|9752209|FG000|COMPLETED|Overall Study||41
8706171|NCT00937118|9752209|FG000|NOT COMPLETED|Overall Study||0
8706172|NCT00937157|9752216|FG000|STARTED|Overall Study||12
8706173|NCT00937157|9752216|FG000|COMPLETED|Overall Study||8
8706174|NCT00937157|9752216|FG000|NOT COMPLETED|Overall Study||4
8706175|NCT00937235|9752222|FG000|STARTED|Overall Study||72
8706176|NCT00937235|9752223|FG001|STARTED|Overall Study||70
8706177|NCT00937235|9752222|FG000|COMPLETED|Overall Study||72
8706178|NCT00937235|9752223|FG001|COMPLETED|Overall Study||70
8706179|NCT00937235|9752222|FG000|NOT COMPLETED|Overall Study||0
8706180|NCT00937235|9752223|FG001|NOT COMPLETED|Overall Study||0
8706181|NCT00937326|9752234|FG000|STARTED|Overall Study||46
8706182|NCT00937326|9752235|FG001|STARTED|Overall Study||45
8706183|NCT00937326|9752236|FG002|STARTED|Overall Study||46
8706184|NCT00937326|9752237|FG003|STARTED|Overall Study||45
8706185|NCT00937326|9752238|FG004|STARTED|Overall Study||45
8706186|NCT00937326|9752234|FG000|COMPLETED|Overall Study||43
8706187|NCT00937326|9752235|FG001|COMPLETED|Overall Study||38
8706188|NCT00937326|9752236|FG002|COMPLETED|Overall Study||42
8706189|NCT00937326|9752237|FG003|COMPLETED|Overall Study||40
8706190|NCT00937326|9752238|FG004|COMPLETED|Overall Study||40
8706191|NCT00937326|9752234|FG000|NOT COMPLETED|Overall Study||3
8706192|NCT00937326|9752235|FG001|NOT COMPLETED|Overall Study||7
8706193|NCT00937326|9752236|FG002|NOT COMPLETED|Overall Study||4
8706194|NCT00937326|9752237|FG003|NOT COMPLETED|Overall Study||5
8706195|NCT00937326|9752238|FG004|NOT COMPLETED|Overall Study||5
8706196|NCT00937378|9752257|FG000|STARTED|Overall Study||167
8706197|NCT00937378|9752258|FG001|STARTED|Overall Study||159
8706198|NCT00937378|9752257|FG000|COMPLETED|Overall Study||149
8706199|NCT00937378|9752258|FG001|COMPLETED|Overall Study||141
8706200|NCT00937378|9752257|FG000|NOT COMPLETED|Overall Study||18
8706201|NCT00937378|9752258|FG001|NOT COMPLETED|Overall Study||18
8706202|NCT00937391|9752266|FG000|STARTED|Stage 1||20
8706203|NCT00937391|9752266|FG000|Treated|Stage 1|Valid for Full Analysis Set (FAS); includes all participants administered Magnevist Injection|20
8706204|NCT00937391|9752266|FG000|COMPLETED|Stage 1||20
8706205|NCT00937391|9752266|FG000|NOT COMPLETED|Stage 1||0
8706206|NCT00937391|9752266|FG000|STARTED|Stage 2|Stage 1 and Stage 2 are independent each enrolling a different set of participants|34
8706207|NCT00937391|9752266|FG000|Treated|Stage 2|Valid for Full Analysis Set; participants administered correct Magnevist dose based on body weight|34
8706208|NCT00937391|9752266|FG000|COMPLETED|Stage 2|The number completed includes participants within the FAS and Per Protocol Set (PPS)|33
8706209|NCT00937391|9752266|FG000|NOT COMPLETED|Stage 2||1
8706210|NCT00937404|9752283|FG000|STARTED|Overall Study||25
8706211|NCT00937404|9752283|FG000|COMPLETED|Overall Study||23
8706212|NCT00937404|9752283|FG000|NOT COMPLETED|Overall Study||2
8706213|NCT00937495|9752287|FG000|STARTED|Overall Study||16
8706214|NCT00937495|9752287|FG000|COMPLETED|Overall Study||14
8706215|NCT00937495|9752287|FG000|NOT COMPLETED|Overall Study||2
8706216|NCT00937521|9752299|FG000|STARTED|Overall Study - Prior to Booster Dose||188
8706217|NCT00937521|9752300|FG001|STARTED|Overall Study - Prior to Booster Dose||190
8706218|NCT00937521|9752301|FG002|STARTED|Overall Study - Prior to Booster Dose||192
8706219|NCT00937521|9752302|FG003|STARTED|Overall Study - Prior to Booster Dose||188
8706220|NCT00937521|9752303|FG004|STARTED|Overall Study - Prior to Booster Dose||191
8706221|NCT00937521|9752304|FG005|STARTED|Overall Study - Prior to Booster Dose||188
8706222|NCT00937521|9752305|FG006|STARTED|Overall Study - Prior to Booster Dose||186
8706223|NCT00937521|9752306|FG007|STARTED|Overall Study - Prior to Booster Dose||184
8706224|NCT00937521|9752299|FG000|Premature Withdrawal|Overall Study - Prior to Booster Dose||3
8706225|NCT00937521|9752300|FG001|Premature Withdrawal|Overall Study - Prior to Booster Dose||5
8706226|NCT00937521|9752301|FG002|Premature Withdrawal|Overall Study - Prior to Booster Dose||6
8706227|NCT00937521|9752302|FG003|Premature Withdrawal|Overall Study - Prior to Booster Dose||1
8706228|NCT00937521|9752303|FG004|Premature Withdrawal|Overall Study - Prior to Booster Dose||3
8706229|NCT00937521|9752304|FG005|Premature Withdrawal|Overall Study - Prior to Booster Dose||1
8706230|NCT00937521|9752305|FG006|Premature Withdrawal|Overall Study - Prior to Booster Dose||5
8706231|NCT00937521|9752306|FG007|Premature Withdrawal|Overall Study - Prior to Booster Dose||1
8706232|NCT00937521|9752299|FG000|COMPLETED|Overall Study - Prior to Booster Dose||185
8706233|NCT00937521|9752300|FG001|COMPLETED|Overall Study - Prior to Booster Dose||185
8706234|NCT00937521|9752301|FG002|COMPLETED|Overall Study - Prior to Booster Dose||186
8706235|NCT00937521|9752302|FG003|COMPLETED|Overall Study - Prior to Booster Dose||187
8706236|NCT00937521|9752303|FG004|COMPLETED|Overall Study - Prior to Booster Dose||188
8706237|NCT00937521|9752304|FG005|COMPLETED|Overall Study - Prior to Booster Dose||187
8706238|NCT00937521|9752305|FG006|COMPLETED|Overall Study - Prior to Booster Dose||181
8706239|NCT00937521|9752306|FG007|COMPLETED|Overall Study - Prior to Booster Dose||183
8706240|NCT00937521|9752299|FG000|NOT COMPLETED|Overall Study - Prior to Booster Dose||3
8706241|NCT00937521|9752300|FG001|NOT COMPLETED|Overall Study - Prior to Booster Dose||5
8706242|NCT00937521|9752301|FG002|NOT COMPLETED|Overall Study - Prior to Booster Dose||6
8706243|NCT00937521|9752302|FG003|NOT COMPLETED|Overall Study - Prior to Booster Dose||1
8706244|NCT00937521|9752303|FG004|NOT COMPLETED|Overall Study - Prior to Booster Dose||3
8706245|NCT00937521|9752304|FG005|NOT COMPLETED|Overall Study - Prior to Booster Dose||1
8706246|NCT00937521|9752305|FG006|NOT COMPLETED|Overall Study - Prior to Booster Dose||5
8706247|NCT00937521|9752306|FG007|NOT COMPLETED|Overall Study - Prior to Booster Dose||1
8706248|NCT00937521|9752299|FG000|STARTED|Booster Phase||155
8706249|NCT00937521|9752300|FG001|STARTED|Booster Phase||163
8706250|NCT00937521|9752301|FG002|STARTED|Booster Phase||169
8706251|NCT00937521|9752302|FG003|STARTED|Booster Phase||170
8706252|NCT00937521|9752303|FG004|STARTED|Booster Phase||168
8706253|NCT00937521|9752304|FG005|STARTED|Booster Phase||165
8706254|NCT00937521|9752305|FG006|STARTED|Booster Phase||165
8706255|NCT00937521|9752306|FG007|STARTED|Booster Phase||161
8706256|NCT00937521|9752299|FG000|Premature Withdrawal|Booster Phase||3
8706257|NCT00937521|9752300|FG001|Premature Withdrawal|Booster Phase||2
8706258|NCT00937521|9752301|FG002|Premature Withdrawal|Booster Phase||5
8706259|NCT00937521|9752302|FG003|Premature Withdrawal|Booster Phase||3
8706260|NCT00937521|9752303|FG004|Premature Withdrawal|Booster Phase||5
8706261|NCT00937521|9752304|FG005|Premature Withdrawal|Booster Phase||5
8706262|NCT00937521|9752305|FG006|Premature Withdrawal|Booster Phase||5
8706263|NCT00937521|9752306|FG007|Premature Withdrawal|Booster Phase||2
8706264|NCT00937521|9752299|FG000|COMPLETED|Booster Phase||152
8706265|NCT00937521|9752300|FG001|COMPLETED|Booster Phase||161
8706266|NCT00937521|9752301|FG002|COMPLETED|Booster Phase||164
8706267|NCT00937521|9752302|FG003|COMPLETED|Booster Phase||167
8706268|NCT00937521|9752303|FG004|COMPLETED|Booster Phase||163
8706269|NCT00937521|9752304|FG005|COMPLETED|Booster Phase||160
8706270|NCT00937521|9752305|FG006|COMPLETED|Booster Phase||160
8706271|NCT00937521|9752306|FG007|COMPLETED|Booster Phase||159
8706272|NCT00937521|9752299|FG000|NOT COMPLETED|Booster Phase||3
8706273|NCT00937521|9752300|FG001|NOT COMPLETED|Booster Phase||2
8706274|NCT00937521|9752301|FG002|NOT COMPLETED|Booster Phase||5
8706275|NCT00937521|9752302|FG003|NOT COMPLETED|Booster Phase||3
8706276|NCT00937521|9752303|FG004|NOT COMPLETED|Booster Phase||5
8706277|NCT00937521|9752304|FG005|NOT COMPLETED|Booster Phase||5
8706278|NCT00937521|9752305|FG006|NOT COMPLETED|Booster Phase||5
8706279|NCT00937521|9752306|FG007|NOT COMPLETED|Booster Phase||2
8706280|NCT00937547|9752342|FG000|STARTED|Overall Study||96
8706281|NCT00937547|9752343|FG001|STARTED|Overall Study||84
8706282|NCT00937547|9752344|FG002|STARTED|Overall Study||149
8706283|NCT00937547|9752342|FG000|Histological Samples|Overall Study||95
8706284|NCT00937547|9752343|FG001|Histological Samples|Overall Study||78
8706285|NCT00937547|9752344|FG002|Histological Samples|Overall Study||142
8706286|NCT00937547|9752342|FG000|COMPLETED|Overall Study||95
8706287|NCT00937547|9752343|FG001|COMPLETED|Overall Study||78
8706288|NCT00937547|9752344|FG002|COMPLETED|Overall Study||142
8706289|NCT00937547|9752342|FG000|NOT COMPLETED|Overall Study||1
8706290|NCT00937547|9752343|FG001|NOT COMPLETED|Overall Study||6
8706291|NCT00937547|9752344|FG002|NOT COMPLETED|Overall Study||7
8706292|NCT00937560|9752352|FG000|STARTED|Initial Treatment||189
8706293|NCT00937560|9752352|FG000|Received Treatment|Initial Treatment||189
8706294|NCT00937560|9752352|FG000|COMPLETED|Initial Treatment||168
8706295|NCT00937560|9752352|FG000|NOT COMPLETED|Initial Treatment||21
8706296|NCT00937560|9752352|FG000|STARTED|Maintenance Treatment||168
8706297|NCT00937560|9752352|FG000|COMPLETED|Maintenance Treatment||150
8706298|NCT00937560|9752352|FG000|NOT COMPLETED|Maintenance Treatment||18
8706299|NCT00937768|9752358|FG000|STARTED|Overall Study||8
8706300|NCT00937768|9752359|FG001|STARTED|Overall Study||8
8706301|NCT00937768|9752358|FG000|COMPLETED|Overall Study||0
8706302|NCT00937768|9752359|FG001|COMPLETED|Overall Study||0
8706303|NCT00937768|9752358|FG000|NOT COMPLETED|Overall Study||8
8557461|NCT03666988|9589346|FG000|STARTED|Part 1 (Up to 28 Months)||3
8557462|NCT03666988|9589347|FG001|STARTED|Part 1 (Up to 28 Months)||16
8557463|NCT03666988|9589348|FG002|STARTED|Part 1 (Up to 28 Months)||12
8557464|NCT03666988|9589349|FG003|STARTED|Part 1 (Up to 28 Months)||0
8557465|NCT03666988|9589350|FG004|STARTED|Part 1 (Up to 28 Months)||0
8557466|NCT03666988|9589351|FG005|STARTED|Part 1 (Up to 28 Months)||0
8557467|NCT03666988|9589346|FG000|COMPLETED|Part 1 (Up to 28 Months)||0
8557468|NCT03666988|9589347|FG001|COMPLETED|Part 1 (Up to 28 Months)||0
8557469|NCT03666988|9589348|FG002|COMPLETED|Part 1 (Up to 28 Months)||0
8557470|NCT03666988|9589349|FG003|COMPLETED|Part 1 (Up to 28 Months)||0
8557471|NCT03666988|9589350|FG004|COMPLETED|Part 1 (Up to 28 Months)||0
8557472|NCT03666988|9589351|FG005|COMPLETED|Part 1 (Up to 28 Months)||0
8557473|NCT03666988|9589346|FG000|NOT COMPLETED|Part 1 (Up to 28 Months)||3
8557474|NCT03666988|9589347|FG001|NOT COMPLETED|Part 1 (Up to 28 Months)||16
8557475|NCT03666988|9589348|FG002|NOT COMPLETED|Part 1 (Up to 28 Months)||12
8557476|NCT03666988|9589349|FG003|NOT COMPLETED|Part 1 (Up to 28 Months)||0
8557477|NCT03666988|9589350|FG004|NOT COMPLETED|Part 1 (Up to 28 Months)||0
8557478|NCT03666988|9589351|FG005|NOT COMPLETED|Part 1 (Up to 28 Months)||0
8557479|NCT03666988|9589346|FG000|STARTED|Part 2 (Up to 48 Months)||0
8557480|NCT03666988|9589347|FG001|STARTED|Part 2 (Up to 48 Months)||0
8557481|NCT03666988|9589348|FG002|STARTED|Part 2 (Up to 48 Months)||0
8557482|NCT03666988|9589349|FG003|STARTED|Part 2 (Up to 48 Months)||0
8557483|NCT03666988|9589350|FG004|STARTED|Part 2 (Up to 48 Months)||0
8557484|NCT03666988|9589351|FG005|STARTED|Part 2 (Up to 48 Months)||0
8557485|NCT03666988|9589346|FG000|COMPLETED|Part 2 (Up to 48 Months)||0
8557486|NCT03666988|9589347|FG001|COMPLETED|Part 2 (Up to 48 Months)||0
8557487|NCT03666988|9589348|FG002|COMPLETED|Part 2 (Up to 48 Months)||0
8557488|NCT03666988|9589349|FG003|COMPLETED|Part 2 (Up to 48 Months)||0
8557489|NCT03666988|9589350|FG004|COMPLETED|Part 2 (Up to 48 Months)||0
8557490|NCT03666988|9589351|FG005|COMPLETED|Part 2 (Up to 48 Months)||0
8557491|NCT03666988|9589346|FG000|NOT COMPLETED|Part 2 (Up to 48 Months)||0
8557492|NCT03666988|9589347|FG001|NOT COMPLETED|Part 2 (Up to 48 Months)||0
8557493|NCT03666988|9589348|FG002|NOT COMPLETED|Part 2 (Up to 48 Months)||0
8557494|NCT03666988|9589349|FG003|NOT COMPLETED|Part 2 (Up to 48 Months)||0
8557495|NCT03666988|9589350|FG004|NOT COMPLETED|Part 2 (Up to 48 Months)||0
8557496|NCT03666988|9589351|FG005|NOT COMPLETED|Part 2 (Up to 48 Months)||0
8557497|NCT03552029|9589371|FG000|STARTED|Overall Study||4
8557498|NCT03552029|9589372|FG001|STARTED|Overall Study||6
8557499|NCT03552029|9589371|FG000|COMPLETED|Overall Study||0
8557500|NCT03552029|9589372|FG001|COMPLETED|Overall Study||0
8557501|NCT03552029|9589371|FG000|NOT COMPLETED|Overall Study||4
8557502|NCT03552029|9589372|FG001|NOT COMPLETED|Overall Study||6
8557503|NCT03549104|9589380|FG000|STARTED|Overall Study||26
8557504|NCT03549104|9589381|FG001|STARTED|Overall Study||25
8557505|NCT03549104|9589380|FG000|COMPLETED|Overall Study||18
8557506|NCT03549104|9589381|FG001|COMPLETED|Overall Study||21
8557507|NCT03549104|9589380|FG000|NOT COMPLETED|Overall Study||8
8557508|NCT03549104|9589381|FG001|NOT COMPLETED|Overall Study||4
8557509|NCT03462719|9589389|FG000|STARTED|Overall Study||106
8557510|NCT03462719|9589390|FG001|STARTED|Overall Study||105
8557511|NCT03462719|9589389|FG000|COMPLETED|Overall Study||11
8557512|NCT03462719|9589390|FG001|COMPLETED|Overall Study||11
8557513|NCT03462719|9589389|FG000|NOT COMPLETED|Overall Study||95
8557514|NCT03462719|9589390|FG001|NOT COMPLETED|Overall Study||94
8557515|NCT03412565|9589400|FG000|STARTED|Overall Study||67
8557516|NCT03412565|9589401|FG001|STARTED|Overall Study||67
8557517|NCT03412565|9589402|FG002|STARTED|Overall Study||65
8557518|NCT03412565|9589403|FG003|STARTED|Overall Study||66
8557519|NCT03412565|9589400|FG000|COMPLETED|Overall Study||66
8557520|NCT03412565|9589401|FG001|COMPLETED|Overall Study||2
8557521|NCT03412565|9589402|FG002|COMPLETED|Overall Study||3
8557522|NCT03412565|9589403|FG003|COMPLETED|Overall Study||12
8557523|NCT03412565|9589400|FG000|NOT COMPLETED|Overall Study||1
8557524|NCT03412565|9589401|FG001|NOT COMPLETED|Overall Study||65
8557525|NCT03412565|9589402|FG002|NOT COMPLETED|Overall Study||62
8557526|NCT03412565|9589403|FG003|NOT COMPLETED|Overall Study||54
8557527|NCT03332589|9589421|FG000|STARTED|Overall Study||4
8557528|NCT03332589|9589422|FG001|STARTED|Overall Study||0
8557529|NCT03332589|9589423|FG002|STARTED|Overall Study||0
8557530|NCT03332589|9589421|FG000|COMPLETED|Overall Study||0
8557531|NCT03332589|9589422|FG001|COMPLETED|Overall Study||0
8557532|NCT03332589|9589423|FG002|COMPLETED|Overall Study||0
8557533|NCT03332589|9589421|FG000|NOT COMPLETED|Overall Study||4
8706304|NCT00937768|9752359|FG001|NOT COMPLETED|Overall Study||8
8706305|NCT00937794|9752365|FG000|STARTED|Overall Study||33
8706306|NCT00937794|9752365|FG000|COMPLETED|Overall Study||33
8706307|NCT00937794|9752365|FG000|NOT COMPLETED|Overall Study||0
8706308|NCT00937833|9752371|FG000|STARTED|Overall Study||73
8706309|NCT00937833|9752372|FG001|STARTED|Overall Study||77
8706310|NCT00937833|9752371|FG000|COMPLETED|Overall Study||58
8706311|NCT00937833|9752372|FG001|COMPLETED|Overall Study||60
8706312|NCT00937833|9752371|FG000|NOT COMPLETED|Overall Study||15
8706313|NCT00937833|9752372|FG001|NOT COMPLETED|Overall Study||17
8706314|NCT00937859|9752380|FG000|STARTED|Overall Study||148
8706315|NCT00937859|9752381|FG001|STARTED|Overall Study||153
8706316|NCT00937859|9752380|FG000|COMPLETED|Overall Study||129
8706317|NCT00937859|9752381|FG001|COMPLETED|Overall Study||134
8706318|NCT00937859|9752380|FG000|NOT COMPLETED|Overall Study||19
8706319|NCT00937859|9752381|FG001|NOT COMPLETED|Overall Study||19
8706320|NCT00937950|9752387|FG000|STARTED|Overall Study||2003
8706321|NCT00937950|9752387|FG000|COMPLETED|Overall Study||1787
8706322|NCT00937950|9752387|FG000|NOT COMPLETED|Overall Study||216
8706323|NCT00938015|9752391|FG000|STARTED|Overall Study||303
8706324|NCT00938015|9752391|FG000|COMPLETED|Overall Study||156
8706325|NCT00938015|9752391|FG000|NOT COMPLETED|Overall Study||147
8706326|NCT00938041|9752395|FG000|STARTED|Overall Study||32
8706327|NCT00938041|9752395|FG000|COMPLETED|Overall Study||5
8706328|NCT00938041|9752395|FG000|NOT COMPLETED|Overall Study||27
8706329|NCT00938314|9752403|FG000|STARTED|Cohort 1||24
8706330|NCT00938314|9752404|FG001|STARTED|Cohort 1||0
8706331|NCT00938314|9752405|FG002|STARTED|Cohort 1||0
8706332|NCT00938314|9752406|FG003|STARTED|Cohort 1||8
8706333|NCT00938314|9752403|FG000|COMPLETED|Cohort 1||22
8706334|NCT00938314|9752404|FG001|COMPLETED|Cohort 1||0
8706335|NCT00938314|9752405|FG002|COMPLETED|Cohort 1||0
8706336|NCT00938314|9752406|FG003|COMPLETED|Cohort 1||6
8706337|NCT00938314|9752403|FG000|NOT COMPLETED|Cohort 1||2
8706338|NCT00938314|9752404|FG001|NOT COMPLETED|Cohort 1||0
8706339|NCT00938314|9752405|FG002|NOT COMPLETED|Cohort 1||0
8706340|NCT00938314|9752406|FG003|NOT COMPLETED|Cohort 1||2
8706341|NCT00938314|9752403|FG000|STARTED|Cohort 2||0
8706342|NCT00938314|9752404|FG001|STARTED|Cohort 2||24
8706343|NCT00938314|9752405|FG002|STARTED|Cohort 2||0
8706344|NCT00938314|9752406|FG003|STARTED|Cohort 2||8
8706345|NCT00938314|9752403|FG000|COMPLETED|Cohort 2||0
8706346|NCT00938314|9752404|FG001|COMPLETED|Cohort 2||18
8706347|NCT00938314|9752405|FG002|COMPLETED|Cohort 2||0
8706348|NCT00938314|9752406|FG003|COMPLETED|Cohort 2||6
8706349|NCT00938314|9752403|FG000|NOT COMPLETED|Cohort 2||0
8706350|NCT00938314|9752404|FG001|NOT COMPLETED|Cohort 2||6
8706351|NCT00938314|9752405|FG002|NOT COMPLETED|Cohort 2||0
8706352|NCT00938314|9752406|FG003|NOT COMPLETED|Cohort 2||2
8706353|NCT00938314|9752403|FG000|STARTED|Cohort 3||0
8706354|NCT00938314|9752404|FG001|STARTED|Cohort 3||0
8706355|NCT00938314|9752405|FG002|STARTED|Cohort 3||24
8706356|NCT00938314|9752406|FG003|STARTED|Cohort 3||8
8706357|NCT00938314|9752403|FG000|COMPLETED|Cohort 3||0
8706358|NCT00938314|9752404|FG001|COMPLETED|Cohort 3||0
8706359|NCT00938314|9752405|FG002|COMPLETED|Cohort 3||20
8706360|NCT00938314|9752406|FG003|COMPLETED|Cohort 3||7
8706361|NCT00938314|9752403|FG000|NOT COMPLETED|Cohort 3||0
8706362|NCT00938314|9752404|FG001|NOT COMPLETED|Cohort 3||0
8706363|NCT00938314|9752405|FG002|NOT COMPLETED|Cohort 3||4
8706364|NCT00938314|9752406|FG003|NOT COMPLETED|Cohort 3||1
8706365|NCT00938327|9752416|FG000|STARTED|Overall Study||332
8706366|NCT00938327|9752416|FG000|COMPLETED|Overall Study||272
8706367|NCT00938327|9752416|FG000|NOT COMPLETED|Overall Study||60
8706368|NCT00938340|9752420|FG000|STARTED|Overall Study||20
8706369|NCT00938340|9752420|FG000|Received Whole Walnut Intervention|Overall Study||16
8706370|NCT00938340|9752420|FG000|Received Walnut Nutmeat Intervention|Overall Study||19
8706371|NCT00938340|9752420|FG000|Received Walnut Skins Intervention|Overall Study||15
8706372|NCT00938340|9752420|FG000|Received Walnut Oil Intervention|Overall Study||15
8706373|NCT00938340|9752420|FG000|COMPLETED|Overall Study||15
8706374|NCT00938340|9752420|FG000|NOT COMPLETED|Overall Study||5
8706375|NCT00938366|9752468|FG000|STARTED|Overall Study||9
8706376|NCT00938366|9752469|FG001|STARTED|Overall Study||9
8706377|NCT00938366|9752468|FG000|COMPLETED|Overall Study||8
8706378|NCT00938366|9752469|FG001|COMPLETED|Overall Study||9
8706379|NCT00938366|9752468|FG000|NOT COMPLETED|Overall Study||1
8706380|NCT00938366|9752469|FG001|NOT COMPLETED|Overall Study||0
8706381|NCT00938392|9752477|FG000|STARTED|Overall Study||362
8706382|NCT00938392|9752478|FG001|STARTED|Overall Study||362
8706383|NCT00938392|9752477|FG000|COMPLETED|Overall Study||360
8706384|NCT00938392|9752478|FG001|COMPLETED|Overall Study||358
8706385|NCT00938392|9752477|FG000|NOT COMPLETED|Overall Study||2
8706386|NCT00938392|9752478|FG001|NOT COMPLETED|Overall Study||4
8706387|NCT00938431|9752487|FG000|STARTED|Overall Study||15
8706388|NCT00938431|9752488|FG001|STARTED|Overall Study||23
8706389|NCT00938431|9752489|FG002|STARTED|Overall Study||9
8706390|NCT00938431|9752487|FG000|COMPLETED|Overall Study||9
8706391|NCT00938431|9752488|FG001|COMPLETED|Overall Study||14
8706392|NCT00938431|9752489|FG002|COMPLETED|Overall Study||1
8706393|NCT00938431|9752487|FG000|NOT COMPLETED|Overall Study||6
8706394|NCT00938431|9752488|FG001|NOT COMPLETED|Overall Study||9
8706395|NCT00938431|9752489|FG002|NOT COMPLETED|Overall Study||8
8706396|NCT00938457|9752501|FG000|STARTED|Overall Study||3
8706397|NCT00938457|9752501|FG000|COMPLETED|Overall Study||3
8706398|NCT00938457|9752501|FG000|NOT COMPLETED|Overall Study||0
8706399|NCT00938470|9752507|FG000|STARTED|Overall Study||34
8706400|NCT00938470|9752508|FG001|STARTED|Overall Study||28
8706401|NCT00938470|9752507|FG000|COMPLETED|Overall Study||27
8706402|NCT00938470|9752508|FG001|COMPLETED|Overall Study||25
8706403|NCT00938470|9752507|FG000|NOT COMPLETED|Overall Study||7
8706404|NCT00938470|9752508|FG001|NOT COMPLETED|Overall Study||3
8706405|NCT00938548|9752516|FG000|STARTED|Overall Study||35
8706406|NCT00938548|9752517|FG001|STARTED|Overall Study||35
8706407|NCT00938548|9752516|FG000|COMPLETED|Overall Study||35
8706408|NCT00938548|9752517|FG001|COMPLETED|Overall Study||35
8706409|NCT00938548|9752516|FG000|NOT COMPLETED|Overall Study||0
8706410|NCT00938548|9752517|FG001|NOT COMPLETED|Overall Study||0
8706411|NCT00938639|9752525|FG000|STARTED|Overall Study||120
8706412|NCT00938639|9752526|FG001|STARTED|Overall Study||120
8706413|NCT00938639|9752525|FG000|COMPLETED|Overall Study||117
8706414|NCT00938639|9752526|FG001|COMPLETED|Overall Study||116
8706415|NCT00938639|9752525|FG000|NOT COMPLETED|Overall Study||3
8706416|NCT00938639|9752526|FG001|NOT COMPLETED|Overall Study||4
8706417|NCT00938704|9752538|FG000|STARTED|Overall Study||33
8706418|NCT00938704|9752539|FG001|STARTED|Overall Study||37
8706419|NCT00938704|9752538|FG000|COMPLETED|Overall Study||33
8706420|NCT00938704|9752539|FG001|COMPLETED|Overall Study||37
8706421|NCT00938704|9752538|FG000|NOT COMPLETED|Overall Study||0
8706422|NCT00938704|9752539|FG001|NOT COMPLETED|Overall Study||0
8706423|NCT00938717|9752547|FG000|STARTED|Overall Study||403
8706424|NCT00938717|9752548|FG001|STARTED|Overall Study||402
8706425|NCT00938717|9752547|FG000|COMPLETED|Overall Study||305
8706426|NCT00938717|9752548|FG001|COMPLETED|Overall Study||294
8706427|NCT00938717|9752547|FG000|NOT COMPLETED|Overall Study||98
8706428|NCT00938717|9752548|FG001|NOT COMPLETED|Overall Study||108
8706429|NCT00938782|9752556|FG000|STARTED|Overall Study|Pre-induction of anesthesia|32
8706430|NCT00938782|9752557|FG001|STARTED|Overall Study|Monitoring started pre-induction of anesthesia|35
8706431|NCT00938782|9752556|FG000|COMPLETED|Overall Study|Upon discharge from PACU|32
8706432|NCT00938782|9752557|FG001|COMPLETED|Overall Study|Upon discharge from PACU|35
8706433|NCT00938782|9752556|FG000|NOT COMPLETED|Overall Study||0
8706434|NCT00938782|9752557|FG001|NOT COMPLETED|Overall Study||0
8706435|NCT00938860|9752565|FG000|STARTED|Overall Study|Intent-to-Treat (ITT) population. ITT population consisted of all randomized patients|50
8706436|NCT00938860|9752566|FG001|STARTED|Overall Study||42
8706437|NCT00938860|9752565|FG000|Efficacy Population|Overall Study||40
8706438|NCT00938860|9752566|FG001|Efficacy Population|Overall Study||41
8706439|NCT00938860|9752565|FG000|COMPLETED|Overall Study||25
8706440|NCT00938860|9752566|FG001|COMPLETED|Overall Study||25
8706441|NCT00938860|9752565|FG000|NOT COMPLETED|Overall Study||25
8706442|NCT00938860|9752566|FG001|NOT COMPLETED|Overall Study||17
8706443|NCT00938886|9752574|FG000|STARTED|Overall Study||75
8706444|NCT00938886|9752575|FG001|STARTED|Overall Study||75
8706445|NCT00938886|9752574|FG000|Attended 1 Counseling Session|Overall Study||70
8706446|NCT00938886|9752575|FG001|Attended 1 Counseling Session|Overall Study||70
8706447|NCT00938886|9752574|FG000|COMPLETED|Overall Study||68
8706448|NCT00938886|9752575|FG001|COMPLETED|Overall Study||65
8706449|NCT00938886|9752574|FG000|NOT COMPLETED|Overall Study||7
8706450|NCT00938886|9752575|FG001|NOT COMPLETED|Overall Study||10
8706451|NCT00938964|9752583|FG000|STARTED|Overall Study||241
8706452|NCT00938964|9752584|FG001|STARTED|Overall Study||237
8706453|NCT00938964|9752583|FG000|COMPLETED|Overall Study||211
8706454|NCT00938964|9752584|FG001|COMPLETED|Overall Study||209
8706455|NCT00938964|9752583|FG000|NOT COMPLETED|Overall Study||30
8706456|NCT00938964|9752584|FG001|NOT COMPLETED|Overall Study||28
8706457|NCT00939003|9752592|FG000|STARTED|Double-blind Treatment Period||97
8706458|NCT00939003|9752593|FG001|STARTED|Double-blind Treatment Period||95
8706459|NCT00939003|9752592|FG000|COMPLETED|Double-blind Treatment Period||95
8706460|NCT00939003|9752593|FG001|COMPLETED|Double-blind Treatment Period||91
8706461|NCT00939003|9752592|FG000|NOT COMPLETED|Double-blind Treatment Period||2
8706462|NCT00939003|9752593|FG001|NOT COMPLETED|Double-blind Treatment Period||4
8706463|NCT00939003|9752592|FG000|STARTED|Open-label Treatment Period||95
8706464|NCT00939003|9752593|FG001|STARTED|Open-label Treatment Period||91
8706465|NCT00939003|9752592|FG000|COMPLETED|Open-label Treatment Period||66
8706466|NCT00939003|9752593|FG001|COMPLETED|Open-label Treatment Period||62
8706467|NCT00939003|9752592|FG000|NOT COMPLETED|Open-label Treatment Period||29
8706468|NCT00939003|9752593|FG001|NOT COMPLETED|Open-label Treatment Period||29
8706469|NCT00939029|9752604|FG000|STARTED|Overall Study||25
8706470|NCT00939029|9752605|FG001|STARTED|Overall Study||27
8706471|NCT00939029|9752604|FG000|COMPLETED|Overall Study||19
8706472|NCT00939029|9752605|FG001|COMPLETED|Overall Study||15
8706473|NCT00939029|9752604|FG000|NOT COMPLETED|Overall Study||6
8706474|NCT00939029|9752605|FG001|NOT COMPLETED|Overall Study||12
8706475|NCT00939055|9752613|FG000|STARTED|Overall Study||73
8706476|NCT00939055|9752614|FG001|STARTED|Overall Study||39
8706477|NCT00939055|9752613|FG000|COMPLETED|Overall Study||69
8706478|NCT00939055|9752614|FG001|COMPLETED|Overall Study||39
8706479|NCT00939055|9752613|FG000|NOT COMPLETED|Overall Study||4
8706480|NCT00939055|9752614|FG001|NOT COMPLETED|Overall Study||0
8706481|NCT00939094|9752623|FG000|STARTED|Overall Study||42
8706482|NCT00939094|9752624|FG001|STARTED|Overall Study||45
8706483|NCT00939094|9752623|FG000|COMPLETED|Overall Study||28
8706484|NCT00939094|9752624|FG001|COMPLETED|Overall Study||35
8706485|NCT00939094|9752623|FG000|NOT COMPLETED|Overall Study||14
8706486|NCT00939094|9752624|FG001|NOT COMPLETED|Overall Study||10
8706487|NCT00939107|9752632|FG000|STARTED|Overall Study||175
8706488|NCT00939107|9752633|FG001|STARTED|Overall Study||175
8706489|NCT00939107|9752632|FG000|12 Months Follow-up|Overall Study||161
8706490|NCT00939107|9752633|FG001|12 Months Follow-up|Overall Study||163
8706491|NCT00939107|9752632|FG000|COMPLETED|Overall Study||161
8706492|NCT00939107|9752633|FG001|COMPLETED|Overall Study||163
8706493|NCT00939107|9752632|FG000|NOT COMPLETED|Overall Study||14
8706494|NCT00939107|9752633|FG001|NOT COMPLETED|Overall Study||12
8706495|NCT00939120|9752641|FG000|STARTED|Overall Study||23
8706496|NCT00939120|9752642|FG001|STARTED|Overall Study||23
8706497|NCT00939120|9752641|FG000|COMPLETED|Overall Study||15
8706498|NCT00939120|9752642|FG001|COMPLETED|Overall Study||18
8706499|NCT00939120|9752641|FG000|NOT COMPLETED|Overall Study||8
8706500|NCT00939120|9752642|FG001|NOT COMPLETED|Overall Study||5
8706501|NCT00939159|9752648|FG000|STARTED|Overall Study||13
8706502|NCT00939159|9752648|FG000|COMPLETED|Overall Study||13
8706503|NCT00939159|9752648|FG000|NOT COMPLETED|Overall Study||0
8706504|NCT00939185|9752652|FG000|STARTED|Overall Study||400
8706505|NCT00939185|9752652|FG000|Received Treatment|Overall Study||390
8706506|NCT00939185|9752652|FG000|COMPLETED|Overall Study||375
8706507|NCT00939185|9752652|FG000|NOT COMPLETED|Overall Study||25
8706508|NCT00939198|9752656|FG000|STARTED|Overall Study||87
8706509|NCT00939198|9752656|FG000|COMPLETED|Overall Study||87
8706510|NCT00939198|9752656|FG000|NOT COMPLETED|Overall Study||0
8706511|NCT00939211|9752661|FG000|STARTED|AZD9164 100 Mcg First, Then Placebo|Cross-over study|28
8706512|NCT00939211|9752661|FG000|COMPLETED|AZD9164 100 Mcg First, Then Placebo||28
8706513|NCT00939211|9752661|FG000|NOT COMPLETED|AZD9164 100 Mcg First, Then Placebo||0
8706514|NCT00939211|9752661|FG000|STARTED|AZD9164 400 Mcg First, Then Placebo||28
8706515|NCT00939211|9752661|FG000|COMPLETED|AZD9164 400 Mcg First, Then Placebo||28
8706516|NCT00939211|9752661|FG000|NOT COMPLETED|AZD9164 400 Mcg First, Then Placebo||0
8706517|NCT00939211|9752661|FG000|STARTED|AZD9164 1200 Mcg First, Then Placebo||28
8706518|NCT00939211|9752661|FG000|COMPLETED|AZD9164 1200 Mcg First, Then Placebo||28
8706519|NCT00939211|9752661|FG000|NOT COMPLETED|AZD9164 1200 Mcg First, Then Placebo||0
8706520|NCT00939211|9752661|FG000|STARTED|Spiriva 18 Mcg First, Then Placebo||28
8706521|NCT00939211|9752661|FG000|COMPLETED|Spiriva 18 Mcg First, Then Placebo||28
8706522|NCT00939211|9752661|FG000|NOT COMPLETED|Spiriva 18 Mcg First, Then Placebo||0
8706523|NCT00939211|9752661|FG000|STARTED|Placebo||28
8706524|NCT00939211|9752661|FG000|COMPLETED|Placebo||28
8706525|NCT00939211|9752661|FG000|NOT COMPLETED|Placebo||0
8706526|NCT00939341|9752673|FG000|STARTED|Overall Study|1022 participants were enrolled. There were 160 screen failures, 862 proceeded to treatment period.|862
8706527|NCT00939341|9752673|FG000|COMPLETED|Overall Study|862 participants entered into the 12-week treatment,66 discontinued, 796 completed the treatment.|796
8706528|NCT00939341|9752673|FG000|NOT COMPLETED|Overall Study||66
8706529|NCT00939367|9752677|FG000|STARTED|First Intervention||15
8706530|NCT00939367|9752678|FG001|STARTED|First Intervention||15
8706531|NCT00939367|9752677|FG000|COMPLETED|First Intervention||15
8706532|NCT00939367|9752678|FG001|COMPLETED|First Intervention||15
8706533|NCT00939367|9752677|FG000|NOT COMPLETED|First Intervention||0
8706534|NCT00939367|9752678|FG001|NOT COMPLETED|First Intervention||0
8706535|NCT00939367|9752677|FG000|STARTED|Second Intervention||15
8706536|NCT00939367|9752678|FG001|STARTED|Second Intervention||15
8706537|NCT00939367|9752677|FG000|COMPLETED|Second Intervention||15
8706538|NCT00939367|9752678|FG001|COMPLETED|Second Intervention||15
8706539|NCT00939367|9752677|FG000|NOT COMPLETED|Second Intervention||0
8706540|NCT00939367|9752678|FG001|NOT COMPLETED|Second Intervention||0
8706541|NCT00939393|9752686|FG000|STARTED|Overall Study||37
8557534|NCT03332589|9589422|FG001|NOT COMPLETED|Overall Study||0
8706542|NCT00939393|9752687|FG001|STARTED|Overall Study||35
8706543|NCT00939393|9752686|FG000|COMPLETED|Overall Study||33
8706544|NCT00939393|9752687|FG001|COMPLETED|Overall Study||35
8706545|NCT00939393|9752686|FG000|NOT COMPLETED|Overall Study||4
8706546|NCT00939393|9752687|FG001|NOT COMPLETED|Overall Study||0
8706547|NCT00939471|9752695|FG000|STARTED|Overall Study||44
8706548|NCT00939471|9752695|FG000|COMPLETED|Overall Study||33
8706549|NCT00939471|9752695|FG000|NOT COMPLETED|Overall Study||11
8706550|NCT00939484|9752702|FG000|STARTED|Overall Study||8
8706551|NCT00939484|9752703|FG001|STARTED|Overall Study||20
8706552|NCT00939484|9752704|FG002|STARTED|Overall Study||3
8706553|NCT00939484|9752702|FG000|COMPLETED|Overall Study||0
8706554|NCT00939484|9752703|FG001|COMPLETED|Overall Study||0
8706555|NCT00939484|9752704|FG002|COMPLETED|Overall Study||0
8706556|NCT00939484|9752702|FG000|NOT COMPLETED|Overall Study||8
8706557|NCT00939484|9752703|FG001|NOT COMPLETED|Overall Study||20
8706558|NCT00939484|9752704|FG002|NOT COMPLETED|Overall Study||3
8706559|NCT00939510|9752714|FG000|STARTED|Overall Study||32
8706560|NCT00939510|9752714|FG000|COMPLETED|Overall Study||31
8706561|NCT00939510|9752714|FG000|NOT COMPLETED|Overall Study||1
8706562|NCT00939523|9752718|FG000|STARTED|Overall Study||9
8812869|NCT01522417|9865944|FG000|STARTED|Overall Study||209
8812870|NCT01522417|9865945|FG001|STARTED|Overall Study||202
8812871|NCT01522417|9865946|FG002|STARTED|Overall Study|Randomization into the long tirofiban arm was initiated on 14 June 2013.|124
8812872|NCT01522417|9865944|FG000|COMPLETED|Overall Study||209
8812873|NCT01522417|9865945|FG001|COMPLETED|Overall Study||202
8812874|NCT01522417|9865946|FG002|COMPLETED|Overall Study|Randomization into the long tirofiban arm was completed on 1 February 2018.|124
8812875|NCT01522417|9865944|FG000|NOT COMPLETED|Overall Study||0
8812876|NCT01522417|9865945|FG001|NOT COMPLETED|Overall Study||0
8812877|NCT01522417|9865946|FG002|NOT COMPLETED|Overall Study||0
8812878|NCT01522443|9865956|FG000|STARTED|Overall Study||61
8812879|NCT01522443|9865957|FG001|STARTED|Overall Study||58
8812880|NCT01522443|9865956|FG000|COMPLETED|Overall Study||8
8812881|NCT01522443|9865957|FG001|COMPLETED|Overall Study||3
8812882|NCT01522443|9865956|FG000|NOT COMPLETED|Overall Study||53
8812883|NCT01522443|9865957|FG001|NOT COMPLETED|Overall Study||55
8812884|NCT01522456|9865963|FG000|STARTED|Overall Study||73
8812885|NCT01522456|9865963|FG000|COMPLETED|Overall Study||65
8812886|NCT01522456|9865963|FG000|NOT COMPLETED|Overall Study||8
8812887|NCT01522651|9865979|FG000|STARTED|Overall Study||26
8812888|NCT01522651|9865980|FG001|STARTED|Overall Study||27
8812889|NCT01522651|9865981|FG002|STARTED|Overall Study||26
8812890|NCT01522651|9865982|FG003|STARTED|Overall Study||28
8812891|NCT01522651|9865983|FG004|STARTED|Overall Study||27
8812892|NCT01522651|9865979|FG000|COMPLETED|Overall Study||17
8812893|NCT01522651|9865980|FG001|COMPLETED|Overall Study||19
8812894|NCT01522651|9865981|FG002|COMPLETED|Overall Study||22
8812895|NCT01522651|9865982|FG003|COMPLETED|Overall Study||20
8812896|NCT01522651|9865983|FG004|COMPLETED|Overall Study||21
8812897|NCT01522651|9865979|FG000|NOT COMPLETED|Overall Study||9
8812898|NCT01522651|9865980|FG001|NOT COMPLETED|Overall Study||8
8812899|NCT01522651|9865981|FG002|NOT COMPLETED|Overall Study||4
8812900|NCT01522651|9865982|FG003|NOT COMPLETED|Overall Study||8
8812901|NCT01522651|9865983|FG004|NOT COMPLETED|Overall Study||6
8812902|NCT01522703|9865997|FG000|STARTED|Overall Study||25
8812903|NCT01522703|9865998|FG001|STARTED|Overall Study||26
8812904|NCT01522703|9865997|FG000|COMPLETED|Overall Study||20
8812905|NCT01522703|9865998|FG001|COMPLETED|Overall Study||20
8812906|NCT01522703|9865997|FG000|NOT COMPLETED|Overall Study||5
8812907|NCT01522703|9865998|FG001|NOT COMPLETED|Overall Study||6
8812908|NCT01522755|9866004|FG000|STARTED|Overall Study||409
8812909|NCT01522755|9866004|FG000|COMPLETED|Overall Study||409
8812910|NCT01522755|9866004|FG000|NOT COMPLETED|Overall Study||0
8706563|NCT00939523|9752718|FG000|COMPLETED|Overall Study||6
8706564|NCT00939523|9752718|FG000|NOT COMPLETED|Overall Study||3
8706565|NCT00939536|9752724|FG000|STARTED|First Intervention||12
8812911|NCT01522924|9866011|FG000|STARTED|Overall Study|There were 42 dental students in the intervention group.|42
8812912|NCT01522924|9866012|FG001|STARTED|Overall Study|There were 52 dental students in the control group.|52
8812913|NCT01522924|9866011|FG000|COMPLETED|Overall Study|There were 42 dental students who completed the second survey after the intervention.|42
8812914|NCT01522924|9866012|FG001|COMPLETED|Overall Study|There were 52 dental students who completed the second survey after the lecture.|52
8812915|NCT01522924|9866011|FG000|NOT COMPLETED|Overall Study||0
8812916|NCT01522924|9866012|FG001|NOT COMPLETED|Overall Study||0
8812917|NCT01522937|9866018|FG000|STARTED|Overall Study||146
8706566|NCT00939536|9752725|FG001|STARTED|First Intervention||12
8706567|NCT00939536|9752724|FG000|COMPLETED|First Intervention||12
8706568|NCT00939536|9752725|FG001|COMPLETED|First Intervention||12
8706569|NCT00939536|9752724|FG000|NOT COMPLETED|First Intervention||0
8706570|NCT00939536|9752725|FG001|NOT COMPLETED|First Intervention||0
8706571|NCT00939536|9752724|FG000|STARTED|Second Intervention||12
8706572|NCT00939536|9752725|FG001|STARTED|Second Intervention||12
8706573|NCT00939536|9752724|FG000|COMPLETED|Second Intervention||12
8706574|NCT00939536|9752725|FG001|COMPLETED|Second Intervention||12
8706575|NCT00939536|9752724|FG000|NOT COMPLETED|Second Intervention||0
8706576|NCT00939536|9752725|FG001|NOT COMPLETED|Second Intervention||0
8706577|NCT00939562|9752731|FG000|STARTED|Period 1||12
8706578|NCT00939562|9752732|FG001|STARTED|Period 1||12
8706579|NCT00939562|9752731|FG000|COMPLETED|Period 1||12
8706580|NCT00939562|9752732|FG001|COMPLETED|Period 1||12
8706581|NCT00939562|9752731|FG000|NOT COMPLETED|Period 1||0
8706582|NCT00939562|9752732|FG001|NOT COMPLETED|Period 1||0
8706583|NCT00939562|9752731|FG000|STARTED|Period 2||12
8706584|NCT00939562|9752732|FG001|STARTED|Period 2||12
8706585|NCT00939562|9752731|FG000|COMPLETED|Period 2||12
8706586|NCT00939562|9752732|FG001|COMPLETED|Period 2||12
8706587|NCT00939562|9752731|FG000|NOT COMPLETED|Period 2||0
8706588|NCT00939562|9752732|FG001|NOT COMPLETED|Period 2||0
8706589|NCT00939627|9752740|FG000|STARTED|Overall Study||27
8706590|NCT00939627|9752741|FG001|STARTED|Overall Study||28
8706591|NCT00939627|9752742|FG002|STARTED|Overall Study||0
8706592|NCT00939627|9752740|FG000|COMPLETED|Overall Study||0
8706593|NCT00939627|9752741|FG001|COMPLETED|Overall Study||0
8706594|NCT00939627|9752742|FG002|COMPLETED|Overall Study||0
8706595|NCT00939627|9752740|FG000|NOT COMPLETED|Overall Study||27
8706596|NCT00939627|9752741|FG001|NOT COMPLETED|Overall Study||28
8706597|NCT00939627|9752742|FG002|NOT COMPLETED|Overall Study||0
8706598|NCT00939640|9752748|FG000|STARTED|Overall Study||14
8706599|NCT00939640|9752748|FG000|COMPLETED|Overall Study||13
8706600|NCT00939640|9752748|FG000|NOT COMPLETED|Overall Study||1
8706601|NCT00939653|9752757|FG000|STARTED|Treatment Course 1||6
8706602|NCT00939653|9752757|FG000|COMPLETED|Treatment Course 1||6
8706603|NCT00939653|9752757|FG000|NOT COMPLETED|Treatment Course 1||0
8706604|NCT00939653|9752757|FG000|STARTED|Treatment Course 2||2
8706605|NCT00939653|9752757|FG000|COMPLETED|Treatment Course 2||2
8706606|NCT00939653|9752757|FG000|NOT COMPLETED|Treatment Course 2||0
8706607|NCT00939653|9752757|FG000|STARTED|Treatment Course 3||0
8706608|NCT00939653|9752757|FG000|COMPLETED|Treatment Course 3||0
8706609|NCT00939653|9752757|FG000|NOT COMPLETED|Treatment Course 3||0
8706610|NCT00939653|9752757|FG000|STARTED|Treatment Course 4||0
8706611|NCT00939653|9752757|FG000|COMPLETED|Treatment Course 4||0
8706612|NCT00939653|9752757|FG000|NOT COMPLETED|Treatment Course 4||0
8706613|NCT00939692|9752764|FG000|STARTED|Period 1 - First Intervention - 5 Days||13
8706614|NCT00939692|9752765|FG001|STARTED|Period 1 - First Intervention - 5 Days||13
8706615|NCT00939692|9752764|FG000|COMPLETED|Period 1 - First Intervention - 5 Days||12
8706616|NCT00939692|9752765|FG001|COMPLETED|Period 1 - First Intervention - 5 Days||13
8706617|NCT00939692|9752764|FG000|NOT COMPLETED|Period 1 - First Intervention - 5 Days||1
8706618|NCT00939692|9752765|FG001|NOT COMPLETED|Period 1 - First Intervention - 5 Days||0
8706619|NCT00939692|9752764|FG000|STARTED|Period 2 - Second Intervent - 5 Days||12
8706620|NCT00939692|9752765|FG001|STARTED|Period 2 - Second Intervent - 5 Days||13
8706621|NCT00939692|9752764|FG000|COMPLETED|Period 2 - Second Intervent - 5 Days||12
8706622|NCT00939692|9752765|FG001|COMPLETED|Period 2 - Second Intervent - 5 Days||12
8706623|NCT00939692|9752764|FG000|NOT COMPLETED|Period 2 - Second Intervent - 5 Days||0
8706624|NCT00939692|9752765|FG001|NOT COMPLETED|Period 2 - Second Intervent - 5 Days||1
8706625|NCT00939705|9752773|FG000|STARTED|Period 1 - First Intervention - 5 Days||9
8706626|NCT00939705|9752774|FG001|STARTED|Period 1 - First Intervention - 5 Days||9
8706627|NCT00939705|9752773|FG000|COMPLETED|Period 1 - First Intervention - 5 Days||9
8706628|NCT00939705|9752774|FG001|COMPLETED|Period 1 - First Intervention - 5 Days||9
8706629|NCT00939705|9752773|FG000|NOT COMPLETED|Period 1 - First Intervention - 5 Days||0
8706630|NCT00939705|9752774|FG001|NOT COMPLETED|Period 1 - First Intervention - 5 Days||0
8706631|NCT00939705|9752773|FG000|STARTED|Period 2 - Washout Period - 21 Days||9
8706632|NCT00939705|9752774|FG001|STARTED|Period 2 - Washout Period - 21 Days||9
8706633|NCT00939705|9752773|FG000|COMPLETED|Period 2 - Washout Period - 21 Days||9
8706634|NCT00939705|9752774|FG001|COMPLETED|Period 2 - Washout Period - 21 Days||9
8706635|NCT00939705|9752773|FG000|NOT COMPLETED|Period 2 - Washout Period - 21 Days||0
8706636|NCT00939705|9752774|FG001|NOT COMPLETED|Period 2 - Washout Period - 21 Days||0
8706637|NCT00939705|9752773|FG000|STARTED|Period 3 - Second Intervent - 5 Days||9
8706638|NCT00939705|9752774|FG001|STARTED|Period 3 - Second Intervent - 5 Days||9
8706639|NCT00939705|9752773|FG000|COMPLETED|Period 3 - Second Intervent - 5 Days||9
8706640|NCT00939705|9752774|FG001|COMPLETED|Period 3 - Second Intervent - 5 Days||9
8706641|NCT00939705|9752773|FG000|NOT COMPLETED|Period 3 - Second Intervent - 5 Days||0
8706642|NCT00939705|9752774|FG001|NOT COMPLETED|Period 3 - Second Intervent - 5 Days||0
8706643|NCT00939731|9752780|FG000|STARTED|First Intervention Period||12
8706644|NCT00939731|9752781|FG001|STARTED|First Intervention Period||12
8706645|NCT00939731|9752780|FG000|COMPLETED|First Intervention Period||12
8706646|NCT00939731|9752781|FG001|COMPLETED|First Intervention Period||12
8706647|NCT00939731|9752780|FG000|NOT COMPLETED|First Intervention Period||0
8706648|NCT00939731|9752781|FG001|NOT COMPLETED|First Intervention Period||0
8706649|NCT00939731|9752780|FG000|STARTED|Washout Period (at Least 14 Days)||12
8706650|NCT00939731|9752781|FG001|STARTED|Washout Period (at Least 14 Days)||12
8706651|NCT00939731|9752780|FG000|COMPLETED|Washout Period (at Least 14 Days)||12
8706652|NCT00939731|9752781|FG001|COMPLETED|Washout Period (at Least 14 Days)||12
8706653|NCT00939731|9752780|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8706654|NCT00939731|9752781|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8706655|NCT00939731|9752780|FG000|STARTED|Second Intervention Period||12
8706656|NCT00939731|9752781|FG001|STARTED|Second Intervention Period||12
8706657|NCT00939731|9752780|FG000|COMPLETED|Second Intervention Period||12
8706658|NCT00939731|9752781|FG001|COMPLETED|Second Intervention Period||12
8706659|NCT00939731|9752780|FG000|NOT COMPLETED|Second Intervention Period||0
8706660|NCT00939731|9752781|FG001|NOT COMPLETED|Second Intervention Period||0
8706661|NCT00939770|9752795|FG000|STARTED|Overall Study||6
8706662|NCT00939770|9752796|FG001|STARTED|Overall Study||8
8706663|NCT00939770|9752797|FG002|STARTED|Overall Study||23
8706664|NCT00939770|9752798|FG003|STARTED|Overall Study||12
8706665|NCT00939770|9752799|FG004|STARTED|Overall Study||38
8706666|NCT00939770|9752800|FG005|STARTED|Overall Study||11
8706667|NCT00939770|9752801|FG006|STARTED|Overall Study||14
8706668|NCT00939770|9752802|FG007|STARTED|Overall Study||10
8706669|NCT00939770|9752795|FG000|COMPLETED|Overall Study||1
8706670|NCT00939770|9752796|FG001|COMPLETED|Overall Study||0
8706671|NCT00939770|9752797|FG002|COMPLETED|Overall Study||3
8706672|NCT00939770|9752798|FG003|COMPLETED|Overall Study||1
8706673|NCT00939770|9752799|FG004|COMPLETED|Overall Study||1
8706674|NCT00939770|9752800|FG005|COMPLETED|Overall Study||0
8706675|NCT00939770|9752801|FG006|COMPLETED|Overall Study||0
8706676|NCT00939770|9752802|FG007|COMPLETED|Overall Study||0
8706677|NCT00939770|9752795|FG000|NOT COMPLETED|Overall Study||5
8706678|NCT00939770|9752796|FG001|NOT COMPLETED|Overall Study||8
8706679|NCT00939770|9752797|FG002|NOT COMPLETED|Overall Study||20
8706680|NCT00939770|9752798|FG003|NOT COMPLETED|Overall Study||11
8706681|NCT00939770|9752799|FG004|NOT COMPLETED|Overall Study||37
8706682|NCT00939770|9752800|FG005|NOT COMPLETED|Overall Study||11
8706683|NCT00939770|9752801|FG006|NOT COMPLETED|Overall Study||14
8706684|NCT00939770|9752802|FG007|NOT COMPLETED|Overall Study||10
8706685|NCT00939783|9752833|FG000|STARTED|Overall Study||649
8706686|NCT00939783|9752833|FG000|Treated|Overall Study||648
8706687|NCT00939783|9752833|FG000|COMPLETED|Overall Study||0
8706688|NCT00939783|9752833|FG000|NOT COMPLETED|Overall Study||649
8706689|NCT00939796|9752837|FG000|STARTED|Overall Study||16
8706690|NCT00939796|9752837|FG000|COMPLETED|Overall Study||16
8706691|NCT00939796|9752837|FG000|NOT COMPLETED|Overall Study||0
8706692|NCT00939809|9752841|FG000|STARTED|Overall Study||31
8706693|NCT00939809|9752841|FG000|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|28
8706694|NCT00939809|9752841|FG000|NOT COMPLETED|Overall Study||3
8706695|NCT00939822|9752847|FG000|STARTED|Overall Study||44
8706696|NCT00939822|9752848|FG001|STARTED|Overall Study||44
8706697|NCT00939822|9752847|FG000|COMPLETED|Overall Study||42
8706698|NCT00939822|9752848|FG001|COMPLETED|Overall Study||41
8706699|NCT00939822|9752847|FG000|NOT COMPLETED|Overall Study||2
8706700|NCT00939822|9752848|FG001|NOT COMPLETED|Overall Study||3
8706701|NCT00939874|9752854|FG000|STARTED|Overall Study||52
8706702|NCT00939874|9752854|FG000|Completed Week 48|Overall Study||37
8706703|NCT00939874|9752854|FG000|COMPLETED|Overall Study||32
8706704|NCT00939874|9752854|FG000|NOT COMPLETED|Overall Study||20
8706705|NCT00939900|9752860|FG000|STARTED|Overall Study||55
8706706|NCT00939900|9752861|FG001|STARTED|Overall Study||55
8706707|NCT00939900|9752860|FG000|COMPLETED|Overall Study||53
8706708|NCT00939900|9752861|FG001|COMPLETED|Overall Study||48
8706709|NCT00939900|9752860|FG000|NOT COMPLETED|Overall Study||2
8706710|NCT00939900|9752861|FG001|NOT COMPLETED|Overall Study||7
8706711|NCT00939952|9752867|FG000|STARTED|Overall Study||7
8706712|NCT00939952|9752867|FG000|COMPLETED|Overall Study||7
8706713|NCT00939952|9752867|FG000|NOT COMPLETED|Overall Study||0
8706714|NCT00939991|9752873|FG000|STARTED|Overall Study||9
8706715|NCT00939991|9752874|FG001|STARTED|Overall Study||39
8706716|NCT00939991|9752873|FG000|COMPLETED|Overall Study||9
8706717|NCT00939991|9752874|FG001|COMPLETED|Overall Study||39
8706718|NCT00939991|9752873|FG000|NOT COMPLETED|Overall Study||0
8706719|NCT00939991|9752874|FG001|NOT COMPLETED|Overall Study||0
8706720|NCT00940017|9752880|FG000|STARTED|Overall Study||24
8706721|NCT00940017|9752880|FG000|Subjects Treated|Overall Study||21
8706722|NCT00940017|9752880|FG000|COMPLETED|Overall Study||20
8706723|NCT00940017|9752880|FG000|NOT COMPLETED|Overall Study||4
8706724|NCT00940108|9752888|FG000|STARTED|Overall Study||82
8706725|NCT00940108|9752889|FG001|STARTED|Overall Study||80
8706726|NCT00940108|9752890|FG002|STARTED|Overall Study||103
8706727|NCT00940108|9752891|FG003|STARTED|Overall Study||104
8706728|NCT00940108|9752888|FG000|COMPLETED|Overall Study||77
8706729|NCT00940108|9752889|FG001|COMPLETED|Overall Study||71
8706730|NCT00940108|9752890|FG002|COMPLETED|Overall Study||100
8706731|NCT00940108|9752891|FG003|COMPLETED|Overall Study||99
8706732|NCT00940108|9752888|FG000|NOT COMPLETED|Overall Study||5
8706733|NCT00940108|9752889|FG001|NOT COMPLETED|Overall Study||9
8706734|NCT00940108|9752890|FG002|NOT COMPLETED|Overall Study||3
8706735|NCT00940108|9752891|FG003|NOT COMPLETED|Overall Study||5
8706736|NCT00940290|9752905|FG000|STARTED|Overall Study||54
8706737|NCT00940290|9752906|FG001|STARTED|Overall Study||53
8706738|NCT00940290|9752907|FG002|STARTED|Overall Study||55
8706739|NCT00940290|9752908|FG003|STARTED|Overall Study||54
8706740|NCT00940290|9752905|FG000|COMPLETED|Overall Study||54
8706741|NCT00940290|9752906|FG001|COMPLETED|Overall Study||53
8706742|NCT00940290|9752907|FG002|COMPLETED|Overall Study||55
8706743|NCT00940290|9752908|FG003|COMPLETED|Overall Study||54
8706744|NCT00940290|9752905|FG000|NOT COMPLETED|Overall Study||0
8706745|NCT00940290|9752906|FG001|NOT COMPLETED|Overall Study||0
8706746|NCT00940290|9752907|FG002|NOT COMPLETED|Overall Study||0
8706747|NCT00940290|9752908|FG003|NOT COMPLETED|Overall Study||0
8706748|NCT00940316|9752921|FG000|STARTED|Reached First Response at 8 Weeks||13
8706749|NCT00940316|9752922|FG001|STARTED|Reached First Response at 8 Weeks||13
8706750|NCT00940316|9752923|FG002|STARTED|Reached First Response at 8 Weeks||2
8706751|NCT00940316|9752921|FG000|COMPLETED|Reached First Response at 8 Weeks||10
8706752|NCT00940316|9752922|FG001|COMPLETED|Reached First Response at 8 Weeks||9
8706753|NCT00940316|9752923|FG002|COMPLETED|Reached First Response at 8 Weeks||2
8706754|NCT00940316|9752921|FG000|NOT COMPLETED|Reached First Response at 8 Weeks||3
8706755|NCT00940316|9752922|FG001|NOT COMPLETED|Reached First Response at 8 Weeks||4
8706756|NCT00940316|9752923|FG002|NOT COMPLETED|Reached First Response at 8 Weeks||0
8706757|NCT00940316|9752921|FG000|STARTED|Moved on to be Treated Cycle 5||10
8706758|NCT00940316|9752922|FG001|STARTED|Moved on to be Treated Cycle 5||9
8706759|NCT00940316|9752923|FG002|STARTED|Moved on to be Treated Cycle 5||2
8706760|NCT00940316|9752921|FG000|COMPLETED|Moved on to be Treated Cycle 5||8
8706761|NCT00940316|9752922|FG001|COMPLETED|Moved on to be Treated Cycle 5||9
8706762|NCT00940316|9752923|FG002|COMPLETED|Moved on to be Treated Cycle 5||2
8706763|NCT00940316|9752921|FG000|NOT COMPLETED|Moved on to be Treated Cycle 5||2
8706764|NCT00940316|9752922|FG001|NOT COMPLETED|Moved on to be Treated Cycle 5||0
8706765|NCT00940316|9752923|FG002|NOT COMPLETED|Moved on to be Treated Cycle 5||0
8706766|NCT00940316|9752921|FG000|STARTED|Treated After Cycle 5||8
8706767|NCT00940316|9752922|FG001|STARTED|Treated After Cycle 5||9
8706768|NCT00940316|9752923|FG002|STARTED|Treated After Cycle 5||2
8706769|NCT00940316|9752921|FG000|COMPLETED|Treated After Cycle 5||8
8706770|NCT00940316|9752922|FG001|COMPLETED|Treated After Cycle 5||8
8706771|NCT00940316|9752923|FG002|COMPLETED|Treated After Cycle 5||1
8706772|NCT00940316|9752921|FG000|NOT COMPLETED|Treated After Cycle 5||0
8706773|NCT00940316|9752922|FG001|NOT COMPLETED|Treated After Cycle 5||1
8706774|NCT00940316|9752923|FG002|NOT COMPLETED|Treated After Cycle 5||1
8706775|NCT00940316|9752921|FG000|STARTED|Crossed Over to Arm A After Progression||0
8706776|NCT00940316|9752922|FG001|STARTED|Crossed Over to Arm A After Progression||3
8706777|NCT00940316|9752923|FG002|STARTED|Crossed Over to Arm A After Progression||0
8706778|NCT00940316|9752921|FG000|Treated for Cycle One|Crossed Over to Arm A After Progression||0
8706779|NCT00940316|9752922|FG001|Treated for Cycle One|Crossed Over to Arm A After Progression||3
8706780|NCT00940316|9752923|FG002|Treated for Cycle One|Crossed Over to Arm A After Progression||0
8706781|NCT00940316|9752921|FG000|COMPLETED|Crossed Over to Arm A After Progression||0
8706782|NCT00940316|9752922|FG001|COMPLETED|Crossed Over to Arm A After Progression||3
8706783|NCT00940316|9752923|FG002|COMPLETED|Crossed Over to Arm A After Progression||0
8706784|NCT00940316|9752921|FG000|NOT COMPLETED|Crossed Over to Arm A After Progression||0
8706785|NCT00940316|9752922|FG001|NOT COMPLETED|Crossed Over to Arm A After Progression||0
8706786|NCT00940316|9752923|FG002|NOT COMPLETED|Crossed Over to Arm A After Progression||0
8706787|NCT00940316|9752921|FG000|STARTED|Follow up Every 3 Months||13
8706788|NCT00940316|9752922|FG001|STARTED|Follow up Every 3 Months||13
8706789|NCT00940316|9752923|FG002|STARTED|Follow up Every 3 Months||2
8706790|NCT00940316|9752921|FG000|COMPLETED|Follow up Every 3 Months||13
8706791|NCT00940316|9752922|FG001|COMPLETED|Follow up Every 3 Months||13
8706792|NCT00940316|9752923|FG002|COMPLETED|Follow up Every 3 Months||2
8706793|NCT00940316|9752921|FG000|NOT COMPLETED|Follow up Every 3 Months||0
8706794|NCT00940316|9752922|FG001|NOT COMPLETED|Follow up Every 3 Months||0
8706795|NCT00940316|9752923|FG002|NOT COMPLETED|Follow up Every 3 Months||0
8706796|NCT00940342|9752942|FG000|STARTED|Overall Study||50
8706797|NCT00940342|9752943|FG001|STARTED|Overall Study||40
8706798|NCT00940342|9752944|FG002|STARTED|Overall Study||40
8706799|NCT00940342|9752942|FG000|COMPLETED|Overall Study||50
8706800|NCT00940342|9752943|FG001|COMPLETED|Overall Study||38
8706801|NCT00940342|9752944|FG002|COMPLETED|Overall Study||39
8706802|NCT00940342|9752942|FG000|NOT COMPLETED|Overall Study||0
8706803|NCT00940342|9752943|FG001|NOT COMPLETED|Overall Study||2
8706804|NCT00940342|9752944|FG002|NOT COMPLETED|Overall Study||1
8706805|NCT00940446|9752954|FG000|STARTED|Overall Study||30
8706806|NCT00940446|9752955|FG001|STARTED|Overall Study||30
8706807|NCT00940446|9752954|FG000|COMPLETED|Overall Study||30
8706808|NCT00940446|9752955|FG001|COMPLETED|Overall Study||30
8706809|NCT00940446|9752954|FG000|NOT COMPLETED|Overall Study||0
8706810|NCT00940446|9752955|FG001|NOT COMPLETED|Overall Study||0
8706811|NCT00940485|9752965|FG000|STARTED|Overall Study||97
8706812|NCT00940485|9752966|FG001|STARTED|Overall Study||100
8706813|NCT00940485|9752965|FG000|COMPLETED|Overall Study||82
8706814|NCT00940485|9752966|FG001|COMPLETED|Overall Study||93
8706815|NCT00940485|9752965|FG000|NOT COMPLETED|Overall Study||15
8706816|NCT00940485|9752966|FG001|NOT COMPLETED|Overall Study||7
8706817|NCT00940537|9752974|FG000|STARTED|Overall Study||5
8706818|NCT00940537|9752975|FG001|STARTED|Overall Study||9
8706819|NCT00940537|9752974|FG000|COMPLETED|Overall Study||5
8706820|NCT00940537|9752975|FG001|COMPLETED|Overall Study||9
8706821|NCT00940537|9752974|FG000|NOT COMPLETED|Overall Study||0
8706822|NCT00940537|9752975|FG001|NOT COMPLETED|Overall Study||0
8706823|NCT00940576|9752982|FG000|STARTED|Overall Study||8
8706824|NCT00940576|9752983|FG001|STARTED|Overall Study||9
8706825|NCT00940576|9752982|FG000|COMPLETED|Overall Study||8
8706826|NCT00940576|9752983|FG001|COMPLETED|Overall Study||9
8706827|NCT00940576|9752982|FG000|NOT COMPLETED|Overall Study||0
8706828|NCT00940576|9752983|FG001|NOT COMPLETED|Overall Study||0
8706829|NCT00940589|9752992|FG000|STARTED|Overall Study||39
8706830|NCT00940589|9752993|FG001|STARTED|Overall Study||34
8706831|NCT00940589|9752992|FG000|COMPLETED|Overall Study||31
8706832|NCT00940589|9752993|FG001|COMPLETED|Overall Study||29
8706833|NCT00940589|9752992|FG000|NOT COMPLETED|Overall Study||8
8706834|NCT00940589|9752993|FG001|NOT COMPLETED|Overall Study||5
8706835|NCT00940602|9753001|FG000|STARTED|Overall Study||149
8706836|NCT00940602|9753002|FG001|STARTED|Overall Study||76
8706837|NCT00940602|9753001|FG000|Safety Analysis Set|Overall Study||148
8706838|NCT00940602|9753002|FG001|Safety Analysis Set|Overall Study||76
8706839|NCT00940602|9753001|FG000|Full Analysis Set|Overall Study||149
8706840|NCT00940602|9753002|FG001|Full Analysis Set|Overall Study||76
8706841|NCT00940602|9753001|FG000|Treated|Overall Study||148
8706842|NCT00940602|9753002|FG001|Treated|Overall Study||76
8706843|NCT00940602|9753001|FG000|Untreated|Overall Study||1
8706844|NCT00940602|9753002|FG001|Untreated|Overall Study||0
8706845|NCT00940602|9753001|FG000|COMPLETED|Overall Study||0
8706846|NCT00940602|9753002|FG001|COMPLETED|Overall Study||0
8706847|NCT00940602|9753001|FG000|NOT COMPLETED|Overall Study||149
8706848|NCT00940602|9753002|FG001|NOT COMPLETED|Overall Study||76
8706849|NCT00940771|9753009|FG000|STARTED|Pre-Entry||10
8706850|NCT00940771|9753009|FG000|COMPLETED|Pre-Entry||10
8706851|NCT00940771|9753009|FG000|NOT COMPLETED|Pre-Entry||0
8706852|NCT00940771|9753009|FG000|STARTED|4 Weeks||10
8706853|NCT00940771|9753009|FG000|COMPLETED|4 Weeks||10
8706854|NCT00940771|9753009|FG000|NOT COMPLETED|4 Weeks||0
8706855|NCT00940771|9753009|FG000|STARTED|12 Weeks||10
8706856|NCT00940771|9753009|FG000|COMPLETED|12 Weeks||10
8706857|NCT00940771|9753009|FG000|NOT COMPLETED|12 Weeks||0
8706858|NCT00940771|9753009|FG000|STARTED|24 Weeks||10
8706859|NCT00940771|9753009|FG000|COMPLETED|24 Weeks||10
8706860|NCT00940771|9753009|FG000|NOT COMPLETED|24 Weeks||0
8706861|NCT00940823|9753015|FG000|STARTED|Overall Study||124
8706862|NCT00940823|9753016|FG001|STARTED|Overall Study||114
8706863|NCT00940823|9753015|FG000|COMPLETED|Overall Study||89
8706864|NCT00940823|9753016|FG001|COMPLETED|Overall Study||82
8706865|NCT00940823|9753015|FG000|NOT COMPLETED|Overall Study||35
8706866|NCT00940823|9753016|FG001|NOT COMPLETED|Overall Study||32
8706867|NCT00940875|9753026|FG000|STARTED|Treatment Phase|Disposition analysis includes 3 participants randomized to G+E but received only gemcitabine|31
8706868|NCT00940875|9753027|FG001|STARTED|Treatment Phase|3 participants randomized to G+E arm received only gemcitabine and were analyzed in Gemcitabine arm|23
8706869|NCT00940875|9753026|FG000|COMPLETED|Treatment Phase||5
8706870|NCT00940875|9753027|FG001|COMPLETED|Treatment Phase||4
8706871|NCT00940875|9753026|FG000|NOT COMPLETED|Treatment Phase||26
8706872|NCT00940875|9753027|FG001|NOT COMPLETED|Treatment Phase||19
8706873|NCT00940875|9753026|FG000|STARTED|Post-Study Treatment||0
8706874|NCT00940875|9753027|FG001|STARTED|Post-Study Treatment||4
8706875|NCT00940875|9753026|FG000|COMPLETED|Post-Study Treatment||0
8706876|NCT00940875|9753027|FG001|COMPLETED|Post-Study Treatment||1
8706877|NCT00940875|9753026|FG000|NOT COMPLETED|Post-Study Treatment||0
8706878|NCT00940875|9753027|FG001|NOT COMPLETED|Post-Study Treatment||3
8706879|NCT00940888|9753034|FG000|STARTED|Overall Study|Total number of subjects consented|1701
8706880|NCT00940888|9753034|FG000|COMPLETED|Overall Study|Subjects that completed the 60 month follow up visit|866
8706881|NCT00940888|9753034|FG000|NOT COMPLETED|Overall Study||835
8706882|NCT00940901|9753040|FG000|STARTED|Weeks 1-8 (Phase 1)||6
8706883|NCT00940901|9753041|FG001|STARTED|Weeks 1-8 (Phase 1)||7
8706884|NCT00940901|9753040|FG000|COMPLETED|Weeks 1-8 (Phase 1)||6
8706885|NCT00940901|9753041|FG001|COMPLETED|Weeks 1-8 (Phase 1)||7
8706886|NCT00940901|9753040|FG000|NOT COMPLETED|Weeks 1-8 (Phase 1)||0
8706887|NCT00940901|9753041|FG001|NOT COMPLETED|Weeks 1-8 (Phase 1)||0
8706888|NCT00940901|9753040|FG000|STARTED|Week 9-16 (Phase 2)||6
8706889|NCT00940901|9753041|FG001|STARTED|Week 9-16 (Phase 2)||7
8706890|NCT00940901|9753040|FG000|COMPLETED|Week 9-16 (Phase 2)||4
8706891|NCT00940901|9753041|FG001|COMPLETED|Week 9-16 (Phase 2)||4
8706892|NCT00940901|9753040|FG000|NOT COMPLETED|Week 9-16 (Phase 2)||2
8706893|NCT00940901|9753041|FG001|NOT COMPLETED|Week 9-16 (Phase 2)||3
8706894|NCT00940927|9753049|FG000|STARTED|Overall Study||81
8706895|NCT00940927|9753049|FG000|COMPLETED|Overall Study||81
8706896|NCT00940927|9753049|FG000|NOT COMPLETED|Overall Study||0
8706897|NCT00940992|9753056|FG000|STARTED|Overall Study||32
8706898|NCT00940992|9753057|FG001|STARTED|Overall Study||30
8706899|NCT00940992|9753058|FG002|STARTED|Overall Study||30
8706900|NCT00940992|9753056|FG000|COMPLETED|Overall Study||28
8706901|NCT00940992|9753057|FG001|COMPLETED|Overall Study||28
8706902|NCT00940992|9753058|FG002|COMPLETED|Overall Study||28
8706903|NCT00940992|9753056|FG000|NOT COMPLETED|Overall Study||4
8706904|NCT00940992|9753057|FG001|NOT COMPLETED|Overall Study||2
8706905|NCT00940992|9753058|FG002|NOT COMPLETED|Overall Study||2
8724713|NCT01027650|9771967|FG006|STARTED|Overall Study||25
8724714|NCT01027650|9771968|FG007|STARTED|Overall Study||24
8724715|NCT01027650|9771961|FG000|COMPLETED|Overall Study||6
8724716|NCT01027650|9771962|FG001|COMPLETED|Overall Study||6
8724717|NCT01027650|9771963|FG002|COMPLETED|Overall Study||6
8724718|NCT01027650|9771964|FG003|COMPLETED|Overall Study||3
8724719|NCT01027650|9771965|FG004|COMPLETED|Overall Study||23
8724720|NCT01027650|9771966|FG005|COMPLETED|Overall Study||24
8724721|NCT01027650|9771967|FG006|COMPLETED|Overall Study||24
8724722|NCT01027650|9771968|FG007|COMPLETED|Overall Study||24
8724723|NCT01027650|9771961|FG000|NOT COMPLETED|Overall Study||0
8724724|NCT01027650|9771962|FG001|NOT COMPLETED|Overall Study||0
8724725|NCT01027650|9771963|FG002|NOT COMPLETED|Overall Study||0
8724726|NCT01027650|9771964|FG003|NOT COMPLETED|Overall Study||0
8724727|NCT01027650|9771965|FG004|NOT COMPLETED|Overall Study||2
8724728|NCT01027650|9771966|FG005|NOT COMPLETED|Overall Study||2
8724729|NCT01027650|9771967|FG006|NOT COMPLETED|Overall Study||1
8724730|NCT01027650|9771968|FG007|NOT COMPLETED|Overall Study||0
8724731|NCT01027754|9771988|FG000|STARTED|Overall Study||57
8724732|NCT01027754|9771989|FG001|STARTED|Overall Study||55
8724733|NCT01027754|9771988|FG000|COMPLETED|Overall Study||55
8724734|NCT01027754|9771989|FG001|COMPLETED|Overall Study||47
8724735|NCT01027754|9771988|FG000|NOT COMPLETED|Overall Study||2
8724736|NCT01027754|9771989|FG001|NOT COMPLETED|Overall Study||8
8724737|NCT01027780|9771997|FG000|STARTED|Overall Study||105
8724738|NCT01027780|9771998|FG001|STARTED|Overall Study||103
8724739|NCT01027780|9771997|FG000|COMPLETED|Overall Study||105
8724740|NCT01027780|9771998|FG001|COMPLETED|Overall Study||102
8724741|NCT01027780|9771997|FG000|NOT COMPLETED|Overall Study||0
8724742|NCT01027780|9771998|FG001|NOT COMPLETED|Overall Study||1
8724743|NCT01027793|9772007|FG000|STARTED|Overall Study||17
8724744|NCT01027793|9772008|FG001|STARTED|Overall Study||15
8724745|NCT01027793|9772007|FG000|COMPLETED|Overall Study||10
8706906|NCT00941005|9753068|FG000|STARTED|Overall Study||61
8706907|NCT00941005|9753069|FG001|STARTED|Overall Study||61
8706908|NCT00941005|9753068|FG000|COMPLETED|Overall Study||61
8706909|NCT00941005|9753069|FG001|COMPLETED|Overall Study||61
8706910|NCT00941005|9753068|FG000|NOT COMPLETED|Overall Study||0
8706911|NCT00941005|9753069|FG001|NOT COMPLETED|Overall Study||0
8706912|NCT00941031|9753081|FG000|STARTED|Induction Period||66
8706913|NCT00941031|9753082|FG001|STARTED|Induction Period||138
8706914|NCT00941031|9753083|FG002|STARTED|Induction Period||133
8706915|NCT00941031|9753084|FG003|STARTED|Induction Period||67
8706916|NCT00941031|9753085|FG004|STARTED|Induction Period||0
8706917|NCT00941031|9753086|FG005|STARTED|Induction Period||0
8706918|NCT00941031|9753087|FG006|STARTED|Induction Period||0
8706919|NCT00941031|9753081|FG000|COMPLETED|Induction Period||61
8706920|NCT00941031|9753082|FG001|COMPLETED|Induction Period||134
8706921|NCT00941031|9753083|FG002|COMPLETED|Induction Period||127
8706922|NCT00941031|9753084|FG003|COMPLETED|Induction Period||58
8706923|NCT00941031|9753085|FG004|COMPLETED|Induction Period||0
8706924|NCT00941031|9753086|FG005|COMPLETED|Induction Period||0
8706925|NCT00941031|9753087|FG006|COMPLETED|Induction Period||0
8706926|NCT00941031|9753081|FG000|NOT COMPLETED|Induction Period||5
8706927|NCT00941031|9753082|FG001|NOT COMPLETED|Induction Period||4
8706928|NCT00941031|9753083|FG002|NOT COMPLETED|Induction Period||6
8706929|NCT00941031|9753084|FG003|NOT COMPLETED|Induction Period||9
8706930|NCT00941031|9753085|FG004|NOT COMPLETED|Induction Period||0
8706931|NCT00941031|9753086|FG005|NOT COMPLETED|Induction Period||0
8706932|NCT00941031|9753087|FG006|NOT COMPLETED|Induction Period||0
8706933|NCT00941031|9753081|FG000|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
8706934|NCT00941031|9753082|FG001|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
8706935|NCT00941031|9753083|FG002|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
8706936|NCT00941031|9753084|FG003|STARTED|Maintenance Period|Non Responders treated with an open label regimen.|0
8706937|NCT00941031|9753085|FG004|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|65
8706938|NCT00941031|9753086|FG005|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|67
8706939|NCT00941031|9753087|FG006|STARTED|Maintenance Period|Non Responders treated with an open label regimen.|247
8706940|NCT00941031|9753081|FG000|COMPLETED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
8706941|NCT00941031|9753082|FG001|COMPLETED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
8706942|NCT00941031|9753083|FG002|COMPLETED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
8706943|NCT00941031|9753084|FG003|COMPLETED|Maintenance Period|Non Responders treated with an open label regimen.|0
8706944|NCT00941031|9753085|FG004|COMPLETED|Maintenance Period||56
8706945|NCT00941031|9753086|FG005|COMPLETED|Maintenance Period||61
8706946|NCT00941031|9753087|FG006|COMPLETED|Maintenance Period||204
8706947|NCT00941031|9753081|FG000|NOT COMPLETED|Maintenance Period||0
8706948|NCT00941031|9753082|FG001|NOT COMPLETED|Maintenance Period||0
8706949|NCT00941031|9753083|FG002|NOT COMPLETED|Maintenance Period||0
8706950|NCT00941031|9753084|FG003|NOT COMPLETED|Maintenance Period||0
8706951|NCT00941031|9753085|FG004|NOT COMPLETED|Maintenance Period||9
8706952|NCT00941031|9753086|FG005|NOT COMPLETED|Maintenance Period||6
8706953|NCT00941031|9753087|FG006|NOT COMPLETED|Maintenance Period||43
8706954|NCT00941070|9753106|FG000|STARTED|Overall Study||26
8706955|NCT00941070|9753106|FG000|COMPLETED|Overall Study||25
8706956|NCT00941070|9753106|FG000|NOT COMPLETED|Overall Study||1
8706957|NCT00941304|9753117|FG000|STARTED|Overall Study||31
8706958|NCT00941304|9753118|FG001|STARTED|Overall Study||30
8706959|NCT00941304|9753119|FG002|STARTED|Overall Study||31
8706960|NCT00941304|9753120|FG003|STARTED|Overall Study||30
8706961|NCT00941304|9753121|FG004|STARTED|Overall Study||31
8706962|NCT00941304|9753117|FG000|COMPLETED|Overall Study||30
8706963|NCT00941304|9753118|FG001|COMPLETED|Overall Study||30
8706964|NCT00941304|9753119|FG002|COMPLETED|Overall Study||31
8706965|NCT00941304|9753120|FG003|COMPLETED|Overall Study||30
8706966|NCT00941304|9753121|FG004|COMPLETED|Overall Study||31
8706967|NCT00941304|9753117|FG000|NOT COMPLETED|Overall Study||1
8706968|NCT00941304|9753118|FG001|NOT COMPLETED|Overall Study||0
8706969|NCT00941304|9753119|FG002|NOT COMPLETED|Overall Study||0
8706970|NCT00941304|9753120|FG003|NOT COMPLETED|Overall Study||0
8706971|NCT00941304|9753121|FG004|NOT COMPLETED|Overall Study||0
8706972|NCT00941330|9753135|FG000|STARTED|Overall Study||15
8706973|NCT00941330|9753136|FG001|STARTED|Overall Study||11
8706974|NCT00941330|9753135|FG000|COMPLETED|Overall Study||14
8706975|NCT00941330|9753136|FG001|COMPLETED|Overall Study||9
8706976|NCT00941330|9753135|FG000|NOT COMPLETED|Overall Study||1
8706977|NCT00941330|9753136|FG001|NOT COMPLETED|Overall Study||2
8706978|NCT00941603|9753148|FG000|STARTED|Overall Study||104
8706979|NCT00941603|9753149|FG001|STARTED|Overall Study||105
8706980|NCT00941603|9753150|FG002|STARTED|Overall Study||104
8706981|NCT00941603|9753151|FG003|STARTED|Overall Study||104
8706982|NCT00941603|9753152|FG004|STARTED|Overall Study||105
8706983|NCT00941603|9753153|FG005|STARTED|Overall Study||97
8706984|NCT00941603|9753148|FG000|COMPLETED|Overall Study||93
8706985|NCT00941603|9753149|FG001|COMPLETED|Overall Study||89
8706986|NCT00941603|9753150|FG002|COMPLETED|Overall Study||99
8706987|NCT00941603|9753151|FG003|COMPLETED|Overall Study||100
8706988|NCT00941603|9753152|FG004|COMPLETED|Overall Study||101
8706989|NCT00941603|9753153|FG005|COMPLETED|Overall Study||94
8706990|NCT00941603|9753148|FG000|NOT COMPLETED|Overall Study||11
8706991|NCT00941603|9753149|FG001|NOT COMPLETED|Overall Study||16
8706992|NCT00941603|9753150|FG002|NOT COMPLETED|Overall Study||5
8706993|NCT00941603|9753151|FG003|NOT COMPLETED|Overall Study||4
8706994|NCT00941603|9753152|FG004|NOT COMPLETED|Overall Study||4
8706995|NCT00941603|9753153|FG005|NOT COMPLETED|Overall Study||3
8706996|NCT00941655|9753169|FG000|STARTED|Overall Study||8
8706997|NCT00941655|9753170|FG001|STARTED|Overall Study||7
8706998|NCT00941655|9753169|FG000|COMPLETED|Overall Study||3
8706999|NCT00941655|9753170|FG001|COMPLETED|Overall Study||2
8707000|NCT00941655|9753169|FG000|NOT COMPLETED|Overall Study||5
8707001|NCT00941655|9753170|FG001|NOT COMPLETED|Overall Study||5
8707002|NCT00941668|9753179|FG000|STARTED|Overall Study||24
8707003|NCT00941668|9753180|FG001|STARTED|Overall Study||25
8707004|NCT00941668|9753179|FG000|COMPLETED|Overall Study||0
8707005|NCT00941668|9753180|FG001|COMPLETED|Overall Study||0
8707006|NCT00941668|9753179|FG000|NOT COMPLETED|Overall Study||24
8707007|NCT00941668|9753180|FG001|NOT COMPLETED|Overall Study||25
8707008|NCT00941681|9753189|FG000|STARTED|Overall Study||12
8707009|NCT00941681|9753190|FG001|STARTED|Overall Study||11
8707010|NCT00941681|9753191|FG002|STARTED|Overall Study||12
8707011|NCT00941681|9753189|FG000|COMPLETED|Overall Study||12
8707012|NCT00941681|9753190|FG001|COMPLETED|Overall Study||10
8707013|NCT00941681|9753191|FG002|COMPLETED|Overall Study||12
8707014|NCT00941681|9753189|FG000|NOT COMPLETED|Overall Study||0
8707015|NCT00941681|9753190|FG001|NOT COMPLETED|Overall Study||1
8707016|NCT00941681|9753191|FG002|NOT COMPLETED|Overall Study||0
8707017|NCT00941720|9753199|FG000|STARTED|Overall Study||71
8707018|NCT00941720|9753199|FG000|COMPLETED|Overall Study||57
8707019|NCT00941720|9753199|FG000|NOT COMPLETED|Overall Study||14
8707020|NCT00941733|9753205|FG000|STARTED|Overall Study||239
8707021|NCT00941733|9753206|FG001|STARTED|Overall Study||119
8707022|NCT00941733|9753205|FG000|COMPLETED|Overall Study|1 year follow-up|165
8707023|NCT00941733|9753206|FG001|COMPLETED|Overall Study|1 year follow-up|91
8707024|NCT00941733|9753205|FG000|NOT COMPLETED|Overall Study||74
8707025|NCT00941733|9753206|FG001|NOT COMPLETED|Overall Study||28
8707026|NCT00941798|9753214|FG000|STARTED|Overall Study||755
8707027|NCT00941798|9753215|FG001|STARTED|Overall Study||763
8707028|NCT00941798|9753214|FG000|Full Analysis Set|Overall Study||749
8707029|NCT00941798|9753215|FG001|Full Analysis Set|Overall Study||759
8707030|NCT00941798|9753214|FG000|COMPLETED|Overall Study||561
8707031|NCT00941798|9753215|FG001|COMPLETED|Overall Study||578
8707032|NCT00941798|9753214|FG000|NOT COMPLETED|Overall Study||194
8707033|NCT00941798|9753215|FG001|NOT COMPLETED|Overall Study||185
8707034|NCT00941863|9753226|FG000|STARTED|Until Primary Completion Date (PCD)||7
8707035|NCT00941863|9753227|FG001|STARTED|Until Primary Completion Date (PCD)||3
8707036|NCT00941863|9753228|FG002|STARTED|Until Primary Completion Date (PCD)||12
8707037|NCT00941863|9753229|FG003|STARTED|Until Primary Completion Date (PCD)||17
8707038|NCT00941863|9753230|FG004|STARTED|Until Primary Completion Date (PCD)||119
8707039|NCT00941863|9753226|FG000|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||7
8707040|NCT00941863|9753227|FG001|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||3
8707041|NCT00941863|9753228|FG002|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||12
8707042|NCT00941863|9753229|FG003|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||17
8707043|NCT00941863|9753230|FG004|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||94
8707044|NCT00941863|9753226|FG000|COMPLETED|Until Primary Completion Date (PCD)||0
8707045|NCT00941863|9753227|FG001|COMPLETED|Until Primary Completion Date (PCD)||0
8707046|NCT00941863|9753228|FG002|COMPLETED|Until Primary Completion Date (PCD)||0
8707047|NCT00941863|9753229|FG003|COMPLETED|Until Primary Completion Date (PCD)||0
8707048|NCT00941863|9753230|FG004|COMPLETED|Until Primary Completion Date (PCD)||25
8707049|NCT00941863|9753226|FG000|NOT COMPLETED|Until Primary Completion Date (PCD)||7
8707050|NCT00941863|9753227|FG001|NOT COMPLETED|Until Primary Completion Date (PCD)||3
8707051|NCT00941863|9753228|FG002|NOT COMPLETED|Until Primary Completion Date (PCD)||12
8707052|NCT00941863|9753229|FG003|NOT COMPLETED|Until Primary Completion Date (PCD)||17
8707053|NCT00941863|9753230|FG004|NOT COMPLETED|Until Primary Completion Date (PCD)||94
8707054|NCT00941863|9753226|FG000|STARTED|Continued After PCD||0
8707055|NCT00941863|9753227|FG001|STARTED|Continued After PCD||0
8707056|NCT00941863|9753228|FG002|STARTED|Continued After PCD||0
8707057|NCT00941863|9753229|FG003|STARTED|Continued After PCD||0
8707058|NCT00941863|9753230|FG004|STARTED|Continued After PCD|25 of 119 participants from the Expansion Phase, were still on the treatment as of 31 May 2005.|25
8707059|NCT00941863|9753226|FG000|COMPLETED|Continued After PCD||0
8707060|NCT00941863|9753227|FG001|COMPLETED|Continued After PCD||0
8707061|NCT00941863|9753228|FG002|COMPLETED|Continued After PCD||0
8707062|NCT00941863|9753229|FG003|COMPLETED|Continued After PCD||0
8707063|NCT00941863|9753230|FG004|COMPLETED|Continued After PCD||6
8707064|NCT00941863|9753226|FG000|NOT COMPLETED|Continued After PCD||0
8707065|NCT00941863|9753227|FG001|NOT COMPLETED|Continued After PCD||0
8707066|NCT00941863|9753228|FG002|NOT COMPLETED|Continued After PCD||0
8707067|NCT00941863|9753229|FG003|NOT COMPLETED|Continued After PCD||0
8707068|NCT00941863|9753230|FG004|NOT COMPLETED|Continued After PCD||19
8707069|NCT00941889|9753248|FG000|STARTED|Overall Study||17
8707070|NCT00941889|9753249|FG001|STARTED|Overall Study||15
8707071|NCT00941889|9753248|FG000|COMPLETED|Overall Study||5
8707072|NCT00941889|9753249|FG001|COMPLETED|Overall Study||3
8707073|NCT00941889|9753248|FG000|NOT COMPLETED|Overall Study||12
8707074|NCT00941889|9753249|FG001|NOT COMPLETED|Overall Study||12
8707075|NCT00941993|9753255|FG000|STARTED|Overall Study||109
8707076|NCT00941993|9753255|FG000|COMPLETED|Overall Study||109
8707077|NCT00941993|9753255|FG000|NOT COMPLETED|Overall Study||0
8707078|NCT00942084|9753260|FG000|STARTED|Overall Study||32
8707079|NCT00942084|9753260|FG000|COMPLETED|Overall Study|There were 2 infant deaths. None determined to be related to study drug.|30
8707080|NCT00942084|9753260|FG000|NOT COMPLETED|Overall Study||2
8707081|NCT00942149|9753264|FG000|STARTED|Overall Study||20
8707082|NCT00942149|9753264|FG000|COMPLETED|Overall Study||20
8707083|NCT00942149|9753264|FG000|NOT COMPLETED|Overall Study||0
8707084|NCT00942162|9753271|FG000|STARTED|Overall Study||71
8707085|NCT00942162|9753272|FG001|STARTED|Overall Study||50
8707086|NCT00942162|9753273|FG002|STARTED|Overall Study||2
8707087|NCT00942162|9753271|FG000|COMPLETED|Overall Study||1
8707088|NCT00942162|9753272|FG001|COMPLETED|Overall Study||0
8707089|NCT00942162|9753273|FG002|COMPLETED|Overall Study||0
8707090|NCT00942162|9753271|FG000|NOT COMPLETED|Overall Study||70
8707091|NCT00942162|9753272|FG001|NOT COMPLETED|Overall Study||50
8707092|NCT00942162|9753273|FG002|NOT COMPLETED|Overall Study||2
8707093|NCT00942175|9753287|FG000|STARTED|Overall Study||40
8707094|NCT00942175|9753288|FG001|STARTED|Overall Study||40
8707095|NCT00942175|9753289|FG002|STARTED|Overall Study||40
8707096|NCT00942175|9753290|FG003|STARTED|Overall Study||40
8707097|NCT00942175|9753287|FG000|COMPLETED|Overall Study||38
8707098|NCT00942175|9753288|FG001|COMPLETED|Overall Study||36
8707099|NCT00942175|9753289|FG002|COMPLETED|Overall Study||38
8707100|NCT00942175|9753290|FG003|COMPLETED|Overall Study||38
8707101|NCT00942175|9753287|FG000|NOT COMPLETED|Overall Study||2
8707102|NCT00942175|9753288|FG001|NOT COMPLETED|Overall Study||4
8707103|NCT00942175|9753289|FG002|NOT COMPLETED|Overall Study||2
8707104|NCT00942175|9753290|FG003|NOT COMPLETED|Overall Study||2
8707105|NCT00942188|9753312|FG000|STARTED|Overall Study||26
8707106|NCT00942188|9753313|FG001|STARTED|Overall Study||26
8707107|NCT00942188|9753314|FG002|STARTED|Overall Study||27
8707108|NCT00942188|9753315|FG003|STARTED|Overall Study||27
8707109|NCT00942188|9753312|FG000|COMPLETED|Overall Study||22
8707110|NCT00942188|9753313|FG001|COMPLETED|Overall Study||16
8707111|NCT00942188|9753314|FG002|COMPLETED|Overall Study||18
8707112|NCT00942188|9753315|FG003|COMPLETED|Overall Study||23
8707113|NCT00942188|9753312|FG000|NOT COMPLETED|Overall Study||4
8707114|NCT00942188|9753313|FG001|NOT COMPLETED|Overall Study||10
8707115|NCT00942188|9753314|FG002|NOT COMPLETED|Overall Study||9
8707116|NCT00942188|9753315|FG003|NOT COMPLETED|Overall Study||4
8707117|NCT00942266|9753327|FG000|STARTED|Overall Study||43
8707118|NCT00942266|9753328|FG001|STARTED|Overall Study||15
8707119|NCT00942266|9753327|FG000|COMPLETED|Overall Study||0
8707120|NCT00942266|9753328|FG001|COMPLETED|Overall Study||0
8707121|NCT00942266|9753327|FG000|NOT COMPLETED|Overall Study||43
8707122|NCT00942266|9753328|FG001|NOT COMPLETED|Overall Study||15
8707123|NCT00942305|9753344|FG000|STARTED|Overall Study||30
8707124|NCT00942305|9753345|FG001|STARTED|Overall Study||10
8707125|NCT00942305|9753346|FG002|STARTED|Overall Study||29
8707126|NCT00942305|9753347|FG003|STARTED|Overall Study||10
8707127|NCT00942305|9753348|FG004|STARTED|Overall Study||39
8707128|NCT00942305|9753349|FG005|STARTED|Overall Study||14
8707129|NCT00942305|9753350|FG006|STARTED|Overall Study||30
8707130|NCT00942305|9753351|FG007|STARTED|Overall Study||10
8707131|NCT00942305|9753352|FG008|STARTED|Overall Study||50
8707132|NCT00942305|9753353|FG009|STARTED|Overall Study||17
8707133|NCT00942305|9753344|FG000|COMPLETED|Overall Study||7
8707134|NCT00942305|9753345|FG001|COMPLETED|Overall Study||5
8707135|NCT00942305|9753346|FG002|COMPLETED|Overall Study||14
8707136|NCT00942305|9753347|FG003|COMPLETED|Overall Study||4
8707137|NCT00942305|9753348|FG004|COMPLETED|Overall Study||14
8707138|NCT00942305|9753349|FG005|COMPLETED|Overall Study||9
8707139|NCT00942305|9753350|FG006|COMPLETED|Overall Study||6
8707140|NCT00942305|9753351|FG007|COMPLETED|Overall Study||5
8707141|NCT00942305|9753352|FG008|COMPLETED|Overall Study||25
8707142|NCT00942305|9753353|FG009|COMPLETED|Overall Study||7
8707143|NCT00942305|9753344|FG000|NOT COMPLETED|Overall Study||23
8707144|NCT00942305|9753345|FG001|NOT COMPLETED|Overall Study||5
8707145|NCT00942305|9753346|FG002|NOT COMPLETED|Overall Study||15
8707146|NCT00942305|9753347|FG003|NOT COMPLETED|Overall Study||6
8707147|NCT00942305|9753348|FG004|NOT COMPLETED|Overall Study||25
8707148|NCT00942305|9753349|FG005|NOT COMPLETED|Overall Study||5
8707149|NCT00942305|9753350|FG006|NOT COMPLETED|Overall Study||24
8707150|NCT00942305|9753351|FG007|NOT COMPLETED|Overall Study||5
8707151|NCT00942305|9753352|FG008|NOT COMPLETED|Overall Study||25
8707152|NCT00942305|9753353|FG009|NOT COMPLETED|Overall Study||10
8707153|NCT00942357|9753377|FG000|STARTED|Overall Study||407
8707154|NCT00942357|9753378|FG001|STARTED|Overall Study||406
8707155|NCT00942357|9753377|FG000|COMPLETED|Overall Study||370
8707156|NCT00942357|9753378|FG001|COMPLETED|Overall Study||366
8707157|NCT00942357|9753377|FG000|NOT COMPLETED|Overall Study||37
8707158|NCT00942357|9753378|FG001|NOT COMPLETED|Overall Study||40
8707159|NCT00942422|9753384|FG000|STARTED|Overall Study||8
8707160|NCT00942422|9753384|FG000|COMPLETED|Overall Study||5
8707161|NCT00942422|9753384|FG000|NOT COMPLETED|Overall Study||3
8707162|NCT00942448|9753392|FG000|STARTED|Overall Study||77
8707163|NCT00942448|9753393|FG001|STARTED|Overall Study||76
8707164|NCT00942448|9753394|FG002|STARTED|Overall Study||78
8707165|NCT00942448|9753395|FG003|STARTED|Overall Study||75
8707166|NCT00942448|9753392|FG000|COMPLETED|Overall Study||77
8707167|NCT00942448|9753393|FG001|COMPLETED|Overall Study||76
8707168|NCT00942448|9753394|FG002|COMPLETED|Overall Study||78
8707169|NCT00942448|9753395|FG003|COMPLETED|Overall Study||75
8707170|NCT00942448|9753392|FG000|NOT COMPLETED|Overall Study||0
8707171|NCT00942448|9753393|FG001|NOT COMPLETED|Overall Study||0
8707172|NCT00942448|9753394|FG002|NOT COMPLETED|Overall Study||0
8707173|NCT00942448|9753395|FG003|NOT COMPLETED|Overall Study||0
8707174|NCT00942578|9753412|FG000|STARTED|Dose Escalation Phase||3
8707175|NCT00942578|9753413|FG001|STARTED|Dose Escalation Phase||3
8707176|NCT00942578|9753414|FG002|STARTED|Dose Escalation Phase||3
8707177|NCT00942578|9753412|FG000|COMPLETED|Dose Escalation Phase||3
8707178|NCT00942578|9753413|FG001|COMPLETED|Dose Escalation Phase||3
8707179|NCT00942578|9753414|FG002|COMPLETED|Dose Escalation Phase||3
8707180|NCT00942578|9753412|FG000|NOT COMPLETED|Dose Escalation Phase||0
8707181|NCT00942578|9753413|FG001|NOT COMPLETED|Dose Escalation Phase||0
8707182|NCT00942578|9753414|FG002|NOT COMPLETED|Dose Escalation Phase||0
8707183|NCT00942578|9753412|FG000|STARTED|Expansion Phase||11
8707184|NCT00942578|9753413|FG001|STARTED|Expansion Phase||0
8707185|NCT00942578|9753414|FG002|STARTED|Expansion Phase||43
8707186|NCT00942578|9753412|FG000|COMPLETED|Expansion Phase||11
8707187|NCT00942578|9753413|FG001|COMPLETED|Expansion Phase||0
8707188|NCT00942578|9753414|FG002|COMPLETED|Expansion Phase||43
8707189|NCT00942578|9753412|FG000|NOT COMPLETED|Expansion Phase||0
8707190|NCT00942578|9753413|FG001|NOT COMPLETED|Expansion Phase||0
8707191|NCT00942578|9753414|FG002|NOT COMPLETED|Expansion Phase||0
8707192|NCT00942604|9753429|FG000|STARTED|Overall Study||100
8707193|NCT00942604|9753430|FG001|STARTED|Overall Study||103
8707194|NCT00942604|9753429|FG000|COMPLETED|Overall Study||98
8707195|NCT00942604|9753430|FG001|COMPLETED|Overall Study||99
8707196|NCT00942604|9753429|FG000|NOT COMPLETED|Overall Study||2
8707197|NCT00942604|9753430|FG001|NOT COMPLETED|Overall Study||4
8707198|NCT00942708|9753436|FG000|STARTED|Overall Study||6
8707199|NCT00942708|9753436|FG000|COMPLETED|Overall Study||5
8707200|NCT00942708|9753436|FG000|NOT COMPLETED|Overall Study||1
8707201|NCT00942734|9753441|FG000|STARTED|Overall Study||43
8707202|NCT00942734|9753441|FG000|COMPLETED|Overall Study||35
8707203|NCT00942734|9753441|FG000|NOT COMPLETED|Overall Study||8
8707204|NCT00942786|9753445|FG000|STARTED|Overall Study||297
8707205|NCT00942786|9753445|FG000|COMPLETED|Overall Study|date of last follow-up|297
8707206|NCT00942786|9753445|FG000|NOT COMPLETED|Overall Study||0
8707207|NCT00942825|9753454|FG000|STARTED|Overall Study||97
8707208|NCT00942825|9753455|FG001|STARTED|Overall Study||98
8707209|NCT00942825|9753454|FG000|COMPLETED|Overall Study||97
8707210|NCT00942825|9753455|FG001|COMPLETED|Overall Study||98
8707211|NCT00942825|9753454|FG000|NOT COMPLETED|Overall Study||0
8707212|NCT00942825|9753455|FG001|NOT COMPLETED|Overall Study||0
8707213|NCT00942851|9753463|FG000|STARTED|Overall Study||12
8707214|NCT00942851|9753464|FG001|STARTED|Overall Study||12
8707215|NCT00942851|9753463|FG000|COMPLETED|Overall Study||12
8707216|NCT00942851|9753464|FG001|COMPLETED|Overall Study||11
8707217|NCT00942851|9753463|FG000|NOT COMPLETED|Overall Study||0
8707218|NCT00942851|9753464|FG001|NOT COMPLETED|Overall Study||1
8707219|NCT00942890|9753476|FG000|STARTED|Overall Study||21
8707220|NCT00942890|9753477|FG001|STARTED|Overall Study||23
8707221|NCT00942890|9753476|FG000|COMPLETED|Overall Study||21
8707222|NCT00942890|9753477|FG001|COMPLETED|Overall Study||23
8707223|NCT00942890|9753476|FG000|NOT COMPLETED|Overall Study||0
8707224|NCT00942890|9753477|FG001|NOT COMPLETED|Overall Study||0
8707225|NCT00942903|9753484|FG000|STARTED|Overall Study||20
8707226|NCT00942903|9753484|FG000|COMPLETED|Overall Study||20
8707227|NCT00942903|9753484|FG000|NOT COMPLETED|Overall Study||0
8707228|NCT00942968|9753488|FG000|STARTED|Overall Study||338
8707229|NCT00942968|9753488|FG000|Treated|Overall Study||334
8707230|NCT00942968|9753488|FG000|COMPLETED|Overall Study||109
8707231|NCT00942968|9753488|FG000|NOT COMPLETED|Overall Study||229
8707232|NCT00942994|9753494|FG000|STARTED|Overall Study||203
8707233|NCT00942994|9753495|FG001|STARTED|Overall Study||209
8707234|NCT00942994|9753494|FG000|COMPLETED|Overall Study||187
8707235|NCT00942994|9753495|FG001|COMPLETED|Overall Study||190
8707236|NCT00942994|9753494|FG000|NOT COMPLETED|Overall Study||16
8707237|NCT00942994|9753495|FG001|NOT COMPLETED|Overall Study||19
8707238|NCT00943072|9753503|FG000|STARTED|Overall Study||115
8707239|NCT00943072|9753504|FG001|STARTED|Overall Study||74
8707240|NCT00943072|9753503|FG000|Participants Received Treatment|Overall Study|Safety population (SAF)|114
8707241|NCT00943072|9753504|FG001|Participants Received Treatment|Overall Study||74
8707242|NCT00943072|9753503|FG000|Full Analysis Set (FAS) Population|Overall Study|FAS population used for analysis of Primary and Secondary Outcome Measures|114
8707243|NCT00943072|9753504|FG001|Full Analysis Set (FAS) Population|Overall Study||73
8707244|NCT00943072|9753503|FG000|COMPLETED|Overall Study|110 Participants completed Week 24, From FAS; 102 Participants completed up to Week 100, From SAF|110
8707245|NCT00943072|9753504|FG001|COMPLETED|Overall Study|60 Participants completed Week 24, From FAS; 50 Participants completed up to Week 100, From SAF|60
8707246|NCT00943072|9753503|FG000|NOT COMPLETED|Overall Study||5
8707247|NCT00943072|9753504|FG001|NOT COMPLETED|Overall Study||14
8707248|NCT00943098|9753514|FG000|STARTED|Overall Study||70
8707249|NCT00943098|9753515|FG001|STARTED|Overall Study|1 patient was excluded from the ITT and therefore the baseline population is 71|72
8707250|NCT00943098|9753514|FG000|COMPLETED|Overall Study||70
8707251|NCT00943098|9753515|FG001|COMPLETED|Overall Study||72
8707252|NCT00943098|9753514|FG000|NOT COMPLETED|Overall Study||0
8707253|NCT00943098|9753515|FG001|NOT COMPLETED|Overall Study||0
8707254|NCT00943111|9753523|FG000|STARTED|52-Weeks Primary Analysis Period||106
8707255|NCT00943111|9753524|FG001|STARTED|52-Weeks Primary Analysis Period||54
8707256|NCT00943111|9753525|FG002|STARTED|52-Weeks Primary Analysis Period||0
8707257|NCT00943111|9753523|FG000|Treated|52-Weeks Primary Analysis Period||106
8707258|NCT00943111|9753524|FG001|Treated|52-Weeks Primary Analysis Period||53
8707259|NCT00943111|9753525|FG002|Treated|52-Weeks Primary Analysis Period||0
8707260|NCT00943111|9753523|FG000|COMPLETED|52-Weeks Primary Analysis Period||104
8707261|NCT00943111|9753524|FG001|COMPLETED|52-Weeks Primary Analysis Period||52
8707262|NCT00943111|9753525|FG002|COMPLETED|52-Weeks Primary Analysis Period||0
8707263|NCT00943111|9753523|FG000|NOT COMPLETED|52-Weeks Primary Analysis Period||2
8707264|NCT00943111|9753524|FG001|NOT COMPLETED|52-Weeks Primary Analysis Period||2
8707265|NCT00943111|9753525|FG002|NOT COMPLETED|52-Weeks Primary Analysis Period||0
8707266|NCT00943111|9753523|FG000|STARTED|5 Years Long-term Treatment Period||0
8707267|NCT00943111|9753524|FG001|STARTED|5 Years Long-term Treatment Period||0
8707268|NCT00943111|9753525|FG002|STARTED|5 Years Long-term Treatment Period|Participants from both the arms of PAP who completed PAP and remained on-study|152
8707269|NCT00943111|9753523|FG000|COMPLETED|5 Years Long-term Treatment Period||0
8707270|NCT00943111|9753524|FG001|COMPLETED|5 Years Long-term Treatment Period||0
8724746|NCT01027793|9772008|FG001|COMPLETED|Overall Study||12
8557535|NCT03332589|9589423|FG002|NOT COMPLETED|Overall Study||0
8707271|NCT00943111|9753525|FG002|COMPLETED|5 Years Long-term Treatment Period||77
8707272|NCT00943111|9753523|FG000|NOT COMPLETED|5 Years Long-term Treatment Period||0
8707273|NCT00943111|9753524|FG001|NOT COMPLETED|5 Years Long-term Treatment Period||0
8707274|NCT00943111|9753525|FG002|NOT COMPLETED|5 Years Long-term Treatment Period||75
8707275|NCT00943124|9753532|FG000|STARTED|Period 1||110
8557536|NCT03277105|9589433|FG000|STARTED|Overall Study||259
8557537|NCT03277105|9589434|FG001|STARTED|Overall Study||263
8557538|NCT03277105|9589433|FG000|Safety Analysis Set|Overall Study||258
8557539|NCT03277105|9589434|FG001|Safety Analysis Set|Overall Study||260
8557540|NCT03277105|9589433|FG000|COMPLETED|Overall Study||0
8557541|NCT03277105|9589434|FG001|COMPLETED|Overall Study||0
8557542|NCT03277105|9589433|FG000|NOT COMPLETED|Overall Study||259
8557543|NCT03277105|9589434|FG001|NOT COMPLETED|Overall Study||263
8557544|NCT03201965|9589443|FG000|STARTED|Overall Study||28
8557545|NCT03201965|9589444|FG001|STARTED|Overall Study||193
8557546|NCT03201965|9589445|FG002|STARTED|Overall Study||195
8557547|NCT03201965|9589443|FG000|Treated|Overall Study||28
8557548|NCT03201965|9589444|FG001|Treated|Overall Study||188
8557549|NCT03201965|9589445|FG002|Treated|Overall Study||193
8557550|NCT03201965|9589443|FG000|COMPLETED|Overall Study||0
8557551|NCT03201965|9589444|FG001|COMPLETED|Overall Study||0
8557552|NCT03201965|9589445|FG002|COMPLETED|Overall Study||0
8557553|NCT03201965|9589443|FG000|NOT COMPLETED|Overall Study||28
8557554|NCT03201965|9589444|FG001|NOT COMPLETED|Overall Study||193
8557555|NCT03201965|9589445|FG002|NOT COMPLETED|Overall Study||195
8568751|NCT00093145|9600958|FG000|At Least One Response Assessment|Overall Study||31
8568752|NCT00093145|9600958|FG000|COMPLETED|Overall Study|Treatment completed upon progressive disease|15
8568753|NCT00093145|9600958|FG000|NOT COMPLETED|Overall Study||17
8568754|NCT00093379|9600962|FG000|STARTED|Overall Study||20
8568755|NCT00093379|9600962|FG000|COMPLETED|Overall Study||20
8568756|NCT00093379|9600962|FG000|NOT COMPLETED|Overall Study||0
8568757|NCT00093470|9600968|FG000|STARTED|Overall Study||73
8568758|NCT00093470|9600969|FG001|STARTED|Overall Study||71
8568759|NCT00093470|9600968|FG000|Treated|Overall Study||72
8568760|NCT00093470|9600969|FG001|Treated|Overall Study||71
8568761|NCT00093470|9600968|FG000|Patients With Toxicity Assessment|Overall Study||72
8568762|NCT00093470|9600969|FG001|Patients With Toxicity Assessment|Overall Study||69
8568763|NCT00093470|9600968|FG000|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicities.|0
8568764|NCT00093470|9600969|FG001|COMPLETED|Overall Study|Patients underwent observation only.|71
8568765|NCT00093470|9600968|FG000|NOT COMPLETED|Overall Study||73
8568766|NCT00093470|9600969|FG001|NOT COMPLETED|Overall Study||0
8568767|NCT00093496|9600977|FG000|STARTED|Overall Study||15
8568768|NCT00093496|9600978|FG001|STARTED|Overall Study||14
8568769|NCT00093496|9600977|FG000|COMPLETED|Overall Study||14
8568770|NCT00093496|9600978|FG001|COMPLETED|Overall Study||11
8568771|NCT00093496|9600977|FG000|NOT COMPLETED|Overall Study||1
8568772|NCT00093496|9600978|FG001|NOT COMPLETED|Overall Study||3
8568773|NCT00093756|9600985|FG000|STARTED|Overall Study||27
8568774|NCT00093756|9600986|FG001|STARTED|Overall Study||21
8568775|NCT00093756|9600985|FG000|COMPLETED|Overall Study||27
8568776|NCT00093756|9600986|FG001|COMPLETED|Overall Study||21
8568777|NCT00093756|9600985|FG000|NOT COMPLETED|Overall Study||0
8568778|NCT00093756|9600986|FG001|NOT COMPLETED|Overall Study||0
8568779|NCT00093782|9600994|FG000|STARTED|Overall Study||36
8568780|NCT00093782|9600994|FG000|COMPLETED|Overall Study||36
8568781|NCT00093782|9600994|FG000|NOT COMPLETED|Overall Study||0
8568782|NCT00093795|9601001|FG000|STARTED|Overall Study||1630
8568783|NCT00093795|9601002|FG001|STARTED|Overall Study||1634
8568784|NCT00093795|9601003|FG002|STARTED|Overall Study||1630
8568785|NCT00093795|9601001|FG000|COMPLETED|Overall Study||1610
8568786|NCT00093795|9601002|FG001|COMPLETED|Overall Study||1618
8568787|NCT00093795|9601003|FG002|COMPLETED|Overall Study||1613
8568788|NCT00093795|9601001|FG000|NOT COMPLETED|Overall Study||20
8568789|NCT00093795|9601002|FG001|NOT COMPLETED|Overall Study||16
8568790|NCT00093795|9601003|FG002|NOT COMPLETED|Overall Study||17
8568791|NCT00093808|9601011|FG000|STARTED|Overall Study||47
8568792|NCT00093808|9601011|FG000|COMPLETED|Overall Study||45
8568793|NCT00093808|9601011|FG000|NOT COMPLETED|Overall Study||2
8568794|NCT00093847|9601017|FG000|STARTED|Overall Study||39
8568795|NCT00093847|9601018|FG001|STARTED|Overall Study||34
8568796|NCT00093847|9601017|FG000|COMPLETED|Overall Study||31
8568797|NCT00093847|9601018|FG001|COMPLETED|Overall Study||24
8568798|NCT00093847|9601017|FG000|NOT COMPLETED|Overall Study||8
8568799|NCT00093847|9601018|FG001|NOT COMPLETED|Overall Study||10
8568800|NCT00093964|9601026|FG000|STARTED|Overall Study||41
8568801|NCT00093964|9601027|FG001|STARTED|Overall Study||40
8568802|NCT00093964|9601026|FG000|COMPLETED|Overall Study||41
8568803|NCT00093964|9601027|FG001|COMPLETED|Overall Study||40
8568804|NCT00093964|9601026|FG000|NOT COMPLETED|Overall Study||0
8568805|NCT00093964|9601027|FG001|NOT COMPLETED|Overall Study||0
8568806|NCT00094055|9601035|FG000|STARTED|Overall Study||60
8568807|NCT00094055|9601035|FG000|COMPLETED|Overall Study||0
8568808|NCT00094055|9601035|FG000|NOT COMPLETED|Overall Study||60
8568809|NCT00094094|9601039|FG000|STARTED|Overall Study||32
8568810|NCT00094094|9601039|FG000|COMPLETED|Overall Study||0
8568811|NCT00094094|9601039|FG000|NOT COMPLETED|Overall Study||32
8928089|NCT02278328|9989242|FG001|COMPLETED|First Intervention (1 Day)||6
8928090|NCT02278328|9989243|FG002|COMPLETED|First Intervention (1 Day)||6
8928091|NCT02278328|9989241|FG000|NOT COMPLETED|First Intervention (1 Day)||0
8928092|NCT02278328|9989242|FG001|NOT COMPLETED|First Intervention (1 Day)||0
8928093|NCT02278328|9989243|FG002|NOT COMPLETED|First Intervention (1 Day)||0
8928094|NCT02278328|9989241|FG000|STARTED|Washout (1 Week)||9
8928095|NCT02278328|9989242|FG001|STARTED|Washout (1 Week)||6
8928096|NCT02278328|9989243|FG002|STARTED|Washout (1 Week)||6
8928097|NCT02278328|9989241|FG000|COMPLETED|Washout (1 Week)||9
8928098|NCT02278328|9989242|FG001|COMPLETED|Washout (1 Week)||6
8707276|NCT00943124|9753533|FG001|STARTED|Period 1||110
8707277|NCT00943124|9753532|FG000|COMPLETED|Period 1||108
8707278|NCT00943124|9753533|FG001|COMPLETED|Period 1||108
8707279|NCT00943124|9753532|FG000|NOT COMPLETED|Period 1||2
8707280|NCT00943124|9753533|FG001|NOT COMPLETED|Period 1||2
8707281|NCT00943124|9753532|FG000|STARTED|Period 2||108
8707282|NCT00943124|9753533|FG001|STARTED|Period 2||108
8707283|NCT00943124|9753532|FG000|COMPLETED|Period 2||108
8707284|NCT00943124|9753533|FG001|COMPLETED|Period 2||108
8707285|NCT00943124|9753532|FG000|NOT COMPLETED|Period 2||0
8707286|NCT00943124|9753533|FG001|NOT COMPLETED|Period 2||0
8707287|NCT00943150|9753541|FG000|STARTED|Overall Study||10
8707288|NCT00943150|9753542|FG001|STARTED|Overall Study||10
8707289|NCT00943150|9753541|FG000|COMPLETED|Overall Study||10
8707290|NCT00943150|9753542|FG001|COMPLETED|Overall Study||10
8707291|NCT00943150|9753541|FG000|NOT COMPLETED|Overall Study||0
8707292|NCT00943150|9753542|FG001|NOT COMPLETED|Overall Study||0
8707293|NCT00943202|9753556|FG000|STARTED|Overall Study||133
8707294|NCT00943202|9753557|FG001|STARTED|Overall Study||133
8707295|NCT00943202|9753558|FG002|STARTED|Overall Study||133
8707296|NCT00943202|9753559|FG003|STARTED|Overall Study||132
8707297|NCT00943202|9753556|FG000|COMPLETED|Overall Study||132
8707298|NCT00943202|9753557|FG001|COMPLETED|Overall Study||131
8707299|NCT00943202|9753558|FG002|COMPLETED|Overall Study||133
8707300|NCT00943202|9753559|FG003|COMPLETED|Overall Study||131
8707301|NCT00943202|9753556|FG000|NOT COMPLETED|Overall Study||1
8707302|NCT00943202|9753557|FG001|NOT COMPLETED|Overall Study||2
8707303|NCT00943202|9753558|FG002|NOT COMPLETED|Overall Study||0
8707304|NCT00943202|9753559|FG003|NOT COMPLETED|Overall Study||1
8707305|NCT00943306|9753570|FG000|STARTED|Overall Study||19
8707306|NCT00943306|9753570|FG000|COMPLETED|Overall Study||16
8707307|NCT00943306|9753570|FG000|NOT COMPLETED|Overall Study||3
8707308|NCT00943319|9753574|FG000|STARTED|Overall Study||50
8707309|NCT00943319|9753574|FG000|COMPLETED|Overall Study||49
8707310|NCT00943319|9753574|FG000|NOT COMPLETED|Overall Study||1
8557556|NCT03091192|9589454|FG000|STARTED|Overall Study||33
8557557|NCT03091192|9589455|FG001|STARTED|Overall Study||27
8557558|NCT03091192|9589454|FG000|COMPLETED|Overall Study||0
8557559|NCT03091192|9589455|FG001|COMPLETED|Overall Study||0
8557560|NCT03091192|9589454|FG000|NOT COMPLETED|Overall Study||33
8557561|NCT03091192|9589455|FG001|NOT COMPLETED|Overall Study||27
8557562|NCT02717611|9589461|FG000|STARTED|Overall Study||60
8557563|NCT02717611|9589461|FG000|COMPLETED|Overall Study||0
8557564|NCT02717611|9589461|FG000|NOT COMPLETED|Overall Study||60
8557565|NCT02489318|9589467|FG000|STARTED|Randomized||527
8557566|NCT02489318|9589468|FG001|STARTED|Randomized||525
8557567|NCT02489318|9589467|FG000|COMPLETED|Randomized||527
8557568|NCT02489318|9589468|FG001|COMPLETED|Randomized||524
8557569|NCT02489318|9589467|FG000|NOT COMPLETED|Randomized||0
8557570|NCT02489318|9589468|FG001|NOT COMPLETED|Randomized||1
8557571|NCT02489318|9589467|FG000|STARTED|Treated||527
8557572|NCT02489318|9589468|FG001|STARTED|Treated||524
8557573|NCT02489318|9589467|FG000|COMPLETED|Treated|Participants crossed over from placebo to apalutamide after positive results at interim analysis.|208
8557574|NCT02489318|9589468|FG001|COMPLETED|Treated||0
8557575|NCT02489318|9589467|FG000|NOT COMPLETED|Treated||319
8707311|NCT00943384|9753578|FG000|STARTED|Overall Study|104 subjects consented and underwent additional screening to determine eligibility to participate|104
8557576|NCT02489318|9589468|FG001|NOT COMPLETED|Treated||524
8557577|NCT02301156|9589477|FG000|STARTED|Overall Study||64
8557578|NCT02301156|9589478|FG001|STARTED|Overall Study||62
8557579|NCT02301156|9589477|FG000|Intent to Treat (ITT) Population|Overall Study||64
8557580|NCT02301156|9589478|FG001|Intent to Treat (ITT) Population|Overall Study||62
8557581|NCT02301156|9589477|FG000|Safety Population|Overall Study||59
8557582|NCT02301156|9589478|FG001|Safety Population|Overall Study||58
8557583|NCT02301156|9589477|FG000|COMPLETED|Overall Study||11
8707312|NCT00943384|9753578|FG000|Treated|Overall Study|81 subjects were eligible and willing to participate in the study and were treated|81
8707313|NCT00943384|9753578|FG000|Treated on Protocol|Overall Study|5 subjects were treated off protocol due to intraoperative decisions made by the surgeon|76
8707314|NCT00943384|9753578|FG000|COMPLETED|Overall Study|evaluated at the Month 24 visit with complete or partial data|55
8707315|NCT00943384|9753578|FG000|NOT COMPLETED|Overall Study||49
8707316|NCT00943436|9753584|FG000|STARTED|Exercise Session: 45 Minutes of Activity||10
8707317|NCT00943436|9753585|FG001|STARTED|Exercise Session: 45 Minutes of Activity||10
8707318|NCT00943436|9753584|FG000|COMPLETED|Exercise Session: 45 Minutes of Activity||10
8707319|NCT00943436|9753585|FG001|COMPLETED|Exercise Session: 45 Minutes of Activity||10
8707320|NCT00943436|9753584|FG000|NOT COMPLETED|Exercise Session: 45 Minutes of Activity||0
8707321|NCT00943436|9753585|FG001|NOT COMPLETED|Exercise Session: 45 Minutes of Activity||0
8707322|NCT00943436|9753584|FG000|STARTED|Rest Session: 45 Minutes of Reading||10
8707323|NCT00943436|9753585|FG001|STARTED|Rest Session: 45 Minutes of Reading||10
8707324|NCT00943436|9753584|FG000|COMPLETED|Rest Session: 45 Minutes of Reading||10
8724747|NCT01027793|9772007|FG000|NOT COMPLETED|Overall Study||7
8707325|NCT00943436|9753585|FG001|COMPLETED|Rest Session: 45 Minutes of Reading||10
8707326|NCT00943436|9753584|FG000|NOT COMPLETED|Rest Session: 45 Minutes of Reading||0
8724748|NCT01027793|9772008|FG001|NOT COMPLETED|Overall Study||3
8707327|NCT00943436|9753585|FG001|NOT COMPLETED|Rest Session: 45 Minutes of Reading||0
8707328|NCT00943488|9753593|FG000|STARTED|Overall Study||204
8707329|NCT00943488|9753594|FG001|STARTED|Overall Study||204
8707330|NCT00943488|9753593|FG000|COMPLETED|Overall Study||203
8707331|NCT00943488|9753594|FG001|COMPLETED|Overall Study||202
8707332|NCT00943488|9753593|FG000|NOT COMPLETED|Overall Study||1
8707333|NCT00943488|9753594|FG001|NOT COMPLETED|Overall Study||2
8707334|NCT00943579|9753602|FG000|STARTED|Overall Study||21
8707335|NCT00943579|9753603|FG001|STARTED|Overall Study||20
8707336|NCT00943579|9753602|FG000|COMPLETED|Overall Study||15
8707337|NCT00943579|9753603|FG001|COMPLETED|Overall Study||15
8707338|NCT00943579|9753602|FG000|NOT COMPLETED|Overall Study||6
8707339|NCT00943579|9753603|FG001|NOT COMPLETED|Overall Study||5
8707340|NCT00943592|9753612|FG000|STARTED|Overall Study||82
8707341|NCT00943592|9753612|FG000|Maximum Tolerated Dose|Overall Study|74 patients received the Maximum Tolerated Dose|74
8707342|NCT00943592|9753612|FG000|COMPLETED|Overall Study|None of the three deaths were attributed to the conditioning regimen|79
8707343|NCT00943592|9753612|FG000|NOT COMPLETED|Overall Study||3
8707344|NCT00943631|9753618|FG000|STARTED|Overall Study||202
8707345|NCT00943631|9753619|FG001|STARTED|Overall Study||204
8707346|NCT00943631|9753618|FG000|COMPLETED|Overall Study||198
8707347|NCT00943631|9753619|FG001|COMPLETED|Overall Study||202
8707348|NCT00943631|9753618|FG000|NOT COMPLETED|Overall Study||4
8707349|NCT00943631|9753619|FG001|NOT COMPLETED|Overall Study||2
8707350|NCT00943670|9753625|FG000|STARTED|Single-agent Trastuzumab Emtansine||51
8707351|NCT00943670|9753625|FG000|Treated|Single-agent Trastuzumab Emtansine||51
8707352|NCT00943670|9753625|FG000|COMPLETED|Single-agent Trastuzumab Emtansine|Completed single-agent treatment defined as receiving 17 cycles of trastuzumab emtansine therapy.|9
8707353|NCT00943670|9753625|FG000|NOT COMPLETED|Single-agent Trastuzumab Emtansine||42
8707354|NCT00943670|9753625|FG000|STARTED|Trastuzumab Emtansine + Pertuzumab|Patients with early progressive disease who elected to receive T-DM1 and pertuzumab.|20
8707355|NCT00943670|9753625|FG000|COMPLETED|Trastuzumab Emtansine + Pertuzumab|Completed treatment defined as receiving a total of 17 cycles of therapy in both treatment periods.|2
8707356|NCT00943670|9753625|FG000|NOT COMPLETED|Trastuzumab Emtansine + Pertuzumab||18
8707357|NCT00943735|9753640|FG000|STARTED|Overall Study||774
8707358|NCT00943735|9753640|FG000|Per Protocol Population|Overall Study||500
8707359|NCT00943735|9753640|FG000|COMPLETED|Overall Study||742
8707360|NCT00943735|9753640|FG000|NOT COMPLETED|Overall Study||32
8707361|NCT00943761|9753646|FG000|STARTED|Overall Study||21
8707362|NCT00943761|9753647|FG001|STARTED|Overall Study||24
8707363|NCT00943761|9753646|FG000|COMPLETED|Overall Study||17
8707364|NCT00943761|9753647|FG001|COMPLETED|Overall Study||23
8707365|NCT00943761|9753646|FG000|NOT COMPLETED|Overall Study||4
8707366|NCT00943761|9753647|FG001|NOT COMPLETED|Overall Study||1
8707367|NCT00943787|9753653|FG000|STARTED|Overall Study||41
8707368|NCT00943787|9753653|FG000|COMPLETED|Overall Study||34
8707369|NCT00943787|9753653|FG000|NOT COMPLETED|Overall Study||7
8707370|NCT00943800|9753657|FG000|STARTED|Overall Study||87
8707371|NCT00943800|9753657|FG000|COMPLETED|Overall Study||87
8707372|NCT00943800|9753657|FG000|NOT COMPLETED|Overall Study||0
8707373|NCT00943826|9753663|FG000|STARTED|Concurrent Phase||458
8707374|NCT00943826|9753664|FG001|STARTED|Concurrent Phase||463
8707375|NCT00943826|9753663|FG000|Treated|Concurrent Phase||452
8707376|NCT00943826|9753664|FG001|Treated|Concurrent Phase||459
8707377|NCT00943826|9753663|FG000|COMPLETED|Concurrent Phase||397
8707378|NCT00943826|9753664|FG001|COMPLETED|Concurrent Phase||421
8707379|NCT00943826|9753663|FG000|NOT COMPLETED|Concurrent Phase||61
8707380|NCT00943826|9753664|FG001|NOT COMPLETED|Concurrent Phase||42
8707381|NCT00943826|9753663|FG000|STARTED|Maintenance Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|396
8707382|NCT00943826|9753664|FG001|STARTED|Maintenance Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|370
8707383|NCT00943826|9753663|FG000|COMPLETED|Maintenance Phase||353
8707384|NCT00943826|9753664|FG001|COMPLETED|Maintenance Phase||331
8707385|NCT00943826|9753663|FG000|NOT COMPLETED|Maintenance Phase||43
8707386|NCT00943826|9753664|FG001|NOT COMPLETED|Maintenance Phase||39
8707387|NCT00943826|9753663|FG000|STARTED|Monotherapy Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|269
8707388|NCT00943826|9753664|FG001|STARTED|Monotherapy Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|159
8707389|NCT00943826|9753663|FG000|COMPLETED|Monotherapy Phase||204
8707390|NCT00943826|9753664|FG001|COMPLETED|Monotherapy Phase||143
8707391|NCT00943826|9753663|FG000|NOT COMPLETED|Monotherapy Phase||65
8707392|NCT00943826|9753664|FG001|NOT COMPLETED|Monotherapy Phase||16
8724749|NCT01027806|9772016|FG000|STARTED|Overall Study||32
8724750|NCT01027806|9772017|FG001|STARTED|Overall Study||32
8724751|NCT01027806|9772016|FG000|COMPLETED|Overall Study||28
8724752|NCT01027806|9772017|FG001|COMPLETED|Overall Study||29
8928099|NCT02278328|9989243|FG002|COMPLETED|Washout (1 Week)||6
8928100|NCT02278328|9989241|FG000|NOT COMPLETED|Washout (1 Week)||0
8928101|NCT02278328|9989242|FG001|NOT COMPLETED|Washout (1 Week)||0
8928102|NCT02278328|9989243|FG002|NOT COMPLETED|Washout (1 Week)||0
8557584|NCT02301156|9589478|FG001|COMPLETED|Overall Study||10
8557585|NCT02301156|9589477|FG000|NOT COMPLETED|Overall Study||53
8557586|NCT02301156|9589478|FG001|NOT COMPLETED|Overall Study||52
8557587|NCT02296125|9589486|FG000|STARTED|Overall Study||279
8557588|NCT02296125|9589487|FG001|STARTED|Overall Study|183 participant received gefitinib and 93 participants received erlotinib.|277
8557589|NCT02296125|9589488|FG002|STARTED|Overall Study|There were 12 participants who were in both the Global and China Extension Osimertinib Arm.|71
8557590|NCT02296125|9589489|FG003|STARTED|Overall Study|There were 7 participants who were in both the Global and China Extension SoC EGFR-TKI Arm.|65
8557591|NCT02296125|9589486|FG000|COMPLETED|Overall Study||61
8557592|NCT02296125|9589487|FG001|COMPLETED|Overall Study||13
8557593|NCT02296125|9589488|FG002|COMPLETED|Overall Study||15
8557594|NCT02296125|9589489|FG003|COMPLETED|Overall Study||3
8557595|NCT02296125|9589486|FG000|NOT COMPLETED|Overall Study||218
8557596|NCT02296125|9589487|FG001|NOT COMPLETED|Overall Study||264
8557597|NCT02296125|9589488|FG002|NOT COMPLETED|Overall Study||56
8557598|NCT02296125|9589489|FG003|NOT COMPLETED|Overall Study||62
8557599|NCT02277444|9589500|FG000|STARTED|Overall Study||130
8557600|NCT02277444|9589500|FG000|Treated|Overall Study||127
8557601|NCT02277444|9589500|FG000|COMPLETED|Overall Study||0
8557602|NCT02277444|9589500|FG000|NOT COMPLETED|Overall Study||130
8557603|NCT02257736|9589506|FG000|STARTED|Overall Study||490
8557604|NCT02257736|9589507|FG001|STARTED|Overall Study||492
8557605|NCT02257736|9589506|FG000|COMPLETED|Overall Study||39
8557606|NCT02257736|9589507|FG001|COMPLETED|Overall Study||45
8557607|NCT02257736|9589506|FG000|NOT COMPLETED|Overall Study||451
8557608|NCT02257736|9589507|FG001|NOT COMPLETED|Overall Study||447
8557609|NCT02252172|9589515|FG000|STARTED|Overall Study||369
8557610|NCT02252172|9589516|FG001|STARTED|Overall Study||368
8557611|NCT02252172|9589515|FG000|Treated|Overall Study||365
8557612|NCT02252172|9589516|FG001|Treated|Overall Study||364
8557613|NCT02252172|9589515|FG000|COMPLETED|Overall Study||90
8557614|NCT02252172|9589516|FG001|COMPLETED|Overall Study||69
8557615|NCT02252172|9589515|FG000|NOT COMPLETED|Overall Study||279
8557616|NCT02252172|9589516|FG001|NOT COMPLETED|Overall Study||299
8557617|NCT02195479|9589524|FG000|STARTED|Overall Study||356
8557618|NCT02195479|9589525|FG001|STARTED|Overall Study||350
8557619|NCT02195479|9589524|FG000|Treated|Overall Study||354
8557620|NCT02195479|9589525|FG001|Treated|Overall Study||346
8557621|NCT02195479|9589524|FG000|COMPLETED|Overall Study|None of the participants completed the study as the study is still on-going.|0
8557622|NCT02195479|9589525|FG001|COMPLETED|Overall Study|None of the participants completed the study as the study is still on-going.|0
8557623|NCT02195479|9589524|FG000|NOT COMPLETED|Overall Study||356
8557624|NCT02195479|9589525|FG001|NOT COMPLETED|Overall Study||350
8557625|NCT02136134|9589533|FG000|STARTED|Overall Study||247
8557626|NCT02136134|9589534|FG001|STARTED|Overall Study||251
8557627|NCT02136134|9589533|FG000|Treated|Overall Study||237
8557628|NCT02136134|9589534|FG001|Treated|Overall Study||243
8557629|NCT02136134|9589533|FG000|COMPLETED|Overall Study||0
8557630|NCT02136134|9589534|FG001|COMPLETED|Overall Study||0
8557631|NCT02136134|9589533|FG000|NOT COMPLETED|Overall Study||247
8557632|NCT02136134|9589534|FG001|NOT COMPLETED|Overall Study||251
8707393|NCT00943826|9753663|FG000|STARTED|After Primary Overall Survival Analysis|Some who completed previous period had discontinued, progressed, or died prior to this period.|27
8707394|NCT00943826|9753664|FG001|STARTED|After Primary Overall Survival Analysis|Some who completed previous period had discontinued, progressed, or died prior to this period.|20
8707395|NCT00943826|9753663|FG000|COMPLETED|After Primary Overall Survival Analysis||0
8707396|NCT00943826|9753664|FG001|COMPLETED|After Primary Overall Survival Analysis||0
8707397|NCT00943826|9753663|FG000|NOT COMPLETED|After Primary Overall Survival Analysis||27
8707398|NCT00943826|9753664|FG001|NOT COMPLETED|After Primary Overall Survival Analysis||20
8707399|NCT00943878|9753675|FG000|STARTED|Overall Study||202
8707400|NCT00943878|9753676|FG001|STARTED|Overall Study||200
8707401|NCT00943878|9753677|FG002|STARTED|Overall Study||203
8707402|NCT00943878|9753678|FG003|STARTED|Overall Study||200
8707403|NCT00943878|9753675|FG000|COMPLETED|Overall Study||200
8707404|NCT00943878|9753676|FG001|COMPLETED|Overall Study||198
8707405|NCT00943878|9753677|FG002|COMPLETED|Overall Study||197
8707406|NCT00943878|9753678|FG003|COMPLETED|Overall Study||198
8707407|NCT00943878|9753675|FG000|NOT COMPLETED|Overall Study||2
8707408|NCT00943878|9753676|FG001|NOT COMPLETED|Overall Study||2
8707409|NCT00943878|9753677|FG002|NOT COMPLETED|Overall Study||6
8707410|NCT00943878|9753678|FG003|NOT COMPLETED|Overall Study||2
8707411|NCT00943904|9753688|FG000|STARTED|Overall Study||31
8707412|NCT00943904|9753688|FG000|COMPLETED|Overall Study||31
8707413|NCT00943904|9753688|FG000|NOT COMPLETED|Overall Study||0
8707414|NCT00943917|9753707|FG000|STARTED|Stage I||51
8707415|NCT00943917|9753708|FG001|STARTED|Stage I||51
8707416|NCT00943917|9753709|FG002|STARTED|Stage I||53
8707417|NCT00943917|9753710|FG003|STARTED|Stage I||0
8707418|NCT00943917|9753711|FG004|STARTED|Stage I||0
8707419|NCT00943917|9753712|FG005|STARTED|Stage I||0
8707420|NCT00943917|9753713|FG006|STARTED|Stage I||0
8707421|NCT00943917|9753714|FG007|STARTED|Stage I||0
8707422|NCT00943917|9753715|FG008|STARTED|Stage I||0
8707423|NCT00943917|9753716|FG009|STARTED|Stage I||0
8707424|NCT00943917|9753717|FG010|STARTED|Stage I||0
8707425|NCT00943917|9753718|FG011|STARTED|Stage I||0
8707426|NCT00943917|9753719|FG012|STARTED|Stage I||0
8707427|NCT00943917|9753720|FG013|STARTED|Stage I||0
8707428|NCT00943917|9753721|FG014|STARTED|Stage I||0
8707429|NCT00943917|9753707|FG000|COMPLETED|Stage I||47
8707430|NCT00943917|9753708|FG001|COMPLETED|Stage I||48
8707431|NCT00943917|9753709|FG002|COMPLETED|Stage I||47
8707432|NCT00943917|9753710|FG003|COMPLETED|Stage I||0
8707433|NCT00943917|9753711|FG004|COMPLETED|Stage I||0
8707434|NCT00943917|9753712|FG005|COMPLETED|Stage I||0
8707435|NCT00943917|9753713|FG006|COMPLETED|Stage I||0
8707436|NCT00943917|9753714|FG007|COMPLETED|Stage I||0
8707437|NCT00943917|9753715|FG008|COMPLETED|Stage I||0
8707438|NCT00943917|9753716|FG009|COMPLETED|Stage I||0
8707439|NCT00943917|9753717|FG010|COMPLETED|Stage I||0
8707440|NCT00943917|9753718|FG011|COMPLETED|Stage I||0
8707441|NCT00943917|9753719|FG012|COMPLETED|Stage I||0
8707442|NCT00943917|9753720|FG013|COMPLETED|Stage I||0
8707443|NCT00943917|9753721|FG014|COMPLETED|Stage I||0
8707444|NCT00943917|9753707|FG000|NOT COMPLETED|Stage I||4
8707445|NCT00943917|9753708|FG001|NOT COMPLETED|Stage I||3
8707446|NCT00943917|9753709|FG002|NOT COMPLETED|Stage I||6
8707447|NCT00943917|9753710|FG003|NOT COMPLETED|Stage I||0
8707448|NCT00943917|9753711|FG004|NOT COMPLETED|Stage I||0
8707449|NCT00943917|9753712|FG005|NOT COMPLETED|Stage I||0
8707450|NCT00943917|9753713|FG006|NOT COMPLETED|Stage I||0
8707451|NCT00943917|9753714|FG007|NOT COMPLETED|Stage I||0
8707452|NCT00943917|9753715|FG008|NOT COMPLETED|Stage I||0
8707453|NCT00943917|9753716|FG009|NOT COMPLETED|Stage I||0
8707454|NCT00943917|9753717|FG010|NOT COMPLETED|Stage I||0
8707455|NCT00943917|9753718|FG011|NOT COMPLETED|Stage I||0
8707456|NCT00943917|9753719|FG012|NOT COMPLETED|Stage I||0
8707457|NCT00943917|9753720|FG013|NOT COMPLETED|Stage I||0
8707458|NCT00943917|9753721|FG014|NOT COMPLETED|Stage I||0
8707459|NCT00943917|9753707|FG000|STARTED|Stage II||0
8707460|NCT00943917|9753708|FG001|STARTED|Stage II||0
8707461|NCT00943917|9753709|FG002|STARTED|Stage II||0
8707462|NCT00943917|9753710|FG003|STARTED|Stage II||20
8707463|NCT00943917|9753711|FG004|STARTED|Stage II||21
8707464|NCT00943917|9753712|FG005|STARTED|Stage II||23
8707465|NCT00943917|9753713|FG006|STARTED|Stage II||23
8707466|NCT00943917|9753714|FG007|STARTED|Stage II||23
8707467|NCT00943917|9753715|FG008|STARTED|Stage II||21
8707468|NCT00943917|9753716|FG009|STARTED|Stage II||0
8707469|NCT00943917|9753717|FG010|STARTED|Stage II||0
8707470|NCT00943917|9753718|FG011|STARTED|Stage II||0
8707471|NCT00943917|9753719|FG012|STARTED|Stage II||0
8707472|NCT00943917|9753720|FG013|STARTED|Stage II||0
8707473|NCT00943917|9753721|FG014|STARTED|Stage II||0
8707474|NCT00943917|9753707|FG000|COMPLETED|Stage II||0
8707475|NCT00943917|9753708|FG001|COMPLETED|Stage II||0
8707476|NCT00943917|9753709|FG002|COMPLETED|Stage II||0
8707477|NCT00943917|9753710|FG003|COMPLETED|Stage II||20
8707478|NCT00943917|9753711|FG004|COMPLETED|Stage II||21
8707479|NCT00943917|9753712|FG005|COMPLETED|Stage II||20
8707480|NCT00943917|9753713|FG006|COMPLETED|Stage II||20
8707481|NCT00943917|9753714|FG007|COMPLETED|Stage II||23
8707482|NCT00943917|9753715|FG008|COMPLETED|Stage II||20
8707483|NCT00943917|9753716|FG009|COMPLETED|Stage II||0
8707484|NCT00943917|9753717|FG010|COMPLETED|Stage II||0
8707485|NCT00943917|9753718|FG011|COMPLETED|Stage II||0
8707486|NCT00943917|9753719|FG012|COMPLETED|Stage II||0
8707487|NCT00943917|9753720|FG013|COMPLETED|Stage II||0
8707488|NCT00943917|9753721|FG014|COMPLETED|Stage II||0
8707489|NCT00943917|9753707|FG000|NOT COMPLETED|Stage II||0
8707490|NCT00943917|9753708|FG001|NOT COMPLETED|Stage II||0
8707491|NCT00943917|9753709|FG002|NOT COMPLETED|Stage II||0
8707492|NCT00943917|9753710|FG003|NOT COMPLETED|Stage II||0
8707493|NCT00943917|9753711|FG004|NOT COMPLETED|Stage II||0
8707494|NCT00943917|9753712|FG005|NOT COMPLETED|Stage II||3
8707495|NCT00943917|9753713|FG006|NOT COMPLETED|Stage II||3
8707496|NCT00943917|9753714|FG007|NOT COMPLETED|Stage II||0
8707497|NCT00943917|9753715|FG008|NOT COMPLETED|Stage II||1
8707498|NCT00943917|9753716|FG009|NOT COMPLETED|Stage II||0
8707499|NCT00943917|9753717|FG010|NOT COMPLETED|Stage II||0
8707500|NCT00943917|9753718|FG011|NOT COMPLETED|Stage II||0
8707501|NCT00943917|9753719|FG012|NOT COMPLETED|Stage II||0
8707502|NCT00943917|9753720|FG013|NOT COMPLETED|Stage II||0
8707503|NCT00943917|9753721|FG014|NOT COMPLETED|Stage II||0
9064142|NCT04322968|10124396|FG003|NOT COMPLETED|Overall Study||0
9064143|NCT04332419|10124406|FG000|STARTED|Overall Study||11
9064144|NCT04332419|10124406|FG000|COMPLETED|Overall Study||10
9064145|NCT04332419|10124406|FG000|NOT COMPLETED|Overall Study||1
9064146|NCT04332081|10124412|FG000|STARTED|Overall Study||20
9064147|NCT04332081|10124413|FG001|STARTED|Overall Study||60
9064148|NCT04332081|10124412|FG000|COMPLETED|Overall Study||20
9064149|NCT04332081|10124413|FG001|COMPLETED|Overall Study||60
9064150|NCT04332081|10124412|FG000|NOT COMPLETED|Overall Study||0
9064151|NCT04332081|10124413|FG001|NOT COMPLETED|Overall Study||0
9064152|NCT04332107|10124421|FG000|STARTED|Day 3||171
9064153|NCT04332107|10124422|FG001|STARTED|Day 3||92
9064154|NCT04332107|10124421|FG000|COMPLETED|Day 3||145
9064155|NCT04332107|10124422|FG001|COMPLETED|Day 3||72
9064156|NCT04332107|10124421|FG000|NOT COMPLETED|Day 3||26
9064157|NCT04332107|10124422|FG001|NOT COMPLETED|Day 3||20
9064158|NCT04332107|10124421|FG000|STARTED|Day 14|Those who had missing measurements at Day 3 but were not completely lost-to-followup were allowed to continue with the trial.|148
9064159|NCT04332107|10124422|FG001|STARTED|Day 14|Those who had missing measurements at Day 3 but were not completely lost-to-followup were allowed to continue with the trial.|78
9064160|NCT04332107|10124421|FG000|COMPLETED|Day 14||131
9064161|NCT04332107|10124422|FG001|COMPLETED|Day 14||70
9064162|NCT04332107|10124421|FG000|NOT COMPLETED|Day 14||17
9064163|NCT04332107|10124422|FG001|NOT COMPLETED|Day 14||8
9064164|NCT04332107|10124421|FG000|STARTED|Day 21|Those who had missing measurements at Day 14 but were not completely lost-to-followup were allowed to continue with the trial.|135
9064165|NCT04332107|10124422|FG001|STARTED|Day 21|Those who had missing measurements at Day 14 but were not completely lost-to-followup were allowed to continue with the trial.|74
9064166|NCT04332107|10124421|FG000|COMPLETED|Day 21||125
9064167|NCT04332107|10124422|FG001|COMPLETED|Day 21||72
9064168|NCT04332107|10124421|FG000|NOT COMPLETED|Day 21||10
9064169|NCT04332107|10124422|FG001|NOT COMPLETED|Day 21||2
9064170|NCT04323592|10124430|FG000|STARTED|Overall Study||83
9064171|NCT04323592|10124431|FG001|STARTED|Overall Study||90
9064172|NCT04323592|10124430|FG000|COMPLETED|Overall Study||83
9064173|NCT04323592|10124431|FG001|COMPLETED|Overall Study||90
9064174|NCT04323592|10124430|FG000|NOT COMPLETED|Overall Study||0
9064175|NCT04323592|10124431|FG001|NOT COMPLETED|Overall Study||0
9064176|NCT04326842|10124439|FG000|STARTED|Overall Study||40
9064177|NCT04326842|10124440|FG001|STARTED|Overall Study||89
9064178|NCT04326842|10124439|FG000|COMPLETED|Overall Study||31
9064179|NCT04326842|10124440|FG001|COMPLETED|Overall Study||31
9064180|NCT04326842|10124439|FG000|NOT COMPLETED|Overall Study||9
9064181|NCT04326842|10124440|FG001|NOT COMPLETED|Overall Study||58
9064182|NCT04325542|10124446|FG000|STARTED|Overall Study|one participant withdraw consent during the study|743
9064183|NCT04325542|10124446|FG000|COMPLETED|Overall Study||742
8557633|NCT02087423|9589543|FG000|STARTED|Overall Study|Treated|111
8557634|NCT02087423|9589544|FG001|STARTED|Overall Study|Treated|265
8557635|NCT02087423|9589545|FG002|STARTED|Overall Study|Treated|68
8557636|NCT02087423|9589543|FG000|Completed 12 Months of Treatment|Overall Study||18
8557637|NCT02087423|9589544|FG001|Completed 12 Months of Treatment|Overall Study||60
8557638|NCT02087423|9589545|FG002|Completed 12 Months of Treatment|Overall Study||26
8707504|NCT00943917|9753707|FG000|STARTED|Stage II Continuation||0
8707505|NCT00943917|9753708|FG001|STARTED|Stage II Continuation||0
8707506|NCT00943917|9753709|FG002|STARTED|Stage II Continuation||0
8707507|NCT00943917|9753710|FG003|STARTED|Stage II Continuation||0
8707508|NCT00943917|9753711|FG004|STARTED|Stage II Continuation||0
8707509|NCT00943917|9753712|FG005|STARTED|Stage II Continuation||0
8707510|NCT00943917|9753713|FG006|STARTED|Stage II Continuation||0
8707511|NCT00943917|9753714|FG007|STARTED|Stage II Continuation||0
8707512|NCT00943917|9753715|FG008|STARTED|Stage II Continuation||0
8707513|NCT00943917|9753716|FG009|STARTED|Stage II Continuation||15
8707514|NCT00943917|9753717|FG010|STARTED|Stage II Continuation||15
8707515|NCT00943917|9753718|FG011|STARTED|Stage II Continuation||13
8707516|NCT00943917|9753719|FG012|STARTED|Stage II Continuation||16
8707517|NCT00943917|9753720|FG013|STARTED|Stage II Continuation||15
8707518|NCT00943917|9753721|FG014|STARTED|Stage II Continuation||12
8707519|NCT00943917|9753707|FG000|COMPLETED|Stage II Continuation||0
8707520|NCT00943917|9753708|FG001|COMPLETED|Stage II Continuation||0
8707521|NCT00943917|9753709|FG002|COMPLETED|Stage II Continuation||0
8707522|NCT00943917|9753710|FG003|COMPLETED|Stage II Continuation||0
8707523|NCT00943917|9753711|FG004|COMPLETED|Stage II Continuation||0
8707524|NCT00943917|9753712|FG005|COMPLETED|Stage II Continuation||0
8707525|NCT00943917|9753713|FG006|COMPLETED|Stage II Continuation||0
8707526|NCT00943917|9753714|FG007|COMPLETED|Stage II Continuation||0
8707527|NCT00943917|9753715|FG008|COMPLETED|Stage II Continuation||0
8707528|NCT00943917|9753716|FG009|COMPLETED|Stage II Continuation||14
8707529|NCT00943917|9753717|FG010|COMPLETED|Stage II Continuation||15
8707530|NCT00943917|9753718|FG011|COMPLETED|Stage II Continuation||11
8707531|NCT00943917|9753719|FG012|COMPLETED|Stage II Continuation||13
8707532|NCT00943917|9753720|FG013|COMPLETED|Stage II Continuation||12
8707533|NCT00943917|9753721|FG014|COMPLETED|Stage II Continuation||8
8707534|NCT00943917|9753707|FG000|NOT COMPLETED|Stage II Continuation||0
8707535|NCT00943917|9753708|FG001|NOT COMPLETED|Stage II Continuation||0
8707536|NCT00943917|9753709|FG002|NOT COMPLETED|Stage II Continuation||0
8707537|NCT00943917|9753710|FG003|NOT COMPLETED|Stage II Continuation||0
8707538|NCT00943917|9753711|FG004|NOT COMPLETED|Stage II Continuation||0
8707539|NCT00943917|9753712|FG005|NOT COMPLETED|Stage II Continuation||0
8707540|NCT00943917|9753713|FG006|NOT COMPLETED|Stage II Continuation||0
8707541|NCT00943917|9753714|FG007|NOT COMPLETED|Stage II Continuation||0
8707542|NCT00943917|9753715|FG008|NOT COMPLETED|Stage II Continuation||0
8707543|NCT00943917|9753716|FG009|NOT COMPLETED|Stage II Continuation||1
8707544|NCT00943917|9753717|FG010|NOT COMPLETED|Stage II Continuation||0
8707545|NCT00943917|9753718|FG011|NOT COMPLETED|Stage II Continuation||2
8707546|NCT00943917|9753719|FG012|NOT COMPLETED|Stage II Continuation||3
8707547|NCT00943917|9753720|FG013|NOT COMPLETED|Stage II Continuation||3
8707548|NCT00943917|9753721|FG014|NOT COMPLETED|Stage II Continuation||4
8707549|NCT00944021|9753759|FG000|STARTED|Overall Study||15
8707550|NCT00944021|9753760|FG001|STARTED|Overall Study||15
8707551|NCT00944021|9753761|FG002|STARTED|Overall Study||15
8707552|NCT00944021|9753762|FG003|STARTED|Overall Study||16
8707553|NCT00944021|9753763|FG004|STARTED|Overall Study||8
8707554|NCT00944021|9753759|FG000|COMPLETED|Overall Study||14
8707555|NCT00944021|9753760|FG001|COMPLETED|Overall Study||15
8707556|NCT00944021|9753761|FG002|COMPLETED|Overall Study||15
8707557|NCT00944021|9753762|FG003|COMPLETED|Overall Study||16
8707558|NCT00944021|9753763|FG004|COMPLETED|Overall Study||8
8707559|NCT00944021|9753759|FG000|NOT COMPLETED|Overall Study||1
8707560|NCT00944021|9753760|FG001|NOT COMPLETED|Overall Study||0
8707561|NCT00944021|9753761|FG002|NOT COMPLETED|Overall Study||0
8707562|NCT00944021|9753762|FG003|NOT COMPLETED|Overall Study||0
8707563|NCT00944021|9753763|FG004|NOT COMPLETED|Overall Study||0
8707564|NCT00944034|9753787|FG000|STARTED|Overall Study||188
8707565|NCT00944034|9753788|FG001|STARTED|Overall Study||157
8707566|NCT00944034|9753789|FG002|STARTED|Overall Study||152
8707567|NCT00944034|9753790|FG003|STARTED|Overall Study||174
8707568|NCT00944034|9753791|FG004|STARTED|Overall Study||164
8707569|NCT00944034|9753792|FG005|STARTED|Overall Study||143
8707570|NCT00944034|9753793|FG006|STARTED|Overall Study||106
8707571|NCT00944034|9753794|FG007|STARTED|Overall Study||78
8707572|NCT00944034|9753795|FG008|STARTED|Overall Study||73
8707573|NCT00944034|9753796|FG009|STARTED|Overall Study||246
8707574|NCT00944034|9753797|FG010|STARTED|Overall Study||51
8707575|NCT00944034|9753798|FG011|STARTED|Overall Study||56
8707576|NCT00944034|9753787|FG000|COMPLETED|Overall Study||183
8707577|NCT00944034|9753788|FG001|COMPLETED|Overall Study||150
8707578|NCT00944034|9753789|FG002|COMPLETED|Overall Study||143
8707579|NCT00944034|9753790|FG003|COMPLETED|Overall Study||170
8707580|NCT00944034|9753791|FG004|COMPLETED|Overall Study||150
8707581|NCT00944034|9753792|FG005|COMPLETED|Overall Study||123
8707582|NCT00944034|9753793|FG006|COMPLETED|Overall Study||102
8707583|NCT00944034|9753794|FG007|COMPLETED|Overall Study||73
8707584|NCT00944034|9753795|FG008|COMPLETED|Overall Study||63
8707585|NCT00944034|9753796|FG009|COMPLETED|Overall Study||236
8707586|NCT00944034|9753797|FG010|COMPLETED|Overall Study||50
8707587|NCT00944034|9753798|FG011|COMPLETED|Overall Study||52
8707588|NCT00944034|9753787|FG000|NOT COMPLETED|Overall Study||5
8707589|NCT00944034|9753788|FG001|NOT COMPLETED|Overall Study||7
8707590|NCT00944034|9753789|FG002|NOT COMPLETED|Overall Study||9
8707591|NCT00944034|9753790|FG003|NOT COMPLETED|Overall Study||4
8707592|NCT00944034|9753791|FG004|NOT COMPLETED|Overall Study||14
8707593|NCT00944034|9753792|FG005|NOT COMPLETED|Overall Study||20
8707594|NCT00944034|9753793|FG006|NOT COMPLETED|Overall Study||4
8707595|NCT00944034|9753794|FG007|NOT COMPLETED|Overall Study||5
8707596|NCT00944034|9753795|FG008|NOT COMPLETED|Overall Study||10
8707597|NCT00944034|9753796|FG009|NOT COMPLETED|Overall Study||10
8707598|NCT00944034|9753797|FG010|NOT COMPLETED|Overall Study||1
8707599|NCT00944034|9753798|FG011|NOT COMPLETED|Overall Study||4
8707600|NCT00944047|9753841|FG000|STARTED|Overall Study||32
8707601|NCT00944047|9753841|FG000|COMPLETED|Overall Study||27
8707602|NCT00944047|9753841|FG000|NOT COMPLETED|Overall Study||5
8707603|NCT00944073|9753847|FG000|STARTED|Overall Study||292
8707604|NCT00944073|9753848|FG001|STARTED|Overall Study||291
8707605|NCT00944073|9753847|FG000|COMPLETED|Overall Study||287
8707606|NCT00944073|9753848|FG001|COMPLETED|Overall Study||287
8707607|NCT00944073|9753847|FG000|NOT COMPLETED|Overall Study||5
8707608|NCT00944073|9753848|FG001|NOT COMPLETED|Overall Study||4
8707609|NCT00944125|9753854|FG000|STARTED|Baseline to 3 Months||19
8707610|NCT00944125|9753855|FG001|STARTED|Baseline to 3 Months||22
8707611|NCT00944125|9753854|FG000|COMPLETED|Baseline to 3 Months||19
8707612|NCT00944125|9753855|FG001|COMPLETED|Baseline to 3 Months||22
8707613|NCT00944125|9753854|FG000|NOT COMPLETED|Baseline to 3 Months||0
8707614|NCT00944125|9753855|FG001|NOT COMPLETED|Baseline to 3 Months||0
8707615|NCT00944125|9753854|FG000|STARTED|3 to 6 Months||19
8707616|NCT00944125|9753855|FG001|STARTED|3 to 6 Months||22
8707617|NCT00944125|9753854|FG000|COMPLETED|3 to 6 Months||19
8707618|NCT00944125|9753855|FG001|COMPLETED|3 to 6 Months||20
8707619|NCT00944125|9753854|FG000|NOT COMPLETED|3 to 6 Months||0
8707620|NCT00944125|9753855|FG001|NOT COMPLETED|3 to 6 Months||2
8707621|NCT00944125|9753854|FG000|STARTED|6 Months to Study Completion||19
8707622|NCT00944125|9753855|FG001|STARTED|6 Months to Study Completion||20
8707623|NCT00944125|9753854|FG000|COMPLETED|6 Months to Study Completion||19
8707624|NCT00944125|9753855|FG001|COMPLETED|6 Months to Study Completion||18
8707625|NCT00944125|9753854|FG000|NOT COMPLETED|6 Months to Study Completion||0
8707626|NCT00944125|9753855|FG001|NOT COMPLETED|6 Months to Study Completion||2
8707627|NCT00944450|9753861|FG000|STARTED|Period 1||6
8707628|NCT00944450|9753862|FG001|STARTED|Period 1||6
8707629|NCT00944450|9753861|FG000|COMPLETED|Period 1||6
8707630|NCT00944450|9753862|FG001|COMPLETED|Period 1||6
8707631|NCT00944450|9753861|FG000|NOT COMPLETED|Period 1||0
8707632|NCT00944450|9753862|FG001|NOT COMPLETED|Period 1||0
8707633|NCT00944450|9753861|FG000|STARTED|Period 2||6
8707634|NCT00944450|9753862|FG001|STARTED|Period 2||6
8707635|NCT00944450|9753861|FG000|COMPLETED|Period 2||6
8707636|NCT00944450|9753862|FG001|COMPLETED|Period 2||6
8707637|NCT00944450|9753861|FG000|NOT COMPLETED|Period 2||0
8707638|NCT00944450|9753862|FG001|NOT COMPLETED|Period 2||0
8707639|NCT00944554|9753870|FG000|STARTED|Overall Study||50
8707640|NCT00944554|9753871|FG001|STARTED|Overall Study||54
8707641|NCT00944554|9753870|FG000|COMPLETED|Overall Study||22
8707642|NCT00944554|9753871|FG001|COMPLETED|Overall Study||25
8707643|NCT00944554|9753870|FG000|NOT COMPLETED|Overall Study||28
8707644|NCT00944554|9753871|FG001|NOT COMPLETED|Overall Study||29
8707645|NCT00944645|9753877|FG000|STARTED|Period 1||94
8707646|NCT00944645|9753878|FG001|STARTED|Period 1||94
8707647|NCT00944645|9753877|FG000|COMPLETED|Period 1||94
8707648|NCT00944645|9753878|FG001|COMPLETED|Period 1||94
8707649|NCT00944645|9753877|FG000|NOT COMPLETED|Period 1||0
8707650|NCT00944645|9753878|FG001|NOT COMPLETED|Period 1||0
9064184|NCT04325542|10124446|FG000|NOT COMPLETED|Overall Study||1
9064185|NCT04329923|10124456|FG000|STARTED|Overall Study||17
9064186|NCT04329923|10124457|FG001|STARTED|Overall Study||17
9064187|NCT04329923|10124458|FG002|STARTED|Overall Study||4
9064188|NCT04329923|10124459|FG003|STARTED|Overall Study||3
9064189|NCT04329923|10124460|FG004|STARTED|Overall Study||66
9064190|NCT04329923|10124461|FG005|STARTED|Overall Study||66
9064191|NCT04329923|10124456|FG000|COMPLETED|Overall Study||16
9064192|NCT04329923|10124457|FG001|COMPLETED|Overall Study||13
9064193|NCT04329923|10124458|FG002|COMPLETED|Overall Study||3
9064194|NCT04329923|10124459|FG003|COMPLETED|Overall Study||2
9064195|NCT04329923|10124460|FG004|COMPLETED|Overall Study||64
9064196|NCT04329923|10124461|FG005|COMPLETED|Overall Study||61
9064197|NCT04329923|10124456|FG000|NOT COMPLETED|Overall Study||1
9064198|NCT04329923|10124457|FG001|NOT COMPLETED|Overall Study||4
9064199|NCT04329923|10124458|FG002|NOT COMPLETED|Overall Study||1
9064200|NCT04329923|10124459|FG003|NOT COMPLETED|Overall Study||1
9064201|NCT04329923|10124460|FG004|NOT COMPLETED|Overall Study||2
9064202|NCT04329923|10124461|FG005|NOT COMPLETED|Overall Study||5
9064203|NCT04328467|10124478|FG000|STARTED|Overall Study||494
9064204|NCT04328467|10124479|FG001|STARTED|Overall Study||495
9064205|NCT04328467|10124480|FG002|STARTED|Overall Study||494
9064206|NCT04328467|10124478|FG000|COMPLETED|Overall Study||490
9064207|NCT04328467|10124479|FG001|COMPLETED|Overall Study||493
9064208|NCT04328467|10124480|FG002|COMPLETED|Overall Study||493
9064209|NCT04328467|10124478|FG000|NOT COMPLETED|Overall Study||4
9064210|NCT04328467|10124479|FG001|NOT COMPLETED|Overall Study||2
9064211|NCT04328467|10124480|FG002|NOT COMPLETED|Overall Study||1
9064212|NCT04322526|10124490|FG000|STARTED|First Intervention (1 Day)||13
9064213|NCT04322526|10124491|FG001|STARTED|First Intervention (1 Day)||12
9064214|NCT04322526|10124490|FG000|COMPLETED|First Intervention (1 Day)||12
9064215|NCT04322526|10124491|FG001|COMPLETED|First Intervention (1 Day)||11
9064216|NCT04322526|10124490|FG000|NOT COMPLETED|First Intervention (1 Day)||1
9064217|NCT04322526|10124491|FG001|NOT COMPLETED|First Intervention (1 Day)||1
8812918|NCT01522937|9866018|FG000|COMPLETED|Overall Study||146
8812919|NCT01522937|9866018|FG000|NOT COMPLETED|Overall Study||0
8812920|NCT01522950|9866025|FG000|STARTED|Overall Study||26
8812921|NCT01522950|9866026|FG001|STARTED|Overall Study||23
8707651|NCT00944645|9753877|FG000|STARTED|Period 2||94
8707652|NCT00944645|9753878|FG001|STARTED|Period 2||94
8707653|NCT00944645|9753877|FG000|COMPLETED|Period 2||86
8707654|NCT00944645|9753878|FG001|COMPLETED|Period 2||85
8707655|NCT00944645|9753877|FG000|NOT COMPLETED|Period 2||8
8707656|NCT00944645|9753878|FG001|NOT COMPLETED|Period 2||9
8707657|NCT00944658|9753886|FG000|STARTED|Treatment 12 Weeks||19
8707658|NCT00944658|9753887|FG001|STARTED|Treatment 12 Weeks||19
8707659|NCT00944658|9753886|FG000|COMPLETED|Treatment 12 Weeks||19
8707660|NCT00944658|9753887|FG001|COMPLETED|Treatment 12 Weeks||17
8707661|NCT00944658|9753886|FG000|NOT COMPLETED|Treatment 12 Weeks||0
8707662|NCT00944658|9753887|FG001|NOT COMPLETED|Treatment 12 Weeks||2
8707663|NCT00944658|9753886|FG000|STARTED|Follow up 4 Weeks||19
8707664|NCT00944658|9753887|FG001|STARTED|Follow up 4 Weeks||17
8707665|NCT00944658|9753886|FG000|COMPLETED|Follow up 4 Weeks||19
8707666|NCT00944658|9753887|FG001|COMPLETED|Follow up 4 Weeks||17
8707667|NCT00944658|9753886|FG000|NOT COMPLETED|Follow up 4 Weeks||0
8707668|NCT00944658|9753887|FG001|NOT COMPLETED|Follow up 4 Weeks||0
8707669|NCT00944671|9753899|FG000|STARTED|Period I||4
8707670|NCT00944671|9753900|FG001|STARTED|Period I||4
8707671|NCT00944671|9753901|FG002|STARTED|Period I||4
8707672|NCT00944671|9753902|FG003|STARTED|Period I||4
8707673|NCT00944671|9753903|FG004|STARTED|Period I||4
8707674|NCT00944671|9753904|FG005|STARTED|Period I||4
8707675|NCT00944671|9753899|FG000|COMPLETED|Period I||4
8707676|NCT00944671|9753900|FG001|COMPLETED|Period I||4
8812922|NCT01522950|9866027|FG002|STARTED|Overall Study||27
8707677|NCT00944671|9753901|FG002|COMPLETED|Period I||4
8707678|NCT00944671|9753902|FG003|COMPLETED|Period I||4
8707679|NCT00944671|9753903|FG004|COMPLETED|Period I||4
8707680|NCT00944671|9753904|FG005|COMPLETED|Period I||4
8707681|NCT00944671|9753899|FG000|NOT COMPLETED|Period I||0
8707682|NCT00944671|9753900|FG001|NOT COMPLETED|Period I||0
8707683|NCT00944671|9753901|FG002|NOT COMPLETED|Period I||0
8707684|NCT00944671|9753902|FG003|NOT COMPLETED|Period I||0
8707685|NCT00944671|9753903|FG004|NOT COMPLETED|Period I||0
8707686|NCT00944671|9753904|FG005|NOT COMPLETED|Period I||0
8707687|NCT00944671|9753899|FG000|STARTED|Period II||4
8707688|NCT00944671|9753900|FG001|STARTED|Period II||4
8707689|NCT00944671|9753901|FG002|STARTED|Period II||4
8707690|NCT00944671|9753902|FG003|STARTED|Period II||4
8707691|NCT00944671|9753903|FG004|STARTED|Period II||4
8707692|NCT00944671|9753904|FG005|STARTED|Period II||4
8707693|NCT00944671|9753899|FG000|COMPLETED|Period II||4
8707694|NCT00944671|9753900|FG001|COMPLETED|Period II||4
8707695|NCT00944671|9753901|FG002|COMPLETED|Period II||4
8707696|NCT00944671|9753902|FG003|COMPLETED|Period II||4
8707697|NCT00944671|9753903|FG004|COMPLETED|Period II||4
8707698|NCT00944671|9753904|FG005|COMPLETED|Period II||4
8707699|NCT00944671|9753899|FG000|NOT COMPLETED|Period II||0
8707700|NCT00944671|9753900|FG001|NOT COMPLETED|Period II||0
8707701|NCT00944671|9753901|FG002|NOT COMPLETED|Period II||0
8707702|NCT00944671|9753902|FG003|NOT COMPLETED|Period II||0
8812923|NCT01522950|9866025|FG000|COMPLETED|Overall Study||20
8812924|NCT01522950|9866026|FG001|COMPLETED|Overall Study||18
8707703|NCT00944671|9753903|FG004|NOT COMPLETED|Period II||0
8707704|NCT00944671|9753904|FG005|NOT COMPLETED|Period II||0
8707705|NCT00944671|9753899|FG000|STARTED|Period III||4
8707706|NCT00944671|9753900|FG001|STARTED|Period III||4
8707707|NCT00944671|9753901|FG002|STARTED|Period III||4
8707708|NCT00944671|9753902|FG003|STARTED|Period III||4
8707709|NCT00944671|9753903|FG004|STARTED|Period III||4
8707710|NCT00944671|9753904|FG005|STARTED|Period III||4
8812925|NCT01522950|9866027|FG002|COMPLETED|Overall Study||22
8707711|NCT00944671|9753899|FG000|COMPLETED|Period III||4
8707712|NCT00944671|9753900|FG001|COMPLETED|Period III||4
8707713|NCT00944671|9753901|FG002|COMPLETED|Period III||4
8707714|NCT00944671|9753902|FG003|COMPLETED|Period III||4
8707715|NCT00944671|9753903|FG004|COMPLETED|Period III||4
8707716|NCT00944671|9753904|FG005|COMPLETED|Period III||4
8707717|NCT00944671|9753899|FG000|NOT COMPLETED|Period III||0
8707718|NCT00944671|9753900|FG001|NOT COMPLETED|Period III||0
8707719|NCT00944671|9753901|FG002|NOT COMPLETED|Period III||0
8707720|NCT00944671|9753902|FG003|NOT COMPLETED|Period III||0
8707721|NCT00944671|9753903|FG004|NOT COMPLETED|Period III||0
8707722|NCT00944671|9753904|FG005|NOT COMPLETED|Period III||0
8707723|NCT00944697|9753914|FG000|STARTED|Overall Study||50
8707724|NCT00944697|9753915|FG001|STARTED|Overall Study||48
8707725|NCT00944697|9753914|FG000|COMPLETED|Overall Study||48
8707726|NCT00944697|9753915|FG001|COMPLETED|Overall Study||43
8707727|NCT00944697|9753914|FG000|NOT COMPLETED|Overall Study||2
8707728|NCT00944697|9753915|FG001|NOT COMPLETED|Overall Study||5
8707729|NCT00944710|9753923|FG000|STARTED|10-week Primary Outcome||40
8707730|NCT00944710|9753924|FG001|STARTED|10-week Primary Outcome||33
8707731|NCT00944710|9753923|FG000|COMPLETED|10-week Primary Outcome||40
8707732|NCT00944710|9753924|FG001|COMPLETED|10-week Primary Outcome||33
8707733|NCT00944710|9753923|FG000|NOT COMPLETED|10-week Primary Outcome||0
8707734|NCT00944710|9753924|FG001|NOT COMPLETED|10-week Primary Outcome||0
8707735|NCT00944710|9753923|FG000|STARTED|12-week Visit (Off-treatment)||40
8707736|NCT00944710|9753924|FG001|STARTED|12-week Visit (Off-treatment)||33
8707737|NCT00944710|9753923|FG000|COMPLETED|12-week Visit (Off-treatment)||40
8707738|NCT00944710|9753924|FG001|COMPLETED|12-week Visit (Off-treatment)||33
8707739|NCT00944710|9753923|FG000|NOT COMPLETED|12-week Visit (Off-treatment)||0
8707740|NCT00944710|9753924|FG001|NOT COMPLETED|12-week Visit (Off-treatment)||0
8707741|NCT00944710|9753923|FG000|STARTED|Additional Post 10-week Primary Outcome||40
8707742|NCT00944710|9753924|FG001|STARTED|Additional Post 10-week Primary Outcome||33
8707743|NCT00944710|9753923|FG000|Eligible to Enter Post 10-week Phase|Additional Post 10-week Primary Outcome||24
8707744|NCT00944710|9753924|FG001|Eligible to Enter Post 10-week Phase|Additional Post 10-week Primary Outcome||26
8707745|NCT00944710|9753923|FG000|COMPLETED|Additional Post 10-week Primary Outcome||23
8707746|NCT00944710|9753924|FG001|COMPLETED|Additional Post 10-week Primary Outcome||22
8707747|NCT00944710|9753923|FG000|NOT COMPLETED|Additional Post 10-week Primary Outcome||17
8707748|NCT00944710|9753924|FG001|NOT COMPLETED|Additional Post 10-week Primary Outcome||11
8707749|NCT00944749|9753930|FG000|STARTED|Overall Study||23
8707750|NCT00944749|9753930|FG000|COMPLETED|Overall Study||22
8707751|NCT00944749|9753930|FG000|NOT COMPLETED|Overall Study||1
8707752|NCT00945061|9753936|FG000|STARTED|Overall Study||12
8707753|NCT00945061|9753937|FG001|STARTED|Overall Study||1
8707754|NCT00945061|9753936|FG000|COMPLETED|Overall Study||12
8707755|NCT00945061|9753937|FG001|COMPLETED|Overall Study||1
8707756|NCT00945061|9753936|FG000|NOT COMPLETED|Overall Study||0
8707757|NCT00945061|9753937|FG001|NOT COMPLETED|Overall Study||0
8707758|NCT00945100|9753954|FG000|STARTED|10-week Primary Outcome||83
8707759|NCT00945100|9753955|FG001|STARTED|10-week Primary Outcome||86
8707760|NCT00945100|9753954|FG000|Completed, Eligible|10-week Primary Outcome|Eligible for Post-10 week phase|55
8707761|NCT00945100|9753955|FG001|Completed, Eligible|10-week Primary Outcome|Eligible for Post-10 week phase|63
8707762|NCT00945100|9753954|FG000|Completed, Not Eligible|10-week Primary Outcome|Not Eligible for Post-10 week phase|27
8707763|NCT00945100|9753955|FG001|Completed, Not Eligible|10-week Primary Outcome|Not Eligible for Post-10 week phase|20
8707764|NCT00945100|9753954|FG000|COMPLETED|10-week Primary Outcome||82
8707765|NCT00945100|9753955|FG001|COMPLETED|10-week Primary Outcome||83
8707766|NCT00945100|9753954|FG000|NOT COMPLETED|10-week Primary Outcome||1
8707767|NCT00945100|9753955|FG001|NOT COMPLETED|10-week Primary Outcome||3
8707768|NCT00945100|9753954|FG000|STARTED|Post-10 Week Primary Outcome|27 participants were not eligible for Post 10 week Primary Outcome phase|55
8707769|NCT00945100|9753955|FG001|STARTED|Post-10 Week Primary Outcome|20 participants were not eligible for Post 10 week Primary Outcome phase|63
8707770|NCT00945100|9753954|FG000|COMPLETED|Post-10 Week Primary Outcome||51
8707771|NCT00945100|9753955|FG001|COMPLETED|Post-10 Week Primary Outcome||56
8707772|NCT00945100|9753954|FG000|NOT COMPLETED|Post-10 Week Primary Outcome||4
8707773|NCT00945100|9753955|FG001|NOT COMPLETED|Post-10 Week Primary Outcome||7
8707774|NCT00945139|9753961|FG000|STARTED|Overall Study||46
8707775|NCT00945139|9753961|FG000|COMPLETED|Overall Study||46
8707776|NCT00945139|9753961|FG000|NOT COMPLETED|Overall Study||0
8707777|NCT00945191|9753966|FG000|STARTED|Overall Study||24
8707778|NCT00945191|9753966|FG000|COMPLETED|Overall Study||0
8707779|NCT00945191|9753966|FG000|NOT COMPLETED|Overall Study||24
8707780|NCT00945243|9753970|FG000|STARTED|Overall Study|Enrolled and Treated Per Protocol|11
8707781|NCT00945243|9753970|FG000|COMPLETED|Overall Study||8
8707782|NCT00945243|9753970|FG000|NOT COMPLETED|Overall Study||3
8707783|NCT00945256|9753979|FG000|STARTED|Overall Study||13
8707784|NCT00945256|9753980|FG001|STARTED|Overall Study||10
8707785|NCT00945256|9753981|FG002|STARTED|Overall Study||15
8707786|NCT00945256|9753982|FG003|STARTED|Overall Study||16
8707787|NCT00945256|9753983|FG004|STARTED|Overall Study||8
8707788|NCT00945256|9753979|FG000|COMPLETED|Overall Study||9
8707789|NCT00945256|9753980|FG001|COMPLETED|Overall Study||8
8707790|NCT00945256|9753981|FG002|COMPLETED|Overall Study||7
8707791|NCT00945256|9753982|FG003|COMPLETED|Overall Study||7
8707792|NCT00945256|9753983|FG004|COMPLETED|Overall Study||7
8707793|NCT00945256|9753979|FG000|NOT COMPLETED|Overall Study||4
8707794|NCT00945256|9753980|FG001|NOT COMPLETED|Overall Study||2
8707795|NCT00945256|9753981|FG002|NOT COMPLETED|Overall Study||8
8707796|NCT00945256|9753982|FG003|NOT COMPLETED|Overall Study||9
8707797|NCT00945256|9753983|FG004|NOT COMPLETED|Overall Study||1
8707798|NCT00945282|9753997|FG000|STARTED|Overall Study||6
8707799|NCT00945282|9753998|FG001|STARTED|Overall Study||2
8707800|NCT00945282|9753997|FG000|COMPLETED|Overall Study||6
8707801|NCT00945282|9753998|FG001|COMPLETED|Overall Study||2
8707802|NCT00945282|9753997|FG000|NOT COMPLETED|Overall Study||0
8707803|NCT00945282|9753998|FG001|NOT COMPLETED|Overall Study||0
8707804|NCT00945295|9754014|FG000|STARTED|Overall Study||15
8707805|NCT00945295|9754015|FG001|STARTED|Overall Study||16
8707806|NCT00945295|9754014|FG000|COMPLETED|Overall Study||15
8707807|NCT00945295|9754015|FG001|COMPLETED|Overall Study||14
8707808|NCT00945295|9754014|FG000|NOT COMPLETED|Overall Study||0
8578771|NCT00178256|9611902|FG000|NOT COMPLETED|Overall Study||4
8578772|NCT00178256|9611903|FG001|NOT COMPLETED|Overall Study||1
8578773|NCT00178256|9611904|FG002|NOT COMPLETED|Overall Study||0
8578774|NCT00178256|9611905|FG003|NOT COMPLETED|Overall Study||2
8578775|NCT00178399|9611912|FG000|STARTED|Overall Study||128
8578776|NCT00178399|9611912|FG000|COMPLETED|Overall Study||115
8707809|NCT00945295|9754015|FG001|NOT COMPLETED|Overall Study||2
8707810|NCT00945321|9754021|FG000|STARTED|Period 1||7
8707811|NCT00945321|9754022|FG001|STARTED|Period 1||7
8707812|NCT00945321|9754023|FG002|STARTED|Period 1||7
8707813|NCT00945321|9754024|FG003|STARTED|Period 1||7
8707814|NCT00945321|9754025|FG004|STARTED|Period 1||7
8707815|NCT00945321|9754026|FG005|STARTED|Period 1||7
8707816|NCT00945321|9754021|FG000|COMPLETED|Period 1||7
8707817|NCT00945321|9754022|FG001|COMPLETED|Period 1||7
8707818|NCT00945321|9754023|FG002|COMPLETED|Period 1||7
8707819|NCT00945321|9754024|FG003|COMPLETED|Period 1||7
8707820|NCT00945321|9754025|FG004|COMPLETED|Period 1||6
8707821|NCT00945321|9754026|FG005|COMPLETED|Period 1||7
8707822|NCT00945321|9754021|FG000|NOT COMPLETED|Period 1||0
8707823|NCT00945321|9754022|FG001|NOT COMPLETED|Period 1||0
8707824|NCT00945321|9754023|FG002|NOT COMPLETED|Period 1||0
8707825|NCT00945321|9754024|FG003|NOT COMPLETED|Period 1||0
8707826|NCT00945321|9754025|FG004|NOT COMPLETED|Period 1||1
8707827|NCT00945321|9754026|FG005|NOT COMPLETED|Period 1||0
8707828|NCT00945321|9754021|FG000|STARTED|Period 2||7
8707829|NCT00945321|9754022|FG001|STARTED|Period 2||7
8707830|NCT00945321|9754023|FG002|STARTED|Period 2||7
8707831|NCT00945321|9754024|FG003|STARTED|Period 2||7
8707832|NCT00945321|9754025|FG004|STARTED|Period 2||6
8707833|NCT00945321|9754026|FG005|STARTED|Period 2||7
8707834|NCT00945321|9754021|FG000|COMPLETED|Period 2||7
8707835|NCT00945321|9754022|FG001|COMPLETED|Period 2||7
8707836|NCT00945321|9754023|FG002|COMPLETED|Period 2||7
8707837|NCT00945321|9754024|FG003|COMPLETED|Period 2||7
8707838|NCT00945321|9754025|FG004|COMPLETED|Period 2||6
8557639|NCT02087423|9589543|FG000|COMPLETED|Overall Study||0
8707839|NCT00945321|9754026|FG005|COMPLETED|Period 2||7
8707840|NCT00945321|9754021|FG000|NOT COMPLETED|Period 2||0
8707841|NCT00945321|9754022|FG001|NOT COMPLETED|Period 2||0
8707842|NCT00945321|9754023|FG002|NOT COMPLETED|Period 2||0
8707843|NCT00945321|9754024|FG003|NOT COMPLETED|Period 2||0
8707844|NCT00945321|9754025|FG004|NOT COMPLETED|Period 2||0
8707845|NCT00945321|9754026|FG005|NOT COMPLETED|Period 2||0
8707846|NCT00945321|9754021|FG000|STARTED|Period 3||7
8928103|NCT02278328|9989241|FG000|STARTED|Second Intervention (1 Day)||9
8928104|NCT02278328|9989242|FG001|STARTED|Second Intervention (1 Day)||6
8928105|NCT02278328|9989243|FG002|STARTED|Second Intervention (1 Day)||6
8928106|NCT02278328|9989241|FG000|COMPLETED|Second Intervention (1 Day)||9
8928107|NCT02278328|9989242|FG001|COMPLETED|Second Intervention (1 Day)||6
8928108|NCT02278328|9989243|FG002|COMPLETED|Second Intervention (1 Day)||6
8928109|NCT02278328|9989241|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
8557640|NCT02087423|9589544|FG001|COMPLETED|Overall Study||0
8928110|NCT02278328|9989242|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
8707847|NCT00945321|9754022|FG001|STARTED|Period 3||7
8707848|NCT00945321|9754023|FG002|STARTED|Period 3||7
8707849|NCT00945321|9754024|FG003|STARTED|Period 3||7
8707850|NCT00945321|9754025|FG004|STARTED|Period 3||6
8707851|NCT00945321|9754026|FG005|STARTED|Period 3||7
8707852|NCT00945321|9754021|FG000|COMPLETED|Period 3||7
8707853|NCT00945321|9754022|FG001|COMPLETED|Period 3||7
8707854|NCT00945321|9754023|FG002|COMPLETED|Period 3||7
8707855|NCT00945321|9754024|FG003|COMPLETED|Period 3||7
8707856|NCT00945321|9754025|FG004|COMPLETED|Period 3||6
8707857|NCT00945321|9754026|FG005|COMPLETED|Period 3||7
8707858|NCT00945321|9754021|FG000|NOT COMPLETED|Period 3||0
8707859|NCT00945321|9754022|FG001|NOT COMPLETED|Period 3||0
8707860|NCT00945321|9754023|FG002|NOT COMPLETED|Period 3||0
8707861|NCT00945321|9754024|FG003|NOT COMPLETED|Period 3||0
8707862|NCT00945321|9754025|FG004|NOT COMPLETED|Period 3||0
8707863|NCT00945321|9754026|FG005|NOT COMPLETED|Period 3||0
8707864|NCT00945321|9754021|FG000|STARTED|Period 4||7
8707865|NCT00945321|9754022|FG001|STARTED|Period 4||7
8707866|NCT00945321|9754023|FG002|STARTED|Period 4||7
8707867|NCT00945321|9754024|FG003|STARTED|Period 4||7
8707868|NCT00945321|9754025|FG004|STARTED|Period 4||6
8707869|NCT00945321|9754026|FG005|STARTED|Period 4||7
8707870|NCT00945321|9754021|FG000|COMPLETED|Period 4||7
8707871|NCT00945321|9754022|FG001|COMPLETED|Period 4||7
8707872|NCT00945321|9754023|FG002|COMPLETED|Period 4||7
8707873|NCT00945321|9754024|FG003|COMPLETED|Period 4||7
8707874|NCT00945321|9754025|FG004|COMPLETED|Period 4||6
8707875|NCT00945321|9754026|FG005|COMPLETED|Period 4||6
8707876|NCT00945321|9754021|FG000|NOT COMPLETED|Period 4||0
8707877|NCT00945321|9754022|FG001|NOT COMPLETED|Period 4||0
8707878|NCT00945321|9754023|FG002|NOT COMPLETED|Period 4||0
8707879|NCT00945321|9754024|FG003|NOT COMPLETED|Period 4||0
8707880|NCT00945321|9754025|FG004|NOT COMPLETED|Period 4||0
8707881|NCT00945321|9754026|FG005|NOT COMPLETED|Period 4||1
8707882|NCT00945334|9754046|FG000|STARTED|Overall Study||19
8707883|NCT00945334|9754047|FG001|STARTED|Overall Study||18
8707884|NCT00945334|9754046|FG000|COMPLETED|Overall Study||16
8707885|NCT00945334|9754047|FG001|COMPLETED|Overall Study||15
8707886|NCT00945334|9754046|FG000|NOT COMPLETED|Overall Study||3
8707887|NCT00945334|9754047|FG001|NOT COMPLETED|Overall Study||3
8707888|NCT00945477|9754053|FG000|STARTED|Overall Study||11
8707889|NCT00945477|9754053|FG000|COMPLETED|Overall Study||5
8707890|NCT00945477|9754053|FG000|NOT COMPLETED|Overall Study||6
8707891|NCT00945555|9754058|FG000|STARTED|Overall Study||264
8707892|NCT00945555|9754058|FG000|COMPLETED|Overall Study||236
8707893|NCT00945555|9754058|FG000|NOT COMPLETED|Overall Study||28
8707894|NCT00945594|9754064|FG000|STARTED|Overall Study||50
8707895|NCT00945594|9754065|FG001|STARTED|Overall Study||50
8707896|NCT00945594|9754064|FG000|COMPLETED|Overall Study||50
8707897|NCT00945594|9754065|FG001|COMPLETED|Overall Study||50
8707898|NCT00945594|9754064|FG000|NOT COMPLETED|Overall Study||0
8707899|NCT00945594|9754065|FG001|NOT COMPLETED|Overall Study||0
8707900|NCT00945659|9754076|FG000|STARTED|Overall Study||39
8707901|NCT00945659|9754077|FG001|STARTED|Overall Study||40
8707902|NCT00945659|9754078|FG002|STARTED|Overall Study||37
8707903|NCT00945659|9754076|FG000|Baseline|Overall Study||39
8707904|NCT00945659|9754077|FG001|Baseline|Overall Study||40
8707905|NCT00945659|9754078|FG002|Baseline|Overall Study||37
8707906|NCT00945659|9754076|FG000|3-Months|Overall Study||38
8707907|NCT00945659|9754077|FG001|3-Months|Overall Study||39
8707908|NCT00945659|9754078|FG002|3-Months|Overall Study||35
8707909|NCT00945659|9754076|FG000|6-Months|Overall Study||31
8707910|NCT00945659|9754077|FG001|6-Months|Overall Study||29
8707911|NCT00945659|9754078|FG002|6-Months|Overall Study||25
8707912|NCT00945659|9754076|FG000|9-Months|Overall Study||32
8707913|NCT00945659|9754077|FG001|9-Months|Overall Study||20
8707914|NCT00945659|9754078|FG002|9-Months|Overall Study||20
8707915|NCT00945659|9754076|FG000|12-Months|Overall Study||32
8707916|NCT00945659|9754077|FG001|12-Months|Overall Study||20
8707917|NCT00945659|9754078|FG002|12-Months|Overall Study||20
8707918|NCT00945659|9754076|FG000|COMPLETED|Overall Study||32
8707919|NCT00945659|9754077|FG001|COMPLETED|Overall Study||20
8707920|NCT00945659|9754078|FG002|COMPLETED|Overall Study||20
8707921|NCT00945659|9754076|FG000|NOT COMPLETED|Overall Study||7
8707922|NCT00945659|9754077|FG001|NOT COMPLETED|Overall Study||20
8707923|NCT00945659|9754078|FG002|NOT COMPLETED|Overall Study||17
8707924|NCT00945750|9754092|FG000|STARTED|Period I||5
8707925|NCT00945750|9754093|FG001|STARTED|Period I||5
8707926|NCT00945750|9754094|FG002|STARTED|Period I||5
8707927|NCT00945750|9754095|FG003|STARTED|Period I||5
8707928|NCT00945750|9754096|FG004|STARTED|Period I||5
8707929|NCT00945750|9754097|FG005|STARTED|Period I||5
8707930|NCT00945750|9754092|FG000|COMPLETED|Period I||5
8707931|NCT00945750|9754093|FG001|COMPLETED|Period I||5
8707932|NCT00945750|9754094|FG002|COMPLETED|Period I||5
8707933|NCT00945750|9754095|FG003|COMPLETED|Period I||5
8707934|NCT00945750|9754096|FG004|COMPLETED|Period I||5
8707935|NCT00945750|9754097|FG005|COMPLETED|Period I||5
8707936|NCT00945750|9754092|FG000|NOT COMPLETED|Period I||0
8707937|NCT00945750|9754093|FG001|NOT COMPLETED|Period I||0
8707938|NCT00945750|9754094|FG002|NOT COMPLETED|Period I||0
8707939|NCT00945750|9754095|FG003|NOT COMPLETED|Period I||0
8707940|NCT00945750|9754096|FG004|NOT COMPLETED|Period I||0
8707941|NCT00945750|9754097|FG005|NOT COMPLETED|Period I||0
8707942|NCT00945750|9754092|FG000|STARTED|Period II||5
8707943|NCT00945750|9754093|FG001|STARTED|Period II||5
8707944|NCT00945750|9754094|FG002|STARTED|Period II||5
8707945|NCT00945750|9754095|FG003|STARTED|Period II||5
8707946|NCT00945750|9754096|FG004|STARTED|Period II||5
8707947|NCT00945750|9754097|FG005|STARTED|Period II||5
8707948|NCT00945750|9754092|FG000|COMPLETED|Period II||5
8707949|NCT00945750|9754093|FG001|COMPLETED|Period II||5
8707950|NCT00945750|9754094|FG002|COMPLETED|Period II||5
8707951|NCT00945750|9754095|FG003|COMPLETED|Period II||5
8707952|NCT00945750|9754096|FG004|COMPLETED|Period II||5
8707953|NCT00945750|9754097|FG005|COMPLETED|Period II||5
8707954|NCT00945750|9754092|FG000|NOT COMPLETED|Period II||0
8707955|NCT00945750|9754093|FG001|NOT COMPLETED|Period II||0
8707956|NCT00945750|9754094|FG002|NOT COMPLETED|Period II||0
8707957|NCT00945750|9754095|FG003|NOT COMPLETED|Period II||0
8707958|NCT00945750|9754096|FG004|NOT COMPLETED|Period II||0
8707959|NCT00945750|9754097|FG005|NOT COMPLETED|Period II||0
8707960|NCT00945750|9754092|FG000|STARTED|Period III||5
8707961|NCT00945750|9754093|FG001|STARTED|Period III||5
8707962|NCT00945750|9754094|FG002|STARTED|Period III||5
8707963|NCT00945750|9754095|FG003|STARTED|Period III||5
8707964|NCT00945750|9754096|FG004|STARTED|Period III||5
8707965|NCT00945750|9754097|FG005|STARTED|Period III||5
8707966|NCT00945750|9754092|FG000|COMPLETED|Period III||5
8707967|NCT00945750|9754093|FG001|COMPLETED|Period III||5
8707968|NCT00945750|9754094|FG002|COMPLETED|Period III||5
8707969|NCT00945750|9754095|FG003|COMPLETED|Period III||5
8707970|NCT00945750|9754096|FG004|COMPLETED|Period III||5
8707971|NCT00945750|9754097|FG005|COMPLETED|Period III||5
8707972|NCT00945750|9754092|FG000|NOT COMPLETED|Period III||0
8707973|NCT00945750|9754093|FG001|NOT COMPLETED|Period III||0
8707974|NCT00945750|9754094|FG002|NOT COMPLETED|Period III||0
8707975|NCT00945750|9754095|FG003|NOT COMPLETED|Period III||0
8707976|NCT00945750|9754096|FG004|NOT COMPLETED|Period III||0
8707977|NCT00945750|9754097|FG005|NOT COMPLETED|Period III||0
8707978|NCT00945815|9754105|FG000|STARTED|Overall Study||35
8707979|NCT00945815|9754105|FG000|Eligible|Overall Study||32
8707980|NCT00945815|9754105|FG000|Eligible and Began Protocol Therapy|Overall Study||31
8707981|NCT00945815|9754105|FG000|COMPLETED|Overall Study||27
8707982|NCT00945815|9754105|FG000|NOT COMPLETED|Overall Study||8
8707983|NCT00945854|9754111|FG000|STARTED|Overall Study||30
8707984|NCT00945854|9754112|FG001|STARTED|Overall Study||30
8707985|NCT00945854|9754111|FG000|COMPLETED|Overall Study||28
8707986|NCT00945854|9754112|FG001|COMPLETED|Overall Study||26
8707987|NCT00945854|9754111|FG000|NOT COMPLETED|Overall Study||2
8707988|NCT00945854|9754112|FG001|NOT COMPLETED|Overall Study||4
8707989|NCT00945893|9754120|FG000|STARTED|Overall Study||60
8707990|NCT00945893|9754121|FG001|STARTED|Overall Study||240
8707991|NCT00945893|9754120|FG000|Day 15 Post Dose 1|Overall Study||60
8707992|NCT00945893|9754121|FG001|Day 15 Post Dose 1|Overall Study||238
8707993|NCT00945893|9754120|FG000|Day 15 Post Dose 2|Overall Study||54
8707994|NCT00945893|9754121|FG001|Day 15 Post Dose 2|Overall Study||226
8707995|NCT00945893|9754120|FG000|COMPLETED|Overall Study||57
8707996|NCT00945893|9754121|FG001|COMPLETED|Overall Study||230
8707997|NCT00945893|9754120|FG000|NOT COMPLETED|Overall Study||3
8707998|NCT00945893|9754121|FG001|NOT COMPLETED|Overall Study||10
8707999|NCT00945906|9754131|FG000|STARTED|Overall Study||61
8708000|NCT00945906|9754131|FG000|COMPLETED|Overall Study||54
8708001|NCT00945906|9754131|FG000|NOT COMPLETED|Overall Study||7
8708002|NCT00945945|9754137|FG000|STARTED|Overall Study||207
8708003|NCT00945945|9754138|FG001|STARTED|Overall Study||217
8708004|NCT00945945|9754137|FG000|COMPLETED|Overall Study||171
8708005|NCT00945945|9754138|FG001|COMPLETED|Overall Study||162
8708006|NCT00945945|9754137|FG000|NOT COMPLETED|Overall Study||36
8708007|NCT00945945|9754138|FG001|NOT COMPLETED|Overall Study||55
8708008|NCT00945958|9754144|FG000|STARTED|Overall Study||161
8708009|NCT00945958|9754144|FG000|COMPLETED|Overall Study||149
8708010|NCT00945958|9754144|FG000|NOT COMPLETED|Overall Study||12
8708011|NCT00946023|9754149|FG000|STARTED|Overall Study||83
8708012|NCT00946023|9754149|FG000|COMPLETED|Overall Study||83
8708013|NCT00946023|9754149|FG000|NOT COMPLETED|Overall Study||0
8708014|NCT00946088|9754155|FG000|STARTED|Overall Study||4
8708015|NCT00946088|9754156|FG001|STARTED|Overall Study||3
8708016|NCT00946088|9754155|FG000|COMPLETED|Overall Study|At least one dose administered and pre-term birth status known.|4
8708017|NCT00946088|9754156|FG001|COMPLETED|Overall Study|At least one dose administered and pre-term birth status known.|2
8708018|NCT00946088|9754155|FG000|NOT COMPLETED|Overall Study||0
8708019|NCT00946088|9754156|FG001|NOT COMPLETED|Overall Study||1
8708020|NCT00946101|9754166|FG000|STARTED|Overall Study|Intent to Treat population, enrolled and randomized|261
8708021|NCT00946101|9754167|FG001|STARTED|Overall Study||65
8708022|NCT00946101|9754166|FG000|Day 15 Post Dose 1|Overall Study||260
8708023|NCT00946101|9754167|FG001|Day 15 Post Dose 1|Overall Study||64
8708024|NCT00946101|9754166|FG000|Day 15 Post Dose 2|Overall Study||254
8708025|NCT00946101|9754167|FG001|Day 15 Post Dose 2|Overall Study||63
8708026|NCT00946101|9754166|FG000|COMPLETED|Overall Study||257
8708027|NCT00946101|9754167|FG001|COMPLETED|Overall Study||63
8708028|NCT00946101|9754166|FG000|NOT COMPLETED|Overall Study||4
8708029|NCT00946101|9754167|FG001|NOT COMPLETED|Overall Study||2
8708030|NCT00946114|9754179|FG000|STARTED|Overall Study||20
8708031|NCT00946114|9754180|FG001|STARTED|Overall Study||12
8708032|NCT00946114|9754179|FG000|COMPLETED|Overall Study||12
8708033|NCT00946114|9754180|FG001|COMPLETED|Overall Study||10
8708034|NCT00946114|9754179|FG000|NOT COMPLETED|Overall Study||8
8708035|NCT00946114|9754180|FG001|NOT COMPLETED|Overall Study||2
8708036|NCT00946153|9754191|FG000|STARTED|Phase 1||6
8708037|NCT00946153|9754192|FG001|STARTED|Phase 1||3
8708038|NCT00946153|9754193|FG002|STARTED|Phase 1||6
8708039|NCT00946153|9754194|FG003|STARTED|Phase 1||5
8708040|NCT00946153|9754195|FG004|STARTED|Phase 1||0
8708041|NCT00946153|9754191|FG000|COMPLETED|Phase 1||6
8708042|NCT00946153|9754192|FG001|COMPLETED|Phase 1||3
8708043|NCT00946153|9754193|FG002|COMPLETED|Phase 1||6
8708044|NCT00946153|9754194|FG003|COMPLETED|Phase 1||5
8708045|NCT00946153|9754195|FG004|COMPLETED|Phase 1||0
8708046|NCT00946153|9754191|FG000|NOT COMPLETED|Phase 1||0
8708047|NCT00946153|9754192|FG001|NOT COMPLETED|Phase 1||0
8708048|NCT00946153|9754193|FG002|NOT COMPLETED|Phase 1||0
8708049|NCT00946153|9754194|FG003|NOT COMPLETED|Phase 1||0
8708050|NCT00946153|9754195|FG004|NOT COMPLETED|Phase 1||0
8708051|NCT00946153|9754191|FG000|STARTED|Phase 2||0
8708052|NCT00946153|9754192|FG001|STARTED|Phase 2||0
8708053|NCT00946153|9754193|FG002|STARTED|Phase 2||0
8708054|NCT00946153|9754194|FG003|STARTED|Phase 2||0
8708055|NCT00946153|9754195|FG004|STARTED|Phase 2||46
8708056|NCT00946153|9754191|FG000|COMPLETED|Phase 2||0
8708057|NCT00946153|9754192|FG001|COMPLETED|Phase 2||0
8708058|NCT00946153|9754193|FG002|COMPLETED|Phase 2||0
8708059|NCT00946153|9754194|FG003|COMPLETED|Phase 2||0
8708060|NCT00946153|9754195|FG004|COMPLETED|Phase 2||33
8708061|NCT00946153|9754191|FG000|NOT COMPLETED|Phase 2||0
8708062|NCT00946153|9754192|FG001|NOT COMPLETED|Phase 2||0
8708063|NCT00946153|9754193|FG002|NOT COMPLETED|Phase 2||0
8708064|NCT00946153|9754194|FG003|NOT COMPLETED|Phase 2||0
8708065|NCT00946153|9754195|FG004|NOT COMPLETED|Phase 2||13
8708066|NCT00946192|9754215|FG000|STARTED|Overall Study||43
8708067|NCT00946192|9754216|FG001|STARTED|Overall Study||40
8708068|NCT00946192|9754217|FG002|STARTED|Overall Study||38
8708069|NCT00946192|9754215|FG000|COMPLETED|Overall Study||25
8708070|NCT00946192|9754216|FG001|COMPLETED|Overall Study||22
8708071|NCT00946192|9754217|FG002|COMPLETED|Overall Study||26
8708072|NCT00946192|9754215|FG000|NOT COMPLETED|Overall Study||18
8708073|NCT00946192|9754216|FG001|NOT COMPLETED|Overall Study||18
8708074|NCT00946192|9754217|FG002|NOT COMPLETED|Overall Study||12
8708075|NCT00946270|9754228|FG000|STARTED|Overall Study||21
8708076|NCT00946270|9754229|FG001|STARTED|Overall Study||20
8708077|NCT00946270|9754230|FG002|STARTED|Overall Study||29
8708078|NCT00946270|9754228|FG000|COMPLETED|Overall Study||21
8708079|NCT00946270|9754229|FG001|COMPLETED|Overall Study||20
8708080|NCT00946270|9754230|FG002|COMPLETED|Overall Study||29
8708081|NCT00946270|9754228|FG000|NOT COMPLETED|Overall Study||0
8708082|NCT00946270|9754229|FG001|NOT COMPLETED|Overall Study||0
8708083|NCT00946270|9754230|FG002|NOT COMPLETED|Overall Study||0
8724753|NCT01027806|9772016|FG000|NOT COMPLETED|Overall Study||4
8724754|NCT01027806|9772017|FG001|NOT COMPLETED|Overall Study||3
8724755|NCT01027819|9772025|FG000|STARTED|Overall Study||40
8724756|NCT01027819|9772026|FG001|STARTED|Overall Study||40
8724757|NCT01027819|9772025|FG000|COMPLETED|Overall Study||40
8724758|NCT01027819|9772026|FG001|COMPLETED|Overall Study||40
8724759|NCT01027819|9772025|FG000|NOT COMPLETED|Overall Study||0
8724760|NCT01027819|9772026|FG001|NOT COMPLETED|Overall Study||0
8724761|NCT01027845|9772034|FG000|STARTED|Primary Vaccination Phase||237
8724762|NCT01027845|9772035|FG001|STARTED|Primary Vaccination Phase||123
8724763|NCT01027845|9772036|FG002|STARTED|Primary Vaccination Phase|Subjects were not yet assigned to this group at the time of the primary vaccination|0
8724764|NCT01027845|9772037|FG003|STARTED|Primary Vaccination Phase|Subjects were not yet assigned to this group at the time of the primary vaccination|0
8724765|NCT01027845|9772034|FG000|COMPLETED|Primary Vaccination Phase||233
8724766|NCT01027845|9772035|FG001|COMPLETED|Primary Vaccination Phase||122
8724767|NCT01027845|9772036|FG002|COMPLETED|Primary Vaccination Phase||0
8724768|NCT01027845|9772037|FG003|COMPLETED|Primary Vaccination Phase||0
8724769|NCT01027845|9772034|FG000|NOT COMPLETED|Primary Vaccination Phase||4
8724770|NCT01027845|9772035|FG001|NOT COMPLETED|Primary Vaccination Phase||1
8724771|NCT01027845|9772036|FG002|NOT COMPLETED|Primary Vaccination Phase||0
8724772|NCT01027845|9772037|FG003|NOT COMPLETED|Primary Vaccination Phase||0
8724773|NCT01027845|9772034|FG000|STARTED|Booster Vaccination Phase||228
8724774|NCT01027845|9772035|FG001|STARTED|Booster Vaccination Phase|Subjects from this group were assigned to DTPa+Prevenar&DTPa-No Prevenar Groups in the booster phase|0
8724775|NCT01027845|9772036|FG002|STARTED|Booster Vaccination Phase||119
8724776|NCT01027845|9772037|FG003|STARTED|Booster Vaccination Phase||1
8724777|NCT01027845|9772034|FG000|COMPLETED|Booster Vaccination Phase||226
8724778|NCT01027845|9772035|FG001|COMPLETED|Booster Vaccination Phase||0
8724779|NCT01027845|9772036|FG002|COMPLETED|Booster Vaccination Phase||119
8724780|NCT01027845|9772037|FG003|COMPLETED|Booster Vaccination Phase||1
8724781|NCT01027845|9772034|FG000|NOT COMPLETED|Booster Vaccination Phase||2
8724782|NCT01027845|9772035|FG001|NOT COMPLETED|Booster Vaccination Phase||0
8724783|NCT01027845|9772036|FG002|NOT COMPLETED|Booster Vaccination Phase||0
8724784|NCT01027845|9772037|FG003|NOT COMPLETED|Booster Vaccination Phase||0
8724785|NCT01027871|9772049|FG000|STARTED|Overall Study||93
8724786|NCT01027871|9772050|FG001|STARTED|Overall Study||98
8708084|NCT00946296|9754240|FG000|STARTED|Overall Study||21
8708085|NCT00946296|9754241|FG001|STARTED|Overall Study||15
8708086|NCT00946296|9754240|FG000|COMPLETED|Overall Study||18
8708087|NCT00946296|9754241|FG001|COMPLETED|Overall Study||15
8708088|NCT00946296|9754240|FG000|NOT COMPLETED|Overall Study||3
8708089|NCT00946296|9754241|FG001|NOT COMPLETED|Overall Study||0
8708090|NCT00946309|9754249|FG000|STARTED|Overall Study||22
8708091|NCT00946309|9754250|FG001|STARTED|Overall Study||23
8708092|NCT00946309|9754249|FG000|COMPLETED|Overall Study||21
8708093|NCT00946309|9754250|FG001|COMPLETED|Overall Study||19
8708094|NCT00946309|9754249|FG000|NOT COMPLETED|Overall Study||1
8708095|NCT00946309|9754250|FG001|NOT COMPLETED|Overall Study||4
8708096|NCT00946322|9754257|FG000|STARTED|Pre-treatment||12
8708097|NCT00946322|9754257|FG000|COMPLETED|Pre-treatment||11
8708098|NCT00946322|9754257|FG000|NOT COMPLETED|Pre-treatment||1
8708099|NCT00946322|9754257|FG000|STARTED|Post-treatment||11
8708100|NCT00946322|9754257|FG000|COMPLETED|Post-treatment||9
8708101|NCT00946322|9754257|FG000|NOT COMPLETED|Post-treatment||2
8708102|NCT00946348|9754263|FG000|STARTED|Overall Study||6
8708103|NCT00946348|9754264|FG001|STARTED|Overall Study||6
8708104|NCT00946348|9754263|FG000|COMPLETED|Overall Study||6
8708105|NCT00946348|9754264|FG001|COMPLETED|Overall Study||6
8708106|NCT00946348|9754263|FG000|NOT COMPLETED|Overall Study||0
8708107|NCT00946348|9754264|FG001|NOT COMPLETED|Overall Study||0
8708108|NCT00946478|9754272|FG000|STARTED|Overall Study||20
8708109|NCT00946478|9754273|FG001|STARTED|Overall Study||20
8708110|NCT00946478|9754272|FG000|COMPLETED|Overall Study||20
8708111|NCT00946478|9754273|FG001|COMPLETED|Overall Study||20
8708112|NCT00946478|9754272|FG000|NOT COMPLETED|Overall Study||0
8708113|NCT00946478|9754273|FG001|NOT COMPLETED|Overall Study||0
8708114|NCT00946530|9754283|FG000|STARTED|Overall Study|32 dyads consisting of 1 AD patient and 1 caregiver were assigned the Bright Light Arm|32
8708115|NCT00946530|9754284|FG001|STARTED|Overall Study|27 dyads consisting of 1 AD patient and 1 caregiver were assigned to the Dim Light (Control) arm|27
8708116|NCT00946530|9754285|FG002|STARTED|Overall Study|32 dyads consisting of 1 AD patient and 1 caregiver were assigned the Bright Light Arm|32
8708117|NCT00946530|9754286|FG003|STARTED|Overall Study|27 dyads consisting of 1 AD patient and 1 caregiver were assigned to the Dim Light (Control) arm|27
8708118|NCT00946530|9754283|FG000|COMPLETED|Overall Study|31 dyads consisting of 1 AD patient and 1 caregiver completed the Bright Light Arm|31
8708119|NCT00946530|9754284|FG001|COMPLETED|Overall Study|23 dyads consisting of 1 AD patient and 1 caregiver completed to the Dim Light (Control) arm|23
8708120|NCT00946530|9754285|FG002|COMPLETED|Overall Study|31 dyads consisting of 1 AD patient and 1 caregiver completed the Bright Light Arm|31
8708121|NCT00946530|9754286|FG003|COMPLETED|Overall Study|23 dyads consisting of 1 AD patient and 1 caregiver were assigned to the Dim Light (Control) arm|23
8708122|NCT00946530|9754283|FG000|NOT COMPLETED|Overall Study||1
8708123|NCT00946530|9754284|FG001|NOT COMPLETED|Overall Study||4
8708124|NCT00946530|9754285|FG002|NOT COMPLETED|Overall Study||1
8708125|NCT00946530|9754286|FG003|NOT COMPLETED|Overall Study||4
8708126|NCT00946647|9754305|FG000|STARTED|Phase 1 Part||6
8708127|NCT00946647|9754306|FG001|STARTED|Phase 1 Part||18
8708128|NCT00946647|9754307|FG002|STARTED|Phase 1 Part||7
8708129|NCT00946647|9754308|FG003|STARTED|Phase 1 Part||0
8708130|NCT00946647|9754309|FG004|STARTED|Phase 1 Part||0
8708131|NCT00946647|9754305|FG000|COMPLETED|Phase 1 Part||0
8708132|NCT00946647|9754306|FG001|COMPLETED|Phase 1 Part||0
8708133|NCT00946647|9754307|FG002|COMPLETED|Phase 1 Part||0
8708134|NCT00946647|9754308|FG003|COMPLETED|Phase 1 Part||0
8708135|NCT00946647|9754309|FG004|COMPLETED|Phase 1 Part||0
8708136|NCT00946647|9754305|FG000|NOT COMPLETED|Phase 1 Part||6
8708137|NCT00946647|9754306|FG001|NOT COMPLETED|Phase 1 Part||18
8708138|NCT00946647|9754307|FG002|NOT COMPLETED|Phase 1 Part||7
8708139|NCT00946647|9754308|FG003|NOT COMPLETED|Phase 1 Part||0
8708140|NCT00946647|9754309|FG004|NOT COMPLETED|Phase 1 Part||0
8708141|NCT00946647|9754305|FG000|STARTED|Phase ll Part||0
8708142|NCT00946647|9754306|FG001|STARTED|Phase ll Part||0
8708143|NCT00946647|9754307|FG002|STARTED|Phase ll Part||0
8708144|NCT00946647|9754308|FG003|STARTED|Phase ll Part||40
8708145|NCT00946647|9754309|FG004|STARTED|Phase ll Part||42
8708146|NCT00946647|9754305|FG000|Safety Set|Phase ll Part||0
8708147|NCT00946647|9754306|FG001|Safety Set|Phase ll Part||0
8708148|NCT00946647|9754307|FG002|Safety Set|Phase ll Part||0
8708149|NCT00946647|9754308|FG003|Safety Set|Phase ll Part|2 pts rand. to this grp did not receive PAN|38
8708150|NCT00946647|9754309|FG004|Safety Set|Phase ll Part|2 pts rand. to PAN+5AZA, did not receive PAN but received 5AZA|42
8708151|NCT00946647|9754305|FG000|COMPLETED|Phase ll Part||0
8708152|NCT00946647|9754306|FG001|COMPLETED|Phase ll Part||0
8708153|NCT00946647|9754307|FG002|COMPLETED|Phase ll Part||0
8708154|NCT00946647|9754308|FG003|COMPLETED|Phase ll Part||0
8708155|NCT00946647|9754309|FG004|COMPLETED|Phase ll Part||0
8708156|NCT00946647|9754305|FG000|NOT COMPLETED|Phase ll Part||0
8708157|NCT00946647|9754306|FG001|NOT COMPLETED|Phase ll Part||0
8708158|NCT00946647|9754307|FG002|NOT COMPLETED|Phase ll Part||0
8708159|NCT00946647|9754308|FG003|NOT COMPLETED|Phase ll Part||40
8708160|NCT00946647|9754309|FG004|NOT COMPLETED|Phase ll Part||42
8708161|NCT00946712|9754324|FG000|STARTED|Overall Study||671
8708162|NCT00946712|9754325|FG001|STARTED|Overall Study||662
8708163|NCT00946712|9754324|FG000|COMPLETED|Overall Study||124
8708164|NCT00946712|9754325|FG001|COMPLETED|Overall Study||0
8708165|NCT00946712|9754324|FG000|NOT COMPLETED|Overall Study||547
8708166|NCT00946712|9754325|FG001|NOT COMPLETED|Overall Study||662
8708167|NCT00946881|9754332|FG000|STARTED|First Treatment||30
8708168|NCT00946881|9754332|FG000|COMPLETED|First Treatment||28
8708169|NCT00946881|9754332|FG000|NOT COMPLETED|First Treatment||2
8708170|NCT00946881|9754332|FG000|STARTED|Retreatment||8
8708171|NCT00946881|9754332|FG000|COMPLETED|Retreatment||7
8708172|NCT00946881|9754332|FG000|NOT COMPLETED|Retreatment||1
8708173|NCT00946920|9754359|FG000|STARTED|Overall Study|Received at least one dose of degarelix.|565
8708174|NCT00946920|9754360|FG001|STARTED|Overall Study|Received at least one dose of goserelin acetate.|283
8708175|NCT00946920|9754359|FG000|Full Analysis Set (FAS)|Overall Study|Received at least one dose of degarelix and had at least one post-dosing efficacy assessment.|565
8708176|NCT00946920|9754360|FG001|Full Analysis Set (FAS)|Overall Study|Received at least one dose of goserelin and had at least one post-dosing efficacy assessment.|282
8708177|NCT00946920|9754359|FG000|COMPLETED|Overall Study||455
8708178|NCT00946920|9754360|FG001|COMPLETED|Overall Study||239
8708179|NCT00946920|9754359|FG000|NOT COMPLETED|Overall Study||110
8708180|NCT00946920|9754360|FG001|NOT COMPLETED|Overall Study||44
8708181|NCT00946998|9754368|FG000|STARTED|Overall Study||102
8708182|NCT00946998|9754369|FG001|STARTED|Overall Study||99
8708183|NCT00946998|9754368|FG000|Received Treatment as Randomized|Overall Study||102
8708184|NCT00946998|9754369|FG001|Received Treatment as Randomized|Overall Study||99
8708185|NCT00946998|9754368|FG000|COMPLETED|Overall Study||97
8708186|NCT00946998|9754369|FG001|COMPLETED|Overall Study||96
8708187|NCT00946998|9754368|FG000|NOT COMPLETED|Overall Study||5
8708188|NCT00946998|9754369|FG001|NOT COMPLETED|Overall Study||3
8708189|NCT00947115|9754378|FG000|STARTED|Overall Study||159
8708190|NCT00947115|9754379|FG001|STARTED|Overall Study||194
8708191|NCT00947115|9754380|FG002|STARTED|Overall Study||171
8708192|NCT00947115|9754378|FG000|COMPLETED|Overall Study||142
8708193|NCT00947115|9754379|FG001|COMPLETED|Overall Study||172
8708194|NCT00947115|9754380|FG002|COMPLETED|Overall Study||156
8708195|NCT00947115|9754378|FG000|NOT COMPLETED|Overall Study||17
8708196|NCT00947115|9754379|FG001|NOT COMPLETED|Overall Study||22
8708197|NCT00947115|9754380|FG002|NOT COMPLETED|Overall Study||15
8708198|NCT00947154|9754388|FG000|STARTED|Overall Study||12
8708199|NCT00947154|9754388|FG000|COMPLETED|Overall Study||11
8708200|NCT00947154|9754388|FG000|NOT COMPLETED|Overall Study||1
8708201|NCT00947167|9754393|FG000|STARTED|Pertuzumab Alone||4
8708202|NCT00947167|9754393|FG000|COMPLETED|Pertuzumab Alone||4
8708203|NCT00947167|9754393|FG000|NOT COMPLETED|Pertuzumab Alone||0
8708204|NCT00947167|9754393|FG000|STARTED|Erlotinib Added to Pertuzumab||3
8708205|NCT00947167|9754393|FG000|COMPLETED|Erlotinib Added to Pertuzumab||3
8708206|NCT00947167|9754393|FG000|NOT COMPLETED|Erlotinib Added to Pertuzumab||0
8708207|NCT00947193|9754397|FG000|STARTED|Overall Study||3
8708208|NCT00947193|9754398|FG001|STARTED|Overall Study||10
8812926|NCT01522950|9866025|FG000|NOT COMPLETED|Overall Study||6
8812927|NCT01522950|9866026|FG001|NOT COMPLETED|Overall Study||5
8812928|NCT01522950|9866027|FG002|NOT COMPLETED|Overall Study||5
8812929|NCT01522963|9866039|FG000|STARTED|Overall Study||24
8708209|NCT00947193|9754397|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
8708210|NCT00947193|9754398|FG001|Received at Least 1 Dose of Study Drug|Overall Study||10
8708211|NCT00947193|9754397|FG000|COMPLETED|Overall Study||0
8708212|NCT00947193|9754398|FG001|COMPLETED|Overall Study||10
8708213|NCT00947193|9754397|FG000|NOT COMPLETED|Overall Study||3
8708214|NCT00947193|9754398|FG001|NOT COMPLETED|Overall Study||0
8708215|NCT00947219|9754406|FG000|STARTED|Overall Study||28
8708216|NCT00947219|9754407|FG001|STARTED|Overall Study||25
8708217|NCT00947219|9754408|FG002|STARTED|Overall Study||26
8708218|NCT00947219|9754406|FG000|COMPLETED|Overall Study||22
8708219|NCT00947219|9754407|FG001|COMPLETED|Overall Study||21
8708220|NCT00947219|9754408|FG002|COMPLETED|Overall Study||22
8708221|NCT00947219|9754406|FG000|NOT COMPLETED|Overall Study||6
8708222|NCT00947219|9754407|FG001|NOT COMPLETED|Overall Study||4
8708223|NCT00947219|9754408|FG002|NOT COMPLETED|Overall Study||4
8708224|NCT00947271|9754420|FG000|STARTED|3 Months Post Intervention||254
8708225|NCT00947271|9754421|FG001|STARTED|3 Months Post Intervention||252
8708226|NCT00947271|9754422|FG002|STARTED|3 Months Post Intervention||254
8708227|NCT00947271|9754423|FG003|STARTED|3 Months Post Intervention||250
8708228|NCT00947271|9754420|FG000|COMPLETED|3 Months Post Intervention||202
8708229|NCT00947271|9754421|FG001|COMPLETED|3 Months Post Intervention||204
8708230|NCT00947271|9754422|FG002|COMPLETED|3 Months Post Intervention||218
8708231|NCT00947271|9754423|FG003|COMPLETED|3 Months Post Intervention||206
8708232|NCT00947271|9754420|FG000|NOT COMPLETED|3 Months Post Intervention||52
8708233|NCT00947271|9754421|FG001|NOT COMPLETED|3 Months Post Intervention||48
8708234|NCT00947271|9754422|FG002|NOT COMPLETED|3 Months Post Intervention||36
8708235|NCT00947271|9754423|FG003|NOT COMPLETED|3 Months Post Intervention||44
8708236|NCT00947271|9754420|FG000|STARTED|6 Months Post Intervention||254
8708237|NCT00947271|9754421|FG001|STARTED|6 Months Post Intervention||252
8708238|NCT00947271|9754422|FG002|STARTED|6 Months Post Intervention||254
8708239|NCT00947271|9754423|FG003|STARTED|6 Months Post Intervention||250
8708240|NCT00947271|9754420|FG000|COMPLETED|6 Months Post Intervention||199
8708241|NCT00947271|9754421|FG001|COMPLETED|6 Months Post Intervention||199
8708242|NCT00947271|9754422|FG002|COMPLETED|6 Months Post Intervention||196
8708243|NCT00947271|9754423|FG003|COMPLETED|6 Months Post Intervention||196
8708244|NCT00947271|9754420|FG000|NOT COMPLETED|6 Months Post Intervention||55
8812930|NCT01522963|9866040|FG001|STARTED|Overall Study||25
8812931|NCT01522963|9866041|FG002|STARTED|Overall Study||25
8708245|NCT00947271|9754421|FG001|NOT COMPLETED|6 Months Post Intervention||53
8708246|NCT00947271|9754422|FG002|NOT COMPLETED|6 Months Post Intervention||58
8708247|NCT00947271|9754423|FG003|NOT COMPLETED|6 Months Post Intervention||54
8708248|NCT00947271|9754420|FG000|STARTED|9 Months Post Intervention||254
8708249|NCT00947271|9754421|FG001|STARTED|9 Months Post Intervention||252
8708250|NCT00947271|9754422|FG002|STARTED|9 Months Post Intervention||254
8708251|NCT00947271|9754423|FG003|STARTED|9 Months Post Intervention||250
8708252|NCT00947271|9754420|FG000|COMPLETED|9 Months Post Intervention||184
8708253|NCT00947271|9754421|FG001|COMPLETED|9 Months Post Intervention||192
8708254|NCT00947271|9754422|FG002|COMPLETED|9 Months Post Intervention||193
8708255|NCT00947271|9754423|FG003|COMPLETED|9 Months Post Intervention||191
8708256|NCT00947271|9754420|FG000|NOT COMPLETED|9 Months Post Intervention||70
8708257|NCT00947271|9754421|FG001|NOT COMPLETED|9 Months Post Intervention||60
8708258|NCT00947271|9754422|FG002|NOT COMPLETED|9 Months Post Intervention||61
8708259|NCT00947271|9754423|FG003|NOT COMPLETED|9 Months Post Intervention||59
8708260|NCT00947271|9754420|FG000|STARTED|12 Months Post Intervention||254
8708261|NCT00947271|9754421|FG001|STARTED|12 Months Post Intervention||252
8708262|NCT00947271|9754422|FG002|STARTED|12 Months Post Intervention||254
8708263|NCT00947271|9754423|FG003|STARTED|12 Months Post Intervention||250
8708264|NCT00947271|9754420|FG000|COMPLETED|12 Months Post Intervention||183
8708265|NCT00947271|9754421|FG001|COMPLETED|12 Months Post Intervention||192
8708266|NCT00947271|9754422|FG002|COMPLETED|12 Months Post Intervention||195
8708267|NCT00947271|9754423|FG003|COMPLETED|12 Months Post Intervention||188
8708268|NCT00947271|9754420|FG000|NOT COMPLETED|12 Months Post Intervention||71
8708269|NCT00947271|9754421|FG001|NOT COMPLETED|12 Months Post Intervention||60
8708270|NCT00947271|9754422|FG002|NOT COMPLETED|12 Months Post Intervention||59
8708271|NCT00947271|9754423|FG003|NOT COMPLETED|12 Months Post Intervention||62
8708272|NCT00947297|9754433|FG000|STARTED|Overall Study||60
8708273|NCT00947297|9754433|FG000|COMPLETED|Overall Study||53
8708274|NCT00947297|9754433|FG000|NOT COMPLETED|Overall Study||7
8708275|NCT00947310|9754441|FG000|STARTED|Overall Study||514
8708276|NCT00947310|9754442|FG001|STARTED|Overall Study||500
8708277|NCT00947310|9754443|FG002|STARTED|Overall Study||486
8708278|NCT00947310|9754441|FG000|COMPLETED|Overall Study||514
8708279|NCT00947310|9754442|FG001|COMPLETED|Overall Study||500
8708280|NCT00947310|9754443|FG002|COMPLETED|Overall Study||486
8708281|NCT00947310|9754441|FG000|NOT COMPLETED|Overall Study||0
8708282|NCT00947310|9754442|FG001|NOT COMPLETED|Overall Study||0
8708283|NCT00947310|9754443|FG002|NOT COMPLETED|Overall Study||0
8708284|NCT00947349|9754455|FG000|STARTED|Triple Treatment Combination Period||4
8708285|NCT00947349|9754456|FG001|STARTED|Triple Treatment Combination Period||6
8708286|NCT00947349|9754457|FG002|STARTED|Triple Treatment Combination Period||6
8708287|NCT00947349|9754458|FG003|STARTED|Triple Treatment Combination Period||6
8708288|NCT00947349|9754455|FG000|COMPLETED|Triple Treatment Combination Period||4
8708289|NCT00947349|9754456|FG001|COMPLETED|Triple Treatment Combination Period||5
8708290|NCT00947349|9754457|FG002|COMPLETED|Triple Treatment Combination Period||6
8708291|NCT00947349|9754458|FG003|COMPLETED|Triple Treatment Combination Period||6
8708292|NCT00947349|9754455|FG000|NOT COMPLETED|Triple Treatment Combination Period||0
8708293|NCT00947349|9754456|FG001|NOT COMPLETED|Triple Treatment Combination Period||1
8708294|NCT00947349|9754457|FG002|NOT COMPLETED|Triple Treatment Combination Period||0
8708295|NCT00947349|9754458|FG003|NOT COMPLETED|Triple Treatment Combination Period||0
8708296|NCT00947349|9754455|FG000|STARTED|Overall Study Standard of Care||4
8708297|NCT00947349|9754456|FG001|STARTED|Overall Study Standard of Care||5
8708298|NCT00947349|9754457|FG002|STARTED|Overall Study Standard of Care||6
8708299|NCT00947349|9754458|FG003|STARTED|Overall Study Standard of Care||6
8708300|NCT00947349|9754455|FG000|COMPLETED|Overall Study Standard of Care||4
8708301|NCT00947349|9754456|FG001|COMPLETED|Overall Study Standard of Care||5
8708302|NCT00947349|9754457|FG002|COMPLETED|Overall Study Standard of Care||4
8708303|NCT00947349|9754458|FG003|COMPLETED|Overall Study Standard of Care||4
8708304|NCT00947349|9754455|FG000|NOT COMPLETED|Overall Study Standard of Care||0
8708305|NCT00947349|9754456|FG001|NOT COMPLETED|Overall Study Standard of Care||0
8708306|NCT00947349|9754457|FG002|NOT COMPLETED|Overall Study Standard of Care||2
8708307|NCT00947349|9754458|FG003|NOT COMPLETED|Overall Study Standard of Care||2
8708308|NCT00947427|9754488|FG000|STARTED|Overall Study||22
8708309|NCT00947427|9754489|FG001|STARTED|Overall Study|2 participants discontinued prior to any study drug administration|49
8708310|NCT00947427|9754488|FG000|COMPLETED|Overall Study||21
8708311|NCT00947427|9754489|FG001|COMPLETED|Overall Study||45
8708312|NCT00947427|9754488|FG000|NOT COMPLETED|Overall Study||1
8708313|NCT00947427|9754489|FG001|NOT COMPLETED|Overall Study||4
8708314|NCT00947505|9754497|FG000|STARTED|Overall Study||33
8708315|NCT00947505|9754498|FG001|STARTED|Overall Study||16
8708316|NCT00947505|9754497|FG000|COMPLETED|Overall Study||24
8708317|NCT00947505|9754498|FG001|COMPLETED|Overall Study||14
8708318|NCT00947505|9754497|FG000|NOT COMPLETED|Overall Study||9
8708319|NCT00947505|9754498|FG001|NOT COMPLETED|Overall Study||2
8708320|NCT00947531|9754506|FG000|STARTED|Overall Study||121
8708321|NCT00947531|9754507|FG001|STARTED|Overall Study||121
8708322|NCT00947531|9754506|FG000|COMPLETED|Overall Study||107
8708323|NCT00947531|9754507|FG001|COMPLETED|Overall Study||110
8708324|NCT00947531|9754506|FG000|NOT COMPLETED|Overall Study||14
8708325|NCT00947531|9754507|FG001|NOT COMPLETED|Overall Study||11
8708326|NCT00947544|9754513|FG000|STARTED|Switch-Over Period (2 Weeks)||11
8708327|NCT00947544|9754514|FG001|STARTED|Switch-Over Period (2 Weeks)||0
8708328|NCT00947544|9754513|FG000|COMPLETED|Switch-Over Period (2 Weeks)||11
8708329|NCT00947544|9754514|FG001|COMPLETED|Switch-Over Period (2 Weeks)||0
8708330|NCT00947544|9754513|FG000|NOT COMPLETED|Switch-Over Period (2 Weeks)||0
8708331|NCT00947544|9754514|FG001|NOT COMPLETED|Switch-Over Period (2 Weeks)||0
8708332|NCT00947544|9754513|FG000|STARTED|Safety-Extension Period (12 Months)||11
8708333|NCT00947544|9754514|FG001|STARTED|Safety-Extension Period (12 Months)|New participants were enrolled due to DSMB approval.|6
8708334|NCT00947544|9754513|FG000|COMPLETED|Safety-Extension Period (12 Months)||10
8708335|NCT00947544|9754514|FG001|COMPLETED|Safety-Extension Period (12 Months)||6
8708336|NCT00947544|9754513|FG000|NOT COMPLETED|Safety-Extension Period (12 Months)||1
8708337|NCT00947544|9754514|FG001|NOT COMPLETED|Safety-Extension Period (12 Months)||0
8708338|NCT00947661|9754526|FG000|STARTED|Overall Study||289
8708339|NCT00947661|9754527|FG001|STARTED|Overall Study||289
8708340|NCT00947661|9754526|FG000|COMPLETED|Overall Study||276
8708341|NCT00947661|9754527|FG001|COMPLETED|Overall Study||274
8708342|NCT00947661|9754526|FG000|NOT COMPLETED|Overall Study||13
8708343|NCT00947661|9754527|FG001|NOT COMPLETED|Overall Study||15
8708344|NCT00947752|9754535|FG000|STARTED|7-Day Run-in Treatment Period|All subjects started with a daily does of F1 for 7 days|147
8708345|NCT00947752|9754536|FG001|STARTED|7-Day Run-in Treatment Period||0
8708346|NCT00947752|9754535|FG000|COMPLETED|7-Day Run-in Treatment Period||147
8708347|NCT00947752|9754536|FG001|COMPLETED|7-Day Run-in Treatment Period||0
8708348|NCT00947752|9754535|FG000|NOT COMPLETED|7-Day Run-in Treatment Period||0
8708349|NCT00947752|9754536|FG001|NOT COMPLETED|7-Day Run-in Treatment Period||0
8708350|NCT00947752|9754535|FG000|STARTED|1st 14-day Treatment Period||76
8708351|NCT00947752|9754536|FG001|STARTED|1st 14-day Treatment Period||71
8708352|NCT00947752|9754535|FG000|COMPLETED|1st 14-day Treatment Period||76
8708353|NCT00947752|9754536|FG001|COMPLETED|1st 14-day Treatment Period||71
8708354|NCT00947752|9754535|FG000|NOT COMPLETED|1st 14-day Treatment Period||0
8708355|NCT00947752|9754536|FG001|NOT COMPLETED|1st 14-day Treatment Period||0
8708356|NCT00947752|9754535|FG000|STARTED|Crossover to 2nd 14-day Treatment Period||71
8708357|NCT00947752|9754536|FG001|STARTED|Crossover to 2nd 14-day Treatment Period||76
8708358|NCT00947752|9754535|FG000|COMPLETED|Crossover to 2nd 14-day Treatment Period||71
8708359|NCT00947752|9754536|FG001|COMPLETED|Crossover to 2nd 14-day Treatment Period||76
8708360|NCT00947752|9754535|FG000|NOT COMPLETED|Crossover to 2nd 14-day Treatment Period||0
8708361|NCT00947752|9754536|FG001|NOT COMPLETED|Crossover to 2nd 14-day Treatment Period||0
8708362|NCT00947765|9754544|FG000|STARTED|Overall Study||30
8708363|NCT00947765|9754545|FG001|STARTED|Overall Study||30
8708364|NCT00947765|9754544|FG000|COMPLETED|Overall Study||30
8708365|NCT00947765|9754545|FG001|COMPLETED|Overall Study||30
8708366|NCT00947765|9754544|FG000|NOT COMPLETED|Overall Study||0
8708367|NCT00947765|9754545|FG001|NOT COMPLETED|Overall Study||0
8708368|NCT00947856|9754553|FG000|STARTED|Treatment Period||78
8708369|NCT00947856|9754554|FG001|STARTED|Treatment Period|Two patients in extension arm re-enrolled in retreatment arm and are represented in both arms|32
8708370|NCT00947856|9754553|FG000|COMPLETED|Treatment Period||0
8708371|NCT00947856|9754554|FG001|COMPLETED|Treatment Period|Patients treated until disease progression, unacceptable toxicity or study closure|0
8708372|NCT00947856|9754553|FG000|NOT COMPLETED|Treatment Period||78
8708373|NCT00947856|9754554|FG001|NOT COMPLETED|Treatment Period||32
8708374|NCT00947856|9754553|FG000|STARTED|Follow-up Period||78
8708375|NCT00947856|9754554|FG001|STARTED|Follow-up Period|All participants were followed after treatment; thus, number started will not match number completed|32
8708376|NCT00947856|9754553|FG000|COMPLETED|Follow-up Period||27
8708377|NCT00947856|9754554|FG001|COMPLETED|Follow-up Period|Completed survival follow-up due to death|9
8708378|NCT00947856|9754553|FG000|NOT COMPLETED|Follow-up Period||51
8708379|NCT00947856|9754554|FG001|NOT COMPLETED|Follow-up Period||23
8708380|NCT00947882|9754573|FG000|STARTED|Overall Study|Started: Randomised.|100
8708381|NCT00947882|9754574|FG001|STARTED|Overall Study||101
8708382|NCT00947882|9754575|FG002|STARTED|Overall Study||101
8708383|NCT00947882|9754576|FG003|STARTED|Overall Study||102
8708384|NCT00947882|9754573|FG000|Full Analysis Set (FAS)|Overall Study|FAS: Received a dose of IMP and completed at least one post-baseline IPSS questionnaire.|100
8708385|NCT00947882|9754574|FG001|Full Analysis Set (FAS)|Overall Study||101
8708386|NCT00947882|9754575|FG002|Full Analysis Set (FAS)|Overall Study|1 patient received 20 mg degarelix but had no post-baseline IPSS value and was excluded from the FAS|100
8708387|NCT00947882|9754576|FG003|Full Analysis Set (FAS)|Overall Study||102
8708388|NCT00947882|9754573|FG000|Actual Treatment|Overall Study|2 placebo patients received 30 mg degarelix|98
8708389|NCT00947882|9754574|FG001|Actual Treatment|Overall Study||101
8708390|NCT00947882|9754575|FG002|Actual Treatment|Overall Study|1 patient randomised to 20 mg degarelix received 30 mg degarelix|100
8708391|NCT00947882|9754576|FG003|Actual Treatment|Overall Study||105
8708392|NCT00947882|9754573|FG000|Safety Analysis Set|Overall Study|Safety Analysis Set: Received a dose of Investigational Medicinal Product (IMP).|98
8708393|NCT00947882|9754574|FG001|Safety Analysis Set|Overall Study||101
8708394|NCT00947882|9754575|FG002|Safety Analysis Set|Overall Study||100
8708395|NCT00947882|9754576|FG003|Safety Analysis Set|Overall Study||105
8708396|NCT00947882|9754573|FG000|Visit 12, Month 6|Overall Study|The trial was stopped when all patients had completed Visit 12, scheduled 6 months after the dosing.|93
8708397|NCT00947882|9754574|FG001|Visit 12, Month 6|Overall Study||91
8708398|NCT00947882|9754575|FG002|Visit 12, Month 6|Overall Study||90
8708399|NCT00947882|9754576|FG003|Visit 12, Month 6|Overall Study||95
8708400|NCT00947882|9754573|FG000|COMPLETED|Overall Study|End of Trial, Month 12: Patients who had completed the 12-month period when the trial was stopped.|26
8708401|NCT00947882|9754574|FG001|COMPLETED|Overall Study||24
8708402|NCT00947882|9754575|FG002|COMPLETED|Overall Study||22
8708403|NCT00947882|9754576|FG003|COMPLETED|Overall Study||20
8708404|NCT00947882|9754573|FG000|NOT COMPLETED|Overall Study||74
8708405|NCT00947882|9754574|FG001|NOT COMPLETED|Overall Study||77
8708406|NCT00947882|9754575|FG002|NOT COMPLETED|Overall Study||79
8708407|NCT00947882|9754576|FG003|NOT COMPLETED|Overall Study||82
8708408|NCT00948025|9754589|FG000|STARTED|Phase 1 (Pilot Phase)||14
8708409|NCT00948025|9754590|FG001|STARTED|Phase 1 (Pilot Phase)||9
8708410|NCT00948025|9754589|FG000|COMPLETED|Phase 1 (Pilot Phase)||5
8708411|NCT00948025|9754590|FG001|COMPLETED|Phase 1 (Pilot Phase)||6
8708412|NCT00948025|9754589|FG000|NOT COMPLETED|Phase 1 (Pilot Phase)||9
8708413|NCT00948025|9754590|FG001|NOT COMPLETED|Phase 1 (Pilot Phase)||3
8708414|NCT00948025|9754589|FG000|STARTED|Phase 2 (Comparative Phase)||0
8708415|NCT00948025|9754590|FG001|STARTED|Phase 2 (Comparative Phase)||0
8708416|NCT00948025|9754589|FG000|COMPLETED|Phase 2 (Comparative Phase)||0
8708417|NCT00948025|9754590|FG001|COMPLETED|Phase 2 (Comparative Phase)||0
8708418|NCT00948025|9754589|FG000|NOT COMPLETED|Phase 2 (Comparative Phase)||0
8708419|NCT00948025|9754590|FG001|NOT COMPLETED|Phase 2 (Comparative Phase)||0
8708420|NCT00948064|9754600|FG000|STARTED|Phase I||31
8708421|NCT00948064|9754601|FG001|STARTED|Phase I||0
8708422|NCT00948064|9754602|FG002|STARTED|Phase I||0
8708423|NCT00948064|9754600|FG000|COMPLETED|Phase I||30
8708424|NCT00948064|9754601|FG001|COMPLETED|Phase I||0
8708425|NCT00948064|9754602|FG002|COMPLETED|Phase I||0
8708426|NCT00948064|9754600|FG000|NOT COMPLETED|Phase I||1
8708427|NCT00948064|9754601|FG001|NOT COMPLETED|Phase I||0
8708428|NCT00948064|9754602|FG002|NOT COMPLETED|Phase I||0
8708429|NCT00948064|9754600|FG000|STARTED|Phase II||0
8708430|NCT00948064|9754601|FG001|STARTED|Phase II||52
8708431|NCT00948064|9754602|FG002|STARTED|Phase II||27
8708432|NCT00948064|9754600|FG000|COMPLETED|Phase II||0
8708433|NCT00948064|9754601|FG001|COMPLETED|Phase II||51
8708434|NCT00948064|9754602|FG002|COMPLETED|Phase II||26
8708435|NCT00948064|9754600|FG000|NOT COMPLETED|Phase II||0
8708436|NCT00948064|9754601|FG001|NOT COMPLETED|Phase II||1
8708437|NCT00948064|9754602|FG002|NOT COMPLETED|Phase II||1
8708438|NCT00948090|9754614|FG000|STARTED|Overall Study||65
8708439|NCT00948090|9754615|FG001|STARTED|Overall Study||1
8708440|NCT00948090|9754616|FG002|STARTED|Overall Study||123
8708441|NCT00948090|9754617|FG003|STARTED|Overall Study||18
8708442|NCT00948090|9754614|FG000|COMPLETED|Overall Study||22
8708443|NCT00948090|9754615|FG001|COMPLETED|Overall Study||0
8708444|NCT00948090|9754616|FG002|COMPLETED|Overall Study||67
8708445|NCT00948090|9754617|FG003|COMPLETED|Overall Study||7
8708446|NCT00948090|9754614|FG000|NOT COMPLETED|Overall Study||43
8708447|NCT00948090|9754615|FG001|NOT COMPLETED|Overall Study||1
8708448|NCT00948090|9754616|FG002|NOT COMPLETED|Overall Study||56
8708449|NCT00948090|9754617|FG003|NOT COMPLETED|Overall Study||11
8708450|NCT00948155|9754626|FG000|STARTED|First Intervention 21 Days||14
8708451|NCT00948155|9754627|FG001|STARTED|First Intervention 21 Days||15
8708452|NCT00948155|9754626|FG000|COMPLETED|First Intervention 21 Days||12
8708453|NCT00948155|9754627|FG001|COMPLETED|First Intervention 21 Days||13
8708454|NCT00948155|9754626|FG000|NOT COMPLETED|First Intervention 21 Days||2
8708455|NCT00948155|9754627|FG001|NOT COMPLETED|First Intervention 21 Days||2
8708456|NCT00948155|9754626|FG000|STARTED|Washout 14 Days||12
8708457|NCT00948155|9754627|FG001|STARTED|Washout 14 Days||13
8708458|NCT00948155|9754626|FG000|COMPLETED|Washout 14 Days||11
8708459|NCT00948155|9754627|FG001|COMPLETED|Washout 14 Days||11
8708460|NCT00948155|9754626|FG000|NOT COMPLETED|Washout 14 Days||1
8708461|NCT00948155|9754627|FG001|NOT COMPLETED|Washout 14 Days||2
8708462|NCT00948155|9754626|FG000|STARTED|Second Intervention 21 Days||11
8812932|NCT01522963|9866042|FG003|STARTED|Overall Study||24
8812933|NCT01522963|9866039|FG000|COMPLETED|Overall Study||22
8812934|NCT01522963|9866040|FG001|COMPLETED|Overall Study||22
8812935|NCT01522963|9866041|FG002|COMPLETED|Overall Study||22
8812936|NCT01522963|9866042|FG003|COMPLETED|Overall Study||18
8812937|NCT01522963|9866039|FG000|NOT COMPLETED|Overall Study||2
8812938|NCT01522963|9866040|FG001|NOT COMPLETED|Overall Study||3
8812939|NCT01522963|9866041|FG002|NOT COMPLETED|Overall Study||3
8812940|NCT01522963|9866042|FG003|NOT COMPLETED|Overall Study||6
8812941|NCT01523275|9866052|FG000|STARTED|Overall Study||6
8812942|NCT01523275|9866053|FG001|STARTED|Overall Study||9
8812943|NCT01523275|9866052|FG000|COMPLETED|Overall Study||4
8812944|NCT01523275|9866053|FG001|COMPLETED|Overall Study||7
8812945|NCT01523275|9866052|FG000|NOT COMPLETED|Overall Study||2
8812946|NCT01523275|9866053|FG001|NOT COMPLETED|Overall Study||2
8812947|NCT01523301|9866061|FG000|STARTED|Overall Study||184
8812948|NCT01523301|9866062|FG001|STARTED|Overall Study||196
8812949|NCT01523301|9866061|FG000|COMPLETED|Overall Study||149
8812950|NCT01523301|9866062|FG001|COMPLETED|Overall Study||164
8812951|NCT01523301|9866061|FG000|NOT COMPLETED|Overall Study||35
8812952|NCT01523301|9866062|FG001|NOT COMPLETED|Overall Study||32
8812953|NCT01523366|9866070|FG000|STARTED|Treatment Period 1||20
8812954|NCT01523366|9866071|FG001|STARTED|Treatment Period 1||20
8812955|NCT01523366|9866070|FG000|COMPLETED|Treatment Period 1||19
8812956|NCT01523366|9866071|FG001|COMPLETED|Treatment Period 1||20
8812957|NCT01523366|9866070|FG000|NOT COMPLETED|Treatment Period 1||1
8812958|NCT01523366|9866071|FG001|NOT COMPLETED|Treatment Period 1||0
8812959|NCT01523366|9866070|FG000|STARTED|Washout Period - 10-14 Days||19
8812960|NCT01523366|9866071|FG001|STARTED|Washout Period - 10-14 Days||20
8812961|NCT01523366|9866070|FG000|COMPLETED|Washout Period - 10-14 Days||19
8812962|NCT01523366|9866071|FG001|COMPLETED|Washout Period - 10-14 Days||20
8812963|NCT01523366|9866070|FG000|NOT COMPLETED|Washout Period - 10-14 Days||0
8812964|NCT01523366|9866071|FG001|NOT COMPLETED|Washout Period - 10-14 Days||0
8812965|NCT01523366|9866070|FG000|STARTED|Treatment Period 2||19
8812966|NCT01523366|9866071|FG001|STARTED|Treatment Period 2||20
8812967|NCT01523366|9866070|FG000|COMPLETED|Treatment Period 2||18
8812968|NCT01523366|9866071|FG001|COMPLETED|Treatment Period 2||20
8812969|NCT01523366|9866070|FG000|NOT COMPLETED|Treatment Period 2||1
8812970|NCT01523366|9866071|FG001|NOT COMPLETED|Treatment Period 2||0
8708463|NCT00948155|9754627|FG001|STARTED|Second Intervention 21 Days||11
8708464|NCT00948155|9754626|FG000|COMPLETED|Second Intervention 21 Days||9
8708465|NCT00948155|9754627|FG001|COMPLETED|Second Intervention 21 Days||8
8708466|NCT00948155|9754626|FG000|NOT COMPLETED|Second Intervention 21 Days||2
8708467|NCT00948155|9754627|FG001|NOT COMPLETED|Second Intervention 21 Days||3
8812971|NCT01523392|9866081|FG000|STARTED|Treatment Period 1||20
8812972|NCT01523392|9866082|FG001|STARTED|Treatment Period 1||14
8812973|NCT01523392|9866081|FG000|COMPLETED|Treatment Period 1||17
8812974|NCT01523392|9866082|FG001|COMPLETED|Treatment Period 1||14
8812975|NCT01523392|9866081|FG000|NOT COMPLETED|Treatment Period 1||3
8812976|NCT01523392|9866082|FG001|NOT COMPLETED|Treatment Period 1||0
8708468|NCT00948246|9754635|FG000|STARTED|Overall Study||110
8708469|NCT00948246|9754635|FG000|COMPLETED|Overall Study||86
8708470|NCT00948246|9754635|FG000|NOT COMPLETED|Overall Study||24
8708471|NCT00948298|9754641|FG000|STARTED|Overall Study||65
8708472|NCT00948298|9754642|FG001|STARTED|Overall Study||65
8708473|NCT00948298|9754641|FG000|COMPLETED|Overall Study||55
8708474|NCT00948298|9754642|FG001|COMPLETED|Overall Study||60
8708475|NCT00948298|9754641|FG000|NOT COMPLETED|Overall Study||10
8708476|NCT00948298|9754642|FG001|NOT COMPLETED|Overall Study||5
8708477|NCT00948389|9754653|FG000|STARTED|Overall Study||6
8708478|NCT00948389|9754654|FG001|STARTED|Overall Study||3
8708479|NCT00948389|9754655|FG002|STARTED|Overall Study||7
8708480|NCT00948389|9754656|FG003|STARTED|Overall Study||9
8708481|NCT00948389|9754657|FG004|STARTED|Overall Study||1
8708482|NCT00948389|9754653|FG000|COMPLETED|Overall Study||0
8708483|NCT00948389|9754654|FG001|COMPLETED|Overall Study||0
8708484|NCT00948389|9754655|FG002|COMPLETED|Overall Study||0
8708485|NCT00948389|9754656|FG003|COMPLETED|Overall Study||0
8708486|NCT00948389|9754657|FG004|COMPLETED|Overall Study||0
8708487|NCT00948389|9754653|FG000|NOT COMPLETED|Overall Study||6
8708488|NCT00948389|9754654|FG001|NOT COMPLETED|Overall Study||3
8708489|NCT00948389|9754655|FG002|NOT COMPLETED|Overall Study||7
8708490|NCT00948389|9754656|FG003|NOT COMPLETED|Overall Study||9
8708491|NCT00948389|9754657|FG004|NOT COMPLETED|Overall Study||1
8708492|NCT00948428|9754674|FG000|STARTED|Overall Study||185
8708493|NCT00948428|9754675|FG001|STARTED|Overall Study||185
8708494|NCT00948428|9754676|FG002|STARTED|Overall Study||92
8708495|NCT00948428|9754674|FG000|COMPLETED|Overall Study||167
8708496|NCT00948428|9754675|FG001|COMPLETED|Overall Study||167
8708497|NCT00948428|9754676|FG002|COMPLETED|Overall Study||84
8708498|NCT00948428|9754674|FG000|NOT COMPLETED|Overall Study||18
8708499|NCT00948428|9754675|FG001|NOT COMPLETED|Overall Study||18
8708500|NCT00948428|9754676|FG002|NOT COMPLETED|Overall Study||8
8708501|NCT00948441|9754686|FG000|STARTED|Overall Study||8
8708502|NCT00948441|9754687|FG001|STARTED|Overall Study||8
8708503|NCT00948441|9754686|FG000|COMPLETED|Overall Study||7
8708504|NCT00948441|9754687|FG001|COMPLETED|Overall Study||4
8708505|NCT00948441|9754686|FG000|NOT COMPLETED|Overall Study||1
8708506|NCT00948441|9754687|FG001|NOT COMPLETED|Overall Study||4
8708507|NCT00948506|9754697|FG000|STARTED|Overall Study||11
8708508|NCT00948506|9754698|FG001|STARTED|Overall Study||9
8708509|NCT00948506|9754697|FG000|COMPLETED|Overall Study||8
8708510|NCT00948506|9754698|FG001|COMPLETED|Overall Study||8
8708511|NCT00948506|9754697|FG000|NOT COMPLETED|Overall Study||3
8708512|NCT00948506|9754698|FG001|NOT COMPLETED|Overall Study||1
8708513|NCT00948610|9754709|FG000|STARTED|Overall Study||10
8708514|NCT00948610|9754710|FG001|STARTED|Overall Study||10
8708515|NCT00948610|9754709|FG000|COMPLETED|Overall Study||9
8708516|NCT00948610|9754710|FG001|COMPLETED|Overall Study||9
8708517|NCT00948610|9754709|FG000|NOT COMPLETED|Overall Study||1
8708518|NCT00948610|9754710|FG001|NOT COMPLETED|Overall Study||1
8708519|NCT00948675|9754718|FG000|STARTED|Overall Study||182
8708520|NCT00948675|9754719|FG001|STARTED|Overall Study||179
8708521|NCT00948675|9754718|FG000|Received Any Amount of Study Drug|Overall Study||171
8708522|NCT00948675|9754719|FG001|Received Any Amount of Study Drug|Overall Study||166
8708523|NCT00948675|9754718|FG000|COMPLETED|Overall Study||181
8708524|NCT00948675|9754719|FG001|COMPLETED|Overall Study||179
8708525|NCT00948675|9754718|FG000|NOT COMPLETED|Overall Study||1
8708526|NCT00948675|9754719|FG001|NOT COMPLETED|Overall Study||0
8708527|NCT00948688|9754725|FG000|STARTED|Period 1: 200 mg Vorinostat||4
8708528|NCT00948688|9754726|FG001|STARTED|Period 1: 200 mg Vorinostat||0
8708529|NCT00948688|9754725|FG000|COMPLETED|Period 1: 200 mg Vorinostat||2
8708530|NCT00948688|9754726|FG001|COMPLETED|Period 1: 200 mg Vorinostat||0
8708531|NCT00948688|9754725|FG000|NOT COMPLETED|Period 1: 200 mg Vorinostat||2
8708532|NCT00948688|9754726|FG001|NOT COMPLETED|Period 1: 200 mg Vorinostat||0
8708533|NCT00948688|9754725|FG000|STARTED|Period 2: 100 mg Vorinostat||0
8708534|NCT00948688|9754726|FG001|STARTED|Period 2: 100 mg Vorinostat||6
8708535|NCT00948688|9754725|FG000|COMPLETED|Period 2: 100 mg Vorinostat||0
8708536|NCT00948688|9754726|FG001|COMPLETED|Period 2: 100 mg Vorinostat||5
8708537|NCT00948688|9754725|FG000|NOT COMPLETED|Period 2: 100 mg Vorinostat||0
8708538|NCT00948688|9754726|FG001|NOT COMPLETED|Period 2: 100 mg Vorinostat||1
8708539|NCT00948766|9754735|FG000|STARTED|Core Study||356
8708540|NCT00948766|9754736|FG001|STARTED|Core Study||360
8708541|NCT00948766|9754735|FG000|Exposed to Study Medication|Core Study||355
8708542|NCT00948766|9754736|FG001|Exposed to Study Medication|Core Study||359
8708543|NCT00948766|9754735|FG000|COMPLETED|Core Study||229
8708544|NCT00948766|9754736|FG001|COMPLETED|Core Study||234
8708545|NCT00948766|9754735|FG000|NOT COMPLETED|Core Study||127
8708546|NCT00948766|9754736|FG001|NOT COMPLETED|Core Study||126
8708547|NCT00948766|9754735|FG000|STARTED|Extension Study|397 of the 463 patients who completed the core study entered the extension study.|397
8708548|NCT00948766|9754736|FG001|STARTED|Extension Study|No patients received this treatment in the extension study.|0
8708549|NCT00948766|9754735|FG000|Exposed to Study Medication|Extension Study||396
8708550|NCT00948766|9754736|FG001|Exposed to Study Medication|Extension Study||0
8708551|NCT00948766|9754735|FG000|COMPLETED|Extension Study||306
8708552|NCT00948766|9754736|FG001|COMPLETED|Extension Study||0
8708553|NCT00948766|9754735|FG000|NOT COMPLETED|Extension Study||91
8708554|NCT00948766|9754736|FG001|NOT COMPLETED|Extension Study||0
8708555|NCT00948792|9754743|FG000|STARTED|Overall Study||21
8708556|NCT00948792|9754743|FG000|COMPLETED|Overall Study||21
8708557|NCT00948792|9754743|FG000|NOT COMPLETED|Overall Study||0
8708558|NCT00948818|9754751|FG000|STARTED|Overall Study||397
8708559|NCT00948818|9754752|FG001|STARTED|Overall Study||406
8708560|NCT00948818|9754751|FG000|COMPLETED|Overall Study||335
8708561|NCT00948818|9754752|FG001|COMPLETED|Overall Study||312
8708562|NCT00948818|9754751|FG000|NOT COMPLETED|Overall Study||62
8708563|NCT00948818|9754752|FG001|NOT COMPLETED|Overall Study||94
8708564|NCT00948857|9754763|FG000|STARTED|Overall Study||3
8708565|NCT00948857|9754764|FG001|STARTED|Overall Study||2
8708566|NCT00948857|9754763|FG000|COMPLETED|Overall Study|3 completed and 1 dropped out.|2
8708567|NCT00948857|9754764|FG001|COMPLETED|Overall Study||2
8708568|NCT00948857|9754763|FG000|NOT COMPLETED|Overall Study||1
8708569|NCT00948857|9754764|FG001|NOT COMPLETED|Overall Study||0
8708570|NCT00948896|9754778|FG000|STARTED|Randomization to 24 Months of Age||98
8708571|NCT00948896|9754779|FG001|STARTED|Randomization to 24 Months of Age||98
8708572|NCT00948896|9754780|FG002|STARTED|Randomization to 24 Months of Age||99
8708573|NCT00948896|9754781|FG003|STARTED|Randomization to 24 Months of Age||98
8708574|NCT00948896|9754782|FG004|STARTED|Randomization to 24 Months of Age||46
8708575|NCT00948896|9754783|FG005|STARTED|Randomization to 24 Months of Age||46
8708576|NCT00948896|9754784|FG006|STARTED|Randomization to 24 Months of Age||47
8708577|NCT00948896|9754785|FG007|STARTED|Randomization to 24 Months of Age||47
8708578|NCT00948896|9754778|FG000|COMPLETED|Randomization to 24 Months of Age||90
8708579|NCT00948896|9754779|FG001|COMPLETED|Randomization to 24 Months of Age||85
8708580|NCT00948896|9754780|FG002|COMPLETED|Randomization to 24 Months of Age||90
8708581|NCT00948896|9754781|FG003|COMPLETED|Randomization to 24 Months of Age||87
8708582|NCT00948896|9754782|FG004|COMPLETED|Randomization to 24 Months of Age||44
8708583|NCT00948896|9754783|FG005|COMPLETED|Randomization to 24 Months of Age||42
8708584|NCT00948896|9754784|FG006|COMPLETED|Randomization to 24 Months of Age||43
8708585|NCT00948896|9754785|FG007|COMPLETED|Randomization to 24 Months of Age||45
8708586|NCT00948896|9754778|FG000|NOT COMPLETED|Randomization to 24 Months of Age||8
8708587|NCT00948896|9754779|FG001|NOT COMPLETED|Randomization to 24 Months of Age||13
8708588|NCT00948896|9754780|FG002|NOT COMPLETED|Randomization to 24 Months of Age||9
8708589|NCT00948896|9754781|FG003|NOT COMPLETED|Randomization to 24 Months of Age||11
8708590|NCT00948896|9754782|FG004|NOT COMPLETED|Randomization to 24 Months of Age||2
8708591|NCT00948896|9754783|FG005|NOT COMPLETED|Randomization to 24 Months of Age||4
8708592|NCT00948896|9754784|FG006|NOT COMPLETED|Randomization to 24 Months of Age||4
8708593|NCT00948896|9754785|FG007|NOT COMPLETED|Randomization to 24 Months of Age||2
8708594|NCT00948896|9754778|FG000|STARTED|24 Months of Age to 36 Months of Age||90
8708595|NCT00948896|9754779|FG001|STARTED|24 Months of Age to 36 Months of Age||85
8708596|NCT00948896|9754780|FG002|STARTED|24 Months of Age to 36 Months of Age||90
8708597|NCT00948896|9754781|FG003|STARTED|24 Months of Age to 36 Months of Age||87
8708598|NCT00948896|9754782|FG004|STARTED|24 Months of Age to 36 Months of Age||44
8708599|NCT00948896|9754783|FG005|STARTED|24 Months of Age to 36 Months of Age||42
8708600|NCT00948896|9754784|FG006|STARTED|24 Months of Age to 36 Months of Age||43
8708601|NCT00948896|9754785|FG007|STARTED|24 Months of Age to 36 Months of Age||45
8708602|NCT00948896|9754778|FG000|COMPLETED|24 Months of Age to 36 Months of Age||87
8708603|NCT00948896|9754779|FG001|COMPLETED|24 Months of Age to 36 Months of Age||83
8708604|NCT00948896|9754780|FG002|COMPLETED|24 Months of Age to 36 Months of Age||85
8708605|NCT00948896|9754781|FG003|COMPLETED|24 Months of Age to 36 Months of Age||85
8708606|NCT00948896|9754782|FG004|COMPLETED|24 Months of Age to 36 Months of Age||43
8708607|NCT00948896|9754783|FG005|COMPLETED|24 Months of Age to 36 Months of Age||40
8708608|NCT00948896|9754784|FG006|COMPLETED|24 Months of Age to 36 Months of Age||43
8708609|NCT00948896|9754785|FG007|COMPLETED|24 Months of Age to 36 Months of Age||45
8708610|NCT00948896|9754778|FG000|NOT COMPLETED|24 Months of Age to 36 Months of Age||3
8708611|NCT00948896|9754779|FG001|NOT COMPLETED|24 Months of Age to 36 Months of Age||2
8708612|NCT00948896|9754780|FG002|NOT COMPLETED|24 Months of Age to 36 Months of Age||5
8708613|NCT00948896|9754781|FG003|NOT COMPLETED|24 Months of Age to 36 Months of Age||2
8708614|NCT00948896|9754782|FG004|NOT COMPLETED|24 Months of Age to 36 Months of Age||1
8708615|NCT00948896|9754783|FG005|NOT COMPLETED|24 Months of Age to 36 Months of Age||2
8708616|NCT00948896|9754784|FG006|NOT COMPLETED|24 Months of Age to 36 Months of Age||0
8708617|NCT00948896|9754785|FG007|NOT COMPLETED|24 Months of Age to 36 Months of Age||0
8708618|NCT00948922|9754810|FG000|STARTED|Overall Study||34
8708619|NCT00948922|9754811|FG001|STARTED|Overall Study||51
8708620|NCT00948922|9754812|FG002|STARTED|Overall Study||39
8708621|NCT00948922|9754810|FG000|COMPLETED|Overall Study||26
8708622|NCT00948922|9754811|FG001|COMPLETED|Overall Study||37
8708623|NCT00948922|9754812|FG002|COMPLETED|Overall Study||38
8708624|NCT00948922|9754810|FG000|NOT COMPLETED|Overall Study||8
8708625|NCT00948922|9754811|FG001|NOT COMPLETED|Overall Study||14
8708626|NCT00948922|9754812|FG002|NOT COMPLETED|Overall Study||1
8708627|NCT00948935|9754824|FG000|STARTED|Overall Study||35
8708628|NCT00948935|9754824|FG000|COMPLETED|Overall Study||35
8708629|NCT00948935|9754824|FG000|NOT COMPLETED|Overall Study||0
8708630|NCT00948974|9754830|FG000|STARTED|Overall Study||40
8708631|NCT00948974|9754831|FG001|STARTED|Overall Study||48
8708632|NCT00948974|9754830|FG000|COMPLETED|Overall Study||17
8708633|NCT00948974|9754831|FG001|COMPLETED|Overall Study||28
8708634|NCT00948974|9754830|FG000|NOT COMPLETED|Overall Study||23
8708635|NCT00948974|9754831|FG001|NOT COMPLETED|Overall Study||20
8708636|NCT00949078|9754839|FG000|STARTED|Overall Study||5
8708637|NCT00949078|9754840|FG001|STARTED|Overall Study||9
8708638|NCT00949078|9754839|FG000|COMPLETED|Overall Study||5
8708639|NCT00949078|9754840|FG001|COMPLETED|Overall Study||9
8708640|NCT00949078|9754839|FG000|NOT COMPLETED|Overall Study||0
8708641|NCT00949078|9754840|FG001|NOT COMPLETED|Overall Study||0
8708642|NCT00949117|9754848|FG000|STARTED|Overall Study||4
8708643|NCT00949117|9754849|FG001|STARTED|Overall Study||5
8708644|NCT00949117|9754848|FG000|COMPLETED|Overall Study||1
8708645|NCT00949117|9754849|FG001|COMPLETED|Overall Study||0
8708646|NCT00949117|9754848|FG000|NOT COMPLETED|Overall Study||3
8708647|NCT00949117|9754849|FG001|NOT COMPLETED|Overall Study||5
8708648|NCT00949234|9754857|FG000|STARTED|Overall Study||267
8708649|NCT00949234|9754857|FG000|COMPLETED|Overall Study||225
8708650|NCT00949234|9754857|FG000|NOT COMPLETED|Overall Study||42
8708651|NCT00949325|9754861|FG000|STARTED|Overall Study||3
8708652|NCT00949325|9754862|FG001|STARTED|Overall Study||18
8708653|NCT00949325|9754863|FG002|STARTED|Overall Study||3
8708654|NCT00949325|9754861|FG000|COMPLETED|Overall Study||3
8708655|NCT00949325|9754862|FG001|COMPLETED|Overall Study||16
8708656|NCT00949325|9754863|FG002|COMPLETED|Overall Study||3
8708657|NCT00949325|9754861|FG000|NOT COMPLETED|Overall Study||0
8708658|NCT00949325|9754862|FG001|NOT COMPLETED|Overall Study||2
8708659|NCT00949325|9754863|FG002|NOT COMPLETED|Overall Study||0
8708660|NCT00949533|9754881|FG000|STARTED|Overall Study||19
8708661|NCT00949533|9754882|FG001|STARTED|Overall Study||18
8708662|NCT00949533|9754881|FG000|COMPLETED|Overall Study||19
8708663|NCT00949533|9754882|FG001|COMPLETED|Overall Study||17
8708664|NCT00949533|9754881|FG000|NOT COMPLETED|Overall Study||0
8708665|NCT00949533|9754882|FG001|NOT COMPLETED|Overall Study||1
8708666|NCT00949650|9754890|FG000|STARTED|Overall Study|Treated patients.|230
8708667|NCT00949650|9754891|FG001|STARTED|Overall Study|Treated patients.|115
8708668|NCT00949650|9754890|FG000|COMPLETED|Overall Study|On treatment at the cut-off date 17MAR2017.|0
8708669|NCT00949650|9754891|FG001|COMPLETED|Overall Study||0
8708670|NCT00949650|9754890|FG000|NOT COMPLETED|Overall Study||230
8708671|NCT00949650|9754891|FG001|NOT COMPLETED|Overall Study||115
8708672|NCT00949702|9754901|FG000|STARTED|Overall Study||132
8708673|NCT00949702|9754901|FG000|COMPLETED|Overall Study||84
8708674|NCT00949702|9754901|FG000|NOT COMPLETED|Overall Study||48
8708675|NCT00949715|9754907|FG000|STARTED|Overall Study||32
8708676|NCT00949715|9754908|FG001|STARTED|Overall Study||33
8708677|NCT00949715|9754907|FG000|COMPLETED|Overall Study||28
8708678|NCT00949715|9754908|FG001|COMPLETED|Overall Study||33
8708679|NCT00949715|9754907|FG000|NOT COMPLETED|Overall Study||4
8708680|NCT00949715|9754908|FG001|NOT COMPLETED|Overall Study||0
8708681|NCT00949884|9754916|FG000|STARTED|Overall Study||420
8708682|NCT00949884|9754917|FG001|STARTED|Overall Study||52
8708683|NCT00949884|9754918|FG002|STARTED|Overall Study||469
8708684|NCT00949884|9754916|FG000|COMPLETED|Overall Study||370
8708685|NCT00949884|9754917|FG001|COMPLETED|Overall Study||37
8708686|NCT00949884|9754918|FG002|COMPLETED|Overall Study||411
8708687|NCT00949884|9754916|FG000|NOT COMPLETED|Overall Study||50
8708688|NCT00949884|9754917|FG001|NOT COMPLETED|Overall Study||15
8708689|NCT00949884|9754918|FG002|NOT COMPLETED|Overall Study||58
8708690|NCT00949910|9754927|FG000|STARTED|Overall Study||6586
8708691|NCT00949910|9754927|FG000|COMPLETED|Overall Study||10
8708692|NCT00949910|9754927|FG000|NOT COMPLETED|Overall Study||6576
8708693|NCT00949975|9754935|FG000|STARTED|Overall Study||212
8708694|NCT00949975|9754936|FG001|STARTED|Overall Study||206
8708695|NCT00949975|9754937|FG002|STARTED|Overall Study||202
8708696|NCT00949975|9754938|FG003|STARTED|Overall Study||218
8708697|NCT00949975|9754935|FG000|COMPLETED|Overall Study||185
8708698|NCT00949975|9754936|FG001|COMPLETED|Overall Study||177
8708699|NCT00949975|9754937|FG002|COMPLETED|Overall Study||183
8708700|NCT00949975|9754938|FG003|COMPLETED|Overall Study||190
8708701|NCT00949975|9754935|FG000|NOT COMPLETED|Overall Study||27
8708702|NCT00949975|9754936|FG001|NOT COMPLETED|Overall Study||29
8708703|NCT00949975|9754937|FG002|NOT COMPLETED|Overall Study||19
8708704|NCT00949975|9754938|FG003|NOT COMPLETED|Overall Study||28
8708705|NCT00950170|9754948|FG000|STARTED|Overall Study||23
8708706|NCT00950170|9754948|FG000|COMPLETED|Overall Study||19
8708707|NCT00950170|9754948|FG000|NOT COMPLETED|Overall Study||4
8708708|NCT00950235|9754972|FG000|STARTED|Overall Study||60
8708709|NCT00950235|9754973|FG001|STARTED|Overall Study||58
8708710|NCT00950235|9754972|FG000|COMPLETED|Overall Study||58
8708711|NCT00950235|9754973|FG001|COMPLETED|Overall Study||54
8708712|NCT00950235|9754972|FG000|NOT COMPLETED|Overall Study||2
8708713|NCT00950235|9754973|FG001|NOT COMPLETED|Overall Study||4
8708714|NCT00950248|9754981|FG000|STARTED|Year 1: Baseline||85
8708715|NCT00950248|9754982|FG001|STARTED|Year 1: Baseline||0
8708716|NCT00950248|9754983|FG002|STARTED|Year 1: Baseline||0
8708717|NCT00950248|9754981|FG000|COMPLETED|Year 1: Baseline||77
8708718|NCT00950248|9754982|FG001|COMPLETED|Year 1: Baseline||0
8708719|NCT00950248|9754983|FG002|COMPLETED|Year 1: Baseline||0
8708720|NCT00950248|9754981|FG000|NOT COMPLETED|Year 1: Baseline||8
8708721|NCT00950248|9754982|FG001|NOT COMPLETED|Year 1: Baseline||0
8708722|NCT00950248|9754983|FG002|NOT COMPLETED|Year 1: Baseline||0
8708723|NCT00950248|9754981|FG000|STARTED|Year 2&3 Treatment Randomization||0
8708724|NCT00950248|9754982|FG001|STARTED|Year 2&3 Treatment Randomization||39
8708725|NCT00950248|9754983|FG002|STARTED|Year 2&3 Treatment Randomization||38
8708726|NCT00950248|9754981|FG000|COMPLETED|Year 2&3 Treatment Randomization||0
8708727|NCT00950248|9754982|FG001|COMPLETED|Year 2&3 Treatment Randomization||33
8708728|NCT00950248|9754983|FG002|COMPLETED|Year 2&3 Treatment Randomization||33
8708729|NCT00950248|9754981|FG000|NOT COMPLETED|Year 2&3 Treatment Randomization||0
8708730|NCT00950248|9754982|FG001|NOT COMPLETED|Year 2&3 Treatment Randomization||6
8708731|NCT00950248|9754983|FG002|NOT COMPLETED|Year 2&3 Treatment Randomization||5
8708732|NCT00950300|9754992|FG000|STARTED|Neoadjuvant/Adjuvant Treatment Periods||299
8708733|NCT00950300|9754993|FG001|STARTED|Neoadjuvant/Adjuvant Treatment Periods||297
8708734|NCT00950300|9754992|FG000|Received Neoadjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||298
8708735|NCT00950300|9754993|FG001|Received Neoadjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||297
8708736|NCT00950300|9754992|FG000|Underwent Surgery|Neoadjuvant/Adjuvant Treatment Periods||277
8708737|NCT00950300|9754993|FG001|Underwent Surgery|Neoadjuvant/Adjuvant Treatment Periods||273
8708738|NCT00950300|9754992|FG000|Entered Adjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||277
8708739|NCT00950300|9754993|FG001|Entered Adjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||274
8708740|NCT00950300|9754992|FG000|COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||257
8708741|NCT00950300|9754993|FG001|COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||255
8708742|NCT00950300|9754992|FG000|NOT COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||42
8708743|NCT00950300|9754993|FG001|NOT COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||42
8708744|NCT00950300|9754992|FG000|STARTED|TFFU Period|Participants could withdraw from the study entirely or advance directly to the TFFU or SFU Period.|265
8708745|NCT00950300|9754993|FG001|STARTED|TFFU Period|Participants could withdraw from the study entirely or advance directly to the TFFU or SFU Period.|268
8708746|NCT00950300|9754992|FG000|COMPLETED|TFFU Period|Includes participants who completed either 2 years of follow-up or 5 years of follow-up.|165
8708747|NCT00950300|9754993|FG001|COMPLETED|TFFU Period|Includes participants who completed either 2 years of follow-up or 5 years of follow-up.|161
8708748|NCT00950300|9754992|FG000|NOT COMPLETED|TFFU Period||100
8708749|NCT00950300|9754993|FG001|NOT COMPLETED|TFFU Period||107
8708750|NCT00950300|9754992|FG000|STARTED|SFU Period|Participants could withdraw from the study entirely or advance directly to the SFU Period.|118
8708751|NCT00950300|9754993|FG001|STARTED|SFU Period|Participants could withdraw from the study entirely or advance directly to the SFU Period.|123
8708752|NCT00950300|9754992|FG000|COMPLETED|SFU Period|Includes participants who completed either 2 years of follow-up or 5 years of follow-up.|40
8708753|NCT00950300|9754993|FG001|COMPLETED|SFU Period|Includes participants who completed either 2 years of follow-up or 5 years of follow-up.|45
8708754|NCT00950300|9754992|FG000|NOT COMPLETED|SFU Period||78
8708755|NCT00950300|9754993|FG001|NOT COMPLETED|SFU Period||78
8708756|NCT00950352|9755002|FG000|STARTED|Overall Study||72
8708757|NCT00950352|9755003|FG001|STARTED|Overall Study||32
8708758|NCT00950352|9755002|FG000|COMPLETED|Overall Study||30
8708759|NCT00950352|9755003|FG001|COMPLETED|Overall Study||21
8708760|NCT00950352|9755002|FG000|NOT COMPLETED|Overall Study||42
8708761|NCT00950352|9755003|FG001|NOT COMPLETED|Overall Study||11
8708762|NCT00950365|9755011|FG000|STARTED|Overall Study||27
8708763|NCT00950365|9755012|FG001|STARTED|Overall Study||52
8708764|NCT00950365|9755011|FG000|COMPLETED|Overall Study||25
8708765|NCT00950365|9755012|FG001|COMPLETED|Overall Study||50
8708766|NCT00950365|9755011|FG000|NOT COMPLETED|Overall Study||2
8708767|NCT00950365|9755012|FG001|NOT COMPLETED|Overall Study||2
8708768|NCT00950599|9755026|FG000|STARTED|Double-Blind Treatment Period||55
8708769|NCT00950599|9755027|FG001|STARTED|Double-Blind Treatment Period||47
8708770|NCT00950599|9755028|FG002|STARTED|Double-Blind Treatment Period||63
8708771|NCT00950599|9755029|FG003|STARTED|Double-Blind Treatment Period||54
8708772|NCT00950599|9755030|FG004|STARTED|Double-Blind Treatment Period||52
8708773|NCT00950599|9755031|FG005|STARTED|Double-Blind Treatment Period||67
8708774|NCT00950599|9755032|FG006|STARTED|Double-Blind Treatment Period||44
8708775|NCT00950599|9755033|FG007|STARTED|Double-Blind Treatment Period||41
8708776|NCT00950599|9755034|FG008|STARTED|Double-Blind Treatment Period||0
8708777|NCT00950599|9755035|FG009|STARTED|Double-Blind Treatment Period||0
8708778|NCT00950599|9755026|FG000|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|48
8708779|NCT00950599|9755027|FG001|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|37
8708780|NCT00950599|9755028|FG002|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|54
8708781|NCT00950599|9755029|FG003|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|43
8708782|NCT00950599|9755030|FG004|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|45
8708783|NCT00950599|9755031|FG005|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|55
8708784|NCT00950599|9755032|FG006|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|44
8708785|NCT00950599|9755033|FG007|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|35
8708786|NCT00950599|9755034|FG008|COMPLETED|Double-Blind Treatment Period||0
8708787|NCT00950599|9755035|FG009|COMPLETED|Double-Blind Treatment Period||0
8708788|NCT00950599|9755026|FG000|NOT COMPLETED|Double-Blind Treatment Period||7
8708789|NCT00950599|9755027|FG001|NOT COMPLETED|Double-Blind Treatment Period||10
8708790|NCT00950599|9755028|FG002|NOT COMPLETED|Double-Blind Treatment Period||9
8708791|NCT00950599|9755029|FG003|NOT COMPLETED|Double-Blind Treatment Period||11
8708792|NCT00950599|9755030|FG004|NOT COMPLETED|Double-Blind Treatment Period||7
8708793|NCT00950599|9755031|FG005|NOT COMPLETED|Double-Blind Treatment Period||12
8708794|NCT00950599|9755032|FG006|NOT COMPLETED|Double-Blind Treatment Period||0
8708795|NCT00950599|9755033|FG007|NOT COMPLETED|Double-Blind Treatment Period||6
8708796|NCT00950599|9755034|FG008|NOT COMPLETED|Double-Blind Treatment Period||0
8708797|NCT00950599|9755035|FG009|NOT COMPLETED|Double-Blind Treatment Period||0
8708798|NCT00950599|9755026|FG000|STARTED|Follow-Up Period||0
8708799|NCT00950599|9755027|FG001|STARTED|Follow-Up Period||0
8708800|NCT00950599|9755028|FG002|STARTED|Follow-Up Period||0
8708801|NCT00950599|9755029|FG003|STARTED|Follow-Up Period||0
8708802|NCT00950599|9755030|FG004|STARTED|Follow-Up Period||0
8708803|NCT00950599|9755031|FG005|STARTED|Follow-Up Period||0
8708804|NCT00950599|9755032|FG006|STARTED|Follow-Up Period||0
8708805|NCT00950599|9755033|FG007|STARTED|Follow-Up Period||0
8708806|NCT00950599|9755034|FG008|STARTED|Follow-Up Period|those completing double blind period (DB) + those rescued/discontinued from DB due to hyperglycemia|309
8708807|NCT00950599|9755035|FG009|STARTED|Follow-Up Period|those completing double blind period (DB) + those rescued/discontinued from DB due to hyperglycemia|80
8708808|NCT00950599|9755026|FG000|COMPLETED|Follow-Up Period||0
8708809|NCT00950599|9755027|FG001|COMPLETED|Follow-Up Period||0
8708810|NCT00950599|9755028|FG002|COMPLETED|Follow-Up Period||0
8708811|NCT00950599|9755029|FG003|COMPLETED|Follow-Up Period||0
8708812|NCT00950599|9755030|FG004|COMPLETED|Follow-Up Period||0
8708813|NCT00950599|9755031|FG005|COMPLETED|Follow-Up Period||0
8708814|NCT00950599|9755032|FG006|COMPLETED|Follow-Up Period||0
8708815|NCT00950599|9755033|FG007|COMPLETED|Follow-Up Period||0
8708816|NCT00950599|9755034|FG008|COMPLETED|Follow-Up Period||296
8708817|NCT00950599|9755035|FG009|COMPLETED|Follow-Up Period||78
8708818|NCT00950599|9755026|FG000|NOT COMPLETED|Follow-Up Period||0
8708819|NCT00950599|9755027|FG001|NOT COMPLETED|Follow-Up Period||0
8708820|NCT00950599|9755028|FG002|NOT COMPLETED|Follow-Up Period||0
8708821|NCT00950599|9755029|FG003|NOT COMPLETED|Follow-Up Period||0
8708822|NCT00950599|9755030|FG004|NOT COMPLETED|Follow-Up Period||0
8708823|NCT00950599|9755031|FG005|NOT COMPLETED|Follow-Up Period||0
8708824|NCT00950599|9755032|FG006|NOT COMPLETED|Follow-Up Period||0
8708825|NCT00950599|9755033|FG007|NOT COMPLETED|Follow-Up Period||0
8708826|NCT00950599|9755034|FG008|NOT COMPLETED|Follow-Up Period||13
8708827|NCT00950599|9755035|FG009|NOT COMPLETED|Follow-Up Period||2
8708828|NCT00950612|9755060|FG000|STARTED|Overall Study||40
8708829|NCT00950612|9755061|FG001|STARTED|Overall Study||20
8708830|NCT00950612|9755060|FG000|COMPLETED|Overall Study||40
8708831|NCT00950612|9755061|FG001|COMPLETED|Overall Study||20
8708832|NCT00950612|9755060|FG000|NOT COMPLETED|Overall Study||0
8708833|NCT00950612|9755061|FG001|NOT COMPLETED|Overall Study||0
8708834|NCT00950651|9755069|FG000|STARTED|Overall Study||215
8708835|NCT00950651|9755070|FG001|STARTED|Overall Study|216 patients randomized but one never took study medication|216
8708836|NCT00950651|9755069|FG000|COMPLETED|Overall Study||184
8708837|NCT00950651|9755070|FG001|COMPLETED|Overall Study||181
8708838|NCT00950651|9755069|FG000|NOT COMPLETED|Overall Study||31
8708839|NCT00950651|9755070|FG001|NOT COMPLETED|Overall Study||35
8708840|NCT00950664|9755078|FG000|STARTED|First Intervention||49
8708841|NCT00950664|9755079|FG001|STARTED|First Intervention||53
8708842|NCT00950664|9755078|FG000|COMPLETED|First Intervention||46
8708843|NCT00950664|9755079|FG001|COMPLETED|First Intervention||48
8708844|NCT00950664|9755078|FG000|NOT COMPLETED|First Intervention||3
8708845|NCT00950664|9755079|FG001|NOT COMPLETED|First Intervention||5
8708846|NCT00950664|9755078|FG000|STARTED|Washout Period of 4 Weeks||46
8708847|NCT00950664|9755079|FG001|STARTED|Washout Period of 4 Weeks||48
8708848|NCT00950664|9755078|FG000|COMPLETED|Washout Period of 4 Weeks||46
8708849|NCT00950664|9755079|FG001|COMPLETED|Washout Period of 4 Weeks||48
8708850|NCT00950664|9755078|FG000|NOT COMPLETED|Washout Period of 4 Weeks||0
8708851|NCT00950664|9755079|FG001|NOT COMPLETED|Washout Period of 4 Weeks||0
8708852|NCT00950664|9755078|FG000|STARTED|Second Intervention||46
8708853|NCT00950664|9755079|FG001|STARTED|Second Intervention||48
8708854|NCT00950664|9755078|FG000|COMPLETED|Second Intervention||0
8708855|NCT00950664|9755079|FG001|COMPLETED|Second Intervention||0
8708856|NCT00950664|9755078|FG000|NOT COMPLETED|Second Intervention||46
8708857|NCT00950664|9755079|FG001|NOT COMPLETED|Second Intervention||48
8724787|NCT01027871|9772051|FG002|STARTED|Overall Study||98
8557641|NCT02087423|9589545|FG002|COMPLETED|Overall Study||0
8557642|NCT02087423|9589543|FG000|NOT COMPLETED|Overall Study||111
8557643|NCT02087423|9589544|FG001|NOT COMPLETED|Overall Study||265
8557644|NCT02087423|9589545|FG002|NOT COMPLETED|Overall Study||68
8557645|NCT02076009|9589557|FG000|STARTED|Overall Study||283
8557646|NCT02076009|9589558|FG001|STARTED|Overall Study||286
8557647|NCT02076009|9589557|FG000|Treated|Overall Study||281
8557648|NCT02076009|9589558|FG001|Treated|Overall Study||283
8557649|NCT02076009|9589557|FG000|COMPLETED|Overall Study||0
8557650|NCT02076009|9589558|FG001|COMPLETED|Overall Study||0
8557651|NCT02076009|9589557|FG000|NOT COMPLETED|Overall Study||283
8557652|NCT02076009|9589558|FG001|NOT COMPLETED|Overall Study||286
8557653|NCT01946204|9589566|FG000|STARTED|Overall Study||401
8557654|NCT01946204|9589567|FG001|STARTED|Overall Study||806
8557655|NCT01946204|9589566|FG000|Treated|Overall Study||398
8557656|NCT01946204|9589567|FG001|Treated|Overall Study||803
8557657|NCT01946204|9589566|FG000|COMPLETED|Overall Study||0
8557658|NCT01946204|9589567|FG001|COMPLETED|Overall Study||0
8557659|NCT01946204|9589566|FG000|NOT COMPLETED|Overall Study||401
8557660|NCT01946204|9589567|FG001|NOT COMPLETED|Overall Study||806
8557661|NCT01626079|9589576|FG000|STARTED|Overall Study||302
8557662|NCT01626079|9589577|FG001|STARTED|Overall Study||312
8557663|NCT01626079|9589578|FG002|STARTED|Overall Study||162
8557664|NCT01626079|9589576|FG000|COMPLETED|Overall Study||152
8557665|NCT01626079|9589577|FG001|COMPLETED|Overall Study||111
8557666|NCT01626079|9589578|FG002|COMPLETED|Overall Study||110
8557667|NCT01626079|9589576|FG000|NOT COMPLETED|Overall Study||150
8557668|NCT01626079|9589577|FG001|NOT COMPLETED|Overall Study||201
8557669|NCT01626079|9589578|FG002|NOT COMPLETED|Overall Study||52
8557670|NCT01615029|9589594|FG000|STARTED|Overall Study||3
8557671|NCT01615029|9589595|FG001|STARTED|Overall Study||3
8557672|NCT01615029|9589596|FG002|STARTED|Overall Study||4
8557673|NCT01615029|9589597|FG003|STARTED|Overall Study||3
8557674|NCT01615029|9589598|FG004|STARTED|Overall Study||32
8557675|NCT01615029|9589594|FG000|COMPLETED|Overall Study||0
8557676|NCT01615029|9589595|FG001|COMPLETED|Overall Study||0
8557677|NCT01615029|9589596|FG002|COMPLETED|Overall Study||0
8557678|NCT01615029|9589597|FG003|COMPLETED|Overall Study||0
8557679|NCT01615029|9589598|FG004|COMPLETED|Overall Study||0
8557680|NCT01615029|9589594|FG000|NOT COMPLETED|Overall Study||3
8708858|NCT00950729|9755085|FG000|STARTED|Driving With Running Shoes|March 2007|48
8708859|NCT00950729|9755085|FG000|COMPLETED|Driving With Running Shoes|June 2007|48
8708860|NCT00950729|9755085|FG000|NOT COMPLETED|Driving With Running Shoes||0
8708861|NCT00950729|9755085|FG000|STARTED|Driving With Plaster Cast||48
8708862|NCT00950729|9755085|FG000|COMPLETED|Driving With Plaster Cast||48
8708863|NCT00950729|9755085|FG000|NOT COMPLETED|Driving With Plaster Cast||0
8708864|NCT00950729|9755085|FG000|STARTED|Driving With Aircast||48
8708865|NCT00950729|9755085|FG000|COMPLETED|Driving With Aircast||48
8708866|NCT00950729|9755085|FG000|NOT COMPLETED|Driving With Aircast||0
8708867|NCT00950742|9755091|FG000|STARTED|Overall Study|entered and treated|16
8708868|NCT00950742|9755092|FG001|STARTED|Overall Study|entered and treated|2
8708869|NCT00950742|9755091|FG000|COMPLETED|Overall Study||0
8708870|NCT00950742|9755092|FG001|COMPLETED|Overall Study||0
8708871|NCT00950742|9755091|FG000|NOT COMPLETED|Overall Study||16
8708872|NCT00950742|9755092|FG001|NOT COMPLETED|Overall Study||2
8708873|NCT00950755|9755102|FG000|STARTED|Dosimetric and Therapeutic Treatment||41
8708874|NCT00950755|9755102|FG000|COMPLETED|Dosimetric and Therapeutic Treatment||0
8708875|NCT00950755|9755102|FG000|NOT COMPLETED|Dosimetric and Therapeutic Treatment||41
8724788|NCT01027871|9772049|FG000|Received at Least One Dose of Study Drug|Overall Study||93
9064218|NCT04322526|10124490|FG000|STARTED|Washout (1 Week)||12
9064219|NCT04322526|10124491|FG001|STARTED|Washout (1 Week)||11
9064220|NCT04322526|10124490|FG000|COMPLETED|Washout (1 Week)||11
9064221|NCT04322526|10124491|FG001|COMPLETED|Washout (1 Week)||9
9064222|NCT04322526|10124490|FG000|NOT COMPLETED|Washout (1 Week)||1
9064223|NCT04322526|10124491|FG001|NOT COMPLETED|Washout (1 Week)||2
9064224|NCT04322526|10124490|FG000|STARTED|Second Intervention (1day)||11
9064225|NCT04322526|10124491|FG001|STARTED|Second Intervention (1day)||9
9064226|NCT04322526|10124490|FG000|COMPLETED|Second Intervention (1day)||11
9064227|NCT04322526|10124491|FG001|COMPLETED|Second Intervention (1day)||9
9064228|NCT04322526|10124490|FG000|NOT COMPLETED|Second Intervention (1day)||0
9064229|NCT04322526|10124491|FG001|NOT COMPLETED|Second Intervention (1day)||0
8557681|NCT01615029|9589595|FG001|NOT COMPLETED|Overall Study||3
8557682|NCT01615029|9589596|FG002|NOT COMPLETED|Overall Study||4
8557683|NCT01615029|9589597|FG003|NOT COMPLETED|Overall Study||3
8557684|NCT01615029|9589598|FG004|NOT COMPLETED|Overall Study||32
8557685|NCT01612351|9589610|FG000|STARTED|Chemotherapy||40
8557686|NCT01612351|9589610|FG000|COMPLETED|Chemotherapy||40
8557687|NCT01612351|9589610|FG000|NOT COMPLETED|Chemotherapy||0
8708876|NCT00950755|9755102|FG000|STARTED|Long-Term Follow-Up|18 of the 41 participants withdrawing from Study BEX104505 enrolled in the LTFU study.|18
8708877|NCT00950755|9755102|FG000|COMPLETED|Long-Term Follow-Up||9
8708878|NCT00950755|9755102|FG000|NOT COMPLETED|Long-Term Follow-Up||9
8708879|NCT00950807|9755106|FG000|STARTED|Treatment Period 1||59
8708880|NCT00950807|9755107|FG001|STARTED|Treatment Period 1||13
8708881|NCT00950807|9755108|FG002|STARTED|Treatment Period 1||14
8708882|NCT00950807|9755109|FG003|STARTED|Treatment Period 1||12
8708883|NCT00950807|9755110|FG004|STARTED|Treatment Period 1||13
8708884|NCT00950807|9755111|FG005|STARTED|Treatment Period 1||13
8708885|NCT00950807|9755112|FG006|STARTED|Treatment Period 1||12
8708886|NCT00950807|9755113|FG007|STARTED|Treatment Period 1||14
8708887|NCT00950807|9755114|FG008|STARTED|Treatment Period 1||13
8708888|NCT00950807|9755115|FG009|STARTED|Treatment Period 1||13
8708889|NCT00950807|9755106|FG000|COMPLETED|Treatment Period 1||56
8708890|NCT00950807|9755107|FG001|COMPLETED|Treatment Period 1||13
8708891|NCT00950807|9755108|FG002|COMPLETED|Treatment Period 1||13
8708892|NCT00950807|9755109|FG003|COMPLETED|Treatment Period 1||12
8708893|NCT00950807|9755110|FG004|COMPLETED|Treatment Period 1||12
8708894|NCT00950807|9755111|FG005|COMPLETED|Treatment Period 1||11
8708895|NCT00950807|9755112|FG006|COMPLETED|Treatment Period 1||12
8708896|NCT00950807|9755113|FG007|COMPLETED|Treatment Period 1||14
8708897|NCT00950807|9755114|FG008|COMPLETED|Treatment Period 1||12
8708898|NCT00950807|9755115|FG009|COMPLETED|Treatment Period 1||13
8708899|NCT00950807|9755106|FG000|NOT COMPLETED|Treatment Period 1||3
8708900|NCT00950807|9755107|FG001|NOT COMPLETED|Treatment Period 1||0
8708901|NCT00950807|9755108|FG002|NOT COMPLETED|Treatment Period 1||1
8708902|NCT00950807|9755109|FG003|NOT COMPLETED|Treatment Period 1||0
8708903|NCT00950807|9755110|FG004|NOT COMPLETED|Treatment Period 1||1
8708904|NCT00950807|9755111|FG005|NOT COMPLETED|Treatment Period 1||2
8708905|NCT00950807|9755112|FG006|NOT COMPLETED|Treatment Period 1||0
8708906|NCT00950807|9755113|FG007|NOT COMPLETED|Treatment Period 1||0
8708907|NCT00950807|9755114|FG008|NOT COMPLETED|Treatment Period 1||1
8708908|NCT00950807|9755115|FG009|NOT COMPLETED|Treatment Period 1||0
8708909|NCT00950807|9755106|FG000|STARTED|Washout Period 1||56
8708910|NCT00950807|9755107|FG001|STARTED|Washout Period 1||13
8708911|NCT00950807|9755108|FG002|STARTED|Washout Period 1||13
8708912|NCT00950807|9755109|FG003|STARTED|Washout Period 1||12
8568812|NCT00094107|9601043|FG000|STARTED|Overall Study||32
8568813|NCT00094107|9601043|FG000|COMPLETED|Overall Study||0
8708913|NCT00950807|9755110|FG004|STARTED|Washout Period 1||12
8708914|NCT00950807|9755111|FG005|STARTED|Washout Period 1||11
8708915|NCT00950807|9755112|FG006|STARTED|Washout Period 1||12
8708916|NCT00950807|9755113|FG007|STARTED|Washout Period 1||14
8708917|NCT00950807|9755114|FG008|STARTED|Washout Period 1||12
8708918|NCT00950807|9755115|FG009|STARTED|Washout Period 1||13
8708919|NCT00950807|9755106|FG000|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|51
8708920|NCT00950807|9755107|FG001|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
8708921|NCT00950807|9755108|FG002|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
8708922|NCT00950807|9755109|FG003|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
8708923|NCT00950807|9755110|FG004|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
8557688|NCT01612351|9589610|FG000|STARTED|Transoral Surgery|One patient completed chemotherapy then withdrew before surgery.|39
8557689|NCT01612351|9589610|FG000|COMPLETED|Transoral Surgery||39
8557690|NCT01612351|9589610|FG000|NOT COMPLETED|Transoral Surgery||0
8557691|NCT01612351|9589610|FG000|STARTED|Post-Operative Treatment||39
8557692|NCT01612351|9589610|FG000|COMPLETED|Post-Operative Treatment|One patient completed chemotherapy then withdrew before surgery.|39
8557693|NCT01612351|9589610|FG000|NOT COMPLETED|Post-Operative Treatment||0
8557694|NCT01590628|9589621|FG000|STARTED|Overall Study||13
8557695|NCT01590628|9589622|FG001|STARTED|Overall Study||3
8557696|NCT01590628|9589621|FG000|COMPLETED|Overall Study||11
8557697|NCT01590628|9589622|FG001|COMPLETED|Overall Study||3
8557698|NCT01590628|9589621|FG000|NOT COMPLETED|Overall Study||2
8557699|NCT01590628|9589622|FG001|NOT COMPLETED|Overall Study||0
8557700|NCT01533714|9589638|FG000|STARTED|Overall Study||10
8557701|NCT01533714|9589639|FG001|STARTED|Overall Study||15
8557702|NCT01533714|9589640|FG002|STARTED|Overall Study||11
8557703|NCT01533714|9589641|FG003|STARTED|Overall Study||15
8557704|NCT01533714|9589642|FG004|STARTED|Overall Study||28
8557705|NCT01533714|9589643|FG005|STARTED|Overall Study||24
8557706|NCT01533714|9589638|FG000|COMPLETED|Overall Study||10
8557707|NCT01533714|9589639|FG001|COMPLETED|Overall Study||12
8557708|NCT01533714|9589640|FG002|COMPLETED|Overall Study||7
8557709|NCT01533714|9589641|FG003|COMPLETED|Overall Study||11
8557710|NCT01533714|9589642|FG004|COMPLETED|Overall Study||21
8557711|NCT01533714|9589643|FG005|COMPLETED|Overall Study||21
8557712|NCT01533714|9589638|FG000|NOT COMPLETED|Overall Study||0
8557713|NCT01533714|9589639|FG001|NOT COMPLETED|Overall Study||3
8557714|NCT01533714|9589640|FG002|NOT COMPLETED|Overall Study||4
8557715|NCT01533714|9589641|FG003|NOT COMPLETED|Overall Study||4
8557716|NCT01533714|9589642|FG004|NOT COMPLETED|Overall Study||7
8557717|NCT01533714|9589643|FG005|NOT COMPLETED|Overall Study||3
8708924|NCT00950807|9755111|FG005|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
8708925|NCT00950807|9755112|FG006|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|10
8708926|NCT00950807|9755113|FG007|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
8708927|NCT00950807|9755114|FG008|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
8708928|NCT00950807|9755115|FG009|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
8708929|NCT00950807|9755106|FG000|NOT COMPLETED|Washout Period 1||5
8708930|NCT00950807|9755107|FG001|NOT COMPLETED|Washout Period 1||0
8708931|NCT00950807|9755108|FG002|NOT COMPLETED|Washout Period 1||0
8708932|NCT00950807|9755109|FG003|NOT COMPLETED|Washout Period 1||1
8708933|NCT00950807|9755110|FG004|NOT COMPLETED|Washout Period 1||1
8708934|NCT00950807|9755111|FG005|NOT COMPLETED|Washout Period 1||0
8708935|NCT00950807|9755112|FG006|NOT COMPLETED|Washout Period 1||2
8708936|NCT00950807|9755113|FG007|NOT COMPLETED|Washout Period 1||1
8708937|NCT00950807|9755114|FG008|NOT COMPLETED|Washout Period 1||1
8708938|NCT00950807|9755115|FG009|NOT COMPLETED|Washout Period 1||0
8708939|NCT00950807|9755106|FG000|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|53
8708940|NCT00950807|9755107|FG001|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
8708941|NCT00950807|9755108|FG002|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|10
8708942|NCT00950807|9755109|FG003|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
8708943|NCT00950807|9755110|FG004|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
8708944|NCT00950807|9755111|FG005|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|10
8708945|NCT00950807|9755112|FG006|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|10
8708946|NCT00950807|9755113|FG007|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
8725184|NCT01029704|9772385|FG007|STARTED|Overall Study||28
8725185|NCT01029704|9772386|FG008|STARTED|Overall Study||26
8708947|NCT00950807|9755114|FG008|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|11
8708948|NCT00950807|9755115|FG009|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|11
8708949|NCT00950807|9755106|FG000|COMPLETED|Treatment Period 2||51
8708950|NCT00950807|9755107|FG001|COMPLETED|Treatment Period 2||12
8708951|NCT00950807|9755108|FG002|COMPLETED|Treatment Period 2||10
8708952|NCT00950807|9755109|FG003|COMPLETED|Treatment Period 2||12
8708953|NCT00950807|9755110|FG004|COMPLETED|Treatment Period 2||13
8708954|NCT00950807|9755111|FG005|COMPLETED|Treatment Period 2||9
8708955|NCT00950807|9755112|FG006|COMPLETED|Treatment Period 2||9
8708956|NCT00950807|9755113|FG007|COMPLETED|Treatment Period 2||10
8708957|NCT00950807|9755114|FG008|COMPLETED|Treatment Period 2||11
8708958|NCT00950807|9755115|FG009|COMPLETED|Treatment Period 2||11
8578777|NCT00178399|9611912|FG000|NOT COMPLETED|Overall Study||13
8578778|NCT00178464|9611917|FG000|STARTED|Overall Study||11
8578779|NCT00178464|9611917|FG000|COMPLETED|Overall Study||9
8578780|NCT00178464|9611917|FG000|NOT COMPLETED|Overall Study||2
8578781|NCT00178503|9611921|FG000|STARTED|MPH Trial: Placebo||24
8578782|NCT00178503|9611921|FG000|COMPLETED|MPH Trial: Placebo||24
8708959|NCT00950807|9755106|FG000|NOT COMPLETED|Treatment Period 2||2
8708960|NCT00950807|9755107|FG001|NOT COMPLETED|Treatment Period 2||1
8708961|NCT00950807|9755108|FG002|NOT COMPLETED|Treatment Period 2||0
8708962|NCT00950807|9755109|FG003|NOT COMPLETED|Treatment Period 2||1
8708963|NCT00950807|9755110|FG004|NOT COMPLETED|Treatment Period 2||0
8708964|NCT00950807|9755111|FG005|NOT COMPLETED|Treatment Period 2||1
8708965|NCT00950807|9755112|FG006|NOT COMPLETED|Treatment Period 2||1
8708966|NCT00950807|9755113|FG007|NOT COMPLETED|Treatment Period 2||3
8708967|NCT00950807|9755114|FG008|NOT COMPLETED|Treatment Period 2||0
8708968|NCT00950807|9755115|FG009|NOT COMPLETED|Treatment Period 2||0
8708969|NCT00950807|9755106|FG000|STARTED|Washout Period 2||51
8708970|NCT00950807|9755107|FG001|STARTED|Washout Period 2||12
8708971|NCT00950807|9755108|FG002|STARTED|Washout Period 2||10
8708972|NCT00950807|9755109|FG003|STARTED|Washout Period 2||12
8708973|NCT00950807|9755110|FG004|STARTED|Washout Period 2||13
8708974|NCT00950807|9755111|FG005|STARTED|Washout Period 2||9
8708975|NCT00950807|9755112|FG006|STARTED|Washout Period 2||9
8708976|NCT00950807|9755113|FG007|STARTED|Washout Period 2||10
8708977|NCT00950807|9755114|FG008|STARTED|Washout Period 2||11
8708978|NCT00950807|9755115|FG009|STARTED|Washout Period 2||11
8708979|NCT00950807|9755106|FG000|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|47
8708980|NCT00950807|9755107|FG001|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
8708981|NCT00950807|9755108|FG002|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|10
8708982|NCT00950807|9755109|FG003|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
8708983|NCT00950807|9755110|FG004|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|12
8708984|NCT00950807|9755111|FG005|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|9
8708985|NCT00950807|9755112|FG006|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|8
8557718|NCT01314118|9589657|FG000|STARTED|Overall Study||131
8557719|NCT01314118|9589657|FG000|COMPLETED|Overall Study||0
8557720|NCT01314118|9589657|FG000|NOT COMPLETED|Overall Study||131
8708986|NCT00950807|9755113|FG007|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|9
8708987|NCT00950807|9755114|FG008|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
8708988|NCT00950807|9755115|FG009|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
8708989|NCT00950807|9755106|FG000|NOT COMPLETED|Washout Period 2||4
8708990|NCT00950807|9755107|FG001|NOT COMPLETED|Washout Period 2||1
8708991|NCT00950807|9755108|FG002|NOT COMPLETED|Washout Period 2||0
8708992|NCT00950807|9755109|FG003|NOT COMPLETED|Washout Period 2||1
8708993|NCT00950807|9755110|FG004|NOT COMPLETED|Washout Period 2||1
8708994|NCT00950807|9755111|FG005|NOT COMPLETED|Washout Period 2||0
8708995|NCT00950807|9755112|FG006|NOT COMPLETED|Washout Period 2||1
8708996|NCT00950807|9755113|FG007|NOT COMPLETED|Washout Period 2||1
8708997|NCT00950807|9755114|FG008|NOT COMPLETED|Washout Period 2||0
8708998|NCT00950807|9755115|FG009|NOT COMPLETED|Washout Period 2||0
8708999|NCT00950807|9755106|FG000|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|46
8709000|NCT00950807|9755107|FG001|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|9
8725186|NCT01029704|9772378|FG000|COMPLETED|Overall Study||5
8557721|NCT01171898|9589665|FG000|STARTED|Overall Study||30
8557722|NCT01171898|9589666|FG001|STARTED|Overall Study||51
8557723|NCT01171898|9589667|FG002|STARTED|Overall Study||25
8557724|NCT01171898|9589668|FG003|STARTED|Overall Study||21
8709001|NCT00950807|9755108|FG002|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|10
8709002|NCT00950807|9755109|FG003|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|11
8725187|NCT01029704|9772379|FG001|COMPLETED|Overall Study||5
8578783|NCT00178503|9611921|FG000|NOT COMPLETED|MPH Trial: Placebo||0
8578784|NCT00178503|9611921|FG000|STARTED|MPH Trial: Low Dose||24
8578785|NCT00178503|9611921|FG000|COMPLETED|MPH Trial: Low Dose||24
8578786|NCT00178503|9611921|FG000|NOT COMPLETED|MPH Trial: Low Dose||0
8578787|NCT00178503|9611921|FG000|STARTED|MPH Trial: Med Dose||24
8578788|NCT00178503|9611921|FG000|COMPLETED|MPH Trial: Med Dose||24
8578789|NCT00178503|9611921|FG000|NOT COMPLETED|MPH Trial: Med Dose||0
8578790|NCT00178503|9611921|FG000|STARTED|MPH Trial: High Dose||24
8578791|NCT00178503|9611921|FG000|COMPLETED|MPH Trial: High Dose||24
8578792|NCT00178503|9611921|FG000|NOT COMPLETED|MPH Trial: High Dose||0
8578793|NCT00178633|9611936|FG000|STARTED|Overall Study||43
8578794|NCT00178633|9611936|FG000|COMPLETED|Overall Study||37
8578795|NCT00178633|9611936|FG000|NOT COMPLETED|Overall Study||6
8578796|NCT00178646|9611944|FG000|STARTED|Overall Study||12
8578797|NCT00178646|9611945|FG001|STARTED|Overall Study||9
8578798|NCT00178646|9611946|FG002|STARTED|Overall Study||11
8578799|NCT00178646|9611944|FG000|COMPLETED|Overall Study||12
8578800|NCT00178646|9611945|FG001|COMPLETED|Overall Study||8
8578801|NCT00178646|9611946|FG002|COMPLETED|Overall Study||10
8578802|NCT00178646|9611944|FG000|NOT COMPLETED|Overall Study||0
8578803|NCT00178646|9611945|FG001|NOT COMPLETED|Overall Study||1
8578804|NCT00178646|9611946|FG002|NOT COMPLETED|Overall Study||1
8578805|NCT00178685|9611960|FG000|STARTED|Overall Study||172
8578806|NCT00178685|9611961|FG001|STARTED|Overall Study||324
8578807|NCT00178685|9611962|FG002|STARTED|Overall Study||324
8578808|NCT00178685|9611960|FG000|COMPLETED|Overall Study||61
8578809|NCT00178685|9611961|FG001|COMPLETED|Overall Study||120
8578810|NCT00178685|9611962|FG002|COMPLETED|Overall Study||128
8578811|NCT00178685|9611960|FG000|NOT COMPLETED|Overall Study||111
8578812|NCT00178685|9611961|FG001|NOT COMPLETED|Overall Study||204
8578813|NCT00178685|9611962|FG002|NOT COMPLETED|Overall Study||196
8578814|NCT00178711|9611972|FG000|STARTED|Overall Study||52
8578815|NCT00178711|9611973|FG001|STARTED|Overall Study||45
8578816|NCT00178711|9611972|FG000|COMPLETED|Overall Study||52
8578817|NCT00178711|9611973|FG001|COMPLETED|Overall Study||45
8578818|NCT00178711|9611972|FG000|NOT COMPLETED|Overall Study||0
8578819|NCT00178711|9611973|FG001|NOT COMPLETED|Overall Study||0
8578820|NCT00178841|9611981|FG000|STARTED|Overall Study||4
8578821|NCT00178841|9611981|FG000|COMPLETED|Overall Study||4
8578822|NCT00178841|9611981|FG000|NOT COMPLETED|Overall Study||0
8578823|NCT00178919|9611988|FG000|STARTED|Overall Study||19
8578824|NCT00178919|9611989|FG001|STARTED|Overall Study||93
8578825|NCT00178919|9611988|FG000|COMPLETED|Overall Study||19
8578826|NCT00178919|9611989|FG001|COMPLETED|Overall Study||68
8578827|NCT00178919|9611988|FG000|NOT COMPLETED|Overall Study||0
8578828|NCT00178919|9611989|FG001|NOT COMPLETED|Overall Study||25
8578829|NCT00179010|9611997|FG000|STARTED|Overall Study||6
8578830|NCT00179010|9611998|FG001|STARTED|Overall Study||7
8578831|NCT00179010|9611997|FG000|COMPLETED|Overall Study||5
8578832|NCT00179010|9611998|FG001|COMPLETED|Overall Study||5
8578833|NCT00179010|9611997|FG000|NOT COMPLETED|Overall Study||1
8578834|NCT00179010|9611998|FG001|NOT COMPLETED|Overall Study||2
8578835|NCT00179309|9612007|FG000|STARTED|Treatment||25
8578836|NCT00179309|9612008|FG001|STARTED|Treatment||23
8578837|NCT00179309|9612007|FG000|COMPLETED|Treatment||21
8578838|NCT00179309|9612008|FG001|COMPLETED|Treatment||18
8578839|NCT00179309|9612007|FG000|NOT COMPLETED|Treatment||4
8578840|NCT00179309|9612008|FG001|NOT COMPLETED|Treatment||5
8578841|NCT00179309|9612007|FG000|STARTED|Crossover||0
8578842|NCT00179309|9612008|FG001|STARTED|Crossover|Crossover was allowed so that patients randomized to B could receive the vaccine upon progression.|3
8578843|NCT00179309|9612007|FG000|COMPLETED|Crossover||0
8578844|NCT00179309|9612008|FG001|COMPLETED|Crossover||3
8578845|NCT00179309|9612007|FG000|NOT COMPLETED|Crossover||0
8578846|NCT00179309|9612008|FG001|NOT COMPLETED|Crossover||0
8578847|NCT00179413|9612016|FG000|STARTED|Overall Study||282
8578848|NCT00179413|9612017|FG001|STARTED|Overall Study||267
8578849|NCT00179413|9612016|FG000|COMPLETED|Overall Study||157
8578850|NCT00179413|9612017|FG001|COMPLETED|Overall Study||152
8578851|NCT00179413|9612016|FG000|NOT COMPLETED|Overall Study||125
8578852|NCT00179413|9612017|FG001|NOT COMPLETED|Overall Study||115
8578853|NCT00179478|9612025|FG000|STARTED|Overall Study||81
8578854|NCT00179478|9612026|FG001|STARTED|Overall Study||74
8578855|NCT00179478|9612025|FG000|COMPLETED|Overall Study||68
8578856|NCT00179478|9612026|FG001|COMPLETED|Overall Study||59
8578857|NCT00179478|9612025|FG000|NOT COMPLETED|Overall Study||13
8578858|NCT00179478|9612026|FG001|NOT COMPLETED|Overall Study||15
8578859|NCT00179517|9612033|FG000|STARTED|Overall Study||20
8578860|NCT00179517|9612034|FG001|STARTED|Overall Study||20
8578861|NCT00179517|9612033|FG000|COMPLETED|Overall Study||18
8578862|NCT00179517|9612034|FG001|COMPLETED|Overall Study||19
8578863|NCT00179517|9612033|FG000|NOT COMPLETED|Overall Study||2
8578864|NCT00179517|9612034|FG001|NOT COMPLETED|Overall Study||1
8578865|NCT00179621|9612043|FG000|STARTED|Double-Blind Period||67
8578866|NCT00179621|9612044|FG001|STARTED|Double-Blind Period||69
8578867|NCT00179621|9612045|FG002|STARTED|Double-Blind Period||69
8578868|NCT00179621|9612046|FG003|STARTED|Double-Blind Period||0
8578869|NCT00179621|9612043|FG000|COMPLETED|Double-Blind Period||3
8578870|NCT00179621|9612044|FG001|COMPLETED|Double-Blind Period||23
8578871|NCT00179621|9612045|FG002|COMPLETED|Double-Blind Period||39
8928111|NCT02278328|9989243|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
8928112|NCT02278328|9989241|FG000|STARTED|Second Washout (1 Week)||9
8928113|NCT02278328|9989242|FG001|STARTED|Second Washout (1 Week)||6
8928114|NCT02278328|9989243|FG002|STARTED|Second Washout (1 Week)||6
8928115|NCT02278328|9989241|FG000|COMPLETED|Second Washout (1 Week)||9
8928116|NCT02278328|9989242|FG001|COMPLETED|Second Washout (1 Week)||6
8928117|NCT02278328|9989243|FG002|COMPLETED|Second Washout (1 Week)||6
8709003|NCT00950807|9755110|FG004|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|12
8709004|NCT00950807|9755111|FG005|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|9
8709005|NCT00950807|9755112|FG006|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|12
8709006|NCT00950807|9755113|FG007|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|10
8709007|NCT00950807|9755114|FG008|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|9
8725188|NCT01029704|9772380|FG002|COMPLETED|Overall Study||5
8725189|NCT01029704|9772381|FG003|COMPLETED|Overall Study||5
8578872|NCT00179621|9612046|FG003|COMPLETED|Double-Blind Period||0
8578873|NCT00179621|9612043|FG000|NOT COMPLETED|Double-Blind Period||64
8578874|NCT00179621|9612044|FG001|NOT COMPLETED|Double-Blind Period||46
8578875|NCT00179621|9612045|FG002|NOT COMPLETED|Double-Blind Period||30
8578876|NCT00179621|9612046|FG003|NOT COMPLETED|Double-Blind Period||0
8578877|NCT00179621|9612043|FG000|STARTED|Open-Label Period||0
8578878|NCT00179621|9612044|FG001|STARTED|Open-Label Period|'Started' includes 23 participants who completed double-blind and 19 who discontinued double-blind.|42
8709008|NCT00950807|9755115|FG009|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|11
8709009|NCT00950807|9755106|FG000|COMPLETED|Treatment Period 3||45
8709010|NCT00950807|9755107|FG001|COMPLETED|Treatment Period 3||9
8709011|NCT00950807|9755108|FG002|COMPLETED|Treatment Period 3||10
8709012|NCT00950807|9755109|FG003|COMPLETED|Treatment Period 3||11
8709013|NCT00950807|9755110|FG004|COMPLETED|Treatment Period 3||12
8578879|NCT00179621|9612045|FG002|STARTED|Open-Label Period|'Started' includes 39 participants who completed double-blind and 8 who discontinued double-blind.|47
8578880|NCT00179621|9612046|FG003|STARTED|Open-Label Period|'Started' includes 1 participant who completed double-blind and 55 who discontinued double-blind.|56
8578881|NCT00179621|9612043|FG000|COMPLETED|Open-Label Period||0
8578882|NCT00179621|9612044|FG001|COMPLETED|Open-Label Period||14
8578883|NCT00179621|9612045|FG002|COMPLETED|Open-Label Period||19
8578884|NCT00179621|9612046|FG003|COMPLETED|Open-Label Period||13
8578885|NCT00179621|9612043|FG000|NOT COMPLETED|Open-Label Period||0
8578886|NCT00179621|9612044|FG001|NOT COMPLETED|Open-Label Period||28
8578887|NCT00179621|9612045|FG002|NOT COMPLETED|Open-Label Period||28
8578888|NCT00179621|9612046|FG003|NOT COMPLETED|Open-Label Period||43
8578889|NCT00179647|9612055|FG000|STARTED|Overall Study||1913
8578890|NCT00179647|9612055|FG000|COMPLETED|Overall Study|Subjects participated in study until they presented with reason for discontinuation.|0
8578891|NCT00179647|9612055|FG000|NOT COMPLETED|Overall Study||1913
8578892|NCT00179660|9612059|FG000|STARTED|Overall Study||50
8578893|NCT00179660|9612059|FG000|Received Study Drug|Overall Study||49
8578894|NCT00179660|9612059|FG000|Completed 12 Cycles of Treatment|Overall Study||12
8578895|NCT00179660|9612059|FG000|COMPLETED|Overall Study|Completed refers to participants ongoing in the study at the time of analysis.|0
8578896|NCT00179660|9612059|FG000|NOT COMPLETED|Overall Study||50
8578897|NCT00179673|9612063|FG000|STARTED|Overall Study||43
8578898|NCT00179673|9612063|FG000|Received Study Drug|Overall Study||43
8578899|NCT00179673|9612063|FG000|COMPLETED|Overall Study|Completed refers to participants ongoing in the study at the time of analysis.|0
8578900|NCT00179673|9612063|FG000|NOT COMPLETED|Overall Study||43
8578901|NCT00179777|9612069|FG000|STARTED|Overall Study||2613
8578902|NCT00179777|9612070|FG001|STARTED|Overall Study||2543
8578903|NCT00179777|9612069|FG000|COMPLETED|Overall Study||1081
8812977|NCT01523392|9866081|FG000|STARTED|Washout Period - 10 to 14 Days|1 patient did not complete 7-9 days of Period 1 treatment but continued in the Washout and Period 2|18
8578904|NCT00179777|9612070|FG001|COMPLETED|Overall Study||1078
8578905|NCT00179777|9612069|FG000|NOT COMPLETED|Overall Study||1532
8578906|NCT00179777|9612070|FG001|NOT COMPLETED|Overall Study||1465
8709014|NCT00950807|9755111|FG005|COMPLETED|Treatment Period 3||9
8709015|NCT00950807|9755112|FG006|COMPLETED|Treatment Period 3||11
8709016|NCT00950807|9755113|FG007|COMPLETED|Treatment Period 3||9
8709017|NCT00950807|9755114|FG008|COMPLETED|Treatment Period 3||9
8709018|NCT00950807|9755115|FG009|COMPLETED|Treatment Period 3||10
8709019|NCT00950807|9755106|FG000|NOT COMPLETED|Treatment Period 3||1
8709020|NCT00950807|9755107|FG001|NOT COMPLETED|Treatment Period 3||0
8709021|NCT00950807|9755108|FG002|NOT COMPLETED|Treatment Period 3||0
8709022|NCT00950807|9755109|FG003|NOT COMPLETED|Treatment Period 3||0
8709023|NCT00950807|9755110|FG004|NOT COMPLETED|Treatment Period 3||0
8709024|NCT00950807|9755111|FG005|NOT COMPLETED|Treatment Period 3||0
8709025|NCT00950807|9755112|FG006|NOT COMPLETED|Treatment Period 3||1
8709026|NCT00950807|9755113|FG007|NOT COMPLETED|Treatment Period 3||1
8709027|NCT00950807|9755114|FG008|NOT COMPLETED|Treatment Period 3||0
8709028|NCT00950807|9755115|FG009|NOT COMPLETED|Treatment Period 3||1
8709029|NCT00950833|9755140|FG000|STARTED|Overall Study||112
8709030|NCT00950833|9755141|FG001|STARTED|Overall Study||108
8709031|NCT00950833|9755142|FG002|STARTED|Overall Study||223
8709032|NCT00950833|9755140|FG000|COMPLETED|Overall Study||112
8709033|NCT00950833|9755141|FG001|COMPLETED|Overall Study||108
8709034|NCT00950833|9755142|FG002|COMPLETED|Overall Study||223
8709035|NCT00950833|9755140|FG000|NOT COMPLETED|Overall Study||0
8709036|NCT00950833|9755141|FG001|NOT COMPLETED|Overall Study||0
8709037|NCT00950833|9755142|FG002|NOT COMPLETED|Overall Study||0
8812978|NCT01523392|9866082|FG001|STARTED|Washout Period - 10 to 14 Days||14
8812979|NCT01523392|9866081|FG000|COMPLETED|Washout Period - 10 to 14 Days||17
8812980|NCT01523392|9866082|FG001|COMPLETED|Washout Period - 10 to 14 Days||14
8812981|NCT01523392|9866081|FG000|NOT COMPLETED|Washout Period - 10 to 14 Days||1
8812982|NCT01523392|9866082|FG001|NOT COMPLETED|Washout Period - 10 to 14 Days||0
8812983|NCT01523392|9866081|FG000|STARTED|Treatment Period 2||17
8812984|NCT01523392|9866082|FG001|STARTED|Treatment Period 2||14
8812985|NCT01523392|9866081|FG000|COMPLETED|Treatment Period 2||17
8812986|NCT01523392|9866082|FG001|COMPLETED|Treatment Period 2||14
8709038|NCT00950859|9755154|FG000|STARTED|Overall Study||27
8709039|NCT00950859|9755155|FG001|STARTED|Overall Study||24
8709040|NCT00950859|9755154|FG000|COMPLETED|Overall Study||11
8709041|NCT00950859|9755155|FG001|COMPLETED|Overall Study||14
8709042|NCT00950859|9755154|FG000|NOT COMPLETED|Overall Study||16
8709043|NCT00950859|9755155|FG001|NOT COMPLETED|Overall Study||10
8709044|NCT00950872|9755161|FG000|STARTED|Overall Study||29
8709045|NCT00950872|9755161|FG000|COMPLETED|Overall Study||26
8709046|NCT00950872|9755161|FG000|NOT COMPLETED|Overall Study||3
8557725|NCT01171898|9589665|FG000|COMPLETED|Overall Study||26
8557726|NCT01171898|9589666|FG001|COMPLETED|Overall Study||32
8557727|NCT01171898|9589667|FG002|COMPLETED|Overall Study||13
8557728|NCT01171898|9589668|FG003|COMPLETED|Overall Study||15
8557729|NCT01171898|9589665|FG000|NOT COMPLETED|Overall Study||4
8557730|NCT01171898|9589666|FG001|NOT COMPLETED|Overall Study||19
8557731|NCT01171898|9589667|FG002|NOT COMPLETED|Overall Study||12
8557732|NCT01171898|9589668|FG003|NOT COMPLETED|Overall Study||6
8568814|NCT00094107|9601043|FG000|NOT COMPLETED|Overall Study||32
8568815|NCT00094172|9601049|FG000|STARTED|Overall Study|Safety Sample: 49; Intent-to-Treat Sample: 49; Per Protocol Sample: 39|50
8568816|NCT00094172|9601050|FG001|STARTED|Overall Study|Safety Sample: 32; Intent-to-Treat Sample: 32; Per Protocol Sample: 28|32
8568817|NCT00094172|9601049|FG000|COMPLETED|Overall Study||36
8568818|NCT00094172|9601050|FG001|COMPLETED|Overall Study||25
8568819|NCT00094172|9601049|FG000|NOT COMPLETED|Overall Study||14
8568820|NCT00094172|9601050|FG001|NOT COMPLETED|Overall Study||7
8568821|NCT00094211|9601060|FG000|STARTED|Overall Study||221
8568822|NCT00094211|9601061|FG001|STARTED|Overall Study||259
8568823|NCT00094211|9601062|FG002|STARTED|Overall Study||230
8568824|NCT00094211|9601063|FG003|STARTED|Overall Study||186
8568825|NCT00094211|9601060|FG000|COMPLETED|Overall Study||212
8568826|NCT00094211|9601061|FG001|COMPLETED|Overall Study||251
8568827|NCT00094211|9601062|FG002|COMPLETED|Overall Study||220
8568828|NCT00094211|9601063|FG003|COMPLETED|Overall Study||179
8568829|NCT00094211|9601060|FG000|NOT COMPLETED|Overall Study||9
8568830|NCT00094211|9601061|FG001|NOT COMPLETED|Overall Study||8
8568831|NCT00094211|9601062|FG002|NOT COMPLETED|Overall Study||10
8568832|NCT00094211|9601063|FG003|NOT COMPLETED|Overall Study||7
8568833|NCT00094302|9601079|FG000|STARTED|Overall Study||1723
8568834|NCT00094302|9601080|FG001|STARTED|Overall Study||1722
8568835|NCT00094302|9601079|FG000|COMPLETED|Overall Study||1306
8568836|NCT00094302|9601080|FG001|COMPLETED|Overall Study||1316
8709047|NCT00950911|9755167|FG000|STARTED|Overall Study||17
8709048|NCT00950911|9755168|FG001|STARTED|Overall Study||18
8709049|NCT00950911|9755167|FG000|COMPLETED|Overall Study||5
8709050|NCT00950911|9755168|FG001|COMPLETED|Overall Study||3
8709051|NCT00950911|9755167|FG000|NOT COMPLETED|Overall Study||12
8709052|NCT00950911|9755168|FG001|NOT COMPLETED|Overall Study||15
8709053|NCT00950950|9755176|FG000|STARTED|Overall Study||12
8709054|NCT00950950|9755177|FG001|STARTED|Overall Study||12
8709055|NCT00950950|9755176|FG000|COMPLETED|Overall Study||11
8709056|NCT00950950|9755177|FG001|COMPLETED|Overall Study||11
8709057|NCT00950950|9755176|FG000|NOT COMPLETED|Overall Study||1
8709058|NCT00950950|9755177|FG001|NOT COMPLETED|Overall Study||1
8709059|NCT00950963|9755186|FG000|STARTED|Overall Study|Patients were randomized from a diabetes registry and were followed as intent to treat|381
8709060|NCT00950963|9755187|FG001|STARTED|Overall Study|Patients were randomized from a diabetes registry and were followed as intent to treat|381
8709061|NCT00950963|9755186|FG000|COMPLETED|Overall Study||352
8709062|NCT00950963|9755187|FG001|COMPLETED|Overall Study||357
8709063|NCT00950963|9755186|FG000|NOT COMPLETED|Overall Study||29
8709064|NCT00950963|9755187|FG001|NOT COMPLETED|Overall Study||24
8709065|NCT00951015|9755197|FG000|STARTED|Randomization Phase 96 Week||53
8709066|NCT00951015|9755198|FG001|STARTED|Randomization Phase 96 Week||51
8709067|NCT00951015|9755199|FG002|STARTED|Randomization Phase 96 Week||51
8709068|NCT00951015|9755200|FG003|STARTED|Randomization Phase 96 Week||50
8709069|NCT00951015|9755201|FG004|STARTED|Randomization Phase 96 Week||0
8709070|NCT00951015|9755197|FG000|COMPLETED|Randomization Phase 96 Week||48
8709071|NCT00951015|9755198|FG001|COMPLETED|Randomization Phase 96 Week||44
8709072|NCT00951015|9755199|FG002|COMPLETED|Randomization Phase 96 Week||46
8709073|NCT00951015|9755200|FG003|COMPLETED|Randomization Phase 96 Week||40
8709074|NCT00951015|9755201|FG004|COMPLETED|Randomization Phase 96 Week||0
8709075|NCT00951015|9755197|FG000|NOT COMPLETED|Randomization Phase 96 Week||5
8709076|NCT00951015|9755198|FG001|NOT COMPLETED|Randomization Phase 96 Week||7
8709077|NCT00951015|9755199|FG002|NOT COMPLETED|Randomization Phase 96 Week||5
8709078|NCT00951015|9755200|FG003|NOT COMPLETED|Randomization Phase 96 Week||10
8709079|NCT00951015|9755201|FG004|NOT COMPLETED|Randomization Phase 96 Week||0
8709080|NCT00951015|9755197|FG000|STARTED|Open-label Phase||0
8709081|NCT00951015|9755198|FG001|STARTED|Open-label Phase||0
8709082|NCT00951015|9755199|FG002|STARTED|Open-label Phase||0
8709083|NCT00951015|9755200|FG003|STARTED|Open-label Phase||0
8709084|NCT00951015|9755201|FG004|STARTED|Open-label Phase||138
8709085|NCT00951015|9755197|FG000|COMPLETED|Open-label Phase||0
8709086|NCT00951015|9755198|FG001|COMPLETED|Open-label Phase||0
8709087|NCT00951015|9755199|FG002|COMPLETED|Open-label Phase||0
8709088|NCT00951015|9755200|FG003|COMPLETED|Open-label Phase||0
8709089|NCT00951015|9755201|FG004|COMPLETED|Open-label Phase||88
8709090|NCT00951015|9755197|FG000|NOT COMPLETED|Open-label Phase||0
8557733|NCT00002931|9589681|FG000|STARTED|Overall Study||48
8557734|NCT00002931|9589681|FG000|COMPLETED|Overall Study||46
8557735|NCT00002931|9589681|FG000|NOT COMPLETED|Overall Study||2
8557736|NCT00003138|9589687|FG000|STARTED|Step 1||61
8557737|NCT00003138|9589688|FG001|STARTED|Step 1||57
8557738|NCT00003138|9589687|FG000|Patients With Complete Data|Step 1||57
8557739|NCT00003138|9589688|FG001|Patients With Complete Data|Step 1||53
8557740|NCT00003138|9589687|FG000|Treated|Step 1||56
8557741|NCT00003138|9589688|FG001|Treated|Step 1||53
8557742|NCT00003138|9589687|FG000|Eligible and Treated|Step 1||52
8557743|NCT00003138|9589688|FG001|Eligible and Treated|Step 1||50
8557744|NCT00003138|9589687|FG000|Patients With QOL Data at 4 Months|Step 1||42
8557745|NCT00003138|9589688|FG001|Patients With QOL Data at 4 Months|Step 1||42
8557746|NCT00003138|9589687|FG000|Patients With Transfusion Data|Step 1||37
8557747|NCT00003138|9589688|FG001|Patients With Transfusion Data|Step 1||42
8557748|NCT00003138|9589687|FG000|COMPLETED|Step 1||0
8557749|NCT00003138|9589688|FG001|COMPLETED|Step 1||0
8557750|NCT00003138|9589687|FG000|NOT COMPLETED|Step 1||61
8557751|NCT00003138|9589688|FG001|NOT COMPLETED|Step 1||57
8557752|NCT00003138|9589687|FG000|STARTED|Step 2 (Cross Over)||26
8557753|NCT00003138|9589688|FG001|STARTED|Step 2 (Cross Over)|Only patients in the supportive care arm are eligible to cross over to the Erythropoietin arm.|0
8557754|NCT00003138|9589687|FG000|COMPLETED|Step 2 (Cross Over)||0
8557755|NCT00003138|9589688|FG001|COMPLETED|Step 2 (Cross Over)||0
8557756|NCT00003138|9589687|FG000|NOT COMPLETED|Step 2 (Cross Over)||26
8557757|NCT00003138|9589688|FG001|NOT COMPLETED|Step 2 (Cross Over)||0
8557758|NCT00003138|9589687|FG000|STARTED|Step 3 (EPO 150 Units/kg and G-CSF)||12
8557759|NCT00003138|9589688|FG001|STARTED|Step 3 (EPO 150 Units/kg and G-CSF)||20
8557760|NCT00003138|9589687|FG000|Treated|Step 3 (EPO 150 Units/kg and G-CSF)||12
8557761|NCT00003138|9589688|FG001|Treated|Step 3 (EPO 150 Units/kg and G-CSF)||19
8557762|NCT00003138|9589687|FG000|COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||0
8557763|NCT00003138|9589688|FG001|COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||0
8557764|NCT00003138|9589687|FG000|NOT COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||12
8557765|NCT00003138|9589688|FG001|NOT COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||20
8557766|NCT00003138|9589687|FG000|STARTED|Step 4 (EPO 300 Units/kg and G-CSF)||6
8557767|NCT00003138|9589688|FG001|STARTED|Step 4 (EPO 300 Units/kg and G-CSF)||7
8557768|NCT00003138|9589687|FG000|COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||0
8557769|NCT00003138|9589688|FG001|COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||0
8557770|NCT00003138|9589687|FG000|NOT COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||6
8557771|NCT00003138|9589688|FG001|NOT COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||7
8557772|NCT00003199|9589697|FG000|STARTED|Overall Study||50
8557773|NCT00003199|9589697|FG000|COMPLETED|Overall Study||28
8557774|NCT00003199|9589697|FG000|NOT COMPLETED|Overall Study||22
8557775|NCT00003222|9589703|FG000|STARTED|Overall Study||13
8557776|NCT00003222|9589704|FG001|STARTED|Overall Study||28
8557777|NCT00003222|9589703|FG000|COMPLETED|Overall Study||13
8557778|NCT00003222|9589704|FG001|COMPLETED|Overall Study|Decline in performance status between enrollment and initiation of therapy.|27
8557779|NCT00003222|9589703|FG000|NOT COMPLETED|Overall Study||0
8578907|NCT00179959|9612080|FG000|STARTED|Overall Study||15
8578908|NCT00179959|9612081|FG001|STARTED|Overall Study||16
8578909|NCT00179959|9612080|FG000|COMPLETED|Overall Study||9
8578910|NCT00179959|9612081|FG001|COMPLETED|Overall Study||13
8578911|NCT00179959|9612080|FG000|NOT COMPLETED|Overall Study||6
8578912|NCT00179959|9612081|FG001|NOT COMPLETED|Overall Study||3
8578913|NCT00179998|9612089|FG000|STARTED|Initial Period - 6 Months||12
8578914|NCT00179998|9612090|FG001|STARTED|Initial Period - 6 Months||12
8578915|NCT00179998|9612089|FG000|COMPLETED|Initial Period - 6 Months||12
8578916|NCT00179998|9612090|FG001|COMPLETED|Initial Period - 6 Months||12
8578917|NCT00179998|9612089|FG000|NOT COMPLETED|Initial Period - 6 Months||0
8578918|NCT00179998|9612090|FG001|NOT COMPLETED|Initial Period - 6 Months||0
8578919|NCT00179998|9612089|FG000|STARTED|Crossover Period - 6 Months||12
8578920|NCT00179998|9612090|FG001|STARTED|Crossover Period - 6 Months||12
8578921|NCT00179998|9612089|FG000|COMPLETED|Crossover Period - 6 Months||12
8578922|NCT00179998|9612090|FG001|COMPLETED|Crossover Period - 6 Months||10
8578923|NCT00179998|9612089|FG000|NOT COMPLETED|Crossover Period - 6 Months||0
8578924|NCT00179998|9612090|FG001|NOT COMPLETED|Crossover Period - 6 Months||2
8578925|NCT00180271|9612102|FG000|STARTED|Overall Study||1089
8578926|NCT00180271|9612103|FG001|STARTED|Overall Study||731
8578927|NCT00180271|9612102|FG000|COMPLETED|Overall Study||1089
8578928|NCT00180271|9612103|FG001|COMPLETED|Overall Study||731
8578929|NCT00180271|9612102|FG000|NOT COMPLETED|Overall Study||0
8578930|NCT00180271|9612103|FG001|NOT COMPLETED|Overall Study||0
8578931|NCT00180297|9612113|FG000|STARTED|Overall Study||107
8578932|NCT00180297|9612114|FG001|STARTED|Overall Study||108
8578933|NCT00180297|9612113|FG000|COMPLETED|Overall Study||61
8578934|NCT00180297|9612114|FG001|COMPLETED|Overall Study||67
8578935|NCT00180297|9612113|FG000|NOT COMPLETED|Overall Study||46
8578936|NCT00180297|9612114|FG001|NOT COMPLETED|Overall Study||41
8578937|NCT00180323|9612120|FG000|STARTED|Overall Study||43
8578938|NCT00180323|9612120|FG000|COMPLETED|Overall Study||43
8578939|NCT00180323|9612120|FG000|NOT COMPLETED|Overall Study||0
8578940|NCT00180479|9612128|FG000|STARTED|Overall Study||669
8578941|NCT00180479|9612129|FG001|STARTED|Overall Study|1 patient randomized never signed consent, therefore no data collected. Analysis group = 332.|333
8578942|NCT00180479|9612128|FG000|COMPLETED|Overall Study||653
8578943|NCT00180479|9612129|FG001|COMPLETED|Overall Study||320
8578944|NCT00180479|9612128|FG000|NOT COMPLETED|Overall Study||16
8578945|NCT00180479|9612129|FG001|NOT COMPLETED|Overall Study||13
8578946|NCT00180661|9612137|FG000|STARTED|Overall Study||19
8578947|NCT00180661|9612138|FG001|STARTED|Overall Study||20
8578948|NCT00180661|9612137|FG000|COMPLETED|Overall Study||19
8578949|NCT00180661|9612138|FG001|COMPLETED|Overall Study||20
8578950|NCT00180661|9612137|FG000|NOT COMPLETED|Overall Study||0
8578951|NCT00180661|9612138|FG001|NOT COMPLETED|Overall Study||0
8578952|NCT00180674|9612144|FG000|STARTED|Phase 1, Observation Period||14
8578953|NCT00180674|9612144|FG000|COMPLETED|Phase 1, Observation Period||10
8578954|NCT00180674|9612144|FG000|NOT COMPLETED|Phase 1, Observation Period||4
8578955|NCT00180674|9612144|FG000|STARTED|Phase 2, Warfarin Treatment Period||10
8578956|NCT00180674|9612144|FG000|COMPLETED|Phase 2, Warfarin Treatment Period||9
8578957|NCT00180674|9612144|FG000|NOT COMPLETED|Phase 2, Warfarin Treatment Period||1
8627575|NCT00519376|9667185|FG015|COMPLETED|Washout Period 1||1
8627576|NCT00519376|9667170|FG000|NOT COMPLETED|Washout Period 1||0
8627577|NCT00519376|9667171|FG001|NOT COMPLETED|Washout Period 1||0
8578958|NCT00180687|9612156|FG000|STARTED|Overall Study||20
8578959|NCT00180687|9612157|FG001|STARTED|Overall Study||20
8578960|NCT00180687|9612158|FG002|STARTED|Overall Study||20
8578961|NCT00180687|9612159|FG003|STARTED|Overall Study||20
8578962|NCT00180687|9612156|FG000|COMPLETED|Overall Study||20
8578963|NCT00180687|9612157|FG001|COMPLETED|Overall Study||20
8578964|NCT00180687|9612158|FG002|COMPLETED|Overall Study||20
8578965|NCT00180687|9612159|FG003|COMPLETED|Overall Study||20
8578966|NCT00180687|9612156|FG000|NOT COMPLETED|Overall Study||0
8578967|NCT00180687|9612157|FG001|NOT COMPLETED|Overall Study||0
8578968|NCT00180687|9612158|FG002|NOT COMPLETED|Overall Study||0
8578969|NCT00180687|9612159|FG003|NOT COMPLETED|Overall Study||0
8578970|NCT00180713|9612171|FG000|STARTED|Overall Study||23
8578971|NCT00180713|9612172|FG001|STARTED|Overall Study||19
8578972|NCT00180713|9612171|FG000|COMPLETED|Overall Study||18
8578973|NCT00180713|9612172|FG001|COMPLETED|Overall Study||16
8578974|NCT00180713|9612171|FG000|NOT COMPLETED|Overall Study||5
8578975|NCT00180713|9612172|FG001|NOT COMPLETED|Overall Study||3
8578976|NCT00181155|9612178|FG000|STARTED|Overall Study||15
8578977|NCT00181155|9612179|FG001|STARTED|Overall Study||3
8578978|NCT00181155|9612178|FG000|COMPLETED|Overall Study||13
8578979|NCT00181155|9612179|FG001|COMPLETED|Overall Study||3
8578980|NCT00181155|9612178|FG000|NOT COMPLETED|Overall Study||2
8578981|NCT00181155|9612179|FG001|NOT COMPLETED|Overall Study||0
8578982|NCT00181168|9612188|FG000|STARTED|Overall Study||30
8578983|NCT00181168|9612189|FG001|STARTED|Overall Study||33
8578984|NCT00181168|9612188|FG000|COMPLETED|Overall Study||30
8578985|NCT00181168|9612189|FG001|COMPLETED|Overall Study||33
8578986|NCT00181168|9612188|FG000|NOT COMPLETED|Overall Study||0
8578987|NCT00181168|9612189|FG001|NOT COMPLETED|Overall Study||0
8578988|NCT00181207|9612197|FG000|STARTED|Overall Study||24
8578989|NCT00181207|9612198|FG001|STARTED|Overall Study||26
8578990|NCT00181207|9612197|FG000|COMPLETED|Overall Study||24
8578991|NCT00181207|9612198|FG001|COMPLETED|Overall Study||26
8578992|NCT00181207|9612197|FG000|NOT COMPLETED|Overall Study||0
8578993|NCT00181207|9612198|FG001|NOT COMPLETED|Overall Study||0
8578994|NCT00181285|9612206|FG000|STARTED|Overall Study||27
8578995|NCT00181285|9612207|FG001|STARTED|Overall Study||25
8578996|NCT00181285|9612206|FG000|COMPLETED|Overall Study||27
8578997|NCT00181285|9612207|FG001|COMPLETED|Overall Study||25
8578998|NCT00181285|9612206|FG000|NOT COMPLETED|Overall Study||0
8578999|NCT00181285|9612207|FG001|NOT COMPLETED|Overall Study||0
8579000|NCT00181363|9612213|FG000|STARTED|Overall Study|10|10
8579001|NCT00181363|9612213|FG000|COMPLETED|Overall Study||10
8579002|NCT00181363|9612213|FG000|NOT COMPLETED|Overall Study||0
8579003|NCT00181610|9612223|FG000|STARTED|Overall Study||4
8579004|NCT00181610|9612224|FG001|STARTED|Overall Study||4
8579005|NCT00181610|9612225|FG002|STARTED|Overall Study||3
8579006|NCT00181610|9612223|FG000|COMPLETED|Overall Study||4
8579007|NCT00181610|9612224|FG001|COMPLETED|Overall Study||3
8579008|NCT00181610|9612225|FG002|COMPLETED|Overall Study||3
8579009|NCT00181610|9612223|FG000|NOT COMPLETED|Overall Study||0
8579010|NCT00181610|9612224|FG001|NOT COMPLETED|Overall Study||1
8579011|NCT00181610|9612225|FG002|NOT COMPLETED|Overall Study||0
8579012|NCT00181623|9612234|FG000|STARTED|Overall Study||6
8579013|NCT00181623|9612234|FG000|COMPLETED|Overall Study||5
8579014|NCT00181623|9612234|FG000|NOT COMPLETED|Overall Study||1
8579015|NCT00181714|9612239|FG000|STARTED|Signed Consent/Enrolled||203
8579016|NCT00181714|9612239|FG000|COMPLETED|Signed Consent/Enrolled||154
8579017|NCT00181714|9612239|FG000|NOT COMPLETED|Signed Consent/Enrolled||49
8579018|NCT00181714|9612239|FG000|STARTED|Began Treatment With OROS-MPH||154
8579019|NCT00181714|9612239|FG000|COMPLETED|Began Treatment With OROS-MPH||30
8579020|NCT00181714|9612239|FG000|NOT COMPLETED|Began Treatment With OROS-MPH||124
8579021|NCT00181766|9612243|FG000|STARTED|Overall Study|Number of subjects enrolled and treated with Atomoxetine.|45
8579022|NCT00181766|9612243|FG000|COMPLETED|Overall Study|Completed the trial.|33
8579023|NCT00181766|9612243|FG000|NOT COMPLETED|Overall Study||12
8579024|NCT00181844|9612247|FG000|STARTED|Signed Consent||51
8579025|NCT00181844|9612247|FG000|COMPLETED|Signed Consent||39
8579026|NCT00181844|9612247|FG000|NOT COMPLETED|Signed Consent||12
8579027|NCT00181844|9612247|FG000|STARTED|Exposed to Study Medication||39
8579028|NCT00181844|9612247|FG000|COMPLETED|Exposed to Study Medication||22
8579029|NCT00181844|9612247|FG000|NOT COMPLETED|Exposed to Study Medication||17
8579030|NCT00181883|9612251|FG000|STARTED|Overall Study||30
8579031|NCT00181883|9612251|FG000|COMPLETED|Overall Study||20
8579032|NCT00181883|9612251|FG000|NOT COMPLETED|Overall Study||10
8579033|NCT00181961|9612257|FG000|STARTED|Overall Study||7
8579034|NCT00181961|9612258|FG001|STARTED|Overall Study||9
8579035|NCT00181961|9612257|FG000|COMPLETED|Overall Study||6
8579036|NCT00181961|9612258|FG001|COMPLETED|Overall Study||4
8579037|NCT00181961|9612257|FG000|NOT COMPLETED|Overall Study||1
8579038|NCT00181961|9612258|FG001|NOT COMPLETED|Overall Study||5
8579039|NCT00182000|9612266|FG000|STARTED|Overall Study||14
8579040|NCT00182000|9612267|FG001|STARTED|Overall Study||15
8579041|NCT00182000|9612266|FG000|COMPLETED|Overall Study||9
8579042|NCT00182000|9612267|FG001|COMPLETED|Overall Study||13
8579043|NCT00182000|9612266|FG000|NOT COMPLETED|Overall Study||5
8579044|NCT00182000|9612267|FG001|NOT COMPLETED|Overall Study||2
8579045|NCT00182078|9612275|FG000|STARTED|Overall Study||9
8579046|NCT00182078|9612276|FG001|STARTED|Overall Study||17
8579047|NCT00182078|9612275|FG000|COMPLETED|Overall Study||8
8579048|NCT00182078|9612276|FG001|COMPLETED|Overall Study||17
8579049|NCT00182078|9612275|FG000|NOT COMPLETED|Overall Study||1
8579050|NCT00182078|9612276|FG001|NOT COMPLETED|Overall Study||0
8579051|NCT00182091|9612286|FG000|STARTED|Overall Study||15
8579052|NCT00182091|9612287|FG001|STARTED|Overall Study||15
8579053|NCT00182091|9612288|FG002|STARTED|Overall Study||25
8579054|NCT00182091|9612289|FG003|STARTED|Overall Study||20
8579055|NCT00182091|9612286|FG000|COMPLETED|Overall Study||14
8579056|NCT00182091|9612287|FG001|COMPLETED|Overall Study||15
8579057|NCT00182091|9612288|FG002|COMPLETED|Overall Study||25
8579058|NCT00182091|9612289|FG003|COMPLETED|Overall Study||20
8579059|NCT00182091|9612286|FG000|NOT COMPLETED|Overall Study||1
8579060|NCT00182091|9612287|FG001|NOT COMPLETED|Overall Study||0
8579061|NCT00182091|9612288|FG002|NOT COMPLETED|Overall Study||0
8579062|NCT00182091|9612289|FG003|NOT COMPLETED|Overall Study||0
8579063|NCT00182325|9612299|FG000|STARTED|Overall Study||97
8579064|NCT00182325|9612300|FG001|STARTED|Overall Study||96
8579065|NCT00182325|9612299|FG000|COMPLETED|Overall Study|63 completed survey, 85 included in intention-to-treat analysis|63
8579066|NCT00182325|9612300|FG001|COMPLETED|Overall Study|43 completed survey, 89 included in intention-to-treat analysis|43
8579067|NCT00182325|9612299|FG000|NOT COMPLETED|Overall Study||34
8579068|NCT00182325|9612300|FG001|NOT COMPLETED|Overall Study||53
8579069|NCT00182689|9612308|FG000|STARTED|Overall Study||40
8579070|NCT00182689|9612309|FG001|STARTED|Overall Study||49
8579071|NCT00182689|9612308|FG000|Eligible|Overall Study||39
8579072|NCT00182689|9612309|FG001|Eligible|Overall Study||45
8579073|NCT00182689|9612308|FG000|Eligible and Began Protocol Therapy|Overall Study||38
8579074|NCT00182689|9612309|FG001|Eligible and Began Protocol Therapy|Overall Study||45
8579075|NCT00182689|9612308|FG000|COMPLETED|Overall Study||0
8579076|NCT00182689|9612309|FG001|COMPLETED|Overall Study||0
8579077|NCT00182689|9612308|FG000|NOT COMPLETED|Overall Study||40
8579078|NCT00182689|9612309|FG001|NOT COMPLETED|Overall Study||49
8579079|NCT00182754|9612321|FG000|STARTED|Overall Study||16
8709091|NCT00951015|9755198|FG001|NOT COMPLETED|Open-label Phase||0
8709092|NCT00951015|9755199|FG002|NOT COMPLETED|Open-label Phase||0
8709093|NCT00951015|9755200|FG003|NOT COMPLETED|Open-label Phase||0
8709094|NCT00951015|9755201|FG004|NOT COMPLETED|Open-label Phase||50
8709095|NCT00951041|9755226|FG000|STARTED|Overall Study||64
8709096|NCT00951041|9755227|FG001|STARTED|Overall Study||66
8709097|NCT00951041|9755226|FG000|COMPLETED|Overall Study||59
8579080|NCT00182754|9612322|FG001|STARTED|Overall Study||17
8579081|NCT00182754|9612321|FG000|COMPLETED|Overall Study||16
8579082|NCT00182754|9612322|FG001|COMPLETED|Overall Study||17
8579083|NCT00182754|9612321|FG000|NOT COMPLETED|Overall Study||0
8579084|NCT00182754|9612322|FG001|NOT COMPLETED|Overall Study||0
8579085|NCT00182767|9612328|FG000|STARTED|Overall Study||6
8579086|NCT00182767|9612329|FG001|STARTED|Overall Study||6
8579087|NCT00182767|9612330|FG002|STARTED|Overall Study||6
8579088|NCT00182767|9612331|FG003|STARTED|Overall Study||3
8579089|NCT00182767|9612332|FG004|STARTED|Overall Study||24
8579090|NCT00182767|9612328|FG000|COMPLETED|Overall Study||6
8579091|NCT00182767|9612329|FG001|COMPLETED|Overall Study||6
8579092|NCT00182767|9612330|FG002|COMPLETED|Overall Study||6
8579093|NCT00182767|9612331|FG003|COMPLETED|Overall Study||3
8579094|NCT00182767|9612332|FG004|COMPLETED|Overall Study||24
8579095|NCT00182767|9612328|FG000|NOT COMPLETED|Overall Study||0
8579096|NCT00182767|9612329|FG001|NOT COMPLETED|Overall Study||0
8579097|NCT00182767|9612330|FG002|NOT COMPLETED|Overall Study||0
8579098|NCT00182767|9612331|FG003|NOT COMPLETED|Overall Study||0
8579099|NCT00182767|9612332|FG004|NOT COMPLETED|Overall Study||0
8579100|NCT00182793|9612346|FG000|STARTED|Overall Study||32
8579101|NCT00182793|9612346|FG000|COMPLETED|Overall Study||32
8579102|NCT00182793|9612346|FG000|NOT COMPLETED|Overall Study||0
8579103|NCT00183092|9612352|FG000|STARTED|Double-blind (Baseline - Month 2)||23
8579104|NCT00183092|9612353|FG001|STARTED|Double-blind (Baseline - Month 2)||28
8579105|NCT00183092|9612354|FG002|STARTED|Double-blind (Baseline - Month 2)||0
8579106|NCT00183092|9612355|FG003|STARTED|Double-blind (Baseline - Month 2)||0
8579107|NCT00183092|9612352|FG000|Alive at Month 2|Double-blind (Baseline - Month 2)||13
8579108|NCT00183092|9612353|FG001|Alive at Month 2|Double-blind (Baseline - Month 2)||19
8579109|NCT00183092|9612354|FG002|Alive at Month 2|Double-blind (Baseline - Month 2)||0
8579110|NCT00183092|9612355|FG003|Alive at Month 2|Double-blind (Baseline - Month 2)||0
8579111|NCT00183092|9612352|FG000|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||10
8579112|NCT00183092|9612353|FG001|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||16
8579113|NCT00183092|9612354|FG002|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||0
8579114|NCT00183092|9612355|FG003|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||0
8579115|NCT00183092|9612352|FG000|COMPLETED|Double-blind (Baseline - Month 2)||11
8579116|NCT00183092|9612353|FG001|COMPLETED|Double-blind (Baseline - Month 2)||16
8579117|NCT00183092|9612354|FG002|COMPLETED|Double-blind (Baseline - Month 2)||0
8579118|NCT00183092|9612355|FG003|COMPLETED|Double-blind (Baseline - Month 2)||0
8579119|NCT00183092|9612352|FG000|NOT COMPLETED|Double-blind (Baseline - Month 2)||12
8579120|NCT00183092|9612353|FG001|NOT COMPLETED|Double-blind (Baseline - Month 2)||12
8579121|NCT00183092|9612354|FG002|NOT COMPLETED|Double-blind (Baseline - Month 2)||0
8579122|NCT00183092|9612355|FG003|NOT COMPLETED|Double-blind (Baseline - Month 2)||0
8579123|NCT00183092|9612352|FG000|STARTED|Open-label Period (Month 2 Until Death)|Participants initially assigned to Quinacrine opted to begin open-label Quinacrine at Month 2|10
8709098|NCT00951041|9755227|FG001|COMPLETED|Overall Study||65
8709099|NCT00951041|9755226|FG000|NOT COMPLETED|Overall Study||5
8579124|NCT00183092|9612353|FG001|STARTED|Open-label Period (Month 2 Until Death)|Participants initially assigned to Placebo opted to begin open-label Quinacrine at Month 2|14
8579125|NCT00183092|9612354|FG002|STARTED|Open-label Period (Month 2 Until Death)|Participants assigned to Quinacrine opted to continue assigned drug during open-label period|1
8579126|NCT00183092|9612355|FG003|STARTED|Open-label Period (Month 2 Until Death)|Participants assigned to Placebo opted to continue assigned drug during open-label period|1
8579127|NCT00183092|9612352|FG000|COMPLETED|Open-label Period (Month 2 Until Death)||0
8579128|NCT00183092|9612353|FG001|COMPLETED|Open-label Period (Month 2 Until Death)||0
8579129|NCT00183092|9612354|FG002|COMPLETED|Open-label Period (Month 2 Until Death)||0
8579130|NCT00183092|9612355|FG003|COMPLETED|Open-label Period (Month 2 Until Death)||0
8579131|NCT00183092|9612352|FG000|NOT COMPLETED|Open-label Period (Month 2 Until Death)||10
8579132|NCT00183092|9612353|FG001|NOT COMPLETED|Open-label Period (Month 2 Until Death)||14
8579133|NCT00183092|9612354|FG002|NOT COMPLETED|Open-label Period (Month 2 Until Death)||1
8579134|NCT00183092|9612355|FG003|NOT COMPLETED|Open-label Period (Month 2 Until Death)||1
8579135|NCT00183170|9612364|FG000|STARTED|First Intervention||103
8579136|NCT00183170|9612365|FG001|STARTED|First Intervention||109
8579137|NCT00183170|9612364|FG000|COMPLETED|First Intervention||101
8579138|NCT00183170|9612365|FG001|COMPLETED|First Intervention||109
8579139|NCT00183170|9612364|FG000|NOT COMPLETED|First Intervention||2
8579140|NCT00183170|9612365|FG001|NOT COMPLETED|First Intervention||0
8579141|NCT00183170|9612364|FG000|STARTED|Washout 1 Week||101
8579142|NCT00183170|9612365|FG001|STARTED|Washout 1 Week||109
8579143|NCT00183170|9612364|FG000|COMPLETED|Washout 1 Week||95
8579144|NCT00183170|9612365|FG001|COMPLETED|Washout 1 Week||101
8579145|NCT00183170|9612364|FG000|NOT COMPLETED|Washout 1 Week||6
8579146|NCT00183170|9612365|FG001|NOT COMPLETED|Washout 1 Week||8
8579147|NCT00183170|9612364|FG000|STARTED|Second Intervention||95
8579148|NCT00183170|9612365|FG001|STARTED|Second Intervention||101
8579149|NCT00183170|9612364|FG000|COMPLETED|Second Intervention||94
8579150|NCT00183170|9612365|FG001|COMPLETED|Second Intervention||99
8579151|NCT00183170|9612364|FG000|NOT COMPLETED|Second Intervention||1
8579152|NCT00183170|9612365|FG001|NOT COMPLETED|Second Intervention||2
8579153|NCT00183196|9612374|FG000|STARTED|Overall Study|2 subjects had no post-randomization data|50
8579154|NCT00183196|9612375|FG001|STARTED|Overall Study|1 subject had no post-randomization data|50
8579155|NCT00183196|9612376|FG002|STARTED|Overall Study|1 subject had no post-randomization data|50
8579156|NCT00183196|9612374|FG000|COMPLETED|Overall Study||30
8579157|NCT00183196|9612375|FG001|COMPLETED|Overall Study||35
8579158|NCT00183196|9612376|FG002|COMPLETED|Overall Study||32
8579159|NCT00183196|9612374|FG000|NOT COMPLETED|Overall Study||20
8579160|NCT00183196|9612375|FG001|NOT COMPLETED|Overall Study||15
8579161|NCT00183196|9612376|FG002|NOT COMPLETED|Overall Study||18
8579162|NCT00183248|9612386|FG000|STARTED|Overall Study||4
8579163|NCT00183248|9612387|FG001|STARTED|Overall Study||5
8579164|NCT00183248|9612386|FG000|COMPLETED|Overall Study||3
8579165|NCT00183248|9612387|FG001|COMPLETED|Overall Study||4
8579166|NCT00183248|9612386|FG000|NOT COMPLETED|Overall Study||1
8579167|NCT00183248|9612387|FG001|NOT COMPLETED|Overall Study||1
8579168|NCT00183274|9612393|FG000|STARTED|Phase 1: Open-Label||268
8579169|NCT00183274|9612394|FG001|STARTED|Phase 1: Open-Label||0
8579170|NCT00183274|9612395|FG002|STARTED|Phase 1: Open-Label||0
8579171|NCT00183274|9612396|FG003|STARTED|Phase 1: Open-Label||0
8579172|NCT00183274|9612397|FG004|STARTED|Phase 1: Open-Label||0
8579173|NCT00183274|9612398|FG005|STARTED|Phase 1: Open-Label||0
8579174|NCT00183274|9612393|FG000|COMPLETED|Phase 1: Open-Label|110 dropouts during phase 1|158
8579175|NCT00183274|9612394|FG001|COMPLETED|Phase 1: Open-Label||0
8579176|NCT00183274|9612395|FG002|COMPLETED|Phase 1: Open-Label||0
8579177|NCT00183274|9612396|FG003|COMPLETED|Phase 1: Open-Label||0
8579178|NCT00183274|9612397|FG004|COMPLETED|Phase 1: Open-Label||0
8579179|NCT00183274|9612398|FG005|COMPLETED|Phase 1: Open-Label||0
8579180|NCT00183274|9612393|FG000|NOT COMPLETED|Phase 1: Open-Label||110
8579181|NCT00183274|9612394|FG001|NOT COMPLETED|Phase 1: Open-Label||0
8579182|NCT00183274|9612395|FG002|NOT COMPLETED|Phase 1: Open-Label||0
8579183|NCT00183274|9612396|FG003|NOT COMPLETED|Phase 1: Open-Label||0
8579184|NCT00183274|9612397|FG004|NOT COMPLETED|Phase 1: Open-Label||0
8579185|NCT00183274|9612398|FG005|NOT COMPLETED|Phase 1: Open-Label||0
8579186|NCT00183274|9612393|FG000|STARTED|Phase 2: Double-Blind|This phase ended after 6 months. There were no longer participants in this phase.|0
8579187|NCT00183274|9612394|FG001|STARTED|Phase 2: Double-Blind|22 did not enter phase 2 due to lack of efficacy and withdrawal of consent|82
8579188|NCT00183274|9612395|FG002|STARTED|Phase 2: Double-Blind|22 did not enter phase 2 due to lack of efficacy and withdrawal of consent|54
8579189|NCT00183274|9612396|FG003|STARTED|Phase 2: Double-Blind||0
8579190|NCT00183274|9612397|FG004|STARTED|Phase 2: Double-Blind||0
8579191|NCT00183274|9612398|FG005|STARTED|Phase 2: Double-Blind||0
8579192|NCT00183274|9612393|FG000|COMPLETED|Phase 2: Double-Blind||0
8579193|NCT00183274|9612394|FG001|COMPLETED|Phase 2: Double-Blind|8 lost to relapse, 18 lost to dropout|56
8579194|NCT00183274|9612395|FG002|COMPLETED|Phase 2: Double-Blind|29 lost to relapse, 14 lost to dropout|11
8579195|NCT00183274|9612396|FG003|COMPLETED|Phase 2: Double-Blind||0
8579196|NCT00183274|9612397|FG004|COMPLETED|Phase 2: Double-Blind||0
8579197|NCT00183274|9612398|FG005|COMPLETED|Phase 2: Double-Blind||0
8579198|NCT00183274|9612393|FG000|NOT COMPLETED|Phase 2: Double-Blind||0
8579199|NCT00183274|9612394|FG001|NOT COMPLETED|Phase 2: Double-Blind||26
8579200|NCT00183274|9612395|FG002|NOT COMPLETED|Phase 2: Double-Blind||43
8579201|NCT00183274|9612396|FG003|NOT COMPLETED|Phase 2: Double-Blind||0
8579202|NCT00183274|9612397|FG004|NOT COMPLETED|Phase 2: Double-Blind||0
8579203|NCT00183274|9612398|FG005|NOT COMPLETED|Phase 2: Double-Blind||0
8579204|NCT00183274|9612393|FG000|STARTED|Phase 3: Double-Blind||0
8579205|NCT00183274|9612394|FG001|STARTED|Phase 3: Double-Blind|Phase 2 ended at the end of 12 months of study.|0
8579206|NCT00183274|9612395|FG002|STARTED|Phase 3: Double-Blind|Phase 2 ended at the end of 12 months of study.|0
8579207|NCT00183274|9612396|FG003|STARTED|Phase 3: Double-Blind|8 completed Phase 2 but did not enter phase 3|15
8579208|NCT00183274|9612397|FG004|STARTED|Phase 3: Double-Blind|8 completed Phase 2 but did not enter phase 3|34
8579209|NCT00183274|9612398|FG005|STARTED|Phase 3: Double-Blind|8 completed Phase 2 but did not enter phase 3|10
8579210|NCT00183274|9612393|FG000|COMPLETED|Phase 3: Double-Blind||0
8579211|NCT00183274|9612394|FG001|COMPLETED|Phase 3: Double-Blind||0
8579212|NCT00183274|9612395|FG002|COMPLETED|Phase 3: Double-Blind||0
8579213|NCT00183274|9612396|FG003|COMPLETED|Phase 3: Double-Blind|1 lost to relapse and 1 lost to dropout|13
8579214|NCT00183274|9612397|FG004|COMPLETED|Phase 3: Double-Blind|11 lost to relapse and 9 lost to dropout|14
8579215|NCT00183274|9612398|FG005|COMPLETED|Phase 3: Double-Blind|2 lost to relapse and 2 lost to dropout|6
8579216|NCT00183274|9612393|FG000|NOT COMPLETED|Phase 3: Double-Blind||0
8579217|NCT00183274|9612394|FG001|NOT COMPLETED|Phase 3: Double-Blind||0
8579218|NCT00183274|9612395|FG002|NOT COMPLETED|Phase 3: Double-Blind||0
8579219|NCT00183274|9612396|FG003|NOT COMPLETED|Phase 3: Double-Blind||2
8579220|NCT00183274|9612397|FG004|NOT COMPLETED|Phase 3: Double-Blind||20
8579221|NCT00183274|9612398|FG005|NOT COMPLETED|Phase 3: Double-Blind||4
8579222|NCT00183339|9612415|FG000|STARTED|Overall Study||10
8579223|NCT00183339|9612416|FG001|STARTED|Overall Study||8
8579224|NCT00183339|9612415|FG000|COMPLETED|Overall Study||4
8579225|NCT00183339|9612416|FG001|COMPLETED|Overall Study||4
8579226|NCT00183339|9612415|FG000|NOT COMPLETED|Overall Study||6
8579227|NCT00183339|9612416|FG001|NOT COMPLETED|Overall Study||4
8579228|NCT00183391|9612427|FG000|STARTED|Block 1 - 5 Weeks||108
8579229|NCT00183391|9612428|FG001|STARTED|Block 1 - 5 Weeks||124
8579230|NCT00183391|9612427|FG000|COMPLETED|Block 1 - 5 Weeks||95
8579231|NCT00183391|9612428|FG001|COMPLETED|Block 1 - 5 Weeks||110
8579232|NCT00183391|9612427|FG000|NOT COMPLETED|Block 1 - 5 Weeks||13
8579233|NCT00183391|9612428|FG001|NOT COMPLETED|Block 1 - 5 Weeks||14
8579234|NCT00183391|9612427|FG000|STARTED|Crossover Placebo - 2 Weeks||95
8579235|NCT00183391|9612428|FG001|STARTED|Crossover Placebo - 2 Weeks||110
8579236|NCT00183391|9612427|FG000|COMPLETED|Crossover Placebo - 2 Weeks||95
8579237|NCT00183391|9612428|FG001|COMPLETED|Crossover Placebo - 2 Weeks||110
8579238|NCT00183391|9612427|FG000|NOT COMPLETED|Crossover Placebo - 2 Weeks||0
8579239|NCT00183391|9612428|FG001|NOT COMPLETED|Crossover Placebo - 2 Weeks||0
8579240|NCT00183391|9612427|FG000|STARTED|Block 2 - 5 Weeks||95
8579241|NCT00183391|9612428|FG001|STARTED|Block 2 - 5 Weeks||110
8579242|NCT00183391|9612427|FG000|COMPLETED|Block 2 - 5 Weeks||91
8579243|NCT00183391|9612428|FG001|COMPLETED|Block 2 - 5 Weeks||108
8579244|NCT00183391|9612427|FG000|NOT COMPLETED|Block 2 - 5 Weeks||4
8579245|NCT00183391|9612428|FG001|NOT COMPLETED|Block 2 - 5 Weeks||2
8579246|NCT00183430|9612438|FG000|STARTED|Overall Study||9
8579247|NCT00183430|9612439|FG001|STARTED|Overall Study||11
8579248|NCT00183430|9612438|FG000|COMPLETED|Overall Study||3
8579249|NCT00183430|9612439|FG001|COMPLETED|Overall Study||11
8579250|NCT00183430|9612438|FG000|NOT COMPLETED|Overall Study||6
8579251|NCT00183430|9612439|FG001|NOT COMPLETED|Overall Study||0
8579252|NCT00183443|9612448|FG000|STARTED|Overall Study||24
8579253|NCT00183443|9612449|FG001|STARTED|Overall Study||26
8579254|NCT00183443|9612450|FG002|STARTED|Overall Study||25
8579255|NCT00183443|9612448|FG000|COMPLETED|Overall Study|13 eligible participants were offered enrollment in the continuation phase|24
8627578|NCT00519376|9667172|FG002|NOT COMPLETED|Washout Period 1||0
8709100|NCT00951041|9755227|FG001|NOT COMPLETED|Overall Study||1
8709101|NCT00951080|9755236|FG000|STARTED|Overall Study||64
8709102|NCT00951080|9755237|FG001|STARTED|Overall Study||68
8709103|NCT00951080|9755236|FG000|COMPLETED|Overall Study||38
8709104|NCT00951080|9755237|FG001|COMPLETED|Overall Study||41
8709105|NCT00951080|9755236|FG000|NOT COMPLETED|Overall Study||26
8709106|NCT00951080|9755237|FG001|NOT COMPLETED|Overall Study||27
8709107|NCT00951093|9755243|FG000|STARTED|Before GBP||53
8709108|NCT00951093|9755243|FG000|COMPLETED|Before GBP||53
8709109|NCT00951093|9755243|FG000|NOT COMPLETED|Before GBP||0
8709110|NCT00951093|9755243|FG000|STARTED|6 Months After GBP||53
8709111|NCT00951093|9755243|FG000|COMPLETED|6 Months After GBP||53
8709112|NCT00951093|9755243|FG000|NOT COMPLETED|6 Months After GBP||0
8709113|NCT00951171|9755251|FG000|STARTED|Overall Study||40
8709114|NCT00951171|9755252|FG001|STARTED|Overall Study||55
8709115|NCT00951171|9755251|FG000|Pregnancy|Overall Study||1
8709116|NCT00951171|9755252|FG001|Pregnancy|Overall Study||7
8709117|NCT00951171|9755251|FG000|COMPLETED|Overall Study||38
8709118|NCT00951171|9755252|FG001|COMPLETED|Overall Study|2 of the cervical occlusion group transferred to standard group because of pain during attempted IUI|55
8709119|NCT00951171|9755251|FG000|NOT COMPLETED|Overall Study||2
8709120|NCT00951171|9755252|FG001|NOT COMPLETED|Overall Study||0
8709121|NCT00951275|9755258|FG000|STARTED|Overall Study||105
8709122|NCT00951275|9755258|FG000|COMPLETED|Overall Study||92
8709123|NCT00951275|9755258|FG000|NOT COMPLETED|Overall Study||13
8709124|NCT00951379|9755264|FG000|STARTED|Overall Study||27
8709125|NCT00951379|9755265|FG001|STARTED|Overall Study||25
8709126|NCT00951379|9755264|FG000|COMPLETED|Overall Study||21
8709127|NCT00951379|9755265|FG001|COMPLETED|Overall Study||23
8709128|NCT00951379|9755264|FG000|NOT COMPLETED|Overall Study||6
8579256|NCT00183443|9612449|FG001|COMPLETED|Overall Study|8 eligible participants were offered enrollment in the continuation phase|26
8579257|NCT00183443|9612450|FG002|COMPLETED|Overall Study|4 eligible participants were offered enrollment in the continuation phase|25
8579258|NCT00183443|9612448|FG000|NOT COMPLETED|Overall Study||0
8579259|NCT00183443|9612449|FG001|NOT COMPLETED|Overall Study||0
8579260|NCT00183443|9612450|FG002|NOT COMPLETED|Overall Study||0
8579261|NCT00183456|9612462|FG000|STARTED|Overall Study||85
8579262|NCT00183456|9612463|FG001|STARTED|Overall Study||84
8579263|NCT00183456|9612464|FG002|STARTED|Overall Study||329
8579264|NCT00183456|9612465|FG003|STARTED|Overall Study||248
8579265|NCT00183456|9612462|FG000|6 Month Follow-up|Overall Study||74
8579266|NCT00183456|9612463|FG001|6 Month Follow-up|Overall Study||77
8579267|NCT00183456|9612464|FG002|6 Month Follow-up|Overall Study||278
8579268|NCT00183456|9612465|FG003|6 Month Follow-up|Overall Study||175
8579269|NCT00183456|9612462|FG000|12 Month Follow-up|Overall Study||76
8579270|NCT00183456|9612463|FG001|12 Month Follow-up|Overall Study||74
8579271|NCT00183456|9612464|FG002|12 Month Follow-up|Overall Study||267
8579272|NCT00183456|9612465|FG003|12 Month Follow-up|Overall Study||186
8579273|NCT00183456|9612462|FG000|18 Month Follow-up|Overall Study||80
8579274|NCT00183456|9612463|FG001|18 Month Follow-up|Overall Study||81
8579275|NCT00183456|9612464|FG002|18 Month Follow-up|Overall Study||303
8579276|NCT00183456|9612465|FG003|18 Month Follow-up|Overall Study||207
8579277|NCT00183456|9612462|FG000|COMPLETED|Overall Study|total # of intervention participants that completed any follow-up (6, 12, or 18 month Follow-up)|82
8579278|NCT00183456|9612463|FG001|COMPLETED|Overall Study|total # of comparison condition participants that completed any follow-up|83
8579279|NCT00183456|9612464|FG002|COMPLETED|Overall Study|total # of network participants that completed any follow-up|313
8579280|NCT00183456|9612465|FG003|COMPLETED|Overall Study|total # of non-randomized index participants that completed any follow-up|220
8579281|NCT00183456|9612462|FG000|NOT COMPLETED|Overall Study||3
8579282|NCT00183456|9612463|FG001|NOT COMPLETED|Overall Study||1
8579283|NCT00183456|9612464|FG002|NOT COMPLETED|Overall Study||16
8579284|NCT00183456|9612465|FG003|NOT COMPLETED|Overall Study||28
8579285|NCT00183469|9612477|FG000|STARTED|Overall Study||41
8579286|NCT00183469|9612478|FG001|STARTED|Overall Study||45
8579287|NCT00183469|9612477|FG000|COMPLETED|Overall Study||13
8579288|NCT00183469|9612478|FG001|COMPLETED|Overall Study||16
8579289|NCT00183469|9612477|FG000|NOT COMPLETED|Overall Study||28
8579290|NCT00183469|9612478|FG001|NOT COMPLETED|Overall Study||29
8579291|NCT00183625|9612486|FG000|STARTED|Overall Study||27
8579292|NCT00183625|9612487|FG001|STARTED|Overall Study||28
8579293|NCT00183625|9612488|FG002|STARTED|Overall Study||28
8579294|NCT00183625|9612489|FG003|STARTED|Overall Study||24
8579295|NCT00183625|9612486|FG000|Obtained Employment|Overall Study||21
8579296|NCT00183625|9612487|FG001|Obtained Employment|Overall Study||18
8579297|NCT00183625|9612488|FG002|Obtained Employment|Overall Study||14
8579298|NCT00183625|9612489|FG003|Obtained Employment|Overall Study||14
8579299|NCT00183625|9612486|FG000|COMPLETED|Overall Study||9
8579300|NCT00183625|9612487|FG001|COMPLETED|Overall Study||10
8579301|NCT00183625|9612488|FG002|COMPLETED|Overall Study||9
8579302|NCT00183625|9612489|FG003|COMPLETED|Overall Study||10
8579303|NCT00183625|9612486|FG000|NOT COMPLETED|Overall Study||18
8579304|NCT00183625|9612487|FG001|NOT COMPLETED|Overall Study||18
8579305|NCT00183625|9612488|FG002|NOT COMPLETED|Overall Study||19
8579306|NCT00183625|9612489|FG003|NOT COMPLETED|Overall Study||14
8579307|NCT00183677|9612497|FG000|STARTED|Overall Study||97
8579308|NCT00183677|9612497|FG000|COMPLETED|Overall Study||53
8579309|NCT00183677|9612497|FG000|NOT COMPLETED|Overall Study||44
8579310|NCT00183729|9612503|FG000|STARTED|Overall Study||17
8579311|NCT00183729|9612504|FG001|STARTED|Overall Study||18
8579312|NCT00183729|9612503|FG000|COMPLETED|Overall Study||14
8579313|NCT00183729|9612504|FG001|COMPLETED|Overall Study||13
8579314|NCT00183729|9612503|FG000|NOT COMPLETED|Overall Study||3
8579315|NCT00183729|9612504|FG001|NOT COMPLETED|Overall Study||5
8579316|NCT00183794|9612510|FG000|STARTED|Overall Study||20
8579317|NCT00183794|9612510|FG000|COMPLETED|Overall Study||20
8579318|NCT00183794|9612510|FG000|NOT COMPLETED|Overall Study||0
8709129|NCT00951379|9755265|FG001|NOT COMPLETED|Overall Study||2
8709130|NCT00951483|9755281|FG000|STARTED|Overall Study||47
8709131|NCT00951483|9755282|FG001|STARTED|Overall Study||44
8709132|NCT00951483|9755281|FG000|COMPLETED|Overall Study||28
8709133|NCT00951483|9755282|FG001|COMPLETED|Overall Study||44
8709134|NCT00951483|9755281|FG000|NOT COMPLETED|Overall Study||19
8709135|NCT00951483|9755282|FG001|NOT COMPLETED|Overall Study||0
8709136|NCT00951496|9755293|FG000|STARTED|Overall Study||521
8709137|NCT00951496|9755294|FG001|STARTED|Overall Study||518
8709138|NCT00951496|9755295|FG002|STARTED|Overall Study||521
8709139|NCT00951496|9755293|FG000|COMPLETED|Overall Study||511
8709140|NCT00951496|9755294|FG001|COMPLETED|Overall Study||510
8709141|NCT00951496|9755295|FG002|COMPLETED|Overall Study||508
8709142|NCT00951496|9755293|FG000|NOT COMPLETED|Overall Study||10
8579319|NCT00183872|9612514|FG000|STARTED|Overall Study||40
8579320|NCT00183872|9612514|FG000|COMPLETED|Overall Study||24
8579321|NCT00183872|9612514|FG000|NOT COMPLETED|Overall Study||16
8579322|NCT00184002|9612518|FG000|STARTED|Overall Study||68
8579323|NCT00184002|9612518|FG000|COMPLETED|Overall Study||51
8579324|NCT00184002|9612518|FG000|NOT COMPLETED|Overall Study||17
8579325|NCT00184028|9612522|FG000|STARTED|Overall Study||12
8579326|NCT00184028|9612522|FG000|COMPLETED|Overall Study||2
8709143|NCT00951496|9755294|FG001|NOT COMPLETED|Overall Study||8
8709144|NCT00951496|9755295|FG002|NOT COMPLETED|Overall Study||13
8579327|NCT00184028|9612522|FG000|NOT COMPLETED|Overall Study||10
8579328|NCT00184054|9612527|FG000|STARTED|Overall Study||11
8579329|NCT00184054|9612527|FG000|COMPLETED|Overall Study||10
8579330|NCT00184054|9612527|FG000|NOT COMPLETED|Overall Study||1
8579331|NCT00184093|9612531|FG000|STARTED|Overall Study|Phase 1 participants = 6 Phase 2 participants = 29|35
8579332|NCT00184093|9612531|FG000|COMPLETED|Overall Study||26
8579333|NCT00184093|9612531|FG000|NOT COMPLETED|Overall Study||9
8579334|NCT00184548|9612539|FG000|STARTED|Overall Study||226
8579335|NCT00184548|9612540|FG001|STARTED|Overall Study||255
8579336|NCT00184548|9612541|FG002|STARTED|Overall Study||47
8579337|NCT00184548|9612542|FG003|STARTED|Overall Study||45
8579338|NCT00184548|9612539|FG000|Exposed|Overall Study|Two subjects withdrew due to ineligibility. Excluded from safety analysis set|224
8579339|NCT00184548|9612540|FG001|Exposed|Overall Study|Three subjects withdrew due to ineligibility, two subjects died. Excluded from safety analysis set|250
8579340|NCT00184548|9612541|FG002|Exposed|Overall Study|One subject withdrew due to ineligibility. Excluded from safety analysis set|46
8579341|NCT00184548|9612542|FG003|Exposed|Overall Study|Four subjects withdrew due to ineligibility, one subject died. Excluded from safety analysis set|40
8579342|NCT00184548|9612539|FG000|COMPLETED|Overall Study||218
8579343|NCT00184548|9612540|FG001|COMPLETED|Overall Study||242
8579344|NCT00184548|9612541|FG002|COMPLETED|Overall Study||44
8579345|NCT00184548|9612542|FG003|COMPLETED|Overall Study||38
8579346|NCT00184548|9612539|FG000|NOT COMPLETED|Overall Study||8
8579347|NCT00184548|9612540|FG001|NOT COMPLETED|Overall Study||13
8579348|NCT00184548|9612541|FG002|NOT COMPLETED|Overall Study||3
8579349|NCT00184548|9612542|FG003|NOT COMPLETED|Overall Study||7
8579350|NCT00184600|9612555|FG000|STARTED|Overall Study||234
8579351|NCT00184600|9612556|FG001|STARTED|Overall Study||239
8579352|NCT00184600|9612557|FG002|STARTED|Overall Study||235
8579353|NCT00184600|9612555|FG000|COMPLETED|Overall Study||189
8579354|NCT00184600|9612556|FG001|COMPLETED|Overall Study||188
8579355|NCT00184600|9612557|FG002|COMPLETED|Overall Study||201
8579356|NCT00184600|9612555|FG000|NOT COMPLETED|Overall Study||45
8579357|NCT00184600|9612556|FG001|NOT COMPLETED|Overall Study||51
8579358|NCT00184600|9612557|FG002|NOT COMPLETED|Overall Study||34
8579359|NCT00184717|9612568|FG000|STARTED|Main Period (GHLIQUID-1516)||39
8579360|NCT00184717|9612569|FG001|STARTED|Main Period (GHLIQUID-1516)||38
8579361|NCT00184717|9612570|FG002|STARTED|Main Period (GHLIQUID-1516)||21
8579362|NCT00184717|9612571|FG003|STARTED|Main Period (GHLIQUID-1516)||0
8579363|NCT00184717|9612572|FG004|STARTED|Main Period (GHLIQUID-1516)||0
8579364|NCT00184717|9612568|FG000|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||38
8579365|NCT00184717|9612569|FG001|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||38
8579366|NCT00184717|9612570|FG002|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||21
8579367|NCT00184717|9612571|FG003|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||0
8579368|NCT00184717|9612572|FG004|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||0
8579369|NCT00184717|9612568|FG000|COMPLETED|Main Period (GHLIQUID-1516)||36
8579370|NCT00184717|9612569|FG001|COMPLETED|Main Period (GHLIQUID-1516)||36
8579371|NCT00184717|9612570|FG002|COMPLETED|Main Period (GHLIQUID-1516)||20
8579372|NCT00184717|9612571|FG003|COMPLETED|Main Period (GHLIQUID-1516)||0
8579373|NCT00184717|9612572|FG004|COMPLETED|Main Period (GHLIQUID-1516)||0
8579374|NCT00184717|9612568|FG000|NOT COMPLETED|Main Period (GHLIQUID-1516)||3
8579375|NCT00184717|9612569|FG001|NOT COMPLETED|Main Period (GHLIQUID-1516)||2
8579376|NCT00184717|9612570|FG002|NOT COMPLETED|Main Period (GHLIQUID-1516)||1
8579377|NCT00184717|9612571|FG003|NOT COMPLETED|Main Period (GHLIQUID-1516)||0
8579378|NCT00184717|9612572|FG004|NOT COMPLETED|Main Period (GHLIQUID-1516)||0
8579379|NCT00184717|9612568|FG000|STARTED|Extension Period (GHLIQUID-1517)|Three subjects did not continue in extension period|33
8579380|NCT00184717|9612569|FG001|STARTED|Extension Period (GHLIQUID-1517)|Three subjects did not continue in extension period|33
8579381|NCT00184717|9612570|FG002|STARTED|Extension Period (GHLIQUID-1517)|Re-randomised to receive 0.033 or 0.067 mg|0
8579382|NCT00184717|9612571|FG003|STARTED|Extension Period (GHLIQUID-1517)|Re-randomised from No treatment group|10
8579383|NCT00184717|9612572|FG004|STARTED|Extension Period (GHLIQUID-1517)|Re-randomised from No treatment group|10
8579384|NCT00184717|9612568|FG000|COMPLETED|Extension Period (GHLIQUID-1517)||23
8579385|NCT00184717|9612569|FG001|COMPLETED|Extension Period (GHLIQUID-1517)||27
8579386|NCT00184717|9612570|FG002|COMPLETED|Extension Period (GHLIQUID-1517)||0
8579387|NCT00184717|9612571|FG003|COMPLETED|Extension Period (GHLIQUID-1517)||7
8579388|NCT00184717|9612572|FG004|COMPLETED|Extension Period (GHLIQUID-1517)||5
8579389|NCT00184717|9612568|FG000|NOT COMPLETED|Extension Period (GHLIQUID-1517)||10
8579390|NCT00184717|9612569|FG001|NOT COMPLETED|Extension Period (GHLIQUID-1517)||6
8579391|NCT00184717|9612570|FG002|NOT COMPLETED|Extension Period (GHLIQUID-1517)||0
8579392|NCT00184717|9612571|FG003|NOT COMPLETED|Extension Period (GHLIQUID-1517)||3
8579393|NCT00184717|9612572|FG004|NOT COMPLETED|Extension Period (GHLIQUID-1517)||5
8579394|NCT00185211|9612584|FG000|STARTED|Placebo-controlled Study (92012)||292
8579395|NCT00185211|9612585|FG001|STARTED|Placebo-controlled Study (92012)||176
8579396|NCT00185211|9612584|FG000|COMPLETED|Placebo-controlled Study (92012)||271
8579397|NCT00185211|9612585|FG001|COMPLETED|Placebo-controlled Study (92012)||166
8579398|NCT00185211|9612584|FG000|NOT COMPLETED|Placebo-controlled Study (92012)||21
8627579|NCT00519376|9667173|FG003|NOT COMPLETED|Washout Period 1||0
9064230|NCT04322500|10124499|FG000|STARTED|Overall Study||13
9064231|NCT04322500|10124500|FG001|STARTED|Overall Study||13
9064232|NCT04322500|10124499|FG000|COMPLETED|Overall Study||13
9064233|NCT04322500|10124500|FG001|COMPLETED|Overall Study||13
9064234|NCT04322500|10124499|FG000|NOT COMPLETED|Overall Study||0
8579399|NCT00185211|9612585|FG001|NOT COMPLETED|Placebo-controlled Study (92012)||10
8579400|NCT00185211|9612584|FG000|STARTED|Follow-up Study (91031 - This Study)|10 of the 271 subjects completing the placebo-controlled study did not consent to the Follow-up.|261
8579401|NCT00185211|9612585|FG001|STARTED|Follow-up Study (91031 - This Study)|9 of the 166 subjects completing the placebo-controlled study did not consent to the Follow-up.|157
8579402|NCT00185211|9612584|FG000|COMPLETED|Follow-up Study (91031 - This Study)||235
8579403|NCT00185211|9612585|FG001|COMPLETED|Follow-up Study (91031 - This Study)||123
8579404|NCT00185211|9612584|FG000|NOT COMPLETED|Follow-up Study (91031 - This Study)||26
8579405|NCT00185211|9612585|FG001|NOT COMPLETED|Follow-up Study (91031 - This Study)||34
8579406|NCT00185380|9612595|FG000|STARTED|Overall Study||240
8579407|NCT00185380|9612596|FG001|STARTED|Overall Study||246
8579408|NCT00185380|9612597|FG002|STARTED|Overall Study||256
8579409|NCT00185380|9612595|FG000|Subjects Received Treatment|Overall Study||239
8579410|NCT00185380|9612596|FG001|Subjects Received Treatment|Overall Study||245
8579411|NCT00185380|9612597|FG002|Subjects Received Treatment|Overall Study||254
8579412|NCT00185380|9612595|FG000|COMPLETED|Overall Study||174
8579413|NCT00185380|9612596|FG001|COMPLETED|Overall Study||174
8579414|NCT00185380|9612597|FG002|COMPLETED|Overall Study||182
8579415|NCT00185380|9612595|FG000|NOT COMPLETED|Overall Study||66
8579416|NCT00185380|9612596|FG001|NOT COMPLETED|Overall Study||72
8579417|NCT00185380|9612597|FG002|NOT COMPLETED|Overall Study||74
8579418|NCT00185458|9612605|FG000|STARTED|Contraception Phase||394
8579419|NCT00185458|9612605|FG000|COMPLETED|Contraception Phase||336
8579420|NCT00185458|9612605|FG000|NOT COMPLETED|Contraception Phase||58
8579421|NCT00185458|9612605|FG000|STARTED|HRT Phase|168 subjects were eligible for the HRT phase out 336 who completed contraception phase.|168
8579422|NCT00185458|9612605|FG000|COMPLETED|HRT Phase||141
8579423|NCT00185458|9612605|FG000|NOT COMPLETED|HRT Phase||27
8579424|NCT00185588|9612621|FG000|STARTED|Overall Study||6
8579425|NCT00185588|9612622|FG001|STARTED|Overall Study||4
8579426|NCT00185588|9612623|FG002|STARTED|Overall Study||6
8579427|NCT00185588|9612624|FG003|STARTED|Overall Study||17
8579428|NCT00185588|9612621|FG000|COMPLETED|Overall Study||3
8579429|NCT00185588|9612622|FG001|COMPLETED|Overall Study||2
8579430|NCT00185588|9612623|FG002|COMPLETED|Overall Study||0
8579431|NCT00185588|9612624|FG003|COMPLETED|Overall Study||13
8579432|NCT00185588|9612621|FG000|NOT COMPLETED|Overall Study||3
8579433|NCT00185588|9612622|FG001|NOT COMPLETED|Overall Study||2
8579434|NCT00185588|9612623|FG002|NOT COMPLETED|Overall Study||6
8579435|NCT00185588|9612624|FG003|NOT COMPLETED|Overall Study||4
8579436|NCT00185614|9612634|FG000|STARTED|Autologous HCT (Auto-HCT)||63
8579437|NCT00185614|9612634|FG000|COMPLETED|Autologous HCT (Auto-HCT)||63
8579438|NCT00185614|9612634|FG000|NOT COMPLETED|Autologous HCT (Auto-HCT)||0
8579439|NCT00185614|9612634|FG000|STARTED|Inter-treatment Period|Not all participants who received autologous transplant continued to receive allogeneic transplant.|63
8579440|NCT00185614|9612634|FG000|COMPLETED|Inter-treatment Period||59
8579441|NCT00185614|9612634|FG000|NOT COMPLETED|Inter-treatment Period||4
8579442|NCT00185614|9612634|FG000|STARTED|Allogenic HCT (Allo-HCT)||59
8579443|NCT00185614|9612634|FG000|COMPLETED|Allogenic HCT (Allo-HCT)||59
8579444|NCT00185614|9612634|FG000|NOT COMPLETED|Allogenic HCT (Allo-HCT)||0
8579445|NCT00185640|9612638|FG000|STARTED|Overall Study||303
8579446|NCT00185640|9612638|FG000|Transplanted|Overall Study||296
8579447|NCT00185640|9612638|FG000|90 Days Post-transplant|Overall Study||161
8579448|NCT00185640|9612638|FG000|COMPLETED|Overall Study||158
8579449|NCT00185640|9612638|FG000|NOT COMPLETED|Overall Study||145
8579450|NCT00185679|9612642|FG000|STARTED|Overall Study||13
8579451|NCT00185679|9612642|FG000|COMPLETED|Overall Study||13
8579452|NCT00185679|9612642|FG000|NOT COMPLETED|Overall Study||0
8579453|NCT00185692|9612646|FG000|STARTED|Overall Study||16
8579454|NCT00185692|9612646|FG000|COMPLETED|Overall Study||0
8579455|NCT00185692|9612646|FG000|NOT COMPLETED|Overall Study||16
8579456|NCT00185731|9612650|FG000|STARTED|Overall Study||25
8579457|NCT00185731|9612650|FG000|COMPLETED|Overall Study||23
8579458|NCT00185731|9612650|FG000|NOT COMPLETED|Overall Study||2
8579459|NCT00185900|9612658|FG000|STARTED|Overall Study||92
8579460|NCT00185900|9612659|FG001|STARTED|Overall Study||100
8579461|NCT00185900|9612658|FG000|COMPLETED|Overall Study||92
8579462|NCT00185900|9612659|FG001|COMPLETED|Overall Study||100
8579463|NCT00185900|9612658|FG000|NOT COMPLETED|Overall Study||0
8579464|NCT00185900|9612659|FG001|NOT COMPLETED|Overall Study||0
8579465|NCT00185965|9612667|FG000|STARTED|Overall Study||15
8579466|NCT00185965|9612668|FG001|STARTED|Overall Study||15
8579467|NCT00185965|9612667|FG000|COMPLETED|Overall Study||15
8579468|NCT00185965|9612668|FG001|COMPLETED|Overall Study||14
8579469|NCT00185965|9612667|FG000|NOT COMPLETED|Overall Study||0
8579470|NCT00185965|9612668|FG001|NOT COMPLETED|Overall Study||1
8579471|NCT00186017|9612676|FG000|STARTED|Overall Study||25
8579472|NCT00186017|9612677|FG001|STARTED|Overall Study||25
8579473|NCT00186017|9612676|FG000|COMPLETED|Overall Study||23
8579474|NCT00186017|9612677|FG001|COMPLETED|Overall Study||22
8579475|NCT00186017|9612676|FG000|NOT COMPLETED|Overall Study||2
8579476|NCT00186017|9612677|FG001|NOT COMPLETED|Overall Study||3
8579477|NCT00186043|9612686|FG000|STARTED|Overall Study||30
8579478|NCT00186043|9612687|FG001|STARTED|Overall Study||25
8579479|NCT00186043|9612686|FG000|COMPLETED|Overall Study||15
8579480|NCT00186043|9612687|FG001|COMPLETED|Overall Study||12
8579481|NCT00186043|9612686|FG000|NOT COMPLETED|Overall Study||15
8579482|NCT00186043|9612687|FG001|NOT COMPLETED|Overall Study||13
8579483|NCT00186056|9612695|FG000|STARTED|Overall Study||14
8579484|NCT00186056|9612696|FG001|STARTED|Overall Study||17
8579485|NCT00186056|9612695|FG000|COMPLETED|Overall Study||12
8579486|NCT00186056|9612696|FG001|COMPLETED|Overall Study||16
8579487|NCT00186056|9612695|FG000|NOT COMPLETED|Overall Study||2
8579488|NCT00186056|9612696|FG001|NOT COMPLETED|Overall Study||1
8579489|NCT00186069|9612704|FG000|STARTED|Overall Study|Enrollment goal was not reached due to the introduction of magnesium sulfate for neuroprotection|15
8579490|NCT00186069|9612705|FG001|STARTED|Overall Study|Enrollment goal was not reached due to the introduction of magnesium sulfate for neuroprotection|15
8579491|NCT00186069|9612704|FG000|COMPLETED|Overall Study||15
8579492|NCT00186069|9612705|FG001|COMPLETED|Overall Study||15
8579493|NCT00186069|9612704|FG000|NOT COMPLETED|Overall Study||0
8579494|NCT00186069|9612705|FG001|NOT COMPLETED|Overall Study||0
8579495|NCT00186121|9612711|FG000|STARTED|Overall Study||35
8579496|NCT00186121|9612711|FG000|COMPLETED|Overall Study||32
8579497|NCT00186121|9612711|FG000|NOT COMPLETED|Overall Study||3
8579498|NCT00186186|9612715|FG000|STARTED|Overall Study||28
8579499|NCT00186186|9612715|FG000|COMPLETED|Overall Study||20
8579500|NCT00186186|9612715|FG000|NOT COMPLETED|Overall Study||8
8579501|NCT00186446|9612720|FG000|STARTED|Overall Study||20
8579502|NCT00186446|9612720|FG000|COMPLETED|Overall Study||11
8579503|NCT00186446|9612720|FG000|NOT COMPLETED|Overall Study||9
8579504|NCT00186485|9612726|FG000|STARTED|Overall Study||28
8579505|NCT00186485|9612726|FG000|COMPLETED|Overall Study||25
8579506|NCT00186485|9612726|FG000|NOT COMPLETED|Overall Study||3
8579507|NCT00186498|9612732|FG000|STARTED|Overall Study||6
8579508|NCT00186498|9612733|FG001|STARTED|Overall Study||5
8579509|NCT00186498|9612732|FG000|COMPLETED|Overall Study||4
8579510|NCT00186498|9612733|FG001|COMPLETED|Overall Study||3
8579511|NCT00186498|9612732|FG000|NOT COMPLETED|Overall Study||2
8579512|NCT00186498|9612733|FG001|NOT COMPLETED|Overall Study||2
8579513|NCT00186537|9612742|FG000|STARTED|Overall Study||19
8709145|NCT00951509|9755306|FG000|STARTED|Overall Study||31
8709146|NCT00951509|9755306|FG000|Driving Condition 1|Overall Study||29
8709147|NCT00951509|9755306|FG000|Driving Condition 2|Overall Study||29
8709148|NCT00951509|9755306|FG000|Driving Condition 3|Overall Study||25
8709149|NCT00951509|9755306|FG000|Driving Condition 4|Overall Study||28
8709150|NCT00951509|9755306|FG000|Driving Condition 5|Overall Study||30
8709151|NCT00951509|9755306|FG000|COMPLETED|Overall Study||29
8709152|NCT00951509|9755306|FG000|NOT COMPLETED|Overall Study||2
8709153|NCT00951561|9755314|FG000|STARTED|Overall Study|Randomized Vipon or Ibuprofen period 1, crossover period 2, randomized period 3, crossover period 4|25
8709154|NCT00951561|9755315|FG001|STARTED|Overall Study||29
8709155|NCT00951561|9755316|FG002|STARTED|Overall Study|1 subject used Vipon periods 1 & 2 instead of Ibuprofen period 2.|21
8709156|NCT00951561|9755317|FG003|STARTED|Overall Study||27
8709157|NCT00951561|9755314|FG000|COMPLETED|Overall Study||25
8709158|NCT00951561|9755315|FG001|COMPLETED|Overall Study||29
8709159|NCT00951561|9755316|FG002|COMPLETED|Overall Study|3 subjects dropped after period 2|18
8709160|NCT00951561|9755317|FG003|COMPLETED|Overall Study|1 subject dropped after period 2|26
8709161|NCT00951561|9755314|FG000|NOT COMPLETED|Overall Study||0
8709162|NCT00951561|9755315|FG001|NOT COMPLETED|Overall Study||0
8709163|NCT00951561|9755316|FG002|NOT COMPLETED|Overall Study||3
8709164|NCT00951561|9755317|FG003|NOT COMPLETED|Overall Study||1
8709165|NCT00951665|9755328|FG000|STARTED|Phase 1b||29
8709166|NCT00951665|9755329|FG001|STARTED|Phase 1b||10
8709167|NCT00951665|9755330|FG002|STARTED|Phase 1b||21
8709168|NCT00951665|9755331|FG003|STARTED|Phase 1b||3
8709169|NCT00951665|9755332|FG004|STARTED|Phase 1b||0
8709170|NCT00951665|9755333|FG005|STARTED|Phase 1b||0
8709171|NCT00951665|9755328|FG000|Started Treatment|Phase 1b||26
8709172|NCT00951665|9755329|FG001|Started Treatment|Phase 1b||10
8709173|NCT00951665|9755330|FG002|Started Treatment|Phase 1b||21
8709174|NCT00951665|9755331|FG003|Started Treatment|Phase 1b||3
8709175|NCT00951665|9755332|FG004|Started Treatment|Phase 1b||0
8709176|NCT00951665|9755333|FG005|Started Treatment|Phase 1b||0
8709177|NCT00951665|9755328|FG000|COMPLETED|Phase 1b||7
8709178|NCT00951665|9755329|FG001|COMPLETED|Phase 1b||6
8709179|NCT00951665|9755330|FG002|COMPLETED|Phase 1b||4
8709180|NCT00951665|9755331|FG003|COMPLETED|Phase 1b||2
8709181|NCT00951665|9755332|FG004|COMPLETED|Phase 1b||0
8709182|NCT00951665|9755333|FG005|COMPLETED|Phase 1b||0
8709183|NCT00951665|9755328|FG000|NOT COMPLETED|Phase 1b||22
8709184|NCT00951665|9755329|FG001|NOT COMPLETED|Phase 1b||4
8709185|NCT00951665|9755330|FG002|NOT COMPLETED|Phase 1b||17
8709186|NCT00951665|9755331|FG003|NOT COMPLETED|Phase 1b||1
8709187|NCT00951665|9755332|FG004|NOT COMPLETED|Phase 1b||0
8709188|NCT00951665|9755333|FG005|NOT COMPLETED|Phase 1b||0
8709189|NCT00951665|9755328|FG000|STARTED|Phase 2a||0
8709190|NCT00951665|9755329|FG001|STARTED|Phase 2a||0
8579514|NCT00186537|9612743|FG001|STARTED|Overall Study||12
8579515|NCT00186537|9612744|FG002|STARTED|Overall Study||16
8709191|NCT00951665|9755330|FG002|STARTED|Phase 2a||0
8709192|NCT00951665|9755331|FG003|STARTED|Phase 2a||0
8709193|NCT00951665|9755332|FG004|STARTED|Phase 2a||22
8709194|NCT00951665|9755333|FG005|STARTED|Phase 2a||22
8709195|NCT00951665|9755328|FG000|COMPLETED|Phase 2a||0
8709196|NCT00951665|9755329|FG001|COMPLETED|Phase 2a||0
8579516|NCT00186537|9612742|FG000|COMPLETED|Overall Study||12
8579517|NCT00186537|9612743|FG001|COMPLETED|Overall Study||12
8579518|NCT00186537|9612744|FG002|COMPLETED|Overall Study||13
8709197|NCT00951665|9755330|FG002|COMPLETED|Phase 2a||0
8709198|NCT00951665|9755331|FG003|COMPLETED|Phase 2a||0
8709199|NCT00951665|9755332|FG004|COMPLETED|Phase 2a||10
8579519|NCT00186537|9612742|FG000|NOT COMPLETED|Overall Study||7
8579520|NCT00186537|9612743|FG001|NOT COMPLETED|Overall Study||0
8579521|NCT00186537|9612744|FG002|NOT COMPLETED|Overall Study||3
8579522|NCT00186628|9612752|FG000|STARTED|Overall Study||36
8579523|NCT00186628|9612752|FG000|COMPLETED|Overall Study||33
8579524|NCT00186628|9612752|FG000|NOT COMPLETED|Overall Study||3
8579525|NCT00186875|9612760|FG000|STARTED|Overall Study||26
8579526|NCT00186875|9612761|FG001|STARTED|Overall Study||14
8579527|NCT00186875|9612760|FG000|COMPLETED|Overall Study||26
8579528|NCT00186875|9612761|FG001|COMPLETED|Overall Study||14
8579529|NCT00186875|9612760|FG000|NOT COMPLETED|Overall Study||0
8579530|NCT00186875|9612761|FG001|NOT COMPLETED|Overall Study||0
8579531|NCT00186901|9612771|FG000|STARTED|Overall Study||134
8579532|NCT00186901|9612772|FG001|STARTED|Overall Study||141
8579533|NCT00186901|9612773|FG002|STARTED|Overall Study||149
8579534|NCT00186901|9612771|FG000|Baseline|Overall Study||134
8579535|NCT00186901|9612772|FG001|Baseline|Overall Study||141
8579536|NCT00186901|9612773|FG002|Baseline|Overall Study||0
8579537|NCT00186901|9612771|FG000|12 Month Follow-up|Overall Study||117
8579538|NCT00186901|9612772|FG001|12 Month Follow-up|Overall Study||122
8579539|NCT00186901|9612773|FG002|12 Month Follow-up|Overall Study||0
8579540|NCT00186901|9612771|FG000|24 Month Follow-up|Overall Study||106
8579541|NCT00186901|9612772|FG001|24 Month Follow-up|Overall Study||107
8579542|NCT00186901|9612773|FG002|24 Month Follow-up|Overall Study||0
8579543|NCT00186901|9612771|FG000|COMPLETED|Overall Study||85
8579544|NCT00186901|9612772|FG001|COMPLETED|Overall Study||96
8579545|NCT00186901|9612773|FG002|COMPLETED|Overall Study||0
8579546|NCT00186901|9612771|FG000|NOT COMPLETED|Overall Study||49
8579547|NCT00186901|9612772|FG001|NOT COMPLETED|Overall Study||45
8579548|NCT00186901|9612773|FG002|NOT COMPLETED|Overall Study||149
8579549|NCT00187096|9612813|FG000|STARTED|Overall Study||10
8579550|NCT00187096|9612814|FG001|STARTED|Overall Study||3
8579551|NCT00187096|9612815|FG002|STARTED|Overall Study||12
8579552|NCT00187096|9612813|FG000|COMPLETED|Overall Study||10
8579553|NCT00187096|9612814|FG001|COMPLETED|Overall Study||3
8579554|NCT00187096|9612815|FG002|COMPLETED|Overall Study||11
8579555|NCT00187096|9612813|FG000|NOT COMPLETED|Overall Study||0
8579556|NCT00187096|9612814|FG001|NOT COMPLETED|Overall Study||0
8579557|NCT00187096|9612815|FG002|NOT COMPLETED|Overall Study||1
8579558|NCT00187135|9612829|FG000|STARTED|Visit One||30
8579559|NCT00187135|9612830|FG001|STARTED|Visit One||28
8579560|NCT00187135|9612831|FG002|STARTED|Visit One||25
8579561|NCT00187135|9612832|FG003|STARTED|Visit One||26
8579562|NCT00187135|9612833|FG004|STARTED|Visit One||25
8579563|NCT00187135|9612834|FG005|STARTED|Visit One||28
8579564|NCT00187135|9612829|FG000|COMPLETED|Visit One||26
8579565|NCT00187135|9612830|FG001|COMPLETED|Visit One||27
8579566|NCT00187135|9612831|FG002|COMPLETED|Visit One||25
8579567|NCT00187135|9612832|FG003|COMPLETED|Visit One||26
8579568|NCT00187135|9612833|FG004|COMPLETED|Visit One||25
8579569|NCT00187135|9612834|FG005|COMPLETED|Visit One||26
8579570|NCT00187135|9612829|FG000|NOT COMPLETED|Visit One||4
8579571|NCT00187135|9612830|FG001|NOT COMPLETED|Visit One||1
8579572|NCT00187135|9612831|FG002|NOT COMPLETED|Visit One||0
8579573|NCT00187135|9612832|FG003|NOT COMPLETED|Visit One||0
8579574|NCT00187135|9612833|FG004|NOT COMPLETED|Visit One||0
8579575|NCT00187135|9612834|FG005|NOT COMPLETED|Visit One||2
8579576|NCT00187135|9612829|FG000|STARTED|Visit Two||26
8579577|NCT00187135|9612830|FG001|STARTED|Visit Two||27
8579578|NCT00187135|9612831|FG002|STARTED|Visit Two||25
8579579|NCT00187135|9612832|FG003|STARTED|Visit Two||26
8579580|NCT00187135|9612833|FG004|STARTED|Visit Two||25
8579581|NCT00187135|9612834|FG005|STARTED|Visit Two||26
8579582|NCT00187135|9612829|FG000|COMPLETED|Visit Two||21
8579583|NCT00187135|9612830|FG001|COMPLETED|Visit Two||24
8579584|NCT00187135|9612831|FG002|COMPLETED|Visit Two||23
8579585|NCT00187135|9612832|FG003|COMPLETED|Visit Two||18
8579586|NCT00187135|9612833|FG004|COMPLETED|Visit Two||19
8579587|NCT00187135|9612834|FG005|COMPLETED|Visit Two||18
8709200|NCT00951665|9755333|FG005|COMPLETED|Phase 2a||15
8709201|NCT00951665|9755328|FG000|NOT COMPLETED|Phase 2a||0
8709202|NCT00951665|9755329|FG001|NOT COMPLETED|Phase 2a||0
8709203|NCT00951665|9755330|FG002|NOT COMPLETED|Phase 2a||0
8709204|NCT00951665|9755331|FG003|NOT COMPLETED|Phase 2a||0
8709205|NCT00951665|9755332|FG004|NOT COMPLETED|Phase 2a||12
8709206|NCT00951665|9755333|FG005|NOT COMPLETED|Phase 2a||7
8709207|NCT00951808|9755367|FG000|STARTED|Overall Study||4
8579588|NCT00187135|9612829|FG000|NOT COMPLETED|Visit Two||5
8579589|NCT00187135|9612830|FG001|NOT COMPLETED|Visit Two||3
8579590|NCT00187135|9612831|FG002|NOT COMPLETED|Visit Two||2
8579591|NCT00187135|9612832|FG003|NOT COMPLETED|Visit Two||8
8709208|NCT00951808|9755368|FG001|STARTED|Overall Study||6
8709209|NCT00951808|9755369|FG002|STARTED|Overall Study||227
8709210|NCT00951808|9755367|FG000|COMPLETED|Overall Study||4
8709211|NCT00951808|9755368|FG001|COMPLETED|Overall Study||6
8579592|NCT00187135|9612833|FG004|NOT COMPLETED|Visit Two||6
8579593|NCT00187135|9612834|FG005|NOT COMPLETED|Visit Two||8
8579594|NCT00187135|9612829|FG000|STARTED|Visit Three||21
8579595|NCT00187135|9612830|FG001|STARTED|Visit Three||24
8579596|NCT00187135|9612831|FG002|STARTED|Visit Three||23
8579597|NCT00187135|9612832|FG003|STARTED|Visit Three||18
8579598|NCT00187135|9612833|FG004|STARTED|Visit Three||19
8579599|NCT00187135|9612834|FG005|STARTED|Visit Three||18
8579600|NCT00187135|9612829|FG000|COMPLETED|Visit Three||14
8709212|NCT00951808|9755369|FG002|COMPLETED|Overall Study|Four subjects withdrew from the study.|223
8579601|NCT00187135|9612830|FG001|COMPLETED|Visit Three||17
8579602|NCT00187135|9612831|FG002|COMPLETED|Visit Three||14
8579603|NCT00187135|9612832|FG003|COMPLETED|Visit Three||9
8579604|NCT00187135|9612833|FG004|COMPLETED|Visit Three||11
8579605|NCT00187135|9612834|FG005|COMPLETED|Visit Three||12
8579606|NCT00187135|9612829|FG000|NOT COMPLETED|Visit Three||7
8579607|NCT00187135|9612830|FG001|NOT COMPLETED|Visit Three||7
8579608|NCT00187135|9612831|FG002|NOT COMPLETED|Visit Three||9
8579609|NCT00187135|9612832|FG003|NOT COMPLETED|Visit Three||9
8579610|NCT00187135|9612833|FG004|NOT COMPLETED|Visit Three||8
8579611|NCT00187135|9612834|FG005|NOT COMPLETED|Visit Three||6
8579612|NCT00187200|9612848|FG000|STARTED|Overall Study||49
8579613|NCT00187200|9612849|FG001|STARTED|Overall Study||44
8579614|NCT00187200|9612848|FG000|COMPLETED|Overall Study||31
8579615|NCT00187200|9612849|FG001|COMPLETED|Overall Study||26
8579616|NCT00187200|9612848|FG000|NOT COMPLETED|Overall Study||18
8579617|NCT00187200|9612849|FG001|NOT COMPLETED|Overall Study||18
8579618|NCT00187278|9612859|FG000|STARTED|Overall Study||918
8579619|NCT00187278|9612860|FG001|STARTED|Overall Study||915
8579620|NCT00187278|9612859|FG000|COMPLETED|Overall Study||908
8579621|NCT00187278|9612860|FG001|COMPLETED|Overall Study||902
8579622|NCT00187278|9612859|FG000|NOT COMPLETED|Overall Study||10
8579623|NCT00187278|9612860|FG001|NOT COMPLETED|Overall Study||13
8579624|NCT00187369|9612870|FG000|STARTED|Mothers||1398
8579625|NCT00187369|9612871|FG001|STARTED|Mothers||1406
8579626|NCT00187369|9612870|FG000|Included in the Study|Mothers||1393
8579627|NCT00187369|9612871|FG001|Included in the Study|Mothers||1393
8579628|NCT00187369|9612870|FG000|COMPLETED|Mothers||1392
8579629|NCT00187369|9612871|FG001|COMPLETED|Mothers||1392
8579630|NCT00187369|9612870|FG000|NOT COMPLETED|Mothers||6
8579631|NCT00187369|9612871|FG001|NOT COMPLETED|Mothers||14
8579632|NCT00187369|9612870|FG000|STARTED|Fetuses or Infants||2795
8579633|NCT00187369|9612871|FG001|STARTED|Fetuses or Infants||2812
8579634|NCT00187369|9612870|FG000|Included in the Study|Fetuses or Infants||2785
8579635|NCT00187369|9612871|FG001|Included in the Study|Fetuses or Infants||2786
8579636|NCT00187369|9612870|FG000|COMPLETED|Fetuses or Infants||2783
8579637|NCT00187369|9612871|FG001|COMPLETED|Fetuses or Infants||2782
8579638|NCT00187369|9612870|FG000|NOT COMPLETED|Fetuses or Infants||12
8579639|NCT00187369|9612871|FG001|NOT COMPLETED|Fetuses or Infants||30
8579640|NCT00187486|9612883|FG000|STARTED|Overall Study||66
8579641|NCT00187486|9612883|FG000|COMPLETED|Overall Study||65
8579642|NCT00187486|9612883|FG000|NOT COMPLETED|Overall Study||1
8579643|NCT00187655|9612887|FG000|STARTED|Overall Study||24
8579644|NCT00187655|9612887|FG000|COMPLETED|Overall Study||24
8579645|NCT00187655|9612887|FG000|NOT COMPLETED|Overall Study||0
8579646|NCT00187681|9612894|FG000|STARTED|Overall Study||12
8579647|NCT00187681|9612895|FG001|STARTED|Overall Study||8
8579648|NCT00187681|9612894|FG000|COMPLETED|Overall Study||12
8579649|NCT00187681|9612895|FG001|COMPLETED|Overall Study||8
8579650|NCT00187681|9612894|FG000|NOT COMPLETED|Overall Study||0
8579651|NCT00187681|9612895|FG001|NOT COMPLETED|Overall Study||0
8579652|NCT00187720|9612905|FG000|STARTED|Overall Study||9
8579653|NCT00187720|9612906|FG001|STARTED|Overall Study||14
8579654|NCT00187720|9612905|FG000|COMPLETED|Overall Study||9
8579655|NCT00187720|9612906|FG001|COMPLETED|Overall Study||14
8579656|NCT00187720|9612905|FG000|NOT COMPLETED|Overall Study||0
8579657|NCT00187720|9612906|FG001|NOT COMPLETED|Overall Study||0
8579658|NCT00187876|9612914|FG000|STARTED|Overall Study||24
8579659|NCT00187876|9612915|FG001|STARTED|Overall Study||43
8579660|NCT00187876|9612914|FG000|COMPLETED|Overall Study||24
8579661|NCT00187876|9612915|FG001|COMPLETED|Overall Study||43
8579662|NCT00187876|9612914|FG000|NOT COMPLETED|Overall Study||0
8579663|NCT00187876|9612915|FG001|NOT COMPLETED|Overall Study||0
8579664|NCT00187889|9612923|FG000|STARTED|Overall Study||25
8579665|NCT00187889|9612924|FG001|STARTED|Overall Study||26
8579666|NCT00187889|9612923|FG000|COMPLETED|Overall Study||19
8579667|NCT00187889|9612924|FG001|COMPLETED|Overall Study||22
8579668|NCT00187889|9612923|FG000|NOT COMPLETED|Overall Study||6
8579669|NCT00187889|9612924|FG001|NOT COMPLETED|Overall Study||4
8579670|NCT00189098|9612933|FG000|STARTED|Overall Study||51
8579671|NCT00189098|9612934|FG001|STARTED|Overall Study||50
8579672|NCT00189098|9612933|FG000|COMPLETED|Overall Study||46
8579673|NCT00189098|9612934|FG001|COMPLETED|Overall Study||44
8579674|NCT00189098|9612933|FG000|NOT COMPLETED|Overall Study||5
8579675|NCT00189098|9612934|FG001|NOT COMPLETED|Overall Study||6
8579676|NCT00189137|9612944|FG000|STARTED|Overall Study||37
8579677|NCT00189137|9612945|FG001|STARTED|Overall Study||43
8579678|NCT00189137|9612944|FG000|COMPLETED|Overall Study||37
8579679|NCT00189137|9612945|FG001|COMPLETED|Overall Study||43
8579680|NCT00189137|9612944|FG000|NOT COMPLETED|Overall Study||0
8579681|NCT00189137|9612945|FG001|NOT COMPLETED|Overall Study||0
8579682|NCT00189202|9612951|FG000|STARTED|Overall Study||49
8579683|NCT00189202|9612951|FG000|COMPLETED|Overall Study||44
8579684|NCT00189202|9612951|FG000|NOT COMPLETED|Overall Study||5
8579685|NCT00189228|9612955|FG000|STARTED|Overall Study||18
8579686|NCT00189228|9612955|FG000|COMPLETED|Overall Study||18
8579687|NCT00189228|9612955|FG000|NOT COMPLETED|Overall Study||0
8579688|NCT00189306|9612959|FG000|STARTED|Treatment Period||169
8579689|NCT00189306|9612959|FG000|COMPLETED|Treatment Period|5 subjects discontinued during treatment - 4 subjects returned for the Posttreatment Period|164
8579690|NCT00189306|9612959|FG000|NOT COMPLETED|Treatment Period||5
8579691|NCT00189306|9612959|FG000|STARTED|Posttreatment Period|5 of the 169 discontinued, but 4 returned for the Posttreatment Period|169
8579692|NCT00189306|9612959|FG000|COMPLETED|Posttreatment Period|11 subjects discontinued during the 12-week Posttreatment Period|157
8579693|NCT00189306|9612959|FG000|NOT COMPLETED|Posttreatment Period||12
8579694|NCT00189306|9612959|FG000|STARTED|Long-Term Follow-up||157
8579695|NCT00189306|9612959|FG000|COMPLETED|Long-Term Follow-up||119
8579696|NCT00189306|9612959|FG000|NOT COMPLETED|Long-Term Follow-up||38
8579697|NCT00189423|9612965|FG000|STARTED|Overall Study||813
8579698|NCT00189423|9612966|FG001|STARTED|Overall Study||840
8579699|NCT00189423|9612965|FG000|COMPLETED|Overall Study||48
8579700|NCT00189423|9612966|FG001|COMPLETED|Overall Study||74
8579701|NCT00189423|9612965|FG000|NOT COMPLETED|Overall Study||765
8579702|NCT00189423|9612966|FG001|NOT COMPLETED|Overall Study||766
8579703|NCT00189436|9612974|FG000|STARTED|Overall Study||31
8579704|NCT00189436|9612975|FG001|STARTED|Overall Study||30
8579705|NCT00189436|9612974|FG000|COMPLETED|Overall Study||23
8579706|NCT00189436|9612975|FG001|COMPLETED|Overall Study||25
8579707|NCT00189436|9612974|FG000|NOT COMPLETED|Overall Study||8
8579708|NCT00189436|9612975|FG001|NOT COMPLETED|Overall Study||5
8579709|NCT00189462|9612983|FG000|STARTED|Overall Study||50
8579710|NCT00189462|9612984|FG001|STARTED|Overall Study||49
8579711|NCT00189462|9612983|FG000|COMPLETED|Overall Study||27
8579712|NCT00189462|9612984|FG001|COMPLETED|Overall Study||28
8579713|NCT00189462|9612983|FG000|NOT COMPLETED|Overall Study||23
8579714|NCT00189462|9612984|FG001|NOT COMPLETED|Overall Study||21
8579715|NCT00189475|9612992|FG000|STARTED|Overall Study||42
8579716|NCT00189475|9612993|FG001|STARTED|Overall Study||42
8579717|NCT00189475|9612992|FG000|COMPLETED|Overall Study||42
8579718|NCT00189475|9612993|FG001|COMPLETED|Overall Study||42
8579719|NCT00189475|9612992|FG000|NOT COMPLETED|Overall Study||0
8579720|NCT00189475|9612993|FG001|NOT COMPLETED|Overall Study||0
8579721|NCT00189488|9613001|FG000|STARTED|Overall Study||78
8579722|NCT00189488|9613002|FG001|STARTED|Overall Study||77
8579723|NCT00189488|9613001|FG000|Received Palifermin/Placebo|Overall Study||75
8579724|NCT00189488|9613002|FG001|Received Palifermin/Placebo|Overall Study||76
8579725|NCT00189488|9613001|FG000|COMPLETED|Overall Study||63
8579726|NCT00189488|9613002|FG001|COMPLETED|Overall Study||55
8579727|NCT00189488|9613001|FG000|NOT COMPLETED|Overall Study||15
8579728|NCT00189488|9613002|FG001|NOT COMPLETED|Overall Study||22
8579729|NCT00189540|9613011|FG000|STARTED|Overall Study||21
8579730|NCT00189540|9613012|FG001|STARTED|Overall Study||6
8579731|NCT00189540|9613011|FG000|COMPLETED|Overall Study||14
8579732|NCT00189540|9613012|FG001|COMPLETED|Overall Study||5
8579733|NCT00189540|9613011|FG000|NOT COMPLETED|Overall Study||7
8579734|NCT00189540|9613012|FG001|NOT COMPLETED|Overall Study||1
8579735|NCT00190671|9613020|FG000|STARTED|Overall Study||42
8579736|NCT00190671|9613021|FG001|STARTED|Overall Study||61
8579737|NCT00190671|9613020|FG000|COMPLETED|Overall Study||15
8579738|NCT00190671|9613021|FG001|COMPLETED|Overall Study||19
8579739|NCT00190671|9613020|FG000|NOT COMPLETED|Overall Study||27
8579740|NCT00190671|9613021|FG001|NOT COMPLETED|Overall Study||42
8579741|NCT00190684|9613028|FG000|STARTED|Overall Study||1553
8579742|NCT00190684|9613028|FG000|Received at Least 1 Dose of Study Drug|Overall Study|1553 patients entered the study; 1551 were enrolled and received study drug.|1551
8579743|NCT00190684|9613028|FG000|COMPLETED|Overall Study|Number of patients that completed overall study (through Period VI)|64
8579744|NCT00190684|9613028|FG000|NOT COMPLETED|Overall Study||1489
8579745|NCT00190749|9613034|FG000|STARTED|Overall Study||68
8579746|NCT00190749|9613035|FG001|STARTED|Overall Study||62
8579747|NCT00190749|9613034|FG000|COMPLETED|Overall Study||42
8579748|NCT00190749|9613035|FG001|COMPLETED|Overall Study||31
8579749|NCT00190749|9613034|FG000|NOT COMPLETED|Overall Study||26
8579750|NCT00190749|9613035|FG001|NOT COMPLETED|Overall Study||31
8579751|NCT00190775|9613043|FG000|STARTED|Overall Study||268
8579752|NCT00190775|9613044|FG001|STARTED|Overall Study||234
8579753|NCT00190775|9613043|FG000|Received Study Drug|Overall Study||266
8579754|NCT00190775|9613044|FG001|Received Study Drug|Overall Study||234
8579755|NCT00190775|9613043|FG000|COMPLETED|Overall Study||119
8579756|NCT00190775|9613044|FG001|COMPLETED|Overall Study||134
8579757|NCT00190775|9613043|FG000|NOT COMPLETED|Overall Study||149
8579758|NCT00190775|9613044|FG001|NOT COMPLETED|Overall Study||100
8579759|NCT00190983|9613057|FG000|STARTED|Overall Study||29
8579760|NCT00190983|9613057|FG000|COMPLETED|Overall Study|Completed means patient received treatment and was evaluable for response.|27
8579761|NCT00190983|9613057|FG000|NOT COMPLETED|Overall Study||2
8579762|NCT00191100|9613063|FG000|STARTED|Overall Study||259
8579763|NCT00191100|9613064|FG001|STARTED|Overall Study||256
8579764|NCT00191100|9613063|FG000|COMPLETED|Overall Study||217
8579765|NCT00191100|9613064|FG001|COMPLETED|Overall Study||244
8579766|NCT00191100|9613063|FG000|NOT COMPLETED|Overall Study||42
8579767|NCT00191100|9613064|FG001|NOT COMPLETED|Overall Study||12
8579768|NCT00191113|9613072|FG000|STARTED|Core Study||78
8579769|NCT00191113|9613073|FG001|STARTED|Core Study||76
8579770|NCT00191113|9613072|FG000|COMPLETED|Core Study||43
8579771|NCT00191113|9613073|FG001|COMPLETED|Core Study||61
8579772|NCT00191113|9613072|FG000|NOT COMPLETED|Core Study||35
8579773|NCT00191113|9613073|FG001|NOT COMPLETED|Core Study||15
8579774|NCT00191113|9613072|FG000|STARTED|Addendum 1||2
8579775|NCT00191113|9613073|FG001|STARTED|Addendum 1|Not Applicable -- only Control patients were eligible for Addendum 1|0
8579776|NCT00191113|9613072|FG000|COMPLETED|Addendum 1||2
8579777|NCT00191113|9613073|FG001|COMPLETED|Addendum 1|Not Applicable -- only Control patients were eligible for Addendum 1|0
8579778|NCT00191113|9613072|FG000|NOT COMPLETED|Addendum 1||0
8579779|NCT00191113|9613073|FG001|NOT COMPLETED|Addendum 1||0
8579780|NCT00191113|9613072|FG000|STARTED|Addendum 2||28
8579781|NCT00191113|9613073|FG001|STARTED|Addendum 2||48
8579782|NCT00191113|9613072|FG000|COMPLETED|Addendum 2||18
8579783|NCT00191113|9613073|FG001|COMPLETED|Addendum 2||31
8579784|NCT00191113|9613072|FG000|NOT COMPLETED|Addendum 2||10
8579785|NCT00191113|9613073|FG001|NOT COMPLETED|Addendum 2||17
8579786|NCT00191113|9613072|FG000|STARTED|Addendum 3||20
8579787|NCT00191113|9613073|FG001|STARTED|Addendum 3||37
8579788|NCT00191113|9613072|FG000|COMPLETED|Addendum 3||20
8579789|NCT00191113|9613073|FG001|COMPLETED|Addendum 3||37
8579790|NCT00191113|9613072|FG000|NOT COMPLETED|Addendum 3||0
8579791|NCT00191113|9613073|FG001|NOT COMPLETED|Addendum 3||0
8579792|NCT00191139|9613087|FG000|STARTED|Overall Study||32
8579793|NCT00191139|9613088|FG001|STARTED|Overall Study||32
8579794|NCT00191139|9613087|FG000|COMPLETED|Overall Study||27
8579795|NCT00191139|9613088|FG001|COMPLETED|Overall Study||20
8579796|NCT00191139|9613087|FG000|NOT COMPLETED|Overall Study||5
8579797|NCT00191139|9613088|FG001|NOT COMPLETED|Overall Study||12
8579798|NCT00191152|9613096|FG000|STARTED|Initial Treatment||239
8579799|NCT00191152|9613097|FG001|STARTED|Initial Treatment||236
8579800|NCT00191152|9613096|FG000|Received Initial Treatment|Initial Treatment||236
8579801|NCT00191152|9613097|FG001|Received Initial Treatment|Initial Treatment||227
8579802|NCT00191152|9613096|FG000|COMPLETED|Initial Treatment||98
8579803|NCT00191152|9613097|FG001|COMPLETED|Initial Treatment||83
8579804|NCT00191152|9613096|FG000|NOT COMPLETED|Initial Treatment||141
8579805|NCT00191152|9613097|FG001|NOT COMPLETED|Initial Treatment||153
8579806|NCT00191152|9613096|FG000|STARTED|Crossover Treatment||77
8579807|NCT00191152|9613097|FG001|STARTED|Crossover Treatment||81
8579808|NCT00191152|9613096|FG000|Received Treatment|Crossover Treatment||76
8579809|NCT00191152|9613097|FG001|Received Treatment|Crossover Treatment||80
8579810|NCT00191152|9613096|FG000|COMPLETED|Crossover Treatment||50
8709213|NCT00951808|9755367|FG000|NOT COMPLETED|Overall Study||0
8709214|NCT00951808|9755368|FG001|NOT COMPLETED|Overall Study||0
8709215|NCT00951808|9755369|FG002|NOT COMPLETED|Overall Study||4
8709216|NCT00951821|9755377|FG000|STARTED|Overall Study||16
8709217|NCT00951821|9755378|FG001|STARTED|Overall Study||8
8709218|NCT00951821|9755377|FG000|COMPLETED|Overall Study||16
8709219|NCT00951821|9755378|FG001|COMPLETED|Overall Study||8
8709220|NCT00951821|9755377|FG000|NOT COMPLETED|Overall Study||0
8709221|NCT00951821|9755378|FG001|NOT COMPLETED|Overall Study||0
8709222|NCT00951899|9755386|FG000|STARTED|Overall Study||19
8709223|NCT00951899|9755387|FG001|STARTED|Overall Study||19
8709224|NCT00951899|9755386|FG000|COMPLETED|Overall Study||19
8709225|NCT00951899|9755387|FG001|COMPLETED|Overall Study||19
8709226|NCT00951899|9755386|FG000|NOT COMPLETED|Overall Study||0
8709227|NCT00951899|9755387|FG001|NOT COMPLETED|Overall Study||0
8709228|NCT00951912|9755396|FG000|STARTED|Overall Study||54
8709229|NCT00951912|9755397|FG001|STARTED|Overall Study||55
8709230|NCT00951912|9755398|FG002|STARTED|Overall Study||56
8709231|NCT00951912|9755396|FG000|COMPLETED|Overall Study||47
8709232|NCT00951912|9755397|FG001|COMPLETED|Overall Study||50
8709233|NCT00951912|9755398|FG002|COMPLETED|Overall Study||54
8709234|NCT00951912|9755396|FG000|NOT COMPLETED|Overall Study||7
8709235|NCT00951912|9755397|FG001|NOT COMPLETED|Overall Study||5
8709236|NCT00951912|9755398|FG002|NOT COMPLETED|Overall Study||2
8709237|NCT00952068|9755406|FG000|STARTED|Overall Study||47
8709238|NCT00952068|9755406|FG000|COMPLETED|Overall Study||40
8709239|NCT00952068|9755406|FG000|NOT COMPLETED|Overall Study||7
8709240|NCT00952081|9755410|FG000|STARTED|Overall Study||22
8709241|NCT00952081|9755410|FG000|COMPLETED|Overall Study||22
8709242|NCT00952081|9755410|FG000|NOT COMPLETED|Overall Study||0
8709243|NCT00952120|9755417|FG000|STARTED|Overall Study||52
8579811|NCT00191152|9613097|FG001|COMPLETED|Crossover Treatment||53
8579812|NCT00191152|9613096|FG000|NOT COMPLETED|Crossover Treatment||27
8579813|NCT00191152|9613097|FG001|NOT COMPLETED|Crossover Treatment||28
8627580|NCT00519376|9667174|FG004|NOT COMPLETED|Washout Period 1||0
8627581|NCT00519376|9667175|FG005|NOT COMPLETED|Washout Period 1||0
8627582|NCT00519376|9667176|FG006|NOT COMPLETED|Washout Period 1||0
8627583|NCT00519376|9667177|FG007|NOT COMPLETED|Washout Period 1||0
8627584|NCT00519376|9667178|FG008|NOT COMPLETED|Washout Period 1||0
8627585|NCT00519376|9667179|FG009|NOT COMPLETED|Washout Period 1||0
8627586|NCT00519376|9667180|FG010|NOT COMPLETED|Washout Period 1||0
8627587|NCT00519376|9667181|FG011|NOT COMPLETED|Washout Period 1||0
8627588|NCT00519376|9667182|FG012|NOT COMPLETED|Washout Period 1||0
8627589|NCT00519376|9667183|FG013|NOT COMPLETED|Washout Period 1||0
8627590|NCT00519376|9667184|FG014|NOT COMPLETED|Washout Period 1||0
8627591|NCT00519376|9667185|FG015|NOT COMPLETED|Washout Period 1||0
8627592|NCT00519376|9667170|FG000|STARTED|Treatment Period 2||2
8627593|NCT00519376|9667171|FG001|STARTED|Treatment Period 2||2
8627594|NCT00519376|9667172|FG002|STARTED|Treatment Period 2||2
8627595|NCT00519376|9667173|FG003|STARTED|Treatment Period 2||2
8627596|NCT00519376|9667174|FG004|STARTED|Treatment Period 2||1
8627597|NCT00519376|9667175|FG005|STARTED|Treatment Period 2||1
8627598|NCT00519376|9667176|FG006|STARTED|Treatment Period 2||1
8627599|NCT00519376|9667177|FG007|STARTED|Treatment Period 2||1
8627600|NCT00519376|9667178|FG008|STARTED|Treatment Period 2||1
8627601|NCT00519376|9667179|FG009|STARTED|Treatment Period 2||1
8627602|NCT00519376|9667180|FG010|STARTED|Treatment Period 2||1
8627603|NCT00519376|9667181|FG011|STARTED|Treatment Period 2||1
8627604|NCT00519376|9667182|FG012|STARTED|Treatment Period 2||1
8627605|NCT00519376|9667183|FG013|STARTED|Treatment Period 2||1
8579814|NCT00191165|9613117|FG000|STARTED|Overall Study||14
8579815|NCT00191165|9613118|FG001|STARTED|Overall Study||13
8579816|NCT00191165|9613117|FG000|COMPLETED|Overall Study||12
8579817|NCT00191165|9613118|FG001|COMPLETED|Overall Study||11
8579818|NCT00191165|9613117|FG000|NOT COMPLETED|Overall Study||2
8579819|NCT00191165|9613118|FG001|NOT COMPLETED|Overall Study||2
8579820|NCT00191191|9613126|FG000|STARTED|Overall Study||114
8579821|NCT00191191|9613127|FG001|STARTED|Overall Study||112
8579822|NCT00191191|9613126|FG000|Safety Analysis Population|Overall Study||114
8579823|NCT00191191|9613127|FG001|Safety Analysis Population|Overall Study||111
8579824|NCT00191191|9613126|FG000|Full Analysis Set Population|Overall Study||108
8579825|NCT00191191|9613127|FG001|Full Analysis Set Population|Overall Study||108
8579826|NCT00191191|9613126|FG000|COMPLETED|Overall Study||0
8579827|NCT00191191|9613127|FG001|COMPLETED|Overall Study||0
8579828|NCT00191191|9613126|FG000|NOT COMPLETED|Overall Study||114
8579829|NCT00191191|9613127|FG001|NOT COMPLETED|Overall Study||112
8579830|NCT00191269|9613135|FG000|STARTED|Overall Study||6
8579831|NCT00191269|9613136|FG001|STARTED|Overall Study||62
8579832|NCT00191269|9613135|FG000|COMPLETED|Overall Study||0
8579833|NCT00191269|9613136|FG001|COMPLETED|Overall Study||4
8579834|NCT00191269|9613135|FG000|NOT COMPLETED|Overall Study||6
8579835|NCT00191269|9613136|FG001|NOT COMPLETED|Overall Study||58
8579836|NCT00191282|9613145|FG000|STARTED|Overall Study||558
8579837|NCT00191282|9613146|FG001|STARTED|Overall Study||558
8579838|NCT00191282|9613145|FG000|COMPLETED|Overall Study||338
8579839|NCT00191282|9613146|FG001|COMPLETED|Overall Study||346
8579840|NCT00191282|9613145|FG000|NOT COMPLETED|Overall Study||220
8579841|NCT00191282|9613146|FG001|NOT COMPLETED|Overall Study||212
8579842|NCT00191308|9613152|FG000|STARTED|Overall Study||30
8579843|NCT00191308|9613152|FG000|COMPLETED|Overall Study||29
8579844|NCT00191308|9613152|FG000|NOT COMPLETED|Overall Study||1
8579845|NCT00191334|9613156|FG000|STARTED|Overall Study||50
8579846|NCT00191334|9613156|FG000|COMPLETED|Overall Study||33
8579847|NCT00191334|9613156|FG000|NOT COMPLETED|Overall Study||17
8579848|NCT00191386|9613160|FG000|STARTED|Overall Study||228
8579849|NCT00191386|9613160|FG000|6 Months|Overall Study||183
8579850|NCT00191386|9613160|FG000|12 Months|Overall Study||149
8709244|NCT00952120|9755418|FG001|STARTED|Overall Study||47
8709245|NCT00952120|9755419|FG002|STARTED|Overall Study||5
8709246|NCT00952120|9755417|FG000|COMPLETED|Overall Study||52
8709247|NCT00952120|9755418|FG001|COMPLETED|Overall Study||47
8709248|NCT00952120|9755419|FG002|COMPLETED|Overall Study||5
8709249|NCT00952120|9755417|FG000|NOT COMPLETED|Overall Study||0
8709250|NCT00952120|9755418|FG001|NOT COMPLETED|Overall Study||0
8579851|NCT00191386|9613160|FG000|2 Years|Overall Study||105
8579852|NCT00191386|9613160|FG000|3 Years|Overall Study||65
8579853|NCT00191386|9613160|FG000|COMPLETED|Overall Study||68
8579854|NCT00191386|9613160|FG000|NOT COMPLETED|Overall Study||160
8579855|NCT00191451|9613167|FG000|STARTED|Overall Study||50
8579856|NCT00191451|9613168|FG001|STARTED|Overall Study||51
8579857|NCT00191451|9613169|FG002|STARTED|Overall Study||49
8579858|NCT00191451|9613167|FG000|Received at Least One Dose of Study Drug|Overall Study||50
8579859|NCT00191451|9613168|FG001|Received at Least One Dose of Study Drug|Overall Study||48
8579860|NCT00191451|9613169|FG002|Received at Least One Dose of Study Drug|Overall Study||47
8579861|NCT00191451|9613167|FG000|COMPLETED|Overall Study||43
8579862|NCT00191451|9613168|FG001|COMPLETED|Overall Study||37
8579863|NCT00191451|9613169|FG002|COMPLETED|Overall Study||35
8579864|NCT00191451|9613167|FG000|NOT COMPLETED|Overall Study||7
8579865|NCT00191451|9613168|FG001|NOT COMPLETED|Overall Study||14
8579866|NCT00191451|9613169|FG002|NOT COMPLETED|Overall Study||14
8579867|NCT00191477|9613179|FG000|STARTED|Overall Study||179
8579868|NCT00191477|9613180|FG001|STARTED|Overall Study||176
8579869|NCT00191477|9613179|FG000|Received Study Drug|Overall Study||166
8579870|NCT00191477|9613180|FG001|Received Study Drug|Overall Study||162
8579871|NCT00191477|9613179|FG000|COMPLETED|Overall Study||41
8579872|NCT00191477|9613180|FG001|COMPLETED|Overall Study||47
8579873|NCT00191477|9613179|FG000|NOT COMPLETED|Overall Study||138
8579874|NCT00191477|9613180|FG001|NOT COMPLETED|Overall Study||129
8579875|NCT00191646|9613188|FG000|STARTED|Overall Study||417
8579876|NCT00191646|9613189|FG001|STARTED|Overall Study||414
8579877|NCT00191646|9613188|FG000|Received Induction Therapy|Overall Study||411
8579878|NCT00191646|9613189|FG001|Received Induction Therapy|Overall Study||409
8579879|NCT00191646|9613188|FG000|Received Consolidation Therapy|Overall Study||169
8579880|NCT00191646|9613189|FG001|Received Consolidation Therapy|Overall Study||183
8579881|NCT00191646|9613188|FG000|Received Crossover Therapy|Overall Study||77
8579882|NCT00191646|9613189|FG001|Received Crossover Therapy|Overall Study||78
8579883|NCT00191646|9613188|FG000|COMPLETED|Overall Study|Completed was defined as the patients treated in either consolidation therapy or crossover therapy.|246
8709251|NCT00952120|9755419|FG002|NOT COMPLETED|Overall Study||0
8724789|NCT01027871|9772050|FG001|Received at Least One Dose of Study Drug|Overall Study||98
8579884|NCT00191646|9613189|FG001|COMPLETED|Overall Study|Completed was defined as the patients treated in either consolidation therapy or crossover therapy.|261
8579885|NCT00191646|9613188|FG000|NOT COMPLETED|Overall Study||171
8579886|NCT00191646|9613189|FG001|NOT COMPLETED|Overall Study||153
8579887|NCT00191724|9613208|FG000|STARTED|Overall Study||6
8579888|NCT00191724|9613209|FG001|STARTED|Overall Study||9
8579889|NCT00191724|9613210|FG002|STARTED|Overall Study||9
8579890|NCT00191724|9613211|FG003|STARTED|Overall Study||8
8579891|NCT00191724|9613212|FG004|STARTED|Overall Study||15
8579892|NCT00191724|9613208|FG000|COMPLETED|Overall Study||5
8579893|NCT00191724|9613209|FG001|COMPLETED|Overall Study||8
8579894|NCT00191724|9613210|FG002|COMPLETED|Overall Study||8
8579895|NCT00191724|9613211|FG003|COMPLETED|Overall Study||5
8579896|NCT00191724|9613212|FG004|COMPLETED|Overall Study||12
8579897|NCT00191724|9613208|FG000|NOT COMPLETED|Overall Study||1
8579898|NCT00191724|9613209|FG001|NOT COMPLETED|Overall Study||1
8579899|NCT00191724|9613210|FG002|NOT COMPLETED|Overall Study||1
8579900|NCT00191724|9613211|FG003|NOT COMPLETED|Overall Study||3
8579901|NCT00191724|9613212|FG004|NOT COMPLETED|Overall Study||3
8579902|NCT00191789|9613224|FG000|STARTED|Overall Study||65
8579903|NCT00191789|9613224|FG000|COMPLETED|Overall Study||40
8579904|NCT00191789|9613224|FG000|NOT COMPLETED|Overall Study||25
8579905|NCT00191815|9613228|FG000|STARTED|Overall Study||70
8579906|NCT00191815|9613228|FG000|Treated|Overall Study||67
8579907|NCT00191815|9613228|FG000|COMPLETED|Overall Study||30
8579908|NCT00191815|9613228|FG000|NOT COMPLETED|Overall Study||40
8579909|NCT00191854|9613235|FG000|STARTED|Overall Study||49
8579910|NCT00191854|9613236|FG001|STARTED|Overall Study||47
8579911|NCT00191854|9613237|FG002|STARTED|Overall Study||51
8579912|NCT00191854|9613235|FG000|Received at Least One Dose of Study Drug|Overall Study||49
8579913|NCT00191854|9613236|FG001|Received at Least One Dose of Study Drug|Overall Study||47
8579914|NCT00191854|9613237|FG002|Received at Least One Dose of Study Drug|Overall Study|Screen failure: discontinued prior to receiving study drug.|50
8579915|NCT00191854|9613235|FG000|COMPLETED|Overall Study||12
8579916|NCT00191854|9613236|FG001|COMPLETED|Overall Study||17
8579917|NCT00191854|9613237|FG002|COMPLETED|Overall Study||12
8579918|NCT00191854|9613235|FG000|NOT COMPLETED|Overall Study||37
8579919|NCT00191854|9613236|FG001|NOT COMPLETED|Overall Study||30
8579920|NCT00191854|9613237|FG002|NOT COMPLETED|Overall Study||39
8579921|NCT00191906|9613249|FG000|STARTED|Study Period II||39
8579922|NCT00191906|9613250|FG001|STARTED|Study Period II||37
8579923|NCT00191906|9613251|FG002|STARTED|Study Period II||27
8579924|NCT00191906|9613252|FG003|STARTED|Study Period II||18
8579925|NCT00191906|9613249|FG000|COMPLETED|Study Period II||39
8579926|NCT00191906|9613250|FG001|COMPLETED|Study Period II||32
8579927|NCT00191906|9613251|FG002|COMPLETED|Study Period II||26
8579928|NCT00191906|9613252|FG003|COMPLETED|Study Period II||18
8579929|NCT00191906|9613249|FG000|NOT COMPLETED|Study Period II||0
8579930|NCT00191906|9613250|FG001|NOT COMPLETED|Study Period II||5
8579931|NCT00191906|9613251|FG002|NOT COMPLETED|Study Period II||1
8579932|NCT00191906|9613252|FG003|NOT COMPLETED|Study Period II||0
8579933|NCT00191906|9613249|FG000|STARTED|Study Period III|These are patients who continued in optional open-label period (1 country). All received atomoxetine|14
8579934|NCT00191906|9613250|FG001|STARTED|Study Period III|These are patients who continued in optional open-label period (1 country). All received atomoxetine|11
8579935|NCT00191906|9613251|FG002|STARTED|Study Period III||0
8579936|NCT00191906|9613252|FG003|STARTED|Study Period III||0
8579937|NCT00191906|9613249|FG000|COMPLETED|Study Period III||9
8579938|NCT00191906|9613250|FG001|COMPLETED|Study Period III||7
8579939|NCT00191906|9613251|FG002|COMPLETED|Study Period III||0
8579940|NCT00191906|9613252|FG003|COMPLETED|Study Period III||0
8579941|NCT00191906|9613249|FG000|NOT COMPLETED|Study Period III||5
8579942|NCT00191906|9613250|FG001|NOT COMPLETED|Study Period III||4
8579943|NCT00191906|9613251|FG002|NOT COMPLETED|Study Period III||0
8579944|NCT00191906|9613252|FG003|NOT COMPLETED|Study Period III||0
8709252|NCT00952133|9755427|FG000|STARTED|Overall Study||59
8709253|NCT00952133|9755428|FG001|STARTED|Overall Study||59
8709254|NCT00952133|9755427|FG000|COMPLETED|Overall Study||59
8709255|NCT00952133|9755428|FG001|COMPLETED|Overall Study||59
8709256|NCT00952133|9755427|FG000|NOT COMPLETED|Overall Study||0
8709257|NCT00952133|9755428|FG001|NOT COMPLETED|Overall Study||0
8709258|NCT00952211|9755438|FG000|STARTED|Overall Study||3
8709259|NCT00952211|9755439|FG001|STARTED|Overall Study||0
8709260|NCT00952211|9755438|FG000|COMPLETED|Overall Study||3
8709261|NCT00952211|9755439|FG001|COMPLETED|Overall Study||0
8709262|NCT00952211|9755438|FG000|NOT COMPLETED|Overall Study||0
8709263|NCT00952211|9755439|FG001|NOT COMPLETED|Overall Study||0
8709264|NCT00952276|9755450|FG000|STARTED|Overall Study||127
8709265|NCT00952276|9755451|FG001|STARTED|Overall Study||115
8709266|NCT00952276|9755452|FG002|STARTED|Overall Study||122
8709267|NCT00952276|9755453|FG003|STARTED|Overall Study||121
8709268|NCT00952276|9755454|FG004|STARTED|Overall Study||63
8709269|NCT00952276|9755450|FG000|COMPLETED|Overall Study||126
8709270|NCT00952276|9755451|FG001|COMPLETED|Overall Study||115
8709271|NCT00952276|9755452|FG002|COMPLETED|Overall Study||122
8709272|NCT00952276|9755453|FG003|COMPLETED|Overall Study||120
8709273|NCT00952276|9755454|FG004|COMPLETED|Overall Study||63
8709274|NCT00952276|9755450|FG000|NOT COMPLETED|Overall Study||1
8709275|NCT00952276|9755451|FG001|NOT COMPLETED|Overall Study||0
8579945|NCT00191945|9613270|FG000|STARTED|Double-Blind Acute Treatment||100
8579946|NCT00191945|9613271|FG001|STARTED|Double-Blind Acute Treatment||51
8579947|NCT00191945|9613270|FG000|COMPLETED|Double-Blind Acute Treatment||94
8579948|NCT00191945|9613271|FG001|COMPLETED|Double-Blind Acute Treatment||48
8579949|NCT00191945|9613270|FG000|NOT COMPLETED|Double-Blind Acute Treatment||6
8579950|NCT00191945|9613271|FG001|NOT COMPLETED|Double-Blind Acute Treatment||3
8579951|NCT00191945|9613270|FG000|STARTED|Open-Label Treatment Extension||94
8579952|NCT00191945|9613271|FG001|STARTED|Open-Label Treatment Extension||48
8579953|NCT00191945|9613270|FG000|COMPLETED|Open-Label Treatment Extension||94
8709276|NCT00952276|9755452|FG002|NOT COMPLETED|Overall Study||0
8579954|NCT00191945|9613271|FG001|COMPLETED|Open-Label Treatment Extension||48
8579955|NCT00191945|9613270|FG000|NOT COMPLETED|Open-Label Treatment Extension||0
8579956|NCT00191945|9613271|FG001|NOT COMPLETED|Open-Label Treatment Extension||0
8579957|NCT00191984|9613278|FG000|STARTED|Overall Study||46
8579958|NCT00191984|9613278|FG000|COMPLETED|Overall Study||7
8579959|NCT00191984|9613278|FG000|NOT COMPLETED|Overall Study||39
8579960|NCT00192023|9613284|FG000|STARTED|Period III - Double-Blind||107
8579961|NCT00192023|9613285|FG001|STARTED|Period III - Double-Blind||32
8579962|NCT00192023|9613284|FG000|COMPLETED|Period III - Double-Blind|6 patients who completed the protocol did not enter optional open-label period.|100
8579963|NCT00192023|9613285|FG001|COMPLETED|Period III - Double-Blind|2 patients who completed the protocol did not enter the optional open-label period.|32
8579964|NCT00192023|9613284|FG000|NOT COMPLETED|Period III - Double-Blind||7
8579965|NCT00192023|9613285|FG001|NOT COMPLETED|Period III - Double-Blind||0
8579966|NCT00192023|9613284|FG000|STARTED|Period IV - Optional Open-Label||124
8579967|NCT00192023|9613285|FG001|STARTED|Period IV - Optional Open-Label|Placebo patients received atomoxetine during the optional open-label period.|0
8579968|NCT00192023|9613284|FG000|COMPLETED|Period IV - Optional Open-Label||49
8579969|NCT00192023|9613285|FG001|COMPLETED|Period IV - Optional Open-Label||0
8579970|NCT00192023|9613284|FG000|NOT COMPLETED|Period IV - Optional Open-Label||75
8579971|NCT00192023|9613285|FG001|NOT COMPLETED|Period IV - Optional Open-Label||0
8579972|NCT00192036|9613291|FG000|STARTED|Overall Study||49
8579973|NCT00192036|9613291|FG000|COMPLETED|Overall Study||28
8579974|NCT00192036|9613291|FG000|NOT COMPLETED|Overall Study||21
8579975|NCT00192075|9613297|FG000|STARTED|Overall Study||42
8579976|NCT00192075|9613298|FG001|STARTED|Overall Study||42
8579977|NCT00192075|9613297|FG000|COMPLETED|Overall Study||3
8579978|NCT00192075|9613298|FG001|COMPLETED|Overall Study||23
8579979|NCT00192075|9613297|FG000|NOT COMPLETED|Overall Study||39
8579980|NCT00192075|9613298|FG001|NOT COMPLETED|Overall Study||19
8579981|NCT00192114|9613309|FG000|STARTED|Overall Study||28
8579982|NCT00192114|9613309|FG000|Received at Least 1 Dose of Study Drug|Overall Study||28
8579983|NCT00192114|9613309|FG000|COMPLETED|Overall Study||4
8579984|NCT00192114|9613309|FG000|NOT COMPLETED|Overall Study||24
8579985|NCT00192296|9613317|FG000|STARTED|Overall Study||6
8579986|NCT00192296|9613318|FG001|STARTED|Overall Study||6
8579987|NCT00192296|9613319|FG002|STARTED|Overall Study||6
8579988|NCT00192296|9613320|FG003|STARTED|Overall Study||6
8579989|NCT00192296|9613317|FG000|COMPLETED|Overall Study||6
8579990|NCT00192296|9613318|FG001|COMPLETED|Overall Study||5
8579991|NCT00192296|9613319|FG002|COMPLETED|Overall Study||6
8579992|NCT00192296|9613320|FG003|COMPLETED|Overall Study||6
8579993|NCT00192296|9613317|FG000|NOT COMPLETED|Overall Study||0
8579994|NCT00192296|9613318|FG001|NOT COMPLETED|Overall Study||1
8579995|NCT00192296|9613319|FG002|NOT COMPLETED|Overall Study||0
8579996|NCT00192296|9613320|FG003|NOT COMPLETED|Overall Study||0
8579997|NCT00192504|9613334|FG000|STARTED|Overall Study||5
8579998|NCT00192504|9613335|FG001|STARTED|Overall Study||5
8579999|NCT00192504|9613336|FG002|STARTED|Overall Study|Baseline demographics are not available on one patient who did not receive study drug.|6
8580000|NCT00192504|9613337|FG003|STARTED|Overall Study||15
8580001|NCT00192504|9613334|FG000|COMPLETED|Overall Study||4
8580002|NCT00192504|9613335|FG001|COMPLETED|Overall Study||5
8580003|NCT00192504|9613336|FG002|COMPLETED|Overall Study||5
8580004|NCT00192504|9613337|FG003|COMPLETED|Overall Study||15
8580005|NCT00192504|9613334|FG000|NOT COMPLETED|Overall Study||1
8580006|NCT00192504|9613335|FG001|NOT COMPLETED|Overall Study||0
8580007|NCT00192504|9613336|FG002|NOT COMPLETED|Overall Study||1
8580008|NCT00192504|9613337|FG003|NOT COMPLETED|Overall Study||0
8580009|NCT00192647|9613349|FG000|STARTED|Overall Study||448
8580010|NCT00192647|9613350|FG001|STARTED|Overall Study||448
8580011|NCT00192647|9613349|FG000|Treated|Overall Study||433
8580012|NCT00192647|9613350|FG001|Treated|Overall Study||438
8580013|NCT00192647|9613349|FG000|COMPLETED|Overall Study||320
8580014|NCT00192647|9613350|FG001|COMPLETED|Overall Study||302
8580015|NCT00192647|9613349|FG000|NOT COMPLETED|Overall Study||128
8580016|NCT00192647|9613350|FG001|NOT COMPLETED|Overall Study||146
8580017|NCT00193037|9613358|FG000|STARTED|Randomized Treatment||50
8580018|NCT00193037|9613359|FG001|STARTED|Randomized Treatment||52
8580019|NCT00193037|9613358|FG000|COMPLETED|Randomized Treatment||32
8580020|NCT00193037|9613359|FG001|COMPLETED|Randomized Treatment||24
8580021|NCT00193037|9613358|FG000|NOT COMPLETED|Randomized Treatment||18
8580022|NCT00193037|9613359|FG001|NOT COMPLETED|Randomized Treatment||28
8580023|NCT00193037|9613358|FG000|STARTED|Crossover Treatment||32
8580024|NCT00193037|9613359|FG001|STARTED|Crossover Treatment||24
8709277|NCT00952276|9755453|FG003|NOT COMPLETED|Overall Study||1
8709278|NCT00952276|9755454|FG004|NOT COMPLETED|Overall Study||0
8709279|NCT00952289|9755468|FG000|STARTED|All Participants||155
8709280|NCT00952289|9755469|FG001|STARTED|All Participants||154
8709281|NCT00952289|9755468|FG000|Safety Population|All Participants||155
8709282|NCT00952289|9755469|FG001|Safety Population|All Participants|Randomized patients who are documented to have received at least 1 dose of study medication.|151
8709283|NCT00952289|9755468|FG000|COMPLETED|All Participants|Represents the number of patients who were still in the study as of 02 November 2010|134
8709284|NCT00952289|9755469|FG001|COMPLETED|All Participants|Includes patients in the study as of 2 November 2010 (78) + those who crossed over to Ruxolitinib.|114
8709285|NCT00952289|9755468|FG000|NOT COMPLETED|All Participants||21
8709286|NCT00952289|9755469|FG001|NOT COMPLETED|All Participants||40
8709287|NCT00952289|9755468|FG000|STARTED|Patients Who Crossed Over to Ruxolitinib||0
8580025|NCT00193037|9613358|FG000|COMPLETED|Crossover Treatment||32
8580026|NCT00193037|9613359|FG001|COMPLETED|Crossover Treatment||24
8580027|NCT00193037|9613358|FG000|NOT COMPLETED|Crossover Treatment||0
8580028|NCT00193037|9613359|FG001|NOT COMPLETED|Crossover Treatment||0
8580029|NCT00193050|9613365|FG000|STARTED|Neoadjuvant Treatment||110
8580030|NCT00193050|9613365|FG000|COMPLETED|Neoadjuvant Treatment||101
8580031|NCT00193050|9613365|FG000|NOT COMPLETED|Neoadjuvant Treatment||9
8580032|NCT00193050|9613365|FG000|STARTED|Surgery|2 patients had surgery after 2 cycles of neoadjuvant treatment|103
8580033|NCT00193050|9613365|FG000|COMPLETED|Surgery||103
8580034|NCT00193050|9613365|FG000|NOT COMPLETED|Surgery||0
8580035|NCT00193050|9613365|FG000|STARTED|Adjuvant|16 patients never initiated postoperative adjuvant therapy|87
8580036|NCT00193050|9613365|FG000|COMPLETED|Adjuvant||77
8580037|NCT00193050|9613365|FG000|NOT COMPLETED|Adjuvant||10
8580038|NCT00193063|9613370|FG000|STARTED|Overall Study||41
8580039|NCT00193063|9613370|FG000|COMPLETED|Overall Study||37
8580040|NCT00193063|9613370|FG000|NOT COMPLETED|Overall Study||4
8580041|NCT00193128|9613376|FG000|STARTED|Overall Study||10
8580042|NCT00193128|9613377|FG001|STARTED|Overall Study||49
8580043|NCT00193128|9613376|FG000|COMPLETED|Overall Study||10
8580044|NCT00193128|9613377|FG001|COMPLETED|Overall Study||39
8580045|NCT00193128|9613376|FG000|NOT COMPLETED|Overall Study||0
8580046|NCT00193128|9613377|FG001|NOT COMPLETED|Overall Study||10
8580047|NCT00193180|9613385|FG000|STARTED|Overall Study||37
8580048|NCT00193180|9613385|FG000|COMPLETED|Overall Study||27
8580049|NCT00193180|9613385|FG000|NOT COMPLETED|Overall Study||10
8580050|NCT00193206|9613390|FG000|STARTED|Preoperative Therapy||123
8580051|NCT00193206|9613390|FG000|COMPLETED|Preoperative Therapy||116
8580052|NCT00193206|9613390|FG000|NOT COMPLETED|Preoperative Therapy||7
8580053|NCT00193206|9613390|FG000|STARTED|Surgery||116
8580054|NCT00193206|9613390|FG000|COMPLETED|Surgery||116
8580055|NCT00193206|9613390|FG000|NOT COMPLETED|Surgery||0
8580056|NCT00193206|9613390|FG000|STARTED|Postoperative Therapy||116
8580057|NCT00193206|9613390|FG000|COMPLETED|Postoperative Therapy||102
8580058|NCT00193206|9613390|FG000|NOT COMPLETED|Postoperative Therapy||14
8580059|NCT00193258|9613394|FG000|STARTED|Overall Study||94
8580060|NCT00193258|9613394|FG000|COMPLETED|Overall Study||94
8580061|NCT00193258|9613394|FG000|NOT COMPLETED|Overall Study||0
8580062|NCT00193375|9613398|FG000|STARTED|Overall Study||60
8580063|NCT00193375|9613398|FG000|COMPLETED|Overall Study||41
8580064|NCT00193375|9613398|FG000|NOT COMPLETED|Overall Study||19
8580065|NCT00193453|9613402|FG000|STARTED|Overall Study||69
8580066|NCT00193453|9613402|FG000|COMPLETED|Overall Study||21
8580067|NCT00193453|9613402|FG000|NOT COMPLETED|Overall Study||48
8580068|NCT00193492|9613408|FG000|STARTED|Overall Study||31
8580069|NCT00193492|9613409|FG001|STARTED|Overall Study||29
8580070|NCT00193492|9613408|FG000|COMPLETED|Overall Study||14
8580071|NCT00193492|9613409|FG001|COMPLETED|Overall Study||14
8580072|NCT00193492|9613408|FG000|NOT COMPLETED|Overall Study||17
8580073|NCT00193492|9613409|FG001|NOT COMPLETED|Overall Study||15
8580074|NCT00193596|9613417|FG000|STARTED|Overall Study||93
8580075|NCT00193596|9613418|FG001|STARTED|Overall Study||105
8580076|NCT00193596|9613417|FG000|COMPLETED|Overall Study||37
8580077|NCT00193596|9613418|FG001|COMPLETED|Overall Study||39
8580078|NCT00193596|9613417|FG000|NOT COMPLETED|Overall Study||56
8580079|NCT00193596|9613418|FG001|NOT COMPLETED|Overall Study||66
8709288|NCT00952289|9755469|FG001|STARTED|Patients Who Crossed Over to Ruxolitinib||111
8709289|NCT00952289|9755468|FG000|COMPLETED|Patients Who Crossed Over to Ruxolitinib||0
8709290|NCT00952289|9755469|FG001|COMPLETED|Patients Who Crossed Over to Ruxolitinib|Number of cross over subjects who were still in the study as of 25 JAN 2013|57
8580080|NCT00193609|9613424|FG000|STARTED|Overall Study||48
8580081|NCT00193609|9613424|FG000|COMPLETED|Overall Study||44
8580082|NCT00193609|9613424|FG000|NOT COMPLETED|Overall Study||4
8580083|NCT00194012|9613430|FG000|STARTED|Randomized Phase||31
8580084|NCT00194012|9613431|FG001|STARTED|Randomized Phase||31
8580085|NCT00194012|9613430|FG000|Received More Than One Dose|Randomized Phase||30
8580086|NCT00194012|9613431|FG001|Received More Than One Dose|Randomized Phase||29
8580087|NCT00194012|9613430|FG000|COMPLETED|Randomized Phase||15
8580088|NCT00194012|9613431|FG001|COMPLETED|Randomized Phase||6
8580089|NCT00194012|9613430|FG000|NOT COMPLETED|Randomized Phase||16
8709291|NCT00952289|9755468|FG000|NOT COMPLETED|Patients Who Crossed Over to Ruxolitinib||0
8709292|NCT00952289|9755469|FG001|NOT COMPLETED|Patients Who Crossed Over to Ruxolitinib||54
8709293|NCT00952315|9755478|FG000|STARTED|Overall Study||90
8709294|NCT00952315|9755479|FG001|STARTED|Overall Study||90
8709295|NCT00952315|9755480|FG002|STARTED|Overall Study||90
8709296|NCT00952315|9755478|FG000|COMPLETED|Overall Study||64
8709297|NCT00952315|9755479|FG001|COMPLETED|Overall Study||66
8709298|NCT00952315|9755480|FG002|COMPLETED|Overall Study||71
8709299|NCT00952315|9755478|FG000|NOT COMPLETED|Overall Study||26
8709300|NCT00952315|9755479|FG001|NOT COMPLETED|Overall Study||24
8709301|NCT00952315|9755480|FG002|NOT COMPLETED|Overall Study||19
8709302|NCT00952341|9755493|FG000|STARTED|Cycle 1||209
8709303|NCT00952341|9755494|FG001|STARTED|Cycle 1||212
8709304|NCT00952341|9755493|FG000|COMPLETED|Cycle 1||189
8709305|NCT00952341|9755494|FG001|COMPLETED|Cycle 1||199
8709306|NCT00952341|9755493|FG000|NOT COMPLETED|Cycle 1||20
8709307|NCT00952341|9755494|FG001|NOT COMPLETED|Cycle 1||13
8709308|NCT00952341|9755493|FG000|STARTED|Cycle 2||110
8580090|NCT00194012|9613431|FG001|NOT COMPLETED|Randomized Phase||25
8580091|NCT00194012|9613430|FG000|STARTED|Open Label Extension (OLE)|Participants from aripiprazole group started OLE (eligible even if randomized period not completed).|22
8709309|NCT00952341|9755494|FG001|STARTED|Cycle 2||130
8580092|NCT00194012|9613431|FG001|STARTED|Open Label Extension (OLE)|Participants from placebo group started OLE (eligible even if randomized period not completed).|21
8580093|NCT00194012|9613430|FG000|COMPLETED|Open Label Extension (OLE)||17
8580094|NCT00194012|9613431|FG001|COMPLETED|Open Label Extension (OLE)||15
8580095|NCT00194012|9613430|FG000|NOT COMPLETED|Open Label Extension (OLE)||5
8580096|NCT00194012|9613431|FG001|NOT COMPLETED|Open Label Extension (OLE)||6
8580097|NCT00194025|9613443|FG000|STARTED|Overall Study|The intent-to-treat population received at least one dose of valproate semisodium.|20
8580098|NCT00194025|9613443|FG000|COMPLETED|Overall Study|5 participants withdrew prematurely|15
8580099|NCT00194025|9613443|FG000|NOT COMPLETED|Overall Study||5
8580100|NCT00194077|9613449|FG000|STARTED|Overall Study||30
8580101|NCT00194077|9613450|FG001|STARTED|Overall Study||30
8580102|NCT00194077|9613449|FG000|COMPLETED|Overall Study|"Lack of efficacy:~Hypomania n=12 Cycling n=5 Mixed state=4 Mania n=1"|6
8580103|NCT00194077|9613450|FG001|COMPLETED|Overall Study|"Lack of efficacy:~hypomania n=17 Cycling n=6 Mania n=5 Mixed state n=1 Concern regarding tx n=1"|0
8580104|NCT00194077|9613449|FG000|NOT COMPLETED|Overall Study||24
8580105|NCT00194077|9613450|FG001|NOT COMPLETED|Overall Study||30
8580106|NCT00194116|9613458|FG000|STARTED|Overall Study||26
8580107|NCT00194116|9613459|FG001|STARTED|Overall Study||28
8580108|NCT00194116|9613458|FG000|COMPLETED|Overall Study||13
8580109|NCT00194116|9613459|FG001|COMPLETED|Overall Study||13
8580110|NCT00194116|9613458|FG000|NOT COMPLETED|Overall Study||13
8580111|NCT00194116|9613459|FG001|NOT COMPLETED|Overall Study||15
8580112|NCT00194129|9613467|FG000|STARTED|Overall Study||15
8580113|NCT00194129|9613468|FG001|STARTED|Overall Study||16
8580114|NCT00194129|9613467|FG000|COMPLETED|Overall Study||5
8580115|NCT00194129|9613468|FG001|COMPLETED|Overall Study||3
8580116|NCT00194129|9613467|FG000|NOT COMPLETED|Overall Study||10
8580117|NCT00194129|9613468|FG001|NOT COMPLETED|Overall Study||13
8580118|NCT00194532|9613483|FG000|STARTED|Overall Study||150
8580119|NCT00194532|9613484|FG001|STARTED|Overall Study||150
8580120|NCT00194532|9613483|FG000|COMPLETED|Overall Study||150
8580121|NCT00194532|9613484|FG001|COMPLETED|Overall Study||150
8580122|NCT00194532|9613483|FG000|NOT COMPLETED|Overall Study||0
8580123|NCT00194532|9613484|FG001|NOT COMPLETED|Overall Study||0
8580124|NCT00194610|9613492|FG000|STARTED|Overall Study||11
8580125|NCT00194610|9613493|FG001|STARTED|Overall Study||9
8580126|NCT00194610|9613492|FG000|COMPLETED|Overall Study||11
8580127|NCT00194610|9613493|FG001|COMPLETED|Overall Study||9
8580128|NCT00194610|9613492|FG000|NOT COMPLETED|Overall Study||0
8580129|NCT00194610|9613493|FG001|NOT COMPLETED|Overall Study||0
8580130|NCT00194675|9613501|FG000|STARTED|Overall Study||27
8580131|NCT00194675|9613502|FG001|STARTED|Overall Study||26
8580132|NCT00194675|9613501|FG000|COMPLETED|Overall Study||22
8580133|NCT00194675|9613502|FG001|COMPLETED|Overall Study||24
8580134|NCT00194675|9613501|FG000|NOT COMPLETED|Overall Study||5
8580135|NCT00194675|9613502|FG001|NOT COMPLETED|Overall Study||2
8580136|NCT00194779|9613510|FG000|STARTED|Overall Study||50
8580137|NCT00194779|9613510|FG000|COMPLETED|Overall Study||50
8580138|NCT00194779|9613510|FG000|NOT COMPLETED|Overall Study||0
8580139|NCT00194792|9613514|FG000|STARTED|Overall Study||28
8580140|NCT00194792|9613514|FG000|COMPLETED|Overall Study||27
8580141|NCT00194792|9613514|FG000|NOT COMPLETED|Overall Study||1
8580142|NCT00194896|9613522|FG000|STARTED|Overall Study||15
8580143|NCT00194896|9613523|FG001|STARTED|Overall Study||15
8580144|NCT00194896|9613524|FG002|STARTED|Overall Study||13
8580145|NCT00194896|9613525|FG003|STARTED|Overall Study||21
8580146|NCT00194896|9613522|FG000|COMPLETED|Overall Study||4
8580147|NCT00194896|9613523|FG001|COMPLETED|Overall Study||10
8580148|NCT00194896|9613524|FG002|COMPLETED|Overall Study||7
8580149|NCT00194896|9613525|FG003|COMPLETED|Overall Study||9
8580150|NCT00194896|9613522|FG000|NOT COMPLETED|Overall Study||11
8580151|NCT00194896|9613523|FG001|NOT COMPLETED|Overall Study||5
8580152|NCT00194896|9613524|FG002|NOT COMPLETED|Overall Study||6
8580153|NCT00194896|9613525|FG003|NOT COMPLETED|Overall Study||12
8580154|NCT00194987|9613537|FG000|STARTED|Overall Study||51
8580155|NCT00194987|9613538|FG001|STARTED|Overall Study||51
8580156|NCT00194987|9613537|FG000|COMPLETED|Overall Study||51
8580157|NCT00194987|9613538|FG001|COMPLETED|Overall Study|"3 women chose to withdraw because they felt the study was too inconvenient."|48
8580158|NCT00194987|9613537|FG000|NOT COMPLETED|Overall Study||0
8580159|NCT00194987|9613538|FG001|NOT COMPLETED|Overall Study||3
8580160|NCT00195013|9613548|FG000|STARTED|Overall Study||14
8580161|NCT00195013|9613549|FG001|STARTED|Overall Study||16
8580162|NCT00195013|9613548|FG000|COMPLETED|Overall Study||12
8580163|NCT00195013|9613549|FG001|COMPLETED|Overall Study||15
8580164|NCT00195013|9613548|FG000|NOT COMPLETED|Overall Study||2
8580165|NCT00195013|9613549|FG001|NOT COMPLETED|Overall Study||1
8580166|NCT00195039|9613555|FG000|STARTED|Overall Study||47
8580167|NCT00195039|9613555|FG000|COMPLETED|Overall Study||47
8580168|NCT00195039|9613555|FG000|NOT COMPLETED|Overall Study||0
8580169|NCT00195260|9613561|FG000|STARTED|Part 1: Dose Escalation||4
8580170|NCT00195260|9613562|FG001|STARTED|Part 1: Dose Escalation||4
8580171|NCT00195260|9613563|FG002|STARTED|Part 1: Dose Escalation||6
8580172|NCT00195260|9613564|FG003|STARTED|Part 1: Dose Escalation||7
8580173|NCT00195260|9613565|FG004|STARTED|Part 1: Dose Escalation||7
8580174|NCT00195260|9613566|FG005|STARTED|Part 1: Dose Escalation||7
8580175|NCT00195260|9613567|FG006|STARTED|Part 1: Dose Escalation||10
8580176|NCT00195260|9613568|FG007|STARTED|Part 1: Dose Escalation||6
8580177|NCT00195260|9613569|FG008|STARTED|Part 1: Dose Escalation||0
8580178|NCT00195260|9613570|FG009|STARTED|Part 1: Dose Escalation||0
8580179|NCT00195260|9613571|FG010|STARTED|Part 1: Dose Escalation||0
8580180|NCT00195260|9613561|FG000|COMPLETED|Part 1: Dose Escalation||0
8580181|NCT00195260|9613562|FG001|COMPLETED|Part 1: Dose Escalation||0
8580182|NCT00195260|9613563|FG002|COMPLETED|Part 1: Dose Escalation||0
8580183|NCT00195260|9613564|FG003|COMPLETED|Part 1: Dose Escalation||0
8580184|NCT00195260|9613565|FG004|COMPLETED|Part 1: Dose Escalation||0
8580185|NCT00195260|9613566|FG005|COMPLETED|Part 1: Dose Escalation||0
8580186|NCT00195260|9613567|FG006|COMPLETED|Part 1: Dose Escalation||0
8580187|NCT00195260|9613568|FG007|COMPLETED|Part 1: Dose Escalation||0
8580188|NCT00195260|9613569|FG008|COMPLETED|Part 1: Dose Escalation||0
8580189|NCT00195260|9613570|FG009|COMPLETED|Part 1: Dose Escalation||0
8580190|NCT00195260|9613571|FG010|COMPLETED|Part 1: Dose Escalation||0
8580191|NCT00195260|9613561|FG000|NOT COMPLETED|Part 1: Dose Escalation||4
8580192|NCT00195260|9613562|FG001|NOT COMPLETED|Part 1: Dose Escalation||4
8580193|NCT00195260|9613563|FG002|NOT COMPLETED|Part 1: Dose Escalation||6
8580194|NCT00195260|9613564|FG003|NOT COMPLETED|Part 1: Dose Escalation||7
8580195|NCT00195260|9613565|FG004|NOT COMPLETED|Part 1: Dose Escalation||7
8580196|NCT00195260|9613566|FG005|NOT COMPLETED|Part 1: Dose Escalation||7
8580197|NCT00195260|9613567|FG006|NOT COMPLETED|Part 1: Dose Escalation||10
8580198|NCT00195260|9613568|FG007|NOT COMPLETED|Part 1: Dose Escalation||6
8580199|NCT00195260|9613569|FG008|NOT COMPLETED|Part 1: Dose Escalation||0
8580200|NCT00195260|9613570|FG009|NOT COMPLETED|Part 1: Dose Escalation||0
8580201|NCT00195260|9613571|FG010|NOT COMPLETED|Part 1: Dose Escalation||0
8580202|NCT00195260|9613561|FG000|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8580203|NCT00195260|9613562|FG001|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8580204|NCT00195260|9613563|FG002|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8580205|NCT00195260|9613564|FG003|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8580206|NCT00195260|9613565|FG004|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8580207|NCT00195260|9613566|FG005|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8580208|NCT00195260|9613567|FG006|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8580209|NCT00195260|9613568|FG007|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8580210|NCT00195260|9613569|FG008|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||37
8580211|NCT00195260|9613570|FG009|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||38
8580212|NCT00195260|9613571|FG010|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||25
8580213|NCT00195260|9613561|FG000|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8580214|NCT00195260|9613562|FG001|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8580215|NCT00195260|9613563|FG002|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8580216|NCT00195260|9613564|FG003|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8580217|NCT00195260|9613565|FG004|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8580218|NCT00195260|9613566|FG005|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8580219|NCT00195260|9613567|FG006|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8580220|NCT00195260|9613568|FG007|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8580221|NCT00195260|9613569|FG008|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||4
8580222|NCT00195260|9613570|FG009|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8580223|NCT00195260|9613571|FG010|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||2
8580224|NCT00195260|9613561|FG000|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8580225|NCT00195260|9613562|FG001|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8580226|NCT00195260|9613563|FG002|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8580227|NCT00195260|9613564|FG003|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8580228|NCT00195260|9613565|FG004|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8580229|NCT00195260|9613566|FG005|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8580230|NCT00195260|9613567|FG006|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8580231|NCT00195260|9613568|FG007|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8580232|NCT00195260|9613569|FG008|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||33
8580233|NCT00195260|9613570|FG009|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||38
8580234|NCT00195260|9613571|FG010|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||23
8580235|NCT00195273|9613601|FG000|STARTED|Overall Study||31
8580236|NCT00195273|9613602|FG001|STARTED|Overall Study||30
8580237|NCT00195273|9613601|FG000|COMPLETED|Overall Study||10
8580238|NCT00195273|9613602|FG001|COMPLETED|Overall Study||16
8580239|NCT00195273|9613601|FG000|NOT COMPLETED|Overall Study||21
8580240|NCT00195273|9613602|FG001|NOT COMPLETED|Overall Study||14
8580241|NCT00195338|9613608|FG000|STARTED|Overall Study||25
8580242|NCT00195338|9613608|FG000|COMPLETED|Overall Study||13
8580243|NCT00195338|9613608|FG000|NOT COMPLETED|Overall Study||12
8580244|NCT00195351|9613614|FG000|STARTED|Overall Study||236
8580245|NCT00195351|9613615|FG001|STARTED|Overall Study||231
8580246|NCT00195351|9613614|FG000|COMPLETED|Overall Study||215
8580247|NCT00195351|9613615|FG001|COMPLETED|Overall Study||215
8580248|NCT00195351|9613614|FG000|NOT COMPLETED|Overall Study||21
8580249|NCT00195351|9613615|FG001|NOT COMPLETED|Overall Study||16
8580250|NCT00195403|9613621|FG000|STARTED|Overall Study||1014
8580251|NCT00195403|9613621|FG000|COMPLETED|Overall Study||1014
8580252|NCT00195403|9613621|FG000|NOT COMPLETED|Overall Study||0
8580253|NCT00195429|9613627|FG000|STARTED|Overall Study||24
8580254|NCT00195429|9613628|FG001|STARTED|Overall Study||23
8580255|NCT00195429|9613627|FG000|COMPLETED|Overall Study||19
8580256|NCT00195429|9613628|FG001|COMPLETED|Overall Study||18
8580257|NCT00195429|9613627|FG000|NOT COMPLETED|Overall Study||5
8580258|NCT00195429|9613628|FG001|NOT COMPLETED|Overall Study||5
8580259|NCT00195442|9613634|FG000|STARTED|Overall Study||288
9064235|NCT04322500|10124500|FG001|NOT COMPLETED|Overall Study||0
8580260|NCT00195442|9613634|FG000|COMPLETED|Overall Study||152
8580261|NCT00195442|9613634|FG000|NOT COMPLETED|Overall Study||136
8580262|NCT00195494|9613640|FG000|STARTED|Year 1||0
8580263|NCT00195494|9613641|FG001|STARTED|Year 1||0
8580264|NCT00195494|9613642|FG002|STARTED|Year 1||0
8580265|NCT00195494|9613643|FG003|STARTED|Year 1||0
8580266|NCT00195494|9613644|FG004|STARTED|Year 1||268
8580267|NCT00195494|9613645|FG005|STARTED|Year 1||274
8580268|NCT00195494|9613640|FG000|COMPLETED|Year 1||0
8580269|NCT00195494|9613641|FG001|COMPLETED|Year 1||0
8580270|NCT00195494|9613642|FG002|COMPLETED|Year 1||0
8580271|NCT00195494|9613643|FG003|COMPLETED|Year 1||0
8580272|NCT00195494|9613644|FG004|COMPLETED|Year 1||189
8580273|NCT00195494|9613645|FG005|COMPLETED|Year 1||221
8580274|NCT00195494|9613640|FG000|NOT COMPLETED|Year 1||0
8580275|NCT00195494|9613641|FG001|NOT COMPLETED|Year 1||0
8580276|NCT00195494|9613642|FG002|NOT COMPLETED|Year 1||0
8580277|NCT00195494|9613643|FG003|NOT COMPLETED|Year 1||0
8580278|NCT00195494|9613644|FG004|NOT COMPLETED|Year 1||79
8580279|NCT00195494|9613645|FG005|NOT COMPLETED|Year 1||53
8580280|NCT00195494|9613640|FG000|STARTED|Year 2|A patient with Year 1 termination had taken drug briefly during Year 2 and thus counted in the data.|111
8580281|NCT00195494|9613641|FG001|STARTED|Year 2||90
8580282|NCT00195494|9613642|FG002|STARTED|Year 2|A patient with Year 1 termination had taken drug briefly during Year 2 and thus counted in the data.|111
8580283|NCT00195494|9613643|FG003|STARTED|Year 2||99
8580284|NCT00195494|9613644|FG004|STARTED|Year 2||0
8580285|NCT00195494|9613645|FG005|STARTED|Year 2||0
8580286|NCT00195494|9613640|FG000|COMPLETED|Year 2||104
8580287|NCT00195494|9613641|FG001|COMPLETED|Year 2||74
8580288|NCT00195494|9613642|FG002|COMPLETED|Year 2||93
8580289|NCT00195494|9613643|FG003|COMPLETED|Year 2||76
8709310|NCT00952341|9755493|FG000|COMPLETED|Cycle 2||101
8709311|NCT00952341|9755494|FG001|COMPLETED|Cycle 2||118
8709312|NCT00952341|9755493|FG000|NOT COMPLETED|Cycle 2||9
8709313|NCT00952341|9755494|FG001|NOT COMPLETED|Cycle 2||12
8709314|NCT00952367|9755500|FG000|STARTED|Overall Study||3641
8709315|NCT00952367|9755500|FG000|COMPLETED|Overall Study||3635
8709316|NCT00952367|9755500|FG000|NOT COMPLETED|Overall Study||6
8709317|NCT00952380|9755509|FG000|STARTED|Overall Study||1
8709318|NCT00952380|9755510|FG001|STARTED|Overall Study||2
8709319|NCT00952380|9755511|FG002|STARTED|Overall Study||8
8709320|NCT00952380|9755512|FG003|STARTED|Overall Study||7
8709321|NCT00952380|9755513|FG004|STARTED|Overall Study||20
8709322|NCT00952380|9755509|FG000|COMPLETED|Overall Study||1
8709323|NCT00952380|9755510|FG001|COMPLETED|Overall Study||1
8709324|NCT00952380|9755511|FG002|COMPLETED|Overall Study||6
8709325|NCT00952380|9755512|FG003|COMPLETED|Overall Study||4
8812987|NCT01523392|9866081|FG000|NOT COMPLETED|Treatment Period 2||0
8812988|NCT01523392|9866082|FG001|NOT COMPLETED|Treatment Period 2||0
8812989|NCT01523457|9866092|FG000|STARTED|Overall Study||44
8812990|NCT01523457|9866093|FG001|STARTED|Overall Study||31
8812991|NCT01523457|9866092|FG000|COMPLETED|Overall Study||37
8812992|NCT01523457|9866093|FG001|COMPLETED|Overall Study||29
8812993|NCT01523457|9866092|FG000|NOT COMPLETED|Overall Study||7
8812994|NCT01523457|9866093|FG001|NOT COMPLETED|Overall Study||2
8812995|NCT01523496|9866103|FG000|STARTED|Overall Study|The supplementation group includes medium and high dose vitamin D supplementation|66
8812996|NCT01523496|9866104|FG001|STARTED|Overall Study||36
8812997|NCT01523496|9866105|FG002|STARTED|Overall Study|The supplementation group includes medium and high dose vitamin D supplementation|58
8812998|NCT01523496|9866106|FG003|STARTED|Overall Study||30
8812999|NCT01523496|9866103|FG000|COMPLETED|Overall Study||56
8813000|NCT01523496|9866104|FG001|COMPLETED|Overall Study||32
8813001|NCT01523496|9866105|FG002|COMPLETED|Overall Study||46
8813002|NCT01523496|9866106|FG003|COMPLETED|Overall Study||27
8813003|NCT01523496|9866103|FG000|NOT COMPLETED|Overall Study||10
8813004|NCT01523496|9866104|FG001|NOT COMPLETED|Overall Study||4
8813005|NCT01523496|9866105|FG002|NOT COMPLETED|Overall Study||12
8813006|NCT01523496|9866106|FG003|NOT COMPLETED|Overall Study||3
9064236|NCT04322682|10124508|FG000|STARTED|Overall Study||2235
9064237|NCT04322682|10124509|FG001|STARTED|Overall Study||2253
9064238|NCT04322682|10124508|FG000|COMPLETED|Overall Study||2192
9064239|NCT04322682|10124509|FG001|COMPLETED|Overall Study||2189
9064240|NCT04322682|10124508|FG000|NOT COMPLETED|Overall Study||43
8580290|NCT00195494|9613644|FG004|COMPLETED|Year 2||0
8580291|NCT00195494|9613645|FG005|COMPLETED|Year 2||0
8580292|NCT00195494|9613640|FG000|NOT COMPLETED|Year 2||7
8580293|NCT00195494|9613641|FG001|NOT COMPLETED|Year 2||16
8580294|NCT00195494|9613642|FG002|NOT COMPLETED|Year 2||18
8580295|NCT00195494|9613643|FG003|NOT COMPLETED|Year 2||23
8580296|NCT00195494|9613644|FG004|NOT COMPLETED|Year 2||0
8580297|NCT00195494|9613645|FG005|NOT COMPLETED|Year 2||0
8709326|NCT00952380|9755513|FG004|COMPLETED|Overall Study||14
8709327|NCT00952380|9755509|FG000|NOT COMPLETED|Overall Study||0
8709328|NCT00952380|9755510|FG001|NOT COMPLETED|Overall Study||1
8709329|NCT00952380|9755511|FG002|NOT COMPLETED|Overall Study||2
8709330|NCT00952380|9755512|FG003|NOT COMPLETED|Overall Study||3
8709331|NCT00952380|9755513|FG004|NOT COMPLETED|Overall Study||6
8709332|NCT00952393|9755530|FG000|STARTED|Overall Study|10|10
8709333|NCT00952393|9755530|FG000|COMPLETED|Overall Study||10
8709334|NCT00952393|9755530|FG000|NOT COMPLETED|Overall Study||0
8709335|NCT00952419|9755537|FG000|STARTED|Overall Study||215
8709336|NCT00952419|9755538|FG001|STARTED|Overall Study||208
8709337|NCT00952419|9755539|FG002|STARTED|Overall Study||51
8709338|NCT00952419|9755537|FG000|COMPLETED|Overall Study||209
8709339|NCT00952419|9755538|FG001|COMPLETED|Overall Study||198
8580298|NCT00195507|9613663|FG000|STARTED|Overall Study||357
8580299|NCT00195507|9613664|FG001|STARTED|Overall Study||363
8580300|NCT00195507|9613663|FG000|COMPLETED|Overall Study||258
8580301|NCT00195507|9613664|FG001|COMPLETED|Overall Study||245
8580302|NCT00195507|9613663|FG000|NOT COMPLETED|Overall Study||99
8580303|NCT00195507|9613664|FG001|NOT COMPLETED|Overall Study||118
8580304|NCT00195624|9613672|FG000|STARTED|Overall Study||5
8580305|NCT00195624|9613673|FG001|STARTED|Overall Study||42
8580306|NCT00195624|9613672|FG000|COMPLETED|Overall Study||5
8580307|NCT00195624|9613673|FG001|COMPLETED|Overall Study||42
8580308|NCT00195624|9613672|FG000|NOT COMPLETED|Overall Study||0
8580309|NCT00195624|9613673|FG001|NOT COMPLETED|Overall Study||0
8580310|NCT00195650|9613679|FG000|STARTED|Overall Study|Participants who received at least 1 adalimumab dose in study;3 enrolled did not receive adalimumab.|846
8580311|NCT00195650|9613679|FG000|COMPLETED|Overall Study||321
8580312|NCT00195650|9613679|FG000|NOT COMPLETED|Overall Study||525
8580313|NCT00195663|9613686|FG000|STARTED|2-year Double-blind Treatment Period||257
8580314|NCT00195663|9613687|FG001|STARTED|2-year Double-blind Treatment Period||274
8580315|NCT00195663|9613688|FG002|STARTED|2-year Double-blind Treatment Period||268
8580316|NCT00195663|9613686|FG000|COMPLETED|2-year Double-blind Treatment Period||164
8580317|NCT00195663|9613687|FG001|COMPLETED|2-year Double-blind Treatment Period||166
8580318|NCT00195663|9613688|FG002|COMPLETED|2-year Double-blind Treatment Period||196
8580319|NCT00195663|9613686|FG000|NOT COMPLETED|2-year Double-blind Treatment Period||93
8580320|NCT00195663|9613687|FG001|NOT COMPLETED|2-year Double-blind Treatment Period||108
8580321|NCT00195663|9613688|FG002|NOT COMPLETED|2-year Double-blind Treatment Period||72
8580322|NCT00195663|9613686|FG000|STARTED|Open-Label Extension Period||155
8580323|NCT00195663|9613687|FG001|STARTED|Open-Label Extension Period||159
8580324|NCT00195663|9613688|FG002|STARTED|Open-Label Extension Period||183
8580325|NCT00195663|9613686|FG000|COMPLETED|Open-Label Extension Period||79
8580326|NCT00195663|9613687|FG001|COMPLETED|Open-Label Extension Period||85
8580327|NCT00195663|9613688|FG002|COMPLETED|Open-Label Extension Period||86
8580328|NCT00195663|9613686|FG000|NOT COMPLETED|Open-Label Extension Period||76
8580329|NCT00195663|9613687|FG001|NOT COMPLETED|Open-Label Extension Period||74
8580330|NCT00195663|9613688|FG002|NOT COMPLETED|Open-Label Extension Period||97
8580331|NCT00195676|9613706|FG000|STARTED|Period O - Open-label Treatment|Number receiving adalimumab in Period O (1 additional participant enrolled but did not receive drug)|1468
8580332|NCT00195676|9613706|FG000|COMPLETED|Period O - Open-label Treatment|254 Period O completers did not consent or were not eligible to continue into Period W and Period R.|862
8580333|NCT00195676|9613706|FG000|NOT COMPLETED|Period O - Open-label Treatment||606
8580334|NCT00195676|9613706|FG000|STARTED|Period W (Withdrawal) - No Treatment|Period O completers with a Physician's Global Assessment =<2 who continued into Periods W and R.|608
8580335|NCT00195676|9613706|FG000|COMPLETED|Period W (Withdrawal) - No Treatment|Non-completers may have entered Period R, whether or not they relapsed (PGA >= 3).|0
8580336|NCT00195676|9613706|FG000|NOT COMPLETED|Period W (Withdrawal) - No Treatment||608
8580337|NCT00195676|9613706|FG000|STARTED|Period R - Retreatment 16 Weeks|Number who entered from Period W, including those who did and did not relapse in that period.|525
8580338|NCT00195676|9613706|FG000|COMPLETED|Period R - Retreatment 16 Weeks||490
8580339|NCT00195676|9613706|FG000|NOT COMPLETED|Period R - Retreatment 16 Weeks||35
8580340|NCT00195702|9613717|FG000|STARTED|Double-blind Phase|For all groups, started indicates when the subjects entered the 52-week double-blind phase.|212
8580341|NCT00195702|9613718|FG001|STARTED|Double-blind Phase||207
8580342|NCT00195702|9613719|FG002|STARTED|Double-blind Phase||200
8580343|NCT00195702|9613720|FG003|STARTED|Double-blind Phase||0
8580344|NCT00195702|9613721|FG004|STARTED|Double-blind Phase||0
8580345|NCT00195702|9613722|FG005|STARTED|Double-blind Phase||0
8580346|NCT00195702|9613717|FG000|COMPLETED|Double-blind Phase||168
8580347|NCT00195702|9613718|FG001|COMPLETED|Double-blind Phase||159
8580348|NCT00195702|9613719|FG002|COMPLETED|Double-blind Phase||140
8580349|NCT00195702|9613720|FG003|COMPLETED|Double-blind Phase||0
8580350|NCT00195702|9613721|FG004|COMPLETED|Double-blind Phase||0
8580351|NCT00195702|9613722|FG005|COMPLETED|Double-blind Phase||0
8580352|NCT00195702|9613717|FG000|NOT COMPLETED|Double-blind Phase||44
8580353|NCT00195702|9613718|FG001|NOT COMPLETED|Double-blind Phase||48
8580354|NCT00195702|9613719|FG002|NOT COMPLETED|Double-blind Phase||60
8580355|NCT00195702|9613720|FG003|NOT COMPLETED|Double-blind Phase||0
8580356|NCT00195702|9613721|FG004|NOT COMPLETED|Double-blind Phase||0
8580357|NCT00195702|9613722|FG005|NOT COMPLETED|Double-blind Phase||0
8580358|NCT00195702|9613717|FG000|STARTED|Open-label Extension Phase||0
8580359|NCT00195702|9613718|FG001|STARTED|Open-label Extension Phase||0
8580360|NCT00195702|9613719|FG002|STARTED|Open-label Extension Phase||0
8580361|NCT00195702|9613720|FG003|STARTED|Open-label Extension Phase|3 subjects completed the double-blind phase but did not enter the open-label extension phase.|165
8580362|NCT00195702|9613721|FG004|STARTED|Open-label Extension Phase|1 subject completed the double-blind phase but did not enter the open-label extension phase.|158
8580363|NCT00195702|9613722|FG005|STARTED|Open-label Extension Phase|6 subjects completed the double-blind phase but did not enter the open-label extension phase.|134
8580364|NCT00195702|9613717|FG000|COMPLETED|Open-label Extension Phase||0
8580365|NCT00195702|9613718|FG001|COMPLETED|Open-label Extension Phase||0
8580366|NCT00195702|9613719|FG002|COMPLETED|Open-label Extension Phase||0
8580367|NCT00195702|9613720|FG003|COMPLETED|Open-label Extension Phase||66
8580368|NCT00195702|9613721|FG004|COMPLETED|Open-label Extension Phase||80
8580369|NCT00195702|9613722|FG005|COMPLETED|Open-label Extension Phase||56
8580370|NCT00195702|9613717|FG000|NOT COMPLETED|Open-label Extension Phase||0
8580371|NCT00195702|9613718|FG001|NOT COMPLETED|Open-label Extension Phase||0
8580372|NCT00195702|9613719|FG002|NOT COMPLETED|Open-label Extension Phase||0
8580373|NCT00195702|9613720|FG003|NOT COMPLETED|Open-label Extension Phase||99
8580374|NCT00195702|9613721|FG004|NOT COMPLETED|Open-label Extension Phase||78
8580375|NCT00195702|9613722|FG005|NOT COMPLETED|Open-label Extension Phase||78
8580376|NCT00195715|9613735|FG000|STARTED|Overall Study||777
8580377|NCT00195715|9613735|FG000|COMPLETED|Overall Study||400
8580378|NCT00195715|9613735|FG000|NOT COMPLETED|Overall Study||377
8580379|NCT00195819|9613739|FG000|STARTED|Double-Blind||44
8580380|NCT00195819|9613740|FG001|STARTED|Double-Blind||38
8580381|NCT00195819|9613739|FG000|COMPLETED|Double-Blind||42
8580382|NCT00195819|9613740|FG001|COMPLETED|Double-Blind||38
8580383|NCT00195819|9613739|FG000|NOT COMPLETED|Double-Blind||2
8580384|NCT00195819|9613740|FG001|NOT COMPLETED|Double-Blind||0
8580385|NCT00195819|9613739|FG000|STARTED|Open-label||0
8580386|NCT00195819|9613740|FG001|STARTED|Open-label||82
8580387|NCT00195819|9613739|FG000|COMPLETED|Open-label||0
8580388|NCT00195819|9613740|FG001|COMPLETED|Open-label||62
8580389|NCT00195819|9613739|FG000|NOT COMPLETED|Open-label||0
8580390|NCT00195819|9613740|FG001|NOT COMPLETED|Open-label||20
8580391|NCT00196105|9613755|FG000|STARTED|Overall Study||64
8580392|NCT00196105|9613756|FG001|STARTED|Overall Study||88
8580393|NCT00196105|9613757|FG002|STARTED|Overall Study||89
8580394|NCT00196105|9613755|FG000|COMPLETED|Overall Study||60
8580395|NCT00196105|9613756|FG001|COMPLETED|Overall Study||83
8580396|NCT00196105|9613757|FG002|COMPLETED|Overall Study||82
8580397|NCT00196105|9613755|FG000|NOT COMPLETED|Overall Study||4
8580398|NCT00196105|9613756|FG001|NOT COMPLETED|Overall Study||5
8580399|NCT00196105|9613757|FG002|NOT COMPLETED|Overall Study||7
8580400|NCT00196196|9613765|FG000|STARTED|Overall Study||274
8580401|NCT00196196|9613765|FG000|COMPLETED|Overall Study||267
8580402|NCT00196196|9613765|FG000|NOT COMPLETED|Overall Study||7
8580403|NCT00196313|9613771|FG000|STARTED|Overall Study||47
8580404|NCT00196313|9613772|FG001|STARTED|Overall Study||48
8580405|NCT00196313|9613771|FG000|COMPLETED|Overall Study||36
8580406|NCT00196313|9613772|FG001|COMPLETED|Overall Study||40
8580407|NCT00196313|9613771|FG000|NOT COMPLETED|Overall Study||11
8580408|NCT00196313|9613772|FG001|NOT COMPLETED|Overall Study||8
8709340|NCT00952419|9755539|FG002|COMPLETED|Overall Study||51
8709341|NCT00952419|9755537|FG000|NOT COMPLETED|Overall Study||6
8709342|NCT00952419|9755538|FG001|NOT COMPLETED|Overall Study||10
8709343|NCT00952419|9755539|FG002|NOT COMPLETED|Overall Study||0
8709344|NCT00952484|9755550|FG000|STARTED|Overall Study||6
8709345|NCT00952484|9755551|FG001|STARTED|Overall Study||7
8709346|NCT00952484|9755552|FG002|STARTED|Overall Study||16
8709347|NCT00952484|9755550|FG000|COMPLETED|Overall Study||6
8709348|NCT00952484|9755551|FG001|COMPLETED|Overall Study||6
8709349|NCT00952484|9755552|FG002|COMPLETED|Overall Study||16
8709350|NCT00952484|9755550|FG000|NOT COMPLETED|Overall Study||0
8709351|NCT00952484|9755551|FG001|NOT COMPLETED|Overall Study||1
8709352|NCT00952484|9755552|FG002|NOT COMPLETED|Overall Study||0
8709353|NCT00952523|9755561|FG000|STARTED|Overall Study||162
8709354|NCT00952523|9755561|FG000|COMPLETED|Overall Study||155
8709355|NCT00952523|9755561|FG000|NOT COMPLETED|Overall Study||7
8709356|NCT00952588|9755569|FG000|STARTED|Overall Study||48
8709357|NCT00952588|9755570|FG001|STARTED|Overall Study||26
8709358|NCT00952588|9755569|FG000|COMPLETED|Overall Study||12
8709359|NCT00952588|9755570|FG001|COMPLETED|Overall Study||2
8709360|NCT00952588|9755569|FG000|NOT COMPLETED|Overall Study||36
8709361|NCT00952588|9755570|FG001|NOT COMPLETED|Overall Study||24
8709362|NCT00952614|9755576|FG000|STARTED|Overall Study||30
8709363|NCT00952614|9755576|FG000|Participants Started Treatment|Overall Study|29 subjects signed consent; 1 agreed for both eyes to enroll. 30 eyes rec'd drug delivery implant|30
8709364|NCT00952614|9755576|FG000|COMPLETED|Overall Study|3 subjects died from unrelated causes, 3 were lost to follow-up & 1 had both eyes included in study.|23
8709365|NCT00952614|9755576|FG000|NOT COMPLETED|Overall Study||7
8580409|NCT00196326|9613779|FG000|STARTED|Overall Study|Took at least one dose of study medication|2235
8580410|NCT00196326|9613779|FG000|Safety Population|Overall Study|Treated participants|2185
8580411|NCT00196326|9613779|FG000|Pregnancy Intent-to-treat Cohort (PITT)|Overall Study|Completed one cycle and 18-35 years old|1735
8580412|NCT00196326|9613779|FG000|COMPLETED|Overall Study||1249
8580413|NCT00196326|9613779|FG000|NOT COMPLETED|Overall Study||986
8580414|NCT00196716|9613783|FG000|STARTED|1.0 mg/kg Period||21
8709366|NCT00952653|9755581|FG000|STARTED|Period 1: MDZ Alone||28
8709367|NCT00952653|9755581|FG000|COMPLETED|Period 1: MDZ Alone||28
8709368|NCT00952653|9755581|FG000|NOT COMPLETED|Period 1: MDZ Alone||0
8709369|NCT00952653|9755581|FG000|STARTED|Period 2: Coadministration DVS SR, MDZ||28
8709370|NCT00952653|9755581|FG000|COMPLETED|Period 2: Coadministration DVS SR, MDZ||28
8709371|NCT00952653|9755581|FG000|NOT COMPLETED|Period 2: Coadministration DVS SR, MDZ||0
8709372|NCT00952705|9755591|FG000|STARTED|Overall Study|Three not treated with Q/LAIV-BFS (1 treated with FluMist/B/Yamagata; 2 withdrew prior to dosing).|1202
8709373|NCT00952705|9755592|FG001|STARTED|Overall Study||300
8709374|NCT00952705|9755593|FG002|STARTED|Overall Study||298
8709375|NCT00952705|9755591|FG000|COMPLETED|Overall Study||1169
8709376|NCT00952705|9755592|FG001|COMPLETED|Overall Study||290
8709377|NCT00952705|9755593|FG002|COMPLETED|Overall Study||288
8709378|NCT00952705|9755591|FG000|NOT COMPLETED|Overall Study||33
8709379|NCT00952705|9755592|FG001|NOT COMPLETED|Overall Study||10
8709380|NCT00952705|9755593|FG002|NOT COMPLETED|Overall Study||10
8709381|NCT00952718|9755607|FG000|STARTED|Overall Study||19
8580415|NCT00196716|9613783|FG000|COMPLETED|1.0 mg/kg Period||21
8580416|NCT00196716|9613783|FG000|NOT COMPLETED|1.0 mg/kg Period||0
8580417|NCT00196716|9613783|FG000|STARTED|0.3 mg/kg Period||21
8580418|NCT00196716|9613783|FG000|COMPLETED|0.3 mg/kg Period||21
8580419|NCT00196716|9613783|FG000|NOT COMPLETED|0.3 mg/kg Period||0
8580420|NCT00196937|9613792|FG000|STARTED|Overall Study||229
8580421|NCT00196937|9613793|FG001|STARTED|Overall Study||226
8580422|NCT00196937|9613794|FG002|STARTED|Overall Study||211
8580423|NCT00196937|9613792|FG000|COMPLETED|Overall Study||220
8580424|NCT00196937|9613793|FG001|COMPLETED|Overall Study||221
8580425|NCT00196937|9613794|FG002|COMPLETED|Overall Study||204
8580426|NCT00196937|9613792|FG000|NOT COMPLETED|Overall Study||9
8580427|NCT00196937|9613793|FG001|NOT COMPLETED|Overall Study||5
8580428|NCT00196937|9613794|FG002|NOT COMPLETED|Overall Study||7
8580429|NCT00196976|9613817|FG000|STARTED|Primary Study||39
8580430|NCT00196976|9613818|FG001|STARTED|Primary Study||41
8580431|NCT00196976|9613819|FG002|STARTED|Primary Study||41
8580432|NCT00196976|9613820|FG003|STARTED|Primary Study||40
8580433|NCT00196976|9613821|FG004|STARTED|Primary Study||40
8580434|NCT00196976|9613822|FG005|STARTED|Primary Study||54
8580435|NCT00196976|9613823|FG006|STARTED|Primary Study||50
8580436|NCT00196976|9613824|FG007|STARTED|Primary Study||52
8580437|NCT00196976|9613825|FG008|STARTED|Primary Study||52
8580438|NCT00196976|9613826|FG009|STARTED|Primary Study||52
8580439|NCT00196976|9613827|FG010|STARTED|Primary Study||0
8580440|NCT00196976|9613828|FG011|STARTED|Primary Study||0
8580441|NCT00196976|9613829|FG012|STARTED|Primary Study||0
8580442|NCT00196976|9613830|FG013|STARTED|Primary Study||0
8580443|NCT00196976|9613817|FG000|COMPLETED|Primary Study||38
8580444|NCT00196976|9613818|FG001|COMPLETED|Primary Study||40
8580445|NCT00196976|9613819|FG002|COMPLETED|Primary Study||37
8580446|NCT00196976|9613820|FG003|COMPLETED|Primary Study||39
8580447|NCT00196976|9613821|FG004|COMPLETED|Primary Study||37
8580448|NCT00196976|9613822|FG005|COMPLETED|Primary Study||52
8580449|NCT00196976|9613823|FG006|COMPLETED|Primary Study||50
8580450|NCT00196976|9613824|FG007|COMPLETED|Primary Study||49
8580451|NCT00196976|9613825|FG008|COMPLETED|Primary Study||52
8580452|NCT00196976|9613826|FG009|COMPLETED|Primary Study||51
8580453|NCT00196976|9613827|FG010|COMPLETED|Primary Study||0
8580454|NCT00196976|9613828|FG011|COMPLETED|Primary Study||0
8580455|NCT00196976|9613829|FG012|COMPLETED|Primary Study||0
8580456|NCT00196976|9613830|FG013|COMPLETED|Primary Study||0
8580457|NCT00196976|9613817|FG000|NOT COMPLETED|Primary Study||1
8580458|NCT00196976|9613818|FG001|NOT COMPLETED|Primary Study||1
8580459|NCT00196976|9613819|FG002|NOT COMPLETED|Primary Study||4
8580460|NCT00196976|9613820|FG003|NOT COMPLETED|Primary Study||1
8580461|NCT00196976|9613821|FG004|NOT COMPLETED|Primary Study||3
8580462|NCT00196976|9613822|FG005|NOT COMPLETED|Primary Study||2
8580463|NCT00196976|9613823|FG006|NOT COMPLETED|Primary Study||0
8580464|NCT00196976|9613824|FG007|NOT COMPLETED|Primary Study||3
8580465|NCT00196976|9613825|FG008|NOT COMPLETED|Primary Study||0
8580466|NCT00196976|9613826|FG009|NOT COMPLETED|Primary Study||1
8580467|NCT00196976|9613827|FG010|NOT COMPLETED|Primary Study||0
8580468|NCT00196976|9613828|FG011|NOT COMPLETED|Primary Study||0
8580469|NCT00196976|9613829|FG012|NOT COMPLETED|Primary Study||0
8580470|NCT00196976|9613830|FG013|NOT COMPLETED|Primary Study||0
8580471|NCT00196976|9613817|FG000|STARTED|Booster Study||0
8580472|NCT00196976|9613818|FG001|STARTED|Booster Study||0
8580473|NCT00196976|9613819|FG002|STARTED|Booster Study||0
8580474|NCT00196976|9613820|FG003|STARTED|Booster Study||0
8709382|NCT00952718|9755608|FG001|STARTED|Overall Study||19
8709383|NCT00952718|9755607|FG000|COMPLETED|Overall Study||13
8709384|NCT00952718|9755608|FG001|COMPLETED|Overall Study||13
8709385|NCT00952718|9755607|FG000|NOT COMPLETED|Overall Study||6
8580475|NCT00196976|9613821|FG004|STARTED|Booster Study||0
8580476|NCT00196976|9613822|FG005|STARTED|Booster Study||0
8580477|NCT00196976|9613823|FG006|STARTED|Booster Study||0
8580478|NCT00196976|9613824|FG007|STARTED|Booster Study||0
8580479|NCT00196976|9613825|FG008|STARTED|Booster Study||0
8580480|NCT00196976|9613826|FG009|STARTED|Booster Study||0
8580481|NCT00196976|9613827|FG010|STARTED|Booster Study||33
8580482|NCT00196976|9613828|FG011|STARTED|Booster Study||32
8580483|NCT00196976|9613829|FG012|STARTED|Booster Study||45
8580484|NCT00196976|9613830|FG013|STARTED|Booster Study||43
8580485|NCT00196976|9613817|FG000|COMPLETED|Booster Study||0
8580486|NCT00196976|9613818|FG001|COMPLETED|Booster Study||0
8580487|NCT00196976|9613819|FG002|COMPLETED|Booster Study||0
8580488|NCT00196976|9613820|FG003|COMPLETED|Booster Study||0
8580489|NCT00196976|9613821|FG004|COMPLETED|Booster Study||0
8580490|NCT00196976|9613822|FG005|COMPLETED|Booster Study||0
8580491|NCT00196976|9613823|FG006|COMPLETED|Booster Study||0
8580492|NCT00196976|9613824|FG007|COMPLETED|Booster Study||0
8580493|NCT00196976|9613825|FG008|COMPLETED|Booster Study||0
8580494|NCT00196976|9613826|FG009|COMPLETED|Booster Study||0
8580495|NCT00196976|9613827|FG010|COMPLETED|Booster Study||31
8580496|NCT00196976|9613828|FG011|COMPLETED|Booster Study||30
8580497|NCT00196976|9613829|FG012|COMPLETED|Booster Study||45
8580498|NCT00196976|9613830|FG013|COMPLETED|Booster Study||43
8580499|NCT00196976|9613817|FG000|NOT COMPLETED|Booster Study||0
8580500|NCT00196976|9613818|FG001|NOT COMPLETED|Booster Study||0
8580501|NCT00196976|9613819|FG002|NOT COMPLETED|Booster Study||0
8580502|NCT00196976|9613820|FG003|NOT COMPLETED|Booster Study||0
8580503|NCT00196976|9613821|FG004|NOT COMPLETED|Booster Study||0
8709386|NCT00952718|9755608|FG001|NOT COMPLETED|Overall Study||6
8580504|NCT00196976|9613822|FG005|NOT COMPLETED|Booster Study||0
8580505|NCT00196976|9613823|FG006|NOT COMPLETED|Booster Study||0
8580506|NCT00196976|9613824|FG007|NOT COMPLETED|Booster Study||0
8580507|NCT00196976|9613825|FG008|NOT COMPLETED|Booster Study||0
8580508|NCT00196976|9613826|FG009|NOT COMPLETED|Booster Study||0
8580509|NCT00196976|9613827|FG010|NOT COMPLETED|Booster Study||2
8580510|NCT00196976|9613828|FG011|NOT COMPLETED|Booster Study||2
8580511|NCT00196976|9613829|FG012|NOT COMPLETED|Booster Study||0
8580512|NCT00196976|9613830|FG013|NOT COMPLETED|Booster Study||0
8580513|NCT00197002|9613873|FG000|STARTED|Overall Study||147
8580514|NCT00197002|9613874|FG001|STARTED|Overall Study||137
8709387|NCT00952731|9755618|FG000|STARTED|Overall Study||13
8709388|NCT00952731|9755619|FG001|STARTED|Overall Study||14
8709389|NCT00952731|9755618|FG000|Randomization|Overall Study||13
8709390|NCT00952731|9755619|FG001|Randomization|Overall Study||14
8709391|NCT00952731|9755618|FG000|Treatment & Pre-Surgery|Overall Study||12
8709392|NCT00952731|9755619|FG001|Treatment & Pre-Surgery|Overall Study||14
8709393|NCT00952731|9755618|FG000|Surgery|Overall Study||12
8709394|NCT00952731|9755619|FG001|Surgery|Overall Study||14
8709395|NCT00952731|9755618|FG000|Follow-up|Overall Study||12
8709396|NCT00952731|9755619|FG001|Follow-up|Overall Study||14
8709397|NCT00952731|9755618|FG000|COMPLETED|Overall Study||12
8709398|NCT00952731|9755619|FG001|COMPLETED|Overall Study||14
8709399|NCT00952731|9755618|FG000|NOT COMPLETED|Overall Study||1
8709400|NCT00952731|9755619|FG001|NOT COMPLETED|Overall Study||0
8709401|NCT00952822|9755625|FG000|STARTED|1st Pharmacokinetic Evaluation||9
8709402|NCT00952822|9755626|FG001|STARTED|1st Pharmacokinetic Evaluation||18
8709403|NCT00952822|9755627|FG002|STARTED|1st Pharmacokinetic Evaluation||11
8709404|NCT00952822|9755628|FG003|STARTED|1st Pharmacokinetic Evaluation||4
8709405|NCT00952822|9755625|FG000|COMPLETED|1st Pharmacokinetic Evaluation||9
8709406|NCT00952822|9755626|FG001|COMPLETED|1st Pharmacokinetic Evaluation||17
8709407|NCT00952822|9755627|FG002|COMPLETED|1st Pharmacokinetic Evaluation||11
8709408|NCT00952822|9755628|FG003|COMPLETED|1st Pharmacokinetic Evaluation||4
8709409|NCT00952822|9755625|FG000|NOT COMPLETED|1st Pharmacokinetic Evaluation||0
8709410|NCT00952822|9755626|FG001|NOT COMPLETED|1st Pharmacokinetic Evaluation||1
8709411|NCT00952822|9755627|FG002|NOT COMPLETED|1st Pharmacokinetic Evaluation||0
8709412|NCT00952822|9755628|FG003|NOT COMPLETED|1st Pharmacokinetic Evaluation||0
8709413|NCT00952822|9755625|FG000|STARTED|2nd Pharmacokinetic Evaluation||9
8709414|NCT00952822|9755626|FG001|STARTED|2nd Pharmacokinetic Evaluation||17
8709415|NCT00952822|9755627|FG002|STARTED|2nd Pharmacokinetic Evaluation||11
8709416|NCT00952822|9755628|FG003|STARTED|2nd Pharmacokinetic Evaluation||4
8709417|NCT00952822|9755625|FG000|COMPLETED|2nd Pharmacokinetic Evaluation||9
8709418|NCT00952822|9755626|FG001|COMPLETED|2nd Pharmacokinetic Evaluation||17
8709419|NCT00952822|9755627|FG002|COMPLETED|2nd Pharmacokinetic Evaluation||10
8709420|NCT00952822|9755628|FG003|COMPLETED|2nd Pharmacokinetic Evaluation||4
8709421|NCT00952822|9755625|FG000|NOT COMPLETED|2nd Pharmacokinetic Evaluation||0
8709422|NCT00952822|9755626|FG001|NOT COMPLETED|2nd Pharmacokinetic Evaluation||0
8709423|NCT00952822|9755627|FG002|NOT COMPLETED|2nd Pharmacokinetic Evaluation||1
8709424|NCT00952822|9755628|FG003|NOT COMPLETED|2nd Pharmacokinetic Evaluation||0
8709425|NCT00952848|9755639|FG000|STARTED|Overall Study||18
8709426|NCT00952848|9755639|FG000|COMPLETED|Overall Study||14
8709427|NCT00952848|9755639|FG000|NOT COMPLETED|Overall Study||4
8709428|NCT00953017|9755647|FG000|STARTED|Overall Study||106
8709429|NCT00953017|9755648|FG001|STARTED|Overall Study||107
8709430|NCT00953017|9755649|FG002|STARTED|Overall Study||106
8709431|NCT00953017|9755650|FG003|STARTED|Overall Study||106
8709432|NCT00953017|9755647|FG000|COMPLETED|Overall Study||101
8709433|NCT00953017|9755648|FG001|COMPLETED|Overall Study||101
8709434|NCT00953017|9755649|FG002|COMPLETED|Overall Study||100
8709435|NCT00953017|9755650|FG003|COMPLETED|Overall Study||101
8709436|NCT00953017|9755647|FG000|NOT COMPLETED|Overall Study||5
8709437|NCT00953017|9755648|FG001|NOT COMPLETED|Overall Study||6
8709438|NCT00953017|9755649|FG002|NOT COMPLETED|Overall Study||6
8709439|NCT00953017|9755650|FG003|NOT COMPLETED|Overall Study||5
8709440|NCT00953043|9755662|FG000|STARTED|Overall Study||30
8709441|NCT00953043|9755663|FG001|STARTED|Overall Study||30
8709442|NCT00953043|9755662|FG000|COMPLETED|Overall Study||26
8709443|NCT00953043|9755663|FG001|COMPLETED|Overall Study||28
8709444|NCT00953043|9755662|FG000|NOT COMPLETED|Overall Study||4
8709445|NCT00953043|9755663|FG001|NOT COMPLETED|Overall Study||2
8709446|NCT00953056|9755675|FG000|STARTED|Overall Study||24
8709447|NCT00953056|9755676|FG001|STARTED|Overall Study||24
8709448|NCT00953056|9755677|FG002|STARTED|Overall Study||24
8709449|NCT00953056|9755678|FG003|STARTED|Overall Study||24
8709450|NCT00953056|9755679|FG004|STARTED|Overall Study||24
8709451|NCT00953056|9755680|FG005|STARTED|Overall Study||24
8709452|NCT00953056|9755675|FG000|COMPLETED|Overall Study||24
8709453|NCT00953056|9755676|FG001|COMPLETED|Overall Study||24
8709454|NCT00953056|9755677|FG002|COMPLETED|Overall Study||24
8709455|NCT00953056|9755678|FG003|COMPLETED|Overall Study||24
8709456|NCT00953056|9755679|FG004|COMPLETED|Overall Study|One participant received placebo at the second dose in error, but completed the study.|22
8709457|NCT00953056|9755680|FG005|COMPLETED|Overall Study||20
8709458|NCT00953056|9755675|FG000|NOT COMPLETED|Overall Study||0
8709459|NCT00953056|9755676|FG001|NOT COMPLETED|Overall Study||0
8709460|NCT00953056|9755677|FG002|NOT COMPLETED|Overall Study||0
8580515|NCT00197002|9613875|FG002|STARTED|Overall Study||149
8580516|NCT00197002|9613873|FG000|COMPLETED|Overall Study||125
8580517|NCT00197002|9613874|FG001|COMPLETED|Overall Study||119
8580518|NCT00197002|9613875|FG002|COMPLETED|Overall Study||132
8580519|NCT00197002|9613873|FG000|NOT COMPLETED|Overall Study||22
8580520|NCT00197002|9613874|FG001|NOT COMPLETED|Overall Study||18
8580521|NCT00197002|9613875|FG002|NOT COMPLETED|Overall Study||17
8580522|NCT00197015|9613889|FG000|STARTED|Overall Study||324
8580523|NCT00197015|9613890|FG001|STARTED|Overall Study||455
8580524|NCT00197015|9613891|FG002|STARTED|Overall Study||462
8580525|NCT00197015|9613889|FG000|COMPLETED|Overall Study||274
8580526|NCT00197015|9613890|FG001|COMPLETED|Overall Study||366
8580527|NCT00197015|9613891|FG002|COMPLETED|Overall Study||385
8580528|NCT00197015|9613889|FG000|NOT COMPLETED|Overall Study||50
8580529|NCT00197015|9613890|FG001|NOT COMPLETED|Overall Study||89
8580530|NCT00197015|9613891|FG002|NOT COMPLETED|Overall Study||77
8580531|NCT00197028|9613901|FG000|STARTED|Overall Study||107
8580532|NCT00197028|9613902|FG001|STARTED|Overall Study||107
8580533|NCT00197028|9613901|FG000|COMPLETED|Overall Study||91
8580534|NCT00197028|9613902|FG001|COMPLETED|Overall Study||86
8580535|NCT00197028|9613901|FG000|NOT COMPLETED|Overall Study||16
8580536|NCT00197028|9613902|FG001|NOT COMPLETED|Overall Study||21
8580537|NCT00197054|9613911|FG000|STARTED|Overall Study||85
8580538|NCT00197054|9613912|FG001|STARTED|Overall Study||85
8580539|NCT00197054|9613913|FG002|STARTED|Overall Study||85
8580540|NCT00197054|9613911|FG000|COMPLETED|Overall Study||68
8709461|NCT00953056|9755678|FG003|NOT COMPLETED|Overall Study||0
8709462|NCT00953056|9755679|FG004|NOT COMPLETED|Overall Study||2
8709463|NCT00953056|9755680|FG005|NOT COMPLETED|Overall Study||4
8709464|NCT00953121|9755699|FG000|STARTED|Overall Study||40
8709465|NCT00953121|9755700|FG001|STARTED|Overall Study||39
8709466|NCT00953121|9755701|FG002|STARTED|Overall Study||25
8709467|NCT00953121|9755699|FG000|COMPLETED|Overall Study||40
8709468|NCT00953121|9755700|FG001|COMPLETED|Overall Study||39
8709469|NCT00953121|9755701|FG002|COMPLETED|Overall Study||25
8709470|NCT00953121|9755699|FG000|NOT COMPLETED|Overall Study||0
8709471|NCT00953121|9755700|FG001|NOT COMPLETED|Overall Study||0
8709472|NCT00953121|9755701|FG002|NOT COMPLETED|Overall Study||0
8709473|NCT00953147|9755712|FG000|STARTED|Overall Study||298
8709474|NCT00953147|9755713|FG001|STARTED|Overall Study||505
8709475|NCT00953147|9755714|FG002|STARTED|Overall Study||307
8709476|NCT00953147|9755712|FG000|COMPLETED|Overall Study||261
8709477|NCT00953147|9755713|FG001|COMPLETED|Overall Study||439
8709478|NCT00953147|9755714|FG002|COMPLETED|Overall Study||265
8709479|NCT00953147|9755712|FG000|NOT COMPLETED|Overall Study||37
8709480|NCT00953147|9755713|FG001|NOT COMPLETED|Overall Study||66
8709481|NCT00953147|9755714|FG002|NOT COMPLETED|Overall Study||42
8709482|NCT00953160|9755722|FG000|STARTED|Overall Study||76
8709483|NCT00953160|9755722|FG000|COMPLETED|Overall Study||49
8709484|NCT00953160|9755722|FG000|NOT COMPLETED|Overall Study||27
8709485|NCT00953173|9755726|FG000|STARTED|Overall Study||671
8709486|NCT00953173|9755726|FG000|COMPLETED|Overall Study||389
8709487|NCT00953173|9755726|FG000|NOT COMPLETED|Overall Study||282
8709488|NCT00953199|9755732|FG000|STARTED|Overall Study||254
8709489|NCT00953199|9755733|FG001|STARTED|Overall Study||252
8709490|NCT00953199|9755732|FG000|COMPLETED|Overall Study||254
8709491|NCT00953199|9755733|FG001|COMPLETED|Overall Study||252
8709492|NCT00953199|9755732|FG000|NOT COMPLETED|Overall Study||0
8709493|NCT00953199|9755733|FG001|NOT COMPLETED|Overall Study||0
8709494|NCT00953212|9755745|FG000|STARTED|Overall Study||76
8709495|NCT00953212|9755746|FG001|STARTED|Overall Study||74
8709496|NCT00953212|9755747|FG002|STARTED|Overall Study||78
8709497|NCT00953212|9755748|FG003|STARTED|Overall Study||76
8709498|NCT00953212|9755745|FG000|COMPLETED|Overall Study||76
8709499|NCT00953212|9755746|FG001|COMPLETED|Overall Study||74
8709500|NCT00953212|9755747|FG002|COMPLETED|Overall Study||78
8709501|NCT00953212|9755748|FG003|COMPLETED|Overall Study||76
8709502|NCT00953212|9755745|FG000|NOT COMPLETED|Overall Study||0
8709503|NCT00953212|9755746|FG001|NOT COMPLETED|Overall Study||0
8709504|NCT00953212|9755747|FG002|NOT COMPLETED|Overall Study||0
8709505|NCT00953212|9755748|FG003|NOT COMPLETED|Overall Study||0
8709506|NCT00953225|9755764|FG000|STARTED|Overall Study||46
8709507|NCT00953225|9755765|FG001|STARTED|Overall Study||37
8709508|NCT00953225|9755764|FG000|COMPLETED|Overall Study||44
8709509|NCT00953225|9755765|FG001|COMPLETED|Overall Study||37
8928118|NCT02278328|9989241|FG000|NOT COMPLETED|Second Washout (1 Week)||0
8580541|NCT00197054|9613912|FG001|COMPLETED|Overall Study||64
8580542|NCT00197054|9613913|FG002|COMPLETED|Overall Study||73
8580543|NCT00197054|9613911|FG000|NOT COMPLETED|Overall Study||17
8580544|NCT00197054|9613912|FG001|NOT COMPLETED|Overall Study||21
8580545|NCT00197054|9613913|FG002|NOT COMPLETED|Overall Study||12
8580546|NCT00197106|9613933|FG000|STARTED|4-Week Run-In Period||257
8580547|NCT00197106|9613934|FG001|STARTED|4-Week Run-In Period||0
8580548|NCT00197106|9613935|FG002|STARTED|4-Week Run-In Period||0
8928119|NCT02278328|9989242|FG001|NOT COMPLETED|Second Washout (1 Week)||0
8580549|NCT00197106|9613933|FG000|COMPLETED|4-Week Run-In Period||158
8580550|NCT00197106|9613934|FG001|COMPLETED|4-Week Run-In Period||0
8580551|NCT00197106|9613935|FG002|COMPLETED|4-Week Run-In Period||0
8580552|NCT00197106|9613933|FG000|NOT COMPLETED|4-Week Run-In Period||99
8580553|NCT00197106|9613934|FG001|NOT COMPLETED|4-Week Run-In Period||0
8580554|NCT00197106|9613935|FG002|NOT COMPLETED|4-Week Run-In Period||0
8580555|NCT00197106|9613933|FG000|STARTED|Overall Treatment Period||0
8580556|NCT00197106|9613934|FG001|STARTED|Overall Treatment Period||78
8580557|NCT00197106|9613935|FG002|STARTED|Overall Treatment Period||80
8928120|NCT02278328|9989243|FG002|NOT COMPLETED|Second Washout (1 Week)||0
8928121|NCT02278328|9989241|FG000|STARTED|Third Intervention (1 Day)||9
8928122|NCT02278328|9989242|FG001|STARTED|Third Intervention (1 Day)||6
8928123|NCT02278328|9989243|FG002|STARTED|Third Intervention (1 Day)||6
8928124|NCT02278328|9989241|FG000|COMPLETED|Third Intervention (1 Day)||9
8928125|NCT02278328|9989242|FG001|COMPLETED|Third Intervention (1 Day)||6
8580558|NCT00197106|9613933|FG000|COMPLETED|Overall Treatment Period||0
8580559|NCT00197106|9613934|FG001|COMPLETED|Overall Treatment Period||77
8580560|NCT00197106|9613935|FG002|COMPLETED|Overall Treatment Period||74
8580561|NCT00197106|9613933|FG000|NOT COMPLETED|Overall Treatment Period||0
8580562|NCT00197106|9613934|FG001|NOT COMPLETED|Overall Treatment Period||1
8580563|NCT00197106|9613935|FG002|NOT COMPLETED|Overall Treatment Period||6
8580564|NCT00197119|9613943|FG000|STARTED|Year 6||126
8580565|NCT00197119|9613944|FG001|STARTED|Year 6||118
8580566|NCT00197119|9613943|FG000|COMPLETED|Year 6||126
8580567|NCT00197119|9613944|FG001|COMPLETED|Year 6||118
8580568|NCT00197119|9613943|FG000|NOT COMPLETED|Year 6||0
8580569|NCT00197119|9613944|FG001|NOT COMPLETED|Year 6||0
8580570|NCT00197119|9613943|FG000|STARTED|Year 7|4 subjects who participated in the Year 6 follow-up time point did not return for this time point.|122
8709510|NCT00953225|9755764|FG000|NOT COMPLETED|Overall Study||2
8709511|NCT00953225|9755765|FG001|NOT COMPLETED|Overall Study||0
8709512|NCT00953290|9755771|FG000|STARTED|Overall Study||4
8709513|NCT00953290|9755771|FG000|COMPLETED|Overall Study||4
8709514|NCT00953290|9755771|FG000|NOT COMPLETED|Overall Study||0
8709515|NCT00953407|9755783|FG000|STARTED|Overall Study||26
8709516|NCT00953407|9755784|FG001|STARTED|Overall Study||25
8709517|NCT00953407|9755785|FG002|STARTED|Overall Study||26
8709518|NCT00953407|9755786|FG003|STARTED|Overall Study||25
8709519|NCT00953407|9755787|FG004|STARTED|Overall Study||24
8709520|NCT00953407|9755783|FG000|COMPLETED|Overall Study||25
8709521|NCT00953407|9755784|FG001|COMPLETED|Overall Study||24
8709522|NCT00953407|9755785|FG002|COMPLETED|Overall Study||25
8709523|NCT00953407|9755786|FG003|COMPLETED|Overall Study||23
8709524|NCT00953407|9755787|FG004|COMPLETED|Overall Study||23
8709525|NCT00953407|9755783|FG000|NOT COMPLETED|Overall Study||1
8709526|NCT00953407|9755784|FG001|NOT COMPLETED|Overall Study||1
8709527|NCT00953407|9755785|FG002|NOT COMPLETED|Overall Study||1
8709528|NCT00953407|9755786|FG003|NOT COMPLETED|Overall Study||2
8709529|NCT00953407|9755787|FG004|NOT COMPLETED|Overall Study||1
8709530|NCT00953524|9755803|FG000|STARTED|Overall Study||249
8709531|NCT00953524|9755804|FG001|STARTED|Overall Study||254
8709532|NCT00953524|9755805|FG002|STARTED|Overall Study||247
8709533|NCT00953524|9755806|FG003|STARTED|Overall Study||99
8709534|NCT00953524|9755803|FG000|COMPLETED|Overall Study||227
8709535|NCT00953524|9755804|FG001|COMPLETED|Overall Study||239
8709536|NCT00953524|9755805|FG002|COMPLETED|Overall Study||233
8709537|NCT00953524|9755806|FG003|COMPLETED|Overall Study||91
8709538|NCT00953524|9755803|FG000|NOT COMPLETED|Overall Study||22
8709539|NCT00953524|9755804|FG001|NOT COMPLETED|Overall Study||15
8709540|NCT00953524|9755805|FG002|NOT COMPLETED|Overall Study||14
8709541|NCT00953524|9755806|FG003|NOT COMPLETED|Overall Study||8
8709542|NCT00953576|9755818|FG000|STARTED|Overall Study||6
8709543|NCT00953576|9755819|FG001|STARTED|Overall Study||5
8709544|NCT00953576|9755818|FG000|DLT Evaluable|Overall Study||3
8709545|NCT00953576|9755819|FG001|DLT Evaluable|Overall Study||5
8709546|NCT00953576|9755818|FG000|Treated|Overall Study||4
8709547|NCT00953576|9755819|FG001|Treated|Overall Study||5
8709548|NCT00953576|9755818|FG000|Pharmacokinetic (PK) Evaluable|Overall Study||4
8709549|NCT00953576|9755819|FG001|Pharmacokinetic (PK) Evaluable|Overall Study||3
8709550|NCT00953576|9755818|FG000|COMPLETED|Overall Study|One participant enrolled on dose level 1 did not receive full dose ketoconazole and was replaced.|4
8709551|NCT00953576|9755819|FG001|COMPLETED|Overall Study||4
8709552|NCT00953576|9755818|FG000|NOT COMPLETED|Overall Study||2
8709553|NCT00953576|9755819|FG001|NOT COMPLETED|Overall Study||1
8709554|NCT00953654|9755831|FG000|STARTED|Overall Study||10
8709555|NCT00953654|9755832|FG001|STARTED|Overall Study||10
8709556|NCT00953654|9755833|FG002|STARTED|Overall Study||10
8709557|NCT00953654|9755831|FG000|COMPLETED|Overall Study||10
8709558|NCT00953654|9755832|FG001|COMPLETED|Overall Study||10
8709559|NCT00953654|9755833|FG002|COMPLETED|Overall Study||10
8709560|NCT00953654|9755831|FG000|NOT COMPLETED|Overall Study||0
8709561|NCT00953654|9755832|FG001|NOT COMPLETED|Overall Study||0
8709562|NCT00953654|9755833|FG002|NOT COMPLETED|Overall Study||0
8709563|NCT00953667|9755841|FG000|STARTED|Overall Study||400
8709564|NCT00953667|9755841|FG000|COMPLETED|Overall Study||277
8709565|NCT00953667|9755841|FG000|NOT COMPLETED|Overall Study||123
8709566|NCT00953706|9755847|FG000|STARTED|Part A (16-Week Double-Blind Treatment)|All subjects who received at least 1 dose of study drug (placebo)|28
8928126|NCT02278328|9989243|FG002|COMPLETED|Third Intervention (1 Day)||6
8580571|NCT00197119|9613944|FG001|STARTED|Year 7|4 subjects who participated in the Year 6 follow-up time point did not return for this time point.|114
8580572|NCT00197119|9613943|FG000|COMPLETED|Year 7||122
8580573|NCT00197119|9613944|FG001|COMPLETED|Year 7||114
8709567|NCT00953706|9755848|FG001|STARTED|Part A (16-Week Double-Blind Treatment)|All subjects who received at least 1 dose of study drug (ivacaftor)|112
8709568|NCT00953706|9755849|FG002|STARTED|Part A (16-Week Double-Blind Treatment)||0
8709569|NCT00953706|9755850|FG003|STARTED|Part A (16-Week Double-Blind Treatment)||0
8709570|NCT00953706|9755847|FG000|COMPLETED|Part A (16-Week Double-Blind Treatment)|Only 5 participants continued in Part B.|26
8725190|NCT01029704|9772382|FG004|COMPLETED|Overall Study||23
8580574|NCT00197119|9613943|FG000|NOT COMPLETED|Year 7||0
8580575|NCT00197119|9613944|FG001|NOT COMPLETED|Year 7||0
8580576|NCT00197119|9613943|FG000|STARTED|Year 8||122
8580577|NCT00197119|9613944|FG001|STARTED|Year 8|One additional subject (compared to Year 7) participated in the current follow-up time point.|115
8709571|NCT00953706|9755848|FG001|COMPLETED|Part A (16-Week Double-Blind Treatment)|Only 33 participants continued in Part B.|104
8709572|NCT00953706|9755849|FG002|COMPLETED|Part A (16-Week Double-Blind Treatment)||0
8709573|NCT00953706|9755850|FG003|COMPLETED|Part A (16-Week Double-Blind Treatment)||0
8709574|NCT00953706|9755847|FG000|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||2
8709575|NCT00953706|9755848|FG001|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||8
8709576|NCT00953706|9755849|FG002|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||0
8709577|NCT00953706|9755850|FG003|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||0
8709578|NCT00953706|9755847|FG000|STARTED|Part B (96-Week Open-Label Extension)||0
8709579|NCT00953706|9755848|FG001|STARTED|Part B (96-Week Open-Label Extension)||0
8709580|NCT00953706|9755849|FG002|STARTED|Part B (96-Week Open-Label Extension)||5
8709581|NCT00953706|9755850|FG003|STARTED|Part B (96-Week Open-Label Extension)||33
8709582|NCT00953706|9755847|FG000|COMPLETED|Part B (96-Week Open-Label Extension)||0
8709583|NCT00953706|9755848|FG001|COMPLETED|Part B (96-Week Open-Label Extension)||0
8709584|NCT00953706|9755849|FG002|COMPLETED|Part B (96-Week Open-Label Extension)||0
8709585|NCT00953706|9755850|FG003|COMPLETED|Part B (96-Week Open-Label Extension)||0
8709586|NCT00953706|9755847|FG000|NOT COMPLETED|Part B (96-Week Open-Label Extension)||0
8709587|NCT00953706|9755848|FG001|NOT COMPLETED|Part B (96-Week Open-Label Extension)||0
8709588|NCT00953706|9755849|FG002|NOT COMPLETED|Part B (96-Week Open-Label Extension)||5
8709589|NCT00953706|9755850|FG003|NOT COMPLETED|Part B (96-Week Open-Label Extension)||33
8709590|NCT00953719|9755862|FG000|STARTED|Overall Study||169
8709591|NCT00953719|9755863|FG001|STARTED|Overall Study||74
8709592|NCT00953719|9755862|FG000|COMPLETED|Overall Study||150
8709593|NCT00953719|9755863|FG001|COMPLETED|Overall Study||69
8709594|NCT00953719|9755862|FG000|NOT COMPLETED|Overall Study||19
8709595|NCT00953719|9755863|FG001|NOT COMPLETED|Overall Study||5
8709596|NCT00953745|9755871|FG000|STARTED|Phase 1: 8 Weeks Escitalopram + Placebo||37
8709597|NCT00953745|9755872|FG001|STARTED|Phase 1: 8 Weeks Escitalopram + Placebo||6
8709598|NCT00953745|9755871|FG000|COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||24
8709599|NCT00953745|9755872|FG001|COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||6
8709600|NCT00953745|9755871|FG000|NOT COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||13
8709601|NCT00953745|9755872|FG001|NOT COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||0
8709602|NCT00953745|9755871|FG000|STARTED|Phase 2: 2 Weeks Escitalopram + Placebo||18
8709603|NCT00953745|9755872|FG001|STARTED|Phase 2: 2 Weeks Escitalopram + Placebo||0
8709604|NCT00953745|9755871|FG000|COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||17
8709605|NCT00953745|9755872|FG001|COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||0
8709606|NCT00953745|9755871|FG000|NOT COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||1
8709607|NCT00953745|9755872|FG001|NOT COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||0
8709608|NCT00953745|9755871|FG000|STARTED|ARP Phase: 6 Weeks Escitalopram + ARP||17
8709609|NCT00953745|9755872|FG001|STARTED|ARP Phase: 6 Weeks Escitalopram + ARP||0
8709610|NCT00953745|9755871|FG000|COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||17
8709611|NCT00953745|9755872|FG001|COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||0
8709612|NCT00953745|9755871|FG000|NOT COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||0
8709613|NCT00953745|9755872|FG001|NOT COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||0
8709614|NCT00953849|9755884|FG000|STARTED|Overall Study||6
8709615|NCT00953849|9755885|FG001|STARTED|Overall Study||6
8709616|NCT00953849|9755886|FG002|STARTED|Overall Study||4
8709617|NCT00953849|9755887|FG003|STARTED|Overall Study||5
8709618|NCT00953849|9755884|FG000|COMPLETED|Overall Study||6
8709619|NCT00953849|9755885|FG001|COMPLETED|Overall Study||6
8709620|NCT00953849|9755886|FG002|COMPLETED|Overall Study||4
8709621|NCT00953849|9755887|FG003|COMPLETED|Overall Study||5
8709622|NCT00953849|9755884|FG000|NOT COMPLETED|Overall Study||0
8709623|NCT00953849|9755885|FG001|NOT COMPLETED|Overall Study||0
8709624|NCT00953849|9755886|FG002|NOT COMPLETED|Overall Study||0
8709625|NCT00953849|9755887|FG003|NOT COMPLETED|Overall Study||0
8709626|NCT00953862|9755901|FG000|STARTED|Overall Study||18
8709627|NCT00953862|9755901|FG000|COMPLETED|Overall Study||12
8709628|NCT00953862|9755901|FG000|NOT COMPLETED|Overall Study||6
8709629|NCT00953927|9755909|FG000|STARTED|Overall Study||1399
8709630|NCT00953927|9755910|FG001|STARTED|Overall Study||1398
8709631|NCT00953927|9755909|FG000|COMPLETED|Overall Study||1294
8709632|NCT00953927|9755910|FG001|COMPLETED|Overall Study||1303
8709633|NCT00953927|9755909|FG000|NOT COMPLETED|Overall Study||105
8709634|NCT00953927|9755910|FG001|NOT COMPLETED|Overall Study||95
8709635|NCT00954109|9755916|FG000|STARTED|Overall Study||11
8709636|NCT00954109|9755916|FG000|COMPLETED|Overall Study||11
8709637|NCT00954109|9755916|FG000|NOT COMPLETED|Overall Study||0
8709638|NCT00954122|9755920|FG000|STARTED|Overall Study||35
8709639|NCT00954122|9755920|FG000|COMPLETED|Overall Study||28
8709640|NCT00954122|9755920|FG000|NOT COMPLETED|Overall Study||7
8709641|NCT00954174|9755929|FG000|STARTED|Overall Study||268
8709642|NCT00954174|9755930|FG001|STARTED|Overall Study||268
8709643|NCT00954174|9755931|FG002|STARTED|Overall Study||51
8709644|NCT00954174|9755932|FG003|STARTED|Overall Study||50
8709645|NCT00954174|9755929|FG000|COMPLETED|Overall Study||142
8709646|NCT00954174|9755930|FG001|COMPLETED|Overall Study||145
8709647|NCT00954174|9755931|FG002|COMPLETED|Overall Study||27
8580578|NCT00197119|9613943|FG000|COMPLETED|Year 8||122
8580579|NCT00197119|9613944|FG001|COMPLETED|Year 8||115
8580580|NCT00197119|9613943|FG000|NOT COMPLETED|Year 8||0
8580581|NCT00197119|9613944|FG001|NOT COMPLETED|Year 8||0
8580582|NCT00197119|9613943|FG000|STARTED|Year 9|One subject participating in the Year 8 time point did not return for the current time point.|121
8580583|NCT00197119|9613944|FG001|STARTED|Year 9|One subject participating in the Year 8 time point did not return for the current time point.|114
8580584|NCT00197119|9613943|FG000|COMPLETED|Year 9||121
8580585|NCT00197119|9613944|FG001|COMPLETED|Year 9||114
8580586|NCT00197119|9613943|FG000|NOT COMPLETED|Year 9||0
8580587|NCT00197119|9613944|FG001|NOT COMPLETED|Year 9||0
8580588|NCT00197119|9613943|FG000|STARTED|Year 10|One subject participating in the Year 9 time point did not return for the current time point.|120
8580589|NCT00197119|9613944|FG001|STARTED|Year 10|Six subjects participating in the Year 9 time point did not return for the current time point.|108
8580590|NCT00197119|9613943|FG000|COMPLETED|Year 10||120
8580591|NCT00197119|9613944|FG001|COMPLETED|Year 10||108
8580592|NCT00197119|9613943|FG000|NOT COMPLETED|Year 10||0
8709648|NCT00954174|9755932|FG003|COMPLETED|Overall Study||25
8709649|NCT00954174|9755929|FG000|NOT COMPLETED|Overall Study||126
8709650|NCT00954174|9755930|FG001|NOT COMPLETED|Overall Study||123
8709651|NCT00954174|9755931|FG002|NOT COMPLETED|Overall Study||24
8709652|NCT00954174|9755932|FG003|NOT COMPLETED|Overall Study||25
8709653|NCT00954356|9755947|FG000|STARTED|Overall Study||41
8709654|NCT00954356|9755948|FG001|STARTED|Overall Study||20
8709655|NCT00954356|9755947|FG000|COMPLETED|Overall Study||41
8709656|NCT00954356|9755948|FG001|COMPLETED|Overall Study||20
8709657|NCT00954356|9755947|FG000|NOT COMPLETED|Overall Study||0
8709658|NCT00954356|9755948|FG001|NOT COMPLETED|Overall Study||0
8709659|NCT00954421|9755954|FG000|STARTED|Screening||16
8709660|NCT00954421|9755954|FG000|COMPLETED|Screening||13
8709661|NCT00954421|9755954|FG000|NOT COMPLETED|Screening||3
8709662|NCT00954421|9755954|FG000|STARTED|Baseline||13
8709663|NCT00954421|9755954|FG000|COMPLETED|Baseline||13
8709664|NCT00954421|9755954|FG000|NOT COMPLETED|Baseline||0
8709665|NCT00954421|9755954|FG000|STARTED|6 Months of DBS||13
8709666|NCT00954421|9755954|FG000|COMPLETED|6 Months of DBS||12
8709667|NCT00954421|9755954|FG000|NOT COMPLETED|6 Months of DBS||1
8709668|NCT00954421|9755954|FG000|STARTED|VIM=ON VO=ON at 6 Months|This is the point of evaluation: Order of assessment was random for periods 4-7|12
8709669|NCT00954421|9755954|FG000|COMPLETED|VIM=ON VO=ON at 6 Months||12
8709670|NCT00954421|9755954|FG000|NOT COMPLETED|VIM=ON VO=ON at 6 Months||0
8709671|NCT00954421|9755954|FG000|STARTED|VIM=OFF VO=OFF at 6 Months||12
8709672|NCT00954421|9755954|FG000|COMPLETED|VIM=OFF VO=OFF at 6 Months||12
8709673|NCT00954421|9755954|FG000|NOT COMPLETED|VIM=OFF VO=OFF at 6 Months||0
8709674|NCT00954421|9755954|FG000|STARTED|VIM=OFF VO=ON at 6 Months||12
8709675|NCT00954421|9755954|FG000|COMPLETED|VIM=OFF VO=ON at 6 Months||12
8709676|NCT00954421|9755954|FG000|NOT COMPLETED|VIM=OFF VO=ON at 6 Months||0
8709677|NCT00954421|9755954|FG000|STARTED|VIM=ON VO=OFF at 6 Months||12
8709678|NCT00954421|9755954|FG000|COMPLETED|VIM=ON VO=OFF at 6 Months||11
8709679|NCT00954421|9755954|FG000|NOT COMPLETED|VIM=ON VO=OFF at 6 Months||1
8709680|NCT00954447|9755962|FG000|STARTED|Overall Study||630
8709681|NCT00954447|9755963|FG001|STARTED|Overall Study||631
8709682|NCT00954447|9755962|FG000|COMPLETED|Overall Study||520
8709683|NCT00954447|9755963|FG001|COMPLETED|Overall Study||543
8709684|NCT00954447|9755962|FG000|NOT COMPLETED|Overall Study||110
8709685|NCT00954447|9755963|FG001|NOT COMPLETED|Overall Study||88
8709686|NCT00954512|9755975|FG000|STARTED|Overall Study||2
8709687|NCT00954512|9755976|FG001|STARTED|Overall Study||3
8709688|NCT00954512|9755977|FG002|STARTED|Overall Study||0
8709689|NCT00954512|9755978|FG003|STARTED|Overall Study||2
8709690|NCT00954512|9755979|FG004|STARTED|Overall Study||4
8709691|NCT00954512|9755980|FG005|STARTED|Overall Study||4
8709692|NCT00954512|9755975|FG000|COMPLETED|Overall Study||0
8709693|NCT00954512|9755976|FG001|COMPLETED|Overall Study||0
8709694|NCT00954512|9755977|FG002|COMPLETED|Overall Study||0
8709695|NCT00954512|9755978|FG003|COMPLETED|Overall Study||0
8709696|NCT00954512|9755979|FG004|COMPLETED|Overall Study||0
8709697|NCT00954512|9755980|FG005|COMPLETED|Overall Study||0
8709698|NCT00954512|9755975|FG000|NOT COMPLETED|Overall Study||2
8709699|NCT00954512|9755976|FG001|NOT COMPLETED|Overall Study||3
8709700|NCT00954512|9755977|FG002|NOT COMPLETED|Overall Study||0
8709701|NCT00954512|9755978|FG003|NOT COMPLETED|Overall Study||2
8709702|NCT00954512|9755979|FG004|NOT COMPLETED|Overall Study||4
8709703|NCT00954512|9755980|FG005|NOT COMPLETED|Overall Study||4
8709704|NCT00954538|9755995|FG000|STARTED|Part I|These subjects did not participate in Part II or III|3
8709705|NCT00954538|9755996|FG001|STARTED|Part I||0
8709706|NCT00954538|9755997|FG002|STARTED|Part I||0
8709707|NCT00954538|9755998|FG003|STARTED|Part I||0
8709708|NCT00954538|9755999|FG004|STARTED|Part I||0
8709709|NCT00954538|9756000|FG005|STARTED|Part I||0
8709710|NCT00954538|9755995|FG000|COMPLETED|Part I||3
8709711|NCT00954538|9755996|FG001|COMPLETED|Part I||0
8709712|NCT00954538|9755997|FG002|COMPLETED|Part I||0
8709713|NCT00954538|9755998|FG003|COMPLETED|Part I||0
8709714|NCT00954538|9755999|FG004|COMPLETED|Part I||0
8709715|NCT00954538|9756000|FG005|COMPLETED|Part I||0
8580593|NCT00197119|9613944|FG001|NOT COMPLETED|Year 10||0
8709716|NCT00954538|9755995|FG000|NOT COMPLETED|Part I||0
8709717|NCT00954538|9755996|FG001|NOT COMPLETED|Part I||0
8709718|NCT00954538|9755997|FG002|NOT COMPLETED|Part I||0
8709719|NCT00954538|9755998|FG003|NOT COMPLETED|Part I||0
8709720|NCT00954538|9755999|FG004|NOT COMPLETED|Part I||0
8709721|NCT00954538|9756000|FG005|NOT COMPLETED|Part I||0
8580594|NCT00197145|9613952|FG000|STARTED|Period 1: Randomized Treatment Phase||13
8580595|NCT00197145|9613953|FG001|STARTED|Period 1: Randomized Treatment Phase||11
8580596|NCT00197145|9613952|FG000|COMPLETED|Period 1: Randomized Treatment Phase||0
8580597|NCT00197145|9613953|FG001|COMPLETED|Period 1: Randomized Treatment Phase||0
8580598|NCT00197145|9613952|FG000|NOT COMPLETED|Period 1: Randomized Treatment Phase||13
8580599|NCT00197145|9613953|FG001|NOT COMPLETED|Period 1: Randomized Treatment Phase||11
8580600|NCT00197145|9613952|FG000|STARTED|Period 2 : Open Label Phase||10
8580601|NCT00197145|9613953|FG001|STARTED|Period 2 : Open Label Phase||0
8580602|NCT00197145|9613952|FG000|COMPLETED|Period 2 : Open Label Phase||0
8580603|NCT00197145|9613953|FG001|COMPLETED|Period 2 : Open Label Phase||0
8580604|NCT00197145|9613952|FG000|NOT COMPLETED|Period 2 : Open Label Phase||10
8580605|NCT00197145|9613953|FG001|NOT COMPLETED|Period 2 : Open Label Phase||0
8580606|NCT00197184|9613962|FG000|STARTED|Overall Study||139
8580607|NCT00197184|9613963|FG001|STARTED|Overall Study||137
8580608|NCT00197184|9613962|FG000|COMPLETED|Overall Study||139
8580609|NCT00197184|9613963|FG001|COMPLETED|Overall Study||137
8580610|NCT00197184|9613962|FG000|NOT COMPLETED|Overall Study||0
8580611|NCT00197184|9613963|FG001|NOT COMPLETED|Overall Study||0
8580612|NCT00197236|9613972|FG000|STARTED|Overall Study||135
8580613|NCT00197236|9613973|FG001|STARTED|Overall Study||127
8580614|NCT00197236|9613974|FG002|STARTED|Overall Study||132
8580615|NCT00197236|9613972|FG000|COMPLETED|Overall Study||121
8580616|NCT00197236|9613973|FG001|COMPLETED|Overall Study||110
8709722|NCT00954538|9755995|FG000|STARTED|Part II||0
8709723|NCT00954538|9755996|FG001|STARTED|Part II|This subject did not participate in Part I or III|1
8709724|NCT00954538|9755997|FG002|STARTED|Part II|These subjects did not participate in Part I or III|3
8709725|NCT00954538|9755998|FG003|STARTED|Part II||0
8709726|NCT00954538|9755999|FG004|STARTED|Part II||0
8709727|NCT00954538|9756000|FG005|STARTED|Part II|These subjects did not participate in Part I and did participate in Part II and III|2
8709728|NCT00954538|9755995|FG000|COMPLETED|Part II||0
8709729|NCT00954538|9755996|FG001|COMPLETED|Part II||1
8709730|NCT00954538|9755997|FG002|COMPLETED|Part II||3
8709731|NCT00954538|9755998|FG003|COMPLETED|Part II||0
8709732|NCT00954538|9755999|FG004|COMPLETED|Part II||0
8709733|NCT00954538|9756000|FG005|COMPLETED|Part II||2
8709734|NCT00954538|9755995|FG000|NOT COMPLETED|Part II||0
8709735|NCT00954538|9755996|FG001|NOT COMPLETED|Part II||0
8709736|NCT00954538|9755997|FG002|NOT COMPLETED|Part II||0
8709737|NCT00954538|9755998|FG003|NOT COMPLETED|Part II||0
8709738|NCT00954538|9755999|FG004|NOT COMPLETED|Part II||0
8709739|NCT00954538|9756000|FG005|NOT COMPLETED|Part II||0
8709740|NCT00954538|9755995|FG000|STARTED|Part III||0
8709741|NCT00954538|9755996|FG001|STARTED|Part III||0
8709742|NCT00954538|9755997|FG002|STARTED|Part III||0
8709743|NCT00954538|9755998|FG003|STARTED|Part III|These subjects did not participate in Part I or II|4
8709744|NCT00954538|9755999|FG004|STARTED|Part III|These subjects did not participate in Part I or II|6
8709745|NCT00954538|9756000|FG005|STARTED|Part III|These subjects did not participate in Part I and did participate in Part II and III|2
8709746|NCT00954538|9755995|FG000|COMPLETED|Part III||0
8709747|NCT00954538|9755996|FG001|COMPLETED|Part III||0
8709748|NCT00954538|9755997|FG002|COMPLETED|Part III||0
8709749|NCT00954538|9755998|FG003|COMPLETED|Part III||4
8709750|NCT00954538|9755999|FG004|COMPLETED|Part III|The subject who did not complete received 1 dose of study drug|5
8709751|NCT00954538|9756000|FG005|COMPLETED|Part III||2
8709752|NCT00954538|9755995|FG000|NOT COMPLETED|Part III||0
8709753|NCT00954538|9755996|FG001|NOT COMPLETED|Part III||0
8709754|NCT00954538|9755997|FG002|NOT COMPLETED|Part III||0
8709755|NCT00954538|9755998|FG003|NOT COMPLETED|Part III||0
8709756|NCT00954538|9755999|FG004|NOT COMPLETED|Part III||1
8709757|NCT00954538|9756000|FG005|NOT COMPLETED|Part III||0
8709758|NCT00954681|9756009|FG000|STARTED|Overall Study||15
8709759|NCT00954681|9756009|FG000|COMPLETED|Overall Study||10
8709760|NCT00954681|9756009|FG000|NOT COMPLETED|Overall Study||5
8709761|NCT00954707|9756013|FG000|STARTED|Overall Study||2509
8709762|NCT00954707|9756013|FG000|COMPLETED|Overall Study|2342 Subjects completed 12-month Phase 1 follow-up; 167 subjects didn't complete the Phase 1.|2342
8709763|NCT00954707|9756013|FG000|NOT COMPLETED|Overall Study||167
8709764|NCT00954733|9756017|FG000|STARTED|Overall Study||40
8709765|NCT00954733|9756017|FG000|COMPLETED|Overall Study||39
8709766|NCT00954733|9756017|FG000|NOT COMPLETED|Overall Study||1
8709767|NCT00954824|9756021|FG000|STARTED|Overall Study||100
8709768|NCT00954824|9756021|FG000|COMPLETED|Overall Study||50
8709769|NCT00954824|9756021|FG000|NOT COMPLETED|Overall Study||50
8709770|NCT00954941|9756027|FG000|STARTED|Overall Study||50
8709771|NCT00954941|9756028|FG001|STARTED|Overall Study||48
8709772|NCT00954941|9756027|FG000|COMPLETED|Overall Study||42
8709773|NCT00954941|9756028|FG001|COMPLETED|Overall Study||41
8709774|NCT00954941|9756027|FG000|NOT COMPLETED|Overall Study||8
8709775|NCT00954941|9756028|FG001|NOT COMPLETED|Overall Study||7
8709776|NCT00954993|9756034|FG000|STARTED|Period 1||3
8709777|NCT00954993|9756034|FG000|COMPLETED|Period 1||3
8709778|NCT00954993|9756034|FG000|NOT COMPLETED|Period 1||0
8580617|NCT00197236|9613974|FG002|COMPLETED|Overall Study||109
8580618|NCT00197236|9613972|FG000|NOT COMPLETED|Overall Study||14
8580619|NCT00197236|9613973|FG001|NOT COMPLETED|Overall Study||17
8580620|NCT00197236|9613974|FG002|NOT COMPLETED|Overall Study||23
8580621|NCT00197392|9613987|FG000|STARTED|Overall Study||214
8709779|NCT00954993|9756034|FG000|STARTED|Washout||3
8709780|NCT00954993|9756034|FG000|COMPLETED|Washout||3
8709781|NCT00954993|9756034|FG000|NOT COMPLETED|Washout||0
8580622|NCT00197392|9613988|FG001|STARTED|Overall Study||220
8580623|NCT00197392|9613987|FG000|Safety Population|Overall Study||214
8580624|NCT00197392|9613988|FG001|Safety Population|Overall Study||220
8580625|NCT00197392|9613987|FG000|Modified Intent to Treat|Overall Study||209
8580626|NCT00197392|9613988|FG001|Modified Intent to Treat|Overall Study||210
8580627|NCT00197392|9613987|FG000|Evaluable|Overall Study||176
8580628|NCT00197392|9613988|FG001|Evaluable|Overall Study||181
8580629|NCT00197392|9613987|FG000|Per Protocol|Overall Study||126
8580630|NCT00197392|9613988|FG001|Per Protocol|Overall Study||134
8580631|NCT00197392|9613987|FG000|COMPLETED|Overall Study||126
8580632|NCT00197392|9613988|FG001|COMPLETED|Overall Study||134
8580633|NCT00197392|9613987|FG000|NOT COMPLETED|Overall Study||88
8580634|NCT00197392|9613988|FG001|NOT COMPLETED|Overall Study||86
8580635|NCT00197496|9614012|FG000|STARTED|Baseline to Discharge||14
8580636|NCT00197496|9614013|FG001|STARTED|Baseline to Discharge||7
8709782|NCT00954993|9756034|FG000|STARTED|Period 2||3
8709783|NCT00954993|9756034|FG000|COMPLETED|Period 2||3
8709784|NCT00954993|9756034|FG000|NOT COMPLETED|Period 2||0
8709785|NCT00955032|9756042|FG000|STARTED|Overall Study||16
8709786|NCT00955032|9756043|FG001|STARTED|Overall Study||8
8709787|NCT00955032|9756042|FG000|COMPLETED|Overall Study||16
8709788|NCT00955032|9756043|FG001|COMPLETED|Overall Study||8
8709789|NCT00955032|9756042|FG000|NOT COMPLETED|Overall Study||0
8709790|NCT00955032|9756043|FG001|NOT COMPLETED|Overall Study||0
8709791|NCT00955110|9756058|FG000|STARTED|Qualification Phase||78
8709792|NCT00955110|9756058|FG000|COMPLETED|Qualification Phase||54
8709793|NCT00955110|9756058|FG000|NOT COMPLETED|Qualification Phase||24
8709794|NCT00955110|9756058|FG000|STARTED|Treatment Phase||41
8709795|NCT00955110|9756058|FG000|Placebo|Treatment Phase||38
8580637|NCT00197496|9614012|FG000|COMPLETED|Baseline to Discharge||12
8580638|NCT00197496|9614013|FG001|COMPLETED|Baseline to Discharge||5
8580639|NCT00197496|9614012|FG000|NOT COMPLETED|Baseline to Discharge||2
8580640|NCT00197496|9614013|FG001|NOT COMPLETED|Baseline to Discharge||2
8580641|NCT00197496|9614012|FG000|STARTED|Follow-up||12
8580642|NCT00197496|9614013|FG001|STARTED|Follow-up||5
8580643|NCT00197496|9614012|FG000|COMPLETED|Follow-up||10
8580644|NCT00197496|9614013|FG001|COMPLETED|Follow-up||4
8580645|NCT00197496|9614012|FG000|NOT COMPLETED|Follow-up||2
8580646|NCT00197496|9614013|FG001|NOT COMPLETED|Follow-up||1
8580647|NCT00198029|9614019|FG000|STARTED|Overall Study||32
8580648|NCT00198029|9614019|FG000|COMPLETED|Overall Study||28
8580649|NCT00198029|9614019|FG000|NOT COMPLETED|Overall Study||4
8580650|NCT00198042|9614023|FG000|STARTED|Overall Study||18
8580651|NCT00198042|9614023|FG000|COMPLETED|Overall Study||18
8580652|NCT00198042|9614023|FG000|NOT COMPLETED|Overall Study||0
8580653|NCT00198081|9614029|FG000|STARTED|Overall Study|Eight (8) persons consented to participate but 3 withdrew prior to beginning protocol treatment.|5
8580654|NCT00198081|9614030|FG001|STARTED|Overall Study|No enrollment on this arm.|0
8580655|NCT00198081|9614029|FG000|COMPLETED|Overall Study||4
8580656|NCT00198081|9614030|FG001|COMPLETED|Overall Study|No enrollment on this arm.|0
8580657|NCT00198081|9614029|FG000|NOT COMPLETED|Overall Study||1
8580658|NCT00198081|9614030|FG001|NOT COMPLETED|Overall Study||0
8580659|NCT00198107|9614043|FG000|STARTED|Double-Blind Period||41
8580660|NCT00198107|9614044|FG001|STARTED|Double-Blind Period||40
8580661|NCT00198107|9614045|FG002|STARTED|Double-Blind Period||0
8580662|NCT00198107|9614043|FG000|1 or More Follow-up Visits|Double-Blind Period||40
8580663|NCT00198107|9614044|FG001|1 or More Follow-up Visits|Double-Blind Period||38
8580664|NCT00198107|9614045|FG002|1 or More Follow-up Visits|Double-Blind Period||0
8580665|NCT00198107|9614043|FG000|COMPLETED|Double-Blind Period||35
8580666|NCT00198107|9614044|FG001|COMPLETED|Double-Blind Period||37
8580667|NCT00198107|9614045|FG002|COMPLETED|Double-Blind Period||0
8580668|NCT00198107|9614043|FG000|NOT COMPLETED|Double-Blind Period||6
8580669|NCT00198107|9614044|FG001|NOT COMPLETED|Double-Blind Period||3
8580670|NCT00198107|9614045|FG002|NOT COMPLETED|Double-Blind Period||0
8580671|NCT00198107|9614043|FG000|STARTED|Pilot Add-On Aripiprazole +D-cycloserine||0
8580672|NCT00198107|9614044|FG001|STARTED|Pilot Add-On Aripiprazole +D-cycloserine||0
8580673|NCT00198107|9614045|FG002|STARTED|Pilot Add-On Aripiprazole +D-cycloserine||10
8580674|NCT00198107|9614043|FG000|COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||0
8580675|NCT00198107|9614044|FG001|COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||0
8580676|NCT00198107|9614045|FG002|COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||8
8580677|NCT00198107|9614043|FG000|NOT COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||0
8580678|NCT00198107|9614044|FG001|NOT COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||0
8580679|NCT00198107|9614045|FG002|NOT COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||2
8580680|NCT00198133|9614055|FG000|STARTED|Overall Study||16
8580681|NCT00198133|9614056|FG001|STARTED|Overall Study||11
8580682|NCT00198133|9614055|FG000|COMPLETED|Overall Study||11
8580683|NCT00198133|9614056|FG001|COMPLETED|Overall Study||3
8580684|NCT00198133|9614055|FG000|NOT COMPLETED|Overall Study||5
8580685|NCT00198133|9614056|FG001|NOT COMPLETED|Overall Study||8
8580686|NCT00198822|9614065|FG000|STARTED|Overall Study|No. of consenting pregnant women in the placebo arm of trial cohort|19876
8580687|NCT00198822|9614066|FG001|STARTED|Overall Study|No. of consenting pregnant women in the vitamin A arm of trial cohort|19826
8709796|NCT00955110|9756058|FG000|Oxymorphone ER 15 mg|Treatment Phase||37
8709797|NCT00955110|9756058|FG000|Oxymorphone ER 30 mg|Treatment Phase||38
8709798|NCT00955110|9756058|FG000|Oxycodone CR 30 mg|Treatment Phase||40
8580688|NCT00198822|9614067|FG002|STARTED|Overall Study|No. of consenting pregnant women in the beta-catorene arm of trial cohort|20019
8580689|NCT00198822|9614065|FG000|COMPLETED|Overall Study|No. of consented pregnant women in placebo arm with vital status known at 12 weeks postpartum|19862
8580690|NCT00198822|9614066|FG001|COMPLETED|Overall Study|No. of consented pregnant women in vitamin A arm with vital status known at 12 weeks postpartum|19806
8580691|NCT00198822|9614067|FG002|COMPLETED|Overall Study|No. of consented pregnant women in beta-catorene arm with vital status known at 12 weeks postpartum|19998
8580692|NCT00198822|9614065|FG000|NOT COMPLETED|Overall Study||14
8580693|NCT00198822|9614066|FG001|NOT COMPLETED|Overall Study||20
8580694|NCT00198822|9614067|FG002|NOT COMPLETED|Overall Study||21
8580695|NCT00199381|9614075|FG000|STARTED|Overall Study||504
8580696|NCT00199381|9614075|FG000|COMPLETED|Overall Study|Premature study termination by the Sponsor.|0
8580697|NCT00199381|9614075|FG000|NOT COMPLETED|Overall Study||504
8580698|NCT00199797|9614079|FG000|STARTED|Overall Study||20
8580699|NCT00199797|9614079|FG000|COMPLETED|Overall Study||17
8580700|NCT00199797|9614079|FG000|NOT COMPLETED|Overall Study||3
8580701|NCT00199836|9614084|FG000|STARTED|Overall Study||14
8580702|NCT00199836|9614084|FG000|COMPLETED|Overall Study||8
8580703|NCT00199836|9614084|FG000|NOT COMPLETED|Overall Study||6
8580704|NCT00199849|9614092|FG000|STARTED|Overall Study||3
8580705|NCT00199849|9614093|FG001|STARTED|Overall Study||7
8580706|NCT00199849|9614094|FG002|STARTED|Overall Study||8
8580707|NCT00199849|9614092|FG000|COMPLETED|Overall Study||3
8580708|NCT00199849|9614093|FG001|COMPLETED|Overall Study||6
8580709|NCT00199849|9614094|FG002|COMPLETED|Overall Study||6
8580710|NCT00199849|9614092|FG000|NOT COMPLETED|Overall Study||0
8580711|NCT00199849|9614093|FG001|NOT COMPLETED|Overall Study||1
8580712|NCT00199849|9614094|FG002|NOT COMPLETED|Overall Study||2
8580713|NCT00199875|9614107|FG000|STARTED|Overall Study||3
8580714|NCT00199875|9614108|FG001|STARTED|Overall Study||3
8580715|NCT00199875|9614109|FG002|STARTED|Overall Study||6
8580716|NCT00199875|9614110|FG003|STARTED|Overall Study||3
8580717|NCT00199875|9614111|FG004|STARTED|Overall Study||3
8580718|NCT00199875|9614107|FG000|COMPLETED|Overall Study||3
8580719|NCT00199875|9614108|FG001|COMPLETED|Overall Study||3
8580720|NCT00199875|9614109|FG002|COMPLETED|Overall Study||6
8580721|NCT00199875|9614110|FG003|COMPLETED|Overall Study||3
8580722|NCT00199875|9614111|FG004|COMPLETED|Overall Study||2
8580723|NCT00199875|9614107|FG000|NOT COMPLETED|Overall Study||0
8580724|NCT00199875|9614108|FG001|NOT COMPLETED|Overall Study||0
8580725|NCT00199875|9614109|FG002|NOT COMPLETED|Overall Study||0
8580726|NCT00199875|9614110|FG003|NOT COMPLETED|Overall Study||0
8580727|NCT00199875|9614111|FG004|NOT COMPLETED|Overall Study||1
8580728|NCT00199888|9614123|FG000|STARTED|Overall Study||26
8580729|NCT00199888|9614123|FG000|COMPLETED|Overall Study||25
8580730|NCT00199888|9614123|FG000|NOT COMPLETED|Overall Study||1
8580731|NCT00199901|9614129|FG000|STARTED|Overall Study||56
8580732|NCT00199901|9614130|FG001|STARTED|Overall Study||54
8580733|NCT00199901|9614129|FG000|COMPLETED|Overall Study||29
8580734|NCT00199901|9614130|FG001|COMPLETED|Overall Study||30
8580735|NCT00199901|9614129|FG000|NOT COMPLETED|Overall Study||27
8580736|NCT00199901|9614130|FG001|NOT COMPLETED|Overall Study||24
8580737|NCT00199914|9614140|FG000|STARTED|Overall Study||53
8580738|NCT00199914|9614141|FG001|STARTED|Overall Study||60
8580739|NCT00199914|9614140|FG000|COMPLETED|Overall Study||50
8580740|NCT00199914|9614141|FG001|COMPLETED|Overall Study||54
8580741|NCT00199914|9614140|FG000|NOT COMPLETED|Overall Study||3
8580742|NCT00199914|9614141|FG001|NOT COMPLETED|Overall Study||6
8580743|NCT00200057|9614147|FG000|STARTED|Overall Study||120
8580744|NCT00200057|9614147|FG000|1 Month Follow-up|Overall Study||117
8580745|NCT00200057|9614147|FG000|3 Month Follow-up|Overall Study||116
8580746|NCT00200057|9614147|FG000|6 Month Follow-up|Overall Study||114
8580747|NCT00200057|9614147|FG000|12 Month Follow-up|Overall Study||111
8580748|NCT00200057|9614147|FG000|COMPLETED|Overall Study||111
8580749|NCT00200057|9614147|FG000|NOT COMPLETED|Overall Study||9
8580750|NCT00200161|9614153|FG000|STARTED|Overall Study||43
8580751|NCT00200161|9614154|FG001|STARTED|Overall Study||42
8580752|NCT00200161|9614153|FG000|COMPLETED|Overall Study||43
8580753|NCT00200161|9614154|FG001|COMPLETED|Overall Study||42
8580754|NCT00200161|9614153|FG000|NOT COMPLETED|Overall Study||0
8580755|NCT00200161|9614154|FG001|NOT COMPLETED|Overall Study||0
8627606|NCT00519376|9667184|FG014|STARTED|Treatment Period 2||1
8627607|NCT00519376|9667185|FG015|STARTED|Treatment Period 2||1
8627608|NCT00519376|9667170|FG000|COMPLETED|Treatment Period 2||2
8627609|NCT00519376|9667171|FG001|COMPLETED|Treatment Period 2||2
8627610|NCT00519376|9667172|FG002|COMPLETED|Treatment Period 2||2
8627611|NCT00519376|9667173|FG003|COMPLETED|Treatment Period 2||2
8627612|NCT00519376|9667174|FG004|COMPLETED|Treatment Period 2||1
8627613|NCT00519376|9667175|FG005|COMPLETED|Treatment Period 2||1
8627614|NCT00519376|9667176|FG006|COMPLETED|Treatment Period 2||1
8627615|NCT00519376|9667177|FG007|COMPLETED|Treatment Period 2||1
8627616|NCT00519376|9667178|FG008|COMPLETED|Treatment Period 2||1
8627617|NCT00519376|9667179|FG009|COMPLETED|Treatment Period 2||1
8627618|NCT00519376|9667180|FG010|COMPLETED|Treatment Period 2||1
8627619|NCT00519376|9667181|FG011|COMPLETED|Treatment Period 2||1
8627620|NCT00519376|9667182|FG012|COMPLETED|Treatment Period 2||0
8627621|NCT00519376|9667183|FG013|COMPLETED|Treatment Period 2||1
8627622|NCT00519376|9667184|FG014|COMPLETED|Treatment Period 2||1
8627623|NCT00519376|9667185|FG015|COMPLETED|Treatment Period 2||1
8627624|NCT00519376|9667170|FG000|NOT COMPLETED|Treatment Period 2||0
8580756|NCT00200343|9614163|FG000|STARTED|Overall Study||199
8580757|NCT00200343|9614164|FG001|STARTED|Overall Study||200
8580758|NCT00200343|9614165|FG002|STARTED|Overall Study||197
8580759|NCT00200343|9614163|FG000|COMPLETED|Overall Study||183
8580760|NCT00200343|9614164|FG001|COMPLETED|Overall Study||192
8580761|NCT00200343|9614165|FG002|COMPLETED|Overall Study||184
8580762|NCT00200343|9614163|FG000|NOT COMPLETED|Overall Study||16
8580763|NCT00200343|9614164|FG001|NOT COMPLETED|Overall Study||8
8580764|NCT00200343|9614165|FG002|NOT COMPLETED|Overall Study||13
8580765|NCT00200356|9614175|FG000|STARTED|Overall Study||199
8580766|NCT00200356|9614176|FG001|STARTED|Overall Study||202
8580767|NCT00200356|9614175|FG000|Safety Analysis Set|Overall Study||194
8580768|NCT00200356|9614176|FG001|Safety Analysis Set|Overall Study||198
8580769|NCT00200356|9614175|FG000|COMPLETED|Overall Study||191
8580770|NCT00200356|9614176|FG001|COMPLETED|Overall Study||195
8580771|NCT00200356|9614175|FG000|NOT COMPLETED|Overall Study||8
8580772|NCT00200356|9614176|FG001|NOT COMPLETED|Overall Study||7
8580773|NCT00200785|9614184|FG000|STARTED|First Intervention||9
8580774|NCT00200785|9614185|FG001|STARTED|First Intervention||6
8580775|NCT00200785|9614184|FG000|COMPLETED|First Intervention||9
8580776|NCT00200785|9614185|FG001|COMPLETED|First Intervention||6
8580777|NCT00200785|9614184|FG000|NOT COMPLETED|First Intervention||0
8580778|NCT00200785|9614185|FG001|NOT COMPLETED|First Intervention||0
8580779|NCT00200785|9614184|FG000|STARTED|Washout Period of 1 Week||9
8580780|NCT00200785|9614185|FG001|STARTED|Washout Period of 1 Week||6
8580781|NCT00200785|9614184|FG000|COMPLETED|Washout Period of 1 Week||9
8580782|NCT00200785|9614185|FG001|COMPLETED|Washout Period of 1 Week||6
8580783|NCT00200785|9614184|FG000|NOT COMPLETED|Washout Period of 1 Week||0
8580784|NCT00200785|9614185|FG001|NOT COMPLETED|Washout Period of 1 Week||0
8580785|NCT00200785|9614184|FG000|STARTED|Second Intervention||9
8580786|NCT00200785|9614185|FG001|STARTED|Second Intervention||6
8580787|NCT00200785|9614184|FG000|COMPLETED|Second Intervention||9
8580788|NCT00200785|9614185|FG001|COMPLETED|Second Intervention||6
8580789|NCT00200785|9614184|FG000|NOT COMPLETED|Second Intervention||0
8580790|NCT00200785|9614185|FG001|NOT COMPLETED|Second Intervention||0
8580791|NCT00200850|9614194|FG000|STARTED|Overall Study||10
8580792|NCT00200850|9614195|FG001|STARTED|Overall Study||10
8580793|NCT00200850|9614196|FG002|STARTED|Overall Study||11
8580794|NCT00200850|9614194|FG000|COMPLETED|Overall Study||7
8580795|NCT00200850|9614195|FG001|COMPLETED|Overall Study||9
8580796|NCT00200850|9614196|FG002|COMPLETED|Overall Study||5
8580797|NCT00200850|9614194|FG000|NOT COMPLETED|Overall Study||3
8580798|NCT00200850|9614195|FG001|NOT COMPLETED|Overall Study||1
8580799|NCT00200850|9614196|FG002|NOT COMPLETED|Overall Study||6
8580800|NCT00200902|9614207|FG000|STARTED|Overall Study||39
8580801|NCT00200902|9614208|FG001|STARTED|Overall Study||29
8580802|NCT00200902|9614209|FG002|STARTED|Overall Study||20
8580803|NCT00200902|9614207|FG000|COMPLETED|Overall Study||29
8580804|NCT00200902|9614208|FG001|COMPLETED|Overall Study||26
8580805|NCT00200902|9614209|FG002|COMPLETED|Overall Study||12
8580806|NCT00200902|9614207|FG000|NOT COMPLETED|Overall Study||10
8580807|NCT00200902|9614208|FG001|NOT COMPLETED|Overall Study||3
8580808|NCT00200902|9614209|FG002|NOT COMPLETED|Overall Study||8
8580809|NCT00200967|9614225|FG000|STARTED|First Treatment Period||42
8580810|NCT00200967|9614226|FG001|STARTED|First Treatment Period||45
8580811|NCT00200967|9614225|FG000|First Treatment Period|First Treatment Period||42
8580812|NCT00200967|9614226|FG001|First Treatment Period|First Treatment Period||45
8580813|NCT00200967|9614225|FG000|COMPLETED|First Treatment Period||36
8580814|NCT00200967|9614226|FG001|COMPLETED|First Treatment Period||44
8580815|NCT00200967|9614225|FG000|NOT COMPLETED|First Treatment Period||6
8580816|NCT00200967|9614226|FG001|NOT COMPLETED|First Treatment Period||1
8580817|NCT00200967|9614225|FG000|STARTED|Wash-out Period||36
8580818|NCT00200967|9614226|FG001|STARTED|Wash-out Period||44
8580819|NCT00200967|9614225|FG000|COMPLETED|Wash-out Period||36
8580820|NCT00200967|9614226|FG001|COMPLETED|Wash-out Period||43
8580821|NCT00200967|9614225|FG000|NOT COMPLETED|Wash-out Period||0
8580822|NCT00200967|9614226|FG001|NOT COMPLETED|Wash-out Period||1
8580823|NCT00200967|9614225|FG000|STARTED|Second Treatment Period||36
8580824|NCT00200967|9614226|FG001|STARTED|Second Treatment Period||43
8580825|NCT00200967|9614225|FG000|COMPLETED|Second Treatment Period||35
8580826|NCT00200967|9614226|FG001|COMPLETED|Second Treatment Period||41
8580827|NCT00200967|9614225|FG000|NOT COMPLETED|Second Treatment Period||1
8580828|NCT00200967|9614226|FG001|NOT COMPLETED|Second Treatment Period||2
8580829|NCT00200967|9614225|FG000|STARTED|Run-out Period||35
8580830|NCT00200967|9614226|FG001|STARTED|Run-out Period||41
8580831|NCT00200967|9614225|FG000|COMPLETED|Run-out Period||34
8580832|NCT00200967|9614226|FG001|COMPLETED|Run-out Period||41
8580833|NCT00200967|9614225|FG000|NOT COMPLETED|Run-out Period||1
8580834|NCT00200967|9614226|FG001|NOT COMPLETED|Run-out Period||0
8580835|NCT00201006|9614235|FG000|STARTED|Overall Study||83
8580836|NCT00201006|9614236|FG001|STARTED|Overall Study||72
8580837|NCT00201006|9614237|FG002|STARTED|Overall Study||79
8580838|NCT00201006|9614235|FG000|COMPLETED|Overall Study||75
8580839|NCT00201006|9614236|FG001|COMPLETED|Overall Study||70
8580840|NCT00201006|9614237|FG002|COMPLETED|Overall Study||75
8580841|NCT00201006|9614235|FG000|NOT COMPLETED|Overall Study||8
8580842|NCT00201006|9614236|FG001|NOT COMPLETED|Overall Study||2
8580843|NCT00201006|9614237|FG002|NOT COMPLETED|Overall Study||4
8580844|NCT00201123|9614248|FG000|STARTED|Overall Study||32
8580845|NCT00201123|9614249|FG001|STARTED|Overall Study||32
8580846|NCT00201123|9614250|FG002|STARTED|Overall Study||32
8580847|NCT00201123|9614248|FG000|Did Not Meet Continuation Criteria|Overall Study||2
8580848|NCT00201123|9614249|FG001|Did Not Meet Continuation Criteria|Overall Study||0
8580849|NCT00201123|9614250|FG002|Did Not Meet Continuation Criteria|Overall Study||5
8580850|NCT00201123|9614248|FG000|COMPLETED|Overall Study||26
8580851|NCT00201123|9614249|FG001|COMPLETED|Overall Study||28
8580852|NCT00201123|9614250|FG002|COMPLETED|Overall Study||23
8580853|NCT00201123|9614248|FG000|NOT COMPLETED|Overall Study||6
8580854|NCT00201123|9614249|FG001|NOT COMPLETED|Overall Study||4
8580855|NCT00201123|9614250|FG002|NOT COMPLETED|Overall Study||9
8580856|NCT00201201|9614264|FG000|STARTED|Overall Study||87
8580857|NCT00201201|9614265|FG001|STARTED|Overall Study||73
8580858|NCT00201201|9614264|FG000|COMPLETED|Overall Study||82
8580859|NCT00201201|9614265|FG001|COMPLETED|Overall Study||66
8580860|NCT00201201|9614264|FG000|NOT COMPLETED|Overall Study||5
8580861|NCT00201201|9614265|FG001|NOT COMPLETED|Overall Study||7
8580862|NCT00201240|9614271|FG000|STARTED|Overall Study||47
8580863|NCT00201240|9614271|FG000|COMPLETED|Overall Study||44
8580864|NCT00201240|9614271|FG000|NOT COMPLETED|Overall Study||3
8580865|NCT00201409|9614278|FG000|STARTED|Overall Study||65
8580866|NCT00201409|9614279|FG001|STARTED|Overall Study||67
8580867|NCT00201409|9614278|FG000|COMPLETED|Overall Study||64
8580868|NCT00201409|9614279|FG001|COMPLETED|Overall Study||66
8580869|NCT00201409|9614278|FG000|NOT COMPLETED|Overall Study||1
8580870|NCT00201409|9614279|FG001|NOT COMPLETED|Overall Study||1
8580871|NCT00201448|9614287|FG000|STARTED|Overall Study||42
8580872|NCT00201448|9614288|FG001|STARTED|Overall Study||40
8580873|NCT00201448|9614287|FG000|COMPLETED|Overall Study||42
8580874|NCT00201448|9614288|FG001|COMPLETED|Overall Study||40
8580875|NCT00201448|9614287|FG000|NOT COMPLETED|Overall Study||0
8580876|NCT00201448|9614288|FG001|NOT COMPLETED|Overall Study||0
8580877|NCT00201643|9614298|FG000|STARTED|Overall Study||223
8580878|NCT00201643|9614299|FG001|STARTED|Overall Study||214
8580879|NCT00201643|9614298|FG000|COMPLETED|Overall Study||218
8580880|NCT00201643|9614299|FG001|COMPLETED|Overall Study||210
8580881|NCT00201643|9614298|FG000|NOT COMPLETED|Overall Study||5
8580882|NCT00201643|9614299|FG001|NOT COMPLETED|Overall Study||4
8580883|NCT00201734|9614307|FG000|STARTED|Overall Study||32
8580884|NCT00201734|9614308|FG001|STARTED|Overall Study||25
8580885|NCT00201734|9614307|FG000|Patients Not Evaluable|Overall Study||3
8580886|NCT00201734|9614308|FG001|Patients Not Evaluable|Overall Study||0
8580887|NCT00201734|9614307|FG000|COMPLETED|Overall Study||29
8580888|NCT00201734|9614308|FG001|COMPLETED|Overall Study||25
8580889|NCT00201734|9614307|FG000|NOT COMPLETED|Overall Study||3
8580890|NCT00201734|9614308|FG001|NOT COMPLETED|Overall Study||0
8580891|NCT00201760|9614317|FG000|STARTED|Overall Study||5
8580892|NCT00201760|9614318|FG001|STARTED|Overall Study||5
8580893|NCT00201760|9614317|FG000|COMPLETED|Overall Study||5
8580894|NCT00201760|9614318|FG001|COMPLETED|Overall Study||5
8580895|NCT00201760|9614317|FG000|NOT COMPLETED|Overall Study||0
8580896|NCT00201760|9614318|FG001|NOT COMPLETED|Overall Study||0
8580897|NCT00201773|9614324|FG000|STARTED|Overall Study||22
8580898|NCT00201773|9614324|FG000|Completed 8 Weeks of Planned Therapy|Overall Study||16
8580899|NCT00201773|9614324|FG000|Received All Exemestane Therapy|Overall Study||5
8580900|NCT00201773|9614324|FG000|Stopped Exemestane After 4 Weeks|Overall Study||1
8580901|NCT00201773|9614324|FG000|COMPLETED|Overall Study||16
8580902|NCT00201773|9614324|FG000|NOT COMPLETED|Overall Study||6
8580903|NCT00201825|9614331|FG000|STARTED|Overall Study||29
8580904|NCT00201825|9614331|FG000|COMPLETED|Overall Study||29
8580905|NCT00201825|9614331|FG000|NOT COMPLETED|Overall Study||0
8580906|NCT00201838|9614337|FG000|STARTED|Overall Study||30
8580907|NCT00201838|9614338|FG001|STARTED|Overall Study||8
8580908|NCT00201838|9614337|FG000|Treatment Cohort|Overall Study||30
8580909|NCT00201838|9614338|FG001|Treatment Cohort|Overall Study||8
8580910|NCT00201838|9614337|FG000|COMPLETED|Overall Study||30
8580911|NCT00201838|9614338|FG001|COMPLETED|Overall Study||8
8580912|NCT00201838|9614337|FG000|NOT COMPLETED|Overall Study||0
8580913|NCT00201838|9614338|FG001|NOT COMPLETED|Overall Study||0
8580914|NCT00201851|9614353|FG000|STARTED|Overall Study||252
8580915|NCT00201851|9614354|FG001|STARTED|Overall Study||257
8580916|NCT00201851|9614355|FG002|STARTED|Overall Study||231
8580917|NCT00201851|9614353|FG000|COMPLETED|Overall Study||244
8580918|NCT00201851|9614354|FG001|COMPLETED|Overall Study||255
8580919|NCT00201851|9614355|FG002|COMPLETED|Overall Study||230
8580920|NCT00201851|9614353|FG000|NOT COMPLETED|Overall Study||8
8580921|NCT00201851|9614354|FG001|NOT COMPLETED|Overall Study||2
8580922|NCT00201851|9614355|FG002|NOT COMPLETED|Overall Study||1
8580923|NCT00201864|9614363|FG000|STARTED|Overall Study||40
8580924|NCT00201864|9614363|FG000|COMPLETED|Overall Study||40
8580925|NCT00201864|9614363|FG000|NOT COMPLETED|Overall Study||0
8580926|NCT00201877|9614369|FG000|STARTED|Overall Study||25
8580927|NCT00201877|9614369|FG000|COMPLETED|Overall Study||25
8580928|NCT00201877|9614369|FG000|NOT COMPLETED|Overall Study||0
8580929|NCT00202449|9614377|FG000|STARTED|Overall Study||18
8580930|NCT00202449|9614378|FG001|STARTED|Overall Study||20
8580931|NCT00202449|9614379|FG002|STARTED|Overall Study||21
8580932|NCT00202449|9614377|FG000|COMPLETED|Overall Study||7
8580933|NCT00202449|9614378|FG001|COMPLETED|Overall Study||9
8580934|NCT00202449|9614379|FG002|COMPLETED|Overall Study||9
8580935|NCT00202449|9614377|FG000|NOT COMPLETED|Overall Study||11
8580936|NCT00202449|9614378|FG001|NOT COMPLETED|Overall Study||11
8580937|NCT00202449|9614379|FG002|NOT COMPLETED|Overall Study||12
8580938|NCT00202644|9614389|FG000|STARTED|Overall Study|One participant not randomized but treated.|76
8580939|NCT00202644|9614390|FG001|STARTED|Overall Study||70
8580940|NCT00202644|9614389|FG000|COMPLETED|Overall Study||41
8580941|NCT00202644|9614390|FG001|COMPLETED|Overall Study||43
8580942|NCT00202644|9614389|FG000|NOT COMPLETED|Overall Study||35
8580943|NCT00202644|9614390|FG001|NOT COMPLETED|Overall Study||27
8580944|NCT00202722|9614396|FG000|STARTED|Overall Study||41
8580945|NCT00202722|9614396|FG000|COMPLETED|Overall Study||41
8580946|NCT00202722|9614396|FG000|NOT COMPLETED|Overall Study||0
8580947|NCT00202839|9614403|FG000|STARTED|Overall Study||78
8580948|NCT00202839|9614404|FG001|STARTED|Overall Study||82
8580949|NCT00202839|9614403|FG000|COMPLETED|Overall Study||54
8580950|NCT00202839|9614404|FG001|COMPLETED|Overall Study||72
8580951|NCT00202839|9614403|FG000|NOT COMPLETED|Overall Study||24
8580952|NCT00202839|9614404|FG001|NOT COMPLETED|Overall Study||10
8580953|NCT00202930|9614410|FG000|STARTED|Overall Study||4
8580954|NCT00202930|9614410|FG000|COMPLETED|Overall Study||4
8580955|NCT00202930|9614410|FG000|NOT COMPLETED|Overall Study||0
8580956|NCT00203021|9614416|FG000|STARTED|Overall Study||107
8580957|NCT00203021|9614417|FG001|STARTED|Overall Study||101
8580958|NCT00203021|9614416|FG000|Received at Least 1 Dose of Study Drug|Overall Study||107
8580959|NCT00203021|9614417|FG001|Received at Least 1 Dose of Study Drug|Overall Study||101
8580960|NCT00203021|9614416|FG000|COMPLETED|Overall Study||28
8580961|NCT00203021|9614417|FG001|COMPLETED|Overall Study||24
8580962|NCT00203021|9614416|FG000|NOT COMPLETED|Overall Study||79
8580963|NCT00203021|9614417|FG001|NOT COMPLETED|Overall Study||77
8709799|NCT00955110|9756058|FG000|Oxycodone CR 60 mg|Treatment Phase||40
8580964|NCT00203047|9614425|FG000|STARTED|Overall Study||204
8580965|NCT00203047|9614426|FG001|STARTED|Overall Study||210
8580966|NCT00203047|9614425|FG000|In Database as of January 29, 2009|Overall Study||199
8580967|NCT00203047|9614426|FG001|In Database as of January 29, 2009|Overall Study||209
8580968|NCT00203047|9614425|FG000|COMPLETED|Overall Study||13
8580969|NCT00203047|9614426|FG001|COMPLETED|Overall Study||7
8580970|NCT00203047|9614425|FG000|NOT COMPLETED|Overall Study||191
8580971|NCT00203047|9614426|FG001|NOT COMPLETED|Overall Study||203
8580972|NCT00203203|9614434|FG000|STARTED|Overall Study||10
8580973|NCT00203203|9614435|FG001|STARTED|Overall Study||20
8580974|NCT00203203|9614434|FG000|COMPLETED|Overall Study||9
8580975|NCT00203203|9614435|FG001|COMPLETED|Overall Study||20
8580976|NCT00203203|9614434|FG000|NOT COMPLETED|Overall Study||1
8580977|NCT00203203|9614435|FG001|NOT COMPLETED|Overall Study||0
8580978|NCT00203216|9614441|FG000|STARTED|Overall Study||31
8580979|NCT00203216|9614441|FG000|COMPLETED|Overall Study||27
8580980|NCT00203216|9614441|FG000|NOT COMPLETED|Overall Study||4
8580981|NCT00203229|9614447|FG000|STARTED|Overall Study||10
8580982|NCT00203229|9614448|FG001|STARTED|Overall Study||10
8580983|NCT00203229|9614447|FG000|COMPLETED|Overall Study||7
8580984|NCT00203229|9614448|FG001|COMPLETED|Overall Study||7
8580985|NCT00203229|9614447|FG000|NOT COMPLETED|Overall Study||3
8580986|NCT00203229|9614448|FG001|NOT COMPLETED|Overall Study||3
8580987|NCT00203242|9614454|FG000|STARTED|Overall Study||15
8580988|NCT00203242|9614454|FG000|COMPLETED|Overall Study||14
8580989|NCT00203242|9614454|FG000|NOT COMPLETED|Overall Study||1
8580990|NCT00203268|9614458|FG000|STARTED|Early Treatment||13
8580991|NCT00203268|9614458|FG000|COMPLETED|Early Treatment||9
8580992|NCT00203268|9614458|FG000|NOT COMPLETED|Early Treatment||4
8580993|NCT00203268|9614458|FG000|STARTED|Late Treatment||9
8580994|NCT00203268|9614458|FG000|COMPLETED|Late Treatment||9
8580995|NCT00203268|9614458|FG000|NOT COMPLETED|Late Treatment||0
8580996|NCT00203294|9614466|FG000|STARTED|Overall Study||22
8580997|NCT00203294|9614467|FG001|STARTED|Overall Study||23
8580998|NCT00203294|9614466|FG000|COMPLETED|Overall Study||14
8580999|NCT00203294|9614467|FG001|COMPLETED|Overall Study||10
8581000|NCT00203294|9614466|FG000|NOT COMPLETED|Overall Study||8
8581001|NCT00203294|9614467|FG001|NOT COMPLETED|Overall Study||13
8581002|NCT00203307|9614475|FG000|STARTED|First Intervention|Double-blind cross-over design. Study terminated early. Results not analyzed.|3
8581003|NCT00203307|9614476|FG001|STARTED|First Intervention||0
8581004|NCT00203307|9614475|FG000|COMPLETED|First Intervention||1
8581005|NCT00203307|9614476|FG001|COMPLETED|First Intervention||0
8581006|NCT00203307|9614475|FG000|NOT COMPLETED|First Intervention||2
8581007|NCT00203307|9614476|FG001|NOT COMPLETED|First Intervention||0
8581008|NCT00203307|9614475|FG000|STARTED|Second Intervention|2 subjects dropped out of the 1st intervention period, due to fatugue.|1
8581009|NCT00203307|9614476|FG001|STARTED|Second Intervention||0
8581010|NCT00203307|9614475|FG000|COMPLETED|Second Intervention||1
8581011|NCT00203307|9614476|FG001|COMPLETED|Second Intervention||0
8581012|NCT00203307|9614475|FG000|NOT COMPLETED|Second Intervention||0
8581013|NCT00203307|9614476|FG001|NOT COMPLETED|Second Intervention||0
8581014|NCT00203411|9614482|FG000|STARTED|Treatment Period||45
8581015|NCT00203411|9614482|FG000|COMPLETED|Treatment Period||45
8581016|NCT00203411|9614482|FG000|NOT COMPLETED|Treatment Period||0
8581017|NCT00203411|9614482|FG000|STARTED|Follow-up||45
8581018|NCT00203411|9614482|FG000|COMPLETED|Follow-up||41
8581019|NCT00203411|9614482|FG000|NOT COMPLETED|Follow-up||4
8581020|NCT00203424|9614487|FG000|STARTED|Treatment Period|23 subjects registered for treatment, 1 withdrew consent after registration,22 received treatment.|22
8627625|NCT00519376|9667171|FG001|NOT COMPLETED|Treatment Period 2||0
8627626|NCT00519376|9667172|FG002|NOT COMPLETED|Treatment Period 2||0
8627627|NCT00519376|9667173|FG003|NOT COMPLETED|Treatment Period 2||0
8627628|NCT00519376|9667174|FG004|NOT COMPLETED|Treatment Period 2||0
8581021|NCT00203424|9614487|FG000|COMPLETED|Treatment Period|Of 11 pts that did not complete treatment,5 stopped due to adverse event and entered followup period|11
8581022|NCT00203424|9614487|FG000|NOT COMPLETED|Treatment Period||11
8581023|NCT00203424|9614487|FG000|STARTED|Follow-up Period|followup includes 11 pts that completed treatment + 5 pts who stopped treatment due to adverse event|16
8581024|NCT00203424|9614487|FG000|COMPLETED|Follow-up Period||10
8581025|NCT00203424|9614487|FG000|NOT COMPLETED|Follow-up Period||6
8581026|NCT00203476|9614494|FG000|STARTED|Overall Study||10
8709800|NCT00955110|9756058|FG000|COMPLETED|Treatment Phase||35
8709801|NCT00955110|9756058|FG000|NOT COMPLETED|Treatment Phase||6
8709802|NCT00955201|9756074|FG000|STARTED|Overall Study||12
8581027|NCT00203476|9614495|FG001|STARTED|Overall Study||10
8581028|NCT00203476|9614496|FG002|STARTED|Overall Study||10
8581029|NCT00203476|9614494|FG000|COMPLETED|Overall Study||9
8581030|NCT00203476|9614495|FG001|COMPLETED|Overall Study||9
8581031|NCT00203476|9614496|FG002|COMPLETED|Overall Study||10
8581032|NCT00203476|9614494|FG000|NOT COMPLETED|Overall Study||1
8581033|NCT00203476|9614495|FG001|NOT COMPLETED|Overall Study||1
8581034|NCT00203476|9614496|FG002|NOT COMPLETED|Overall Study||0
8581035|NCT00203502|9614504|FG000|STARTED|Overall Study||40
8581036|NCT00203502|9614504|FG000|COMPLETED|Overall Study||39
8581037|NCT00203502|9614504|FG000|NOT COMPLETED|Overall Study||1
8581038|NCT00203892|9614511|FG000|STARTED|Overall Study||7
8581039|NCT00203892|9614512|FG001|STARTED|Overall Study||10
8581040|NCT00203892|9614513|FG002|STARTED|Overall Study||6
8581041|NCT00203892|9614511|FG000|Received at Least 3 Doses of CEA Vaccine|Overall Study|This group of patients were evaluable for the primary outcome.|5
8581042|NCT00203892|9614512|FG001|Received at Least 3 Doses of CEA Vaccine|Overall Study|This group of patients were evaluable for the primary outcome.|5
8581043|NCT00203892|9614513|FG002|Received at Least 3 Doses of CEA Vaccine|Overall Study|This group of patients were evaluable for the primary outcome.|4
8581044|NCT00203892|9614511|FG000|COMPLETED|Overall Study|2 patients not completing study were randomized but never treated|5
8581045|NCT00203892|9614512|FG001|COMPLETED|Overall Study|2 patients not completing study were randomized but never treated|8
8581046|NCT00203892|9614513|FG002|COMPLETED|Overall Study||6
8581047|NCT00203892|9614511|FG000|NOT COMPLETED|Overall Study||2
8581048|NCT00203892|9614512|FG001|NOT COMPLETED|Overall Study||2
8581049|NCT00203892|9614513|FG002|NOT COMPLETED|Overall Study||0
8581050|NCT00203931|9614523|FG000|STARTED|Overall Study||27
8581051|NCT00203931|9614524|FG001|STARTED|Overall Study||28
8581052|NCT00203931|9614523|FG000|COMPLETED|Overall Study|These are the evaluable patients who received at least 3 doses of cetuximab.|20
8581053|NCT00203931|9614524|FG001|COMPLETED|Overall Study|These are the evaluable patients who received at least 3 doses of cetuximab.|23
8581054|NCT00203931|9614523|FG000|NOT COMPLETED|Overall Study||7
8581055|NCT00203931|9614524|FG001|NOT COMPLETED|Overall Study||5
8581056|NCT00203996|9614540|FG000|STARTED|Overall Study||0
8581057|NCT00203996|9614541|FG001|STARTED|Overall Study||0
8581058|NCT00203996|9614542|FG002|STARTED|Overall Study||0
8581059|NCT00203996|9614543|FG003|STARTED|Overall Study||19
8581060|NCT00203996|9614544|FG004|STARTED|Overall Study||4
8581061|NCT00203996|9614545|FG005|STARTED|Overall Study||3
8581062|NCT00203996|9614546|FG006|STARTED|Overall Study||2
8581063|NCT00203996|9614547|FG007|STARTED|Overall Study||4
8581064|NCT00203996|9614548|FG008|STARTED|Overall Study||2
8581065|NCT00203996|9614549|FG009|STARTED|Overall Study||3
8581066|NCT00203996|9614540|FG000|Aim 3 Only: First Intervention|Overall Study||0
8581067|NCT00203996|9614541|FG001|Aim 3 Only: First Intervention|Overall Study||0
8581068|NCT00203996|9614542|FG002|Aim 3 Only: First Intervention|Overall Study||0
8581069|NCT00203996|9614543|FG003|Aim 3 Only: First Intervention|Overall Study||0
8581070|NCT00203996|9614544|FG004|Aim 3 Only: First Intervention|Overall Study||0
8581071|NCT00203996|9614545|FG005|Aim 3 Only: First Intervention|Overall Study||3
8581072|NCT00203996|9614546|FG006|Aim 3 Only: First Intervention|Overall Study||2
8581073|NCT00203996|9614547|FG007|Aim 3 Only: First Intervention|Overall Study||4
8581074|NCT00203996|9614548|FG008|Aim 3 Only: First Intervention|Overall Study||2
8581075|NCT00203996|9614549|FG009|Aim 3 Only: First Intervention|Overall Study||3
8581076|NCT00203996|9614540|FG000|Aim 3 Only: Washout|Overall Study||0
8581077|NCT00203996|9614541|FG001|Aim 3 Only: Washout|Overall Study||0
8581078|NCT00203996|9614542|FG002|Aim 3 Only: Washout|Overall Study||0
8581079|NCT00203996|9614543|FG003|Aim 3 Only: Washout|Overall Study||0
8581080|NCT00203996|9614544|FG004|Aim 3 Only: Washout|Overall Study||0
8581081|NCT00203996|9614545|FG005|Aim 3 Only: Washout|Overall Study||3
8581082|NCT00203996|9614546|FG006|Aim 3 Only: Washout|Overall Study||2
8581083|NCT00203996|9614547|FG007|Aim 3 Only: Washout|Overall Study||2
8581084|NCT00203996|9614548|FG008|Aim 3 Only: Washout|Overall Study||2
8581085|NCT00203996|9614549|FG009|Aim 3 Only: Washout|Overall Study||2
8581086|NCT00203996|9614540|FG000|Aim 3 Only: Second Intervention|Overall Study||0
8581087|NCT00203996|9614541|FG001|Aim 3 Only: Second Intervention|Overall Study||0
8581088|NCT00203996|9614542|FG002|Aim 3 Only: Second Intervention|Overall Study||0
8581089|NCT00203996|9614543|FG003|Aim 3 Only: Second Intervention|Overall Study||0
8581090|NCT00203996|9614544|FG004|Aim 3 Only: Second Intervention|Overall Study||0
8581091|NCT00203996|9614545|FG005|Aim 3 Only: Second Intervention|Overall Study||3
8581092|NCT00203996|9614546|FG006|Aim 3 Only: Second Intervention|Overall Study||2
8581093|NCT00203996|9614547|FG007|Aim 3 Only: Second Intervention|Overall Study||2
8709803|NCT00955201|9756075|FG001|STARTED|Overall Study||11
8709804|NCT00955201|9756076|FG002|STARTED|Overall Study||11
8709805|NCT00955201|9756077|FG003|STARTED|Overall Study||11
8581094|NCT00203996|9614548|FG008|Aim 3 Only: Second Intervention|Overall Study||2
8581095|NCT00203996|9614549|FG009|Aim 3 Only: Second Intervention|Overall Study||2
8581096|NCT00203996|9614540|FG000|Aim 3 Only: Second Washout|Overall Study||0
8581097|NCT00203996|9614541|FG001|Aim 3 Only: Second Washout|Overall Study||0
8581098|NCT00203996|9614542|FG002|Aim 3 Only: Second Washout|Overall Study||0
8581099|NCT00203996|9614543|FG003|Aim 3 Only: Second Washout|Overall Study||0
8581100|NCT00203996|9614544|FG004|Aim 3 Only: Second Washout|Overall Study||0
8928127|NCT02278328|9989241|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
8928128|NCT02278328|9989242|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
8928129|NCT02278328|9989243|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
8928130|NCT02278328|9989241|FG000|STARTED|Third Washout (1 Week)||9
8928131|NCT02278328|9989242|FG001|STARTED|Third Washout (1 Week)||6
8928132|NCT02278328|9989243|FG002|STARTED|Third Washout (1 Week)||6
8928133|NCT02278328|9989241|FG000|COMPLETED|Third Washout (1 Week)||9
8581101|NCT00203996|9614545|FG005|Aim 3 Only: Second Washout|Overall Study||3
8581102|NCT00203996|9614546|FG006|Aim 3 Only: Second Washout|Overall Study||2
8581103|NCT00203996|9614547|FG007|Aim 3 Only: Second Washout|Overall Study||2
8581104|NCT00203996|9614548|FG008|Aim 3 Only: Second Washout|Overall Study||2
8581105|NCT00203996|9614549|FG009|Aim 3 Only: Second Washout|Overall Study||2
8581106|NCT00203996|9614540|FG000|Aim 3 Only: Third Intervention|Overall Study||0
8581107|NCT00203996|9614541|FG001|Aim 3 Only: Third Intervention|Overall Study||0
8581108|NCT00203996|9614542|FG002|Aim 3 Only: Third Intervention|Overall Study||0
8581109|NCT00203996|9614543|FG003|Aim 3 Only: Third Intervention|Overall Study||0
8581110|NCT00203996|9614544|FG004|Aim 3 Only: Third Intervention|Overall Study||0
8581111|NCT00203996|9614545|FG005|Aim 3 Only: Third Intervention|Overall Study||3
8581112|NCT00203996|9614546|FG006|Aim 3 Only: Third Intervention|Overall Study||2
8581113|NCT00203996|9614547|FG007|Aim 3 Only: Third Intervention|Overall Study||2
8581114|NCT00203996|9614548|FG008|Aim 3 Only: Third Intervention|Overall Study||2
8581115|NCT00203996|9614549|FG009|Aim 3 Only: Third Intervention|Overall Study||2
8581116|NCT00203996|9614540|FG000|COMPLETED|Overall Study||0
8581117|NCT00203996|9614541|FG001|COMPLETED|Overall Study||0
8581118|NCT00203996|9614542|FG002|COMPLETED|Overall Study||0
8581119|NCT00203996|9614543|FG003|COMPLETED|Overall Study||9
8581120|NCT00203996|9614544|FG004|COMPLETED|Overall Study||3
8581121|NCT00203996|9614545|FG005|COMPLETED|Overall Study||3
8581122|NCT00203996|9614546|FG006|COMPLETED|Overall Study||2
8581123|NCT00203996|9614547|FG007|COMPLETED|Overall Study||2
8581124|NCT00203996|9614548|FG008|COMPLETED|Overall Study||2
8581125|NCT00203996|9614549|FG009|COMPLETED|Overall Study||2
8581126|NCT00203996|9614540|FG000|NOT COMPLETED|Overall Study||0
8581127|NCT00203996|9614541|FG001|NOT COMPLETED|Overall Study||0
8581128|NCT00203996|9614542|FG002|NOT COMPLETED|Overall Study||0
8581129|NCT00203996|9614543|FG003|NOT COMPLETED|Overall Study||10
8581130|NCT00203996|9614544|FG004|NOT COMPLETED|Overall Study||1
8581131|NCT00203996|9614545|FG005|NOT COMPLETED|Overall Study||0
8581132|NCT00203996|9614546|FG006|NOT COMPLETED|Overall Study||0
8581133|NCT00203996|9614547|FG007|NOT COMPLETED|Overall Study||2
8581134|NCT00203996|9614548|FG008|NOT COMPLETED|Overall Study||0
8581135|NCT00203996|9614549|FG009|NOT COMPLETED|Overall Study||1
8581136|NCT00204373|9614565|FG000|STARTED|Overall Study||72
8581137|NCT00204373|9614565|FG000|COMPLETED|Overall Study||72
8581138|NCT00204373|9614565|FG000|NOT COMPLETED|Overall Study||0
8581139|NCT00204932|9614571|FG000|STARTED|Overall Study||24
8581140|NCT00204932|9614572|FG001|STARTED|Overall Study||24
8581141|NCT00204932|9614571|FG000|COMPLETED|Overall Study||22
8581142|NCT00204932|9614572|FG001|COMPLETED|Overall Study||18
8581143|NCT00204932|9614571|FG000|NOT COMPLETED|Overall Study||2
8581144|NCT00204932|9614572|FG001|NOT COMPLETED|Overall Study||6
8581145|NCT00205179|9614580|FG000|STARTED|Overall Study||32
8581146|NCT00205179|9614581|FG001|STARTED|Overall Study||33
8581147|NCT00205179|9614580|FG000|COMPLETED|Overall Study||30
8581148|NCT00205179|9614581|FG001|COMPLETED|Overall Study||29
8581149|NCT00205179|9614580|FG000|NOT COMPLETED|Overall Study||2
8581150|NCT00205179|9614581|FG001|NOT COMPLETED|Overall Study||4
8581151|NCT00205348|9614588|FG000|STARTED|Overall Study||146
8581152|NCT00205348|9614588|FG000|COMPLETED|Overall Study||116
8581153|NCT00205348|9614588|FG000|NOT COMPLETED|Overall Study||30
8581154|NCT00205374|9614594|FG000|STARTED|Overall Study||10
8581155|NCT00205374|9614595|FG001|STARTED|Overall Study||9
8581156|NCT00205374|9614594|FG000|COMPLETED|Overall Study||10
8581157|NCT00205374|9614595|FG001|COMPLETED|Overall Study||9
8581158|NCT00205374|9614594|FG000|NOT COMPLETED|Overall Study||0
8581159|NCT00205374|9614595|FG001|NOT COMPLETED|Overall Study||0
8581160|NCT00205504|9614603|FG000|STARTED|Overall Study||21
8581161|NCT00205504|9614604|FG001|STARTED|Overall Study||15
8581162|NCT00205504|9614603|FG000|COMPLETED|Overall Study||14
8581163|NCT00205504|9614604|FG001|COMPLETED|Overall Study||15
8581164|NCT00205504|9614603|FG000|NOT COMPLETED|Overall Study||7
8581165|NCT00205504|9614604|FG001|NOT COMPLETED|Overall Study||0
8581166|NCT00205660|9614616|FG000|STARTED|Overall Study||14
8581167|NCT00205660|9614617|FG001|STARTED|Overall Study||37
8581168|NCT00205660|9614616|FG000|COMPLETED|Overall Study||12
8581169|NCT00205660|9614617|FG001|COMPLETED|Overall Study||35
8581170|NCT00205660|9614616|FG000|NOT COMPLETED|Overall Study||2
8581171|NCT00205660|9614617|FG001|NOT COMPLETED|Overall Study||2
8581172|NCT00205699|9614627|FG000|STARTED|Overall Study||49
8581173|NCT00205699|9614628|FG001|STARTED|Overall Study||46
8581174|NCT00205699|9614629|FG002|STARTED|Overall Study||49
8581175|NCT00205699|9614627|FG000|COMPLETED|Overall Study||46
8581176|NCT00205699|9614628|FG001|COMPLETED|Overall Study||40
8581177|NCT00205699|9614629|FG002|COMPLETED|Overall Study||43
8581178|NCT00205699|9614627|FG000|NOT COMPLETED|Overall Study||3
8581179|NCT00205699|9614628|FG001|NOT COMPLETED|Overall Study||6
8581180|NCT00205699|9614629|FG002|NOT COMPLETED|Overall Study||6
8581181|NCT00205712|9614642|FG000|STARTED|Overall Study||20
8581182|NCT00205712|9614643|FG001|STARTED|Overall Study||20
8581183|NCT00205712|9614642|FG000|COMPLETED|Overall Study||20
8581184|NCT00205712|9614643|FG001|COMPLETED|Overall Study||19
8581185|NCT00205712|9614642|FG000|NOT COMPLETED|Overall Study||0
8581186|NCT00205712|9614643|FG001|NOT COMPLETED|Overall Study||1
8581187|NCT00205777|9614655|FG000|STARTED|Core Study (Up to 3 Years)||1907
8581188|NCT00205777|9614656|FG001|STARTED|Core Study (Up to 3 Years)||1904
8581189|NCT00205777|9614657|FG002|STARTED|Core Study (Up to 3 Years)||1884
8581190|NCT00205777|9614658|FG003|STARTED|Core Study (Up to 3 Years)||1914
8581191|NCT00205777|9614659|FG004|STARTED|Core Study (Up to 3 Years)||0
8581192|NCT00205777|9614660|FG005|STARTED|Core Study (Up to 3 Years)||0
8581193|NCT00205777|9614655|FG000|TREATED|Core Study (Up to 3 Years)||1886
8581194|NCT00205777|9614656|FG001|TREATED|Core Study (Up to 3 Years)||1872
8581195|NCT00205777|9614657|FG002|TREATED|Core Study (Up to 3 Years)||1849
8581196|NCT00205777|9614658|FG003|TREATED|Core Study (Up to 3 Years)||1885
8581197|NCT00205777|9614659|FG004|TREATED|Core Study (Up to 3 Years)||0
8581198|NCT00205777|9614660|FG005|TREATED|Core Study (Up to 3 Years)||0
8581199|NCT00205777|9614655|FG000|COMPLETED|Core Study (Up to 3 Years)||1279
8581200|NCT00205777|9614656|FG001|COMPLETED|Core Study (Up to 3 Years)||1245
8581201|NCT00205777|9614657|FG002|COMPLETED|Core Study (Up to 3 Years)||1277
8581202|NCT00205777|9614658|FG003|COMPLETED|Core Study (Up to 3 Years)||1282
8581203|NCT00205777|9614659|FG004|COMPLETED|Core Study (Up to 3 Years)||0
8581204|NCT00205777|9614660|FG005|COMPLETED|Core Study (Up to 3 Years)||0
8581205|NCT00205777|9614655|FG000|NOT COMPLETED|Core Study (Up to 3 Years)||628
8581206|NCT00205777|9614656|FG001|NOT COMPLETED|Core Study (Up to 3 Years)||659
8581207|NCT00205777|9614657|FG002|NOT COMPLETED|Core Study (Up to 3 Years)||607
8581208|NCT00205777|9614658|FG003|NOT COMPLETED|Core Study (Up to 3 Years)||632
8581209|NCT00205777|9614659|FG004|NOT COMPLETED|Core Study (Up to 3 Years)||0
8581210|NCT00205777|9614660|FG005|NOT COMPLETED|Core Study (Up to 3 Years)||0
8581211|NCT00205777|9614655|FG000|STARTED|Completed Core Study, Entered SE I||1279
8581212|NCT00205777|9614656|FG001|STARTED|Completed Core Study, Entered SE I||1245
8581213|NCT00205777|9614657|FG002|STARTED|Completed Core Study, Entered SE I||1277
8581214|NCT00205777|9614658|FG003|STARTED|Completed Core Study, Entered SE I||1282
8581215|NCT00205777|9614659|FG004|STARTED|Completed Core Study, Entered SE I||0
8581216|NCT00205777|9614660|FG005|STARTED|Completed Core Study, Entered SE I||0
8581217|NCT00205777|9614655|FG000|COMPLETED|Completed Core Study, Entered SE I||1047
8581218|NCT00205777|9614656|FG001|COMPLETED|Completed Core Study, Entered SE I||1041
8581219|NCT00205777|9614657|FG002|COMPLETED|Completed Core Study, Entered SE I||1070
8581220|NCT00205777|9614658|FG003|COMPLETED|Completed Core Study, Entered SE I||1058
8581221|NCT00205777|9614659|FG004|COMPLETED|Completed Core Study, Entered SE I||0
8581222|NCT00205777|9614660|FG005|COMPLETED|Completed Core Study, Entered SE I||0
8581223|NCT00205777|9614655|FG000|NOT COMPLETED|Completed Core Study, Entered SE I||232
8581224|NCT00205777|9614656|FG001|NOT COMPLETED|Completed Core Study, Entered SE I||204
8581225|NCT00205777|9614657|FG002|NOT COMPLETED|Completed Core Study, Entered SE I||207
8581226|NCT00205777|9614658|FG003|NOT COMPLETED|Completed Core Study, Entered SE I||224
8581227|NCT00205777|9614659|FG004|NOT COMPLETED|Completed Core Study, Entered SE I||0
8581228|NCT00205777|9614660|FG005|NOT COMPLETED|Completed Core Study, Entered SE I||0
8581229|NCT00205777|9614655|FG000|STARTED|Study Extension I||1047
8581230|NCT00205777|9614656|FG001|STARTED|Study Extension I||0
8581231|NCT00205777|9614657|FG002|STARTED|Study Extension I||1070
8581232|NCT00205777|9614658|FG003|STARTED|Study Extension I||1058
8581233|NCT00205777|9614659|FG004|STARTED|Study Extension I||1041
8581234|NCT00205777|9614660|FG005|STARTED|Study Extension I||0
8581235|NCT00205777|9614655|FG000|COMPLETED|Study Extension I||833
8581236|NCT00205777|9614656|FG001|COMPLETED|Study Extension I||0
8581237|NCT00205777|9614657|FG002|COMPLETED|Study Extension I||0
8581238|NCT00205777|9614658|FG003|COMPLETED|Study Extension I||830
8581239|NCT00205777|9614659|FG004|COMPLETED|Study Extension I||840
8581240|NCT00205777|9614660|FG005|COMPLETED|Study Extension I||0
8581241|NCT00205777|9614655|FG000|NOT COMPLETED|Study Extension I||214
8709806|NCT00955201|9756074|FG000|COMPLETED|Overall Study||8
8709807|NCT00955201|9756075|FG001|COMPLETED|Overall Study||11
8709808|NCT00955201|9756076|FG002|COMPLETED|Overall Study||10
8709809|NCT00955201|9756077|FG003|COMPLETED|Overall Study||7
8709810|NCT00955201|9756074|FG000|NOT COMPLETED|Overall Study||4
8709811|NCT00955201|9756075|FG001|NOT COMPLETED|Overall Study||0
8709812|NCT00955201|9756076|FG002|NOT COMPLETED|Overall Study||1
8709813|NCT00955201|9756077|FG003|NOT COMPLETED|Overall Study||4
8709814|NCT00955253|9756096|FG000|STARTED|First Intervention (Day 2)||7
8709815|NCT00955253|9756097|FG001|STARTED|First Intervention (Day 2)||6
8709816|NCT00955253|9756096|FG000|COMPLETED|First Intervention (Day 2)||7
8709817|NCT00955253|9756097|FG001|COMPLETED|First Intervention (Day 2)||6
8581242|NCT00205777|9614656|FG001|NOT COMPLETED|Study Extension I||0
8581243|NCT00205777|9614657|FG002|NOT COMPLETED|Study Extension I||1070
8581244|NCT00205777|9614658|FG003|NOT COMPLETED|Study Extension I||228
8581245|NCT00205777|9614659|FG004|NOT COMPLETED|Study Extension I||201
8709818|NCT00955253|9756096|FG000|NOT COMPLETED|First Intervention (Day 2)||0
8581246|NCT00205777|9614660|FG005|NOT COMPLETED|Study Extension I||0
8581247|NCT00205777|9614655|FG000|STARTED|Completed SE I, Entered Extension SE II||833
8581248|NCT00205777|9614656|FG001|STARTED|Completed SE I, Entered Extension SE II||0
8581249|NCT00205777|9614657|FG002|STARTED|Completed SE I, Entered Extension SE II||0
8581250|NCT00205777|9614658|FG003|STARTED|Completed SE I, Entered Extension SE II||830
8581251|NCT00205777|9614659|FG004|STARTED|Completed SE I, Entered Extension SE II||840
8581252|NCT00205777|9614660|FG005|STARTED|Completed SE I, Entered Extension SE II||0
8581253|NCT00205777|9614655|FG000|COMPLETED|Completed SE I, Entered Extension SE II||560
8581254|NCT00205777|9614656|FG001|COMPLETED|Completed SE I, Entered Extension SE II||0
8581255|NCT00205777|9614657|FG002|COMPLETED|Completed SE I, Entered Extension SE II||0
8581256|NCT00205777|9614658|FG003|COMPLETED|Completed SE I, Entered Extension SE II||590
8581257|NCT00205777|9614659|FG004|COMPLETED|Completed SE I, Entered Extension SE II||582
8581258|NCT00205777|9614660|FG005|COMPLETED|Completed SE I, Entered Extension SE II||0
8581259|NCT00205777|9614655|FG000|NOT COMPLETED|Completed SE I, Entered Extension SE II||273
8581260|NCT00205777|9614656|FG001|NOT COMPLETED|Completed SE I, Entered Extension SE II||0
8581261|NCT00205777|9614657|FG002|NOT COMPLETED|Completed SE I, Entered Extension SE II||0
8581262|NCT00205777|9614658|FG003|NOT COMPLETED|Completed SE I, Entered Extension SE II||240
8581263|NCT00205777|9614659|FG004|NOT COMPLETED|Completed SE I, Entered Extension SE II||258
8581264|NCT00205777|9614660|FG005|NOT COMPLETED|Completed SE I, Entered Extension SE II||0
8581265|NCT00205777|9614655|FG000|STARTED|Study Extension II||0
8581266|NCT00205777|9614656|FG001|STARTED|Study Extension II||0
8581267|NCT00205777|9614657|FG002|STARTED|Study Extension II||0
8581268|NCT00205777|9614658|FG003|STARTED|Study Extension II||590
8581269|NCT00205777|9614659|FG004|STARTED|Study Extension II||0
8581270|NCT00205777|9614660|FG005|STARTED|Study Extension II||1142
8581271|NCT00205777|9614655|FG000|TREATED|Study Extension II||0
8581272|NCT00205777|9614656|FG001|TREATED|Study Extension II||0
8581273|NCT00205777|9614657|FG002|TREATED|Study Extension II||0
8581274|NCT00205777|9614658|FG003|TREATED|Study Extension II||519
8581275|NCT00205777|9614659|FG004|TREATED|Study Extension II||0
8581276|NCT00205777|9614660|FG005|TREATED|Study Extension II||1011
8581277|NCT00205777|9614655|FG000|COMPLETED|Study Extension II||0
8581278|NCT00205777|9614656|FG001|COMPLETED|Study Extension II||0
8581279|NCT00205777|9614657|FG002|COMPLETED|Study Extension II||0
8581280|NCT00205777|9614658|FG003|COMPLETED|Study Extension II||441
8581281|NCT00205777|9614659|FG004|COMPLETED|Study Extension II||0
8581282|NCT00205777|9614660|FG005|COMPLETED|Study Extension II||860
8581283|NCT00205777|9614655|FG000|NOT COMPLETED|Study Extension II||0
8581284|NCT00205777|9614656|FG001|NOT COMPLETED|Study Extension II||0
8581285|NCT00205777|9614657|FG002|NOT COMPLETED|Study Extension II||0
8581286|NCT00205777|9614658|FG003|NOT COMPLETED|Study Extension II||149
8581287|NCT00205777|9614659|FG004|NOT COMPLETED|Study Extension II||0
8581288|NCT00205777|9614660|FG005|NOT COMPLETED|Study Extension II||282
8581289|NCT00205803|9614677|FG000|STARTED|Infant Series||122
8581290|NCT00205803|9614678|FG001|STARTED|Infant Series||127
8581291|NCT00205803|9614677|FG000|Vaccinated Dose 1|Infant Series||121
8581292|NCT00205803|9614678|FG001|Vaccinated Dose 1|Infant Series||126
8581293|NCT00205803|9614677|FG000|Vaccinated Dose 2|Infant Series||115
8581294|NCT00205803|9614678|FG001|Vaccinated Dose 2|Infant Series||122
8581295|NCT00205803|9614677|FG000|Vaccinated Dose 3|Infant Series||110
8581296|NCT00205803|9614678|FG001|Vaccinated Dose 3|Infant Series||118
8581297|NCT00205803|9614677|FG000|COMPLETED|Infant Series||104
8581298|NCT00205803|9614678|FG001|COMPLETED|Infant Series||116
8581299|NCT00205803|9614677|FG000|NOT COMPLETED|Infant Series||18
8581300|NCT00205803|9614678|FG001|NOT COMPLETED|Infant Series||11
8581301|NCT00205803|9614677|FG000|STARTED|After Infant Series||104
8581302|NCT00205803|9614678|FG001|STARTED|After Infant Series||116
8581303|NCT00205803|9614677|FG000|COMPLETED|After Infant Series||86
8581304|NCT00205803|9614678|FG001|COMPLETED|After Infant Series||103
8581305|NCT00205803|9614677|FG000|NOT COMPLETED|After Infant Series||18
8581306|NCT00205803|9614678|FG001|NOT COMPLETED|After Infant Series||13
8581307|NCT00205803|9614677|FG000|STARTED|Toddler Dose||86
8581308|NCT00205803|9614678|FG001|STARTED|Toddler Dose||103
8581309|NCT00205803|9614677|FG000|COMPLETED|Toddler Dose||84
8581310|NCT00205803|9614678|FG001|COMPLETED|Toddler Dose||100
8581311|NCT00205803|9614677|FG000|NOT COMPLETED|Toddler Dose||2
8581312|NCT00205803|9614678|FG001|NOT COMPLETED|Toddler Dose||3
8581313|NCT00205855|9614702|FG000|STARTED|Overall Study||65
8581314|NCT00205855|9614702|FG000|COMPLETED|Overall Study||44
8581315|NCT00205855|9614702|FG000|NOT COMPLETED|Overall Study||21
8581316|NCT00205881|9614706|FG000|STARTED|Overall Study||32
8581317|NCT00205881|9614706|FG000|COMPLETED|Overall Study|32 enrolled. 1 unilateral. 25 bilateral for data analysis at 8 months. 16 completed study.|16
8581318|NCT00205881|9614706|FG000|NOT COMPLETED|Overall Study||16
8581319|NCT00206076|9614713|FG000|STARTED|Overall Study||9
8581320|NCT00206076|9614714|FG001|STARTED|Overall Study||10
8581321|NCT00206076|9614713|FG000|COMPLETED|Overall Study||6
8581322|NCT00206076|9614714|FG001|COMPLETED|Overall Study||9
8581323|NCT00206076|9614713|FG000|NOT COMPLETED|Overall Study||3
8581324|NCT00206076|9614714|FG001|NOT COMPLETED|Overall Study||1
8581325|NCT00206102|9614724|FG000|STARTED|Overall Study||596
8581326|NCT00206102|9614725|FG001|STARTED|Overall Study||502
8581327|NCT00206102|9614724|FG000|COMPLETED|Overall Study||188
8581328|NCT00206102|9614725|FG001|COMPLETED|Overall Study||187
8581329|NCT00206102|9614724|FG000|NOT COMPLETED|Overall Study||408
8581330|NCT00206102|9614725|FG001|NOT COMPLETED|Overall Study||315
8581331|NCT00206323|9614733|FG000|STARTED|Overall Study||14
8581332|NCT00206323|9614734|FG001|STARTED|Overall Study||15
8581333|NCT00206323|9614733|FG000|COMPLETED|Overall Study||8
8581334|NCT00206323|9614734|FG001|COMPLETED|Overall Study||12
8581335|NCT00206323|9614733|FG000|NOT COMPLETED|Overall Study||6
8581336|NCT00206323|9614734|FG001|NOT COMPLETED|Overall Study||3
8581337|NCT00206336|9614740|FG000|STARTED|Overall Study||20
8581338|NCT00206336|9614740|FG000|COMPLETED|Overall Study||20
8581339|NCT00206336|9614740|FG000|NOT COMPLETED|Overall Study||0
8581340|NCT00206427|9614744|FG000|STARTED|Overall Study|Received First Dose|49
8581341|NCT00206427|9614744|FG000|COMPLETED|Overall Study|Complete 6-week therapy|47
8581342|NCT00206427|9614744|FG000|NOT COMPLETED|Overall Study||2
8581343|NCT00206440|9614750|FG000|STARTED|Overall Study||21
8581344|NCT00206440|9614751|FG001|STARTED|Overall Study||22
8581345|NCT00206440|9614750|FG000|COMPLETED|Overall Study||16
8581346|NCT00206440|9614751|FG001|COMPLETED|Overall Study||18
8581347|NCT00206440|9614750|FG000|NOT COMPLETED|Overall Study||5
8581348|NCT00206440|9614751|FG001|NOT COMPLETED|Overall Study||4
8581349|NCT00206518|9614759|FG000|STARTED|Overall Study||83
8581350|NCT00206518|9614760|FG001|STARTED|Overall Study||84
8581351|NCT00206518|9614759|FG000|COMPLETED|Overall Study||73
8581352|NCT00206518|9614760|FG001|COMPLETED|Overall Study||78
8581353|NCT00206518|9614759|FG000|NOT COMPLETED|Overall Study||10
8581354|NCT00206518|9614760|FG001|NOT COMPLETED|Overall Study||6
8581355|NCT00206726|9614766|FG000|STARTED|Overall Study||60
8581356|NCT00206726|9614766|FG000|Treatment Started|Overall Study|Safety population (3 withdrew consent prior to receiving study drug)|57
8581357|NCT00206726|9614766|FG000|4 Cycles Completed|Overall Study|per protocol population|41
8581358|NCT00206726|9614766|FG000|COMPLETED|Overall Study|4-6 cycles of treatment with assessments at 2, 6, and 9 months post last dose|9
8581359|NCT00206726|9614766|FG000|NOT COMPLETED|Overall Study||51
8581360|NCT00207090|9614770|FG000|STARTED|Overall Study|Number of participants treated|15
8581361|NCT00207090|9614770|FG000|COMPLETED|Overall Study||8
8581362|NCT00207090|9614770|FG000|NOT COMPLETED|Overall Study||7
8581363|NCT00207142|9614782|FG000|STARTED|Induction Phase||252
8581364|NCT00207142|9614783|FG001|STARTED|Induction Phase||0
8581365|NCT00207142|9614784|FG002|STARTED|Induction Phase||0
8581366|NCT00207142|9614785|FG003|STARTED|Induction Phase||0
8581367|NCT00207142|9614782|FG000|COMPLETED|Induction Phase|Subjects randomized into Maintenance Phase=172 (87 ATV +85 ATV/RTV); Rescue Phase subjects=50|222
8581368|NCT00207142|9614783|FG001|COMPLETED|Induction Phase||0
8581369|NCT00207142|9614784|FG002|COMPLETED|Induction Phase||0
8581370|NCT00207142|9614785|FG003|COMPLETED|Induction Phase||0
8581371|NCT00207142|9614782|FG000|NOT COMPLETED|Induction Phase||30
8581372|NCT00207142|9614783|FG001|NOT COMPLETED|Induction Phase||0
8581373|NCT00207142|9614784|FG002|NOT COMPLETED|Induction Phase||0
8581374|NCT00207142|9614785|FG003|NOT COMPLETED|Induction Phase||0
8581375|NCT00207142|9614782|FG000|STARTED|Maintenance Phase/Rescue Phase||0
8581376|NCT00207142|9614783|FG001|STARTED|Maintenance Phase/Rescue Phase||87
8581377|NCT00207142|9614784|FG002|STARTED|Maintenance Phase/Rescue Phase||85
8581378|NCT00207142|9614785|FG003|STARTED|Maintenance Phase/Rescue Phase||50
8581379|NCT00207142|9614782|FG000|COMPLETED|Maintenance Phase/Rescue Phase||0
8581380|NCT00207142|9614783|FG001|COMPLETED|Maintenance Phase/Rescue Phase||78
8581381|NCT00207142|9614784|FG002|COMPLETED|Maintenance Phase/Rescue Phase||72
8581382|NCT00207142|9614785|FG003|COMPLETED|Maintenance Phase/Rescue Phase||41
8581383|NCT00207142|9614782|FG000|NOT COMPLETED|Maintenance Phase/Rescue Phase||0
8581384|NCT00207142|9614783|FG001|NOT COMPLETED|Maintenance Phase/Rescue Phase||9
8581385|NCT00207142|9614784|FG002|NOT COMPLETED|Maintenance Phase/Rescue Phase||13
8581386|NCT00207142|9614785|FG003|NOT COMPLETED|Maintenance Phase/Rescue Phase||9
8581387|NCT00207714|9614805|FG000|STARTED|Overall Study||35
8581388|NCT00207714|9614806|FG001|STARTED|Overall Study||35
8581389|NCT00207714|9614807|FG002|STARTED|Overall Study||34
8581390|NCT00207714|9614808|FG003|STARTED|Overall Study||34
8581391|NCT00207714|9614809|FG004|STARTED|Overall Study||34
8581392|NCT00207714|9614805|FG000|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|21
8581393|NCT00207714|9614806|FG001|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|28
8581394|NCT00207714|9614807|FG002|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|24
8581395|NCT00207714|9614808|FG003|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|26
8581396|NCT00207714|9614809|FG004|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|29
8581397|NCT00207714|9614805|FG000|NOT COMPLETED|Overall Study||14
8581398|NCT00207714|9614806|FG001|NOT COMPLETED|Overall Study||7
8581399|NCT00207714|9614807|FG002|NOT COMPLETED|Overall Study||10
8581400|NCT00207714|9614808|FG003|NOT COMPLETED|Overall Study||8
8581401|NCT00207714|9614809|FG004|NOT COMPLETED|Overall Study||5
8581402|NCT00207727|9614833|FG000|STARTED|Overall Study||49
8581403|NCT00207727|9614834|FG001|STARTED|Overall Study||50
8581404|NCT00207727|9614835|FG002|STARTED|Overall Study||50
8581405|NCT00207727|9614836|FG003|STARTED|Overall Study||50
8581406|NCT00207727|9614837|FG004|STARTED|Overall Study||50
8581407|NCT00207727|9614833|FG000|COMPLETED|Overall Study||11
8581408|NCT00207727|9614834|FG001|COMPLETED|Overall Study||8
8581409|NCT00207727|9614835|FG002|COMPLETED|Overall Study||9
8581410|NCT00207727|9614836|FG003|COMPLETED|Overall Study||13
8581411|NCT00207727|9614837|FG004|COMPLETED|Overall Study||16
8581412|NCT00207727|9614833|FG000|NOT COMPLETED|Overall Study||38
8581413|NCT00207727|9614834|FG001|NOT COMPLETED|Overall Study||42
8581414|NCT00207727|9614835|FG002|NOT COMPLETED|Overall Study||41
8581415|NCT00207727|9614836|FG003|NOT COMPLETED|Overall Study||37
8581416|NCT00207727|9614837|FG004|NOT COMPLETED|Overall Study||34
8581417|NCT00207740|9614853|FG000|STARTED|Overall Study||78
8581418|NCT00207740|9614854|FG001|STARTED|Overall Study||77
8581419|NCT00207740|9614855|FG002|STARTED|Overall Study||76
8581420|NCT00207740|9614856|FG003|STARTED|Overall Study||78
8581421|NCT00207740|9614853|FG000|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|49
8581422|NCT00207740|9614854|FG001|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|36
8581423|NCT00207740|9614855|FG002|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|36
8581424|NCT00207740|9614856|FG003|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|35
8581425|NCT00207740|9614853|FG000|NOT COMPLETED|Overall Study||29
8581426|NCT00207740|9614854|FG001|NOT COMPLETED|Overall Study||41
8581427|NCT00207740|9614855|FG002|NOT COMPLETED|Overall Study||40
8581428|NCT00207740|9614856|FG003|NOT COMPLETED|Overall Study||43
8581429|NCT00207883|9614872|FG000|STARTED|Overall Study||93
8581430|NCT00207883|9614873|FG001|STARTED|Overall Study||119
8581431|NCT00207883|9614872|FG000|COMPLETED|Overall Study||93
8581432|NCT00207883|9614873|FG001|COMPLETED|Overall Study||119
8581433|NCT00207883|9614872|FG000|NOT COMPLETED|Overall Study||0
8581434|NCT00207883|9614873|FG001|NOT COMPLETED|Overall Study||0
8581435|NCT00208026|9614879|FG000|STARTED|Overall Study||3
8581436|NCT00208026|9614879|FG000|COMPLETED|Overall Study||3
8581437|NCT00208026|9614879|FG000|NOT COMPLETED|Overall Study||0
8581438|NCT00208091|9614885|FG000|STARTED|Overall Study||16
8581439|NCT00208091|9614885|FG000|COMPLETED|Overall Study||16
8581440|NCT00208091|9614885|FG000|NOT COMPLETED|Overall Study||0
8581441|NCT00208325|9614897|FG000|STARTED|Overall Study||193
8581442|NCT00208325|9614898|FG001|STARTED|Overall Study||196
8581443|NCT00208325|9614899|FG002|STARTED|Overall Study||170
8581444|NCT00208325|9614900|FG003|STARTED|Overall Study||161
8581445|NCT00208325|9614897|FG000|COMPLETED|Overall Study||142
8581446|NCT00208325|9614898|FG001|COMPLETED|Overall Study||142
8581447|NCT00208325|9614899|FG002|COMPLETED|Overall Study||156
8581448|NCT00208325|9614900|FG003|COMPLETED|Overall Study||147
8581449|NCT00208325|9614897|FG000|NOT COMPLETED|Overall Study||51
8581450|NCT00208325|9614898|FG001|NOT COMPLETED|Overall Study||54
8581451|NCT00208325|9614899|FG002|NOT COMPLETED|Overall Study||14
8581452|NCT00208325|9614900|FG003|NOT COMPLETED|Overall Study||14
8581453|NCT00208494|9614912|FG000|STARTED|Overall Study||194
8581454|NCT00208494|9614913|FG001|STARTED|Overall Study||196
8581455|NCT00208494|9614912|FG000|COMPLETED|Overall Study||164
8581456|NCT00208494|9614913|FG001|COMPLETED|Overall Study||162
8581457|NCT00208494|9614912|FG000|NOT COMPLETED|Overall Study||30
8581458|NCT00208494|9614913|FG001|NOT COMPLETED|Overall Study||34
8581459|NCT00208507|9614921|FG000|STARTED|Overall Study||177
8581460|NCT00208507|9614922|FG001|STARTED|Overall Study||87
8581461|NCT00208507|9614921|FG000|COMPLETED|Overall Study||163
8581462|NCT00208507|9614922|FG001|COMPLETED|Overall Study||79
8581463|NCT00208507|9614921|FG000|NOT COMPLETED|Overall Study||14
8581464|NCT00208507|9614922|FG001|NOT COMPLETED|Overall Study||8
8581465|NCT00208767|9614930|FG000|STARTED|Overall Study||80
8581466|NCT00208767|9614931|FG001|STARTED|Overall Study||40
8581467|NCT00208767|9614930|FG000|COMPLETED|Overall Study||53
8581468|NCT00208767|9614931|FG001|COMPLETED|Overall Study||33
8581469|NCT00208767|9614930|FG000|NOT COMPLETED|Overall Study||27
8581470|NCT00208767|9614931|FG001|NOT COMPLETED|Overall Study||7
8581471|NCT00208949|9614939|FG000|STARTED|Overall Study||25
8581472|NCT00208949|9614940|FG001|STARTED|Overall Study||25
8581473|NCT00208949|9614939|FG000|COMPLETED|Overall Study||25
8581474|NCT00208949|9614940|FG001|COMPLETED|Overall Study||25
8581475|NCT00208949|9614939|FG000|NOT COMPLETED|Overall Study||0
8581476|NCT00208949|9614940|FG001|NOT COMPLETED|Overall Study||0
8581477|NCT00208975|9614946|FG000|STARTED|Overall Study||15
8581478|NCT00208975|9614946|FG000|COMPLETED|Overall Study||15
8581479|NCT00208975|9614946|FG000|NOT COMPLETED|Overall Study||0
8581480|NCT00209092|9614953|FG000|STARTED|Overall Study||25
8581481|NCT00209092|9614954|FG001|STARTED|Overall Study||26
8581482|NCT00209092|9614953|FG000|COMPLETED|Overall Study||17
8581483|NCT00209092|9614954|FG001|COMPLETED|Overall Study||24
8581484|NCT00209092|9614953|FG000|NOT COMPLETED|Overall Study||8
8581485|NCT00209092|9614954|FG001|NOT COMPLETED|Overall Study||2
8581486|NCT00209170|9614962|FG000|STARTED|Overall Study||7
8581487|NCT00209170|9614963|FG001|STARTED|Overall Study||7
8581488|NCT00209170|9614962|FG000|COMPLETED|Overall Study||5
8581489|NCT00209170|9614963|FG001|COMPLETED|Overall Study||4
8581490|NCT00209170|9614962|FG000|NOT COMPLETED|Overall Study||2
8581491|NCT00209170|9614963|FG001|NOT COMPLETED|Overall Study||3
8581492|NCT00209274|9614971|FG000|STARTED|Overall Study||184
8581493|NCT00209274|9614972|FG001|STARTED|Overall Study||95
8581494|NCT00209274|9614971|FG000|COMPLETED|Overall Study||113
8581495|NCT00209274|9614972|FG001|COMPLETED|Overall Study||48
8581496|NCT00209274|9614971|FG000|NOT COMPLETED|Overall Study||71
8581497|NCT00209274|9614972|FG001|NOT COMPLETED|Overall Study||47
8581498|NCT00209339|9614978|FG000|STARTED|At 12 Months Follow-up||55
8581499|NCT00209339|9614978|FG000|COMPLETED|At 12 Months Follow-up||40
8581500|NCT00209339|9614978|FG000|NOT COMPLETED|At 12 Months Follow-up||15
8581501|NCT00209339|9614978|FG000|STARTED|At 24 Months Follow-up||40
8581502|NCT00209339|9614978|FG000|COMPLETED|At 24 Months Follow-up||29
8581503|NCT00209339|9614978|FG000|NOT COMPLETED|At 24 Months Follow-up||11
8581504|NCT00209339|9614978|FG000|STARTED|At 3 Years Follow-up||29
8581505|NCT00209339|9614978|FG000|COMPLETED|At 3 Years Follow-up||28
8581506|NCT00209339|9614978|FG000|NOT COMPLETED|At 3 Years Follow-up||1
8581507|NCT00209339|9614978|FG000|STARTED|At 4 Years Follow-up||28
8581508|NCT00209339|9614978|FG000|COMPLETED|At 4 Years Follow-up||23
8581509|NCT00209339|9614978|FG000|NOT COMPLETED|At 4 Years Follow-up||5
8581510|NCT00209339|9614978|FG000|STARTED|At 5 Years Follow-up||23
8581511|NCT00209339|9614978|FG000|COMPLETED|At 5 Years Follow-up||15
8581512|NCT00209339|9614978|FG000|NOT COMPLETED|At 5 Years Follow-up||8
8581513|NCT00209417|9614984|FG000|STARTED|Overall Study||321
8581514|NCT00209417|9614985|FG001|STARTED|Overall Study||327
8581515|NCT00209417|9614984|FG000|COMPLETED|Overall Study||321
8581516|NCT00209417|9614985|FG001|COMPLETED|Overall Study||327
8581517|NCT00209417|9614984|FG000|NOT COMPLETED|Overall Study||0
8581518|NCT00209417|9614985|FG001|NOT COMPLETED|Overall Study||0
8581519|NCT00209560|9614993|FG000|STARTED|Overall Study||121
8581520|NCT00209560|9614994|FG001|STARTED|Overall Study||42
8581521|NCT00209560|9614993|FG000|COMPLETED|Overall Study||120
8581522|NCT00209560|9614994|FG001|COMPLETED|Overall Study||42
8581523|NCT00209560|9614993|FG000|NOT COMPLETED|Overall Study||1
8581524|NCT00209560|9614994|FG001|NOT COMPLETED|Overall Study||0
8581525|NCT00210106|9615000|FG000|STARTED|Overall Study||52
8581526|NCT00210106|9615000|FG000|Safety Population|Overall Study||49
8581527|NCT00210106|9615000|FG000|COMPLETED|Overall Study||38
8581528|NCT00210106|9615000|FG000|NOT COMPLETED|Overall Study||14
8581529|NCT00210119|9615005|FG000|STARTED|Overall Study||19
8581530|NCT00210119|9615005|FG000|COMPLETED|Overall Study||17
8581531|NCT00210119|9615005|FG000|NOT COMPLETED|Overall Study||2
8581532|NCT00210184|9615009|FG000|STARTED|Overall Study||42
8581533|NCT00210184|9615009|FG000|COMPLETED|Overall Study||40
8581534|NCT00210184|9615009|FG000|NOT COMPLETED|Overall Study||2
8581535|NCT00210353|9615016|FG000|STARTED|Overall Study||151
8581536|NCT00210353|9615017|FG001|STARTED|Overall Study||152
8581537|NCT00210353|9615018|FG002|STARTED|Overall Study||151
8581538|NCT00210353|9615016|FG000|COMPLETED|Overall Study||113
8581539|NCT00210353|9615017|FG001|COMPLETED|Overall Study||107
8581540|NCT00210353|9615018|FG002|COMPLETED|Overall Study||125
8581541|NCT00210353|9615016|FG000|NOT COMPLETED|Overall Study||38
8581542|NCT00210353|9615017|FG001|NOT COMPLETED|Overall Study||45
8581543|NCT00210353|9615018|FG002|NOT COMPLETED|Overall Study||26
8581544|NCT00210470|9615031|FG000|STARTED|Overall Study||27
8581545|NCT00210470|9615031|FG000|COMPLETED|Overall Study||27
8581546|NCT00210470|9615031|FG000|NOT COMPLETED|Overall Study||0
8581547|NCT00210626|9615040|FG000|STARTED|Overall Study||97
8581548|NCT00210626|9615041|FG001|STARTED|Overall Study||95
8581549|NCT00210626|9615040|FG000|COMPLETED|Overall Study||49
8581550|NCT00210626|9615041|FG001|COMPLETED|Overall Study||50
8581551|NCT00210626|9615040|FG000|NOT COMPLETED|Overall Study||48
8581552|NCT00210626|9615041|FG001|NOT COMPLETED|Overall Study||45
8581553|NCT00210639|9615049|FG000|STARTED|Overall Study||124
8581554|NCT00210639|9615050|FG001|STARTED|Overall Study||83
8581555|NCT00210639|9615049|FG000|COMPLETED|Overall Study||61
8581556|NCT00210639|9615050|FG001|COMPLETED|Overall Study||41
8581557|NCT00210639|9615049|FG000|NOT COMPLETED|Overall Study||63
8581558|NCT00210639|9615050|FG001|NOT COMPLETED|Overall Study||42
8581559|NCT00211081|9615056|FG000|STARTED|Overall Study||12
8581560|NCT00211081|9615056|FG000|COMPLETED|Overall Study||10
8581561|NCT00211081|9615056|FG000|NOT COMPLETED|Overall Study||2
8581562|NCT00211172|9615062|FG000|STARTED|Overall Study||449
8581563|NCT00211172|9615063|FG001|STARTED|Overall Study||458
8581564|NCT00211172|9615062|FG000|COMPLETED|Overall Study|39 patients died or lost health plan eligibility|410
8581565|NCT00211172|9615063|FG001|COMPLETED|Overall Study|32 patients died or lost health plan eligibility|426
8581566|NCT00211172|9615062|FG000|NOT COMPLETED|Overall Study||39
8581567|NCT00211172|9615063|FG001|NOT COMPLETED|Overall Study||32
8581568|NCT00211185|9615069|FG000|STARTED|Overall Study||49
8581569|NCT00211185|9615069|FG000|COMPLETED|Overall Study||29
8581570|NCT00211185|9615069|FG000|NOT COMPLETED|Overall Study||20
8581571|NCT00211237|9615075|FG000|STARTED|Baseline||70
8581572|NCT00211237|9615076|FG001|STARTED|Baseline||64
8581573|NCT00211237|9615077|FG002|STARTED|Baseline||0
8581574|NCT00211237|9615075|FG000|COMPLETED|Baseline||68
8581575|NCT00211237|9615076|FG001|COMPLETED|Baseline||61
8581576|NCT00211237|9615077|FG002|COMPLETED|Baseline||0
8581577|NCT00211237|9615075|FG000|NOT COMPLETED|Baseline||2
8581578|NCT00211237|9615076|FG001|NOT COMPLETED|Baseline||3
8581579|NCT00211237|9615077|FG002|NOT COMPLETED|Baseline||0
8581580|NCT00211237|9615075|FG000|STARTED|1 Month||68
8581581|NCT00211237|9615076|FG001|STARTED|1 Month||61
8581582|NCT00211237|9615077|FG002|STARTED|1 Month||0
8581583|NCT00211237|9615075|FG000|COMPLETED|1 Month||65
8581584|NCT00211237|9615076|FG001|COMPLETED|1 Month||52
8581585|NCT00211237|9615077|FG002|COMPLETED|1 Month||0
8581586|NCT00211237|9615075|FG000|NOT COMPLETED|1 Month||3
8581587|NCT00211237|9615076|FG001|NOT COMPLETED|1 Month||9
8581588|NCT00211237|9615077|FG002|NOT COMPLETED|1 Month||0
8581589|NCT00211237|9615075|FG000|STARTED|3 Months||65
8581590|NCT00211237|9615076|FG001|STARTED|3 Months|34 patients crossed over to Balloon Kyphoplasty.|18
8581591|NCT00211237|9615077|FG002|STARTED|3 Months||34
8581592|NCT00211237|9615075|FG000|COMPLETED|3 Months||57
8581593|NCT00211237|9615076|FG001|COMPLETED|3 Months||14
8581594|NCT00211237|9615077|FG002|COMPLETED|3 Months||33
8581595|NCT00211237|9615075|FG000|NOT COMPLETED|3 Months||8
8581596|NCT00211237|9615076|FG001|NOT COMPLETED|3 Months||4
8581597|NCT00211237|9615077|FG002|NOT COMPLETED|3 Months||1
8581598|NCT00211237|9615075|FG000|STARTED|6 Months||57
8581599|NCT00211237|9615076|FG001|STARTED|6 Months|3 patients crossed over Balloon Kyphoplasty|11
8581600|NCT00211237|9615077|FG002|STARTED|6 Months||36
8581601|NCT00211237|9615075|FG000|COMPLETED|6 Months||49
8581602|NCT00211237|9615076|FG001|COMPLETED|6 Months||9
8581603|NCT00211237|9615077|FG002|COMPLETED|6 Months||33
8581604|NCT00211237|9615075|FG000|NOT COMPLETED|6 Months||8
8581605|NCT00211237|9615076|FG001|NOT COMPLETED|6 Months||2
8581606|NCT00211237|9615077|FG002|NOT COMPLETED|6 Months||3
8581607|NCT00211237|9615075|FG000|STARTED|12 Months||49
8581608|NCT00211237|9615076|FG001|STARTED|12 Months|1 patient crossed over Balloon Kyphoplasty|8
8581609|NCT00211237|9615077|FG002|STARTED|12 Months||34
8581610|NCT00211237|9615075|FG000|COMPLETED|12 Months||40
8581611|NCT00211237|9615076|FG001|COMPLETED|12 Months||6
8581612|NCT00211237|9615077|FG002|COMPLETED|12 Months||28
8581613|NCT00211237|9615075|FG000|NOT COMPLETED|12 Months||9
8581614|NCT00211237|9615076|FG001|NOT COMPLETED|12 Months||2
8581615|NCT00211237|9615077|FG002|NOT COMPLETED|12 Months||6
8581616|NCT00211510|9615096|FG000|STARTED|Overall Study||72
8581617|NCT00211510|9615097|FG001|STARTED|Overall Study||74
8581618|NCT00211510|9615096|FG000|COMPLETED|Overall Study||66
8581619|NCT00211510|9615097|FG001|COMPLETED|Overall Study||72
8581620|NCT00211510|9615096|FG000|NOT COMPLETED|Overall Study||6
8581621|NCT00211510|9615097|FG001|NOT COMPLETED|Overall Study||2
8581622|NCT00211536|9615108|FG000|STARTED|Overall Study||53
8581623|NCT00211536|9615109|FG001|STARTED|Overall Study||54
8581624|NCT00211536|9615108|FG000|As Treated Data Analysis Set|Overall Study|This set includes all subjects followed to Visit 5 (90 days, first insulin refill for MIP group).|52
8581625|NCT00211536|9615109|FG001|As Treated Data Analysis Set|Overall Study||48
8581626|NCT00211536|9615108|FG000|COMPLETED|Overall Study||49
8581627|NCT00211536|9615109|FG001|COMPLETED|Overall Study|This set includes all subjects followed to Visit 5 (90 days, first insulin refill for MIP group).|47
8581628|NCT00211536|9615108|FG000|NOT COMPLETED|Overall Study||4
8581629|NCT00211536|9615109|FG001|NOT COMPLETED|Overall Study||7
8581630|NCT00211692|9615117|FG000|STARTED|Overall Study||33
8581631|NCT00211692|9615118|FG001|STARTED|Overall Study||31
8581632|NCT00211692|9615117|FG000|COMPLETED|Overall Study||33
8581633|NCT00211692|9615118|FG001|COMPLETED|Overall Study||31
8581634|NCT00211692|9615117|FG000|NOT COMPLETED|Overall Study||0
8581635|NCT00211692|9615118|FG001|NOT COMPLETED|Overall Study||0
8581636|NCT00211757|9615126|FG000|STARTED|Overall Study||11
8581637|NCT00211757|9615127|FG001|STARTED|Overall Study||16
8581638|NCT00211757|9615126|FG000|COMPLETED|Overall Study||10
8581639|NCT00211757|9615127|FG001|COMPLETED|Overall Study||14
8581640|NCT00211757|9615126|FG000|NOT COMPLETED|Overall Study||1
8581641|NCT00211757|9615127|FG001|NOT COMPLETED|Overall Study||2
8581642|NCT00211809|9615135|FG000|STARTED|Overall Study||17
8581643|NCT00211809|9615135|FG000|COMPLETED|Overall Study||11
8581644|NCT00211809|9615135|FG000|NOT COMPLETED|Overall Study||6
8581645|NCT00211887|9615144|FG000|STARTED|Overall Study||499
8581646|NCT00211887|9615145|FG001|STARTED|Overall Study||250
8581647|NCT00211887|9615146|FG002|STARTED|Overall Study||259
8581648|NCT00211887|9615144|FG000|COMPLETED|Overall Study||397
8581649|NCT00211887|9615145|FG001|COMPLETED|Overall Study||194
8581650|NCT00211887|9615146|FG002|COMPLETED|Overall Study||223
8581651|NCT00211887|9615144|FG000|NOT COMPLETED|Overall Study||102
8581652|NCT00211887|9615145|FG001|NOT COMPLETED|Overall Study||56
8581653|NCT00211887|9615146|FG002|NOT COMPLETED|Overall Study||36
8627629|NCT00519376|9667175|FG005|NOT COMPLETED|Treatment Period 2||0
8627630|NCT00519376|9667176|FG006|NOT COMPLETED|Treatment Period 2||0
8627631|NCT00519376|9667177|FG007|NOT COMPLETED|Treatment Period 2||0
8627632|NCT00519376|9667178|FG008|NOT COMPLETED|Treatment Period 2||0
8627633|NCT00519376|9667179|FG009|NOT COMPLETED|Treatment Period 2||0
8627634|NCT00519376|9667180|FG010|NOT COMPLETED|Treatment Period 2||0
8627635|NCT00519376|9667181|FG011|NOT COMPLETED|Treatment Period 2||0
8709819|NCT00955253|9756097|FG001|NOT COMPLETED|First Intervention (Day 2)||0
8627636|NCT00519376|9667182|FG012|NOT COMPLETED|Treatment Period 2||1
8627637|NCT00519376|9667183|FG013|NOT COMPLETED|Treatment Period 2||0
8627638|NCT00519376|9667184|FG014|NOT COMPLETED|Treatment Period 2||0
8627639|NCT00519376|9667185|FG015|NOT COMPLETED|Treatment Period 2||0
8627640|NCT00519376|9667170|FG000|STARTED|Washout Period 2||2
8627641|NCT00519376|9667171|FG001|STARTED|Washout Period 2||2
8627642|NCT00519376|9667172|FG002|STARTED|Washout Period 2||2
8627643|NCT00519376|9667173|FG003|STARTED|Washout Period 2||2
8627644|NCT00519376|9667174|FG004|STARTED|Washout Period 2||1
8627645|NCT00519376|9667175|FG005|STARTED|Washout Period 2||1
8627646|NCT00519376|9667176|FG006|STARTED|Washout Period 2||1
8627647|NCT00519376|9667177|FG007|STARTED|Washout Period 2||1
8627648|NCT00519376|9667178|FG008|STARTED|Washout Period 2||1
8627649|NCT00519376|9667179|FG009|STARTED|Washout Period 2||1
8627650|NCT00519376|9667180|FG010|STARTED|Washout Period 2||1
8627651|NCT00519376|9667181|FG011|STARTED|Washout Period 2||1
8627652|NCT00519376|9667182|FG012|STARTED|Washout Period 2||0
8627653|NCT00519376|9667183|FG013|STARTED|Washout Period 2||1
8627654|NCT00519376|9667184|FG014|STARTED|Washout Period 2||1
8627655|NCT00519376|9667185|FG015|STARTED|Washout Period 2||1
8627656|NCT00519376|9667170|FG000|COMPLETED|Washout Period 2||2
8627657|NCT00519376|9667171|FG001|COMPLETED|Washout Period 2||2
8627658|NCT00519376|9667172|FG002|COMPLETED|Washout Period 2||2
8581654|NCT00212134|9615156|FG000|STARTED|Phase 1 (to Age 1 Year)||57
8581655|NCT00212134|9615157|FG001|STARTED|Phase 1 (to Age 1 Year)||57
8581656|NCT00212134|9615156|FG000|Complete First Endpoint at 1 Year|Phase 1 (to Age 1 Year)||57
8581657|NCT00212134|9615157|FG001|Complete First Endpoint at 1 Year|Phase 1 (to Age 1 Year)||57
8581658|NCT00212134|9615156|FG000|COMPLETED|Phase 1 (to Age 1 Year)|Age 1 data collection visit|57
8581659|NCT00212134|9615157|FG001|COMPLETED|Phase 1 (to Age 1 Year)|Age 1 data collection visit|57
8581660|NCT00212134|9615156|FG000|NOT COMPLETED|Phase 1 (to Age 1 Year)||0
8581661|NCT00212134|9615157|FG001|NOT COMPLETED|Phase 1 (to Age 1 Year)||0
8581662|NCT00212134|9615156|FG000|STARTED|Phase 2 (Age 1 Year to Age 5 Years)|Visual acuity assessment at Age 4.5 Years and final visit at Age 5 Years.|57
8581663|NCT00212134|9615157|FG001|STARTED|Phase 2 (Age 1 Year to Age 5 Years)|Visual acuity assessment at Age 4.5 Years and final visit at Age 5 Years.|57
8581664|NCT00212134|9615156|FG000|COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)||57
8581665|NCT00212134|9615157|FG001|COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)|Patient lost to follow-up.|56
8581666|NCT00212134|9615156|FG000|NOT COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)||0
8581667|NCT00212134|9615157|FG001|NOT COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)||1
8581668|NCT00212134|9615156|FG000|STARTED|Phase 3 (Age 10 Years)||57
8581669|NCT00212134|9615157|FG001|STARTED|Phase 3 (Age 10 Years)||56
8581670|NCT00212134|9615156|FG000|COMPLETED|Phase 3 (Age 10 Years)||55
8581671|NCT00212134|9615157|FG001|COMPLETED|Phase 3 (Age 10 Years)||55
8581672|NCT00212134|9615156|FG000|NOT COMPLETED|Phase 3 (Age 10 Years)||2
8581673|NCT00212134|9615157|FG001|NOT COMPLETED|Phase 3 (Age 10 Years)||1
8581674|NCT00212264|9615170|FG000|STARTED|Overall Study||70
8581675|NCT00212264|9615171|FG001|STARTED|Overall Study||70
8581676|NCT00212264|9615172|FG002|STARTED|Overall Study||68
8581677|NCT00212264|9615170|FG000|COMPLETED|Overall Study||58
8581678|NCT00212264|9615171|FG001|COMPLETED|Overall Study||54
8581679|NCT00212264|9615172|FG002|COMPLETED|Overall Study||64
8581680|NCT00212264|9615170|FG000|NOT COMPLETED|Overall Study||12
8581681|NCT00212264|9615171|FG001|NOT COMPLETED|Overall Study||16
8581682|NCT00212264|9615172|FG002|NOT COMPLETED|Overall Study||4
8581683|NCT00212355|9615180|FG000|STARTED|Overall Study||37
8581684|NCT00212355|9615180|FG000|COMPLETED|Overall Study||34
8581685|NCT00212355|9615180|FG000|NOT COMPLETED|Overall Study||3
8581686|NCT00212446|9615184|FG000|STARTED|Overall Study||8
8581687|NCT00212446|9615184|FG000|COMPLETED|Overall Study||8
8581688|NCT00212446|9615184|FG000|NOT COMPLETED|Overall Study||0
8581689|NCT00212758|9615188|FG000|STARTED|First Intervention (7 Days)||8
8581690|NCT00212758|9615189|FG001|STARTED|First Intervention (7 Days)||9
8581691|NCT00212758|9615188|FG000|COMPLETED|First Intervention (7 Days)||8
8581692|NCT00212758|9615189|FG001|COMPLETED|First Intervention (7 Days)||9
8581693|NCT00212758|9615188|FG000|NOT COMPLETED|First Intervention (7 Days)||0
8581694|NCT00212758|9615189|FG001|NOT COMPLETED|First Intervention (7 Days)||0
8581695|NCT00212758|9615188|FG000|STARTED|Wash Out Period (2 Weeks)||8
8581696|NCT00212758|9615189|FG001|STARTED|Wash Out Period (2 Weeks)||9
8581697|NCT00212758|9615188|FG000|COMPLETED|Wash Out Period (2 Weeks)||8
8581698|NCT00212758|9615189|FG001|COMPLETED|Wash Out Period (2 Weeks)||9
8581699|NCT00212758|9615188|FG000|NOT COMPLETED|Wash Out Period (2 Weeks)||0
8581700|NCT00212758|9615189|FG001|NOT COMPLETED|Wash Out Period (2 Weeks)||0
8581701|NCT00212758|9615188|FG000|STARTED|Second Intervention (7 Days)||8
8581702|NCT00212758|9615189|FG001|STARTED|Second Intervention (7 Days)||9
8581703|NCT00212758|9615188|FG000|COMPLETED|Second Intervention (7 Days)||8
8581704|NCT00212758|9615189|FG001|COMPLETED|Second Intervention (7 Days)||9
8581705|NCT00212758|9615188|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
8581706|NCT00212758|9615189|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
8581707|NCT00212758|9615188|FG000|STARTED|Standard Therapy of GH (12 Months)||8
8581708|NCT00212758|9615189|FG001|STARTED|Standard Therapy of GH (12 Months)||9
8581709|NCT00212758|9615188|FG000|COMPLETED|Standard Therapy of GH (12 Months)||6
8581710|NCT00212758|9615189|FG001|COMPLETED|Standard Therapy of GH (12 Months)||8
8581711|NCT00212758|9615188|FG000|NOT COMPLETED|Standard Therapy of GH (12 Months)||2
8581712|NCT00212758|9615189|FG001|NOT COMPLETED|Standard Therapy of GH (12 Months)||1
8581713|NCT00212888|9615198|FG000|STARTED|Overall Study||19
8581714|NCT00212888|9615199|FG001|STARTED|Overall Study||18
8581715|NCT00212888|9615200|FG002|STARTED|Overall Study||15
8581716|NCT00212888|9615198|FG000|COMPLETED|Overall Study||16
8581717|NCT00212888|9615199|FG001|COMPLETED|Overall Study||18
8581718|NCT00212888|9615200|FG002|COMPLETED|Overall Study||14
8581719|NCT00212888|9615198|FG000|NOT COMPLETED|Overall Study||3
8581720|NCT00212888|9615199|FG001|NOT COMPLETED|Overall Study||0
8581721|NCT00212888|9615200|FG002|NOT COMPLETED|Overall Study||1
8581722|NCT00213135|9615213|FG000|STARTED|Overall Study||456
8581723|NCT00213135|9615214|FG001|STARTED|Overall Study||433
8581724|NCT00213135|9615215|FG002|STARTED|Overall Study||437
8581725|NCT00213135|9615213|FG000|COMPLETED|Overall Study||406
8581726|NCT00213135|9615214|FG001|COMPLETED|Overall Study||398
8581727|NCT00213135|9615215|FG002|COMPLETED|Overall Study||380
8581728|NCT00213135|9615213|FG000|NOT COMPLETED|Overall Study||50
8581729|NCT00213135|9615214|FG001|NOT COMPLETED|Overall Study||35
8581730|NCT00213135|9615215|FG002|NOT COMPLETED|Overall Study||57
8581731|NCT00213148|9615227|FG000|STARTED|Cycle 1 (1 Month)||77
8581732|NCT00213148|9615228|FG001|STARTED|Cycle 1 (1 Month)||0
8581733|NCT00213148|9615229|FG002|STARTED|Cycle 1 (1 Month)||79
8581734|NCT00213148|9615230|FG003|STARTED|Cycle 1 (1 Month)||76
8581735|NCT00213148|9615231|FG004|STARTED|Cycle 1 (1 Month)||39
8581736|NCT00213148|9615227|FG000|COMPLETED|Cycle 1 (1 Month)||53
8581737|NCT00213148|9615228|FG001|COMPLETED|Cycle 1 (1 Month)||0
8581738|NCT00213148|9615229|FG002|COMPLETED|Cycle 1 (1 Month)||60
8581739|NCT00213148|9615230|FG003|COMPLETED|Cycle 1 (1 Month)||58
8581740|NCT00213148|9615231|FG004|COMPLETED|Cycle 1 (1 Month)||17
8581741|NCT00213148|9615227|FG000|NOT COMPLETED|Cycle 1 (1 Month)||24
8581742|NCT00213148|9615228|FG001|NOT COMPLETED|Cycle 1 (1 Month)||0
8581743|NCT00213148|9615229|FG002|NOT COMPLETED|Cycle 1 (1 Month)||19
8581744|NCT00213148|9615230|FG003|NOT COMPLETED|Cycle 1 (1 Month)||18
8581745|NCT00213148|9615231|FG004|NOT COMPLETED|Cycle 1 (1 Month)||22
8581746|NCT00213148|9615227|FG000|STARTED|Cycle 2 (1 Month)||43
8581747|NCT00213148|9615228|FG001|STARTED|Cycle 2 (1 Month)||10
8581748|NCT00213148|9615229|FG002|STARTED|Cycle 2 (1 Month)||42
8581749|NCT00213148|9615230|FG003|STARTED|Cycle 2 (1 Month)||52
8581750|NCT00213148|9615231|FG004|STARTED|Cycle 2 (1 Month)||41
8581751|NCT00213148|9615227|FG000|COMPLETED|Cycle 2 (1 Month)||29
8581752|NCT00213148|9615228|FG001|COMPLETED|Cycle 2 (1 Month)||4
8581753|NCT00213148|9615229|FG002|COMPLETED|Cycle 2 (1 Month)||28
8581754|NCT00213148|9615230|FG003|COMPLETED|Cycle 2 (1 Month)||33
8581755|NCT00213148|9615231|FG004|COMPLETED|Cycle 2 (1 Month)||11
8581756|NCT00213148|9615227|FG000|NOT COMPLETED|Cycle 2 (1 Month)||14
8581757|NCT00213148|9615228|FG001|NOT COMPLETED|Cycle 2 (1 Month)||6
8581758|NCT00213148|9615229|FG002|NOT COMPLETED|Cycle 2 (1 Month)||14
8581759|NCT00213148|9615230|FG003|NOT COMPLETED|Cycle 2 (1 Month)||19
8581760|NCT00213148|9615231|FG004|NOT COMPLETED|Cycle 2 (1 Month)||30
8581761|NCT00213148|9615227|FG000|STARTED|Cycle 3 (1 Month)||23
8581762|NCT00213148|9615228|FG001|STARTED|Cycle 3 (1 Month)||10
8581763|NCT00213148|9615229|FG002|STARTED|Cycle 3 (1 Month)||26
8581764|NCT00213148|9615230|FG003|STARTED|Cycle 3 (1 Month)||24
8581765|NCT00213148|9615231|FG004|STARTED|Cycle 3 (1 Month)||22
8581766|NCT00213148|9615227|FG000|COMPLETED|Cycle 3 (1 Month)||23
8581767|NCT00213148|9615228|FG001|COMPLETED|Cycle 3 (1 Month)||8
8581768|NCT00213148|9615229|FG002|COMPLETED|Cycle 3 (1 Month)||25
8581769|NCT00213148|9615230|FG003|COMPLETED|Cycle 3 (1 Month)||23
8581770|NCT00213148|9615231|FG004|COMPLETED|Cycle 3 (1 Month)||21
8581771|NCT00213148|9615227|FG000|NOT COMPLETED|Cycle 3 (1 Month)||0
8581772|NCT00213148|9615228|FG001|NOT COMPLETED|Cycle 3 (1 Month)||2
8581773|NCT00213148|9615229|FG002|NOT COMPLETED|Cycle 3 (1 Month)||1
8581774|NCT00213148|9615230|FG003|NOT COMPLETED|Cycle 3 (1 Month)||1
8581775|NCT00213148|9615231|FG004|NOT COMPLETED|Cycle 3 (1 Month)||1
8581776|NCT00213239|9615253|FG000|STARTED|Overall Study||32
8581777|NCT00213239|9615254|FG001|STARTED|Overall Study||32
8581778|NCT00213239|9615253|FG000|COMPLETED|Overall Study||32
8581779|NCT00213239|9615254|FG001|COMPLETED|Overall Study||32
8581780|NCT00213239|9615253|FG000|NOT COMPLETED|Overall Study||0
8581781|NCT00213239|9615254|FG001|NOT COMPLETED|Overall Study||0
8581782|NCT00213980|9615262|FG000|STARTED|Overall Study||32
8581783|NCT00213980|9615263|FG001|STARTED|Overall Study||36
8581784|NCT00213980|9615262|FG000|COMPLETED|Overall Study||26
8581785|NCT00213980|9615263|FG001|COMPLETED|Overall Study||29
8581786|NCT00213980|9615262|FG000|NOT COMPLETED|Overall Study||6
8581787|NCT00213980|9615263|FG001|NOT COMPLETED|Overall Study||7
8581788|NCT00214019|9615269|FG000|STARTED|Overall Study||36
8581789|NCT00214019|9615269|FG000|Placebo/Placebo Arm|Overall Study||6
8581790|NCT00214019|9615269|FG000|Placebo/Salmeterol Arm|Overall Study||6
8581791|NCT00214019|9615269|FG000|Fluticasone/Placebo Arm|Overall Study||6
8581792|NCT00214019|9615269|FG000|Fluticason/Salmeterol Arm|Overall Study||6
8581793|NCT00214019|9615269|FG000|COMPLETED|Overall Study||6
8581794|NCT00214019|9615269|FG000|NOT COMPLETED|Overall Study||30
8581795|NCT00214045|9615278|FG000|STARTED|Overall Study||18
8581796|NCT00214045|9615279|FG001|STARTED|Overall Study||18
8581797|NCT00214045|9615278|FG000|COMPLETED|Overall Study||18
8581798|NCT00214045|9615279|FG001|COMPLETED|Overall Study||18
8581799|NCT00214045|9615278|FG000|NOT COMPLETED|Overall Study||0
8581800|NCT00214045|9615279|FG001|NOT COMPLETED|Overall Study||0
8581801|NCT00214097|9615288|FG000|STARTED|Overall Study|Escalation to the next higher level will occur when > 20 pt yrs of F/U and > 5 pts followed >1 yr|101
8581802|NCT00214097|9615289|FG001|STARTED|Overall Study|Escalation to the next higher level will occur when > 20 pt yrs of F/U and > 5 pts followed >1 yr|111
8581803|NCT00214097|9615290|FG002|STARTED|Overall Study||135
8581804|NCT00214097|9615288|FG000|COMPLETED|Overall Study||101
8581805|NCT00214097|9615289|FG001|COMPLETED|Overall Study||111
8581806|NCT00214097|9615290|FG002|COMPLETED|Overall Study||135
8581807|NCT00214097|9615288|FG000|NOT COMPLETED|Overall Study||0
8581808|NCT00214097|9615289|FG001|NOT COMPLETED|Overall Study||0
8581809|NCT00214097|9615290|FG002|NOT COMPLETED|Overall Study||0
8581810|NCT00214136|9615304|FG000|STARTED|Overall Study||30
8581811|NCT00214136|9615304|FG000|COMPLETED|Overall Study||25
8581812|NCT00214136|9615304|FG000|NOT COMPLETED|Overall Study||5
8581813|NCT00214201|9615310|FG000|STARTED|Overall Study||20
8581814|NCT00214201|9615311|FG001|STARTED|Overall Study||20
8581815|NCT00214201|9615310|FG000|COMPLETED|Overall Study||18
8581816|NCT00214201|9615311|FG001|COMPLETED|Overall Study||18
8581817|NCT00214201|9615310|FG000|NOT COMPLETED|Overall Study||2
8581818|NCT00214201|9615311|FG001|NOT COMPLETED|Overall Study||2
8581819|NCT00214383|9615320|FG000|STARTED|Overall Study||148
8581820|NCT00214383|9615321|FG001|STARTED|Overall Study||153
8581821|NCT00214383|9615320|FG000|COMPLETED|Overall Study||132
8581822|NCT00214383|9615321|FG001|COMPLETED|Overall Study||127
8581823|NCT00214383|9615320|FG000|NOT COMPLETED|Overall Study||16
8581824|NCT00214383|9615321|FG001|NOT COMPLETED|Overall Study||26
8581825|NCT00214422|9615330|FG000|STARTED|Overall Study||12
8581826|NCT00214422|9615331|FG001|STARTED|Overall Study||3
8581827|NCT00214422|9615332|FG002|STARTED|Overall Study||4
8581828|NCT00214422|9615330|FG000|COMPLETED|Overall Study||7
8581829|NCT00214422|9615331|FG001|COMPLETED|Overall Study||2
8581830|NCT00214422|9615332|FG002|COMPLETED|Overall Study||3
8581831|NCT00214422|9615330|FG000|NOT COMPLETED|Overall Study||5
8581832|NCT00214422|9615331|FG001|NOT COMPLETED|Overall Study||1
8581833|NCT00214422|9615332|FG002|NOT COMPLETED|Overall Study||1
8581834|NCT00214461|9615348|FG000|STARTED|Overall Study||12
8581835|NCT00214461|9615349|FG001|STARTED|Overall Study||12
8581836|NCT00214461|9615350|FG002|STARTED|Overall Study||12
8581837|NCT00214461|9615351|FG003|STARTED|Overall Study||12
8581838|NCT00214461|9615348|FG000|COMPLETED|Overall Study||12
8581839|NCT00214461|9615349|FG001|COMPLETED|Overall Study||12
8581840|NCT00214461|9615350|FG002|COMPLETED|Overall Study||10
8581841|NCT00214461|9615351|FG003|COMPLETED|Overall Study||11
8581842|NCT00214461|9615348|FG000|NOT COMPLETED|Overall Study||0
8581843|NCT00214461|9615349|FG001|NOT COMPLETED|Overall Study||0
8581844|NCT00214461|9615350|FG002|NOT COMPLETED|Overall Study||2
8581845|NCT00214461|9615351|FG003|NOT COMPLETED|Overall Study||1
8581846|NCT00214487|9615363|FG000|STARTED|Overall Study||43
8581847|NCT00214487|9615364|FG001|STARTED|Overall Study||43
8581848|NCT00214487|9615363|FG000|COMPLETED|Overall Study||38
8581849|NCT00214487|9615364|FG001|COMPLETED|Overall Study||40
8581850|NCT00214487|9615363|FG000|NOT COMPLETED|Overall Study||5
8581851|NCT00214487|9615364|FG001|NOT COMPLETED|Overall Study||3
8581852|NCT00214526|9615372|FG000|STARTED|Randomized||56
8581853|NCT00214526|9615373|FG001|STARTED|Randomized||56
8581854|NCT00214526|9615372|FG000|COMPLETED|Randomized||55
8581855|NCT00214526|9615373|FG001|COMPLETED|Randomized||54
8581856|NCT00214526|9615372|FG000|NOT COMPLETED|Randomized||1
8581857|NCT00214526|9615373|FG001|NOT COMPLETED|Randomized||2
8581858|NCT00214526|9615372|FG000|STARTED|Treatment Period||55
8581859|NCT00214526|9615373|FG001|STARTED|Treatment Period||54
8581860|NCT00214526|9615372|FG000|COMPLETED|Treatment Period||53
8581861|NCT00214526|9615373|FG001|COMPLETED|Treatment Period||49
8581862|NCT00214526|9615372|FG000|NOT COMPLETED|Treatment Period||2
8581863|NCT00214526|9615373|FG001|NOT COMPLETED|Treatment Period||5
8581864|NCT00214526|9615372|FG000|STARTED|Post-Treatment Period||53
8581865|NCT00214526|9615373|FG001|STARTED|Post-Treatment Period||49
8581866|NCT00214526|9615372|FG000|COMPLETED|Post-Treatment Period||52
8581867|NCT00214526|9615373|FG001|COMPLETED|Post-Treatment Period||49
8581868|NCT00214526|9615372|FG000|NOT COMPLETED|Post-Treatment Period||1
8581869|NCT00214526|9615373|FG001|NOT COMPLETED|Post-Treatment Period||0
8581870|NCT00214539|9615383|FG000|STARTED|Randomized||17
8581871|NCT00214539|9615384|FG001|STARTED|Randomized||17
8581872|NCT00214539|9615383|FG000|COMPLETED|Randomized||15
8581873|NCT00214539|9615384|FG001|COMPLETED|Randomized||17
8581874|NCT00214539|9615383|FG000|NOT COMPLETED|Randomized||2
8581875|NCT00214539|9615384|FG001|NOT COMPLETED|Randomized||0
8581876|NCT00214539|9615383|FG000|STARTED|Treatment Period||15
8581877|NCT00214539|9615384|FG001|STARTED|Treatment Period||17
8581878|NCT00214539|9615383|FG000|COMPLETED|Treatment Period||15
8581879|NCT00214539|9615384|FG001|COMPLETED|Treatment Period||17
8581880|NCT00214539|9615383|FG000|NOT COMPLETED|Treatment Period||0
8581881|NCT00214539|9615384|FG001|NOT COMPLETED|Treatment Period||0
8581882|NCT00214539|9615383|FG000|STARTED|Steroid Stable (Post-Tx to 22-Weeks)||15
8581883|NCT00214539|9615384|FG001|STARTED|Steroid Stable (Post-Tx to 22-Weeks)||17
8581884|NCT00214539|9615383|FG000|COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||15
8581885|NCT00214539|9615384|FG001|COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||17
8581886|NCT00214539|9615383|FG000|NOT COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||0
8581887|NCT00214539|9615384|FG001|NOT COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||0
8581888|NCT00214539|9615383|FG000|STARTED|Reduced Steroid (Post-SS to 52-Weeks)||15
8581889|NCT00214539|9615384|FG001|STARTED|Reduced Steroid (Post-SS to 52-Weeks)||17
8581890|NCT00214539|9615383|FG000|COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||15
8581891|NCT00214539|9615384|FG001|COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||17
8581892|NCT00214539|9615383|FG000|NOT COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||0
8581893|NCT00214539|9615384|FG001|NOT COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||0
8581894|NCT00214786|9615394|FG000|STARTED|Overall Study||4
8581895|NCT00214786|9615394|FG000|COMPLETED|Overall Study||1
8581896|NCT00214786|9615394|FG000|NOT COMPLETED|Overall Study||3
8581897|NCT00214890|9615400|FG000|STARTED|Overall Study||10
8581898|NCT00214890|9615401|FG001|STARTED|Overall Study||11
8581899|NCT00214890|9615400|FG000|COMPLETED|Overall Study||10
8581900|NCT00214890|9615401|FG001|COMPLETED|Overall Study||11
8581901|NCT00214890|9615400|FG000|NOT COMPLETED|Overall Study||0
8581902|NCT00214890|9615401|FG001|NOT COMPLETED|Overall Study||0
8581903|NCT00214903|9615411|FG000|STARTED|Overall Study||10043
8581904|NCT00214903|9615412|FG001|STARTED|Overall Study||13384
8581905|NCT00214903|9615413|FG002|STARTED|Overall Study||4113
8581906|NCT00214903|9615414|FG003|STARTED|Overall Study||3057
8581907|NCT00214903|9615411|FG000|COMPLETED|Overall Study||10043
8581908|NCT00214903|9615412|FG001|COMPLETED|Overall Study||13384
8581909|NCT00214903|9615413|FG002|COMPLETED|Overall Study||4113
8581910|NCT00214903|9615414|FG003|COMPLETED|Overall Study||3057
8581911|NCT00214903|9615411|FG000|NOT COMPLETED|Overall Study||0
8581912|NCT00214903|9615412|FG001|NOT COMPLETED|Overall Study||0
8581913|NCT00214903|9615413|FG002|NOT COMPLETED|Overall Study||0
8581914|NCT00214903|9615414|FG003|NOT COMPLETED|Overall Study||0
8581915|NCT00215137|9615424|FG000|STARTED|Open Label Escitalopram||14
8581916|NCT00215137|9615425|FG001|STARTED|Open Label Escitalopram||0
8581917|NCT00215137|9615426|FG002|STARTED|Open Label Escitalopram||0
8581918|NCT00215137|9615424|FG000|COMPLETED|Open Label Escitalopram||13
8581919|NCT00215137|9615425|FG001|COMPLETED|Open Label Escitalopram||0
8581920|NCT00215137|9615426|FG002|COMPLETED|Open Label Escitalopram||0
8581921|NCT00215137|9615424|FG000|NOT COMPLETED|Open Label Escitalopram||1
8581922|NCT00215137|9615425|FG001|NOT COMPLETED|Open Label Escitalopram||0
8581923|NCT00215137|9615426|FG002|NOT COMPLETED|Open Label Escitalopram||0
8581924|NCT00215137|9615424|FG000|STARTED|Randomization Period||0
8581925|NCT00215137|9615425|FG001|STARTED|Randomization Period||7
8581926|NCT00215137|9615426|FG002|STARTED|Randomization Period||5
8581927|NCT00215137|9615424|FG000|COMPLETED|Randomization Period||0
8581928|NCT00215137|9615425|FG001|COMPLETED|Randomization Period||5
8581929|NCT00215137|9615426|FG002|COMPLETED|Randomization Period||5
8581930|NCT00215137|9615424|FG000|NOT COMPLETED|Randomization Period||0
8581931|NCT00215137|9615425|FG001|NOT COMPLETED|Randomization Period||2
8581932|NCT00215137|9615426|FG002|NOT COMPLETED|Randomization Period||0
8581933|NCT00215150|9615434|FG000|STARTED|Open Label Phase|Number of subjects consented|51
8581934|NCT00215150|9615434|FG000|COMPLETED|Open Label Phase||21
8581935|NCT00215150|9615434|FG000|NOT COMPLETED|Open Label Phase||30
8581936|NCT00215150|9615434|FG000|STARTED|Randomization Phase Ziprasidone||10
8581937|NCT00215150|9615434|FG000|COMPLETED|Randomization Phase Ziprasidone||7
8581938|NCT00215150|9615434|FG000|NOT COMPLETED|Randomization Phase Ziprasidone||3
8581939|NCT00215150|9615434|FG000|STARTED|Randomization Phase Placebo||11
8581940|NCT00215150|9615434|FG000|COMPLETED|Randomization Phase Placebo||10
8581941|NCT00215150|9615434|FG000|NOT COMPLETED|Randomization Phase Placebo||1
8581942|NCT00215540|9615445|FG000|STARTED|Overall Study||45
8581943|NCT00215540|9615446|FG001|STARTED|Overall Study||47
8581944|NCT00215540|9615447|FG002|STARTED|Overall Study||44
8581945|NCT00215540|9615445|FG000|COMPLETED|Overall Study||44
8581946|NCT00215540|9615446|FG001|COMPLETED|Overall Study||47
8581947|NCT00215540|9615447|FG002|COMPLETED|Overall Study||44
8581948|NCT00215540|9615445|FG000|NOT COMPLETED|Overall Study||1
8581949|NCT00215540|9615446|FG001|NOT COMPLETED|Overall Study||0
8581950|NCT00215540|9615447|FG002|NOT COMPLETED|Overall Study||0
8581951|NCT00215553|9615462|FG000|STARTED|Overall Study||5
8581952|NCT00215553|9615463|FG001|STARTED|Overall Study||6
8581953|NCT00215553|9615464|FG002|STARTED|Overall Study||6
8581954|NCT00215553|9615465|FG003|STARTED|Overall Study||5
8581955|NCT00215553|9615466|FG004|STARTED|Overall Study||28
8581956|NCT00215553|9615467|FG005|STARTED|Overall Study||38
8581957|NCT00215553|9615468|FG006|STARTED|Overall Study||36
8581958|NCT00215553|9615462|FG000|COMPLETED|Overall Study||5
8581959|NCT00215553|9615463|FG001|COMPLETED|Overall Study||5
8581960|NCT00215553|9615464|FG002|COMPLETED|Overall Study||4
8581961|NCT00215553|9615465|FG003|COMPLETED|Overall Study||4
8581962|NCT00215553|9615466|FG004|COMPLETED|Overall Study||26
8581963|NCT00215553|9615467|FG005|COMPLETED|Overall Study||32
8581964|NCT00215553|9615468|FG006|COMPLETED|Overall Study||36
8581965|NCT00215553|9615462|FG000|NOT COMPLETED|Overall Study||0
8581966|NCT00215553|9615463|FG001|NOT COMPLETED|Overall Study||1
8581967|NCT00215553|9615464|FG002|NOT COMPLETED|Overall Study||2
8581968|NCT00215553|9615465|FG003|NOT COMPLETED|Overall Study||1
8581969|NCT00215553|9615466|FG004|NOT COMPLETED|Overall Study||2
8581970|NCT00215553|9615467|FG005|NOT COMPLETED|Overall Study||6
8581971|NCT00215553|9615468|FG006|NOT COMPLETED|Overall Study||0
8581972|NCT00215644|9615486|FG000|STARTED|Overall Study||36
8581973|NCT00215644|9615487|FG001|STARTED|Overall Study||36
8581974|NCT00215644|9615486|FG000|Treated|Overall Study||35
8581975|NCT00215644|9615487|FG001|Treated|Overall Study||36
8581976|NCT00215644|9615486|FG000|COMPLETED|Overall Study||0
8581977|NCT00215644|9615487|FG001|COMPLETED|Overall Study||0
8581978|NCT00215644|9615486|FG000|NOT COMPLETED|Overall Study||36
8581979|NCT00215644|9615487|FG001|NOT COMPLETED|Overall Study||36
8581980|NCT00215657|9615501|FG000|STARTED|Overall Study||26
8581981|NCT00215657|9615502|FG001|STARTED|Overall Study||12
8581982|NCT00215657|9615503|FG002|STARTED|Overall Study||13
8581983|NCT00215657|9615504|FG003|STARTED|Overall Study||24
8581984|NCT00215657|9615505|FG004|STARTED|Overall Study||27
8581985|NCT00215657|9615506|FG005|STARTED|Overall Study||24
8581986|NCT00215657|9615507|FG006|STARTED|Overall Study||27
8581987|NCT00215657|9615508|FG007|STARTED|Overall Study||27
8581988|NCT00215657|9615501|FG000|Intention-to-treat Population|Overall Study||25
8581989|NCT00215657|9615502|FG001|Intention-to-treat Population|Overall Study||12
8581990|NCT00215657|9615503|FG002|Intention-to-treat Population|Overall Study||12
8581991|NCT00215657|9615504|FG003|Intention-to-treat Population|Overall Study||24
8581992|NCT00215657|9615505|FG004|Intention-to-treat Population|Overall Study||24
8581993|NCT00215657|9615506|FG005|Intention-to-treat Population|Overall Study||24
8581994|NCT00215657|9615507|FG006|Intention-to-treat Population|Overall Study||24
8581995|NCT00215657|9615508|FG007|Intention-to-treat Population|Overall Study||27
8581996|NCT00215657|9615501|FG000|Started FE200486 CS07A|Overall Study||20
8581997|NCT00215657|9615502|FG001|Started FE200486 CS07A|Overall Study||6
8581998|NCT00215657|9615503|FG002|Started FE200486 CS07A|Overall Study||7
8581999|NCT00215657|9615504|FG003|Started FE200486 CS07A|Overall Study||24
8582000|NCT00215657|9615505|FG004|Started FE200486 CS07A|Overall Study||17
8582001|NCT00215657|9615506|FG005|Started FE200486 CS07A|Overall Study||20
8582002|NCT00215657|9615507|FG006|Started FE200486 CS07A|Overall Study||14
8582003|NCT00215657|9615508|FG007|Started FE200486 CS07A|Overall Study||23
8582004|NCT00215657|9615501|FG000|COMPLETED|Overall Study|Participants ongoing at the time of study closure were considered to have completed the study.|4
8582005|NCT00215657|9615502|FG001|COMPLETED|Overall Study||1
8582006|NCT00215657|9615503|FG002|COMPLETED|Overall Study||2
8582007|NCT00215657|9615504|FG003|COMPLETED|Overall Study||6
8582008|NCT00215657|9615505|FG004|COMPLETED|Overall Study||4
8582009|NCT00215657|9615506|FG005|COMPLETED|Overall Study||4
8582010|NCT00215657|9615507|FG006|COMPLETED|Overall Study||4
8582011|NCT00215657|9615508|FG007|COMPLETED|Overall Study||11
8582012|NCT00215657|9615501|FG000|NOT COMPLETED|Overall Study||22
8582013|NCT00215657|9615502|FG001|NOT COMPLETED|Overall Study||11
8582014|NCT00215657|9615503|FG002|NOT COMPLETED|Overall Study||11
8582015|NCT00215657|9615504|FG003|NOT COMPLETED|Overall Study||18
8582016|NCT00215657|9615505|FG004|NOT COMPLETED|Overall Study||23
8582017|NCT00215657|9615506|FG005|NOT COMPLETED|Overall Study||20
8582018|NCT00215657|9615507|FG006|NOT COMPLETED|Overall Study||23
8582019|NCT00215657|9615508|FG007|NOT COMPLETED|Overall Study||16
8582020|NCT00215683|9615529|FG000|STARTED|Overall Study|Safety analysis set|45
8582021|NCT00215683|9615530|FG001|STARTED|Overall Study||48
8582022|NCT00215683|9615531|FG002|STARTED|Overall Study||44
8582023|NCT00215683|9615529|FG000|Switched to 160 mg|Overall Study|A protocol amendment changed the dosage to 160 mg (40 mg/mL) for all participants|32
8582024|NCT00215683|9615530|FG001|Switched to 160 mg|Overall Study||41
8582025|NCT00215683|9615531|FG002|Switched to 160 mg|Overall Study||36
8582026|NCT00215683|9615529|FG000|COMPLETED|Overall Study|Participants ongoing at the time of study closure were considered to have completed the study|16
8582027|NCT00215683|9615530|FG001|COMPLETED|Overall Study||22
8582028|NCT00215683|9615531|FG002|COMPLETED|Overall Study||12
8582029|NCT00215683|9615529|FG000|NOT COMPLETED|Overall Study||29
8582030|NCT00215683|9615530|FG001|NOT COMPLETED|Overall Study||26
8582031|NCT00215683|9615531|FG002|NOT COMPLETED|Overall Study||32
8582032|NCT00215787|9615539|FG000|STARTED|Overall Study||20
8582033|NCT00215787|9615539|FG000|COMPLETED|Overall Study||20
8582034|NCT00215787|9615539|FG000|NOT COMPLETED|Overall Study||0
8582035|NCT00215930|9615543|FG000|STARTED|Overall Study||53
8582036|NCT00215930|9615543|FG000|COMPLETED|Overall Study||53
8582037|NCT00215930|9615543|FG000|NOT COMPLETED|Overall Study||0
8582038|NCT00215943|9615550|FG000|STARTED|Overall Study||36
8582039|NCT00215943|9615551|FG001|STARTED|Overall Study||37
8582040|NCT00215943|9615550|FG000|COMPLETED|Overall Study||27
8582041|NCT00215943|9615551|FG001|COMPLETED|Overall Study||23
8582042|NCT00215943|9615550|FG000|NOT COMPLETED|Overall Study||9
8582043|NCT00215943|9615551|FG001|NOT COMPLETED|Overall Study||14
8582044|NCT00216060|9615559|FG000|STARTED|Overall Study||32
8582045|NCT00216060|9615560|FG001|STARTED|Overall Study||31
8582046|NCT00216060|9615559|FG000|COMPLETED|Overall Study||32
8582047|NCT00216060|9615560|FG001|COMPLETED|Overall Study||31
8582048|NCT00216060|9615559|FG000|NOT COMPLETED|Overall Study||0
8582049|NCT00216060|9615560|FG001|NOT COMPLETED|Overall Study||0
8582050|NCT00216086|9615568|FG000|STARTED|Overall Study||22
8582051|NCT00216086|9615568|FG000|COMPLETED|Overall Study||18
8582052|NCT00216086|9615568|FG000|NOT COMPLETED|Overall Study||4
8582053|NCT00216099|9615572|FG000|STARTED|Overall Study||49
8582054|NCT00216099|9615572|FG000|Toxicity Analysis|Overall Study||49
8582055|NCT00216099|9615572|FG000|Response Analysis|Overall Study||48
8582056|NCT00216099|9615572|FG000|COMPLETED|Overall Study||48
8582057|NCT00216099|9615572|FG000|NOT COMPLETED|Overall Study||1
8582058|NCT00216125|9615576|FG000|STARTED|Pre-Randomization Phase||243
8582059|NCT00216125|9615577|FG001|STARTED|Pre-Randomization Phase||0
8582060|NCT00216125|9615578|FG002|STARTED|Pre-Randomization Phase||0
8582061|NCT00216125|9615576|FG000|DSMB Cohort for Futility|Pre-Randomization Phase||203
8582062|NCT00216125|9615577|FG001|DSMB Cohort for Futility|Pre-Randomization Phase||0
8582063|NCT00216125|9615578|FG002|DSMB Cohort for Futility|Pre-Randomization Phase||0
8582064|NCT00216125|9615576|FG000|COMPLETED|Pre-Randomization Phase||166
8582065|NCT00216125|9615577|FG001|COMPLETED|Pre-Randomization Phase||0
8582066|NCT00216125|9615578|FG002|COMPLETED|Pre-Randomization Phase||0
8582067|NCT00216125|9615576|FG000|NOT COMPLETED|Pre-Randomization Phase||77
8582068|NCT00216125|9615577|FG001|NOT COMPLETED|Pre-Randomization Phase||0
8582069|NCT00216125|9615578|FG002|NOT COMPLETED|Pre-Randomization Phase||0
8582070|NCT00216125|9615576|FG000|STARTED|Randomization Phase||0
8582071|NCT00216125|9615577|FG001|STARTED|Randomization Phase||84
8582072|NCT00216125|9615578|FG002|STARTED|Randomization Phase||82
8582073|NCT00216125|9615576|FG000|DSMB Cohort for Futility|Randomization Phase||0
8582074|NCT00216125|9615577|FG001|DSMB Cohort for Futility|Randomization Phase||73
8582075|NCT00216125|9615578|FG002|DSMB Cohort for Futility|Randomization Phase||74
8582076|NCT00216125|9615576|FG000|COMPLETED|Randomization Phase||0
8582077|NCT00216125|9615577|FG001|COMPLETED|Randomization Phase||73
8582078|NCT00216125|9615578|FG002|COMPLETED|Randomization Phase||74
8582079|NCT00216125|9615576|FG000|NOT COMPLETED|Randomization Phase||0
8582080|NCT00216125|9615577|FG001|NOT COMPLETED|Randomization Phase||11
8582081|NCT00216125|9615578|FG002|NOT COMPLETED|Randomization Phase||8
8582082|NCT00216203|9615585|FG000|STARTED|Overall Study||36
8582083|NCT00216203|9615585|FG000|COMPLETED|Overall Study||34
8582084|NCT00216203|9615585|FG000|NOT COMPLETED|Overall Study||2
8582085|NCT00216320|9615593|FG000|STARTED|Phase 1 (Weeks 0 - 6)||43
8582086|NCT00216320|9615594|FG001|STARTED|Phase 1 (Weeks 0 - 6)||39
8582087|NCT00216320|9615595|FG002|STARTED|Phase 1 (Weeks 0 - 6)||30
8582088|NCT00216320|9615593|FG000|COMPLETED|Phase 1 (Weeks 0 - 6)||43
8582089|NCT00216320|9615594|FG001|COMPLETED|Phase 1 (Weeks 0 - 6)||35
8582090|NCT00216320|9615595|FG002|COMPLETED|Phase 1 (Weeks 0 - 6)||25
8582091|NCT00216320|9615593|FG000|NOT COMPLETED|Phase 1 (Weeks 0 - 6)||0
8582092|NCT00216320|9615594|FG001|NOT COMPLETED|Phase 1 (Weeks 0 - 6)||4
8582093|NCT00216320|9615595|FG002|NOT COMPLETED|Phase 1 (Weeks 0 - 6)||5
8582094|NCT00216320|9615593|FG000|STARTED|Phase 2 (Weeks 6 -12)||43
8582095|NCT00216320|9615594|FG001|STARTED|Phase 2 (Weeks 6 -12)||35
8582096|NCT00216320|9615595|FG002|STARTED|Phase 2 (Weeks 6 -12)||25
8582097|NCT00216320|9615593|FG000|COMPLETED|Phase 2 (Weeks 6 -12)||38
8582098|NCT00216320|9615594|FG001|COMPLETED|Phase 2 (Weeks 6 -12)||31
8582099|NCT00216320|9615595|FG002|COMPLETED|Phase 2 (Weeks 6 -12)||24
8582100|NCT00216320|9615593|FG000|NOT COMPLETED|Phase 2 (Weeks 6 -12)||5
8582101|NCT00216320|9615594|FG001|NOT COMPLETED|Phase 2 (Weeks 6 -12)||4
8582102|NCT00216320|9615595|FG002|NOT COMPLETED|Phase 2 (Weeks 6 -12)||1
8582103|NCT00216476|9615606|FG000|STARTED|Overall Study||329
8582104|NCT00216476|9615607|FG001|STARTED|Overall Study||337
8582105|NCT00216476|9615608|FG002|STARTED|Overall Study||45
8582106|NCT00216476|9615606|FG000|COMPLETED|Overall Study||224
8582107|NCT00216476|9615607|FG001|COMPLETED|Overall Study||230
8582108|NCT00216476|9615608|FG002|COMPLETED|Overall Study||28
8582109|NCT00216476|9615606|FG000|NOT COMPLETED|Overall Study||105
8582110|NCT00216476|9615607|FG001|NOT COMPLETED|Overall Study||107
8582111|NCT00216476|9615608|FG002|NOT COMPLETED|Overall Study||17
8582112|NCT00216671|9615621|FG000|STARTED|Overall Study||110
8582113|NCT00216671|9615622|FG001|STARTED|Overall Study||110
8582114|NCT00216671|9615621|FG000|COMPLETED|Overall Study||75
8582115|NCT00216671|9615622|FG001|COMPLETED|Overall Study||60
8582116|NCT00216671|9615621|FG000|NOT COMPLETED|Overall Study||35
8582117|NCT00216671|9615622|FG001|NOT COMPLETED|Overall Study||50
8582118|NCT00216736|9615630|FG000|STARTED|Overall Study||32
8582119|NCT00216736|9615631|FG001|STARTED|Overall Study||31
8582120|NCT00216736|9615630|FG000|COMPLETED|Overall Study||31
8582121|NCT00216736|9615631|FG001|COMPLETED|Overall Study||30
8582122|NCT00216736|9615630|FG000|NOT COMPLETED|Overall Study||1
8582123|NCT00216736|9615631|FG001|NOT COMPLETED|Overall Study||1
8582124|NCT00217022|9615639|FG000|STARTED|Overall Study||12
8582125|NCT00217022|9615640|FG001|STARTED|Overall Study||4
8582126|NCT00217022|9615639|FG000|COMPLETED|Overall Study||11
8582127|NCT00217022|9615640|FG001|COMPLETED|Overall Study||3
8582128|NCT00217022|9615639|FG000|NOT COMPLETED|Overall Study||1
8582129|NCT00217022|9615640|FG001|NOT COMPLETED|Overall Study||1
8582130|NCT00217087|9615648|FG000|STARTED|Overall Study||36
8582131|NCT00217087|9615649|FG001|STARTED|Overall Study||37
8582132|NCT00217087|9615648|FG000|COMPLETED|Overall Study||25
8582133|NCT00217087|9615649|FG001|COMPLETED|Overall Study||17
8582134|NCT00217087|9615648|FG000|NOT COMPLETED|Overall Study||11
8582135|NCT00217087|9615649|FG001|NOT COMPLETED|Overall Study||20
8582136|NCT00217399|9615661|FG000|STARTED|Overall Study||35
8582137|NCT00217399|9615661|FG000|COMPLETED|Overall Study||35
8582138|NCT00217399|9615661|FG000|NOT COMPLETED|Overall Study||0
8582139|NCT00217425|9615667|FG000|STARTED|Overall Study||46
8582140|NCT00217425|9615667|FG000|Treated|Overall Study||44
8582141|NCT00217425|9615667|FG000|Eligible and Treated|Overall Study||39
8582142|NCT00217425|9615667|FG000|COMPLETED|Overall Study||9
8582143|NCT00217425|9615667|FG000|NOT COMPLETED|Overall Study||37
8582144|NCT00217438|9615673|FG000|STARTED|Overall Study||66
8582145|NCT00217438|9615674|FG001|STARTED|Overall Study||64
8582146|NCT00217438|9615673|FG000|COMPLETED|Overall Study||66
8582147|NCT00217438|9615674|FG001|COMPLETED|Overall Study|One patient did not complete Day 80-120 evaluation tests after returning to referring physician.|63
8582148|NCT00217438|9615673|FG000|NOT COMPLETED|Overall Study||0
8582149|NCT00217438|9615674|FG001|NOT COMPLETED|Overall Study||1
8582150|NCT00217464|9615680|FG000|STARTED|Overall Study||17
8582151|NCT00217464|9615680|FG000|COMPLETED|Overall Study||0
8582152|NCT00217464|9615680|FG000|NOT COMPLETED|Overall Study||17
8582153|NCT00217490|9615688|FG000|STARTED|Overall Study||154
8582154|NCT00217490|9615689|FG001|STARTED|Overall Study||153
8582155|NCT00217490|9615690|FG002|STARTED|Overall Study||155
8582156|NCT00217490|9615691|FG003|STARTED|Overall Study||153
8582157|NCT00217490|9615688|FG000|COMPLETED|Overall Study||137
8582158|NCT00217490|9615689|FG001|COMPLETED|Overall Study||128
8582159|NCT00217490|9615690|FG002|COMPLETED|Overall Study||131
8582160|NCT00217490|9615691|FG003|COMPLETED|Overall Study||130
8582161|NCT00217490|9615688|FG000|NOT COMPLETED|Overall Study||17
8582162|NCT00217490|9615689|FG001|NOT COMPLETED|Overall Study||25
8582163|NCT00217490|9615690|FG002|NOT COMPLETED|Overall Study||24
8582164|NCT00217490|9615691|FG003|NOT COMPLETED|Overall Study||23
8582165|NCT00217581|9615705|FG000|STARTED|Overall Study||39
8582166|NCT00217581|9615705|FG000|COMPLETED|Overall Study||38
8582167|NCT00217581|9615705|FG000|NOT COMPLETED|Overall Study||1
8582168|NCT00217594|9615710|FG000|STARTED|Overall Study||31
8582169|NCT00217594|9615710|FG000|COMPLETED|Overall Study||31
8582170|NCT00217594|9615710|FG000|NOT COMPLETED|Overall Study||0
8582171|NCT00217620|9615714|FG000|STARTED|Overall Study||51
8582172|NCT00217620|9615714|FG000|Eligible|Overall Study||38
8582173|NCT00217620|9615714|FG000|Eligible and Began Protocol Therapy|Overall Study||37
8582174|NCT00217620|9615714|FG000|COMPLETED|Overall Study||0
8582175|NCT00217620|9615714|FG000|NOT COMPLETED|Overall Study||51
8582176|NCT00217672|9615722|FG000|STARTED|Allocation||69
8582177|NCT00217672|9615723|FG001|STARTED|Allocation|When bevacizumab became available, study converted to a 1-arm open-label trial with just bevacizumab|7
8582178|NCT00217672|9615722|FG000|COMPLETED|Allocation||67
8582179|NCT00217672|9615723|FG001|COMPLETED|Allocation||7
8582180|NCT00217672|9615722|FG000|NOT COMPLETED|Allocation||2
8582181|NCT00217672|9615723|FG001|NOT COMPLETED|Allocation||0
8582182|NCT00217672|9615722|FG000|STARTED|Treatment||67
8582183|NCT00217672|9615723|FG001|STARTED|Treatment|When bevacizumab became available, study converted to a 1-arm open-label trial with just bevacizumab|7
8582184|NCT00217672|9615722|FG000|COMPLETED|Treatment||0
8582185|NCT00217672|9615723|FG001|COMPLETED|Treatment||0
8582186|NCT00217672|9615722|FG000|NOT COMPLETED|Treatment||67
8582187|NCT00217672|9615723|FG001|NOT COMPLETED|Treatment||7
8582188|NCT00217672|9615722|FG000|STARTED|Follow-up|when bevacizumab became available, converted to a 1-arm open-label trial (67+7=74)|74
8582189|NCT00217672|9615723|FG001|STARTED|Follow-up||0
8582190|NCT00217672|9615722|FG000|COMPLETED|Follow-up||69
8582191|NCT00217672|9615723|FG001|COMPLETED|Follow-up||0
8582192|NCT00217672|9615722|FG000|NOT COMPLETED|Follow-up||5
8582193|NCT00217672|9615723|FG001|NOT COMPLETED|Follow-up||0
8582194|NCT00217724|9615727|FG000|STARTED|Course 1, (Glutamine/Placebo Arms)||8
8582195|NCT00217724|9615728|FG001|STARTED|Course 1, (Glutamine/Placebo Arms)||10
8582196|NCT00217724|9615727|FG000|COMPLETED|Course 1, (Glutamine/Placebo Arms)||5
8582197|NCT00217724|9615728|FG001|COMPLETED|Course 1, (Glutamine/Placebo Arms)||9
8582198|NCT00217724|9615727|FG000|NOT COMPLETED|Course 1, (Glutamine/Placebo Arms)||3
8582199|NCT00217724|9615728|FG001|NOT COMPLETED|Course 1, (Glutamine/Placebo Arms)||1
8582200|NCT00217724|9615727|FG000|STARTED|Course 2, (Glutamine/Placebo Crossover)||9
8582201|NCT00217724|9615728|FG001|STARTED|Course 2, (Glutamine/Placebo Crossover)||5
8582202|NCT00217724|9615727|FG000|COMPLETED|Course 2, (Glutamine/Placebo Crossover)||8
8582203|NCT00217724|9615728|FG001|COMPLETED|Course 2, (Glutamine/Placebo Crossover)||5
8582204|NCT00217724|9615727|FG000|NOT COMPLETED|Course 2, (Glutamine/Placebo Crossover)||1
8582205|NCT00217724|9615728|FG001|NOT COMPLETED|Course 2, (Glutamine/Placebo Crossover)||0
8582206|NCT00217971|9615736|FG000|STARTED|Overall Study||79
8582207|NCT00217971|9615737|FG001|STARTED|Overall Study||77
8582208|NCT00217971|9615736|FG000|COMPLETED|Overall Study||55
8582209|NCT00217971|9615737|FG001|COMPLETED|Overall Study||44
8582210|NCT00217971|9615736|FG000|NOT COMPLETED|Overall Study||24
8582211|NCT00217971|9615737|FG001|NOT COMPLETED|Overall Study||33
8582212|NCT00218023|9615747|FG000|STARTED|Overall Study||22
8582213|NCT00218023|9615748|FG001|STARTED|Overall Study||25
8582214|NCT00218023|9615749|FG002|STARTED|Overall Study||16
8582215|NCT00218023|9615750|FG003|STARTED|Overall Study||18
8582216|NCT00218023|9615747|FG000|Received Drug or Placebo in Phase II|Overall Study||18
8709820|NCT00955253|9756096|FG000|STARTED|Second Intervention (Day 4)||7
8709821|NCT00955253|9756097|FG001|STARTED|Second Intervention (Day 4)||6
8709822|NCT00955253|9756096|FG000|COMPLETED|Second Intervention (Day 4)||7
8709823|NCT00955253|9756097|FG001|COMPLETED|Second Intervention (Day 4)||6
8582217|NCT00218023|9615748|FG001|Received Drug or Placebo in Phase II|Overall Study||24
8582218|NCT00218023|9615749|FG002|Received Drug or Placebo in Phase II|Overall Study||15
8582219|NCT00218023|9615750|FG003|Received Drug or Placebo in Phase II|Overall Study||18
8582220|NCT00218023|9615747|FG000|COMPLETED|Overall Study||9
8582221|NCT00218023|9615748|FG001|COMPLETED|Overall Study||10
8582222|NCT00218023|9615749|FG002|COMPLETED|Overall Study||6
8582223|NCT00218023|9615750|FG003|COMPLETED|Overall Study||11
8582224|NCT00218023|9615747|FG000|NOT COMPLETED|Overall Study||13
8582225|NCT00218023|9615748|FG001|NOT COMPLETED|Overall Study||15
8582226|NCT00218023|9615749|FG002|NOT COMPLETED|Overall Study||10
8582227|NCT00218023|9615750|FG003|NOT COMPLETED|Overall Study||7
8582228|NCT00218062|9615764|FG000|STARTED|Overall Study||22
8582229|NCT00218062|9615765|FG001|STARTED|Overall Study||20
8582230|NCT00218062|9615766|FG002|STARTED|Overall Study||15
8582231|NCT00218062|9615767|FG003|STARTED|Overall Study||16
8582232|NCT00218062|9615764|FG000|Received First Dose of Study Medication|Overall Study||16
8582233|NCT00218062|9615765|FG001|Received First Dose of Study Medication|Overall Study||11
8582234|NCT00218062|9615766|FG002|Received First Dose of Study Medication|Overall Study||10
8582235|NCT00218062|9615767|FG003|Received First Dose of Study Medication|Overall Study||12
8582236|NCT00218062|9615764|FG000|COMPLETED|Overall Study||7
8582237|NCT00218062|9615765|FG001|COMPLETED|Overall Study||4
8582238|NCT00218062|9615766|FG002|COMPLETED|Overall Study||3
8582239|NCT00218062|9615767|FG003|COMPLETED|Overall Study||3
8582240|NCT00218062|9615764|FG000|NOT COMPLETED|Overall Study||15
8582241|NCT00218062|9615765|FG001|NOT COMPLETED|Overall Study||16
8582242|NCT00218062|9615766|FG002|NOT COMPLETED|Overall Study||12
8582243|NCT00218062|9615767|FG003|NOT COMPLETED|Overall Study||13
8582244|NCT00218257|9615777|FG000|STARTED|Intervention 1||23
8582245|NCT00218257|9615778|FG001|STARTED|Intervention 1||22
8582246|NCT00218257|9615777|FG000|COMPLETED|Intervention 1||23
8582247|NCT00218257|9615778|FG001|COMPLETED|Intervention 1||22
8582248|NCT00218257|9615777|FG000|NOT COMPLETED|Intervention 1||0
8582249|NCT00218257|9615778|FG001|NOT COMPLETED|Intervention 1||0
8582250|NCT00218257|9615777|FG000|STARTED|Period Between Visit 1 and 2||23
8582251|NCT00218257|9615778|FG001|STARTED|Period Between Visit 1 and 2||22
8582252|NCT00218257|9615777|FG000|COMPLETED|Period Between Visit 1 and 2||19
8582253|NCT00218257|9615778|FG001|COMPLETED|Period Between Visit 1 and 2||19
8582254|NCT00218257|9615777|FG000|NOT COMPLETED|Period Between Visit 1 and 2||4
8582255|NCT00218257|9615778|FG001|NOT COMPLETED|Period Between Visit 1 and 2||3
8582256|NCT00218257|9615777|FG000|STARTED|Intervention 2||19
8582257|NCT00218257|9615778|FG001|STARTED|Intervention 2||19
8582258|NCT00218257|9615777|FG000|COMPLETED|Intervention 2||19
8582259|NCT00218257|9615778|FG001|COMPLETED|Intervention 2||19
8582260|NCT00218257|9615777|FG000|NOT COMPLETED|Intervention 2||0
8582261|NCT00218257|9615778|FG001|NOT COMPLETED|Intervention 2||0
8582262|NCT00218296|9615789|FG000|STARTED|Overall Study||163
8582263|NCT00218296|9615790|FG001|STARTED|Overall Study||169
8582264|NCT00218296|9615789|FG000|Attended Visti|Overall Study||97
8582265|NCT00218296|9615790|FG001|Attended Visti|Overall Study||102
8582266|NCT00218296|9615789|FG000|COMPLETED|Overall Study||52
8582267|NCT00218296|9615790|FG001|COMPLETED|Overall Study||48
8582268|NCT00218296|9615789|FG000|NOT COMPLETED|Overall Study||111
8582269|NCT00218296|9615790|FG001|NOT COMPLETED|Overall Study||121
8582270|NCT00218335|9615802|FG000|STARTED|Overall Study||114
8582271|NCT00218335|9615803|FG001|STARTED|Overall Study||113
8582272|NCT00218335|9615804|FG002|STARTED|Overall Study||373
8582273|NCT00218335|9615805|FG003|STARTED|Overall Study||424
8582274|NCT00218335|9615802|FG000|6 Month Follow-up|Overall Study||103
8582275|NCT00218335|9615803|FG001|6 Month Follow-up|Overall Study||99
8582276|NCT00218335|9615804|FG002|6 Month Follow-up|Overall Study||219
8582277|NCT00218335|9615805|FG003|6 Month Follow-up|Overall Study||301
8582278|NCT00218335|9615802|FG000|12 Month Follow-up|Overall Study||95
8582279|NCT00218335|9615803|FG001|12 Month Follow-up|Overall Study||102
8582280|NCT00218335|9615804|FG002|12 Month Follow-up|Overall Study||244
8582281|NCT00218335|9615805|FG003|12 Month Follow-up|Overall Study||303
8582282|NCT00218335|9615802|FG000|18 Month Follow-up|Overall Study||101
8582283|NCT00218335|9615803|FG001|18 Month Follow-up|Overall Study||108
8582284|NCT00218335|9615804|FG002|18 Month Follow-up|Overall Study||296
8582285|NCT00218335|9615805|FG003|18 Month Follow-up|Overall Study||368
8582286|NCT00218335|9615802|FG000|COMPLETED|Overall Study||108
8582287|NCT00218335|9615803|FG001|COMPLETED|Overall Study||110
8582288|NCT00218335|9615804|FG002|COMPLETED|Overall Study||319
8582289|NCT00218335|9615805|FG003|COMPLETED|Overall Study||388
8582290|NCT00218335|9615802|FG000|NOT COMPLETED|Overall Study||6
8582291|NCT00218335|9615803|FG001|NOT COMPLETED|Overall Study||3
8582292|NCT00218335|9615804|FG002|NOT COMPLETED|Overall Study||54
8582293|NCT00218335|9615805|FG003|NOT COMPLETED|Overall Study||36
8582294|NCT00218387|9615820|FG000|STARTED|Overall Study||40
8582295|NCT00218387|9615821|FG001|STARTED|Overall Study||43
8582296|NCT00218387|9615822|FG002|STARTED|Overall Study||40
8582297|NCT00218387|9615820|FG000|COMPLETED|Overall Study||25
8582298|NCT00218387|9615821|FG001|COMPLETED|Overall Study||25
8582299|NCT00218387|9615822|FG002|COMPLETED|Overall Study||17
8582300|NCT00218387|9615820|FG000|NOT COMPLETED|Overall Study||15
8582301|NCT00218387|9615821|FG001|NOT COMPLETED|Overall Study||18
8582302|NCT00218387|9615822|FG002|NOT COMPLETED|Overall Study||23
8582303|NCT00218426|9615833|FG000|STARTED|Overall Study||102
8582304|NCT00218426|9615834|FG001|STARTED|Overall Study||102
8582305|NCT00218426|9615835|FG002|STARTED|Overall Study||102
8582306|NCT00218426|9615833|FG000|COMPLETED|Overall Study||54
8582307|NCT00218426|9615834|FG001|COMPLETED|Overall Study||16
8582308|NCT00218426|9615835|FG002|COMPLETED|Overall Study||11
8582309|NCT00218426|9615833|FG000|NOT COMPLETED|Overall Study||48
8582310|NCT00218426|9615834|FG001|NOT COMPLETED|Overall Study||86
8582311|NCT00218426|9615835|FG002|NOT COMPLETED|Overall Study||91
8582312|NCT00218439|9615848|FG000|STARTED|First Intervention (4 Weeks)||58
8582313|NCT00218439|9615849|FG001|STARTED|First Intervention (4 Weeks)||47
8582314|NCT00218439|9615848|FG000|COMPLETED|First Intervention (4 Weeks)||40
8582315|NCT00218439|9615849|FG001|COMPLETED|First Intervention (4 Weeks)||35
8582316|NCT00218439|9615848|FG000|NOT COMPLETED|First Intervention (4 Weeks)||18
8582317|NCT00218439|9615849|FG001|NOT COMPLETED|First Intervention (4 Weeks)||12
8582318|NCT00218439|9615848|FG000|STARTED|Second Intervention (4 Weeks)||40
8582319|NCT00218439|9615849|FG001|STARTED|Second Intervention (4 Weeks)||35
8582320|NCT00218439|9615848|FG000|COMPLETED|Second Intervention (4 Weeks)||33
8582321|NCT00218439|9615849|FG001|COMPLETED|Second Intervention (4 Weeks)||30
8582322|NCT00218439|9615848|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||7
8582323|NCT00218439|9615849|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||5
8582324|NCT00218465|9615865|FG000|STARTED|Overall Study||50
8582325|NCT00218465|9615866|FG001|STARTED|Overall Study||48
8582326|NCT00218465|9615865|FG000|COMPLETED|Overall Study||33
8582327|NCT00218465|9615866|FG001|COMPLETED|Overall Study||30
8582328|NCT00218465|9615865|FG000|NOT COMPLETED|Overall Study||17
8709824|NCT00955253|9756096|FG000|NOT COMPLETED|Second Intervention (Day 4)||0
8709825|NCT00955253|9756097|FG001|NOT COMPLETED|Second Intervention (Day 4)||0
8709826|NCT00955266|9756104|FG000|STARTED|Overall Study||4
8709827|NCT00955266|9756105|FG001|STARTED|Overall Study||4
8709828|NCT00955266|9756104|FG000|COMPLETED|Overall Study||4
8709829|NCT00955266|9756105|FG001|COMPLETED|Overall Study||4
8709830|NCT00955266|9756104|FG000|NOT COMPLETED|Overall Study||0
8582329|NCT00218465|9615866|FG001|NOT COMPLETED|Overall Study||18
8582330|NCT00218491|9615875|FG000|STARTED|Overall Study||40
8582331|NCT00218491|9615876|FG001|STARTED|Overall Study||33
8582332|NCT00218491|9615877|FG002|STARTED|Overall Study||38
8582333|NCT00218491|9615875|FG000|COMPLETED|Overall Study||40
8582334|NCT00218491|9615876|FG001|COMPLETED|Overall Study||33
8582335|NCT00218491|9615877|FG002|COMPLETED|Overall Study||38
8582336|NCT00218491|9615875|FG000|NOT COMPLETED|Overall Study||0
8582337|NCT00218491|9615876|FG001|NOT COMPLETED|Overall Study||0
8582338|NCT00218491|9615877|FG002|NOT COMPLETED|Overall Study||0
8582339|NCT00218543|9615885|FG000|STARTED|Overall Study||20
8709831|NCT00955266|9756105|FG001|NOT COMPLETED|Overall Study||0
8709832|NCT00955279|9756114|FG000|STARTED|Overall Study||58
8582340|NCT00218543|9615885|FG000|COMPLETED|Overall Study|13 reached the maintenance dose phase of treatment; 9 completed at least six weeks of treatment.|5
8582341|NCT00218543|9615885|FG000|NOT COMPLETED|Overall Study||15
8582342|NCT00218634|9615891|FG000|STARTED|Overall Study||44
8582343|NCT00218634|9615892|FG001|STARTED|Overall Study||45
8582344|NCT00218634|9615891|FG000|COMPLETED|Overall Study||36
8582345|NCT00218634|9615892|FG001|COMPLETED|Overall Study||30
8582346|NCT00218634|9615891|FG000|NOT COMPLETED|Overall Study||8
8582347|NCT00218634|9615892|FG001|NOT COMPLETED|Overall Study||15
8582348|NCT00219141|9615904|FG000|STARTED|Overall Study||154
8582349|NCT00219141|9615905|FG001|STARTED|Overall Study||152
8582350|NCT00219141|9615906|FG002|STARTED|Overall Study||154
8582351|NCT00219141|9615904|FG000|COMPLETED|Overall Study||140
8582352|NCT00219141|9615905|FG001|COMPLETED|Overall Study||131
8582353|NCT00219141|9615906|FG002|COMPLETED|Overall Study||142
8582354|NCT00219141|9615904|FG000|NOT COMPLETED|Overall Study||14
8582355|NCT00219141|9615905|FG001|NOT COMPLETED|Overall Study||21
8582356|NCT00219141|9615906|FG002|NOT COMPLETED|Overall Study||12
8582357|NCT00219284|9615916|FG000|STARTED|Treatment Phase - 16 Weeks||180
8582358|NCT00219284|9615917|FG001|STARTED|Treatment Phase - 16 Weeks||179
8582359|NCT00219284|9615916|FG000|COMPLETED|Treatment Phase - 16 Weeks||136
8582360|NCT00219284|9615917|FG001|COMPLETED|Treatment Phase - 16 Weeks||128
8582361|NCT00219284|9615916|FG000|NOT COMPLETED|Treatment Phase - 16 Weeks||44
8582362|NCT00219284|9615917|FG001|NOT COMPLETED|Treatment Phase - 16 Weeks||51
8582363|NCT00219284|9615916|FG000|STARTED|Extension Phase - 8 Weeks|Not all subjects who completed the treatment phase chose to enter this optional extension phase.|114
8582364|NCT00219284|9615917|FG001|STARTED|Extension Phase - 8 Weeks|Not all subjects who completed the treatment phase chose to enter this optional extension phase.|106
8582365|NCT00219284|9615916|FG000|COMPLETED|Extension Phase - 8 Weeks||112
8582366|NCT00219284|9615917|FG001|COMPLETED|Extension Phase - 8 Weeks||99
8582367|NCT00219284|9615916|FG000|NOT COMPLETED|Extension Phase - 8 Weeks||2
8582368|NCT00219284|9615917|FG001|NOT COMPLETED|Extension Phase - 8 Weeks||7
8582369|NCT00219349|9615923|FG000|STARTED|Cognitive Behavioral Therapy Phase||25
8582370|NCT00219349|9615923|FG000|COMPLETED|Cognitive Behavioral Therapy Phase||15
8582371|NCT00219349|9615923|FG000|NOT COMPLETED|Cognitive Behavioral Therapy Phase||10
8582372|NCT00219349|9615923|FG000|STARTED|Escitalopram Phase|7 responders to CBT were ineligible to start and 1 declined, leaving 7 who started escitalopram|7
8582373|NCT00219349|9615923|FG000|COMPLETED|Escitalopram Phase||4
8582374|NCT00219349|9615923|FG000|NOT COMPLETED|Escitalopram Phase||3
8582375|NCT00219544|9615927|FG000|STARTED|Single Blind Treatment Period||256
8582376|NCT00219544|9615928|FG001|STARTED|Single Blind Treatment Period||0
8582377|NCT00219544|9615927|FG000|COMPLETED|Single Blind Treatment Period||234
8582378|NCT00219544|9615928|FG001|COMPLETED|Single Blind Treatment Period||0
8582379|NCT00219544|9615927|FG000|NOT COMPLETED|Single Blind Treatment Period||22
8582380|NCT00219544|9615928|FG001|NOT COMPLETED|Single Blind Treatment Period||0
8582381|NCT00219544|9615927|FG000|STARTED|Double Blind Treatment Period||80
8582382|NCT00219544|9615928|FG001|STARTED|Double Blind Treatment Period||77
8582383|NCT00219544|9615927|FG000|COMPLETED|Double Blind Treatment Period||80
8582384|NCT00219544|9615928|FG001|COMPLETED|Double Blind Treatment Period||77
8582385|NCT00219544|9615927|FG000|NOT COMPLETED|Double Blind Treatment Period||0
8709833|NCT00955279|9756115|FG001|STARTED|Overall Study||55
8709834|NCT00955279|9756116|FG002|STARTED|Overall Study||60
8709835|NCT00955279|9756114|FG000|COMPLETED|Overall Study||55
8709836|NCT00955279|9756115|FG001|COMPLETED|Overall Study||51
8709837|NCT00955279|9756116|FG002|COMPLETED|Overall Study||52
8709838|NCT00955279|9756114|FG000|NOT COMPLETED|Overall Study||3
8709839|NCT00955279|9756115|FG001|NOT COMPLETED|Overall Study||4
8709840|NCT00955279|9756116|FG002|NOT COMPLETED|Overall Study||8
8709841|NCT00955305|9756126|FG000|STARTED|Overall Study||88
8709842|NCT00955305|9756127|FG001|STARTED|Overall Study||87
8709843|NCT00955305|9756126|FG000|Treated|Overall Study||83
8709844|NCT00955305|9756127|FG001|Treated|Overall Study||82
8709845|NCT00955305|9756126|FG000|Eligible and Treated|Overall Study||78
8709846|NCT00955305|9756127|FG001|Eligible and Treated|Overall Study||75
8709847|NCT00955305|9756126|FG000|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicities.|0
8709848|NCT00955305|9756127|FG001|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicities.|0
8709849|NCT00955305|9756126|FG000|NOT COMPLETED|Overall Study||88
8582386|NCT00219544|9615928|FG001|NOT COMPLETED|Double Blind Treatment Period||0
8582387|NCT00219557|9615939|FG000|STARTED|Phase 1||8
8582388|NCT00219557|9615940|FG001|STARTED|Phase 1||0
8582389|NCT00219557|9615941|FG002|STARTED|Phase 1||0
8582390|NCT00219557|9615939|FG000|COMPLETED|Phase 1||1
8582391|NCT00219557|9615940|FG001|COMPLETED|Phase 1||0
8582392|NCT00219557|9615941|FG002|COMPLETED|Phase 1||0
8582393|NCT00219557|9615939|FG000|NOT COMPLETED|Phase 1||7
8582394|NCT00219557|9615940|FG001|NOT COMPLETED|Phase 1||0
8709850|NCT00955305|9756127|FG001|NOT COMPLETED|Overall Study||87
8709851|NCT00955357|9756135|FG000|STARTED|Titration Phase||96
8709852|NCT00955357|9756136|FG001|STARTED|Titration Phase||360
8582395|NCT00219557|9615941|FG002|NOT COMPLETED|Phase 1||0
8582396|NCT00219557|9615939|FG000|STARTED|Phase 2||0
8582397|NCT00219557|9615940|FG001|STARTED|Phase 2||69
8582398|NCT00219557|9615941|FG002|STARTED|Phase 2||34
8709853|NCT00955357|9756135|FG000|COMPLETED|Titration Phase||80
8582399|NCT00219557|9615939|FG000|Treated|Phase 2||0
8582400|NCT00219557|9615940|FG001|Treated|Phase 2||68
8709854|NCT00955357|9756136|FG001|COMPLETED|Titration Phase||294
8582401|NCT00219557|9615941|FG002|Treated|Phase 2||31
8582402|NCT00219557|9615939|FG000|COMPLETED|Phase 2||0
8582403|NCT00219557|9615940|FG001|COMPLETED|Phase 2||0
8582404|NCT00219557|9615941|FG002|COMPLETED|Phase 2||1
8582405|NCT00219557|9615939|FG000|NOT COMPLETED|Phase 2||0
8582406|NCT00219557|9615940|FG001|NOT COMPLETED|Phase 2||69
8582407|NCT00219557|9615941|FG002|NOT COMPLETED|Phase 2||33
8582408|NCT00220636|9615950|FG000|STARTED|Overall Study||15
8582409|NCT00220636|9615950|FG000|COMPLETED|Overall Study||11
8582410|NCT00220636|9615950|FG000|NOT COMPLETED|Overall Study||4
8582411|NCT00220701|9615957|FG000|STARTED|Overall Study||17
8582412|NCT00220701|9615958|FG001|STARTED|Overall Study||17
8582413|NCT00220701|9615957|FG000|COMPLETED|Overall Study||12
8582414|NCT00220701|9615958|FG001|COMPLETED|Overall Study||13
8582415|NCT00220701|9615957|FG000|NOT COMPLETED|Overall Study||5
8582416|NCT00220701|9615958|FG001|NOT COMPLETED|Overall Study||4
8582417|NCT00220727|9615966|FG000|STARTED|First Infusion (Week 0)||4
8582418|NCT00220727|9615967|FG001|STARTED|First Infusion (Week 0)||4
8582419|NCT00220727|9615966|FG000|COMPLETED|First Infusion (Week 0)||4
8582420|NCT00220727|9615967|FG001|COMPLETED|First Infusion (Week 0)||4
8582421|NCT00220727|9615966|FG000|NOT COMPLETED|First Infusion (Week 0)||0
8582422|NCT00220727|9615967|FG001|NOT COMPLETED|First Infusion (Week 0)||0
8582423|NCT00220727|9615966|FG000|STARTED|Second Infusion (Week <6)||4
8582424|NCT00220727|9615967|FG001|STARTED|Second Infusion (Week <6)||4
8582425|NCT00220727|9615966|FG000|COMPLETED|Second Infusion (Week <6)||3
8582426|NCT00220727|9615967|FG001|COMPLETED|Second Infusion (Week <6)||4
8582427|NCT00220727|9615966|FG000|NOT COMPLETED|Second Infusion (Week <6)||1
8582428|NCT00220727|9615967|FG001|NOT COMPLETED|Second Infusion (Week <6)||0
8582429|NCT00220740|9615977|FG000|STARTED|Efficacy Period||59
8582430|NCT00220740|9615978|FG001|STARTED|Efficacy Period||58
8582431|NCT00220740|9615977|FG000|COMPLETED|Efficacy Period||33
8582432|NCT00220740|9615978|FG001|COMPLETED|Efficacy Period||12
8582433|NCT00220740|9615977|FG000|NOT COMPLETED|Efficacy Period||26
8582434|NCT00220740|9615978|FG001|NOT COMPLETED|Efficacy Period||46
8582435|NCT00220740|9615977|FG000|STARTED|Rescue Treatment|Only the subjects who failed the treatment in the Efficacy period entered the Rescue period.|45
8582436|NCT00220740|9615978|FG001|STARTED|Rescue Treatment|Only the subjects who failed the treatment in the Efficacy period entered the Rescue period.|23
8582437|NCT00220740|9615977|FG000|COMPLETED|Rescue Treatment||26
8582438|NCT00220740|9615978|FG001|COMPLETED|Rescue Treatment||5
8582439|NCT00220740|9615977|FG000|NOT COMPLETED|Rescue Treatment||19
8582440|NCT00220740|9615978|FG001|NOT COMPLETED|Rescue Treatment||18
8582441|NCT00220740|9615977|FG000|STARTED|Withdrawal Period|The subjects who were success in Efficacy or Rescue Period were re-randomized to Withdrawal period.|43
8582442|NCT00220740|9615978|FG001|STARTED|Withdrawal Period|The subjects who were success in Efficacy or Rescue Period were re-randomized to Withdrawal period.|31
8582443|NCT00220740|9615977|FG000|COMPLETED|Withdrawal Period||37
8582444|NCT00220740|9615978|FG001|COMPLETED|Withdrawal Period||16
8582445|NCT00220740|9615977|FG000|NOT COMPLETED|Withdrawal Period||6
8582446|NCT00220740|9615978|FG001|NOT COMPLETED|Withdrawal Period||15
8582447|NCT00220779|9615989|FG000|STARTED|Overall Study||45
8582448|NCT00220779|9615990|FG001|STARTED|Overall Study||42
8582449|NCT00220779|9615991|FG002|STARTED|Overall Study||41
8582450|NCT00220779|9615989|FG000|COMPLETED|Overall Study||38
8582451|NCT00220779|9615990|FG001|COMPLETED|Overall Study||38
8582452|NCT00220779|9615991|FG002|COMPLETED|Overall Study||37
8582453|NCT00220779|9615989|FG000|NOT COMPLETED|Overall Study||7
8582454|NCT00220779|9615990|FG001|NOT COMPLETED|Overall Study||4
8582455|NCT00220779|9615991|FG002|NOT COMPLETED|Overall Study||4
8582456|NCT00220805|9616001|FG000|STARTED|Overall Study||30
8582457|NCT00220805|9616002|FG001|STARTED|Overall Study||27
8582458|NCT00220805|9616001|FG000|COMPLETED|Overall Study||22
8582459|NCT00220805|9616002|FG001|COMPLETED|Overall Study||16
8582460|NCT00220805|9616001|FG000|NOT COMPLETED|Overall Study||8
8582461|NCT00220805|9616002|FG001|NOT COMPLETED|Overall Study||11
8582462|NCT00220961|9616010|FG000|STARTED|Overall Study||299
8582463|NCT00220961|9616011|FG001|STARTED|Overall Study||303
8582464|NCT00220961|9616010|FG000|COMPLETED|Overall Study||228
8582465|NCT00220961|9616011|FG001|COMPLETED|Overall Study||213
8582466|NCT00220961|9616010|FG000|NOT COMPLETED|Overall Study||71
8582467|NCT00220961|9616011|FG001|NOT COMPLETED|Overall Study||90
8582468|NCT00221104|9616019|FG000|STARTED|Overall Study||793
8582469|NCT00221104|9616020|FG001|STARTED|Overall Study||785
8582470|NCT00221104|9616019|FG000|COMPLETED|Overall Study||710
8582471|NCT00221104|9616020|FG001|COMPLETED|Overall Study||709
8582472|NCT00221104|9616019|FG000|NOT COMPLETED|Overall Study||83
8582473|NCT00221104|9616020|FG001|NOT COMPLETED|Overall Study||76
8582474|NCT00221117|9616030|FG000|STARTED|Overall Study||12
8582475|NCT00221117|9616031|FG001|STARTED|Overall Study|One participant dropped out of the study after signing consent but prior to baseline assessments.|9
8582476|NCT00221117|9616030|FG000|COMPLETED|Overall Study||12
8582477|NCT00221117|9616031|FG001|COMPLETED|Overall Study||9
8582478|NCT00221117|9616030|FG000|NOT COMPLETED|Overall Study||0
8582479|NCT00221117|9616031|FG001|NOT COMPLETED|Overall Study||0
8582480|NCT00221195|9616041|FG000|STARTED|Therapy 1 (Months 1-6)||17
8582481|NCT00221195|9616042|FG001|STARTED|Therapy 1 (Months 1-6)||17
8582482|NCT00221195|9616041|FG000|COMPLETED|Therapy 1 (Months 1-6)||14
8582483|NCT00221195|9616042|FG001|COMPLETED|Therapy 1 (Months 1-6)||15
8582484|NCT00221195|9616041|FG000|NOT COMPLETED|Therapy 1 (Months 1-6)||3
8582485|NCT00221195|9616042|FG001|NOT COMPLETED|Therapy 1 (Months 1-6)||2
8582486|NCT00221195|9616041|FG000|STARTED|Washout Period (Months 7-9)||14
8582487|NCT00221195|9616042|FG001|STARTED|Washout Period (Months 7-9)||15
8582488|NCT00221195|9616041|FG000|COMPLETED|Washout Period (Months 7-9)||14
8582489|NCT00221195|9616042|FG001|COMPLETED|Washout Period (Months 7-9)||14
8582490|NCT00221195|9616041|FG000|NOT COMPLETED|Washout Period (Months 7-9)||0
8582491|NCT00221195|9616042|FG001|NOT COMPLETED|Washout Period (Months 7-9)||1
8582492|NCT00221195|9616041|FG000|STARTED|Therapy 2 (Months 10-15)||14
8582493|NCT00221195|9616042|FG001|STARTED|Therapy 2 (Months 10-15)||14
8582494|NCT00221195|9616041|FG000|COMPLETED|Therapy 2 (Months 10-15)||12
8582495|NCT00221195|9616042|FG001|COMPLETED|Therapy 2 (Months 10-15)||14
8582496|NCT00221195|9616041|FG000|NOT COMPLETED|Therapy 2 (Months 10-15)||2
8582497|NCT00221195|9616042|FG001|NOT COMPLETED|Therapy 2 (Months 10-15)||0
8582498|NCT00221299|9616052|FG000|STARTED|Overall Study||11
8582499|NCT00221299|9616053|FG001|STARTED|Overall Study||13
8582500|NCT00221299|9616054|FG002|STARTED|Overall Study||14
8582501|NCT00221299|9616055|FG003|STARTED|Overall Study||11
8582502|NCT00221299|9616052|FG000|COMPLETED|Overall Study||10
8582503|NCT00221299|9616053|FG001|COMPLETED|Overall Study||11
8582504|NCT00221299|9616054|FG002|COMPLETED|Overall Study||14
8582505|NCT00221299|9616055|FG003|COMPLETED|Overall Study||10
8582506|NCT00221299|9616052|FG000|NOT COMPLETED|Overall Study||1
8582507|NCT00221299|9616053|FG001|NOT COMPLETED|Overall Study||2
8582508|NCT00221299|9616054|FG002|NOT COMPLETED|Overall Study||0
8582509|NCT00221299|9616055|FG003|NOT COMPLETED|Overall Study||1
8582510|NCT00221338|9616065|FG000|STARTED|Overall Study||374
8582511|NCT00221338|9616066|FG001|STARTED|Overall Study||376
8582512|NCT00221338|9616065|FG000|COMPLETED|Overall Study||350
8582513|NCT00221338|9616066|FG001|COMPLETED|Overall Study||347
8582514|NCT00221338|9616065|FG000|NOT COMPLETED|Overall Study||24
8582515|NCT00221338|9616066|FG001|NOT COMPLETED|Overall Study||29
8582516|NCT00221403|9616075|FG000|STARTED|Overall Study||18
8582517|NCT00221403|9616076|FG001|STARTED|Overall Study||21
8582518|NCT00221403|9616077|FG002|STARTED|Overall Study||7
8582519|NCT00221403|9616075|FG000|COMPLETED|Overall Study||16
8582520|NCT00221403|9616076|FG001|COMPLETED|Overall Study||16
8582521|NCT00221403|9616077|FG002|COMPLETED|Overall Study||7
8582522|NCT00221403|9616075|FG000|NOT COMPLETED|Overall Study||2
8582523|NCT00221403|9616076|FG001|NOT COMPLETED|Overall Study||5
8582524|NCT00221403|9616077|FG002|NOT COMPLETED|Overall Study||0
8582525|NCT00222105|9616085|FG000|STARTED|Overall Study||25
8582526|NCT00222105|9616085|FG000|COMPLETED|Overall Study||11
8582527|NCT00222105|9616085|FG000|NOT COMPLETED|Overall Study||14
8582528|NCT00222131|9616091|FG000|STARTED|Overall Study||38
8582529|NCT00222131|9616092|FG001|STARTED|Overall Study||35
8582530|NCT00222131|9616091|FG000|COMPLETED|Overall Study||38
8582531|NCT00222131|9616092|FG001|COMPLETED|Overall Study||35
8582532|NCT00222131|9616091|FG000|NOT COMPLETED|Overall Study||0
8582533|NCT00222131|9616092|FG001|NOT COMPLETED|Overall Study||0
8582534|NCT00222729|9616098|FG000|STARTED|Overall Study||40
8582535|NCT00222729|9616098|FG000|COMPLETED|Overall Study||37
8582536|NCT00222729|9616098|FG000|NOT COMPLETED|Overall Study||3
8582537|NCT00223080|9616104|FG000|STARTED|Overall Study||8197
8582538|NCT00223080|9616105|FG001|STARTED|Overall Study||8198
8582539|NCT00223080|9616104|FG000|COMPLETED|Overall Study||7401
8582540|NCT00223080|9616105|FG001|COMPLETED|Overall Study||7401
8582541|NCT00223080|9616104|FG000|NOT COMPLETED|Overall Study||796
8582542|NCT00223080|9616105|FG001|NOT COMPLETED|Overall Study||797
8582543|NCT00223236|9616113|FG000|STARTED|Overall Study|23 completed baseline assessment but 16 completed at least one treatment visit.|16
8582544|NCT00223236|9616114|FG001|STARTED|Overall Study|21 completed baseline assessment but 18 completed at least one treatment visit.|18
8582545|NCT00223236|9616113|FG000|COMPLETED|Overall Study|9 completed 12 week trial.|9
8582546|NCT00223236|9616114|FG001|COMPLETED|Overall Study|4 completed 12 week trial.|4
8582547|NCT00223236|9616113|FG000|NOT COMPLETED|Overall Study||7
8582548|NCT00223236|9616114|FG001|NOT COMPLETED|Overall Study||14
8582549|NCT00223262|9616122|FG000|STARTED|Overall Study||16
8582550|NCT00223262|9616123|FG001|STARTED|Overall Study||12
8582551|NCT00223262|9616122|FG000|COMPLETED|Overall Study||8
8582552|NCT00223262|9616123|FG001|COMPLETED|Overall Study||11
8582553|NCT00223262|9616122|FG000|NOT COMPLETED|Overall Study||8
8582554|NCT00223262|9616123|FG001|NOT COMPLETED|Overall Study||1
8582555|NCT00223496|9616129|FG000|STARTED|Overall Study|32 people consented, 19 were baselined|32
8582556|NCT00223496|9616129|FG000|COMPLETED|Overall Study||10
8582557|NCT00223496|9616129|FG000|NOT COMPLETED|Overall Study||22
8582558|NCT00223652|9616135|FG000|STARTED|T-CBT 12 Weeks, TAU 20 Weeks||41
8582559|NCT00223652|9616136|FG001|STARTED|T-CBT 12 Weeks, TAU 20 Weeks||44
8582560|NCT00223652|9616135|FG000|COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||40
8582561|NCT00223652|9616136|FG001|COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||41
8582562|NCT00223652|9616135|FG000|NOT COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||1
8582563|NCT00223652|9616136|FG001|NOT COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||3
8582564|NCT00223652|9616135|FG000|STARTED|T-CBT 20 Weeks, TAU 20 Weeks||40
8582565|NCT00223652|9616136|FG001|STARTED|T-CBT 20 Weeks, TAU 20 Weeks||41
8582566|NCT00223652|9616135|FG000|COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||40
8582567|NCT00223652|9616136|FG001|COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||41
8582568|NCT00223652|9616135|FG000|NOT COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||0
8582569|NCT00223652|9616136|FG001|NOT COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||0
8582570|NCT00223652|9616135|FG000|STARTED|T-CBT and TAU 6 Month Follow-up||40
8582571|NCT00223652|9616136|FG001|STARTED|T-CBT and TAU 6 Month Follow-up||41
8582572|NCT00223652|9616135|FG000|COMPLETED|T-CBT and TAU 6 Month Follow-up||39
8582573|NCT00223652|9616136|FG001|COMPLETED|T-CBT and TAU 6 Month Follow-up||37
8582574|NCT00223652|9616135|FG000|NOT COMPLETED|T-CBT and TAU 6 Month Follow-up||1
8582575|NCT00223652|9616136|FG001|NOT COMPLETED|T-CBT and TAU 6 Month Follow-up||4
8582576|NCT00223665|9616143|FG000|STARTED|Overall Study||102
8582577|NCT00223665|9616143|FG000|COMPLETED|Overall Study||102
8582578|NCT00223665|9616143|FG000|NOT COMPLETED|Overall Study||0
8709855|NCT00955357|9756135|FG000|NOT COMPLETED|Titration Phase||16
8709856|NCT00955357|9756136|FG001|NOT COMPLETED|Titration Phase||66
8709857|NCT00955357|9756135|FG000|STARTED|Maintenance Phase||80
8709858|NCT00955357|9756136|FG001|STARTED|Maintenance Phase||294
8709859|NCT00955357|9756135|FG000|COMPLETED|Maintenance Phase||68
8582579|NCT00223678|9616150|FG000|STARTED|Overall Study||13
8582580|NCT00223678|9616151|FG001|STARTED|Overall Study||7
8582581|NCT00223678|9616150|FG000|COMPLETED|Overall Study||13
8582582|NCT00223678|9616151|FG001|COMPLETED|Overall Study||7
8582583|NCT00223678|9616150|FG000|NOT COMPLETED|Overall Study||0
8582584|NCT00223678|9616151|FG001|NOT COMPLETED|Overall Study||0
8582585|NCT00223704|9616160|FG000|STARTED|Overall Study||38
8582586|NCT00223704|9616161|FG001|STARTED|Overall Study||37
8582587|NCT00223704|9616162|FG002|STARTED|Overall Study||40
8582588|NCT00223704|9616160|FG000|COMPLETED|Overall Study||38
8582589|NCT00223704|9616161|FG001|COMPLETED|Overall Study||37
8582590|NCT00223704|9616162|FG002|COMPLETED|Overall Study||40
8582591|NCT00223704|9616160|FG000|NOT COMPLETED|Overall Study||0
8582592|NCT00223704|9616161|FG001|NOT COMPLETED|Overall Study||0
8582593|NCT00223704|9616162|FG002|NOT COMPLETED|Overall Study||0
8582594|NCT00223795|9616170|FG000|STARTED|First Intervention - Eight Weeks||26
8582595|NCT00223795|9616171|FG001|STARTED|First Intervention - Eight Weeks||27
8582596|NCT00223795|9616170|FG000|COMPLETED|First Intervention - Eight Weeks||19
8582597|NCT00223795|9616171|FG001|COMPLETED|First Intervention - Eight Weeks||18
8582598|NCT00223795|9616170|FG000|NOT COMPLETED|First Intervention - Eight Weeks||7
8582599|NCT00223795|9616171|FG001|NOT COMPLETED|First Intervention - Eight Weeks||9
8582600|NCT00223795|9616170|FG000|STARTED|Second Intervention - All Use Canes 4 mo||19
8582601|NCT00223795|9616171|FG001|STARTED|Second Intervention - All Use Canes 4 mo||18
8582602|NCT00223795|9616170|FG000|COMPLETED|Second Intervention - All Use Canes 4 mo||18
8582603|NCT00223795|9616171|FG001|COMPLETED|Second Intervention - All Use Canes 4 mo||17
8582604|NCT00223795|9616170|FG000|NOT COMPLETED|Second Intervention - All Use Canes 4 mo||1
8582605|NCT00223795|9616171|FG001|NOT COMPLETED|Second Intervention - All Use Canes 4 mo||1
8582606|NCT00223808|9616181|FG000|STARTED|Overall Study||22
8582607|NCT00223808|9616182|FG001|STARTED|Overall Study||22
8582608|NCT00223808|9616183|FG002|STARTED|Overall Study||23
8582609|NCT00223808|9616181|FG000|COMPLETED|Overall Study|Completed at least the immediate post-treatment testing with 5 or more hours of treatment.|19
8582610|NCT00223808|9616182|FG001|COMPLETED|Overall Study|Completed at least the immediate post-treatment testing with 5 or more hours of treatment.|17
8582611|NCT00223808|9616183|FG002|COMPLETED|Overall Study|Completed at least the immediate post-treatment testing with 5 or more hours of treatment.|18
8582612|NCT00223808|9616181|FG000|NOT COMPLETED|Overall Study||3
8582613|NCT00223808|9616182|FG001|NOT COMPLETED|Overall Study||5
8582614|NCT00223808|9616183|FG002|NOT COMPLETED|Overall Study||5
8582615|NCT00223821|9616193|FG000|STARTED|Overall Study||32
8582616|NCT00223821|9616194|FG001|STARTED|Overall Study||32
8582617|NCT00223821|9616193|FG000|Completed Therapy|Overall Study||31
8582618|NCT00223821|9616194|FG001|Completed Therapy|Overall Study||28
8582619|NCT00223821|9616193|FG000|Completed Post-treatment Assessment|Overall Study||31
8582620|NCT00223821|9616194|FG001|Completed Post-treatment Assessment|Overall Study||27
8582621|NCT00223821|9616193|FG000|Completed 6-month Follow-up|Overall Study||28
8582622|NCT00223821|9616194|FG001|Completed 6-month Follow-up|Overall Study||25
8582623|NCT00223821|9616193|FG000|COMPLETED|Overall Study||28
8582624|NCT00223821|9616194|FG001|COMPLETED|Overall Study||22
8582625|NCT00223821|9616193|FG000|NOT COMPLETED|Overall Study||4
8582626|NCT00223821|9616194|FG001|NOT COMPLETED|Overall Study||10
8627659|NCT00519376|9667173|FG003|COMPLETED|Washout Period 2||2
8627660|NCT00519376|9667174|FG004|COMPLETED|Washout Period 2||1
8627661|NCT00519376|9667175|FG005|COMPLETED|Washout Period 2||1
8627662|NCT00519376|9667176|FG006|COMPLETED|Washout Period 2||1
8627663|NCT00519376|9667177|FG007|COMPLETED|Washout Period 2||1
8627664|NCT00519376|9667178|FG008|COMPLETED|Washout Period 2||1
8627665|NCT00519376|9667179|FG009|COMPLETED|Washout Period 2||1
8627666|NCT00519376|9667180|FG010|COMPLETED|Washout Period 2||1
8627667|NCT00519376|9667181|FG011|COMPLETED|Washout Period 2||1
8627668|NCT00519376|9667182|FG012|COMPLETED|Washout Period 2||0
8627669|NCT00519376|9667183|FG013|COMPLETED|Washout Period 2||1
8627670|NCT00519376|9667184|FG014|COMPLETED|Washout Period 2||1
8627671|NCT00519376|9667185|FG015|COMPLETED|Washout Period 2||1
8627672|NCT00519376|9667170|FG000|NOT COMPLETED|Washout Period 2||0
8627673|NCT00519376|9667171|FG001|NOT COMPLETED|Washout Period 2||0
8627674|NCT00519376|9667172|FG002|NOT COMPLETED|Washout Period 2||0
8627675|NCT00519376|9667173|FG003|NOT COMPLETED|Washout Period 2||0
8627676|NCT00519376|9667174|FG004|NOT COMPLETED|Washout Period 2||0
8627677|NCT00519376|9667175|FG005|NOT COMPLETED|Washout Period 2||0
8627678|NCT00519376|9667176|FG006|NOT COMPLETED|Washout Period 2||0
8627679|NCT00519376|9667177|FG007|NOT COMPLETED|Washout Period 2||0
8627680|NCT00519376|9667178|FG008|NOT COMPLETED|Washout Period 2||0
8709860|NCT00955357|9756136|FG001|COMPLETED|Maintenance Phase||249
8709861|NCT00955357|9756135|FG000|NOT COMPLETED|Maintenance Phase||12
8582627|NCT00223977|9616203|FG000|STARTED|Overall Study||46
8582628|NCT00223977|9616204|FG001|STARTED|Overall Study||58
8582629|NCT00223977|9616205|FG002|STARTED|Overall Study||42
8582630|NCT00223977|9616203|FG000|COMPLETED|Overall Study||37
8582631|NCT00223977|9616204|FG001|COMPLETED|Overall Study||47
8582632|NCT00223977|9616205|FG002|COMPLETED|Overall Study||39
8582633|NCT00223977|9616203|FG000|NOT COMPLETED|Overall Study||9
8582634|NCT00223977|9616204|FG001|NOT COMPLETED|Overall Study||11
8582635|NCT00223977|9616205|FG002|NOT COMPLETED|Overall Study||3
8582636|NCT00223990|9616215|FG000|STARTED|Overall Study||200
8582637|NCT00223990|9616216|FG001|STARTED|Overall Study||200
8582638|NCT00223990|9616215|FG000|COMPLETED|Overall Study||193
8582639|NCT00223990|9616216|FG001|COMPLETED|Overall Study||191
8582640|NCT00223990|9616215|FG000|NOT COMPLETED|Overall Study||7
8582641|NCT00223990|9616216|FG001|NOT COMPLETED|Overall Study||9
8582642|NCT00224016|9616224|FG000|STARTED|Titration Period||39
8582643|NCT00224016|9616225|FG001|STARTED|Titration Period||16
8582644|NCT00224016|9616224|FG000|COMPLETED|Titration Period||38
8582645|NCT00224016|9616225|FG001|COMPLETED|Titration Period||15
8582646|NCT00224016|9616224|FG000|NOT COMPLETED|Titration Period||1
8582647|NCT00224016|9616225|FG001|NOT COMPLETED|Titration Period||1
8582648|NCT00224016|9616224|FG000|STARTED|Maintenance Period||38
8582649|NCT00224016|9616225|FG001|STARTED|Maintenance Period||15
8582650|NCT00224016|9616224|FG000|COMPLETED|Maintenance Period||36
8582651|NCT00224016|9616225|FG001|COMPLETED|Maintenance Period||14
8582652|NCT00224016|9616224|FG000|NOT COMPLETED|Maintenance Period||2
8582653|NCT00224016|9616225|FG001|NOT COMPLETED|Maintenance Period||1
8582654|NCT00224016|9616224|FG000|STARTED|Follow-Up Period||35
8582655|NCT00224016|9616225|FG001|STARTED|Follow-Up Period|This group of subjects did not proceed to follow-up period.|0
8582656|NCT00224016|9616224|FG000|COMPLETED|Follow-Up Period||35
8582657|NCT00224016|9616225|FG001|COMPLETED|Follow-Up Period||0
8582658|NCT00224016|9616224|FG000|NOT COMPLETED|Follow-Up Period||0
8582659|NCT00224016|9616225|FG001|NOT COMPLETED|Follow-Up Period||0
8582660|NCT00224029|9616231|FG000|STARTED|Overall Study||24
8582661|NCT00224029|9616231|FG000|COMPLETED|Overall Study||18
8582662|NCT00224029|9616231|FG000|NOT COMPLETED|Overall Study||6
8582663|NCT00224042|9616237|FG000|STARTED|Overall Study||26
8582664|NCT00224042|9616238|FG001|STARTED|Overall Study||26
8582665|NCT00224042|9616237|FG000|COMPLETED|Overall Study||20
8582666|NCT00224042|9616238|FG001|COMPLETED|Overall Study||20
8582667|NCT00224042|9616237|FG000|NOT COMPLETED|Overall Study||6
8582668|NCT00224042|9616238|FG001|NOT COMPLETED|Overall Study||6
8582669|NCT00224055|9616246|FG000|STARTED|Overall Study||44
8582670|NCT00224055|9616247|FG001|STARTED|Overall Study||45
8582671|NCT00224055|9616246|FG000|COMPLETED|Overall Study||29
8582672|NCT00224055|9616247|FG001|COMPLETED|Overall Study||31
8582673|NCT00224055|9616246|FG000|NOT COMPLETED|Overall Study||15
8582674|NCT00224055|9616247|FG001|NOT COMPLETED|Overall Study||14
8582675|NCT00224107|9616255|FG000|STARTED|Overall Study||233
8582676|NCT00224107|9616256|FG001|STARTED|Overall Study||228
8582677|NCT00224107|9616255|FG000|COMPLETED|Overall Study||202
8582678|NCT00224107|9616256|FG001|COMPLETED|Overall Study||214
8582679|NCT00224107|9616255|FG000|NOT COMPLETED|Overall Study||31
8582680|NCT00224107|9616256|FG001|NOT COMPLETED|Overall Study||14
8582681|NCT00224120|9616264|FG000|STARTED|Overall Study||233
8582682|NCT00224120|9616265|FG001|STARTED|Overall Study||229
8582683|NCT00224120|9616264|FG000|COMPLETED|Overall Study||211
8582684|NCT00224120|9616265|FG001|COMPLETED|Overall Study||205
8582685|NCT00224120|9616264|FG000|NOT COMPLETED|Overall Study||22
8582686|NCT00224120|9616265|FG001|NOT COMPLETED|Overall Study||24
8582687|NCT00224133|9616271|FG000|STARTED|Overall Study||661
8582688|NCT00224133|9616271|FG000|COMPLETED|Overall Study||435
8582689|NCT00224133|9616271|FG000|NOT COMPLETED|Overall Study||226
8582690|NCT00224289|9616275|FG000|STARTED|Overall Study||17
8582691|NCT00224289|9616275|FG000|COMPLETED|Overall Study||17
8582692|NCT00224289|9616275|FG000|NOT COMPLETED|Overall Study||0
8582693|NCT00224484|9616282|FG000|STARTED|Overall Study||2977
8582694|NCT00224484|9616283|FG001|STARTED|Overall Study||1491
8582695|NCT00224484|9616284|FG002|STARTED|Overall Study||1487
8582696|NCT00224484|9616282|FG000|COMPLETED|Overall Study||2831
8582697|NCT00224484|9616283|FG001|COMPLETED|Overall Study||1426
8582698|NCT00224484|9616284|FG002|COMPLETED|Overall Study||1425
8582699|NCT00224484|9616282|FG000|NOT COMPLETED|Overall Study||146
8582700|NCT00224484|9616283|FG001|NOT COMPLETED|Overall Study||65
8582701|NCT00224484|9616284|FG002|NOT COMPLETED|Overall Study||62
8582702|NCT00224770|9616298|FG000|STARTED|Overall Study||42
8582703|NCT00224770|9616299|FG001|STARTED|Overall Study||54
8582704|NCT00224770|9616300|FG002|STARTED|Overall Study||14
8582705|NCT00224770|9616298|FG000|COMPLETED|Overall Study||38
8582706|NCT00224770|9616299|FG001|COMPLETED|Overall Study||52
8582707|NCT00224770|9616300|FG002|COMPLETED|Overall Study||14
8582708|NCT00224770|9616298|FG000|NOT COMPLETED|Overall Study||4
8582709|NCT00224770|9616299|FG001|NOT COMPLETED|Overall Study||2
8582710|NCT00224770|9616300|FG002|NOT COMPLETED|Overall Study||0
8582711|NCT00224874|9616313|FG000|STARTED|Overall Study||46
8582712|NCT00224874|9616314|FG001|STARTED|Overall Study||45
8582713|NCT00224874|9616315|FG002|STARTED|Overall Study||47
8582714|NCT00224874|9616316|FG003|STARTED|Overall Study||42
8582715|NCT00224874|9616313|FG000|COMPLETED|Overall Study||46
8582716|NCT00224874|9616314|FG001|COMPLETED|Overall Study||45
8582717|NCT00224874|9616315|FG002|COMPLETED|Overall Study||46
8582718|NCT00224874|9616316|FG003|COMPLETED|Overall Study||42
8582719|NCT00224874|9616313|FG000|NOT COMPLETED|Overall Study||0
8582720|NCT00224874|9616314|FG001|NOT COMPLETED|Overall Study||0
8582721|NCT00224874|9616315|FG002|NOT COMPLETED|Overall Study||1
8582722|NCT00224874|9616316|FG003|NOT COMPLETED|Overall Study||0
8582723|NCT00224887|9616328|FG000|STARTED|Overall Study||154
8582724|NCT00224887|9616329|FG001|STARTED|Overall Study||153
8582725|NCT00224887|9616328|FG000|COMPLETED|Overall Study||148
8582726|NCT00224887|9616329|FG001|COMPLETED|Overall Study||147
8582727|NCT00224887|9616328|FG000|NOT COMPLETED|Overall Study||6
8582728|NCT00224887|9616329|FG001|NOT COMPLETED|Overall Study||6
8582729|NCT00224952|9616338|FG000|STARTED|Overall Study||53
8582730|NCT00224952|9616339|FG001|STARTED|Overall Study||87
8582731|NCT00224952|9616340|FG002|STARTED|Overall Study||134
8582732|NCT00224952|9616338|FG000|COMPLETED|Overall Study||53
8582733|NCT00224952|9616339|FG001|COMPLETED|Overall Study||87
8582734|NCT00224952|9616340|FG002|COMPLETED|Overall Study||134
8582735|NCT00224952|9616338|FG000|NOT COMPLETED|Overall Study||0
8582736|NCT00224952|9616339|FG001|NOT COMPLETED|Overall Study||0
8582737|NCT00224952|9616340|FG002|NOT COMPLETED|Overall Study||0
8582738|NCT00225017|9616351|FG000|STARTED|Overall Study||26
8582739|NCT00225017|9616352|FG001|STARTED|Overall Study||24
8582740|NCT00225017|9616351|FG000|COMPLETED|Overall Study||26
8582741|NCT00225017|9616352|FG001|COMPLETED|Overall Study|1 subject did not complete week 24 assessments|23
8582742|NCT00225017|9616351|FG000|NOT COMPLETED|Overall Study||0
8582743|NCT00225017|9616352|FG001|NOT COMPLETED|Overall Study||1
8582744|NCT00225147|9616362|FG000|STARTED|Double-blind Phase||13
8582745|NCT00225147|9616363|FG001|STARTED|Double-blind Phase||12
8582746|NCT00225147|9616364|FG002|STARTED|Double-blind Phase||13
8582747|NCT00225147|9616365|FG003|STARTED|Double-blind Phase||0
8582748|NCT00225147|9616362|FG000|COMPLETED|Double-blind Phase||13
8582749|NCT00225147|9616363|FG001|COMPLETED|Double-blind Phase||12
8582750|NCT00225147|9616364|FG002|COMPLETED|Double-blind Phase||13
8582751|NCT00225147|9616365|FG003|COMPLETED|Double-blind Phase||0
8582752|NCT00225147|9616362|FG000|NOT COMPLETED|Double-blind Phase||0
8582753|NCT00225147|9616363|FG001|NOT COMPLETED|Double-blind Phase||0
8582754|NCT00225147|9616364|FG002|NOT COMPLETED|Double-blind Phase||0
8582755|NCT00225147|9616365|FG003|NOT COMPLETED|Double-blind Phase||0
8582756|NCT00225147|9616362|FG000|STARTED|Open-label Phase||0
8582757|NCT00225147|9616363|FG001|STARTED|Open-label Phase||0
8582758|NCT00225147|9616364|FG002|STARTED|Open-label Phase||0
8582759|NCT00225147|9616365|FG003|STARTED|Open-label Phase||62
8582760|NCT00225147|9616362|FG000|COMPLETED|Open-label Phase||0
8582761|NCT00225147|9616363|FG001|COMPLETED|Open-label Phase||0
8582762|NCT00225147|9616364|FG002|COMPLETED|Open-label Phase||0
8582763|NCT00225147|9616365|FG003|COMPLETED|Open-label Phase||52
8582764|NCT00225147|9616362|FG000|NOT COMPLETED|Open-label Phase||0
8582765|NCT00225147|9616363|FG001|NOT COMPLETED|Open-label Phase||0
8582766|NCT00225147|9616364|FG002|NOT COMPLETED|Open-label Phase||0
8582767|NCT00225147|9616365|FG003|NOT COMPLETED|Open-label Phase||10
8582768|NCT00225212|9616377|FG000|STARTED|Overall Study||35
8582769|NCT00225212|9616377|FG000|COMPLETED|Overall Study||29
8582770|NCT00225212|9616377|FG000|NOT COMPLETED|Overall Study||6
8582771|NCT00225251|9616383|FG000|STARTED|Overall Study||11
8582772|NCT00225251|9616384|FG001|STARTED|Overall Study||7
8582773|NCT00225251|9616383|FG000|COMPLETED|Overall Study||10
8582774|NCT00225251|9616384|FG001|COMPLETED|Overall Study||6
8582775|NCT00225251|9616383|FG000|NOT COMPLETED|Overall Study||1
8582776|NCT00225251|9616384|FG001|NOT COMPLETED|Overall Study||1
8582777|NCT00225277|9616392|FG000|STARTED|Overall Study|274 subjects randomized, but four subjects did not receive drug.|274
8582778|NCT00225277|9616393|FG001|STARTED|Overall Study|Mean treatment durations were 56.3 weeks (glimepiride) and 56.5 weeks (pioglitazone).|273
8709862|NCT00955357|9756136|FG001|NOT COMPLETED|Maintenance Phase||45
8709863|NCT00955409|9756152|FG000|STARTED|Overall Study|Started=Randomized|21
8709864|NCT00955409|9756153|FG001|STARTED|Overall Study|Started=Randomized|6
8709865|NCT00955409|9756154|FG002|STARTED|Overall Study|Started=Randomized|41
8709866|NCT00955409|9756155|FG003|STARTED|Overall Study|Started=Randomized.|25
8709867|NCT00955409|9756156|FG004|STARTED|Overall Study|Started=Randomized|5
8709868|NCT00955409|9756157|FG005|STARTED|Overall Study|Started=Randomized|9
8709869|NCT00955409|9756158|FG006|STARTED|Overall Study|Started=Randomized|27
8709870|NCT00955409|9756159|FG007|STARTED|Overall Study|Started=Randomized|6
8582779|NCT00225277|9616392|FG000|COMPLETED|Overall Study||177
8582780|NCT00225277|9616393|FG001|COMPLETED|Overall Study||178
8582781|NCT00225277|9616392|FG000|NOT COMPLETED|Overall Study||97
8582782|NCT00225277|9616393|FG001|NOT COMPLETED|Overall Study||95
8582783|NCT00225420|9616399|FG000|STARTED|Overall Study||9
8582784|NCT00225420|9616400|FG001|STARTED|Overall Study||6
8582785|NCT00225420|9616401|FG002|STARTED|Overall Study||3
8582786|NCT00225420|9616399|FG000|COMPLETED|Overall Study||9
8582787|NCT00225420|9616400|FG001|COMPLETED|Overall Study||6
8582788|NCT00225420|9616401|FG002|COMPLETED|Overall Study||3
8582789|NCT00225420|9616399|FG000|NOT COMPLETED|Overall Study||0
8582790|NCT00225420|9616400|FG001|NOT COMPLETED|Overall Study||0
8582791|NCT00225420|9616401|FG002|NOT COMPLETED|Overall Study||0
8709871|NCT00955409|9756160|FG008|STARTED|Overall Study|Started=Randomized|16
8582792|NCT00225498|9616408|FG000|STARTED|Overall Study||10
8582793|NCT00225498|9616408|FG000|COMPLETED|Overall Study|The only analyses with adequate statistical power were of the 10 ziprasidone nonresponders.|10
8582794|NCT00225498|9616408|FG000|NOT COMPLETED|Overall Study||0
8582795|NCT00225732|9616414|FG000|STARTED|Overall Study||153
8582796|NCT00225732|9616415|FG001|STARTED|Overall Study||166
8582797|NCT00225732|9616414|FG000|COMPLETED|Overall Study||153
8582798|NCT00225732|9616415|FG001|COMPLETED|Overall Study||166
8582799|NCT00225732|9616414|FG000|NOT COMPLETED|Overall Study||0
8582800|NCT00225732|9616415|FG001|NOT COMPLETED|Overall Study||0
8582801|NCT00225758|9616421|FG000|STARTED|Overall Study||27
8582802|NCT00225758|9616421|FG000|COMPLETED|Overall Study||23
8582803|NCT00225758|9616421|FG000|NOT COMPLETED|Overall Study||4
8582804|NCT00225784|9616427|FG000|STARTED|Overall Study||37
8582805|NCT00225784|9616427|FG000|COMPLETED|Overall Study||33
8582806|NCT00225784|9616427|FG000|NOT COMPLETED|Overall Study||4
8582807|NCT00226239|9616434|FG000|STARTED|TPE, Induction Therapy||39
8709872|NCT00955409|9756161|FG009|STARTED|Overall Study|Started=Randomized|4
8709873|NCT00955409|9756152|FG000|Treated|Overall Study||21
8709874|NCT00955409|9756153|FG001|Treated|Overall Study||6
8709875|NCT00955409|9756154|FG002|Treated|Overall Study||41
8582808|NCT00226239|9616434|FG000|COMPLETED|TPE, Induction Therapy||37
8582809|NCT00226239|9616434|FG000|NOT COMPLETED|TPE, Induction Therapy||2
8582810|NCT00226239|9616434|FG000|STARTED|XPE, Definitive Therapy||37
8582811|NCT00226239|9616434|FG000|COMPLETED|XPE, Definitive Therapy||33
8582812|NCT00226239|9616434|FG000|NOT COMPLETED|XPE, Definitive Therapy||4
8582813|NCT00226239|9616434|FG000|STARTED|Maintenance Cetuximab||31
8582814|NCT00226239|9616434|FG000|COMPLETED|Maintenance Cetuximab||17
8582815|NCT00226239|9616434|FG000|NOT COMPLETED|Maintenance Cetuximab||14
8582816|NCT00226499|9616442|FG000|STARTED|Overall Study||2489
8582817|NCT00226499|9616443|FG001|STARTED|Overall Study||2487
8582818|NCT00226499|9616444|FG002|STARTED|Overall Study||827
8582819|NCT00226499|9616442|FG000|COMPLETED|Overall Study||1415
8582820|NCT00226499|9616443|FG001|COMPLETED|Overall Study||1415
8582821|NCT00226499|9616444|FG002|COMPLETED|Overall Study||468
8582822|NCT00226499|9616442|FG000|NOT COMPLETED|Overall Study||1074
8582823|NCT00226499|9616443|FG001|NOT COMPLETED|Overall Study||1072
8582824|NCT00226499|9616444|FG002|NOT COMPLETED|Overall Study||359
8582825|NCT00226577|9616454|FG000|STARTED|Overall Study||52
8582826|NCT00226577|9616454|FG000|COMPLETED|Overall Study||52
8582827|NCT00226577|9616454|FG000|NOT COMPLETED|Overall Study||0
8582828|NCT00226590|9616458|FG000|STARTED|Overall Study||39
8582829|NCT00226590|9616458|FG000|COMPLETED|Overall Study||39
8582830|NCT00226590|9616458|FG000|NOT COMPLETED|Overall Study||0
8582831|NCT00226655|9616463|FG000|STARTED|Overall Study||112
8582832|NCT00226655|9616463|FG000|COMPLETED|Overall Study||33
8582833|NCT00226655|9616463|FG000|NOT COMPLETED|Overall Study||79
8582834|NCT00226811|9616467|FG000|STARTED|Overall Study||78
8582835|NCT00226811|9616467|FG000|COMPLETED|Overall Study||2
8582836|NCT00226811|9616467|FG000|NOT COMPLETED|Overall Study||76
8582837|NCT00226941|9616475|FG000|STARTED|Overall Study||6
8582838|NCT00226941|9616476|FG001|STARTED|Overall Study||6
8582839|NCT00226941|9616477|FG002|STARTED|Overall Study||4
8582840|NCT00226941|9616478|FG003|STARTED|Overall Study||7
8582841|NCT00226941|9616475|FG000|COMPLETED|Overall Study||6
8582842|NCT00226941|9616476|FG001|COMPLETED|Overall Study||6
8582843|NCT00226941|9616477|FG002|COMPLETED|Overall Study||4
8582844|NCT00226941|9616478|FG003|COMPLETED|Overall Study||5
8582845|NCT00226941|9616475|FG000|NOT COMPLETED|Overall Study||0
8582846|NCT00226941|9616476|FG001|NOT COMPLETED|Overall Study||0
8582847|NCT00226941|9616477|FG002|NOT COMPLETED|Overall Study||0
8582848|NCT00226941|9616478|FG003|NOT COMPLETED|Overall Study||2
8582849|NCT00227019|9616494|FG000|STARTED|Overall Study||16
8582850|NCT00227019|9616494|FG000|COMPLETED|Overall Study||16
8582851|NCT00227019|9616494|FG000|NOT COMPLETED|Overall Study||0
8582852|NCT00227266|9616502|FG000|STARTED|Overall Study||31
8582853|NCT00227266|9616503|FG001|STARTED|Overall Study||30
8582854|NCT00227266|9616504|FG002|STARTED|Overall Study||33
8582855|NCT00227266|9616502|FG000|COMPLETED|Overall Study||30
8582856|NCT00227266|9616503|FG001|COMPLETED|Overall Study||30
8582857|NCT00227266|9616504|FG002|COMPLETED|Overall Study||29
8582858|NCT00227266|9616502|FG000|NOT COMPLETED|Overall Study||1
8582859|NCT00227266|9616503|FG001|NOT COMPLETED|Overall Study||0
8582860|NCT00227266|9616504|FG002|NOT COMPLETED|Overall Study||4
8582861|NCT00227305|9616515|FG000|STARTED|Overall Study|enrolled|381
8582862|NCT00227305|9616515|FG000|Drug Received|Overall Study|safety population|380
8582863|NCT00227305|9616515|FG000|COMPLETED|Overall Study|Completed 26 weeks|237
8582864|NCT00227305|9616515|FG000|NOT COMPLETED|Overall Study||144
8582865|NCT00227344|9616521|FG000|STARTED|Overall Study||87
8582866|NCT00227344|9616522|FG001|STARTED|Overall Study||42
8582867|NCT00227344|9616521|FG000|COMPLETED|Overall Study||75
8582868|NCT00227344|9616522|FG001|COMPLETED|Overall Study||37
8582869|NCT00227344|9616521|FG000|NOT COMPLETED|Overall Study||12
8582870|NCT00227344|9616522|FG001|NOT COMPLETED|Overall Study||5
8582871|NCT00227370|9616530|FG000|STARTED|Overall Study|Placebo Group|66
8582872|NCT00227370|9616531|FG001|STARTED|Overall Study|Treatment Group|70
8582873|NCT00227370|9616530|FG000|COMPLETED|Overall Study||45
8582874|NCT00227370|9616531|FG001|COMPLETED|Overall Study||46
8582875|NCT00227370|9616530|FG000|NOT COMPLETED|Overall Study||21
8582876|NCT00227370|9616531|FG001|NOT COMPLETED|Overall Study||24
8582877|NCT00227539|9616537|FG000|STARTED|Overall Study||25
8582878|NCT00227539|9616537|FG000|COMPLETED|Overall Study||24
8582879|NCT00227539|9616537|FG000|NOT COMPLETED|Overall Study||1
8582880|NCT00227591|9616541|FG000|STARTED|Overall Study|48 pts registered to the study|48
8582881|NCT00227591|9616541|FG000|Began Treatment|Overall Study||47
8582882|NCT00227591|9616541|FG000|COMPLETED|Overall Study||47
8582883|NCT00227591|9616541|FG000|NOT COMPLETED|Overall Study||1
8582884|NCT00227617|9616545|FG000|STARTED|Stage 1||22
8582885|NCT00227617|9616546|FG001|STARTED|Stage 1||12
8582886|NCT00227617|9616547|FG002|STARTED|Stage 1||2
8582887|NCT00227617|9616545|FG000|COMPLETED|Stage 1||22
8582888|NCT00227617|9616546|FG001|COMPLETED|Stage 1||12
8582889|NCT00227617|9616547|FG002|COMPLETED|Stage 1||2
8582890|NCT00227617|9616545|FG000|NOT COMPLETED|Stage 1||0
8582891|NCT00227617|9616546|FG001|NOT COMPLETED|Stage 1||0
8582892|NCT00227617|9616547|FG002|NOT COMPLETED|Stage 1||0
8582893|NCT00227617|9616545|FG000|STARTED|Stage 2||0
8582894|NCT00227617|9616546|FG001|STARTED|Stage 2||0
8582895|NCT00227617|9616547|FG002|STARTED|Stage 2||0
8582896|NCT00227617|9616545|FG000|COMPLETED|Stage 2||0
8582897|NCT00227617|9616546|FG001|COMPLETED|Stage 2||0
8582898|NCT00227617|9616547|FG002|COMPLETED|Stage 2||0
8582899|NCT00227617|9616545|FG000|NOT COMPLETED|Stage 2||0
8582900|NCT00227617|9616546|FG001|NOT COMPLETED|Stage 2||0
8582901|NCT00227617|9616547|FG002|NOT COMPLETED|Stage 2||0
8582902|NCT00227721|9616559|FG000|STARTED|Overall Study||30
8582903|NCT00227721|9616559|FG000|COMPLETED|Overall Study||29
8582904|NCT00227721|9616559|FG000|NOT COMPLETED|Overall Study||1
8582905|NCT00227760|9616563|FG000|STARTED|Overall Study||44
8582906|NCT00227760|9616563|FG000|COMPLETED|Overall Study||44
8582907|NCT00227760|9616563|FG000|NOT COMPLETED|Overall Study||0
8582908|NCT00227877|9616571|FG000|STARTED|Pre-visit Assessment||1075
8582909|NCT00227877|9616572|FG001|STARTED|Pre-visit Assessment||1031
8582910|NCT00227877|9616573|FG002|STARTED|Pre-visit Assessment||297
8582911|NCT00227877|9616574|FG003|STARTED|Pre-visit Assessment||292
8582912|NCT00227877|9616571|FG000|COMPLETED|Pre-visit Assessment|Final analysis sample|1068
8582913|NCT00227877|9616572|FG001|COMPLETED|Pre-visit Assessment|Final analysis sample|1028
8582914|NCT00227877|9616573|FG002|COMPLETED|Pre-visit Assessment|Final analysis sample|297
8582915|NCT00227877|9616574|FG003|COMPLETED|Pre-visit Assessment|Final analysis sample|292
8582916|NCT00227877|9616571|FG000|NOT COMPLETED|Pre-visit Assessment||7
8582917|NCT00227877|9616572|FG001|NOT COMPLETED|Pre-visit Assessment||3
8582918|NCT00227877|9616573|FG002|NOT COMPLETED|Pre-visit Assessment||0
8582919|NCT00227877|9616574|FG003|NOT COMPLETED|Pre-visit Assessment||0
8709876|NCT00955409|9756155|FG003|Treated|Overall Study||24
8709877|NCT00955409|9756156|FG004|Treated|Overall Study||5
8582920|NCT00227877|9616571|FG000|STARTED|Post-visit Checklist||1068
8582921|NCT00227877|9616572|FG001|STARTED|Post-visit Checklist||1028
8582922|NCT00227877|9616573|FG002|STARTED|Post-visit Checklist||297
8582923|NCT00227877|9616574|FG003|STARTED|Post-visit Checklist||292
8582924|NCT00227877|9616571|FG000|COMPLETED|Post-visit Checklist||1044
8582925|NCT00227877|9616572|FG001|COMPLETED|Post-visit Checklist||1015
8582926|NCT00227877|9616573|FG002|COMPLETED|Post-visit Checklist||296
8582927|NCT00227877|9616574|FG003|COMPLETED|Post-visit Checklist||292
8582928|NCT00227877|9616571|FG000|NOT COMPLETED|Post-visit Checklist||24
8582929|NCT00227877|9616572|FG001|NOT COMPLETED|Post-visit Checklist||13
8582930|NCT00227877|9616573|FG002|NOT COMPLETED|Post-visit Checklist||1
8582931|NCT00227877|9616574|FG003|NOT COMPLETED|Post-visit Checklist||0
8582932|NCT00227877|9616571|FG000|STARTED|3-months Follow-up||1068
8582933|NCT00227877|9616572|FG001|STARTED|3-months Follow-up||1028
8582934|NCT00227877|9616573|FG002|STARTED|3-months Follow-up||297
8582935|NCT00227877|9616574|FG003|STARTED|3-months Follow-up||292
8582936|NCT00227877|9616571|FG000|COMPLETED|3-months Follow-up||755
8582937|NCT00227877|9616572|FG001|COMPLETED|3-months Follow-up||761
8582938|NCT00227877|9616573|FG002|COMPLETED|3-months Follow-up||245
8582939|NCT00227877|9616574|FG003|COMPLETED|3-months Follow-up||271
8582940|NCT00227877|9616571|FG000|NOT COMPLETED|3-months Follow-up||313
8582941|NCT00227877|9616572|FG001|NOT COMPLETED|3-months Follow-up||267
8582942|NCT00227877|9616573|FG002|NOT COMPLETED|3-months Follow-up||52
8582943|NCT00227877|9616574|FG003|NOT COMPLETED|3-months Follow-up||21
8582944|NCT00227877|9616571|FG000|STARTED|12-months Follow-up||1068
8582945|NCT00227877|9616572|FG001|STARTED|12-months Follow-up||1028
8582946|NCT00227877|9616573|FG002|STARTED|12-months Follow-up||297
8582947|NCT00227877|9616574|FG003|STARTED|12-months Follow-up||292
8582948|NCT00227877|9616571|FG000|COMPLETED|12-months Follow-up||758
8582949|NCT00227877|9616572|FG001|COMPLETED|12-months Follow-up||765
8582950|NCT00227877|9616573|FG002|COMPLETED|12-months Follow-up||266
8582951|NCT00227877|9616574|FG003|COMPLETED|12-months Follow-up||266
8582952|NCT00227877|9616571|FG000|NOT COMPLETED|12-months Follow-up||310
8582953|NCT00227877|9616572|FG001|NOT COMPLETED|12-months Follow-up||263
8582954|NCT00227877|9616573|FG002|NOT COMPLETED|12-months Follow-up||31
8582955|NCT00227877|9616574|FG003|NOT COMPLETED|12-months Follow-up||26
8582956|NCT00227903|9616588|FG000|STARTED|Overall Study||91
8582957|NCT00227903|9616589|FG001|STARTED|Overall Study||92
8582958|NCT00227903|9616588|FG000|Received ≥ 1 Follow-up Assessment|Overall Study|1 participant did not receive any treatment sessions.|86
8582959|NCT00227903|9616589|FG001|Received ≥ 1 Follow-up Assessment|Overall Study|4 participants did not receive any treatment sessions.|82
8627681|NCT00519376|9667179|FG009|NOT COMPLETED|Washout Period 2||0
8627682|NCT00519376|9667180|FG010|NOT COMPLETED|Washout Period 2||0
8627683|NCT00519376|9667181|FG011|NOT COMPLETED|Washout Period 2||0
8627684|NCT00519376|9667182|FG012|NOT COMPLETED|Washout Period 2||0
8627685|NCT00519376|9667183|FG013|NOT COMPLETED|Washout Period 2||0
8627686|NCT00519376|9667184|FG014|NOT COMPLETED|Washout Period 2||0
8627687|NCT00519376|9667185|FG015|NOT COMPLETED|Washout Period 2||0
8627688|NCT00519376|9667170|FG000|STARTED|Treatment Period 3||2
8627689|NCT00519376|9667171|FG001|STARTED|Treatment Period 3||2
8582960|NCT00227903|9616588|FG000|COMPLETED|Overall Study|Participants with at least 1 follow-up assessment were analyzed|86
8582961|NCT00227903|9616589|FG001|COMPLETED|Overall Study|Participants with at least 1 follow-up assessment were analyzed|82
8582962|NCT00227903|9616588|FG000|NOT COMPLETED|Overall Study||5
8582963|NCT00227903|9616589|FG001|NOT COMPLETED|Overall Study||10
8582964|NCT00227994|9616597|FG000|STARTED|Overall Study||20
8582965|NCT00227994|9616598|FG001|STARTED|Overall Study||20
8582966|NCT00227994|9616597|FG000|COMPLETED|Overall Study||13
8582967|NCT00227994|9616598|FG001|COMPLETED|Overall Study||13
8582968|NCT00227994|9616597|FG000|NOT COMPLETED|Overall Study||7
8582969|NCT00227994|9616598|FG001|NOT COMPLETED|Overall Study||7
8582970|NCT00228384|9616606|FG000|STARTED|Overall Study||72
8582971|NCT00228384|9616607|FG001|STARTED|Overall Study||76
8582972|NCT00228384|9616606|FG000|Baseline|Overall Study||72
8582973|NCT00228384|9616607|FG001|Baseline|Overall Study||76
8582974|NCT00228384|9616606|FG000|30-Day Follow-up (Safety Outcome)|Overall Study||69
8582975|NCT00228384|9616607|FG001|30-Day Follow-up (Safety Outcome)|Overall Study||72
8582976|NCT00228384|9616606|FG000|Three Year Follow-up (Final)|Overall Study||43
8582977|NCT00228384|9616607|FG001|Three Year Follow-up (Final)|Overall Study||47
8582978|NCT00228384|9616606|FG000|COMPLETED|Overall Study||43
8582979|NCT00228384|9616607|FG001|COMPLETED|Overall Study||47
8582980|NCT00228384|9616606|FG000|NOT COMPLETED|Overall Study||29
8582981|NCT00228384|9616607|FG001|NOT COMPLETED|Overall Study||29
8582982|NCT00228423|9616615|FG000|STARTED|Overall Study||56
8582983|NCT00228423|9616616|FG001|STARTED|Overall Study||57
8582984|NCT00228423|9616615|FG000|COMPLETED|Overall Study||46
8582985|NCT00228423|9616616|FG001|COMPLETED|Overall Study||45
8582986|NCT00228423|9616615|FG000|NOT COMPLETED|Overall Study||10
8582987|NCT00228423|9616616|FG001|NOT COMPLETED|Overall Study||12
8582988|NCT00228553|9616622|FG000|STARTED|Overall Study||743
8582989|NCT00228553|9616622|FG000|COMPLETED|Overall Study||313
8582990|NCT00228553|9616622|FG000|NOT COMPLETED|Overall Study||430
8582991|NCT00228566|9616626|FG000|STARTED|Overall Study||247
8582992|NCT00228566|9616626|FG000|COMPLETED|Overall Study||176
8582993|NCT00228566|9616626|FG000|NOT COMPLETED|Overall Study||71
8582994|NCT00228813|9616630|FG000|STARTED|Overall Study||8
8582995|NCT00228813|9616630|FG000|COMPLETED|Overall Study||4
8582996|NCT00228813|9616630|FG000|NOT COMPLETED|Overall Study||4
8582997|NCT00228917|9616642|FG000|STARTED|Overall Study||193
8582998|NCT00228917|9616643|FG001|STARTED|Overall Study||96
8582999|NCT00228917|9616644|FG002|STARTED|Overall Study||65
8583000|NCT00228917|9616645|FG003|STARTED|Overall Study||33
8583001|NCT00228917|9616646|FG004|STARTED|Overall Study||205
8583002|NCT00228917|9616647|FG005|STARTED|Overall Study||104
8583003|NCT00228917|9616648|FG006|STARTED|Overall Study||69
8583004|NCT00228917|9616649|FG007|STARTED|Overall Study||33
8583005|NCT00228917|9616642|FG000|COMPLETED|Overall Study||193
8583006|NCT00228917|9616643|FG001|COMPLETED|Overall Study||96
8583007|NCT00228917|9616644|FG002|COMPLETED|Overall Study||65
8583008|NCT00228917|9616645|FG003|COMPLETED|Overall Study||33
8583009|NCT00228917|9616646|FG004|COMPLETED|Overall Study||205
8583010|NCT00228917|9616647|FG005|COMPLETED|Overall Study||102
8583011|NCT00228917|9616648|FG006|COMPLETED|Overall Study||69
8583012|NCT00228917|9616649|FG007|COMPLETED|Overall Study||33
8583013|NCT00228917|9616642|FG000|NOT COMPLETED|Overall Study||0
8583014|NCT00228917|9616643|FG001|NOT COMPLETED|Overall Study||0
8583015|NCT00228917|9616644|FG002|NOT COMPLETED|Overall Study||0
8583016|NCT00228917|9616645|FG003|NOT COMPLETED|Overall Study||0
8583017|NCT00228917|9616646|FG004|NOT COMPLETED|Overall Study||0
8583018|NCT00228917|9616647|FG005|NOT COMPLETED|Overall Study||2
8583019|NCT00228917|9616648|FG006|NOT COMPLETED|Overall Study||0
8583020|NCT00228917|9616649|FG007|NOT COMPLETED|Overall Study||0
8583021|NCT00228943|9616663|FG000|STARTED|Week 1||28
8583022|NCT00228943|9616663|FG000|COMPLETED|Week 1||28
8583023|NCT00228943|9616663|FG000|NOT COMPLETED|Week 1||0
8583024|NCT00228943|9616663|FG000|STARTED|Week 2||28
8583025|NCT00228943|9616663|FG000|COMPLETED|Week 2||27
8583026|NCT00228943|9616663|FG000|NOT COMPLETED|Week 2||1
8583027|NCT00229203|9616671|FG000|STARTED|Overall Study||32
8583028|NCT00229203|9616672|FG001|STARTED|Overall Study||19
8583029|NCT00229203|9616671|FG000|COMPLETED|Overall Study||0
8583030|NCT00229203|9616672|FG001|COMPLETED|Overall Study||0
8583031|NCT00229203|9616671|FG000|NOT COMPLETED|Overall Study||32
8583032|NCT00229203|9616672|FG001|NOT COMPLETED|Overall Study||19
8583033|NCT00229619|9616678|FG000|STARTED|Overall Study||11
8583034|NCT00229619|9616678|FG000|COMPLETED|Overall Study||11
8583035|NCT00229619|9616678|FG000|NOT COMPLETED|Overall Study||0
8583036|NCT00229658|9616686|FG000|STARTED|Overall Study||766
8583037|NCT00229658|9616687|FG001|STARTED|Overall Study||531
8583038|NCT00229658|9616686|FG000|COMPLETED|Overall Study||541
8583039|NCT00229658|9616687|FG001|COMPLETED|Overall Study||364
8583040|NCT00229658|9616686|FG000|NOT COMPLETED|Overall Study||225
8583041|NCT00229658|9616687|FG001|NOT COMPLETED|Overall Study||167
8583042|NCT00229723|9616700|FG000|STARTED|Concomitant Phase|Received randomized treatment|60
8583043|NCT00229723|9616701|FG001|STARTED|Concomitant Phase|Received randomized treatment|24
8583044|NCT00229723|9616702|FG002|STARTED|Concomitant Phase|Received randomized treatment|31
8583045|NCT00229723|9616703|FG003|STARTED|Concomitant Phase|Received randomized treatment|31
8583046|NCT00229723|9616704|FG004|STARTED|Concomitant Phase|Received randomized treatment|24
8583047|NCT00229723|9616705|FG005|STARTED|Concomitant Phase|Received randomized treatment|34
8583048|NCT00229723|9616706|FG006|STARTED|Concomitant Phase|Received randomized treatment|22
8583049|NCT00229723|9616700|FG000|COMPLETED|Concomitant Phase||50
8583050|NCT00229723|9616701|FG001|COMPLETED|Concomitant Phase||19
8583051|NCT00229723|9616702|FG002|COMPLETED|Concomitant Phase||25
8583052|NCT00229723|9616703|FG003|COMPLETED|Concomitant Phase||26
8583053|NCT00229723|9616704|FG004|COMPLETED|Concomitant Phase||22
8583054|NCT00229723|9616705|FG005|COMPLETED|Concomitant Phase||31
8583055|NCT00229723|9616706|FG006|COMPLETED|Concomitant Phase||19
8583056|NCT00229723|9616700|FG000|NOT COMPLETED|Concomitant Phase||10
8583057|NCT00229723|9616701|FG001|NOT COMPLETED|Concomitant Phase||5
8583058|NCT00229723|9616702|FG002|NOT COMPLETED|Concomitant Phase||6
8583059|NCT00229723|9616703|FG003|NOT COMPLETED|Concomitant Phase||5
8583060|NCT00229723|9616704|FG004|NOT COMPLETED|Concomitant Phase||2
8583061|NCT00229723|9616705|FG005|NOT COMPLETED|Concomitant Phase||3
8583062|NCT00229723|9616706|FG006|NOT COMPLETED|Concomitant Phase||3
8583063|NCT00229723|9616700|FG000|STARTED|Maintenance Phase||50
8583064|NCT00229723|9616701|FG001|STARTED|Maintenance Phase||19
8583065|NCT00229723|9616702|FG002|STARTED|Maintenance Phase||25
8583066|NCT00229723|9616703|FG003|STARTED|Maintenance Phase||26
8583067|NCT00229723|9616704|FG004|STARTED|Maintenance Phase||22
8583068|NCT00229723|9616705|FG005|STARTED|Maintenance Phase||31
8583069|NCT00229723|9616706|FG006|STARTED|Maintenance Phase||19
8583070|NCT00229723|9616700|FG000|COMPLETED|Maintenance Phase|Completed study on randomized treatment|25
8583071|NCT00229723|9616701|FG001|COMPLETED|Maintenance Phase|Completed study on randomized treatment|5
8583072|NCT00229723|9616702|FG002|COMPLETED|Maintenance Phase|Completed study on randomized treatment|16
8583073|NCT00229723|9616703|FG003|COMPLETED|Maintenance Phase|Completed study on randomized treatment|9
8583074|NCT00229723|9616704|FG004|COMPLETED|Maintenance Phase|Completed study on randomized treatment|7
8583075|NCT00229723|9616705|FG005|COMPLETED|Maintenance Phase|Completed study on randomized treatment|12
8583076|NCT00229723|9616706|FG006|COMPLETED|Maintenance Phase|Completed study on randomized treatment|9
8583077|NCT00229723|9616700|FG000|NOT COMPLETED|Maintenance Phase||25
8583078|NCT00229723|9616701|FG001|NOT COMPLETED|Maintenance Phase||14
8583079|NCT00229723|9616702|FG002|NOT COMPLETED|Maintenance Phase||9
8583080|NCT00229723|9616703|FG003|NOT COMPLETED|Maintenance Phase||17
8583081|NCT00229723|9616704|FG004|NOT COMPLETED|Maintenance Phase||15
8583082|NCT00229723|9616705|FG005|NOT COMPLETED|Maintenance Phase||19
8583083|NCT00229723|9616706|FG006|NOT COMPLETED|Maintenance Phase||10
8583084|NCT00229957|9616724|FG000|STARTED|Overall Study||152
8583085|NCT00229957|9616725|FG001|STARTED|Overall Study||151
8583086|NCT00229957|9616724|FG000|COMPLETED|Overall Study||132
8583087|NCT00229957|9616725|FG001|COMPLETED|Overall Study||139
8583088|NCT00229957|9616724|FG000|NOT COMPLETED|Overall Study||20
8583089|NCT00229957|9616725|FG001|NOT COMPLETED|Overall Study||12
8583090|NCT00230009|9616733|FG000|STARTED|Single Session Intervention/Control||50
8583091|NCT00230009|9616734|FG001|STARTED|Single Session Intervention/Control||50
8583092|NCT00230009|9616733|FG000|COMPLETED|Single Session Intervention/Control||50
8583093|NCT00230009|9616734|FG001|COMPLETED|Single Session Intervention/Control||50
8583094|NCT00230009|9616733|FG000|NOT COMPLETED|Single Session Intervention/Control||0
8583095|NCT00230009|9616734|FG001|NOT COMPLETED|Single Session Intervention/Control||0
8583096|NCT00230009|9616733|FG000|STARTED|Follow-up||50
8583097|NCT00230009|9616734|FG001|STARTED|Follow-up||50
8583098|NCT00230009|9616733|FG000|COMPLETED|Follow-up||19
8583099|NCT00230009|9616734|FG001|COMPLETED|Follow-up||24
8583100|NCT00230009|9616733|FG000|NOT COMPLETED|Follow-up||31
8583101|NCT00230009|9616734|FG001|NOT COMPLETED|Follow-up||26
8583102|NCT00230022|9616742|FG000|STARTED|Overall Study||15
8583103|NCT00230022|9616743|FG001|STARTED|Overall Study||15
8583104|NCT00230022|9616742|FG000|COMPLETED|Overall Study||15
8583105|NCT00230022|9616743|FG001|COMPLETED|Overall Study||15
8583106|NCT00230022|9616742|FG000|NOT COMPLETED|Overall Study||0
8583107|NCT00230022|9616743|FG001|NOT COMPLETED|Overall Study||0
8583108|NCT00230048|9616751|FG000|STARTED|Overall Study||52
8583109|NCT00230048|9616752|FG001|STARTED|Overall Study||55
8583110|NCT00230048|9616751|FG000|Completed Intervention/Control Session|Overall Study||52
8583111|NCT00230048|9616752|FG001|Completed Intervention/Control Session|Overall Study||55
8583112|NCT00230048|9616751|FG000|COMPLETED|Overall Study||39
8583113|NCT00230048|9616752|FG001|COMPLETED|Overall Study||37
8583114|NCT00230048|9616751|FG000|NOT COMPLETED|Overall Study||13
8583115|NCT00230048|9616752|FG001|NOT COMPLETED|Overall Study||18
8583116|NCT00230100|9616762|FG000|STARTED|Overall Study||29
8583117|NCT00230100|9616763|FG001|STARTED|Overall Study||17
8583118|NCT00230100|9616762|FG000|COMPLETED|Overall Study||29
8583119|NCT00230100|9616763|FG001|COMPLETED|Overall Study||17
8583120|NCT00230100|9616762|FG000|NOT COMPLETED|Overall Study||0
8583121|NCT00230100|9616763|FG001|NOT COMPLETED|Overall Study||0
8583122|NCT00230126|9616771|FG000|STARTED|Overall Study||30
8583123|NCT00230126|9616772|FG001|STARTED|Overall Study||28
8583124|NCT00230126|9616771|FG000|COMPLETED|Overall Study||28
8583125|NCT00230126|9616772|FG001|COMPLETED|Overall Study||27
8583126|NCT00230126|9616771|FG000|NOT COMPLETED|Overall Study||2
8583127|NCT00230126|9616772|FG001|NOT COMPLETED|Overall Study||1
8583128|NCT00230178|9616783|FG000|STARTED|Overall Study|Intent-to-treat (ITT)population: randomized patients|94
8583129|NCT00230178|9616784|FG001|STARTED|Overall Study||93
8583130|NCT00230178|9616785|FG002|STARTED|Overall Study||93
8583131|NCT00230178|9616783|FG000|Treated|Overall Study|Modified ITT population: ITT patients with at least 1 dose of study drug|92
8583132|NCT00230178|9616784|FG001|Treated|Overall Study||92
8583133|NCT00230178|9616785|FG002|Treated|Overall Study||91
8583134|NCT00230178|9616783|FG000|COMPLETED|Overall Study||90
8583135|NCT00230178|9616784|FG001|COMPLETED|Overall Study||86
8583136|NCT00230178|9616785|FG002|COMPLETED|Overall Study||86
8583137|NCT00230178|9616783|FG000|NOT COMPLETED|Overall Study||4
8583138|NCT00230178|9616784|FG001|NOT COMPLETED|Overall Study||7
8583139|NCT00230178|9616785|FG002|NOT COMPLETED|Overall Study||7
8583140|NCT00230282|9616793|FG000|STARTED|Fludarabine + Cyclophosphamide||25
8583141|NCT00230282|9616793|FG000|COMPLETED|Fludarabine + Cyclophosphamide||17
8583142|NCT00230282|9616793|FG000|NOT COMPLETED|Fludarabine + Cyclophosphamide||8
8583143|NCT00230282|9616793|FG000|STARTED|Maintanence Therapy With Alemtuzumab||17
8583144|NCT00230282|9616793|FG000|COMPLETED|Maintanence Therapy With Alemtuzumab||17
8583145|NCT00230282|9616793|FG000|NOT COMPLETED|Maintanence Therapy With Alemtuzumab||0
8583146|NCT00230737|9616800|FG000|STARTED|Overall Study||9
8583147|NCT00230737|9616801|FG001|STARTED|Overall Study||10
8583148|NCT00230737|9616802|FG002|STARTED|Overall Study||8
8583149|NCT00230737|9616800|FG000|COMPLETED|Overall Study||9
8583150|NCT00230737|9616801|FG001|COMPLETED|Overall Study||10
8583151|NCT00230737|9616802|FG002|COMPLETED|Overall Study||8
8583152|NCT00230737|9616800|FG000|NOT COMPLETED|Overall Study||0
8583153|NCT00230737|9616801|FG001|NOT COMPLETED|Overall Study||0
8583154|NCT00230737|9616802|FG002|NOT COMPLETED|Overall Study||0
8583155|NCT00230802|9616812|FG000|STARTED|Overall Study||25
8583156|NCT00230802|9616813|FG001|STARTED|Overall Study||23
8583157|NCT00230802|9616812|FG000|COMPLETED|Overall Study||25
8583158|NCT00230802|9616813|FG001|COMPLETED|Overall Study||23
8583159|NCT00230802|9616812|FG000|NOT COMPLETED|Overall Study||0
8583160|NCT00230802|9616813|FG001|NOT COMPLETED|Overall Study||0
8583161|NCT00230971|9616823|FG000|STARTED|Randomization||235
8583162|NCT00230971|9616824|FG001|STARTED|Randomization||238
8583163|NCT00230971|9616823|FG000|COMPLETED|Randomization||232
8583164|NCT00230971|9616824|FG001|COMPLETED|Randomization||235
8583165|NCT00230971|9616823|FG000|NOT COMPLETED|Randomization||3
8583166|NCT00230971|9616824|FG001|NOT COMPLETED|Randomization||3
8583167|NCT00230971|9616823|FG000|STARTED|Baseline Participants||232
8583168|NCT00230971|9616824|FG001|STARTED|Baseline Participants||235
8583169|NCT00230971|9616823|FG000|COMPLETED|Baseline Participants||210
8583170|NCT00230971|9616824|FG001|COMPLETED|Baseline Participants||216
8583171|NCT00230971|9616823|FG000|NOT COMPLETED|Baseline Participants||22
8583172|NCT00230971|9616824|FG001|NOT COMPLETED|Baseline Participants||19
8583173|NCT00231062|9616830|FG000|STARTED|Overall Study||115
8583174|NCT00231062|9616830|FG000|COMPLETED|Overall Study||109
8583175|NCT00231062|9616830|FG000|NOT COMPLETED|Overall Study||6
8583176|NCT00231114|9616836|FG000|STARTED|Randomized||196
8583177|NCT00231114|9616837|FG001|STARTED|Randomized||101
8583178|NCT00231114|9616836|FG000|COMPLETED|Randomized||190
8583179|NCT00231114|9616837|FG001|COMPLETED|Randomized||98
8583180|NCT00231114|9616836|FG000|NOT COMPLETED|Randomized||6
8583181|NCT00231114|9616837|FG001|NOT COMPLETED|Randomized||3
8583182|NCT00231114|9616836|FG000|STARTED|Treatment Period||190
8583183|NCT00231114|9616837|FG001|STARTED|Treatment Period||98
8583184|NCT00231114|9616836|FG000|COMPLETED|Treatment Period||189
8583185|NCT00231114|9616837|FG001|COMPLETED|Treatment Period||98
8583186|NCT00231114|9616836|FG000|NOT COMPLETED|Treatment Period||1
8583187|NCT00231114|9616837|FG001|NOT COMPLETED|Treatment Period||0
8583188|NCT00231114|9616836|FG000|STARTED|Post-Treatment Period||189
8583189|NCT00231114|9616837|FG001|STARTED|Post-Treatment Period||98
8583190|NCT00231114|9616836|FG000|COMPLETED|Post-Treatment Period||181
8583191|NCT00231114|9616837|FG001|COMPLETED|Post-Treatment Period||97
8583192|NCT00231114|9616836|FG000|NOT COMPLETED|Post-Treatment Period||8
8583193|NCT00231114|9616837|FG001|NOT COMPLETED|Post-Treatment Period||1
8583194|NCT00231179|9616847|FG000|STARTED|Overall Study||152
8583195|NCT00231179|9616848|FG001|STARTED|Overall Study||150
8583196|NCT00231179|9616847|FG000|COMPLETED|Overall Study|128 (95%) in intervention group completed the five year follow-up visit.|128
8583197|NCT00231179|9616848|FG001|COMPLETED|Overall Study|126 (93%) in the control group completed the five year follow-up visit.|126
8583198|NCT00231179|9616847|FG000|NOT COMPLETED|Overall Study||24
8583199|NCT00231179|9616848|FG001|NOT COMPLETED|Overall Study||24
8583200|NCT00231283|9616854|FG000|STARTED|Overall Study||100
8583201|NCT00231283|9616854|FG000|COMPLETED|Overall Study||95
8583202|NCT00231283|9616854|FG000|NOT COMPLETED|Overall Study||5
8583203|NCT00231309|9616858|FG000|STARTED|Overall Study||10
8583204|NCT00231309|9616858|FG000|COMPLETED|Overall Study||10
8583205|NCT00231309|9616858|FG000|NOT COMPLETED|Overall Study||0
8709878|NCT00955409|9756157|FG005|Treated|Overall Study||9
8709879|NCT00955409|9756158|FG006|Treated|Overall Study||27
8709880|NCT00955409|9756159|FG007|Treated|Overall Study||6
8709881|NCT00955409|9756160|FG008|Treated|Overall Study||16
8709882|NCT00955409|9756161|FG009|Treated|Overall Study||4
8709883|NCT00955409|9756152|FG000|Completed Treatment|Overall Study||12
8709884|NCT00955409|9756153|FG001|Completed Treatment|Overall Study||5
8709885|NCT00955409|9756154|FG002|Completed Treatment|Overall Study||15
8583206|NCT00231413|9616870|FG000|STARTED|Overall Study||88
8583207|NCT00231413|9616871|FG001|STARTED|Overall Study||50
8583208|NCT00231413|9616872|FG002|STARTED|Overall Study||49
8583209|NCT00231413|9616873|FG003|STARTED|Overall Study||48
8583210|NCT00231413|9616874|FG004|STARTED|Overall Study||48
8583211|NCT00231413|9616875|FG005|STARTED|Overall Study||50
8583212|NCT00231413|9616876|FG006|STARTED|Overall Study||50
8583213|NCT00231413|9616870|FG000|COMPLETED|Overall Study||80
8583214|NCT00231413|9616871|FG001|COMPLETED|Overall Study||45
8583215|NCT00231413|9616872|FG002|COMPLETED|Overall Study||42
8583216|NCT00231413|9616873|FG003|COMPLETED|Overall Study||45
8583217|NCT00231413|9616874|FG004|COMPLETED|Overall Study||45
8583218|NCT00231413|9616875|FG005|COMPLETED|Overall Study||45
8583219|NCT00231413|9616876|FG006|COMPLETED|Overall Study||46
8583220|NCT00231413|9616870|FG000|NOT COMPLETED|Overall Study||8
8583221|NCT00231413|9616871|FG001|NOT COMPLETED|Overall Study||5
8583222|NCT00231413|9616872|FG002|NOT COMPLETED|Overall Study||7
8583223|NCT00231413|9616873|FG003|NOT COMPLETED|Overall Study||3
8583224|NCT00231413|9616874|FG004|NOT COMPLETED|Overall Study||3
8583225|NCT00231413|9616875|FG005|NOT COMPLETED|Overall Study||5
8583226|NCT00231413|9616876|FG006|NOT COMPLETED|Overall Study||4
8583227|NCT00231465|9616892|FG000|STARTED|Overall Study||44
8583228|NCT00231465|9616892|FG000|COMPLETED|Overall Study||42
8583229|NCT00231465|9616892|FG000|NOT COMPLETED|Overall Study||2
8583230|NCT00231478|9616898|FG000|STARTED|Overall Study||87
8583231|NCT00231478|9616899|FG001|STARTED|Overall Study||84
8583232|NCT00231478|9616898|FG000|COMPLETED|Overall Study||79
8583233|NCT00231478|9616899|FG001|COMPLETED|Overall Study||78
8583234|NCT00231478|9616898|FG000|NOT COMPLETED|Overall Study||8
8583235|NCT00231478|9616899|FG001|NOT COMPLETED|Overall Study||6
8583236|NCT00231777|9616907|FG000|STARTED|Overall Study||170
8583237|NCT00231777|9616908|FG001|STARTED|Overall Study||46
8583238|NCT00231777|9616907|FG000|COMPLETED|Overall Study||164
8583239|NCT00231777|9616908|FG001|COMPLETED|Overall Study||44
8583240|NCT00231777|9616907|FG000|NOT COMPLETED|Overall Study||6
8583241|NCT00231777|9616908|FG001|NOT COMPLETED|Overall Study||2
8583242|NCT00231816|9616916|FG000|STARTED|Overall Study||382
8583243|NCT00231816|9616917|FG001|STARTED|Overall Study||381
8583244|NCT00231816|9616916|FG000|Vaccinated at Visit 1|Overall Study||382
8583245|NCT00231816|9616917|FG001|Vaccinated at Visit 1|Overall Study|One participant was randomized but not vaccinated|380
8583246|NCT00231816|9616916|FG000|Vaccinated at Visit 2|Overall Study||369
8583247|NCT00231816|9616917|FG001|Vaccinated at Visit 2|Overall Study||371
8583248|NCT00231816|9616916|FG000|COMPLETED|Overall Study|Participant received required vaccines and returned completed vaccination report cards at Visits 2&3|366
8583249|NCT00231816|9616917|FG001|COMPLETED|Overall Study|Participant received required vaccines and returned completed vaccination report cards at Visits 2&3|369
8583250|NCT00231816|9616916|FG000|NOT COMPLETED|Overall Study||16
8583251|NCT00231816|9616917|FG001|NOT COMPLETED|Overall Study||12
8583252|NCT00231842|9616924|FG000|STARTED|Overall Study||30
8583253|NCT00231842|9616924|FG000|Initiated Therapy|Overall Study||27
8583254|NCT00231842|9616924|FG000|Completed First 3 Cycles|Overall Study||27
8583255|NCT00231842|9616924|FG000|Completed Prescribed RT|Overall Study||27
8583256|NCT00231842|9616924|FG000|Completed Full Prescribed Therapy|Overall Study||19
8583257|NCT00231842|9616924|FG000|COMPLETED|Overall Study||19
8583258|NCT00231842|9616924|FG000|NOT COMPLETED|Overall Study||11
8583259|NCT00231868|9616929|FG000|STARTED|Overall Study||81
8583260|NCT00231868|9616929|FG000|COMPLETED|Overall Study||65
8583261|NCT00231868|9616929|FG000|NOT COMPLETED|Overall Study||16
8583262|NCT00231894|9616935|FG000|STARTED|Overall Study||31
8583263|NCT00231894|9616936|FG001|STARTED|Overall Study||25
8583264|NCT00231894|9616935|FG000|COMPLETED|Overall Study||30
8583265|NCT00231894|9616936|FG001|COMPLETED|Overall Study||24
8583266|NCT00231894|9616935|FG000|NOT COMPLETED|Overall Study||1
8583267|NCT00231894|9616936|FG001|NOT COMPLETED|Overall Study||1
8583268|NCT00232180|9616950|FG000|STARTED|Double-blind (DB) Phase|Three participants in each arm were enrolled after data cut-off.|1367
8583269|NCT00232180|9616951|FG001|STARTED|Double-blind (DB) Phase|Three participants in each arm were enrolled after data cut-off.|1376
8583270|NCT00232180|9616952|FG002|STARTED|Double-blind (DB) Phase||0
8583271|NCT00232180|9616950|FG000|Treated|Double-blind (DB) Phase||1364
8583272|NCT00232180|9616951|FG001|Treated|Double-blind (DB) Phase||1372
8583273|NCT00232180|9616952|FG002|Treated|Double-blind (DB) Phase||0
8583274|NCT00232180|9616950|FG000|COMPLETED|Double-blind (DB) Phase||826
8583275|NCT00232180|9616951|FG001|COMPLETED|Double-blind (DB) Phase||771
8583276|NCT00232180|9616952|FG002|COMPLETED|Double-blind (DB) Phase||0
8583277|NCT00232180|9616950|FG000|NOT COMPLETED|Double-blind (DB) Phase||541
8583278|NCT00232180|9616951|FG001|NOT COMPLETED|Double-blind (DB) Phase||605
8583279|NCT00232180|9616952|FG002|NOT COMPLETED|Double-blind (DB) Phase||0
8583280|NCT00232180|9616950|FG000|STARTED|Open Label Phase||0
8583281|NCT00232180|9616951|FG001|STARTED|Open Label Phase||0
8583282|NCT00232180|9616952|FG002|STARTED|Open Label Phase||1246
8583283|NCT00232180|9616950|FG000|Treated|Open Label Phase||0
8583284|NCT00232180|9616951|FG001|Treated|Open Label Phase||0
8583285|NCT00232180|9616952|FG002|Treated|Open Label Phase||1245
8583286|NCT00232180|9616950|FG000|COMPLETED|Open Label Phase||0
8583287|NCT00232180|9616951|FG001|COMPLETED|Open Label Phase||0
8583288|NCT00232180|9616952|FG002|COMPLETED|Open Label Phase||1098
8583289|NCT00232180|9616950|FG000|NOT COMPLETED|Open Label Phase||0
8583290|NCT00232180|9616951|FG001|NOT COMPLETED|Open Label Phase||0
8583291|NCT00232180|9616952|FG002|NOT COMPLETED|Open Label Phase||148
8583292|NCT00232479|9616961|FG000|STARTED|Overall Study||44
8583293|NCT00232479|9616961|FG000|COMPLETED|Overall Study||44
8583294|NCT00232479|9616961|FG000|NOT COMPLETED|Overall Study||0
8583295|NCT00232505|9616968|FG000|STARTED|Overall Study||31
8583296|NCT00232505|9616969|FG001|STARTED|Overall Study||71
8583297|NCT00232505|9616968|FG000|Not Evaluable|Overall Study||0
8583298|NCT00232505|9616969|FG001|Not Evaluable|Overall Study||6
8583299|NCT00232505|9616968|FG000|Early Progressors|Overall Study||2
8583300|NCT00232505|9616969|FG001|Early Progressors|Overall Study||5
8583301|NCT00232505|9616968|FG000|Off Protocol|Overall Study||5
8583302|NCT00232505|9616969|FG001|Off Protocol|Overall Study||0
8583303|NCT00232505|9616968|FG000|COMPLETED|Overall Study||26
8583304|NCT00232505|9616969|FG001|COMPLETED|Overall Study||60
8583305|NCT00232505|9616968|FG000|NOT COMPLETED|Overall Study||5
8583306|NCT00232505|9616969|FG001|NOT COMPLETED|Overall Study||11
8583307|NCT00232544|9616981|FG000|STARTED|Overall Study||124
8583308|NCT00232544|9616982|FG001|STARTED|Overall Study||126
8583309|NCT00232544|9616981|FG000|COMPLETED|Overall Study||104
8583310|NCT00232544|9616982|FG001|COMPLETED|Overall Study||111
8583311|NCT00232544|9616981|FG000|NOT COMPLETED|Overall Study||20
8583312|NCT00232544|9616982|FG001|NOT COMPLETED|Overall Study||15
8583313|NCT00232557|9616990|FG000|STARTED|Overall Study||71
8583314|NCT00232557|9616991|FG001|STARTED|Overall Study||65
8583315|NCT00232557|9616990|FG000|COMPLETED|Overall Study||68
8583316|NCT00232557|9616991|FG001|COMPLETED|Overall Study||60
8583317|NCT00232557|9616990|FG000|NOT COMPLETED|Overall Study||3
8583318|NCT00232557|9616991|FG001|NOT COMPLETED|Overall Study||5
8583319|NCT00232583|9616999|FG000|STARTED|Overall Study||29
8583320|NCT00232583|9617000|FG001|STARTED|Overall Study||29
8583321|NCT00232583|9616999|FG000|COMPLETED|Overall Study||19
8583322|NCT00232583|9617000|FG001|COMPLETED|Overall Study||16
8583323|NCT00232583|9616999|FG000|NOT COMPLETED|Overall Study||10
8583324|NCT00232583|9617000|FG001|NOT COMPLETED|Overall Study||13
8583325|NCT00232596|9617012|FG000|STARTED|6-Week Titration Phase||152
8583326|NCT00232596|9617013|FG001|STARTED|6-Week Titration Phase||154
8583327|NCT00232596|9617012|FG000|COMPLETED|6-Week Titration Phase||138
8583328|NCT00232596|9617013|FG001|COMPLETED|6-Week Titration Phase||125
8583329|NCT00232596|9617012|FG000|NOT COMPLETED|6-Week Titration Phase||14
8583330|NCT00232596|9617013|FG001|NOT COMPLETED|6-Week Titration Phase||29
8583331|NCT00232596|9617012|FG000|STARTED|12-Week Maintenance Phase||138
8583332|NCT00232596|9617013|FG001|STARTED|12-Week Maintenance Phase||125
8583333|NCT00232596|9617012|FG000|COMPLETED|12-Week Maintenance Phase|"One participant withdrew after being considered a completer and is listed as an early withdraw."|126
8583334|NCT00232596|9617013|FG001|COMPLETED|12-Week Maintenance Phase||97
8583335|NCT00232596|9617012|FG000|NOT COMPLETED|12-Week Maintenance Phase||12
8583336|NCT00232596|9617013|FG001|NOT COMPLETED|12-Week Maintenance Phase||28
8583337|NCT00232739|9617031|FG000|STARTED|Overall Study||100
8583338|NCT00232739|9617031|FG000|COMPLETED|Overall Study||91
8583339|NCT00232739|9617031|FG000|NOT COMPLETED|Overall Study||9
8583340|NCT00233064|9617037|FG000|STARTED|Overall Study||211
8583341|NCT00233064|9617038|FG001|STARTED|Overall Study||202
8583342|NCT00233064|9617037|FG000|COMPLETED|Overall Study||197
8583343|NCT00233064|9617038|FG001|COMPLETED|Overall Study||190
8583344|NCT00233064|9617037|FG000|NOT COMPLETED|Overall Study||14
8583345|NCT00233064|9617038|FG001|NOT COMPLETED|Overall Study||12
8583346|NCT00233103|9617047|FG000|STARTED|Overall Study||27
8583347|NCT00233103|9617048|FG001|STARTED|Overall Study||25
8583348|NCT00233103|9617047|FG000|COMPLETED|Overall Study||22
8583349|NCT00233103|9617048|FG001|COMPLETED|Overall Study||19
8583350|NCT00233103|9617047|FG000|NOT COMPLETED|Overall Study||5
8583351|NCT00233103|9617048|FG001|NOT COMPLETED|Overall Study||6
8583352|NCT00233324|9617058|FG000|STARTED|Main Study||318
8583353|NCT00233324|9617059|FG001|STARTED|Main Study||335
8583354|NCT00233324|9617060|FG002|STARTED|Main Study||336
8583355|NCT00233324|9617061|FG003|STARTED|Main Study||327
8583356|NCT00233324|9617058|FG000|COMPLETED|Main Study||250
8583357|NCT00233324|9617059|FG001|COMPLETED|Main Study||275
8583358|NCT00233324|9617060|FG002|COMPLETED|Main Study||274
8583359|NCT00233324|9617061|FG003|COMPLETED|Main Study||280
8583360|NCT00233324|9617058|FG000|NOT COMPLETED|Main Study||68
8583361|NCT00233324|9617059|FG001|NOT COMPLETED|Main Study||60
8583362|NCT00233324|9617060|FG002|NOT COMPLETED|Main Study||62
8583363|NCT00233324|9617061|FG003|NOT COMPLETED|Main Study||47
8583364|NCT00233324|9617058|FG000|STARTED|Follow up at 18-22 Months Corrected Age||250
8583365|NCT00233324|9617059|FG001|STARTED|Follow up at 18-22 Months Corrected Age||275
8583366|NCT00233324|9617060|FG002|STARTED|Follow up at 18-22 Months Corrected Age||274
8583367|NCT00233324|9617061|FG003|STARTED|Follow up at 18-22 Months Corrected Age||280
8583368|NCT00233324|9617058|FG000|COMPLETED|Follow up at 18-22 Months Corrected Age||237
8583369|NCT00233324|9617059|FG001|COMPLETED|Follow up at 18-22 Months Corrected Age||261
8583370|NCT00233324|9617060|FG002|COMPLETED|Follow up at 18-22 Months Corrected Age||256
8583371|NCT00233324|9617061|FG003|COMPLETED|Follow up at 18-22 Months Corrected Age||269
8583372|NCT00233324|9617058|FG000|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||13
8583373|NCT00233324|9617059|FG001|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||14
8583374|NCT00233324|9617060|FG002|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||18
8583375|NCT00233324|9617061|FG003|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||11
8583376|NCT00233363|9617080|FG000|STARTED|Overall Study||53
8583377|NCT00233363|9617081|FG001|STARTED|Overall Study||51
8583378|NCT00233363|9617080|FG000|COMPLETED|Overall Study||50
8583379|NCT00233363|9617081|FG001|COMPLETED|Overall Study||46
8583380|NCT00233363|9617080|FG000|NOT COMPLETED|Overall Study||3
8583381|NCT00233363|9617081|FG001|NOT COMPLETED|Overall Study||5
8583382|NCT00233389|9617089|FG000|STARTED|Overall Study||154
8583383|NCT00233389|9617090|FG001|STARTED|Overall Study||147
8583384|NCT00233389|9617089|FG000|COMPLETED|Overall Study||136
8583385|NCT00233389|9617090|FG001|COMPLETED|Overall Study||131
8583386|NCT00233389|9617089|FG000|NOT COMPLETED|Overall Study||18
8583387|NCT00233389|9617090|FG001|NOT COMPLETED|Overall Study||16
8583388|NCT00233402|9617098|FG000|STARTED|Overall Study||384
8583389|NCT00233402|9617099|FG001|STARTED|Overall Study||395
8583390|NCT00233402|9617098|FG000|COMPLETED|Overall Study||280
8583391|NCT00233402|9617099|FG001|COMPLETED|Overall Study||271
8583392|NCT00233402|9617098|FG000|NOT COMPLETED|Overall Study||104
8583393|NCT00233402|9617099|FG001|NOT COMPLETED|Overall Study||124
8583394|NCT00233454|9617107|FG000|STARTED|Overall Study||26
8583395|NCT00233454|9617107|FG000|2 Months (for Response Rate)|Overall Study||26
8583396|NCT00233454|9617107|FG000|COMPLETED|Overall Study||20
8583397|NCT00233454|9617107|FG000|NOT COMPLETED|Overall Study||6
8583398|NCT00233480|9617113|FG000|STARTED|Overall Study||14
8583399|NCT00233480|9617114|FG001|STARTED|Overall Study||13
8583400|NCT00233480|9617113|FG000|COMPLETED|Overall Study||14
8583401|NCT00233480|9617114|FG001|COMPLETED|Overall Study||12
8583402|NCT00233480|9617113|FG000|NOT COMPLETED|Overall Study||0
8583403|NCT00233480|9617114|FG001|NOT COMPLETED|Overall Study||1
8583404|NCT00233519|9617124|FG000|STARTED|Overall Study||7
8583405|NCT00233519|9617125|FG001|STARTED|Overall Study||10
8583406|NCT00233519|9617124|FG000|COMPLETED|Overall Study||6
8583407|NCT00233519|9617125|FG001|COMPLETED|Overall Study||9
8583408|NCT00233519|9617124|FG000|NOT COMPLETED|Overall Study||1
8583409|NCT00233519|9617125|FG001|NOT COMPLETED|Overall Study||1
8583410|NCT00233948|9617133|FG000|STARTED|Overall Study||4
8583411|NCT00233948|9617134|FG001|STARTED|Overall Study||3
8583412|NCT00233948|9617135|FG002|STARTED|Overall Study||3
8583413|NCT00233948|9617136|FG003|STARTED|Overall Study||3
8583414|NCT00233948|9617137|FG004|STARTED|Overall Study||4
8583415|NCT00233948|9617138|FG005|STARTED|Overall Study||12
8583416|NCT00233948|9617133|FG000|COMPLETED|Overall Study||3
8583417|NCT00233948|9617134|FG001|COMPLETED|Overall Study||3
8583418|NCT00233948|9617135|FG002|COMPLETED|Overall Study||3
8583419|NCT00233948|9617136|FG003|COMPLETED|Overall Study||3
8583420|NCT00233948|9617137|FG004|COMPLETED|Overall Study||4
8583421|NCT00233948|9617138|FG005|COMPLETED|Overall Study||12
8583422|NCT00233948|9617133|FG000|NOT COMPLETED|Overall Study||1
8583423|NCT00233948|9617134|FG001|NOT COMPLETED|Overall Study||0
8583424|NCT00233948|9617135|FG002|NOT COMPLETED|Overall Study||0
8583425|NCT00233948|9617136|FG003|NOT COMPLETED|Overall Study||0
8583426|NCT00233948|9617137|FG004|NOT COMPLETED|Overall Study||0
8583427|NCT00233948|9617138|FG005|NOT COMPLETED|Overall Study||0
8583428|NCT00233987|9617153|FG000|STARTED|Overall Study||98
8583429|NCT00233987|9617153|FG000|Eligible|Overall Study||94
8583430|NCT00233987|9617153|FG000|Eligible and Treated|Overall Study||92
8583431|NCT00233987|9617153|FG000|COMPLETED|Overall Study||83
8583432|NCT00233987|9617153|FG000|NOT COMPLETED|Overall Study||15
8583433|NCT00234039|9617157|FG000|STARTED|Overall Study||58
8583434|NCT00234039|9617157|FG000|Eligible|Overall Study||49
8583435|NCT00234039|9617157|FG000|Eligible and Began Protocol Therapy|Overall Study||47
8583436|NCT00234039|9617157|FG000|COMPLETED|Overall Study||8
8583437|NCT00234039|9617157|FG000|NOT COMPLETED|Overall Study||50
8627690|NCT00519376|9667172|FG002|STARTED|Treatment Period 3||2
8627691|NCT00519376|9667173|FG003|STARTED|Treatment Period 3||2
8627692|NCT00519376|9667174|FG004|STARTED|Treatment Period 3||1
8627693|NCT00519376|9667175|FG005|STARTED|Treatment Period 3||1
8627694|NCT00519376|9667176|FG006|STARTED|Treatment Period 3||1
8627695|NCT00519376|9667177|FG007|STARTED|Treatment Period 3||1
8627696|NCT00519376|9667178|FG008|STARTED|Treatment Period 3||1
8627697|NCT00519376|9667179|FG009|STARTED|Treatment Period 3||1
8627698|NCT00519376|9667180|FG010|STARTED|Treatment Period 3||1
8627699|NCT00519376|9667181|FG011|STARTED|Treatment Period 3||1
8627700|NCT00519376|9667182|FG012|STARTED|Treatment Period 3||0
8627701|NCT00519376|9667183|FG013|STARTED|Treatment Period 3||1
8627702|NCT00519376|9667184|FG014|STARTED|Treatment Period 3||1
8627703|NCT00519376|9667185|FG015|STARTED|Treatment Period 3||1
8627704|NCT00519376|9667170|FG000|COMPLETED|Treatment Period 3||2
8627705|NCT00519376|9667171|FG001|COMPLETED|Treatment Period 3||2
8627706|NCT00519376|9667172|FG002|COMPLETED|Treatment Period 3||2
8627707|NCT00519376|9667173|FG003|COMPLETED|Treatment Period 3||2
8627708|NCT00519376|9667174|FG004|COMPLETED|Treatment Period 3||1
8627709|NCT00519376|9667175|FG005|COMPLETED|Treatment Period 3||1
8627710|NCT00519376|9667176|FG006|COMPLETED|Treatment Period 3||1
8627711|NCT00519376|9667177|FG007|COMPLETED|Treatment Period 3||1
8627712|NCT00519376|9667178|FG008|COMPLETED|Treatment Period 3||1
8627713|NCT00519376|9667179|FG009|COMPLETED|Treatment Period 3||1
8627714|NCT00519376|9667180|FG010|COMPLETED|Treatment Period 3||1
8627715|NCT00519376|9667181|FG011|COMPLETED|Treatment Period 3||1
8627716|NCT00519376|9667182|FG012|COMPLETED|Treatment Period 3||0
8627717|NCT00519376|9667183|FG013|COMPLETED|Treatment Period 3||1
8627718|NCT00519376|9667184|FG014|COMPLETED|Treatment Period 3||1
8627719|NCT00519376|9667185|FG015|COMPLETED|Treatment Period 3||1
8627720|NCT00519376|9667170|FG000|NOT COMPLETED|Treatment Period 3||0
8627721|NCT00519376|9667171|FG001|NOT COMPLETED|Treatment Period 3||0
8627722|NCT00519376|9667172|FG002|NOT COMPLETED|Treatment Period 3||0
8627723|NCT00519376|9667173|FG003|NOT COMPLETED|Treatment Period 3||0
8627724|NCT00519376|9667174|FG004|NOT COMPLETED|Treatment Period 3||0
8627725|NCT00519376|9667175|FG005|NOT COMPLETED|Treatment Period 3||0
8627726|NCT00519376|9667176|FG006|NOT COMPLETED|Treatment Period 3||0
8627727|NCT00519376|9667177|FG007|NOT COMPLETED|Treatment Period 3||0
8627728|NCT00519376|9667178|FG008|NOT COMPLETED|Treatment Period 3||0
8627729|NCT00519376|9667179|FG009|NOT COMPLETED|Treatment Period 3||0
8627730|NCT00519376|9667180|FG010|NOT COMPLETED|Treatment Period 3||0
8627731|NCT00519376|9667181|FG011|NOT COMPLETED|Treatment Period 3||0
8583438|NCT00234052|9617161|FG000|STARTED|Treatment||51
8583439|NCT00234052|9617161|FG000|Started Treatment|Treatment||50
8583440|NCT00234052|9617161|FG000|Completed 6 Cycles|Treatment||33
8583441|NCT00234052|9617161|FG000|Went Into Maintenance Phase|Treatment||30
8583442|NCT00234052|9617161|FG000|COMPLETED|Treatment||30
8583443|NCT00234052|9617161|FG000|NOT COMPLETED|Treatment||21
8583444|NCT00234052|9617161|FG000|STARTED|Follow-up for 5 Years|All patients that are treated on study go into the follow up period.|50
8583445|NCT00234052|9617161|FG000|COMPLETED|Follow-up for 5 Years||1
8583446|NCT00234052|9617161|FG000|NOT COMPLETED|Follow-up for 5 Years||49
8583447|NCT00234065|9617167|FG000|STARTED|Overall Study||1356
8583448|NCT00234065|9617168|FG001|STARTED|Overall Study||1360
8583449|NCT00234065|9617167|FG000|COMPLETED|Overall Study||881
8583450|NCT00234065|9617168|FG001|COMPLETED|Overall Study||1004
8583451|NCT00234065|9617167|FG000|NOT COMPLETED|Overall Study||475
8583452|NCT00234065|9617168|FG001|NOT COMPLETED|Overall Study||356
8583453|NCT00234078|9617178|FG000|STARTED|Overall Study||72
8583454|NCT00234078|9617179|FG001|STARTED|Overall Study||72
8583455|NCT00234078|9617180|FG002|STARTED|Overall Study||74
8583456|NCT00234078|9617181|FG003|STARTED|Overall Study||72
8583457|NCT00234078|9617178|FG000|COMPLETED|Overall Study||66
8583458|NCT00234078|9617179|FG001|COMPLETED|Overall Study||63
8583459|NCT00234078|9617180|FG002|COMPLETED|Overall Study||64
8583460|NCT00234078|9617181|FG003|COMPLETED|Overall Study||68
8583461|NCT00234078|9617178|FG000|NOT COMPLETED|Overall Study||6
8583462|NCT00234078|9617179|FG001|NOT COMPLETED|Overall Study||9
8583463|NCT00234078|9617180|FG002|NOT COMPLETED|Overall Study||10
8583464|NCT00234078|9617181|FG003|NOT COMPLETED|Overall Study||4
8583465|NCT00234104|9617195|FG000|STARTED|Overall Study||30
8583466|NCT00234104|9617196|FG001|STARTED|Overall Study||29
8583467|NCT00234104|9617197|FG002|STARTED|Overall Study||34
8583468|NCT00234104|9617198|FG003|STARTED|Overall Study||29
8583469|NCT00234104|9617195|FG000|COMPLETED|Overall Study||26
8583470|NCT00234104|9617196|FG001|COMPLETED|Overall Study||28
8583471|NCT00234104|9617197|FG002|COMPLETED|Overall Study||29
8583472|NCT00234104|9617198|FG003|COMPLETED|Overall Study||21
8583473|NCT00234104|9617195|FG000|NOT COMPLETED|Overall Study||4
8583474|NCT00234104|9617196|FG001|NOT COMPLETED|Overall Study||1
8583475|NCT00234104|9617197|FG002|NOT COMPLETED|Overall Study||5
8583476|NCT00234104|9617198|FG003|NOT COMPLETED|Overall Study||8
8583477|NCT00234286|9617208|FG000|STARTED|Overall Study|We reviewed eletronic health records for 6066 deceased individuals within 6 VA Hospitals|6066
8583478|NCT00234286|9617208|FG000|COMPLETED|Overall Study|We reviewed eletronic health records for 6066 deceased individuals within 6 VA Hospitals|6066
8583479|NCT00234286|9617208|FG000|NOT COMPLETED|Overall Study||0
8583480|NCT00234494|9617241|FG000|STARTED|Overall Study||45
8583481|NCT00234494|9617241|FG000|COMPLETED|Overall Study||43
8583482|NCT00234494|9617241|FG000|NOT COMPLETED|Overall Study||2
8583483|NCT00234533|9617245|FG000|STARTED|Overall Study||251
8583484|NCT00234533|9617245|FG000|COMPLETED|Overall Study||240
8583485|NCT00234533|9617245|FG000|NOT COMPLETED|Overall Study||11
8583486|NCT00234832|9617252|FG000|STARTED|Overall Study|Subjects completed the 6-week Lead-in Period and were dispensed randomized study drug.|4906
8583487|NCT00234832|9617253|FG001|STARTED|Overall Study|Subjects completed the 6-week Lead-in Period and were dispensed randomized study drug.|4898
8583488|NCT00234832|9617252|FG000|COMPLETED|Overall Study|Subjects completed the Randomization Phase.|3890
8583489|NCT00234832|9617253|FG001|COMPLETED|Overall Study|Subjects completed the Randomization Phase.|3902
8583490|NCT00234832|9617252|FG000|NOT COMPLETED|Overall Study||1016
8583491|NCT00234832|9617253|FG001|NOT COMPLETED|Overall Study||996
8583492|NCT00234884|9617266|FG000|STARTED|Overall Study||3435
8583493|NCT00234884|9617266|FG000|COMPLETED|Overall Study||1805
8583494|NCT00234884|9617266|FG000|NOT COMPLETED|Overall Study||1630
8583495|NCT00235391|9617276|FG000|STARTED|Overall Study||97
8583496|NCT00235391|9617277|FG001|STARTED|Overall Study||200
8583497|NCT00235391|9617278|FG002|STARTED|Overall Study||172
8583498|NCT00235391|9617279|FG003|STARTED|Overall Study||1164
8583499|NCT00235391|9617280|FG004|STARTED|Overall Study||43
8583500|NCT00235391|9617281|FG005|STARTED|Overall Study||7
8583501|NCT00235391|9617276|FG000|Deferasirox Treatment|Overall Study||97
8583502|NCT00235391|9617277|FG001|Deferasirox Treatment|Overall Study||200
8583503|NCT00235391|9617278|FG002|Deferasirox Treatment|Overall Study||172
8583504|NCT00235391|9617279|FG003|Deferasirox Treatment|Overall Study||1164
8583505|NCT00235391|9617280|FG004|Deferasirox Treatment|Overall Study||43
8583506|NCT00235391|9617281|FG005|Deferasirox Treatment|Overall Study||7
8583507|NCT00235391|9617276|FG000|COMPLETED|Overall Study||85
8583508|NCT00235391|9617277|FG001|COMPLETED|Overall Study||182
8583509|NCT00235391|9617278|FG002|COMPLETED|Overall Study||148
8583510|NCT00235391|9617279|FG003|COMPLETED|Overall Study||944
8583511|NCT00235391|9617280|FG004|COMPLETED|Overall Study||31
8583512|NCT00235391|9617281|FG005|COMPLETED|Overall Study||3
8583513|NCT00235391|9617276|FG000|NOT COMPLETED|Overall Study||12
8583514|NCT00235391|9617277|FG001|NOT COMPLETED|Overall Study||18
8583515|NCT00235391|9617278|FG002|NOT COMPLETED|Overall Study||24
8583516|NCT00235391|9617279|FG003|NOT COMPLETED|Overall Study||220
8583517|NCT00235391|9617280|FG004|NOT COMPLETED|Overall Study||12
8583518|NCT00235391|9617281|FG005|NOT COMPLETED|Overall Study||4
8583519|NCT00235443|9617296|FG000|STARTED|Overall Study||11
8583520|NCT00235443|9617297|FG001|STARTED|Overall Study||57
8583521|NCT00235443|9617298|FG002|STARTED|Overall Study||85
8583522|NCT00235443|9617299|FG003|STARTED|Overall Study||205
8583523|NCT00235443|9617300|FG004|STARTED|Overall Study||39
8583524|NCT00235443|9617301|FG005|STARTED|Overall Study||54
8583525|NCT00235443|9617296|FG000|COMPLETED|Overall Study||3
8583526|NCT00235443|9617297|FG001|COMPLETED|Overall Study||19
8583527|NCT00235443|9617298|FG002|COMPLETED|Overall Study||23
8583528|NCT00235443|9617299|FG003|COMPLETED|Overall Study||108
8583529|NCT00235443|9617300|FG004|COMPLETED|Overall Study||9
8583530|NCT00235443|9617301|FG005|COMPLETED|Overall Study||9
8583531|NCT00235443|9617296|FG000|NOT COMPLETED|Overall Study||8
8583532|NCT00235443|9617297|FG001|NOT COMPLETED|Overall Study||38
8583533|NCT00235443|9617298|FG002|NOT COMPLETED|Overall Study||62
8583534|NCT00235443|9617299|FG003|NOT COMPLETED|Overall Study||97
8583535|NCT00235443|9617300|FG004|NOT COMPLETED|Overall Study||30
8583536|NCT00235443|9617301|FG005|NOT COMPLETED|Overall Study||45
8583537|NCT00235456|9617319|FG000|STARTED|Overall Study||150
8583538|NCT00235456|9617320|FG001|STARTED|Overall Study||150
8583539|NCT00235456|9617319|FG000|COMPLETED|Overall Study||148
8583540|NCT00235456|9617320|FG001|COMPLETED|Overall Study||143
8583541|NCT00235456|9617319|FG000|NOT COMPLETED|Overall Study||2
8583542|NCT00235456|9617320|FG001|NOT COMPLETED|Overall Study||7
8583543|NCT00235495|9617328|FG000|STARTED|Overall Study||422
8583544|NCT00235495|9617329|FG001|STARTED|Overall Study||419
8583545|NCT00235495|9617328|FG000|COMPLETED|Overall Study||354
8583546|NCT00235495|9617329|FG001|COMPLETED|Overall Study||351
8583547|NCT00235495|9617328|FG000|NOT COMPLETED|Overall Study||68
8583548|NCT00235495|9617329|FG001|NOT COMPLETED|Overall Study||68
8583549|NCT00235547|9617337|FG000|STARTED|2 Month Follow-up Survey||154
8583550|NCT00235547|9617338|FG001|STARTED|2 Month Follow-up Survey||144
8583551|NCT00235547|9617337|FG000|COMPLETED|2 Month Follow-up Survey||108
8583552|NCT00235547|9617338|FG001|COMPLETED|2 Month Follow-up Survey||104
8583553|NCT00235547|9617337|FG000|NOT COMPLETED|2 Month Follow-up Survey||46
8583554|NCT00235547|9617338|FG001|NOT COMPLETED|2 Month Follow-up Survey||40
8583555|NCT00235547|9617337|FG000|STARTED|6 Month Follow-up Survey||154
8583556|NCT00235547|9617338|FG001|STARTED|6 Month Follow-up Survey||144
8583557|NCT00235547|9617337|FG000|COMPLETED|6 Month Follow-up Survey||83
8583558|NCT00235547|9617338|FG001|COMPLETED|6 Month Follow-up Survey||76
8583559|NCT00235547|9617337|FG000|NOT COMPLETED|6 Month Follow-up Survey||71
8583560|NCT00235547|9617338|FG001|NOT COMPLETED|6 Month Follow-up Survey||68
8583561|NCT00235573|9617344|FG000|STARTED|Overall Study|35 subjects screened; 14 not eligible; 21 started and completed study|21
8583562|NCT00235573|9617344|FG000|COMPLETED|Overall Study||21
8583563|NCT00235573|9617344|FG000|NOT COMPLETED|Overall Study||0
8583564|NCT00235716|9617352|FG000|STARTED|Overall Study||152
8583565|NCT00235716|9617353|FG001|STARTED|Overall Study||155
8583566|NCT00235716|9617354|FG002|STARTED|Overall Study||154
8583567|NCT00235716|9617355|FG003|STARTED|Overall Study||152
8583568|NCT00235716|9617352|FG000|COMPLETED|Overall Study||90
8583569|NCT00235716|9617353|FG001|COMPLETED|Overall Study||88
8583570|NCT00235716|9617354|FG002|COMPLETED|Overall Study||89
8583571|NCT00235716|9617355|FG003|COMPLETED|Overall Study||90
8583572|NCT00235716|9617352|FG000|NOT COMPLETED|Overall Study||62
8583573|NCT00235716|9617353|FG001|NOT COMPLETED|Overall Study||67
8583574|NCT00235716|9617354|FG002|NOT COMPLETED|Overall Study||65
8583575|NCT00235716|9617355|FG003|NOT COMPLETED|Overall Study||62
8583576|NCT00235755|9617368|FG000|STARTED|4-Week Titration Phase||179
8583577|NCT00235755|9617369|FG001|STARTED|4-Week Titration Phase||181
8583578|NCT00235755|9617370|FG002|STARTED|4-Week Titration Phase||179
8583579|NCT00235755|9617368|FG000|COMPLETED|4-Week Titration Phase||168
8583580|NCT00235755|9617369|FG001|COMPLETED|4-Week Titration Phase||162
8583581|NCT00235755|9617370|FG002|COMPLETED|4-Week Titration Phase||153
8583582|NCT00235755|9617368|FG000|NOT COMPLETED|4-Week Titration Phase||11
8583583|NCT00235755|9617369|FG001|NOT COMPLETED|4-Week Titration Phase||19
8583584|NCT00235755|9617370|FG002|NOT COMPLETED|4-Week Titration Phase||26
8583585|NCT00235755|9617368|FG000|STARTED|12-Week Maintenance Phase||168
8583586|NCT00235755|9617369|FG001|STARTED|12-Week Maintenance Phase||162
8583587|NCT00235755|9617370|FG002|STARTED|12-Week Maintenance Phase||153
8583588|NCT00235755|9617368|FG000|COMPLETED|12-Week Maintenance Phase||152
8583589|NCT00235755|9617369|FG001|COMPLETED|12-Week Maintenance Phase||135
8583590|NCT00235755|9617370|FG002|COMPLETED|12-Week Maintenance Phase||122
8583591|NCT00235755|9617368|FG000|NOT COMPLETED|12-Week Maintenance Phase||16
8583592|NCT00235755|9617369|FG001|NOT COMPLETED|12-Week Maintenance Phase||27
8583593|NCT00235755|9617370|FG002|NOT COMPLETED|12-Week Maintenance Phase||31
8583594|NCT00235833|9617393|FG000|STARTED|Overall Study||25
8583595|NCT00235833|9617393|FG000|COMPLETED|Overall Study||9
8583596|NCT00235833|9617393|FG000|NOT COMPLETED|Overall Study||16
8583597|NCT00235872|9617397|FG000|STARTED|Overall Study||309
8583598|NCT00235872|9617397|FG000|COMPLETED|Overall Study||162
8583599|NCT00235872|9617397|FG000|NOT COMPLETED|Overall Study||147
8583600|NCT00235989|9617405|FG000|STARTED|Core Treatment Period (CT)||0
8583601|NCT00235989|9617406|FG001|STARTED|Core Treatment Period (CT)||0
8583602|NCT00235989|9617407|FG002|STARTED|Core Treatment Period (CT)||0
8583603|NCT00235989|9617408|FG003|STARTED|Core Treatment Period (CT)||0
8583604|NCT00235989|9617409|FG004|STARTED|Core Treatment Period (CT)||36
8583605|NCT00235989|9617410|FG005|STARTED|Core Treatment Period (CT)||27
8583606|NCT00235989|9617405|FG000|COMPLETED|Core Treatment Period (CT)||0
8583607|NCT00235989|9617406|FG001|COMPLETED|Core Treatment Period (CT)||0
8583608|NCT00235989|9617407|FG002|COMPLETED|Core Treatment Period (CT)||0
8583609|NCT00235989|9617408|FG003|COMPLETED|Core Treatment Period (CT)||0
8583610|NCT00235989|9617409|FG004|COMPLETED|Core Treatment Period (CT)||36
8583611|NCT00235989|9617410|FG005|COMPLETED|Core Treatment Period (CT)||25
8583612|NCT00235989|9617405|FG000|NOT COMPLETED|Core Treatment Period (CT)||0
8583613|NCT00235989|9617406|FG001|NOT COMPLETED|Core Treatment Period (CT)||0
8583614|NCT00235989|9617407|FG002|NOT COMPLETED|Core Treatment Period (CT)||0
8583615|NCT00235989|9617408|FG003|NOT COMPLETED|Core Treatment Period (CT)||0
8583616|NCT00235989|9617409|FG004|NOT COMPLETED|Core Treatment Period (CT)||0
8583617|NCT00235989|9617410|FG005|NOT COMPLETED|Core Treatment Period (CT)||2
8583618|NCT00235989|9617405|FG000|STARTED|Extension Treatment Period (ET)||16
8583619|NCT00235989|9617406|FG001|STARTED|Extension Treatment Period (ET)||6
8583620|NCT00235989|9617407|FG002|STARTED|Extension Treatment Period (ET)||19
8583621|NCT00235989|9617408|FG003|STARTED|Extension Treatment Period (ET)||20
8583622|NCT00235989|9617409|FG004|STARTED|Extension Treatment Period (ET)||0
8583623|NCT00235989|9617410|FG005|STARTED|Extension Treatment Period (ET)||0
8583624|NCT00235989|9617405|FG000|COMPLETED|Extension Treatment Period (ET)||8
8583625|NCT00235989|9617406|FG001|COMPLETED|Extension Treatment Period (ET)||2
8583626|NCT00235989|9617407|FG002|COMPLETED|Extension Treatment Period (ET)||14
8583627|NCT00235989|9617408|FG003|COMPLETED|Extension Treatment Period (ET)||14
8583628|NCT00235989|9617409|FG004|COMPLETED|Extension Treatment Period (ET)||0
8583629|NCT00235989|9617410|FG005|COMPLETED|Extension Treatment Period (ET)||0
8583630|NCT00235989|9617405|FG000|NOT COMPLETED|Extension Treatment Period (ET)||8
8583631|NCT00235989|9617406|FG001|NOT COMPLETED|Extension Treatment Period (ET)||4
8583632|NCT00235989|9617407|FG002|NOT COMPLETED|Extension Treatment Period (ET)||5
8583633|NCT00235989|9617408|FG003|NOT COMPLETED|Extension Treatment Period (ET)||6
8583634|NCT00235989|9617409|FG004|NOT COMPLETED|Extension Treatment Period (ET)||0
8583635|NCT00235989|9617410|FG005|NOT COMPLETED|Extension Treatment Period (ET)||0
8583636|NCT00236080|9617425|FG000|STARTED|Overall Study||29
8583637|NCT00236080|9617426|FG001|STARTED|Overall Study||28
8583638|NCT00236080|9617427|FG002|STARTED|Overall Study||27
8583639|NCT00236080|9617428|FG003|STARTED|Overall Study||25
8583640|NCT00236080|9617429|FG004|STARTED|Overall Study||27
8583641|NCT00236080|9617425|FG000|COMPLETED|Overall Study||27
8583642|NCT00236080|9617426|FG001|COMPLETED|Overall Study||27
8583643|NCT00236080|9617427|FG002|COMPLETED|Overall Study||22
8583644|NCT00236080|9617428|FG003|COMPLETED|Overall Study||23
8583645|NCT00236080|9617429|FG004|COMPLETED|Overall Study||26
8583646|NCT00236080|9617425|FG000|NOT COMPLETED|Overall Study||2
8583647|NCT00236080|9617426|FG001|NOT COMPLETED|Overall Study||1
8583648|NCT00236080|9617427|FG002|NOT COMPLETED|Overall Study||5
8583649|NCT00236080|9617428|FG003|NOT COMPLETED|Overall Study||2
8583650|NCT00236080|9617429|FG004|NOT COMPLETED|Overall Study||1
8583651|NCT00236184|9617443|FG000|STARTED|Overall Study||310
8583652|NCT00236184|9617444|FG001|STARTED|Overall Study||319
8583653|NCT00236184|9617443|FG000|COMPLETED|Overall Study||292
8583654|NCT00236184|9617444|FG001|COMPLETED|Overall Study||308
8583655|NCT00236184|9617443|FG000|NOT COMPLETED|Overall Study||18
8583656|NCT00236184|9617444|FG001|NOT COMPLETED|Overall Study||11
8583657|NCT00236197|9617452|FG000|STARTED|Overall Study||312
8583658|NCT00236197|9617453|FG001|STARTED|Overall Study||307
8583659|NCT00236197|9617452|FG000|COMPLETED|Overall Study||307
8583660|NCT00236197|9617453|FG001|COMPLETED|Overall Study||293
8583661|NCT00236197|9617452|FG000|NOT COMPLETED|Overall Study||5
8583662|NCT00236197|9617453|FG001|NOT COMPLETED|Overall Study||14
8583663|NCT00236899|9617463|FG000|STARTED|Overall Study||60
8583664|NCT00236899|9617464|FG001|STARTED|Overall Study||64
8583665|NCT00236899|9617465|FG002|STARTED|Overall Study||58
8583666|NCT00236899|9617466|FG003|STARTED|Overall Study||59
8583667|NCT00236899|9617463|FG000|COMPLETED|Overall Study||18
8583668|NCT00236899|9617464|FG001|COMPLETED|Overall Study||24
8583669|NCT00236899|9617465|FG002|COMPLETED|Overall Study||14
8583670|NCT00236899|9617466|FG003|COMPLETED|Overall Study||19
8583671|NCT00236899|9617463|FG000|NOT COMPLETED|Overall Study||42
8583672|NCT00236899|9617464|FG001|NOT COMPLETED|Overall Study||40
8583673|NCT00236899|9617465|FG002|NOT COMPLETED|Overall Study||44
8583674|NCT00236899|9617466|FG003|NOT COMPLETED|Overall Study||40
8583675|NCT00236938|9617485|FG000|STARTED|Overall Study||75
8583676|NCT00236938|9617486|FG001|STARTED|Overall Study||46
8583677|NCT00236938|9617485|FG000|COMPLETED|Overall Study||62
8583678|NCT00236938|9617486|FG001|COMPLETED|Overall Study||26
8583679|NCT00236938|9617485|FG000|NOT COMPLETED|Overall Study||13
8583680|NCT00236938|9617486|FG001|NOT COMPLETED|Overall Study||20
8583681|NCT00236951|9617496|FG000|STARTED|Overall Study||59
8583682|NCT00236951|9617497|FG001|STARTED|Overall Study||77
8583683|NCT00236951|9617498|FG002|STARTED|Overall Study||40
8583684|NCT00236951|9617499|FG003|STARTED|Overall Study||48
8583685|NCT00236951|9617496|FG000|COMPLETED|Overall Study||33
8583686|NCT00236951|9617497|FG001|COMPLETED|Overall Study||46
8583687|NCT00236951|9617498|FG002|COMPLETED|Overall Study||21
8583688|NCT00236951|9617499|FG003|COMPLETED|Overall Study||17
8583689|NCT00236951|9617496|FG000|NOT COMPLETED|Overall Study||26
8583690|NCT00236951|9617497|FG001|NOT COMPLETED|Overall Study||31
8583691|NCT00236951|9617498|FG002|NOT COMPLETED|Overall Study||19
8583692|NCT00236951|9617499|FG003|NOT COMPLETED|Overall Study||31
8583693|NCT00236977|9617511|FG000|STARTED|Overall Study||91
8583694|NCT00236977|9617512|FG001|STARTED|Overall Study||91
8583695|NCT00236977|9617511|FG000|COMPLETED|Overall Study||70
8583696|NCT00236977|9617512|FG001|COMPLETED|Overall Study||72
8583697|NCT00236977|9617511|FG000|NOT COMPLETED|Overall Study||21
8583698|NCT00236977|9617512|FG001|NOT COMPLETED|Overall Study||19
8583699|NCT00237042|9617521|FG000|STARTED|Treatment||60
8583700|NCT00237042|9617522|FG001|STARTED|Treatment||57
8583701|NCT00237042|9617523|FG002|STARTED|Treatment||74
8583702|NCT00237042|9617521|FG000|COMPLETED|Treatment||54
8583703|NCT00237042|9617522|FG001|COMPLETED|Treatment||50
8583704|NCT00237042|9617523|FG002|COMPLETED|Treatment||36
8583705|NCT00237042|9617521|FG000|NOT COMPLETED|Treatment||6
8583706|NCT00237042|9617522|FG001|NOT COMPLETED|Treatment||7
8583707|NCT00237042|9617523|FG002|NOT COMPLETED|Treatment||38
8583708|NCT00237042|9617521|FG000|STARTED|Short Term (6 Month) Follow up|Greater than number completing treatment: intent to treat analysis|59
8583709|NCT00237042|9617522|FG001|STARTED|Short Term (6 Month) Follow up|Greater than number completing treatment: intent to treat analysis|55
8583710|NCT00237042|9617523|FG002|STARTED|Short Term (6 Month) Follow up|Greater than number completing treatment: intent to treat analysis|57
8583711|NCT00237042|9617521|FG000|COMPLETED|Short Term (6 Month) Follow up||50
8583712|NCT00237042|9617522|FG001|COMPLETED|Short Term (6 Month) Follow up||47
8583713|NCT00237042|9617523|FG002|COMPLETED|Short Term (6 Month) Follow up||46
8583714|NCT00237042|9617521|FG000|NOT COMPLETED|Short Term (6 Month) Follow up||9
8583715|NCT00237042|9617522|FG001|NOT COMPLETED|Short Term (6 Month) Follow up||8
8583716|NCT00237042|9617523|FG002|NOT COMPLETED|Short Term (6 Month) Follow up||11
8583717|NCT00237042|9617521|FG000|STARTED|Long Term (12 Month) Follow up|Greater than number completing treatment: intent to treat analysis|59
8583718|NCT00237042|9617522|FG001|STARTED|Long Term (12 Month) Follow up|Greater than number completing treatment: intent to treat analysis|55
8583719|NCT00237042|9617523|FG002|STARTED|Long Term (12 Month) Follow up|Greater than number completing treatment: intent to treat analysis|57
8583720|NCT00237042|9617521|FG000|COMPLETED|Long Term (12 Month) Follow up||48
8583721|NCT00237042|9617522|FG001|COMPLETED|Long Term (12 Month) Follow up||46
8583722|NCT00237042|9617523|FG002|COMPLETED|Long Term (12 Month) Follow up||48
8583723|NCT00237042|9617521|FG000|NOT COMPLETED|Long Term (12 Month) Follow up||11
8583724|NCT00237042|9617522|FG001|NOT COMPLETED|Long Term (12 Month) Follow up||9
8583725|NCT00237042|9617523|FG002|NOT COMPLETED|Long Term (12 Month) Follow up||9
8583726|NCT00237185|9617533|FG000|STARTED|Core||74
8583727|NCT00237185|9617534|FG001|STARTED|Core||74
8583728|NCT00237185|9617533|FG000|Treated Participants|Core||73
8583729|NCT00237185|9617534|FG001|Treated Participants|Core||74
8583730|NCT00237185|9617533|FG000|COMPLETED|Core||30
8583731|NCT00237185|9617534|FG001|COMPLETED|Core||37
8583732|NCT00237185|9617533|FG000|NOT COMPLETED|Core||44
8583733|NCT00237185|9617534|FG001|NOT COMPLETED|Core||37
8583734|NCT00237185|9617533|FG000|STARTED|Extension|A portion of the participants, who completed the core, entered the extension.|24
8583735|NCT00237185|9617534|FG001|STARTED|Extension|A portion of the participants, who completed the core, entered the extension.|32
8583736|NCT00237185|9617533|FG000|COMPLETED|Extension||8
8583737|NCT00237185|9617534|FG001|COMPLETED|Extension||13
8583738|NCT00237185|9617533|FG000|NOT COMPLETED|Extension||16
8583739|NCT00237185|9617534|FG001|NOT COMPLETED|Extension||19
8583740|NCT00237458|9617540|FG000|STARTED|Overall Study||7
8583741|NCT00237458|9617540|FG000|COMPLETED|Overall Study||4
8583742|NCT00237458|9617540|FG000|NOT COMPLETED|Overall Study||3
8583743|NCT00237666|9617544|FG000|STARTED|Overall Study||30
8583744|NCT00237666|9617544|FG000|COMPLETED|Overall Study||24
8583745|NCT00237666|9617544|FG000|NOT COMPLETED|Overall Study||6
8583746|NCT00237692|9617552|FG000|STARTED|Overall Study||147
8583747|NCT00237692|9617553|FG001|STARTED|Overall Study||148
8583748|NCT00237692|9617554|FG002|STARTED|Overall Study||149
8583749|NCT00237692|9617555|FG003|STARTED|Overall Study||147
8583750|NCT00237692|9617552|FG000|6 Month f/u|Overall Study||132
8583751|NCT00237692|9617553|FG001|6 Month f/u|Overall Study||134
8583752|NCT00237692|9617554|FG002|6 Month f/u|Overall Study||135
8583753|NCT00237692|9617555|FG003|6 Month f/u|Overall Study||134
8583754|NCT00237692|9617552|FG000|12 Month f/u|Overall Study||137
8583755|NCT00237692|9617553|FG001|12 Month f/u|Overall Study||127
8583756|NCT00237692|9617554|FG002|12 Month f/u|Overall Study||132
8583757|NCT00237692|9617555|FG003|12 Month f/u|Overall Study||127
8583758|NCT00237692|9617552|FG000|18 Month f/u|Overall Study||124
8583759|NCT00237692|9617553|FG001|18 Month f/u|Overall Study||131
8583760|NCT00237692|9617554|FG002|18 Month f/u|Overall Study||126
8583761|NCT00237692|9617555|FG003|18 Month f/u|Overall Study||122
8583762|NCT00237692|9617552|FG000|COMPLETED|Overall Study||129
8583763|NCT00237692|9617553|FG001|COMPLETED|Overall Study||134
8583764|NCT00237692|9617554|FG002|COMPLETED|Overall Study||127
8583765|NCT00237692|9617555|FG003|COMPLETED|Overall Study||128
8583766|NCT00237692|9617552|FG000|NOT COMPLETED|Overall Study||18
8583767|NCT00237692|9617553|FG001|NOT COMPLETED|Overall Study||14
8583768|NCT00237692|9617554|FG002|NOT COMPLETED|Overall Study||22
8583769|NCT00237692|9617555|FG003|NOT COMPLETED|Overall Study||19
8583770|NCT00237718|9617567|FG000|STARTED|Overall Study||160
8583771|NCT00237718|9617568|FG001|STARTED|Overall Study||165
8583772|NCT00237718|9617567|FG000|COMPLETED|Overall Study||114
8583773|NCT00237718|9617568|FG001|COMPLETED|Overall Study||124
8583774|NCT00237718|9617567|FG000|NOT COMPLETED|Overall Study||46
8583775|NCT00237718|9617568|FG001|NOT COMPLETED|Overall Study||41
8583776|NCT00237744|9617577|FG000|STARTED|Overall Study||11
8583777|NCT00237744|9617578|FG001|STARTED|Overall Study||11
8583778|NCT00237744|9617579|FG002|STARTED|Overall Study||18
8583779|NCT00237744|9617577|FG000|COMPLETED|Overall Study||8
8583780|NCT00237744|9617578|FG001|COMPLETED|Overall Study||10
8583781|NCT00237744|9617579|FG002|COMPLETED|Overall Study||18
8583782|NCT00237744|9617577|FG000|NOT COMPLETED|Overall Study||3
8583783|NCT00237744|9617578|FG001|NOT COMPLETED|Overall Study||1
8583784|NCT00237744|9617579|FG002|NOT COMPLETED|Overall Study||0
8583785|NCT00237770|9617592|FG000|STARTED|Overall Study||9
8583786|NCT00237770|9617593|FG001|STARTED|Overall Study||7
8583787|NCT00237770|9617592|FG000|COMPLETED|Overall Study||9
8583788|NCT00237770|9617593|FG001|COMPLETED|Overall Study||7
8583789|NCT00237770|9617592|FG000|NOT COMPLETED|Overall Study||0
8583790|NCT00237770|9617593|FG001|NOT COMPLETED|Overall Study||0
8583791|NCT00237796|9617605|FG000|STARTED|Overall Study||41
8583792|NCT00237796|9617606|FG001|STARTED|Overall Study||38
8583793|NCT00237796|9617605|FG000|COMPLETED|Overall Study||31
8583794|NCT00237796|9617606|FG001|COMPLETED|Overall Study||33
8583795|NCT00237796|9617605|FG000|NOT COMPLETED|Overall Study||10
8583796|NCT00237796|9617606|FG001|NOT COMPLETED|Overall Study||5
8583797|NCT00237809|9617617|FG000|STARTED|Overall Study||27
8583798|NCT00237809|9617618|FG001|STARTED|Overall Study||27
8583799|NCT00237809|9617619|FG002|STARTED|Overall Study||24
8583800|NCT00237809|9617620|FG003|STARTED|Overall Study||26
8583801|NCT00237809|9617617|FG000|COMPLETED|Overall Study||16
8583802|NCT00237809|9617618|FG001|COMPLETED|Overall Study||17
8583803|NCT00237809|9617619|FG002|COMPLETED|Overall Study||15
8583804|NCT00237809|9617620|FG003|COMPLETED|Overall Study||17
8583805|NCT00237809|9617617|FG000|NOT COMPLETED|Overall Study||11
8583806|NCT00237809|9617618|FG001|NOT COMPLETED|Overall Study||10
8583807|NCT00237809|9617619|FG002|NOT COMPLETED|Overall Study||9
8583808|NCT00237809|9617620|FG003|NOT COMPLETED|Overall Study||9
8583809|NCT00238108|9617632|FG000|STARTED|Overall Study||8
8583810|NCT00238108|9617633|FG001|STARTED|Overall Study||8
8583811|NCT00238108|9617632|FG000|COMPLETED|Overall Study||8
8583812|NCT00238108|9617633|FG001|COMPLETED|Overall Study||8
8583813|NCT00238108|9617632|FG000|NOT COMPLETED|Overall Study||0
8583814|NCT00238108|9617633|FG001|NOT COMPLETED|Overall Study||0
8583815|NCT00238121|9617641|FG000|STARTED|Overall Study||40
8583816|NCT00238121|9617642|FG001|STARTED|Overall Study||16
8583817|NCT00238121|9617641|FG000|COMPLETED|Overall Study||37
8583818|NCT00238121|9617642|FG001|COMPLETED|Overall Study||14
8583819|NCT00238121|9617641|FG000|NOT COMPLETED|Overall Study||3
8583820|NCT00238121|9617642|FG001|NOT COMPLETED|Overall Study||2
8583821|NCT00238238|9617650|FG000|STARTED|Overall Study||3
8583822|NCT00238238|9617651|FG001|STARTED|Overall Study||48
8583823|NCT00238238|9617652|FG002|STARTED|Overall Study||46
8583824|NCT00238238|9617650|FG000|COMPLETED|Overall Study||3
8583825|NCT00238238|9617651|FG001|COMPLETED|Overall Study||45
8583826|NCT00238238|9617652|FG002|COMPLETED|Overall Study||46
8583827|NCT00238238|9617650|FG000|NOT COMPLETED|Overall Study||0
8583828|NCT00238238|9617651|FG001|NOT COMPLETED|Overall Study||3
8583829|NCT00238238|9617652|FG002|NOT COMPLETED|Overall Study||0
8583830|NCT00238264|9617660|FG000|STARTED|Overall Study||92
8583831|NCT00238264|9617660|FG000|COMPLETED|Overall Study||56
8583832|NCT00238264|9617660|FG000|NOT COMPLETED|Overall Study||36
8583833|NCT00238303|9617667|FG000|STARTED|Overall Study||68
8583834|NCT00238303|9617668|FG001|STARTED|Overall Study||15
8583835|NCT00238303|9617669|FG002|STARTED|Overall Study||20
8583836|NCT00238303|9617667|FG000|COMPLETED|Overall Study||53
8583837|NCT00238303|9617668|FG001|COMPLETED|Overall Study||13
8583838|NCT00238303|9617669|FG002|COMPLETED|Overall Study||11
8583839|NCT00238303|9617667|FG000|NOT COMPLETED|Overall Study||15
8583840|NCT00238303|9617668|FG001|NOT COMPLETED|Overall Study||2
8709886|NCT00955409|9756155|FG003|Completed Treatment|Overall Study||17
8709887|NCT00955409|9756156|FG004|Completed Treatment|Overall Study||3
8709888|NCT00955409|9756157|FG005|Completed Treatment|Overall Study||7
8709889|NCT00955409|9756158|FG006|Completed Treatment|Overall Study||4
8709890|NCT00955409|9756159|FG007|Completed Treatment|Overall Study||3
8709891|NCT00955409|9756160|FG008|Completed Treatment|Overall Study||2
8709892|NCT00955409|9756161|FG009|Completed Treatment|Overall Study||4
8709893|NCT00955409|9756152|FG000|COMPLETED|Overall Study|Completed study|11
8709894|NCT00955409|9756153|FG001|COMPLETED|Overall Study|Completed study|5
8709895|NCT00955409|9756154|FG002|COMPLETED|Overall Study|Completed study|15
8709896|NCT00955409|9756155|FG003|COMPLETED|Overall Study|Completed study|17
8709897|NCT00955409|9756156|FG004|COMPLETED|Overall Study|Completed study|3
8709898|NCT00955409|9756157|FG005|COMPLETED|Overall Study|Completed study|6
8709899|NCT00955409|9756158|FG006|COMPLETED|Overall Study|Completed study|3
8709900|NCT00955409|9756159|FG007|COMPLETED|Overall Study|Completed study|2
8709901|NCT00955409|9756160|FG008|COMPLETED|Overall Study|Completed study|2
8709902|NCT00955409|9756161|FG009|COMPLETED|Overall Study|Completed study|3
8709903|NCT00955409|9756152|FG000|NOT COMPLETED|Overall Study||10
8709904|NCT00955409|9756153|FG001|NOT COMPLETED|Overall Study||1
8583841|NCT00238303|9617669|FG002|NOT COMPLETED|Overall Study||9
8583842|NCT00238355|9617678|FG000|STARTED|Overall Study||13
8583843|NCT00238355|9617678|FG000|COMPLETED|Overall Study||10
8583844|NCT00238355|9617678|FG000|NOT COMPLETED|Overall Study||3
8583845|NCT00238433|9617682|FG000|STARTED|Overall Study||37
8583846|NCT00238433|9617682|FG000|COMPLETED|Overall Study||34
8583847|NCT00238433|9617682|FG000|NOT COMPLETED|Overall Study||3
8583848|NCT00238615|9617687|FG000|STARTED|Overall Study||13
8583849|NCT00238615|9617687|FG000|COMPLETED|Overall Study||13
8583850|NCT00238615|9617687|FG000|NOT COMPLETED|Overall Study||0
8583851|NCT00239005|9617695|FG000|STARTED|Overall Study||69
8583852|NCT00239005|9617696|FG001|STARTED|Overall Study||65
8709905|NCT00955409|9756154|FG002|NOT COMPLETED|Overall Study||26
8709906|NCT00955409|9756155|FG003|NOT COMPLETED|Overall Study||8
8709907|NCT00955409|9756156|FG004|NOT COMPLETED|Overall Study||2
8709908|NCT00955409|9756157|FG005|NOT COMPLETED|Overall Study||3
8583853|NCT00239005|9617695|FG000|Intention-to-treat Population (ITT)|Overall Study||68
8583854|NCT00239005|9617696|FG001|Intention-to-treat Population (ITT)|Overall Study||61
8583855|NCT00239005|9617695|FG000|COMPLETED|Overall Study||57
8583856|NCT00239005|9617696|FG001|COMPLETED|Overall Study||53
8583857|NCT00239005|9617695|FG000|NOT COMPLETED|Overall Study||12
8583858|NCT00239005|9617696|FG001|NOT COMPLETED|Overall Study||12
8583859|NCT00239226|9617706|FG000|STARTED|Overall Study||30
8583860|NCT00239226|9617707|FG001|STARTED|Overall Study||18
8583861|NCT00239226|9617708|FG002|STARTED|Overall Study||37
8583862|NCT00239226|9617709|FG003|STARTED|Overall Study||17
8583863|NCT00239226|9617706|FG000|COMPLETED|Overall Study||29
8583864|NCT00239226|9617707|FG001|COMPLETED|Overall Study||18
8583865|NCT00239226|9617708|FG002|COMPLETED|Overall Study||36
8583866|NCT00239226|9617709|FG003|COMPLETED|Overall Study||14
8583867|NCT00239226|9617706|FG000|NOT COMPLETED|Overall Study||1
8583868|NCT00239226|9617707|FG001|NOT COMPLETED|Overall Study||0
8583869|NCT00239226|9617708|FG002|NOT COMPLETED|Overall Study||1
8583870|NCT00239226|9617709|FG003|NOT COMPLETED|Overall Study||3
8583871|NCT00239356|9617721|FG000|STARTED|Overall Study||97
8583872|NCT00239356|9617722|FG001|STARTED|Overall Study||20
8583873|NCT00239356|9617721|FG000|COMPLETED|Overall Study||58
8583874|NCT00239356|9617722|FG001|COMPLETED|Overall Study||11
8583875|NCT00239356|9617721|FG000|NOT COMPLETED|Overall Study||39
8583876|NCT00239356|9617722|FG001|NOT COMPLETED|Overall Study||9
8583877|NCT00239577|9617732|FG000|STARTED|Primary Phase||22
8583878|NCT00239577|9617733|FG001|STARTED|Primary Phase||22
8583879|NCT00239577|9617734|FG002|STARTED|Primary Phase||21
8583880|NCT00239577|9617735|FG003|STARTED|Primary Phase||21
8583881|NCT00239577|9617732|FG000|COMPLETED|Primary Phase||17
8583882|NCT00239577|9617733|FG001|COMPLETED|Primary Phase||19
8583883|NCT00239577|9617734|FG002|COMPLETED|Primary Phase||18
8583884|NCT00239577|9617735|FG003|COMPLETED|Primary Phase||21
8583885|NCT00239577|9617732|FG000|NOT COMPLETED|Primary Phase||5
8583886|NCT00239577|9617733|FG001|NOT COMPLETED|Primary Phase||3
8583887|NCT00239577|9617734|FG002|NOT COMPLETED|Primary Phase||3
8583888|NCT00239577|9617735|FG003|NOT COMPLETED|Primary Phase||0
8583889|NCT00239577|9617732|FG000|STARTED|Booster Phase|The subjects belonging to this group did not receive a booster dose of Dengue vaccine.|0
8583890|NCT00239577|9617733|FG001|STARTED|Booster Phase||9
8583891|NCT00239577|9617734|FG002|STARTED|Booster Phase||12
8583892|NCT00239577|9617735|FG003|STARTED|Booster Phase|The subjects belonging to this group did not receive an additional dose of Placebo.|0
8583893|NCT00239577|9617732|FG000|COMPLETED|Booster Phase|The subjects belonging to this group did not receive a booster dose of Dengue vaccine.|0
8583894|NCT00239577|9617733|FG001|COMPLETED|Booster Phase||9
8583895|NCT00239577|9617734|FG002|COMPLETED|Booster Phase||12
8583896|NCT00239577|9617735|FG003|COMPLETED|Booster Phase|The subjects belonging to this group did not receive an additional dose of Placebo.|0
8583897|NCT00239577|9617732|FG000|NOT COMPLETED|Booster Phase||0
8583898|NCT00239577|9617733|FG001|NOT COMPLETED|Booster Phase||0
8583899|NCT00239577|9617734|FG002|NOT COMPLETED|Booster Phase||0
8583900|NCT00239577|9617735|FG003|NOT COMPLETED|Booster Phase||0
8583901|NCT00239590|9617747|FG000|STARTED|Randomized||14
8583902|NCT00239590|9617748|FG001|STARTED|Randomized||14
8583903|NCT00239590|9617747|FG000|COMPLETED|Randomized||14
8583904|NCT00239590|9617748|FG001|COMPLETED|Randomized||12
8583905|NCT00239590|9617747|FG000|NOT COMPLETED|Randomized||0
8583906|NCT00239590|9617748|FG001|NOT COMPLETED|Randomized||2
8583907|NCT00239590|9617747|FG000|STARTED|Started Intervention After Randomization||14
8583908|NCT00239590|9617748|FG001|STARTED|Started Intervention After Randomization||12
8583909|NCT00239590|9617747|FG000|COMPLETED|Started Intervention After Randomization||14
8583910|NCT00239590|9617748|FG001|COMPLETED|Started Intervention After Randomization||12
8583911|NCT00239590|9617747|FG000|NOT COMPLETED|Started Intervention After Randomization||0
8583912|NCT00239590|9617748|FG001|NOT COMPLETED|Started Intervention After Randomization||0
8583913|NCT00239590|9617747|FG000|STARTED|Completed Study Protocol||14
8583914|NCT00239590|9617748|FG001|STARTED|Completed Study Protocol||12
8583915|NCT00239590|9617747|FG000|COMPLETED|Completed Study Protocol||13
8583916|NCT00239590|9617748|FG001|COMPLETED|Completed Study Protocol||10
8583917|NCT00239590|9617747|FG000|NOT COMPLETED|Completed Study Protocol||1
8583918|NCT00239590|9617748|FG001|NOT COMPLETED|Completed Study Protocol||2
8583919|NCT00239642|9617759|FG000|STARTED|Overall Study||49
8583920|NCT00239642|9617760|FG001|STARTED|Overall Study||47
8583921|NCT00239642|9617761|FG002|STARTED|Overall Study||49
8583922|NCT00239642|9617759|FG000|COMPLETED|Overall Study||47
8583923|NCT00239642|9617760|FG001|COMPLETED|Overall Study||47
8583924|NCT00239642|9617761|FG002|COMPLETED|Overall Study||47
8583925|NCT00239642|9617759|FG000|NOT COMPLETED|Overall Study||2
8583926|NCT00239642|9617760|FG001|NOT COMPLETED|Overall Study||0
8583927|NCT00239642|9617761|FG002|NOT COMPLETED|Overall Study||2
8583928|NCT00239681|9617771|FG000|STARTED|Overall Study||8901
8583929|NCT00239681|9617772|FG001|STARTED|Overall Study||8901
8583930|NCT00239681|9617771|FG000|Randomized and Treated (Safety Pop)|Overall Study||8869
8583931|NCT00239681|9617772|FG001|Randomized and Treated (Safety Pop)|Overall Study||8864
8583932|NCT00239681|9617771|FG000|COMPLETED|Overall Study||8208
8583933|NCT00239681|9617772|FG001|COMPLETED|Overall Study||8186
8583934|NCT00239681|9617771|FG000|NOT COMPLETED|Overall Study||693
8583935|NCT00239681|9617772|FG001|NOT COMPLETED|Overall Study||715
8583936|NCT00239733|9617778|FG000|STARTED|Overall Study||6
8583937|NCT00239733|9617778|FG000|COMPLETED|Overall Study||6
8583938|NCT00239733|9617778|FG000|NOT COMPLETED|Overall Study||0
8583939|NCT00239837|9617784|FG000|STARTED|Overall Study||48
8583940|NCT00239837|9617785|FG001|STARTED|Overall Study||52
8583941|NCT00239837|9617784|FG000|6 Months|Overall Study||48
8583942|NCT00239837|9617785|FG001|6 Months|Overall Study||50
8583943|NCT00239837|9617784|FG000|COMPLETED|Overall Study|3-year follow-up|45
8583944|NCT00239837|9617785|FG001|COMPLETED|Overall Study|3-year follow-up|45
8583945|NCT00239837|9617784|FG000|NOT COMPLETED|Overall Study||3
8583946|NCT00239837|9617785|FG001|NOT COMPLETED|Overall Study||7
8583947|NCT00239928|9617793|FG000|STARTED|Overall Study||61
8583948|NCT00239928|9617793|FG000|COMPLETED|Overall Study||51
8583949|NCT00239928|9617793|FG000|NOT COMPLETED|Overall Study||10
8583950|NCT00240071|9617797|FG000|STARTED|Overall Study||30
8583951|NCT00240071|9617797|FG000|COMPLETED|Overall Study|3 patients withdrew consent after 29, 5 and 3 1/2 months on study.|27
8583952|NCT00240071|9617797|FG000|NOT COMPLETED|Overall Study||3
8583953|NCT00240097|9617802|FG000|STARTED|Part I||30
8583954|NCT00240097|9617802|FG000|COMPLETED|Part I||26
8583955|NCT00240097|9617802|FG000|NOT COMPLETED|Part I||4
8583956|NCT00240097|9617802|FG000|STARTED|Part II||26
8583957|NCT00240097|9617802|FG000|COMPLETED|Part II||3
8583958|NCT00240097|9617802|FG000|NOT COMPLETED|Part II||23
8583959|NCT00240110|9617812|FG000|STARTED|Overall Study||13
8583960|NCT00240110|9617813|FG001|STARTED|Overall Study||13
8583961|NCT00240110|9617812|FG000|COMPLETED|Overall Study||7
8583962|NCT00240110|9617813|FG001|COMPLETED|Overall Study||6
8583963|NCT00240110|9617812|FG000|NOT COMPLETED|Overall Study||6
8583964|NCT00240110|9617813|FG001|NOT COMPLETED|Overall Study||7
8583965|NCT00240162|9617821|FG000|STARTED|Overall Study||21
8583966|NCT00240162|9617821|FG000|COMPLETED|Overall Study||21
8583967|NCT00240162|9617821|FG000|NOT COMPLETED|Overall Study||0
8583968|NCT00240331|9617827|FG000|STARTED|Overall Study|Two patients were incorrectly randomised and not included in the analyses.|1389
8709909|NCT00955409|9756158|FG006|NOT COMPLETED|Overall Study||24
8709910|NCT00955409|9756159|FG007|NOT COMPLETED|Overall Study||4
8709911|NCT00955409|9756160|FG008|NOT COMPLETED|Overall Study||14
8709912|NCT00955409|9756161|FG009|NOT COMPLETED|Overall Study||1
8709913|NCT00955474|9756189|FG000|STARTED|Overall Study||12
8709914|NCT00955474|9756190|FG001|STARTED|Overall Study||13
8583969|NCT00240331|9617828|FG001|STARTED|Overall Study|One patient was incorrectly randomised and not included in the analyses|1384
8583970|NCT00240331|9617827|FG000|COMPLETED|Overall Study|Vital status was obtained for all randomised patients at the end of the study|1263
8583971|NCT00240331|9617828|FG001|COMPLETED|Overall Study|Vital status was obtained for all randomised patients at the end of the study|1250
8583972|NCT00240331|9617827|FG000|NOT COMPLETED|Overall Study||126
8583973|NCT00240331|9617828|FG001|NOT COMPLETED|Overall Study||134
8583974|NCT00240487|9617836|FG000|STARTED|Overall Study||24
8583975|NCT00240487|9617837|FG001|STARTED|Overall Study||28
8583976|NCT00240487|9617836|FG000|COMPLETED|Overall Study||24
8583977|NCT00240487|9617837|FG001|COMPLETED|Overall Study||28
8583978|NCT00240487|9617836|FG000|NOT COMPLETED|Overall Study||0
8583979|NCT00240487|9617837|FG001|NOT COMPLETED|Overall Study||0
8583980|NCT00240526|9617847|FG000|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|19
8583981|NCT00240526|9617848|FG001|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|19
8583982|NCT00240526|9617849|FG002|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|14
8583983|NCT00240526|9617850|FG003|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|21
8583984|NCT00240526|9617847|FG000|COMPLETED|Year 15||19
8583985|NCT00240526|9617848|FG001|COMPLETED|Year 15||19
8583986|NCT00240526|9617849|FG002|COMPLETED|Year 15||14
8583987|NCT00240526|9617850|FG003|COMPLETED|Year 15||21
8583988|NCT00240526|9617847|FG000|NOT COMPLETED|Year 15||0
8583989|NCT00240526|9617848|FG001|NOT COMPLETED|Year 15||0
8583990|NCT00240526|9617849|FG002|NOT COMPLETED|Year 15||0
8583991|NCT00240526|9617850|FG003|NOT COMPLETED|Year 15||0
8583992|NCT00240526|9617847|FG000|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|17
8709915|NCT00955474|9756189|FG000|COMPLETED|Overall Study||5
8709916|NCT00955474|9756190|FG001|COMPLETED|Overall Study||8
8709917|NCT00955474|9756189|FG000|NOT COMPLETED|Overall Study||7
8709918|NCT00955474|9756190|FG001|NOT COMPLETED|Overall Study||5
8709919|NCT00955487|9756200|FG000|STARTED|Overall Study||10
8709920|NCT00955487|9756201|FG001|STARTED|Overall Study||9
8709921|NCT00955487|9756202|FG002|STARTED|Overall Study||17
8583993|NCT00240526|9617848|FG001|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|19
8583994|NCT00240526|9617849|FG002|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|16
8709922|NCT00955487|9756203|FG003|STARTED|Overall Study||21
8709923|NCT00955487|9756204|FG004|STARTED|Overall Study||32
8709924|NCT00955487|9756205|FG005|STARTED|Overall Study||35
8709925|NCT00955487|9756200|FG000|COMPLETED|Overall Study||10
8709926|NCT00955487|9756201|FG001|COMPLETED|Overall Study||9
8709927|NCT00955487|9756202|FG002|COMPLETED|Overall Study||17
8583995|NCT00240526|9617850|FG003|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|22
8583996|NCT00240526|9617847|FG000|COMPLETED|Year 16||17
8583997|NCT00240526|9617848|FG001|COMPLETED|Year 16||19
8583998|NCT00240526|9617849|FG002|COMPLETED|Year 16||16
8583999|NCT00240526|9617850|FG003|COMPLETED|Year 16||22
8584000|NCT00240526|9617847|FG000|NOT COMPLETED|Year 16||0
8584001|NCT00240526|9617848|FG001|NOT COMPLETED|Year 16||0
8709928|NCT00955487|9756203|FG003|COMPLETED|Overall Study||21
8709929|NCT00955487|9756204|FG004|COMPLETED|Overall Study||32
8709930|NCT00955487|9756205|FG005|COMPLETED|Overall Study||35
8584002|NCT00240526|9617849|FG002|NOT COMPLETED|Year 16||0
8584003|NCT00240526|9617850|FG003|NOT COMPLETED|Year 16||0
8584004|NCT00240526|9617847|FG000|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|19
8584005|NCT00240526|9617848|FG001|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|17
8584006|NCT00240526|9617849|FG002|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|13
8584007|NCT00240526|9617850|FG003|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|20
8584008|NCT00240526|9617847|FG000|COMPLETED|Year 17||19
8584009|NCT00240526|9617848|FG001|COMPLETED|Year 17||17
8584010|NCT00240526|9617849|FG002|COMPLETED|Year 17||13
8584011|NCT00240526|9617850|FG003|COMPLETED|Year 17||20
8584012|NCT00240526|9617847|FG000|NOT COMPLETED|Year 17||0
8584013|NCT00240526|9617848|FG001|NOT COMPLETED|Year 17||0
8584014|NCT00240526|9617849|FG002|NOT COMPLETED|Year 17||0
8584015|NCT00240526|9617850|FG003|NOT COMPLETED|Year 17||0
8584016|NCT00240526|9617847|FG000|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|16
8584017|NCT00240526|9617848|FG001|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|17
8584018|NCT00240526|9617849|FG002|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|14
8584019|NCT00240526|9617850|FG003|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|20
8584020|NCT00240526|9617847|FG000|COMPLETED|Year 18||16
8584021|NCT00240526|9617848|FG001|COMPLETED|Year 18||17
8584022|NCT00240526|9617849|FG002|COMPLETED|Year 18||14
8584023|NCT00240526|9617850|FG003|COMPLETED|Year 18||20
8584024|NCT00240526|9617847|FG000|NOT COMPLETED|Year 18||0
8584025|NCT00240526|9617848|FG001|NOT COMPLETED|Year 18||0
8584026|NCT00240526|9617849|FG002|NOT COMPLETED|Year 18||0
8584027|NCT00240526|9617850|FG003|NOT COMPLETED|Year 18||0
8584028|NCT00240526|9617847|FG000|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|17
8584029|NCT00240526|9617848|FG001|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|16
8584030|NCT00240526|9617849|FG002|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|12
8584031|NCT00240526|9617850|FG003|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|18
8584032|NCT00240526|9617847|FG000|COMPLETED|Year 19||17
8584033|NCT00240526|9617848|FG001|COMPLETED|Year 19||16
8584034|NCT00240526|9617849|FG002|COMPLETED|Year 19||12
8584035|NCT00240526|9617850|FG003|COMPLETED|Year 19||18
8584036|NCT00240526|9617847|FG000|NOT COMPLETED|Year 19||0
8584037|NCT00240526|9617848|FG001|NOT COMPLETED|Year 19||0
8584038|NCT00240526|9617849|FG002|NOT COMPLETED|Year 19||0
8584039|NCT00240526|9617850|FG003|NOT COMPLETED|Year 19||0
8584040|NCT00240526|9617847|FG000|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|19
8584041|NCT00240526|9617848|FG001|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|17
8584042|NCT00240526|9617849|FG002|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|13
8584043|NCT00240526|9617850|FG003|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|20
8584044|NCT00240526|9617847|FG000|COMPLETED|Year 20||19
8584045|NCT00240526|9617848|FG001|COMPLETED|Year 20||17
8584046|NCT00240526|9617849|FG002|COMPLETED|Year 20||13
8584047|NCT00240526|9617850|FG003|COMPLETED|Year 20||20
8584048|NCT00240526|9617847|FG000|NOT COMPLETED|Year 20||0
8709931|NCT00955487|9756200|FG000|NOT COMPLETED|Overall Study||0
8709932|NCT00955487|9756201|FG001|NOT COMPLETED|Overall Study||0
8709933|NCT00955487|9756202|FG002|NOT COMPLETED|Overall Study||0
8709934|NCT00955487|9756203|FG003|NOT COMPLETED|Overall Study||0
8709935|NCT00955487|9756204|FG004|NOT COMPLETED|Overall Study||0
8709936|NCT00955487|9756205|FG005|NOT COMPLETED|Overall Study||0
8709937|NCT00955513|9756220|FG000|STARTED|Overall Study||80
8709938|NCT00955513|9756221|FG001|STARTED|Overall Study||80
8709939|NCT00955513|9756222|FG002|STARTED|Overall Study||82
8709940|NCT00955513|9756220|FG000|COMPLETED|Overall Study||79
8709941|NCT00955513|9756221|FG001|COMPLETED|Overall Study||78
8709942|NCT00955513|9756222|FG002|COMPLETED|Overall Study||79
8709943|NCT00955513|9756220|FG000|NOT COMPLETED|Overall Study||1
8709944|NCT00955513|9756221|FG001|NOT COMPLETED|Overall Study||2
8709945|NCT00955513|9756222|FG002|NOT COMPLETED|Overall Study||3
8709946|NCT00955617|9756230|FG000|STARTED|First MRA (Between Day0 and Day21)||10
8709947|NCT00955617|9756231|FG001|STARTED|First MRA (Between Day0 and Day21)||10
8709948|NCT00955617|9756230|FG000|COMPLETED|First MRA (Between Day0 and Day21)||10
8709949|NCT00955617|9756231|FG001|COMPLETED|First MRA (Between Day0 and Day21)||10
8709950|NCT00955617|9756230|FG000|NOT COMPLETED|First MRA (Between Day0 and Day21)||0
8709951|NCT00955617|9756231|FG001|NOT COMPLETED|First MRA (Between Day0 and Day21)||0
8709952|NCT00955617|9756230|FG000|STARTED|Second MRA (Between Day 1 and Day 51)||10
8709953|NCT00955617|9756231|FG001|STARTED|Second MRA (Between Day 1 and Day 51)||10
8709954|NCT00955617|9756230|FG000|COMPLETED|Second MRA (Between Day 1 and Day 51)||7
8709955|NCT00955617|9756231|FG001|COMPLETED|Second MRA (Between Day 1 and Day 51)||7
8725191|NCT01029704|9772383|FG005|COMPLETED|Overall Study||20
8584049|NCT00240526|9617848|FG001|NOT COMPLETED|Year 20||0
8584050|NCT00240526|9617849|FG002|NOT COMPLETED|Year 20||0
8584051|NCT00240526|9617850|FG003|NOT COMPLETED|Year 20||0
8584052|NCT00240539|9617868|FG000|STARTED|Overall Study||2
8584053|NCT00240539|9617869|FG001|STARTED|Overall Study||2
8584054|NCT00240539|9617870|FG002|STARTED|Overall Study||31
8584055|NCT00240539|9617871|FG003|STARTED|Overall Study||1
8584056|NCT00240539|9617868|FG000|COMPLETED|Overall Study||2
8584057|NCT00240539|9617869|FG001|COMPLETED|Overall Study||2
8584058|NCT00240539|9617870|FG002|COMPLETED|Overall Study||31
8584059|NCT00240539|9617871|FG003|COMPLETED|Overall Study||1
8584060|NCT00240539|9617868|FG000|NOT COMPLETED|Overall Study||0
8584061|NCT00240539|9617869|FG001|NOT COMPLETED|Overall Study||0
8584062|NCT00240539|9617870|FG002|NOT COMPLETED|Overall Study||0
8584063|NCT00240539|9617871|FG003|NOT COMPLETED|Overall Study||0
8584064|NCT00240981|9617883|FG000|STARTED|Overall Study||106
8584065|NCT00240981|9617884|FG001|STARTED|Overall Study||103
8584066|NCT00240981|9617883|FG000|Intent to Treat Sample|Overall Study||82
8584067|NCT00240981|9617884|FG001|Intent to Treat Sample|Overall Study||83
8584068|NCT00240981|9617883|FG000|COMPLETED|Overall Study||68
8584069|NCT00240981|9617884|FG001|COMPLETED|Overall Study||70
8584070|NCT00240981|9617883|FG000|NOT COMPLETED|Overall Study||38
8584071|NCT00240981|9617884|FG001|NOT COMPLETED|Overall Study||33
8584072|NCT00240994|9617891|FG000|STARTED|Overall Study||35
8584073|NCT00240994|9617891|FG000|COMPLETED|Overall Study||32
8584074|NCT00240994|9617891|FG000|NOT COMPLETED|Overall Study||3
8584075|NCT00241176|9617895|FG000|STARTED|Overall Study||11
8584076|NCT00241176|9617895|FG000|COMPLETED|Overall Study||11
8584077|NCT00241176|9617895|FG000|NOT COMPLETED|Overall Study||0
8584078|NCT00241280|9617902|FG000|STARTED|Overall Study||247
8584079|NCT00241280|9617903|FG001|STARTED|Overall Study||254
8584080|NCT00241280|9617902|FG000|COMPLETED|Overall Study||199
8584081|NCT00241280|9617903|FG001|COMPLETED|Overall Study||186
8584082|NCT00241280|9617902|FG000|NOT COMPLETED|Overall Study||48
8584083|NCT00241280|9617903|FG001|NOT COMPLETED|Overall Study||68
8584084|NCT00241358|9617913|FG000|STARTED|Overall Study||25
8584085|NCT00241358|9617914|FG001|STARTED|Overall Study||46
8584086|NCT00241358|9617915|FG002|STARTED|Overall Study||21
8584087|NCT00241358|9617913|FG000|COMPLETED|Overall Study||25
8584088|NCT00241358|9617914|FG001|COMPLETED|Overall Study||45
8584089|NCT00241358|9617915|FG002|COMPLETED|Overall Study||20
8584090|NCT00241358|9617913|FG000|NOT COMPLETED|Overall Study||0
8584091|NCT00241358|9617914|FG001|NOT COMPLETED|Overall Study||1
8584092|NCT00241358|9617915|FG002|NOT COMPLETED|Overall Study||1
8584093|NCT00241631|9617924|FG000|STARTED|Run in (2 Weeks)||25
8584094|NCT00241631|9617925|FG001|STARTED|Run in (2 Weeks)||24
8584095|NCT00241631|9617924|FG000|COMPLETED|Run in (2 Weeks)||22
8584096|NCT00241631|9617925|FG001|COMPLETED|Run in (2 Weeks)||21
8584097|NCT00241631|9617924|FG000|NOT COMPLETED|Run in (2 Weeks)||3
8584098|NCT00241631|9617925|FG001|NOT COMPLETED|Run in (2 Weeks)||3
8584099|NCT00241631|9617924|FG000|STARTED|Phase 1 (4 Weeks)||22
8584100|NCT00241631|9617925|FG001|STARTED|Phase 1 (4 Weeks)||21
8709956|NCT00955617|9756230|FG000|NOT COMPLETED|Second MRA (Between Day 1 and Day 51)||3
8709957|NCT00955617|9756231|FG001|NOT COMPLETED|Second MRA (Between Day 1 and Day 51)||3
8709958|NCT00955682|9756239|FG000|STARTED|Year 2 Period||253
8709959|NCT00955682|9756240|FG001|STARTED|Year 2 Period||42
8709960|NCT00955682|9756239|FG000|COMPLETED|Year 2 Period||253
8709961|NCT00955682|9756240|FG001|COMPLETED|Year 2 Period||42
8709962|NCT00955682|9756239|FG000|NOT COMPLETED|Year 2 Period||0
8709963|NCT00955682|9756240|FG001|NOT COMPLETED|Year 2 Period||0
8709964|NCT00955682|9756239|FG000|STARTED|Year 3 Period||273
8584101|NCT00241631|9617924|FG000|COMPLETED|Phase 1 (4 Weeks)||14
8584102|NCT00241631|9617925|FG001|COMPLETED|Phase 1 (4 Weeks)||16
8584103|NCT00241631|9617924|FG000|NOT COMPLETED|Phase 1 (4 Weeks)||8
8584104|NCT00241631|9617925|FG001|NOT COMPLETED|Phase 1 (4 Weeks)||5
8584105|NCT00241631|9617924|FG000|STARTED|Wash Out (2 Weeks)||14
8584106|NCT00241631|9617925|FG001|STARTED|Wash Out (2 Weeks)||16
8584107|NCT00241631|9617924|FG000|COMPLETED|Wash Out (2 Weeks)||14
8584108|NCT00241631|9617925|FG001|COMPLETED|Wash Out (2 Weeks)||16
8584109|NCT00241631|9617924|FG000|NOT COMPLETED|Wash Out (2 Weeks)||0
8584110|NCT00241631|9617925|FG001|NOT COMPLETED|Wash Out (2 Weeks)||0
8584111|NCT00241631|9617924|FG000|STARTED|Phase 2 (4 Weeks)||14
8584112|NCT00241631|9617925|FG001|STARTED|Phase 2 (4 Weeks)||16
8584113|NCT00241631|9617924|FG000|COMPLETED|Phase 2 (4 Weeks)||14
8584114|NCT00241631|9617925|FG001|COMPLETED|Phase 2 (4 Weeks)||16
8584115|NCT00241631|9617924|FG000|NOT COMPLETED|Phase 2 (4 Weeks)||0
8584116|NCT00241631|9617925|FG001|NOT COMPLETED|Phase 2 (4 Weeks)||0
8584117|NCT00241644|9617935|FG000|STARTED|First Efficacy Period (Year 1)||1647
8584118|NCT00241644|9617936|FG001|STARTED|First Efficacy Period (Year 1)||1651
8584119|NCT00241644|9617937|FG002|STARTED|First Efficacy Period (Year 1)||1641
8584120|NCT00241644|9617938|FG003|STARTED|First Efficacy Period (Year 1)||3298
8709965|NCT00955682|9756240|FG001|STARTED|Year 3 Period||47
8584121|NCT00241644|9617935|FG000|COMPLETED|First Efficacy Period (Year 1)||1420
8584122|NCT00241644|9617936|FG001|COMPLETED|First Efficacy Period (Year 1)||1383
8584123|NCT00241644|9617937|FG002|COMPLETED|First Efficacy Period (Year 1)||1392
8584124|NCT00241644|9617938|FG003|COMPLETED|First Efficacy Period (Year 1)||2803
8584125|NCT00241644|9617935|FG000|NOT COMPLETED|First Efficacy Period (Year 1)||227
8584126|NCT00241644|9617936|FG001|NOT COMPLETED|First Efficacy Period (Year 1)||268
8584127|NCT00241644|9617937|FG002|NOT COMPLETED|First Efficacy Period (Year 1)||249
8584128|NCT00241644|9617938|FG003|NOT COMPLETED|First Efficacy Period (Year 1)||495
8584129|NCT00241644|9617935|FG000|STARTED|Second Efficacy Period (Year 2)||771
8584130|NCT00241644|9617936|FG001|STARTED|Second Efficacy Period (Year 2)||754
8584131|NCT00241644|9617937|FG002|STARTED|Second Efficacy Period (Year 2)||746
8584132|NCT00241644|9617938|FG003|STARTED|Second Efficacy Period (Year 2)||1525
8584133|NCT00241644|9617935|FG000|COMPLETED|Second Efficacy Period (Year 2)||710
8584134|NCT00241644|9617936|FG001|COMPLETED|Second Efficacy Period (Year 2)||697
8709966|NCT00955682|9756239|FG000|COMPLETED|Year 3 Period||273
8584135|NCT00241644|9617937|FG002|COMPLETED|Second Efficacy Period (Year 2)||682
8584136|NCT00241644|9617938|FG003|COMPLETED|Second Efficacy Period (Year 2)||1407
8584137|NCT00241644|9617935|FG000|NOT COMPLETED|Second Efficacy Period (Year 2)||61
8584138|NCT00241644|9617936|FG001|NOT COMPLETED|Second Efficacy Period (Year 2)||57
8584139|NCT00241644|9617937|FG002|NOT COMPLETED|Second Efficacy Period (Year 2)||64
8584140|NCT00241644|9617938|FG003|NOT COMPLETED|Second Efficacy Period (Year 2)||118
8584141|NCT00241839|9617950|FG000|STARTED|Overall Study||71
8584142|NCT00241839|9617951|FG001|STARTED|Overall Study||71
8584143|NCT00241839|9617950|FG000|COMPLETED|Overall Study|N=52 represents number with both baseline and 8-10 week data. N<52 implies missing data.|52
8584144|NCT00241839|9617951|FG001|COMPLETED|Overall Study|N=53 represents number with both baseline and 8-10 week data. N<53 implies missing data.|53
8584145|NCT00241839|9617950|FG000|NOT COMPLETED|Overall Study||19
8584146|NCT00241839|9617951|FG001|NOT COMPLETED|Overall Study||18
8584147|NCT00241904|9617959|FG000|STARTED|Overall Study||261
8584148|NCT00241904|9617960|FG001|STARTED|Overall Study||264
8584149|NCT00241904|9617959|FG000|COMPLETED|Overall Study||227
8584150|NCT00241904|9617960|FG001|COMPLETED|Overall Study||240
8584151|NCT00241904|9617959|FG000|NOT COMPLETED|Overall Study||34
8584152|NCT00241904|9617960|FG001|NOT COMPLETED|Overall Study||24
8584153|NCT00241969|9617969|FG000|STARTED|Overall Study||36
8584154|NCT00241969|9617970|FG001|STARTED|Overall Study||42
8584155|NCT00241969|9617969|FG000|COMPLETED|Overall Study||36
8584156|NCT00241969|9617970|FG001|COMPLETED|Overall Study||42
8584157|NCT00241969|9617969|FG000|NOT COMPLETED|Overall Study||0
8584158|NCT00241969|9617970|FG001|NOT COMPLETED|Overall Study||0
8584159|NCT00242216|9617978|FG000|STARTED|Overall Study||39
8584160|NCT00242216|9617979|FG001|STARTED|Overall Study||37
8584161|NCT00242216|9617978|FG000|COMPLETED|Overall Study||21
8584162|NCT00242216|9617979|FG001|COMPLETED|Overall Study||15
8584163|NCT00242216|9617978|FG000|NOT COMPLETED|Overall Study||18
8584164|NCT00242216|9617979|FG001|NOT COMPLETED|Overall Study||22
8584165|NCT00242385|9617985|FG000|STARTED|Period 1||14
8584166|NCT00242385|9617986|FG001|STARTED|Period 1||11
8584167|NCT00242385|9617985|FG000|COMPLETED|Period 1||14
8584168|NCT00242385|9617986|FG001|COMPLETED|Period 1||11
8584169|NCT00242385|9617985|FG000|NOT COMPLETED|Period 1||0
8584170|NCT00242385|9617986|FG001|NOT COMPLETED|Period 1||0
8584171|NCT00242385|9617985|FG000|STARTED|Period 2||14
8584172|NCT00242385|9617986|FG001|STARTED|Period 2||11
8584173|NCT00242385|9617985|FG000|COMPLETED|Period 2||14
8584174|NCT00242385|9617986|FG001|COMPLETED|Period 2||11
8584175|NCT00242385|9617985|FG000|NOT COMPLETED|Period 2||0
8584176|NCT00242385|9617986|FG001|NOT COMPLETED|Period 2||0
8584177|NCT00242502|9617992|FG000|STARTED|Overall Study||59
8584178|NCT00242502|9617992|FG000|COMPLETED|Overall Study||59
8584179|NCT00242502|9617992|FG000|NOT COMPLETED|Overall Study||0
8584180|NCT00242567|9617998|FG000|STARTED|Overall Study||259
8584181|NCT00242567|9617999|FG001|STARTED|Overall Study||263
8584182|NCT00242567|9617998|FG000|Received at Least 1 Dose of Study Drug|Overall Study||259
8584183|NCT00242567|9617999|FG001|Received at Least 1 Dose of Study Drug|Overall Study||72
8584184|NCT00242567|9617998|FG000|Never Received Study Drug|Overall Study||0
8584185|NCT00242567|9617999|FG001|Never Received Study Drug|Overall Study||191
8584186|NCT00242567|9617998|FG000|COMPLETED|Overall Study||93
8584187|NCT00242567|9617999|FG001|COMPLETED|Overall Study||123
8584188|NCT00242567|9617998|FG000|NOT COMPLETED|Overall Study||166
8584189|NCT00242567|9617999|FG001|NOT COMPLETED|Overall Study||140
8584190|NCT00242580|9618010|FG000|STARTED|Overall Study||32
8584191|NCT00242580|9618011|FG001|STARTED|Overall Study||41
8584192|NCT00242580|9618012|FG002|STARTED|Overall Study||38
8584193|NCT00242580|9618010|FG000|COMPLETED|Overall Study|"Completed indicates 12 month data."|22
8584194|NCT00242580|9618011|FG001|COMPLETED|Overall Study||29
8584195|NCT00242580|9618012|FG002|COMPLETED|Overall Study||24
8584196|NCT00242580|9618010|FG000|NOT COMPLETED|Overall Study||10
8584197|NCT00242580|9618011|FG001|NOT COMPLETED|Overall Study||12
8584198|NCT00242580|9618012|FG002|NOT COMPLETED|Overall Study||14
8584199|NCT00242619|9618022|FG000|STARTED|Overall Study||8
8584200|NCT00242619|9618023|FG001|STARTED|Overall Study||4
8584201|NCT00242619|9618022|FG000|COMPLETED|Overall Study||8
8584202|NCT00242619|9618023|FG001|COMPLETED|Overall Study||4
8584203|NCT00242619|9618022|FG000|NOT COMPLETED|Overall Study||0
8584204|NCT00242619|9618023|FG001|NOT COMPLETED|Overall Study||0
8584205|NCT00242632|9618033|FG000|STARTED|Overall Study||11
8584206|NCT00242632|9618034|FG001|STARTED|Overall Study||11
8584207|NCT00242632|9618033|FG000|COMPLETED|Overall Study||11
8584208|NCT00242632|9618034|FG001|COMPLETED|Overall Study||11
8584209|NCT00242632|9618033|FG000|NOT COMPLETED|Overall Study||0
8584210|NCT00242632|9618034|FG001|NOT COMPLETED|Overall Study||0
8584211|NCT00242658|9618041|FG000|STARTED|Overall Study||187
8584212|NCT00242658|9618042|FG001|STARTED|Overall Study||207
8584213|NCT00242658|9618041|FG000|COMPLETED|Overall Study||165
8584214|NCT00242658|9618042|FG001|COMPLETED|Overall Study||188
8584215|NCT00242658|9618041|FG000|NOT COMPLETED|Overall Study||22
8584216|NCT00242658|9618042|FG001|NOT COMPLETED|Overall Study||19
8584217|NCT00242684|9618048|FG000|STARTED|Overall Study||446
8584218|NCT00242684|9618048|FG000|COMPLETED|Overall Study||446
8584219|NCT00242684|9618048|FG000|NOT COMPLETED|Overall Study||0
8584220|NCT00242710|9618056|FG000|STARTED|Core Study (up to Year 1)||373
8584221|NCT00242710|9618057|FG001|STARTED|Core Study (up to Year 1)||353
8584222|NCT00242710|9618058|FG002|STARTED|Core Study (up to Year 1)||183
8584223|NCT00242710|9618059|FG003|STARTED|Core Study (up to Year 1)||174
8584224|NCT00242710|9618056|FG000|Treated|Core Study (up to Year 1)||361
8584225|NCT00242710|9618057|FG001|Treated|Core Study (up to Year 1)||349
8584226|NCT00242710|9618058|FG002|Treated|Core Study (up to Year 1)||179
8584227|NCT00242710|9618059|FG003|Treated|Core Study (up to Year 1)||172
8584228|NCT00242710|9618056|FG000|COMPLETED|Core Study (up to Year 1)||287
8584229|NCT00242710|9618057|FG001|COMPLETED|Core Study (up to Year 1)||289
8584230|NCT00242710|9618058|FG002|COMPLETED|Core Study (up to Year 1)||132
8584231|NCT00242710|9618059|FG003|COMPLETED|Core Study (up to Year 1)||143
8584232|NCT00242710|9618056|FG000|NOT COMPLETED|Core Study (up to Year 1)||86
8584233|NCT00242710|9618057|FG001|NOT COMPLETED|Core Study (up to Year 1)||64
8584234|NCT00242710|9618058|FG002|NOT COMPLETED|Core Study (up to Year 1)||51
8584235|NCT00242710|9618059|FG003|NOT COMPLETED|Core Study (up to Year 1)||31
8584236|NCT00242710|9618056|FG000|STARTED|Period Between Core Study and Extension||287
8709967|NCT00955682|9756240|FG001|COMPLETED|Year 3 Period||47
8709968|NCT00955682|9756239|FG000|NOT COMPLETED|Year 3 Period||0
8709969|NCT00955682|9756240|FG001|NOT COMPLETED|Year 3 Period||0
8709970|NCT00955682|9756239|FG000|STARTED|Year 4 Period||246
8709971|NCT00955682|9756240|FG001|STARTED|Year 4 Period||48
8709972|NCT00955682|9756239|FG000|COMPLETED|Year 4 Period||246
8709973|NCT00955682|9756240|FG001|COMPLETED|Year 4 Period||48
8709974|NCT00955682|9756239|FG000|NOT COMPLETED|Year 4 Period||0
8709975|NCT00955682|9756240|FG001|NOT COMPLETED|Year 4 Period||0
8709976|NCT00955682|9756239|FG000|STARTED|Booster Period (Month 48- 49)||245
8709977|NCT00955682|9756240|FG001|STARTED|Booster Period (Month 48- 49)||48
8709978|NCT00955682|9756239|FG000|COMPLETED|Booster Period (Month 48- 49)||244
8709979|NCT00955682|9756240|FG001|COMPLETED|Booster Period (Month 48- 49)||47
8709980|NCT00955682|9756239|FG000|NOT COMPLETED|Booster Period (Month 48- 49)||1
8709981|NCT00955682|9756240|FG001|NOT COMPLETED|Booster Period (Month 48- 49)||1
8709982|NCT00955682|9756239|FG000|STARTED|Year 5 Period||239
8709983|NCT00955682|9756240|FG001|STARTED|Year 5 Period||47
8709984|NCT00955682|9756239|FG000|COMPLETED|Year 5 Period||239
8709985|NCT00955682|9756240|FG001|COMPLETED|Year 5 Period||47
8709986|NCT00955682|9756239|FG000|NOT COMPLETED|Year 5 Period||0
8709987|NCT00955682|9756240|FG001|NOT COMPLETED|Year 5 Period||0
8709988|NCT00955708|9756254|FG000|STARTED|Overall Study||1308
8709989|NCT00955708|9756254|FG000|COMPLETED|Overall Study||250
8709990|NCT00955708|9756254|FG000|NOT COMPLETED|Overall Study||1058
8709991|NCT00955721|9756260|FG000|STARTED|Overall Study||9
8709992|NCT00955721|9756261|FG001|STARTED|Overall Study||0
8709993|NCT00955721|9756260|FG000|COMPLETED|Overall Study||6
8709994|NCT00955721|9756261|FG001|COMPLETED|Overall Study||0
8709995|NCT00955721|9756260|FG000|NOT COMPLETED|Overall Study||3
8709996|NCT00955721|9756261|FG001|NOT COMPLETED|Overall Study||0
8709997|NCT00955747|9756270|FG000|STARTED|Overall Study||253
8709998|NCT00955747|9756271|FG001|STARTED|Overall Study||241
8709999|NCT00955747|9756270|FG000|COMPLETED|Overall Study||184
8710000|NCT00955747|9756271|FG001|COMPLETED|Overall Study||172
8710001|NCT00955747|9756270|FG000|NOT COMPLETED|Overall Study||69
8710002|NCT00955747|9756271|FG001|NOT COMPLETED|Overall Study||69
8710003|NCT00955825|9756279|FG000|STARTED|Overall Study||233
8710004|NCT00955825|9756280|FG001|STARTED|Overall Study||240
8710005|NCT00955825|9756279|FG000|COMPLETED|Overall Study||207
8710006|NCT00955825|9756280|FG001|COMPLETED|Overall Study||223
8710007|NCT00955825|9756279|FG000|NOT COMPLETED|Overall Study||26
8710008|NCT00955825|9756280|FG001|NOT COMPLETED|Overall Study||17
8710009|NCT00955877|9756289|FG000|STARTED|Overall Study|Drug manufacturer ceased producing the drug prior to completion of 10 enrolled in this arm.|6
8710010|NCT00955877|9756290|FG001|STARTED|Overall Study|No patients were enrolled because analysis of previous arm wasn't completed.|0
8710011|NCT00955877|9756291|FG002|STARTED|Overall Study||7
8710012|NCT00955877|9756289|FG000|COMPLETED|Overall Study||6
8710013|NCT00955877|9756290|FG001|COMPLETED|Overall Study||0
8710014|NCT00955877|9756291|FG002|COMPLETED|Overall Study||7
8813007|NCT01523587|9866122|FG000|STARTED|Overall Study||398
8813008|NCT01523587|9866123|FG001|STARTED|Overall Study||397
8710015|NCT00955877|9756289|FG000|NOT COMPLETED|Overall Study||0
8710016|NCT00955877|9756290|FG001|NOT COMPLETED|Overall Study||0
8710017|NCT00955877|9756291|FG002|NOT COMPLETED|Overall Study||0
8813009|NCT01523587|9866122|FG000|Treated|Overall Study||392
8813010|NCT01523587|9866123|FG001|Treated|Overall Study||395
8584237|NCT00242710|9618057|FG001|STARTED|Period Between Core Study and Extension||289
8584238|NCT00242710|9618058|FG002|STARTED|Period Between Core Study and Extension||132
8584239|NCT00242710|9618059|FG003|STARTED|Period Between Core Study and Extension||143
8627732|NCT00519376|9667182|FG012|NOT COMPLETED|Treatment Period 3||0
8627733|NCT00519376|9667183|FG013|NOT COMPLETED|Treatment Period 3||0
8627734|NCT00519376|9667184|FG014|NOT COMPLETED|Treatment Period 3||0
8627735|NCT00519376|9667185|FG015|NOT COMPLETED|Treatment Period 3||0
8627736|NCT00519376|9667170|FG000|STARTED|Washout Period 3||2
8627737|NCT00519376|9667171|FG001|STARTED|Washout Period 3||2
8627738|NCT00519376|9667172|FG002|STARTED|Washout Period 3||2
8627739|NCT00519376|9667173|FG003|STARTED|Washout Period 3||2
8627740|NCT00519376|9667174|FG004|STARTED|Washout Period 3||1
8627741|NCT00519376|9667175|FG005|STARTED|Washout Period 3||1
8627742|NCT00519376|9667176|FG006|STARTED|Washout Period 3||1
8627743|NCT00519376|9667177|FG007|STARTED|Washout Period 3||1
8627744|NCT00519376|9667178|FG008|STARTED|Washout Period 3||1
8627745|NCT00519376|9667179|FG009|STARTED|Washout Period 3||1
8627746|NCT00519376|9667180|FG010|STARTED|Washout Period 3||1
8627747|NCT00519376|9667181|FG011|STARTED|Washout Period 3||1
8627748|NCT00519376|9667182|FG012|STARTED|Washout Period 3||0
8710018|NCT00955903|9756302|FG000|STARTED|Overall Study||55
8584240|NCT00242710|9618056|FG000|COMPLETED|Period Between Core Study and Extension||168
8584241|NCT00242710|9618057|FG001|COMPLETED|Period Between Core Study and Extension||177
8584242|NCT00242710|9618058|FG002|COMPLETED|Period Between Core Study and Extension||84
8584243|NCT00242710|9618059|FG003|COMPLETED|Period Between Core Study and Extension||94
8584244|NCT00242710|9618056|FG000|NOT COMPLETED|Period Between Core Study and Extension||119
8584245|NCT00242710|9618057|FG001|NOT COMPLETED|Period Between Core Study and Extension||112
8584246|NCT00242710|9618058|FG002|NOT COMPLETED|Period Between Core Study and Extension||48
8584247|NCT00242710|9618059|FG003|NOT COMPLETED|Period Between Core Study and Extension||49
8584248|NCT00242710|9618056|FG000|STARTED|Study Extension (up to Year 2)||168
8584249|NCT00242710|9618057|FG001|STARTED|Study Extension (up to Year 2)||177
8584250|NCT00242710|9618058|FG002|STARTED|Study Extension (up to Year 2)||84
8584251|NCT00242710|9618059|FG003|STARTED|Study Extension (up to Year 2)||94
8584252|NCT00242710|9618056|FG000|COMPLETED|Study Extension (up to Year 2)||141
8584253|NCT00242710|9618057|FG001|COMPLETED|Study Extension (up to Year 2)||148
8584254|NCT00242710|9618058|FG002|COMPLETED|Study Extension (up to Year 2)||69
8584255|NCT00242710|9618059|FG003|COMPLETED|Study Extension (up to Year 2)||84
8584256|NCT00242710|9618056|FG000|NOT COMPLETED|Study Extension (up to Year 2)||27
8584257|NCT00242710|9618057|FG001|NOT COMPLETED|Study Extension (up to Year 2)||29
8584258|NCT00242710|9618058|FG002|NOT COMPLETED|Study Extension (up to Year 2)||15
8584259|NCT00242710|9618059|FG003|NOT COMPLETED|Study Extension (up to Year 2)||10
8584260|NCT00243022|9618071|FG000|STARTED|Overall Study||7
8584261|NCT00243022|9618072|FG001|STARTED|Overall Study||5
8584262|NCT00243022|9618071|FG000|COMPLETED|Overall Study||5
8584263|NCT00243022|9618072|FG001|COMPLETED|Overall Study||4
8584264|NCT00243022|9618071|FG000|NOT COMPLETED|Overall Study||2
8584265|NCT00243022|9618072|FG001|NOT COMPLETED|Overall Study||1
8584266|NCT00243061|9618079|FG000|STARTED|Overall Study||24
8584267|NCT00243061|9618079|FG000|COMPLETED|Overall Study||24
8584268|NCT00243061|9618079|FG000|NOT COMPLETED|Overall Study||0
8584269|NCT00243074|9618084|FG000|STARTED|Overall Study||54
8584270|NCT00243074|9618084|FG000|COMPLETED|Overall Study||0
8584271|NCT00243074|9618084|FG000|NOT COMPLETED|Overall Study||54
8584272|NCT00243152|9618089|FG000|STARTED|Overall Study||3
8584273|NCT00243152|9618090|FG001|STARTED|Overall Study||3
8584274|NCT00243152|9618089|FG000|Scan 1: Drug or Placebo|Overall Study||3
8584275|NCT00243152|9618090|FG001|Scan 1: Drug or Placebo|Overall Study||3
8584276|NCT00243152|9618089|FG000|Scan 2: Placebo or Drug|Overall Study||3
8584277|NCT00243152|9618090|FG001|Scan 2: Placebo or Drug|Overall Study||3
8584278|NCT00243152|9618089|FG000|COMPLETED|Overall Study||3
8584279|NCT00243152|9618090|FG001|COMPLETED|Overall Study||3
8584280|NCT00243152|9618089|FG000|NOT COMPLETED|Overall Study||0
8584281|NCT00243152|9618090|FG001|NOT COMPLETED|Overall Study||0
8710019|NCT00955903|9756303|FG001|STARTED|Overall Study||54
8710020|NCT00955903|9756304|FG002|STARTED|Overall Study||55
8710021|NCT00955903|9756302|FG000|COMPLETED|Overall Study||49
8584282|NCT00243191|9618097|FG000|STARTED|Overall Study||18
8584283|NCT00243191|9618097|FG000|COMPLETED|Overall Study||18
8584284|NCT00243191|9618097|FG000|NOT COMPLETED|Overall Study||0
8584285|NCT00243230|9618104|FG000|STARTED|Double-Blind Period||39
8584286|NCT00243230|9618105|FG001|STARTED|Double-Blind Period||40
8584287|NCT00243230|9618106|FG002|STARTED|Double-Blind Period||37
8584288|NCT00243230|9618107|FG003|STARTED|Double-Blind Period||0
8584289|NCT00243230|9618104|FG000|Treated|Double-Blind Period||39
8584290|NCT00243230|9618105|FG001|Treated|Double-Blind Period||40
8584291|NCT00243230|9618106|FG002|Treated|Double-Blind Period||35
8584292|NCT00243230|9618107|FG003|Treated|Double-Blind Period||0
8584293|NCT00243230|9618104|FG000|COMPLETED|Double-Blind Period||33
8584294|NCT00243230|9618105|FG001|COMPLETED|Double-Blind Period||35
8584295|NCT00243230|9618106|FG002|COMPLETED|Double-Blind Period||18
8584296|NCT00243230|9618107|FG003|COMPLETED|Double-Blind Period||0
8584297|NCT00243230|9618104|FG000|NOT COMPLETED|Double-Blind Period||6
8584298|NCT00243230|9618105|FG001|NOT COMPLETED|Double-Blind Period||5
8584299|NCT00243230|9618106|FG002|NOT COMPLETED|Double-Blind Period||19
8584300|NCT00243230|9618107|FG003|NOT COMPLETED|Double-Blind Period||0
8584301|NCT00243230|9618104|FG000|STARTED|Open Label Period||0
8584302|NCT00243230|9618105|FG001|STARTED|Open Label Period||0
8584303|NCT00243230|9618106|FG002|STARTED|Open Label Period||0
8584304|NCT00243230|9618107|FG003|STARTED|Open Label Period||85
8584305|NCT00243230|9618104|FG000|COMPLETED|Open Label Period||0
8584306|NCT00243230|9618105|FG001|COMPLETED|Open Label Period||0
8584307|NCT00243230|9618106|FG002|COMPLETED|Open Label Period||0
8584308|NCT00243230|9618107|FG003|COMPLETED|Open Label Period||0
8584309|NCT00243230|9618104|FG000|NOT COMPLETED|Open Label Period||0
8584310|NCT00243230|9618105|FG001|NOT COMPLETED|Open Label Period||0
8584311|NCT00243230|9618106|FG002|NOT COMPLETED|Open Label Period||0
8584312|NCT00243230|9618107|FG003|NOT COMPLETED|Open Label Period||85
8584313|NCT00243243|9618119|FG000|STARTED|Overall Study||10
8584314|NCT00243243|9618120|FG001|STARTED|Overall Study||10
8584315|NCT00243243|9618119|FG000|COMPLETED|Overall Study||10
8584316|NCT00243243|9618120|FG001|COMPLETED|Overall Study||10
8584317|NCT00243243|9618119|FG000|NOT COMPLETED|Overall Study||0
8584318|NCT00243243|9618120|FG001|NOT COMPLETED|Overall Study||0
8584319|NCT00243269|9618130|FG000|STARTED|Overall Study||31
8584320|NCT00243269|9618131|FG001|STARTED|Overall Study||11
8584321|NCT00243269|9618132|FG002|STARTED|Overall Study||12
8584322|NCT00243269|9618133|FG003|STARTED|Overall Study||29
8584323|NCT00243269|9618130|FG000|COMPLETED|Overall Study||28
8584324|NCT00243269|9618131|FG001|COMPLETED|Overall Study||10
8584325|NCT00243269|9618132|FG002|COMPLETED|Overall Study||11
8584326|NCT00243269|9618133|FG003|COMPLETED|Overall Study||25
8584327|NCT00243269|9618130|FG000|NOT COMPLETED|Overall Study||3
8584328|NCT00243269|9618131|FG001|NOT COMPLETED|Overall Study||1
8584329|NCT00243269|9618132|FG002|NOT COMPLETED|Overall Study||1
8584330|NCT00243269|9618133|FG003|NOT COMPLETED|Overall Study||4
8584331|NCT00243347|9618143|FG000|STARTED|Overall Study|Treated|19
8584332|NCT00243347|9618143|FG000|COMPLETED|Overall Study|Completed study|0
8584333|NCT00243347|9618143|FG000|NOT COMPLETED|Overall Study||19
8584334|NCT00243386|9618147|FG000|STARTED|On-Demand Regimen (Study Part 1)||73
8584335|NCT00243386|9618148|FG001|STARTED|On-Demand Regimen (Study Part 1)|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
8584336|NCT00243386|9618149|FG002|STARTED|On-Demand Regimen (Study Part 1)|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
8584337|NCT00243386|9618147|FG000|COMPLETED|On-Demand Regimen (Study Part 1)||69
8584338|NCT00243386|9618148|FG001|COMPLETED|On-Demand Regimen (Study Part 1)||0
8584339|NCT00243386|9618149|FG002|COMPLETED|On-Demand Regimen (Study Part 1)||0
8584340|NCT00243386|9618147|FG000|NOT COMPLETED|On-Demand Regimen (Study Part 1)||4
8584341|NCT00243386|9618148|FG001|NOT COMPLETED|On-Demand Regimen (Study Part 1)||0
8584342|NCT00243386|9618149|FG002|NOT COMPLETED|On-Demand Regimen (Study Part 1)||0
8584343|NCT00243386|9618147|FG000|STARTED|End of Part 1, But Prior to Prophylaxis||69
8584344|NCT00243386|9618148|FG001|STARTED|End of Part 1, But Prior to Prophylaxis|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
8584345|NCT00243386|9618149|FG002|STARTED|End of Part 1, But Prior to Prophylaxis|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
8584346|NCT00243386|9618147|FG000|COMPLETED|End of Part 1, But Prior to Prophylaxis||66
8584347|NCT00243386|9618148|FG001|COMPLETED|End of Part 1, But Prior to Prophylaxis||0
8584348|NCT00243386|9618149|FG002|COMPLETED|End of Part 1, But Prior to Prophylaxis||0
8584349|NCT00243386|9618147|FG000|NOT COMPLETED|End of Part 1, But Prior to Prophylaxis||3
8584350|NCT00243386|9618148|FG001|NOT COMPLETED|End of Part 1, But Prior to Prophylaxis||0
8584351|NCT00243386|9618149|FG002|NOT COMPLETED|End of Part 1, But Prior to Prophylaxis||0
8584352|NCT00243386|9618147|FG000|STARTED|PK-Driven or Standard Prophylaxis|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
8584353|NCT00243386|9618148|FG001|STARTED|PK-Driven or Standard Prophylaxis||34
8584354|NCT00243386|9618149|FG002|STARTED|PK-Driven or Standard Prophylaxis||32
8584355|NCT00243386|9618147|FG000|COMPLETED|PK-Driven or Standard Prophylaxis||0
8584356|NCT00243386|9618148|FG001|COMPLETED|PK-Driven or Standard Prophylaxis||31
8584357|NCT00243386|9618149|FG002|COMPLETED|PK-Driven or Standard Prophylaxis||32
8584358|NCT00243386|9618147|FG000|NOT COMPLETED|PK-Driven or Standard Prophylaxis||0
8584359|NCT00243386|9618148|FG001|NOT COMPLETED|PK-Driven or Standard Prophylaxis||3
8584360|NCT00243386|9618149|FG002|NOT COMPLETED|PK-Driven or Standard Prophylaxis||0
8584361|NCT00243412|9618187|FG000|STARTED|Overall Study|Intent to treat|21
8584362|NCT00243412|9618188|FG001|STARTED|Overall Study|Intent to treat|21
8584363|NCT00243412|9618187|FG000|Safety Evaluable|Overall Study||21
8584364|NCT00243412|9618188|FG001|Safety Evaluable|Overall Study||20
8584365|NCT00243412|9618187|FG000|COMPLETED|Overall Study|Completed Week 104|11
8584366|NCT00243412|9618188|FG001|COMPLETED|Overall Study|Completed Week 104|10
8584367|NCT00243412|9618187|FG000|NOT COMPLETED|Overall Study||10
8584368|NCT00243412|9618188|FG001|NOT COMPLETED|Overall Study||11
8584369|NCT00243503|9618194|FG000|STARTED|Overall Study|3 participants discontinued and only took Trastuzumab.|60
8584370|NCT00243503|9618194|FG000|COMPLETED|Overall Study||2
8584371|NCT00243503|9618194|FG000|NOT COMPLETED|Overall Study||58
8584372|NCT00243659|9618201|FG000|STARTED|Overall Study||22
8584373|NCT00243659|9618202|FG001|STARTED|Overall Study||8
8584374|NCT00243659|9618201|FG000|COMPLETED|Overall Study||20
8584375|NCT00243659|9618202|FG001|COMPLETED|Overall Study||5
8584376|NCT00243659|9618201|FG000|NOT COMPLETED|Overall Study||2
8584377|NCT00243659|9618202|FG001|NOT COMPLETED|Overall Study||3
8584378|NCT00243841|9618211|FG000|STARTED|Overall Study||3
8584379|NCT00243841|9618212|FG001|STARTED|Overall Study||6
8584380|NCT00243841|9618213|FG002|STARTED|Overall Study||5
8584381|NCT00243841|9618214|FG003|STARTED|Overall Study||3
8584382|NCT00243841|9618215|FG004|STARTED|Overall Study||39
8584383|NCT00243841|9618216|FG005|STARTED|Overall Study||21
8584384|NCT00243841|9618211|FG000|COMPLETED|Overall Study||3
8584385|NCT00243841|9618212|FG001|COMPLETED|Overall Study||6
8584386|NCT00243841|9618213|FG002|COMPLETED|Overall Study||4
8584387|NCT00243841|9618214|FG003|COMPLETED|Overall Study||3
8584388|NCT00243841|9618215|FG004|COMPLETED|Overall Study||39
8584389|NCT00243841|9618216|FG005|COMPLETED|Overall Study||19
8584390|NCT00243841|9618211|FG000|NOT COMPLETED|Overall Study||0
8584391|NCT00243841|9618212|FG001|NOT COMPLETED|Overall Study||0
8584392|NCT00243841|9618213|FG002|NOT COMPLETED|Overall Study||1
8584393|NCT00243841|9618214|FG003|NOT COMPLETED|Overall Study||0
8584394|NCT00243841|9618215|FG004|NOT COMPLETED|Overall Study||0
8584395|NCT00243841|9618216|FG005|NOT COMPLETED|Overall Study||2
8584396|NCT00243919|9618235|FG000|STARTED|Overall Study||139
8584397|NCT00243919|9618236|FG001|STARTED|Overall Study||143
8584398|NCT00243919|9618237|FG002|STARTED|Overall Study||126
8584399|NCT00243919|9618235|FG000|COMPLETED|Overall Study||122
8584400|NCT00243919|9618236|FG001|COMPLETED|Overall Study||125
8584401|NCT00243919|9618237|FG002|COMPLETED|Overall Study||115
8584402|NCT00243919|9618235|FG000|NOT COMPLETED|Overall Study||17
8584403|NCT00243919|9618236|FG001|NOT COMPLETED|Overall Study||18
8584404|NCT00243919|9618237|FG002|NOT COMPLETED|Overall Study||11
8584405|NCT00243932|9618248|FG000|STARTED|Stage 1: Dose Selection||35
8584406|NCT00243932|9618249|FG001|STARTED|Stage 1: Dose Selection||35
8584407|NCT00243932|9618250|FG002|STARTED|Stage 1: Dose Selection||35
8584408|NCT00243932|9618248|FG000|COMPLETED|Stage 1: Dose Selection||33
8584409|NCT00243932|9618249|FG001|COMPLETED|Stage 1: Dose Selection||35
8584410|NCT00243932|9618250|FG002|COMPLETED|Stage 1: Dose Selection||35
8710022|NCT00955903|9756303|FG001|COMPLETED|Overall Study||51
8710023|NCT00955903|9756304|FG002|COMPLETED|Overall Study||48
8710024|NCT00955903|9756302|FG000|NOT COMPLETED|Overall Study||6
8710025|NCT00955903|9756303|FG001|NOT COMPLETED|Overall Study||3
8710026|NCT00955903|9756304|FG002|NOT COMPLETED|Overall Study||7
8710027|NCT00955916|9756312|FG000|STARTED|Overall Study||38
8710028|NCT00955916|9756312|FG000|COMPLETED|Overall Study||38
8710029|NCT00955916|9756312|FG000|NOT COMPLETED|Overall Study||0
8710030|NCT00955955|9756319|FG000|STARTED|Overall Study||19
8710031|NCT00955955|9756320|FG001|STARTED|Overall Study||28
8710032|NCT00955955|9756321|FG002|STARTED|Overall Study||28
8710033|NCT00955955|9756319|FG000|COMPLETED|Overall Study||17
8710034|NCT00955955|9756320|FG001|COMPLETED|Overall Study||28
8710035|NCT00955955|9756321|FG002|COMPLETED|Overall Study||28
8710036|NCT00955955|9756319|FG000|NOT COMPLETED|Overall Study||2
8584411|NCT00243932|9618248|FG000|NOT COMPLETED|Stage 1: Dose Selection||2
8584412|NCT00243932|9618249|FG001|NOT COMPLETED|Stage 1: Dose Selection||0
8584413|NCT00243932|9618250|FG002|NOT COMPLETED|Stage 1: Dose Selection||0
8584414|NCT00243932|9618248|FG000|STARTED|Stage 2: Efficacy|40 newly randomized pts. Efficacy analysis included Stage 1 + Stage 2 patients|40
8584415|NCT00243932|9618249|FG001|STARTED|Stage 2: Efficacy|40 newly randomized pts. Efficacy analysis included Stage 1 + Stage 2 patients|40
8584416|NCT00243932|9618250|FG002|STARTED|Stage 2: Efficacy|No new pts. randomized because selection procedure in Stage 1 selected the 2,700 mg dose.|0
8584417|NCT00243932|9618248|FG000|COMPLETED|Stage 2: Efficacy||40
8584418|NCT00243932|9618249|FG001|COMPLETED|Stage 2: Efficacy||40
8584419|NCT00243932|9618250|FG002|COMPLETED|Stage 2: Efficacy||0
8584420|NCT00243932|9618248|FG000|NOT COMPLETED|Stage 2: Efficacy||0
8584421|NCT00243932|9618249|FG001|NOT COMPLETED|Stage 2: Efficacy||0
8584422|NCT00243932|9618250|FG002|NOT COMPLETED|Stage 2: Efficacy||0
8584423|NCT00244101|9618261|FG000|STARTED|Overall Study||209
8584424|NCT00244101|9618262|FG001|STARTED|Overall Study||223
8584425|NCT00244101|9618263|FG002|STARTED|Overall Study||216
8584426|NCT00244101|9618261|FG000|COMPLETED|Overall Study||209
8584427|NCT00244101|9618262|FG001|COMPLETED|Overall Study||223
8584428|NCT00244101|9618263|FG002|COMPLETED|Overall Study||216
8584429|NCT00244101|9618261|FG000|NOT COMPLETED|Overall Study||0
8584430|NCT00244101|9618262|FG001|NOT COMPLETED|Overall Study||0
8584431|NCT00244101|9618263|FG002|NOT COMPLETED|Overall Study||0
8627749|NCT00519376|9667183|FG013|STARTED|Washout Period 3||1
8627750|NCT00519376|9667184|FG014|STARTED|Washout Period 3||1
8627751|NCT00519376|9667185|FG015|STARTED|Washout Period 3||1
8627752|NCT00519376|9667170|FG000|COMPLETED|Washout Period 3||2
8627753|NCT00519376|9667171|FG001|COMPLETED|Washout Period 3||2
8627754|NCT00519376|9667172|FG002|COMPLETED|Washout Period 3||2
8627755|NCT00519376|9667173|FG003|COMPLETED|Washout Period 3||2
8627756|NCT00519376|9667174|FG004|COMPLETED|Washout Period 3||1
8627757|NCT00519376|9667175|FG005|COMPLETED|Washout Period 3||1
8627758|NCT00519376|9667176|FG006|COMPLETED|Washout Period 3||1
8627759|NCT00519376|9667177|FG007|COMPLETED|Washout Period 3||1
8627760|NCT00519376|9667178|FG008|COMPLETED|Washout Period 3||1
8627761|NCT00519376|9667179|FG009|COMPLETED|Washout Period 3||1
8627762|NCT00519376|9667180|FG010|COMPLETED|Washout Period 3||1
8627763|NCT00519376|9667181|FG011|COMPLETED|Washout Period 3||1
8627764|NCT00519376|9667182|FG012|COMPLETED|Washout Period 3||0
8627765|NCT00519376|9667183|FG013|COMPLETED|Washout Period 3||1
8627766|NCT00519376|9667184|FG014|COMPLETED|Washout Period 3||1
8627767|NCT00519376|9667185|FG015|COMPLETED|Washout Period 3||1
8627768|NCT00519376|9667170|FG000|NOT COMPLETED|Washout Period 3||0
8627769|NCT00519376|9667171|FG001|NOT COMPLETED|Washout Period 3||0
8627770|NCT00519376|9667172|FG002|NOT COMPLETED|Washout Period 3||0
8627771|NCT00519376|9667173|FG003|NOT COMPLETED|Washout Period 3||0
8627772|NCT00519376|9667174|FG004|NOT COMPLETED|Washout Period 3||0
8627773|NCT00519376|9667175|FG005|NOT COMPLETED|Washout Period 3||0
8627774|NCT00519376|9667176|FG006|NOT COMPLETED|Washout Period 3||0
8627775|NCT00519376|9667177|FG007|NOT COMPLETED|Washout Period 3||0
8627776|NCT00519376|9667178|FG008|NOT COMPLETED|Washout Period 3||0
8627777|NCT00519376|9667179|FG009|NOT COMPLETED|Washout Period 3||0
8627778|NCT00519376|9667180|FG010|NOT COMPLETED|Washout Period 3||0
8627779|NCT00519376|9667181|FG011|NOT COMPLETED|Washout Period 3||0
8627780|NCT00519376|9667182|FG012|NOT COMPLETED|Washout Period 3||0
8627781|NCT00519376|9667183|FG013|NOT COMPLETED|Washout Period 3||0
8627782|NCT00519376|9667184|FG014|NOT COMPLETED|Washout Period 3||0
8627783|NCT00519376|9667185|FG015|NOT COMPLETED|Washout Period 3||0
8710037|NCT00955955|9756320|FG001|NOT COMPLETED|Overall Study||0
8627784|NCT00519376|9667170|FG000|STARTED|Treatment Period 4||2
8627785|NCT00519376|9667171|FG001|STARTED|Treatment Period 4||2
8627786|NCT00519376|9667172|FG002|STARTED|Treatment Period 4||2
8627787|NCT00519376|9667173|FG003|STARTED|Treatment Period 4||2
8627788|NCT00519376|9667174|FG004|STARTED|Treatment Period 4||1
8710038|NCT00955955|9756321|FG002|NOT COMPLETED|Overall Study||0
8584432|NCT00244140|9618273|FG000|STARTED|Overall Study||412
8584433|NCT00244140|9618274|FG001|STARTED|Overall Study||22
8584434|NCT00244140|9618273|FG000|COMPLETED|Overall Study||412
8584435|NCT00244140|9618274|FG001|COMPLETED|Overall Study||22
8584436|NCT00244140|9618273|FG000|NOT COMPLETED|Overall Study||0
8584437|NCT00244140|9618274|FG001|NOT COMPLETED|Overall Study||0
8584438|NCT00244374|9618280|FG000|STARTED|Pre-Randomization Cross-sectional Study||546
8584439|NCT00244374|9618281|FG001|STARTED|Pre-Randomization Cross-sectional Study||0
8584440|NCT00244374|9618282|FG002|STARTED|Pre-Randomization Cross-sectional Study||0
8584441|NCT00244374|9618283|FG003|STARTED|Pre-Randomization Cross-sectional Study||0
8584442|NCT00244374|9618284|FG004|STARTED|Pre-Randomization Cross-sectional Study||0
8584443|NCT00244374|9618280|FG000|COMPLETED|Pre-Randomization Cross-sectional Study||409
8584444|NCT00244374|9618281|FG001|COMPLETED|Pre-Randomization Cross-sectional Study||0
8584445|NCT00244374|9618282|FG002|COMPLETED|Pre-Randomization Cross-sectional Study||0
8584446|NCT00244374|9618283|FG003|COMPLETED|Pre-Randomization Cross-sectional Study||0
8584447|NCT00244374|9618284|FG004|COMPLETED|Pre-Randomization Cross-sectional Study||0
8584448|NCT00244374|9618280|FG000|NOT COMPLETED|Pre-Randomization Cross-sectional Study||137
8584449|NCT00244374|9618281|FG001|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
8584450|NCT00244374|9618282|FG002|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
8584451|NCT00244374|9618283|FG003|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
8584452|NCT00244374|9618284|FG004|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
8584453|NCT00244374|9618280|FG000|STARTED|Evaluation for Vaccine Adherence Cohort|440 study participants enrolled prior to 3/31/2007 were evaluated for vaccine adherence cohort|440
8584454|NCT00244374|9618281|FG001|STARTED|Evaluation for Vaccine Adherence Cohort||0
8584455|NCT00244374|9618282|FG002|STARTED|Evaluation for Vaccine Adherence Cohort||0
8584456|NCT00244374|9618283|FG003|STARTED|Evaluation for Vaccine Adherence Cohort||0
8584457|NCT00244374|9618284|FG004|STARTED|Evaluation for Vaccine Adherence Cohort||0
8584458|NCT00244374|9618280|FG000|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||217
8584459|NCT00244374|9618281|FG001|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
8584460|NCT00244374|9618282|FG002|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
8584461|NCT00244374|9618283|FG003|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
8584462|NCT00244374|9618284|FG004|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
8584463|NCT00244374|9618280|FG000|COMPLETED|Evaluation for Vaccine Adherence Cohort||167
8584464|NCT00244374|9618281|FG001|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
8584465|NCT00244374|9618282|FG002|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
8584466|NCT00244374|9618283|FG003|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
8584467|NCT00244374|9618284|FG004|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
8584468|NCT00244374|9618280|FG000|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||273
8584469|NCT00244374|9618281|FG001|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
8584470|NCT00244374|9618282|FG002|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
8584471|NCT00244374|9618283|FG003|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
8584472|NCT00244374|9618284|FG004|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
8584473|NCT00244374|9618280|FG000|STARTED|Vaccine Adherence Cohort|Eligible and willing cross-sectional study participants progressed to adherence cohort randomization|0
8584474|NCT00244374|9618281|FG001|STARTED|Vaccine Adherence Cohort||47
8584475|NCT00244374|9618282|FG002|STARTED|Vaccine Adherence Cohort||43
8584476|NCT00244374|9618283|FG003|STARTED|Vaccine Adherence Cohort||36
8584477|NCT00244374|9618284|FG004|STARTED|Vaccine Adherence Cohort||41
8584478|NCT00244374|9618280|FG000|COMPLETED|Vaccine Adherence Cohort||0
8584479|NCT00244374|9618281|FG001|COMPLETED|Vaccine Adherence Cohort||47
8584480|NCT00244374|9618282|FG002|COMPLETED|Vaccine Adherence Cohort||43
8584481|NCT00244374|9618283|FG003|COMPLETED|Vaccine Adherence Cohort||36
8584482|NCT00244374|9618284|FG004|COMPLETED|Vaccine Adherence Cohort||41
8584483|NCT00244374|9618280|FG000|NOT COMPLETED|Vaccine Adherence Cohort||0
8584484|NCT00244374|9618281|FG001|NOT COMPLETED|Vaccine Adherence Cohort||0
8584485|NCT00244374|9618282|FG002|NOT COMPLETED|Vaccine Adherence Cohort||0
8584486|NCT00244374|9618283|FG003|NOT COMPLETED|Vaccine Adherence Cohort||0
8584487|NCT00244374|9618284|FG004|NOT COMPLETED|Vaccine Adherence Cohort||0
8584488|NCT00244621|9618303|FG000|STARTED|Double-blind Treatment Period||29
8584489|NCT00244621|9618304|FG001|STARTED|Double-blind Treatment Period||32
8584490|NCT00244621|9618305|FG002|STARTED|Double-blind Treatment Period||32
8584491|NCT00244621|9618303|FG000|COMPLETED|Double-blind Treatment Period||27
8584492|NCT00244621|9618304|FG001|COMPLETED|Double-blind Treatment Period||29
8584493|NCT00244621|9618305|FG002|COMPLETED|Double-blind Treatment Period||30
8584494|NCT00244621|9618303|FG000|NOT COMPLETED|Double-blind Treatment Period||2
8584495|NCT00244621|9618304|FG001|NOT COMPLETED|Double-blind Treatment Period||3
8584496|NCT00244621|9618305|FG002|NOT COMPLETED|Double-blind Treatment Period||2
8584497|NCT00244621|9618303|FG000|STARTED|Open-label Treatment Period|One participant discontinued study due to Adverse Event after completing the double-blind period.|26
8584498|NCT00244621|9618304|FG001|STARTED|Open-label Treatment Period||29
8584499|NCT00244621|9618305|FG002|STARTED|Open-label Treatment Period||30
8584500|NCT00244621|9618303|FG000|COMPLETED|Open-label Treatment Period||25
8584501|NCT00244621|9618304|FG001|COMPLETED|Open-label Treatment Period||28
8584502|NCT00244621|9618305|FG002|COMPLETED|Open-label Treatment Period||28
8584503|NCT00244621|9618303|FG000|NOT COMPLETED|Open-label Treatment Period||1
8584504|NCT00244621|9618304|FG001|NOT COMPLETED|Open-label Treatment Period||1
8584505|NCT00244621|9618305|FG002|NOT COMPLETED|Open-label Treatment Period||2
8584506|NCT00244712|9618315|FG000|STARTED|Overall Study||343
8584507|NCT00244712|9618316|FG001|STARTED|Overall Study||345
8584508|NCT00244712|9618315|FG000|COMPLETED|Overall Study||234
8584509|NCT00244712|9618316|FG001|COMPLETED|Overall Study||221
8584510|NCT00244712|9618315|FG000|NOT COMPLETED|Overall Study||109
8584511|NCT00244712|9618316|FG001|NOT COMPLETED|Overall Study||124
8584512|NCT00244725|9618326|FG000|STARTED|Overall Study||237
8584513|NCT00244725|9618327|FG001|STARTED|Overall Study||245
8584514|NCT00244725|9618328|FG002|STARTED|Overall Study||239
8584515|NCT00244725|9618329|FG003|STARTED|Overall Study||237
8584516|NCT00244725|9618326|FG000|COMPLETED|Overall Study||214
8584517|NCT00244725|9618327|FG001|COMPLETED|Overall Study||226
8584518|NCT00244725|9618328|FG002|COMPLETED|Overall Study||215
8584519|NCT00244725|9618329|FG003|COMPLETED|Overall Study||216
8584520|NCT00244725|9618326|FG000|NOT COMPLETED|Overall Study||23
8584521|NCT00244725|9618327|FG001|NOT COMPLETED|Overall Study||19
8584522|NCT00244725|9618328|FG002|NOT COMPLETED|Overall Study||24
8584523|NCT00244725|9618329|FG003|NOT COMPLETED|Overall Study||21
8584524|NCT00244751|9618342|FG000|STARTED|Overall Study||88
8584525|NCT00244751|9618343|FG001|STARTED|Overall Study||89
8584526|NCT00244751|9618344|FG002|STARTED|Overall Study||88
8584527|NCT00244751|9618342|FG000|COMPLETED|Overall Study||72
8584528|NCT00244751|9618343|FG001|COMPLETED|Overall Study||74
8584529|NCT00244751|9618344|FG002|COMPLETED|Overall Study||78
8584530|NCT00244751|9618342|FG000|NOT COMPLETED|Overall Study||16
8584531|NCT00244751|9618343|FG001|NOT COMPLETED|Overall Study||15
8584532|NCT00244751|9618344|FG002|NOT COMPLETED|Overall Study||10
8584533|NCT00244764|9618361|FG000|STARTED|Overall Study||225
8584534|NCT00244764|9618361|FG000|COMPLETED|Overall Study||129
8584535|NCT00244764|9618361|FG000|NOT COMPLETED|Overall Study||96
8584536|NCT00244855|9618368|FG000|STARTED|Overall Study||7
8584537|NCT00244855|9618369|FG001|STARTED|Overall Study||25
8584538|NCT00244855|9618368|FG000|COMPLETED|Overall Study||7
8584539|NCT00244855|9618369|FG001|COMPLETED|Overall Study||24
8584540|NCT00244855|9618368|FG000|NOT COMPLETED|Overall Study||0
8584541|NCT00244855|9618369|FG001|NOT COMPLETED|Overall Study||1
8584542|NCT00244881|9618377|FG000|STARTED|Overall Study||26
8584543|NCT00244881|9618377|FG000|COMPLETED|Overall Study||23
8584544|NCT00244881|9618377|FG000|NOT COMPLETED|Overall Study||3
8584545|NCT00244933|9618381|FG000|STARTED|Overall Study||19
8584546|NCT00244933|9618381|FG000|COMPLETED|Overall Study||17
8584547|NCT00244933|9618381|FG000|NOT COMPLETED|Overall Study||2
8584548|NCT00244985|9618385|FG000|STARTED|Overall Study||42
8584549|NCT00244985|9618385|FG000|COMPLETED|Overall Study||42
8584550|NCT00244985|9618385|FG000|NOT COMPLETED|Overall Study||0
8584551|NCT00245011|9618389|FG000|STARTED|Overall Study||11
8584552|NCT00245011|9618389|FG000|COMPLETED|Overall Study|Subject had disease progression prior to completing study.|10
8584553|NCT00245011|9618389|FG000|NOT COMPLETED|Overall Study||1
8584554|NCT00245037|9618393|FG000|STARTED|Overall Study||147
8584555|NCT00245037|9618393|FG000|COMPLETED|Overall Study|17 participants died from infectious complications.|130
8584556|NCT00245037|9618393|FG000|NOT COMPLETED|Overall Study||17
8584557|NCT00245050|9618399|FG000|STARTED|Overall Study||18
8584558|NCT00245050|9618400|FG001|STARTED|Overall Study||16
8584559|NCT00245050|9618399|FG000|COMPLETED|Overall Study||15
8584560|NCT00245050|9618400|FG001|COMPLETED|Overall Study||14
8584561|NCT00245050|9618399|FG000|NOT COMPLETED|Overall Study||3
8584562|NCT00245050|9618400|FG001|NOT COMPLETED|Overall Study||2
8584563|NCT00245063|9618408|FG000|STARTED|Overall Study||12
8584564|NCT00245063|9618409|FG001|STARTED|Overall Study||13
8584565|NCT00245063|9618408|FG000|COMPLETED|Overall Study||5
8584566|NCT00245063|9618409|FG001|COMPLETED|Overall Study||8
8584567|NCT00245063|9618408|FG000|NOT COMPLETED|Overall Study||7
8584568|NCT00245063|9618409|FG001|NOT COMPLETED|Overall Study||5
8584569|NCT00245102|9618421|FG000|STARTED|Overall Study||44
8584570|NCT00245102|9618422|FG001|STARTED|Overall Study||16
8584571|NCT00245102|9618423|FG002|STARTED|Overall Study||46
8584572|NCT00245102|9618424|FG003|STARTED|Overall Study||13
8584573|NCT00245102|9618425|FG004|STARTED|Overall Study||5
8584574|NCT00245102|9618426|FG005|STARTED|Overall Study||23
8584575|NCT00245102|9618421|FG000|COMPLETED|Overall Study||37
8584576|NCT00245102|9618422|FG001|COMPLETED|Overall Study||12
8584577|NCT00245102|9618423|FG002|COMPLETED|Overall Study||39
8584578|NCT00245102|9618424|FG003|COMPLETED|Overall Study||10
8584579|NCT00245102|9618425|FG004|COMPLETED|Overall Study||5
8584580|NCT00245102|9618426|FG005|COMPLETED|Overall Study||19
8584581|NCT00245102|9618421|FG000|NOT COMPLETED|Overall Study||7
8584582|NCT00245102|9618422|FG001|NOT COMPLETED|Overall Study||4
8584583|NCT00245102|9618423|FG002|NOT COMPLETED|Overall Study||7
8584584|NCT00245102|9618424|FG003|NOT COMPLETED|Overall Study||3
8584585|NCT00245102|9618425|FG004|NOT COMPLETED|Overall Study||0
8584586|NCT00245102|9618426|FG005|NOT COMPLETED|Overall Study||4
8584587|NCT00245219|9618443|FG000|STARTED|Overall Study||91
8584588|NCT00245219|9618444|FG001|STARTED|Overall Study||94
8584589|NCT00245219|9618445|FG002|STARTED|Overall Study||60
8584590|NCT00245219|9618443|FG000|COMPLETED|Overall Study||85
8584591|NCT00245219|9618444|FG001|COMPLETED|Overall Study||88
8584592|NCT00245219|9618445|FG002|COMPLETED|Overall Study||58
8584593|NCT00245219|9618443|FG000|NOT COMPLETED|Overall Study||6
8584594|NCT00245219|9618444|FG001|NOT COMPLETED|Overall Study||6
8584595|NCT00245219|9618445|FG002|NOT COMPLETED|Overall Study||2
8584596|NCT00245466|9618456|FG000|STARTED|Overall Study||43
8584597|NCT00245466|9618457|FG001|STARTED|Overall Study||46
8584598|NCT00245466|9618458|FG002|STARTED|Overall Study||40
8584599|NCT00245466|9618456|FG000|Started FE200486 CS02A|Overall Study||32
8584600|NCT00245466|9618457|FG001|Started FE200486 CS02A|Overall Study||30
8584601|NCT00245466|9618458|FG002|Started FE200486 CS02A|Overall Study||26
8584602|NCT00245466|9618456|FG000|COMPLETED|Overall Study|Defined as those participants ongoing when the extension study was terminated|7
8584603|NCT00245466|9618457|FG001|COMPLETED|Overall Study||2
8584604|NCT00245466|9618458|FG002|COMPLETED|Overall Study||3
8584605|NCT00245466|9618456|FG000|NOT COMPLETED|Overall Study||36
8584606|NCT00245466|9618457|FG001|NOT COMPLETED|Overall Study||44
8584607|NCT00245466|9618458|FG002|NOT COMPLETED|Overall Study||37
8584608|NCT00245518|9618468|FG000|STARTED|Overall Study||17
8584609|NCT00245518|9618469|FG001|STARTED|Overall Study||16
8584610|NCT00245518|9618468|FG000|COMPLETED|Overall Study||17
8584611|NCT00245518|9618469|FG001|COMPLETED|Overall Study||16
8584612|NCT00245518|9618468|FG000|NOT COMPLETED|Overall Study||0
8584613|NCT00245518|9618469|FG001|NOT COMPLETED|Overall Study||0
8584614|NCT00245557|9618477|FG000|STARTED|Overall Study||17
8584615|NCT00245557|9618478|FG001|STARTED|Overall Study||26
8584616|NCT00245557|9618477|FG000|COMPLETED|Overall Study||11
8584617|NCT00245557|9618478|FG001|COMPLETED|Overall Study||10
8584618|NCT00245557|9618477|FG000|NOT COMPLETED|Overall Study||6
8584619|NCT00245557|9618478|FG001|NOT COMPLETED|Overall Study||16
8584620|NCT00245583|9618487|FG000|STARTED|Overall Study||20
8584621|NCT00245583|9618488|FG001|STARTED|Overall Study||22
8584622|NCT00245583|9618487|FG000|COMPLETED|Overall Study||14
8584623|NCT00245583|9618488|FG001|COMPLETED|Overall Study||13
8584624|NCT00245583|9618487|FG000|NOT COMPLETED|Overall Study||6
8584625|NCT00245583|9618488|FG001|NOT COMPLETED|Overall Study||9
8584626|NCT00245635|9618496|FG000|STARTED|Overall Study||25
8584627|NCT00245635|9618497|FG001|STARTED|Overall Study||18
8584628|NCT00245635|9618496|FG000|COMPLETED|Overall Study||25
8584629|NCT00245635|9618497|FG001|COMPLETED|Overall Study||18
8584630|NCT00245635|9618496|FG000|NOT COMPLETED|Overall Study||0
8584631|NCT00245635|9618497|FG001|NOT COMPLETED|Overall Study||0
8584632|NCT00245765|9618506|FG000|STARTED|Overall Study||59
8584633|NCT00245765|9618507|FG001|STARTED|Overall Study||59
8584634|NCT00245765|9618508|FG002|STARTED|Overall Study||58
8584635|NCT00245765|9618506|FG000|Safety Population|Overall Study|One subject in the Placebo (PBO) group received one injection of CDP870 200 mg on one occasion.|58
8584636|NCT00245765|9618507|FG001|Safety Population|Overall Study|For safety analysis, the PBO group subj. who received CDP870 was considered to be in the 200mg group|60
8584637|NCT00245765|9618508|FG002|Safety Population|Overall Study|One subject in the 400 mg group was randomized by mistake but did not receive study medication.|57
8584638|NCT00245765|9618506|FG000|COMPLETED|Overall Study||27
8584639|NCT00245765|9618507|FG001|COMPLETED|Overall Study||45
8584640|NCT00245765|9618508|FG002|COMPLETED|Overall Study||50
8584641|NCT00245765|9618506|FG000|NOT COMPLETED|Overall Study||32
8584642|NCT00245765|9618507|FG001|NOT COMPLETED|Overall Study||14
8584643|NCT00245765|9618508|FG002|NOT COMPLETED|Overall Study||8
8584644|NCT00245856|9618516|FG000|STARTED|Period One||28
8584645|NCT00245856|9618517|FG001|STARTED|Period One||0
8928134|NCT02278328|9989242|FG001|COMPLETED|Third Washout (1 Week)||6
8928135|NCT02278328|9989243|FG002|COMPLETED|Third Washout (1 Week)||6
8928136|NCT02278328|9989241|FG000|NOT COMPLETED|Third Washout (1 Week)||0
8928137|NCT02278328|9989242|FG001|NOT COMPLETED|Third Washout (1 Week)||0
8928138|NCT02278328|9989243|FG002|NOT COMPLETED|Third Washout (1 Week)||0
8928139|NCT02278341|9989251|FG000|STARTED|Overall Study||415
8928140|NCT02278341|9989252|FG001|STARTED|Overall Study||421
8928141|NCT02278341|9989251|FG000|Received Treatment|Overall Study||414
8584646|NCT00245856|9618516|FG000|COMPLETED|Period One||28
8584647|NCT00245856|9618517|FG001|COMPLETED|Period One||0
8710039|NCT00955968|9756337|FG000|STARTED|Overall Study||828
8710040|NCT00955968|9756338|FG001|STARTED|Overall Study||825
8710041|NCT00955968|9756337|FG000|COMPLETED|Overall Study||691
8710042|NCT00955968|9756338|FG001|COMPLETED|Overall Study||699
8710043|NCT00955968|9756337|FG000|NOT COMPLETED|Overall Study||137
8710044|NCT00955968|9756338|FG001|NOT COMPLETED|Overall Study||126
8710045|NCT00956020|9756347|FG000|STARTED|Overall Study||4
8710046|NCT00956020|9756347|FG000|COMPLETED|Overall Study||4
8710047|NCT00956020|9756347|FG000|NOT COMPLETED|Overall Study||0
8584648|NCT00245856|9618516|FG000|NOT COMPLETED|Period One||0
8584649|NCT00245856|9618517|FG001|NOT COMPLETED|Period One||0
8584650|NCT00245856|9618516|FG000|STARTED|Period Two||0
8584651|NCT00245856|9618517|FG001|STARTED|Period Two||39
8584652|NCT00245856|9618516|FG000|COMPLETED|Period Two||0
8584653|NCT00245856|9618517|FG001|COMPLETED|Period Two||38
8584654|NCT00245856|9618516|FG000|NOT COMPLETED|Period Two||0
8584655|NCT00245856|9618517|FG001|NOT COMPLETED|Period Two||1
8584656|NCT00246012|9618533|FG000|STARTED|Overall Study||3
8584657|NCT00246012|9618534|FG001|STARTED|Overall Study||3
8584658|NCT00246012|9618535|FG002|STARTED|Overall Study||3
8584659|NCT00246012|9618536|FG003|STARTED|Overall Study||3
8584660|NCT00246012|9618537|FG004|STARTED|Overall Study||3
8584661|NCT00246012|9618538|FG005|STARTED|Overall Study||32
8584662|NCT00246012|9618539|FG006|STARTED|Overall Study||32
8710048|NCT00956085|9756360|FG000|STARTED|Overall Study||12
8710049|NCT00956085|9756360|FG000|COMPLETED|Overall Study||12
8584663|NCT00246012|9618540|FG007|STARTED|Overall Study||33
8584664|NCT00246012|9618541|FG008|STARTED|Overall Study||32
8710050|NCT00956085|9756360|FG000|NOT COMPLETED|Overall Study||0
8584665|NCT00246012|9618533|FG000|Treated|Overall Study||3
8584666|NCT00246012|9618534|FG001|Treated|Overall Study||3
8584667|NCT00246012|9618535|FG002|Treated|Overall Study||3
8584668|NCT00246012|9618536|FG003|Treated|Overall Study||3
8584669|NCT00246012|9618537|FG004|Treated|Overall Study||3
8584670|NCT00246012|9618538|FG005|Treated|Overall Study||31
8584671|NCT00246012|9618539|FG006|Treated|Overall Study||31
8584672|NCT00246012|9618540|FG007|Treated|Overall Study||33
8584673|NCT00246012|9618541|FG008|Treated|Overall Study||32
8584674|NCT00246012|9618533|FG000|COMPLETED|Overall Study||0
8584675|NCT00246012|9618534|FG001|COMPLETED|Overall Study||2
8584676|NCT00246012|9618535|FG002|COMPLETED|Overall Study||1
8584677|NCT00246012|9618536|FG003|COMPLETED|Overall Study||0
8584678|NCT00246012|9618537|FG004|COMPLETED|Overall Study||0
8584679|NCT00246012|9618538|FG005|COMPLETED|Overall Study||4
8584680|NCT00246012|9618539|FG006|COMPLETED|Overall Study||1
8584681|NCT00246012|9618540|FG007|COMPLETED|Overall Study||5
8584682|NCT00246012|9618541|FG008|COMPLETED|Overall Study||4
8710051|NCT00956254|9756364|FG000|STARTED|Overall Study||18
8710052|NCT00956254|9756364|FG000|COMPLETED|Overall Study||18
8710053|NCT00956254|9756364|FG000|NOT COMPLETED|Overall Study||0
8710054|NCT00956293|9756372|FG000|STARTED|Main Period (Pre-randomization)||0
8710055|NCT00956293|9756373|FG001|STARTED|Main Period (Pre-randomization)||0
8710056|NCT00956293|9756374|FG002|STARTED|Main Period (Pre-randomization)||207
8584683|NCT00246012|9618533|FG000|NOT COMPLETED|Overall Study||3
8584684|NCT00246012|9618534|FG001|NOT COMPLETED|Overall Study||1
8584685|NCT00246012|9618535|FG002|NOT COMPLETED|Overall Study||2
8584686|NCT00246012|9618536|FG003|NOT COMPLETED|Overall Study||3
8584687|NCT00246012|9618537|FG004|NOT COMPLETED|Overall Study||3
8584688|NCT00246012|9618538|FG005|NOT COMPLETED|Overall Study||28
8584689|NCT00246012|9618539|FG006|NOT COMPLETED|Overall Study||31
8584690|NCT00246012|9618540|FG007|NOT COMPLETED|Overall Study||28
8584691|NCT00246012|9618541|FG008|NOT COMPLETED|Overall Study||28
8584692|NCT00246025|9618567|FG000|STARTED|Overall Study||124
8584693|NCT00246025|9618568|FG001|STARTED|Overall Study||133
8584694|NCT00246025|9618569|FG002|STARTED|Overall Study||126
8584695|NCT00246025|9618570|FG003|STARTED|Overall Study||129
8584696|NCT00246025|9618567|FG000|COMPLETED|Overall Study||114
8584697|NCT00246025|9618568|FG001|COMPLETED|Overall Study||124
8584698|NCT00246025|9618569|FG002|COMPLETED|Overall Study||116
8584699|NCT00246025|9618570|FG003|COMPLETED|Overall Study||116
8584700|NCT00246025|9618567|FG000|NOT COMPLETED|Overall Study||10
8584701|NCT00246025|9618568|FG001|NOT COMPLETED|Overall Study||9
8584702|NCT00246025|9618569|FG002|NOT COMPLETED|Overall Study||10
8584703|NCT00246025|9618570|FG003|NOT COMPLETED|Overall Study||13
8584704|NCT00246090|9618580|FG000|STARTED|Overall Study||298
8584705|NCT00246090|9618580|FG000|COMPLETED|Overall Study||3
8584706|NCT00246090|9618580|FG000|NOT COMPLETED|Overall Study||295
8584707|NCT00246129|9618586|FG000|STARTED|Overall Study||82
8584708|NCT00246129|9618587|FG001|STARTED|Overall Study||41
8584709|NCT00246129|9618586|FG000|COMPLETED|Overall Study||75
8584710|NCT00246129|9618587|FG001|COMPLETED|Overall Study||39
8584711|NCT00246129|9618586|FG000|NOT COMPLETED|Overall Study||7
8584712|NCT00246129|9618587|FG001|NOT COMPLETED|Overall Study||2
8584713|NCT00246259|9618598|FG000|STARTED|Overall Study||44
8584714|NCT00246259|9618599|FG001|STARTED|Overall Study||41
8584715|NCT00246259|9618598|FG000|Eligible for Intent-to-treat (ITT)|Overall Study||42
8584716|NCT00246259|9618599|FG001|Eligible for Intent-to-treat (ITT)|Overall Study||35
8584717|NCT00246259|9618598|FG000|COMPLETED|Overall Study||16
8584718|NCT00246259|9618599|FG001|COMPLETED|Overall Study||15
8584719|NCT00246259|9618598|FG000|NOT COMPLETED|Overall Study||28
8584720|NCT00246259|9618599|FG001|NOT COMPLETED|Overall Study||26
8584721|NCT00246324|9618605|FG000|STARTED|Overall Study||16
8584722|NCT00246324|9618605|FG000|COMPLETED|Overall Study||15
8584723|NCT00246324|9618605|FG000|NOT COMPLETED|Overall Study||1
8584724|NCT00246337|9618618|FG000|STARTED|Overall Study||147
8584725|NCT00246337|9618619|FG001|STARTED|Overall Study||16
8710057|NCT00956293|9756372|FG000|Enrolled Safety Set|Main Period (Pre-randomization)||0
8710058|NCT00956293|9756373|FG001|Enrolled Safety Set|Main Period (Pre-randomization)||0
8584726|NCT00246337|9618620|FG002|STARTED|Overall Study||18
8584727|NCT00246337|9618621|FG003|STARTED|Overall Study||17
8584728|NCT00246337|9618622|FG004|STARTED|Overall Study||16
8584729|NCT00246337|9618623|FG005|STARTED|Overall Study||54
8584730|NCT00246337|9618624|FG006|STARTED|Overall Study||54
8584731|NCT00246337|9618625|FG007|STARTED|Overall Study||53
8584732|NCT00246337|9618626|FG008|STARTED|Overall Study||45
8584733|NCT00246337|9618618|FG000|Completed Period (Initial Dose)|Overall Study||46
8584734|NCT00246337|9618619|FG001|Completed Period (Initial Dose)|Overall Study||4
8584735|NCT00246337|9618620|FG002|Completed Period (Initial Dose)|Overall Study||9
8584736|NCT00246337|9618621|FG003|Completed Period (Initial Dose)|Overall Study||5
8584737|NCT00246337|9618622|FG004|Completed Period (Initial Dose)|Overall Study||8
8584738|NCT00246337|9618623|FG005|Completed Period (Initial Dose)|Overall Study||29
8584739|NCT00246337|9618624|FG006|Completed Period (Initial Dose)|Overall Study||29
8584740|NCT00246337|9618625|FG007|Completed Period (Initial Dose)|Overall Study||27
8710059|NCT00956293|9756374|FG002|Enrolled Safety Set|Main Period (Pre-randomization)||203
8584741|NCT00246337|9618626|FG008|Completed Period (Initial Dose)|Overall Study||19
8584742|NCT00246337|9618618|FG000|Completed Period (Both Doses)|Overall Study||69
8584743|NCT00246337|9618619|FG001|Completed Period (Both Doses)|Overall Study||10
8584744|NCT00246337|9618620|FG002|Completed Period (Both Doses)|Overall Study||6
8584745|NCT00246337|9618621|FG003|Completed Period (Both Doses)|Overall Study||11
8584746|NCT00246337|9618622|FG004|Completed Period (Both Doses)|Overall Study||4
8584747|NCT00246337|9618623|FG005|Completed Period (Both Doses)|Overall Study||10
8584748|NCT00246337|9618624|FG006|Completed Period (Both Doses)|Overall Study||16
8584749|NCT00246337|9618625|FG007|Completed Period (Both Doses)|Overall Study||13
8584750|NCT00246337|9618626|FG008|Completed Period (Both Doses)|Overall Study||15
8584751|NCT00246337|9618618|FG000|COMPLETED|Overall Study||115
8584752|NCT00246337|9618619|FG001|COMPLETED|Overall Study||14
8584753|NCT00246337|9618620|FG002|COMPLETED|Overall Study||15
8584754|NCT00246337|9618621|FG003|COMPLETED|Overall Study||16
8584755|NCT00246337|9618622|FG004|COMPLETED|Overall Study||12
8584756|NCT00246337|9618623|FG005|COMPLETED|Overall Study||39
8584757|NCT00246337|9618624|FG006|COMPLETED|Overall Study||45
8584758|NCT00246337|9618625|FG007|COMPLETED|Overall Study||40
8584759|NCT00246337|9618626|FG008|COMPLETED|Overall Study||34
8584760|NCT00246337|9618618|FG000|NOT COMPLETED|Overall Study||32
8584761|NCT00246337|9618619|FG001|NOT COMPLETED|Overall Study||2
8584762|NCT00246337|9618620|FG002|NOT COMPLETED|Overall Study||3
8584763|NCT00246337|9618621|FG003|NOT COMPLETED|Overall Study||1
8584764|NCT00246337|9618622|FG004|NOT COMPLETED|Overall Study||4
8584765|NCT00246337|9618623|FG005|NOT COMPLETED|Overall Study||15
8584766|NCT00246337|9618624|FG006|NOT COMPLETED|Overall Study||9
8584767|NCT00246337|9618625|FG007|NOT COMPLETED|Overall Study||13
8584768|NCT00246337|9618626|FG008|NOT COMPLETED|Overall Study||11
8584769|NCT00246376|9618651|FG000|STARTED|Overall Study||41
8584770|NCT00246376|9618652|FG001|STARTED|Overall Study||43
8584771|NCT00246376|9618653|FG002|STARTED|Overall Study||45
8584772|NCT00246376|9618654|FG003|STARTED|Overall Study||47
8584773|NCT00246376|9618655|FG004|STARTED|Overall Study||45
8584774|NCT00246376|9618651|FG000|After Dietary run-in at Two Weeks|Overall Study||30
8584775|NCT00246376|9618652|FG001|After Dietary run-in at Two Weeks|Overall Study||38
8584776|NCT00246376|9618653|FG002|After Dietary run-in at Two Weeks|Overall Study||41
8584777|NCT00246376|9618654|FG003|After Dietary run-in at Two Weeks|Overall Study||40
8584778|NCT00246376|9618655|FG004|After Dietary run-in at Two Weeks|Overall Study||42
8584779|NCT00246376|9618651|FG000|COMPLETED|Overall Study||26
8584780|NCT00246376|9618652|FG001|COMPLETED|Overall Study||24
8584781|NCT00246376|9618653|FG002|COMPLETED|Overall Study||29
8584782|NCT00246376|9618654|FG003|COMPLETED|Overall Study||21
8584783|NCT00246376|9618655|FG004|COMPLETED|Overall Study||28
8584784|NCT00246376|9618651|FG000|NOT COMPLETED|Overall Study||15
8584785|NCT00246376|9618652|FG001|NOT COMPLETED|Overall Study||19
8584786|NCT00246376|9618653|FG002|NOT COMPLETED|Overall Study||16
8584787|NCT00246376|9618654|FG003|NOT COMPLETED|Overall Study||26
8584788|NCT00246376|9618655|FG004|NOT COMPLETED|Overall Study||17
8584789|NCT00246441|9618675|FG000|STARTED|Overall Study||20
8584790|NCT00246441|9618676|FG001|STARTED|Overall Study||22
8584791|NCT00246441|9618675|FG000|COMPLETED|Overall Study||19
8584792|NCT00246441|9618676|FG001|COMPLETED|Overall Study||22
8584793|NCT00246441|9618675|FG000|NOT COMPLETED|Overall Study||1
8584794|NCT00246441|9618676|FG001|NOT COMPLETED|Overall Study||0
8584795|NCT00246519|9618684|FG000|STARTED|Overall Study||442
8584796|NCT00246519|9618685|FG001|STARTED|Overall Study||446
8584797|NCT00246519|9618684|FG000|COMPLETED|Overall Study||386
8584798|NCT00246519|9618685|FG001|COMPLETED|Overall Study||382
8584799|NCT00246519|9618684|FG000|NOT COMPLETED|Overall Study||56
8584800|NCT00246519|9618685|FG001|NOT COMPLETED|Overall Study||64
8584801|NCT00246571|9618693|FG000|STARTED|Overall Study||113
8584802|NCT00246571|9618694|FG001|STARTED|Overall Study||104
8584803|NCT00246571|9618693|FG000|Randomized But Not Treated|Overall Study||3
8584804|NCT00246571|9618694|FG001|Randomized But Not Treated|Overall Study||1
8584805|NCT00246571|9618693|FG000|COMPLETED|Overall Study||0
8584806|NCT00246571|9618694|FG001|COMPLETED|Overall Study||0
8584807|NCT00246571|9618693|FG000|NOT COMPLETED|Overall Study||113
8584808|NCT00246571|9618694|FG001|NOT COMPLETED|Overall Study||104
8584809|NCT00246740|9618702|FG000|STARTED|Initial Enrollment||28
8584810|NCT00246740|9618703|FG001|STARTED|Initial Enrollment||28
8584811|NCT00246740|9618702|FG000|COMPLETED|Initial Enrollment||22
8584812|NCT00246740|9618703|FG001|COMPLETED|Initial Enrollment||20
8584813|NCT00246740|9618702|FG000|NOT COMPLETED|Initial Enrollment||6
8584814|NCT00246740|9618703|FG001|NOT COMPLETED|Initial Enrollment||8
8584815|NCT00246740|9618702|FG000|STARTED|Experimental Phase||22
8584816|NCT00246740|9618703|FG001|STARTED|Experimental Phase||20
8584817|NCT00246740|9618702|FG000|COMPLETED|Experimental Phase||22
8584818|NCT00246740|9618703|FG001|COMPLETED|Experimental Phase||20
8584819|NCT00246740|9618702|FG000|NOT COMPLETED|Experimental Phase||0
8584820|NCT00246740|9618703|FG001|NOT COMPLETED|Experimental Phase||0
8584821|NCT00246753|9618709|FG000|STARTED|Overall Study||29
8584822|NCT00246753|9618709|FG000|COMPLETED|Overall Study||21
8584823|NCT00246753|9618709|FG000|NOT COMPLETED|Overall Study||8
8584824|NCT00246805|9618715|FG000|STARTED|Phase 1||34
8584825|NCT00246805|9618716|FG001|STARTED|Phase 1||33
8584826|NCT00246805|9618715|FG000|COMPLETED|Phase 1||33
8584827|NCT00246805|9618716|FG001|COMPLETED|Phase 1||33
8584828|NCT00246805|9618715|FG000|NOT COMPLETED|Phase 1||1
8584829|NCT00246805|9618716|FG001|NOT COMPLETED|Phase 1||0
8584830|NCT00246805|9618715|FG000|STARTED|Phase 2||33
8584831|NCT00246805|9618716|FG001|STARTED|Phase 2||33
8584832|NCT00246805|9618715|FG000|COMPLETED|Phase 2||33
8584833|NCT00246805|9618716|FG001|COMPLETED|Phase 2||33
8584834|NCT00246805|9618715|FG000|NOT COMPLETED|Phase 2||0
8584835|NCT00246805|9618716|FG001|NOT COMPLETED|Phase 2||0
8584836|NCT00247273|9618724|FG000|STARTED|Overall Study||644
8584837|NCT00247273|9618725|FG001|STARTED|Overall Study||650
8584838|NCT00247273|9618724|FG000|Intent to Treat Population|Overall Study|Two subjects not included as they did not take any study medication.|642
8584839|NCT00247273|9618725|FG001|Intent to Treat Population|Overall Study||650
8584840|NCT00247273|9618724|FG000|COMPLETED|Overall Study||498
8584841|NCT00247273|9618725|FG001|COMPLETED|Overall Study||513
8584842|NCT00247273|9618724|FG000|NOT COMPLETED|Overall Study||146
8584843|NCT00247273|9618725|FG001|NOT COMPLETED|Overall Study||137
8584844|NCT00247377|9618733|FG000|STARTED|Overall Study||111
8584845|NCT00247377|9618734|FG001|STARTED|Overall Study||86
8584846|NCT00247377|9618733|FG000|COMPLETED|Overall Study||111
8584847|NCT00247377|9618734|FG001|COMPLETED|Overall Study||86
8584848|NCT00247377|9618733|FG000|NOT COMPLETED|Overall Study||0
8584849|NCT00247377|9618734|FG001|NOT COMPLETED|Overall Study||0
8584850|NCT00247416|9618742|FG000|STARTED|Overall Study||26
8584851|NCT00247416|9618743|FG001|STARTED|Overall Study||33
8584852|NCT00247416|9618742|FG000|COMPLETED|Overall Study||25
8584853|NCT00247416|9618743|FG001|COMPLETED|Overall Study||31
8584854|NCT00247416|9618742|FG000|NOT COMPLETED|Overall Study||1
8584855|NCT00247416|9618743|FG001|NOT COMPLETED|Overall Study||2
8584856|NCT00247611|9618753|FG000|STARTED|Baselined|Participants randomized|304
8584857|NCT00247611|9618754|FG001|STARTED|Baselined|Participants randomized|290
8584858|NCT00247611|9618753|FG000|COMPLETED|Baselined|Randomized participants who completed at least 2 adherence assessments/sessions|287
8584859|NCT00247611|9618754|FG001|COMPLETED|Baselined|Randomized participants who completed at least 2 adherence assessments/sessions|277
8584860|NCT00247611|9618753|FG000|NOT COMPLETED|Baselined||17
8584861|NCT00247611|9618754|FG001|NOT COMPLETED|Baselined||13
8584862|NCT00247611|9618753|FG000|STARTED|Intention to Treat Sample|Participants randomized|304
8584863|NCT00247611|9618754|FG001|STARTED|Intention to Treat Sample|Participants randomized|290
8584864|NCT00247611|9618753|FG000|COMPLETED|Intention to Treat Sample|Randomized participants who completed at least 2 adherence assessments/sessions|287
8584865|NCT00247611|9618754|FG001|COMPLETED|Intention to Treat Sample|Randomized participants who completed at least 2 adherence assessments/sessions|277
8584866|NCT00247611|9618753|FG000|NOT COMPLETED|Intention to Treat Sample||17
8584867|NCT00247611|9618754|FG001|NOT COMPLETED|Intention to Treat Sample||13
8584868|NCT00247611|9618753|FG000|STARTED|On Protocol Sample|ITT sample participants|287
8584869|NCT00247611|9618754|FG001|STARTED|On Protocol Sample|ITT sample participants|277
8584870|NCT00247611|9618753|FG000|COMPLETED|On Protocol Sample|Participants with no interruptions in ART receipt and completing 6 or more LifeWindows assessments|176
8584871|NCT00247611|9618754|FG001|COMPLETED|On Protocol Sample|Participants with no interruptions in ART receipt and completing 6 or more LifeWindows assessments|152
8584872|NCT00247611|9618753|FG000|NOT COMPLETED|On Protocol Sample||111
8584873|NCT00247611|9618754|FG001|NOT COMPLETED|On Protocol Sample||125
8584874|NCT00247624|9618768|FG000|STARTED|Overall Study||30
8584875|NCT00247624|9618769|FG001|STARTED|Overall Study||30
8584876|NCT00247624|9618768|FG000|COMPLETED|Overall Study||25
8584877|NCT00247624|9618769|FG001|COMPLETED|Overall Study||26
8584878|NCT00247624|9618768|FG000|NOT COMPLETED|Overall Study||5
8584879|NCT00247624|9618769|FG001|NOT COMPLETED|Overall Study||4
8584880|NCT00247676|9618775|FG000|STARTED|Overall Study||37
8584881|NCT00247676|9618775|FG000|COMPLETED|Overall Study||1
8710060|NCT00956293|9756372|FG000|COMPLETED|Main Period (Pre-randomization)||0
8710061|NCT00956293|9756373|FG001|COMPLETED|Main Period (Pre-randomization)||0
8710062|NCT00956293|9756374|FG002|COMPLETED|Main Period (Pre-randomization)||77
8710063|NCT00956293|9756372|FG000|NOT COMPLETED|Main Period (Pre-randomization)||0
8710064|NCT00956293|9756373|FG001|NOT COMPLETED|Main Period (Pre-randomization)||0
8584882|NCT00247676|9618775|FG000|NOT COMPLETED|Overall Study||36
8584883|NCT00247728|9618782|FG000|STARTED|Overall Study||58
8584884|NCT00247728|9618783|FG001|STARTED|Overall Study||57
8584885|NCT00247728|9618784|FG002|STARTED|Overall Study||57
8584886|NCT00247728|9618782|FG000|COMPLETED|Overall Study||55
8584887|NCT00247728|9618783|FG001|COMPLETED|Overall Study||51
8584888|NCT00247728|9618784|FG002|COMPLETED|Overall Study||43
8584889|NCT00247728|9618782|FG000|NOT COMPLETED|Overall Study||3
8584890|NCT00247728|9618783|FG001|NOT COMPLETED|Overall Study||6
8584891|NCT00247728|9618784|FG002|NOT COMPLETED|Overall Study||14
8584892|NCT00247962|9618796|FG000|STARTED|Overall Study||379
8584893|NCT00247962|9618797|FG001|STARTED|Overall Study||187
8584894|NCT00247962|9618796|FG000|COMPLETED|Overall Study||353
8584895|NCT00247962|9618797|FG001|COMPLETED|Overall Study||168
8584896|NCT00247962|9618796|FG000|NOT COMPLETED|Overall Study||26
8584897|NCT00247962|9618797|FG001|NOT COMPLETED|Overall Study||19
8584898|NCT00248040|9618806|FG000|STARTED|Overall Study||25
8584899|NCT00248040|9618807|FG001|STARTED|Overall Study||23
8584900|NCT00248040|9618808|FG002|STARTED|Overall Study||26
8584901|NCT00248040|9618806|FG000|COMPLETED|Overall Study||22
8584902|NCT00248040|9618807|FG001|COMPLETED|Overall Study||22
8584903|NCT00248040|9618808|FG002|COMPLETED|Overall Study||22
8584904|NCT00248040|9618806|FG000|NOT COMPLETED|Overall Study||3
8584905|NCT00248040|9618807|FG001|NOT COMPLETED|Overall Study||1
8584906|NCT00248040|9618808|FG002|NOT COMPLETED|Overall Study||4
8584907|NCT00248170|9618819|FG000|STARTED|Overall Study||2078
8584908|NCT00248170|9618820|FG001|STARTED|Overall Study||2094
8584909|NCT00248170|9618819|FG000|Intent-to-treat (ITT)|Overall Study||2061
8584910|NCT00248170|9618820|FG001|Intent-to-treat (ITT)|Overall Study||2075
8584911|NCT00248170|9618819|FG000|Safety Set|Overall Study||2049
8584912|NCT00248170|9618820|FG001|Safety Set|Overall Study||2062
8584913|NCT00248170|9618819|FG000|COMPLETED|Overall Study||1317
8584914|NCT00248170|9618820|FG001|COMPLETED|Overall Study||1286
8584915|NCT00248170|9618819|FG000|NOT COMPLETED|Overall Study||761
8584916|NCT00248170|9618820|FG001|NOT COMPLETED|Overall Study||808
8584917|NCT00248495|9618826|FG000|STARTED|Overall Study||38
8584918|NCT00248495|9618826|FG000|COMPLETED|Overall Study||37
8584919|NCT00248495|9618826|FG000|NOT COMPLETED|Overall Study||1
8584920|NCT00248534|9618830|FG000|STARTED|Overall Study||16
8584921|NCT00248534|9618830|FG000|COMPLETED|Overall Study||16
8584922|NCT00248534|9618830|FG000|NOT COMPLETED|Overall Study||0
8584923|NCT00248547|9618836|FG000|STARTED|Overall Study||20
8584924|NCT00248547|9618837|FG001|STARTED|Overall Study||20
8584925|NCT00248547|9618836|FG000|COMPLETED|Overall Study||20
8584926|NCT00248547|9618837|FG001|COMPLETED|Overall Study||20
8584927|NCT00248547|9618836|FG000|NOT COMPLETED|Overall Study||0
8584928|NCT00248547|9618837|FG001|NOT COMPLETED|Overall Study||0
8584929|NCT00248560|9618843|FG000|STARTED|Overall Study||36
8584930|NCT00248560|9618843|FG000|COMPLETED|Overall Study||36
8584931|NCT00248560|9618843|FG000|NOT COMPLETED|Overall Study||0
8584932|NCT00248612|9618852|FG000|STARTED|Overall Study||24
8584933|NCT00248612|9618853|FG001|STARTED|Overall Study||21
8584934|NCT00248612|9618854|FG002|STARTED|Overall Study||14
8584935|NCT00248612|9618855|FG003|STARTED|Overall Study||22
8584936|NCT00248612|9618852|FG000|COMPLETED|Overall Study||24
8584937|NCT00248612|9618853|FG001|COMPLETED|Overall Study||21
8584938|NCT00248612|9618854|FG002|COMPLETED|Overall Study||14
8584939|NCT00248612|9618855|FG003|COMPLETED|Overall Study||22
8584940|NCT00248612|9618852|FG000|NOT COMPLETED|Overall Study||0
8584941|NCT00248612|9618853|FG001|NOT COMPLETED|Overall Study||0
8584942|NCT00248612|9618854|FG002|NOT COMPLETED|Overall Study||0
8584943|NCT00248612|9618855|FG003|NOT COMPLETED|Overall Study||0
8584944|NCT00248625|9618869|FG000|STARTED|Overall Study||92
8584945|NCT00248625|9618870|FG001|STARTED|Overall Study||92
8584946|NCT00248625|9618869|FG000|COMPLETED|Overall Study||92
8584947|NCT00248625|9618870|FG001|COMPLETED|Overall Study||90
8584948|NCT00248625|9618869|FG000|NOT COMPLETED|Overall Study||0
8584949|NCT00248625|9618870|FG001|NOT COMPLETED|Overall Study||2
8584950|NCT00248638|9618878|FG000|STARTED|Overall Study||75
8584951|NCT00248638|9618879|FG001|STARTED|Overall Study||75
8584952|NCT00248638|9618878|FG000|COMPLETED|Overall Study||75
8584953|NCT00248638|9618879|FG001|COMPLETED|Overall Study||75
8584954|NCT00248638|9618878|FG000|NOT COMPLETED|Overall Study||0
8584955|NCT00248638|9618879|FG001|NOT COMPLETED|Overall Study||0
8584956|NCT00248651|9618890|FG000|STARTED|Overall Study||97
8584957|NCT00248651|9618891|FG001|STARTED|Overall Study||98
8584958|NCT00248651|9618892|FG002|STARTED|Overall Study||97
8584959|NCT00248651|9618890|FG000|Completed 12 Weeks of Treatment|Overall Study||78
8584960|NCT00248651|9618891|FG001|Completed 12 Weeks of Treatment|Overall Study||66
8584961|NCT00248651|9618892|FG002|Completed 12 Weeks of Treatment|Overall Study||75
8584962|NCT00248651|9618890|FG000|COMPLETED|Overall Study||69
8584963|NCT00248651|9618891|FG001|COMPLETED|Overall Study||58
8584964|NCT00248651|9618892|FG002|COMPLETED|Overall Study||65
8584965|NCT00248651|9618890|FG000|NOT COMPLETED|Overall Study||28
8584966|NCT00248651|9618891|FG001|NOT COMPLETED|Overall Study||40
8584967|NCT00248651|9618892|FG002|NOT COMPLETED|Overall Study||32
8584968|NCT00248781|9618902|FG000|STARTED|Overall Study||52
8584969|NCT00248781|9618903|FG001|STARTED|Overall Study||51
8584970|NCT00248781|9618902|FG000|COMPLETED|Overall Study||42
8584971|NCT00248781|9618903|FG001|COMPLETED|Overall Study||47
8710065|NCT00956293|9756374|FG002|NOT COMPLETED|Main Period (Pre-randomization)||130
8710066|NCT00956293|9756372|FG000|STARTED|Main Period (Randomization)||24
8710067|NCT00956293|9756373|FG001|STARTED|Main Period (Randomization)||53
8710068|NCT00956293|9756374|FG002|STARTED|Main Period (Randomization)||0
8710069|NCT00956293|9756372|FG000|Full Analysis Set|Main Period (Randomization)||24
8710070|NCT00956293|9756373|FG001|Full Analysis Set|Main Period (Randomization)|Two participants, randomized to this arm, did not receive everolimus.|51
8710071|NCT00956293|9756374|FG002|Full Analysis Set|Main Period (Randomization)||0
8710072|NCT00956293|9756372|FG000|Randomized Safety Set|Main Period (Randomization)||24
8710073|NCT00956293|9756373|FG001|Randomized Safety Set|Main Period (Randomization)||51
8710074|NCT00956293|9756374|FG002|Randomized Safety Set|Main Period (Randomization)||0
8584972|NCT00248781|9618902|FG000|NOT COMPLETED|Overall Study||10
8584973|NCT00248781|9618903|FG001|NOT COMPLETED|Overall Study||4
8584974|NCT00248794|9618912|FG000|STARTED|Overall Study||25
8584975|NCT00248794|9618913|FG001|STARTED|Overall Study||24
8584976|NCT00248794|9618914|FG002|STARTED|Overall Study||10
8584977|NCT00248794|9618912|FG000|COMPLETED|Overall Study||19
8584978|NCT00248794|9618913|FG001|COMPLETED|Overall Study||16
8584979|NCT00248794|9618914|FG002|COMPLETED|Overall Study||7
8584980|NCT00248794|9618912|FG000|NOT COMPLETED|Overall Study||6
8584981|NCT00248794|9618913|FG001|NOT COMPLETED|Overall Study||8
8584982|NCT00248794|9618914|FG002|NOT COMPLETED|Overall Study||3
8584983|NCT00248807|9618930|FG000|STARTED|Overall Study||19
8584984|NCT00248807|9618931|FG001|STARTED|Overall Study||11
8584985|NCT00248807|9618930|FG000|COMPLETED|Overall Study||19
8584986|NCT00248807|9618931|FG001|COMPLETED|Overall Study||11
8584987|NCT00248807|9618930|FG000|NOT COMPLETED|Overall Study||0
8584988|NCT00248807|9618931|FG001|NOT COMPLETED|Overall Study||0
8584989|NCT00248833|9618946|FG000|STARTED|Overall Study||12
8584990|NCT00248833|9618947|FG001|STARTED|Overall Study||11
8584991|NCT00248833|9618948|FG002|STARTED|Overall Study||11
8584992|NCT00248833|9618946|FG000|COMPLETED|Overall Study||9
8584993|NCT00248833|9618947|FG001|COMPLETED|Overall Study||8
8584994|NCT00248833|9618948|FG002|COMPLETED|Overall Study||9
8584995|NCT00248833|9618946|FG000|NOT COMPLETED|Overall Study||3
8584996|NCT00248833|9618947|FG001|NOT COMPLETED|Overall Study||3
8584997|NCT00248833|9618948|FG002|NOT COMPLETED|Overall Study||2
8584998|NCT00249002|9618958|FG000|STARTED|Overall Study||9
8584999|NCT00249002|9618958|FG000|COMPLETED|Overall Study||2
8585000|NCT00249002|9618958|FG000|NOT COMPLETED|Overall Study||7
8585001|NCT00249249|9618966|FG000|STARTED|Overall Study||321
8585002|NCT00249249|9618967|FG001|STARTED|Overall Study||103
8585003|NCT00249249|9618968|FG002|STARTED|Overall Study||303
8585004|NCT00249249|9618969|FG003|STARTED|Overall Study||103
8585005|NCT00249249|9618966|FG000|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|316
8585006|NCT00249249|9618967|FG001|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|102
8585007|NCT00249249|9618968|FG002|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|300
8585008|NCT00249249|9618969|FG003|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|103
8585009|NCT00249249|9618966|FG000|COMPLETED|Overall Study||301
8585010|NCT00249249|9618967|FG001|COMPLETED|Overall Study||98
8585011|NCT00249249|9618968|FG002|COMPLETED|Overall Study||288
8585012|NCT00249249|9618969|FG003|COMPLETED|Overall Study||100
8585013|NCT00249249|9618966|FG000|NOT COMPLETED|Overall Study||20
8585014|NCT00249249|9618967|FG001|NOT COMPLETED|Overall Study||5
8585015|NCT00249249|9618968|FG002|NOT COMPLETED|Overall Study||15
8585016|NCT00249249|9618969|FG003|NOT COMPLETED|Overall Study||3
8585017|NCT00249288|9618981|FG000|STARTED|Overall Study||19
8585018|NCT00249288|9618982|FG001|STARTED|Overall Study||19
8585019|NCT00249288|9618981|FG000|Initiated Treatment|Overall Study||17
8585020|NCT00249288|9618982|FG001|Initiated Treatment|Overall Study||15
8585021|NCT00249288|9618981|FG000|COMPLETED|Overall Study||14
8585022|NCT00249288|9618982|FG001|COMPLETED|Overall Study||14
8585023|NCT00249288|9618981|FG000|NOT COMPLETED|Overall Study||5
8585024|NCT00249288|9618982|FG001|NOT COMPLETED|Overall Study||5
8585025|NCT00249379|9618998|FG000|STARTED|Overall Study||14
8585026|NCT00249379|9618999|FG001|STARTED|Overall Study||12
8585027|NCT00249379|9618998|FG000|COMPLETED|Overall Study||6
8585028|NCT00249379|9618999|FG001|COMPLETED|Overall Study||4
8710075|NCT00956293|9756372|FG000|COMPLETED|Main Period (Randomization)||23
8710076|NCT00956293|9756373|FG001|COMPLETED|Main Period (Randomization)||26
8710077|NCT00956293|9756374|FG002|COMPLETED|Main Period (Randomization)||0
8710078|NCT00956293|9756372|FG000|NOT COMPLETED|Main Period (Randomization)||1
8710079|NCT00956293|9756373|FG001|NOT COMPLETED|Main Period (Randomization)||27
8710080|NCT00956293|9756374|FG002|NOT COMPLETED|Main Period (Randomization)||0
8585029|NCT00249379|9618998|FG000|NOT COMPLETED|Overall Study||8
8585030|NCT00249379|9618999|FG001|NOT COMPLETED|Overall Study||8
8585031|NCT00249444|9619007|FG000|STARTED|Overall Study||42
8585032|NCT00249444|9619008|FG001|STARTED|Overall Study||44
8585033|NCT00249444|9619007|FG000|COMPLETED|Overall Study||30
8585034|NCT00249444|9619008|FG001|COMPLETED|Overall Study||29
8585035|NCT00249444|9619007|FG000|NOT COMPLETED|Overall Study||12
8585036|NCT00249444|9619008|FG001|NOT COMPLETED|Overall Study||15
8585037|NCT00249470|9619016|FG000|STARTED|Overall Study||28
8585038|NCT00249470|9619017|FG001|STARTED|Overall Study||28
8585039|NCT00249470|9619016|FG000|COMPLETED|Overall Study||28
8585040|NCT00249470|9619017|FG001|COMPLETED|Overall Study||28
8585041|NCT00249470|9619016|FG000|NOT COMPLETED|Overall Study||0
8585042|NCT00249470|9619017|FG001|NOT COMPLETED|Overall Study||0
8585043|NCT00249496|9619025|FG000|STARTED|Overall Study||24
8585044|NCT00249496|9619026|FG001|STARTED|Overall Study||27
8710081|NCT00956293|9756372|FG000|STARTED|Follow-up Period||20
8710082|NCT00956293|9756373|FG001|STARTED|Follow-up Period||32
8710083|NCT00956293|9756374|FG002|STARTED|Follow-up Period||0
8710084|NCT00956293|9756372|FG000|COMPLETED|Follow-up Period||0
8813011|NCT01523587|9866122|FG000|COMPLETED|Overall Study||0
8813012|NCT01523587|9866123|FG001|COMPLETED|Overall Study||0
8813013|NCT01523587|9866122|FG000|NOT COMPLETED|Overall Study||398
8813014|NCT01523587|9866123|FG001|NOT COMPLETED|Overall Study||397
8813015|NCT01523613|9866132|FG000|STARTED|Overall Study|- 30 single restorations (30 R)|30
8813016|NCT01523613|9866133|FG001|STARTED|Overall Study|- 30 single restorations (30 F)|30
8813017|NCT01523613|9866134|FG002|STARTED|Overall Study|- 66 paired restorations (33R + 33F)|33
8813018|NCT01523613|9866132|FG000|COMPLETED|Overall Study|- 23 single restorations (23R)|23
8585045|NCT00249496|9619025|FG000|COMPLETED|Overall Study||24
8710085|NCT00956293|9756373|FG001|COMPLETED|Follow-up Period||0
8813019|NCT01523613|9866133|FG001|COMPLETED|Overall Study|- 25 single restorations (25F)|25
8585046|NCT00249496|9619026|FG001|COMPLETED|Overall Study||26
8585047|NCT00249496|9619025|FG000|NOT COMPLETED|Overall Study||0
8585048|NCT00249496|9619026|FG001|NOT COMPLETED|Overall Study||1
8585049|NCT00249613|9619036|FG000|STARTED|Baseline||152
8585050|NCT00249613|9619037|FG001|STARTED|Baseline||139
8585051|NCT00249613|9619036|FG000|COMPLETED|Baseline||152
8585052|NCT00249613|9619037|FG001|COMPLETED|Baseline||139
8585053|NCT00249613|9619036|FG000|NOT COMPLETED|Baseline||0
8585054|NCT00249613|9619037|FG001|NOT COMPLETED|Baseline||0
8585055|NCT00249613|9619036|FG000|STARTED|12 Month Follow-up||152
8585056|NCT00249613|9619037|FG001|STARTED|12 Month Follow-up||139
8585057|NCT00249613|9619036|FG000|COMPLETED|12 Month Follow-up||135
8585058|NCT00249613|9619037|FG001|COMPLETED|12 Month Follow-up||124
8585059|NCT00249613|9619036|FG000|NOT COMPLETED|12 Month Follow-up||17
8585060|NCT00249613|9619037|FG001|NOT COMPLETED|12 Month Follow-up||15
8585061|NCT00249769|9619049|FG000|STARTED|Overall Study||100
8585062|NCT00249769|9619050|FG001|STARTED|Overall Study||250
8585063|NCT00249769|9619051|FG002|STARTED|Overall Study||250
8585064|NCT00249769|9619049|FG000|Received LJEV|Overall Study||100
8585065|NCT00249769|9619050|FG001|Received LJEV|Overall Study||236
8585066|NCT00249769|9619051|FG002|Received LJEV|Overall Study||224
8585067|NCT00249769|9619049|FG000|Received Measles Vaccine|Overall Study||97
8585068|NCT00249769|9619050|FG001|Received Measles Vaccine|Overall Study||236
8585069|NCT00249769|9619051|FG002|Received Measles Vaccine|Overall Study||235
8585070|NCT00249769|9619049|FG000|COMPLETED|Overall Study||98
8585071|NCT00249769|9619050|FG001|COMPLETED|Overall Study||235
8585072|NCT00249769|9619051|FG002|COMPLETED|Overall Study||222
8585073|NCT00249769|9619049|FG000|NOT COMPLETED|Overall Study||2
8585074|NCT00249769|9619050|FG001|NOT COMPLETED|Overall Study||15
8585075|NCT00249769|9619051|FG002|NOT COMPLETED|Overall Study||28
8585076|NCT00249795|9619061|FG000|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|4518
8585077|NCT00249795|9619062|FG001|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|4498
8585078|NCT00249795|9619061|FG000|COMPLETED|Overall Study|started and completed study drug|3124
8585079|NCT00249795|9619062|FG001|COMPLETED|Overall Study|started and completed study drug|3108
8585080|NCT00249795|9619061|FG000|NOT COMPLETED|Overall Study||1394
8585081|NCT00249795|9619062|FG001|NOT COMPLETED|Overall Study||1390
8585082|NCT00249808|9619068|FG000|STARTED|Overall Study||1266
8585083|NCT00249808|9619068|FG000|COMPLETED|Overall Study||1084
8585084|NCT00249808|9619068|FG000|NOT COMPLETED|Overall Study||182
8585085|NCT00249821|9619074|FG000|STARTED|Overall Study||10
8585086|NCT00249821|9619075|FG001|STARTED|Overall Study||12
8585087|NCT00249821|9619074|FG000|COMPLETED|Overall Study||10
8585088|NCT00249821|9619075|FG001|COMPLETED|Overall Study||11
8585089|NCT00249821|9619074|FG000|NOT COMPLETED|Overall Study||0
8585090|NCT00249821|9619075|FG001|NOT COMPLETED|Overall Study||1
8585091|NCT00249834|9619089|FG000|STARTED|Overall Study||1
8585092|NCT00249834|9619090|FG001|STARTED|Overall Study||48
8585093|NCT00249834|9619091|FG002|STARTED|Overall Study||45
8585094|NCT00249834|9619092|FG003|STARTED|Overall Study||34
8585095|NCT00249834|9619093|FG004|STARTED|Overall Study||24
8585096|NCT00249834|9619094|FG005|STARTED|Overall Study||10
8585097|NCT00249834|9619095|FG006|STARTED|Overall Study||2
8585098|NCT00249834|9619096|FG007|STARTED|Overall Study||2
8585099|NCT00249834|9619089|FG000|COMPLETED|Overall Study||0
8585100|NCT00249834|9619090|FG001|COMPLETED|Overall Study||29
8585101|NCT00249834|9619091|FG002|COMPLETED|Overall Study||31
8585102|NCT00249834|9619092|FG003|COMPLETED|Overall Study||26
8585103|NCT00249834|9619093|FG004|COMPLETED|Overall Study||19
8585104|NCT00249834|9619094|FG005|COMPLETED|Overall Study||8
8585105|NCT00249834|9619095|FG006|COMPLETED|Overall Study||1
8585106|NCT00249834|9619096|FG007|COMPLETED|Overall Study||2
8585107|NCT00249834|9619089|FG000|NOT COMPLETED|Overall Study||1
8585108|NCT00249834|9619090|FG001|NOT COMPLETED|Overall Study||19
8585109|NCT00249834|9619091|FG002|NOT COMPLETED|Overall Study||14
8585110|NCT00249834|9619092|FG003|NOT COMPLETED|Overall Study||8
8585111|NCT00249834|9619093|FG004|NOT COMPLETED|Overall Study||5
8585112|NCT00249834|9619094|FG005|NOT COMPLETED|Overall Study||2
8585113|NCT00249834|9619095|FG006|NOT COMPLETED|Overall Study||1
8585114|NCT00249834|9619096|FG007|NOT COMPLETED|Overall Study||0
8585115|NCT00249873|9619110|FG000|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|3772
8585116|NCT00249873|9619111|FG001|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|3782
8585117|NCT00249873|9619110|FG000|COMPLETED|Overall Study|started and completed study drug|2442
8585118|NCT00249873|9619111|FG001|COMPLETED|Overall Study|started and completed study drug|2528
8585119|NCT00249873|9619110|FG000|NOT COMPLETED|Overall Study||1330
8585120|NCT00249873|9619111|FG001|NOT COMPLETED|Overall Study||1254
8585121|NCT00250276|9619121|FG000|STARTED|Overall Study||199
8585122|NCT00250276|9619122|FG001|STARTED|Overall Study||198
8585123|NCT00250276|9619123|FG002|STARTED|Overall Study||201
8585124|NCT00250276|9619124|FG003|STARTED|Overall Study||200
8585125|NCT00250276|9619121|FG000|COMPLETED|Overall Study||182
8585126|NCT00250276|9619122|FG001|COMPLETED|Overall Study||177
8585127|NCT00250276|9619123|FG002|COMPLETED|Overall Study||182
8585128|NCT00250276|9619124|FG003|COMPLETED|Overall Study||181
8585129|NCT00250276|9619121|FG000|NOT COMPLETED|Overall Study||17
8585130|NCT00250276|9619122|FG001|NOT COMPLETED|Overall Study||21
8585131|NCT00250276|9619123|FG002|NOT COMPLETED|Overall Study||19
8585132|NCT00250276|9619124|FG003|NOT COMPLETED|Overall Study||19
8585133|NCT00250432|9619141|FG000|STARTED|Overall Study||104
8585134|NCT00250432|9619142|FG001|STARTED|Overall Study||100
8585135|NCT00250432|9619141|FG000|COMPLETED|Overall Study||59
8585136|NCT00250432|9619142|FG001|COMPLETED|Overall Study||53
8585137|NCT00250432|9619141|FG000|NOT COMPLETED|Overall Study||45
8585138|NCT00250432|9619142|FG001|NOT COMPLETED|Overall Study||47
8585139|NCT00250484|9619150|FG000|STARTED|Overall Study||9
8585140|NCT00250484|9619151|FG001|STARTED|Overall Study||8
8585141|NCT00250484|9619150|FG000|COMPLETED|Overall Study||9
8585142|NCT00250484|9619151|FG001|COMPLETED|Overall Study||8
8585143|NCT00250484|9619150|FG000|NOT COMPLETED|Overall Study||0
8585144|NCT00250484|9619151|FG001|NOT COMPLETED|Overall Study||0
8585145|NCT00250497|9619159|FG000|STARTED|Overall Study||182
8585146|NCT00250497|9619160|FG001|STARTED|Overall Study||174
8585147|NCT00250497|9619159|FG000|COMPLETED|Overall Study||177
8585148|NCT00250497|9619160|FG001|COMPLETED|Overall Study||159
8585149|NCT00250497|9619159|FG000|NOT COMPLETED|Overall Study||5
8585150|NCT00250497|9619160|FG001|NOT COMPLETED|Overall Study||15
8585151|NCT00250588|9619169|FG000|STARTED|Overall Study||81
8585152|NCT00250588|9619170|FG001|STARTED|Overall Study||84
8585153|NCT00250588|9619171|FG002|STARTED|Overall Study||87
8585154|NCT00250588|9619169|FG000|COMPLETED|Overall Study||72
8585155|NCT00250588|9619170|FG001|COMPLETED|Overall Study||65
8585156|NCT00250588|9619171|FG002|COMPLETED|Overall Study||74
8585157|NCT00250588|9619169|FG000|NOT COMPLETED|Overall Study||9
8585158|NCT00250588|9619170|FG001|NOT COMPLETED|Overall Study||19
8585159|NCT00250588|9619171|FG002|NOT COMPLETED|Overall Study||13
8585160|NCT00250679|9619182|FG000|STARTED|Overall Study||147
8585161|NCT00250679|9619183|FG001|STARTED|Overall Study||149
8585162|NCT00250679|9619184|FG002|STARTED|Overall Study||147
8585163|NCT00250679|9619182|FG000|COMPLETED|Overall Study||108
8585164|NCT00250679|9619183|FG001|COMPLETED|Overall Study||100
8585165|NCT00250679|9619184|FG002|COMPLETED|Overall Study||103
8585166|NCT00250679|9619182|FG000|NOT COMPLETED|Overall Study||39
8585167|NCT00250679|9619183|FG001|NOT COMPLETED|Overall Study||49
8585168|NCT00250679|9619184|FG002|NOT COMPLETED|Overall Study||44
8585169|NCT00250705|9619192|FG000|STARTED|Overall Study||12
8585170|NCT00250705|9619192|FG000|COMPLETED|Overall Study||10
8585171|NCT00250705|9619192|FG000|NOT COMPLETED|Overall Study||2
8585172|NCT00250835|9619198|FG000|STARTED|Overall Study||38
8585173|NCT00250835|9619198|FG000|COMPLETED|Overall Study||37
8585174|NCT00250835|9619198|FG000|NOT COMPLETED|Overall Study||1
8585175|NCT00250926|9619202|FG000|STARTED|Overall Study||23
8585176|NCT00250926|9619202|FG000|COMPLETED|Overall Study||23
8585177|NCT00250926|9619202|FG000|NOT COMPLETED|Overall Study||0
8585178|NCT00251004|9619210|FG000|STARTED|Overall Study||277
8585179|NCT00251004|9619211|FG001|STARTED|Overall Study||279
8585180|NCT00251004|9619212|FG002|STARTED|Overall Study||277
8585181|NCT00251004|9619210|FG000|12 Month Analysis|Overall Study|Under 12 month analysis under group 1, 179 Completed study medication.|241
8585182|NCT00251004|9619211|FG001|12 Month Analysis|Overall Study|Under 12 month analysis under group 2, 175 Completed study medication.|249
8585183|NCT00251004|9619212|FG002|12 Month Analysis|Overall Study|Under 12 month analysis under group 3, 200 Completed study medication.|253
8585184|NCT00251004|9619210|FG000|24 Month Analysis|Overall Study|Under 24 month analysis under group 1, 167 Completed study medication.|232
8585185|NCT00251004|9619211|FG001|24 Month Analysis|Overall Study|Under 24 month analysis under group 2, 161 Completed study medication.|238
8585186|NCT00251004|9619212|FG002|24 Month Analysis|Overall Study|Under 24 month analysis under group 3, 185 Completed study medication.|246
8585187|NCT00251004|9619210|FG000|COMPLETED|Overall Study||232
8585188|NCT00251004|9619211|FG001|COMPLETED|Overall Study||238
8585189|NCT00251004|9619212|FG002|COMPLETED|Overall Study||246
8585190|NCT00251004|9619210|FG000|NOT COMPLETED|Overall Study||45
8585191|NCT00251004|9619211|FG001|NOT COMPLETED|Overall Study||41
8585192|NCT00251004|9619212|FG002|NOT COMPLETED|Overall Study||31
8585193|NCT00251225|9619220|FG000|STARTED|Overall Study||49
8585194|NCT00251225|9619220|FG000|COMPLETED|Overall Study||49
8585195|NCT00251225|9619220|FG000|NOT COMPLETED|Overall Study||0
8585196|NCT00251238|9619226|FG000|STARTED|Overall Study||21
8585197|NCT00251238|9619227|FG001|STARTED|Overall Study||20
8585198|NCT00251238|9619226|FG000|COMPLETED|Overall Study||21
8585199|NCT00251238|9619227|FG001|COMPLETED|Overall Study||20
8585200|NCT00251238|9619226|FG000|NOT COMPLETED|Overall Study||0
8585201|NCT00251238|9619227|FG001|NOT COMPLETED|Overall Study||0
8585202|NCT00251303|9619235|FG000|STARTED|Overall Study|78 subjects signed any consent. 60 started drug (30 riluzole & 30 placebo).|30
8585203|NCT00251303|9619236|FG001|STARTED|Overall Study||30
8585204|NCT00251303|9619235|FG000|COMPLETED|Overall Study||22
8585205|NCT00251303|9619236|FG001|COMPLETED|Overall Study||29
8585206|NCT00251303|9619235|FG000|NOT COMPLETED|Overall Study||8
8585207|NCT00251303|9619236|FG001|NOT COMPLETED|Overall Study||1
8710086|NCT00956293|9756374|FG002|COMPLETED|Follow-up Period||0
8710087|NCT00956293|9756372|FG000|NOT COMPLETED|Follow-up Period||20
8710088|NCT00956293|9756373|FG001|NOT COMPLETED|Follow-up Period||32
8710089|NCT00956293|9756374|FG002|NOT COMPLETED|Follow-up Period||0
8710090|NCT00956540|9756384|FG000|STARTED|Overall Study||54
8710091|NCT00956540|9756385|FG001|STARTED|Overall Study||50
8710092|NCT00956540|9756386|FG002|STARTED|Overall Study||46
8710093|NCT00956540|9756387|FG003|STARTED|Overall Study||45
8585208|NCT00251316|9619246|FG000|STARTED|Overall Study||17
8585209|NCT00251316|9619247|FG001|STARTED|Overall Study||17
8585210|NCT00251316|9619246|FG000|COMPLETED|Overall Study||15
8585211|NCT00251316|9619247|FG001|COMPLETED|Overall Study||14
8710094|NCT00956540|9756384|FG000|COMPLETED|Overall Study||51
8710095|NCT00956540|9756385|FG001|COMPLETED|Overall Study||46
8585212|NCT00251316|9619246|FG000|NOT COMPLETED|Overall Study||2
8585213|NCT00251316|9619247|FG001|NOT COMPLETED|Overall Study||3
8585214|NCT00251589|9619257|FG000|STARTED|Overall Study|4 of the 16 patients participated in Phase I and II portions. 12 participated in Phase II only.|16
8585215|NCT00251589|9619258|FG001|STARTED|Overall Study||3
8585216|NCT00251589|9619259|FG002|STARTED|Overall Study||2
8585217|NCT00251589|9619260|FG003|STARTED|Overall Study||2
8585218|NCT00251589|9619257|FG000|COMPLETED|Overall Study||1
8585219|NCT00251589|9619258|FG001|COMPLETED|Overall Study||0
8585220|NCT00251589|9619259|FG002|COMPLETED|Overall Study||0
8585221|NCT00251589|9619260|FG003|COMPLETED|Overall Study||0
8585222|NCT00251589|9619257|FG000|NOT COMPLETED|Overall Study||15
8585223|NCT00251589|9619258|FG001|NOT COMPLETED|Overall Study||3
8585224|NCT00251589|9619259|FG002|NOT COMPLETED|Overall Study||2
8585225|NCT00251589|9619260|FG003|NOT COMPLETED|Overall Study||2
8585226|NCT00251641|9619272|FG000|STARTED|Overall Study||653
8585227|NCT00251641|9619273|FG001|STARTED|Overall Study||215
8585228|NCT00251641|9619272|FG000|COMPLETED|Overall Study||541
8585229|NCT00251641|9619273|FG001|COMPLETED|Overall Study||127
8585230|NCT00251641|9619272|FG000|NOT COMPLETED|Overall Study||112
8585231|NCT00251641|9619273|FG001|NOT COMPLETED|Overall Study||88
8585232|NCT00251693|9619284|FG000|STARTED|Overall Study||680
8710096|NCT00956540|9756386|FG002|COMPLETED|Overall Study||43
8710097|NCT00956540|9756387|FG003|COMPLETED|Overall Study||41
8710098|NCT00956540|9756384|FG000|NOT COMPLETED|Overall Study||3
8710099|NCT00956540|9756385|FG001|NOT COMPLETED|Overall Study||4
8710100|NCT00956540|9756386|FG002|NOT COMPLETED|Overall Study||3
8710101|NCT00956540|9756387|FG003|NOT COMPLETED|Overall Study||4
8710102|NCT00956592|9756399|FG000|STARTED|Overall Study||150
8710103|NCT00956592|9756400|FG001|STARTED|Overall Study||150
8710104|NCT00956592|9756399|FG000|COMPLETED|Overall Study||149
8710105|NCT00956592|9756400|FG001|COMPLETED|Overall Study||147
8710106|NCT00956592|9756399|FG000|NOT COMPLETED|Overall Study||1
8710107|NCT00956592|9756400|FG001|NOT COMPLETED|Overall Study||3
8710108|NCT00956631|9756408|FG000|STARTED|Overall Study||78
8710109|NCT00956631|9756408|FG000|COMPLETED|Overall Study||62
8710110|NCT00956631|9756408|FG000|NOT COMPLETED|Overall Study||16
8710111|NCT00956657|9756416|FG000|STARTED|Overall Study||18
8710112|NCT00956657|9756417|FG001|STARTED|Overall Study||13
8710113|NCT00956657|9756416|FG000|COMPLETED|Overall Study||18
8710114|NCT00956657|9756417|FG001|COMPLETED|Overall Study||13
8710115|NCT00956657|9756416|FG000|NOT COMPLETED|Overall Study||0
8710116|NCT00956657|9756417|FG001|NOT COMPLETED|Overall Study||0
8710117|NCT00956709|9756425|FG000|STARTED|Overall Study||16
8710118|NCT00956709|9756426|FG001|STARTED|Overall Study||19
8710119|NCT00956709|9756425|FG000|COMPLETED|Overall Study||16
8710120|NCT00956709|9756426|FG001|COMPLETED|Overall Study||19
8710121|NCT00956709|9756425|FG000|NOT COMPLETED|Overall Study||0
8710122|NCT00956709|9756426|FG001|NOT COMPLETED|Overall Study||0
8710123|NCT00956761|9756432|FG000|STARTED|Overall Study||63
8710124|NCT00956761|9756432|FG000|COMPLETED|Overall Study||63
8710125|NCT00956761|9756432|FG000|NOT COMPLETED|Overall Study||0
8710126|NCT00956813|9756439|FG000|STARTED|Flaxseed and Placebo||105
8710127|NCT00956813|9756440|FG001|STARTED|Flaxseed and Placebo||105
8710128|NCT00956813|9756439|FG000|COMPLETED|Flaxseed and Placebo||97
8710129|NCT00956813|9756440|FG001|COMPLETED|Flaxseed and Placebo||100
8710130|NCT00956813|9756439|FG000|NOT COMPLETED|Flaxseed and Placebo||8
8710131|NCT00956813|9756440|FG001|NOT COMPLETED|Flaxseed and Placebo||5
8710132|NCT00956813|9756439|FG000|STARTED|Continuation Phase||80
8710133|NCT00956813|9756440|FG001|STARTED|Continuation Phase||0
8710134|NCT00956813|9756439|FG000|COMPLETED|Continuation Phase||80
8710135|NCT00956813|9756440|FG001|COMPLETED|Continuation Phase||0
8710136|NCT00956813|9756439|FG000|NOT COMPLETED|Continuation Phase||0
8710137|NCT00956813|9756440|FG001|NOT COMPLETED|Continuation Phase||0
8710138|NCT00956839|9756450|FG000|STARTED|Overall Study||14
8710139|NCT00956839|9756451|FG001|STARTED|Overall Study||13
8710140|NCT00956839|9756452|FG002|STARTED|Overall Study||13
8710141|NCT00956839|9756450|FG000|COMPLETED|Overall Study||11
8710142|NCT00956839|9756451|FG001|COMPLETED|Overall Study||13
8710143|NCT00956839|9756452|FG002|COMPLETED|Overall Study||10
8710144|NCT00956839|9756450|FG000|NOT COMPLETED|Overall Study||3
8710145|NCT00956839|9756451|FG001|NOT COMPLETED|Overall Study||0
8710146|NCT00956839|9756452|FG002|NOT COMPLETED|Overall Study||3
8710147|NCT00956930|9756462|FG000|STARTED|Overall Study||24
8710148|NCT00956930|9756463|FG001|STARTED|Overall Study||21
8710149|NCT00956930|9756462|FG000|COMPLETED|Overall Study||24
8710150|NCT00956930|9756463|FG001|COMPLETED|Overall Study||21
8710151|NCT00956930|9756462|FG000|NOT COMPLETED|Overall Study||0
8585233|NCT00251693|9619285|FG001|STARTED|Overall Study||668
8585234|NCT00251693|9619286|FG002|STARTED|Overall Study||690
8710152|NCT00956930|9756463|FG001|NOT COMPLETED|Overall Study||0
8710153|NCT00956943|9756473|FG000|STARTED|Overall Study||43
8710154|NCT00956943|9756474|FG001|STARTED|Overall Study||44
8710155|NCT00956943|9756473|FG000|Baseline|Overall Study||43
8710156|NCT00956943|9756474|FG001|Baseline|Overall Study||44
8710157|NCT00956943|9756473|FG000|COMPLETED|Overall Study||34
8710158|NCT00956943|9756474|FG001|COMPLETED|Overall Study||34
8710159|NCT00956943|9756473|FG000|NOT COMPLETED|Overall Study||9
8710160|NCT00956943|9756474|FG001|NOT COMPLETED|Overall Study||10
8710161|NCT00957008|9756484|FG000|STARTED|Overall Study||49
8710162|NCT00957008|9756485|FG001|STARTED|Overall Study||49
8710163|NCT00957008|9756486|FG002|STARTED|Overall Study||49
8710164|NCT00957008|9756487|FG003|STARTED|Overall Study||50
8710165|NCT00957008|9756484|FG000|COMPLETED|Overall Study||28
8585235|NCT00251693|9619284|FG000|COMPLETED|Overall Study||629
8585236|NCT00251693|9619285|FG001|COMPLETED|Overall Study||624
8585237|NCT00251693|9619286|FG002|COMPLETED|Overall Study||644
8710166|NCT00957008|9756485|FG001|COMPLETED|Overall Study||37
8710167|NCT00957008|9756486|FG002|COMPLETED|Overall Study||32
8710168|NCT00957008|9756487|FG003|COMPLETED|Overall Study||26
8710169|NCT00957008|9756484|FG000|NOT COMPLETED|Overall Study||21
8710170|NCT00957008|9756485|FG001|NOT COMPLETED|Overall Study||12
8710171|NCT00957008|9756486|FG002|NOT COMPLETED|Overall Study||17
8710172|NCT00957008|9756487|FG003|NOT COMPLETED|Overall Study||24
8585238|NCT00251693|9619284|FG000|NOT COMPLETED|Overall Study||51
8585239|NCT00251693|9619285|FG001|NOT COMPLETED|Overall Study||44
8585240|NCT00251693|9619286|FG002|NOT COMPLETED|Overall Study||46
8585241|NCT00251719|9619297|FG000|STARTED|Overall Study||694
8585242|NCT00251719|9619298|FG001|STARTED|Overall Study||687
8585243|NCT00251719|9619299|FG002|STARTED|Overall Study||673
8585244|NCT00251719|9619297|FG000|COMPLETED|Overall Study||641
8585245|NCT00251719|9619298|FG001|COMPLETED|Overall Study||642
8585246|NCT00251719|9619299|FG002|COMPLETED|Overall Study||643
8585247|NCT00251719|9619297|FG000|NOT COMPLETED|Overall Study||53
8585248|NCT00251719|9619298|FG001|NOT COMPLETED|Overall Study||45
8585249|NCT00251719|9619299|FG002|NOT COMPLETED|Overall Study||30
8585250|NCT00251745|9619310|FG000|STARTED|Overall Study||292
8585251|NCT00251745|9619311|FG001|STARTED|Overall Study||312
8585252|NCT00251745|9619312|FG002|STARTED|Overall Study||304
8585253|NCT00251745|9619310|FG000|COMPLETED|Overall Study||264
8585254|NCT00251745|9619311|FG001|COMPLETED|Overall Study||285
8585255|NCT00251745|9619312|FG002|COMPLETED|Overall Study||277
8585256|NCT00251745|9619310|FG000|NOT COMPLETED|Overall Study||28
8585257|NCT00251745|9619311|FG001|NOT COMPLETED|Overall Study||27
8585258|NCT00251745|9619312|FG002|NOT COMPLETED|Overall Study||27
8585259|NCT00251758|9619323|FG000|STARTED|Overall Study||292
8585260|NCT00251758|9619324|FG001|STARTED|Overall Study||312
8585261|NCT00251758|9619325|FG002|STARTED|Overall Study||304
8585262|NCT00251758|9619323|FG000|COMPLETED|Overall Study||264
8585263|NCT00251758|9619324|FG001|COMPLETED|Overall Study||285
8585264|NCT00251758|9619325|FG002|COMPLETED|Overall Study||277
8585265|NCT00251758|9619323|FG000|NOT COMPLETED|Overall Study||28
8585266|NCT00251758|9619324|FG001|NOT COMPLETED|Overall Study||27
8585267|NCT00251758|9619325|FG002|NOT COMPLETED|Overall Study||27
8585268|NCT00251862|9619336|FG000|STARTED|Overall Study||280
8585269|NCT00251862|9619337|FG001|STARTED|Overall Study||269
8585270|NCT00251862|9619338|FG002|STARTED|Overall Study||276
8585271|NCT00251862|9619336|FG000|COMPLETED|Overall Study||280
8585272|NCT00251862|9619337|FG001|COMPLETED|Overall Study||269
8585273|NCT00251862|9619338|FG002|COMPLETED|Overall Study||276
8585274|NCT00251862|9619336|FG000|NOT COMPLETED|Overall Study||0
8585275|NCT00251862|9619337|FG001|NOT COMPLETED|Overall Study||0
8585276|NCT00251862|9619338|FG002|NOT COMPLETED|Overall Study||0
8585277|NCT00251927|9619348|FG000|STARTED|Overall Study|Randomised|288
8585278|NCT00251927|9619349|FG001|STARTED|Overall Study|Randomised|266
8585279|NCT00251927|9619348|FG000|COMPLETED|Overall Study|Completed 5 year visit|180
8585280|NCT00251927|9619349|FG001|COMPLETED|Overall Study|Completed 5 year visit|192
8585281|NCT00251927|9619348|FG000|NOT COMPLETED|Overall Study||108
8585282|NCT00251927|9619349|FG001|NOT COMPLETED|Overall Study||74
8585283|NCT00251979|9619358|FG000|STARTED|Overall Study|ITT population|375
8585284|NCT00251979|9619359|FG001|STARTED|Overall Study|ITT population|389
8585285|NCT00251979|9619358|FG000|COMPLETED|Overall Study||337
8585286|NCT00251979|9619359|FG001|COMPLETED|Overall Study||349
8585287|NCT00251979|9619358|FG000|NOT COMPLETED|Overall Study||38
8585288|NCT00251979|9619359|FG001|NOT COMPLETED|Overall Study||40
8585289|NCT00252057|9619367|FG000|STARTED|Overall Study||373
8585290|NCT00252057|9619368|FG001|STARTED|Overall Study||376
8585291|NCT00252057|9619367|FG000|COMPLETED|Overall Study||370
8585292|NCT00252057|9619368|FG001|COMPLETED|Overall Study||368
8585293|NCT00252057|9619367|FG000|NOT COMPLETED|Overall Study||3
8585294|NCT00252057|9619368|FG001|NOT COMPLETED|Overall Study||8
8585295|NCT00252187|9619376|FG000|STARTED|Overall Study||24
8585296|NCT00252187|9619377|FG001|STARTED|Overall Study||21
8585297|NCT00252187|9619376|FG000|COMPLETED|Overall Study||20
8585298|NCT00252187|9619377|FG001|COMPLETED|Overall Study||20
8585299|NCT00252187|9619376|FG000|NOT COMPLETED|Overall Study||4
8585300|NCT00252187|9619377|FG001|NOT COMPLETED|Overall Study||1
8585301|NCT00252239|9619387|FG000|STARTED|Overall Study||31
8585302|NCT00252239|9619388|FG001|STARTED|Overall Study||31
8585303|NCT00252239|9619389|FG002|STARTED|Overall Study||19
8585304|NCT00252239|9619390|FG003|STARTED|Overall Study||31
8585305|NCT00252239|9619387|FG000|COMPLETED|Overall Study||30
8585306|NCT00252239|9619388|FG001|COMPLETED|Overall Study||31
8585307|NCT00252239|9619389|FG002|COMPLETED|Overall Study||17
8585308|NCT00252239|9619390|FG003|COMPLETED|Overall Study||30
8585309|NCT00252239|9619387|FG000|NOT COMPLETED|Overall Study||1
8585310|NCT00252239|9619388|FG001|NOT COMPLETED|Overall Study||0
8585311|NCT00252239|9619389|FG002|NOT COMPLETED|Overall Study||2
8585312|NCT00252239|9619390|FG003|NOT COMPLETED|Overall Study||1
8627789|NCT00519376|9667175|FG005|STARTED|Treatment Period 4||1
8627790|NCT00519376|9667176|FG006|STARTED|Treatment Period 4||1
8627791|NCT00519376|9667177|FG007|STARTED|Treatment Period 4||1
8627792|NCT00519376|9667178|FG008|STARTED|Treatment Period 4||1
8627793|NCT00519376|9667179|FG009|STARTED|Treatment Period 4||1
8627794|NCT00519376|9667180|FG010|STARTED|Treatment Period 4||1
8627795|NCT00519376|9667181|FG011|STARTED|Treatment Period 4||1
8627796|NCT00519376|9667182|FG012|STARTED|Treatment Period 4||0
8627797|NCT00519376|9667183|FG013|STARTED|Treatment Period 4||1
8627798|NCT00519376|9667184|FG014|STARTED|Treatment Period 4||1
8627799|NCT00519376|9667185|FG015|STARTED|Treatment Period 4||1
8627800|NCT00519376|9667170|FG000|COMPLETED|Treatment Period 4||2
8627801|NCT00519376|9667171|FG001|COMPLETED|Treatment Period 4||2
8627802|NCT00519376|9667172|FG002|COMPLETED|Treatment Period 4||1
8627803|NCT00519376|9667173|FG003|COMPLETED|Treatment Period 4||2
8627804|NCT00519376|9667174|FG004|COMPLETED|Treatment Period 4||1
8585313|NCT00252382|9619400|FG000|STARTED|Overall Study||31
8585314|NCT00252382|9619400|FG000|COMPLETED|Overall Study||5
8585315|NCT00252382|9619400|FG000|NOT COMPLETED|Overall Study||26
8585316|NCT00252499|9619407|FG000|STARTED|Overall Study||5
8585317|NCT00252499|9619408|FG001|STARTED|Overall Study||2
8585318|NCT00252499|9619409|FG002|STARTED|Overall Study||6
8585319|NCT00252499|9619407|FG000|COMPLETED|Overall Study||4
8585320|NCT00252499|9619408|FG001|COMPLETED|Overall Study||2
8585321|NCT00252499|9619409|FG002|COMPLETED|Overall Study||6
8585322|NCT00252499|9619407|FG000|NOT COMPLETED|Overall Study||1
8585323|NCT00252499|9619408|FG001|NOT COMPLETED|Overall Study||0
8585324|NCT00252499|9619409|FG002|NOT COMPLETED|Overall Study||0
8585325|NCT00252512|9619419|FG000|STARTED|Intervention||165
8585326|NCT00252512|9619420|FG001|STARTED|Intervention||165
8585327|NCT00252512|9619419|FG000|COMPLETED|Intervention||136
8585328|NCT00252512|9619420|FG001|COMPLETED|Intervention||134
8585329|NCT00252512|9619419|FG000|NOT COMPLETED|Intervention||29
8585330|NCT00252512|9619420|FG001|NOT COMPLETED|Intervention||31
8585331|NCT00252512|9619419|FG000|STARTED|Six Month Follow up||136
8585332|NCT00252512|9619420|FG001|STARTED|Six Month Follow up||134
8585333|NCT00252512|9619419|FG000|COMPLETED|Six Month Follow up||132
8585334|NCT00252512|9619420|FG001|COMPLETED|Six Month Follow up||122
8585335|NCT00252512|9619419|FG000|NOT COMPLETED|Six Month Follow up||4
8585336|NCT00252512|9619420|FG001|NOT COMPLETED|Six Month Follow up||12
8585337|NCT00252512|9619419|FG000|STARTED|12 Month Follow up||132
8585338|NCT00252512|9619420|FG001|STARTED|12 Month Follow up||122
8585339|NCT00252512|9619419|FG000|COMPLETED|12 Month Follow up||123
8585340|NCT00252512|9619420|FG001|COMPLETED|12 Month Follow up||121
8585341|NCT00252512|9619419|FG000|NOT COMPLETED|12 Month Follow up||9
8585342|NCT00252512|9619420|FG001|NOT COMPLETED|12 Month Follow up||1
8585343|NCT00252538|9619426|FG000|STARTED|Overall Study||19
8585344|NCT00252538|9619427|FG001|STARTED|Overall Study||114
8585345|NCT00252538|9619426|FG000|COMPLETED|Overall Study||19
8585346|NCT00252538|9619427|FG001|COMPLETED|Overall Study||114
8585347|NCT00252538|9619426|FG000|NOT COMPLETED|Overall Study||0
8585348|NCT00252538|9619427|FG001|NOT COMPLETED|Overall Study||0
8585349|NCT00252564|9619434|FG000|STARTED|Overall Study|From randomization|124
8585350|NCT00252564|9619435|FG001|STARTED|Overall Study|From randomization|123
8585351|NCT00252564|9619434|FG000|COMPLETED|Overall Study|Received 6+ cycles OR had response (RECIST criteria, CR or PR)|85
8585352|NCT00252564|9619435|FG001|COMPLETED|Overall Study|Received 6+ cycles OR had response (RECIST criteria, CR or PR)|79
8585353|NCT00252564|9619434|FG000|NOT COMPLETED|Overall Study||39
8585354|NCT00252564|9619435|FG001|NOT COMPLETED|Overall Study||44
8585355|NCT00252577|9619441|FG000|STARTED|Overall Study||130
8585356|NCT00252577|9619441|FG000|COMPLETED|Overall Study||110
8585357|NCT00252577|9619441|FG000|NOT COMPLETED|Overall Study||20
8585358|NCT00252590|9619448|FG000|STARTED|Overall Study||35
8585359|NCT00252590|9619449|FG001|STARTED|Overall Study||30
8585360|NCT00252590|9619450|FG002|STARTED|Overall Study||34
8585361|NCT00252590|9619448|FG000|COMPLETED|Overall Study||33
8585362|NCT00252590|9619449|FG001|COMPLETED|Overall Study||28
8585363|NCT00252590|9619450|FG002|COMPLETED|Overall Study||31
8585364|NCT00252590|9619448|FG000|NOT COMPLETED|Overall Study||2
8585365|NCT00252590|9619449|FG001|NOT COMPLETED|Overall Study||2
8585366|NCT00252590|9619450|FG002|NOT COMPLETED|Overall Study||3
8585367|NCT00252629|9619461|FG000|STARTED|Overall Study||9
8585368|NCT00252629|9619462|FG001|STARTED|Overall Study||9
8585369|NCT00252629|9619463|FG002|STARTED|Overall Study|We used data from the 18 veterans with GWS in addition to the 11 control|11
8585370|NCT00252629|9619461|FG000|COMPLETED|Overall Study|One participant assigned to therapeutic CPAP was excluded from the trial before starting treatment.|8
8585371|NCT00252629|9619462|FG001|COMPLETED|Overall Study||9
8585372|NCT00252629|9619463|FG002|COMPLETED|Overall Study|We used data from the 18 veterans with GWS in addition to the 11 control|11
8585373|NCT00252629|9619461|FG000|NOT COMPLETED|Overall Study||1
8585374|NCT00252629|9619462|FG001|NOT COMPLETED|Overall Study||0
8585375|NCT00252629|9619463|FG002|NOT COMPLETED|Overall Study||0
8585376|NCT00252694|9619478|FG000|STARTED|Overall Study||951
8585377|NCT00252694|9619479|FG001|STARTED|Overall Study||954
8585378|NCT00252694|9619478|FG000|COMPLETED|Overall Study||807
8585379|NCT00252694|9619479|FG001|COMPLETED|Overall Study||800
8585380|NCT00252694|9619478|FG000|NOT COMPLETED|Overall Study||144
8585381|NCT00252694|9619479|FG001|NOT COMPLETED|Overall Study||154
8585382|NCT00252720|9619487|FG000|STARTED|Overall Study||951
8585383|NCT00252720|9619488|FG001|STARTED|Overall Study||954
8585384|NCT00252720|9619487|FG000|COMPLETED|Overall Study||819
8585385|NCT00252720|9619488|FG001|COMPLETED|Overall Study||789
8585386|NCT00252720|9619487|FG000|NOT COMPLETED|Overall Study||132
8585387|NCT00252720|9619488|FG001|NOT COMPLETED|Overall Study||165
8585388|NCT00252733|9619496|FG000|STARTED|Overall Study||711
8585389|NCT00252733|9619497|FG001|STARTED|Overall Study||710
8585390|NCT00252733|9619496|FG000|COMPLETED|Overall Study||605
8585391|NCT00252733|9619497|FG001|COMPLETED|Overall Study||618
8585392|NCT00252733|9619496|FG000|NOT COMPLETED|Overall Study||106
8585393|NCT00252733|9619497|FG001|NOT COMPLETED|Overall Study||92
8585394|NCT00252967|9619505|FG000|STARTED|Overall Study||31
8585395|NCT00252967|9619506|FG001|STARTED|Overall Study||33
8585396|NCT00252967|9619505|FG000|COMPLETED|Overall Study||31
8585397|NCT00252967|9619506|FG001|COMPLETED|Overall Study||33
8585398|NCT00252967|9619505|FG000|NOT COMPLETED|Overall Study||0
8585399|NCT00252967|9619506|FG001|NOT COMPLETED|Overall Study||0
8585400|NCT00253019|9619515|FG000|STARTED|Overall Study||111
8585401|NCT00253019|9619516|FG001|STARTED|Overall Study||109
8585402|NCT00253019|9619517|FG002|STARTED|Overall Study||101
8585403|NCT00253019|9619515|FG000|COMPLETED|Overall Study||82
8585404|NCT00253019|9619516|FG001|COMPLETED|Overall Study||78
8585405|NCT00253019|9619517|FG002|COMPLETED|Overall Study||83
8585406|NCT00253019|9619515|FG000|NOT COMPLETED|Overall Study||29
8585407|NCT00253019|9619516|FG001|NOT COMPLETED|Overall Study||31
8585408|NCT00253019|9619517|FG002|NOT COMPLETED|Overall Study||18
8585409|NCT00253370|9619525|FG000|STARTED|Overall Study||44
8585410|NCT00253370|9619525|FG000|COMPLETED|Overall Study||1
8585411|NCT00253370|9619525|FG000|NOT COMPLETED|Overall Study||43
8585412|NCT00253435|9619532|FG000|STARTED|Overall Study|Total number is 42|42
8585413|NCT00253435|9619533|FG001|STARTED|Overall Study|This cohort opened as long as the poor risk group is open to accrual.|8
8585414|NCT00253435|9619532|FG000|1st Interim Analysis|Overall Study|First interim analysis: need 2+ responses in first 15 patients. Goal met study continued.|15
8585415|NCT00253435|9619533|FG001|1st Interim Analysis|Overall Study|Only interim analysis: need 1+ response in first 10 patients.|8
8585416|NCT00253435|9619532|FG000|2nd Interim Analysis|Overall Study|Second interim analysis: need 3+ responses in first 25 patients. Goal met study continued.|10
8585417|NCT00253435|9619533|FG001|2nd Interim Analysis|Overall Study|This cohort opened as long as the poor risk group is open to accrual.|0
8585418|NCT00253435|9619532|FG000|3rd Interim Analysis|Overall Study|Third interim analysis: need 4+ responses in first 35 patients. Goal met study continued.|10
8585419|NCT00253435|9619533|FG001|3rd Interim Analysis|Overall Study|This cohort opened as long as the poor risk group is open to accrual.|0
8585420|NCT00253435|9619532|FG000|COMPLETED|Overall Study|Forty-two evaluable poor risk patients enrolled.|42
8585421|NCT00253435|9619533|FG001|COMPLETED|Overall Study|Eight evaluable patients enrolled.|8
8585422|NCT00253435|9619532|FG000|NOT COMPLETED|Overall Study||0
8585423|NCT00253435|9619533|FG001|NOT COMPLETED|Overall Study||0
8585424|NCT00253448|9619539|FG000|STARTED|Overall Study||35
8585425|NCT00253448|9619539|FG000|COMPLETED|Overall Study||34
8585426|NCT00253448|9619539|FG000|NOT COMPLETED|Overall Study||1
8585427|NCT00253513|9619543|FG000|STARTED|Overall Study||60
8585428|NCT00253513|9619543|FG000|COMPLETED|Overall Study||60
8585429|NCT00253513|9619543|FG000|NOT COMPLETED|Overall Study||0
8585430|NCT00253630|9619547|FG000|STARTED|Overall Study||37
8585431|NCT00253630|9619547|FG000|COMPLETED|Overall Study||35
8585432|NCT00253630|9619547|FG000|NOT COMPLETED|Overall Study||2
8585433|NCT00253643|9619555|FG000|STARTED|Overall Study||14
8585434|NCT00253643|9619556|FG001|STARTED|Overall Study||15
8585435|NCT00253643|9619557|FG002|STARTED|Overall Study||29
8585436|NCT00253643|9619558|FG003|STARTED|Overall Study||31
8585437|NCT00253643|9619555|FG000|COMPLETED|Overall Study||14
8585438|NCT00253643|9619556|FG001|COMPLETED|Overall Study||15
8585439|NCT00253643|9619557|FG002|COMPLETED|Overall Study||28
8585440|NCT00253643|9619558|FG003|COMPLETED|Overall Study||28
8585441|NCT00253643|9619555|FG000|NOT COMPLETED|Overall Study||0
8585442|NCT00253643|9619556|FG001|NOT COMPLETED|Overall Study||0
8585443|NCT00253643|9619557|FG002|NOT COMPLETED|Overall Study||1
8585444|NCT00253643|9619558|FG003|NOT COMPLETED|Overall Study||3
8585445|NCT00253708|9619571|FG000|STARTED|Overall Study||20
8585446|NCT00253708|9619572|FG001|STARTED|Overall Study||10
8585447|NCT00253708|9619573|FG002|STARTED|Overall Study||9
8585448|NCT00253708|9619571|FG000|COMPLETED|Overall Study||20
8585449|NCT00253708|9619572|FG001|COMPLETED|Overall Study||10
8585450|NCT00253708|9619573|FG002|COMPLETED|Overall Study||8
8585451|NCT00253708|9619571|FG000|NOT COMPLETED|Overall Study||0
8585452|NCT00253708|9619572|FG001|NOT COMPLETED|Overall Study||0
8585453|NCT00253708|9619573|FG002|NOT COMPLETED|Overall Study||1
8585454|NCT00253747|9619583|FG000|STARTED|Overall Study||127
8585455|NCT00253747|9619584|FG001|STARTED|Overall Study||128
8585456|NCT00253747|9619583|FG000|COMPLETED|Overall Study||103
8585457|NCT00253747|9619584|FG001|COMPLETED|Overall Study||101
8585458|NCT00253747|9619583|FG000|NOT COMPLETED|Overall Study||24
8585459|NCT00253747|9619584|FG001|NOT COMPLETED|Overall Study||27
8585460|NCT00253890|9619602|FG000|STARTED|Overall Study||69
8585461|NCT00253890|9619603|FG001|STARTED|Overall Study||68
8585462|NCT00253890|9619602|FG000|COMPLETED|Overall Study||62
8585463|NCT00253890|9619603|FG001|COMPLETED|Overall Study||61
8585464|NCT00253890|9619602|FG000|NOT COMPLETED|Overall Study||7
8585465|NCT00253890|9619603|FG001|NOT COMPLETED|Overall Study||7
8585466|NCT00254072|9619611|FG000|STARTED|Overall Study||180
8585467|NCT00254072|9619612|FG001|STARTED|Overall Study||175
8585468|NCT00254072|9619611|FG000|COMPLETED|Overall Study||180
8585469|NCT00254072|9619612|FG001|COMPLETED|Overall Study||175
8585470|NCT00254072|9619611|FG000|NOT COMPLETED|Overall Study||0
8585471|NCT00254072|9619612|FG001|NOT COMPLETED|Overall Study||0
8585472|NCT00254163|9619620|FG000|STARTED|Overall Study||92
8585473|NCT00254163|9619621|FG001|STARTED|Overall Study||92
8585474|NCT00254163|9619620|FG000|COMPLETED|Overall Study||47
8585475|NCT00254163|9619621|FG001|COMPLETED|Overall Study||46
8585476|NCT00254163|9619620|FG000|NOT COMPLETED|Overall Study||45
8585477|NCT00254163|9619621|FG001|NOT COMPLETED|Overall Study||46
8585478|NCT00254293|9619633|FG000|STARTED|Short Term (12 Week) Randomized Dosing||7
8585479|NCT00254293|9619634|FG001|STARTED|Short Term (12 Week) Randomized Dosing||4
8585480|NCT00254293|9619635|FG002|STARTED|Short Term (12 Week) Randomized Dosing||29
8585481|NCT00254293|9619636|FG003|STARTED|Short Term (12 Week) Randomized Dosing||6
8585482|NCT00254293|9619637|FG004|STARTED|Short Term (12 Week) Randomized Dosing||5
8627805|NCT00519376|9667175|FG005|COMPLETED|Treatment Period 4||1
8627806|NCT00519376|9667176|FG006|COMPLETED|Treatment Period 4||1
8585483|NCT00254293|9619638|FG005|STARTED|Short Term (12 Week) Randomized Dosing|2, 2, 9, 2, and 2 were randomized to placebo in body weight Groups 1, 2, 3, 4, 5, respectively.|17
8585484|NCT00254293|9619639|FG006|STARTED|Short Term (12 Week) Randomized Dosing||0
8585485|NCT00254293|9619633|FG000|COMPLETED|Short Term (12 Week) Randomized Dosing||7
8585486|NCT00254293|9619634|FG001|COMPLETED|Short Term (12 Week) Randomized Dosing||3
8585487|NCT00254293|9619635|FG002|COMPLETED|Short Term (12 Week) Randomized Dosing||26
8585488|NCT00254293|9619636|FG003|COMPLETED|Short Term (12 Week) Randomized Dosing||5
8585489|NCT00254293|9619637|FG004|COMPLETED|Short Term (12 Week) Randomized Dosing||5
8585490|NCT00254293|9619638|FG005|COMPLETED|Short Term (12 Week) Randomized Dosing||17
8585491|NCT00254293|9619639|FG006|COMPLETED|Short Term (12 Week) Randomized Dosing||0
8585492|NCT00254293|9619633|FG000|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
8585493|NCT00254293|9619634|FG001|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||1
8585494|NCT00254293|9619635|FG002|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||3
8585495|NCT00254293|9619636|FG003|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||1
8585496|NCT00254293|9619637|FG004|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
8585497|NCT00254293|9619638|FG005|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
8585498|NCT00254293|9619639|FG006|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
8585499|NCT00254293|9619633|FG000|STARTED|LTE Open Label Variable SC Dosing|Participants who received ST placebo rolled over to 75mg SC dose group (by body weight, <60kg).|11
8585500|NCT00254293|9619634|FG001|STARTED|LTE Open Label Variable SC Dosing|Participants rolled over to 125mg dose group summarized as one group (body weight <60 to >100 kg).|0
8585501|NCT00254293|9619635|FG002|STARTED|LTE Open Label Variable SC Dosing|Variable SC dose group: 125 mg Weekly, body weight <60 to >100kg (Groups 2, 3, 4 in ST Period).|42
8710173|NCT00957021|9756501|FG000|STARTED|Overall Study||354
8710174|NCT00957021|9756501|FG000|COMPLETED|Overall Study|Completed/Not completed counts are based on participant status at the 2 yr primary outcome interval.|237
8710175|NCT00957021|9756501|FG000|NOT COMPLETED|Overall Study||117
8710176|NCT00957047|9756510|FG000|STARTED|PART I||100
8710177|NCT00957047|9756511|FG001|STARTED|PART I||96
8710178|NCT00957047|9756512|FG002|STARTED|PART I||101
8710179|NCT00957047|9756513|FG003|STARTED|PART I||98
8710180|NCT00957047|9756514|FG004|STARTED|PART I||0
8710181|NCT00957047|9756510|FG000|Randomized/Safety Population|PART I||100
8710182|NCT00957047|9756511|FG001|Randomized/Safety Population|PART I||96
8710183|NCT00957047|9756512|FG002|Randomized/Safety Population|PART I||101
8710184|NCT00957047|9756513|FG003|Randomized/Safety Population|PART I||98
8710185|NCT00957047|9756514|FG004|Randomized/Safety Population|PART I||0
8710186|NCT00957047|9756510|FG000|Intention-to-treat (ITT) Population|PART I||100
8710187|NCT00957047|9756511|FG001|Intention-to-treat (ITT) Population|PART I||96
8710188|NCT00957047|9756512|FG002|Intention-to-treat (ITT) Population|PART I||100
8710189|NCT00957047|9756513|FG003|Intention-to-treat (ITT) Population|PART I||97
8710190|NCT00957047|9756514|FG004|Intention-to-treat (ITT) Population|PART I||0
8710191|NCT00957047|9756510|FG000|Per-Protocol Population|PART I||81
8710192|NCT00957047|9756511|FG001|Per-Protocol Population|PART I||70
8710193|NCT00957047|9756512|FG002|Per-Protocol Population|PART I||75
8710194|NCT00957047|9756513|FG003|Per-Protocol Population|PART I||54
8710195|NCT00957047|9756514|FG004|Per-Protocol Population|PART I||0
8710196|NCT00957047|9756510|FG000|COMPLETED|PART I||94
8710197|NCT00957047|9756511|FG001|COMPLETED|PART I||83
8710198|NCT00957047|9756512|FG002|COMPLETED|PART I||80
8710199|NCT00957047|9756513|FG003|COMPLETED|PART I||68
8710200|NCT00957047|9756514|FG004|COMPLETED|PART I||0
8710201|NCT00957047|9756510|FG000|NOT COMPLETED|PART I||6
8710202|NCT00957047|9756511|FG001|NOT COMPLETED|PART I||13
8710203|NCT00957047|9756512|FG002|NOT COMPLETED|PART I||21
8710204|NCT00957047|9756513|FG003|NOT COMPLETED|PART I||30
8710205|NCT00957047|9756514|FG004|NOT COMPLETED|PART I||0
8710206|NCT00957047|9756510|FG000|STARTED|PART II||0
8710207|NCT00957047|9756511|FG001|STARTED|PART II||0
8710208|NCT00957047|9756512|FG002|STARTED|PART II||0
8710209|NCT00957047|9756513|FG003|STARTED|PART II||0
8710210|NCT00957047|9756514|FG004|STARTED|PART II|325 patients who completed Part I were enrolled in Part II.|325
8710211|NCT00957047|9756510|FG000|Terminated Prematurely|PART II||0
8710212|NCT00957047|9756511|FG001|Terminated Prematurely|PART II||0
8710213|NCT00957047|9756512|FG002|Terminated Prematurely|PART II||0
8710214|NCT00957047|9756513|FG003|Terminated Prematurely|PART II||0
8710215|NCT00957047|9756514|FG004|Terminated Prematurely|PART II|Terminated Prematurely during 1-year Open-Label Period|102
8710216|NCT00957047|9756510|FG000|COMPLETED|PART II||0
8710217|NCT00957047|9756511|FG001|COMPLETED|PART II||0
8710218|NCT00957047|9756512|FG002|COMPLETED|PART II||0
8710219|NCT00957047|9756513|FG003|COMPLETED|PART II||0
8710220|NCT00957047|9756514|FG004|COMPLETED|PART II||223
8710221|NCT00957047|9756510|FG000|NOT COMPLETED|PART II||0
8710222|NCT00957047|9756511|FG001|NOT COMPLETED|PART II||0
8710223|NCT00957047|9756512|FG002|NOT COMPLETED|PART II||0
8710224|NCT00957047|9756513|FG003|NOT COMPLETED|PART II||0
8710225|NCT00957047|9756514|FG004|NOT COMPLETED|PART II||102
8710226|NCT00957229|9756534|FG000|STARTED|Study Start||15
8710227|NCT00957229|9756535|FG001|STARTED|Study Start||26
8710228|NCT00957229|9756534|FG000|COMPLETED|Study Start||14
8710229|NCT00957229|9756535|FG001|COMPLETED|Study Start||23
8710230|NCT00957229|9756534|FG000|NOT COMPLETED|Study Start||1
8710231|NCT00957229|9756535|FG001|NOT COMPLETED|Study Start||3
8710232|NCT00957229|9756534|FG000|STARTED|Reallocated to or Continued Vismodegib||14
8710233|NCT00957229|9756535|FG001|STARTED|Reallocated to or Continued Vismodegib||23
8710234|NCT00957229|9756534|FG000|COMPLETED|Reallocated to or Continued Vismodegib||11
8585502|NCT00254293|9619636|FG003|STARTED|LTE Open Label Variable SC Dosing|Participants rolled over to 125mg dose group summarized as one group (body weight <60 to >100 kg).|0
8585503|NCT00254293|9619637|FG004|STARTED|LTE Open Label Variable SC Dosing|Participants who received ST placebo rolled over to variable SC dose group (by body weight, >100kg).|10
8585504|NCT00254293|9619638|FG005|STARTED|LTE Open Label Variable SC Dosing|Participants rolled over to a variable SC dose group of 75, 125 or 200 mg Weekly by body weight.|0
8585505|NCT00254293|9619639|FG006|STARTED|LTE Open Label Variable SC Dosing|Participant rolled over from LTE (Variable Dose Period) to LTE (Fixed Dose Period).|0
8585506|NCT00254293|9619633|FG000|COMPLETED|LTE Open Label Variable SC Dosing||8
8585507|NCT00254293|9619634|FG001|COMPLETED|LTE Open Label Variable SC Dosing||0
8585508|NCT00254293|9619635|FG002|COMPLETED|LTE Open Label Variable SC Dosing||32
8585509|NCT00254293|9619636|FG003|COMPLETED|LTE Open Label Variable SC Dosing||0
8585510|NCT00254293|9619637|FG004|COMPLETED|LTE Open Label Variable SC Dosing||8
8585511|NCT00254293|9619638|FG005|COMPLETED|LTE Open Label Variable SC Dosing||0
8585512|NCT00254293|9619639|FG006|COMPLETED|LTE Open Label Variable SC Dosing||0
8585513|NCT00254293|9619633|FG000|NOT COMPLETED|LTE Open Label Variable SC Dosing||3
8585514|NCT00254293|9619634|FG001|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
8585515|NCT00254293|9619635|FG002|NOT COMPLETED|LTE Open Label Variable SC Dosing||10
8585516|NCT00254293|9619636|FG003|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
8585517|NCT00254293|9619637|FG004|NOT COMPLETED|LTE Open Label Variable SC Dosing||2
8585518|NCT00254293|9619638|FG005|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
8585519|NCT00254293|9619639|FG006|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
8585520|NCT00254293|9619633|FG000|STARTED|LTE Open Label Fixed Dosing||0
8585521|NCT00254293|9619634|FG001|STARTED|LTE Open Label Fixed Dosing||0
8585522|NCT00254293|9619635|FG002|STARTED|LTE Open Label Fixed Dosing||0
8585523|NCT00254293|9619636|FG003|STARTED|LTE Open Label Fixed Dosing||0
8585524|NCT00254293|9619637|FG004|STARTED|LTE Open Label Fixed Dosing||0
8585525|NCT00254293|9619638|FG005|STARTED|LTE Open Label Fixed Dosing||0
8585526|NCT00254293|9619639|FG006|STARTED|LTE Open Label Fixed Dosing||48
8585527|NCT00254293|9619633|FG000|COMPLETED|LTE Open Label Fixed Dosing||0
8585528|NCT00254293|9619634|FG001|COMPLETED|LTE Open Label Fixed Dosing||0
8585529|NCT00254293|9619635|FG002|COMPLETED|LTE Open Label Fixed Dosing||0
8585530|NCT00254293|9619636|FG003|COMPLETED|LTE Open Label Fixed Dosing||0
8585531|NCT00254293|9619637|FG004|COMPLETED|LTE Open Label Fixed Dosing||0
8585532|NCT00254293|9619638|FG005|COMPLETED|LTE Open Label Fixed Dosing||0
8585533|NCT00254293|9619639|FG006|COMPLETED|LTE Open Label Fixed Dosing||35
8585534|NCT00254293|9619633|FG000|NOT COMPLETED|LTE Open Label Fixed Dosing||0
8585535|NCT00254293|9619634|FG001|NOT COMPLETED|LTE Open Label Fixed Dosing||0
8585536|NCT00254293|9619635|FG002|NOT COMPLETED|LTE Open Label Fixed Dosing||0
8585537|NCT00254293|9619636|FG003|NOT COMPLETED|LTE Open Label Fixed Dosing||0
8585538|NCT00254293|9619637|FG004|NOT COMPLETED|LTE Open Label Fixed Dosing||0
8585539|NCT00254293|9619638|FG005|NOT COMPLETED|LTE Open Label Fixed Dosing||0
8585540|NCT00254293|9619639|FG006|NOT COMPLETED|LTE Open Label Fixed Dosing||13
8585541|NCT00254397|9619686|FG000|STARTED|Overall Study||10
8585542|NCT00254397|9619687|FG001|STARTED|Overall Study||6
8585543|NCT00254397|9619688|FG002|STARTED|Overall Study||37
8585544|NCT00254397|9619689|FG003|STARTED|Overall Study||45
8585545|NCT00254397|9619686|FG000|COMPLETED|Overall Study||4
8585546|NCT00254397|9619687|FG001|COMPLETED|Overall Study||5
8585547|NCT00254397|9619688|FG002|COMPLETED|Overall Study||18
8585548|NCT00254397|9619689|FG003|COMPLETED|Overall Study||20
8585549|NCT00254397|9619686|FG000|NOT COMPLETED|Overall Study||6
8585550|NCT00254397|9619687|FG001|NOT COMPLETED|Overall Study||1
8585551|NCT00254397|9619688|FG002|NOT COMPLETED|Overall Study||19
8585552|NCT00254397|9619689|FG003|NOT COMPLETED|Overall Study||25
8585553|NCT00254410|9619698|FG000|STARTED|Overall Study||30
8585554|NCT00254410|9619698|FG000|COMPLETED|Overall Study||30
8585555|NCT00254410|9619698|FG000|NOT COMPLETED|Overall Study||0
8585556|NCT00254462|9619704|FG000|STARTED|Overall Study||44
8585557|NCT00254462|9619705|FG001|STARTED|Overall Study||49
8585558|NCT00254462|9619704|FG000|COMPLETED|Overall Study||36
8585559|NCT00254462|9619705|FG001|COMPLETED|Overall Study||39
8585560|NCT00254462|9619704|FG000|NOT COMPLETED|Overall Study||8
8585561|NCT00254462|9619705|FG001|NOT COMPLETED|Overall Study||10
8585562|NCT00254488|9619715|FG000|STARTED|Overall Study||112
8585563|NCT00254488|9619716|FG001|STARTED|Overall Study||112
8585564|NCT00254488|9619715|FG000|COMPLETED|Overall Study||55
8585565|NCT00254488|9619716|FG001|COMPLETED|Overall Study||63
8585566|NCT00254488|9619715|FG000|NOT COMPLETED|Overall Study||57
8585567|NCT00254488|9619716|FG001|NOT COMPLETED|Overall Study||49
8585568|NCT00254501|9619724|FG000|STARTED|Overall Study||32
8585569|NCT00254501|9619725|FG001|STARTED|Overall Study||37
8585570|NCT00254501|9619724|FG000|COMPLETED|Overall Study||31
8585571|NCT00254501|9619725|FG001|COMPLETED|Overall Study||36
8585572|NCT00254501|9619724|FG000|NOT COMPLETED|Overall Study||1
8585573|NCT00254501|9619725|FG001|NOT COMPLETED|Overall Study||1
8585574|NCT00254540|9619735|FG000|STARTED|Overall Study|All 25 subjects enrolled were included in Intent-To Treat population.|25
8585575|NCT00254540|9619736|FG001|STARTED|Overall Study|All 26 subjects enrolled were included in Intent-To Treat population.|26
8585576|NCT00254540|9619735|FG000|COMPLETED|Overall Study||6
8585577|NCT00254540|9619736|FG001|COMPLETED|Overall Study||4
8585578|NCT00254540|9619735|FG000|NOT COMPLETED|Overall Study||19
8585579|NCT00254540|9619736|FG001|NOT COMPLETED|Overall Study||22
8585580|NCT00254566|9619745|FG000|STARTED|Overall Study||198
8585581|NCT00254566|9619746|FG001|STARTED|Overall Study||198
8585582|NCT00254566|9619745|FG000|COMPLETED|Overall Study||167
8585583|NCT00254566|9619746|FG001|COMPLETED|Overall Study||172
8585584|NCT00254566|9619745|FG000|NOT COMPLETED|Overall Study||31
8585585|NCT00254566|9619746|FG001|NOT COMPLETED|Overall Study||26
8585586|NCT00254592|9619752|FG000|STARTED|Overall Study||43
8585587|NCT00254592|9619752|FG000|COMPLETED|Overall Study||41
8585588|NCT00254592|9619752|FG000|NOT COMPLETED|Overall Study||2
8585589|NCT00254982|9619758|FG000|STARTED|Overall Study||297
8585590|NCT00254982|9619759|FG001|STARTED|Overall Study||296
8585591|NCT00254982|9619758|FG000|COMPLETED|Overall Study||261
8585592|NCT00254982|9619759|FG001|COMPLETED|Overall Study||265
8585593|NCT00254982|9619758|FG000|NOT COMPLETED|Overall Study||36
8585594|NCT00254982|9619759|FG001|NOT COMPLETED|Overall Study||31
8585595|NCT00254995|9619767|FG000|STARTED|Overall Study||31561
8585596|NCT00254995|9619768|FG001|STARTED|Overall Study||31065
8585597|NCT00254995|9619767|FG000|COMPLETED|Overall Study||31561
8585598|NCT00254995|9619768|FG001|COMPLETED|Overall Study||31065
8585599|NCT00254995|9619767|FG000|NOT COMPLETED|Overall Study||0
8585600|NCT00254995|9619768|FG001|NOT COMPLETED|Overall Study||0
8710235|NCT00957229|9756535|FG001|COMPLETED|Reallocated to or Continued Vismodegib||21
8710236|NCT00957229|9756534|FG000|NOT COMPLETED|Reallocated to or Continued Vismodegib||3
8710237|NCT00957229|9756535|FG001|NOT COMPLETED|Reallocated to or Continued Vismodegib||2
8710238|NCT00957242|9756543|FG000|STARTED|Overall Study||73
8710239|NCT00957242|9756544|FG001|STARTED|Overall Study||72
8710240|NCT00957242|9756543|FG000|COMPLETED|Overall Study||73
8710241|NCT00957242|9756544|FG001|COMPLETED|Overall Study||72
8710242|NCT00957242|9756543|FG000|NOT COMPLETED|Overall Study||0
8710243|NCT00957242|9756544|FG001|NOT COMPLETED|Overall Study||0
8710244|NCT00957268|9756557|FG000|STARTED|Overall Study||5
8710245|NCT00957268|9756558|FG001|STARTED|Overall Study||4
8710246|NCT00957268|9756559|FG002|STARTED|Overall Study||8
8710247|NCT00957268|9756560|FG003|STARTED|Overall Study||7
8710248|NCT00957268|9756561|FG004|STARTED|Overall Study||22
8710249|NCT00957268|9756557|FG000|COMPLETED|Overall Study||5
8710250|NCT00957268|9756558|FG001|COMPLETED|Overall Study||4
8710251|NCT00957268|9756559|FG002|COMPLETED|Overall Study||7
8710252|NCT00957268|9756560|FG003|COMPLETED|Overall Study||7
8710253|NCT00957268|9756561|FG004|COMPLETED|Overall Study||22
8710254|NCT00957268|9756557|FG000|NOT COMPLETED|Overall Study||0
8710255|NCT00957268|9756558|FG001|NOT COMPLETED|Overall Study||0
8710256|NCT00957268|9756559|FG002|NOT COMPLETED|Overall Study||1
8710257|NCT00957268|9756560|FG003|NOT COMPLETED|Overall Study||0
8710258|NCT00957268|9756561|FG004|NOT COMPLETED|Overall Study||0
8710259|NCT00957333|9756573|FG000|STARTED|Overall Study||44
8710260|NCT00957333|9756573|FG000|COMPLETED|Overall Study||44
8710261|NCT00957333|9756573|FG000|NOT COMPLETED|Overall Study||0
8724790|NCT01027871|9772051|FG002|Received at Least One Dose of Study Drug|Overall Study||97
8724791|NCT01027871|9772049|FG000|COMPLETED|Overall Study||91
8724792|NCT01027871|9772050|FG001|COMPLETED|Overall Study||85
8724793|NCT01027871|9772051|FG002|COMPLETED|Overall Study||91
8724794|NCT01027871|9772049|FG000|NOT COMPLETED|Overall Study||2
8724795|NCT01027871|9772050|FG001|NOT COMPLETED|Overall Study||13
8724796|NCT01027871|9772051|FG002|NOT COMPLETED|Overall Study||7
8724797|NCT01027884|9772066|FG000|STARTED|Overall Study||34
8724798|NCT01027884|9772067|FG001|STARTED|Overall Study||32
8724799|NCT01027884|9772066|FG000|COMPLETED|Overall Study||30
8724800|NCT01027884|9772067|FG001|COMPLETED|Overall Study||25
8724801|NCT01027884|9772066|FG000|NOT COMPLETED|Overall Study||4
8724802|NCT01027884|9772067|FG001|NOT COMPLETED|Overall Study||7
8724803|NCT01027897|9772075|FG000|STARTED|Overall Study||30
8724804|NCT01027897|9772075|FG000|COMPLETED|Overall Study||28
8724805|NCT01027897|9772075|FG000|NOT COMPLETED|Overall Study||2
8724806|NCT01027910|9772081|FG000|STARTED|Overall Study||6
8724807|NCT01027910|9772082|FG001|STARTED|Overall Study||14
8724808|NCT01027910|9772081|FG000|COMPLETED|Overall Study||6
8724809|NCT01027910|9772082|FG001|COMPLETED|Overall Study||14
8724810|NCT01027910|9772081|FG000|NOT COMPLETED|Overall Study||0
8724811|NCT01027910|9772082|FG001|NOT COMPLETED|Overall Study||0
8724812|NCT01027949|9772090|FG000|STARTED|Overall Study||894
8724813|NCT01027949|9772090|FG000|COMPLETED|Overall Study||208
8724814|NCT01027949|9772090|FG000|NOT COMPLETED|Overall Study||686
8724815|NCT01028014|9772100|FG000|STARTED|Overall Study||10
8724816|NCT01028014|9772101|FG001|STARTED|Overall Study||10
8724817|NCT01028014|9772102|FG002|STARTED|Overall Study||10
8724818|NCT01028014|9772103|FG003|STARTED|Overall Study||10
8724819|NCT01028014|9772104|FG004|STARTED|Overall Study||10
8724820|NCT01028014|9772105|FG005|STARTED|Overall Study||6
8724821|NCT01028014|9772100|FG000|COMPLETED|Overall Study||9
8724822|NCT01028014|9772101|FG001|COMPLETED|Overall Study||8
8585601|NCT00255008|9619780|FG000|STARTED|Overall Study||45
8585602|NCT00255008|9619781|FG001|STARTED|Overall Study||9
8585603|NCT00255008|9619782|FG002|STARTED|Overall Study||33
8585604|NCT00255008|9619783|FG003|STARTED|Overall Study||34
8585605|NCT00255008|9619780|FG000|COMPLETED|Overall Study|The study was terminated early and as a result only 42 patients completed the study.|13
8585606|NCT00255008|9619781|FG001|COMPLETED|Overall Study||0
8724823|NCT01028014|9772102|FG002|COMPLETED|Overall Study||10
8724824|NCT01028014|9772103|FG003|COMPLETED|Overall Study||9
8724825|NCT01028014|9772104|FG004|COMPLETED|Overall Study||9
8724826|NCT01028014|9772105|FG005|COMPLETED|Overall Study||4
8724827|NCT01028014|9772100|FG000|NOT COMPLETED|Overall Study||1
8724828|NCT01028014|9772101|FG001|NOT COMPLETED|Overall Study||2
8585607|NCT00255008|9619782|FG002|COMPLETED|Overall Study||17
8585608|NCT00255008|9619783|FG003|COMPLETED|Overall Study||12
8585609|NCT00255008|9619780|FG000|NOT COMPLETED|Overall Study||32
8585610|NCT00255008|9619781|FG001|NOT COMPLETED|Overall Study||9
8710262|NCT00957359|9756579|FG000|STARTED|Overall Study||14
8710263|NCT00957359|9756580|FG001|STARTED|Overall Study||15
8710264|NCT00957359|9756579|FG000|COMPLETED|Overall Study||14
8710265|NCT00957359|9756580|FG001|COMPLETED|Overall Study||15
8710266|NCT00957359|9756579|FG000|NOT COMPLETED|Overall Study||0
8710267|NCT00957359|9756580|FG001|NOT COMPLETED|Overall Study||0
8710268|NCT00957372|9756589|FG000|STARTED|PART I||80
8710269|NCT00957372|9756590|FG001|STARTED|PART I||85
8585611|NCT00255008|9619782|FG002|NOT COMPLETED|Overall Study||16
8585612|NCT00255008|9619783|FG003|NOT COMPLETED|Overall Study||22
8585613|NCT00255034|9619795|FG000|STARTED|Overall Study||79
8585614|NCT00255034|9619796|FG001|STARTED|Overall Study||64
8585615|NCT00255034|9619795|FG000|COMPLETED|Overall Study||64
8585616|NCT00255034|9619796|FG001|COMPLETED|Overall Study||26
8585617|NCT00255034|9619795|FG000|NOT COMPLETED|Overall Study||15
8585618|NCT00255034|9619796|FG001|NOT COMPLETED|Overall Study||38
8585619|NCT00255047|9619806|FG000|STARTED|Overall Study||538
8585620|NCT00255047|9619807|FG001|STARTED|Overall Study||535
8585621|NCT00255047|9619808|FG002|STARTED|Overall Study||546
8585622|NCT00255047|9619809|FG003|STARTED|Overall Study||548
8585623|NCT00255047|9619806|FG000|COMPLETED|Overall Study||490
8585624|NCT00255047|9619807|FG001|COMPLETED|Overall Study||487
8585625|NCT00255047|9619808|FG002|COMPLETED|Overall Study||496
8585626|NCT00255047|9619809|FG003|COMPLETED|Overall Study||502
8585627|NCT00255047|9619806|FG000|NOT COMPLETED|Overall Study||48
8710270|NCT00957372|9756591|FG002|STARTED|PART I||88
8710271|NCT00957372|9756592|FG003|STARTED|PART I||0
8710272|NCT00957372|9756589|FG000|Safety Population|PART I||80
8710273|NCT00957372|9756590|FG001|Safety Population|PART I||85
8710274|NCT00957372|9756591|FG002|Safety Population|PART I||87
8710275|NCT00957372|9756592|FG003|Safety Population|PART I||0
8710276|NCT00957372|9756589|FG000|Intention-to-Treat Population|PART I||77
8710277|NCT00957372|9756590|FG001|Intention-to-Treat Population|PART I||84
8710278|NCT00957372|9756591|FG002|Intention-to-Treat Population|PART I||84
8710279|NCT00957372|9756592|FG003|Intention-to-Treat Population|PART I||0
8710280|NCT00957372|9756589|FG000|Per-Protocol Population|PART I||35
8710281|NCT00957372|9756590|FG001|Per-Protocol Population|PART I||47
8710282|NCT00957372|9756591|FG002|Per-Protocol Population|PART I||51
8710283|NCT00957372|9756592|FG003|Per-Protocol Population|PART I||0
8710284|NCT00957372|9756589|FG000|Randomized But Not Treated|PART I||0
8710285|NCT00957372|9756590|FG001|Randomized But Not Treated|PART I||0
8710286|NCT00957372|9756591|FG002|Randomized But Not Treated|PART I||1
8710287|NCT00957372|9756592|FG003|Randomized But Not Treated|PART I||0
8710288|NCT00957372|9756589|FG000|COMPLETED|PART I||80
8710289|NCT00957372|9756590|FG001|COMPLETED|PART I||85
8710290|NCT00957372|9756591|FG002|COMPLETED|PART I||87
8710291|NCT00957372|9756592|FG003|COMPLETED|PART I||0
8710292|NCT00957372|9756589|FG000|NOT COMPLETED|PART I||0
8710293|NCT00957372|9756590|FG001|NOT COMPLETED|PART I||0
8710294|NCT00957372|9756591|FG002|NOT COMPLETED|PART I||1
8710295|NCT00957372|9756592|FG003|NOT COMPLETED|PART I||0
8710296|NCT00957372|9756589|FG000|STARTED|PART II||0
8710297|NCT00957372|9756590|FG001|STARTED|PART II||0
8710298|NCT00957372|9756591|FG002|STARTED|PART II||0
8710299|NCT00957372|9756592|FG003|STARTED|PART II||194
8710300|NCT00957372|9756589|FG000|Safety Population|PART II||0
8710301|NCT00957372|9756590|FG001|Safety Population|PART II||0
8710302|NCT00957372|9756591|FG002|Safety Population|PART II||0
8710303|NCT00957372|9756592|FG003|Safety Population|PART II||194
8710304|NCT00957372|9756589|FG000|Intention-to-treat (ITT) Population|PART II||0
8710305|NCT00957372|9756590|FG001|Intention-to-treat (ITT) Population|PART II||0
8710306|NCT00957372|9756591|FG002|Intention-to-treat (ITT) Population|PART II||0
8710307|NCT00957372|9756592|FG003|Intention-to-treat (ITT) Population|PART II||191
8710308|NCT00957372|9756589|FG000|Per-Protocol Population|PART II||0
8710309|NCT00957372|9756590|FG001|Per-Protocol Population|PART II||0
8710310|NCT00957372|9756591|FG002|Per-Protocol Population|PART II||0
8710311|NCT00957372|9756592|FG003|Per-Protocol Population|PART II||108
8710312|NCT00957372|9756589|FG000|COMPLETED|PART II||0
8710313|NCT00957372|9756590|FG001|COMPLETED|PART II||0
8710314|NCT00957372|9756591|FG002|COMPLETED|PART II||0
8710315|NCT00957372|9756592|FG003|COMPLETED|PART II||150
8710316|NCT00957372|9756589|FG000|NOT COMPLETED|PART II||0
8710317|NCT00957372|9756590|FG001|NOT COMPLETED|PART II||0
8710318|NCT00957372|9756591|FG002|NOT COMPLETED|PART II||0
8710319|NCT00957372|9756592|FG003|NOT COMPLETED|PART II||44
8710320|NCT00957424|9756608|FG000|STARTED|Overall Study||67
8710321|NCT00957424|9756608|FG000|Follow-up #1|Overall Study||59
8585628|NCT00255047|9619807|FG001|NOT COMPLETED|Overall Study||48
8585629|NCT00255047|9619808|FG002|NOT COMPLETED|Overall Study||50
8585630|NCT00255047|9619809|FG003|NOT COMPLETED|Overall Study||46
8585631|NCT00255086|9619821|FG000|STARTED|Overall Study||9
8585632|NCT00255086|9619822|FG001|STARTED|Overall Study||8
8585633|NCT00255086|9619821|FG000|COMPLETED|Overall Study||7
8585634|NCT00255086|9619822|FG001|COMPLETED|Overall Study||6
8585635|NCT00255086|9619821|FG000|NOT COMPLETED|Overall Study||2
8710322|NCT00957424|9756608|FG000|Follow-up #2|Overall Study||50
8710323|NCT00957424|9756608|FG000|COMPLETED|Overall Study||44
8710324|NCT00957424|9756608|FG000|NOT COMPLETED|Overall Study||23
8710325|NCT00957528|9756615|FG000|STARTED|Overall Study||8
8710326|NCT00957528|9756616|FG001|STARTED|Overall Study||9
8585636|NCT00255086|9619822|FG001|NOT COMPLETED|Overall Study||2
8585637|NCT00255125|9619831|FG000|STARTED|Overall Study||42
8585638|NCT00255125|9619832|FG001|STARTED|Overall Study||44
8585639|NCT00255125|9619831|FG000|COMPLETED|Overall Study||42
8585640|NCT00255125|9619832|FG001|COMPLETED|Overall Study||44
8585641|NCT00255125|9619831|FG000|NOT COMPLETED|Overall Study||0
8585642|NCT00255125|9619832|FG001|NOT COMPLETED|Overall Study||0
8585643|NCT00255151|9619843|FG000|STARTED|Overall Study||140
8585644|NCT00255151|9619844|FG001|STARTED|Overall Study||159
8585645|NCT00255151|9619845|FG002|STARTED|Overall Study||152
8585646|NCT00255151|9619843|FG000|COMPLETED|Overall Study||17
8585647|NCT00255151|9619844|FG001|COMPLETED|Overall Study||110
8585648|NCT00255151|9619845|FG002|COMPLETED|Overall Study||103
8585649|NCT00255151|9619843|FG000|NOT COMPLETED|Overall Study||123
8585650|NCT00255151|9619844|FG001|NOT COMPLETED|Overall Study||49
8585651|NCT00255151|9619845|FG002|NOT COMPLETED|Overall Study||49
8585652|NCT00255164|9619856|FG000|STARTED|Overall Study||140
8585653|NCT00255164|9619857|FG001|STARTED|Overall Study||159
8585654|NCT00255164|9619858|FG002|STARTED|Overall Study||152
8585655|NCT00255164|9619856|FG000|COMPLETED|Overall Study||17
8585656|NCT00255164|9619857|FG001|COMPLETED|Overall Study||110
8585657|NCT00255164|9619858|FG002|COMPLETED|Overall Study||103
8585658|NCT00255164|9619856|FG000|NOT COMPLETED|Overall Study||123
8585659|NCT00255164|9619857|FG001|NOT COMPLETED|Overall Study||49
8585660|NCT00255164|9619858|FG002|NOT COMPLETED|Overall Study||49
8585661|NCT00255177|9619870|FG000|STARTED|Overall Study||11
8585662|NCT00255177|9619871|FG001|STARTED|Overall Study||14
8585663|NCT00255177|9619872|FG002|STARTED|Overall Study||13
8585664|NCT00255177|9619873|FG003|STARTED|Overall Study||6
8585665|NCT00255177|9619870|FG000|COMPLETED|Overall Study||9
8585666|NCT00255177|9619871|FG001|COMPLETED|Overall Study||13
8585667|NCT00255177|9619872|FG002|COMPLETED|Overall Study||12
8585668|NCT00255177|9619873|FG003|COMPLETED|Overall Study||4
8585669|NCT00255177|9619870|FG000|NOT COMPLETED|Overall Study||2
8585670|NCT00255177|9619871|FG001|NOT COMPLETED|Overall Study||1
8585671|NCT00255177|9619872|FG002|NOT COMPLETED|Overall Study||1
8585672|NCT00255177|9619873|FG003|NOT COMPLETED|Overall Study||2
8585673|NCT00255190|9619885|FG000|STARTED|Overall Study||153
8585674|NCT00255190|9619886|FG001|STARTED|Overall Study||438
8585675|NCT00255190|9619885|FG000|COMPLETED|Overall Study||103
8585676|NCT00255190|9619886|FG001|COMPLETED|Overall Study||281
8585677|NCT00255190|9619885|FG000|NOT COMPLETED|Overall Study||50
8585678|NCT00255190|9619886|FG001|NOT COMPLETED|Overall Study||157
8585679|NCT00255346|9619897|FG000|STARTED|Overall Study||10
8585680|NCT00255346|9619898|FG001|STARTED|Overall Study||6
8585681|NCT00255346|9619899|FG002|STARTED|Overall Study||8
8710327|NCT00957528|9756617|FG002|STARTED|Overall Study||9
8710328|NCT00957528|9756615|FG000|COMPLETED|Overall Study||8
8710329|NCT00957528|9756616|FG001|COMPLETED|Overall Study||8
8710330|NCT00957528|9756617|FG002|COMPLETED|Overall Study||8
8710331|NCT00957528|9756615|FG000|NOT COMPLETED|Overall Study||0
8710332|NCT00957528|9756616|FG001|NOT COMPLETED|Overall Study||1
8710333|NCT00957528|9756617|FG002|NOT COMPLETED|Overall Study||1
8710334|NCT00957580|9756628|FG000|STARTED|Overall Study||33
8710335|NCT00957580|9756629|FG001|STARTED|Overall Study||33
8710336|NCT00957580|9756630|FG002|STARTED|Overall Study||15
8710337|NCT00957580|9756628|FG000|Treated|Overall Study||33
8710338|NCT00957580|9756629|FG001|Treated|Overall Study||32
8710339|NCT00957580|9756630|FG002|Treated|Overall Study||15
8585682|NCT00255346|9619900|FG003|STARTED|Overall Study||11
8585683|NCT00255346|9619901|FG004|STARTED|Overall Study||33
8585684|NCT00255346|9619897|FG000|COMPLETED|Overall Study||9
8585685|NCT00255346|9619898|FG001|COMPLETED|Overall Study||6
8585686|NCT00255346|9619899|FG002|COMPLETED|Overall Study||8
8585687|NCT00255346|9619900|FG003|COMPLETED|Overall Study||11
8585688|NCT00255346|9619901|FG004|COMPLETED|Overall Study||33
8585689|NCT00255346|9619897|FG000|NOT COMPLETED|Overall Study||1
8585690|NCT00255346|9619898|FG001|NOT COMPLETED|Overall Study||0
8585691|NCT00255346|9619899|FG002|NOT COMPLETED|Overall Study||0
8585692|NCT00255346|9619900|FG003|NOT COMPLETED|Overall Study||0
8585693|NCT00255346|9619901|FG004|NOT COMPLETED|Overall Study||0
8585694|NCT00255684|9619909|FG000|STARTED|Overall Study||16
8585695|NCT00255684|9619909|FG000|COMPLETED|Overall Study||16
8585696|NCT00255684|9619909|FG000|NOT COMPLETED|Overall Study||0
8585697|NCT00255723|9619915|FG000|STARTED|Overall Study||56
8585698|NCT00255723|9619916|FG001|STARTED|Overall Study||41
8585699|NCT00255723|9619915|FG000|COMPLETED|Overall Study||54
8585700|NCT00255723|9619916|FG001|COMPLETED|Overall Study||39
8585701|NCT00255723|9619915|FG000|NOT COMPLETED|Overall Study||2
8585702|NCT00255723|9619916|FG001|NOT COMPLETED|Overall Study||2
8585703|NCT00255801|9619922|FG000|STARTED|Overall Study||37
8585704|NCT00255801|9619922|FG000|COMPLETED|Overall Study||37
8585705|NCT00255801|9619922|FG000|NOT COMPLETED|Overall Study||0
8585706|NCT00255840|9619928|FG000|STARTED|Overall Study||408
8585707|NCT00255840|9619929|FG001|STARTED|Overall Study||404
8585708|NCT00255840|9619928|FG000|COMPLETED|Overall Study||345
8585709|NCT00255840|9619929|FG001|COMPLETED|Overall Study||334
8585710|NCT00255840|9619928|FG000|NOT COMPLETED|Overall Study||63
8585711|NCT00255840|9619929|FG001|NOT COMPLETED|Overall Study||70
8585712|NCT00255944|9619937|FG000|STARTED|Overall Study||1311
8585713|NCT00255944|9619938|FG001|STARTED|Overall Study||1311
8585714|NCT00255944|9619937|FG000|COMPLETED|Overall Study||514
8710340|NCT00957580|9756628|FG000|COMPLETED|Overall Study||33
8710341|NCT00957580|9756629|FG001|COMPLETED|Overall Study||31
8585715|NCT00255944|9619938|FG001|COMPLETED|Overall Study||477
8585716|NCT00255944|9619937|FG000|NOT COMPLETED|Overall Study||797
8585717|NCT00255944|9619938|FG001|NOT COMPLETED|Overall Study||834
8585718|NCT00255970|9619946|FG000|STARTED|Overall Study||21
8585719|NCT00255970|9619947|FG001|STARTED|Overall Study||19
8585720|NCT00255970|9619946|FG000|Screening Visit|Overall Study||21
8585721|NCT00255970|9619947|FG001|Screening Visit|Overall Study||19
8585722|NCT00255970|9619946|FG000|Final Visit Week 24|Overall Study||21
8585723|NCT00255970|9619947|FG001|Final Visit Week 24|Overall Study||19
8585724|NCT00255970|9619946|FG000|COMPLETED|Overall Study||21
8585725|NCT00255970|9619947|FG001|COMPLETED|Overall Study||19
8585726|NCT00255970|9619946|FG000|NOT COMPLETED|Overall Study||0
8585727|NCT00255970|9619947|FG001|NOT COMPLETED|Overall Study||0
8585728|NCT00256126|9619955|FG000|STARTED|Overall Study||149
8585729|NCT00256126|9619956|FG001|STARTED|Overall Study||169
8585730|NCT00256126|9619955|FG000|COMPLETED|Overall Study||147
8585731|NCT00256126|9619956|FG001|COMPLETED|Overall Study||167
8585732|NCT00256126|9619955|FG000|NOT COMPLETED|Overall Study||2
8585733|NCT00256126|9619956|FG001|NOT COMPLETED|Overall Study||2
8585734|NCT00256204|9619966|FG000|STARTED|Overall Study||298
8585735|NCT00256204|9619967|FG001|STARTED|Overall Study||288
8585736|NCT00256204|9619968|FG002|STARTED|Overall Study||295
8585737|NCT00256204|9619969|FG003|STARTED|Overall Study||293
8585738|NCT00256204|9619966|FG000|COMPLETED|Overall Study||231
8585739|NCT00256204|9619967|FG001|COMPLETED|Overall Study||238
8585740|NCT00256204|9619968|FG002|COMPLETED|Overall Study||241
8585741|NCT00256204|9619969|FG003|COMPLETED|Overall Study||244
8585742|NCT00256204|9619966|FG000|NOT COMPLETED|Overall Study||67
8585743|NCT00256204|9619967|FG001|NOT COMPLETED|Overall Study||50
8585744|NCT00256204|9619968|FG002|NOT COMPLETED|Overall Study||54
8585745|NCT00256204|9619969|FG003|NOT COMPLETED|Overall Study||49
8585746|NCT00256217|9619982|FG000|STARTED|Overall Study||42
8585747|NCT00256217|9619982|FG000|COMPLETED|Overall Study||34
8585748|NCT00256217|9619982|FG000|NOT COMPLETED|Overall Study||8
8585749|NCT00256243|9619986|FG000|STARTED|Overall Study||48
8585750|NCT00256243|9619986|FG000|COMPLETED|Overall Study||38
8585751|NCT00256243|9619986|FG000|NOT COMPLETED|Overall Study||10
8585752|NCT00256282|9619991|FG000|STARTED|Overall Study||52
8585753|NCT00256282|9619991|FG000|COMPLETED|Overall Study||36
8585754|NCT00256282|9619991|FG000|NOT COMPLETED|Overall Study||16
8585755|NCT00256308|9619995|FG000|STARTED|Overall Study||6
8585756|NCT00256308|9619995|FG000|COMPLETED|Overall Study||4
8585757|NCT00256308|9619995|FG000|NOT COMPLETED|Overall Study||2
8585758|NCT00256451|9619999|FG000|STARTED|Session1||10
8585759|NCT00256451|9620000|FG001|STARTED|Session1||11
8585760|NCT00256451|9620001|FG002|STARTED|Session1||11
8585761|NCT00256451|9620002|FG003|STARTED|Session1||11
8585762|NCT00256451|9619999|FG000|COMPLETED|Session1||10
8585763|NCT00256451|9620000|FG001|COMPLETED|Session1||11
8585764|NCT00256451|9620001|FG002|COMPLETED|Session1||11
8585765|NCT00256451|9620002|FG003|COMPLETED|Session1||11
8710342|NCT00957580|9756630|FG002|COMPLETED|Overall Study||15
8710343|NCT00957580|9756628|FG000|NOT COMPLETED|Overall Study||0
8710344|NCT00957580|9756629|FG001|NOT COMPLETED|Overall Study||2
8710345|NCT00957580|9756630|FG002|NOT COMPLETED|Overall Study||0
8710346|NCT00957593|9756653|FG000|STARTED|Overall Study||127
8710347|NCT00957593|9756654|FG001|STARTED|Overall Study||125
8710348|NCT00957593|9756653|FG000|COMPLETED|Overall Study||127
8710349|NCT00957593|9756654|FG001|COMPLETED|Overall Study||125
8710350|NCT00957593|9756653|FG000|NOT COMPLETED|Overall Study||0
8710351|NCT00957593|9756654|FG001|NOT COMPLETED|Overall Study||0
8710352|NCT00957658|9756662|FG000|STARTED|Overall Study||234
8710353|NCT00957658|9756662|FG000|COMPLETED|Overall Study|Completed/Not completed counts are based on participant status at the 2yr primary outcome interval.|169
8710354|NCT00957658|9756662|FG000|NOT COMPLETED|Overall Study||65
8710355|NCT00957671|9756668|FG000|STARTED|Overall Study|15 subjects began the treatment phase.|15
8710356|NCT00957671|9756668|FG000|COMPLETED|Overall Study|15 subjects completed the treatment phase of the study.|15
8710357|NCT00957671|9756668|FG000|NOT COMPLETED|Overall Study||0
8710358|NCT00957684|9756677|FG000|STARTED|PART I||102
8710359|NCT00957684|9756678|FG001|STARTED|PART I||98
8710360|NCT00957684|9756679|FG002|STARTED|PART I||100
8710361|NCT00957684|9756680|FG003|STARTED|PART I||102
8710362|NCT00957684|9756681|FG004|STARTED|PART I||0
8585766|NCT00256451|9619999|FG000|NOT COMPLETED|Session1||0
8710363|NCT00957684|9756677|FG000|Randomised (Safety Population)|PART I||102
8710364|NCT00957684|9756678|FG001|Randomised (Safety Population)|PART I||98
8710365|NCT00957684|9756679|FG002|Randomised (Safety Population)|PART I||100
8710366|NCT00957684|9756680|FG003|Randomised (Safety Population)|PART I||102
8585767|NCT00256451|9620000|FG001|NOT COMPLETED|Session1||0
8585768|NCT00256451|9620001|FG002|NOT COMPLETED|Session1||0
8585769|NCT00256451|9620002|FG003|NOT COMPLETED|Session1||0
8585770|NCT00256451|9619999|FG000|STARTED|Session2||9
8585771|NCT00256451|9620000|FG001|STARTED|Session2||11
8585772|NCT00256451|9620001|FG002|STARTED|Session2||10
8585773|NCT00256451|9620002|FG003|STARTED|Session2||10
8585774|NCT00256451|9619999|FG000|COMPLETED|Session2||9
8585775|NCT00256451|9620000|FG001|COMPLETED|Session2||11
8585776|NCT00256451|9620001|FG002|COMPLETED|Session2||10
8585777|NCT00256451|9620002|FG003|COMPLETED|Session2||10
8585778|NCT00256451|9619999|FG000|NOT COMPLETED|Session2||0
8585779|NCT00256451|9620000|FG001|NOT COMPLETED|Session2||0
8585780|NCT00256451|9620001|FG002|NOT COMPLETED|Session2||0
8585781|NCT00256451|9620002|FG003|NOT COMPLETED|Session2||0
8585782|NCT00256451|9619999|FG000|STARTED|Session3||9
8585783|NCT00256451|9620000|FG001|STARTED|Session3||9
8585784|NCT00256451|9620001|FG002|STARTED|Session3||10
8585785|NCT00256451|9620002|FG003|STARTED|Session3||9
8585786|NCT00256451|9619999|FG000|COMPLETED|Session3||9
8585787|NCT00256451|9620000|FG001|COMPLETED|Session3||9
8585788|NCT00256451|9620001|FG002|COMPLETED|Session3||10
8585789|NCT00256451|9620002|FG003|COMPLETED|Session3||9
8585790|NCT00256451|9619999|FG000|NOT COMPLETED|Session3||0
8585791|NCT00256451|9620000|FG001|NOT COMPLETED|Session3||0
8585792|NCT00256451|9620001|FG002|NOT COMPLETED|Session3||0
8585793|NCT00256451|9620002|FG003|NOT COMPLETED|Session3||0
8585794|NCT00256451|9619999|FG000|STARTED|Session4||9
8585795|NCT00256451|9620000|FG001|STARTED|Session4||8
8585796|NCT00256451|9620001|FG002|STARTED|Session4||10
8585797|NCT00256451|9620002|FG003|STARTED|Session4||8
8585798|NCT00256451|9619999|FG000|COMPLETED|Session4||9
8585799|NCT00256451|9620000|FG001|COMPLETED|Session4||8
8585800|NCT00256451|9620001|FG002|COMPLETED|Session4||10
8585801|NCT00256451|9620002|FG003|COMPLETED|Session4||8
8585802|NCT00256451|9619999|FG000|NOT COMPLETED|Session4||0
8585803|NCT00256451|9620000|FG001|NOT COMPLETED|Session4||0
8585804|NCT00256451|9620001|FG002|NOT COMPLETED|Session4||0
8585805|NCT00256451|9620002|FG003|NOT COMPLETED|Session4||0
8585806|NCT00256698|9620014|FG000|STARTED|Overall Study||258
8585807|NCT00256698|9620015|FG001|STARTED|Overall Study||256
8585808|NCT00256698|9620014|FG000|COMPLETED|Overall Study||91
8585809|NCT00256698|9620015|FG001|COMPLETED|Overall Study||84
8585810|NCT00256698|9620014|FG000|NOT COMPLETED|Overall Study||167
8585811|NCT00256698|9620015|FG001|NOT COMPLETED|Overall Study||172
8585812|NCT00256724|9620023|FG000|STARTED|Overall Study||23
8585813|NCT00256724|9620024|FG001|STARTED|Overall Study||24
8585814|NCT00256724|9620023|FG000|COMPLETED|Overall Study||18
8585815|NCT00256724|9620024|FG001|COMPLETED|Overall Study||16
8585816|NCT00256724|9620023|FG000|NOT COMPLETED|Overall Study||5
8585817|NCT00256724|9620024|FG001|NOT COMPLETED|Overall Study||8
8585818|NCT00256750|9620033|FG000|STARTED|Transplanted Pre-Treatment||221
8585819|NCT00256750|9620034|FG001|STARTED|Transplanted Pre-Treatment||226
8585820|NCT00256750|9620035|FG002|STARTED|Transplanted Pre-Treatment||219
8585821|NCT00256750|9620033|FG000|COMPLETED|Transplanted Pre-Treatment||215
8585822|NCT00256750|9620034|FG001|COMPLETED|Transplanted Pre-Treatment||226
8585823|NCT00256750|9620035|FG002|COMPLETED|Transplanted Pre-Treatment||219
8585824|NCT00256750|9620033|FG000|NOT COMPLETED|Transplanted Pre-Treatment||6
8585825|NCT00256750|9620034|FG001|NOT COMPLETED|Transplanted Pre-Treatment||0
8585826|NCT00256750|9620035|FG002|NOT COMPLETED|Transplanted Pre-Treatment||0
8585827|NCT00256750|9620033|FG000|STARTED|Post-Transplant Treated (12 Months)||215
8585828|NCT00256750|9620034|FG001|STARTED|Post-Transplant Treated (12 Months)||226
8585829|NCT00256750|9620035|FG002|STARTED|Post-Transplant Treated (12 Months)||219
8585830|NCT00256750|9620033|FG000|COMPLETED|Post-Transplant Treated (12 Months)||174
8585831|NCT00256750|9620034|FG001|COMPLETED|Post-Transplant Treated (12 Months)||183
8585832|NCT00256750|9620035|FG002|COMPLETED|Post-Transplant Treated (12 Months)||173
8585833|NCT00256750|9620033|FG000|NOT COMPLETED|Post-Transplant Treated (12 Months)||41
8585834|NCT00256750|9620034|FG001|NOT COMPLETED|Post-Transplant Treated (12 Months)||43
8585835|NCT00256750|9620035|FG002|NOT COMPLETED|Post-Transplant Treated (12 Months)||46
8585836|NCT00256750|9620033|FG000|STARTED|Post-Transplant Treated (24 Months)||174
8585837|NCT00256750|9620034|FG001|STARTED|Post-Transplant Treated (24 Months)||183
8585838|NCT00256750|9620035|FG002|STARTED|Post-Transplant Treated (24 Months)||173
8585839|NCT00256750|9620033|FG000|COMPLETED|Post-Transplant Treated (24 Months)||153
8585840|NCT00256750|9620034|FG001|COMPLETED|Post-Transplant Treated (24 Months)||176
8585841|NCT00256750|9620035|FG002|COMPLETED|Post-Transplant Treated (24 Months)||164
8585842|NCT00256750|9620033|FG000|NOT COMPLETED|Post-Transplant Treated (24 Months)||21
8585843|NCT00256750|9620034|FG001|NOT COMPLETED|Post-Transplant Treated (24 Months)||7
8585844|NCT00256750|9620035|FG002|NOT COMPLETED|Post-Transplant Treated (24 Months)||9
8585845|NCT00256750|9620033|FG000|STARTED|Post-Transplant Treated (36 Months)||153
8585846|NCT00256750|9620034|FG001|STARTED|Post-Transplant Treated (36 Months)||176
8585847|NCT00256750|9620035|FG002|STARTED|Post-Transplant Treated (36 Months)||164
8585848|NCT00256750|9620033|FG000|COMPLETED|Post-Transplant Treated (36 Months)||143
8585849|NCT00256750|9620034|FG001|COMPLETED|Post-Transplant Treated (36 Months)||170
8585850|NCT00256750|9620035|FG002|COMPLETED|Post-Transplant Treated (36 Months)||158
8585851|NCT00256750|9620033|FG000|NOT COMPLETED|Post-Transplant Treated (36 Months)||10
8585852|NCT00256750|9620034|FG001|NOT COMPLETED|Post-Transplant Treated (36 Months)||6
8585853|NCT00256750|9620035|FG002|NOT COMPLETED|Post-Transplant Treated (36 Months)||6
8585854|NCT00256750|9620033|FG000|STARTED|Long Term Extension (LTE; 84 Months)|Participants on drug through month 36 eligible to enroll in LTE; 2 ineligible, 5 withdrew or refused|136
8585855|NCT00256750|9620034|FG001|STARTED|Long Term Extension (LTE; 84 Months)|Participants on drug through month 36 were eligible to enroll in LTE; 4 withdrew or refused.|166
8585856|NCT00256750|9620035|FG002|STARTED|Long Term Extension (LTE; 84 Months)|Participants on drug through month 36 were eligible to enroll in LTE; 3 withdrew or refused.|155
8585857|NCT00256750|9620033|FG000|COMPLETED|Long Term Extension (LTE; 84 Months)||89
8585858|NCT00256750|9620034|FG001|COMPLETED|Long Term Extension (LTE; 84 Months)||136
8585859|NCT00256750|9620035|FG002|COMPLETED|Long Term Extension (LTE; 84 Months)||127
8585860|NCT00256750|9620033|FG000|NOT COMPLETED|Long Term Extension (LTE; 84 Months)||47
8585861|NCT00256750|9620034|FG001|NOT COMPLETED|Long Term Extension (LTE; 84 Months)||30
8585862|NCT00256750|9620035|FG002|NOT COMPLETED|Long Term Extension (LTE; 84 Months)||28
8585863|NCT00256776|9620046|FG000|STARTED|Overall Study||135
8585864|NCT00256776|9620047|FG001|STARTED|Overall Study||134
8585865|NCT00256776|9620046|FG000|COMPLETED|Overall Study||52
8585866|NCT00256776|9620047|FG001|COMPLETED|Overall Study||54
8585867|NCT00256776|9620046|FG000|NOT COMPLETED|Overall Study||83
8585868|NCT00256776|9620047|FG001|NOT COMPLETED|Overall Study||80
8585869|NCT00256854|9620061|FG000|STARTED|Overall Study||26
8585870|NCT00256854|9620062|FG001|STARTED|Overall Study||26
8585871|NCT00256854|9620063|FG002|STARTED|Overall Study||26
8585872|NCT00256854|9620064|FG003|STARTED|Overall Study||27
8585873|NCT00256854|9620065|FG004|STARTED|Overall Study||16
8585874|NCT00256854|9620066|FG005|STARTED|Overall Study||14
8585875|NCT00256854|9620061|FG000|COMPLETED|Overall Study||23
8585876|NCT00256854|9620062|FG001|COMPLETED|Overall Study||22
8585877|NCT00256854|9620063|FG002|COMPLETED|Overall Study||23
8585878|NCT00256854|9620064|FG003|COMPLETED|Overall Study||24
8585879|NCT00256854|9620065|FG004|COMPLETED|Overall Study||15
8585880|NCT00256854|9620066|FG005|COMPLETED|Overall Study||13
8585881|NCT00256854|9620061|FG000|NOT COMPLETED|Overall Study||3
8585882|NCT00256854|9620062|FG001|NOT COMPLETED|Overall Study||4
8585883|NCT00256854|9620063|FG002|NOT COMPLETED|Overall Study||3
8585884|NCT00256854|9620064|FG003|NOT COMPLETED|Overall Study||3
8585885|NCT00256854|9620065|FG004|NOT COMPLETED|Overall Study||1
8585886|NCT00256854|9620066|FG005|NOT COMPLETED|Overall Study||1
8585887|NCT00256867|9620089|FG000|STARTED|Overall Study||47
8585888|NCT00256867|9620090|FG001|STARTED|Overall Study||44
8710367|NCT00957684|9756681|FG004|Randomised (Safety Population)|PART I||0
8710368|NCT00957684|9756677|FG000|Intention-to-treat (ITT) Population|PART I||98
8710369|NCT00957684|9756678|FG001|Intention-to-treat (ITT) Population|PART I||98
8710370|NCT00957684|9756679|FG002|Intention-to-treat (ITT) Population|PART I||99
8710371|NCT00957684|9756680|FG003|Intention-to-treat (ITT) Population|PART I||102
8710372|NCT00957684|9756681|FG004|Intention-to-treat (ITT) Population|PART I||0
8710373|NCT00957684|9756677|FG000|Per-protocol (PP)Population|PART I||72
8710374|NCT00957684|9756678|FG001|Per-protocol (PP)Population|PART I||86
8710375|NCT00957684|9756679|FG002|Per-protocol (PP)Population|PART I||94
8710376|NCT00957684|9756680|FG003|Per-protocol (PP)Population|PART I||91
8710377|NCT00957684|9756681|FG004|Per-protocol (PP)Population|PART I||0
8710378|NCT00957684|9756677|FG000|COMPLETED|PART I||71
8710379|NCT00957684|9756678|FG001|COMPLETED|PART I||85
8710380|NCT00957684|9756679|FG002|COMPLETED|PART I||90
8710381|NCT00957684|9756680|FG003|COMPLETED|PART I||84
8710382|NCT00957684|9756681|FG004|COMPLETED|PART I||0
8710383|NCT00957684|9756677|FG000|NOT COMPLETED|PART I||31
8710384|NCT00957684|9756678|FG001|NOT COMPLETED|PART I||13
8710385|NCT00957684|9756679|FG002|NOT COMPLETED|PART I||10
8710386|NCT00957684|9756680|FG003|NOT COMPLETED|PART I||18
8710387|NCT00957684|9756681|FG004|NOT COMPLETED|PART I||0
8710388|NCT00957684|9756677|FG000|STARTED|PART II||0
8710389|NCT00957684|9756678|FG001|STARTED|PART II||0
8710390|NCT00957684|9756679|FG002|STARTED|PART II||0
8710391|NCT00957684|9756680|FG003|STARTED|PART II||0
8710392|NCT00957684|9756681|FG004|STARTED|PART II||314
8710393|NCT00957684|9756677|FG000|Patients Entered Part II|PART II||0
8585889|NCT00256867|9620091|FG002|STARTED|Overall Study||45
8585890|NCT00256867|9620092|FG003|STARTED|Overall Study||46
8585891|NCT00256867|9620093|FG004|STARTED|Overall Study||48
8585892|NCT00256867|9620094|FG005|STARTED|Overall Study||46
8585893|NCT00256867|9620095|FG006|STARTED|Overall Study||46
8585894|NCT00256867|9620096|FG007|STARTED|Overall Study||47
8585895|NCT00256867|9620089|FG000|COMPLETED|Overall Study||45
8585896|NCT00256867|9620090|FG001|COMPLETED|Overall Study||39
8585897|NCT00256867|9620091|FG002|COMPLETED|Overall Study||40
8585898|NCT00256867|9620092|FG003|COMPLETED|Overall Study||40
8585899|NCT00256867|9620093|FG004|COMPLETED|Overall Study||41
8585900|NCT00256867|9620094|FG005|COMPLETED|Overall Study||40
8585901|NCT00256867|9620095|FG006|COMPLETED|Overall Study||41
8585902|NCT00256867|9620096|FG007|COMPLETED|Overall Study||36
8585903|NCT00256867|9620089|FG000|NOT COMPLETED|Overall Study||2
8585904|NCT00256867|9620090|FG001|NOT COMPLETED|Overall Study||5
8585905|NCT00256867|9620091|FG002|NOT COMPLETED|Overall Study||5
8585906|NCT00256867|9620092|FG003|NOT COMPLETED|Overall Study||6
8585907|NCT00256867|9620093|FG004|NOT COMPLETED|Overall Study||7
8585908|NCT00256867|9620094|FG005|NOT COMPLETED|Overall Study||6
8585909|NCT00256867|9620095|FG006|NOT COMPLETED|Overall Study||5
8585910|NCT00256867|9620096|FG007|NOT COMPLETED|Overall Study||11
8585911|NCT00256984|9620119|FG000|STARTED|Overall Study||75
8585912|NCT00256984|9620119|FG000|COMPLETED|Overall Study||59
8585913|NCT00256984|9620119|FG000|NOT COMPLETED|Overall Study||16
8585914|NCT00256997|9620125|FG000|STARTED|Overall Study||81
8585915|NCT00256997|9620126|FG001|STARTED|Overall Study||86
8585916|NCT00256997|9620125|FG000|Treated|Overall Study||79
8585917|NCT00256997|9620126|FG001|Treated|Overall Study||86
8585918|NCT00256997|9620125|FG000|COMPLETED|Overall Study||33
8585919|NCT00256997|9620126|FG001|COMPLETED|Overall Study||31
8585920|NCT00256997|9620125|FG000|NOT COMPLETED|Overall Study||48
8585921|NCT00256997|9620126|FG001|NOT COMPLETED|Overall Study||55
8585922|NCT00257010|9620133|FG000|STARTED|Overall Study||447
8585923|NCT00257010|9620133|FG000|COMPLETED|Overall Study||319
8585924|NCT00257010|9620133|FG000|NOT COMPLETED|Overall Study||128
8710394|NCT00957684|9756678|FG001|Patients Entered Part II|PART II||0
8710395|NCT00957684|9756679|FG002|Patients Entered Part II|PART II||0
8710396|NCT00957684|9756680|FG003|Patients Entered Part II|PART II||0
8585925|NCT00257166|9620139|FG000|STARTED|Overall Study||150
8585926|NCT00257166|9620140|FG001|STARTED|Overall Study||88
8585927|NCT00257166|9620139|FG000|Treated|Overall Study||149
8585928|NCT00257166|9620140|FG001|Treated|Overall Study||88
8585929|NCT00257166|9620139|FG000|COMPLETED|Overall Study||97
8585930|NCT00257166|9620140|FG001|COMPLETED|Overall Study||51
8585931|NCT00257166|9620139|FG000|NOT COMPLETED|Overall Study||53
8585932|NCT00257166|9620140|FG001|NOT COMPLETED|Overall Study||37
8585933|NCT00257192|9620148|FG000|STARTED|Overall Study||193
8585934|NCT00257192|9620149|FG001|STARTED|Overall Study|Includes 1 subject randomized but not treated|91
8585935|NCT00257192|9620148|FG000|Received Study Treatment|Overall Study||193
8585936|NCT00257192|9620149|FG001|Received Study Treatment|Overall Study||90
8585937|NCT00257192|9620148|FG000|COMPLETED|Overall Study||135
8585938|NCT00257192|9620149|FG001|COMPLETED|Overall Study||52
8585939|NCT00257192|9620148|FG000|NOT COMPLETED|Overall Study||58
8585940|NCT00257192|9620149|FG001|NOT COMPLETED|Overall Study||39
8585941|NCT00257309|9620157|FG000|STARTED|Overall Study||134
8585942|NCT00257309|9620158|FG001|STARTED|Overall Study||132
8585943|NCT00257309|9620157|FG000|COMPLETED|Overall Study||132
8585944|NCT00257309|9620158|FG001|COMPLETED|Overall Study||130
8585945|NCT00257309|9620157|FG000|NOT COMPLETED|Overall Study||2
8585946|NCT00257309|9620158|FG001|NOT COMPLETED|Overall Study||2
8585947|NCT00257322|9620164|FG000|STARTED|Overall Study|20 subjects accrued.|20
8585948|NCT00257322|9620164|FG000|COMPLETED|Overall Study|4 subjects withdrew from this study.|16
8585949|NCT00257322|9620164|FG000|NOT COMPLETED|Overall Study||4
8585950|NCT00257556|9620170|FG000|STARTED|Overall Study||38
8585951|NCT00257556|9620171|FG001|STARTED|Overall Study||42
8585952|NCT00257556|9620170|FG000|All Patients Treated Population|Overall Study|Also the safety population. One randomized patient did not receive study medication.|37
8585953|NCT00257556|9620171|FG001|All Patients Treated Population|Overall Study|Also the safety population. Three randomized patients did not receive study medication.|39
8585954|NCT00257556|9620170|FG000|COMPLETED|Overall Study||24
8585955|NCT00257556|9620171|FG001|COMPLETED|Overall Study||32
8585956|NCT00257556|9620170|FG000|NOT COMPLETED|Overall Study||14
8585957|NCT00257556|9620171|FG001|NOT COMPLETED|Overall Study||10
8585958|NCT00257608|9620179|FG000|STARTED|Chemotherapy Phase||1145
8585959|NCT00257608|9620180|FG001|STARTED|Chemotherapy Phase||0
8585960|NCT00257608|9620181|FG002|STARTED|Chemotherapy Phase||0
8585961|NCT00257608|9620179|FG000|COMPLETED|Chemotherapy Phase||769
8585962|NCT00257608|9620180|FG001|COMPLETED|Chemotherapy Phase||0
8585963|NCT00257608|9620181|FG002|COMPLETED|Chemotherapy Phase||0
8585964|NCT00257608|9620179|FG000|NOT COMPLETED|Chemotherapy Phase||376
8585965|NCT00257608|9620180|FG001|NOT COMPLETED|Chemotherapy Phase||0
8585966|NCT00257608|9620181|FG002|NOT COMPLETED|Chemotherapy Phase||0
8585967|NCT00257608|9620179|FG000|STARTED|Post Chemotherapy Phase||0
8585968|NCT00257608|9620180|FG001|STARTED|Post Chemotherapy Phase||373
8585969|NCT00257608|9620181|FG002|STARTED|Post Chemotherapy Phase||370
8585970|NCT00257608|9620179|FG000|COMPLETED|Post Chemotherapy Phase||0
8585971|NCT00257608|9620180|FG001|COMPLETED|Post Chemotherapy Phase||109
8585972|NCT00257608|9620181|FG002|COMPLETED|Post Chemotherapy Phase||126
8585973|NCT00257608|9620179|FG000|NOT COMPLETED|Post Chemotherapy Phase||0
8585974|NCT00257608|9620180|FG001|NOT COMPLETED|Post Chemotherapy Phase||264
8585975|NCT00257608|9620181|FG002|NOT COMPLETED|Post Chemotherapy Phase||244
8585976|NCT00257660|9620196|FG000|STARTED|Overall Study||55
8585977|NCT00257660|9620197|FG001|STARTED|Overall Study||61
8585978|NCT00257660|9620196|FG000|COMPLETED|Overall Study||45
8585979|NCT00257660|9620197|FG001|COMPLETED|Overall Study||38
8585980|NCT00257660|9620196|FG000|NOT COMPLETED|Overall Study||10
8585981|NCT00257660|9620197|FG001|NOT COMPLETED|Overall Study||23
8585982|NCT00257686|9620209|FG000|STARTED|Overall Study||209
8585983|NCT00257686|9620210|FG001|STARTED|Overall Study||108
8585984|NCT00257686|9620211|FG002|STARTED|Overall Study||226
8585985|NCT00257686|9620212|FG003|STARTED|Overall Study||99
8585986|NCT00257686|9620213|FG004|STARTED|Overall Study||216
8585987|NCT00257686|9620214|FG005|STARTED|Overall Study||104
8585988|NCT00257686|9620209|FG000|Safety Population|Overall Study|Subjects who received at least one dose of study medication|207
8585989|NCT00257686|9620210|FG001|Safety Population|Overall Study|Subjects who received at least one dose of study medication|103
8585990|NCT00257686|9620211|FG002|Safety Population|Overall Study|Subjects who received at least one dose of study medication|224
8585991|NCT00257686|9620212|FG003|Safety Population|Overall Study|Subjects who received at least one dose of study medication|96
8585992|NCT00257686|9620213|FG004|Safety Population|Overall Study|Subjects who received at least one dose of study medication|210
8585993|NCT00257686|9620214|FG005|Safety Population|Overall Study|Subjects who received at least one dose of study medication|102
8585994|NCT00257686|9620209|FG000|COMPLETED|Overall Study||188
8585995|NCT00257686|9620210|FG001|COMPLETED|Overall Study||89
8585996|NCT00257686|9620211|FG002|COMPLETED|Overall Study||208
8585997|NCT00257686|9620212|FG003|COMPLETED|Overall Study||88
8585998|NCT00257686|9620213|FG004|COMPLETED|Overall Study||194
8585999|NCT00257686|9620214|FG005|COMPLETED|Overall Study||95
8586000|NCT00257686|9620209|FG000|NOT COMPLETED|Overall Study||21
8586001|NCT00257686|9620210|FG001|NOT COMPLETED|Overall Study||19
8586002|NCT00257686|9620211|FG002|NOT COMPLETED|Overall Study||18
8586003|NCT00257686|9620212|FG003|NOT COMPLETED|Overall Study||11
8586004|NCT00257686|9620213|FG004|NOT COMPLETED|Overall Study||22
8586005|NCT00257686|9620214|FG005|NOT COMPLETED|Overall Study||9
8586006|NCT00257725|9620228|FG000|STARTED|Overall Study||11
8586007|NCT00257725|9620228|FG000|COMPLETED|Overall Study||8
8586008|NCT00257725|9620228|FG000|NOT COMPLETED|Overall Study||3
8586009|NCT00257894|9620235|FG000|STARTED|Overall Study||21
8586010|NCT00257894|9620236|FG001|STARTED|Overall Study||20
8586011|NCT00257894|9620235|FG000|COMPLETED|Overall Study||17
8586012|NCT00257894|9620236|FG001|COMPLETED|Overall Study||15
8586013|NCT00257894|9620235|FG000|NOT COMPLETED|Overall Study||4
8586014|NCT00257894|9620236|FG001|NOT COMPLETED|Overall Study||5
8586015|NCT00257920|9620244|FG000|STARTED|Period: First Intervention||21
8586016|NCT00257920|9620245|FG001|STARTED|Period: First Intervention||20
8586017|NCT00257920|9620244|FG000|COMPLETED|Period: First Intervention||21
8586018|NCT00257920|9620245|FG001|COMPLETED|Period: First Intervention||20
8586019|NCT00257920|9620244|FG000|NOT COMPLETED|Period: First Intervention||0
8586020|NCT00257920|9620245|FG001|NOT COMPLETED|Period: First Intervention||0
8586021|NCT00257920|9620244|FG000|STARTED|Period: Washout Period of Two Weeks||21
8586022|NCT00257920|9620245|FG001|STARTED|Period: Washout Period of Two Weeks||20
8586023|NCT00257920|9620244|FG000|COMPLETED|Period: Washout Period of Two Weeks||21
8586024|NCT00257920|9620245|FG001|COMPLETED|Period: Washout Period of Two Weeks||19
8586025|NCT00257920|9620244|FG000|NOT COMPLETED|Period: Washout Period of Two Weeks||0
8586026|NCT00257920|9620245|FG001|NOT COMPLETED|Period: Washout Period of Two Weeks||1
8586027|NCT00257920|9620244|FG000|STARTED|Period: Second Intervention||21
8586028|NCT00257920|9620245|FG001|STARTED|Period: Second Intervention||19
8586029|NCT00257920|9620244|FG000|COMPLETED|Period: Second Intervention||19
8586030|NCT00257920|9620245|FG001|COMPLETED|Period: Second Intervention||18
8586031|NCT00257920|9620244|FG000|NOT COMPLETED|Period: Second Intervention||2
8586032|NCT00257920|9620245|FG001|NOT COMPLETED|Period: Second Intervention||1
8586033|NCT00257933|9620254|FG000|STARTED|Overall Study||74
8586034|NCT00257933|9620255|FG001|STARTED|Overall Study||78
8710397|NCT00957684|9756681|FG004|Patients Entered Part II|PART II||314
8710398|NCT00957684|9756677|FG000|COMPLETED|PART II||0
8710399|NCT00957684|9756678|FG001|COMPLETED|PART II||0
8710400|NCT00957684|9756679|FG002|COMPLETED|PART II||0
8710401|NCT00957684|9756680|FG003|COMPLETED|PART II||0
8710402|NCT00957684|9756681|FG004|COMPLETED|PART II||239
8710403|NCT00957684|9756677|FG000|NOT COMPLETED|PART II||0
8710404|NCT00957684|9756678|FG001|NOT COMPLETED|PART II||0
8710405|NCT00957684|9756679|FG002|NOT COMPLETED|PART II||0
8710406|NCT00957684|9756680|FG003|NOT COMPLETED|PART II||0
8710407|NCT00957684|9756681|FG004|NOT COMPLETED|PART II||75
8710408|NCT00957723|9756691|FG000|STARTED|Overall Study||411
8710409|NCT00957723|9756691|FG000|COMPLETED|Overall Study|Completed/Not completed counts are based on participant status at the 2yr primary outcome interval.|298
8710410|NCT00957723|9756691|FG000|NOT COMPLETED|Overall Study||113
8710411|NCT00957801|9756701|FG000|STARTED|Overall Study||7
8710412|NCT00957801|9756702|FG001|STARTED|Overall Study||7
8710413|NCT00957801|9756703|FG002|STARTED|Overall Study||7
8710414|NCT00957801|9756704|FG003|STARTED|Overall Study||8
8710415|NCT00957801|9756701|FG000|COMPLETED|Overall Study||7
8710416|NCT00957801|9756702|FG001|COMPLETED|Overall Study||7
8710417|NCT00957801|9756703|FG002|COMPLETED|Overall Study||7
8710418|NCT00957801|9756704|FG003|COMPLETED|Overall Study||7
8710419|NCT00957801|9756701|FG000|NOT COMPLETED|Overall Study||0
8710420|NCT00957801|9756702|FG001|NOT COMPLETED|Overall Study||0
8710421|NCT00957801|9756703|FG002|NOT COMPLETED|Overall Study||0
8710422|NCT00957801|9756704|FG003|NOT COMPLETED|Overall Study||1
8710423|NCT00957853|9756717|FG000|STARTED|Overall Study||4
8710424|NCT00957853|9756718|FG001|STARTED|Overall Study||6
8710425|NCT00957853|9756719|FG002|STARTED|Overall Study||5
8710426|NCT00957853|9756717|FG000|Randomization|Overall Study||4
8710427|NCT00957853|9756718|FG001|Randomization|Overall Study||6
8710428|NCT00957853|9756719|FG002|Randomization|Overall Study||5
8710429|NCT00957853|9756717|FG000|Neoadjuvant Tx Completion|Overall Study||3
8710430|NCT00957853|9756718|FG001|Neoadjuvant Tx Completion|Overall Study||6
8710431|NCT00957853|9756719|FG002|Neoadjuvant Tx Completion|Overall Study||5
8710432|NCT00957853|9756717|FG000|COMPLETED|Overall Study||3
8710433|NCT00957853|9756718|FG001|COMPLETED|Overall Study||6
8710434|NCT00957853|9756719|FG002|COMPLETED|Overall Study||5
8710435|NCT00957853|9756717|FG000|NOT COMPLETED|Overall Study||1
8710436|NCT00957853|9756718|FG001|NOT COMPLETED|Overall Study||0
8710437|NCT00957853|9756719|FG002|NOT COMPLETED|Overall Study||0
8710438|NCT00957905|9756729|FG000|STARTED|Part A||7
8710439|NCT00957905|9756730|FG001|STARTED|Part A||0
8710440|NCT00957905|9756729|FG000|COMPLETED|Part A||7
8710441|NCT00957905|9756730|FG001|COMPLETED|Part A||0
8710442|NCT00957905|9756729|FG000|NOT COMPLETED|Part A||0
8710443|NCT00957905|9756730|FG001|NOT COMPLETED|Part A||0
8710444|NCT00957905|9756729|FG000|STARTED|Part B||0
8710445|NCT00957905|9756730|FG001|STARTED|Part B||29
8710446|NCT00957905|9756729|FG000|COMPLETED|Part B||0
8710447|NCT00957905|9756730|FG001|COMPLETED|Part B||25
8586035|NCT00257933|9620254|FG000|COMPLETED|Overall Study||74
8586036|NCT00257933|9620255|FG001|COMPLETED|Overall Study||78
8710448|NCT00957905|9756729|FG000|NOT COMPLETED|Part B||0
8710449|NCT00957905|9756730|FG001|NOT COMPLETED|Part B||4
8710450|NCT00957931|9756736|FG000|STARTED|Overall Study||6
8710451|NCT00957931|9756736|FG000|COMPLETED|Overall Study||2
8586037|NCT00257933|9620254|FG000|NOT COMPLETED|Overall Study||0
8586038|NCT00257933|9620255|FG001|NOT COMPLETED|Overall Study||0
8586039|NCT00258011|9620261|FG000|STARTED|Overall Study||3
8710452|NCT00957931|9756736|FG000|NOT COMPLETED|Overall Study||4
8710453|NCT00957944|9756742|FG000|STARTED|First Intervention- 24 Hours||20
8710454|NCT00957944|9756743|FG001|STARTED|First Intervention- 24 Hours||20
8586040|NCT00258011|9620261|FG000|COMPLETED|Overall Study||3
8586041|NCT00258011|9620261|FG000|NOT COMPLETED|Overall Study||0
8586042|NCT00258128|9620267|FG000|STARTED|Overall Study||8
8586043|NCT00258128|9620268|FG001|STARTED|Overall Study||9
8586044|NCT00258128|9620267|FG000|COMPLETED|Overall Study||8
8586045|NCT00258128|9620268|FG001|COMPLETED|Overall Study||9
8586046|NCT00258128|9620267|FG000|NOT COMPLETED|Overall Study||0
8586047|NCT00258128|9620268|FG001|NOT COMPLETED|Overall Study||0
8586048|NCT00258154|9620278|FG000|STARTED|Overall Study|Healthy infants who started in the RotaTeq™ concomitantly with INFANRIX™ hexa group.|201
8586049|NCT00258154|9620279|FG001|STARTED|Overall Study|Healthy infants who started in the Placebo concomitantly with INFANRIX™ hexa group.|202
8586050|NCT00258154|9620278|FG000|Vaccinated at Visit 1|Overall Study||201
8586051|NCT00258154|9620279|FG001|Vaccinated at Visit 1|Overall Study||202
8586052|NCT00258154|9620278|FG000|Vaccinated at Visit 2|Overall Study||198
8586053|NCT00258154|9620279|FG001|Vaccinated at Visit 2|Overall Study||198
8586054|NCT00258154|9620278|FG000|Vaccinated at Visit 3|Overall Study||195
8586055|NCT00258154|9620279|FG001|Vaccinated at Visit 3|Overall Study||197
8586056|NCT00258154|9620278|FG000|COMPLETED|Overall Study|Subjects who completed the study.|192
8586057|NCT00258154|9620279|FG001|COMPLETED|Overall Study|Subjects who completed the study.|195
8586058|NCT00258154|9620278|FG000|NOT COMPLETED|Overall Study||9
8586059|NCT00258154|9620279|FG001|NOT COMPLETED|Overall Study||7
8586060|NCT00258180|9620285|FG000|STARTED|Overall Study||2
8586061|NCT00258180|9620285|FG000|COMPLETED|Overall Study||2
8586062|NCT00258180|9620285|FG000|NOT COMPLETED|Overall Study||0
8586063|NCT00258206|9620290|FG000|STARTED|Overall Study||21
8586064|NCT00258206|9620290|FG000|COMPLETED|Overall Study||21
8586065|NCT00258206|9620290|FG000|NOT COMPLETED|Overall Study||0
8586066|NCT00258310|9620294|FG000|STARTED|Overall Study||35
8586067|NCT00258310|9620294|FG000|COMPLETED|Overall Study||35
8586068|NCT00258310|9620294|FG000|NOT COMPLETED|Overall Study||0
8586069|NCT00258349|9620298|FG000|STARTED|Overall Study||16
8586070|NCT00258349|9620298|FG000|HER2-positive by Central Review|Overall Study||10
8586071|NCT00258349|9620298|FG000|COMPLETED|Overall Study||16
8586072|NCT00258349|9620298|FG000|NOT COMPLETED|Overall Study||0
8586073|NCT00258362|9620304|FG000|STARTED|Overall Study||41
8586074|NCT00258362|9620304|FG000|COMPLETED|Overall Study||41
8586075|NCT00258362|9620304|FG000|NOT COMPLETED|Overall Study||0
8586076|NCT00258440|9620312|FG000|STARTED|Overall Study||1
8586077|NCT00258440|9620313|FG001|STARTED|Overall Study||0
8586078|NCT00258440|9620314|FG002|STARTED|Overall Study||6
8586079|NCT00258440|9620312|FG000|COMPLETED|Overall Study||1
8586080|NCT00258440|9620313|FG001|COMPLETED|Overall Study||0
8586081|NCT00258440|9620314|FG002|COMPLETED|Overall Study||5
8586082|NCT00258440|9620312|FG000|NOT COMPLETED|Overall Study||0
8586083|NCT00258440|9620313|FG001|NOT COMPLETED|Overall Study||0
8586084|NCT00258440|9620314|FG002|NOT COMPLETED|Overall Study||1
8586085|NCT00258674|9620325|FG000|STARTED|Overall Study||597
8586086|NCT00258674|9620326|FG001|STARTED|Overall Study||811
8586087|NCT00258674|9620327|FG002|STARTED|Overall Study||602
8586088|NCT00258674|9620325|FG000|COMPLETED|Overall Study||565
8586089|NCT00258674|9620326|FG001|COMPLETED|Overall Study||758
8586090|NCT00258674|9620327|FG002|COMPLETED|Overall Study||568
8586091|NCT00258674|9620325|FG000|NOT COMPLETED|Overall Study||32
8586092|NCT00258674|9620326|FG001|NOT COMPLETED|Overall Study||53
8586093|NCT00258674|9620327|FG002|NOT COMPLETED|Overall Study||34
8586094|NCT00258817|9620337|FG000|STARTED|Overall Study||15
8586095|NCT00258817|9620338|FG001|STARTED|Overall Study||15
8586096|NCT00258817|9620337|FG000|COMPLETED|Overall Study||15
8586097|NCT00258817|9620338|FG001|COMPLETED|Overall Study||15
8586098|NCT00258817|9620337|FG000|NOT COMPLETED|Overall Study||0
8586099|NCT00258817|9620338|FG001|NOT COMPLETED|Overall Study||0
8586100|NCT00258830|9620346|FG000|STARTED|Overall Study||60
8586101|NCT00258830|9620347|FG001|STARTED|Overall Study||60
8586102|NCT00258830|9620346|FG000|COMPLETED|Overall Study||60
8586103|NCT00258830|9620347|FG001|COMPLETED|Overall Study||60
8586104|NCT00258830|9620346|FG000|NOT COMPLETED|Overall Study||0
8586105|NCT00258830|9620347|FG001|NOT COMPLETED|Overall Study||0
8586106|NCT00258856|9620357|FG000|STARTED|Overall Study||59
8586107|NCT00258856|9620358|FG001|STARTED|Overall Study||58
8586108|NCT00258856|9620359|FG002|STARTED|Overall Study||58
8586109|NCT00258856|9620360|FG003|STARTED|Overall Study||59
8586110|NCT00258856|9620357|FG000|COMPLETED|Overall Study||56
8586111|NCT00258856|9620358|FG001|COMPLETED|Overall Study||58
8586112|NCT00258856|9620359|FG002|COMPLETED|Overall Study||56
8586113|NCT00258856|9620360|FG003|COMPLETED|Overall Study||58
8586114|NCT00258856|9620357|FG000|NOT COMPLETED|Overall Study||3
8586115|NCT00258856|9620358|FG001|NOT COMPLETED|Overall Study||0
8586116|NCT00258856|9620359|FG002|NOT COMPLETED|Overall Study||2
8586117|NCT00258856|9620360|FG003|NOT COMPLETED|Overall Study||1
8586118|NCT00258882|9620372|FG000|STARTED|Adacel Recipients Historic Cohort Method||124139
8586119|NCT00258882|9620373|FG001|STARTED|Adacel Recipients Historic Cohort Method||203154
8586120|NCT00258882|9620372|FG000|COMPLETED|Adacel Recipients Historic Cohort Method||124139
8586121|NCT00258882|9620373|FG001|COMPLETED|Adacel Recipients Historic Cohort Method||203154
8586122|NCT00258882|9620372|FG000|NOT COMPLETED|Adacel Recipients Historic Cohort Method||0
8586123|NCT00258882|9620373|FG001|NOT COMPLETED|Adacel Recipients Historic Cohort Method||0
8586124|NCT00258882|9620372|FG000|STARTED|Adacel Recipients-Risk Interval Method||124139
8586125|NCT00258882|9620373|FG001|STARTED|Adacel Recipients-Risk Interval Method|Study participants served as their own controls for this analysis|0
8586126|NCT00258882|9620372|FG000|COMPLETED|Adacel Recipients-Risk Interval Method||124139
8586127|NCT00258882|9620373|FG001|COMPLETED|Adacel Recipients-Risk Interval Method||0
8586128|NCT00258882|9620372|FG000|NOT COMPLETED|Adacel Recipients-Risk Interval Method||0
8586129|NCT00258882|9620373|FG001|NOT COMPLETED|Adacel Recipients-Risk Interval Method||0
8586130|NCT00258882|9620372|FG000|STARTED|Pregnancy Surveillance|Adacel recipients who were pregnant at the time of vaccination or within 28 days thereafter.|225
8586131|NCT00258882|9620373|FG001|STARTED|Pregnancy Surveillance|Non-vaccinated age-matched subjects with first positive pregnancy test in the same month (± 1 month)|675
8586132|NCT00258882|9620372|FG000|COMPLETED|Pregnancy Surveillance||225
8586133|NCT00258882|9620373|FG001|COMPLETED|Pregnancy Surveillance||675
8586134|NCT00258882|9620372|FG000|NOT COMPLETED|Pregnancy Surveillance||0
8586135|NCT00258882|9620373|FG001|NOT COMPLETED|Pregnancy Surveillance||0
8586136|NCT00258895|9620383|FG000|STARTED|Overall Study||487
8586137|NCT00258895|9620384|FG001|STARTED|Overall Study||162
8586138|NCT00258895|9620383|FG000|COMPLETED|Overall Study||477
8586139|NCT00258895|9620384|FG001|COMPLETED|Overall Study||159
8586140|NCT00258895|9620383|FG000|NOT COMPLETED|Overall Study||10
8586141|NCT00258895|9620384|FG001|NOT COMPLETED|Overall Study||3
8586142|NCT00258908|9620390|FG000|STARTED|Overall Study|3 participants were not vaccinated and were not included in the final analysis and in this report.|112
8586143|NCT00258908|9620390|FG000|COMPLETED|Overall Study||112
8586144|NCT00258908|9620390|FG000|NOT COMPLETED|Overall Study||0
8586145|NCT00258960|9620394|FG000|STARTED|Overall Study|49 patients included but 1 is not considered due to not receive any treatment and died before start|49
8586146|NCT00258960|9620394|FG000|COMPLETED|Overall Study||32
8586147|NCT00258960|9620394|FG000|NOT COMPLETED|Overall Study||17
8586148|NCT00259012|9620400|FG000|STARTED|Overall Study||33
8586149|NCT00259012|9620401|FG001|STARTED|Overall Study||34
8586150|NCT00259012|9620400|FG000|COMPLETED|Overall Study||31
8586151|NCT00259012|9620401|FG001|COMPLETED|Overall Study||30
8586152|NCT00259012|9620400|FG000|NOT COMPLETED|Overall Study||2
8586153|NCT00259012|9620401|FG001|NOT COMPLETED|Overall Study||4
8586154|NCT00259090|9620410|FG000|STARTED|Overall Study|Doesn't include protocol deviators, those who didn't complete the study or had missing tumor samples|35
8586155|NCT00259090|9620411|FG001|STARTED|Overall Study|Doesn't include protocol deviators, those who didn't complete the study or had missing tumor samples|31
8586156|NCT00259090|9620412|FG002|STARTED|Overall Study|Doesn't include protocol deviators, those who didn't complete the study or had missing tumor samples|37
8586157|NCT00259090|9620410|FG000|COMPLETED|Overall Study||35
8586158|NCT00259090|9620411|FG001|COMPLETED|Overall Study||31
8586159|NCT00259090|9620412|FG002|COMPLETED|Overall Study||37
8586160|NCT00259090|9620410|FG000|NOT COMPLETED|Overall Study||0
8586161|NCT00259090|9620411|FG001|NOT COMPLETED|Overall Study||0
8586162|NCT00259090|9620412|FG002|NOT COMPLETED|Overall Study||0
8586163|NCT00259272|9620424|FG000|STARTED|Overall Study||36
8586164|NCT00259272|9620425|FG001|STARTED|Overall Study||31
8586165|NCT00259272|9620426|FG002|STARTED|Overall Study||26
8586166|NCT00259272|9620427|FG003|STARTED|Overall Study||48
8586167|NCT00259272|9620424|FG000|COMPLETED|Overall Study||21
8586168|NCT00259272|9620425|FG001|COMPLETED|Overall Study||24
8586169|NCT00259272|9620426|FG002|COMPLETED|Overall Study||21
8586170|NCT00259272|9620427|FG003|COMPLETED|Overall Study||27
8586171|NCT00259272|9620424|FG000|NOT COMPLETED|Overall Study||15
8586172|NCT00259272|9620425|FG001|NOT COMPLETED|Overall Study||7
8586173|NCT00259272|9620426|FG002|NOT COMPLETED|Overall Study||5
8586174|NCT00259272|9620427|FG003|NOT COMPLETED|Overall Study||21
8586175|NCT00259285|9620442|FG000|STARTED|Overall Study||10
8586176|NCT00259285|9620442|FG000|COMPLETED|Overall Study||10
8586177|NCT00259285|9620442|FG000|NOT COMPLETED|Overall Study||0
8627807|NCT00519376|9667177|FG007|COMPLETED|Treatment Period 4||1
8627808|NCT00519376|9667178|FG008|COMPLETED|Treatment Period 4||1
8627809|NCT00519376|9667179|FG009|COMPLETED|Treatment Period 4||1
8627810|NCT00519376|9667180|FG010|COMPLETED|Treatment Period 4||1
8627811|NCT00519376|9667181|FG011|COMPLETED|Treatment Period 4||1
8627812|NCT00519376|9667182|FG012|COMPLETED|Treatment Period 4||0
8627813|NCT00519376|9667183|FG013|COMPLETED|Treatment Period 4||1
8627814|NCT00519376|9667184|FG014|COMPLETED|Treatment Period 4||1
8627815|NCT00519376|9667185|FG015|COMPLETED|Treatment Period 4||1
8627816|NCT00519376|9667170|FG000|NOT COMPLETED|Treatment Period 4||0
8627817|NCT00519376|9667171|FG001|NOT COMPLETED|Treatment Period 4||0
8627818|NCT00519376|9667172|FG002|NOT COMPLETED|Treatment Period 4||1
8627819|NCT00519376|9667173|FG003|NOT COMPLETED|Treatment Period 4||0
8627820|NCT00519376|9667174|FG004|NOT COMPLETED|Treatment Period 4||0
8627821|NCT00519376|9667175|FG005|NOT COMPLETED|Treatment Period 4||0
8627822|NCT00519376|9667176|FG006|NOT COMPLETED|Treatment Period 4||0
8627823|NCT00519376|9667177|FG007|NOT COMPLETED|Treatment Period 4||0
8710455|NCT00957944|9756742|FG000|COMPLETED|First Intervention- 24 Hours||20
8710456|NCT00957944|9756743|FG001|COMPLETED|First Intervention- 24 Hours||19
8710457|NCT00957944|9756742|FG000|NOT COMPLETED|First Intervention- 24 Hours||0
8710458|NCT00957944|9756743|FG001|NOT COMPLETED|First Intervention- 24 Hours||1
8627824|NCT00519376|9667178|FG008|NOT COMPLETED|Treatment Period 4||0
8627825|NCT00519376|9667179|FG009|NOT COMPLETED|Treatment Period 4||0
8627826|NCT00519376|9667180|FG010|NOT COMPLETED|Treatment Period 4||0
8627827|NCT00519376|9667181|FG011|NOT COMPLETED|Treatment Period 4||0
8627828|NCT00519376|9667182|FG012|NOT COMPLETED|Treatment Period 4||0
8627829|NCT00519376|9667183|FG013|NOT COMPLETED|Treatment Period 4||0
8627830|NCT00519376|9667184|FG014|NOT COMPLETED|Treatment Period 4||0
8710459|NCT00957944|9756742|FG000|STARTED|Washout Period of at Least 5 Days||20
8710460|NCT00957944|9756743|FG001|STARTED|Washout Period of at Least 5 Days||19
8586178|NCT00259298|9620446|FG000|STARTED|Overall Study||12
8586179|NCT00259298|9620446|FG000|Received at Least 1 Dose of Study Drug|Overall Study||10
8586180|NCT00259298|9620446|FG000|COMPLETED|Overall Study||9
8586181|NCT00259298|9620446|FG000|NOT COMPLETED|Overall Study||3
8586182|NCT00259610|9620454|FG000|STARTED|Overall Study||244
8586183|NCT00259610|9620455|FG001|STARTED|Overall Study||132
8586184|NCT00259610|9620456|FG002|STARTED|Overall Study||255
8586185|NCT00259610|9620457|FG003|STARTED|Overall Study||124
8586186|NCT00259610|9620454|FG000|COMPLETED|Overall Study||168
8586187|NCT00259610|9620455|FG001|COMPLETED|Overall Study||86
8586188|NCT00259610|9620456|FG002|COMPLETED|Overall Study||182
8586189|NCT00259610|9620457|FG003|COMPLETED|Overall Study||81
8586190|NCT00259610|9620454|FG000|NOT COMPLETED|Overall Study||76
8586191|NCT00259610|9620455|FG001|NOT COMPLETED|Overall Study||46
8586192|NCT00259610|9620456|FG002|NOT COMPLETED|Overall Study||73
8586193|NCT00259610|9620457|FG003|NOT COMPLETED|Overall Study||43
8586194|NCT00259649|9620467|FG000|STARTED|Overall Study||71
8586195|NCT00259649|9620467|FG000|COMPLETED|Overall Study||61
8710461|NCT00957944|9756742|FG000|COMPLETED|Washout Period of at Least 5 Days||20
8710462|NCT00957944|9756743|FG001|COMPLETED|Washout Period of at Least 5 Days||19
8710463|NCT00957944|9756742|FG000|NOT COMPLETED|Washout Period of at Least 5 Days||0
8710464|NCT00957944|9756743|FG001|NOT COMPLETED|Washout Period of at Least 5 Days||0
8710465|NCT00957944|9756742|FG000|STARTED|Second Intervention- 24 Hours||20
8710466|NCT00957944|9756743|FG001|STARTED|Second Intervention- 24 Hours||19
8710467|NCT00957944|9756742|FG000|Pharmacokinetic Set (PKS)|Second Intervention- 24 Hours||20
8710468|NCT00957944|9756743|FG001|Pharmacokinetic Set (PKS)|Second Intervention- 24 Hours|One subject that fullfilled predefined criteria for patch adhesiveness was excluded from the PKS|18
8710469|NCT00957944|9756742|FG000|COMPLETED|Second Intervention- 24 Hours||20
8710470|NCT00957944|9756743|FG001|COMPLETED|Second Intervention- 24 Hours||19
8710471|NCT00957944|9756742|FG000|NOT COMPLETED|Second Intervention- 24 Hours||0
8710472|NCT00957944|9756743|FG001|NOT COMPLETED|Second Intervention- 24 Hours||0
8710473|NCT00957996|9756751|FG000|STARTED|Overall Study||117
8710474|NCT00957996|9756752|FG001|STARTED|Overall Study||117
8710475|NCT00957996|9756751|FG000|COMPLETED|Overall Study||91
8710476|NCT00957996|9756752|FG001|COMPLETED|Overall Study||89
8710477|NCT00957996|9756751|FG000|NOT COMPLETED|Overall Study||26
8710478|NCT00957996|9756752|FG001|NOT COMPLETED|Overall Study||28
8710479|NCT00958009|9756760|FG000|STARTED|Overall Study||109
8710480|NCT00958009|9756760|FG000|COMPLETED|Overall Study||107
8710481|NCT00958009|9756760|FG000|NOT COMPLETED|Overall Study||2
8710482|NCT00958035|9756766|FG000|STARTED|Overall Study||46
8710483|NCT00958035|9756767|FG001|STARTED|Overall Study||43
8710484|NCT00958035|9756766|FG000|COMPLETED|Overall Study||43
8710485|NCT00958035|9756767|FG001|COMPLETED|Overall Study||39
8710486|NCT00958035|9756766|FG000|NOT COMPLETED|Overall Study||3
8710487|NCT00958035|9756767|FG001|NOT COMPLETED|Overall Study||4
8710488|NCT00958074|9756775|FG000|STARTED|Overall Study||4
8710489|NCT00958074|9756776|FG001|STARTED|Overall Study||7
8710490|NCT00958074|9756775|FG000|COMPLETED|Overall Study||4
8710491|NCT00958074|9756776|FG001|COMPLETED|Overall Study||6
8710492|NCT00958074|9756775|FG000|NOT COMPLETED|Overall Study||0
8710493|NCT00958074|9756776|FG001|NOT COMPLETED|Overall Study||1
8710494|NCT00958126|9756790|FG000|STARTED|Overall Study||49
8710495|NCT00958126|9756791|FG001|STARTED|Overall Study||205
8710496|NCT00958126|9756792|FG002|STARTED|Overall Study||201
8710497|NCT00958126|9756793|FG003|STARTED|Overall Study||203
8710498|NCT00958126|9756794|FG004|STARTED|Overall Study||50
8710499|NCT00958126|9756795|FG005|STARTED|Overall Study||203
8710500|NCT00958126|9756796|FG006|STARTED|Overall Study||200
8710501|NCT00958126|9756797|FG007|STARTED|Overall Study||202
8710502|NCT00958126|9756790|FG000|COMPLETED|Overall Study||48
8710503|NCT00958126|9756791|FG001|COMPLETED|Overall Study||196
8710504|NCT00958126|9756792|FG002|COMPLETED|Overall Study||191
8710505|NCT00958126|9756793|FG003|COMPLETED|Overall Study||192
8710506|NCT00958126|9756794|FG004|COMPLETED|Overall Study||50
8710507|NCT00958126|9756795|FG005|COMPLETED|Overall Study||202
8710508|NCT00958126|9756796|FG006|COMPLETED|Overall Study||199
8710509|NCT00958126|9756797|FG007|COMPLETED|Overall Study||202
8710510|NCT00958126|9756790|FG000|NOT COMPLETED|Overall Study||1
8710511|NCT00958126|9756791|FG001|NOT COMPLETED|Overall Study||9
8710512|NCT00958126|9756792|FG002|NOT COMPLETED|Overall Study||10
8710513|NCT00958126|9756793|FG003|NOT COMPLETED|Overall Study||11
8710514|NCT00958126|9756794|FG004|NOT COMPLETED|Overall Study||0
8710515|NCT00958126|9756795|FG005|NOT COMPLETED|Overall Study||1
8710516|NCT00958126|9756796|FG006|NOT COMPLETED|Overall Study||1
8710517|NCT00958126|9756797|FG007|NOT COMPLETED|Overall Study||0
8710518|NCT00958165|9756819|FG000|STARTED|Overall Study|81 enrolled participants resulted in 72 eligible participants that were treated.|81
8586196|NCT00259649|9620467|FG000|NOT COMPLETED|Overall Study||10
8586197|NCT00259740|9620473|FG000|STARTED|Overall Study||43
8586198|NCT00259740|9620474|FG001|STARTED|Overall Study||53
8586199|NCT00259740|9620473|FG000|Received Study Medication|Overall Study||42
8586200|NCT00259740|9620474|FG001|Received Study Medication|Overall Study||53
8710519|NCT00958165|9756819|FG000|Treated|Overall Study||72
8710520|NCT00958165|9756819|FG000|COMPLETED|Overall Study|Of the 72 treated participants, 67 completed follow-up and were evaluable for effectiveness.|67
8710521|NCT00958165|9756819|FG000|NOT COMPLETED|Overall Study||14
8710522|NCT00958191|9756823|FG000|STARTED|Overall Study||221
8710523|NCT00958191|9756823|FG000|COMPLETED|Overall Study||110
8586201|NCT00259740|9620473|FG000|COMPLETED|Overall Study||0
8586202|NCT00259740|9620474|FG001|COMPLETED|Overall Study||0
8586203|NCT00259740|9620473|FG000|NOT COMPLETED|Overall Study||43
8586204|NCT00259740|9620474|FG001|NOT COMPLETED|Overall Study||53
8586205|NCT00259857|9620482|FG000|STARTED|12 Months Treatment||11
8586206|NCT00259857|9620483|FG001|STARTED|12 Months Treatment||11
8586207|NCT00259857|9620482|FG000|COMPLETED|12 Months Treatment||10
8586208|NCT00259857|9620483|FG001|COMPLETED|12 Months Treatment||9
8586209|NCT00259857|9620482|FG000|NOT COMPLETED|12 Months Treatment||1
8586210|NCT00259857|9620483|FG001|NOT COMPLETED|12 Months Treatment||2
8586211|NCT00259857|9620482|FG000|STARTED|24 Months Treatment||10
8586212|NCT00259857|9620483|FG001|STARTED|24 Months Treatment||9
8586213|NCT00259857|9620482|FG000|COMPLETED|24 Months Treatment||10
8586214|NCT00259857|9620483|FG001|COMPLETED|24 Months Treatment||6
8586215|NCT00259857|9620482|FG000|NOT COMPLETED|24 Months Treatment||0
8586216|NCT00259857|9620483|FG001|NOT COMPLETED|24 Months Treatment||3
8586217|NCT00260065|9620489|FG000|STARTED|Overall Study||99
8586218|NCT00260065|9620489|FG000|COMPLETED|Overall Study||6
8710524|NCT00958191|9756823|FG000|NOT COMPLETED|Overall Study||111
8710525|NCT00958217|9756831|FG000|STARTED|Overall Study||61
8710526|NCT00958217|9756832|FG001|STARTED|Overall Study||62
8710527|NCT00958217|9756831|FG000|End of Treatment|Overall Study|Participants had a maximum of 16 weeks to complete 12 individual psychotherapy sessions|56
8586219|NCT00260065|9620489|FG000|NOT COMPLETED|Overall Study||93
8586220|NCT00260195|9620495|FG000|STARTED|Overall Study||39
8586221|NCT00260195|9620496|FG001|STARTED|Overall Study||37
8586222|NCT00260195|9620495|FG000|COMPLETED|Overall Study||39
8586223|NCT00260195|9620496|FG001|COMPLETED|Overall Study||37
8586224|NCT00260195|9620495|FG000|NOT COMPLETED|Overall Study||0
8586225|NCT00260195|9620496|FG001|NOT COMPLETED|Overall Study||0
8586226|NCT00260208|9620505|FG000|STARTED|Overall Study|"Started indicates safety population."|184
8586227|NCT00260208|9620506|FG001|STARTED|Overall Study||172
8586228|NCT00260208|9620505|FG000|Intent to Treat (ITT) Population|Overall Study||182
8586229|NCT00260208|9620506|FG001|Intent to Treat (ITT) Population|Overall Study||169
8586230|NCT00260208|9620505|FG000|Modified ITT|Overall Study||101
8586231|NCT00260208|9620506|FG001|Modified ITT|Overall Study||96
8586232|NCT00260208|9620505|FG000|COMPLETED|Overall Study||137
8586233|NCT00260208|9620506|FG001|COMPLETED|Overall Study||138
8586234|NCT00260208|9620505|FG000|NOT COMPLETED|Overall Study||47
8586235|NCT00260208|9620506|FG001|NOT COMPLETED|Overall Study||34
8586236|NCT00260429|9620514|FG000|STARTED|Overall Study||23
8586237|NCT00260429|9620515|FG001|STARTED|Overall Study||12
8586238|NCT00260429|9620514|FG000|COMPLETED|Overall Study||21
8586239|NCT00260429|9620515|FG001|COMPLETED|Overall Study||12
8586240|NCT00260429|9620514|FG000|NOT COMPLETED|Overall Study||2
8586241|NCT00260429|9620515|FG001|NOT COMPLETED|Overall Study||0
8586242|NCT00260533|9620523|FG000|STARTED|Overall Study||14
8586243|NCT00260533|9620524|FG001|STARTED|Overall Study||13
8586244|NCT00260533|9620523|FG000|COMPLETED|Overall Study||11
8586245|NCT00260533|9620524|FG001|COMPLETED|Overall Study||10
8586246|NCT00260533|9620523|FG000|NOT COMPLETED|Overall Study||3
8586247|NCT00260533|9620524|FG001|NOT COMPLETED|Overall Study||3
8586248|NCT00260689|9620533|FG000|STARTED|Overall Study||60
8586249|NCT00260689|9620534|FG001|STARTED|Overall Study||60
8586250|NCT00260689|9620535|FG002|STARTED|Overall Study||16
8586251|NCT00260689|9620533|FG000|COMPLETED|Overall Study||19
8586252|NCT00260689|9620534|FG001|COMPLETED|Overall Study||11
8586253|NCT00260689|9620535|FG002|COMPLETED|Overall Study||1
8586254|NCT00260689|9620533|FG000|NOT COMPLETED|Overall Study||41
8586255|NCT00260689|9620534|FG001|NOT COMPLETED|Overall Study||49
8586256|NCT00260689|9620535|FG002|NOT COMPLETED|Overall Study||15
8586257|NCT00260832|9620545|FG000|STARTED|Overall Study||243
8586258|NCT00260832|9620546|FG001|STARTED|Overall Study||242
8586259|NCT00260832|9620545|FG000|COMPLETED|Overall Study|At study completion, these subjects chose to remain on treatment|15
8586260|NCT00260832|9620546|FG001|COMPLETED|Overall Study|At study completion, these subjects chose to remain on treatment|31
8586261|NCT00260832|9620545|FG000|NOT COMPLETED|Overall Study||228
8586262|NCT00260832|9620546|FG001|NOT COMPLETED|Overall Study||211
8586263|NCT00260962|9620554|FG000|STARTED|Overall Study||18
8586264|NCT00260962|9620555|FG001|STARTED|Overall Study||16
8586265|NCT00260962|9620554|FG000|COMPLETED|Overall Study||14
8586266|NCT00260962|9620555|FG001|COMPLETED|Overall Study||14
8586267|NCT00260962|9620554|FG000|NOT COMPLETED|Overall Study||4
8586268|NCT00260962|9620555|FG001|NOT COMPLETED|Overall Study||2
8586269|NCT00261040|9620563|FG000|STARTED|Overall Study||20
8586270|NCT00261040|9620564|FG001|STARTED|Overall Study||20
8586271|NCT00261040|9620563|FG000|COMPLETED|Overall Study||19
8586272|NCT00261040|9620564|FG001|COMPLETED|Overall Study||20
8586273|NCT00261040|9620563|FG000|NOT COMPLETED|Overall Study||1
8586274|NCT00261040|9620564|FG001|NOT COMPLETED|Overall Study||0
8586275|NCT00261443|9620572|FG000|STARTED|1: Confirmation of Partial Nonresponse||1270
8586276|NCT00261443|9620573|FG001|STARTED|1: Confirmation of Partial Nonresponse||0
8586277|NCT00261443|9620574|FG002|STARTED|1: Confirmation of Partial Nonresponse||0
8586278|NCT00261443|9620572|FG000|COMPLETED|1: Confirmation of Partial Nonresponse||686
8586279|NCT00261443|9620573|FG001|COMPLETED|1: Confirmation of Partial Nonresponse||0
8724829|NCT01028014|9772102|FG002|NOT COMPLETED|Overall Study||0
8586280|NCT00261443|9620574|FG002|COMPLETED|1: Confirmation of Partial Nonresponse||0
8586281|NCT00261443|9620572|FG000|NOT COMPLETED|1: Confirmation of Partial Nonresponse||584
8627831|NCT00519376|9667185|FG015|NOT COMPLETED|Treatment Period 4||0
8586282|NCT00261443|9620573|FG001|NOT COMPLETED|1: Confirmation of Partial Nonresponse||0
8586283|NCT00261443|9620574|FG002|NOT COMPLETED|1: Confirmation of Partial Nonresponse||0
8586284|NCT00261443|9620572|FG000|STARTED|2: Stability & Maintenance of Stability||686
8586285|NCT00261443|9620573|FG001|STARTED|2: Stability & Maintenance of Stability||0
8586286|NCT00261443|9620574|FG002|STARTED|2: Stability & Maintenance of Stability||0
8586287|NCT00261443|9620572|FG000|COMPLETED|2: Stability & Maintenance of Stability||346
8586288|NCT00261443|9620573|FG001|COMPLETED|2: Stability & Maintenance of Stability||0
8586289|NCT00261443|9620574|FG002|COMPLETED|2: Stability & Maintenance of Stability||0
8586290|NCT00261443|9620572|FG000|NOT COMPLETED|2: Stability & Maintenance of Stability||340
8586291|NCT00261443|9620573|FG001|NOT COMPLETED|2: Stability & Maintenance of Stability||0
8586292|NCT00261443|9620574|FG002|NOT COMPLETED|2: Stability & Maintenance of Stability||0
8586293|NCT00261443|9620572|FG000|STARTED|3: Assessment of Relapse||0
8586294|NCT00261443|9620573|FG001|STARTED|3: Assessment of Relapse||169
8586295|NCT00261443|9620574|FG002|STARTED|3: Assessment of Relapse||168
8586296|NCT00261443|9620572|FG000|COMPLETED|3: Assessment of Relapse||0
8586297|NCT00261443|9620573|FG001|COMPLETED|3: Assessment of Relapse||89
8586298|NCT00261443|9620574|FG002|COMPLETED|3: Assessment of Relapse||103
8586299|NCT00261443|9620572|FG000|NOT COMPLETED|3: Assessment of Relapse||0
8586300|NCT00261443|9620573|FG001|NOT COMPLETED|3: Assessment of Relapse||80
8586301|NCT00261443|9620574|FG002|NOT COMPLETED|3: Assessment of Relapse||65
8586302|NCT00261443|9620572|FG000|STARTED|4: Extension Phase||0
8586303|NCT00261443|9620573|FG001|STARTED|4: Extension Phase||19
8586304|NCT00261443|9620574|FG002|STARTED|4: Extension Phase||23
8586305|NCT00261443|9620572|FG000|COMPLETED|4: Extension Phase||0
8586306|NCT00261443|9620573|FG001|COMPLETED|4: Extension Phase||16
8586307|NCT00261443|9620574|FG002|COMPLETED|4: Extension Phase||21
8586308|NCT00261443|9620572|FG000|NOT COMPLETED|4: Extension Phase||0
8586309|NCT00261443|9620573|FG001|NOT COMPLETED|4: Extension Phase||3
8586310|NCT00261443|9620574|FG002|NOT COMPLETED|4: Extension Phase||2
8586311|NCT00261495|9620587|FG000|STARTED|Titration Phase (Weeks 0 to 4)||254
8586312|NCT00261495|9620588|FG001|STARTED|Titration Phase (Weeks 0 to 4)||250
8586313|NCT00261495|9620587|FG000|COMPLETED|Titration Phase (Weeks 0 to 4)||206
8586314|NCT00261495|9620588|FG001|COMPLETED|Titration Phase (Weeks 0 to 4)||185
8586315|NCT00261495|9620587|FG000|NOT COMPLETED|Titration Phase (Weeks 0 to 4)||48
8586316|NCT00261495|9620588|FG001|NOT COMPLETED|Titration Phase (Weeks 0 to 4)||65
8586317|NCT00261495|9620587|FG000|STARTED|Maintenance Phase (Weeks 4 to 24)||206
8586318|NCT00261495|9620588|FG001|STARTED|Maintenance Phase (Weeks 4 to 24)||185
8586319|NCT00261495|9620587|FG000|COMPLETED|Maintenance Phase (Weeks 4 to 24)||140
8586320|NCT00261495|9620588|FG001|COMPLETED|Maintenance Phase (Weeks 4 to 24)||137
8586321|NCT00261495|9620587|FG000|NOT COMPLETED|Maintenance Phase (Weeks 4 to 24)||66
8586322|NCT00261495|9620588|FG001|NOT COMPLETED|Maintenance Phase (Weeks 4 to 24)||48
8586323|NCT00261495|9620587|FG000|STARTED|Extension Phase (Weeks 24 to 52)|Number started is different to number completed maintenance phase owing to drop outs (80 subjects).|60
8586324|NCT00261495|9620588|FG001|STARTED|Extension Phase (Weeks 24 to 52)|Number started is different to number completed maintenance phase owing to drop outs (85 subjects).|52
8586325|NCT00261495|9620587|FG000|COMPLETED|Extension Phase (Weeks 24 to 52)||50
8586326|NCT00261495|9620588|FG001|COMPLETED|Extension Phase (Weeks 24 to 52)||47
8586327|NCT00261495|9620587|FG000|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||10
8586328|NCT00261495|9620588|FG001|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||5
8586329|NCT00261716|9620596|FG000|STARTED|Overall Study||17
8586330|NCT00261716|9620597|FG001|STARTED|Overall Study||21
8586331|NCT00261716|9620596|FG000|COMPLETED|Overall Study||11
8586332|NCT00261716|9620597|FG001|COMPLETED|Overall Study||11
8586333|NCT00261716|9620596|FG000|NOT COMPLETED|Overall Study||6
8586334|NCT00261716|9620597|FG001|NOT COMPLETED|Overall Study||10
8586335|NCT00261833|9620609|FG000|STARTED|Overall Study||93
8586336|NCT00261833|9620610|FG001|STARTED|Overall Study||87
8586337|NCT00261833|9620609|FG000|COMPLETED|Overall Study||84
8586338|NCT00261833|9620610|FG001|COMPLETED|Overall Study||69
8586339|NCT00261833|9620609|FG000|NOT COMPLETED|Overall Study||9
8586340|NCT00261833|9620610|FG001|NOT COMPLETED|Overall Study||18
8586341|NCT00261846|9620626|FG000|STARTED|Period 1: Part 1 (Dose Escalation)||3
8586342|NCT00261846|9620627|FG001|STARTED|Period 1: Part 1 (Dose Escalation)||3
8586343|NCT00261846|9620628|FG002|STARTED|Period 1: Part 1 (Dose Escalation)||12
8586344|NCT00261846|9620629|FG003|STARTED|Period 1: Part 1 (Dose Escalation)||0
8586345|NCT00261846|9620630|FG004|STARTED|Period 1: Part 1 (Dose Escalation)||0
8928142|NCT02278341|9989252|FG001|Received Treatment|Overall Study||420
8928143|NCT02278341|9989251|FG000|COMPLETED|Overall Study||297
8928144|NCT02278341|9989252|FG001|COMPLETED|Overall Study||329
8928145|NCT02278341|9989251|FG000|NOT COMPLETED|Overall Study||118
8928146|NCT02278341|9989252|FG001|NOT COMPLETED|Overall Study||92
8586346|NCT00261846|9620631|FG005|STARTED|Period 1: Part 1 (Dose Escalation)||0
8586347|NCT00261846|9620632|FG006|STARTED|Period 1: Part 1 (Dose Escalation)||0
8586348|NCT00261846|9620633|FG007|STARTED|Period 1: Part 1 (Dose Escalation)||0
8586349|NCT00261846|9620634|FG008|STARTED|Period 1: Part 1 (Dose Escalation)||0
8586350|NCT00261846|9620635|FG009|STARTED|Period 1: Part 1 (Dose Escalation)||0
8586351|NCT00261846|9620636|FG010|STARTED|Period 1: Part 1 (Dose Escalation)||0
8586352|NCT00261846|9620637|FG011|STARTED|Period 1: Part 1 (Dose Escalation)||0
8586353|NCT00261846|9620626|FG000|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
8586354|NCT00261846|9620627|FG001|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
8928147|NCT02278354|9989261|FG000|STARTED|Overall Study||12
8586355|NCT00261846|9620628|FG002|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
8586356|NCT00261846|9620629|FG003|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
8586357|NCT00261846|9620630|FG004|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
8586358|NCT00261846|9620631|FG005|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
8586359|NCT00261846|9620632|FG006|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
8586360|NCT00261846|9620633|FG007|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
8586361|NCT00261846|9620634|FG008|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
8586362|NCT00261846|9620635|FG009|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
8586363|NCT00261846|9620636|FG010|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
8586364|NCT00261846|9620637|FG011|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
8586365|NCT00261846|9620626|FG000|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||3
8586366|NCT00261846|9620627|FG001|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||3
8586367|NCT00261846|9620628|FG002|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||12
8586368|NCT00261846|9620629|FG003|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
8586369|NCT00261846|9620630|FG004|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
8586370|NCT00261846|9620631|FG005|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
8586371|NCT00261846|9620632|FG006|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
8586372|NCT00261846|9620633|FG007|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
8586373|NCT00261846|9620634|FG008|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
8586374|NCT00261846|9620635|FG009|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
8586375|NCT00261846|9620636|FG010|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
8586376|NCT00261846|9620637|FG011|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
8586377|NCT00261846|9620626|FG000|STARTED|Period 2: Part 2 (Efficacy)||0
8586378|NCT00261846|9620627|FG001|STARTED|Period 2: Part 2 (Efficacy)||0
8586379|NCT00261846|9620628|FG002|STARTED|Period 2: Part 2 (Efficacy)||0
8586380|NCT00261846|9620629|FG003|STARTED|Period 2: Part 2 (Efficacy)|17 participants from Part 1 (Bosutinib 400mg, 500mg, 600mg cohort) continued in Part 2 of the study.|195
8586381|NCT00261846|9620630|FG004|STARTED|Period 2: Part 2 (Efficacy)||89
8586382|NCT00261846|9620631|FG005|STARTED|Period 2: Part 2 (Efficacy)||5
8586383|NCT00261846|9620632|FG006|STARTED|Period 2: Part 2 (Efficacy)||38
8586384|NCT00261846|9620633|FG007|STARTED|Period 2: Part 2 (Efficacy)||50
8586385|NCT00261846|9620634|FG008|STARTED|Period 2: Part 2 (Efficacy)||26
8586386|NCT00261846|9620635|FG009|STARTED|Period 2: Part 2 (Efficacy)|1 participant from Part 1 (Bosutinib 600mg cohort) continued in Part 2 of the study.|79
8586387|NCT00261846|9620636|FG010|STARTED|Period 2: Part 2 (Efficacy)||64
8586388|NCT00261846|9620637|FG011|STARTED|Period 2: Part 2 (Efficacy)||24
8586389|NCT00261846|9620626|FG000|COMPLETED|Period 2: Part 2 (Efficacy)||0
8586390|NCT00261846|9620627|FG001|COMPLETED|Period 2: Part 2 (Efficacy)||0
8586391|NCT00261846|9620628|FG002|COMPLETED|Period 2: Part 2 (Efficacy)||0
8586392|NCT00261846|9620629|FG003|COMPLETED|Period 2: Part 2 (Efficacy)||60
8586393|NCT00261846|9620630|FG004|COMPLETED|Period 2: Part 2 (Efficacy)||39
8586394|NCT00261846|9620631|FG005|COMPLETED|Period 2: Part 2 (Efficacy)||3
8586395|NCT00261846|9620632|FG006|COMPLETED|Period 2: Part 2 (Efficacy)||16
8586396|NCT00261846|9620633|FG007|COMPLETED|Period 2: Part 2 (Efficacy)||21
8586397|NCT00261846|9620634|FG008|COMPLETED|Period 2: Part 2 (Efficacy)||12
8586398|NCT00261846|9620635|FG009|COMPLETED|Period 2: Part 2 (Efficacy)||30
8586399|NCT00261846|9620636|FG010|COMPLETED|Period 2: Part 2 (Efficacy)||15
8586400|NCT00261846|9620637|FG011|COMPLETED|Period 2: Part 2 (Efficacy)||1
8586401|NCT00261846|9620626|FG000|NOT COMPLETED|Period 2: Part 2 (Efficacy)||0
8586402|NCT00261846|9620627|FG001|NOT COMPLETED|Period 2: Part 2 (Efficacy)||0
8586403|NCT00261846|9620628|FG002|NOT COMPLETED|Period 2: Part 2 (Efficacy)||0
8586404|NCT00261846|9620629|FG003|NOT COMPLETED|Period 2: Part 2 (Efficacy)||135
8586405|NCT00261846|9620630|FG004|NOT COMPLETED|Period 2: Part 2 (Efficacy)||50
8586406|NCT00261846|9620631|FG005|NOT COMPLETED|Period 2: Part 2 (Efficacy)||2
8586407|NCT00261846|9620632|FG006|NOT COMPLETED|Period 2: Part 2 (Efficacy)||22
8586408|NCT00261846|9620633|FG007|NOT COMPLETED|Period 2: Part 2 (Efficacy)||29
8586409|NCT00261846|9620634|FG008|NOT COMPLETED|Period 2: Part 2 (Efficacy)||14
8586410|NCT00261846|9620635|FG009|NOT COMPLETED|Period 2: Part 2 (Efficacy)||49
8586411|NCT00261846|9620636|FG010|NOT COMPLETED|Period 2: Part 2 (Efficacy)||49
8586412|NCT00261846|9620637|FG011|NOT COMPLETED|Period 2: Part 2 (Efficacy)||23
8586413|NCT00261950|9620676|FG000|STARTED|Overall Study||110
8586414|NCT00261950|9620676|FG000|COMPLETED|Overall Study||84
8586415|NCT00261950|9620676|FG000|NOT COMPLETED|Overall Study||26
8586416|NCT00262002|9620687|FG000|STARTED|Overall Study||90
8586417|NCT00262002|9620688|FG001|STARTED|Overall Study||90
8586418|NCT00262002|9620689|FG002|STARTED|Overall Study||45
8586419|NCT00262002|9620690|FG003|STARTED|Overall Study||98
8586420|NCT00262002|9620691|FG004|STARTED|Overall Study||98
8586421|NCT00262002|9620692|FG005|STARTED|Overall Study||90
8586422|NCT00262002|9620693|FG006|STARTED|Overall Study||90
8586423|NCT00262002|9620687|FG000|COMPLETED|Overall Study||79
8586424|NCT00262002|9620688|FG001|COMPLETED|Overall Study||84
8586425|NCT00262002|9620689|FG002|COMPLETED|Overall Study||45
8586426|NCT00262002|9620690|FG003|COMPLETED|Overall Study||93
8586427|NCT00262002|9620691|FG004|COMPLETED|Overall Study||91
8586428|NCT00262002|9620692|FG005|COMPLETED|Overall Study||83
8586429|NCT00262002|9620693|FG006|COMPLETED|Overall Study||84
8586430|NCT00262002|9620687|FG000|NOT COMPLETED|Overall Study||11
8586431|NCT00262002|9620688|FG001|NOT COMPLETED|Overall Study||6
8586432|NCT00262002|9620689|FG002|NOT COMPLETED|Overall Study||0
8586433|NCT00262002|9620690|FG003|NOT COMPLETED|Overall Study||5
8586434|NCT00262002|9620691|FG004|NOT COMPLETED|Overall Study||7
8586435|NCT00262002|9620692|FG005|NOT COMPLETED|Overall Study||7
8586436|NCT00262002|9620693|FG006|NOT COMPLETED|Overall Study||6
8586437|NCT00262028|9620767|FG000|STARTED|Overall Study||152
8586438|NCT00262028|9620768|FG001|STARTED|Overall Study||153
8586439|NCT00262028|9620769|FG002|STARTED|Overall Study||157
8586440|NCT00262028|9620770|FG003|STARTED|Overall Study||157
8586441|NCT00262028|9620771|FG004|STARTED|Overall Study||74
8586442|NCT00262028|9620772|FG005|STARTED|Overall Study||73
8586443|NCT00262028|9620773|FG006|STARTED|Overall Study||71
8586444|NCT00262028|9620774|FG007|STARTED|Overall Study||73
8586445|NCT00262028|9620775|FG008|STARTED|Overall Study||100
8586446|NCT00262028|9620767|FG000|COMPLETED|Overall Study||128
8586447|NCT00262028|9620768|FG001|COMPLETED|Overall Study||126
8586448|NCT00262028|9620769|FG002|COMPLETED|Overall Study||137
8586449|NCT00262028|9620770|FG003|COMPLETED|Overall Study||134
8586450|NCT00262028|9620771|FG004|COMPLETED|Overall Study||62
8586451|NCT00262028|9620772|FG005|COMPLETED|Overall Study||60
8586452|NCT00262028|9620773|FG006|COMPLETED|Overall Study||59
8586453|NCT00262028|9620774|FG007|COMPLETED|Overall Study||55
8586454|NCT00262028|9620775|FG008|COMPLETED|Overall Study||81
8586455|NCT00262028|9620767|FG000|NOT COMPLETED|Overall Study||24
8586456|NCT00262028|9620768|FG001|NOT COMPLETED|Overall Study||27
8586457|NCT00262028|9620769|FG002|NOT COMPLETED|Overall Study||20
8586458|NCT00262028|9620770|FG003|NOT COMPLETED|Overall Study||23
8586459|NCT00262028|9620771|FG004|NOT COMPLETED|Overall Study||12
8586460|NCT00262028|9620772|FG005|NOT COMPLETED|Overall Study||13
8586461|NCT00262028|9620773|FG006|NOT COMPLETED|Overall Study||12
8586462|NCT00262028|9620774|FG007|NOT COMPLETED|Overall Study||18
8586463|NCT00262028|9620775|FG008|NOT COMPLETED|Overall Study||19
8586464|NCT00262041|9620821|FG000|STARTED|Overall Study||164
8586465|NCT00262041|9620822|FG001|STARTED|Overall Study||151
8586466|NCT00262041|9620823|FG002|STARTED|Overall Study||209
8586467|NCT00262041|9620821|FG000|COMPLETED|Overall Study||162
8586468|NCT00262041|9620822|FG001|COMPLETED|Overall Study||147
8586469|NCT00262041|9620823|FG002|COMPLETED|Overall Study||203
8586470|NCT00262041|9620821|FG000|NOT COMPLETED|Overall Study||2
8586471|NCT00262041|9620822|FG001|NOT COMPLETED|Overall Study||4
8586472|NCT00262041|9620823|FG002|NOT COMPLETED|Overall Study||6
8586473|NCT00262067|9620841|FG000|STARTED|Overall Study||415
8586474|NCT00262067|9620842|FG001|STARTED|Overall Study||207
8586475|NCT00262067|9620843|FG002|STARTED|Overall Study||409
8586476|NCT00262067|9620844|FG003|STARTED|Overall Study||206
8586477|NCT00262067|9620841|FG000|COMPLETED|Overall Study||196
8586478|NCT00262067|9620842|FG001|COMPLETED|Overall Study||107
8586479|NCT00262067|9620843|FG002|COMPLETED|Overall Study||193
8586480|NCT00262067|9620844|FG003|COMPLETED|Overall Study||93
8586481|NCT00262067|9620841|FG000|NOT COMPLETED|Overall Study||219
8586482|NCT00262067|9620842|FG001|NOT COMPLETED|Overall Study||100
8586483|NCT00262067|9620843|FG002|NOT COMPLETED|Overall Study||216
8586484|NCT00262067|9620844|FG003|NOT COMPLETED|Overall Study||113
8586485|NCT00262080|9620857|FG000|STARTED|Double Blind Treatment Period|One patient was randomized to receive ecallantide but was treated with placebo.|36
8586486|NCT00262080|9620858|FG001|STARTED|Double Blind Treatment Period|One patient was randomized to receive placebo but was treated with ecallantide.|36
8586487|NCT00262080|9620859|FG002|STARTED|Double Blind Treatment Period||0
8586488|NCT00262080|9620857|FG000|COMPLETED|Double Blind Treatment Period||35
8586489|NCT00262080|9620858|FG001|COMPLETED|Double Blind Treatment Period||36
8586490|NCT00262080|9620859|FG002|COMPLETED|Double Blind Treatment Period||0
8586491|NCT00262080|9620857|FG000|NOT COMPLETED|Double Blind Treatment Period||1
8586492|NCT00262080|9620858|FG001|NOT COMPLETED|Double Blind Treatment Period||0
8586493|NCT00262080|9620859|FG002|NOT COMPLETED|Double Blind Treatment Period||0
8586494|NCT00262080|9620857|FG000|STARTED|Repeat Dose Treatment Period|Not all patients treated in the double-blind part came for treatment in the repeat-dose part.|22
8586495|NCT00262080|9620858|FG001|STARTED|Repeat Dose Treatment Period|Not all patients treated in the double-blind part came for treatment in the repeat-dose part.|26
8586496|NCT00262080|9620859|FG002|STARTED|Repeat Dose Treatment Period|This arm represents new patients, not treated in the double-blind part of the study.|19
8586497|NCT00262080|9620857|FG000|COMPLETED|Repeat Dose Treatment Period|Some patients participated in only the double-blind or the open label phase.|18
8586498|NCT00262080|9620858|FG001|COMPLETED|Repeat Dose Treatment Period||25
8586499|NCT00262080|9620859|FG002|COMPLETED|Repeat Dose Treatment Period||14
8586500|NCT00262080|9620857|FG000|NOT COMPLETED|Repeat Dose Treatment Period||4
8586501|NCT00262080|9620858|FG001|NOT COMPLETED|Repeat Dose Treatment Period||1
8586502|NCT00262080|9620859|FG002|NOT COMPLETED|Repeat Dose Treatment Period||5
8586503|NCT00262119|9620870|FG000|STARTED|Overall Study||385
8586504|NCT00262119|9620871|FG001|STARTED|Overall Study||398
8586505|NCT00262119|9620872|FG002|STARTED|Overall Study||383
8586506|NCT00262119|9620870|FG000|COMPLETED|Overall Study||327
8586507|NCT00262119|9620871|FG001|COMPLETED|Overall Study||328
8586508|NCT00262119|9620872|FG002|COMPLETED|Overall Study||325
8586509|NCT00262119|9620870|FG000|NOT COMPLETED|Overall Study||58
8586510|NCT00262119|9620871|FG001|NOT COMPLETED|Overall Study||70
8586511|NCT00262119|9620872|FG002|NOT COMPLETED|Overall Study||58
8586512|NCT00262223|9620882|FG000|STARTED|Treatment Phase||32
8586513|NCT00262223|9620883|FG001|STARTED|Treatment Phase||37
8586514|NCT00262223|9620882|FG000|COMPLETED|Treatment Phase||28
8586515|NCT00262223|9620883|FG001|COMPLETED|Treatment Phase||29
8586516|NCT00262223|9620882|FG000|NOT COMPLETED|Treatment Phase||4
8586517|NCT00262223|9620883|FG001|NOT COMPLETED|Treatment Phase||8
8586518|NCT00262223|9620882|FG000|STARTED|1-week Post-treatment Follow-up||28
8586519|NCT00262223|9620883|FG001|STARTED|1-week Post-treatment Follow-up||29
8586520|NCT00262223|9620882|FG000|COMPLETED|1-week Post-treatment Follow-up||24
8586521|NCT00262223|9620883|FG001|COMPLETED|1-week Post-treatment Follow-up||25
8586522|NCT00262223|9620882|FG000|NOT COMPLETED|1-week Post-treatment Follow-up||4
8586523|NCT00262223|9620883|FG001|NOT COMPLETED|1-week Post-treatment Follow-up||4
8586524|NCT00262223|9620882|FG000|STARTED|6-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|28
8586525|NCT00262223|9620883|FG001|STARTED|6-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|29
8586526|NCT00262223|9620882|FG000|COMPLETED|6-month Post-treatment Follow-up||22
8586527|NCT00262223|9620883|FG001|COMPLETED|6-month Post-treatment Follow-up||28
8586528|NCT00262223|9620882|FG000|NOT COMPLETED|6-month Post-treatment Follow-up||6
8586529|NCT00262223|9620883|FG001|NOT COMPLETED|6-month Post-treatment Follow-up||1
8586530|NCT00262223|9620882|FG000|STARTED|12-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|28
8586531|NCT00262223|9620883|FG001|STARTED|12-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|29
8586532|NCT00262223|9620882|FG000|COMPLETED|12-month Post-treatment Follow-up||21
8586533|NCT00262223|9620883|FG001|COMPLETED|12-month Post-treatment Follow-up||22
8586534|NCT00262223|9620882|FG000|NOT COMPLETED|12-month Post-treatment Follow-up||7
8586535|NCT00262223|9620883|FG001|NOT COMPLETED|12-month Post-treatment Follow-up||7
8586536|NCT00262301|9620893|FG000|STARTED|Double-blind Phase||16
8586537|NCT00262301|9620894|FG001|STARTED|Double-blind Phase||16
8586538|NCT00262301|9620895|FG002|STARTED|Double-blind Phase||0
8586539|NCT00262301|9620893|FG000|COMPLETED|Double-blind Phase||15
8586540|NCT00262301|9620894|FG001|COMPLETED|Double-blind Phase||15
8586541|NCT00262301|9620895|FG002|COMPLETED|Double-blind Phase||0
8586542|NCT00262301|9620893|FG000|NOT COMPLETED|Double-blind Phase||1
8586543|NCT00262301|9620894|FG001|NOT COMPLETED|Double-blind Phase||1
8586544|NCT00262301|9620895|FG002|NOT COMPLETED|Double-blind Phase||0
8586545|NCT00262301|9620893|FG000|STARTED|Open-label Phase||0
8586546|NCT00262301|9620894|FG001|STARTED|Open-label Phase||0
8586547|NCT00262301|9620895|FG002|STARTED|Open-label Phase|"14/57 patients crossed over from the double-blind phase (7/14 were treated with 100 U/kg rhC1INH)"|57
8586548|NCT00262301|9620893|FG000|COMPLETED|Open-label Phase||0
8586549|NCT00262301|9620894|FG001|COMPLETED|Open-label Phase||0
8586550|NCT00262301|9620895|FG002|COMPLETED|Open-label Phase||57
8586551|NCT00262301|9620893|FG000|NOT COMPLETED|Open-label Phase||0
8586552|NCT00262301|9620894|FG001|NOT COMPLETED|Open-label Phase||0
8586553|NCT00262301|9620895|FG002|NOT COMPLETED|Open-label Phase||0
8586554|NCT00262314|9620903|FG000|STARTED|Overall Study|Patients with validated data who received at least 1 dose of Novantrone®|509
8586555|NCT00262314|9620903|FG000|COMPLETED|Overall Study|Patients in the study for 5 years +/-3 months are considered to have completed the 5-year study|172
8586556|NCT00262314|9620903|FG000|NOT COMPLETED|Overall Study||337
8586557|NCT00262509|9620909|FG000|STARTED|Overall Study||8
8586558|NCT00262509|9620910|FG001|STARTED|Overall Study||9
8586559|NCT00262509|9620909|FG000|COMPLETED|Overall Study||8
8586560|NCT00262509|9620910|FG001|COMPLETED|Overall Study||9
8586561|NCT00262509|9620909|FG000|NOT COMPLETED|Overall Study||0
8586562|NCT00262509|9620910|FG001|NOT COMPLETED|Overall Study||0
8586563|NCT00262522|9620920|FG000|STARTED|Study Start Through 8 Weeks||167
8586564|NCT00262522|9620921|FG001|STARTED|Study Start Through 8 Weeks||166
8586565|NCT00262522|9620922|FG002|STARTED|Study Start Through 8 Weeks||166
8586566|NCT00262522|9620923|FG003|STARTED|Study Start Through 8 Weeks||165
8586567|NCT00262522|9620920|FG000|COMPLETED|Study Start Through 8 Weeks||163
8586568|NCT00262522|9620921|FG001|COMPLETED|Study Start Through 8 Weeks||161
8586569|NCT00262522|9620922|FG002|COMPLETED|Study Start Through 8 Weeks||155
8586570|NCT00262522|9620923|FG003|COMPLETED|Study Start Through 8 Weeks||160
8586571|NCT00262522|9620920|FG000|NOT COMPLETED|Study Start Through 8 Weeks||4
8586572|NCT00262522|9620921|FG001|NOT COMPLETED|Study Start Through 8 Weeks||5
8586573|NCT00262522|9620922|FG002|NOT COMPLETED|Study Start Through 8 Weeks||11
8586574|NCT00262522|9620923|FG003|NOT COMPLETED|Study Start Through 8 Weeks||5
8586575|NCT00262522|9620920|FG000|STARTED|Study Start Through 48 Weeks|Number of subjects who started the study, not the number who completed the first 8 weeks.|333
8586576|NCT00262522|9620921|FG001|STARTED|Study Start Through 48 Weeks|After Week 8, these subjects received the tablet formulation once daily through the end of study.|0
8586577|NCT00262522|9620922|FG002|STARTED|Study Start Through 48 Weeks|Number of subjects who started the study, not the number who completed the first 8 weeks.|331
8586578|NCT00262522|9620923|FG003|STARTED|Study Start Through 48 Weeks|After Week 8, these subjects received the tablet formulation twice daily through the end of study.|0
8586579|NCT00262522|9620920|FG000|COMPLETED|Study Start Through 48 Weeks||284
8586580|NCT00262522|9620921|FG001|COMPLETED|Study Start Through 48 Weeks||0
8586581|NCT00262522|9620922|FG002|COMPLETED|Study Start Through 48 Weeks||276
8586582|NCT00262522|9620923|FG003|COMPLETED|Study Start Through 48 Weeks||0
8586583|NCT00262522|9620920|FG000|NOT COMPLETED|Study Start Through 48 Weeks||49
8586584|NCT00262522|9620921|FG001|NOT COMPLETED|Study Start Through 48 Weeks||0
8586585|NCT00262522|9620922|FG002|NOT COMPLETED|Study Start Through 48 Weeks||55
8586586|NCT00262522|9620923|FG003|NOT COMPLETED|Study Start Through 48 Weeks||0
8586587|NCT00262522|9620920|FG000|STARTED|Study Start Through 96 Weeks|Number of subjects who started the study, not the number who completed the first 48 weeks.|333
8586588|NCT00262522|9620921|FG001|STARTED|Study Start Through 96 Weeks|After Week 8, these subjects received the tablet formulation once daily through the end of study.|0
8586589|NCT00262522|9620922|FG002|STARTED|Study Start Through 96 Weeks|Number of subjects who started the study, not the number who completed the first 48 weeks.|331
8586590|NCT00262522|9620923|FG003|STARTED|Study Start Through 96 Weeks|After Week 8, these subjects received the tablet formulation twice daily through the end of study.|0
8586591|NCT00262522|9620920|FG000|COMPLETED|Study Start Through 96 Weeks||256
8586592|NCT00262522|9620921|FG001|COMPLETED|Study Start Through 96 Weeks||0
8586593|NCT00262522|9620922|FG002|COMPLETED|Study Start Through 96 Weeks||254
8586594|NCT00262522|9620923|FG003|COMPLETED|Study Start Through 96 Weeks||0
8586595|NCT00262522|9620920|FG000|NOT COMPLETED|Study Start Through 96 Weeks||77
8586596|NCT00262522|9620921|FG001|NOT COMPLETED|Study Start Through 96 Weeks||0
8586597|NCT00262522|9620922|FG002|NOT COMPLETED|Study Start Through 96 Weeks||77
8586598|NCT00262522|9620923|FG003|NOT COMPLETED|Study Start Through 96 Weeks||0
8586599|NCT00262600|9620934|FG000|STARTED|Overall Study||6015
8586600|NCT00262600|9620935|FG001|STARTED|Overall Study||6076
8586601|NCT00262600|9620936|FG002|STARTED|Overall Study||6022
8586602|NCT00262600|9620934|FG000|COMPLETED|Overall Study||5780
8586603|NCT00262600|9620935|FG001|COMPLETED|Overall Study||5824
8586604|NCT00262600|9620936|FG002|COMPLETED|Overall Study||5756
8586605|NCT00262600|9620934|FG000|NOT COMPLETED|Overall Study||235
8586606|NCT00262600|9620935|FG001|NOT COMPLETED|Overall Study||252
8586607|NCT00262600|9620936|FG002|NOT COMPLETED|Overall Study||266
8586608|NCT00262639|9620948|FG000|STARTED|Overall Study||18
8586609|NCT00262639|9620949|FG001|STARTED|Overall Study||26
8586610|NCT00262639|9620950|FG002|STARTED|Overall Study||9
8586611|NCT00262639|9620951|FG003|STARTED|Overall Study||7
8586612|NCT00262639|9620948|FG000|COMPLETED|Overall Study||18
8586613|NCT00262639|9620949|FG001|COMPLETED|Overall Study||26
8586614|NCT00262639|9620950|FG002|COMPLETED|Overall Study||9
8586615|NCT00262639|9620951|FG003|COMPLETED|Overall Study||7
8586616|NCT00262639|9620948|FG000|NOT COMPLETED|Overall Study||0
8586617|NCT00262639|9620949|FG001|NOT COMPLETED|Overall Study||0
8586618|NCT00262639|9620950|FG002|NOT COMPLETED|Overall Study||0
8586619|NCT00262639|9620951|FG003|NOT COMPLETED|Overall Study||0
8586620|NCT00262730|9620961|FG000|STARTED|Overall Study||97
8586621|NCT00262730|9620961|FG000|COMPLETED|Overall Study||97
8586622|NCT00262730|9620961|FG000|NOT COMPLETED|Overall Study||0
8586623|NCT00262743|9620967|FG000|STARTED|Overall Study||27
8586624|NCT00262743|9620968|FG001|STARTED|Overall Study||42
8586625|NCT00262743|9620967|FG000|COMPLETED|Overall Study||27
8586626|NCT00262743|9620968|FG001|COMPLETED|Overall Study||30
8586627|NCT00262743|9620967|FG000|NOT COMPLETED|Overall Study||0
8586628|NCT00262743|9620968|FG001|NOT COMPLETED|Overall Study||12
8586629|NCT00262821|9620974|FG000|STARTED|Overall Study||198
8586630|NCT00262821|9620975|FG001|STARTED|Overall Study||204
8586631|NCT00262821|9620974|FG000|COMPLETED|Overall Study||194
8586632|NCT00262821|9620975|FG001|COMPLETED|Overall Study||185
8586633|NCT00262821|9620974|FG000|NOT COMPLETED|Overall Study||4
8586634|NCT00262821|9620975|FG001|NOT COMPLETED|Overall Study||19
8586635|NCT00262834|9620983|FG000|STARTED|Overall Study||25
8586636|NCT00262834|9620984|FG001|STARTED|Overall Study||29
8586637|NCT00262834|9620983|FG000|COMPLETED|Overall Study||24
8710528|NCT00958217|9756832|FG001|End of Treatment|Overall Study|Participants had a maximum of 16 weeks to complete 12 individual psychotherapy sessions|57
8710529|NCT00958217|9756831|FG000|COMPLETED|Overall Study|Participants were assessed quarterly for one year following end of treatment|37
8710530|NCT00958217|9756832|FG001|COMPLETED|Overall Study|Participants were assessed quarterly for one year following end of treatment|37
8710531|NCT00958217|9756831|FG000|NOT COMPLETED|Overall Study||24
8710532|NCT00958217|9756832|FG001|NOT COMPLETED|Overall Study||25
8710533|NCT00958243|9756845|FG000|STARTED|Overall Study||26
8710534|NCT00958243|9756846|FG001|STARTED|Overall Study||105
8710535|NCT00958243|9756847|FG002|STARTED|Overall Study||96
8710536|NCT00958243|9756848|FG003|STARTED|Overall Study||28
8710537|NCT00958243|9756849|FG004|STARTED|Overall Study||109
8710538|NCT00958243|9756850|FG005|STARTED|Overall Study||109
8710539|NCT00958243|9756845|FG000|COMPLETED|Overall Study||24
8710540|NCT00958243|9756846|FG001|COMPLETED|Overall Study||99
8710541|NCT00958243|9756847|FG002|COMPLETED|Overall Study||82
8710542|NCT00958243|9756848|FG003|COMPLETED|Overall Study||25
8710543|NCT00958243|9756849|FG004|COMPLETED|Overall Study||100
8710544|NCT00958243|9756850|FG005|COMPLETED|Overall Study||99
8710545|NCT00958243|9756845|FG000|NOT COMPLETED|Overall Study||2
8586638|NCT00262834|9620984|FG001|COMPLETED|Overall Study||25
8586639|NCT00262834|9620983|FG000|NOT COMPLETED|Overall Study||1
8586640|NCT00262834|9620984|FG001|NOT COMPLETED|Overall Study||4
8586641|NCT00262847|9620993|FG000|STARTED|Overall Study|Total enrolled and included in efficacy analysis|625
8586642|NCT00262847|9620994|FG001|STARTED|Overall Study|Total enrolled and included in efficacy analysis|625
8586643|NCT00262847|9620995|FG002|STARTED|Overall Study|Total enrolled and included in efficacy analysis|623
8586644|NCT00262847|9620993|FG000|COMPLETED|Overall Study||107
8586645|NCT00262847|9620994|FG001|COMPLETED|Overall Study||112
8586646|NCT00262847|9620995|FG002|COMPLETED|Overall Study||227
8586647|NCT00262847|9620993|FG000|NOT COMPLETED|Overall Study||518
8710546|NCT00958243|9756846|FG001|NOT COMPLETED|Overall Study||6
8710547|NCT00958243|9756847|FG002|NOT COMPLETED|Overall Study||14
8710548|NCT00958243|9756848|FG003|NOT COMPLETED|Overall Study||3
8710549|NCT00958243|9756849|FG004|NOT COMPLETED|Overall Study||9
8710550|NCT00958243|9756850|FG005|NOT COMPLETED|Overall Study||10
8710551|NCT00958256|9756870|FG000|STARTED|Overall Study||21
8710552|NCT00958256|9756870|FG000|COMPLETED|Overall Study||18
8710553|NCT00958256|9756870|FG000|NOT COMPLETED|Overall Study||3
8586648|NCT00262847|9620994|FG001|NOT COMPLETED|Overall Study||513
8586649|NCT00262847|9620995|FG002|NOT COMPLETED|Overall Study||396
8586650|NCT00262860|9621006|FG000|STARTED|Overall Study||18
8586651|NCT00262860|9621006|FG000|COMPLETED|Overall Study||16
8586652|NCT00262860|9621006|FG000|NOT COMPLETED|Overall Study||2
8586653|NCT00262873|9621010|FG000|STARTED|Overall Study||8
8586654|NCT00262873|9621010|FG000|COMPLETED|Overall Study||0
8586655|NCT00262873|9621010|FG000|NOT COMPLETED|Overall Study||8
8586656|NCT00262925|9621014|FG000|STARTED|Overall Study|7 patients were enrolled to step 1, and 5 patients were enrolled to step 2|12
8586657|NCT00262925|9621014|FG000|COMPLETED|Overall Study||1
8586658|NCT00262925|9621014|FG000|NOT COMPLETED|Overall Study||11
8586659|NCT00262951|9621020|FG000|STARTED|Overall Study||23
8586660|NCT00262951|9621020|FG000|COMPLETED|Overall Study||7
8586661|NCT00262951|9621020|FG000|NOT COMPLETED|Overall Study||16
8586662|NCT00262964|9621026|FG000|STARTED|Overall Study||11
8586663|NCT00262964|9621027|FG001|STARTED|Overall Study||11
8586664|NCT00262964|9621028|FG002|STARTED|Overall Study||17
8586665|NCT00262964|9621029|FG003|STARTED|Overall Study||12
8586666|NCT00262964|9621026|FG000|COMPLETED|Overall Study||11
8586667|NCT00262964|9621027|FG001|COMPLETED|Overall Study||11
8586668|NCT00262964|9621028|FG002|COMPLETED|Overall Study||17
8586669|NCT00262964|9621029|FG003|COMPLETED|Overall Study||12
8586670|NCT00262964|9621026|FG000|NOT COMPLETED|Overall Study||0
8586671|NCT00262964|9621027|FG001|NOT COMPLETED|Overall Study||0
8586672|NCT00262964|9621028|FG002|NOT COMPLETED|Overall Study||0
8586673|NCT00262964|9621029|FG003|NOT COMPLETED|Overall Study||0
8586674|NCT00263211|9621053|FG000|STARTED|Overall Study||24
8586675|NCT00263211|9621054|FG001|STARTED|Overall Study||24
8586676|NCT00263211|9621053|FG000|COMPLETED|Overall Study||19
8586677|NCT00263211|9621054|FG001|COMPLETED|Overall Study||23
8586678|NCT00263211|9621053|FG000|NOT COMPLETED|Overall Study||5
8586679|NCT00263211|9621054|FG001|NOT COMPLETED|Overall Study||1
8586680|NCT00263328|9621066|FG000|STARTED|Overall Study||18
8586681|NCT00263328|9621067|FG001|STARTED|Overall Study||14
8586682|NCT00263328|9621068|FG002|STARTED|Overall Study||13
8586683|NCT00263328|9621066|FG000|COMPLETED|Overall Study||10
8586684|NCT00263328|9621067|FG001|COMPLETED|Overall Study||12
8586685|NCT00263328|9621068|FG002|COMPLETED|Overall Study||6
8586686|NCT00263328|9621066|FG000|NOT COMPLETED|Overall Study||8
8586687|NCT00263328|9621067|FG001|NOT COMPLETED|Overall Study||2
8586688|NCT00263328|9621068|FG002|NOT COMPLETED|Overall Study||7
8586689|NCT00263562|9621080|FG000|STARTED|Overall Study||9
8586690|NCT00263562|9621081|FG001|STARTED|Overall Study||9
8586691|NCT00263562|9621080|FG000|COMPLETED|Overall Study||6
8586692|NCT00263562|9621081|FG001|COMPLETED|Overall Study||9
8586693|NCT00263562|9621080|FG000|NOT COMPLETED|Overall Study||3
8586694|NCT00263562|9621081|FG001|NOT COMPLETED|Overall Study||0
8586695|NCT00263575|9621089|FG000|STARTED|Titration Period||139
8586696|NCT00263575|9621089|FG000|COMPLETED|Titration Period||96
8586697|NCT00263575|9621089|FG000|NOT COMPLETED|Titration Period||43
8586698|NCT00263575|9621089|FG000|STARTED|Maintence Period||96
8586699|NCT00263575|9621089|FG000|COMPLETED|Maintence Period||19
8586700|NCT00263575|9621089|FG000|NOT COMPLETED|Maintence Period||77
8586701|NCT00263588|9621097|FG000|STARTED|Overall Study||95
8586702|NCT00263588|9621098|FG001|STARTED|Overall Study||147
8586703|NCT00263588|9621097|FG000|COMPLETED|Overall Study||14
8586704|NCT00263588|9621098|FG001|COMPLETED|Overall Study||15
8586705|NCT00263588|9621097|FG000|NOT COMPLETED|Overall Study||81
8586706|NCT00263588|9621098|FG001|NOT COMPLETED|Overall Study||132
8586707|NCT00263666|9621107|FG000|STARTED|Overall Study||50
8586708|NCT00263666|9621108|FG001|STARTED|Overall Study||50
8586709|NCT00263666|9621107|FG000|COMPLETED|Overall Study||43
8586710|NCT00263666|9621108|FG001|COMPLETED|Overall Study||39
8586711|NCT00263666|9621107|FG000|NOT COMPLETED|Overall Study||7
8586712|NCT00263666|9621108|FG001|NOT COMPLETED|Overall Study||11
8586713|NCT00263757|9621116|FG000|STARTED|Overall Study||12
8586714|NCT00263757|9621117|FG001|STARTED|Overall Study||13
8586715|NCT00263757|9621116|FG000|COMPLETED|Overall Study||4
8586716|NCT00263757|9621117|FG001|COMPLETED|Overall Study||5
8586717|NCT00263757|9621116|FG000|NOT COMPLETED|Overall Study||8
8586718|NCT00263757|9621117|FG001|NOT COMPLETED|Overall Study||8
8586719|NCT00263887|9621125|FG000|STARTED|Overall Study||38
8586720|NCT00263887|9621126|FG001|STARTED|Overall Study||39
8586721|NCT00263887|9621125|FG000|COMPLETED|Overall Study||35
8586722|NCT00263887|9621126|FG001|COMPLETED|Overall Study||32
8586723|NCT00263887|9621125|FG000|NOT COMPLETED|Overall Study||3
8586724|NCT00263887|9621126|FG001|NOT COMPLETED|Overall Study||7
8586725|NCT00264004|9621136|FG000|STARTED|Overall Study|Randomised|30
8586726|NCT00264004|9621137|FG001|STARTED|Overall Study|Randomised|32
8586727|NCT00264004|9621138|FG002|STARTED|Overall Study|Randomised|30
8586728|NCT00264004|9621139|FG003|STARTED|Overall Study|Randomised|34
8586729|NCT00264004|9621136|FG000|COMPLETED|Overall Study|Completed 12 weeks treatment|13
8586730|NCT00264004|9621137|FG001|COMPLETED|Overall Study|Completed 12 weeks treatment|21
8586731|NCT00264004|9621138|FG002|COMPLETED|Overall Study|Completed 12 weeks treatment|16
8586732|NCT00264004|9621139|FG003|COMPLETED|Overall Study|Completed 12 weeks treatment|19
8586733|NCT00264004|9621136|FG000|NOT COMPLETED|Overall Study||17
8586734|NCT00264004|9621137|FG001|NOT COMPLETED|Overall Study||11
8586735|NCT00264004|9621138|FG002|NOT COMPLETED|Overall Study||14
8586736|NCT00264004|9621139|FG003|NOT COMPLETED|Overall Study||15
8586737|NCT00264238|9621149|FG000|STARTED|Overall Study||15
8586738|NCT00264238|9621149|FG000|COMPLETED|Overall Study||14
8586739|NCT00264238|9621149|FG000|NOT COMPLETED|Overall Study||1
8586740|NCT00264290|9621157|FG000|STARTED|Intervention (8 Weeks)||16
8586741|NCT00264290|9621158|FG001|STARTED|Intervention (8 Weeks)||14
8586742|NCT00264290|9621157|FG000|COMPLETED|Intervention (8 Weeks)||15
8586743|NCT00264290|9621158|FG001|COMPLETED|Intervention (8 Weeks)||14
8586744|NCT00264290|9621157|FG000|NOT COMPLETED|Intervention (8 Weeks)||1
8586745|NCT00264290|9621158|FG001|NOT COMPLETED|Intervention (8 Weeks)||0
8586746|NCT00264290|9621157|FG000|STARTED|Observation (4 Weeks)||15
8586747|NCT00264290|9621158|FG001|STARTED|Observation (4 Weeks)||14
8586748|NCT00264290|9621157|FG000|COMPLETED|Observation (4 Weeks)||15
8586749|NCT00264290|9621158|FG001|COMPLETED|Observation (4 Weeks)||14
8586750|NCT00264290|9621157|FG000|NOT COMPLETED|Observation (4 Weeks)||0
8586751|NCT00264290|9621158|FG001|NOT COMPLETED|Observation (4 Weeks)||0
8586752|NCT00264303|9621170|FG000|STARTED|Overall Study||438
8586753|NCT00264303|9621171|FG001|STARTED|Overall Study||448
8586754|NCT00264303|9621170|FG000|COMPLETED|Overall Study||413
8586755|NCT00264303|9621171|FG001|COMPLETED|Overall Study||419
8586756|NCT00264303|9621170|FG000|NOT COMPLETED|Overall Study||25
8586757|NCT00264303|9621171|FG001|NOT COMPLETED|Overall Study||29
8586758|NCT00264381|9621179|FG000|STARTED|Overall Study||35
8586759|NCT00264381|9621180|FG001|STARTED|Overall Study||37
8586760|NCT00264381|9621179|FG000|COMPLETED|Overall Study||35
8586761|NCT00264381|9621180|FG001|COMPLETED|Overall Study||37
8586762|NCT00264381|9621179|FG000|NOT COMPLETED|Overall Study||0
8586763|NCT00264381|9621180|FG001|NOT COMPLETED|Overall Study||0
8586764|NCT00264498|9621188|FG000|STARTED|Randomized Treatment||17
8586765|NCT00264498|9621189|FG001|STARTED|Randomized Treatment||18
8586766|NCT00264498|9621188|FG000|COMPLETED|Randomized Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
8586767|NCT00264498|9621189|FG001|COMPLETED|Randomized Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
8586768|NCT00264498|9621188|FG000|NOT COMPLETED|Randomized Treatment||17
8586769|NCT00264498|9621189|FG001|NOT COMPLETED|Randomized Treatment||18
8586770|NCT00264498|9621188|FG000|STARTED|Crossover Treatment||6
8586771|NCT00264498|9621189|FG001|STARTED|Crossover Treatment||9
8586772|NCT00264498|9621188|FG000|COMPLETED|Crossover Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
8586773|NCT00264498|9621189|FG001|COMPLETED|Crossover Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
8586774|NCT00264498|9621188|FG000|NOT COMPLETED|Crossover Treatment||6
8710554|NCT00958282|9756876|FG000|STARTED|Overall Study||22
8710555|NCT00958282|9756877|FG001|STARTED|Overall Study||21
8710556|NCT00958282|9756876|FG000|COMPLETED|Overall Study||12
8710557|NCT00958282|9756877|FG001|COMPLETED|Overall Study||15
8710558|NCT00958282|9756876|FG000|NOT COMPLETED|Overall Study||10
8710559|NCT00958282|9756877|FG001|NOT COMPLETED|Overall Study||6
8710560|NCT00958308|9756886|FG000|STARTED|Overall Study||84
8710561|NCT00958308|9756887|FG001|STARTED|Overall Study||85
8710562|NCT00958308|9756888|FG002|STARTED|Overall Study||86
8710563|NCT00958308|9756886|FG000|COMPLETED|Overall Study||84
8710564|NCT00958308|9756887|FG001|COMPLETED|Overall Study||85
8710565|NCT00958308|9756888|FG002|COMPLETED|Overall Study||86
8710566|NCT00958308|9756886|FG000|NOT COMPLETED|Overall Study||0
8710567|NCT00958308|9756887|FG001|NOT COMPLETED|Overall Study||0
8710568|NCT00958308|9756888|FG002|NOT COMPLETED|Overall Study||0
8710569|NCT00958334|9756899|FG000|STARTED|Overall Study||22
8710570|NCT00958334|9756900|FG001|STARTED|Overall Study||22
8710571|NCT00958334|9756901|FG002|STARTED|Overall Study||21
8710572|NCT00958334|9756899|FG000|COMPLETED|Overall Study||8
8710573|NCT00958334|9756900|FG001|COMPLETED|Overall Study||5
8710574|NCT00958334|9756901|FG002|COMPLETED|Overall Study||8
8710575|NCT00958334|9756899|FG000|NOT COMPLETED|Overall Study||14
8710576|NCT00958334|9756900|FG001|NOT COMPLETED|Overall Study||17
8710577|NCT00958334|9756901|FG002|NOT COMPLETED|Overall Study||13
8710578|NCT00958360|9756911|FG000|STARTED|Overall Study||163
8710579|NCT00958360|9756912|FG001|STARTED|Overall Study||160
8710580|NCT00958360|9756911|FG000|COMPLETED|Overall Study||152
8710581|NCT00958360|9756912|FG001|COMPLETED|Overall Study||150
8710582|NCT00958360|9756911|FG000|NOT COMPLETED|Overall Study||11
8710583|NCT00958360|9756912|FG001|NOT COMPLETED|Overall Study||10
8710584|NCT00958412|9756918|FG000|STARTED|Overall Study||18
8710585|NCT00958412|9756918|FG000|COMPLETED|Overall Study||0
8710586|NCT00958412|9756918|FG000|NOT COMPLETED|Overall Study||18
8710587|NCT00958438|9756925|FG000|STARTED|Overall Study||82
8710588|NCT00958438|9756926|FG001|STARTED|Overall Study||82
8710589|NCT00958438|9756927|FG002|STARTED|Overall Study||84
8710590|NCT00958438|9756925|FG000|COMPLETED|Overall Study||72
8710591|NCT00958438|9756926|FG001|COMPLETED|Overall Study||72
8710592|NCT00958438|9756927|FG002|COMPLETED|Overall Study||78
8710593|NCT00958438|9756925|FG000|NOT COMPLETED|Overall Study||10
8710594|NCT00958438|9756926|FG001|NOT COMPLETED|Overall Study||10
8710595|NCT00958438|9756927|FG002|NOT COMPLETED|Overall Study||6
8710596|NCT00958477|9756939|FG000|STARTED|Overall Study||8
8586775|NCT00264498|9621189|FG001|NOT COMPLETED|Crossover Treatment||9
8586776|NCT00264537|9621199|FG000|STARTED|Overall Study||160
8586777|NCT00264537|9621200|FG001|STARTED|Overall Study||159
8586778|NCT00264537|9621201|FG002|STARTED|Overall Study||159
8710597|NCT00958477|9756940|FG001|STARTED|Overall Study||6
8710598|NCT00958477|9756941|FG002|STARTED|Overall Study||6
8710599|NCT00958477|9756942|FG003|STARTED|Overall Study||6
8710600|NCT00958477|9756939|FG000|COMPLETED|Overall Study||8
8586779|NCT00264537|9621202|FG003|STARTED|Overall Study||159
8586780|NCT00264537|9621199|FG000|COMPLETED|Overall Study||110
8586781|NCT00264537|9621200|FG001|COMPLETED|Overall Study||101
8586782|NCT00264537|9621201|FG002|COMPLETED|Overall Study||109
8586783|NCT00264537|9621202|FG003|COMPLETED|Overall Study||99
8586784|NCT00264537|9621199|FG000|NOT COMPLETED|Overall Study||50
8586785|NCT00264537|9621200|FG001|NOT COMPLETED|Overall Study||58
8586786|NCT00264537|9621201|FG002|NOT COMPLETED|Overall Study||50
8586787|NCT00264537|9621202|FG003|NOT COMPLETED|Overall Study||60
8586788|NCT00264550|9621218|FG000|STARTED|Overall Study||133
8586789|NCT00264550|9621219|FG001|STARTED|Overall Study||133
8586790|NCT00264550|9621220|FG002|STARTED|Overall Study||89
8586791|NCT00264550|9621221|FG003|STARTED|Overall Study||89
8586792|NCT00264550|9621218|FG000|COMPLETED|Overall Study||90
8586793|NCT00264550|9621219|FG001|COMPLETED|Overall Study||92
8586794|NCT00264550|9621220|FG002|COMPLETED|Overall Study||72
8586795|NCT00264550|9621221|FG003|COMPLETED|Overall Study||59
8586796|NCT00264550|9621218|FG000|NOT COMPLETED|Overall Study||43
8586797|NCT00264550|9621219|FG001|NOT COMPLETED|Overall Study||41
8586798|NCT00264550|9621220|FG002|NOT COMPLETED|Overall Study||17
8586799|NCT00264550|9621221|FG003|NOT COMPLETED|Overall Study||30
8586800|NCT00264576|9621233|FG000|STARTED|Overall Study||308
8586801|NCT00264576|9621234|FG001|STARTED|Overall Study||305
8586802|NCT00264576|9621233|FG000|COMPLETED|Overall Study||307
8586803|NCT00264576|9621234|FG001|COMPLETED|Overall Study||304
8586804|NCT00264576|9621233|FG000|NOT COMPLETED|Overall Study||1
8586805|NCT00264576|9621234|FG001|NOT COMPLETED|Overall Study||1
8586806|NCT00264641|9621243|FG000|STARTED|Overall Study||10
8586807|NCT00264641|9621244|FG001|STARTED|Overall Study||10
8586808|NCT00264641|9621243|FG000|Initiation of the Study|Overall Study||10
8586809|NCT00264641|9621244|FG001|Initiation of the Study|Overall Study||10
8586810|NCT00264641|9621243|FG000|COMPLETED|Overall Study||10
8586811|NCT00264641|9621244|FG001|COMPLETED|Overall Study||10
8586812|NCT00264641|9621243|FG000|NOT COMPLETED|Overall Study||0
8586813|NCT00264641|9621244|FG001|NOT COMPLETED|Overall Study||0
8586814|NCT00264797|9621251|FG000|STARTED|Overall Study||151
8586815|NCT00264797|9621252|FG001|STARTED|Overall Study||152
8710601|NCT00958477|9756940|FG001|COMPLETED|Overall Study||6
8710602|NCT00958477|9756941|FG002|COMPLETED|Overall Study||6
8710603|NCT00958477|9756942|FG003|COMPLETED|Overall Study||6
8710604|NCT00958477|9756939|FG000|NOT COMPLETED|Overall Study||0
8710605|NCT00958477|9756940|FG001|NOT COMPLETED|Overall Study||0
8710606|NCT00958477|9756941|FG002|NOT COMPLETED|Overall Study||0
8710607|NCT00958477|9756942|FG003|NOT COMPLETED|Overall Study||0
8710608|NCT00958568|9756958|FG000|STARTED|SPII (Wk 0-8, Acute Open-label)||892
8710609|NCT00958568|9756959|FG001|STARTED|SPII (Wk 0-8, Acute Open-label)||0
8710610|NCT00958568|9756960|FG002|STARTED|SPII (Wk 0-8, Acute Open-label)||0
8710611|NCT00958568|9756961|FG003|STARTED|SPII (Wk 0-8, Acute Open-label)||0
8710612|NCT00958568|9756958|FG000|COMPLETED|SPII (Wk 0-8, Acute Open-label)||655
8710613|NCT00958568|9756959|FG001|COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
8710614|NCT00958568|9756960|FG002|COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
8710615|NCT00958568|9756961|FG003|COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
8710616|NCT00958568|9756958|FG000|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||237
8710617|NCT00958568|9756959|FG001|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
8710618|NCT00958568|9756960|FG002|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
8710619|NCT00958568|9756961|FG003|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
8710620|NCT00958568|9756958|FG000|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||0
8710621|NCT00958568|9756959|FG001|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||655
8710622|NCT00958568|9756960|FG002|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||0
8710623|NCT00958568|9756961|FG003|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||0
8710624|NCT00958568|9756958|FG000|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
8710625|NCT00958568|9756959|FG001|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||444
8710626|NCT00958568|9756960|FG002|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
8586816|NCT00264797|9621251|FG000|COMPLETED|Overall Study||118
8586817|NCT00264797|9621252|FG001|COMPLETED|Overall Study||109
8586818|NCT00264797|9621251|FG000|NOT COMPLETED|Overall Study||33
8586819|NCT00264797|9621252|FG001|NOT COMPLETED|Overall Study||43
8586820|NCT00264810|9621260|FG000|STARTED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|120
8586821|NCT00264810|9621261|FG001|STARTED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|120
8586822|NCT00264810|9621260|FG000|COMPLETED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|97
8627832|NCT00519428|9667200|FG000|STARTED|Overall Study||78
8627833|NCT00519428|9667201|FG001|STARTED|Overall Study||84
8627834|NCT00519428|9667202|FG002|STARTED|Overall Study||83
8627835|NCT00519428|9667200|FG000|COMPLETED|Overall Study||57
8627836|NCT00519428|9667201|FG001|COMPLETED|Overall Study||69
8627837|NCT00519428|9667202|FG002|COMPLETED|Overall Study||58
8627838|NCT00519428|9667200|FG000|NOT COMPLETED|Overall Study||21
8627839|NCT00519428|9667201|FG001|NOT COMPLETED|Overall Study||15
8627840|NCT00519428|9667202|FG002|NOT COMPLETED|Overall Study||25
8627841|NCT00519532|9667213|FG000|STARTED|Overall Study||84
8627842|NCT00519532|9667213|FG000|COMPLETED|Overall Study||66
8627843|NCT00519532|9667213|FG000|NOT COMPLETED|Overall Study||18
8627844|NCT00519584|9667221|FG000|STARTED|Overall Study||54
8627845|NCT00519584|9667222|FG001|STARTED|Overall Study||54
8627846|NCT00519584|9667223|FG002|STARTED|Overall Study||54
8586823|NCT00264810|9621261|FG001|COMPLETED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|94
8586824|NCT00264810|9621260|FG000|NOT COMPLETED|Baseline||23
8586825|NCT00264810|9621261|FG001|NOT COMPLETED|Baseline||26
8586826|NCT00264810|9621260|FG000|STARTED|Post-Operative Stabilization Period|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|97
8586827|NCT00264810|9621261|FG001|STARTED|Post-Operative Stabilization Period|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|94
8586828|NCT00264810|9621260|FG000|COMPLETED|Post-Operative Stabilization Period||97
8586829|NCT00264810|9621261|FG001|COMPLETED|Post-Operative Stabilization Period||94
8586830|NCT00264810|9621260|FG000|NOT COMPLETED|Post-Operative Stabilization Period||0
8586831|NCT00264810|9621261|FG001|NOT COMPLETED|Post-Operative Stabilization Period||0
8586832|NCT00264810|9621260|FG000|STARTED|Stimulation Optimization Period||97
8586833|NCT00264810|9621261|FG001|STARTED|Stimulation Optimization Period||94
8586834|NCT00264810|9621260|FG000|COMPLETED|Stimulation Optimization Period||96
8586835|NCT00264810|9621261|FG001|COMPLETED|Stimulation Optimization Period||93
8586836|NCT00264810|9621260|FG000|NOT COMPLETED|Stimulation Optimization Period||1
8586837|NCT00264810|9621261|FG001|NOT COMPLETED|Stimulation Optimization Period||1
8586838|NCT00264810|9621260|FG000|STARTED|Blinded Evaluation Period||96
8586839|NCT00264810|9621261|FG001|STARTED|Blinded Evaluation Period||93
8586840|NCT00264810|9621260|FG000|COMPLETED|Blinded Evaluation Period||95
8586841|NCT00264810|9621261|FG001|COMPLETED|Blinded Evaluation Period||92
8586842|NCT00264810|9621260|FG000|NOT COMPLETED|Blinded Evaluation Period||1
8586843|NCT00264810|9621261|FG001|NOT COMPLETED|Blinded Evaluation Period||1
8586844|NCT00264810|9621260|FG000|STARTED|Open Label Evaluation Period||95
8586845|NCT00264810|9621261|FG001|STARTED|Open Label Evaluation Period||92
8586846|NCT00264810|9621260|FG000|1-year Post-implant|Open Label Evaluation Period||92
8586847|NCT00264810|9621261|FG001|1-year Post-implant|Open Label Evaluation Period||90
8586848|NCT00264810|9621260|FG000|COMPLETED|Open Label Evaluation Period||89
8586849|NCT00264810|9621261|FG001|COMPLETED|Open Label Evaluation Period||86
8586850|NCT00264810|9621260|FG000|NOT COMPLETED|Open Label Evaluation Period||6
8586851|NCT00264810|9621261|FG001|NOT COMPLETED|Open Label Evaluation Period||6
8586852|NCT00264849|9621271|FG000|STARTED|Overall Study||275
8586853|NCT00264849|9621272|FG001|STARTED|Overall Study||131
8586854|NCT00264849|9621271|FG000|COMPLETED|Overall Study||253
8586855|NCT00264849|9621272|FG001|COMPLETED|Overall Study||106
8586856|NCT00264849|9621271|FG000|NOT COMPLETED|Overall Study||22
8586857|NCT00264849|9621272|FG001|NOT COMPLETED|Overall Study||25
8586858|NCT00264875|9621278|FG000|STARTED|Overall Study||220
8586859|NCT00264875|9621278|FG000|COMPLETED|Overall Study||190
8586860|NCT00264875|9621278|FG000|NOT COMPLETED|Overall Study||30
8586861|NCT00265083|9621285|FG000|STARTED|Overall Study||78
8586862|NCT00265083|9621286|FG001|STARTED|Overall Study|One patient did not receive study agent.|138
8586863|NCT00265083|9621287|FG002|STARTED|Overall Study||140
8586864|NCT00265083|9621285|FG000|COMPLETED|Overall Study||61
8586865|NCT00265083|9621286|FG001|COMPLETED|Overall Study|One patient did not receive study agent.|96
8586866|NCT00265083|9621287|FG002|COMPLETED|Overall Study||98
8586867|NCT00265083|9621285|FG000|NOT COMPLETED|Overall Study||17
8586868|NCT00265083|9621286|FG001|NOT COMPLETED|Overall Study||42
8586869|NCT00265083|9621287|FG002|NOT COMPLETED|Overall Study||42
8586870|NCT00265096|9621299|FG000|STARTED|Overall Study||113
8586871|NCT00265096|9621300|FG001|STARTED|Overall Study||146
8586872|NCT00265096|9621301|FG002|STARTED|Overall Study||146
8586873|NCT00265096|9621299|FG000|COMPLETED|Overall Study|Indicates number of patients that were continuing SC study agent at Wk 24|77
8586874|NCT00265096|9621300|FG001|COMPLETED|Overall Study|Indicates number of patients that were continuing SC study agent at Wk 24|95
8586875|NCT00265096|9621301|FG002|COMPLETED|Overall Study|Indicates number of patients that were continuing SC study agent at Wk 24|107
8586876|NCT00265096|9621299|FG000|NOT COMPLETED|Overall Study||36
8586877|NCT00265096|9621300|FG001|NOT COMPLETED|Overall Study||51
8586878|NCT00265096|9621301|FG002|NOT COMPLETED|Overall Study||39
8586879|NCT00265109|9621311|FG000|STARTED|Overall Study||17
8586880|NCT00265109|9621311|FG000|COMPLETED|Overall Study||11
8586881|NCT00265109|9621311|FG000|NOT COMPLETED|Overall Study||6
8586882|NCT00265122|9621322|FG000|STARTED|Intervention Period 1 (Weeks 0 to 8):||26
8586883|NCT00265122|9621323|FG001|STARTED|Intervention Period 1 (Weeks 0 to 8):||25
8586884|NCT00265122|9621324|FG002|STARTED|Intervention Period 1 (Weeks 0 to 8):||27
8586885|NCT00265122|9621325|FG003|STARTED|Intervention Period 1 (Weeks 0 to 8):||26
8586886|NCT00265122|9621326|FG004|STARTED|Intervention Period 1 (Weeks 0 to 8):||14
8586887|NCT00265122|9621327|FG005|STARTED|Intervention Period 1 (Weeks 0 to 8):||13
8586888|NCT00265122|9621322|FG000|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||24
8586889|NCT00265122|9621323|FG001|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||23
8586890|NCT00265122|9621324|FG002|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||22
8710627|NCT00958568|9756961|FG003|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
8710628|NCT00958568|9756958|FG000|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
8710629|NCT00958568|9756959|FG001|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||211
8710630|NCT00958568|9756960|FG002|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
8710631|NCT00958568|9756961|FG003|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
8710632|NCT00958568|9756958|FG000|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||0
8710633|NCT00958568|9756959|FG001|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||0
8586891|NCT00265122|9621325|FG003|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||24
8586892|NCT00265122|9621326|FG004|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||13
8586893|NCT00265122|9621327|FG005|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||13
8586894|NCT00265122|9621322|FG000|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||2
8586895|NCT00265122|9621323|FG001|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||2
8586896|NCT00265122|9621324|FG002|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||5
8586897|NCT00265122|9621325|FG003|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||2
8586898|NCT00265122|9621326|FG004|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||1
8586899|NCT00265122|9621327|FG005|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||0
8586900|NCT00265122|9621322|FG000|STARTED|Intervention Period 2 (Weeks 8 to 28):||24
8586901|NCT00265122|9621323|FG001|STARTED|Intervention Period 2 (Weeks 8 to 28):||23
8586902|NCT00265122|9621324|FG002|STARTED|Intervention Period 2 (Weeks 8 to 28):||22
8586903|NCT00265122|9621325|FG003|STARTED|Intervention Period 2 (Weeks 8 to 28):||24
8586904|NCT00265122|9621326|FG004|STARTED|Intervention Period 2 (Weeks 8 to 28):||13
8586905|NCT00265122|9621327|FG005|STARTED|Intervention Period 2 (Weeks 8 to 28):||13
8586906|NCT00265122|9621322|FG000|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||17
8586907|NCT00265122|9621323|FG001|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||22
8586908|NCT00265122|9621324|FG002|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||18
8586909|NCT00265122|9621325|FG003|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||20
8586910|NCT00265122|9621326|FG004|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||8
8586911|NCT00265122|9621327|FG005|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||12
8586912|NCT00265122|9621322|FG000|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||7
8586913|NCT00265122|9621323|FG001|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||1
8586914|NCT00265122|9621324|FG002|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||4
8586915|NCT00265122|9621325|FG003|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||4
8586916|NCT00265122|9621326|FG004|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||5
8586917|NCT00265122|9621327|FG005|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||1
8586918|NCT00265148|9621348|FG000|STARTED|Overall Study||40
8586919|NCT00265148|9621349|FG001|STARTED|Overall Study||40
8586920|NCT00265148|9621348|FG000|COMPLETED|Overall Study||31
8586921|NCT00265148|9621349|FG001|COMPLETED|Overall Study||31
8586922|NCT00265148|9621348|FG000|NOT COMPLETED|Overall Study||9
8586923|NCT00265148|9621349|FG001|NOT COMPLETED|Overall Study||9
8586924|NCT00265200|9621356|FG000|STARTED|Overall Study||28
8586925|NCT00265200|9621356|FG000|COMPLETED|Overall Study||24
8586926|NCT00265200|9621356|FG000|NOT COMPLETED|Overall Study||4
8586927|NCT00265239|9621362|FG000|STARTED|Overall Study||52
8586928|NCT00265239|9621363|FG001|STARTED|Overall Study||52
8586929|NCT00265239|9621362|FG000|COMPLETED|Overall Study||50
8586930|NCT00265239|9621363|FG001|COMPLETED|Overall Study||51
8586931|NCT00265239|9621362|FG000|NOT COMPLETED|Overall Study||2
8586932|NCT00265239|9621363|FG001|NOT COMPLETED|Overall Study||1
8586933|NCT00265317|9621373|FG000|STARTED|Lead-In||13
8586934|NCT00265317|9621374|FG001|STARTED|Lead-In||17
8710634|NCT00958568|9756960|FG002|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||221
8710635|NCT00958568|9756961|FG003|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||223
8710636|NCT00958568|9756958|FG000|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
8710637|NCT00958568|9756959|FG001|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
8710638|NCT00958568|9756960|FG002|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||139
8710639|NCT00958568|9756961|FG003|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||117
8710640|NCT00958568|9756958|FG000|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
8710641|NCT00958568|9756959|FG001|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
8710642|NCT00958568|9756960|FG002|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||82
8710643|NCT00958568|9756961|FG003|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||106
8710644|NCT00958581|9756975|FG000|STARTED|Overall Study||61
8710645|NCT00958581|9756976|FG001|STARTED|Overall Study||61
8710646|NCT00958581|9756977|FG002|STARTED|Overall Study||55
8710647|NCT00958581|9756975|FG000|COMPLETED|Overall Study||61
8710648|NCT00958581|9756976|FG001|COMPLETED|Overall Study||61
8710649|NCT00958581|9756977|FG002|COMPLETED|Overall Study||55
8710650|NCT00958581|9756975|FG000|NOT COMPLETED|Overall Study||0
8710651|NCT00958581|9756976|FG001|NOT COMPLETED|Overall Study||0
8710652|NCT00958581|9756977|FG002|NOT COMPLETED|Overall Study||0
8710653|NCT00958711|9756990|FG000|STARTED|Overall Study||42
8710654|NCT00958711|9756991|FG001|STARTED|Overall Study||48
8710655|NCT00958711|9756990|FG000|COMPLETED|Overall Study||29
9064241|NCT04322682|10124509|FG001|NOT COMPLETED|Overall Study||64
9064242|NCT04321980|10124517|FG000|STARTED|Overall Study||4
9064243|NCT04321980|10124518|FG001|STARTED|Overall Study||4
9064244|NCT04321980|10124517|FG000|COMPLETED|Overall Study||4
9064245|NCT04321980|10124518|FG001|COMPLETED|Overall Study||4
9064246|NCT04321980|10124517|FG000|NOT COMPLETED|Overall Study||0
9064247|NCT04321980|10124518|FG001|NOT COMPLETED|Overall Study||0
9064248|NCT04322396|10124526|FG000|STARTED|Overall Study||56
9064249|NCT04322396|10124527|FG001|STARTED|Overall Study||61
8710656|NCT00958711|9756991|FG001|COMPLETED|Overall Study||27
8710657|NCT00958711|9756990|FG000|NOT COMPLETED|Overall Study||13
8710658|NCT00958711|9756991|FG001|NOT COMPLETED|Overall Study||21
8710659|NCT00958724|9756997|FG000|STARTED|Overall Study||6
9064250|NCT04322396|10124526|FG000|COMPLETED|Overall Study||56
9064251|NCT04322396|10124527|FG001|COMPLETED|Overall Study||61
8586935|NCT00265317|9621375|FG002|STARTED|Lead-In||0
8586936|NCT00265317|9621376|FG003|STARTED|Lead-In||0
8710660|NCT00958724|9756997|FG000|COMPLETED|Overall Study||0
8710661|NCT00958724|9756997|FG000|NOT COMPLETED|Overall Study||6
8710662|NCT00958776|9757003|FG000|STARTED|Overall Study||137
8586937|NCT00265317|9621373|FG000|COMPLETED|Lead-In||1
8586938|NCT00265317|9621374|FG001|COMPLETED|Lead-In||0
8586939|NCT00265317|9621375|FG002|COMPLETED|Lead-In||0
8586940|NCT00265317|9621376|FG003|COMPLETED|Lead-In||0
8586941|NCT00265317|9621373|FG000|NOT COMPLETED|Lead-In||12
8586942|NCT00265317|9621374|FG001|NOT COMPLETED|Lead-In||17
8586943|NCT00265317|9621375|FG002|NOT COMPLETED|Lead-In||0
8586944|NCT00265317|9621376|FG003|NOT COMPLETED|Lead-In||0
8586945|NCT00265317|9621373|FG000|STARTED|Phase 2||0
8586946|NCT00265317|9621374|FG001|STARTED|Phase 2||0
8586947|NCT00265317|9621375|FG002|STARTED|Phase 2||65
8586948|NCT00265317|9621376|FG003|STARTED|Phase 2||67
8586949|NCT00265317|9621373|FG000|COMPLETED|Phase 2||0
8586950|NCT00265317|9621374|FG001|COMPLETED|Phase 2||0
8586951|NCT00265317|9621375|FG002|COMPLETED|Phase 2||1
8586952|NCT00265317|9621376|FG003|COMPLETED|Phase 2||2
8586953|NCT00265317|9621373|FG000|NOT COMPLETED|Phase 2||0
8586954|NCT00265317|9621374|FG001|NOT COMPLETED|Phase 2||0
8586955|NCT00265317|9621375|FG002|NOT COMPLETED|Phase 2||64
8586956|NCT00265317|9621376|FG003|NOT COMPLETED|Phase 2||65
8710663|NCT00958776|9757004|FG001|STARTED|Overall Study||268
8710664|NCT00958776|9757003|FG000|COMPLETED|Overall Study||121
8710665|NCT00958776|9757004|FG001|COMPLETED|Overall Study||239
8710666|NCT00958776|9757003|FG000|NOT COMPLETED|Overall Study||16
8710667|NCT00958776|9757004|FG001|NOT COMPLETED|Overall Study||29
8710668|NCT00958789|9757011|FG000|STARTED|Overall Study||180
8710669|NCT00958789|9757011|FG000|COMPLETED|Overall Study|Participant status at the 2 year primary outcome interval determined Completed/Not Completed counts.|130
8710670|NCT00958789|9757011|FG000|NOT COMPLETED|Overall Study||50
8710671|NCT00958828|9757020|FG000|STARTED|Period 1, 1 Week of Wear||89
8710672|NCT00958828|9757021|FG001|STARTED|Period 1, 1 Week of Wear||89
8710673|NCT00958828|9757020|FG000|COMPLETED|Period 1, 1 Week of Wear||89
8710674|NCT00958828|9757021|FG001|COMPLETED|Period 1, 1 Week of Wear||88
8710675|NCT00958828|9757020|FG000|NOT COMPLETED|Period 1, 1 Week of Wear||0
8710676|NCT00958828|9757021|FG001|NOT COMPLETED|Period 1, 1 Week of Wear||1
8710677|NCT00958828|9757020|FG000|STARTED|Period 2, 1 Week of Wear||89
8710678|NCT00958828|9757021|FG001|STARTED|Period 2, 1 Week of Wear||88
8710679|NCT00958828|9757020|FG000|COMPLETED|Period 2, 1 Week of Wear||89
8710680|NCT00958828|9757021|FG001|COMPLETED|Period 2, 1 Week of Wear||87
8710681|NCT00958828|9757020|FG000|NOT COMPLETED|Period 2, 1 Week of Wear||0
8710682|NCT00958828|9757021|FG001|NOT COMPLETED|Period 2, 1 Week of Wear||1
8710683|NCT00958841|9757027|FG000|STARTED|Overall Study||118
8710684|NCT00958841|9757027|FG000|Completed Month 6 (M6)|Overall Study||90
8710685|NCT00958841|9757027|FG000|Entered in Extension|Overall Study||63
8710686|NCT00958841|9757027|FG000|COMPLETED|Overall Study|Completed = Completed extension|22
8710687|NCT00958841|9757027|FG000|NOT COMPLETED|Overall Study||96
8710688|NCT00958880|9757043|FG000|STARTED|Overall Study||20
8710689|NCT00958880|9757044|FG001|STARTED|Overall Study||20
8710690|NCT00958880|9757043|FG000|COMPLETED|Overall Study||18
8710691|NCT00958880|9757044|FG001|COMPLETED|Overall Study||18
8710692|NCT00958880|9757043|FG000|NOT COMPLETED|Overall Study||2
8710693|NCT00958880|9757044|FG001|NOT COMPLETED|Overall Study||2
8710694|NCT00958919|9757050|FG000|STARTED|First Intervention||7
8710695|NCT00958919|9757051|FG001|STARTED|First Intervention||7
8586957|NCT00265330|9621395|FG000|STARTED|Overall Study||162
8586958|NCT00265330|9621395|FG000|COMPLETED|Overall Study||67
8586959|NCT00265330|9621395|FG000|NOT COMPLETED|Overall Study||95
8586960|NCT00265382|9621399|FG000|STARTED|Overall Study||221
8586961|NCT00265382|9621399|FG000|COMPLETED|Overall Study||76
8586962|NCT00265382|9621399|FG000|NOT COMPLETED|Overall Study||145
8586963|NCT00265395|9621405|FG000|STARTED|Overall Study||86
8586964|NCT00265395|9621406|FG001|STARTED|Overall Study||73
8586965|NCT00265395|9621405|FG000|COMPLETED|Overall Study||78
8586966|NCT00265395|9621406|FG001|COMPLETED|Overall Study||56
8710696|NCT00958919|9757050|FG000|COMPLETED|First Intervention||7
8710697|NCT00958919|9757051|FG001|COMPLETED|First Intervention||7
8710698|NCT00958919|9757050|FG000|NOT COMPLETED|First Intervention||0
8710699|NCT00958919|9757051|FG001|NOT COMPLETED|First Intervention||0
8710700|NCT00958919|9757050|FG000|STARTED|Second Intervention||7
8710701|NCT00958919|9757051|FG001|STARTED|Second Intervention||7
8710702|NCT00958919|9757050|FG000|COMPLETED|Second Intervention||7
8710703|NCT00958919|9757051|FG001|COMPLETED|Second Intervention||7
8710704|NCT00958919|9757050|FG000|NOT COMPLETED|Second Intervention||0
8710705|NCT00958919|9757051|FG001|NOT COMPLETED|Second Intervention||0
8710706|NCT00959049|9757070|FG000|STARTED|Overall Study||231
8710707|NCT00959049|9757071|FG001|STARTED|Overall Study||254
8710708|NCT00959049|9757072|FG002|STARTED|Overall Study||254
8710709|NCT00959049|9757073|FG003|STARTED|Overall Study||228
8710710|NCT00959049|9757074|FG004|STARTED|Overall Study||257
8710711|NCT00959049|9757075|FG005|STARTED|Overall Study||250
8710712|NCT00959049|9757070|FG000|COMPLETED|Overall Study||213
8586967|NCT00265395|9621405|FG000|NOT COMPLETED|Overall Study||8
8586968|NCT00265395|9621406|FG001|NOT COMPLETED|Overall Study||17
8586969|NCT00265473|9621411|FG000|STARTED|Overall Study||5
8586970|NCT00265473|9621411|FG000|COMPLETED|Overall Study||5
8586971|NCT00265473|9621411|FG000|NOT COMPLETED|Overall Study||0
8586972|NCT00265512|9621418|FG000|STARTED|Overall Study||213
8586973|NCT00265512|9621419|FG001|STARTED|Overall Study||454
8586974|NCT00265512|9621418|FG000|COMPLETED|Overall Study||168
8586975|NCT00265512|9621419|FG001|COMPLETED|Overall Study||359
8586976|NCT00265512|9621418|FG000|NOT COMPLETED|Overall Study||45
8586977|NCT00265512|9621419|FG001|NOT COMPLETED|Overall Study||95
8586978|NCT00265538|9621427|FG000|STARTED|Overall Study||196
8586979|NCT00265538|9621428|FG001|STARTED|Overall Study||170
8586980|NCT00265538|9621429|FG002|STARTED|Overall Study||182
8586981|NCT00265538|9621430|FG003|STARTED|Overall Study||286
8586982|NCT00265538|9621427|FG000|COMPLETED|Overall Study||186
8586983|NCT00265538|9621428|FG001|COMPLETED|Overall Study||161
8586984|NCT00265538|9621429|FG002|COMPLETED|Overall Study||171
8586985|NCT00265538|9621430|FG003|COMPLETED|Overall Study||267
8586986|NCT00265538|9621427|FG000|NOT COMPLETED|Overall Study||10
8586987|NCT00265538|9621428|FG001|NOT COMPLETED|Overall Study||9
8586988|NCT00265538|9621429|FG002|NOT COMPLETED|Overall Study||11
8586989|NCT00265538|9621430|FG003|NOT COMPLETED|Overall Study||19
8586990|NCT00265564|9621444|FG000|STARTED|Overall Study||59
8586991|NCT00265564|9621445|FG001|STARTED|Overall Study||58
8586992|NCT00265564|9621444|FG000|COMPLETED|Overall Study||49
8586993|NCT00265564|9621445|FG001|COMPLETED|Overall Study||49
8586994|NCT00265564|9621444|FG000|NOT COMPLETED|Overall Study||10
8586995|NCT00265564|9621445|FG001|NOT COMPLETED|Overall Study||9
8586996|NCT00265616|9621453|FG000|STARTED|Overall Study||14
8586997|NCT00265616|9621454|FG001|STARTED|Overall Study||9
8586998|NCT00265616|9621453|FG000|COMPLETED|Overall Study||14
8710713|NCT00959049|9757071|FG001|COMPLETED|Overall Study||247
8710714|NCT00959049|9757072|FG002|COMPLETED|Overall Study||253
8710715|NCT00959049|9757073|FG003|COMPLETED|Overall Study||217
8710716|NCT00959049|9757074|FG004|COMPLETED|Overall Study||248
8710717|NCT00959049|9757075|FG005|COMPLETED|Overall Study||249
8710718|NCT00959049|9757070|FG000|NOT COMPLETED|Overall Study||18
8710719|NCT00959049|9757071|FG001|NOT COMPLETED|Overall Study||7
8710720|NCT00959049|9757072|FG002|NOT COMPLETED|Overall Study||1
8710721|NCT00959049|9757073|FG003|NOT COMPLETED|Overall Study||11
8710722|NCT00959049|9757074|FG004|NOT COMPLETED|Overall Study||9
8710723|NCT00959049|9757075|FG005|NOT COMPLETED|Overall Study||1
8710724|NCT00959166|9757102|FG000|STARTED|Overall Study||24
8710725|NCT00959166|9757103|FG001|STARTED|Overall Study||57
8710726|NCT00959166|9757102|FG000|COMPLETED|Overall Study||24
8710727|NCT00959166|9757103|FG001|COMPLETED|Overall Study||57
8710728|NCT00959166|9757102|FG000|NOT COMPLETED|Overall Study||0
8710729|NCT00959166|9757103|FG001|NOT COMPLETED|Overall Study||0
8710730|NCT00959192|9757113|FG000|STARTED|Overall Study||6
8710731|NCT00959192|9757114|FG001|STARTED|Overall Study||9
8710732|NCT00959192|9757115|FG002|STARTED|Overall Study||9
8710733|NCT00959192|9757116|FG003|STARTED|Overall Study||8
8710734|NCT00959192|9757113|FG000|COMPLETED|Overall Study||4
8710735|NCT00959192|9757114|FG001|COMPLETED|Overall Study||8
8710736|NCT00959192|9757115|FG002|COMPLETED|Overall Study||6
8710737|NCT00959192|9757116|FG003|COMPLETED|Overall Study||7
8710738|NCT00959192|9757113|FG000|NOT COMPLETED|Overall Study||2
8710739|NCT00959192|9757114|FG001|NOT COMPLETED|Overall Study||1
8710740|NCT00959192|9757115|FG002|NOT COMPLETED|Overall Study||3
8710741|NCT00959192|9757116|FG003|NOT COMPLETED|Overall Study||1
8710742|NCT00959374|9757127|FG000|STARTED|Overall Study|Of the 241 enrolled subjects, 229 were randomized and treated|241
8710743|NCT00959374|9757127|FG000|COMPLETED|Overall Study||218
8710744|NCT00959374|9757127|FG000|NOT COMPLETED|Overall Study||23
8710745|NCT00959647|9757135|FG000|STARTED|Overall Study||19
8710746|NCT00959647|9757135|FG000|COMPLETED|Overall Study||0
8710747|NCT00959647|9757135|FG000|NOT COMPLETED|Overall Study||19
8710748|NCT00959660|9757143|FG000|STARTED|Overall Study||26
8710749|NCT00959660|9757144|FG001|STARTED|Overall Study||24
8710750|NCT00959660|9757145|FG002|STARTED|Overall Study||25
8710751|NCT00959660|9757146|FG003|STARTED|Overall Study||25
8710752|NCT00959660|9757143|FG000|COMPLETED|Overall Study||24
8710753|NCT00959660|9757144|FG001|COMPLETED|Overall Study||24
8710754|NCT00959660|9757145|FG002|COMPLETED|Overall Study||22
8710755|NCT00959660|9757146|FG003|COMPLETED|Overall Study||22
8710756|NCT00959660|9757143|FG000|NOT COMPLETED|Overall Study||2
8710757|NCT00959660|9757144|FG001|NOT COMPLETED|Overall Study||0
8710758|NCT00959660|9757145|FG002|NOT COMPLETED|Overall Study||3
8710759|NCT00959660|9757146|FG003|NOT COMPLETED|Overall Study||3
8710760|NCT00959699|9757158|FG000|STARTED|Treatment Period||34
8710761|NCT00959699|9757159|FG001|STARTED|Treatment Period||65
8710762|NCT00959699|9757158|FG000|Treated|Treatment Period||34
8710763|NCT00959699|9757159|FG001|Treated|Treatment Period||64
8710764|NCT00959699|9757158|FG000|COMPLETED|Treatment Period|At TW24, 4 participants not achieving undetectable HCV-RNA crossed-over and received boceprevir.|11
8710765|NCT00959699|9757159|FG001|COMPLETED|Treatment Period||40
8710766|NCT00959699|9757158|FG000|NOT COMPLETED|Treatment Period||23
8710767|NCT00959699|9757159|FG001|NOT COMPLETED|Treatment Period||25
8710768|NCT00959699|9757158|FG000|STARTED|Follow-up Period|1 participant didn't enter Follow-up; participants discontinuing treatment could enter Follow-up.|33
8813020|NCT01523613|9866134|FG002|COMPLETED|Overall Study|- 42 paired restorations (21R and 21F)|21
8813021|NCT01523613|9866132|FG000|NOT COMPLETED|Overall Study||7
8813022|NCT01523613|9866133|FG001|NOT COMPLETED|Overall Study||5
8813023|NCT01523613|9866134|FG002|NOT COMPLETED|Overall Study||12
8813024|NCT01523704|9866144|FG000|STARTED|Overall Study|January 2012|636
8813025|NCT01523704|9866145|FG001|STARTED|Overall Study|January 2012|638
8813026|NCT01523704|9866144|FG000|COMPLETED|Overall Study|February 2016 (Enrollment: as of October 2013)|558
8586999|NCT00265616|9621454|FG001|COMPLETED|Overall Study||9
8587000|NCT00265616|9621453|FG000|NOT COMPLETED|Overall Study||0
8587001|NCT00265616|9621454|FG001|NOT COMPLETED|Overall Study||0
8587002|NCT00265759|9621466|FG000|STARTED|Overall Study||124
8587003|NCT00265759|9621467|FG001|STARTED|Overall Study||128
8587004|NCT00265759|9621468|FG002|STARTED|Overall Study||125
8587005|NCT00265759|9621469|FG003|STARTED|Overall Study||245
8587006|NCT00265759|9621466|FG000|COMPLETED|Overall Study||124
8587007|NCT00265759|9621467|FG001|COMPLETED|Overall Study||127
8587008|NCT00265759|9621468|FG002|COMPLETED|Overall Study||123
8587009|NCT00265759|9621469|FG003|COMPLETED|Overall Study||236
8587010|NCT00265759|9621466|FG000|NOT COMPLETED|Overall Study||0
8587011|NCT00265759|9621467|FG001|NOT COMPLETED|Overall Study||1
8587012|NCT00265759|9621468|FG002|NOT COMPLETED|Overall Study||2
8587013|NCT00265759|9621469|FG003|NOT COMPLETED|Overall Study||9
8587014|NCT00265785|9621480|FG000|STARTED|Overall Study||27
8587015|NCT00265785|9621480|FG000|Eligible|Overall Study||26
8587016|NCT00265785|9621480|FG000|Eligible and Began Protocol Treatment|Overall Study||24
8587017|NCT00265785|9621480|FG000|COMPLETED|Overall Study||0
8587018|NCT00265785|9621480|FG000|NOT COMPLETED|Overall Study||27
8710769|NCT00959699|9757159|FG001|STARTED|Follow-up Period|2 participants didn't enter Follow-up; participants discontinuing treatment could enter Follow-up.|62
8710770|NCT00959699|9757158|FG000|COMPLETED|Follow-up Period||27
8710771|NCT00959699|9757159|FG001|COMPLETED|Follow-up Period||56
8710772|NCT00959699|9757158|FG000|NOT COMPLETED|Follow-up Period||6
8710773|NCT00959699|9757159|FG001|NOT COMPLETED|Follow-up Period||6
8710774|NCT00959751|9757168|FG000|STARTED|Overall Study||97
8710775|NCT00959751|9757169|FG001|STARTED|Overall Study||98
8710776|NCT00959751|9757168|FG000|COMPLETED|Overall Study||88
8710777|NCT00959751|9757169|FG001|COMPLETED|Overall Study||86
8710778|NCT00959751|9757168|FG000|NOT COMPLETED|Overall Study||9
8710779|NCT00959751|9757169|FG001|NOT COMPLETED|Overall Study||12
8710780|NCT00959764|9757178|FG000|STARTED|Overall Study||271
8710781|NCT00959764|9757179|FG001|STARTED|Overall Study||185
8710782|NCT00959764|9757180|FG002|STARTED|Overall Study||109
8710783|NCT00959764|9757178|FG000|COMPLETED|Overall Study||176
8710784|NCT00959764|9757179|FG001|COMPLETED|Overall Study||128
8710785|NCT00959764|9757180|FG002|COMPLETED|Overall Study||73
8710786|NCT00959764|9757178|FG000|NOT COMPLETED|Overall Study||95
8710787|NCT00959764|9757179|FG001|NOT COMPLETED|Overall Study||57
8710788|NCT00959764|9757180|FG002|NOT COMPLETED|Overall Study||36
8710789|NCT00959842|9757191|FG000|STARTED|Overall Study|17 were recruited and at baseline. 2 dropped out before starting the study drug. 15 finished|15
8710790|NCT00959842|9757191|FG000|COMPLETED|Overall Study||15
8710791|NCT00959842|9757191|FG000|NOT COMPLETED|Overall Study||0
8710792|NCT00959894|9757195|FG000|STARTED|Overall Study|One (1) additional subject became ineligible on the day of entry and never started study medication.|79
8710793|NCT00959894|9757195|FG000|COMPLETED|Overall Study||63
8710794|NCT00959894|9757195|FG000|NOT COMPLETED|Overall Study||16
8710795|NCT00959907|9757202|FG000|STARTED|Overall Study||30
8710796|NCT00959907|9757203|FG001|STARTED|Overall Study||29
8710797|NCT00959907|9757202|FG000|COMPLETED|Overall Study||27
8710798|NCT00959907|9757203|FG001|COMPLETED|Overall Study||28
8710799|NCT00959907|9757202|FG000|NOT COMPLETED|Overall Study||3
8710800|NCT00959907|9757203|FG001|NOT COMPLETED|Overall Study||1
8710801|NCT00959920|9757211|FG000|STARTED|Overall Study||72
8710802|NCT00959920|9757212|FG001|STARTED|Overall Study||67
8710803|NCT00959920|9757211|FG000|COMPLETED|Overall Study||72
8710804|NCT00959920|9757212|FG001|COMPLETED|Overall Study||66
8710805|NCT00959920|9757211|FG000|NOT COMPLETED|Overall Study||0
8710806|NCT00959920|9757212|FG001|NOT COMPLETED|Overall Study||1
8710807|NCT00959946|9757228|FG000|STARTED|Overall Study||2
8710808|NCT00959946|9757229|FG001|STARTED|Overall Study||4
8710809|NCT00959946|9757230|FG002|STARTED|Overall Study||4
8710810|NCT00959946|9757231|FG003|STARTED|Overall Study||5
8710811|NCT00959946|9757232|FG004|STARTED|Overall Study||4
8710812|NCT00959946|9757233|FG005|STARTED|Overall Study||9
8710813|NCT00959946|9757234|FG006|STARTED|Overall Study||2
8710814|NCT00959946|9757235|FG007|STARTED|Overall Study||2
8710815|NCT00959946|9757228|FG000|COMPLETED|Overall Study||0
8710816|NCT00959946|9757229|FG001|COMPLETED|Overall Study||0
8710817|NCT00959946|9757230|FG002|COMPLETED|Overall Study||0
8710818|NCT00959946|9757231|FG003|COMPLETED|Overall Study||0
8710819|NCT00959946|9757232|FG004|COMPLETED|Overall Study||0
8710820|NCT00959946|9757233|FG005|COMPLETED|Overall Study||0
8710821|NCT00959946|9757234|FG006|COMPLETED|Overall Study||0
8710822|NCT00959946|9757235|FG007|COMPLETED|Overall Study||0
8710823|NCT00959946|9757228|FG000|NOT COMPLETED|Overall Study||2
8587019|NCT00265850|9621487|FG000|STARTED|Overall Study||899
8587020|NCT00265850|9621488|FG001|STARTED|Overall Study||902
8587021|NCT00265850|9621489|FG002|STARTED|Overall Study||533
8710824|NCT00959946|9757229|FG001|NOT COMPLETED|Overall Study||4
8710825|NCT00959946|9757230|FG002|NOT COMPLETED|Overall Study||4
8710826|NCT00959946|9757231|FG003|NOT COMPLETED|Overall Study||5
8710827|NCT00959946|9757232|FG004|NOT COMPLETED|Overall Study||4
8710828|NCT00959946|9757233|FG005|NOT COMPLETED|Overall Study||9
8710829|NCT00959946|9757234|FG006|NOT COMPLETED|Overall Study||2
8710830|NCT00959946|9757235|FG007|NOT COMPLETED|Overall Study||2
8710831|NCT00959985|9757262|FG000|STARTED|Overall Study||8
8710832|NCT00959985|9757263|FG001|STARTED|Overall Study||7
8710833|NCT00959985|9757264|FG002|STARTED|Overall Study||4
8710834|NCT00959985|9757265|FG003|STARTED|Overall Study||4
8710835|NCT00959985|9757262|FG000|COMPLETED|Overall Study||8
8710836|NCT00959985|9757263|FG001|COMPLETED|Overall Study||7
8710837|NCT00959985|9757264|FG002|COMPLETED|Overall Study||4
8710838|NCT00959985|9757265|FG003|COMPLETED|Overall Study||4
8710839|NCT00959985|9757262|FG000|NOT COMPLETED|Overall Study||0
8710840|NCT00959985|9757263|FG001|NOT COMPLETED|Overall Study||0
8587022|NCT00265850|9621487|FG000|COMPLETED|Overall Study||899
8587023|NCT00265850|9621488|FG001|COMPLETED|Overall Study||902
8587024|NCT00265850|9621489|FG002|COMPLETED|Overall Study||533
8587025|NCT00265850|9621487|FG000|NOT COMPLETED|Overall Study||0
8587026|NCT00265850|9621488|FG001|NOT COMPLETED|Overall Study||0
8587027|NCT00265850|9621489|FG002|NOT COMPLETED|Overall Study||0
8587028|NCT00265889|9621496|FG000|STARTED|Overall Study||42
8587029|NCT00265889|9621496|FG000|Cycle 1: 1st Regimen/Transplant|Overall Study||37
8587030|NCT00265889|9621496|FG000|Cycle 2: 2nd Regimen/Transplant|Overall Study||37
8710841|NCT00959985|9757264|FG002|NOT COMPLETED|Overall Study||0
8710842|NCT00959985|9757265|FG003|NOT COMPLETED|Overall Study||0
8710843|NCT00960011|9757277|FG000|STARTED|Overall Study||33
8710844|NCT00960011|9757278|FG001|STARTED|Overall Study||25
8710845|NCT00960011|9757277|FG000|COMPLETED|Overall Study||22
8710846|NCT00960011|9757278|FG001|COMPLETED|Overall Study||23
8710847|NCT00960011|9757277|FG000|NOT COMPLETED|Overall Study||11
8710848|NCT00960011|9757278|FG001|NOT COMPLETED|Overall Study||2
8710849|NCT00960063|9757321|FG000|STARTED|Overall Study||1
8710850|NCT00960063|9757322|FG001|STARTED|Overall Study||0
8710851|NCT00960063|9757323|FG002|STARTED|Overall Study||3
8710852|NCT00960063|9757321|FG000|COMPLETED|Overall Study||0
8710853|NCT00960063|9757322|FG001|COMPLETED|Overall Study||0
8710854|NCT00960063|9757323|FG002|COMPLETED|Overall Study||0
8710855|NCT00960063|9757321|FG000|NOT COMPLETED|Overall Study||1
8710856|NCT00960063|9757322|FG001|NOT COMPLETED|Overall Study||0
8710857|NCT00960063|9757323|FG002|NOT COMPLETED|Overall Study||3
8710858|NCT00960076|9757333|FG000|STARTED|Overall Study|Randomized and treated|138
8710859|NCT00960076|9757334|FG001|STARTED|Overall Study|Randomized and treated|144
8710860|NCT00960076|9757333|FG000|COMPLETED|Overall Study|Completing 18 weeks of treatment|130
8710861|NCT00960076|9757334|FG001|COMPLETED|Overall Study|Completing 18 weeks of treatment|119
8710862|NCT00960076|9757333|FG000|NOT COMPLETED|Overall Study||8
8710863|NCT00960076|9757334|FG001|NOT COMPLETED|Overall Study||25
8710864|NCT00960115|9757342|FG000|STARTED|Overall Study||114
8710865|NCT00960115|9757343|FG001|STARTED|Overall Study||58
8710866|NCT00960115|9757342|FG000|COMPLETED|Overall Study||95
8710867|NCT00960115|9757343|FG001|COMPLETED|Overall Study||43
8710868|NCT00960115|9757342|FG000|NOT COMPLETED|Overall Study||19
8710869|NCT00960115|9757343|FG001|NOT COMPLETED|Overall Study||15
8710870|NCT00960193|9757349|FG000|STARTED|Colchicine Alone||24
8710871|NCT00960193|9757349|FG000|COMPLETED|Colchicine Alone||24
8710872|NCT00960193|9757349|FG000|NOT COMPLETED|Colchicine Alone||0
8710873|NCT00960193|9757349|FG000|STARTED|14 Day Washout Period||24
8710874|NCT00960193|9757349|FG000|COMPLETED|14 Day Washout Period||23
8710875|NCT00960193|9757349|FG000|NOT COMPLETED|14 Day Washout Period||1
8710876|NCT00960193|9757349|FG000|STARTED|Seville Orange Juice Alone||23
8710877|NCT00960193|9757349|FG000|COMPLETED|Seville Orange Juice Alone||23
8710878|NCT00960193|9757349|FG000|NOT COMPLETED|Seville Orange Juice Alone||0
8710879|NCT00960193|9757349|FG000|STARTED|Colchicine With Seville Orange Juice||23
8710880|NCT00960193|9757349|FG000|COMPLETED|Colchicine With Seville Orange Juice||23
8710881|NCT00960193|9757349|FG000|NOT COMPLETED|Colchicine With Seville Orange Juice||0
8710882|NCT00960206|9757359|FG000|STARTED|Overall Study||190
8710883|NCT00960206|9757360|FG001|STARTED|Overall Study||185
8710884|NCT00960206|9757361|FG002|STARTED|Overall Study||89
8710885|NCT00960206|9757359|FG000|COMPLETED|Overall Study||150
8710886|NCT00960206|9757360|FG001|COMPLETED|Overall Study||158
8710887|NCT00960206|9757361|FG002|COMPLETED|Overall Study||77
8710888|NCT00960206|9757359|FG000|NOT COMPLETED|Overall Study||40
8710889|NCT00960206|9757360|FG001|NOT COMPLETED|Overall Study||27
8710890|NCT00960206|9757361|FG002|NOT COMPLETED|Overall Study||12
8710891|NCT00960323|9757370|FG000|STARTED|Colchicine Alone||24
8710892|NCT00960323|9757370|FG000|COMPLETED|Colchicine Alone||24
8710893|NCT00960323|9757370|FG000|NOT COMPLETED|Colchicine Alone||0
8710894|NCT00960323|9757370|FG000|STARTED|14 Day Washout Period||24
8710895|NCT00960323|9757370|FG000|COMPLETED|14 Day Washout Period||24
8710896|NCT00960323|9757370|FG000|NOT COMPLETED|14 Day Washout Period||0
8710897|NCT00960323|9757370|FG000|STARTED|Atorvastatin Alone||24
8710898|NCT00960323|9757370|FG000|COMPLETED|Atorvastatin Alone||23
8710899|NCT00960323|9757370|FG000|NOT COMPLETED|Atorvastatin Alone||1
8710900|NCT00960323|9757370|FG000|STARTED|Colchicine and Atorvastatin||23
8710901|NCT00960323|9757370|FG000|COMPLETED|Colchicine and Atorvastatin||23
8587031|NCT00265889|9621496|FG000|COMPLETED|Overall Study||37
8587032|NCT00265889|9621496|FG000|NOT COMPLETED|Overall Study||5
8587033|NCT00265941|9621502|FG000|STARTED|Overall Study||470
8710902|NCT00960323|9757370|FG000|NOT COMPLETED|Colchicine and Atorvastatin||0
8710903|NCT00960375|9757380|FG000|STARTED|Overall Study||92
8710904|NCT00960375|9757381|FG001|STARTED|Overall Study||87
8710905|NCT00960375|9757380|FG000|COMPLETED|Overall Study||72
8710906|NCT00960375|9757381|FG001|COMPLETED|Overall Study||65
8710907|NCT00960375|9757380|FG000|NOT COMPLETED|Overall Study||20
8710908|NCT00960375|9757381|FG001|NOT COMPLETED|Overall Study||22
8710909|NCT00960440|9757391|FG000|STARTED|Overall Study||133
8710910|NCT00960440|9757392|FG001|STARTED|Overall Study||134
8710911|NCT00960440|9757393|FG002|STARTED|Overall Study||66
8710912|NCT00960440|9757394|FG003|STARTED|Overall Study||66
8710913|NCT00960440|9757391|FG000|COMPLETED|Overall Study||107
8710914|NCT00960440|9757392|FG001|COMPLETED|Overall Study||103
8710915|NCT00960440|9757393|FG002|COMPLETED|Overall Study||53
8710916|NCT00960440|9757394|FG003|COMPLETED|Overall Study||48
8710917|NCT00960440|9757391|FG000|NOT COMPLETED|Overall Study||26
8587034|NCT00265941|9621503|FG001|STARTED|Overall Study||470
8587035|NCT00265941|9621502|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|447
8587036|NCT00265941|9621503|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|444
8587037|NCT00265941|9621502|FG000|NOT COMPLETED|Overall Study||23
8587038|NCT00265941|9621503|FG001|NOT COMPLETED|Overall Study||26
8587039|NCT00265980|9621517|FG000|STARTED|Overall Study||22
8587040|NCT00265980|9621517|FG000|Weight Initial|Overall Study||22
8587041|NCT00265980|9621517|FG000|Weight -10% Placebo|Overall Study||22
8587042|NCT00265980|9621517|FG000|Weight -10% Leptin|Overall Study||22
8587043|NCT00265980|9621517|FG000|COMPLETED|Overall Study||22
8587044|NCT00265980|9621517|FG000|NOT COMPLETED|Overall Study||0
8587045|NCT00266032|9621524|FG000|STARTED|Treatment|all randomized subjects, baseline data for full analysis set (FAS) only|691
8587046|NCT00266032|9621525|FG001|STARTED|Treatment|all randomized subjects, baseline data for full analysis set (FAS) only|236
8587047|NCT00266032|9621526|FG002|STARTED|Treatment|all randomized subjects, baseline data for full analysis set (FAS) only|239
8587048|NCT00266032|9621524|FG000|Patients Treated|Treatment||684
8587049|NCT00266032|9621525|FG001|Patients Treated|Treatment||221
8587050|NCT00266032|9621526|FG002|Patients Treated|Treatment||229
8587051|NCT00266032|9621524|FG000|Patients Treated and in FAS|Treatment|FAS|642
8587052|NCT00266032|9621525|FG001|Patients Treated and in FAS|Treatment|FAS|209
8587053|NCT00266032|9621526|FG002|Patients Treated and in FAS|Treatment|FAS|216
8587054|NCT00266032|9621524|FG000|COMPLETED|Treatment|not all entered period 2 (open-label safety extension)|580
8587055|NCT00266032|9621525|FG001|COMPLETED|Treatment|not all entered period 2 (open-label safety extension)|172
8587056|NCT00266032|9621526|FG002|COMPLETED|Treatment|not all entered period 2 (open-label safety extension)|192
8587057|NCT00266032|9621524|FG000|NOT COMPLETED|Treatment||111
8587058|NCT00266032|9621525|FG001|NOT COMPLETED|Treatment||64
8587059|NCT00266032|9621526|FG002|NOT COMPLETED|Treatment||47
8587060|NCT00266032|9621524|FG000|STARTED|Open-label Safety Extension|treatment for subjects of all 3 treatment groups in 2nd period, except for 28 in subgroups|489
8587061|NCT00266032|9621525|FG001|STARTED|Open-label Safety Extension|7 subjects continued their treatment in second period (safety extension)|129
8587062|NCT00266032|9621526|FG002|STARTED|Open-label Safety Extension|21 subjects continued their treatment in second period (safety extension)|165
8587063|NCT00266032|9621524|FG000|COMPLETED|Open-label Safety Extension||448
8587064|NCT00266032|9621525|FG001|COMPLETED|Open-label Safety Extension||115
8587065|NCT00266032|9621526|FG002|COMPLETED|Open-label Safety Extension||140
8587066|NCT00266032|9621524|FG000|NOT COMPLETED|Open-label Safety Extension||41
8587067|NCT00266032|9621525|FG001|NOT COMPLETED|Open-label Safety Extension||14
8587068|NCT00266032|9621526|FG002|NOT COMPLETED|Open-label Safety Extension||25
8587069|NCT00266110|9621534|FG000|STARTED|Overall Study||17
8587070|NCT00266110|9621534|FG000|COMPLETED|Overall Study||10
8587071|NCT00266110|9621534|FG000|NOT COMPLETED|Overall Study||7
8587072|NCT00266227|9621541|FG000|STARTED|Initial Treatment||0
8587073|NCT00266227|9621542|FG001|STARTED|Initial Treatment||0
8587074|NCT00266227|9621543|FG002|STARTED|Initial Treatment||559
8710918|NCT00960440|9757392|FG001|NOT COMPLETED|Overall Study||31
8710919|NCT00960440|9757393|FG002|NOT COMPLETED|Overall Study||13
8710920|NCT00960440|9757394|FG003|NOT COMPLETED|Overall Study||18
8710921|NCT00960505|9757409|FG000|STARTED|Overall Study||34
8710922|NCT00960505|9757410|FG001|STARTED|Overall Study||35
8710923|NCT00960505|9757411|FG002|STARTED|Overall Study||31
8710924|NCT00960505|9757409|FG000|COMPLETED|Overall Study||21
8710925|NCT00960505|9757410|FG001|COMPLETED|Overall Study||25
8710926|NCT00960505|9757411|FG002|COMPLETED|Overall Study||23
8710927|NCT00960505|9757409|FG000|NOT COMPLETED|Overall Study||13
8710928|NCT00960505|9757410|FG001|NOT COMPLETED|Overall Study||10
8710929|NCT00960505|9757411|FG002|NOT COMPLETED|Overall Study||8
8710930|NCT00960531|9757429|FG000|STARTED|Overall Study|Started=Randomized|21
8710931|NCT00960531|9757430|FG001|STARTED|Overall Study|Started=Randomized|6
8710932|NCT00960531|9757431|FG002|STARTED|Overall Study|Started=Randomized|41
8710933|NCT00960531|9757432|FG003|STARTED|Overall Study|Started=Randomized.|25
8710934|NCT00960531|9757433|FG004|STARTED|Overall Study|Started=Randomized|5
8710935|NCT00960531|9757434|FG005|STARTED|Overall Study|Started=Randomized|9
8710936|NCT00960531|9757435|FG006|STARTED|Overall Study|Started=Randomized|27
8710937|NCT00960531|9757436|FG007|STARTED|Overall Study|Started=Randomized|6
8710938|NCT00960531|9757437|FG008|STARTED|Overall Study|Started=Randomized|16
8710939|NCT00960531|9757438|FG009|STARTED|Overall Study|Started=Randomized|4
8710940|NCT00960531|9757429|FG000|Treated|Overall Study||21
8710941|NCT00960531|9757430|FG001|Treated|Overall Study||6
8710942|NCT00960531|9757431|FG002|Treated|Overall Study||41
8710943|NCT00960531|9757432|FG003|Treated|Overall Study||24
8710944|NCT00960531|9757433|FG004|Treated|Overall Study||5
8710945|NCT00960531|9757434|FG005|Treated|Overall Study||9
8710946|NCT00960531|9757435|FG006|Treated|Overall Study||27
8710947|NCT00960531|9757436|FG007|Treated|Overall Study||6
8710948|NCT00960531|9757437|FG008|Treated|Overall Study||16
8710949|NCT00960531|9757438|FG009|Treated|Overall Study||4
8813027|NCT01523704|9866145|FG001|COMPLETED|Overall Study|February 2016 (Enrollment: as of October 2013)|550
8710950|NCT00960531|9757429|FG000|Completed Treatment|Overall Study||12
8710951|NCT00960531|9757430|FG001|Completed Treatment|Overall Study||5
8710952|NCT00960531|9757431|FG002|Completed Treatment|Overall Study||15
8710953|NCT00960531|9757432|FG003|Completed Treatment|Overall Study||17
8710954|NCT00960531|9757433|FG004|Completed Treatment|Overall Study||3
8710955|NCT00960531|9757434|FG005|Completed Treatment|Overall Study||7
8587075|NCT00266227|9621541|FG000|COMPLETED|Initial Treatment||0
8587076|NCT00266227|9621542|FG001|COMPLETED|Initial Treatment||0
8587077|NCT00266227|9621543|FG002|COMPLETED|Initial Treatment||482
8587078|NCT00266227|9621541|FG000|NOT COMPLETED|Initial Treatment||0
8587079|NCT00266227|9621542|FG001|NOT COMPLETED|Initial Treatment||0
8587080|NCT00266227|9621543|FG002|NOT COMPLETED|Initial Treatment||77
8587081|NCT00266227|9621541|FG000|STARTED|Retreatment: Up to Week 48||318
8587082|NCT00266227|9621542|FG001|STARTED|Retreatment: Up to Week 48||157
8587083|NCT00266227|9621543|FG002|STARTED|Retreatment: Up to Week 48||0
8587084|NCT00266227|9621541|FG000|COMPLETED|Retreatment: Up to Week 48||291
8587085|NCT00266227|9621542|FG001|COMPLETED|Retreatment: Up to Week 48||134
8587086|NCT00266227|9621543|FG002|COMPLETED|Retreatment: Up to Week 48||0
8587087|NCT00266227|9621541|FG000|NOT COMPLETED|Retreatment: Up to Week 48||27
8587088|NCT00266227|9621542|FG001|NOT COMPLETED|Retreatment: Up to Week 48||23
8587089|NCT00266227|9621543|FG002|NOT COMPLETED|Retreatment: Up to Week 48||0
8587090|NCT00266227|9621541|FG000|STARTED|Retreatment: Week 48 to Week 72||291
8587091|NCT00266227|9621542|FG001|STARTED|Retreatment: Week 48 to Week 72||134
8587092|NCT00266227|9621543|FG002|STARTED|Retreatment: Week 48 to Week 72||0
8587093|NCT00266227|9621541|FG000|COMPLETED|Retreatment: Week 48 to Week 72||227
8587094|NCT00266227|9621542|FG001|COMPLETED|Retreatment: Week 48 to Week 72||92
8710956|NCT00960531|9757435|FG006|Completed Treatment|Overall Study||4
8710957|NCT00960531|9757436|FG007|Completed Treatment|Overall Study||3
8710958|NCT00960531|9757437|FG008|Completed Treatment|Overall Study||2
8710959|NCT00960531|9757438|FG009|Completed Treatment|Overall Study||4
8710960|NCT00960531|9757429|FG000|COMPLETED|Overall Study|Completed study|11
8710961|NCT00960531|9757430|FG001|COMPLETED|Overall Study|Completed study|5
8710962|NCT00960531|9757431|FG002|COMPLETED|Overall Study|Completed study|15
8710963|NCT00960531|9757432|FG003|COMPLETED|Overall Study|Completed study|17
8710964|NCT00960531|9757433|FG004|COMPLETED|Overall Study|Completed study|3
8710965|NCT00960531|9757434|FG005|COMPLETED|Overall Study|Completed study|6
8710966|NCT00960531|9757435|FG006|COMPLETED|Overall Study|Completed study|3
8710967|NCT00960531|9757436|FG007|COMPLETED|Overall Study|Completed study|2
8710968|NCT00960531|9757437|FG008|COMPLETED|Overall Study|Completed study|2
8710969|NCT00960531|9757438|FG009|COMPLETED|Overall Study|Completed study|3
8710970|NCT00960531|9757429|FG000|NOT COMPLETED|Overall Study||10
8710971|NCT00960531|9757430|FG001|NOT COMPLETED|Overall Study||1
8710972|NCT00960531|9757431|FG002|NOT COMPLETED|Overall Study||26
8710973|NCT00960531|9757432|FG003|NOT COMPLETED|Overall Study||8
8710974|NCT00960531|9757433|FG004|NOT COMPLETED|Overall Study||2
8710975|NCT00960531|9757434|FG005|NOT COMPLETED|Overall Study||3
8710976|NCT00960531|9757435|FG006|NOT COMPLETED|Overall Study||24
8710977|NCT00960531|9757436|FG007|NOT COMPLETED|Overall Study||4
8710978|NCT00960531|9757437|FG008|NOT COMPLETED|Overall Study||14
8710979|NCT00960531|9757438|FG009|NOT COMPLETED|Overall Study||1
8710980|NCT00960570|9757464|FG000|STARTED|Efavirenz Alone||30
8710981|NCT00960570|9757464|FG000|COMPLETED|Efavirenz Alone||30
8710982|NCT00960570|9757464|FG000|NOT COMPLETED|Efavirenz Alone||0
8710983|NCT00960570|9757464|FG000|STARTED|21 Day Washout Period||30
8710984|NCT00960570|9757464|FG000|COMPLETED|21 Day Washout Period||28
8710985|NCT00960570|9757464|FG000|NOT COMPLETED|21 Day Washout Period||2
8710986|NCT00960570|9757464|FG000|STARTED|Fenofibric Acid Alone||28
8710987|NCT00960570|9757464|FG000|COMPLETED|Fenofibric Acid Alone||28
8710988|NCT00960570|9757464|FG000|NOT COMPLETED|Fenofibric Acid Alone||0
8710989|NCT00960570|9757464|FG000|STARTED|1 Day Period Between Dosing||28
8710990|NCT00960570|9757464|FG000|COMPLETED|1 Day Period Between Dosing||25
8710991|NCT00960570|9757464|FG000|NOT COMPLETED|1 Day Period Between Dosing||3
8710992|NCT00960570|9757464|FG000|STARTED|Efavirenz and Fenofibric Acid||25
8710993|NCT00960570|9757464|FG000|COMPLETED|Efavirenz and Fenofibric Acid||25
8710994|NCT00960570|9757464|FG000|NOT COMPLETED|Efavirenz and Fenofibric Acid||0
8710995|NCT00960622|9757473|FG000|STARTED|Overall Study||10
8710996|NCT00960622|9757474|FG001|STARTED|Overall Study||10
8710997|NCT00960622|9757473|FG000|COMPLETED|Overall Study||10
8710998|NCT00960622|9757474|FG001|COMPLETED|Overall Study||7
8710999|NCT00960622|9757473|FG000|NOT COMPLETED|Overall Study||0
8711000|NCT00960622|9757474|FG001|NOT COMPLETED|Overall Study||3
8711001|NCT00960661|9757482|FG000|STARTED|Basal Insulin Optimization Phase (BIO)||1036
8711002|NCT00960661|9757483|FG001|STARTED|Basal Insulin Optimization Phase (BIO)||0
8587095|NCT00266227|9621543|FG002|COMPLETED|Retreatment: Week 48 to Week 72||0
8587096|NCT00266227|9621541|FG000|NOT COMPLETED|Retreatment: Week 48 to Week 72||64
8587097|NCT00266227|9621542|FG001|NOT COMPLETED|Retreatment: Week 48 to Week 72||42
8587098|NCT00266227|9621543|FG002|NOT COMPLETED|Retreatment: Week 48 to Week 72||0
8587099|NCT00266279|9621552|FG000|STARTED|Overall Study||17
8587100|NCT00266279|9621552|FG000|COMPLETED|Overall Study||15
8587101|NCT00266279|9621552|FG000|NOT COMPLETED|Overall Study||2
8587102|NCT00266409|9621561|FG000|STARTED|Overall Study||137
8587103|NCT00266409|9621562|FG001|STARTED|Overall Study||138
8587104|NCT00266409|9621563|FG002|STARTED|Overall Study||72
8711003|NCT00960661|9757484|FG002|STARTED|Basal Insulin Optimization Phase (BIO)||0
8711004|NCT00960661|9757482|FG000|COMPLETED|Basal Insulin Optimization Phase (BIO)||637
8711005|NCT00960661|9757483|FG001|COMPLETED|Basal Insulin Optimization Phase (BIO)||0
8711006|NCT00960661|9757484|FG002|COMPLETED|Basal Insulin Optimization Phase (BIO)||0
8711007|NCT00960661|9757482|FG000|NOT COMPLETED|Basal Insulin Optimization Phase (BIO)||399
8711008|NCT00960661|9757483|FG001|NOT COMPLETED|Basal Insulin Optimization Phase (BIO)||0
8587105|NCT00266409|9621564|FG003|STARTED|Overall Study||71
8587106|NCT00266409|9621561|FG000|COMPLETED|Overall Study||92
8587107|NCT00266409|9621562|FG001|COMPLETED|Overall Study||92
8587108|NCT00266409|9621563|FG002|COMPLETED|Overall Study||55
8587109|NCT00266409|9621564|FG003|COMPLETED|Overall Study||49
8587110|NCT00266409|9621561|FG000|NOT COMPLETED|Overall Study||45
8587111|NCT00266409|9621562|FG001|NOT COMPLETED|Overall Study||46
8587112|NCT00266409|9621563|FG002|NOT COMPLETED|Overall Study||17
8587113|NCT00266409|9621564|FG003|NOT COMPLETED|Overall Study||22
8587114|NCT00266630|9621576|FG000|STARTED|Overall Study||100
8587115|NCT00266630|9621577|FG001|STARTED|Overall Study||39
8587116|NCT00266630|9621576|FG000|COMPLETED|Overall Study||58
8711009|NCT00960661|9757484|FG002|NOT COMPLETED|Basal Insulin Optimization Phase (BIO)||0
8711010|NCT00960661|9757482|FG000|STARTED|Interventional Phase||0
8711011|NCT00960661|9757483|FG001|STARTED|Interventional Phase||316
8711012|NCT00960661|9757484|FG002|STARTED|Interventional Phase||321
8711013|NCT00960661|9757482|FG000|Intent to Treat Population|Interventional Phase||0
8711014|NCT00960661|9757483|FG001|Intent to Treat Population|Interventional Phase|all randomized participants who took at least one dose of study drug|315
8711015|NCT00960661|9757484|FG002|Intent to Treat Population|Interventional Phase|all randomized participants who took at least one dose of study drug|312
8711016|NCT00960661|9757482|FG000|Per Protocol Population|Interventional Phase||0
8711017|NCT00960661|9757483|FG001|Per Protocol Population|Interventional Phase|all randomized participants who completed study and had no violations|247
8711018|NCT00960661|9757484|FG002|Per Protocol Population|Interventional Phase|all randomized participants who completed study and had no violations|263
8711019|NCT00960661|9757482|FG000|COMPLETED|Interventional Phase||0
8711020|NCT00960661|9757483|FG001|COMPLETED|Interventional Phase||264
8711021|NCT00960661|9757484|FG002|COMPLETED|Interventional Phase||275
8711022|NCT00960661|9757482|FG000|NOT COMPLETED|Interventional Phase||0
8711023|NCT00960661|9757483|FG001|NOT COMPLETED|Interventional Phase||52
8711024|NCT00960661|9757484|FG002|NOT COMPLETED|Interventional Phase||46
8711025|NCT00960687|9757490|FG000|STARTED|First Intervention||27
8711026|NCT00960687|9757491|FG001|STARTED|First Intervention||27
8711027|NCT00960687|9757490|FG000|COMPLETED|First Intervention||27
8711028|NCT00960687|9757491|FG001|COMPLETED|First Intervention||27
8711029|NCT00960687|9757490|FG000|NOT COMPLETED|First Intervention||0
8711030|NCT00960687|9757491|FG001|NOT COMPLETED|First Intervention||0
8711031|NCT00960687|9757490|FG000|STARTED|Washout Period of 7 Days||27
8711032|NCT00960687|9757491|FG001|STARTED|Washout Period of 7 Days||27
8711033|NCT00960687|9757490|FG000|COMPLETED|Washout Period of 7 Days|three subjects withdrew due to adverse events and one subject withdrew for personal reasons.|23
8711034|NCT00960687|9757491|FG001|COMPLETED|Washout Period of 7 Days|two subjects withdrew due to adverse events and one subject withdrew for personal reasons.|24
8711035|NCT00960687|9757490|FG000|NOT COMPLETED|Washout Period of 7 Days||4
8711036|NCT00960687|9757491|FG001|NOT COMPLETED|Washout Period of 7 Days||3
8711037|NCT00960687|9757490|FG000|STARTED|Second Intervention||23
8711038|NCT00960687|9757491|FG001|STARTED|Second Intervention||24
8711039|NCT00960687|9757490|FG000|COMPLETED|Second Intervention||23
8711040|NCT00960687|9757491|FG001|COMPLETED|Second Intervention||24
8711041|NCT00960687|9757490|FG000|NOT COMPLETED|Second Intervention||0
8711042|NCT00960687|9757491|FG001|NOT COMPLETED|Second Intervention||0
8711043|NCT00960778|9757499|FG000|STARTED|Overall Study||17
8711044|NCT00960778|9757500|FG001|STARTED|Overall Study||16
8711045|NCT00960778|9757499|FG000|COMPLETED|Overall Study||8
8711046|NCT00960778|9757500|FG001|COMPLETED|Overall Study||13
8711047|NCT00960778|9757499|FG000|NOT COMPLETED|Overall Study||9
8711048|NCT00960778|9757500|FG001|NOT COMPLETED|Overall Study||3
8711049|NCT00960804|9757509|FG000|STARTED|Overall Study||7
8711050|NCT00960804|9757510|FG001|STARTED|Overall Study||4
8711051|NCT00960804|9757511|FG002|STARTED|Overall Study||10
8711052|NCT00960804|9757509|FG000|COMPLETED|Overall Study||0
8711053|NCT00960804|9757510|FG001|COMPLETED|Overall Study||0
8711054|NCT00960804|9757511|FG002|COMPLETED|Overall Study||0
8711055|NCT00960804|9757509|FG000|NOT COMPLETED|Overall Study||7
8711056|NCT00960804|9757510|FG001|NOT COMPLETED|Overall Study||4
8711057|NCT00960804|9757511|FG002|NOT COMPLETED|Overall Study||10
8711058|NCT00960843|9757521|FG000|STARTED|Overall Study||25
8711059|NCT00960843|9757522|FG001|STARTED|Overall Study||26
8711060|NCT00960843|9757521|FG000|COMPLETED|Overall Study||23
8711061|NCT00960843|9757522|FG001|COMPLETED|Overall Study||21
8711062|NCT00960843|9757521|FG000|NOT COMPLETED|Overall Study||2
8711063|NCT00960843|9757522|FG001|NOT COMPLETED|Overall Study||5
8587117|NCT00266630|9621577|FG001|COMPLETED|Overall Study||11
8587118|NCT00266630|9621576|FG000|NOT COMPLETED|Overall Study||42
8587119|NCT00266630|9621577|FG001|NOT COMPLETED|Overall Study||28
8587120|NCT00266656|9621587|FG000|STARTED|Overall Study||36
8587121|NCT00266656|9621588|FG001|STARTED|Overall Study||33
8587122|NCT00266656|9621587|FG000|COMPLETED|Overall Study||22
8587123|NCT00266656|9621588|FG001|COMPLETED|Overall Study||20
8587124|NCT00266656|9621587|FG000|NOT COMPLETED|Overall Study||14
8711064|NCT00960856|9757528|FG000|STARTED|Period I||10
8711065|NCT00960856|9757529|FG001|STARTED|Period I||9
8711066|NCT00960856|9757530|FG002|STARTED|Period I||9
8711067|NCT00960856|9757531|FG003|STARTED|Period I||9
8711068|NCT00960856|9757528|FG000|COMPLETED|Period I||10
8711069|NCT00960856|9757529|FG001|COMPLETED|Period I||9
8711070|NCT00960856|9757530|FG002|COMPLETED|Period I||9
8587125|NCT00266656|9621588|FG001|NOT COMPLETED|Overall Study||13
8587126|NCT00266695|9621594|FG000|STARTED|Overall Study||203
8587127|NCT00266695|9621594|FG000|COMPLETED|Overall Study||174
8587128|NCT00266695|9621594|FG000|NOT COMPLETED|Overall Study||29
8587129|NCT00266708|9621600|FG000|STARTED|Overall Study||20
8587130|NCT00266708|9621601|FG001|STARTED|Overall Study||22
8587131|NCT00266708|9621600|FG000|COMPLETED|Overall Study||16
8587132|NCT00266708|9621601|FG001|COMPLETED|Overall Study||13
8587133|NCT00266708|9621600|FG000|NOT COMPLETED|Overall Study||4
8587134|NCT00266708|9621601|FG001|NOT COMPLETED|Overall Study||9
8587135|NCT00266799|9621609|FG000|STARTED|Overall Study||98
8587136|NCT00266799|9621610|FG001|STARTED|Overall Study||102
8587137|NCT00266799|9621609|FG000|COMPLETED|Overall Study||62
8587138|NCT00266799|9621610|FG001|COMPLETED|Overall Study||68
8587139|NCT00266799|9621609|FG000|NOT COMPLETED|Overall Study||36
8587140|NCT00266799|9621610|FG001|NOT COMPLETED|Overall Study||34
8587141|NCT00266812|9621618|FG000|STARTED|Overall Study||22
8587142|NCT00266812|9621619|FG001|STARTED|Overall Study||13
8587143|NCT00266812|9621618|FG000|COMPLETED|Overall Study||1
8587144|NCT00266812|9621619|FG001|COMPLETED|Overall Study||2
8587145|NCT00266812|9621618|FG000|NOT COMPLETED|Overall Study||21
8587146|NCT00266812|9621619|FG001|NOT COMPLETED|Overall Study||11
8587147|NCT00266825|9621627|FG000|STARTED|Enrolled and Allocated Intervention||172
8587148|NCT00266825|9621628|FG001|STARTED|Enrolled and Allocated Intervention||178
8587149|NCT00266825|9621627|FG000|COMPLETED|Enrolled and Allocated Intervention||172
8587150|NCT00266825|9621628|FG001|COMPLETED|Enrolled and Allocated Intervention||178
8587151|NCT00266825|9621627|FG000|NOT COMPLETED|Enrolled and Allocated Intervention||0
8587152|NCT00266825|9621628|FG001|NOT COMPLETED|Enrolled and Allocated Intervention||0
8587153|NCT00266825|9621627|FG000|STARTED|Completed Follow-Up||172
8587154|NCT00266825|9621628|FG001|STARTED|Completed Follow-Up||178
8587155|NCT00266825|9621627|FG000|COMPLETED|Completed Follow-Up||147
8587156|NCT00266825|9621628|FG001|COMPLETED|Completed Follow-Up||154
8587157|NCT00266825|9621627|FG000|NOT COMPLETED|Completed Follow-Up||25
8587158|NCT00266825|9621628|FG001|NOT COMPLETED|Completed Follow-Up||24
8587159|NCT00266851|9621639|FG000|STARTED|Overall Study||37
8587160|NCT00266851|9621640|FG001|STARTED|Overall Study||38
8587161|NCT00266851|9621641|FG002|STARTED|Overall Study||22
8587162|NCT00266851|9621639|FG000|Completed 3 Month Follow up|Overall Study||26
8587163|NCT00266851|9621640|FG001|Completed 3 Month Follow up|Overall Study||22
8587164|NCT00266851|9621641|FG002|Completed 3 Month Follow up|Overall Study||15
8587165|NCT00266851|9621639|FG000|Completed 6 Month Follow up|Overall Study||27
8587166|NCT00266851|9621640|FG001|Completed 6 Month Follow up|Overall Study||22
8587167|NCT00266851|9621641|FG002|Completed 6 Month Follow up|Overall Study||17
8587168|NCT00266851|9621639|FG000|Completed 9 Month Follow up|Overall Study||22
8587169|NCT00266851|9621640|FG001|Completed 9 Month Follow up|Overall Study||23
8587170|NCT00266851|9621641|FG002|Completed 9 Month Follow up|Overall Study||15
8587171|NCT00266851|9621639|FG000|Completed 12 Month Follow up|Overall Study||25
8587172|NCT00266851|9621640|FG001|Completed 12 Month Follow up|Overall Study||19
8587173|NCT00266851|9621641|FG002|Completed 12 Month Follow up|Overall Study||13
8587174|NCT00266851|9621639|FG000|COMPLETED|Overall Study||37
8587175|NCT00266851|9621640|FG001|COMPLETED|Overall Study||38
8587176|NCT00266851|9621641|FG002|COMPLETED|Overall Study||22
8587177|NCT00266851|9621639|FG000|NOT COMPLETED|Overall Study||0
8587178|NCT00266851|9621640|FG001|NOT COMPLETED|Overall Study||0
8587179|NCT00266851|9621641|FG002|NOT COMPLETED|Overall Study||0
8711071|NCT00960856|9757531|FG003|COMPLETED|Period I||9
8711072|NCT00960856|9757528|FG000|NOT COMPLETED|Period I||0
8711073|NCT00960856|9757529|FG001|NOT COMPLETED|Period I||0
8711074|NCT00960856|9757530|FG002|NOT COMPLETED|Period I||0
8711075|NCT00960856|9757531|FG003|NOT COMPLETED|Period I||0
8711076|NCT00960856|9757528|FG000|STARTED|Washout Period of 7 Days||10
8711077|NCT00960856|9757529|FG001|STARTED|Washout Period of 7 Days||9
8711078|NCT00960856|9757530|FG002|STARTED|Washout Period of 7 Days||9
8711079|NCT00960856|9757531|FG003|STARTED|Washout Period of 7 Days||9
8627847|NCT00519584|9667224|FG003|STARTED|Overall Study||56
8627848|NCT00519584|9667221|FG000|COMPLETED|Overall Study||54
8627849|NCT00519584|9667222|FG001|COMPLETED|Overall Study||54
8627850|NCT00519584|9667223|FG002|COMPLETED|Overall Study||54
8627851|NCT00519584|9667224|FG003|COMPLETED|Overall Study||56
8627852|NCT00519584|9667221|FG000|NOT COMPLETED|Overall Study||0
8627853|NCT00519584|9667222|FG001|NOT COMPLETED|Overall Study||0
8627854|NCT00519584|9667223|FG002|NOT COMPLETED|Overall Study||0
8627855|NCT00519584|9667224|FG003|NOT COMPLETED|Overall Study||0
8627856|NCT00519623|9667234|FG000|STARTED|Overall Study||9
8627857|NCT00519623|9667234|FG000|COMPLETED|Overall Study||8
8627858|NCT00519623|9667234|FG000|NOT COMPLETED|Overall Study||1
8627859|NCT00519636|9667242|FG000|STARTED|Treatment Period 1||91
8627860|NCT00519636|9667243|FG001|STARTED|Treatment Period 1||86
8627861|NCT00519636|9667244|FG002|STARTED|Treatment Period 1||90
8711080|NCT00960856|9757528|FG000|COMPLETED|Washout Period of 7 Days||10
8711081|NCT00960856|9757529|FG001|COMPLETED|Washout Period of 7 Days|personal reasons|7
8711082|NCT00960856|9757530|FG002|COMPLETED|Washout Period of 7 Days||9
8627862|NCT00519636|9667245|FG003|STARTED|Treatment Period 1||93
8627863|NCT00519636|9667242|FG000|COMPLETED|Treatment Period 1||89
8627864|NCT00519636|9667243|FG001|COMPLETED|Treatment Period 1||86
8627865|NCT00519636|9667244|FG002|COMPLETED|Treatment Period 1||89
8627866|NCT00519636|9667245|FG003|COMPLETED|Treatment Period 1||93
8627867|NCT00519636|9667242|FG000|NOT COMPLETED|Treatment Period 1||2
8627868|NCT00519636|9667243|FG001|NOT COMPLETED|Treatment Period 1||0
8627869|NCT00519636|9667244|FG002|NOT COMPLETED|Treatment Period 1||1
8587180|NCT00266864|9621655|FG000|STARTED|Overall Study||18
8587181|NCT00266864|9621656|FG001|STARTED|Overall Study||13
8587182|NCT00266864|9621655|FG000|COMPLETED|Overall Study||13
8587183|NCT00266864|9621656|FG001|COMPLETED|Overall Study||11
8587184|NCT00266864|9621655|FG000|NOT COMPLETED|Overall Study||5
8587185|NCT00266864|9621656|FG001|NOT COMPLETED|Overall Study||2
8587186|NCT00266877|9621665|FG000|STARTED|Overall Study||91
8587187|NCT00266877|9621666|FG001|STARTED|Overall Study||48
8587188|NCT00266877|9621667|FG002|STARTED|Overall Study||28
8587189|NCT00266877|9621665|FG000|COMPLETED|Overall Study||0
8587190|NCT00266877|9621666|FG001|COMPLETED|Overall Study||0
8587191|NCT00266877|9621667|FG002|COMPLETED|Overall Study||0
8587192|NCT00266877|9621665|FG000|NOT COMPLETED|Overall Study||91
8587193|NCT00266877|9621666|FG001|NOT COMPLETED|Overall Study||48
8587194|NCT00266877|9621667|FG002|NOT COMPLETED|Overall Study||28
8587195|NCT00267007|9621677|FG000|STARTED|Overall Study|2 additional patients were randomized but never received study medication and no data were collected|19
8587196|NCT00267007|9621678|FG001|STARTED|Overall Study||11
8587197|NCT00267007|9621677|FG000|COMPLETED|Overall Study||11
8587198|NCT00267007|9621678|FG001|COMPLETED|Overall Study||10
8587199|NCT00267007|9621677|FG000|NOT COMPLETED|Overall Study||8
8587200|NCT00267007|9621678|FG001|NOT COMPLETED|Overall Study||1
8587201|NCT00267020|9621686|FG000|STARTED|Overall Study||86
8587202|NCT00267020|9621687|FG001|STARTED|Overall Study||44
8587203|NCT00267020|9621686|FG000|Received at Least 1 Dose|Overall Study||82
8587204|NCT00267020|9621687|FG001|Received at Least 1 Dose|Overall Study||39
8587205|NCT00267020|9621686|FG000|Per-Protocol Population|Overall Study|With: cancer of the pancreas;no other chemotherapy;disease at baseline;received 1 dose of study drug|81
8587206|NCT00267020|9621687|FG001|Per-Protocol Population|Overall Study|With: cancer of the pancreas;no other chemotherapy;disease at baseline;received 1 dose of study drug|38
8587207|NCT00267020|9621686|FG000|COMPLETED|Overall Study||0
8587208|NCT00267020|9621687|FG001|COMPLETED|Overall Study||1
8587209|NCT00267020|9621686|FG000|NOT COMPLETED|Overall Study||86
8587210|NCT00267020|9621687|FG001|NOT COMPLETED|Overall Study||43
8587211|NCT00267046|9621695|FG000|STARTED|Overall Study||32
8587212|NCT00267046|9621696|FG001|STARTED|Overall Study||16
8587213|NCT00267046|9621695|FG000|COMPLETED|Overall Study||20
8587214|NCT00267046|9621696|FG001|COMPLETED|Overall Study||5
8587215|NCT00267046|9621695|FG000|NOT COMPLETED|Overall Study||12
8711083|NCT00960856|9757531|FG003|COMPLETED|Washout Period of 7 Days||9
8711084|NCT00960856|9757528|FG000|NOT COMPLETED|Washout Period of 7 Days||0
8711085|NCT00960856|9757529|FG001|NOT COMPLETED|Washout Period of 7 Days||2
8711086|NCT00960856|9757530|FG002|NOT COMPLETED|Washout Period of 7 Days||0
8711087|NCT00960856|9757531|FG003|NOT COMPLETED|Washout Period of 7 Days||0
8711088|NCT00960856|9757528|FG000|STARTED|Period II||10
8587216|NCT00267046|9621696|FG001|NOT COMPLETED|Overall Study||11
8587217|NCT00267059|9621702|FG000|STARTED|Overall Study||44
8587218|NCT00267059|9621702|FG000|COMPLETED|Overall Study||44
8587219|NCT00267059|9621702|FG000|NOT COMPLETED|Overall Study||0
8587220|NCT00267085|9621706|FG000|STARTED|Overall Study||10
8587221|NCT00267085|9621706|FG000|COMPLETED|Overall Study||10
8587222|NCT00267085|9621706|FG000|NOT COMPLETED|Overall Study||0
8587223|NCT00267098|9621718|FG000|STARTED|Overall Study||109
8587224|NCT00267098|9621719|FG001|STARTED|Overall Study||51
8587225|NCT00267098|9621720|FG002|STARTED|Overall Study||243
8587226|NCT00267098|9621721|FG003|STARTED|Overall Study||241
8587227|NCT00267098|9621722|FG004|STARTED|Overall Study||47
8587228|NCT00267098|9621723|FG005|STARTED|Overall Study||106
8587229|NCT00267098|9621724|FG006|STARTED|Overall Study||101
8587230|NCT00267098|9621725|FG007|STARTED|Overall Study||20
8587231|NCT00267098|9621718|FG000|COMPLETED|Overall Study||0
8587232|NCT00267098|9621719|FG001|COMPLETED|Overall Study||0
8587233|NCT00267098|9621720|FG002|COMPLETED|Overall Study||149
8587234|NCT00267098|9621721|FG003|COMPLETED|Overall Study||135
8587235|NCT00267098|9621722|FG004|COMPLETED|Overall Study||10
8587236|NCT00267098|9621723|FG005|COMPLETED|Overall Study||66
8587237|NCT00267098|9621724|FG006|COMPLETED|Overall Study||55
8587238|NCT00267098|9621725|FG007|COMPLETED|Overall Study||5
8587239|NCT00267098|9621718|FG000|NOT COMPLETED|Overall Study||109
8587240|NCT00267098|9621719|FG001|NOT COMPLETED|Overall Study||51
8587241|NCT00267098|9621720|FG002|NOT COMPLETED|Overall Study||94
8587242|NCT00267098|9621721|FG003|NOT COMPLETED|Overall Study||106
8587243|NCT00267098|9621722|FG004|NOT COMPLETED|Overall Study||37
8587244|NCT00267098|9621723|FG005|NOT COMPLETED|Overall Study||40
8587245|NCT00267098|9621724|FG006|NOT COMPLETED|Overall Study||46
8587246|NCT00267098|9621725|FG007|NOT COMPLETED|Overall Study||15
8587247|NCT00267111|9621750|FG000|STARTED|Overall Study||55
8587248|NCT00267111|9621751|FG001|STARTED|Overall Study||55
8587249|NCT00267111|9621750|FG000|COMPLETED|Overall Study||55
8587250|NCT00267111|9621751|FG001|COMPLETED|Overall Study||55
8587251|NCT00267111|9621750|FG000|NOT COMPLETED|Overall Study||0
8587252|NCT00267111|9621751|FG001|NOT COMPLETED|Overall Study||0
8587253|NCT00267150|9621758|FG000|STARTED|Overall Study||31
8587254|NCT00267150|9621758|FG000|COMPLETED|Overall Study||30
8587255|NCT00267150|9621758|FG000|NOT COMPLETED|Overall Study||1
8587256|NCT00267189|9621764|FG000|STARTED|Overall Study|Intention to treat (ITT) population.|72
8587257|NCT00267189|9621765|FG001|STARTED|Overall Study||73
8587258|NCT00267189|9621764|FG000|Completed Study Medication|Overall Study||54
8711089|NCT00960856|9757529|FG001|STARTED|Period II||7
8711090|NCT00960856|9757530|FG002|STARTED|Period II||9
8587259|NCT00267189|9621765|FG001|Completed Study Medication|Overall Study||72
8587260|NCT00267189|9621764|FG000|COMPLETED|Overall Study|"Completed indicates completed study."|67
8711091|NCT00960856|9757531|FG003|STARTED|Period II||9
8711092|NCT00960856|9757528|FG000|COMPLETED|Period II||10
8711093|NCT00960856|9757529|FG001|COMPLETED|Period II||7
8711094|NCT00960856|9757530|FG002|COMPLETED|Period II||9
8711095|NCT00960856|9757531|FG003|COMPLETED|Period II||9
8711096|NCT00960856|9757528|FG000|NOT COMPLETED|Period II||0
8711097|NCT00960856|9757529|FG001|NOT COMPLETED|Period II||0
8711098|NCT00960856|9757530|FG002|NOT COMPLETED|Period II||0
8711099|NCT00960856|9757531|FG003|NOT COMPLETED|Period II||0
8711100|NCT00960856|9757528|FG000|STARTED|Washout Period of 7 Days||10
8711101|NCT00960856|9757529|FG001|STARTED|Washout Period of 7 Days||7
8711102|NCT00960856|9757530|FG002|STARTED|Washout Period of 7 Days||9
8711103|NCT00960856|9757531|FG003|STARTED|Washout Period of 7 Days||9
8711104|NCT00960856|9757528|FG000|COMPLETED|Washout Period of 7 Days||10
8711105|NCT00960856|9757529|FG001|COMPLETED|Washout Period of 7 Days||7
8711106|NCT00960856|9757530|FG002|COMPLETED|Washout Period of 7 Days||9
8711107|NCT00960856|9757531|FG003|COMPLETED|Washout Period of 7 Days||9
8711108|NCT00960856|9757528|FG000|NOT COMPLETED|Washout Period of 7 Days||0
8711109|NCT00960856|9757529|FG001|NOT COMPLETED|Washout Period of 7 Days||0
8711110|NCT00960856|9757530|FG002|NOT COMPLETED|Washout Period of 7 Days||0
8711111|NCT00960856|9757531|FG003|NOT COMPLETED|Washout Period of 7 Days||0
8711112|NCT00960856|9757528|FG000|STARTED|Period III||10
8711113|NCT00960856|9757529|FG001|STARTED|Period III||7
8711114|NCT00960856|9757530|FG002|STARTED|Period III||9
8711115|NCT00960856|9757531|FG003|STARTED|Period III||9
8711116|NCT00960856|9757528|FG000|COMPLETED|Period III||10
8711117|NCT00960856|9757529|FG001|COMPLETED|Period III||7
8711118|NCT00960856|9757530|FG002|COMPLETED|Period III||9
8711119|NCT00960856|9757531|FG003|COMPLETED|Period III||9
8711120|NCT00960856|9757528|FG000|NOT COMPLETED|Period III||0
8711121|NCT00960856|9757529|FG001|NOT COMPLETED|Period III||0
8711122|NCT00960856|9757530|FG002|NOT COMPLETED|Period III||0
8711123|NCT00960856|9757531|FG003|NOT COMPLETED|Period III||0
8711124|NCT00960856|9757528|FG000|STARTED|Washout Period of 7 Days||10
8711125|NCT00960856|9757529|FG001|STARTED|Washout Period of 7 Days||7
8711126|NCT00960856|9757530|FG002|STARTED|Washout Period of 7 Days||9
8711127|NCT00960856|9757531|FG003|STARTED|Washout Period of 7 Days||9
8711128|NCT00960856|9757528|FG000|COMPLETED|Washout Period of 7 Days||10
8711129|NCT00960856|9757529|FG001|COMPLETED|Washout Period of 7 Days||7
8711130|NCT00960856|9757530|FG002|COMPLETED|Washout Period of 7 Days||8
8711131|NCT00960856|9757531|FG003|COMPLETED|Washout Period of 7 Days||9
8711132|NCT00960856|9757528|FG000|NOT COMPLETED|Washout Period of 7 Days||0
8711133|NCT00960856|9757529|FG001|NOT COMPLETED|Washout Period of 7 Days||0
8711134|NCT00960856|9757530|FG002|NOT COMPLETED|Washout Period of 7 Days||1
8711135|NCT00960856|9757531|FG003|NOT COMPLETED|Washout Period of 7 Days||0
8711136|NCT00960856|9757528|FG000|STARTED|Period IV||10
8711137|NCT00960856|9757529|FG001|STARTED|Period IV||7
8711138|NCT00960856|9757530|FG002|STARTED|Period IV||8
8711139|NCT00960856|9757531|FG003|STARTED|Period IV||9
8711140|NCT00960856|9757528|FG000|COMPLETED|Period IV||10
8711141|NCT00960856|9757529|FG001|COMPLETED|Period IV||7
8711142|NCT00960856|9757530|FG002|COMPLETED|Period IV||8
8711143|NCT00960856|9757531|FG003|COMPLETED|Period IV||9
8711144|NCT00960856|9757528|FG000|NOT COMPLETED|Period IV||0
8711145|NCT00960856|9757529|FG001|NOT COMPLETED|Period IV||0
8711146|NCT00960856|9757530|FG002|NOT COMPLETED|Period IV||0
8711147|NCT00960856|9757531|FG003|NOT COMPLETED|Period IV||0
8711148|NCT00960869|9757543|FG000|STARTED|Overall Study||259
8711149|NCT00960869|9757544|FG001|STARTED|Overall Study||260
8711150|NCT00960869|9757543|FG000|Intent-to-Treat Population (ITT)|Overall Study||259
8711151|NCT00960869|9757544|FG001|Intent-to-Treat Population (ITT)|Overall Study||260
8711152|NCT00960869|9757543|FG000|Safety Popluation|Overall Study|3 rand to PA32540 took EC-ASA 325mg/3 rand to EC-ASA 325mg took PA32540 counted by actual treatment.|257
8711153|NCT00960869|9757544|FG001|Safety Popluation|Overall Study|3 rand to PA32540 took EC-ASA 325mg/3 rand to EC-ASA 325mg took PA32540 counted by actual treatment.|259
8587261|NCT00267189|9621765|FG001|COMPLETED|Overall Study||72
8587262|NCT00267189|9621764|FG000|NOT COMPLETED|Overall Study||5
8587263|NCT00267189|9621765|FG001|NOT COMPLETED|Overall Study||1
8587264|NCT00267202|9621773|FG000|STARTED|Overall Study||136
8587265|NCT00267202|9621774|FG001|STARTED|Overall Study||139
8587266|NCT00267202|9621773|FG000|COMPLETED|Overall Study||83
8587267|NCT00267202|9621774|FG001|COMPLETED|Overall Study||105
8587268|NCT00267202|9621773|FG000|NOT COMPLETED|Overall Study||53
8587269|NCT00267202|9621774|FG001|NOT COMPLETED|Overall Study||34
8587270|NCT00267293|9621784|FG000|STARTED|Overall Study||20
8711154|NCT00960869|9757543|FG000|COMPLETED|Overall Study||206
8711155|NCT00960869|9757544|FG001|COMPLETED|Overall Study||198
8711156|NCT00960869|9757543|FG000|NOT COMPLETED|Overall Study||53
8711157|NCT00960869|9757544|FG001|NOT COMPLETED|Overall Study||62
8711158|NCT00960934|9757556|FG000|STARTED|Overall Study||64
8711159|NCT00960934|9757557|FG001|STARTED|Overall Study||63
8711160|NCT00960934|9757558|FG002|STARTED|Overall Study||64
8711161|NCT00960934|9757559|FG003|STARTED|Overall Study||64
8711162|NCT00960934|9757560|FG004|STARTED|Overall Study||64
8711163|NCT00960934|9757561|FG005|STARTED|Overall Study||64
8587271|NCT00267293|9621785|FG001|STARTED|Overall Study||20
8587272|NCT00267293|9621786|FG002|STARTED|Overall Study||20
8587273|NCT00267293|9621784|FG000|COMPLETED|Overall Study||20
8587274|NCT00267293|9621785|FG001|COMPLETED|Overall Study||20
8587275|NCT00267293|9621786|FG002|COMPLETED|Overall Study||20
8587276|NCT00267293|9621784|FG000|NOT COMPLETED|Overall Study||0
8587277|NCT00267293|9621785|FG001|NOT COMPLETED|Overall Study||0
8587278|NCT00267293|9621786|FG002|NOT COMPLETED|Overall Study||0
8587279|NCT00267488|9621794|FG000|STARTED|Overall Study||37
8587280|NCT00267488|9621794|FG000|COMPLETED|Overall Study||26
8587281|NCT00267488|9621794|FG000|NOT COMPLETED|Overall Study||11
8587282|NCT00267631|9621800|FG000|STARTED|Overall Study||2361
8587283|NCT00267631|9621801|FG001|STARTED|Overall Study||3031
8587284|NCT00267631|9621800|FG000|COMPLETED|Overall Study||2361
8587285|NCT00267631|9621801|FG001|COMPLETED|Overall Study||3031
8587286|NCT00267631|9621800|FG000|NOT COMPLETED|Overall Study||0
8587287|NCT00267631|9621801|FG001|NOT COMPLETED|Overall Study||0
8587288|NCT00267644|9621809|FG000|STARTED|Overall Study||13
8587289|NCT00267644|9621810|FG001|STARTED|Overall Study||63
8587290|NCT00267644|9621809|FG000|COMPLETED|Overall Study||13
8587291|NCT00267644|9621810|FG001|COMPLETED|Overall Study||63
8711164|NCT00960934|9757556|FG000|Number Treated|Overall Study||64
8587292|NCT00267644|9621809|FG000|NOT COMPLETED|Overall Study||0
8711165|NCT00960934|9757557|FG001|Number Treated|Overall Study|1 participant was randomized but not treated|62
8711166|NCT00960934|9757558|FG002|Number Treated|Overall Study||64
8711167|NCT00960934|9757559|FG003|Number Treated|Overall Study||64
8711168|NCT00960934|9757560|FG004|Number Treated|Overall Study|1 participant was randomized but not treated|63
8711169|NCT00960934|9757561|FG005|Number Treated|Overall Study|1 participant was randomized but not treated|63
8711170|NCT00960934|9757556|FG000|COMPLETED|Overall Study||0
8711171|NCT00960934|9757557|FG001|COMPLETED|Overall Study||0
8711172|NCT00960934|9757558|FG002|COMPLETED|Overall Study||0
8711173|NCT00960934|9757559|FG003|COMPLETED|Overall Study||0
8711174|NCT00960934|9757560|FG004|COMPLETED|Overall Study||0
8711175|NCT00960934|9757561|FG005|COMPLETED|Overall Study||0
8711176|NCT00960934|9757556|FG000|NOT COMPLETED|Overall Study||64
8587293|NCT00267644|9621810|FG001|NOT COMPLETED|Overall Study||0
8587294|NCT00267670|9621820|FG000|STARTED|Overall Study||19
8587295|NCT00267670|9621821|FG001|STARTED|Overall Study||7
8587296|NCT00267670|9621820|FG000|COMPLETED|Overall Study||15
8587297|NCT00267670|9621821|FG001|COMPLETED|Overall Study||7
8587298|NCT00267670|9621820|FG000|NOT COMPLETED|Overall Study||4
8587299|NCT00267670|9621821|FG001|NOT COMPLETED|Overall Study||0
8587300|NCT00267696|9621828|FG000|STARTED|Overall Study||45
8587301|NCT00267696|9621828|FG000|COMPLETED|Overall Study||45
8587302|NCT00267696|9621828|FG000|NOT COMPLETED|Overall Study||0
8587303|NCT00267748|9621835|FG000|STARTED|Non-randomized Period||25
8587304|NCT00267748|9621836|FG001|STARTED|Non-randomized Period||0
8587305|NCT00267748|9621837|FG002|STARTED|Non-randomized Period||0
8587306|NCT00267748|9621835|FG000|COMPLETED|Non-randomized Period||2
8587307|NCT00267748|9621836|FG001|COMPLETED|Non-randomized Period||0
8587308|NCT00267748|9621837|FG002|COMPLETED|Non-randomized Period||0
8587309|NCT00267748|9621835|FG000|NOT COMPLETED|Non-randomized Period||23
8587310|NCT00267748|9621836|FG001|NOT COMPLETED|Non-randomized Period||0
8587311|NCT00267748|9621837|FG002|NOT COMPLETED|Non-randomized Period||0
8587312|NCT00267748|9621835|FG000|STARTED|Randomized Period||0
8587313|NCT00267748|9621836|FG001|STARTED|Randomized Period||146
8587314|NCT00267748|9621837|FG002|STARTED|Randomized Period||146
8587315|NCT00267748|9621835|FG000|Treated|Randomized Period||0
8587316|NCT00267748|9621836|FG001|Treated|Randomized Period||146
8587317|NCT00267748|9621837|FG002|Treated|Randomized Period||143
8587318|NCT00267748|9621835|FG000|COMPLETED|Randomized Period||0
8587319|NCT00267748|9621836|FG001|COMPLETED|Randomized Period||19
8587320|NCT00267748|9621837|FG002|COMPLETED|Randomized Period||14
8587321|NCT00267748|9621835|FG000|NOT COMPLETED|Randomized Period||0
8587322|NCT00267748|9621836|FG001|NOT COMPLETED|Randomized Period||127
8587323|NCT00267748|9621837|FG002|NOT COMPLETED|Randomized Period||132
8587324|NCT00267774|9621846|FG000|STARTED|Overall Study||509
8587325|NCT00267774|9621847|FG001|STARTED|Overall Study||496
8587326|NCT00267774|9621846|FG000|COMPLETED|Overall Study||509
8587327|NCT00267774|9621847|FG001|COMPLETED|Overall Study||496
8587328|NCT00267774|9621846|FG000|NOT COMPLETED|Overall Study||0
8587329|NCT00267774|9621847|FG001|NOT COMPLETED|Overall Study||0
8587330|NCT00267865|9621853|FG000|STARTED|Induction Treatment||12
8587331|NCT00267865|9621853|FG000|COMPLETED|Induction Treatment||9
8587332|NCT00267865|9621853|FG000|NOT COMPLETED|Induction Treatment||3
8587333|NCT00267865|9621853|FG000|STARTED|Consolidation Treatment||5
8587334|NCT00267865|9621853|FG000|COMPLETED|Consolidation Treatment||5
8587335|NCT00267865|9621853|FG000|NOT COMPLETED|Consolidation Treatment||0
8587336|NCT00267956|9621859|FG000|STARTED|Controlled Period||70
8587337|NCT00267956|9621860|FG001|STARTED|Controlled Period||76
8587338|NCT00267956|9621861|FG002|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
8587339|NCT00267956|9621862|FG003|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
8587340|NCT00267956|9621859|FG000|COMPLETED|Controlled Period||57
8587341|NCT00267956|9621860|FG001|COMPLETED|Controlled Period||72
8587342|NCT00267956|9621861|FG002|COMPLETED|Controlled Period||0
8711177|NCT00960934|9757557|FG001|NOT COMPLETED|Overall Study||63
8711178|NCT00960934|9757558|FG002|NOT COMPLETED|Overall Study||64
8587343|NCT00267956|9621862|FG003|COMPLETED|Controlled Period||0
8587344|NCT00267956|9621859|FG000|NOT COMPLETED|Controlled Period||13
8711179|NCT00960934|9757559|FG003|NOT COMPLETED|Overall Study||64
8711180|NCT00960934|9757560|FG004|NOT COMPLETED|Overall Study||64
8587345|NCT00267956|9621860|FG001|NOT COMPLETED|Controlled Period||4
8587346|NCT00267956|9621861|FG002|NOT COMPLETED|Controlled Period||0
8587347|NCT00267956|9621862|FG003|NOT COMPLETED|Controlled Period||0
8587348|NCT00267956|9621859|FG000|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
8587349|NCT00267956|9621860|FG001|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
8587350|NCT00267956|9621861|FG002|STARTED|After Controlled Period||57
8587351|NCT00267956|9621862|FG003|STARTED|After Controlled Period||72
8587352|NCT00267956|9621859|FG000|COMPLETED|After Controlled Period||0
8587353|NCT00267956|9621860|FG001|COMPLETED|After Controlled Period||0
8587354|NCT00267956|9621861|FG002|COMPLETED|After Controlled Period||52
8587355|NCT00267956|9621862|FG003|COMPLETED|After Controlled Period||70
8587356|NCT00267956|9621859|FG000|NOT COMPLETED|After Controlled Period||0
8587357|NCT00267956|9621860|FG001|NOT COMPLETED|After Controlled Period||0
8587358|NCT00267956|9621861|FG002|NOT COMPLETED|After Controlled Period||5
8587359|NCT00267956|9621862|FG003|NOT COMPLETED|After Controlled Period||2
8587360|NCT00267969|9621873|FG000|STARTED|Controlled Period|Number of patients randomized|255
8587361|NCT00267969|9621874|FG001|STARTED|Controlled Period|Number of patients randomized|255
8587362|NCT00267969|9621875|FG002|STARTED|Controlled Period|Number of patients randomized|256
8587363|NCT00267969|9621876|FG003|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
8587364|NCT00267969|9621877|FG004|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
8587365|NCT00267969|9621878|FG005|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
8587366|NCT00267969|9621879|FG006|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
8587367|NCT00267969|9621873|FG000|COMPLETED|Controlled Period||243
8587368|NCT00267969|9621874|FG001|COMPLETED|Controlled Period||254
8587369|NCT00267969|9621875|FG002|COMPLETED|Controlled Period||245
8587370|NCT00267969|9621876|FG003|COMPLETED|Controlled Period||0
8587371|NCT00267969|9621877|FG004|COMPLETED|Controlled Period||0
8587372|NCT00267969|9621878|FG005|COMPLETED|Controlled Period||0
8587373|NCT00267969|9621879|FG006|COMPLETED|Controlled Period||0
8587374|NCT00267969|9621873|FG000|NOT COMPLETED|Controlled Period||12
8587375|NCT00267969|9621874|FG001|NOT COMPLETED|Controlled Period||1
8587376|NCT00267969|9621875|FG002|NOT COMPLETED|Controlled Period||11
8587377|NCT00267969|9621876|FG003|NOT COMPLETED|Controlled Period||0
8587378|NCT00267969|9621877|FG004|NOT COMPLETED|Controlled Period||0
8587379|NCT00267969|9621878|FG005|NOT COMPLETED|Controlled Period||0
8587380|NCT00267969|9621879|FG006|NOT COMPLETED|Controlled Period||0
8587381|NCT00267969|9621873|FG000|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
8587382|NCT00267969|9621874|FG001|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
8587383|NCT00267969|9621875|FG002|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
8587384|NCT00267969|9621876|FG003|STARTED|After Controlled Period||123
8587385|NCT00267969|9621877|FG004|STARTED|After Controlled Period||120
8587386|NCT00267969|9621878|FG005|STARTED|After Controlled Period||254
8587387|NCT00267969|9621879|FG006|STARTED|After Controlled Period||245
8587388|NCT00267969|9621873|FG000|COMPLETED|After Controlled Period||0
8587389|NCT00267969|9621874|FG001|COMPLETED|After Controlled Period||0
8587390|NCT00267969|9621875|FG002|COMPLETED|After Controlled Period||0
8587391|NCT00267969|9621876|FG003|COMPLETED|After Controlled Period||87
8587392|NCT00267969|9621877|FG004|COMPLETED|After Controlled Period||85
8587393|NCT00267969|9621878|FG005|COMPLETED|After Controlled Period||172
8587394|NCT00267969|9621879|FG006|COMPLETED|After Controlled Period||173
8587395|NCT00267969|9621873|FG000|NOT COMPLETED|After Controlled Period||0
8587396|NCT00267969|9621874|FG001|NOT COMPLETED|After Controlled Period||0
8587397|NCT00267969|9621875|FG002|NOT COMPLETED|After Controlled Period||0
8587398|NCT00267969|9621876|FG003|NOT COMPLETED|After Controlled Period||36
8587399|NCT00267969|9621877|FG004|NOT COMPLETED|After Controlled Period||35
8587400|NCT00267969|9621878|FG005|NOT COMPLETED|After Controlled Period||82
8587401|NCT00267969|9621879|FG006|NOT COMPLETED|After Controlled Period||72
8587402|NCT00268203|9621897|FG000|STARTED|Overall Study||765
8587403|NCT00268203|9621897|FG000|Completed 2 Years of Follow-up|Overall Study||62
8587404|NCT00268203|9621897|FG000|COMPLETED|Overall Study|These participants completed 10 years of follow-up.|118
8587405|NCT00268203|9621897|FG000|NOT COMPLETED|Overall Study||647
8587406|NCT00268242|9621901|FG000|STARTED|Overall Study||24
8587407|NCT00268242|9621901|FG000|COMPLETED|Overall Study||23
8587408|NCT00268242|9621901|FG000|NOT COMPLETED|Overall Study||1
8587409|NCT00268346|9621907|FG000|STARTED|Overall Study||18
8587410|NCT00268346|9621908|FG001|STARTED|Overall Study||40
8587411|NCT00268346|9621907|FG000|Started Treatment|Overall Study||18
8587412|NCT00268346|9621908|FG001|Started Treatment|Overall Study||40
8587413|NCT00268346|9621907|FG000|COMPLETED|Overall Study||18
8587414|NCT00268346|9621908|FG001|COMPLETED|Overall Study||37
8587415|NCT00268346|9621907|FG000|NOT COMPLETED|Overall Study||0
8587416|NCT00268346|9621908|FG001|NOT COMPLETED|Overall Study||3
8587417|NCT00268437|9621914|FG000|STARTED|Overall Study||27
8587418|NCT00268437|9621914|FG000|COMPLETED|Overall Study||26
8587419|NCT00268437|9621914|FG000|NOT COMPLETED|Overall Study||1
8587420|NCT00268762|9621919|FG000|STARTED|Overall Study||65
8587421|NCT00268762|9621919|FG000|COMPLETED|Overall Study||65
8587422|NCT00268762|9621919|FG000|NOT COMPLETED|Overall Study||0
8587423|NCT00268892|9621926|FG000|STARTED|Overall Study||90
8587424|NCT00268892|9621927|FG001|STARTED|Overall Study||95
8587425|NCT00268892|9621928|FG002|STARTED|Overall Study||93
8587426|NCT00268892|9621926|FG000|Switched to Higher Dose|Overall Study||59
8587427|NCT00268892|9621927|FG001|Switched to Higher Dose|Overall Study||68
8587428|NCT00268892|9621928|FG002|Switched to Higher Dose|Overall Study||76
8587429|NCT00268892|9621926|FG000|COMPLETED|Overall Study||51
8587430|NCT00268892|9621927|FG001|COMPLETED|Overall Study||53
8587431|NCT00268892|9621928|FG002|COMPLETED|Overall Study||54
8587432|NCT00268892|9621926|FG000|NOT COMPLETED|Overall Study||39
8587433|NCT00268892|9621927|FG001|NOT COMPLETED|Overall Study||42
8587434|NCT00268892|9621928|FG002|NOT COMPLETED|Overall Study||39
8587435|NCT00268905|9621939|FG000|STARTED|Overall Study||43
8587436|NCT00268905|9621940|FG001|STARTED|Overall Study||9
8587437|NCT00268905|9621941|FG002|STARTED|Overall Study||12
8587438|NCT00268905|9621939|FG000|COMPLETED|Overall Study||0
8587439|NCT00268905|9621940|FG001|COMPLETED|Overall Study||0
8587440|NCT00268905|9621941|FG002|COMPLETED|Overall Study||0
8587441|NCT00268905|9621939|FG000|NOT COMPLETED|Overall Study||43
8587442|NCT00268905|9621940|FG001|NOT COMPLETED|Overall Study||9
8587443|NCT00268905|9621941|FG002|NOT COMPLETED|Overall Study||12
8587444|NCT00268983|9621951|FG000|STARTED|Overall Study||6
8587445|NCT00268983|9621952|FG001|STARTED|Overall Study||8
8587446|NCT00268983|9621951|FG000|COMPLETED|Overall Study||3
8587447|NCT00268983|9621952|FG001|COMPLETED|Overall Study||8
8587448|NCT00268983|9621951|FG000|NOT COMPLETED|Overall Study||3
8587449|NCT00268983|9621952|FG001|NOT COMPLETED|Overall Study||0
8587450|NCT00268996|9621960|FG000|STARTED|Overall Study||151
8587451|NCT00268996|9621961|FG001|STARTED|Overall Study||172
8587452|NCT00268996|9621960|FG000|COMPLETED|Overall Study||130
8587453|NCT00268996|9621961|FG001|COMPLETED|Overall Study||152
8587454|NCT00268996|9621960|FG000|NOT COMPLETED|Overall Study||21
8587455|NCT00268996|9621961|FG001|NOT COMPLETED|Overall Study||20
8587456|NCT00269087|9621969|FG000|STARTED|Overall Study||122
8587457|NCT00269087|9621969|FG000|COMPLETED|Overall Study||88
8587458|NCT00269087|9621969|FG000|NOT COMPLETED|Overall Study||34
8587459|NCT00269113|9621975|FG000|STARTED|Overall Study||177
8587460|NCT00269113|9621976|FG001|STARTED|Overall Study||183
8587461|NCT00269113|9621975|FG000|COMPLETED|Overall Study||103
8587462|NCT00269113|9621976|FG001|COMPLETED|Overall Study||146
8587463|NCT00269113|9621975|FG000|NOT COMPLETED|Overall Study||74
8587464|NCT00269113|9621976|FG001|NOT COMPLETED|Overall Study||37
8587465|NCT00269152|9621984|FG000|STARTED|Overall Study|One participant in Pemetrexed+Carboplatin actually received Pemetrexed+Cisplatin|63
8587466|NCT00269152|9621985|FG001|STARTED|Overall Study|4 were randomized without receiving any study drug.|59
8587467|NCT00269152|9621984|FG000|COMPLETED|Overall Study||45
8587468|NCT00269152|9621985|FG001|COMPLETED|Overall Study||49
8587469|NCT00269152|9621984|FG000|NOT COMPLETED|Overall Study||18
8587470|NCT00269152|9621985|FG001|NOT COMPLETED|Overall Study||10
8587471|NCT00269399|9621993|FG000|STARTED|Overall Study||119
8587472|NCT00269399|9621994|FG001|STARTED|Overall Study||118
8587473|NCT00269399|9621993|FG000|COMPLETED|Overall Study||78
8587474|NCT00269399|9621994|FG001|COMPLETED|Overall Study||91
8587475|NCT00269399|9621993|FG000|NOT COMPLETED|Overall Study||41
8587476|NCT00269399|9621994|FG001|NOT COMPLETED|Overall Study||27
8587477|NCT00269477|9622004|FG000|STARTED|Overall Study||9
8587478|NCT00269477|9622005|FG001|STARTED|Overall Study||18
8587479|NCT00269477|9622006|FG002|STARTED|Overall Study||58
8587480|NCT00269477|9622007|FG003|STARTED|Overall Study||60
8587481|NCT00269477|9622004|FG000|COMPLETED|Overall Study||4
8587482|NCT00269477|9622005|FG001|COMPLETED|Overall Study||12
8587483|NCT00269477|9622006|FG002|COMPLETED|Overall Study||57
8587484|NCT00269477|9622007|FG003|COMPLETED|Overall Study||60
8587485|NCT00269477|9622004|FG000|NOT COMPLETED|Overall Study||5
8587486|NCT00269477|9622005|FG001|NOT COMPLETED|Overall Study||6
8587487|NCT00269477|9622006|FG002|NOT COMPLETED|Overall Study||1
8587488|NCT00269477|9622007|FG003|NOT COMPLETED|Overall Study||0
8587489|NCT00269633|9622019|FG000|STARTED|Overall Study||4
8587490|NCT00269633|9622020|FG001|STARTED|Overall Study||5
8587491|NCT00269633|9622019|FG000|COMPLETED|Overall Study||3
8587492|NCT00269633|9622020|FG001|COMPLETED|Overall Study||5
8587493|NCT00269633|9622019|FG000|NOT COMPLETED|Overall Study||1
8587494|NCT00269633|9622020|FG001|NOT COMPLETED|Overall Study||0
8587495|NCT00269919|9622026|FG000|STARTED|Overall Study||40
8587496|NCT00269919|9622026|FG000|Treated|Overall Study||39
8587497|NCT00269919|9622026|FG000|COMPLETED|Overall Study||13
8587498|NCT00269919|9622026|FG000|NOT COMPLETED|Overall Study||27
8587499|NCT00270205|9622035|FG000|STARTED|Overall Study||6
8587500|NCT00270205|9622036|FG001|STARTED|Overall Study|7 participants enrolled. One never started study vaccination and was excluded from all analyses.|6
8587501|NCT00270205|9622037|FG002|STARTED|Overall Study||6
8587502|NCT00270205|9622038|FG003|STARTED|Overall Study||7
8587503|NCT00270205|9622035|FG000|COMPLETED|Overall Study||5
8587504|NCT00270205|9622036|FG001|COMPLETED|Overall Study||6
8587505|NCT00270205|9622037|FG002|COMPLETED|Overall Study||6
8587506|NCT00270205|9622038|FG003|COMPLETED|Overall Study||6
8587507|NCT00270205|9622035|FG000|NOT COMPLETED|Overall Study||1
8587508|NCT00270205|9622036|FG001|NOT COMPLETED|Overall Study||0
8587509|NCT00270205|9622037|FG002|NOT COMPLETED|Overall Study||0
8587510|NCT00270205|9622038|FG003|NOT COMPLETED|Overall Study||1
8587511|NCT00270231|9622048|FG000|STARTED|First Intervention||32
8587512|NCT00270231|9622049|FG001|STARTED|First Intervention||32
8587513|NCT00270231|9622048|FG000|COMPLETED|First Intervention||31
8587514|NCT00270231|9622049|FG001|COMPLETED|First Intervention||31
8587515|NCT00270231|9622048|FG000|NOT COMPLETED|First Intervention||1
8711181|NCT00960934|9757561|FG005|NOT COMPLETED|Overall Study||64
8711182|NCT00960986|9757579|FG000|STARTED|Period 1 (Screening and Washout)||59
8711183|NCT00960986|9757580|FG001|STARTED|Period 1 (Screening and Washout)||63
8711184|NCT00960986|9757581|FG002|STARTED|Period 1 (Screening and Washout)||63
8711185|NCT00960986|9757582|FG003|STARTED|Period 1 (Screening and Washout)||64
8711186|NCT00960986|9757579|FG000|COMPLETED|Period 1 (Screening and Washout)||56
8711187|NCT00960986|9757580|FG001|COMPLETED|Period 1 (Screening and Washout)||59
8711188|NCT00960986|9757581|FG002|COMPLETED|Period 1 (Screening and Washout)||59
8711189|NCT00960986|9757582|FG003|COMPLETED|Period 1 (Screening and Washout)||61
8711190|NCT00960986|9757579|FG000|NOT COMPLETED|Period 1 (Screening and Washout)||3
8587516|NCT00270231|9622049|FG001|NOT COMPLETED|First Intervention||1
8587517|NCT00270231|9622048|FG000|STARTED|Washout Period||31
8587518|NCT00270231|9622049|FG001|STARTED|Washout Period||31
8587519|NCT00270231|9622048|FG000|COMPLETED|Washout Period||30
8587520|NCT00270231|9622049|FG001|COMPLETED|Washout Period||31
8587521|NCT00270231|9622048|FG000|NOT COMPLETED|Washout Period||1
8587522|NCT00270231|9622049|FG001|NOT COMPLETED|Washout Period||0
8587523|NCT00270231|9622048|FG000|STARTED|Second Intervention||30
8587524|NCT00270231|9622049|FG001|STARTED|Second Intervention||31
8587525|NCT00270231|9622048|FG000|COMPLETED|Second Intervention||30
8587526|NCT00270231|9622049|FG001|COMPLETED|Second Intervention||30
8587527|NCT00270231|9622048|FG000|NOT COMPLETED|Second Intervention||0
8587528|NCT00270231|9622049|FG001|NOT COMPLETED|Second Intervention||1
8587529|NCT00270257|9622057|FG000|STARTED|Overall Study||623
8587530|NCT00270257|9622058|FG001|STARTED|Overall Study|1 excluded from analysis (enrollment date exceeded eligibility window by 13 days)|628
8587531|NCT00270257|9622057|FG000|Week 8|Overall Study||510
8587532|NCT00270257|9622058|FG001|Week 8|Overall Study||443
8587533|NCT00270257|9622057|FG000|Week 26|Overall Study||460
8587534|NCT00270257|9622058|FG001|Week 26|Overall Study||440
8587535|NCT00270257|9622057|FG000|Week 52|Overall Study||362
8587536|NCT00270257|9622058|FG001|Week 52|Overall Study||340
8587537|NCT00270257|9622057|FG000|Week 78|Overall Study||283
8587538|NCT00270257|9622058|FG001|Week 78|Overall Study||285
8587539|NCT00270257|9622057|FG000|Visit 104|Overall Study||211
8587540|NCT00270257|9622058|FG001|Visit 104|Overall Study||204
8587541|NCT00270257|9622057|FG000|COMPLETED|Overall Study||211
8587542|NCT00270257|9622058|FG001|COMPLETED|Overall Study||204
8587543|NCT00270257|9622057|FG000|NOT COMPLETED|Overall Study||412
8587544|NCT00270257|9622058|FG001|NOT COMPLETED|Overall Study||424
8587545|NCT00270296|9622069|FG000|STARTED|Overall Study||285
8587546|NCT00270296|9622070|FG001|STARTED|Overall Study||275
8587547|NCT00270296|9622071|FG002|STARTED|Overall Study||170
8587548|NCT00270296|9622069|FG000|COMPLETED|Overall Study||186
8587549|NCT00270296|9622070|FG001|COMPLETED|Overall Study||185
8587550|NCT00270296|9622071|FG002|COMPLETED|Overall Study||109
8587551|NCT00270296|9622069|FG000|NOT COMPLETED|Overall Study||99
8587552|NCT00270296|9622070|FG001|NOT COMPLETED|Overall Study||90
8587553|NCT00270296|9622071|FG002|NOT COMPLETED|Overall Study||61
8587554|NCT00270634|9622083|FG000|STARTED|Overall Study||87
8587555|NCT00270634|9622084|FG001|STARTED|Overall Study||77
8587556|NCT00270634|9622085|FG002|STARTED|Overall Study||84
8587557|NCT00270634|9622086|FG003|STARTED|Overall Study||86
8587558|NCT00270634|9622083|FG000|COMPLETED|Overall Study||70
8587559|NCT00270634|9622084|FG001|COMPLETED|Overall Study||64
8587560|NCT00270634|9622085|FG002|COMPLETED|Overall Study||62
8587561|NCT00270634|9622086|FG003|COMPLETED|Overall Study||81
8587562|NCT00270634|9622083|FG000|NOT COMPLETED|Overall Study||17
8587563|NCT00270634|9622084|FG001|NOT COMPLETED|Overall Study||13
8587564|NCT00270634|9622085|FG002|NOT COMPLETED|Overall Study||22
8587565|NCT00270634|9622086|FG003|NOT COMPLETED|Overall Study||5
8587566|NCT00270790|9622100|FG000|STARTED|Overall Study||21
8587567|NCT00270790|9622100|FG000|COMPLETED|Overall Study||16
8587568|NCT00270790|9622100|FG000|NOT COMPLETED|Overall Study||5
8587569|NCT00270842|9622107|FG000|STARTED|Overall Study||33
8587570|NCT00270842|9622108|FG001|STARTED|Overall Study||34
8587571|NCT00270842|9622109|FG002|STARTED|Overall Study||34
8587572|NCT00270842|9622107|FG000|COMPLETED|Overall Study||18
8587573|NCT00270842|9622108|FG001|COMPLETED|Overall Study||18
8587574|NCT00270842|9622109|FG002|COMPLETED|Overall Study||18
8587575|NCT00270842|9622107|FG000|NOT COMPLETED|Overall Study||15
8587576|NCT00270842|9622108|FG001|NOT COMPLETED|Overall Study||16
8587577|NCT00270842|9622109|FG002|NOT COMPLETED|Overall Study||16
8587578|NCT00270855|9622119|FG000|STARTED|Overall Study||15
8587579|NCT00270855|9622120|FG001|STARTED|Overall Study||14
8587580|NCT00270855|9622119|FG000|COMPLETED|Overall Study||7
8587581|NCT00270855|9622120|FG001|COMPLETED|Overall Study||6
8587582|NCT00270855|9622119|FG000|NOT COMPLETED|Overall Study||8
8587583|NCT00270855|9622120|FG001|NOT COMPLETED|Overall Study||8
8711191|NCT00960986|9757580|FG001|NOT COMPLETED|Period 1 (Screening and Washout)||4
8587584|NCT00270894|9622128|FG000|STARTED|Overall Study||30
8587585|NCT00270894|9622128|FG000|COMPLETED|Overall Study||28
8587586|NCT00270894|9622128|FG000|NOT COMPLETED|Overall Study||2
8587587|NCT00270998|9622135|FG000|STARTED|3 Month Follow-up||149
8587588|NCT00270998|9622136|FG001|STARTED|3 Month Follow-up||146
8587589|NCT00270998|9622137|FG002|STARTED|3 Month Follow-up|1 participant randomized to combined found ineligible at first treatment visit, removed from study.|150
8587590|NCT00270998|9622135|FG000|COMPLETED|3 Month Follow-up||110
8587591|NCT00270998|9622136|FG001|COMPLETED|3 Month Follow-up||124
8587592|NCT00270998|9622137|FG002|COMPLETED|3 Month Follow-up||132
8587593|NCT00270998|9622135|FG000|NOT COMPLETED|3 Month Follow-up||39
8587594|NCT00270998|9622136|FG001|NOT COMPLETED|3 Month Follow-up||22
8587595|NCT00270998|9622137|FG002|NOT COMPLETED|3 Month Follow-up||18
8587596|NCT00270998|9622135|FG000|STARTED|12 Month Follow-up||110
8587597|NCT00270998|9622136|FG001|STARTED|12 Month Follow-up||124
8587598|NCT00270998|9622137|FG002|STARTED|12 Month Follow-up||132
8587599|NCT00270998|9622135|FG000|COMPLETED|12 Month Follow-up||96
8587600|NCT00270998|9622136|FG001|COMPLETED|12 Month Follow-up||99
8587601|NCT00270998|9622137|FG002|COMPLETED|12 Month Follow-up||111
8587602|NCT00270998|9622135|FG000|NOT COMPLETED|12 Month Follow-up||14
8587603|NCT00270998|9622136|FG001|NOT COMPLETED|12 Month Follow-up||25
8587604|NCT00270998|9622137|FG002|NOT COMPLETED|12 Month Follow-up||21
8587605|NCT00271024|9622151|FG000|STARTED|Overall Study||80
8587606|NCT00271024|9622152|FG001|STARTED|Overall Study||77
8587607|NCT00271024|9622153|FG002|STARTED|Overall Study||88
8587608|NCT00271024|9622154|FG003|STARTED|Overall Study||88
8587609|NCT00271024|9622151|FG000|Received Study Treatment|Overall Study|n=4 did not start treatment (3 lost interest, 1 unknown)|76
8587610|NCT00271024|9622152|FG001|Received Study Treatment|Overall Study|n=6 did not start treatment (1 diff treat. desired, 3 lost interest, 1 began psych meds, 1 unknown)|71
8587611|NCT00271024|9622153|FG002|Received Study Treatment|Overall Study|n=3 did not start treatment (2 lost interest, 1 unknown)|85
8587612|NCT00271024|9622154|FG003|Received Study Treatment|Overall Study|n=5 did not start treatment (2 health problems, 1 wanted diff. treatment method, 2 lost interest)|83
8587613|NCT00271024|9622151|FG000|COMPLETED|Overall Study|Discontinued: 1 smoking related, 1 reaction to tablet, 6 time commitment, 2 other, 8 unspecified|58
8587614|NCT00271024|9622152|FG001|COMPLETED|Overall Study|Discontinued: 5 smoking related, 3 reaction to tablet, 2 time commitment, 1 other, 9 unspecified|51
8587615|NCT00271024|9622153|FG002|COMPLETED|Overall Study|Discontinued: 5 smoking related, 4 reaction to tablet, 4 time commitment, 3 other, 4 unspecified|65
8587616|NCT00271024|9622154|FG003|COMPLETED|Overall Study|Discontinued: 9 smoking related, 2 reaction to tablet, 4 time commitment, 1 other, 3 unspecified|64
8587617|NCT00271024|9622151|FG000|NOT COMPLETED|Overall Study||22
8587618|NCT00271024|9622152|FG001|NOT COMPLETED|Overall Study||26
8587619|NCT00271024|9622153|FG002|NOT COMPLETED|Overall Study||23
8587620|NCT00271024|9622154|FG003|NOT COMPLETED|Overall Study||24
8587621|NCT00271154|9622166|FG000|STARTED|Overall Study||191
8587622|NCT00271154|9622167|FG001|STARTED|Overall Study||419
8587623|NCT00271154|9622166|FG000|COMPLETED|Overall Study||191
8587624|NCT00271154|9622167|FG001|COMPLETED|Overall Study||419
8587625|NCT00271154|9622166|FG000|NOT COMPLETED|Overall Study||0
8587626|NCT00271154|9622167|FG001|NOT COMPLETED|Overall Study||0
8587627|NCT00271219|9622176|FG000|STARTED|Overall Study||89
8587628|NCT00271219|9622177|FG001|STARTED|Overall Study||86
8587629|NCT00271219|9622176|FG000|COMPLETED|Overall Study||73
8587630|NCT00271219|9622177|FG001|COMPLETED|Overall Study||58
8587631|NCT00271219|9622176|FG000|NOT COMPLETED|Overall Study||16
8587632|NCT00271219|9622177|FG001|NOT COMPLETED|Overall Study||28
8587633|NCT00271375|9622190|FG000|STARTED|Overall Study||114
8587634|NCT00271375|9622191|FG001|STARTED|Overall Study||83
8587635|NCT00271375|9622192|FG002|STARTED|Overall Study||57
8587636|NCT00271375|9622190|FG000|COMPLETED|Overall Study||114
8587637|NCT00271375|9622191|FG001|COMPLETED|Overall Study||83
8587638|NCT00271375|9622192|FG002|COMPLETED|Overall Study||57
8587639|NCT00271375|9622190|FG000|NOT COMPLETED|Overall Study||0
8587640|NCT00271375|9622191|FG001|NOT COMPLETED|Overall Study||0
8587641|NCT00271375|9622192|FG002|NOT COMPLETED|Overall Study||0
8587642|NCT00271505|9622201|FG000|STARTED|Overall Study||43
8587643|NCT00271505|9622201|FG000|COMPLETED|Overall Study||38
8587644|NCT00271505|9622201|FG000|NOT COMPLETED|Overall Study||5
8587645|NCT00271570|9622208|FG000|STARTED|Overall Study||12
8587646|NCT00271570|9622209|FG001|STARTED|Overall Study||12
8587647|NCT00271570|9622208|FG000|COMPLETED|Overall Study||12
8587648|NCT00271570|9622209|FG001|COMPLETED|Overall Study||12
8587649|NCT00271570|9622208|FG000|NOT COMPLETED|Overall Study||0
8587650|NCT00271570|9622209|FG001|NOT COMPLETED|Overall Study||0
8587651|NCT00271596|9622217|FG000|STARTED|Overall Study||17
8587652|NCT00271596|9622218|FG001|STARTED|Overall Study||16
8587653|NCT00271596|9622217|FG000|COMPLETED|Overall Study||16
8587654|NCT00271596|9622218|FG001|COMPLETED|Overall Study||15
8587655|NCT00271596|9622217|FG000|NOT COMPLETED|Overall Study||1
8587656|NCT00271596|9622218|FG001|NOT COMPLETED|Overall Study||1
8587657|NCT00271609|9622226|FG000|STARTED|Overall Study||56
8587658|NCT00271609|9622227|FG001|STARTED|Overall Study||32
8587659|NCT00271609|9622226|FG000|COMPLETED|Overall Study||43
8587660|NCT00271609|9622227|FG001|COMPLETED|Overall Study||29
8587661|NCT00271609|9622226|FG000|NOT COMPLETED|Overall Study||13
8587662|NCT00271609|9622227|FG001|NOT COMPLETED|Overall Study||3
8587663|NCT00271739|9622235|FG000|STARTED|Overall Study||844
8587664|NCT00271739|9622236|FG001|STARTED|Overall Study||821
8587665|NCT00271739|9622235|FG000|COMPLETED|Overall Study||729
8587666|NCT00271739|9622236|FG001|COMPLETED|Overall Study||716
8587667|NCT00271739|9622235|FG000|NOT COMPLETED|Overall Study||115
8587668|NCT00271739|9622236|FG001|NOT COMPLETED|Overall Study||105
8587669|NCT00271856|9622244|FG000|STARTED|Overall Study||89
8587670|NCT00271856|9622245|FG001|STARTED|Overall Study||88
8587671|NCT00271856|9622244|FG000|COMPLETED|Overall Study||78
8587672|NCT00271856|9622245|FG001|COMPLETED|Overall Study||70
8587673|NCT00271856|9622244|FG000|NOT COMPLETED|Overall Study||11
8587674|NCT00271856|9622245|FG001|NOT COMPLETED|Overall Study||18
8587675|NCT00272038|9622251|FG000|STARTED|Overall Study||29
8587676|NCT00272038|9622251|FG000|COMPLETED|Overall Study||22
8587677|NCT00272038|9622251|FG000|NOT COMPLETED|Overall Study||7
8587678|NCT00272168|9622258|FG000|STARTED|Overall Study||47
8587679|NCT00272168|9622259|FG001|STARTED|Overall Study||41
8587680|NCT00272168|9622258|FG000|COMPLETED|Overall Study||37
8587681|NCT00272168|9622259|FG001|COMPLETED|Overall Study||31
8587682|NCT00272168|9622258|FG000|NOT COMPLETED|Overall Study||10
8587683|NCT00272168|9622259|FG001|NOT COMPLETED|Overall Study||10
8587684|NCT00272311|9622270|FG000|STARTED|Overall Study||14
8587685|NCT00272311|9622271|FG001|STARTED|Overall Study||14
8587686|NCT00272311|9622272|FG002|STARTED|Overall Study||14
8587687|NCT00272311|9622273|FG003|STARTED|Overall Study||14
8587688|NCT00272311|9622274|FG004|STARTED|Overall Study||14
8587689|NCT00272311|9622270|FG000|COMPLETED|Overall Study||14
8587690|NCT00272311|9622271|FG001|COMPLETED|Overall Study||14
8587691|NCT00272311|9622272|FG002|COMPLETED|Overall Study||14
8587692|NCT00272311|9622273|FG003|COMPLETED|Overall Study||14
8587693|NCT00272311|9622274|FG004|COMPLETED|Overall Study||14
8587694|NCT00272311|9622270|FG000|NOT COMPLETED|Overall Study||0
8587695|NCT00272311|9622271|FG001|NOT COMPLETED|Overall Study||0
8587696|NCT00272311|9622272|FG002|NOT COMPLETED|Overall Study||0
8587697|NCT00272311|9622273|FG003|NOT COMPLETED|Overall Study||0
8587698|NCT00272311|9622274|FG004|NOT COMPLETED|Overall Study||0
8587699|NCT00272337|9622291|FG000|STARTED|Overall Study||8
8587700|NCT00272337|9622292|FG001|STARTED|Overall Study||7
8587701|NCT00272337|9622293|FG002|STARTED|Overall Study||7
8587702|NCT00272337|9622294|FG003|STARTED|Overall Study||7
8587703|NCT00272337|9622295|FG004|STARTED|Overall Study||8
8587704|NCT00272337|9622291|FG000|COMPLETED|Overall Study||8
8587705|NCT00272337|9622292|FG001|COMPLETED|Overall Study||7
8587706|NCT00272337|9622293|FG002|COMPLETED|Overall Study||7
8587707|NCT00272337|9622294|FG003|COMPLETED|Overall Study||7
8587708|NCT00272337|9622295|FG004|COMPLETED|Overall Study||8
8587709|NCT00272337|9622291|FG000|NOT COMPLETED|Overall Study||0
8587710|NCT00272337|9622292|FG001|NOT COMPLETED|Overall Study||0
8587711|NCT00272337|9622293|FG002|NOT COMPLETED|Overall Study||0
8587712|NCT00272337|9622294|FG003|NOT COMPLETED|Overall Study||0
8587713|NCT00272337|9622295|FG004|NOT COMPLETED|Overall Study||0
8587714|NCT00272779|9622309|FG000|STARTED|Baseline Through Week 48|Number of participants randomized to ATV|440
8587715|NCT00272779|9622310|FG001|STARTED|Baseline Through Week 48|Number of participants randomized to LPV|443
8587716|NCT00272779|9622309|FG000|RECEIVED ANY TREATMENT|Baseline Through Week 48|1 participant randomized to LPV received ATV instead (treatment error)|441
8587717|NCT00272779|9622310|FG001|RECEIVED ANY TREATMENT|Baseline Through Week 48|3 participants received ATV instead of LPV (treatment error), 3 participants never treated with LPV|437
8587718|NCT00272779|9622309|FG000|TREATED AS RANDOMIZED|Baseline Through Week 48||438
8587719|NCT00272779|9622310|FG001|TREATED AS RANDOMIZED|Baseline Through Week 48||440
8587720|NCT00272779|9622309|FG000|Discontinued Before Week 48|Baseline Through Week 48||39
8587721|NCT00272779|9622310|FG001|Discontinued Before Week 48|Baseline Through Week 48||58
8587722|NCT00272779|9622309|FG000|Discontinued on or After Week 48|Baseline Through Week 48||14
8587723|NCT00272779|9622310|FG001|Discontinued on or After Week 48|Baseline Through Week 48||14
8587724|NCT00272779|9622309|FG000|STILL ON TREATMENT|Baseline Through Week 48||385
8587725|NCT00272779|9622310|FG001|STILL ON TREATMENT|Baseline Through Week 48||368
8587726|NCT00272779|9622309|FG000|COMPLETED|Baseline Through Week 48||0
8587727|NCT00272779|9622310|FG001|COMPLETED|Baseline Through Week 48||0
8587728|NCT00272779|9622309|FG000|NOT COMPLETED|Baseline Through Week 48||440
8587729|NCT00272779|9622310|FG001|NOT COMPLETED|Baseline Through Week 48||443
8587730|NCT00272779|9622309|FG000|STARTED|Baseline Through Week 96|Number randomized to ATV|440
8587731|NCT00272779|9622310|FG001|STARTED|Baseline Through Week 96|Number randomized to LPV|443
8587732|NCT00272779|9622309|FG000|RECEIVED ANY TREATMENT|Baseline Through Week 96|1 participant randomized to LPV received ATV instead (treatment error)|441
8587733|NCT00272779|9622310|FG001|RECEIVED ANY TREATMENT|Baseline Through Week 96|3 participants received ATV instead of LPV (treatment error) and 3 participants never treated|437
8587734|NCT00272779|9622309|FG000|COMPLETED|Baseline Through Week 96||301
8587735|NCT00272779|9622310|FG001|COMPLETED|Baseline Through Week 96||307
8587736|NCT00272779|9622309|FG000|NOT COMPLETED|Baseline Through Week 96||139
8587737|NCT00272779|9622310|FG001|NOT COMPLETED|Baseline Through Week 96||136
8587738|NCT00272792|9622319|FG000|STARTED|Part 1: Responsiveness||90
8587739|NCT00272792|9622320|FG001|STARTED|Part 1: Responsiveness||0
8587740|NCT00272792|9622319|FG000|COMPLETED|Part 1: Responsiveness||89
8587741|NCT00272792|9622320|FG001|COMPLETED|Part 1: Responsiveness||0
8587742|NCT00272792|9622319|FG000|NOT COMPLETED|Part 1: Responsiveness||1
8587743|NCT00272792|9622320|FG001|NOT COMPLETED|Part 1: Responsiveness||0
8587744|NCT00272792|9622319|FG000|STARTED|Part 2: Blinded, Placebo Control Period||33
8587745|NCT00272792|9622320|FG001|STARTED|Part 2: Blinded, Placebo Control Period||12
8587746|NCT00272792|9622319|FG000|COMPLETED|Part 2: Blinded, Placebo Control Period||32
8587747|NCT00272792|9622320|FG001|COMPLETED|Part 2: Blinded, Placebo Control Period||9
8587748|NCT00272792|9622319|FG000|NOT COMPLETED|Part 2: Blinded, Placebo Control Period||1
8587749|NCT00272792|9622320|FG001|NOT COMPLETED|Part 2: Blinded, Placebo Control Period||3
8587750|NCT00272844|9622326|FG000|STARTED|Overall Study||23
8587751|NCT00272844|9622326|FG000|COMPLETED|Overall Study||18
8587752|NCT00272844|9622326|FG000|NOT COMPLETED|Overall Study||5
8587753|NCT00272961|9622335|FG000|STARTED|Placebo Run-in Phase: Up to Week 2||60
8587754|NCT00272961|9622336|FG001|STARTED|Placebo Run-in Phase: Up to Week 2||0
8587755|NCT00272961|9622337|FG002|STARTED|Placebo Run-in Phase: Up to Week 2||0
8587756|NCT00272961|9622338|FG003|STARTED|Placebo Run-in Phase: Up to Week 2||0
8587757|NCT00272961|9622339|FG004|STARTED|Placebo Run-in Phase: Up to Week 2||0
8587758|NCT00272961|9622335|FG000|COMPLETED|Placebo Run-in Phase: Up to Week 2||49
8587759|NCT00272961|9622336|FG001|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
8587760|NCT00272961|9622337|FG002|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
8587761|NCT00272961|9622338|FG003|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
8587762|NCT00272961|9622339|FG004|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
8587763|NCT00272961|9622335|FG000|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||11
8587764|NCT00272961|9622336|FG001|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
8587765|NCT00272961|9622337|FG002|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
8587766|NCT00272961|9622338|FG003|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
8587767|NCT00272961|9622339|FG004|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
8587768|NCT00272961|9622335|FG000|STARTED|Treatment Phase: Week 3 Up to Week 12||10
8587769|NCT00272961|9622336|FG001|STARTED|Treatment Phase: Week 3 Up to Week 12||8
8587770|NCT00272961|9622337|FG002|STARTED|Treatment Phase: Week 3 Up to Week 12||11
8587771|NCT00272961|9622338|FG003|STARTED|Treatment Phase: Week 3 Up to Week 12||10
8587772|NCT00272961|9622339|FG004|STARTED|Treatment Phase: Week 3 Up to Week 12||10
8587773|NCT00272961|9622335|FG000|COMPLETED|Treatment Phase: Week 3 Up to Week 12||8
8587774|NCT00272961|9622336|FG001|COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
8587775|NCT00272961|9622337|FG002|COMPLETED|Treatment Phase: Week 3 Up to Week 12||7
8587776|NCT00272961|9622338|FG003|COMPLETED|Treatment Phase: Week 3 Up to Week 12||7
8587777|NCT00272961|9622339|FG004|COMPLETED|Treatment Phase: Week 3 Up to Week 12||6
8587778|NCT00272961|9622335|FG000|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||2
8587779|NCT00272961|9622336|FG001|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
8587780|NCT00272961|9622337|FG002|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
8587781|NCT00272961|9622338|FG003|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||3
8587782|NCT00272961|9622339|FG004|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
8587783|NCT00272987|9622354|FG000|STARTED|Overall Study||29
8587784|NCT00272987|9622355|FG001|STARTED|Overall Study||14
8587785|NCT00272987|9622356|FG002|STARTED|Overall Study||20
8587786|NCT00272987|9622354|FG000|COMPLETED|Overall Study||20
8587787|NCT00272987|9622355|FG001|COMPLETED|Overall Study||10
8587788|NCT00272987|9622356|FG002|COMPLETED|Overall Study||9
8587789|NCT00272987|9622354|FG000|NOT COMPLETED|Overall Study||9
8587790|NCT00272987|9622355|FG001|NOT COMPLETED|Overall Study||4
8587791|NCT00272987|9622356|FG002|NOT COMPLETED|Overall Study||11
8587792|NCT00273052|9622366|FG000|STARTED|Overall Study||290
8587793|NCT00273052|9622367|FG001|STARTED|Overall Study||278
8587794|NCT00273052|9622366|FG000|COMPLETED|Overall Study||221
8587795|NCT00273052|9622367|FG001|COMPLETED|Overall Study||190
8587796|NCT00273052|9622366|FG000|NOT COMPLETED|Overall Study||69
8587797|NCT00273052|9622367|FG001|NOT COMPLETED|Overall Study||88
8587798|NCT00273182|9622373|FG000|STARTED|Overall Study||1999
8587799|NCT00273182|9622373|FG000|COMPLETED|Overall Study||1014
8587800|NCT00273182|9622373|FG000|NOT COMPLETED|Overall Study||985
8587801|NCT00273364|9622380|FG000|STARTED|Overall Study||55
8587802|NCT00273364|9622381|FG001|STARTED|Overall Study||55
8587803|NCT00273364|9622380|FG000|COMPLETED|Overall Study||55
8587804|NCT00273364|9622381|FG001|COMPLETED|Overall Study||55
8587805|NCT00273364|9622380|FG000|NOT COMPLETED|Overall Study||0
8587806|NCT00273364|9622381|FG001|NOT COMPLETED|Overall Study||0
8587807|NCT00273754|9622389|FG000|STARTED|Overall Study||36
8587808|NCT00273754|9622390|FG001|STARTED|Overall Study||36
8587809|NCT00273754|9622389|FG000|COMPLETED|Overall Study||36
8587810|NCT00273754|9622390|FG001|COMPLETED|Overall Study||36
8587811|NCT00273754|9622389|FG000|NOT COMPLETED|Overall Study||0
8587812|NCT00273754|9622390|FG001|NOT COMPLETED|Overall Study||0
8587813|NCT00273793|9622402|FG000|STARTED|Overall Study||36
8587814|NCT00273793|9622403|FG001|STARTED|Overall Study||38
8587815|NCT00273793|9622404|FG002|STARTED|Overall Study||18
8711192|NCT00960986|9757581|FG002|NOT COMPLETED|Period 1 (Screening and Washout)||4
8711193|NCT00960986|9757582|FG003|NOT COMPLETED|Period 1 (Screening and Washout)||3
8711194|NCT00960986|9757579|FG000|STARTED|Period 2 (1-week Initial Dosing Period)||56
8711195|NCT00960986|9757580|FG001|STARTED|Period 2 (1-week Initial Dosing Period)||59
8711196|NCT00960986|9757581|FG002|STARTED|Period 2 (1-week Initial Dosing Period)||59
8711197|NCT00960986|9757582|FG003|STARTED|Period 2 (1-week Initial Dosing Period)||61
8587816|NCT00273793|9622405|FG003|STARTED|Overall Study||60
8587817|NCT00273793|9622406|FG004|STARTED|Overall Study||58
8587818|NCT00273793|9622407|FG005|STARTED|Overall Study||29
8587819|NCT00273793|9622402|FG000|COMPLETED|Overall Study||36
8587820|NCT00273793|9622403|FG001|COMPLETED|Overall Study||38
8587821|NCT00273793|9622404|FG002|COMPLETED|Overall Study||18
8587822|NCT00273793|9622405|FG003|COMPLETED|Overall Study||60
8587823|NCT00273793|9622406|FG004|COMPLETED|Overall Study||58
8587824|NCT00273793|9622407|FG005|COMPLETED|Overall Study||29
8587825|NCT00273793|9622402|FG000|NOT COMPLETED|Overall Study||0
8587826|NCT00273793|9622403|FG001|NOT COMPLETED|Overall Study||0
8587827|NCT00273793|9622404|FG002|NOT COMPLETED|Overall Study||0
8587828|NCT00273793|9622405|FG003|NOT COMPLETED|Overall Study||0
8587829|NCT00273793|9622406|FG004|NOT COMPLETED|Overall Study||0
8587830|NCT00273793|9622407|FG005|NOT COMPLETED|Overall Study||0
8587831|NCT00273858|9622421|FG000|STARTED|Overall Study||880
8587832|NCT00273858|9622421|FG000|COMPLETED|Overall Study||343
8587833|NCT00273858|9622421|FG000|NOT COMPLETED|Overall Study||537
8587834|NCT00273910|9622431|FG000|STARTED|Overall Study||19
8587835|NCT00273910|9622432|FG001|STARTED|Overall Study||19
8587836|NCT00273910|9622433|FG002|STARTED|Overall Study||18
8587837|NCT00273910|9622434|FG003|STARTED|Overall Study||19
8587838|NCT00273910|9622435|FG004|STARTED|Overall Study||15
8587839|NCT00273910|9622436|FG005|STARTED|Overall Study||14
8587840|NCT00273910|9622431|FG000|COMPLETED|Overall Study||19
8587841|NCT00273910|9622432|FG001|COMPLETED|Overall Study||19
8587842|NCT00273910|9622433|FG002|COMPLETED|Overall Study||18
8587843|NCT00273910|9622434|FG003|COMPLETED|Overall Study||19
8587844|NCT00273910|9622435|FG004|COMPLETED|Overall Study||15
8587845|NCT00273910|9622436|FG005|COMPLETED|Overall Study||14
8587846|NCT00273910|9622431|FG000|NOT COMPLETED|Overall Study||0
8587847|NCT00273910|9622432|FG001|NOT COMPLETED|Overall Study||0
8587848|NCT00273910|9622433|FG002|NOT COMPLETED|Overall Study||0
8587849|NCT00273910|9622434|FG003|NOT COMPLETED|Overall Study||0
8587850|NCT00273910|9622435|FG004|NOT COMPLETED|Overall Study||0
8587851|NCT00273910|9622436|FG005|NOT COMPLETED|Overall Study||0
8587852|NCT00274261|9622452|FG000|STARTED|Overall Study||932
8587853|NCT00274261|9622453|FG001|STARTED|Overall Study||633
8587854|NCT00274261|9622452|FG000|COMPLETED|Overall Study||443
8587855|NCT00274261|9622453|FG001|COMPLETED|Overall Study||296
8587856|NCT00274261|9622452|FG000|NOT COMPLETED|Overall Study||489
8587857|NCT00274261|9622453|FG001|NOT COMPLETED|Overall Study||337
8587858|NCT00274287|9622461|FG000|STARTED|Overall Study||15
8587859|NCT00274287|9622461|FG000|COMPLETED|Overall Study||13
8587860|NCT00274287|9622461|FG000|NOT COMPLETED|Overall Study||2
8587861|NCT00274456|9622470|FG000|STARTED|Overall Study||76
8587862|NCT00274456|9622471|FG001|STARTED|Overall Study||76
8587863|NCT00274456|9622472|FG002|STARTED|Overall Study||74
8587864|NCT00274456|9622473|FG003|STARTED|Overall Study||74
8587865|NCT00274456|9622470|FG000|At Least One Response Assessment|Overall Study||73
8587866|NCT00274456|9622471|FG001|At Least One Response Assessment|Overall Study||76
8587867|NCT00274456|9622472|FG002|At Least One Response Assessment|Overall Study||73
8587868|NCT00274456|9622473|FG003|At Least One Response Assessment|Overall Study||70
8587869|NCT00274456|9622470|FG000|COMPLETED|Overall Study|Treatment completed upon progressive disease|39
8587870|NCT00274456|9622471|FG001|COMPLETED|Overall Study|Treatment completed upon progressive disease|49
8587871|NCT00274456|9622472|FG002|COMPLETED|Overall Study|Treatment completed upon progressive disease|39
8587872|NCT00274456|9622473|FG003|COMPLETED|Overall Study|Treatment completed upon progressive disease|29
8587873|NCT00274456|9622470|FG000|NOT COMPLETED|Overall Study||37
8587874|NCT00274456|9622471|FG001|NOT COMPLETED|Overall Study||27
8587875|NCT00274456|9622472|FG002|NOT COMPLETED|Overall Study||35
8587876|NCT00274456|9622473|FG003|NOT COMPLETED|Overall Study||45
8587877|NCT00274469|9622485|FG000|STARTED|Overall Study|Number of patients randomized|102
8587878|NCT00274469|9622486|FG001|STARTED|Overall Study|Number of patients randomized|103
8587879|NCT00274469|9622485|FG000|COMPLETED|Overall Study|Number of patients ongoing study treatment at data cut-off|23
8587880|NCT00274469|9622486|FG001|COMPLETED|Overall Study|Number of patients ongoing study treatment at data cut-off|10
8587881|NCT00274469|9622485|FG000|NOT COMPLETED|Overall Study||79
8587882|NCT00274469|9622486|FG001|NOT COMPLETED|Overall Study||93
8587883|NCT00274625|9622494|FG000|STARTED|Overall Study||199
8587884|NCT00274625|9622495|FG001|STARTED|Overall Study||203
8587885|NCT00274625|9622494|FG000|COMPLETED|Overall Study||139
8587886|NCT00274625|9622495|FG001|COMPLETED|Overall Study||141
8587887|NCT00274625|9622494|FG000|NOT COMPLETED|Overall Study||60
8587888|NCT00274625|9622495|FG001|NOT COMPLETED|Overall Study||62
8587889|NCT00274651|9622503|FG000|STARTED|Overall Study||29
8587890|NCT00274651|9622504|FG001|STARTED|Overall Study||24
8587891|NCT00274651|9622503|FG000|COMPLETED|Overall Study||1
8587892|NCT00274651|9622504|FG001|COMPLETED|Overall Study||4
8587893|NCT00274651|9622503|FG000|NOT COMPLETED|Overall Study||28
8587894|NCT00274651|9622504|FG001|NOT COMPLETED|Overall Study||20
8587895|NCT00274716|9622517|FG000|STARTED|Phase A||54
8587896|NCT00274716|9622518|FG001|STARTED|Phase A||54
8587897|NCT00274716|9622519|FG002|STARTED|Phase A||52
8587898|NCT00274716|9622520|FG003|STARTED|Phase A||51
8587899|NCT00274716|9622521|FG004|STARTED|Phase A||19
8587900|NCT00274716|9622522|FG005|STARTED|Phase A||19
8587901|NCT00274716|9622517|FG000|COMPLETED|Phase A||43
8587902|NCT00274716|9622518|FG001|COMPLETED|Phase A||44
8587903|NCT00274716|9622519|FG002|COMPLETED|Phase A||44
8587904|NCT00274716|9622520|FG003|COMPLETED|Phase A||42
8587905|NCT00274716|9622521|FG004|COMPLETED|Phase A||16
8587906|NCT00274716|9622522|FG005|COMPLETED|Phase A||15
8587907|NCT00274716|9622517|FG000|NOT COMPLETED|Phase A||11
8587908|NCT00274716|9622518|FG001|NOT COMPLETED|Phase A||10
8587909|NCT00274716|9622519|FG002|NOT COMPLETED|Phase A||8
8587910|NCT00274716|9622520|FG003|NOT COMPLETED|Phase A||9
8587911|NCT00274716|9622521|FG004|NOT COMPLETED|Phase A||3
8587912|NCT00274716|9622522|FG005|NOT COMPLETED|Phase A||4
8587913|NCT00274716|9622517|FG000|STARTED|Phase B||43
8587914|NCT00274716|9622518|FG001|STARTED|Phase B||44
8587915|NCT00274716|9622519|FG002|STARTED|Phase B||44
8587916|NCT00274716|9622520|FG003|STARTED|Phase B||42
8587917|NCT00274716|9622521|FG004|STARTED|Phase B||16
8587918|NCT00274716|9622522|FG005|STARTED|Phase B||15
8587919|NCT00274716|9622517|FG000|COMPLETED|Phase B||42
8587920|NCT00274716|9622518|FG001|COMPLETED|Phase B||40
8587921|NCT00274716|9622519|FG002|COMPLETED|Phase B||41
8587922|NCT00274716|9622520|FG003|COMPLETED|Phase B||41
8587923|NCT00274716|9622521|FG004|COMPLETED|Phase B||16
8587924|NCT00274716|9622522|FG005|COMPLETED|Phase B||14
8587925|NCT00274716|9622517|FG000|NOT COMPLETED|Phase B||1
8587926|NCT00274716|9622518|FG001|NOT COMPLETED|Phase B||4
8587927|NCT00274716|9622519|FG002|NOT COMPLETED|Phase B||3
8587928|NCT00274716|9622520|FG003|NOT COMPLETED|Phase B||1
8587929|NCT00274716|9622521|FG004|NOT COMPLETED|Phase B||0
8587930|NCT00274716|9622522|FG005|NOT COMPLETED|Phase B||1
8587931|NCT00274742|9622546|FG000|STARTED|Overall Study||12
8587932|NCT00274742|9622547|FG001|STARTED|Overall Study||13
8587933|NCT00274742|9622548|FG002|STARTED|Overall Study||6
8587934|NCT00274742|9622549|FG003|STARTED|Overall Study||9
8587935|NCT00274742|9622550|FG004|STARTED|Overall Study||32
8587936|NCT00274742|9622551|FG005|STARTED|Overall Study||4
8587937|NCT00274742|9622546|FG000|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|12
8587938|NCT00274742|9622547|FG001|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|5
8587939|NCT00274742|9622548|FG002|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|4
8587940|NCT00274742|9622549|FG003|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|4
8587941|NCT00274742|9622550|FG004|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|16
8587942|NCT00274742|9622551|FG005|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|1
8587943|NCT00274742|9622546|FG000|NOT COMPLETED|Overall Study||0
8587944|NCT00274742|9622547|FG001|NOT COMPLETED|Overall Study||8
8587945|NCT00274742|9622548|FG002|NOT COMPLETED|Overall Study||2
8587946|NCT00274742|9622549|FG003|NOT COMPLETED|Overall Study||5
8587947|NCT00274742|9622550|FG004|NOT COMPLETED|Overall Study||16
8587948|NCT00274742|9622551|FG005|NOT COMPLETED|Overall Study||3
8587949|NCT00274768|9622571|FG000|STARTED|Overall Study||26
8587950|NCT00274768|9622571|FG000|COMPLETED|Overall Study||26
8587951|NCT00274768|9622571|FG000|NOT COMPLETED|Overall Study||0
8587952|NCT00274781|9622575|FG000|STARTED|Overall Study||30
8587953|NCT00274781|9622575|FG000|COMPLETED|Overall Study||30
8587954|NCT00274781|9622575|FG000|NOT COMPLETED|Overall Study||0
8587955|NCT00274846|9622580|FG000|STARTED|Overall Study||21
8587956|NCT00274846|9622580|FG000|COMPLETED|Overall Study|Evaluable patients - received adequate natural killer (NK) cells|20
8587957|NCT00274846|9622580|FG000|NOT COMPLETED|Overall Study||1
8587958|NCT00274924|9622588|FG000|STARTED|Step 1 (R-CHOP X 3 Cycles)||17
8587959|NCT00274924|9622589|FG001|STARTED|Step 1 (R-CHOP X 3 Cycles)||77
8587960|NCT00274924|9622590|FG002|STARTED|Step 1 (R-CHOP X 3 Cycles)||6
8587961|NCT00274924|9622588|FG000|Treated|Step 1 (R-CHOP X 3 Cycles)||17
8587962|NCT00274924|9622589|FG001|Treated|Step 1 (R-CHOP X 3 Cycles)||77
8587963|NCT00274924|9622590|FG002|Treated|Step 1 (R-CHOP X 3 Cycles)||5
8587964|NCT00274924|9622588|FG000|Eligible and Treated|Step 1 (R-CHOP X 3 Cycles)||13
8587965|NCT00274924|9622589|FG001|Eligible and Treated|Step 1 (R-CHOP X 3 Cycles)||63
8587966|NCT00274924|9622590|FG002|Eligible and Treated|Step 1 (R-CHOP X 3 Cycles)||4
8587967|NCT00274924|9622588|FG000|COMPLETED|Step 1 (R-CHOP X 3 Cycles)||13
8587968|NCT00274924|9622589|FG001|COMPLETED|Step 1 (R-CHOP X 3 Cycles)||63
8587969|NCT00274924|9622590|FG002|COMPLETED|Step 1 (R-CHOP X 3 Cycles)||0
8587970|NCT00274924|9622588|FG000|NOT COMPLETED|Step 1 (R-CHOP X 3 Cycles)||4
8587971|NCT00274924|9622589|FG001|NOT COMPLETED|Step 1 (R-CHOP X 3 Cycles)||14
8587972|NCT00274924|9622590|FG002|NOT COMPLETED|Step 1 (R-CHOP X 3 Cycles)||6
8711198|NCT00960986|9757579|FG000|COMPLETED|Period 2 (1-week Initial Dosing Period)||56
8711199|NCT00960986|9757580|FG001|COMPLETED|Period 2 (1-week Initial Dosing Period)||59
8711200|NCT00960986|9757581|FG002|COMPLETED|Period 2 (1-week Initial Dosing Period)||59
8711201|NCT00960986|9757582|FG003|COMPLETED|Period 2 (1-week Initial Dosing Period)||61
8711202|NCT00960986|9757579|FG000|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
8711203|NCT00960986|9757580|FG001|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
8711204|NCT00960986|9757581|FG002|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
8711205|NCT00960986|9757582|FG003|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
8711206|NCT00960986|9757579|FG000|STARTED|Period 3 (7-week Therapy Period)||56
8587973|NCT00274924|9622588|FG000|STARTED|Step 2 (Tx Based on Mid-treatment PET)|All patients who started step 2 therapy were included regardless of eligibility.|17
8587974|NCT00274924|9622589|FG001|STARTED|Step 2 (Tx Based on Mid-treatment PET)|One patient withdrew from the study after step 1 treatment.|76
8587975|NCT00274924|9622590|FG002|STARTED|Step 2 (Tx Based on Mid-treatment PET)||0
8587976|NCT00274924|9622588|FG000|Eligible and Treated|Step 2 (Tx Based on Mid-treatment PET)||13
8587977|NCT00274924|9622589|FG001|Eligible and Treated|Step 2 (Tx Based on Mid-treatment PET)||61
8587978|NCT00274924|9622590|FG002|Eligible and Treated|Step 2 (Tx Based on Mid-treatment PET)||0
8587979|NCT00274924|9622588|FG000|COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||10
8587980|NCT00274924|9622589|FG001|COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||58
8587981|NCT00274924|9622590|FG002|COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||0
8587982|NCT00274924|9622588|FG000|NOT COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||7
8587983|NCT00274924|9622589|FG001|NOT COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||18
8587984|NCT00274924|9622590|FG002|NOT COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||0
8587985|NCT00274937|9622597|FG000|STARTED|Overall Study||111
8587986|NCT00274937|9622597|FG000|COMPLETED|Overall Study||91
8587987|NCT00274937|9622597|FG000|NOT COMPLETED|Overall Study||20
8587988|NCT00275002|9622603|FG000|STARTED|Overall Study||25
8587989|NCT00275002|9622604|FG001|STARTED|Overall Study||16
8587990|NCT00275002|9622603|FG000|COMPLETED|Overall Study||3
8587991|NCT00275002|9622604|FG001|COMPLETED|Overall Study||0
8587992|NCT00275002|9622603|FG000|NOT COMPLETED|Overall Study||22
8587993|NCT00275002|9622604|FG001|NOT COMPLETED|Overall Study||16
8587994|NCT00275028|9622610|FG000|STARTED|Overall Study||47
8587995|NCT00275028|9622610|FG000|COMPLETED|Overall Study|Participants are treated until one of the below milestones is reached. Completion is N/A.|0
8587996|NCT00275028|9622610|FG000|NOT COMPLETED|Overall Study||47
8587997|NCT00275262|9622616|FG000|STARTED|Overall Study||12
8587998|NCT00275262|9622617|FG001|STARTED|Overall Study||13
8587999|NCT00275262|9622616|FG000|COMPLETED|Overall Study|Patients who completed the entire 12 month study period|6
8588000|NCT00275262|9622617|FG001|COMPLETED|Overall Study|Patients who completed the entire 12 month study period|4
8588001|NCT00275262|9622616|FG000|NOT COMPLETED|Overall Study||6
8588002|NCT00275262|9622617|FG001|NOT COMPLETED|Overall Study||9
8588003|NCT00275275|9622626|FG000|STARTED|Overall Study||20
8588004|NCT00275275|9622627|FG001|STARTED|Overall Study||20
8588005|NCT00275275|9622628|FG002|STARTED|Overall Study|One participant was removed after enrollment and before any data was collected for him.|21
8588006|NCT00275275|9622626|FG000|COMPLETED|Overall Study||14
8588007|NCT00275275|9622627|FG001|COMPLETED|Overall Study||18
8588008|NCT00275275|9622628|FG002|COMPLETED|Overall Study||15
8588009|NCT00275275|9622626|FG000|NOT COMPLETED|Overall Study||6
8588010|NCT00275275|9622627|FG001|NOT COMPLETED|Overall Study||2
8588011|NCT00275275|9622628|FG002|NOT COMPLETED|Overall Study||6
8588012|NCT00275301|9622636|FG000|STARTED|Overall Study||19
8588013|NCT00275301|9622636|FG000|COMPLETED|Overall Study||14
8588014|NCT00275301|9622636|FG000|NOT COMPLETED|Overall Study||5
8588015|NCT00275392|9622642|FG000|STARTED|Overall Study||20
8588016|NCT00275392|9622643|FG001|STARTED|Overall Study||19
8588017|NCT00275392|9622642|FG000|COMPLETED|Overall Study||20
8588018|NCT00275392|9622643|FG001|COMPLETED|Overall Study||17
8588019|NCT00275392|9622642|FG000|NOT COMPLETED|Overall Study||0
8588020|NCT00275392|9622643|FG001|NOT COMPLETED|Overall Study||2
8588021|NCT00275509|9622651|FG000|STARTED|Overall Study||30
8588022|NCT00275509|9622652|FG001|STARTED|Overall Study||26
8588023|NCT00275509|9622651|FG000|COMPLETED|Overall Study||30
8588024|NCT00275509|9622652|FG001|COMPLETED|Overall Study||25
8588025|NCT00275509|9622651|FG000|NOT COMPLETED|Overall Study||0
8588026|NCT00275509|9622652|FG001|NOT COMPLETED|Overall Study||1
8588027|NCT00275561|9622660|FG000|STARTED|Overall Study||21
8588028|NCT00275561|9622661|FG001|STARTED|Overall Study||21
8588029|NCT00275561|9622660|FG000|COMPLETED|Overall Study||19
8588030|NCT00275561|9622661|FG001|COMPLETED|Overall Study||15
8588031|NCT00275561|9622660|FG000|NOT COMPLETED|Overall Study||2
8588032|NCT00275561|9622661|FG001|NOT COMPLETED|Overall Study||6
8588033|NCT00275821|9622670|FG000|STARTED|Overall Study||120
8588034|NCT00275821|9622671|FG001|STARTED|Overall Study||118
8588035|NCT00275821|9622672|FG002|STARTED|Overall Study||115
8588036|NCT00275821|9622670|FG000|COMPLETED|Overall Study||106
8588037|NCT00275821|9622671|FG001|COMPLETED|Overall Study||95
8588038|NCT00275821|9622672|FG002|COMPLETED|Overall Study||103
8588039|NCT00275821|9622670|FG000|NOT COMPLETED|Overall Study||14
8588040|NCT00275821|9622671|FG001|NOT COMPLETED|Overall Study||23
8588041|NCT00275821|9622672|FG002|NOT COMPLETED|Overall Study||12
8588042|NCT00275834|9622683|FG000|STARTED|Overall Study||74
8588043|NCT00275834|9622684|FG001|STARTED|Overall Study||76
8588044|NCT00275834|9622685|FG002|STARTED|Overall Study||75
8588045|NCT00275834|9622683|FG000|Completed Study While on Study Drug|Overall Study||54
8588046|NCT00275834|9622684|FG001|Completed Study While on Study Drug|Overall Study||51
8588047|NCT00275834|9622685|FG002|Completed Study While on Study Drug|Overall Study||62
8588048|NCT00275834|9622683|FG000|COMPLETED|Overall Study||71
8588049|NCT00275834|9622684|FG001|COMPLETED|Overall Study||73
8588050|NCT00275834|9622685|FG002|COMPLETED|Overall Study||74
8588051|NCT00275834|9622683|FG000|NOT COMPLETED|Overall Study||3
8588052|NCT00275834|9622684|FG001|NOT COMPLETED|Overall Study||3
8588053|NCT00275834|9622685|FG002|NOT COMPLETED|Overall Study||1
8588054|NCT00276094|9622698|FG000|STARTED|Overall Study||282
8588055|NCT00276094|9622699|FG001|STARTED|Overall Study||276
8588056|NCT00276094|9622700|FG002|STARTED|Overall Study||268
8588057|NCT00276094|9622698|FG000|COMPLETED|Overall Study||225
8588058|NCT00276094|9622699|FG001|COMPLETED|Overall Study||234
8588059|NCT00276094|9622700|FG002|COMPLETED|Overall Study||230
8588060|NCT00276094|9622698|FG000|NOT COMPLETED|Overall Study||57
8588061|NCT00276094|9622699|FG001|NOT COMPLETED|Overall Study||42
8588062|NCT00276094|9622700|FG002|NOT COMPLETED|Overall Study||38
8588063|NCT00276159|9622708|FG000|STARTED|Overall Study||6
8588064|NCT00276159|9622708|FG000|COMPLETED|Overall Study||0
8588065|NCT00276159|9622708|FG000|NOT COMPLETED|Overall Study||6
8627870|NCT00519636|9667245|FG003|NOT COMPLETED|Treatment Period 1||0
8627871|NCT00519636|9667242|FG000|STARTED|Washout Period||89
8627872|NCT00519636|9667243|FG001|STARTED|Washout Period||86
8627873|NCT00519636|9667244|FG002|STARTED|Washout Period||89
8627874|NCT00519636|9667245|FG003|STARTED|Washout Period||93
8627875|NCT00519636|9667242|FG000|COMPLETED|Washout Period||69
8627876|NCT00519636|9667243|FG001|COMPLETED|Washout Period||72
8627877|NCT00519636|9667244|FG002|COMPLETED|Washout Period||75
8627878|NCT00519636|9667245|FG003|COMPLETED|Washout Period||88
8627879|NCT00519636|9667242|FG000|NOT COMPLETED|Washout Period||20
8627880|NCT00519636|9667243|FG001|NOT COMPLETED|Washout Period||14
8627881|NCT00519636|9667244|FG002|NOT COMPLETED|Washout Period||14
8627882|NCT00519636|9667245|FG003|NOT COMPLETED|Washout Period||5
8627883|NCT00519636|9667242|FG000|STARTED|Treatment Period 2||69
8627884|NCT00519636|9667243|FG001|STARTED|Treatment Period 2||72
8627885|NCT00519636|9667244|FG002|STARTED|Treatment Period 2||75
8588066|NCT00276250|9622715|FG000|STARTED|Overall Study||4
8588067|NCT00276250|9622716|FG001|STARTED|Overall Study||1
8588068|NCT00276250|9622717|FG002|STARTED|Overall Study||0
8588069|NCT00276250|9622715|FG000|COMPLETED|Overall Study||4
8588070|NCT00276250|9622716|FG001|COMPLETED|Overall Study||1
8588071|NCT00276250|9622717|FG002|COMPLETED|Overall Study||0
8588072|NCT00276250|9622715|FG000|NOT COMPLETED|Overall Study||0
8588073|NCT00276250|9622716|FG001|NOT COMPLETED|Overall Study||0
8588074|NCT00276250|9622717|FG002|NOT COMPLETED|Overall Study||0
8588075|NCT00276380|9622727|FG000|STARTED|Overall Study||102
8588076|NCT00276380|9622728|FG001|STARTED|Overall Study||102
8588077|NCT00276380|9622727|FG000|COMPLETED|Overall Study||88
8588078|NCT00276380|9622728|FG001|COMPLETED|Overall Study||88
8588079|NCT00276380|9622727|FG000|NOT COMPLETED|Overall Study||14
8588080|NCT00276380|9622728|FG001|NOT COMPLETED|Overall Study||14
8588081|NCT00276406|9622737|FG000|STARTED|Overall Study||16
8588082|NCT00276406|9622738|FG001|STARTED|Overall Study||14
8588083|NCT00276406|9622737|FG000|COMPLETED|Overall Study|14 of 16 subjects tolerated 360mg daily, while 2 of 16 tolerated 180mg daily.|16
8588084|NCT00276406|9622738|FG001|COMPLETED|Overall Study||14
8588085|NCT00276406|9622737|FG000|NOT COMPLETED|Overall Study||0
8588086|NCT00276406|9622738|FG001|NOT COMPLETED|Overall Study||0
8588087|NCT00276549|9622744|FG000|STARTED|Overall Study||35
8588088|NCT00276549|9622744|FG000|COMPLETED|Overall Study||35
8588089|NCT00276549|9622744|FG000|NOT COMPLETED|Overall Study||0
8588090|NCT00276614|9622748|FG000|STARTED|Overall Study||4
8588091|NCT00276614|9622748|FG000|COMPLETED|Overall Study||1
8588092|NCT00276614|9622748|FG000|NOT COMPLETED|Overall Study||3
8588093|NCT00276744|9622752|FG000|STARTED|PART A||240
8588094|NCT00276744|9622752|FG000|COMPLETED|PART A||142
8588095|NCT00276744|9622752|FG000|NOT COMPLETED|PART A||98
8588096|NCT00276744|9622752|FG000|STARTED|PART B|This study was terminated before participants could reach this stage of the study.|0
8588097|NCT00276744|9622752|FG000|COMPLETED|PART B||0
8588098|NCT00276744|9622752|FG000|NOT COMPLETED|PART B||0
8588099|NCT00276861|9622756|FG000|STARTED|Overall Study||10
8588100|NCT00276861|9622756|FG000|COMPLETED|Overall Study||10
8588101|NCT00276861|9622756|FG000|NOT COMPLETED|Overall Study||0
8588102|NCT00277095|9622761|FG000|STARTED|Overall Study|Anatomy of 1 patient did not allow ProACT to be implanted, hence only 123 patients were implanted.|124
8588103|NCT00277095|9622761|FG000|COMPLETED|Overall Study|Details of patients who did not complete study are given below.|103
8588104|NCT00277095|9622761|FG000|NOT COMPLETED|Overall Study||21
8588105|NCT00277212|9622765|FG000|STARTED|Phase 1 - Single-Blind Treatment||787
8588106|NCT00277212|9622766|FG001|STARTED|Phase 1 - Single-Blind Treatment||0
8588107|NCT00277212|9622767|FG002|STARTED|Phase 1 - Single-Blind Treatment||0
8588108|NCT00277212|9622765|FG000|Phase 1 Safety Sample|Phase 1 - Single-Blind Treatment||787
8588109|NCT00277212|9622766|FG001|Phase 1 Safety Sample|Phase 1 - Single-Blind Treatment||0
8588110|NCT00277212|9622767|FG002|Phase 1 Safety Sample|Phase 1 - Single-Blind Treatment||0
8588111|NCT00277212|9622765|FG000|Phase 1 Efficacy Sample|Phase 1 - Single-Blind Treatment||756
8588112|NCT00277212|9622766|FG001|Phase 1 Efficacy Sample|Phase 1 - Single-Blind Treatment||0
8588113|NCT00277212|9622767|FG002|Phase 1 Efficacy Sample|Phase 1 - Single-Blind Treatment||0
8588114|NCT00277212|9622765|FG000|COMPLETED|Phase 1 - Single-Blind Treatment||352
8588115|NCT00277212|9622766|FG001|COMPLETED|Phase 1 - Single-Blind Treatment||0
8588116|NCT00277212|9622767|FG002|COMPLETED|Phase 1 - Single-Blind Treatment||0
8588117|NCT00277212|9622765|FG000|NOT COMPLETED|Phase 1 - Single-Blind Treatment||435
8588118|NCT00277212|9622766|FG001|NOT COMPLETED|Phase 1 - Single-Blind Treatment||0
8588119|NCT00277212|9622767|FG002|NOT COMPLETED|Phase 1 - Single-Blind Treatment||0
8588120|NCT00277212|9622765|FG000|STARTED|Phase 2 - Double-Blind Treatment||0
8588121|NCT00277212|9622766|FG001|STARTED|Phase 2 - Double-Blind Treatment||173
8588122|NCT00277212|9622767|FG002|STARTED|Phase 2 - Double-Blind Treatment|1 participant did not want to continue in the study for personal reasons, and did not enter Phase 2.|178
8588123|NCT00277212|9622765|FG000|Phase 2 Safety Sample|Phase 2 - Double-Blind Treatment||0
8588124|NCT00277212|9622766|FG001|Phase 2 Safety Sample|Phase 2 - Double-Blind Treatment||165
8588125|NCT00277212|9622767|FG002|Phase 2 Safety Sample|Phase 2 - Double-Blind Treatment||176
8588126|NCT00277212|9622765|FG000|Phase 2 Efficacy Sample|Phase 2 - Double-Blind Treatment||0
8711207|NCT00960986|9757580|FG001|STARTED|Period 3 (7-week Therapy Period)||59
8711208|NCT00960986|9757581|FG002|STARTED|Period 3 (7-week Therapy Period)||59
8711209|NCT00960986|9757582|FG003|STARTED|Period 3 (7-week Therapy Period)||61
8711210|NCT00960986|9757579|FG000|COMPLETED|Period 3 (7-week Therapy Period)||26
8711211|NCT00960986|9757580|FG001|COMPLETED|Period 3 (7-week Therapy Period)||36
8711212|NCT00960986|9757581|FG002|COMPLETED|Period 3 (7-week Therapy Period)||39
8711213|NCT00960986|9757582|FG003|COMPLETED|Period 3 (7-week Therapy Period)||36
8711214|NCT00960986|9757579|FG000|NOT COMPLETED|Period 3 (7-week Therapy Period)||30
8711215|NCT00960986|9757580|FG001|NOT COMPLETED|Period 3 (7-week Therapy Period)||23
8711216|NCT00960986|9757581|FG002|NOT COMPLETED|Period 3 (7-week Therapy Period)||20
8711217|NCT00960986|9757582|FG003|NOT COMPLETED|Period 3 (7-week Therapy Period)||25
8711218|NCT00960999|9757594|FG000|STARTED|Overall Study||47
8711219|NCT00960999|9757595|FG001|STARTED|Overall Study||47
8711220|NCT00960999|9757594|FG000|Eligible|Overall Study||39
8711221|NCT00960999|9757595|FG001|Eligible|Overall Study||45
8711222|NCT00960999|9757594|FG000|Started Protocol Treatment|Overall Study||39
8711223|NCT00960999|9757595|FG001|Started Protocol Treatment|Overall Study||45
8711224|NCT00960999|9757594|FG000|Primary Endpoint Population|Overall Study||38
8588127|NCT00277212|9622766|FG001|Phase 2 Efficacy Sample|Phase 2 - Double-Blind Treatment||164
8588128|NCT00277212|9622767|FG002|Phase 2 Efficacy Sample|Phase 2 - Double-Blind Treatment||174
8588129|NCT00277212|9622765|FG000|COMPLETED|Phase 2 - Double-Blind Treatment||0
8588130|NCT00277212|9622766|FG001|COMPLETED|Phase 2 - Double-Blind Treatment||53
8588131|NCT00277212|9622767|FG002|COMPLETED|Phase 2 - Double-Blind Treatment||65
8588132|NCT00277212|9622765|FG000|NOT COMPLETED|Phase 2 - Double-Blind Treatment||0
8588133|NCT00277212|9622766|FG001|NOT COMPLETED|Phase 2 - Double-Blind Treatment||120
8588134|NCT00277212|9622767|FG002|NOT COMPLETED|Phase 2 - Double-Blind Treatment||113
8588135|NCT00277355|9622777|FG000|STARTED|Overall Study||87
8588136|NCT00277355|9622778|FG001|STARTED|Overall Study||27
8588137|NCT00277355|9622777|FG000|COMPLETED|Overall Study||73
8588138|NCT00277355|9622778|FG001|COMPLETED|Overall Study||22
8588139|NCT00277355|9622777|FG000|NOT COMPLETED|Overall Study||14
8588140|NCT00277355|9622778|FG001|NOT COMPLETED|Overall Study||5
8588141|NCT00277394|9622787|FG000|STARTED|Overall Study||269
8588142|NCT00277394|9622788|FG001|STARTED|Overall Study||270
8588143|NCT00277394|9622787|FG000|COMPLETED|Overall Study||232
8588144|NCT00277394|9622788|FG001|COMPLETED|Overall Study||246
8588145|NCT00277394|9622787|FG000|NOT COMPLETED|Overall Study||37
8588146|NCT00277394|9622788|FG001|NOT COMPLETED|Overall Study||24
8588147|NCT00277446|9622794|FG000|STARTED|Overall Study||13
8588148|NCT00277446|9622794|FG000|COMPLETED|Overall Study||13
8588149|NCT00277446|9622794|FG000|NOT COMPLETED|Overall Study||0
8588150|NCT00277524|9622798|FG000|STARTED|Overall Study||621
8588151|NCT00277524|9622799|FG001|STARTED|Overall Study||324
8711225|NCT00960999|9757595|FG001|Primary Endpoint Population|Overall Study||38
8711226|NCT00960999|9757594|FG000|Peak SUV at 8 Weeks|Overall Study||3
8711227|NCT00960999|9757595|FG001|Peak SUV at 8 Weeks|Overall Study||11
8711228|NCT00960999|9757594|FG000|Peak SUV at 1 Year|Overall Study||4
8711229|NCT00960999|9757595|FG001|Peak SUV at 1 Year|Overall Study||7
8711230|NCT00960999|9757594|FG000|Normalized SUV at 8 Weeks|Overall Study||3
8711231|NCT00960999|9757595|FG001|Normalized SUV at 8 Weeks|Overall Study||9
8711232|NCT00960999|9757594|FG000|Normalized SUV at 1 Year|Overall Study||4
8588152|NCT00277524|9622800|FG002|STARTED|Overall Study||1088
8588153|NCT00277524|9622801|FG003|STARTED|Overall Study||850
8588154|NCT00277524|9622798|FG000|COMPLETED|Overall Study||621
8588155|NCT00277524|9622799|FG001|COMPLETED|Overall Study||324
8588156|NCT00277524|9622800|FG002|COMPLETED|Overall Study||1088
8588157|NCT00277524|9622801|FG003|COMPLETED|Overall Study||850
8588158|NCT00277524|9622798|FG000|NOT COMPLETED|Overall Study||0
8588159|NCT00277524|9622799|FG001|NOT COMPLETED|Overall Study||0
8588160|NCT00277524|9622800|FG002|NOT COMPLETED|Overall Study||0
8588161|NCT00277524|9622801|FG003|NOT COMPLETED|Overall Study||0
8588162|NCT00278109|9622819|FG000|STARTED|Overall Study||25
8588163|NCT00278109|9622819|FG000|Completed 3 Cycles of Chemotherapy|Overall Study||25
8588164|NCT00278109|9622819|FG000|COMPLETED|Overall Study||21
8588165|NCT00278109|9622819|FG000|NOT COMPLETED|Overall Study||4
8588166|NCT00278148|9622823|FG000|STARTED|Phase I - Dose Escalation||4
8588167|NCT00278148|9622824|FG001|STARTED|Phase I - Dose Escalation||2
8588168|NCT00278148|9622825|FG002|STARTED|Phase I - Dose Escalation||3
8588169|NCT00278148|9622823|FG000|COMPLETED|Phase I - Dose Escalation||4
8588170|NCT00278148|9622824|FG001|COMPLETED|Phase I - Dose Escalation||2
8588171|NCT00278148|9622825|FG002|COMPLETED|Phase I - Dose Escalation||3
8588172|NCT00278148|9622823|FG000|NOT COMPLETED|Phase I - Dose Escalation||0
8588173|NCT00278148|9622824|FG001|NOT COMPLETED|Phase I - Dose Escalation||0
8588174|NCT00278148|9622825|FG002|NOT COMPLETED|Phase I - Dose Escalation||0
8588175|NCT00278148|9622823|FG000|STARTED|Phase II - Expansion Phase||0
8588176|NCT00278148|9622824|FG001|STARTED|Phase II - Expansion Phase||0
8588177|NCT00278148|9622825|FG002|STARTED|Phase II - Expansion Phase|Includes the 3 participants from phase I|26
8588178|NCT00278148|9622823|FG000|COMPLETED|Phase II - Expansion Phase||0
8588179|NCT00278148|9622824|FG001|COMPLETED|Phase II - Expansion Phase||0
8588180|NCT00278148|9622825|FG002|COMPLETED|Phase II - Expansion Phase||20
8588181|NCT00278148|9622823|FG000|NOT COMPLETED|Phase II - Expansion Phase||0
8588182|NCT00278148|9622824|FG001|NOT COMPLETED|Phase II - Expansion Phase||0
8588183|NCT00278148|9622825|FG002|NOT COMPLETED|Phase II - Expansion Phase||6
8588184|NCT00278161|9622832|FG000|STARTED|Overall Study||81
8588185|NCT00278161|9622832|FG000|COMPLETED|Overall Study||70
8588186|NCT00278161|9622832|FG000|NOT COMPLETED|Overall Study||11
8588187|NCT00278200|9622838|FG000|STARTED|Overall Study||2
8588188|NCT00278200|9622839|FG001|STARTED|Overall Study||12
8588189|NCT00278200|9622838|FG000|COMPLETED|Overall Study||1
8588190|NCT00278200|9622839|FG001|COMPLETED|Overall Study||8
8813028|NCT01523704|9866144|FG000|NOT COMPLETED|Overall Study||78
8813029|NCT01523704|9866145|FG001|NOT COMPLETED|Overall Study||88
8588191|NCT00278200|9622838|FG000|NOT COMPLETED|Overall Study||1
8588192|NCT00278200|9622839|FG001|NOT COMPLETED|Overall Study||4
8588193|NCT00278395|9622845|FG000|STARTED|Overall Study||14
8588194|NCT00278395|9622845|FG000|COMPLETED|Overall Study||11
8588195|NCT00278395|9622845|FG000|NOT COMPLETED|Overall Study||3
8588196|NCT00278473|9622854|FG000|STARTED|Overall Study||45
8588197|NCT00278473|9622855|FG001|STARTED|Overall Study||43
8588198|NCT00278473|9622854|FG000|COMPLETED|Overall Study||41
8588199|NCT00278473|9622855|FG001|COMPLETED|Overall Study||40
8588200|NCT00278473|9622854|FG000|NOT COMPLETED|Overall Study||4
8588201|NCT00278473|9622855|FG001|NOT COMPLETED|Overall Study||3
8588202|NCT00278512|9622863|FG000|STARTED|Overall Study||7
8588203|NCT00278512|9622864|FG001|STARTED|Overall Study||0
8588204|NCT00278512|9622863|FG000|COMPLETED|Overall Study||6
8813030|NCT01523743|9866152|FG000|STARTED|Period 1||63
8813031|NCT01523743|9866153|FG001|STARTED|Period 1||62
8813032|NCT01523743|9866152|FG000|COMPLETED|Period 1||53
8813033|NCT01523743|9866153|FG001|COMPLETED|Period 1||60
8588205|NCT00278512|9622864|FG001|COMPLETED|Overall Study||0
8588206|NCT00278512|9622863|FG000|NOT COMPLETED|Overall Study||1
8588207|NCT00278512|9622864|FG001|NOT COMPLETED|Overall Study||0
8588208|NCT00278525|9622872|FG000|STARTED|Overall Study||9
8588209|NCT00278525|9622873|FG001|STARTED|Overall Study||10
8588210|NCT00278525|9622872|FG000|COMPLETED|Overall Study|7 participants crossed to HSCT arm in accordance with the protocol|9
8588211|NCT00278525|9622873|FG001|COMPLETED|Overall Study|7 participant crossed over to the HSCT arm and underwent HSCT, in accordance with the protocol.|10
8588212|NCT00278525|9622872|FG000|NOT COMPLETED|Overall Study||0
8588213|NCT00278525|9622873|FG001|NOT COMPLETED|Overall Study||0
8588214|NCT00278538|9622879|FG000|STARTED|Overall Study||32
8588215|NCT00278538|9622879|FG000|COMPLETED|Overall Study||30
8588216|NCT00278538|9622879|FG000|NOT COMPLETED|Overall Study||2
8588217|NCT00278564|9622883|FG000|STARTED|Overall Study||7
8588218|NCT00278564|9622883|FG000|COMPLETED|Overall Study||3
8588219|NCT00278564|9622883|FG000|NOT COMPLETED|Overall Study||4
8588220|NCT00278629|9622887|FG000|STARTED|Overall Study||80
8588221|NCT00278629|9622887|FG000|COMPLETED|Overall Study||66
8588222|NCT00278629|9622887|FG000|NOT COMPLETED|Overall Study||14
8588223|NCT00278655|9622892|FG000|STARTED|Overall Study||21
8588224|NCT00278655|9622892|FG000|COMPLETED|Overall Study||21
8588225|NCT00278655|9622892|FG000|NOT COMPLETED|Overall Study||0
8588226|NCT00278863|9622899|FG000|STARTED|Overall Study||49
8588227|NCT00278863|9622900|FG001|STARTED|Overall Study||47
8588228|NCT00278863|9622899|FG000|COMPLETED|Overall Study||44
8588229|NCT00278863|9622900|FG001|COMPLETED|Overall Study||45
8588230|NCT00278863|9622899|FG000|NOT COMPLETED|Overall Study||5
8588231|NCT00278863|9622900|FG001|NOT COMPLETED|Overall Study||2
8588232|NCT00278876|9622906|FG000|STARTED|Overall Study||47
8588233|NCT00278876|9622906|FG000|COMPLETED|Overall Study||38
8588234|NCT00278876|9622906|FG000|NOT COMPLETED|Overall Study||9
8588235|NCT00278889|9622913|FG000|STARTED|Overall Study|Randomised|73
8588236|NCT00278889|9622914|FG001|STARTED|Overall Study|Randomised|74
8588237|NCT00278889|9622915|FG002|STARTED|Overall Study|Randomised|68
8588238|NCT00278889|9622913|FG000|Overall Survival Analysis|Overall Study|Ongoing at data cut-off for OS analysis (30 January 2009)|16
8588239|NCT00278889|9622914|FG001|Overall Survival Analysis|Overall Study|Ongoing at data cut-off for OS analysis (30 January 2009)|20
8588240|NCT00278889|9622915|FG002|Overall Survival Analysis|Overall Study|Ongoing at data cut-off for OS analysis (30 January 2009)|19
8588241|NCT00278889|9622913|FG000|COMPLETED|Overall Study|Ongoing at data cut-off for PFS analysis (November 2007)|48
8588242|NCT00278889|9622914|FG001|COMPLETED|Overall Study|Ongoing at data cut-off for PFS analysis (November 2007)|47
8588243|NCT00278889|9622915|FG002|COMPLETED|Overall Study|Ongoing at data cut-off for PFS analysis (November 2007)|48
8588244|NCT00278889|9622913|FG000|NOT COMPLETED|Overall Study||25
8588245|NCT00278889|9622914|FG001|NOT COMPLETED|Overall Study||27
8588246|NCT00278889|9622915|FG002|NOT COMPLETED|Overall Study||20
8588247|NCT00278954|9622923|FG000|STARTED|Overall Study||50
8588248|NCT00278954|9622923|FG000|COMPLETED|Overall Study||45
8588249|NCT00278954|9622923|FG000|NOT COMPLETED|Overall Study||5
8588250|NCT00278993|9622927|FG000|STARTED|Overall Study||108
8588251|NCT00278993|9622927|FG000|COMPLETED|Overall Study||1
8588252|NCT00278993|9622927|FG000|NOT COMPLETED|Overall Study||107
8588253|NCT00279201|9622933|FG000|STARTED|Initiation||1046
8588254|NCT00279201|9622934|FG001|STARTED|Initiation||1045
8588255|NCT00279201|9622935|FG002|STARTED|Initiation||0
8588256|NCT00279201|9622936|FG003|STARTED|Initiation||0
8588257|NCT00279201|9622937|FG004|STARTED|Initiation||0
8588258|NCT00279201|9622938|FG005|STARTED|Initiation||0
8588259|NCT00279201|9622933|FG000|COMPLETED|Initiation||918
8588260|NCT00279201|9622934|FG001|COMPLETED|Initiation||900
8588261|NCT00279201|9622935|FG002|COMPLETED|Initiation||0
8588262|NCT00279201|9622936|FG003|COMPLETED|Initiation||0
8588263|NCT00279201|9622937|FG004|COMPLETED|Initiation||0
8588264|NCT00279201|9622938|FG005|COMPLETED|Initiation||0
8588265|NCT00279201|9622933|FG000|NOT COMPLETED|Initiation||128
8588266|NCT00279201|9622934|FG001|NOT COMPLETED|Initiation||145
8588267|NCT00279201|9622935|FG002|NOT COMPLETED|Initiation||0
8588268|NCT00279201|9622936|FG003|NOT COMPLETED|Initiation||0
8588269|NCT00279201|9622937|FG004|NOT COMPLETED|Initiation||0
8588270|NCT00279201|9622938|FG005|NOT COMPLETED|Initiation||0
8588271|NCT00279201|9622933|FG000|STARTED|Maintenance|100 left the study after initiation. 399 had HbA1c>7% and enrolled in intensification addendum.|419
8588272|NCT00279201|9622934|FG001|STARTED|Maintenance|82 left the study after initiation. 345 had HbA1c>7% and enrolled in intensification addendum.|473
8588273|NCT00279201|9622935|FG002|STARTED|Maintenance||0
8588274|NCT00279201|9622936|FG003|STARTED|Maintenance||0
8588275|NCT00279201|9622937|FG004|STARTED|Maintenance||0
8588276|NCT00279201|9622938|FG005|STARTED|Maintenance||0
8588277|NCT00279201|9622933|FG000|COMPLETED|Maintenance||188
8588278|NCT00279201|9622934|FG001|COMPLETED|Maintenance||239
8588279|NCT00279201|9622935|FG002|COMPLETED|Maintenance||0
8813034|NCT01523743|9866152|FG000|NOT COMPLETED|Period 1||10
8813035|NCT01523743|9866153|FG001|NOT COMPLETED|Period 1||2
8813036|NCT01523743|9866152|FG000|STARTED|Period 2||53
8588280|NCT00279201|9622936|FG003|COMPLETED|Maintenance||0
8588281|NCT00279201|9622937|FG004|COMPLETED|Maintenance||0
8588282|NCT00279201|9622938|FG005|COMPLETED|Maintenance||0
8588283|NCT00279201|9622933|FG000|NOT COMPLETED|Maintenance||231
8588284|NCT00279201|9622934|FG001|NOT COMPLETED|Maintenance||234
8588285|NCT00279201|9622935|FG002|NOT COMPLETED|Maintenance||0
8588286|NCT00279201|9622936|FG003|NOT COMPLETED|Maintenance||0
8588287|NCT00279201|9622937|FG004|NOT COMPLETED|Maintenance||0
8588288|NCT00279201|9622938|FG005|NOT COMPLETED|Maintenance||0
8588289|NCT00279201|9622933|FG000|STARTED|Intensification Addendum||0
8588290|NCT00279201|9622934|FG001|STARTED|Intensification Addendum||0
8588291|NCT00279201|9622935|FG002|STARTED|Intensification Addendum||174
8588292|NCT00279201|9622936|FG003|STARTED|Intensification Addendum||200
8588293|NCT00279201|9622937|FG004|STARTED|Intensification Addendum||171
8588294|NCT00279201|9622938|FG005|STARTED|Intensification Addendum||199
8588295|NCT00279201|9622933|FG000|COMPLETED|Intensification Addendum||0
8588296|NCT00279201|9622934|FG001|COMPLETED|Intensification Addendum||0
8588297|NCT00279201|9622935|FG002|COMPLETED|Intensification Addendum||151
8588298|NCT00279201|9622936|FG003|COMPLETED|Intensification Addendum||172
8588299|NCT00279201|9622937|FG004|COMPLETED|Intensification Addendum||142
8588300|NCT00279201|9622938|FG005|COMPLETED|Intensification Addendum||162
8588301|NCT00279201|9622933|FG000|NOT COMPLETED|Intensification Addendum||0
8588302|NCT00279201|9622934|FG001|NOT COMPLETED|Intensification Addendum||0
8588303|NCT00279201|9622935|FG002|NOT COMPLETED|Intensification Addendum||23
8588304|NCT00279201|9622936|FG003|NOT COMPLETED|Intensification Addendum||28
8588305|NCT00279201|9622937|FG004|NOT COMPLETED|Intensification Addendum||29
8588306|NCT00279201|9622938|FG005|NOT COMPLETED|Intensification Addendum||37
8588307|NCT00279214|9622973|FG000|STARTED|Overall Study||22
8588308|NCT00279214|9622974|FG001|STARTED|Overall Study||21
8588309|NCT00279214|9622973|FG000|COMPLETED|Overall Study|Completed means the number of per-protocol patients in the study|19
8588310|NCT00279214|9622974|FG001|COMPLETED|Overall Study|Completed means the number of per-protocol patients in the study|19
8588311|NCT00279214|9622973|FG000|NOT COMPLETED|Overall Study||3
8588312|NCT00279214|9622974|FG001|NOT COMPLETED|Overall Study||2
8588313|NCT00279305|9622982|FG000|STARTED|Overall Study||57
8588314|NCT00279305|9622983|FG001|STARTED|Overall Study||30
8588315|NCT00279305|9622982|FG000|COMPLETED|Overall Study||49
8588316|NCT00279305|9622983|FG001|COMPLETED|Overall Study||29
8588317|NCT00279305|9622982|FG000|NOT COMPLETED|Overall Study||8
8588318|NCT00279305|9622983|FG001|NOT COMPLETED|Overall Study||1
8588319|NCT00279500|9622989|FG000|STARTED|Overall Study|6 patients treated|6
8588320|NCT00279500|9622989|FG000|COMPLETED|Overall Study|6 patients treated|6
8588321|NCT00279500|9622989|FG000|NOT COMPLETED|Overall Study||0
8588322|NCT00279591|9622995|FG000|STARTED|Overall Study||48
8588323|NCT00279591|9622996|FG001|STARTED|Overall Study||46
8588324|NCT00279591|9622995|FG000|COMPLETED|Overall Study||48
8588325|NCT00279591|9622996|FG001|COMPLETED|Overall Study||46
8588326|NCT00279591|9622995|FG000|NOT COMPLETED|Overall Study||0
8588327|NCT00279591|9622996|FG001|NOT COMPLETED|Overall Study||0
8588328|NCT00279708|9623006|FG000|STARTED|Overall Study|"Started meaning randomized"|27
8588329|NCT00279708|9623007|FG001|STARTED|Overall Study||28
8588330|NCT00279708|9623006|FG000|COMPLETED|Overall Study||24
8588331|NCT00279708|9623007|FG001|COMPLETED|Overall Study||24
8588332|NCT00279708|9623006|FG000|NOT COMPLETED|Overall Study||3
8588333|NCT00279708|9623007|FG001|NOT COMPLETED|Overall Study||4
8588334|NCT00279812|9623019|FG000|STARTED|Overall Study||21
8588335|NCT00279812|9623020|FG001|STARTED|Overall Study||26
8588336|NCT00279812|9623021|FG002|STARTED|Overall Study||24
8588337|NCT00279812|9623022|FG003|STARTED|Overall Study||23
8588338|NCT00279812|9623023|FG004|STARTED|Overall Study||20
8588339|NCT00279812|9623024|FG005|STARTED|Overall Study||19
8588340|NCT00279812|9623019|FG000|COMPLETED|Overall Study||20
8588341|NCT00279812|9623020|FG001|COMPLETED|Overall Study||20
8588342|NCT00279812|9623021|FG002|COMPLETED|Overall Study||21
8588343|NCT00279812|9623022|FG003|COMPLETED|Overall Study||23
8588344|NCT00279812|9623023|FG004|COMPLETED|Overall Study||17
8588345|NCT00279812|9623024|FG005|COMPLETED|Overall Study||18
8588346|NCT00279812|9623019|FG000|NOT COMPLETED|Overall Study||1
8588347|NCT00279812|9623020|FG001|NOT COMPLETED|Overall Study||6
8588348|NCT00279812|9623021|FG002|NOT COMPLETED|Overall Study||3
8588349|NCT00279812|9623022|FG003|NOT COMPLETED|Overall Study||0
8588350|NCT00279812|9623023|FG004|NOT COMPLETED|Overall Study||3
8588351|NCT00279812|9623024|FG005|NOT COMPLETED|Overall Study||1
8588352|NCT00279916|9623040|FG000|STARTED|Overall Study||45
8588353|NCT00279916|9623041|FG001|STARTED|Overall Study||46
8588354|NCT00279916|9623040|FG000|COMPLETED|Overall Study||38
8588355|NCT00279916|9623041|FG001|COMPLETED|Overall Study||41
8588356|NCT00279916|9623040|FG000|NOT COMPLETED|Overall Study||7
8588357|NCT00279916|9623041|FG001|NOT COMPLETED|Overall Study||5
8588358|NCT00279955|9623050|FG000|STARTED|Overall Study||157
8588359|NCT00279955|9623051|FG001|STARTED|Overall Study||486
8588360|NCT00279955|9623052|FG002|STARTED|Overall Study||358
8588361|NCT00279955|9623050|FG000|COMPLETED|Overall Study||157
8588362|NCT00279955|9623051|FG001|COMPLETED|Overall Study||486
8588363|NCT00279955|9623052|FG002|COMPLETED|Overall Study|They are still counted as completes, though they are never used for the analyses of objectives.|358
8588364|NCT00279955|9623050|FG000|NOT COMPLETED|Overall Study||0
8588365|NCT00279955|9623051|FG001|NOT COMPLETED|Overall Study||0
8588366|NCT00279955|9623052|FG002|NOT COMPLETED|Overall Study||0
8588367|NCT00280059|9623061|FG000|STARTED|Efficacy Assessment Phase||330
8588368|NCT00280059|9623062|FG001|STARTED|Efficacy Assessment Phase||330
8588369|NCT00280059|9623061|FG000|COMPLETED|Efficacy Assessment Phase|Week 56: up to end of efficacy assessment phase (excluding extension phase).|236
8627886|NCT00519636|9667245|FG003|STARTED|Treatment Period 2||88
8588370|NCT00280059|9623062|FG001|COMPLETED|Efficacy Assessment Phase|Week 56: up to end of efficacy assessment phase (excluding extension phase).|250
8588371|NCT00280059|9623061|FG000|NOT COMPLETED|Efficacy Assessment Phase||94
8588372|NCT00280059|9623062|FG001|NOT COMPLETED|Efficacy Assessment Phase||80
8588373|NCT00280059|9623061|FG000|STARTED|Extension Phase|Optional phase; number entered was less than the number who completed the efficacy assessment phase.|194
8588374|NCT00280059|9623062|FG001|STARTED|Extension Phase|Optional phase; number entered was less than the number who completed the efficacy assessment phase.|215
8588375|NCT00280059|9623061|FG000|COMPLETED|Extension Phase||145
8588376|NCT00280059|9623062|FG001|COMPLETED|Extension Phase||177
8588377|NCT00280059|9623061|FG000|NOT COMPLETED|Extension Phase||49
8588378|NCT00280059|9623062|FG001|NOT COMPLETED|Extension Phase||38
8588379|NCT00280150|9623080|FG000|STARTED|Overall Study||5
8588380|NCT00280150|9623081|FG001|STARTED|Overall Study||5
8588381|NCT00280150|9623082|FG002|STARTED|Overall Study||6
8588382|NCT00280150|9623083|FG003|STARTED|Overall Study||30
8588383|NCT00280150|9623080|FG000|Cohort Induction|Overall Study||5
8588384|NCT00280150|9623081|FG001|Cohort Induction|Overall Study||5
8588385|NCT00280150|9623082|FG002|Cohort Induction|Overall Study||6
8588386|NCT00280150|9623083|FG003|Cohort Induction|Overall Study||30
8588387|NCT00280150|9623080|FG000|Consolidation Therapy|Overall Study||2
8588388|NCT00280150|9623081|FG001|Consolidation Therapy|Overall Study||5
8588389|NCT00280150|9623082|FG002|Consolidation Therapy|Overall Study||3
8588390|NCT00280150|9623083|FG003|Consolidation Therapy|Overall Study|Phase II participants did not receive consolidation therapy.|0
8588391|NCT00280150|9623080|FG000|COMPLETED|Overall Study||2
8588392|NCT00280150|9623081|FG001|COMPLETED|Overall Study||4
8588393|NCT00280150|9623082|FG002|COMPLETED|Overall Study||1
8588394|NCT00280150|9623083|FG003|COMPLETED|Overall Study||20
8588395|NCT00280150|9623080|FG000|NOT COMPLETED|Overall Study||3
8588396|NCT00280150|9623081|FG001|NOT COMPLETED|Overall Study||1
8588397|NCT00280150|9623082|FG002|NOT COMPLETED|Overall Study||5
8588398|NCT00280150|9623083|FG003|NOT COMPLETED|Overall Study||10
8588399|NCT00280241|9623094|FG000|STARTED|Overall Study||65
8588400|NCT00280241|9623094|FG000|COMPLETED|Overall Study||55
8588401|NCT00280241|9623094|FG000|NOT COMPLETED|Overall Study||10
8588402|NCT00280293|9623100|FG000|STARTED|Overall Study||55
8588403|NCT00280293|9623101|FG001|STARTED|Overall Study||57
8588404|NCT00280293|9623100|FG000|COMPLETED|Overall Study||29
8588405|NCT00280293|9623101|FG001|COMPLETED|Overall Study||34
8588406|NCT00280293|9623100|FG000|NOT COMPLETED|Overall Study||26
8588407|NCT00280293|9623101|FG001|NOT COMPLETED|Overall Study||23
8588408|NCT00280384|9623115|FG000|STARTED|Overall Study||6
8588409|NCT00280384|9623116|FG001|STARTED|Overall Study||6
8588410|NCT00280384|9623117|FG002|STARTED|Overall Study||6
8588411|NCT00280384|9623118|FG003|STARTED|Overall Study||6
8588412|NCT00280384|9623119|FG004|STARTED|Overall Study||6
8588413|NCT00280384|9623120|FG005|STARTED|Overall Study||6
8588414|NCT00280384|9623121|FG006|STARTED|Overall Study||6
8588415|NCT00280384|9623122|FG007|STARTED|Overall Study||6
8588416|NCT00280384|9623115|FG000|COMPLETED|Overall Study||6
8588417|NCT00280384|9623116|FG001|COMPLETED|Overall Study||6
8588418|NCT00280384|9623117|FG002|COMPLETED|Overall Study||6
8588419|NCT00280384|9623118|FG003|COMPLETED|Overall Study||6
8588420|NCT00280384|9623119|FG004|COMPLETED|Overall Study||6
8588421|NCT00280384|9623120|FG005|COMPLETED|Overall Study||6
8588422|NCT00280384|9623121|FG006|COMPLETED|Overall Study||6
8588423|NCT00280384|9623122|FG007|COMPLETED|Overall Study||6
8588424|NCT00280384|9623115|FG000|NOT COMPLETED|Overall Study||0
8588425|NCT00280384|9623116|FG001|NOT COMPLETED|Overall Study||0
8588426|NCT00280384|9623117|FG002|NOT COMPLETED|Overall Study||0
8588427|NCT00280384|9623118|FG003|NOT COMPLETED|Overall Study||0
8588428|NCT00280384|9623119|FG004|NOT COMPLETED|Overall Study||0
8588429|NCT00280384|9623120|FG005|NOT COMPLETED|Overall Study||0
8588430|NCT00280384|9623121|FG006|NOT COMPLETED|Overall Study||0
8588431|NCT00280384|9623122|FG007|NOT COMPLETED|Overall Study||0
8588432|NCT00280397|9623140|FG000|STARTED|Overall Study||27
8588433|NCT00280397|9623140|FG000|COMPLETED|Overall Study||26
8588434|NCT00280397|9623140|FG000|NOT COMPLETED|Overall Study||1
8588435|NCT00280566|9623148|FG000|STARTED|Period 1 Open Label Ziprasidone|1 subject inappropriately randomized into 2 different sites. Data from this subject was excluded.|584
8588436|NCT00280566|9623149|FG001|STARTED|Period 1 Open Label Ziprasidone||0
8588437|NCT00280566|9623150|FG002|STARTED|Period 1 Open Label Ziprasidone||0
8588438|NCT00280566|9623148|FG000|COMPLETED|Period 1 Open Label Ziprasidone|Subject excluded as described above is counted as 2; enrolled in 2 sites (2 identification numbers)|241
8588439|NCT00280566|9623149|FG001|COMPLETED|Period 1 Open Label Ziprasidone||0
8588440|NCT00280566|9623150|FG002|COMPLETED|Period 1 Open Label Ziprasidone||0
8588441|NCT00280566|9623148|FG000|NOT COMPLETED|Period 1 Open Label Ziprasidone||343
8588442|NCT00280566|9623149|FG001|NOT COMPLETED|Period 1 Open Label Ziprasidone||0
8588443|NCT00280566|9623150|FG002|NOT COMPLETED|Period 1 Open Label Ziprasidone||0
8588444|NCT00280566|9623148|FG000|STARTED|Period 2 Double Blind|1 subject in Period 1 did not want to be randomized into Period 2|0
8588445|NCT00280566|9623149|FG001|STARTED|Period 2 Double Blind||127
8588446|NCT00280566|9623150|FG002|STARTED|Period 2 Double Blind||111
8588447|NCT00280566|9623148|FG000|COMPLETED|Period 2 Double Blind||0
8588448|NCT00280566|9623149|FG001|COMPLETED|Period 2 Double Blind||84
8813037|NCT01523743|9866153|FG001|STARTED|Period 2||60
8813038|NCT01523743|9866152|FG000|COMPLETED|Period 2||52
8813039|NCT01523743|9866153|FG001|COMPLETED|Period 2||58
8588449|NCT00280566|9623150|FG002|COMPLETED|Period 2 Double Blind||54
8588450|NCT00280566|9623148|FG000|NOT COMPLETED|Period 2 Double Blind||0
8588451|NCT00280566|9623149|FG001|NOT COMPLETED|Period 2 Double Blind||43
8588452|NCT00280566|9623150|FG002|NOT COMPLETED|Period 2 Double Blind||57
8588453|NCT00280683|9623159|FG000|STARTED|Overall Study||10
8588454|NCT00280683|9623160|FG001|STARTED|Overall Study||10
8588455|NCT00280683|9623159|FG000|COMPLETED|Overall Study|Reasons for subjects discontinuing included inability to adhere to the schedule or adverse event.|8
8588456|NCT00280683|9623160|FG001|COMPLETED|Overall Study||7
8588457|NCT00280683|9623159|FG000|NOT COMPLETED|Overall Study||2
8588458|NCT00280683|9623160|FG001|NOT COMPLETED|Overall Study||3
8588459|NCT00280735|9623168|FG000|STARTED|Overall Study||75
8588460|NCT00280735|9623168|FG000|Received Treatment|Overall Study||72
8588461|NCT00280735|9623168|FG000|Received Adequate Exposure|Overall Study||57
8588462|NCT00280735|9623168|FG000|COMPLETED|Overall Study||57
8588463|NCT00280735|9623168|FG000|NOT COMPLETED|Overall Study||18
8588464|NCT00280748|9623176|FG000|STARTED|Overall Study||10
8588465|NCT00280748|9623176|FG000|COMPLETED|Overall Study||6
8588466|NCT00280748|9623176|FG000|NOT COMPLETED|Overall Study||4
8588467|NCT00280826|9623180|FG000|STARTED|Overall Study||6
8711233|NCT00960999|9757595|FG001|Normalized SUV at 1 Year|Overall Study||7
8711234|NCT00960999|9757594|FG000|FEV1 by Best Response|Overall Study||26
8711235|NCT00960999|9757595|FG001|FEV1 by Best Response|Overall Study||33
8588468|NCT00280826|9623180|FG000|COMPLETED|Overall Study||6
8588469|NCT00280826|9623180|FG000|NOT COMPLETED|Overall Study||0
8588470|NCT00280904|9623184|FG000|STARTED|Overall Study||433
8588471|NCT00280904|9623184|FG000|COMPLETED|Overall Study||433
8588472|NCT00280904|9623184|FG000|NOT COMPLETED|Overall Study||0
8588473|NCT00280917|9623193|FG000|STARTED|Overall Study||65
8588474|NCT00280917|9623194|FG001|STARTED|Overall Study||63
8588475|NCT00280917|9623195|FG002|STARTED|Overall Study||63
8588476|NCT00280917|9623196|FG003|STARTED|Overall Study||63
8588477|NCT00280917|9623193|FG000|COMPLETED|Overall Study||63
8588478|NCT00280917|9623194|FG001|COMPLETED|Overall Study||57
8588479|NCT00280917|9623195|FG002|COMPLETED|Overall Study||57
8588480|NCT00280917|9623196|FG003|COMPLETED|Overall Study||61
8588481|NCT00280917|9623193|FG000|NOT COMPLETED|Overall Study||2
8588482|NCT00280917|9623194|FG001|NOT COMPLETED|Overall Study||6
8588483|NCT00280917|9623195|FG002|NOT COMPLETED|Overall Study||6
8588484|NCT00280917|9623196|FG003|NOT COMPLETED|Overall Study||2
8588485|NCT00281021|9623206|FG000|STARTED|Overall Study||26
8588486|NCT00281021|9623206|FG000|COMPLETED|Overall Study||24
8588487|NCT00281021|9623206|FG000|NOT COMPLETED|Overall Study||2
8588488|NCT00281099|9623212|FG000|STARTED|Overall Study||513
8588489|NCT00281099|9623213|FG001|STARTED|Overall Study||518
8588490|NCT00281099|9623212|FG000|COMPLETED|Overall Study||308
8588491|NCT00281099|9623213|FG001|COMPLETED|Overall Study||296
8588492|NCT00281099|9623212|FG000|NOT COMPLETED|Overall Study||205
8588493|NCT00281099|9623213|FG001|NOT COMPLETED|Overall Study||222
8588494|NCT00281463|9623220|FG000|STARTED|Overall Study||45
8588495|NCT00281463|9623220|FG000|COMPLETED|Overall Study||45
8588496|NCT00281463|9623220|FG000|NOT COMPLETED|Overall Study||0
8588497|NCT00281528|9623227|FG000|STARTED|Overall Study||75
8588498|NCT00281528|9623228|FG001|STARTED|Overall Study||54
8588499|NCT00281528|9623229|FG002|STARTED|Overall Study||79
8588500|NCT00281528|9623227|FG000|COMPLETED|Overall Study|No participants completed because they continued in the study until disease progression|0
8588501|NCT00281528|9623228|FG001|COMPLETED|Overall Study|No participants completed because they continued in the study until disease progression|0
8588502|NCT00281528|9623229|FG002|COMPLETED|Overall Study|No participants completed because they continued in the study until disease progression|0
8588503|NCT00281528|9623227|FG000|NOT COMPLETED|Overall Study||75
8588504|NCT00281528|9623228|FG001|NOT COMPLETED|Overall Study||54
8588505|NCT00281528|9623229|FG002|NOT COMPLETED|Overall Study||79
8588506|NCT00281580|9623253|FG000|STARTED|Overall Study||46
8588507|NCT00281580|9623254|FG001|STARTED|Overall Study||42
8588508|NCT00281580|9623255|FG002|STARTED|Overall Study||130
8588509|NCT00281580|9623256|FG003|STARTED|Overall Study||135
8588510|NCT00281580|9623257|FG004|STARTED|Overall Study||44
8588511|NCT00281580|9623258|FG005|STARTED|Overall Study||46
8588512|NCT00281580|9623259|FG006|STARTED|Overall Study||44
8588513|NCT00281580|9623260|FG007|STARTED|Overall Study||47
8588514|NCT00281580|9623261|FG008|STARTED|Overall Study||143
8588515|NCT00281580|9623262|FG009|STARTED|Overall Study||129
8588516|NCT00281580|9623263|FG010|STARTED|Overall Study||48
8588517|NCT00281580|9623264|FG011|STARTED|Overall Study||146
8588518|NCT00281580|9623265|FG012|STARTED|Overall Study||142
8588519|NCT00281580|9623266|FG013|STARTED|Overall Study||50
8588520|NCT00281580|9623267|FG014|STARTED|Overall Study||140
8588521|NCT00281580|9623268|FG015|STARTED|Overall Study||129
8588522|NCT00281580|9623253|FG000|COMPLETED|Overall Study||39
8588523|NCT00281580|9623254|FG001|COMPLETED|Overall Study||41
8588524|NCT00281580|9623255|FG002|COMPLETED|Overall Study||125
8588525|NCT00281580|9623256|FG003|COMPLETED|Overall Study||118
8588526|NCT00281580|9623257|FG004|COMPLETED|Overall Study||40
8588527|NCT00281580|9623258|FG005|COMPLETED|Overall Study||43
8588528|NCT00281580|9623259|FG006|COMPLETED|Overall Study||39
8588529|NCT00281580|9623260|FG007|COMPLETED|Overall Study||46
8588530|NCT00281580|9623261|FG008|COMPLETED|Overall Study||135
8588531|NCT00281580|9623262|FG009|COMPLETED|Overall Study||117
8588532|NCT00281580|9623263|FG010|COMPLETED|Overall Study||44
8711236|NCT00960999|9757594|FG000|DLCO by Best Response|Overall Study||23
8711237|NCT00960999|9757595|FG001|DLCO by Best Response|Overall Study||28
8711238|NCT00960999|9757594|FG000|COMPLETED|Overall Study||39
8711239|NCT00960999|9757595|FG001|COMPLETED|Overall Study||45
8588533|NCT00281580|9623264|FG011|COMPLETED|Overall Study||136
8588534|NCT00281580|9623265|FG012|COMPLETED|Overall Study||129
8588535|NCT00281580|9623266|FG013|COMPLETED|Overall Study||43
8588536|NCT00281580|9623267|FG014|COMPLETED|Overall Study||133
8588537|NCT00281580|9623268|FG015|COMPLETED|Overall Study||116
8588538|NCT00281580|9623253|FG000|NOT COMPLETED|Overall Study||7
8588539|NCT00281580|9623254|FG001|NOT COMPLETED|Overall Study||1
8588540|NCT00281580|9623255|FG002|NOT COMPLETED|Overall Study||5
8588541|NCT00281580|9623256|FG003|NOT COMPLETED|Overall Study||17
8588542|NCT00281580|9623257|FG004|NOT COMPLETED|Overall Study||4
8588543|NCT00281580|9623258|FG005|NOT COMPLETED|Overall Study||3
8588544|NCT00281580|9623259|FG006|NOT COMPLETED|Overall Study||5
8588545|NCT00281580|9623260|FG007|NOT COMPLETED|Overall Study||1
8588546|NCT00281580|9623261|FG008|NOT COMPLETED|Overall Study||8
8588547|NCT00281580|9623262|FG009|NOT COMPLETED|Overall Study||12
8588548|NCT00281580|9623263|FG010|NOT COMPLETED|Overall Study||4
8588549|NCT00281580|9623264|FG011|NOT COMPLETED|Overall Study||10
8588550|NCT00281580|9623265|FG012|NOT COMPLETED|Overall Study||13
8588551|NCT00281580|9623266|FG013|NOT COMPLETED|Overall Study||7
8588552|NCT00281580|9623267|FG014|NOT COMPLETED|Overall Study||7
8588553|NCT00281580|9623268|FG015|NOT COMPLETED|Overall Study||13
8588554|NCT00281632|9623337|FG000|STARTED|Overall Study||36
8588555|NCT00281632|9623337|FG000|COMPLETED|Overall Study|Three participants were ongoing in the study at the time of the data cut-off (30 Apr 2008).|0
8588556|NCT00281632|9623337|FG000|NOT COMPLETED|Overall Study||36
8588557|NCT00281671|9623349|FG000|STARTED|Overall Study||5
8588558|NCT00281671|9623350|FG001|STARTED|Overall Study||4
8588559|NCT00281671|9623349|FG000|COMPLETED|Overall Study||5
8588560|NCT00281671|9623350|FG001|COMPLETED|Overall Study||4
8588561|NCT00281671|9623349|FG000|NOT COMPLETED|Overall Study||0
8588562|NCT00281671|9623350|FG001|NOT COMPLETED|Overall Study||0
8588563|NCT00281684|9623363|FG000|STARTED|Overall Study||37
8588564|NCT00281684|9623364|FG001|STARTED|Overall Study||36
8588565|NCT00281684|9623365|FG002|STARTED|Overall Study||34
8588566|NCT00281684|9623366|FG003|STARTED|Overall Study||38
8588567|NCT00281684|9623363|FG000|COMPLETED|Overall Study||36
8588568|NCT00281684|9623364|FG001|COMPLETED|Overall Study||36
8588569|NCT00281684|9623365|FG002|COMPLETED|Overall Study||33
8588570|NCT00281684|9623366|FG003|COMPLETED|Overall Study||38
8588571|NCT00281684|9623363|FG000|NOT COMPLETED|Overall Study||1
8588572|NCT00281684|9623364|FG001|NOT COMPLETED|Overall Study||0
8588573|NCT00281684|9623365|FG002|NOT COMPLETED|Overall Study||1
8588574|NCT00281684|9623366|FG003|NOT COMPLETED|Overall Study||0
8588575|NCT00281697|9623380|FG000|STARTED|Overall Study||459
8588576|NCT00281697|9623381|FG001|STARTED|Overall Study||225
8588577|NCT00281697|9623380|FG000|COMPLETED|Overall Study||58
8588578|NCT00281697|9623381|FG001|COMPLETED|Overall Study||28
8588579|NCT00281697|9623380|FG000|NOT COMPLETED|Overall Study||401
8588580|NCT00281697|9623381|FG001|NOT COMPLETED|Overall Study||197
8588581|NCT00281827|9623387|FG000|STARTED|Overall Study||22
8588582|NCT00281827|9623387|FG000|COMPLETED|Overall Study|All patients received 3 cycles of therapy; 2 did not receive all 3 thalidomide cycles|22
8588583|NCT00281827|9623387|FG000|NOT COMPLETED|Overall Study||0
8588584|NCT00281840|9623393|FG000|STARTED|Overall Study||30
8588585|NCT00281840|9623393|FG000|COMPLETED|Overall Study||5
8588586|NCT00281840|9623393|FG000|NOT COMPLETED|Overall Study||25
8588587|NCT00281918|9623400|FG000|STARTED|Overall Study|Informed consent unavailable for 2 patients at time of analysis; intent-to-treat population was 407.|409
8588588|NCT00281918|9623401|FG001|STARTED|Overall Study|Informed consent unavailable for 5 patients at time of analysis; intent-to-treat population was 403.|408
8588589|NCT00281918|9623400|FG000|Safety Population; Received Study Drug|Overall Study||398
8588590|NCT00281918|9623401|FG001|Safety Population; Received Study Drug|Overall Study||402
8588591|NCT00281918|9623400|FG000|COMPLETED|Overall Study|Completed all 6 cycles of study medication.|267
8588592|NCT00281918|9623401|FG001|COMPLETED|Overall Study|Completed all 6 cycles of study medication.|300
8588593|NCT00281918|9623400|FG000|NOT COMPLETED|Overall Study||142
8588594|NCT00281918|9623401|FG001|NOT COMPLETED|Overall Study||108
8588595|NCT00281957|9623409|FG000|STARTED|Overall Study||67
8588596|NCT00281957|9623410|FG001|STARTED|Overall Study||42
8588597|NCT00281957|9623409|FG000|Eligible|Overall Study||66
8588598|NCT00281957|9623410|FG001|Eligible|Overall Study||40
8588599|NCT00281957|9623409|FG000|Eligible and Received Treatment|Overall Study||63
8588600|NCT00281957|9623410|FG001|Eligible and Received Treatment|Overall Study||39
8588601|NCT00281957|9623409|FG000|COMPLETED|Overall Study||0
8588602|NCT00281957|9623410|FG001|COMPLETED|Overall Study||0
8588603|NCT00281957|9623409|FG000|NOT COMPLETED|Overall Study||67
8588604|NCT00281957|9623410|FG001|NOT COMPLETED|Overall Study||42
8588605|NCT00282048|9623418|FG000|STARTED|Overall Study||62
8588606|NCT00282048|9623418|FG000|COMPLETED|Overall Study||0
8588607|NCT00282048|9623418|FG000|NOT COMPLETED|Overall Study||62
8588608|NCT00282087|9623422|FG000|STARTED|Overall Study||47
8588609|NCT00282087|9623422|FG000|COMPLETED|Overall Study|One patient died during cycle 1 of treatment because of infectious complications of AIDS.|46
8588610|NCT00282087|9623422|FG000|NOT COMPLETED|Overall Study||1
8588611|NCT00282113|9623430|FG000|STARTED|Overall Study||31
8588612|NCT00282113|9623431|FG001|STARTED|Overall Study||30
8588613|NCT00282113|9623432|FG002|STARTED|Overall Study||29
8588614|NCT00282113|9623430|FG000|COMPLETED|Overall Study||30
8588615|NCT00282113|9623431|FG001|COMPLETED|Overall Study||30
8711240|NCT00960999|9757594|FG000|NOT COMPLETED|Overall Study||8
8588616|NCT00282113|9623432|FG002|COMPLETED|Overall Study||29
8588617|NCT00282113|9623430|FG000|NOT COMPLETED|Overall Study||1
8588618|NCT00282113|9623431|FG001|NOT COMPLETED|Overall Study||0
8588619|NCT00282113|9623432|FG002|NOT COMPLETED|Overall Study||0
8588620|NCT00282152|9623442|FG000|STARTED|Overall Study||15
8588621|NCT00282152|9623443|FG001|STARTED|Overall Study||15
8588622|NCT00282152|9623442|FG000|COMPLETED|Overall Study||14
8588623|NCT00282152|9623443|FG001|COMPLETED|Overall Study||15
8588624|NCT00282152|9623442|FG000|NOT COMPLETED|Overall Study||1
8588625|NCT00282152|9623443|FG001|NOT COMPLETED|Overall Study||0
8588626|NCT00282243|9623450|FG000|STARTED|Pharmacokinetic Treatment Period||70
8588627|NCT00282243|9623450|FG000|Received Tacrolimus|Pharmacokinetic Treatment Period||70
8588628|NCT00282243|9623450|FG000|Received Tacrolimus MR|Pharmacokinetic Treatment Period||69
8588629|NCT00282243|9623450|FG000|COMPLETED|Pharmacokinetic Treatment Period||65
8588630|NCT00282243|9623450|FG000|NOT COMPLETED|Pharmacokinetic Treatment Period||5
8588631|NCT00282243|9623450|FG000|STARTED|Extension Treatment Period||65
8588632|NCT00282243|9623450|FG000|COMPLETED|Extension Treatment Period||43
8588633|NCT00282243|9623450|FG000|NOT COMPLETED|Extension Treatment Period||22
8588634|NCT00282256|9623454|FG000|STARTED|Pharmacokinetic Treatment Period||19
8588635|NCT00282256|9623454|FG000|Received Tacrolimus|Pharmacokinetic Treatment Period||19
8588636|NCT00282256|9623454|FG000|Received Tacrolimus MR|Pharmacokinetic Treatment Period||18
8588637|NCT00282256|9623454|FG000|COMPLETED|Pharmacokinetic Treatment Period||18
8588638|NCT00282256|9623454|FG000|NOT COMPLETED|Pharmacokinetic Treatment Period||1
8588639|NCT00282256|9623454|FG000|STARTED|Extension Treatment Period||18
8588640|NCT00282256|9623454|FG000|COMPLETED|Extension Treatment Period||16
8588641|NCT00282256|9623454|FG000|NOT COMPLETED|Extension Treatment Period||2
8588642|NCT00282282|9623458|FG000|STARTED|Overall Study|31 patients enrolled but 2 patients did not go through with transplant|29
8588643|NCT00282282|9623458|FG000|COMPLETED|Overall Study||29
8588644|NCT00282282|9623458|FG000|NOT COMPLETED|Overall Study||0
8588645|NCT00282295|9623466|FG000|STARTED|Overall Study||446
8588646|NCT00282295|9623467|FG001|STARTED|Overall Study||446
8588647|NCT00282295|9623468|FG002|STARTED|Overall Study||449
8588648|NCT00282295|9623466|FG000|COMPLETED|Overall Study||443
8588649|NCT00282295|9623467|FG001|COMPLETED|Overall Study||429
8588650|NCT00282295|9623468|FG002|COMPLETED|Overall Study||441
8588651|NCT00282295|9623466|FG000|NOT COMPLETED|Overall Study||3
8588652|NCT00282295|9623467|FG001|NOT COMPLETED|Overall Study||17
8588653|NCT00282295|9623468|FG002|NOT COMPLETED|Overall Study||8
8588654|NCT00282308|9623483|FG000|STARTED|Treatment Period||69
8588655|NCT00282308|9623484|FG001|STARTED|Treatment Period||34
8588656|NCT00282308|9623485|FG002|STARTED|Treatment Period|Participant Flow is reported separately for the treatment groups for this Period.|0
8588657|NCT00282308|9623483|FG000|COMPLETED|Treatment Period||65
8588658|NCT00282308|9623484|FG001|COMPLETED|Treatment Period||28
8588659|NCT00282308|9623485|FG002|COMPLETED|Treatment Period||0
8588660|NCT00282308|9623483|FG000|NOT COMPLETED|Treatment Period||4
8588661|NCT00282308|9623484|FG001|NOT COMPLETED|Treatment Period||6
8588662|NCT00282308|9623485|FG002|NOT COMPLETED|Treatment Period||0
8588663|NCT00282308|9623483|FG000|STARTED|Optional Extension Re-treatment Period|Participant Flow is reported for the combined treatment groups for this Period.|0
8588664|NCT00282308|9623484|FG001|STARTED|Optional Extension Re-treatment Period|Participant Flow is reported for the combined treatment groups for this Period.|0
8588665|NCT00282308|9623485|FG002|STARTED|Optional Extension Re-treatment Period|Not all patients who completed the Treatment Period entered this Optional Re-treatment Period.|78
8588666|NCT00282308|9623483|FG000|COMPLETED|Optional Extension Re-treatment Period||0
8588667|NCT00282308|9623484|FG001|COMPLETED|Optional Extension Re-treatment Period||0
8588668|NCT00282308|9623485|FG002|COMPLETED|Optional Extension Re-treatment Period||72
8588669|NCT00282308|9623483|FG000|NOT COMPLETED|Optional Extension Re-treatment Period||0
8588670|NCT00282308|9623484|FG001|NOT COMPLETED|Optional Extension Re-treatment Period||0
8588671|NCT00282308|9623485|FG002|NOT COMPLETED|Optional Extension Re-treatment Period||6
8588672|NCT00282308|9623483|FG000|STARTED|Safety Follow-up Period|Participant Flow is reported for the combined treatment groups for this Period.|0
8588673|NCT00282308|9623484|FG001|STARTED|Safety Follow-up Period|Participant Flow is reported for the combined treatment groups for this Period.|0
8588674|NCT00282308|9623485|FG002|STARTED|Safety Follow-up Period|Some patients entered this Safety Follow-up Period directly from the Treatment Period.|100
8588675|NCT00282308|9623483|FG000|COMPLETED|Safety Follow-up Period||0
8588676|NCT00282308|9623484|FG001|COMPLETED|Safety Follow-up Period||0
8588677|NCT00282308|9623485|FG002|COMPLETED|Safety Follow-up Period||81
8588678|NCT00282308|9623483|FG000|NOT COMPLETED|Safety Follow-up Period||0
8588679|NCT00282308|9623484|FG001|NOT COMPLETED|Safety Follow-up Period||0
8588680|NCT00282308|9623485|FG002|NOT COMPLETED|Safety Follow-up Period||19
8588681|NCT00282334|9623497|FG000|STARTED|Overall Study||113
8588682|NCT00282334|9623498|FG001|STARTED|Overall Study||123
8588683|NCT00282334|9623497|FG000|COMPLETED|Overall Study||105
8588684|NCT00282334|9623498|FG001|COMPLETED|Overall Study||118
8588685|NCT00282334|9623497|FG000|NOT COMPLETED|Overall Study||8
8588686|NCT00282334|9623498|FG001|NOT COMPLETED|Overall Study||5
8588687|NCT00282347|9623506|FG000|STARTED|Treatment Period||72
8588688|NCT00282347|9623507|FG001|STARTED|Treatment Period||72
8588689|NCT00282347|9623506|FG000|COMPLETED|Treatment Period||67
8588690|NCT00282347|9623507|FG001|COMPLETED|Treatment Period||63
8588691|NCT00282347|9623506|FG000|NOT COMPLETED|Treatment Period||5
8588692|NCT00282347|9623507|FG001|NOT COMPLETED|Treatment Period||9
8588693|NCT00282347|9623506|FG000|STARTED|Safety Follow-up Period||67
8588694|NCT00282347|9623507|FG001|STARTED|Safety Follow-up Period||63
8588695|NCT00282347|9623506|FG000|COMPLETED|Safety Follow-up Period||64
8588696|NCT00282347|9623507|FG001|COMPLETED|Safety Follow-up Period||57
8588697|NCT00282347|9623506|FG000|NOT COMPLETED|Safety Follow-up Period||3
8588698|NCT00282347|9623507|FG001|NOT COMPLETED|Safety Follow-up Period||6
8588699|NCT00282347|9623506|FG000|STARTED|B Cell Follow-up Period||20
8588700|NCT00282347|9623507|FG001|STARTED|B Cell Follow-up Period||4
8588701|NCT00282347|9623506|FG000|COMPLETED|B Cell Follow-up Period||15
8588702|NCT00282347|9623507|FG001|COMPLETED|B Cell Follow-up Period||4
8588703|NCT00282347|9623506|FG000|NOT COMPLETED|B Cell Follow-up Period||5
8588704|NCT00282347|9623507|FG001|NOT COMPLETED|B Cell Follow-up Period||0
8588705|NCT00282412|9623515|FG000|STARTED|Overall Study||4
8588706|NCT00282412|9623515|FG000|COMPLETED|Overall Study|Two late deaths non-treatment related. One from pulmonary embolism and one from late leukemia.|2
8588707|NCT00282412|9623515|FG000|NOT COMPLETED|Overall Study||2
8588708|NCT00282438|9623521|FG000|STARTED|Overall Study||1
8588709|NCT00282438|9623522|FG001|STARTED|Overall Study||1
8588710|NCT00282438|9623521|FG000|COMPLETED|Overall Study||0
8588711|NCT00282438|9623522|FG001|COMPLETED|Overall Study||0
8588712|NCT00282438|9623521|FG000|NOT COMPLETED|Overall Study||1
8588713|NCT00282438|9623522|FG001|NOT COMPLETED|Overall Study||1
8588714|NCT00282464|9623530|FG000|STARTED|Overall Study||185
8588715|NCT00282464|9623531|FG001|STARTED|Overall Study||196
8588716|NCT00282464|9623530|FG000|COMPLETED|Overall Study||112
8588717|NCT00282464|9623531|FG001|COMPLETED|Overall Study||134
8588718|NCT00282464|9623530|FG000|NOT COMPLETED|Overall Study||73
8588719|NCT00282464|9623531|FG001|NOT COMPLETED|Overall Study||62
8588720|NCT00282568|9623537|FG000|STARTED|Pharmacokinetic Treatment Period||70
8588721|NCT00282568|9623537|FG000|Received Tacrolimus|Pharmacokinetic Treatment Period||68
8588722|NCT00282568|9623537|FG000|Received Tacrolimus MR|Pharmacokinetic Treatment Period||67
8588723|NCT00282568|9623537|FG000|COMPLETED|Pharmacokinetic Treatment Period||67
8588724|NCT00282568|9623537|FG000|NOT COMPLETED|Pharmacokinetic Treatment Period||3
8588725|NCT00282568|9623537|FG000|STARTED|Extended Treatment Period|One patient who completed the PK period did not enter the extended treatment period.|66
8588726|NCT00282568|9623537|FG000|COMPLETED|Extended Treatment Period||42
8588727|NCT00282568|9623537|FG000|NOT COMPLETED|Extended Treatment Period||24
8588728|NCT00282672|9623545|FG000|STARTED|1 Year||22
8588729|NCT00282672|9623546|FG001|STARTED|1 Year||42
8588730|NCT00282672|9623547|FG002|STARTED|1 Year||21
8588731|NCT00282672|9623548|FG003|STARTED|1 Year||42
8588732|NCT00282672|9623545|FG000|COMPLETED|1 Year||19
8588733|NCT00282672|9623546|FG001|COMPLETED|1 Year||40
8588734|NCT00282672|9623547|FG002|COMPLETED|1 Year||20
8588735|NCT00282672|9623548|FG003|COMPLETED|1 Year||38
8588736|NCT00282672|9623545|FG000|NOT COMPLETED|1 Year||3
8588737|NCT00282672|9623546|FG001|NOT COMPLETED|1 Year||2
8588738|NCT00282672|9623547|FG002|NOT COMPLETED|1 Year||1
8588739|NCT00282672|9623548|FG003|NOT COMPLETED|1 Year||4
8588740|NCT00282672|9623545|FG000|STARTED|2 Year: Sham Crossed Over to RFA|19 crossed over to RFA treatment|19
8588741|NCT00282672|9623546|FG001|STARTED|2 Year: Sham Crossed Over to RFA||40
8588742|NCT00282672|9623547|FG002|STARTED|2 Year: Sham Crossed Over to RFA|16 Crossed over to RFA treatment|16
8588743|NCT00282672|9623548|FG003|STARTED|2 Year: Sham Crossed Over to RFA||38
8588744|NCT00282672|9623545|FG000|COMPLETED|2 Year: Sham Crossed Over to RFA||16
8588745|NCT00282672|9623546|FG001|COMPLETED|2 Year: Sham Crossed Over to RFA||39
8588746|NCT00282672|9623547|FG002|COMPLETED|2 Year: Sham Crossed Over to RFA||15
8588747|NCT00282672|9623548|FG003|COMPLETED|2 Year: Sham Crossed Over to RFA||36
8588748|NCT00282672|9623545|FG000|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||3
8588749|NCT00282672|9623546|FG001|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||1
8588750|NCT00282672|9623547|FG002|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||1
8588751|NCT00282672|9623548|FG003|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||2
8588752|NCT00282672|9623545|FG000|STARTED|5 Year: Follow up|1 withdrew|15
8588753|NCT00282672|9623546|FG001|STARTED|5 Year: Follow up|7 withdrew|32
8588754|NCT00282672|9623547|FG002|STARTED|5 Year: Follow up|3 withdrew|12
8588755|NCT00282672|9623548|FG003|STARTED|5 Year: Follow up|11 withdrew|25
8588756|NCT00282672|9623545|FG000|COMPLETED|5 Year: Follow up||14
8588757|NCT00282672|9623546|FG001|COMPLETED|5 Year: Follow up||27
8588758|NCT00282672|9623547|FG002|COMPLETED|5 Year: Follow up||12
8588759|NCT00282672|9623548|FG003|COMPLETED|5 Year: Follow up||20
8588760|NCT00282672|9623545|FG000|NOT COMPLETED|5 Year: Follow up||1
8588761|NCT00282672|9623546|FG001|NOT COMPLETED|5 Year: Follow up||5
8588762|NCT00282672|9623547|FG002|NOT COMPLETED|5 Year: Follow up||0
8588763|NCT00282672|9623548|FG003|NOT COMPLETED|5 Year: Follow up||5
8588764|NCT00282815|9623584|FG000|STARTED|Overall Study||15
8711241|NCT00960999|9757595|FG001|NOT COMPLETED|Overall Study||2
8711242|NCT00961051|9757603|FG000|STARTED|Overall Study||177
8711243|NCT00961051|9757604|FG001|STARTED|Overall Study||93
8711244|NCT00961051|9757603|FG000|COMPLETED|Overall Study||165
8711245|NCT00961051|9757604|FG001|COMPLETED|Overall Study||79
8711246|NCT00961051|9757603|FG000|NOT COMPLETED|Overall Study||12
8711247|NCT00961051|9757604|FG001|NOT COMPLETED|Overall Study||14
8711248|NCT00961116|9757610|FG000|STARTED|First Intervention||27
8711249|NCT00961116|9757611|FG001|STARTED|First Intervention||27
8711250|NCT00961116|9757610|FG000|COMPLETED|First Intervention||27
8711251|NCT00961116|9757611|FG001|COMPLETED|First Intervention||27
8588765|NCT00282815|9623585|FG001|STARTED|Overall Study||17
8711252|NCT00961116|9757610|FG000|NOT COMPLETED|First Intervention||0
8711253|NCT00961116|9757611|FG001|NOT COMPLETED|First Intervention||0
8588766|NCT00282815|9623584|FG000|COMPLETED|Overall Study||8
8588767|NCT00282815|9623585|FG001|COMPLETED|Overall Study||11
8588768|NCT00282815|9623584|FG000|NOT COMPLETED|Overall Study||7
8588769|NCT00282815|9623585|FG001|NOT COMPLETED|Overall Study||6
8588770|NCT00282828|9623597|FG000|STARTED|Overall Study||63
8588771|NCT00282828|9623598|FG001|STARTED|Overall Study||59
8588772|NCT00282828|9623599|FG002|STARTED|Overall Study||59
8588773|NCT00282828|9623597|FG000|COMPLETED|Overall Study||57
8588774|NCT00282828|9623598|FG001|COMPLETED|Overall Study||47
8588775|NCT00282828|9623599|FG002|COMPLETED|Overall Study||50
8588776|NCT00282828|9623597|FG000|NOT COMPLETED|Overall Study||6
8588777|NCT00282828|9623598|FG001|NOT COMPLETED|Overall Study||12
8588778|NCT00282828|9623599|FG002|NOT COMPLETED|Overall Study||9
8588779|NCT00282841|9623607|FG000|STARTED|Overall Study|Anticipated recruitment 400; stopped due to funding and poor recruitment.|61
8588780|NCT00282841|9623607|FG000|COMPLETED|Overall Study||61
8588781|NCT00282841|9623607|FG000|NOT COMPLETED|Overall Study||0
8588782|NCT00282919|9623612|FG000|STARTED|Overall Study||110
8588783|NCT00282919|9623612|FG000|COMPLETED|Overall Study||103
8588784|NCT00282919|9623612|FG000|NOT COMPLETED|Overall Study||7
8588785|NCT00282971|9623618|FG000|STARTED|Overall Study||180
8588786|NCT00282971|9623619|FG001|STARTED|Overall Study||171
8588787|NCT00282971|9623618|FG000|COMPLETED|Overall Study||146
8588788|NCT00282971|9623619|FG001|COMPLETED|Overall Study||149
8588789|NCT00282971|9623618|FG000|NOT COMPLETED|Overall Study||34
8588790|NCT00282971|9623619|FG001|NOT COMPLETED|Overall Study||22
8588791|NCT00282984|9623627|FG000|STARTED|Overall Study||353
8588792|NCT00282984|9623628|FG001|STARTED|Overall Study||350
8588793|NCT00282984|9623627|FG000|COMPLETED|Overall Study||302
8588794|NCT00282984|9623628|FG001|COMPLETED|Overall Study||289
8588795|NCT00282984|9623627|FG000|NOT COMPLETED|Overall Study||51
8588796|NCT00282984|9623628|FG001|NOT COMPLETED|Overall Study||61
8588797|NCT00283049|9623637|FG000|STARTED|Overall Study|2 randomized patients did not receive study drug and were not included in the safety population|128
8588798|NCT00283049|9623638|FG001|STARTED|Overall Study|1 randomized patient did not receive study drug and was not included in the safety population|128
8588799|NCT00283049|9623639|FG002|STARTED|Overall Study|1 randomized patient did not receive study drug and was not included in the safety population|130
8588800|NCT00283049|9623637|FG000|COMPLETED|Overall Study||70
8588801|NCT00283049|9623638|FG001|COMPLETED|Overall Study||83
8588802|NCT00283049|9623639|FG002|COMPLETED|Overall Study||76
8588803|NCT00283049|9623637|FG000|NOT COMPLETED|Overall Study||58
8588804|NCT00283049|9623638|FG001|NOT COMPLETED|Overall Study||45
8588805|NCT00283049|9623639|FG002|NOT COMPLETED|Overall Study||54
8588806|NCT00283062|9623651|FG000|STARTED|Overall Study||55
8588807|NCT00283062|9623652|FG001|STARTED|Overall Study||55
8588808|NCT00283062|9623653|FG002|STARTED|Overall Study||56
8588809|NCT00283062|9623654|FG003|STARTED|Overall Study||62
8588810|NCT00283062|9623651|FG000|ADMINISTERED STUDY TREATMENT|Overall Study||50
8588811|NCT00283062|9623652|FG001|ADMINISTERED STUDY TREATMENT|Overall Study||51
8588812|NCT00283062|9623653|FG002|ADMINISTERED STUDY TREATMENT|Overall Study||20
8588813|NCT00283062|9623654|FG003|ADMINISTERED STUDY TREATMENT|Overall Study||17
8588814|NCT00283062|9623651|FG000|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||44
8588815|NCT00283062|9623652|FG001|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||48
8588816|NCT00283062|9623653|FG002|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||15
8588817|NCT00283062|9623654|FG003|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||13
8588818|NCT00283062|9623651|FG000|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study||43
8588819|NCT00283062|9623652|FG001|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study|Not applicable, since participants in this arm did not receive chemotherapy.|0
8588820|NCT00283062|9623653|FG002|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study||15
8588821|NCT00283062|9623654|FG003|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study|Not applicable, since participants in this arm did not receive chemotherapy.|0
8588822|NCT00283062|9623651|FG000|COMPLETED|Overall Study||43
8588823|NCT00283062|9623652|FG001|COMPLETED|Overall Study||48
8588824|NCT00283062|9623653|FG002|COMPLETED|Overall Study||15
8588825|NCT00283062|9623654|FG003|COMPLETED|Overall Study||13
8588826|NCT00283062|9623651|FG000|NOT COMPLETED|Overall Study||12
8588827|NCT00283062|9623652|FG001|NOT COMPLETED|Overall Study||7
8588828|NCT00283062|9623653|FG002|NOT COMPLETED|Overall Study||41
8588829|NCT00283062|9623654|FG003|NOT COMPLETED|Overall Study||49
8588830|NCT00283075|9623664|FG000|STARTED|Overall Study||25
8588831|NCT00283075|9623665|FG001|STARTED|Overall Study||6
8588832|NCT00283075|9623664|FG000|COMPLETED|Overall Study||25
8588833|NCT00283075|9623665|FG001|COMPLETED|Overall Study||6
8588834|NCT00283075|9623664|FG000|NOT COMPLETED|Overall Study||0
8588835|NCT00283075|9623665|FG001|NOT COMPLETED|Overall Study||0
8588836|NCT00283244|9623679|FG000|STARTED|Overall Study||44
8588837|NCT00283244|9623680|FG001|STARTED|Overall Study||51
8588838|NCT00283244|9623681|FG002|STARTED|Overall Study||51
8588839|NCT00283244|9623679|FG000|COMPLETED|Overall Study|19 patients went on to receive second line Erlotinib|26
8588840|NCT00283244|9623680|FG001|COMPLETED|Overall Study|Patients treated until progression or unacceptable toxicity; 12 patients received 2nd line therapy|0
8588841|NCT00283244|9623681|FG002|COMPLETED|Overall Study|Patients treated until progression or unacceptable toxicity; 9 patients received 2nd line therapy|0
8588842|NCT00283244|9623679|FG000|NOT COMPLETED|Overall Study||18
8588843|NCT00283244|9623680|FG001|NOT COMPLETED|Overall Study||51
8588844|NCT00283244|9623681|FG002|NOT COMPLETED|Overall Study||51
8588845|NCT00283283|9623694|FG000|STARTED|Overall Study||274
8588846|NCT00283283|9623695|FG001|STARTED|Overall Study||284
8588847|NCT00283283|9623696|FG002|STARTED|Overall Study||280
8588848|NCT00283283|9623697|FG003|STARTED|Overall Study||276
8588849|NCT00283283|9623694|FG000|COMPLETED|Overall Study||274
8588850|NCT00283283|9623695|FG001|COMPLETED|Overall Study||284
8588851|NCT00283283|9623696|FG002|COMPLETED|Overall Study||280
8588852|NCT00283283|9623697|FG003|COMPLETED|Overall Study||276
8588853|NCT00283283|9623694|FG000|NOT COMPLETED|Overall Study||0
8588854|NCT00283283|9623695|FG001|NOT COMPLETED|Overall Study||0
8588855|NCT00283283|9623696|FG002|NOT COMPLETED|Overall Study||0
8588856|NCT00283283|9623697|FG003|NOT COMPLETED|Overall Study||0
8588857|NCT00283296|9623712|FG000|STARTED|Overall Study||14
8588858|NCT00283296|9623712|FG000|COMPLETED|Overall Study|Completed in-lab and in-home trial.|9
8588859|NCT00283296|9623712|FG000|NOT COMPLETED|Overall Study||5
8588860|NCT00283387|9623717|FG000|STARTED|First Intervention||6
8588861|NCT00283387|9623718|FG001|STARTED|First Intervention||7
8588862|NCT00283387|9623717|FG000|COMPLETED|First Intervention||5
8588863|NCT00283387|9623718|FG001|COMPLETED|First Intervention||5
8588864|NCT00283387|9623717|FG000|NOT COMPLETED|First Intervention||1
8588865|NCT00283387|9623718|FG001|NOT COMPLETED|First Intervention||2
8588866|NCT00283387|9623717|FG000|STARTED|Washout Period of 2 Months||5
8588867|NCT00283387|9623718|FG001|STARTED|Washout Period of 2 Months||5
8588868|NCT00283387|9623717|FG000|COMPLETED|Washout Period of 2 Months||5
8588869|NCT00283387|9623718|FG001|COMPLETED|Washout Period of 2 Months||5
8588870|NCT00283387|9623717|FG000|NOT COMPLETED|Washout Period of 2 Months||0
8588871|NCT00283387|9623718|FG001|NOT COMPLETED|Washout Period of 2 Months||0
8588872|NCT00283387|9623717|FG000|STARTED|Second Intervention||5
8588873|NCT00283387|9623718|FG001|STARTED|Second Intervention||5
8588874|NCT00283387|9623717|FG000|COMPLETED|Second Intervention||5
8588875|NCT00283387|9623718|FG001|COMPLETED|Second Intervention||5
8588876|NCT00283387|9623717|FG000|NOT COMPLETED|Second Intervention||0
8588877|NCT00283387|9623718|FG001|NOT COMPLETED|Second Intervention||0
8588878|NCT00283400|9623728|FG000|STARTED|Overall Study||20
8588879|NCT00283400|9623729|FG001|STARTED|Overall Study||20
8588880|NCT00283400|9623730|FG002|STARTED|Overall Study||7
8588881|NCT00283400|9623731|FG003|STARTED|Overall Study||0
8588882|NCT00283400|9623728|FG000|COMPLETED|Overall Study||18
8588883|NCT00283400|9623729|FG001|COMPLETED|Overall Study||19
8588884|NCT00283400|9623730|FG002|COMPLETED|Overall Study||6
8588885|NCT00283400|9623731|FG003|COMPLETED|Overall Study||0
8588886|NCT00283400|9623728|FG000|NOT COMPLETED|Overall Study||2
8588887|NCT00283400|9623729|FG001|NOT COMPLETED|Overall Study||1
8588888|NCT00283400|9623730|FG002|NOT COMPLETED|Overall Study||1
8588889|NCT00283400|9623731|FG003|NOT COMPLETED|Overall Study||0
8588890|NCT00283439|9623745|FG000|STARTED|Overall Study||8
8588891|NCT00283439|9623746|FG001|STARTED|Overall Study||11
8711254|NCT00961116|9757610|FG000|STARTED|Washout Period of 7 Days||27
8711255|NCT00961116|9757611|FG001|STARTED|Washout Period of 7 Days||27
8711256|NCT00961116|9757610|FG000|COMPLETED|Washout Period of 7 Days||25
8711257|NCT00961116|9757611|FG001|COMPLETED|Washout Period of 7 Days||24
8711258|NCT00961116|9757610|FG000|NOT COMPLETED|Washout Period of 7 Days||2
8711259|NCT00961116|9757611|FG001|NOT COMPLETED|Washout Period of 7 Days||3
8588892|NCT00283439|9623747|FG002|STARTED|Overall Study||11
8588893|NCT00283439|9623748|FG003|STARTED|Overall Study||9
8588894|NCT00283439|9623745|FG000|COMPLETED|Overall Study||0
8588895|NCT00283439|9623746|FG001|COMPLETED|Overall Study||0
8588896|NCT00283439|9623747|FG002|COMPLETED|Overall Study||0
8588897|NCT00283439|9623748|FG003|COMPLETED|Overall Study||0
8588898|NCT00283439|9623745|FG000|NOT COMPLETED|Overall Study||8
8588899|NCT00283439|9623746|FG001|NOT COMPLETED|Overall Study||11
8588900|NCT00283439|9623747|FG002|NOT COMPLETED|Overall Study||11
8588901|NCT00283439|9623748|FG003|NOT COMPLETED|Overall Study||9
8588902|NCT00283504|9623760|FG000|STARTED|Overall Study||7
8588903|NCT00283504|9623761|FG001|STARTED|Overall Study||6
8588904|NCT00283504|9623760|FG000|COMPLETED|Overall Study||7
8588905|NCT00283504|9623761|FG001|COMPLETED|Overall Study||6
8588906|NCT00283504|9623760|FG000|NOT COMPLETED|Overall Study||0
8588907|NCT00283504|9623761|FG001|NOT COMPLETED|Overall Study||0
8588908|NCT00283595|9623771|FG000|STARTED|Overall Study||10
8588909|NCT00283595|9623772|FG001|STARTED|Overall Study||11
8588910|NCT00283595|9623771|FG000|COMPLETED|Overall Study||9
8588911|NCT00283595|9623772|FG001|COMPLETED|Overall Study||9
8588912|NCT00283595|9623771|FG000|NOT COMPLETED|Overall Study||1
8588913|NCT00283595|9623772|FG001|NOT COMPLETED|Overall Study||2
8711260|NCT00961116|9757610|FG000|STARTED|Second Intervention||25
8588914|NCT00283686|9623782|FG000|STARTED|Overall Study||140
8588915|NCT00283686|9623783|FG001|STARTED|Overall Study||133
8588916|NCT00283686|9623784|FG002|STARTED|Overall Study||144
8588917|NCT00283686|9623785|FG003|STARTED|Overall Study||141
8588918|NCT00283686|9623782|FG000|COMPLETED|Overall Study||111
8588919|NCT00283686|9623783|FG001|COMPLETED|Overall Study||92
8588920|NCT00283686|9623784|FG002|COMPLETED|Overall Study||111
8588921|NCT00283686|9623785|FG003|COMPLETED|Overall Study||109
8588922|NCT00283686|9623782|FG000|NOT COMPLETED|Overall Study||29
8588923|NCT00283686|9623783|FG001|NOT COMPLETED|Overall Study||41
8588924|NCT00283686|9623784|FG002|NOT COMPLETED|Overall Study||33
8588925|NCT00283686|9623785|FG003|NOT COMPLETED|Overall Study||32
8588926|NCT00283712|9623797|FG000|STARTED|Overall Study||10
8588927|NCT00283712|9623798|FG001|STARTED|Overall Study||10
8588928|NCT00283712|9623797|FG000|Intent-to-treat Sample|Overall Study||10
8588929|NCT00283712|9623798|FG001|Intent-to-treat Sample|Overall Study||10
8588930|NCT00283712|9623797|FG000|Safety Sample|Overall Study||10
8588931|NCT00283712|9623798|FG001|Safety Sample|Overall Study||10
8588932|NCT00283712|9623797|FG000|Per-Protocol Sample|Overall Study||6
8588933|NCT00283712|9623798|FG001|Per-Protocol Sample|Overall Study||7
8588934|NCT00283712|9623797|FG000|COMPLETED|Overall Study||10
8588935|NCT00283712|9623798|FG001|COMPLETED|Overall Study|One subject in placebo arm died prior to study completion.|9
8588936|NCT00283712|9623797|FG000|NOT COMPLETED|Overall Study||0
8588937|NCT00283712|9623798|FG001|NOT COMPLETED|Overall Study||1
8627887|NCT00519636|9667242|FG000|COMPLETED|Treatment Period 2||69
8627888|NCT00519636|9667243|FG001|COMPLETED|Treatment Period 2||71
8627889|NCT00519636|9667244|FG002|COMPLETED|Treatment Period 2||74
8627890|NCT00519636|9667245|FG003|COMPLETED|Treatment Period 2||86
8627891|NCT00519636|9667242|FG000|NOT COMPLETED|Treatment Period 2||0
8627892|NCT00519636|9667243|FG001|NOT COMPLETED|Treatment Period 2||1
8627893|NCT00519636|9667244|FG002|NOT COMPLETED|Treatment Period 2||1
8627894|NCT00519636|9667245|FG003|NOT COMPLETED|Treatment Period 2||2
8627895|NCT00519636|9667242|FG000|STARTED|Post Study Period||69
8627896|NCT00519636|9667243|FG001|STARTED|Post Study Period||71
8627897|NCT00519636|9667244|FG002|STARTED|Post Study Period||74
8627898|NCT00519636|9667245|FG003|STARTED|Post Study Period||86
8627899|NCT00519636|9667242|FG000|COMPLETED|Post Study Period||69
8711261|NCT00961116|9757611|FG001|STARTED|Second Intervention||24
8711262|NCT00961116|9757610|FG000|COMPLETED|Second Intervention||25
8711263|NCT00961116|9757611|FG001|COMPLETED|Second Intervention||24
8813040|NCT01523743|9866152|FG000|NOT COMPLETED|Period 2||1
8813041|NCT01523743|9866153|FG001|NOT COMPLETED|Period 2||2
8813042|NCT01523756|9866159|FG000|STARTED|Baseline Period||11
8813043|NCT01523756|9866160|FG001|STARTED|Baseline Period||9
8813044|NCT01523756|9866159|FG000|COMPLETED|Baseline Period||11
8813045|NCT01523756|9866160|FG001|COMPLETED|Baseline Period||8
8813046|NCT01523756|9866159|FG000|NOT COMPLETED|Baseline Period||0
8813047|NCT01523756|9866160|FG001|NOT COMPLETED|Baseline Period||1
8813048|NCT01523756|9866159|FG000|STARTED|Test Period 1||11
8813049|NCT01523756|9866160|FG001|STARTED|Test Period 1||8
8813050|NCT01523756|9866159|FG000|COMPLETED|Test Period 1||10
8813051|NCT01523756|9866160|FG001|COMPLETED|Test Period 1||8
8813052|NCT01523756|9866159|FG000|NOT COMPLETED|Test Period 1||1
8813053|NCT01523756|9866160|FG001|NOT COMPLETED|Test Period 1||0
8813054|NCT01523756|9866159|FG000|STARTED|Test Period 2||10
8813055|NCT01523756|9866160|FG001|STARTED|Test Period 2||8
8813056|NCT01523756|9866159|FG000|COMPLETED|Test Period 2||10
8813057|NCT01523756|9866160|FG001|COMPLETED|Test Period 2||7
8813058|NCT01523756|9866159|FG000|NOT COMPLETED|Test Period 2||0
8813059|NCT01523756|9866160|FG001|NOT COMPLETED|Test Period 2||1
8813060|NCT01523782|9866171|FG000|STARTED|Overall Study||3
8627900|NCT00519636|9667243|FG001|COMPLETED|Post Study Period||71
8627901|NCT00519636|9667244|FG002|COMPLETED|Post Study Period||74
8627902|NCT00519636|9667245|FG003|COMPLETED|Post Study Period||85
8627903|NCT00519636|9667242|FG000|NOT COMPLETED|Post Study Period||0
8627904|NCT00519636|9667243|FG001|NOT COMPLETED|Post Study Period||0
8627905|NCT00519636|9667244|FG002|NOT COMPLETED|Post Study Period||0
8627906|NCT00519636|9667245|FG003|NOT COMPLETED|Post Study Period||1
8627907|NCT00519649|9667259|FG000|STARTED|Overall Study||300
8627908|NCT00519649|9667259|FG000|COMPLETED|Overall Study||299
8627909|NCT00519649|9667259|FG000|NOT COMPLETED|Overall Study||1
8627910|NCT00519779|9667265|FG000|STARTED|Overall Study||34
8627911|NCT00519779|9667266|FG001|STARTED|Overall Study||34
8627912|NCT00519779|9667265|FG000|COMPLETED|Overall Study||34
8627913|NCT00519779|9667266|FG001|COMPLETED|Overall Study||33
8627914|NCT00519779|9667265|FG000|NOT COMPLETED|Overall Study||0
8627915|NCT00519779|9667266|FG001|NOT COMPLETED|Overall Study||1
8627916|NCT00519831|9667272|FG000|STARTED|Overall Study||16
8627917|NCT00519831|9667272|FG000|COMPLETED|Overall Study||13
8627918|NCT00519831|9667272|FG000|NOT COMPLETED|Overall Study||3
8627919|NCT00519896|9667276|FG000|STARTED|Overall Study||35
8627920|NCT00519896|9667276|FG000|COMPLETED|Overall Study||33
8627921|NCT00519896|9667276|FG000|NOT COMPLETED|Overall Study||2
8627922|NCT00520013|9667283|FG000|STARTED|Overall Study||23
8627923|NCT00520013|9667284|FG001|STARTED|Overall Study||25
8627924|NCT00520013|9667285|FG002|STARTED|Overall Study|Excludes a pt who went off-study (on reg day) due to consent that may not have been informed (ESL).|11
8627925|NCT00520013|9667283|FG000|Treated|Overall Study||23
8711264|NCT00961116|9757610|FG000|NOT COMPLETED|Second Intervention||0
8711265|NCT00961116|9757611|FG001|NOT COMPLETED|Second Intervention||0
8711266|NCT00961181|9757618|FG000|STARTED|Overall Study||81
8711267|NCT00961181|9757618|FG000|COMPLETED|Overall Study||76
8711268|NCT00961181|9757618|FG000|NOT COMPLETED|Overall Study||5
8711269|NCT00961220|9757622|FG000|STARTED|Overall Study||17
8711270|NCT00961220|9757622|FG000|COMPLETED|Overall Study||10
8627926|NCT00520013|9667284|FG001|Treated|Overall Study||25
8627927|NCT00520013|9667285|FG002|Treated|Overall Study||11
8627928|NCT00520013|9667283|FG000|COMPLETED|Overall Study||11
8627929|NCT00520013|9667284|FG001|COMPLETED|Overall Study||10
8627930|NCT00520013|9667285|FG002|COMPLETED|Overall Study||0
8627931|NCT00520013|9667283|FG000|NOT COMPLETED|Overall Study||12
8711271|NCT00961220|9757622|FG000|NOT COMPLETED|Overall Study||7
8711272|NCT00961233|9757630|FG000|STARTED|Overall Study||13
8813061|NCT01523782|9866172|FG001|STARTED|Overall Study||13
8813062|NCT01523782|9866173|FG002|STARTED|Overall Study||14
8813063|NCT01523782|9866171|FG000|COMPLETED|Overall Study||2
8813064|NCT01523782|9866172|FG001|COMPLETED|Overall Study||13
8813065|NCT01523782|9866173|FG002|COMPLETED|Overall Study||9
8588938|NCT00283803|9623804|FG000|STARTED|Overall Study||32
8588939|NCT00283803|9623804|FG000|COMPLETED|Overall Study||19
8588940|NCT00283803|9623804|FG000|NOT COMPLETED|Overall Study||13
8588941|NCT00283816|9623810|FG000|STARTED|Overall Study||18
8588942|NCT00283816|9623811|FG001|STARTED|Overall Study||18
8588943|NCT00283816|9623810|FG000|COMPLETED|Overall Study||16
8588944|NCT00283816|9623811|FG001|COMPLETED|Overall Study||16
8588945|NCT00283816|9623810|FG000|NOT COMPLETED|Overall Study||2
8588946|NCT00283816|9623811|FG001|NOT COMPLETED|Overall Study||2
8588947|NCT00283842|9623824|FG000|STARTED|Overall Study||63
8588948|NCT00283842|9623825|FG001|STARTED|Overall Study||87
8588949|NCT00283842|9623826|FG002|STARTED|Overall Study||99
8588950|NCT00283842|9623827|FG003|STARTED|Overall Study||69
8588951|NCT00283842|9623828|FG004|STARTED|Overall Study||90
8588952|NCT00283842|9623824|FG000|COMPLETED|Overall Study||51
8588953|NCT00283842|9623825|FG001|COMPLETED|Overall Study||69
8588954|NCT00283842|9623826|FG002|COMPLETED|Overall Study||68
8588955|NCT00283842|9623827|FG003|COMPLETED|Overall Study||42
8588956|NCT00283842|9623828|FG004|COMPLETED|Overall Study||75
8588957|NCT00283842|9623824|FG000|NOT COMPLETED|Overall Study||12
8588958|NCT00283842|9623825|FG001|NOT COMPLETED|Overall Study||18
8588959|NCT00283842|9623826|FG002|NOT COMPLETED|Overall Study||31
8588960|NCT00283842|9623827|FG003|NOT COMPLETED|Overall Study||27
8588961|NCT00283842|9623828|FG004|NOT COMPLETED|Overall Study||15
8588962|NCT00283933|9623840|FG000|STARTED|Treatment Period||5
8588963|NCT00283933|9623840|FG000|Safety Population|Treatment Period||5
8588964|NCT00283933|9623840|FG000|Pharmacodynamic (PD) Population|Treatment Period||5
8588965|NCT00283933|9623840|FG000|COMPLETED|Treatment Period||5
8588966|NCT00283933|9623840|FG000|NOT COMPLETED|Treatment Period||0
8588967|NCT00283933|9623840|FG000|STARTED|Extension Period||5
8588968|NCT00283933|9623840|FG000|COMPLETED|Extension Period||5
8588969|NCT00283933|9623840|FG000|NOT COMPLETED|Extension Period||0
8588970|NCT00284050|9623847|FG000|STARTED|Overall Study||51
8588971|NCT00284050|9623848|FG001|STARTED|Overall Study||51
8588972|NCT00284050|9623849|FG002|STARTED|Overall Study||49
8588973|NCT00284050|9623847|FG000|COMPLETED|Overall Study||46
8588974|NCT00284050|9623848|FG001|COMPLETED|Overall Study||46
8588975|NCT00284050|9623849|FG002|COMPLETED|Overall Study||40
8588976|NCT00284050|9623847|FG000|NOT COMPLETED|Overall Study||5
8588977|NCT00284050|9623848|FG001|NOT COMPLETED|Overall Study||5
8588978|NCT00284050|9623849|FG002|NOT COMPLETED|Overall Study||9
8588979|NCT00284089|9623861|FG000|STARTED|Single Dose Phase||6
8588980|NCT00284089|9623862|FG001|STARTED|Single Dose Phase||6
8588981|NCT00284089|9623863|FG002|STARTED|Single Dose Phase|Group B patients did not participate in the Single Dose Phase of the study.|0
8588982|NCT00284089|9623864|FG003|STARTED|Single Dose Phase|Group B patients did not participate in the Single Dose Phase of the study.|0
8588983|NCT00284089|9623861|FG000|COMPLETED|Single Dose Phase||6
8588984|NCT00284089|9623862|FG001|COMPLETED|Single Dose Phase||6
8588985|NCT00284089|9623863|FG002|COMPLETED|Single Dose Phase||0
8588986|NCT00284089|9623864|FG003|COMPLETED|Single Dose Phase||0
8588987|NCT00284089|9623861|FG000|NOT COMPLETED|Single Dose Phase||0
8588988|NCT00284089|9623862|FG001|NOT COMPLETED|Single Dose Phase||0
8588989|NCT00284089|9623863|FG002|NOT COMPLETED|Single Dose Phase||0
8588990|NCT00284089|9623864|FG003|NOT COMPLETED|Single Dose Phase||0
8588991|NCT00284089|9623861|FG000|STARTED|Multiple Dose Phase|1 subject chose to receive other treatment & discontinued before starting the multiple dose phase.|5
8588992|NCT00284089|9623862|FG001|STARTED|Multiple Dose Phase||6
8588993|NCT00284089|9623863|FG002|STARTED|Multiple Dose Phase||35
8588994|NCT00284089|9623864|FG003|STARTED|Multiple Dose Phase||41
8588995|NCT00284089|9623861|FG000|COMPLETED|Multiple Dose Phase||4
8588996|NCT00284089|9623862|FG001|COMPLETED|Multiple Dose Phase||6
8588997|NCT00284089|9623863|FG002|COMPLETED|Multiple Dose Phase||31
8588998|NCT00284089|9623864|FG003|COMPLETED|Multiple Dose Phase||37
8588999|NCT00284089|9623861|FG000|NOT COMPLETED|Multiple Dose Phase||1
8589000|NCT00284089|9623862|FG001|NOT COMPLETED|Multiple Dose Phase||0
8589001|NCT00284089|9623863|FG002|NOT COMPLETED|Multiple Dose Phase||4
8589002|NCT00284089|9623864|FG003|NOT COMPLETED|Multiple Dose Phase||4
8589003|NCT00284089|9623861|FG000|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|3
8589004|NCT00284089|9623862|FG001|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|6
8589005|NCT00284089|9623863|FG002|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|28
8589006|NCT00284089|9623864|FG003|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|33
8589007|NCT00284089|9623861|FG000|COMPLETED|Extension Phase||1
8589008|NCT00284089|9623862|FG001|COMPLETED|Extension Phase||6
8589009|NCT00284089|9623863|FG002|COMPLETED|Extension Phase||22
8589010|NCT00284089|9623864|FG003|COMPLETED|Extension Phase||21
8589011|NCT00284089|9623861|FG000|NOT COMPLETED|Extension Phase||2
8589012|NCT00284089|9623862|FG001|NOT COMPLETED|Extension Phase||0
8589013|NCT00284089|9623863|FG002|NOT COMPLETED|Extension Phase||6
8589014|NCT00284089|9623864|FG003|NOT COMPLETED|Extension Phase||12
8589015|NCT00284141|9623874|FG000|STARTED|Overall Study||98
8589016|NCT00284141|9623874|FG000|TREATED|Overall Study|Participants received at least part of one dose of Aflibercept.|96
8589017|NCT00284141|9623874|FG000|ONGOING TREATMENT|Overall Study|Participants were still on study treatment at the clinical database cut-off date.|2
8589018|NCT00284141|9623874|FG000|COMPLETED|Overall Study|Participants met treatment discontinuation criteria or were still ongoing treatment.|0
8589019|NCT00284141|9623874|FG000|NOT COMPLETED|Overall Study||98
8589020|NCT00284154|9623880|FG000|STARTED|Overall Study||51
8589021|NCT00284154|9623880|FG000|COMPLETED|Overall Study||9
8589022|NCT00284154|9623880|FG000|NOT COMPLETED|Overall Study||42
8589023|NCT00284180|9623886|FG000|STARTED|Overall Study||11
8589024|NCT00284180|9623887|FG001|STARTED|Overall Study||21
8589025|NCT00284180|9623886|FG000|COMPLETED|Overall Study||11
8589026|NCT00284180|9623887|FG001|COMPLETED|Overall Study||17
8589027|NCT00284180|9623886|FG000|NOT COMPLETED|Overall Study||0
8589028|NCT00284180|9623887|FG001|NOT COMPLETED|Overall Study||4
8589029|NCT00284518|9623897|FG000|STARTED|Overall Study||97
8589030|NCT00284518|9623898|FG001|STARTED|Overall Study||94
8589031|NCT00284518|9623899|FG002|STARTED|Overall Study||95
8589032|NCT00284518|9623900|FG003|STARTED|Overall Study||94
8589033|NCT00284518|9623897|FG000|COMPLETED|Overall Study||71
8589034|NCT00284518|9623898|FG001|COMPLETED|Overall Study||66
8589035|NCT00284518|9623899|FG002|COMPLETED|Overall Study||67
8589036|NCT00284518|9623900|FG003|COMPLETED|Overall Study||61
8589037|NCT00284518|9623897|FG000|NOT COMPLETED|Overall Study||26
8589038|NCT00284518|9623898|FG001|NOT COMPLETED|Overall Study||28
8589039|NCT00284518|9623899|FG002|NOT COMPLETED|Overall Study||28
8589040|NCT00284518|9623900|FG003|NOT COMPLETED|Overall Study||33
8589041|NCT00284557|9623912|FG000|STARTED|Overall Study||67
8589042|NCT00284557|9623913|FG001|STARTED|Overall Study||63
8589043|NCT00284557|9623912|FG000|COMPLETED|Overall Study||58
8589044|NCT00284557|9623913|FG001|COMPLETED|Overall Study||50
8589045|NCT00284557|9623912|FG000|NOT COMPLETED|Overall Study||9
8589046|NCT00284557|9623913|FG001|NOT COMPLETED|Overall Study||13
8589047|NCT00284739|9623921|FG000|STARTED|Overall Study||11
8589048|NCT00284739|9623922|FG001|STARTED|Overall Study||9
8589049|NCT00284739|9623921|FG000|COMPLETED|Overall Study||11
8589050|NCT00284739|9623922|FG001|COMPLETED|Overall Study||9
8589051|NCT00284739|9623921|FG000|NOT COMPLETED|Overall Study||0
8589052|NCT00284739|9623922|FG001|NOT COMPLETED|Overall Study||0
8589053|NCT00284934|9623930|FG000|STARTED|Overall Study||48
8589054|NCT00284934|9623931|FG001|STARTED|Overall Study||46
8589055|NCT00284934|9623930|FG000|Intent-to-treat Population (ITT)|Overall Study||47
8589056|NCT00284934|9623931|FG001|Intent-to-treat Population (ITT)|Overall Study||45
8589057|NCT00284934|9623930|FG000|COMPLETED|Overall Study||44
8589058|NCT00284934|9623931|FG001|COMPLETED|Overall Study||43
8589059|NCT00284934|9623930|FG000|NOT COMPLETED|Overall Study||4
8589060|NCT00284934|9623931|FG001|NOT COMPLETED|Overall Study||3
8589061|NCT00285012|9623939|FG000|STARTED|Assigned to Study Treatment (Tx)||250
8589062|NCT00285012|9623940|FG001|STARTED|Assigned to Study Treatment (Tx)||254
8589063|NCT00285012|9623939|FG000|COMPLETED|Assigned to Study Treatment (Tx)||248
8589064|NCT00285012|9623940|FG001|COMPLETED|Assigned to Study Treatment (Tx)||251
8589065|NCT00285012|9623939|FG000|NOT COMPLETED|Assigned to Study Treatment (Tx)||2
8589066|NCT00285012|9623940|FG001|NOT COMPLETED|Assigned to Study Treatment (Tx)||3
8589067|NCT00285012|9623939|FG000|STARTED|Received Study Tx||248
8589068|NCT00285012|9623940|FG001|STARTED|Received Study Tx||251
8589069|NCT00285012|9623939|FG000|Completed Tx (May Continue in Study)|Received Study Tx|After treatment completion at Wk 12, subjects may continue in nontreatment follow-up phase|207
8589070|NCT00285012|9623940|FG001|Completed Tx (May Continue in Study)|Received Study Tx|After treatment completion at Wk 12, subjects may continue in nontreatment follow-up phase|193
8589071|NCT00285012|9623939|FG000|Discontinued Tx (May Continue in Study)|Received Study Tx|Discontinued Tx=12 Adverse Event (AE); 10 Lost to follow up; 13 subject withdrawal; 6 other, unknown|41
8589072|NCT00285012|9623940|FG001|Discontinued Tx (May Continue in Study)|Received Study Tx|Discontinued Tx=14 AE;3 Lack of efficacy;10 Lost to follow up;25 subject withdrawal;6 other, unknown|58
8589073|NCT00285012|9623939|FG000|COMPLETED|Received Study Tx|Completed study through nontreatment follow-up phase Week 13 to Week 52|176
8589074|NCT00285012|9623940|FG001|COMPLETED|Received Study Tx|Completed study through nontreatment follow-up phase Week 13 to Week 52|157
8589075|NCT00285012|9623939|FG000|NOT COMPLETED|Received Study Tx||72
8589076|NCT00285012|9623940|FG001|NOT COMPLETED|Received Study Tx||94
8589077|NCT00285207|9623948|FG000|STARTED|Overall Study||70
8589078|NCT00285207|9623949|FG001|STARTED|Overall Study||77
8589079|NCT00285207|9623948|FG000|Treated|Overall Study||63
8589080|NCT00285207|9623949|FG001|Treated|Overall Study||75
8589081|NCT00285207|9623948|FG000|COMPLETED|Overall Study||61
8589082|NCT00285207|9623949|FG001|COMPLETED|Overall Study||71
8589083|NCT00285207|9623948|FG000|NOT COMPLETED|Overall Study||9
8589084|NCT00285207|9623949|FG001|NOT COMPLETED|Overall Study||6
8589085|NCT00285246|9623955|FG000|STARTED|Overall Study||838
8589086|NCT00285246|9623955|FG000|COMPLETED|Overall Study|Number of participants who were eligible and completed at least one phase of data collection|790
8589087|NCT00285246|9623955|FG000|NOT COMPLETED|Overall Study||48
8589088|NCT00285467|9623961|FG000|STARTED|Overall Study||25
8589089|NCT00285467|9623962|FG001|STARTED|Overall Study||22
8589090|NCT00285467|9623961|FG000|COMPLETED|Overall Study||25
8589091|NCT00285467|9623962|FG001|COMPLETED|Overall Study||22
8589092|NCT00285467|9623961|FG000|NOT COMPLETED|Overall Study||0
8589093|NCT00285467|9623962|FG001|NOT COMPLETED|Overall Study||0
9064252|NCT04322396|10124526|FG000|NOT COMPLETED|Overall Study||0
9064253|NCT04322396|10124527|FG001|NOT COMPLETED|Overall Study||0
9064254|NCT04320823|10124535|FG000|STARTED|Overall Study||1717
9064255|NCT04320823|10124536|FG001|STARTED|Overall Study||1726
9064256|NCT04320823|10124535|FG000|COMPLETED|Overall Study|Includes 47 donors who withdrew from the study after one or more donations.|1717
9064257|NCT04320823|10124536|FG001|COMPLETED|Overall Study|Includes 38 donors who withdrew from the study after one or more donations.|1726
8589094|NCT00285584|9623970|FG000|STARTED|Enrollment (Month 0)||20
8589095|NCT00285584|9623971|FG001|STARTED|Enrollment (Month 0)||21
8589096|NCT00285584|9623970|FG000|COMPLETED|Enrollment (Month 0)||20
8589097|NCT00285584|9623971|FG001|COMPLETED|Enrollment (Month 0)||21
8589098|NCT00285584|9623970|FG000|NOT COMPLETED|Enrollment (Month 0)||0
8589099|NCT00285584|9623971|FG001|NOT COMPLETED|Enrollment (Month 0)||0
8589100|NCT00285584|9623970|FG000|STARTED|Month 3||20
8589101|NCT00285584|9623971|FG001|STARTED|Month 3||21
8589102|NCT00285584|9623970|FG000|COMPLETED|Month 3||16
8589103|NCT00285584|9623971|FG001|COMPLETED|Month 3||18
8589104|NCT00285584|9623970|FG000|NOT COMPLETED|Month 3||4
8589105|NCT00285584|9623971|FG001|NOT COMPLETED|Month 3||3
8589106|NCT00285584|9623970|FG000|STARTED|Month 6||16
8589107|NCT00285584|9623971|FG001|STARTED|Month 6||18
8589108|NCT00285584|9623970|FG000|COMPLETED|Month 6||16
8589109|NCT00285584|9623971|FG001|COMPLETED|Month 6||17
8589110|NCT00285584|9623970|FG000|NOT COMPLETED|Month 6||0
8589111|NCT00285584|9623971|FG001|NOT COMPLETED|Month 6||1
8589112|NCT00285584|9623970|FG000|STARTED|Month 9||16
8589113|NCT00285584|9623971|FG001|STARTED|Month 9||17
8589114|NCT00285584|9623970|FG000|COMPLETED|Month 9||15
8589115|NCT00285584|9623971|FG001|COMPLETED|Month 9||14
8589116|NCT00285584|9623970|FG000|NOT COMPLETED|Month 9||1
8589117|NCT00285584|9623971|FG001|NOT COMPLETED|Month 9||3
8589118|NCT00285649|9623984|FG000|STARTED|Overall Study||72
8589119|NCT00285649|9623985|FG001|STARTED|Overall Study||72
8589120|NCT00285649|9623986|FG002|STARTED|Overall Study||48
8589121|NCT00285649|9623984|FG000|COMPLETED|Overall Study||63
8589122|NCT00285649|9623985|FG001|COMPLETED|Overall Study||66
8589123|NCT00285649|9623986|FG002|COMPLETED|Overall Study||42
8589124|NCT00285649|9623984|FG000|NOT COMPLETED|Overall Study||9
8589125|NCT00285649|9623985|FG001|NOT COMPLETED|Overall Study||6
8589126|NCT00285649|9623986|FG002|NOT COMPLETED|Overall Study||6
8589127|NCT00285779|9623996|FG000|STARTED|Placebo-controlled Period (wk 1-12)||14
8589128|NCT00285779|9623997|FG001|STARTED|Placebo-controlled Period (wk 1-12)||13
8589129|NCT00285779|9623996|FG000|COMPLETED|Placebo-controlled Period (wk 1-12)||11
8589130|NCT00285779|9623997|FG001|COMPLETED|Placebo-controlled Period (wk 1-12)||12
8589131|NCT00285779|9623996|FG000|NOT COMPLETED|Placebo-controlled Period (wk 1-12)||3
8589132|NCT00285779|9623997|FG001|NOT COMPLETED|Placebo-controlled Period (wk 1-12)||1
8589133|NCT00285779|9623996|FG000|STARTED|Open Label Period (wk 12-24)||11
8589134|NCT00285779|9623997|FG001|STARTED|Open Label Period (wk 12-24)||12
8589135|NCT00285779|9623996|FG000|COMPLETED|Open Label Period (wk 12-24)||9
8589136|NCT00285779|9623997|FG001|COMPLETED|Open Label Period (wk 12-24)||10
8589137|NCT00285779|9623996|FG000|NOT COMPLETED|Open Label Period (wk 12-24)||2
8589138|NCT00285779|9623997|FG001|NOT COMPLETED|Open Label Period (wk 12-24)||2
8589139|NCT00285779|9623996|FG000|STARTED|Follow-up Period (wk 24-32)||9
8589140|NCT00285779|9623997|FG001|STARTED|Follow-up Period (wk 24-32)||10
8589141|NCT00285779|9623996|FG000|COMPLETED|Follow-up Period (wk 24-32)||8
8589142|NCT00285779|9623997|FG001|COMPLETED|Follow-up Period (wk 24-32)||10
8589143|NCT00285779|9623996|FG000|NOT COMPLETED|Follow-up Period (wk 24-32)||1
8589144|NCT00285779|9623997|FG001|NOT COMPLETED|Follow-up Period (wk 24-32)||0
8589145|NCT00285818|9624005|FG000|STARTED|Overall Study||6
8589146|NCT00285818|9624006|FG001|STARTED|Overall Study||5
8589147|NCT00285818|9624005|FG000|COMPLETED|Overall Study||2
8589148|NCT00285818|9624006|FG001|COMPLETED|Overall Study||3
8589149|NCT00285818|9624005|FG000|NOT COMPLETED|Overall Study||4
8589150|NCT00285818|9624006|FG001|NOT COMPLETED|Overall Study||2
8589151|NCT00285857|9624012|FG000|STARTED|Overall Study||30
8589152|NCT00285857|9624012|FG000|COMPLETED|Overall Study||26
8589153|NCT00285857|9624012|FG000|NOT COMPLETED|Overall Study||4
8589154|NCT00286078|9624023|FG000|STARTED|Overall Study||72
8589155|NCT00286078|9624024|FG001|STARTED|Overall Study||68
8589156|NCT00286078|9624023|FG000|12 Weeks|Overall Study||63
8589157|NCT00286078|9624024|FG001|12 Weeks|Overall Study||62
8589158|NCT00286078|9624023|FG000|COMPLETED|Overall Study||40
8589159|NCT00286078|9624024|FG001|COMPLETED|Overall Study||34
8589160|NCT00286078|9624023|FG000|NOT COMPLETED|Overall Study||32
8589161|NCT00286078|9624024|FG001|NOT COMPLETED|Overall Study||34
8589162|NCT00286091|9624032|FG000|STARTED|Double-blind Treatment Phase||716
8589163|NCT00286091|9624033|FG001|STARTED|Double-blind Treatment Phase||716
8589164|NCT00286091|9624032|FG000|Received Treatment|Double-blind Treatment Phase|4 participants received ≥ 1 dose of denosumab in error|709
8589165|NCT00286091|9624033|FG001|Received Treatment|Double-blind Treatment Phase||716
8589166|NCT00286091|9624032|FG000|On Study at Primary Data Analysis Cutoff|Double-blind Treatment Phase|Primary analysis cut-off date was 30 July 2010|164
8589167|NCT00286091|9624033|FG001|On Study at Primary Data Analysis Cutoff|Double-blind Treatment Phase|Primary analysis cut-off date was 30 July 2010|174
8589168|NCT00286091|9624032|FG000|COMPLETED|Double-blind Treatment Phase|On study through blinded treatment cutoff date of 09 January 2011|132
8589169|NCT00286091|9624033|FG001|COMPLETED|Double-blind Treatment Phase|On study through blinded treatment cutoff date of 09 January 2011|123
8589170|NCT00286091|9624032|FG000|NOT COMPLETED|Double-blind Treatment Phase||584
8589171|NCT00286091|9624033|FG001|NOT COMPLETED|Double-blind Treatment Phase||593
8589172|NCT00286091|9624032|FG000|STARTED|Open-label Treatment Phase|Participants in the Czech Republic and UK are reported separately (Study 20080585; NCT01824342)|110
8589173|NCT00286091|9624033|FG001|STARTED|Open-label Treatment Phase|Participants in the Czech Republic and UK are reported separately (Study 20080585; NCT01824342)|104
8589174|NCT00286091|9624032|FG000|Received Treatment|Open-label Treatment Phase||109
8589175|NCT00286091|9624033|FG001|Received Treatment|Open-label Treatment Phase||101
8589176|NCT00286091|9624032|FG000|COMPLETED|Open-label Treatment Phase|Completed 3 years of open-label treatment|33
8589177|NCT00286091|9624033|FG001|COMPLETED|Open-label Treatment Phase|Completed 3 years of open-label treatment|33
8589178|NCT00286091|9624032|FG000|NOT COMPLETED|Open-label Treatment Phase||77
8589179|NCT00286091|9624033|FG001|NOT COMPLETED|Open-label Treatment Phase||71
8589180|NCT00286156|9624044|FG000|STARTED|Overall Study||10
8589181|NCT00286156|9624045|FG001|STARTED|Overall Study||10
8589182|NCT00286156|9624046|FG002|STARTED|Overall Study||10
8589183|NCT00286156|9624044|FG000|COMPLETED|Overall Study||8
8589184|NCT00286156|9624045|FG001|COMPLETED|Overall Study||9
8589185|NCT00286156|9624046|FG002|COMPLETED|Overall Study||9
8589186|NCT00286156|9624044|FG000|NOT COMPLETED|Overall Study||2
8589187|NCT00286156|9624045|FG001|NOT COMPLETED|Overall Study||1
8589188|NCT00286156|9624046|FG002|NOT COMPLETED|Overall Study||1
8589189|NCT00286182|9624056|FG000|STARTED|Overall Study||28
8589190|NCT00286182|9624057|FG001|STARTED|Overall Study||28
8589191|NCT00286182|9624056|FG000|COMPLETED|Overall Study||23
8589192|NCT00286182|9624057|FG001|COMPLETED|Overall Study||25
8589193|NCT00286182|9624056|FG000|NOT COMPLETED|Overall Study||5
8589194|NCT00286182|9624057|FG001|NOT COMPLETED|Overall Study||3
8589195|NCT00286221|9624067|FG000|STARTED|Overall Study||39
8589196|NCT00286221|9624068|FG001|STARTED|Overall Study||40
8589197|NCT00286221|9624069|FG002|STARTED|Overall Study||40
8589198|NCT00286221|9624070|FG003|STARTED|Overall Study||40
8589199|NCT00286221|9624067|FG000|COMPLETED|Overall Study||29
8589200|NCT00286221|9624068|FG001|COMPLETED|Overall Study||35
8589201|NCT00286221|9624069|FG002|COMPLETED|Overall Study||31
8589202|NCT00286221|9624070|FG003|COMPLETED|Overall Study||34
8589203|NCT00286221|9624067|FG000|NOT COMPLETED|Overall Study||10
8589204|NCT00286221|9624068|FG001|NOT COMPLETED|Overall Study||5
8589205|NCT00286221|9624069|FG002|NOT COMPLETED|Overall Study||9
8589206|NCT00286221|9624070|FG003|NOT COMPLETED|Overall Study||6
8589207|NCT00286234|9624084|FG000|STARTED|Overall Study||17
8589208|NCT00286234|9624085|FG001|STARTED|Overall Study||17
8589209|NCT00286234|9624086|FG002|STARTED|Overall Study||17
8589210|NCT00286234|9624087|FG003|STARTED|Overall Study||17
8589211|NCT00286234|9624084|FG000|COMPLETED|Overall Study||15
8589212|NCT00286234|9624085|FG001|COMPLETED|Overall Study||15
8589213|NCT00286234|9624086|FG002|COMPLETED|Overall Study||17
8589214|NCT00286234|9624087|FG003|COMPLETED|Overall Study||13
8589215|NCT00286234|9624084|FG000|NOT COMPLETED|Overall Study||2
8589216|NCT00286234|9624085|FG001|NOT COMPLETED|Overall Study||2
8589217|NCT00286234|9624086|FG002|NOT COMPLETED|Overall Study||0
8589218|NCT00286234|9624087|FG003|NOT COMPLETED|Overall Study||4
8589219|NCT00286325|9624097|FG000|STARTED|Overall Study||8
8589220|NCT00286325|9624097|FG000|COMPLETED|Overall Study||8
8589221|NCT00286325|9624097|FG000|NOT COMPLETED|Overall Study||0
8589222|NCT00286429|9624104|FG000|STARTED|Overall Study||130
8589223|NCT00286429|9624105|FG001|STARTED|Overall Study||131
8589224|NCT00286429|9624106|FG002|STARTED|Overall Study||129
8589225|NCT00286429|9624104|FG000|COMPLETED|Overall Study||55
8589226|NCT00286429|9624105|FG001|COMPLETED|Overall Study||83
8589227|NCT00286429|9624106|FG002|COMPLETED|Overall Study||77
8589228|NCT00286429|9624104|FG000|NOT COMPLETED|Overall Study||75
8589229|NCT00286429|9624105|FG001|NOT COMPLETED|Overall Study||48
8589230|NCT00286429|9624106|FG002|NOT COMPLETED|Overall Study||52
8589231|NCT00286442|9624117|FG000|STARTED|Overall Study||213
8589232|NCT00286442|9624118|FG001|STARTED|Overall Study||210
8589233|NCT00286442|9624119|FG002|STARTED|Overall Study||104
8589234|NCT00286442|9624117|FG000|COMPLETED|Overall Study||176
8589235|NCT00286442|9624118|FG001|COMPLETED|Overall Study||165
8589236|NCT00286442|9624119|FG002|COMPLETED|Overall Study||72
8589237|NCT00286442|9624117|FG000|NOT COMPLETED|Overall Study||37
8589238|NCT00286442|9624118|FG001|NOT COMPLETED|Overall Study||45
8589239|NCT00286442|9624119|FG002|NOT COMPLETED|Overall Study||32
8589240|NCT00286455|9624130|FG000|STARTED|Overall Study||65
8589241|NCT00286455|9624131|FG001|STARTED|Overall Study||133
8589242|NCT00286455|9624132|FG002|STARTED|Overall Study||131
8589243|NCT00286455|9624130|FG000|COMPLETED|Overall Study||40
8589244|NCT00286455|9624131|FG001|COMPLETED|Overall Study||105
8589245|NCT00286455|9624132|FG002|COMPLETED|Overall Study||107
8589246|NCT00286455|9624130|FG000|NOT COMPLETED|Overall Study||25
8589247|NCT00286455|9624131|FG001|NOT COMPLETED|Overall Study||28
8589248|NCT00286455|9624132|FG002|NOT COMPLETED|Overall Study||24
8589249|NCT00286468|9624143|FG000|STARTED|Overall Study||99
8589250|NCT00286468|9624144|FG001|STARTED|Overall Study||203
8589251|NCT00286468|9624145|FG002|STARTED|Overall Study||198
8589252|NCT00286468|9624143|FG000|COMPLETED|Overall Study||62
8589253|NCT00286468|9624144|FG001|COMPLETED|Overall Study||153
8589254|NCT00286468|9624145|FG002|COMPLETED|Overall Study||148
8589255|NCT00286468|9624143|FG000|NOT COMPLETED|Overall Study||37
8589256|NCT00286468|9624144|FG001|NOT COMPLETED|Overall Study||50
8589257|NCT00286468|9624145|FG002|NOT COMPLETED|Overall Study||50
8589258|NCT00286494|9624156|FG000|STARTED|Overall Study||97
8589259|NCT00286494|9624157|FG001|STARTED|Overall Study||197
8589260|NCT00286494|9624158|FG002|STARTED|Overall Study||199
8589261|NCT00286494|9624156|FG000|COMPLETED|Overall Study||71
8589262|NCT00286494|9624157|FG001|COMPLETED|Overall Study||153
8589263|NCT00286494|9624158|FG002|COMPLETED|Overall Study||160
8589264|NCT00286494|9624156|FG000|NOT COMPLETED|Overall Study||26
8589265|NCT00286494|9624157|FG001|NOT COMPLETED|Overall Study||44
8589266|NCT00286494|9624158|FG002|NOT COMPLETED|Overall Study||39
8589267|NCT00286728|9624168|FG000|STARTED|Overall Study||142
8589268|NCT00286728|9624169|FG001|STARTED|Overall Study||145
8589269|NCT00286728|9624168|FG000|COMPLETED|Overall Study||106
8589270|NCT00286728|9624169|FG001|COMPLETED|Overall Study||116
8589271|NCT00286728|9624168|FG000|NOT COMPLETED|Overall Study||36
8589272|NCT00286728|9624169|FG001|NOT COMPLETED|Overall Study||29
8589273|NCT00286741|9624177|FG000|STARTED|Overall Study||133
8589274|NCT00286741|9624178|FG001|STARTED|Overall Study||106
8589275|NCT00286741|9624177|FG000|COMPLETED|Overall Study||122
8589276|NCT00286741|9624178|FG001|COMPLETED|Overall Study||89
8589277|NCT00286741|9624177|FG000|NOT COMPLETED|Overall Study||11
8589278|NCT00286741|9624178|FG001|NOT COMPLETED|Overall Study||17
8589279|NCT00286754|9624190|FG000|STARTED|Overall Study||176
8589280|NCT00286754|9624191|FG001|STARTED|Overall Study||177
8589281|NCT00286754|9624192|FG002|STARTED|Overall Study||180
8589282|NCT00286754|9624190|FG000|COMPLETED|Overall Study||156
8589283|NCT00286754|9624191|FG001|COMPLETED|Overall Study||159
8589284|NCT00286754|9624192|FG002|COMPLETED|Overall Study||170
8589285|NCT00286754|9624190|FG000|NOT COMPLETED|Overall Study||20
8589286|NCT00286754|9624191|FG001|NOT COMPLETED|Overall Study||18
8589287|NCT00286754|9624192|FG002|NOT COMPLETED|Overall Study||10
8589288|NCT00286949|9624206|FG000|STARTED|Overall Study||12
8589289|NCT00286949|9624206|FG000|COMPLETED|Overall Study||12
8589290|NCT00286949|9624206|FG000|NOT COMPLETED|Overall Study||0
8589291|NCT00287053|9624214|FG000|STARTED|Overall Study||30
8589292|NCT00287053|9624215|FG001|STARTED|Overall Study||27
8589293|NCT00287053|9624214|FG000|COMPLETED|Overall Study||26
8589294|NCT00287053|9624215|FG001|COMPLETED|Overall Study||26
8589295|NCT00287053|9624214|FG000|NOT COMPLETED|Overall Study||4
8589296|NCT00287053|9624215|FG001|NOT COMPLETED|Overall Study||1
8589297|NCT00287079|9624223|FG000|STARTED|Overall Study||32
8589298|NCT00287079|9624224|FG001|STARTED|Overall Study||3
8589299|NCT00287079|9624223|FG000|COMPLETED|Overall Study||10
8589300|NCT00287079|9624224|FG001|COMPLETED|Overall Study||2
8589301|NCT00287079|9624223|FG000|NOT COMPLETED|Overall Study||22
8589302|NCT00287079|9624224|FG001|NOT COMPLETED|Overall Study||1
8589303|NCT00287118|9624230|FG000|STARTED|Overall Study||189
8589304|NCT00287118|9624230|FG000|COMPLETED|Overall Study||137
8589305|NCT00287118|9624230|FG000|NOT COMPLETED|Overall Study||52
8589306|NCT00287222|9624234|FG000|STARTED|Overall Study||21
8589307|NCT00287222|9624234|FG000|COMPLETED|Overall Study||21
8589308|NCT00287222|9624234|FG000|NOT COMPLETED|Overall Study||0
8589309|NCT00287287|9624238|FG000|STARTED|Overall Study||25
8589310|NCT00287287|9624238|FG000|COMPLETED|Overall Study||25
8589311|NCT00287287|9624238|FG000|NOT COMPLETED|Overall Study||0
8589312|NCT00287339|9624244|FG000|STARTED|Overall Study||22
8589313|NCT00287339|9624245|FG001|STARTED|Overall Study||18
8589314|NCT00287339|9624244|FG000|COMPLETED|Overall Study||22
8589315|NCT00287339|9624245|FG001|COMPLETED|Overall Study||18
8589316|NCT00287339|9624244|FG000|NOT COMPLETED|Overall Study||0
8589317|NCT00287339|9624245|FG001|NOT COMPLETED|Overall Study||0
8589318|NCT00287365|9624251|FG000|STARTED|Overall Study||25
8589319|NCT00287365|9624251|FG000|COMPLETED|Overall Study||12
8589320|NCT00287365|9624251|FG000|NOT COMPLETED|Overall Study||13
8589321|NCT00287469|9624258|FG000|STARTED|Overall Study||1000
8589322|NCT00287469|9624259|FG001|STARTED|Overall Study||1000
8589323|NCT00287469|9624258|FG000|COMPLETED|Overall Study||780
8589324|NCT00287469|9624259|FG001|COMPLETED|Overall Study||786
8589325|NCT00287469|9624258|FG000|NOT COMPLETED|Overall Study||220
8589326|NCT00287469|9624259|FG001|NOT COMPLETED|Overall Study||214
8589327|NCT00287586|9624269|FG000|STARTED|Overall Study||156
8589328|NCT00287586|9624270|FG001|STARTED|Overall Study||152
8589329|NCT00287586|9624269|FG000|Intent-to-treat: Received Study Drug|Overall Study||155
8589330|NCT00287586|9624270|FG001|Intent-to-treat: Received Study Drug|Overall Study||151
8589331|NCT00287586|9624269|FG000|COMPLETED|Overall Study||111
8589332|NCT00287586|9624270|FG001|COMPLETED|Overall Study||100
8589333|NCT00287586|9624269|FG000|NOT COMPLETED|Overall Study||45
8589334|NCT00287586|9624270|FG001|NOT COMPLETED|Overall Study||52
8589335|NCT00287690|9624278|FG000|STARTED|Overall Study||33
8589336|NCT00287690|9624279|FG001|STARTED|Overall Study||38
8589337|NCT00287690|9624278|FG000|COMPLETED|Overall Study||13
8589338|NCT00287690|9624279|FG001|COMPLETED|Overall Study||12
8589339|NCT00287690|9624278|FG000|NOT COMPLETED|Overall Study||20
8589340|NCT00287690|9624279|FG001|NOT COMPLETED|Overall Study||26
8589341|NCT00287716|9624288|FG000|STARTED|Overall Study||174
8589342|NCT00287716|9624289|FG001|STARTED|Overall Study||87
8589343|NCT00287716|9624290|FG002|STARTED|Overall Study||174
8589344|NCT00287716|9624288|FG000|COMPLETED|Overall Study||136
8589345|NCT00287716|9624289|FG001|COMPLETED|Overall Study||70
8589346|NCT00287716|9624290|FG002|COMPLETED|Overall Study||143
8589347|NCT00287716|9624288|FG000|NOT COMPLETED|Overall Study||38
8589348|NCT00287716|9624289|FG001|NOT COMPLETED|Overall Study||17
8589349|NCT00287716|9624290|FG002|NOT COMPLETED|Overall Study||31
8589350|NCT00287729|9624300|FG000|STARTED|Overall Study||171
8589351|NCT00287729|9624301|FG001|STARTED|Overall Study||173
8589352|NCT00287729|9624300|FG000|COMPLETED|Overall Study||137
8589353|NCT00287729|9624301|FG001|COMPLETED|Overall Study||142
8589354|NCT00287729|9624300|FG000|NOT COMPLETED|Overall Study||34
8589355|NCT00287729|9624301|FG001|NOT COMPLETED|Overall Study||31
8589356|NCT00287872|9624307|FG000|STARTED|Overall Study||30
8589357|NCT00287872|9624307|FG000|COMPLETED|Overall Study||30
8589358|NCT00287872|9624307|FG000|NOT COMPLETED|Overall Study||0
8589359|NCT00287989|9624315|FG000|STARTED|Overall Study||28
8589360|NCT00287989|9624316|FG001|STARTED|Overall Study||29
8589361|NCT00287989|9624317|FG002|STARTED|Overall Study||29
8589362|NCT00287989|9624315|FG000|COMPLETED|Overall Study||28
8589363|NCT00287989|9624316|FG001|COMPLETED|Overall Study||29
8589364|NCT00287989|9624317|FG002|COMPLETED|Overall Study||29
8589365|NCT00287989|9624315|FG000|NOT COMPLETED|Overall Study||0
8589366|NCT00287989|9624316|FG001|NOT COMPLETED|Overall Study||0
8589367|NCT00287989|9624317|FG002|NOT COMPLETED|Overall Study||0
8589368|NCT00288015|9624325|FG000|STARTED|Registered to Study||32
8589369|NCT00288015|9624325|FG000|COMPLETED|Registered to Study||32
8589370|NCT00288015|9624325|FG000|NOT COMPLETED|Registered to Study||0
8589371|NCT00288015|9624325|FG000|STARTED|Bevacizumab Treatment Cycles 1-2||32
8589372|NCT00288015|9624325|FG000|COMPLETED|Bevacizumab Treatment Cycles 1-2||30
8589373|NCT00288015|9624325|FG000|NOT COMPLETED|Bevacizumab Treatment Cycles 1-2||2
8589374|NCT00288015|9624325|FG000|STARTED|First Response Assessment||30
8589375|NCT00288015|9624325|FG000|COMPLETED|First Response Assessment||26
8589376|NCT00288015|9624325|FG000|NOT COMPLETED|First Response Assessment||4
8589377|NCT00288015|9624325|FG000|STARTED|Continued Bevacizumab Cycle 3+||26
8589378|NCT00288015|9624325|FG000|COMPLETED|Continued Bevacizumab Cycle 3+||19
8589379|NCT00288015|9624325|FG000|NOT COMPLETED|Continued Bevacizumab Cycle 3+||7
8589380|NCT00288015|9624325|FG000|STARTED|Follow up for Survival x 2 Years||29
8589381|NCT00288015|9624325|FG000|COMPLETED|Follow up for Survival x 2 Years||3
8589382|NCT00288015|9624325|FG000|NOT COMPLETED|Follow up for Survival x 2 Years||26
8589383|NCT00288054|9624329|FG000|STARTED|Overall Study||24
8589384|NCT00288054|9624329|FG000|COMPLETED|Overall Study||0
8589385|NCT00288054|9624329|FG000|NOT COMPLETED|Overall Study||24
8589386|NCT00288067|9624335|FG000|STARTED|Overall Study||32
8589387|NCT00288067|9624335|FG000|COMPLETED|Overall Study||32
8589388|NCT00288067|9624335|FG000|NOT COMPLETED|Overall Study||0
8589389|NCT00288366|9624343|FG000|STARTED|Overall Study||23
8589390|NCT00288366|9624344|FG001|STARTED|Overall Study||26
8589391|NCT00288366|9624343|FG000|COMPLETED|Overall Study||23
8589392|NCT00288366|9624344|FG001|COMPLETED|Overall Study||26
8589393|NCT00288366|9624343|FG000|NOT COMPLETED|Overall Study||0
8589394|NCT00288366|9624344|FG001|NOT COMPLETED|Overall Study||0
8589395|NCT00288509|9624350|FG000|STARTED|Treatment Cycle 1||108
8589396|NCT00288509|9624350|FG000|COMPLETED|Treatment Cycle 1||102
8589397|NCT00288509|9624350|FG000|NOT COMPLETED|Treatment Cycle 1||6
8589398|NCT00288509|9624350|FG000|STARTED|Treatment Cycle 2|2 subjects completed Cycle 1 but withdrew before Cycle 2 due to insufficient clinical response|100
8589399|NCT00288509|9624350|FG000|COMPLETED|Treatment Cycle 2||97
8589400|NCT00288509|9624350|FG000|NOT COMPLETED|Treatment Cycle 2||3
8589401|NCT00288509|9624350|FG000|STARTED|Treatment Cycle 3|One subject completed Cycle 2 but withdrew before Cycle 3 due to insufficient clinical response|96
8589402|NCT00288509|9624350|FG000|COMPLETED|Treatment Cycle 3||91
8589403|NCT00288509|9624350|FG000|NOT COMPLETED|Treatment Cycle 3||5
8589404|NCT00288509|9624350|FG000|STARTED|Treatment Cycle 4|3 subjects completed Cycle 3 but withdrew before Cycle 4, treatment stopped according to protocol|88
8589405|NCT00288509|9624350|FG000|COMPLETED|Treatment Cycle 4||80
8589406|NCT00288509|9624350|FG000|NOT COMPLETED|Treatment Cycle 4||8
8589407|NCT00288574|9624356|FG000|STARTED|Overall Study||49
8589408|NCT00288574|9624357|FG001|STARTED|Overall Study||44
8589409|NCT00288574|9624356|FG000|COMPLETED|Overall Study||49
8589410|NCT00288574|9624357|FG001|COMPLETED|Overall Study||44
8589411|NCT00288574|9624356|FG000|NOT COMPLETED|Overall Study||0
8589412|NCT00288574|9624357|FG001|NOT COMPLETED|Overall Study||0
8589413|NCT00288587|9624368|FG000|STARTED|Overall Study||19
8589414|NCT00288587|9624369|FG001|STARTED|Overall Study||17
8589415|NCT00288587|9624368|FG000|COMPLETED|Overall Study||14
8589416|NCT00288587|9624369|FG001|COMPLETED|Overall Study||7
8589417|NCT00288587|9624368|FG000|NOT COMPLETED|Overall Study||5
8589418|NCT00288587|9624369|FG001|NOT COMPLETED|Overall Study||10
8589419|NCT00288600|9624377|FG000|STARTED|Overall Study||46
8589420|NCT00288600|9624378|FG001|STARTED|Overall Study||46
8589421|NCT00288600|9624377|FG000|COMPLETED|Overall Study||46
8589422|NCT00288600|9624378|FG001|COMPLETED|Overall Study||46
8589423|NCT00288600|9624377|FG000|NOT COMPLETED|Overall Study||0
8589424|NCT00288600|9624378|FG001|NOT COMPLETED|Overall Study||0
8589425|NCT00288626|9624384|FG000|STARTED|Overall Study||24
8589426|NCT00288626|9624384|FG000|COMPLETED|Overall Study||17
8589427|NCT00288626|9624384|FG000|NOT COMPLETED|Overall Study||7
8589428|NCT00288639|9624390|FG000|STARTED|Overall Study||98
8589429|NCT00288639|9624390|FG000|COMPLETED|Overall Study||86
8589430|NCT00288639|9624390|FG000|NOT COMPLETED|Overall Study||12
8589431|NCT00288704|9624397|FG000|STARTED|Part A, Double Blind, Weeks 1-6||24
8589432|NCT00288704|9624398|FG001|STARTED|Part A, Double Blind, Weeks 1-6||23
8589433|NCT00288704|9624399|FG002|STARTED|Part A, Double Blind, Weeks 1-6|Subjects enrolled into the open-label phase do not complete this part of the study.|0
8589434|NCT00288704|9624397|FG000|COMPLETED|Part A, Double Blind, Weeks 1-6||24
8589435|NCT00288704|9624398|FG001|COMPLETED|Part A, Double Blind, Weeks 1-6||22
8589436|NCT00288704|9624399|FG002|COMPLETED|Part A, Double Blind, Weeks 1-6||0
8589437|NCT00288704|9624397|FG000|NOT COMPLETED|Part A, Double Blind, Weeks 1-6||0
8589438|NCT00288704|9624398|FG001|NOT COMPLETED|Part A, Double Blind, Weeks 1-6||1
8589439|NCT00288704|9624399|FG002|NOT COMPLETED|Part A, Double Blind, Weeks 1-6||0
8589440|NCT00288704|9624397|FG000|STARTED|Part B, Randomized Withdrawal, Wks 15-24|1 subject discontinued during weeks 6-14 due to non-compliance with study drug dosing procedures.|23
8589441|NCT00288704|9624398|FG001|STARTED|Part B, Randomized Withdrawal, Wks 15-24||22
8589442|NCT00288704|9624399|FG002|STARTED|Part B, Randomized Withdrawal, Wks 15-24||0
8589443|NCT00288704|9624397|FG000|COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||23
8589444|NCT00288704|9624398|FG001|COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||21
8589445|NCT00288704|9624399|FG002|COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||0
8589446|NCT00288704|9624397|FG000|NOT COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||0
8589447|NCT00288704|9624398|FG001|NOT COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||1
8589448|NCT00288704|9624399|FG002|NOT COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||0
8589449|NCT00288704|9624397|FG000|STARTED|Open-Label Extension (OLE) Weeks 24-117|After week 24, all subjects are treated with Open label rilonacept.|0
8589450|NCT00288704|9624398|FG001|STARTED|Open-Label Extension (OLE) Weeks 24-117||0
8589451|NCT00288704|9624399|FG002|STARTED|Open-Label Extension (OLE) Weeks 24-117||101
8589452|NCT00288704|9624397|FG000|COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
8589453|NCT00288704|9624398|FG001|COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
8589454|NCT00288704|9624399|FG002|COMPLETED|Open-Label Extension (OLE) Weeks 24-117||81
8589455|NCT00288704|9624397|FG000|NOT COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
8589456|NCT00288704|9624398|FG001|NOT COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
8589457|NCT00288704|9624399|FG002|NOT COMPLETED|Open-Label Extension (OLE) Weeks 24-117||20
8589458|NCT00288860|9624408|FG000|STARTED|Overall Study||412
8589459|NCT00288860|9624409|FG001|STARTED|Overall Study||425
8589460|NCT00288860|9624408|FG000|Completed Intake Survey|Overall Study||408
8589461|NCT00288860|9624409|FG001|Completed Intake Survey|Overall Study||417
8589462|NCT00288860|9624408|FG000|Completed 4 Month fu Survey|Overall Study||275
8589463|NCT00288860|9624409|FG001|Completed 4 Month fu Survey|Overall Study||299
8589464|NCT00288860|9624408|FG000|Completed 12 Month fu Survey|Overall Study||257
8589465|NCT00288860|9624409|FG001|Completed 12 Month fu Survey|Overall Study||281
8589466|NCT00288860|9624408|FG000|COMPLETED|Overall Study|310 completed either 4 or 12 month survey. Used all with intake (n = 408) in intent-to-treat.|310
8589467|NCT00288860|9624409|FG001|COMPLETED|Overall Study|328 completed 4 or 12 month survey. Used all with intake (n=417) in intent to treat.|328
8589468|NCT00288860|9624408|FG000|NOT COMPLETED|Overall Study||102
8589469|NCT00288860|9624409|FG001|NOT COMPLETED|Overall Study||97
8589470|NCT00288886|9624420|FG000|STARTED|Overall Study||91
8589471|NCT00288886|9624421|FG001|STARTED|Overall Study||92
8589472|NCT00288886|9624420|FG000|3-month Follow Up|Overall Study||82
8589473|NCT00288886|9624421|FG001|3-month Follow Up|Overall Study||85
8589474|NCT00288886|9624420|FG000|6-month Follow Up|Overall Study||85
8589475|NCT00288886|9624421|FG001|6-month Follow Up|Overall Study||84
8589476|NCT00288886|9624420|FG000|12-month Follow Up|Overall Study||80
8589477|NCT00288886|9624421|FG001|12-month Follow Up|Overall Study||81
8589478|NCT00288886|9624420|FG000|COMPLETED|Overall Study||80
8589479|NCT00288886|9624421|FG001|COMPLETED|Overall Study||81
8589480|NCT00288886|9624420|FG000|NOT COMPLETED|Overall Study||11
8589481|NCT00288886|9624421|FG001|NOT COMPLETED|Overall Study||11
8589482|NCT00288912|9624430|FG000|STARTED|Overall Study||175
8589483|NCT00288912|9624431|FG001|STARTED|Overall Study||174
8589484|NCT00288912|9624432|FG002|STARTED|Overall Study||174
8589485|NCT00288912|9624430|FG000|COMPLETED|Overall Study||158
8589486|NCT00288912|9624431|FG001|COMPLETED|Overall Study||157
8589487|NCT00288912|9624432|FG002|COMPLETED|Overall Study||146
8589488|NCT00288912|9624430|FG000|NOT COMPLETED|Overall Study||17
8589489|NCT00288912|9624431|FG001|NOT COMPLETED|Overall Study||17
8589490|NCT00288912|9624432|FG002|NOT COMPLETED|Overall Study||28
8589491|NCT00289016|9624440|FG000|STARTED|Overall Study||50
8589492|NCT00289016|9624440|FG000|COMPLETED|Overall Study||13
8589493|NCT00289016|9624440|FG000|NOT COMPLETED|Overall Study||37
8589494|NCT00289094|9624446|FG000|STARTED|Overall Study||50
8589495|NCT00289094|9624447|FG001|STARTED|Overall Study||49
8589496|NCT00289094|9624446|FG000|COMPLETED|Overall Study||3
8589497|NCT00289094|9624447|FG001|COMPLETED|Overall Study||2
8589498|NCT00289094|9624446|FG000|NOT COMPLETED|Overall Study||47
8589499|NCT00289094|9624447|FG001|NOT COMPLETED|Overall Study||47
8589500|NCT00289107|9624455|FG000|STARTED|Overall Study||77
8589501|NCT00289107|9624456|FG001|STARTED|Overall Study||72
8589502|NCT00289107|9624455|FG000|COMPLETED|Overall Study||24
8589503|NCT00289107|9624456|FG001|COMPLETED|Overall Study||28
8589504|NCT00289107|9624455|FG000|NOT COMPLETED|Overall Study||53
8589505|NCT00289107|9624456|FG001|NOT COMPLETED|Overall Study||44
8589506|NCT00289120|9624462|FG000|STARTED|Overall Study||13
8589507|NCT00289120|9624462|FG000|COMPLETED|Overall Study||13
8589508|NCT00289120|9624462|FG000|NOT COMPLETED|Overall Study||0
8589509|NCT00289133|9624472|FG000|STARTED|Overall Study||461
8589510|NCT00289133|9624473|FG001|STARTED|Overall Study||477
8589511|NCT00289133|9624472|FG000|COMPLETED|Overall Study||189
8589512|NCT00289133|9624473|FG001|COMPLETED|Overall Study||179
8589513|NCT00289133|9624472|FG000|NOT COMPLETED|Overall Study||272
8589514|NCT00289133|9624473|FG001|NOT COMPLETED|Overall Study||298
8589515|NCT00289185|9624485|FG000|STARTED|Overall Study||170
8589516|NCT00289185|9624486|FG001|STARTED|Overall Study||170
8589517|NCT00289185|9624485|FG000|COMPLETED|Overall Study||142
8589518|NCT00289185|9624486|FG001|COMPLETED|Overall Study||144
8589519|NCT00289185|9624485|FG000|NOT COMPLETED|Overall Study||28
8589520|NCT00289185|9624486|FG001|NOT COMPLETED|Overall Study||26
8589521|NCT00289198|9624495|FG000|STARTED|Overall Study||151
8589522|NCT00289198|9624496|FG001|STARTED|Overall Study||151
8589523|NCT00289198|9624495|FG000|COMPLETED|Overall Study||120
8589524|NCT00289198|9624496|FG001|COMPLETED|Overall Study||121
8589525|NCT00289198|9624495|FG000|NOT COMPLETED|Overall Study||31
8589526|NCT00289198|9624496|FG001|NOT COMPLETED|Overall Study||30
8589527|NCT00289211|9624506|FG000|STARTED|Overall Study||36
8589528|NCT00289211|9624507|FG001|STARTED|Overall Study||35
8589529|NCT00289211|9624508|FG002|STARTED|Overall Study||12
8589530|NCT00289211|9624506|FG000|COMPLETED|Overall Study||36
8589531|NCT00289211|9624507|FG001|COMPLETED|Overall Study||34
8589532|NCT00289211|9624508|FG002|COMPLETED|Overall Study||2
8589533|NCT00289211|9624506|FG000|NOT COMPLETED|Overall Study||0
8589534|NCT00289211|9624507|FG001|NOT COMPLETED|Overall Study||1
8589535|NCT00289211|9624508|FG002|NOT COMPLETED|Overall Study||10
8589536|NCT00289276|9624516|FG000|STARTED|First Part of FAST Study (Pivotal)|11 patients were re-consented under version 7 of the CIP, but are included in Pivotal results only|47
8589537|NCT00289276|9624517|FG001|STARTED|First Part of FAST Study (Pivotal)||0
8589538|NCT00289276|9624516|FG000|COMPLETED|First Part of FAST Study (Pivotal)||47
8589539|NCT00289276|9624517|FG001|COMPLETED|First Part of FAST Study (Pivotal)||0
8589540|NCT00289276|9624516|FG000|NOT COMPLETED|First Part of FAST Study (Pivotal)||0
8589541|NCT00289276|9624517|FG001|NOT COMPLETED|First Part of FAST Study (Pivotal)||0
8589542|NCT00289276|9624516|FG000|STARTED|Second Part of FAST Study (Expansion)||0
8589543|NCT00289276|9624517|FG001|STARTED|Second Part of FAST Study (Expansion)||109
8589544|NCT00289276|9624516|FG000|COMPLETED|Second Part of FAST Study (Expansion)||0
8589545|NCT00289276|9624517|FG001|COMPLETED|Second Part of FAST Study (Expansion)||106
8589546|NCT00289276|9624516|FG000|NOT COMPLETED|Second Part of FAST Study (Expansion)||0
8589547|NCT00289276|9624517|FG001|NOT COMPLETED|Second Part of FAST Study (Expansion)||3
8589548|NCT00289289|9624526|FG000|STARTED|Overall Study||132
8589549|NCT00289289|9624527|FG001|STARTED|Overall Study||124
8589550|NCT00289289|9624528|FG002|STARTED|Overall Study||144
8589551|NCT00289289|9624526|FG000|COMPLETED|Overall Study||113
8589552|NCT00289289|9624527|FG001|COMPLETED|Overall Study||114
8589553|NCT00289289|9624528|FG002|COMPLETED|Overall Study||95
8589554|NCT00289289|9624526|FG000|NOT COMPLETED|Overall Study||19
8589555|NCT00289289|9624527|FG001|NOT COMPLETED|Overall Study||10
8589556|NCT00289289|9624528|FG002|NOT COMPLETED|Overall Study||49
8589557|NCT00289315|9624538|FG000|STARTED|Overall Study||713
8589558|NCT00289315|9624539|FG001|STARTED|Overall Study||760
8589559|NCT00289315|9624540|FG002|STARTED|Overall Study||587
8589560|NCT00289315|9624538|FG000|COMPLETED|Overall Study||612
8589561|NCT00289315|9624539|FG001|COMPLETED|Overall Study||638
8589562|NCT00289315|9624540|FG002|COMPLETED|Overall Study||447
8589563|NCT00289315|9624538|FG000|NOT COMPLETED|Overall Study||101
8589564|NCT00289315|9624539|FG001|NOT COMPLETED|Overall Study||122
8589565|NCT00289315|9624540|FG002|NOT COMPLETED|Overall Study||140
8589566|NCT00289341|9624550|FG000|STARTED|Overall Study||12
8589567|NCT00289341|9624551|FG001|STARTED|Overall Study||12
8589568|NCT00289341|9624550|FG000|COMPLETED|Overall Study||12
8589569|NCT00289341|9624551|FG001|COMPLETED|Overall Study||12
8589570|NCT00289341|9624550|FG000|NOT COMPLETED|Overall Study||0
8711273|NCT00961233|9757631|FG001|STARTED|Overall Study||12
8711274|NCT00961233|9757630|FG000|COMPLETED|Overall Study||11
8711275|NCT00961233|9757631|FG001|COMPLETED|Overall Study||11
8711276|NCT00961233|9757630|FG000|NOT COMPLETED|Overall Study||2
8711277|NCT00961233|9757631|FG001|NOT COMPLETED|Overall Study||1
8711278|NCT00961259|9757639|FG000|STARTED|First Intervention||18
8711279|NCT00961259|9757640|FG001|STARTED|First Intervention||18
8711280|NCT00961259|9757641|FG002|STARTED|First Intervention||18
8711281|NCT00961259|9757639|FG000|COMPLETED|First Intervention||18
8711282|NCT00961259|9757640|FG001|COMPLETED|First Intervention||18
8711283|NCT00961259|9757641|FG002|COMPLETED|First Intervention||18
8711284|NCT00961259|9757639|FG000|NOT COMPLETED|First Intervention||0
8711285|NCT00961259|9757640|FG001|NOT COMPLETED|First Intervention||0
8711286|NCT00961259|9757641|FG002|NOT COMPLETED|First Intervention||0
8711287|NCT00961259|9757639|FG000|STARTED|Washout Period of 7 Days||18
8711288|NCT00961259|9757640|FG001|STARTED|Washout Period of 7 Days||18
8711289|NCT00961259|9757641|FG002|STARTED|Washout Period of 7 Days||18
8711290|NCT00961259|9757639|FG000|COMPLETED|Washout Period of 7 Days||18
8711291|NCT00961259|9757640|FG001|COMPLETED|Washout Period of 7 Days|dropped due to concomitant medication used prior to admission.|17
8711292|NCT00961259|9757641|FG002|COMPLETED|Washout Period of 7 Days||18
8711293|NCT00961259|9757639|FG000|NOT COMPLETED|Washout Period of 7 Days||0
8711294|NCT00961259|9757640|FG001|NOT COMPLETED|Washout Period of 7 Days||1
8711295|NCT00961259|9757641|FG002|NOT COMPLETED|Washout Period of 7 Days||0
8711296|NCT00961259|9757639|FG000|STARTED|Second Intervention||18
8711297|NCT00961259|9757640|FG001|STARTED|Second Intervention||17
8711298|NCT00961259|9757641|FG002|STARTED|Second Intervention||18
8711299|NCT00961259|9757639|FG000|COMPLETED|Second Intervention||18
8711300|NCT00961259|9757640|FG001|COMPLETED|Second Intervention||17
8711301|NCT00961259|9757641|FG002|COMPLETED|Second Intervention||18
8711302|NCT00961259|9757639|FG000|NOT COMPLETED|Second Intervention||0
8589571|NCT00289341|9624551|FG001|NOT COMPLETED|Overall Study||0
8589572|NCT00289458|9624564|FG000|STARTED|Overall Study||25
8589573|NCT00289458|9624565|FG001|STARTED|Overall Study||26
8589574|NCT00289458|9624566|FG002|STARTED|Overall Study||28
8589575|NCT00289458|9624564|FG000|COMPLETED|Overall Study||19
8589576|NCT00289458|9624565|FG001|COMPLETED|Overall Study||20
8589577|NCT00289458|9624566|FG002|COMPLETED|Overall Study||22
8589578|NCT00289458|9624564|FG000|NOT COMPLETED|Overall Study||6
8589579|NCT00289458|9624565|FG001|NOT COMPLETED|Overall Study||6
8589580|NCT00289458|9624566|FG002|NOT COMPLETED|Overall Study||6
8589581|NCT00289471|9624574|FG000|STARTED|Overall Study||630
8589582|NCT00289471|9624574|FG000|COMPLETED|Overall Study||630
8589583|NCT00289471|9624574|FG000|NOT COMPLETED|Overall Study||0
8589584|NCT00289536|9624578|FG000|STARTED|Period 1||9
8589585|NCT00289536|9624579|FG001|STARTED|Period 1||8
8589586|NCT00289536|9624580|FG002|STARTED|Period 1||9
8589587|NCT00289536|9624578|FG000|COMPLETED|Period 1||9
8589588|NCT00289536|9624579|FG001|COMPLETED|Period 1||8
8589589|NCT00289536|9624580|FG002|COMPLETED|Period 1||9
8589590|NCT00289536|9624578|FG000|NOT COMPLETED|Period 1||0
8589591|NCT00289536|9624579|FG001|NOT COMPLETED|Period 1||0
8589592|NCT00289536|9624580|FG002|NOT COMPLETED|Period 1||0
8589593|NCT00289536|9624578|FG000|STARTED|Period 2|5 participants received Medium Dose and 5 participants received High Dose in Period 1|10
8589594|NCT00289536|9624579|FG001|STARTED|Period 2|5 participants received Low Dose and 4 participants received High Dose in Period 1|9
8589595|NCT00289536|9624580|FG002|STARTED|Period 2|4 participants received Low Dose and 3 participants received Medium Dose in Period 1|7
8589596|NCT00289536|9624578|FG000|COMPLETED|Period 2||10
8589597|NCT00289536|9624579|FG001|COMPLETED|Period 2||9
8589598|NCT00289536|9624580|FG002|COMPLETED|Period 2||7
8589599|NCT00289536|9624578|FG000|NOT COMPLETED|Period 2||0
8589600|NCT00289536|9624579|FG001|NOT COMPLETED|Period 2||0
8589601|NCT00289536|9624580|FG002|NOT COMPLETED|Period 2||0
8589602|NCT00289536|9624578|FG000|STARTED|Period 3|3 participants received Medium Dose and 4 participants received High Dose in Period 2|7
8589603|NCT00289536|9624579|FG001|STARTED|Period 3|5 participants received Low Dose and 4 participants received High Dose in Period 2|9
8589604|NCT00289536|9624580|FG002|STARTED|Period 3|5 participants received Low Dose and 5 participants received Medium Dose in Period 2|10
8589605|NCT00289536|9624578|FG000|COMPLETED|Period 3||7
8589606|NCT00289536|9624579|FG001|COMPLETED|Period 3||9
8589607|NCT00289536|9624580|FG002|COMPLETED|Period 3||9
8589608|NCT00289536|9624578|FG000|NOT COMPLETED|Period 3||0
8589609|NCT00289536|9624579|FG001|NOT COMPLETED|Period 3||0
8589610|NCT00289536|9624580|FG002|NOT COMPLETED|Period 3||1
8589611|NCT00289653|9624586|FG000|STARTED|Overall Study||23
8589612|NCT00289653|9624586|FG000|COMPLETED|Overall Study||12
8589613|NCT00289653|9624586|FG000|NOT COMPLETED|Overall Study||11
8589614|NCT00289718|9624591|FG000|STARTED|Overall Study||51
8589615|NCT00289718|9624591|FG000|COMPLETED|Overall Study||51
8589616|NCT00289718|9624591|FG000|NOT COMPLETED|Overall Study||0
8589617|NCT00289731|9624603|FG000|STARTED|Overall Study||199
8589618|NCT00289731|9624604|FG001|STARTED|Overall Study||200
8589619|NCT00289731|9624605|FG002|STARTED|Overall Study||197
8589620|NCT00289731|9624603|FG000|COMPLETED|Overall Study||197
8589621|NCT00289731|9624604|FG001|COMPLETED|Overall Study||198
8589622|NCT00289731|9624605|FG002|COMPLETED|Overall Study||195
8589623|NCT00289731|9624603|FG000|NOT COMPLETED|Overall Study||2
8589624|NCT00289731|9624604|FG001|NOT COMPLETED|Overall Study||2
8589625|NCT00289731|9624605|FG002|NOT COMPLETED|Overall Study||2
8589626|NCT00289744|9624615|FG000|STARTED|Year 6 Long-term Follow-up|Number of subjects who come back at Year 6 blood sampling time-point|178
8589627|NCT00289744|9624616|FG001|STARTED|Year 6 Long-term Follow-up||0
8589628|NCT00289744|9624617|FG002|STARTED|Year 6 Long-term Follow-up||0
8589629|NCT00289744|9624615|FG000|COMPLETED|Year 6 Long-term Follow-up||178
8589630|NCT00289744|9624616|FG001|COMPLETED|Year 6 Long-term Follow-up||0
8589631|NCT00289744|9624617|FG002|COMPLETED|Year 6 Long-term Follow-up||0
8589632|NCT00289744|9624615|FG000|NOT COMPLETED|Year 6 Long-term Follow-up||0
8589633|NCT00289744|9624616|FG001|NOT COMPLETED|Year 6 Long-term Follow-up||0
8589634|NCT00289744|9624617|FG002|NOT COMPLETED|Year 6 Long-term Follow-up||0
8589635|NCT00289744|9624615|FG000|STARTED|Year 7 Long-term Follow-up|Subjects who came back at Year 7 blood sampling time-point|175
8589636|NCT00289744|9624616|FG001|STARTED|Year 7 Long-term Follow-up||0
8589637|NCT00289744|9624617|FG002|STARTED|Year 7 Long-term Follow-up||0
8589638|NCT00289744|9624615|FG000|COMPLETED|Year 7 Long-term Follow-up||175
8589639|NCT00289744|9624616|FG001|COMPLETED|Year 7 Long-term Follow-up||0
8589640|NCT00289744|9624617|FG002|COMPLETED|Year 7 Long-term Follow-up||0
8589641|NCT00289744|9624615|FG000|NOT COMPLETED|Year 7 Long-term Follow-up||0
8589642|NCT00289744|9624616|FG001|NOT COMPLETED|Year 7 Long-term Follow-up||0
8589643|NCT00289744|9624617|FG002|NOT COMPLETED|Year 7 Long-term Follow-up||0
8589644|NCT00289744|9624615|FG000|STARTED|Year 8 Long-term Follow-up|Subjects who came back at Year 8 blood sampling time-point|174
8589645|NCT00289744|9624616|FG001|STARTED|Year 8 Long-term Follow-up||0
8589646|NCT00289744|9624617|FG002|STARTED|Year 8 Long-term Follow-up||0
8589647|NCT00289744|9624615|FG000|COMPLETED|Year 8 Long-term Follow-up||174
8589648|NCT00289744|9624616|FG001|COMPLETED|Year 8 Long-term Follow-up||0
8589649|NCT00289744|9624617|FG002|COMPLETED|Year 8 Long-term Follow-up||0
8589650|NCT00289744|9624615|FG000|NOT COMPLETED|Year 8 Long-term Follow-up||0
8589651|NCT00289744|9624616|FG001|NOT COMPLETED|Year 8 Long-term Follow-up||0
8589652|NCT00289744|9624617|FG002|NOT COMPLETED|Year 8 Long-term Follow-up||0
8589653|NCT00289744|9624615|FG000|STARTED|Year 9 Long-term Follow-up|Subjects who came back at Year 9 blood sampling time-point|173
8589654|NCT00289744|9624616|FG001|STARTED|Year 9 Long-term Follow-up||0
8589655|NCT00289744|9624617|FG002|STARTED|Year 9 Long-term Follow-up||0
8589656|NCT00289744|9624615|FG000|COMPLETED|Year 9 Long-term Follow-up||173
8589657|NCT00289744|9624616|FG001|COMPLETED|Year 9 Long-term Follow-up||0
8589658|NCT00289744|9624617|FG002|COMPLETED|Year 9 Long-term Follow-up||0
8589659|NCT00289744|9624615|FG000|NOT COMPLETED|Year 9 Long-term Follow-up||0
8589660|NCT00289744|9624616|FG001|NOT COMPLETED|Year 9 Long-term Follow-up||0
8589661|NCT00289744|9624617|FG002|NOT COMPLETED|Year 9 Long-term Follow-up||0
8627932|NCT00520013|9667284|FG001|NOT COMPLETED|Overall Study||15
8589662|NCT00289744|9624615|FG000|STARTED|Year 10 Long-term Follow-up|Subjects who came back at Year 10 blood sampling time-point|171
8589663|NCT00289744|9624616|FG001|STARTED|Year 10 Long-term Follow-up||0
8589664|NCT00289744|9624617|FG002|STARTED|Year 10 Long-term Follow-up||0
8589665|NCT00289744|9624615|FG000|COMPLETED|Year 10 Long-term Follow-up||171
8589666|NCT00289744|9624616|FG001|COMPLETED|Year 10 Long-term Follow-up||0
8589667|NCT00289744|9624617|FG002|COMPLETED|Year 10 Long-term Follow-up||0
8589668|NCT00289744|9624615|FG000|NOT COMPLETED|Year 10 Long-term Follow-up||0
8589669|NCT00289744|9624616|FG001|NOT COMPLETED|Year 10 Long-term Follow-up||0
8589670|NCT00289744|9624617|FG002|NOT COMPLETED|Year 10 Long-term Follow-up||0
8589671|NCT00289744|9624615|FG000|STARTED|Additional Dose Phase||0
8589672|NCT00289744|9624616|FG001|STARTED|Additional Dose Phase||19
8589673|NCT00289744|9624617|FG002|STARTED|Additional Dose Phase||6
8589674|NCT00289744|9624615|FG000|COMPLETED|Additional Dose Phase||0
8589675|NCT00289744|9624616|FG001|COMPLETED|Additional Dose Phase||19
8589676|NCT00289744|9624617|FG002|COMPLETED|Additional Dose Phase||6
8589677|NCT00289744|9624615|FG000|NOT COMPLETED|Additional Dose Phase||0
8589678|NCT00289744|9624616|FG001|NOT COMPLETED|Additional Dose Phase||0
8589679|NCT00289744|9624617|FG002|NOT COMPLETED|Additional Dose Phase||0
8589680|NCT00289757|9624625|FG000|STARTED|Overall Study||78
8589681|NCT00289757|9624625|FG000|COMPLETED|Overall Study||78
8589682|NCT00289757|9624625|FG000|NOT COMPLETED|Overall Study||0
8589683|NCT00289770|9624629|FG000|STARTED|Year 11||37
8589684|NCT00289770|9624629|FG000|COMPLETED|Year 11||37
8589685|NCT00289770|9624629|FG000|NOT COMPLETED|Year 11||0
8589686|NCT00289770|9624629|FG000|STARTED|Year 12||40
8589687|NCT00289770|9624629|FG000|COMPLETED|Year 12||40
8589688|NCT00289770|9624629|FG000|NOT COMPLETED|Year 12||0
8589689|NCT00289770|9624629|FG000|STARTED|Year 13||37
8589690|NCT00289770|9624629|FG000|COMPLETED|Year 13||37
8589691|NCT00289770|9624629|FG000|NOT COMPLETED|Year 13||0
8589692|NCT00289770|9624629|FG000|STARTED|Year 14||43
8589693|NCT00289770|9624629|FG000|COMPLETED|Year 14||43
8589694|NCT00289770|9624629|FG000|NOT COMPLETED|Year 14||0
8589695|NCT00289770|9624629|FG000|STARTED|Year 15||50
8589696|NCT00289770|9624629|FG000|COMPLETED|Year 15||49
8589697|NCT00289770|9624629|FG000|NOT COMPLETED|Year 15||1
8589698|NCT00289783|9624635|FG000|STARTED|Primary Phase||3136
8589699|NCT00289783|9624636|FG001|STARTED|Primary Phase||1044
8589700|NCT00289783|9624635|FG000|COMPLETED|Primary Phase||2888
8589701|NCT00289783|9624636|FG001|COMPLETED|Primary Phase||961
8589702|NCT00289783|9624635|FG000|NOT COMPLETED|Primary Phase||248
8589703|NCT00289783|9624636|FG001|NOT COMPLETED|Primary Phase||83
8589704|NCT00289783|9624635|FG000|STARTED|Fourth Dose Phase||2769
8589705|NCT00289783|9624636|FG001|STARTED|Fourth Dose Phase||923
8589706|NCT00289783|9624635|FG000|COMPLETED|Fourth Dose Phase||2682
8589707|NCT00289783|9624636|FG001|COMPLETED|Fourth Dose Phase||899
8589708|NCT00289783|9624635|FG000|NOT COMPLETED|Fourth Dose Phase||87
8589709|NCT00289783|9624636|FG001|NOT COMPLETED|Fourth Dose Phase||24
8589710|NCT00289848|9624652|FG000|STARTED|Overall Study||352
8589711|NCT00289848|9624653|FG001|STARTED|Overall Study||178
8589712|NCT00289848|9624652|FG000|COMPLETED|Overall Study||306
8589713|NCT00289848|9624653|FG001|COMPLETED|Overall Study||133
8589714|NCT00289848|9624652|FG000|NOT COMPLETED|Overall Study||46
8589715|NCT00289848|9624653|FG001|NOT COMPLETED|Overall Study||45
8589716|NCT00289900|9624665|FG000|STARTED|Overall Study||297
8589717|NCT00289900|9624666|FG001|STARTED|Overall Study||436
8589718|NCT00289900|9624667|FG002|STARTED|Overall Study||298
8589719|NCT00289900|9624668|FG003|STARTED|Overall Study||439
8589720|NCT00289900|9624669|FG004|STARTED|Overall Study||437
8589721|NCT00289900|9624670|FG005|STARTED|Overall Study||433
8589722|NCT00289900|9624665|FG000|Treated|Overall Study||297
8589723|NCT00289900|9624666|FG001|Treated|Overall Study||435
8589724|NCT00289900|9624667|FG002|Treated|Overall Study||298
8589725|NCT00289900|9624668|FG003|Treated|Overall Study||439
8589726|NCT00289900|9624669|FG004|Treated|Overall Study||437
8589727|NCT00289900|9624670|FG005|Treated|Overall Study||433
8589728|NCT00289900|9624665|FG000|COMPLETED|Overall Study||229
8589729|NCT00289900|9624666|FG001|COMPLETED|Overall Study||316
8589730|NCT00289900|9624667|FG002|COMPLETED|Overall Study||265
8589731|NCT00289900|9624668|FG003|COMPLETED|Overall Study||380
8589732|NCT00289900|9624669|FG004|COMPLETED|Overall Study||392
8589733|NCT00289900|9624670|FG005|COMPLETED|Overall Study||372
8589734|NCT00289900|9624665|FG000|NOT COMPLETED|Overall Study||68
8589735|NCT00289900|9624666|FG001|NOT COMPLETED|Overall Study||120
8589736|NCT00289900|9624667|FG002|NOT COMPLETED|Overall Study||33
8589737|NCT00289900|9624668|FG003|NOT COMPLETED|Overall Study||59
8589738|NCT00289900|9624669|FG004|NOT COMPLETED|Overall Study||45
8589739|NCT00289900|9624670|FG005|NOT COMPLETED|Overall Study||61
8589740|NCT00289913|9624692|FG000|STARTED|Visit 1 (Stage I and Stage II)||155
8589741|NCT00289913|9624693|FG001|STARTED|Visit 1 (Stage I and Stage II)||151
8589742|NCT00289913|9624694|FG002|STARTED|Visit 1 (Stage I and Stage II)||159
8589743|NCT00289913|9624695|FG003|STARTED|Visit 1 (Stage I and Stage II)||152
8589744|NCT00289913|9624696|FG004|STARTED|Visit 1 (Stage I and Stage II)|Participants were enrolled during Stage II.|654
8589745|NCT00289913|9624692|FG000|COMPLETED|Visit 1 (Stage I and Stage II)||146
8589746|NCT00289913|9624693|FG001|COMPLETED|Visit 1 (Stage I and Stage II)||135
8589747|NCT00289913|9624694|FG002|COMPLETED|Visit 1 (Stage I and Stage II)||150
8589748|NCT00289913|9624695|FG003|COMPLETED|Visit 1 (Stage I and Stage II)||141
8589749|NCT00289913|9624696|FG004|COMPLETED|Visit 1 (Stage I and Stage II)||645
8589750|NCT00289913|9624692|FG000|NOT COMPLETED|Visit 1 (Stage I and Stage II)||9
8589751|NCT00289913|9624693|FG001|NOT COMPLETED|Visit 1 (Stage I and Stage II)||16
8589752|NCT00289913|9624694|FG002|NOT COMPLETED|Visit 1 (Stage I and Stage II)||9
8589753|NCT00289913|9624695|FG003|NOT COMPLETED|Visit 1 (Stage I and Stage II)||11
8589754|NCT00289913|9624696|FG004|NOT COMPLETED|Visit 1 (Stage I and Stage II)||9
8589755|NCT00289913|9624692|FG000|STARTED|Visit 2 (Stage I and Stage II)||146
8589756|NCT00289913|9624693|FG001|STARTED|Visit 2 (Stage I and Stage II)||135
8589757|NCT00289913|9624694|FG002|STARTED|Visit 2 (Stage I and Stage II)||150
8589758|NCT00289913|9624695|FG003|STARTED|Visit 2 (Stage I and Stage II)||141
8589759|NCT00289913|9624696|FG004|STARTED|Visit 2 (Stage I and Stage II)|No vaccine administered at Visit 2 (Stage II), therefore there was no safety F/U period.|645
8589760|NCT00289913|9624692|FG000|COMPLETED|Visit 2 (Stage I and Stage II)||131
8589761|NCT00289913|9624693|FG001|COMPLETED|Visit 2 (Stage I and Stage II)||114
8589762|NCT00289913|9624694|FG002|COMPLETED|Visit 2 (Stage I and Stage II)||140
8589763|NCT00289913|9624695|FG003|COMPLETED|Visit 2 (Stage I and Stage II)||135
8589764|NCT00289913|9624696|FG004|COMPLETED|Visit 2 (Stage I and Stage II)||605
8589765|NCT00289913|9624692|FG000|NOT COMPLETED|Visit 2 (Stage I and Stage II)||15
8589766|NCT00289913|9624693|FG001|NOT COMPLETED|Visit 2 (Stage I and Stage II)||21
8589767|NCT00289913|9624694|FG002|NOT COMPLETED|Visit 2 (Stage I and Stage II)||10
8589768|NCT00289913|9624695|FG003|NOT COMPLETED|Visit 2 (Stage I and Stage II)||6
8589769|NCT00289913|9624696|FG004|NOT COMPLETED|Visit 2 (Stage I and Stage II)||40
8589770|NCT00289913|9624692|FG000|STARTED|Visit 3 (Stage I and Stage II)||131
8589771|NCT00289913|9624693|FG001|STARTED|Visit 3 (Stage I and Stage II)||114
8589772|NCT00289913|9624694|FG002|STARTED|Visit 3 (Stage I and Stage II)||140
8589773|NCT00289913|9624695|FG003|STARTED|Visit 3 (Stage I and Stage II)||135
8589774|NCT00289913|9624696|FG004|STARTED|Visit 3 (Stage I and Stage II)||605
8589775|NCT00289913|9624692|FG000|COMPLETED|Visit 3 (Stage I and Stage II)||122
8589776|NCT00289913|9624693|FG001|COMPLETED|Visit 3 (Stage I and Stage II)||106
8589777|NCT00289913|9624694|FG002|COMPLETED|Visit 3 (Stage I and Stage II)||138
8589778|NCT00289913|9624695|FG003|COMPLETED|Visit 3 (Stage I and Stage II)||131
8589779|NCT00289913|9624696|FG004|COMPLETED|Visit 3 (Stage I and Stage II)||597
8589780|NCT00289913|9624692|FG000|NOT COMPLETED|Visit 3 (Stage I and Stage II)||9
8589781|NCT00289913|9624693|FG001|NOT COMPLETED|Visit 3 (Stage I and Stage II)||8
8589782|NCT00289913|9624694|FG002|NOT COMPLETED|Visit 3 (Stage I and Stage II)||2
8589783|NCT00289913|9624695|FG003|NOT COMPLETED|Visit 3 (Stage I and Stage II)||4
8589784|NCT00289913|9624696|FG004|NOT COMPLETED|Visit 3 (Stage I and Stage II)||8
8589785|NCT00289913|9624692|FG000|STARTED|Visit 4 (Stage I and Stage II)||122
8589786|NCT00289913|9624693|FG001|STARTED|Visit 4 (Stage I and Stage II)||106
8589787|NCT00289913|9624694|FG002|STARTED|Visit 4 (Stage I and Stage II)||138
8589788|NCT00289913|9624695|FG003|STARTED|Visit 4 (Stage I and Stage II)||131
8589789|NCT00289913|9624696|FG004|STARTED|Visit 4 (Stage I and Stage II)||597
8589790|NCT00289913|9624692|FG000|COMPLETED|Visit 4 (Stage I and Stage II)||122
8589791|NCT00289913|9624693|FG001|COMPLETED|Visit 4 (Stage I and Stage II)||106
8589792|NCT00289913|9624694|FG002|COMPLETED|Visit 4 (Stage I and Stage II)||138
8589793|NCT00289913|9624695|FG003|COMPLETED|Visit 4 (Stage I and Stage II)||131
8589794|NCT00289913|9624696|FG004|COMPLETED|Visit 4 (Stage I and Stage II)||597
8589795|NCT00289913|9624692|FG000|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
8589796|NCT00289913|9624693|FG001|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
8589797|NCT00289913|9624694|FG002|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
8589798|NCT00289913|9624695|FG003|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
8589799|NCT00289913|9624696|FG004|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
8589800|NCT00289978|9624714|FG000|STARTED|Overall Study||429
8589801|NCT00289978|9624715|FG001|STARTED|Overall Study||425
8589802|NCT00289978|9624716|FG002|STARTED|Overall Study||418
8589803|NCT00289978|9624714|FG000|COMPLETED|Overall Study|296 completed on study drug, 35 completed off study drug.|332
8589804|NCT00289978|9624715|FG001|COMPLETED|Overall Study|345 completed on study drug, 24 completed off study drug.|369
8589805|NCT00289978|9624716|FG002|COMPLETED|Overall Study|303 completed on study drug, 29 completed off study drug.|332
8589806|NCT00289978|9624714|FG000|NOT COMPLETED|Overall Study||97
8589807|NCT00289978|9624715|FG001|NOT COMPLETED|Overall Study||56
8589808|NCT00289978|9624716|FG002|NOT COMPLETED|Overall Study||86
8589809|NCT00289991|9624726|FG000|STARTED|Overall Study||234
8589810|NCT00289991|9624727|FG001|STARTED|Overall Study||255
8589811|NCT00289991|9624726|FG000|COMPLETED|Overall Study||176
8589812|NCT00289991|9624727|FG001|COMPLETED|Overall Study||175
8589813|NCT00289991|9624726|FG000|NOT COMPLETED|Overall Study||58
8589814|NCT00289991|9624727|FG001|NOT COMPLETED|Overall Study||80
8589815|NCT00290147|9624735|FG000|STARTED|Overall Study||10
8589816|NCT00290147|9624736|FG001|STARTED|Overall Study||12
8589817|NCT00290147|9624735|FG000|COMPLETED|Overall Study||10
8589818|NCT00290147|9624736|FG001|COMPLETED|Overall Study||12
8589819|NCT00290147|9624735|FG000|NOT COMPLETED|Overall Study||0
8589820|NCT00290147|9624736|FG001|NOT COMPLETED|Overall Study||0
8589821|NCT00290186|9624744|FG000|STARTED|Overall Study||25
8589822|NCT00290186|9624745|FG001|STARTED|Overall Study||24
8589823|NCT00290186|9624744|FG000|Completed Baseline Assessments|Overall Study||25
8589824|NCT00290186|9624745|FG001|Completed Baseline Assessments|Overall Study||24
8589825|NCT00290186|9624744|FG000|Completed 8 Weeks of Treatment|Overall Study||24
8589826|NCT00290186|9624745|FG001|Completed 8 Weeks of Treatment|Overall Study||22
8589827|NCT00290186|9624744|FG000|Completed Post-treatment Assessments|Overall Study||24
8589828|NCT00290186|9624745|FG001|Completed Post-treatment Assessments|Overall Study||22
8589829|NCT00290186|9624744|FG000|Completed 3-month Followup Assessments|Overall Study||20
8589830|NCT00290186|9624745|FG001|Completed 3-month Followup Assessments|Overall Study||21
8589831|NCT00290186|9624744|FG000|Completed 6-month Followup Assessments|Overall Study||20
8589832|NCT00290186|9624745|FG001|Completed 6-month Followup Assessments|Overall Study||19
8589833|NCT00290186|9624744|FG000|COMPLETED|Overall Study||20
8589834|NCT00290186|9624745|FG001|COMPLETED|Overall Study||19
8589835|NCT00290186|9624744|FG000|NOT COMPLETED|Overall Study||5
8589836|NCT00290186|9624745|FG001|NOT COMPLETED|Overall Study||5
8589837|NCT00290199|9624755|FG000|STARTED|Overall Study||87
8589838|NCT00290199|9624756|FG001|STARTED|Overall Study||82
8589839|NCT00290199|9624755|FG000|COMPLETED|Overall Study||87
8589840|NCT00290199|9624756|FG001|COMPLETED|Overall Study||82
8589841|NCT00290199|9624755|FG000|NOT COMPLETED|Overall Study||0
8589842|NCT00290199|9624756|FG001|NOT COMPLETED|Overall Study||0
8589843|NCT00290238|9624766|FG000|STARTED|Overall Study||57
8589844|NCT00290238|9624767|FG001|STARTED|Overall Study|One subject had an invalid birth date and was excluded from the Age Categorical counts.|65
8589845|NCT00290238|9624766|FG000|COMPLETED|Overall Study||15
8589846|NCT00290238|9624767|FG001|COMPLETED|Overall Study||24
8589847|NCT00290238|9624766|FG000|NOT COMPLETED|Overall Study||42
8589848|NCT00290238|9624767|FG001|NOT COMPLETED|Overall Study||41
8589849|NCT00290290|9624775|FG000|STARTED|Overall Study||440
8589850|NCT00290290|9624776|FG001|STARTED|Overall Study||409
8589851|NCT00290290|9624775|FG000|COMPLETED|Overall Study||422
8589852|NCT00290290|9624776|FG001|COMPLETED|Overall Study||391
8589853|NCT00290290|9624775|FG000|NOT COMPLETED|Overall Study||18
8589854|NCT00290290|9624776|FG001|NOT COMPLETED|Overall Study||18
8589855|NCT00290329|9624785|FG000|STARTED|Overall Study||102
8589856|NCT00290329|9624786|FG001|STARTED|Overall Study||86
8589857|NCT00290329|9624787|FG002|STARTED|Overall Study||61
8589858|NCT00290329|9624785|FG000|COMPLETED|Overall Study||102
8589859|NCT00290329|9624786|FG001|COMPLETED|Overall Study||86
8589860|NCT00290329|9624787|FG002|COMPLETED|Overall Study||61
8589861|NCT00290329|9624785|FG000|NOT COMPLETED|Overall Study||0
8589862|NCT00290329|9624786|FG001|NOT COMPLETED|Overall Study||0
8589863|NCT00290329|9624787|FG002|NOT COMPLETED|Overall Study||0
8589864|NCT00290342|9624799|FG000|STARTED|Overall Study||224
8589865|NCT00290342|9624800|FG001|STARTED|Overall Study||228
8589866|NCT00290342|9624799|FG000|COMPLETED|Overall Study||217
8589867|NCT00290342|9624800|FG001|COMPLETED|Overall Study||223
8589868|NCT00290342|9624799|FG000|NOT COMPLETED|Overall Study||7
8589869|NCT00290342|9624800|FG001|NOT COMPLETED|Overall Study||5
8627933|NCT00520013|9667285|FG002|NOT COMPLETED|Overall Study||11
8627934|NCT00520039|9667293|FG000|STARTED|Overall Study||28
8627935|NCT00520039|9667294|FG001|STARTED|Overall Study||24
8627936|NCT00520039|9667293|FG000|COMPLETED|Overall Study||21
8627937|NCT00520039|9667294|FG001|COMPLETED|Overall Study||19
8627938|NCT00520039|9667293|FG000|NOT COMPLETED|Overall Study||7
8627939|NCT00520039|9667294|FG001|NOT COMPLETED|Overall Study||5
8627940|NCT00520130|9667304|FG000|STARTED|Overall Study||44
8627941|NCT00520130|9667305|FG001|STARTED|Overall Study||45
8627942|NCT00520130|9667304|FG000|COMPLETED|Overall Study||39
8627943|NCT00520130|9667305|FG001|COMPLETED|Overall Study||44
8627944|NCT00520130|9667304|FG000|NOT COMPLETED|Overall Study||5
8627945|NCT00520130|9667305|FG001|NOT COMPLETED|Overall Study||1
8627946|NCT00520234|9667317|FG000|STARTED|Overall Study||118
8627947|NCT00520234|9667318|FG001|STARTED|Overall Study||104
8627948|NCT00520234|9667317|FG000|COMPLETED|Overall Study||117
8627949|NCT00520234|9667318|FG001|COMPLETED|Overall Study||102
8627950|NCT00520234|9667317|FG000|NOT COMPLETED|Overall Study||1
8627951|NCT00520234|9667318|FG001|NOT COMPLETED|Overall Study||2
8627952|NCT00520286|9667327|FG000|STARTED|Overall Study||142
8627953|NCT00520286|9667328|FG001|STARTED|Overall Study||68
8627954|NCT00520286|9667327|FG000|COMPLETED|Overall Study||76
8627955|NCT00520286|9667328|FG001|COMPLETED|Overall Study||36
8627956|NCT00520286|9667327|FG000|NOT COMPLETED|Overall Study||66
8627957|NCT00520286|9667328|FG001|NOT COMPLETED|Overall Study||32
8627958|NCT00520299|9667337|FG000|STARTED|Overall Study||6
8627959|NCT00520299|9667338|FG001|STARTED|Overall Study||6
8627960|NCT00520299|9667339|FG002|STARTED|Overall Study||19
8627961|NCT00520299|9667337|FG000|COMPLETED|Overall Study|Defined as completion of 1 treatment cycle|6
8627962|NCT00520299|9667338|FG001|COMPLETED|Overall Study||3
8627963|NCT00520299|9667339|FG002|COMPLETED|Overall Study||13
8627964|NCT00520299|9667337|FG000|NOT COMPLETED|Overall Study||0
8627965|NCT00520299|9667338|FG001|NOT COMPLETED|Overall Study||3
8627966|NCT00520299|9667339|FG002|NOT COMPLETED|Overall Study||6
8627967|NCT00520351|9667349|FG000|STARTED|First Intervention|Start date is Sep.06, 2007|15
8627968|NCT00520351|9667350|FG001|STARTED|First Intervention|Start date is Sep.06, 2007|15
8627969|NCT00520351|9667349|FG000|COMPLETED|First Intervention|End date is Feb.25, 2008|14
8627970|NCT00520351|9667350|FG001|COMPLETED|First Intervention|End date is Feb.25, 2008|14
8627971|NCT00520351|9667349|FG000|NOT COMPLETED|First Intervention||1
8627972|NCT00520351|9667350|FG001|NOT COMPLETED|First Intervention||1
8627973|NCT00520351|9667349|FG000|STARTED|Second Intervention||14
8627974|NCT00520351|9667350|FG001|STARTED|Second Intervention||14
8627975|NCT00520351|9667349|FG000|COMPLETED|Second Intervention||14
8627976|NCT00520351|9667350|FG001|COMPLETED|Second Intervention||14
8627977|NCT00520351|9667349|FG000|NOT COMPLETED|Second Intervention||0
8627978|NCT00520351|9667350|FG001|NOT COMPLETED|Second Intervention||0
8627979|NCT00520403|9667356|FG000|STARTED|Bevacizumab + IFN/Vinblastine||25
8627980|NCT00520403|9667356|FG000|COMPLETED|Bevacizumab + IFN/Vinblastine||7
8627981|NCT00520403|9667356|FG000|NOT COMPLETED|Bevacizumab + IFN/Vinblastine||18
8629568|NCT00530920|9669339|FG001|COMPLETED|Overall Study||25
8589870|NCT00290355|9624808|FG000|STARTED|Overall Study||122
8589871|NCT00290355|9624809|FG001|STARTED|Overall Study||60
8589872|NCT00290355|9624808|FG000|COMPLETED|Overall Study||105
8589873|NCT00290355|9624809|FG001|COMPLETED|Overall Study||55
8589874|NCT00290355|9624808|FG000|NOT COMPLETED|Overall Study||17
8589875|NCT00290355|9624809|FG001|NOT COMPLETED|Overall Study||5
8589876|NCT00290433|9624815|FG000|STARTED|Overall Study||53
8589877|NCT00290433|9624815|FG000|COMPLETED|Overall Study||17
8589878|NCT00290433|9624815|FG000|NOT COMPLETED|Overall Study||36
8589879|NCT00290472|9624822|FG000|STARTED|Overall Study||32
8589880|NCT00290472|9624823|FG001|STARTED|Overall Study||39
8589881|NCT00290472|9624824|FG002|STARTED|Overall Study||18
8589882|NCT00290472|9624822|FG000|COMPLETED|Overall Study||32
8589883|NCT00290472|9624823|FG001|COMPLETED|Overall Study||39
8589884|NCT00290472|9624824|FG002|COMPLETED|Overall Study||18
8589885|NCT00290472|9624822|FG000|NOT COMPLETED|Overall Study||0
8589886|NCT00290472|9624823|FG001|NOT COMPLETED|Overall Study||0
8589887|NCT00290472|9624824|FG002|NOT COMPLETED|Overall Study||0
8589888|NCT00290498|9624832|FG000|STARTED|Overall Study||49
8589889|NCT00290498|9624833|FG001|STARTED|Overall Study||10
8589890|NCT00290498|9624832|FG000|COMPLETED|Overall Study||41
8589891|NCT00290498|9624833|FG001|COMPLETED|Overall Study||10
8589892|NCT00290498|9624832|FG000|NOT COMPLETED|Overall Study||8
8589893|NCT00290498|9624833|FG001|NOT COMPLETED|Overall Study||0
8589894|NCT00290537|9624840|FG000|STARTED|Overall Study||4
8589895|NCT00290537|9624841|FG001|STARTED|Overall Study||0
8589896|NCT00290537|9624840|FG000|COMPLETED|Overall Study||4
8589897|NCT00290537|9624841|FG001|COMPLETED|Overall Study||0
8589898|NCT00290537|9624840|FG000|NOT COMPLETED|Overall Study||0
8589899|NCT00290537|9624841|FG001|NOT COMPLETED|Overall Study||0
8589900|NCT00290589|9624848|FG000|STARTED|Overall Study||39
8589901|NCT00290589|9624849|FG001|STARTED|Overall Study||43
8589902|NCT00290589|9624848|FG000|COMPLETED|Overall Study||37
8589903|NCT00290589|9624849|FG001|COMPLETED|Overall Study||41
8589904|NCT00290589|9624848|FG000|NOT COMPLETED|Overall Study||2
8589905|NCT00290589|9624849|FG001|NOT COMPLETED|Overall Study||2
8589906|NCT00290615|9624855|FG000|STARTED|Overall Study||30
8589907|NCT00290615|9624855|FG000|COMPLETED|Overall Study||30
8589908|NCT00290615|9624855|FG000|NOT COMPLETED|Overall Study||0
8589909|NCT00290654|9624859|FG000|STARTED|Overall Study||41
8589910|NCT00290654|9624859|FG000|COMPLETED|Overall Study||41
8589911|NCT00290654|9624859|FG000|NOT COMPLETED|Overall Study||0
8589912|NCT00290693|9624863|FG000|STARTED|Overall Study||45
8589913|NCT00290693|9624863|FG000|COMPLETED|Overall Study||43
8589914|NCT00290693|9624863|FG000|NOT COMPLETED|Overall Study||2
8589915|NCT00290706|9624872|FG000|STARTED|Overall Study||5
8589916|NCT00290706|9624873|FG001|STARTED|Overall Study||6
8589917|NCT00290706|9624874|FG002|STARTED|Overall Study||7
8589918|NCT00290706|9624875|FG003|STARTED|Overall Study||14
8589919|NCT00290706|9624872|FG000|Attempted1st Cycle|Overall Study||5
8589920|NCT00290706|9624873|FG001|Attempted1st Cycle|Overall Study||6
8589921|NCT00290706|9624874|FG002|Attempted1st Cycle|Overall Study||7
8589922|NCT00290706|9624875|FG003|Attempted1st Cycle|Overall Study||14
8589923|NCT00290706|9624872|FG000|Reached 1st Response/Cycle 3|Overall Study||0
8589924|NCT00290706|9624873|FG001|Reached 1st Response/Cycle 3|Overall Study||0
8589925|NCT00290706|9624874|FG002|Reached 1st Response/Cycle 3|Overall Study||1
8589926|NCT00290706|9624875|FG003|Reached 1st Response/Cycle 3|Overall Study||2
8589927|NCT00290706|9624872|FG000|COMPLETED|Overall Study||0
8589928|NCT00290706|9624873|FG001|COMPLETED|Overall Study||0
8589929|NCT00290706|9624874|FG002|COMPLETED|Overall Study||1
8589930|NCT00290706|9624875|FG003|COMPLETED|Overall Study||2
8589931|NCT00290706|9624872|FG000|NOT COMPLETED|Overall Study||5
8589932|NCT00290706|9624873|FG001|NOT COMPLETED|Overall Study||6
8589933|NCT00290706|9624874|FG002|NOT COMPLETED|Overall Study||6
8589934|NCT00290706|9624875|FG003|NOT COMPLETED|Overall Study||12
8589935|NCT00290732|9624888|FG000|STARTED|Overall Study||3
8589936|NCT00290732|9624889|FG001|STARTED|Overall Study||4
8589937|NCT00290732|9624890|FG002|STARTED|Overall Study||4
8589938|NCT00290732|9624891|FG003|STARTED|Overall Study||6
8589939|NCT00290732|9624892|FG004|STARTED|Overall Study||3
8589940|NCT00290732|9624888|FG000|COMPLETED|Overall Study||3
8589941|NCT00290732|9624889|FG001|COMPLETED|Overall Study||3
8589942|NCT00290732|9624890|FG002|COMPLETED|Overall Study||3
8589943|NCT00290732|9624891|FG003|COMPLETED|Overall Study||6
8589944|NCT00290732|9624892|FG004|COMPLETED|Overall Study||3
8589945|NCT00290732|9624888|FG000|NOT COMPLETED|Overall Study||0
8589946|NCT00290732|9624889|FG001|NOT COMPLETED|Overall Study||1
8589947|NCT00290732|9624890|FG002|NOT COMPLETED|Overall Study||1
8589948|NCT00290732|9624891|FG003|NOT COMPLETED|Overall Study||0
8589949|NCT00290732|9624892|FG004|NOT COMPLETED|Overall Study||0
8589950|NCT00290745|9624905|FG000|STARTED|Overall Study||79
8589951|NCT00290745|9624905|FG000|COMPLETED|Overall Study||67
8589952|NCT00290745|9624905|FG000|NOT COMPLETED|Overall Study||12
8589953|NCT00290771|9624911|FG000|STARTED|Overall Study||131
8589954|NCT00290771|9624912|FG001|STARTED|Overall Study||100
8589955|NCT00290771|9624911|FG000|COMPLETED|Overall Study||4
8589956|NCT00290771|9624912|FG001|COMPLETED|Overall Study||3
8589957|NCT00290771|9624911|FG000|NOT COMPLETED|Overall Study||127
8589958|NCT00290771|9624912|FG001|NOT COMPLETED|Overall Study||97
8589959|NCT00290810|9624919|FG000|STARTED|Overall Study||12
8589960|NCT00290810|9624919|FG000|COMPLETED|Overall Study||12
8589961|NCT00290810|9624919|FG000|NOT COMPLETED|Overall Study||0
8589962|NCT00290888|9624925|FG000|STARTED|Overall Study||41
8589963|NCT00290888|9624926|FG001|STARTED|Overall Study||45
8589964|NCT00290888|9624925|FG000|COMPLETED|Overall Study||38
8589965|NCT00290888|9624926|FG001|COMPLETED|Overall Study||44
8589966|NCT00290888|9624925|FG000|NOT COMPLETED|Overall Study||3
8589967|NCT00290888|9624926|FG001|NOT COMPLETED|Overall Study||1
8589968|NCT00291018|9624936|FG000|STARTED|Overall Study|Enrolled and Treated. 111 PDC subjects were Enrolled but only 103 were Treated.|103
8589969|NCT00291018|9624937|FG001|STARTED|Overall Study|Enrolled and Treated. 117 ACDF subjects were Enrolled but only 106 were Treated.|106
8589970|NCT00291018|9624938|FG002|STARTED|Overall Study|Enrolled and Treated. 140 PDC-CA subjects were Enrolled but only 136 were Treated.|136
8589971|NCT00291018|9624936|FG000|Evaluated at 24 Months|Overall Study||99
8589972|NCT00291018|9624937|FG001|Evaluated at 24 Months|Overall Study||92
8589973|NCT00291018|9624938|FG002|Evaluated at 24 Months|Overall Study||105
8589974|NCT00291018|9624936|FG000|COMPLETED|Overall Study|Evaluated at 84 Months|78
8589975|NCT00291018|9624937|FG001|COMPLETED|Overall Study|Evaluated at 84 Months|64
8589976|NCT00291018|9624938|FG002|COMPLETED|Overall Study|Evaluated at 84 Months|93
8589977|NCT00291018|9624936|FG000|NOT COMPLETED|Overall Study||25
8589978|NCT00291018|9624937|FG001|NOT COMPLETED|Overall Study||42
8589979|NCT00291018|9624938|FG002|NOT COMPLETED|Overall Study||43
8589980|NCT00291135|9624949|FG000|STARTED|Overall Study||42
8589981|NCT00291135|9624949|FG000|COMPLETED|Overall Study||42
8589982|NCT00291135|9624949|FG000|NOT COMPLETED|Overall Study||0
8589983|NCT00291161|9624957|FG000|STARTED|Overall Study||316
8589984|NCT00291161|9624958|FG001|STARTED|Overall Study||192
8589985|NCT00291161|9624959|FG002|STARTED|Overall Study||299
8589986|NCT00291161|9624960|FG003|STARTED|Overall Study||187
8589987|NCT00291161|9624957|FG000|COMPLETED|Overall Study||235
8589988|NCT00291161|9624958|FG001|COMPLETED|Overall Study||134
8589989|NCT00291161|9624959|FG002|COMPLETED|Overall Study||206
8589990|NCT00291161|9624960|FG003|COMPLETED|Overall Study||122
8589991|NCT00291161|9624957|FG000|NOT COMPLETED|Overall Study||81
8589992|NCT00291161|9624958|FG001|NOT COMPLETED|Overall Study||58
8589993|NCT00291161|9624959|FG002|NOT COMPLETED|Overall Study||93
8589994|NCT00291161|9624960|FG003|NOT COMPLETED|Overall Study||65
8589995|NCT00291187|9624972|FG000|STARTED|Overall Study||103
8589996|NCT00291187|9624973|FG001|STARTED|Overall Study||100
8589997|NCT00291187|9624974|FG002|STARTED|Overall Study||103
8589998|NCT00291187|9624975|FG003|STARTED|Overall Study||106
8589999|NCT00291187|9624972|FG000|COMPLETED|Overall Study||103
8590000|NCT00291187|9624973|FG001|COMPLETED|Overall Study||100
8590001|NCT00291187|9624974|FG002|COMPLETED|Overall Study||102
8590002|NCT00291187|9624975|FG003|COMPLETED|Overall Study||106
8590003|NCT00291187|9624972|FG000|NOT COMPLETED|Overall Study||0
8590004|NCT00291187|9624973|FG001|NOT COMPLETED|Overall Study||0
8590005|NCT00291187|9624974|FG002|NOT COMPLETED|Overall Study||1
8590006|NCT00291187|9624975|FG003|NOT COMPLETED|Overall Study||0
8590007|NCT00291226|9624991|FG000|STARTED|Overall Study||4
8590008|NCT00291226|9624992|FG001|STARTED|Overall Study||4
8590009|NCT00291226|9624991|FG000|COMPLETED|Overall Study||3
8590010|NCT00291226|9624992|FG001|COMPLETED|Overall Study||3
8590011|NCT00291226|9624991|FG000|NOT COMPLETED|Overall Study||1
8590012|NCT00291226|9624992|FG001|NOT COMPLETED|Overall Study||1
8590013|NCT00291317|9624998|FG000|STARTED|Overall Study||6
8590014|NCT00291317|9624998|FG000|COMPLETED|Overall Study||6
8590015|NCT00291317|9624998|FG000|NOT COMPLETED|Overall Study||0
8590016|NCT00291330|9625005|FG000|STARTED|Overall Study|Started Treatment|1273
8590017|NCT00291330|9625006|FG001|STARTED|Overall Study|Started Treatment|1266
8590018|NCT00291330|9625005|FG000|COMPLETED|Overall Study|Completed planned observation time|1172
8590019|NCT00291330|9625006|FG001|COMPLETED|Overall Study|Completed planned observation time|1169
8590020|NCT00291330|9625005|FG000|NOT COMPLETED|Overall Study||101
8590021|NCT00291330|9625006|FG001|NOT COMPLETED|Overall Study||97
8590022|NCT00291343|9625014|FG000|STARTED|Overall Study||203
8590023|NCT00291343|9625015|FG001|STARTED|Overall Study||93
8590024|NCT00291343|9625014|FG000|COMPLETED|Overall Study||203
8590025|NCT00291343|9625015|FG001|COMPLETED|Overall Study||93
8590026|NCT00291343|9625014|FG000|NOT COMPLETED|Overall Study||0
8590027|NCT00291343|9625015|FG001|NOT COMPLETED|Overall Study||0
8590028|NCT00291447|9625025|FG000|STARTED|Overall Study||2
8590029|NCT00291447|9625026|FG001|STARTED|Overall Study||2
8590030|NCT00291447|9625027|FG002|STARTED|Overall Study||2
8590031|NCT00291447|9625028|FG003|STARTED|Overall Study||2
8590032|NCT00291447|9625025|FG000|COMPLETED|Overall Study||2
8590033|NCT00291447|9625026|FG001|COMPLETED|Overall Study||2
8590034|NCT00291447|9625027|FG002|COMPLETED|Overall Study||2
8590035|NCT00291447|9625028|FG003|COMPLETED|Overall Study||2
8590036|NCT00291447|9625025|FG000|NOT COMPLETED|Overall Study||0
8590037|NCT00291447|9625026|FG001|NOT COMPLETED|Overall Study||0
8590038|NCT00291447|9625027|FG002|NOT COMPLETED|Overall Study||0
8590039|NCT00291447|9625028|FG003|NOT COMPLETED|Overall Study||0
8590040|NCT00291499|9625041|FG000|STARTED|Overall Study||81
8590041|NCT00291499|9625042|FG001|STARTED|Overall Study||82
8590042|NCT00291499|9625041|FG000|Intention to Treat (ITT)|Overall Study||80
8590043|NCT00291499|9625042|FG001|Intention to Treat (ITT)|Overall Study||82
8590044|NCT00291499|9625041|FG000|Per Protocol (PP)|Overall Study||72
8590045|NCT00291499|9625042|FG001|Per Protocol (PP)|Overall Study||67
8590046|NCT00291499|9625041|FG000|Safety Population|Overall Study||81
8590047|NCT00291499|9625042|FG001|Safety Population|Overall Study||82
8590048|NCT00291499|9625041|FG000|COMPLETED|Overall Study||72
8590049|NCT00291499|9625042|FG001|COMPLETED|Overall Study||67
8590050|NCT00291499|9625041|FG000|NOT COMPLETED|Overall Study||9
8590051|NCT00291499|9625042|FG001|NOT COMPLETED|Overall Study||15
8590052|NCT00291551|9625048|FG000|STARTED|Overall Study||39
8590053|NCT00291551|9625048|FG000|COMPLETED|Overall Study||26
8590054|NCT00291551|9625048|FG000|NOT COMPLETED|Overall Study||13
8590055|NCT00291577|9625053|FG000|STARTED|Overall Study||22
8590056|NCT00291577|9625053|FG000|COMPLETED|Overall Study|Subject End of Study=Completed; not per protocol reason. PI reason=withdrawn during active treatment|1
8590057|NCT00291577|9625053|FG000|NOT COMPLETED|Overall Study||21
8590058|NCT00291642|9625062|FG000|STARTED|Overall Study||78
8590059|NCT00291642|9625063|FG001|STARTED|Overall Study||116
8590060|NCT00291642|9625064|FG002|STARTED|Overall Study||119
8590061|NCT00291642|9625065|FG003|STARTED|Overall Study||119
8590062|NCT00291642|9625066|FG004|STARTED|Overall Study||119
8590063|NCT00291642|9625062|FG000|COMPLETED|Overall Study||76
8590064|NCT00291642|9625063|FG001|COMPLETED|Overall Study||116
8590065|NCT00291642|9625064|FG002|COMPLETED|Overall Study||117
8590066|NCT00291642|9625065|FG003|COMPLETED|Overall Study||119
8590067|NCT00291642|9625066|FG004|COMPLETED|Overall Study||118
8590068|NCT00291642|9625062|FG000|NOT COMPLETED|Overall Study||2
8590069|NCT00291642|9625063|FG001|NOT COMPLETED|Overall Study||0
8590070|NCT00291642|9625064|FG002|NOT COMPLETED|Overall Study||2
8590071|NCT00291642|9625065|FG003|NOT COMPLETED|Overall Study||0
8590072|NCT00291642|9625066|FG004|NOT COMPLETED|Overall Study||1
8590073|NCT00291655|9625078|FG000|STARTED|Overall Study||130
8590074|NCT00291655|9625078|FG000|COMPLETED|Overall Study||115
8590075|NCT00291655|9625078|FG000|NOT COMPLETED|Overall Study||15
8590076|NCT00291668|9625085|FG000|STARTED|Overall Study||32
8590077|NCT00291668|9625086|FG001|STARTED|Overall Study||30
8590078|NCT00291668|9625087|FG002|STARTED|Overall Study||32
8590079|NCT00291668|9625085|FG000|COMPLETED|Overall Study||28
8590080|NCT00291668|9625086|FG001|COMPLETED|Overall Study||29
8590081|NCT00291668|9625087|FG002|COMPLETED|Overall Study||31
8590082|NCT00291668|9625085|FG000|NOT COMPLETED|Overall Study||4
8590083|NCT00291668|9625086|FG001|NOT COMPLETED|Overall Study||1
8590084|NCT00291668|9625087|FG002|NOT COMPLETED|Overall Study||1
8590085|NCT00291694|9625097|FG000|STARTED|Overall Study||24
8590086|NCT00291694|9625098|FG001|STARTED|Overall Study||48
8590087|NCT00291694|9625097|FG000|COMPLETED|Overall Study||21
8590088|NCT00291694|9625098|FG001|COMPLETED|Overall Study||43
8590089|NCT00291694|9625097|FG000|NOT COMPLETED|Overall Study||3
8590090|NCT00291694|9625098|FG001|NOT COMPLETED|Overall Study||5
8590091|NCT00291876|9625106|FG000|STARTED|Month 138||107
8590092|NCT00291876|9625106|FG000|COMPLETED|Month 138||107
8590093|NCT00291876|9625106|FG000|NOT COMPLETED|Month 138||0
8590094|NCT00291876|9625106|FG000|STARTED|Month 150||117
8590095|NCT00291876|9625106|FG000|COMPLETED|Month 150||117
8590096|NCT00291876|9625106|FG000|NOT COMPLETED|Month 150||0
8590097|NCT00291876|9625106|FG000|STARTED|Month 162||127
8590098|NCT00291876|9625106|FG000|COMPLETED|Month 162||127
8590099|NCT00291876|9625106|FG000|NOT COMPLETED|Month 162||0
8590100|NCT00291876|9625106|FG000|STARTED|Month 174||127
8590101|NCT00291876|9625106|FG000|COMPLETED|Month 174||127
8590102|NCT00291876|9625106|FG000|NOT COMPLETED|Month 174||0
8590103|NCT00291876|9625106|FG000|STARTED|Month 186||129
8590104|NCT00291876|9625106|FG000|COMPLETED|Month 186||129
8590105|NCT00291876|9625106|FG000|NOT COMPLETED|Month 186||0
8590106|NCT00291876|9625106|FG000|STARTED|Month 198||135
8590107|NCT00291876|9625106|FG000|COMPLETED|Month 198||135
8590108|NCT00291876|9625106|FG000|NOT COMPLETED|Month 198||0
8590109|NCT00291876|9625106|FG000|STARTED|Month 210||124
8590110|NCT00291876|9625106|FG000|COMPLETED|Month 210||124
8590111|NCT00291876|9625106|FG000|NOT COMPLETED|Month 210||0
8590112|NCT00291876|9625106|FG000|STARTED|Month 222||114
8590113|NCT00291876|9625106|FG000|COMPLETED|Month 222||114
8590114|NCT00291876|9625106|FG000|NOT COMPLETED|Month 222||0
8590115|NCT00291876|9625106|FG000|STARTED|Month 234||110
8590116|NCT00291876|9625106|FG000|COMPLETED|Month 234||110
8590117|NCT00291876|9625106|FG000|NOT COMPLETED|Month 234||0
8590118|NCT00291876|9625106|FG000|STARTED|Month 246||116
8590119|NCT00291876|9625106|FG000|COMPLETED|Month 246||116
8590120|NCT00291876|9625106|FG000|NOT COMPLETED|Month 246||0
8590121|NCT00292045|9625110|FG000|STARTED|Core Study (Through Week 13)||15
8711303|NCT00961259|9757640|FG001|NOT COMPLETED|Second Intervention||0
8711304|NCT00961259|9757641|FG002|NOT COMPLETED|Second Intervention||0
8590122|NCT00292045|9625110|FG000|COMPLETED|Core Study (Through Week 13)||13
8590123|NCT00292045|9625110|FG000|NOT COMPLETED|Core Study (Through Week 13)||2
8590124|NCT00292045|9625110|FG000|STARTED|Extended Treatment Beyond Week 13||10
8590125|NCT00292045|9625110|FG000|COMPLETED|Extended Treatment Beyond Week 13||10
8590126|NCT00292045|9625110|FG000|NOT COMPLETED|Extended Treatment Beyond Week 13||0
8590127|NCT00292162|9625116|FG000|STARTED|Overall Study||19
8590128|NCT00292162|9625117|FG001|STARTED|Overall Study||22
8590129|NCT00292162|9625116|FG000|COMPLETED|Overall Study||18
8590130|NCT00292162|9625117|FG001|COMPLETED|Overall Study||20
8590131|NCT00292162|9625116|FG000|NOT COMPLETED|Overall Study||1
8590132|NCT00292162|9625117|FG001|NOT COMPLETED|Overall Study||2
8590133|NCT00292188|9625125|FG000|STARTED|Single-Blind||368
8590134|NCT00292188|9625126|FG001|STARTED|Single-Blind||0
8590135|NCT00292188|9625127|FG002|STARTED|Single-Blind||0
8590136|NCT00292188|9625125|FG000|Received Treatment|Single-Blind||367
8590137|NCT00292188|9625126|FG001|Received Treatment|Single-Blind||0
8590138|NCT00292188|9625127|FG002|Received Treatment|Single-Blind||0
8590139|NCT00292188|9625125|FG000|COMPLETED|Single-Blind||254
8590140|NCT00292188|9625126|FG001|COMPLETED|Single-Blind||0
8711305|NCT00961259|9757639|FG000|STARTED|Washout Period of 7 Days||18
8711306|NCT00961259|9757640|FG001|STARTED|Washout Period of 7 Days||17
8711307|NCT00961259|9757641|FG002|STARTED|Washout Period of 7 Days||18
8711308|NCT00961259|9757639|FG000|COMPLETED|Washout Period of 7 Days||18
8711309|NCT00961259|9757640|FG001|COMPLETED|Washout Period of 7 Days||17
8711310|NCT00961259|9757641|FG002|COMPLETED|Washout Period of 7 Days||18
8711311|NCT00961259|9757639|FG000|NOT COMPLETED|Washout Period of 7 Days||0
8711312|NCT00961259|9757640|FG001|NOT COMPLETED|Washout Period of 7 Days||0
8711313|NCT00961259|9757641|FG002|NOT COMPLETED|Washout Period of 7 Days||0
8590141|NCT00292188|9625127|FG002|COMPLETED|Single-Blind||0
8590142|NCT00292188|9625125|FG000|NOT COMPLETED|Single-Blind||114
8590143|NCT00292188|9625126|FG001|NOT COMPLETED|Single-Blind||0
8590144|NCT00292188|9625127|FG002|NOT COMPLETED|Single-Blind||0
8590145|NCT00292188|9625125|FG000|STARTED|Double-Blind||0
8590146|NCT00292188|9625126|FG001|STARTED|Double-Blind||127
8590147|NCT00292188|9625127|FG002|STARTED|Double-Blind||127
8590148|NCT00292188|9625125|FG000|COMPLETED|Double-Blind||0
8590149|NCT00292188|9625126|FG001|COMPLETED|Double-Blind||96
8590150|NCT00292188|9625127|FG002|COMPLETED|Double-Blind||98
8590151|NCT00292188|9625125|FG000|NOT COMPLETED|Double-Blind||0
8590152|NCT00292188|9625126|FG001|NOT COMPLETED|Double-Blind||31
8590153|NCT00292188|9625127|FG002|NOT COMPLETED|Double-Blind||29
8590154|NCT00292227|9625136|FG000|STARTED|Patch Period||66
8590155|NCT00292227|9625137|FG001|STARTED|Patch Period||31
8590156|NCT00292227|9625138|FG002|STARTED|Patch Period||33
8590157|NCT00292227|9625136|FG000|COMPLETED|Patch Period||65
8590158|NCT00292227|9625137|FG001|COMPLETED|Patch Period||31
8590159|NCT00292227|9625138|FG002|COMPLETED|Patch Period||30
8590160|NCT00292227|9625136|FG000|NOT COMPLETED|Patch Period||1
8590161|NCT00292227|9625137|FG001|NOT COMPLETED|Patch Period||0
8590162|NCT00292227|9625138|FG002|NOT COMPLETED|Patch Period||3
8590163|NCT00292227|9625136|FG000|STARTED|Cross-over Period 1 (Day 32)||65
8590164|NCT00292227|9625137|FG001|STARTED|Cross-over Period 1 (Day 32)||31
8590165|NCT00292227|9625138|FG002|STARTED|Cross-over Period 1 (Day 32)||30
8590166|NCT00292227|9625136|FG000|COMPLETED|Cross-over Period 1 (Day 32)||65
8590167|NCT00292227|9625137|FG001|COMPLETED|Cross-over Period 1 (Day 32)||31
8590168|NCT00292227|9625138|FG002|COMPLETED|Cross-over Period 1 (Day 32)||30
8590169|NCT00292227|9625136|FG000|NOT COMPLETED|Cross-over Period 1 (Day 32)||0
8590170|NCT00292227|9625137|FG001|NOT COMPLETED|Cross-over Period 1 (Day 32)||0
8590171|NCT00292227|9625138|FG002|NOT COMPLETED|Cross-over Period 1 (Day 32)||0
8590172|NCT00292227|9625136|FG000|STARTED|Cross-over Period 2 (Day 39)||65
8590173|NCT00292227|9625137|FG001|STARTED|Cross-over Period 2 (Day 39)||31
8590174|NCT00292227|9625138|FG002|STARTED|Cross-over Period 2 (Day 39)||30
8590175|NCT00292227|9625136|FG000|COMPLETED|Cross-over Period 2 (Day 39)||65
8590176|NCT00292227|9625137|FG001|COMPLETED|Cross-over Period 2 (Day 39)||31
8590177|NCT00292227|9625138|FG002|COMPLETED|Cross-over Period 2 (Day 39)||30
8590178|NCT00292227|9625136|FG000|NOT COMPLETED|Cross-over Period 2 (Day 39)||0
8590179|NCT00292227|9625137|FG001|NOT COMPLETED|Cross-over Period 2 (Day 39)||0
8590180|NCT00292227|9625138|FG002|NOT COMPLETED|Cross-over Period 2 (Day 39)||0
8590181|NCT00292318|9625148|FG000|STARTED|Overall Study||4
8590182|NCT00292318|9625149|FG001|STARTED|Overall Study||3
8590183|NCT00292318|9625148|FG000|COMPLETED|Overall Study||2
8590184|NCT00292318|9625149|FG001|COMPLETED|Overall Study||2
8590185|NCT00292318|9625148|FG000|NOT COMPLETED|Overall Study||2
8590186|NCT00292318|9625149|FG001|NOT COMPLETED|Overall Study||1
8590187|NCT00292370|9625158|FG000|STARTED|Phase I - Open-Label Paroxetine (OLP)||124
8590188|NCT00292370|9625159|FG001|STARTED|Phase I - Open-Label Paroxetine (OLP)||0
8590189|NCT00292370|9625160|FG002|STARTED|Phase I - Open-Label Paroxetine (OLP)||0
8590190|NCT00292370|9625158|FG000|COMPLETED|Phase I - Open-Label Paroxetine (OLP)||78
8590191|NCT00292370|9625159|FG001|COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
8590192|NCT00292370|9625160|FG002|COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
8590193|NCT00292370|9625158|FG000|NOT COMPLETED|Phase I - Open-Label Paroxetine (OLP)||46
8590194|NCT00292370|9625159|FG001|NOT COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
8590195|NCT00292370|9625160|FG002|NOT COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
8590196|NCT00292370|9625158|FG000|STARTED|Phase II: OLP + DB Quetiapine or Placebo|"78 Completed Ph I~28 Excluded Ph II:~20 responded~7 declined~1 medical~50 to Arm 2 & 3"|0
8590197|NCT00292370|9625159|FG001|STARTED|Phase II: OLP + DB Quetiapine or Placebo|25 out of 50 in Arm I PhI, eligible for Ph II|25
8590198|NCT00292370|9625160|FG002|STARTED|Phase II: OLP + DB Quetiapine or Placebo|25 out of 50 in Arm I PhI, eligible for Ph II|25
8711314|NCT00961259|9757639|FG000|STARTED|Third Intervention||18
8711315|NCT00961259|9757640|FG001|STARTED|Third Intervention||17
8711316|NCT00961259|9757641|FG002|STARTED|Third Intervention||18
8590199|NCT00292370|9625158|FG000|COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||0
8590200|NCT00292370|9625159|FG001|COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||21
8590201|NCT00292370|9625160|FG002|COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||18
8590202|NCT00292370|9625158|FG000|NOT COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||0
8590203|NCT00292370|9625159|FG001|NOT COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||4
8590204|NCT00292370|9625160|FG002|NOT COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||7
8590205|NCT00292461|9625169|FG000|STARTED|Overall Study||34
8590206|NCT00292461|9625170|FG001|STARTED|Overall Study||30
8590207|NCT00292461|9625169|FG000|COMPLETED|Overall Study||24
8590208|NCT00292461|9625170|FG001|COMPLETED|Overall Study||24
8590209|NCT00292461|9625169|FG000|NOT COMPLETED|Overall Study||10
8590210|NCT00292461|9625170|FG001|NOT COMPLETED|Overall Study||6
8590211|NCT00292591|9625179|FG000|STARTED|Overall Study||166
8590212|NCT00292591|9625180|FG001|STARTED|Overall Study||167
8590213|NCT00292591|9625181|FG002|STARTED|Overall Study||168
8590214|NCT00292591|9625179|FG000|COMPLETED|Overall Study||102
8590215|NCT00292591|9625180|FG001|COMPLETED|Overall Study||111
8590216|NCT00292591|9625181|FG002|COMPLETED|Overall Study||110
8590217|NCT00292591|9625179|FG000|NOT COMPLETED|Overall Study||64
8590218|NCT00292591|9625180|FG001|NOT COMPLETED|Overall Study||56
8590219|NCT00292591|9625181|FG002|NOT COMPLETED|Overall Study||58
8590220|NCT00292942|9625193|FG000|STARTED|Overall Study||6
8590221|NCT00292942|9625194|FG001|STARTED|Overall Study||6
8590222|NCT00292942|9625195|FG002|STARTED|Overall Study||7
8590223|NCT00292942|9625196|FG003|STARTED|Overall Study||7
8590224|NCT00292942|9625193|FG000|COMPLETED|Overall Study||6
8590225|NCT00292942|9625194|FG001|COMPLETED|Overall Study||6
8590226|NCT00292942|9625195|FG002|COMPLETED|Overall Study||6
8590227|NCT00292942|9625196|FG003|COMPLETED|Overall Study||6
8590228|NCT00292942|9625193|FG000|NOT COMPLETED|Overall Study||0
8590229|NCT00292942|9625194|FG001|NOT COMPLETED|Overall Study||0
8590230|NCT00292942|9625195|FG002|NOT COMPLETED|Overall Study||1
8590231|NCT00292942|9625196|FG003|NOT COMPLETED|Overall Study||1
8590232|NCT00292981|9625209|FG000|STARTED|Overall Study||57
8590233|NCT00292981|9625209|FG000|COMPLETED|Overall Study||18
8590234|NCT00292981|9625209|FG000|NOT COMPLETED|Overall Study||39
8590235|NCT00293020|9625213|FG000|STARTED|Overall Study||244
8590236|NCT00293020|9625213|FG000|COMPLETED|Overall Study||82
8590237|NCT00293020|9625213|FG000|NOT COMPLETED|Overall Study||162
8590238|NCT00293033|9625217|FG000|STARTED|Open-label Titration Period|152 subjects enrolled; 151 subjects received at least one dose of study drug|151
8590239|NCT00293033|9625217|FG000|COMPLETED|Open-label Titration Period||82
8590240|NCT00293033|9625217|FG000|NOT COMPLETED|Open-label Titration Period||69
8590241|NCT00293033|9625217|FG000|STARTED|Double-blind Treatment Period|82 randomized; 1 didn't take double-blind drug; 1 didn't report a pain assessment within 30 minutes|82
8590242|NCT00293033|9625217|FG000|COMPLETED|Double-blind Treatment Period||70
8590243|NCT00293033|9625217|FG000|NOT COMPLETED|Double-blind Treatment Period||12
8590244|NCT00293059|9625227|FG000|STARTED|Overall Study||120
8590245|NCT00293059|9625228|FG001|STARTED|Overall Study||70
8590246|NCT00293059|9625227|FG000|Subjects Received Treatment|Overall Study||119
8590247|NCT00293059|9625228|FG001|Subjects Received Treatment|Overall Study||66
8590248|NCT00293059|9625227|FG000|Cycle 1/Treatment Day 28|Overall Study||115
8590249|NCT00293059|9625228|FG001|Cycle 1/Treatment Day 28|Overall Study||64
8590250|NCT00293059|9625227|FG000|Cycle 3/Treatment Day 84|Overall Study||100
8590251|NCT00293059|9625228|FG001|Cycle 3/Treatment Day 84|Overall Study||55
8590252|NCT00293059|9625227|FG000|Cycle 7/Treatment Day 196|Overall Study|Includes participants that prematurely discontinued and may not be counted in earlier visits.|113
8590253|NCT00293059|9625228|FG001|Cycle 7/Treatment Day 196|Overall Study|Includes participants that prematurely discontinued and may not be counted in earlier visits.|62
8590254|NCT00293059|9625227|FG000|COMPLETED|Overall Study||85
8590255|NCT00293059|9625228|FG001|COMPLETED|Overall Study||51
8590256|NCT00293059|9625227|FG000|NOT COMPLETED|Overall Study||35
8590257|NCT00293059|9625228|FG001|NOT COMPLETED|Overall Study||19
8590258|NCT00293202|9625236|FG000|STARTED|Overall Study||5
8590259|NCT00293202|9625237|FG001|STARTED|Overall Study||5
8590260|NCT00293202|9625236|FG000|COMPLETED|Overall Study||2
8590261|NCT00293202|9625237|FG001|COMPLETED|Overall Study||3
8590262|NCT00293202|9625236|FG000|NOT COMPLETED|Overall Study||3
8590263|NCT00293202|9625237|FG001|NOT COMPLETED|Overall Study||2
8590264|NCT00293215|9625249|FG000|STARTED|Overall Study||6
8590265|NCT00293215|9625250|FG001|STARTED|Overall Study||3
8590266|NCT00293215|9625249|FG000|COMPLETED|Overall Study||1
8590267|NCT00293215|9625250|FG001|COMPLETED|Overall Study||0
8590268|NCT00293215|9625249|FG000|NOT COMPLETED|Overall Study||5
8590269|NCT00293215|9625250|FG001|NOT COMPLETED|Overall Study||3
8590270|NCT00293241|9625258|FG000|STARTED|Overall Study||299
8590271|NCT00293241|9625259|FG001|STARTED|Overall Study||306
8590272|NCT00293241|9625258|FG000|COMPLETED|Overall Study||263
8590273|NCT00293241|9625259|FG001|COMPLETED|Overall Study||265
8590274|NCT00293241|9625258|FG000|NOT COMPLETED|Overall Study||36
8590275|NCT00293241|9625259|FG001|NOT COMPLETED|Overall Study||41
8590276|NCT00293254|9625270|FG000|STARTED|Primary Study - Double-Blind Week 0-48||232
8590277|NCT00293254|9625271|FG001|STARTED|Primary Study - Double-Blind Week 0-48||119
8590278|NCT00293254|9625270|FG000|Treated|Primary Study - Double-Blind Week 0-48||230
8590279|NCT00293254|9625271|FG001|Treated|Primary Study - Double-Blind Week 0-48||119
8590280|NCT00293254|9625270|FG000|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48|Excludes participants who entered the Open-Label Post-Virologic Failure (OLPVF) Phase|177
8590281|NCT00293254|9625271|FG001|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48|Excludes participants who entered the OLPVF phase|55
8590282|NCT00293254|9625270|FG000|COMPLETED|Primary Study - Double-Blind Week 0-48||177
8590283|NCT00293254|9625271|FG001|COMPLETED|Primary Study - Double-Blind Week 0-48||55
8590284|NCT00293254|9625270|FG000|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||55
8590285|NCT00293254|9625271|FG001|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||64
8590286|NCT00293254|9625270|FG000|STARTED|Extension - Double-Blind Week 49-156||177
8590287|NCT00293254|9625271|FG001|STARTED|Extension - Double-Blind Week 49-156|1 of 55 participants who completed Week 48 did not enter the extension study.|54
8590288|NCT00293254|9625270|FG000|COMPLETED|Extension - Double-Blind Week 49-156||120
8590289|NCT00293254|9625271|FG001|COMPLETED|Extension - Double-Blind Week 49-156||25
8590290|NCT00293254|9625270|FG000|NOT COMPLETED|Extension - Double-Blind Week 49-156||57
8590291|NCT00293254|9625271|FG001|NOT COMPLETED|Extension - Double-Blind Week 49-156||29
8590292|NCT00293254|9625270|FG000|STARTED|Extension - Open-Label Week 157-240||120
8590293|NCT00293254|9625271|FG001|STARTED|Extension - Open-Label Week 157-240|6 of 25 participants who completed the double-blind phase did not enter this open-label phase.|19
8590294|NCT00293254|9625270|FG000|COMPLETED|Extension - Open-Label Week 157-240||110
8590295|NCT00293254|9625271|FG001|COMPLETED|Extension - Open-Label Week 157-240||18
8590296|NCT00293254|9625270|FG000|NOT COMPLETED|Extension - Open-Label Week 157-240||10
8590297|NCT00293254|9625271|FG001|NOT COMPLETED|Extension - Open-Label Week 157-240||1
8590298|NCT00293254|9625270|FG000|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|50
8590299|NCT00293254|9625271|FG001|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|64
8590300|NCT00293254|9625270|FG000|COMPLETED|Open-Label Post Virologic Failure Phase||19
8590301|NCT00293254|9625271|FG001|COMPLETED|Open-Label Post Virologic Failure Phase||37
8590302|NCT00293254|9625270|FG000|NOT COMPLETED|Open-Label Post Virologic Failure Phase||31
8590303|NCT00293254|9625271|FG001|NOT COMPLETED|Open-Label Post Virologic Failure Phase||27
8590304|NCT00293267|9625281|FG000|STARTED|Primary Study - Double-Blind Week 0-48||234
8590305|NCT00293267|9625282|FG001|STARTED|Primary Study - Double-Blind Week 0-48||118
8590306|NCT00293267|9625281|FG000|Treated|Primary Study - Double-Blind Week 0-48||232
8590307|NCT00293267|9625282|FG001|Treated|Primary Study - Double-Blind Week 0-48||118
8590308|NCT00293267|9625281|FG000|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48|Excludes participants who entered the open-label post virological failure (OLPVF) phase|193
8590309|NCT00293267|9625282|FG001|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48||50
8590310|NCT00293267|9625281|FG000|COMPLETED|Primary Study - Double-Blind Week 0-48||193
8590311|NCT00293267|9625282|FG001|COMPLETED|Primary Study - Double-Blind Week 0-48||50
8590312|NCT00293267|9625281|FG000|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||41
8590313|NCT00293267|9625282|FG001|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||68
8590314|NCT00293267|9625281|FG000|STARTED|Extension - Double-Blind Week 49-156|2 participants who completed Week 48 did not enter the extension study|191
8590315|NCT00293267|9625282|FG001|STARTED|Extension - Double-Blind Week 49-156||50
8590316|NCT00293267|9625281|FG000|COMPLETED|Extension - Double-Blind Week 49-156||139
8590317|NCT00293267|9625282|FG001|COMPLETED|Extension - Double-Blind Week 49-156||35
8590318|NCT00293267|9625281|FG000|NOT COMPLETED|Extension - Double-Blind Week 49-156||52
8590319|NCT00293267|9625282|FG001|NOT COMPLETED|Extension - Double-Blind Week 49-156||15
8590320|NCT00293267|9625281|FG000|STARTED|Extension - Open-Label Week 157-240|8 of 139 participants who completed the double-blind phase did not enter this open-label phase|131
8590321|NCT00293267|9625282|FG001|STARTED|Extension - Open-Label Week 157-240|7 of 35 participants who completed the double-blind phase did not enter this open-label phase|28
8590322|NCT00293267|9625281|FG000|COMPLETED|Extension - Open-Label Week 157-240||111
8590323|NCT00293267|9625282|FG001|COMPLETED|Extension - Open-Label Week 157-240||26
8590324|NCT00293267|9625281|FG000|NOT COMPLETED|Extension - Open-Label Week 157-240||20
8590325|NCT00293267|9625282|FG001|NOT COMPLETED|Extension - Open-Label Week 157-240||2
8590326|NCT00293267|9625281|FG000|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|48
8590327|NCT00293267|9625282|FG001|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|66
8590328|NCT00293267|9625281|FG000|COMPLETED|Open-Label Post Virologic Failure Phase||15
8590329|NCT00293267|9625282|FG001|COMPLETED|Open-Label Post Virologic Failure Phase||29
8590330|NCT00293267|9625281|FG000|NOT COMPLETED|Open-Label Post Virologic Failure Phase||33
8590331|NCT00293267|9625282|FG001|NOT COMPLETED|Open-Label Post Virologic Failure Phase||37
8590332|NCT00293293|9625292|FG000|STARTED|Overall Study||20
8590333|NCT00293293|9625293|FG001|STARTED|Overall Study||23
8590334|NCT00293293|9625292|FG000|COMPLETED|Overall Study||18
8590335|NCT00293293|9625293|FG001|COMPLETED|Overall Study||21
8590336|NCT00293293|9625292|FG000|NOT COMPLETED|Overall Study||2
8590337|NCT00293293|9625293|FG001|NOT COMPLETED|Overall Study||2
8590338|NCT00293384|9625300|FG000|STARTED|Overall Study||40
8590339|NCT00293384|9625300|FG000|COMPLETED|Overall Study||35
8590340|NCT00293384|9625300|FG000|NOT COMPLETED|Overall Study||5
8590341|NCT00293397|9625304|FG000|STARTED|Overall Study||20
8590342|NCT00293397|9625304|FG000|Received First DEB-TACE|Overall Study|1 patient death after baseline inclusion screening and before first treatment|19
8590343|NCT00293397|9625304|FG000|COMPLETED|Overall Study|1 patient death within 30 days post-TACE - not attributed to TACE procedure|18
8590344|NCT00293397|9625304|FG000|NOT COMPLETED|Overall Study||2
8590345|NCT00293423|9625311|FG000|STARTED|Surgical Resection||28
8590346|NCT00293423|9625312|FG001|STARTED|Surgical Resection||68
8590347|NCT00293423|9625311|FG000|COMPLETED|Surgical Resection||12
8590348|NCT00293423|9625312|FG001|COMPLETED|Surgical Resection||41
8590349|NCT00293423|9625311|FG000|NOT COMPLETED|Surgical Resection||16
8590350|NCT00293423|9625312|FG001|NOT COMPLETED|Surgical Resection||27
8590351|NCT00293423|9625311|FG000|STARTED|Vaccination Treatment Period||12
8590352|NCT00293423|9625312|FG001|STARTED|Vaccination Treatment Period||41
8590353|NCT00293423|9625311|FG000|COMPLETED|Vaccination Treatment Period||12
8590354|NCT00293423|9625312|FG001|COMPLETED|Vaccination Treatment Period||38
8590355|NCT00293423|9625311|FG000|NOT COMPLETED|Vaccination Treatment Period||0
8590356|NCT00293423|9625312|FG001|NOT COMPLETED|Vaccination Treatment Period||3
8590357|NCT00293462|9625321|FG000|STARTED|Overall Study||31
8590358|NCT00293462|9625322|FG001|STARTED|Overall Study||29
8590359|NCT00293462|9625323|FG002|STARTED|Overall Study||31
8590360|NCT00293462|9625321|FG000|COMPLETED|Overall Study||24
8590361|NCT00293462|9625322|FG001|COMPLETED|Overall Study||21
8590362|NCT00293462|9625323|FG002|COMPLETED|Overall Study||19
8590363|NCT00293462|9625321|FG000|NOT COMPLETED|Overall Study||7
8590364|NCT00293462|9625322|FG001|NOT COMPLETED|Overall Study||8
8590365|NCT00293462|9625323|FG002|NOT COMPLETED|Overall Study||12
8590366|NCT00293540|9625333|FG000|STARTED|Overall Study||122
8590367|NCT00293540|9625334|FG001|STARTED|Overall Study||127
8590368|NCT00293540|9625333|FG000|COMPLETED|Overall Study||115
8590369|NCT00293540|9625334|FG001|COMPLETED|Overall Study||119
8590370|NCT00293540|9625333|FG000|NOT COMPLETED|Overall Study||7
8590371|NCT00293540|9625334|FG001|NOT COMPLETED|Overall Study||8
8590372|NCT00293579|9625340|FG000|STARTED|Overall Study||5
8590373|NCT00293579|9625340|FG000|COMPLETED|Overall Study||4
8590374|NCT00293579|9625340|FG000|NOT COMPLETED|Overall Study||1
8590375|NCT00293709|9625345|FG000|STARTED|Overall Study||149
8590376|NCT00293709|9625345|FG000|COMPLETED|Overall Study||102
8590377|NCT00293709|9625345|FG000|NOT COMPLETED|Overall Study||47
8590378|NCT00293722|9625349|FG000|STARTED|Overall Study||1291
8590379|NCT00293722|9625349|FG000|COMPLETED|Overall Study||864
8590380|NCT00293722|9625349|FG000|NOT COMPLETED|Overall Study||427
8590381|NCT00293813|9625356|FG000|STARTED|Overall Study||82
8590382|NCT00293813|9625357|FG001|STARTED|Overall Study||83
8590383|NCT00293813|9625358|FG002|STARTED|Overall Study||82
8590384|NCT00293813|9625356|FG000|COMPLETED|Overall Study||69
8590385|NCT00293813|9625357|FG001|COMPLETED|Overall Study||74
8590386|NCT00293813|9625358|FG002|COMPLETED|Overall Study||74
8590387|NCT00293813|9625356|FG000|NOT COMPLETED|Overall Study||13
8590388|NCT00293813|9625357|FG001|NOT COMPLETED|Overall Study||9
8590389|NCT00293813|9625358|FG002|NOT COMPLETED|Overall Study||8
8590390|NCT00294047|9625368|FG000|STARTED|Month 48||2881
8590391|NCT00294047|9625369|FG001|STARTED|Month 48||2871
8590392|NCT00294047|9625368|FG000|Participated up to Month 48|Month 48||2305
8590393|NCT00294047|9625369|FG001|Participated up to Month 48|Month 48||2281
8590394|NCT00294047|9625368|FG000|COMPLETED|Month 48||2456
8590395|NCT00294047|9625369|FG001|COMPLETED|Month 48||2438
8590396|NCT00294047|9625368|FG000|NOT COMPLETED|Month 48||425
8590397|NCT00294047|9625369|FG001|NOT COMPLETED|Month 48||433
8590398|NCT00294047|9625368|FG000|STARTED|Month 84||2877
8590399|NCT00294047|9625369|FG001|STARTED|Month 84||2870
8590400|NCT00294047|9625368|FG000|COMPLETED|Month 84|The number of subjects who remained up to Month 48 in the Cervarix Group = 2146|1904
8590401|NCT00294047|9625369|FG001|COMPLETED|Month 84|The number of subjects who remained up to Month 48 in the Aluminium Hydroxide Group = 2116|1881
8590402|NCT00294047|9625368|FG000|NOT COMPLETED|Month 84||973
8590403|NCT00294047|9625369|FG001|NOT COMPLETED|Month 84||989
8590404|NCT00294060|9625376|FG000|STARTED|Overall Study||2013
8590405|NCT00294060|9625376|FG000|COMPLETED|Overall Study||840
8590406|NCT00294060|9625376|FG000|NOT COMPLETED|Overall Study||1173
8590407|NCT00294398|9625382|FG000|STARTED|Overall Study||78
8590408|NCT00294398|9625383|FG001|STARTED|Overall Study||74
8590409|NCT00294398|9625382|FG000|COMPLETED|Overall Study||57
8590410|NCT00294398|9625383|FG001|COMPLETED|Overall Study||48
8590411|NCT00294398|9625382|FG000|NOT COMPLETED|Overall Study||21
8590412|NCT00294398|9625383|FG001|NOT COMPLETED|Overall Study||26
8590413|NCT00294515|9625391|FG000|STARTED|Overall Study|Randomized|166
8590414|NCT00294515|9625392|FG001|STARTED|Overall Study|Randomized|160
8590415|NCT00294515|9625391|FG000|COMPLETED|Overall Study||132
8590416|NCT00294515|9625392|FG001|COMPLETED|Overall Study||132
8590417|NCT00294515|9625391|FG000|NOT COMPLETED|Overall Study||34
8590418|NCT00294515|9625392|FG001|NOT COMPLETED|Overall Study||28
8590419|NCT00294554|9625400|FG000|STARTED|Overall Study||10
8590420|NCT00294554|9625401|FG001|STARTED|Overall Study||10
8590421|NCT00294554|9625400|FG000|COMPLETED|Overall Study||10
8590422|NCT00294554|9625401|FG001|COMPLETED|Overall Study|"1 S withdrew @ 20 wks for lack perceived benefit~1 S withdrawn @ 13 wks b/o extreme agitation"|8
8590423|NCT00294554|9625400|FG000|NOT COMPLETED|Overall Study||0
8590424|NCT00294554|9625401|FG001|NOT COMPLETED|Overall Study||2
8590425|NCT00294632|9625409|FG000|STARTED|Phase I Dose Escalation Period||14
8590426|NCT00294632|9625410|FG001|STARTED|Phase I Dose Escalation Period||0
8590427|NCT00294632|9625409|FG000|Cohort 1: 10 mg|Phase I Dose Escalation Period||3
8590428|NCT00294632|9625410|FG001|Cohort 1: 10 mg|Phase I Dose Escalation Period||0
8590429|NCT00294632|9625409|FG000|Cohort 2: 15 mg|Phase I Dose Escalation Period||3
8590430|NCT00294632|9625410|FG001|Cohort 2: 15 mg|Phase I Dose Escalation Period||0
8590431|NCT00294632|9625409|FG000|Cohort 3: 20 mg|Phase I Dose Escalation Period||6
8590432|NCT00294632|9625410|FG001|Cohort 3: 20 mg|Phase I Dose Escalation Period||0
8590433|NCT00294632|9625409|FG000|Cohort 4: 25 mg|Phase I Dose Escalation Period||2
8590434|NCT00294632|9625410|FG001|Cohort 4: 25 mg|Phase I Dose Escalation Period||0
8590435|NCT00294632|9625409|FG000|COMPLETED|Phase I Dose Escalation Period||14
8590436|NCT00294632|9625410|FG001|COMPLETED|Phase I Dose Escalation Period||0
8590437|NCT00294632|9625409|FG000|NOT COMPLETED|Phase I Dose Escalation Period||0
8590438|NCT00294632|9625410|FG001|NOT COMPLETED|Phase I Dose Escalation Period||0
8590439|NCT00294632|9625409|FG000|STARTED|Phase II: 20 mg Lenalidomide||6
8590440|NCT00294632|9625410|FG001|STARTED|Phase II: 20 mg Lenalidomide||38
8590441|NCT00294632|9625409|FG000|COMPLETED|Phase II: 20 mg Lenalidomide||6
8590442|NCT00294632|9625410|FG001|COMPLETED|Phase II: 20 mg Lenalidomide||38
8590443|NCT00294632|9625409|FG000|NOT COMPLETED|Phase II: 20 mg Lenalidomide||0
8629569|NCT00530920|9669340|FG002|COMPLETED|Overall Study||24
8590444|NCT00294632|9625410|FG001|NOT COMPLETED|Phase II: 20 mg Lenalidomide||0
8590445|NCT00294645|9625419|FG000|STARTED|Overall Study||295
8590446|NCT00294645|9625420|FG001|STARTED|Overall Study||602
8590447|NCT00294645|9625419|FG000|COMPLETED|Overall Study||247
8590448|NCT00294645|9625420|FG001|COMPLETED|Overall Study||510
8590449|NCT00294645|9625419|FG000|NOT COMPLETED|Overall Study||48
8590450|NCT00294645|9625420|FG001|NOT COMPLETED|Overall Study||92
8590451|NCT00294658|9625428|FG000|STARTED|Overall Study||66
8590452|NCT00294658|9625429|FG001|STARTED|Overall Study||60
8590453|NCT00294658|9625428|FG000|COMPLETED|Overall Study||60
8590454|NCT00294658|9625429|FG001|COMPLETED|Overall Study||51
8590455|NCT00294658|9625428|FG000|NOT COMPLETED|Overall Study||6
8590456|NCT00294658|9625429|FG001|NOT COMPLETED|Overall Study||9
8590457|NCT00294671|9625437|FG000|STARTED|Overall Study||64
8590458|NCT00294671|9625438|FG001|STARTED|Overall Study||66
8590459|NCT00294671|9625437|FG000|COMPLETED|Overall Study||37
8590460|NCT00294671|9625438|FG001|COMPLETED|Overall Study||26
8590461|NCT00294671|9625437|FG000|NOT COMPLETED|Overall Study||27
8590462|NCT00294671|9625438|FG001|NOT COMPLETED|Overall Study||40
8590463|NCT00294684|9625446|FG000|STARTED|Overall Study||70
8590464|NCT00294684|9625447|FG001|STARTED|Overall Study||70
8590465|NCT00294684|9625446|FG000|COMPLETED|Overall Study||65
8590466|NCT00294684|9625447|FG001|COMPLETED|Overall Study||62
8590467|NCT00294684|9625446|FG000|NOT COMPLETED|Overall Study||5
8590468|NCT00294684|9625447|FG001|NOT COMPLETED|Overall Study||8
8590469|NCT00294723|9625456|FG000|STARTED|Double-Blind Period 52 Weeks|Randomised|247
8590470|NCT00294723|9625457|FG001|STARTED|Double-Blind Period 52 Weeks|Randomised|251
8590471|NCT00294723|9625458|FG002|STARTED|Double-Blind Period 52 Weeks|Randomised|248
8590472|NCT00294723|9625456|FG000|Exposed to Study Drug|Double-Blind Period 52 Weeks|Subject withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|246
8590473|NCT00294723|9625457|FG001|Exposed to Study Drug|Double-Blind Period 52 Weeks||251
8590474|NCT00294723|9625458|FG002|Exposed to Study Drug|Double-Blind Period 52 Weeks||248
8590475|NCT00294723|9625456|FG000|COMPLETED|Double-Blind Period 52 Weeks||173
8590476|NCT00294723|9625457|FG001|COMPLETED|Double-Blind Period 52 Weeks||162
8590477|NCT00294723|9625458|FG002|COMPLETED|Double-Blind Period 52 Weeks||152
8590478|NCT00294723|9625456|FG000|NOT COMPLETED|Double-Blind Period 52 Weeks||74
8590479|NCT00294723|9625457|FG001|NOT COMPLETED|Double-Blind Period 52 Weeks||89
8590480|NCT00294723|9625458|FG002|NOT COMPLETED|Double-Blind Period 52 Weeks||96
8590481|NCT00294723|9625456|FG000|STARTED|Open-Label Extension 52 Weeks|19 subjects did not continue into the extension period|154
8590482|NCT00294723|9625457|FG001|STARTED|Open-Label Extension 52 Weeks|13 subjects did not continue into the extension period|149
8590483|NCT00294723|9625458|FG002|STARTED|Open-Label Extension 52 Weeks|15 subjects did not continue into the extension period|137
8590484|NCT00294723|9625456|FG000|COMPLETED|Open-Label Extension 52 Weeks||114
8590485|NCT00294723|9625457|FG001|COMPLETED|Open-Label Extension 52 Weeks||110
8590486|NCT00294723|9625458|FG002|COMPLETED|Open-Label Extension 52 Weeks||97
8590487|NCT00294723|9625456|FG000|NOT COMPLETED|Open-Label Extension 52 Weeks||40
8590488|NCT00294723|9625457|FG001|NOT COMPLETED|Open-Label Extension 52 Weeks||39
8590489|NCT00294723|9625458|FG002|NOT COMPLETED|Open-Label Extension 52 Weeks||40
8590490|NCT00294723|9625456|FG000|STARTED|Additional Open-Label Extension 91 Weeks|52 subjects did not continue into the extension period|62
8590491|NCT00294723|9625457|FG001|STARTED|Additional Open-Label Extension 91 Weeks|57 subjects did not continue into the extension period|53
8590492|NCT00294723|9625458|FG002|STARTED|Additional Open-Label Extension 91 Weeks|69 subjects did not continue into the extension period|28
8590493|NCT00294723|9625456|FG000|COMPLETED|Additional Open-Label Extension 91 Weeks||34
8590494|NCT00294723|9625457|FG001|COMPLETED|Additional Open-Label Extension 91 Weeks||32
8590495|NCT00294723|9625458|FG002|COMPLETED|Additional Open-Label Extension 91 Weeks||8
8590496|NCT00294723|9625456|FG000|NOT COMPLETED|Additional Open-Label Extension 91 Weeks||28
8590497|NCT00294723|9625457|FG001|NOT COMPLETED|Additional Open-Label Extension 91 Weeks||21
8590498|NCT00294723|9625458|FG002|NOT COMPLETED|Additional Open-Label Extension 91 Weeks||20
8590499|NCT00294762|9625471|FG000|STARTED|Overall Study||72
8590500|NCT00294762|9625472|FG001|STARTED|Overall Study||71
8590501|NCT00294762|9625471|FG000|COMPLETED|Overall Study||69
8590502|NCT00294762|9625472|FG001|COMPLETED|Overall Study||68
8590503|NCT00294762|9625471|FG000|NOT COMPLETED|Overall Study||3
8590504|NCT00294762|9625472|FG001|NOT COMPLETED|Overall Study||3
8590505|NCT00295009|9625484|FG000|STARTED|Overall Study||93
8590506|NCT00295009|9625485|FG001|STARTED|Overall Study||183
8590507|NCT00295009|9625486|FG002|STARTED|Overall Study||51
8590508|NCT00295009|9625487|FG003|STARTED|Overall Study||82
8590509|NCT00295009|9625488|FG004|STARTED|Overall Study||174
8590510|NCT00295009|9625489|FG005|STARTED|Overall Study||269
8590511|NCT00295009|9625484|FG000|Treated|Overall Study||80
8590512|NCT00295009|9625485|FG001|Treated|Overall Study||162
8590513|NCT00295009|9625486|FG002|Treated|Overall Study||50
8590514|NCT00295009|9625487|FG003|Treated|Overall Study||72
8590515|NCT00295009|9625488|FG004|Treated|Overall Study||165
8590516|NCT00295009|9625489|FG005|Treated|Overall Study||259
8590517|NCT00295009|9625484|FG000|Completed 24 Month Analysis|Overall Study||71
8590518|NCT00295009|9625485|FG001|Completed 24 Month Analysis|Overall Study||148
8590519|NCT00295009|9625486|FG002|Completed 24 Month Analysis|Overall Study||45
8590520|NCT00295009|9625487|FG003|Completed 24 Month Analysis|Overall Study||60
8590521|NCT00295009|9625488|FG004|Completed 24 Month Analysis|Overall Study||133
8590522|NCT00295009|9625489|FG005|Completed 24 Month Analysis|Overall Study||198
8590523|NCT00295009|9625484|FG000|COMPLETED|Overall Study|Completed 60 month visit|52
8590524|NCT00295009|9625485|FG001|COMPLETED|Overall Study|Completed 60 month visit|134
8590525|NCT00295009|9625486|FG002|COMPLETED|Overall Study|Completed 60 month visit|39
8590526|NCT00295009|9625487|FG003|COMPLETED|Overall Study|Completed 60 month visit|57
8590527|NCT00295009|9625488|FG004|COMPLETED|Overall Study|Completed 60 month visit|116
8590528|NCT00295009|9625489|FG005|COMPLETED|Overall Study|Continued Access patients were only followed out to 24 months|0
8590529|NCT00295009|9625484|FG000|NOT COMPLETED|Overall Study||41
8590530|NCT00295009|9625485|FG001|NOT COMPLETED|Overall Study||49
8590531|NCT00295009|9625486|FG002|NOT COMPLETED|Overall Study||12
8590532|NCT00295009|9625487|FG003|NOT COMPLETED|Overall Study||25
8590533|NCT00295009|9625488|FG004|NOT COMPLETED|Overall Study||58
8590534|NCT00295009|9625489|FG005|NOT COMPLETED|Overall Study||269
8590535|NCT00295022|9625506|FG000|STARTED|Overall Study||105
8590536|NCT00295022|9625507|FG001|STARTED|Overall Study||157
8590537|NCT00295022|9625508|FG002|STARTED|Overall Study||156
8590538|NCT00295022|9625506|FG000|COMPLETED|Overall Study||104
8590539|NCT00295022|9625507|FG001|COMPLETED|Overall Study||156
8590540|NCT00295022|9625508|FG002|COMPLETED|Overall Study||151
8590541|NCT00295022|9625506|FG000|NOT COMPLETED|Overall Study||1
8590542|NCT00295022|9625507|FG001|NOT COMPLETED|Overall Study||1
8590543|NCT00295022|9625508|FG002|NOT COMPLETED|Overall Study||5
8590544|NCT00295061|9625520|FG000|STARTED|Overall Study||12
8590545|NCT00295061|9625521|FG001|STARTED|Overall Study||12
8590546|NCT00295061|9625520|FG000|COMPLETED|Overall Study||12
8590547|NCT00295061|9625521|FG001|COMPLETED|Overall Study||12
8590548|NCT00295061|9625520|FG000|NOT COMPLETED|Overall Study||0
8590549|NCT00295061|9625521|FG001|NOT COMPLETED|Overall Study||0
8590550|NCT00295503|9625527|FG000|STARTED|Overall Study||53
8590551|NCT00295503|9625527|FG000|COMPLETED|Overall Study||53
8590552|NCT00295503|9625527|FG000|NOT COMPLETED|Overall Study||0
8590553|NCT00295620|9625534|FG000|STARTED|Overall Study||1732
8590554|NCT00295620|9625535|FG001|STARTED|Overall Study||1738
8590555|NCT00295620|9625534|FG000|Safety Analysis Set|Overall Study||1705
8590556|NCT00295620|9625535|FG001|Safety Analysis Set|Overall Study||1710
8590557|NCT00295620|9625534|FG000|COMPLETED|Overall Study||860
8590558|NCT00295620|9625535|FG001|COMPLETED|Overall Study||842
8590559|NCT00295620|9625534|FG000|NOT COMPLETED|Overall Study||872
8590560|NCT00295620|9625535|FG001|NOT COMPLETED|Overall Study||896
8590561|NCT00295633|9625544|FG000|STARTED|Overall Study||195
8590562|NCT00295633|9625545|FG001|STARTED|Overall Study||186
8590563|NCT00295633|9625546|FG002|STARTED|Overall Study||184
8590564|NCT00295633|9625544|FG000|Completed Study Without Being Rescued|Overall Study||88
8590565|NCT00295633|9625545|FG001|Completed Study Without Being Rescued|Overall Study||82
8590566|NCT00295633|9625546|FG002|Completed Study Without Being Rescued|Overall Study||51
8590567|NCT00295633|9625544|FG000|COMPLETED|Overall Study||133
8590568|NCT00295633|9625545|FG001|COMPLETED|Overall Study||119
8590569|NCT00295633|9625546|FG002|COMPLETED|Overall Study||108
8590570|NCT00295633|9625544|FG000|NOT COMPLETED|Overall Study||62
8590571|NCT00295633|9625545|FG001|NOT COMPLETED|Overall Study||67
8590572|NCT00295633|9625546|FG002|NOT COMPLETED|Overall Study||76
8590573|NCT00295750|9625557|FG000|STARTED|Overall Study|randomized|206
8590574|NCT00295750|9625558|FG001|STARTED|Overall Study|randomized|210
8590575|NCT00295750|9625559|FG002|STARTED|Overall Study|randomized|204
8590576|NCT00295750|9625557|FG000|Intent-to-treat (ITT) Population|Overall Study|randomized and exposed patients|202
8590577|NCT00295750|9625558|FG001|Intent-to-treat (ITT) Population|Overall Study|randomized and exposed patients|207
8590578|NCT00295750|9625559|FG002|Intent-to-treat (ITT) Population|Overall Study|randomized and exposed patients|201
8590579|NCT00295750|9625557|FG000|COMPLETED|Overall Study||163
8590580|NCT00295750|9625558|FG001|COMPLETED|Overall Study||169
8590581|NCT00295750|9625559|FG002|COMPLETED|Overall Study||172
8590582|NCT00295750|9625557|FG000|NOT COMPLETED|Overall Study||43
8590583|NCT00295750|9625558|FG001|NOT COMPLETED|Overall Study||41
8590584|NCT00295750|9625559|FG002|NOT COMPLETED|Overall Study||32
8590585|NCT00295854|9625570|FG000|STARTED|Overall Study||95
8590586|NCT00295854|9625571|FG001|STARTED|Overall Study||108
8590587|NCT00295854|9625572|FG002|STARTED|Overall Study||102
8590588|NCT00295854|9625570|FG000|Safety Population (N=304)|Overall Study||95
8590589|NCT00295854|9625571|FG001|Safety Population (N=304)|Overall Study||108
8590590|NCT00295854|9625572|FG002|Safety Population (N=304)|Overall Study||101
8590591|NCT00295854|9625570|FG000|ITT Population (N=296)|Overall Study||92
8590592|NCT00295854|9625571|FG001|ITT Population (N=296)|Overall Study||105
8590593|NCT00295854|9625572|FG002|ITT Population (N=296)|Overall Study||99
8590594|NCT00295854|9625570|FG000|COMPLETED|Overall Study||77
8590595|NCT00295854|9625571|FG001|COMPLETED|Overall Study||87
8590596|NCT00295854|9625572|FG002|COMPLETED|Overall Study||87
8711317|NCT00961259|9757639|FG000|COMPLETED|Third Intervention||18
8711318|NCT00961259|9757640|FG001|COMPLETED|Third Intervention||17
8711319|NCT00961259|9757641|FG002|COMPLETED|Third Intervention||18
8711320|NCT00961259|9757639|FG000|NOT COMPLETED|Third Intervention||0
8590597|NCT00295854|9625570|FG000|NOT COMPLETED|Overall Study||18
8590598|NCT00295854|9625571|FG001|NOT COMPLETED|Overall Study||21
8590599|NCT00295854|9625572|FG002|NOT COMPLETED|Overall Study||15
8590600|NCT00295867|9625580|FG000|STARTED|Overall Study||45
8711321|NCT00961259|9757640|FG001|NOT COMPLETED|Third Intervention||0
8711322|NCT00961259|9757641|FG002|NOT COMPLETED|Third Intervention||0
8590601|NCT00295867|9625580|FG000|COMPLETED|Overall Study||34
8590602|NCT00295867|9625580|FG000|NOT COMPLETED|Overall Study||11
8590603|NCT00295880|9625584|FG000|STARTED|Overall Study||12
8590604|NCT00295880|9625584|FG000|COMPLETED|Overall Study||10
8711323|NCT00961298|9757650|FG000|STARTED|Two Week Placebo Run in||15
8711324|NCT00961298|9757650|FG000|COMPLETED|Two Week Placebo Run in||14
8711325|NCT00961298|9757650|FG000|NOT COMPLETED|Two Week Placebo Run in||1
8711326|NCT00961298|9757650|FG000|STARTED|12 Weeks Duloxetine Treatment Phase||14
8711327|NCT00961298|9757650|FG000|COMPLETED|12 Weeks Duloxetine Treatment Phase||11
8711328|NCT00961298|9757650|FG000|NOT COMPLETED|12 Weeks Duloxetine Treatment Phase||3
8711329|NCT00961311|9757654|FG000|STARTED|Overall Study||51
8711330|NCT00961311|9757654|FG000|COMPLETED|Overall Study||51
8590605|NCT00295880|9625584|FG000|NOT COMPLETED|Overall Study||2
8590606|NCT00295932|9625599|FG000|STARTED|Overall Study||4
8590607|NCT00295932|9625600|FG001|STARTED|Overall Study||6
8590608|NCT00295932|9625601|FG002|STARTED|Overall Study||3
8590609|NCT00295932|9625602|FG003|STARTED|Overall Study||4
8590610|NCT00295932|9625603|FG004|STARTED|Overall Study||2
8711331|NCT00961311|9757654|FG000|NOT COMPLETED|Overall Study||0
8711332|NCT00961350|9757660|FG000|STARTED|Overall Study||265
8711333|NCT00961350|9757661|FG001|STARTED|Overall Study||265
8711334|NCT00961350|9757660|FG000|Intent-to-Treat Population (ITT)|Overall Study||265
8711335|NCT00961350|9757661|FG001|Intent-to-Treat Population (ITT)|Overall Study||265
8711336|NCT00961350|9757660|FG000|Safety Population|Overall Study|1. One sub rand to PA32540 took EC-Aspirin|264
8711337|NCT00961350|9757661|FG001|Safety Population|Overall Study||265
8711338|NCT00961350|9757660|FG000|COMPLETED|Overall Study||218
8711339|NCT00961350|9757661|FG001|COMPLETED|Overall Study||198
8711340|NCT00961350|9757660|FG000|NOT COMPLETED|Overall Study||47
8711341|NCT00961350|9757661|FG001|NOT COMPLETED|Overall Study||67
8711342|NCT00961402|9757669|FG000|STARTED|Overall Study||64
8711343|NCT00961402|9757670|FG001|STARTED|Overall Study||66
8711344|NCT00961402|9757669|FG000|Randomized|Overall Study||64
8711345|NCT00961402|9757670|FG001|Randomized|Overall Study||66
8711346|NCT00961402|9757669|FG000|COMPLETED|Overall Study||63
8711347|NCT00961402|9757670|FG001|COMPLETED|Overall Study||61
8711348|NCT00961402|9757669|FG000|NOT COMPLETED|Overall Study||1
8711349|NCT00961402|9757670|FG001|NOT COMPLETED|Overall Study||5
8711350|NCT00961415|9757678|FG000|STARTED|Induction Treatment Phase||376
8711351|NCT00961415|9757679|FG001|STARTED|Induction Treatment Phase||0
8711352|NCT00961415|9757680|FG002|STARTED|Induction Treatment Phase||0
8711353|NCT00961415|9757678|FG000|COMPLETED|Induction Treatment Phase||253
8711354|NCT00961415|9757679|FG001|COMPLETED|Induction Treatment Phase||0
8711355|NCT00961415|9757680|FG002|COMPLETED|Induction Treatment Phase||0
8711356|NCT00961415|9757678|FG000|NOT COMPLETED|Induction Treatment Phase||123
8711357|NCT00961415|9757679|FG001|NOT COMPLETED|Induction Treatment Phase||0
8711358|NCT00961415|9757680|FG002|NOT COMPLETED|Induction Treatment Phase||0
8711359|NCT00961415|9757678|FG000|STARTED|Maintenance Treatment Phase||0
8711360|NCT00961415|9757679|FG001|STARTED|Maintenance Treatment Phase||125
8711361|NCT00961415|9757680|FG002|STARTED|Maintenance Treatment Phase||128
8711362|NCT00961415|9757678|FG000|COMPLETED|Maintenance Treatment Phase||0
8711363|NCT00961415|9757679|FG001|COMPLETED|Maintenance Treatment Phase||77
8711364|NCT00961415|9757680|FG002|COMPLETED|Maintenance Treatment Phase||83
8711365|NCT00961415|9757678|FG000|NOT COMPLETED|Maintenance Treatment Phase||0
8711366|NCT00961415|9757679|FG001|NOT COMPLETED|Maintenance Treatment Phase||48
8711367|NCT00961415|9757680|FG002|NOT COMPLETED|Maintenance Treatment Phase||45
8711368|NCT00961441|9757696|FG000|STARTED|Overall Study||12
8711369|NCT00961441|9757697|FG001|STARTED|Overall Study||13
8711370|NCT00961441|9757696|FG000|Pharmacokinetic (PK-PP) Population|Overall Study||12
8711371|NCT00961441|9757697|FG001|Pharmacokinetic (PK-PP) Population|Overall Study|Two subjects were excluded due to study medication noncompliance, one due to wrong dosing regimen.|10
8711372|NCT00961441|9757696|FG000|COMPLETED|Overall Study||12
8711373|NCT00961441|9757697|FG001|COMPLETED|Overall Study||13
8711374|NCT00961441|9757696|FG000|NOT COMPLETED|Overall Study||0
8711375|NCT00961441|9757697|FG001|NOT COMPLETED|Overall Study||0
8711376|NCT00961532|9757703|FG000|STARTED|Overall Study||14
8711377|NCT00961532|9757703|FG000|COMPLETED|Overall Study||14
8711378|NCT00961532|9757703|FG000|NOT COMPLETED|Overall Study||0
8711379|NCT00961571|9757707|FG000|STARTED|Overall Study||50
8711380|NCT00961571|9757707|FG000|COMPLETED|Overall Study|high percentage of patient drop-off study prior cancer progression|11
8711381|NCT00961571|9757707|FG000|NOT COMPLETED|Overall Study||39
8711382|NCT00961636|9757714|FG000|STARTED|Overall Study||463
8711383|NCT00961636|9757715|FG001|STARTED|Overall Study||456
8711384|NCT00961636|9757716|FG002|STARTED|Overall Study||233
8711385|NCT00961636|9757714|FG000|COMPLETED|Overall Study||356
8711386|NCT00961636|9757715|FG001|COMPLETED|Overall Study||325
8711387|NCT00961636|9757716|FG002|COMPLETED|Overall Study||201
8711388|NCT00961636|9757714|FG000|NOT COMPLETED|Overall Study||107
8711389|NCT00961636|9757715|FG001|NOT COMPLETED|Overall Study||131
8711390|NCT00961636|9757716|FG002|NOT COMPLETED|Overall Study||32
8711391|NCT00961649|9757728|FG000|STARTED|Overall Study||41
8711392|NCT00961649|9757729|FG001|STARTED|Overall Study||44
8711393|NCT00961649|9757730|FG002|STARTED|Overall Study||44
8711394|NCT00961649|9757731|FG003|STARTED|Overall Study||41
8711395|NCT00961649|9757728|FG000|COMPLETED|Overall Study||32
8711396|NCT00961649|9757729|FG001|COMPLETED|Overall Study||40
8711397|NCT00961649|9757730|FG002|COMPLETED|Overall Study||39
8590611|NCT00295932|9625604|FG005|STARTED|Overall Study||18
8590612|NCT00295932|9625605|FG006|STARTED|Overall Study||3
8590613|NCT00295932|9625606|FG007|STARTED|Overall Study||4
8590614|NCT00295932|9625607|FG008|STARTED|Overall Study||10
8590615|NCT00295932|9625608|FG009|STARTED|Overall Study||12
8590616|NCT00295932|9625609|FG010|STARTED|Overall Study||13
8590617|NCT00295932|9625599|FG000|COMPLETED|Overall Study||4
8590618|NCT00295932|9625600|FG001|COMPLETED|Overall Study||6
8590619|NCT00295932|9625601|FG002|COMPLETED|Overall Study||3
8590620|NCT00295932|9625602|FG003|COMPLETED|Overall Study||4
8590621|NCT00295932|9625603|FG004|COMPLETED|Overall Study||2
8590622|NCT00295932|9625604|FG005|COMPLETED|Overall Study||18
8590623|NCT00295932|9625605|FG006|COMPLETED|Overall Study||3
8590624|NCT00295932|9625606|FG007|COMPLETED|Overall Study||4
8590625|NCT00295932|9625607|FG008|COMPLETED|Overall Study||10
8590626|NCT00295932|9625608|FG009|COMPLETED|Overall Study||12
8590627|NCT00295932|9625609|FG010|COMPLETED|Overall Study||12
8590628|NCT00295932|9625599|FG000|NOT COMPLETED|Overall Study||0
8590629|NCT00295932|9625600|FG001|NOT COMPLETED|Overall Study||0
8590630|NCT00295932|9625601|FG002|NOT COMPLETED|Overall Study||0
8590631|NCT00295932|9625602|FG003|NOT COMPLETED|Overall Study||0
8590632|NCT00295932|9625603|FG004|NOT COMPLETED|Overall Study||0
8590633|NCT00295932|9625604|FG005|NOT COMPLETED|Overall Study||0
8590634|NCT00295932|9625605|FG006|NOT COMPLETED|Overall Study||0
8590635|NCT00295932|9625606|FG007|NOT COMPLETED|Overall Study||0
8590636|NCT00295932|9625607|FG008|NOT COMPLETED|Overall Study||0
8711398|NCT00961649|9757731|FG003|COMPLETED|Overall Study||37
8711399|NCT00961649|9757728|FG000|NOT COMPLETED|Overall Study||9
8711400|NCT00961649|9757729|FG001|NOT COMPLETED|Overall Study||4
8711401|NCT00961649|9757730|FG002|NOT COMPLETED|Overall Study||5
8711402|NCT00961649|9757731|FG003|NOT COMPLETED|Overall Study||4
8590637|NCT00295932|9625608|FG009|NOT COMPLETED|Overall Study||0
8590638|NCT00295932|9625609|FG010|NOT COMPLETED|Overall Study||1
8590639|NCT00296036|9625637|FG000|STARTED|Overall Study||19
8590640|NCT00296036|9625638|FG001|STARTED|Overall Study||18
8590641|NCT00296036|9625639|FG002|STARTED|Overall Study||18
8590642|NCT00296036|9625640|FG003|STARTED|Overall Study||17
8590643|NCT00296036|9625641|FG004|STARTED|Overall Study||33
8590644|NCT00296036|9625642|FG005|STARTED|Overall Study||32
8590645|NCT00296036|9625637|FG000|COMPLETED|Overall Study||18
8590646|NCT00296036|9625638|FG001|COMPLETED|Overall Study||18
8590647|NCT00296036|9625639|FG002|COMPLETED|Overall Study||16
8590648|NCT00296036|9625640|FG003|COMPLETED|Overall Study||16
8590649|NCT00296036|9625641|FG004|COMPLETED|Overall Study||31
8590650|NCT00296036|9625642|FG005|COMPLETED|Overall Study||28
8590651|NCT00296036|9625637|FG000|NOT COMPLETED|Overall Study||1
8590652|NCT00296036|9625638|FG001|NOT COMPLETED|Overall Study||0
8590653|NCT00296036|9625639|FG002|NOT COMPLETED|Overall Study||2
8590654|NCT00296036|9625640|FG003|NOT COMPLETED|Overall Study||1
8590655|NCT00296036|9625641|FG004|NOT COMPLETED|Overall Study||2
8590656|NCT00296036|9625642|FG005|NOT COMPLETED|Overall Study||4
8590657|NCT00296140|9625661|FG000|STARTED|Overall Study||33
8590658|NCT00296140|9625662|FG001|STARTED|Overall Study||33
8590659|NCT00296140|9625661|FG000|COMPLETED|Overall Study||30
8590660|NCT00296140|9625662|FG001|COMPLETED|Overall Study||33
8590661|NCT00296140|9625661|FG000|NOT COMPLETED|Overall Study||3
8590662|NCT00296140|9625662|FG001|NOT COMPLETED|Overall Study||0
8590663|NCT00296192|9625673|FG000|STARTED|Overall Study||17
8590664|NCT00296192|9625674|FG001|STARTED|Overall Study||16
8590665|NCT00296192|9625675|FG002|STARTED|Overall Study||16
8590666|NCT00296192|9625676|FG003|STARTED|Overall Study||17
8590667|NCT00296192|9625677|FG004|STARTED|Overall Study||16
8590668|NCT00296192|9625673|FG000|COMPLETED|Overall Study||17
8590669|NCT00296192|9625674|FG001|COMPLETED|Overall Study||16
8590670|NCT00296192|9625675|FG002|COMPLETED|Overall Study||16
8590671|NCT00296192|9625676|FG003|COMPLETED|Overall Study||17
8590672|NCT00296192|9625677|FG004|COMPLETED|Overall Study||16
8590673|NCT00296192|9625673|FG000|NOT COMPLETED|Overall Study||0
8590674|NCT00296192|9625674|FG001|NOT COMPLETED|Overall Study||0
8590675|NCT00296192|9625675|FG002|NOT COMPLETED|Overall Study||0
8590676|NCT00296192|9625676|FG003|NOT COMPLETED|Overall Study||0
8590677|NCT00296192|9625677|FG004|NOT COMPLETED|Overall Study||0
8590678|NCT00296231|9625689|FG000|STARTED|Overall Study||14
8590679|NCT00296231|9625689|FG000|COMPLETED|Overall Study||14
8590680|NCT00296231|9625689|FG000|NOT COMPLETED|Overall Study||0
8590681|NCT00296244|9625695|FG000|STARTED|Overall Study||20
8590682|NCT00296244|9625696|FG001|STARTED|Overall Study||20
8590683|NCT00296244|9625695|FG000|COMPLETED|Overall Study||20
8590684|NCT00296244|9625696|FG001|COMPLETED|Overall Study||19
8590685|NCT00296244|9625695|FG000|NOT COMPLETED|Overall Study||0
8590686|NCT00296244|9625696|FG001|NOT COMPLETED|Overall Study||1
8590687|NCT00296296|9625709|FG000|STARTED|Overall Study||11
8590688|NCT00296296|9625710|FG001|STARTED|Overall Study||18
8590689|NCT00296296|9625709|FG000|COMPLETED|Overall Study||9
8590690|NCT00296296|9625710|FG001|COMPLETED|Overall Study||5
8590691|NCT00296296|9625709|FG000|NOT COMPLETED|Overall Study||2
8590692|NCT00296296|9625710|FG001|NOT COMPLETED|Overall Study||13
8590693|NCT00296322|9625718|FG000|STARTED|Overall Study||258
8590694|NCT00296322|9625719|FG001|STARTED|Overall Study||263
8590695|NCT00296322|9625718|FG000|COMPLETED|Overall Study||237
8590696|NCT00296322|9625719|FG001|COMPLETED|Overall Study||184
8590697|NCT00296322|9625718|FG000|NOT COMPLETED|Overall Study||21
8590698|NCT00296322|9625719|FG001|NOT COMPLETED|Overall Study||79
8590699|NCT00296335|9625727|FG000|STARTED|Overall Study||424
8711403|NCT00961662|9757744|FG000|STARTED|Overall Study||57
8590700|NCT00296335|9625728|FG001|STARTED|Overall Study||431
8590701|NCT00296335|9625727|FG000|COMPLETED|Overall Study||394
8590702|NCT00296335|9625728|FG001|COMPLETED|Overall Study||309
8590703|NCT00296335|9625727|FG000|NOT COMPLETED|Overall Study||30
8590704|NCT00296335|9625728|FG001|NOT COMPLETED|Overall Study||122
8590705|NCT00296374|9625739|FG000|STARTED|Overall Study||118
8590706|NCT00296374|9625740|FG001|STARTED|Overall Study||124
8590707|NCT00296374|9625741|FG002|STARTED|Overall Study||111
8590708|NCT00296374|9625739|FG000|COMPLETED|Overall Study||93
8590709|NCT00296374|9625740|FG001|COMPLETED|Overall Study||101
8590710|NCT00296374|9625741|FG002|COMPLETED|Overall Study||82
8590711|NCT00296374|9625739|FG000|NOT COMPLETED|Overall Study||25
8590712|NCT00296374|9625740|FG001|NOT COMPLETED|Overall Study||23
8590713|NCT00296374|9625741|FG002|NOT COMPLETED|Overall Study||29
8590714|NCT00296400|9625758|FG000|STARTED|Overall Study||70
8590715|NCT00296400|9625759|FG001|STARTED|Overall Study||87
8590716|NCT00296400|9625760|FG002|STARTED|Overall Study||80
8590717|NCT00296400|9625758|FG000|COMPLETED|Overall Study||53
8590718|NCT00296400|9625759|FG001|COMPLETED|Overall Study||69
8590719|NCT00296400|9625760|FG002|COMPLETED|Overall Study||67
8590720|NCT00296400|9625758|FG000|NOT COMPLETED|Overall Study||17
8590721|NCT00296400|9625759|FG001|NOT COMPLETED|Overall Study||18
8590722|NCT00296400|9625760|FG002|NOT COMPLETED|Overall Study||13
8590723|NCT00296491|9625775|FG000|STARTED|Overall Study|Please note: Outcome Measures generally conducts analysis of 2 of the 4 Arms at a time.|182
8590724|NCT00296491|9625776|FG001|STARTED|Overall Study||182
8590725|NCT00296491|9625777|FG002|STARTED|Overall Study||180
8590726|NCT00296491|9625778|FG003|STARTED|Overall Study||181
8590727|NCT00296491|9625775|FG000|COMPLETED|Overall Study||140
8590728|NCT00296491|9625776|FG001|COMPLETED|Overall Study||129
8590729|NCT00296491|9625777|FG002|COMPLETED|Overall Study||137
8590730|NCT00296491|9625778|FG003|COMPLETED|Overall Study||138
8590731|NCT00296491|9625775|FG000|NOT COMPLETED|Overall Study||42
8590732|NCT00296491|9625776|FG001|NOT COMPLETED|Overall Study||53
8590733|NCT00296491|9625777|FG002|NOT COMPLETED|Overall Study||43
8590734|NCT00296491|9625778|FG003|NOT COMPLETED|Overall Study||43
8590735|NCT00296504|9625803|FG000|STARTED|Interim Analysis||119
8590736|NCT00296504|9625804|FG001|STARTED|Interim Analysis||18
8590737|NCT00296504|9625805|FG002|STARTED|Interim Analysis||221
8590738|NCT00296504|9625806|FG003|STARTED|Interim Analysis||54
8590739|NCT00296504|9625807|FG004|STARTED|Interim Analysis||73
8590740|NCT00296504|9625808|FG005|STARTED|Interim Analysis||78
8590741|NCT00296504|9625809|FG006|STARTED|Interim Analysis||104
8590742|NCT00296504|9625810|FG007|STARTED|Interim Analysis||86
8590743|NCT00296504|9625811|FG008|STARTED|Interim Analysis||0
8590744|NCT00296504|9625803|FG000|Ongoing|Interim Analysis||32
8590745|NCT00296504|9625804|FG001|Ongoing|Interim Analysis||12
8590746|NCT00296504|9625805|FG002|Ongoing|Interim Analysis||16
8590747|NCT00296504|9625806|FG003|Ongoing|Interim Analysis||22
8590748|NCT00296504|9625807|FG004|Ongoing|Interim Analysis||0
8590749|NCT00296504|9625808|FG005|Ongoing|Interim Analysis||0
8590750|NCT00296504|9625809|FG006|Ongoing|Interim Analysis||30
8590751|NCT00296504|9625810|FG007|Ongoing|Interim Analysis||1
8590752|NCT00296504|9625811|FG008|Ongoing|Interim Analysis||0
8590753|NCT00296504|9625803|FG000|COMPLETED|Interim Analysis||43
8590754|NCT00296504|9625804|FG001|COMPLETED|Interim Analysis||0
8590755|NCT00296504|9625805|FG002|COMPLETED|Interim Analysis||116
8590756|NCT00296504|9625806|FG003|COMPLETED|Interim Analysis||11
8590757|NCT00296504|9625807|FG004|COMPLETED|Interim Analysis||36
8590758|NCT00296504|9625808|FG005|COMPLETED|Interim Analysis||41
8590759|NCT00296504|9625809|FG006|COMPLETED|Interim Analysis||30
8590760|NCT00296504|9625810|FG007|COMPLETED|Interim Analysis||37
8590761|NCT00296504|9625811|FG008|COMPLETED|Interim Analysis||0
8590762|NCT00296504|9625803|FG000|NOT COMPLETED|Interim Analysis||76
8590763|NCT00296504|9625804|FG001|NOT COMPLETED|Interim Analysis||18
8590764|NCT00296504|9625805|FG002|NOT COMPLETED|Interim Analysis||105
8590765|NCT00296504|9625806|FG003|NOT COMPLETED|Interim Analysis||43
8590766|NCT00296504|9625807|FG004|NOT COMPLETED|Interim Analysis||37
8590767|NCT00296504|9625808|FG005|NOT COMPLETED|Interim Analysis||37
8590768|NCT00296504|9625809|FG006|NOT COMPLETED|Interim Analysis||74
8590769|NCT00296504|9625810|FG007|NOT COMPLETED|Interim Analysis||49
8590770|NCT00296504|9625811|FG008|NOT COMPLETED|Interim Analysis||0
8590771|NCT00296504|9625803|FG000|STARTED|Final Analysis||0
8590772|NCT00296504|9625804|FG001|STARTED|Final Analysis||0
8590773|NCT00296504|9625805|FG002|STARTED|Final Analysis||0
8590774|NCT00296504|9625806|FG003|STARTED|Final Analysis||0
8590775|NCT00296504|9625807|FG004|STARTED|Final Analysis||0
8590776|NCT00296504|9625808|FG005|STARTED|Final Analysis||0
8590777|NCT00296504|9625809|FG006|STARTED|Final Analysis||0
8590778|NCT00296504|9625810|FG007|STARTED|Final Analysis||0
8590779|NCT00296504|9625811|FG008|STARTED|Final Analysis|Continued in study; commercial supplies of FPV were unavailable locally at end of Interim Analysis.|111
8590780|NCT00296504|9625803|FG000|COMPLETED|Final Analysis||0
8590781|NCT00296504|9625804|FG001|COMPLETED|Final Analysis||0
8590782|NCT00296504|9625805|FG002|COMPLETED|Final Analysis||0
8590783|NCT00296504|9625806|FG003|COMPLETED|Final Analysis||0
8590784|NCT00296504|9625807|FG004|COMPLETED|Final Analysis||0
8590785|NCT00296504|9625808|FG005|COMPLETED|Final Analysis||0
8590786|NCT00296504|9625809|FG006|COMPLETED|Final Analysis||0
8590787|NCT00296504|9625810|FG007|COMPLETED|Final Analysis||0
8590788|NCT00296504|9625811|FG008|COMPLETED|Final Analysis||90
8590789|NCT00296504|9625803|FG000|NOT COMPLETED|Final Analysis||0
8590790|NCT00296504|9625804|FG001|NOT COMPLETED|Final Analysis||0
8590791|NCT00296504|9625805|FG002|NOT COMPLETED|Final Analysis||0
8590792|NCT00296504|9625806|FG003|NOT COMPLETED|Final Analysis||0
8590793|NCT00296504|9625807|FG004|NOT COMPLETED|Final Analysis||0
8590794|NCT00296504|9625808|FG005|NOT COMPLETED|Final Analysis||0
8590795|NCT00296504|9625809|FG006|NOT COMPLETED|Final Analysis||0
8590796|NCT00296504|9625810|FG007|NOT COMPLETED|Final Analysis||0
8590797|NCT00296504|9625811|FG008|NOT COMPLETED|Final Analysis||21
8590798|NCT00296517|9625838|FG000|STARTED|Dose Level 1 - Week 1||159
8590799|NCT00296517|9625839|FG001|STARTED|Dose Level 1 - Week 1||166
8590800|NCT00296517|9625838|FG000|COMPLETED|Dose Level 1 - Week 1||159
8590801|NCT00296517|9625839|FG001|COMPLETED|Dose Level 1 - Week 1||166
8590802|NCT00296517|9625838|FG000|NOT COMPLETED|Dose Level 1 - Week 1||0
8590803|NCT00296517|9625839|FG001|NOT COMPLETED|Dose Level 1 - Week 1||0
8590804|NCT00296517|9625838|FG000|STARTED|Dose Level 2 - Week 2||159
8590805|NCT00296517|9625839|FG001|STARTED|Dose Level 2 - Week 2||166
8590806|NCT00296517|9625838|FG000|COMPLETED|Dose Level 2 - Week 2||157
8590807|NCT00296517|9625839|FG001|COMPLETED|Dose Level 2 - Week 2||161
8590808|NCT00296517|9625838|FG000|NOT COMPLETED|Dose Level 2 - Week 2||2
8590809|NCT00296517|9625839|FG001|NOT COMPLETED|Dose Level 2 - Week 2||5
8590810|NCT00296517|9625838|FG000|STARTED|Dose Level 3 - Weeks 3-12||157
8590811|NCT00296517|9625839|FG001|STARTED|Dose Level 3 - Weeks 3-12||161
8590812|NCT00296517|9625838|FG000|COMPLETED|Dose Level 3 - Weeks 3-12||112
8590813|NCT00296517|9625839|FG001|COMPLETED|Dose Level 3 - Weeks 3-12||99
8590814|NCT00296517|9625838|FG000|NOT COMPLETED|Dose Level 3 - Weeks 3-12||45
8590815|NCT00296517|9625839|FG001|NOT COMPLETED|Dose Level 3 - Weeks 3-12||62
8590816|NCT00296647|9625850|FG000|STARTED|Overall Study||282
8590817|NCT00296647|9625851|FG001|STARTED|Overall Study||261
8590818|NCT00296647|9625852|FG002|STARTED|Overall Study||256
8590819|NCT00296647|9625853|FG003|STARTED|Overall Study||279
8590820|NCT00296647|9625854|FG004|STARTED|Overall Study||268
8590821|NCT00296647|9625850|FG000|COMPLETED|Overall Study||250
8590822|NCT00296647|9625851|FG001|COMPLETED|Overall Study||233
8590823|NCT00296647|9625852|FG002|COMPLETED|Overall Study||222
8590824|NCT00296647|9625853|FG003|COMPLETED|Overall Study||262
8590825|NCT00296647|9625854|FG004|COMPLETED|Overall Study||248
8590826|NCT00296647|9625850|FG000|NOT COMPLETED|Overall Study||32
8590827|NCT00296647|9625851|FG001|NOT COMPLETED|Overall Study||28
8590828|NCT00296647|9625852|FG002|NOT COMPLETED|Overall Study||34
8590829|NCT00296647|9625853|FG003|NOT COMPLETED|Overall Study||17
8590830|NCT00296647|9625854|FG004|NOT COMPLETED|Overall Study||20
8590831|NCT00296725|9625866|FG000|STARTED|Phase 1: Fluoxetine (1-12 Weeks)||17
8590832|NCT00296725|9625866|FG000|COMPLETED|Phase 1: Fluoxetine (1-12 Weeks)||12
8590833|NCT00296725|9625866|FG000|NOT COMPLETED|Phase 1: Fluoxetine (1-12 Weeks)||5
8590834|NCT00296725|9625866|FG000|STARTED|Phase 2: Imipramine (1-6 Weeks)||8
8590835|NCT00296725|9625866|FG000|COMPLETED|Phase 2: Imipramine (1-6 Weeks)||7
8590836|NCT00296725|9625866|FG000|NOT COMPLETED|Phase 2: Imipramine (1-6 Weeks)||1
8590837|NCT00296816|9625874|FG000|STARTED|Overall Study||132
8590838|NCT00296816|9625874|FG000|COMPLETED|Overall Study|Completed study treatment for a minimum of three years|58
8590839|NCT00296816|9625874|FG000|NOT COMPLETED|Overall Study||74
8590840|NCT00297037|9625880|FG000|STARTED|Overall Study||10
8590841|NCT00297037|9625881|FG001|STARTED|Overall Study||11
8590842|NCT00297037|9625880|FG000|COMPLETED|Overall Study||8
8590843|NCT00297037|9625881|FG001|COMPLETED|Overall Study||11
8590844|NCT00297037|9625880|FG000|NOT COMPLETED|Overall Study||2
8590845|NCT00297037|9625881|FG001|NOT COMPLETED|Overall Study||0
8627982|NCT00520403|9667356|FG000|STARTED|Bevacizumab Monotherapy|2 of 7 participants completing Bevacizumab+IFN/vinblastine cycles initiated bevacizumab monotherapy|2
8627983|NCT00520403|9667356|FG000|COMPLETED|Bevacizumab Monotherapy||0
8627984|NCT00520403|9667356|FG000|NOT COMPLETED|Bevacizumab Monotherapy||2
8627985|NCT00520468|9667360|FG000|STARTED|Overall Study||14
8627986|NCT00520468|9667360|FG000|COMPLETED|Overall Study||14
8627987|NCT00520468|9667360|FG000|NOT COMPLETED|Overall Study||0
8627988|NCT00520481|9667366|FG000|STARTED|Overall Study||31
8627989|NCT00520481|9667367|FG001|STARTED|Overall Study||10
8627990|NCT00520481|9667366|FG000|Received at Least 1 Dose of Study Drug|Overall Study||31
8627991|NCT00520481|9667367|FG001|Received at Least 1 Dose of Study Drug|Overall Study||10
8711404|NCT00961662|9757745|FG001|STARTED|Overall Study||51
8711405|NCT00961662|9757746|FG002|STARTED|Overall Study||53
8627992|NCT00520481|9667366|FG000|COMPLETED|Overall Study||24
8627993|NCT00520481|9667367|FG001|COMPLETED|Overall Study||9
8627994|NCT00520481|9667366|FG000|NOT COMPLETED|Overall Study||7
8627995|NCT00520481|9667367|FG001|NOT COMPLETED|Overall Study||1
8627996|NCT00520494|9667375|FG000|STARTED|Overall Study||18
8627997|NCT00520494|9667375|FG000|COMPLETED|Overall Study||17
8627998|NCT00520494|9667375|FG000|NOT COMPLETED|Overall Study||1
8627999|NCT00520533|9667379|FG000|STARTED|Overall Study||8
8628000|NCT00520533|9667379|FG000|COMPLETED|Overall Study||4
8628001|NCT00520533|9667379|FG000|NOT COMPLETED|Overall Study||4
8628002|NCT00520546|9667384|FG000|STARTED|Overall Study||44
8628003|NCT00520546|9667384|FG000|COMPLETED|Overall Study||38
8628004|NCT00520546|9667384|FG000|NOT COMPLETED|Overall Study||6
8628005|NCT00520572|9667399|FG000|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|64
8628006|NCT00520572|9667400|FG001|STARTED|Overall Study|Participants randomised.|64
8628007|NCT00520572|9667401|FG002|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|64
8628008|NCT00520572|9667402|FG003|STARTED|Overall Study|Participants randomised.|64
8628009|NCT00520572|9667403|FG004|STARTED|Overall Study|Participants randomised.|65
8628010|NCT00520572|9667404|FG005|STARTED|Overall Study|Participants randomised.|64
8628011|NCT00520572|9667399|FG000|COMPLETED|Overall Study|Participants completed the study.|52
8629570|NCT00530920|9669338|FG000|NOT COMPLETED|Overall Study||0
8590846|NCT00297102|9625891|FG000|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|765
8590847|NCT00297102|9625892|FG001|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|758
8590848|NCT00297102|9625891|FG000|COMPLETED|Overall Study||502
8590849|NCT00297102|9625892|FG001|COMPLETED|Overall Study||525
8590850|NCT00297102|9625891|FG000|NOT COMPLETED|Overall Study||263
8711406|NCT00961662|9757744|FG000|COMPLETED|Overall Study||35
8711407|NCT00961662|9757745|FG001|COMPLETED|Overall Study||32
8711408|NCT00961662|9757746|FG002|COMPLETED|Overall Study||34
8711409|NCT00961662|9757744|FG000|NOT COMPLETED|Overall Study||22
8711410|NCT00961662|9757745|FG001|NOT COMPLETED|Overall Study||19
8590851|NCT00297102|9625892|FG001|NOT COMPLETED|Overall Study||233
8590852|NCT00297115|9625900|FG000|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|772
8590853|NCT00297115|9625901|FG001|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|796
8590854|NCT00297115|9625900|FG000|COMPLETED|Overall Study||527
8590855|NCT00297115|9625901|FG001|COMPLETED|Overall Study||550
8590856|NCT00297115|9625900|FG000|NOT COMPLETED|Overall Study||245
8590857|NCT00297115|9625901|FG001|NOT COMPLETED|Overall Study||246
8590858|NCT00297167|9625907|FG000|STARTED|First Double-blind Intervention Period||17
8590859|NCT00297167|9625908|FG001|STARTED|First Double-blind Intervention Period||16
8590860|NCT00297167|9625909|FG002|STARTED|First Double-blind Intervention Period||0
8590861|NCT00297167|9625907|FG000|COMPLETED|First Double-blind Intervention Period||17
8590862|NCT00297167|9625908|FG001|COMPLETED|First Double-blind Intervention Period||16
8590863|NCT00297167|9625909|FG002|COMPLETED|First Double-blind Intervention Period||0
8590864|NCT00297167|9625907|FG000|NOT COMPLETED|First Double-blind Intervention Period||0
8590865|NCT00297167|9625908|FG001|NOT COMPLETED|First Double-blind Intervention Period||0
8590866|NCT00297167|9625909|FG002|NOT COMPLETED|First Double-blind Intervention Period||0
8590867|NCT00297167|9625907|FG000|STARTED|Open-label Dose Normalization Period 1||0
8590868|NCT00297167|9625908|FG001|STARTED|Open-label Dose Normalization Period 1||0
8590869|NCT00297167|9625909|FG002|STARTED|Open-label Dose Normalization Period 1||33
8590870|NCT00297167|9625907|FG000|COMPLETED|Open-label Dose Normalization Period 1||0
8590871|NCT00297167|9625908|FG001|COMPLETED|Open-label Dose Normalization Period 1||0
8590872|NCT00297167|9625909|FG002|COMPLETED|Open-label Dose Normalization Period 1||32
8590873|NCT00297167|9625907|FG000|NOT COMPLETED|Open-label Dose Normalization Period 1||0
8590874|NCT00297167|9625908|FG001|NOT COMPLETED|Open-label Dose Normalization Period 1||0
8590875|NCT00297167|9625909|FG002|NOT COMPLETED|Open-label Dose Normalization Period 1||1
8711411|NCT00961662|9757746|FG002|NOT COMPLETED|Overall Study||19
8711412|NCT00961896|9757757|FG000|STARTED|Overall Study||8
8711413|NCT00961896|9757758|FG001|STARTED|Overall Study||3
8711414|NCT00961896|9757759|FG002|STARTED|Overall Study||7
8711415|NCT00961896|9757757|FG000|COMPLETED|Overall Study||8
8711416|NCT00961896|9757758|FG001|COMPLETED|Overall Study||3
8711417|NCT00961896|9757759|FG002|COMPLETED|Overall Study||6
8711418|NCT00961896|9757757|FG000|NOT COMPLETED|Overall Study||0
8711419|NCT00961896|9757758|FG001|NOT COMPLETED|Overall Study||0
8711420|NCT00961896|9757759|FG002|NOT COMPLETED|Overall Study||1
8711421|NCT00961961|9757774|FG000|STARTED|Phase I||177
8711422|NCT00961961|9757775|FG001|STARTED|Phase I||0
8711423|NCT00961961|9757776|FG002|STARTED|Phase I||0
8711424|NCT00961961|9757777|FG003|STARTED|Phase I||0
8711425|NCT00961961|9757774|FG000|COMPLETED|Phase I||51
8711426|NCT00961961|9757775|FG001|COMPLETED|Phase I||0
8590876|NCT00297167|9625907|FG000|STARTED|Second Double-blind Intervention Period||17
8590877|NCT00297167|9625908|FG001|STARTED|Second Double-blind Intervention Period||15
8590878|NCT00297167|9625909|FG002|STARTED|Second Double-blind Intervention Period||0
8590879|NCT00297167|9625907|FG000|COMPLETED|Second Double-blind Intervention Period||16
8590880|NCT00297167|9625908|FG001|COMPLETED|Second Double-blind Intervention Period||15
8590881|NCT00297167|9625909|FG002|COMPLETED|Second Double-blind Intervention Period||0
8590882|NCT00297167|9625907|FG000|NOT COMPLETED|Second Double-blind Intervention Period||1
8590883|NCT00297167|9625908|FG001|NOT COMPLETED|Second Double-blind Intervention Period||0
8590884|NCT00297167|9625909|FG002|NOT COMPLETED|Second Double-blind Intervention Period||0
8590885|NCT00297167|9625907|FG000|STARTED|Open-label Dose Normalization Period 2||0
8590886|NCT00297167|9625908|FG001|STARTED|Open-label Dose Normalization Period 2||0
8590887|NCT00297167|9625909|FG002|STARTED|Open-label Dose Normalization Period 2||31
8590888|NCT00297167|9625907|FG000|COMPLETED|Open-label Dose Normalization Period 2||0
8590889|NCT00297167|9625908|FG001|COMPLETED|Open-label Dose Normalization Period 2||0
8590890|NCT00297167|9625909|FG002|COMPLETED|Open-label Dose Normalization Period 2||31
8590891|NCT00297167|9625907|FG000|NOT COMPLETED|Open-label Dose Normalization Period 2||0
8590892|NCT00297167|9625908|FG001|NOT COMPLETED|Open-label Dose Normalization Period 2||0
8711427|NCT00961961|9757776|FG002|COMPLETED|Phase I||0
8711428|NCT00961961|9757777|FG003|COMPLETED|Phase I||0
8711429|NCT00961961|9757774|FG000|NOT COMPLETED|Phase I||126
8711430|NCT00961961|9757775|FG001|NOT COMPLETED|Phase I||0
8711431|NCT00961961|9757776|FG002|NOT COMPLETED|Phase I||0
8711432|NCT00961961|9757777|FG003|NOT COMPLETED|Phase I||0
8711433|NCT00961961|9757774|FG000|STARTED|Phase II|This is a Phase I category. Not relevant in Phase II.|0
8711434|NCT00961961|9757775|FG001|STARTED|Phase II|This is a Phase I category. Not relevant in Phase II.|0
8711435|NCT00961961|9757776|FG002|STARTED|Phase II||29
8711436|NCT00961961|9757777|FG003|STARTED|Phase II||22
8711437|NCT00961961|9757774|FG000|COMPLETED|Phase II||0
8711438|NCT00961961|9757775|FG001|COMPLETED|Phase II||0
8590893|NCT00297167|9625909|FG002|NOT COMPLETED|Open-label Dose Normalization Period 2||0
8590894|NCT00297232|9625916|FG000|STARTED|Overall Study||1094
8590895|NCT00297232|9625916|FG000|COMPLETED|Overall Study||489
8590896|NCT00297232|9625916|FG000|NOT COMPLETED|Overall Study||605
8590897|NCT00297258|9625920|FG000|STARTED|Overall Study||142
8590898|NCT00297258|9625920|FG000|COMPLETED|Overall Study||0
8590899|NCT00297258|9625920|FG000|NOT COMPLETED|Overall Study||142
8590900|NCT00297427|9625929|FG000|STARTED|Phase 1: Initial Intervention|Intention-to-treat analysis; all randomized subjects were included in analysis|64
8590901|NCT00297427|9625930|FG001|STARTED|Phase 1: Initial Intervention|Intention-to-treat analysis; all randomized subjects were included in analysis|63
8590902|NCT00297427|9625929|FG000|COMPLETED|Phase 1: Initial Intervention||56
8590903|NCT00297427|9625930|FG001|COMPLETED|Phase 1: Initial Intervention||54
8590904|NCT00297427|9625929|FG000|NOT COMPLETED|Phase 1: Initial Intervention||8
8590905|NCT00297427|9625930|FG001|NOT COMPLETED|Phase 1: Initial Intervention||9
8590906|NCT00297427|9625929|FG000|STARTED|Phase 2: Optional Crossover for Sham||54
8590907|NCT00297427|9625930|FG001|STARTED|Phase 2: Optional Crossover for Sham|There was no cross-over to sham acupuncture as this was a wait list control design|0
8590908|NCT00297427|9625929|FG000|Crossed Over to True Acupuncture|Phase 2: Optional Crossover for Sham|54 subjects completed the sham acupuncture & were offered the opportunity to cross-over; 12 declined|42
8590909|NCT00297427|9625930|FG001|Crossed Over to True Acupuncture|Phase 2: Optional Crossover for Sham|There was no cross-over to sham acupuncture as this was a wait list control design|0
8590910|NCT00297427|9625929|FG000|COMPLETED|Phase 2: Optional Crossover for Sham||38
8590911|NCT00297427|9625930|FG001|COMPLETED|Phase 2: Optional Crossover for Sham|There was no cross-over to sham acupuncture as this was a wait list control design|0
8590912|NCT00297427|9625929|FG000|NOT COMPLETED|Phase 2: Optional Crossover for Sham||16
8590913|NCT00297427|9625930|FG001|NOT COMPLETED|Phase 2: Optional Crossover for Sham||0
8590914|NCT00297427|9625929|FG000|STARTED|Phase 3: Follow-up Post-True Acupuncture||94
8590915|NCT00297427|9625930|FG001|STARTED|Phase 3: Follow-up Post-True Acupuncture|Only subjects who received true acupuncture initially or after cross-over entered follow-up|0
8590916|NCT00297427|9625929|FG000|COMPLETED|Phase 3: Follow-up Post-True Acupuncture|Subjects who completed=/>1 follow-up visits and were evaluated for booster acupuncture|60
8590917|NCT00297427|9625930|FG001|COMPLETED|Phase 3: Follow-up Post-True Acupuncture|Only subjects who received true acupuncture initially or after cross-over entered follow-up|0
8590918|NCT00297427|9625929|FG000|NOT COMPLETED|Phase 3: Follow-up Post-True Acupuncture||34
8590919|NCT00297427|9625930|FG001|NOT COMPLETED|Phase 3: Follow-up Post-True Acupuncture||0
8590920|NCT00297479|9625947|FG000|STARTED|Overall Study||103
8590921|NCT00297479|9625948|FG001|STARTED|Overall Study||155
8590922|NCT00297479|9625949|FG002|STARTED|Overall Study||154
8590923|NCT00297479|9625947|FG000|4-Week Follow Up|Overall Study||78
8590924|NCT00297479|9625948|FG001|4-Week Follow Up|Overall Study||132
8590925|NCT00297479|9625949|FG002|4-Week Follow Up|Overall Study||128
8590926|NCT00297479|9625947|FG000|26- Week Follow Up|Overall Study||66
8590927|NCT00297479|9625948|FG001|26- Week Follow Up|Overall Study||101
8590928|NCT00297479|9625949|FG002|26- Week Follow Up|Overall Study||103
8590929|NCT00297479|9625947|FG000|COMPLETED|Overall Study||66
8590930|NCT00297479|9625948|FG001|COMPLETED|Overall Study||101
8590931|NCT00297479|9625949|FG002|COMPLETED|Overall Study||103
8590932|NCT00297479|9625947|FG000|NOT COMPLETED|Overall Study||37
8590933|NCT00297479|9625948|FG001|NOT COMPLETED|Overall Study||54
8590934|NCT00297479|9625949|FG002|NOT COMPLETED|Overall Study||51
8590935|NCT00297492|9625960|FG000|STARTED|Set Quit Date||297
8590936|NCT00297492|9625961|FG001|STARTED|Set Quit Date||299
8590937|NCT00297492|9625962|FG002|STARTED|Set Quit Date||150
8590938|NCT00297492|9625960|FG000|COMPLETED|Set Quit Date||290
8590939|NCT00297492|9625961|FG001|COMPLETED|Set Quit Date||286
8590940|NCT00297492|9625962|FG002|COMPLETED|Set Quit Date||145
8590941|NCT00297492|9625960|FG000|NOT COMPLETED|Set Quit Date||7
8590942|NCT00297492|9625961|FG001|NOT COMPLETED|Set Quit Date||13
8590943|NCT00297492|9625962|FG002|NOT COMPLETED|Set Quit Date||5
8590944|NCT00297492|9625960|FG000|STARTED|6 Month Follow-up||290
8590945|NCT00297492|9625961|FG001|STARTED|6 Month Follow-up||286
8590946|NCT00297492|9625962|FG002|STARTED|6 Month Follow-up||145
8590947|NCT00297492|9625960|FG000|COMPLETED|6 Month Follow-up||227
8590948|NCT00297492|9625961|FG001|COMPLETED|6 Month Follow-up||237
8590949|NCT00297492|9625962|FG002|COMPLETED|6 Month Follow-up||118
8590950|NCT00297492|9625960|FG000|NOT COMPLETED|6 Month Follow-up||63
8590951|NCT00297492|9625961|FG001|NOT COMPLETED|6 Month Follow-up||49
8590952|NCT00297492|9625962|FG002|NOT COMPLETED|6 Month Follow-up||27
8590953|NCT00297596|9625970|FG000|STARTED|Overall Study||25
8590954|NCT00297596|9625970|FG000|COMPLETED|Overall Study||25
8590955|NCT00297596|9625970|FG000|NOT COMPLETED|Overall Study||0
8590956|NCT00297648|9625974|FG000|STARTED|Overall Study||89
8590957|NCT00297648|9625974|FG000|COMPLETED|Overall Study||53
8590958|NCT00297648|9625974|FG000|NOT COMPLETED|Overall Study||36
8590959|NCT00297778|9625980|FG000|STARTED|Overall Study||152
8590960|NCT00297778|9625981|FG001|STARTED|Overall Study||144
8590961|NCT00297778|9625980|FG000|COMPLETED|Overall Study||133
8590962|NCT00297778|9625981|FG001|COMPLETED|Overall Study||124
8590963|NCT00297778|9625980|FG000|NOT COMPLETED|Overall Study||19
8590964|NCT00297778|9625981|FG001|NOT COMPLETED|Overall Study||20
8590965|NCT00297830|9625990|FG000|STARTED|Baseline||41
8590966|NCT00297830|9625991|FG001|STARTED|Baseline||43
8590967|NCT00297830|9625992|FG002|STARTED|Baseline||27
8590968|NCT00297830|9625990|FG000|COMPLETED|Baseline||41
8590969|NCT00297830|9625991|FG001|COMPLETED|Baseline||43
8590970|NCT00297830|9625992|FG002|COMPLETED|Baseline||27
8590971|NCT00297830|9625990|FG000|NOT COMPLETED|Baseline||0
8590972|NCT00297830|9625991|FG001|NOT COMPLETED|Baseline||0
8590973|NCT00297830|9625992|FG002|NOT COMPLETED|Baseline||0
8590974|NCT00297830|9625990|FG000|STARTED|6 Month Visit||41
8590975|NCT00297830|9625991|FG001|STARTED|6 Month Visit||43
8590976|NCT00297830|9625992|FG002|STARTED|6 Month Visit||27
8590977|NCT00297830|9625990|FG000|COMPLETED|6 Month Visit||38
8590978|NCT00297830|9625991|FG001|COMPLETED|6 Month Visit||41
8590979|NCT00297830|9625992|FG002|COMPLETED|6 Month Visit||24
8590980|NCT00297830|9625990|FG000|NOT COMPLETED|6 Month Visit||3
8590981|NCT00297830|9625991|FG001|NOT COMPLETED|6 Month Visit||2
8590982|NCT00297830|9625992|FG002|NOT COMPLETED|6 Month Visit||3
8590983|NCT00297830|9625990|FG000|STARTED|12 Month Visit||38
8590984|NCT00297830|9625991|FG001|STARTED|12 Month Visit||41
8590985|NCT00297830|9625992|FG002|STARTED|12 Month Visit||24
8590986|NCT00297830|9625990|FG000|COMPLETED|12 Month Visit||37
8590987|NCT00297830|9625991|FG001|COMPLETED|12 Month Visit||35
8590988|NCT00297830|9625992|FG002|COMPLETED|12 Month Visit||24
8590989|NCT00297830|9625990|FG000|NOT COMPLETED|12 Month Visit||1
8590990|NCT00297830|9625991|FG001|NOT COMPLETED|12 Month Visit||6
8590991|NCT00297830|9625992|FG002|NOT COMPLETED|12 Month Visit||0
8590992|NCT00297882|9626002|FG000|STARTED|Day 14||204
8590993|NCT00297882|9626003|FG001|STARTED|Day 14||612
8590994|NCT00297882|9626002|FG000|COMPLETED|Day 14||192
8590995|NCT00297882|9626003|FG001|COMPLETED|Day 14||563
8590996|NCT00297882|9626002|FG000|NOT COMPLETED|Day 14||12
8590997|NCT00297882|9626003|FG001|NOT COMPLETED|Day 14||49
8590998|NCT00297882|9626002|FG000|STARTED|Day 28||192
8590999|NCT00297882|9626003|FG001|STARTED|Day 28||563
8591000|NCT00297882|9626002|FG000|COMPLETED|Day 28||176
8591001|NCT00297882|9626003|FG001|COMPLETED|Day 28||540
8591002|NCT00297882|9626002|FG000|NOT COMPLETED|Day 28||16
8591003|NCT00297882|9626003|FG001|NOT COMPLETED|Day 28||23
8591004|NCT00298038|9626013|FG000|STARTED|Overall Study||140
8591005|NCT00298038|9626014|FG001|STARTED|Overall Study||159
8591006|NCT00298038|9626013|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||140
8591007|NCT00298038|9626014|FG001|Received At Least 1 Dose Of Study Drug|Overall Study||159
8591008|NCT00298038|9626013|FG000|COMPLETED|Overall Study||88
8591009|NCT00298038|9626014|FG001|COMPLETED|Overall Study||66
8591010|NCT00298038|9626013|FG000|NOT COMPLETED|Overall Study||52
8591011|NCT00298038|9626014|FG001|NOT COMPLETED|Overall Study||93
8591012|NCT00298090|9626020|FG000|STARTED|Overall Study||47
8591013|NCT00298090|9626020|FG000|COMPLETED|Overall Study|Eighteen subjects were not included in final analysis due to incomplete data sets|29
8591014|NCT00298090|9626020|FG000|NOT COMPLETED|Overall Study||18
8591015|NCT00298155|9626027|FG000|STARTED|Overall Study||12
8591016|NCT00298155|9626028|FG001|STARTED|Overall Study||10
8591017|NCT00298155|9626029|FG002|STARTED|Overall Study||13
8591018|NCT00298155|9626027|FG000|COMPLETED|Overall Study||12
8591019|NCT00298155|9626028|FG001|COMPLETED|Overall Study||10
8591020|NCT00298155|9626029|FG002|COMPLETED|Overall Study||13
8591021|NCT00298155|9626027|FG000|NOT COMPLETED|Overall Study||0
8591022|NCT00298155|9626028|FG001|NOT COMPLETED|Overall Study||0
8591023|NCT00298155|9626029|FG002|NOT COMPLETED|Overall Study||0
8591024|NCT00298233|9626039|FG000|STARTED|Overall Study||39
8591025|NCT00298233|9626040|FG001|STARTED|Overall Study||41
8591026|NCT00298233|9626041|FG002|STARTED|Overall Study||122
8591027|NCT00298233|9626042|FG003|STARTED|Overall Study||124
8591028|NCT00298233|9626039|FG000|COMPLETED|Overall Study||39
8591029|NCT00298233|9626040|FG001|COMPLETED|Overall Study||41
8591030|NCT00298233|9626041|FG002|COMPLETED|Overall Study||122
8591031|NCT00298233|9626042|FG003|COMPLETED|Overall Study||124
8591032|NCT00298233|9626039|FG000|NOT COMPLETED|Overall Study||0
8591033|NCT00298233|9626040|FG001|NOT COMPLETED|Overall Study||0
8591034|NCT00298233|9626041|FG002|NOT COMPLETED|Overall Study||0
8591035|NCT00298233|9626042|FG003|NOT COMPLETED|Overall Study||0
8591036|NCT00298272|9626050|FG000|STARTED|Double-blind Phase|enrolled and randomized (2:1 scheme)|36
8591037|NCT00298272|9626051|FG001|STARTED|Double-blind Phase||18
8591038|NCT00298272|9626050|FG000|Safety Population|Double-blind Phase|received treatment|33
8591039|NCT00298272|9626051|FG001|Safety Population|Double-blind Phase||18
8591040|NCT00298272|9626050|FG000|Completed to Week 24|Double-blind Phase|received full course of rituximab therapy|31
8591041|NCT00298272|9626051|FG001|Completed to Week 24|Double-blind Phase|received full course of placebo therapy|18
8591042|NCT00298272|9626050|FG000|Completed to Week 56|Double-blind Phase||8
8591043|NCT00298272|9626051|FG001|Completed to Week 56|Double-blind Phase||3
8591044|NCT00298272|9626050|FG000|COMPLETED|Double-blind Phase||28
8591045|NCT00298272|9626051|FG001|COMPLETED|Double-blind Phase||18
8591046|NCT00298272|9626050|FG000|NOT COMPLETED|Double-blind Phase||8
8591047|NCT00298272|9626051|FG001|NOT COMPLETED|Double-blind Phase||0
8591048|NCT00298272|9626050|FG000|STARTED|Open Label Retreatment Phase||22
8591049|NCT00298272|9626051|FG001|STARTED|Open Label Retreatment Phase||16
8591050|NCT00298272|9626050|FG000|Completed to Week 24|Open Label Retreatment Phase|received full course of open-label rituximab therapy|22
8591051|NCT00298272|9626051|FG001|Completed to Week 24|Open Label Retreatment Phase|received full course of open-label rituximab therapy|15
8591052|NCT00298272|9626050|FG000|Completed to Week 56|Open Label Retreatment Phase||13
8591053|NCT00298272|9626051|FG001|Completed to Week 56|Open Label Retreatment Phase||12
8591054|NCT00298272|9626050|FG000|COMPLETED|Open Label Retreatment Phase||13
8591055|NCT00298272|9626051|FG001|COMPLETED|Open Label Retreatment Phase||12
8591056|NCT00298272|9626050|FG000|NOT COMPLETED|Open Label Retreatment Phase||9
8591057|NCT00298272|9626051|FG001|NOT COMPLETED|Open Label Retreatment Phase||4
8591058|NCT00298272|9626050|FG000|STARTED|Safety Follow-up Phase||22
8591059|NCT00298272|9626051|FG001|STARTED|Safety Follow-up Phase||17
8591060|NCT00298272|9626050|FG000|COMPLETED|Safety Follow-up Phase||18
8591061|NCT00298272|9626051|FG001|COMPLETED|Safety Follow-up Phase||13
8591062|NCT00298272|9626050|FG000|NOT COMPLETED|Safety Follow-up Phase||4
8591063|NCT00298272|9626051|FG001|NOT COMPLETED|Safety Follow-up Phase||4
8591064|NCT00298363|9626063|FG000|STARTED|Overall Study||45
8591065|NCT00298363|9626064|FG001|STARTED|Overall Study||45
8591066|NCT00298363|9626065|FG002|STARTED|Overall Study||22
8591067|NCT00298363|9626063|FG000|COMPLETED|Overall Study|22 completed while taking DB TDF; 6 completed following switch from DB TDF to OL FTC/TDF.|28
8591068|NCT00298363|9626064|FG001|COMPLETED|Overall Study|34 completed while taking DB FTC/TDF; 3 completed following switch from DB TDF to OL FTC/TDF.|37
8591069|NCT00298363|9626065|FG002|COMPLETED|Overall Study|13 completed while taking DB ETV; 3 completed following switch from DB ETV to OL FTC/TDF.|16
8591070|NCT00298363|9626063|FG000|NOT COMPLETED|Overall Study||17
8591071|NCT00298363|9626064|FG001|NOT COMPLETED|Overall Study||8
8591072|NCT00298363|9626065|FG002|NOT COMPLETED|Overall Study||6
8591073|NCT00298389|9626082|FG000|STARTED|Overall Study||20
8591074|NCT00298389|9626083|FG001|STARTED|Overall Study||17
8591075|NCT00298389|9626084|FG002|STARTED|Overall Study||19
8591076|NCT00298389|9626082|FG000|COMPLETED|Overall Study||20
8591077|NCT00298389|9626083|FG001|COMPLETED|Overall Study||17
8591078|NCT00298389|9626084|FG002|COMPLETED|Overall Study||19
8591079|NCT00298389|9626082|FG000|NOT COMPLETED|Overall Study||0
8591080|NCT00298389|9626083|FG001|NOT COMPLETED|Overall Study||0
8591081|NCT00298389|9626084|FG002|NOT COMPLETED|Overall Study||0
8591082|NCT00298558|9626096|FG000|STARTED|Baseline||711
8591083|NCT00298558|9626097|FG001|STARTED|Baseline||705
8591084|NCT00298558|9626098|FG002|STARTED|Baseline||712
8591085|NCT00298558|9626099|FG003|STARTED|Baseline||704
8591086|NCT00298558|9626096|FG000|COMPLETED|Baseline||711
8591087|NCT00298558|9626097|FG001|COMPLETED|Baseline||705
8591088|NCT00298558|9626098|FG002|COMPLETED|Baseline||712
8591089|NCT00298558|9626099|FG003|COMPLETED|Baseline||704
8591090|NCT00298558|9626096|FG000|NOT COMPLETED|Baseline||0
8591091|NCT00298558|9626097|FG001|NOT COMPLETED|Baseline||0
8591092|NCT00298558|9626098|FG002|NOT COMPLETED|Baseline||0
8591093|NCT00298558|9626099|FG003|NOT COMPLETED|Baseline||0
8591094|NCT00298558|9626096|FG000|STARTED|Intervention||711
8591095|NCT00298558|9626097|FG001|STARTED|Intervention||705
8591096|NCT00298558|9626098|FG002|STARTED|Intervention||712
8591097|NCT00298558|9626099|FG003|STARTED|Intervention||704
8591098|NCT00298558|9626096|FG000|COMPLETED|Intervention||620
8591099|NCT00298558|9626097|FG001|COMPLETED|Intervention||627
8591100|NCT00298558|9626098|FG002|COMPLETED|Intervention||637
8591101|NCT00298558|9626099|FG003|COMPLETED|Intervention||285
8591102|NCT00298558|9626096|FG000|NOT COMPLETED|Intervention||91
8591103|NCT00298558|9626097|FG001|NOT COMPLETED|Intervention||78
8591104|NCT00298558|9626098|FG002|NOT COMPLETED|Intervention||75
8591105|NCT00298558|9626099|FG003|NOT COMPLETED|Intervention||419
8591106|NCT00298558|9626096|FG000|STARTED|Immediate Post Test||711
8591107|NCT00298558|9626097|FG001|STARTED|Immediate Post Test||705
8591108|NCT00298558|9626098|FG002|STARTED|Immediate Post Test||712
8591109|NCT00298558|9626099|FG003|STARTED|Immediate Post Test||704
8591110|NCT00298558|9626096|FG000|COMPLETED|Immediate Post Test||640
8591111|NCT00298558|9626097|FG001|COMPLETED|Immediate Post Test||629
8591112|NCT00298558|9626098|FG002|COMPLETED|Immediate Post Test||653
8591113|NCT00298558|9626099|FG003|COMPLETED|Immediate Post Test||639
8591114|NCT00298558|9626096|FG000|NOT COMPLETED|Immediate Post Test||71
8591115|NCT00298558|9626097|FG001|NOT COMPLETED|Immediate Post Test||76
8591116|NCT00298558|9626098|FG002|NOT COMPLETED|Immediate Post Test||59
8591117|NCT00298558|9626099|FG003|NOT COMPLETED|Immediate Post Test||65
8591118|NCT00298558|9626096|FG000|STARTED|Booster||372
8591119|NCT00298558|9626097|FG001|STARTED|Booster||371
8591120|NCT00298558|9626098|FG002|STARTED|Booster||370
8591121|NCT00298558|9626099|FG003|STARTED|Booster||0
8591122|NCT00298558|9626096|FG000|COMPLETED|Booster||283
8591123|NCT00298558|9626097|FG001|COMPLETED|Booster||301
8591124|NCT00298558|9626098|FG002|COMPLETED|Booster||295
8591125|NCT00298558|9626099|FG003|COMPLETED|Booster||0
8591126|NCT00298558|9626096|FG000|NOT COMPLETED|Booster||89
8591127|NCT00298558|9626097|FG001|NOT COMPLETED|Booster||70
8591128|NCT00298558|9626098|FG002|NOT COMPLETED|Booster||75
8591129|NCT00298558|9626099|FG003|NOT COMPLETED|Booster||0
8591130|NCT00298558|9626096|FG000|STARTED|1st Annual (A1)||640
8591131|NCT00298558|9626097|FG001|STARTED|1st Annual (A1)||629
8591132|NCT00298558|9626098|FG002|STARTED|1st Annual (A1)||653
8591133|NCT00298558|9626099|FG003|STARTED|1st Annual (A1)||639
8591134|NCT00298558|9626096|FG000|COMPLETED|1st Annual (A1)||585
8591135|NCT00298558|9626097|FG001|COMPLETED|1st Annual (A1)||566
8591136|NCT00298558|9626098|FG002|COMPLETED|1st Annual (A1)||601
8591137|NCT00298558|9626099|FG003|COMPLETED|1st Annual (A1)||584
8591138|NCT00298558|9626096|FG000|NOT COMPLETED|1st Annual (A1)||55
8591139|NCT00298558|9626097|FG001|NOT COMPLETED|1st Annual (A1)||63
8591140|NCT00298558|9626098|FG002|NOT COMPLETED|1st Annual (A1)||52
8591141|NCT00298558|9626099|FG003|NOT COMPLETED|1st Annual (A1)||55
8591142|NCT00298558|9626096|FG000|STARTED|2nd Annual (A2)||585
8591143|NCT00298558|9626097|FG001|STARTED|2nd Annual (A2)||566
8591144|NCT00298558|9626098|FG002|STARTED|2nd Annual (A2)||601
8591145|NCT00298558|9626099|FG003|STARTED|2nd Annual (A2)||584
8591146|NCT00298558|9626096|FG000|COMPLETED|2nd Annual (A2)||563
8591147|NCT00298558|9626097|FG001|COMPLETED|2nd Annual (A2)||555
8591148|NCT00298558|9626098|FG002|COMPLETED|2nd Annual (A2)||574
8591149|NCT00298558|9626099|FG003|COMPLETED|2nd Annual (A2)||552
8591150|NCT00298558|9626096|FG000|NOT COMPLETED|2nd Annual (A2)||22
8591151|NCT00298558|9626097|FG001|NOT COMPLETED|2nd Annual (A2)||11
8591152|NCT00298558|9626098|FG002|NOT COMPLETED|2nd Annual (A2)||27
8591153|NCT00298558|9626099|FG003|NOT COMPLETED|2nd Annual (A2)||32
8591154|NCT00298558|9626096|FG000|STARTED|3rd Annual Booster||372
8591155|NCT00298558|9626097|FG001|STARTED|3rd Annual Booster||371
8591156|NCT00298558|9626098|FG002|STARTED|3rd Annual Booster||370
8591157|NCT00298558|9626099|FG003|STARTED|3rd Annual Booster||0
8591158|NCT00298558|9626096|FG000|COMPLETED|3rd Annual Booster||250
8591159|NCT00298558|9626097|FG001|COMPLETED|3rd Annual Booster||243
8591160|NCT00298558|9626098|FG002|COMPLETED|3rd Annual Booster||230
8591161|NCT00298558|9626099|FG003|COMPLETED|3rd Annual Booster||0
8591162|NCT00298558|9626096|FG000|NOT COMPLETED|3rd Annual Booster||122
8591163|NCT00298558|9626097|FG001|NOT COMPLETED|3rd Annual Booster||128
8591164|NCT00298558|9626098|FG002|NOT COMPLETED|3rd Annual Booster||140
8591165|NCT00298558|9626099|FG003|NOT COMPLETED|3rd Annual Booster||0
8591166|NCT00298558|9626096|FG000|STARTED|3rd Annual (A3) and 5th Annual (A5)||563
8591167|NCT00298558|9626097|FG001|STARTED|3rd Annual (A3) and 5th Annual (A5)||555
8591168|NCT00298558|9626098|FG002|STARTED|3rd Annual (A3) and 5th Annual (A5)||574
8591169|NCT00298558|9626099|FG003|STARTED|3rd Annual (A3) and 5th Annual (A5)||552
8591170|NCT00298558|9626096|FG000|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||472
8591171|NCT00298558|9626097|FG001|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||469
8591172|NCT00298558|9626098|FG002|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||490
8591173|NCT00298558|9626099|FG003|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||448
8591174|NCT00298558|9626096|FG000|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||91
8591175|NCT00298558|9626097|FG001|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||86
8591176|NCT00298558|9626098|FG002|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||84
8591177|NCT00298558|9626099|FG003|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||104
8591178|NCT00298558|9626096|FG000|STARTED|10th Annual (A10)||472
8591179|NCT00298558|9626097|FG001|STARTED|10th Annual (A10)||469
8591180|NCT00298558|9626098|FG002|STARTED|10th Annual (A10)||490
8591181|NCT00298558|9626099|FG003|STARTED|10th Annual (A10)||448
8591182|NCT00298558|9626096|FG000|COMPLETED|10th Annual (A10)||300
8591183|NCT00298558|9626097|FG001|COMPLETED|10th Annual (A10)||316
8591184|NCT00298558|9626098|FG002|COMPLETED|10th Annual (A10)||319
8591185|NCT00298558|9626099|FG003|COMPLETED|10th Annual (A10)||285
8591186|NCT00298558|9626096|FG000|NOT COMPLETED|10th Annual (A10)||172
8591187|NCT00298558|9626097|FG001|NOT COMPLETED|10th Annual (A10)||153
8591188|NCT00298558|9626098|FG002|NOT COMPLETED|10th Annual (A10)||171
8591189|NCT00298558|9626099|FG003|NOT COMPLETED|10th Annual (A10)||163
8591190|NCT00298610|9626109|FG000|STARTED|Overall Study||30
8591191|NCT00298610|9626109|FG000|COMPLETED|Overall Study||30
8591192|NCT00298610|9626109|FG000|NOT COMPLETED|Overall Study||0
8591193|NCT00298766|9626113|FG000|STARTED|Overall Study||70
8591194|NCT00298766|9626113|FG000|COMPLETED|Overall Study||24
8591195|NCT00298766|9626113|FG000|NOT COMPLETED|Overall Study||46
8591196|NCT00298831|9626117|FG000|STARTED|Overall Study||224
8591197|NCT00298831|9626117|FG000|Treated|Overall Study||197
8591198|NCT00298831|9626117|FG000|COMPLETED|Overall Study||192
8591199|NCT00298831|9626117|FG000|NOT COMPLETED|Overall Study||32
8591200|NCT00298896|9626121|FG000|STARTED|Overall Study||55
8591201|NCT00298896|9626121|FG000|COMPLETED|Overall Study||5
8591202|NCT00298896|9626121|FG000|NOT COMPLETED|Overall Study||50
8591203|NCT00299000|9626127|FG000|STARTED|Overall Study||2
8591204|NCT00299000|9626128|FG001|STARTED|Overall Study||2
8591205|NCT00299000|9626127|FG000|COMPLETED|Overall Study||2
8591206|NCT00299000|9626128|FG001|COMPLETED|Overall Study||2
8591207|NCT00299000|9626127|FG000|NOT COMPLETED|Overall Study||0
8591208|NCT00299000|9626128|FG001|NOT COMPLETED|Overall Study||0
8591209|NCT00299104|9626137|FG000|STARTED|Treatment Period||251
8591210|NCT00299104|9626138|FG001|STARTED|Treatment Period||252
8591211|NCT00299104|9626139|FG002|STARTED|Treatment Period||252
8591212|NCT00299104|9626137|FG000|Safety/ITT: Received Study Drug|Treatment Period||249
8591213|NCT00299104|9626138|FG001|Safety/ITT: Received Study Drug|Treatment Period||249
8591214|NCT00299104|9626139|FG002|Safety/ITT: Received Study Drug|Treatment Period||250
8591215|NCT00299104|9626137|FG000|Completed Week 24|Treatment Period||227
8591216|NCT00299104|9626138|FG001|Completed Week 24|Treatment Period||240
8591217|NCT00299104|9626139|FG002|Completed Week 24|Treatment Period||241
8591218|NCT00299104|9626137|FG000|Completed Week 52|Treatment Period||213
8591219|NCT00299104|9626138|FG001|Completed Week 52|Treatment Period||227
8591220|NCT00299104|9626139|FG002|Completed Week 52|Treatment Period||232
8591221|NCT00299104|9626137|FG000|Completed Week 104|Treatment Period||178
8591222|NCT00299104|9626138|FG001|Completed Week 104|Treatment Period||213
8591223|NCT00299104|9626139|FG002|Completed Week 104|Treatment Period||216
8591224|NCT00299104|9626137|FG000|COMPLETED|Treatment Period|Completed Week 152|62
8591225|NCT00299104|9626138|FG001|COMPLETED|Treatment Period||77
8591226|NCT00299104|9626139|FG002|COMPLETED|Treatment Period||80
8591227|NCT00299104|9626137|FG000|NOT COMPLETED|Treatment Period||189
8591228|NCT00299104|9626138|FG001|NOT COMPLETED|Treatment Period||175
8591229|NCT00299104|9626139|FG002|NOT COMPLETED|Treatment Period||172
8591230|NCT00299104|9626137|FG000|STARTED|Safety Follow-Up (SFU) Period|All participants who received treatment were to enter SFU even if withdrawn during treatment period.|184
8591231|NCT00299104|9626138|FG001|STARTED|Safety Follow-Up (SFU) Period|All participants who received treatment were to enter SFU even if withdrawn during treatment period.|212
8629571|NCT00530920|9669339|FG001|NOT COMPLETED|Overall Study||2
8591232|NCT00299104|9626139|FG002|STARTED|Safety Follow-Up (SFU) Period|All participants who received treatment were to enter SFU even if withdrawn during treatment period.|213
8591233|NCT00299104|9626137|FG000|COMPLETED|Safety Follow-Up (SFU) Period||129
8591234|NCT00299104|9626138|FG001|COMPLETED|Safety Follow-Up (SFU) Period||171
8591235|NCT00299104|9626139|FG002|COMPLETED|Safety Follow-Up (SFU) Period||176
8591236|NCT00299104|9626137|FG000|NOT COMPLETED|Safety Follow-Up (SFU) Period||55
8591237|NCT00299104|9626138|FG001|NOT COMPLETED|Safety Follow-Up (SFU) Period||41
8591238|NCT00299104|9626139|FG002|NOT COMPLETED|Safety Follow-Up (SFU) Period||37
8591239|NCT00299104|9626137|FG000|STARTED|Extended Safety Follow-Up (ESFU) Period|Only participants with CD19+ B-cell counts below baseline level or less than 80 cells/microliter.|34
8591240|NCT00299104|9626138|FG001|STARTED|Extended Safety Follow-Up (ESFU) Period|Only participants with CD19+ B-cell counts below baseline level or less than 80 cells/microliter.|40
8591241|NCT00299104|9626139|FG002|STARTED|Extended Safety Follow-Up (ESFU) Period|Only participants with CD19+ B-cell counts below baseline level or less than 80 cells/microliter.|51
8591242|NCT00299104|9626137|FG000|COMPLETED|Extended Safety Follow-Up (ESFU) Period||29
8591243|NCT00299104|9626138|FG001|COMPLETED|Extended Safety Follow-Up (ESFU) Period||31
8591244|NCT00299104|9626139|FG002|COMPLETED|Extended Safety Follow-Up (ESFU) Period||39
8591245|NCT00299104|9626137|FG000|NOT COMPLETED|Extended Safety Follow-Up (ESFU) Period||5
8591246|NCT00299104|9626138|FG001|NOT COMPLETED|Extended Safety Follow-Up (ESFU) Period||9
8591247|NCT00299104|9626139|FG002|NOT COMPLETED|Extended Safety Follow-Up (ESFU) Period||12
8591248|NCT00299130|9626150|FG000|STARTED|Treatment Period (up to 5 Years)||172
8591249|NCT00299130|9626151|FG001|STARTED|Treatment Period (up to 5 Years)||168
8591250|NCT00299130|9626152|FG002|STARTED|Treatment Period (up to 5 Years)||171
8591251|NCT00299130|9626150|FG000|Treated|Treatment Period (up to 5 Years)|155 participants in placebo arm switched to active therapy (rituximab 2 x 0.5g) between Weeks 16-48.|172
8591252|NCT00299130|9626151|FG001|Treated|Treatment Period (up to 5 Years)||167
8591253|NCT00299130|9626152|FG002|Treated|Treatment Period (up to 5 Years)||170
8591254|NCT00299130|9626150|FG000|Completed 24 Weeks|Treatment Period (up to 5 Years)||159
8591255|NCT00299130|9626151|FG001|Completed 24 Weeks|Treatment Period (up to 5 Years)||162
8591256|NCT00299130|9626152|FG002|Completed 24 Weeks|Treatment Period (up to 5 Years)||166
8591257|NCT00299130|9626150|FG000|Completed 48 Weeks|Treatment Period (up to 5 Years)||155
8591258|NCT00299130|9626151|FG001|Completed 48 Weeks|Treatment Period (up to 5 Years)||157
8591259|NCT00299130|9626152|FG002|Completed 48 Weeks|Treatment Period (up to 5 Years)||158
8591260|NCT00299130|9626150|FG000|Completed 144 Weeks|Treatment Period (up to 5 Years)||133
8591261|NCT00299130|9626151|FG001|Completed 144 Weeks|Treatment Period (up to 5 Years)||138
8591262|NCT00299130|9626152|FG002|Completed 144 Weeks|Treatment Period (up to 5 Years)||132
8591263|NCT00299130|9626150|FG000|COMPLETED|Treatment Period (up to 5 Years)||119
8591264|NCT00299130|9626151|FG001|COMPLETED|Treatment Period (up to 5 Years)||125
8591265|NCT00299130|9626152|FG002|COMPLETED|Treatment Period (up to 5 Years)||121
8591266|NCT00299130|9626150|FG000|NOT COMPLETED|Treatment Period (up to 5 Years)||53
8591267|NCT00299130|9626151|FG001|NOT COMPLETED|Treatment Period (up to 5 Years)||43
8591268|NCT00299130|9626152|FG002|NOT COMPLETED|Treatment Period (up to 5 Years)||50
8591269|NCT00299130|9626150|FG000|STARTED|Safety Follow-up (SFU) (48 Weeks)||167
8591270|NCT00299130|9626151|FG001|STARTED|Safety Follow-up (SFU) (48 Weeks)||165
8591271|NCT00299130|9626152|FG002|STARTED|Safety Follow-up (SFU) (48 Weeks)||168
8591272|NCT00299130|9626150|FG000|COMPLETED|Safety Follow-up (SFU) (48 Weeks)||122
8591273|NCT00299130|9626151|FG001|COMPLETED|Safety Follow-up (SFU) (48 Weeks)||120
8591274|NCT00299130|9626152|FG002|COMPLETED|Safety Follow-up (SFU) (48 Weeks)||123
8591275|NCT00299130|9626150|FG000|NOT COMPLETED|Safety Follow-up (SFU) (48 Weeks)||45
8591276|NCT00299130|9626151|FG001|NOT COMPLETED|Safety Follow-up (SFU) (48 Weeks)||45
8591277|NCT00299130|9626152|FG002|NOT COMPLETED|Safety Follow-up (SFU) (48 Weeks)||45
8591278|NCT00299130|9626150|FG000|STARTED|Extended SFU (ESFU) (up to 5.1 Years)||0
8591279|NCT00299130|9626151|FG001|STARTED|Extended SFU (ESFU) (up to 5.1 Years)||82
8591280|NCT00299130|9626152|FG002|STARTED|Extended SFU (ESFU) (up to 5.1 Years)||44
8591281|NCT00299130|9626150|FG000|COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||0
8591282|NCT00299130|9626151|FG001|COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||74
8591283|NCT00299130|9626152|FG002|COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||38
8591284|NCT00299130|9626150|FG000|NOT COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||0
8591285|NCT00299130|9626151|FG001|NOT COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||8
8591286|NCT00299130|9626152|FG002|NOT COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||6
8591287|NCT00299156|9626170|FG000|STARTED|Period 1 (Non-Randomized)||32
8591288|NCT00299156|9626171|FG001|STARTED|Period 1 (Non-Randomized)||0
8591289|NCT00299156|9626172|FG002|STARTED|Period 1 (Non-Randomized)||0
8591290|NCT00299156|9626170|FG000|COMPLETED|Period 1 (Non-Randomized)||32
8591291|NCT00299156|9626171|FG001|COMPLETED|Period 1 (Non-Randomized)||0
8591292|NCT00299156|9626172|FG002|COMPLETED|Period 1 (Non-Randomized)||0
8591293|NCT00299156|9626170|FG000|NOT COMPLETED|Period 1 (Non-Randomized)||0
8591294|NCT00299156|9626171|FG001|NOT COMPLETED|Period 1 (Non-Randomized)||0
8591295|NCT00299156|9626172|FG002|NOT COMPLETED|Period 1 (Non-Randomized)||0
8591296|NCT00299156|9626170|FG000|STARTED|Period 2 (Randomized)||0
8591297|NCT00299156|9626171|FG001|STARTED|Period 2 (Randomized)||17
8591298|NCT00299156|9626172|FG002|STARTED|Period 2 (Randomized)||16
8591299|NCT00299156|9626170|FG000|COMPLETED|Period 2 (Randomized)||0
8591300|NCT00299156|9626171|FG001|COMPLETED|Period 2 (Randomized)||16
8591301|NCT00299156|9626172|FG002|COMPLETED|Period 2 (Randomized)||16
8591302|NCT00299156|9626170|FG000|NOT COMPLETED|Period 2 (Randomized)||0
8591303|NCT00299156|9626171|FG001|NOT COMPLETED|Period 2 (Randomized)||1
8591304|NCT00299156|9626172|FG002|NOT COMPLETED|Period 2 (Randomized)||0
8591305|NCT00299182|9626187|FG000|STARTED|Overall Study||6
8591306|NCT00299182|9626188|FG001|STARTED|Overall Study||4
8591307|NCT00299182|9626189|FG002|STARTED|Overall Study||6
8591308|NCT00299182|9626190|FG003|STARTED|Overall Study||14
8591309|NCT00299182|9626191|FG004|STARTED|Overall Study||8
8591310|NCT00299182|9626192|FG005|STARTED|Overall Study||7
8591311|NCT00299182|9626193|FG006|STARTED|Overall Study||5
8591312|NCT00299182|9626187|FG000|COMPLETED|Overall Study||6
8591313|NCT00299182|9626188|FG001|COMPLETED|Overall Study||4
8591314|NCT00299182|9626189|FG002|COMPLETED|Overall Study||4
8591315|NCT00299182|9626190|FG003|COMPLETED|Overall Study||14
8591316|NCT00299182|9626191|FG004|COMPLETED|Overall Study||5
8591317|NCT00299182|9626192|FG005|COMPLETED|Overall Study||4
8591318|NCT00299182|9626193|FG006|COMPLETED|Overall Study||4
8591319|NCT00299182|9626187|FG000|NOT COMPLETED|Overall Study||0
8591320|NCT00299182|9626188|FG001|NOT COMPLETED|Overall Study||0
8591321|NCT00299182|9626189|FG002|NOT COMPLETED|Overall Study||2
8591322|NCT00299182|9626190|FG003|NOT COMPLETED|Overall Study||0
8591323|NCT00299182|9626191|FG004|NOT COMPLETED|Overall Study||3
8591324|NCT00299182|9626192|FG005|NOT COMPLETED|Overall Study||3
8591325|NCT00299182|9626193|FG006|NOT COMPLETED|Overall Study||1
8591326|NCT00299221|9626213|FG000|STARTED|Overall Study||79
8591327|NCT00299221|9626214|FG001|STARTED|Overall Study||71
8591328|NCT00299221|9626213|FG000|COMPLETED|Overall Study||79
8591329|NCT00299221|9626214|FG001|COMPLETED|Overall Study||71
8591330|NCT00299221|9626213|FG000|NOT COMPLETED|Overall Study||0
8591331|NCT00299221|9626214|FG001|NOT COMPLETED|Overall Study||0
8591332|NCT00299416|9626220|FG000|STARTED|Overall Study||30
8591333|NCT00299416|9626220|FG000|COMPLETED|Overall Study||30
8591334|NCT00299416|9626220|FG000|NOT COMPLETED|Overall Study||0
8591335|NCT00299494|9626230|FG000|STARTED|Overall Study||5
8591336|NCT00299494|9626231|FG001|STARTED|Overall Study||3
8591337|NCT00299494|9626232|FG002|STARTED|Overall Study||7
8591338|NCT00299494|9626233|FG003|STARTED|Overall Study||34
8591339|NCT00299494|9626234|FG004|STARTED|Overall Study|1 participant received rituximab only, and did not receive inotuzumab ozogamicin|40
8591340|NCT00299494|9626235|FG005|STARTED|Overall Study||30
8591341|NCT00299494|9626230|FG000|COMPLETED|Overall Study||2
8591342|NCT00299494|9626231|FG001|COMPLETED|Overall Study||2
8591343|NCT00299494|9626232|FG002|COMPLETED|Overall Study||3
8591344|NCT00299494|9626233|FG003|COMPLETED|Overall Study||24
8591345|NCT00299494|9626234|FG004|COMPLETED|Overall Study||13
8591346|NCT00299494|9626235|FG005|COMPLETED|Overall Study||4
8591347|NCT00299494|9626230|FG000|NOT COMPLETED|Overall Study||3
8591348|NCT00299494|9626231|FG001|NOT COMPLETED|Overall Study||1
8591349|NCT00299494|9626232|FG002|NOT COMPLETED|Overall Study||4
8591350|NCT00299494|9626233|FG003|NOT COMPLETED|Overall Study||10
8591351|NCT00299494|9626234|FG004|NOT COMPLETED|Overall Study||27
8591352|NCT00299494|9626235|FG005|NOT COMPLETED|Overall Study||26
8591353|NCT00299546|9626263|FG000|STARTED|Overall Study||155
8591354|NCT00299546|9626264|FG001|STARTED|Overall Study||153
8591355|NCT00299546|9626265|FG002|STARTED|Overall Study||153
8591356|NCT00299546|9626263|FG000|COMPLETED|Overall Study||55
8711439|NCT00961961|9757776|FG002|COMPLETED|Phase II||17
8711440|NCT00961961|9757777|FG003|COMPLETED|Phase II||14
8711441|NCT00961961|9757774|FG000|NOT COMPLETED|Phase II||0
8711442|NCT00961961|9757775|FG001|NOT COMPLETED|Phase II||0
8711443|NCT00961961|9757776|FG002|NOT COMPLETED|Phase II||12
8711444|NCT00961961|9757777|FG003|NOT COMPLETED|Phase II||8
8711445|NCT00962000|9757797|FG000|STARTED|Period 1 - 1 Week||21
8711446|NCT00962000|9757798|FG001|STARTED|Period 1 - 1 Week||21
8711447|NCT00962000|9757797|FG000|COMPLETED|Period 1 - 1 Week||21
8711448|NCT00962000|9757798|FG001|COMPLETED|Period 1 - 1 Week||21
8711449|NCT00962000|9757797|FG000|NOT COMPLETED|Period 1 - 1 Week||0
8711450|NCT00962000|9757798|FG001|NOT COMPLETED|Period 1 - 1 Week||0
8711451|NCT00962000|9757797|FG000|STARTED|Period 2 - 1 Week||21
8711452|NCT00962000|9757798|FG001|STARTED|Period 2 - 1 Week||21
8711453|NCT00962000|9757797|FG000|COMPLETED|Period 2 - 1 Week||21
8711454|NCT00962000|9757798|FG001|COMPLETED|Period 2 - 1 Week||21
8711455|NCT00962000|9757797|FG000|NOT COMPLETED|Period 2 - 1 Week||0
8711456|NCT00962000|9757798|FG001|NOT COMPLETED|Period 2 - 1 Week||0
8711457|NCT00962000|9757797|FG000|STARTED|Period 3 - 1 Week||21
8591357|NCT00299546|9626264|FG001|COMPLETED|Overall Study||61
8591358|NCT00299546|9626265|FG002|COMPLETED|Overall Study||67
8711458|NCT00962000|9757798|FG001|STARTED|Period 3 - 1 Week||21
8711459|NCT00962000|9757797|FG000|COMPLETED|Period 3 - 1 Week||21
8711460|NCT00962000|9757798|FG001|COMPLETED|Period 3 - 1 Week||21
8711461|NCT00962000|9757797|FG000|NOT COMPLETED|Period 3 - 1 Week||0
8711462|NCT00962000|9757798|FG001|NOT COMPLETED|Period 3 - 1 Week||0
8711463|NCT00962000|9757797|FG000|STARTED|Period 4 - 1 Week||21
8711464|NCT00962000|9757798|FG001|STARTED|Period 4 - 1 Week||21
8591359|NCT00299546|9626263|FG000|NOT COMPLETED|Overall Study||100
8591360|NCT00299546|9626264|FG001|NOT COMPLETED|Overall Study||92
8591361|NCT00299546|9626265|FG002|NOT COMPLETED|Overall Study||86
8591362|NCT00299689|9626274|FG000|STARTED|Overall Study||69
8591363|NCT00299689|9626274|FG000|COMPLETED|Overall Study||69
8591364|NCT00299689|9626274|FG000|NOT COMPLETED|Overall Study||0
8591365|NCT00299702|9626280|FG000|STARTED|Overall Study||179
8591366|NCT00299702|9626281|FG001|STARTED|Overall Study||176
8591367|NCT00299702|9626280|FG000|COMPLETED|Overall Study||126
8591368|NCT00299702|9626281|FG001|COMPLETED|Overall Study||126
8591369|NCT00299702|9626280|FG000|NOT COMPLETED|Overall Study||53
8591370|NCT00299702|9626281|FG001|NOT COMPLETED|Overall Study||50
8591371|NCT00299741|9626287|FG000|STARTED|Overall Study||36
8591372|NCT00299741|9626287|FG000|COMPLETED|Overall Study||36
8591373|NCT00299741|9626287|FG000|NOT COMPLETED|Overall Study||0
8591374|NCT00299975|9626294|FG000|STARTED|Overall Study||32
8591375|NCT00299975|9626295|FG001|STARTED|Overall Study||32
8591376|NCT00299975|9626296|FG002|STARTED|Overall Study||33
8591377|NCT00299975|9626294|FG000|Received Allocated Intervention|Overall Study||32
8591378|NCT00299975|9626295|FG001|Received Allocated Intervention|Overall Study||32
8591379|NCT00299975|9626296|FG002|Received Allocated Intervention|Overall Study||32
8591380|NCT00299975|9626294|FG000|COMPLETED|Overall Study||29
8591381|NCT00299975|9626295|FG001|COMPLETED|Overall Study||31
8591382|NCT00299975|9626296|FG002|COMPLETED|Overall Study||25
8591383|NCT00299975|9626294|FG000|NOT COMPLETED|Overall Study||3
8591384|NCT00299975|9626295|FG001|NOT COMPLETED|Overall Study||1
8591385|NCT00299975|9626296|FG002|NOT COMPLETED|Overall Study||8
8591386|NCT00299988|9626306|FG000|STARTED|Overall Study||16
8591387|NCT00299988|9626307|FG001|STARTED|Overall Study||8
8591388|NCT00299988|9626306|FG000|COMPLETED|Overall Study||16
8591389|NCT00299988|9626307|FG001|COMPLETED|Overall Study||8
8591390|NCT00299988|9626306|FG000|NOT COMPLETED|Overall Study||0
8591391|NCT00299988|9626307|FG001|NOT COMPLETED|Overall Study||0
8591392|NCT00300053|9626317|FG000|STARTED|Overall Study|started = randomized and treated/injected|55
8591393|NCT00300053|9626318|FG001|STARTED|Overall Study|started = randomized and treated/injected|56
8591394|NCT00300053|9626319|FG002|STARTED|Overall Study|started = randomized and treated/injected|56
8591395|NCT00300053|9626317|FG000|3-Month Evaluation|Overall Study||55
8591396|NCT00300053|9626318|FG001|3-Month Evaluation|Overall Study||56
8591397|NCT00300053|9626319|FG002|3-Month Evaluation|Overall Study||54
8591398|NCT00300053|9626317|FG000|6-Month Evaluation|Overall Study||54
8591399|NCT00300053|9626318|FG001|6-Month Evaluation|Overall Study||55
8591400|NCT00300053|9626319|FG002|6-Month Evaluation|Overall Study||53
8591401|NCT00300053|9626317|FG000|COMPLETED|Overall Study||53
8591402|NCT00300053|9626318|FG001|COMPLETED|Overall Study||53
8591403|NCT00300053|9626319|FG002|COMPLETED|Overall Study||50
8591404|NCT00300053|9626317|FG000|NOT COMPLETED|Overall Study||2
8591405|NCT00300053|9626318|FG001|NOT COMPLETED|Overall Study||3
8591406|NCT00300053|9626319|FG002|NOT COMPLETED|Overall Study||6
8591407|NCT00300235|9626333|FG000|STARTED|Overall Study||208
8591408|NCT00300235|9626334|FG001|STARTED|Overall Study||240
8591409|NCT00300235|9626335|FG002|STARTED|Overall Study||398
8591410|NCT00300235|9626336|FG003|STARTED|Overall Study||362
8591411|NCT00300235|9626337|FG004|STARTED|Overall Study||251
8591412|NCT00300235|9626333|FG000|COMPLETED|Overall Study||208
8591413|NCT00300235|9626334|FG001|COMPLETED|Overall Study||240
8591414|NCT00300235|9626335|FG002|COMPLETED|Overall Study||398
8591415|NCT00300235|9626336|FG003|COMPLETED|Overall Study||362
8591416|NCT00300235|9626337|FG004|COMPLETED|Overall Study||251
8591417|NCT00300235|9626333|FG000|NOT COMPLETED|Overall Study||0
8591418|NCT00300235|9626334|FG001|NOT COMPLETED|Overall Study||0
8591419|NCT00300235|9626335|FG002|NOT COMPLETED|Overall Study||0
8591420|NCT00300235|9626336|FG003|NOT COMPLETED|Overall Study||0
8591421|NCT00300235|9626337|FG004|NOT COMPLETED|Overall Study||0
8591422|NCT00300274|9626352|FG000|STARTED|Overall Study||282
8591423|NCT00300274|9626353|FG001|STARTED|Overall Study||168
8591424|NCT00300274|9626354|FG002|STARTED|Overall Study||271
8591425|NCT00300274|9626352|FG000|Completed 12 Month|Overall Study||250
8591426|NCT00300274|9626353|FG001|Completed 12 Month|Overall Study||149
8591427|NCT00300274|9626354|FG002|Completed 12 Month|Overall Study||248
8591428|NCT00300274|9626352|FG000|COMPLETED|Overall Study||236
8591429|NCT00300274|9626353|FG001|COMPLETED|Overall Study||141
8591430|NCT00300274|9626354|FG002|COMPLETED|Overall Study||226
8591431|NCT00300274|9626352|FG000|NOT COMPLETED|Overall Study||46
8591432|NCT00300274|9626353|FG001|NOT COMPLETED|Overall Study||27
8591433|NCT00300274|9626354|FG002|NOT COMPLETED|Overall Study||45
8591434|NCT00300365|9626364|FG000|STARTED|Overall Study||38
8591435|NCT00300365|9626365|FG001|STARTED|Overall Study||40
8591436|NCT00300365|9626364|FG000|COMPLETED|Overall Study||34
8591437|NCT00300365|9626365|FG001|COMPLETED|Overall Study||38
8591438|NCT00300365|9626364|FG000|NOT COMPLETED|Overall Study||4
8591439|NCT00300365|9626365|FG001|NOT COMPLETED|Overall Study||2
8591440|NCT00300391|9626373|FG000|STARTED|Overall Study||16
8591441|NCT00300391|9626374|FG001|STARTED|Overall Study||14
8591442|NCT00300391|9626373|FG000|COMPLETED|Overall Study||16
8591443|NCT00300391|9626374|FG001|COMPLETED|Overall Study||14
8591444|NCT00300391|9626373|FG000|NOT COMPLETED|Overall Study||0
8591445|NCT00300391|9626374|FG001|NOT COMPLETED|Overall Study||0
8591446|NCT00300430|9626384|FG000|STARTED|Overall Study|"Started = received combo therapy in double-blind and/or open-label study."|1186
8591447|NCT00300430|9626385|FG001|STARTED|Overall Study|"Started = received combo therapy in double-blind and/or open-label study."|514
8591448|NCT00300430|9626386|FG002|STARTED|Overall Study|"Started = received combo therapy in double-blind and/or open-label study."|501
8591449|NCT00300430|9626384|FG000|COMPLETED|Overall Study|"Completed = completed both the double-blind and open-label studies."|819
8591450|NCT00300430|9626385|FG001|COMPLETED|Overall Study|"Completed = completed both the double-blind and open-label studies."|345
8591451|NCT00300430|9626386|FG002|COMPLETED|Overall Study|"Completed = completed both the double-blind and open-label studies."|350
8591452|NCT00300430|9626384|FG000|NOT COMPLETED|Overall Study||367
8591453|NCT00300430|9626385|FG001|NOT COMPLETED|Overall Study||169
8591454|NCT00300430|9626386|FG002|NOT COMPLETED|Overall Study||151
8629572|NCT00530920|9669340|FG002|NOT COMPLETED|Overall Study||4
8591455|NCT00300456|9626400|FG000|STARTED|Overall Study|"For all arms, started means treated."|119
8591456|NCT00300456|9626401|FG001|STARTED|Overall Study||118
8591457|NCT00300456|9626402|FG002|STARTED|Overall Study||119
8591458|NCT00300456|9626403|FG003|STARTED|Overall Study||119
8591459|NCT00300456|9626404|FG004|STARTED|Overall Study||116
8591460|NCT00300456|9626405|FG005|STARTED|Overall Study||59
8591461|NCT00300456|9626400|FG000|COMPLETED|Overall Study||103
8591462|NCT00300456|9626401|FG001|COMPLETED|Overall Study||102
8591463|NCT00300456|9626402|FG002|COMPLETED|Overall Study||98
8591464|NCT00300456|9626403|FG003|COMPLETED|Overall Study||105
8591465|NCT00300456|9626404|FG004|COMPLETED|Overall Study||99
8591466|NCT00300456|9626405|FG005|COMPLETED|Overall Study||48
8591467|NCT00300456|9626400|FG000|NOT COMPLETED|Overall Study||16
8591468|NCT00300456|9626401|FG001|NOT COMPLETED|Overall Study||16
8591469|NCT00300456|9626402|FG002|NOT COMPLETED|Overall Study||21
8591470|NCT00300456|9626403|FG003|NOT COMPLETED|Overall Study||14
8591471|NCT00300456|9626404|FG004|NOT COMPLETED|Overall Study||17
8591472|NCT00300456|9626405|FG005|NOT COMPLETED|Overall Study||11
8711465|NCT00962000|9757797|FG000|COMPLETED|Period 4 - 1 Week||21
8711466|NCT00962000|9757798|FG001|COMPLETED|Period 4 - 1 Week||21
8711467|NCT00962000|9757797|FG000|NOT COMPLETED|Period 4 - 1 Week||0
8711468|NCT00962000|9757798|FG001|NOT COMPLETED|Period 4 - 1 Week||0
8724830|NCT01028014|9772103|FG003|NOT COMPLETED|Overall Study||1
8724831|NCT01028014|9772104|FG004|NOT COMPLETED|Overall Study||1
8724832|NCT01028014|9772105|FG005|NOT COMPLETED|Overall Study||2
8724833|NCT01028027|9772121|FG000|STARTED|Overall Study||180
8724834|NCT01028027|9772122|FG001|STARTED|Overall Study||177
8724835|NCT01028027|9772121|FG000|COMPLETED|Overall Study||164
8724836|NCT01028027|9772122|FG001|COMPLETED|Overall Study||164
8724837|NCT01028027|9772121|FG000|NOT COMPLETED|Overall Study||16
8724838|NCT01028027|9772122|FG001|NOT COMPLETED|Overall Study||13
8724839|NCT01028053|9772128|FG000|STARTED|Overall Study||365
8724840|NCT01028053|9772128|FG000|COMPLETED|Overall Study||232
8724841|NCT01028053|9772128|FG000|NOT COMPLETED|Overall Study||133
8813066|NCT01523782|9866171|FG000|NOT COMPLETED|Overall Study||1
8591473|NCT00300469|9626425|FG000|STARTED|Overall Study|"For all arms, started means treated."|110
8591474|NCT00300469|9626426|FG001|STARTED|Overall Study||110
8591475|NCT00300469|9626427|FG002|STARTED|Overall Study||112
8591476|NCT00300469|9626428|FG003|STARTED|Overall Study||113
8591477|NCT00300469|9626429|FG004|STARTED|Overall Study||109
8591478|NCT00300469|9626430|FG005|STARTED|Overall Study||55
8591479|NCT00300469|9626425|FG000|COMPLETED|Overall Study||89
8591480|NCT00300469|9626426|FG001|COMPLETED|Overall Study||89
8591481|NCT00300469|9626427|FG002|COMPLETED|Overall Study||95
8591482|NCT00300469|9626428|FG003|COMPLETED|Overall Study||104
8591483|NCT00300469|9626429|FG004|COMPLETED|Overall Study||95
8591484|NCT00300469|9626430|FG005|COMPLETED|Overall Study||46
8591485|NCT00300469|9626425|FG000|NOT COMPLETED|Overall Study||21
8591486|NCT00300469|9626426|FG001|NOT COMPLETED|Overall Study||21
8591487|NCT00300469|9626427|FG002|NOT COMPLETED|Overall Study||17
8591488|NCT00300469|9626428|FG003|NOT COMPLETED|Overall Study||9
8591489|NCT00300469|9626429|FG004|NOT COMPLETED|Overall Study||14
8591490|NCT00300469|9626430|FG005|NOT COMPLETED|Overall Study||9
8591491|NCT00300482|9626450|FG000|STARTED|Overall Study|"For all arms, started means treated."|261
8591492|NCT00300482|9626451|FG001|STARTED|Overall Study||261
8591493|NCT00300482|9626452|FG002|STARTED|Overall Study||259
8591494|NCT00300482|9626453|FG003|STARTED|Overall Study||261
8591495|NCT00300482|9626454|FG004|STARTED|Overall Study||266
8591496|NCT00300482|9626455|FG005|STARTED|Overall Study||131
8591497|NCT00300482|9626450|FG000|COMPLETED|Overall Study||220
8591498|NCT00300482|9626451|FG001|COMPLETED|Overall Study||220
8591499|NCT00300482|9626452|FG002|COMPLETED|Overall Study||208
8591500|NCT00300482|9626453|FG003|COMPLETED|Overall Study||237
8591501|NCT00300482|9626454|FG004|COMPLETED|Overall Study||243
8591502|NCT00300482|9626455|FG005|COMPLETED|Overall Study||115
8591503|NCT00300482|9626450|FG000|NOT COMPLETED|Overall Study||41
8591504|NCT00300482|9626451|FG001|NOT COMPLETED|Overall Study||41
8591505|NCT00300482|9626452|FG002|NOT COMPLETED|Overall Study||51
8591506|NCT00300482|9626453|FG003|NOT COMPLETED|Overall Study||24
8591507|NCT00300482|9626454|FG004|NOT COMPLETED|Overall Study||23
8591508|NCT00300482|9626455|FG005|NOT COMPLETED|Overall Study||16
8591509|NCT00300495|9626471|FG000|STARTED|Overall Study||10
8591510|NCT00300495|9626472|FG001|STARTED|Overall Study||9
8591511|NCT00300495|9626471|FG000|COMPLETED|Overall Study||6
8591512|NCT00300495|9626472|FG001|COMPLETED|Overall Study||8
8591513|NCT00300495|9626471|FG000|NOT COMPLETED|Overall Study||4
8591514|NCT00300495|9626472|FG001|NOT COMPLETED|Overall Study||1
8591515|NCT00300677|9626478|FG000|STARTED|Overall Study||12
8591516|NCT00300677|9626478|FG000|COMPLETED|Overall Study||12
8591517|NCT00300677|9626478|FG000|NOT COMPLETED|Overall Study||0
8591518|NCT00300742|9626482|FG000|STARTED|Overall Study||5
8591519|NCT00300742|9626482|FG000|COMPLETED|Overall Study||3
8591520|NCT00300742|9626482|FG000|NOT COMPLETED|Overall Study||2
8591521|NCT00300755|9626490|FG000|STARTED|Overall Study||18
8591522|NCT00300755|9626491|FG001|STARTED|Overall Study||21
8591523|NCT00300755|9626492|FG002|STARTED|Overall Study||21
8724842|NCT01028131|9772138|FG000|STARTED|Overall Study||26
8724843|NCT01028131|9772139|FG001|STARTED|Overall Study||26
8724844|NCT01028131|9772140|FG002|STARTED|Overall Study||28
8724845|NCT01028131|9772141|FG003|STARTED|Overall Study||30
8724846|NCT01028131|9772138|FG000|Completed Intervention/Control Session|Overall Study||26
8813067|NCT01523782|9866172|FG001|NOT COMPLETED|Overall Study||0
8591524|NCT00300755|9626490|FG000|COMPLETED|Overall Study||17
8591525|NCT00300755|9626491|FG001|COMPLETED|Overall Study||17
8591526|NCT00300755|9626492|FG002|COMPLETED|Overall Study||19
8591527|NCT00300755|9626490|FG000|NOT COMPLETED|Overall Study||1
8591528|NCT00300755|9626491|FG001|NOT COMPLETED|Overall Study||4
8591529|NCT00300755|9626492|FG002|NOT COMPLETED|Overall Study||2
8591530|NCT00300781|9626502|FG000|STARTED|Overall Study||66
8591531|NCT00300781|9626503|FG001|STARTED|Overall Study||70
8591532|NCT00300781|9626502|FG000|COMPLETED|Overall Study||3
8591533|NCT00300781|9626503|FG001|COMPLETED|Overall Study||8
8591534|NCT00300781|9626502|FG000|NOT COMPLETED|Overall Study||63
8591535|NCT00300781|9626503|FG001|NOT COMPLETED|Overall Study||62
8591536|NCT00300885|9626511|FG000|STARTED|Treatment||464
8591537|NCT00300885|9626512|FG001|STARTED|Treatment|ongoing in double -blind treatment at data cut-off|462
8591538|NCT00300885|9626511|FG000|Received Treatment|Treatment||463
8591539|NCT00300885|9626512|FG001|Received Treatment|Treatment||459
8591540|NCT00300885|9626511|FG000|COMPLETED|Treatment||91
8591541|NCT00300885|9626512|FG001|COMPLETED|Treatment||88
8591542|NCT00300885|9626511|FG000|NOT COMPLETED|Treatment||373
8591543|NCT00300885|9626512|FG001|NOT COMPLETED|Treatment||374
8591544|NCT00300885|9626511|FG000|STARTED|Follow-up|Subjects entered Follow-up period after termination of Treatment period due to any reason.|354
8591545|NCT00300885|9626512|FG001|STARTED|Follow-up|Subjects entered Follow-up period after termination of Treatment period due to any reason.|369
8591546|NCT00300885|9626511|FG000|COMPLETED|Follow-up|Subjects still in Follow up period at data cut-off date.|176
8591547|NCT00300885|9626512|FG001|COMPLETED|Follow-up|Subjects still in Follow up period at data cut-off date.|174
8591548|NCT00300885|9626511|FG000|NOT COMPLETED|Follow-up||178
8591549|NCT00300885|9626512|FG001|NOT COMPLETED|Follow-up||195
8591550|NCT00301028|9626518|FG000|STARTED|Overall Study||47
8591551|NCT00301028|9626518|FG000|COMPLETED|Overall Study||47
8591552|NCT00301028|9626518|FG000|NOT COMPLETED|Overall Study||0
8591553|NCT00301067|9626522|FG000|STARTED|Completed DLT Period/1st Cycle||4
8591554|NCT00301067|9626523|FG001|STARTED|Completed DLT Period/1st Cycle||3
8591555|NCT00301067|9626524|FG002|STARTED|Completed DLT Period/1st Cycle||3
8591556|NCT00301067|9626525|FG003|STARTED|Completed DLT Period/1st Cycle|Patients did not participate in the DLT portion of the trial, they completed 1st cycle of treatment.|10
8591557|NCT00301067|9626522|FG000|COMPLETED|Completed DLT Period/1st Cycle||3
8591558|NCT00301067|9626523|FG001|COMPLETED|Completed DLT Period/1st Cycle||3
8591559|NCT00301067|9626524|FG002|COMPLETED|Completed DLT Period/1st Cycle||3
8591560|NCT00301067|9626525|FG003|COMPLETED|Completed DLT Period/1st Cycle||9
8591561|NCT00301067|9626522|FG000|NOT COMPLETED|Completed DLT Period/1st Cycle||1
8591562|NCT00301067|9626523|FG001|NOT COMPLETED|Completed DLT Period/1st Cycle||0
8591563|NCT00301067|9626524|FG002|NOT COMPLETED|Completed DLT Period/1st Cycle||0
8591564|NCT00301067|9626525|FG003|NOT COMPLETED|Completed DLT Period/1st Cycle||1
8591565|NCT00301067|9626522|FG000|STARTED|Reached 1st Response/2 Cycles||3
8591566|NCT00301067|9626523|FG001|STARTED|Reached 1st Response/2 Cycles||3
8591567|NCT00301067|9626524|FG002|STARTED|Reached 1st Response/2 Cycles||3
8591568|NCT00301067|9626525|FG003|STARTED|Reached 1st Response/2 Cycles||9
8591569|NCT00301067|9626522|FG000|COMPLETED|Reached 1st Response/2 Cycles||1
8591570|NCT00301067|9626523|FG001|COMPLETED|Reached 1st Response/2 Cycles||2
8591571|NCT00301067|9626524|FG002|COMPLETED|Reached 1st Response/2 Cycles||2
8591572|NCT00301067|9626525|FG003|COMPLETED|Reached 1st Response/2 Cycles||7
8591573|NCT00301067|9626522|FG000|NOT COMPLETED|Reached 1st Response/2 Cycles||2
8591574|NCT00301067|9626523|FG001|NOT COMPLETED|Reached 1st Response/2 Cycles||1
8591575|NCT00301067|9626524|FG002|NOT COMPLETED|Reached 1st Response/2 Cycles||1
8591576|NCT00301067|9626525|FG003|NOT COMPLETED|Reached 1st Response/2 Cycles||2
8591577|NCT00301067|9626522|FG000|STARTED|Completed 4 Cycles of Treatment||1
8591578|NCT00301067|9626523|FG001|STARTED|Completed 4 Cycles of Treatment||2
8591579|NCT00301067|9626524|FG002|STARTED|Completed 4 Cycles of Treatment||2
8591580|NCT00301067|9626525|FG003|STARTED|Completed 4 Cycles of Treatment||7
8591581|NCT00301067|9626522|FG000|COMPLETED|Completed 4 Cycles of Treatment||0
8591582|NCT00301067|9626523|FG001|COMPLETED|Completed 4 Cycles of Treatment||1
8591583|NCT00301067|9626524|FG002|COMPLETED|Completed 4 Cycles of Treatment||0
8591584|NCT00301067|9626525|FG003|COMPLETED|Completed 4 Cycles of Treatment||2
8591585|NCT00301067|9626522|FG000|NOT COMPLETED|Completed 4 Cycles of Treatment||1
8591586|NCT00301067|9626523|FG001|NOT COMPLETED|Completed 4 Cycles of Treatment||1
8591587|NCT00301067|9626524|FG002|NOT COMPLETED|Completed 4 Cycles of Treatment||2
8591588|NCT00301067|9626525|FG003|NOT COMPLETED|Completed 4 Cycles of Treatment||5
8591589|NCT00301067|9626522|FG000|STARTED|Completed 12 Cycles of Treatment||0
8591590|NCT00301067|9626523|FG001|STARTED|Completed 12 Cycles of Treatment||1
8591591|NCT00301067|9626524|FG002|STARTED|Completed 12 Cycles of Treatment||0
8591592|NCT00301067|9626525|FG003|STARTED|Completed 12 Cycles of Treatment||2
8591593|NCT00301067|9626522|FG000|COMPLETED|Completed 12 Cycles of Treatment||0
8591594|NCT00301067|9626523|FG001|COMPLETED|Completed 12 Cycles of Treatment||0
8591595|NCT00301067|9626524|FG002|COMPLETED|Completed 12 Cycles of Treatment||0
8591596|NCT00301067|9626525|FG003|COMPLETED|Completed 12 Cycles of Treatment||0
8591597|NCT00301067|9626522|FG000|NOT COMPLETED|Completed 12 Cycles of Treatment||0
8591598|NCT00301067|9626523|FG001|NOT COMPLETED|Completed 12 Cycles of Treatment||1
8591599|NCT00301067|9626524|FG002|NOT COMPLETED|Completed 12 Cycles of Treatment||0
8591600|NCT00301067|9626525|FG003|NOT COMPLETED|Completed 12 Cycles of Treatment||2
8591601|NCT00301067|9626522|FG000|STARTED|Follow up Until Death||4
8591602|NCT00301067|9626523|FG001|STARTED|Follow up Until Death||3
8591603|NCT00301067|9626524|FG002|STARTED|Follow up Until Death||3
8591604|NCT00301067|9626525|FG003|STARTED|Follow up Until Death||3
8591605|NCT00301067|9626522|FG000|COMPLETED|Follow up Until Death||3
8591606|NCT00301067|9626523|FG001|COMPLETED|Follow up Until Death||3
8591607|NCT00301067|9626524|FG002|COMPLETED|Follow up Until Death||3
8591608|NCT00301067|9626525|FG003|COMPLETED|Follow up Until Death||2
8591609|NCT00301067|9626522|FG000|NOT COMPLETED|Follow up Until Death||1
8591610|NCT00301067|9626523|FG001|NOT COMPLETED|Follow up Until Death||0
8591611|NCT00301067|9626524|FG002|NOT COMPLETED|Follow up Until Death||0
8591612|NCT00301067|9626525|FG003|NOT COMPLETED|Follow up Until Death||1
8591613|NCT00301366|9626536|FG000|STARTED|Overall Study||38
8591614|NCT00301366|9626536|FG000|COMPLETED|Overall Study||37
8591615|NCT00301366|9626536|FG000|NOT COMPLETED|Overall Study||1
8591616|NCT00301418|9626540|FG000|STARTED|Overall Study||11
8591617|NCT00301418|9626540|FG000|COMPLETED|Overall Study||11
8591618|NCT00301418|9626540|FG000|NOT COMPLETED|Overall Study||0
8591619|NCT00301756|9626544|FG000|STARTED|Overall Study||32
8591620|NCT00301756|9626544|FG000|COMPLETED|Overall Study||32
8591621|NCT00301756|9626544|FG000|NOT COMPLETED|Overall Study||0
8591622|NCT00301808|9626550|FG000|STARTED|Overall Study||29
8591623|NCT00301808|9626550|FG000|COMPLETED|Overall Study||17
8591624|NCT00301808|9626550|FG000|NOT COMPLETED|Overall Study||12
8591625|NCT00301821|9626554|FG000|STARTED|Overall Study||107
8591626|NCT00301821|9626554|FG000|COMPLETED|Overall Study||81
8591627|NCT00301821|9626554|FG000|NOT COMPLETED|Overall Study||26
8591628|NCT00301834|9626558|FG000|STARTED|Overall Study||35
8591629|NCT00301834|9626558|FG000|COMPLETED|Overall Study||34
8591630|NCT00301834|9626558|FG000|NOT COMPLETED|Overall Study||1
8591631|NCT00301873|9626565|FG000|STARTED|Overall Study||59
8591632|NCT00301873|9626565|FG000|COMPLETED|Overall Study||59
8591633|NCT00301873|9626565|FG000|NOT COMPLETED|Overall Study||0
8591634|NCT00301964|9626569|FG000|STARTED|Overall Study||56
8591635|NCT00301964|9626569|FG000|COMPLETED|Overall Study|Total number of eligible and evaluable participants|52
8591636|NCT00301964|9626569|FG000|NOT COMPLETED|Overall Study||4
8591637|NCT00302003|9626579|FG000|STARTED|Overall Study||287
8591638|NCT00302003|9626579|FG000|COMPLETED|Overall Study||207
8591639|NCT00302003|9626579|FG000|NOT COMPLETED|Overall Study||80
8591640|NCT00302042|9626585|FG000|STARTED|Overall Study||46
8591641|NCT00302042|9626586|FG001|STARTED|Overall Study||46
8591642|NCT00302042|9626585|FG000|COMPLETED|Overall Study||39
8591643|NCT00302042|9626586|FG001|COMPLETED|Overall Study||38
8591644|NCT00302042|9626585|FG000|NOT COMPLETED|Overall Study||7
8591645|NCT00302042|9626586|FG001|NOT COMPLETED|Overall Study||8
8591646|NCT00302055|9626594|FG000|STARTED|Overall Study||23
8591647|NCT00302055|9626595|FG001|STARTED|Overall Study||49
8591648|NCT00302055|9626594|FG000|COMPLETED|Overall Study||14
8591649|NCT00302055|9626595|FG001|COMPLETED|Overall Study||36
8591650|NCT00302055|9626594|FG000|NOT COMPLETED|Overall Study||9
8591651|NCT00302055|9626595|FG001|NOT COMPLETED|Overall Study||13
8591652|NCT00302068|9626604|FG000|STARTED|Overall Study||37
8591653|NCT00302068|9626605|FG001|STARTED|Overall Study||40
8591654|NCT00302068|9626606|FG002|STARTED|Overall Study||24
8591655|NCT00302068|9626604|FG000|COMPLETED|Overall Study||36
8591656|NCT00302068|9626605|FG001|COMPLETED|Overall Study||36
8591657|NCT00302068|9626606|FG002|COMPLETED|Overall Study||23
8591658|NCT00302068|9626604|FG000|NOT COMPLETED|Overall Study||1
8591659|NCT00302068|9626605|FG001|NOT COMPLETED|Overall Study||4
8591660|NCT00302068|9626606|FG002|NOT COMPLETED|Overall Study||1
8591661|NCT00302081|9626618|FG000|STARTED|Overall Study||237
8591662|NCT00302081|9626619|FG001|STARTED|Overall Study||229
8591663|NCT00302081|9626620|FG002|STARTED|Overall Study||230
8591664|NCT00302081|9626618|FG000|COMPLETED|Overall Study||181
8591665|NCT00302081|9626619|FG001|COMPLETED|Overall Study||186
8591666|NCT00302081|9626620|FG002|COMPLETED|Overall Study||178
8591667|NCT00302081|9626618|FG000|NOT COMPLETED|Overall Study||56
8591668|NCT00302081|9626619|FG001|NOT COMPLETED|Overall Study||43
8591669|NCT00302081|9626620|FG002|NOT COMPLETED|Overall Study||52
8591670|NCT00302107|9626630|FG000|STARTED|Overall Study||39
8591671|NCT00302107|9626631|FG001|STARTED|Overall Study||39
8591672|NCT00302107|9626630|FG000|COMPLETED|Overall Study||31
8591673|NCT00302107|9626631|FG001|COMPLETED|Overall Study||30
8591674|NCT00302107|9626630|FG000|NOT COMPLETED|Overall Study||8
8591675|NCT00302107|9626631|FG001|NOT COMPLETED|Overall Study||9
8591676|NCT00302133|9626639|FG000|STARTED|Overall Study||9
8591677|NCT00302133|9626640|FG001|STARTED|Overall Study||9
8591678|NCT00302133|9626639|FG000|COMPLETED|Overall Study||5
8591679|NCT00302133|9626640|FG001|COMPLETED|Overall Study||5
8591680|NCT00302133|9626639|FG000|NOT COMPLETED|Overall Study||4
8591681|NCT00302133|9626640|FG001|NOT COMPLETED|Overall Study||4
8591682|NCT00302159|9626646|FG000|STARTED|Overall Study||43
8591683|NCT00302159|9626646|FG000|COMPLETED|Overall Study||41
8591684|NCT00302159|9626646|FG000|NOT COMPLETED|Overall Study||2
8591685|NCT00302211|9626654|FG000|STARTED|Double Blind Period (New Patients)|These subjects had the option to continue with the same dose of iloprost during the OL period|26
8591686|NCT00302211|9626655|FG001|STARTED|Double Blind Period (New Patients)|These subjects had the option to continue with the same dose of iloprost during the OL period|27
8591687|NCT00302211|9626656|FG002|STARTED|Double Blind Period (New Patients)|These subjects could receive either iloprost 4x/day or 6x/day in the OL period|14
8591688|NCT00302211|9626657|FG003|STARTED|Double Blind Period (New Patients)||0
8591689|NCT00302211|9626658|FG004|STARTED|Double Blind Period (New Patients)||0
8591690|NCT00302211|9626654|FG000|COMPLETED|Double Blind Period (New Patients)||23
8591691|NCT00302211|9626655|FG001|COMPLETED|Double Blind Period (New Patients)||25
8591692|NCT00302211|9626656|FG002|COMPLETED|Double Blind Period (New Patients)||10
8591693|NCT00302211|9626657|FG003|COMPLETED|Double Blind Period (New Patients)||0
8591694|NCT00302211|9626658|FG004|COMPLETED|Double Blind Period (New Patients)||0
8591695|NCT00302211|9626654|FG000|NOT COMPLETED|Double Blind Period (New Patients)||3
8591696|NCT00302211|9626655|FG001|NOT COMPLETED|Double Blind Period (New Patients)||2
8591697|NCT00302211|9626656|FG002|NOT COMPLETED|Double Blind Period (New Patients)||4
8591698|NCT00302211|9626657|FG003|NOT COMPLETED|Double Blind Period (New Patients)||0
8591699|NCT00302211|9626658|FG004|NOT COMPLETED|Double Blind Period (New Patients)||0
8591700|NCT00302211|9626654|FG000|STARTED|Open Label-Patients From Double-Blind||0
8591701|NCT00302211|9626655|FG001|STARTED|Open Label-Patients From Double-Blind||0
8591702|NCT00302211|9626656|FG002|STARTED|Open Label-Patients From Double-Blind||0
8591703|NCT00302211|9626657|FG003|STARTED|Open Label-Patients From Double-Blind|21 patients (pts) in 6x/day DB phase & 5 patients in placebo 6x/day DB phase enrolled in OL 6x/day|26
8591704|NCT00302211|9626658|FG004|STARTED|Open Label-Patients From Double-Blind|26 pts in 4x/day + placebo 2x/day DB phase & 6 pts in placebo 6x/day DB phase enrolled in OL 4x/day|32
8591705|NCT00302211|9626654|FG000|COMPLETED|Open Label-Patients From Double-Blind||0
8591706|NCT00302211|9626655|FG001|COMPLETED|Open Label-Patients From Double-Blind||0
8591707|NCT00302211|9626656|FG002|COMPLETED|Open Label-Patients From Double-Blind||0
8591708|NCT00302211|9626657|FG003|COMPLETED|Open Label-Patients From Double-Blind||18
8591709|NCT00302211|9626658|FG004|COMPLETED|Open Label-Patients From Double-Blind||24
8591710|NCT00302211|9626654|FG000|NOT COMPLETED|Open Label-Patients From Double-Blind||0
8591711|NCT00302211|9626655|FG001|NOT COMPLETED|Open Label-Patients From Double-Blind||0
8591712|NCT00302211|9626656|FG002|NOT COMPLETED|Open Label-Patients From Double-Blind||0
8591713|NCT00302211|9626657|FG003|NOT COMPLETED|Open Label-Patients From Double-Blind||8
8591714|NCT00302211|9626658|FG004|NOT COMPLETED|Open Label-Patients From Double-Blind||8
8591715|NCT00302328|9626673|FG000|STARTED|Overall Study||25
8591716|NCT00302328|9626674|FG001|STARTED|Overall Study||35
8591717|NCT00302328|9626675|FG002|STARTED|Overall Study||18
8591718|NCT00302328|9626673|FG000|COMPLETED|Overall Study||25
8591719|NCT00302328|9626674|FG001|COMPLETED|Overall Study|developed cancer during the study|34
8591720|NCT00302328|9626675|FG002|COMPLETED|Overall Study||18
8591721|NCT00302328|9626673|FG000|NOT COMPLETED|Overall Study||0
8591722|NCT00302328|9626674|FG001|NOT COMPLETED|Overall Study||1
8591723|NCT00302328|9626675|FG002|NOT COMPLETED|Overall Study||0
8591724|NCT00302458|9626686|FG000|STARTED|Overall Study||29
8591725|NCT00302458|9626686|FG000|COMPLETED|Overall Study||26
8591726|NCT00302458|9626686|FG000|NOT COMPLETED|Overall Study||3
8591727|NCT00302718|9626698|FG000|STARTED|Overall Study||20
8591728|NCT00302718|9626699|FG001|STARTED|Overall Study||21
8591729|NCT00302718|9626700|FG002|STARTED|Overall Study||21
8591730|NCT00302718|9626701|FG003|STARTED|Overall Study||21
8591731|NCT00302718|9626698|FG000|COMPLETED|Overall Study||19
8591732|NCT00302718|9626699|FG001|COMPLETED|Overall Study||20
8591733|NCT00302718|9626700|FG002|COMPLETED|Overall Study||19
8591734|NCT00302718|9626701|FG003|COMPLETED|Overall Study||19
8591735|NCT00302718|9626698|FG000|NOT COMPLETED|Overall Study||1
8591736|NCT00302718|9626699|FG001|NOT COMPLETED|Overall Study||1
8591737|NCT00302718|9626700|FG002|NOT COMPLETED|Overall Study||2
8591738|NCT00302718|9626701|FG003|NOT COMPLETED|Overall Study||2
8591739|NCT00302731|9626720|FG000|STARTED|Overall Study||6
8591740|NCT00302731|9626721|FG001|STARTED|Overall Study||6
8591741|NCT00302731|9626722|FG002|STARTED|Overall Study||5
8591742|NCT00302731|9626723|FG003|STARTED|Overall Study||4
8591743|NCT00302731|9626720|FG000|COMPLETED|Overall Study||2
8591744|NCT00302731|9626721|FG001|COMPLETED|Overall Study||1
8591745|NCT00302731|9626722|FG002|COMPLETED|Overall Study||2
8591746|NCT00302731|9626723|FG003|COMPLETED|Overall Study||4
8591747|NCT00302731|9626720|FG000|NOT COMPLETED|Overall Study||4
8591748|NCT00302731|9626721|FG001|NOT COMPLETED|Overall Study||5
8591749|NCT00302731|9626722|FG002|NOT COMPLETED|Overall Study||3
8591750|NCT00302731|9626723|FG003|NOT COMPLETED|Overall Study||0
8591751|NCT00302848|9626736|FG000|STARTED|Overall Study||16534
8591752|NCT00302848|9626737|FG001|STARTED|Overall Study||15428
8591753|NCT00302848|9626738|FG002|STARTED|Overall Study||26341
8591754|NCT00302848|9626736|FG000|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 1.5 and 5.0 years.|16133
8591755|NCT00302848|9626737|FG001|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 1.5 and 5.0 years.|15009
8591756|NCT00302848|9626738|FG002|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 1.5 and 5.0 years.|25762
8591757|NCT00302848|9626736|FG000|NOT COMPLETED|Overall Study||401
8591758|NCT00302848|9626737|FG001|NOT COMPLETED|Overall Study||419
8591759|NCT00302848|9626738|FG002|NOT COMPLETED|Overall Study||579
8591760|NCT00302952|9626747|FG000|STARTED|Overall Study||34
8591761|NCT00302952|9626748|FG001|STARTED|Overall Study||30
8591762|NCT00302952|9626747|FG000|Started Intent-to-Treat (ITT)|Overall Study||34
8591763|NCT00302952|9626748|FG001|Started Intent-to-Treat (ITT)|Overall Study||30
8591764|NCT00302952|9626747|FG000|Completed Intent-to-Treat (ITT)|Overall Study||34
8591765|NCT00302952|9626748|FG001|Completed Intent-to-Treat (ITT)|Overall Study|One participant did not have a baseline C-reactive Protein and was excluded from the ITT population.|29
8591766|NCT00302952|9626747|FG000|COMPLETED|Overall Study||31
8591767|NCT00302952|9626748|FG001|COMPLETED|Overall Study||25
8591768|NCT00302952|9626747|FG000|NOT COMPLETED|Overall Study||3
8591769|NCT00302952|9626748|FG001|NOT COMPLETED|Overall Study||5
8591770|NCT00303069|9626758|FG000|STARTED|Overall Study||31
8591771|NCT00303069|9626759|FG001|STARTED|Overall Study||28
8591772|NCT00303069|9626760|FG002|STARTED|Overall Study||34
8591773|NCT00303069|9626761|FG003|STARTED|Overall Study||31
8591774|NCT00303069|9626758|FG000|COMPLETED|Overall Study||29
8591775|NCT00303069|9626759|FG001|COMPLETED|Overall Study||28
8591776|NCT00303069|9626760|FG002|COMPLETED|Overall Study||33
8591777|NCT00303069|9626761|FG003|COMPLETED|Overall Study||29
8591778|NCT00303069|9626758|FG000|NOT COMPLETED|Overall Study||2
8591779|NCT00303069|9626759|FG001|NOT COMPLETED|Overall Study||0
8591780|NCT00303069|9626760|FG002|NOT COMPLETED|Overall Study||1
8591781|NCT00303069|9626761|FG003|NOT COMPLETED|Overall Study||2
8591782|NCT00303108|9626774|FG000|STARTED|Overall Study||43
8591783|NCT00303108|9626775|FG001|STARTED|Overall Study||46
8591784|NCT00303108|9626776|FG002|STARTED|Overall Study||47
8591785|NCT00303108|9626774|FG000|COMPLETED|Overall Study||31
8591786|NCT00303108|9626775|FG001|COMPLETED|Overall Study||37
8591787|NCT00303108|9626776|FG002|COMPLETED|Overall Study||31
8591788|NCT00303108|9626774|FG000|NOT COMPLETED|Overall Study||12
8591789|NCT00303108|9626775|FG001|NOT COMPLETED|Overall Study||9
8591790|NCT00303108|9626776|FG002|NOT COMPLETED|Overall Study||16
8591791|NCT00303186|9626783|FG000|STARTED|Overall Study||107
8591792|NCT00303186|9626783|FG000|COMPLETED|Overall Study||55
8591793|NCT00303186|9626783|FG000|NOT COMPLETED|Overall Study||52
8591794|NCT00303316|9626789|FG000|STARTED|Overall Study||232
8591795|NCT00303316|9626790|FG001|STARTED|Overall Study||226
8591796|NCT00303316|9626789|FG000|COMPLETED|Overall Study||230
8591797|NCT00303316|9626790|FG001|COMPLETED|Overall Study||223
8591798|NCT00303316|9626789|FG000|NOT COMPLETED|Overall Study||2
8591799|NCT00303316|9626790|FG001|NOT COMPLETED|Overall Study||3
8591800|NCT00303329|9626798|FG000|STARTED|Overall Study||85
8591801|NCT00303329|9626799|FG001|STARTED|Overall Study||99
8591802|NCT00303329|9626798|FG000|COMPLETED|Overall Study||50
8591803|NCT00303329|9626799|FG001|COMPLETED|Overall Study||37
8591804|NCT00303329|9626798|FG000|NOT COMPLETED|Overall Study||35
8591805|NCT00303329|9626799|FG001|NOT COMPLETED|Overall Study||62
8591806|NCT00303446|9626807|FG000|STARTED|Overall Study||25
8591807|NCT00303446|9626808|FG001|STARTED|Overall Study||25
8591808|NCT00303446|9626807|FG000|COMPLETED|Overall Study||23
8591809|NCT00303446|9626808|FG001|COMPLETED|Overall Study||21
8591810|NCT00303446|9626807|FG000|NOT COMPLETED|Overall Study||2
8591811|NCT00303446|9626808|FG001|NOT COMPLETED|Overall Study||4
8591812|NCT00303459|9626816|FG000|STARTED|Overall Study||159
8591813|NCT00303459|9626817|FG001|STARTED|Overall Study|One subject randomized to placebo did not receive study treatment|175
8591814|NCT00303459|9626816|FG000|COMPLETED|Overall Study||76
8591815|NCT00303459|9626817|FG001|COMPLETED|Overall Study||86
8591816|NCT00303459|9626816|FG000|NOT COMPLETED|Overall Study||83
8591817|NCT00303459|9626817|FG001|NOT COMPLETED|Overall Study||89
8591818|NCT00303472|9626831|FG000|STARTED|Treatment Period||6
8591819|NCT00303472|9626832|FG001|STARTED|Treatment Period||11
8591820|NCT00303472|9626833|FG002|STARTED|Treatment Period||11
8591821|NCT00303472|9626834|FG003|STARTED|Treatment Period||16
8591822|NCT00303472|9626835|FG004|STARTED|Treatment Period||11
8591823|NCT00303472|9626836|FG005|STARTED|Treatment Period||12
8591824|NCT00303472|9626837|FG006|STARTED|Treatment Period||5
8591825|NCT00303472|9626831|FG000|COMPLETED|Treatment Period||6
8591826|NCT00303472|9626832|FG001|COMPLETED|Treatment Period||11
8591827|NCT00303472|9626833|FG002|COMPLETED|Treatment Period||11
8591828|NCT00303472|9626834|FG003|COMPLETED|Treatment Period||14
8591829|NCT00303472|9626835|FG004|COMPLETED|Treatment Period||8
8591830|NCT00303472|9626836|FG005|COMPLETED|Treatment Period||11
8591831|NCT00303472|9626837|FG006|COMPLETED|Treatment Period||3
8591832|NCT00303472|9626831|FG000|NOT COMPLETED|Treatment Period||0
8591833|NCT00303472|9626832|FG001|NOT COMPLETED|Treatment Period||0
8591834|NCT00303472|9626833|FG002|NOT COMPLETED|Treatment Period||0
8591835|NCT00303472|9626834|FG003|NOT COMPLETED|Treatment Period||2
8591836|NCT00303472|9626835|FG004|NOT COMPLETED|Treatment Period||3
8591837|NCT00303472|9626836|FG005|NOT COMPLETED|Treatment Period||1
8591838|NCT00303472|9626837|FG006|NOT COMPLETED|Treatment Period||2
8591839|NCT00303472|9626831|FG000|STARTED|Treatment Extension (Optional)||6
8591840|NCT00303472|9626832|FG001|STARTED|Treatment Extension (Optional)||11
8591841|NCT00303472|9626833|FG002|STARTED|Treatment Extension (Optional)||11
8591842|NCT00303472|9626834|FG003|STARTED|Treatment Extension (Optional)||13
8591843|NCT00303472|9626835|FG004|STARTED|Treatment Extension (Optional)||5
8591844|NCT00303472|9626836|FG005|STARTED|Treatment Extension (Optional)||5
8591845|NCT00303472|9626837|FG006|STARTED|Treatment Extension (Optional)||1
8591846|NCT00303472|9626831|FG000|COMPLETED|Treatment Extension (Optional)||1
8591847|NCT00303472|9626832|FG001|COMPLETED|Treatment Extension (Optional)||5
8591848|NCT00303472|9626833|FG002|COMPLETED|Treatment Extension (Optional)||2
8591849|NCT00303472|9626834|FG003|COMPLETED|Treatment Extension (Optional)||5
8591850|NCT00303472|9626835|FG004|COMPLETED|Treatment Extension (Optional)||1
8591851|NCT00303472|9626836|FG005|COMPLETED|Treatment Extension (Optional)||4
8591852|NCT00303472|9626837|FG006|COMPLETED|Treatment Extension (Optional)||1
8591853|NCT00303472|9626831|FG000|NOT COMPLETED|Treatment Extension (Optional)||5
8591854|NCT00303472|9626832|FG001|NOT COMPLETED|Treatment Extension (Optional)||6
8591855|NCT00303472|9626833|FG002|NOT COMPLETED|Treatment Extension (Optional)||9
8591856|NCT00303472|9626834|FG003|NOT COMPLETED|Treatment Extension (Optional)||8
8591857|NCT00303472|9626835|FG004|NOT COMPLETED|Treatment Extension (Optional)||4
8591858|NCT00303472|9626836|FG005|NOT COMPLETED|Treatment Extension (Optional)||1
8591859|NCT00303472|9626837|FG006|NOT COMPLETED|Treatment Extension (Optional)||0
8591860|NCT00303485|9626855|FG000|STARTED|Overall Study||49
8591861|NCT00303485|9626856|FG001|STARTED|Overall Study||17
8591862|NCT00303485|9626855|FG000|COMPLETED|Overall Study||48
8591863|NCT00303485|9626856|FG001|COMPLETED|Overall Study||15
8591864|NCT00303485|9626855|FG000|NOT COMPLETED|Overall Study||1
8591865|NCT00303485|9626856|FG001|NOT COMPLETED|Overall Study||2
8591866|NCT00303511|9626862|FG000|STARTED|Overall Study||10
8591867|NCT00303511|9626862|FG000|COMPLETED|Overall Study||10
8591868|NCT00303511|9626862|FG000|NOT COMPLETED|Overall Study||0
8591869|NCT00303602|9626868|FG000|STARTED|Overall Study||84
8591870|NCT00303602|9626869|FG001|STARTED|Overall Study||65
8591871|NCT00303602|9626868|FG000|COMPLETED|Overall Study||65
8591872|NCT00303602|9626869|FG001|COMPLETED|Overall Study||50
8591873|NCT00303602|9626868|FG000|NOT COMPLETED|Overall Study||19
8591874|NCT00303602|9626869|FG001|NOT COMPLETED|Overall Study||15
8591875|NCT00303628|9626877|FG000|STARTED|Overall Study||176
8591876|NCT00303628|9626878|FG001|STARTED|Overall Study||179
8591877|NCT00303628|9626877|FG000|Eligible|Overall Study||171
8591878|NCT00303628|9626878|FG001|Eligible|Overall Study||177
8591879|NCT00303628|9626877|FG000|Treated|Overall Study||173
8591880|NCT00303628|9626878|FG001|Treated|Overall Study||174
8591881|NCT00303628|9626877|FG000|COMPLETED|Overall Study||126
8591882|NCT00303628|9626878|FG001|COMPLETED|Overall Study||106
8591883|NCT00303628|9626877|FG000|NOT COMPLETED|Overall Study||50
8591884|NCT00303628|9626878|FG001|NOT COMPLETED|Overall Study||73
8591885|NCT00303667|9626886|FG000|STARTED|Overall Study||8
8591886|NCT00303667|9626887|FG001|STARTED|Overall Study||39
8591887|NCT00303667|9626886|FG000|COMPLETED|Overall Study||8
8591888|NCT00303667|9626887|FG001|COMPLETED|Overall Study|Completed = remained alive and on study through Day 0 (day of transplant)|35
8591889|NCT00303667|9626886|FG000|NOT COMPLETED|Overall Study||0
8591890|NCT00303667|9626887|FG001|NOT COMPLETED|Overall Study||4
8591891|NCT00303719|9626895|FG000|STARTED|Overall Study||13
8591892|NCT00303719|9626896|FG001|STARTED|Overall Study||329
8591893|NCT00303719|9626895|FG000|COMPLETED|Overall Study||13
8591894|NCT00303719|9626896|FG001|COMPLETED|Overall Study||292
8591895|NCT00303719|9626895|FG000|NOT COMPLETED|Overall Study||0
8591896|NCT00303719|9626896|FG001|NOT COMPLETED|Overall Study||37
8591897|NCT00303823|9626905|FG000|STARTED|Overall Study||50
8591898|NCT00303823|9626906|FG001|STARTED|Overall Study||48
8591899|NCT00303823|9626905|FG000|COMPLETED|Overall Study||35
8591900|NCT00303823|9626906|FG001|COMPLETED|Overall Study||38
8591901|NCT00303823|9626905|FG000|NOT COMPLETED|Overall Study||15
8591902|NCT00303823|9626906|FG001|NOT COMPLETED|Overall Study||10
8591903|NCT00303862|9626912|FG000|STARTED|Overall Study||10
8591904|NCT00303862|9626912|FG000|COMPLETED|Overall Study||10
8591905|NCT00303862|9626912|FG000|NOT COMPLETED|Overall Study||0
8591906|NCT00303901|9626916|FG000|STARTED|Overall Study||40
8591907|NCT00303901|9626916|FG000|COMPLETED|Overall Study||40
8591908|NCT00303901|9626916|FG000|NOT COMPLETED|Overall Study||0
8591909|NCT00303953|9626920|FG000|STARTED|Overall Study||22
8591910|NCT00303953|9626920|FG000|Eligible|Overall Study||21
8591911|NCT00303953|9626920|FG000|Eligible and Treated|Overall Study||20
8591912|NCT00303953|9626920|FG000|COMPLETED|Overall Study||3
8591913|NCT00303953|9626920|FG000|NOT COMPLETED|Overall Study||19
8591914|NCT00303966|9626924|FG000|STARTED|Overall Study||5
8591915|NCT00303966|9626924|FG000|COMPLETED|Overall Study||5
8591916|NCT00303966|9626924|FG000|NOT COMPLETED|Overall Study||0
8591917|NCT00303979|9626931|FG000|STARTED|Overall Study|at baseline|15177
8591918|NCT00303979|9626932|FG001|STARTED|Overall Study|at 6 months|9992
8591919|NCT00303979|9626933|FG002|STARTED|Overall Study|at 18 months|9641
8591920|NCT00303979|9626931|FG000|COMPLETED|Overall Study|at 24 Months|7605
8591921|NCT00303979|9626932|FG001|COMPLETED|Overall Study|at 6 months|9992
8591922|NCT00303979|9626933|FG002|COMPLETED|Overall Study|at 18 months|9641
8591923|NCT00303979|9626931|FG000|NOT COMPLETED|Overall Study||7572
8591924|NCT00303979|9626932|FG001|NOT COMPLETED|Overall Study||0
8591925|NCT00303979|9626933|FG002|NOT COMPLETED|Overall Study||0
8591926|NCT00304031|9626953|FG000|STARTED|Concomitant RT+TMZ (Pre-randomization)|All participants registered to concomitant treatment; randomized after completing this treatment.|1125
8591927|NCT00304031|9626954|FG001|STARTED|Concomitant RT+TMZ (Pre-randomization)|Participants were not randomized to adjuvant TMZ until after completion of concomitant treatment.|0
8591928|NCT00304031|9626955|FG002|STARTED|Concomitant RT+TMZ (Pre-randomization)|Participants were not randomized to adjuvant TMZ until after completion of concomitant treatment.|0
8591929|NCT00304031|9626953|FG000|Eligible Pre-randomization Population|Concomitant RT+TMZ (Pre-randomization)||1125
8591930|NCT00304031|9626954|FG001|Eligible Pre-randomization Population|Concomitant RT+TMZ (Pre-randomization)||0
8591931|NCT00304031|9626955|FG002|Eligible Pre-randomization Population|Concomitant RT+TMZ (Pre-randomization)||0
8591932|NCT00304031|9626953|FG000|Eligible Pre-randomization Follow-up|Concomitant RT+TMZ (Pre-randomization)||1120
8591933|NCT00304031|9626954|FG001|Eligible Pre-randomization Follow-up|Concomitant RT+TMZ (Pre-randomization)||0
8591934|NCT00304031|9626955|FG002|Eligible Pre-randomization Follow-up|Concomitant RT+TMZ (Pre-randomization)||0
8591935|NCT00304031|9626953|FG000|COMPLETED|Concomitant RT+TMZ (Pre-randomization)|These participants completed concomitant treatment and met requirements for randomization.|833
8591936|NCT00304031|9626954|FG001|COMPLETED|Concomitant RT+TMZ (Pre-randomization)||0
8591937|NCT00304031|9626955|FG002|COMPLETED|Concomitant RT+TMZ (Pre-randomization)||0
8591938|NCT00304031|9626953|FG000|NOT COMPLETED|Concomitant RT+TMZ (Pre-randomization)||292
8591939|NCT00304031|9626954|FG001|NOT COMPLETED|Concomitant RT+TMZ (Pre-randomization)||0
8591940|NCT00304031|9626955|FG002|NOT COMPLETED|Concomitant RT+TMZ (Pre-randomization)||0
8591941|NCT00304031|9626953|FG000|STARTED|Randomization to Adjuvant TMZ Arm||0
8591942|NCT00304031|9626954|FG001|STARTED|Randomization to Adjuvant TMZ Arm||411
8591943|NCT00304031|9626955|FG002|STARTED|Randomization to Adjuvant TMZ Arm||422
8591944|NCT00304031|9626953|FG000|Eligible Population|Randomization to Adjuvant TMZ Arm||0
8591945|NCT00304031|9626954|FG001|Eligible Population|Randomization to Adjuvant TMZ Arm||411
8591946|NCT00304031|9626955|FG002|Eligible Population|Randomization to Adjuvant TMZ Arm||420
8591947|NCT00304031|9626953|FG000|Unmethylated MGMT Population|Randomization to Adjuvant TMZ Arm||0
8591948|NCT00304031|9626954|FG001|Unmethylated MGMT Population|Randomization to Adjuvant TMZ Arm||254
8591949|NCT00304031|9626955|FG002|Unmethylated MGMT Population|Randomization to Adjuvant TMZ Arm||262
8591950|NCT00304031|9626953|FG000|Methylated MGMT Population|Randomization to Adjuvant TMZ Arm||0
8591951|NCT00304031|9626954|FG001|Methylated MGMT Population|Randomization to Adjuvant TMZ Arm||122
8591952|NCT00304031|9626955|FG002|Methylated MGMT Population|Randomization to Adjuvant TMZ Arm||122
8591953|NCT00304031|9626953|FG000|Quality of Life Population|Randomization to Adjuvant TMZ Arm||0
8591954|NCT00304031|9626954|FG001|Quality of Life Population|Randomization to Adjuvant TMZ Arm||96
8591955|NCT00304031|9626955|FG002|Quality of Life Population|Randomization to Adjuvant TMZ Arm||95
8591956|NCT00304031|9626953|FG000|COMPLETED|Randomization to Adjuvant TMZ Arm||0
8591957|NCT00304031|9626954|FG001|COMPLETED|Randomization to Adjuvant TMZ Arm|Randomized participants contributing data to results are considered to have completed the study.|411
8591958|NCT00304031|9626955|FG002|COMPLETED|Randomization to Adjuvant TMZ Arm|Randomized participants contributing data to results are considered to have completed the study.|420
8591959|NCT00304031|9626953|FG000|NOT COMPLETED|Randomization to Adjuvant TMZ Arm||0
8591960|NCT00304031|9626954|FG001|NOT COMPLETED|Randomization to Adjuvant TMZ Arm||0
8591961|NCT00304031|9626955|FG002|NOT COMPLETED|Randomization to Adjuvant TMZ Arm||2
8628012|NCT00520572|9667400|FG001|COMPLETED|Overall Study|Participants completed the study.|50
8628013|NCT00520572|9667401|FG002|COMPLETED|Overall Study|Participants completed the study.|49
8628014|NCT00520572|9667402|FG003|COMPLETED|Overall Study|Participants completed the study.|50
8628015|NCT00520572|9667403|FG004|COMPLETED|Overall Study|Participants completed the study.|53
8628016|NCT00520572|9667404|FG005|COMPLETED|Overall Study|Participants completed the study.|62
8628017|NCT00520572|9667399|FG000|NOT COMPLETED|Overall Study||12
8628018|NCT00520572|9667400|FG001|NOT COMPLETED|Overall Study||14
8628019|NCT00520572|9667401|FG002|NOT COMPLETED|Overall Study||15
8628020|NCT00520572|9667402|FG003|NOT COMPLETED|Overall Study||14
8628021|NCT00520572|9667403|FG004|NOT COMPLETED|Overall Study||12
8628022|NCT00520572|9667404|FG005|NOT COMPLETED|Overall Study||2
8628023|NCT00520676|9667420|FG000|STARTED|Overall Study||128
8628024|NCT00520676|9667421|FG001|STARTED|Overall Study||132
8628025|NCT00520676|9667420|FG000|Received at Least 1 Dose of Study Drug|Overall Study||118
8628026|NCT00520676|9667421|FG001|Received at Least 1 Dose of Study Drug|Overall Study||127
8628027|NCT00520676|9667420|FG000|Qualified Intent-to-treat (Q-ITT)|Overall Study||106
8628028|NCT00520676|9667421|FG001|Qualified Intent-to-treat (Q-ITT)|Overall Study||105
8628029|NCT00520676|9667420|FG000|COMPLETED|Overall Study||27
8628030|NCT00520676|9667421|FG001|COMPLETED|Overall Study||29
8628031|NCT00520676|9667420|FG000|NOT COMPLETED|Overall Study||101
8628032|NCT00520676|9667421|FG001|NOT COMPLETED|Overall Study||103
8628033|NCT00520741|9667429|FG000|STARTED|Overall Study||106
8628034|NCT00520741|9667430|FG001|STARTED|Overall Study|One subject was randomized at 2 sites and excluded from the Safety Set.|319
8628035|NCT00520741|9667429|FG000|COMPLETED|Overall Study||69
8628036|NCT00520741|9667430|FG001|COMPLETED|Overall Study||194
8628037|NCT00520741|9667429|FG000|NOT COMPLETED|Overall Study||37
8628038|NCT00520741|9667430|FG001|NOT COMPLETED|Overall Study||125
8628039|NCT00520845|9667438|FG000|STARTED|Overall Study||23
8628040|NCT00520845|9667438|FG000|COMPLETED|Overall Study||1
8628041|NCT00520845|9667438|FG000|NOT COMPLETED|Overall Study||22
8628042|NCT00520884|9667444|FG000|STARTED|Overall Study||3
8628043|NCT00520884|9667445|FG001|STARTED|Overall Study||2
8628044|NCT00520884|9667446|FG002|STARTED|Overall Study||2
8628045|NCT00520884|9667447|FG003|STARTED|Overall Study||3
8628046|NCT00520884|9667444|FG000|COMPLETED|Overall Study||3
8628047|NCT00520884|9667445|FG001|COMPLETED|Overall Study||2
8628048|NCT00520884|9667446|FG002|COMPLETED|Overall Study||2
8628049|NCT00520884|9667447|FG003|COMPLETED|Overall Study||3
8628050|NCT00520884|9667444|FG000|NOT COMPLETED|Overall Study||0
8628051|NCT00520884|9667445|FG001|NOT COMPLETED|Overall Study||0
8628052|NCT00520884|9667446|FG002|NOT COMPLETED|Overall Study||0
8628053|NCT00520884|9667447|FG003|NOT COMPLETED|Overall Study||0
8628054|NCT00520910|9667456|FG000|STARTED|Overall Study||5
8628055|NCT00520910|9667457|FG001|STARTED|Overall Study||5
8628056|NCT00520910|9667456|FG000|COMPLETED|Overall Study||5
8628057|NCT00520910|9667457|FG001|COMPLETED|Overall Study||5
8628058|NCT00520910|9667456|FG000|NOT COMPLETED|Overall Study||0
8628059|NCT00520910|9667457|FG001|NOT COMPLETED|Overall Study||0
8628060|NCT00520936|9667471|FG000|STARTED|Overall Study|75 participants entered the study and 72 were enrolled and received study drug.|10
8628061|NCT00520936|9667472|FG001|STARTED|Overall Study||11
8628062|NCT00520936|9667473|FG002|STARTED|Overall Study||9
8628063|NCT00520936|9667474|FG003|STARTED|Overall Study||5
8628064|NCT00520936|9667475|FG004|STARTED|Overall Study||6
8628065|NCT00520936|9667476|FG005|STARTED|Overall Study||10
8591962|NCT00304083|9626972|FG000|STARTED|Overall Study||34
8591963|NCT00304083|9626973|FG001|STARTED|Overall Study||14
8591964|NCT00304083|9626972|FG000|Completed 4 Cycles|Overall Study||22
8591965|NCT00304083|9626973|FG001|Completed 4 Cycles|Overall Study||7
8591966|NCT00304083|9626972|FG000|Patients Treated With Surgery|Overall Study||7
8591967|NCT00304083|9626973|FG001|Patients Treated With Surgery|Overall Study||3
8591968|NCT00304083|9626972|FG000|Patients Treated With Surgery and RT|Overall Study||5
8591969|NCT00304083|9626973|FG001|Patients Treated With Surgery and RT|Overall Study||1
8591970|NCT00304083|9626972|FG000|Patients Treated With RT Only|Overall Study||4
8591971|NCT00304083|9626973|FG001|Patients Treated With RT Only|Overall Study||2
8591972|NCT00304083|9626972|FG000|Patients Had Neither RT or Surgery|Overall Study||6
8591973|NCT00304083|9626973|FG001|Patients Had Neither RT or Surgery|Overall Study||1
8591974|NCT00304083|9626972|FG000|COMPLETED|Overall Study||12
8591975|NCT00304083|9626973|FG001|COMPLETED|Overall Study||6
8591976|NCT00304083|9626972|FG000|NOT COMPLETED|Overall Study||22
8591977|NCT00304083|9626973|FG001|NOT COMPLETED|Overall Study||8
8591978|NCT00304096|9626981|FG000|STARTED|Overall Study||6
8591979|NCT00304096|9626982|FG001|STARTED|Overall Study||5
8591980|NCT00304096|9626981|FG000|COMPLETED|Overall Study||6
8591981|NCT00304096|9626982|FG001|COMPLETED|Overall Study|6 patients enrolled, 1 not treated|5
8591982|NCT00304096|9626981|FG000|NOT COMPLETED|Overall Study||0
8591983|NCT00304096|9626982|FG001|NOT COMPLETED|Overall Study||0
8591984|NCT00304161|9626990|FG000|STARTED|Overall Study||28
8591985|NCT00304161|9626991|FG001|STARTED|Overall Study||27
8591986|NCT00304161|9626990|FG000|COMPLETED|Overall Study||22
8591987|NCT00304161|9626991|FG001|COMPLETED|Overall Study||21
8591988|NCT00304161|9626990|FG000|NOT COMPLETED|Overall Study||6
8591989|NCT00304161|9626991|FG001|NOT COMPLETED|Overall Study||6
8591990|NCT00304187|9626999|FG000|STARTED|Overall Study||15
8591991|NCT00304187|9627000|FG001|STARTED|Overall Study||14
8591992|NCT00304187|9626999|FG000|COMPLETED|Overall Study||13
8591993|NCT00304187|9627000|FG001|COMPLETED|Overall Study||13
8591994|NCT00304187|9626999|FG000|NOT COMPLETED|Overall Study||2
8591995|NCT00304187|9627000|FG001|NOT COMPLETED|Overall Study||1
8591996|NCT00304265|9627010|FG000|STARTED|Overall Study||117
8591997|NCT00304265|9627011|FG001|STARTED|Overall Study||98
8591998|NCT00304265|9627010|FG000|COMPLETED|Overall Study||117
8591999|NCT00304265|9627011|FG001|COMPLETED|Overall Study||98
8592000|NCT00304265|9627010|FG000|NOT COMPLETED|Overall Study||0
8592001|NCT00304265|9627011|FG001|NOT COMPLETED|Overall Study||0
8592002|NCT00304278|9627017|FG000|STARTED|Overall Study||21
8592003|NCT00304278|9627017|FG000|COMPLETED|Overall Study||19
8592004|NCT00304278|9627017|FG000|NOT COMPLETED|Overall Study||2
8592005|NCT00304356|9627021|FG000|STARTED|Nitazoxanide||27
8592006|NCT00304356|9627021|FG000|COMPLETED|Nitazoxanide||22
8592007|NCT00304356|9627021|FG000|NOT COMPLETED|Nitazoxanide||5
8592008|NCT00304356|9627021|FG000|STARTED|Nitazoxanide||27
8592009|NCT00304356|9627021|FG000|COMPLETED|Nitazoxanide||22
8592010|NCT00304356|9627021|FG000|NOT COMPLETED|Nitazoxanide||5
8592011|NCT00304512|9627028|FG000|STARTED|Treatment Period||2
8592012|NCT00304512|9627029|FG001|STARTED|Treatment Period||4
8592013|NCT00304512|9627030|FG002|STARTED|Treatment Period||3
8592014|NCT00304512|9627028|FG000|Safety Population|Treatment Period||2
8592015|NCT00304512|9627029|FG001|Safety Population|Treatment Period||4
8592016|NCT00304512|9627030|FG002|Safety Population|Treatment Period||3
8592017|NCT00304512|9627028|FG000|Pharmacokinetic (PK) Population|Treatment Period||2
8592018|NCT00304512|9627029|FG001|Pharmacokinetic (PK) Population|Treatment Period||4
8592019|NCT00304512|9627030|FG002|Pharmacokinetic (PK) Population|Treatment Period||3
8592020|NCT00304512|9627028|FG000|Pharmacodynamic (PD) Population|Treatment Period||2
8592021|NCT00304512|9627029|FG001|Pharmacodynamic (PD) Population|Treatment Period||4
8592022|NCT00304512|9627030|FG002|Pharmacodynamic (PD) Population|Treatment Period||3
8592023|NCT00304512|9627028|FG000|COMPLETED|Treatment Period||2
8592024|NCT00304512|9627029|FG001|COMPLETED|Treatment Period||4
8592025|NCT00304512|9627030|FG002|COMPLETED|Treatment Period||3
8592026|NCT00304512|9627028|FG000|NOT COMPLETED|Treatment Period||0
8592027|NCT00304512|9627029|FG001|NOT COMPLETED|Treatment Period||0
8592028|NCT00304512|9627030|FG002|NOT COMPLETED|Treatment Period||0
8592029|NCT00304512|9627028|FG000|STARTED|Extension Period||2
8592030|NCT00304512|9627029|FG001|STARTED|Extension Period||4
8592031|NCT00304512|9627030|FG002|STARTED|Extension Period||3
8592032|NCT00304512|9627028|FG000|COMPLETED|Extension Period||2
8592033|NCT00304512|9627029|FG001|COMPLETED|Extension Period||4
8592034|NCT00304512|9627030|FG002|COMPLETED|Extension Period||3
8592035|NCT00304512|9627028|FG000|NOT COMPLETED|Extension Period||0
8592036|NCT00304512|9627029|FG001|NOT COMPLETED|Extension Period||0
8592037|NCT00304512|9627030|FG002|NOT COMPLETED|Extension Period||0
8592038|NCT00304707|9627040|FG000|STARTED|Overall Study||73
8592039|NCT00304707|9627041|FG001|STARTED|Overall Study||70
8592040|NCT00304707|9627040|FG000|COMPLETED|Overall Study||66
8592041|NCT00304707|9627041|FG001|COMPLETED|Overall Study||64
8592042|NCT00304707|9627040|FG000|NOT COMPLETED|Overall Study||7
8592043|NCT00304707|9627041|FG001|NOT COMPLETED|Overall Study||6
8592044|NCT00304746|9627049|FG000|STARTED|Overall Study||50
8592045|NCT00304746|9627050|FG001|STARTED|Overall Study||50
8592046|NCT00304746|9627049|FG000|COMPLETED|Overall Study||50
8592047|NCT00304746|9627050|FG001|COMPLETED|Overall Study||50
8592048|NCT00304746|9627049|FG000|NOT COMPLETED|Overall Study||0
8592049|NCT00304746|9627050|FG001|NOT COMPLETED|Overall Study||0
8592050|NCT04721171|9627058|FG000|STARTED|Overall Study||2
8592051|NCT04721171|9627059|FG001|STARTED|Overall Study||2
8592052|NCT04721171|9627058|FG000|COMPLETED|Overall Study||2
8592053|NCT04721171|9627059|FG001|COMPLETED|Overall Study||2
8592054|NCT04721171|9627058|FG000|NOT COMPLETED|Overall Study||0
8592055|NCT04721171|9627059|FG001|NOT COMPLETED|Overall Study||0
8592056|NCT04717323|9627069|FG000|STARTED|Overall Study||0
8592057|NCT04717323|9627070|FG001|STARTED|Overall Study||10
8592058|NCT04717323|9627069|FG000|COMPLETED|Overall Study||0
8592059|NCT04717323|9627070|FG001|COMPLETED|Overall Study||10
8592060|NCT04717323|9627069|FG000|NOT COMPLETED|Overall Study||0
8592061|NCT04717323|9627070|FG001|NOT COMPLETED|Overall Study||0
8592062|NCT04511338|9627078|FG000|STARTED|Period 1||8
8592063|NCT04511338|9627079|FG001|STARTED|Period 1||8
8592064|NCT04511338|9627078|FG000|COMPLETED|Period 1||7
8592065|NCT04511338|9627079|FG001|COMPLETED|Period 1||8
8592066|NCT04511338|9627078|FG000|NOT COMPLETED|Period 1||1
8592067|NCT04511338|9627079|FG001|NOT COMPLETED|Period 1||0
8592068|NCT04511338|9627078|FG000|STARTED|Washout|"We followed the rules in protocol (brief version in SARP sec. 3.1) to withdraw or move subjects to the next period.~Period 1:~Dialyzer with Endexo has grade 4 clotting, subjects is withdrawn from the study~CombiSet with grade 4 clotting only (not the dialyzer): subjects end Period 1, move to Washout, and then Period 2~There was a subject with CombiSet bloodline grade 4 clotting in the 50% heparin reduction HD. The subject was moved to washout period without any heparin free sessions."|8
8592069|NCT04511338|9627079|FG001|STARTED|Washout||8
8592070|NCT04511338|9627078|FG000|COMPLETED|Washout||8
8592071|NCT04511338|9627079|FG001|COMPLETED|Washout||8
8592072|NCT04511338|9627078|FG000|NOT COMPLETED|Washout||0
8592073|NCT04511338|9627079|FG001|NOT COMPLETED|Washout||0
8592074|NCT04511338|9627078|FG000|STARTED|Period 2||8
8592075|NCT04511338|9627079|FG001|STARTED|Period 2||8
8592076|NCT04511338|9627078|FG000|COMPLETED|Period 2||8
8592077|NCT04511338|9627079|FG001|COMPLETED|Period 2||5
8592078|NCT04511338|9627078|FG000|NOT COMPLETED|Period 2||0
8592079|NCT04511338|9627079|FG001|NOT COMPLETED|Period 2||3
8592080|NCT04496414|9627085|FG000|STARTED|Overall Study||50
8592081|NCT04496414|9627085|FG000|COMPLETED|Overall Study||50
8592082|NCT04496414|9627085|FG000|NOT COMPLETED|Overall Study||0
8592083|NCT04493931|9627096|FG000|STARTED|Cohort1:Treatment Period 1(Up to 3 Days)||14
8592084|NCT04493931|9627097|FG001|STARTED|Cohort1:Treatment Period 1(Up to 3 Days)||0
8592085|NCT04493931|9627098|FG002|STARTED|Cohort1:Treatment Period 1(Up to 3 Days)||0
8592086|NCT04493931|9627099|FG003|STARTED|Cohort1:Treatment Period 1(Up to 3 Days)||0
8592087|NCT04493931|9627100|FG004|STARTED|Cohort1:Treatment Period 1(Up to 3 Days)||0
8592088|NCT04493931|9627101|FG005|STARTED|Cohort1:Treatment Period 1(Up to 3 Days)||0
8592089|NCT04493931|9627102|FG006|STARTED|Cohort1:Treatment Period 1(Up to 3 Days)||0
8592090|NCT04493931|9627096|FG000|COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||13
8592091|NCT04493931|9627097|FG001|COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0
8592092|NCT04493931|9627098|FG002|COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0
8592093|NCT04493931|9627099|FG003|COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0
8592094|NCT04493931|9627100|FG004|COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0
8592095|NCT04493931|9627101|FG005|COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0
8592096|NCT04493931|9627102|FG006|COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0
8592097|NCT04493931|9627096|FG000|NOT COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||1
8592098|NCT04493931|9627097|FG001|NOT COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0
8592099|NCT04493931|9627098|FG002|NOT COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0
8592100|NCT04493931|9627099|FG003|NOT COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0
8592101|NCT04493931|9627100|FG004|NOT COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0
8592102|NCT04493931|9627101|FG005|NOT COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0
8592103|NCT04493931|9627102|FG006|NOT COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0
8592104|NCT04493931|9627096|FG000|STARTED|Cohort 1:Washout Period 1 (Up to 3 Days)||13
8592105|NCT04493931|9627097|FG001|STARTED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
8592106|NCT04493931|9627098|FG002|STARTED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
8592107|NCT04493931|9627099|FG003|STARTED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
8592108|NCT04493931|9627100|FG004|STARTED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
8592109|NCT04493931|9627101|FG005|STARTED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
8592110|NCT04493931|9627102|FG006|STARTED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
8592111|NCT04493931|9627096|FG000|COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||13
8592112|NCT04493931|9627097|FG001|COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
8592113|NCT04493931|9627098|FG002|COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
8592114|NCT04493931|9627099|FG003|COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
8592115|NCT04493931|9627100|FG004|COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
8592116|NCT04493931|9627101|FG005|COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
8592117|NCT04493931|9627102|FG006|COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
8592118|NCT04493931|9627096|FG000|NOT COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
8592119|NCT04493931|9627097|FG001|NOT COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
8592120|NCT04493931|9627098|FG002|NOT COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
8592121|NCT04493931|9627099|FG003|NOT COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
8592122|NCT04493931|9627100|FG004|NOT COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
8592123|NCT04493931|9627101|FG005|NOT COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
8592124|NCT04493931|9627102|FG006|NOT COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
8592125|NCT04493931|9627096|FG000|STARTED|Cohort1:Treatment Period 2(Up to 4 Days)||13
8592126|NCT04493931|9627097|FG001|STARTED|Cohort1:Treatment Period 2(Up to 4 Days)||0
8592127|NCT04493931|9627098|FG002|STARTED|Cohort1:Treatment Period 2(Up to 4 Days)||0
8592128|NCT04493931|9627099|FG003|STARTED|Cohort1:Treatment Period 2(Up to 4 Days)||0
8592129|NCT04493931|9627100|FG004|STARTED|Cohort1:Treatment Period 2(Up to 4 Days)||0
8592130|NCT04493931|9627101|FG005|STARTED|Cohort1:Treatment Period 2(Up to 4 Days)||0
8592131|NCT04493931|9627102|FG006|STARTED|Cohort1:Treatment Period 2(Up to 4 Days)||0
8592132|NCT04493931|9627096|FG000|COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||13
8592133|NCT04493931|9627097|FG001|COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0
8592134|NCT04493931|9627098|FG002|COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0
8592135|NCT04493931|9627099|FG003|COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0
8592136|NCT04493931|9627100|FG004|COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0
8592137|NCT04493931|9627101|FG005|COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0
8592138|NCT04493931|9627102|FG006|COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0
8592139|NCT04493931|9627096|FG000|NOT COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0
8592140|NCT04493931|9627097|FG001|NOT COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0
8592141|NCT04493931|9627098|FG002|NOT COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0
8592142|NCT04493931|9627099|FG003|NOT COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0
8592143|NCT04493931|9627100|FG004|NOT COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0
8592144|NCT04493931|9627101|FG005|NOT COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0
8592145|NCT04493931|9627102|FG006|NOT COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0
8592146|NCT04493931|9627096|FG000|STARTED|Cohort 1: Follow-up (Up to 7 Days)||13
8592147|NCT04493931|9627097|FG001|STARTED|Cohort 1: Follow-up (Up to 7 Days)||0
8592148|NCT04493931|9627098|FG002|STARTED|Cohort 1: Follow-up (Up to 7 Days)||0
8592149|NCT04493931|9627099|FG003|STARTED|Cohort 1: Follow-up (Up to 7 Days)||0
8592150|NCT04493931|9627100|FG004|STARTED|Cohort 1: Follow-up (Up to 7 Days)||0
8592151|NCT04493931|9627101|FG005|STARTED|Cohort 1: Follow-up (Up to 7 Days)||0
8592152|NCT04493931|9627102|FG006|STARTED|Cohort 1: Follow-up (Up to 7 Days)||0
8592153|NCT04493931|9627096|FG000|COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||13
8592154|NCT04493931|9627097|FG001|COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0
8592155|NCT04493931|9627098|FG002|COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0
8592156|NCT04493931|9627099|FG003|COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0
8592157|NCT04493931|9627100|FG004|COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0
8592158|NCT04493931|9627101|FG005|COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0
8592159|NCT04493931|9627102|FG006|COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0
8592160|NCT04493931|9627096|FG000|NOT COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0
8592161|NCT04493931|9627097|FG001|NOT COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0
8592162|NCT04493931|9627098|FG002|NOT COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0
8592163|NCT04493931|9627099|FG003|NOT COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0
8592164|NCT04493931|9627100|FG004|NOT COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0
8592165|NCT04493931|9627101|FG005|NOT COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0
8592166|NCT04493931|9627102|FG006|NOT COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0
8592167|NCT04493931|9627096|FG000|STARTED|Cohort2:Treatment Period 1(Up to 3 Days)||0
8592168|NCT04493931|9627097|FG001|STARTED|Cohort2:Treatment Period 1(Up to 3 Days)||17
8592169|NCT04493931|9627098|FG002|STARTED|Cohort2:Treatment Period 1(Up to 3 Days)||0
8592170|NCT04493931|9627099|FG003|STARTED|Cohort2:Treatment Period 1(Up to 3 Days)||0
8592171|NCT04493931|9627100|FG004|STARTED|Cohort2:Treatment Period 1(Up to 3 Days)||0
8592172|NCT04493931|9627101|FG005|STARTED|Cohort2:Treatment Period 1(Up to 3 Days)||0
8592173|NCT04493931|9627102|FG006|STARTED|Cohort2:Treatment Period 1(Up to 3 Days)||0
8592174|NCT04493931|9627096|FG000|COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0
8592175|NCT04493931|9627097|FG001|COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||17
8592176|NCT04493931|9627098|FG002|COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0
8592177|NCT04493931|9627099|FG003|COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0
8592178|NCT04493931|9627100|FG004|COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0
8592179|NCT04493931|9627101|FG005|COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0
8592180|NCT04493931|9627102|FG006|COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0
8592181|NCT04493931|9627096|FG000|NOT COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0
8592182|NCT04493931|9627097|FG001|NOT COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0
8592183|NCT04493931|9627098|FG002|NOT COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0
8592184|NCT04493931|9627099|FG003|NOT COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0
8592185|NCT04493931|9627100|FG004|NOT COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0
8592186|NCT04493931|9627101|FG005|NOT COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0
8592187|NCT04493931|9627102|FG006|NOT COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0
8592188|NCT04493931|9627096|FG000|STARTED|Cohort 2:Washout Period 1(Up to 3 Days)||0
8592189|NCT04493931|9627097|FG001|STARTED|Cohort 2:Washout Period 1(Up to 3 Days)||17
8592190|NCT04493931|9627098|FG002|STARTED|Cohort 2:Washout Period 1(Up to 3 Days)||0
8592191|NCT04493931|9627099|FG003|STARTED|Cohort 2:Washout Period 1(Up to 3 Days)||0
8592192|NCT04493931|9627100|FG004|STARTED|Cohort 2:Washout Period 1(Up to 3 Days)||0
8592193|NCT04493931|9627101|FG005|STARTED|Cohort 2:Washout Period 1(Up to 3 Days)||0
8592194|NCT04493931|9627102|FG006|STARTED|Cohort 2:Washout Period 1(Up to 3 Days)||0
8592195|NCT04493931|9627096|FG000|COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0
8592196|NCT04493931|9627097|FG001|COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||17
8592197|NCT04493931|9627098|FG002|COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0
8592198|NCT04493931|9627099|FG003|COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0
8592199|NCT04493931|9627100|FG004|COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0
8592200|NCT04493931|9627101|FG005|COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0
8592201|NCT04493931|9627102|FG006|COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0
8592202|NCT04493931|9627096|FG000|NOT COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0
8592203|NCT04493931|9627097|FG001|NOT COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0
8592204|NCT04493931|9627098|FG002|NOT COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0
8592205|NCT04493931|9627099|FG003|NOT COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0
8592206|NCT04493931|9627100|FG004|NOT COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0
8592207|NCT04493931|9627101|FG005|NOT COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0
8592208|NCT04493931|9627102|FG006|NOT COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0
8592209|NCT04493931|9627096|FG000|STARTED|Cohort2:Treatment Period2(Up to 10 Days)||0
8592210|NCT04493931|9627097|FG001|STARTED|Cohort2:Treatment Period2(Up to 10 Days)||17
8592211|NCT04493931|9627098|FG002|STARTED|Cohort2:Treatment Period2(Up to 10 Days)||0
8592212|NCT04493931|9627099|FG003|STARTED|Cohort2:Treatment Period2(Up to 10 Days)||0
8592213|NCT04493931|9627100|FG004|STARTED|Cohort2:Treatment Period2(Up to 10 Days)||0
8592214|NCT04493931|9627101|FG005|STARTED|Cohort2:Treatment Period2(Up to 10 Days)||0
8592215|NCT04493931|9627102|FG006|STARTED|Cohort2:Treatment Period2(Up to 10 Days)||0
8592216|NCT04493931|9627096|FG000|COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0
8592217|NCT04493931|9627097|FG001|COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||14
8592218|NCT04493931|9627098|FG002|COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0
8592219|NCT04493931|9627099|FG003|COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0
8592220|NCT04493931|9627100|FG004|COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0
8592221|NCT04493931|9627101|FG005|COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0
8592222|NCT04493931|9627102|FG006|COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0
8592223|NCT04493931|9627096|FG000|NOT COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0
8592224|NCT04493931|9627097|FG001|NOT COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||3
8592225|NCT04493931|9627098|FG002|NOT COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0
8592226|NCT04493931|9627099|FG003|NOT COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0
8592227|NCT04493931|9627100|FG004|NOT COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0
8592228|NCT04493931|9627101|FG005|NOT COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0
8592229|NCT04493931|9627102|FG006|NOT COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0
8592230|NCT04493931|9627096|FG000|STARTED|Cohort 2: Follow-up (Up to 10 Days)||0
8592231|NCT04493931|9627097|FG001|STARTED|Cohort 2: Follow-up (Up to 10 Days)||14
8592232|NCT04493931|9627098|FG002|STARTED|Cohort 2: Follow-up (Up to 10 Days)||0
8592233|NCT04493931|9627099|FG003|STARTED|Cohort 2: Follow-up (Up to 10 Days)||0
8592234|NCT04493931|9627100|FG004|STARTED|Cohort 2: Follow-up (Up to 10 Days)||0
8592235|NCT04493931|9627101|FG005|STARTED|Cohort 2: Follow-up (Up to 10 Days)||0
8592236|NCT04493931|9627102|FG006|STARTED|Cohort 2: Follow-up (Up to 10 Days)||0
8592237|NCT04493931|9627096|FG000|COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0
8592238|NCT04493931|9627097|FG001|COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||14
8592239|NCT04493931|9627098|FG002|COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0
8592240|NCT04493931|9627099|FG003|COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0
8592241|NCT04493931|9627100|FG004|COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0
8592242|NCT04493931|9627101|FG005|COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0
8592243|NCT04493931|9627102|FG006|COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0
8592244|NCT04493931|9627096|FG000|NOT COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0
8592245|NCT04493931|9627097|FG001|NOT COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0
8592246|NCT04493931|9627098|FG002|NOT COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0
8592247|NCT04493931|9627099|FG003|NOT COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0
8592248|NCT04493931|9627100|FG004|NOT COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0
8592249|NCT04493931|9627101|FG005|NOT COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0
8592250|NCT04493931|9627102|FG006|NOT COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0
8592251|NCT04493931|9627096|FG000|STARTED|Cohort3:Treatment Period 1(Up to 5 Days)||0
8592252|NCT04493931|9627097|FG001|STARTED|Cohort3:Treatment Period 1(Up to 5 Days)||0
8592253|NCT04493931|9627098|FG002|STARTED|Cohort3:Treatment Period 1(Up to 5 Days)||10
8592254|NCT04493931|9627099|FG003|STARTED|Cohort3:Treatment Period 1(Up to 5 Days)||9
8592255|NCT04493931|9627100|FG004|STARTED|Cohort3:Treatment Period 1(Up to 5 Days)||0
8592256|NCT04493931|9627101|FG005|STARTED|Cohort3:Treatment Period 1(Up to 5 Days)||0
8592257|NCT04493931|9627102|FG006|STARTED|Cohort3:Treatment Period 1(Up to 5 Days)||0
8592258|NCT04493931|9627096|FG000|COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0
8592259|NCT04493931|9627097|FG001|COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0
8592260|NCT04493931|9627098|FG002|COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||9
8592261|NCT04493931|9627099|FG003|COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||9
8592262|NCT04493931|9627100|FG004|COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0
8592263|NCT04493931|9627101|FG005|COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0
8592264|NCT04493931|9627102|FG006|COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0
8592265|NCT04493931|9627096|FG000|NOT COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0
8592266|NCT04493931|9627097|FG001|NOT COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0
8592267|NCT04493931|9627098|FG002|NOT COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||1
8592268|NCT04493931|9627099|FG003|NOT COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0
8592269|NCT04493931|9627100|FG004|NOT COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0
8592270|NCT04493931|9627101|FG005|NOT COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0
8592271|NCT04493931|9627102|FG006|NOT COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0
8592272|NCT04493931|9627096|FG000|STARTED|Cohort3:Washout Period 1(Up to 10 Days)||0
8592273|NCT04493931|9627097|FG001|STARTED|Cohort3:Washout Period 1(Up to 10 Days)||0
8592274|NCT04493931|9627098|FG002|STARTED|Cohort3:Washout Period 1(Up to 10 Days)||9
8592275|NCT04493931|9627099|FG003|STARTED|Cohort3:Washout Period 1(Up to 10 Days)||9
8592276|NCT04493931|9627100|FG004|STARTED|Cohort3:Washout Period 1(Up to 10 Days)||0
8592277|NCT04493931|9627101|FG005|STARTED|Cohort3:Washout Period 1(Up to 10 Days)||0
8592278|NCT04493931|9627102|FG006|STARTED|Cohort3:Washout Period 1(Up to 10 Days)||0
8592279|NCT04493931|9627096|FG000|COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0
8592280|NCT04493931|9627097|FG001|COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0
8592281|NCT04493931|9627098|FG002|COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||9
8592282|NCT04493931|9627099|FG003|COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||9
8592283|NCT04493931|9627100|FG004|COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0
8592284|NCT04493931|9627101|FG005|COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0
8592285|NCT04493931|9627102|FG006|COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0
8592286|NCT04493931|9627096|FG000|NOT COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0
8592287|NCT04493931|9627097|FG001|NOT COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0
8592288|NCT04493931|9627098|FG002|NOT COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0
8592289|NCT04493931|9627099|FG003|NOT COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0
8592290|NCT04493931|9627100|FG004|NOT COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0
8592291|NCT04493931|9627101|FG005|NOT COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0
8592292|NCT04493931|9627102|FG006|NOT COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0
8592293|NCT04493931|9627096|FG000|STARTED|Cohort3:Treatment Period 2(Up to 5 Days)||0
8592294|NCT04493931|9627097|FG001|STARTED|Cohort3:Treatment Period 2(Up to 5 Days)||0
8592295|NCT04493931|9627098|FG002|STARTED|Cohort3:Treatment Period 2(Up to 5 Days)||9
8592296|NCT04493931|9627099|FG003|STARTED|Cohort3:Treatment Period 2(Up to 5 Days)||9
8592297|NCT04493931|9627100|FG004|STARTED|Cohort3:Treatment Period 2(Up to 5 Days)||0
8592298|NCT04493931|9627101|FG005|STARTED|Cohort3:Treatment Period 2(Up to 5 Days)||0
8592299|NCT04493931|9627102|FG006|STARTED|Cohort3:Treatment Period 2(Up to 5 Days)||0
8592300|NCT04493931|9627096|FG000|COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0
8592301|NCT04493931|9627097|FG001|COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0
8592302|NCT04493931|9627098|FG002|COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||9
8592303|NCT04493931|9627099|FG003|COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||9
8592304|NCT04493931|9627100|FG004|COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0
8592305|NCT04493931|9627101|FG005|COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0
8592306|NCT04493931|9627102|FG006|COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0
8592307|NCT04493931|9627096|FG000|NOT COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0
8592308|NCT04493931|9627097|FG001|NOT COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0
8592309|NCT04493931|9627098|FG002|NOT COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0
8592310|NCT04493931|9627099|FG003|NOT COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0
8592311|NCT04493931|9627100|FG004|NOT COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0
8592312|NCT04493931|9627101|FG005|NOT COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0
8592313|NCT04493931|9627102|FG006|NOT COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0
8592314|NCT04493931|9627096|FG000|STARTED|Cohort 3: Follow-up (Up to 10 Days)||0
8592315|NCT04493931|9627097|FG001|STARTED|Cohort 3: Follow-up (Up to 10 Days)||0
8592316|NCT04493931|9627098|FG002|STARTED|Cohort 3: Follow-up (Up to 10 Days)||9
8592317|NCT04493931|9627099|FG003|STARTED|Cohort 3: Follow-up (Up to 10 Days)||9
8592318|NCT04493931|9627100|FG004|STARTED|Cohort 3: Follow-up (Up to 10 Days)||0
8592319|NCT04493931|9627101|FG005|STARTED|Cohort 3: Follow-up (Up to 10 Days)||0
8592320|NCT04493931|9627102|FG006|STARTED|Cohort 3: Follow-up (Up to 10 Days)||0
8592321|NCT04493931|9627096|FG000|COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0
8592322|NCT04493931|9627097|FG001|COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0
8592323|NCT04493931|9627098|FG002|COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||9
8592324|NCT04493931|9627099|FG003|COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||9
8592325|NCT04493931|9627100|FG004|COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0
8592326|NCT04493931|9627101|FG005|COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0
8592327|NCT04493931|9627102|FG006|COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0
8592328|NCT04493931|9627096|FG000|NOT COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0
8592329|NCT04493931|9627097|FG001|NOT COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0
8592330|NCT04493931|9627098|FG002|NOT COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0
8592331|NCT04493931|9627099|FG003|NOT COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0
8592332|NCT04493931|9627100|FG004|NOT COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0
8592333|NCT04493931|9627101|FG005|NOT COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0
8592334|NCT04493931|9627102|FG006|NOT COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0
8592335|NCT04493931|9627096|FG000|STARTED|Cohort4:Treatment Period 1(Up to 3 Days)||0
8592336|NCT04493931|9627097|FG001|STARTED|Cohort4:Treatment Period 1(Up to 3 Days)||0
8592337|NCT04493931|9627098|FG002|STARTED|Cohort4:Treatment Period 1(Up to 3 Days)||0
8592338|NCT04493931|9627099|FG003|STARTED|Cohort4:Treatment Period 1(Up to 3 Days)||0
8592339|NCT04493931|9627100|FG004|STARTED|Cohort4:Treatment Period 1(Up to 3 Days)||6
8592340|NCT04493931|9627101|FG005|STARTED|Cohort4:Treatment Period 1(Up to 3 Days)||5
8592341|NCT04493931|9627102|FG006|STARTED|Cohort4:Treatment Period 1(Up to 3 Days)||3
8592342|NCT04493931|9627096|FG000|COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0
8592343|NCT04493931|9627097|FG001|COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0
8592344|NCT04493931|9627098|FG002|COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0
8592345|NCT04493931|9627099|FG003|COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0
8592346|NCT04493931|9627100|FG004|COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||6
8592347|NCT04493931|9627101|FG005|COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||5
8592348|NCT04493931|9627102|FG006|COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||3
8592349|NCT04493931|9627096|FG000|NOT COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0
8592350|NCT04493931|9627097|FG001|NOT COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0
8592351|NCT04493931|9627098|FG002|NOT COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0
8592352|NCT04493931|9627099|FG003|NOT COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0
8592353|NCT04493931|9627100|FG004|NOT COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0
8592354|NCT04493931|9627101|FG005|NOT COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0
8592355|NCT04493931|9627102|FG006|NOT COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0
8592356|NCT04493931|9627096|FG000|STARTED|Cohort4:Washout Period 1(Up to 3 Days)||0
8592357|NCT04493931|9627097|FG001|STARTED|Cohort4:Washout Period 1(Up to 3 Days)||0
8592358|NCT04493931|9627098|FG002|STARTED|Cohort4:Washout Period 1(Up to 3 Days)||0
8592359|NCT04493931|9627099|FG003|STARTED|Cohort4:Washout Period 1(Up to 3 Days)||0
8592360|NCT04493931|9627100|FG004|STARTED|Cohort4:Washout Period 1(Up to 3 Days)||6
8592361|NCT04493931|9627101|FG005|STARTED|Cohort4:Washout Period 1(Up to 3 Days)||5
8592362|NCT04493931|9627102|FG006|STARTED|Cohort4:Washout Period 1(Up to 3 Days)||3
8592363|NCT04493931|9627096|FG000|COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0
8711469|NCT00962013|9757804|FG000|STARTED|Overall Study||120
8711470|NCT00962013|9757804|FG000|COMPLETED|Overall Study|Number of participants with 5 year primary endpoint data|52
8711471|NCT00962013|9757804|FG000|NOT COMPLETED|Overall Study||68
8711472|NCT00962039|9757810|FG000|STARTED|Overall Study||40
8711473|NCT00962039|9757811|FG001|STARTED|Overall Study||41
8711474|NCT00962039|9757810|FG000|COMPLETED|Overall Study||35
8711475|NCT00962039|9757811|FG001|COMPLETED|Overall Study||37
8711476|NCT00962039|9757810|FG000|NOT COMPLETED|Overall Study||5
8711477|NCT00962039|9757811|FG001|NOT COMPLETED|Overall Study||4
8711478|NCT00962065|9757820|FG000|STARTED|Overall Study||12
8711479|NCT00962065|9757821|FG001|STARTED|Overall Study||12
8711480|NCT00962065|9757822|FG002|STARTED|Overall Study||12
8711481|NCT00962065|9757820|FG000|COMPLETED|Overall Study||12
8711482|NCT00962065|9757821|FG001|COMPLETED|Overall Study||12
8711483|NCT00962065|9757822|FG002|COMPLETED|Overall Study||12
8711484|NCT00962065|9757820|FG000|NOT COMPLETED|Overall Study||0
8711485|NCT00962065|9757821|FG001|NOT COMPLETED|Overall Study||0
8711486|NCT00962065|9757822|FG002|NOT COMPLETED|Overall Study||0
8711487|NCT00962078|9757832|FG000|STARTED|Overall Study||35
8711488|NCT00962078|9757833|FG001|STARTED|Overall Study||36
8711489|NCT00962078|9757832|FG000|COMPLETED|Overall Study||30
8711490|NCT00962078|9757833|FG001|COMPLETED|Overall Study||30
8711491|NCT00962078|9757832|FG000|NOT COMPLETED|Overall Study||5
8711492|NCT00962078|9757833|FG001|NOT COMPLETED|Overall Study||6
8711493|NCT00962091|9757846|FG000|STARTED|Overall Study||4
8711494|NCT00962091|9757847|FG001|STARTED|Overall Study||9
8711495|NCT00962091|9757848|FG002|STARTED|Overall Study||10
8711496|NCT00962091|9757849|FG003|STARTED|Overall Study||3
8592364|NCT04493931|9627097|FG001|COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0
8592365|NCT04493931|9627098|FG002|COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0
8592366|NCT04493931|9627099|FG003|COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0
8592367|NCT04493931|9627100|FG004|COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||6
8592368|NCT04493931|9627101|FG005|COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||5
8592369|NCT04493931|9627102|FG006|COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||3
8592370|NCT04493931|9627096|FG000|NOT COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0
8592371|NCT04493931|9627097|FG001|NOT COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0
8592372|NCT04493931|9627098|FG002|NOT COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0
8592373|NCT04493931|9627099|FG003|NOT COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0
8592374|NCT04493931|9627100|FG004|NOT COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0
8592375|NCT04493931|9627101|FG005|NOT COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0
8592376|NCT04493931|9627102|FG006|NOT COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0
8592377|NCT04493931|9627096|FG000|STARTED|Cohort4:Treatment Period 2(Up to 3 Days)||0
8592378|NCT04493931|9627097|FG001|STARTED|Cohort4:Treatment Period 2(Up to 3 Days)||0
8592379|NCT04493931|9627098|FG002|STARTED|Cohort4:Treatment Period 2(Up to 3 Days)||0
8592380|NCT04493931|9627099|FG003|STARTED|Cohort4:Treatment Period 2(Up to 3 Days)||0
8592381|NCT04493931|9627100|FG004|STARTED|Cohort4:Treatment Period 2(Up to 3 Days)||6
8592382|NCT04493931|9627101|FG005|STARTED|Cohort4:Treatment Period 2(Up to 3 Days)||5
8592383|NCT04493931|9627102|FG006|STARTED|Cohort4:Treatment Period 2(Up to 3 Days)||3
8592384|NCT04493931|9627096|FG000|COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0
8592385|NCT04493931|9627097|FG001|COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0
8592386|NCT04493931|9627098|FG002|COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0
8592387|NCT04493931|9627099|FG003|COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0
8711497|NCT00962091|9757850|FG004|STARTED|Overall Study||3
8711498|NCT00962091|9757851|FG005|STARTED|Overall Study||12
8711499|NCT00962091|9757852|FG006|STARTED|Overall Study||12
8711500|NCT00962091|9757846|FG000|COMPLETED|Overall Study||3
8711501|NCT00962091|9757847|FG001|COMPLETED|Overall Study||7
8592388|NCT04493931|9627100|FG004|COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||6
8592389|NCT04493931|9627101|FG005|COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||5
8592390|NCT04493931|9627102|FG006|COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||3
8592391|NCT04493931|9627096|FG000|NOT COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0
8592392|NCT04493931|9627097|FG001|NOT COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0
8592393|NCT04493931|9627098|FG002|NOT COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0
8592394|NCT04493931|9627099|FG003|NOT COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0
8592395|NCT04493931|9627100|FG004|NOT COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0
8592396|NCT04493931|9627101|FG005|NOT COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0
8592397|NCT04493931|9627102|FG006|NOT COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0
8592398|NCT04493931|9627096|FG000|STARTED|Cohort4:Washout Period 2(Up to 3 Days)||0
8592399|NCT04493931|9627097|FG001|STARTED|Cohort4:Washout Period 2(Up to 3 Days)||0
8592400|NCT04493931|9627098|FG002|STARTED|Cohort4:Washout Period 2(Up to 3 Days)||0
8592401|NCT04493931|9627099|FG003|STARTED|Cohort4:Washout Period 2(Up to 3 Days)||0
8592402|NCT04493931|9627100|FG004|STARTED|Cohort4:Washout Period 2(Up to 3 Days)||6
8592403|NCT04493931|9627101|FG005|STARTED|Cohort4:Washout Period 2(Up to 3 Days)||5
8592404|NCT04493931|9627102|FG006|STARTED|Cohort4:Washout Period 2(Up to 3 Days)||3
8592405|NCT04493931|9627096|FG000|COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0
8592406|NCT04493931|9627097|FG001|COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0
8592407|NCT04493931|9627098|FG002|COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0
8592408|NCT04493931|9627099|FG003|COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0
8592409|NCT04493931|9627100|FG004|COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||6
8592410|NCT04493931|9627101|FG005|COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||5
8592411|NCT04493931|9627102|FG006|COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||3
8592412|NCT04493931|9627096|FG000|NOT COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0
8592413|NCT04493931|9627097|FG001|NOT COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0
8592414|NCT04493931|9627098|FG002|NOT COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0
8592415|NCT04493931|9627099|FG003|NOT COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0
8592416|NCT04493931|9627100|FG004|NOT COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0
8592417|NCT04493931|9627101|FG005|NOT COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0
8592418|NCT04493931|9627102|FG006|NOT COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0
8592419|NCT04493931|9627096|FG000|STARTED|Cohort4:Treatment Period 3(Up to 3 Days)||0
8592420|NCT04493931|9627097|FG001|STARTED|Cohort4:Treatment Period 3(Up to 3 Days)||0
8592421|NCT04493931|9627098|FG002|STARTED|Cohort4:Treatment Period 3(Up to 3 Days)||0
8592422|NCT04493931|9627099|FG003|STARTED|Cohort4:Treatment Period 3(Up to 3 Days)||0
8592423|NCT04493931|9627100|FG004|STARTED|Cohort4:Treatment Period 3(Up to 3 Days)||6
8592424|NCT04493931|9627101|FG005|STARTED|Cohort4:Treatment Period 3(Up to 3 Days)||5
8592425|NCT04493931|9627102|FG006|STARTED|Cohort4:Treatment Period 3(Up to 3 Days)||3
8592426|NCT04493931|9627096|FG000|COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0
8592427|NCT04493931|9627097|FG001|COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0
8592428|NCT04493931|9627098|FG002|COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0
8592429|NCT04493931|9627099|FG003|COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0
8592430|NCT04493931|9627100|FG004|COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||6
8592431|NCT04493931|9627101|FG005|COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||5
8592432|NCT04493931|9627102|FG006|COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||3
8592433|NCT04493931|9627096|FG000|NOT COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0
8592434|NCT04493931|9627097|FG001|NOT COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0
8592435|NCT04493931|9627098|FG002|NOT COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0
8592436|NCT04493931|9627099|FG003|NOT COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0
8592437|NCT04493931|9627100|FG004|NOT COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0
8592438|NCT04493931|9627101|FG005|NOT COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0
8592439|NCT04493931|9627102|FG006|NOT COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0
8592440|NCT04493931|9627096|FG000|STARTED|Cohort 4: Follow-up (Up to 7 Days)||0
8592441|NCT04493931|9627097|FG001|STARTED|Cohort 4: Follow-up (Up to 7 Days)||0
8592442|NCT04493931|9627098|FG002|STARTED|Cohort 4: Follow-up (Up to 7 Days)||0
8592443|NCT04493931|9627099|FG003|STARTED|Cohort 4: Follow-up (Up to 7 Days)||0
8592444|NCT04493931|9627100|FG004|STARTED|Cohort 4: Follow-up (Up to 7 Days)||6
8592445|NCT04493931|9627101|FG005|STARTED|Cohort 4: Follow-up (Up to 7 Days)||5
8592446|NCT04493931|9627102|FG006|STARTED|Cohort 4: Follow-up (Up to 7 Days)||3
8592447|NCT04493931|9627096|FG000|COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0
8592448|NCT04493931|9627097|FG001|COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0
8592449|NCT04493931|9627098|FG002|COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0
8592450|NCT04493931|9627099|FG003|COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0
8592451|NCT04493931|9627100|FG004|COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||6
8592452|NCT04493931|9627101|FG005|COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||5
8592453|NCT04493931|9627102|FG006|COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||3
8592454|NCT04493931|9627096|FG000|NOT COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0
8592455|NCT04493931|9627097|FG001|NOT COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0
8592456|NCT04493931|9627098|FG002|NOT COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0
8592457|NCT04493931|9627099|FG003|NOT COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0
8592458|NCT04493931|9627100|FG004|NOT COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0
8592459|NCT04493931|9627101|FG005|NOT COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0
8592460|NCT04493931|9627102|FG006|NOT COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0
8628066|NCT00520936|9667477|FG006|STARTED|Overall Study||11
8628067|NCT00520936|9667478|FG007|STARTED|Overall Study||10
8628068|NCT00520936|9667471|FG000|COMPLETED|Overall Study|Study completion defined as treated until disease progression. Completed=progressive disease.|10
8628069|NCT00520936|9667472|FG001|COMPLETED|Overall Study||7
8628070|NCT00520936|9667473|FG002|COMPLETED|Overall Study||7
8628071|NCT00520936|9667474|FG003|COMPLETED|Overall Study||5
8628072|NCT00520936|9667475|FG004|COMPLETED|Overall Study||5
8628073|NCT00520936|9667476|FG005|COMPLETED|Overall Study||10
8628074|NCT00520936|9667477|FG006|COMPLETED|Overall Study||7
8628075|NCT00520936|9667478|FG007|COMPLETED|Overall Study||9
8628076|NCT00520936|9667471|FG000|NOT COMPLETED|Overall Study||0
8628077|NCT00520936|9667472|FG001|NOT COMPLETED|Overall Study||4
8628078|NCT00520936|9667473|FG002|NOT COMPLETED|Overall Study||2
8628079|NCT00520936|9667474|FG003|NOT COMPLETED|Overall Study||0
8628080|NCT00520936|9667475|FG004|NOT COMPLETED|Overall Study||1
8628081|NCT00520936|9667476|FG005|NOT COMPLETED|Overall Study||0
8628082|NCT00520936|9667477|FG006|NOT COMPLETED|Overall Study||4
8628083|NCT00520936|9667478|FG007|NOT COMPLETED|Overall Study||1
8628084|NCT00520975|9667491|FG000|STARTED|Overall Study||48
8628085|NCT00520975|9667492|FG001|STARTED|Overall Study||48
8628086|NCT00520975|9667491|FG000|Treated and Reported Adverse Events Data|Overall Study||47
8628087|NCT00520975|9667492|FG001|Treated and Reported Adverse Events Data|Overall Study||45
8628088|NCT00520975|9667491|FG000|COMPLETED|Overall Study|Treatment continued until progression or intolerable toxicity.|0
8628089|NCT00520975|9667492|FG001|COMPLETED|Overall Study|Treatment continued until progression or intolerable toxicity.|0
8628090|NCT00520975|9667491|FG000|NOT COMPLETED|Overall Study||48
8628091|NCT00520975|9667492|FG001|NOT COMPLETED|Overall Study||48
8628092|NCT00521001|9667498|FG000|STARTED|Overall Study||49
8628093|NCT00521001|9667498|FG000|COMPLETED|Overall Study||48
8628094|NCT00521001|9667498|FG000|NOT COMPLETED|Overall Study||1
8628095|NCT00521014|9667502|FG000|STARTED|Overall Study||14
8628096|NCT00521014|9667502|FG000|COMPLETED|Overall Study||13
8628097|NCT00521014|9667502|FG000|NOT COMPLETED|Overall Study||1
8628098|NCT00521053|9667506|FG000|STARTED|Treatment Phase||80
8628099|NCT00521053|9667506|FG000|Received 1 Cycle of PV-10|Treatment Phase||35
8628100|NCT00521053|9667506|FG000|Received 2 Cycles of PV-10|Treatment Phase||26
8628101|NCT00521053|9667506|FG000|Received 3 Cycles of PV-10|Treatment Phase||16
8628102|NCT00521053|9667506|FG000|Received 4 Cycles of PV-10|Treatment Phase||3
8628103|NCT00521053|9667506|FG000|COMPLETED|Treatment Phase||80
8628104|NCT00521053|9667506|FG000|NOT COMPLETED|Treatment Phase||0
8628105|NCT00521053|9667506|FG000|STARTED|Observation Phase||80
8628106|NCT00521053|9667506|FG000|COMPLETED|Observation Phase||12
8628107|NCT00521053|9667506|FG000|NOT COMPLETED|Observation Phase||68
8628108|NCT00521079|9667515|FG000|STARTED|Overall Study||192
8628109|NCT00521079|9667516|FG001|STARTED|Overall Study||102
8628110|NCT00521079|9667515|FG000|Surgical Roll-In|Overall Study||9
8628111|NCT00521079|9667516|FG001|Surgical Roll-In|Overall Study||5
8628112|NCT00521079|9667515|FG000|COMPLETED|Overall Study||178
8628113|NCT00521079|9667516|FG001|COMPLETED|Overall Study||97
8628114|NCT00521079|9667515|FG000|NOT COMPLETED|Overall Study||14
8628115|NCT00521079|9667516|FG001|NOT COMPLETED|Overall Study||5
8628116|NCT00521144|9667527|FG000|STARTED|Overall Study||6
8628117|NCT00521144|9667528|FG001|STARTED|Overall Study||5
8628118|NCT00521144|9667529|FG002|STARTED|Overall Study||3
8628119|NCT00521144|9667530|FG003|STARTED|Overall Study||1
8628120|NCT00521144|9667531|FG004|STARTED|Overall Study||7
8628121|NCT00521144|9667527|FG000|COMPLETED|Overall Study||2
8628122|NCT00521144|9667528|FG001|COMPLETED|Overall Study||2
8628123|NCT00521144|9667529|FG002|COMPLETED|Overall Study||1
8628124|NCT00521144|9667530|FG003|COMPLETED|Overall Study||0
8628125|NCT00521144|9667531|FG004|COMPLETED|Overall Study||0
8628126|NCT00521144|9667527|FG000|NOT COMPLETED|Overall Study||4
8628127|NCT00521144|9667528|FG001|NOT COMPLETED|Overall Study||3
8628128|NCT00521144|9667529|FG002|NOT COMPLETED|Overall Study||2
8628129|NCT00521144|9667530|FG003|NOT COMPLETED|Overall Study||1
8628130|NCT00521144|9667531|FG004|NOT COMPLETED|Overall Study||7
8628131|NCT00521339|9667543|FG000|STARTED|Treatment Phase||31
8628132|NCT00521339|9667544|FG001|STARTED|Treatment Phase||0
8628133|NCT00521339|9667545|FG002|STARTED|Treatment Phase||0
8628134|NCT00521339|9667543|FG000|Received Apremilast|Treatment Phase|1 participant withdrew consent prior to first visit and was excluded from safety population|30
8628135|NCT00521339|9667544|FG001|Received Apremilast|Treatment Phase||0
8628136|NCT00521339|9667545|FG002|Received Apremilast|Treatment Phase||0
8628137|NCT00521339|9667543|FG000|COMPLETED|Treatment Phase||19
8628138|NCT00521339|9667544|FG001|COMPLETED|Treatment Phase||0
8628139|NCT00521339|9667545|FG002|COMPLETED|Treatment Phase||0
8628140|NCT00521339|9667543|FG000|NOT COMPLETED|Treatment Phase||12
8628141|NCT00521339|9667544|FG001|NOT COMPLETED|Treatment Phase||0
8628142|NCT00521339|9667545|FG002|NOT COMPLETED|Treatment Phase||0
8628143|NCT00521339|9667543|FG000|STARTED|Treatment Extension Phase||0
8628144|NCT00521339|9667544|FG001|STARTED|Treatment Extension Phase|Some participants had completed the treatment phase prior to inception of extension phase|4
8628145|NCT00521339|9667545|FG002|STARTED|Treatment Extension Phase|Some participants had completed the treatment phase prior to inception of extension phase|7
8628146|NCT00521339|9667543|FG000|COMPLETED|Treatment Extension Phase||0
8628147|NCT00521339|9667544|FG001|COMPLETED|Treatment Extension Phase||4
8628148|NCT00521339|9667545|FG002|COMPLETED|Treatment Extension Phase||4
8592461|NCT04428034|9627132|FG000|STARTED|Enrollment to Intervention Completion||45
8592462|NCT04428034|9627132|FG000|Attended at Least 2 Intervention Sessions in One Cohort|Enrollment to Intervention Completion|"Forty-five (45) participants enrolled and completed the baseline survey. Of those who completed they baseline survey, six participants of those who completed the baseline survey did not attend at least 2 sessions. Three participants started the intervention in one cohort, but completed in another (off-protocol). One participant was found to be a fraudulent case, identified through none-varying (straight line) responses to survey questions."|35
8592463|NCT04428034|9627132|FG000|COMPLETED|Enrollment to Intervention Completion||35
8592464|NCT04428034|9627132|FG000|NOT COMPLETED|Enrollment to Intervention Completion||10
8592465|NCT04428034|9627132|FG000|STARTED|4-Week Follow Up Survey||35
8592466|NCT04428034|9627132|FG000|COMPLETED|4-Week Follow Up Survey||29
8592467|NCT04428034|9627132|FG000|NOT COMPLETED|4-Week Follow Up Survey||6
8592468|NCT04428034|9627132|FG000|STARTED|8-Week Follow Up Survey||29
8592469|NCT04428034|9627132|FG000|COMPLETED|8-Week Follow Up Survey|Of those 27 who completed the 8-week follow up survey, one participant skipped the 4-week follow up survey but completed the 8-week survey.|27
8592470|NCT04428034|9627132|FG000|NOT COMPLETED|8-Week Follow Up Survey||2
8592471|NCT04262947|9627139|FG000|STARTED|Overall Study||13
8592472|NCT04262947|9627140|FG001|STARTED|Overall Study||13
8592473|NCT04262947|9627141|FG002|STARTED|Overall Study||12
8592474|NCT04262947|9627139|FG000|COMPLETED|Overall Study||13
8592475|NCT04262947|9627140|FG001|COMPLETED|Overall Study||13
8592476|NCT04262947|9627141|FG002|COMPLETED|Overall Study||12
8592477|NCT04262947|9627139|FG000|NOT COMPLETED|Overall Study||0
8592478|NCT04262947|9627140|FG001|NOT COMPLETED|Overall Study||0
8592479|NCT04262947|9627141|FG002|NOT COMPLETED|Overall Study||0
8592480|NCT04177680|9627149|FG000|STARTED|Overall Study||49
8592481|NCT04177680|9627150|FG001|STARTED|Overall Study||51
8592482|NCT04177680|9627149|FG000|COMPLETED|Overall Study||47
8592483|NCT04177680|9627150|FG001|COMPLETED|Overall Study||48
8592484|NCT04177680|9627149|FG000|NOT COMPLETED|Overall Study||2
8592485|NCT04177680|9627150|FG001|NOT COMPLETED|Overall Study||3
8592486|NCT03999554|9627161|FG000|STARTED|Overall Study||42
8592487|NCT03999554|9627162|FG001|STARTED|Overall Study||41
8592488|NCT03999554|9627163|FG002|STARTED|Overall Study||40
8592489|NCT03999554|9627164|FG003|STARTED|Overall Study||42
8592490|NCT03999554|9627165|FG004|STARTED|Overall Study||41
8592491|NCT03999554|9627161|FG000|COMPLETED|Overall Study||36
8592492|NCT03999554|9627162|FG001|COMPLETED|Overall Study||34
8592493|NCT03999554|9627163|FG002|COMPLETED|Overall Study||28
8592494|NCT03999554|9627164|FG003|COMPLETED|Overall Study||35
8592495|NCT03999554|9627165|FG004|COMPLETED|Overall Study||32
8592496|NCT03999554|9627161|FG000|NOT COMPLETED|Overall Study||6
8592497|NCT03999554|9627162|FG001|NOT COMPLETED|Overall Study||7
8592498|NCT03999554|9627163|FG002|NOT COMPLETED|Overall Study||12
8592499|NCT03999554|9627164|FG003|NOT COMPLETED|Overall Study||7
8592500|NCT03999554|9627165|FG004|NOT COMPLETED|Overall Study||9
8628149|NCT00521339|9667543|FG000|NOT COMPLETED|Treatment Extension Phase||0
8628150|NCT00521339|9667544|FG001|NOT COMPLETED|Treatment Extension Phase||0
8628151|NCT00521339|9667545|FG002|NOT COMPLETED|Treatment Extension Phase||3
8628152|NCT00521339|9667543|FG000|STARTED|Observational Follow Up Phase||14
8628153|NCT00521339|9667544|FG001|STARTED|Observational Follow Up Phase||4
8628154|NCT00521339|9667545|FG002|STARTED|Observational Follow Up Phase||4
8628155|NCT00521339|9667543|FG000|COMPLETED|Observational Follow Up Phase||14
8628156|NCT00521339|9667544|FG001|COMPLETED|Observational Follow Up Phase||4
8628157|NCT00521339|9667545|FG002|COMPLETED|Observational Follow Up Phase||4
8628158|NCT00521339|9667543|FG000|NOT COMPLETED|Observational Follow Up Phase||0
8628159|NCT00521339|9667544|FG001|NOT COMPLETED|Observational Follow Up Phase||0
8628160|NCT00521339|9667545|FG002|NOT COMPLETED|Observational Follow Up Phase||0
8628161|NCT00521352|9667568|FG000|STARTED|Overall Study||12
8628162|NCT00521352|9667569|FG001|STARTED|Overall Study||13
8628163|NCT00521352|9667568|FG000|COMPLETED|Overall Study||11
8628164|NCT00521352|9667569|FG001|COMPLETED|Overall Study||10
8628165|NCT00521352|9667568|FG000|NOT COMPLETED|Overall Study||1
8628166|NCT00521352|9667569|FG001|NOT COMPLETED|Overall Study||3
8628167|NCT00521365|9667575|FG000|STARTED|Overall Study|98 participants were screened and obtain 88 patients who receive study treatment|88
8628168|NCT00521365|9667575|FG000|Modified Intention to Treat (mITT)|Overall Study|Participants who have an YMRS assessment at inclusion, and at least one assessment after inclusion|88
8628169|NCT00521365|9667575|FG000|Per Protocol (PP) Population|Overall Study|All participants without protocol deviations|68
8628170|NCT00521365|9667575|FG000|Safety Analysis Set|Overall Study|All participants who received study treatment|88
8628171|NCT00521365|9667575|FG000|COMPLETED|Overall Study|68 participants completed the study and 68 completed without protocol deviations|68
8628172|NCT00521365|9667575|FG000|NOT COMPLETED|Overall Study||20
8628173|NCT00521404|9667579|FG000|STARTED|Overall Study||62
8628174|NCT00521404|9667579|FG000|COMPLETED|Overall Study||0
8628175|NCT00521404|9667579|FG000|NOT COMPLETED|Overall Study||62
8628176|NCT00521456|9667585|FG000|STARTED|Overall Study||176
8628177|NCT00521456|9667586|FG001|STARTED|Overall Study||87
8628178|NCT00521456|9667585|FG000|COMPLETED|Overall Study||163
8628179|NCT00521456|9667586|FG001|COMPLETED|Overall Study||59
8628180|NCT00521456|9667585|FG000|NOT COMPLETED|Overall Study||13
8628181|NCT00521456|9667586|FG001|NOT COMPLETED|Overall Study||28
8628182|NCT00521586|9667594|FG000|STARTED|Initial Vaccination (Year 0)||554
8628183|NCT00521586|9667595|FG001|STARTED|Initial Vaccination (Year 0)||562
8628184|NCT00521586|9667594|FG000|Vaccinated Dose 1|Initial Vaccination (Year 0)||551
8592501|NCT03651622|9627181|FG000|STARTED|Diet Period 1 (Randomization 1)||23
8592502|NCT03651622|9627182|FG001|STARTED|Diet Period 1 (Randomization 1)||24
8592503|NCT03651622|9627183|FG002|STARTED|Diet Period 1 (Randomization 1)||21
8592504|NCT03651622|9627181|FG000|COMPLETED|Diet Period 1 (Randomization 1)||19
8592505|NCT03651622|9627182|FG001|COMPLETED|Diet Period 1 (Randomization 1)||17
8592506|NCT03651622|9627183|FG002|COMPLETED|Diet Period 1 (Randomization 1)||12
8592507|NCT03651622|9627181|FG000|NOT COMPLETED|Diet Period 1 (Randomization 1)||4
8592508|NCT03651622|9627182|FG001|NOT COMPLETED|Diet Period 1 (Randomization 1)||7
8592509|NCT03651622|9627183|FG002|NOT COMPLETED|Diet Period 1 (Randomization 1)||9
8592510|NCT03651622|9627181|FG000|STARTED|Diet Period 2 (Randomization 2)||19
8592511|NCT03651622|9627182|FG001|STARTED|Diet Period 2 (Randomization 2)||15
8592512|NCT03651622|9627183|FG002|STARTED|Diet Period 2 (Randomization 2)||14
8592513|NCT03651622|9627181|FG000|Number of Participants Rerandomized From Hypocaloric, Low Carbohydrate Diet|Diet Period 2 (Randomization 2)||0
8592514|NCT03651622|9627182|FG001|Number of Participants Rerandomized From Hypocaloric, Low Carbohydrate Diet|Diet Period 2 (Randomization 2)||5
8592515|NCT03651622|9627183|FG002|Number of Participants Rerandomized From Hypocaloric, Low Carbohydrate Diet|Diet Period 2 (Randomization 2)||5
8592516|NCT03651622|9627181|FG000|Number of Participants Rerandomized From Hypocaloric, Moderate Low Fat Diet|Diet Period 2 (Randomization 2)||5
8592517|NCT03651622|9627182|FG001|Number of Participants Rerandomized From Hypocaloric, Moderate Low Fat Diet|Diet Period 2 (Randomization 2)||0
8592518|NCT03651622|9627183|FG002|Number of Participants Rerandomized From Hypocaloric, Moderate Low Fat Diet|Diet Period 2 (Randomization 2)||6
8592519|NCT03651622|9627181|FG000|Number of Participants Rerandomized From Mediterranean, no Caloric Restriction Diet|Diet Period 2 (Randomization 2)||5
8592520|NCT03651622|9627182|FG001|Number of Participants Rerandomized From Mediterranean, no Caloric Restriction Diet|Diet Period 2 (Randomization 2)||4
8592521|NCT03651622|9627183|FG002|Number of Participants Rerandomized From Mediterranean, no Caloric Restriction Diet|Diet Period 2 (Randomization 2)||0
8592522|NCT03651622|9627181|FG000|Number of Participants Not Rerandomized|Diet Period 2 (Randomization 2)||9
8592523|NCT03651622|9627182|FG001|Number of Participants Not Rerandomized|Diet Period 2 (Randomization 2)||6
8592524|NCT03651622|9627183|FG002|Number of Participants Not Rerandomized|Diet Period 2 (Randomization 2)||3
8592525|NCT03651622|9627181|FG000|COMPLETED|Diet Period 2 (Randomization 2)||17
8592526|NCT03651622|9627182|FG001|COMPLETED|Diet Period 2 (Randomization 2)||13
8592527|NCT03651622|9627183|FG002|COMPLETED|Diet Period 2 (Randomization 2)||11
8592528|NCT03651622|9627181|FG000|NOT COMPLETED|Diet Period 2 (Randomization 2)||2
8592529|NCT03651622|9627182|FG001|NOT COMPLETED|Diet Period 2 (Randomization 2)||2
8592530|NCT03651622|9627183|FG002|NOT COMPLETED|Diet Period 2 (Randomization 2)||3
8592531|NCT03651622|9627181|FG000|STARTED|Diet Period 3 (Randomization 3)||14
8592532|NCT03651622|9627182|FG001|STARTED|Diet Period 3 (Randomization 3)||9
8592533|NCT03651622|9627183|FG002|STARTED|Diet Period 3 (Randomization 3)||18
8592534|NCT03651622|9627181|FG000|Number of Participants Rerandomized From Hypocaloric, Low Carbohydrate Diet|Diet Period 3 (Randomization 3)||0
8592535|NCT03651622|9627182|FG001|Number of Participants Rerandomized From Hypocaloric, Low Carbohydrate Diet|Diet Period 3 (Randomization 3)||2
8592536|NCT03651622|9627183|FG002|Number of Participants Rerandomized From Hypocaloric, Low Carbohydrate Diet|Diet Period 3 (Randomization 3)||10
8592537|NCT03651622|9627181|FG000|Number of Participants Rerandomized From Hypocaloric, Moderate Low Fat Diet|Diet Period 3 (Randomization 3)||4
8592538|NCT03651622|9627182|FG001|Number of Participants Rerandomized From Hypocaloric, Moderate Low Fat Diet|Diet Period 3 (Randomization 3)||0
8592539|NCT03651622|9627183|FG002|Number of Participants Rerandomized From Hypocaloric, Moderate Low Fat Diet|Diet Period 3 (Randomization 3)||6
8592540|NCT03651622|9627181|FG000|Number of Participants Rerandomized From Mediterranean|Diet Period 3 (Randomization 3)||6
8592541|NCT03651622|9627182|FG001|Number of Participants Rerandomized From Mediterranean|Diet Period 3 (Randomization 3)||4
8592542|NCT03651622|9627183|FG002|Number of Participants Rerandomized From Mediterranean|Diet Period 3 (Randomization 3)||0
8592543|NCT03651622|9627181|FG000|Number of Participants Not Rerandomized|Diet Period 3 (Randomization 3)||4
8592544|NCT03651622|9627182|FG001|Number of Participants Not Rerandomized|Diet Period 3 (Randomization 3)||3
8592545|NCT03651622|9627183|FG002|Number of Participants Not Rerandomized|Diet Period 3 (Randomization 3)||2
8592546|NCT03651622|9627181|FG000|COMPLETED|Diet Period 3 (Randomization 3)||14
8592547|NCT03651622|9627182|FG001|COMPLETED|Diet Period 3 (Randomization 3)||9
8592548|NCT03651622|9627183|FG002|COMPLETED|Diet Period 3 (Randomization 3)||17
8592549|NCT03651622|9627181|FG000|NOT COMPLETED|Diet Period 3 (Randomization 3)||0
8592550|NCT03651622|9627182|FG001|NOT COMPLETED|Diet Period 3 (Randomization 3)||0
8592551|NCT03651622|9627183|FG002|NOT COMPLETED|Diet Period 3 (Randomization 3)||1
8592552|NCT03563716|9627193|FG000|STARTED|Overall Study||68
8592553|NCT03563716|9627194|FG001|STARTED|Overall Study||67
8592554|NCT03563716|9627193|FG000|COMPLETED|Overall Study||0
8592555|NCT03563716|9627194|FG001|COMPLETED|Overall Study|"One participant who died had as reason for discontinuation Withdrawal by Subject"|0
8592556|NCT03563716|9627193|FG000|NOT COMPLETED|Overall Study||68
8592557|NCT03563716|9627194|FG001|NOT COMPLETED|Overall Study||67
8592558|NCT03410992|9627202|FG000|STARTED|Initial Treatment Period: up to Wk16||86
8592559|NCT03410992|9627203|FG001|STARTED|Initial Treatment Period: up to Wk16||349
8592560|NCT03410992|9627204|FG002|STARTED|Initial Treatment Period: up to Wk16||0
8592561|NCT03410992|9627205|FG003|STARTED|Initial Treatment Period: up to Wk16||0
8592562|NCT03410992|9627206|FG004|STARTED|Initial Treatment Period: up to Wk16||0
8592563|NCT03410992|9627207|FG005|STARTED|Initial Treatment Period: up to Wk16||0
8592564|NCT03410992|9627208|FG006|STARTED|Initial Treatment Period: up to Wk16||0
8592565|NCT03410992|9627209|FG007|STARTED|Initial Treatment Period: up to Wk16||0
8592566|NCT03410992|9627210|FG008|STARTED|Initial Treatment Period: up to Wk16||0
8592567|NCT03410992|9627211|FG009|STARTED|Initial Treatment Period: up to Wk16||0
8592568|NCT03410992|9627212|FG010|STARTED|Initial Treatment Period: up to Wk16||0
8592569|NCT03410992|9627202|FG000|COMPLETED|Initial Treatment Period: up to Wk16||82
8592570|NCT03410992|9627203|FG001|COMPLETED|Initial Treatment Period: up to Wk16||340
8592571|NCT03410992|9627204|FG002|COMPLETED|Initial Treatment Period: up to Wk16||0
8592572|NCT03410992|9627205|FG003|COMPLETED|Initial Treatment Period: up to Wk16||0
8592573|NCT03410992|9627206|FG004|COMPLETED|Initial Treatment Period: up to Wk16||0
8592574|NCT03410992|9627207|FG005|COMPLETED|Initial Treatment Period: up to Wk16||0
8592575|NCT03410992|9627208|FG006|COMPLETED|Initial Treatment Period: up to Wk16||0
8592576|NCT03410992|9627209|FG007|COMPLETED|Initial Treatment Period: up to Wk16||0
8592577|NCT03410992|9627210|FG008|COMPLETED|Initial Treatment Period: up to Wk16||0
8592578|NCT03410992|9627211|FG009|COMPLETED|Initial Treatment Period: up to Wk16||0
8592579|NCT03410992|9627212|FG010|COMPLETED|Initial Treatment Period: up to Wk16||0
8592580|NCT03410992|9627202|FG000|NOT COMPLETED|Initial Treatment Period: up to Wk16||4
8592581|NCT03410992|9627203|FG001|NOT COMPLETED|Initial Treatment Period: up to Wk16||9
8592582|NCT03410992|9627204|FG002|NOT COMPLETED|Initial Treatment Period: up to Wk16||0
8592583|NCT03410992|9627205|FG003|NOT COMPLETED|Initial Treatment Period: up to Wk16||0
8592584|NCT03410992|9627206|FG004|NOT COMPLETED|Initial Treatment Period: up to Wk16||0
8592585|NCT03410992|9627207|FG005|NOT COMPLETED|Initial Treatment Period: up to Wk16||0
8592586|NCT03410992|9627208|FG006|NOT COMPLETED|Initial Treatment Period: up to Wk16||0
8592587|NCT03410992|9627209|FG007|NOT COMPLETED|Initial Treatment Period: up to Wk16||0
8592588|NCT03410992|9627210|FG008|NOT COMPLETED|Initial Treatment Period: up to Wk16||0
8592589|NCT03410992|9627211|FG009|NOT COMPLETED|Initial Treatment Period: up to Wk16||0
8592590|NCT03410992|9627212|FG010|NOT COMPLETED|Initial Treatment Period: up to Wk16||0
8592591|NCT03410992|9627202|FG000|STARTED|Week 16 Assessment||82
8592592|NCT03410992|9627203|FG001|STARTED|Week 16 Assessment||340
8592593|NCT03410992|9627204|FG002|STARTED|Week 16 Assessment||0
8592594|NCT03410992|9627205|FG003|STARTED|Week 16 Assessment||0
8592595|NCT03410992|9627206|FG004|STARTED|Week 16 Assessment||0
8592596|NCT03410992|9627207|FG005|STARTED|Week 16 Assessment||0
8592597|NCT03410992|9627208|FG006|STARTED|Week 16 Assessment||0
8592598|NCT03410992|9627209|FG007|STARTED|Week 16 Assessment||0
8592599|NCT03410992|9627210|FG008|STARTED|Week 16 Assessment||0
8592600|NCT03410992|9627211|FG009|STARTED|Week 16 Assessment||0
8592601|NCT03410992|9627212|FG010|STARTED|Week 16 Assessment||0
8592602|NCT03410992|9627202|FG000|Received Escape Treatment|Week 16 Assessment||81
8592603|NCT03410992|9627203|FG001|Received Escape Treatment|Week 16 Assessment||23
8592604|NCT03410992|9627204|FG002|Received Escape Treatment|Week 16 Assessment||0
8592605|NCT03410992|9627205|FG003|Received Escape Treatment|Week 16 Assessment||0
8592606|NCT03410992|9627206|FG004|Received Escape Treatment|Week 16 Assessment||0
8592607|NCT03410992|9627207|FG005|Received Escape Treatment|Week 16 Assessment||0
8592608|NCT03410992|9627208|FG006|Received Escape Treatment|Week 16 Assessment||0
8592609|NCT03410992|9627209|FG007|Received Escape Treatment|Week 16 Assessment||0
8592610|NCT03410992|9627210|FG008|Received Escape Treatment|Week 16 Assessment||0
8592611|NCT03410992|9627211|FG009|Received Escape Treatment|Week 16 Assessment||0
8592612|NCT03410992|9627212|FG010|Received Escape Treatment|Week 16 Assessment||0
8592613|NCT03410992|9627202|FG000|COMPLETED|Week 16 Assessment||1
8592614|NCT03410992|9627203|FG001|COMPLETED|Week 16 Assessment||311
8592615|NCT03410992|9627204|FG002|COMPLETED|Week 16 Assessment||0
8592616|NCT03410992|9627205|FG003|COMPLETED|Week 16 Assessment||0
8592617|NCT03410992|9627206|FG004|COMPLETED|Week 16 Assessment||0
8711502|NCT00962091|9757848|FG002|COMPLETED|Overall Study||9
8592618|NCT03410992|9627207|FG005|COMPLETED|Week 16 Assessment||0
8592619|NCT03410992|9627208|FG006|COMPLETED|Week 16 Assessment||0
8592620|NCT03410992|9627209|FG007|COMPLETED|Week 16 Assessment||0
8592621|NCT03410992|9627210|FG008|COMPLETED|Week 16 Assessment||0
8592622|NCT03410992|9627211|FG009|COMPLETED|Week 16 Assessment||0
8592623|NCT03410992|9627212|FG010|COMPLETED|Week 16 Assessment||0
8592624|NCT03410992|9627202|FG000|NOT COMPLETED|Week 16 Assessment||81
8592625|NCT03410992|9627203|FG001|NOT COMPLETED|Week 16 Assessment||29
8592626|NCT03410992|9627204|FG002|NOT COMPLETED|Week 16 Assessment||0
8592627|NCT03410992|9627205|FG003|NOT COMPLETED|Week 16 Assessment||0
8592628|NCT03410992|9627206|FG004|NOT COMPLETED|Week 16 Assessment||0
8592629|NCT03410992|9627207|FG005|NOT COMPLETED|Week 16 Assessment||0
8592630|NCT03410992|9627208|FG006|NOT COMPLETED|Week 16 Assessment||0
8592631|NCT03410992|9627209|FG007|NOT COMPLETED|Week 16 Assessment||0
8592632|NCT03410992|9627210|FG008|NOT COMPLETED|Week 16 Assessment||0
8592633|NCT03410992|9627211|FG009|NOT COMPLETED|Week 16 Assessment||0
8592634|NCT03410992|9627212|FG010|NOT COMPLETED|Week 16 Assessment||0
8592635|NCT03410992|9627202|FG000|STARTED|Randomized-Withdrawal Period: up to Wk56||0
8592636|NCT03410992|9627203|FG001|STARTED|Randomized-Withdrawal Period: up to Wk56||0
8592637|NCT03410992|9627204|FG002|STARTED|Randomized-Withdrawal Period: up to Wk56||1
8592638|NCT03410992|9627205|FG003|STARTED|Randomized-Withdrawal Period: up to Wk56||105
8592639|NCT03410992|9627206|FG004|STARTED|Randomized-Withdrawal Period: up to Wk56||100
8592640|NCT03410992|9627207|FG005|STARTED|Randomized-Withdrawal Period: up to Wk56||106
8592641|NCT03410992|9627208|FG006|STARTED|Randomized-Withdrawal Period: up to Wk56||0
8711503|NCT00962091|9757849|FG003|COMPLETED|Overall Study||2
8592642|NCT03410992|9627209|FG007|STARTED|Randomized-Withdrawal Period: up to Wk56||0
8592643|NCT03410992|9627210|FG008|STARTED|Randomized-Withdrawal Period: up to Wk56||0
8592644|NCT03410992|9627211|FG009|STARTED|Randomized-Withdrawal Period: up to Wk56||0
8592645|NCT03410992|9627212|FG010|STARTED|Randomized-Withdrawal Period: up to Wk56||0
8592646|NCT03410992|9627202|FG000|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||0
8592647|NCT03410992|9627203|FG001|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||0
8592648|NCT03410992|9627204|FG002|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||0
8592649|NCT03410992|9627205|FG003|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||67
8592650|NCT03410992|9627206|FG004|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||4
8592651|NCT03410992|9627207|FG005|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||7
8592652|NCT03410992|9627208|FG006|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||0
8592653|NCT03410992|9627209|FG007|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||0
8592654|NCT03410992|9627210|FG008|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||0
8592655|NCT03410992|9627211|FG009|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||0
8592656|NCT03410992|9627212|FG010|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||0
8592657|NCT03410992|9627202|FG000|COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
8592658|NCT03410992|9627203|FG001|COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
8592659|NCT03410992|9627204|FG002|COMPLETED|Randomized-Withdrawal Period: up to Wk56||1
8592660|NCT03410992|9627205|FG003|COMPLETED|Randomized-Withdrawal Period: up to Wk56||33
8592661|NCT03410992|9627206|FG004|COMPLETED|Randomized-Withdrawal Period: up to Wk56||93
8592662|NCT03410992|9627207|FG005|COMPLETED|Randomized-Withdrawal Period: up to Wk56||94
8592663|NCT03410992|9627208|FG006|COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
8592664|NCT03410992|9627209|FG007|COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
8592665|NCT03410992|9627210|FG008|COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
8592666|NCT03410992|9627211|FG009|COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
8592667|NCT03410992|9627212|FG010|COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
8592668|NCT03410992|9627202|FG000|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
8592669|NCT03410992|9627203|FG001|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
8592670|NCT03410992|9627204|FG002|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
8592671|NCT03410992|9627205|FG003|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||72
8592672|NCT03410992|9627206|FG004|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||7
8592673|NCT03410992|9627207|FG005|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||12
8592674|NCT03410992|9627208|FG006|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
8592675|NCT03410992|9627209|FG007|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
8592676|NCT03410992|9627210|FG008|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
8592677|NCT03410992|9627211|FG009|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
8592678|NCT03410992|9627212|FG010|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
8592679|NCT03410992|9627202|FG000|STARTED|Escape Treatment: 12 Weeks||0
8592680|NCT03410992|9627203|FG001|STARTED|Escape Treatment: 12 Weeks||0
8592681|NCT03410992|9627204|FG002|STARTED|Escape Treatment: 12 Weeks||0
8592682|NCT03410992|9627205|FG003|STARTED|Escape Treatment: 12 Weeks||0
8592683|NCT03410992|9627206|FG004|STARTED|Escape Treatment: 12 Weeks||0
8592684|NCT03410992|9627207|FG005|STARTED|Escape Treatment: 12 Weeks||0
8592685|NCT03410992|9627208|FG006|STARTED|Escape Treatment: 12 Weeks||81
8592686|NCT03410992|9627209|FG007|STARTED|Escape Treatment: 12 Weeks||23
8592687|NCT03410992|9627210|FG008|STARTED|Escape Treatment: 12 Weeks||67
8592688|NCT03410992|9627211|FG009|STARTED|Escape Treatment: 12 Weeks||4
8592689|NCT03410992|9627212|FG010|STARTED|Escape Treatment: 12 Weeks||7
8592690|NCT03410992|9627202|FG000|COMPLETED|Escape Treatment: 12 Weeks||0
8592691|NCT03410992|9627203|FG001|COMPLETED|Escape Treatment: 12 Weeks||0
8592692|NCT03410992|9627204|FG002|COMPLETED|Escape Treatment: 12 Weeks||0
8592693|NCT03410992|9627205|FG003|COMPLETED|Escape Treatment: 12 Weeks||0
8592694|NCT03410992|9627206|FG004|COMPLETED|Escape Treatment: 12 Weeks||0
8592695|NCT03410992|9627207|FG005|COMPLETED|Escape Treatment: 12 Weeks||0
8592696|NCT03410992|9627208|FG006|COMPLETED|Escape Treatment: 12 Weeks||81
8592697|NCT03410992|9627209|FG007|COMPLETED|Escape Treatment: 12 Weeks||22
8592698|NCT03410992|9627210|FG008|COMPLETED|Escape Treatment: 12 Weeks||66
8592699|NCT03410992|9627211|FG009|COMPLETED|Escape Treatment: 12 Weeks||4
8592700|NCT03410992|9627212|FG010|COMPLETED|Escape Treatment: 12 Weeks||7
8592701|NCT03410992|9627202|FG000|NOT COMPLETED|Escape Treatment: 12 Weeks||0
8592702|NCT03410992|9627203|FG001|NOT COMPLETED|Escape Treatment: 12 Weeks||0
8592703|NCT03410992|9627204|FG002|NOT COMPLETED|Escape Treatment: 12 Weeks||0
8592704|NCT03410992|9627205|FG003|NOT COMPLETED|Escape Treatment: 12 Weeks||0
8592705|NCT03410992|9627206|FG004|NOT COMPLETED|Escape Treatment: 12 Weeks||0
8592706|NCT03410992|9627207|FG005|NOT COMPLETED|Escape Treatment: 12 Weeks||0
8592707|NCT03410992|9627208|FG006|NOT COMPLETED|Escape Treatment: 12 Weeks||0
8592708|NCT03410992|9627209|FG007|NOT COMPLETED|Escape Treatment: 12 Weeks||1
8592709|NCT03410992|9627210|FG008|NOT COMPLETED|Escape Treatment: 12 Weeks||1
8592710|NCT03410992|9627211|FG009|NOT COMPLETED|Escape Treatment: 12 Weeks||0
8592711|NCT03410992|9627212|FG010|NOT COMPLETED|Escape Treatment: 12 Weeks||0
8592712|NCT03197935|9627244|FG000|STARTED|Overall Study||168
8592713|NCT03197935|9627245|FG001|STARTED|Overall Study||165
8592714|NCT03197935|9627244|FG000|COMPLETED|Overall Study||0
8592715|NCT03197935|9627245|FG001|COMPLETED|Overall Study||0
8592716|NCT03197935|9627244|FG000|NOT COMPLETED|Overall Study||168
8592717|NCT03197935|9627245|FG001|NOT COMPLETED|Overall Study||165
8592718|NCT03138096|9627257|FG000|STARTED|Overall Study||3
8592719|NCT03138096|9627258|FG001|STARTED|Overall Study||3
8592720|NCT03138096|9627259|FG002|STARTED|Overall Study||12
8592721|NCT03138096|9627260|FG003|STARTED|Overall Study||6
8592722|NCT03138096|9627261|FG004|STARTED|Overall Study|Phase 2 was not started because of unsufficient effectivity of the Pb(PfCS@UIS4) immunizations as pre-determined in the study protocol.|0
8592723|NCT03138096|9627257|FG000|COMPLETED|Overall Study||3
8592724|NCT03138096|9627258|FG001|COMPLETED|Overall Study||3
8592725|NCT03138096|9627259|FG002|COMPLETED|Overall Study||12
8592726|NCT03138096|9627260|FG003|COMPLETED|Overall Study||6
8592727|NCT03138096|9627261|FG004|COMPLETED|Overall Study||0
8592728|NCT03138096|9627257|FG000|NOT COMPLETED|Overall Study||0
8592729|NCT03138096|9627258|FG001|NOT COMPLETED|Overall Study||0
8592730|NCT03138096|9627259|FG002|NOT COMPLETED|Overall Study||0
8592731|NCT03138096|9627260|FG003|NOT COMPLETED|Overall Study||0
8592732|NCT03138096|9627261|FG004|NOT COMPLETED|Overall Study||0
8592733|NCT02678351|9627284|FG000|STARTED|Overall Study||74
8592734|NCT02678351|9627284|FG000|COMPLETED|Overall Study||73
8592735|NCT02678351|9627284|FG000|NOT COMPLETED|Overall Study||1
8592736|NCT02578732|9627288|FG000|STARTED|Overall Study||28
8592737|NCT02578732|9627288|FG000|COMPLETED|Overall Study||28
8592738|NCT02578732|9627288|FG000|NOT COMPLETED|Overall Study||0
8592739|NCT02272790|9627298|FG000|STARTED|Overall Study||9
8592740|NCT02272790|9627299|FG001|STARTED|Overall Study||39
8592741|NCT02272790|9627300|FG002|STARTED|Overall Study||23
8592742|NCT02272790|9627301|FG003|STARTED|Overall Study||12
8592743|NCT02272790|9627302|FG004|STARTED|Overall Study||6
8592744|NCT02272790|9627303|FG005|STARTED|Overall Study||6
8592745|NCT02272790|9627298|FG000|COMPLETED|Overall Study||9
8592746|NCT02272790|9627299|FG001|COMPLETED|Overall Study||38
8592747|NCT02272790|9627300|FG002|COMPLETED|Overall Study||23
8592748|NCT02272790|9627301|FG003|COMPLETED|Overall Study||12
8592749|NCT02272790|9627302|FG004|COMPLETED|Overall Study||6
8592750|NCT02272790|9627303|FG005|COMPLETED|Overall Study||6
8592751|NCT02272790|9627298|FG000|NOT COMPLETED|Overall Study||0
8711504|NCT00962091|9757850|FG004|COMPLETED|Overall Study||3
8711505|NCT00962091|9757851|FG005|COMPLETED|Overall Study||11
8711506|NCT00962091|9757852|FG006|COMPLETED|Overall Study||11
8711507|NCT00962091|9757846|FG000|NOT COMPLETED|Overall Study||1
8711508|NCT00962091|9757847|FG001|NOT COMPLETED|Overall Study||2
8711509|NCT00962091|9757848|FG002|NOT COMPLETED|Overall Study||1
8592752|NCT02272790|9627299|FG001|NOT COMPLETED|Overall Study||1
8592753|NCT02272790|9627300|FG002|NOT COMPLETED|Overall Study||0
8592754|NCT02272790|9627301|FG003|NOT COMPLETED|Overall Study||0
8592755|NCT02272790|9627302|FG004|NOT COMPLETED|Overall Study||0
8592756|NCT02272790|9627303|FG005|NOT COMPLETED|Overall Study||0
8628185|NCT00521586|9667595|FG001|Vaccinated Dose 1|Initial Vaccination (Year 0)||560
8628186|NCT00521586|9667594|FG000|Vaccinated Dose 2|Initial Vaccination (Year 0)||538
8628187|NCT00521586|9667595|FG001|Vaccinated Dose 2|Initial Vaccination (Year 0)||543
8628188|NCT00521586|9667594|FG000|Initially Reported to Complete Year 0|Initial Vaccination (Year 0)|Initially 1060 participants were reported to complete follow-up(Year 0),but 1066 actually completed.|531
8628189|NCT00521586|9667595|FG001|Initially Reported to Complete Year 0|Initial Vaccination (Year 0)|Initially 1060 participants were reported to complete follow-up(Year 0),but 1066 actually completed.|529
8628190|NCT00521586|9667594|FG000|COMPLETED|Initial Vaccination (Year 0)|6 additional participants initially reported to have withdrawn, actually completed follow-up(Year 0)|533
8628191|NCT00521586|9667595|FG001|COMPLETED|Initial Vaccination (Year 0)|6 additional participants initially reported to have withdrawn, actually completed follow-up(Year 0)|533
8628192|NCT00521586|9667594|FG000|NOT COMPLETED|Initial Vaccination (Year 0)||21
8628193|NCT00521586|9667595|FG001|NOT COMPLETED|Initial Vaccination (Year 0)||29
8628194|NCT00521586|9667594|FG000|STARTED|Follow-up (From 6-month[Year 0]-Year 5)||533
8628195|NCT00521586|9667595|FG001|STARTED|Follow-up (From 6-month[Year 0]-Year 5)||533
8628196|NCT00521586|9667594|FG000|COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||364
8628197|NCT00521586|9667595|FG001|COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||363
8628198|NCT00521586|9667594|FG000|NOT COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||169
8628199|NCT00521586|9667595|FG001|NOT COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||170
8628200|NCT00521586|9667594|FG000|STARTED|Revaccination With 13vPnC (Year 5)||364
8628201|NCT00521586|9667595|FG001|STARTED|Revaccination With 13vPnC (Year 5)||363
8628202|NCT00521586|9667594|FG000|Vaccinated 13vPnC (Year 5)|Revaccination With 13vPnC (Year 5)||364
8628203|NCT00521586|9667595|FG001|Vaccinated 13vPnC (Year 5)|Revaccination With 13vPnC (Year 5)||363
8628204|NCT00521586|9667594|FG000|Completed 1 Month Follow-up|Revaccination With 13vPnC (Year 5)||363
8628205|NCT00521586|9667595|FG001|Completed 1 Month Follow-up|Revaccination With 13vPnC (Year 5)||359
8628206|NCT00521586|9667594|FG000|Completed 6 Month Follow-up|Revaccination With 13vPnC (Year 5)||361
8628207|NCT00521586|9667595|FG001|Completed 6 Month Follow-up|Revaccination With 13vPnC (Year 5)||351
8628208|NCT00521586|9667594|FG000|COMPLETED|Revaccination With 13vPnC (Year 5)||361
8628209|NCT00521586|9667595|FG001|COMPLETED|Revaccination With 13vPnC (Year 5)||351
8628210|NCT00521586|9667594|FG000|NOT COMPLETED|Revaccination With 13vPnC (Year 5)||3
8628211|NCT00521586|9667595|FG001|NOT COMPLETED|Revaccination With 13vPnC (Year 5)||12
8628212|NCT00521976|9667613|FG000|STARTED|Overall Study||871
8628213|NCT00521976|9667613|FG000|COMPLETED|Overall Study||871
8628214|NCT00521976|9667613|FG000|NOT COMPLETED|Overall Study||0
8711510|NCT00962091|9757849|FG003|NOT COMPLETED|Overall Study||1
8592757|NCT01961531|9627323|FG000|STARTED|Overall Study||40
8592758|NCT01961531|9627323|FG000|COMPLETED|Overall Study||40
8592759|NCT01961531|9627323|FG000|NOT COMPLETED|Overall Study||0
8592760|NCT01880541|9627329|FG000|STARTED|Overall Study||10
8592761|NCT01880541|9627330|FG001|STARTED|Overall Study||20
8592762|NCT01880541|9627329|FG000|COMPLETED|Overall Study||10
8592763|NCT01880541|9627330|FG001|COMPLETED|Overall Study||20
8592764|NCT01880541|9627329|FG000|NOT COMPLETED|Overall Study||0
8592765|NCT01880541|9627330|FG001|NOT COMPLETED|Overall Study||0
8592766|NCT01693692|9627339|FG000|STARTED|Overall Study||130
8592767|NCT01693692|9627340|FG001|STARTED|Overall Study||131
8592768|NCT01693692|9627341|FG002|STARTED|Overall Study||131
8592769|NCT01693692|9627339|FG000|Received Study Drug|Overall Study||128
8592770|NCT01693692|9627340|FG001|Received Study Drug|Overall Study||127
8592771|NCT01693692|9627341|FG002|Received Study Drug|Overall Study||128
8592772|NCT01693692|9627339|FG000|COMPLETED|Overall Study||100
8592773|NCT01693692|9627340|FG001|COMPLETED|Overall Study||97
8592774|NCT01693692|9627341|FG002|COMPLETED|Overall Study||95
8592775|NCT01693692|9627339|FG000|NOT COMPLETED|Overall Study||30
8592776|NCT01693692|9627340|FG001|NOT COMPLETED|Overall Study||34
8592777|NCT01693692|9627341|FG002|NOT COMPLETED|Overall Study||36
8592778|NCT01685606|9627349|FG000|STARTED|Overall Study||6
8592779|NCT01685606|9627349|FG000|COMPLETED|Overall Study||5
8592780|NCT01685606|9627349|FG000|NOT COMPLETED|Overall Study||1
8592781|NCT01650350|9627353|FG000|STARTED|Overall Study||7
8592782|NCT01650350|9627353|FG000|COMPLETED|Overall Study||7
8592783|NCT01650350|9627353|FG000|NOT COMPLETED|Overall Study||0
8592784|NCT01650285|9627359|FG000|STARTED|Overall Study||5
8592785|NCT01650285|9627359|FG000|COMPLETED|Overall Study||4
8592786|NCT01650285|9627359|FG000|NOT COMPLETED|Overall Study||1
8592787|NCT01083771|9627363|FG000|STARTED|Overall Study||21
8592788|NCT01083771|9627363|FG000|COMPLETED|Overall Study||16
8592789|NCT01083771|9627363|FG000|NOT COMPLETED|Overall Study||5
8711511|NCT00962091|9757850|FG004|NOT COMPLETED|Overall Study||0
8711512|NCT00962091|9757851|FG005|NOT COMPLETED|Overall Study||1
8711513|NCT00962091|9757852|FG006|NOT COMPLETED|Overall Study||1
8711514|NCT00962104|9757878|FG000|STARTED|Overall Study||195
8711515|NCT00962104|9757879|FG001|STARTED|Overall Study||196
8711516|NCT00962104|9757878|FG000|Full Analysis Set|Overall Study|2 participants were excluded because they failed to take the assigned study medication.|193
8592790|NCT00743197|9627369|FG000|STARTED|Overall Study||1
8592791|NCT00743197|9627370|FG001|STARTED|Overall Study||2
8711517|NCT00962104|9757879|FG001|Full Analysis Set|Overall Study|1 participant was excluded because that participant failed to take the assigned study medication.|195
8711518|NCT00962104|9757878|FG000|COMPLETED|Overall Study||155
8711519|NCT00962104|9757879|FG001|COMPLETED|Overall Study||171
8711520|NCT00962104|9757878|FG000|NOT COMPLETED|Overall Study||40
8711521|NCT00962104|9757879|FG001|NOT COMPLETED|Overall Study||25
8711522|NCT00962208|9757887|FG000|STARTED|Overall Study||51
8711523|NCT00962208|9757888|FG001|STARTED|Overall Study||51
8711524|NCT00962208|9757887|FG000|COMPLETED|Overall Study||37
8711525|NCT00962208|9757888|FG001|COMPLETED|Overall Study||41
8711526|NCT00962208|9757887|FG000|NOT COMPLETED|Overall Study||14
8711527|NCT00962208|9757888|FG001|NOT COMPLETED|Overall Study||10
8711528|NCT00962247|9757894|FG000|STARTED|Usual Sedentary||61
8711529|NCT00962247|9757894|FG000|COMPLETED|Usual Sedentary||61
8711530|NCT00962247|9757894|FG000|NOT COMPLETED|Usual Sedentary||0
8711531|NCT00962247|9757894|FG000|STARTED|25% Reduction of Sedentary Activity||61
8711532|NCT00962247|9757894|FG000|COMPLETED|25% Reduction of Sedentary Activity||56
8711533|NCT00962247|9757894|FG000|NOT COMPLETED|25% Reduction of Sedentary Activity||5
8711534|NCT00962247|9757894|FG000|STARTED|50% Reduction of Sedentary Activity||56
8711535|NCT00962247|9757894|FG000|COMPLETED|50% Reduction of Sedentary Activity||56
8711536|NCT00962247|9757894|FG000|NOT COMPLETED|50% Reduction of Sedentary Activity||0
8711537|NCT00962390|9757904|FG000|STARTED|Overall Study||29
8711538|NCT00962390|9757905|FG001|STARTED|Overall Study||29
8711539|NCT00962390|9757906|FG002|STARTED|Overall Study||29
8711540|NCT00962390|9757907|FG003|STARTED|Overall Study||29
8711541|NCT00962390|9757904|FG000|COMPLETED|Overall Study||25
8711542|NCT00962390|9757905|FG001|COMPLETED|Overall Study||26
8711543|NCT00962390|9757906|FG002|COMPLETED|Overall Study||25
8711544|NCT00962390|9757907|FG003|COMPLETED|Overall Study||28
8711545|NCT00962390|9757904|FG000|NOT COMPLETED|Overall Study||4
8711546|NCT00962390|9757905|FG001|NOT COMPLETED|Overall Study||3
8711547|NCT00962390|9757906|FG002|NOT COMPLETED|Overall Study||4
8711548|NCT00962390|9757907|FG003|NOT COMPLETED|Overall Study||1
8711549|NCT00962585|9757921|FG000|STARTED|Overall Study||43
8711550|NCT00962585|9757922|FG001|STARTED|Overall Study||42
8592792|NCT00743197|9627369|FG000|COMPLETED|Overall Study||0
8592793|NCT00743197|9627370|FG001|COMPLETED|Overall Study||0
8592794|NCT00743197|9627369|FG000|NOT COMPLETED|Overall Study||1
8592795|NCT00743197|9627370|FG001|NOT COMPLETED|Overall Study||2
8592796|NCT00304915|9627378|FG000|STARTED|Overall Study||123
8592797|NCT00304915|9627379|FG001|STARTED|Overall Study||126
8711551|NCT00962585|9757923|FG002|STARTED|Overall Study||42
8711552|NCT00962585|9757924|FG003|STARTED|Overall Study||42
8711553|NCT00962585|9757921|FG000|COMPLETED|Overall Study||37
8711554|NCT00962585|9757922|FG001|COMPLETED|Overall Study||40
8711555|NCT00962585|9757923|FG002|COMPLETED|Overall Study||39
8711556|NCT00962585|9757924|FG003|COMPLETED|Overall Study||42
8592798|NCT00304915|9627378|FG000|COMPLETED|Overall Study||105
8592799|NCT00304915|9627379|FG001|COMPLETED|Overall Study||110
8592800|NCT00304915|9627378|FG000|NOT COMPLETED|Overall Study||18
8592801|NCT00304915|9627379|FG001|NOT COMPLETED|Overall Study||16
8592802|NCT00304954|9627389|FG000|STARTED|Overall Study||4
8592803|NCT00304954|9627390|FG001|STARTED|Overall Study||3
8592804|NCT00304954|9627391|FG002|STARTED|Overall Study||3
8592805|NCT00304954|9627392|FG003|STARTED|Overall Study||3
8592806|NCT00304954|9627389|FG000|COMPLETED|Overall Study||3
8592807|NCT00304954|9627390|FG001|COMPLETED|Overall Study||3
8592808|NCT00304954|9627391|FG002|COMPLETED|Overall Study||2
8592809|NCT00304954|9627392|FG003|COMPLETED|Overall Study||3
8592810|NCT00304954|9627389|FG000|NOT COMPLETED|Overall Study||1
8592811|NCT00304954|9627390|FG001|NOT COMPLETED|Overall Study||0
8592812|NCT00304954|9627391|FG002|NOT COMPLETED|Overall Study||1
8592813|NCT00304954|9627392|FG003|NOT COMPLETED|Overall Study||0
8592814|NCT00305006|9627412|FG000|STARTED|Overall Study||22
8592815|NCT00305006|9627413|FG001|STARTED|Overall Study||22
8592816|NCT00305006|9627412|FG000|COMPLETED|Overall Study||21
8592817|NCT00305006|9627413|FG001|COMPLETED|Overall Study||21
8592818|NCT00305006|9627412|FG000|NOT COMPLETED|Overall Study||1
8592819|NCT00305006|9627413|FG001|NOT COMPLETED|Overall Study||1
8592820|NCT00305058|9627421|FG000|STARTED|Overall Study||97
8592821|NCT00305058|9627422|FG001|STARTED|Overall Study||97
8592822|NCT00305058|9627421|FG000|Inclusion/Exclusion Verification|Overall Study||96
8592823|NCT00305058|9627422|FG001|Inclusion/Exclusion Verification|Overall Study||97
8592824|NCT00305058|9627421|FG000|All Outcome Data Collected|Overall Study||93
8592825|NCT00305058|9627422|FG001|All Outcome Data Collected|Overall Study||95
8592826|NCT00305058|9627421|FG000|Data Collection Forms Filed for Analysis|Overall Study||90
8592827|NCT00305058|9627422|FG001|Data Collection Forms Filed for Analysis|Overall Study||93
8592828|NCT00305058|9627421|FG000|COMPLETED|Overall Study||90
8592829|NCT00305058|9627422|FG001|COMPLETED|Overall Study||93
8592830|NCT00305058|9627421|FG000|NOT COMPLETED|Overall Study||7
8592831|NCT00305058|9627422|FG001|NOT COMPLETED|Overall Study||4
8592832|NCT00305084|9627433|FG000|STARTED|Overall Study||3
8592833|NCT00305084|9627434|FG001|STARTED|Overall Study||3
8592834|NCT00305084|9627435|FG002|STARTED|Overall Study||3
8592835|NCT00305084|9627436|FG003|STARTED|Overall Study||3
8592836|NCT00305084|9627437|FG004|STARTED|Overall Study||3
8592837|NCT00305084|9627433|FG000|COMPLETED|Overall Study||3
8592838|NCT00305084|9627434|FG001|COMPLETED|Overall Study||3
8592839|NCT00305084|9627435|FG002|COMPLETED|Overall Study||3
8592840|NCT00305084|9627436|FG003|COMPLETED|Overall Study||3
8592841|NCT00305084|9627437|FG004|COMPLETED|Overall Study||3
8592842|NCT00305084|9627433|FG000|NOT COMPLETED|Overall Study||0
8592843|NCT00305084|9627434|FG001|NOT COMPLETED|Overall Study||0
8592844|NCT00305084|9627435|FG002|NOT COMPLETED|Overall Study||0
8592845|NCT00305084|9627436|FG003|NOT COMPLETED|Overall Study||0
8592846|NCT00305084|9627437|FG004|NOT COMPLETED|Overall Study||0
8592847|NCT00305110|9627477|FG000|STARTED|Overall Study||298
8592848|NCT00305110|9627477|FG000|All Necessary Data Collected|Overall Study||269
8592849|NCT00305110|9627477|FG000|COMPLETED|Overall Study||269
8592850|NCT00305110|9627477|FG000|NOT COMPLETED|Overall Study||29
8592851|NCT00305162|9627483|FG000|STARTED|48 Hour Follow-up Period||4435
8592852|NCT00305162|9627484|FG001|STARTED|48 Hour Follow-up Period||4447
8592853|NCT00305162|9627483|FG000|Intent-to-treat (ITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|3933
8592854|NCT00305162|9627484|FG001|Intent-to-treat (ITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|3924
8592855|NCT00305162|9627483|FG000|Intent-to-treat (ITT): STEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|482
8592856|NCT00305162|9627484|FG001|Intent-to-treat (ITT): STEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|507
8592857|NCT00305162|9627483|FG000|Modified ITT (mITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|3889
8592858|NCT00305162|9627484|FG001|Modified ITT (mITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|3865
8592859|NCT00305162|9627483|FG000|Modified ITT (mITT): STEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|446
8592860|NCT00305162|9627484|FG001|Modified ITT (mITT): STEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|447
8592861|NCT00305162|9627483|FG000|Safety Population|48 Hour Follow-up Period|Patients who received at least 1 dose of study drug, according to the actual treatment received.|4374
8592862|NCT00305162|9627484|FG001|Safety Population|48 Hour Follow-up Period|Patients who received at least 1 dose of study drug, according to the actual treatment received.|4365
8592863|NCT00305162|9627483|FG000|COMPLETED|48 Hour Follow-up Period|intent-to-treat (ITT) completers at 48 hour follow-up|4415
8592864|NCT00305162|9627484|FG001|COMPLETED|48 Hour Follow-up Period|intent-to-treat (ITT) completers at 48 hour follow-up|4431
8592865|NCT00305162|9627483|FG000|NOT COMPLETED|48 Hour Follow-up Period||20
8592866|NCT00305162|9627484|FG001|NOT COMPLETED|48 Hour Follow-up Period||16
8592867|NCT00305162|9627483|FG000|STARTED|30-day Follow-up Period||4435
8592868|NCT00305162|9627484|FG001|STARTED|30-day Follow-up Period||4447
8592869|NCT00305162|9627483|FG000|Intent-to-treat (ITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days|3902
8592870|NCT00305162|9627484|FG001|Intent-to-treat (ITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days|3883
8592871|NCT00305162|9627483|FG000|Intent-to-treat (ITT): STEMI|30-day Follow-up Period|Completed through 30-days|471
8592872|NCT00305162|9627484|FG001|Intent-to-treat (ITT): STEMI|30-day Follow-up Period|Completed through 30-days|501
8592873|NCT00305162|9627483|FG000|Modified ITT (mITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|3860
8592874|NCT00305162|9627484|FG001|Modified ITT (mITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|3827
8592875|NCT00305162|9627483|FG000|Modified ITT (mITT): STEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|438
8592876|NCT00305162|9627484|FG001|Modified ITT (mITT): STEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|444
8592877|NCT00305162|9627483|FG000|COMPLETED|30-day Follow-up Period|intent-to-treat (ITT) completers at 30-day follow-up|4373
8592878|NCT00305162|9627484|FG001|COMPLETED|30-day Follow-up Period|intent-to-treat (ITT) completers at 30-day follow-up|4384
8592879|NCT00305162|9627483|FG000|NOT COMPLETED|30-day Follow-up Period||62
8592880|NCT00305162|9627484|FG001|NOT COMPLETED|30-day Follow-up Period||63
8592881|NCT00305162|9627483|FG000|STARTED|1 Year Follow-up Period||4435
8592882|NCT00305162|9627484|FG001|STARTED|1 Year Follow-up Period||4447
8592883|NCT00305162|9627483|FG000|Intent-to-treat (ITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year|3900
8592884|NCT00305162|9627484|FG001|Intent-to-treat (ITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year|3878
8592885|NCT00305162|9627483|FG000|Intent-to-treat (ITT): STEMI|1 Year Follow-up Period|Completed through 1 year|480
8592886|NCT00305162|9627484|FG001|Intent-to-treat (ITT): STEMI|1 Year Follow-up Period|Completed through 1 year|504
8592887|NCT00305162|9627483|FG000|Modified ITT (mITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|3851
8711557|NCT00962585|9757921|FG000|NOT COMPLETED|Overall Study||6
8711558|NCT00962585|9757922|FG001|NOT COMPLETED|Overall Study||2
8711559|NCT00962585|9757923|FG002|NOT COMPLETED|Overall Study||3
8711560|NCT00962585|9757924|FG003|NOT COMPLETED|Overall Study||0
8711561|NCT00962598|9757938|FG000|STARTED|Overall Study||7
8711562|NCT00962598|9757939|FG001|STARTED|Overall Study||9
8711563|NCT00962598|9757938|FG000|COMPLETED|Overall Study||7
8711564|NCT00962598|9757939|FG001|COMPLETED|Overall Study||9
8711565|NCT00962598|9757938|FG000|NOT COMPLETED|Overall Study||0
8711566|NCT00962598|9757939|FG001|NOT COMPLETED|Overall Study||0
8711567|NCT00962650|9757945|FG000|STARTED|Overall Study||10
8711568|NCT00962650|9757945|FG000|COMPLETED|Overall Study||8
8711569|NCT00962650|9757945|FG000|NOT COMPLETED|Overall Study||2
8711570|NCT00962741|9757949|FG000|STARTED|Overall Study||127
8711571|NCT00962741|9757949|FG000|COMPLETED|Overall Study||119
8711572|NCT00962741|9757949|FG000|NOT COMPLETED|Overall Study||8
8711573|NCT00962754|9757955|FG000|STARTED|Overall Study||86
8711574|NCT00962754|9757956|FG001|STARTED|Overall Study||84
8711575|NCT00962754|9757955|FG000|COMPLETED|Overall Study||86
8711576|NCT00962754|9757956|FG001|COMPLETED|Overall Study||84
8711577|NCT00962754|9757955|FG000|NOT COMPLETED|Overall Study||0
8711578|NCT00962754|9757956|FG001|NOT COMPLETED|Overall Study||0
8711579|NCT00962780|9757968|FG000|STARTED|Overall Study||151
8711580|NCT00962780|9757969|FG001|STARTED|Overall Study||152
8711581|NCT00962780|9757968|FG000|Vaccinated 13vPnC Dose 1|Overall Study||150
8711582|NCT00962780|9757969|FG001|Vaccinated 13vPnC Dose 1|Overall Study||151
8711583|NCT00962780|9757968|FG000|Vaccinated 13vPnC Dose 2|Overall Study||145
8711584|NCT00962780|9757969|FG001|Vaccinated 13vPnC Dose 2|Overall Study||145
8711585|NCT00962780|9757968|FG000|Vaccinated 13vPnC Dose 3|Overall Study||144
8711586|NCT00962780|9757969|FG001|Vaccinated 13vPnC Dose 3|Overall Study||142
8711587|NCT00962780|9757968|FG000|Vaccinated 23vPS Dose|Overall Study||143
8711588|NCT00962780|9757969|FG001|Vaccinated 23vPS Dose|Overall Study||139
8711589|NCT00962780|9757968|FG000|COMPLETED|Overall Study||141
8711590|NCT00962780|9757969|FG001|COMPLETED|Overall Study||138
8711591|NCT00962780|9757968|FG000|NOT COMPLETED|Overall Study||10
8711592|NCT00962780|9757969|FG001|NOT COMPLETED|Overall Study||14
8711593|NCT00962871|9757985|FG000|STARTED|Overall Study||6
8711594|NCT00962871|9757986|FG001|STARTED|Overall Study||6
8711595|NCT00962871|9757987|FG002|STARTED|Overall Study||12
8711596|NCT00962871|9757988|FG003|STARTED|Overall Study||6
8711597|NCT00962871|9757985|FG000|COMPLETED|Overall Study||6
8711598|NCT00962871|9757986|FG001|COMPLETED|Overall Study||6
8711599|NCT00962871|9757987|FG002|COMPLETED|Overall Study||12
8711600|NCT00962871|9757988|FG003|COMPLETED|Overall Study||6
8711601|NCT00962871|9757985|FG000|NOT COMPLETED|Overall Study||0
8711602|NCT00962871|9757986|FG001|NOT COMPLETED|Overall Study||0
8711603|NCT00962871|9757987|FG002|NOT COMPLETED|Overall Study||0
8711604|NCT00962871|9757988|FG003|NOT COMPLETED|Overall Study||0
8711605|NCT00962949|9758000|FG000|STARTED|Overall Study||13
8711606|NCT00962949|9758001|FG001|STARTED|Overall Study||15
8711607|NCT00962949|9758000|FG000|COMPLETED|Overall Study||13
8711608|NCT00962949|9758001|FG001|COMPLETED|Overall Study||15
8711609|NCT00962949|9758000|FG000|NOT COMPLETED|Overall Study||0
8711610|NCT00962949|9758001|FG001|NOT COMPLETED|Overall Study||0
8711611|NCT00963105|9758010|FG000|STARTED|Overall Study||34
8711612|NCT00963105|9758011|FG001|STARTED|Overall Study||35
8711613|NCT00963105|9758012|FG002|STARTED|Overall Study||35
8711614|NCT00963105|9758010|FG000|Received Treatment|Overall Study||34
8711615|NCT00963105|9758011|FG001|Received Treatment|Overall Study||34
8711616|NCT00963105|9758012|FG002|Received Treatment|Overall Study||35
8711617|NCT00963105|9758010|FG000|COMPLETED|Overall Study||34
8711618|NCT00963105|9758011|FG001|COMPLETED|Overall Study||35
8711619|NCT00963105|9758012|FG002|COMPLETED|Overall Study||35
8711620|NCT00963105|9758010|FG000|NOT COMPLETED|Overall Study||0
8711621|NCT00963105|9758011|FG001|NOT COMPLETED|Overall Study||0
8711622|NCT00963105|9758012|FG002|NOT COMPLETED|Overall Study||0
8711623|NCT00963157|9758025|FG000|STARTED|Overall Study||156
8592888|NCT00305162|9627484|FG001|Modified ITT (mITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|3818
8592889|NCT00305162|9627483|FG000|Modified ITT (mITT): STEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|446
8592890|NCT00305162|9627484|FG001|Modified ITT (mITT): STEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|444
8592891|NCT00305162|9627483|FG000|COMPLETED|1 Year Follow-up Period|intent-to-treat (ITT) completers at 1-year follow-up|4380
8592892|NCT00305162|9627484|FG001|COMPLETED|1 Year Follow-up Period|intent-to-treat (ITT) completers at 1-year follow-up|4382
8592893|NCT00305162|9627483|FG000|NOT COMPLETED|1 Year Follow-up Period||55
8592894|NCT00305162|9627484|FG001|NOT COMPLETED|1 Year Follow-up Period||65
8592895|NCT00305227|9627493|FG000|STARTED|Overall Study||50
8592896|NCT00305227|9627494|FG001|STARTED|Overall Study||50
8592897|NCT00305227|9627493|FG000|COMPLETED|Overall Study|with at least 8 weeks of observation|43
8592898|NCT00305227|9627494|FG001|COMPLETED|Overall Study|with at least 8 weeks of observation|44
8592899|NCT00305227|9627493|FG000|NOT COMPLETED|Overall Study||7
8592900|NCT00305227|9627494|FG001|NOT COMPLETED|Overall Study||6
8592901|NCT00305253|9627502|FG000|STARTED|Overall Study||432
8592902|NCT00305253|9627503|FG001|STARTED|Overall Study||559
8592903|NCT00305253|9627502|FG000|COMPLETED|Overall Study||432
8592904|NCT00305253|9627503|FG001|COMPLETED|Overall Study||558
8592905|NCT00305253|9627502|FG000|NOT COMPLETED|Overall Study||0
8592906|NCT00305253|9627503|FG001|NOT COMPLETED|Overall Study||1
8592907|NCT00305448|9627512|FG000|STARTED|Overall Study||45
8592908|NCT00305448|9627513|FG001|STARTED|Overall Study||51
8592909|NCT00305448|9627514|FG002|STARTED|Overall Study||47
8592910|NCT00305448|9627512|FG000|COMPLETED|Overall Study||14
8592911|NCT00305448|9627513|FG001|COMPLETED|Overall Study||17
8592912|NCT00305448|9627514|FG002|COMPLETED|Overall Study||14
8592913|NCT00305448|9627512|FG000|NOT COMPLETED|Overall Study||31
8592914|NCT00305448|9627513|FG001|NOT COMPLETED|Overall Study||34
8711624|NCT00963157|9758026|FG001|STARTED|Overall Study||163
8711625|NCT00963157|9758027|FG002|STARTED|Overall Study||160
8711626|NCT00963157|9758028|FG003|STARTED|Overall Study||157
8711627|NCT00963157|9758029|FG004|STARTED|Overall Study||153
8711628|NCT00963157|9758025|FG000|COMPLETED|Overall Study||151
8711629|NCT00963157|9758026|FG001|COMPLETED|Overall Study||159
8711630|NCT00963157|9758027|FG002|COMPLETED|Overall Study||155
8711631|NCT00963157|9758028|FG003|COMPLETED|Overall Study||150
8711632|NCT00963157|9758029|FG004|COMPLETED|Overall Study||151
8711633|NCT00963157|9758025|FG000|NOT COMPLETED|Overall Study||5
8711634|NCT00963157|9758026|FG001|NOT COMPLETED|Overall Study||4
8711635|NCT00963157|9758027|FG002|NOT COMPLETED|Overall Study||5
8711636|NCT00963157|9758028|FG003|NOT COMPLETED|Overall Study||7
8711637|NCT00963157|9758029|FG004|NOT COMPLETED|Overall Study||2
8711638|NCT00963235|9758041|FG000|STARTED|Overall Study||331
8711639|NCT00963235|9758041|FG000|Vaccinated Dose 1|Overall Study||329
8711640|NCT00963235|9758041|FG000|Vaccinated Dose 2|Overall Study||300
8711641|NCT00963235|9758041|FG000|Vaccinated Dose 3|Overall Study||279
8711642|NCT00963235|9758041|FG000|Completed Dose 3 1-month Blood Draw|Overall Study||277
8711643|NCT00963235|9758041|FG000|COMPLETED|Overall Study||271
8711644|NCT00963235|9758041|FG000|NOT COMPLETED|Overall Study||60
8711645|NCT00963430|9758050|FG000|STARTED|Overall Study||60
8711646|NCT00963430|9758051|FG001|STARTED|Overall Study||60
8711647|NCT00963430|9758050|FG000|COMPLETED|Overall Study||59
8711648|NCT00963430|9758051|FG001|COMPLETED|Overall Study||57
8711649|NCT00963430|9758050|FG000|NOT COMPLETED|Overall Study||1
8711650|NCT00963430|9758051|FG001|NOT COMPLETED|Overall Study||3
8711651|NCT00963482|9758059|FG000|STARTED|Overall Study||53
8711652|NCT00963482|9758060|FG001|STARTED|Overall Study||50
8711653|NCT00963482|9758059|FG000|COMPLETED|Overall Study||25
8711654|NCT00963482|9758060|FG001|COMPLETED|Overall Study||33
8711655|NCT00963482|9758059|FG000|NOT COMPLETED|Overall Study||28
8711656|NCT00963482|9758060|FG001|NOT COMPLETED|Overall Study||17
8711657|NCT00963508|9758068|FG000|STARTED|Overall Study||206
8711658|NCT00963508|9758069|FG001|STARTED|Overall Study||197
8711659|NCT00963508|9758068|FG000|COMPLETED|Overall Study||196
8711660|NCT00963508|9758069|FG001|COMPLETED|Overall Study||169
8711661|NCT00963508|9758068|FG000|NOT COMPLETED|Overall Study||10
8711662|NCT00963508|9758069|FG001|NOT COMPLETED|Overall Study||28
8711663|NCT00963547|9758079|FG000|STARTED|Overall Study||4
8711664|NCT00963547|9758080|FG001|STARTED|Overall Study||11
8711665|NCT00963547|9758081|FG002|STARTED|Overall Study||12
8711666|NCT00963547|9758082|FG003|STARTED|Overall Study||6
8711667|NCT00963547|9758083|FG004|STARTED|Overall Study|Study terminated before Part 2 enrollment.|0
8711668|NCT00963547|9758084|FG005|STARTED|Overall Study|Study terminated before Part 2 enrollment.|0
8711669|NCT00963547|9758085|FG006|STARTED|Overall Study|Study terminated before Part 2 enrollment.|0
8711670|NCT00963547|9758079|FG000|Treated|Overall Study||3
8711671|NCT00963547|9758080|FG001|Treated|Overall Study||11
8711672|NCT00963547|9758081|FG002|Treated|Overall Study||11
8711673|NCT00963547|9758082|FG003|Treated|Overall Study||6
8711674|NCT00963547|9758083|FG004|Treated|Overall Study|Study terminated before Part 2 enrollment.|0
8711675|NCT00963547|9758084|FG005|Treated|Overall Study|Study terminated before Part 2 enrollment.|0
8711676|NCT00963547|9758085|FG006|Treated|Overall Study|Study terminated before Part 2 enrollment.|0
8711677|NCT00963547|9758079|FG000|COMPLETED|Overall Study||0
8711678|NCT00963547|9758080|FG001|COMPLETED|Overall Study||0
8711679|NCT00963547|9758081|FG002|COMPLETED|Overall Study||0
8711680|NCT00963547|9758082|FG003|COMPLETED|Overall Study||0
8592915|NCT00305448|9627514|FG002|NOT COMPLETED|Overall Study||33
8592916|NCT00305565|9627526|FG000|STARTED|Overall Study (Safety Population)||111
8592917|NCT00305565|9627527|FG001|STARTED|Overall Study (Safety Population)||107
8592918|NCT00305565|9627528|FG002|STARTED|Overall Study (Safety Population)||113
8592919|NCT00305565|9627526|FG000|COMPLETED|Overall Study (Safety Population)||97
8592920|NCT00305565|9627527|FG001|COMPLETED|Overall Study (Safety Population)||95
8592921|NCT00305565|9627528|FG002|COMPLETED|Overall Study (Safety Population)||106
8592922|NCT00305565|9627526|FG000|NOT COMPLETED|Overall Study (Safety Population)||14
8592923|NCT00305565|9627527|FG001|NOT COMPLETED|Overall Study (Safety Population)||12
8711681|NCT00963547|9758083|FG004|COMPLETED|Overall Study|Study terminated before Part 2 enrollment.|0
8711682|NCT00963547|9758084|FG005|COMPLETED|Overall Study|Study terminated before Part 2 enrollment.|0
8711683|NCT00963547|9758085|FG006|COMPLETED|Overall Study|Study terminated before Part 2 enrollment.|0
8711684|NCT00963547|9758079|FG000|NOT COMPLETED|Overall Study||4
8711685|NCT00963547|9758080|FG001|NOT COMPLETED|Overall Study||11
8711686|NCT00963547|9758081|FG002|NOT COMPLETED|Overall Study||12
8711687|NCT00963547|9758082|FG003|NOT COMPLETED|Overall Study||6
8711688|NCT00963547|9758083|FG004|NOT COMPLETED|Overall Study||0
8711689|NCT00963547|9758084|FG005|NOT COMPLETED|Overall Study||0
8711690|NCT00963547|9758085|FG006|NOT COMPLETED|Overall Study||0
8711691|NCT00963560|9758101|FG000|STARTED|Overall Study||47
8711692|NCT00963560|9758102|FG001|STARTED|Overall Study||44
8711693|NCT00963560|9758103|FG002|STARTED|Overall Study||41
8711694|NCT00963560|9758101|FG000|COMPLETED|Overall Study||44
8711695|NCT00963560|9758102|FG001|COMPLETED|Overall Study||41
8711696|NCT00963560|9758103|FG002|COMPLETED|Overall Study||41
8711697|NCT00963560|9758101|FG000|NOT COMPLETED|Overall Study||3
8711698|NCT00963560|9758102|FG001|NOT COMPLETED|Overall Study||3
8711699|NCT00963560|9758103|FG002|NOT COMPLETED|Overall Study||0
8711700|NCT00963638|9758113|FG000|STARTED|Overall Study||20
8711701|NCT00963638|9758114|FG001|STARTED|Overall Study||20
8711702|NCT00963638|9758113|FG000|COMPLETED|Overall Study||20
8711703|NCT00963638|9758114|FG001|COMPLETED|Overall Study||20
8711704|NCT00963638|9758113|FG000|NOT COMPLETED|Overall Study||0
8711705|NCT00963638|9758114|FG001|NOT COMPLETED|Overall Study||0
8711706|NCT00963677|9758122|FG000|STARTED|Overall Study|Patients without predicted difficult intubation|35
8711707|NCT00963677|9758123|FG001|STARTED|Overall Study|Patients with predicted difficult intubation but not ventilation|20
8711708|NCT00963677|9758122|FG000|COMPLETED|Overall Study||35
8711709|NCT00963677|9758123|FG001|COMPLETED|Overall Study|Two patients were excluded from the study due to the difficult ventilation with facemask ventilation|18
8711710|NCT00963677|9758122|FG000|NOT COMPLETED|Overall Study||0
8711711|NCT00963677|9758123|FG001|NOT COMPLETED|Overall Study||2
8711712|NCT00963807|9758129|FG000|STARTED|Overall Study||26
8711713|NCT00963807|9758129|FG000|Completed Baseline Imaging|Overall Study||11
8711714|NCT00963807|9758129|FG000|Completed Post-Cycle 1 Imaging|Overall Study||9
8711715|NCT00963807|9758129|FG000|Completed Post-Cycle 2 FLT Imaging|Overall Study||9
8711716|NCT00963807|9758129|FG000|Completed Post-Cycle 2 FDG Imaging|Overall Study||8
8711717|NCT00963807|9758129|FG000|COMPLETED|Overall Study||8
8711718|NCT00963807|9758129|FG000|NOT COMPLETED|Overall Study||18
8711719|NCT00963820|9758135|FG000|STARTED|Dose Escalation Phase||3
8711720|NCT00963820|9758136|FG001|STARTED|Dose Escalation Phase||3
8711721|NCT00963820|9758137|FG002|STARTED|Dose Escalation Phase||3
8711722|NCT00963820|9758138|FG003|STARTED|Dose Escalation Phase||3
8711723|NCT00963820|9758139|FG004|STARTED|Dose Escalation Phase||4
8711724|NCT00963820|9758140|FG005|STARTED|Dose Escalation Phase||3
8711725|NCT00963820|9758141|FG006|STARTED|Dose Escalation Phase||8
8711726|NCT00963820|9758142|FG007|STARTED|Dose Escalation Phase||5
8711727|NCT00963820|9758143|FG008|STARTED|Dose Escalation Phase|Expansion cohorts were not part of Dose Escalation except as noted in comments.|0
8711728|NCT00963820|9758144|FG009|STARTED|Dose Escalation Phase||0
8711729|NCT00963820|9758145|FG010|STARTED|Dose Escalation Phase||0
8711730|NCT00963820|9758146|FG011|STARTED|Dose Escalation Phase||0
8711731|NCT00963820|9758135|FG000|COMPLETED|Dose Escalation Phase||0
8711732|NCT00963820|9758136|FG001|COMPLETED|Dose Escalation Phase||0
8711733|NCT00963820|9758137|FG002|COMPLETED|Dose Escalation Phase||0
8711734|NCT00963820|9758138|FG003|COMPLETED|Dose Escalation Phase||0
8711735|NCT00963820|9758139|FG004|COMPLETED|Dose Escalation Phase||0
8711736|NCT00963820|9758140|FG005|COMPLETED|Dose Escalation Phase||0
8711737|NCT00963820|9758141|FG006|COMPLETED|Dose Escalation Phase||0
8711738|NCT00963820|9758142|FG007|COMPLETED|Dose Escalation Phase||0
8711739|NCT00963820|9758143|FG008|COMPLETED|Dose Escalation Phase||0
8711740|NCT00963820|9758144|FG009|COMPLETED|Dose Escalation Phase||0
8711741|NCT00963820|9758145|FG010|COMPLETED|Dose Escalation Phase||0
8711742|NCT00963820|9758146|FG011|COMPLETED|Dose Escalation Phase||0
8711743|NCT00963820|9758135|FG000|NOT COMPLETED|Dose Escalation Phase||3
8711744|NCT00963820|9758136|FG001|NOT COMPLETED|Dose Escalation Phase||3
8711745|NCT00963820|9758137|FG002|NOT COMPLETED|Dose Escalation Phase||3
8711746|NCT00963820|9758138|FG003|NOT COMPLETED|Dose Escalation Phase||3
8711747|NCT00963820|9758139|FG004|NOT COMPLETED|Dose Escalation Phase||4
8711748|NCT00963820|9758140|FG005|NOT COMPLETED|Dose Escalation Phase||3
8711749|NCT00963820|9758141|FG006|NOT COMPLETED|Dose Escalation Phase||8
8592924|NCT00305565|9627528|FG002|NOT COMPLETED|Overall Study (Safety Population)||7
8592925|NCT00305565|9627526|FG000|STARTED|Overall Study (ITT Population)||102
8711750|NCT00963820|9758142|FG007|NOT COMPLETED|Dose Escalation Phase||5
8711751|NCT00963820|9758143|FG008|NOT COMPLETED|Dose Escalation Phase||0
8592926|NCT00305565|9627527|FG001|STARTED|Overall Study (ITT Population)||101
8592927|NCT00305565|9627528|FG002|STARTED|Overall Study (ITT Population)||107
8592928|NCT00305565|9627526|FG000|COMPLETED|Overall Study (ITT Population)||89
8592929|NCT00305565|9627527|FG001|COMPLETED|Overall Study (ITT Population)||90
8592930|NCT00305565|9627528|FG002|COMPLETED|Overall Study (ITT Population)||102
8592931|NCT00305565|9627526|FG000|NOT COMPLETED|Overall Study (ITT Population)||13
8592932|NCT00305565|9627527|FG001|NOT COMPLETED|Overall Study (ITT Population)||11
8592933|NCT00305565|9627528|FG002|NOT COMPLETED|Overall Study (ITT Population)||5
8592934|NCT00305578|9627539|FG000|STARTED|Overall Study||15
8592935|NCT00305578|9627540|FG001|STARTED|Overall Study||14
8592936|NCT00305578|9627539|FG000|COMPLETED|Overall Study||12
8592937|NCT00305578|9627540|FG001|COMPLETED|Overall Study||12
8592938|NCT00305578|9627539|FG000|NOT COMPLETED|Overall Study||3
8592939|NCT00305578|9627540|FG001|NOT COMPLETED|Overall Study||2
8592940|NCT00305604|9627548|FG000|STARTED|Overall Study||102
8592941|NCT00305604|9627549|FG001|STARTED|Overall Study||104
8592942|NCT00305604|9627548|FG000|COMPLETED|Overall Study||70
8592943|NCT00305604|9627549|FG001|COMPLETED|Overall Study||57
8592944|NCT00305604|9627548|FG000|NOT COMPLETED|Overall Study||32
8592945|NCT00305604|9627549|FG001|NOT COMPLETED|Overall Study||47
8592946|NCT00305682|9627561|FG000|STARTED|Overall Study||98
8592947|NCT00305682|9627562|FG001|STARTED|Overall Study||71
8592948|NCT00305682|9627563|FG002|STARTED|Overall Study||7
8592949|NCT00305682|9627564|FG003|STARTED|Overall Study||34
8592950|NCT00305682|9627565|FG004|STARTED|Overall Study||39
8592951|NCT00305682|9627566|FG005|STARTED|Overall Study||35
8592952|NCT00305682|9627561|FG000|COMPLETED|Overall Study||98
8592953|NCT00305682|9627562|FG001|COMPLETED|Overall Study||71
8592954|NCT00305682|9627563|FG002|COMPLETED|Overall Study||7
8592955|NCT00305682|9627564|FG003|COMPLETED|Overall Study||34
8592956|NCT00305682|9627565|FG004|COMPLETED|Overall Study||39
8592957|NCT00305682|9627566|FG005|COMPLETED|Overall Study||35
8592958|NCT00305682|9627561|FG000|NOT COMPLETED|Overall Study||0
8592959|NCT00305682|9627562|FG001|NOT COMPLETED|Overall Study||0
8592960|NCT00305682|9627563|FG002|NOT COMPLETED|Overall Study||0
8592961|NCT00305682|9627564|FG003|NOT COMPLETED|Overall Study||0
8592962|NCT00305682|9627565|FG004|NOT COMPLETED|Overall Study||0
8592963|NCT00305682|9627566|FG005|NOT COMPLETED|Overall Study||0
8592964|NCT00305695|9627582|FG000|STARTED|Overall Study||81
8592965|NCT00305695|9627583|FG001|STARTED|Overall Study||79
8592966|NCT00305695|9627582|FG000|COMPLETED|Overall Study||40
8592967|NCT00305695|9627583|FG001|COMPLETED|Overall Study||52
8592968|NCT00305695|9627582|FG000|NOT COMPLETED|Overall Study||41
8592969|NCT00305695|9627583|FG001|NOT COMPLETED|Overall Study||27
8592970|NCT00305760|9627589|FG000|STARTED|Overall Study||60
8592971|NCT00305760|9627589|FG000|COMPLETED|Overall Study||13
8592972|NCT00305760|9627589|FG000|NOT COMPLETED|Overall Study||47
8592973|NCT00305773|9627595|FG000|STARTED|Overall Study||15
8592974|NCT00305773|9627596|FG001|STARTED|Overall Study||22
8592975|NCT00305773|9627595|FG000|COMPLETED|Overall Study||1
8592976|NCT00305773|9627596|FG001|COMPLETED|Overall Study||4
8592977|NCT00305773|9627595|FG000|NOT COMPLETED|Overall Study||14
8592978|NCT00305773|9627596|FG001|NOT COMPLETED|Overall Study||18
8592979|NCT00305864|9627606|FG000|STARTED|Overall Study||7
8592980|NCT00305864|9627607|FG001|STARTED|Overall Study||10
8592981|NCT00305864|9627608|FG002|STARTED|Overall Study||7
8592982|NCT00305864|9627609|FG003|STARTED|Overall Study||94
8592983|NCT00305864|9627606|FG000|COMPLETED|Overall Study||7
8592984|NCT00305864|9627607|FG001|COMPLETED|Overall Study||9
8592985|NCT00305864|9627608|FG002|COMPLETED|Overall Study||6
8592986|NCT00305864|9627609|FG003|COMPLETED|Overall Study||81
8592987|NCT00305864|9627606|FG000|NOT COMPLETED|Overall Study||0
8592988|NCT00305864|9627607|FG001|NOT COMPLETED|Overall Study||1
8711752|NCT00963820|9758144|FG009|NOT COMPLETED|Dose Escalation Phase||0
8711753|NCT00963820|9758145|FG010|NOT COMPLETED|Dose Escalation Phase||0
8711754|NCT00963820|9758146|FG011|NOT COMPLETED|Dose Escalation Phase||0
8711755|NCT00963820|9758135|FG000|STARTED|Expansion Phase|Dose escalation cohorts were not part of the Expansion Phase except as noted in comments.|0
8711756|NCT00963820|9758136|FG001|STARTED|Expansion Phase||0
8711757|NCT00963820|9758137|FG002|STARTED|Expansion Phase||0
8711758|NCT00963820|9758138|FG003|STARTED|Expansion Phase||0
8711759|NCT00963820|9758139|FG004|STARTED|Expansion Phase||0
8711760|NCT00963820|9758140|FG005|STARTED|Expansion Phase||0
8711761|NCT00963820|9758141|FG006|STARTED|Expansion Phase||0
8711762|NCT00963820|9758142|FG007|STARTED|Expansion Phase||0
8711763|NCT00963820|9758143|FG008|STARTED|Expansion Phase|Includes 2 participants from the dose escalation cohort 2.97 mg/m^2.|11
8711764|NCT00963820|9758144|FG009|STARTED|Expansion Phase|Includes 1 participant from the dose escalation cohort 2.97 mg/m^2.|10
8711765|NCT00963820|9758145|FG010|STARTED|Expansion Phase|Includes only participants who are proteasome inhibitor (PI)-naïve.|6
8711766|NCT00963820|9758146|FG011|STARTED|Expansion Phase|Includes participants with last dose of carfilzomib 21 to 60 days before 1st ixazomib citrate dose.|4
8928148|NCT02278354|9989262|FG001|STARTED|Overall Study||23
8928149|NCT02278354|9989261|FG000|Flortaucipir PET Scan|Overall Study||10
8928150|NCT02278354|9989262|FG001|Flortaucipir PET Scan|Overall Study||20
8928151|NCT02278354|9989261|FG000|COMPLETED|Overall Study||8
8928152|NCT02278354|9989262|FG001|COMPLETED|Overall Study||20
8928153|NCT02278354|9989261|FG000|NOT COMPLETED|Overall Study||4
8592989|NCT00305864|9627608|FG002|NOT COMPLETED|Overall Study||1
8592990|NCT00305864|9627609|FG003|NOT COMPLETED|Overall Study||13
8592991|NCT00305877|9627621|FG000|STARTED|Overall Study||69
8592992|NCT00305877|9627622|FG001|STARTED|Overall Study||68
8592993|NCT00305877|9627621|FG000|Treated|Overall Study||67
8592994|NCT00305877|9627622|FG001|Treated|Overall Study||63
8592995|NCT00305877|9627621|FG000|Eligible|Overall Study||66
8592996|NCT00305877|9627622|FG001|Eligible|Overall Study||66
8592997|NCT00305877|9627621|FG000|Included in Efficacy Analysis|Overall Study||65
8592998|NCT00305877|9627622|FG001|Included in Efficacy Analysis|Overall Study||62
8592999|NCT00305877|9627621|FG000|COMPLETED|Overall Study||45
8593000|NCT00305877|9627622|FG001|COMPLETED|Overall Study||34
8593001|NCT00305877|9627621|FG000|NOT COMPLETED|Overall Study||24
8593002|NCT00305877|9627622|FG001|NOT COMPLETED|Overall Study||34
8593003|NCT00305942|9627628|FG000|STARTED|Overall Study||61
8593004|NCT00305942|9627628|FG000|COMPLETED|Overall Study||23
8593005|NCT00305942|9627628|FG000|NOT COMPLETED|Overall Study||38
8593006|NCT00306163|9627634|FG000|STARTED|Overall Study||19
8593007|NCT00306163|9627635|FG001|STARTED|Overall Study||18
8593008|NCT00306163|9627634|FG000|COMPLETED|Overall Study||19
8593009|NCT00306163|9627635|FG001|COMPLETED|Overall Study||18
8593010|NCT00306163|9627634|FG000|NOT COMPLETED|Overall Study||0
8593011|NCT00306163|9627635|FG001|NOT COMPLETED|Overall Study||0
8593012|NCT00306189|9627645|FG000|STARTED|Overall Study||57
8593013|NCT00306189|9627646|FG001|STARTED|Overall Study||56
8593014|NCT00306189|9627647|FG002|STARTED|Overall Study||56
8593015|NCT00306189|9627648|FG003|STARTED|Overall Study||57
8593016|NCT00306189|9627645|FG000|COMPLETED|Overall Study||48
8593017|NCT00306189|9627646|FG001|COMPLETED|Overall Study||50
8593018|NCT00306189|9627647|FG002|COMPLETED|Overall Study||45
8593019|NCT00306189|9627648|FG003|COMPLETED|Overall Study||52
8711767|NCT00963820|9758135|FG000|COMPLETED|Expansion Phase||0
8711768|NCT00963820|9758136|FG001|COMPLETED|Expansion Phase||0
8711769|NCT00963820|9758137|FG002|COMPLETED|Expansion Phase||0
8711770|NCT00963820|9758138|FG003|COMPLETED|Expansion Phase||0
8711771|NCT00963820|9758139|FG004|COMPLETED|Expansion Phase||0
8711772|NCT00963820|9758140|FG005|COMPLETED|Expansion Phase||0
8711773|NCT00963820|9758141|FG006|COMPLETED|Expansion Phase||0
8711774|NCT00963820|9758142|FG007|COMPLETED|Expansion Phase||0
8711775|NCT00963820|9758143|FG008|COMPLETED|Expansion Phase|Participant was ongoing at the time of data cut off for analysis|1
8711776|NCT00963820|9758144|FG009|COMPLETED|Expansion Phase|Participant was ongoing at the time of data cut off for analysis|1
8711777|NCT00963820|9758145|FG010|COMPLETED|Expansion Phase|Participant was ongoing at the time of data cut off for analysis|1
8711778|NCT00963820|9758146|FG011|COMPLETED|Expansion Phase||0
8711779|NCT00963820|9758135|FG000|NOT COMPLETED|Expansion Phase||0
8711780|NCT00963820|9758136|FG001|NOT COMPLETED|Expansion Phase||0
8711781|NCT00963820|9758137|FG002|NOT COMPLETED|Expansion Phase||0
8711782|NCT00963820|9758138|FG003|NOT COMPLETED|Expansion Phase||0
8711783|NCT00963820|9758139|FG004|NOT COMPLETED|Expansion Phase||0
8711784|NCT00963820|9758140|FG005|NOT COMPLETED|Expansion Phase||0
8711785|NCT00963820|9758141|FG006|NOT COMPLETED|Expansion Phase||0
8711786|NCT00963820|9758142|FG007|NOT COMPLETED|Expansion Phase||0
8711787|NCT00963820|9758143|FG008|NOT COMPLETED|Expansion Phase||10
8711788|NCT00963820|9758144|FG009|NOT COMPLETED|Expansion Phase||9
8711789|NCT00963820|9758145|FG010|NOT COMPLETED|Expansion Phase||5
8711790|NCT00963820|9758146|FG011|NOT COMPLETED|Expansion Phase||4
8711791|NCT00963859|9758163|FG000|STARTED|Overall Study||11
8711792|NCT00963859|9758163|FG000|COMPLETED|Overall Study||11
8711793|NCT00963859|9758163|FG000|NOT COMPLETED|Overall Study||0
8711794|NCT00963872|9758169|FG000|STARTED|Overall Study||25
8711795|NCT00963872|9758170|FG001|STARTED|Overall Study||6
8711796|NCT00963872|9758169|FG000|COMPLETED|Overall Study||24
8711797|NCT00963872|9758170|FG001|COMPLETED|Overall Study||5
8711798|NCT00963872|9758169|FG000|NOT COMPLETED|Overall Study||1
8711799|NCT00963872|9758170|FG001|NOT COMPLETED|Overall Study||1
8711800|NCT00963911|9758176|FG000|STARTED|Overall Study||1674
8711801|NCT00963911|9758176|FG000|COMPLETED|Overall Study||1674
8711802|NCT00963911|9758176|FG000|NOT COMPLETED|Overall Study||0
8711803|NCT00963924|9758182|FG000|STARTED|Overall Study||18
8711804|NCT00963924|9758183|FG001|STARTED|Overall Study||18
8711805|NCT00963924|9758182|FG000|COMPLETED|Overall Study||17
8711806|NCT00963924|9758183|FG001|COMPLETED|Overall Study||15
8711807|NCT00963924|9758182|FG000|NOT COMPLETED|Overall Study||1
8711808|NCT00963924|9758183|FG001|NOT COMPLETED|Overall Study||3
8711809|NCT00963937|9758194|FG000|STARTED|Overall Study||89
8711810|NCT00963937|9758195|FG001|STARTED|Overall Study||44
8711811|NCT00963937|9758196|FG002|STARTED|Overall Study||45
8711812|NCT00963937|9758194|FG000|COMPLETED|Overall Study||70
8711813|NCT00963937|9758195|FG001|COMPLETED|Overall Study||33
8593020|NCT00306189|9627645|FG000|NOT COMPLETED|Overall Study||9
8593021|NCT00306189|9627646|FG001|NOT COMPLETED|Overall Study||6
8593022|NCT00306189|9627647|FG002|NOT COMPLETED|Overall Study||11
8593023|NCT00306189|9627648|FG003|NOT COMPLETED|Overall Study||5
8593024|NCT00306202|9627661|FG000|STARTED|Overall Study|Started = Treated. 18 were enrolled; 1 no longer met study criteria and was never treated|17
8593025|NCT00306202|9627662|FG001|STARTED|Overall Study|Started=Treated. 20 were enrolled;3 never treated(2 no longer met study criteria;1 withdrew consent)|17
8593026|NCT00306202|9627663|FG002|STARTED|Overall Study|Started = Treated. 25 were enrolled; 1 no longer met study criteria and was never treated|24
8711814|NCT00963937|9758196|FG002|COMPLETED|Overall Study||41
8711815|NCT00963937|9758194|FG000|NOT COMPLETED|Overall Study||19
8711816|NCT00963937|9758195|FG001|NOT COMPLETED|Overall Study||11
8711817|NCT00963937|9758196|FG002|NOT COMPLETED|Overall Study||4
8711818|NCT00963989|9758207|FG000|STARTED|Overall Study||146
8593027|NCT00306202|9627661|FG000|COMPLETED|Overall Study|Completed = Off-treatment|17
8593028|NCT00306202|9627662|FG001|COMPLETED|Overall Study|Completed = Off-treatment|17
8593029|NCT00306202|9627663|FG002|COMPLETED|Overall Study|Completed = Off-treatment|24
8593030|NCT00306202|9627661|FG000|NOT COMPLETED|Overall Study||0
8593031|NCT00306202|9627662|FG001|NOT COMPLETED|Overall Study||0
8593032|NCT00306202|9627663|FG002|NOT COMPLETED|Overall Study||0
8593033|NCT00306293|9627709|FG000|STARTED|Period 1 (Day 1 to Day 60)||35
8593034|NCT00306293|9627710|FG001|STARTED|Period 1 (Day 1 to Day 60)||35
8593035|NCT00306293|9627709|FG000|COMPLETED|Period 1 (Day 1 to Day 60)||27
8593036|NCT00306293|9627710|FG001|COMPLETED|Period 1 (Day 1 to Day 60)||27
8593037|NCT00306293|9627709|FG000|NOT COMPLETED|Period 1 (Day 1 to Day 60)||8
8593038|NCT00306293|9627710|FG001|NOT COMPLETED|Period 1 (Day 1 to Day 60)||8
8593039|NCT00306293|9627709|FG000|STARTED|Washout (Day 61 to Day 66)||27
8593040|NCT00306293|9627710|FG001|STARTED|Washout (Day 61 to Day 66)||27
8593041|NCT00306293|9627709|FG000|COMPLETED|Washout (Day 61 to Day 66)||27
8593042|NCT00306293|9627710|FG001|COMPLETED|Washout (Day 61 to Day 66)||27
8593043|NCT00306293|9627709|FG000|NOT COMPLETED|Washout (Day 61 to Day 66)||0
8593044|NCT00306293|9627710|FG001|NOT COMPLETED|Washout (Day 61 to Day 66)||0
8593045|NCT00306293|9627709|FG000|STARTED|Period 2 (Day 67 to Day 126 )||27
8593046|NCT00306293|9627710|FG001|STARTED|Period 2 (Day 67 to Day 126 )||27
8593047|NCT00306293|9627709|FG000|COMPLETED|Period 2 (Day 67 to Day 126 )||24
8593048|NCT00306293|9627710|FG001|COMPLETED|Period 2 (Day 67 to Day 126 )||26
8593049|NCT00306293|9627709|FG000|NOT COMPLETED|Period 2 (Day 67 to Day 126 )||3
8593050|NCT00306293|9627710|FG001|NOT COMPLETED|Period 2 (Day 67 to Day 126 )||1
8593051|NCT00306384|9627721|FG000|STARTED|Overall Study||1396
8593052|NCT00306384|9627722|FG001|STARTED|Overall Study||1399
8593053|NCT00306384|9627723|FG002|STARTED|Overall Study||528
8593054|NCT00306384|9627721|FG000|Safety Set|Overall Study|Patients who received at least one dose of study drug|1395
8593055|NCT00306384|9627722|FG001|Safety Set|Overall Study|Patients who received at least one dose of study drug|1398
8593056|NCT00306384|9627723|FG002|Safety Set|Overall Study|Patients who received at least one dose of study drug|527
8593057|NCT00306384|9627721|FG000|COMPLETED|Overall Study||854
8593058|NCT00306384|9627722|FG001|COMPLETED|Overall Study||891
8593059|NCT00306384|9627723|FG002|COMPLETED|Overall Study||251
8593060|NCT00306384|9627721|FG000|NOT COMPLETED|Overall Study||542
8593061|NCT00306384|9627722|FG001|NOT COMPLETED|Overall Study||508
8593062|NCT00306384|9627723|FG002|NOT COMPLETED|Overall Study||277
8593063|NCT00306488|9627731|FG000|STARTED|Overall Study||11
8593064|NCT00306488|9627731|FG000|COMPLETED|Overall Study||10
8593065|NCT00306488|9627731|FG000|NOT COMPLETED|Overall Study||1
8593066|NCT00306527|9627740|FG000|STARTED|Overall Study||533
8593067|NCT00306527|9627741|FG001|STARTED|Overall Study||534
8593068|NCT00306527|9627742|FG002|STARTED|Overall Study||572
8593069|NCT00306527|9627743|FG003|STARTED|Overall Study||596
8593070|NCT00306527|9627740|FG000|COMPLETED|Overall Study||527
8593071|NCT00306527|9627741|FG001|COMPLETED|Overall Study||527
8711819|NCT00963989|9758207|FG000|COMPLETED|Overall Study||127
8711820|NCT00963989|9758207|FG000|NOT COMPLETED|Overall Study||19
8711821|NCT00964028|9758213|FG000|STARTED|Overall Study||25
8711822|NCT00964028|9758214|FG001|STARTED|Overall Study||25
8711823|NCT00964028|9758213|FG000|COMPLETED|Overall Study||25
8711824|NCT00964028|9758214|FG001|COMPLETED|Overall Study||24
8711825|NCT00964028|9758213|FG000|NOT COMPLETED|Overall Study||0
8711826|NCT00964028|9758214|FG001|NOT COMPLETED|Overall Study||1
8711827|NCT00964119|9758220|FG000|STARTED|Overall Study||15
8711828|NCT00964119|9758220|FG000|COMPLETED|Overall Study||15
8711829|NCT00964119|9758220|FG000|NOT COMPLETED|Overall Study||0
8711830|NCT00964158|9758227|FG000|STARTED|Overall Study||53
8711831|NCT00964158|9758228|FG001|STARTED|Overall Study||57
8711832|NCT00964158|9758229|FG002|STARTED|Overall Study||100
8711833|NCT00964158|9758227|FG000|COMPLETED|Overall Study||53
8711834|NCT00964158|9758228|FG001|COMPLETED|Overall Study||56
8711835|NCT00964158|9758229|FG002|COMPLETED|Overall Study||92
8711836|NCT00964158|9758227|FG000|NOT COMPLETED|Overall Study||0
8711837|NCT00964158|9758228|FG001|NOT COMPLETED|Overall Study||1
8711838|NCT00964158|9758229|FG002|NOT COMPLETED|Overall Study||8
8711839|NCT00964223|9758240|FG000|STARTED|Split Face Treatment (Weeks 1 and 2)||28
8711840|NCT00964223|9758240|FG000|COMPLETED|Split Face Treatment (Weeks 1 and 2)||28
8711841|NCT00964223|9758240|FG000|NOT COMPLETED|Split Face Treatment (Weeks 1 and 2)||0
8711842|NCT00964223|9758240|FG000|STARTED|Full Face Treatment (Weeks 5 and 8)||28
8711843|NCT00964223|9758240|FG000|COMPLETED|Full Face Treatment (Weeks 5 and 8)||27
8711844|NCT00964223|9758240|FG000|NOT COMPLETED|Full Face Treatment (Weeks 5 and 8)||1
8711845|NCT00964353|9758247|FG000|STARTED|Overall Study||181
8711846|NCT00964353|9758248|FG001|STARTED|Overall Study||178
8628215|NCT00521989|9667622|FG000|STARTED|Overall Study||56
8628216|NCT00521989|9667623|FG001|STARTED|Overall Study||54
8628217|NCT00521989|9667624|FG002|STARTED|Overall Study||57
8628218|NCT00521989|9667625|FG003|STARTED|Overall Study||54
8628219|NCT00521989|9667626|FG004|STARTED|Overall Study||58
8628220|NCT00521989|9667622|FG000|COMPLETED|Overall Study||36
8628221|NCT00521989|9667623|FG001|COMPLETED|Overall Study||37
8628222|NCT00521989|9667624|FG002|COMPLETED|Overall Study||41
8628223|NCT00521989|9667625|FG003|COMPLETED|Overall Study||42
8628224|NCT00521989|9667626|FG004|COMPLETED|Overall Study||35
8628225|NCT00521989|9667622|FG000|NOT COMPLETED|Overall Study||20
8628226|NCT00521989|9667623|FG001|NOT COMPLETED|Overall Study||17
8628227|NCT00521989|9667624|FG002|NOT COMPLETED|Overall Study||16
8593072|NCT00306527|9627742|FG002|COMPLETED|Overall Study|3 of 4 deaths in the elderly subjects resulted in premature discontinuation. Refer to OM2 .|567
8593073|NCT00306527|9627743|FG003|COMPLETED|Overall Study||590
8593074|NCT00306527|9627740|FG000|NOT COMPLETED|Overall Study||6
8593075|NCT00306527|9627741|FG001|NOT COMPLETED|Overall Study||7
8593076|NCT00306527|9627742|FG002|NOT COMPLETED|Overall Study||5
8593077|NCT00306527|9627743|FG003|NOT COMPLETED|Overall Study||6
8593078|NCT00306592|9627757|FG000|STARTED|Overall Study||404
8593079|NCT00306592|9627758|FG001|STARTED|Overall Study||690
8593080|NCT00306592|9627757|FG000|Completed at 24 Weeks|Overall Study||207
8593081|NCT00306592|9627758|FG001|Completed at 24 Weeks|Overall Study||0
8593082|NCT00306592|9627757|FG000|Completed Between 24 and 48 Weeks|Overall Study||85
8593083|NCT00306592|9627758|FG001|Completed Between 24 and 48 Weeks|Overall Study||0
8593084|NCT00306592|9627757|FG000|Completed at 48 Weeks|Overall Study||81
8593085|NCT00306592|9627758|FG001|Completed at 48 Weeks|Overall Study||632
8593086|NCT00306592|9627757|FG000|Entered 101-MS-321 Extension Study|Overall Study||22
8593087|NCT00306592|9627758|FG001|Entered 101-MS-321 Extension Study|Overall Study|pertains to participants transitioning from 101-MS-322 (NCT00306592) study only|0
8593088|NCT00306592|9627757|FG000|COMPLETED|Overall Study||373
8593089|NCT00306592|9627758|FG001|COMPLETED|Overall Study||632
8593090|NCT00306592|9627757|FG000|NOT COMPLETED|Overall Study||31
8593091|NCT00306592|9627758|FG001|NOT COMPLETED|Overall Study||58
8593092|NCT00306670|9627764|FG000|STARTED|Overall Study|no patients recruited; Genentech, the study sponsor, pulled funding and discontinued the protocol|0
8593093|NCT00306670|9627765|FG001|STARTED|Overall Study|2 patients recruited; Genentech, the study sponsor, discontinued trial before treatment started|2
8593094|NCT00306670|9627764|FG000|COMPLETED|Overall Study|no patients recruited; Genentech, the study sponsor, pulled funding and discontinued the protocol|0
8593095|NCT00306670|9627765|FG001|COMPLETED|Overall Study|2 patients recruited; Genentech, the study sponsor, discontinued study before treatment initiated|0
8593096|NCT00306670|9627764|FG000|NOT COMPLETED|Overall Study||0
8593097|NCT00306670|9627765|FG001|NOT COMPLETED|Overall Study||2
8593098|NCT00306787|9627773|FG000|STARTED|Overall Study||579
8593099|NCT00306787|9627774|FG001|STARTED|Overall Study||600
8711847|NCT00964353|9758247|FG000|COMPLETED|Overall Study||181
8711848|NCT00964353|9758248|FG001|COMPLETED|Overall Study||178
8711849|NCT00964353|9758247|FG000|NOT COMPLETED|Overall Study||0
8711850|NCT00964353|9758248|FG001|NOT COMPLETED|Overall Study||0
8711851|NCT00964366|9758256|FG000|STARTED|Overall Study|27 of the 28 enrolled were eligible after screening.|28
8711852|NCT00964366|9758257|FG001|STARTED|Overall Study||25
8711853|NCT00964366|9758256|FG000|COMPLETED|Overall Study||27
8711854|NCT00964366|9758257|FG001|COMPLETED|Overall Study||24
8711855|NCT00964366|9758256|FG000|NOT COMPLETED|Overall Study||1
8711856|NCT00964366|9758257|FG001|NOT COMPLETED|Overall Study||1
8711857|NCT00964392|9758265|FG000|STARTED|Overall Study|Both safety and efficacy cohort: Total 128 (3 MEP Excluded)|125
8711858|NCT00964392|9758266|FG001|STARTED|Overall Study|Both safety and efficacy cohort: Total 292 (10 LEP Excluded)|282
8711859|NCT00964392|9758265|FG000|COMPLETED|Overall Study||72
8711860|NCT00964392|9758266|FG001|COMPLETED|Overall Study||92
8711861|NCT00964392|9758265|FG000|NOT COMPLETED|Overall Study||53
8711862|NCT00964392|9758266|FG001|NOT COMPLETED|Overall Study||190
8711863|NCT00964431|9758276|FG000|STARTED|Overall Study||50
8711864|NCT00964431|9758277|FG001|STARTED|Overall Study||51
8711865|NCT00964431|9758278|FG002|STARTED|Overall Study||51
8711866|NCT00964431|9758279|FG003|STARTED|Overall Study||51
8711867|NCT00964431|9758276|FG000|COMPLETED|Overall Study||50
8711868|NCT00964431|9758277|FG001|COMPLETED|Overall Study||51
8711869|NCT00964431|9758278|FG002|COMPLETED|Overall Study||51
8711870|NCT00964431|9758279|FG003|COMPLETED|Overall Study||51
8711871|NCT00964431|9758276|FG000|NOT COMPLETED|Overall Study||0
8711872|NCT00964431|9758277|FG001|NOT COMPLETED|Overall Study||0
8711873|NCT00964431|9758278|FG002|NOT COMPLETED|Overall Study||0
8711874|NCT00964431|9758279|FG003|NOT COMPLETED|Overall Study||0
8711875|NCT00964444|9758289|FG000|STARTED|Overall Study||10
8593100|NCT00306787|9627773|FG000|Received Study Drug (Safety Population)|Overall Study||371
8593101|NCT00306787|9627774|FG001|Received Study Drug (Safety Population)|Overall Study||385
8593102|NCT00306787|9627773|FG000|Intent to Treat (ITT) Population|Overall Study||370
8593103|NCT00306787|9627774|FG001|Intent to Treat (ITT) Population|Overall Study||381
8593104|NCT00306787|9627773|FG000|COMPLETED|Overall Study||345
8593105|NCT00306787|9627774|FG001|COMPLETED|Overall Study||359
8593106|NCT00306787|9627773|FG000|NOT COMPLETED|Overall Study||234
8593107|NCT00306787|9627774|FG001|NOT COMPLETED|Overall Study||241
8593108|NCT00306852|9627782|FG000|STARTED|Overall Study||105
8593109|NCT00306852|9627783|FG001|STARTED|Overall Study||107
8593110|NCT00306852|9627782|FG000|COMPLETED|Overall Study||76
8593111|NCT00306852|9627783|FG001|COMPLETED|Overall Study||69
8593112|NCT00306852|9627782|FG000|NOT COMPLETED|Overall Study||29
8593113|NCT00306852|9627783|FG001|NOT COMPLETED|Overall Study||38
8593114|NCT00306891|9627793|FG000|STARTED|Part A||23
8593115|NCT00306891|9627794|FG001|STARTED|Part A||22
8593116|NCT00306891|9627795|FG002|STARTED|Part A||0
8593117|NCT00306891|9627796|FG003|STARTED|Part A||0
8593118|NCT00306891|9627793|FG000|COMPLETED|Part A||18
8593119|NCT00306891|9627794|FG001|COMPLETED|Part A||16
8593120|NCT00306891|9627795|FG002|COMPLETED|Part A||0
8593121|NCT00306891|9627796|FG003|COMPLETED|Part A||0
8593122|NCT00306891|9627793|FG000|NOT COMPLETED|Part A||5
8593123|NCT00306891|9627794|FG001|NOT COMPLETED|Part A||6
8711876|NCT00964444|9758289|FG000|COMPLETED|Overall Study||10
8593124|NCT00306891|9627795|FG002|NOT COMPLETED|Part A||0
8593125|NCT00306891|9627796|FG003|NOT COMPLETED|Part A||0
8593126|NCT00306891|9627793|FG000|STARTED|Part B||0
8593127|NCT00306891|9627794|FG001|STARTED|Part B||0
8593128|NCT00306891|9627795|FG002|STARTED|Part B|In Part B: Cediranib 45 mg Fixed Dose 4 new patients were randomized|16
8593129|NCT00306891|9627796|FG003|STARTED|Part B|in Part B: Cediranib Dose Escalation 11 new patients were randomized.|31
8593130|NCT00306891|9627793|FG000|COMPLETED|Part B||0
8593131|NCT00306891|9627794|FG001|COMPLETED|Part B||0
8593132|NCT00306891|9627795|FG002|COMPLETED|Part B||5
8593133|NCT00306891|9627796|FG003|COMPLETED|Part B||14
8593134|NCT00306891|9627793|FG000|NOT COMPLETED|Part B||0
8593135|NCT00306891|9627794|FG001|NOT COMPLETED|Part B||0
8593136|NCT00306891|9627795|FG002|NOT COMPLETED|Part B||11
8593137|NCT00306891|9627796|FG003|NOT COMPLETED|Part B||17
8593138|NCT00306917|9627809|FG000|STARTED|Overall Study|400 subjects were to be followed for 5 years; due to slow enrollment study closed early with 245.|121
8593139|NCT00306917|9627810|FG001|STARTED|Overall Study|400 subjects were to be followed for 5 years; due to slow enrollment study closed early with 245.|124
8593140|NCT00306917|9627809|FG000|Postoperative to 6 Month Follow up|Overall Study||93
8593141|NCT00306917|9627810|FG001|Postoperative to 6 Month Follow up|Overall Study||100
8593142|NCT00306917|9627809|FG000|12 Month Follow|Overall Study||86
8593143|NCT00306917|9627810|FG001|12 Month Follow|Overall Study||94
8593144|NCT00306917|9627809|FG000|24 Month Follow up|Overall Study||60
8593145|NCT00306917|9627810|FG001|24 Month Follow up|Overall Study||71
8593146|NCT00306917|9627809|FG000|36 Month Follow up|Overall Study||56
8593147|NCT00306917|9627810|FG001|36 Month Follow up|Overall Study||42
8593148|NCT00306917|9627809|FG000|48 Month Follow up|Overall Study||29
8593149|NCT00306917|9627810|FG001|48 Month Follow up|Overall Study||22
8593150|NCT00306917|9627809|FG000|60 Month Follow up|Overall Study||13
8593151|NCT00306917|9627810|FG001|60 Month Follow up|Overall Study||15
8593152|NCT00306917|9627809|FG000|COMPLETED|Overall Study||13
8593153|NCT00306917|9627810|FG001|COMPLETED|Overall Study||15
8593154|NCT00306917|9627809|FG000|NOT COMPLETED|Overall Study||108
8593155|NCT00306917|9627810|FG001|NOT COMPLETED|Overall Study||109
8593156|NCT00306995|9627823|FG000|STARTED|Study Part I||55
8593157|NCT00306995|9627824|FG001|STARTED|Study Part I||55
8593158|NCT00306995|9627825|FG002|STARTED|Study Part I||55
8593159|NCT00306995|9627826|FG003|STARTED|Study Part I||55
8593160|NCT00306995|9627827|FG004|STARTED|Study Part I||55
8593161|NCT00306995|9627828|FG005|STARTED|Study Part I||55
8593162|NCT00306995|9627829|FG006|STARTED|Study Part I||55
8593163|NCT00306995|9627823|FG000|COMPLETED|Study Part I||55
8593164|NCT00306995|9627824|FG001|COMPLETED|Study Part I||55
8593165|NCT00306995|9627825|FG002|COMPLETED|Study Part I||55
8593166|NCT00306995|9627826|FG003|COMPLETED|Study Part I||55
8593167|NCT00306995|9627827|FG004|COMPLETED|Study Part I||55
8593168|NCT00306995|9627828|FG005|COMPLETED|Study Part I||55
8593169|NCT00306995|9627829|FG006|COMPLETED|Study Part I||54
8593170|NCT00306995|9627823|FG000|NOT COMPLETED|Study Part I||0
8593171|NCT00306995|9627824|FG001|NOT COMPLETED|Study Part I||0
8593172|NCT00306995|9627825|FG002|NOT COMPLETED|Study Part I||0
8593173|NCT00306995|9627826|FG003|NOT COMPLETED|Study Part I||0
8593174|NCT00306995|9627827|FG004|NOT COMPLETED|Study Part I||0
8593175|NCT00306995|9627828|FG005|NOT COMPLETED|Study Part I||0
8593176|NCT00306995|9627829|FG006|NOT COMPLETED|Study Part I||1
8593177|NCT00306995|9627823|FG000|STARTED|Study Part II for Subset 1||27
8593178|NCT00306995|9627824|FG001|STARTED|Study Part II for Subset 1||26
8593179|NCT00306995|9627825|FG002|STARTED|Study Part II for Subset 1||27
8593180|NCT00306995|9627826|FG003|STARTED|Study Part II for Subset 1||27
8593181|NCT00306995|9627827|FG004|STARTED|Study Part II for Subset 1||27
8593182|NCT00306995|9627828|FG005|STARTED|Study Part II for Subset 1||26
8593183|NCT00306995|9627829|FG006|STARTED|Study Part II for Subset 1||23
8593184|NCT00306995|9627823|FG000|COMPLETED|Study Part II for Subset 1||27
8593185|NCT00306995|9627824|FG001|COMPLETED|Study Part II for Subset 1||26
8593186|NCT00306995|9627825|FG002|COMPLETED|Study Part II for Subset 1||27
8593187|NCT00306995|9627826|FG003|COMPLETED|Study Part II for Subset 1||27
8593188|NCT00306995|9627827|FG004|COMPLETED|Study Part II for Subset 1||27
8593189|NCT00306995|9627828|FG005|COMPLETED|Study Part II for Subset 1||26
8711877|NCT00964444|9758289|FG000|NOT COMPLETED|Overall Study||0
8711878|NCT00964496|9758295|FG000|STARTED|Overall Study||28
8711879|NCT00964496|9758296|FG001|STARTED|Overall Study||27
8711880|NCT00964496|9758295|FG000|COMPLETED|Overall Study||26
8711881|NCT00964496|9758296|FG001|COMPLETED|Overall Study||26
8593190|NCT00306995|9627829|FG006|COMPLETED|Study Part II for Subset 1||23
8593191|NCT00306995|9627823|FG000|NOT COMPLETED|Study Part II for Subset 1||0
8593192|NCT00306995|9627824|FG001|NOT COMPLETED|Study Part II for Subset 1||0
8593193|NCT00306995|9627825|FG002|NOT COMPLETED|Study Part II for Subset 1||0
8593194|NCT00306995|9627826|FG003|NOT COMPLETED|Study Part II for Subset 1||0
8593195|NCT00306995|9627827|FG004|NOT COMPLETED|Study Part II for Subset 1||0
8593196|NCT00306995|9627828|FG005|NOT COMPLETED|Study Part II for Subset 1||0
8593197|NCT00306995|9627829|FG006|NOT COMPLETED|Study Part II for Subset 1||0
8593198|NCT00306995|9627823|FG000|STARTED|Study Part II for Subset 2||23
8593199|NCT00306995|9627824|FG001|STARTED|Study Part II for Subset 2||24
8593200|NCT00306995|9627825|FG002|STARTED|Study Part II for Subset 2||23
8593201|NCT00306995|9627826|FG003|STARTED|Study Part II for Subset 2||22
8593202|NCT00306995|9627827|FG004|STARTED|Study Part II for Subset 2||23
8593203|NCT00306995|9627828|FG005|STARTED|Study Part II for Subset 2||26
8711882|NCT00964496|9758295|FG000|NOT COMPLETED|Overall Study||2
8711883|NCT00964496|9758296|FG001|NOT COMPLETED|Overall Study||1
8711884|NCT00964548|9758304|FG000|STARTED|Overall Study||5
8711885|NCT00964548|9758305|FG001|STARTED|Overall Study||5
8711886|NCT00964548|9758304|FG000|COMPLETED|Overall Study||5
8711887|NCT00964548|9758305|FG001|COMPLETED|Overall Study||5
8711888|NCT00964548|9758304|FG000|NOT COMPLETED|Overall Study||0
8711889|NCT00964548|9758305|FG001|NOT COMPLETED|Overall Study||0
8711890|NCT00964678|9758311|FG000|STARTED|Overall Study||10
8711891|NCT00964678|9758311|FG000|COMPLETED|Overall Study||6
8711892|NCT00964678|9758311|FG000|NOT COMPLETED|Overall Study||4
8711893|NCT00964743|9758316|FG000|STARTED|Overall Study||2
8593204|NCT00306995|9627829|FG006|STARTED|Study Part II for Subset 2||24
8593205|NCT00306995|9627823|FG000|COMPLETED|Study Part II for Subset 2||23
8593206|NCT00306995|9627824|FG001|COMPLETED|Study Part II for Subset 2||23
8593207|NCT00306995|9627825|FG002|COMPLETED|Study Part II for Subset 2||23
8593208|NCT00306995|9627826|FG003|COMPLETED|Study Part II for Subset 2||22
8593209|NCT00306995|9627827|FG004|COMPLETED|Study Part II for Subset 2||23
8593210|NCT00306995|9627828|FG005|COMPLETED|Study Part II for Subset 2||26
8593211|NCT00306995|9627829|FG006|COMPLETED|Study Part II for Subset 2||24
8593212|NCT00306995|9627823|FG000|NOT COMPLETED|Study Part II for Subset 2||0
8593213|NCT00306995|9627824|FG001|NOT COMPLETED|Study Part II for Subset 2||1
8593214|NCT00306995|9627825|FG002|NOT COMPLETED|Study Part II for Subset 2||0
8593215|NCT00306995|9627826|FG003|NOT COMPLETED|Study Part II for Subset 2||0
8593216|NCT00306995|9627827|FG004|NOT COMPLETED|Study Part II for Subset 2||0
8593217|NCT00306995|9627828|FG005|NOT COMPLETED|Study Part II for Subset 2||0
8593218|NCT00306995|9627829|FG006|NOT COMPLETED|Study Part II for Subset 2||0
8593219|NCT00307034|9627876|FG000|STARTED|Overall Study||175
8593220|NCT00307034|9627877|FG001|STARTED|Overall Study||176
8593221|NCT00307034|9627876|FG000|COMPLETED|Overall Study||173
8593222|NCT00307034|9627877|FG001|COMPLETED|Overall Study||169
8593223|NCT00307034|9627876|FG000|NOT COMPLETED|Overall Study||2
8593224|NCT00307034|9627877|FG001|NOT COMPLETED|Overall Study||7
8593225|NCT00307047|9627885|FG000|STARTED|Overall Study||2458
8593226|NCT00307047|9627886|FG001|STARTED|Overall Study||1229
8593227|NCT00307047|9627885|FG000|COMPLETED|Overall Study||2389
8593228|NCT00307047|9627886|FG001|COMPLETED|Overall Study||1180
8593229|NCT00307047|9627885|FG000|NOT COMPLETED|Overall Study||69
8593230|NCT00307047|9627886|FG001|NOT COMPLETED|Overall Study||49
8593231|NCT00307086|9627892|FG000|STARTED|Overall Study||30
8593232|NCT00307086|9627892|FG000|COMPLETED|Overall Study||25
8593233|NCT00307086|9627892|FG000|NOT COMPLETED|Overall Study||5
8711894|NCT00964743|9758316|FG000|COMPLETED|Overall Study||0
8711895|NCT00964743|9758316|FG000|NOT COMPLETED|Overall Study||2
8711896|NCT00964782|9758322|FG000|STARTED|Overall Study||8
8711897|NCT00964782|9758323|FG001|STARTED|Overall Study||8
8711898|NCT00964782|9758322|FG000|COMPLETED|Overall Study||7
8711899|NCT00964782|9758323|FG001|COMPLETED|Overall Study||8
8711900|NCT00964782|9758322|FG000|NOT COMPLETED|Overall Study||1
8711901|NCT00964782|9758323|FG001|NOT COMPLETED|Overall Study||0
8711902|NCT00964795|9758331|FG000|STARTED|Overall Study|randomized|323
8711903|NCT00964795|9758331|FG000|Number of Participants Treated|Overall Study||320
8711904|NCT00964795|9758331|FG000|COMPLETED|Overall Study|Prior to amendment 4, 16 participants completed up to Week 120. No participants completed Week 180.|16
8711905|NCT00964795|9758331|FG000|NOT COMPLETED|Overall Study||307
8593234|NCT00307125|9627898|FG000|STARTED|Screening Phase||757
8593235|NCT00307125|9627899|FG001|STARTED|Screening Phase||0
8593236|NCT00307125|9627900|FG002|STARTED|Screening Phase||0
8593237|NCT00307125|9627898|FG000|COMPLETED|Screening Phase||303
8593238|NCT00307125|9627899|FG001|COMPLETED|Screening Phase||0
8593239|NCT00307125|9627900|FG002|COMPLETED|Screening Phase||0
8593240|NCT00307125|9627898|FG000|NOT COMPLETED|Screening Phase||454
8593241|NCT00307125|9627899|FG001|NOT COMPLETED|Screening Phase||0
8593242|NCT00307125|9627900|FG002|NOT COMPLETED|Screening Phase||0
8593243|NCT00307125|9627898|FG000|STARTED|Pilot Phase||0
8593244|NCT00307125|9627899|FG001|STARTED|Pilot Phase||15
8593245|NCT00307125|9627900|FG002|STARTED|Pilot Phase||7
8593246|NCT00307125|9627898|FG000|COMPLETED|Pilot Phase||0
8593247|NCT00307125|9627899|FG001|COMPLETED|Pilot Phase|2 participants had reduced follow-up|13
8593248|NCT00307125|9627900|FG002|COMPLETED|Pilot Phase|1 participant had reduced follow-up|6
8593249|NCT00307125|9627898|FG000|NOT COMPLETED|Pilot Phase||0
8593250|NCT00307125|9627899|FG001|NOT COMPLETED|Pilot Phase||2
8593251|NCT00307125|9627900|FG002|NOT COMPLETED|Pilot Phase||1
8593252|NCT00307151|9627914|FG000|STARTED|Overall Study||82
8593253|NCT00307151|9627915|FG001|STARTED|Overall Study||82
8593254|NCT00307151|9627916|FG002|STARTED|Overall Study||147
8593255|NCT00307151|9627917|FG003|STARTED|Overall Study|One participant never started treatment, were not followed and not included in analysis.|140
8593256|NCT00307151|9627914|FG000|COMPLETED|Overall Study|Results are through date DSMB closed Cohort I to accrual (April 20, 2009)|71
8593257|NCT00307151|9627915|FG001|COMPLETED|Overall Study|Results are through date DSMB closed Cohort I to accrual (April 20, 2009)|75
8593258|NCT00307151|9627916|FG002|COMPLETED|Overall Study|Results are through date DSMB recommended Cohort II results be unblinded (October 27, 2010)|127
8711906|NCT00964860|9758338|FG000|STARTED|Overall Study||30
8711907|NCT00964860|9758339|FG001|STARTED|Overall Study||30
8711908|NCT00964860|9758338|FG000|COMPLETED|Overall Study||30
8711909|NCT00964860|9758339|FG001|COMPLETED|Overall Study||29
8711910|NCT00964860|9758338|FG000|NOT COMPLETED|Overall Study||0
8711911|NCT00964860|9758339|FG001|NOT COMPLETED|Overall Study||1
8593259|NCT00307151|9627917|FG003|COMPLETED|Overall Study|Results are through date DSMB recommended Cohort II results be unblinded (October 27, 2010)|129
8593260|NCT00307151|9627914|FG000|NOT COMPLETED|Overall Study||11
8593261|NCT00307151|9627915|FG001|NOT COMPLETED|Overall Study||7
8593262|NCT00307151|9627916|FG002|NOT COMPLETED|Overall Study||20
8593263|NCT00307151|9627917|FG003|NOT COMPLETED|Overall Study||11
8593264|NCT00307164|9627929|FG000|STARTED|Overall Study||83
8593265|NCT00307164|9627930|FG001|STARTED|Overall Study||82
8593266|NCT00307164|9627929|FG000|COMPLETED|Overall Study||68
8593267|NCT00307164|9627930|FG001|COMPLETED|Overall Study||68
8593268|NCT00307164|9627929|FG000|NOT COMPLETED|Overall Study||15
8593269|NCT00307164|9627930|FG001|NOT COMPLETED|Overall Study||14
8593270|NCT00307294|9627936|FG000|STARTED|Overall Study||40
8593271|NCT00307294|9627936|FG000|COMPLETED|Overall Study||39
8593272|NCT00307294|9627936|FG000|NOT COMPLETED|Overall Study||1
8593273|NCT00307333|9627943|FG000|STARTED|Overall Study||1511
8593274|NCT00307333|9627944|FG001|STARTED|Overall Study||1492
8593275|NCT00307333|9627943|FG000|COMPLETED|Overall Study||1500
8593276|NCT00307333|9627944|FG001|COMPLETED|Overall Study||1489
8593277|NCT00307333|9627943|FG000|NOT COMPLETED|Overall Study||11
8593278|NCT00307333|9627944|FG001|NOT COMPLETED|Overall Study||3
8593279|NCT00307437|9627953|FG000|STARTED|Controlled Period||410
8593280|NCT00307437|9627954|FG001|STARTED|Controlled Period||409
8593281|NCT00307437|9627955|FG002|STARTED|Controlled Period||411
8593282|NCT00307437|9627956|FG003|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
8593283|NCT00307437|9627957|FG004|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
8593284|NCT00307437|9627958|FG005|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
8593285|NCT00307437|9627959|FG006|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
8593286|NCT00307437|9627953|FG000|COMPLETED|Controlled Period||394
8593287|NCT00307437|9627954|FG001|COMPLETED|Controlled Period||403
8593288|NCT00307437|9627955|FG002|COMPLETED|Controlled Period||402
8593289|NCT00307437|9627956|FG003|COMPLETED|Controlled Period||0
8593290|NCT00307437|9627957|FG004|COMPLETED|Controlled Period||0
8593291|NCT00307437|9627958|FG005|COMPLETED|Controlled Period||0
8593292|NCT00307437|9627959|FG006|COMPLETED|Controlled Period||0
8593293|NCT00307437|9627953|FG000|NOT COMPLETED|Controlled Period||16
8593294|NCT00307437|9627954|FG001|NOT COMPLETED|Controlled Period||6
8593295|NCT00307437|9627955|FG002|NOT COMPLETED|Controlled Period||9
8593296|NCT00307437|9627956|FG003|NOT COMPLETED|Controlled Period||0
8593297|NCT00307437|9627957|FG004|NOT COMPLETED|Controlled Period||0
8593298|NCT00307437|9627958|FG005|NOT COMPLETED|Controlled Period||0
8593299|NCT00307437|9627959|FG006|NOT COMPLETED|Controlled Period||0
8711912|NCT00964886|9758349|FG000|STARTED|Overall Study||38
8711913|NCT00964886|9758350|FG001|STARTED|Overall Study||34
8711914|NCT00964886|9758351|FG002|STARTED|Overall Study||37
8711915|NCT00964886|9758352|FG003|STARTED|Overall Study||33
8711916|NCT00964886|9758349|FG000|COMPLETED|Overall Study||27
8711917|NCT00964886|9758350|FG001|COMPLETED|Overall Study||27
8711918|NCT00964886|9758351|FG002|COMPLETED|Overall Study||21
8711919|NCT00964886|9758352|FG003|COMPLETED|Overall Study||24
8711920|NCT00964886|9758349|FG000|NOT COMPLETED|Overall Study||11
8711921|NCT00964886|9758350|FG001|NOT COMPLETED|Overall Study||7
8711922|NCT00964886|9758351|FG002|NOT COMPLETED|Overall Study||16
8711923|NCT00964886|9758352|FG003|NOT COMPLETED|Overall Study||9
8711924|NCT00965081|9758368|FG000|STARTED|Overall Study|2 randomized participants had no post-baseline measures and are not included in outcome measures.|155
8711925|NCT00965081|9758369|FG001|STARTED|Overall Study||153
8711926|NCT00965081|9758368|FG000|COMPLETED|Overall Study|In addition, 16/17 rescue participants completed study on protocol-specified study medication.|121
8711927|NCT00965081|9758369|FG001|COMPLETED|Overall Study||110
8711928|NCT00965081|9758368|FG000|NOT COMPLETED|Overall Study||34
8711929|NCT00965081|9758369|FG001|NOT COMPLETED|Overall Study||43
8711930|NCT00965094|9758378|FG000|STARTED|Overall Study||19
8711931|NCT00965094|9758379|FG001|STARTED|Overall Study||17
8711932|NCT00965094|9758378|FG000|COMPLETED|Overall Study||14
8711933|NCT00965094|9758379|FG001|COMPLETED|Overall Study||16
8711934|NCT00965094|9758378|FG000|NOT COMPLETED|Overall Study||5
8711935|NCT00965094|9758379|FG001|NOT COMPLETED|Overall Study||1
8711936|NCT00965185|9758388|FG000|STARTED|Overall Study||19
8711937|NCT00965185|9758389|FG001|STARTED|Overall Study||21
8593300|NCT00307437|9627953|FG000|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
8593301|NCT00307437|9627954|FG001|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
8593302|NCT00307437|9627955|FG002|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
8593303|NCT00307437|9627956|FG003|STARTED|After Controlled Period||197
8593304|NCT00307437|9627957|FG004|STARTED|After Controlled Period|2 participants from placebo group in CP did not crossover to this group after CP.|195
8593305|NCT00307437|9627958|FG005|STARTED|After Controlled Period||403
8593306|NCT00307437|9627959|FG006|STARTED|After Controlled Period||402
8593307|NCT00307437|9627953|FG000|COMPLETED|After Controlled Period||0
8593308|NCT00307437|9627954|FG001|COMPLETED|After Controlled Period||0
8711938|NCT00965185|9758388|FG000|1 Month Visit|Overall Study||18
8711939|NCT00965185|9758389|FG001|1 Month Visit|Overall Study||21
8711940|NCT00965185|9758388|FG000|3 Month Visit|Overall Study||18
8711941|NCT00965185|9758389|FG001|3 Month Visit|Overall Study||21
8711942|NCT00965185|9758388|FG000|6 Month Visit|Overall Study||18
8593309|NCT00307437|9627955|FG002|COMPLETED|After Controlled Period||0
8593310|NCT00307437|9627956|FG003|COMPLETED|After Controlled Period||139
8593311|NCT00307437|9627957|FG004|COMPLETED|After Controlled Period||140
8593312|NCT00307437|9627958|FG005|COMPLETED|After Controlled Period||281
8711943|NCT00965185|9758389|FG001|6 Month Visit|Overall Study||21
8711944|NCT00965185|9758388|FG000|9 Month Visit|Overall Study||18
8711945|NCT00965185|9758389|FG001|9 Month Visit|Overall Study||21
8711946|NCT00965185|9758388|FG000|COMPLETED|Overall Study||17
8711947|NCT00965185|9758389|FG001|COMPLETED|Overall Study||20
8711948|NCT00965185|9758388|FG000|NOT COMPLETED|Overall Study||2
8711949|NCT00965185|9758389|FG001|NOT COMPLETED|Overall Study||1
8711950|NCT00965237|9758397|FG000|STARTED|Period 1, One Week of Wear||8
8711951|NCT00965237|9758398|FG001|STARTED|Period 1, One Week of Wear||8
8711952|NCT00965237|9758397|FG000|COMPLETED|Period 1, One Week of Wear||8
8711953|NCT00965237|9758398|FG001|COMPLETED|Period 1, One Week of Wear||8
8711954|NCT00965237|9758397|FG000|NOT COMPLETED|Period 1, One Week of Wear||0
8711955|NCT00965237|9758398|FG001|NOT COMPLETED|Period 1, One Week of Wear||0
8711956|NCT00965237|9758397|FG000|STARTED|Period 2, One Week of Wear||8
8711957|NCT00965237|9758398|FG001|STARTED|Period 2, One Week of Wear||8
8711958|NCT00965237|9758397|FG000|COMPLETED|Period 2, One Week of Wear||8
8711959|NCT00965237|9758398|FG001|COMPLETED|Period 2, One Week of Wear||8
8711960|NCT00965237|9758397|FG000|NOT COMPLETED|Period 2, One Week of Wear||0
8711961|NCT00965237|9758398|FG001|NOT COMPLETED|Period 2, One Week of Wear||0
8711962|NCT00965250|9758406|FG000|STARTED|Overall Study||37
8711963|NCT00965250|9758407|FG001|STARTED|Overall Study||12
8711964|NCT00965250|9758406|FG000|COMPLETED|Overall Study||37
8711965|NCT00965250|9758407|FG001|COMPLETED|Overall Study||12
8711966|NCT00965250|9758406|FG000|NOT COMPLETED|Overall Study||0
8711967|NCT00965250|9758407|FG001|NOT COMPLETED|Overall Study||0
8711968|NCT00965263|9758415|FG000|STARTED|Overall Study||6
8711969|NCT00965263|9758416|FG001|STARTED|Overall Study||9
8711970|NCT00965263|9758415|FG000|COMPLETED|Overall Study||4
8711971|NCT00965263|9758416|FG001|COMPLETED|Overall Study||6
8711972|NCT00965263|9758415|FG000|NOT COMPLETED|Overall Study||2
8711973|NCT00965263|9758416|FG001|NOT COMPLETED|Overall Study||3
8711974|NCT00965341|9758442|FG000|STARTED|Overall Study||19
8711975|NCT00965341|9758443|FG001|STARTED|Overall Study||24
8711976|NCT00965341|9758442|FG000|COMPLETED|Overall Study||13
8711977|NCT00965341|9758443|FG001|COMPLETED|Overall Study||16
8711978|NCT00965341|9758442|FG000|NOT COMPLETED|Overall Study||6
8711979|NCT00965341|9758443|FG001|NOT COMPLETED|Overall Study||8
8711980|NCT00965419|9758449|FG000|STARTED|Open Label Treatment for Responders||267
8711981|NCT00965419|9758449|FG000|Not Lost to f/u at First Post-baseline|Open Label Treatment for Responders||264
8711982|NCT00965419|9758449|FG000|COMPLETED|Open Label Treatment for Responders||20
8711983|NCT00965419|9758449|FG000|NOT COMPLETED|Open Label Treatment for Responders||247
8711984|NCT00965419|9758449|FG000|STARTED|Follow-up Phase||80
8711985|NCT00965419|9758449|FG000|COMPLETED|Follow-up Phase||18
8711986|NCT00965419|9758449|FG000|NOT COMPLETED|Follow-up Phase||62
8711987|NCT00965458|9758456|FG000|STARTED|Overall Study||33
8711988|NCT00965458|9758457|FG001|STARTED|Overall Study||16
8711989|NCT00965458|9758456|FG000|COMPLETED|Overall Study||31
8711990|NCT00965458|9758457|FG001|COMPLETED|Overall Study||12
8711991|NCT00965458|9758456|FG000|NOT COMPLETED|Overall Study||2
8711992|NCT00965458|9758457|FG001|NOT COMPLETED|Overall Study||4
8711993|NCT00965484|9758465|FG000|STARTED|Overall Study||136
8711994|NCT00965484|9758465|FG000|COMPLETED|Overall Study||134
8711995|NCT00965484|9758465|FG000|NOT COMPLETED|Overall Study||2
8711996|NCT00965497|9758469|FG000|STARTED|Overall Study||14
8711997|NCT00965497|9758469|FG000|COMPLETED|Overall Study||13
8711998|NCT00965497|9758469|FG000|NOT COMPLETED|Overall Study||1
8711999|NCT00965523|9758473|FG000|STARTED|Study 221|Study 221 (Safety Analysis Set).|81
8712000|NCT00965523|9758473|FG000|COMPLETED|Study 221||74
8712001|NCT00965523|9758473|FG000|NOT COMPLETED|Study 221||7
8712002|NCT00965523|9758473|FG000|STARTED|Study 224|Six subjects continued into Study 224 from Study 221.|6
8712003|NCT00965523|9758473|FG000|COMPLETED|Study 224||0
8712004|NCT00965523|9758473|FG000|NOT COMPLETED|Study 224||6
8712005|NCT00965562|9758480|FG000|STARTED|Overall Study||16
8712006|NCT00965562|9758481|FG001|STARTED|Overall Study||17
8712007|NCT00965562|9758482|FG002|STARTED|Overall Study||16
8712008|NCT00965562|9758480|FG000|Women With at Least 2 Follow up Visits|Overall Study|3 patients with no follow up visits: 1 out of contact, 2 patient requests|13
8712009|NCT00965562|9758481|FG001|Women With at Least 2 Follow up Visits|Overall Study|4 patients with no follow up visits: 2 out of contact, 2 patient requests|13
8712010|NCT00965562|9758482|FG002|Women With at Least 2 Follow up Visits|Overall Study|3 patients with no follow up visits: 3 out of contact|13
8712011|NCT00965562|9758480|FG000|Women Who Participated Full Follow up|Overall Study|7 patients discontinued intervention: 2 out of contact, 4 patient requests, 1 suspended by IRB|6
8712012|NCT00965562|9758481|FG001|Women Who Participated Full Follow up|Overall Study|3 patients discontinued intervention: 1 out of contact, 2 patient requests|10
8712013|NCT00965562|9758482|FG002|Women Who Participated Full Follow up|Overall Study|2 patients discontinued intervention: 2 patient requests|11
8712014|NCT00965562|9758480|FG000|COMPLETED|Overall Study|Participants who completed at least 2 visits were analyzed.|13
8712015|NCT00965562|9758481|FG001|COMPLETED|Overall Study|Participants who completed at least 2 visits were analyzed.|13
8712016|NCT00965562|9758482|FG002|COMPLETED|Overall Study|Participants who completed at least 2 visits were analyzed.|13
8712017|NCT00965562|9758480|FG000|NOT COMPLETED|Overall Study||3
8593313|NCT00307437|9627959|FG006|COMPLETED|After Controlled Period||289
8593314|NCT00307437|9627953|FG000|NOT COMPLETED|After Controlled Period||0
8593315|NCT00307437|9627954|FG001|NOT COMPLETED|After Controlled Period||0
8593316|NCT00307437|9627955|FG002|NOT COMPLETED|After Controlled Period||0
8593317|NCT00307437|9627956|FG003|NOT COMPLETED|After Controlled Period||58
8593318|NCT00307437|9627957|FG004|NOT COMPLETED|After Controlled Period||55
8593319|NCT00307437|9627958|FG005|NOT COMPLETED|After Controlled Period||122
8593320|NCT00307437|9627959|FG006|NOT COMPLETED|After Controlled Period||113
8593321|NCT00307489|9627983|FG000|STARTED|Baseline Through Week 48||53
8593322|NCT00307489|9627984|FG001|STARTED|Baseline Through Week 48||52
8593323|NCT00307489|9627983|FG000|COMPLETED|Baseline Through Week 48|16 of the 52 subjects switched to open-label FTC/TDF prior to Week 48.|52
8593324|NCT00307489|9627984|FG001|COMPLETED|Baseline Through Week 48|9 of the 50 subjects switched to open-label FTC/TDF prior to Week 48.|50
8593325|NCT00307489|9627983|FG000|NOT COMPLETED|Baseline Through Week 48||1
8593326|NCT00307489|9627984|FG001|NOT COMPLETED|Baseline Through Week 48||2
8593327|NCT00307489|9627983|FG000|STARTED|Week 48 Through Week 168||52
8593328|NCT00307489|9627984|FG001|STARTED|Week 48 Through Week 168||50
8593329|NCT00307489|9627983|FG000|COMPLETED|Week 48 Through Week 168|11 of the 46 subjects switched to open-label FTC/TDF prior to Week 168.|46
8593330|NCT00307489|9627984|FG001|COMPLETED|Week 48 Through Week 168|5 of the 44 subjects switched to open-label FTC/TDF prior to Week 168.|44
8593331|NCT00307489|9627983|FG000|NOT COMPLETED|Week 48 Through Week 168||6
8593332|NCT00307489|9627984|FG001|NOT COMPLETED|Week 48 Through Week 168||6
8593333|NCT00307684|9627990|FG000|STARTED|Open Label Phase||0
8593334|NCT00307684|9627991|FG001|STARTED|Open Label Phase||0
8593335|NCT00307684|9627992|FG002|STARTED|Open Label Phase|1 screening failure|155
8593336|NCT00307684|9627990|FG000|COMPLETED|Open Label Phase||0
8593337|NCT00307684|9627991|FG001|COMPLETED|Open Label Phase||0
8593338|NCT00307684|9627992|FG002|COMPLETED|Open Label Phase||99
8593339|NCT00307684|9627990|FG000|NOT COMPLETED|Open Label Phase||0
8593340|NCT00307684|9627991|FG001|NOT COMPLETED|Open Label Phase||0
8593341|NCT00307684|9627992|FG002|NOT COMPLETED|Open Label Phase||56
8593342|NCT00307684|9627990|FG000|STARTED|Double Blind Phase||23
8593343|NCT00307684|9627991|FG001|STARTED|Double Blind Phase||22
8593344|NCT00307684|9627992|FG002|STARTED|Double Blind Phase||0
8593345|NCT00307684|9627990|FG000|COMPLETED|Double Blind Phase||21
8593346|NCT00307684|9627991|FG001|COMPLETED|Double Blind Phase||17
8593347|NCT00307684|9627992|FG002|COMPLETED|Double Blind Phase||0
8593348|NCT00307684|9627990|FG000|NOT COMPLETED|Double Blind Phase||2
8593349|NCT00307684|9627991|FG001|NOT COMPLETED|Double Blind Phase||5
8593350|NCT00307684|9627992|FG002|NOT COMPLETED|Double Blind Phase||0
8593351|NCT00307736|9628000|FG000|STARTED|Overall Study||3
8593352|NCT00307736|9628001|FG001|STARTED|Overall Study||3
8593353|NCT00307736|9628002|FG002|STARTED|Overall Study||3
8593354|NCT00307736|9628003|FG003|STARTED|Overall Study||23
8593355|NCT00307736|9628000|FG000|COMPLETED|Overall Study||3
8593356|NCT00307736|9628001|FG001|COMPLETED|Overall Study||3
8593357|NCT00307736|9628002|FG002|COMPLETED|Overall Study||0
8593358|NCT00307736|9628003|FG003|COMPLETED|Overall Study||20
8712018|NCT00965562|9758481|FG001|NOT COMPLETED|Overall Study||4
8712019|NCT00965562|9758482|FG002|NOT COMPLETED|Overall Study||3
8712020|NCT00965575|9758493|FG000|STARTED|Overall Study|cross over, total enrolled 11|6
8712021|NCT00965575|9758494|FG001|STARTED|Overall Study|cross over, total enrolled 11|5
8712022|NCT00965575|9758493|FG000|COMPLETED|Overall Study||5
8712023|NCT00965575|9758494|FG001|COMPLETED|Overall Study||5
8712024|NCT00965575|9758493|FG000|NOT COMPLETED|Overall Study||1
8712025|NCT00965575|9758494|FG001|NOT COMPLETED|Overall Study||0
8712026|NCT00965718|9758502|FG000|STARTED|Overall Study||20
8712027|NCT00965718|9758502|FG000|COMPLETED|Overall Study||16
8712028|NCT00965718|9758502|FG000|NOT COMPLETED|Overall Study||4
8712029|NCT00965731|9758508|FG000|STARTED|Overall Study||7
8712030|NCT00965731|9758509|FG001|STARTED|Overall Study|Dose level given only after lower dose was successfully administered|20
8712031|NCT00965731|9758508|FG000|COMPLETED|Overall Study||0
8712032|NCT00965731|9758509|FG001|COMPLETED|Overall Study||0
8712033|NCT00965731|9758508|FG000|NOT COMPLETED|Overall Study||7
8712034|NCT00965731|9758509|FG001|NOT COMPLETED|Overall Study||20
8712035|NCT00965848|9758520|FG000|STARTED|Overall Study||107
8712036|NCT00965848|9758521|FG001|STARTED|Overall Study||34
8712037|NCT00965848|9758522|FG002|STARTED|Overall Study||127
8712038|NCT00965848|9758520|FG000|COMPLETED|Overall Study||78
8712039|NCT00965848|9758521|FG001|COMPLETED|Overall Study||32
8712040|NCT00965848|9758522|FG002|COMPLETED|Overall Study||117
8712041|NCT00965848|9758520|FG000|NOT COMPLETED|Overall Study||29
8712042|NCT00965848|9758521|FG001|NOT COMPLETED|Overall Study||2
8712043|NCT00965848|9758522|FG002|NOT COMPLETED|Overall Study||10
8712044|NCT00966186|9758532|FG000|STARTED|Overall Study||60
8712045|NCT00966186|9758533|FG001|STARTED|Overall Study||60
8593359|NCT00307736|9628000|FG000|NOT COMPLETED|Overall Study||0
8593360|NCT00307736|9628001|FG001|NOT COMPLETED|Overall Study||0
8593361|NCT00307736|9628002|FG002|NOT COMPLETED|Overall Study||3
8593362|NCT00307736|9628003|FG003|NOT COMPLETED|Overall Study||3
8593363|NCT00307801|9628016|FG000|STARTED|Overall Study||149
8593364|NCT00307801|9628017|FG001|STARTED|Overall Study||82
8593365|NCT00307801|9628016|FG000|Subjects Received Treatment|Overall Study||145
8593366|NCT00307801|9628017|FG001|Subjects Received Treatment|Overall Study||81
8712046|NCT00966186|9758532|FG000|COMPLETED|Overall Study||60
8712047|NCT00966186|9758533|FG001|COMPLETED|Overall Study||60
8712048|NCT00966186|9758532|FG000|NOT COMPLETED|Overall Study||0
8712049|NCT00966186|9758533|FG001|NOT COMPLETED|Overall Study||0
8593367|NCT00307801|9628016|FG000|Cycle 1, Visit 5, Baseline|Overall Study||145
8593368|NCT00307801|9628017|FG001|Cycle 1, Visit 5, Baseline|Overall Study||81
8593369|NCT00307801|9628016|FG000|Cycle 3, Visit 7, Treatment Day 84|Overall Study||130
8593370|NCT00307801|9628017|FG001|Cycle 3, Visit 7, Treatment Day 84|Overall Study||71
8593371|NCT00307801|9628016|FG000|Cycle 7, Treatment Day 196|Overall Study|Includes subjects that prematurely discontinued the study and may not be counted in earlier visits.|141
8593372|NCT00307801|9628017|FG001|Cycle 7, Treatment Day 196|Overall Study|Includes subjects that prematurely discontinued the study and may not be counted in earlier visits.|77
8593373|NCT00307801|9628016|FG000|COMPLETED|Overall Study||117
8593374|NCT00307801|9628017|FG001|COMPLETED|Overall Study||65
8593375|NCT00307801|9628016|FG000|NOT COMPLETED|Overall Study||32
8593376|NCT00307801|9628017|FG001|NOT COMPLETED|Overall Study||17
8593377|NCT00307931|9628024|FG000|STARTED|Overall Study|Number of subjects who entered the study and have been treated|16
8593378|NCT00307931|9628024|FG000|COMPLETED|Overall Study|Number of subjects who completed the Week 12 visit|15
8593379|NCT00307931|9628024|FG000|NOT COMPLETED|Overall Study||1
8593380|NCT00308061|9628030|FG000|STARTED|Overall Study||20
8593381|NCT00308061|9628031|FG001|STARTED|Overall Study||20
8593382|NCT00308061|9628030|FG000|COMPLETED|Overall Study||20
8593383|NCT00308061|9628031|FG001|COMPLETED|Overall Study||20
8593384|NCT00308061|9628030|FG000|NOT COMPLETED|Overall Study||0
8593385|NCT00308061|9628031|FG001|NOT COMPLETED|Overall Study||0
8593386|NCT00308074|9628038|FG000|STARTED|Overall Study||14
8593387|NCT00308074|9628038|FG000|COMPLETED|Overall Study||13
8593388|NCT00308074|9628038|FG000|NOT COMPLETED|Overall Study||1
8593389|NCT00308087|9628044|FG000|STARTED|Overall Study||37
8593390|NCT00308087|9628045|FG001|STARTED|Overall Study||38
8593391|NCT00308087|9628044|FG000|COMPLETED|Overall Study|Completers finished treatment and the 24 month follow-up.|1
8593392|NCT00308087|9628045|FG001|COMPLETED|Overall Study|Completers finished treatment and the 24 month follow-up.|1
8593393|NCT00308087|9628044|FG000|NOT COMPLETED|Overall Study||36
8593394|NCT00308087|9628045|FG001|NOT COMPLETED|Overall Study||37
8593395|NCT00308139|9628053|FG000|STARTED|Overall Study||152
8593396|NCT00308139|9628054|FG001|STARTED|Overall Study||151
8593397|NCT00308139|9628053|FG000|Intent to Treat (ITT)|Overall Study|Subjects who received at least one injection of lead-in exenatide 5 mcg.|148
8593398|NCT00308139|9628054|FG001|Intent to Treat (ITT)|Overall Study|Subjects who received at least one injection of lead-in exenatide 5 mcg.|147
8593399|NCT00308139|9628053|FG000|ITT in the 30-Week Assessment|Overall Study|ITT Subjects who received at least one injection of randomized dose.|148
8593400|NCT00308139|9628054|FG001|ITT in the 30-Week Assessment|Overall Study|ITT Subjects who received at least one injection of randomized dose.|145
8593401|NCT00308139|9628053|FG000|Pharmacokinetics Population|Overall Study||129
8593402|NCT00308139|9628054|FG001|Pharmacokinetics Population|Overall Study||0
8593403|NCT00308139|9628053|FG000|Evaluable Meal Tolerance Cohort|Overall Study||27
8593404|NCT00308139|9628054|FG001|Evaluable Meal Tolerance Cohort|Overall Study||24
8593405|NCT00308139|9628053|FG000|30-Week Completed|Overall Study|Subjects who completed 30 weeks of assessment|128
8593406|NCT00308139|9628054|FG001|30-Week Completed|Overall Study|Subjects who completed 30 weeks of assessment|130
8593407|NCT00308139|9628053|FG000|COMPLETED|Overall Study|Subjects who completed 364 weeks of assessment|58
8593408|NCT00308139|9628054|FG001|COMPLETED|Overall Study|Subjects who completed 364 weeks of assessment|64
8593409|NCT00308139|9628053|FG000|NOT COMPLETED|Overall Study||94
8593410|NCT00308139|9628054|FG001|NOT COMPLETED|Overall Study||87
8593411|NCT00308230|9628083|FG000|STARTED|Overall Study||6
8593412|NCT00308230|9628084|FG001|STARTED|Overall Study||8
8593413|NCT00308230|9628085|FG002|STARTED|Overall Study||20
8593414|NCT00308230|9628083|FG000|COMPLETED|Overall Study||6
8593415|NCT00308230|9628084|FG001|COMPLETED|Overall Study||8
8593416|NCT00308230|9628085|FG002|COMPLETED|Overall Study||20
8593417|NCT00308230|9628083|FG000|NOT COMPLETED|Overall Study||0
8593418|NCT00308230|9628084|FG001|NOT COMPLETED|Overall Study||0
8593419|NCT00308230|9628085|FG002|NOT COMPLETED|Overall Study||0
8593420|NCT00308282|9628097|FG000|STARTED|Overall Study||34
8593421|NCT00308282|9628098|FG001|STARTED|Overall Study||34
8593422|NCT00308282|9628099|FG002|STARTED|Overall Study||34
8593423|NCT00308282|9628100|FG003|STARTED|Overall Study||34
8593424|NCT00308282|9628097|FG000|Received at Least One Dose of Study Drug|Overall Study||34
8593425|NCT00308282|9628098|FG001|Received at Least One Dose of Study Drug|Overall Study||34
8593426|NCT00308282|9628099|FG002|Received at Least One Dose of Study Drug|Overall Study||34
8593427|NCT00308282|9628100|FG003|Received at Least One Dose of Study Drug|Overall Study||34
8593428|NCT00308282|9628097|FG000|COMPLETED|Overall Study||31
8593429|NCT00308282|9628098|FG001|COMPLETED|Overall Study||30
8593430|NCT00308282|9628099|FG002|COMPLETED|Overall Study||33
8593431|NCT00308282|9628100|FG003|COMPLETED|Overall Study||32
8593432|NCT00308282|9628097|FG000|NOT COMPLETED|Overall Study||3
8593433|NCT00308282|9628098|FG001|NOT COMPLETED|Overall Study||4
8593434|NCT00308282|9628099|FG002|NOT COMPLETED|Overall Study||1
8593435|NCT00308282|9628100|FG003|NOT COMPLETED|Overall Study||2
8593436|NCT00308308|9628115|FG000|STARTED|Overall Study||301
8593437|NCT00308308|9628116|FG001|STARTED|Overall Study||288
8593438|NCT00308308|9628115|FG000|COMPLETED|Overall Study||198
8593439|NCT00308308|9628116|FG001|COMPLETED|Overall Study||220
8593440|NCT00308308|9628115|FG000|NOT COMPLETED|Overall Study||103
8593441|NCT00308308|9628116|FG001|NOT COMPLETED|Overall Study||68
8593442|NCT00308555|9628124|FG000|STARTED|Overall Study||13
8593443|NCT00308555|9628125|FG001|STARTED|Overall Study||11
8593444|NCT00308555|9628124|FG000|COMPLETED|Overall Study||10
8593445|NCT00308555|9628125|FG001|COMPLETED|Overall Study||11
8593446|NCT00308555|9628124|FG000|NOT COMPLETED|Overall Study||3
8593447|NCT00308555|9628125|FG001|NOT COMPLETED|Overall Study||0
8593448|NCT00308581|9628131|FG000|STARTED|Induction Phase|Not applicable in this period|0
8593449|NCT00308581|9628132|FG001|STARTED|Induction Phase|Not applicable in this period|0
8593450|NCT00308581|9628133|FG002|STARTED|Induction Phase||539
8593451|NCT00308581|9628131|FG000|COMPLETED|Induction Phase|Not applicable in this period|0
8593452|NCT00308581|9628132|FG001|COMPLETED|Induction Phase|Not applicable in this period|0
8593453|NCT00308581|9628133|FG002|COMPLETED|Induction Phase||373
8593454|NCT00308581|9628131|FG000|NOT COMPLETED|Induction Phase||0
8593455|NCT00308581|9628132|FG001|NOT COMPLETED|Induction Phase||0
8593456|NCT00308581|9628133|FG002|NOT COMPLETED|Induction Phase||166
8593457|NCT00308581|9628131|FG000|STARTED|Randomized Maintenance Phase||187
8593458|NCT00308581|9628132|FG001|STARTED|Randomized Maintenance Phase||186
8593459|NCT00308581|9628133|FG002|STARTED|Randomized Maintenance Phase||0
8593460|NCT00308581|9628131|FG000|COMPLETED|Randomized Maintenance Phase||82
8593461|NCT00308581|9628132|FG001|COMPLETED|Randomized Maintenance Phase||83
8593462|NCT00308581|9628133|FG002|COMPLETED|Randomized Maintenance Phase||0
8593463|NCT00308581|9628131|FG000|NOT COMPLETED|Randomized Maintenance Phase||105
8593464|NCT00308581|9628132|FG001|NOT COMPLETED|Randomized Maintenance Phase||103
8593465|NCT00308581|9628133|FG002|NOT COMPLETED|Randomized Maintenance Phase||0
8593466|NCT00308620|9628144|FG000|STARTED|Overall Study||3
8593467|NCT00308620|9628145|FG001|STARTED|Overall Study||4
8593468|NCT00308620|9628146|FG002|STARTED|Overall Study||6
8593469|NCT00308620|9628144|FG000|COMPLETED|Overall Study||2
8593470|NCT00308620|9628145|FG001|COMPLETED|Overall Study||3
8593471|NCT00308620|9628146|FG002|COMPLETED|Overall Study||5
8593472|NCT00308620|9628144|FG000|NOT COMPLETED|Overall Study||1
8593473|NCT00308620|9628145|FG001|NOT COMPLETED|Overall Study||1
8593474|NCT00308620|9628146|FG002|NOT COMPLETED|Overall Study||1
8593475|NCT00308711|9628157|FG000|STARTED|Overall Study||428
8593476|NCT00308711|9628158|FG001|STARTED|Overall Study||444
8712050|NCT00966238|9758545|FG000|STARTED|Overall Study||20
8712051|NCT00966238|9758546|FG001|STARTED|Overall Study||20
8712052|NCT00966238|9758547|FG002|STARTED|Overall Study||20
8712053|NCT00966238|9758548|FG003|STARTED|Overall Study||20
8712054|NCT00966238|9758549|FG004|STARTED|Overall Study||20
8712055|NCT00966238|9758550|FG005|STARTED|Overall Study||20
8712056|NCT00966238|9758545|FG000|COMPLETED|Overall Study||20
8712057|NCT00966238|9758546|FG001|COMPLETED|Overall Study||20
8712058|NCT00966238|9758547|FG002|COMPLETED|Overall Study||20
8712059|NCT00966238|9758548|FG003|COMPLETED|Overall Study||20
8712060|NCT00966238|9758549|FG004|COMPLETED|Overall Study||20
8712061|NCT00966238|9758550|FG005|COMPLETED|Overall Study||20
8712062|NCT00966238|9758545|FG000|NOT COMPLETED|Overall Study||0
8712063|NCT00966238|9758546|FG001|NOT COMPLETED|Overall Study||0
8712064|NCT00966238|9758547|FG002|NOT COMPLETED|Overall Study||0
8712065|NCT00966238|9758548|FG003|NOT COMPLETED|Overall Study||0
8712066|NCT00966238|9758549|FG004|NOT COMPLETED|Overall Study||0
8712067|NCT00966238|9758550|FG005|NOT COMPLETED|Overall Study||0
8712068|NCT00966264|9758566|FG000|STARTED|Overall Study||119
8712069|NCT00966264|9758567|FG001|STARTED|Overall Study||117
8712070|NCT00966264|9758566|FG000|COMPLETED|Overall Study|5 years results|115
8712071|NCT00966264|9758567|FG001|COMPLETED|Overall Study|5 years results|114
8712072|NCT00966264|9758566|FG000|NOT COMPLETED|Overall Study||4
8712073|NCT00966264|9758567|FG001|NOT COMPLETED|Overall Study||3
8712074|NCT00966277|9758575|FG000|STARTED|Overall Study||38
8712075|NCT00966277|9758576|FG001|STARTED|Overall Study||37
8712076|NCT00966277|9758575|FG000|COMPLETED|Overall Study|Four participants did not receive study treatment, see 'Reasons Not Completed.'|34
8712077|NCT00966277|9758576|FG001|COMPLETED|Overall Study|Four participants did not receive study treatment, see 'Reasons Not Completed.'|33
8712078|NCT00966277|9758575|FG000|NOT COMPLETED|Overall Study||4
8712079|NCT00966277|9758576|FG001|NOT COMPLETED|Overall Study||4
8712080|NCT00966355|9758585|FG000|STARTED|Overall Study||344
8712081|NCT00966355|9758586|FG001|STARTED|Overall Study||345
8712082|NCT00966355|9758587|FG002|STARTED|Overall Study||345
8712083|NCT00966355|9758585|FG000|COMPLETED|Overall Study||260
8712084|NCT00966355|9758586|FG001|COMPLETED|Overall Study||259
8712085|NCT00966355|9758587|FG002|COMPLETED|Overall Study||261
8712086|NCT00966355|9758585|FG000|NOT COMPLETED|Overall Study||84
8712087|NCT00966355|9758586|FG001|NOT COMPLETED|Overall Study||86
8712088|NCT00966355|9758587|FG002|NOT COMPLETED|Overall Study||84
8712089|NCT00966433|9758598|FG000|STARTED|Overall Study||11
8712090|NCT00966433|9758599|FG001|STARTED|Overall Study||11
8712091|NCT00966433|9758600|FG002|STARTED|Overall Study||11
8712092|NCT00966433|9758598|FG000|COMPLETED|Overall Study||10
8712093|NCT00966433|9758599|FG001|COMPLETED|Overall Study||10
8593477|NCT00308711|9628159|FG002|STARTED|Overall Study||436
8593478|NCT00308711|9628157|FG000|COMPLETED|Overall Study||426
8593479|NCT00308711|9628158|FG001|COMPLETED|Overall Study||440
8593480|NCT00308711|9628159|FG002|COMPLETED|Overall Study||431
8593481|NCT00308711|9628157|FG000|NOT COMPLETED|Overall Study||2
8593482|NCT00308711|9628158|FG001|NOT COMPLETED|Overall Study||4
8593483|NCT00308711|9628159|FG002|NOT COMPLETED|Overall Study||5
8712094|NCT00966433|9758600|FG002|COMPLETED|Overall Study||11
8712095|NCT00966433|9758598|FG000|NOT COMPLETED|Overall Study||1
8712096|NCT00966433|9758599|FG001|NOT COMPLETED|Overall Study||1
8712097|NCT00966433|9758600|FG002|NOT COMPLETED|Overall Study||0
8712098|NCT00966446|9758613|FG000|STARTED|Overall Study||76
8712099|NCT00966446|9758614|FG001|STARTED|Overall Study||74
8593484|NCT00308737|9628170|FG000|STARTED|Overall Study||938
8593485|NCT00308737|9628171|FG001|STARTED|Overall Study||951
8593486|NCT00308737|9628172|FG002|STARTED|Overall Study||164
8593487|NCT00308737|9628170|FG000|COMPLETED|Overall Study||475
8593488|NCT00308737|9628171|FG001|COMPLETED|Overall Study||662
8593489|NCT00308737|9628172|FG002|COMPLETED|Overall Study||127
8593490|NCT00308737|9628170|FG000|NOT COMPLETED|Overall Study||463
8593491|NCT00308737|9628171|FG001|NOT COMPLETED|Overall Study||289
8593492|NCT00308737|9628172|FG002|NOT COMPLETED|Overall Study||37
8593493|NCT00308750|9628183|FG000|STARTED|Overall Study||72
8593494|NCT00308750|9628184|FG001|STARTED|Overall Study||74
8593495|NCT00308750|9628185|FG002|STARTED|Overall Study||72
8593496|NCT00308750|9628183|FG000|Received at Least 1 Dose of Study Drug|Overall Study||67
8593497|NCT00308750|9628184|FG001|Received at Least 1 Dose of Study Drug|Overall Study||72
8593498|NCT00308750|9628185|FG002|Received at Least 1 Dose of Study Drug|Overall Study||70
8712100|NCT00966446|9758615|FG002|STARTED|Overall Study||73
8712101|NCT00966446|9758613|FG000|COMPLETED|Overall Study||48
8712102|NCT00966446|9758614|FG001|COMPLETED|Overall Study||49
8712103|NCT00966446|9758615|FG002|COMPLETED|Overall Study||52
8712104|NCT00966446|9758613|FG000|NOT COMPLETED|Overall Study||28
8712105|NCT00966446|9758614|FG001|NOT COMPLETED|Overall Study||25
8712106|NCT00966446|9758615|FG002|NOT COMPLETED|Overall Study||21
8712107|NCT00966550|9758625|FG000|STARTED|Overall Study||13
8712108|NCT00966550|9758626|FG001|STARTED|Overall Study||12
8712109|NCT00966550|9758625|FG000|COMPLETED|Overall Study||13
8712110|NCT00966550|9758626|FG001|COMPLETED|Overall Study||12
8712111|NCT00966550|9758625|FG000|NOT COMPLETED|Overall Study||0
8712112|NCT00966550|9758626|FG001|NOT COMPLETED|Overall Study||0
8712113|NCT00966641|9758632|FG000|STARTED|First Intervention||17
8712114|NCT00966641|9758633|FG001|STARTED|First Intervention||17
8712115|NCT00966641|9758632|FG000|COMPLETED|First Intervention||17
8712116|NCT00966641|9758633|FG001|COMPLETED|First Intervention||17
8712117|NCT00966641|9758632|FG000|NOT COMPLETED|First Intervention||0
8712118|NCT00966641|9758633|FG001|NOT COMPLETED|First Intervention||0
8712119|NCT00966641|9758632|FG000|STARTED|Second Intervention||17
8712120|NCT00966641|9758633|FG001|STARTED|Second Intervention||17
8712121|NCT00966641|9758632|FG000|COMPLETED|Second Intervention||17
8712122|NCT00966641|9758633|FG001|COMPLETED|Second Intervention||17
8712123|NCT00966641|9758632|FG000|NOT COMPLETED|Second Intervention||0
8712124|NCT00966641|9758633|FG001|NOT COMPLETED|Second Intervention||0
8712125|NCT00966693|9758643|FG000|STARTED|Overall Study||3
8712126|NCT00966693|9758644|FG001|STARTED|Overall Study||3
8712127|NCT00966693|9758645|FG002|STARTED|Overall Study||9
8712128|NCT00966693|9758646|FG003|STARTED|Overall Study||49
8712129|NCT00966693|9758643|FG000|Phase 1 Completed|Overall Study||2
8712130|NCT00966693|9758644|FG001|Phase 1 Completed|Overall Study||3
8712131|NCT00966693|9758645|FG002|Phase 1 Completed|Overall Study||6
8712132|NCT00966693|9758646|FG003|Phase 1 Completed|Overall Study||0
8712133|NCT00966693|9758643|FG000|Phase 2 Completed|Overall Study||0
8712134|NCT00966693|9758644|FG001|Phase 2 Completed|Overall Study||0
8712135|NCT00966693|9758645|FG002|Phase 2 Completed|Overall Study||0
8712136|NCT00966693|9758646|FG003|Phase 2 Completed|Overall Study||46
8712137|NCT00966693|9758643|FG000|COMPLETED|Overall Study||2
8712138|NCT00966693|9758644|FG001|COMPLETED|Overall Study||3
8712139|NCT00966693|9758645|FG002|COMPLETED|Overall Study||6
8712140|NCT00966693|9758646|FG003|COMPLETED|Overall Study||26
8712141|NCT00966693|9758643|FG000|NOT COMPLETED|Overall Study||1
8712142|NCT00966693|9758644|FG001|NOT COMPLETED|Overall Study||0
8712143|NCT00966693|9758645|FG002|NOT COMPLETED|Overall Study||3
8712144|NCT00966693|9758646|FG003|NOT COMPLETED|Overall Study||23
8712145|NCT00966719|9758658|FG000|STARTED|Overall Study||50
8712146|NCT00966719|9758659|FG001|STARTED|Overall Study||49
8712147|NCT00966719|9758658|FG000|COMPLETED|Overall Study||44
8712148|NCT00966719|9758659|FG001|COMPLETED|Overall Study||38
8712149|NCT00966719|9758658|FG000|NOT COMPLETED|Overall Study||6
8712150|NCT00966719|9758659|FG001|NOT COMPLETED|Overall Study||11
8712151|NCT00966823|9758665|FG000|STARTED|Overall Study||3
8712152|NCT00966823|9758665|FG000|COMPLETED|Overall Study||2
8712153|NCT00966823|9758665|FG000|NOT COMPLETED|Overall Study||1
8593499|NCT00308750|9628183|FG000|COMPLETED|Overall Study||0
8593500|NCT00308750|9628184|FG001|COMPLETED|Overall Study||34
8593501|NCT00308750|9628185|FG002|COMPLETED|Overall Study||23
8593502|NCT00308750|9628183|FG000|NOT COMPLETED|Overall Study||72
8593503|NCT00308750|9628184|FG001|NOT COMPLETED|Overall Study||40
8593504|NCT00308750|9628185|FG002|NOT COMPLETED|Overall Study||49
8628228|NCT00521989|9667625|FG003|NOT COMPLETED|Overall Study||12
8628229|NCT00521989|9667626|FG004|NOT COMPLETED|Overall Study||23
8628230|NCT00522041|9667640|FG000|STARTED|Overall Study||123
8628231|NCT00522041|9667641|FG001|STARTED|Overall Study||125
8628232|NCT00522041|9667640|FG000|Received Treatment|Overall Study||123
8628233|NCT00522041|9667641|FG001|Received Treatment|Overall Study||124
8628234|NCT00522041|9667640|FG000|COMPLETED|Overall Study||106
8628235|NCT00522041|9667641|FG001|COMPLETED|Overall Study||113
8628236|NCT00522041|9667640|FG000|NOT COMPLETED|Overall Study||17
8628237|NCT00522041|9667641|FG001|NOT COMPLETED|Overall Study||12
8628238|NCT00522171|9667650|FG000|STARTED|Overall Study||15
8628239|NCT00522171|9667651|FG001|STARTED|Overall Study||15
8628240|NCT00522171|9667650|FG000|COMPLETED|Overall Study||15
8628241|NCT00522171|9667651|FG001|COMPLETED|Overall Study||15
8628242|NCT00522171|9667650|FG000|NOT COMPLETED|Overall Study||0
8628243|NCT00522171|9667651|FG001|NOT COMPLETED|Overall Study||0
8593505|NCT00308997|9628196|FG000|STARTED|Overall Study||56
8593506|NCT00308997|9628197|FG001|STARTED|Overall Study||29
8593507|NCT00308997|9628196|FG000|COMPLETED|Overall Study||55
8593508|NCT00308997|9628197|FG001|COMPLETED|Overall Study||28
8593509|NCT00308997|9628196|FG000|NOT COMPLETED|Overall Study||1
8593510|NCT00308997|9628197|FG001|NOT COMPLETED|Overall Study||1
8593511|NCT00309140|9628203|FG000|STARTED|Overall Study||23
8593512|NCT00309140|9628203|FG000|Received at Least 1 Dose of Study Drug|Overall Study||23
8593513|NCT00309140|9628203|FG000|COMPLETED|Overall Study||23
8593514|NCT00309140|9628203|FG000|NOT COMPLETED|Overall Study||0
8593515|NCT00309166|9628209|FG000|STARTED|Overall Study||181
8593516|NCT00309166|9628210|FG001|STARTED|Overall Study||89
8593517|NCT00309166|9628209|FG000|COMPLETED|Overall Study||176
8593518|NCT00309166|9628210|FG001|COMPLETED|Overall Study||86
8593519|NCT00309166|9628209|FG000|NOT COMPLETED|Overall Study||5
8593520|NCT00309166|9628210|FG001|NOT COMPLETED|Overall Study||3
8593521|NCT00309244|9628218|FG000|STARTED|Overall Study||334
8593522|NCT00309244|9628219|FG001|STARTED|Overall Study||343
8712154|NCT00966849|9758672|FG000|STARTED|Overall Study||3660
8712155|NCT00966849|9758673|FG001|STARTED|Overall Study||3976
8712156|NCT00966849|9758674|FG002|STARTED|Overall Study||3169
8712157|NCT00966849|9758672|FG000|COMPLETED|Overall Study||2119
8712158|NCT00966849|9758673|FG001|COMPLETED|Overall Study||2498
8712159|NCT00966849|9758674|FG002|COMPLETED|Overall Study||1876
8712160|NCT00966849|9758672|FG000|NOT COMPLETED|Overall Study||1541
8712161|NCT00966849|9758673|FG001|NOT COMPLETED|Overall Study||1478
8712162|NCT00966849|9758674|FG002|NOT COMPLETED|Overall Study||1293
8712163|NCT00966875|9758691|FG000|STARTED|Part A||54
8712164|NCT00966875|9758692|FG001|STARTED|Part A||40
8712165|NCT00966875|9758693|FG002|STARTED|Part A||35
8712166|NCT00966875|9758694|FG003|STARTED|Part A||37
8712167|NCT00966875|9758695|FG004|STARTED|Part A||57
8712168|NCT00966875|9758696|FG005|STARTED|Part A||37
8712169|NCT00966875|9758697|FG006|STARTED|Part A||64
8712170|NCT00966875|9758698|FG007|STARTED|Part A||65
8712171|NCT00966875|9758699|FG008|STARTED|Part A||59
8712172|NCT00966875|9758691|FG000|Received ≥1 Doses of Study Drug|Part A||54
8712173|NCT00966875|9758692|FG001|Received ≥1 Doses of Study Drug|Part A||40
8712174|NCT00966875|9758693|FG002|Received ≥1 Doses of Study Drug|Part A||35
8712175|NCT00966875|9758694|FG003|Received ≥1 Doses of Study Drug|Part A||37
8712176|NCT00966875|9758695|FG004|Received ≥1 Doses of Study Drug|Part A||57
8712177|NCT00966875|9758696|FG005|Received ≥1 Doses of Study Drug|Part A||37
8712178|NCT00966875|9758697|FG006|Received ≥1 Doses of Study Drug|Part A||64
8712179|NCT00966875|9758698|FG007|Received ≥1 Doses of Study Drug|Part A||65
8712180|NCT00966875|9758699|FG008|Received ≥1 Doses of Study Drug|Part A||59
8712181|NCT00966875|9758691|FG000|COMPLETED|Part A||48
8712182|NCT00966875|9758692|FG001|COMPLETED|Part A||36
8712183|NCT00966875|9758693|FG002|COMPLETED|Part A||33
8712184|NCT00966875|9758694|FG003|COMPLETED|Part A||34
8712185|NCT00966875|9758695|FG004|COMPLETED|Part A||52
8712186|NCT00966875|9758696|FG005|COMPLETED|Part A||33
8712187|NCT00966875|9758697|FG006|COMPLETED|Part A||52
8712188|NCT00966875|9758698|FG007|COMPLETED|Part A||58
8712189|NCT00966875|9758699|FG008|COMPLETED|Part A||51
8712190|NCT00966875|9758691|FG000|NOT COMPLETED|Part A||6
8712191|NCT00966875|9758692|FG001|NOT COMPLETED|Part A||4
8712192|NCT00966875|9758693|FG002|NOT COMPLETED|Part A||2
8712193|NCT00966875|9758694|FG003|NOT COMPLETED|Part A||3
8712194|NCT00966875|9758695|FG004|NOT COMPLETED|Part A||5
8712195|NCT00966875|9758696|FG005|NOT COMPLETED|Part A||4
8712196|NCT00966875|9758697|FG006|NOT COMPLETED|Part A||12
8712197|NCT00966875|9758698|FG007|NOT COMPLETED|Part A||7
8712198|NCT00966875|9758699|FG008|NOT COMPLETED|Part A||8
8712199|NCT00966875|9758691|FG000|STARTED|Part B|Two (2) participants who completed Part A did not enter Part B.|46
8712200|NCT00966875|9758692|FG001|STARTED|Part B||36
8712201|NCT00966875|9758693|FG002|STARTED|Part B||33
8712202|NCT00966875|9758694|FG003|STARTED|Part B||34
8712203|NCT00966875|9758695|FG004|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|51
8712204|NCT00966875|9758696|FG005|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|32
8712205|NCT00966875|9758697|FG006|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|51
8712206|NCT00966875|9758698|FG007|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|57
8712207|NCT00966875|9758699|FG008|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|50
8712208|NCT00966875|9758691|FG000|COMPLETED|Part B||41
8712209|NCT00966875|9758692|FG001|COMPLETED|Part B||33
8712210|NCT00966875|9758693|FG002|COMPLETED|Part B||27
8712211|NCT00966875|9758694|FG003|COMPLETED|Part B||31
8712212|NCT00966875|9758695|FG004|COMPLETED|Part B||44
8712213|NCT00966875|9758696|FG005|COMPLETED|Part B||26
8593523|NCT00309244|9628218|FG000|COMPLETED|Overall Study||216
8593524|NCT00309244|9628219|FG001|COMPLETED|Overall Study||246
8593525|NCT00309244|9628218|FG000|NOT COMPLETED|Overall Study||118
8593526|NCT00309244|9628219|FG001|NOT COMPLETED|Overall Study||97
8593527|NCT00309387|9628227|FG000|STARTED|Overall Study||510
8593528|NCT00309387|9628228|FG001|STARTED|Overall Study||510
8593529|NCT00309387|9628227|FG000|COMPLETED|Overall Study||368
8712214|NCT00966875|9758697|FG006|COMPLETED|Part B||29
8712215|NCT00966875|9758698|FG007|COMPLETED|Part B||38
8712216|NCT00966875|9758699|FG008|COMPLETED|Part B||32
8712217|NCT00966875|9758691|FG000|NOT COMPLETED|Part B||5
8712218|NCT00966875|9758692|FG001|NOT COMPLETED|Part B||3
8712219|NCT00966875|9758693|FG002|NOT COMPLETED|Part B||6
8712220|NCT00966875|9758694|FG003|NOT COMPLETED|Part B||3
8712221|NCT00966875|9758695|FG004|NOT COMPLETED|Part B||7
8593530|NCT00309387|9628228|FG001|COMPLETED|Overall Study||351
8593531|NCT00309387|9628227|FG000|NOT COMPLETED|Overall Study||142
8593532|NCT00309387|9628228|FG001|NOT COMPLETED|Overall Study||159
8593533|NCT00309452|9628237|FG000|STARTED|Overall Study||60
8593534|NCT00309452|9628238|FG001|STARTED|Overall Study||60
8593535|NCT00309452|9628237|FG000|COMPLETED|Overall Study||57
8593536|NCT00309452|9628238|FG001|COMPLETED|Overall Study||60
8593537|NCT00309452|9628237|FG000|NOT COMPLETED|Overall Study||3
8593538|NCT00309452|9628238|FG001|NOT COMPLETED|Overall Study||0
8593539|NCT00309465|9628250|FG000|STARTED|Overall Study||58
8593540|NCT00309465|9628251|FG001|STARTED|Overall Study||58
8593541|NCT00309465|9628252|FG002|STARTED|Overall Study||58
8593542|NCT00309465|9628253|FG003|STARTED|Overall Study||76
8593543|NCT00309465|9628254|FG004|STARTED|Overall Study||76
8593544|NCT00309465|9628255|FG005|STARTED|Overall Study||76
8712222|NCT00966875|9758696|FG005|NOT COMPLETED|Part B||6
8712223|NCT00966875|9758697|FG006|NOT COMPLETED|Part B||22
8712224|NCT00966875|9758698|FG007|NOT COMPLETED|Part B||19
8712225|NCT00966875|9758699|FG008|NOT COMPLETED|Part B||18
8712226|NCT00966940|9758774|FG000|STARTED|Period 1, First 6 Weeks||28
8712227|NCT00966940|9758775|FG001|STARTED|Period 1, First 6 Weeks||23
8712228|NCT00966940|9758774|FG000|COMPLETED|Period 1, First 6 Weeks||25
8712229|NCT00966940|9758775|FG001|COMPLETED|Period 1, First 6 Weeks||23
8712230|NCT00966940|9758774|FG000|NOT COMPLETED|Period 1, First 6 Weeks||3
8712231|NCT00966940|9758775|FG001|NOT COMPLETED|Period 1, First 6 Weeks||0
8712232|NCT00966940|9758774|FG000|STARTED|Period 2, Second 6 Weeks||25
8712233|NCT00966940|9758775|FG001|STARTED|Period 2, Second 6 Weeks||23
8712234|NCT00966940|9758774|FG000|COMPLETED|Period 2, Second 6 Weeks||25
8712235|NCT00966940|9758775|FG001|COMPLETED|Period 2, Second 6 Weeks||23
8712236|NCT00966940|9758774|FG000|NOT COMPLETED|Period 2, Second 6 Weeks||0
8712237|NCT00966940|9758775|FG001|NOT COMPLETED|Period 2, Second 6 Weeks||0
8712238|NCT00967005|9758783|FG000|STARTED|Overall Study||13
8712239|NCT00967005|9758784|FG001|STARTED|Overall Study||15
8712240|NCT00967005|9758783|FG000|Treatment Completion|Overall Study||10
8712241|NCT00967005|9758784|FG001|Treatment Completion|Overall Study||10
8712242|NCT00967005|9758783|FG000|COMPLETED|Overall Study||6
8712243|NCT00967005|9758784|FG001|COMPLETED|Overall Study||5
8712244|NCT00967005|9758783|FG000|NOT COMPLETED|Overall Study||7
8712245|NCT00967005|9758784|FG001|NOT COMPLETED|Overall Study||10
8712246|NCT00967018|9758790|FG000|STARTED|Overall Study||77
8712247|NCT00967018|9758790|FG000|COMPLETED|Overall Study||56
8712248|NCT00967018|9758790|FG000|NOT COMPLETED|Overall Study||21
8712249|NCT00967044|9758794|FG000|STARTED|Overall Study||30
8712250|NCT00967044|9758794|FG000|COMPLETED|Overall Study||30
8712251|NCT00967044|9758794|FG000|NOT COMPLETED|Overall Study||0
8712252|NCT00967226|9758800|FG000|STARTED|Overall Study||11
8712253|NCT00967226|9758801|FG001|STARTED|Overall Study||8
8712254|NCT00967226|9758800|FG000|COMPLETED|Overall Study||9
8712255|NCT00967226|9758801|FG001|COMPLETED|Overall Study||2
8712256|NCT00967226|9758800|FG000|NOT COMPLETED|Overall Study||2
8712257|NCT00967226|9758801|FG001|NOT COMPLETED|Overall Study||6
8712258|NCT00967330|9758833|FG000|STARTED|Overall Study||122
8712259|NCT00967330|9758834|FG001|STARTED|Overall Study||60
8712260|NCT00967330|9758833|FG000|COMPLETED|Overall Study||0
8712261|NCT00967330|9758834|FG001|COMPLETED|Overall Study||0
8712262|NCT00967330|9758833|FG000|NOT COMPLETED|Overall Study||122
8712263|NCT00967330|9758834|FG001|NOT COMPLETED|Overall Study||60
8712264|NCT00967343|9758840|FG000|STARTED|Overall Study||40
8712265|NCT00967343|9758840|FG000|COMPLETED|Overall Study||2
8712266|NCT00967343|9758840|FG000|NOT COMPLETED|Overall Study||38
8712267|NCT00967369|9758846|FG000|STARTED|Overall Study||10
8712268|NCT00967369|9758847|FG001|STARTED|Overall Study||10
8712269|NCT00967369|9758846|FG000|Relapsed|Overall Study||4
8712270|NCT00967369|9758847|FG001|Relapsed|Overall Study||7
8712271|NCT00967369|9758846|FG000|Refractory|Overall Study||6
8712272|NCT00967369|9758847|FG001|Refractory|Overall Study||3
8712273|NCT00967369|9758846|FG000|COMPLETED|Overall Study||10
8712274|NCT00967369|9758847|FG001|COMPLETED|Overall Study||10
8712275|NCT00967369|9758846|FG000|NOT COMPLETED|Overall Study||0
8712276|NCT00967369|9758847|FG001|NOT COMPLETED|Overall Study||0
8712277|NCT00967473|9758853|FG000|STARTED|Overall Study||15
8712278|NCT00967473|9758853|FG000|COMPLETED|Overall Study||15
8712279|NCT00967473|9758853|FG000|NOT COMPLETED|Overall Study||0
8712280|NCT00967486|9758859|FG000|STARTED|Overall Study||98
8712281|NCT00967486|9758860|FG001|STARTED|Overall Study||102
8712282|NCT00967486|9758859|FG000|COMPLETED|Overall Study||98
8712283|NCT00967486|9758860|FG001|COMPLETED|Overall Study||102
8712284|NCT00967486|9758859|FG000|NOT COMPLETED|Overall Study||0
8712285|NCT00967486|9758860|FG001|NOT COMPLETED|Overall Study||0
8712286|NCT00967499|9758868|FG000|STARTED|Overall Study||111
8712287|NCT00967499|9758869|FG001|STARTED|Overall Study||109
8712288|NCT00967499|9758868|FG000|Treated (Full Analysis Set)|Overall Study||48
8712289|NCT00967499|9758869|FG001|Treated (Full Analysis Set)|Overall Study||50
8712290|NCT00967499|9758868|FG000|COMPLETED|Overall Study||46
8712291|NCT00967499|9758869|FG001|COMPLETED|Overall Study||49
8712292|NCT00967499|9758868|FG000|NOT COMPLETED|Overall Study||65
8712293|NCT00967499|9758869|FG001|NOT COMPLETED|Overall Study||60
8712294|NCT00967551|9758877|FG000|STARTED|Overall Study||68
8593545|NCT00309465|9628250|FG000|COMPLETED|Overall Study||58
8593546|NCT00309465|9628251|FG001|COMPLETED|Overall Study||58
8593547|NCT00309465|9628252|FG002|COMPLETED|Overall Study||58
8712295|NCT00967551|9758878|FG001|STARTED|Overall Study||75
8593548|NCT00309465|9628253|FG003|COMPLETED|Overall Study|One subject was excluded due to eligibility error.|75
8593549|NCT00309465|9628254|FG004|COMPLETED|Overall Study||76
8593550|NCT00309465|9628255|FG005|COMPLETED|Overall Study||76
8593551|NCT00309465|9628250|FG000|NOT COMPLETED|Overall Study||0
8593552|NCT00309465|9628251|FG001|NOT COMPLETED|Overall Study||0
8593553|NCT00309465|9628252|FG002|NOT COMPLETED|Overall Study||0
8593554|NCT00309465|9628253|FG003|NOT COMPLETED|Overall Study||1
8593555|NCT00309465|9628254|FG004|NOT COMPLETED|Overall Study||0
8593556|NCT00309465|9628255|FG005|NOT COMPLETED|Overall Study||0
8593557|NCT00309608|9628274|FG000|STARTED|Overall Study||71
8593558|NCT00309608|9628275|FG001|STARTED|Overall Study||65
8593559|NCT00309608|9628276|FG002|STARTED|Overall Study||66
8593560|NCT00309608|9628277|FG003|STARTED|Overall Study||66
8712296|NCT00967551|9758877|FG000|COMPLETED|Overall Study||68
8712297|NCT00967551|9758878|FG001|COMPLETED|Overall Study||75
8712298|NCT00967551|9758877|FG000|NOT COMPLETED|Overall Study||0
8712299|NCT00967551|9758878|FG001|NOT COMPLETED|Overall Study||0
8712300|NCT00967616|9758886|FG000|STARTED|Overall Study||50
8712301|NCT00967616|9758887|FG001|STARTED|Overall Study||50
8712302|NCT00967616|9758886|FG000|COMPLETED|Overall Study||0
8712303|NCT00967616|9758887|FG001|COMPLETED|Overall Study||0
8712304|NCT00967616|9758886|FG000|NOT COMPLETED|Overall Study||50
8712305|NCT00967616|9758887|FG001|NOT COMPLETED|Overall Study||50
8712306|NCT00967668|9758896|FG000|STARTED|Overall Study||162
8712307|NCT00967668|9758897|FG001|STARTED|Overall Study||160
8712308|NCT00967668|9758898|FG002|STARTED|Overall Study||159
8712309|NCT00967668|9758896|FG000|3-mo Assessment|Overall Study||131
8712310|NCT00967668|9758897|FG001|3-mo Assessment|Overall Study||127
8712311|NCT00967668|9758898|FG002|3-mo Assessment|Overall Study||115
8712312|NCT00967668|9758896|FG000|Completed Year 1 - 12-mo Assessment|Overall Study||120
8712313|NCT00967668|9758897|FG001|Completed Year 1 - 12-mo Assessment|Overall Study||122
8712314|NCT00967668|9758898|FG002|Completed Year 1 - 12-mo Assessment|Overall Study||119
8712315|NCT00967668|9758896|FG000|18-mo Assessment|Overall Study||95
8712316|NCT00967668|9758897|FG001|18-mo Assessment|Overall Study||102
8712317|NCT00967668|9758898|FG002|18-mo Assessment|Overall Study||92
8712318|NCT00967668|9758896|FG000|COMPLETED|Overall Study||91
8712319|NCT00967668|9758897|FG001|COMPLETED|Overall Study||104
8712320|NCT00967668|9758898|FG002|COMPLETED|Overall Study||90
8712321|NCT00967668|9758896|FG000|NOT COMPLETED|Overall Study||71
8712322|NCT00967668|9758897|FG001|NOT COMPLETED|Overall Study||56
8712323|NCT00967668|9758898|FG002|NOT COMPLETED|Overall Study||69
8712324|NCT00967694|9758909|FG000|STARTED|Overall Study||26
8712325|NCT00967694|9758909|FG000|COMPLETED|Overall Study|5 discontinued during N2O administration due to agitation ⁄ dysphoria, one due to nausea⁄vomiting.|20
8712326|NCT00967694|9758909|FG000|NOT COMPLETED|Overall Study||6
8712327|NCT00967798|9758915|FG000|STARTED|Overall Study||17
8712328|NCT00967798|9758916|FG001|STARTED|Overall Study||16
8712329|NCT00967798|9758915|FG000|COMPLETED|Overall Study||8
8712330|NCT00967798|9758916|FG001|COMPLETED|Overall Study||13
8712331|NCT00967798|9758915|FG000|NOT COMPLETED|Overall Study||9
8712332|NCT00967798|9758916|FG001|NOT COMPLETED|Overall Study||3
8712333|NCT00967941|9758925|FG000|STARTED|Overall Study||67
8712334|NCT00967941|9758926|FG001|STARTED|Overall Study||54
8712335|NCT00967941|9758927|FG002|STARTED|Overall Study||60
8712336|NCT00967941|9758925|FG000|COMPLETED|Overall Study||62
8712337|NCT00967941|9758926|FG001|COMPLETED|Overall Study||51
8712338|NCT00967941|9758927|FG002|COMPLETED|Overall Study||56
8712339|NCT00967941|9758925|FG000|NOT COMPLETED|Overall Study||5
8712340|NCT00967941|9758926|FG001|NOT COMPLETED|Overall Study||3
8712341|NCT00967941|9758927|FG002|NOT COMPLETED|Overall Study||4
8724847|NCT01028131|9772139|FG001|Completed Intervention/Control Session|Overall Study||26
8724848|NCT01028131|9772140|FG002|Completed Intervention/Control Session|Overall Study||28
8724849|NCT01028131|9772141|FG003|Completed Intervention/Control Session|Overall Study||30
8724850|NCT01028131|9772138|FG000|COMPLETED|Overall Study||23
8593561|NCT00309608|9628278|FG004|STARTED|Overall Study||65
8593562|NCT00309608|9628274|FG000|COMPLETED|Overall Study||57
8593563|NCT00309608|9628275|FG001|COMPLETED|Overall Study||52
8593564|NCT00309608|9628276|FG002|COMPLETED|Overall Study||56
8593565|NCT00309608|9628277|FG003|COMPLETED|Overall Study||60
8724851|NCT01028131|9772139|FG001|COMPLETED|Overall Study||23
8724852|NCT01028131|9772140|FG002|COMPLETED|Overall Study||22
8724853|NCT01028131|9772141|FG003|COMPLETED|Overall Study||26
8724854|NCT01028131|9772138|FG000|NOT COMPLETED|Overall Study||3
8724855|NCT01028131|9772139|FG001|NOT COMPLETED|Overall Study||3
8724856|NCT01028131|9772140|FG002|NOT COMPLETED|Overall Study||6
8724857|NCT01028131|9772141|FG003|NOT COMPLETED|Overall Study||4
8724858|NCT01028222|9772153|FG000|STARTED|Overall Study||42
8593566|NCT00309608|9628278|FG004|COMPLETED|Overall Study||61
8593567|NCT00309608|9628274|FG000|NOT COMPLETED|Overall Study||14
8593568|NCT00309608|9628275|FG001|NOT COMPLETED|Overall Study||13
8593569|NCT00309608|9628276|FG002|NOT COMPLETED|Overall Study||10
8724859|NCT01028222|9772154|FG001|STARTED|Overall Study||13
8724860|NCT01028222|9772153|FG000|Cross Over From DTIC to Nilotinib|Overall Study||0
8724861|NCT01028222|9772154|FG001|Cross Over From DTIC to Nilotinib|Overall Study||10
8724862|NCT01028222|9772153|FG000|COMPLETED|Overall Study||4
8724863|NCT01028222|9772154|FG001|COMPLETED|Overall Study||0
8724864|NCT01028222|9772153|FG000|NOT COMPLETED|Overall Study||38
8724865|NCT01028222|9772154|FG001|NOT COMPLETED|Overall Study||13
8724866|NCT01028352|9772161|FG000|STARTED|Overall Study||35
8724867|NCT01028352|9772161|FG000|COMPLETED|Overall Study||29
8593570|NCT00309608|9628277|FG003|NOT COMPLETED|Overall Study||6
8593571|NCT00309608|9628278|FG004|NOT COMPLETED|Overall Study||4
8593572|NCT00309738|9628292|FG000|STARTED|Overall Study||236
8593573|NCT00309738|9628293|FG001|STARTED|Overall Study||119
8593574|NCT00309738|9628292|FG000|Safety Population|Overall Study|Subjects who received at least one dose of study medication|233
8593575|NCT00309738|9628293|FG001|Safety Population|Overall Study|Subjects who received at least one dose of study medication|119
8593576|NCT00309738|9628292|FG000|COMPLETED|Overall Study||223
8593577|NCT00309738|9628293|FG001|COMPLETED|Overall Study||107
8593578|NCT00309738|9628292|FG000|NOT COMPLETED|Overall Study||13
8593579|NCT00309738|9628293|FG001|NOT COMPLETED|Overall Study||12
8593580|NCT00309751|9628301|FG000|STARTED|Overall Study||279
8593581|NCT00309751|9628302|FG001|STARTED|Overall Study||139
8593582|NCT00309751|9628301|FG000|Safety Population|Overall Study|Subjects who received at least 1 dose of study drug|275
8593583|NCT00309751|9628302|FG001|Safety Population|Overall Study|Subjects who received at least 1 dose of study drug|137
8593584|NCT00309751|9628301|FG000|COMPLETED|Overall Study||248
8593585|NCT00309751|9628302|FG001|COMPLETED|Overall Study||124
8593586|NCT00309751|9628301|FG000|NOT COMPLETED|Overall Study||31
8593587|NCT00309751|9628302|FG001|NOT COMPLETED|Overall Study||15
8593588|NCT00309777|9628312|FG000|STARTED|Overall Study||315
8593589|NCT00309777|9628313|FG001|STARTED|Overall Study||108
8593590|NCT00309777|9628314|FG002|STARTED|Overall Study||323
8593591|NCT00309777|9628315|FG003|STARTED|Overall Study||111
8593592|NCT00309777|9628312|FG000|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|311
8593593|NCT00309777|9628313|FG001|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|107
8593594|NCT00309777|9628314|FG002|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|320
8593595|NCT00309777|9628315|FG003|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|110
8593596|NCT00309777|9628312|FG000|COMPLETED|Overall Study||292
8593597|NCT00309777|9628313|FG001|COMPLETED|Overall Study||99
8593598|NCT00309777|9628314|FG002|COMPLETED|Overall Study||304
8593599|NCT00309777|9628315|FG003|COMPLETED|Overall Study||107
8593600|NCT00309777|9628312|FG000|NOT COMPLETED|Overall Study||23
8593601|NCT00309777|9628313|FG001|NOT COMPLETED|Overall Study||9
8593602|NCT00309777|9628314|FG002|NOT COMPLETED|Overall Study||19
8593603|NCT00309777|9628315|FG003|NOT COMPLETED|Overall Study||4
8593604|NCT00309842|9628325|FG000|STARTED|Overall Study||213
8593605|NCT00309842|9628325|FG000|COMPLETED|Overall Study||212
8712342|NCT00967993|9758935|FG000|STARTED|Overall Study||22
8712343|NCT00967993|9758935|FG000|COMPLETED|Overall Study||18
8712344|NCT00967993|9758935|FG000|NOT COMPLETED|Overall Study||4
8712345|NCT00968019|9758939|FG000|STARTED|Overall Study||318
8712346|NCT00968019|9758939|FG000|COMPLETED|Overall Study||303
8712347|NCT00968019|9758939|FG000|NOT COMPLETED|Overall Study||15
8712348|NCT00968032|9758943|FG000|STARTED|Overall Study||63
8813068|NCT01523782|9866173|FG002|NOT COMPLETED|Overall Study||5
8813069|NCT01523808|9866185|FG000|STARTED|Overall Study||3
8813070|NCT01523808|9866186|FG001|STARTED|Overall Study||3
8813071|NCT01523808|9866187|FG002|STARTED|Overall Study||3
8712349|NCT00968032|9758943|FG000|COMPLETED|Overall Study|"1 patient not receiving investigational device due to failure in usage~1 patient denied latest FU"|61
8712350|NCT00968032|9758943|FG000|NOT COMPLETED|Overall Study||2
8712351|NCT00968071|9758947|FG000|STARTED|Overall Study||71
8712352|NCT00968071|9758947|FG000|COMPLETED|Overall Study||71
8712353|NCT00968071|9758947|FG000|NOT COMPLETED|Overall Study||0
8712354|NCT00968227|9758951|FG000|STARTED|Overall Study||56
8712355|NCT00968227|9758951|FG000|COMPLETED|Overall Study||56
8712356|NCT00968227|9758951|FG000|NOT COMPLETED|Overall Study||0
8712357|NCT00968253|9758958|FG000|STARTED|Overall Study||3
8712358|NCT00968253|9758959|FG001|STARTED|Overall Study||9
8712359|NCT00968253|9758960|FG002|STARTED|Overall Study||12
8928154|NCT02278354|9989262|FG001|NOT COMPLETED|Overall Study||3
8928155|NCT02278367|9989272|FG000|STARTED|Overall Study||69
8928156|NCT02278367|9989273|FG001|STARTED|Overall Study||110
8928157|NCT02278367|9989272|FG000|COMPLETED|Overall Study||59
8928158|NCT02278367|9989273|FG001|COMPLETED|Overall Study||110
8593606|NCT00309842|9628325|FG000|NOT COMPLETED|Overall Study||1
8593607|NCT00309907|9628329|FG000|STARTED|Overall Study||39
8593608|NCT00309907|9628329|FG000|COMPLETED|Overall Study||19
8813072|NCT01523808|9866188|FG003|STARTED|Overall Study||3
8813073|NCT01523808|9866185|FG000|COMPLETED|Overall Study||0
8813074|NCT01523808|9866186|FG001|COMPLETED|Overall Study||3
8813075|NCT01523808|9866187|FG002|COMPLETED|Overall Study||1
8813076|NCT01523808|9866188|FG003|COMPLETED|Overall Study||0
8813077|NCT01523808|9866185|FG000|NOT COMPLETED|Overall Study||3
8813078|NCT01523808|9866186|FG001|NOT COMPLETED|Overall Study||0
8813079|NCT01523808|9866187|FG002|NOT COMPLETED|Overall Study||2
8813080|NCT01523808|9866188|FG003|NOT COMPLETED|Overall Study||3
8813081|NCT01523821|9866210|FG000|STARTED|Overall Study||8
8813082|NCT01523821|9866211|FG001|STARTED|Overall Study||6
8813083|NCT01523821|9866212|FG002|STARTED|Overall Study||6
8813084|NCT01523821|9866210|FG000|COMPLETED|Overall Study||8
8813085|NCT01523821|9866211|FG001|COMPLETED|Overall Study||6
8928159|NCT02278367|9989272|FG000|NOT COMPLETED|Overall Study||10
8928160|NCT02278367|9989273|FG001|NOT COMPLETED|Overall Study||0
8593609|NCT00309907|9628329|FG000|NOT COMPLETED|Overall Study||20
8593610|NCT00309946|9628334|FG000|STARTED|Overall Study||51
8593611|NCT00309946|9628334|FG000|COMPLETED|Overall Study||50
8593612|NCT00309946|9628334|FG000|NOT COMPLETED|Overall Study||1
8593613|NCT00309959|9628338|FG000|STARTED|Overall Study||37
8593614|NCT00309959|9628338|FG000|COMPLETED|Overall Study||35
8593615|NCT00309959|9628338|FG000|NOT COMPLETED|Overall Study||2
8593616|NCT00310037|9628349|FG000|STARTED|Overall Study||52
8593617|NCT00310037|9628350|FG001|STARTED|Overall Study||50
8593618|NCT00310037|9628349|FG000|COMPLETED|Overall Study||34
8593619|NCT00310037|9628350|FG001|COMPLETED|Overall Study||33
8593620|NCT00310037|9628349|FG000|NOT COMPLETED|Overall Study||18
8593621|NCT00310037|9628350|FG001|NOT COMPLETED|Overall Study||17
8712360|NCT00968253|9758958|FG000|COMPLETED|Overall Study||3
8712361|NCT00968253|9758959|FG001|COMPLETED|Overall Study||6
8712362|NCT00968253|9758960|FG002|COMPLETED|Overall Study||5
8712363|NCT00968253|9758958|FG000|NOT COMPLETED|Overall Study||0
8712364|NCT00968253|9758959|FG001|NOT COMPLETED|Overall Study||3
8712365|NCT00968253|9758960|FG002|NOT COMPLETED|Overall Study||7
8712366|NCT00968344|9758971|FG000|STARTED|Overall Study|Includes screen fails|20
8712367|NCT00968344|9758972|FG001|STARTED|Overall Study|Includes screen fails|20
8712368|NCT00968344|9758971|FG000|COMPLETED|Overall Study||10
8712369|NCT00968344|9758972|FG001|COMPLETED|Overall Study||9
8712370|NCT00968344|9758971|FG000|NOT COMPLETED|Overall Study||10
8712371|NCT00968344|9758972|FG001|NOT COMPLETED|Overall Study||11
8712372|NCT00968526|9758980|FG000|STARTED|Overall Study||138
8712373|NCT00968526|9758981|FG001|STARTED|Overall Study||102
8712374|NCT00968526|9758980|FG000|COMPLETED|Overall Study||135
8712375|NCT00968526|9758981|FG001|COMPLETED|Overall Study||102
8712376|NCT00968526|9758980|FG000|NOT COMPLETED|Overall Study||3
8712377|NCT00968526|9758981|FG001|NOT COMPLETED|Overall Study||0
8712378|NCT00968539|9758998|FG000|STARTED|Overall Study||64
8712379|NCT00968539|9758999|FG001|STARTED|Overall Study||66
8712380|NCT00968539|9758998|FG000|COMPLETED|Overall Study||63
8712381|NCT00968539|9758999|FG001|COMPLETED|Overall Study||66
8712382|NCT00968539|9758998|FG000|NOT COMPLETED|Overall Study||1
8712383|NCT00968539|9758999|FG001|NOT COMPLETED|Overall Study||0
8712384|NCT00968617|9759006|FG000|STARTED|Overall Study||7
8712385|NCT00968617|9759006|FG000|COMPLETED|Overall Study||1
8712386|NCT00968617|9759006|FG000|NOT COMPLETED|Overall Study||6
8712387|NCT00968669|9759014|FG000|STARTED|Overall Study||82
8712388|NCT00968669|9759015|FG001|STARTED|Overall Study||81
8712389|NCT00968669|9759016|FG002|STARTED|Overall Study||83
8712390|NCT00968669|9759017|FG003|STARTED|Overall Study||81
8712391|NCT00968669|9759014|FG000|COMPLETED|Overall Study||64
8712392|NCT00968669|9759015|FG001|COMPLETED|Overall Study||63
8712393|NCT00968669|9759016|FG002|COMPLETED|Overall Study||72
8712394|NCT00968669|9759017|FG003|COMPLETED|Overall Study||72
8712395|NCT00968669|9759014|FG000|NOT COMPLETED|Overall Study||18
8712396|NCT00968669|9759015|FG001|NOT COMPLETED|Overall Study||18
8712397|NCT00968669|9759016|FG002|NOT COMPLETED|Overall Study||11
8712398|NCT00968669|9759017|FG003|NOT COMPLETED|Overall Study||9
8712399|NCT00968708|9759029|FG000|STARTED|Overall Study||2679
8712400|NCT00968708|9759030|FG001|STARTED|Overall Study||2701
8712401|NCT00968708|9759029|FG000|Treated|Overall Study||2676
8712402|NCT00968708|9759030|FG001|Treated|Overall Study||2698
8712403|NCT00968708|9759029|FG000|COMPLETED|Overall Study||2361
8712404|NCT00968708|9759030|FG001|COMPLETED|Overall Study||2403
8712405|NCT00968708|9759029|FG000|NOT COMPLETED|Overall Study||318
8712406|NCT00968708|9759030|FG001|NOT COMPLETED|Overall Study||298
8712407|NCT00968799|9759036|FG000|STARTED|Overall Study||6
8712408|NCT00968799|9759036|FG000|COMPLETED|Overall Study||4
8712409|NCT00968799|9759036|FG000|NOT COMPLETED|Overall Study||2
8712410|NCT00968812|9759043|FG000|STARTED|Overall Study||483
8712411|NCT00968812|9759044|FG001|STARTED|Overall Study||485
8712412|NCT00968812|9759045|FG002|STARTED|Overall Study||482
8712413|NCT00968812|9759043|FG000|COMPLETED|Overall Study||343
8712414|NCT00968812|9759044|FG001|COMPLETED|Overall Study||323
8712415|NCT00968812|9759045|FG002|COMPLETED|Overall Study||314
8712416|NCT00968812|9759043|FG000|NOT COMPLETED|Overall Study||140
8712417|NCT00968812|9759044|FG001|NOT COMPLETED|Overall Study||162
8712418|NCT00968812|9759045|FG002|NOT COMPLETED|Overall Study||168
8712419|NCT00968838|9759058|FG000|STARTED|Overall Study||50
8712420|NCT00968838|9759059|FG001|STARTED|Overall Study||58
8712421|NCT00968838|9759058|FG000|COMPLETED|Overall Study||50
8712422|NCT00968838|9759059|FG001|COMPLETED|Overall Study||58
8712423|NCT00968838|9759058|FG000|NOT COMPLETED|Overall Study||0
8712424|NCT00968838|9759059|FG001|NOT COMPLETED|Overall Study||0
8593622|NCT00310050|9628356|FG000|STARTED|Overall Study||4
8593623|NCT00310050|9628356|FG000|COMPLETED|Overall Study||3
8593624|NCT00310050|9628356|FG000|NOT COMPLETED|Overall Study||1
8593625|NCT00310076|9628360|FG000|STARTED|Overall Study||29
8593626|NCT00310076|9628360|FG000|COMPLETED|Overall Study||26
8593627|NCT00310076|9628360|FG000|NOT COMPLETED|Overall Study||3
8593628|NCT00310310|9628366|FG000|STARTED|Overall Study||120
8712425|NCT00968890|9759067|FG000|STARTED|Overall Study||84
8712426|NCT00968890|9759068|FG001|STARTED|Overall Study||84
8712427|NCT00968890|9759067|FG000|COMPLETED|Overall Study||84
8712428|NCT00968890|9759068|FG001|COMPLETED|Overall Study||84
8712429|NCT00968890|9759067|FG000|NOT COMPLETED|Overall Study||0
8712430|NCT00968890|9759068|FG001|NOT COMPLETED|Overall Study||0
8712431|NCT00968968|9759076|FG000|STARTED|Overall Study||20
8712432|NCT00968968|9759077|FG001|STARTED|Overall Study||17
8712433|NCT00968968|9759076|FG000|COMPLETED|Overall Study||4
8712434|NCT00968968|9759077|FG001|COMPLETED|Overall Study||3
8712435|NCT00968968|9759076|FG000|NOT COMPLETED|Overall Study||16
8593629|NCT00310310|9628367|FG001|STARTED|Overall Study||120
8593630|NCT00310310|9628366|FG000|COMPLETED|Overall Study||90
8593631|NCT00310310|9628367|FG001|COMPLETED|Overall Study||100
8593632|NCT00310310|9628366|FG000|NOT COMPLETED|Overall Study||30
8593633|NCT00310310|9628367|FG001|NOT COMPLETED|Overall Study||20
8593634|NCT00310362|9628376|FG000|STARTED|Overall Study||1199
8593635|NCT00310362|9628377|FG001|STARTED|Overall Study||1205
8593636|NCT00310362|9628378|FG002|STARTED|Overall Study||1206
8593637|NCT00310362|9628376|FG000|COMPLETED|Overall Study||1199
8593638|NCT00310362|9628377|FG001|COMPLETED|Overall Study||1205
8593639|NCT00310362|9628378|FG002|COMPLETED|Overall Study||1206
8593640|NCT00310362|9628376|FG000|NOT COMPLETED|Overall Study||0
8593641|NCT00310362|9628377|FG001|NOT COMPLETED|Overall Study||0
8593642|NCT00310362|9628378|FG002|NOT COMPLETED|Overall Study||0
8593643|NCT00310375|9628394|FG000|STARTED|Primary Reporting Phase||102
8593644|NCT00310375|9628395|FG001|STARTED|Primary Reporting Phase||79
8593645|NCT00310375|9628396|FG002|STARTED|Primary Reporting Phase||0
8593646|NCT00310375|9628394|FG000|COMPLETED|Primary Reporting Phase||11
8593647|NCT00310375|9628395|FG001|COMPLETED|Primary Reporting Phase||11
8593648|NCT00310375|9628396|FG002|COMPLETED|Primary Reporting Phase||0
8593649|NCT00310375|9628394|FG000|NOT COMPLETED|Primary Reporting Phase||91
8593650|NCT00310375|9628395|FG001|NOT COMPLETED|Primary Reporting Phase||68
8593651|NCT00310375|9628396|FG002|NOT COMPLETED|Primary Reporting Phase||0
8593652|NCT00310375|9628394|FG000|STARTED|Safety Follow-up Continuation Phase||0
8593653|NCT00310375|9628395|FG001|STARTED|Safety Follow-up Continuation Phase||0
8593654|NCT00310375|9628396|FG002|STARTED|Safety Follow-up Continuation Phase||19
8593655|NCT00310375|9628394|FG000|COMPLETED|Safety Follow-up Continuation Phase||0
8593656|NCT00310375|9628395|FG001|COMPLETED|Safety Follow-up Continuation Phase||0
8712436|NCT00968968|9759077|FG001|NOT COMPLETED|Overall Study||14
8712437|NCT00968981|9759087|FG000|STARTED|Overall Study||23
8712438|NCT00968981|9759088|FG001|STARTED|Overall Study||22
8712439|NCT00968981|9759089|FG002|STARTED|Overall Study||22
8712440|NCT00968981|9759087|FG000|Pharmacokinetic(PK) Evaluable Population|Overall Study|Participants with sufficient data to ensure reliable estimation of PK for at least Day 1 PK profile.|20
8712441|NCT00968981|9759088|FG001|Pharmacokinetic(PK) Evaluable Population|Overall Study|Participants with sufficient data to ensure reliable estimation of PK for at least Day 1 PK profile.|21
8712442|NCT00968981|9759089|FG002|Pharmacokinetic(PK) Evaluable Population|Overall Study|Participants with sufficient data to ensure reliable estimation of PK for at least Day 1 PK profile.|22
8712443|NCT00968981|9759087|FG000|COMPLETED|Overall Study||1
8712444|NCT00968981|9759088|FG001|COMPLETED|Overall Study||0
8712445|NCT00968981|9759089|FG002|COMPLETED|Overall Study||0
8712446|NCT00968981|9759087|FG000|NOT COMPLETED|Overall Study||22
8712447|NCT00968981|9759088|FG001|NOT COMPLETED|Overall Study||22
8712448|NCT00968981|9759089|FG002|NOT COMPLETED|Overall Study||22
8712449|NCT00969124|9759098|FG000|STARTED|Overall Study||328
8712450|NCT00969124|9759098|FG000|COMPLETED|Overall Study||298
8712451|NCT00969124|9759098|FG000|NOT COMPLETED|Overall Study||30
8712452|NCT00969150|9759105|FG000|STARTED|Overall Study||182
8712453|NCT00969150|9759106|FG001|STARTED|Overall Study||175
8712454|NCT00969150|9759105|FG000|COMPLETED|Overall Study||149
8712455|NCT00969150|9759106|FG001|COMPLETED|Overall Study||135
8712456|NCT00969150|9759105|FG000|NOT COMPLETED|Overall Study||33
8712457|NCT00969150|9759106|FG001|NOT COMPLETED|Overall Study||40
8712458|NCT00969228|9759114|FG000|STARTED|Overall Study||508
8712459|NCT00969228|9759115|FG001|STARTED|Overall Study||176
8712460|NCT00969228|9759114|FG000|COMPLETED|Overall Study||465
8712461|NCT00969228|9759115|FG001|COMPLETED|Overall Study||162
8712462|NCT00969228|9759114|FG000|NOT COMPLETED|Overall Study||43
8712463|NCT00969228|9759115|FG001|NOT COMPLETED|Overall Study||14
8712464|NCT00969280|9759123|FG000|STARTED|Overall Study||21
8712465|NCT00969280|9759124|FG001|STARTED|Overall Study||21
8712466|NCT00969280|9759123|FG000|COMPLETED|Overall Study||19
8712467|NCT00969280|9759124|FG001|COMPLETED|Overall Study||18
8712468|NCT00969280|9759123|FG000|NOT COMPLETED|Overall Study||2
8712469|NCT00969280|9759124|FG001|NOT COMPLETED|Overall Study||3
8712470|NCT00969332|9759130|FG000|STARTED|Overall Study||62
8712471|NCT00969332|9759130|FG000|COMPLETED|Overall Study||51
8712472|NCT00969332|9759130|FG000|NOT COMPLETED|Overall Study||11
8712473|NCT00969436|9759138|FG000|STARTED|Overall Study||180
8712474|NCT00969436|9759139|FG001|STARTED|Overall Study||180
8712475|NCT00969436|9759140|FG002|STARTED|Overall Study||90
8712476|NCT00969436|9759138|FG000|COMPLETED|Overall Study||155
8712477|NCT00969436|9759139|FG001|COMPLETED|Overall Study||159
8712478|NCT00969436|9759140|FG002|COMPLETED|Overall Study||79
8712479|NCT00969436|9759138|FG000|NOT COMPLETED|Overall Study||25
8712480|NCT00969436|9759139|FG001|NOT COMPLETED|Overall Study||21
8712481|NCT00969436|9759140|FG002|NOT COMPLETED|Overall Study||11
8712482|NCT00969501|9759148|FG000|STARTED|Overall Study||32
8712483|NCT00969501|9759148|FG000|COMPLETED|Overall Study||27
8712484|NCT00969501|9759148|FG000|NOT COMPLETED|Overall Study||5
8813086|NCT01523821|9866212|FG002|COMPLETED|Overall Study||6
8593657|NCT00310375|9628396|FG002|COMPLETED|Safety Follow-up Continuation Phase|Met the protocol defined stopping criteria|18
8593658|NCT00310375|9628394|FG000|NOT COMPLETED|Safety Follow-up Continuation Phase||0
8593659|NCT00310375|9628395|FG001|NOT COMPLETED|Safety Follow-up Continuation Phase||0
8593660|NCT00310375|9628396|FG002|NOT COMPLETED|Safety Follow-up Continuation Phase||1
8593661|NCT00310401|9628407|FG000|STARTED|Overall Study||260
8712485|NCT00969540|9759154|FG000|STARTED|Overall Study||4
8712486|NCT00969540|9759155|FG001|STARTED|Overall Study||4
8593662|NCT00310401|9628408|FG001|STARTED|Overall Study||246
8593663|NCT00310401|9628407|FG000|COMPLETED|Overall Study||260
8593664|NCT00310401|9628408|FG001|COMPLETED|Overall Study||246
8593665|NCT00310401|9628407|FG000|NOT COMPLETED|Overall Study||0
8593666|NCT00310401|9628408|FG001|NOT COMPLETED|Overall Study||0
8593667|NCT00310427|9628418|FG000|STARTED|Overall Study||27
8593668|NCT00310427|9628419|FG001|STARTED|Overall Study||26
8593669|NCT00310427|9628418|FG000|COMPLETED|Overall Study||25
8593670|NCT00310427|9628419|FG001|COMPLETED|Overall Study||25
8593671|NCT00310427|9628418|FG000|NOT COMPLETED|Overall Study||2
8593672|NCT00310427|9628419|FG001|NOT COMPLETED|Overall Study||1
8593673|NCT00310440|9628427|FG000|STARTED|Overall Study||165
8593674|NCT00310440|9628428|FG001|STARTED|Overall Study||154
8712487|NCT00969540|9759154|FG000|COMPLETED|Overall Study||3
8712488|NCT00969540|9759155|FG001|COMPLETED|Overall Study||3
8813087|NCT01523821|9866210|FG000|NOT COMPLETED|Overall Study||0
8813088|NCT01523821|9866211|FG001|NOT COMPLETED|Overall Study||0
8813089|NCT01523821|9866212|FG002|NOT COMPLETED|Overall Study||0
8813090|NCT01523834|9866220|FG000|STARTED|Overall Study|Started Induction Phase|35
8813091|NCT01523834|9866220|FG000|Consolidation Phase|Overall Study|Started Consolidation Phase|7
8813092|NCT01523834|9866220|FG000|Maintenance Phase|Overall Study|Started Maintenance Phase|6
8813093|NCT01523834|9866220|FG000|COMPLETED|Overall Study||4
8813094|NCT01523834|9866220|FG000|NOT COMPLETED|Overall Study||31
8813095|NCT01523873|9866225|FG000|STARTED|Overall Study||35921
8813096|NCT01523873|9866225|FG000|Administered With Dotarem|Overall Study||35474
8813097|NCT01523873|9866225|FG000|COMPLETED|Overall Study||35499
8813098|NCT01523873|9866225|FG000|NOT COMPLETED|Overall Study||422
8813099|NCT01523886|9866233|FG000|STARTED|Overall Study||25
8813100|NCT01523886|9866234|FG001|STARTED|Overall Study||24
8813101|NCT01523886|9866233|FG000|COMPLETED|Overall Study||25
8813102|NCT01523886|9866234|FG001|COMPLETED|Overall Study||23
8813103|NCT01523886|9866233|FG000|NOT COMPLETED|Overall Study||0
8813104|NCT01523886|9866234|FG001|NOT COMPLETED|Overall Study||1
8813105|NCT01523899|9866242|FG000|STARTED|Overall Study||126
8813106|NCT01523899|9866243|FG001|STARTED|Overall Study||126
8813107|NCT01523899|9866242|FG000|COMPLETED|Overall Study||126
8813108|NCT01523899|9866243|FG001|COMPLETED|Overall Study||126
8813109|NCT01523899|9866242|FG000|NOT COMPLETED|Overall Study||0
8813110|NCT01523899|9866243|FG001|NOT COMPLETED|Overall Study||0
8813111|NCT01523964|9866254|FG000|STARTED|Overall Study||31
8813112|NCT01523964|9866255|FG001|STARTED|Overall Study||30
8813113|NCT01523964|9866256|FG002|STARTED|Overall Study||16
8813114|NCT01523964|9866257|FG003|STARTED|Overall Study||15
8813115|NCT01523964|9866254|FG000|COMPLETED|Overall Study||31
8813116|NCT01523964|9866255|FG001|COMPLETED|Overall Study||30
8813117|NCT01523964|9866256|FG002|COMPLETED|Overall Study||16
8813118|NCT01523964|9866257|FG003|COMPLETED|Overall Study||15
8813119|NCT01523964|9866254|FG000|NOT COMPLETED|Overall Study||0
8813120|NCT01523964|9866255|FG001|NOT COMPLETED|Overall Study||0
8813121|NCT01523964|9866256|FG002|NOT COMPLETED|Overall Study||0
8813122|NCT01523964|9866257|FG003|NOT COMPLETED|Overall Study||0
8813123|NCT01524133|9866270|FG000|STARTED|Treatment Phase||71
8813124|NCT01524133|9866271|FG001|STARTED|Treatment Phase||69
8813125|NCT01524133|9866272|FG002|STARTED|Treatment Phase||67
8813126|NCT01524133|9866270|FG000|COMPLETED|Treatment Phase|Completed Both Assigned treatment|52
8813127|NCT01524133|9866271|FG001|COMPLETED|Treatment Phase|Completed Both Assigned Treatments|37
8813128|NCT01524133|9866272|FG002|COMPLETED|Treatment Phase|Completed both assigned treatments|31
8813129|NCT01524133|9866270|FG000|NOT COMPLETED|Treatment Phase||19
8813130|NCT01524133|9866271|FG001|NOT COMPLETED|Treatment Phase||32
8813131|NCT01524133|9866272|FG002|NOT COMPLETED|Treatment Phase||36
8813132|NCT01524133|9866270|FG000|STARTED|Overall Study 52 Weeks||71
8813133|NCT01524133|9866271|FG001|STARTED|Overall Study 52 Weeks||69
8813134|NCT01524133|9866272|FG002|STARTED|Overall Study 52 Weeks||67
8813135|NCT01524133|9866270|FG000|COMPLETED|Overall Study 52 Weeks||50
8593675|NCT00310440|9628427|FG000|COMPLETED|Overall Study||139
8593676|NCT00310440|9628428|FG001|COMPLETED|Overall Study||141
8593677|NCT00310440|9628427|FG000|NOT COMPLETED|Overall Study||26
8712489|NCT00969540|9759154|FG000|NOT COMPLETED|Overall Study||1
8712490|NCT00969540|9759155|FG001|NOT COMPLETED|Overall Study||1
8712491|NCT00969553|9759182|FG000|STARTED|Overall Study||3
8712492|NCT00969553|9759183|FG001|STARTED|Overall Study||3
8712493|NCT00969553|9759184|FG002|STARTED|Overall Study||6
8712494|NCT00969553|9759185|FG003|STARTED|Overall Study||17
8593678|NCT00310440|9628428|FG001|NOT COMPLETED|Overall Study||13
8593679|NCT00310466|9628436|FG000|STARTED|Overall Study||113
8593680|NCT00310466|9628437|FG001|STARTED|Overall Study||113
8593681|NCT00310466|9628436|FG000|COMPLETED|Overall Study||95
8593682|NCT00310466|9628437|FG001|COMPLETED|Overall Study||101
8593683|NCT00310466|9628436|FG000|NOT COMPLETED|Overall Study||18
8593684|NCT00310466|9628437|FG001|NOT COMPLETED|Overall Study||12
8593685|NCT00310791|9628445|FG000|STARTED|Overall Study||40
8593686|NCT00310791|9628446|FG001|STARTED|Overall Study||40
8593687|NCT00310791|9628445|FG000|COMPLETED|Overall Study||30
8593688|NCT00310791|9628446|FG001|COMPLETED|Overall Study||30
8593689|NCT00310791|9628445|FG000|NOT COMPLETED|Overall Study||10
8593690|NCT00310791|9628446|FG001|NOT COMPLETED|Overall Study||10
8712495|NCT00969553|9759186|FG004|STARTED|Overall Study||3
8712496|NCT00969553|9759187|FG005|STARTED|Overall Study||4
8813136|NCT01524133|9866271|FG001|COMPLETED|Overall Study 52 Weeks||49
8813137|NCT01524133|9866272|FG002|COMPLETED|Overall Study 52 Weeks||40
8712497|NCT00969553|9759188|FG006|STARTED|Overall Study||4
8712498|NCT00969553|9759189|FG007|STARTED|Overall Study||16
8712499|NCT00969553|9759190|FG008|STARTED|Overall Study||3
8593691|NCT00310804|9628454|FG000|STARTED|Overall Study||1029
8593692|NCT00310804|9628455|FG001|STARTED|Overall Study||171
8593693|NCT00310804|9628454|FG000|COMPLETED|Overall Study||1024
8593694|NCT00310804|9628455|FG001|COMPLETED|Overall Study||171
8593695|NCT00310804|9628454|FG000|NOT COMPLETED|Overall Study||5
8593696|NCT00310804|9628455|FG001|NOT COMPLETED|Overall Study||0
8593697|NCT00310817|9628479|FG000|STARTED|Overall Study||207
8712500|NCT00969553|9759182|FG000|COMPLETED|Overall Study||0
8712501|NCT00969553|9759183|FG001|COMPLETED|Overall Study||0
8712502|NCT00969553|9759184|FG002|COMPLETED|Overall Study||0
8712503|NCT00969553|9759185|FG003|COMPLETED|Overall Study|on-treatment at analysis data base lock date (27-Oct-2011)|1
8712504|NCT00969553|9759186|FG004|COMPLETED|Overall Study||0
8712505|NCT00969553|9759187|FG005|COMPLETED|Overall Study||0
8712506|NCT00969553|9759188|FG006|COMPLETED|Overall Study||0
8712507|NCT00969553|9759189|FG007|COMPLETED|Overall Study|on-treatment at analysis data base lock date (27-Oct-2011)|2
8712508|NCT00969553|9759190|FG008|COMPLETED|Overall Study||0
8712509|NCT00969553|9759182|FG000|NOT COMPLETED|Overall Study||3
8712510|NCT00969553|9759183|FG001|NOT COMPLETED|Overall Study||3
8712511|NCT00969553|9759184|FG002|NOT COMPLETED|Overall Study||6
8712512|NCT00969553|9759185|FG003|NOT COMPLETED|Overall Study||16
8712513|NCT00969553|9759186|FG004|NOT COMPLETED|Overall Study||3
8712514|NCT00969553|9759187|FG005|NOT COMPLETED|Overall Study||4
8712515|NCT00969553|9759188|FG006|NOT COMPLETED|Overall Study||4
8712516|NCT00969553|9759189|FG007|NOT COMPLETED|Overall Study||14
8712517|NCT00969553|9759190|FG008|NOT COMPLETED|Overall Study||3
8712518|NCT00969618|9759218|FG000|STARTED|Overall Study||211
8712519|NCT00969618|9759218|FG000|COMPLETED|Overall Study||133
8712520|NCT00969618|9759218|FG000|NOT COMPLETED|Overall Study||78
8712521|NCT00969709|9759226|FG000|STARTED|Overall Study||176
8712522|NCT00969709|9759227|FG001|STARTED|Overall Study||178
8712523|NCT00969709|9759228|FG002|STARTED|Overall Study||179
8712524|NCT00969709|9759229|FG003|STARTED|Overall Study||180
8712525|NCT00969709|9759226|FG000|COMPLETED|Overall Study||138
8712526|NCT00969709|9759227|FG001|COMPLETED|Overall Study||130
8712527|NCT00969709|9759228|FG002|COMPLETED|Overall Study||121
8712528|NCT00969709|9759229|FG003|COMPLETED|Overall Study||117
8712529|NCT00969709|9759226|FG000|NOT COMPLETED|Overall Study||38
8712530|NCT00969709|9759227|FG001|NOT COMPLETED|Overall Study||48
8712531|NCT00969709|9759228|FG002|NOT COMPLETED|Overall Study||58
8712532|NCT00969709|9759229|FG003|NOT COMPLETED|Overall Study||63
8712533|NCT00969761|9759255|FG000|STARTED|Discont. Before Start of Treat. Cycle 2||3
8712534|NCT00969761|9759256|FG001|STARTED|Discont. Before Start of Treat. Cycle 2||3
8712535|NCT00969761|9759257|FG002|STARTED|Discont. Before Start of Treat. Cycle 2||12
8712536|NCT00969761|9759258|FG003|STARTED|Discont. Before Start of Treat. Cycle 2||6
8712537|NCT00969761|9759259|FG004|STARTED|Discont. Before Start of Treat. Cycle 2||3
8712538|NCT00969761|9759260|FG005|STARTED|Discont. Before Start of Treat. Cycle 2||3
8712539|NCT00969761|9759261|FG006|STARTED|Discont. Before Start of Treat. Cycle 2||3
8712540|NCT00969761|9759262|FG007|STARTED|Discont. Before Start of Treat. Cycle 2||6
8712541|NCT00969761|9759263|FG008|STARTED|Discont. Before Start of Treat. Cycle 2||13
8712542|NCT00969761|9759264|FG009|STARTED|Discont. Before Start of Treat. Cycle 2||3
8712543|NCT00969761|9759265|FG010|STARTED|Discont. Before Start of Treat. Cycle 2||3
8712544|NCT00969761|9759266|FG011|STARTED|Discont. Before Start of Treat. Cycle 2||3
8712545|NCT00969761|9759255|FG000|COMPLETED|Discont. Before Start of Treat. Cycle 2||2
8712546|NCT00969761|9759256|FG001|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
8712547|NCT00969761|9759257|FG002|COMPLETED|Discont. Before Start of Treat. Cycle 2||10
8712548|NCT00969761|9759258|FG003|COMPLETED|Discont. Before Start of Treat. Cycle 2||5
8712549|NCT00969761|9759259|FG004|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
8712550|NCT00969761|9759260|FG005|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
8712551|NCT00969761|9759261|FG006|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
8712552|NCT00969761|9759262|FG007|COMPLETED|Discont. Before Start of Treat. Cycle 2||6
8712553|NCT00969761|9759263|FG008|COMPLETED|Discont. Before Start of Treat. Cycle 2||11
8712554|NCT00969761|9759264|FG009|COMPLETED|Discont. Before Start of Treat. Cycle 2||2
8712555|NCT00969761|9759265|FG010|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
8712556|NCT00969761|9759266|FG011|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
8712557|NCT00969761|9759255|FG000|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||1
8712558|NCT00969761|9759256|FG001|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
8712559|NCT00969761|9759257|FG002|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||2
8712560|NCT00969761|9759258|FG003|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||1
8712561|NCT00969761|9759259|FG004|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
8712562|NCT00969761|9759260|FG005|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
8712563|NCT00969761|9759261|FG006|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
8712564|NCT00969761|9759262|FG007|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
8712565|NCT00969761|9759263|FG008|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||2
8712566|NCT00969761|9759264|FG009|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||1
8712567|NCT00969761|9759265|FG010|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
8712568|NCT00969761|9759266|FG011|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
8712569|NCT00969761|9759255|FG000|STARTED|Treated in and Beyond Treat. Cycle 2||2
8593698|NCT00310817|9628480|FG001|STARTED|Overall Study||206
8593699|NCT00310817|9628481|FG002|STARTED|Overall Study||128
8593700|NCT00310817|9628482|FG003|STARTED|Overall Study||82
8593701|NCT00310817|9628479|FG000|COMPLETED|Overall Study||196
8593702|NCT00310817|9628480|FG001|COMPLETED|Overall Study||198
8593703|NCT00310817|9628481|FG002|COMPLETED|Overall Study||120
8593704|NCT00310817|9628482|FG003|COMPLETED|Overall Study||74
8593705|NCT00310817|9628479|FG000|NOT COMPLETED|Overall Study||11
8593706|NCT00310817|9628480|FG001|NOT COMPLETED|Overall Study||8
8593707|NCT00310817|9628481|FG002|NOT COMPLETED|Overall Study||8
8593708|NCT00310817|9628482|FG003|NOT COMPLETED|Overall Study||8
8593709|NCT00310856|9628528|FG000|STARTED|Overall Study||64
8593710|NCT00310856|9628529|FG001|STARTED|Overall Study||61
8593711|NCT00310856|9628530|FG002|STARTED|Overall Study||50
8593712|NCT00310856|9628528|FG000|COMPLETED|Overall Study||59
8712570|NCT00969761|9759256|FG001|STARTED|Treated in and Beyond Treat. Cycle 2||3
8712571|NCT00969761|9759257|FG002|STARTED|Treated in and Beyond Treat. Cycle 2||10
8712572|NCT00969761|9759258|FG003|STARTED|Treated in and Beyond Treat. Cycle 2||5
8712573|NCT00969761|9759259|FG004|STARTED|Treated in and Beyond Treat. Cycle 2||3
8712574|NCT00969761|9759260|FG005|STARTED|Treated in and Beyond Treat. Cycle 2||3
8712575|NCT00969761|9759261|FG006|STARTED|Treated in and Beyond Treat. Cycle 2||3
8712576|NCT00969761|9759262|FG007|STARTED|Treated in and Beyond Treat. Cycle 2||6
8712577|NCT00969761|9759263|FG008|STARTED|Treated in and Beyond Treat. Cycle 2||11
8712578|NCT00969761|9759264|FG009|STARTED|Treated in and Beyond Treat. Cycle 2||2
8712579|NCT00969761|9759265|FG010|STARTED|Treated in and Beyond Treat. Cycle 2||3
8712580|NCT00969761|9759266|FG011|STARTED|Treated in and Beyond Treat. Cycle 2||3
8712581|NCT00969761|9759255|FG000|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
8712582|NCT00969761|9759256|FG001|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
8712583|NCT00969761|9759257|FG002|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
8712584|NCT00969761|9759258|FG003|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
8712585|NCT00969761|9759259|FG004|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
8712586|NCT00969761|9759260|FG005|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
8712587|NCT00969761|9759261|FG006|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
8712588|NCT00969761|9759262|FG007|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
8593713|NCT00310856|9628529|FG001|COMPLETED|Overall Study||56
8593714|NCT00310856|9628530|FG002|COMPLETED|Overall Study||42
8593715|NCT00310856|9628528|FG000|NOT COMPLETED|Overall Study||5
8593716|NCT00310856|9628529|FG001|NOT COMPLETED|Overall Study||5
8593717|NCT00310856|9628530|FG002|NOT COMPLETED|Overall Study||8
8593718|NCT00311155|9628539|FG000|STARTED|Overall Study||694
8593719|NCT00311155|9628539|FG000|COMPLETED|Overall Study|Some participants had multiple reasons for discontinuation|601
8593720|NCT00311155|9628539|FG000|NOT COMPLETED|Overall Study||93
8593721|NCT00311168|9628545|FG000|STARTED|First Intervention||66
8593722|NCT00311168|9628546|FG001|STARTED|First Intervention||68
8593723|NCT00311168|9628545|FG000|COMPLETED|First Intervention||59
8593724|NCT00311168|9628546|FG001|COMPLETED|First Intervention||62
8593725|NCT00311168|9628545|FG000|NOT COMPLETED|First Intervention||7
8593726|NCT00311168|9628546|FG001|NOT COMPLETED|First Intervention||6
8593727|NCT00311168|9628545|FG000|STARTED|Second Intervention||59
8593728|NCT00311168|9628546|FG001|STARTED|Second Intervention||62
8593729|NCT00311168|9628545|FG000|COMPLETED|Second Intervention||49
8593730|NCT00311168|9628546|FG001|COMPLETED|Second Intervention||58
8593731|NCT00311168|9628545|FG000|NOT COMPLETED|Second Intervention||10
8593732|NCT00311168|9628546|FG001|NOT COMPLETED|Second Intervention||4
8593733|NCT00311181|9628554|FG000|STARTED|Overall Study||217
8593734|NCT00311181|9628554|FG000|COMPLETED|Overall Study||121
8593735|NCT00311181|9628554|FG000|NOT COMPLETED|Overall Study||96
8593736|NCT00311246|9628558|FG000|STARTED|Overall Study||11
8593737|NCT00311246|9628558|FG000|COMPLETED|Overall Study||11
8593738|NCT00311246|9628558|FG000|NOT COMPLETED|Overall Study||0
8593739|NCT00311311|9628567|FG000|STARTED|Overall Study||37
8593740|NCT00311311|9628568|FG001|STARTED|Overall Study||35
8593741|NCT00311311|9628567|FG000|COMPLETED|Overall Study||29
8593742|NCT00311311|9628568|FG001|COMPLETED|Overall Study||26
8593743|NCT00311311|9628567|FG000|NOT COMPLETED|Overall Study||8
8593744|NCT00311311|9628568|FG001|NOT COMPLETED|Overall Study||9
8593745|NCT00311363|9628577|FG000|STARTED|24-Week Single-Blind Treatment Period||327
8593746|NCT00311363|9628578|FG001|STARTED|24-Week Single-Blind Treatment Period||0
8593747|NCT00311363|9628579|FG002|STARTED|24-Week Single-Blind Treatment Period||0
8593748|NCT00311363|9628577|FG000|COMPLETED|24-Week Single-Blind Treatment Period||221
8593749|NCT00311363|9628578|FG001|COMPLETED|24-Week Single-Blind Treatment Period||0
8593750|NCT00311363|9628579|FG002|COMPLETED|24-Week Single-Blind Treatment Period||0
8712589|NCT00969761|9759263|FG008|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
8593751|NCT00311363|9628577|FG000|NOT COMPLETED|24-Week Single-Blind Treatment Period||106
8593752|NCT00311363|9628578|FG001|NOT COMPLETED|24-Week Single-Blind Treatment Period||0
8593753|NCT00311363|9628579|FG002|NOT COMPLETED|24-Week Single-Blind Treatment Period||0
8593754|NCT00311363|9628577|FG000|STARTED|12-Week Double-Blind Treatment Period||0
8593755|NCT00311363|9628578|FG001|STARTED|12-Week Double-Blind Treatment Period||98
8593756|NCT00311363|9628579|FG002|STARTED|12-Week Double-Blind Treatment Period||96
8593757|NCT00311363|9628577|FG000|COMPLETED|12-Week Double-Blind Treatment Period||0
8593758|NCT00311363|9628578|FG001|COMPLETED|12-Week Double-Blind Treatment Period||84
8593759|NCT00311363|9628579|FG002|COMPLETED|12-Week Double-Blind Treatment Period||84
8593760|NCT00311363|9628577|FG000|NOT COMPLETED|12-Week Double-Blind Treatment Period||0
8593761|NCT00311363|9628578|FG001|NOT COMPLETED|12-Week Double-Blind Treatment Period||14
8593762|NCT00311363|9628579|FG002|NOT COMPLETED|12-Week Double-Blind Treatment Period||12
8593763|NCT00311376|9628592|FG000|STARTED|Treatment Cycle 1||132
8593764|NCT00311376|9628593|FG001|STARTED|Treatment Cycle 1||135
8593765|NCT00311376|9628594|FG002|STARTED|Treatment Cycle 1||149
8593766|NCT00311376|9628592|FG000|COMPLETED|Treatment Cycle 1||105
8593767|NCT00311376|9628593|FG001|COMPLETED|Treatment Cycle 1||118
8712590|NCT00969761|9759264|FG009|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
8712591|NCT00969761|9759265|FG010|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
8712592|NCT00969761|9759266|FG011|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
8712593|NCT00969761|9759255|FG000|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||2
8712594|NCT00969761|9759256|FG001|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
8712595|NCT00969761|9759257|FG002|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||10
8712596|NCT00969761|9759258|FG003|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||5
8712597|NCT00969761|9759259|FG004|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
8712598|NCT00969761|9759260|FG005|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
8712599|NCT00969761|9759261|FG006|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
8712600|NCT00969761|9759262|FG007|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||6
8712601|NCT00969761|9759263|FG008|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||11
8712602|NCT00969761|9759264|FG009|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||2
8712603|NCT00969761|9759265|FG010|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
8712604|NCT00969761|9759266|FG011|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
8712605|NCT00969878|9759294|FG000|STARTED|Overall Study||148
8712606|NCT00969878|9759295|FG001|STARTED|Overall Study||152
8712607|NCT00969878|9759294|FG000|COMPLETED|Overall Study||118
8712608|NCT00969878|9759295|FG001|COMPLETED|Overall Study||126
8712609|NCT00969878|9759294|FG000|NOT COMPLETED|Overall Study||30
8712610|NCT00969878|9759295|FG001|NOT COMPLETED|Overall Study||26
8712611|NCT00970073|9759306|FG000|STARTED|Overall Study||10
8712612|NCT00970073|9759307|FG001|STARTED|Overall Study||10
8712613|NCT00970073|9759308|FG002|STARTED|Overall Study||10
8712614|NCT00970073|9759306|FG000|COMPLETED|Overall Study||10
8712615|NCT00970073|9759307|FG001|COMPLETED|Overall Study||10
8712616|NCT00970073|9759308|FG002|COMPLETED|Overall Study||10
8712617|NCT00970073|9759306|FG000|NOT COMPLETED|Overall Study||0
8712618|NCT00970073|9759307|FG001|NOT COMPLETED|Overall Study||0
8712619|NCT00970073|9759308|FG002|NOT COMPLETED|Overall Study||0
8712620|NCT00970203|9759318|FG000|STARTED|Overall Study||7
8712621|NCT00970203|9759319|FG001|STARTED|Overall Study||6
8712622|NCT00970203|9759318|FG000|COMPLETED|Overall Study||7
8712623|NCT00970203|9759319|FG001|COMPLETED|Overall Study||6
8712624|NCT00970203|9759318|FG000|NOT COMPLETED|Overall Study||0
8712625|NCT00970203|9759319|FG001|NOT COMPLETED|Overall Study||0
8712626|NCT00970216|9759325|FG000|STARTED|Overall Study||160
8712627|NCT00970216|9759325|FG000|COMPLETED|Overall Study||80
8712628|NCT00970216|9759325|FG000|NOT COMPLETED|Overall Study||80
8712629|NCT00970268|9759331|FG000|STARTED|Overall Study||139
8712630|NCT00970268|9759332|FG001|STARTED|Overall Study||152
8712631|NCT00970268|9759331|FG000|COMPLETED|Overall Study||96
8712632|NCT00970268|9759332|FG001|COMPLETED|Overall Study||103
8712633|NCT00970268|9759331|FG000|NOT COMPLETED|Overall Study||43
8712634|NCT00970268|9759332|FG001|NOT COMPLETED|Overall Study||49
8712635|NCT00970281|9759346|FG000|STARTED|Overall Study||46
8712636|NCT00970281|9759347|FG001|STARTED|Overall Study||45
8712637|NCT00970281|9759346|FG000|Full Analysis Set|Overall Study|1 participant in the olanzapine arm discontinued before the first intramuscular (IM) injection.|45
8712638|NCT00970281|9759347|FG001|Full Analysis Set|Overall Study||45
8593768|NCT00311376|9628594|FG002|COMPLETED|Treatment Cycle 1||132
8593769|NCT00311376|9628592|FG000|NOT COMPLETED|Treatment Cycle 1||27
8712639|NCT00970281|9759346|FG000|COMPLETED|Overall Study||44
8712640|NCT00970281|9759347|FG001|COMPLETED|Overall Study||29
8712641|NCT00970281|9759346|FG000|NOT COMPLETED|Overall Study||2
8712642|NCT00970281|9759347|FG001|NOT COMPLETED|Overall Study||16
8712643|NCT00970294|9759353|FG000|STARTED|Overall Study||11
8712644|NCT00970294|9759353|FG000|COMPLETED|Overall Study||6
8712645|NCT00970294|9759353|FG000|NOT COMPLETED|Overall Study||5
8712646|NCT00970307|9759360|FG000|STARTED|Overall Study||141
8712647|NCT00970307|9759361|FG001|STARTED|Overall Study||139
8712648|NCT00970307|9759362|FG002|STARTED|Overall Study||141
8712649|NCT00970307|9759360|FG000|COMPLETED|Overall Study||138
8712650|NCT00970307|9759361|FG001|COMPLETED|Overall Study||136
8712651|NCT00970307|9759362|FG002|COMPLETED|Overall Study||139
8712652|NCT00970307|9759360|FG000|NOT COMPLETED|Overall Study||3
8712653|NCT00970307|9759361|FG001|NOT COMPLETED|Overall Study||3
8712654|NCT00970307|9759362|FG002|NOT COMPLETED|Overall Study||2
8712655|NCT00970320|9759375|FG000|STARTED|Overall Study||25
8712656|NCT00970320|9759376|FG001|STARTED|Overall Study||24
8712657|NCT00970320|9759377|FG002|STARTED|Overall Study||48
8712658|NCT00970320|9759378|FG003|STARTED|Overall Study||50
8712659|NCT00970320|9759379|FG004|STARTED|Overall Study||1571
8712660|NCT00970320|9759375|FG000|COMPLETED|Overall Study||25
8712661|NCT00970320|9759376|FG001|COMPLETED|Overall Study||13
8712662|NCT00970320|9759377|FG002|COMPLETED|Overall Study||35
8712663|NCT00970320|9759378|FG003|COMPLETED|Overall Study||36
8712664|NCT00970320|9759379|FG004|COMPLETED|Overall Study||1031
8712665|NCT00970320|9759375|FG000|NOT COMPLETED|Overall Study||0
8593770|NCT00311376|9628593|FG001|NOT COMPLETED|Treatment Cycle 1||17
8593771|NCT00311376|9628594|FG002|NOT COMPLETED|Treatment Cycle 1||17
8593772|NCT00311376|9628592|FG000|STARTED|Treatment Cycle 2|69 from the 300U group + 46 from the Placebo group entered Cycle 2|115
8593773|NCT00311376|9628593|FG001|STARTED|Treatment Cycle 2|74 from the 200U group + 51 from the Placebo group entered Cycle 2|125
8593774|NCT00311376|9628594|FG002|STARTED|Treatment Cycle 2|Cycle 1 Placebo pts were randomized to receive 300U or 200U in Cycle 2|0
8593775|NCT00311376|9628592|FG000|COMPLETED|Treatment Cycle 2||106
8593776|NCT00311376|9628593|FG001|COMPLETED|Treatment Cycle 2||112
8593777|NCT00311376|9628594|FG002|COMPLETED|Treatment Cycle 2||0
8593778|NCT00311376|9628592|FG000|NOT COMPLETED|Treatment Cycle 2||9
8593779|NCT00311376|9628593|FG001|NOT COMPLETED|Treatment Cycle 2||13
8593780|NCT00311376|9628594|FG002|NOT COMPLETED|Treatment Cycle 2||0
8593781|NCT00311402|9628604|FG000|STARTED|Overall Study||655
8593782|NCT00311402|9628605|FG001|STARTED|Overall Study||639
8593783|NCT00311402|9628604|FG000|COMPLETED|Overall Study||445
8593784|NCT00311402|9628605|FG001|COMPLETED|Overall Study||462
8593785|NCT00311402|9628604|FG000|NOT COMPLETED|Overall Study||210
8593786|NCT00311402|9628605|FG001|NOT COMPLETED|Overall Study||177
8593787|NCT00311584|9628613|FG000|STARTED|Overall Study||29
8593788|NCT00311584|9628614|FG001|STARTED|Overall Study||30
8593789|NCT00311584|9628613|FG000|COMPLETED|Overall Study||9
8593790|NCT00311584|9628614|FG001|COMPLETED|Overall Study||7
8593791|NCT00311584|9628613|FG000|NOT COMPLETED|Overall Study||20
8593792|NCT00311584|9628614|FG001|NOT COMPLETED|Overall Study||23
8593793|NCT00311623|9628623|FG000|STARTED|Overall Study||10
8593794|NCT00311623|9628624|FG001|STARTED|Overall Study||20
8593795|NCT00311623|9628625|FG002|STARTED|Overall Study||2
8593796|NCT00311623|9628623|FG000|COMPLETED|Overall Study||10
8593797|NCT00311623|9628624|FG001|COMPLETED|Overall Study||20
8593798|NCT00311623|9628625|FG002|COMPLETED|Overall Study||0
8593799|NCT00311623|9628623|FG000|NOT COMPLETED|Overall Study||0
8593800|NCT00311623|9628624|FG001|NOT COMPLETED|Overall Study||0
8712666|NCT00970320|9759376|FG001|NOT COMPLETED|Overall Study||11
8712667|NCT00970320|9759377|FG002|NOT COMPLETED|Overall Study||13
8712668|NCT00970320|9759378|FG003|NOT COMPLETED|Overall Study||14
8712669|NCT00970320|9759379|FG004|NOT COMPLETED|Overall Study||540
8712670|NCT00970359|9759391|FG000|STARTED|Overall Study||24
8712671|NCT00970359|9759391|FG000|COMPLETED|Overall Study||20
8712672|NCT00970359|9759391|FG000|NOT COMPLETED|Overall Study||4
8712673|NCT00970489|9759397|FG000|STARTED|Overall Study||758
8712674|NCT00970489|9759398|FG001|STARTED|Overall Study||758
8712675|NCT00970489|9759397|FG000|COMPLETED|Overall Study||704
8712676|NCT00970489|9759398|FG001|COMPLETED|Overall Study||717
8712677|NCT00970489|9759397|FG000|NOT COMPLETED|Overall Study||54
8712678|NCT00970489|9759398|FG001|NOT COMPLETED|Overall Study||41
8712679|NCT00970502|9759404|FG000|STARTED|Overall Study||15
8712680|NCT00970502|9759404|FG000|COMPLETED|Overall Study||14
8712681|NCT00970502|9759404|FG000|NOT COMPLETED|Overall Study||1
8712682|NCT00970593|9759419|FG000|STARTED|Overall Study||11
8712683|NCT00970593|9759420|FG001|STARTED|Overall Study||15
8712684|NCT00970593|9759421|FG002|STARTED|Overall Study||13
8712685|NCT00970593|9759422|FG003|STARTED|Overall Study||12
8712686|NCT00970593|9759423|FG004|STARTED|Overall Study||20
8712687|NCT00970593|9759424|FG005|STARTED|Overall Study||5
8712688|NCT00970593|9759425|FG006|STARTED|Overall Study||16
8712689|NCT00970593|9759419|FG000|COMPLETED|Overall Study||10
8712690|NCT00970593|9759420|FG001|COMPLETED|Overall Study||14
8712691|NCT00970593|9759421|FG002|COMPLETED|Overall Study||7
8712692|NCT00970593|9759422|FG003|COMPLETED|Overall Study||12
8712693|NCT00970593|9759423|FG004|COMPLETED|Overall Study||20
8712694|NCT00970593|9759424|FG005|COMPLETED|Overall Study||5
8712695|NCT00970593|9759425|FG006|COMPLETED|Overall Study||14
8712696|NCT00970593|9759419|FG000|NOT COMPLETED|Overall Study||1
8712697|NCT00970593|9759420|FG001|NOT COMPLETED|Overall Study||1
8712698|NCT00970593|9759421|FG002|NOT COMPLETED|Overall Study||6
8712699|NCT00970593|9759422|FG003|NOT COMPLETED|Overall Study||0
8712700|NCT00970593|9759423|FG004|NOT COMPLETED|Overall Study||0
8712701|NCT00970593|9759424|FG005|NOT COMPLETED|Overall Study||0
8712702|NCT00970593|9759425|FG006|NOT COMPLETED|Overall Study||2
8712703|NCT00970632|9759448|FG000|STARTED|Overall Study||172
8712704|NCT00970632|9759449|FG001|STARTED|Overall Study||171
8712705|NCT00970632|9759450|FG002|STARTED|Overall Study||168
8593801|NCT00311623|9628625|FG002|NOT COMPLETED|Overall Study||2
8593802|NCT00311766|9628636|FG000|STARTED|Overall Study||8
8593803|NCT00311766|9628637|FG001|STARTED|Overall Study||22
8593804|NCT00311766|9628636|FG000|COMPLETED|Overall Study||8
8593805|NCT00311766|9628637|FG001|COMPLETED|Overall Study||17
8593806|NCT00311766|9628636|FG000|NOT COMPLETED|Overall Study||0
8712706|NCT00970632|9759448|FG000|COMPLETED|Overall Study||148
8712707|NCT00970632|9759449|FG001|COMPLETED|Overall Study||156
8712708|NCT00970632|9759450|FG002|COMPLETED|Overall Study||150
8712709|NCT00970632|9759448|FG000|NOT COMPLETED|Overall Study||24
8712710|NCT00970632|9759449|FG001|NOT COMPLETED|Overall Study||15
8712711|NCT00970632|9759450|FG002|NOT COMPLETED|Overall Study||18
8712712|NCT00970684|9759458|FG000|STARTED|Overall Study||13
8593807|NCT00311766|9628637|FG001|NOT COMPLETED|Overall Study||5
8593808|NCT00312195|9628645|FG000|STARTED|Overall Study||138
8712713|NCT00970684|9759458|FG000|COMPLETED|Overall Study||3
8712714|NCT00970684|9759458|FG000|NOT COMPLETED|Overall Study||10
8712715|NCT00970814|9759464|FG000|STARTED|Overall Study||66
8712716|NCT00970814|9759465|FG001|STARTED|Overall Study||64
8593809|NCT00312195|9628646|FG001|STARTED|Overall Study||129
8593810|NCT00312195|9628645|FG000|COMPLETED|Overall Study||132
8593811|NCT00312195|9628646|FG001|COMPLETED|Overall Study||123
8593812|NCT00312195|9628645|FG000|NOT COMPLETED|Overall Study||6
8593813|NCT00312195|9628646|FG001|NOT COMPLETED|Overall Study||6
8593814|NCT00312208|9628656|FG000|STARTED|Overall Study|1649 patients randomized, 1634 patients treated|1649
8593815|NCT00312208|9628657|FG001|STARTED|Overall Study|1649 patients randomized 1635 patients treated|1649
8593816|NCT00312208|9628656|FG000|COMPLETED|Overall Study||1477
8593817|NCT00312208|9628657|FG001|COMPLETED|Overall Study||1526
8593818|NCT00312208|9628656|FG000|NOT COMPLETED|Overall Study||172
8593819|NCT00312208|9628657|FG001|NOT COMPLETED|Overall Study||123
8593820|NCT00312221|9628666|FG000|STARTED|Open-label Run-in Period||652
8593821|NCT00312221|9628667|FG001|STARTED|Open-label Run-in Period||0
8593822|NCT00312221|9628668|FG002|STARTED|Open-label Run-in Period||0
8593823|NCT00312221|9628669|FG003|STARTED|Open-label Run-in Period||0
8593824|NCT00312221|9628666|FG000|COMPLETED|Open-label Run-in Period||418
8593825|NCT00312221|9628667|FG001|COMPLETED|Open-label Run-in Period||0
8593826|NCT00312221|9628668|FG002|COMPLETED|Open-label Run-in Period||0
8593827|NCT00312221|9628669|FG003|COMPLETED|Open-label Run-in Period||0
8593828|NCT00312221|9628666|FG000|NOT COMPLETED|Open-label Run-in Period||234
8593829|NCT00312221|9628667|FG001|NOT COMPLETED|Open-label Run-in Period||0
8593830|NCT00312221|9628668|FG002|NOT COMPLETED|Open-label Run-in Period||0
8593831|NCT00312221|9628669|FG003|NOT COMPLETED|Open-label Run-in Period||0
8593832|NCT00312221|9628666|FG000|STARTED|Double-blind Phase||0
8593833|NCT00312221|9628667|FG001|STARTED|Double-blind Phase||136
8593834|NCT00312221|9628668|FG002|STARTED|Double-blind Phase||149
8712717|NCT00970814|9759464|FG000|COMPLETED|Overall Study||58
8712718|NCT00970814|9759465|FG001|COMPLETED|Overall Study||50
8712719|NCT00970814|9759464|FG000|NOT COMPLETED|Overall Study||8
8712720|NCT00970814|9759465|FG001|NOT COMPLETED|Overall Study||14
8712721|NCT00970853|9759473|FG000|STARTED|Overall Study||89
8712722|NCT00970853|9759474|FG001|STARTED|Overall Study||98
8712723|NCT00970853|9759473|FG000|COMPLETED|Overall Study||89
8712724|NCT00970853|9759474|FG001|COMPLETED|Overall Study||98
8712725|NCT00970853|9759473|FG000|NOT COMPLETED|Overall Study||0
8712726|NCT00970853|9759474|FG001|NOT COMPLETED|Overall Study||0
8712727|NCT00970944|9759482|FG000|STARTED|Overall Study||87
8712728|NCT00970944|9759483|FG001|STARTED|Overall Study||97
8712729|NCT00970944|9759482|FG000|COMPLETED|Overall Study||86
8712730|NCT00970944|9759483|FG001|COMPLETED|Overall Study||95
8712731|NCT00970944|9759482|FG000|NOT COMPLETED|Overall Study||1
8712732|NCT00970944|9759483|FG001|NOT COMPLETED|Overall Study||2
8712733|NCT00971048|9759494|FG000|STARTED|Overall Study||30
8712734|NCT00971048|9759495|FG001|STARTED|Overall Study||33
8712735|NCT00971048|9759496|FG002|STARTED|Overall Study||12
8712736|NCT00971048|9759497|FG003|STARTED|Overall Study||13
8712737|NCT00971048|9759494|FG000|COMPLETED|Overall Study||29
8712738|NCT00971048|9759495|FG001|COMPLETED|Overall Study||31
8712739|NCT00971048|9759496|FG002|COMPLETED|Overall Study||11
8712740|NCT00971048|9759497|FG003|COMPLETED|Overall Study||11
8712741|NCT00971048|9759494|FG000|NOT COMPLETED|Overall Study||1
8813138|NCT01524133|9866270|FG000|NOT COMPLETED|Overall Study 52 Weeks||21
8813139|NCT01524133|9866271|FG001|NOT COMPLETED|Overall Study 52 Weeks||20
8813140|NCT01524133|9866272|FG002|NOT COMPLETED|Overall Study 52 Weeks||27
8813141|NCT01524198|9866282|FG000|STARTED|Overall Study||471
8593835|NCT00312221|9628669|FG003|STARTED|Double-blind Phase||133
8593836|NCT00312221|9628666|FG000|COMPLETED|Double-blind Phase||0
8712742|NCT00971048|9759495|FG001|NOT COMPLETED|Overall Study||2
8712743|NCT00971048|9759496|FG002|NOT COMPLETED|Overall Study||1
8712744|NCT00971048|9759497|FG003|NOT COMPLETED|Overall Study||2
8712745|NCT00971178|9759512|FG000|STARTED|Overall Study||35
8712746|NCT00971178|9759513|FG001|STARTED|Overall Study||35
8712747|NCT00971178|9759514|FG002|STARTED|Overall Study||35
8712748|NCT00971178|9759512|FG000|COMPLETED|Overall Study||33
8712749|NCT00971178|9759513|FG001|COMPLETED|Overall Study||33
8712750|NCT00971178|9759514|FG002|COMPLETED|Overall Study||33
8712751|NCT00971178|9759512|FG000|NOT COMPLETED|Overall Study||2
8712752|NCT00971178|9759513|FG001|NOT COMPLETED|Overall Study||2
8712753|NCT00971178|9759514|FG002|NOT COMPLETED|Overall Study||2
8712754|NCT00971204|9759522|FG000|STARTED|Overall Study|100 enrolled participants|100
8712755|NCT00971204|9759522|FG000|Treated|Overall Study||86
8712756|NCT00971204|9759522|FG000|COMPLETED|Overall Study|86 participants were treated and of these 86, 76 completed the study.|76
8712757|NCT00971204|9759522|FG000|NOT COMPLETED|Overall Study||24
8712758|NCT00971243|9759531|FG000|STARTED|Double Blind Period||87
8712759|NCT00971243|9759532|FG001|STARTED|Double Blind Period||93
8712760|NCT00971243|9759533|FG002|STARTED|Double Blind Period||91
8712761|NCT00971243|9759534|FG003|STARTED|Double Blind Period|One subject who did not receive any study drug was excluded from the ITT|88
8712762|NCT00971243|9759535|FG004|STARTED|Double Blind Period||88
8712763|NCT00971243|9759531|FG000|COMPLETED|Double Blind Period||68
8593837|NCT00312221|9628667|FG001|COMPLETED|Double-blind Phase||77
8712764|NCT00971243|9759532|FG001|COMPLETED|Double Blind Period||82
8712765|NCT00971243|9759533|FG002|COMPLETED|Double Blind Period||72
8712766|NCT00971243|9759534|FG003|COMPLETED|Double Blind Period||74
8712767|NCT00971243|9759535|FG004|COMPLETED|Double Blind Period||70
8712768|NCT00971243|9759531|FG000|NOT COMPLETED|Double Blind Period||19
8712769|NCT00971243|9759532|FG001|NOT COMPLETED|Double Blind Period||11
8712770|NCT00971243|9759533|FG002|NOT COMPLETED|Double Blind Period||19
8593838|NCT00312221|9628668|FG002|COMPLETED|Double-blind Phase||77
8593839|NCT00312221|9628669|FG003|COMPLETED|Double-blind Phase||63
8593840|NCT00312221|9628666|FG000|NOT COMPLETED|Double-blind Phase||0
8593841|NCT00312221|9628667|FG001|NOT COMPLETED|Double-blind Phase||59
8593842|NCT00312221|9628668|FG002|NOT COMPLETED|Double-blind Phase||72
8593843|NCT00312221|9628669|FG003|NOT COMPLETED|Double-blind Phase||70
8593844|NCT00312338|9628680|FG000|STARTED|Overall Study||105
8593845|NCT00312338|9628681|FG001|STARTED|Overall Study||57
8593846|NCT00312338|9628680|FG000|COMPLETED|Overall Study||83
8593847|NCT00312338|9628681|FG001|COMPLETED|Overall Study||54
8593848|NCT00312338|9628680|FG000|NOT COMPLETED|Overall Study||22
8593849|NCT00312338|9628681|FG001|NOT COMPLETED|Overall Study||3
8712771|NCT00971243|9759534|FG003|NOT COMPLETED|Double Blind Period||14
8712772|NCT00971243|9759535|FG004|NOT COMPLETED|Double Blind Period||18
8712773|NCT00971243|9759531|FG000|STARTED|Open-label Period||68
8712774|NCT00971243|9759532|FG001|STARTED|Open-label Period|One Subject did not entered because of the failure of inclusion/exclusion criteria.|81
8712775|NCT00971243|9759533|FG002|STARTED|Open-label Period|One Subject did not entered the Open-label Period because of the withdrawal of consent.|71
8712776|NCT00971243|9759534|FG003|STARTED|Open-label Period||74
8712777|NCT00971243|9759535|FG004|STARTED|Open-label Period||70
8712778|NCT00971243|9759531|FG000|COMPLETED|Open-label Period||60
8712779|NCT00971243|9759532|FG001|COMPLETED|Open-label Period||71
8712780|NCT00971243|9759533|FG002|COMPLETED|Open-label Period||66
8712781|NCT00971243|9759534|FG003|COMPLETED|Open-label Period||64
8712782|NCT00971243|9759535|FG004|COMPLETED|Open-label Period||64
8712783|NCT00971243|9759531|FG000|NOT COMPLETED|Open-label Period||8
8712784|NCT00971243|9759532|FG001|NOT COMPLETED|Open-label Period||10
8712785|NCT00971243|9759533|FG002|NOT COMPLETED|Open-label Period||5
8712786|NCT00971243|9759534|FG003|NOT COMPLETED|Open-label Period||10
8712787|NCT00971243|9759535|FG004|NOT COMPLETED|Open-label Period||6
8712788|NCT00971282|9759547|FG000|STARTED|Overall Study||30
8712789|NCT00971282|9759547|FG000|COMPLETED|Overall Study||30
8712790|NCT00971282|9759547|FG000|NOT COMPLETED|Overall Study||0
8712791|NCT00971295|9759553|FG000|STARTED|Overall Study||10
8712792|NCT00971295|9759554|FG001|STARTED|Overall Study||10
8712793|NCT00971295|9759553|FG000|COMPLETED|Overall Study||10
8712794|NCT00971295|9759554|FG001|COMPLETED|Overall Study||9
8712795|NCT00971295|9759553|FG000|NOT COMPLETED|Overall Study||0
8712796|NCT00971295|9759554|FG001|NOT COMPLETED|Overall Study||1
8712797|NCT00971321|9759562|FG000|STARTED|Up to Day 42||104
8712798|NCT00971321|9759563|FG001|STARTED|Up to Day 42||53
8712799|NCT00971321|9759562|FG000|COMPLETED|Up to Day 42||104
8712800|NCT00971321|9759563|FG001|COMPLETED|Up to Day 42||53
8712801|NCT00971321|9759562|FG000|NOT COMPLETED|Up to Day 42||0
8712802|NCT00971321|9759563|FG001|NOT COMPLETED|Up to Day 42||0
8712803|NCT00971321|9759562|FG000|STARTED|Up to Month 7||104
8712804|NCT00971321|9759563|FG001|STARTED|Up to Month 7||53
8712805|NCT00971321|9759562|FG000|COMPLETED|Up to Month 7||100
8712806|NCT00971321|9759563|FG001|COMPLETED|Up to Month 7||51
8712807|NCT00971321|9759562|FG000|NOT COMPLETED|Up to Month 7||4
8712808|NCT00971321|9759563|FG001|NOT COMPLETED|Up to Month 7||2
8712809|NCT00971321|9759562|FG000|STARTED|Up to Month 11-12||104
8712810|NCT00971321|9759563|FG001|STARTED|Up to Month 11-12||53
8712811|NCT00971321|9759562|FG000|COMPLETED|Up to Month 11-12||99
8712812|NCT00971321|9759563|FG001|COMPLETED|Up to Month 11-12||50
8712813|NCT00971321|9759562|FG000|NOT COMPLETED|Up to Month 11-12||5
8712814|NCT00971321|9759563|FG001|NOT COMPLETED|Up to Month 11-12||3
8712815|NCT00971425|9759571|FG000|STARTED|Overall Study||72
8712816|NCT00971425|9759572|FG001|STARTED|Overall Study||73
8712817|NCT00971425|9759571|FG000|COMPLETED|Overall Study||71
8712818|NCT00971425|9759572|FG001|COMPLETED|Overall Study||71
8712819|NCT00971425|9759571|FG000|NOT COMPLETED|Overall Study||1
8712820|NCT00971425|9759572|FG001|NOT COMPLETED|Overall Study||2
8712821|NCT00971620|9759580|FG000|STARTED|Overall Study||9
8712822|NCT00971620|9759581|FG001|STARTED|Overall Study||9
8712823|NCT00971620|9759580|FG000|COMPLETED|Overall Study||9
8712824|NCT00971620|9759581|FG001|COMPLETED|Overall Study||9
8593850|NCT00312377|9628689|FG000|STARTED|Overall Study|randomised patients|694
8712825|NCT00971620|9759580|FG000|NOT COMPLETED|Overall Study||0
8712826|NCT00971620|9759581|FG001|NOT COMPLETED|Overall Study||0
8712827|NCT00971633|9759587|FG000|STARTED|Period 1||2
8712828|NCT00971633|9759588|FG001|STARTED|Period 1||2
8712829|NCT00971633|9759589|FG002|STARTED|Period 1||2
8712830|NCT00971633|9759590|FG003|STARTED|Period 1||2
8712831|NCT00971633|9759591|FG004|STARTED|Period 1||2
8712832|NCT00971633|9759592|FG005|STARTED|Period 1||2
8712833|NCT00971633|9759587|FG000|COMPLETED|Period 1||2
8712834|NCT00971633|9759588|FG001|COMPLETED|Period 1||2
8712835|NCT00971633|9759589|FG002|COMPLETED|Period 1||2
8712836|NCT00971633|9759590|FG003|COMPLETED|Period 1||2
8712837|NCT00971633|9759591|FG004|COMPLETED|Period 1||2
8712838|NCT00971633|9759592|FG005|COMPLETED|Period 1||2
8712839|NCT00971633|9759587|FG000|NOT COMPLETED|Period 1||0
8712840|NCT00971633|9759588|FG001|NOT COMPLETED|Period 1||0
8712841|NCT00971633|9759589|FG002|NOT COMPLETED|Period 1||0
8712842|NCT00971633|9759590|FG003|NOT COMPLETED|Period 1||0
8712843|NCT00971633|9759591|FG004|NOT COMPLETED|Period 1||0
8712844|NCT00971633|9759592|FG005|NOT COMPLETED|Period 1||0
8712845|NCT00971633|9759587|FG000|STARTED|Period 2||2
8712846|NCT00971633|9759588|FG001|STARTED|Period 2||2
8712847|NCT00971633|9759589|FG002|STARTED|Period 2||2
8712848|NCT00971633|9759590|FG003|STARTED|Period 2||2
8712849|NCT00971633|9759591|FG004|STARTED|Period 2||2
8593851|NCT00312377|9628690|FG001|STARTED|Overall Study|randomised patients|697
8593852|NCT00312377|9628689|FG000|COMPLETED|Overall Study|ongoing study treatment at data cut-off|50
8593853|NCT00312377|9628690|FG001|COMPLETED|Overall Study|ongoing study treatment at data cut-off|29
8593854|NCT00312377|9628689|FG000|NOT COMPLETED|Overall Study||644
8593855|NCT00312377|9628690|FG001|NOT COMPLETED|Overall Study||668
8593856|NCT00312494|9628699|FG000|STARTED|Overall Study||232
8593857|NCT00312494|9628700|FG001|STARTED|Overall Study||226
8593858|NCT00312494|9628701|FG002|STARTED|Overall Study||222
8593859|NCT00312494|9628699|FG000|Received Study Treatment|Overall Study|1 subject randomized to higher dose; received lower dose at baseline, higher dose weeks 1 and 2.|223
8593860|NCT00312494|9628700|FG001|Received Study Treatment|Overall Study||216
8593861|NCT00312494|9628701|FG002|Received Study Treatment|Overall Study||217
8593862|NCT00312494|9628699|FG000|COMPLETED|Overall Study|1 subject randomized to higher dose; received lower dose baseline and/or week 1; higher dose week 2.|161
8593863|NCT00312494|9628700|FG001|COMPLETED|Overall Study||168
8593864|NCT00312494|9628701|FG002|COMPLETED|Overall Study||179
8593865|NCT00312494|9628699|FG000|NOT COMPLETED|Overall Study||71
8593866|NCT00312494|9628700|FG001|NOT COMPLETED|Overall Study||58
8593867|NCT00312494|9628701|FG002|NOT COMPLETED|Overall Study||43
8593868|NCT00312572|9628711|FG000|STARTED|Overall Study||101
8593869|NCT00312572|9628712|FG001|STARTED|Overall Study||103
8593870|NCT00312572|9628711|FG000|COMPLETED|Overall Study||85
8593871|NCT00312572|9628712|FG001|COMPLETED|Overall Study||82
8593872|NCT00312572|9628711|FG000|NOT COMPLETED|Overall Study||16
8593873|NCT00312572|9628712|FG001|NOT COMPLETED|Overall Study||21
8593874|NCT00312663|9628723|FG000|STARTED|Immunization Phase||5
8593875|NCT00312663|9628724|FG001|STARTED|Immunization Phase||13
8593876|NCT00312663|9628725|FG002|STARTED|Immunization Phase||0
8593877|NCT00312663|9628723|FG000|COMPLETED|Immunization Phase||5
8593878|NCT00312663|9628724|FG001|COMPLETED|Immunization Phase||12
8593879|NCT00312663|9628725|FG002|COMPLETED|Immunization Phase||0
8593880|NCT00312663|9628723|FG000|NOT COMPLETED|Immunization Phase||0
8593881|NCT00312663|9628724|FG001|NOT COMPLETED|Immunization Phase||1
8593882|NCT00312663|9628725|FG002|NOT COMPLETED|Immunization Phase||0
8593883|NCT00312663|9628723|FG000|STARTED|Challenge Phase|low dose subjects didn't participate in the challenge phase|0
8593884|NCT00312663|9628724|FG001|STARTED|Challenge Phase|10 subjects from the high dose group participated in the challenge phase|10
8593885|NCT00312663|9628725|FG002|STARTED|Challenge Phase|6 non-immunized subjects participated in the challenge phase|6
8593886|NCT00312663|9628723|FG000|COMPLETED|Challenge Phase||0
8593887|NCT00312663|9628724|FG001|COMPLETED|Challenge Phase||10
8593888|NCT00312663|9628725|FG002|COMPLETED|Challenge Phase||6
8593889|NCT00312663|9628723|FG000|NOT COMPLETED|Challenge Phase||0
8593890|NCT00312663|9628724|FG001|NOT COMPLETED|Challenge Phase||0
8593891|NCT00312663|9628725|FG002|NOT COMPLETED|Challenge Phase||0
8593892|NCT00312702|9628737|FG000|STARTED|Immunization Phase||5
8593893|NCT00312702|9628738|FG001|STARTED|Immunization Phase||13
8593894|NCT00312702|9628739|FG002|STARTED|Immunization Phase||0
8593895|NCT00312702|9628737|FG000|COMPLETED|Immunization Phase||5
8593896|NCT00312702|9628738|FG001|COMPLETED|Immunization Phase||12
8593897|NCT00312702|9628739|FG002|COMPLETED|Immunization Phase||0
8593898|NCT00312702|9628737|FG000|NOT COMPLETED|Immunization Phase||0
8593899|NCT00312702|9628738|FG001|NOT COMPLETED|Immunization Phase||1
8593900|NCT00312702|9628739|FG002|NOT COMPLETED|Immunization Phase||0
8593901|NCT00312702|9628737|FG000|STARTED|Challenge Phase|low dose subjects didn't participate in the challenge phase|0
8593902|NCT00312702|9628738|FG001|STARTED|Challenge Phase|12 subjects from the high dose group participated in the challenge phase|12
8593903|NCT00312702|9628739|FG002|STARTED|Challenge Phase|1 non-immunized subjects participated in the challenge phase.|1
8593904|NCT00312702|9628737|FG000|COMPLETED|Challenge Phase||0
8593905|NCT00312702|9628738|FG001|COMPLETED|Challenge Phase||12
8593906|NCT00312702|9628739|FG002|COMPLETED|Challenge Phase||1
8593907|NCT00312702|9628737|FG000|NOT COMPLETED|Challenge Phase||0
8593908|NCT00312702|9628738|FG001|NOT COMPLETED|Challenge Phase||0
8593909|NCT00312702|9628739|FG002|NOT COMPLETED|Challenge Phase||0
8593910|NCT00312728|9628747|FG000|STARTED|Overall Study||115
8593911|NCT00312728|9628747|FG000|COMPLETED|Overall Study||5
8593912|NCT00312728|9628747|FG000|NOT COMPLETED|Overall Study||110
8593913|NCT00312845|9628753|FG000|STARTED|Overall Study||336
8593914|NCT00312845|9628754|FG001|STARTED|Overall Study||340
8593915|NCT00312845|9628753|FG000|COMPLETED|Overall Study||237
8593916|NCT00312845|9628754|FG001|COMPLETED|Overall Study||245
8593917|NCT00312845|9628753|FG000|NOT COMPLETED|Overall Study||99
8593918|NCT00312845|9628754|FG001|NOT COMPLETED|Overall Study||95
8593919|NCT00312858|9628762|FG000|STARTED|Overall Study||330
8593920|NCT00312858|9628763|FG001|STARTED|Overall Study||323
8593921|NCT00312858|9628762|FG000|Visit 1|Overall Study||330
8593922|NCT00312858|9628763|FG001|Visit 1|Overall Study||323
8593923|NCT00312858|9628762|FG000|Visit 2|Overall Study||305
8593924|NCT00312858|9628763|FG001|Visit 2|Overall Study||294
8593925|NCT00312858|9628762|FG000|Visit 3|Overall Study||273
8593926|NCT00312858|9628763|FG001|Visit 3|Overall Study||261
8593927|NCT00312858|9628762|FG000|Visit 4|Overall Study||262
8593928|NCT00312858|9628763|FG001|Visit 4|Overall Study||240
8593929|NCT00312858|9628762|FG000|COMPLETED|Overall Study||262
8593930|NCT00312858|9628763|FG001|COMPLETED|Overall Study||230
8593931|NCT00312858|9628762|FG000|NOT COMPLETED|Overall Study||68
8593932|NCT00312858|9628763|FG001|NOT COMPLETED|Overall Study||93
8593933|NCT00312884|9628771|FG000|STARTED|Overall Study||91
8593934|NCT00312884|9628772|FG001|STARTED|Overall Study||91
8593935|NCT00312884|9628771|FG000|COMPLETED|Overall Study||74
8593936|NCT00312884|9628772|FG001|COMPLETED|Overall Study||79
8593937|NCT00312884|9628771|FG000|NOT COMPLETED|Overall Study||17
8593938|NCT00312884|9628772|FG001|NOT COMPLETED|Overall Study||12
8593939|NCT00312897|9628780|FG000|STARTED|Overall Study||27
8593940|NCT00312897|9628781|FG001|STARTED|Overall Study||24
8593941|NCT00312897|9628780|FG000|COMPLETED|Overall Study||21
8593942|NCT00312897|9628781|FG001|COMPLETED|Overall Study||18
8593943|NCT00312897|9628780|FG000|NOT COMPLETED|Overall Study||6
8593944|NCT00312897|9628781|FG001|NOT COMPLETED|Overall Study||6
8593945|NCT00312923|9628789|FG000|STARTED|Overall Study||28
8593946|NCT00312923|9628790|FG001|STARTED|Overall Study||26
8593947|NCT00312923|9628789|FG000|COMPLETED|Overall Study||19
8593948|NCT00312923|9628790|FG001|COMPLETED|Overall Study||20
8593949|NCT00312923|9628789|FG000|NOT COMPLETED|Overall Study||9
8593950|NCT00312923|9628790|FG001|NOT COMPLETED|Overall Study||6
8593951|NCT00313014|9628799|FG000|STARTED|Overall Study||221
8593952|NCT00313014|9628800|FG001|STARTED|Overall Study||219
8593953|NCT00313014|9628801|FG002|STARTED|Overall Study||220
8593954|NCT00313014|9628799|FG000|COMPLETED|Overall Study||128
8593955|NCT00313014|9628800|FG001|COMPLETED|Overall Study||146
8593956|NCT00313014|9628801|FG002|COMPLETED|Overall Study||159
8593957|NCT00313014|9628799|FG000|NOT COMPLETED|Overall Study||93
8593958|NCT00313014|9628800|FG001|NOT COMPLETED|Overall Study||73
8593959|NCT00313014|9628801|FG002|NOT COMPLETED|Overall Study||61
8712850|NCT00971633|9759592|FG005|STARTED|Period 2||2
8712851|NCT00971633|9759587|FG000|COMPLETED|Period 2||2
8712852|NCT00971633|9759588|FG001|COMPLETED|Period 2||2
8712853|NCT00971633|9759589|FG002|COMPLETED|Period 2||2
8712854|NCT00971633|9759590|FG003|COMPLETED|Period 2||2
8712855|NCT00971633|9759591|FG004|COMPLETED|Period 2||2
8712856|NCT00971633|9759592|FG005|COMPLETED|Period 2||2
8712857|NCT00971633|9759587|FG000|NOT COMPLETED|Period 2||0
8712858|NCT00971633|9759588|FG001|NOT COMPLETED|Period 2||0
8712859|NCT00971633|9759589|FG002|NOT COMPLETED|Period 2||0
8712860|NCT00971633|9759590|FG003|NOT COMPLETED|Period 2||0
8712861|NCT00971633|9759591|FG004|NOT COMPLETED|Period 2||0
8712862|NCT00971633|9759592|FG005|NOT COMPLETED|Period 2||0
8712863|NCT00971633|9759587|FG000|STARTED|Period 3||2
8712864|NCT00971633|9759588|FG001|STARTED|Period 3||2
8712865|NCT00971633|9759589|FG002|STARTED|Period 3||2
8712866|NCT00971633|9759590|FG003|STARTED|Period 3||2
8712867|NCT00971633|9759591|FG004|STARTED|Period 3||2
8712868|NCT00971633|9759592|FG005|STARTED|Period 3||2
8712869|NCT00971633|9759587|FG000|COMPLETED|Period 3||2
8712870|NCT00971633|9759588|FG001|COMPLETED|Period 3||2
8712871|NCT00971633|9759589|FG002|COMPLETED|Period 3||2
8712872|NCT00971633|9759590|FG003|COMPLETED|Period 3||2
8712873|NCT00971633|9759591|FG004|COMPLETED|Period 3||2
8712874|NCT00971633|9759592|FG005|COMPLETED|Period 3||2
8712875|NCT00971633|9759587|FG000|NOT COMPLETED|Period 3||0
8712876|NCT00971633|9759588|FG001|NOT COMPLETED|Period 3||0
8712877|NCT00971633|9759589|FG002|NOT COMPLETED|Period 3||0
8712878|NCT00971633|9759590|FG003|NOT COMPLETED|Period 3||0
8712879|NCT00971633|9759591|FG004|NOT COMPLETED|Period 3||0
8712880|NCT00971633|9759592|FG005|NOT COMPLETED|Period 3||0
8712881|NCT00971737|9759602|FG000|STARTED|Overall Study||30
8712882|NCT00971737|9759603|FG001|STARTED|Overall Study||30
8712883|NCT00971737|9759602|FG000|COMPLETED|Overall Study||30
8712884|NCT00971737|9759603|FG001|COMPLETED|Overall Study||30
8712885|NCT00971737|9759602|FG000|NOT COMPLETED|Overall Study||0
8712886|NCT00971737|9759603|FG001|NOT COMPLETED|Overall Study||0
8712887|NCT00971750|9759609|FG000|STARTED|Overall Study||253
8712888|NCT00971750|9759609|FG000|COMPLETED|Overall Study||253
8712889|NCT00971750|9759609|FG000|NOT COMPLETED|Overall Study||0
8712890|NCT00971789|9759615|FG000|STARTED|Overall Study||18
8712891|NCT00971789|9759615|FG000|COMPLETED|Overall Study||18
8712892|NCT00971789|9759615|FG000|NOT COMPLETED|Overall Study||0
8712893|NCT00971841|9759619|FG000|STARTED|Overall Study||1
8712894|NCT00971841|9759619|FG000|COMPLETED|Overall Study||1
8712895|NCT00971841|9759619|FG000|NOT COMPLETED|Overall Study||0
8712896|NCT00971932|9759623|FG000|STARTED|Overall Study|Number of participants treated.|33
8712897|NCT00971932|9759623|FG000|COMPLETED|Overall Study||26
8712898|NCT00971932|9759623|FG000|NOT COMPLETED|Overall Study||7
8712899|NCT00971945|9759627|FG000|STARTED|Overall Study||6
8712900|NCT00971945|9759627|FG000|COMPLETED|Overall Study||0
8712901|NCT00971945|9759627|FG000|NOT COMPLETED|Overall Study||6
8712902|NCT00971997|9759631|FG000|STARTED|Overall Study||135
8712903|NCT00971997|9759631|FG000|COMPLETED|Overall Study||116
8593960|NCT00313144|9628810|FG000|STARTED|Overall Study||127
8593961|NCT00313144|9628810|FG000|COMPLETED|Overall Study||17
8593962|NCT00313144|9628810|FG000|NOT COMPLETED|Overall Study||110
8593963|NCT00313170|9628826|FG000|STARTED|Overall Study||47
8593964|NCT00313170|9628827|FG001|STARTED|Overall Study||51
8593965|NCT00313170|9628828|FG002|STARTED|Overall Study||46
8593966|NCT00313170|9628826|FG000|COMPLETED|Overall Study||11
8593967|NCT00313170|9628827|FG001|COMPLETED|Overall Study||17
8593968|NCT00313170|9628828|FG002|COMPLETED|Overall Study||14
8593969|NCT00313170|9628826|FG000|NOT COMPLETED|Overall Study||36
8593970|NCT00313170|9628827|FG001|NOT COMPLETED|Overall Study||34
8593971|NCT00313170|9628828|FG002|NOT COMPLETED|Overall Study||32
8593972|NCT00313209|9628839|FG000|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|466
8712904|NCT00971997|9759631|FG000|NOT COMPLETED|Overall Study||19
8712905|NCT00972088|9759638|FG000|STARTED|Overall Study||26
8593973|NCT00313209|9628840|FG001|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|467
8593974|NCT00313209|9628839|FG000|COMPLETED|Overall Study||359
8593975|NCT00313209|9628840|FG001|COMPLETED|Overall Study||385
8593976|NCT00313209|9628839|FG000|NOT COMPLETED|Overall Study||107
8593977|NCT00313209|9628840|FG001|NOT COMPLETED|Overall Study||82
8593978|NCT00313300|9628851|FG000|STARTED|Randomized in Phase A (26 Weeks)||184
8593979|NCT00313300|9628852|FG001|STARTED|Randomized in Phase A (26 Weeks)||179
8593980|NCT00313300|9628853|FG002|STARTED|Randomized in Phase A (26 Weeks)||184
8593981|NCT00313300|9628854|FG003|STARTED|Randomized in Phase A (26 Weeks)||0
8593982|NCT00313300|9628855|FG004|STARTED|Randomized in Phase A (26 Weeks)||0
8593983|NCT00313300|9628851|FG000|COMPLETED|Randomized in Phase A (26 Weeks)||130
8593984|NCT00313300|9628852|FG001|COMPLETED|Randomized in Phase A (26 Weeks)||140
8593985|NCT00313300|9628853|FG002|COMPLETED|Randomized in Phase A (26 Weeks)||149
8593986|NCT00313300|9628854|FG003|COMPLETED|Randomized in Phase A (26 Weeks)||0
8593987|NCT00313300|9628855|FG004|COMPLETED|Randomized in Phase A (26 Weeks)||0
8593988|NCT00313300|9628851|FG000|NOT COMPLETED|Randomized in Phase A (26 Weeks)||54
8593989|NCT00313300|9628852|FG001|NOT COMPLETED|Randomized in Phase A (26 Weeks)||39
8593990|NCT00313300|9628853|FG002|NOT COMPLETED|Randomized in Phase A (26 Weeks)||35
8593991|NCT00313300|9628854|FG003|NOT COMPLETED|Randomized in Phase A (26 Weeks)||0
8593992|NCT00313300|9628855|FG004|NOT COMPLETED|Randomized in Phase A (26 Weeks)||0
8593993|NCT00313300|9628851|FG000|STARTED|Randomized in Phase B (26 Weeks)||427
8593994|NCT00313300|9628852|FG001|STARTED|Randomized in Phase B (26 Weeks)||138
8593995|NCT00313300|9628853|FG002|STARTED|Randomized in Phase B (26 Weeks)||134
8593996|NCT00313300|9628854|FG003|STARTED|Randomized in Phase B (26 Weeks)||248
8593997|NCT00313300|9628855|FG004|STARTED|Randomized in Phase B (26 Weeks)||221
8593998|NCT00313300|9628851|FG000|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||368
8593999|NCT00313300|9628852|FG001|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||120
8594000|NCT00313300|9628853|FG002|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||110
8594001|NCT00313300|9628854|FG003|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||248
8594002|NCT00313300|9628855|FG004|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||221
8594003|NCT00313300|9628851|FG000|COMPLETED|Randomized in Phase B (26 Weeks)||333
8594004|NCT00313300|9628852|FG001|COMPLETED|Randomized in Phase B (26 Weeks)||105
8594005|NCT00313300|9628853|FG002|COMPLETED|Randomized in Phase B (26 Weeks)||94
8594006|NCT00313300|9628854|FG003|COMPLETED|Randomized in Phase B (26 Weeks)||15
8594007|NCT00313300|9628855|FG004|COMPLETED|Randomized in Phase B (26 Weeks)||13
8594008|NCT00313300|9628851|FG000|NOT COMPLETED|Randomized in Phase B (26 Weeks)||94
8594009|NCT00313300|9628852|FG001|NOT COMPLETED|Randomized in Phase B (26 Weeks)||33
8594010|NCT00313300|9628853|FG002|NOT COMPLETED|Randomized in Phase B (26 Weeks)||40
8594011|NCT00313300|9628854|FG003|NOT COMPLETED|Randomized in Phase B (26 Weeks)||233
8594012|NCT00313300|9628855|FG004|NOT COMPLETED|Randomized in Phase B (26 Weeks)||208
8594013|NCT00313300|9628851|FG000|STARTED|Follow-Up(30days)-Randomized Phase A||163
8594014|NCT00313300|9628852|FG001|STARTED|Follow-Up(30days)-Randomized Phase A||162
8594015|NCT00313300|9628853|FG002|STARTED|Follow-Up(30days)-Randomized Phase A||174
8594016|NCT00313300|9628854|FG003|STARTED|Follow-Up(30days)-Randomized Phase A||0
8594017|NCT00313300|9628855|FG004|STARTED|Follow-Up(30days)-Randomized Phase A||0
8594018|NCT00313300|9628851|FG000|COMPLETED|Follow-Up(30days)-Randomized Phase A||158
8594019|NCT00313300|9628852|FG001|COMPLETED|Follow-Up(30days)-Randomized Phase A||156
8594020|NCT00313300|9628853|FG002|COMPLETED|Follow-Up(30days)-Randomized Phase A||172
8594021|NCT00313300|9628854|FG003|COMPLETED|Follow-Up(30days)-Randomized Phase A||0
8594022|NCT00313300|9628855|FG004|COMPLETED|Follow-Up(30days)-Randomized Phase A||0
8594023|NCT00313300|9628851|FG000|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||5
8594024|NCT00313300|9628852|FG001|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||6
8594025|NCT00313300|9628853|FG002|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||2
8594026|NCT00313300|9628854|FG003|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||0
8594027|NCT00313300|9628855|FG004|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||0
8712906|NCT00972088|9759638|FG000|COMPLETED|Overall Study||26
8712907|NCT00972088|9759638|FG000|NOT COMPLETED|Overall Study||0
8712908|NCT00972153|9759645|FG000|STARTED|Overall Study||12
8712909|NCT00972153|9759646|FG001|STARTED|Overall Study||12
8712910|NCT00972153|9759647|FG002|STARTED|Overall Study||12
8712911|NCT00972153|9759645|FG000|COMPLETED|Overall Study||12
8712912|NCT00972153|9759646|FG001|COMPLETED|Overall Study|One case excluded due to technical problem with measuring equipment.|11
8712913|NCT00972153|9759647|FG002|COMPLETED|Overall Study||12
8712914|NCT00972153|9759645|FG000|NOT COMPLETED|Overall Study||0
8712915|NCT00972153|9759646|FG001|NOT COMPLETED|Overall Study||1
8712916|NCT00972153|9759647|FG002|NOT COMPLETED|Overall Study||0
8712917|NCT00972205|9759655|FG000|STARTED|Overall Study||12
8712918|NCT00972205|9759655|FG000|COMPLETED|Overall Study||12
8712919|NCT00972205|9759655|FG000|NOT COMPLETED|Overall Study||0
8712920|NCT00972244|9759664|FG000|STARTED|Overall Study||59
8712921|NCT00972244|9759665|FG001|STARTED|Overall Study||56
8712922|NCT00972244|9759666|FG002|STARTED|Overall Study||58
8712923|NCT00972244|9759667|FG003|STARTED|Overall Study||52
8712924|NCT00972244|9759668|FG004|STARTED|Overall Study||54
8712925|NCT00972244|9759664|FG000|COMPLETED|Overall Study||54
8712926|NCT00972244|9759665|FG001|COMPLETED|Overall Study||51
8712927|NCT00972244|9759666|FG002|COMPLETED|Overall Study||56
8712928|NCT00972244|9759667|FG003|COMPLETED|Overall Study||52
8594028|NCT00313300|9628851|FG000|STARTED|Follow-Up(30days)-Randomized Phase B||383
8594029|NCT00313300|9628852|FG001|STARTED|Follow-Up(30days)-Randomized Phase B||123
8594030|NCT00313300|9628853|FG002|STARTED|Follow-Up(30days)-Randomized Phase B||119
8594031|NCT00313300|9628854|FG003|STARTED|Follow-Up(30days)-Randomized Phase B||222
8594032|NCT00313300|9628855|FG004|STARTED|Follow-Up(30days)-Randomized Phase B||201
8594033|NCT00313300|9628851|FG000|COMPLETED|Follow-Up(30days)-Randomized Phase B||380
8594034|NCT00313300|9628852|FG001|COMPLETED|Follow-Up(30days)-Randomized Phase B||123
8594035|NCT00313300|9628853|FG002|COMPLETED|Follow-Up(30days)-Randomized Phase B||117
8594036|NCT00313300|9628854|FG003|COMPLETED|Follow-Up(30days)-Randomized Phase B||217
8594037|NCT00313300|9628855|FG004|COMPLETED|Follow-Up(30days)-Randomized Phase B||199
8594038|NCT00313300|9628851|FG000|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||3
8594039|NCT00313300|9628852|FG001|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||0
8594040|NCT00313300|9628853|FG002|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||2
8594041|NCT00313300|9628854|FG003|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||5
8594042|NCT00313300|9628855|FG004|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||2
8594043|NCT00313313|9628876|FG000|STARTED|Overall Study||248
8594044|NCT00313313|9628877|FG001|STARTED|Overall Study||253
8594045|NCT00313313|9628878|FG002|STARTED|Overall Study||267
8594046|NCT00313313|9628876|FG000|COMPLETED|Overall Study|61 subjects completed the study without being rescued|185
8594047|NCT00313313|9628877|FG001|COMPLETED|Overall Study|55 subjects completed the study without being rescued|187
8594048|NCT00313313|9628878|FG002|COMPLETED|Overall Study|26 subjects completed the study without being rescued|185
8594049|NCT00313313|9628876|FG000|NOT COMPLETED|Overall Study||63
8594050|NCT00313313|9628877|FG001|NOT COMPLETED|Overall Study||66
8594051|NCT00313313|9628878|FG002|NOT COMPLETED|Overall Study||82
8594052|NCT00313443|9628886|FG000|STARTED|Overall Study||30
8594053|NCT00313443|9628886|FG000|COMPLETED|Overall Study||30
8594054|NCT00313443|9628886|FG000|NOT COMPLETED|Overall Study||0
8594055|NCT00313560|9628890|FG000|STARTED|Overall Study||48
8594056|NCT00313560|9628890|FG000|COMPLETED|Overall Study||48
8594057|NCT00313560|9628890|FG000|NOT COMPLETED|Overall Study||0
8594058|NCT00313586|9628902|FG000|STARTED|Overall Study||75
8594059|NCT00313586|9628903|FG001|STARTED|Overall Study||75
8594060|NCT00313586|9628904|FG002|STARTED|Overall Study||24
8594061|NCT00313586|9628905|FG003|STARTED|Overall Study||23
8594062|NCT00313586|9628902|FG000|Treated|Overall Study||74
8594063|NCT00313586|9628903|FG001|Treated|Overall Study||75
8594064|NCT00313586|9628904|FG002|Treated|Overall Study||24
8594065|NCT00313586|9628905|FG003|Treated|Overall Study||23
8594066|NCT00313586|9628902|FG000|COMPLETED|Overall Study||5
8594067|NCT00313586|9628903|FG001|COMPLETED|Overall Study||5
8594068|NCT00313586|9628904|FG002|COMPLETED|Overall Study||0
8594069|NCT00313586|9628905|FG003|COMPLETED|Overall Study||0
8594070|NCT00313586|9628902|FG000|NOT COMPLETED|Overall Study||70
8594071|NCT00313586|9628903|FG001|NOT COMPLETED|Overall Study||70
8594072|NCT00313586|9628904|FG002|NOT COMPLETED|Overall Study||24
8594073|NCT00313586|9628905|FG003|NOT COMPLETED|Overall Study||23
8594074|NCT00313612|9628915|FG000|STARTED|Overall Study||19
8594075|NCT00313612|9628916|FG001|STARTED|Overall Study||20
8594076|NCT00313612|9628915|FG000|COMPLETED|Overall Study||19
8594077|NCT00313612|9628916|FG001|COMPLETED|Overall Study||19
8594078|NCT00313612|9628915|FG000|NOT COMPLETED|Overall Study||0
8594079|NCT00313612|9628916|FG001|NOT COMPLETED|Overall Study||1
8594080|NCT00313703|9628926|FG000|STARTED|Overall Study||186
8594081|NCT00313703|9628927|FG001|STARTED|Overall Study||34
8594082|NCT00313703|9628928|FG002|STARTED|Overall Study||77
8594083|NCT00313703|9628929|FG003|STARTED|Overall Study||12
8594084|NCT00313703|9628926|FG000|COMPLETED|Overall Study|Some subjects lost to follow-up|175
8594085|NCT00313703|9628927|FG001|COMPLETED|Overall Study|Some subjects lost-to follow-up|32
8594086|NCT00313703|9628928|FG002|COMPLETED|Overall Study|Some subjects lost-to-follow-up|72
8594087|NCT00313703|9628929|FG003|COMPLETED|Overall Study|Outcomes not reported due to heterogeneity of this group|0
8594088|NCT00313703|9628926|FG000|NOT COMPLETED|Overall Study||11
8594089|NCT00313703|9628927|FG001|NOT COMPLETED|Overall Study||2
8594090|NCT00313703|9628928|FG002|NOT COMPLETED|Overall Study||5
8594091|NCT00313703|9628929|FG003|NOT COMPLETED|Overall Study||12
8712929|NCT00972244|9759668|FG004|COMPLETED|Overall Study||45
8712930|NCT00972244|9759664|FG000|NOT COMPLETED|Overall Study||5
8712931|NCT00972244|9759665|FG001|NOT COMPLETED|Overall Study||5
8712932|NCT00972244|9759666|FG002|NOT COMPLETED|Overall Study||2
8712933|NCT00972244|9759667|FG003|NOT COMPLETED|Overall Study||0
8712934|NCT00972244|9759668|FG004|NOT COMPLETED|Overall Study||9
8712935|NCT00972283|9759682|FG000|STARTED|Main: Week 0 to 52 (NN1250-3582)||755
8712936|NCT00972283|9759683|FG001|STARTED|Main: Week 0 to 52 (NN1250-3582)||251
8712937|NCT00972283|9759682|FG000|Full Analysis Set|Main: Week 0 to 52 (NN1250-3582)|11 subjects were excluded due to closure of a site|744
8594092|NCT00313716|9628945|FG000|STARTED|Overall Study||18
8594093|NCT00313716|9628946|FG001|STARTED|Overall Study||31
8594094|NCT00313716|9628947|FG002|STARTED|Overall Study||50
8594095|NCT00313716|9628948|FG003|STARTED|Overall Study||20
8594096|NCT00313716|9628949|FG004|STARTED|Overall Study||33
8594097|NCT00313716|9628950|FG005|STARTED|Overall Study||48
8594098|NCT00313716|9628945|FG000|COMPLETED|Overall Study||13
8594099|NCT00313716|9628946|FG001|COMPLETED|Overall Study||23
8594100|NCT00313716|9628947|FG002|COMPLETED|Overall Study||38
8594101|NCT00313716|9628948|FG003|COMPLETED|Overall Study||16
8594102|NCT00313716|9628949|FG004|COMPLETED|Overall Study||27
8712938|NCT00972283|9759683|FG001|Full Analysis Set|Main: Week 0 to 52 (NN1250-3582)|3 subjects were excluded due to closure of a site|248
8712939|NCT00972283|9759682|FG000|Exposed|Main: Week 0 to 52 (NN1250-3582)|2 subjects were withdrawn prior to exposure to trial products|753
8712940|NCT00972283|9759683|FG001|Exposed|Main: Week 0 to 52 (NN1250-3582)||251
8712941|NCT00972283|9759682|FG000|COMPLETED|Main: Week 0 to 52 (NN1250-3582)||618
8712942|NCT00972283|9759683|FG001|COMPLETED|Main: Week 0 to 52 (NN1250-3582)||211
8712943|NCT00972283|9759682|FG000|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3582)||137
8594103|NCT00313716|9628950|FG005|COMPLETED|Overall Study||35
8594104|NCT00313716|9628945|FG000|NOT COMPLETED|Overall Study||5
8594105|NCT00313716|9628946|FG001|NOT COMPLETED|Overall Study||8
8594106|NCT00313716|9628947|FG002|NOT COMPLETED|Overall Study||12
8594107|NCT00313716|9628948|FG003|NOT COMPLETED|Overall Study||4
8594108|NCT00313716|9628949|FG004|NOT COMPLETED|Overall Study||6
8594109|NCT00313716|9628950|FG005|NOT COMPLETED|Overall Study||13
8594110|NCT00313729|9628968|FG000|STARTED|Overall Study||120
8594111|NCT00313729|9628968|FG000|COMPLETED|Overall Study||120
8594112|NCT00313729|9628968|FG000|NOT COMPLETED|Overall Study||0
8594113|NCT00313781|9628974|FG000|STARTED|Before Crossover||102
8594114|NCT00313781|9628975|FG001|STARTED|Before Crossover||102
8594115|NCT00313781|9628976|FG002|STARTED|Before Crossover||0
8594116|NCT00313781|9628974|FG000|Treated|Before Crossover||97
8594117|NCT00313781|9628975|FG001|Treated|Before Crossover||102
8594118|NCT00313781|9628976|FG002|Treated|Before Crossover||0
8594119|NCT00313781|9628974|FG000|COMPLETED|Before Crossover||27
8594120|NCT00313781|9628975|FG001|COMPLETED|Before Crossover||23
8594121|NCT00313781|9628976|FG002|COMPLETED|Before Crossover||0
8594122|NCT00313781|9628974|FG000|NOT COMPLETED|Before Crossover||75
8594123|NCT00313781|9628975|FG001|NOT COMPLETED|Before Crossover||79
8594124|NCT00313781|9628976|FG002|NOT COMPLETED|Before Crossover||0
8594125|NCT00313781|9628974|FG000|STARTED|After Crossover||0
8594126|NCT00313781|9628975|FG001|STARTED|After Crossover||0
8594127|NCT00313781|9628976|FG002|STARTED|After Crossover||37
8594128|NCT00313781|9628974|FG000|COMPLETED|After Crossover||0
8594129|NCT00313781|9628975|FG001|COMPLETED|After Crossover||0
8594130|NCT00313781|9628976|FG002|COMPLETED|After Crossover||10
8594131|NCT00313781|9628974|FG000|NOT COMPLETED|After Crossover||0
8594132|NCT00313781|9628975|FG001|NOT COMPLETED|After Crossover||0
8594133|NCT00313781|9628976|FG002|NOT COMPLETED|After Crossover||27
8594134|NCT00313820|9628987|FG000|STARTED|Assigned to Treatment||111
8594135|NCT00313820|9628988|FG001|STARTED|Assigned to Treatment||109
8594136|NCT00313820|9628987|FG000|COMPLETED|Assigned to Treatment||110
8594137|NCT00313820|9628988|FG001|COMPLETED|Assigned to Treatment||109
8594138|NCT00313820|9628987|FG000|NOT COMPLETED|Assigned to Treatment||1
8594139|NCT00313820|9628988|FG001|NOT COMPLETED|Assigned to Treatment||0
8594140|NCT00313820|9628987|FG000|STARTED|Pregabalin or Placebo Treatment Period||110
8594141|NCT00313820|9628988|FG001|STARTED|Pregabalin or Placebo Treatment Period||109
8594142|NCT00313820|9628987|FG000|COMPLETED|Pregabalin or Placebo Treatment Period||93
8594143|NCT00313820|9628988|FG001|COMPLETED|Pregabalin or Placebo Treatment Period||90
8594144|NCT00313820|9628987|FG000|NOT COMPLETED|Pregabalin or Placebo Treatment Period||17
8594145|NCT00313820|9628988|FG001|NOT COMPLETED|Pregabalin or Placebo Treatment Period||19
8594146|NCT00313846|9628996|FG000|STARTED|Overall Study||162
8594147|NCT00313846|9628997|FG001|STARTED|Overall Study|327 subjects were randomized: 1 subject was lost to follow-up (N = 326).|164
8594148|NCT00313846|9628996|FG000|COMPLETED|Overall Study||157
8594149|NCT00313846|9628997|FG001|COMPLETED|Overall Study||153
8594150|NCT00313846|9628996|FG000|NOT COMPLETED|Overall Study||5
8594151|NCT00313846|9628997|FG001|NOT COMPLETED|Overall Study||11
8594152|NCT00313911|9629006|FG000|STARTED|Overall Study|N for outcomes adjusted to include participant in Group 2 that got vaccine assigned to this group.|1422
8594153|NCT00313911|9629007|FG001|STARTED|Overall Study|A participant in this group mistakenly got Group 1 vaccine. N in outcomes adjusted accordingly.|711
8594154|NCT00313911|9629006|FG000|COMPLETED|Overall Study||1328
8594155|NCT00313911|9629007|FG001|COMPLETED|Overall Study||670
8594156|NCT00313911|9629006|FG000|NOT COMPLETED|Overall Study||94
8594157|NCT00313911|9629007|FG001|NOT COMPLETED|Overall Study||41
8594158|NCT00314106|9629015|FG000|STARTED|Overall Study||18
8594159|NCT00314106|9629016|FG001|STARTED|Overall Study||8
8594160|NCT00314106|9629015|FG000|COMPLETED|Overall Study||18
8594161|NCT00314106|9629016|FG001|COMPLETED|Overall Study||8
8594162|NCT00314106|9629015|FG000|NOT COMPLETED|Overall Study||0
8712944|NCT00972283|9759683|FG001|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3582)||40
8712945|NCT00972283|9759682|FG000|STARTED|Extension: Week 53 to 78 (NN1250-3667)|52 subjects did not continue into the extension from main trial|566
8712946|NCT00972283|9759683|FG001|STARTED|Extension: Week 53 to 78 (NN1250-3667)|20 subjects did not continue into the extension from main trial|191
8712947|NCT00972283|9759682|FG000|COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||539
8594163|NCT00314106|9629016|FG001|NOT COMPLETED|Overall Study||0
8594164|NCT00314132|9629024|FG000|STARTED|Overall Study||403
8594165|NCT00314132|9629025|FG001|STARTED|Overall Study||1601
8594166|NCT00314132|9629024|FG000|COMPLETED|Overall Study||395
8594167|NCT00314132|9629025|FG001|COMPLETED|Overall Study||1583
8594168|NCT00314132|9629024|FG000|NOT COMPLETED|Overall Study||8
8594169|NCT00314132|9629025|FG001|NOT COMPLETED|Overall Study||18
8594170|NCT00314145|9629035|FG000|STARTED|Overall Study||410
8594171|NCT00314145|9629036|FG001|STARTED|Overall Study||410
8594172|NCT00314145|9629035|FG000|COMPLETED|Overall Study||389
8594173|NCT00314145|9629036|FG001|COMPLETED|Overall Study||381
8594174|NCT00314145|9629035|FG000|NOT COMPLETED|Overall Study||21
8594175|NCT00314145|9629036|FG001|NOT COMPLETED|Overall Study||29
8594176|NCT00314236|9629045|FG000|STARTED|Overall Study||41
8594177|NCT00314236|9629046|FG001|STARTED|Overall Study||39
8594178|NCT00314236|9629045|FG000|COMPLETED|Overall Study||41
8594179|NCT00314236|9629046|FG001|COMPLETED|Overall Study||37
8594180|NCT00314236|9629045|FG000|NOT COMPLETED|Overall Study||0
8594181|NCT00314236|9629046|FG001|NOT COMPLETED|Overall Study||2
8594182|NCT00314249|9629054|FG000|STARTED|Overall Study||509
8594183|NCT00314249|9629055|FG001|STARTED|Overall Study||516
8594184|NCT00314249|9629054|FG000|COMPLETED|Overall Study||357
8594185|NCT00314249|9629055|FG001|COMPLETED|Overall Study||353
8594186|NCT00314249|9629054|FG000|NOT COMPLETED|Overall Study||152
8594187|NCT00314249|9629055|FG001|NOT COMPLETED|Overall Study||163
8594188|NCT00314262|9629061|FG000|STARTED|Overall Study||12
8594189|NCT00314262|9629061|FG000|COMPLETED|Overall Study||7
8594190|NCT00314262|9629061|FG000|NOT COMPLETED|Overall Study||5
8594191|NCT00314340|9629065|FG000|STARTED|Overall Study||12
8594192|NCT00314340|9629065|FG000|ER Morphine|Overall Study||11
8594193|NCT00314340|9629065|FG000|Hydrocodone Plus APAP|Overall Study||12
8594194|NCT00314340|9629065|FG000|Placebo|Overall Study||12
8594195|NCT00314340|9629065|FG000|COMPLETED|Overall Study||11
8594196|NCT00314340|9629065|FG000|NOT COMPLETED|Overall Study||1
8594197|NCT00314574|9629073|FG000|STARTED|Overall Study||423
8594198|NCT00314574|9629074|FG001|STARTED|Overall Study||427
8594199|NCT00314574|9629073|FG000|Received at Least One Dose of Study Drug|Overall Study||421
8594200|NCT00314574|9629074|FG001|Received at Least One Dose of Study Drug|Overall Study||427
8594201|NCT00314574|9629073|FG000|Safety Population|Overall Study|1 patient in the placebo arm received Xolair and was added to the Xolair arm for Safety analyses.|420
8594202|NCT00314574|9629074|FG001|Safety Population|Overall Study||428
8594203|NCT00314574|9629073|FG000|COMPLETED|Overall Study||329
8594204|NCT00314574|9629074|FG001|COMPLETED|Overall Study||344
8594205|NCT00314574|9629073|FG000|NOT COMPLETED|Overall Study||94
8594206|NCT00314574|9629074|FG001|NOT COMPLETED|Overall Study||83
8594207|NCT00314795|9629080|FG000|STARTED|Overall Study||22
8594208|NCT00314795|9629080|FG000|COMPLETED|Overall Study||2
8594209|NCT00314795|9629080|FG000|NOT COMPLETED|Overall Study||20
8594210|NCT00314808|9629084|FG000|STARTED|Overall Study||33
8594211|NCT00314808|9629084|FG000|COMPLETED|Overall Study|Completed 2 cycles of Dronabinol or terminated early due to treatment-related adverse events (AE)|25
8594212|NCT00314808|9629084|FG000|NOT COMPLETED|Overall Study||8
8594213|NCT00314951|9629090|FG000|STARTED|Enrollment||323
8594214|NCT00314951|9629091|FG001|STARTED|Enrollment||306
8594215|NCT00314951|9629090|FG000|COMPLETED|Enrollment|6 subjects took incorrect treatment assignment, 6 subjects didn't take drug|323
8594216|NCT00314951|9629091|FG001|COMPLETED|Enrollment|6 subjects took incorrect treatment assignment, 6 subjects didn't take drug|300
8594217|NCT00314951|9629090|FG000|NOT COMPLETED|Enrollment||0
8594218|NCT00314951|9629091|FG001|NOT COMPLETED|Enrollment||6
8594219|NCT00314951|9629090|FG000|STARTED|Treatment||323
8594220|NCT00314951|9629091|FG001|STARTED|Treatment||300
8594221|NCT00314951|9629090|FG000|COMPLETED|Treatment||307
8594222|NCT00314951|9629091|FG001|COMPLETED|Treatment||289
8594223|NCT00314951|9629090|FG000|NOT COMPLETED|Treatment||16
8594224|NCT00314951|9629091|FG001|NOT COMPLETED|Treatment||11
8594225|NCT00314951|9629090|FG000|STARTED|Follow-up||307
8712948|NCT00972283|9759683|FG001|COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||183
8712949|NCT00972283|9759682|FG000|NOT COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||27
8712950|NCT00972283|9759683|FG001|NOT COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||8
8712951|NCT00972322|9759691|FG000|STARTED|Overall Study||28
8712952|NCT00972322|9759692|FG001|STARTED|Overall Study||28
8712953|NCT00972322|9759691|FG000|COMPLETED|Overall Study||25
8594226|NCT00314951|9629091|FG001|STARTED|Follow-up||289
8594227|NCT00314951|9629090|FG000|COMPLETED|Follow-up||263
8594228|NCT00314951|9629091|FG001|COMPLETED|Follow-up||255
8594229|NCT00314951|9629090|FG000|NOT COMPLETED|Follow-up||44
8594230|NCT00314951|9629091|FG001|NOT COMPLETED|Follow-up||34
8594231|NCT00315055|9629099|FG000|STARTED|Overall Study||155
8594232|NCT00315055|9629100|FG001|STARTED|Overall Study||155
8594233|NCT00315055|9629099|FG000|COMPLETED|Overall Study||152
8594234|NCT00315055|9629100|FG001|COMPLETED|Overall Study||150
8594235|NCT00315055|9629099|FG000|NOT COMPLETED|Overall Study||3
8594236|NCT00315055|9629100|FG001|NOT COMPLETED|Overall Study||5
8594237|NCT00315120|9629113|FG000|STARTED|Overall Study||115
8712954|NCT00972322|9759692|FG001|COMPLETED|Overall Study||25
8712955|NCT00972322|9759691|FG000|NOT COMPLETED|Overall Study||3
8712956|NCT00972322|9759692|FG001|NOT COMPLETED|Overall Study||3
8712957|NCT00972335|9759698|FG000|STARTED|Overall Study|One patient was enrolled but showed no evidence of disease at study entry and was not treated|17
8724868|NCT01028352|9772161|FG000|NOT COMPLETED|Overall Study||6
8594238|NCT00315120|9629114|FG001|STARTED|Overall Study||118
8594239|NCT00315120|9629115|FG002|STARTED|Overall Study||115
8594240|NCT00315120|9629116|FG003|STARTED|Overall Study||107
8594241|NCT00315120|9629113|FG000|COMPLETED|Overall Study||115
8594242|NCT00315120|9629114|FG001|COMPLETED|Overall Study||118
8594243|NCT00315120|9629115|FG002|COMPLETED|Overall Study||115
8594244|NCT00315120|9629116|FG003|COMPLETED|Overall Study||107
8594245|NCT00315120|9629113|FG000|NOT COMPLETED|Overall Study||0
8594246|NCT00315120|9629114|FG001|NOT COMPLETED|Overall Study||0
8594247|NCT00315120|9629115|FG002|NOT COMPLETED|Overall Study||0
8594248|NCT00315120|9629116|FG003|NOT COMPLETED|Overall Study||0
8594249|NCT00315146|9629132|FG000|STARTED|Overall Study||22
8594250|NCT00315146|9629133|FG001|STARTED|Overall Study||22
8594251|NCT00315146|9629134|FG002|STARTED|Overall Study||22
8594252|NCT00315146|9629135|FG003|STARTED|Overall Study||22
8594253|NCT00315146|9629132|FG000|COMPLETED|Overall Study||20
8594254|NCT00315146|9629133|FG001|COMPLETED|Overall Study||19
8594255|NCT00315146|9629134|FG002|COMPLETED|Overall Study||20
8594256|NCT00315146|9629135|FG003|COMPLETED|Overall Study||22
8594257|NCT00315146|9629132|FG000|NOT COMPLETED|Overall Study||2
8594258|NCT00315146|9629133|FG001|NOT COMPLETED|Overall Study||3
8594259|NCT00315146|9629134|FG002|NOT COMPLETED|Overall Study||2
8594260|NCT00315146|9629135|FG003|NOT COMPLETED|Overall Study||0
8594261|NCT00315302|9629153|FG000|STARTED|Overall Study||90
8594262|NCT00315302|9629154|FG001|STARTED|Overall Study||90
8594263|NCT00315302|9629155|FG002|STARTED|Overall Study||26
8594264|NCT00315302|9629156|FG003|STARTED|Overall Study||34
8594265|NCT00315302|9629153|FG000|5 Week Visit|Overall Study||85
8594266|NCT00315302|9629154|FG001|5 Week Visit|Overall Study||86
8594267|NCT00315302|9629155|FG002|5 Week Visit|Overall Study||26
8594268|NCT00315302|9629156|FG003|5 Week Visit|Overall Study||30
8594269|NCT00315302|9629153|FG000|10 Week Visit|Overall Study|Can be higher as includes subjects who may have missed the 5 week visit|86
8594270|NCT00315302|9629154|FG001|10 Week Visit|Overall Study||85
8594271|NCT00315302|9629155|FG002|10 Week Visit|Overall Study||24
8594272|NCT00315302|9629156|FG003|10 Week Visit|Overall Study||29
8594273|NCT00315302|9629153|FG000|18 Week Primary Outcome Visit|Overall Study||84
8594274|NCT00315302|9629154|FG001|18 Week Primary Outcome Visit|Overall Study|Can be higher as includes subjects who may have missed the 10 week or other visit|88
8594275|NCT00315302|9629155|FG002|18 Week Primary Outcome Visit|Overall Study||24
8594276|NCT00315302|9629156|FG003|18 Week Primary Outcome Visit|Overall Study|Can be higher as includes subjects who may have missed the 10 week or other visit|31
8594277|NCT00315302|9629153|FG000|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|16
8594278|NCT00315302|9629154|FG001|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|13
8594279|NCT00315302|9629155|FG002|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|9
8594280|NCT00315302|9629156|FG003|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|11
8594281|NCT00315302|9629153|FG000|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|84
8594282|NCT00315302|9629154|FG001|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|88
8594283|NCT00315302|9629155|FG002|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|24
8594284|NCT00315302|9629156|FG003|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|31
8594285|NCT00315302|9629153|FG000|NOT COMPLETED|Overall Study||6
8594286|NCT00315302|9629154|FG001|NOT COMPLETED|Overall Study||2
8594287|NCT00315302|9629155|FG002|NOT COMPLETED|Overall Study||2
8594288|NCT00315302|9629156|FG003|NOT COMPLETED|Overall Study||3
8594289|NCT00315328|9629170|FG000|STARTED|Overall Study|Includes subjects with moderate amblyopia only (20/40 to 20/100 at baseline)|98
8594290|NCT00315328|9629171|FG001|STARTED|Overall Study|Includes subjects with moderate amblyopia only (20/40 to 20/100 at baseline)|95
8594291|NCT00315328|9629172|FG002|STARTED|Overall Study|Includes subjects with severe amblyopia only (20/125 to 20/400 at baseline)|18
8594292|NCT00315328|9629173|FG003|STARTED|Overall Study|Includes subjects with severe amblyopia only (20/125 to 20/400 at baseline)|22
8594293|NCT00315328|9629170|FG000|5 Week Visit|Overall Study||91
8594294|NCT00315328|9629171|FG001|5 Week Visit|Overall Study||89
8594295|NCT00315328|9629172|FG002|5 Week Visit|Overall Study||17
8594296|NCT00315328|9629173|FG003|5 Week Visit|Overall Study||19
8594297|NCT00315328|9629170|FG000|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|84
8594298|NCT00315328|9629171|FG001|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|88
8594299|NCT00315328|9629172|FG002|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|13
8594300|NCT00315328|9629173|FG003|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|20
8594301|NCT00315328|9629170|FG000|NOT COMPLETED|Overall Study||14
8594302|NCT00315328|9629171|FG001|NOT COMPLETED|Overall Study||7
8594303|NCT00315328|9629172|FG002|NOT COMPLETED|Overall Study||5
8594304|NCT00315328|9629173|FG003|NOT COMPLETED|Overall Study||2
8594305|NCT00315341|9629185|FG000|STARTED|Overall Study||740
8594306|NCT00315341|9629186|FG001|STARTED|Overall Study||529
8594307|NCT00315341|9629185|FG000|COMPLETED|Overall Study||340
8594308|NCT00315341|9629186|FG001|COMPLETED|Overall Study||391
8594309|NCT00315341|9629185|FG000|NOT COMPLETED|Overall Study||400
8594310|NCT00315341|9629186|FG001|NOT COMPLETED|Overall Study||138
8594311|NCT00315445|9629195|FG000|STARTED|Overall Study||45
8594312|NCT00315445|9629196|FG001|STARTED|Overall Study||43
8594313|NCT00315445|9629197|FG002|STARTED|Overall Study||46
8594314|NCT00315445|9629195|FG000|COMPLETED|Overall Study||18
8594315|NCT00315445|9629196|FG001|COMPLETED|Overall Study||27
8594316|NCT00315445|9629197|FG002|COMPLETED|Overall Study||22
8594317|NCT00315445|9629195|FG000|NOT COMPLETED|Overall Study||27
8594318|NCT00315445|9629196|FG001|NOT COMPLETED|Overall Study||16
8594319|NCT00315445|9629197|FG002|NOT COMPLETED|Overall Study||24
8594320|NCT00315458|9629207|FG000|STARTED|Overall Study||51
8594321|NCT00315458|9629208|FG001|STARTED|Overall Study||56
8594322|NCT00315458|9629209|FG002|STARTED|Overall Study||159
8594323|NCT00315458|9629210|FG003|STARTED|Overall Study||39
8594324|NCT00315458|9629207|FG000|COMPLETED|Overall Study||48
8594325|NCT00315458|9629208|FG001|COMPLETED|Overall Study||44
8594326|NCT00315458|9629209|FG002|COMPLETED|Overall Study||107
8594327|NCT00315458|9629210|FG003|COMPLETED|Overall Study||10
8594328|NCT00315458|9629207|FG000|NOT COMPLETED|Overall Study||3
8594329|NCT00315458|9629208|FG001|NOT COMPLETED|Overall Study||12
8594330|NCT00315458|9629209|FG002|NOT COMPLETED|Overall Study||52
8594331|NCT00315458|9629210|FG003|NOT COMPLETED|Overall Study||29
8594332|NCT00315588|9629220|FG000|STARTED|Overall Study||7
8594333|NCT00315588|9629220|FG000|COMPLETED|Overall Study||7
8594334|NCT00315588|9629220|FG000|NOT COMPLETED|Overall Study||0
8594335|NCT00315614|9629226|FG000|STARTED|Overall Study||3
8594336|NCT00315614|9629226|FG000|COMPLETED|Overall Study||3
8594337|NCT00315614|9629226|FG000|NOT COMPLETED|Overall Study||0
8594338|NCT00315627|9629231|FG000|STARTED|Overall Study||3
8594339|NCT00315627|9629231|FG000|COMPLETED|Overall Study||3
8594340|NCT00315627|9629231|FG000|NOT COMPLETED|Overall Study||0
8594341|NCT00315705|9629239|FG000|STARTED|Phase 1||25
8594342|NCT00315705|9629239|FG000|COMPLETED|Phase 1|No Phase 1 participants completed the treatment period (i.e. all 8 cycles and follow-up)|0
8594343|NCT00315705|9629239|FG000|NOT COMPLETED|Phase 1||25
8594344|NCT00315705|9629239|FG000|STARTED|Phase 2|Phase 1 and phase 2 are separate populations|25
8594345|NCT00315705|9629239|FG000|COMPLETED|Phase 2|No Phase 2 participants completed the treatment period (i.e. all 8 cycles and follow-up)|0
8594346|NCT00315705|9629239|FG000|NOT COMPLETED|Phase 2||25
8594347|NCT00315731|9629256|FG000|STARTED|Overall Study||15
8594348|NCT00315731|9629256|FG000|COMPLETED|Overall Study||9
8594349|NCT00315731|9629256|FG000|NOT COMPLETED|Overall Study||6
8712958|NCT00972335|9759698|FG000|COMPLETED|Overall Study|Patients were on study until an event or condition occured which required them to come off study|0
8712959|NCT00972335|9759698|FG000|NOT COMPLETED|Overall Study||17
8712960|NCT00972374|9759705|FG000|STARTED|Overall Study||15
8712961|NCT00972374|9759706|FG001|STARTED|Overall Study||15
8712962|NCT00972374|9759707|FG002|STARTED|Overall Study||14
8712963|NCT00972374|9759705|FG000|COMPLETED|Overall Study||13
8594350|NCT00315822|9629264|FG000|STARTED|Overall Study||198
8594351|NCT00315822|9629265|FG001|STARTED|Overall Study||202
8594352|NCT00315822|9629264|FG000|COMPLETED|Overall Study||198
8594353|NCT00315822|9629265|FG001|COMPLETED|Overall Study||202
8594354|NCT00315822|9629264|FG000|NOT COMPLETED|Overall Study||0
8594355|NCT00315822|9629265|FG001|NOT COMPLETED|Overall Study||0
8594356|NCT00315939|9629273|FG000|STARTED|Admission 1 (3 Months)||59
8594357|NCT00315939|9629274|FG001|STARTED|Admission 1 (3 Months)||61
8594358|NCT00315939|9629273|FG000|COMPLETED|Admission 1 (3 Months)||56
8594359|NCT00315939|9629274|FG001|COMPLETED|Admission 1 (3 Months)||55
8594360|NCT00315939|9629273|FG000|NOT COMPLETED|Admission 1 (3 Months)||3
8594361|NCT00315939|9629274|FG001|NOT COMPLETED|Admission 1 (3 Months)||6
8594362|NCT00315939|9629273|FG000|STARTED|Admission 2 (3 Months)||56
8594363|NCT00315939|9629274|FG001|STARTED|Admission 2 (3 Months)||55
8594364|NCT00315939|9629273|FG000|COMPLETED|Admission 2 (3 Months)||52
8594365|NCT00315939|9629274|FG001|COMPLETED|Admission 2 (3 Months)||51
8594366|NCT00315939|9629273|FG000|NOT COMPLETED|Admission 2 (3 Months)||4
8594367|NCT00315939|9629274|FG001|NOT COMPLETED|Admission 2 (3 Months)||4
8594368|NCT00315939|9629273|FG000|STARTED|Admission 3 (3 Months)||52
8594369|NCT00315939|9629274|FG001|STARTED|Admission 3 (3 Months)||51
8594370|NCT00315939|9629273|FG000|COMPLETED|Admission 3 (3 Months)||48
8594371|NCT00315939|9629274|FG001|COMPLETED|Admission 3 (3 Months)||49
8594372|NCT00315939|9629273|FG000|NOT COMPLETED|Admission 3 (3 Months)||4
8594373|NCT00315939|9629274|FG001|NOT COMPLETED|Admission 3 (3 Months)||2
8594374|NCT00316004|9629282|FG000|STARTED|Overall Study||373
8594375|NCT00316004|9629283|FG001|STARTED|Overall Study||355
8594376|NCT00316004|9629284|FG002|STARTED|Overall Study||603
8594377|NCT00316004|9629282|FG000|COMPLETED|Overall Study||359
8594378|NCT00316004|9629283|FG001|COMPLETED|Overall Study||341
8594379|NCT00316004|9629284|FG002|COMPLETED|Overall Study||582
8594380|NCT00316004|9629282|FG000|NOT COMPLETED|Overall Study||14
8594381|NCT00316004|9629283|FG001|NOT COMPLETED|Overall Study||14
8594382|NCT00316004|9629284|FG002|NOT COMPLETED|Overall Study||21
8594383|NCT00316017|9629295|FG000|STARTED|Overall Study|"11 of 11 not completed due to Bag Opened Not Given (BONG)"|231
8594384|NCT00316017|9629296|FG001|STARTED|Overall Study|12 of 13 not completed due to BONG; 1 not completed was a prisoner who was excluded|269
8594385|NCT00316017|9629297|FG002|STARTED|Overall Study|19 of 19 not complete due to BONG|395
8594386|NCT00316017|9629295|FG000|COMPLETED|Overall Study||220
8594387|NCT00316017|9629296|FG001|COMPLETED|Overall Study||256
8594388|NCT00316017|9629297|FG002|COMPLETED|Overall Study||376
8594389|NCT00316017|9629295|FG000|NOT COMPLETED|Overall Study||11
8594390|NCT00316017|9629296|FG001|NOT COMPLETED|Overall Study||13
8594391|NCT00316017|9629297|FG002|NOT COMPLETED|Overall Study||19
8628244|NCT00522275|9667657|FG000|STARTED|Overall Study||308
8628245|NCT00522275|9667657|FG000|COMPLETED|Overall Study||138
8628246|NCT00522275|9667657|FG000|NOT COMPLETED|Overall Study||170
8628247|NCT00522379|9667666|FG000|STARTED|Overall Study||101
8628248|NCT00522379|9667667|FG001|STARTED|Overall Study||107
8628249|NCT00522379|9667668|FG002|STARTED|Overall Study||104
8628250|NCT00522379|9667669|FG003|STARTED|Overall Study||94
8628251|NCT00522379|9667670|FG004|STARTED|Overall Study||108
8628252|NCT00522379|9667666|FG000|COMPLETED|Overall Study||79
8628253|NCT00522379|9667667|FG001|COMPLETED|Overall Study||84
8628254|NCT00522379|9667668|FG002|COMPLETED|Overall Study||82
8628255|NCT00522379|9667669|FG003|COMPLETED|Overall Study||80
8628256|NCT00522379|9667670|FG004|COMPLETED|Overall Study||81
8594392|NCT00316082|9629310|FG000|STARTED|Overall Study||74
8594393|NCT00316082|9629311|FG001|STARTED|Overall Study||74
8594394|NCT00316082|9629312|FG002|STARTED|Overall Study||71
8594395|NCT00316082|9629313|FG003|STARTED|Overall Study||72
8594396|NCT00316082|9629314|FG004|STARTED|Overall Study||74
8594397|NCT00316082|9629310|FG000|Completed Study Without Being Rescued|Overall Study||25
8594398|NCT00316082|9629311|FG001|Completed Study Without Being Rescued|Overall Study||35
8594399|NCT00316082|9629312|FG002|Completed Study Without Being Rescued|Overall Study||29
8594400|NCT00316082|9629313|FG003|Completed Study Without Being Rescued|Overall Study||27
8594401|NCT00316082|9629314|FG004|Completed Study Without Being Rescued|Overall Study||31
8594402|NCT00316082|9629310|FG000|COMPLETED|Overall Study||41
8594403|NCT00316082|9629311|FG001|COMPLETED|Overall Study||52
8594404|NCT00316082|9629312|FG002|COMPLETED|Overall Study||44
8594405|NCT00316082|9629313|FG003|COMPLETED|Overall Study||46
8594406|NCT00316082|9629314|FG004|COMPLETED|Overall Study||48
8594407|NCT00316082|9629310|FG000|NOT COMPLETED|Overall Study||33
8594408|NCT00316082|9629311|FG001|NOT COMPLETED|Overall Study||22
8594409|NCT00316082|9629312|FG002|NOT COMPLETED|Overall Study||27
8594410|NCT00316082|9629313|FG003|NOT COMPLETED|Overall Study||26
8594411|NCT00316082|9629314|FG004|NOT COMPLETED|Overall Study||26
8594412|NCT00316121|9629332|FG000|STARTED|Overall Study||92
8594413|NCT00316121|9629333|FG001|STARTED|Overall Study||46
8594414|NCT00316121|9629332|FG000|COMPLETED|Overall Study||70
8594415|NCT00316121|9629333|FG001|COMPLETED|Overall Study||37
8594416|NCT00316121|9629332|FG000|NOT COMPLETED|Overall Study||22
8594417|NCT00316121|9629333|FG001|NOT COMPLETED|Overall Study||9
8594418|NCT00316173|9629341|FG000|STARTED|Run-in Phase||22
8594419|NCT00316173|9629342|FG001|STARTED|Run-in Phase||0
8594420|NCT00316173|9629341|FG000|COMPLETED|Run-in Phase||15
8594421|NCT00316173|9629342|FG001|COMPLETED|Run-in Phase||0
8594422|NCT00316173|9629341|FG000|NOT COMPLETED|Run-in Phase||7
8594423|NCT00316173|9629342|FG001|NOT COMPLETED|Run-in Phase||0
8594424|NCT00316173|9629341|FG000|STARTED|Treatment Phase||0
8594425|NCT00316173|9629342|FG001|STARTED|Treatment Phase||55
8594426|NCT00316173|9629341|FG000|COMPLETED|Treatment Phase||0
8594427|NCT00316173|9629342|FG001|COMPLETED|Treatment Phase||13
8594428|NCT00316173|9629341|FG000|NOT COMPLETED|Treatment Phase||0
8594429|NCT00316173|9629342|FG001|NOT COMPLETED|Treatment Phase||42
8594430|NCT00316186|9629347|FG000|STARTED|Overall Study||33
8594431|NCT00316186|9629347|FG000|COMPLETED|Overall Study||21
8594432|NCT00316186|9629347|FG000|NOT COMPLETED|Overall Study||12
8594433|NCT00316199|9629351|FG000|STARTED|Overall Study||60
8594434|NCT00316199|9629351|FG000|COMPLETED|Overall Study||48
8594435|NCT00316199|9629351|FG000|NOT COMPLETED|Overall Study||12
8594436|NCT00316225|9629355|FG000|STARTED|Overall Study||31
8594437|NCT00316225|9629355|FG000|COMPLETED|Overall Study||6
8594438|NCT00316225|9629355|FG000|NOT COMPLETED|Overall Study||25
8594439|NCT00316264|9629362|FG000|STARTED|Overall Study||83
8594440|NCT00316264|9629363|FG001|STARTED|Overall Study||84
8594441|NCT00316264|9629364|FG002|STARTED|Overall Study||93
8594442|NCT00316264|9629362|FG000|COMPLETED|Overall Study||77
8594443|NCT00316264|9629363|FG001|COMPLETED|Overall Study||77
8594444|NCT00316264|9629364|FG002|COMPLETED|Overall Study||87
8594445|NCT00316264|9629362|FG000|NOT COMPLETED|Overall Study||6
8594446|NCT00316264|9629363|FG001|NOT COMPLETED|Overall Study||7
8594447|NCT00316264|9629364|FG002|NOT COMPLETED|Overall Study||6
8594448|NCT00316277|9629374|FG000|STARTED|Phase 1 (12 Weeks)||329
8594449|NCT00316277|9629375|FG001|STARTED|Phase 1 (12 Weeks)||324
8594450|NCT00316277|9629374|FG000|COMPLETED|Phase 1 (12 Weeks)||19
8594451|NCT00316277|9629375|FG001|COMPLETED|Phase 1 (12 Weeks)||24
8594452|NCT00316277|9629374|FG000|NOT COMPLETED|Phase 1 (12 Weeks)||310
8594453|NCT00316277|9629375|FG001|NOT COMPLETED|Phase 1 (12 Weeks)||300
8594454|NCT00316277|9629374|FG000|STARTED|Phase 2 (24 Weeks)||180
8594455|NCT00316277|9629375|FG001|STARTED|Phase 2 (24 Weeks)||180
8594456|NCT00316277|9629374|FG000|COMPLETED|Phase 2 (24 Weeks)||161
8594457|NCT00316277|9629375|FG001|COMPLETED|Phase 2 (24 Weeks)||161
8594458|NCT00316277|9629374|FG000|NOT COMPLETED|Phase 2 (24 Weeks)||19
8594459|NCT00316277|9629375|FG001|NOT COMPLETED|Phase 2 (24 Weeks)||19
8594460|NCT00316303|9629391|FG000|STARTED|Overall Study||118
8594461|NCT00316303|9629392|FG001|STARTED|Overall Study||118
8594462|NCT00316303|9629391|FG000|COMPLETED|Overall Study||107
8594463|NCT00316303|9629392|FG001|COMPLETED|Overall Study||102
8594464|NCT00316303|9629391|FG000|NOT COMPLETED|Overall Study||11
8594465|NCT00316303|9629392|FG001|NOT COMPLETED|Overall Study||16
8594466|NCT00316355|9629403|FG000|STARTED|Overall Study||15
8594467|NCT00316355|9629404|FG001|STARTED|Overall Study||19
8594468|NCT00316355|9629403|FG000|Started Treatment|Overall Study||12
8594469|NCT00316355|9629404|FG001|Started Treatment|Overall Study||18
8594470|NCT00316355|9629403|FG000|COMPLETED|Overall Study||10
8594471|NCT00316355|9629404|FG001|COMPLETED|Overall Study||12
8594472|NCT00316355|9629403|FG000|NOT COMPLETED|Overall Study||5
8594473|NCT00316355|9629404|FG001|NOT COMPLETED|Overall Study||7
8594474|NCT00316524|9629414|FG000|STARTED|Overall Study||183
8594475|NCT00316524|9629415|FG001|STARTED|Overall Study||181
8594476|NCT00316524|9629416|FG002|STARTED|Overall Study||181
8594477|NCT00316524|9629417|FG003|STARTED|Overall Study||200
8594478|NCT00316524|9629414|FG000|COMPLETED|Overall Study||175
8594479|NCT00316524|9629415|FG001|COMPLETED|Overall Study||173
8594480|NCT00316524|9629416|FG002|COMPLETED|Overall Study||175
8594481|NCT00316524|9629417|FG003|COMPLETED|Overall Study||200
8594482|NCT00316524|9629414|FG000|NOT COMPLETED|Overall Study||8
8594483|NCT00316524|9629415|FG001|NOT COMPLETED|Overall Study||8
8594484|NCT00316524|9629416|FG002|NOT COMPLETED|Overall Study||6
8594485|NCT00316524|9629417|FG003|NOT COMPLETED|Overall Study||0
8594486|NCT00316589|9629435|FG000|STARTED|Overall Study||88
8594487|NCT00316589|9629436|FG001|STARTED|Overall Study||352
8594488|NCT00316589|9629437|FG002|STARTED|Overall Study||9
8594489|NCT00316589|9629438|FG003|STARTED|Overall Study||132
8594490|NCT00316589|9629435|FG000|COMPLETED|Overall Study||87
8594491|NCT00316589|9629436|FG001|COMPLETED|Overall Study||328
8594492|NCT00316589|9629437|FG002|COMPLETED|Overall Study||8
8594493|NCT00316589|9629438|FG003|COMPLETED|Overall Study||127
8594494|NCT00316589|9629435|FG000|NOT COMPLETED|Overall Study||1
8594495|NCT00316589|9629436|FG001|NOT COMPLETED|Overall Study||24
8594496|NCT00316589|9629437|FG002|NOT COMPLETED|Overall Study||1
8594497|NCT00316589|9629438|FG003|NOT COMPLETED|Overall Study||5
8594498|NCT00316602|9629452|FG000|STARTED|Overall Study||282
8594499|NCT00316602|9629453|FG001|STARTED|Overall Study||350
8594500|NCT00316602|9629452|FG000|COMPLETED|Overall Study||272
8594501|NCT00316602|9629453|FG001|COMPLETED|Overall Study||325
8594502|NCT00316602|9629452|FG000|NOT COMPLETED|Overall Study||10
8594503|NCT00316602|9629453|FG001|NOT COMPLETED|Overall Study||25
8594504|NCT00316693|9629461|FG000|STARTED|Overall Study||519
8594505|NCT00316693|9629462|FG001|STARTED|Overall Study||521
8594506|NCT00316693|9629461|FG000|COMPLETED|Overall Study||442
8594507|NCT00316693|9629462|FG001|COMPLETED|Overall Study||436
8594508|NCT00316693|9629461|FG000|NOT COMPLETED|Overall Study||77
8594509|NCT00316693|9629462|FG001|NOT COMPLETED|Overall Study||85
8594510|NCT00316706|9629470|FG000|STARTED|Overall Study||626
8594511|NCT00316706|9629471|FG001|STARTED|Overall Study||619
8594512|NCT00316706|9629470|FG000|COMPLETED|Overall Study|Subjects in Cervarix group that completed the study at Month 48|588
8594513|NCT00316706|9629471|FG001|COMPLETED|Overall Study|Subjects in Havrix group that completed the study at Month 24|571
8594514|NCT00316706|9629470|FG000|NOT COMPLETED|Overall Study||38
8594515|NCT00316706|9629471|FG001|NOT COMPLETED|Overall Study||48
8594516|NCT00316719|9629479|FG000|STARTED|Overall Study||52
8594517|NCT00316719|9629480|FG001|STARTED|Overall Study||53
8594518|NCT00316719|9629479|FG000|COMPLETED|Overall Study||50
8594519|NCT00316719|9629480|FG001|COMPLETED|Overall Study||47
8594520|NCT00316719|9629479|FG000|NOT COMPLETED|Overall Study||2
8594521|NCT00316719|9629480|FG001|NOT COMPLETED|Overall Study||6
8594522|NCT00316862|9629486|FG000|STARTED|Overall Study||82
8594523|NCT00316862|9629486|FG000|COMPLETED|Overall Study||82
8594524|NCT00316862|9629486|FG000|NOT COMPLETED|Overall Study||0
8594525|NCT00316888|9629492|FG000|STARTED|Overall Study||28
8594526|NCT00316888|9629493|FG001|STARTED|Overall Study||35
8594527|NCT00316888|9629492|FG000|Eligible|Overall Study||28
8594528|NCT00316888|9629493|FG001|Eligible|Overall Study||35
8594529|NCT00316888|9629492|FG000|Treated|Overall Study|Received induction and/or chemo+radiation therapy|28
8594530|NCT00316888|9629493|FG001|Treated|Overall Study||34
8594531|NCT00316888|9629492|FG000|Started Induction Chemotherapy|Overall Study||28
8594532|NCT00316888|9629493|FG001|Started Induction Chemotherapy|Overall Study|Induction chemotherapy was removed for patients on this arm|0
8594533|NCT00316888|9629492|FG000|Started Chemo+Radiation+Cetuximab|Overall Study|One patient did not start chemo+radiation therapy after completing induction therapy|27
8594534|NCT00316888|9629493|FG001|Started Chemo+Radiation+Cetuximab|Overall Study||34
8594535|NCT00316888|9629492|FG000|COMPLETED|Overall Study||22
8594536|NCT00316888|9629493|FG001|COMPLETED|Overall Study||27
8594537|NCT00316888|9629492|FG000|NOT COMPLETED|Overall Study||6
8594538|NCT00316888|9629493|FG001|NOT COMPLETED|Overall Study||8
8594539|NCT00316914|9629501|FG000|STARTED|Overall Study||50
8594540|NCT00316914|9629502|FG001|STARTED|Overall Study||52
8594541|NCT00316914|9629501|FG000|COMPLETED|Overall Study||17
8594542|NCT00316914|9629502|FG001|COMPLETED|Overall Study||16
8594543|NCT00316914|9629501|FG000|NOT COMPLETED|Overall Study||33
8594544|NCT00316914|9629502|FG001|NOT COMPLETED|Overall Study||36
8594545|NCT00317044|9629511|FG000|STARTED|Overall Study||320
8594546|NCT00317044|9629512|FG001|STARTED|Overall Study||313
8594547|NCT00317044|9629513|FG002|STARTED|Overall Study||328
8594548|NCT00317044|9629511|FG000|COMPLETED|Overall Study||272
8594549|NCT00317044|9629512|FG001|COMPLETED|Overall Study||273
8594550|NCT00317044|9629513|FG002|COMPLETED|Overall Study||283
8594551|NCT00317044|9629511|FG000|NOT COMPLETED|Overall Study||48
8594552|NCT00317044|9629512|FG001|NOT COMPLETED|Overall Study||40
8594553|NCT00317044|9629513|FG002|NOT COMPLETED|Overall Study||45
8594554|NCT00317109|9629523|FG000|STARTED|Overall Study||84
8594555|NCT00317109|9629524|FG001|STARTED|Overall Study||84
8594556|NCT00317109|9629523|FG000|COMPLETED|Overall Study||81
8594557|NCT00317109|9629524|FG001|COMPLETED|Overall Study||84
8594558|NCT00317109|9629523|FG000|NOT COMPLETED|Overall Study||3
8594559|NCT00317109|9629524|FG001|NOT COMPLETED|Overall Study||0
8594560|NCT00317226|9629530|FG000|STARTED|Overall Study||127
8594561|NCT00317226|9629530|FG000|COMPLETED|Overall Study||104
8594562|NCT00317226|9629530|FG000|NOT COMPLETED|Overall Study||23
8594563|NCT00317239|9629536|FG000|STARTED|Overall Study||147
8594564|NCT00317239|9629537|FG001|STARTED|Overall Study||103
8594565|NCT00317239|9629536|FG000|COMPLETED|Overall Study||134
8594566|NCT00317239|9629537|FG001|COMPLETED|Overall Study||84
8594567|NCT00317239|9629536|FG000|NOT COMPLETED|Overall Study||13
8594568|NCT00317239|9629537|FG001|NOT COMPLETED|Overall Study||19
8594569|NCT00317356|9629547|FG000|STARTED|Overall Study||11
8594570|NCT00317356|9629548|FG001|STARTED|Overall Study||11
8594571|NCT00317356|9629549|FG002|STARTED|Overall Study||10
8594572|NCT00317356|9629550|FG003|STARTED|Overall Study||11
8594573|NCT00317356|9629547|FG000|COMPLETED|Overall Study||10
8594574|NCT00317356|9629548|FG001|COMPLETED|Overall Study||9
8594575|NCT00317356|9629549|FG002|COMPLETED|Overall Study||9
8594576|NCT00317356|9629550|FG003|COMPLETED|Overall Study||8
8594577|NCT00317356|9629547|FG000|NOT COMPLETED|Overall Study||1
8594578|NCT00317356|9629548|FG001|NOT COMPLETED|Overall Study||2
8594579|NCT00317356|9629549|FG002|NOT COMPLETED|Overall Study||1
8594580|NCT00317356|9629550|FG003|NOT COMPLETED|Overall Study||3
8594581|NCT00317369|9629563|FG000|STARTED|Overall Study||10
8594582|NCT00317369|9629564|FG001|STARTED|Overall Study||9
8594583|NCT00317369|9629565|FG002|STARTED|Overall Study||10
8594584|NCT00317369|9629563|FG000|COMPLETED|Overall Study||8
8594585|NCT00317369|9629564|FG001|COMPLETED|Overall Study||7
8594586|NCT00317369|9629565|FG002|COMPLETED|Overall Study||8
8594587|NCT00317369|9629563|FG000|NOT COMPLETED|Overall Study||2
8594588|NCT00317369|9629564|FG001|NOT COMPLETED|Overall Study||2
8594589|NCT00317369|9629565|FG002|NOT COMPLETED|Overall Study||2
8594590|NCT00317473|9629579|FG000|STARTED|Overall Study||30
8594591|NCT00317473|9629580|FG001|STARTED|Overall Study||15
8594592|NCT00317473|9629581|FG002|STARTED|Overall Study||30
8594593|NCT00317473|9629582|FG003|STARTED|Overall Study||15
8594594|NCT00317473|9629583|FG004|STARTED|Overall Study||30
8594595|NCT00317473|9629584|FG005|STARTED|Overall Study||15
8594596|NCT00317473|9629579|FG000|COMPLETED|Overall Study||26
8594597|NCT00317473|9629580|FG001|COMPLETED|Overall Study||12
8594598|NCT00317473|9629581|FG002|COMPLETED|Overall Study||27
8594599|NCT00317473|9629582|FG003|COMPLETED|Overall Study||13
8594600|NCT00317473|9629583|FG004|COMPLETED|Overall Study||22
8594601|NCT00317473|9629584|FG005|COMPLETED|Overall Study||12
8594602|NCT00317473|9629579|FG000|NOT COMPLETED|Overall Study||4
8594603|NCT00317473|9629580|FG001|NOT COMPLETED|Overall Study||3
8594604|NCT00317473|9629581|FG002|NOT COMPLETED|Overall Study||3
8594605|NCT00317473|9629582|FG003|NOT COMPLETED|Overall Study||2
8594606|NCT00317473|9629583|FG004|NOT COMPLETED|Overall Study||8
8594607|NCT00317473|9629584|FG005|NOT COMPLETED|Overall Study||3
8594608|NCT00317603|9629608|FG000|STARTED|Overall Study||15
8594609|NCT00317603|9629608|FG000|Treated|Overall Study||12
8594610|NCT00317603|9629608|FG000|COMPLETED|Overall Study||12
8594611|NCT00317603|9629608|FG000|NOT COMPLETED|Overall Study||3
8594612|NCT00317642|9629614|FG000|STARTED|Overall Study||163
8594613|NCT00317642|9629615|FG001|STARTED|Overall Study||163
8594614|NCT00317642|9629614|FG000|Full Analysis Set|Overall Study|AML Centrally Confirmed|162
8594615|NCT00317642|9629615|FG001|Full Analysis Set|Overall Study|AML Centrally Confirmed|158
8594616|NCT00317642|9629614|FG000|Received >= 1 Study Drug (Safety Set)|Overall Study||161
8594617|NCT00317642|9629615|FG001|Received >= 1 Study Drug (Safety Set)|Overall Study||155
8594618|NCT00317642|9629614|FG000|COMPLETED|Overall Study|achieved remission and completed consolidation|41
8594619|NCT00317642|9629615|FG001|COMPLETED|Overall Study|achieved remission and completed consolidation|28
8594620|NCT00317642|9629614|FG000|NOT COMPLETED|Overall Study||122
8594621|NCT00317642|9629615|FG001|NOT COMPLETED|Overall Study||135
8594622|NCT00317720|9629628|FG000|STARTED|Overall Study||40
8594623|NCT00317720|9629629|FG001|STARTED|Overall Study||7
8594624|NCT00317720|9629628|FG000|COMPLETED|Overall Study||40
8594625|NCT00317720|9629629|FG001|COMPLETED|Overall Study||7
8594626|NCT00317720|9629628|FG000|NOT COMPLETED|Overall Study||0
8594627|NCT00317720|9629629|FG001|NOT COMPLETED|Overall Study||0
8594628|NCT00317941|9629635|FG000|STARTED|Overall Study||73
8594629|NCT00317941|9629636|FG001|STARTED|Overall Study||79
8594630|NCT00317941|9629637|FG002|STARTED|Overall Study||68
8594631|NCT00317941|9629635|FG000|Participants Received Treatment|Overall Study||73
8594632|NCT00317941|9629636|FG001|Participants Received Treatment|Overall Study||79
8594633|NCT00317941|9629637|FG002|Participants Received Treatment|Overall Study||68
8594634|NCT00317941|9629635|FG000|Fulfilled Requirement Safety Population|Overall Study||73
8594635|NCT00317941|9629636|FG001|Fulfilled Requirement Safety Population|Overall Study||77
8594636|NCT00317941|9629637|FG002|Fulfilled Requirement Safety Population|Overall Study||65
8594637|NCT00317941|9629635|FG000|Fulfilled Requirements PP Population|Overall Study||66
8594638|NCT00317941|9629636|FG001|Fulfilled Requirements PP Population|Overall Study||76
8594639|NCT00317941|9629637|FG002|Fulfilled Requirements PP Population|Overall Study||63
8594640|NCT00317941|9629635|FG000|COMPLETED|Overall Study||66
8594641|NCT00317941|9629636|FG001|COMPLETED|Overall Study||74
8594642|NCT00317941|9629637|FG002|COMPLETED|Overall Study||60
8594643|NCT00317941|9629635|FG000|NOT COMPLETED|Overall Study||7
8594644|NCT00317941|9629636|FG001|NOT COMPLETED|Overall Study||5
8594645|NCT00317941|9629637|FG002|NOT COMPLETED|Overall Study||8
8594646|NCT00318136|9629646|FG000|STARTED|Overall Study||47
8594647|NCT00318136|9629646|FG000|COMPLETED|Overall Study||2
8594648|NCT00318136|9629646|FG000|NOT COMPLETED|Overall Study||45
8594649|NCT00318149|9629656|FG000|STARTED|Overall Study||75
8594650|NCT00318149|9629657|FG001|STARTED|Overall Study||50
8594651|NCT00318149|9629658|FG002|STARTED|Overall Study||75
8594652|NCT00318149|9629659|FG003|STARTED|Overall Study||75
8594653|NCT00318149|9629660|FG004|STARTED|Overall Study||75
8594654|NCT00318149|9629661|FG005|STARTED|Overall Study||75
8594655|NCT00318149|9629656|FG000|COMPLETED|Overall Study||75
8594656|NCT00318149|9629657|FG001|COMPLETED|Overall Study||50
8594657|NCT00318149|9629658|FG002|COMPLETED|Overall Study||75
8594658|NCT00318149|9629659|FG003|COMPLETED|Overall Study||75
8594659|NCT00318149|9629660|FG004|COMPLETED|Overall Study||75
8594660|NCT00318149|9629661|FG005|COMPLETED|Overall Study||73
8594661|NCT00318149|9629656|FG000|NOT COMPLETED|Overall Study||0
8594662|NCT00318149|9629657|FG001|NOT COMPLETED|Overall Study||0
8594663|NCT00318149|9629658|FG002|NOT COMPLETED|Overall Study||0
8594664|NCT00318149|9629659|FG003|NOT COMPLETED|Overall Study||0
8594665|NCT00318149|9629660|FG004|NOT COMPLETED|Overall Study||0
8594666|NCT00318149|9629661|FG005|NOT COMPLETED|Overall Study||2
8594667|NCT00318292|9629679|FG000|STARTED|Overall Study||45
8594668|NCT00318292|9629680|FG001|STARTED|Overall Study||45
8594669|NCT00318292|9629679|FG000|COMPLETED|Overall Study||45
8594670|NCT00318292|9629680|FG001|COMPLETED|Overall Study||45
8594671|NCT00318292|9629679|FG000|NOT COMPLETED|Overall Study||0
8594672|NCT00318292|9629680|FG001|NOT COMPLETED|Overall Study||0
8594673|NCT00318357|9629688|FG000|STARTED|Overall Study||173
8594674|NCT00318357|9629689|FG001|STARTED|Overall Study||136
8712964|NCT00972374|9759706|FG001|COMPLETED|Overall Study||15
8712965|NCT00972374|9759707|FG002|COMPLETED|Overall Study||13
8712966|NCT00972374|9759705|FG000|NOT COMPLETED|Overall Study||2
8712967|NCT00972374|9759706|FG001|NOT COMPLETED|Overall Study||0
8594675|NCT00318357|9629688|FG000|COMPLETED|Overall Study||134
8594676|NCT00318357|9629689|FG001|COMPLETED|Overall Study||104
8594677|NCT00318357|9629688|FG000|NOT COMPLETED|Overall Study||39
8594678|NCT00318357|9629689|FG001|NOT COMPLETED|Overall Study||32
8594679|NCT00318370|9629695|FG000|STARTED|Period 1||28
8594680|NCT00318370|9629696|FG001|STARTED|Period 1||0
8594681|NCT00318370|9629697|FG002|STARTED|Period 1||0
8594682|NCT00318370|9629695|FG000|COMPLETED|Period 1|21 participants proceeded from Far Only to Chemo Plus Far.|21
8594683|NCT00318370|9629696|FG001|COMPLETED|Period 1||0
8594684|NCT00318370|9629697|FG002|COMPLETED|Period 1||0
8594685|NCT00318370|9629695|FG000|NOT COMPLETED|Period 1||7
8594686|NCT00318370|9629696|FG001|NOT COMPLETED|Period 1||0
8594687|NCT00318370|9629697|FG002|NOT COMPLETED|Period 1||0
8594688|NCT00318370|9629695|FG000|STARTED|Period 2||0
8594689|NCT00318370|9629696|FG001|STARTED|Period 2|26 participants enrolled directly into Chemo Plus Far plus 21 participants from Far Only.|47
8594690|NCT00318370|9629697|FG002|STARTED|Period 2||0
8594691|NCT00318370|9629695|FG000|COMPLETED|Period 2||0
8594692|NCT00318370|9629696|FG001|COMPLETED|Period 2||36
8594693|NCT00318370|9629697|FG002|COMPLETED|Period 2||0
8594694|NCT00318370|9629695|FG000|NOT COMPLETED|Period 2||0
8594695|NCT00318370|9629696|FG001|NOT COMPLETED|Period 2||11
8594696|NCT00318370|9629697|FG002|NOT COMPLETED|Period 2||0
8594697|NCT00318370|9629695|FG000|STARTED|Period 3||0
8594698|NCT00318370|9629696|FG001|STARTED|Period 3||0
8594699|NCT00318370|9629697|FG002|STARTED|Period 3||36
8594700|NCT00318370|9629695|FG000|COMPLETED|Period 3||0
8594701|NCT00318370|9629696|FG001|COMPLETED|Period 3||0
8594702|NCT00318370|9629697|FG002|COMPLETED|Period 3||3
8594703|NCT00318370|9629695|FG000|NOT COMPLETED|Period 3||0
8594704|NCT00318370|9629696|FG001|NOT COMPLETED|Period 3||0
8594705|NCT00318370|9629697|FG002|NOT COMPLETED|Period 3||33
9064258|NCT04320823|10124535|FG000|NOT COMPLETED|Overall Study||0
9064259|NCT04320823|10124536|FG001|NOT COMPLETED|Overall Study||0
9064260|NCT04320615|10124560|FG000|STARTED|Overall Study||144
8594706|NCT00318409|9629705|FG000|STARTED|Overall Study||20
8594707|NCT00318409|9629706|FG001|STARTED|Overall Study||10
8594708|NCT00318409|9629705|FG000|COMPLETED|Overall Study||18
8594709|NCT00318409|9629706|FG001|COMPLETED|Overall Study||9
8594710|NCT00318409|9629705|FG000|NOT COMPLETED|Overall Study||2
8594711|NCT00318409|9629706|FG001|NOT COMPLETED|Overall Study||1
8594712|NCT00318461|9629718|FG000|STARTED|Double-Blind, 6 Months|Randomised|242
8594713|NCT00318461|9629719|FG001|STARTED|Double-Blind, 6 Months|Randomised|241
8594714|NCT00318461|9629720|FG002|STARTED|Double-Blind, 6 Months|Randomised|242
8594715|NCT00318461|9629721|FG003|STARTED|Double-Blind, 6 Months|Randomised|122
8594716|NCT00318461|9629722|FG004|STARTED|Double-Blind, 6 Months|Randomised|244
8594717|NCT00318461|9629718|FG000|Exposed to Study Drug|Double-Blind, 6 Months||242
8594718|NCT00318461|9629719|FG001|Exposed to Study Drug|Double-Blind, 6 Months|Subject withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|240
8594719|NCT00318461|9629720|FG002|Exposed to Study Drug|Double-Blind, 6 Months||242
8594720|NCT00318461|9629721|FG003|Exposed to Study Drug|Double-Blind, 6 Months|Subject withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|121
8594721|NCT00318461|9629722|FG004|Exposed to Study Drug|Double-Blind, 6 Months|Subjects withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|242
8594722|NCT00318461|9629718|FG000|COMPLETED|Double-Blind, 6 Months||208
8594723|NCT00318461|9629719|FG001|COMPLETED|Double-Blind, 6 Months||197
8594724|NCT00318461|9629720|FG002|COMPLETED|Double-Blind, 6 Months||191
8594725|NCT00318461|9629721|FG003|COMPLETED|Double-Blind, 6 Months||74
8594726|NCT00318461|9629722|FG004|COMPLETED|Double-Blind, 6 Months||210
8594727|NCT00318461|9629718|FG000|NOT COMPLETED|Double-Blind, 6 Months||34
8594728|NCT00318461|9629719|FG001|NOT COMPLETED|Double-Blind, 6 Months||44
8594729|NCT00318461|9629720|FG002|NOT COMPLETED|Double-Blind, 6 Months||51
8712968|NCT00972374|9759707|FG002|NOT COMPLETED|Overall Study||1
8594730|NCT00318461|9629721|FG003|NOT COMPLETED|Double-Blind, 6 Months||48
8594731|NCT00318461|9629722|FG004|NOT COMPLETED|Double-Blind, 6 Months||34
8594732|NCT00318461|9629718|FG000|STARTED|Open-Label Extension, 18 Months||208
8594733|NCT00318461|9629719|FG001|STARTED|Open-Label Extension, 18 Months||197
8594734|NCT00318461|9629720|FG002|STARTED|Open-Label Extension, 18 Months||191
8594735|NCT00318461|9629721|FG003|STARTED|Open-Label Extension, 18 Months||74
8712969|NCT00972439|9759717|FG000|STARTED|Overall Study||17
9064261|NCT04320615|10124561|FG001|STARTED|Overall Study||294
8594736|NCT00318461|9629722|FG004|STARTED|Open-Label Extension, 18 Months||210
8594737|NCT00318461|9629718|FG000|COMPLETED|Open-Label Extension, 18 Months||130
8594738|NCT00318461|9629719|FG001|COMPLETED|Open-Label Extension, 18 Months||137
8594739|NCT00318461|9629720|FG002|COMPLETED|Open-Label Extension, 18 Months||118
8594740|NCT00318461|9629721|FG003|COMPLETED|Open-Label Extension, 18 Months||31
8594741|NCT00318461|9629722|FG004|COMPLETED|Open-Label Extension, 18 Months||113
8594742|NCT00318461|9629718|FG000|NOT COMPLETED|Open-Label Extension, 18 Months||78
8594743|NCT00318461|9629719|FG001|NOT COMPLETED|Open-Label Extension, 18 Months||60
8594744|NCT00318461|9629720|FG002|NOT COMPLETED|Open-Label Extension, 18 Months||73
8594745|NCT00318461|9629721|FG003|NOT COMPLETED|Open-Label Extension, 18 Months||43
8594746|NCT00318461|9629722|FG004|NOT COMPLETED|Open-Label Extension, 18 Months||97
8594747|NCT00318474|9629736|FG000|STARTED|Overall Study||25
8594748|NCT00318474|9629737|FG001|STARTED|Overall Study||27
8594749|NCT00318474|9629736|FG000|COMPLETED|Overall Study||7
8594750|NCT00318474|9629737|FG001|COMPLETED|Overall Study||10
8594751|NCT00318474|9629736|FG000|NOT COMPLETED|Overall Study||18
8594752|NCT00318474|9629737|FG001|NOT COMPLETED|Overall Study||17
8594753|NCT00318565|9629743|FG000|STARTED|Overall Study||291
8594754|NCT00318565|9629743|FG000|COMPLETED|Overall Study||267
8594755|NCT00318565|9629743|FG000|NOT COMPLETED|Overall Study||24
8594756|NCT00318591|9629749|FG000|STARTED|Overall Study||105
8594757|NCT00318591|9629750|FG001|STARTED|Overall Study||114
8594758|NCT00318591|9629749|FG000|COMPLETED|Overall Study||45
8594759|NCT00318591|9629750|FG001|COMPLETED|Overall Study||69
8594760|NCT00318591|9629749|FG000|NOT COMPLETED|Overall Study||60
8594761|NCT00318591|9629750|FG001|NOT COMPLETED|Overall Study||45
8594762|NCT00318643|9629763|FG000|STARTED|Overall Study||3
8594763|NCT00318643|9629764|FG001|STARTED|Overall Study||3
8594764|NCT00318643|9629765|FG002|STARTED|Overall Study||6
8594765|NCT00318643|9629766|FG003|STARTED|Overall Study||3
8594766|NCT00318643|9629767|FG004|STARTED|Overall Study||12
8594767|NCT00318643|9629763|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
8594768|NCT00318643|9629764|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
8594769|NCT00318643|9629765|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
8594770|NCT00318643|9629766|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
8594771|NCT00318643|9629767|FG004|Received at Least 1 Dose of Study Drug|Overall Study||12
8594772|NCT00318643|9629763|FG000|COMPLETED|Overall Study||3
8594773|NCT00318643|9629764|FG001|COMPLETED|Overall Study||3
8594774|NCT00318643|9629765|FG002|COMPLETED|Overall Study||6
8594775|NCT00318643|9629766|FG003|COMPLETED|Overall Study||3
8594776|NCT00318643|9629767|FG004|COMPLETED|Overall Study||9
8594777|NCT00318643|9629763|FG000|NOT COMPLETED|Overall Study||0
8594778|NCT00318643|9629764|FG001|NOT COMPLETED|Overall Study||0
8594779|NCT00318643|9629765|FG002|NOT COMPLETED|Overall Study||0
8594780|NCT00318643|9629766|FG003|NOT COMPLETED|Overall Study||0
8594781|NCT00318643|9629767|FG004|NOT COMPLETED|Overall Study||3
8594782|NCT00318708|9629782|FG000|STARTED|Overall Study||47
8594783|NCT00318708|9629783|FG001|STARTED|Overall Study||45
8594784|NCT00318708|9629782|FG000|8-week Milestone|Overall Study||42
8594785|NCT00318708|9629783|FG001|8-week Milestone|Overall Study||42
8594786|NCT00318708|9629782|FG000|COMPLETED|Overall Study||39
8594787|NCT00318708|9629783|FG001|COMPLETED|Overall Study||40
8594788|NCT00318708|9629782|FG000|NOT COMPLETED|Overall Study||8
8594789|NCT00318708|9629783|FG001|NOT COMPLETED|Overall Study||5
8594790|NCT00318812|9629795|FG000|STARTED|Overall Study||18
8594791|NCT00318812|9629796|FG001|STARTED|Overall Study||22
8594792|NCT00318812|9629795|FG000|COMPLETED|Overall Study||18
8594793|NCT00318812|9629796|FG001|COMPLETED|Overall Study||22
8594794|NCT00318812|9629795|FG000|NOT COMPLETED|Overall Study||0
8594795|NCT00318812|9629796|FG001|NOT COMPLETED|Overall Study||0
8594796|NCT00318929|9629802|FG000|STARTED|Overall Study||14
8594797|NCT00318929|9629802|FG000|COMPLETED|Overall Study||14
8594798|NCT00318929|9629802|FG000|NOT COMPLETED|Overall Study||0
8594799|NCT00319020|9629808|FG000|STARTED|Overall Study||15
8594800|NCT00319020|9629809|FG001|STARTED|Overall Study||21
8594801|NCT00319020|9629808|FG000|Enrollment in FUTURE 2 (F-2)|Overall Study||13
8594802|NCT00319020|9629809|FG001|Enrollment in FUTURE 2 (F-2)|Overall Study||20
8594803|NCT00319020|9629808|FG000|COMPLETED|Overall Study||8
8594804|NCT00319020|9629809|FG001|COMPLETED|Overall Study||8
8594805|NCT00319020|9629808|FG000|NOT COMPLETED|Overall Study||7
8594806|NCT00319020|9629809|FG001|NOT COMPLETED|Overall Study||13
8594807|NCT00319046|9629817|FG000|STARTED|Overall Study|One patient was excluded from analysis as the baseline liver volume not available|42
8594808|NCT00319046|9629817|FG000|COMPLETED|Overall Study||34
8594809|NCT00319046|9629817|FG000|NOT COMPLETED|Overall Study||8
8594810|NCT00319098|9629825|FG000|STARTED|Overall Study||3802
8594811|NCT00319098|9629826|FG001|STARTED|Overall Study||1269
8712970|NCT00972439|9759718|FG001|STARTED|Overall Study||16
8712971|NCT00972439|9759717|FG000|COMPLETED|Overall Study||17
8712972|NCT00972439|9759718|FG001|COMPLETED|Overall Study||16
8712973|NCT00972439|9759717|FG000|NOT COMPLETED|Overall Study||0
8712974|NCT00972439|9759718|FG001|NOT COMPLETED|Overall Study||0
8712975|NCT00972504|9759724|FG000|STARTED|Overall Study||54
8712976|NCT00972504|9759724|FG000|COMPLETED|Overall Study||51
8594812|NCT00319098|9629825|FG000|COMPLETED|Overall Study||3667
8594813|NCT00319098|9629826|FG001|COMPLETED|Overall Study||1237
8594814|NCT00319098|9629825|FG000|NOT COMPLETED|Overall Study||135
8594815|NCT00319098|9629826|FG001|NOT COMPLETED|Overall Study||32
8712977|NCT00972504|9759724|FG000|NOT COMPLETED|Overall Study||3
8594816|NCT00319111|9629836|FG000|STARTED|Overall Study|148 patients enrolled in BENEFIT OL & 3 prematurely discontinued from BENEFIT (NCT00313222)|151
8594817|NCT00319111|9629836|FG000|COMPLETED|Overall Study||104
8594818|NCT00319111|9629836|FG000|NOT COMPLETED|Overall Study||47
8594819|NCT00319254|9629840|FG000|STARTED|Overall Study||75
8594820|NCT00319254|9629840|FG000|Treated|Overall Study||73
8594821|NCT00319254|9629840|FG000|COMPLETED|Overall Study||21
8594822|NCT00319254|9629840|FG000|NOT COMPLETED|Overall Study||54
8594823|NCT00319436|9629846|FG000|STARTED|Overall Study||23
8594824|NCT00319436|9629847|FG001|STARTED|Overall Study||24
8594825|NCT00319436|9629846|FG000|COMPLETED|Overall Study||17
8594826|NCT00319436|9629847|FG001|COMPLETED|Overall Study||17
8594827|NCT00319436|9629846|FG000|NOT COMPLETED|Overall Study||6
8594828|NCT00319436|9629847|FG001|NOT COMPLETED|Overall Study||7
8594829|NCT00319501|9629855|FG000|STARTED|Double-blind Period|Randomized participants|124
8594830|NCT00319501|9629856|FG001|STARTED|Double-blind Period|Randomized participants|110
8594831|NCT00319501|9629855|FG000|Received Treatment|Double-blind Period||82
8594832|NCT00319501|9629856|FG001|Received Treatment|Double-blind Period||81
8594833|NCT00319501|9629855|FG000|COMPLETED|Double-blind Period||81
8594834|NCT00319501|9629856|FG001|COMPLETED|Double-blind Period||78
8594835|NCT00319501|9629855|FG000|NOT COMPLETED|Double-blind Period||43
8594836|NCT00319501|9629856|FG001|NOT COMPLETED|Double-blind Period||32
8594837|NCT00319501|9629855|FG000|STARTED|Open-label Period|Participants who continued to meet eligibility requirements|161
8594838|NCT00319501|9629856|FG001|STARTED|Open-label Period||0
8594839|NCT00319501|9629855|FG000|Received Treatment|Open-label Period||128
8594840|NCT00319501|9629856|FG001|Received Treatment|Open-label Period||0
8594841|NCT00319501|9629855|FG000|COMPLETED|Open-label Period|Competed=continuing treatment|45
8594842|NCT00319501|9629856|FG001|COMPLETED|Open-label Period||0
8594843|NCT00319501|9629855|FG000|NOT COMPLETED|Open-label Period||116
8594844|NCT00319501|9629856|FG001|NOT COMPLETED|Open-label Period||0
8594845|NCT00319501|9629855|FG000|STARTED|Open-label Extension Period|Eligible participants who chose to continue treatment|51
8594846|NCT00319501|9629856|FG001|STARTED|Open-label Extension Period||0
8594847|NCT00319501|9629855|FG000|Received Treatment|Open-label Extension Period||33
8594848|NCT00319501|9629856|FG001|Received Treatment|Open-label Extension Period||0
8594849|NCT00319501|9629855|FG000|COMPLETED|Open-label Extension Period||0
8594850|NCT00319501|9629856|FG001|COMPLETED|Open-label Extension Period||0
8594851|NCT00319501|9629855|FG000|NOT COMPLETED|Open-label Extension Period||51
8594852|NCT00319501|9629856|FG001|NOT COMPLETED|Open-label Extension Period||0
8594853|NCT00319553|9629869|FG000|STARTED|Overall Study||323
8594854|NCT00319553|9629870|FG001|STARTED|Overall Study||321
8594855|NCT00319553|9629869|FG000|COMPLETED|Overall Study||319
8594856|NCT00319553|9629870|FG001|COMPLETED|Overall Study||317
8594857|NCT00319553|9629869|FG000|NOT COMPLETED|Overall Study||4
8594858|NCT00319553|9629870|FG001|NOT COMPLETED|Overall Study||4
8594859|NCT00319592|9629878|FG000|STARTED|Overall Study||30
8594860|NCT00319592|9629879|FG001|STARTED|Overall Study||30
8594861|NCT00319592|9629878|FG000|COMPLETED|Overall Study||29
8594862|NCT00319592|9629879|FG001|COMPLETED|Overall Study||29
8594863|NCT00319592|9629878|FG000|NOT COMPLETED|Overall Study||1
8594864|NCT00319592|9629879|FG001|NOT COMPLETED|Overall Study||1
8594865|NCT00319644|9629887|FG000|STARTED|Overall Study||21
8594866|NCT00319644|9629888|FG001|STARTED|Overall Study||16
8594867|NCT00319644|9629887|FG000|COMPLETED|Overall Study||21
8594868|NCT00319644|9629888|FG001|COMPLETED|Overall Study||16
8594869|NCT00319644|9629887|FG000|NOT COMPLETED|Overall Study||0
8594870|NCT00319644|9629888|FG001|NOT COMPLETED|Overall Study||0
8594871|NCT00319696|9629894|FG000|STARTED|Overall Study||116
8594872|NCT00319696|9629894|FG000|COMPLETED|Overall Study||56
8594873|NCT00319696|9629894|FG000|NOT COMPLETED|Overall Study||60
8594874|NCT00319735|9629904|FG000|STARTED|Overall Study||41
8594875|NCT00319735|9629904|FG000|COMPLETED|Overall Study||39
8594876|NCT00319735|9629904|FG000|NOT COMPLETED|Overall Study||2
8594877|NCT00319748|9629909|FG000|STARTED|Overall Study||13
8594878|NCT00319748|9629909|FG000|COMPLETED|Overall Study||13
8594879|NCT00319748|9629909|FG000|NOT COMPLETED|Overall Study||0
8594880|NCT00319956|9629921|FG000|STARTED|Overall Study||111
8594881|NCT00319956|9629922|FG001|STARTED|Overall Study||109
8594882|NCT00319956|9629921|FG000|COMPLETED|Overall Study||91
8594883|NCT00319956|9629922|FG001|COMPLETED|Overall Study||85
8594884|NCT00319956|9629921|FG000|NOT COMPLETED|Overall Study||20
8594885|NCT00319956|9629922|FG001|NOT COMPLETED|Overall Study||24
8594886|NCT00319982|9629930|FG000|STARTED|Overall Study||19
8594887|NCT00319982|9629931|FG001|STARTED|Overall Study||20
8594888|NCT00319982|9629930|FG000|COMPLETED|Overall Study||18
8594889|NCT00319982|9629931|FG001|COMPLETED|Overall Study||20
8594890|NCT00319982|9629930|FG000|NOT COMPLETED|Overall Study||1
8594891|NCT00319982|9629931|FG001|NOT COMPLETED|Overall Study||0
8594892|NCT00320112|9629939|FG000|STARTED|Overall Study||125
8594893|NCT00320112|9629940|FG001|STARTED|Overall Study||119
8594894|NCT00320112|9629939|FG000|COMPLETED|Overall Study||117
8594895|NCT00320112|9629940|FG001|COMPLETED|Overall Study||114
8594896|NCT00320112|9629939|FG000|NOT COMPLETED|Overall Study||8
8594897|NCT00320112|9629940|FG001|NOT COMPLETED|Overall Study||5
8594898|NCT00320190|9629954|FG000|STARTED|First 12 Months||19
8594899|NCT00320190|9629955|FG001|STARTED|First 12 Months||13
8594900|NCT00320190|9629954|FG000|COMPLETED|First 12 Months||11
8594901|NCT00320190|9629955|FG001|COMPLETED|First 12 Months||3
8594902|NCT00320190|9629954|FG000|NOT COMPLETED|First 12 Months||8
8594903|NCT00320190|9629955|FG001|NOT COMPLETED|First 12 Months||10
8594904|NCT00320190|9629954|FG000|STARTED|Long-term (12-month) Extension||11
8594905|NCT00320190|9629955|FG001|STARTED|Long-term (12-month) Extension||3
8594906|NCT00320190|9629954|FG000|COMPLETED|Long-term (12-month) Extension||2
8594907|NCT00320190|9629955|FG001|COMPLETED|Long-term (12-month) Extension||1
8594908|NCT00320190|9629954|FG000|NOT COMPLETED|Long-term (12-month) Extension||9
8594909|NCT00320190|9629955|FG001|NOT COMPLETED|Long-term (12-month) Extension||2
8594910|NCT00320216|9629966|FG000|STARTED|Overall Study||64
8594911|NCT00320216|9629967|FG001|STARTED|Overall Study|1 patient randomized but not treated was included as discontinued due to Other reason.|64
8594912|NCT00320216|9629968|FG002|STARTED|Overall Study|1 patient randomized but not treated was included as discontinued due to Other reason.|64
8594913|NCT00320216|9629969|FG003|STARTED|Overall Study||64
8594914|NCT00320216|9629970|FG004|STARTED|Overall Study||64
8594915|NCT00320216|9629966|FG000|COMPLETED|Overall Study||48
8594916|NCT00320216|9629967|FG001|COMPLETED|Overall Study||54
8594917|NCT00320216|9629968|FG002|COMPLETED|Overall Study||58
8594918|NCT00320216|9629969|FG003|COMPLETED|Overall Study||61
8594919|NCT00320216|9629970|FG004|COMPLETED|Overall Study||58
8594920|NCT00320216|9629966|FG000|NOT COMPLETED|Overall Study||16
8594921|NCT00320216|9629967|FG001|NOT COMPLETED|Overall Study||10
8594922|NCT00320216|9629968|FG002|NOT COMPLETED|Overall Study||6
8594923|NCT00320216|9629969|FG003|NOT COMPLETED|Overall Study||3
8594924|NCT00320216|9629970|FG004|NOT COMPLETED|Overall Study||6
8594925|NCT00320242|9629987|FG000|STARTED|Overall Study||16
8594926|NCT00320242|9629988|FG001|STARTED|Overall Study||16
8594927|NCT00320242|9629987|FG000|COMPLETED|Overall Study||14
8594928|NCT00320242|9629988|FG001|COMPLETED|Overall Study||12
8594929|NCT00320242|9629987|FG000|NOT COMPLETED|Overall Study||2
8594930|NCT00320242|9629988|FG001|NOT COMPLETED|Overall Study||4
8594931|NCT00320255|9630001|FG000|STARTED|Overall Study||30
8594932|NCT00320255|9630002|FG001|STARTED|Overall Study||32
8594933|NCT00320255|9630003|FG002|STARTED|Overall Study||30
8594934|NCT00320255|9630004|FG003|STARTED|Overall Study||33
8594935|NCT00320255|9630005|FG004|STARTED|Overall Study||2
8594936|NCT00320255|9630006|FG005|STARTED|Overall Study||3
8594937|NCT00320255|9630001|FG000|Received Treatment|Overall Study||29
8594938|NCT00320255|9630002|FG001|Received Treatment|Overall Study||32
8594939|NCT00320255|9630003|FG002|Received Treatment|Overall Study||29
8594940|NCT00320255|9630004|FG003|Received Treatment|Overall Study||32
8594941|NCT00320255|9630005|FG004|Received Treatment|Overall Study||2
8594942|NCT00320255|9630006|FG005|Received Treatment|Overall Study||3
8594943|NCT00320255|9630001|FG000|COMPLETED|Overall Study||19
8594944|NCT00320255|9630002|FG001|COMPLETED|Overall Study||25
8594945|NCT00320255|9630003|FG002|COMPLETED|Overall Study||24
8594946|NCT00320255|9630004|FG003|COMPLETED|Overall Study||25
8594947|NCT00320255|9630005|FG004|COMPLETED|Overall Study||2
8594948|NCT00320255|9630006|FG005|COMPLETED|Overall Study||3
8594949|NCT00320255|9630001|FG000|NOT COMPLETED|Overall Study||11
8594950|NCT00320255|9630002|FG001|NOT COMPLETED|Overall Study||7
8594951|NCT00320255|9630003|FG002|NOT COMPLETED|Overall Study||6
8594952|NCT00320255|9630004|FG003|NOT COMPLETED|Overall Study||8
8594953|NCT00320255|9630005|FG004|NOT COMPLETED|Overall Study||0
8594954|NCT00320255|9630006|FG005|NOT COMPLETED|Overall Study||0
8594955|NCT00320281|9630023|FG000|STARTED|Overall Study||10
8594956|NCT00320281|9630024|FG001|STARTED|Overall Study||9
8594957|NCT00320281|9630023|FG000|COMPLETED|Overall Study||10
8594958|NCT00320281|9630024|FG001|COMPLETED|Overall Study||9
8594959|NCT00320281|9630023|FG000|NOT COMPLETED|Overall Study||0
8594960|NCT00320281|9630024|FG001|NOT COMPLETED|Overall Study||0
8594961|NCT00320372|9630035|FG000|STARTED|Overall Study||494
8594962|NCT00320372|9630036|FG001|STARTED|Overall Study||301
8594963|NCT00320372|9630035|FG000|VNS Therapy D-23 Original|Overall Study||335
8594964|NCT00320372|9630036|FG001|VNS Therapy D-23 Original|Overall Study||0
8594965|NCT00320372|9630035|FG000|VNS Therapy D-21 (NCT00305565) Rollovers|Overall Study||159
8594966|NCT00320372|9630036|FG001|VNS Therapy D-21 (NCT00305565) Rollovers|Overall Study||0
8594967|NCT00320372|9630035|FG000|COMPLETED|Overall Study||299
8594968|NCT00320372|9630036|FG001|COMPLETED|Overall Study||138
8594969|NCT00320372|9630035|FG000|NOT COMPLETED|Overall Study||195
8594970|NCT00320372|9630036|FG001|NOT COMPLETED|Overall Study||163
8594971|NCT00320385|9630052|FG000|STARTED|Overall Study||148
8594972|NCT00320385|9630053|FG001|STARTED|Overall Study||148
8594973|NCT00320385|9630052|FG000|COMPLETED|Overall Study||130
8594974|NCT00320385|9630053|FG001|COMPLETED|Overall Study||126
8594975|NCT00320385|9630052|FG000|NOT COMPLETED|Overall Study||18
8594976|NCT00320385|9630053|FG001|NOT COMPLETED|Overall Study||22
8594977|NCT00320398|9630061|FG000|STARTED|Overall Study||58
8594978|NCT00320398|9630062|FG001|STARTED|Overall Study||56
8594979|NCT00320398|9630061|FG000|COMPLETED|Overall Study||56
8594980|NCT00320398|9630062|FG001|COMPLETED|Overall Study||52
8594981|NCT00320398|9630061|FG000|NOT COMPLETED|Overall Study||2
8594982|NCT00320398|9630062|FG001|NOT COMPLETED|Overall Study||4
8594983|NCT00320411|9630069|FG000|STARTED|Overall Study||62
8594984|NCT00320411|9630069|FG000|COMPLETED|Overall Study||58
8594985|NCT00320411|9630069|FG000|NOT COMPLETED|Overall Study||4
8594986|NCT00320424|9630073|FG000|STARTED|Overall Study||48
8594987|NCT00320424|9630073|FG000|COMPLETED|Overall Study||42
8594988|NCT00320424|9630073|FG000|NOT COMPLETED|Overall Study||6
8594989|NCT00320489|9630079|FG000|STARTED|Overall Study||264
8594990|NCT00320489|9630080|FG001|STARTED|Overall Study||260
8594991|NCT00320489|9630079|FG000|COMPLETED|Overall Study||119
8594992|NCT00320489|9630080|FG001|COMPLETED|Overall Study||124
8594993|NCT00320489|9630079|FG000|NOT COMPLETED|Overall Study||145
8594994|NCT00320489|9630080|FG001|NOT COMPLETED|Overall Study||136
8594995|NCT00320515|9630086|FG000|STARTED|Overall Study||69
8594996|NCT00320515|9630086|FG000|COMPLETED|Overall Study||20
8594997|NCT00320515|9630086|FG000|NOT COMPLETED|Overall Study||49
8594998|NCT00320528|9630093|FG000|STARTED|Study Period II||98
8594999|NCT00320528|9630094|FG001|STARTED|Study Period II||41
8595000|NCT00320528|9630095|FG002|STARTED|Study Period II||130
8595001|NCT00320528|9630093|FG000|Received at Least One Dose of Study Drug|Study Period II||97
8595002|NCT00320528|9630094|FG001|Received at Least One Dose of Study Drug|Study Period II||38
8595003|NCT00320528|9630095|FG002|Received at Least One Dose of Study Drug|Study Period II||128
8595004|NCT00320528|9630093|FG000|COMPLETED|Study Period II||87
8595005|NCT00320528|9630094|FG001|COMPLETED|Study Period II||31
8595006|NCT00320528|9630095|FG002|COMPLETED|Study Period II||108
8595007|NCT00320528|9630093|FG000|NOT COMPLETED|Study Period II||11
8595008|NCT00320528|9630094|FG001|NOT COMPLETED|Study Period II||10
8595009|NCT00320528|9630095|FG002|NOT COMPLETED|Study Period II||22
8595010|NCT00320528|9630093|FG000|STARTED|Study Period III||87
8595011|NCT00320528|9630094|FG001|STARTED|Study Period III||31
8595012|NCT00320528|9630095|FG002|STARTED|Study Period III||108
8595013|NCT00320528|9630093|FG000|COMPLETED|Study Period III||0
8595014|NCT00320528|9630094|FG001|COMPLETED|Study Period III||0
8595015|NCT00320528|9630095|FG002|COMPLETED|Study Period III||2
8595016|NCT00320528|9630093|FG000|NOT COMPLETED|Study Period III||87
8595017|NCT00320528|9630094|FG001|NOT COMPLETED|Study Period III||31
8595018|NCT00320528|9630095|FG002|NOT COMPLETED|Study Period III||106
8595019|NCT00320541|9630105|FG000|STARTED|Overall Study||94
8595020|NCT00320541|9630106|FG001|STARTED|Overall Study||93
8595021|NCT00320541|9630105|FG000|COMPLETED|Overall Study||44
8595022|NCT00320541|9630106|FG001|COMPLETED|Overall Study||36
8595023|NCT00320541|9630105|FG000|NOT COMPLETED|Overall Study||50
8595024|NCT00320541|9630106|FG001|NOT COMPLETED|Overall Study||57
8595025|NCT00320593|9630114|FG000|STARTED|Overall Study||59
8595026|NCT00320593|9630115|FG001|STARTED|Overall Study||59
8595027|NCT00320593|9630114|FG000|COMPLETED|Overall Study|Completed defined as completing the 3 year primary outcome exam|52
8595028|NCT00320593|9630115|FG001|COMPLETED|Overall Study|Completed defined as completing the 3 year primary outcome exam|58
8595029|NCT00320593|9630114|FG000|NOT COMPLETED|Overall Study||7
8595030|NCT00320593|9630115|FG001|NOT COMPLETED|Overall Study||1
8595031|NCT00320606|9630121|FG000|STARTED|Overall Study||20
8595032|NCT00320606|9630121|FG000|COMPLETED|Overall Study||17
8595033|NCT00320606|9630121|FG000|NOT COMPLETED|Overall Study||3
8595034|NCT00320671|9630128|FG000|STARTED|Overall Study||102
8595035|NCT00320671|9630129|FG001|STARTED|Overall Study||96
8595036|NCT00320671|9630128|FG000|COMPLETED|Overall Study||69
8595037|NCT00320671|9630129|FG001|COMPLETED|Overall Study||58
8595038|NCT00320671|9630128|FG000|NOT COMPLETED|Overall Study||33
8595039|NCT00320671|9630129|FG001|NOT COMPLETED|Overall Study||38
8595040|NCT00320710|9630138|FG000|STARTED|Overall Study||200
8595041|NCT00320710|9630139|FG001|STARTED|Overall Study||203
8595042|NCT00320710|9630140|FG002|STARTED|Overall Study||13
8595043|NCT00320710|9630138|FG000|Treated (Safety Set)|Overall Study||198
8595044|NCT00320710|9630139|FG001|Treated (Safety Set)|Overall Study||202
8595045|NCT00320710|9630140|FG002|Treated (Safety Set)|Overall Study||13
8595046|NCT00320710|9630138|FG000|COMPLETED|Overall Study||106
8595047|NCT00320710|9630139|FG001|COMPLETED|Overall Study||127
8595048|NCT00320710|9630140|FG002|COMPLETED|Overall Study||8
8595049|NCT00320710|9630138|FG000|NOT COMPLETED|Overall Study||94
8595050|NCT00320710|9630139|FG001|NOT COMPLETED|Overall Study||76
8595051|NCT00320710|9630140|FG002|NOT COMPLETED|Overall Study||5
8595052|NCT00320749|9630147|FG000|STARTED|Overall Study||3
8595053|NCT00320749|9630148|FG001|STARTED|Overall Study||8
8595054|NCT00320749|9630149|FG002|STARTED|Overall Study||10
8595055|NCT00320749|9630147|FG000|COMPLETED|Overall Study||3
8595056|NCT00320749|9630148|FG001|COMPLETED|Overall Study||6
8595057|NCT00320749|9630149|FG002|COMPLETED|Overall Study||1
8595058|NCT00320749|9630147|FG000|NOT COMPLETED|Overall Study||0
8595059|NCT00320749|9630148|FG001|NOT COMPLETED|Overall Study||2
8595060|NCT00320749|9630149|FG002|NOT COMPLETED|Overall Study||9
8595061|NCT00320788|9630159|FG000|STARTED|Overall Study||32
8595062|NCT00320788|9630160|FG001|STARTED|Overall Study||32
8595063|NCT00320788|9630161|FG002|STARTED|Overall Study||32
8595064|NCT00320788|9630162|FG003|STARTED|Overall Study|Participants Randomized|32
8595065|NCT00320788|9630163|FG004|STARTED|Overall Study||31
8595066|NCT00320788|9630159|FG000|Participants Received Treatment (SAF)|Overall Study||32
8595067|NCT00320788|9630160|FG001|Participants Received Treatment (SAF)|Overall Study||32
8595068|NCT00320788|9630161|FG002|Participants Received Treatment (SAF)|Overall Study|One participant in this group did not receive treatment and was not included in the SAF and FAS|31
8595069|NCT00320788|9630162|FG003|Participants Received Treatment (SAF)|Overall Study|One participant in this group did not receive treatment and was not included in the SAF and FAS|31
8595070|NCT00320788|9630163|FG004|Participants Received Treatment (SAF)|Overall Study||31
8595071|NCT00320788|9630159|FG000|COMPLETED|Overall Study||26
8595072|NCT00320788|9630160|FG001|COMPLETED|Overall Study||26
8595073|NCT00320788|9630161|FG002|COMPLETED|Overall Study||29
8595074|NCT00320788|9630162|FG003|COMPLETED|Overall Study||27
8595075|NCT00320788|9630163|FG004|COMPLETED|Overall Study||26
8595076|NCT00320788|9630159|FG000|NOT COMPLETED|Overall Study||6
8595077|NCT00320788|9630160|FG001|NOT COMPLETED|Overall Study||6
8595078|NCT00320788|9630161|FG002|NOT COMPLETED|Overall Study||3
8595079|NCT00320788|9630162|FG003|NOT COMPLETED|Overall Study||5
8595080|NCT00320788|9630163|FG004|NOT COMPLETED|Overall Study||5
8595081|NCT00320801|9630183|FG000|STARTED|Open-label Run-in Period||188
8595082|NCT00320801|9630184|FG001|STARTED|Open-label Run-in Period||0
8595083|NCT00320801|9630185|FG002|STARTED|Open-label Run-in Period||0
8595084|NCT00320801|9630186|FG003|STARTED|Open-label Run-in Period||0
8595085|NCT00320801|9630183|FG000|COMPLETED|Open-label Run-in Period||96
8595086|NCT00320801|9630184|FG001|COMPLETED|Open-label Run-in Period||0
8595087|NCT00320801|9630185|FG002|COMPLETED|Open-label Run-in Period||0
8595088|NCT00320801|9630186|FG003|COMPLETED|Open-label Run-in Period||0
8595089|NCT00320801|9630183|FG000|NOT COMPLETED|Open-label Run-in Period||92
8595090|NCT00320801|9630184|FG001|NOT COMPLETED|Open-label Run-in Period||0
8595091|NCT00320801|9630185|FG002|NOT COMPLETED|Open-label Run-in Period||0
8595092|NCT00320801|9630186|FG003|NOT COMPLETED|Open-label Run-in Period||0
8595093|NCT00320801|9630183|FG000|STARTED|Double-blind Phase||0
8595094|NCT00320801|9630184|FG001|STARTED|Double-blind Phase||47
8595095|NCT00320801|9630185|FG002|STARTED|Double-blind Phase||49
8595096|NCT00320801|9630186|FG003|STARTED|Double-blind Phase||0
8595097|NCT00320801|9630183|FG000|COMPLETED|Double-blind Phase||0
8595098|NCT00320801|9630184|FG001|COMPLETED|Double-blind Phase||36
8595099|NCT00320801|9630185|FG002|COMPLETED|Double-blind Phase||35
8595100|NCT00320801|9630186|FG003|COMPLETED|Double-blind Phase||0
8595101|NCT00320801|9630183|FG000|NOT COMPLETED|Double-blind Phase||0
8595102|NCT00320801|9630184|FG001|NOT COMPLETED|Double-blind Phase||11
8595103|NCT00320801|9630185|FG002|NOT COMPLETED|Double-blind Phase||14
8595104|NCT00320801|9630186|FG003|NOT COMPLETED|Double-blind Phase||0
8595105|NCT00320801|9630183|FG000|STARTED|Extension Phase||0
8595106|NCT00320801|9630184|FG001|STARTED|Extension Phase||0
8595107|NCT00320801|9630185|FG002|STARTED|Extension Phase||0
8595108|NCT00320801|9630186|FG003|STARTED|Extension Phase||55
8595109|NCT00320801|9630183|FG000|COMPLETED|Extension Phase||0
8595110|NCT00320801|9630184|FG001|COMPLETED|Extension Phase||0
8595111|NCT00320801|9630185|FG002|COMPLETED|Extension Phase||0
8595112|NCT00320801|9630186|FG003|COMPLETED|Extension Phase||7
8595113|NCT00320801|9630183|FG000|NOT COMPLETED|Extension Phase||0
8595114|NCT00320801|9630184|FG001|NOT COMPLETED|Extension Phase||0
8595115|NCT00320801|9630185|FG002|NOT COMPLETED|Extension Phase||0
8595116|NCT00320801|9630186|FG003|NOT COMPLETED|Extension Phase||48
8595117|NCT00321048|9630198|FG000|STARTED|Overall Study||28
8595118|NCT00321048|9630199|FG001|STARTED|Overall Study||29
8595119|NCT00321048|9630198|FG000|COMPLETED|Overall Study||22
8595120|NCT00321048|9630199|FG001|COMPLETED|Overall Study||21
8595121|NCT00321048|9630198|FG000|NOT COMPLETED|Overall Study||6
8595122|NCT00321048|9630199|FG001|NOT COMPLETED|Overall Study||8
8595123|NCT00321269|9630207|FG000|STARTED|Overall Study||74
8595124|NCT00321269|9630208|FG001|STARTED|Overall Study||74
8595125|NCT00321269|9630207|FG000|COMPLETED|Overall Study||66
8595126|NCT00321269|9630208|FG001|COMPLETED|Overall Study||68
8595127|NCT00321269|9630207|FG000|NOT COMPLETED|Overall Study||8
8595128|NCT00321269|9630208|FG001|NOT COMPLETED|Overall Study||6
8595129|NCT00321321|9630216|FG000|STARTED|Overall Study||12
8595130|NCT00321321|9630216|FG000|COMPLETED|Overall Study||12
8595131|NCT00321321|9630216|FG000|NOT COMPLETED|Overall Study||0
8595132|NCT00321373|9630223|FG000|STARTED|Overall Study||407
8595133|NCT00321373|9630224|FG001|STARTED|Overall Study||406
8595134|NCT00321373|9630225|FG002|STARTED|Overall Study||407
8595135|NCT00321373|9630223|FG000|COMPLETED|Overall Study||405
8595136|NCT00321373|9630224|FG001|COMPLETED|Overall Study||406
8595137|NCT00321373|9630225|FG002|COMPLETED|Overall Study||404
8595138|NCT00321373|9630223|FG000|NOT COMPLETED|Overall Study||2
8595139|NCT00321373|9630224|FG001|NOT COMPLETED|Overall Study||0
8595140|NCT00321373|9630225|FG002|NOT COMPLETED|Overall Study||3
8595141|NCT00321464|9630235|FG000|STARTED|Overall Study||1020
8595142|NCT00321464|9630236|FG001|STARTED|Overall Study||1026
8595143|NCT00321464|9630235|FG000|Received Investigational Product|Overall Study||1014
8595144|NCT00321464|9630236|FG001|Received Investigational Product|Overall Study||1019
8595145|NCT00321464|9630235|FG000|COMPLETED|Overall Study||461
8595146|NCT00321464|9630236|FG001|COMPLETED|Overall Study||468
8595147|NCT00321464|9630235|FG000|NOT COMPLETED|Overall Study||559
8595148|NCT00321464|9630236|FG001|NOT COMPLETED|Overall Study||558
8595149|NCT00321594|9630244|FG000|STARTED|Phase I, Level 1-4||3
8595150|NCT00321594|9630245|FG001|STARTED|Phase I, Level 1-4||3
8595151|NCT00321594|9630246|FG002|STARTED|Phase I, Level 1-4||6
8595152|NCT00321594|9630247|FG003|STARTED|Phase I, Level 1-4||6
8595153|NCT00321594|9630248|FG004|STARTED|Phase I, Level 1-4||0
8595154|NCT00321594|9630244|FG000|COMPLETED|Phase I, Level 1-4||3
8595155|NCT00321594|9630245|FG001|COMPLETED|Phase I, Level 1-4||3
8595156|NCT00321594|9630246|FG002|COMPLETED|Phase I, Level 1-4||6
8595157|NCT00321594|9630247|FG003|COMPLETED|Phase I, Level 1-4||6
8595158|NCT00321594|9630248|FG004|COMPLETED|Phase I, Level 1-4||0
8595159|NCT00321594|9630244|FG000|NOT COMPLETED|Phase I, Level 1-4||0
8595160|NCT00321594|9630245|FG001|NOT COMPLETED|Phase I, Level 1-4||0
8595161|NCT00321594|9630246|FG002|NOT COMPLETED|Phase I, Level 1-4||0
8595162|NCT00321594|9630247|FG003|NOT COMPLETED|Phase I, Level 1-4||0
8595163|NCT00321594|9630248|FG004|NOT COMPLETED|Phase I, Level 1-4||0
8595164|NCT00321594|9630244|FG000|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|0
8595165|NCT00321594|9630245|FG001|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|0
8628257|NCT00522379|9667666|FG000|NOT COMPLETED|Overall Study||22
8595166|NCT00321594|9630246|FG002|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|0
8595167|NCT00321594|9630247|FG003|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|6
8595168|NCT00321594|9630248|FG004|STARTED|Phase II, MTD Dose|last six patients in Phase I, Level 4 include in Phase II MTD Dose total number = 6 + 36 = 42|36
8595169|NCT00321594|9630244|FG000|COMPLETED|Phase II, MTD Dose||0
8595170|NCT00321594|9630245|FG001|COMPLETED|Phase II, MTD Dose||0
8595171|NCT00321594|9630246|FG002|COMPLETED|Phase II, MTD Dose||0
8595172|NCT00321594|9630247|FG003|COMPLETED|Phase II, MTD Dose||6
8595173|NCT00321594|9630248|FG004|COMPLETED|Phase II, MTD Dose||36
8595174|NCT00321594|9630244|FG000|NOT COMPLETED|Phase II, MTD Dose||0
8595175|NCT00321594|9630245|FG001|NOT COMPLETED|Phase II, MTD Dose||0
8595176|NCT00321594|9630246|FG002|NOT COMPLETED|Phase II, MTD Dose||0
8595177|NCT00321594|9630247|FG003|NOT COMPLETED|Phase II, MTD Dose||0
8595178|NCT00321594|9630248|FG004|NOT COMPLETED|Phase II, MTD Dose||0
8595179|NCT00321620|9630262|FG000|STARTED|Overall Study||951
8595180|NCT00321620|9630263|FG001|STARTED|Overall Study||950
8595181|NCT00321620|9630262|FG000|Received Investigational Product|Overall Study||946
8595182|NCT00321620|9630263|FG001|Received Investigational Product|Overall Study||942
8595183|NCT00321620|9630262|FG000|COMPLETED|Overall Study||208
8813142|NCT01524198|9866283|FG001|STARTED|Overall Study||474
8813143|NCT01524198|9866282|FG000|COMPLETED|Overall Study||448
8813144|NCT01524198|9866283|FG001|COMPLETED|Overall Study||458
8595184|NCT00321620|9630263|FG001|COMPLETED|Overall Study||228
8595185|NCT00321620|9630262|FG000|NOT COMPLETED|Overall Study||743
8595186|NCT00321620|9630263|FG001|NOT COMPLETED|Overall Study||722
8595187|NCT00321646|9630269|FG000|STARTED|Neoadjuvant Chemotherapy||42
8595188|NCT00321646|9630269|FG000|COMPLETED|Neoadjuvant Chemotherapy|1 pt withdrew before start of therapy, 38 completed 6 cycles neoadjuvant therapy.|38
8595189|NCT00321646|9630269|FG000|NOT COMPLETED|Neoadjuvant Chemotherapy||4
8595190|NCT00321646|9630269|FG000|STARTED|Prostatectomy||37
8595191|NCT00321646|9630269|FG000|COMPLETED|Prostatectomy||37
8595192|NCT00321646|9630269|FG000|NOT COMPLETED|Prostatectomy||0
8595193|NCT00321672|9630277|FG000|STARTED|Overall Study||165
8595194|NCT00321672|9630278|FG001|STARTED|Overall Study|One randomized to 30 minutes received 60 minutes. Under 30 for efficacy and under 60 for safety.|89
8595195|NCT00321672|9630279|FG002|STARTED|Overall Study||167
8595196|NCT00321672|9630280|FG003|STARTED|Overall Study|One randomized to 30 minutes received 60 minutes. Under 30 for efficacy and under 60 for safety.|73
8595197|NCT00321672|9630277|FG000|COMPLETED|Overall Study||153
8595198|NCT00321672|9630278|FG001|COMPLETED|Overall Study||81
8595199|NCT00321672|9630279|FG002|COMPLETED|Overall Study||156
8595200|NCT00321672|9630280|FG003|COMPLETED|Overall Study||71
8595201|NCT00321672|9630277|FG000|NOT COMPLETED|Overall Study||12
8595202|NCT00321672|9630278|FG001|NOT COMPLETED|Overall Study||8
8595203|NCT00321672|9630279|FG002|NOT COMPLETED|Overall Study||11
8595204|NCT00321672|9630280|FG003|NOT COMPLETED|Overall Study||2
8595205|NCT00321685|9630294|FG000|STARTED|Overall Study||57
8595206|NCT00321685|9630294|FG000|Eligible|Overall Study||55
8595207|NCT00321685|9630294|FG000|Started Protocol Therapy|Overall Study||55
8595208|NCT00321685|9630294|FG000|Eligible and Treated|Overall Study||53
8595209|NCT00321685|9630294|FG000|COMPLETED|Overall Study||18
8595210|NCT00321685|9630294|FG000|NOT COMPLETED|Overall Study||39
8595211|NCT00321711|9630303|FG000|STARTED|Part A||13
8595212|NCT00321711|9630304|FG001|STARTED|Part A||13
8595213|NCT00321711|9630305|FG002|STARTED|Part A||14
8595214|NCT00321711|9630306|FG003|STARTED|Part A||0
8595215|NCT00321711|9630307|FG004|STARTED|Part A||0
8595216|NCT00321711|9630303|FG000|COMPLETED|Part A|Participants in Part A were not eligible for enrollment in Part B|8
8595217|NCT00321711|9630304|FG001|COMPLETED|Part A|Participants in Part A were not eligible for enrollment in Part B|3
8595218|NCT00321711|9630305|FG002|COMPLETED|Part A|Participants in Part A were not eligible for enrollment in Part B|3
8595219|NCT00321711|9630306|FG003|COMPLETED|Part A||0
8595220|NCT00321711|9630307|FG004|COMPLETED|Part A||0
8595221|NCT00321711|9630303|FG000|NOT COMPLETED|Part A||5
8595222|NCT00321711|9630304|FG001|NOT COMPLETED|Part A||10
8595223|NCT00321711|9630305|FG002|NOT COMPLETED|Part A||11
8595224|NCT00321711|9630306|FG003|NOT COMPLETED|Part A||0
8712978|NCT00972517|9759734|FG000|STARTED|Overall Study||31
8712979|NCT00972517|9759735|FG001|STARTED|Overall Study||31
8595225|NCT00321711|9630307|FG004|NOT COMPLETED|Part A||0
8595226|NCT00321711|9630303|FG000|STARTED|Part B|Participants in Part A were not eligible for enrollment in Part B|0
8595227|NCT00321711|9630304|FG001|STARTED|Part B|Participants in Part A were not eligible for enrollment in Part B|0
8595228|NCT00321711|9630305|FG002|STARTED|Part B|Participants in Part A were not eligible for enrollment in Part B|0
8595229|NCT00321711|9630306|FG003|STARTED|Part B||14
8595230|NCT00321711|9630307|FG004|STARTED|Part B||15
8595231|NCT00321711|9630303|FG000|COMPLETED|Part B||0
8595232|NCT00321711|9630304|FG001|COMPLETED|Part B||0
8595233|NCT00321711|9630305|FG002|COMPLETED|Part B||0
8595234|NCT00321711|9630306|FG003|COMPLETED|Part B||8
8595235|NCT00321711|9630307|FG004|COMPLETED|Part B||10
8595236|NCT00321711|9630303|FG000|NOT COMPLETED|Part B||0
8595237|NCT00321711|9630304|FG001|NOT COMPLETED|Part B||0
8595238|NCT00321711|9630305|FG002|NOT COMPLETED|Part B||0
8595239|NCT00321711|9630306|FG003|NOT COMPLETED|Part B||6
8595240|NCT00321711|9630307|FG004|NOT COMPLETED|Part B||5
8595241|NCT00321737|9630322|FG000|STARTED|Overall Study||147
8712980|NCT00972517|9759736|FG002|STARTED|Overall Study||60
8712981|NCT00972517|9759737|FG003|STARTED|Overall Study||30
8813145|NCT01524198|9866282|FG000|NOT COMPLETED|Overall Study||23
8595242|NCT00321737|9630323|FG001|STARTED|Overall Study||140
8595243|NCT00321737|9630324|FG002|STARTED|Overall Study||158
8595244|NCT00321737|9630322|FG000|COMPLETED|Overall Study||25
8595245|NCT00321737|9630323|FG001|COMPLETED|Overall Study||92
8595246|NCT00321737|9630324|FG002|COMPLETED|Overall Study||104
8595247|NCT00321737|9630322|FG000|NOT COMPLETED|Overall Study||122
8595248|NCT00321737|9630323|FG001|NOT COMPLETED|Overall Study||48
8595249|NCT00321737|9630324|FG002|NOT COMPLETED|Overall Study||54
8595250|NCT00321763|9630336|FG000|STARTED|Overall Study||850
8595251|NCT00321763|9630337|FG001|STARTED|Overall Study||850
8595252|NCT00321763|9630338|FG002|STARTED|Overall Study||854
8595253|NCT00321763|9630339|FG003|STARTED|Overall Study||570
8595254|NCT00321763|9630336|FG000|COMPLETED|Overall Study||844
8595255|NCT00321763|9630337|FG001|COMPLETED|Overall Study||848
8595256|NCT00321763|9630338|FG002|COMPLETED|Overall Study||848
8595257|NCT00321763|9630339|FG003|COMPLETED|Overall Study||565
8595258|NCT00321763|9630336|FG000|NOT COMPLETED|Overall Study||6
8595259|NCT00321763|9630337|FG001|NOT COMPLETED|Overall Study||2
8595260|NCT00321763|9630338|FG002|NOT COMPLETED|Overall Study||6
8595261|NCT00321763|9630339|FG003|NOT COMPLETED|Overall Study||5
8595262|NCT00321789|9630353|FG000|STARTED|Overall Study||127
8595263|NCT00321789|9630354|FG001|STARTED|Overall Study||128
8595264|NCT00321789|9630353|FG000|COMPLETED|Overall Study||112
8595265|NCT00321789|9630354|FG001|COMPLETED|Overall Study||112
8595266|NCT00321789|9630353|FG000|NOT COMPLETED|Overall Study||15
8595267|NCT00321789|9630354|FG001|NOT COMPLETED|Overall Study||16
8595268|NCT00321828|9630360|FG000|STARTED|Overall Study||90
8595269|NCT00321828|9630360|FG000|COMPLETED|Overall Study||86
8595270|NCT00321828|9630360|FG000|NOT COMPLETED|Overall Study||4
8595271|NCT00321854|9630366|FG000|STARTED|Overall Study||261
8595272|NCT00321854|9630367|FG001|STARTED|Overall Study||274
8595273|NCT00321854|9630366|FG000|COMPLETED|Overall Study||198
8595274|NCT00321854|9630367|FG001|COMPLETED|Overall Study||192
8595275|NCT00321854|9630366|FG000|NOT COMPLETED|Overall Study||63
8595276|NCT00321854|9630367|FG001|NOT COMPLETED|Overall Study||82
8595277|NCT00321893|9630377|FG000|STARTED|Overall Study||101
8595278|NCT00321893|9630378|FG001|STARTED|Overall Study||101
8595279|NCT00321893|9630377|FG000|COMPLETED|Overall Study||77
8595280|NCT00321893|9630378|FG001|COMPLETED|Overall Study||87
8595281|NCT00321893|9630377|FG000|NOT COMPLETED|Overall Study||24
8595282|NCT00321893|9630378|FG001|NOT COMPLETED|Overall Study||14
8595283|NCT00321906|9630386|FG000|STARTED|Overall Study||94
8595284|NCT00321906|9630387|FG001|STARTED|Overall Study||87
8595285|NCT00321906|9630386|FG000|COMPLETED|Overall Study||48
8595286|NCT00321906|9630387|FG001|COMPLETED|Overall Study||31
8595287|NCT00321906|9630386|FG000|NOT COMPLETED|Overall Study||46
8595288|NCT00321906|9630387|FG001|NOT COMPLETED|Overall Study||56
8595289|NCT00321919|9630395|FG000|STARTED|Overall Study||301
8595290|NCT00321919|9630396|FG001|STARTED|Overall Study||302
8595291|NCT00321919|9630395|FG000|COMPLETED|Overall Study||226
8595292|NCT00321919|9630396|FG001|COMPLETED|Overall Study||250
8595293|NCT00321919|9630395|FG000|NOT COMPLETED|Overall Study||75
8595294|NCT00321919|9630396|FG001|NOT COMPLETED|Overall Study||52
8628258|NCT00522379|9667667|FG001|NOT COMPLETED|Overall Study||23
8628259|NCT00522379|9667668|FG002|NOT COMPLETED|Overall Study||22
8628260|NCT00522379|9667669|FG003|NOT COMPLETED|Overall Study||14
8628261|NCT00522379|9667670|FG004|NOT COMPLETED|Overall Study||27
8628262|NCT00522392|9667684|FG000|STARTED|Overall Study||23
8628263|NCT00522392|9667685|FG001|STARTED|Overall Study||25
8628264|NCT00522392|9667684|FG000|Pts w/ Measurable Disease at Baseline|Overall Study||16
8628265|NCT00522392|9667685|FG001|Pts w/ Measurable Disease at Baseline|Overall Study||16
8628266|NCT00522392|9667684|FG000|Pts w/ QOL Assessments Complete|Overall Study||12
8628267|NCT00522392|9667685|FG001|Pts w/ QOL Assessments Complete|Overall Study||8
8628268|NCT00522392|9667684|FG000|COMPLETED|Overall Study||15
8628269|NCT00522392|9667685|FG001|COMPLETED|Overall Study||12
8628270|NCT00522392|9667684|FG000|NOT COMPLETED|Overall Study||8
8628271|NCT00522392|9667685|FG001|NOT COMPLETED|Overall Study||13
8628272|NCT00522418|9667693|FG000|STARTED|Overall Study||59
8628273|NCT00522418|9667694|FG001|STARTED|Overall Study||63
8628274|NCT00522418|9667693|FG000|Safety Set|Overall Study|Data of 5 randomized patients removed due to lack of ICF approval by site's local ethics committee.|54
8628275|NCT00522418|9667694|FG001|Safety Set|Overall Study|Data of 5 randomized patients removed due to lack of ICF approval by site's local ethics committee.|58
8628276|NCT00522418|9667693|FG000|Efficacy Set|Overall Study|6 pts. data excluded: exited prior to collection of baseline data & one postbaseline followup QOLIE|48
8628277|NCT00522418|9667694|FG001|Efficacy Set|Overall Study|10 pts. data excluded: exited prior to collection of baseline data & one postbaseline followup QOLIE|48
8628278|NCT00522418|9667693|FG000|Baseline and Month 3|Overall Study|Completed Baseline and Month 3|47
8628279|NCT00522418|9667694|FG001|Baseline and Month 3|Overall Study|Completed Baseline and Month 3|47
8628280|NCT00522418|9667693|FG000|Baseline and Month 6|Overall Study|Completed Baseline and Month 6|38
8628281|NCT00522418|9667694|FG001|Baseline and Month 6|Overall Study|Completed Baseline and Month 6|45
8628282|NCT00522418|9667693|FG000|Baseline and Month 9|Overall Study|Completed Baseline and Month 9|33
8628283|NCT00522418|9667694|FG001|Baseline and Month 9|Overall Study|Completed Baseline and Month 9|35
8628284|NCT00522418|9667693|FG000|Baseline and Month 12|Overall Study|Completed Baseline and Month 12|31
8628285|NCT00522418|9667694|FG001|Baseline and Month 12|Overall Study|Completed Baseline and Month 12|29
8628286|NCT00522418|9667693|FG000|COMPLETED|Overall Study|Completed 2-year follow-up|2
8628287|NCT00522418|9667694|FG001|COMPLETED|Overall Study|Completed 2-year follow-up|5
8595295|NCT00321932|9630405|FG000|STARTED|Overall Study||29
8595296|NCT00321932|9630406|FG001|STARTED|Overall Study||32
8595297|NCT00321932|9630405|FG000|COMPLETED|Overall Study||19
8595298|NCT00321932|9630406|FG001|COMPLETED|Overall Study||11
8595299|NCT00321932|9630405|FG000|NOT COMPLETED|Overall Study||10
8595300|NCT00321932|9630406|FG001|NOT COMPLETED|Overall Study||21
8595301|NCT00321971|9630415|FG000|STARTED|Overall Study|Subject recruitment began in February 2007 and ended in December 2011|36
8595302|NCT00321971|9630416|FG001|STARTED|Overall Study||37
8595303|NCT00321971|9630415|FG000|COMPLETED|Overall Study||28
8595304|NCT00321971|9630416|FG001|COMPLETED|Overall Study||26
8595305|NCT00321971|9630415|FG000|NOT COMPLETED|Overall Study||8
8595306|NCT00321971|9630416|FG001|NOT COMPLETED|Overall Study||11
8595307|NCT00321984|9630425|FG000|STARTED|Overall Study||317
8595308|NCT00321984|9630426|FG001|STARTED|Overall Study||315
8595309|NCT00321984|9630427|FG002|STARTED|Overall Study||315
8595310|NCT00321984|9630425|FG000|COMPLETED|Overall Study||290
8595311|NCT00321984|9630426|FG001|COMPLETED|Overall Study||294
8595312|NCT00321984|9630427|FG002|COMPLETED|Overall Study||289
8595313|NCT00321984|9630425|FG000|NOT COMPLETED|Overall Study||27
8595314|NCT00321984|9630426|FG001|NOT COMPLETED|Overall Study||21
8595315|NCT00321984|9630427|FG002|NOT COMPLETED|Overall Study||26
8595316|NCT00322023|9630438|FG000|STARTED|Overall Study||12
8595317|NCT00322023|9630439|FG001|STARTED|Overall Study||21
8595318|NCT00322023|9630440|FG002|STARTED|Overall Study||22
8595319|NCT00322023|9630438|FG000|COMPLETED|Overall Study||12
8595320|NCT00322023|9630439|FG001|COMPLETED|Overall Study||19
8595321|NCT00322023|9630440|FG002|COMPLETED|Overall Study||16
8595322|NCT00322023|9630438|FG000|NOT COMPLETED|Overall Study||0
8595323|NCT00322023|9630439|FG001|NOT COMPLETED|Overall Study||2
8595324|NCT00322023|9630440|FG002|NOT COMPLETED|Overall Study||6
8595325|NCT00322049|9630452|FG000|STARTED|Overall Study||4
8595326|NCT00322049|9630453|FG001|STARTED|Overall Study||10
8595327|NCT00322049|9630454|FG002|STARTED|Overall Study||20
8595328|NCT00322049|9630455|FG003|STARTED|Overall Study||17
8595329|NCT00322049|9630452|FG000|COMPLETED|Overall Study||4
8595330|NCT00322049|9630453|FG001|COMPLETED|Overall Study||9
8595331|NCT00322049|9630454|FG002|COMPLETED|Overall Study||20
8595332|NCT00322049|9630455|FG003|COMPLETED|Overall Study||16
8595333|NCT00322049|9630452|FG000|NOT COMPLETED|Overall Study||0
8595334|NCT00322049|9630453|FG001|NOT COMPLETED|Overall Study||1
8595335|NCT00322049|9630454|FG002|NOT COMPLETED|Overall Study||0
8595336|NCT00322049|9630455|FG003|NOT COMPLETED|Overall Study||1
8595337|NCT00322101|9630476|FG000|STARTED|Overall Study||14
8595338|NCT00322101|9630477|FG001|STARTED|Overall Study||11
8595339|NCT00322101|9630476|FG000|COMPLETED|Overall Study||14
8595340|NCT00322101|9630477|FG001|COMPLETED|Overall Study||11
8595341|NCT00322101|9630476|FG000|NOT COMPLETED|Overall Study||0
8595342|NCT00322101|9630477|FG001|NOT COMPLETED|Overall Study||0
8595343|NCT00322153|9630485|FG000|STARTED|Overall Study|Randomized to placebo|335
8595344|NCT00322153|9630486|FG001|STARTED|Overall Study|Randomized to Memantine ER|342
8595345|NCT00322153|9630485|FG000|SAFETY POPULATION|Overall Study|Safety population defined as all patients who took at least one dose of double-blind study drug.|335
8595346|NCT00322153|9630486|FG001|SAFETY POPULATION|Overall Study|Safety population: one patient was randomized but did not receive double-blind study drug.|341
8595347|NCT00322153|9630485|FG000|COMPLETED|Overall Study||272
8595348|NCT00322153|9630486|FG001|COMPLETED|Overall Study||273
8595349|NCT00322153|9630485|FG000|NOT COMPLETED|Overall Study||63
8595350|NCT00322153|9630486|FG001|NOT COMPLETED|Overall Study||69
8595351|NCT00322231|9630494|FG000|STARTED|Period 1||51
8595352|NCT00322231|9630495|FG001|STARTED|Period 1||50
8595353|NCT00322231|9630494|FG000|COMPLETED|Period 1||51
8595354|NCT00322231|9630495|FG001|COMPLETED|Period 1||50
8595355|NCT00322231|9630494|FG000|NOT COMPLETED|Period 1||0
8595356|NCT00322231|9630495|FG001|NOT COMPLETED|Period 1||0
8595357|NCT00322231|9630494|FG000|STARTED|Period 2||51
8595358|NCT00322231|9630495|FG001|STARTED|Period 2|One participant was lost between Period 1 and Period 2|49
8595359|NCT00322231|9630494|FG000|COMPLETED|Period 2||51
8595360|NCT00322231|9630495|FG001|COMPLETED|Period 2||49
8595361|NCT00322231|9630494|FG000|NOT COMPLETED|Period 2||0
8595362|NCT00322231|9630495|FG001|NOT COMPLETED|Period 2||0
8595363|NCT00322309|9630507|FG000|STARTED|Overall Study||11
8595364|NCT00322309|9630508|FG001|STARTED|Overall Study||13
8595365|NCT00322309|9630507|FG000|COMPLETED|Overall Study||9
8595366|NCT00322309|9630508|FG001|COMPLETED|Overall Study||9
8595367|NCT00322309|9630507|FG000|NOT COMPLETED|Overall Study||2
8595368|NCT00322309|9630508|FG001|NOT COMPLETED|Overall Study||4
8595369|NCT00322335|9630520|FG000|STARTED|Subjects 18 Months After Booster Dose||58
8595370|NCT00322335|9630521|FG001|STARTED|Subjects 18 Months After Booster Dose||123
8595371|NCT00322335|9630522|FG002|STARTED|Subjects 18 Months After Booster Dose|Subjects who received Meningitec booster outside scope study NCT00323050 eliminated from this period|3
8595372|NCT00322335|9630520|FG000|COMPLETED|Subjects 18 Months After Booster Dose||58
8595373|NCT00322335|9630521|FG001|COMPLETED|Subjects 18 Months After Booster Dose||123
8595374|NCT00322335|9630522|FG002|COMPLETED|Subjects 18 Months After Booster Dose||3
8595375|NCT00322335|9630520|FG000|NOT COMPLETED|Subjects 18 Months After Booster Dose||0
8595376|NCT00322335|9630521|FG001|NOT COMPLETED|Subjects 18 Months After Booster Dose||0
8595377|NCT00322335|9630522|FG002|NOT COMPLETED|Subjects 18 Months After Booster Dose||0
8595378|NCT00322335|9630520|FG000|STARTED|Subjects 30 Months After Booster Dose||54
8595379|NCT00322335|9630521|FG001|STARTED|Subjects 30 Months After Booster Dose||119
8595380|NCT00322335|9630522|FG002|STARTED|Subjects 30 Months After Booster Dose|Subjects eliminated from previous timepoint were included again from this timepoint onwards|57
8595381|NCT00322335|9630520|FG000|COMPLETED|Subjects 30 Months After Booster Dose||54
8595382|NCT00322335|9630521|FG001|COMPLETED|Subjects 30 Months After Booster Dose||119
8595383|NCT00322335|9630522|FG002|COMPLETED|Subjects 30 Months After Booster Dose||57
8595384|NCT00322335|9630520|FG000|NOT COMPLETED|Subjects 30 Months After Booster Dose||0
8595385|NCT00322335|9630521|FG001|NOT COMPLETED|Subjects 30 Months After Booster Dose||0
8595386|NCT00322335|9630522|FG002|NOT COMPLETED|Subjects 30 Months After Booster Dose||0
8595387|NCT00322335|9630520|FG000|STARTED|Subjects 42 Months After Booster Dose||51
8595388|NCT00322335|9630521|FG001|STARTED|Subjects 42 Months After Booster Dose||113
8595389|NCT00322335|9630522|FG002|STARTED|Subjects 42 Months After Booster Dose||56
8595390|NCT00322335|9630520|FG000|COMPLETED|Subjects 42 Months After Booster Dose||51
8595391|NCT00322335|9630521|FG001|COMPLETED|Subjects 42 Months After Booster Dose||113
8595392|NCT00322335|9630522|FG002|COMPLETED|Subjects 42 Months After Booster Dose||56
8595393|NCT00322335|9630520|FG000|NOT COMPLETED|Subjects 42 Months After Booster Dose||0
8595394|NCT00322335|9630521|FG001|NOT COMPLETED|Subjects 42 Months After Booster Dose||0
8595395|NCT00322335|9630522|FG002|NOT COMPLETED|Subjects 42 Months After Booster Dose||0
8595396|NCT00322335|9630520|FG000|STARTED|Subjects 54 Months After Booster Dose||50
8595397|NCT00322335|9630521|FG001|STARTED|Subjects 54 Months After Booster Dose||108
8595398|NCT00322335|9630522|FG002|STARTED|Subjects 54 Months After Booster Dose||56
8595399|NCT00322335|9630520|FG000|COMPLETED|Subjects 54 Months After Booster Dose||50
8595400|NCT00322335|9630521|FG001|COMPLETED|Subjects 54 Months After Booster Dose||108
8595401|NCT00322335|9630522|FG002|COMPLETED|Subjects 54 Months After Booster Dose||56
8595402|NCT00322335|9630520|FG000|NOT COMPLETED|Subjects 54 Months After Booster Dose||0
8595403|NCT00322335|9630521|FG001|NOT COMPLETED|Subjects 54 Months After Booster Dose||0
8595404|NCT00322335|9630522|FG002|NOT COMPLETED|Subjects 54 Months After Booster Dose||0
8595405|NCT00322335|9630520|FG000|STARTED|Subjects 66 Months After Booster Dose||48
8595406|NCT00322335|9630521|FG001|STARTED|Subjects 66 Months After Booster Dose||104
8595407|NCT00322335|9630522|FG002|STARTED|Subjects 66 Months After Booster Dose||53
8595408|NCT00322335|9630520|FG000|COMPLETED|Subjects 66 Months After Booster Dose||48
8595409|NCT00322335|9630521|FG001|COMPLETED|Subjects 66 Months After Booster Dose||104
8595410|NCT00322335|9630522|FG002|COMPLETED|Subjects 66 Months After Booster Dose||53
8595411|NCT00322335|9630520|FG000|NOT COMPLETED|Subjects 66 Months After Booster Dose||0
8595412|NCT00322335|9630521|FG001|NOT COMPLETED|Subjects 66 Months After Booster Dose||0
8595413|NCT00322335|9630522|FG002|NOT COMPLETED|Subjects 66 Months After Booster Dose||0
8595414|NCT00322348|9630532|FG000|STARTED|Overall Study||49
8595415|NCT00322348|9630533|FG001|STARTED|Overall Study||49
8595416|NCT00322348|9630532|FG000|Received Study Treatment|Overall Study||50
8595417|NCT00322348|9630533|FG001|Received Study Treatment|Overall Study||48
8595418|NCT00322348|9630532|FG000|COMPLETED|Overall Study|Number of participants completed up to Week 96|12
8595419|NCT00322348|9630533|FG001|COMPLETED|Overall Study|Number of participants completed up to Week 96|16
8595420|NCT00322348|9630532|FG000|NOT COMPLETED|Overall Study||37
8595421|NCT00322348|9630533|FG001|NOT COMPLETED|Overall Study||33
8595422|NCT00322374|9630542|FG000|STARTED|Enrollment||0
8595423|NCT00322374|9630543|FG001|STARTED|Enrollment||0
8595424|NCT00322374|9630544|FG002|STARTED|Enrollment||0
8595425|NCT00322374|9630545|FG003|STARTED|Enrollment||42
8595426|NCT00322374|9630542|FG000|COMPLETED|Enrollment||0
8595427|NCT00322374|9630543|FG001|COMPLETED|Enrollment||0
8595428|NCT00322374|9630544|FG002|COMPLETED|Enrollment||0
8595429|NCT00322374|9630545|FG003|COMPLETED|Enrollment||42
8595430|NCT00322374|9630542|FG000|NOT COMPLETED|Enrollment||0
8595431|NCT00322374|9630543|FG001|NOT COMPLETED|Enrollment||0
8595432|NCT00322374|9630544|FG002|NOT COMPLETED|Enrollment||0
8595433|NCT00322374|9630545|FG003|NOT COMPLETED|Enrollment||0
8595434|NCT00322374|9630542|FG000|STARTED|Starting Dose||6
8595435|NCT00322374|9630543|FG001|STARTED|Starting Dose||0
8595436|NCT00322374|9630544|FG002|STARTED|Starting Dose||0
8595437|NCT00322374|9630545|FG003|STARTED|Starting Dose||0
8595438|NCT00322374|9630542|FG000|COMPLETED|Starting Dose||0
8595439|NCT00322374|9630543|FG001|COMPLETED|Starting Dose||0
8595440|NCT00322374|9630544|FG002|COMPLETED|Starting Dose||0
8595441|NCT00322374|9630545|FG003|COMPLETED|Starting Dose||0
8595442|NCT00322374|9630542|FG000|NOT COMPLETED|Starting Dose||6
8712982|NCT00972517|9759738|FG004|STARTED|Overall Study||34
8712983|NCT00972517|9759739|FG005|STARTED|Overall Study||58
8712984|NCT00972517|9759734|FG000|COMPLETED|Overall Study||31
8712985|NCT00972517|9759735|FG001|COMPLETED|Overall Study||30
8712986|NCT00972517|9759736|FG002|COMPLETED|Overall Study||60
8595443|NCT00322374|9630543|FG001|NOT COMPLETED|Starting Dose||0
8595444|NCT00322374|9630544|FG002|NOT COMPLETED|Starting Dose||0
8595445|NCT00322374|9630545|FG003|NOT COMPLETED|Starting Dose||0
8595446|NCT00322374|9630542|FG000|STARTED|First Escalation||0
8595447|NCT00322374|9630543|FG001|STARTED|First Escalation||30
8595448|NCT00322374|9630544|FG002|STARTED|First Escalation||0
8595449|NCT00322374|9630545|FG003|STARTED|First Escalation||0
8595450|NCT00322374|9630542|FG000|COMPLETED|First Escalation||0
8595451|NCT00322374|9630543|FG001|COMPLETED|First Escalation||0
8595452|NCT00322374|9630544|FG002|COMPLETED|First Escalation||0
8595453|NCT00322374|9630545|FG003|COMPLETED|First Escalation||0
8595454|NCT00322374|9630542|FG000|NOT COMPLETED|First Escalation||0
8712987|NCT00972517|9759737|FG003|COMPLETED|Overall Study||27
8712988|NCT00972517|9759738|FG004|COMPLETED|Overall Study||33
8595455|NCT00322374|9630543|FG001|NOT COMPLETED|First Escalation||30
8595456|NCT00322374|9630544|FG002|NOT COMPLETED|First Escalation||0
8595457|NCT00322374|9630545|FG003|NOT COMPLETED|First Escalation||0
8595458|NCT00322374|9630542|FG000|STARTED|Second Escalation||0
8595459|NCT00322374|9630543|FG001|STARTED|Second Escalation||0
8595460|NCT00322374|9630544|FG002|STARTED|Second Escalation||6
8595461|NCT00322374|9630545|FG003|STARTED|Second Escalation||0
8595462|NCT00322374|9630542|FG000|COMPLETED|Second Escalation||0
8595463|NCT00322374|9630543|FG001|COMPLETED|Second Escalation||0
8595464|NCT00322374|9630544|FG002|COMPLETED|Second Escalation||0
8595465|NCT00322374|9630545|FG003|COMPLETED|Second Escalation||0
8595466|NCT00322374|9630542|FG000|NOT COMPLETED|Second Escalation||0
8595467|NCT00322374|9630543|FG001|NOT COMPLETED|Second Escalation||0
8595468|NCT00322374|9630544|FG002|NOT COMPLETED|Second Escalation||6
8595469|NCT00322374|9630545|FG003|NOT COMPLETED|Second Escalation||0
8595470|NCT00322387|9630560|FG000|STARTED|Treatment Period|Plerixafor PM=7, Plerixafor AM=6, Low CD34+ Count/Plerixafor PM=0, and Plerixafor After Chemo=1|14
8595471|NCT00322387|9630561|FG001|STARTED|Treatment Period|Plerixafor PM=12, Plerixafor AM=9, Low CD34+ Count/Plerixafor PM=1, and Plerixafor After Chemo=4|26
8595472|NCT00322387|9630560|FG000|COMPLETED|Treatment Period|Completed refers to completed all treatment visits.|14
8595473|NCT00322387|9630561|FG001|COMPLETED|Treatment Period|Completed refers to completed all treatment visits.|25
8595474|NCT00322387|9630560|FG000|NOT COMPLETED|Treatment Period||0
8595475|NCT00322387|9630561|FG001|NOT COMPLETED|Treatment Period||1
8595476|NCT00322387|9630560|FG000|STARTED|Follow-up Period|Participants who had transplants|14
8595477|NCT00322387|9630561|FG001|STARTED|Follow-up Period|Participants who had transplants. One participant did not complete therapy but had a transplant.|26
8595478|NCT00322387|9630560|FG000|COMPLETED|Follow-up Period|Follow-up visit 12 months post-transplant|12
8595479|NCT00322387|9630561|FG001|COMPLETED|Follow-up Period|Follow-up visit 12 months post-transplant|23
8595480|NCT00322387|9630560|FG000|NOT COMPLETED|Follow-up Period||2
8595481|NCT00322387|9630561|FG001|NOT COMPLETED|Follow-up Period||3
8595482|NCT00322439|9630578|FG000|STARTED|Overall Study||2511
8595483|NCT00322439|9630578|FG000|Received at Least 1 Dose of Etanercept|Overall Study||2510
8595484|NCT00322439|9630578|FG000|COMPLETED|Overall Study||1455
8595485|NCT00322439|9630578|FG000|NOT COMPLETED|Overall Study||1056
8595486|NCT00322452|9630584|FG000|STARTED|Overall Study|Number of patients randomized|609
8595487|NCT00322452|9630585|FG001|STARTED|Overall Study|Number of patients randomized|608
8595488|NCT00322452|9630584|FG000|COMPLETED|Overall Study|Patients still in study at PFS Data Cut Off (14 April 2008), 97 remained at OS DCO (14 June 2010)|362
8595489|NCT00322452|9630585|FG001|COMPLETED|Overall Study|Patients still in study at PFS Data Cut Off (14 April 2008), 84 remained at OS DCO (14 June 2010)|332
8595490|NCT00322452|9630584|FG000|NOT COMPLETED|Overall Study||247
8595491|NCT00322452|9630585|FG001|NOT COMPLETED|Overall Study||276
8595492|NCT00322465|9630595|FG000|STARTED|Overall Study|Randomized|76
8595493|NCT00322465|9630596|FG001|STARTED|Overall Study|Randomized|73
8595494|NCT00322465|9630597|FG002|STARTED|Overall Study|Randomized|77
8595495|NCT00322465|9630598|FG003|STARTED|Overall Study|Randomized|79
8595496|NCT00322465|9630595|FG000|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|56
8595497|NCT00322465|9630596|FG001|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|49
8595498|NCT00322465|9630597|FG002|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|51
8595499|NCT00322465|9630598|FG003|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|53
8595500|NCT00322465|9630595|FG000|NOT COMPLETED|Overall Study||20
8595501|NCT00322465|9630596|FG001|NOT COMPLETED|Overall Study||24
8595502|NCT00322465|9630597|FG002|NOT COMPLETED|Overall Study||26
8595503|NCT00322465|9630598|FG003|NOT COMPLETED|Overall Study||26
8595504|NCT00322491|9630613|FG000|STARTED|Overall Study||23
8595505|NCT00322491|9630614|FG001|STARTED|Overall Study||26
8595506|NCT00322491|9630613|FG000|COMPLETED|Overall Study||21
8595507|NCT00322491|9630614|FG001|COMPLETED|Overall Study||24
8595508|NCT00322491|9630613|FG000|NOT COMPLETED|Overall Study||2
8595509|NCT00322491|9630614|FG001|NOT COMPLETED|Overall Study||2
8595510|NCT00322556|9630621|FG000|STARTED|Overall Study||55
8595511|NCT00322556|9630621|FG000|COMPLETED|Overall Study||43
8595512|NCT00322556|9630621|FG000|NOT COMPLETED|Overall Study||12
8595513|NCT00322621|9630628|FG000|STARTED|Period II - Acute Therapy Phase||216
8595514|NCT00322621|9630629|FG001|STARTED|Period II - Acute Therapy Phase||0
8595515|NCT00322621|9630630|FG002|STARTED|Period II - Acute Therapy Phase||0
8595516|NCT00322621|9630628|FG000|COMPLETED|Period II - Acute Therapy Phase||184
8595517|NCT00322621|9630629|FG001|COMPLETED|Period II - Acute Therapy Phase||0
8595518|NCT00322621|9630630|FG002|COMPLETED|Period II - Acute Therapy Phase||0
8595519|NCT00322621|9630628|FG000|NOT COMPLETED|Period II - Acute Therapy Phase||32
8595520|NCT00322621|9630629|FG001|NOT COMPLETED|Period II - Acute Therapy Phase||0
8595521|NCT00322621|9630630|FG002|NOT COMPLETED|Period II - Acute Therapy Phase||0
8595522|NCT00322621|9630628|FG000|STARTED|Period III - Maintenance / Rescue Phase||0
8595523|NCT00322621|9630629|FG001|STARTED|Period III - Maintenance / Rescue Phase||115
8595524|NCT00322621|9630630|FG002|STARTED|Period III - Maintenance / Rescue Phase||69
8595525|NCT00322621|9630628|FG000|COMPLETED|Period III - Maintenance / Rescue Phase||0
8595526|NCT00322621|9630629|FG001|COMPLETED|Period III - Maintenance / Rescue Phase||86
8595527|NCT00322621|9630630|FG002|COMPLETED|Period III - Maintenance / Rescue Phase||33
8595528|NCT00322621|9630628|FG000|NOT COMPLETED|Period III - Maintenance / Rescue Phase||0
8595529|NCT00322621|9630629|FG001|NOT COMPLETED|Period III - Maintenance / Rescue Phase||29
8595530|NCT00322621|9630630|FG002|NOT COMPLETED|Period III - Maintenance / Rescue Phase||36
8595531|NCT00322712|9630643|FG000|STARTED|Overall Study||12
8595532|NCT00322712|9630643|FG000|COMPLETED|Overall Study||11
8595533|NCT00322712|9630643|FG000|NOT COMPLETED|Overall Study||1
8595534|NCT00322777|9630649|FG000|STARTED|Overall Study||39
8595535|NCT00322777|9630650|FG001|STARTED|Overall Study||45
8595536|NCT00322777|9630649|FG000|"Data Collection at BASELINE|"|Overall Study||39
8595537|NCT00322777|9630650|FG001|"Data Collection at BASELINE|"|Overall Study||45
8595538|NCT00322777|9630649|FG000|Data Collection at Week 8|Overall Study||39
8595539|NCT00322777|9630650|FG001|Data Collection at Week 8|Overall Study||45
8595540|NCT00322777|9630649|FG000|Data Collection at Week 16|Overall Study||39
8595541|NCT00322777|9630650|FG001|Data Collection at Week 16|Overall Study||45
8595542|NCT00322777|9630649|FG000|Data Collection at Week 24|Overall Study||39
8595543|NCT00322777|9630650|FG001|Data Collection at Week 24|Overall Study||45
8595544|NCT00322777|9630649|FG000|COMPLETED|Overall Study||39
8595545|NCT00322777|9630650|FG001|COMPLETED|Overall Study||45
8595546|NCT00322777|9630649|FG000|NOT COMPLETED|Overall Study||0
8595547|NCT00322777|9630650|FG001|NOT COMPLETED|Overall Study||0
8595548|NCT00322842|9630658|FG000|STARTED|Overall Study||4
8595549|NCT00322842|9630659|FG001|STARTED|Overall Study||31
8595550|NCT00322842|9630658|FG000|COMPLETED|Overall Study|One participant discontinued (d/c) treatment early, received a transplant, and completed the study.|2
8595551|NCT00322842|9630659|FG001|COMPLETED|Overall Study|One participant d/c treatment early, received a transplant, and was lost to follow-up after 6 months|29
8595552|NCT00322842|9630658|FG000|NOT COMPLETED|Overall Study||2
8595553|NCT00322842|9630659|FG001|NOT COMPLETED|Overall Study||2
8595554|NCT00322868|9630666|FG000|STARTED|Overall Study||21
8595555|NCT00322868|9630666|FG000|COMPLETED|Overall Study||20
8595556|NCT00322868|9630666|FG000|NOT COMPLETED|Overall Study||1
8595557|NCT00322881|9630671|FG000|STARTED|Overall Study||12
8595558|NCT00322881|9630671|FG000|COMPLETED|Overall Study||7
8595559|NCT00322881|9630671|FG000|NOT COMPLETED|Overall Study||5
8595560|NCT00323063|9630677|FG000|STARTED|Overall Study||26
8595561|NCT00323063|9630678|FG001|STARTED|Overall Study||23
8595562|NCT00323063|9630677|FG000|COMPLETED|Overall Study||24
8595563|NCT00323063|9630678|FG001|COMPLETED|Overall Study||23
8595564|NCT00323063|9630677|FG000|NOT COMPLETED|Overall Study||2
8595565|NCT00323063|9630678|FG001|NOT COMPLETED|Overall Study||0
8595566|NCT00323115|9630684|FG000|STARTED|Vaccine Administration||11
8595567|NCT00323115|9630684|FG000|COMPLETED|Vaccine Administration||10
8595568|NCT00323115|9630684|FG000|NOT COMPLETED|Vaccine Administration||1
8595569|NCT00323115|9630684|FG000|STARTED|Adjuvant Therapy & Survival Follow-Up||10
8595570|NCT00323115|9630684|FG000|COMPLETED|Adjuvant Therapy & Survival Follow-Up||2
8595571|NCT00323115|9630684|FG000|NOT COMPLETED|Adjuvant Therapy & Survival Follow-Up||8
8595572|NCT00323193|9630695|FG000|STARTED|Overall Study||53
8595573|NCT00323193|9630696|FG001|STARTED|Overall Study||56
8595574|NCT00323193|9630695|FG000|COMPLETED|Overall Study||30
8595575|NCT00323193|9630696|FG001|COMPLETED|Overall Study||41
8595576|NCT00323193|9630695|FG000|NOT COMPLETED|Overall Study||23
8595577|NCT00323193|9630696|FG001|NOT COMPLETED|Overall Study||15
8595578|NCT00323258|9630704|FG000|STARTED|Primary Outcome (Phone Call at 6 Months)||71
8595579|NCT00323258|9630705|FG001|STARTED|Primary Outcome (Phone Call at 6 Months)||72
8595580|NCT00323258|9630704|FG000|COMPLETED|Primary Outcome (Phone Call at 6 Months)||55
8595581|NCT00323258|9630705|FG001|COMPLETED|Primary Outcome (Phone Call at 6 Months)||53
8595582|NCT00323258|9630704|FG000|NOT COMPLETED|Primary Outcome (Phone Call at 6 Months)||16
8595583|NCT00323258|9630705|FG001|NOT COMPLETED|Primary Outcome (Phone Call at 6 Months)||19
8595584|NCT00323258|9630704|FG000|STARTED|Secondary Outcome (6 Mon Refill Records)||71
8595585|NCT00323258|9630705|FG001|STARTED|Secondary Outcome (6 Mon Refill Records)||72
8595586|NCT00323258|9630704|FG000|COMPLETED|Secondary Outcome (6 Mon Refill Records)||57
8595587|NCT00323258|9630705|FG001|COMPLETED|Secondary Outcome (6 Mon Refill Records)||58
8595588|NCT00323258|9630704|FG000|NOT COMPLETED|Secondary Outcome (6 Mon Refill Records)||14
8595589|NCT00323258|9630705|FG001|NOT COMPLETED|Secondary Outcome (6 Mon Refill Records)||14
8595590|NCT00323271|9630713|FG000|STARTED|Overall Study||13
8595591|NCT00323271|9630714|FG001|STARTED|Overall Study||12
8595592|NCT00323271|9630713|FG000|COMPLETED|Overall Study||11
8595593|NCT00323271|9630714|FG001|COMPLETED|Overall Study||9
8595594|NCT00323271|9630713|FG000|NOT COMPLETED|Overall Study||2
8595595|NCT00323271|9630714|FG001|NOT COMPLETED|Overall Study||3
8595596|NCT00323284|9630722|FG000|STARTED|12 Months Follow-up||116
8595597|NCT00323284|9630723|FG001|STARTED|12 Months Follow-up||123
8595598|NCT00323284|9630722|FG000|COMPLETED|12 Months Follow-up||111
8595599|NCT00323284|9630723|FG001|COMPLETED|12 Months Follow-up||114
8595600|NCT00323284|9630722|FG000|NOT COMPLETED|12 Months Follow-up||5
8595601|NCT00323284|9630723|FG001|NOT COMPLETED|12 Months Follow-up||9
8595602|NCT00323284|9630722|FG000|STARTED|24 Months Follow-up||116
8595603|NCT00323284|9630723|FG001|STARTED|24 Months Follow-up||123
8595604|NCT00323284|9630722|FG000|COMPLETED|24 Months Follow-up||98
8595605|NCT00323284|9630723|FG001|COMPLETED|24 Months Follow-up||101
8595606|NCT00323284|9630722|FG000|NOT COMPLETED|24 Months Follow-up||18
8595607|NCT00323284|9630723|FG001|NOT COMPLETED|24 Months Follow-up||22
8595608|NCT00323297|9630731|FG000|STARTED|Part A (Double Blind Randomized)||53
8595609|NCT00323297|9630732|FG001|STARTED|Part A (Double Blind Randomized)||50
8595610|NCT00323297|9630731|FG000|COMPLETED|Part A (Double Blind Randomized)||48
8595611|NCT00323297|9630732|FG001|COMPLETED|Part A (Double Blind Randomized)||43
8628288|NCT00522418|9667693|FG000|NOT COMPLETED|Overall Study||57
8595612|NCT00323297|9630731|FG000|NOT COMPLETED|Part A (Double Blind Randomized)||5
8595613|NCT00323297|9630732|FG001|NOT COMPLETED|Part A (Double Blind Randomized)||7
8595614|NCT00323297|9630731|FG000|STARTED|Part B (Open-label)||48
8712989|NCT00972517|9759739|FG005|COMPLETED|Overall Study||58
8712990|NCT00972517|9759734|FG000|NOT COMPLETED|Overall Study||0
8712991|NCT00972517|9759735|FG001|NOT COMPLETED|Overall Study||1
8712992|NCT00972517|9759736|FG002|NOT COMPLETED|Overall Study||0
8712993|NCT00972517|9759737|FG003|NOT COMPLETED|Overall Study||3
8712994|NCT00972517|9759738|FG004|NOT COMPLETED|Overall Study||1
8712995|NCT00972517|9759739|FG005|NOT COMPLETED|Overall Study||0
8712996|NCT00972530|9759761|FG000|STARTED|Overall Study||44
8712997|NCT00972530|9759762|FG001|STARTED|Overall Study||46
8712998|NCT00972530|9759761|FG000|COMPLETED|Overall Study||44
8712999|NCT00972530|9759762|FG001|COMPLETED|Overall Study||46
8713000|NCT00972530|9759761|FG000|NOT COMPLETED|Overall Study||0
8713001|NCT00972530|9759762|FG001|NOT COMPLETED|Overall Study||0
8713002|NCT00972543|9759770|FG000|STARTED|Overall Study||5
8713003|NCT00972543|9759771|FG001|STARTED|Overall Study||1
8713004|NCT00972543|9759770|FG000|COMPLETED|Overall Study||0
8713005|NCT00972543|9759771|FG001|COMPLETED|Overall Study||0
8595615|NCT00323297|9630732|FG001|STARTED|Part B (Open-label)||43
8595616|NCT00323297|9630731|FG000|COMPLETED|Part B (Open-label)||39
8595617|NCT00323297|9630732|FG001|COMPLETED|Part B (Open-label)||31
8595618|NCT00323297|9630731|FG000|NOT COMPLETED|Part B (Open-label)||9
8595619|NCT00323297|9630732|FG001|NOT COMPLETED|Part B (Open-label)||12
8595620|NCT00323310|9630738|FG000|STARTED|Overall Study||92
8595621|NCT00323310|9630738|FG000|COMPLETED|Overall Study||89
8595622|NCT00323310|9630738|FG000|NOT COMPLETED|Overall Study||3
8595623|NCT00323362|9630742|FG000|STARTED|Overall Study||17
8595624|NCT00323362|9630742|FG000|COMPLETED|Overall Study||17
8595625|NCT00323362|9630742|FG000|NOT COMPLETED|Overall Study||0
8595626|NCT00323414|9630748|FG000|STARTED|Overall Study||18
8595627|NCT00323414|9630749|FG001|STARTED|Overall Study||19
8595628|NCT00323414|9630748|FG000|COMPLETED|Overall Study||18
8595629|NCT00323414|9630749|FG001|COMPLETED|Overall Study||18
8595630|NCT00323414|9630748|FG000|NOT COMPLETED|Overall Study||0
8595631|NCT00323414|9630749|FG001|NOT COMPLETED|Overall Study||1
8595632|NCT00323427|9630757|FG000|STARTED|Overall Study||69
8595633|NCT00323427|9630758|FG001|STARTED|Overall Study||66
8595634|NCT00323427|9630757|FG000|COMPLETED|Overall Study||38
8595635|NCT00323427|9630758|FG001|COMPLETED|Overall Study||43
8595636|NCT00323427|9630757|FG000|NOT COMPLETED|Overall Study||31
8595637|NCT00323427|9630758|FG001|NOT COMPLETED|Overall Study||23
8595638|NCT00323453|9630766|FG000|STARTED|Overall Study||61
8595639|NCT00323453|9630767|FG001|STARTED|Overall Study||48
8595640|NCT00323453|9630766|FG000|COMPLETED|Overall Study||61
8595641|NCT00323453|9630767|FG001|COMPLETED|Overall Study||48
8595642|NCT00323453|9630766|FG000|NOT COMPLETED|Overall Study||0
8595643|NCT00323453|9630767|FG001|NOT COMPLETED|Overall Study||0
8595644|NCT00323479|9630773|FG000|STARTED|Overall Study||114
8595645|NCT00323479|9630773|FG000|Safety Population|Overall Study|Patients who taken at least one dose of treatment|110
8595646|NCT00323479|9630773|FG000|COMPLETED|Overall Study|with at least 1 evaluation for primary efficacy endpoint|106
8595647|NCT00323479|9630773|FG000|NOT COMPLETED|Overall Study||8
8595648|NCT00323492|9630779|FG000|STARTED|Study Phase 1||47
8595649|NCT00323492|9630780|FG001|STARTED|Study Phase 1||45
8595650|NCT00323492|9630781|FG002|STARTED|Study Phase 1|Not applicable to Phase 1.|0
8595651|NCT00323492|9630779|FG000|Intent-to-Treat (ITT) Analysis Set|Study Phase 1|One subject was excluded from ITT analysis set due to protocol violation.|46
8595652|NCT00323492|9630780|FG001|Intent-to-Treat (ITT) Analysis Set|Study Phase 1||45
8595653|NCT00323492|9630781|FG002|Intent-to-Treat (ITT) Analysis Set|Study Phase 1||0
8595654|NCT00323492|9630779|FG000|COMPLETED|Study Phase 1||45
8595655|NCT00323492|9630780|FG001|COMPLETED|Study Phase 1||45
8595656|NCT00323492|9630781|FG002|COMPLETED|Study Phase 1||0
8595657|NCT00323492|9630779|FG000|NOT COMPLETED|Study Phase 1||2
8595658|NCT00323492|9630780|FG001|NOT COMPLETED|Study Phase 1||0
8595659|NCT00323492|9630781|FG002|NOT COMPLETED|Study Phase 1||0
8595660|NCT00323492|9630779|FG000|STARTED|Study Phase 2|1/45 subjects completed Phase 1 but did not start Phase 2. Week 48 ITT N=46|44
8595661|NCT00323492|9630780|FG001|STARTED|Study Phase 2|2/45 subjects completed Phase 1 but did not start Phase 2. Week 48 ITT N=20 (no switch to Truvada)|18
8595662|NCT00323492|9630781|FG002|STARTED|Study Phase 2|N=25 switched to Truvada in Phase 2.|25
8595663|NCT00323492|9630779|FG000|COMPLETED|Study Phase 2||40
8595664|NCT00323492|9630780|FG001|COMPLETED|Study Phase 2||17
8595665|NCT00323492|9630781|FG002|COMPLETED|Study Phase 2||24
8595666|NCT00323492|9630779|FG000|NOT COMPLETED|Study Phase 2||4
8595667|NCT00323492|9630780|FG001|NOT COMPLETED|Study Phase 2||1
8595668|NCT00323492|9630781|FG002|NOT COMPLETED|Study Phase 2||1
8595669|NCT00323557|9630790|FG000|STARTED|Overall Study|GM-CSF pre and post vaccine.|25
8595670|NCT00323557|9630791|FG001|STARTED|Overall Study||7
8595671|NCT00323557|9630790|FG000|COMPLETED|Overall Study||24
8595672|NCT00323557|9630791|FG001|COMPLETED|Overall Study||7
8595673|NCT00323557|9630790|FG000|NOT COMPLETED|Overall Study||1
8595674|NCT00323557|9630791|FG001|NOT COMPLETED|Overall Study||0
8595675|NCT00323609|9630800|FG000|STARTED|Overall Study||191
8595676|NCT00323609|9630801|FG001|STARTED|Overall Study||190
8713006|NCT00972543|9759770|FG000|NOT COMPLETED|Overall Study||5
8713007|NCT00972543|9759771|FG001|NOT COMPLETED|Overall Study||1
8713008|NCT00972595|9759777|FG000|STARTED|Period 1||23
8713009|NCT00972595|9759778|FG001|STARTED|Period 1||22
8713010|NCT00972595|9759777|FG000|COMPLETED|Period 1||22
8595677|NCT00323609|9630802|FG002|STARTED|Overall Study||8
8595678|NCT00323609|9630803|FG003|STARTED|Overall Study||15
8595679|NCT00323609|9630800|FG000|COMPLETED|Overall Study|Revision retains subjects with follow-up data in a visit window when terminated in same visit window|100
8595680|NCT00323609|9630801|FG001|COMPLETED|Overall Study|Revision retains subjects with follow-up data in a visit window when terminated in same visit window|91
8595681|NCT00323609|9630802|FG002|COMPLETED|Overall Study||0
8595682|NCT00323609|9630803|FG003|COMPLETED|Overall Study||0
8595683|NCT00323609|9630800|FG000|NOT COMPLETED|Overall Study||91
8595684|NCT00323609|9630801|FG001|NOT COMPLETED|Overall Study||99
8595685|NCT00323609|9630802|FG002|NOT COMPLETED|Overall Study||8
8595686|NCT00323609|9630803|FG003|NOT COMPLETED|Overall Study||15
8595687|NCT00323622|9630817|FG000|STARTED|Overall Study||176
8595688|NCT00323622|9630818|FG001|STARTED|Overall Study||515
8595689|NCT00323622|9630819|FG002|STARTED|Overall Study||42
8595690|NCT00323622|9630820|FG003|STARTED|Overall Study||134
8595691|NCT00323622|9630821|FG004|STARTED|Overall Study||159
8595692|NCT00323622|9630822|FG005|STARTED|Overall Study||528
8595693|NCT00323622|9630823|FG006|STARTED|Overall Study||43
8595694|NCT00323622|9630824|FG007|STARTED|Overall Study||140
8595695|NCT00323622|9630817|FG000|COMPLETED|Overall Study||145
8595696|NCT00323622|9630818|FG001|COMPLETED|Overall Study||423
8595697|NCT00323622|9630819|FG002|COMPLETED|Overall Study||38
8595698|NCT00323622|9630820|FG003|COMPLETED|Overall Study||122
8595699|NCT00323622|9630821|FG004|COMPLETED|Overall Study||120
8595700|NCT00323622|9630822|FG005|COMPLETED|Overall Study||454
8595701|NCT00323622|9630823|FG006|COMPLETED|Overall Study||38
8595702|NCT00323622|9630824|FG007|COMPLETED|Overall Study||125
8595703|NCT00323622|9630817|FG000|NOT COMPLETED|Overall Study||31
8595704|NCT00323622|9630818|FG001|NOT COMPLETED|Overall Study||92
8595705|NCT00323622|9630819|FG002|NOT COMPLETED|Overall Study||4
8595706|NCT00323622|9630820|FG003|NOT COMPLETED|Overall Study||12
8595707|NCT00323622|9630821|FG004|NOT COMPLETED|Overall Study||39
8595708|NCT00323622|9630822|FG005|NOT COMPLETED|Overall Study||74
8595709|NCT00323622|9630823|FG006|NOT COMPLETED|Overall Study||5
8595710|NCT00323622|9630824|FG007|NOT COMPLETED|Overall Study||15
8595711|NCT00323739|9630850|FG000|STARTED|Overall Study||80
8595712|NCT00323739|9630850|FG000|COMPLETED|Overall Study||80
8595713|NCT00323739|9630850|FG000|NOT COMPLETED|Overall Study||0
8595714|NCT00323869|9630854|FG000|STARTED|Overall Study|Enrollment|48
8595715|NCT00323869|9630854|FG000|Treatment Initiation|Overall Study|One participant died before receiving therapy, not included in analysis|47
8595716|NCT00323869|9630854|FG000|COMPLETED|Overall Study||47
8595717|NCT00323869|9630854|FG000|NOT COMPLETED|Overall Study||1
8595718|NCT00323882|9630863|FG000|STARTED|Overall Study||8
8595719|NCT00323882|9630864|FG001|STARTED|Overall Study||6
8595720|NCT00323882|9630865|FG002|STARTED|Overall Study||16
8595721|NCT00323882|9630866|FG003|STARTED|Overall Study||7
8595722|NCT00323882|9630867|FG004|STARTED|Overall Study||34
8595723|NCT00323882|9630863|FG000|COMPLETED|Overall Study||0
8595724|NCT00323882|9630864|FG001|COMPLETED|Overall Study||0
8595725|NCT00323882|9630865|FG002|COMPLETED|Overall Study||3
8595726|NCT00323882|9630866|FG003|COMPLETED|Overall Study||0
8595727|NCT00323882|9630867|FG004|COMPLETED|Overall Study||2
8595728|NCT00323882|9630863|FG000|NOT COMPLETED|Overall Study||8
8595729|NCT00323882|9630864|FG001|NOT COMPLETED|Overall Study||6
8595730|NCT00323882|9630865|FG002|NOT COMPLETED|Overall Study||13
8595731|NCT00323882|9630866|FG003|NOT COMPLETED|Overall Study||7
8595732|NCT00323882|9630867|FG004|NOT COMPLETED|Overall Study||32
8595733|NCT00323960|9630891|FG000|STARTED|Overall Study||47
8595734|NCT00323960|9630892|FG001|STARTED|Overall Study||46
8595735|NCT00323960|9630893|FG002|STARTED|Overall Study||46
8595736|NCT00323960|9630891|FG000|COMPLETED|Overall Study||47
8595737|NCT00323960|9630892|FG001|COMPLETED|Overall Study||46
8595738|NCT00323960|9630893|FG002|COMPLETED|Overall Study||46
8595739|NCT00323960|9630891|FG000|NOT COMPLETED|Overall Study||0
8595740|NCT00323960|9630892|FG001|NOT COMPLETED|Overall Study||0
8595741|NCT00323960|9630893|FG002|NOT COMPLETED|Overall Study||0
8595742|NCT00324038|9630906|FG000|STARTED|Overall Study||110
8595743|NCT00324038|9630907|FG001|STARTED|Overall Study||109
8595744|NCT00324038|9630906|FG000|COMPLETED|Overall Study||61
8595745|NCT00324038|9630907|FG001|COMPLETED|Overall Study||58
8595746|NCT00324038|9630906|FG000|NOT COMPLETED|Overall Study||49
8595747|NCT00324038|9630907|FG001|NOT COMPLETED|Overall Study||51
8595748|NCT00324116|9630913|FG000|STARTED|Overall Study|subjects received treatment|81
8595749|NCT00324116|9630913|FG000|COMPLETED|Overall Study||49
8595750|NCT00324116|9630913|FG000|NOT COMPLETED|Overall Study||32
8595751|NCT00324155|9630919|FG000|STARTED|Enrolled and Randomized||250
8595752|NCT00324155|9630920|FG001|STARTED|Enrolled and Randomized||252
8595753|NCT00324155|9630919|FG000|COMPLETED|Enrolled and Randomized|3 randomized but who did not receive treatment (no longer met study criteria).|247
8595754|NCT00324155|9630920|FG001|COMPLETED|Enrolled and Randomized|1 randomized but who did not receive treatment (lost to follow-up).|251
8595755|NCT00324155|9630919|FG000|NOT COMPLETED|Enrolled and Randomized||3
8595756|NCT00324155|9630920|FG001|NOT COMPLETED|Enrolled and Randomized||1
8595757|NCT00324155|9630919|FG000|STARTED|Received Treatment in Induction Phase||247
8595758|NCT00324155|9630920|FG001|STARTED|Received Treatment in Induction Phase||251
8595759|NCT00324155|9630919|FG000|COMPLETED|Received Treatment in Induction Phase|45 participants on treatment at end of Induction Phase. Study undergoing closure.|45
8595760|NCT00324155|9630920|FG001|COMPLETED|Received Treatment in Induction Phase|54 participants on treatment at end of Induction Phase. Study undergoing closure.|54
8595761|NCT00324155|9630919|FG000|NOT COMPLETED|Received Treatment in Induction Phase||202
8595762|NCT00324155|9630920|FG001|NOT COMPLETED|Received Treatment in Induction Phase||197
8595763|NCT00324155|9630919|FG000|STARTED|Received Treatment in Maintenance Phase|2 completed Induction Phase but did not enter Maintenance Phase|43
8595764|NCT00324155|9630920|FG001|STARTED|Received Treatment in Maintenance Phase|1 completed Induction Phase but did not enter Maintenance Phase|53
8595765|NCT00324155|9630919|FG000|COMPLETED|Received Treatment in Maintenance Phase|Study is in closure at this time. 11 in Maintenance Phase not yet summarized.|11
8595766|NCT00324155|9630920|FG001|COMPLETED|Received Treatment in Maintenance Phase|Study is in closure. 6 participants in Maintenance Phase not yet summarized.|6
8595767|NCT00324155|9630919|FG000|NOT COMPLETED|Received Treatment in Maintenance Phase||32
8595768|NCT00324155|9630920|FG001|NOT COMPLETED|Received Treatment in Maintenance Phase||47
8595769|NCT00324155|9630919|FG000|STARTED|Follow-up Phase|All participants received study drug. Follow-up was performed for those leaving earlier phases.|247
8595770|NCT00324155|9630920|FG001|STARTED|Follow-up Phase|All participants received study drug. Follow-up was performed for those leaving earlier phases.|251
8595771|NCT00324155|9630919|FG000|COMPLETED|Follow-up Phase||236
8595772|NCT00324155|9630920|FG001|COMPLETED|Follow-up Phase||245
8595773|NCT00324155|9630919|FG000|NOT COMPLETED|Follow-up Phase||11
8595774|NCT00324155|9630920|FG001|NOT COMPLETED|Follow-up Phase||6
8595775|NCT00324168|9630941|FG000|STARTED|Overall Study||250
8595776|NCT00324168|9630942|FG001|STARTED|Overall Study||250
8595777|NCT00324168|9630941|FG000|COMPLETED|Overall Study||222
8595778|NCT00324168|9630942|FG001|COMPLETED|Overall Study||220
8595779|NCT00324168|9630941|FG000|NOT COMPLETED|Overall Study||28
8595780|NCT00324168|9630942|FG001|NOT COMPLETED|Overall Study||30
8595781|NCT00324233|9630950|FG000|STARTED|First Period||18
8595782|NCT00324233|9630951|FG001|STARTED|First Period||18
8595783|NCT00324233|9630950|FG000|COMPLETED|First Period||17
8595784|NCT00324233|9630951|FG001|COMPLETED|First Period||18
8595785|NCT00324233|9630950|FG000|NOT COMPLETED|First Period||1
8595786|NCT00324233|9630951|FG001|NOT COMPLETED|First Period||0
8595787|NCT00324233|9630950|FG000|STARTED|Second Period||17
8595788|NCT00324233|9630951|FG001|STARTED|Second Period||18
8595789|NCT00324233|9630950|FG000|COMPLETED|Second Period||12
8595790|NCT00324233|9630951|FG001|COMPLETED|Second Period||11
8595791|NCT00324233|9630950|FG000|NOT COMPLETED|Second Period||5
8595792|NCT00324233|9630951|FG001|NOT COMPLETED|Second Period||7
8595793|NCT00324259|9630959|FG000|STARTED|Overall Study||34
8595794|NCT00324259|9630960|FG001|STARTED|Overall Study||32
8595795|NCT00324259|9630959|FG000|COMPLETED|Overall Study||34
8595796|NCT00324259|9630960|FG001|COMPLETED|Overall Study||32
8595797|NCT00324259|9630959|FG000|NOT COMPLETED|Overall Study||0
8595798|NCT00324259|9630960|FG001|NOT COMPLETED|Overall Study||0
8595799|NCT00324272|9630971|FG000|STARTED|Overall Study||18
8595800|NCT00324272|9630972|FG001|STARTED|Overall Study||20
8595801|NCT00324272|9630973|FG002|STARTED|Overall Study||18
8595802|NCT00324272|9630974|FG003|STARTED|Overall Study||18
8595803|NCT00324272|9630971|FG000|COMPLETED|Overall Study||18
8595804|NCT00324272|9630972|FG001|COMPLETED|Overall Study||20
8595805|NCT00324272|9630973|FG002|COMPLETED|Overall Study||18
8595806|NCT00324272|9630974|FG003|COMPLETED|Overall Study||18
8595807|NCT00324272|9630971|FG000|NOT COMPLETED|Overall Study||0
8595808|NCT00324272|9630972|FG001|NOT COMPLETED|Overall Study||0
8595809|NCT00324272|9630973|FG002|NOT COMPLETED|Overall Study||0
8595810|NCT00324272|9630974|FG003|NOT COMPLETED|Overall Study||0
8595811|NCT00324350|9630986|FG000|STARTED|Overall Study||3655
8595812|NCT00324350|9630987|FG001|STARTED|Overall Study||3632
8595813|NCT00324350|9630986|FG000|Non-Vertebral Fracture Follow-Up|Overall Study||3655
8595814|NCT00324350|9630987|FG001|Non-Vertebral Fracture Follow-Up|Overall Study||3632
8595815|NCT00324350|9630986|FG000|Falls Follow-Up|Overall Study||3364
8595816|NCT00324350|9630987|FG001|Falls Follow-Up|Overall Study||3418
8595817|NCT00324350|9630986|FG000|COMPLETED|Overall Study||3655
8595818|NCT00324350|9630987|FG001|COMPLETED|Overall Study||3632
8595819|NCT00324350|9630986|FG000|NOT COMPLETED|Overall Study||0
8595820|NCT00324350|9630987|FG001|NOT COMPLETED|Overall Study||0
8595821|NCT00324415|9630994|FG000|STARTED|Overall Study||45
8595822|NCT00324415|9630994|FG000|COMPLETED|Overall Study||45
8595823|NCT00324415|9630994|FG000|NOT COMPLETED|Overall Study||0
8595824|NCT00324649|9631001|FG000|STARTED|Overall Study||39
8595825|NCT00324649|9631002|FG001|STARTED|Overall Study||41
8595826|NCT00324649|9631001|FG000|COMPLETED|Overall Study||37
8595827|NCT00324649|9631002|FG001|COMPLETED|Overall Study||36
8595828|NCT00324649|9631001|FG000|NOT COMPLETED|Overall Study||2
8595829|NCT00324649|9631002|FG001|NOT COMPLETED|Overall Study||5
8595830|NCT00324675|9631010|FG000|STARTED|Overall Study||14
8595831|NCT00324675|9631011|FG001|STARTED|Overall Study||14
8595832|NCT00324675|9631010|FG000|COMPLETED|Overall Study||13
8595833|NCT00324675|9631011|FG001|COMPLETED|Overall Study||14
8595834|NCT00324675|9631010|FG000|NOT COMPLETED|Overall Study||1
8595835|NCT00324675|9631011|FG001|NOT COMPLETED|Overall Study||0
8595836|NCT00324701|9631019|FG000|STARTED|Overall Study||120
8595837|NCT00324701|9631020|FG001|STARTED|Overall Study||121
8595838|NCT00324701|9631019|FG000|Week 8 Assessment|Overall Study||108
8595839|NCT00324701|9631020|FG001|Week 8 Assessment|Overall Study||107
8595840|NCT00324701|9631019|FG000|COMPLETED|Overall Study||100
8595841|NCT00324701|9631020|FG001|COMPLETED|Overall Study||104
8595842|NCT00324701|9631019|FG000|NOT COMPLETED|Overall Study||20
8595843|NCT00324701|9631020|FG001|NOT COMPLETED|Overall Study||17
8595844|NCT00324740|9631026|FG000|STARTED|Overall Study||7
8595845|NCT00324740|9631027|FG001|STARTED|Overall Study||3
8595846|NCT00324740|9631028|FG002|STARTED|Overall Study||4
8595847|NCT00324740|9631026|FG000|COMPLETED|Overall Study||6
8595848|NCT00324740|9631027|FG001|COMPLETED|Overall Study||3
8595849|NCT00324740|9631028|FG002|COMPLETED|Overall Study||3
8595850|NCT00324740|9631026|FG000|NOT COMPLETED|Overall Study||1
8595851|NCT00324740|9631027|FG001|NOT COMPLETED|Overall Study||0
8595852|NCT00324740|9631028|FG002|NOT COMPLETED|Overall Study||1
8595853|NCT00324753|9631037|FG000|STARTED|Overall Study||190
8595854|NCT00324753|9631038|FG001|STARTED|Overall Study||264
8595855|NCT00324753|9631037|FG000|COMPLETED|Overall Study||190
8595856|NCT00324753|9631038|FG001|COMPLETED|Overall Study||264
8595857|NCT00324753|9631037|FG000|NOT COMPLETED|Overall Study||0
8595858|NCT00324753|9631038|FG001|NOT COMPLETED|Overall Study||0
8595859|NCT00324857|9631050|FG000|STARTED|Overall Study||167
8595860|NCT00324857|9631051|FG001|STARTED|Overall Study||168
8595861|NCT00324857|9631052|FG002|STARTED|Overall Study||165
8595862|NCT00324857|9631053|FG003|STARTED|Overall Study||163
8595863|NCT00324857|9631050|FG000|COMPLETED|Overall Study||161
8595864|NCT00324857|9631051|FG001|COMPLETED|Overall Study||162
8595865|NCT00324857|9631052|FG002|COMPLETED|Overall Study||158
8595866|NCT00324857|9631053|FG003|COMPLETED|Overall Study||158
8595867|NCT00324857|9631050|FG000|NOT COMPLETED|Overall Study||6
8595868|NCT00324857|9631051|FG001|NOT COMPLETED|Overall Study||6
8595869|NCT00324857|9631052|FG002|NOT COMPLETED|Overall Study||7
8595870|NCT00324857|9631053|FG003|NOT COMPLETED|Overall Study||5
8595871|NCT00324870|9631067|FG000|STARTED|Overall Study||37
8595872|NCT00324870|9631067|FG000|COMPLETED|Overall Study||37
8595873|NCT00324870|9631067|FG000|NOT COMPLETED|Overall Study||0
8595874|NCT00324896|9631073|FG000|STARTED|Overall Study||15
8595875|NCT00324896|9631074|FG001|STARTED|Overall Study||15
8595876|NCT00324896|9631073|FG000|COMPLETED|Overall Study||12
8595877|NCT00324896|9631074|FG001|COMPLETED|Overall Study||7
8595878|NCT00324896|9631073|FG000|NOT COMPLETED|Overall Study||3
8595879|NCT00324896|9631074|FG001|NOT COMPLETED|Overall Study||8
8595880|NCT00324961|9631080|FG000|STARTED|Overall Study||533
8595881|NCT00324961|9631080|FG000|COMPLETED|Overall Study||490
8595882|NCT00324961|9631080|FG000|NOT COMPLETED|Overall Study||43
8595883|NCT00324987|9631088|FG000|STARTED|Overall Study||6
8595884|NCT00324987|9631089|FG001|STARTED|Overall Study||6
8595885|NCT00324987|9631088|FG000|COMPLETED|Overall Study|Patients were to be treated until progression|0
8595886|NCT00324987|9631089|FG001|COMPLETED|Overall Study|Patients were to be treated until progression|0
8595887|NCT00324987|9631088|FG000|NOT COMPLETED|Overall Study||6
8595888|NCT00324987|9631089|FG001|NOT COMPLETED|Overall Study||6
8595889|NCT00325039|9631097|FG000|STARTED|Overall Study||298
8595890|NCT00325039|9631098|FG001|STARTED|Overall Study||299
8595891|NCT00325039|9631097|FG000|COMPLETED|Overall Study||280
8595892|NCT00325039|9631098|FG001|COMPLETED|Overall Study||285
8595893|NCT00325039|9631097|FG000|NOT COMPLETED|Overall Study||18
8595894|NCT00325039|9631098|FG001|NOT COMPLETED|Overall Study||14
8595895|NCT00325078|9631107|FG000|STARTED|Overall Study||8
8813146|NCT01524198|9866283|FG001|NOT COMPLETED|Overall Study||16
8595896|NCT00325078|9631108|FG001|STARTED|Overall Study||7
8595897|NCT00325078|9631109|FG002|STARTED|Overall Study||25
8595898|NCT00325078|9631107|FG000|COMPLETED|Overall Study||3
8595899|NCT00325078|9631108|FG001|COMPLETED|Overall Study||2
8595900|NCT00325078|9631109|FG002|COMPLETED|Overall Study||23
8595901|NCT00325078|9631107|FG000|NOT COMPLETED|Overall Study||5
8595902|NCT00325078|9631108|FG001|NOT COMPLETED|Overall Study||5
8595903|NCT00325078|9631109|FG002|NOT COMPLETED|Overall Study||2
8595904|NCT00325130|9631120|FG000|STARTED|Overall Study||518
8595905|NCT00325130|9631121|FG001|STARTED|Overall Study||524
8595906|NCT00325130|9631120|FG000|COMPLETED|Overall Study||499
8595907|NCT00325130|9631121|FG001|COMPLETED|Overall Study||494
8595908|NCT00325130|9631120|FG000|NOT COMPLETED|Overall Study||19
8595909|NCT00325130|9631121|FG001|NOT COMPLETED|Overall Study||30
8595910|NCT00325143|9631127|FG000|STARTED|Overall Study||702
8595911|NCT00325143|9631127|FG000|COMPLETED|Overall Study||676
8595912|NCT00325143|9631127|FG000|NOT COMPLETED|Overall Study||26
8595913|NCT00325156|9631131|FG000|STARTED|Overall Study||2590
8595914|NCT00325156|9631131|FG000|COMPLETED|Overall Study||2478
8595915|NCT00325156|9631131|FG000|NOT COMPLETED|Overall Study||112
8595916|NCT00325195|9631138|FG000|STARTED|Randomized||90
8595917|NCT00325195|9631139|FG001|STARTED|Randomized||89
8595918|NCT00325195|9631140|FG002|STARTED|Randomized||46
8595919|NCT00325195|9631138|FG000|COMPLETED|Randomized||85
8595920|NCT00325195|9631139|FG001|COMPLETED|Randomized||84
8713011|NCT00972595|9759778|FG001|COMPLETED|Period 1||22
8713012|NCT00972595|9759777|FG000|NOT COMPLETED|Period 1||1
8713013|NCT00972595|9759778|FG001|NOT COMPLETED|Period 1||0
8595921|NCT00325195|9631140|FG002|COMPLETED|Randomized||43
8713014|NCT00972595|9759777|FG000|STARTED|Period 2||22
8713015|NCT00972595|9759778|FG001|STARTED|Period 2||22
8713016|NCT00972595|9759777|FG000|COMPLETED|Period 2||22
8713017|NCT00972595|9759778|FG001|COMPLETED|Period 2||22
8713018|NCT00972595|9759777|FG000|NOT COMPLETED|Period 2||0
8713019|NCT00972595|9759778|FG001|NOT COMPLETED|Period 2||0
8713020|NCT00972621|9759786|FG000|STARTED|Overall Study||200
8713021|NCT00972621|9759787|FG001|STARTED|Overall Study||200
8713022|NCT00972621|9759786|FG000|COMPLETED|Overall Study||200
8713023|NCT00972621|9759787|FG001|COMPLETED|Overall Study|One subject discontinued due to lens exchange.|199
8713024|NCT00972621|9759786|FG000|NOT COMPLETED|Overall Study||0
8713025|NCT00972621|9759787|FG001|NOT COMPLETED|Overall Study||1
8595922|NCT00325195|9631138|FG000|NOT COMPLETED|Randomized||5
8595923|NCT00325195|9631139|FG001|NOT COMPLETED|Randomized||5
8595924|NCT00325195|9631140|FG002|NOT COMPLETED|Randomized||3
8595925|NCT00325195|9631138|FG000|STARTED|Received Intervention: ITT Population||85
8595926|NCT00325195|9631139|FG001|STARTED|Received Intervention: ITT Population||84
8595927|NCT00325195|9631140|FG002|STARTED|Received Intervention: ITT Population||43
8595928|NCT00325195|9631138|FG000|COMPLETED|Received Intervention: ITT Population||59
8595929|NCT00325195|9631139|FG001|COMPLETED|Received Intervention: ITT Population||59
8595930|NCT00325195|9631140|FG002|COMPLETED|Received Intervention: ITT Population||39
8595931|NCT00325195|9631138|FG000|NOT COMPLETED|Received Intervention: ITT Population||26
8595932|NCT00325195|9631139|FG001|NOT COMPLETED|Received Intervention: ITT Population||25
8595933|NCT00325195|9631140|FG002|NOT COMPLETED|Received Intervention: ITT Population||4
8595934|NCT00325234|9631150|FG000|STARTED|Overall Study||69
8595935|NCT00325234|9631151|FG001|STARTED|Overall Study||66
8595936|NCT00325234|9631150|FG000|Received At Least 1 Dose of Study Drug|Overall Study||65
8595937|NCT00325234|9631151|FG001|Received At Least 1 Dose of Study Drug|Overall Study||66
8595938|NCT00325234|9631150|FG000|COMPLETED|Overall Study||0
8595939|NCT00325234|9631151|FG001|COMPLETED|Overall Study||0
8595940|NCT00325234|9631150|FG000|NOT COMPLETED|Overall Study||69
8595941|NCT00325234|9631151|FG001|NOT COMPLETED|Overall Study||66
8595942|NCT00325403|9631161|FG000|STARTED|Overall Study||116
8595943|NCT00325403|9631162|FG001|STARTED|Overall Study||233
8595944|NCT00325403|9631161|FG000|COMPLETED|Overall Study|98 subjects receiving placebo completed the study on study drug|98
8595945|NCT00325403|9631162|FG001|COMPLETED|Overall Study|182 subjects receiving oral treprostinil completed the study on study drug|182
8595946|NCT00325403|9631161|FG000|NOT COMPLETED|Overall Study||18
8595947|NCT00325403|9631162|FG001|NOT COMPLETED|Overall Study||51
8595948|NCT00325416|9631172|FG000|STARTED|Phase I: Dose Escalation||70
8595949|NCT00325416|9631173|FG001|STARTED|Phase I: Dose Escalation||60
8595950|NCT00325416|9631172|FG000|COMPLETED|Phase I: Dose Escalation||48
8595951|NCT00325416|9631173|FG001|COMPLETED|Phase I: Dose Escalation||44
8595952|NCT00325416|9631172|FG000|NOT COMPLETED|Phase I: Dose Escalation||22
8595953|NCT00325416|9631173|FG001|NOT COMPLETED|Phase I: Dose Escalation||16
8595954|NCT00325416|9631172|FG000|STARTED|Phase II: Treatment at MTD||78
8595955|NCT00325416|9631173|FG001|STARTED|Phase II: Treatment at MTD||42
8595956|NCT00325416|9631172|FG000|Proceeded From Phase I to Phase II|Phase II: Treatment at MTD||38
8595957|NCT00325416|9631173|FG001|Proceeded From Phase I to Phase II|Phase II: Treatment at MTD||34
8595958|NCT00325416|9631172|FG000|Enrolled During Phase II|Phase II: Treatment at MTD||40
8595959|NCT00325416|9631173|FG001|Enrolled During Phase II|Phase II: Treatment at MTD||8
8595960|NCT00325416|9631172|FG000|COMPLETED|Phase II: Treatment at MTD||78
8595961|NCT00325416|9631173|FG001|COMPLETED|Phase II: Treatment at MTD||40
8595962|NCT00325416|9631172|FG000|NOT COMPLETED|Phase II: Treatment at MTD||0
8595963|NCT00325416|9631173|FG001|NOT COMPLETED|Phase II: Treatment at MTD||2
8595964|NCT00325442|9631181|FG000|STARTED|Overall Study||176
8595965|NCT00325442|9631182|FG001|STARTED|Overall Study||174
8595966|NCT00325442|9631181|FG000|COMPLETED|Overall Study||167
8595967|NCT00325442|9631182|FG001|COMPLETED|Overall Study||153
8595968|NCT00325442|9631181|FG000|NOT COMPLETED|Overall Study||9
8595969|NCT00325442|9631182|FG001|NOT COMPLETED|Overall Study||21
8595970|NCT00325468|9631196|FG000|STARTED|Overall Study||23
8595971|NCT00325468|9631197|FG001|STARTED|Overall Study||17
8595972|NCT00325468|9631198|FG002|STARTED|Overall Study||14
8595973|NCT00325468|9631199|FG003|STARTED|Overall Study||124
8595974|NCT00325468|9631200|FG004|STARTED|Overall Study||22
8595975|NCT00325468|9631196|FG000|COMPLETED|Overall Study||12
8595976|NCT00325468|9631197|FG001|COMPLETED|Overall Study||12
8595977|NCT00325468|9631198|FG002|COMPLETED|Overall Study||10
8595978|NCT00325468|9631199|FG003|COMPLETED|Overall Study||90
8595979|NCT00325468|9631200|FG004|COMPLETED|Overall Study||14
8595980|NCT00325468|9631196|FG000|NOT COMPLETED|Overall Study||11
8595981|NCT00325468|9631197|FG001|NOT COMPLETED|Overall Study||5
8595982|NCT00325468|9631198|FG002|NOT COMPLETED|Overall Study||4
8595983|NCT00325468|9631199|FG003|NOT COMPLETED|Overall Study||34
8595984|NCT00325468|9631200|FG004|NOT COMPLETED|Overall Study||8
8595985|NCT00325598|9631215|FG000|STARTED|Overall Study||50
8595986|NCT00325598|9631216|FG001|STARTED|Overall Study||50
8595987|NCT00325598|9631215|FG000|COMPLETED|Overall Study||50
8595988|NCT00325598|9631216|FG001|COMPLETED|Overall Study||50
8595989|NCT00325598|9631215|FG000|NOT COMPLETED|Overall Study||0
8595990|NCT00325598|9631216|FG001|NOT COMPLETED|Overall Study||0
8595991|NCT00325754|9631226|FG000|STARTED|Overall Study||11
8595992|NCT00325754|9631227|FG001|STARTED|Overall Study||11
8595993|NCT00325754|9631226|FG000|COMPLETED|Overall Study||7
8595994|NCT00325754|9631227|FG001|COMPLETED|Overall Study||10
8595995|NCT00325754|9631226|FG000|NOT COMPLETED|Overall Study||4
8595996|NCT00325754|9631227|FG001|NOT COMPLETED|Overall Study||1
8595997|NCT00325780|9631233|FG000|STARTED|Overall Study||1355
8595998|NCT00325780|9631233|FG000|Safety Population|Overall Study|Patients who received at least one dose of study treatment in this extension study.|1353
8595999|NCT00325780|9631233|FG000|COMPLETED|Overall Study||1200
8596000|NCT00325780|9631233|FG000|NOT COMPLETED|Overall Study||155
8596001|NCT00325819|9631239|FG000|STARTED|Overall Study||185
8596002|NCT00325819|9631240|FG001|STARTED|Overall Study||189
8596003|NCT00325819|9631239|FG000|COMPLETED|Overall Study||176
8596004|NCT00325819|9631240|FG001|COMPLETED|Overall Study||176
8596005|NCT00325819|9631239|FG000|NOT COMPLETED|Overall Study||9
8596006|NCT00325819|9631240|FG001|NOT COMPLETED|Overall Study||13
8596007|NCT00325897|9631250|FG000|STARTED|Overall Study||570
8596008|NCT00325897|9631251|FG001|STARTED|Overall Study||572
8596009|NCT00325897|9631250|FG000|COMPLETED|Overall Study||558
8596010|NCT00325897|9631251|FG001|COMPLETED|Overall Study||559
8596011|NCT00325897|9631250|FG000|NOT COMPLETED|Overall Study||12
8596012|NCT00325897|9631251|FG001|NOT COMPLETED|Overall Study||13
8596013|NCT00326001|9631262|FG000|STARTED|Overall Study||236
8596014|NCT00326001|9631263|FG001|STARTED|Overall Study||227
8596015|NCT00326001|9631262|FG000|COMPLETED|Overall Study||229
8596016|NCT00326001|9631263|FG001|COMPLETED|Overall Study||219
8596017|NCT00326001|9631262|FG000|NOT COMPLETED|Overall Study||7
8596018|NCT00326001|9631263|FG001|NOT COMPLETED|Overall Study||8
8596019|NCT00326118|9631271|FG000|STARTED|Active Phase||324
8596020|NCT00326118|9631272|FG001|STARTED|Active Phase||109
8596021|NCT00326118|9631271|FG000|COMPLETED|Active Phase||320
8596022|NCT00326118|9631272|FG001|COMPLETED|Active Phase||108
8596023|NCT00326118|9631271|FG000|NOT COMPLETED|Active Phase||4
8596024|NCT00326118|9631272|FG001|NOT COMPLETED|Active Phase||1
8596025|NCT00326118|9631271|FG000|STARTED|Year 1 Follow-up||295
8596026|NCT00326118|9631272|FG001|STARTED|Year 1 Follow-up||100
8596027|NCT00326118|9631271|FG000|COMPLETED|Year 1 Follow-up||295
8596028|NCT00326118|9631272|FG001|COMPLETED|Year 1 Follow-up||100
8596029|NCT00326118|9631271|FG000|NOT COMPLETED|Year 1 Follow-up||0
8596030|NCT00326118|9631272|FG001|NOT COMPLETED|Year 1 Follow-up||0
8596031|NCT00326118|9631271|FG000|STARTED|Year 2 Follow-up||270
8596032|NCT00326118|9631272|FG001|STARTED|Year 2 Follow-up||92
8596033|NCT00326118|9631271|FG000|COMPLETED|Year 2 Follow-up||270
8596034|NCT00326118|9631272|FG001|COMPLETED|Year 2 Follow-up||92
8596035|NCT00326118|9631271|FG000|NOT COMPLETED|Year 2 Follow-up||0
8596036|NCT00326118|9631272|FG001|NOT COMPLETED|Year 2 Follow-up||0
8596037|NCT00326118|9631271|FG000|STARTED|Year 3 Follow-up||256
8596038|NCT00326118|9631272|FG001|STARTED|Year 3 Follow-up||89
8596039|NCT00326118|9631271|FG000|COMPLETED|Year 3 Follow-up||256
8596040|NCT00326118|9631272|FG001|COMPLETED|Year 3 Follow-up||89
8596041|NCT00326118|9631271|FG000|NOT COMPLETED|Year 3 Follow-up||0
8596042|NCT00326118|9631272|FG001|NOT COMPLETED|Year 3 Follow-up||0
8596043|NCT00326118|9631271|FG000|STARTED|Year 4 Follow-up||228
8596044|NCT00326118|9631272|FG001|STARTED|Year 4 Follow-up||80
8596045|NCT00326118|9631271|FG000|COMPLETED|Year 4 Follow-up||228
8596046|NCT00326118|9631272|FG001|COMPLETED|Year 4 Follow-up||80
8596047|NCT00326118|9631271|FG000|NOT COMPLETED|Year 4 Follow-up||0
8596048|NCT00326118|9631272|FG001|NOT COMPLETED|Year 4 Follow-up||0
8596049|NCT00326118|9631271|FG000|STARTED|Year 5 Follow up||217
8596050|NCT00326118|9631272|FG001|STARTED|Year 5 Follow up||78
8596051|NCT00326118|9631271|FG000|COMPLETED|Year 5 Follow up||217
8596052|NCT00326118|9631272|FG001|COMPLETED|Year 5 Follow up||78
8596053|NCT00326118|9631271|FG000|NOT COMPLETED|Year 5 Follow up||0
8596054|NCT00326118|9631272|FG001|NOT COMPLETED|Year 5 Follow up||0
8596055|NCT00326170|9631279|FG000|STARTED|Overall Study||34
8596056|NCT00326170|9631279|FG000|COMPLETED|Overall Study||34
8596057|NCT00326170|9631279|FG000|NOT COMPLETED|Overall Study||0
8596058|NCT00326196|9631285|FG000|STARTED|Overall Study||101
8596059|NCT00326196|9631286|FG001|STARTED|Overall Study||97
8596060|NCT00326196|9631285|FG000|COMPLETED|Overall Study||101
8596061|NCT00326196|9631286|FG001|COMPLETED|Overall Study||97
8596062|NCT00326196|9631285|FG000|NOT COMPLETED|Overall Study||0
8596063|NCT00326196|9631286|FG001|NOT COMPLETED|Overall Study||0
8596064|NCT00326209|9631292|FG000|STARTED|Overall Study||393
8596065|NCT00326209|9631292|FG000|Safety Population|Overall Study||388
8596066|NCT00326209|9631292|FG000|COMPLETED|Overall Study||111
8596067|NCT00326209|9631292|FG000|NOT COMPLETED|Overall Study||282
8596068|NCT00326417|9631298|FG000|STARTED|Overall Study||14
8596069|NCT00326417|9631299|FG001|STARTED|Overall Study||41
8596070|NCT00326417|9631300|FG002|STARTED|Overall Study||39
8596071|NCT00326417|9631301|FG003|STARTED|Overall Study||3
8596072|NCT00326417|9631298|FG000|Phase I|Overall Study||6
8596073|NCT00326417|9631299|FG001|Phase I|Overall Study||6
8596074|NCT00326417|9631300|FG002|Phase I|Overall Study||6
8596075|NCT00326417|9631301|FG003|Phase I|Overall Study||3
8596076|NCT00326417|9631298|FG000|Phase II|Overall Study||8
8596077|NCT00326417|9631299|FG001|Phase II|Overall Study||35
8596078|NCT00326417|9631300|FG002|Phase II|Overall Study||33
8596079|NCT00326417|9631301|FG003|Phase II|Overall Study||0
8596080|NCT00326417|9631298|FG000|COMPLETED|Overall Study|Dose level was closed for excessive toxicity after 8 patients in Phase II accrued.|0
8596081|NCT00326417|9631299|FG001|COMPLETED|Overall Study||41
8596082|NCT00326417|9631300|FG002|COMPLETED|Overall Study||38
8596083|NCT00326417|9631301|FG003|COMPLETED|Overall Study|Arm was closed to accrual after 3 patients experienced graft failure.|0
8596084|NCT00326417|9631298|FG000|NOT COMPLETED|Overall Study||14
8596085|NCT00326417|9631299|FG001|NOT COMPLETED|Overall Study||0
8596086|NCT00326417|9631300|FG002|NOT COMPLETED|Overall Study||1
8596087|NCT00326417|9631301|FG003|NOT COMPLETED|Overall Study||3
8596088|NCT00326495|9631309|FG000|STARTED|Overall Study||51
8596089|NCT00326495|9631309|FG000|COMPLETED|Overall Study||46
8596090|NCT00326495|9631309|FG000|NOT COMPLETED|Overall Study||5
8596091|NCT00326599|9631317|FG000|STARTED|Overall Study||6
8596092|NCT00326599|9631318|FG001|STARTED|Overall Study||3
8596093|NCT00326599|9631319|FG002|STARTED|Overall Study||58
8596094|NCT00326599|9631320|FG003|STARTED|Overall Study||29
8596095|NCT00326599|9631317|FG000|COMPLETED|Overall Study||0
8596096|NCT00326599|9631318|FG001|COMPLETED|Overall Study||2
8596097|NCT00326599|9631319|FG002|COMPLETED|Overall Study||5
8596098|NCT00326599|9631320|FG003|COMPLETED|Overall Study||10
8596099|NCT00326599|9631317|FG000|NOT COMPLETED|Overall Study||6
8596100|NCT00326599|9631318|FG001|NOT COMPLETED|Overall Study||1
8596101|NCT00326599|9631319|FG002|NOT COMPLETED|Overall Study||53
8596102|NCT00326599|9631320|FG003|NOT COMPLETED|Overall Study||19
8596103|NCT00326612|9631331|FG000|STARTED|Overall Study||179
8596104|NCT00326612|9631332|FG001|STARTED|Overall Study||179
8596105|NCT00326612|9631331|FG000|COMPLETED|Overall Study||50
8596106|NCT00326612|9631332|FG001|COMPLETED|Overall Study||42
8596107|NCT00326612|9631331|FG000|NOT COMPLETED|Overall Study||129
8596108|NCT00326612|9631332|FG001|NOT COMPLETED|Overall Study||137
8596109|NCT00326625|9631344|FG000|STARTED|Overall Study||184
8596110|NCT00326625|9631345|FG001|STARTED|Overall Study||182
8596111|NCT00326625|9631344|FG000|COMPLETED|Overall Study||130
8596112|NCT00326625|9631345|FG001|COMPLETED|Overall Study||144
8596113|NCT00326625|9631344|FG000|NOT COMPLETED|Overall Study||54
8596114|NCT00326625|9631345|FG001|NOT COMPLETED|Overall Study||38
8596115|NCT00326716|9631353|FG000|STARTED|Pre-Natal Mothers||20
8596116|NCT00326716|9631354|FG001|STARTED|Pre-Natal Mothers||21
8596117|NCT00326716|9631355|FG002|STARTED|Pre-Natal Mothers||0
8596118|NCT00326716|9631356|FG003|STARTED|Pre-Natal Mothers||0
8596119|NCT00326716|9631353|FG000|COMPLETED|Pre-Natal Mothers|Completion was defined as completing the study.|19
8596120|NCT00326716|9631354|FG001|COMPLETED|Pre-Natal Mothers|Completion was defined as completing the study.|19
8596121|NCT00326716|9631355|FG002|COMPLETED|Pre-Natal Mothers|Completion was defined as completing all follow up visits through 6 months.|0
8596122|NCT00326716|9631356|FG003|COMPLETED|Pre-Natal Mothers|Completion was defined as completing all follow up visits through 6 months.|0
8596123|NCT00326716|9631353|FG000|NOT COMPLETED|Pre-Natal Mothers||1
8596124|NCT00326716|9631354|FG001|NOT COMPLETED|Pre-Natal Mothers||2
8596125|NCT00326716|9631355|FG002|NOT COMPLETED|Pre-Natal Mothers||0
8596126|NCT00326716|9631356|FG003|NOT COMPLETED|Pre-Natal Mothers||0
8596127|NCT00326716|9631353|FG000|STARTED|Infants||0
8596128|NCT00326716|9631354|FG001|STARTED|Infants||0
8596129|NCT00326716|9631355|FG002|STARTED|Infants|All infants were followed.|20
8596130|NCT00326716|9631356|FG003|STARTED|Infants|All infants were followed. One mother withdrew consent pre-delivery and her infant was not followed.|20
8596131|NCT00326716|9631353|FG000|COMPLETED|Infants||0
8596132|NCT00326716|9631354|FG001|COMPLETED|Infants||0
8596133|NCT00326716|9631355|FG002|COMPLETED|Infants||20
8596134|NCT00326716|9631356|FG003|COMPLETED|Infants||20
8596135|NCT00326716|9631353|FG000|NOT COMPLETED|Infants||0
8596136|NCT00326716|9631354|FG001|NOT COMPLETED|Infants||0
8596137|NCT00326716|9631355|FG002|NOT COMPLETED|Infants||0
8596138|NCT00326716|9631356|FG003|NOT COMPLETED|Infants||0
8596139|NCT00326781|9631388|FG000|STARTED|Overall Study||344
8596140|NCT00326781|9631389|FG001|STARTED|Overall Study||330
8596141|NCT00326781|9631388|FG000|COMPLETED|Overall Study||302
8596142|NCT00326781|9631389|FG001|COMPLETED|Overall Study||298
8596143|NCT00326781|9631388|FG000|NOT COMPLETED|Overall Study||42
8596144|NCT00326781|9631389|FG001|NOT COMPLETED|Overall Study||32
8596145|NCT00326872|9631395|FG000|STARTED|Overall Study||26
8596146|NCT00326872|9631395|FG000|COMPLETED|Overall Study||26
8596147|NCT00326872|9631395|FG000|NOT COMPLETED|Overall Study||0
8596148|NCT00326885|9631399|FG000|STARTED|Overall Study||32
8596149|NCT00326885|9631399|FG000|COMPLETED|Overall Study||25
8596150|NCT00326885|9631399|FG000|NOT COMPLETED|Overall Study||7
8596151|NCT00326911|9631406|FG000|STARTED|Overall Study|This number reflects all randomized patients.|30
8596152|NCT00326911|9631407|FG001|STARTED|Overall Study|This number reflects all randomized patients.|31
8596153|NCT00326911|9631406|FG000|COMPLETED|Overall Study|This number reflects all treated patients.|29
8596154|NCT00326911|9631407|FG001|COMPLETED|Overall Study|This number reflects all treated patients.|29
8596155|NCT00326911|9631406|FG000|NOT COMPLETED|Overall Study||1
8596156|NCT00326911|9631407|FG001|NOT COMPLETED|Overall Study||2
8596157|NCT00326924|9631415|FG000|STARTED|Overall Study||188
8596158|NCT00326924|9631416|FG001|STARTED|Overall Study||189
8596159|NCT00326924|9631415|FG000|COMPLETED|Overall Study||187
8596160|NCT00326924|9631416|FG001|COMPLETED|Overall Study||188
8596161|NCT00326924|9631415|FG000|NOT COMPLETED|Overall Study||1
8596162|NCT00326924|9631416|FG001|NOT COMPLETED|Overall Study||1
8596163|NCT00326950|9631422|FG000|STARTED|Overall Study||15
8596164|NCT00326950|9631422|FG000|COMPLETED|Overall Study||14
8596165|NCT00326950|9631422|FG000|NOT COMPLETED|Overall Study||1
8596166|NCT00326963|9631426|FG000|STARTED|Overall Study||140
8596167|NCT00326963|9631426|FG000|COMPLETED|Overall Study||107
8596168|NCT00326963|9631426|FG000|NOT COMPLETED|Overall Study||33
8596169|NCT00327015|9631435|FG000|STARTED|Overall Study||320
8596170|NCT00327015|9631436|FG001|STARTED|Overall Study||323
8596171|NCT00327015|9631437|FG002|STARTED|Overall Study||335
8596172|NCT00327015|9631438|FG003|STARTED|Overall Study||328
8596173|NCT00327015|9631435|FG000|Completed Study Without Being Rescued|Overall Study||179
8596174|NCT00327015|9631436|FG001|Completed Study Without Being Rescued|Overall Study||177
8596175|NCT00327015|9631437|FG002|Completed Study Without Being Rescued|Overall Study||113
8596176|NCT00327015|9631438|FG003|Completed Study Without Being Rescued|Overall Study||144
8596177|NCT00327015|9631435|FG000|COMPLETED|Overall Study||229
8596178|NCT00327015|9631436|FG001|COMPLETED|Overall Study||231
8596179|NCT00327015|9631437|FG002|COMPLETED|Overall Study||209
8596180|NCT00327015|9631438|FG003|COMPLETED|Overall Study||219
8596181|NCT00327015|9631435|FG000|NOT COMPLETED|Overall Study||91
8596182|NCT00327015|9631436|FG001|NOT COMPLETED|Overall Study||92
8596183|NCT00327015|9631437|FG002|NOT COMPLETED|Overall Study||126
8596184|NCT00327015|9631438|FG003|NOT COMPLETED|Overall Study||109
8596185|NCT00327171|9631450|FG000|STARTED|Overall Study||109
8596186|NCT00327171|9631451|FG001|STARTED|Overall Study||109
8596187|NCT00327171|9631450|FG000|COMPLETED|Overall Study|Participants received treatment until they met treatment discontinuation criteria|1
8596188|NCT00327171|9631451|FG001|COMPLETED|Overall Study|Participants received treatment until they met treatment discontinuation criteria|0
8596189|NCT00327171|9631450|FG000|NOT COMPLETED|Overall Study||108
8596190|NCT00327171|9631451|FG001|NOT COMPLETED|Overall Study||109
8628289|NCT00522418|9667694|FG001|NOT COMPLETED|Overall Study||58
8628290|NCT00522431|9667702|FG000|STARTED|Overall Study||149
8628291|NCT00522431|9667702|FG000|COMPLETED|Overall Study||138
8628292|NCT00522431|9667702|FG000|NOT COMPLETED|Overall Study||11
8628293|NCT00522548|9667708|FG000|STARTED|Overall Study||18
8628294|NCT00522548|9667709|FG001|STARTED|Overall Study||19
8628295|NCT00522548|9667708|FG000|Consented to Pharmacokinetic Study|Overall Study||11
8628296|NCT00522548|9667709|FG001|Consented to Pharmacokinetic Study|Overall Study||10
8628297|NCT00522548|9667708|FG000|Completed 0/2 PK Visits|Overall Study||3
8628298|NCT00522548|9667709|FG001|Completed 0/2 PK Visits|Overall Study||4
8628299|NCT00522548|9667708|FG000|Completed 1/2 PK Visits|Overall Study||1
8628300|NCT00522548|9667709|FG001|Completed 1/2 PK Visits|Overall Study||1
8628301|NCT00522548|9667708|FG000|Completed 2/2 PK Visits|Overall Study||7
8628302|NCT00522548|9667709|FG001|Completed 2/2 PK Visits|Overall Study||5
8628303|NCT00522548|9667708|FG000|COMPLETED|Overall Study||16
8628304|NCT00522548|9667709|FG001|COMPLETED|Overall Study||15
8628305|NCT00522548|9667708|FG000|NOT COMPLETED|Overall Study||2
8628306|NCT00522548|9667709|FG001|NOT COMPLETED|Overall Study||4
8628307|NCT00522626|9667715|FG000|STARTED|Overall Study||19
8628308|NCT00522626|9667715|FG000|COMPLETED|Overall Study||12
8628309|NCT00522626|9667715|FG000|NOT COMPLETED|Overall Study||7
8628310|NCT00522795|9667719|FG000|STARTED|Overall Study||40
8628311|NCT00522795|9667719|FG000|COMPLETED|Overall Study||40
8628312|NCT00522795|9667719|FG000|NOT COMPLETED|Overall Study||0
8628313|NCT00522873|9667725|FG000|STARTED|Overall Study||490
8628314|NCT00522873|9667726|FG001|STARTED|Overall Study||172
8628315|NCT00522873|9667725|FG000|Received Treatment|Overall Study||489
8628316|NCT00522873|9667726|FG001|Received Treatment|Overall Study||172
8628317|NCT00522873|9667725|FG000|COMPLETED|Overall Study|394 women completed study medication. 398 women completed the study.|394
8628318|NCT00522873|9667726|FG001|COMPLETED|Overall Study|128 women completed study medication. 129 women completed the study.|128
8628319|NCT00522873|9667725|FG000|NOT COMPLETED|Overall Study||96
8628320|NCT00522873|9667726|FG001|NOT COMPLETED|Overall Study||44
8628321|NCT00522925|9667735|FG000|STARTED|Overall Study||36
8628322|NCT00522925|9667736|FG001|STARTED|Overall Study||39
8628323|NCT00522925|9667737|FG002|STARTED|Overall Study||38
8628324|NCT00522925|9667735|FG000|COMPLETED|Overall Study||28
8628325|NCT00522925|9667736|FG001|COMPLETED|Overall Study||38
8628326|NCT00522925|9667737|FG002|COMPLETED|Overall Study||36
8628327|NCT00522925|9667735|FG000|NOT COMPLETED|Overall Study||8
8628328|NCT00522925|9667736|FG001|NOT COMPLETED|Overall Study||1
8628329|NCT00522925|9667737|FG002|NOT COMPLETED|Overall Study||2
8628330|NCT00522951|9667745|FG000|STARTED|Period 1||86
8628331|NCT00522951|9667746|FG001|STARTED|Period 1||79
8628332|NCT00522951|9667745|FG000|Received Treatment|Period 1||86
8628333|NCT00522951|9667746|FG001|Received Treatment|Period 1||78
8628334|NCT00522951|9667745|FG000|COMPLETED|Period 1||86
8628335|NCT00522951|9667746|FG001|COMPLETED|Period 1||78
8628336|NCT00522951|9667745|FG000|NOT COMPLETED|Period 1||0
8628337|NCT00522951|9667746|FG001|NOT COMPLETED|Period 1||1
8628338|NCT00522951|9667745|FG000|STARTED|Washout Period||86
8628339|NCT00522951|9667746|FG001|STARTED|Washout Period||78
8628340|NCT00522951|9667745|FG000|COMPLETED|Washout Period||86
8628341|NCT00522951|9667746|FG001|COMPLETED|Washout Period||76
8628342|NCT00522951|9667745|FG000|NOT COMPLETED|Washout Period||0
8628343|NCT00522951|9667746|FG001|NOT COMPLETED|Washout Period||2
8628344|NCT00522951|9667745|FG000|STARTED|Period 2||86
8628345|NCT00522951|9667746|FG001|STARTED|Period 2||76
8628346|NCT00522951|9667745|FG000|Subjects Received Treatment|Period 2||84
8628347|NCT00522951|9667746|FG001|Subjects Received Treatment|Period 2||75
8628348|NCT00522951|9667745|FG000|COMPLETED|Period 2||84
8628349|NCT00522951|9667746|FG001|COMPLETED|Period 2||75
8628350|NCT00522951|9667745|FG000|NOT COMPLETED|Period 2||2
8628351|NCT00522951|9667746|FG001|NOT COMPLETED|Period 2||1
8628352|NCT00523237|9667756|FG000|STARTED|Overall Study||14
8628353|NCT00523237|9667756|FG000|COMPLETED|Overall Study||14
8628354|NCT00523237|9667756|FG000|NOT COMPLETED|Overall Study||0
8628355|NCT00523302|9667762|FG000|STARTED|Overall Study||10
8628356|NCT00523302|9667763|FG001|STARTED|Overall Study||10
8628357|NCT00523302|9667762|FG000|COMPLETED|Overall Study||10
8628358|NCT00523302|9667763|FG001|COMPLETED|Overall Study||10
8628359|NCT00523302|9667762|FG000|NOT COMPLETED|Overall Study||0
8628360|NCT00523302|9667763|FG001|NOT COMPLETED|Overall Study||0
8628361|NCT00523341|9667771|FG000|STARTED|Overall Study||2207
8628362|NCT00523341|9667772|FG001|STARTED|Overall Study||2343
8628363|NCT00523341|9667771|FG000|Received Treatment|Overall Study||2206
8628364|NCT00523341|9667772|FG001|Received Treatment|Overall Study||2343
8628365|NCT00523341|9667771|FG000|COMPLETED|Overall Study||1283
8628366|NCT00523341|9667772|FG001|COMPLETED|Overall Study||1343
8628367|NCT00523341|9667771|FG000|NOT COMPLETED|Overall Study||924
8628368|NCT00523341|9667772|FG001|NOT COMPLETED|Overall Study||1000
8596191|NCT00327340|9631459|FG000|STARTED|Overall Study||23
8596192|NCT00327340|9631460|FG001|STARTED|Overall Study||46
8596193|NCT00327340|9631459|FG000|COMPLETED|Overall Study||8
8596194|NCT00327340|9631460|FG001|COMPLETED|Overall Study||16
8596195|NCT00327340|9631459|FG000|NOT COMPLETED|Overall Study||15
8596196|NCT00327340|9631460|FG001|NOT COMPLETED|Overall Study||30
8596197|NCT00327392|9631468|FG000|STARTED|Overall Study||123
8596198|NCT00327392|9631468|FG000|COMPLETED|Overall Study||123
8596199|NCT00327392|9631468|FG000|NOT COMPLETED|Overall Study||0
8596200|NCT00327444|9631474|FG000|STARTED|Double Blind Treatment (DB) Period||26
8596201|NCT00327444|9631475|FG001|STARTED|Double Blind Treatment (DB) Period||29
8596202|NCT00327444|9631474|FG000|SAFETY|Double Blind Treatment (DB) Period|Excludes one participant from the Placebo arm who received aflibercept in error in the DB period.|25
8596203|NCT00327444|9631475|FG001|SAFETY|Double Blind Treatment (DB) Period|Includes 1 from Placebo who received aflibercept in DB period|30
8596204|NCT00327444|9631474|FG000|COMPLETED|Double Blind Treatment (DB) Period||0
8596205|NCT00327444|9631475|FG001|COMPLETED|Double Blind Treatment (DB) Period||0
8596206|NCT00327444|9631474|FG000|NOT COMPLETED|Double Blind Treatment (DB) Period||26
8596207|NCT00327444|9631475|FG001|NOT COMPLETED|Double Blind Treatment (DB) Period||29
8596208|NCT00327444|9631474|FG000|STARTED|Open Label Treatment (OL) Period||11
8596209|NCT00327444|9631475|FG001|STARTED|Open Label Treatment (OL) Period||10
8596210|NCT00327444|9631474|FG000|ONGOING TREATMENT|Open Label Treatment (OL) Period||1
8596211|NCT00327444|9631475|FG001|ONGOING TREATMENT|Open Label Treatment (OL) Period||0
8596212|NCT00327444|9631474|FG000|COMPLETED|Open Label Treatment (OL) Period|All participants were treated till they met treatment discontinuation criteria|0
8596213|NCT00327444|9631475|FG001|COMPLETED|Open Label Treatment (OL) Period|All participants were treated till they met treatment discontinuation criteria|0
8596214|NCT00327444|9631474|FG000|NOT COMPLETED|Open Label Treatment (OL) Period||11
8596215|NCT00327444|9631475|FG001|NOT COMPLETED|Open Label Treatment (OL) Period||10
8596216|NCT00327470|9631485|FG000|STARTED|Overall Study||107
8596217|NCT00327470|9631486|FG001|STARTED|Overall Study||181
8596218|NCT00327470|9631485|FG000|Treated|Overall Study||107
8596219|NCT00327470|9631486|FG001|Treated|Overall Study||179
8596220|NCT00327470|9631485|FG000|COMPLETED|Overall Study||78
8596221|NCT00327470|9631486|FG001|COMPLETED|Overall Study||118
8596222|NCT00327470|9631485|FG000|NOT COMPLETED|Overall Study||29
8596223|NCT00327470|9631486|FG001|NOT COMPLETED|Overall Study||63
8596224|NCT00327717|9631494|FG000|STARTED|Overall Study||120
8596225|NCT00327717|9631495|FG001|STARTED|Overall Study||120
8596226|NCT00327717|9631494|FG000|COMPLETED|Overall Study||111
8596227|NCT00327717|9631495|FG001|COMPLETED|Overall Study||106
8596228|NCT00327717|9631494|FG000|NOT COMPLETED|Overall Study||9
8596229|NCT00327717|9631495|FG001|NOT COMPLETED|Overall Study||14
8596230|NCT00328016|9631503|FG000|STARTED|Overall Study||23
8596231|NCT00328016|9631504|FG001|STARTED|Overall Study||21
8596232|NCT00328016|9631503|FG000|COMPLETED|Overall Study||23
8596233|NCT00328016|9631504|FG001|COMPLETED|Overall Study||21
8596234|NCT00328016|9631503|FG000|NOT COMPLETED|Overall Study||0
8596235|NCT00328016|9631504|FG001|NOT COMPLETED|Overall Study||0
8596236|NCT00328042|9631513|FG000|STARTED|Overall Study||69
8596237|NCT00328042|9631514|FG001|STARTED|Overall Study||65
8596238|NCT00328042|9631513|FG000|COMPLETED|Overall Study||69
8596239|NCT00328042|9631514|FG001|COMPLETED|Overall Study||63
8596240|NCT00328042|9631513|FG000|NOT COMPLETED|Overall Study||0
8596241|NCT00328042|9631514|FG001|NOT COMPLETED|Overall Study||2
8596242|NCT00328094|9631524|FG000|STARTED|Overall Study||117
8596243|NCT00328094|9631525|FG001|STARTED|Overall Study||125
8596244|NCT00328094|9631524|FG000|COMPLETED|Overall Study|2 did not receive intervention. 1 patient refusal|114
8596245|NCT00328094|9631525|FG001|COMPLETED|Overall Study|3 did not receive interevention. 1 post induction arrest. 1 case cancelled.|122
8596246|NCT00328094|9631524|FG000|NOT COMPLETED|Overall Study||3
8596247|NCT00328094|9631525|FG001|NOT COMPLETED|Overall Study||3
8596248|NCT00328172|9631536|FG000|STARTED|Overall Study||67
8596249|NCT00328172|9631537|FG001|STARTED|Overall Study||58
8596250|NCT00328172|9631538|FG002|STARTED|Overall Study||57
8596251|NCT00328172|9631539|FG003|STARTED|Overall Study||55
8596252|NCT00328172|9631540|FG004|STARTED|Overall Study||65
8596253|NCT00328172|9631536|FG000|COMPLETED|Overall Study||45
8596254|NCT00328172|9631537|FG001|COMPLETED|Overall Study||44
8596255|NCT00328172|9631538|FG002|COMPLETED|Overall Study||47
8596256|NCT00328172|9631539|FG003|COMPLETED|Overall Study||42
8596257|NCT00328172|9631540|FG004|COMPLETED|Overall Study||60
8596258|NCT00328172|9631536|FG000|NOT COMPLETED|Overall Study||22
8596259|NCT00328172|9631537|FG001|NOT COMPLETED|Overall Study||14
8596260|NCT00328172|9631538|FG002|NOT COMPLETED|Overall Study||10
8596261|NCT00328172|9631539|FG003|NOT COMPLETED|Overall Study||13
8596262|NCT00328172|9631540|FG004|NOT COMPLETED|Overall Study||5
8596263|NCT00328198|9631552|FG000|STARTED|Treatment|16 participants escalated the dose. 70 participants started at the 30 mg target dose.|86
8596264|NCT00328198|9631552|FG000|COMPLETED|Treatment|Depending upon protocol version, completed treatment was either 12 or 18 weeks in duration.|48
8596265|NCT00328198|9631552|FG000|NOT COMPLETED|Treatment||38
8596266|NCT00328198|9631552|FG000|STARTED|Follow-up|Eight participants did not enter Follow-up|78
8596267|NCT00328198|9631552|FG000|COMPLETED|Follow-up||43
8596268|NCT00328198|9631552|FG000|NOT COMPLETED|Follow-up||35
8596269|NCT00328263|9631558|FG000|STARTED|Overall Study||216
8596270|NCT00328263|9631559|FG001|STARTED|Overall Study||221
8596271|NCT00328263|9631558|FG000|COMPLETED|Overall Study|3 deaths occured during the study. None of the deaths were causally related to the study product.|213
8596272|NCT00328263|9631559|FG001|COMPLETED|Overall Study|4 deaths occured during the study. None of the deaths were causally related to the study product.|217
8596273|NCT00328263|9631558|FG000|NOT COMPLETED|Overall Study||3
8596274|NCT00328263|9631559|FG001|NOT COMPLETED|Overall Study||4
8596275|NCT00328510|9631567|FG000|STARTED|Overall Study||42
8596276|NCT00328510|9631568|FG001|STARTED|Overall Study||41
8596277|NCT00328510|9631567|FG000|COMPLETED|Overall Study||32
8596278|NCT00328510|9631568|FG001|COMPLETED|Overall Study||37
8596279|NCT00328510|9631567|FG000|NOT COMPLETED|Overall Study||10
8596280|NCT00328510|9631568|FG001|NOT COMPLETED|Overall Study||4
8596281|NCT00328562|9631574|FG000|STARTED|Overall Study||13
8596282|NCT00328562|9631574|FG000|COMPLETED|Overall Study||12
8596283|NCT00328562|9631574|FG000|NOT COMPLETED|Overall Study||1
8596284|NCT00328614|9631584|FG000|STARTED|Overall Study||4
8596285|NCT00328614|9631585|FG001|STARTED|Overall Study||4
8596286|NCT00328614|9631586|FG002|STARTED|Overall Study||6
8596287|NCT00328614|9631587|FG003|STARTED|Overall Study||6
8596288|NCT00328614|9631588|FG004|STARTED|Overall Study||6
8596289|NCT00328614|9631589|FG005|STARTED|Overall Study||6
8596290|NCT00328614|9631584|FG000|COMPLETED|Overall Study||4
8596291|NCT00328614|9631585|FG001|COMPLETED|Overall Study||4
8713026|NCT00972725|9759795|FG000|STARTED|Overall Study||13
8713027|NCT00972725|9759796|FG001|STARTED|Overall Study||15
8713028|NCT00972725|9759795|FG000|COMPLETED|Overall Study||13
8713029|NCT00972725|9759796|FG001|COMPLETED|Overall Study||15
8713030|NCT00972725|9759795|FG000|NOT COMPLETED|Overall Study||0
8713031|NCT00972725|9759796|FG001|NOT COMPLETED|Overall Study||0
8596292|NCT00328614|9631586|FG002|COMPLETED|Overall Study||6
8596293|NCT00328614|9631587|FG003|COMPLETED|Overall Study||5
8596294|NCT00328614|9631588|FG004|COMPLETED|Overall Study||5
8596295|NCT00328614|9631589|FG005|COMPLETED|Overall Study||5
8596296|NCT00328614|9631584|FG000|NOT COMPLETED|Overall Study||0
8596297|NCT00328614|9631585|FG001|NOT COMPLETED|Overall Study||0
8596298|NCT00328614|9631586|FG002|NOT COMPLETED|Overall Study||0
8596299|NCT00328614|9631587|FG003|NOT COMPLETED|Overall Study||1
8596300|NCT00328614|9631588|FG004|NOT COMPLETED|Overall Study||1
8596301|NCT00328614|9631589|FG005|NOT COMPLETED|Overall Study||1
8596302|NCT00328627|9631610|FG000|STARTED|Overall Study||129
8596303|NCT00328627|9631611|FG001|STARTED|Overall Study||128
8596304|NCT00328627|9631612|FG002|STARTED|Overall Study||129
8596305|NCT00328627|9631613|FG003|STARTED|Overall Study||130
8596306|NCT00328627|9631614|FG004|STARTED|Overall Study||130
8596307|NCT00328627|9631615|FG005|STARTED|Overall Study||130
8596308|NCT00328627|9631616|FG006|STARTED|Overall Study||129
8596309|NCT00328627|9631617|FG007|STARTED|Overall Study||130
8596310|NCT00328627|9631618|FG008|STARTED|Overall Study||130
8596311|NCT00328627|9631619|FG009|STARTED|Overall Study||129
8596312|NCT00328627|9631620|FG010|STARTED|Overall Study||130
8596313|NCT00328627|9631621|FG011|STARTED|Overall Study||130
8596314|NCT00328627|9631610|FG000|Safety Set|Overall Study|All patients who took at least 1 dose of double-blind study drug.|129
8596315|NCT00328627|9631611|FG001|Safety Set|Overall Study||128
8596316|NCT00328627|9631612|FG002|Safety Set|Overall Study||129
8596317|NCT00328627|9631613|FG003|Safety Set|Overall Study||129
8596318|NCT00328627|9631614|FG004|Safety Set|Overall Study||130
8596319|NCT00328627|9631615|FG005|Safety Set|Overall Study||130
8596320|NCT00328627|9631616|FG006|Safety Set|Overall Study||129
8596321|NCT00328627|9631617|FG007|Safety Set|Overall Study||130
8596322|NCT00328627|9631618|FG008|Safety Set|Overall Study||130
8596323|NCT00328627|9631619|FG009|Safety Set|Overall Study||129
8596324|NCT00328627|9631620|FG010|Safety Set|Overall Study||130
8596325|NCT00328627|9631621|FG011|Safety Set|Overall Study||130
8596326|NCT00328627|9631610|FG000|COMPLETED|Overall Study||70
8596327|NCT00328627|9631611|FG001|COMPLETED|Overall Study||97
8713032|NCT00972777|9759804|FG000|STARTED|Overall Study||231
8713033|NCT00972777|9759805|FG001|STARTED|Overall Study||243
8713034|NCT00972777|9759804|FG000|COMPLETED|Overall Study||217
8713035|NCT00972777|9759805|FG001|COMPLETED|Overall Study||229
8596328|NCT00328627|9631612|FG002|COMPLETED|Overall Study||101
8596329|NCT00328627|9631613|FG003|COMPLETED|Overall Study||93
8596330|NCT00328627|9631614|FG004|COMPLETED|Overall Study||115
8596331|NCT00328627|9631615|FG005|COMPLETED|Overall Study||110
8596332|NCT00328627|9631616|FG006|COMPLETED|Overall Study||94
8596333|NCT00328627|9631617|FG007|COMPLETED|Overall Study||116
8596334|NCT00328627|9631618|FG008|COMPLETED|Overall Study||113
8596335|NCT00328627|9631619|FG009|COMPLETED|Overall Study||97
8596336|NCT00328627|9631620|FG010|COMPLETED|Overall Study||112
8596337|NCT00328627|9631621|FG011|COMPLETED|Overall Study||114
8596338|NCT00328627|9631610|FG000|NOT COMPLETED|Overall Study||59
8596339|NCT00328627|9631611|FG001|NOT COMPLETED|Overall Study||31
8596340|NCT00328627|9631612|FG002|NOT COMPLETED|Overall Study||28
8596341|NCT00328627|9631613|FG003|NOT COMPLETED|Overall Study||37
8596342|NCT00328627|9631614|FG004|NOT COMPLETED|Overall Study||15
8596343|NCT00328627|9631615|FG005|NOT COMPLETED|Overall Study||20
8596344|NCT00328627|9631616|FG006|NOT COMPLETED|Overall Study||35
8596345|NCT00328627|9631617|FG007|NOT COMPLETED|Overall Study||14
8596346|NCT00328627|9631618|FG008|NOT COMPLETED|Overall Study||17
8596347|NCT00328627|9631619|FG009|NOT COMPLETED|Overall Study||32
8596348|NCT00328627|9631620|FG010|NOT COMPLETED|Overall Study||18
8596349|NCT00328627|9631621|FG011|NOT COMPLETED|Overall Study||16
8596350|NCT00328770|9631655|FG000|STARTED|Overall Study||70
8596351|NCT00328770|9631655|FG000|COMPLETED|Overall Study||70
8596352|NCT00328770|9631655|FG000|NOT COMPLETED|Overall Study||0
8713036|NCT00972777|9759804|FG000|NOT COMPLETED|Overall Study||14
8596353|NCT00328783|9631660|FG000|STARTED|Overall Study||112
8596354|NCT00328783|9631660|FG000|COMPLETED|Overall Study||86
8596355|NCT00328783|9631660|FG000|NOT COMPLETED|Overall Study||26
8596356|NCT00328861|9631668|FG000|STARTED|Overall Study||7
8596357|NCT00328861|9631669|FG001|STARTED|Overall Study||1
8596358|NCT00328861|9631668|FG000|COMPLETED|Overall Study||7
8596359|NCT00328861|9631669|FG001|COMPLETED|Overall Study||1
8596360|NCT00328861|9631668|FG000|NOT COMPLETED|Overall Study||0
8596361|NCT00328861|9631669|FG001|NOT COMPLETED|Overall Study||0
8596362|NCT00328926|9631678|FG000|STARTED|Overall Study||5
8596363|NCT00328926|9631679|FG001|STARTED|Overall Study||3
8596364|NCT00328926|9631680|FG002|STARTED|Overall Study||3
8596365|NCT00328926|9631678|FG000|COMPLETED|Overall Study||3
8596366|NCT00328926|9631679|FG001|COMPLETED|Overall Study||0
8596367|NCT00328926|9631680|FG002|COMPLETED|Overall Study||1
8596368|NCT00328926|9631678|FG000|NOT COMPLETED|Overall Study||2
8596369|NCT00328926|9631679|FG001|NOT COMPLETED|Overall Study||3
8596370|NCT00328926|9631680|FG002|NOT COMPLETED|Overall Study||2
8596371|NCT00329030|9631690|FG000|STARTED|Overall Study||111
8596372|NCT00329030|9631691|FG001|STARTED|Overall Study||113
8596373|NCT00329030|9631690|FG000|COMPLETED|Overall Study||103
8596374|NCT00329030|9631691|FG001|COMPLETED|Overall Study||107
8596375|NCT00329030|9631690|FG000|NOT COMPLETED|Overall Study||8
8596376|NCT00329030|9631691|FG001|NOT COMPLETED|Overall Study||6
8596377|NCT00329160|9631697|FG000|STARTED|Overall Study||214
8596378|NCT00329160|9631697|FG000|Observation Period|Overall Study||214
8596379|NCT00329160|9631697|FG000|Treatment Period|Overall Study||214
8596380|NCT00329160|9631697|FG000|COMPLETED|Overall Study||126
8596381|NCT00329160|9631697|FG000|NOT COMPLETED|Overall Study||88
8596382|NCT00329238|9631703|FG000|STARTED|Overall Study|2866 were randomized. A total of ten did not receive treatment resulting in 2856 starting study.|1430
8596383|NCT00329238|9631704|FG001|STARTED|Overall Study|2866 were randomized. A total of ten did not receive treatment resulting in 2856 starting study.|1426
8596384|NCT00329238|9631703|FG000|COMPLETED|Overall Study||1154
8596385|NCT00329238|9631704|FG001|COMPLETED|Overall Study||1145
8596386|NCT00329238|9631703|FG000|NOT COMPLETED|Overall Study||276
8596387|NCT00329238|9631704|FG001|NOT COMPLETED|Overall Study||281
8596388|NCT00329303|9631714|FG000|STARTED|Overall Study||34
8596389|NCT00329303|9631715|FG001|STARTED|Overall Study||37
8596390|NCT00329303|9631714|FG000|COMPLETED|Overall Study||32
8596391|NCT00329303|9631715|FG001|COMPLETED|Overall Study||35
8596392|NCT00329303|9631714|FG000|NOT COMPLETED|Overall Study||2
8596393|NCT00329303|9631715|FG001|NOT COMPLETED|Overall Study||2
8596394|NCT00329407|9631722|FG000|STARTED|Overall Study||10
8596395|NCT00329407|9631722|FG000|COMPLETED|Overall Study||9
8596396|NCT00329407|9631722|FG000|NOT COMPLETED|Overall Study||1
8596397|NCT00329420|9631729|FG000|STARTED|Re-induction Phase||18
8596398|NCT00329420|9631730|FG001|STARTED|Re-induction Phase||13
8596399|NCT00329420|9631731|FG002|STARTED|Re-induction Phase||15
8596400|NCT00329420|9631729|FG000|COMPLETED|Re-induction Phase|Completed = Reached Week 14 (end of re-induction phase) and responded to re-induction at that time.|12
8596401|NCT00329420|9631730|FG001|COMPLETED|Re-induction Phase|Completed = Reached Week 14 (end of re-induction phase) and responded to re-induction at that time.|7
8596402|NCT00329420|9631731|FG002|COMPLETED|Re-induction Phase|Completed = Reached Week 14 (end of re-induction phase) and responded to re-induction at that time.|7
8596403|NCT00329420|9631729|FG000|NOT COMPLETED|Re-induction Phase||6
8596404|NCT00329420|9631730|FG001|NOT COMPLETED|Re-induction Phase||6
8596405|NCT00329420|9631731|FG002|NOT COMPLETED|Re-induction Phase||8
8596406|NCT00329420|9631729|FG000|STARTED|4-weekly Dosing Phase (Responders Only)||12
8596407|NCT00329420|9631730|FG001|STARTED|4-weekly Dosing Phase (Responders Only)||7
8596408|NCT00329420|9631731|FG002|STARTED|4-weekly Dosing Phase (Responders Only)||7
8596409|NCT00329420|9631729|FG000|COMPLETED|4-weekly Dosing Phase (Responders Only)||8
8596410|NCT00329420|9631730|FG001|COMPLETED|4-weekly Dosing Phase (Responders Only)||5
8596411|NCT00329420|9631731|FG002|COMPLETED|4-weekly Dosing Phase (Responders Only)||6
8596412|NCT00329420|9631729|FG000|NOT COMPLETED|4-weekly Dosing Phase (Responders Only)||4
8596413|NCT00329420|9631730|FG001|NOT COMPLETED|4-weekly Dosing Phase (Responders Only)||2
8596414|NCT00329420|9631731|FG002|NOT COMPLETED|4-weekly Dosing Phase (Responders Only)||1
8596415|NCT00329433|9631743|FG000|STARTED|Overall Study||61
8596416|NCT00329433|9631744|FG001|STARTED|Overall Study||59
8596417|NCT00329433|9631743|FG000|COMPLETED|Overall Study||61
8596418|NCT00329433|9631744|FG001|COMPLETED|Overall Study||59
8596419|NCT00329433|9631743|FG000|NOT COMPLETED|Overall Study||0
8596420|NCT00329433|9631744|FG001|NOT COMPLETED|Overall Study||0
8596421|NCT00329524|9631750|FG000|STARTED|Overall Study||5
8596422|NCT00329524|9631750|FG000|COMPLETED|Overall Study||5
8596423|NCT00329524|9631750|FG000|NOT COMPLETED|Overall Study||0
8596424|NCT00329550|9631757|FG000|STARTED|Overall Study||9
8596425|NCT00329550|9631758|FG001|STARTED|Overall Study||15
8596426|NCT00329550|9631759|FG002|STARTED|Overall Study|1 subject in Safety Set is not in Full Analysis Set due to Good Clinical Practice non-compliance.|16
8596427|NCT00329550|9631757|FG000|COMPLETED|Overall Study||5
8596428|NCT00329550|9631758|FG001|COMPLETED|Overall Study||11
8596429|NCT00329550|9631759|FG002|COMPLETED|Overall Study||12
8596430|NCT00329550|9631757|FG000|NOT COMPLETED|Overall Study||4
8596431|NCT00329550|9631758|FG001|NOT COMPLETED|Overall Study||4
8596432|NCT00329550|9631759|FG002|NOT COMPLETED|Overall Study||4
8596433|NCT00329602|9631771|FG000|STARTED|26-Week Double-Blind Treatment Phase|"Numbers of participants in the Participant Flow section are based on the Safety Population."|207
8596434|NCT00329602|9631772|FG001|STARTED|26-Week Double-Blind Treatment Phase||197
8596435|NCT00329602|9631773|FG002|STARTED|26-Week Double-Blind Treatment Phase||0
8596436|NCT00329602|9631771|FG000|COMPLETED|26-Week Double-Blind Treatment Phase||88
8596437|NCT00329602|9631772|FG001|COMPLETED|26-Week Double-Blind Treatment Phase||98
8596438|NCT00329602|9631773|FG002|COMPLETED|26-Week Double-Blind Treatment Phase||0
8596439|NCT00329602|9631771|FG000|NOT COMPLETED|26-Week Double-Blind Treatment Phase||119
8596440|NCT00329602|9631772|FG001|NOT COMPLETED|26-Week Double-Blind Treatment Phase||99
8596441|NCT00329602|9631773|FG002|NOT COMPLETED|26-Week Double-Blind Treatment Phase||0
8596442|NCT00329602|9631771|FG000|STARTED|40-Week Open-Label Treatment Phase||0
8596443|NCT00329602|9631772|FG001|STARTED|40-Week Open-Label Treatment Phase||0
8596444|NCT00329602|9631773|FG002|STARTED|40-Week Open-Label Treatment Phase|148 and 121 par. randomized to DB placebo and ropinirole IR, respectively, entered the OL phase.|269
8596445|NCT00329602|9631771|FG000|COMPLETED|40-Week Open-Label Treatment Phase||0
8596446|NCT00329602|9631772|FG001|COMPLETED|40-Week Open-Label Treatment Phase||0
8596447|NCT00329602|9631773|FG002|COMPLETED|40-Week Open-Label Treatment Phase||233
8596448|NCT00329602|9631771|FG000|NOT COMPLETED|40-Week Open-Label Treatment Phase||0
8596449|NCT00329602|9631772|FG001|NOT COMPLETED|40-Week Open-Label Treatment Phase||0
8596450|NCT00329602|9631773|FG002|NOT COMPLETED|40-Week Open-Label Treatment Phase||36
8596451|NCT00329641|9631789|FG000|STARTED|Overall Study||25
8596452|NCT00329641|9631789|FG000|Eligible|Overall Study||25
8596453|NCT00329641|9631789|FG000|Eligible and Received Treatment|Overall Study||24
8596454|NCT00329641|9631789|FG000|COMPLETED|Overall Study||19
8596455|NCT00329641|9631789|FG000|NOT COMPLETED|Overall Study||6
8596456|NCT00329719|9631798|FG000|STARTED|Overall Study||12
8596457|NCT00329719|9631799|FG001|STARTED|Overall Study||49
8596458|NCT00329719|9631800|FG002|STARTED|Overall Study||9
8596459|NCT00329719|9631801|FG003|STARTED|Overall Study||45
8596460|NCT00329719|9631798|FG000|COMPLETED|Overall Study||12
8596461|NCT00329719|9631799|FG001|COMPLETED|Overall Study||49
8596462|NCT00329719|9631800|FG002|COMPLETED|Overall Study||9
8596463|NCT00329719|9631801|FG003|COMPLETED|Overall Study||44
8596464|NCT00329719|9631798|FG000|NOT COMPLETED|Overall Study||0
8596465|NCT00329719|9631799|FG001|NOT COMPLETED|Overall Study||0
8596466|NCT00329719|9631800|FG002|NOT COMPLETED|Overall Study||0
8596467|NCT00329719|9631801|FG003|NOT COMPLETED|Overall Study||1
8596468|NCT00329745|9631813|FG000|STARTED|Overall Study||4359
8596469|NCT00329745|9631814|FG001|STARTED|Overall Study||4328
8596470|NCT00329745|9631813|FG000|COMPLETED|Overall Study||4272
8596471|NCT00329745|9631814|FG001|COMPLETED|Overall Study||4226
8596472|NCT00329745|9631813|FG000|NOT COMPLETED|Overall Study||87
8596473|NCT00329745|9631814|FG001|NOT COMPLETED|Overall Study||102
8596474|NCT00329771|9631820|FG000|STARTED|Overall Study||28
8596475|NCT00329771|9631820|FG000|COMPLETED|Overall Study|3 subjects withdrew or were lost to follow-up|25
8596476|NCT00329771|9631820|FG000|NOT COMPLETED|Overall Study||3
8596477|NCT00329784|9631828|FG000|STARTED|Overall Study||270
8596478|NCT00329784|9631829|FG001|STARTED|Overall Study||272
8596479|NCT00329784|9631830|FG002|STARTED|Overall Study||51
8596480|NCT00329784|9631831|FG003|STARTED|Overall Study||47
8596481|NCT00329784|9631828|FG000|COMPLETED|Overall Study||265
8596482|NCT00329784|9631829|FG001|COMPLETED|Overall Study||267
8596483|NCT00329784|9631830|FG002|COMPLETED|Overall Study||51
8596484|NCT00329784|9631831|FG003|COMPLETED|Overall Study||47
8596485|NCT00329784|9631828|FG000|NOT COMPLETED|Overall Study||5
8596486|NCT00329784|9631829|FG001|NOT COMPLETED|Overall Study||5
8596487|NCT00329784|9631830|FG002|NOT COMPLETED|Overall Study||0
8596488|NCT00329784|9631831|FG003|NOT COMPLETED|Overall Study||0
8596489|NCT00329797|9631845|FG000|STARTED|Overall Study||57
8596490|NCT00329797|9631846|FG001|STARTED|Overall Study||52
8596491|NCT00329797|9631845|FG000|COMPLETED|Overall Study||50
8596492|NCT00329797|9631846|FG001|COMPLETED|Overall Study||46
8596493|NCT00329797|9631845|FG000|NOT COMPLETED|Overall Study||7
8596494|NCT00329797|9631846|FG001|NOT COMPLETED|Overall Study||6
8596495|NCT00329836|9631852|FG000|STARTED|Overall Study||41
8596496|NCT00329836|9631852|FG000|COMPLETED|Overall Study||41
8596497|NCT00329836|9631852|FG000|NOT COMPLETED|Overall Study||0
8596498|NCT00329849|9631858|FG000|STARTED|Overall Study||950
8596499|NCT00329849|9631859|FG001|STARTED|Overall Study||550
8596500|NCT00329849|9631858|FG000|COMPLETED|Overall Study||944
8596501|NCT00329849|9631859|FG001|COMPLETED|Overall Study||546
8596502|NCT00329849|9631858|FG000|NOT COMPLETED|Overall Study||6
8596503|NCT00329849|9631859|FG001|NOT COMPLETED|Overall Study||4
8596504|NCT00329901|9631872|FG000|STARTED|Overall Study||361
8596505|NCT00329901|9631873|FG001|STARTED|Overall Study||354
8596506|NCT00329901|9631874|FG002|STARTED|Overall Study||357
8596507|NCT00329901|9631872|FG000|COMPLETED|Overall Study||352
8596508|NCT00329901|9631873|FG001|COMPLETED|Overall Study||349
8596509|NCT00329901|9631874|FG002|COMPLETED|Overall Study||353
8596510|NCT00329901|9631872|FG000|NOT COMPLETED|Overall Study||9
8596511|NCT00329901|9631873|FG001|NOT COMPLETED|Overall Study||5
8596512|NCT00329901|9631874|FG002|NOT COMPLETED|Overall Study||4
8596513|NCT00330161|9631886|FG000|STARTED|Overall Study||29
8596514|NCT00330161|9631886|FG000|COMPLETED|Overall Study||29
8596515|NCT00330161|9631886|FG000|NOT COMPLETED|Overall Study||0
8596516|NCT00330174|9631892|FG000|STARTED|Overall Study||45
8596517|NCT00330174|9631893|FG001|STARTED|Overall Study||45
8596518|NCT00330174|9631892|FG000|COMPLETED|Overall Study||23
8596519|NCT00330174|9631893|FG001|COMPLETED|Overall Study||26
8596520|NCT00330174|9631892|FG000|NOT COMPLETED|Overall Study||22
8596521|NCT00330174|9631893|FG001|NOT COMPLETED|Overall Study||19
8596522|NCT00330187|9631903|FG000|STARTED|Overall Study||37
8596523|NCT00330187|9631904|FG001|STARTED|Overall Study||36
8596524|NCT00330187|9631905|FG002|STARTED|Overall Study||29
8596525|NCT00330187|9631906|FG003|STARTED|Overall Study||32
8596526|NCT00330187|9631903|FG000|COMPLETED|Overall Study||17
8596527|NCT00330187|9631904|FG001|COMPLETED|Overall Study||18
8596528|NCT00330187|9631905|FG002|COMPLETED|Overall Study||11
8596529|NCT00330187|9631906|FG003|COMPLETED|Overall Study||18
8596530|NCT00330187|9631903|FG000|NOT COMPLETED|Overall Study||20
8596531|NCT00330187|9631904|FG001|NOT COMPLETED|Overall Study||18
8596532|NCT00330187|9631905|FG002|NOT COMPLETED|Overall Study||18
8596533|NCT00330187|9631906|FG003|NOT COMPLETED|Overall Study||14
8596534|NCT00330343|9631916|FG000|STARTED|Overall Study||64
8596535|NCT00330343|9631916|FG000|COMPLETED|Overall Study||59
8596536|NCT00330343|9631916|FG000|NOT COMPLETED|Overall Study||5
8596537|NCT00330382|9631922|FG000|STARTED|Overall Study||67
8596538|NCT00330382|9631923|FG001|STARTED|Overall Study||65
8596539|NCT00330382|9631922|FG000|COMPLETED|Overall Study||43
8596540|NCT00330382|9631923|FG001|COMPLETED|Overall Study||48
8596541|NCT00330382|9631922|FG000|NOT COMPLETED|Overall Study||24
8596542|NCT00330382|9631923|FG001|NOT COMPLETED|Overall Study||17
8596543|NCT00330421|9631930|FG000|STARTED|Overall Study||15
8596544|NCT00330421|9631931|FG001|STARTED|Overall Study||0
8596545|NCT00330421|9631930|FG000|COMPLETED|Overall Study||15
8596546|NCT00330421|9631931|FG001|COMPLETED|Overall Study||0
8596547|NCT00330421|9631930|FG000|NOT COMPLETED|Overall Study||0
8596548|NCT00330421|9631931|FG001|NOT COMPLETED|Overall Study||0
8596549|NCT00330460|9631937|FG000|STARTED|Overall Study||595
8596550|NCT00330460|9631938|FG001|STARTED|Overall Study||594
8596551|NCT00330460|9631937|FG000|COMPLETED|Overall Study||553
8596552|NCT00330460|9631938|FG001|COMPLETED|Overall Study||561
8596553|NCT00330460|9631937|FG000|NOT COMPLETED|Overall Study||42
8596554|NCT00330460|9631938|FG001|NOT COMPLETED|Overall Study||33
8596555|NCT00330551|9631946|FG000|STARTED|Overall Study||40
8596556|NCT00330551|9631947|FG001|STARTED|Overall Study||43
8596557|NCT00330551|9631946|FG000|COMPLETED|Overall Study||30
8596558|NCT00330551|9631947|FG001|COMPLETED|Overall Study||27
8596559|NCT00330551|9631946|FG000|NOT COMPLETED|Overall Study||10
8596560|NCT00330551|9631947|FG001|NOT COMPLETED|Overall Study||16
8596561|NCT00330564|9631955|FG000|STARTED|Overall Study||15
8596562|NCT00330564|9631955|FG000|COMPLETED|Overall Study||15
8596563|NCT00330564|9631955|FG000|NOT COMPLETED|Overall Study||0
8596564|NCT00330616|9631959|FG000|STARTED|Overall Study||35
8596565|NCT00330616|9631959|FG000|COMPLETED|Overall Study||14
8596566|NCT00330616|9631959|FG000|NOT COMPLETED|Overall Study||21
8596567|NCT00330668|9631963|FG000|STARTED|BID Dosing Period||114
8596568|NCT00330668|9631963|FG000|COMPLETED|BID Dosing Period||78
8596569|NCT00330668|9631963|FG000|NOT COMPLETED|BID Dosing Period||36
8596570|NCT00330668|9631963|FG000|STARTED|QD Dosing Period||78
8596571|NCT00330668|9631963|FG000|COMPLETED|QD Dosing Period||0
8596572|NCT00330668|9631963|FG000|NOT COMPLETED|QD Dosing Period||78
8596573|NCT00330681|9631969|FG000|STARTED|Overall Study||102
8596574|NCT00330681|9631970|FG001|STARTED|Overall Study||104
8596575|NCT00330681|9631969|FG000|COMPLETED|Overall Study||93
8596576|NCT00330681|9631970|FG001|COMPLETED|Overall Study||90
8596577|NCT00330681|9631969|FG000|NOT COMPLETED|Overall Study||9
8596578|NCT00330681|9631970|FG001|NOT COMPLETED|Overall Study||14
8596579|NCT00330733|9631978|FG000|STARTED|Overall Study||37
8596580|NCT00330733|9631979|FG001|STARTED|Overall Study||34
8596581|NCT00330733|9631978|FG000|Received Study Medication|Overall Study||36
8596582|NCT00330733|9631979|FG001|Received Study Medication|Overall Study||34
8596583|NCT00330733|9631978|FG000|COMPLETED|Overall Study||30
8596584|NCT00330733|9631979|FG001|COMPLETED|Overall Study||29
8596585|NCT00330733|9631978|FG000|NOT COMPLETED|Overall Study||7
8596586|NCT00330733|9631979|FG001|NOT COMPLETED|Overall Study||5
8596587|NCT00330759|9631987|FG000|STARTED|Overall Study||890
8596588|NCT00330759|9631988|FG001|STARTED|Overall Study||886
8596589|NCT00330759|9631987|FG000|Received Investigational Product|Overall Study||878
8596590|NCT00330759|9631988|FG001|Received Investigational Product|Overall Study||878
8596591|NCT00330759|9631987|FG000|COMPLETED|Overall Study||178
8596592|NCT00330759|9631988|FG001|COMPLETED|Overall Study||180
8596593|NCT00330759|9631987|FG000|NOT COMPLETED|Overall Study||712
8596594|NCT00330759|9631988|FG001|NOT COMPLETED|Overall Study||706
8596595|NCT00330863|9631996|FG000|STARTED|Overall Study||153
8596596|NCT00330863|9631997|FG001|STARTED|Overall Study||152
8596597|NCT00330863|9631996|FG000|COMPLETED|Overall Study||72
8596598|NCT00330863|9631997|FG001|COMPLETED|Overall Study||72
8713037|NCT00972777|9759805|FG001|NOT COMPLETED|Overall Study||14
8713038|NCT00972816|9759819|FG000|STARTED|Overall Study||173
8713039|NCT00972816|9759820|FG001|STARTED|Overall Study||169
8713040|NCT00972816|9759821|FG002|STARTED|Overall Study||169
8713041|NCT00972816|9759822|FG003|STARTED|Overall Study||169
8713042|NCT00972816|9759823|FG004|STARTED|Overall Study||169
8596599|NCT00330863|9631996|FG000|NOT COMPLETED|Overall Study||81
8596600|NCT00330863|9631997|FG001|NOT COMPLETED|Overall Study||80
8596601|NCT00330876|9632003|FG000|STARTED|Overall Study||449
8596602|NCT00330876|9632004|FG001|STARTED|Overall Study||90
8596603|NCT00330876|9632003|FG000|COMPLETED|Overall Study||378
8596604|NCT00330876|9632004|FG001|COMPLETED|Overall Study||77
8596605|NCT00330876|9632003|FG000|NOT COMPLETED|Overall Study||71
8596606|NCT00330876|9632004|FG001|NOT COMPLETED|Overall Study||13
8596607|NCT00330915|9632010|FG000|STARTED|Overall Study||37
8596608|NCT00330915|9632010|FG000|COMPLETED|Overall Study||37
8713043|NCT00972816|9759824|FG005|STARTED|Overall Study||169
8713044|NCT00972816|9759825|FG006|STARTED|Overall Study||169
8713045|NCT00972816|9759826|FG007|STARTED|Overall Study||170
8713046|NCT00972816|9759819|FG000|COMPLETED|Overall Study||156
8713047|NCT00972816|9759820|FG001|COMPLETED|Overall Study||158
8713048|NCT00972816|9759821|FG002|COMPLETED|Overall Study||160
8713049|NCT00972816|9759822|FG003|COMPLETED|Overall Study||161
8713050|NCT00972816|9759823|FG004|COMPLETED|Overall Study||157
8596609|NCT00330915|9632010|FG000|NOT COMPLETED|Overall Study||0
8596610|NCT00330928|9632014|FG000|STARTED|Overall Study|Subjects that signed consent and were subject to research procedures.|106
8596611|NCT00330928|9632014|FG000|7 Day Phone Contact|Overall Study||99
8596612|NCT00330928|9632014|FG000|1 Year Phone Contact|Overall Study||89
8596613|NCT00330928|9632014|FG000|COMPLETED|Overall Study||89
8596614|NCT00330928|9632014|FG000|NOT COMPLETED|Overall Study||17
8596615|NCT00330967|9632020|FG000|STARTED|Overall Study||0
8596616|NCT00330967|9632021|FG001|STARTED|Overall Study||25
8596617|NCT00330967|9632020|FG000|COMPLETED|Overall Study||0
8596618|NCT00330967|9632021|FG001|COMPLETED|Overall Study||11
8596619|NCT00330967|9632020|FG000|NOT COMPLETED|Overall Study||0
8596620|NCT00330967|9632021|FG001|NOT COMPLETED|Overall Study||14
8596621|NCT00331006|9632027|FG000|STARTED|Screening Phase||23
8596622|NCT00331006|9632027|FG000|COMPLETED|Screening Phase|subjects eligible for the treatment phase if inhibitor titer following Factor VIII was at least 5 BU|16
8596623|NCT00331006|9632027|FG000|NOT COMPLETED|Screening Phase||7
8596624|NCT00331006|9632027|FG000|STARTED|Treatment Phase||16
8596625|NCT00331006|9632027|FG000|COMPLETED|Treatment Phase||15
8596626|NCT00331006|9632027|FG000|NOT COMPLETED|Treatment Phase||1
8596627|NCT00331006|9632027|FG000|STARTED|Follow-Up Phase I||15
8596628|NCT00331006|9632027|FG000|COMPLETED|Follow-Up Phase I||14
8596629|NCT00331006|9632027|FG000|NOT COMPLETED|Follow-Up Phase I||1
8596630|NCT00331006|9632027|FG000|STARTED|Follow-Up Phase II||14
8596631|NCT00331006|9632027|FG000|COMPLETED|Follow-Up Phase II||11
8596632|NCT00331006|9632027|FG000|NOT COMPLETED|Follow-Up Phase II||3
8596633|NCT00331136|9632035|FG000|STARTED|Overall Study||15
8596634|NCT00331136|9632036|FG001|STARTED|Overall Study||15
8596635|NCT00331136|9632037|FG002|STARTED|Overall Study||15
8596636|NCT00331136|9632038|FG003|STARTED|Overall Study||15
8596637|NCT00331136|9632035|FG000|COMPLETED|Overall Study||10
8596638|NCT00331136|9632036|FG001|COMPLETED|Overall Study||8
8596639|NCT00331136|9632037|FG002|COMPLETED|Overall Study||15
8596640|NCT00331136|9632038|FG003|COMPLETED|Overall Study||14
8596641|NCT00331136|9632035|FG000|NOT COMPLETED|Overall Study||5
8596642|NCT00331136|9632036|FG001|NOT COMPLETED|Overall Study||7
8596643|NCT00331136|9632037|FG002|NOT COMPLETED|Overall Study||0
8596644|NCT00331136|9632038|FG003|NOT COMPLETED|Overall Study||1
8596645|NCT00331162|9632050|FG000|STARTED|Overall Study||113
8596646|NCT00331162|9632051|FG001|STARTED|Overall Study||109
8596647|NCT00331162|9632050|FG000|COMPLETED|Overall Study||113
8596648|NCT00331162|9632051|FG001|COMPLETED|Overall Study||109
8596649|NCT00331162|9632050|FG000|NOT COMPLETED|Overall Study||0
8596650|NCT00331162|9632051|FG001|NOT COMPLETED|Overall Study||0
8596651|NCT00331344|9632057|FG000|STARTED|Phase I||3
8596652|NCT00331344|9632058|FG001|STARTED|Phase I||3
8596653|NCT00331344|9632059|FG002|STARTED|Phase I||3
8596654|NCT00331344|9632060|FG003|STARTED|Phase I||6
8596655|NCT00331344|9632061|FG004|STARTED|Phase I||6
8596656|NCT00331344|9632062|FG005|STARTED|Phase I||5
8596657|NCT00331344|9632063|FG006|STARTED|Phase I||4
8596658|NCT00331344|9632064|FG007|STARTED|Phase I|1 participant who was enrolled died prior to initiating protocol therapy.|6
8596659|NCT00331344|9632065|FG008|STARTED|Phase I||0
8596660|NCT00331344|9632057|FG000|COMPLETED|Phase I||3
8596661|NCT00331344|9632058|FG001|COMPLETED|Phase I||3
8596662|NCT00331344|9632059|FG002|COMPLETED|Phase I||3
8596663|NCT00331344|9632060|FG003|COMPLETED|Phase I|1 participant reached dose limiting toxicity|5
8596664|NCT00331344|9632061|FG004|COMPLETED|Phase I|2 participants reached dose limiting toxicity|4
8596665|NCT00331344|9632062|FG005|COMPLETED|Phase I|2 participants reached dose limiting toxicity|3
8596666|NCT00331344|9632063|FG006|COMPLETED|Phase I||4
8596667|NCT00331344|9632064|FG007|COMPLETED|Phase I|1 participant reached dose limiting toxicity|5
8596668|NCT00331344|9632065|FG008|COMPLETED|Phase I||0
8596669|NCT00331344|9632057|FG000|NOT COMPLETED|Phase I||0
8596670|NCT00331344|9632058|FG001|NOT COMPLETED|Phase I||0
8596671|NCT00331344|9632059|FG002|NOT COMPLETED|Phase I||0
8596672|NCT00331344|9632060|FG003|NOT COMPLETED|Phase I||1
8596673|NCT00331344|9632061|FG004|NOT COMPLETED|Phase I||2
8596674|NCT00331344|9632062|FG005|NOT COMPLETED|Phase I||2
8596675|NCT00331344|9632063|FG006|NOT COMPLETED|Phase I||0
8596676|NCT00331344|9632064|FG007|NOT COMPLETED|Phase I||1
8596677|NCT00331344|9632065|FG008|NOT COMPLETED|Phase I||0
8596678|NCT00331344|9632057|FG000|STARTED|Phase II||0
8596679|NCT00331344|9632058|FG001|STARTED|Phase II||0
8596680|NCT00331344|9632059|FG002|STARTED|Phase II||0
8713051|NCT00972816|9759824|FG005|COMPLETED|Overall Study||158
8596681|NCT00331344|9632060|FG003|STARTED|Phase II||0
8596682|NCT00331344|9632061|FG004|STARTED|Phase II||0
8596683|NCT00331344|9632062|FG005|STARTED|Phase II||0
8596684|NCT00331344|9632063|FG006|STARTED|Phase II||0
8596685|NCT00331344|9632064|FG007|STARTED|Phase II|6 patients in Phase I Group VIa continued to the Phase II period.|6
8596686|NCT00331344|9632065|FG008|STARTED|Phase II|Protocol enrollment (63) minus 11 ineligible prior to receiving treatment.|52
8596687|NCT00331344|9632057|FG000|COMPLETED|Phase II||0
8596688|NCT00331344|9632058|FG001|COMPLETED|Phase II||0
8596689|NCT00331344|9632059|FG002|COMPLETED|Phase II||0
8713052|NCT00972816|9759825|FG006|COMPLETED|Overall Study||159
8713053|NCT00972816|9759826|FG007|COMPLETED|Overall Study||161
8713054|NCT00972816|9759819|FG000|NOT COMPLETED|Overall Study||17
8713055|NCT00972816|9759820|FG001|NOT COMPLETED|Overall Study||11
8713056|NCT00972816|9759821|FG002|NOT COMPLETED|Overall Study||9
8713057|NCT00972816|9759822|FG003|NOT COMPLETED|Overall Study||8
8713058|NCT00972816|9759823|FG004|NOT COMPLETED|Overall Study||12
8713059|NCT00972816|9759824|FG005|NOT COMPLETED|Overall Study||11
8713060|NCT00972816|9759825|FG006|NOT COMPLETED|Overall Study||10
8713061|NCT00972816|9759826|FG007|NOT COMPLETED|Overall Study||9
8713062|NCT00972959|9759844|FG000|STARTED|Overall Study||17
8713063|NCT00972959|9759844|FG000|COMPLETED|Overall Study||17
8713064|NCT00972959|9759844|FG000|NOT COMPLETED|Overall Study||0
8713065|NCT00973102|9759850|FG000|STARTED|Overall Study||24
8713066|NCT00973102|9759851|FG001|STARTED|Overall Study||26
8713067|NCT00973102|9759850|FG000|COMPLETED|Overall Study||23
8713068|NCT00973102|9759851|FG001|COMPLETED|Overall Study||25
8713069|NCT00973102|9759850|FG000|NOT COMPLETED|Overall Study||1
8713070|NCT00973102|9759851|FG001|NOT COMPLETED|Overall Study||1
8713071|NCT00973349|9759873|FG000|STARTED|Overall Study||170
8713072|NCT00973349|9759874|FG001|STARTED|Overall Study||168
8713073|NCT00973349|9759875|FG002|STARTED|Overall Study||171
8713074|NCT00973349|9759876|FG003|STARTED|Overall Study||168
8713075|NCT00973349|9759877|FG004|STARTED|Overall Study||170
8713076|NCT00973349|9759878|FG005|STARTED|Overall Study||169
8713077|NCT00973349|9759879|FG006|STARTED|Overall Study||174
8713078|NCT00973349|9759880|FG007|STARTED|Overall Study||169
8713079|NCT00973349|9759881|FG008|STARTED|Overall Study||171
8713080|NCT00973349|9759882|FG009|STARTED|Overall Study||169
8713081|NCT00973349|9759883|FG010|STARTED|Overall Study||174
8713082|NCT00973349|9759884|FG011|STARTED|Overall Study||169
8713083|NCT00973349|9759885|FG012|STARTED|Overall Study||169
8713084|NCT00973349|9759886|FG013|STARTED|Overall Study||171
8713085|NCT00973349|9759887|FG014|STARTED|Overall Study||170
8713086|NCT00973349|9759888|FG015|STARTED|Overall Study||167
8713087|NCT00973349|9759873|FG000|COMPLETED|Overall Study||166
8713088|NCT00973349|9759874|FG001|COMPLETED|Overall Study||165
8596690|NCT00331344|9632060|FG003|COMPLETED|Phase II||0
8596691|NCT00331344|9632061|FG004|COMPLETED|Phase II||0
8596692|NCT00331344|9632062|FG005|COMPLETED|Phase II||0
8596693|NCT00331344|9632063|FG006|COMPLETED|Phase II||0
8596694|NCT00331344|9632064|FG007|COMPLETED|Phase II||6
8596695|NCT00331344|9632065|FG008|COMPLETED|Phase II||48
8596696|NCT00331344|9632057|FG000|NOT COMPLETED|Phase II||0
8596697|NCT00331344|9632058|FG001|NOT COMPLETED|Phase II||0
8596698|NCT00331344|9632059|FG002|NOT COMPLETED|Phase II||0
8596699|NCT00331344|9632060|FG003|NOT COMPLETED|Phase II||0
8596700|NCT00331344|9632061|FG004|NOT COMPLETED|Phase II||0
8596701|NCT00331344|9632062|FG005|NOT COMPLETED|Phase II||0
8596702|NCT00331344|9632063|FG006|NOT COMPLETED|Phase II||0
8596703|NCT00331344|9632064|FG007|NOT COMPLETED|Phase II||0
8596704|NCT00331344|9632065|FG008|NOT COMPLETED|Phase II||4
8596705|NCT00331409|9632078|FG000|STARTED|Overall Study|19 patients were enrolled in the first stage due to 4 patients who withdrew early.|19
8596706|NCT00331409|9632078|FG000|COMPLETED|Overall Study|15 patients accrued to the first stage;if>9 were progression-free at 3 months,enrollment continued.|15
8596707|NCT00331409|9632078|FG000|NOT COMPLETED|Overall Study||4
8596708|NCT00331422|9632082|FG000|STARTED|Overall Study|Patients who met study criteria and received at least one dose of study drug.|7
8596709|NCT00331422|9632082|FG000|COMPLETED|Overall Study|Completed all 6 courses of chemotherapy and had surgery to remove all tumor lesions.|2
8596710|NCT00331422|9632082|FG000|NOT COMPLETED|Overall Study||5
8596711|NCT00331552|9632089|FG000|STARTED|Period 1: Doxil 30 mg/m^2 (Phase I)||3
8596712|NCT00331552|9632090|FG001|STARTED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
8596713|NCT00331552|9632089|FG000|COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||3
8596714|NCT00331552|9632090|FG001|COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
8596715|NCT00331552|9632089|FG000|NOT COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
8596716|NCT00331552|9632090|FG001|NOT COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
8596717|NCT00331552|9632089|FG000|STARTED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
8596718|NCT00331552|9632090|FG001|STARTED|Period 2: Doxil 35 mg/m^2 (Phase I)||3
8596719|NCT00331552|9632089|FG000|COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
8596720|NCT00331552|9632090|FG001|COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||3
8596721|NCT00331552|9632089|FG000|NOT COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
8596722|NCT00331552|9632090|FG001|NOT COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
8596723|NCT00331552|9632089|FG000|STARTED|Period 3: Phase II||24
8596724|NCT00331552|9632090|FG001|STARTED|Period 3: Phase II||0
8596725|NCT00331552|9632089|FG000|COMPLETED|Period 3: Phase II||22
8596726|NCT00331552|9632090|FG001|COMPLETED|Period 3: Phase II||0
8596727|NCT00331552|9632089|FG000|NOT COMPLETED|Period 3: Phase II||2
8596728|NCT00331552|9632090|FG001|NOT COMPLETED|Period 3: Phase II||0
8596729|NCT00331630|9632101|FG000|STARTED|Treatment on Study||30
8713089|NCT00973349|9759875|FG002|COMPLETED|Overall Study||166
8713090|NCT00973349|9759876|FG003|COMPLETED|Overall Study||163
8713091|NCT00973349|9759877|FG004|COMPLETED|Overall Study||165
8713092|NCT00973349|9759878|FG005|COMPLETED|Overall Study||165
8713093|NCT00973349|9759879|FG006|COMPLETED|Overall Study||172
8713094|NCT00973349|9759880|FG007|COMPLETED|Overall Study||166
8713095|NCT00973349|9759881|FG008|COMPLETED|Overall Study||167
8713096|NCT00973349|9759882|FG009|COMPLETED|Overall Study||163
8596730|NCT00331630|9632101|FG000|Completed 1st Cycle|Treatment on Study||30
8713097|NCT00973349|9759883|FG010|COMPLETED|Overall Study||174
8596731|NCT00331630|9632101|FG000|Completed 4 Cycles|Treatment on Study||30
8596732|NCT00331630|9632101|FG000|COMPLETED|Treatment on Study||30
8596733|NCT00331630|9632101|FG000|NOT COMPLETED|Treatment on Study||0
8596734|NCT00331630|9632101|FG000|STARTED|Evaluated for and Completed SOC Surgery||30
8596735|NCT00331630|9632101|FG000|COMPLETED|Evaluated for and Completed SOC Surgery||28
8596736|NCT00331630|9632101|FG000|NOT COMPLETED|Evaluated for and Completed SOC Surgery||2
8713098|NCT00973349|9759884|FG011|COMPLETED|Overall Study||167
8713099|NCT00973349|9759885|FG012|COMPLETED|Overall Study||168
8713100|NCT00973349|9759886|FG013|COMPLETED|Overall Study||171
8713101|NCT00973349|9759887|FG014|COMPLETED|Overall Study||168
8713102|NCT00973349|9759888|FG015|COMPLETED|Overall Study||165
8713103|NCT00973349|9759873|FG000|NOT COMPLETED|Overall Study||4
8596737|NCT00331630|9632101|FG000|STARTED|Follow up for 5 Years|One patient did not enter follow up as was lost to follow up|29
8596738|NCT00331630|9632101|FG000|COMPLETED|Follow up for 5 Years||0
8596739|NCT00331630|9632101|FG000|NOT COMPLETED|Follow up for 5 Years||29
8596740|NCT00331682|9632105|FG000|STARTED|Overall Study||10
8596741|NCT00331682|9632105|FG000|COMPLETED|Overall Study||9
8596742|NCT00331682|9632105|FG000|NOT COMPLETED|Overall Study||1
8596743|NCT00331760|9632111|FG000|STARTED|Overall Study||58
8596744|NCT00331760|9632112|FG001|STARTED|Overall Study||48
8596745|NCT00331760|9632111|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|43
8596746|NCT00331760|9632112|FG001|COMPLETED|Overall Study||40
8596747|NCT00331760|9632111|FG000|NOT COMPLETED|Overall Study||15
8596748|NCT00331760|9632112|FG001|NOT COMPLETED|Overall Study||8
8596749|NCT00331799|9632119|FG000|STARTED|Overall Study||18
8596750|NCT00331799|9632119|FG000|COMPLETED|Overall Study||15
8596751|NCT00331799|9632119|FG000|NOT COMPLETED|Overall Study||3
8596752|NCT00331864|9632125|FG000|STARTED|Overall Study||513
8596753|NCT00331864|9632126|FG001|STARTED|Overall Study||18
8596754|NCT00331864|9632125|FG000|COMPLETED|Overall Study||455
8596755|NCT00331864|9632126|FG001|COMPLETED|Overall Study||14
8596756|NCT00331864|9632125|FG000|NOT COMPLETED|Overall Study||58
8596757|NCT00331864|9632126|FG001|NOT COMPLETED|Overall Study||4
8596758|NCT00332163|9632134|FG000|STARTED|Overall Study||48
8596759|NCT00332163|9632135|FG001|STARTED|Overall Study||47
8596760|NCT00332163|9632134|FG000|Received Treatment|Overall Study||48
8596761|NCT00332163|9632135|FG001|Received Treatment|Overall Study||47
8596762|NCT00332163|9632134|FG000|COMPLETED|Overall Study||48
8596763|NCT00332163|9632135|FG001|COMPLETED|Overall Study||47
8596764|NCT00332163|9632134|FG000|NOT COMPLETED|Overall Study||0
8596765|NCT00332163|9632135|FG001|NOT COMPLETED|Overall Study||0
8596766|NCT00332189|9632141|FG000|STARTED|Overall Study||111
8596767|NCT00332189|9632141|FG000|COMPLETED|Overall Study|Subjects in this extension study continued until there was market approval in their region.|90
8596768|NCT00332189|9632141|FG000|NOT COMPLETED|Overall Study||21
8596769|NCT00332202|9632148|FG000|STARTED|Overall Study||504
8596770|NCT00332202|9632149|FG001|STARTED|Overall Study||254
8596771|NCT00332202|9632148|FG000|Received At Least One Dose of Study Drug|Overall Study||493
8596772|NCT00332202|9632149|FG001|Received At Least One Dose of Study Drug|Overall Study||249
8596773|NCT00332202|9632148|FG000|COMPLETED|Overall Study||263
8596774|NCT00332202|9632149|FG001|COMPLETED|Overall Study||129
8596775|NCT00332202|9632148|FG000|NOT COMPLETED|Overall Study||241
8596776|NCT00332202|9632149|FG001|NOT COMPLETED|Overall Study||125
8596777|NCT00332241|9632166|FG000|STARTED|Overall Study||51
8596778|NCT00332241|9632167|FG001|STARTED|Overall Study||47
8596779|NCT00332241|9632166|FG000|COMPLETED|Overall Study||36
8596780|NCT00332241|9632167|FG001|COMPLETED|Overall Study||39
8596781|NCT00332241|9632166|FG000|NOT COMPLETED|Overall Study||15
8596782|NCT00332241|9632167|FG001|NOT COMPLETED|Overall Study||8
8596783|NCT00332332|9632173|FG000|STARTED|Overall Study||246
8596784|NCT00332332|9632173|FG000|Received Study Medication|Overall Study||230
8596785|NCT00332332|9632173|FG000|COMPLETED|Overall Study||178
8596786|NCT00332332|9632173|FG000|NOT COMPLETED|Overall Study||68
8596787|NCT00332462|9632177|FG000|STARTED|Overall Study|Safety and Intention to treat population.|34
8596788|NCT00332462|9632177|FG000|Patients Treated With Sandimmun® i.v.|Overall Study||34
8596789|NCT00332462|9632177|FG000|Patients Treated With Sandimmun® Optoral|Overall Study||29
8596790|NCT00332462|9632177|FG000|COMPLETED|Overall Study||18
8596791|NCT00332462|9632177|FG000|NOT COMPLETED|Overall Study||16
8596792|NCT00332488|9632187|FG000|STARTED|Initial Treatment Phase (Weeks 0 - 12)||183
8596793|NCT00332488|9632188|FG001|STARTED|Initial Treatment Phase (Weeks 0 - 12)||170
8596794|NCT00332488|9632189|FG002|STARTED|Initial Treatment Phase (Weeks 0 - 12)||175
8596795|NCT00332488|9632187|FG000|COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||133
8596796|NCT00332488|9632188|FG001|COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||152
8596797|NCT00332488|9632189|FG002|COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||119
8596798|NCT00332488|9632187|FG000|NOT COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||50
8713104|NCT00973349|9759874|FG001|NOT COMPLETED|Overall Study||3
8713105|NCT00973349|9759875|FG002|NOT COMPLETED|Overall Study||5
8713106|NCT00973349|9759876|FG003|NOT COMPLETED|Overall Study||5
8713107|NCT00973349|9759877|FG004|NOT COMPLETED|Overall Study||5
8596799|NCT00332488|9632188|FG001|NOT COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||18
8596800|NCT00332488|9632189|FG002|NOT COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||56
8596801|NCT00332488|9632187|FG000|STARTED|Transfer Treatment Phase (Weeks 12 - 24)|Subjects on TI who achieved an HbA1c < 7.5% or had an HbA1c decrease from baseline >= 1.0%|29
8713108|NCT00973349|9759878|FG005|NOT COMPLETED|Overall Study||4
8596802|NCT00332488|9632188|FG001|STARTED|Transfer Treatment Phase (Weeks 12 - 24)|Subjects on treatment who achieved an HbA1c < 7.5% or had an HbA1c decrease from baseline >= 1.0%|72
8596803|NCT00332488|9632189|FG002|STARTED|Transfer Treatment Phase (Weeks 12 - 24)|Subjects in this arm who met HbA1c criteria + subjects from other arms who did not|254
8596804|NCT00332488|9632187|FG000|COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||27
8596805|NCT00332488|9632188|FG001|COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||70
8596806|NCT00332488|9632189|FG002|COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||233
8596807|NCT00332488|9632187|FG000|NOT COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||2
8596808|NCT00332488|9632188|FG001|NOT COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||2
8596809|NCT00332488|9632189|FG002|NOT COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||21
8596810|NCT00332579|9632201|FG000|STARTED|Overall Study||12
8596811|NCT00332579|9632202|FG001|STARTED|Overall Study||13
8713109|NCT00973349|9759879|FG006|NOT COMPLETED|Overall Study||2
8713110|NCT00973349|9759880|FG007|NOT COMPLETED|Overall Study||3
8596812|NCT00332579|9632201|FG000|COMPLETED|Overall Study||11
8596813|NCT00332579|9632202|FG001|COMPLETED|Overall Study||12
8596814|NCT00332579|9632201|FG000|NOT COMPLETED|Overall Study||1
8596815|NCT00332579|9632202|FG001|NOT COMPLETED|Overall Study||1
8596816|NCT00332605|9632211|FG000|STARTED|Overall Study||14
8596817|NCT00332605|9632212|FG001|STARTED|Overall Study||14
8596818|NCT00332605|9632213|FG002|STARTED|Overall Study||17
8596819|NCT00332605|9632211|FG000|COMPLETED|Overall Study||12
8596820|NCT00332605|9632212|FG001|COMPLETED|Overall Study||12
8596821|NCT00332605|9632213|FG002|COMPLETED|Overall Study||9
8596822|NCT00332605|9632211|FG000|NOT COMPLETED|Overall Study||2
8596823|NCT00332605|9632212|FG001|NOT COMPLETED|Overall Study||2
8596824|NCT00332605|9632213|FG002|NOT COMPLETED|Overall Study||8
8596825|NCT00332644|9632227|FG000|STARTED|Overall Study||262
8596826|NCT00332644|9632228|FG001|STARTED|Overall Study||260
8596827|NCT00332644|9632229|FG002|STARTED|Overall Study||267
8596828|NCT00332644|9632230|FG003|STARTED|Overall Study||264
8596829|NCT00332644|9632231|FG004|STARTED|Overall Study||262
8596830|NCT00332644|9632232|FG005|STARTED|Overall Study||189
8596831|NCT00332644|9632227|FG000|COMPLETED|Overall Study||250
8596832|NCT00332644|9632228|FG001|COMPLETED|Overall Study||238
8596833|NCT00332644|9632229|FG002|COMPLETED|Overall Study||258
8596834|NCT00332644|9632230|FG003|COMPLETED|Overall Study||244
8596835|NCT00332644|9632231|FG004|COMPLETED|Overall Study||250
8596836|NCT00332644|9632232|FG005|COMPLETED|Overall Study||174
8596837|NCT00332644|9632227|FG000|NOT COMPLETED|Overall Study||12
8596838|NCT00332644|9632228|FG001|NOT COMPLETED|Overall Study||22
8596839|NCT00332644|9632229|FG002|NOT COMPLETED|Overall Study||9
8596840|NCT00332644|9632230|FG003|NOT COMPLETED|Overall Study||20
8596841|NCT00332644|9632231|FG004|NOT COMPLETED|Overall Study||12
8596842|NCT00332644|9632232|FG005|NOT COMPLETED|Overall Study||15
8596843|NCT00332696|9632248|FG000|STARTED|Overall Study||32
8596844|NCT00332696|9632249|FG001|STARTED|Overall Study||32
8596845|NCT00332696|9632248|FG000|Completed Day 14 Visit|Overall Study|Primary Endpoint|21
8596846|NCT00332696|9632249|FG001|Completed Day 14 Visit|Overall Study||15
8596847|NCT00332696|9632248|FG000|COMPLETED|Overall Study|Completed Month 3 Visit|2
8596848|NCT00332696|9632249|FG001|COMPLETED|Overall Study||2
8596849|NCT00332696|9632248|FG000|NOT COMPLETED|Overall Study||30
8596850|NCT00332696|9632249|FG001|NOT COMPLETED|Overall Study||30
8596851|NCT00332709|9632257|FG000|STARTED|Overall Study||40
8596852|NCT00332709|9632258|FG001|STARTED|Overall Study||41
8596853|NCT00332709|9632257|FG000|COMPLETED|Overall Study||24
8596854|NCT00332709|9632258|FG001|COMPLETED|Overall Study||21
8596855|NCT00332709|9632257|FG000|NOT COMPLETED|Overall Study||16
8596856|NCT00332709|9632258|FG001|NOT COMPLETED|Overall Study||20
8596857|NCT00332722|9632266|FG000|STARTED|Overall Study||60
8596858|NCT00332722|9632267|FG001|STARTED|Overall Study||60
8596859|NCT00332722|9632266|FG000|COMPLETED|Overall Study||60
8596860|NCT00332722|9632267|FG001|COMPLETED|Overall Study||60
8596861|NCT00332722|9632266|FG000|NOT COMPLETED|Overall Study||0
8596862|NCT00332722|9632267|FG001|NOT COMPLETED|Overall Study||0
8596863|NCT00332839|9632275|FG000|STARTED|Core (Months 0 - 12)||47
8596864|NCT00332839|9632276|FG001|STARTED|Core (Months 0 - 12)||46
8596865|NCT00332839|9632275|FG000|Safety Set|Core (Months 0 - 12)||47
8596866|NCT00332839|9632276|FG001|Safety Set|Core (Months 0 - 12)||46
8596867|NCT00332839|9632275|FG000|COMPLETED|Core (Months 0 - 12)||37
8596868|NCT00332839|9632276|FG001|COMPLETED|Core (Months 0 - 12)||28
8596869|NCT00332839|9632275|FG000|NOT COMPLETED|Core (Months 0 - 12)||10
8596870|NCT00332839|9632276|FG001|NOT COMPLETED|Core (Months 0 - 12)||18
8713111|NCT00973349|9759881|FG008|NOT COMPLETED|Overall Study||4
8596871|NCT00332839|9632275|FG000|STARTED|Follow-up (Months 12 - 60)|Follow-up included core participants (completed or discontinued) who wished to be followed.|33
8596872|NCT00332839|9632276|FG001|STARTED|Follow-up (Months 12 - 60)|Follow-up included core participants (completed or discontinued) who wished to be followed.|34
8596873|NCT00332839|9632275|FG000|COMPLETED|Follow-up (Months 12 - 60)||29
8596874|NCT00332839|9632276|FG001|COMPLETED|Follow-up (Months 12 - 60)||31
8596875|NCT00332839|9632275|FG000|NOT COMPLETED|Follow-up (Months 12 - 60)||4
8596876|NCT00332839|9632276|FG001|NOT COMPLETED|Follow-up (Months 12 - 60)||3
8596877|NCT00333138|9632285|FG000|STARTED|Core Study (6 Months)||93
8596878|NCT00333138|9632286|FG001|STARTED|Core Study (6 Months)||94
8596879|NCT00333138|9632287|FG002|STARTED|Core Study (6 Months)||94
8596880|NCT00333138|9632285|FG000|COMPLETED|Core Study (6 Months)||86
8596881|NCT00333138|9632286|FG001|COMPLETED|Core Study (6 Months)||88
8596882|NCT00333138|9632287|FG002|COMPLETED|Core Study (6 Months)||82
8596883|NCT00333138|9632285|FG000|NOT COMPLETED|Core Study (6 Months)||7
8596884|NCT00333138|9632286|FG001|NOT COMPLETED|Core Study (6 Months)||6
8596885|NCT00333138|9632287|FG002|NOT COMPLETED|Core Study (6 Months)||12
8596886|NCT00333138|9632285|FG000|STARTED|Extension Study (Month6 to End of Study)||83
8596887|NCT00333138|9632286|FG001|STARTED|Extension Study (Month6 to End of Study)||87
8596888|NCT00333138|9632287|FG002|STARTED|Extension Study (Month6 to End of Study)||80
8596889|NCT00333138|9632285|FG000|COMPLETED|Extension Study (Month6 to End of Study)||40
8596890|NCT00333138|9632286|FG001|COMPLETED|Extension Study (Month6 to End of Study)||45
8596891|NCT00333138|9632287|FG002|COMPLETED|Extension Study (Month6 to End of Study)||37
8596892|NCT00333138|9632285|FG000|NOT COMPLETED|Extension Study (Month6 to End of Study)||43
8596893|NCT00333138|9632286|FG001|NOT COMPLETED|Extension Study (Month6 to End of Study)||42
8596894|NCT00333138|9632287|FG002|NOT COMPLETED|Extension Study (Month6 to End of Study)||43
8596895|NCT00333177|9632301|FG000|STARTED|Overall Study||12
8596896|NCT00333177|9632302|FG001|STARTED|Overall Study||17
8596897|NCT00333177|9632303|FG002|STARTED|Overall Study||17
8596898|NCT00333177|9632304|FG003|STARTED|Overall Study||14
8596899|NCT00333177|9632301|FG000|Received Intervention|Overall Study||12
8596900|NCT00333177|9632302|FG001|Received Intervention|Overall Study||16
8596901|NCT00333177|9632303|FG002|Received Intervention|Overall Study||16
8596902|NCT00333177|9632304|FG003|Received Intervention|Overall Study||12
8596903|NCT00333177|9632301|FG000|COMPLETED|Overall Study||12
8596904|NCT00333177|9632302|FG001|COMPLETED|Overall Study||16
8596905|NCT00333177|9632303|FG002|COMPLETED|Overall Study||16
8596906|NCT00333177|9632304|FG003|COMPLETED|Overall Study||12
8596907|NCT00333177|9632301|FG000|NOT COMPLETED|Overall Study||0
8596908|NCT00333177|9632302|FG001|NOT COMPLETED|Overall Study||1
8596909|NCT00333177|9632303|FG002|NOT COMPLETED|Overall Study||1
8596910|NCT00333177|9632304|FG003|NOT COMPLETED|Overall Study||2
8596911|NCT00333359|9632318|FG000|STARTED|Overall Study||199
8596912|NCT00333359|9632319|FG001|STARTED|Overall Study||382
8596913|NCT00333359|9632318|FG000|COMPLETED|Overall Study||126
8596914|NCT00333359|9632319|FG001|COMPLETED|Overall Study||260
8596915|NCT00333359|9632318|FG000|NOT COMPLETED|Overall Study||73
8596916|NCT00333359|9632319|FG001|NOT COMPLETED|Overall Study||122
8596917|NCT00333437|9632327|FG000|STARTED|Overall Study||7
8596918|NCT00333437|9632327|FG000|COMPLETED|Overall Study||7
8596919|NCT00333437|9632327|FG000|NOT COMPLETED|Overall Study||0
8596920|NCT00333606|9632334|FG000|STARTED|Overall Study||30
8596921|NCT00333606|9632335|FG001|STARTED|Overall Study||30
8596922|NCT00333606|9632334|FG000|COMPLETED|Overall Study||30
8596923|NCT00333606|9632335|FG001|COMPLETED|Overall Study||30
8928161|NCT02278471|9989281|FG000|STARTED|Overall Study||155
8928162|NCT02278471|9989282|FG001|STARTED|Overall Study||148
8928163|NCT02278471|9989281|FG000|COMPLETED|Overall Study||147
8928164|NCT02278471|9989282|FG001|COMPLETED|Overall Study||128
8928165|NCT02278471|9989281|FG000|NOT COMPLETED|Overall Study||8
8928166|NCT02278471|9989282|FG001|NOT COMPLETED|Overall Study||20
8928167|NCT02278484|9989289|FG000|STARTED|Overall Study||50
8928168|NCT02278484|9989289|FG000|COMPLETED|Overall Study||50
8928169|NCT02278484|9989289|FG000|NOT COMPLETED|Overall Study||0
8928170|NCT02278562|9989297|FG000|STARTED|Overall Study||9
8928171|NCT02278562|9989298|FG001|STARTED|Overall Study||7
8928172|NCT02278562|9989299|FG002|STARTED|Overall Study||8
8928173|NCT02278562|9989297|FG000|COMPLETED|Overall Study||9
8928174|NCT02278562|9989298|FG001|COMPLETED|Overall Study||7
8928175|NCT02278562|9989299|FG002|COMPLETED|Overall Study||8
8928176|NCT02278562|9989297|FG000|NOT COMPLETED|Overall Study||0
8928177|NCT02278562|9989298|FG001|NOT COMPLETED|Overall Study||0
8928178|NCT02278562|9989299|FG002|NOT COMPLETED|Overall Study||0
8928179|NCT02278614|9989309|FG000|STARTED|Overall Study||127
8928180|NCT02278614|9989310|FG001|STARTED|Overall Study||115
8928181|NCT02278614|9989309|FG000|COMPLETED|Overall Study||122
8928182|NCT02278614|9989310|FG001|COMPLETED|Overall Study||110
8928183|NCT02278614|9989309|FG000|NOT COMPLETED|Overall Study||5
8928184|NCT02278614|9989310|FG001|NOT COMPLETED|Overall Study||5
8928185|NCT02278640|9989316|FG000|STARTED|Overall Study||40
8928186|NCT02278640|9989316|FG000|COMPLETED|Overall Study||40
8928187|NCT02278640|9989316|FG000|NOT COMPLETED|Overall Study||0
8596924|NCT00333606|9632334|FG000|NOT COMPLETED|Overall Study||0
8596925|NCT00333606|9632335|FG001|NOT COMPLETED|Overall Study||0
8596926|NCT00333619|9632345|FG000|STARTED|Overall Study||110
8596927|NCT00333619|9632346|FG001|STARTED|Overall Study||109
8596928|NCT00333619|9632345|FG000|Post-treatment|Overall Study||109
8596929|NCT00333619|9632346|FG001|Post-treatment|Overall Study||109
8596930|NCT00333619|9632345|FG000|3-month Follow-up|Overall Study||101
8596931|NCT00333619|9632346|FG001|3-month Follow-up|Overall Study||105
8596932|NCT00333619|9632345|FG000|COMPLETED|Overall Study||89
8596933|NCT00333619|9632346|FG001|COMPLETED|Overall Study||99
8596934|NCT00333619|9632345|FG000|NOT COMPLETED|Overall Study||21
8596935|NCT00333619|9632346|FG001|NOT COMPLETED|Overall Study||10
8596936|NCT00333710|9632357|FG000|STARTED|Overall Study||19
8596937|NCT00333710|9632358|FG001|STARTED|Overall Study||18
8596938|NCT00333710|9632359|FG002|STARTED|Overall Study||16
8596939|NCT00333710|9632357|FG000|COMPLETED|Overall Study||8
8596940|NCT00333710|9632358|FG001|COMPLETED|Overall Study||14
8596941|NCT00333710|9632359|FG002|COMPLETED|Overall Study||15
8596942|NCT00333710|9632357|FG000|NOT COMPLETED|Overall Study||11
8928188|NCT02278783|9989320|FG000|STARTED|Overall Study||1
8928189|NCT02278783|9989320|FG000|COMPLETED|Overall Study||1
8596943|NCT00333710|9632358|FG001|NOT COMPLETED|Overall Study||4
8596944|NCT00333710|9632359|FG002|NOT COMPLETED|Overall Study||1
8596945|NCT00333775|9632370|FG000|STARTED|Overall Study||241
8596946|NCT00333775|9632371|FG001|STARTED|Overall Study||248
8596947|NCT00333775|9632372|FG002|STARTED|Overall Study||247
8596948|NCT00333775|9632370|FG000|Received Treatment|Overall Study||238
8596949|NCT00333775|9632371|FG001|Received Treatment|Overall Study||247
8596950|NCT00333775|9632372|FG002|Received Treatment|Overall Study||245
8596951|NCT00333775|9632370|FG000|COMPLETED|Overall Study||0
8596952|NCT00333775|9632371|FG001|COMPLETED|Overall Study||0
8596953|NCT00333775|9632372|FG002|COMPLETED|Overall Study||0
8596954|NCT00333775|9632370|FG000|NOT COMPLETED|Overall Study||241
8596955|NCT00333775|9632371|FG001|NOT COMPLETED|Overall Study||248
8596956|NCT00333775|9632372|FG002|NOT COMPLETED|Overall Study||247
8596957|NCT00333788|9632380|FG000|STARTED|Overall Study|Participant flow based on All Subjects population; Baseline characteristics based on ITT population.|233
8596958|NCT00333788|9632380|FG000|COMPLETED|Overall Study||71
8596959|NCT00333788|9632380|FG000|NOT COMPLETED|Overall Study||162
8596960|NCT00333801|9632386|FG000|STARTED|Overall Study||43
8596961|NCT00333801|9632387|FG001|STARTED|Overall Study||42
8596962|NCT00333801|9632386|FG000|COMPLETED|Overall Study||35
8596963|NCT00333801|9632387|FG001|COMPLETED|Overall Study||36
8596964|NCT00333801|9632386|FG000|NOT COMPLETED|Overall Study||8
8596965|NCT00333801|9632387|FG001|NOT COMPLETED|Overall Study||6
8596966|NCT00333814|9632396|FG000|STARTED|Overall Study||76
8596967|NCT00333814|9632397|FG001|STARTED|Overall Study||77
8596968|NCT00333814|9632398|FG002|STARTED|Overall Study||76
8596969|NCT00333814|9632396|FG000|COMPLETED|Overall Study||73
8596970|NCT00333814|9632397|FG001|COMPLETED|Overall Study||73
8596971|NCT00333814|9632398|FG002|COMPLETED|Overall Study||71
8596972|NCT00333814|9632396|FG000|NOT COMPLETED|Overall Study||3
8596973|NCT00333814|9632397|FG001|NOT COMPLETED|Overall Study||4
8596974|NCT00333814|9632398|FG002|NOT COMPLETED|Overall Study||5
8596975|NCT00333840|9632408|FG000|STARTED|First-line Treatment Period||553
8596976|NCT00333840|9632409|FG001|STARTED|First-line Treatment Period||553
8596977|NCT00333840|9632410|FG002|STARTED|First-line Treatment Period||0
8596978|NCT00333840|9632411|FG003|STARTED|First-line Treatment Period||0
8596979|NCT00333840|9632408|FG000|Safety Population; Received Study Drug|First-line Treatment Period||551
8596980|NCT00333840|9632409|FG001|Safety Population; Received Study Drug|First-line Treatment Period||533
8596981|NCT00333840|9632410|FG002|Safety Population; Received Study Drug|First-line Treatment Period||0
8596982|NCT00333840|9632411|FG003|Safety Population; Received Study Drug|First-line Treatment Period||0
8596983|NCT00333840|9632408|FG000|COMPLETED|First-line Treatment Period||267
8596984|NCT00333840|9632409|FG001|COMPLETED|First-line Treatment Period||7
8596985|NCT00333840|9632410|FG002|COMPLETED|First-line Treatment Period||0
8596986|NCT00333840|9632411|FG003|COMPLETED|First-line Treatment Period||0
8596987|NCT00333840|9632408|FG000|NOT COMPLETED|First-line Treatment Period||286
8596988|NCT00333840|9632409|FG001|NOT COMPLETED|First-line Treatment Period||546
8596989|NCT00333840|9632410|FG002|NOT COMPLETED|First-line Treatment Period||0
8596990|NCT00333840|9632411|FG003|NOT COMPLETED|First-line Treatment Period||0
8596991|NCT00333840|9632408|FG000|STARTED|Second-line Treatment Period||0
8596992|NCT00333840|9632409|FG001|STARTED|Second-line Treatment Period||0
8596993|NCT00333840|9632410|FG002|STARTED|Second-line Treatment Period||14
8596994|NCT00333840|9632411|FG003|STARTED|Second-line Treatment Period||363
8596995|NCT00333840|9632408|FG000|COMPLETED|Second-line Treatment Period||0
8596996|NCT00333840|9632409|FG001|COMPLETED|Second-line Treatment Period||0
8596997|NCT00333840|9632410|FG002|COMPLETED|Second-line Treatment Period||0
8596998|NCT00333840|9632411|FG003|COMPLETED|Second-line Treatment Period||175
8596999|NCT00333840|9632408|FG000|NOT COMPLETED|Second-line Treatment Period||0
8597000|NCT00333840|9632409|FG001|NOT COMPLETED|Second-line Treatment Period||0
8597001|NCT00333840|9632410|FG002|NOT COMPLETED|Second-line Treatment Period||14
8597002|NCT00333840|9632411|FG003|NOT COMPLETED|Second-line Treatment Period||188
8597003|NCT00333866|9632429|FG000|STARTED|Overall Study||189
8597004|NCT00333866|9632430|FG001|STARTED|Overall Study||187
8597005|NCT00333866|9632431|FG002|STARTED|Overall Study||184
8597006|NCT00333866|9632432|FG003|STARTED|Overall Study||187
8597007|NCT00333866|9632429|FG000|TREATED|Overall Study||184
8597008|NCT00333866|9632430|FG001|TREATED|Overall Study||184
8597009|NCT00333866|9632431|FG002|TREATED|Overall Study||182
8597010|NCT00333866|9632432|FG003|TREATED|Overall Study||186
8597011|NCT00333866|9632429|FG000|COMPLETED|Overall Study||141
8597012|NCT00333866|9632430|FG001|COMPLETED|Overall Study||123
8597013|NCT00333866|9632431|FG002|COMPLETED|Overall Study||133
8597014|NCT00333866|9632432|FG003|COMPLETED|Overall Study||121
8597015|NCT00333866|9632429|FG000|NOT COMPLETED|Overall Study||48
8597016|NCT00333866|9632430|FG001|NOT COMPLETED|Overall Study||64
8597017|NCT00333866|9632431|FG002|NOT COMPLETED|Overall Study||51
8597018|NCT00333866|9632432|FG003|NOT COMPLETED|Overall Study||66
8597019|NCT00333879|9632442|FG000|STARTED|Overall Study||4
8597020|NCT00333879|9632442|FG000|COMPLETED|Overall Study||4
8597021|NCT00333879|9632442|FG000|NOT COMPLETED|Overall Study||0
8597022|NCT00333970|9632448|FG000|STARTED|Overall Study||50
8597023|NCT00333970|9632449|FG001|STARTED|Overall Study||25
8597024|NCT00333970|9632448|FG000|COMPLETED|Overall Study||37
8597025|NCT00333970|9632449|FG001|COMPLETED|Overall Study||18
8597026|NCT00333970|9632448|FG000|NOT COMPLETED|Overall Study||13
8597027|NCT00333970|9632449|FG001|NOT COMPLETED|Overall Study||7
8597028|NCT00333983|9632458|FG000|STARTED|Overall Study||20
8597029|NCT00333983|9632459|FG001|STARTED|Overall Study||21
8597030|NCT00333983|9632460|FG002|STARTED|Overall Study||21
8597031|NCT00333983|9632458|FG000|COMPLETED|Overall Study||17
8597032|NCT00333983|9632459|FG001|COMPLETED|Overall Study||16
8597033|NCT00333983|9632460|FG002|COMPLETED|Overall Study||19
8597034|NCT00333983|9632458|FG000|NOT COMPLETED|Overall Study||3
8597035|NCT00333983|9632459|FG001|NOT COMPLETED|Overall Study||5
8597036|NCT00333983|9632460|FG002|NOT COMPLETED|Overall Study||2
8597037|NCT00334061|9632468|FG000|STARTED|Overall Study|June 2006|125
8597038|NCT00334061|9632468|FG000|COMPLETED|Overall Study|November 2007|125
8597039|NCT00334061|9632468|FG000|NOT COMPLETED|Overall Study||0
8628369|NCT00523367|9667778|FG000|STARTED|Overall Study||25
8628370|NCT00523367|9667778|FG000|COMPLETED|Overall Study||2
8628371|NCT00523367|9667778|FG000|NOT COMPLETED|Overall Study||23
8628372|NCT00523419|9667782|FG000|STARTED|Overall Study||32
8628373|NCT00523419|9667782|FG000|COMPLETED|Overall Study||0
8628374|NCT00523419|9667782|FG000|NOT COMPLETED|Overall Study||32
8628375|NCT00523549|9667788|FG000|STARTED|Overall Study||114
8628376|NCT00523549|9667789|FG001|STARTED|Overall Study||115
8628377|NCT00523549|9667788|FG000|COMPLETED|Overall Study||95
8628378|NCT00523549|9667789|FG001|COMPLETED|Overall Study||99
8628379|NCT00523549|9667788|FG000|NOT COMPLETED|Overall Study||19
8628380|NCT00523549|9667789|FG001|NOT COMPLETED|Overall Study||16
8628381|NCT00523614|9667797|FG000|STARTED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|680
8628382|NCT00523614|9667798|FG001|STARTED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|2720
8628383|NCT00523614|9667797|FG000|COMPLETED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|680
8628384|NCT00523614|9667798|FG001|COMPLETED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|2720
8628385|NCT00523614|9667797|FG000|NOT COMPLETED|Overall Study||0
8628386|NCT00523614|9667798|FG001|NOT COMPLETED|Overall Study||0
8628387|NCT00523640|9667804|FG000|STARTED|Overall Study||30
8628388|NCT00523640|9667804|FG000|COMPLETED|Overall Study|1 patient died before starting treatment|29
8628389|NCT00523640|9667804|FG000|NOT COMPLETED|Overall Study||1
8628390|NCT00523705|9667810|FG000|STARTED|Overall Study||7
8628391|NCT00523705|9667811|FG001|STARTED|Overall Study||4
8628392|NCT00523705|9667810|FG000|COMPLETED|Overall Study||7
8628393|NCT00523705|9667811|FG001|COMPLETED|Overall Study|1 withdrew due to no time|3
8628394|NCT00523705|9667810|FG000|NOT COMPLETED|Overall Study||0
8628395|NCT00523705|9667811|FG001|NOT COMPLETED|Overall Study||1
8628396|NCT00523718|9667819|FG000|STARTED|Overall Study||20
8628397|NCT00523718|9667820|FG001|STARTED|Overall Study||18
8628398|NCT00523718|9667819|FG000|COMPLETED|Overall Study||17
8628399|NCT00523718|9667820|FG001|COMPLETED|Overall Study||18
8628400|NCT00523718|9667819|FG000|NOT COMPLETED|Overall Study||3
8628401|NCT00523718|9667820|FG001|NOT COMPLETED|Overall Study||0
8628402|NCT00523744|9667826|FG000|STARTED|Phase 1 - Amlodipine+Olmesartan||257
8628403|NCT00523744|9667826|FG000|COMPLETED|Phase 1 - Amlodipine+Olmesartan||251
8628404|NCT00523744|9667826|FG000|NOT COMPLETED|Phase 1 - Amlodipine+Olmesartan||6
8628405|NCT00523744|9667826|FG000|STARTED|Phase 2 - Amlodipine+Valsartan|Only patients with mean sitting diastolic BP ≥ 90 mmHg at the end of Phase 1 entered this phase.|176
8628406|NCT00523744|9667826|FG000|COMPLETED|Phase 2 - Amlodipine+Valsartan||173
8628407|NCT00523744|9667826|FG000|NOT COMPLETED|Phase 2 - Amlodipine+Valsartan||3
8628408|NCT00523744|9667826|FG000|STARTED|Phase 3 - Amlodipine+Valsartan+HCTZ|Only patients with systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg at the end of Phase 2.|91
8628409|NCT00523744|9667826|FG000|COMPLETED|Phase 3 - Amlodipine+Valsartan+HCTZ||91
8628410|NCT00523744|9667826|FG000|NOT COMPLETED|Phase 3 - Amlodipine+Valsartan+HCTZ||0
8628411|NCT00523848|9667833|FG000|STARTED|Overall Study||46
8628412|NCT00523848|9667833|FG000|Treated With Study Therapy|Overall Study||44
8628413|NCT00523848|9667833|FG000|COMPLETED|Overall Study||22
8628414|NCT00523848|9667833|FG000|NOT COMPLETED|Overall Study||24
8628415|NCT00523978|9667839|FG000|STARTED|Overall Study||171
8628416|NCT00523978|9667840|FG001|STARTED|Overall Study||87
8628417|NCT00523978|9667839|FG000|COMPLETED|Overall Study||162
8628418|NCT00523978|9667840|FG001|COMPLETED|Overall Study||79
8628419|NCT00523978|9667839|FG000|NOT COMPLETED|Overall Study||9
8628420|NCT00523978|9667840|FG001|NOT COMPLETED|Overall Study||8
8628421|NCT00523991|9667849|FG000|STARTED|Overall Study||219
8628422|NCT00523991|9667850|FG001|STARTED|Overall Study||238
8628423|NCT00523991|9667849|FG000|COMPLETED|Overall Study||198
8628424|NCT00523991|9667850|FG001|COMPLETED|Overall Study||211
8628425|NCT00523991|9667849|FG000|NOT COMPLETED|Overall Study||21
8628426|NCT00523991|9667850|FG001|NOT COMPLETED|Overall Study||27
8628427|NCT00524017|9667858|FG000|STARTED|Overall Study||13
8628428|NCT00524017|9667859|FG001|STARTED|Overall Study||6
8628429|NCT00524017|9667858|FG000|COMPLETED|Overall Study||13
8628430|NCT00524017|9667859|FG001|COMPLETED|Overall Study||5
8628431|NCT00524017|9667858|FG000|NOT COMPLETED|Overall Study||0
8628432|NCT00524017|9667859|FG001|NOT COMPLETED|Overall Study||1
8628433|NCT00524030|9667867|FG000|STARTED|Overall Study||32
8628434|NCT00524030|9667868|FG001|STARTED|Overall Study||129
8628435|NCT00524030|9667867|FG000|Completed Double-Blind Treatment Phase|Overall Study||15
8628436|NCT00524030|9667868|FG001|Completed Double-Blind Treatment Phase|Overall Study||70
8628437|NCT00524030|9667867|FG000|Completed Taper/Titration Phase|Overall Study||15
8628438|NCT00524030|9667868|FG001|Completed Taper/Titration Phase|Overall Study||70
8628439|NCT00524030|9667867|FG000|COMPLETED|Overall Study||15
8597040|NCT00334074|9632472|FG000|STARTED|Overall Study||30
8597041|NCT00334074|9632472|FG000|COMPLETED|Overall Study||30
8597042|NCT00334074|9632472|FG000|NOT COMPLETED|Overall Study||0
8597043|NCT00334113|9632479|FG000|STARTED|Overall Study||32
8597044|NCT00334113|9632480|FG001|STARTED|Overall Study||34
8597045|NCT00334113|9632479|FG000|COMPLETED|Overall Study||30
8597046|NCT00334113|9632480|FG001|COMPLETED|Overall Study||31
8597047|NCT00334113|9632479|FG000|NOT COMPLETED|Overall Study||2
8597048|NCT00334113|9632480|FG001|NOT COMPLETED|Overall Study||3
8597049|NCT00334204|9632486|FG000|STARTED|Overall Study||58
8597050|NCT00334204|9632486|FG000|COMPLETED|Overall Study||56
8597051|NCT00334204|9632486|FG000|NOT COMPLETED|Overall Study||2
8597052|NCT00334282|9632493|FG000|STARTED|Overall Study||290
8597053|NCT00334282|9632494|FG001|STARTED|Overall Study||145
8597054|NCT00334282|9632493|FG000|COMPLETED|Overall Study||68
8597055|NCT00334282|9632494|FG001|COMPLETED|Overall Study||37
8597056|NCT00334282|9632493|FG000|NOT COMPLETED|Overall Study||222
8597057|NCT00334282|9632494|FG001|NOT COMPLETED|Overall Study||108
8597058|NCT00334295|9632504|FG000|STARTED|Overall Study||35
8597059|NCT00334295|9632504|FG000|COMPLETED|Overall Study||30
8597060|NCT00334295|9632504|FG000|NOT COMPLETED|Overall Study||5
8597061|NCT00334542|9632508|FG000|STARTED|Overall Study||50
8597062|NCT00334542|9632508|FG000|COMPLETED|Overall Study||45
8597063|NCT00334542|9632508|FG000|NOT COMPLETED|Overall Study||5
8597064|NCT00334633|9632516|FG000|STARTED|Overall Study||197
8597065|NCT00334633|9632517|FG001|STARTED|Overall Study||200
8597066|NCT00334633|9632518|FG002|STARTED|Overall Study||196
8597067|NCT00334633|9632516|FG000|COMPLETED|Overall Study||117
8597068|NCT00334633|9632517|FG001|COMPLETED|Overall Study||118
8597069|NCT00334633|9632518|FG002|COMPLETED|Overall Study||114
8597070|NCT00334633|9632516|FG000|NOT COMPLETED|Overall Study||80
8597071|NCT00334633|9632517|FG001|NOT COMPLETED|Overall Study||82
8597072|NCT00334633|9632518|FG002|NOT COMPLETED|Overall Study||82
8597073|NCT00334737|9632532|FG000|STARTED|Hospital Phase||34
8597074|NCT00334737|9632533|FG001|STARTED|Hospital Phase||34
8597075|NCT00334737|9632534|FG002|STARTED|Hospital Phase||34
8597076|NCT00334737|9632532|FG000|COMPLETED|Hospital Phase||32
8597077|NCT00334737|9632533|FG001|COMPLETED|Hospital Phase||32
8597078|NCT00334737|9632534|FG002|COMPLETED|Hospital Phase||30
8597079|NCT00334737|9632532|FG000|NOT COMPLETED|Hospital Phase||2
8597080|NCT00334737|9632533|FG001|NOT COMPLETED|Hospital Phase||2
8597081|NCT00334737|9632534|FG002|NOT COMPLETED|Hospital Phase||4
8597082|NCT00334737|9632532|FG000|STARTED|Follow up Phase||32
8597083|NCT00334737|9632533|FG001|STARTED|Follow up Phase||32
8597084|NCT00334737|9632534|FG002|STARTED|Follow up Phase||30
8597085|NCT00334737|9632532|FG000|COMPLETED|Follow up Phase||27
8597086|NCT00334737|9632533|FG001|COMPLETED|Follow up Phase||29
8597087|NCT00334737|9632534|FG002|COMPLETED|Follow up Phase||24
8597088|NCT00334737|9632532|FG000|NOT COMPLETED|Follow up Phase||5
8597089|NCT00334737|9632533|FG001|NOT COMPLETED|Follow up Phase||3
8597090|NCT00334737|9632534|FG002|NOT COMPLETED|Follow up Phase||6
8597091|NCT00334802|9632544|FG000|STARTED|Overall Study||6
8597092|NCT00334802|9632545|FG001|STARTED|Overall Study||56
8597093|NCT00334802|9632544|FG000|COMPLETED|Overall Study||0
8597094|NCT00334802|9632545|FG001|COMPLETED|Overall Study||16
8597095|NCT00334802|9632544|FG000|NOT COMPLETED|Overall Study||6
8597096|NCT00334802|9632545|FG001|NOT COMPLETED|Overall Study||40
8597097|NCT00334893|9632556|FG000|STARTED|Overall Study||37
8597098|NCT00334893|9632557|FG001|STARTED|Overall Study||37
8597099|NCT00334893|9632556|FG000|COMPLETED|Overall Study||36
8597100|NCT00334893|9632557|FG001|COMPLETED|Overall Study||37
8597101|NCT00334893|9632556|FG000|NOT COMPLETED|Overall Study||1
8597102|NCT00334893|9632557|FG001|NOT COMPLETED|Overall Study||0
8597103|NCT00334958|9632567|FG000|STARTED|Overall Study||176
8597104|NCT00334958|9632568|FG001|STARTED|Overall Study|1 participant withdrawn prior to study drug dosing due to not obtaining labs|180
8597105|NCT00334958|9632567|FG000|COMPLETED|Overall Study||139
8597106|NCT00334958|9632568|FG001|COMPLETED|Overall Study||156
8597107|NCT00334958|9632567|FG000|NOT COMPLETED|Overall Study||37
8597108|NCT00334958|9632568|FG001|NOT COMPLETED|Overall Study||24
8597109|NCT00335140|9632574|FG000|STARTED|Overall Study||26
8597110|NCT00335140|9632574|FG000|Eligible|Overall Study||25
8597111|NCT00335140|9632574|FG000|Treated|Overall Study||25
8597112|NCT00335140|9632574|FG000|COMPLETED|Overall Study||25
8597113|NCT00335140|9632574|FG000|NOT COMPLETED|Overall Study||1
8597114|NCT00335153|9632578|FG000|STARTED|Nasojejunal (NJ) Test Period||354
8597115|NCT00335153|9632578|FG000|COMPLETED|Nasojejunal (NJ) Test Period||324
8597116|NCT00335153|9632578|FG000|NOT COMPLETED|Nasojejunal (NJ) Test Period||30
8597117|NCT00335153|9632578|FG000|STARTED|Post-PEG-J Long-Term Treatment Period||324
8597118|NCT00335153|9632578|FG000|COMPLETED|Post-PEG-J Long-Term Treatment Period||272
8597119|NCT00335153|9632578|FG000|NOT COMPLETED|Post-PEG-J Long-Term Treatment Period||52
8597120|NCT00335257|9632585|FG000|STARTED|Overall Study||15542
8597121|NCT00335257|9632586|FG001|STARTED|Overall Study||9377
8597122|NCT00335257|9632587|FG002|STARTED|Overall Study||60190
8597123|NCT00335257|9632585|FG000|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 6.0 years.|15542
8597124|NCT00335257|9632586|FG001|COMPLETED|Overall Study||9377
8597125|NCT00335257|9632587|FG002|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 6.0 years.|60190
8597126|NCT00335257|9632585|FG000|NOT COMPLETED|Overall Study||0
8597127|NCT00335257|9632586|FG001|NOT COMPLETED|Overall Study||0
8597128|NCT00335257|9632587|FG002|NOT COMPLETED|Overall Study||0
8597129|NCT00335283|9632603|FG000|STARTED|Overall Study||36
8597130|NCT00335283|9632604|FG001|STARTED|Overall Study||39
8597131|NCT00335283|9632603|FG000|COMPLETED|Overall Study||30
8597132|NCT00335283|9632604|FG001|COMPLETED|Overall Study||34
8597133|NCT00335283|9632603|FG000|NOT COMPLETED|Overall Study||6
8597134|NCT00335283|9632604|FG001|NOT COMPLETED|Overall Study||5
8597135|NCT00335322|9632613|FG000|STARTED|Overall Study||115
8597136|NCT00335322|9632614|FG001|STARTED|Overall Study||107
8597137|NCT00335322|9632615|FG002|STARTED|Overall Study||105
8597138|NCT00335322|9632613|FG000|COMPLETED|Overall Study||114
8597139|NCT00335322|9632614|FG001|COMPLETED|Overall Study||105
8597140|NCT00335322|9632615|FG002|COMPLETED|Overall Study||103
8597141|NCT00335322|9632613|FG000|NOT COMPLETED|Overall Study||1
8597142|NCT00335322|9632614|FG001|NOT COMPLETED|Overall Study||2
8597143|NCT00335322|9632615|FG002|NOT COMPLETED|Overall Study||2
8597144|NCT00335452|9632630|FG000|STARTED|Overall Study|Randomized|6312
8597145|NCT00335452|9632631|FG001|STARTED|Overall Study|Randomized|6254
8597146|NCT00335452|9632632|FG002|STARTED|Overall Study|Randomized|6267
8597147|NCT00335452|9632633|FG003|STARTED|Overall Study|Randomized|6253
8597148|NCT00335452|9632630|FG000|TREATED WITH CLOPIDOGREL|Overall Study||6271
8597149|NCT00335452|9632631|FG001|TREATED WITH CLOPIDOGREL|Overall Study||6218
8597150|NCT00335452|9632632|FG002|TREATED WITH CLOPIDOGREL|Overall Study||6228
8597151|NCT00335452|9632633|FG003|TREATED WITH CLOPIDOGREL|Overall Study||6217
8597152|NCT00335452|9632630|FG000|TREATED WITH ASA|Overall Study||6302
8597153|NCT00335452|9632631|FG001|TREATED WITH ASA|Overall Study||6251
8597154|NCT00335452|9632632|FG002|TREATED WITH ASA|Overall Study||6261
8597155|NCT00335452|9632633|FG003|TREATED WITH ASA|Overall Study||6247
8597156|NCT00335452|9632630|FG000|COMPLETED|Overall Study|Completed 30 days follow-up period|6154
8597157|NCT00335452|9632631|FG001|COMPLETED|Overall Study|Completed 30 days follow-up period|6107
8597158|NCT00335452|9632632|FG002|COMPLETED|Overall Study|Completed 30 days follow-up period|6108
8597159|NCT00335452|9632633|FG003|COMPLETED|Overall Study|Completed 30 days follow-up period|6122
8597160|NCT00335452|9632630|FG000|NOT COMPLETED|Overall Study||158
8597161|NCT00335452|9632631|FG001|NOT COMPLETED|Overall Study||147
8597162|NCT00335452|9632632|FG002|NOT COMPLETED|Overall Study||159
8597163|NCT00335452|9632633|FG003|NOT COMPLETED|Overall Study||131
8597164|NCT00335478|9632648|FG000|STARTED|Overall Study||54
8597165|NCT00335478|9632648|FG000|COMPLETED|Overall Study||30
8597166|NCT00335478|9632648|FG000|NOT COMPLETED|Overall Study||24
8597167|NCT00335504|9632656|FG000|STARTED|Overall Study||22
8597168|NCT00335504|9632657|FG001|STARTED|Overall Study||21
8597169|NCT00335504|9632658|FG002|STARTED|Overall Study||20
8597170|NCT00335504|9632659|FG003|STARTED|Overall Study||22
8597171|NCT00335504|9632656|FG000|COMPLETED|Overall Study||22
8597172|NCT00335504|9632657|FG001|COMPLETED|Overall Study||21
8597173|NCT00335504|9632658|FG002|COMPLETED|Overall Study||20
8597174|NCT00335504|9632659|FG003|COMPLETED|Overall Study||22
8597175|NCT00335504|9632656|FG000|NOT COMPLETED|Overall Study||0
8597176|NCT00335504|9632657|FG001|NOT COMPLETED|Overall Study||0
8597177|NCT00335504|9632658|FG002|NOT COMPLETED|Overall Study||0
8713112|NCT00973349|9759882|FG009|NOT COMPLETED|Overall Study||6
8713113|NCT00973349|9759883|FG010|NOT COMPLETED|Overall Study||0
8597178|NCT00335504|9632659|FG003|NOT COMPLETED|Overall Study||0
8597179|NCT00335517|9632669|FG000|STARTED|Overall Study||100
8597180|NCT00335517|9632669|FG000|COMPLETED|Overall Study|Due to pharmacy error two patients were enolled and recieved EREM, but were not included in analysis|98
8597181|NCT00335517|9632669|FG000|NOT COMPLETED|Overall Study||2
8597182|NCT00335556|9632679|FG000|STARTED|Overall Study||68
8597183|NCT00335556|9632680|FG001|STARTED|Overall Study||98
8597184|NCT00335556|9632681|FG002|STARTED|Overall Study||7
8597185|NCT00335556|9632682|FG003|STARTED|Overall Study||10
8597186|NCT00335556|9632683|FG004|STARTED|Overall Study||78
8597187|NCT00335556|9632684|FG005|STARTED|Overall Study||30
8597188|NCT00335556|9632679|FG000|COMPLETED|Overall Study||66
8597189|NCT00335556|9632680|FG001|COMPLETED|Overall Study||64
8597190|NCT00335556|9632681|FG002|COMPLETED|Overall Study||2
8597191|NCT00335556|9632682|FG003|COMPLETED|Overall Study||5
8597192|NCT00335556|9632683|FG004|COMPLETED|Overall Study||77
8597193|NCT00335556|9632684|FG005|COMPLETED|Overall Study||29
8597194|NCT00335556|9632679|FG000|NOT COMPLETED|Overall Study||2
8597195|NCT00335556|9632680|FG001|NOT COMPLETED|Overall Study||34
8597196|NCT00335556|9632681|FG002|NOT COMPLETED|Overall Study||5
8597197|NCT00335556|9632682|FG003|NOT COMPLETED|Overall Study||5
8597198|NCT00335556|9632683|FG004|NOT COMPLETED|Overall Study||1
8597199|NCT00335556|9632684|FG005|NOT COMPLETED|Overall Study||1
8597200|NCT00335725|9632705|FG000|STARTED|Overall Study||75
8713114|NCT00973349|9759884|FG011|NOT COMPLETED|Overall Study||2
8597201|NCT00335725|9632706|FG001|STARTED|Overall Study||76
8597202|NCT00335725|9632705|FG000|COMPLETED|Overall Study||71
8597203|NCT00335725|9632706|FG001|COMPLETED|Overall Study||71
8597204|NCT00335725|9632705|FG000|NOT COMPLETED|Overall Study||4
8597205|NCT00335725|9632706|FG001|NOT COMPLETED|Overall Study||5
8597206|NCT00335738|9632715|FG000|STARTED|Overall Study||108
8597207|NCT00335738|9632716|FG001|STARTED|Overall Study||223
8597208|NCT00335738|9632715|FG000|COMPLETED|Overall Study||97
8597209|NCT00335738|9632716|FG001|COMPLETED|Overall Study||219
8597210|NCT00335738|9632715|FG000|NOT COMPLETED|Overall Study||11
8597211|NCT00335738|9632716|FG001|NOT COMPLETED|Overall Study||4
8597212|NCT00335764|9632728|FG000|STARTED|Overall Study||17
8597213|NCT00335764|9632729|FG001|STARTED|Overall Study||13
8713115|NCT00973349|9759885|FG012|NOT COMPLETED|Overall Study||1
8597214|NCT00335764|9632730|FG002|STARTED|Overall Study||24
8597215|NCT00335764|9632731|FG003|STARTED|Overall Study||19
8597216|NCT00335764|9632732|FG004|STARTED|Overall Study||19
8597217|NCT00335764|9632728|FG000|COMPLETED|Overall Study||16
8597218|NCT00335764|9632729|FG001|COMPLETED|Overall Study||13
8597219|NCT00335764|9632730|FG002|COMPLETED|Overall Study||24
8597220|NCT00335764|9632731|FG003|COMPLETED|Overall Study||19
8597221|NCT00335764|9632732|FG004|COMPLETED|Overall Study||18
8597222|NCT00335764|9632728|FG000|NOT COMPLETED|Overall Study||1
8597223|NCT00335764|9632729|FG001|NOT COMPLETED|Overall Study||0
8597224|NCT00335764|9632730|FG002|NOT COMPLETED|Overall Study||0
8597225|NCT00335764|9632731|FG003|NOT COMPLETED|Overall Study||0
8597226|NCT00335764|9632732|FG004|NOT COMPLETED|Overall Study||1
8597227|NCT00335829|9632768|FG000|STARTED|Overall Study||26
8597228|NCT00335829|9632768|FG000|Received Bevacizumab|Overall Study||26
8597229|NCT00335829|9632768|FG000|Received First TACE|Overall Study|1 patient left after receiving bevacizumab but prior to first TACE|25
8597230|NCT00335829|9632768|FG000|COMPLETED|Overall Study||23
8597231|NCT00335829|9632768|FG000|NOT COMPLETED|Overall Study||3
8597232|NCT00335959|9632772|FG000|STARTED|Overall Study||7
8597233|NCT00335959|9632772|FG000|Eligible|Overall Study||6
8597234|NCT00335959|9632772|FG000|Eligible and Began Protocol Therapy|Overall Study||6
8597235|NCT00335959|9632772|FG000|COMPLETED|Overall Study||4
8597236|NCT00335959|9632772|FG000|NOT COMPLETED|Overall Study||3
8597237|NCT00335972|9632779|FG000|STARTED|Overall Study||71
8597238|NCT00335972|9632780|FG001|STARTED|Overall Study||71
8597239|NCT00335972|9632779|FG000|COMPLETED|Overall Study||71
8597240|NCT00335972|9632780|FG001|COMPLETED|Overall Study||68
8597241|NCT00335972|9632779|FG000|NOT COMPLETED|Overall Study||0
8597242|NCT00335972|9632780|FG001|NOT COMPLETED|Overall Study||3
8597243|NCT00336024|9632788|FG000|STARTED|Overall Study||46
8597244|NCT00336024|9632789|FG001|STARTED|Overall Study||45
8597245|NCT00336024|9632788|FG000|COMPLETED|Overall Study||26
8597246|NCT00336024|9632789|FG001|COMPLETED|Overall Study||26
8597247|NCT00336024|9632788|FG000|NOT COMPLETED|Overall Study||20
8597248|NCT00336024|9632789|FG001|NOT COMPLETED|Overall Study||19
8597249|NCT00336232|9632795|FG000|STARTED|Baseline (200mcg Daily)||59
8597250|NCT00336232|9632795|FG000|COMPLETED|Baseline (200mcg Daily)||42
8597251|NCT00336232|9632795|FG000|NOT COMPLETED|Baseline (200mcg Daily)||17
8597252|NCT00336232|9632795|FG000|STARTED|Low Vitamin K (10mcg Daily)||42
8597253|NCT00336232|9632795|FG000|COMPLETED|Low Vitamin K (10mcg Daily)||42
8597254|NCT00336232|9632795|FG000|NOT COMPLETED|Low Vitamin K (10mcg Daily)||0
8597255|NCT00336232|9632795|FG000|STARTED|High Vitamin K (500mcg Daily)||42
8597256|NCT00336232|9632795|FG000|COMPLETED|High Vitamin K (500mcg Daily)||42
8597257|NCT00336232|9632795|FG000|NOT COMPLETED|High Vitamin K (500mcg Daily)||0
8597258|NCT00336284|9632801|FG000|STARTED|Overall Study||977
8597259|NCT00336284|9632802|FG001|STARTED|Overall Study||473
8597260|NCT00336284|9632801|FG000|COMPLETED|Overall Study||741
8597261|NCT00336284|9632802|FG001|COMPLETED|Overall Study||322
8597262|NCT00336284|9632801|FG000|NOT COMPLETED|Overall Study||236
8597263|NCT00336284|9632802|FG001|NOT COMPLETED|Overall Study||151
8597264|NCT00336323|9632813|FG000|STARTED|Overall Study||19
8597265|NCT00336323|9632814|FG001|STARTED|Overall Study||22
8597266|NCT00336323|9632815|FG002|STARTED|Overall Study||24
8597267|NCT00336323|9632816|FG003|STARTED|Overall Study||22
8597268|NCT00336323|9632817|FG004|STARTED|Overall Study||22
8597269|NCT00336323|9632813|FG000|3 Week Visit|Overall Study||18
8597270|NCT00336323|9632814|FG001|3 Week Visit|Overall Study||21
8597271|NCT00336323|9632815|FG002|3 Week Visit|Overall Study||24
8597272|NCT00336323|9632816|FG003|3 Week Visit|Overall Study||22
8597273|NCT00336323|9632817|FG004|3 Week Visit|Overall Study|Laser given late at six weeks for one patient|20
8597274|NCT00336323|9632813|FG000|6 Week Visit|Overall Study||18
8597275|NCT00336323|9632814|FG001|6 Week Visit|Overall Study||22
8597276|NCT00336323|9632815|FG002|6 Week Visit|Overall Study||24
8597277|NCT00336323|9632816|FG003|6 Week Visit|Overall Study||22
8597278|NCT00336323|9632817|FG004|6 Week Visit|Overall Study|1 patient was dropped - injection was given late at 9 wks for one patient|20
8597279|NCT00336323|9632813|FG000|9 Week Visit|Overall Study||18
8597280|NCT00336323|9632814|FG001|9 Week Visit|Overall Study||21
8597281|NCT00336323|9632815|FG002|9 Week Visit|Overall Study||23
8597282|NCT00336323|9632816|FG003|9 Week Visit|Overall Study||21
8597283|NCT00336323|9632817|FG004|9 Week Visit|Overall Study||19
8597284|NCT00336323|9632813|FG000|12 Week Visit|Overall Study||19
8597285|NCT00336323|9632814|FG001|12 Week Visit|Overall Study||21
8597286|NCT00336323|9632815|FG002|12 Week Visit|Overall Study||24
8597287|NCT00336323|9632816|FG003|12 Week Visit|Overall Study||22
8597288|NCT00336323|9632817|FG004|12 Week Visit|Overall Study|1 patient was dropped from study|20
8597289|NCT00336323|9632813|FG000|18 Week Visit|Overall Study||19
8597290|NCT00336323|9632814|FG001|18 Week Visit|Overall Study||22
8597291|NCT00336323|9632815|FG002|18 Week Visit|Overall Study||23
8597292|NCT00336323|9632816|FG003|18 Week Visit|Overall Study||21
8597293|NCT00336323|9632817|FG004|18 Week Visit|Overall Study|1 patient was dropped from the study|18
8597294|NCT00336323|9632813|FG000|24 Week Visit|Overall Study||18
8597295|NCT00336323|9632814|FG001|24 Week Visit|Overall Study|1 patient was dropped from the study|20
8597296|NCT00336323|9632815|FG002|24 Week Visit|Overall Study|1 patient was dropped from the study|22
8597297|NCT00336323|9632816|FG003|24 Week Visit|Overall Study||22
8597298|NCT00336323|9632817|FG004|24 Week Visit|Overall Study||19
8597299|NCT00336323|9632813|FG000|COMPLETED|Overall Study||19
8597300|NCT00336323|9632814|FG001|COMPLETED|Overall Study||21
8597301|NCT00336323|9632815|FG002|COMPLETED|Overall Study||23
8597302|NCT00336323|9632816|FG003|COMPLETED|Overall Study||22
8597303|NCT00336323|9632817|FG004|COMPLETED|Overall Study||19
8597304|NCT00336323|9632813|FG000|NOT COMPLETED|Overall Study||0
8597305|NCT00336323|9632814|FG001|NOT COMPLETED|Overall Study||1
8597306|NCT00336323|9632815|FG002|NOT COMPLETED|Overall Study||1
8597307|NCT00336323|9632816|FG003|NOT COMPLETED|Overall Study||0
8597308|NCT00336323|9632817|FG004|NOT COMPLETED|Overall Study||3
8597309|NCT00336479|9632837|FG000|STARTED|Overall Study||75
8597310|NCT00336479|9632838|FG001|STARTED|Overall Study||79
8597311|NCT00336479|9632839|FG002|STARTED|Overall Study||79
8597312|NCT00336479|9632840|FG003|STARTED|Overall Study||17
8597313|NCT00336479|9632837|FG000|COMPLETED|Overall Study||38
8597314|NCT00336479|9632838|FG001|COMPLETED|Overall Study||54
8597315|NCT00336479|9632839|FG002|COMPLETED|Overall Study||53
8597316|NCT00336479|9632840|FG003|COMPLETED|Overall Study||13
8597317|NCT00336479|9632837|FG000|NOT COMPLETED|Overall Study||37
8597318|NCT00336479|9632838|FG001|NOT COMPLETED|Overall Study||25
8597319|NCT00336479|9632839|FG002|NOT COMPLETED|Overall Study||26
8597320|NCT00336479|9632840|FG003|NOT COMPLETED|Overall Study||4
8597321|NCT00336492|9632854|FG000|STARTED|Overall Study||15
8597322|NCT00336492|9632855|FG001|STARTED|Overall Study||22
8597323|NCT00336492|9632856|FG002|STARTED|Overall Study||23
8597324|NCT00336492|9632854|FG000|COMPLETED|Overall Study||0
8597325|NCT00336492|9632855|FG001|COMPLETED|Overall Study||18
8597326|NCT00336492|9632856|FG002|COMPLETED|Overall Study||12
8597327|NCT00336492|9632854|FG000|NOT COMPLETED|Overall Study||15
8597328|NCT00336492|9632855|FG001|NOT COMPLETED|Overall Study||4
8597329|NCT00336492|9632856|FG002|NOT COMPLETED|Overall Study||11
8597330|NCT00336505|9632866|FG000|STARTED|Overall Study|All subjects who were randomized and dosed.|291
8597331|NCT00336505|9632867|FG001|STARTED|Overall Study|All subjects who were randomized and dosed.|291
8597332|NCT00336505|9632866|FG000|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|254
8597333|NCT00336505|9632867|FG001|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|264
8597334|NCT00336505|9632866|FG000|NOT COMPLETED|Overall Study||37
8597335|NCT00336505|9632867|FG001|NOT COMPLETED|Overall Study||27
8597336|NCT00336544|9632875|FG000|STARTED|Overall Study|All subjects who were randomized and dosed.|261
8597337|NCT00336544|9632876|FG001|STARTED|Overall Study|All subjects who were randomized and dosed.|260
8597338|NCT00336544|9632875|FG000|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|242
8597339|NCT00336544|9632876|FG001|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|238
8597340|NCT00336544|9632875|FG000|NOT COMPLETED|Overall Study||19
8597341|NCT00336544|9632876|FG001|NOT COMPLETED|Overall Study||22
8597342|NCT00336583|9632882|FG000|STARTED|Overall Study||27
8597343|NCT00336583|9632882|FG000|COMPLETED|Overall Study||25
8597344|NCT00336583|9632882|FG000|NOT COMPLETED|Overall Study||2
8597345|NCT00336700|9632886|FG000|STARTED|Overall Study||25
8597346|NCT00336700|9632886|FG000|COMPLETED|Overall Study||25
8597347|NCT00336700|9632886|FG000|NOT COMPLETED|Overall Study||0
8597348|NCT00336817|9632892|FG000|STARTED|Overall Study||15
8597349|NCT00336817|9632893|FG001|STARTED|Overall Study||15
8597350|NCT00336817|9632892|FG000|COMPLETED|Overall Study||14
8597351|NCT00336817|9632893|FG001|COMPLETED|Overall Study||13
8597352|NCT00336817|9632892|FG000|NOT COMPLETED|Overall Study||1
8597353|NCT00336817|9632893|FG001|NOT COMPLETED|Overall Study||2
8597354|NCT00336856|9632901|FG000|STARTED|Overall Study|Number of patients consented and registered for the study|35
8597355|NCT00336856|9632901|FG000|COMPLETED|Overall Study||31
8597356|NCT00336856|9632901|FG000|NOT COMPLETED|Overall Study||4
8597357|NCT00336895|9632905|FG000|STARTED|Overall Study||30
8597358|NCT00336895|9632905|FG000|COMPLETED|Overall Study||26
8597359|NCT00336895|9632905|FG000|NOT COMPLETED|Overall Study||4
8597360|NCT00337077|9632912|FG000|STARTED|Overall Study||43
8597361|NCT00337077|9632913|FG001|STARTED|Overall Study||53
8597362|NCT00337077|9632914|FG002|STARTED|Overall Study||25
8597363|NCT00337077|9632912|FG000|Treated|Overall Study||42
8597364|NCT00337077|9632913|FG001|Treated|Overall Study||52
8597365|NCT00337077|9632914|FG002|Treated|Overall Study||25
8597366|NCT00337077|9632912|FG000|Toxicity Assessed|Overall Study||42
8597367|NCT00337077|9632913|FG001|Toxicity Assessed|Overall Study||51
8597368|NCT00337077|9632914|FG002|Toxicity Assessed|Overall Study||25
8597369|NCT00337077|9632912|FG000|Eligible and Treated|Overall Study||41
8597370|NCT00337077|9632913|FG001|Eligible and Treated|Overall Study||51
8597371|NCT00337077|9632914|FG002|Eligible and Treated|Overall Study||24
8597372|NCT00337077|9632912|FG000|Patients With Measurable Disease|Overall Study||26
8597373|NCT00337077|9632913|FG001|Patients With Measurable Disease|Overall Study||38
8597374|NCT00337077|9632914|FG002|Patients With Measurable Disease|Overall Study||13
8597375|NCT00337077|9632912|FG000|COMPLETED|Overall Study|No completion of treatment because treatment was given until PD or unacceptable toxicity.|0
8597376|NCT00337077|9632913|FG001|COMPLETED|Overall Study|No completion of treatment because treatment was given until PD or unacceptable toxicity.|0
8597377|NCT00337077|9632914|FG002|COMPLETED|Overall Study|No completion of treatment because treatment was given until PD or unacceptable toxicity.|0
8597378|NCT00337077|9632912|FG000|NOT COMPLETED|Overall Study||43
8597379|NCT00337077|9632913|FG001|NOT COMPLETED|Overall Study||53
8597380|NCT00337077|9632914|FG002|NOT COMPLETED|Overall Study||25
8597381|NCT00337103|9632922|FG000|STARTED|Overall Study||554
8597382|NCT00337103|9632923|FG001|STARTED|Overall Study||548
8597383|NCT00337103|9632922|FG000|Treated (Safety Population)|Overall Study||544
8597384|NCT00337103|9632923|FG001|Treated (Safety Population)|Overall Study||546
8597385|NCT00337103|9632922|FG000|COMPLETED|Overall Study||0
8597386|NCT00337103|9632923|FG001|COMPLETED|Overall Study||0
8597387|NCT00337103|9632922|FG000|NOT COMPLETED|Overall Study||554
8597388|NCT00337103|9632923|FG001|NOT COMPLETED|Overall Study||548
8597389|NCT00337129|9632930|FG000|STARTED|Overall Study||40
8597390|NCT00337129|9632930|FG000|COMPLETED|Overall Study|Treatment is not for a fixed period and continues until discontinuation criterion is met.|0
8597391|NCT00337129|9632930|FG000|NOT COMPLETED|Overall Study||40
8597392|NCT00337168|9632934|FG000|STARTED|Overall Study||37
8597393|NCT00337168|9632934|FG000|Eligible|Overall Study||37
8597394|NCT00337168|9632934|FG000|Eligible and Treated|Overall Study||36
8597395|NCT00337168|9632934|FG000|COMPLETED|Overall Study||29
8597396|NCT00337168|9632934|FG000|NOT COMPLETED|Overall Study||8
8597397|NCT00337181|9632941|FG000|STARTED|Overall Study||49
8597398|NCT00337181|9632942|FG001|STARTED|Overall Study||65
8597399|NCT00337181|9632941|FG000|COMPLETED|Overall Study||49
8597400|NCT00337181|9632942|FG001|COMPLETED|Overall Study||65
8597401|NCT00337181|9632941|FG000|NOT COMPLETED|Overall Study||0
8597402|NCT00337181|9632942|FG001|NOT COMPLETED|Overall Study||0
8597403|NCT00337194|9632950|FG000|STARTED|Overall Study||23
8597404|NCT00337194|9632951|FG001|STARTED|Overall Study||7
8597405|NCT00337194|9632950|FG000|COMPLETED|Overall Study||11
8597406|NCT00337194|9632951|FG001|COMPLETED|Overall Study||3
8597407|NCT00337194|9632950|FG000|NOT COMPLETED|Overall Study||12
8597408|NCT00337194|9632951|FG001|NOT COMPLETED|Overall Study||4
8597409|NCT00337207|9632959|FG000|STARTED|Overall Study||55
8597410|NCT00337207|9632959|FG000|COMPLETED|Overall Study||52
8597411|NCT00337207|9632959|FG000|NOT COMPLETED|Overall Study||3
8597412|NCT00337272|9632966|FG000|STARTED|Screening Period (Pre-randomization)|22 subjects were consented. All subjects received placebo during the 2 week screening period.|22
8597413|NCT00337272|9632967|FG001|STARTED|Screening Period (Pre-randomization)||0
8597414|NCT00337272|9632966|FG000|COMPLETED|Screening Period (Pre-randomization)|16 subjects completed the screening period and were eligible for randomization.|16
8597415|NCT00337272|9632967|FG001|COMPLETED|Screening Period (Pre-randomization)||0
8597416|NCT00337272|9632966|FG000|NOT COMPLETED|Screening Period (Pre-randomization)||6
8597417|NCT00337272|9632967|FG001|NOT COMPLETED|Screening Period (Pre-randomization)||0
8597418|NCT00337272|9632966|FG000|STARTED|Treatment Period|16 subjects were randomized to either placebo or ramelteon before starting treatment period.|7
8597419|NCT00337272|9632967|FG001|STARTED|Treatment Period|16 subjects were randomized to either placebo or ramelteon before starting treatment period.|9
8597420|NCT00337272|9632966|FG000|Randomization|Treatment Period||7
8597421|NCT00337272|9632967|FG001|Randomization|Treatment Period||9
8597422|NCT00337272|9632966|FG000|COMPLETED|Treatment Period||6
8597423|NCT00337272|9632967|FG001|COMPLETED|Treatment Period||7
8597424|NCT00337272|9632966|FG000|NOT COMPLETED|Treatment Period||1
8597425|NCT00337272|9632967|FG001|NOT COMPLETED|Treatment Period||2
8597426|NCT00337272|9632966|FG000|STARTED|Withdrawal Period|Subjects in both groups received placebo for one week.|6
8597427|NCT00337272|9632967|FG001|STARTED|Withdrawal Period|Subjects in both groups received placebo for one week.|7
8597428|NCT00337272|9632966|FG000|COMPLETED|Withdrawal Period||6
8597429|NCT00337272|9632967|FG001|COMPLETED|Withdrawal Period||6
8597430|NCT00337272|9632966|FG000|NOT COMPLETED|Withdrawal Period||0
8597431|NCT00337272|9632967|FG001|NOT COMPLETED|Withdrawal Period||1
8597432|NCT00337285|9632973|FG000|STARTED|Overall Study||349
8597433|NCT00337285|9632973|FG000|COMPLETED|Overall Study||191
8597434|NCT00337285|9632973|FG000|NOT COMPLETED|Overall Study||158
8597435|NCT00337350|9632979|FG000|STARTED|Overall Study||9
8597436|NCT00337350|9632980|FG001|STARTED|Overall Study||11
8597437|NCT00337350|9632979|FG000|COMPLETED|Overall Study||8
8597438|NCT00337350|9632980|FG001|COMPLETED|Overall Study||10
8597439|NCT00337350|9632979|FG000|NOT COMPLETED|Overall Study||1
8597440|NCT00337350|9632980|FG001|NOT COMPLETED|Overall Study||1
8597441|NCT00337428|9632988|FG000|STARTED|Overall Study||419
8597442|NCT00337428|9632989|FG001|STARTED|Overall Study||424
8597443|NCT00337428|9632988|FG000|COMPLETED|Overall Study||415
8597444|NCT00337428|9632989|FG001|COMPLETED|Overall Study||421
8597445|NCT00337428|9632988|FG000|NOT COMPLETED|Overall Study||4
8597446|NCT00337428|9632989|FG001|NOT COMPLETED|Overall Study||3
8597447|NCT00337467|9632995|FG000|STARTED|Overall Study||61
8597448|NCT00337467|9632995|FG000|Discontinued Prior to Week 96|Overall Study|5 of these participants discontinued prior to Week 48|10
8597449|NCT00337467|9632995|FG000|COMPLETED|Overall Study||51
8597450|NCT00337467|9632995|FG000|NOT COMPLETED|Overall Study||10
8597451|NCT00337571|9633006|FG000|STARTED|Overall Study||52
8597452|NCT00337571|9633007|FG001|STARTED|Overall Study||53
8597453|NCT00337571|9633008|FG002|STARTED|Overall Study||59
8597454|NCT00337571|9633009|FG003|STARTED|Overall Study||54
8597455|NCT00337571|9633006|FG000|COMPLETED|Overall Study||38
8597456|NCT00337571|9633007|FG001|COMPLETED|Overall Study||44
8597457|NCT00337571|9633008|FG002|COMPLETED|Overall Study||49
8597458|NCT00337571|9633009|FG003|COMPLETED|Overall Study||47
8597459|NCT00337571|9633006|FG000|NOT COMPLETED|Overall Study||14
8597460|NCT00337571|9633007|FG001|NOT COMPLETED|Overall Study||9
8597461|NCT00337571|9633008|FG002|NOT COMPLETED|Overall Study||10
8597462|NCT00337571|9633009|FG003|NOT COMPLETED|Overall Study||7
8597463|NCT00337610|9633021|FG000|STARTED|Overall Study||96
8597464|NCT00337610|9633022|FG001|STARTED|Overall Study||94
8597465|NCT00337610|9633021|FG000|Completed Week 18|Overall Study||89
8597466|NCT00337610|9633022|FG001|Completed Week 18|Overall Study||82
8597467|NCT00337610|9633021|FG000|COMPLETED|Overall Study||79
8597468|NCT00337610|9633022|FG001|COMPLETED|Overall Study||80
8597469|NCT00337610|9633021|FG000|NOT COMPLETED|Overall Study||17
8597470|NCT00337610|9633022|FG001|NOT COMPLETED|Overall Study||14
8597471|NCT00337662|9633031|FG000|STARTED|Study Period II||0
8597472|NCT00337662|9633032|FG001|STARTED|Study Period II||0
8597473|NCT00337662|9633033|FG002|STARTED|Study Period II||0
8597474|NCT00337662|9633034|FG003|STARTED|Study Period II||628
8597475|NCT00337662|9633031|FG000|COMPLETED|Study Period II||0
8597476|NCT00337662|9633032|FG001|COMPLETED|Study Period II||0
8597477|NCT00337662|9633033|FG002|COMPLETED|Study Period II||0
8597478|NCT00337662|9633034|FG003|COMPLETED|Study Period II||522
8597479|NCT00337662|9633031|FG000|NOT COMPLETED|Study Period II||0
8597480|NCT00337662|9633032|FG001|NOT COMPLETED|Study Period II||0
8597481|NCT00337662|9633033|FG002|NOT COMPLETED|Study Period II||0
8597482|NCT00337662|9633034|FG003|NOT COMPLETED|Study Period II||106
8713116|NCT00973349|9759886|FG013|NOT COMPLETED|Overall Study||0
8713117|NCT00973349|9759887|FG014|NOT COMPLETED|Overall Study||2
8713118|NCT00973349|9759888|FG015|NOT COMPLETED|Overall Study||2
8713119|NCT00973362|9759916|FG000|STARTED|Baseline Evaluation||11644
8597483|NCT00337662|9633031|FG000|STARTED|Study Period III||186
8597484|NCT00337662|9633032|FG001|STARTED|Study Period III||192
8597485|NCT00337662|9633033|FG002|STARTED|Study Period III||144
8597486|NCT00337662|9633034|FG003|STARTED|Study Period III||0
8597487|NCT00337662|9633031|FG000|COMPLETED|Study Period III||126
8597488|NCT00337662|9633032|FG001|COMPLETED|Study Period III||134
8597489|NCT00337662|9633033|FG002|COMPLETED|Study Period III||100
8597490|NCT00337662|9633034|FG003|COMPLETED|Study Period III||0
8597491|NCT00337662|9633031|FG000|NOT COMPLETED|Study Period III||60
8597492|NCT00337662|9633032|FG001|NOT COMPLETED|Study Period III||58
8597493|NCT00337662|9633033|FG002|NOT COMPLETED|Study Period III||44
8597494|NCT00337662|9633034|FG003|NOT COMPLETED|Study Period III||0
8597495|NCT00337727|9633047|FG000|STARTED|Overall Study||430
8597496|NCT00337727|9633048|FG001|STARTED|Overall Study||418
8597497|NCT00337727|9633047|FG000|COMPLETED|Overall Study||412
8597498|NCT00337727|9633048|FG001|COMPLETED|Overall Study||406
8597499|NCT00337727|9633047|FG000|NOT COMPLETED|Overall Study||18
8597500|NCT00337727|9633048|FG001|NOT COMPLETED|Overall Study||12
8597501|NCT00337779|9633056|FG000|STARTED|Overall Study||586
8597502|NCT00337779|9633057|FG001|STARTED|Overall Study||569
8597503|NCT00337779|9633056|FG000|COMPLETED|Overall Study||534
8597504|NCT00337779|9633057|FG001|COMPLETED|Overall Study||490
8713120|NCT00973362|9759917|FG001|STARTED|Baseline Evaluation||1252
8713121|NCT00973362|9759916|FG000|Evaluable for Analysis|Baseline Evaluation||10871
8713122|NCT00973362|9759917|FG001|Evaluable for Analysis|Baseline Evaluation||958
8713123|NCT00973362|9759916|FG000|Conclusive Disease Status|Baseline Evaluation||819
8713124|NCT00973362|9759917|FG001|Conclusive Disease Status|Baseline Evaluation||939
8713125|NCT00973362|9759916|FG000|COMPLETED|Baseline Evaluation||10871
8713126|NCT00973362|9759917|FG001|COMPLETED|Baseline Evaluation||1029
8713127|NCT00973362|9759916|FG000|NOT COMPLETED|Baseline Evaluation||773
8713128|NCT00973362|9759917|FG001|NOT COMPLETED|Baseline Evaluation||223
8713129|NCT00973362|9759916|FG000|STARTED|3-Year Follow-up||10871
8713130|NCT00973362|9759917|FG001|STARTED|3-Year Follow-up|ASC-US study arm did not have a follow-up period|0
8713131|NCT00973362|9759916|FG000|COMPLETED|3-Year Follow-up||10854
8713132|NCT00973362|9759917|FG001|COMPLETED|3-Year Follow-up||0
8713133|NCT00973362|9759916|FG000|NOT COMPLETED|3-Year Follow-up||17
8713134|NCT00973362|9759917|FG001|NOT COMPLETED|3-Year Follow-up||0
8713135|NCT00973479|9759928|FG000|STARTED|Overall Study||197
8713136|NCT00973479|9759929|FG001|STARTED|Overall Study||395
8713137|NCT00973479|9759928|FG000|COMPLETED|Overall Study||160
8713138|NCT00973479|9759929|FG001|COMPLETED|Overall Study||326
8713139|NCT00973479|9759928|FG000|NOT COMPLETED|Overall Study||37
8713140|NCT00973479|9759929|FG001|NOT COMPLETED|Overall Study||69
8713141|NCT00973622|9759939|FG000|STARTED|Overall Study|75 passed telephone interview; 28 passed in-person interview, were enrolled, and sent for MRI.|47
8713142|NCT00973622|9759940|FG001|STARTED|Overall Study|21 passed telephone interview; 19 passed the in-person interview, were enrolled, and sent for MRI.|19
8713143|NCT00973622|9759939|FG000|COMPLETED|Overall Study|Completed three sessions of rTMS|16
8713144|NCT00973622|9759940|FG001|COMPLETED|Overall Study|Completed three sessions of rTMS|14
8713145|NCT00973622|9759939|FG000|NOT COMPLETED|Overall Study||31
8713146|NCT00973622|9759940|FG001|NOT COMPLETED|Overall Study||5
8713147|NCT00973674|9759948|FG000|STARTED|Overall Study||24
8713148|NCT00973674|9759949|FG001|STARTED|Overall Study||26
8713149|NCT00973674|9759948|FG000|COMPLETED|Overall Study||22
8713150|NCT00973674|9759949|FG001|COMPLETED|Overall Study||26
8713151|NCT00973674|9759948|FG000|NOT COMPLETED|Overall Study||2
8713152|NCT00973674|9759949|FG001|NOT COMPLETED|Overall Study||0
8713153|NCT00973700|9759961|FG000|STARTED|Overall Study||56
8713154|NCT00973700|9759962|FG001|STARTED|Overall Study||56
8713155|NCT00973700|9759963|FG002|STARTED|Overall Study||168
8713156|NCT00973700|9759964|FG003|STARTED|Overall Study||336
8713157|NCT00973700|9759965|FG004|STARTED|Overall Study||168
8597505|NCT00337779|9633056|FG000|NOT COMPLETED|Overall Study||52
8713158|NCT00973700|9759961|FG000|COMPLETED|Overall Study||49
8713159|NCT00973700|9759962|FG001|COMPLETED|Overall Study||54
8713160|NCT00973700|9759963|FG002|COMPLETED|Overall Study||158
8597506|NCT00337779|9633057|FG001|NOT COMPLETED|Overall Study||79
8597507|NCT00337818|9633066|FG000|STARTED|Overall Study||458
8597508|NCT00337818|9633067|FG001|STARTED|Overall Study||154
8597509|NCT00337818|9633068|FG002|STARTED|Overall Study||158
8597510|NCT00337818|9633066|FG000|COMPLETED|Overall Study||169
8597511|NCT00337818|9633067|FG001|COMPLETED|Overall Study||63
8597512|NCT00337818|9633068|FG002|COMPLETED|Overall Study||51
8597513|NCT00337818|9633066|FG000|NOT COMPLETED|Overall Study||289
8597514|NCT00337818|9633067|FG001|NOT COMPLETED|Overall Study||91
8597515|NCT00337818|9633068|FG002|NOT COMPLETED|Overall Study||107
8597516|NCT00337935|9633078|FG000|STARTED|Overall Study||39
8597517|NCT00337935|9633079|FG001|STARTED|Overall Study||118
8597518|NCT00337935|9633078|FG000|COMPLETED|Overall Study||29
8597519|NCT00337935|9633079|FG001|COMPLETED|Overall Study||91
8597520|NCT00337935|9633078|FG000|NOT COMPLETED|Overall Study||10
8597521|NCT00337935|9633079|FG001|NOT COMPLETED|Overall Study||27
8597522|NCT00337987|9633086|FG000|STARTED|Overall Study||49
8597523|NCT00337987|9633086|FG000|COMPLETED|Overall Study||49
8597524|NCT00337987|9633086|FG000|NOT COMPLETED|Overall Study||0
8597525|NCT00338039|9633090|FG000|STARTED|Overall Study||69
8597526|NCT00338039|9633090|FG000|COMPLETED|Overall Study||69
8597527|NCT00338039|9633090|FG000|NOT COMPLETED|Overall Study||0
8597528|NCT00338286|9633096|FG000|STARTED|Overall Study||1048
8597529|NCT00338286|9633097|FG001|STARTED|Overall Study||1050
8597530|NCT00338286|9633096|FG000|COMPLETED|Overall Study||815
8597531|NCT00338286|9633097|FG001|COMPLETED|Overall Study||837
8597532|NCT00338286|9633096|FG000|NOT COMPLETED|Overall Study||233
8597533|NCT00338286|9633097|FG001|NOT COMPLETED|Overall Study||213
8597534|NCT00338598|9633105|FG000|STARTED|Overall Study||10
8597535|NCT00338598|9633106|FG001|STARTED|Overall Study||10
8597536|NCT00338598|9633105|FG000|COMPLETED|Overall Study||10
8597537|NCT00338598|9633106|FG001|COMPLETED|Overall Study||8
8597538|NCT00338598|9633105|FG000|NOT COMPLETED|Overall Study||0
8597539|NCT00338598|9633106|FG001|NOT COMPLETED|Overall Study||2
8597540|NCT00338728|9633112|FG000|STARTED|Overall Study||59
8597541|NCT00338728|9633112|FG000|COMPLETED|Overall Study||45
8597542|NCT00338728|9633112|FG000|NOT COMPLETED|Overall Study||14
8597543|NCT00338741|9633118|FG000|STARTED|Overall Study|2 subjects signed a consent form but no data were received for either subject|34
8597544|NCT00338741|9633119|FG001|STARTED|Overall Study||2
8597545|NCT00338741|9633118|FG000|COMPLETED|Overall Study||32
8597546|NCT00338741|9633119|FG001|COMPLETED|Overall Study||2
8597547|NCT00338741|9633118|FG000|NOT COMPLETED|Overall Study||2
8597548|NCT00338741|9633119|FG001|NOT COMPLETED|Overall Study||0
8713161|NCT00973700|9759964|FG003|COMPLETED|Overall Study||318
8713162|NCT00973700|9759965|FG004|COMPLETED|Overall Study||158
8713163|NCT00973700|9759961|FG000|NOT COMPLETED|Overall Study||7
8713164|NCT00973700|9759962|FG001|NOT COMPLETED|Overall Study||2
8713165|NCT00973700|9759963|FG002|NOT COMPLETED|Overall Study||10
8713166|NCT00973700|9759964|FG003|NOT COMPLETED|Overall Study||18
8713167|NCT00973700|9759965|FG004|NOT COMPLETED|Overall Study||10
8713168|NCT00973739|9759992|FG000|STARTED|Overall Study||21
8713169|NCT00973739|9759992|FG000|COMPLETED|Overall Study||17
8713170|NCT00973739|9759992|FG000|NOT COMPLETED|Overall Study||4
8713171|NCT00973752|9759996|FG000|STARTED|Overall Study||30
8713172|NCT00973752|9759996|FG000|COMPLETED|Overall Study||30
8713173|NCT00973752|9759996|FG000|NOT COMPLETED|Overall Study||0
8713174|NCT00973765|9760002|FG000|STARTED|Overall Study|96|96
8713175|NCT00973765|9760003|FG001|STARTED|Overall Study|116|116
8713176|NCT00973765|9760002|FG000|COMPLETED|Overall Study|88|88
8713177|NCT00973765|9760003|FG001|COMPLETED|Overall Study|102|102
8713178|NCT00973765|9760002|FG000|NOT COMPLETED|Overall Study||8
8713179|NCT00973765|9760003|FG001|NOT COMPLETED|Overall Study||14
8713180|NCT00973921|9760009|FG000|STARTED|Overall Study||40
8713181|NCT00973921|9760009|FG000|COMPLETED|Overall Study||31
8713182|NCT00973921|9760009|FG000|NOT COMPLETED|Overall Study||9
8713183|NCT00973973|9760015|FG000|STARTED|Double-blind Treatment Phase (Weeks 1-8)||69
8713184|NCT00973973|9760016|FG001|STARTED|Double-blind Treatment Phase (Weeks 1-8)||68
8713185|NCT00973973|9760015|FG000|Received Study Drug|Double-blind Treatment Phase (Weeks 1-8)||69
8713186|NCT00973973|9760016|FG001|Received Study Drug|Double-blind Treatment Phase (Weeks 1-8)||68
8713187|NCT00973973|9760015|FG000|COMPLETED|Double-blind Treatment Phase (Weeks 1-8)||63
8713188|NCT00973973|9760016|FG001|COMPLETED|Double-blind Treatment Phase (Weeks 1-8)||60
8713189|NCT00973973|9760015|FG000|NOT COMPLETED|Double-blind Treatment Phase (Weeks 1-8)||6
8713190|NCT00973973|9760016|FG001|NOT COMPLETED|Double-blind Treatment Phase (Weeks 1-8)||8
8713191|NCT00973973|9760015|FG000|STARTED|Open-label Treatment Phase (Weeks 8-24)||63
8713192|NCT00973973|9760016|FG001|STARTED|Open-label Treatment Phase (Weeks 8-24)||60
8713193|NCT00973973|9760015|FG000|COMPLETED|Open-label Treatment Phase (Weeks 8-24)||57
8713194|NCT00973973|9760016|FG001|COMPLETED|Open-label Treatment Phase (Weeks 8-24)||55
8597549|NCT00338806|9633127|FG000|STARTED|Acute Phase||2
8597550|NCT00338806|9633128|FG001|STARTED|Acute Phase||5
8597551|NCT00338806|9633127|FG000|COMPLETED|Acute Phase||2
8597552|NCT00338806|9633128|FG001|COMPLETED|Acute Phase||4
8597553|NCT00338806|9633127|FG000|NOT COMPLETED|Acute Phase||0
8597554|NCT00338806|9633128|FG001|NOT COMPLETED|Acute Phase||1
8597555|NCT00338806|9633127|FG000|STARTED|Follow-up||2
8597556|NCT00338806|9633128|FG001|STARTED|Follow-up||4
8597557|NCT00338806|9633127|FG000|COMPLETED|Follow-up||1
8597558|NCT00338806|9633128|FG001|COMPLETED|Follow-up||1
8597559|NCT00338806|9633127|FG000|NOT COMPLETED|Follow-up||1
8597560|NCT00338806|9633128|FG001|NOT COMPLETED|Follow-up||3
8597561|NCT00338884|9633136|FG000|STARTED|Overall Study||120
8597562|NCT00338884|9633136|FG000|Received Treatment|Overall Study||119
8597563|NCT00338884|9633136|FG000|COMPLETED|Overall Study||42
8597564|NCT00338884|9633136|FG000|NOT COMPLETED|Overall Study||78
8597565|NCT00338949|9633142|FG000|STARTED|Subject Screening||36
8597566|NCT00338949|9633143|FG001|STARTED|Subject Screening||41
8597567|NCT00338949|9633142|FG000|COMPLETED|Subject Screening||25
8597568|NCT00338949|9633143|FG001|COMPLETED|Subject Screening||30
8597569|NCT00338949|9633142|FG000|NOT COMPLETED|Subject Screening||11
8597570|NCT00338949|9633143|FG001|NOT COMPLETED|Subject Screening||11
8597571|NCT00338949|9633142|FG000|STARTED|Randomization||25
8597572|NCT00338949|9633143|FG001|STARTED|Randomization||30
8597573|NCT00338949|9633142|FG000|COMPLETED|Randomization|1 subject withdrew after relapse and hospitalization|24
8597574|NCT00338949|9633143|FG001|COMPLETED|Randomization|"Reasons for drop out:~2- insomnia 2- symptom exacerbation~1- akathisia"|25
8597575|NCT00338949|9633142|FG000|NOT COMPLETED|Randomization||1
8597576|NCT00338949|9633143|FG001|NOT COMPLETED|Randomization||5
8597577|NCT00338962|9633153|FG000|STARTED|Overall Study||22
8597578|NCT00338962|9633154|FG001|STARTED|Overall Study||20
8597579|NCT00338962|9633155|FG002|STARTED|Overall Study||22
8597580|NCT00338962|9633156|FG003|STARTED|Overall Study||24
8597581|NCT00338962|9633153|FG000|COMPLETED|Overall Study||14
8597582|NCT00338962|9633154|FG001|COMPLETED|Overall Study||16
8597583|NCT00338962|9633155|FG002|COMPLETED|Overall Study||16
8597584|NCT00338962|9633156|FG003|COMPLETED|Overall Study||21
8597585|NCT00338962|9633153|FG000|NOT COMPLETED|Overall Study||8
8597586|NCT00338962|9633154|FG001|NOT COMPLETED|Overall Study||4
8597587|NCT00338962|9633155|FG002|NOT COMPLETED|Overall Study||6
8597588|NCT00338962|9633156|FG003|NOT COMPLETED|Overall Study||3
8597589|NCT00338988|9633166|FG000|STARTED|Overall Study||44
8597590|NCT00338988|9633166|FG000|COMPLETED|Overall Study||43
8597591|NCT00338988|9633166|FG000|NOT COMPLETED|Overall Study||1
8597592|NCT00339040|9633173|FG000|STARTED|Stage I||96
8597593|NCT00339040|9633174|FG001|STARTED|Stage I||30
8597594|NCT00339040|9633173|FG000|Vaccination 1 at Week 0|Stage I||96
8597595|NCT00339040|9633174|FG001|Vaccination 1 at Week 0|Stage I||30
8597596|NCT00339040|9633173|FG000|Vaccination 2 at Week 8|Stage I||95
8597597|NCT00339040|9633174|FG001|Vaccination 2 at Week 8|Stage I||30
8597598|NCT00339040|9633173|FG000|Vaccination 3 at Week 24|Stage I||94
8597599|NCT00339040|9633174|FG001|Vaccination 3 at Week 24|Stage I||30
8597600|NCT00339040|9633173|FG000|COMPLETED|Stage I||94
8597601|NCT00339040|9633174|FG001|COMPLETED|Stage I||29
8597602|NCT00339040|9633173|FG000|NOT COMPLETED|Stage I||2
8597603|NCT00339040|9633174|FG001|NOT COMPLETED|Stage I||1
8597604|NCT00339040|9633173|FG000|STARTED|Stage II||94
8597605|NCT00339040|9633174|FG001|STARTED|Stage II||29
8597606|NCT00339040|9633173|FG000|Vaccination 4 at Week 96|Stage II||84
8597607|NCT00339040|9633174|FG001|Vaccination 4 at Week 96|Stage II||29
8597608|NCT00339040|9633173|FG000|Vaccination 5 at Week 104|Stage II||0
8597609|NCT00339040|9633174|FG001|Vaccination 5 at Week 104|Stage II||28
8597610|NCT00339040|9633173|FG000|Vaccination 6 at Week 120|Stage II||0
8597611|NCT00339040|9633174|FG001|Vaccination 6 at Week 120|Stage II||27
8597612|NCT00339040|9633173|FG000|COMPLETED|Stage II||84
8597613|NCT00339040|9633174|FG001|COMPLETED|Stage II||27
8597614|NCT00339040|9633173|FG000|NOT COMPLETED|Stage II||10
8597615|NCT00339040|9633174|FG001|NOT COMPLETED|Stage II||2
8597616|NCT00339079|9633184|FG000|STARTED|Overall Study||53
8597617|NCT00339079|9633185|FG001|STARTED|Overall Study||44
8597618|NCT00339079|9633186|FG002|STARTED|Overall Study||45
8597619|NCT00339079|9633187|FG003|STARTED|Overall Study||53
8597620|NCT00339079|9633184|FG000|COMPLETED|Overall Study||20
8597621|NCT00339079|9633185|FG001|COMPLETED|Overall Study||21
8597622|NCT00339079|9633186|FG002|COMPLETED|Overall Study||27
8597623|NCT00339079|9633187|FG003|COMPLETED|Overall Study||29
8597624|NCT00339079|9633184|FG000|NOT COMPLETED|Overall Study||33
8597625|NCT00339079|9633185|FG001|NOT COMPLETED|Overall Study||23
8597626|NCT00339079|9633186|FG002|NOT COMPLETED|Overall Study||18
8597627|NCT00339079|9633187|FG003|NOT COMPLETED|Overall Study||24
8597628|NCT00339144|9633204|FG000|STARTED|Overall Study|Number of participants enrolled and treated|9
8597629|NCT00339144|9633205|FG001|STARTED|Overall Study|Number of participants enrolled and treated|3
8597630|NCT00339144|9633206|FG002|STARTED|Overall Study|Number of participants enrolled and treated|4
8597631|NCT00339144|9633204|FG000|COMPLETED|Overall Study||0
8597632|NCT00339144|9633205|FG001|COMPLETED|Overall Study||0
8597633|NCT00339144|9633206|FG002|COMPLETED|Overall Study||0
8597634|NCT00339144|9633204|FG000|NOT COMPLETED|Overall Study||9
8597635|NCT00339144|9633205|FG001|NOT COMPLETED|Overall Study||3
8597636|NCT00339144|9633206|FG002|NOT COMPLETED|Overall Study||4
8597637|NCT00339183|9633217|FG000|STARTED|Overall Study||591
8597638|NCT00339183|9633218|FG001|STARTED|Overall Study||595
8597639|NCT00339183|9633217|FG000|Received Study Drug|Overall Study|Includes one participant who received FOLFIRI Alone|588
8597640|NCT00339183|9633218|FG001|Received Study Drug|Overall Study||593
8597641|NCT00339183|9633217|FG000|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|470
8597642|NCT00339183|9633218|FG001|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|490
8597643|NCT00339183|9633217|FG000|NOT COMPLETED|Overall Study||121
8597644|NCT00339183|9633218|FG001|NOT COMPLETED|Overall Study||105
8597645|NCT00339833|9633230|FG000|STARTED|Overall Study||28
8597646|NCT00339833|9633231|FG001|STARTED|Overall Study||26
8597647|NCT00339833|9633230|FG000|COMPLETED|Overall Study||22
8597648|NCT00339833|9633231|FG001|COMPLETED|Overall Study||18
8597649|NCT00339833|9633230|FG000|NOT COMPLETED|Overall Study||6
8597650|NCT00339833|9633231|FG001|NOT COMPLETED|Overall Study||8
8597651|NCT00340379|9633239|FG000|STARTED|Overall Study||35
8597652|NCT00340379|9633240|FG001|STARTED|Overall Study||37
8597653|NCT00340379|9633239|FG000|COMPLETED|Overall Study||27
8597654|NCT00340379|9633240|FG001|COMPLETED|Overall Study||28
8597655|NCT00340379|9633239|FG000|NOT COMPLETED|Overall Study||8
8597656|NCT00340379|9633240|FG001|NOT COMPLETED|Overall Study||9
8597657|NCT00340678|9633250|FG000|STARTED|Overall Study||46
8597658|NCT00340678|9633251|FG001|STARTED|Overall Study||46
8597659|NCT00340678|9633252|FG002|STARTED|Overall Study||39
8597660|NCT00340678|9633253|FG003|STARTED|Overall Study||39
8597661|NCT00340678|9633250|FG000|COMPLETED|Overall Study||45
8597662|NCT00340678|9633251|FG001|COMPLETED|Overall Study||46
8597663|NCT00340678|9633252|FG002|COMPLETED|Overall Study||39
8597664|NCT00340678|9633253|FG003|COMPLETED|Overall Study||39
8597665|NCT00340678|9633250|FG000|NOT COMPLETED|Overall Study||1
8597666|NCT00340678|9633251|FG001|NOT COMPLETED|Overall Study||0
8597667|NCT00340678|9633252|FG002|NOT COMPLETED|Overall Study||0
8597668|NCT00340678|9633253|FG003|NOT COMPLETED|Overall Study||0
8597669|NCT00340704|9633270|FG000|STARTED|PK Study||10
8597670|NCT00340704|9633271|FG001|STARTED|PK Study||10
8597671|NCT00340704|9633272|FG002|STARTED|PK Study||11
8597672|NCT00340704|9633273|FG003|STARTED|PK Study||0
8597673|NCT00340704|9633274|FG004|STARTED|PK Study||0
8597674|NCT00340704|9633275|FG005|STARTED|PK Study||0
8597675|NCT00340704|9633276|FG006|STARTED|PK Study||0
8597676|NCT00340704|9633277|FG007|STARTED|PK Study||0
8597677|NCT00340704|9633278|FG008|STARTED|PK Study||0
8597678|NCT00340704|9633270|FG000|COMPLETED|PK Study||10
8597679|NCT00340704|9633271|FG001|COMPLETED|PK Study||9
8597680|NCT00340704|9633272|FG002|COMPLETED|PK Study||10
8597681|NCT00340704|9633273|FG003|COMPLETED|PK Study||0
8597682|NCT00340704|9633274|FG004|COMPLETED|PK Study||0
8597683|NCT00340704|9633275|FG005|COMPLETED|PK Study||0
8597684|NCT00340704|9633276|FG006|COMPLETED|PK Study||0
8597685|NCT00340704|9633277|FG007|COMPLETED|PK Study||0
8597686|NCT00340704|9633278|FG008|COMPLETED|PK Study||0
8597687|NCT00340704|9633270|FG000|NOT COMPLETED|PK Study||0
8597688|NCT00340704|9633271|FG001|NOT COMPLETED|PK Study||1
8597689|NCT00340704|9633272|FG002|NOT COMPLETED|PK Study||1
8597690|NCT00340704|9633273|FG003|NOT COMPLETED|PK Study||0
8597691|NCT00340704|9633274|FG004|NOT COMPLETED|PK Study||0
8597692|NCT00340704|9633275|FG005|NOT COMPLETED|PK Study||0
8597693|NCT00340704|9633276|FG006|NOT COMPLETED|PK Study||0
8597694|NCT00340704|9633277|FG007|NOT COMPLETED|PK Study||0
8597695|NCT00340704|9633278|FG008|NOT COMPLETED|PK Study||0
8597696|NCT00340704|9633270|FG000|STARTED|Group D- Denovo & 527.51 Rollover Study||0
8597697|NCT00340704|9633271|FG001|STARTED|Group D- Denovo & 527.51 Rollover Study||0
8597698|NCT00340704|9633272|FG002|STARTED|Group D- Denovo & 527.51 Rollover Study||0
8597699|NCT00340704|9633273|FG003|STARTED|Group D- Denovo & 527.51 Rollover Study||29
8597700|NCT00340704|9633274|FG004|STARTED|Group D- Denovo & 527.51 Rollover Study||21
8597701|NCT00340704|9633275|FG005|STARTED|Group D- Denovo & 527.51 Rollover Study||37
8597702|NCT00340704|9633276|FG006|STARTED|Group D- Denovo & 527.51 Rollover Study||54
8597703|NCT00340704|9633277|FG007|STARTED|Group D- Denovo & 527.51 Rollover Study||13
8597704|NCT00340704|9633278|FG008|STARTED|Group D- Denovo & 527.51 Rollover Study||29
8597705|NCT00340704|9633270|FG000|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
8597706|NCT00340704|9633271|FG001|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
8597707|NCT00340704|9633272|FG002|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
8597708|NCT00340704|9633273|FG003|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||7
8597709|NCT00340704|9633274|FG004|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||5
8597710|NCT00340704|9633275|FG005|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||18
8597711|NCT00340704|9633276|FG006|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
8597712|NCT00340704|9633277|FG007|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
8597713|NCT00340704|9633278|FG008|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
8597714|NCT00340704|9633270|FG000|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
8597715|NCT00340704|9633271|FG001|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
8597716|NCT00340704|9633272|FG002|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
8597717|NCT00340704|9633273|FG003|COMPLETED|Group D- Denovo & 527.51 Rollover Study||27
8597718|NCT00340704|9633274|FG004|COMPLETED|Group D- Denovo & 527.51 Rollover Study||16
8597719|NCT00340704|9633275|FG005|COMPLETED|Group D- Denovo & 527.51 Rollover Study||30
8597720|NCT00340704|9633276|FG006|COMPLETED|Group D- Denovo & 527.51 Rollover Study||1
8597721|NCT00340704|9633277|FG007|COMPLETED|Group D- Denovo & 527.51 Rollover Study||1
8597722|NCT00340704|9633278|FG008|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
8597723|NCT00340704|9633270|FG000|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
8597724|NCT00340704|9633271|FG001|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
8597725|NCT00340704|9633272|FG002|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
8597726|NCT00340704|9633273|FG003|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||2
8597727|NCT00340704|9633274|FG004|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||5
8597728|NCT00340704|9633275|FG005|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||7
8597729|NCT00340704|9633276|FG006|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||53
8597730|NCT00340704|9633277|FG007|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||12
8597731|NCT00340704|9633278|FG008|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||29
8597732|NCT00340834|9633309|FG000|STARTED|Core Phase of Study||426
8597733|NCT00340834|9633310|FG001|STARTED|Core Phase of Study||431
8597734|NCT00340834|9633311|FG002|STARTED|Core Phase of Study||435
8597735|NCT00340834|9633312|FG003|STARTED|Core Phase of Study|This group was formed at the beginning of the extension phase of the study.|0
8597736|NCT00340834|9633313|FG004|STARTED|Core Phase of Study|This group was formed at the beginning of the extension phase of the study.|0
8597737|NCT00340834|9633309|FG000|COMPLETED|Core Phase of Study|On study drug: 358, Off study drug: 11|369
8597738|NCT00340834|9633310|FG001|COMPLETED|Core Phase of Study|On study drug: 385, Off study drug: 13|398
8597739|NCT00340834|9633311|FG002|COMPLETED|Core Phase of Study|On study drug: 380, Off study drug: 6|386
8597740|NCT00340834|9633312|FG003|COMPLETED|Core Phase of Study||0
8597741|NCT00340834|9633313|FG004|COMPLETED|Core Phase of Study||0
8597742|NCT00340834|9633309|FG000|NOT COMPLETED|Core Phase of Study||57
8597743|NCT00340834|9633310|FG001|NOT COMPLETED|Core Phase of Study||33
8597744|NCT00340834|9633311|FG002|NOT COMPLETED|Core Phase of Study||49
8597745|NCT00340834|9633312|FG003|NOT COMPLETED|Core Phase of Study||0
8597746|NCT00340834|9633313|FG004|NOT COMPLETED|Core Phase of Study||0
8597747|NCT00340834|9633309|FG000|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|330
8597748|NCT00340834|9633310|FG001|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|357
8597749|NCT00340834|9633311|FG002|STARTED|Extension Phase of Study|This group did not exist in the extension phase of the study.|0
8597750|NCT00340834|9633312|FG003|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|176
8597751|NCT00340834|9633313|FG004|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|167
8597752|NCT00340834|9633309|FG000|Received Study Drug|Extension Phase of Study||330
8597753|NCT00340834|9633310|FG001|Received Study Drug|Extension Phase of Study||356
8597754|NCT00340834|9633311|FG002|Received Study Drug|Extension Phase of Study||0
8597755|NCT00340834|9633312|FG003|Received Study Drug|Extension Phase of Study||174
8597756|NCT00340834|9633313|FG004|Received Study Drug|Extension Phase of Study||167
8597757|NCT00340834|9633309|FG000|COMPLETED|Extension Phase of Study||245
8597758|NCT00340834|9633310|FG001|COMPLETED|Extension Phase of Study||281
8597759|NCT00340834|9633311|FG002|COMPLETED|Extension Phase of Study||0
8597760|NCT00340834|9633312|FG003|COMPLETED|Extension Phase of Study||123
8597761|NCT00340834|9633313|FG004|COMPLETED|Extension Phase of Study||123
8597762|NCT00340834|9633309|FG000|NOT COMPLETED|Extension Phase of Study||85
8597763|NCT00340834|9633310|FG001|NOT COMPLETED|Extension Phase of Study||76
8597764|NCT00340834|9633311|FG002|NOT COMPLETED|Extension Phase of Study||0
8597765|NCT00340834|9633312|FG003|NOT COMPLETED|Extension Phase of Study||53
8597766|NCT00340834|9633313|FG004|NOT COMPLETED|Extension Phase of Study||44
8597767|NCT00342355|9633327|FG000|STARTED|Overall Study||444
8597768|NCT00342355|9633328|FG001|STARTED|Overall Study||440
8597769|NCT00342355|9633329|FG002|STARTED|Overall Study||444
8597770|NCT00342355|9633330|FG003|STARTED|Overall Study||443
8597771|NCT00342355|9633327|FG000|COMPLETED|Overall Study||444
8597772|NCT00342355|9633328|FG001|COMPLETED|Overall Study||440
8597773|NCT00342355|9633329|FG002|COMPLETED|Overall Study||444
8597774|NCT00342355|9633330|FG003|COMPLETED|Overall Study||443
8597775|NCT00342355|9633327|FG000|NOT COMPLETED|Overall Study||0
8597776|NCT00342355|9633328|FG001|NOT COMPLETED|Overall Study||0
8597777|NCT00342355|9633329|FG002|NOT COMPLETED|Overall Study||0
8597778|NCT00342355|9633330|FG003|NOT COMPLETED|Overall Study||0
8597779|NCT00342563|9633344|FG000|STARTED|Overall Study||41
8597780|NCT00342563|9633345|FG001|STARTED|Overall Study||27
8597781|NCT00342563|9633346|FG002|STARTED|Overall Study||40
8597782|NCT00342563|9633347|FG003|STARTED|Overall Study||28
8597783|NCT00342563|9633344|FG000|COMPLETED|Overall Study||35
8597784|NCT00342563|9633345|FG001|COMPLETED|Overall Study||19
8597785|NCT00342563|9633346|FG002|COMPLETED|Overall Study||26
8597786|NCT00342563|9633347|FG003|COMPLETED|Overall Study||22
8597787|NCT00342563|9633344|FG000|NOT COMPLETED|Overall Study||6
8597788|NCT00342563|9633345|FG001|NOT COMPLETED|Overall Study||8
8597789|NCT00342563|9633346|FG002|NOT COMPLETED|Overall Study||14
8597790|NCT00342563|9633347|FG003|NOT COMPLETED|Overall Study||6
8713195|NCT00973973|9760015|FG000|NOT COMPLETED|Open-label Treatment Phase (Weeks 8-24)||6
8713196|NCT00973973|9760016|FG001|NOT COMPLETED|Open-label Treatment Phase (Weeks 8-24)||5
8713197|NCT00974051|9760022|FG000|STARTED|Overall Study||6
8713198|NCT00974051|9760023|FG001|STARTED|Overall Study||4
8713199|NCT00974051|9760024|FG002|STARTED|Overall Study||6
8713200|NCT00974051|9760022|FG000|COMPLETED|Overall Study||6
8713201|NCT00974051|9760023|FG001|COMPLETED|Overall Study||4
8713202|NCT00974051|9760024|FG002|COMPLETED|Overall Study||6
8713203|NCT00974051|9760022|FG000|NOT COMPLETED|Overall Study||0
8713204|NCT00974051|9760023|FG001|NOT COMPLETED|Overall Study||0
8713205|NCT00974051|9760024|FG002|NOT COMPLETED|Overall Study||0
8713206|NCT00974090|9760035|FG000|STARTED|Period 1: Double Blind Period||98
8713207|NCT00974090|9760036|FG001|STARTED|Period 1: Double Blind Period||96
8713208|NCT00974090|9760035|FG000|COMPLETED|Period 1: Double Blind Period||95
8713209|NCT00974090|9760036|FG001|COMPLETED|Period 1: Double Blind Period||95
8713210|NCT00974090|9760035|FG000|NOT COMPLETED|Period 1: Double Blind Period||3
8713211|NCT00974090|9760036|FG001|NOT COMPLETED|Period 1: Double Blind Period||1
8713212|NCT00974090|9760035|FG000|STARTED|Period 2: Open-label Period||95
8713213|NCT00974090|9760036|FG001|STARTED|Period 2: Open-label Period||95
8713214|NCT00974090|9760035|FG000|COMPLETED|Period 2: Open-label Period||87
8713215|NCT00974090|9760036|FG001|COMPLETED|Period 2: Open-label Period||85
8597791|NCT00342628|9633362|FG000|STARTED|Overall Study||100
8597792|NCT00342628|9633363|FG001|STARTED|Overall Study||101
8597793|NCT00342628|9633364|FG002|STARTED|Overall Study||100
8597794|NCT00342628|9633362|FG000|COMPLETED|Overall Study|84 completed 4 injections, 4 were lost-to-followup after the 4th injection|80
8597795|NCT00342628|9633363|FG001|COMPLETED|Overall Study|83 completed 4 injections, 3 were lost-to-followup after 4th injection|80
8597796|NCT00342628|9633364|FG002|COMPLETED|Overall Study|97 completed 3 injections of DTP alone, 16 were lost-to-followup for blood drawing at 12 months.|81
8597797|NCT00342628|9633362|FG000|NOT COMPLETED|Overall Study||20
8597798|NCT00342628|9633363|FG001|NOT COMPLETED|Overall Study||21
8597799|NCT00342628|9633364|FG002|NOT COMPLETED|Overall Study||19
8597800|NCT00343044|9633372|FG000|STARTED|Overall Study||40
8597801|NCT00343044|9633372|FG000|COMPLETED|Overall Study||40
8597802|NCT00343044|9633372|FG000|NOT COMPLETED|Overall Study||0
8597803|NCT00343083|9633376|FG000|STARTED|Overall Study||43
8597804|NCT00343083|9633376|FG000|COMPLETED|Overall Study||22
8597805|NCT00343083|9633376|FG000|NOT COMPLETED|Overall Study||21
8597806|NCT00343252|9633383|FG000|STARTED|All Randomized Participants||361
8597807|NCT00343252|9633384|FG001|STARTED|All Randomized Participants||351
8597808|NCT00343252|9633383|FG000|COMPLETED|All Randomized Participants||259
8597809|NCT00343252|9633384|FG001|COMPLETED|All Randomized Participants||269
8597810|NCT00343252|9633383|FG000|NOT COMPLETED|All Randomized Participants||102
8597811|NCT00343252|9633384|FG001|NOT COMPLETED|All Randomized Participants||82
8597812|NCT00343252|9633383|FG000|STARTED|6 Months (All Treated Participants)|361 participants were randomized but 1 did not receive study drug and was not analyzed.|360
8597813|NCT00343252|9633384|FG001|STARTED|6 Months (All Treated Participants)|351 participants were randomized but 1 did not receive study drug and was not analyzed.|350
8597814|NCT00343252|9633383|FG000|COMPLETED|6 Months (All Treated Participants)||304
8597815|NCT00343252|9633384|FG001|COMPLETED|6 Months (All Treated Participants)||306
8597816|NCT00343252|9633383|FG000|NOT COMPLETED|6 Months (All Treated Participants)||56
8597817|NCT00343252|9633384|FG001|NOT COMPLETED|6 Months (All Treated Participants)||44
8597818|NCT00343252|9633383|FG000|STARTED|12 Months (All Treated Participants)|361 participants were randomized but 1 did not receive study drug and was not analyzed.|360
8597819|NCT00343252|9633384|FG001|STARTED|12 Months (All Treated Participants)|351 participants were randomized but 1 did not receive study drug and was not analyzed.|350
8597820|NCT00343252|9633383|FG000|COMPLETED|12 Months (All Treated Participants)|Completed 12 Months.|274
8597821|NCT00343252|9633384|FG001|COMPLETED|12 Months (All Treated Participants)|Completed 12 Months.|281
8597822|NCT00343252|9633383|FG000|NOT COMPLETED|12 Months (All Treated Participants)||86
8597823|NCT00343252|9633384|FG001|NOT COMPLETED|12 Months (All Treated Participants)||69
8597824|NCT00343252|9633383|FG000|STARTED|18 Months (All Treated Participants)||360
8597825|NCT00343252|9633384|FG001|STARTED|18 Months (All Treated Participants)||350
8597826|NCT00343252|9633383|FG000|COMPLETED|18 Months (All Treated Participants)||259
8597827|NCT00343252|9633384|FG001|COMPLETED|18 Months (All Treated Participants)||269
8597828|NCT00343252|9633383|FG000|NOT COMPLETED|18 Months (All Treated Participants)||101
8597829|NCT00343252|9633384|FG001|NOT COMPLETED|18 Months (All Treated Participants)||81
8597830|NCT00343291|9633392|FG000|STARTED|Overall Study||60
8597831|NCT00343291|9633393|FG001|STARTED|Overall Study||61
8597832|NCT00343291|9633392|FG000|RECEIVED AT LEAST ONE DOSE OF STUDY DRUG|Overall Study||58
8597833|NCT00343291|9633393|FG001|RECEIVED AT LEAST ONE DOSE OF STUDY DRUG|Overall Study||58
8597834|NCT00343291|9633392|FG000|COMPLETED|Overall Study|Participants completed 6 cycles of treatment. Did not start subsequent weekly cetuximab monotherapy.|3
8597835|NCT00343291|9633393|FG001|COMPLETED|Overall Study|Participants completed 6 cycles of treatment. Did not start subsequent weekly cetuximab monotherapy.|5
8597836|NCT00343291|9633392|FG000|NOT COMPLETED|Overall Study||57
8597837|NCT00343291|9633393|FG001|NOT COMPLETED|Overall Study||56
8597838|NCT00343382|9633402|FG000|STARTED|Overall Study||64
8597839|NCT00343382|9633403|FG001|STARTED|Overall Study||65
8597840|NCT00343382|9633404|FG002|STARTED|Overall Study||66
8597841|NCT00343382|9633402|FG000|COMPLETED|Overall Study||60
8597842|NCT00343382|9633403|FG001|COMPLETED|Overall Study||51
8597843|NCT00343382|9633404|FG002|COMPLETED|Overall Study||49
8597844|NCT00343382|9633402|FG000|NOT COMPLETED|Overall Study||4
8597845|NCT00343382|9633403|FG001|NOT COMPLETED|Overall Study||14
8597846|NCT00343382|9633404|FG002|NOT COMPLETED|Overall Study||17
8597847|NCT00343460|9633418|FG000|STARTED|Cycle 1||475
8597848|NCT00343460|9633419|FG001|STARTED|Cycle 1||481
8597849|NCT00343460|9633420|FG002|STARTED|Cycle 1||472
8597850|NCT00343460|9633418|FG000|COMPLETED|Cycle 1||453
8597851|NCT00343460|9633419|FG001|COMPLETED|Cycle 1||459
8597852|NCT00343460|9633420|FG002|COMPLETED|Cycle 1||454
8597853|NCT00343460|9633418|FG000|NOT COMPLETED|Cycle 1||22
8597854|NCT00343460|9633419|FG001|NOT COMPLETED|Cycle 1||22
8597855|NCT00343460|9633420|FG002|NOT COMPLETED|Cycle 1||18
8597856|NCT00343460|9633418|FG000|STARTED|Cycle 2 - 4||584
8597857|NCT00343460|9633419|FG001|STARTED|Cycle 2 - 4||565
8597858|NCT00343460|9633420|FG002|STARTED|Cycle 2 - 4||0
8597859|NCT00343460|9633418|FG000|COMPLETED|Cycle 2 - 4||528
8597860|NCT00343460|9633419|FG001|COMPLETED|Cycle 2 - 4||515
8597861|NCT00343460|9633420|FG002|COMPLETED|Cycle 2 - 4||0
8597862|NCT00343460|9633418|FG000|NOT COMPLETED|Cycle 2 - 4||56
8597863|NCT00343460|9633419|FG001|NOT COMPLETED|Cycle 2 - 4||50
8597864|NCT00343460|9633420|FG002|NOT COMPLETED|Cycle 2 - 4||0
8597865|NCT00343512|9633438|FG000|STARTED|Overall Study||34
8597866|NCT00343512|9633438|FG000|COMPLETED|Overall Study||32
8597867|NCT00343512|9633438|FG000|NOT COMPLETED|Overall Study||2
8597868|NCT00343564|9633454|FG000|STARTED|Overall Study||6
8597869|NCT00343564|9633455|FG001|STARTED|Overall Study||7
8597870|NCT00343564|9633456|FG002|STARTED|Overall Study||3
8597871|NCT00343564|9633457|FG003|STARTED|Overall Study||7
8597872|NCT00343564|9633458|FG004|STARTED|Overall Study||10
8597873|NCT00343564|9633459|FG005|STARTED|Overall Study||9
8597874|NCT00343564|9633460|FG006|STARTED|Overall Study||4
8597875|NCT00343564|9633461|FG007|STARTED|Overall Study||3
8597876|NCT00343564|9633462|FG008|STARTED|Overall Study||3
8597877|NCT00343564|9633463|FG009|STARTED|Overall Study||8
8597878|NCT00343564|9633464|FG010|STARTED|Overall Study||8
8597879|NCT00343564|9633454|FG000|COMPLETED|Overall Study||6
8597880|NCT00343564|9633455|FG001|COMPLETED|Overall Study||7
8597881|NCT00343564|9633456|FG002|COMPLETED|Overall Study||3
8597882|NCT00343564|9633457|FG003|COMPLETED|Overall Study||7
8597883|NCT00343564|9633458|FG004|COMPLETED|Overall Study||10
8597884|NCT00343564|9633459|FG005|COMPLETED|Overall Study||9
8597885|NCT00343564|9633460|FG006|COMPLETED|Overall Study||4
8597886|NCT00343564|9633461|FG007|COMPLETED|Overall Study||3
8597887|NCT00343564|9633462|FG008|COMPLETED|Overall Study||3
8597888|NCT00343564|9633463|FG009|COMPLETED|Overall Study||8
8597889|NCT00343564|9633464|FG010|COMPLETED|Overall Study||8
8597890|NCT00343564|9633454|FG000|NOT COMPLETED|Overall Study||0
8597891|NCT00343564|9633455|FG001|NOT COMPLETED|Overall Study||0
8597892|NCT00343564|9633456|FG002|NOT COMPLETED|Overall Study||0
8597893|NCT00343564|9633457|FG003|NOT COMPLETED|Overall Study||0
8597894|NCT00343564|9633458|FG004|NOT COMPLETED|Overall Study||0
8597895|NCT00343564|9633459|FG005|NOT COMPLETED|Overall Study||0
8597896|NCT00343564|9633460|FG006|NOT COMPLETED|Overall Study||0
8597897|NCT00343564|9633461|FG007|NOT COMPLETED|Overall Study||0
8597898|NCT00343564|9633462|FG008|NOT COMPLETED|Overall Study||0
8597899|NCT00343564|9633463|FG009|NOT COMPLETED|Overall Study||0
8597900|NCT00343564|9633464|FG010|NOT COMPLETED|Overall Study||0
8597901|NCT00343642|9633562|FG000|STARTED|Overall Study||19
8597902|NCT00343642|9633563|FG001|STARTED|Overall Study||19
8597903|NCT00343642|9633564|FG002|STARTED|Overall Study||16
8597904|NCT00343642|9633562|FG000|Upto 3 Months Complete or Flare|Overall Study||2
8597905|NCT00343642|9633563|FG001|Upto 3 Months Complete or Flare|Overall Study||0
8597906|NCT00343642|9633564|FG002|Upto 3 Months Complete or Flare|Overall Study||1
8597907|NCT00343642|9633562|FG000|3-6 Months Complete or Flare|Overall Study||4
8597908|NCT00343642|9633563|FG001|3-6 Months Complete or Flare|Overall Study||2
8597909|NCT00343642|9633564|FG002|3-6 Months Complete or Flare|Overall Study||2
8597910|NCT00343642|9633562|FG000|COMPLETED|Overall Study||10
8597911|NCT00343642|9633563|FG001|COMPLETED|Overall Study||11
8597912|NCT00343642|9633564|FG002|COMPLETED|Overall Study||9
8597913|NCT00343642|9633562|FG000|NOT COMPLETED|Overall Study||9
8597914|NCT00343642|9633563|FG001|NOT COMPLETED|Overall Study||8
8597915|NCT00343642|9633564|FG002|NOT COMPLETED|Overall Study||7
8597916|NCT00343785|9633575|FG000|STARTED|Overall Study||21
8597917|NCT00343785|9633575|FG000|COMPLETED|Overall Study||21
8597918|NCT00343785|9633575|FG000|NOT COMPLETED|Overall Study||0
8597919|NCT00343863|9633582|FG000|STARTED|Overall Study||7
8597920|NCT00343863|9633583|FG001|STARTED|Overall Study||34
8597921|NCT00343863|9633582|FG000|COMPLETED|Overall Study||7
8597922|NCT00343863|9633583|FG001|COMPLETED|Overall Study||34
8597923|NCT00343863|9633582|FG000|NOT COMPLETED|Overall Study||0
8597924|NCT00343863|9633583|FG001|NOT COMPLETED|Overall Study||0
8597925|NCT00343889|9633593|FG000|STARTED|Overall Study||190
8597926|NCT00343889|9633594|FG001|STARTED|Overall Study||189
8597927|NCT00343889|9633593|FG000|COMPLETED|Overall Study||187
8597928|NCT00343889|9633594|FG001|COMPLETED|Overall Study||188
8597929|NCT00343889|9633593|FG000|NOT COMPLETED|Overall Study||3
8597930|NCT00343889|9633594|FG001|NOT COMPLETED|Overall Study||1
8597931|NCT00343915|9633602|FG000|STARTED|Primary Study||258
8597932|NCT00343915|9633603|FG001|STARTED|Primary Study||126
8597933|NCT00343915|9633602|FG000|COMPLETED|Primary Study||254
8597934|NCT00343915|9633603|FG001|COMPLETED|Primary Study||123
8597935|NCT00343915|9633602|FG000|NOT COMPLETED|Primary Study||4
8597936|NCT00343915|9633603|FG001|NOT COMPLETED|Primary Study||3
8597937|NCT00343915|9633602|FG000|STARTED|Month 30 Follow-up|Subjects, previously vaccinated, that returned for the Month 30 follow-up.|179
8597938|NCT00343915|9633603|FG001|STARTED|Month 30 Follow-up||88
8597939|NCT00343915|9633602|FG000|COMPLETED|Month 30 Follow-up||179
8597940|NCT00343915|9633603|FG001|COMPLETED|Month 30 Follow-up||88
8597941|NCT00343915|9633602|FG000|NOT COMPLETED|Month 30 Follow-up||0
8597942|NCT00343915|9633603|FG001|NOT COMPLETED|Month 30 Follow-up||0
8597943|NCT00343915|9633602|FG000|STARTED|Month 42 Follow-up|Subjects, previously vaccinated, that returned for the Month 42 follow-up.|174
8597944|NCT00343915|9633603|FG001|STARTED|Month 42 Follow-up||84
8597945|NCT00343915|9633602|FG000|COMPLETED|Month 42 Follow-up||174
8597946|NCT00343915|9633603|FG001|COMPLETED|Month 42 Follow-up||84
8597947|NCT00343915|9633602|FG000|NOT COMPLETED|Month 42 Follow-up||0
8597948|NCT00343915|9633603|FG001|NOT COMPLETED|Month 42 Follow-up||0
8597949|NCT00343915|9633602|FG000|STARTED|Month 54 Follow-up|Subjects, previously vaccinated, that returned for the Month 54 follow-up.|166
8597950|NCT00343915|9633603|FG001|STARTED|Month 54 Follow-up||79
8597951|NCT00343915|9633602|FG000|COMPLETED|Month 54 Follow-up||166
8597952|NCT00343915|9633603|FG001|COMPLETED|Month 54 Follow-up||79
8597953|NCT00343915|9633602|FG000|NOT COMPLETED|Month 54 Follow-up||0
8597954|NCT00343915|9633603|FG001|NOT COMPLETED|Month 54 Follow-up||0
8597955|NCT00343915|9633602|FG000|STARTED|Month 66 Follow-up|Subjects, previously vaccinated, that returned for the Month 66 follow-up.|158
8597956|NCT00343915|9633603|FG001|STARTED|Month 66 Follow-up||76
8597957|NCT00343915|9633602|FG000|COMPLETED|Month 66 Follow-up||158
8597958|NCT00343915|9633603|FG001|COMPLETED|Month 66 Follow-up||76
8597959|NCT00343915|9633602|FG000|NOT COMPLETED|Month 66 Follow-up||0
8597960|NCT00343915|9633603|FG001|NOT COMPLETED|Month 66 Follow-up||0
8597961|NCT00344032|9633614|FG000|STARTED|Overall Study||176
8597962|NCT00344032|9633615|FG001|STARTED|Overall Study||178
8597963|NCT00344032|9633614|FG000|COMPLETED|Overall Study||162
8597964|NCT00344032|9633615|FG001|COMPLETED|Overall Study||168
8597965|NCT00344032|9633614|FG000|NOT COMPLETED|Overall Study||14
8597966|NCT00344032|9633615|FG001|NOT COMPLETED|Overall Study||10
8597967|NCT00344175|9633623|FG000|STARTED|Overall Study||121
8597968|NCT00344175|9633624|FG001|STARTED|Overall Study||57
8597969|NCT00344175|9633623|FG000|COMPLETED|Overall Study||109
8597970|NCT00344175|9633624|FG001|COMPLETED|Overall Study||47
8597971|NCT00344175|9633623|FG000|NOT COMPLETED|Overall Study||12
8597972|NCT00344175|9633624|FG001|NOT COMPLETED|Overall Study||10
8597973|NCT00344305|9633632|FG000|STARTED|Overall Study||100
8597974|NCT00344305|9633633|FG001|STARTED|Overall Study||100
8597975|NCT00344305|9633632|FG000|COMPLETED|Overall Study||98
8597976|NCT00344305|9633633|FG001|COMPLETED|Overall Study||99
8597977|NCT00344305|9633632|FG000|NOT COMPLETED|Overall Study||2
8597978|NCT00344305|9633633|FG001|NOT COMPLETED|Overall Study||1
8597979|NCT00344318|9633644|FG000|STARTED|Overall Study||300
8597980|NCT00344318|9633645|FG001|STARTED|Overall Study||303
8597981|NCT00344318|9633646|FG002|STARTED|Overall Study||100
8597982|NCT00344318|9633647|FG003|STARTED|Overall Study||103
8597983|NCT00344318|9633644|FG000|COMPLETED|Overall Study||296
8597984|NCT00344318|9633645|FG001|COMPLETED|Overall Study||298
8597985|NCT00344318|9633646|FG002|COMPLETED|Overall Study||99
8597986|NCT00344318|9633647|FG003|COMPLETED|Overall Study||100
8597987|NCT00344318|9633644|FG000|NOT COMPLETED|Overall Study||4
8597988|NCT00344318|9633645|FG001|NOT COMPLETED|Overall Study||5
8597989|NCT00344318|9633646|FG002|NOT COMPLETED|Overall Study||1
8597990|NCT00344318|9633647|FG003|NOT COMPLETED|Overall Study||3
8597991|NCT00344370|9633661|FG000|STARTED|Overall Study||143
8597992|NCT00344370|9633662|FG001|STARTED|Overall Study||71
8597993|NCT00344370|9633661|FG000|COMPLETED|Overall Study||128
8597994|NCT00344370|9633662|FG001|COMPLETED|Overall Study||68
8597995|NCT00344370|9633661|FG000|NOT COMPLETED|Overall Study||15
8597996|NCT00344370|9633662|FG001|NOT COMPLETED|Overall Study||3
8628440|NCT00524030|9667868|FG001|COMPLETED|Overall Study||70
8628441|NCT00524030|9667867|FG000|NOT COMPLETED|Overall Study||17
8628442|NCT00524030|9667868|FG001|NOT COMPLETED|Overall Study||59
8628443|NCT00524043|9667878|FG000|STARTED|Overall Study|One patient was randomly assigned to treatment but did not receive placebo.|64
8628444|NCT00524043|9667879|FG001|STARTED|Overall Study||70
8628445|NCT00524043|9667880|FG002|STARTED|Overall Study||66
8628446|NCT00524043|9667878|FG000|COMPLETED|Overall Study||34
8628447|NCT00524043|9667879|FG001|COMPLETED|Overall Study||42
8628448|NCT00524043|9667880|FG002|COMPLETED|Overall Study||35
8628449|NCT00524043|9667878|FG000|NOT COMPLETED|Overall Study||30
8628450|NCT00524043|9667879|FG001|NOT COMPLETED|Overall Study||28
8628451|NCT00524043|9667880|FG002|NOT COMPLETED|Overall Study||31
8628452|NCT00524121|9667888|FG000|STARTED|Overall Study||22
8628453|NCT00524121|9667888|FG000|COMPLETED|Overall Study||3
8628454|NCT00524121|9667888|FG000|NOT COMPLETED|Overall Study||19
8628455|NCT00524173|9667905|FG000|STARTED|Overall Study||17
8628456|NCT00524173|9667906|FG001|STARTED|Overall Study||15
8628457|NCT00524173|9667905|FG000|COMPLETED|Overall Study||12
8628458|NCT00524173|9667906|FG001|COMPLETED|Overall Study||13
8628459|NCT00524173|9667905|FG000|NOT COMPLETED|Overall Study||5
8628460|NCT00524173|9667906|FG001|NOT COMPLETED|Overall Study||2
8628461|NCT00524225|9667912|FG000|STARTED|Overall Study||3
8628462|NCT00524225|9667912|FG000|COMPLETED|Overall Study||3
8628463|NCT00524225|9667912|FG000|NOT COMPLETED|Overall Study||0
8628464|NCT00524264|9667919|FG000|STARTED|Overall Study||164
8628465|NCT00524264|9667920|FG001|STARTED|Overall Study||84
8628466|NCT00524264|9667919|FG000|COMPLETED|Overall Study||144
8628467|NCT00524264|9667920|FG001|COMPLETED|Overall Study||57
8628468|NCT00524264|9667919|FG000|NOT COMPLETED|Overall Study||20
8628469|NCT00524264|9667920|FG001|NOT COMPLETED|Overall Study||27
8628470|NCT00524303|9667929|FG000|STARTED|Overall Study||33
8628471|NCT00524303|9667930|FG001|STARTED|Overall Study||34
8628472|NCT00524303|9667931|FG002|STARTED|Overall Study||33
8628473|NCT00524303|9667929|FG000|COMPLETED|Overall Study||21
8628474|NCT00524303|9667930|FG001|COMPLETED|Overall Study||24
8628475|NCT00524303|9667931|FG002|COMPLETED|Overall Study||15
8628476|NCT00524303|9667929|FG000|NOT COMPLETED|Overall Study||12
8628477|NCT00524303|9667930|FG001|NOT COMPLETED|Overall Study||10
8628478|NCT00524303|9667931|FG002|NOT COMPLETED|Overall Study||18
8628479|NCT00524316|9667942|FG000|STARTED|Overall Study||16
8628480|NCT00524316|9667942|FG000|COMPLETED|Overall Study||0
8628481|NCT00524316|9667942|FG000|NOT COMPLETED|Overall Study||16
8628482|NCT00524342|9667946|FG000|STARTED|Overall Study||7
8628483|NCT00524342|9667946|FG000|COMPLETED|Overall Study||7
8628484|NCT00524342|9667946|FG000|NOT COMPLETED|Overall Study||0
8628485|NCT00524368|9667952|FG000|STARTED|Overall Study||294
8628486|NCT00524368|9667953|FG001|STARTED|Overall Study||296
8628487|NCT00524368|9667952|FG000|COMPLETED|Overall Study||253
8628488|NCT00524368|9667953|FG001|COMPLETED|Overall Study||248
8628489|NCT00524368|9667952|FG000|NOT COMPLETED|Overall Study||41
8628490|NCT00524368|9667953|FG001|NOT COMPLETED|Overall Study||48
8597997|NCT00344448|9633670|FG000|STARTED|Screening|No randomization during the screening phase|6
8597998|NCT00344448|9633671|FG001|STARTED|Screening||4
8597999|NCT00344448|9633670|FG000|COMPLETED|Screening||6
8598000|NCT00344448|9633671|FG001|COMPLETED|Screening||3
8598001|NCT00344448|9633670|FG000|NOT COMPLETED|Screening||0
8598002|NCT00344448|9633671|FG001|NOT COMPLETED|Screening||1
8598003|NCT00344448|9633670|FG000|STARTED|Double Blind, Placebo Controlled||6
8598004|NCT00344448|9633671|FG001|STARTED|Double Blind, Placebo Controlled||3
8598005|NCT00344448|9633670|FG000|COMPLETED|Double Blind, Placebo Controlled||4
8598006|NCT00344448|9633671|FG001|COMPLETED|Double Blind, Placebo Controlled||3
8598007|NCT00344448|9633670|FG000|NOT COMPLETED|Double Blind, Placebo Controlled||2
8598008|NCT00344448|9633671|FG001|NOT COMPLETED|Double Blind, Placebo Controlled||0
8598009|NCT00344448|9633670|FG000|STARTED|Open Label||4
8598010|NCT00344448|9633671|FG001|STARTED|Open Label||3
8598011|NCT00344448|9633670|FG000|COMPLETED|Open Label||2
8598012|NCT00344448|9633671|FG001|COMPLETED|Open Label||2
8598013|NCT00344448|9633670|FG000|NOT COMPLETED|Open Label||2
8598014|NCT00344448|9633671|FG001|NOT COMPLETED|Open Label||1
8598015|NCT00344461|9633677|FG000|STARTED|Overall Study||54
8598016|NCT00344461|9633677|FG000|COMPLETED|Overall Study||33
8598017|NCT00344461|9633677|FG000|NOT COMPLETED|Overall Study||21
8598018|NCT00344500|9633684|FG000|STARTED|Overall Study||48
8598019|NCT00344500|9633685|FG001|STARTED|Overall Study||60
8598020|NCT00344500|9633686|FG002|STARTED|Overall Study||14
8598021|NCT00344500|9633684|FG000|COMPLETED|Overall Study||25
8598022|NCT00344500|9633685|FG001|COMPLETED|Overall Study||25
8598023|NCT00344500|9633686|FG002|COMPLETED|Overall Study||12
8598024|NCT00344500|9633684|FG000|NOT COMPLETED|Overall Study||23
8598025|NCT00344500|9633685|FG001|NOT COMPLETED|Overall Study||35
8598026|NCT00344500|9633686|FG002|NOT COMPLETED|Overall Study||2
8598027|NCT00344682|9633695|FG000|STARTED|Overall Study||16
8598028|NCT00344682|9633696|FG001|STARTED|Overall Study||15
8598029|NCT00344682|9633695|FG000|COMPLETED|Overall Study||12
8598030|NCT00344682|9633696|FG001|COMPLETED|Overall Study||14
8598031|NCT00344682|9633695|FG000|NOT COMPLETED|Overall Study||4
8598032|NCT00344682|9633696|FG001|NOT COMPLETED|Overall Study||1
8598033|NCT00344773|9633702|FG000|STARTED|Overall Study||46
8598034|NCT00344773|9633702|FG000|COMPLETED|Overall Study||25
8598035|NCT00344773|9633702|FG000|NOT COMPLETED|Overall Study||21
8598036|NCT00344968|9633709|FG000|STARTED|Overall Study||185
8598037|NCT00344968|9633710|FG001|STARTED|Overall Study||376
8598038|NCT00344968|9633711|FG002|STARTED|Overall Study||395
8598039|NCT00344968|9633709|FG000|COMPLETED|Overall Study||126
8598040|NCT00344968|9633710|FG001|COMPLETED|Overall Study||274
8598041|NCT00344968|9633711|FG002|COMPLETED|Overall Study||279
8598042|NCT00344968|9633709|FG000|NOT COMPLETED|Overall Study||59
8598043|NCT00344968|9633710|FG001|NOT COMPLETED|Overall Study||102
8598044|NCT00344968|9633711|FG002|NOT COMPLETED|Overall Study||116
8598045|NCT00345033|9633722|FG000|STARTED|Overall Study||20
8598046|NCT00345033|9633723|FG001|STARTED|Overall Study||18
8598047|NCT00345033|9633722|FG000|COMPLETED|Overall Study||16
8598048|NCT00345033|9633723|FG001|COMPLETED|Overall Study||14
8598049|NCT00345033|9633722|FG000|NOT COMPLETED|Overall Study||4
8598050|NCT00345033|9633723|FG001|NOT COMPLETED|Overall Study||4
8598051|NCT00345046|9633732|FG000|STARTED|Overall Study||18
8598052|NCT00345046|9633733|FG001|STARTED|Overall Study||22
8598053|NCT00345046|9633734|FG002|STARTED|Overall Study||16
8598054|NCT00345046|9633732|FG000|COMPLETED|Overall Study||17
8598055|NCT00345046|9633733|FG001|COMPLETED|Overall Study||21
8598056|NCT00345046|9633734|FG002|COMPLETED|Overall Study||14
8598057|NCT00345046|9633732|FG000|NOT COMPLETED|Overall Study||1
8598058|NCT00345046|9633733|FG001|NOT COMPLETED|Overall Study||1
8598059|NCT00345046|9633734|FG002|NOT COMPLETED|Overall Study||2
8598060|NCT00345176|9633746|FG000|STARTED|Overall Study||1012
8598061|NCT00345176|9633747|FG001|STARTED|Overall Study||1044
8598062|NCT00345176|9633748|FG002|STARTED|Overall Study||1068
8598063|NCT00345176|9633749|FG003|STARTED|Overall Study||1079
8598064|NCT00345176|9633746|FG000|COMPLETED|Overall Study||1007
8598065|NCT00345176|9633747|FG001|COMPLETED|Overall Study||1038
8598066|NCT00345176|9633748|FG002|COMPLETED|Overall Study||1062
8598067|NCT00345176|9633749|FG003|COMPLETED|Overall Study||1069
8598068|NCT00345176|9633746|FG000|NOT COMPLETED|Overall Study||5
8598069|NCT00345176|9633747|FG001|NOT COMPLETED|Overall Study||6
8598070|NCT00345176|9633748|FG002|NOT COMPLETED|Overall Study||6
8598071|NCT00345176|9633749|FG003|NOT COMPLETED|Overall Study||10
8598072|NCT00345254|9633763|FG000|STARTED|Overall Study||30
8598073|NCT00345254|9633764|FG001|STARTED|Overall Study||30
8598074|NCT00345254|9633763|FG000|COMPLETED|Overall Study||30
8598075|NCT00345254|9633764|FG001|COMPLETED|Overall Study||30
8598076|NCT00345254|9633763|FG000|NOT COMPLETED|Overall Study||0
8598077|NCT00345254|9633764|FG001|NOT COMPLETED|Overall Study||0
8598078|NCT00345293|9633770|FG000|STARTED|Overall Study||10
8598079|NCT00345293|9633771|FG001|STARTED|Overall Study||3
8598080|NCT00345293|9633770|FG000|COMPLETED|Overall Study||8
8598081|NCT00345293|9633771|FG001|COMPLETED|Overall Study||3
8598082|NCT00345293|9633770|FG000|NOT COMPLETED|Overall Study||2
8598083|NCT00345293|9633771|FG001|NOT COMPLETED|Overall Study||0
8598084|NCT00345332|9633779|FG000|STARTED|Overall Study||11
8598085|NCT00345332|9633780|FG001|STARTED|Overall Study||20
8598086|NCT00345332|9633779|FG000|COMPLETED|Overall Study||11
8598087|NCT00345332|9633780|FG001|COMPLETED|Overall Study||20
8598088|NCT00345332|9633779|FG000|NOT COMPLETED|Overall Study||0
8598089|NCT00345332|9633780|FG001|NOT COMPLETED|Overall Study||0
8598090|NCT00345371|9633788|FG000|STARTED|Overall Study||69
8598091|NCT00345371|9633789|FG001|STARTED|Overall Study||71
8598092|NCT00345371|9633788|FG000|COMPLETED|Overall Study||39
8598093|NCT00345371|9633789|FG001|COMPLETED|Overall Study||38
8598094|NCT00345371|9633788|FG000|NOT COMPLETED|Overall Study||30
8598095|NCT00345371|9633789|FG001|NOT COMPLETED|Overall Study||33
8598096|NCT00345384|9633797|FG000|STARTED|Overall Study||19
8598097|NCT00345384|9633798|FG001|STARTED|Overall Study||19
8598098|NCT00345384|9633797|FG000|COMPLETED|Overall Study||19
8598099|NCT00345384|9633798|FG001|COMPLETED|Overall Study||19
8598100|NCT00345384|9633797|FG000|NOT COMPLETED|Overall Study||0
8598101|NCT00345384|9633798|FG001|NOT COMPLETED|Overall Study||0
8598102|NCT00345397|9633806|FG000|STARTED|Overall Study||7
8598103|NCT00345397|9633806|FG000|COMPLETED|Overall Study||6
8598104|NCT00345397|9633806|FG000|NOT COMPLETED|Overall Study||1
8598105|NCT00345540|9633811|FG000|STARTED|Overall Study|1 subject enrolled but not treated (off-trial for patient discretion)|16
8598106|NCT00345540|9633811|FG000|COMPLETED|Overall Study||15
8598107|NCT00345540|9633811|FG000|NOT COMPLETED|Overall Study||1
8598108|NCT00345579|9633817|FG000|STARTED|Overall Study||3278
8598109|NCT00345579|9633818|FG001|STARTED|Overall Study||1113
8598110|NCT00345579|9633817|FG000|COMPLETED|Overall Study||3114
8598111|NCT00345579|9633818|FG001|COMPLETED|Overall Study||1048
8598112|NCT00345579|9633817|FG000|NOT COMPLETED|Overall Study||164
8598113|NCT00345579|9633818|FG001|NOT COMPLETED|Overall Study||65
8598114|NCT00345592|9633827|FG000|STARTED|Overall Study||199
8598115|NCT00345592|9633828|FG001|STARTED|Overall Study||197
8598116|NCT00345592|9633827|FG000|COMPLETED|Overall Study||174
8598117|NCT00345592|9633828|FG001|COMPLETED|Overall Study||173
8598118|NCT00345592|9633827|FG000|NOT COMPLETED|Overall Study||25
8598119|NCT00345592|9633828|FG001|NOT COMPLETED|Overall Study||24
8598120|NCT00345605|9633834|FG000|STARTED|Initial Washout||6
8598121|NCT00345605|9633835|FG001|STARTED|Initial Washout||6
8598122|NCT00345605|9633834|FG000|COMPLETED|Initial Washout||6
8598123|NCT00345605|9633835|FG001|COMPLETED|Initial Washout||6
8598124|NCT00345605|9633834|FG000|NOT COMPLETED|Initial Washout||0
8598125|NCT00345605|9633835|FG001|NOT COMPLETED|Initial Washout||0
8598126|NCT00345605|9633834|FG000|STARTED|Arm 1||6
8598127|NCT00345605|9633835|FG001|STARTED|Arm 1||6
8598128|NCT00345605|9633834|FG000|COMPLETED|Arm 1||6
8598129|NCT00345605|9633835|FG001|COMPLETED|Arm 1||5
8598130|NCT00345605|9633834|FG000|NOT COMPLETED|Arm 1||0
8598131|NCT00345605|9633835|FG001|NOT COMPLETED|Arm 1||1
8598132|NCT00345605|9633834|FG000|STARTED|Interval||6
8598133|NCT00345605|9633835|FG001|STARTED|Interval||6
8598134|NCT00345605|9633834|FG000|COMPLETED|Interval||6
8598135|NCT00345605|9633835|FG001|COMPLETED|Interval||6
8598136|NCT00345605|9633834|FG000|NOT COMPLETED|Interval||0
8598137|NCT00345605|9633835|FG001|NOT COMPLETED|Interval||0
8598138|NCT00345605|9633834|FG000|STARTED|Crossover Wash-out||6
8598139|NCT00345605|9633835|FG001|STARTED|Crossover Wash-out||6
8598140|NCT00345605|9633834|FG000|COMPLETED|Crossover Wash-out||6
8598141|NCT00345605|9633835|FG001|COMPLETED|Crossover Wash-out||6
8598142|NCT00345605|9633834|FG000|NOT COMPLETED|Crossover Wash-out||0
8598143|NCT00345605|9633835|FG001|NOT COMPLETED|Crossover Wash-out||0
8598144|NCT00345605|9633834|FG000|STARTED|Arm 2, Opposite Treatment||6
8598145|NCT00345605|9633835|FG001|STARTED|Arm 2, Opposite Treatment||6
8598146|NCT00345605|9633834|FG000|COMPLETED|Arm 2, Opposite Treatment||5
8598147|NCT00345605|9633835|FG001|COMPLETED|Arm 2, Opposite Treatment||6
8598148|NCT00345605|9633834|FG000|NOT COMPLETED|Arm 2, Opposite Treatment||1
8598149|NCT00345605|9633835|FG001|NOT COMPLETED|Arm 2, Opposite Treatment||0
8598150|NCT00345631|9633846|FG000|STARTED|Overall Study||87
8598151|NCT00345631|9633847|FG001|STARTED|Overall Study||267
8598152|NCT00345631|9633848|FG002|STARTED|Overall Study||134
8598153|NCT00345631|9633846|FG000|COMPLETED|Overall Study||83
8598154|NCT00345631|9633847|FG001|COMPLETED|Overall Study||259
8598155|NCT00345631|9633848|FG002|COMPLETED|Overall Study||128
8598156|NCT00345631|9633846|FG000|NOT COMPLETED|Overall Study||4
8598157|NCT00345631|9633847|FG001|NOT COMPLETED|Overall Study||8
8598158|NCT00345631|9633848|FG002|NOT COMPLETED|Overall Study||6
8598159|NCT00345683|9633860|FG000|STARTED|Overall Study||3010
8598160|NCT00345683|9633861|FG001|STARTED|Overall Study||1010
8598161|NCT00345683|9633860|FG000|COMPLETED|Overall Study||2985
8598162|NCT00345683|9633861|FG001|COMPLETED|Overall Study||1001
8598163|NCT00345683|9633860|FG000|NOT COMPLETED|Overall Study||25
8598164|NCT00345683|9633861|FG001|NOT COMPLETED|Overall Study||9
8598165|NCT00345839|9633869|FG000|STARTED|Overall Study|Randomized to cinacalcet|1948
8598166|NCT00345839|9633870|FG001|STARTED|Overall Study|Randomized to placebo|1935
8598167|NCT00345839|9633869|FG000|COMPLETED|Overall Study|Participants who completed study includes those with ended study due to death.|1799
8598168|NCT00345839|9633870|FG001|COMPLETED|Overall Study|Participants who completed study includes those with ended study due to death.|1776
8598169|NCT00345839|9633869|FG000|NOT COMPLETED|Overall Study||149
8598170|NCT00345839|9633870|FG001|NOT COMPLETED|Overall Study||159
8598171|NCT00345865|9633881|FG000|STARTED|Overall Study||171
8598172|NCT00345865|9633882|FG001|STARTED|Overall Study||149
8598173|NCT00345865|9633883|FG002|STARTED|Overall Study||2
8598174|NCT00345865|9633884|FG003|STARTED|Overall Study||5
8598175|NCT00345865|9633885|FG004|STARTED|Overall Study||146
8598176|NCT00345865|9633881|FG000|COMPLETED|Overall Study||171
8713216|NCT00974090|9760035|FG000|NOT COMPLETED|Period 2: Open-label Period||8
8713217|NCT00974090|9760036|FG001|NOT COMPLETED|Period 2: Open-label Period||10
8713218|NCT00974142|9760046|FG000|STARTED|Overall Study||8
8598177|NCT00345865|9633882|FG001|COMPLETED|Overall Study||149
8598178|NCT00345865|9633883|FG002|COMPLETED|Overall Study||2
8598179|NCT00345865|9633884|FG003|COMPLETED|Overall Study||5
8598180|NCT00345865|9633885|FG004|COMPLETED|Overall Study||146
8598181|NCT00345865|9633881|FG000|NOT COMPLETED|Overall Study||0
8598182|NCT00345865|9633882|FG001|NOT COMPLETED|Overall Study||0
8598183|NCT00345865|9633883|FG002|NOT COMPLETED|Overall Study||0
8598184|NCT00345865|9633884|FG003|NOT COMPLETED|Overall Study||0
8598185|NCT00345865|9633885|FG004|NOT COMPLETED|Overall Study||0
8598186|NCT00345878|9633899|FG000|STARTED|Overall Study||135
8598187|NCT00345878|9633900|FG001|STARTED|Overall Study||136
8598188|NCT00345878|9633899|FG000|COMPLETED|Overall Study||131
8598189|NCT00345878|9633900|FG001|COMPLETED|Overall Study||135
8598190|NCT00345878|9633899|FG000|NOT COMPLETED|Overall Study||4
8598191|NCT00345878|9633900|FG001|NOT COMPLETED|Overall Study||1
8598192|NCT00345969|9633908|FG000|STARTED|Overall Study||12
8598193|NCT00345969|9633909|FG001|STARTED|Overall Study||13
8598194|NCT00345969|9633908|FG000|COMPLETED|Overall Study||11
8598195|NCT00345969|9633909|FG001|COMPLETED|Overall Study||11
8598196|NCT00345969|9633908|FG000|NOT COMPLETED|Overall Study||1
8598197|NCT00345969|9633909|FG001|NOT COMPLETED|Overall Study||2
8598198|NCT00346034|9633915|FG000|STARTED|Overall Study||357
8598199|NCT00346034|9633915|FG000|COMPLETED|Overall Study||300
8598200|NCT00346034|9633915|FG000|NOT COMPLETED|Overall Study||57
8598201|NCT00346073|9633921|FG000|STARTED|Overall Study||1522
8598202|NCT00346073|9633922|FG001|STARTED|Overall Study||762
8598203|NCT00346073|9633921|FG000|COMPLETED|Overall Study||1481
8598204|NCT00346073|9633922|FG001|COMPLETED|Overall Study||738
8598205|NCT00346073|9633921|FG000|NOT COMPLETED|Overall Study||41
8598206|NCT00346073|9633922|FG001|NOT COMPLETED|Overall Study||24
8598207|NCT00346151|9633928|FG000|STARTED|Overall Study||5
8598208|NCT00346151|9633928|FG000|COMPLETED|Overall Study||2
8598209|NCT00346151|9633928|FG000|NOT COMPLETED|Overall Study||3
8598210|NCT00346216|9633935|FG000|STARTED|Overall Study||8072
8598211|NCT00346216|9633936|FG001|STARTED|Overall Study||8040
8598212|NCT00346216|9633937|FG002|STARTED|Overall Study||7969
8598213|NCT00346216|9633935|FG000|COMPLETED|Overall Study||5664
8598214|NCT00346216|9633936|FG001|COMPLETED|Overall Study||5580
8598215|NCT00346216|9633937|FG002|COMPLETED|Overall Study||5621
8598216|NCT00346216|9633935|FG000|NOT COMPLETED|Overall Study||2408
8598217|NCT00346216|9633936|FG001|NOT COMPLETED|Overall Study||2460
8598218|NCT00346216|9633937|FG002|NOT COMPLETED|Overall Study||2348
8598219|NCT00346268|9633947|FG000|STARTED|Overall Study||52
8598220|NCT00346268|9633948|FG001|STARTED|Overall Study||53
8598221|NCT00346268|9633947|FG000|COMPLETED|Overall Study||50
8598222|NCT00346268|9633948|FG001|COMPLETED|Overall Study||50
8598223|NCT00346268|9633947|FG000|NOT COMPLETED|Overall Study||2
8598224|NCT00346268|9633948|FG001|NOT COMPLETED|Overall Study||3
8598225|NCT00346333|9633956|FG000|STARTED|Overall Study||121
8598226|NCT00346333|9633957|FG001|STARTED|Overall Study||119
8598227|NCT00346333|9633956|FG000|COMPLETED|Overall Study||116
8598228|NCT00346333|9633957|FG001|COMPLETED|Overall Study||111
8598229|NCT00346333|9633956|FG000|NOT COMPLETED|Overall Study||5
8598230|NCT00346333|9633957|FG001|NOT COMPLETED|Overall Study||8
8713219|NCT00974142|9760047|FG001|STARTED|Overall Study||9
8713220|NCT00974142|9760046|FG000|COMPLETED|Overall Study||8
8713221|NCT00974142|9760047|FG001|COMPLETED|Overall Study||9
8713222|NCT00974142|9760046|FG000|NOT COMPLETED|Overall Study||0
8713223|NCT00974142|9760047|FG001|NOT COMPLETED|Overall Study||0
8713224|NCT00974220|9760055|FG000|STARTED|Treatment Period 1||9
8713225|NCT00974220|9760056|FG001|STARTED|Treatment Period 1||7
8713226|NCT00974220|9760055|FG000|COMPLETED|Treatment Period 1||7
8713227|NCT00974220|9760056|FG001|COMPLETED|Treatment Period 1||5
8713228|NCT00974220|9760055|FG000|NOT COMPLETED|Treatment Period 1||2
8713229|NCT00974220|9760056|FG001|NOT COMPLETED|Treatment Period 1||2
8713230|NCT00974220|9760055|FG000|STARTED|Treatment Period 2||7
8713231|NCT00974220|9760056|FG001|STARTED|Treatment Period 2||5
8713232|NCT00974220|9760055|FG000|COMPLETED|Treatment Period 2||7
8713233|NCT00974220|9760056|FG001|COMPLETED|Treatment Period 2||5
8713234|NCT00974220|9760055|FG000|NOT COMPLETED|Treatment Period 2||0
8713235|NCT00974220|9760056|FG001|NOT COMPLETED|Treatment Period 2||0
8724869|NCT01028378|9772165|FG000|STARTED|Overall Study|212 participants (249 eyes) with myopia|212
8724870|NCT01028378|9772165|FG000|COMPLETED|Overall Study|195 participants (230 eyes) with myopia|195
8598231|NCT00346398|9633967|FG000|STARTED|Overall Study||25
8598232|NCT00346398|9633968|FG001|STARTED|Overall Study||26
8724871|NCT01028378|9772165|FG000|NOT COMPLETED|Overall Study||17
8724872|NCT01028391|9772171|FG000|STARTED|Overall Study||164
8724873|NCT01028391|9772172|FG001|STARTED|Overall Study||153
8724874|NCT01028391|9772171|FG000|COMPLETED|Overall Study||150
8724875|NCT01028391|9772172|FG001|COMPLETED|Overall Study||142
8724876|NCT01028391|9772171|FG000|NOT COMPLETED|Overall Study||14
8724877|NCT01028391|9772172|FG001|NOT COMPLETED|Overall Study||11
8598233|NCT00346398|9633967|FG000|COMPLETED|Overall Study||22
8598234|NCT00346398|9633968|FG001|COMPLETED|Overall Study||24
8598235|NCT00346398|9633967|FG000|NOT COMPLETED|Overall Study||3
8598236|NCT00346398|9633968|FG001|NOT COMPLETED|Overall Study||2
8598237|NCT00346476|9633974|FG000|STARTED|Overall Study||1250
8598238|NCT00346476|9633974|FG000|COMPLETED|Overall Study||1250
8598239|NCT00346476|9633974|FG000|NOT COMPLETED|Overall Study||0
8598240|NCT00346632|9633980|FG000|STARTED|Overall Study||3
8598241|NCT00346632|9633981|FG001|STARTED|Overall Study||3
8598242|NCT00346632|9633982|FG002|STARTED|Overall Study||6
8598243|NCT00346632|9633983|FG003|STARTED|Overall Study||3
8598244|NCT00346632|9633984|FG004|STARTED|Overall Study||4
8598245|NCT00346632|9633985|FG005|STARTED|Overall Study||2
8598246|NCT00346632|9633986|FG006|STARTED|Overall Study||5
8598247|NCT00346632|9633987|FG007|STARTED|Overall Study||4
8598248|NCT00346632|9633988|FG008|STARTED|Overall Study||4
8598249|NCT00346632|9633989|FG009|STARTED|Overall Study||3
8598250|NCT00346632|9633980|FG000|COMPLETED|Overall Study||0
8598251|NCT00346632|9633981|FG001|COMPLETED|Overall Study||0
8598252|NCT00346632|9633982|FG002|COMPLETED|Overall Study||0
8598253|NCT00346632|9633983|FG003|COMPLETED|Overall Study||0
8598254|NCT00346632|9633984|FG004|COMPLETED|Overall Study||0
8598255|NCT00346632|9633985|FG005|COMPLETED|Overall Study||0
8598256|NCT00346632|9633986|FG006|COMPLETED|Overall Study||0
8598257|NCT00346632|9633987|FG007|COMPLETED|Overall Study||0
8598258|NCT00346632|9633988|FG008|COMPLETED|Overall Study||0
8598259|NCT00346632|9633989|FG009|COMPLETED|Overall Study||0
8598260|NCT00346632|9633980|FG000|NOT COMPLETED|Overall Study||3
8598261|NCT00346632|9633981|FG001|NOT COMPLETED|Overall Study||3
8598262|NCT00346632|9633982|FG002|NOT COMPLETED|Overall Study||6
8598263|NCT00346632|9633983|FG003|NOT COMPLETED|Overall Study||3
8598264|NCT00346632|9633984|FG004|NOT COMPLETED|Overall Study||4
8598265|NCT00346632|9633985|FG005|NOT COMPLETED|Overall Study||2
8598266|NCT00346632|9633986|FG006|NOT COMPLETED|Overall Study||5
8598267|NCT00346632|9633987|FG007|NOT COMPLETED|Overall Study||4
8598268|NCT00346632|9633988|FG008|NOT COMPLETED|Overall Study||4
8598269|NCT00346632|9633989|FG009|NOT COMPLETED|Overall Study||3
8598270|NCT00346697|9634053|FG000|STARTED|Overall Study||24
8598271|NCT00346697|9634054|FG001|STARTED|Overall Study||24
8598272|NCT00346697|9634053|FG000|COMPLETED|Overall Study||24
8598273|NCT00346697|9634054|FG001|COMPLETED|Overall Study||23
8598274|NCT00346697|9634053|FG000|NOT COMPLETED|Overall Study||0
8598275|NCT00346697|9634054|FG001|NOT COMPLETED|Overall Study||1
8598276|NCT00346775|9634062|FG000|STARTED|Period 1: Intervention Period 1||49
8598277|NCT00346775|9634063|FG001|STARTED|Period 1: Intervention Period 1||48
8598278|NCT00346775|9634062|FG000|COMPLETED|Period 1: Intervention Period 1||44
8598279|NCT00346775|9634063|FG001|COMPLETED|Period 1: Intervention Period 1||45
8598280|NCT00346775|9634062|FG000|NOT COMPLETED|Period 1: Intervention Period 1||5
8598281|NCT00346775|9634063|FG001|NOT COMPLETED|Period 1: Intervention Period 1||3
8598282|NCT00346775|9634062|FG000|STARTED|Period 2: Washout Period (7 Days)||44
8598283|NCT00346775|9634063|FG001|STARTED|Period 2: Washout Period (7 Days)||45
8598284|NCT00346775|9634062|FG000|COMPLETED|Period 2: Washout Period (7 Days)||44
8598285|NCT00346775|9634063|FG001|COMPLETED|Period 2: Washout Period (7 Days)||45
8598286|NCT00346775|9634062|FG000|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
8598287|NCT00346775|9634063|FG001|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
8598288|NCT00346775|9634062|FG000|STARTED|Period 3: Intervention Period 2||44
8598289|NCT00346775|9634063|FG001|STARTED|Period 3: Intervention Period 2||45
8598290|NCT00346775|9634062|FG000|COMPLETED|Period 3: Intervention Period 2||44
8598291|NCT00346775|9634063|FG001|COMPLETED|Period 3: Intervention Period 2||45
8598292|NCT00346775|9634062|FG000|NOT COMPLETED|Period 3: Intervention Period 2||0
8598293|NCT00346775|9634063|FG001|NOT COMPLETED|Period 3: Intervention Period 2||0
8598294|NCT00346905|9634073|FG000|STARTED|Overall Study||16
8598295|NCT00346905|9634073|FG000|COMPLETED|Overall Study||12
8598296|NCT00346905|9634073|FG000|NOT COMPLETED|Overall Study||4
8598297|NCT00347009|9634077|FG000|STARTED|Overall Study||155
8598298|NCT00347009|9634077|FG000|COMPLETED|Overall Study||128
8598299|NCT00347009|9634077|FG000|NOT COMPLETED|Overall Study||27
8598300|NCT00347022|9634083|FG000|STARTED|Overall Study||74
8598301|NCT00347022|9634084|FG001|STARTED|Overall Study||71
8598302|NCT00347022|9634083|FG000|COMPLETED|Overall Study||62
8598303|NCT00347022|9634084|FG001|COMPLETED|Overall Study||66
8598304|NCT00347022|9634083|FG000|NOT COMPLETED|Overall Study||12
8598305|NCT00347022|9634084|FG001|NOT COMPLETED|Overall Study||5
8598306|NCT00347269|9634092|FG000|STARTED|Overall Study||503
8598307|NCT00347269|9634093|FG001|STARTED|Overall Study||501
8598308|NCT00347269|9634092|FG000|COMPLETED|Overall Study||409
8598309|NCT00347269|9634093|FG001|COMPLETED|Overall Study||395
8598310|NCT00347269|9634092|FG000|NOT COMPLETED|Overall Study||94
8598311|NCT00347269|9634093|FG001|NOT COMPLETED|Overall Study||106
8598312|NCT00347308|9634099|FG000|STARTED|Overall Study||40
8598313|NCT00347308|9634099|FG000|COMPLETED|Overall Study||40
8598314|NCT00347308|9634099|FG000|NOT COMPLETED|Overall Study||0
8598315|NCT00347360|9634118|FG000|STARTED|Overall Study||44
8598316|NCT00347360|9634119|FG001|STARTED|Overall Study||43
8598317|NCT00347360|9634120|FG002|STARTED|Overall Study||43
8598318|NCT00347360|9634121|FG003|STARTED|Overall Study||43
8598319|NCT00347360|9634122|FG004|STARTED|Overall Study||44
8598320|NCT00347360|9634123|FG005|STARTED|Overall Study||44
8598321|NCT00347360|9634124|FG006|STARTED|Overall Study||44
8598322|NCT00347360|9634125|FG007|STARTED|Overall Study||43
8598323|NCT00347360|9634126|FG008|STARTED|Overall Study||44
8598324|NCT00347360|9634127|FG009|STARTED|Overall Study||44
8598325|NCT00347360|9634128|FG010|STARTED|Overall Study||44
8598326|NCT00347360|9634129|FG011|STARTED|Overall Study||43
8598327|NCT00347360|9634130|FG012|STARTED|Overall Study||44
8598328|NCT00347360|9634131|FG013|STARTED|Overall Study||44
8598329|NCT00347360|9634132|FG014|STARTED|Overall Study||43
8598330|NCT00347360|9634118|FG000|COMPLETED|Overall Study||39
8598331|NCT00347360|9634119|FG001|COMPLETED|Overall Study||35
8598332|NCT00347360|9634120|FG002|COMPLETED|Overall Study||37
8598333|NCT00347360|9634121|FG003|COMPLETED|Overall Study||30
8598334|NCT00347360|9634122|FG004|COMPLETED|Overall Study||39
8598335|NCT00347360|9634123|FG005|COMPLETED|Overall Study||36
8598336|NCT00347360|9634124|FG006|COMPLETED|Overall Study||37
8598337|NCT00347360|9634125|FG007|COMPLETED|Overall Study||40
8598338|NCT00347360|9634126|FG008|COMPLETED|Overall Study||38
8598339|NCT00347360|9634127|FG009|COMPLETED|Overall Study||35
8598340|NCT00347360|9634128|FG010|COMPLETED|Overall Study||39
8598341|NCT00347360|9634129|FG011|COMPLETED|Overall Study||37
8598342|NCT00347360|9634130|FG012|COMPLETED|Overall Study||34
8598343|NCT00347360|9634131|FG013|COMPLETED|Overall Study||36
8598344|NCT00347360|9634132|FG014|COMPLETED|Overall Study||39
8598345|NCT00347360|9634118|FG000|NOT COMPLETED|Overall Study||5
8598346|NCT00347360|9634119|FG001|NOT COMPLETED|Overall Study||8
8598347|NCT00347360|9634120|FG002|NOT COMPLETED|Overall Study||6
8598348|NCT00347360|9634121|FG003|NOT COMPLETED|Overall Study||13
8598349|NCT00347360|9634122|FG004|NOT COMPLETED|Overall Study||5
8598350|NCT00347360|9634123|FG005|NOT COMPLETED|Overall Study||8
8598351|NCT00347360|9634124|FG006|NOT COMPLETED|Overall Study||7
8598352|NCT00347360|9634125|FG007|NOT COMPLETED|Overall Study||3
8598353|NCT00347360|9634126|FG008|NOT COMPLETED|Overall Study||6
8598354|NCT00347360|9634127|FG009|NOT COMPLETED|Overall Study||9
8598355|NCT00347360|9634128|FG010|NOT COMPLETED|Overall Study||5
8598356|NCT00347360|9634129|FG011|NOT COMPLETED|Overall Study||6
8598357|NCT00347360|9634130|FG012|NOT COMPLETED|Overall Study||10
8598358|NCT00347360|9634131|FG013|NOT COMPLETED|Overall Study||8
8598359|NCT00347360|9634132|FG014|NOT COMPLETED|Overall Study||4
8598360|NCT00347438|9634164|FG000|STARTED|Overall Study||18
8598361|NCT00347438|9634164|FG000|COMPLETED|Overall Study||16
8598362|NCT00347438|9634164|FG000|NOT COMPLETED|Overall Study||2
8598363|NCT00347776|9634171|FG000|STARTED|1.5 Month Follow-up||484
8598364|NCT00347776|9634172|FG001|STARTED|1.5 Month Follow-up||483
8598365|NCT00347776|9634173|FG002|STARTED|1.5 Month Follow-up||485
8598366|NCT00347776|9634171|FG000|COMPLETED|1.5 Month Follow-up||470
8598367|NCT00347776|9634172|FG001|COMPLETED|1.5 Month Follow-up|473 had no recurrence.2 were lost to follow-up but were still eligible for follow-up at next visits|475
8598368|NCT00347776|9634173|FG002|COMPLETED|1.5 Month Follow-up|472 had no recurrence.1 was lost to follow-up but was still eligible for follow-up at next visits|473
8598369|NCT00347776|9634171|FG000|NOT COMPLETED|1.5 Month Follow-up||14
8598370|NCT00347776|9634172|FG001|NOT COMPLETED|1.5 Month Follow-up||8
8598371|NCT00347776|9634173|FG002|NOT COMPLETED|1.5 Month Follow-up||12
8598372|NCT00347776|9634171|FG000|STARTED|6 Month Follow-up||470
8598373|NCT00347776|9634172|FG001|STARTED|6 Month Follow-up||475
8598374|NCT00347776|9634173|FG002|STARTED|6 Month Follow-up||473
8598375|NCT00347776|9634171|FG000|COMPLETED|6 Month Follow-up|440 had no recurrence.8 were lost to follow-up but were still eligible for follow-up at next visits|448
8598376|NCT00347776|9634172|FG001|COMPLETED|6 Month Follow-up|459 had no recurrence.3 were lost to follow-up but were still eligible for follow-up at next visits|462
8598377|NCT00347776|9634173|FG002|COMPLETED|6 Month Follow-up|452 had no recurrence.3 were lost to follow-up but were still eligible for follow-up at next visits|455
8598378|NCT00347776|9634171|FG000|NOT COMPLETED|6 Month Follow-up||22
8598379|NCT00347776|9634172|FG001|NOT COMPLETED|6 Month Follow-up||13
8598380|NCT00347776|9634173|FG002|NOT COMPLETED|6 Month Follow-up||18
8598381|NCT00347776|9634171|FG000|STARTED|12 Month Follow-up||448
8598382|NCT00347776|9634172|FG001|STARTED|12 Month Follow-up||462
8598383|NCT00347776|9634173|FG002|STARTED|12 Month Follow-up||455
8598384|NCT00347776|9634171|FG000|COMPLETED|12 Month Follow-up||425
8598385|NCT00347776|9634172|FG001|COMPLETED|12 Month Follow-up||446
8598386|NCT00347776|9634173|FG002|COMPLETED|12 Month Follow-up||436
8598387|NCT00347776|9634171|FG000|NOT COMPLETED|12 Month Follow-up||23
8598388|NCT00347776|9634172|FG001|NOT COMPLETED|12 Month Follow-up||16
8598389|NCT00347776|9634173|FG002|NOT COMPLETED|12 Month Follow-up||19
8598390|NCT00347919|9634184|FG000|STARTED|Overall Study|Safety Population|73
8598391|NCT00347919|9634185|FG001|STARTED|Overall Study|Safety Population|76
8598392|NCT00347919|9634186|FG002|STARTED|Overall Study|Safety Population|40
8598393|NCT00347919|9634184|FG000|COMPLETED|Overall Study||2
8598394|NCT00347919|9634185|FG001|COMPLETED|Overall Study||0
8598395|NCT00347919|9634186|FG002|COMPLETED|Overall Study||2
8598396|NCT00347919|9634184|FG000|NOT COMPLETED|Overall Study||71
8598397|NCT00347919|9634185|FG001|NOT COMPLETED|Overall Study||76
8598398|NCT00347919|9634186|FG002|NOT COMPLETED|Overall Study||38
8598399|NCT00347932|9634198|FG000|STARTED|Overall Study|As Randomized population - received at least one dose of study medication|475
8598400|NCT00347932|9634199|FG001|STARTED|Overall Study|As Randomized Population - received at least one dose of study medication|482
8598401|NCT00347932|9634198|FG000|COMPLETED|Overall Study||444
8598402|NCT00347932|9634199|FG001|COMPLETED|Overall Study||430
8598403|NCT00347932|9634198|FG000|NOT COMPLETED|Overall Study||31
8598404|NCT00347932|9634199|FG001|NOT COMPLETED|Overall Study||52
8598405|NCT00347958|9634205|FG000|STARTED|Overall Study||544
8598406|NCT00347958|9634205|FG000|COMPLETED|Overall Study||540
8598407|NCT00347958|9634205|FG000|NOT COMPLETED|Overall Study||4
8598408|NCT00348140|9634212|FG000|STARTED|Overall Study||487
8598409|NCT00348140|9634213|FG001|STARTED|Overall Study||490
8598410|NCT00348140|9634214|FG002|STARTED|Overall Study||491
8598411|NCT00348140|9634212|FG000|COMPLETED|Overall Study||361
8598412|NCT00348140|9634213|FG001|COMPLETED|Overall Study||351
8598413|NCT00348140|9634214|FG002|COMPLETED|Overall Study||328
8598414|NCT00348140|9634212|FG000|NOT COMPLETED|Overall Study||126
8598415|NCT00348140|9634213|FG001|NOT COMPLETED|Overall Study||139
8598416|NCT00348140|9634214|FG002|NOT COMPLETED|Overall Study||163
8598417|NCT00348205|9634223|FG000|STARTED|Overall Study||80
8598418|NCT00348205|9634223|FG000|COMPLETED|Overall Study||78
8598419|NCT00348205|9634223|FG000|NOT COMPLETED|Overall Study||2
8598420|NCT00348283|9634229|FG000|STARTED|Induction||0
8598421|NCT00348283|9634230|FG001|STARTED|Induction|Subjects received an open- label dose of 80 mg adalimumab at Week 2 (induction dose).|135
8598422|NCT00348283|9634229|FG000|COMPLETED|Induction||0
8598423|NCT00348283|9634230|FG001|COMPLETED|Induction|Subjects provided more than one reason for discontinuing during induction.|129
8598424|NCT00348283|9634229|FG000|NOT COMPLETED|Induction||0
8598425|NCT00348283|9634230|FG001|NOT COMPLETED|Induction||6
8598426|NCT00348283|9634229|FG000|STARTED|Double Blind|At Week 4, subjects were randomized to either adalimumab 40 mg eow or placebo eow.|65
8598427|NCT00348283|9634230|FG001|STARTED|Double Blind|At Week 4, subjects were randomized to either adalimumab 40 mg eow or placebo eow.|64
8598428|NCT00348283|9634229|FG000|COMPLETED|Double Blind||60
8598429|NCT00348283|9634230|FG001|COMPLETED|Double Blind||54
8598430|NCT00348283|9634229|FG000|NOT COMPLETED|Double Blind||5
8598431|NCT00348283|9634230|FG001|NOT COMPLETED|Double Blind||10
8598432|NCT00348283|9634229|FG000|STARTED|Open Label|No comparator was used in the Open Label portion of the study.|0
8598433|NCT00348283|9634230|FG001|STARTED|Open Label|14 subjects completed the Double Blind portion of the study but did not enter the Open Label period.|100
8598434|NCT00348283|9634229|FG000|COMPLETED|Open Label||0
8598435|NCT00348283|9634230|FG001|COMPLETED|Open Label||66
8598436|NCT00348283|9634229|FG000|NOT COMPLETED|Open Label||0
8598437|NCT00348283|9634230|FG001|NOT COMPLETED|Open Label||34
8598438|NCT00348309|9634239|FG000|STARTED|Overall Study||496
8598439|NCT00348309|9634240|FG001|STARTED|Overall Study||494
8598440|NCT00348309|9634241|FG002|STARTED|Overall Study||489
8598441|NCT00348309|9634239|FG000|COMPLETED|Overall Study||362
8598442|NCT00348309|9634240|FG001|COMPLETED|Overall Study||396
8598443|NCT00348309|9634241|FG002|COMPLETED|Overall Study||346
8598444|NCT00348309|9634239|FG000|NOT COMPLETED|Overall Study||134
8598445|NCT00348309|9634240|FG001|NOT COMPLETED|Overall Study||98
8713236|NCT00974233|9760062|FG000|STARTED|Induction Chemoimmunotherapy||34
8713237|NCT00974233|9760062|FG000|COMPLETED|Induction Chemoimmunotherapy||19
8713238|NCT00974233|9760062|FG000|NOT COMPLETED|Induction Chemoimmunotherapy||15
8713239|NCT00974233|9760062|FG000|STARTED|Maintenance Lenalidomide||19
8713240|NCT00974233|9760062|FG000|COMPLETED|Maintenance Lenalidomide||6
8713241|NCT00974233|9760062|FG000|NOT COMPLETED|Maintenance Lenalidomide||13
8713242|NCT00974246|9760074|FG000|STARTED|Overall Study||27
8713243|NCT00974246|9760074|FG000|COMPLETED|Overall Study||27
8598446|NCT00348309|9634241|FG002|NOT COMPLETED|Overall Study||143
8598447|NCT00348348|9634252|FG000|STARTED|Overall Study|Received at least one drop of study medication (Safety Population)|579
8598448|NCT00348348|9634253|FG001|STARTED|Overall Study|Received at least one drop of study medication(Safety Population)|582
8598449|NCT00348348|9634252|FG000|COMPLETED|Overall Study||554
8598450|NCT00348348|9634253|FG001|COMPLETED|Overall Study||555
8598451|NCT00348348|9634252|FG000|NOT COMPLETED|Overall Study||25
8598452|NCT00348348|9634253|FG001|NOT COMPLETED|Overall Study||27
8598453|NCT00348374|9634261|FG000|STARTED|Overall Study||88
8598454|NCT00348374|9634262|FG001|STARTED|Overall Study||103
8598455|NCT00348374|9634261|FG000|Received Study Treatment|Overall Study||88
8598456|NCT00348374|9634262|FG001|Received Study Treatment|Overall Study||96
8598457|NCT00348374|9634261|FG000|COMPLETED|Overall Study||69
8598458|NCT00348374|9634262|FG001|COMPLETED|Overall Study||71
8598459|NCT00348374|9634261|FG000|NOT COMPLETED|Overall Study||19
8598460|NCT00348374|9634262|FG001|NOT COMPLETED|Overall Study||32
8598461|NCT00348595|9634271|FG000|STARTED|Overall Study||26
8598462|NCT00348595|9634272|FG001|STARTED|Overall Study||34
8598463|NCT00348595|9634271|FG000|COMPLETED|Overall Study||21
8598464|NCT00348595|9634272|FG001|COMPLETED|Overall Study||26
8598465|NCT00348595|9634271|FG000|NOT COMPLETED|Overall Study||5
8598466|NCT00348595|9634272|FG001|NOT COMPLETED|Overall Study||8
8598467|NCT00348673|9634286|FG000|STARTED|Stage 1||6
8598468|NCT00348673|9634287|FG001|STARTED|Stage 1||6
8598469|NCT00348673|9634288|FG002|STARTED|Stage 1||7
8598470|NCT00348673|9634289|FG003|STARTED|Stage 1||6
8598471|NCT00348673|9634290|FG004|STARTED|Stage 1||4
8598472|NCT00348673|9634291|FG005|STARTED|Stage 1||0
8598473|NCT00348673|9634292|FG006|STARTED|Stage 1||0
8598474|NCT00348673|9634293|FG007|STARTED|Stage 1||0
8598475|NCT00348673|9634294|FG008|STARTED|Stage 1||0
8598476|NCT00348673|9634286|FG000|Treated|Stage 1||6
8598477|NCT00348673|9634287|FG001|Treated|Stage 1||6
8598478|NCT00348673|9634288|FG002|Treated|Stage 1||6
8598479|NCT00348673|9634289|FG003|Treated|Stage 1||6
8598480|NCT00348673|9634290|FG004|Treated|Stage 1||4
8598481|NCT00348673|9634291|FG005|Treated|Stage 1||0
8598482|NCT00348673|9634292|FG006|Treated|Stage 1||0
8598483|NCT00348673|9634293|FG007|Treated|Stage 1||0
8598484|NCT00348673|9634294|FG008|Treated|Stage 1||0
8598485|NCT00348673|9634286|FG000|COMPLETED|Stage 1||6
8598486|NCT00348673|9634287|FG001|COMPLETED|Stage 1||6
8598487|NCT00348673|9634288|FG002|COMPLETED|Stage 1||6
8598488|NCT00348673|9634289|FG003|COMPLETED|Stage 1||6
8598489|NCT00348673|9634290|FG004|COMPLETED|Stage 1||4
8598490|NCT00348673|9634291|FG005|COMPLETED|Stage 1||0
8598491|NCT00348673|9634292|FG006|COMPLETED|Stage 1||0
8598492|NCT00348673|9634293|FG007|COMPLETED|Stage 1||0
8598493|NCT00348673|9634294|FG008|COMPLETED|Stage 1||0
8598494|NCT00348673|9634286|FG000|NOT COMPLETED|Stage 1||0
8598495|NCT00348673|9634287|FG001|NOT COMPLETED|Stage 1||0
8598496|NCT00348673|9634288|FG002|NOT COMPLETED|Stage 1||1
8598497|NCT00348673|9634289|FG003|NOT COMPLETED|Stage 1||0
8598498|NCT00348673|9634290|FG004|NOT COMPLETED|Stage 1||0
8598499|NCT00348673|9634291|FG005|NOT COMPLETED|Stage 1||0
8598500|NCT00348673|9634292|FG006|NOT COMPLETED|Stage 1||0
8598501|NCT00348673|9634293|FG007|NOT COMPLETED|Stage 1||0
8598502|NCT00348673|9634294|FG008|NOT COMPLETED|Stage 1||0
8598503|NCT00348673|9634286|FG000|STARTED|Stage 2||0
8598504|NCT00348673|9634287|FG001|STARTED|Stage 2||0
8598505|NCT00348673|9634288|FG002|STARTED|Stage 2||0
8598506|NCT00348673|9634289|FG003|STARTED|Stage 2||0
8598507|NCT00348673|9634290|FG004|STARTED|Stage 2||0
8598508|NCT00348673|9634291|FG005|STARTED|Stage 2||6
8598509|NCT00348673|9634292|FG006|STARTED|Stage 2||6
8598510|NCT00348673|9634293|FG007|STARTED|Stage 2||6
8598511|NCT00348673|9634294|FG008|STARTED|Stage 2||2
8598512|NCT00348673|9634286|FG000|COMPLETED|Stage 2||0
8598513|NCT00348673|9634287|FG001|COMPLETED|Stage 2||0
8598514|NCT00348673|9634288|FG002|COMPLETED|Stage 2||0
8598515|NCT00348673|9634289|FG003|COMPLETED|Stage 2||0
8598516|NCT00348673|9634290|FG004|COMPLETED|Stage 2||0
8598517|NCT00348673|9634291|FG005|COMPLETED|Stage 2||6
8598518|NCT00348673|9634292|FG006|COMPLETED|Stage 2||6
8598519|NCT00348673|9634293|FG007|COMPLETED|Stage 2||6
8598520|NCT00348673|9634294|FG008|COMPLETED|Stage 2||2
8598521|NCT00348673|9634286|FG000|NOT COMPLETED|Stage 2||0
8598522|NCT00348673|9634287|FG001|NOT COMPLETED|Stage 2||0
8598523|NCT00348673|9634288|FG002|NOT COMPLETED|Stage 2||0
8598524|NCT00348673|9634289|FG003|NOT COMPLETED|Stage 2||0
8598525|NCT00348673|9634290|FG004|NOT COMPLETED|Stage 2||0
8598526|NCT00348673|9634291|FG005|NOT COMPLETED|Stage 2||0
8598527|NCT00348673|9634292|FG006|NOT COMPLETED|Stage 2||0
8598528|NCT00348673|9634293|FG007|NOT COMPLETED|Stage 2||0
8598529|NCT00348673|9634294|FG008|NOT COMPLETED|Stage 2||0
8598530|NCT00348686|9634312|FG000|STARTED|Overall Study||315
8598531|NCT00348686|9634312|FG000|COMPLETED|Overall Study||249
8598532|NCT00348686|9634312|FG000|NOT COMPLETED|Overall Study||66
8598533|NCT00348790|9634316|FG000|STARTED|Began Treatment||25
8598534|NCT00348790|9634316|FG000|COMPLETED|Began Treatment||25
8598535|NCT00348790|9634316|FG000|NOT COMPLETED|Began Treatment||0
8598536|NCT00348790|9634316|FG000|STARTED|Completed Treatment||25
8598537|NCT00348790|9634316|FG000|COMPLETED|Completed Treatment||0
8598538|NCT00348790|9634316|FG000|NOT COMPLETED|Completed Treatment||25
8598539|NCT00348816|9634321|FG000|STARTED|Overall Study||20
8598540|NCT00348816|9634321|FG000|COMPLETED|Overall Study||19
8598541|NCT00348816|9634321|FG000|NOT COMPLETED|Overall Study||1
8598542|NCT00348881|9634329|FG000|STARTED|Overall Study||1424
8598543|NCT00348881|9634330|FG001|STARTED|Overall Study||709
8598544|NCT00348881|9634329|FG000|COMPLETED|Overall Study||1407
8598545|NCT00348881|9634330|FG001|COMPLETED|Overall Study||697
8598546|NCT00348881|9634329|FG000|NOT COMPLETED|Overall Study||17
8598547|NCT00348881|9634330|FG001|NOT COMPLETED|Overall Study||12
8598548|NCT00348933|9634340|FG000|STARTED|Overall Study||90
8598549|NCT00348933|9634340|FG000|COMPLETED|Overall Study||65
8598550|NCT00348933|9634340|FG000|NOT COMPLETED|Overall Study||25
8598551|NCT00348946|9634347|FG000|STARTED|Overall Study||46
8598552|NCT00348946|9634348|FG001|STARTED|Overall Study||47
8598553|NCT00348946|9634347|FG000|COMPLETED|Overall Study||35
8598554|NCT00348946|9634348|FG001|COMPLETED|Overall Study||35
8598555|NCT00348946|9634347|FG000|NOT COMPLETED|Overall Study||11
8598556|NCT00348946|9634348|FG001|NOT COMPLETED|Overall Study||12
8598557|NCT00349336|9634358|FG000|STARTED|Overall Study||32
8598558|NCT00349336|9634359|FG001|STARTED|Overall Study||32
8598559|NCT00349336|9634358|FG000|COMPLETED|Overall Study||19
8598560|NCT00349336|9634359|FG001|COMPLETED|Overall Study||18
8598561|NCT00349336|9634358|FG000|NOT COMPLETED|Overall Study||13
8598562|NCT00349336|9634359|FG001|NOT COMPLETED|Overall Study||14
8598563|NCT00349349|9634368|FG000|STARTED|Overall Study||95
8598564|NCT00349349|9634369|FG001|STARTED|Overall Study||112
8598565|NCT00349349|9634370|FG002|STARTED|Overall Study||16
8598566|NCT00349349|9634368|FG000|COMPLETED|Overall Study||42
8598567|NCT00349349|9634369|FG001|COMPLETED|Overall Study||50
8598568|NCT00349349|9634370|FG002|COMPLETED|Overall Study||10
8598569|NCT00349349|9634368|FG000|NOT COMPLETED|Overall Study||53
8598570|NCT00349349|9634369|FG001|NOT COMPLETED|Overall Study||62
8598571|NCT00349349|9634370|FG002|NOT COMPLETED|Overall Study||6
8598572|NCT00349388|9634382|FG000|STARTED|Overall Study|no patients enrolled|0
8598573|NCT00349388|9634383|FG001|STARTED|Overall Study||1
8598574|NCT00349388|9634382|FG000|COMPLETED|Overall Study|no patients enrolled , therefore no patients completed|0
8598575|NCT00349388|9634383|FG001|COMPLETED|Overall Study||1
8598576|NCT00349388|9634382|FG000|NOT COMPLETED|Overall Study||0
8598577|NCT00349388|9634383|FG001|NOT COMPLETED|Overall Study||0
8598578|NCT00349622|9634391|FG000|STARTED|Overall Study||340
8598579|NCT00349622|9634392|FG001|STARTED|Overall Study||173
8598580|NCT00349622|9634391|FG000|COMPLETED|Overall Study||162
8598581|NCT00349622|9634392|FG001|COMPLETED|Overall Study||77
8598582|NCT00349622|9634391|FG000|NOT COMPLETED|Overall Study||178
8598583|NCT00349622|9634392|FG001|NOT COMPLETED|Overall Study||96
8598584|NCT00349713|9634401|FG000|STARTED|Overall Study||20
8598585|NCT00349713|9634402|FG001|STARTED|Overall Study||20
8598586|NCT00349713|9634403|FG002|STARTED|Overall Study||20
8598587|NCT00349713|9634401|FG000|COMPLETED|Overall Study||20
8598588|NCT00349713|9634402|FG001|COMPLETED|Overall Study||20
8598589|NCT00349713|9634403|FG002|COMPLETED|Overall Study||20
8598590|NCT00349713|9634401|FG000|NOT COMPLETED|Overall Study||0
8598591|NCT00349713|9634402|FG001|NOT COMPLETED|Overall Study||0
8598592|NCT00349713|9634403|FG002|NOT COMPLETED|Overall Study||0
8598593|NCT00349752|9634413|FG000|STARTED|Overall Study||87
8598594|NCT00349752|9634414|FG001|STARTED|Overall Study||87
8598595|NCT00349752|9634413|FG000|COMPLETED|Overall Study||28
8598596|NCT00349752|9634414|FG001|COMPLETED|Overall Study||23
8598597|NCT00349752|9634413|FG000|NOT COMPLETED|Overall Study||59
8598598|NCT00349752|9634414|FG001|NOT COMPLETED|Overall Study||64
8598599|NCT00349778|9634420|FG000|STARTED|Overall Study||102
8598600|NCT00349778|9634420|FG000|COMPLETED|Overall Study||102
8598601|NCT00349778|9634420|FG000|NOT COMPLETED|Overall Study||0
8598602|NCT00349908|9634426|FG000|STARTED|Overall Study||10
8598603|NCT00349908|9634427|FG001|STARTED|Overall Study||10
8598604|NCT00349908|9634426|FG000|COMPLETED|Overall Study||10
8598605|NCT00349908|9634427|FG001|COMPLETED|Overall Study|9 returned for 30 day follow-up, 7 returned for 6 month and 6/7 had 6 month angiogram|6
8598606|NCT00349908|9634426|FG000|NOT COMPLETED|Overall Study||0
8598607|NCT00349908|9634427|FG001|NOT COMPLETED|Overall Study||4
8598608|NCT00349921|9634438|FG000|STARTED|First Spinal Injection||10
8598609|NCT00349921|9634439|FG001|STARTED|First Spinal Injection||10
8598610|NCT00349921|9634440|FG002|STARTED|First Spinal Injection||1
8598611|NCT00349921|9634441|FG003|STARTED|First Spinal Injection||1
8598612|NCT00349921|9634438|FG000|COMPLETED|First Spinal Injection||9
8598613|NCT00349921|9634439|FG001|COMPLETED|First Spinal Injection||10
8598614|NCT00349921|9634440|FG002|COMPLETED|First Spinal Injection||0
8598615|NCT00349921|9634441|FG003|COMPLETED|First Spinal Injection||1
8598616|NCT00349921|9634438|FG000|NOT COMPLETED|First Spinal Injection||1
8598617|NCT00349921|9634439|FG001|NOT COMPLETED|First Spinal Injection||0
8598618|NCT00349921|9634440|FG002|NOT COMPLETED|First Spinal Injection||1
8598619|NCT00349921|9634441|FG003|NOT COMPLETED|First Spinal Injection||0
8598620|NCT00349921|9634438|FG000|STARTED|Second Spinal Injection|One patient experienced an adverse event after period one and did not participate in period two|9
8598621|NCT00349921|9634439|FG001|STARTED|Second Spinal Injection||10
8598622|NCT00349921|9634440|FG002|STARTED|Second Spinal Injection||0
8598623|NCT00349921|9634441|FG003|STARTED|Second Spinal Injection||1
8598624|NCT00349921|9634438|FG000|COMPLETED|Second Spinal Injection||9
8598625|NCT00349921|9634439|FG001|COMPLETED|Second Spinal Injection||10
8598626|NCT00349921|9634440|FG002|COMPLETED|Second Spinal Injection||0
8598627|NCT00349921|9634441|FG003|COMPLETED|Second Spinal Injection||1
8598628|NCT00349921|9634438|FG000|NOT COMPLETED|Second Spinal Injection||0
8598629|NCT00349921|9634439|FG001|NOT COMPLETED|Second Spinal Injection||0
8598630|NCT00349921|9634440|FG002|NOT COMPLETED|Second Spinal Injection||0
8598631|NCT00349921|9634441|FG003|NOT COMPLETED|Second Spinal Injection||0
8598632|NCT00349973|9634452|FG000|STARTED|Overall Study||12
8598633|NCT00349973|9634453|FG001|STARTED|Overall Study||8
8598634|NCT00349973|9634452|FG000|COMPLETED|Overall Study||8
8598635|NCT00349973|9634453|FG001|COMPLETED|Overall Study||5
8598636|NCT00349973|9634452|FG000|NOT COMPLETED|Overall Study||4
8598637|NCT00349973|9634453|FG001|NOT COMPLETED|Overall Study||3
8598638|NCT00350025|9634461|FG000|STARTED|Overall Study||11
8598639|NCT00350025|9634462|FG001|STARTED|Overall Study||30
8598640|NCT00350025|9634461|FG000|COMPLETED|Overall Study||11
8598641|NCT00350025|9634462|FG001|COMPLETED|Overall Study||28
8598642|NCT00350025|9634461|FG000|NOT COMPLETED|Overall Study||0
8598643|NCT00350025|9634462|FG001|NOT COMPLETED|Overall Study||2
8598644|NCT00350142|9634468|FG000|STARTED|Overall Study||20
8598645|NCT00350142|9634468|FG000|COMPLETED|Overall Study||20
8598646|NCT00350142|9634468|FG000|NOT COMPLETED|Overall Study||0
8598647|NCT00350207|9634476|FG000|STARTED|Overall Study||128
8598648|NCT00350207|9634477|FG001|STARTED|Overall Study||134
8598649|NCT00350207|9634478|FG002|STARTED|Overall Study||126
8598650|NCT00350207|9634476|FG000|COMPLETED|Overall Study||120
8598651|NCT00350207|9634477|FG001|COMPLETED|Overall Study||128
8598652|NCT00350207|9634478|FG002|COMPLETED|Overall Study||119
8598653|NCT00350207|9634476|FG000|NOT COMPLETED|Overall Study||8
8598654|NCT00350207|9634477|FG001|NOT COMPLETED|Overall Study||6
8598655|NCT00350207|9634478|FG002|NOT COMPLETED|Overall Study||7
8598656|NCT00350220|9634488|FG000|STARTED|Overall Study||30
8598657|NCT00350220|9634489|FG001|STARTED|Overall Study||30
8598658|NCT00350220|9634488|FG000|COMPLETED|Overall Study||30
8598659|NCT00350220|9634489|FG001|COMPLETED|Overall Study||30
8598660|NCT00350220|9634488|FG000|NOT COMPLETED|Overall Study||0
8598661|NCT00350220|9634489|FG001|NOT COMPLETED|Overall Study||0
8598662|NCT00350272|9634497|FG000|STARTED|Blinded 12 Week Treatment||39
8598663|NCT00350272|9634498|FG001|STARTED|Blinded 12 Week Treatment||37
8598664|NCT00350272|9634497|FG000|COMPLETED|Blinded 12 Week Treatment||30
8598665|NCT00350272|9634498|FG001|COMPLETED|Blinded 12 Week Treatment||35
8598666|NCT00350272|9634497|FG000|NOT COMPLETED|Blinded 12 Week Treatment||9
8598667|NCT00350272|9634498|FG001|NOT COMPLETED|Blinded 12 Week Treatment||2
8598668|NCT00350272|9634497|FG000|STARTED|Open-Label 84 Week Treatment||30
8598669|NCT00350272|9634498|FG001|STARTED|Open-Label 84 Week Treatment||35
8598670|NCT00350272|9634497|FG000|COMPLETED|Open-Label 84 Week Treatment||21
8598671|NCT00350272|9634498|FG001|COMPLETED|Open-Label 84 Week Treatment||27
8598672|NCT00350272|9634497|FG000|NOT COMPLETED|Open-Label 84 Week Treatment||9
8598673|NCT00350272|9634498|FG001|NOT COMPLETED|Open-Label 84 Week Treatment||8
8598674|NCT00350298|9634508|FG000|STARTED|Overall Study||101
8598675|NCT00350298|9634509|FG001|STARTED|Overall Study||99
8598676|NCT00350298|9634508|FG000|COMPLETED|Overall Study||92
8598677|NCT00350298|9634509|FG001|COMPLETED|Overall Study||86
8598678|NCT00350298|9634508|FG000|NOT COMPLETED|Overall Study||9
8598679|NCT00350298|9634509|FG001|NOT COMPLETED|Overall Study||13
8598680|NCT00350337|9634519|FG000|STARTED|Overall Study||22
8598681|NCT00350337|9634520|FG001|STARTED|Overall Study||22
8598682|NCT00350337|9634521|FG002|STARTED|Overall Study||21
8713244|NCT00974246|9760074|FG000|NOT COMPLETED|Overall Study||0
8713245|NCT00974259|9760081|FG000|STARTED|Overall Study||59
8713246|NCT00974259|9760082|FG001|STARTED|Overall Study||63
8713247|NCT00974259|9760081|FG000|COMPLETED|Overall Study||57
8928190|NCT02278783|9989320|FG000|NOT COMPLETED|Overall Study||0
8928191|NCT02278939|9989326|FG000|STARTED|Overall Study||33
8928192|NCT02278939|9989327|FG001|STARTED|Overall Study||34
8928193|NCT02278939|9989326|FG000|COMPLETED|Overall Study||28
8928194|NCT02278939|9989327|FG001|COMPLETED|Overall Study||33
8598683|NCT00350337|9634522|FG003|STARTED|Overall Study||21
8598684|NCT00350337|9634519|FG000|COMPLETED|Overall Study||17
8598685|NCT00350337|9634520|FG001|COMPLETED|Overall Study||19
8598686|NCT00350337|9634521|FG002|COMPLETED|Overall Study||18
8598687|NCT00350337|9634522|FG003|COMPLETED|Overall Study||21
8598688|NCT00350337|9634519|FG000|NOT COMPLETED|Overall Study||5
8598689|NCT00350337|9634520|FG001|NOT COMPLETED|Overall Study||3
8598690|NCT00350337|9634521|FG002|NOT COMPLETED|Overall Study||3
8598691|NCT00350337|9634522|FG003|NOT COMPLETED|Overall Study||0
8598692|NCT00350363|9634533|FG000|STARTED|Overall Study||60
8598693|NCT00350363|9634533|FG000|COMPLETED|Overall Study||60
8598694|NCT00350363|9634533|FG000|NOT COMPLETED|Overall Study||0
8598695|NCT00350402|9634539|FG000|STARTED|Overall Study||21
8598696|NCT00350402|9634540|FG001|STARTED|Overall Study||21
8598697|NCT00350402|9634539|FG000|COMPLETED|Overall Study||20
8598698|NCT00350402|9634540|FG001|COMPLETED|Overall Study||20
8598699|NCT00350402|9634539|FG000|NOT COMPLETED|Overall Study||1
8598700|NCT00350402|9634540|FG001|NOT COMPLETED|Overall Study||1
8598701|NCT00350519|9634554|FG000|STARTED|Overall Study||18
8598702|NCT00350519|9634555|FG001|STARTED|Overall Study||19
8598703|NCT00350519|9634554|FG000|COMPLETED|Overall Study||14
8598704|NCT00350519|9634555|FG001|COMPLETED|Overall Study||13
8598705|NCT00350519|9634554|FG000|NOT COMPLETED|Overall Study||4
8598706|NCT00350519|9634555|FG001|NOT COMPLETED|Overall Study||6
8928195|NCT02278939|9989326|FG000|NOT COMPLETED|Overall Study||5
8928196|NCT02278939|9989327|FG001|NOT COMPLETED|Overall Study||1
8928197|NCT02278952|9989333|FG000|STARTED|Overall Study|The number of biopsy procedures performed during the time the patient was enrolled in the study.|50
8928198|NCT02278952|9989333|FG000|COMPLETED|Overall Study|The number of biopsy samples assayed during the time the patient was enrolled in the study.|44
8928199|NCT02278952|9989333|FG000|NOT COMPLETED|Overall Study||6
8928200|NCT02279043|9989346|FG000|STARTED|Overall Study||175
8928201|NCT02279043|9989347|FG001|STARTED|Overall Study||315
8928202|NCT02279043|9989348|FG002|STARTED|Overall Study||140
8928203|NCT02279043|9989346|FG000|COMPLETED|Overall Study||128
8928204|NCT02279043|9989347|FG001|COMPLETED|Overall Study||226
8928205|NCT02279043|9989348|FG002|COMPLETED|Overall Study||140
8928206|NCT02279043|9989346|FG000|NOT COMPLETED|Overall Study||47
8928207|NCT02279043|9989347|FG001|NOT COMPLETED|Overall Study||89
8928208|NCT02279043|9989348|FG002|NOT COMPLETED|Overall Study||0
8928209|NCT02279082|9989354|FG000|STARTED|Overall Study|Intentions were to have 173 participants, but only 167 participants received study drug.|167
8928210|NCT02279082|9989354|FG000|COMPLETED|Overall Study||134
8928211|NCT02279082|9989354|FG000|NOT COMPLETED|Overall Study||33
8928212|NCT02279108|9989360|FG000|STARTED|Overall Study||50
8928213|NCT02279108|9989361|FG001|STARTED|Overall Study||50
8928214|NCT02279108|9989360|FG000|COMPLETED|Overall Study||50
8928215|NCT02279108|9989361|FG001|COMPLETED|Overall Study||49
8928216|NCT02279108|9989360|FG000|NOT COMPLETED|Overall Study||0
8928217|NCT02279108|9989361|FG001|NOT COMPLETED|Overall Study||1
8928218|NCT02279160|9989369|FG000|STARTED|Overall Study||40
8928219|NCT02279160|9989370|FG001|STARTED|Overall Study||21
8928220|NCT02279160|9989369|FG000|COMPLETED|Overall Study||34
8928221|NCT02279160|9989370|FG001|COMPLETED|Overall Study||19
8928222|NCT02279160|9989369|FG000|NOT COMPLETED|Overall Study||6
8928223|NCT02279160|9989370|FG001|NOT COMPLETED|Overall Study||2
8928224|NCT02279173|9989376|FG000|STARTED|Overall Study||203
8928225|NCT02279173|9989376|FG000|Received Treatment|Overall Study||203
8928226|NCT02279173|9989376|FG000|Enrolled Under Protocol Supplement|Overall Study||79
8928227|NCT02279173|9989376|FG000|COMPLETED|Overall Study||109
8928228|NCT02279173|9989376|FG000|NOT COMPLETED|Overall Study||94
8928229|NCT02279407|9989386|FG000|STARTED|Overall Study||22
8598707|NCT00350532|9634563|FG000|STARTED|Overall Study||24
8598708|NCT00350532|9634564|FG001|STARTED|Overall Study||19
8598709|NCT00350532|9634563|FG000|COMPLETED|Overall Study||24
8598710|NCT00350532|9634564|FG001|COMPLETED|Overall Study||19
8598711|NCT00350532|9634563|FG000|NOT COMPLETED|Overall Study||0
8598712|NCT00350532|9634564|FG001|NOT COMPLETED|Overall Study||0
8598713|NCT00350545|9634570|FG000|STARTED|Overall Study||37
8713248|NCT00974259|9760082|FG001|COMPLETED|Overall Study||62
8713249|NCT00974259|9760081|FG000|NOT COMPLETED|Overall Study||2
8713250|NCT00974259|9760082|FG001|NOT COMPLETED|Overall Study||1
8928230|NCT02279407|9989387|FG001|STARTED|Overall Study||21
8928231|NCT02279407|9989388|FG002|STARTED|Overall Study||20
8928232|NCT02279407|9989389|FG003|STARTED|Overall Study||21
8928233|NCT02279407|9989386|FG000|COMPLETED|Overall Study||20
8928234|NCT02279407|9989387|FG001|COMPLETED|Overall Study||20
8928235|NCT02279407|9989388|FG002|COMPLETED|Overall Study||15
8928236|NCT02279407|9989389|FG003|COMPLETED|Overall Study||20
8928237|NCT02279407|9989386|FG000|NOT COMPLETED|Overall Study||2
8598714|NCT00350545|9634570|FG000|COMPLETED|Overall Study||35
8598715|NCT00350545|9634570|FG000|NOT COMPLETED|Overall Study||2
8598716|NCT00350636|9634576|FG000|STARTED|Overall Study||389
8598717|NCT00350636|9634577|FG001|STARTED|Overall Study||400
8598718|NCT00350636|9634576|FG000|COMPLETED|Overall Study||346
8598719|NCT00350636|9634577|FG001|COMPLETED|Overall Study||355
8598720|NCT00350636|9634576|FG000|NOT COMPLETED|Overall Study||43
8598721|NCT00350636|9634577|FG001|NOT COMPLETED|Overall Study||45
8598722|NCT00350727|9634586|FG000|STARTED|Phase I: Dose Escalation||34
8598723|NCT00350727|9634587|FG001|STARTED|Phase I: Dose Escalation||0
8598724|NCT00350727|9634588|FG002|STARTED|Phase I: Dose Escalation||0
8598725|NCT00350727|9634586|FG000|COMPLETED|Phase I: Dose Escalation||0
8598726|NCT00350727|9634587|FG001|COMPLETED|Phase I: Dose Escalation||0
8598727|NCT00350727|9634588|FG002|COMPLETED|Phase I: Dose Escalation||0
8598728|NCT00350727|9634586|FG000|NOT COMPLETED|Phase I: Dose Escalation||34
8598729|NCT00350727|9634587|FG001|NOT COMPLETED|Phase I: Dose Escalation||0
8598730|NCT00350727|9634588|FG002|NOT COMPLETED|Phase I: Dose Escalation||0
8598731|NCT00350727|9634586|FG000|STARTED|Phase II||0
8598732|NCT00350727|9634587|FG001|STARTED|Phase II||19
8598733|NCT00350727|9634588|FG002|STARTED|Phase II||22
8598734|NCT00350727|9634586|FG000|COMPLETED|Phase II||0
8598735|NCT00350727|9634587|FG001|COMPLETED|Phase II||0
8598736|NCT00350727|9634588|FG002|COMPLETED|Phase II||0
8598737|NCT00350727|9634586|FG000|NOT COMPLETED|Phase II||0
8598738|NCT00350727|9634587|FG001|NOT COMPLETED|Phase II||19
8598739|NCT00350727|9634588|FG002|NOT COMPLETED|Phase II||22
8598740|NCT00350779|9634609|FG000|STARTED|Overall Study||170
8598741|NCT00350779|9634610|FG001|STARTED|Overall Study||92
8598742|NCT00350779|9634609|FG000|COMPLETED|Overall Study||148
8598743|NCT00350779|9634610|FG001|COMPLETED|Overall Study||71
8598744|NCT00350779|9634609|FG000|NOT COMPLETED|Overall Study||22
8598745|NCT00350779|9634610|FG001|NOT COMPLETED|Overall Study||21
8598746|NCT00350792|9634618|FG000|STARTED|Overall Study||62
8598747|NCT00350792|9634618|FG000|COMPLETED|Overall Study||29
8598748|NCT00350792|9634618|FG000|NOT COMPLETED|Overall Study||33
8598749|NCT00350870|9634626|FG000|STARTED|Overall Study||27
8598750|NCT00350870|9634627|FG001|STARTED|Overall Study||28
8598751|NCT00350870|9634628|FG002|STARTED|Overall Study||22
8598752|NCT00350870|9634629|FG003|STARTED|Overall Study||22
8598753|NCT00350870|9634626|FG000|Had at Least 1 Day of Med|Overall Study||19
8598754|NCT00350870|9634627|FG001|Had at Least 1 Day of Med|Overall Study||24
8598755|NCT00350870|9634628|FG002|Had at Least 1 Day of Med|Overall Study||18
8598756|NCT00350870|9634629|FG003|Had at Least 1 Day of Med|Overall Study||19
8598757|NCT00350870|9634626|FG000|COMPLETED|Overall Study||5
8598758|NCT00350870|9634627|FG001|COMPLETED|Overall Study||11
8598759|NCT00350870|9634628|FG002|COMPLETED|Overall Study||6
8598760|NCT00350870|9634629|FG003|COMPLETED|Overall Study||7
8598761|NCT00350870|9634626|FG000|NOT COMPLETED|Overall Study||22
8598762|NCT00350870|9634627|FG001|NOT COMPLETED|Overall Study||17
8598763|NCT00350870|9634628|FG002|NOT COMPLETED|Overall Study||16
8598764|NCT00350870|9634629|FG003|NOT COMPLETED|Overall Study||15
8598765|NCT00351000|9634639|FG000|STARTED|Overall Study||24
8598766|NCT00351000|9634639|FG000|COMPLETED|Overall Study||21
8598767|NCT00351000|9634639|FG000|NOT COMPLETED|Overall Study||3
8598768|NCT00351039|9634646|FG000|STARTED|Overall Study||8
8598769|NCT00351039|9634646|FG000|COMPLETED|Overall Study|The study was halted before Phase II was initiated.|8
8598770|NCT00351039|9634646|FG000|NOT COMPLETED|Overall Study||0
8598771|NCT00351273|9634654|FG000|STARTED|Overall Study||15
8598772|NCT00351273|9634655|FG001|STARTED|Overall Study||12
8598773|NCT00351273|9634656|FG002|STARTED|Overall Study||15
8598774|NCT00351273|9634654|FG000|COMPLETED|Overall Study||14
8598775|NCT00351273|9634655|FG001|COMPLETED|Overall Study||10
8598776|NCT00351273|9634656|FG002|COMPLETED|Overall Study||10
8598777|NCT00351273|9634654|FG000|NOT COMPLETED|Overall Study||1
8598778|NCT00351273|9634655|FG001|NOT COMPLETED|Overall Study||2
8598779|NCT00351273|9634656|FG002|NOT COMPLETED|Overall Study||5
8598780|NCT00351299|9634671|FG000|STARTED|Overall Study||25
8598781|NCT00351299|9634672|FG001|STARTED|Overall Study||28
8598782|NCT00351299|9634671|FG000|COMPLETED|Overall Study||25
8598783|NCT00351299|9634672|FG001|COMPLETED|Overall Study||28
8598784|NCT00351299|9634671|FG000|NOT COMPLETED|Overall Study||0
8598785|NCT00351299|9634672|FG001|NOT COMPLETED|Overall Study||0
8598786|NCT00351351|9634684|FG000|STARTED|Overall Study||34
8598787|NCT00351351|9634685|FG001|STARTED|Overall Study||36
8598788|NCT00351351|9634684|FG000|COMPLETED|Overall Study||25
8598789|NCT00351351|9634685|FG001|COMPLETED|Overall Study||32
8598790|NCT00351351|9634684|FG000|NOT COMPLETED|Overall Study||9
8598791|NCT00351351|9634685|FG001|NOT COMPLETED|Overall Study||4
8598792|NCT00351377|9634691|FG000|STARTED|Overall Study||111
8598793|NCT00351377|9634691|FG000|COMPLETED|Overall Study||104
8598794|NCT00351377|9634691|FG000|NOT COMPLETED|Overall Study||7
8598795|NCT00351416|9634697|FG000|STARTED|Overall Study||6
8598796|NCT00351416|9634698|FG001|STARTED|Overall Study||9
8598797|NCT00351416|9634697|FG000|COMPLETED|Overall Study||6
8598798|NCT00351416|9634698|FG001|COMPLETED|Overall Study||9
8598799|NCT00351416|9634697|FG000|NOT COMPLETED|Overall Study||0
8598800|NCT00351416|9634698|FG001|NOT COMPLETED|Overall Study||0
8598801|NCT00351468|9634704|FG000|STARTED|Overall Study||302
8598802|NCT00351468|9634704|FG000|Subjects From TRA100773A|Overall Study||51
8598803|NCT00351468|9634704|FG000|Subjects From TRA100773B|Overall Study||61
8598804|NCT00351468|9634704|FG000|Subjects From TRA102537 Raise|Overall Study||146
8598805|NCT00351468|9634704|FG000|Subjects From TRA108057 Repeat|Overall Study||43
8598806|NCT00351468|9634704|FG000|Unknown - Not From Previous Trial|Overall Study|Mistakenly enrolled (not in any of the 3 trials) On 50 mg/d eltrombopag for 18 days and withdrawn|1
8598807|NCT00351468|9634704|FG000|COMPLETED|Overall Study||135
8598808|NCT00351468|9634704|FG000|NOT COMPLETED|Overall Study||167
8598809|NCT00351533|9634711|FG000|STARTED|Overall Study||41
8598810|NCT00351533|9634712|FG001|STARTED|Overall Study||49
8598811|NCT00351533|9634711|FG000|COMPLETED|Overall Study|Pts did not undergo BALs if not intubated|39
8598812|NCT00351533|9634712|FG001|COMPLETED|Overall Study|Pts did not undergo BALs if not intubated|44
8598813|NCT00351533|9634711|FG000|NOT COMPLETED|Overall Study||2
8598814|NCT00351533|9634712|FG001|NOT COMPLETED|Overall Study||5
8598815|NCT00351611|9634720|FG000|STARTED|Overall Study||89
8598816|NCT00351611|9634721|FG001|STARTED|Overall Study||98
8598817|NCT00351611|9634720|FG000|Treated|Overall Study||89
8598818|NCT00351611|9634721|FG001|Treated|Overall Study||98
8598819|NCT00351611|9634720|FG000|COMPLETED|Overall Study||75
8598820|NCT00351611|9634721|FG001|COMPLETED|Overall Study||88
8598821|NCT00351611|9634720|FG000|NOT COMPLETED|Overall Study||14
8598822|NCT00351611|9634721|FG001|NOT COMPLETED|Overall Study||10
8598823|NCT00351741|9634729|FG000|STARTED|Overall Study||31
8598824|NCT00351741|9634730|FG001|STARTED|Overall Study||31
8598825|NCT00351741|9634729|FG000|COMPLETED|Overall Study||31
8598826|NCT00351741|9634730|FG001|COMPLETED|Overall Study||31
8598827|NCT00351741|9634729|FG000|NOT COMPLETED|Overall Study||0
8598828|NCT00351741|9634730|FG001|NOT COMPLETED|Overall Study||0
8598829|NCT00351819|9634738|FG000|STARTED|Overall Study||43
8598830|NCT00351819|9634739|FG001|STARTED|Overall Study||41
8598831|NCT00351819|9634738|FG000|COMPLETED|Overall Study||36
8598832|NCT00351819|9634739|FG001|COMPLETED|Overall Study||29
8598833|NCT00351819|9634738|FG000|NOT COMPLETED|Overall Study||7
8598834|NCT00351819|9634739|FG001|NOT COMPLETED|Overall Study||12
8628491|NCT00524420|9667961|FG000|STARTED|Overall Study|One was incorrectly randomized;she did not have a BIRS of >7. Was excluded from efficacy analysis.|8
8628492|NCT00524420|9667962|FG001|STARTED|Overall Study||11
8628493|NCT00524420|9667961|FG000|COMPLETED|Overall Study|1 dropped out after treatment 10 because of poor response and was included in the efficacy analyses.|7
8628494|NCT00524420|9667962|FG001|COMPLETED|Overall Study||11
8628495|NCT00524420|9667961|FG000|NOT COMPLETED|Overall Study||1
8628496|NCT00524420|9667962|FG001|NOT COMPLETED|Overall Study||0
8628497|NCT00524472|9667972|FG000|STARTED|Overall Study||709
8628498|NCT00524472|9667973|FG001|STARTED|Overall Study||730
8628499|NCT00524472|9667972|FG000|COMPLETED|Overall Study||709
8628500|NCT00524472|9667973|FG001|COMPLETED|Overall Study||730
8628501|NCT00524472|9667972|FG000|NOT COMPLETED|Overall Study||0
8628502|NCT00524472|9667973|FG001|NOT COMPLETED|Overall Study||0
8628503|NCT00524537|9667979|FG000|STARTED|Overall Study|All Treated Population: All participants who received at least 1 injection of Humira in the registry|5025
8628504|NCT00524537|9667979|FG000|Discontinued|Overall Study|Discontinued from study|2811
8628505|NCT00524537|9667979|FG000|Re-enrolled|Overall Study|Discontinued from study and later re-enrolled in study|339
8628506|NCT00524537|9667979|FG000|Discontinued After Re-enrollment|Overall Study|Discontinued from study after re-enrollment|102
8628507|NCT00524537|9667979|FG000|COMPLETED|Overall Study|Still enrolled in study at the end of study|2451
8628508|NCT00524537|9667979|FG000|NOT COMPLETED|Overall Study||2574
8628509|NCT00524576|9667985|FG000|STARTED|Overall Study||97
8628510|NCT00524576|9667986|FG001|STARTED|Overall Study||47
8628511|NCT00524576|9667985|FG000|COMPLETED|Overall Study||97
8628512|NCT00524576|9667986|FG001|COMPLETED|Overall Study||47
8628513|NCT00524576|9667985|FG000|NOT COMPLETED|Overall Study||0
8628514|NCT00524576|9667986|FG001|NOT COMPLETED|Overall Study||0
8628515|NCT00524589|9667992|FG000|STARTED|Overall Study||18
8628516|NCT00524589|9667992|FG000|COMPLETED|Overall Study||0
8628517|NCT00524589|9667992|FG000|NOT COMPLETED|Overall Study||18
8628518|NCT00524680|9668000|FG000|STARTED|Overall Study||37
8628519|NCT00524680|9668001|FG001|STARTED|Overall Study||35
8628520|NCT00524680|9668002|FG002|STARTED|Overall Study||36
8628521|NCT00524680|9668003|FG003|STARTED|Overall Study||40
8628522|NCT00524680|9668000|FG000|COMPLETED|Overall Study||34
8628523|NCT00524680|9668001|FG001|COMPLETED|Overall Study||34
8628524|NCT00524680|9668002|FG002|COMPLETED|Overall Study||33
8628525|NCT00524680|9668003|FG003|COMPLETED|Overall Study||34
8628526|NCT00524680|9668000|FG000|NOT COMPLETED|Overall Study||3
8628527|NCT00524680|9668001|FG001|NOT COMPLETED|Overall Study||1
8628528|NCT00524680|9668002|FG002|NOT COMPLETED|Overall Study||3
8628529|NCT00524680|9668003|FG003|NOT COMPLETED|Overall Study||6
8628530|NCT00524745|9668017|FG000|STARTED|Overall Study||229
8628531|NCT00524745|9668018|FG001|STARTED|Overall Study||206
8628532|NCT00524745|9668019|FG002|STARTED|Overall Study||241
8628533|NCT00524745|9668020|FG003|STARTED|Overall Study||227
8628534|NCT00524745|9668017|FG000|COMPLETED|Overall Study||195
8628535|NCT00524745|9668018|FG001|COMPLETED|Overall Study||193
8628536|NCT00524745|9668019|FG002|COMPLETED|Overall Study||212
8628537|NCT00524745|9668020|FG003|COMPLETED|Overall Study||205
8628538|NCT00524745|9668017|FG000|NOT COMPLETED|Overall Study||34
8628539|NCT00524745|9668018|FG001|NOT COMPLETED|Overall Study||13
8628540|NCT00524745|9668019|FG002|NOT COMPLETED|Overall Study||29
8628541|NCT00524745|9668020|FG003|NOT COMPLETED|Overall Study||22
8628542|NCT00524771|9668032|FG000|STARTED|Overall Study||17084
8628543|NCT00524771|9668033|FG001|STARTED|Overall Study||17016
8628544|NCT00524771|9668032|FG000|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 4.0 years.|16864
8598835|NCT00351936|9634745|FG000|STARTED|Overall Study||15
8598836|NCT00351936|9634745|FG000|COMPLETED|Overall Study||15
8598837|NCT00351936|9634745|FG000|NOT COMPLETED|Overall Study||0
8598838|NCT00352001|9634750|FG000|STARTED|Overall Study||37
8598839|NCT00352001|9634750|FG000|Azacitidine 75mg/Lenalidomide 5mg-14 Day|Overall Study||3
8598840|NCT00352001|9634750|FG000|Azacitidine 75mg/Lenalidomide 5mg-21 Day|Overall Study||3
8598841|NCT00352001|9634750|FG000|Azacitidine 75mg/Lenalidomide 10mg-14day|Overall Study||3
8598842|NCT00352001|9634750|FG000|COMPLETED|Overall Study||37
8598843|NCT00352001|9634750|FG000|NOT COMPLETED|Overall Study||0
8598844|NCT00352053|9634756|FG000|STARTED|Double-Blind Phase (Through Week 48)||45
8598845|NCT00352053|9634757|FG001|STARTED|Double-Blind Phase (Through Week 48)||42
8598846|NCT00352053|9634756|FG000|COMPLETED|Double-Blind Phase (Through Week 48)||27
8598847|NCT00352053|9634757|FG001|COMPLETED|Double-Blind Phase (Through Week 48)|The 10 participants discontinued for virologic failure enrolled early in the open-label extension.|29
8598848|NCT00352053|9634756|FG000|NOT COMPLETED|Double-Blind Phase (Through Week 48)||18
8598849|NCT00352053|9634757|FG001|NOT COMPLETED|Double-Blind Phase (Through Week 48)||13
8598850|NCT00352053|9634756|FG000|STARTED|First Extension Phase (Weeks 48-144)|3 participants completed the double-blind phase but did not enroll in the 1st extension phase.|24
8598851|NCT00352053|9634757|FG001|STARTED|First Extension Phase (Weeks 48-144)|3 participants completed the double-blind phase but did not enroll in the 1st extension phase.|36
8598852|NCT00352053|9634756|FG000|COMPLETED|First Extension Phase (Weeks 48-144)||12
8598853|NCT00352053|9634757|FG001|COMPLETED|First Extension Phase (Weeks 48-144)||19
8598854|NCT00352053|9634756|FG000|NOT COMPLETED|First Extension Phase (Weeks 48-144)||12
8598855|NCT00352053|9634757|FG001|NOT COMPLETED|First Extension Phase (Weeks 48-144)||17
8598856|NCT00352053|9634756|FG000|STARTED|Second Extension Phase (Weeks 144-240)|3 participants completed the 1st extension phase but did not enroll in the 2nd extension phase.|9
8598857|NCT00352053|9634757|FG001|STARTED|Second Extension Phase (Weeks 144-240)|5 participants completed the 1st extension phase but did not enroll in the 2nd extension phase.|14
8598858|NCT00352053|9634756|FG000|COMPLETED|Second Extension Phase (Weeks 144-240)||4
8598859|NCT00352053|9634757|FG001|COMPLETED|Second Extension Phase (Weeks 144-240)||9
8598860|NCT00352053|9634756|FG000|NOT COMPLETED|Second Extension Phase (Weeks 144-240)||5
8598861|NCT00352053|9634757|FG001|NOT COMPLETED|Second Extension Phase (Weeks 144-240)||5
8598862|NCT00352053|9634756|FG000|STARTED|Third Extension Phase (Weeks 240-294)|3 participants completed the 2nd extension phase but did not enroll in the 3rd extension phase.|1
8598863|NCT00352053|9634757|FG001|STARTED|Third Extension Phase (Weeks 240-294)|5 participants completed the 2nd extension phase but did not enroll in the 3rd extension phase.|4
8598864|NCT00352053|9634756|FG000|COMPLETED|Third Extension Phase (Weeks 240-294)||0
8598865|NCT00352053|9634757|FG001|COMPLETED|Third Extension Phase (Weeks 240-294)||2
8598866|NCT00352053|9634756|FG000|NOT COMPLETED|Third Extension Phase (Weeks 240-294)||1
8598867|NCT00352053|9634757|FG001|NOT COMPLETED|Third Extension Phase (Weeks 240-294)||2
8598868|NCT00352105|9634771|FG000|STARTED|Overall Study||60
8598869|NCT00352105|9634771|FG000|COMPLETED|Overall Study||20
8598870|NCT00352105|9634771|FG000|NOT COMPLETED|Overall Study||40
8598871|NCT00352365|9634775|FG000|STARTED|Induction Therapy||41
8713251|NCT00974311|9760090|FG000|STARTED|DB Phase (up to 24 Months)||800
8713252|NCT00974311|9760091|FG001|STARTED|DB Phase (up to 24 Months)||399
8713253|NCT00974311|9760090|FG000|COMPLETED|DB Phase (up to 24 Months)||109
8713254|NCT00974311|9760091|FG001|COMPLETED|DB Phase (up to 24 Months)||50
8713255|NCT00974311|9760090|FG000|NOT COMPLETED|DB Phase (up to 24 Months)||691
8713256|NCT00974311|9760091|FG001|NOT COMPLETED|DB Phase (up to 24 Months)||349
8713257|NCT00974311|9760090|FG000|STARTED|OLE Phase (up to 77 Months)||109
8713258|NCT00974311|9760091|FG001|STARTED|OLE Phase (up to 77 Months)||50
8713259|NCT00974311|9760090|FG000|COMPLETED|OLE Phase (up to 77 Months)||0
8713260|NCT00974311|9760091|FG001|COMPLETED|OLE Phase (up to 77 Months)||0
8713261|NCT00974311|9760090|FG000|NOT COMPLETED|OLE Phase (up to 77 Months)||109
8713262|NCT00974311|9760091|FG001|NOT COMPLETED|OLE Phase (up to 77 Months)||50
8713263|NCT00974350|9760103|FG000|STARTED|Overall Study||45
8713264|NCT00974350|9760104|FG001|STARTED|Overall Study||47
8713265|NCT00974350|9760105|FG002|STARTED|Overall Study||32
8713266|NCT00974350|9760103|FG000|COMPLETED|Overall Study||42
8713267|NCT00974350|9760104|FG001|COMPLETED|Overall Study||47
8713268|NCT00974350|9760105|FG002|COMPLETED|Overall Study||31
8713269|NCT00974350|9760103|FG000|NOT COMPLETED|Overall Study||3
8713270|NCT00974350|9760104|FG001|NOT COMPLETED|Overall Study||0
8713271|NCT00974350|9760105|FG002|NOT COMPLETED|Overall Study||1
8713272|NCT00974363|9760116|FG000|STARTED|Overall Study||521
8713273|NCT00974363|9760117|FG001|STARTED|Overall Study||168
8713274|NCT00974363|9760116|FG000|COMPLETED|Overall Study||521
8713275|NCT00974363|9760117|FG001|COMPLETED|Overall Study||168
8713276|NCT00974363|9760116|FG000|NOT COMPLETED|Overall Study||0
8713277|NCT00974363|9760117|FG001|NOT COMPLETED|Overall Study||0
8713278|NCT00974376|9760125|FG000|STARTED|Overall Study||75
8713279|NCT00974376|9760126|FG001|STARTED|Overall Study||75
8713280|NCT00974376|9760125|FG000|COMPLETED|Overall Study||41
8713281|NCT00974376|9760126|FG001|COMPLETED|Overall Study||42
8713282|NCT00974376|9760125|FG000|NOT COMPLETED|Overall Study||34
8713283|NCT00974376|9760126|FG001|NOT COMPLETED|Overall Study||33
8713284|NCT00974480|9760135|FG000|STARTED|Overall Study||40
8713285|NCT00974480|9760136|FG001|STARTED|Overall Study||40
8713286|NCT00974480|9760137|FG002|STARTED|Overall Study||40
8713287|NCT00974480|9760135|FG000|COMPLETED|Overall Study||29
8713288|NCT00974480|9760136|FG001|COMPLETED|Overall Study||33
8713289|NCT00974480|9760137|FG002|COMPLETED|Overall Study||30
8598872|NCT00352365|9634775|FG000|Eligible|Induction Therapy||38
8598873|NCT00352365|9634775|FG000|Eligible and Began Protocol Therapy|Induction Therapy||37
8598874|NCT00352365|9634775|FG000|COMPLETED|Induction Therapy||14
8598875|NCT00352365|9634775|FG000|NOT COMPLETED|Induction Therapy||27
8598876|NCT00352365|9634775|FG000|STARTED|Maintenance Therapy||12
8598877|NCT00352365|9634775|FG000|Eligible and Began Protocol Therapy|Maintenance Therapy||8
8598878|NCT00352365|9634775|FG000|COMPLETED|Maintenance Therapy||0
8598879|NCT00352365|9634775|FG000|NOT COMPLETED|Maintenance Therapy||12
8598880|NCT00352417|9634785|FG000|STARTED|Overall Study||24
8598881|NCT00352417|9634786|FG001|STARTED|Overall Study||26
8598882|NCT00352417|9634785|FG000|COMPLETED|Overall Study||19
8598883|NCT00352417|9634786|FG001|COMPLETED|Overall Study||21
8598884|NCT00352417|9634785|FG000|NOT COMPLETED|Overall Study||5
8598885|NCT00352417|9634786|FG001|NOT COMPLETED|Overall Study||5
8598886|NCT00352612|9634794|FG000|STARTED|Overall Study||100
8598887|NCT00352612|9634795|FG001|STARTED|Overall Study||100
8598888|NCT00352612|9634794|FG000|COMPLETED|Overall Study||100
8598889|NCT00352612|9634795|FG001|COMPLETED|Overall Study||100
8598890|NCT00352612|9634794|FG000|NOT COMPLETED|Overall Study||0
8598891|NCT00352612|9634795|FG001|NOT COMPLETED|Overall Study||0
8598892|NCT00352664|9634803|FG000|STARTED|Overall Study||27
8598893|NCT00352664|9634804|FG001|STARTED|Overall Study||0
8598894|NCT00352664|9634803|FG000|COMPLETED|Overall Study||20
8598895|NCT00352664|9634804|FG001|COMPLETED|Overall Study||0
8598896|NCT00352664|9634803|FG000|NOT COMPLETED|Overall Study||7
8598897|NCT00352664|9634804|FG001|NOT COMPLETED|Overall Study||0
8598898|NCT00352690|9634812|FG000|STARTED|Overall Study||10
8598899|NCT00352690|9634813|FG001|STARTED|Overall Study||0
8598900|NCT00352690|9634812|FG000|COMPLETED|Overall Study||8
8598901|NCT00352690|9634813|FG001|COMPLETED|Overall Study||0
8598902|NCT00352690|9634812|FG000|NOT COMPLETED|Overall Study||2
8598903|NCT00352690|9634813|FG001|NOT COMPLETED|Overall Study||0
8598904|NCT00352755|9634819|FG000|STARTED|Overall Study||18
8598905|NCT00352755|9634819|FG000|COMPLETED|Overall Study||16
8598906|NCT00352755|9634819|FG000|NOT COMPLETED|Overall Study||2
8598907|NCT00352781|9634823|FG000|STARTED|Overall Study||1767
8598908|NCT00352781|9634823|FG000|COMPLETED|Overall Study||884
8598909|NCT00352781|9634823|FG000|NOT COMPLETED|Overall Study||883
8598910|NCT00352794|9634827|FG000|STARTED|Overall Study||40
8598911|NCT00352794|9634827|FG000|COMPLETED|Overall Study||40
8598912|NCT00352794|9634827|FG000|NOT COMPLETED|Overall Study||0
8598913|NCT00352846|9634833|FG000|STARTED|Overall Study||37
8598914|NCT00352846|9634834|FG001|STARTED|Overall Study||37
8598915|NCT00352846|9634833|FG000|COMPLETED|Overall Study||29
8598916|NCT00352846|9634834|FG001|COMPLETED|Overall Study||24
8598917|NCT00352846|9634833|FG000|NOT COMPLETED|Overall Study||8
8598918|NCT00352846|9634834|FG001|NOT COMPLETED|Overall Study||13
8598919|NCT00352885|9634842|FG000|STARTED|Overall Study||9
8598920|NCT00352885|9634843|FG001|STARTED|Overall Study||11
8598921|NCT00352885|9634842|FG000|Completed Cycle 1 of IL-2 Treatment|Overall Study||9
8598922|NCT00352885|9634843|FG001|Completed Cycle 1 of IL-2 Treatment|Overall Study||11
8598923|NCT00352885|9634842|FG000|Completed Cycle 2 of IL-2 Treatment|Overall Study||8
8598924|NCT00352885|9634843|FG001|Completed Cycle 2 of IL-2 Treatment|Overall Study||9
8598925|NCT00352885|9634842|FG000|Completed Cycle 3 of IL-2 Treatment|Overall Study||4
8598926|NCT00352885|9634843|FG001|Completed Cycle 3 of IL-2 Treatment|Overall Study||7
8598927|NCT00352885|9634842|FG000|COMPLETED|Overall Study||3
8598928|NCT00352885|9634843|FG001|COMPLETED|Overall Study||4
8598929|NCT00352885|9634842|FG000|NOT COMPLETED|Overall Study||6
8598930|NCT00352885|9634843|FG001|NOT COMPLETED|Overall Study||7
8598931|NCT00352911|9634851|FG000|STARTED|150mg Twice Daily (14 Days)||16
8598932|NCT00352911|9634852|FG001|STARTED|150mg Twice Daily (14 Days)||3
8598933|NCT00352911|9634851|FG000|COMPLETED|150mg Twice Daily (14 Days)||16
8598934|NCT00352911|9634852|FG001|COMPLETED|150mg Twice Daily (14 Days)||3
8598935|NCT00352911|9634851|FG000|NOT COMPLETED|150mg Twice Daily (14 Days)||0
8598936|NCT00352911|9634852|FG001|NOT COMPLETED|150mg Twice Daily (14 Days)||0
8598937|NCT00352911|9634851|FG000|STARTED|300mg Twice Daily (14 Days)||16
8598938|NCT00352911|9634852|FG001|STARTED|300mg Twice Daily (14 Days)||3
8598939|NCT00352911|9634851|FG000|COMPLETED|300mg Twice Daily (14 Days)||15
8598940|NCT00352911|9634852|FG001|COMPLETED|300mg Twice Daily (14 Days)||3
8598941|NCT00352911|9634851|FG000|NOT COMPLETED|300mg Twice Daily (14 Days)||1
8598942|NCT00352911|9634852|FG001|NOT COMPLETED|300mg Twice Daily (14 Days)||0
8598943|NCT00352976|9634858|FG000|STARTED|Overall Study||83
8598944|NCT00352976|9634858|FG000|COMPLETED|Overall Study||83
8598945|NCT00352976|9634858|FG000|NOT COMPLETED|Overall Study||0
8598946|NCT00353119|9634865|FG000|STARTED|First Intervention Day 0 to Week 12||5
8598947|NCT00353119|9634866|FG001|STARTED|First Intervention Day 0 to Week 12||10
8598948|NCT00353119|9634865|FG000|COMPLETED|First Intervention Day 0 to Week 12||5
8598949|NCT00353119|9634866|FG001|COMPLETED|First Intervention Day 0 to Week 12||10
8598950|NCT00353119|9634865|FG000|NOT COMPLETED|First Intervention Day 0 to Week 12||0
8598951|NCT00353119|9634866|FG001|NOT COMPLETED|First Intervention Day 0 to Week 12||0
8598952|NCT00353119|9634865|FG000|STARTED|Second Intervention Week 12 to Week 28||5
8598953|NCT00353119|9634866|FG001|STARTED|Second Intervention Week 12 to Week 28||10
8598954|NCT00353119|9634865|FG000|COMPLETED|Second Intervention Week 12 to Week 28||5
8598955|NCT00353119|9634866|FG001|COMPLETED|Second Intervention Week 12 to Week 28||10
8598956|NCT00353119|9634865|FG000|NOT COMPLETED|Second Intervention Week 12 to Week 28||0
8598957|NCT00353119|9634866|FG001|NOT COMPLETED|Second Intervention Week 12 to Week 28||0
8598958|NCT00353262|9634875|FG000|STARTED|Overall Study||36
8598959|NCT00353262|9634875|FG000|COMPLETED|Overall Study||7
8598960|NCT00353262|9634875|FG000|NOT COMPLETED|Overall Study||29
8598961|NCT00353301|9634879|FG000|STARTED|Overall Study||25
8598962|NCT00353301|9634879|FG000|COMPLETED|Overall Study||25
8598963|NCT00353301|9634879|FG000|NOT COMPLETED|Overall Study||0
8598964|NCT00353366|9634883|FG000|STARTED|Overall Study||1439
8598965|NCT00353366|9634883|FG000|COMPLETED|Overall Study||1296
8598966|NCT00353366|9634883|FG000|NOT COMPLETED|Overall Study||143
8598967|NCT00353418|9634889|FG000|STARTED|Overall Study||138
8598968|NCT00353418|9634890|FG001|STARTED|Overall Study||277
8598969|NCT00353418|9634889|FG000|COMPLETED|Overall Study||55
8598970|NCT00353418|9634890|FG001|COMPLETED|Overall Study||119
8598971|NCT00353418|9634889|FG000|NOT COMPLETED|Overall Study||83
8598972|NCT00353418|9634890|FG001|NOT COMPLETED|Overall Study||158
8598973|NCT00353431|9634898|FG000|STARTED|Overall Study||63
8598974|NCT00353431|9634899|FG001|STARTED|Overall Study||67
8598975|NCT00353431|9634898|FG000|COMPLETED|Overall Study||63
8598976|NCT00353431|9634899|FG001|COMPLETED|Overall Study||67
8598977|NCT00353431|9634898|FG000|NOT COMPLETED|Overall Study||0
8598978|NCT00353431|9634899|FG001|NOT COMPLETED|Overall Study||0
8598979|NCT00353496|9634907|FG000|STARTED|Overall Study||101
8598980|NCT00353496|9634908|FG001|STARTED|Overall Study||103
8598981|NCT00353496|9634907|FG000|COMPLETED|Overall Study|Patients who completed specified assessments or met primary efficacy endpoint criteria for an event.|85
8598982|NCT00353496|9634908|FG001|COMPLETED|Overall Study||86
8598983|NCT00353496|9634907|FG000|NOT COMPLETED|Overall Study||16
8598984|NCT00353496|9634908|FG001|NOT COMPLETED|Overall Study||17
8598985|NCT00353522|9634917|FG000|STARTED|Overall Study||89
8598986|NCT00353522|9634918|FG001|STARTED|Overall Study||46
8598987|NCT00353522|9634917|FG000|COMPLETED|Overall Study||74
8598988|NCT00353522|9634918|FG001|COMPLETED|Overall Study||37
8598989|NCT00353522|9634917|FG000|NOT COMPLETED|Overall Study||15
8598990|NCT00353522|9634918|FG001|NOT COMPLETED|Overall Study||9
8598991|NCT00353652|9634926|FG000|STARTED|First Intervention - 3 Months||15
8598992|NCT00353652|9634927|FG001|STARTED|First Intervention - 3 Months||15
8598993|NCT00353652|9634928|FG002|STARTED|First Intervention - 3 Months||6
8598994|NCT00353652|9634929|FG003|STARTED|First Intervention - 3 Months||7
8598995|NCT00353652|9634930|FG004|STARTED|First Intervention - 3 Months||3
8598996|NCT00353652|9634931|FG005|STARTED|First Intervention - 3 Months||0
8598997|NCT00353652|9634932|FG006|STARTED|First Intervention - 3 Months||1
8598998|NCT00353652|9634933|FG007|STARTED|First Intervention - 3 Months||0
8598999|NCT00353652|9634926|FG000|COMPLETED|First Intervention - 3 Months||12
8599000|NCT00353652|9634927|FG001|COMPLETED|First Intervention - 3 Months||11
8599001|NCT00353652|9634928|FG002|COMPLETED|First Intervention - 3 Months||6
8599002|NCT00353652|9634929|FG003|COMPLETED|First Intervention - 3 Months||7
8599003|NCT00353652|9634930|FG004|COMPLETED|First Intervention - 3 Months||3
8599004|NCT00353652|9634931|FG005|COMPLETED|First Intervention - 3 Months||0
8599005|NCT00353652|9634932|FG006|COMPLETED|First Intervention - 3 Months||1
8599006|NCT00353652|9634933|FG007|COMPLETED|First Intervention - 3 Months||0
8599007|NCT00353652|9634926|FG000|NOT COMPLETED|First Intervention - 3 Months||3
8599008|NCT00353652|9634927|FG001|NOT COMPLETED|First Intervention - 3 Months||4
8599009|NCT00353652|9634928|FG002|NOT COMPLETED|First Intervention - 3 Months||0
8599010|NCT00353652|9634929|FG003|NOT COMPLETED|First Intervention - 3 Months||0
8599011|NCT00353652|9634930|FG004|NOT COMPLETED|First Intervention - 3 Months||0
8599012|NCT00353652|9634931|FG005|NOT COMPLETED|First Intervention - 3 Months||0
8599013|NCT00353652|9634932|FG006|NOT COMPLETED|First Intervention - 3 Months||0
8599014|NCT00353652|9634933|FG007|NOT COMPLETED|First Intervention - 3 Months||0
8599015|NCT00353652|9634926|FG000|STARTED|Second Intervention - 3 Months||12
8599016|NCT00353652|9634927|FG001|STARTED|Second Intervention - 3 Months||11
8599017|NCT00353652|9634928|FG002|STARTED|Second Intervention - 3 Months||6
8599018|NCT00353652|9634929|FG003|STARTED|Second Intervention - 3 Months||7
8599019|NCT00353652|9634930|FG004|STARTED|Second Intervention - 3 Months||3
8599020|NCT00353652|9634931|FG005|STARTED|Second Intervention - 3 Months||0
8599021|NCT00353652|9634932|FG006|STARTED|Second Intervention - 3 Months||1
8599022|NCT00353652|9634933|FG007|STARTED|Second Intervention - 3 Months||0
8599023|NCT00353652|9634926|FG000|COMPLETED|Second Intervention - 3 Months||12
8599024|NCT00353652|9634927|FG001|COMPLETED|Second Intervention - 3 Months||11
8599025|NCT00353652|9634928|FG002|COMPLETED|Second Intervention - 3 Months||6
8599026|NCT00353652|9634929|FG003|COMPLETED|Second Intervention - 3 Months||7
8599027|NCT00353652|9634930|FG004|COMPLETED|Second Intervention - 3 Months||3
8599028|NCT00353652|9634931|FG005|COMPLETED|Second Intervention - 3 Months||0
8599029|NCT00353652|9634932|FG006|COMPLETED|Second Intervention - 3 Months||1
8599030|NCT00353652|9634933|FG007|COMPLETED|Second Intervention - 3 Months||0
8599031|NCT00353652|9634926|FG000|NOT COMPLETED|Second Intervention - 3 Months||0
8599032|NCT00353652|9634927|FG001|NOT COMPLETED|Second Intervention - 3 Months||0
8599033|NCT00353652|9634928|FG002|NOT COMPLETED|Second Intervention - 3 Months||0
8599034|NCT00353652|9634929|FG003|NOT COMPLETED|Second Intervention - 3 Months||0
8599035|NCT00353652|9634930|FG004|NOT COMPLETED|Second Intervention - 3 Months||0
8599036|NCT00353652|9634931|FG005|NOT COMPLETED|Second Intervention - 3 Months||0
8599037|NCT00353652|9634932|FG006|NOT COMPLETED|Second Intervention - 3 Months||0
8599038|NCT00353652|9634933|FG007|NOT COMPLETED|Second Intervention - 3 Months||0
8599039|NCT00353652|9634926|FG000|STARTED|Third Intervention - 3 Months||0
8599040|NCT00353652|9634927|FG001|STARTED|Third Intervention - 3 Months||0
8599041|NCT00353652|9634928|FG002|STARTED|Third Intervention - 3 Months||6
8599042|NCT00353652|9634929|FG003|STARTED|Third Intervention - 3 Months||7
8599043|NCT00353652|9634930|FG004|STARTED|Third Intervention - 3 Months||3
8599044|NCT00353652|9634931|FG005|STARTED|Third Intervention - 3 Months||0
8599045|NCT00353652|9634932|FG006|STARTED|Third Intervention - 3 Months||1
8599046|NCT00353652|9634933|FG007|STARTED|Third Intervention - 3 Months||0
8599047|NCT00353652|9634926|FG000|COMPLETED|Third Intervention - 3 Months||0
8599048|NCT00353652|9634927|FG001|COMPLETED|Third Intervention - 3 Months||0
8599049|NCT00353652|9634928|FG002|COMPLETED|Third Intervention - 3 Months||6
8599050|NCT00353652|9634929|FG003|COMPLETED|Third Intervention - 3 Months||6
8599051|NCT00353652|9634930|FG004|COMPLETED|Third Intervention - 3 Months||3
8599052|NCT00353652|9634931|FG005|COMPLETED|Third Intervention - 3 Months||0
8599053|NCT00353652|9634932|FG006|COMPLETED|Third Intervention - 3 Months||1
8599054|NCT00353652|9634933|FG007|COMPLETED|Third Intervention - 3 Months||0
8599055|NCT00353652|9634926|FG000|NOT COMPLETED|Third Intervention - 3 Months||0
9064262|NCT04320615|10124560|FG000|COMPLETED|Overall Study||96
9064263|NCT04320615|10124561|FG001|COMPLETED|Overall Study||190
9064264|NCT04320615|10124560|FG000|NOT COMPLETED|Overall Study||48
9064265|NCT04320615|10124561|FG001|NOT COMPLETED|Overall Study||104
9064266|NCT04318535|10124571|FG000|STARTED|Treatment Period 1 (Day -1 to Day 5)||12
8599056|NCT00353652|9634927|FG001|NOT COMPLETED|Third Intervention - 3 Months||0
8599057|NCT00353652|9634928|FG002|NOT COMPLETED|Third Intervention - 3 Months||0
8599058|NCT00353652|9634929|FG003|NOT COMPLETED|Third Intervention - 3 Months||1
8599059|NCT00353652|9634930|FG004|NOT COMPLETED|Third Intervention - 3 Months||0
8599060|NCT00353652|9634931|FG005|NOT COMPLETED|Third Intervention - 3 Months||0
8599061|NCT00353652|9634932|FG006|NOT COMPLETED|Third Intervention - 3 Months||0
8599062|NCT00353652|9634933|FG007|NOT COMPLETED|Third Intervention - 3 Months||0
8599063|NCT00353704|9634950|FG000|STARTED|Overall Study||25
8599064|NCT00353704|9634951|FG001|STARTED|Overall Study||25
8599065|NCT00353704|9634950|FG000|COMPLETED|Overall Study||22
8599066|NCT00353704|9634951|FG001|COMPLETED|Overall Study||24
8599067|NCT00353704|9634950|FG000|NOT COMPLETED|Overall Study||3
8599068|NCT00353704|9634951|FG001|NOT COMPLETED|Overall Study||1
8599069|NCT00353795|9634957|FG000|STARTED|Overall Study||179
8599070|NCT00353795|9634957|FG000|COMPLETED|Overall Study||179
8599071|NCT00353795|9634957|FG000|NOT COMPLETED|Overall Study||0
8599072|NCT00353834|9634963|FG000|STARTED|Overall Study||26
8599073|NCT00353834|9634964|FG001|STARTED|Overall Study||27
8599074|NCT00353834|9634963|FG000|COMPLETED|Overall Study||26
8599075|NCT00353834|9634964|FG001|COMPLETED|Overall Study||27
8599076|NCT00353834|9634963|FG000|NOT COMPLETED|Overall Study||0
8599077|NCT00353834|9634964|FG001|NOT COMPLETED|Overall Study||0
8599078|NCT00353873|9634972|FG000|STARTED|Overall Study||153
8599079|NCT00353873|9634973|FG001|STARTED|Overall Study||150
8599080|NCT00353873|9634972|FG000|COMPLETED|Overall Study||147
8599081|NCT00353873|9634973|FG001|COMPLETED|Overall Study||147
8599082|NCT00353873|9634972|FG000|NOT COMPLETED|Overall Study||6
8599083|NCT00353873|9634973|FG001|NOT COMPLETED|Overall Study||3
8599084|NCT00353977|9634979|FG000|STARTED|Overall Study||38
8599085|NCT00353977|9634979|FG000|COMPLETED|Overall Study||38
8599086|NCT00353977|9634979|FG000|NOT COMPLETED|Overall Study||0
8599087|NCT00354029|9634985|FG000|STARTED|Overall Study||43
8599088|NCT00354029|9634986|FG001|STARTED|Overall Study||40
8599089|NCT00354029|9634985|FG000|COMPLETED|Overall Study||39
8599090|NCT00354029|9634986|FG001|COMPLETED|Overall Study||38
8599091|NCT00354029|9634985|FG000|NOT COMPLETED|Overall Study||4
8599092|NCT00354029|9634986|FG001|NOT COMPLETED|Overall Study||2
8599093|NCT00354107|9634992|FG000|STARTED|Overall Study||5
8599094|NCT00354107|9634992|FG000|COMPLETED|Overall Study||0
8599095|NCT00354107|9634992|FG000|NOT COMPLETED|Overall Study||5
8599096|NCT00354159|9634998|FG000|STARTED|Randomized Study Period||202
8599097|NCT00354159|9634999|FG001|STARTED|Randomized Study Period||198
8599098|NCT00354159|9634998|FG000|COMPLETED|Randomized Study Period||180
8599099|NCT00354159|9634999|FG001|COMPLETED|Randomized Study Period||176
8599100|NCT00354159|9634998|FG000|NOT COMPLETED|Randomized Study Period||22
8599101|NCT00354159|9634999|FG001|NOT COMPLETED|Randomized Study Period||22
8599102|NCT00354159|9634998|FG000|STARTED|Long-term Follow-up|Number entering post 12-month non-randomized long-term follow-up period|180
8599103|NCT00354159|9634999|FG001|STARTED|Long-term Follow-up|Number entering post 12-month non-randomized long-term follow-up period|176
8599104|NCT00354159|9634998|FG000|COMPLETED|Long-term Follow-up|All subjects were exited at the time of study closure|0
8599105|NCT00354159|9634999|FG001|COMPLETED|Long-term Follow-up|All subjects were exited at the time of study closure|0
8599106|NCT00354159|9634998|FG000|NOT COMPLETED|Long-term Follow-up||180
8599107|NCT00354159|9634999|FG001|NOT COMPLETED|Long-term Follow-up||176
8599108|NCT00354172|9635012|FG000|STARTED|Overall Study||16
8599109|NCT00354172|9635012|FG000|COMPLETED|Overall Study|1 patient did not reach umbilical cord blood transplant|15
8599110|NCT00354172|9635012|FG000|NOT COMPLETED|Overall Study||1
8599111|NCT00354224|9635016|FG000|STARTED|Overall Study||10
8599112|NCT00354224|9635016|FG000|COMPLETED|Overall Study||10
8599113|NCT00354224|9635016|FG000|NOT COMPLETED|Overall Study||0
8599114|NCT00354341|9635022|FG000|STARTED|Overall Study||88
8599115|NCT00354341|9635023|FG001|STARTED|Overall Study||82
8599116|NCT00354341|9635022|FG000|COMPLETED|Overall Study||85
8599117|NCT00354341|9635023|FG001|COMPLETED|Overall Study||75
8599118|NCT00354341|9635022|FG000|NOT COMPLETED|Overall Study||3
9064267|NCT04318535|10124572|FG001|STARTED|Treatment Period 1 (Day -1 to Day 5)||12
8599119|NCT00354341|9635023|FG001|NOT COMPLETED|Overall Study||7
8599120|NCT00354432|9635033|FG000|STARTED|Overall Study||30
8599121|NCT00354432|9635034|FG001|STARTED|Overall Study||30
8599122|NCT00354432|9635035|FG002|STARTED|Overall Study||30
8599123|NCT00354432|9635036|FG003|STARTED|Overall Study||30
8599124|NCT00354432|9635033|FG000|COMPLETED|Overall Study||24
8599125|NCT00354432|9635034|FG001|COMPLETED|Overall Study||22
8599126|NCT00354432|9635035|FG002|COMPLETED|Overall Study||20
8599127|NCT00354432|9635036|FG003|COMPLETED|Overall Study||20
8599128|NCT00354432|9635033|FG000|NOT COMPLETED|Overall Study||6
8599129|NCT00354432|9635034|FG001|NOT COMPLETED|Overall Study||8
8599130|NCT00354432|9635035|FG002|NOT COMPLETED|Overall Study||10
8599131|NCT00354432|9635036|FG003|NOT COMPLETED|Overall Study||10
8599132|NCT00354484|9635048|FG000|STARTED|Overall Study||142
8599133|NCT00354484|9635049|FG001|STARTED|Overall Study||147
8599134|NCT00354484|9635048|FG000|COMPLETED|Overall Study||138
8599135|NCT00354484|9635049|FG001|COMPLETED|Overall Study||144
8599136|NCT00354484|9635048|FG000|NOT COMPLETED|Overall Study||4
8599137|NCT00354484|9635049|FG001|NOT COMPLETED|Overall Study||3
8599138|NCT00354601|9635055|FG000|STARTED|Overall Study||2
8599139|NCT00354601|9635055|FG000|COMPLETED|Overall Study||0
8599140|NCT00354601|9635055|FG000|NOT COMPLETED|Overall Study||2
8599141|NCT00354614|9635059|FG000|STARTED|Overall Study||81
8599142|NCT00354614|9635059|FG000|COMPLETED|Overall Study||53
8599143|NCT00354614|9635059|FG000|NOT COMPLETED|Overall Study||28
8599144|NCT00354640|9635063|FG000|STARTED|Overall Study||11
8599145|NCT00354640|9635063|FG000|COMPLETED|Overall Study||11
8599146|NCT00354640|9635063|FG000|NOT COMPLETED|Overall Study||0
8599147|NCT00354679|9635067|FG000|STARTED|Overall Study||34
8599148|NCT00354679|9635067|FG000|COMPLETED|Overall Study||33
8599149|NCT00354679|9635067|FG000|NOT COMPLETED|Overall Study||1
8599150|NCT00354744|9635071|FG000|STARTED|Overall Study||109
8599151|NCT00354744|9635071|FG000|COMPLETED|Overall Study||67
8599152|NCT00354744|9635071|FG000|NOT COMPLETED|Overall Study||42
8599153|NCT00354770|9635079|FG000|STARTED|Overall Study||25
8599154|NCT00354770|9635080|FG001|STARTED|Overall Study||25
8599155|NCT00354770|9635079|FG000|COMPLETED|Overall Study||22
8599156|NCT00354770|9635080|FG001|COMPLETED|Overall Study||22
8599157|NCT00354770|9635079|FG000|NOT COMPLETED|Overall Study||3
8599158|NCT00354770|9635080|FG001|NOT COMPLETED|Overall Study||3
8599159|NCT00354887|9635086|FG000|STARTED|Overall Study||30
8599160|NCT00354887|9635086|FG000|COMPLETED|Overall Study||29
8599161|NCT00354887|9635086|FG000|NOT COMPLETED|Overall Study||1
8599162|NCT00354913|9635090|FG000|STARTED|Overall Study||21
8599163|NCT00354913|9635090|FG000|COMPLETED|Overall Study||21
8599164|NCT00354913|9635090|FG000|NOT COMPLETED|Overall Study||0
8599165|NCT00354978|9635094|FG000|STARTED|Overall Study||43
8599166|NCT00354978|9635094|FG000|COMPLETED|Overall Study||43
8599167|NCT00354978|9635094|FG000|NOT COMPLETED|Overall Study||0
8599168|NCT00355030|9635100|FG000|STARTED|Study Period 1 Treatment||46
8599169|NCT00355030|9635101|FG001|STARTED|Study Period 1 Treatment||45
8599170|NCT00355030|9635100|FG000|Received At Least One Dose of Study Drug|Study Period 1 Treatment|1 non-eligible participant received somatropin from previous control group|45
8599171|NCT00355030|9635101|FG001|Received At Least One Dose of Study Drug|Study Period 1 Treatment|2 non-eligible participants received somatropin from previous control group|43
8599172|NCT00355030|9635100|FG000|COMPLETED|Study Period 1 Treatment|Participants from the Netherlands exited the study after Study Period 1.|1
8599173|NCT00355030|9635101|FG001|COMPLETED|Study Period 1 Treatment|Participants from the Netherlands exited the study after Study Period 1.|1
8599174|NCT00355030|9635100|FG000|NOT COMPLETED|Study Period 1 Treatment||45
8599175|NCT00355030|9635101|FG001|NOT COMPLETED|Study Period 1 Treatment||44
8599176|NCT00355030|9635100|FG000|STARTED|Study Period 2 Long Term Follow-Up|Participants from France were given the option to re-consent for Study Period 2.|20
8599177|NCT00355030|9635101|FG001|STARTED|Study Period 2 Long Term Follow-Up|Participants from France were given the option to re-consent for Study Period 2.|19
8599178|NCT00355030|9635100|FG000|COMPLETED|Study Period 2 Long Term Follow-Up||19
8599179|NCT00355030|9635101|FG001|COMPLETED|Study Period 2 Long Term Follow-Up||17
8599180|NCT00355030|9635100|FG000|NOT COMPLETED|Study Period 2 Long Term Follow-Up||1
8599181|NCT00355030|9635101|FG001|NOT COMPLETED|Study Period 2 Long Term Follow-Up||2
8599182|NCT00355056|9635109|FG000|STARTED|Randomization Period||107
8599183|NCT00355056|9635110|FG001|STARTED|Randomization Period||123
8599184|NCT00355056|9635109|FG000|COMPLETED|Randomization Period||103
8599185|NCT00355056|9635110|FG001|COMPLETED|Randomization Period||117
8599186|NCT00355056|9635109|FG000|NOT COMPLETED|Randomization Period||4
8599187|NCT00355056|9635110|FG001|NOT COMPLETED|Randomization Period||6
8599188|NCT00355056|9635109|FG000|STARTED|Optional Patent Foramen Ovale Closure|A sham procedure was not part of this period.|0
8599189|NCT00355056|9635110|FG001|STARTED|Optional Patent Foramen Ovale Closure|Participants who completed Sham Procedure randomization Arm were eligible. 87/103 consented.|87
8599190|NCT00355056|9635109|FG000|COMPLETED|Optional Patent Foramen Ovale Closure||0
8599191|NCT00355056|9635110|FG001|COMPLETED|Optional Patent Foramen Ovale Closure||84
8599192|NCT00355056|9635109|FG000|NOT COMPLETED|Optional Patent Foramen Ovale Closure||0
8599193|NCT00355056|9635110|FG001|NOT COMPLETED|Optional Patent Foramen Ovale Closure||3
8599194|NCT00355082|9635126|FG000|STARTED|Double-Blind (DB) Treatment Phase|112 participants have baseline data; 1 participant did not receive study drug.|113
8599195|NCT00355082|9635127|FG001|STARTED|Double-Blind (DB) Treatment Phase|111 participants have baseline data; 2 participants did not receive study drug.|113
8599196|NCT00355082|9635128|FG002|STARTED|Double-Blind (DB) Treatment Phase||0
8599197|NCT00355082|9635126|FG000|COMPLETED|Double-Blind (DB) Treatment Phase||94
8599198|NCT00355082|9635127|FG001|COMPLETED|Double-Blind (DB) Treatment Phase||79
8599199|NCT00355082|9635128|FG002|COMPLETED|Double-Blind (DB) Treatment Phase||0
8599200|NCT00355082|9635126|FG000|NOT COMPLETED|Double-Blind (DB) Treatment Phase||19
8599201|NCT00355082|9635127|FG001|NOT COMPLETED|Double-Blind (DB) Treatment Phase||34
8599202|NCT00355082|9635128|FG002|NOT COMPLETED|Double-Blind (DB) Treatment Phase||0
8599203|NCT00355082|9635126|FG000|STARTED|Continuation Phase|83 and 101 participants from the 250 and 300 mg groups (DB Phase), respectively, entered the CP.|184
8599204|NCT00355082|9635127|FG001|STARTED|Continuation Phase||0
8599205|NCT00355082|9635128|FG002|STARTED|Continuation Phase|"See Pre-assign. Details for reasons why number starting CP does not equal number completing TP."|11
8599206|NCT00355082|9635126|FG000|COMPLETED|Continuation Phase||160
8599207|NCT00355082|9635127|FG001|COMPLETED|Continuation Phase||0
8599208|NCT00355082|9635128|FG002|COMPLETED|Continuation Phase||8
8599209|NCT00355082|9635126|FG000|NOT COMPLETED|Continuation Phase||24
8599210|NCT00355082|9635127|FG001|NOT COMPLETED|Continuation Phase||0
8599211|NCT00355082|9635128|FG002|NOT COMPLETED|Continuation Phase||3
8599212|NCT00355121|9635142|FG000|STARTED|Overall Study||353
8599213|NCT00355121|9635143|FG001|STARTED|Overall Study||353
8599214|NCT00355121|9635144|FG002|STARTED|Overall Study||175
8599215|NCT00355121|9635142|FG000|COMPLETED|Overall Study||332
8599216|NCT00355121|9635143|FG001|COMPLETED|Overall Study||324
8599217|NCT00355121|9635144|FG002|COMPLETED|Overall Study||170
8599218|NCT00355121|9635142|FG000|NOT COMPLETED|Overall Study||21
8599219|NCT00355121|9635143|FG001|NOT COMPLETED|Overall Study||29
8599220|NCT00355121|9635144|FG002|NOT COMPLETED|Overall Study||5
8599221|NCT00355134|9635160|FG000|STARTED|Core Phase||370
8599222|NCT00355134|9635161|FG001|STARTED|Core Phase||358
8599223|NCT00355134|9635162|FG002|STARTED|Core Phase||355
8599224|NCT00355134|9635163|FG003|STARTED|Core Phase||0
8599225|NCT00355134|9635164|FG004|STARTED|Core Phase||0
8599226|NCT00355134|9635160|FG000|COMPLETED|Core Phase||251
8599227|NCT00355134|9635161|FG001|COMPLETED|Core Phase||272
8599228|NCT00355134|9635162|FG002|COMPLETED|Core Phase||255
8599229|NCT00355134|9635163|FG003|COMPLETED|Core Phase||0
8599230|NCT00355134|9635164|FG004|COMPLETED|Core Phase||0
8599231|NCT00355134|9635160|FG000|NOT COMPLETED|Core Phase||119
8599232|NCT00355134|9635161|FG001|NOT COMPLETED|Core Phase||86
8599233|NCT00355134|9635162|FG002|NOT COMPLETED|Core Phase||100
8599234|NCT00355134|9635163|FG003|NOT COMPLETED|Core Phase||0
8599235|NCT00355134|9635164|FG004|NOT COMPLETED|Core Phase||0
8599236|NCT00355134|9635160|FG000|STARTED|Extension Phase||203
8599237|NCT00355134|9635161|FG001|STARTED|Extension Phase||217
8599238|NCT00355134|9635162|FG002|STARTED|Extension Phase||0
8599239|NCT00355134|9635163|FG003|STARTED|Extension Phase||105
8599240|NCT00355134|9635164|FG004|STARTED|Extension Phase||107
8599241|NCT00355134|9635160|FG000|COMPLETED|Extension Phase||172
8599242|NCT00355134|9635161|FG001|COMPLETED|Extension Phase||180
8599243|NCT00355134|9635162|FG002|COMPLETED|Extension Phase||0
8599244|NCT00355134|9635163|FG003|COMPLETED|Extension Phase||89
8599245|NCT00355134|9635164|FG004|COMPLETED|Extension Phase||88
8599246|NCT00355134|9635160|FG000|NOT COMPLETED|Extension Phase||31
8599247|NCT00355134|9635161|FG001|NOT COMPLETED|Extension Phase||37
8599248|NCT00355134|9635162|FG002|NOT COMPLETED|Extension Phase||0
8599249|NCT00355134|9635163|FG003|NOT COMPLETED|Extension Phase||16
8599250|NCT00355134|9635164|FG004|NOT COMPLETED|Extension Phase||19
8599251|NCT00355147|9635176|FG000|STARTED|Overall Study||87
8599252|NCT00355147|9635177|FG001|STARTED|Overall Study||87
8713290|NCT00974480|9760135|FG000|NOT COMPLETED|Overall Study||11
8713291|NCT00974480|9760136|FG001|NOT COMPLETED|Overall Study||7
8713292|NCT00974480|9760137|FG002|NOT COMPLETED|Overall Study||10
8713293|NCT00974493|9760153|FG000|STARTED|Overall Study||527
8713294|NCT00974493|9760154|FG001|STARTED|Overall Study||527
8713295|NCT00974493|9760153|FG000|COMPLETED|Overall Study||509
8713296|NCT00974493|9760154|FG001|COMPLETED|Overall Study||506
8713297|NCT00974493|9760153|FG000|NOT COMPLETED|Overall Study||18
8713298|NCT00974493|9760154|FG001|NOT COMPLETED|Overall Study||21
8713299|NCT00974675|9760164|FG000|STARTED|Overall Study||8
8713300|NCT00974675|9760165|FG001|STARTED|Overall Study||8
8713301|NCT00974675|9760166|FG002|STARTED|Overall Study||3
8713302|NCT00974675|9760167|FG003|STARTED|Overall Study||4
8713303|NCT00974675|9760164|FG000|COMPLETED|Overall Study||6
8713304|NCT00974675|9760165|FG001|COMPLETED|Overall Study||7
8713305|NCT00974675|9760166|FG002|COMPLETED|Overall Study||1
8713306|NCT00974675|9760167|FG003|COMPLETED|Overall Study||2
8713307|NCT00974675|9760164|FG000|NOT COMPLETED|Overall Study||2
8713308|NCT00974675|9760165|FG001|NOT COMPLETED|Overall Study||1
8713309|NCT00974675|9760166|FG002|NOT COMPLETED|Overall Study||2
8713310|NCT00974675|9760167|FG003|NOT COMPLETED|Overall Study||2
8713311|NCT00974818|9760179|FG000|STARTED|Overall Study||25
8599253|NCT00355147|9635176|FG000|COMPLETED|Overall Study||69
8599254|NCT00355147|9635177|FG001|COMPLETED|Overall Study||67
8599255|NCT00355147|9635176|FG000|NOT COMPLETED|Overall Study||18
8713312|NCT00974818|9760180|FG001|STARTED|Overall Study||25
8599256|NCT00355147|9635177|FG001|NOT COMPLETED|Overall Study||20
8599257|NCT00355199|9635189|FG000|STARTED|Overall Study||120
8713313|NCT00974818|9760179|FG000|COMPLETED|Overall Study||25
8599258|NCT00355199|9635190|FG001|STARTED|Overall Study||126
8599259|NCT00355199|9635189|FG000|COMPLETED|Overall Study||113
8599260|NCT00355199|9635190|FG001|COMPLETED|Overall Study||122
8713314|NCT00974818|9760180|FG001|COMPLETED|Overall Study||25
8713315|NCT00974818|9760179|FG000|NOT COMPLETED|Overall Study||0
8599261|NCT00355199|9635189|FG000|NOT COMPLETED|Overall Study||7
8599262|NCT00355199|9635190|FG001|NOT COMPLETED|Overall Study||4
8599263|NCT00355264|9635196|FG000|STARTED|Part 1 (2 Weeks)||12
8599264|NCT00355264|9635196|FG000|COMPLETED|Part 1 (2 Weeks)||12
8599265|NCT00355264|9635196|FG000|NOT COMPLETED|Part 1 (2 Weeks)||0
8599266|NCT00355264|9635196|FG000|STARTED|Part 2 (8 Weeks)||12
8599267|NCT00355264|9635196|FG000|COMPLETED|Part 2 (8 Weeks)||12
8599268|NCT00355264|9635196|FG000|NOT COMPLETED|Part 2 (8 Weeks)||0
8599269|NCT00355264|9635196|FG000|STARTED|Part 3 (7 Weeks of Extension)||2
8599270|NCT00355264|9635196|FG000|COMPLETED|Part 3 (7 Weeks of Extension)||2
8599271|NCT00355264|9635196|FG000|NOT COMPLETED|Part 3 (7 Weeks of Extension)||0
8599272|NCT00355264|9635196|FG000|STARTED|Extension (Variable Duration)||12
8599273|NCT00355264|9635196|FG000|COMPLETED|Extension (Variable Duration)||10
8599274|NCT00355264|9635196|FG000|NOT COMPLETED|Extension (Variable Duration)||2
8599275|NCT00355342|9635207|FG000|STARTED|Overall Study||94
8599276|NCT00355342|9635208|FG001|STARTED|Overall Study||92
8599277|NCT00355342|9635207|FG000|COMPLETED|Overall Study||55
8599278|NCT00355342|9635208|FG001|COMPLETED|Overall Study||56
8599279|NCT00355342|9635207|FG000|NOT COMPLETED|Overall Study||39
8599280|NCT00355342|9635208|FG001|NOT COMPLETED|Overall Study||36
8599281|NCT00355368|9635216|FG000|STARTED|Overall Study||210
8599282|NCT00355368|9635217|FG001|STARTED|Overall Study||210
8599283|NCT00355368|9635216|FG000|COMPLETED|Overall Study||200
8599284|NCT00355368|9635217|FG001|COMPLETED|Overall Study||201
8599285|NCT00355368|9635216|FG000|NOT COMPLETED|Overall Study||10
8599286|NCT00355368|9635217|FG001|NOT COMPLETED|Overall Study||9
8599287|NCT00355394|9635225|FG000|STARTED|Overall Study||15
8599288|NCT00355394|9635226|FG001|STARTED|Overall Study||16
8599289|NCT00355394|9635225|FG000|COMPLETED|Overall Study||15
8599290|NCT00355394|9635226|FG001|COMPLETED|Overall Study||16
8599291|NCT00355394|9635225|FG000|NOT COMPLETED|Overall Study||0
8599292|NCT00355394|9635226|FG001|NOT COMPLETED|Overall Study||0
8599293|NCT00355472|9635234|FG000|STARTED|Overall Study||16
8713316|NCT00974818|9760180|FG001|NOT COMPLETED|Overall Study||0
8713317|NCT00974974|9760188|FG000|STARTED|IR CD-LD Dose Adjustment||0
8713318|NCT00974974|9760189|FG001|STARTED|IR CD-LD Dose Adjustment||471
8713319|NCT00974974|9760188|FG000|COMPLETED|IR CD-LD Dose Adjustment||0
8599294|NCT00355472|9635234|FG000|COMPLETED|Overall Study||15
8599295|NCT00355472|9635234|FG000|NOT COMPLETED|Overall Study||1
8599296|NCT00355615|9635250|FG000|STARTED|Randomized Double Blind Period||42
8599297|NCT00355615|9635251|FG001|STARTED|Randomized Double Blind Period||44
8599298|NCT00355615|9635252|FG002|STARTED|Randomized Double Blind Period||45
8599299|NCT00355615|9635253|FG003|STARTED|Randomized Double Blind Period||46
8599300|NCT00355615|9635254|FG004|STARTED|Randomized Double Blind Period|open label phase followed the randomized phase|0
8599301|NCT00355615|9635250|FG000|COMPLETED|Randomized Double Blind Period|1 dropped out due to adverse event|41
8599302|NCT00355615|9635251|FG001|COMPLETED|Randomized Double Blind Period||44
8599303|NCT00355615|9635252|FG002|COMPLETED|Randomized Double Blind Period|45 were randomized but 1 never received drug|44
8599304|NCT00355615|9635253|FG003|COMPLETED|Randomized Double Blind Period|1 dropped out due to an adverse event|45
8599305|NCT00355615|9635254|FG004|COMPLETED|Randomized Double Blind Period||0
8599306|NCT00355615|9635250|FG000|NOT COMPLETED|Randomized Double Blind Period||1
8599307|NCT00355615|9635251|FG001|NOT COMPLETED|Randomized Double Blind Period||0
8599308|NCT00355615|9635252|FG002|NOT COMPLETED|Randomized Double Blind Period||1
8599309|NCT00355615|9635253|FG003|NOT COMPLETED|Randomized Double Blind Period||1
8599310|NCT00355615|9635254|FG004|NOT COMPLETED|Randomized Double Blind Period||0
8599311|NCT00355615|9635250|FG000|STARTED|40-week Rosuvastatin Open Label Period||0
8599312|NCT00355615|9635251|FG001|STARTED|40-week Rosuvastatin Open Label Period||0
8599313|NCT00355615|9635252|FG002|STARTED|40-week Rosuvastatin Open Label Period||0
8599314|NCT00355615|9635253|FG003|STARTED|40-week Rosuvastatin Open Label Period||0
8599315|NCT00355615|9635254|FG004|STARTED|40-week Rosuvastatin Open Label Period||173
8599316|NCT00355615|9635250|FG000|COMPLETED|40-week Rosuvastatin Open Label Period||0
8599317|NCT00355615|9635251|FG001|COMPLETED|40-week Rosuvastatin Open Label Period||0
8599318|NCT00355615|9635252|FG002|COMPLETED|40-week Rosuvastatin Open Label Period||0
8599319|NCT00355615|9635253|FG003|COMPLETED|40-week Rosuvastatin Open Label Period||0
8599320|NCT00355615|9635254|FG004|COMPLETED|40-week Rosuvastatin Open Label Period||164
8599321|NCT00355615|9635250|FG000|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
8599322|NCT00355615|9635251|FG001|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
8599323|NCT00355615|9635252|FG002|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
8599324|NCT00355615|9635253|FG003|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
8599325|NCT00355615|9635254|FG004|NOT COMPLETED|40-week Rosuvastatin Open Label Period||9
8599326|NCT00355706|9635267|FG000|STARTED|Overall Study||50
8599327|NCT00355706|9635268|FG001|STARTED|Overall Study||50
8599328|NCT00355706|9635267|FG000|COMPLETED|Overall Study||50
8599329|NCT00355706|9635268|FG001|COMPLETED|Overall Study||50
8599330|NCT00355706|9635267|FG000|NOT COMPLETED|Overall Study||0
8599331|NCT00355706|9635268|FG001|NOT COMPLETED|Overall Study||0
8599332|NCT00355784|9635279|FG000|STARTED|Overall Study||9
8599333|NCT00355784|9635280|FG001|STARTED|Overall Study||8
8599334|NCT00355784|9635281|FG002|STARTED|Overall Study||7
8599335|NCT00355784|9635279|FG000|COMPLETED|Overall Study||9
8599336|NCT00355784|9635280|FG001|COMPLETED|Overall Study||8
8599337|NCT00355784|9635281|FG002|COMPLETED|Overall Study||5
8599338|NCT00355784|9635279|FG000|NOT COMPLETED|Overall Study||0
8599339|NCT00355784|9635280|FG001|NOT COMPLETED|Overall Study||0
8599340|NCT00355784|9635281|FG002|NOT COMPLETED|Overall Study||2
8599341|NCT00355797|9635293|FG000|STARTED|Overall Study||741
8599342|NCT00355797|9635294|FG001|STARTED|Overall Study||369
8599343|NCT00355797|9635295|FG002|STARTED|Overall Study||381
8599344|NCT00355797|9635293|FG000|COMPLETED|Overall Study||501
8599345|NCT00355797|9635294|FG001|COMPLETED|Overall Study||221
8599346|NCT00355797|9635295|FG002|COMPLETED|Overall Study||239
8599347|NCT00355797|9635293|FG000|NOT COMPLETED|Overall Study||240
8599348|NCT00355797|9635294|FG001|NOT COMPLETED|Overall Study||148
8599349|NCT00355797|9635295|FG002|NOT COMPLETED|Overall Study||142
8599350|NCT00355914|9635305|FG000|STARTED|Overall Study||60
8599351|NCT00355914|9635306|FG001|STARTED|Overall Study||60
8599352|NCT00355914|9635305|FG000|COMPLETED|Overall Study||60
8599353|NCT00355914|9635306|FG001|COMPLETED|Overall Study||60
8599354|NCT00355914|9635305|FG000|NOT COMPLETED|Overall Study||0
8599355|NCT00355914|9635306|FG001|NOT COMPLETED|Overall Study||0
8599356|NCT00356031|9635314|FG000|STARTED|Overall Study||20
8599357|NCT00356031|9635314|FG000|COMPLETED|Overall Study||20
8599358|NCT00356031|9635314|FG000|NOT COMPLETED|Overall Study||0
8599359|NCT00356057|9635323|FG000|STARTED|Overall Study||58
8599360|NCT00356057|9635324|FG001|STARTED|Overall Study||61
8599361|NCT00356057|9635325|FG002|STARTED|Overall Study||34
8599362|NCT00356057|9635323|FG000|IMPLANTED|Overall Study||49
8599363|NCT00356057|9635324|FG001|IMPLANTED|Overall Study||52
8599364|NCT00356057|9635325|FG002|IMPLANTED|Overall Study||25
8599365|NCT00356057|9635323|FG000|COMPLETED|Overall Study||45
8599366|NCT00356057|9635324|FG001|COMPLETED|Overall Study||47
8599367|NCT00356057|9635325|FG002|COMPLETED|Overall Study||22
8599368|NCT00356057|9635323|FG000|NOT COMPLETED|Overall Study||13
8599369|NCT00356057|9635324|FG001|NOT COMPLETED|Overall Study||14
8599370|NCT00356057|9635325|FG002|NOT COMPLETED|Overall Study||12
8599371|NCT00356122|9635337|FG000|STARTED|TREATMENT||53
8599372|NCT00356122|9635337|FG000|COMPLETED|TREATMENT||8
8599373|NCT00356122|9635337|FG000|NOT COMPLETED|TREATMENT||45
8599374|NCT00356122|9635337|FG000|STARTED|FOLLOW-UP||53
8599375|NCT00356122|9635337|FG000|COMPLETED|FOLLOW-UP||12
8599376|NCT00356122|9635337|FG000|NOT COMPLETED|FOLLOW-UP||41
8599377|NCT00356135|9635344|FG000|STARTED|Overall Study||47
8599378|NCT00356135|9635345|FG001|STARTED|Overall Study||48
8599379|NCT00356135|9635346|FG002|STARTED|Overall Study||44
8599380|NCT00356135|9635344|FG000|COMPLETED|Overall Study||43
8599381|NCT00356135|9635345|FG001|COMPLETED|Overall Study||46
8599382|NCT00356135|9635346|FG002|COMPLETED|Overall Study||39
8599383|NCT00356135|9635344|FG000|NOT COMPLETED|Overall Study||4
8599384|NCT00356135|9635345|FG001|NOT COMPLETED|Overall Study||2
8599385|NCT00356135|9635346|FG002|NOT COMPLETED|Overall Study||5
8599386|NCT00356148|9635358|FG000|STARTED|Overall Study||189
8599387|NCT00356148|9635359|FG001|STARTED|Overall Study||183
8599388|NCT00356148|9635358|FG000|COMPLETED|Overall Study||187
8599389|NCT00356148|9635359|FG001|COMPLETED|Overall Study||182
8599390|NCT00356148|9635358|FG000|NOT COMPLETED|Overall Study||2
8599391|NCT00356148|9635359|FG001|NOT COMPLETED|Overall Study||1
8599392|NCT00356200|9635368|FG000|STARTED|Cohort 1: 10 ug/ml||5
8599393|NCT00356200|9635369|FG001|STARTED|Cohort 1: 10 ug/ml||0
8599394|NCT00356200|9635368|FG000|COMPLETED|Cohort 1: 10 ug/ml||4
8599395|NCT00356200|9635369|FG001|COMPLETED|Cohort 1: 10 ug/ml||0
8599396|NCT00356200|9635368|FG000|NOT COMPLETED|Cohort 1: 10 ug/ml||1
8599397|NCT00356200|9635369|FG001|NOT COMPLETED|Cohort 1: 10 ug/ml||0
8599398|NCT00356200|9635368|FG000|STARTED|Cohort 2: 100 ug/ml (New Patients)||0
8599399|NCT00356200|9635369|FG001|STARTED|Cohort 2: 100 ug/ml (New Patients)||5
8599400|NCT00356200|9635368|FG000|COMPLETED|Cohort 2: 100 ug/ml (New Patients)||0
8599401|NCT00356200|9635369|FG001|COMPLETED|Cohort 2: 100 ug/ml (New Patients)||3
8599402|NCT00356200|9635368|FG000|NOT COMPLETED|Cohort 2: 100 ug/ml (New Patients)||0
8599403|NCT00356200|9635369|FG001|NOT COMPLETED|Cohort 2: 100 ug/ml (New Patients)||2
8599404|NCT00356265|9635384|FG000|STARTED|Overall Study||7
8599405|NCT00356265|9635385|FG001|STARTED|Overall Study||2
8599406|NCT00356265|9635386|FG002|STARTED|Overall Study||6
8599407|NCT00356265|9635384|FG000|COMPLETED|Overall Study||7
8599408|NCT00356265|9635385|FG001|COMPLETED|Overall Study||2
8599409|NCT00356265|9635386|FG002|COMPLETED|Overall Study||5
8599410|NCT00356265|9635384|FG000|NOT COMPLETED|Overall Study||0
8599411|NCT00356265|9635385|FG001|NOT COMPLETED|Overall Study||0
8599412|NCT00356265|9635386|FG002|NOT COMPLETED|Overall Study||1
8599413|NCT00356278|9635398|FG000|STARTED|Overall Study||53
8599414|NCT00356278|9635399|FG001|STARTED|Overall Study||50
8599415|NCT00356278|9635400|FG002|STARTED|Overall Study||53
8599416|NCT00356278|9635398|FG000|COMPLETED|Overall Study||28
8599417|NCT00356278|9635399|FG001|COMPLETED|Overall Study||35
8599418|NCT00356278|9635400|FG002|COMPLETED|Overall Study||34
8599419|NCT00356278|9635398|FG000|NOT COMPLETED|Overall Study||25
8599420|NCT00356278|9635399|FG001|NOT COMPLETED|Overall Study||15
8599421|NCT00356278|9635400|FG002|NOT COMPLETED|Overall Study||19
8599422|NCT00356304|9635410|FG000|STARTED|Overall Study||26
8599423|NCT00356304|9635411|FG001|STARTED|Overall Study||24
8599424|NCT00356304|9635410|FG000|COMPLETED|Overall Study||24
8599425|NCT00356304|9635411|FG001|COMPLETED|Overall Study||20
8599426|NCT00356304|9635410|FG000|NOT COMPLETED|Overall Study||2
8599427|NCT00356304|9635411|FG001|NOT COMPLETED|Overall Study||4
8599428|NCT00356369|9635419|FG000|STARTED|Active Phase||374
8599429|NCT00356369|9635420|FG001|STARTED|Active Phase||126
8599430|NCT00356369|9635419|FG000|COMPLETED|Active Phase||372
8599431|NCT00356369|9635420|FG001|COMPLETED|Active Phase||125
8599432|NCT00356369|9635419|FG000|NOT COMPLETED|Active Phase||2
8599433|NCT00356369|9635420|FG001|NOT COMPLETED|Active Phase||1
8599434|NCT00356369|9635419|FG000|STARTED|Year 1||364
8599435|NCT00356369|9635420|FG001|STARTED|Year 1||121
8599436|NCT00356369|9635419|FG000|COMPLETED|Year 1||364
8599437|NCT00356369|9635420|FG001|COMPLETED|Year 1||121
8599438|NCT00356369|9635419|FG000|NOT COMPLETED|Year 1||0
8599439|NCT00356369|9635420|FG001|NOT COMPLETED|Year 1||0
8599440|NCT00356369|9635419|FG000|STARTED|Year 2||354
8599441|NCT00356369|9635420|FG001|STARTED|Year 2||117
8599442|NCT00356369|9635419|FG000|COMPLETED|Year 2||354
8599443|NCT00356369|9635420|FG001|COMPLETED|Year 2||117
8599444|NCT00356369|9635419|FG000|NOT COMPLETED|Year 2||0
8599445|NCT00356369|9635420|FG001|NOT COMPLETED|Year 2||0
8599446|NCT00356369|9635419|FG000|STARTED|Year 3||344
8599447|NCT00356369|9635420|FG001|STARTED|Year 3||116
8599448|NCT00356369|9635419|FG000|COMPLETED|Year 3||344
8599449|NCT00356369|9635420|FG001|COMPLETED|Year 3||116
8599450|NCT00356369|9635419|FG000|NOT COMPLETED|Year 3||0
8599451|NCT00356369|9635420|FG001|NOT COMPLETED|Year 3||0
8599452|NCT00356369|9635419|FG000|STARTED|Year 4||317
8599453|NCT00356369|9635420|FG001|STARTED|Year 4||109
8599454|NCT00356369|9635419|FG000|COMPLETED|Year 4||317
8599455|NCT00356369|9635420|FG001|COMPLETED|Year 4||109
8599456|NCT00356369|9635419|FG000|NOT COMPLETED|Year 4||0
8599457|NCT00356369|9635420|FG001|NOT COMPLETED|Year 4||0
8599458|NCT00356369|9635419|FG000|STARTED|Year 5||299
8599459|NCT00356369|9635420|FG001|STARTED|Year 5||105
8599460|NCT00356369|9635419|FG000|COMPLETED|Year 5||299
8599461|NCT00356369|9635420|FG001|COMPLETED|Year 5||105
8713320|NCT00974974|9760189|FG001|COMPLETED|IR CD-LD Dose Adjustment||450
8713321|NCT00974974|9760188|FG000|NOT COMPLETED|IR CD-LD Dose Adjustment||0
8713322|NCT00974974|9760189|FG001|NOT COMPLETED|IR CD-LD Dose Adjustment||21
8713323|NCT00974974|9760188|FG000|STARTED|IPX066 Dose Conversion|All subjects who completed IR Dose adjustment entered into IPX066 dose conversion.|450
8713324|NCT00974974|9760189|FG001|STARTED|IPX066 Dose Conversion|IR is not applicable in IPX066 dose conversion.|0
8713325|NCT00974974|9760188|FG000|COMPLETED|IPX066 Dose Conversion||393
8713326|NCT00974974|9760189|FG001|COMPLETED|IPX066 Dose Conversion||0
8713327|NCT00974974|9760188|FG000|NOT COMPLETED|IPX066 Dose Conversion||57
8713328|NCT00974974|9760189|FG001|NOT COMPLETED|IPX066 Dose Conversion||0
8713329|NCT00974974|9760188|FG000|STARTED|Maintenance - Double Blind Treatment|All subjects who completed IPX066 Dose Conversion were randomized to either IPX066 or IR.|201
8713330|NCT00974974|9760189|FG001|STARTED|Maintenance - Double Blind Treatment|All subjects who completed IPX066 Dose Conversion were randomized to either IPX066 or IR.|192
8713331|NCT00974974|9760188|FG000|COMPLETED|Maintenance - Double Blind Treatment||186
8713332|NCT00974974|9760189|FG001|COMPLETED|Maintenance - Double Blind Treatment||182
8713333|NCT00974974|9760188|FG000|NOT COMPLETED|Maintenance - Double Blind Treatment||15
8713334|NCT00974974|9760189|FG001|NOT COMPLETED|Maintenance - Double Blind Treatment||10
8713335|NCT00975000|9760197|FG000|STARTED|Overall Study||57
8713336|NCT00975000|9760198|FG001|STARTED|Overall Study||57
8713337|NCT00975000|9760197|FG000|Completed Titration Phase|Overall Study||54
8713338|NCT00975000|9760198|FG001|Completed Titration Phase|Overall Study||55
8713339|NCT00975000|9760197|FG000|Completed Efficacy Assessment Phase|Overall Study||54
8713340|NCT00975000|9760198|FG001|Completed Efficacy Assessment Phase|Overall Study||54
8713341|NCT00975000|9760197|FG000|Completed Maintenance Phase|Overall Study||52
8713342|NCT00975000|9760198|FG001|Completed Maintenance Phase|Overall Study||52
8713343|NCT00975000|9760197|FG000|COMPLETED|Overall Study|Completed post-treatment follow-up phase|52
8713344|NCT00975000|9760198|FG001|COMPLETED|Overall Study|Completed post-treatment follow-up phase|52
8713345|NCT00975000|9760197|FG000|NOT COMPLETED|Overall Study||5
8713346|NCT00975000|9760198|FG001|NOT COMPLETED|Overall Study||5
8713347|NCT00975130|9760204|FG000|STARTED|Study Part 1||3366
8713348|NCT00975130|9760205|FG001|STARTED|Study Part 1||0
8713349|NCT00975130|9760206|FG002|STARTED|Study Part 1||0
8713350|NCT00975130|9760204|FG000|COMPLETED|Study Part 1||3086
8713351|NCT00975130|9760205|FG001|COMPLETED|Study Part 1||0
8713352|NCT00975130|9760206|FG002|COMPLETED|Study Part 1||0
8713353|NCT00975130|9760204|FG000|NOT COMPLETED|Study Part 1||280
8713354|NCT00975130|9760205|FG001|NOT COMPLETED|Study Part 1||0
8713355|NCT00975130|9760206|FG002|NOT COMPLETED|Study Part 1||0
8713356|NCT00975130|9760204|FG000|STARTED|Study Part 2||0
8713357|NCT00975130|9760205|FG001|STARTED|Study Part 2|Good/moderate responders without remission at the end of Part 1 were invited to enroll in Part 2.|250
8599462|NCT00356369|9635419|FG000|NOT COMPLETED|Year 5||0
8599463|NCT00356369|9635420|FG001|NOT COMPLETED|Year 5||0
8599464|NCT00356408|9635430|FG000|STARTED|Overall Study|106 subjects enrolled, however only 103 were included in the Intent to Treat (ITT) population.|103
8713358|NCT00975130|9760206|FG002|STARTED|Study Part 2|Good/moderate responders without remission at the end of Part 1 were invited to enroll in Part 2.|255
8713359|NCT00975130|9760204|FG000|COMPLETED|Study Part 2||0
8713360|NCT00975130|9760205|FG001|COMPLETED|Study Part 2||212
8713361|NCT00975130|9760206|FG002|COMPLETED|Study Part 2||238
8713362|NCT00975130|9760204|FG000|NOT COMPLETED|Study Part 2||0
8713363|NCT00975130|9760205|FG001|NOT COMPLETED|Study Part 2||38
8599465|NCT00356408|9635430|FG000|COMPLETED|Overall Study||43
8599466|NCT00356408|9635430|FG000|NOT COMPLETED|Overall Study||60
8599467|NCT00356434|9635443|FG000|STARTED|Overall Study||4
8599468|NCT00356434|9635444|FG001|STARTED|Overall Study||7
8599469|NCT00356434|9635443|FG000|COMPLETED|Overall Study||4
8599470|NCT00356434|9635444|FG001|COMPLETED|Overall Study||7
8713364|NCT00975130|9760206|FG002|NOT COMPLETED|Study Part 2||17
8599471|NCT00356434|9635443|FG000|NOT COMPLETED|Overall Study||0
8599472|NCT00356434|9635444|FG001|NOT COMPLETED|Overall Study||0
8599473|NCT00356525|9635455|FG000|STARTED|Overall Study||14
8599474|NCT00356525|9635456|FG001|STARTED|Overall Study||11
8599475|NCT00356525|9635457|FG002|STARTED|Overall Study||7
8599476|NCT00356525|9635458|FG003|STARTED|Overall Study||9
8599477|NCT00356525|9635455|FG000|COMPLETED|Overall Study||0
8599478|NCT00356525|9635456|FG001|COMPLETED|Overall Study||0
8599479|NCT00356525|9635457|FG002|COMPLETED|Overall Study||0
8599480|NCT00356525|9635458|FG003|COMPLETED|Overall Study||0
8599481|NCT00356525|9635455|FG000|NOT COMPLETED|Overall Study||14
8599482|NCT00356525|9635456|FG001|NOT COMPLETED|Overall Study||11
8599483|NCT00356525|9635457|FG002|NOT COMPLETED|Overall Study||7
8599484|NCT00356525|9635458|FG003|NOT COMPLETED|Overall Study||9
8599485|NCT00356590|9635468|FG000|STARTED|Overall Study||468
8599486|NCT00356590|9635468|FG000|COMPLETED|Overall Study||194
8599487|NCT00356590|9635468|FG000|NOT COMPLETED|Overall Study||274
8599488|NCT00356603|9635474|FG000|STARTED|Overall Study||39
8599489|NCT00356603|9635475|FG001|STARTED|Overall Study||36
8599490|NCT00356603|9635474|FG000|COMPLETED|Overall Study||33
8599491|NCT00356603|9635475|FG001|COMPLETED|Overall Study||33
8599492|NCT00356603|9635474|FG000|NOT COMPLETED|Overall Study||6
8599493|NCT00356603|9635475|FG001|NOT COMPLETED|Overall Study||3
8599494|NCT00356759|9635485|FG000|STARTED|Overall Study||126
8599495|NCT00356759|9635486|FG001|STARTED|Overall Study||124
8599496|NCT00356759|9635485|FG000|COMPLETED|Overall Study||112
8599497|NCT00356759|9635486|FG001|COMPLETED|Overall Study||114
8599498|NCT00356759|9635485|FG000|NOT COMPLETED|Overall Study||14
8599499|NCT00356759|9635486|FG001|NOT COMPLETED|Overall Study||10
8599500|NCT00356811|9635492|FG000|STARTED|Overall Study||57
8599501|NCT00356811|9635492|FG000|COMPLETED|Overall Study||8
8599502|NCT00356811|9635492|FG000|NOT COMPLETED|Overall Study||49
8599503|NCT00356863|9635499|FG000|STARTED|Overall Study||504
8599504|NCT00356863|9635500|FG001|STARTED|Overall Study||520
8599505|NCT00356863|9635499|FG000|COMPLETED|Overall Study||412
8599506|NCT00356863|9635500|FG001|COMPLETED|Overall Study||445
8599507|NCT00356863|9635499|FG000|NOT COMPLETED|Overall Study||92
8599508|NCT00356863|9635500|FG001|NOT COMPLETED|Overall Study||75
8599509|NCT00356889|9635510|FG000|STARTED|Overall Study||56
8599510|NCT00356889|9635510|FG000|COMPLETED|Overall Study||53
8599511|NCT00356889|9635510|FG000|NOT COMPLETED|Overall Study||3
8599512|NCT00356915|9635518|FG000|STARTED|Overall Study||593
8599513|NCT00356915|9635519|FG001|STARTED|Overall Study||590
8599514|NCT00356915|9635520|FG002|STARTED|Overall Study||198
8599515|NCT00356915|9635518|FG000|COMPLETED|Overall Study||517
8599516|NCT00356915|9635519|FG001|COMPLETED|Overall Study||496
8599517|NCT00356915|9635520|FG002|COMPLETED|Overall Study||156
8599518|NCT00356915|9635518|FG000|NOT COMPLETED|Overall Study||76
8599519|NCT00356915|9635519|FG001|NOT COMPLETED|Overall Study||94
8599520|NCT00356915|9635520|FG002|NOT COMPLETED|Overall Study||42
8599521|NCT00356993|9635534|FG000|STARTED|Overall Study||6009
8599522|NCT00356993|9635534|FG000|COMPLETED|Overall Study||2088
8599523|NCT00356993|9635534|FG000|NOT COMPLETED|Overall Study||3921
8599524|NCT00357006|9635541|FG000|STARTED|Overall Study||62
8599525|NCT00357006|9635542|FG001|STARTED|Overall Study||56
8599526|NCT00357006|9635543|FG002|STARTED|Overall Study||62
8599527|NCT00357006|9635541|FG000|COMPLETED|Overall Study||60
8599528|NCT00357006|9635542|FG001|COMPLETED|Overall Study||51
8599529|NCT00357006|9635543|FG002|COMPLETED|Overall Study||59
8599530|NCT00357006|9635541|FG000|NOT COMPLETED|Overall Study||2
8599531|NCT00357006|9635542|FG001|NOT COMPLETED|Overall Study||5
8599532|NCT00357006|9635543|FG002|NOT COMPLETED|Overall Study||3
8599533|NCT00357032|9635551|FG000|STARTED|Overall Study||12
8599534|NCT00357032|9635551|FG000|COMPLETED|Overall Study||12
8599535|NCT00357032|9635551|FG000|NOT COMPLETED|Overall Study||0
8599536|NCT00357097|9635557|FG000|STARTED|Overall Study|199 were randomized. Only 198 took investigational product.|199
8599537|NCT00357097|9635558|FG001|STARTED|Overall Study||67
8599538|NCT00357097|9635557|FG000|COMPLETED|Overall Study||145
8599539|NCT00357097|9635558|FG001|COMPLETED|Overall Study||38
8599540|NCT00357097|9635557|FG000|NOT COMPLETED|Overall Study||54
8599541|NCT00357097|9635558|FG001|NOT COMPLETED|Overall Study||29
8599542|NCT00357110|9635566|FG000|STARTED|Overall Study||6
8599543|NCT00357110|9635567|FG001|STARTED|Overall Study||7
8599544|NCT00357110|9635566|FG000|COMPLETED|Overall Study||1
8599545|NCT00357110|9635567|FG001|COMPLETED|Overall Study||2
8599546|NCT00357110|9635566|FG000|NOT COMPLETED|Overall Study||5
8599547|NCT00357110|9635567|FG001|NOT COMPLETED|Overall Study||5
8599548|NCT00357162|9635573|FG000|STARTED|Overall Study||21
8599549|NCT00357162|9635573|FG000|COMPLETED|Overall Study||21
8599550|NCT00357162|9635573|FG000|NOT COMPLETED|Overall Study||0
8599551|NCT00357214|9635581|FG000|STARTED|Overall Study||43
8599552|NCT00357214|9635582|FG001|STARTED|Overall Study||43
8599553|NCT00357214|9635583|FG002|STARTED|Overall Study||42
8599554|NCT00357214|9635584|FG003|STARTED|Overall Study||43
8599555|NCT00357214|9635581|FG000|COMPLETED|Overall Study||39
8599556|NCT00357214|9635582|FG001|COMPLETED|Overall Study||39
8599557|NCT00357214|9635583|FG002|COMPLETED|Overall Study||42
8599558|NCT00357214|9635584|FG003|COMPLETED|Overall Study||42
8599559|NCT00357214|9635581|FG000|NOT COMPLETED|Overall Study||4
8599560|NCT00357214|9635582|FG001|NOT COMPLETED|Overall Study||4
8599561|NCT00357214|9635583|FG002|NOT COMPLETED|Overall Study||0
8599562|NCT00357214|9635584|FG003|NOT COMPLETED|Overall Study||1
8599563|NCT00357331|9635596|FG000|STARTED|Overall Study||42
8599564|NCT00357331|9635597|FG001|STARTED|Overall Study||41
8599565|NCT00357331|9635596|FG000|COMPLETED|Overall Study||42
8599566|NCT00357331|9635597|FG001|COMPLETED|Overall Study||41
8599567|NCT00357331|9635596|FG000|NOT COMPLETED|Overall Study||0
8599568|NCT00357331|9635597|FG001|NOT COMPLETED|Overall Study||0
8599569|NCT00357370|9635606|FG000|STARTED|Cohort 1||4
8599570|NCT00357370|9635607|FG001|STARTED|Cohort 1||0
8599571|NCT00357370|9635608|FG002|STARTED|Cohort 1||0
8599572|NCT00357370|9635606|FG000|COMPLETED|Cohort 1||4
8599573|NCT00357370|9635607|FG001|COMPLETED|Cohort 1||0
8599574|NCT00357370|9635608|FG002|COMPLETED|Cohort 1||0
8599575|NCT00357370|9635606|FG000|NOT COMPLETED|Cohort 1||0
8599576|NCT00357370|9635607|FG001|NOT COMPLETED|Cohort 1||0
8599577|NCT00357370|9635608|FG002|NOT COMPLETED|Cohort 1||0
8599578|NCT00357370|9635606|FG000|STARTED|Cohort 2||24
8599579|NCT00357370|9635607|FG001|STARTED|Cohort 2||23
8599580|NCT00357370|9635608|FG002|STARTED|Cohort 2||24
8599581|NCT00357370|9635606|FG000|COMPLETED|Cohort 2||22
8599582|NCT00357370|9635607|FG001|COMPLETED|Cohort 2||16
8599583|NCT00357370|9635608|FG002|COMPLETED|Cohort 2||22
8599584|NCT00357370|9635606|FG000|NOT COMPLETED|Cohort 2||2
8599585|NCT00357370|9635607|FG001|NOT COMPLETED|Cohort 2||7
8599586|NCT00357370|9635608|FG002|NOT COMPLETED|Cohort 2||2
8599587|NCT00357396|9635618|FG000|STARTED|Overall Study||6
8599588|NCT00357396|9635619|FG001|STARTED|Overall Study||4
8599589|NCT00357396|9635618|FG000|COMPLETED|Overall Study||5
8599590|NCT00357396|9635619|FG001|COMPLETED|Overall Study||4
8599591|NCT00357396|9635618|FG000|NOT COMPLETED|Overall Study||1
8599592|NCT00357396|9635619|FG001|NOT COMPLETED|Overall Study||0
8599593|NCT00357500|9635624|FG000|STARTED|Overall Study||101
8599594|NCT00357500|9635624|FG000|Began Protocol Therapy|Overall Study|4 pts did not start treatment due either to removal of consent or inability to get insurance.|97
8599595|NCT00357500|9635624|FG000|COMPLETED|Overall Study||24
8599596|NCT00357500|9635624|FG000|NOT COMPLETED|Overall Study||77
8599597|NCT00357552|9635628|FG000|STARTED|Screening|The number of participants who started this period, is the number of participants who screened.|207
8599598|NCT00357552|9635628|FG000|COMPLETED|Screening|The number of participants who completed this period, is the number of participants who enrolled.|123
8599599|NCT00357552|9635628|FG000|NOT COMPLETED|Screening||84
8599600|NCT00357552|9635628|FG000|STARTED|Weeks 0 to 24||123
8599601|NCT00357552|9635628|FG000|COMPLETED|Weeks 0 to 24|One subject died prior to week 24.|122
8599602|NCT00357552|9635628|FG000|NOT COMPLETED|Weeks 0 to 24||1
8599603|NCT00357552|9635628|FG000|STARTED|Weeks 24 to 104||122
8599604|NCT00357552|9635628|FG000|COMPLETED|Weeks 24 to 104||117
8599605|NCT00357552|9635628|FG000|NOT COMPLETED|Weeks 24 to 104||5
8599606|NCT00357656|9635638|FG000|STARTED|Overall Study||31
8599607|NCT00357656|9635639|FG001|STARTED|Overall Study||32
8599608|NCT00357656|9635638|FG000|COMPLETED|Overall Study||31
8599609|NCT00357656|9635639|FG001|COMPLETED|Overall Study||29
8599610|NCT00357656|9635638|FG000|NOT COMPLETED|Overall Study||0
8599611|NCT00357656|9635639|FG001|NOT COMPLETED|Overall Study||3
8599612|NCT00357734|9635657|FG000|STARTED|Overall Study||14
8599613|NCT00357734|9635657|FG000|Patients Received 250 mg of ZD1839|Overall Study||13
8599614|NCT00357734|9635657|FG000|Patient Received 500 mg of ZD1839|Overall Study||1
8599615|NCT00357734|9635657|FG000|COMPLETED|Overall Study||10
8599616|NCT00357734|9635657|FG000|NOT COMPLETED|Overall Study||4
8599617|NCT00357760|9635663|FG000|STARTED|Overall Study||59
8599618|NCT00357760|9635664|FG001|STARTED|Overall Study||35
8599619|NCT00357760|9635663|FG000|Patients Who Started Treatment|Overall Study||57
8599620|NCT00357760|9635664|FG001|Patients Who Started Treatment|Overall Study||34
8599621|NCT00357760|9635663|FG000|Eligible and Treated Patients|Overall Study||57
8599622|NCT00357760|9635664|FG001|Eligible and Treated Patients|Overall Study||32
8599623|NCT00357760|9635663|FG000|Patients Who Undergo Dose Escalation|Overall Study|Only patients who progressed on the low dose (Arm B) had the opportunity to undergo dose escalation.|0
8599624|NCT00357760|9635664|FG001|Patients Who Undergo Dose Escalation|Overall Study||16
8599625|NCT00357760|9635663|FG000|COMPLETED|Overall Study|Patients continued receiving protocol treatment until progressive disease or unacceptable toxicity.|0
8599626|NCT00357760|9635664|FG001|COMPLETED|Overall Study|Patients continued receiving protocol treatment until progressive disease or unacceptable toxicity.|0
8599627|NCT00357760|9635663|FG000|NOT COMPLETED|Overall Study||59
8599628|NCT00357760|9635664|FG001|NOT COMPLETED|Overall Study||35
8599629|NCT00357877|9635672|FG000|STARTED|Overall Study||493
8599630|NCT00357877|9635673|FG001|STARTED|Overall Study||490
8599631|NCT00357877|9635672|FG000|COMPLETED|Overall Study||467
8599632|NCT00357877|9635673|FG001|COMPLETED|Overall Study||460
8599633|NCT00357877|9635672|FG000|NOT COMPLETED|Overall Study||26
8599634|NCT00357877|9635673|FG001|NOT COMPLETED|Overall Study||30
8628545|NCT00524771|9668033|FG001|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 4.0 years.|16431
8628546|NCT00524771|9668032|FG000|NOT COMPLETED|Overall Study||220
8628547|NCT00524771|9668033|FG001|NOT COMPLETED|Overall Study||585
8628548|NCT00524940|9668040|FG000|STARTED|Overall Study||124
8628549|NCT00524940|9668040|FG000|COMPLETED|Overall Study||124
8628550|NCT00524940|9668040|FG000|NOT COMPLETED|Overall Study||0
8628551|NCT00525031|9668046|FG000|STARTED|Overall Study||27
8628552|NCT00525031|9668047|FG001|STARTED|Overall Study||25
8628553|NCT00525031|9668046|FG000|COMPLETED|Overall Study||26
8628554|NCT00525031|9668047|FG001|COMPLETED|Overall Study||24
8628555|NCT00525031|9668046|FG000|NOT COMPLETED|Overall Study||1
8628556|NCT00525031|9668047|FG001|NOT COMPLETED|Overall Study||1
8628557|NCT00525044|9668056|FG000|STARTED|Overall Study||124
8599635|NCT00357903|9635683|FG000|STARTED|Overall Study||581
8599636|NCT00357903|9635684|FG001|STARTED|Overall Study||58
8599637|NCT00357903|9635683|FG000|COMPLETED|Overall Study||218
8599638|NCT00357903|9635684|FG001|COMPLETED|Overall Study||15
8599639|NCT00357903|9635683|FG000|NOT COMPLETED|Overall Study||363
8599640|NCT00357903|9635684|FG001|NOT COMPLETED|Overall Study||43
8599641|NCT00357955|9635693|FG000|STARTED|Overall Study||64
8599642|NCT00357955|9635694|FG001|STARTED|Overall Study||54
8599643|NCT00357955|9635693|FG000|COMPLETED|Overall Study||58
8599644|NCT00357955|9635694|FG001|COMPLETED|Overall Study||51
8599645|NCT00357955|9635693|FG000|NOT COMPLETED|Overall Study||6
8599646|NCT00357955|9635694|FG001|NOT COMPLETED|Overall Study||3
8599647|NCT00357968|9635702|FG000|STARTED|First Maintenance Dose Phase||102
8599648|NCT00357968|9635703|FG001|STARTED|First Maintenance Dose Phase||99
8599649|NCT00357968|9635702|FG000|Received Loading Dose|First Maintenance Dose Phase||102
8599650|NCT00357968|9635703|FG001|Received Loading Dose|First Maintenance Dose Phase||99
8599651|NCT00357968|9635702|FG000|Percutaneous Coronary Intervention (PCI)|First Maintenance Dose Phase||55
8599652|NCT00357968|9635703|FG001|Percutaneous Coronary Intervention (PCI)|First Maintenance Dose Phase||57
8599653|NCT00357968|9635702|FG000|Started Maintenance Dose|First Maintenance Dose Phase||55
8599654|NCT00357968|9635703|FG001|Started Maintenance Dose|First Maintenance Dose Phase||55
8599655|NCT00357968|9635702|FG000|COMPLETED|First Maintenance Dose Phase||54
8599656|NCT00357968|9635703|FG001|COMPLETED|First Maintenance Dose Phase||55
8599657|NCT00357968|9635702|FG000|NOT COMPLETED|First Maintenance Dose Phase||48
8599658|NCT00357968|9635703|FG001|NOT COMPLETED|First Maintenance Dose Phase||44
8599659|NCT00357968|9635702|FG000|STARTED|Crossover Maintenance Dose Phase|1 subject discontinued study drug-did not take clopidogrel during the 2nd phase but completed study|54
8599660|NCT00357968|9635703|FG001|STARTED|Crossover Maintenance Dose Phase||55
8599661|NCT00357968|9635702|FG000|COMPLETED|Crossover Maintenance Dose Phase||54
8599662|NCT00357968|9635703|FG001|COMPLETED|Crossover Maintenance Dose Phase||55
8599663|NCT00357968|9635702|FG000|NOT COMPLETED|Crossover Maintenance Dose Phase||0
8599664|NCT00357968|9635703|FG001|NOT COMPLETED|Crossover Maintenance Dose Phase||0
8599665|NCT00357994|9635726|FG000|STARTED|Overall Study||37
8599666|NCT00357994|9635727|FG001|STARTED|Overall Study||34
8599667|NCT00357994|9635726|FG000|COMPLETED|Overall Study||35
8599668|NCT00357994|9635727|FG001|COMPLETED|Overall Study||31
8599669|NCT00357994|9635726|FG000|NOT COMPLETED|Overall Study||2
8599670|NCT00357994|9635727|FG001|NOT COMPLETED|Overall Study||3
8599671|NCT00358007|9635733|FG000|STARTED|Overall Study||30
8599672|NCT00358007|9635733|FG000|COMPLETED|Overall Study||28
8599673|NCT00358007|9635733|FG000|NOT COMPLETED|Overall Study||2
8599674|NCT00358150|9635737|FG000|STARTED|Overall Study||26
8599675|NCT00358150|9635737|FG000|COMPLETED|Overall Study||19
8599676|NCT00358150|9635737|FG000|NOT COMPLETED|Overall Study||7
8599677|NCT00358215|9635746|FG000|STARTED|Overall Study||1142
8599678|NCT00358215|9635747|FG001|STARTED|Overall Study||1136
8599679|NCT00358215|9635746|FG000|Received Investigational Product|Overall Study||1140
8599680|NCT00358215|9635747|FG001|Received Investigational Product|Overall Study||1133
8599681|NCT00358215|9635746|FG000|COMPLETED|Overall Study|Participants who completed investigational product|463
8599682|NCT00358215|9635747|FG001|COMPLETED|Overall Study|Participants who completed investigational product|484
8599683|NCT00358215|9635746|FG000|NOT COMPLETED|Overall Study||679
8599684|NCT00358215|9635747|FG001|NOT COMPLETED|Overall Study||652
8599685|NCT00358332|9635757|FG000|STARTED|Overall Study||15
8599686|NCT00358332|9635758|FG001|STARTED|Overall Study||30
8599687|NCT00358332|9635759|FG002|STARTED|Overall Study||30
8599688|NCT00358332|9635760|FG003|STARTED|Overall Study||25
8599689|NCT00358332|9635757|FG000|COMPLETED|Overall Study||15
8599690|NCT00358332|9635758|FG001|COMPLETED|Overall Study||27
8599691|NCT00358332|9635759|FG002|COMPLETED|Overall Study||29
8599692|NCT00358332|9635760|FG003|COMPLETED|Overall Study||25
8599693|NCT00358332|9635757|FG000|NOT COMPLETED|Overall Study||0
8599694|NCT00358332|9635758|FG001|NOT COMPLETED|Overall Study||3
8599695|NCT00358332|9635759|FG002|NOT COMPLETED|Overall Study||1
8599696|NCT00358332|9635760|FG003|NOT COMPLETED|Overall Study||0
8599697|NCT00358436|9635772|FG000|STARTED|Overall Study||600
8599698|NCT00358436|9635773|FG001|STARTED|Overall Study||204
8599699|NCT00358436|9635772|FG000|COMPLETED|Overall Study||446
8599700|NCT00358436|9635773|FG001|COMPLETED|Overall Study||118
8599701|NCT00358436|9635772|FG000|NOT COMPLETED|Overall Study||154
8599702|NCT00358436|9635773|FG001|NOT COMPLETED|Overall Study||86
8599703|NCT00358449|9635784|FG000|STARTED|Overall Study||19
8599704|NCT00358449|9635785|FG001|STARTED|Overall Study||20
8599705|NCT00358449|9635786|FG002|STARTED|Overall Study||20
8599706|NCT00358449|9635784|FG000|COMPLETED|Overall Study||15
8599707|NCT00358449|9635785|FG001|COMPLETED|Overall Study||19
8599708|NCT00358449|9635786|FG002|COMPLETED|Overall Study||18
8599709|NCT00358449|9635784|FG000|NOT COMPLETED|Overall Study||4
8599710|NCT00358449|9635785|FG001|NOT COMPLETED|Overall Study||1
8599711|NCT00358449|9635786|FG002|NOT COMPLETED|Overall Study||2
8599712|NCT00358462|9635798|FG000|STARTED|Overall Study||304
8599713|NCT00358462|9635799|FG001|STARTED|Overall Study||302
8599714|NCT00358462|9635798|FG000|COMPLETED|Overall Study||245
8599715|NCT00358462|9635799|FG001|COMPLETED|Overall Study||238
8599716|NCT00358462|9635798|FG000|NOT COMPLETED|Overall Study||59
8599717|NCT00358462|9635799|FG001|NOT COMPLETED|Overall Study||64
8599718|NCT00358501|9635817|FG000|STARTED|Overall Study||102
8599719|NCT00358501|9635818|FG001|STARTED|Overall Study||32
8599720|NCT00358501|9635817|FG000|COMPLETED|Overall Study||102
8599721|NCT00358501|9635818|FG001|COMPLETED|Overall Study||32
8599722|NCT00358501|9635817|FG000|NOT COMPLETED|Overall Study||0
8599723|NCT00358501|9635818|FG001|NOT COMPLETED|Overall Study||0
8599724|NCT00358579|9635827|FG000|STARTED|Overall Study||353
8599725|NCT00358579|9635828|FG001|STARTED|Overall Study||374
8599726|NCT00358579|9635827|FG000|COMPLETED|Overall Study||353
8599727|NCT00358579|9635828|FG001|COMPLETED|Overall Study||374
8599728|NCT00358579|9635827|FG000|NOT COMPLETED|Overall Study||0
8599729|NCT00358579|9635828|FG001|NOT COMPLETED|Overall Study||0
8599730|NCT00358644|9635834|FG000|STARTED|Overall Study||55
8599731|NCT00358644|9635834|FG000|COMPLETED|Overall Study||5
8599732|NCT00358644|9635834|FG000|NOT COMPLETED|Overall Study||50
8599733|NCT00358657|9635838|FG000|STARTED|Overall Study||14
8599734|NCT00358657|9635838|FG000|COMPLETED|Overall Study||14
8599735|NCT00358657|9635838|FG000|NOT COMPLETED|Overall Study||0
8599736|NCT00358670|9635844|FG000|STARTED|Overall Study||222
8599737|NCT00358670|9635845|FG001|STARTED|Overall Study||219
8599738|NCT00358670|9635844|FG000|COMPLETED|Overall Study||0
8599739|NCT00358670|9635845|FG001|COMPLETED|Overall Study||0
8599740|NCT00358670|9635844|FG000|NOT COMPLETED|Overall Study||222
8599741|NCT00358670|9635845|FG001|NOT COMPLETED|Overall Study||219
8599742|NCT00358735|9635853|FG000|STARTED|Overall Study||204
8599743|NCT00358735|9635854|FG001|STARTED|Overall Study||207
8599744|NCT00358735|9635853|FG000|Completed Safety|Overall Study||198
8599745|NCT00358735|9635854|FG001|Completed Safety|Overall Study||194
8599746|NCT00358735|9635853|FG000|Not Completed Safety|Overall Study||6
8599747|NCT00358735|9635854|FG001|Not Completed Safety|Overall Study||13
8599748|NCT00358735|9635853|FG000|COMPLETED|Overall Study|Efficacy|196
8599749|NCT00358735|9635854|FG001|COMPLETED|Overall Study|Efficacy|190
8599750|NCT00358735|9635853|FG000|NOT COMPLETED|Overall Study||8
8599751|NCT00358735|9635854|FG001|NOT COMPLETED|Overall Study||17
8599752|NCT00358826|9635864|FG000|STARTED|Core Study||49
8599753|NCT00358826|9635865|FG001|STARTED|Core Study||46
8599754|NCT00358826|9635866|FG002|STARTED|Core Study||44
8599755|NCT00358826|9635867|FG003|STARTED|Core Study||52
8599756|NCT00358826|9635868|FG004|STARTED|Core Study||0
8599757|NCT00358826|9635869|FG005|STARTED|Core Study||0
8599758|NCT00358826|9635870|FG006|STARTED|Core Study||0
8599759|NCT00358826|9635871|FG007|STARTED|Core Study||0
8599760|NCT00358826|9635864|FG000|COMPLETED|Core Study||46
8599761|NCT00358826|9635865|FG001|COMPLETED|Core Study||41
8599762|NCT00358826|9635866|FG002|COMPLETED|Core Study||42
8599763|NCT00358826|9635867|FG003|COMPLETED|Core Study||50
8599764|NCT00358826|9635868|FG004|COMPLETED|Core Study||0
8599765|NCT00358826|9635869|FG005|COMPLETED|Core Study||0
8599766|NCT00358826|9635870|FG006|COMPLETED|Core Study||0
8599767|NCT00358826|9635871|FG007|COMPLETED|Core Study||0
8599768|NCT00358826|9635864|FG000|NOT COMPLETED|Core Study||3
8599769|NCT00358826|9635865|FG001|NOT COMPLETED|Core Study||5
8599770|NCT00358826|9635866|FG002|NOT COMPLETED|Core Study||2
8599771|NCT00358826|9635867|FG003|NOT COMPLETED|Core Study||2
8599772|NCT00358826|9635868|FG004|NOT COMPLETED|Core Study||0
8599773|NCT00358826|9635869|FG005|NOT COMPLETED|Core Study||0
8599774|NCT00358826|9635870|FG006|NOT COMPLETED|Core Study||0
8599775|NCT00358826|9635871|FG007|NOT COMPLETED|Core Study||0
8599776|NCT00358826|9635864|FG000|STARTED|MDCT Substudy||0
8599777|NCT00358826|9635865|FG001|STARTED|MDCT Substudy||0
8599778|NCT00358826|9635866|FG002|STARTED|MDCT Substudy||0
8599779|NCT00358826|9635867|FG003|STARTED|MDCT Substudy||0
8599780|NCT00358826|9635868|FG004|STARTED|MDCT Substudy||25
8599781|NCT00358826|9635869|FG005|STARTED|MDCT Substudy||22
8599782|NCT00358826|9635870|FG006|STARTED|MDCT Substudy||19
8599783|NCT00358826|9635871|FG007|STARTED|MDCT Substudy||27
8599784|NCT00358826|9635864|FG000|COMPLETED|MDCT Substudy||0
8599785|NCT00358826|9635865|FG001|COMPLETED|MDCT Substudy||0
8599786|NCT00358826|9635866|FG002|COMPLETED|MDCT Substudy||0
8599787|NCT00358826|9635867|FG003|COMPLETED|MDCT Substudy||0
8599788|NCT00358826|9635868|FG004|COMPLETED|MDCT Substudy||24
8599789|NCT00358826|9635869|FG005|COMPLETED|MDCT Substudy||20
8599790|NCT00358826|9635870|FG006|COMPLETED|MDCT Substudy||19
8599791|NCT00358826|9635871|FG007|COMPLETED|MDCT Substudy||27
8599792|NCT00358826|9635864|FG000|NOT COMPLETED|MDCT Substudy||0
8599793|NCT00358826|9635865|FG001|NOT COMPLETED|MDCT Substudy||0
8599794|NCT00358826|9635866|FG002|NOT COMPLETED|MDCT Substudy||0
8599795|NCT00358826|9635867|FG003|NOT COMPLETED|MDCT Substudy||0
8599796|NCT00358826|9635868|FG004|NOT COMPLETED|MDCT Substudy||1
8599797|NCT00358826|9635869|FG005|NOT COMPLETED|MDCT Substudy||2
8599798|NCT00358826|9635870|FG006|NOT COMPLETED|MDCT Substudy||0
8599799|NCT00358826|9635871|FG007|NOT COMPLETED|MDCT Substudy||0
8599800|NCT00358917|9635887|FG000|STARTED|Overall Study||300
8599801|NCT00358917|9635888|FG001|STARTED|Overall Study||299
8599802|NCT00358917|9635887|FG000|COMPLETED|Overall Study||234
8599803|NCT00358917|9635888|FG001|COMPLETED|Overall Study||230
8599804|NCT00358917|9635887|FG000|NOT COMPLETED|Overall Study||66
8599805|NCT00358917|9635888|FG001|NOT COMPLETED|Overall Study||69
8599806|NCT00358956|9635896|FG000|STARTED|Overall Study||19
8599807|NCT00358956|9635896|FG000|COMPLETED|Overall Study|ongoing study treatment at data cut-off|11
8599808|NCT00358956|9635896|FG000|NOT COMPLETED|Overall Study||8
8599809|NCT00359021|9635902|FG000|STARTED|Overall Study||256
8599810|NCT00359021|9635903|FG001|STARTED|Overall Study||247
8599811|NCT00359021|9635902|FG000|COMPLETED|Overall Study||175
8599812|NCT00359021|9635903|FG001|COMPLETED|Overall Study||195
8599813|NCT00359021|9635902|FG000|NOT COMPLETED|Overall Study||81
8599814|NCT00359021|9635903|FG001|NOT COMPLETED|Overall Study||52
8599815|NCT00359073|9635913|FG000|STARTED|Overall Study||12
8599816|NCT00359073|9635914|FG001|STARTED|Overall Study||13
8599817|NCT00359073|9635913|FG000|COMPLETED|Overall Study||8
8599818|NCT00359073|9635914|FG001|COMPLETED|Overall Study||11
8599819|NCT00359073|9635913|FG000|NOT COMPLETED|Overall Study||4
8599820|NCT00359073|9635914|FG001|NOT COMPLETED|Overall Study||2
8599821|NCT00359203|9635924|FG000|STARTED|Overall Study||39
8599822|NCT00359203|9635925|FG001|STARTED|Overall Study||38
8599823|NCT00359203|9635924|FG000|COMPLETED|Overall Study||39
8599824|NCT00359203|9635925|FG001|COMPLETED|Overall Study||38
8599825|NCT00359203|9635924|FG000|NOT COMPLETED|Overall Study||0
8599826|NCT00359203|9635925|FG001|NOT COMPLETED|Overall Study||0
8599827|NCT00359281|9635940|FG000|STARTED|Overall Study||16
8599828|NCT00359281|9635941|FG001|STARTED|Overall Study||15
8599829|NCT00359281|9635942|FG002|STARTED|Overall Study||10
8599830|NCT00359281|9635943|FG003|STARTED|Overall Study||10
8599831|NCT00359281|9635944|FG004|STARTED|Overall Study||10
8599832|NCT00359281|9635945|FG005|STARTED|Overall Study||15
8599833|NCT00359281|9635946|FG006|STARTED|Overall Study||18
8599834|NCT00359281|9635947|FG007|STARTED|Overall Study||15
8599835|NCT00359281|9635948|FG008|STARTED|Overall Study||20
8599836|NCT00359281|9635940|FG000|COMPLETED|Overall Study||15
8599837|NCT00359281|9635941|FG001|COMPLETED|Overall Study||15
8599838|NCT00359281|9635942|FG002|COMPLETED|Overall Study||10
8599839|NCT00359281|9635943|FG003|COMPLETED|Overall Study||10
8599840|NCT00359281|9635944|FG004|COMPLETED|Overall Study||10
8599841|NCT00359281|9635945|FG005|COMPLETED|Overall Study||15
8599842|NCT00359281|9635946|FG006|COMPLETED|Overall Study||16
8599843|NCT00359281|9635947|FG007|COMPLETED|Overall Study||15
8599844|NCT00359281|9635948|FG008|COMPLETED|Overall Study||20
8599845|NCT00359281|9635940|FG000|NOT COMPLETED|Overall Study||1
8599846|NCT00359281|9635941|FG001|NOT COMPLETED|Overall Study||0
8599847|NCT00359281|9635942|FG002|NOT COMPLETED|Overall Study||0
8599848|NCT00359281|9635943|FG003|NOT COMPLETED|Overall Study||0
8599849|NCT00359281|9635944|FG004|NOT COMPLETED|Overall Study||0
8599850|NCT00359281|9635945|FG005|NOT COMPLETED|Overall Study||0
8599851|NCT00359281|9635946|FG006|NOT COMPLETED|Overall Study||2
8599852|NCT00359281|9635947|FG007|NOT COMPLETED|Overall Study||0
8599853|NCT00359281|9635948|FG008|NOT COMPLETED|Overall Study||0
8599854|NCT00359294|9635980|FG000|STARTED|Overall Study||1
8599855|NCT00359294|9635981|FG001|STARTED|Overall Study||1
8599856|NCT00359294|9635982|FG002|STARTED|Overall Study||3
8599857|NCT00359294|9635983|FG003|STARTED|Overall Study||4
8599858|NCT00359294|9635984|FG004|STARTED|Overall Study||3
8599859|NCT00359294|9635980|FG000|COMPLETED|Overall Study||0
8599860|NCT00359294|9635981|FG001|COMPLETED|Overall Study||0
8599861|NCT00359294|9635982|FG002|COMPLETED|Overall Study||0
8599862|NCT00359294|9635983|FG003|COMPLETED|Overall Study||0
8713365|NCT00975143|9760221|FG000|STARTED|Overall Study||464
8713366|NCT00975143|9760222|FG001|STARTED|Overall Study||461
8713367|NCT00975143|9760221|FG000|Completed Treatment (Week 20)|Overall Study||403
8713368|NCT00975143|9760222|FG001|Completed Treatment (Week 20)|Overall Study||410
8713369|NCT00975143|9760221|FG000|COMPLETED|Overall Study||394
8713370|NCT00975143|9760222|FG001|COMPLETED|Overall Study||401
8713371|NCT00975143|9760221|FG000|NOT COMPLETED|Overall Study||70
8713372|NCT00975143|9760222|FG001|NOT COMPLETED|Overall Study||60
8713373|NCT00975156|9760230|FG000|STARTED|Overall Study||11
8713374|NCT00975156|9760231|FG001|STARTED|Overall Study||10
8713375|NCT00975156|9760230|FG000|COMPLETED|Overall Study||11
8713376|NCT00975156|9760231|FG001|COMPLETED|Overall Study||9
8599863|NCT00359294|9635984|FG004|COMPLETED|Overall Study||0
8599864|NCT00359294|9635980|FG000|NOT COMPLETED|Overall Study||1
8599865|NCT00359294|9635981|FG001|NOT COMPLETED|Overall Study||1
8713377|NCT00975156|9760230|FG000|NOT COMPLETED|Overall Study||0
8713378|NCT00975156|9760231|FG001|NOT COMPLETED|Overall Study||1
8713379|NCT00975195|9760243|FG000|STARTED|Overall Study||1244
8713380|NCT00975195|9760244|FG001|STARTED|Overall Study||1244
8713381|NCT00975195|9760243|FG000|COMPLETED|Overall Study|Includes open-label treatment if appropriate|1016
8713382|NCT00975195|9760244|FG001|COMPLETED|Overall Study|Includes open-label treatment if appropriate|1011
8713383|NCT00975195|9760243|FG000|NOT COMPLETED|Overall Study||228
8713384|NCT00975195|9760244|FG001|NOT COMPLETED|Overall Study||233
8599866|NCT00359294|9635982|FG002|NOT COMPLETED|Overall Study||3
8599867|NCT00359294|9635983|FG003|NOT COMPLETED|Overall Study||4
8599868|NCT00359294|9635984|FG004|NOT COMPLETED|Overall Study||3
8599869|NCT00359424|9635994|FG000|STARTED|Overall Study||434
8599870|NCT00359424|9635995|FG001|STARTED|Overall Study||222
8599871|NCT00359424|9635994|FG000|90 Day Follow up|Overall Study||343
8713385|NCT00975221|9760252|FG000|STARTED|Titration Phase (Weeks 1-12)||34
8599872|NCT00359424|9635995|FG001|90 Day Follow up|Overall Study||172
8599873|NCT00359424|9635994|FG000|180 Day Follow up|Overall Study||325
8599874|NCT00359424|9635995|FG001|180 Day Follow up|Overall Study||167
8599875|NCT00359424|9635994|FG000|270 Day Follow up|Overall Study||313
8599876|NCT00359424|9635995|FG001|270 Day Follow up|Overall Study||159
8599877|NCT00359424|9635994|FG000|COMPLETED|Overall Study||304
8599878|NCT00359424|9635995|FG001|COMPLETED|Overall Study||155
8599879|NCT00359424|9635994|FG000|NOT COMPLETED|Overall Study||130
8599880|NCT00359424|9635995|FG001|NOT COMPLETED|Overall Study||67
8599881|NCT00359619|9636008|FG000|STARTED|Overall Study||88
8599882|NCT00359619|9636009|FG001|STARTED|Overall Study||50
8599883|NCT00359619|9636010|FG002|STARTED|Overall Study||49
8599884|NCT00359619|9636011|FG003|STARTED|Overall Study||48
8599885|NCT00359619|9636012|FG004|STARTED|Overall Study||48
8599886|NCT00359619|9636013|FG005|STARTED|Overall Study||50
8599887|NCT00359619|9636014|FG006|STARTED|Overall Study||50
8599888|NCT00359619|9636008|FG000|COMPLETED|Overall Study||80
8599889|NCT00359619|9636009|FG001|COMPLETED|Overall Study||45
8599890|NCT00359619|9636010|FG002|COMPLETED|Overall Study||42
8599891|NCT00359619|9636011|FG003|COMPLETED|Overall Study||45
8599892|NCT00359619|9636012|FG004|COMPLETED|Overall Study||45
8599893|NCT00359619|9636013|FG005|COMPLETED|Overall Study||45
8599894|NCT00359619|9636014|FG006|COMPLETED|Overall Study||46
8599895|NCT00359619|9636008|FG000|NOT COMPLETED|Overall Study||8
8599896|NCT00359619|9636009|FG001|NOT COMPLETED|Overall Study||5
8599897|NCT00359619|9636010|FG002|NOT COMPLETED|Overall Study||7
8599898|NCT00359619|9636011|FG003|NOT COMPLETED|Overall Study||3
8599899|NCT00359619|9636012|FG004|NOT COMPLETED|Overall Study||3
8599900|NCT00359619|9636013|FG005|NOT COMPLETED|Overall Study||5
8599901|NCT00359619|9636014|FG006|NOT COMPLETED|Overall Study||4
8599902|NCT00359632|9636032|FG000|STARTED|Overall Study||24
8599903|NCT00359632|9636033|FG001|STARTED|Overall Study||9
8599904|NCT00359632|9636032|FG000|COMPLETED|Overall Study||20
8599905|NCT00359632|9636033|FG001|COMPLETED|Overall Study||9
8599906|NCT00359632|9636032|FG000|NOT COMPLETED|Overall Study||4
8599907|NCT00359632|9636033|FG001|NOT COMPLETED|Overall Study||0
8599908|NCT00359736|9636041|FG000|STARTED|Overall Study||14
8599909|NCT00359736|9636042|FG001|STARTED|Overall Study||15
8599910|NCT00359736|9636041|FG000|COMPLETED|Overall Study||14
8599911|NCT00359736|9636042|FG001|COMPLETED|Overall Study||15
8599912|NCT00359736|9636041|FG000|NOT COMPLETED|Overall Study||0
8599913|NCT00359736|9636042|FG001|NOT COMPLETED|Overall Study||0
8713386|NCT00975221|9760253|FG001|STARTED|Titration Phase (Weeks 1-12)||33
8713387|NCT00975221|9760252|FG000|Received Study Drug|Titration Phase (Weeks 1-12)||34
8713388|NCT00975221|9760253|FG001|Received Study Drug|Titration Phase (Weeks 1-12)||33
8713389|NCT00975221|9760252|FG000|COMPLETED|Titration Phase (Weeks 1-12)||31
8713390|NCT00975221|9760253|FG001|COMPLETED|Titration Phase (Weeks 1-12)||29
8713391|NCT00975221|9760252|FG000|NOT COMPLETED|Titration Phase (Weeks 1-12)||3
8713392|NCT00975221|9760253|FG001|NOT COMPLETED|Titration Phase (Weeks 1-12)||4
8713393|NCT00975221|9760252|FG000|STARTED|Efficacy Assessment Phase (Weeks 13-28)|1 participant who completed the Titration Phase did not enter the EAP|30
8713394|NCT00975221|9760253|FG001|STARTED|Efficacy Assessment Phase (Weeks 13-28)||29
8713395|NCT00975221|9760252|FG000|COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||30
8713396|NCT00975221|9760253|FG001|COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||28
8713397|NCT00975221|9760252|FG000|NOT COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||0
8713398|NCT00975221|9760253|FG001|NOT COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||1
8713399|NCT00975221|9760252|FG000|STARTED|Open-label Extension Phase (Weeks 29-52)|1 participant who completed the EAP did not enter the open-label phase|29
8713400|NCT00975221|9760253|FG001|STARTED|Open-label Extension Phase (Weeks 29-52)||28
8713401|NCT00975221|9760252|FG000|COMPLETED|Open-label Extension Phase (Weeks 29-52)||27
8713402|NCT00975221|9760253|FG001|COMPLETED|Open-label Extension Phase (Weeks 29-52)||27
8713403|NCT00975221|9760252|FG000|NOT COMPLETED|Open-label Extension Phase (Weeks 29-52)||2
8713404|NCT00975221|9760253|FG001|NOT COMPLETED|Open-label Extension Phase (Weeks 29-52)||1
8713405|NCT00975286|9760263|FG000|STARTED|Overall Study|Randomized.|223
8713406|NCT00975286|9760264|FG001|STARTED|Overall Study||223
8713407|NCT00975286|9760263|FG000|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|223
8713408|NCT00975286|9760264|FG001|Safety Population|Overall Study||223
8713409|NCT00975286|9760263|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|223
8713410|NCT00975286|9760264|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||223
8713411|NCT00975286|9760263|FG000|COMPLETED|Overall Study||211
8713412|NCT00975286|9760264|FG001|COMPLETED|Overall Study||194
8713413|NCT00975286|9760263|FG000|NOT COMPLETED|Overall Study||12
8713414|NCT00975286|9760264|FG001|NOT COMPLETED|Overall Study||29
8713415|NCT00975416|9760272|FG000|STARTED|Overall Study||14
8713416|NCT00975416|9760273|FG001|STARTED|Overall Study||16
8713417|NCT00975416|9760272|FG000|COMPLETED|Overall Study||11
8713418|NCT00975416|9760273|FG001|COMPLETED|Overall Study||11
8599914|NCT00359762|9636052|FG000|STARTED|Period II||514
8599915|NCT00359762|9636053|FG001|STARTED|Period II||0
8599916|NCT00359762|9636054|FG002|STARTED|Period II||0
8599917|NCT00359762|9636055|FG003|STARTED|Period II||0
8599918|NCT00359762|9636056|FG004|STARTED|Period II||515
8599919|NCT00359762|9636052|FG000|Intent to Treat (ITT) Safety Population|Period II||508
8599920|NCT00359762|9636053|FG001|Intent to Treat (ITT) Safety Population|Period II||0
8599921|NCT00359762|9636054|FG002|Intent to Treat (ITT) Safety Population|Period II||0
8599922|NCT00359762|9636055|FG003|Intent to Treat (ITT) Safety Population|Period II||0
8599923|NCT00359762|9636056|FG004|Intent to Treat (ITT) Safety Population|Period II||511
8599924|NCT00359762|9636052|FG000|ITT Efficacy Population|Period II||487
8599925|NCT00359762|9636053|FG001|ITT Efficacy Population|Period II||0
8599926|NCT00359762|9636054|FG002|ITT Efficacy Population|Period II||0
8599927|NCT00359762|9636055|FG003|ITT Efficacy Population|Period II||0
8599928|NCT00359762|9636056|FG004|ITT Efficacy Population|Period II||490
8599929|NCT00359762|9636052|FG000|Met Primary Endpoint|Period II||262
8599930|NCT00359762|9636053|FG001|Met Primary Endpoint|Period II||0
8599931|NCT00359762|9636054|FG002|Met Primary Endpoint|Period II||0
8599932|NCT00359762|9636055|FG003|Met Primary Endpoint|Period II||0
8599933|NCT00359762|9636056|FG004|Met Primary Endpoint|Period II||203
8599934|NCT00359762|9636052|FG000|Without Treatment Failure|Period II||124
8599935|NCT00359762|9636053|FG001|Without Treatment Failure|Period II||0
8599936|NCT00359762|9636054|FG002|Without Treatment Failure|Period II||0
8599937|NCT00359762|9636055|FG003|Without Treatment Failure|Period II||0
8599938|NCT00359762|9636056|FG004|Without Treatment Failure|Period II||138
8599939|NCT00359762|9636052|FG000|COMPLETED|Period II||386
8599940|NCT00359762|9636053|FG001|COMPLETED|Period II||0
8599941|NCT00359762|9636054|FG002|COMPLETED|Period II||0
8599942|NCT00359762|9636055|FG003|COMPLETED|Period II||0
8599943|NCT00359762|9636056|FG004|COMPLETED|Period II||341
8599944|NCT00359762|9636052|FG000|NOT COMPLETED|Period II||128
8599945|NCT00359762|9636053|FG001|NOT COMPLETED|Period II||0
8599946|NCT00359762|9636054|FG002|NOT COMPLETED|Period II||0
8599947|NCT00359762|9636055|FG003|NOT COMPLETED|Period II||0
8599948|NCT00359762|9636056|FG004|NOT COMPLETED|Period II||174
8599949|NCT00359762|9636052|FG000|STARTED|Period III||0
8599950|NCT00359762|9636053|FG001|STARTED|Period III||77
8599951|NCT00359762|9636054|FG002|STARTED|Period III||77
8599952|NCT00359762|9636055|FG003|STARTED|Period III||166
8599953|NCT00359762|9636056|FG004|STARTED|Period III||0
8599954|NCT00359762|9636052|FG000|Extension ITT Safety Population|Period III||0
8599955|NCT00359762|9636053|FG001|Extension ITT Safety Population|Period III||74
8599956|NCT00359762|9636054|FG002|Extension ITT Safety Population|Period III||76
8599957|NCT00359762|9636055|FG003|Extension ITT Safety Population|Period III||166
8599958|NCT00359762|9636056|FG004|Extension ITT Safety Population|Period III||0
8599959|NCT00359762|9636052|FG000|Extension ITT Efficacy Population|Period III||0
8599960|NCT00359762|9636053|FG001|Extension ITT Efficacy Population|Period III||73
8599961|NCT00359762|9636054|FG002|Extension ITT Efficacy Population|Period III||75
8599962|NCT00359762|9636055|FG003|Extension ITT Efficacy Population|Period III||164
8599963|NCT00359762|9636056|FG004|Extension ITT Efficacy Population|Period III||0
8599964|NCT00359762|9636052|FG000|COMPLETED|Period III||0
8599965|NCT00359762|9636053|FG001|COMPLETED|Period III||48
8599966|NCT00359762|9636054|FG002|COMPLETED|Period III||47
8599967|NCT00359762|9636055|FG003|COMPLETED|Period III||101
8599968|NCT00359762|9636056|FG004|COMPLETED|Period III||0
8599969|NCT00359762|9636052|FG000|NOT COMPLETED|Period III||0
8599970|NCT00359762|9636053|FG001|NOT COMPLETED|Period III||29
8599971|NCT00359762|9636054|FG002|NOT COMPLETED|Period III||30
8599972|NCT00359762|9636055|FG003|NOT COMPLETED|Period III||65
8599973|NCT00359762|9636056|FG004|NOT COMPLETED|Period III||0
8599974|NCT00359762|9636052|FG000|STARTED|Period I||0
8599975|NCT00359762|9636053|FG001|STARTED|Period I||0
8599976|NCT00359762|9636054|FG002|STARTED|Period I||0
8599977|NCT00359762|9636055|FG003|STARTED|Period I||0
8599978|NCT00359762|9636056|FG004|STARTED|Period I||0
8713419|NCT00975416|9760272|FG000|NOT COMPLETED|Overall Study||3
8713420|NCT00975416|9760273|FG001|NOT COMPLETED|Overall Study||5
8713421|NCT00975481|9760280|FG000|STARTED|First Intervention Period||6
8713422|NCT00975481|9760281|FG001|STARTED|First Intervention Period||6
8713423|NCT00975481|9760282|FG002|STARTED|First Intervention Period||6
8713424|NCT00975481|9760283|FG003|STARTED|First Intervention Period||6
8713425|NCT00975481|9760284|FG004|STARTED|First Intervention Period||6
8713426|NCT00975481|9760285|FG005|STARTED|First Intervention Period||6
8713427|NCT00975481|9760280|FG000|COMPLETED|First Intervention Period||6
8713428|NCT00975481|9760281|FG001|COMPLETED|First Intervention Period||6
8713429|NCT00975481|9760282|FG002|COMPLETED|First Intervention Period||6
8713430|NCT00975481|9760283|FG003|COMPLETED|First Intervention Period||6
8713431|NCT00975481|9760284|FG004|COMPLETED|First Intervention Period||6
8713432|NCT00975481|9760285|FG005|COMPLETED|First Intervention Period||6
8713433|NCT00975481|9760280|FG000|NOT COMPLETED|First Intervention Period||0
8713434|NCT00975481|9760281|FG001|NOT COMPLETED|First Intervention Period||0
8713435|NCT00975481|9760282|FG002|NOT COMPLETED|First Intervention Period||0
8713436|NCT00975481|9760283|FG003|NOT COMPLETED|First Intervention Period||0
8713437|NCT00975481|9760284|FG004|NOT COMPLETED|First Intervention Period||0
8713438|NCT00975481|9760285|FG005|NOT COMPLETED|First Intervention Period||0
8713439|NCT00975481|9760280|FG000|STARTED|Washout Period (at Least 7 Days)||6
8713440|NCT00975481|9760281|FG001|STARTED|Washout Period (at Least 7 Days)||6
8713441|NCT00975481|9760282|FG002|STARTED|Washout Period (at Least 7 Days)||6
8713442|NCT00975481|9760283|FG003|STARTED|Washout Period (at Least 7 Days)||6
8599979|NCT00359762|9636052|FG000|COMPLETED|Period I||0
8599980|NCT00359762|9636053|FG001|COMPLETED|Period I||0
8599981|NCT00359762|9636054|FG002|COMPLETED|Period I||0
8599982|NCT00359762|9636055|FG003|COMPLETED|Period I||0
8599983|NCT00359762|9636056|FG004|COMPLETED|Period I||0
8599984|NCT00359762|9636052|FG000|NOT COMPLETED|Period I||0
8599985|NCT00359762|9636053|FG001|NOT COMPLETED|Period I||0
8599986|NCT00359762|9636054|FG002|NOT COMPLETED|Period I||0
8599987|NCT00359762|9636055|FG003|NOT COMPLETED|Period I||0
8599988|NCT00359762|9636056|FG004|NOT COMPLETED|Period I||0
8599989|NCT00359788|9636072|FG000|STARTED|Overall Study||173
8599990|NCT00359788|9636073|FG001|STARTED|Overall Study||176
8599991|NCT00359788|9636072|FG000|COMPLETED|Overall Study||150
8599992|NCT00359788|9636073|FG001|COMPLETED|Overall Study||159
8599993|NCT00359788|9636072|FG000|NOT COMPLETED|Overall Study||23
8599994|NCT00359788|9636073|FG001|NOT COMPLETED|Overall Study||17
8599995|NCT00359801|9636081|FG000|STARTED|Overall Study||987
8599996|NCT00359801|9636082|FG001|STARTED|Overall Study||989
8713443|NCT00975481|9760284|FG004|STARTED|Washout Period (at Least 7 Days)||6
8599997|NCT00359801|9636081|FG000|COMPLETED|Overall Study|7 additional subjects had missing data and final status (completed/discontinued) is unknown.|682
8599998|NCT00359801|9636082|FG001|COMPLETED|Overall Study|4 additional subjects had missing data and final status (completed/discontinued) is unknown.|769
8599999|NCT00359801|9636081|FG000|NOT COMPLETED|Overall Study||305
8600000|NCT00359801|9636082|FG001|NOT COMPLETED|Overall Study||220
8600001|NCT00359944|9636091|FG000|STARTED|Overall Study||50
8600002|NCT00359944|9636092|FG001|STARTED|Overall Study||47
8600003|NCT00359944|9636093|FG002|STARTED|Overall Study||57
8600004|NCT00359944|9636091|FG000|COMPLETED|Overall Study||34
8600005|NCT00359944|9636092|FG001|COMPLETED|Overall Study||28
8600006|NCT00359944|9636093|FG002|COMPLETED|Overall Study||38
8600007|NCT00359944|9636091|FG000|NOT COMPLETED|Overall Study||16
8600008|NCT00359944|9636092|FG001|NOT COMPLETED|Overall Study||19
8600009|NCT00359944|9636093|FG002|NOT COMPLETED|Overall Study||19
8600010|NCT00359983|9636104|FG000|STARTED|Year 1 Persistence Follow-up||138
8600011|NCT00359983|9636105|FG001|STARTED|Year 1 Persistence Follow-up||70
8600012|NCT00359983|9636106|FG002|STARTED|Year 1 Persistence Follow-up||62
8600013|NCT00359983|9636104|FG000|COMPLETED|Year 1 Persistence Follow-up||138
8600014|NCT00359983|9636105|FG001|COMPLETED|Year 1 Persistence Follow-up||70
8600015|NCT00359983|9636106|FG002|COMPLETED|Year 1 Persistence Follow-up||62
8600016|NCT00359983|9636104|FG000|NOT COMPLETED|Year 1 Persistence Follow-up||0
8600017|NCT00359983|9636105|FG001|NOT COMPLETED|Year 1 Persistence Follow-up||0
8600018|NCT00359983|9636106|FG002|NOT COMPLETED|Year 1 Persistence Follow-up||0
8600019|NCT00359983|9636104|FG000|STARTED|Year 3 Persistence Follow-up||103
8600020|NCT00359983|9636105|FG001|STARTED|Year 3 Persistence Follow-up||47
8600021|NCT00359983|9636106|FG002|STARTED|Year 3 Persistence Follow-up||51
8600022|NCT00359983|9636104|FG000|COMPLETED|Year 3 Persistence Follow-up||103
8600023|NCT00359983|9636105|FG001|COMPLETED|Year 3 Persistence Follow-up||47
8600024|NCT00359983|9636106|FG002|COMPLETED|Year 3 Persistence Follow-up||51
8600025|NCT00359983|9636104|FG000|NOT COMPLETED|Year 3 Persistence Follow-up||0
8600026|NCT00359983|9636105|FG001|NOT COMPLETED|Year 3 Persistence Follow-up||0
8600027|NCT00359983|9636106|FG002|NOT COMPLETED|Year 3 Persistence Follow-up||0
8600028|NCT00359983|9636104|FG000|STARTED|Year 5 Persistence Follow-up||95
8600029|NCT00359983|9636105|FG001|STARTED|Year 5 Persistence Follow-up||44
8600030|NCT00359983|9636106|FG002|STARTED|Year 5 Persistence Follow-up||42
8600031|NCT00359983|9636104|FG000|COMPLETED|Year 5 Persistence Follow-up||95
8600032|NCT00359983|9636105|FG001|COMPLETED|Year 5 Persistence Follow-up||44
8600033|NCT00359983|9636106|FG002|COMPLETED|Year 5 Persistence Follow-up||42
8600034|NCT00359983|9636104|FG000|NOT COMPLETED|Year 5 Persistence Follow-up||0
8600035|NCT00359983|9636105|FG001|NOT COMPLETED|Year 5 Persistence Follow-up||0
8600036|NCT00359983|9636106|FG002|NOT COMPLETED|Year 5 Persistence Follow-up||0
8600037|NCT00360009|9636117|FG000|STARTED|Overall Study||10
8600038|NCT00360009|9636118|FG001|STARTED|Overall Study||26
8600039|NCT00360009|9636119|FG002|STARTED|Overall Study||26
8600040|NCT00360009|9636117|FG000|COMPLETED|Overall Study||10
8600041|NCT00360009|9636118|FG001|COMPLETED|Overall Study||22
8600042|NCT00360009|9636119|FG002|COMPLETED|Overall Study||23
8600043|NCT00360009|9636117|FG000|NOT COMPLETED|Overall Study||0
8600044|NCT00360009|9636118|FG001|NOT COMPLETED|Overall Study||4
8600045|NCT00360009|9636119|FG002|NOT COMPLETED|Overall Study||3
8600046|NCT00360126|9636127|FG000|STARTED|Overall Study||11
8600047|NCT00360126|9636127|FG000|COMPLETED|Overall Study||11
8600048|NCT00360126|9636127|FG000|NOT COMPLETED|Overall Study||0
8600049|NCT00360230|9636138|FG000|STARTED|Overall Study||90
8600050|NCT00360230|9636139|FG001|STARTED|Overall Study||90
8600051|NCT00360230|9636140|FG002|STARTED|Overall Study||45
8600052|NCT00360230|9636141|FG003|STARTED|Overall Study||90
8600053|NCT00360230|9636142|FG004|STARTED|Overall Study||90
8600054|NCT00360230|9636143|FG005|STARTED|Overall Study||90
8600055|NCT00360230|9636144|FG006|STARTED|Overall Study||45
8600056|NCT00360230|9636138|FG000|COMPLETED|Overall Study||84
8600057|NCT00360230|9636139|FG001|COMPLETED|Overall Study||87
8600058|NCT00360230|9636140|FG002|COMPLETED|Overall Study||42
8600059|NCT00360230|9636141|FG003|COMPLETED|Overall Study||88
8600060|NCT00360230|9636142|FG004|COMPLETED|Overall Study||85
8600061|NCT00360230|9636143|FG005|COMPLETED|Overall Study||86
8600062|NCT00360230|9636144|FG006|COMPLETED|Overall Study||43
8600063|NCT00360230|9636138|FG000|NOT COMPLETED|Overall Study||6
8600064|NCT00360230|9636139|FG001|NOT COMPLETED|Overall Study||3
8600065|NCT00360230|9636140|FG002|NOT COMPLETED|Overall Study||3
8600066|NCT00360230|9636141|FG003|NOT COMPLETED|Overall Study||2
8600067|NCT00360230|9636142|FG004|NOT COMPLETED|Overall Study||5
8600068|NCT00360230|9636143|FG005|NOT COMPLETED|Overall Study||4
8600069|NCT00360230|9636144|FG006|NOT COMPLETED|Overall Study||2
8600070|NCT00360243|9636166|FG000|STARTED|Overall Study||337
8600071|NCT00360243|9636167|FG001|STARTED|Overall Study||363
8600072|NCT00360243|9636168|FG002|STARTED|Overall Study||336
8600073|NCT00360243|9636169|FG003|STARTED|Overall Study||349
8600074|NCT00360243|9636166|FG000|COMPLETED|Overall Study||235
8600075|NCT00360243|9636167|FG001|COMPLETED|Overall Study||243
8600076|NCT00360243|9636168|FG002|COMPLETED|Overall Study||180
8600077|NCT00360243|9636169|FG003|COMPLETED|Overall Study||224
8600078|NCT00360243|9636166|FG000|NOT COMPLETED|Overall Study||102
8600079|NCT00360243|9636167|FG001|NOT COMPLETED|Overall Study||120
8600080|NCT00360243|9636168|FG002|NOT COMPLETED|Overall Study||156
8600081|NCT00360243|9636169|FG003|NOT COMPLETED|Overall Study||125
8600082|NCT00360269|9636181|FG000|STARTED|Overall Study||19
8600083|NCT00360269|9636182|FG001|STARTED|Overall Study||19
8600084|NCT00360269|9636181|FG000|COMPLETED|Overall Study||9
8600085|NCT00360269|9636182|FG001|COMPLETED|Overall Study||7
8600086|NCT00360269|9636181|FG000|NOT COMPLETED|Overall Study||10
8600087|NCT00360269|9636182|FG001|NOT COMPLETED|Overall Study||12
8600088|NCT00360282|9636188|FG000|STARTED|First Intervention||6
8600089|NCT00360282|9636189|FG001|STARTED|First Intervention||8
8600090|NCT00360282|9636190|FG002|STARTED|First Intervention||7
8600091|NCT00360282|9636191|FG003|STARTED|First Intervention||6
8600092|NCT00360282|9636188|FG000|COMPLETED|First Intervention||6
8600093|NCT00360282|9636189|FG001|COMPLETED|First Intervention||8
8600094|NCT00360282|9636190|FG002|COMPLETED|First Intervention||7
8600095|NCT00360282|9636191|FG003|COMPLETED|First Intervention||6
8600096|NCT00360282|9636188|FG000|NOT COMPLETED|First Intervention||0
8600097|NCT00360282|9636189|FG001|NOT COMPLETED|First Intervention||0
8600098|NCT00360282|9636190|FG002|NOT COMPLETED|First Intervention||0
8600099|NCT00360282|9636191|FG003|NOT COMPLETED|First Intervention||0
8600100|NCT00360282|9636188|FG000|STARTED|Washout 1-3 Weeks||6
8600101|NCT00360282|9636189|FG001|STARTED|Washout 1-3 Weeks||8
8600102|NCT00360282|9636190|FG002|STARTED|Washout 1-3 Weeks||7
8600103|NCT00360282|9636191|FG003|STARTED|Washout 1-3 Weeks||6
8600104|NCT00360282|9636188|FG000|COMPLETED|Washout 1-3 Weeks||6
8600105|NCT00360282|9636189|FG001|COMPLETED|Washout 1-3 Weeks||8
8600106|NCT00360282|9636190|FG002|COMPLETED|Washout 1-3 Weeks||6
8600107|NCT00360282|9636191|FG003|COMPLETED|Washout 1-3 Weeks||6
8600108|NCT00360282|9636188|FG000|NOT COMPLETED|Washout 1-3 Weeks||0
8600109|NCT00360282|9636189|FG001|NOT COMPLETED|Washout 1-3 Weeks||0
8600110|NCT00360282|9636190|FG002|NOT COMPLETED|Washout 1-3 Weeks||1
8600111|NCT00360282|9636191|FG003|NOT COMPLETED|Washout 1-3 Weeks||0
8600112|NCT00360282|9636188|FG000|STARTED|Second Intervention||6
8600113|NCT00360282|9636189|FG001|STARTED|Second Intervention||8
8600114|NCT00360282|9636190|FG002|STARTED|Second Intervention||6
8600115|NCT00360282|9636191|FG003|STARTED|Second Intervention||6
8600116|NCT00360282|9636188|FG000|COMPLETED|Second Intervention||6
8600117|NCT00360282|9636189|FG001|COMPLETED|Second Intervention||7
8600118|NCT00360282|9636190|FG002|COMPLETED|Second Intervention||6
8600119|NCT00360282|9636191|FG003|COMPLETED|Second Intervention||6
8600120|NCT00360282|9636188|FG000|NOT COMPLETED|Second Intervention||0
8600121|NCT00360282|9636189|FG001|NOT COMPLETED|Second Intervention||1
8600122|NCT00360282|9636190|FG002|NOT COMPLETED|Second Intervention||0
8600123|NCT00360282|9636191|FG003|NOT COMPLETED|Second Intervention||0
8600124|NCT00360308|9636202|FG000|STARTED|Overall Study||247
8600125|NCT00360308|9636203|FG001|STARTED|Overall Study||234
8600126|NCT00360308|9636204|FG002|STARTED|Overall Study||242
8600127|NCT00360308|9636202|FG000|COMPLETED|Overall Study||171
8600128|NCT00360308|9636203|FG001|COMPLETED|Overall Study||155
8600129|NCT00360308|9636204|FG002|COMPLETED|Overall Study||154
8600130|NCT00360308|9636202|FG000|NOT COMPLETED|Overall Study||76
8600131|NCT00360308|9636203|FG001|NOT COMPLETED|Overall Study||79
8600132|NCT00360308|9636204|FG002|NOT COMPLETED|Overall Study||88
8713444|NCT00975481|9760285|FG005|STARTED|Washout Period (at Least 7 Days)||6
8713445|NCT00975481|9760280|FG000|COMPLETED|Washout Period (at Least 7 Days)||6
8713446|NCT00975481|9760281|FG001|COMPLETED|Washout Period (at Least 7 Days)||6
8713447|NCT00975481|9760282|FG002|COMPLETED|Washout Period (at Least 7 Days)||6
8713448|NCT00975481|9760283|FG003|COMPLETED|Washout Period (at Least 7 Days)||6
8713449|NCT00975481|9760284|FG004|COMPLETED|Washout Period (at Least 7 Days)||6
8713450|NCT00975481|9760285|FG005|COMPLETED|Washout Period (at Least 7 Days)||6
8713451|NCT00975481|9760280|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8713452|NCT00975481|9760281|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8713453|NCT00975481|9760282|FG002|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8713454|NCT00975481|9760283|FG003|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8713455|NCT00975481|9760284|FG004|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8713456|NCT00975481|9760285|FG005|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8713457|NCT00975481|9760280|FG000|STARTED|Second Intervention Period||6
8713458|NCT00975481|9760281|FG001|STARTED|Second Intervention Period||6
8713459|NCT00975481|9760282|FG002|STARTED|Second Intervention Period||6
8713460|NCT00975481|9760283|FG003|STARTED|Second Intervention Period||6
8713461|NCT00975481|9760284|FG004|STARTED|Second Intervention Period||6
8713462|NCT00975481|9760285|FG005|STARTED|Second Intervention Period||6
8713463|NCT00975481|9760280|FG000|COMPLETED|Second Intervention Period||4
8713464|NCT00975481|9760281|FG001|COMPLETED|Second Intervention Period||5
8713465|NCT00975481|9760282|FG002|COMPLETED|Second Intervention Period||5
8713466|NCT00975481|9760283|FG003|COMPLETED|Second Intervention Period||6
8713467|NCT00975481|9760284|FG004|COMPLETED|Second Intervention Period||6
8713468|NCT00975481|9760285|FG005|COMPLETED|Second Intervention Period||6
8713469|NCT00975481|9760280|FG000|NOT COMPLETED|Second Intervention Period||2
8713470|NCT00975481|9760281|FG001|NOT COMPLETED|Second Intervention Period||1
8713471|NCT00975481|9760282|FG002|NOT COMPLETED|Second Intervention Period||1
8713472|NCT00975481|9760283|FG003|NOT COMPLETED|Second Intervention Period||0
8600133|NCT00360334|9636218|FG000|STARTED|Overall Study||118
8600134|NCT00360334|9636219|FG001|STARTED|Overall Study||117
8600135|NCT00360334|9636218|FG000|Full Analysis Set (FAS)|Overall Study|FAS = received ≥ 1 dose of study drug|118
8600136|NCT00360334|9636219|FG001|Full Analysis Set (FAS)|Overall Study|FAS = received ≥ 1 dose of study drug|116
8600137|NCT00360334|9636218|FG000|COMPLETED|Overall Study||99
8600138|NCT00360334|9636219|FG001|COMPLETED|Overall Study||104
8600139|NCT00360334|9636218|FG000|NOT COMPLETED|Overall Study||19
8600140|NCT00360334|9636219|FG001|NOT COMPLETED|Overall Study||13
8600141|NCT00360360|9636225|FG000|STARTED|Overall Study||60
8600142|NCT00360360|9636225|FG000|COMPLETED|Overall Study||54
8600143|NCT00360360|9636225|FG000|NOT COMPLETED|Overall Study||6
8600144|NCT00360399|9636232|FG000|STARTED|Overall Study||114
8600145|NCT00360399|9636233|FG001|STARTED|Overall Study||115
8600146|NCT00360399|9636234|FG002|STARTED|Overall Study||115
8600147|NCT00360399|9636232|FG000|Had Post-randomization Assessment|Overall Study||105
8600148|NCT00360399|9636233|FG001|Had Post-randomization Assessment|Overall Study||106
8600149|NCT00360399|9636234|FG002|Had Post-randomization Assessment|Overall Study||105
8600150|NCT00360399|9636232|FG000|COMPLETED|Overall Study||86
8600151|NCT00360399|9636233|FG001|COMPLETED|Overall Study||79
8600152|NCT00360399|9636234|FG002|COMPLETED|Overall Study||69
8600153|NCT00360399|9636232|FG000|NOT COMPLETED|Overall Study||28
8600154|NCT00360399|9636233|FG001|NOT COMPLETED|Overall Study||36
8600155|NCT00360399|9636234|FG002|NOT COMPLETED|Overall Study||46
8600156|NCT00360412|9636244|FG000|STARTED|Overall Study||333
8600157|NCT00360412|9636245|FG001|STARTED|Overall Study||664
8600158|NCT00360412|9636244|FG000|COMPLETED|Overall Study||0
8600159|NCT00360412|9636245|FG001|COMPLETED|Overall Study||2
8600160|NCT00360412|9636244|FG000|NOT COMPLETED|Overall Study||333
8600161|NCT00360412|9636245|FG001|NOT COMPLETED|Overall Study||662
8600162|NCT00360490|9636253|FG000|STARTED|Overall Study||82
8600163|NCT00360490|9636254|FG001|STARTED|Overall Study||83
8600164|NCT00360490|9636253|FG000|COMPLETED|Overall Study||73
8600165|NCT00360490|9636254|FG001|COMPLETED|Overall Study||72
8600166|NCT00360490|9636253|FG000|NOT COMPLETED|Overall Study||9
8600167|NCT00360490|9636254|FG001|NOT COMPLETED|Overall Study||11
8600168|NCT00360529|9636263|FG000|STARTED|Overall Study||295
8600169|NCT00360529|9636264|FG001|STARTED|Overall Study||295
8600170|NCT00360529|9636265|FG002|STARTED|Overall Study||290
8600171|NCT00360529|9636263|FG000|COMPLETED|Overall Study||234
8600172|NCT00360529|9636264|FG001|COMPLETED|Overall Study||230
8600173|NCT00360529|9636265|FG002|COMPLETED|Overall Study||199
8600174|NCT00360529|9636263|FG000|NOT COMPLETED|Overall Study||61
8600175|NCT00360529|9636264|FG001|NOT COMPLETED|Overall Study||65
8600176|NCT00360529|9636265|FG002|NOT COMPLETED|Overall Study||91
8600177|NCT00360555|9636277|FG000|STARTED|Overall Study||396
8600178|NCT00360555|9636278|FG001|STARTED|Overall Study||393
8600179|NCT00360555|9636279|FG002|STARTED|Overall Study||396
8600180|NCT00360555|9636280|FG003|STARTED|Overall Study||399
8600181|NCT00360555|9636277|FG000|COMPLETED|Overall Study||274
8600182|NCT00360555|9636278|FG001|COMPLETED|Overall Study||259
8600183|NCT00360555|9636279|FG002|COMPLETED|Overall Study||251
8600184|NCT00360555|9636280|FG003|COMPLETED|Overall Study||287
8600185|NCT00360555|9636277|FG000|NOT COMPLETED|Overall Study||122
8600186|NCT00360555|9636278|FG001|NOT COMPLETED|Overall Study||134
8600187|NCT00360555|9636279|FG002|NOT COMPLETED|Overall Study||145
8600188|NCT00360555|9636280|FG003|NOT COMPLETED|Overall Study||112
8600189|NCT00360568|9636292|FG000|STARTED|Overall Study||33
8600190|NCT00360568|9636293|FG001|STARTED|Overall Study||29
8600191|NCT00360568|9636292|FG000|COMPLETED|Overall Study||31
8600192|NCT00360568|9636293|FG001|COMPLETED|Overall Study||24
8600193|NCT00360568|9636292|FG000|NOT COMPLETED|Overall Study||2
8600194|NCT00360568|9636293|FG001|NOT COMPLETED|Overall Study||5
8600195|NCT00360672|9636301|FG000|STARTED|Overall Study||27
8600196|NCT00360672|9636301|FG000|COMPLETED|Overall Study||27
8600197|NCT00360672|9636301|FG000|NOT COMPLETED|Overall Study||0
8600198|NCT00360685|9636307|FG000|STARTED|Overall Study||47
8600199|NCT00360685|9636308|FG001|STARTED|Overall Study||42
8600200|NCT00360685|9636307|FG000|COMPLETED|Overall Study||47
8600201|NCT00360685|9636308|FG001|COMPLETED|Overall Study||42
8600202|NCT00360685|9636307|FG000|NOT COMPLETED|Overall Study||0
8600203|NCT00360685|9636308|FG001|NOT COMPLETED|Overall Study||0
8600204|NCT00360698|9636317|FG000|STARTED|Run-In||0
8600205|NCT00360698|9636318|FG001|STARTED|Run-In||135
8600206|NCT00360698|9636317|FG000|COMPLETED|Run-In||0
8600207|NCT00360698|9636318|FG001|COMPLETED|Run-In|19 patients completed the run-in but were not eligible for randomization in the treatment period|125
8600208|NCT00360698|9636317|FG000|NOT COMPLETED|Run-In||0
8600209|NCT00360698|9636318|FG001|NOT COMPLETED|Run-In||10
8600210|NCT00360698|9636317|FG000|STARTED|Treatment Period||49
8600211|NCT00360698|9636318|FG001|STARTED|Treatment Period||57
8600212|NCT00360698|9636317|FG000|COMPLETED|Treatment Period||48
8600213|NCT00360698|9636318|FG001|COMPLETED|Treatment Period||56
8600214|NCT00360698|9636317|FG000|NOT COMPLETED|Treatment Period||1
8600215|NCT00360698|9636318|FG001|NOT COMPLETED|Treatment Period||1
8600216|NCT00360724|9636326|FG000|STARTED|Overall Study||33
8600217|NCT00360724|9636327|FG001|STARTED|Overall Study||32
8600218|NCT00360724|9636326|FG000|COMPLETED|Overall Study||29
8600219|NCT00360724|9636327|FG001|COMPLETED|Overall Study||28
8600220|NCT00360724|9636326|FG000|NOT COMPLETED|Overall Study||4
8600221|NCT00360724|9636327|FG001|NOT COMPLETED|Overall Study||4
8600222|NCT00360828|9636336|FG000|STARTED|Overall Study||10
8600223|NCT00360828|9636336|FG000|COMPLETED|Overall Study||9
8600224|NCT00360828|9636336|FG000|NOT COMPLETED|Overall Study||1
8600225|NCT00360971|9636342|FG000|STARTED|Overall Study||10
8600226|NCT00360971|9636343|FG001|STARTED|Overall Study||11
8600227|NCT00360971|9636342|FG000|COMPLETED|Overall Study|Subjects with data for planned primary analysis are considered to have completed the study.|10
8600228|NCT00360971|9636343|FG001|COMPLETED|Overall Study|Subjects with data for planned primary analysis are considered to have completed the study.|11
8600229|NCT00360971|9636342|FG000|NOT COMPLETED|Overall Study||0
8600230|NCT00360971|9636343|FG001|NOT COMPLETED|Overall Study||0
8600231|NCT00361140|9636352|FG000|STARTED|Overall Study||40
8600232|NCT00361140|9636353|FG001|STARTED|Overall Study||29
8600233|NCT00361140|9636354|FG002|STARTED|Overall Study||3
8600234|NCT00361140|9636352|FG000|COMPLETED|Overall Study||40
8600235|NCT00361140|9636353|FG001|COMPLETED|Overall Study||29
8600236|NCT00361140|9636354|FG002|COMPLETED|Overall Study||3
8600237|NCT00361140|9636352|FG000|NOT COMPLETED|Overall Study||0
8600238|NCT00361140|9636353|FG001|NOT COMPLETED|Overall Study||0
8600239|NCT00361140|9636354|FG002|NOT COMPLETED|Overall Study||0
8600240|NCT00361218|9636362|FG000|STARTED|Overall Study|met eligibility criteria and enrolled in the study|53
8600241|NCT00361218|9636362|FG000|Completed Baseline Assessment|Overall Study||47
8600242|NCT00361218|9636362|FG000|COMPLETED|Overall Study||30
8600243|NCT00361218|9636362|FG000|NOT COMPLETED|Overall Study||23
8600244|NCT00361231|9636366|FG000|STARTED|Overall Study||35
8600245|NCT00361231|9636366|FG000|COMPLETED|Overall Study||1
8600246|NCT00361231|9636366|FG000|NOT COMPLETED|Overall Study||34
8600247|NCT00361257|9636372|FG000|STARTED|Step 1: Minocycline vs. Placebo||52
8600248|NCT00361257|9636373|FG001|STARTED|Step 1: Minocycline vs. Placebo||55
8600249|NCT00361257|9636372|FG000|COMPLETED|Step 1: Minocycline vs. Placebo||40
8600250|NCT00361257|9636373|FG001|COMPLETED|Step 1: Minocycline vs. Placebo||43
8600251|NCT00361257|9636372|FG000|NOT COMPLETED|Step 1: Minocycline vs. Placebo||12
8600252|NCT00361257|9636373|FG001|NOT COMPLETED|Step 1: Minocycline vs. Placebo||12
8600253|NCT00361257|9636372|FG000|STARTED|Step 2: Minocycline(Open Label) for All|40 participants completed Step 1; however,12 decided not to enroll Step 2,so 40-12=28 started Step 2|28
8600254|NCT00361257|9636373|FG001|STARTED|Step 2: Minocycline(Open Label) for All|43 participants completed Step 1; however, 9 decided not to enroll Step 2,so 43-9=34 started Step 2.|34
8600255|NCT00361257|9636372|FG000|COMPLETED|Step 2: Minocycline(Open Label) for All||13
8600256|NCT00361257|9636373|FG001|COMPLETED|Step 2: Minocycline(Open Label) for All||19
8600257|NCT00361257|9636372|FG000|NOT COMPLETED|Step 2: Minocycline(Open Label) for All||15
8600258|NCT00361257|9636373|FG001|NOT COMPLETED|Step 2: Minocycline(Open Label) for All||15
8600259|NCT00361270|9636385|FG000|STARTED|Overall Study||49
8600260|NCT00361270|9636386|FG001|STARTED|Overall Study||39
8600261|NCT00361270|9636387|FG002|STARTED|Overall Study||35
8600262|NCT00361270|9636388|FG003|STARTED|Overall Study||38
8600263|NCT00361270|9636385|FG000|COMPLETED|Overall Study||25
8600264|NCT00361270|9636386|FG001|COMPLETED|Overall Study||25
8600265|NCT00361270|9636387|FG002|COMPLETED|Overall Study||25
8600266|NCT00361270|9636388|FG003|COMPLETED|Overall Study||25
8600267|NCT00361270|9636385|FG000|NOT COMPLETED|Overall Study||24
8600268|NCT00361270|9636386|FG001|NOT COMPLETED|Overall Study||14
8600269|NCT00361270|9636387|FG002|NOT COMPLETED|Overall Study||10
8600270|NCT00361270|9636388|FG003|NOT COMPLETED|Overall Study||13
8600271|NCT00361283|9636405|FG000|STARTED|Overall Study||108
8600272|NCT00361283|9636405|FG000|COMPLETED|Overall Study||81
8600273|NCT00361283|9636405|FG000|NOT COMPLETED|Overall Study||27
8600274|NCT00361296|9636409|FG000|STARTED|Overall Study||5
8600275|NCT00361296|9636409|FG000|COMPLETED|Overall Study||2
8600276|NCT00361296|9636409|FG000|NOT COMPLETED|Overall Study||3
8600277|NCT00361335|9636418|FG000|STARTED|IV Period: Baseline to E0||129
8600278|NCT00361335|9636419|FG001|STARTED|IV Period: Baseline to E0||128
8600279|NCT00361335|9636420|FG002|STARTED|IV Period: Baseline to E0||128
8600280|NCT00361335|9636421|FG003|STARTED|IV Period: Baseline to E0||129
8600281|NCT00361335|9636422|FG004|STARTED|IV Period: Baseline to E0||129
8600282|NCT00361335|9636423|FG005|STARTED|IV Period: Baseline to E0|"0 in column indicates this reporting group is not relevant to the IV Period."|0
8600283|NCT00361335|9636424|FG006|STARTED|IV Period: Baseline to E0|"0 in column indicates this reporting group is not relevant to the IV Period."|0
8600284|NCT00361335|9636418|FG000|COMPLETED|IV Period: Baseline to E0||109
8600285|NCT00361335|9636419|FG001|COMPLETED|IV Period: Baseline to E0||99
8600286|NCT00361335|9636420|FG002|COMPLETED|IV Period: Baseline to E0||107
8600287|NCT00361335|9636421|FG003|COMPLETED|IV Period: Baseline to E0||102
8600288|NCT00361335|9636422|FG004|COMPLETED|IV Period: Baseline to E0||105
8600289|NCT00361335|9636423|FG005|COMPLETED|IV Period: Baseline to E0||0
8600290|NCT00361335|9636424|FG006|COMPLETED|IV Period: Baseline to E0||0
8600291|NCT00361335|9636418|FG000|NOT COMPLETED|IV Period: Baseline to E0||20
8600292|NCT00361335|9636419|FG001|NOT COMPLETED|IV Period: Baseline to E0||29
8600293|NCT00361335|9636420|FG002|NOT COMPLETED|IV Period: Baseline to E0||21
8600294|NCT00361335|9636421|FG003|NOT COMPLETED|IV Period: Baseline to E0||27
8600295|NCT00361335|9636422|FG004|NOT COMPLETED|IV Period: Baseline to E0||24
8600296|NCT00361335|9636423|FG005|NOT COMPLETED|IV Period: Baseline to E0||0
8600297|NCT00361335|9636424|FG006|NOT COMPLETED|IV Period: Baseline to E0||0
8600298|NCT00361335|9636418|FG000|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|82
8600299|NCT00361335|9636419|FG001|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|59
8600300|NCT00361335|9636420|FG002|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|104
8600301|NCT00361335|9636421|FG003|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|63
8600302|NCT00361335|9636422|FG004|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|3
8600303|NCT00361335|9636423|FG005|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|24
8600304|NCT00361335|9636424|FG006|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|173
8600305|NCT00361335|9636418|FG000|COMPLETED|SC Period: Week E0 to Week E24||80
8600306|NCT00361335|9636419|FG001|COMPLETED|SC Period: Week E0 to Week E24||56
8600307|NCT00361335|9636420|FG002|COMPLETED|SC Period: Week E0 to Week E24||99
8600308|NCT00361335|9636421|FG003|COMPLETED|SC Period: Week E0 to Week E24||59
8600309|NCT00361335|9636422|FG004|COMPLETED|SC Period: Week E0 to Week E24||3
8600310|NCT00361335|9636423|FG005|COMPLETED|SC Period: Week E0 to Week E24||23
8600311|NCT00361335|9636424|FG006|COMPLETED|SC Period: Week E0 to Week E24||164
8600312|NCT00361335|9636418|FG000|NOT COMPLETED|SC Period: Week E0 to Week E24||2
8600313|NCT00361335|9636419|FG001|NOT COMPLETED|SC Period: Week E0 to Week E24||3
8600314|NCT00361335|9636420|FG002|NOT COMPLETED|SC Period: Week E0 to Week E24||5
8600315|NCT00361335|9636421|FG003|NOT COMPLETED|SC Period: Week E0 to Week E24||4
8600316|NCT00361335|9636422|FG004|NOT COMPLETED|SC Period: Week E0 to Week E24||0
8600317|NCT00361335|9636423|FG005|NOT COMPLETED|SC Period: Week E0 to Week E24||1
8600318|NCT00361335|9636424|FG006|NOT COMPLETED|SC Period: Week E0 to Week E24||9
8600319|NCT00361374|9636443|FG000|STARTED|Overall Study||66
8600320|NCT00361374|9636444|FG001|STARTED|Overall Study||65
8600321|NCT00361374|9636445|FG002|STARTED|Overall Study||65
8600322|NCT00361374|9636443|FG000|COMPLETED|Overall Study||51
8600323|NCT00361374|9636444|FG001|COMPLETED|Overall Study||50
8600324|NCT00361374|9636445|FG002|COMPLETED|Overall Study||53
8600325|NCT00361374|9636443|FG000|NOT COMPLETED|Overall Study||15
8600326|NCT00361374|9636444|FG001|NOT COMPLETED|Overall Study||15
8600327|NCT00361374|9636445|FG002|NOT COMPLETED|Overall Study||12
8600328|NCT00361439|9636455|FG000|STARTED|Overall Study||8
8600329|NCT00361439|9636456|FG001|STARTED|Overall Study||9
8600330|NCT00361439|9636455|FG000|COMPLETED|Overall Study||8
8600331|NCT00361439|9636456|FG001|COMPLETED|Overall Study||9
8600332|NCT00361439|9636455|FG000|NOT COMPLETED|Overall Study||0
8600333|NCT00361439|9636456|FG001|NOT COMPLETED|Overall Study||0
8600334|NCT00361504|9636464|FG000|STARTED|Overall Study|Number of participants who received at least 1 dose of study medication|894
8600335|NCT00361504|9636465|FG001|STARTED|Overall Study|Number of participants who received at least 1 dose of study medication|223
8600336|NCT00361504|9636464|FG000|COMPLETED|Overall Study||413
8600337|NCT00361504|9636465|FG001|COMPLETED|Overall Study||78
8600338|NCT00361504|9636464|FG000|NOT COMPLETED|Overall Study||481
8600339|NCT00361504|9636465|FG001|NOT COMPLETED|Overall Study||145
8600340|NCT00361569|9636475|FG000|STARTED|Overall Study||150
8600341|NCT00361569|9636476|FG001|STARTED|Overall Study||161
8600342|NCT00361569|9636477|FG002|STARTED|Overall Study||155
8600343|NCT00361569|9636478|FG003|STARTED|Overall Study||156
8600344|NCT00361569|9636475|FG000|COMPLETED|Overall Study||138
8600345|NCT00361569|9636476|FG001|COMPLETED|Overall Study||150
8600346|NCT00361569|9636477|FG002|COMPLETED|Overall Study||137
8600347|NCT00361569|9636478|FG003|COMPLETED|Overall Study||135
8600348|NCT00361569|9636475|FG000|NOT COMPLETED|Overall Study||12
8600349|NCT00361569|9636476|FG001|NOT COMPLETED|Overall Study||11
8600350|NCT00361569|9636477|FG002|NOT COMPLETED|Overall Study||18
8600351|NCT00361569|9636478|FG003|NOT COMPLETED|Overall Study||21
8600352|NCT00361595|9636488|FG000|STARTED|Overall Study||35
8600353|NCT00361595|9636488|FG000|COMPLETED|Overall Study||35
8600354|NCT00361595|9636488|FG000|NOT COMPLETED|Overall Study||0
8600355|NCT00361634|9636492|FG000|STARTED|Overall Study||14
8628558|NCT00525044|9668057|FG001|STARTED|Overall Study||125
8713473|NCT00975481|9760284|FG004|NOT COMPLETED|Second Intervention Period||0
8713474|NCT00975481|9760285|FG005|NOT COMPLETED|Second Intervention Period||0
8713475|NCT00975481|9760280|FG000|STARTED|Washout Period (at Least 7 Days)||4
8713476|NCT00975481|9760281|FG001|STARTED|Washout Period (at Least 7 Days)||5
8713477|NCT00975481|9760282|FG002|STARTED|Washout Period (at Least 7 Days)||5
8713478|NCT00975481|9760283|FG003|STARTED|Washout Period (at Least 7 Days)||6
8713479|NCT00975481|9760284|FG004|STARTED|Washout Period (at Least 7 Days)||6
8713480|NCT00975481|9760285|FG005|STARTED|Washout Period (at Least 7 Days)||6
8713481|NCT00975481|9760280|FG000|COMPLETED|Washout Period (at Least 7 Days)||4
8713482|NCT00975481|9760281|FG001|COMPLETED|Washout Period (at Least 7 Days)||5
8713483|NCT00975481|9760282|FG002|COMPLETED|Washout Period (at Least 7 Days)||5
8713484|NCT00975481|9760283|FG003|COMPLETED|Washout Period (at Least 7 Days)||6
8713485|NCT00975481|9760284|FG004|COMPLETED|Washout Period (at Least 7 Days)||6
8713486|NCT00975481|9760285|FG005|COMPLETED|Washout Period (at Least 7 Days)||6
8713487|NCT00975481|9760280|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8713488|NCT00975481|9760281|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8713489|NCT00975481|9760282|FG002|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8713490|NCT00975481|9760283|FG003|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8713491|NCT00975481|9760284|FG004|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8713492|NCT00975481|9760285|FG005|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8713493|NCT00975481|9760280|FG000|STARTED|Third Intervention Period||4
8713494|NCT00975481|9760281|FG001|STARTED|Third Intervention Period||5
8713495|NCT00975481|9760282|FG002|STARTED|Third Intervention Period||5
8713496|NCT00975481|9760283|FG003|STARTED|Third Intervention Period||6
8713497|NCT00975481|9760284|FG004|STARTED|Third Intervention Period||6
8713498|NCT00975481|9760285|FG005|STARTED|Third Intervention Period||6
8713499|NCT00975481|9760280|FG000|COMPLETED|Third Intervention Period||4
8813147|NCT01524224|9866297|FG000|STARTED|Overall Study||4
8813148|NCT01524224|9866298|FG001|STARTED|Overall Study||3
8813149|NCT01524224|9866299|FG002|STARTED|Overall Study||3
8600356|NCT00361634|9636492|FG000|Treated|Overall Study|The safety analysis set consisted of all patients who received at least one dose of etanercept.|13
8600357|NCT00361634|9636492|FG000|COMPLETED|Overall Study||12
8600358|NCT00361634|9636492|FG000|NOT COMPLETED|Overall Study||2
8600359|NCT00361712|9636498|FG000|STARTED|Overall Study||20
8600360|NCT00361712|9636499|FG001|STARTED|Overall Study||21
8600361|NCT00361712|9636498|FG000|COMPLETED|Overall Study||20
8600362|NCT00361712|9636499|FG001|COMPLETED|Overall Study||21
8600363|NCT00361712|9636498|FG000|NOT COMPLETED|Overall Study||0
8600364|NCT00361712|9636499|FG001|NOT COMPLETED|Overall Study||0
8600365|NCT00361842|9636507|FG000|STARTED|Overall Study||28
8600366|NCT00361842|9636508|FG001|STARTED|Overall Study||35
8600367|NCT00361842|9636507|FG000|COMPLETED|Overall Study||1
8600368|NCT00361842|9636508|FG001|COMPLETED|Overall Study||1
8600369|NCT00361842|9636507|FG000|NOT COMPLETED|Overall Study||27
8600370|NCT00361842|9636508|FG001|NOT COMPLETED|Overall Study||34
8600371|NCT00361972|9636518|FG000|STARTED|Overall Study||8
8600372|NCT00361972|9636519|FG001|STARTED|Overall Study||9
8600373|NCT00361972|9636518|FG000|COMPLETED|Overall Study||8
8600374|NCT00361972|9636519|FG001|COMPLETED|Overall Study||9
8600375|NCT00361972|9636518|FG000|NOT COMPLETED|Overall Study||0
8600376|NCT00361972|9636519|FG001|NOT COMPLETED|Overall Study||0
8600377|NCT00362115|9636533|FG000|STARTED|Overall Study||65
8600378|NCT00362115|9636534|FG001|STARTED|Overall Study|1 participant failed to receive double-blind medication.|65
8600379|NCT00362115|9636535|FG002|STARTED|Overall Study||64
8600380|NCT00362115|9636536|FG003|STARTED|Overall Study|1 participant failed to receive double-blind medication.|63
8600381|NCT00362115|9636537|FG004|STARTED|Overall Study||64
8600382|NCT00362115|9636538|FG005|STARTED|Overall Study|1 participant failed to receive double-blind medication.|64
8600383|NCT00362115|9636539|FG006|STARTED|Overall Study|1 participant failed to receive double-blind medication.|64
8600384|NCT00362115|9636533|FG000|COMPLETED|Overall Study||63
8600385|NCT00362115|9636534|FG001|COMPLETED|Overall Study||59
8600386|NCT00362115|9636535|FG002|COMPLETED|Overall Study||57
8600387|NCT00362115|9636536|FG003|COMPLETED|Overall Study||59
8600388|NCT00362115|9636537|FG004|COMPLETED|Overall Study||57
8600389|NCT00362115|9636538|FG005|COMPLETED|Overall Study||57
8600390|NCT00362115|9636539|FG006|COMPLETED|Overall Study||52
8600391|NCT00362115|9636533|FG000|NOT COMPLETED|Overall Study||2
8600392|NCT00362115|9636534|FG001|NOT COMPLETED|Overall Study||6
8600393|NCT00362115|9636535|FG002|NOT COMPLETED|Overall Study||7
8600394|NCT00362115|9636536|FG003|NOT COMPLETED|Overall Study||4
8600395|NCT00362115|9636537|FG004|NOT COMPLETED|Overall Study||7
8600396|NCT00362115|9636538|FG005|NOT COMPLETED|Overall Study||7
8600397|NCT00362115|9636539|FG006|NOT COMPLETED|Overall Study||12
8600398|NCT00362128|9636555|FG000|STARTED|Overall Study|Enrollment was initiated in 2007.|2072
8600399|NCT00362128|9636555|FG000|COMPLETED|Overall Study|Enrollment was completed in October 2009.|2072
8600400|NCT00362128|9636555|FG000|NOT COMPLETED|Overall Study||0
8600401|NCT00362180|9636568|FG000|STARTED|Treated Period||4
8600402|NCT00362180|9636569|FG001|STARTED|Treated Period||2
8600403|NCT00362180|9636570|FG002|STARTED|Treated Period||1
8600404|NCT00362180|9636571|FG003|STARTED|Treated Period||0
8600405|NCT00362180|9636572|FG004|STARTED|Treated Period||11
8600406|NCT00362180|9636573|FG005|STARTED|Treated Period||10
8600407|NCT00362180|9636574|FG006|STARTED|Treated Period||6
8600408|NCT00362180|9636575|FG007|STARTED|Treated Period||3
8600409|NCT00362180|9636576|FG008|STARTED|Treated Period||1
8600410|NCT00362180|9636568|FG000|COMPLETED|Treated Period||3
8600411|NCT00362180|9636569|FG001|COMPLETED|Treated Period||2
8600412|NCT00362180|9636570|FG002|COMPLETED|Treated Period||1
8600413|NCT00362180|9636571|FG003|COMPLETED|Treated Period||0
8600414|NCT00362180|9636572|FG004|COMPLETED|Treated Period||11
8600415|NCT00362180|9636573|FG005|COMPLETED|Treated Period||9
8600416|NCT00362180|9636574|FG006|COMPLETED|Treated Period||6
8600417|NCT00362180|9636575|FG007|COMPLETED|Treated Period||2
8600418|NCT00362180|9636576|FG008|COMPLETED|Treated Period||1
8600419|NCT00362180|9636568|FG000|NOT COMPLETED|Treated Period||1
8600420|NCT00362180|9636569|FG001|NOT COMPLETED|Treated Period||0
8600421|NCT00362180|9636570|FG002|NOT COMPLETED|Treated Period||0
8600422|NCT00362180|9636571|FG003|NOT COMPLETED|Treated Period||0
8600423|NCT00362180|9636572|FG004|NOT COMPLETED|Treated Period||0
8600424|NCT00362180|9636573|FG005|NOT COMPLETED|Treated Period||1
8600425|NCT00362180|9636574|FG006|NOT COMPLETED|Treated Period||0
8600426|NCT00362180|9636575|FG007|NOT COMPLETED|Treated Period||1
8600427|NCT00362180|9636576|FG008|NOT COMPLETED|Treated Period||0
8600428|NCT00362180|9636568|FG000|STARTED|20 Week Safety Follow-up||3
8600429|NCT00362180|9636569|FG001|STARTED|20 Week Safety Follow-up||2
8600430|NCT00362180|9636570|FG002|STARTED|20 Week Safety Follow-up||1
8600431|NCT00362180|9636571|FG003|STARTED|20 Week Safety Follow-up||0
8600432|NCT00362180|9636572|FG004|STARTED|20 Week Safety Follow-up||11
8600433|NCT00362180|9636573|FG005|STARTED|20 Week Safety Follow-up||9
8600434|NCT00362180|9636574|FG006|STARTED|20 Week Safety Follow-up|This observational cohort did not include a safety follow-up period.|0
8600435|NCT00362180|9636575|FG007|STARTED|20 Week Safety Follow-up||3
8600436|NCT00362180|9636576|FG008|STARTED|20 Week Safety Follow-up||1
8600437|NCT00362180|9636568|FG000|COMPLETED|20 Week Safety Follow-up||3
8600438|NCT00362180|9636569|FG001|COMPLETED|20 Week Safety Follow-up||2
8600439|NCT00362180|9636570|FG002|COMPLETED|20 Week Safety Follow-up||1
8600440|NCT00362180|9636571|FG003|COMPLETED|20 Week Safety Follow-up||0
8600441|NCT00362180|9636572|FG004|COMPLETED|20 Week Safety Follow-up||11
8600442|NCT00362180|9636573|FG005|COMPLETED|20 Week Safety Follow-up||9
8600443|NCT00362180|9636574|FG006|COMPLETED|20 Week Safety Follow-up||0
8600444|NCT00362180|9636575|FG007|COMPLETED|20 Week Safety Follow-up||3
8600445|NCT00362180|9636576|FG008|COMPLETED|20 Week Safety Follow-up||1
8600446|NCT00362180|9636568|FG000|NOT COMPLETED|20 Week Safety Follow-up||0
8600447|NCT00362180|9636569|FG001|NOT COMPLETED|20 Week Safety Follow-up||0
8600448|NCT00362180|9636570|FG002|NOT COMPLETED|20 Week Safety Follow-up||0
8600449|NCT00362180|9636571|FG003|NOT COMPLETED|20 Week Safety Follow-up||0
8600450|NCT00362180|9636572|FG004|NOT COMPLETED|20 Week Safety Follow-up||0
8600451|NCT00362180|9636573|FG005|NOT COMPLETED|20 Week Safety Follow-up||0
8600452|NCT00362180|9636574|FG006|NOT COMPLETED|20 Week Safety Follow-up||0
8600453|NCT00362180|9636575|FG007|NOT COMPLETED|20 Week Safety Follow-up||0
8600454|NCT00362180|9636576|FG008|NOT COMPLETED|20 Week Safety Follow-up||0
8600455|NCT00362232|9636596|FG000|STARTED|Treatment (12 +/- 2 Days)||1584
8600456|NCT00362232|9636597|FG001|STARTED|Treatment (12 +/- 2 Days)||1564
8600457|NCT00362232|9636596|FG000|Received Treatment|Treatment (12 +/- 2 Days)|Safety population|1526
8600458|NCT00362232|9636597|FG001|Received Treatment|Treatment (12 +/- 2 Days)|Safety population|1508
8600459|NCT00362232|9636596|FG000|COMPLETED|Treatment (12 +/- 2 Days)||1425
8600460|NCT00362232|9636597|FG001|COMPLETED|Treatment (12 +/- 2 Days)||1413
8600461|NCT00362232|9636596|FG000|NOT COMPLETED|Treatment (12 +/- 2 Days)||159
8600462|NCT00362232|9636597|FG001|NOT COMPLETED|Treatment (12 +/- 2 Days)||151
8600463|NCT00362232|9636596|FG000|STARTED|Follow-up (30 (+ 5) Days)||1471
8600464|NCT00362232|9636597|FG001|STARTED|Follow-up (30 (+ 5) Days)||1455
8713500|NCT00975481|9760281|FG001|COMPLETED|Third Intervention Period||5
8713501|NCT00975481|9760282|FG002|COMPLETED|Third Intervention Period||5
8713502|NCT00975481|9760283|FG003|COMPLETED|Third Intervention Period||6
8713503|NCT00975481|9760284|FG004|COMPLETED|Third Intervention Period||6
8713504|NCT00975481|9760285|FG005|COMPLETED|Third Intervention Period||6
8713505|NCT00975481|9760280|FG000|NOT COMPLETED|Third Intervention Period||0
8713506|NCT00975481|9760281|FG001|NOT COMPLETED|Third Intervention Period||0
8713507|NCT00975481|9760282|FG002|NOT COMPLETED|Third Intervention Period||0
8713508|NCT00975481|9760283|FG003|NOT COMPLETED|Third Intervention Period||0
8713509|NCT00975481|9760284|FG004|NOT COMPLETED|Third Intervention Period||0
8713510|NCT00975481|9760285|FG005|NOT COMPLETED|Third Intervention Period||0
8713511|NCT00975481|9760280|FG000|STARTED|Washout Period (at Least 7 Days)||4
8713512|NCT00975481|9760281|FG001|STARTED|Washout Period (at Least 7 Days)||5
8713513|NCT00975481|9760282|FG002|STARTED|Washout Period (at Least 7 Days)||5
8713514|NCT00975481|9760283|FG003|STARTED|Washout Period (at Least 7 Days)||6
8713515|NCT00975481|9760284|FG004|STARTED|Washout Period (at Least 7 Days)||6
8713516|NCT00975481|9760285|FG005|STARTED|Washout Period (at Least 7 Days)||6
8713517|NCT00975481|9760280|FG000|COMPLETED|Washout Period (at Least 7 Days)||4
8713518|NCT00975481|9760281|FG001|COMPLETED|Washout Period (at Least 7 Days)||5
8713519|NCT00975481|9760282|FG002|COMPLETED|Washout Period (at Least 7 Days)||5
8713520|NCT00975481|9760283|FG003|COMPLETED|Washout Period (at Least 7 Days)||6
8713521|NCT00975481|9760284|FG004|COMPLETED|Washout Period (at Least 7 Days)||6
8713522|NCT00975481|9760285|FG005|COMPLETED|Washout Period (at Least 7 Days)||6
8713523|NCT00975481|9760280|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8713524|NCT00975481|9760281|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8713525|NCT00975481|9760282|FG002|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8713526|NCT00975481|9760283|FG003|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8713527|NCT00975481|9760284|FG004|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8713528|NCT00975481|9760285|FG005|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8713529|NCT00975481|9760280|FG000|STARTED|Fourth Intervention Period||4
8713530|NCT00975481|9760281|FG001|STARTED|Fourth Intervention Period||5
8713531|NCT00975481|9760282|FG002|STARTED|Fourth Intervention Period||5
8713532|NCT00975481|9760283|FG003|STARTED|Fourth Intervention Period||6
8713533|NCT00975481|9760284|FG004|STARTED|Fourth Intervention Period||6
8713534|NCT00975481|9760285|FG005|STARTED|Fourth Intervention Period||6
8713535|NCT00975481|9760280|FG000|COMPLETED|Fourth Intervention Period||4
8713536|NCT00975481|9760281|FG001|COMPLETED|Fourth Intervention Period||5
8713537|NCT00975481|9760282|FG002|COMPLETED|Fourth Intervention Period||4
8713538|NCT00975481|9760283|FG003|COMPLETED|Fourth Intervention Period||5
8713539|NCT00975481|9760284|FG004|COMPLETED|Fourth Intervention Period||6
8713540|NCT00975481|9760285|FG005|COMPLETED|Fourth Intervention Period||6
8713541|NCT00975481|9760280|FG000|NOT COMPLETED|Fourth Intervention Period||0
8713542|NCT00975481|9760281|FG001|NOT COMPLETED|Fourth Intervention Period||0
8713543|NCT00975481|9760282|FG002|NOT COMPLETED|Fourth Intervention Period||1
8713544|NCT00975481|9760283|FG003|NOT COMPLETED|Fourth Intervention Period||1
8713545|NCT00975481|9760284|FG004|NOT COMPLETED|Fourth Intervention Period||0
8713546|NCT00975481|9760285|FG005|NOT COMPLETED|Fourth Intervention Period||0
8713547|NCT00975481|9760280|FG000|STARTED|Washout Period (at Least 7 Days)||4
8713548|NCT00975481|9760281|FG001|STARTED|Washout Period (at Least 7 Days)||5
8713549|NCT00975481|9760282|FG002|STARTED|Washout Period (at Least 7 Days)||4
8713550|NCT00975481|9760283|FG003|STARTED|Washout Period (at Least 7 Days)||5
8713551|NCT00975481|9760284|FG004|STARTED|Washout Period (at Least 7 Days)||6
8713552|NCT00975481|9760285|FG005|STARTED|Washout Period (at Least 7 Days)||6
8725192|NCT01029704|9772384|FG006|COMPLETED|Overall Study||19
8600465|NCT00362232|9636596|FG000|COMPLETED|Follow-up (30 (+ 5) Days)||1433
8600466|NCT00362232|9636597|FG001|COMPLETED|Follow-up (30 (+ 5) Days)||1416
8600467|NCT00362232|9636596|FG000|NOT COMPLETED|Follow-up (30 (+ 5) Days)||38
8600468|NCT00362232|9636597|FG001|NOT COMPLETED|Follow-up (30 (+ 5) Days)||39
8600469|NCT00362297|9636605|FG000|STARTED|Treatment 1 (Initial Drug Assignment)||16
8600470|NCT00362297|9636606|FG001|STARTED|Treatment 1 (Initial Drug Assignment)||15
8600471|NCT00362297|9636605|FG000|COMPLETED|Treatment 1 (Initial Drug Assignment)||16
8600472|NCT00362297|9636606|FG001|COMPLETED|Treatment 1 (Initial Drug Assignment)||11
8600473|NCT00362297|9636605|FG000|NOT COMPLETED|Treatment 1 (Initial Drug Assignment)||0
8600474|NCT00362297|9636606|FG001|NOT COMPLETED|Treatment 1 (Initial Drug Assignment)||4
8600475|NCT00362297|9636605|FG000|STARTED|Treatment 2||16
8600476|NCT00362297|9636606|FG001|STARTED|Treatment 2||11
8600477|NCT00362297|9636605|FG000|COMPLETED|Treatment 2||16
8600478|NCT00362297|9636606|FG001|COMPLETED|Treatment 2||11
8600479|NCT00362297|9636605|FG000|NOT COMPLETED|Treatment 2||0
8600480|NCT00362297|9636606|FG001|NOT COMPLETED|Treatment 2||0
8600481|NCT00362336|9636615|FG000|STARTED|Overall Study||243
8600482|NCT00362336|9636616|FG001|STARTED|Overall Study||242
8600483|NCT00362336|9636617|FG002|STARTED|Overall Study||137
8600484|NCT00362336|9636615|FG000|COMPLETED|Overall Study||233
8600485|NCT00362336|9636616|FG001|COMPLETED|Overall Study||235
8600486|NCT00362336|9636617|FG002|COMPLETED|Overall Study||134
8600487|NCT00362336|9636615|FG000|NOT COMPLETED|Overall Study||10
8600488|NCT00362336|9636616|FG001|NOT COMPLETED|Overall Study||7
8600489|NCT00362336|9636617|FG002|NOT COMPLETED|Overall Study||3
8600490|NCT00362375|9636634|FG000|STARTED|Overall Study|Number eligible and randomized|161
8600491|NCT00362375|9636635|FG001|STARTED|Overall Study|Number eligible and randomized|152
8600492|NCT00362375|9636634|FG000|COMPLETED|Overall Study|Number completed 6-month follow-up assessment|121
8600493|NCT00362375|9636635|FG001|COMPLETED|Overall Study|Number completed 6-month follow-up assessment|117
8600494|NCT00362375|9636634|FG000|NOT COMPLETED|Overall Study||40
8600495|NCT00362375|9636635|FG001|NOT COMPLETED|Overall Study||35
8600496|NCT00362414|9636641|FG000|STARTED|Overall Study||15
8600497|NCT00362414|9636641|FG000|COMPLETED|Overall Study||12
8600498|NCT00362414|9636641|FG000|NOT COMPLETED|Overall Study||3
8600499|NCT00362440|9636650|FG000|STARTED|Overall Study||5
8600500|NCT00362440|9636651|FG001|STARTED|Overall Study||4
8713553|NCT00975481|9760280|FG000|COMPLETED|Washout Period (at Least 7 Days)||4
8713554|NCT00975481|9760281|FG001|COMPLETED|Washout Period (at Least 7 Days)||5
8713555|NCT00975481|9760282|FG002|COMPLETED|Washout Period (at Least 7 Days)||4
8713556|NCT00975481|9760283|FG003|COMPLETED|Washout Period (at Least 7 Days)||5
8713557|NCT00975481|9760284|FG004|COMPLETED|Washout Period (at Least 7 Days)||6
8713558|NCT00975481|9760285|FG005|COMPLETED|Washout Period (at Least 7 Days)||6
8713559|NCT00975481|9760280|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8713560|NCT00975481|9760281|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8713561|NCT00975481|9760282|FG002|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8713562|NCT00975481|9760283|FG003|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8713563|NCT00975481|9760284|FG004|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8713564|NCT00975481|9760285|FG005|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8713565|NCT00975481|9760280|FG000|STARTED|Fifth Intervention Period||4
8713566|NCT00975481|9760281|FG001|STARTED|Fifth Intervention Period||5
8813150|NCT01524224|9866300|FG003|STARTED|Overall Study||3
8813151|NCT01524224|9866301|FG004|STARTED|Overall Study||4
8813152|NCT01524224|9866302|FG005|STARTED|Overall Study||3
8813153|NCT01524224|9866303|FG006|STARTED|Overall Study||3
8813154|NCT01524224|9866304|FG007|STARTED|Overall Study||6
8813155|NCT01524224|9866297|FG000|Received at Least One Dose of Study Drug|Overall Study||4
8813156|NCT01524224|9866298|FG001|Received at Least One Dose of Study Drug|Overall Study||3
8813157|NCT01524224|9866299|FG002|Received at Least One Dose of Study Drug|Overall Study||3
8813158|NCT01524224|9866300|FG003|Received at Least One Dose of Study Drug|Overall Study||3
8813159|NCT01524224|9866301|FG004|Received at Least One Dose of Study Drug|Overall Study||4
8813160|NCT01524224|9866302|FG005|Received at Least One Dose of Study Drug|Overall Study||3
8813161|NCT01524224|9866303|FG006|Received at Least One Dose of Study Drug|Overall Study||3
8813162|NCT01524224|9866304|FG007|Received at Least One Dose of Study Drug|Overall Study||6
8813163|NCT01524224|9866297|FG000|COMPLETED|Overall Study||1
8813164|NCT01524224|9866298|FG001|COMPLETED|Overall Study||2
8813165|NCT01524224|9866299|FG002|COMPLETED|Overall Study||1
8713567|NCT00975481|9760282|FG002|STARTED|Fifth Intervention Period||4
8713568|NCT00975481|9760283|FG003|STARTED|Fifth Intervention Period||5
8713569|NCT00975481|9760284|FG004|STARTED|Fifth Intervention Period||6
8713570|NCT00975481|9760285|FG005|STARTED|Fifth Intervention Period||6
8713571|NCT00975481|9760280|FG000|COMPLETED|Fifth Intervention Period||4
8713572|NCT00975481|9760281|FG001|COMPLETED|Fifth Intervention Period||5
8713573|NCT00975481|9760282|FG002|COMPLETED|Fifth Intervention Period||4
8713574|NCT00975481|9760283|FG003|COMPLETED|Fifth Intervention Period||5
8713575|NCT00975481|9760284|FG004|COMPLETED|Fifth Intervention Period||5
8713576|NCT00975481|9760285|FG005|COMPLETED|Fifth Intervention Period||6
8713577|NCT00975481|9760280|FG000|NOT COMPLETED|Fifth Intervention Period||0
8713578|NCT00975481|9760281|FG001|NOT COMPLETED|Fifth Intervention Period||0
8813166|NCT01524224|9866300|FG003|COMPLETED|Overall Study||1
8813167|NCT01524224|9866301|FG004|COMPLETED|Overall Study||0
8600501|NCT00362440|9636650|FG000|COMPLETED|Overall Study||3
8600502|NCT00362440|9636651|FG001|COMPLETED|Overall Study||3
8600503|NCT00362440|9636650|FG000|NOT COMPLETED|Overall Study||2
8600504|NCT00362440|9636651|FG001|NOT COMPLETED|Overall Study||1
8600505|NCT00362453|9636659|FG000|STARTED|Overall Study||20
8600506|NCT00362453|9636660|FG001|STARTED|Overall Study||20
8600507|NCT00362453|9636659|FG000|COMPLETED|Overall Study|No patient withdrew from the study (20/20 participants completed follow-ups at 12, 24 and 48 weeks).|20
8600508|NCT00362453|9636660|FG001|COMPLETED|Overall Study|No patient withdrew from the study (20/20 participants completed follow-ups at 12, 24 and 48 weeks).|20
8600509|NCT00362453|9636659|FG000|NOT COMPLETED|Overall Study||0
8600510|NCT00362453|9636660|FG001|NOT COMPLETED|Overall Study||0
8600511|NCT00362466|9636668|FG000|STARTED|Overall Study||2
8600512|NCT00362466|9636669|FG001|STARTED|Overall Study||1
8600513|NCT00362466|9636668|FG000|COMPLETED|Overall Study||2
8600514|NCT00362466|9636669|FG001|COMPLETED|Overall Study||1
8600515|NCT00362466|9636668|FG000|NOT COMPLETED|Overall Study||0
8600516|NCT00362466|9636669|FG001|NOT COMPLETED|Overall Study||0
8600517|NCT00362609|9636677|FG000|STARTED|Overall Study||19
8600518|NCT00362609|9636678|FG001|STARTED|Overall Study||40
8600519|NCT00362609|9636677|FG000|COMPLETED|Overall Study||19
8600520|NCT00362609|9636678|FG001|COMPLETED|Overall Study||38
8600521|NCT00362609|9636677|FG000|NOT COMPLETED|Overall Study||0
8600522|NCT00362609|9636678|FG001|NOT COMPLETED|Overall Study||2
8600523|NCT00362648|9636688|FG000|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|2733
8600524|NCT00362648|9636689|FG001|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|2735
8600525|NCT00362648|9636690|FG002|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|1018
8600526|NCT00362648|9636691|FG003|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|1018
8600527|NCT00362648|9636688|FG000|Vaccinated at Visit 1|Overall Study||2733
8600528|NCT00362648|9636689|FG001|Vaccinated at Visit 1|Overall Study||2735
8600529|NCT00362648|9636690|FG002|Vaccinated at Visit 1|Overall Study||1018
8600530|NCT00362648|9636691|FG003|Vaccinated at Visit 1|Overall Study||1018
8600531|NCT00362648|9636688|FG000|Vaccinated at Visit 2|Overall Study||2657
8600532|NCT00362648|9636689|FG001|Vaccinated at Visit 2|Overall Study||2666
8600533|NCT00362648|9636690|FG002|Vaccinated at Visit 2|Overall Study||1013
8600534|NCT00362648|9636691|FG003|Vaccinated at Visit 2|Overall Study||1009
8600535|NCT00362648|9636688|FG000|Vaccinated at Visit 3|Overall Study||2613
8600536|NCT00362648|9636689|FG001|Vaccinated at Visit 3|Overall Study||2612
8600537|NCT00362648|9636690|FG002|Vaccinated at Visit 3|Overall Study||1009
8600538|NCT00362648|9636691|FG003|Vaccinated at Visit 3|Overall Study||1007
8600539|NCT00362648|9636688|FG000|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|2607
8600540|NCT00362648|9636689|FG001|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|2601
8600541|NCT00362648|9636690|FG002|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|1009
8600542|NCT00362648|9636691|FG003|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|1007
8928238|NCT02279407|9989387|FG001|NOT COMPLETED|Overall Study||1
8928239|NCT02279407|9989388|FG002|NOT COMPLETED|Overall Study||5
8600543|NCT00362648|9636688|FG000|NOT COMPLETED|Overall Study||126
8600544|NCT00362648|9636689|FG001|NOT COMPLETED|Overall Study||134
8600545|NCT00362648|9636690|FG002|NOT COMPLETED|Overall Study||9
8600546|NCT00362648|9636691|FG003|NOT COMPLETED|Overall Study||11
8600547|NCT00362817|9636705|FG000|STARTED|Overall Study||17
8600548|NCT00362817|9636705|FG000|COMPLETED|Overall Study||17
8600549|NCT00362817|9636705|FG000|NOT COMPLETED|Overall Study||0
8600550|NCT00362882|9636712|FG000|STARTED|Overall Study||40
8600551|NCT00362882|9636713|FG001|STARTED|Overall Study||41
8600552|NCT00362882|9636712|FG000|COMPLETED|Overall Study||40
8600553|NCT00362882|9636713|FG001|COMPLETED|Overall Study||41
8600554|NCT00362882|9636712|FG000|NOT COMPLETED|Overall Study||0
8600555|NCT00362882|9636713|FG001|NOT COMPLETED|Overall Study||0
8600556|NCT00363051|9636721|FG000|STARTED|Overall Study||115
8600557|NCT00363051|9636722|FG001|STARTED|Overall Study||45
8600558|NCT00363051|9636721|FG000|COMPLETED|Overall Study|Patients with documented disease progression per RECIST criteria|77
8600559|NCT00363051|9636722|FG001|COMPLETED|Overall Study||23
8600560|NCT00363051|9636721|FG000|NOT COMPLETED|Overall Study||38
8600561|NCT00363051|9636722|FG001|NOT COMPLETED|Overall Study||22
8600562|NCT00363077|9636732|FG000|STARTED|Overall Study||75
8600563|NCT00363077|9636733|FG001|STARTED|Overall Study||75
8600564|NCT00363077|9636732|FG000|COMPLETED|Overall Study||75
8600565|NCT00363077|9636733|FG001|COMPLETED|Overall Study||75
8600566|NCT00363077|9636732|FG000|NOT COMPLETED|Overall Study||0
8600567|NCT00363077|9636733|FG001|NOT COMPLETED|Overall Study||0
8600568|NCT00363129|9636741|FG000|STARTED|Overall Study||96
8713579|NCT00975481|9760282|FG002|NOT COMPLETED|Fifth Intervention Period||0
8713580|NCT00975481|9760283|FG003|NOT COMPLETED|Fifth Intervention Period||0
8713581|NCT00975481|9760284|FG004|NOT COMPLETED|Fifth Intervention Period||1
8713582|NCT00975481|9760285|FG005|NOT COMPLETED|Fifth Intervention Period||0
8713583|NCT00975481|9760280|FG000|STARTED|Washout Period (at Least 7 Days)||4
8713584|NCT00975481|9760281|FG001|STARTED|Washout Period (at Least 7 Days)||5
8813168|NCT01524224|9866302|FG005|COMPLETED|Overall Study||1
8813169|NCT01524224|9866303|FG006|COMPLETED|Overall Study||0
8600569|NCT00363129|9636742|FG001|STARTED|Overall Study||93
8600570|NCT00363129|9636741|FG000|COMPLETED|Overall Study||67
8600571|NCT00363129|9636742|FG001|COMPLETED|Overall Study||60
8600572|NCT00363129|9636741|FG000|NOT COMPLETED|Overall Study||29
8600573|NCT00363129|9636742|FG001|NOT COMPLETED|Overall Study||33
8600574|NCT00363142|9636750|FG000|STARTED|Overall Study||140
8813170|NCT01524224|9866304|FG007|COMPLETED|Overall Study||0
8813171|NCT01524224|9866297|FG000|NOT COMPLETED|Overall Study||3
8600575|NCT00363142|9636751|FG001|STARTED|Overall Study||69
8600576|NCT00363142|9636750|FG000|COMPLETED|Overall Study||133
8600577|NCT00363142|9636751|FG001|COMPLETED|Overall Study||66
8600578|NCT00363142|9636750|FG000|NOT COMPLETED|Overall Study||7
8600579|NCT00363142|9636751|FG001|NOT COMPLETED|Overall Study||3
8600580|NCT00363168|9636762|FG000|STARTED|Overall Study||5
8600581|NCT00363168|9636763|FG001|STARTED|Overall Study||2
8600582|NCT00363168|9636762|FG000|COMPLETED|Overall Study||5
8600583|NCT00363168|9636763|FG001|COMPLETED|Overall Study||2
8600584|NCT00363168|9636762|FG000|NOT COMPLETED|Overall Study||0
8600585|NCT00363168|9636763|FG001|NOT COMPLETED|Overall Study||0
8600586|NCT00363246|9636769|FG000|STARTED|Overall Study||766
8600587|NCT00363246|9636769|FG000|COMPLETED|Overall Study||669
8600588|NCT00363246|9636769|FG000|NOT COMPLETED|Overall Study||97
8600589|NCT00363298|9636776|FG000|STARTED|First Study Week||12
8600590|NCT00363298|9636777|FG001|STARTED|First Study Week||12
8600591|NCT00363298|9636776|FG000|COMPLETED|First Study Week|At end of week 1, 6/12 subjects met Y-BOCS response criterion and began 4-week continuation phase|6
8600592|NCT00363298|9636777|FG001|COMPLETED|First Study Week|At end of week 1, 7/12 subjects met Y-BOCS response criterion and began 4-week continuation phase|7
8600593|NCT00363298|9636776|FG000|NOT COMPLETED|First Study Week||6
8600594|NCT00363298|9636777|FG001|NOT COMPLETED|First Study Week||5
8600595|NCT00363298|9636776|FG000|STARTED|4-week Study Continuation Phase||6
8600596|NCT00363298|9636777|FG001|STARTED|4-week Study Continuation Phase||7
8600597|NCT00363298|9636776|FG000|COMPLETED|4-week Study Continuation Phase||5
8600598|NCT00363298|9636777|FG001|COMPLETED|4-week Study Continuation Phase||7
8600599|NCT00363298|9636776|FG000|NOT COMPLETED|4-week Study Continuation Phase||1
8600600|NCT00363298|9636777|FG001|NOT COMPLETED|4-week Study Continuation Phase||0
8600601|NCT00363311|9636786|FG000|STARTED|Overall Study||155
8600602|NCT00363311|9636787|FG001|STARTED|Overall Study||147
8600603|NCT00363311|9636786|FG000|COMPLETED|Overall Study||79
8600604|NCT00363311|9636787|FG001|COMPLETED|Overall Study||102
8600605|NCT00363311|9636786|FG000|NOT COMPLETED|Overall Study||76
8600606|NCT00363311|9636787|FG001|NOT COMPLETED|Overall Study||45
8600607|NCT00363415|9636795|FG000|STARTED|Overall Study||453
8600608|NCT00363415|9636796|FG001|STARTED|Overall Study||455
8600609|NCT00363415|9636795|FG000|Received at Least One Dose of Study Drug|Overall Study||433
8600610|NCT00363415|9636796|FG001|Received at Least One Dose of Study Drug|Overall Study||447
8600611|NCT00363415|9636795|FG000|COMPLETED|Overall Study||92
8600612|NCT00363415|9636796|FG001|COMPLETED|Overall Study||206
8600613|NCT00363415|9636795|FG000|NOT COMPLETED|Overall Study||361
8600614|NCT00363415|9636796|FG001|NOT COMPLETED|Overall Study||249
8600615|NCT00363467|9636802|FG000|STARTED|Overall Study||3
8600616|NCT00363467|9636802|FG000|COMPLETED|Overall Study||2
8600617|NCT00363467|9636802|FG000|NOT COMPLETED|Overall Study||1
8600618|NCT00363480|9636806|FG000|STARTED|Overall Study||221
8600619|NCT00363480|9636806|FG000|COMPLETED|Overall Study||204
8600620|NCT00363480|9636806|FG000|NOT COMPLETED|Overall Study||17
8713585|NCT00975481|9760282|FG002|STARTED|Washout Period (at Least 7 Days)||4
8713586|NCT00975481|9760283|FG003|STARTED|Washout Period (at Least 7 Days)||5
8713587|NCT00975481|9760284|FG004|STARTED|Washout Period (at Least 7 Days)||5
8713588|NCT00975481|9760285|FG005|STARTED|Washout Period (at Least 7 Days)||6
8813172|NCT01524224|9866298|FG001|NOT COMPLETED|Overall Study||1
8813173|NCT01524224|9866299|FG002|NOT COMPLETED|Overall Study||2
8813174|NCT01524224|9866300|FG003|NOT COMPLETED|Overall Study||2
8813175|NCT01524224|9866301|FG004|NOT COMPLETED|Overall Study||4
8813176|NCT01524224|9866302|FG005|NOT COMPLETED|Overall Study||2
9064268|NCT04318535|10124573|FG002|STARTED|Treatment Period 1 (Day -1 to Day 5)||12
9064269|NCT04318535|10124571|FG000|COMPLETED|Treatment Period 1 (Day -1 to Day 5)||12
9064270|NCT04318535|10124572|FG001|COMPLETED|Treatment Period 1 (Day -1 to Day 5)||12
9064271|NCT04318535|10124573|FG002|COMPLETED|Treatment Period 1 (Day -1 to Day 5)||12
9064272|NCT04318535|10124571|FG000|NOT COMPLETED|Treatment Period 1 (Day -1 to Day 5)||0
9064273|NCT04318535|10124572|FG001|NOT COMPLETED|Treatment Period 1 (Day -1 to Day 5)||0
8813177|NCT01524224|9866303|FG006|NOT COMPLETED|Overall Study||3
8813178|NCT01524224|9866304|FG007|NOT COMPLETED|Overall Study||6
8813179|NCT01524289|9866324|FG000|STARTED|Overall Study||204
8713589|NCT00975481|9760280|FG000|COMPLETED|Washout Period (at Least 7 Days)||4
8713590|NCT00975481|9760281|FG001|COMPLETED|Washout Period (at Least 7 Days)||5
8713591|NCT00975481|9760282|FG002|COMPLETED|Washout Period (at Least 7 Days)||4
8713592|NCT00975481|9760283|FG003|COMPLETED|Washout Period (at Least 7 Days)||5
8713593|NCT00975481|9760284|FG004|COMPLETED|Washout Period (at Least 7 Days)||5
8713594|NCT00975481|9760285|FG005|COMPLETED|Washout Period (at Least 7 Days)||6
8713595|NCT00975481|9760280|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8713596|NCT00975481|9760281|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8713597|NCT00975481|9760282|FG002|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8713598|NCT00975481|9760283|FG003|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8713599|NCT00975481|9760284|FG004|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8713600|NCT00975481|9760285|FG005|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8813180|NCT01524289|9866325|FG001|STARTED|Overall Study||102
8600621|NCT00363545|9636812|FG000|STARTED|Overall Study||636
8600622|NCT00363545|9636813|FG001|STARTED|Overall Study||638
8600623|NCT00363545|9636812|FG000|COMPLETED|Overall Study||592
8600624|NCT00363545|9636813|FG001|COMPLETED|Overall Study||581
8600625|NCT00363545|9636812|FG000|NOT COMPLETED|Overall Study||44
8600626|NCT00363545|9636813|FG001|NOT COMPLETED|Overall Study||57
8813181|NCT01524289|9866324|FG000|Treated|Overall Study||203
8813182|NCT01524289|9866325|FG001|Treated|Overall Study||102
8813183|NCT01524289|9866324|FG000|COMPLETED|Overall Study||174
8813184|NCT01524289|9866325|FG001|COMPLETED|Overall Study||88
8813185|NCT01524289|9866324|FG000|NOT COMPLETED|Overall Study||30
8813186|NCT01524289|9866325|FG001|NOT COMPLETED|Overall Study||14
8813187|NCT01524302|9866335|FG000|STARTED|Overall Study||6
8813188|NCT01524302|9866336|FG001|STARTED|Overall Study||6
8813189|NCT01524302|9866335|FG000|COMPLETED|Overall Study||6
8813190|NCT01524302|9866336|FG001|COMPLETED|Overall Study||6
8813191|NCT01524302|9866335|FG000|NOT COMPLETED|Overall Study||0
8600627|NCT00363649|9636821|FG000|STARTED|Overall Study||18
8600628|NCT00363649|9636822|FG001|STARTED|Overall Study||16
8600629|NCT00363649|9636821|FG000|Crossed Over to Arm B|Overall Study||9
8600630|NCT00363649|9636822|FG001|Crossed Over to Arm B|Overall Study||0
8600631|NCT00363649|9636821|FG000|Crossed Over to Arm A|Overall Study||0
8600632|NCT00363649|9636822|FG001|Crossed Over to Arm A|Overall Study||12
8600633|NCT00363649|9636821|FG000|Did Not Cross Over|Overall Study||2
8600634|NCT00363649|9636822|FG001|Did Not Cross Over|Overall Study||3
8600635|NCT00363649|9636821|FG000|COMPLETED|Overall Study||11
8600636|NCT00363649|9636822|FG001|COMPLETED|Overall Study||15
8600637|NCT00363649|9636821|FG000|NOT COMPLETED|Overall Study||7
8600638|NCT00363649|9636822|FG001|NOT COMPLETED|Overall Study||1
8628559|NCT00525044|9668056|FG000|COMPLETED|Overall Study||124
8628560|NCT00525044|9668057|FG001|COMPLETED|Overall Study||124
8628561|NCT00525044|9668056|FG000|NOT COMPLETED|Overall Study||0
8628562|NCT00525044|9668057|FG001|NOT COMPLETED|Overall Study||1
8628563|NCT00525057|9668065|FG000|STARTED|Overall Study||25
8628564|NCT00525057|9668066|FG001|STARTED|Overall Study||25
8628565|NCT00525057|9668065|FG000|COMPLETED|Overall Study||25
8628566|NCT00525057|9668066|FG001|COMPLETED|Overall Study||25
8628567|NCT00525057|9668065|FG000|NOT COMPLETED|Overall Study||0
8628568|NCT00525057|9668066|FG001|NOT COMPLETED|Overall Study||0
8628569|NCT00525135|9668072|FG000|STARTED|Overall Study||5
8628570|NCT00525135|9668072|FG000|COMPLETED|Overall Study||5
8628571|NCT00525135|9668072|FG000|NOT COMPLETED|Overall Study||0
8713601|NCT00975481|9760280|FG000|STARTED|Sixth Intervention Period||4
8713602|NCT00975481|9760281|FG001|STARTED|Sixth Intervention Period||5
8713603|NCT00975481|9760282|FG002|STARTED|Sixth Intervention Period||4
8713604|NCT00975481|9760283|FG003|STARTED|Sixth Intervention Period||5
8713605|NCT00975481|9760284|FG004|STARTED|Sixth Intervention Period||5
8713606|NCT00975481|9760285|FG005|STARTED|Sixth Intervention Period||6
8713607|NCT00975481|9760280|FG000|COMPLETED|Sixth Intervention Period||4
8713608|NCT00975481|9760281|FG001|COMPLETED|Sixth Intervention Period||5
8713609|NCT00975481|9760282|FG002|COMPLETED|Sixth Intervention Period||4
8713610|NCT00975481|9760283|FG003|COMPLETED|Sixth Intervention Period||5
8713611|NCT00975481|9760284|FG004|COMPLETED|Sixth Intervention Period||5
8713612|NCT00975481|9760285|FG005|COMPLETED|Sixth Intervention Period||6
8713613|NCT00975481|9760280|FG000|NOT COMPLETED|Sixth Intervention Period||0
8713614|NCT00975481|9760281|FG001|NOT COMPLETED|Sixth Intervention Period||0
8713615|NCT00975481|9760282|FG002|NOT COMPLETED|Sixth Intervention Period||0
8713616|NCT00975481|9760283|FG003|NOT COMPLETED|Sixth Intervention Period||0
8713617|NCT00975481|9760284|FG004|NOT COMPLETED|Sixth Intervention Period||0
8713618|NCT00975481|9760285|FG005|NOT COMPLETED|Sixth Intervention Period||0
8713619|NCT00975507|9760305|FG000|STARTED|Overall Study||323
8713620|NCT00975507|9760306|FG001|STARTED|Overall Study||157
8713621|NCT00975507|9760305|FG000|Vaccinated at Visit 1|Overall Study||323
8713622|NCT00975507|9760306|FG001|Vaccinated at Visit 1|Overall Study||157
8713623|NCT00975507|9760305|FG000|Vaccinated at Visit 2|Overall Study||310
8713624|NCT00975507|9760306|FG001|Vaccinated at Visit 2|Overall Study|Per-protocol, subjects receiving M-M-R™ II + VARIVAX™ at Visit 1 were not vaccinated at Visit 2|0
8713625|NCT00975507|9760305|FG000|COMPLETED|Overall Study||303
8713626|NCT00975507|9760306|FG001|COMPLETED|Overall Study||153
8713627|NCT00975507|9760305|FG000|NOT COMPLETED|Overall Study||20
8713628|NCT00975507|9760306|FG001|NOT COMPLETED|Overall Study||4
8713629|NCT00975585|9760316|FG000|STARTED|Overall Study||184
8713630|NCT00975585|9760317|FG001|STARTED|Overall Study||195
8713631|NCT00975585|9760316|FG000|COMPLETED|Overall Study||177
8713632|NCT00975585|9760317|FG001|COMPLETED|Overall Study||183
8713633|NCT00975585|9760316|FG000|NOT COMPLETED|Overall Study||7
8713634|NCT00975585|9760317|FG001|NOT COMPLETED|Overall Study||12
8713635|NCT00975637|9760330|FG000|STARTED|Overall Study||40
8713636|NCT00975637|9760331|FG001|STARTED|Overall Study||39
8713637|NCT00975637|9760332|FG002|STARTED|Overall Study||42
8628572|NCT00525148|9668080|FG000|STARTED|Overall Study|entered and treated|23
8628573|NCT00525148|9668081|FG001|STARTED|Overall Study|entered and treated|38
8628574|NCT00525148|9668082|FG002|STARTED|Overall Study|entered and treated|7
8628575|NCT00525148|9668083|FG003|STARTED|Overall Study|entered and treated|61
8628576|NCT00525148|9668080|FG000|COMPLETED|Overall Study||0
8628577|NCT00525148|9668081|FG001|COMPLETED|Overall Study||0
8628578|NCT00525148|9668082|FG002|COMPLETED|Overall Study||0
8628579|NCT00525148|9668083|FG003|COMPLETED|Overall Study||0
8628580|NCT00525148|9668080|FG000|NOT COMPLETED|Overall Study||23
8628581|NCT00525148|9668081|FG001|NOT COMPLETED|Overall Study||38
8628582|NCT00525148|9668082|FG002|NOT COMPLETED|Overall Study||7
8628583|NCT00525148|9668083|FG003|NOT COMPLETED|Overall Study||61
8628584|NCT00525161|9668093|FG000|STARTED|Overall Study||11
8713638|NCT00975637|9760333|FG003|STARTED|Overall Study||38
8813192|NCT01524302|9866336|FG001|NOT COMPLETED|Overall Study||0
8600639|NCT00363675|9636828|FG000|STARTED|Overall Study||3
8600640|NCT00363675|9636828|FG000|Completed Testing|Overall Study||3
8600641|NCT00363675|9636828|FG000|COMPLETED|Overall Study||3
8600642|NCT00363675|9636828|FG000|NOT COMPLETED|Overall Study||0
8600643|NCT00363766|9636835|FG000|STARTED|Overall Study||32
8600644|NCT00363766|9636836|FG001|STARTED|Overall Study||20
8600645|NCT00363766|9636835|FG000|COMPLETED|Overall Study||0
8600646|NCT00363766|9636836|FG001|COMPLETED|Overall Study||0
8600647|NCT00363766|9636835|FG000|NOT COMPLETED|Overall Study||32
8600648|NCT00363766|9636836|FG001|NOT COMPLETED|Overall Study||20
8600649|NCT00363779|9636843|FG000|STARTED|Overall Study||5
8600650|NCT00363779|9636843|FG000|COMPLETED|Overall Study||5
8600651|NCT00363779|9636843|FG000|NOT COMPLETED|Overall Study||0
8600652|NCT00363805|9636850|FG000|STARTED|Overall Study||42
8600653|NCT00363805|9636851|FG001|STARTED|Overall Study||63
8600654|NCT00363805|9636852|FG002|STARTED|Overall Study||73
8600655|NCT00363805|9636850|FG000|COMPLETED|Overall Study||38
8600656|NCT00363805|9636851|FG001|COMPLETED|Overall Study||57
8600657|NCT00363805|9636852|FG002|COMPLETED|Overall Study||70
8600658|NCT00363805|9636850|FG000|NOT COMPLETED|Overall Study||4
8600659|NCT00363805|9636851|FG001|NOT COMPLETED|Overall Study||6
8600660|NCT00363805|9636852|FG002|NOT COMPLETED|Overall Study||3
8600661|NCT00363883|9636860|FG000|STARTED|Overall Study||14
8600662|NCT00363883|9636860|FG000|COMPLETED|Overall Study||14
8600663|NCT00363883|9636860|FG000|NOT COMPLETED|Overall Study||0
8600664|NCT00363896|9636866|FG000|STARTED|Overall Study||627
8600665|NCT00363896|9636867|FG001|STARTED|Overall Study||216
8600666|NCT00363896|9636866|FG000|COMPLETED|Overall Study||538
8600667|NCT00363896|9636867|FG001|COMPLETED|Overall Study||169
8600668|NCT00363896|9636866|FG000|NOT COMPLETED|Overall Study||89
8600669|NCT00363896|9636867|FG001|NOT COMPLETED|Overall Study||47
8600670|NCT00364013|9636878|FG000|STARTED|Overall Study||593
8600671|NCT00364013|9636879|FG001|STARTED|Overall Study||590
8600672|NCT00364013|9636878|FG000|Received Study Drug|Overall Study|One participant randomized to this group did not receive any panitumumab|586
8600673|NCT00364013|9636879|FG001|Received Study Drug|Overall Study||583
8600674|NCT00364013|9636878|FG000|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|492
8600675|NCT00364013|9636879|FG001|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|495
8600676|NCT00364013|9636878|FG000|NOT COMPLETED|Overall Study||101
8600677|NCT00364013|9636879|FG001|NOT COMPLETED|Overall Study||95
8600678|NCT00364130|9636891|FG000|STARTED|Intervention Period||69
8600679|NCT00364130|9636892|FG001|STARTED|Intervention Period||69
8600680|NCT00364130|9636891|FG000|COMPLETED|Intervention Period||60
8600681|NCT00364130|9636892|FG001|COMPLETED|Intervention Period||61
8600682|NCT00364130|9636891|FG000|NOT COMPLETED|Intervention Period||9
8600683|NCT00364130|9636892|FG001|NOT COMPLETED|Intervention Period||8
8600684|NCT00364130|9636891|FG000|STARTED|Post Intervention Follow-up Period||60
8600685|NCT00364130|9636892|FG001|STARTED|Post Intervention Follow-up Period||61
8600686|NCT00364130|9636891|FG000|COMPLETED|Post Intervention Follow-up Period||55
8600687|NCT00364130|9636892|FG001|COMPLETED|Post Intervention Follow-up Period||50
8600688|NCT00364130|9636891|FG000|NOT COMPLETED|Post Intervention Follow-up Period||5
8600689|NCT00364130|9636892|FG001|NOT COMPLETED|Post Intervention Follow-up Period||11
8600690|NCT00364156|9636902|FG000|STARTED|Overall Study||282
8600691|NCT00364156|9636903|FG001|STARTED|Overall Study||286
8600692|NCT00364156|9636902|FG000|COMPLETED|Overall Study||203
8600693|NCT00364156|9636903|FG001|COMPLETED|Overall Study||205
8600694|NCT00364156|9636902|FG000|NOT COMPLETED|Overall Study||79
8600695|NCT00364156|9636903|FG001|NOT COMPLETED|Overall Study||81
8600696|NCT00364182|9636912|FG000|STARTED|First Intervention||3
8600697|NCT00364182|9636913|FG001|STARTED|First Intervention||22
8600698|NCT00364182|9636914|FG002|STARTED|First Intervention||25
8600699|NCT00364182|9636912|FG000|COMPLETED|First Intervention||0
8600700|NCT00364182|9636913|FG001|COMPLETED|First Intervention||22
8600701|NCT00364182|9636914|FG002|COMPLETED|First Intervention||25
8600702|NCT00364182|9636912|FG000|NOT COMPLETED|First Intervention||3
8600703|NCT00364182|9636913|FG001|NOT COMPLETED|First Intervention||0
8713639|NCT00975637|9760334|FG004|STARTED|Overall Study||39
8713640|NCT00975637|9760330|FG000|COMPLETED|Overall Study||37
8713641|NCT00975637|9760331|FG001|COMPLETED|Overall Study||38
8713642|NCT00975637|9760332|FG002|COMPLETED|Overall Study||40
8713643|NCT00975637|9760333|FG003|COMPLETED|Overall Study||32
8600704|NCT00364182|9636914|FG002|NOT COMPLETED|First Intervention||0
8600705|NCT00364182|9636912|FG000|STARTED|Second Intervention||0
8600706|NCT00364182|9636913|FG001|STARTED|Second Intervention||22
8600707|NCT00364182|9636914|FG002|STARTED|Second Intervention||25
8600708|NCT00364182|9636912|FG000|Randomized|Second Intervention||0
8600709|NCT00364182|9636913|FG001|Randomized|Second Intervention||22
8600710|NCT00364182|9636914|FG002|Randomized|Second Intervention||25
8600711|NCT00364182|9636912|FG000|COMPLETED|Second Intervention||0
8600712|NCT00364182|9636913|FG001|COMPLETED|Second Intervention||20
8600713|NCT00364182|9636914|FG002|COMPLETED|Second Intervention||23
8600714|NCT00364182|9636912|FG000|NOT COMPLETED|Second Intervention||0
8600715|NCT00364182|9636913|FG001|NOT COMPLETED|Second Intervention||2
8600716|NCT00364182|9636914|FG002|NOT COMPLETED|Second Intervention||2
8600717|NCT00364182|9636912|FG000|STARTED|Third Intervention||0
8713644|NCT00975637|9760334|FG004|COMPLETED|Overall Study||37
8600718|NCT00364182|9636913|FG001|STARTED|Third Intervention||20
8713645|NCT00975637|9760330|FG000|NOT COMPLETED|Overall Study||3
8600719|NCT00364182|9636914|FG002|STARTED|Third Intervention||23
8600720|NCT00364182|9636912|FG000|COMPLETED|Third Intervention||0
8600721|NCT00364182|9636913|FG001|COMPLETED|Third Intervention||19
8600722|NCT00364182|9636914|FG002|COMPLETED|Third Intervention||22
8600723|NCT00364182|9636912|FG000|NOT COMPLETED|Third Intervention||0
8600724|NCT00364182|9636913|FG001|NOT COMPLETED|Third Intervention||1
8600725|NCT00364182|9636914|FG002|NOT COMPLETED|Third Intervention||1
8600726|NCT00364182|9636912|FG000|STARTED|Fourth Intervention||0
8600727|NCT00364182|9636913|FG001|STARTED|Fourth Intervention||19
8600728|NCT00364182|9636914|FG002|STARTED|Fourth Intervention||22
8600729|NCT00364182|9636912|FG000|COMPLETED|Fourth Intervention||0
8600730|NCT00364182|9636913|FG001|COMPLETED|Fourth Intervention||19
8600731|NCT00364182|9636914|FG002|COMPLETED|Fourth Intervention||22
8713646|NCT00975637|9760331|FG001|NOT COMPLETED|Overall Study||1
8713647|NCT00975637|9760332|FG002|NOT COMPLETED|Overall Study||2
8713648|NCT00975637|9760333|FG003|NOT COMPLETED|Overall Study||6
8713649|NCT00975637|9760334|FG004|NOT COMPLETED|Overall Study||2
8713650|NCT00975650|9760346|FG000|STARTED|Period 1||13
8713651|NCT00975650|9760347|FG001|STARTED|Period 1||16
8713652|NCT00975650|9760348|FG002|STARTED|Period 1||14
8713653|NCT00975650|9760349|FG003|STARTED|Period 1||14
8713654|NCT00975650|9760346|FG000|COMPLETED|Period 1||13
8713655|NCT00975650|9760347|FG001|COMPLETED|Period 1||16
8713656|NCT00975650|9760348|FG002|COMPLETED|Period 1||14
8713657|NCT00975650|9760349|FG003|COMPLETED|Period 1||14
8713658|NCT00975650|9760346|FG000|NOT COMPLETED|Period 1||0
8713659|NCT00975650|9760347|FG001|NOT COMPLETED|Period 1||0
8713660|NCT00975650|9760348|FG002|NOT COMPLETED|Period 1||0
8713661|NCT00975650|9760349|FG003|NOT COMPLETED|Period 1||0
8713662|NCT00975650|9760346|FG000|STARTED|Period 2||13
8713663|NCT00975650|9760347|FG001|STARTED|Period 2||16
8713664|NCT00975650|9760348|FG002|STARTED|Period 2||14
8713665|NCT00975650|9760349|FG003|STARTED|Period 2||14
8713666|NCT00975650|9760346|FG000|COMPLETED|Period 2||12
8713667|NCT00975650|9760347|FG001|COMPLETED|Period 2||14
8713668|NCT00975650|9760348|FG002|COMPLETED|Period 2||14
8713669|NCT00975650|9760349|FG003|COMPLETED|Period 2||14
8713670|NCT00975650|9760346|FG000|NOT COMPLETED|Period 2||1
8713671|NCT00975650|9760347|FG001|NOT COMPLETED|Period 2||2
8713672|NCT00975650|9760348|FG002|NOT COMPLETED|Period 2||0
8713673|NCT00975650|9760349|FG003|NOT COMPLETED|Period 2||0
8713674|NCT00975650|9760346|FG000|STARTED|Period 3||12
8713675|NCT00975650|9760347|FG001|STARTED|Period 3||14
8713676|NCT00975650|9760348|FG002|STARTED|Period 3||14
8713677|NCT00975650|9760349|FG003|STARTED|Period 3||14
8713678|NCT00975650|9760346|FG000|COMPLETED|Period 3||12
8713679|NCT00975650|9760347|FG001|COMPLETED|Period 3||14
8713680|NCT00975650|9760348|FG002|COMPLETED|Period 3||14
8713681|NCT00975650|9760349|FG003|COMPLETED|Period 3||14
8713682|NCT00975650|9760346|FG000|NOT COMPLETED|Period 3||0
8713683|NCT00975650|9760347|FG001|NOT COMPLETED|Period 3||0
8713684|NCT00975650|9760348|FG002|NOT COMPLETED|Period 3||0
8713685|NCT00975650|9760349|FG003|NOT COMPLETED|Period 3||0
8713686|NCT00975650|9760346|FG000|STARTED|Period 4||12
8713687|NCT00975650|9760347|FG001|STARTED|Period 4||14
8713688|NCT00975650|9760348|FG002|STARTED|Period 4||14
8713689|NCT00975650|9760349|FG003|STARTED|Period 4||14
8713690|NCT00975650|9760346|FG000|COMPLETED|Period 4||12
8713691|NCT00975650|9760347|FG001|COMPLETED|Period 4||14
8713692|NCT00975650|9760348|FG002|COMPLETED|Period 4||14
8713693|NCT00975650|9760349|FG003|COMPLETED|Period 4||14
8713694|NCT00975650|9760346|FG000|NOT COMPLETED|Period 4||0
8713695|NCT00975650|9760347|FG001|NOT COMPLETED|Period 4||0
8713696|NCT00975650|9760348|FG002|NOT COMPLETED|Period 4||0
8713697|NCT00975650|9760349|FG003|NOT COMPLETED|Period 4||0
8713698|NCT00975676|9760361|FG000|STARTED|Overall Study||32
8713699|NCT00975676|9760362|FG001|STARTED|Overall Study||91
8713700|NCT00975676|9760361|FG000|COMPLETED|Overall Study||26
8713701|NCT00975676|9760362|FG001|COMPLETED|Overall Study||83
8713702|NCT00975676|9760361|FG000|NOT COMPLETED|Overall Study||6
8713703|NCT00975676|9760362|FG001|NOT COMPLETED|Overall Study||8
8713704|NCT00975689|9760375|FG000|STARTED|Overall Study||17
8713705|NCT00975689|9760376|FG001|STARTED|Overall Study||18
8713706|NCT00975689|9760375|FG000|COMPLETED|Overall Study||15
8713707|NCT00975689|9760376|FG001|COMPLETED|Overall Study||15
8713708|NCT00975689|9760375|FG000|NOT COMPLETED|Overall Study||2
8713709|NCT00975689|9760376|FG001|NOT COMPLETED|Overall Study||3
8713710|NCT00975715|9760384|FG000|STARTED|Titration Period||48
8713711|NCT00975715|9760385|FG001|STARTED|Titration Period||51
8713712|NCT00975715|9760384|FG000|COMPLETED|Titration Period||41
8713713|NCT00975715|9760385|FG001|COMPLETED|Titration Period||51
8713714|NCT00975715|9760384|FG000|NOT COMPLETED|Titration Period||7
8600732|NCT00364182|9636912|FG000|NOT COMPLETED|Fourth Intervention||0
8600733|NCT00364182|9636913|FG001|NOT COMPLETED|Fourth Intervention||0
8600734|NCT00364182|9636914|FG002|NOT COMPLETED|Fourth Intervention||0
8600735|NCT00364286|9636924|FG000|STARTED|Overall Study||17
8713715|NCT00975715|9760385|FG001|NOT COMPLETED|Titration Period||0
8713716|NCT00975715|9760384|FG000|STARTED|Maintenance Period||41
8713717|NCT00975715|9760385|FG001|STARTED|Maintenance Period||51
8713718|NCT00975715|9760384|FG000|COMPLETED|Maintenance Period||39
8713719|NCT00975715|9760385|FG001|COMPLETED|Maintenance Period||50
8713720|NCT00975715|9760384|FG000|NOT COMPLETED|Maintenance Period||2
8713721|NCT00975715|9760385|FG001|NOT COMPLETED|Maintenance Period||1
8713722|NCT00975780|9760393|FG000|STARTED|Allocation||400
8713723|NCT00975780|9760394|FG001|STARTED|Allocation||434
8600736|NCT00364286|9636924|FG000|COMPLETED|Overall Study||14
8600737|NCT00364286|9636924|FG000|NOT COMPLETED|Overall Study||3
8600738|NCT00364351|9636930|FG000|STARTED|Overall Study|randomised patients|623
8600739|NCT00364351|9636931|FG001|STARTED|Overall Study|randomised patients|617
8600740|NCT00364351|9636930|FG000|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 26 Sep 2008.|31
8600741|NCT00364351|9636931|FG001|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 26 Sep 2008.|34
8600742|NCT00364351|9636930|FG000|NOT COMPLETED|Overall Study||592
8600743|NCT00364351|9636931|FG001|NOT COMPLETED|Overall Study||583
8600744|NCT00364377|9636939|FG000|STARTED|Overall Study||11
8600745|NCT00364377|9636940|FG001|STARTED|Overall Study||11
8600746|NCT00364377|9636939|FG000|COMPLETED|Overall Study||11
8600747|NCT00364377|9636940|FG001|COMPLETED|Overall Study||11
8600748|NCT00364377|9636939|FG000|NOT COMPLETED|Overall Study||0
8600749|NCT00364377|9636940|FG001|NOT COMPLETED|Overall Study||0
8600750|NCT00364533|9636951|FG000|STARTED|Overall Study||77
8600751|NCT00364533|9636952|FG001|STARTED|Overall Study||71
8600752|NCT00364533|9636953|FG002|STARTED|Overall Study||75
8600753|NCT00364533|9636954|FG003|STARTED|Overall Study||67
8600754|NCT00364533|9636955|FG004|STARTED|Overall Study||75
8600755|NCT00364533|9636951|FG000|COMPLETED|Overall Study||35
8600756|NCT00364533|9636952|FG001|COMPLETED|Overall Study||31
8600757|NCT00364533|9636953|FG002|COMPLETED|Overall Study||30
8600758|NCT00364533|9636954|FG003|COMPLETED|Overall Study||36
8600759|NCT00364533|9636955|FG004|COMPLETED|Overall Study||24
8600760|NCT00364533|9636951|FG000|NOT COMPLETED|Overall Study||42
8600761|NCT00364533|9636952|FG001|NOT COMPLETED|Overall Study||40
8600762|NCT00364533|9636953|FG002|NOT COMPLETED|Overall Study||45
8600763|NCT00364533|9636954|FG003|NOT COMPLETED|Overall Study||31
8600764|NCT00364533|9636955|FG004|NOT COMPLETED|Overall Study||51
8600765|NCT00364611|9636969|FG000|STARTED|Overall Study||52
8600766|NCT00364611|9636970|FG001|STARTED|Overall Study||21
8600767|NCT00364611|9636969|FG000|TREATED (SAFTEY POPULATION)|Overall Study|Received at least one dose of study medication|52
8600768|NCT00364611|9636970|FG001|TREATED (SAFTEY POPULATION)|Overall Study|Received at least one dose of study medication|20
8600769|NCT00364611|9636969|FG000|COMPLETED|Overall Study|Ongoing treatment (June 2011-initial analysis). Continued treatment till March 2012 (study closed).|1
8600770|NCT00364611|9636970|FG001|COMPLETED|Overall Study||0
8600771|NCT00364611|9636969|FG000|NOT COMPLETED|Overall Study||51
8600772|NCT00364611|9636970|FG001|NOT COMPLETED|Overall Study||21
8600773|NCT00364793|9636980|FG000|STARTED|Overall Study||15
8600774|NCT00364793|9636981|FG001|STARTED|Overall Study||10
8713724|NCT00975780|9760393|FG000|COMPLETED|Allocation||400
8713725|NCT00975780|9760394|FG001|COMPLETED|Allocation||434
8713726|NCT00975780|9760393|FG000|NOT COMPLETED|Allocation||0
8713727|NCT00975780|9760394|FG001|NOT COMPLETED|Allocation||0
8713728|NCT00975780|9760393|FG000|STARTED|Follow Up||400
8713729|NCT00975780|9760394|FG001|STARTED|Follow Up||434
8713730|NCT00975780|9760393|FG000|COMPLETED|Follow Up||298
8713731|NCT00975780|9760394|FG001|COMPLETED|Follow Up||277
8713732|NCT00975780|9760393|FG000|NOT COMPLETED|Follow Up||102
8713733|NCT00975780|9760394|FG001|NOT COMPLETED|Follow Up||157
8713734|NCT00975806|9760403|FG000|STARTED|Overall Study||5
8713735|NCT00975806|9760404|FG001|STARTED|Overall Study||7
8713736|NCT00975806|9760405|FG002|STARTED|Overall Study||4
8713737|NCT00975806|9760403|FG000|COMPLETED|Overall Study|Participants were prematurely discontinued|0
8713738|NCT00975806|9760404|FG001|COMPLETED|Overall Study|Participants were prematurely discontinued|0
8713739|NCT00975806|9760405|FG002|COMPLETED|Overall Study|Participants were prematurely discontinued|0
8713740|NCT00975806|9760403|FG000|NOT COMPLETED|Overall Study||5
8713741|NCT00975806|9760404|FG001|NOT COMPLETED|Overall Study||7
8713742|NCT00975806|9760405|FG002|NOT COMPLETED|Overall Study||4
8713743|NCT00975884|9760417|FG000|STARTED|Overall Study||184
8713744|NCT00975884|9760418|FG001|STARTED|Overall Study||122
8713745|NCT00975884|9760417|FG000|COMPLETED|Overall Study||168
8713746|NCT00975884|9760418|FG001|COMPLETED|Overall Study||107
8713747|NCT00975884|9760417|FG000|NOT COMPLETED|Overall Study||16
8713748|NCT00975884|9760418|FG001|NOT COMPLETED|Overall Study||15
8713749|NCT00975923|9760436|FG000|STARTED|Overall Study||30
8713750|NCT00975923|9760437|FG001|STARTED|Overall Study||30
8713751|NCT00975923|9760436|FG000|COMPLETED|Overall Study||30
8713752|NCT00975923|9760437|FG001|COMPLETED|Overall Study|1 hospital was sold, yielding 29 hospitals in the Tool Kit Group|29
8713753|NCT00975923|9760436|FG000|NOT COMPLETED|Overall Study||0
8713754|NCT00975923|9760437|FG001|NOT COMPLETED|Overall Study||1
8713755|NCT00975975|9760444|FG000|STARTED|Overall Study||17
8713756|NCT00975975|9760444|FG000|COMPLETED|Overall Study||11
8713757|NCT00975975|9760444|FG000|NOT COMPLETED|Overall Study||6
8713758|NCT00976027|9760450|FG000|STARTED|Overall Study||6108
8713759|NCT00976027|9760451|FG001|STARTED|Overall Study||3050
8713760|NCT00976027|9760450|FG000|COMPLETED|Overall Study||5697
8713761|NCT00976027|9760451|FG001|COMPLETED|Overall Study||2835
8713762|NCT00976027|9760450|FG000|NOT COMPLETED|Overall Study||411
8713763|NCT00976027|9760451|FG001|NOT COMPLETED|Overall Study||215
8713764|NCT00976183|9760457|FG000|STARTED|Overall Study||18
8713765|NCT00976183|9760457|FG000|COMPLETED|Overall Study|The study was closed on 05/30/12 due to adverse events. We did not complete enrollment|18
8713766|NCT00976183|9760457|FG000|NOT COMPLETED|Overall Study||0
8713767|NCT00976209|9760463|FG000|STARTED|Treatment Period 1||165
8713768|NCT00976209|9760464|FG001|STARTED|Treatment Period 1||166
8600775|NCT00364793|9636982|FG002|STARTED|Overall Study||4
8600776|NCT00364793|9636983|FG003|STARTED|Overall Study||8
8600777|NCT00364793|9636980|FG000|COMPLETED|Overall Study||7
8600778|NCT00364793|9636981|FG001|COMPLETED|Overall Study||5
8600779|NCT00364793|9636982|FG002|COMPLETED|Overall Study||0
8600780|NCT00364793|9636983|FG003|COMPLETED|Overall Study||5
8600781|NCT00364793|9636980|FG000|NOT COMPLETED|Overall Study||8
8600782|NCT00364793|9636981|FG001|NOT COMPLETED|Overall Study||5
8600783|NCT00364793|9636982|FG002|NOT COMPLETED|Overall Study||4
8600784|NCT00364793|9636983|FG003|NOT COMPLETED|Overall Study||3
8600785|NCT00364819|9636996|FG000|STARTED|Overall Study||6
8600786|NCT00364819|9636996|FG000|COMPLETED|Overall Study||6
8600787|NCT00364819|9636996|FG000|NOT COMPLETED|Overall Study||0
8600788|NCT00364832|9637009|FG000|STARTED|Core Period||16
8600789|NCT00364832|9637010|FG001|STARTED|Core Period||15
8600790|NCT00364832|9637011|FG002|STARTED|Core Period||15
8600791|NCT00364832|9637012|FG003|STARTED|Core Period||16
8600792|NCT00364832|9637013|FG004|STARTED|Core Period||16
8600793|NCT00364832|9637014|FG005|STARTED|Core Period||12
8600794|NCT00364832|9637015|FG006|STARTED|Core Period||16
8600795|NCT00364832|9637016|FG007|STARTED|Core Period||15
8600796|NCT00364832|9637017|FG008|STARTED|Core Period||16
8600797|NCT00364832|9637018|FG009|STARTED|Core Period||0
8600798|NCT00364832|9637019|FG010|STARTED|Core Period||0
8600799|NCT00364832|9637020|FG011|STARTED|Core Period||0
8600800|NCT00364832|9637009|FG000|COMPLETED|Core Period||14
8600801|NCT00364832|9637010|FG001|COMPLETED|Core Period||13
8600802|NCT00364832|9637011|FG002|COMPLETED|Core Period||14
8600803|NCT00364832|9637012|FG003|COMPLETED|Core Period||15
8600804|NCT00364832|9637013|FG004|COMPLETED|Core Period||16
8600805|NCT00364832|9637014|FG005|COMPLETED|Core Period||12
8600806|NCT00364832|9637015|FG006|COMPLETED|Core Period||12
8600807|NCT00364832|9637016|FG007|COMPLETED|Core Period||14
8600808|NCT00364832|9637017|FG008|COMPLETED|Core Period||16
8600809|NCT00364832|9637018|FG009|COMPLETED|Core Period||0
8600810|NCT00364832|9637019|FG010|COMPLETED|Core Period||0
8600811|NCT00364832|9637020|FG011|COMPLETED|Core Period||0
8600812|NCT00364832|9637009|FG000|NOT COMPLETED|Core Period||2
8600813|NCT00364832|9637010|FG001|NOT COMPLETED|Core Period||2
8600814|NCT00364832|9637011|FG002|NOT COMPLETED|Core Period||1
8600815|NCT00364832|9637012|FG003|NOT COMPLETED|Core Period||1
8600816|NCT00364832|9637013|FG004|NOT COMPLETED|Core Period||0
8600817|NCT00364832|9637014|FG005|NOT COMPLETED|Core Period||0
8600818|NCT00364832|9637015|FG006|NOT COMPLETED|Core Period||4
8600819|NCT00364832|9637016|FG007|NOT COMPLETED|Core Period||1
8600820|NCT00364832|9637017|FG008|NOT COMPLETED|Core Period||0
8600821|NCT00364832|9637018|FG009|NOT COMPLETED|Core Period||0
8600822|NCT00364832|9637019|FG010|NOT COMPLETED|Core Period||0
8600823|NCT00364832|9637020|FG011|NOT COMPLETED|Core Period||0
8600824|NCT00364832|9637009|FG000|STARTED|Extension Year 1||0
8600825|NCT00364832|9637010|FG001|STARTED|Extension Year 1||0
8600826|NCT00364832|9637011|FG002|STARTED|Extension Year 1||0
8600827|NCT00364832|9637012|FG003|STARTED|Extension Year 1||0
8600828|NCT00364832|9637013|FG004|STARTED|Extension Year 1||0
8600829|NCT00364832|9637014|FG005|STARTED|Extension Year 1||0
8600830|NCT00364832|9637015|FG006|STARTED|Extension Year 1||0
8600831|NCT00364832|9637016|FG007|STARTED|Extension Year 1||0
8600832|NCT00364832|9637017|FG008|STARTED|Extension Year 1||0
8600833|NCT00364832|9637018|FG009|STARTED|Extension Year 1|Participants (Cohorts A, D, and G) who completed core, entered extension period (entry optional).|18
8600834|NCT00364832|9637019|FG010|STARTED|Extension Year 1|Participants (Cohorts B, E, and H) who completed core, entered extension period (entry optional).|17
8600835|NCT00364832|9637020|FG011|STARTED|Extension Year 1|Participants (Cohorts C, F, and I) who completed core, entered extension period (entry optional).|27
8600836|NCT00364832|9637009|FG000|COMPLETED|Extension Year 1||0
8600837|NCT00364832|9637010|FG001|COMPLETED|Extension Year 1||0
8600838|NCT00364832|9637011|FG002|COMPLETED|Extension Year 1||0
8600839|NCT00364832|9637012|FG003|COMPLETED|Extension Year 1||0
8600840|NCT00364832|9637013|FG004|COMPLETED|Extension Year 1||0
8600841|NCT00364832|9637014|FG005|COMPLETED|Extension Year 1||0
8600842|NCT00364832|9637015|FG006|COMPLETED|Extension Year 1||0
8600843|NCT00364832|9637016|FG007|COMPLETED|Extension Year 1||0
8600844|NCT00364832|9637017|FG008|COMPLETED|Extension Year 1||0
8600845|NCT00364832|9637018|FG009|COMPLETED|Extension Year 1||14
8600846|NCT00364832|9637019|FG010|COMPLETED|Extension Year 1||15
8600847|NCT00364832|9637020|FG011|COMPLETED|Extension Year 1||17
8600848|NCT00364832|9637009|FG000|NOT COMPLETED|Extension Year 1||0
8600849|NCT00364832|9637010|FG001|NOT COMPLETED|Extension Year 1||0
8600850|NCT00364832|9637011|FG002|NOT COMPLETED|Extension Year 1||0
8600851|NCT00364832|9637012|FG003|NOT COMPLETED|Extension Year 1||0
8600852|NCT00364832|9637013|FG004|NOT COMPLETED|Extension Year 1||0
8600853|NCT00364832|9637014|FG005|NOT COMPLETED|Extension Year 1||0
8600854|NCT00364832|9637015|FG006|NOT COMPLETED|Extension Year 1||0
8600855|NCT00364832|9637016|FG007|NOT COMPLETED|Extension Year 1||0
8600856|NCT00364832|9637017|FG008|NOT COMPLETED|Extension Year 1||0
8600857|NCT00364832|9637018|FG009|NOT COMPLETED|Extension Year 1||4
8600858|NCT00364832|9637019|FG010|NOT COMPLETED|Extension Year 1||2
8600859|NCT00364832|9637020|FG011|NOT COMPLETED|Extension Year 1||10
8600860|NCT00364832|9637009|FG000|STARTED|Extension Year 2||0
8600861|NCT00364832|9637010|FG001|STARTED|Extension Year 2||0
8600862|NCT00364832|9637011|FG002|STARTED|Extension Year 2||0
8600863|NCT00364832|9637012|FG003|STARTED|Extension Year 2||0
8600864|NCT00364832|9637013|FG004|STARTED|Extension Year 2||0
8600865|NCT00364832|9637014|FG005|STARTED|Extension Year 2||0
8600866|NCT00364832|9637015|FG006|STARTED|Extension Year 2||0
8600867|NCT00364832|9637016|FG007|STARTED|Extension Year 2||0
8600868|NCT00364832|9637017|FG008|STARTED|Extension Year 2||0
8600869|NCT00364832|9637018|FG009|STARTED|Extension Year 2||14
8600870|NCT00364832|9637019|FG010|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|14
8600871|NCT00364832|9637020|FG011|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|14
8600872|NCT00364832|9637009|FG000|COMPLETED|Extension Year 2||0
8600873|NCT00364832|9637010|FG001|COMPLETED|Extension Year 2||0
8600874|NCT00364832|9637011|FG002|COMPLETED|Extension Year 2||0
8600875|NCT00364832|9637012|FG003|COMPLETED|Extension Year 2||0
8600876|NCT00364832|9637013|FG004|COMPLETED|Extension Year 2||0
8600877|NCT00364832|9637014|FG005|COMPLETED|Extension Year 2||0
8600878|NCT00364832|9637015|FG006|COMPLETED|Extension Year 2||0
8600879|NCT00364832|9637016|FG007|COMPLETED|Extension Year 2||0
8600880|NCT00364832|9637017|FG008|COMPLETED|Extension Year 2||0
8600881|NCT00364832|9637018|FG009|COMPLETED|Extension Year 2||9
8600882|NCT00364832|9637019|FG010|COMPLETED|Extension Year 2||9
8600883|NCT00364832|9637020|FG011|COMPLETED|Extension Year 2||11
8600884|NCT00364832|9637009|FG000|NOT COMPLETED|Extension Year 2||0
8600885|NCT00364832|9637010|FG001|NOT COMPLETED|Extension Year 2||0
8600886|NCT00364832|9637011|FG002|NOT COMPLETED|Extension Year 2||0
8600887|NCT00364832|9637012|FG003|NOT COMPLETED|Extension Year 2||0
8600888|NCT00364832|9637013|FG004|NOT COMPLETED|Extension Year 2||0
8600889|NCT00364832|9637014|FG005|NOT COMPLETED|Extension Year 2||0
8600890|NCT00364832|9637015|FG006|NOT COMPLETED|Extension Year 2||0
8600891|NCT00364832|9637016|FG007|NOT COMPLETED|Extension Year 2||0
8600892|NCT00364832|9637017|FG008|NOT COMPLETED|Extension Year 2||0
8600893|NCT00364832|9637018|FG009|NOT COMPLETED|Extension Year 2||5
8600894|NCT00364832|9637019|FG010|NOT COMPLETED|Extension Year 2||5
8600895|NCT00364832|9637020|FG011|NOT COMPLETED|Extension Year 2||3
8600896|NCT00364845|9637039|FG000|STARTED|Overall Study||28
8600897|NCT00364845|9637040|FG001|STARTED|Overall Study||23
8600898|NCT00364845|9637039|FG000|COMPLETED|Overall Study|Completed 36-week titration/treatment phase|17
8600899|NCT00364845|9637040|FG001|COMPLETED|Overall Study|Completed 36-week titration/treatment phase|12
8600900|NCT00364845|9637039|FG000|NOT COMPLETED|Overall Study||11
8600901|NCT00364845|9637040|FG001|NOT COMPLETED|Overall Study||11
8600902|NCT00364858|9637048|FG000|STARTED|Overall Study||33
8600903|NCT00364858|9637049|FG001|STARTED|Overall Study||62
8600904|NCT00364858|9637048|FG000|COMPLETED|Overall Study||26
8600905|NCT00364858|9637049|FG001|COMPLETED|Overall Study||40
8600906|NCT00364858|9637048|FG000|NOT COMPLETED|Overall Study||7
8600907|NCT00364858|9637049|FG001|NOT COMPLETED|Overall Study||22
8600908|NCT00364923|9637056|FG000|STARTED|Treatment With Pralatrexate|Received at least one dose of pralatrexate.|111
8600909|NCT00364923|9637056|FG000|COMPLETED|Treatment With Pralatrexate|Treatment duration not limited. After treatment ends, patients attend survival follow-up visits.|107
8600910|NCT00364923|9637056|FG000|NOT COMPLETED|Treatment With Pralatrexate||4
8600911|NCT00364923|9637056|FG000|STARTED|Survival Follow-up, After Pralatrexate|Patients (pts) who stop treatment with pralatrexate are followed for survival|107
8600912|NCT00364923|9637056|FG000|COMPLETED|Survival Follow-up, After Pralatrexate|Pts who completed follow-up either died, were followed for 24 months, or withdrew|83
8600913|NCT00364923|9637056|FG000|NOT COMPLETED|Survival Follow-up, After Pralatrexate||24
8600914|NCT00364949|9637062|FG000|STARTED|Overall Study||31
8600915|NCT00364949|9637063|FG001|STARTED|Overall Study||39
8600916|NCT00364949|9637062|FG000|COMPLETED|Overall Study||31
8600917|NCT00364949|9637063|FG001|COMPLETED|Overall Study||39
8600918|NCT00364949|9637062|FG000|NOT COMPLETED|Overall Study||0
8600919|NCT00364949|9637063|FG001|NOT COMPLETED|Overall Study||0
8600920|NCT00365053|9637069|FG000|STARTED|Overall Study||13
8600921|NCT00365053|9637069|FG000|COMPLETED|Overall Study||13
8600922|NCT00365053|9637069|FG000|NOT COMPLETED|Overall Study||0
8600923|NCT00365105|9637075|FG000|STARTED|Overall Study||129
8600924|NCT00365105|9637076|FG001|STARTED|Overall Study||132
8600925|NCT00365105|9637075|FG000|Eligible|Overall Study||124
8600926|NCT00365105|9637076|FG001|Eligible|Overall Study||124
8600927|NCT00365105|9637075|FG000|Eligible With Adverse Event Data|Overall Study||123
8600928|NCT00365105|9637076|FG001|Eligible With Adverse Event Data|Overall Study||124
8600929|NCT00365105|9637075|FG000|COMPLETED|Overall Study||124
8600930|NCT00365105|9637076|FG001|COMPLETED|Overall Study||124
8600931|NCT00365105|9637075|FG000|NOT COMPLETED|Overall Study||5
8600932|NCT00365105|9637076|FG001|NOT COMPLETED|Overall Study||8
8600933|NCT00365144|9637082|FG000|STARTED|Overall Study||36
8713769|NCT00976209|9760463|FG000|COMPLETED|Treatment Period 1||162
8713770|NCT00976209|9760464|FG001|COMPLETED|Treatment Period 1||165
8713771|NCT00976209|9760463|FG000|NOT COMPLETED|Treatment Period 1||3
8713772|NCT00976209|9760464|FG001|NOT COMPLETED|Treatment Period 1||1
8713773|NCT00976209|9760463|FG000|STARTED|Wash-out Period||162
8713774|NCT00976209|9760464|FG001|STARTED|Wash-out Period||165
8713775|NCT00976209|9760463|FG000|COMPLETED|Wash-out Period||158
8600934|NCT00365144|9637082|FG000|COMPLETED|Overall Study||36
8600935|NCT00365144|9637082|FG000|NOT COMPLETED|Overall Study||0
8600936|NCT00365209|9637087|FG000|STARTED|Stage 1: Receiving 2g Curcumin||23
8713776|NCT00976209|9760464|FG001|COMPLETED|Wash-out Period||163
8713777|NCT00976209|9760463|FG000|NOT COMPLETED|Wash-out Period||4
8600937|NCT00365209|9637087|FG000|COMPLETED|Stage 1: Receiving 2g Curcumin||21
8600938|NCT00365209|9637087|FG000|NOT COMPLETED|Stage 1: Receiving 2g Curcumin||2
8713778|NCT00976209|9760464|FG001|NOT COMPLETED|Wash-out Period||2
8600939|NCT00365209|9637087|FG000|STARTED|Stage 2: Receiving 4g Curcumin||21
8600940|NCT00365209|9637087|FG000|COMPLETED|Stage 2: Receiving 4g Curcumin||19
8600941|NCT00365209|9637087|FG000|NOT COMPLETED|Stage 2: Receiving 4g Curcumin||2
8600942|NCT00365261|9637094|FG000|STARTED|Overall Study||23
8600943|NCT00365261|9637095|FG001|STARTED|Overall Study||22
8600944|NCT00365261|9637094|FG000|COMPLETED|Overall Study||20
8713779|NCT00976209|9760463|FG000|STARTED|Treatment Period 2||158
8713780|NCT00976209|9760464|FG001|STARTED|Treatment Period 2||163
8713781|NCT00976209|9760463|FG000|COMPLETED|Treatment Period 2||158
8600945|NCT00365261|9637095|FG001|COMPLETED|Overall Study||19
8600946|NCT00365261|9637094|FG000|NOT COMPLETED|Overall Study||3
8600947|NCT00365261|9637095|FG001|NOT COMPLETED|Overall Study||3
8600948|NCT00365274|9637103|FG000|STARTED|Overall Study||6
8600949|NCT00365274|9637103|FG000|COMPLETED|Overall Study||6
8600950|NCT00365274|9637103|FG000|NOT COMPLETED|Overall Study||0
8600951|NCT00365300|9637109|FG000|STARTED|Open-label Phase||129
8600952|NCT00365300|9637110|FG001|STARTED|Open-label Phase||0
8600953|NCT00365300|9637109|FG000|COMPLETED|Open-label Phase||107
8600954|NCT00365300|9637110|FG001|COMPLETED|Open-label Phase||0
8600955|NCT00365300|9637109|FG000|NOT COMPLETED|Open-label Phase||22
8600956|NCT00365300|9637110|FG001|NOT COMPLETED|Open-label Phase||0
8600957|NCT00365300|9637109|FG000|STARTED|Double-blind Phase||54
8600958|NCT00365300|9637110|FG001|STARTED|Double-blind Phase||54
8600959|NCT00365300|9637109|FG000|COMPLETED|Double-blind Phase||43
8600960|NCT00365300|9637110|FG001|COMPLETED|Double-blind Phase||45
8600961|NCT00365300|9637109|FG000|NOT COMPLETED|Double-blind Phase||11
8600962|NCT00365300|9637110|FG001|NOT COMPLETED|Double-blind Phase||9
8600963|NCT00365352|9637122|FG000|STARTED|Overall Study||97
8600964|NCT00365352|9637123|FG001|STARTED|Overall Study||115
8600965|NCT00365352|9637124|FG002|STARTED|Overall Study||113
8600966|NCT00365352|9637122|FG000|Safety Population|Overall Study||96
8600967|NCT00365352|9637123|FG001|Safety Population|Overall Study||115
8600968|NCT00365352|9637124|FG002|Safety Population|Overall Study||111
8600969|NCT00365352|9637122|FG000|Modified Intent-to-Treat Population|Overall Study||96
8600970|NCT00365352|9637123|FG001|Modified Intent-to-Treat Population|Overall Study||114
8600971|NCT00365352|9637124|FG002|Modified Intent-to-Treat Population|Overall Study||111
8600972|NCT00365352|9637122|FG000|COMPLETED|Overall Study||77
8600973|NCT00365352|9637123|FG001|COMPLETED|Overall Study||104
8600974|NCT00365352|9637124|FG002|COMPLETED|Overall Study||98
8600975|NCT00365352|9637122|FG000|NOT COMPLETED|Overall Study||20
8600976|NCT00365352|9637123|FG001|NOT COMPLETED|Overall Study||11
8600977|NCT00365352|9637124|FG002|NOT COMPLETED|Overall Study||15
8600978|NCT00365365|9637138|FG000|STARTED|Overall Study||78
8600979|NCT00365365|9637139|FG001|STARTED|Overall Study||77
8600980|NCT00365365|9637140|FG002|STARTED|Overall Study||59
8600981|NCT00365365|9637138|FG000|TREATED (SAFETY POPULATION)|Overall Study||78
8600982|NCT00365365|9637139|FG001|TREATED (SAFETY POPULATION)|Overall Study||75
8600983|NCT00365365|9637140|FG002|TREATED (SAFETY POPULATION)|Overall Study||59
8600984|NCT00365365|9637138|FG000|COMPLETED TREATMENT|Overall Study||38
8600985|NCT00365365|9637139|FG001|COMPLETED TREATMENT|Overall Study||36
8600986|NCT00365365|9637140|FG002|COMPLETED TREATMENT|Overall Study||45
8600987|NCT00365365|9637138|FG000|COMPLETED|Overall Study||44
8600988|NCT00365365|9637139|FG001|COMPLETED|Overall Study||41
8600989|NCT00365365|9637140|FG002|COMPLETED|Overall Study||44
8600990|NCT00365365|9637138|FG000|NOT COMPLETED|Overall Study||34
8713782|NCT00976209|9760464|FG001|COMPLETED|Treatment Period 2||161
8713783|NCT00976209|9760463|FG000|NOT COMPLETED|Treatment Period 2||0
8713784|NCT00976209|9760464|FG001|NOT COMPLETED|Treatment Period 2||2
8713785|NCT00976248|9760469|FG000|STARTED|Overall Study||33
8713786|NCT00976248|9760469|FG000|COMPLETED|Overall Study||33
8713787|NCT00976248|9760469|FG000|NOT COMPLETED|Overall Study||0
8713788|NCT00976274|9760476|FG000|STARTED|Overall Study||31
8713789|NCT00976274|9760477|FG001|STARTED|Overall Study||29
8713790|NCT00976274|9760476|FG000|COMPLETED|Overall Study||24
8713791|NCT00976274|9760477|FG001|COMPLETED|Overall Study||21
8713792|NCT00976274|9760476|FG000|NOT COMPLETED|Overall Study||7
8713793|NCT00976274|9760477|FG001|NOT COMPLETED|Overall Study||8
8713794|NCT00976352|9760485|FG000|STARTED|Overall Study||3
8713795|NCT00976352|9760486|FG001|STARTED|Overall Study||10
8713796|NCT00976352|9760485|FG000|COMPLETED|Overall Study||3
8713797|NCT00976352|9760486|FG001|COMPLETED|Overall Study|Last evaluation of last subject in cohort.|6
8600991|NCT00365365|9637139|FG001|NOT COMPLETED|Overall Study||36
8600992|NCT00365365|9637140|FG002|NOT COMPLETED|Overall Study||15
8600993|NCT00365378|9637150|FG000|STARTED|Vaccination (Day 1 to Month 7)||1204
8600994|NCT00365378|9637151|FG001|STARTED|Vaccination (Day 1 to Month 7)||1205
8600995|NCT00365378|9637152|FG002|STARTED|Vaccination (Day 1 to Month 7)||0
8600996|NCT00365378|9637150|FG000|Entered Vaccination Period|Vaccination (Day 1 to Month 7)||1193
8600997|NCT00365378|9637151|FG001|Entered Vaccination Period|Vaccination (Day 1 to Month 7)||1198
8600998|NCT00365378|9637152|FG002|Entered Vaccination Period|Vaccination (Day 1 to Month 7)||0
8713798|NCT00976352|9760485|FG000|NOT COMPLETED|Overall Study||0
8713799|NCT00976352|9760486|FG001|NOT COMPLETED|Overall Study||4
8713800|NCT00976391|9760498|FG000|STARTED|Treatment Period (52 Weeks)||285
8713801|NCT00976391|9760499|FG001|STARTED|Treatment Period (52 Weeks)||281
8713802|NCT00976391|9760498|FG000|COMPLETED|Treatment Period (52 Weeks)||243
8713803|NCT00976391|9760499|FG001|COMPLETED|Treatment Period (52 Weeks)||242
8713804|NCT00976391|9760498|FG000|NOT COMPLETED|Treatment Period (52 Weeks)||42
8713805|NCT00976391|9760499|FG001|NOT COMPLETED|Treatment Period (52 Weeks)||39
8713806|NCT00976391|9760498|FG000|STARTED|Follow-up Period (8 Weeks)||285
8713807|NCT00976391|9760499|FG001|STARTED|Follow-up Period (8 Weeks)||281
8713808|NCT00976391|9760498|FG000|COMPLETED|Follow-up Period (8 Weeks)||256
8600999|NCT00365378|9637150|FG000|COMPLETED|Vaccination (Day 1 to Month 7)||993
8601000|NCT00365378|9637151|FG001|COMPLETED|Vaccination (Day 1 to Month 7)||1038
8601001|NCT00365378|9637152|FG002|COMPLETED|Vaccination (Day 1 to Month 7)||0
8601002|NCT00365378|9637150|FG000|NOT COMPLETED|Vaccination (Day 1 to Month 7)||211
8601003|NCT00365378|9637151|FG001|NOT COMPLETED|Vaccination (Day 1 to Month 7)||167
8601004|NCT00365378|9637152|FG002|NOT COMPLETED|Vaccination (Day 1 to Month 7)||0
8601005|NCT00365378|9637150|FG000|STARTED|Follow-up (Month 7 Though Month 48)||993
8601006|NCT00365378|9637151|FG001|STARTED|Follow-up (Month 7 Though Month 48)||1038
8601007|NCT00365378|9637152|FG002|STARTED|Follow-up (Month 7 Though Month 48)||0
8601008|NCT00365378|9637150|FG000|COMPLETED|Follow-up (Month 7 Though Month 48)||835
8601009|NCT00365378|9637151|FG001|COMPLETED|Follow-up (Month 7 Though Month 48)||836
8601010|NCT00365378|9637152|FG002|COMPLETED|Follow-up (Month 7 Though Month 48)||0
8601011|NCT00365378|9637150|FG000|NOT COMPLETED|Follow-up (Month 7 Though Month 48)||158
8601012|NCT00365378|9637151|FG001|NOT COMPLETED|Follow-up (Month 7 Though Month 48)||202
8601013|NCT00365378|9637152|FG002|NOT COMPLETED|Follow-up (Month 7 Though Month 48)||0
8601014|NCT00365378|9637150|FG000|STARTED|Extension||0
8601015|NCT00365378|9637151|FG001|STARTED|Extension||0
8601016|NCT00365378|9637152|FG002|STARTED|Extension||400
8601017|NCT00365378|9637150|FG000|COMPLETED|Extension||0
8601018|NCT00365378|9637151|FG001|COMPLETED|Extension||0
8601019|NCT00365378|9637152|FG002|COMPLETED|Extension||203
8601020|NCT00365378|9637150|FG000|NOT COMPLETED|Extension||0
8601021|NCT00365378|9637151|FG001|NOT COMPLETED|Extension||0
8601022|NCT00365378|9637152|FG002|NOT COMPLETED|Extension||197
8601023|NCT00365391|9637159|FG000|STARTED|Overall Study||27
8601024|NCT00365391|9637159|FG000|COMPLETED|Overall Study||27
8601025|NCT00365391|9637159|FG000|NOT COMPLETED|Overall Study||0
8601026|NCT00365417|9637163|FG000|STARTED|Overall Study||45
8713809|NCT00976391|9760499|FG001|COMPLETED|Follow-up Period (8 Weeks)||247
8713810|NCT00976391|9760498|FG000|NOT COMPLETED|Follow-up Period (8 Weeks)||29
8713811|NCT00976391|9760499|FG001|NOT COMPLETED|Follow-up Period (8 Weeks)||34
8713812|NCT00976404|9760507|FG000|STARTED|Overall Study||14
8713813|NCT00976404|9760508|FG001|STARTED|Overall Study||14
8713814|NCT00976404|9760507|FG000|COMPLETED|Overall Study||14
8713815|NCT00976404|9760508|FG001|COMPLETED|Overall Study||14
8713816|NCT00976404|9760507|FG000|NOT COMPLETED|Overall Study||0
8713817|NCT00976404|9760508|FG001|NOT COMPLETED|Overall Study||0
8713818|NCT00976456|9760518|FG000|STARTED|Overall Study||135
8713819|NCT00976456|9760519|FG001|STARTED|Overall Study||136
8713820|NCT00976456|9760518|FG000|COMPLETED|Overall Study||92
8713821|NCT00976456|9760519|FG001|COMPLETED|Overall Study||98
8713822|NCT00976456|9760518|FG000|NOT COMPLETED|Overall Study||43
8713823|NCT00976456|9760519|FG001|NOT COMPLETED|Overall Study||38
8713824|NCT00976482|9760525|FG000|STARTED|Overall Study||1745
8713825|NCT00976482|9760525|FG000|Eligible for Last Follow up|Overall Study||1487
8713826|NCT00976482|9760525|FG000|COMPLETED|Overall Study||1486
8713827|NCT00976482|9760525|FG000|NOT COMPLETED|Overall Study||259
8713828|NCT00976495|9760532|FG000|STARTED|Overall Study||25
8713829|NCT00976495|9760533|FG001|STARTED|Overall Study||24
8713830|NCT00976495|9760534|FG002|STARTED|Overall Study||26
8713831|NCT00976495|9760532|FG000|COMPLETED|Overall Study||25
8713832|NCT00976495|9760533|FG001|COMPLETED|Overall Study||23
8713833|NCT00976495|9760534|FG002|COMPLETED|Overall Study||26
8713834|NCT00976495|9760532|FG000|NOT COMPLETED|Overall Study||0
8713835|NCT00976495|9760533|FG001|NOT COMPLETED|Overall Study||1
8713836|NCT00976495|9760534|FG002|NOT COMPLETED|Overall Study||0
8713837|NCT00976508|9760544|FG000|STARTED|Overall Study|18 subjects were enrolled; 17 subjects were treated; 1 subject was not eligible.|17
8713838|NCT00976508|9760545|FG001|STARTED|Overall Study||6
8713839|NCT00976508|9760544|FG000|COMPLETED|Overall Study|These subjects withdrew from last study treatment due to progressive disease.|3
8713840|NCT00976508|9760545|FG001|COMPLETED|Overall Study||0
8713841|NCT00976508|9760544|FG000|NOT COMPLETED|Overall Study||14
8713842|NCT00976508|9760545|FG001|NOT COMPLETED|Overall Study||6
8713843|NCT00976521|9760558|FG000|STARTED|Overall Study||118
8713844|NCT00976521|9760559|FG001|STARTED|Overall Study||111
8713845|NCT00976521|9760560|FG002|STARTED|Overall Study||111
8713846|NCT00976521|9760561|FG003|STARTED|Overall Study||112
8713847|NCT00976521|9760558|FG000|COMPLETED|Overall Study||109
8713848|NCT00976521|9760559|FG001|COMPLETED|Overall Study||99
8713849|NCT00976521|9760560|FG002|COMPLETED|Overall Study||102
8713850|NCT00976521|9760561|FG003|COMPLETED|Overall Study||93
8713851|NCT00976521|9760558|FG000|NOT COMPLETED|Overall Study||9
8713852|NCT00976521|9760559|FG001|NOT COMPLETED|Overall Study||12
8601027|NCT00365417|9637163|FG000|COMPLETED|Overall Study||45
8713853|NCT00976521|9760560|FG002|NOT COMPLETED|Overall Study||9
8713854|NCT00976521|9760561|FG003|NOT COMPLETED|Overall Study||19
8713855|NCT00976560|9760574|FG000|STARTED|Overall Study||64
8713856|NCT00976560|9760575|FG001|STARTED|Overall Study||64
8713857|NCT00976560|9760574|FG000|COMPLETED|Overall Study||50
8601028|NCT00365417|9637163|FG000|NOT COMPLETED|Overall Study||0
8601029|NCT00365456|9637168|FG000|STARTED|Trial Period I (12 Months)||407
8601030|NCT00365456|9637169|FG001|STARTED|Trial Period I (12 Months)||0
8601031|NCT00365456|9637168|FG000|COMPLETED|Trial Period I (12 Months)||282
8713858|NCT00976560|9760575|FG001|COMPLETED|Overall Study||51
8713859|NCT00976560|9760574|FG000|NOT COMPLETED|Overall Study||14
8601032|NCT00365456|9637169|FG001|COMPLETED|Trial Period I (12 Months)||0
8601033|NCT00365456|9637168|FG000|NOT COMPLETED|Trial Period I (12 Months)||125
8601034|NCT00365456|9637169|FG001|NOT COMPLETED|Trial Period I (12 Months)||0
8601035|NCT00365456|9637168|FG000|STARTED|Trial Period II (12 Months)||0
8601036|NCT00365456|9637169|FG001|STARTED|Trial Period II (12 Months)||282
8601037|NCT00365456|9637168|FG000|COMPLETED|Trial Period II (12 Months)||0
8601038|NCT00365456|9637169|FG001|COMPLETED|Trial Period II (12 Months)||268
8601039|NCT00365456|9637168|FG000|NOT COMPLETED|Trial Period II (12 Months)||0
8601040|NCT00365456|9637169|FG001|NOT COMPLETED|Trial Period II (12 Months)||14
8601041|NCT00365456|9637168|FG000|STARTED|Trial Period III (12 Months)||136
8601042|NCT00365456|9637169|FG001|STARTED|Trial Period III (12 Months)||132
8601043|NCT00365456|9637168|FG000|COMPLETED|Trial Period III (12 Months)||118
8601044|NCT00365456|9637169|FG001|COMPLETED|Trial Period III (12 Months)||127
8601045|NCT00365456|9637168|FG000|NOT COMPLETED|Trial Period III (12 Months)||18
8601046|NCT00365456|9637169|FG001|NOT COMPLETED|Trial Period III (12 Months)||5
8601047|NCT00365508|9637177|FG000|STARTED|Overall Study||321
8601048|NCT00365508|9637178|FG001|STARTED|Overall Study||321
8601049|NCT00365508|9637177|FG000|COMPLETED|Overall Study||182
8601050|NCT00365508|9637178|FG001|COMPLETED|Overall Study||167
8601051|NCT00365508|9637177|FG000|NOT COMPLETED|Overall Study||139
8601052|NCT00365508|9637178|FG001|NOT COMPLETED|Overall Study||154
8601053|NCT00365547|9637184|FG000|STARTED|Overall Study||46
8601054|NCT00365547|9637184|FG000|COMPLETED|Overall Study||43
8601055|NCT00365547|9637184|FG000|NOT COMPLETED|Overall Study||3
8601056|NCT00365599|9637191|FG000|STARTED|Overall Study||43
8601057|NCT00365599|9637191|FG000|COMPLETED|Overall Study||43
8601058|NCT00365599|9637191|FG000|NOT COMPLETED|Overall Study||0
8601059|NCT00365716|9637200|FG000|STARTED|Base Study (Day 1 to Month 7)||290
8601060|NCT00365716|9637201|FG001|STARTED|Base Study (Day 1 to Month 7)||284
8601061|NCT00365716|9637202|FG002|STARTED|Base Study (Day 1 to Month 7)||292
8601062|NCT00365716|9637203|FG003|STARTED|Base Study (Day 1 to Month 7)||146
8601063|NCT00365716|9637204|FG004|STARTED|Base Study (Day 1 to Month 7)||146
8601064|NCT00365716|9637205|FG005|STARTED|Base Study (Day 1 to Month 7)||0
8601065|NCT00365716|9637206|FG006|STARTED|Base Study (Day 1 to Month 7)||0
8601066|NCT00365716|9637200|FG000|COMPLETED|Base Study (Day 1 to Month 7)||269
8601067|NCT00365716|9637201|FG001|COMPLETED|Base Study (Day 1 to Month 7)||260
8713860|NCT00976560|9760575|FG001|NOT COMPLETED|Overall Study||13
8713861|NCT00976573|9760583|FG000|STARTED|Overall Study||75
8713862|NCT00976573|9760584|FG001|STARTED|Overall Study||74
8713863|NCT00976573|9760583|FG000|COMPLETED|Overall Study||71
8713864|NCT00976573|9760584|FG001|COMPLETED|Overall Study||71
8713865|NCT00976573|9760583|FG000|NOT COMPLETED|Overall Study||4
8713866|NCT00976573|9760584|FG001|NOT COMPLETED|Overall Study||3
8713867|NCT00976599|9760592|FG000|STARTED|Overall Study||15
8713868|NCT00976599|9760593|FG001|STARTED|Overall Study||14
8713869|NCT00976599|9760592|FG000|COMPLETED|Overall Study||15
8713870|NCT00976599|9760593|FG001|COMPLETED|Overall Study||14
8713871|NCT00976599|9760592|FG000|NOT COMPLETED|Overall Study||0
8713872|NCT00976599|9760593|FG001|NOT COMPLETED|Overall Study||0
8713873|NCT00976664|9760601|FG000|STARTED|Overall Study||25
8713874|NCT00976664|9760602|FG001|STARTED|Overall Study||25
8713875|NCT00976664|9760601|FG000|COMPLETED|Overall Study||22
8713876|NCT00976664|9760602|FG001|COMPLETED|Overall Study||24
8713877|NCT00976664|9760601|FG000|NOT COMPLETED|Overall Study||3
8713878|NCT00976664|9760602|FG001|NOT COMPLETED|Overall Study||1
8713879|NCT00976677|9760610|FG000|STARTED|Overall Study||5
8713880|NCT00976677|9760611|FG001|STARTED|Overall Study||5
8713881|NCT00976677|9760610|FG000|COMPLETED|Overall Study||0
8713882|NCT00976677|9760611|FG001|COMPLETED|Overall Study||0
8713883|NCT00976677|9760610|FG000|NOT COMPLETED|Overall Study||5
8713884|NCT00976677|9760611|FG001|NOT COMPLETED|Overall Study||5
8713885|NCT00976703|9760619|FG000|STARTED|Overall Study||99
8713886|NCT00976703|9760620|FG001|STARTED|Overall Study||98
8713887|NCT00976703|9760619|FG000|COMPLETED|Overall Study||96
8713888|NCT00976703|9760620|FG001|COMPLETED|Overall Study||95
8713889|NCT00976703|9760619|FG000|NOT COMPLETED|Overall Study||3
8713890|NCT00976703|9760620|FG001|NOT COMPLETED|Overall Study||3
8713891|NCT00976716|9760626|FG000|STARTED|Overall Study||80
8713892|NCT00976716|9760626|FG000|COMPLETED|Overall Study||79
8713893|NCT00976716|9760626|FG000|NOT COMPLETED|Overall Study||1
8713894|NCT00976820|9760635|FG000|STARTED|Overall Study||67
8713895|NCT00976820|9760636|FG001|STARTED|Overall Study||128
8713896|NCT00976820|9760637|FG002|STARTED|Overall Study||64
8713897|NCT00976820|9760638|FG003|STARTED|Overall Study||63
8713898|NCT00976820|9760635|FG000|COMPLETED|Overall Study||59
8713899|NCT00976820|9760636|FG001|COMPLETED|Overall Study||108
8713900|NCT00976820|9760637|FG002|COMPLETED|Overall Study||60
8601068|NCT00365716|9637202|FG002|COMPLETED|Base Study (Day 1 to Month 7)||271
8601069|NCT00365716|9637203|FG003|COMPLETED|Base Study (Day 1 to Month 7)||136
8601070|NCT00365716|9637204|FG004|COMPLETED|Base Study (Day 1 to Month 7)||139
8601071|NCT00365716|9637205|FG005|COMPLETED|Base Study (Day 1 to Month 7)||0
8601072|NCT00365716|9637206|FG006|COMPLETED|Base Study (Day 1 to Month 7)||0
8601073|NCT00365716|9637200|FG000|NOT COMPLETED|Base Study (Day 1 to Month 7)||21
8713901|NCT00976820|9760638|FG003|COMPLETED|Overall Study||56
8713902|NCT00976820|9760635|FG000|NOT COMPLETED|Overall Study||8
8713903|NCT00976820|9760636|FG001|NOT COMPLETED|Overall Study||20
8713904|NCT00976820|9760637|FG002|NOT COMPLETED|Overall Study||4
8713905|NCT00976820|9760638|FG003|NOT COMPLETED|Overall Study||7
8713906|NCT00976898|9760689|FG000|STARTED|Overall Study||83
8601074|NCT00365716|9637201|FG001|NOT COMPLETED|Base Study (Day 1 to Month 7)||24
8601075|NCT00365716|9637202|FG002|NOT COMPLETED|Base Study (Day 1 to Month 7)||21
8601076|NCT00365716|9637203|FG003|NOT COMPLETED|Base Study (Day 1 to Month 7)||10
8601077|NCT00365716|9637204|FG004|NOT COMPLETED|Base Study (Day 1 to Month 7)||7
8601078|NCT00365716|9637205|FG005|NOT COMPLETED|Base Study (Day 1 to Month 7)||0
8601079|NCT00365716|9637206|FG006|NOT COMPLETED|Base Study (Day 1 to Month 7)||0
8601080|NCT00365716|9637200|FG000|STARTED|Long Term Follow-up (Month 7 toMonth 36)||269
8601081|NCT00365716|9637201|FG001|STARTED|Long Term Follow-up (Month 7 toMonth 36)||260
8601082|NCT00365716|9637202|FG002|STARTED|Long Term Follow-up (Month 7 toMonth 36)||271
8601083|NCT00365716|9637203|FG003|STARTED|Long Term Follow-up (Month 7 toMonth 36)||136
8601084|NCT00365716|9637204|FG004|STARTED|Long Term Follow-up (Month 7 toMonth 36)||139
8601085|NCT00365716|9637205|FG005|STARTED|Long Term Follow-up (Month 7 toMonth 36)||0
8713907|NCT00976898|9760689|FG000|COMPLETED|Overall Study||78
8713908|NCT00976898|9760689|FG000|NOT COMPLETED|Overall Study||5
8713909|NCT00976911|9760695|FG000|STARTED|Overall Study||182
8713910|NCT00976911|9760696|FG001|STARTED|Overall Study||179
8713911|NCT00976911|9760695|FG000|COMPLETED|Overall Study|At time of clinical cutoff for overall survival and safety (25 January 2013)|0
8713912|NCT00976911|9760696|FG001|COMPLETED|Overall Study|At time of clinical cutoff for overall survival and safety (25 January 2013)|0
8713913|NCT00976911|9760695|FG000|NOT COMPLETED|Overall Study||182
8713914|NCT00976911|9760696|FG001|NOT COMPLETED|Overall Study||179
8713915|NCT00976937|9760704|FG000|STARTED|Overall Study|Randomized|158
8713916|NCT00976937|9760705|FG001|STARTED|Overall Study||161
8713917|NCT00976937|9760704|FG000|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|158
8713918|NCT00976937|9760705|FG001|Treated/Safety Population|Overall Study||161
8713919|NCT00976937|9760704|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All randomized patients who received at least 1 dose of study drug.|158
8713920|NCT00976937|9760705|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||161
8713921|NCT00976937|9760704|FG000|COMPLETED|Overall Study||142
8713922|NCT00976937|9760705|FG001|COMPLETED|Overall Study||150
8713923|NCT00976937|9760704|FG000|NOT COMPLETED|Overall Study||16
8713924|NCT00976937|9760705|FG001|NOT COMPLETED|Overall Study||11
8713925|NCT00976950|9760711|FG000|STARTED|Overall Study||42
8713926|NCT00976950|9760711|FG000|COMPLETED|Overall Study||36
8713927|NCT00976950|9760711|FG000|NOT COMPLETED|Overall Study||6
8713928|NCT00976989|9760718|FG000|STARTED|Overall Study||73
8713929|NCT00976989|9760719|FG001|STARTED|Overall Study||75
8713930|NCT00976989|9760720|FG002|STARTED|Overall Study||77
8713931|NCT00976989|9760718|FG000|COMPLETED|Overall Study||60
8713932|NCT00976989|9760719|FG001|COMPLETED|Overall Study||63
8713933|NCT00976989|9760720|FG002|COMPLETED|Overall Study||60
8713934|NCT00976989|9760718|FG000|NOT COMPLETED|Overall Study||13
8713935|NCT00976989|9760719|FG001|NOT COMPLETED|Overall Study||12
8713936|NCT00976989|9760720|FG002|NOT COMPLETED|Overall Study||17
8713937|NCT00977080|9760732|FG000|STARTED|Overall Study||62
8713938|NCT00977080|9760733|FG001|STARTED|Overall Study||64
8713939|NCT00977080|9760734|FG002|STARTED|Overall Study||72
8713940|NCT00977080|9760735|FG003|STARTED|Overall Study||70
8713941|NCT00977080|9760732|FG000|COMPLETED|Overall Study||50
8713942|NCT00977080|9760733|FG001|COMPLETED|Overall Study||44
8713943|NCT00977080|9760734|FG002|COMPLETED|Overall Study||56
8713944|NCT00977080|9760735|FG003|COMPLETED|Overall Study||53
8713945|NCT00977080|9760732|FG000|NOT COMPLETED|Overall Study||12
8713946|NCT00977080|9760733|FG001|NOT COMPLETED|Overall Study||20
8713947|NCT00977080|9760734|FG002|NOT COMPLETED|Overall Study||16
8713948|NCT00977080|9760735|FG003|NOT COMPLETED|Overall Study||17
8713949|NCT00977106|9760747|FG000|STARTED|Overall Study||47
8713950|NCT00977106|9760748|FG001|STARTED|Overall Study|Includes 3 participants who were randomized to placebo, but received tocilizumab.|56
8713951|NCT00977106|9760747|FG000|COMPLETED|Overall Study||37
8713952|NCT00977106|9760748|FG001|COMPLETED|Overall Study||45
8713953|NCT00977106|9760747|FG000|NOT COMPLETED|Overall Study||10
8713954|NCT00977106|9760748|FG001|NOT COMPLETED|Overall Study||11
8713955|NCT00977171|9760756|FG000|STARTED|Overall Study||3
8713956|NCT00977171|9760756|FG000|COMPLETED|Overall Study||3
8713957|NCT00977171|9760756|FG000|NOT COMPLETED|Overall Study||0
8713958|NCT00977184|9760762|FG000|STARTED|Overall Study||13
8713959|NCT00977184|9760763|FG001|STARTED|Overall Study||13
8713960|NCT00977184|9760762|FG000|COMPLETED|Overall Study||13
8713961|NCT00977184|9760763|FG001|COMPLETED|Overall Study||13
8713962|NCT00977184|9760762|FG000|NOT COMPLETED|Overall Study||0
8713963|NCT00977184|9760763|FG001|NOT COMPLETED|Overall Study||0
8713964|NCT00977197|9760778|FG000|STARTED|Overall Study||41
8713965|NCT00977197|9760779|FG001|STARTED|Overall Study||44
8713966|NCT00977197|9760778|FG000|COMPLETED|Overall Study||32
8713967|NCT00977197|9760779|FG001|COMPLETED|Overall Study||35
8713968|NCT00977197|9760778|FG000|NOT COMPLETED|Overall Study||9
8601086|NCT00365716|9637206|FG006|STARTED|Long Term Follow-up (Month 7 toMonth 36)||0
8713969|NCT00977197|9760779|FG001|NOT COMPLETED|Overall Study||9
8713970|NCT00977314|9760787|FG000|STARTED|Overall Study||30
8713971|NCT00977314|9760788|FG001|STARTED|Overall Study|First 5 subjects enrolled were pilot subjects and not included in analysis.|5
8713972|NCT00977314|9760787|FG000|COMPLETED|Overall Study||28
8713973|NCT00977314|9760788|FG001|COMPLETED|Overall Study|First 5 subjects enrolled were pilot subjects and not included in analysis.|5
8713974|NCT00977314|9760787|FG000|NOT COMPLETED|Overall Study||2
8713975|NCT00977314|9760788|FG001|NOT COMPLETED|Overall Study||0
8601087|NCT00365716|9637200|FG000|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||137
8601088|NCT00365716|9637201|FG001|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||245
8601089|NCT00365716|9637202|FG002|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||251
8601090|NCT00365716|9637203|FG003|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||57
8601091|NCT00365716|9637204|FG004|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||57
8713976|NCT00977379|9760796|FG000|STARTED|Overall Study|Randomized|12
8713977|NCT00977379|9760797|FG001|STARTED|Overall Study|Randomized|12
8713978|NCT00977379|9760796|FG000|Treated|Overall Study||12
8713979|NCT00977379|9760797|FG001|Treated|Overall Study||11
8713980|NCT00977379|9760796|FG000|COMPLETED|Overall Study||0
8713981|NCT00977379|9760797|FG001|COMPLETED|Overall Study||0
8713982|NCT00977379|9760796|FG000|NOT COMPLETED|Overall Study||12
8713983|NCT00977379|9760797|FG001|NOT COMPLETED|Overall Study||12
8713984|NCT00977431|9760808|FG000|STARTED|Overall Study||7
8713985|NCT00977431|9760809|FG001|STARTED|Overall Study||6
8713986|NCT00977431|9760810|FG002|STARTED|Overall Study||7
8713987|NCT00977431|9760811|FG003|STARTED|Overall Study||3
8713988|NCT00977431|9760812|FG004|STARTED|Overall Study||13
8713989|NCT00977431|9760808|FG000|Discontinued Afatinib Before/on Day 42|Overall Study||1
8713990|NCT00977431|9760809|FG001|Discontinued Afatinib Before/on Day 42|Overall Study||0
8713991|NCT00977431|9760810|FG002|Discontinued Afatinib Before/on Day 42|Overall Study||4
8713992|NCT00977431|9760811|FG003|Discontinued Afatinib Before/on Day 42|Overall Study||0
8713993|NCT00977431|9760812|FG004|Discontinued Afatinib Before/on Day 42|Overall Study||3
8713994|NCT00977431|9760808|FG000|COMPLETED|Overall Study||0
8713995|NCT00977431|9760809|FG001|COMPLETED|Overall Study||0
8713996|NCT00977431|9760810|FG002|COMPLETED|Overall Study||0
8713997|NCT00977431|9760811|FG003|COMPLETED|Overall Study||0
8713998|NCT00977431|9760812|FG004|COMPLETED|Overall Study||0
8713999|NCT00977431|9760808|FG000|NOT COMPLETED|Overall Study||7
8714000|NCT00977431|9760809|FG001|NOT COMPLETED|Overall Study||6
8714001|NCT00977431|9760810|FG002|NOT COMPLETED|Overall Study||7
8714002|NCT00977431|9760811|FG003|NOT COMPLETED|Overall Study||3
8714003|NCT00977431|9760812|FG004|NOT COMPLETED|Overall Study||13
8714004|NCT00977470|9760830|FG000|STARTED|Overall Study||38
8714005|NCT00977470|9760831|FG001|STARTED|Overall Study||38
8714006|NCT00977470|9760830|FG000|COMPLETED|Overall Study||0
8714007|NCT00977470|9760831|FG001|COMPLETED|Overall Study||0
8714008|NCT00977470|9760830|FG000|NOT COMPLETED|Overall Study||38
8714009|NCT00977470|9760831|FG001|NOT COMPLETED|Overall Study||38
8714010|NCT00977548|9760837|FG000|STARTED|Overall Study||39
8714011|NCT00977548|9760837|FG000|COMPLETED|Overall Study||26
8714012|NCT00977548|9760837|FG000|NOT COMPLETED|Overall Study||13
8714013|NCT00977561|9760843|FG000|STARTED|Overall Study||5
8714014|NCT00977561|9760844|FG001|STARTED|Overall Study||4
8714015|NCT00977561|9760843|FG000|COMPLETED|Overall Study||0
8714016|NCT00977561|9760844|FG001|COMPLETED|Overall Study||0
8714017|NCT00977561|9760843|FG000|NOT COMPLETED|Overall Study||5
8714018|NCT00977561|9760844|FG001|NOT COMPLETED|Overall Study||4
8714019|NCT00977613|9760852|FG000|STARTED|Overall Study||50
8714020|NCT00977613|9760852|FG000|COMPLETED|Overall Study||34
8714021|NCT00977613|9760852|FG000|NOT COMPLETED|Overall Study||16
8714022|NCT00977665|9760858|FG000|STARTED|Overall Study||84
8928240|NCT02279407|9989389|FG003|NOT COMPLETED|Overall Study||1
8928241|NCT02279420|9989399|FG000|STARTED|Overall Study||73
8928242|NCT02279420|9989399|FG000|COMPLETED|Overall Study||50
8928243|NCT02279420|9989399|FG000|NOT COMPLETED|Overall Study||23
8928244|NCT02279498|9989405|FG000|STARTED|Overall Study||65
8928245|NCT02279498|9989406|FG001|STARTED|Overall Study||63
8928246|NCT02279498|9989405|FG000|COMPLETED|Overall Study||47
8714023|NCT00977665|9760859|FG001|STARTED|Overall Study||90
8714024|NCT00977665|9760858|FG000|COMPLETED|Overall Study||63
8714025|NCT00977665|9760859|FG001|COMPLETED|Overall Study||75
8714026|NCT00977665|9760858|FG000|NOT COMPLETED|Overall Study||21
8714027|NCT00977665|9760859|FG001|NOT COMPLETED|Overall Study||15
8714028|NCT00977704|9760865|FG000|STARTED|Overall Study||20
8714029|NCT00977704|9760865|FG000|COMPLETED|Overall Study||20
8714030|NCT00977704|9760865|FG000|NOT COMPLETED|Overall Study||0
8714031|NCT00977769|9760872|FG000|STARTED|Overall Study||25
8714032|NCT00977769|9760873|FG001|STARTED|Overall Study||26
8928247|NCT02279498|9989406|FG001|COMPLETED|Overall Study||59
8928248|NCT02279498|9989405|FG000|NOT COMPLETED|Overall Study||18
8601092|NCT00365716|9637205|FG005|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
8601093|NCT00365716|9637206|FG006|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
8601094|NCT00365716|9637200|FG000|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||132
8601095|NCT00365716|9637201|FG001|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||15
8601096|NCT00365716|9637202|FG002|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||20
8601097|NCT00365716|9637203|FG003|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||79
8601098|NCT00365716|9637204|FG004|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||82
8601099|NCT00365716|9637205|FG005|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
8601100|NCT00365716|9637206|FG006|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
8601101|NCT00365716|9637200|FG000|STARTED|Extension 1||0
8601102|NCT00365716|9637201|FG001|STARTED|Extension 1||0
8601103|NCT00365716|9637202|FG002|STARTED|Extension 1||0
8601104|NCT00365716|9637203|FG003|STARTED|Extension 1||0
8601105|NCT00365716|9637204|FG004|STARTED|Extension 1||0
8601106|NCT00365716|9637205|FG005|STARTED|Extension 1||241
8601107|NCT00365716|9637206|FG006|STARTED|Extension 1||0
8601108|NCT00365716|9637200|FG000|COMPLETED|Extension 1||0
8601109|NCT00365716|9637201|FG001|COMPLETED|Extension 1||0
8601110|NCT00365716|9637202|FG002|COMPLETED|Extension 1||0
8601111|NCT00365716|9637203|FG003|COMPLETED|Extension 1||0
8601112|NCT00365716|9637204|FG004|COMPLETED|Extension 1||0
8601113|NCT00365716|9637205|FG005|COMPLETED|Extension 1||219
8601114|NCT00365716|9637206|FG006|COMPLETED|Extension 1||0
8601115|NCT00365716|9637200|FG000|NOT COMPLETED|Extension 1||0
8601116|NCT00365716|9637201|FG001|NOT COMPLETED|Extension 1||0
8601117|NCT00365716|9637202|FG002|NOT COMPLETED|Extension 1||0
8601118|NCT00365716|9637203|FG003|NOT COMPLETED|Extension 1||0
8601119|NCT00365716|9637204|FG004|NOT COMPLETED|Extension 1||0
8601120|NCT00365716|9637205|FG005|NOT COMPLETED|Extension 1||22
8601121|NCT00365716|9637206|FG006|NOT COMPLETED|Extension 1||0
8601122|NCT00365716|9637200|FG000|STARTED|Extension 2||0
8601123|NCT00365716|9637201|FG001|STARTED|Extension 2||0
8601124|NCT00365716|9637202|FG002|STARTED|Extension 2||0
8601125|NCT00365716|9637203|FG003|STARTED|Extension 2||0
8601126|NCT00365716|9637204|FG004|STARTED|Extension 2||0
8601127|NCT00365716|9637205|FG005|STARTED|Extension 2||0
8601128|NCT00365716|9637206|FG006|STARTED|Extension 2|17 Participants continued into Extension 2 from Extension 1|17
8601129|NCT00365716|9637200|FG000|COMPLETED|Extension 2||0
8601130|NCT00365716|9637201|FG001|COMPLETED|Extension 2||0
8601131|NCT00365716|9637202|FG002|COMPLETED|Extension 2||0
8601132|NCT00365716|9637203|FG003|COMPLETED|Extension 2||0
8601133|NCT00365716|9637204|FG004|COMPLETED|Extension 2||0
8601134|NCT00365716|9637205|FG005|COMPLETED|Extension 2||0
8601135|NCT00365716|9637206|FG006|COMPLETED|Extension 2||7
8601136|NCT00365716|9637200|FG000|NOT COMPLETED|Extension 2||0
8601137|NCT00365716|9637201|FG001|NOT COMPLETED|Extension 2||0
8601138|NCT00365716|9637202|FG002|NOT COMPLETED|Extension 2||0
8601139|NCT00365716|9637203|FG003|NOT COMPLETED|Extension 2||0
8601140|NCT00365716|9637204|FG004|NOT COMPLETED|Extension 2||0
8601141|NCT00365716|9637205|FG005|NOT COMPLETED|Extension 2||0
8601142|NCT00365716|9637206|FG006|NOT COMPLETED|Extension 2||10
8601143|NCT00365768|9637222|FG000|STARTED|Overall Study||24
8601144|NCT00365768|9637223|FG001|STARTED|Overall Study||25
8601145|NCT00365768|9637222|FG000|COMPLETED|Overall Study||24
8714033|NCT00977769|9760874|FG002|STARTED|Overall Study||25
8714034|NCT00977769|9760872|FG000|COMPLETED|Overall Study||25
8714035|NCT00977769|9760873|FG001|COMPLETED|Overall Study||26
8714036|NCT00977769|9760874|FG002|COMPLETED|Overall Study||25
8714037|NCT00977769|9760872|FG000|NOT COMPLETED|Overall Study||0
8714038|NCT00977769|9760873|FG001|NOT COMPLETED|Overall Study||0
8714039|NCT00977769|9760874|FG002|NOT COMPLETED|Overall Study||0
8714040|NCT00977808|9760882|FG000|STARTED|Overall Study||12
8714041|NCT00977808|9760882|FG000|Completion of Open-Loop Admission|Overall Study||12
8714042|NCT00977808|9760882|FG000|Completion of Closed-Loop Admission|Overall Study||11
8714043|NCT00977808|9760882|FG000|COMPLETED|Overall Study||11
8714044|NCT00977808|9760882|FG000|NOT COMPLETED|Overall Study||1
8714045|NCT00977938|9760891|FG000|STARTED|Treatment (12-30 mo. Post Procedure)||5020
8714046|NCT00977938|9760892|FG001|STARTED|Treatment (12-30 mo. Post Procedure)||4941
8714047|NCT00977938|9760893|FG002|STARTED|Treatment (12-30 mo. Post Procedure)||842
8714048|NCT00977938|9760894|FG003|STARTED|Treatment (12-30 mo. Post Procedure)||845
8714049|NCT00977938|9760891|FG000|COMPLETED|Treatment (12-30 mo. Post Procedure)||4783
8714050|NCT00977938|9760892|FG001|COMPLETED|Treatment (12-30 mo. Post Procedure)||4716
8714051|NCT00977938|9760893|FG002|COMPLETED|Treatment (12-30 mo. Post Procedure)||796
8714052|NCT00977938|9760894|FG003|COMPLETED|Treatment (12-30 mo. Post Procedure)||784
8714053|NCT00977938|9760891|FG000|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||237
8714054|NCT00977938|9760892|FG001|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||225
8714055|NCT00977938|9760893|FG002|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||46
8714056|NCT00977938|9760894|FG003|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||61
8714057|NCT00977938|9760891|FG000|STARTED|Observation (30-33 mo. Post Procedure)||4783
8714058|NCT00977938|9760892|FG001|STARTED|Observation (30-33 mo. Post Procedure)||4716
8714059|NCT00977938|9760893|FG002|STARTED|Observation (30-33 mo. Post Procedure)||796
8601146|NCT00365768|9637223|FG001|COMPLETED|Overall Study||25
8601147|NCT00365768|9637222|FG000|NOT COMPLETED|Overall Study||0
8601148|NCT00365768|9637223|FG001|NOT COMPLETED|Overall Study||0
8601149|NCT00365794|9637229|FG000|STARTED|Overall Study|22 subjects were enrolled since only 20 completed all post treatment measures.|22
8601150|NCT00365794|9637229|FG000|COMPLETED|Overall Study||20
8601151|NCT00365794|9637229|FG000|NOT COMPLETED|Overall Study||2
8601152|NCT00365846|9637234|FG000|STARTED|Overall Study||29
8601153|NCT00365846|9637234|FG000|COMPLETED|Overall Study||28
8601154|NCT00365846|9637234|FG000|NOT COMPLETED|Overall Study||1
8601155|NCT00365859|9637243|FG000|STARTED|Overall Study||86
8601156|NCT00365859|9637244|FG001|STARTED|Overall Study||70
8601157|NCT00365859|9637245|FG002|STARTED|Overall Study||174
8601158|NCT00365859|9637246|FG003|STARTED|Overall Study||330
8714060|NCT00977938|9760894|FG003|STARTED|Observation (30-33 mo. Post Procedure)||784
8714061|NCT00977938|9760891|FG000|COMPLETED|Observation (30-33 mo. Post Procedure)||4732
8714062|NCT00977938|9760892|FG001|COMPLETED|Observation (30-33 mo. Post Procedure)||4658
8714063|NCT00977938|9760893|FG002|COMPLETED|Observation (30-33 mo. Post Procedure)||784
8601159|NCT00365859|9637243|FG000|Safety Population|Overall Study||86
8601160|NCT00365859|9637244|FG001|Safety Population|Overall Study||70
8601161|NCT00365859|9637245|FG002|Safety Population|Overall Study||174
8601162|NCT00365859|9637246|FG003|Safety Population|Overall Study||330
8714064|NCT00977938|9760894|FG003|COMPLETED|Observation (30-33 mo. Post Procedure)||781
8714065|NCT00977938|9760891|FG000|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||51
8714066|NCT00977938|9760892|FG001|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||58
8714067|NCT00977938|9760893|FG002|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||12
8714068|NCT00977938|9760894|FG003|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||3
8714069|NCT00978029|9760909|FG000|STARTED|Overall Study||65
8714070|NCT00978029|9760910|FG001|STARTED|Overall Study||66
8714071|NCT00978029|9760911|FG002|STARTED|Overall Study||65
8714072|NCT00978029|9760909|FG000|COMPLETED|Overall Study||64
8714073|NCT00978029|9760910|FG001|COMPLETED|Overall Study||63
8714074|NCT00978029|9760911|FG002|COMPLETED|Overall Study||59
8714075|NCT00978029|9760909|FG000|NOT COMPLETED|Overall Study||1
8714076|NCT00978029|9760910|FG001|NOT COMPLETED|Overall Study||3
8714077|NCT00978029|9760911|FG002|NOT COMPLETED|Overall Study||6
8714078|NCT00978042|9760921|FG000|STARTED|Initial Treatment Period||235
8714079|NCT00978042|9760922|FG001|STARTED|Initial Treatment Period||47
8714080|NCT00978042|9760921|FG000|MITT_treated With VOLUMA XC|Initial Treatment Period||235
8714081|NCT00978042|9760922|FG001|MITT_treated With VOLUMA XC|Initial Treatment Period||35
8714082|NCT00978042|9760921|FG000|COMPLETED|Initial Treatment Period|Completed 24-month Follow-Up|174
8714083|NCT00978042|9760922|FG001|COMPLETED|Initial Treatment Period||32
8714084|NCT00978042|9760921|FG000|NOT COMPLETED|Initial Treatment Period||61
8714085|NCT00978042|9760922|FG001|NOT COMPLETED|Initial Treatment Period||15
8714086|NCT00978042|9760921|FG000|STARTED|Received Repeat Treatment|Participants who were deemed eligible for re-treatment.|141
8714087|NCT00978042|9760922|FG001|STARTED|Received Repeat Treatment|Participants who were deemed eligible for re-treatment.|26
8714088|NCT00978042|9760921|FG000|COMPLETED|Received Repeat Treatment|Completed=Completed Repeat Treatment Follow-up|98
8714089|NCT00978042|9760922|FG001|COMPLETED|Received Repeat Treatment||23
8714090|NCT00978042|9760921|FG000|NOT COMPLETED|Received Repeat Treatment||43
8714091|NCT00978042|9760922|FG001|NOT COMPLETED|Received Repeat Treatment||3
8714092|NCT00978068|9760930|FG000|STARTED|Overall Study||87
8714093|NCT00978068|9760931|FG001|STARTED|Overall Study||89
8714094|NCT00978068|9760930|FG000|Initiated Study Drugs|Overall Study||84
8714095|NCT00978068|9760931|FG001|Initiated Study Drugs|Overall Study||86
8714096|NCT00978068|9760930|FG000|COMPLETED|Overall Study||83
8714097|NCT00978068|9760931|FG001|COMPLETED|Overall Study||80
8714098|NCT00978068|9760930|FG000|NOT COMPLETED|Overall Study||4
8714099|NCT00978068|9760931|FG001|NOT COMPLETED|Overall Study||9
8714100|NCT00978120|9760945|FG000|STARTED|Overall Study||110
8714101|NCT00978120|9760946|FG001|STARTED|Overall Study||107
8714102|NCT00978120|9760947|FG002|STARTED|Overall Study||87
8714103|NCT00978120|9760948|FG003|STARTED|Overall Study||86
8714104|NCT00978120|9760945|FG000|COMPLETED|Overall Study||108
8714105|NCT00978120|9760946|FG001|COMPLETED|Overall Study||107
8714106|NCT00978120|9760947|FG002|COMPLETED|Overall Study||84
8714107|NCT00978120|9760948|FG003|COMPLETED|Overall Study||84
8714108|NCT00978120|9760945|FG000|NOT COMPLETED|Overall Study||2
8714109|NCT00978120|9760946|FG001|NOT COMPLETED|Overall Study||0
8714110|NCT00978120|9760947|FG002|NOT COMPLETED|Overall Study||3
8714111|NCT00978120|9760948|FG003|NOT COMPLETED|Overall Study||2
8714112|NCT00978250|9760966|FG000|STARTED|Overall Study||25
8714113|NCT00978250|9760967|FG001|STARTED|Overall Study||30
8714114|NCT00978250|9760968|FG002|STARTED|Overall Study||18
8714115|NCT00978250|9760969|FG003|STARTED|Overall Study||22
8714116|NCT00978250|9760966|FG000|COMPLETED|Overall Study||25
8714117|NCT00978250|9760967|FG001|COMPLETED|Overall Study||29
8714118|NCT00978250|9760968|FG002|COMPLETED|Overall Study||18
8714119|NCT00978250|9760969|FG003|COMPLETED|Overall Study||21
8714120|NCT00978250|9760966|FG000|NOT COMPLETED|Overall Study||0
8714121|NCT00978250|9760967|FG001|NOT COMPLETED|Overall Study||1
8714122|NCT00978250|9760968|FG002|NOT COMPLETED|Overall Study||0
8714123|NCT00978250|9760969|FG003|NOT COMPLETED|Overall Study||1
8714124|NCT00978341|9760981|FG000|STARTED|First Intervention||8
8714125|NCT00978341|9760982|FG001|STARTED|First Intervention||7
8714126|NCT00978341|9760981|FG000|COMPLETED|First Intervention||8
8714127|NCT00978341|9760982|FG001|COMPLETED|First Intervention||7
8714128|NCT00978341|9760981|FG000|NOT COMPLETED|First Intervention||0
8714129|NCT00978341|9760982|FG001|NOT COMPLETED|First Intervention||0
8714130|NCT00978341|9760981|FG000|STARTED|Washout Period of 2 Weeks||8
8714131|NCT00978341|9760982|FG001|STARTED|Washout Period of 2 Weeks||7
8714132|NCT00978341|9760981|FG000|COMPLETED|Washout Period of 2 Weeks||7
8714133|NCT00978341|9760982|FG001|COMPLETED|Washout Period of 2 Weeks||7
8714134|NCT00978341|9760981|FG000|NOT COMPLETED|Washout Period of 2 Weeks||1
8714135|NCT00978341|9760982|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
8714136|NCT00978341|9760981|FG000|STARTED|Second Intervention||7
8714137|NCT00978341|9760982|FG001|STARTED|Second Intervention||7
8714138|NCT00978341|9760981|FG000|COMPLETED|Second Intervention||7
8714139|NCT00978341|9760982|FG001|COMPLETED|Second Intervention||7
8714140|NCT00978341|9760981|FG000|NOT COMPLETED|Second Intervention||0
8714141|NCT00978341|9760982|FG001|NOT COMPLETED|Second Intervention||0
8714142|NCT00978380|9760989|FG000|STARTED|Overall Study||63
8714143|NCT00978380|9760989|FG000|COMPLETED|Overall Study||44
8714144|NCT00978380|9760989|FG000|NOT COMPLETED|Overall Study||19
8714145|NCT00978432|9760997|FG000|STARTED|Overall Study||10
8714146|NCT00978432|9760998|FG001|STARTED|Overall Study||5
8714147|NCT00978432|9760999|FG002|STARTED|Overall Study||18
8714148|NCT00978432|9760997|FG000|COMPLETED|Overall Study||7
8714149|NCT00978432|9760998|FG001|COMPLETED|Overall Study||4
8601163|NCT00365859|9637243|FG000|Efficacy Population|Overall Study|1 patient was lost to follow-up and 1 not included due to moderate sedation (total=2)|84
8601164|NCT00365859|9637244|FG001|Efficacy Population|Overall Study|1 not included due to increased alanine aminotransferase (ALT) prior to treatment with aripiprazole|69
8601165|NCT00365859|9637245|FG002|Efficacy Population|Overall Study|3 lost to follow-up, 1 not included due to mild increased appetite, 1 to family emergency (total=5)|169
8601166|NCT00365859|9637246|FG003|Efficacy Population|Overall Study||322
8601167|NCT00365859|9637243|FG000|COMPLETED|Overall Study||55
8601168|NCT00365859|9637244|FG001|COMPLETED|Overall Study||37
8601169|NCT00365859|9637245|FG002|COMPLETED|Overall Study||107
8601170|NCT00365859|9637246|FG003|COMPLETED|Overall Study||199
8601171|NCT00365859|9637243|FG000|NOT COMPLETED|Overall Study||31
8601172|NCT00365859|9637244|FG001|NOT COMPLETED|Overall Study||33
8601173|NCT00365859|9637245|FG002|NOT COMPLETED|Overall Study||67
8601174|NCT00365859|9637246|FG003|NOT COMPLETED|Overall Study||131
8601175|NCT00365872|9637258|FG000|STARTED|Overall Study||5
8601176|NCT00365872|9637259|FG001|STARTED|Overall Study||6
8601177|NCT00365872|9637260|FG002|STARTED|Overall Study||6
8601178|NCT00365872|9637258|FG000|COMPLETED|Overall Study||5
8601179|NCT00365872|9637259|FG001|COMPLETED|Overall Study||6
8601180|NCT00365872|9637260|FG002|COMPLETED|Overall Study||6
8601181|NCT00365872|9637258|FG000|NOT COMPLETED|Overall Study||0
8601182|NCT00365872|9637259|FG001|NOT COMPLETED|Overall Study||0
8601183|NCT00365872|9637260|FG002|NOT COMPLETED|Overall Study||0
8601184|NCT00365976|9637269|FG000|STARTED|Overall Study||33
8601185|NCT00365976|9637270|FG001|STARTED|Overall Study||25
8601186|NCT00365976|9637269|FG000|COMPLETED|Overall Study||32
8601187|NCT00365976|9637270|FG001|COMPLETED|Overall Study||20
8601188|NCT00365976|9637269|FG000|NOT COMPLETED|Overall Study||1
8714150|NCT00978432|9760999|FG002|COMPLETED|Overall Study||13
8714151|NCT00978432|9760997|FG000|NOT COMPLETED|Overall Study||3
8714152|NCT00978432|9760998|FG001|NOT COMPLETED|Overall Study||1
8714153|NCT00978432|9760999|FG002|NOT COMPLETED|Overall Study||5
8714154|NCT00978445|9761007|FG000|STARTED|Overall Study||12
8714155|NCT00978445|9761008|FG001|STARTED|Overall Study||13
8714156|NCT00978445|9761007|FG000|COMPLETED|Overall Study||10
8714157|NCT00978445|9761008|FG001|COMPLETED|Overall Study||12
8714158|NCT00978445|9761007|FG000|NOT COMPLETED|Overall Study||2
8714159|NCT00978445|9761008|FG001|NOT COMPLETED|Overall Study||1
8714160|NCT00978562|9761015|FG000|STARTED|Overall Study||7
8714161|NCT00978562|9761015|FG000|COMPLETED|Overall Study||7
8714162|NCT00978562|9761015|FG000|NOT COMPLETED|Overall Study||0
8714163|NCT00978627|9761022|FG000|STARTED|Main: Week 0 to 26 (NN5401-3594)||366
8714164|NCT00978627|9761023|FG001|STARTED|Main: Week 0 to 26 (NN5401-3594)||182
8714165|NCT00978627|9761022|FG000|Exposed|Main: Week 0 to 26 (NN5401-3594)|Four subjects withdrew prior to exposure to trial products|362
8714166|NCT00978627|9761023|FG001|Exposed|Main: Week 0 to 26 (NN5401-3594)|Two subjects withdrew prior to exposure to trial products|180
8714167|NCT00978627|9761022|FG000|COMPLETED|Main: Week 0 to 26 (NN5401-3594)||320
8714168|NCT00978627|9761023|FG001|COMPLETED|Main: Week 0 to 26 (NN5401-3594)||156
8714169|NCT00978627|9761022|FG000|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3594)||46
8714170|NCT00978627|9761023|FG001|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3594)||26
8714171|NCT00978627|9761022|FG000|STARTED|Extension: Week 27 to 52 (NN5401-3645)|Sixty six subjects from main trial did not continue into extension trial|254
8714172|NCT00978627|9761023|FG001|STARTED|Extension: Week 27 to 52 (NN5401-3645)|Thirty four subjects from main trial did not continue into extension trial|122
8714173|NCT00978627|9761022|FG000|COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||233
8714174|NCT00978627|9761023|FG001|COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||113
8714175|NCT00978627|9761022|FG000|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||21
8714176|NCT00978627|9761023|FG001|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||9
8714177|NCT00978731|9761033|FG000|STARTED|Overall Study||22
8714178|NCT00978731|9761034|FG001|STARTED|Overall Study||15
8714179|NCT00978731|9761035|FG002|STARTED|Overall Study||5
8714180|NCT00978731|9761036|FG003|STARTED|Overall Study||4
8714181|NCT00978731|9761033|FG000|COMPLETED|Overall Study||0
8714182|NCT00978731|9761034|FG001|COMPLETED|Overall Study||0
8714183|NCT00978731|9761035|FG002|COMPLETED|Overall Study||0
8714184|NCT00978731|9761036|FG003|COMPLETED|Overall Study||0
8714185|NCT00978731|9761033|FG000|NOT COMPLETED|Overall Study||22
8714186|NCT00978731|9761034|FG001|NOT COMPLETED|Overall Study||15
8714187|NCT00978731|9761035|FG002|NOT COMPLETED|Overall Study||5
8714188|NCT00978731|9761036|FG003|NOT COMPLETED|Overall Study||4
8714189|NCT00978757|9761052|FG000|STARTED|Overall Study|June 2001|22
8714190|NCT00978757|9761053|FG001|STARTED|Overall Study|June 2001|20
8714191|NCT00978757|9761052|FG000|COMPLETED|Overall Study|June 2008|21
8714192|NCT00978757|9761053|FG001|COMPLETED|Overall Study|June 2008|17
8714193|NCT00978757|9761052|FG000|NOT COMPLETED|Overall Study||1
8601189|NCT00365976|9637270|FG001|NOT COMPLETED|Overall Study||5
8601190|NCT00365989|9637276|FG000|STARTED|Overall Study||50
8601191|NCT00365989|9637276|FG000|COMPLETED|Overall Study||48
8601192|NCT00365989|9637276|FG000|NOT COMPLETED|Overall Study||2
8714194|NCT00978757|9761053|FG001|NOT COMPLETED|Overall Study||3
8714195|NCT00979017|9761059|FG000|STARTED|Overall Study||41
8714196|NCT00979017|9761059|FG000|COMPLETED|Overall Study||41
8714197|NCT00979017|9761059|FG000|NOT COMPLETED|Overall Study||0
8601193|NCT00366028|9637283|FG000|STARTED|Overall Study||889
8601194|NCT00366028|9637284|FG001|STARTED|Overall Study||735
8601195|NCT00366028|9637283|FG000|COMPLETED|Overall Study||889
8601196|NCT00366028|9637284|FG001|COMPLETED|Overall Study||735
8601197|NCT00366028|9637283|FG000|NOT COMPLETED|Overall Study||0
8601198|NCT00366028|9637284|FG001|NOT COMPLETED|Overall Study||0
8601199|NCT00366106|9637292|FG000|STARTED|Overall Study||32
8601200|NCT00366106|9637292|FG000|COMPLETED|Overall Study||32
8601201|NCT00366106|9637292|FG000|NOT COMPLETED|Overall Study||0
8601202|NCT00366249|9637298|FG000|STARTED|Overall Study||553
8601203|NCT00366249|9637299|FG001|STARTED|Overall Study||508
8601204|NCT00366249|9637298|FG000|COMPLETED|Overall Study||422
8601205|NCT00366249|9637299|FG001|COMPLETED|Overall Study||430
8601206|NCT00366249|9637298|FG000|NOT COMPLETED|Overall Study||131
8601207|NCT00366249|9637299|FG001|NOT COMPLETED|Overall Study||78
8601208|NCT00366275|9637305|FG000|STARTED|Overall Study||64
8601209|NCT00366275|9637305|FG000|COMPLETED|Overall Study||58
8601210|NCT00366275|9637305|FG000|NOT COMPLETED|Overall Study||6
8601211|NCT00366301|9637313|FG000|STARTED|Overall Study||124
8601212|NCT00366301|9637314|FG001|STARTED|Overall Study||126
8601213|NCT00366301|9637315|FG002|STARTED|Overall Study||126
8601214|NCT00366301|9637316|FG003|STARTED|Overall Study||124
8601215|NCT00366301|9637313|FG000|Either 6W or 14W CRP Obtained|Overall Study||120
8601216|NCT00366301|9637314|FG001|Either 6W or 14W CRP Obtained|Overall Study||124
8601217|NCT00366301|9637315|FG002|Either 6W or 14W CRP Obtained|Overall Study||124
8601218|NCT00366301|9637316|FG003|Either 6W or 14W CRP Obtained|Overall Study||119
8601219|NCT00366301|9637313|FG000|COMPLETED|Overall Study||116
8601220|NCT00366301|9637314|FG001|COMPLETED|Overall Study||120
8601221|NCT00366301|9637315|FG002|COMPLETED|Overall Study||122
8601222|NCT00366301|9637316|FG003|COMPLETED|Overall Study||116
8601223|NCT00366301|9637313|FG000|NOT COMPLETED|Overall Study||8
8601224|NCT00366301|9637314|FG001|NOT COMPLETED|Overall Study||6
8601225|NCT00366301|9637315|FG002|NOT COMPLETED|Overall Study||4
8601226|NCT00366301|9637316|FG003|NOT COMPLETED|Overall Study||8
8601227|NCT00366340|9637328|FG000|STARTED|Infant Series||301
8601228|NCT00366340|9637329|FG001|STARTED|Infant Series||303
8601229|NCT00366340|9637328|FG000|Vaccinated Dose 1|Infant Series||300
8601230|NCT00366340|9637329|FG001|Vaccinated Dose 1|Infant Series||303
8601231|NCT00366340|9637328|FG000|Vaccinated Dose 2|Infant Series||296
8601232|NCT00366340|9637329|FG001|Vaccinated Dose 2|Infant Series||297
8601233|NCT00366340|9637328|FG000|Vaccinated Dose 3|Infant Series||294
8601234|NCT00366340|9637329|FG001|Vaccinated Dose 3|Infant Series||293
8601235|NCT00366340|9637328|FG000|COMPLETED|Infant Series||293
8601236|NCT00366340|9637329|FG001|COMPLETED|Infant Series||293
8601237|NCT00366340|9637328|FG000|NOT COMPLETED|Infant Series||8
8601238|NCT00366340|9637329|FG001|NOT COMPLETED|Infant Series||10
8601239|NCT00366340|9637328|FG000|STARTED|After the Infant Series||293
8601240|NCT00366340|9637329|FG001|STARTED|After the Infant Series||293
8601241|NCT00366340|9637328|FG000|COMPLETED|After the Infant Series||290
8601242|NCT00366340|9637329|FG001|COMPLETED|After the Infant Series||287
8601243|NCT00366340|9637328|FG000|NOT COMPLETED|After the Infant Series||3
8601244|NCT00366340|9637329|FG001|NOT COMPLETED|After the Infant Series||6
8601245|NCT00366340|9637328|FG000|STARTED|Toddler Dose||290
8601246|NCT00366340|9637329|FG001|STARTED|Toddler Dose||287
8601247|NCT00366340|9637328|FG000|COMPLETED|Toddler Dose||289
8601248|NCT00366340|9637329|FG001|COMPLETED|Toddler Dose||286
8601249|NCT00366340|9637328|FG000|NOT COMPLETED|Toddler Dose||1
8601250|NCT00366340|9637329|FG001|NOT COMPLETED|Toddler Dose||1
8601251|NCT00366444|9637361|FG000|STARTED|Overall Study||102
8601252|NCT00366444|9637362|FG001|STARTED|Overall Study||99
8601253|NCT00366444|9637361|FG000|COMPLETED|Overall Study||101
8601254|NCT00366444|9637362|FG001|COMPLETED|Overall Study||97
8601255|NCT00366444|9637361|FG000|NOT COMPLETED|Overall Study||1
8601256|NCT00366444|9637362|FG001|NOT COMPLETED|Overall Study||2
8601257|NCT00366457|9637368|FG000|STARTED|Overall Study||32
8601258|NCT00366457|9637368|FG000|COMPLETED|Overall Study||30
8601259|NCT00366457|9637368|FG000|NOT COMPLETED|Overall Study||2
8601260|NCT00366535|9637374|FG000|STARTED|First Phase: 12 Weeks||27
8601261|NCT00366535|9637375|FG001|STARTED|First Phase: 12 Weeks||29
8601262|NCT00366535|9637374|FG000|COMPLETED|First Phase: 12 Weeks||24
8601263|NCT00366535|9637375|FG001|COMPLETED|First Phase: 12 Weeks||21
8601264|NCT00366535|9637374|FG000|NOT COMPLETED|First Phase: 12 Weeks||3
8601265|NCT00366535|9637375|FG001|NOT COMPLETED|First Phase: 12 Weeks||8
8601266|NCT00366535|9637374|FG000|STARTED|Washout Period (at Least a Week)||24
8601267|NCT00366535|9637375|FG001|STARTED|Washout Period (at Least a Week)||21
8601268|NCT00366535|9637374|FG000|COMPLETED|Washout Period (at Least a Week)||24
8601269|NCT00366535|9637375|FG001|COMPLETED|Washout Period (at Least a Week)||21
8601270|NCT00366535|9637374|FG000|NOT COMPLETED|Washout Period (at Least a Week)||0
8601271|NCT00366535|9637375|FG001|NOT COMPLETED|Washout Period (at Least a Week)||0
8601272|NCT00366535|9637374|FG000|STARTED|Second Phase: 12 Weeks||24
8601273|NCT00366535|9637375|FG001|STARTED|Second Phase: 12 Weeks||21
8601274|NCT00366535|9637374|FG000|COMPLETED|Second Phase: 12 Weeks||21
8601275|NCT00366535|9637375|FG001|COMPLETED|Second Phase: 12 Weeks||18
8601276|NCT00366535|9637374|FG000|NOT COMPLETED|Second Phase: 12 Weeks||3
8601277|NCT00366535|9637375|FG001|NOT COMPLETED|Second Phase: 12 Weeks||3
8601278|NCT00366548|9637391|FG000|STARTED|Infant Series||250
8601279|NCT00366548|9637392|FG001|STARTED|Infant Series||250
8601280|NCT00366548|9637391|FG000|Vaccinated Dose 1|Infant Series||250
8601281|NCT00366548|9637392|FG001|Vaccinated Dose 1|Infant Series||250
8601282|NCT00366548|9637391|FG000|Vaccinated Dose 2|Infant Series||246
8601283|NCT00366548|9637392|FG001|Vaccinated Dose 2|Infant Series||249
8601284|NCT00366548|9637391|FG000|Vaccinated Dose 3|Infant Series||246
8601285|NCT00366548|9637392|FG001|Vaccinated Dose 3|Infant Series||247
8601286|NCT00366548|9637391|FG000|COMPLETED|Infant Series||246
8601287|NCT00366548|9637392|FG001|COMPLETED|Infant Series||245
8601288|NCT00366548|9637391|FG000|NOT COMPLETED|Infant Series||4
8601289|NCT00366548|9637392|FG001|NOT COMPLETED|Infant Series||5
8601290|NCT00366548|9637391|FG000|STARTED|After Infant Series||246
8601291|NCT00366548|9637392|FG001|STARTED|After Infant Series||245
8601292|NCT00366548|9637391|FG000|COMPLETED|After Infant Series||240
8601293|NCT00366548|9637392|FG001|COMPLETED|After Infant Series||244
8601294|NCT00366548|9637391|FG000|NOT COMPLETED|After Infant Series||6
8601295|NCT00366548|9637392|FG001|NOT COMPLETED|After Infant Series||1
8601296|NCT00366548|9637391|FG000|STARTED|Toddler Dose||240
8601297|NCT00366548|9637392|FG001|STARTED|Toddler Dose||244
8601298|NCT00366548|9637391|FG000|COMPLETED|Toddler Dose||240
8601299|NCT00366548|9637392|FG001|COMPLETED|Toddler Dose||244
8601300|NCT00366548|9637391|FG000|NOT COMPLETED|Toddler Dose||0
8601301|NCT00366548|9637392|FG001|NOT COMPLETED|Toddler Dose||0
8601302|NCT00366626|9637418|FG000|STARTED|Overall Study||38
8601303|NCT00366626|9637419|FG001|STARTED|Overall Study||45
8601304|NCT00366626|9637418|FG000|COMPLETED|Overall Study||38
8601305|NCT00366626|9637419|FG001|COMPLETED|Overall Study||45
8601306|NCT00366626|9637418|FG000|NOT COMPLETED|Overall Study||0
8601307|NCT00366626|9637419|FG001|NOT COMPLETED|Overall Study||0
8601308|NCT00366678|9637429|FG000|STARTED|Infant Series||304
8601309|NCT00366678|9637430|FG001|STARTED|Infant Series||309
8601310|NCT00366678|9637431|FG002|STARTED|Infant Series||0
8601311|NCT00366678|9637429|FG000|Vaccinated Dose 1|Infant Series||302
8601312|NCT00366678|9637430|FG001|Vaccinated Dose 1|Infant Series||309
8601313|NCT00366678|9637431|FG002|Vaccinated Dose 1|Infant Series||0
8601314|NCT00366678|9637429|FG000|Vaccinated Dose 2|Infant Series||295
8601315|NCT00366678|9637430|FG001|Vaccinated Dose 2|Infant Series||304
8601316|NCT00366678|9637431|FG002|Vaccinated Dose 2|Infant Series||0
8601317|NCT00366678|9637429|FG000|Vaccinated Dose 3|Infant Series||291
8601318|NCT00366678|9637430|FG001|Vaccinated Dose 3|Infant Series||302
8601319|NCT00366678|9637431|FG002|Vaccinated Dose 3|Infant Series||0
8601320|NCT00366678|9637429|FG000|COMPLETED|Infant Series||290
8601321|NCT00366678|9637430|FG001|COMPLETED|Infant Series||299
8601322|NCT00366678|9637431|FG002|COMPLETED|Infant Series||0
8601323|NCT00366678|9637429|FG000|NOT COMPLETED|Infant Series||14
8601324|NCT00366678|9637430|FG001|NOT COMPLETED|Infant Series||10
8601325|NCT00366678|9637431|FG002|NOT COMPLETED|Infant Series||0
8601326|NCT00366678|9637429|FG000|STARTED|After Infant||290
8601327|NCT00366678|9637430|FG001|STARTED|After Infant||299
8601328|NCT00366678|9637431|FG002|STARTED|After Infant||0
8601329|NCT00366678|9637429|FG000|COMPLETED|After Infant||273
8601330|NCT00366678|9637430|FG001|COMPLETED|After Infant||289
8601331|NCT00366678|9637431|FG002|COMPLETED|After Infant||0
8601332|NCT00366678|9637429|FG000|NOT COMPLETED|After Infant||17
8601333|NCT00366678|9637430|FG001|NOT COMPLETED|After Infant||10
8601334|NCT00366678|9637431|FG002|NOT COMPLETED|After Infant||0
8601335|NCT00366678|9637429|FG000|STARTED|Toddler Dose||273
8601336|NCT00366678|9637430|FG001|STARTED|Toddler Dose||152
8601337|NCT00366678|9637431|FG002|STARTED|Toddler Dose||137
8601338|NCT00366678|9637429|FG000|COMPLETED|Toddler Dose||268
8601339|NCT00366678|9637430|FG001|COMPLETED|Toddler Dose||151
8601340|NCT00366678|9637431|FG002|COMPLETED|Toddler Dose||137
8601341|NCT00366678|9637429|FG000|NOT COMPLETED|Toddler Dose||5
8601342|NCT00366678|9637430|FG001|NOT COMPLETED|Toddler Dose||1
8601343|NCT00366678|9637431|FG002|NOT COMPLETED|Toddler Dose||0
8601344|NCT00366899|9637478|FG000|STARTED|Infant Series|1 participant was counted twice, 1 participant randomized to 13vPnC, incorrectly received 7vPnC|303
8601345|NCT00366899|9637479|FG001|STARTED|Infant Series|1 participant randomized to 7vPnC but never vaccinated|303
8601346|NCT00366899|9637478|FG000|Vaccinated Dose 1|Infant Series|2 participants randomized to 13vPnC, incorrectly received 7vPnC|302
8601347|NCT00366899|9637479|FG001|Vaccinated Dose 1|Infant Series||302
8601348|NCT00366899|9637478|FG000|Vaccinated Dose 2|Infant Series|1 participant randomized to 13vPnC, incorrectly received 7vPnC|296
8601349|NCT00366899|9637479|FG001|Vaccinated Dose 2|Infant Series||293
8601350|NCT00366899|9637478|FG000|COMPLETED|Infant Series||294
8601351|NCT00366899|9637479|FG001|COMPLETED|Infant Series||291
8601352|NCT00366899|9637478|FG000|NOT COMPLETED|Infant Series||9
8601353|NCT00366899|9637479|FG001|NOT COMPLETED|Infant Series||12
8601354|NCT00366899|9637478|FG000|STARTED|After Infant Series||294
8601355|NCT00366899|9637479|FG001|STARTED|After Infant Series||291
8601356|NCT00366899|9637478|FG000|COMPLETED|After Infant Series||287
8601357|NCT00366899|9637479|FG001|COMPLETED|After Infant Series||282
8601358|NCT00366899|9637478|FG000|NOT COMPLETED|After Infant Series||7
8601359|NCT00366899|9637479|FG001|NOT COMPLETED|After Infant Series||9
8601360|NCT00366899|9637478|FG000|STARTED|Toddler Dose||287
8601361|NCT00366899|9637479|FG001|STARTED|Toddler Dose||282
8601362|NCT00366899|9637478|FG000|COMPLETED|Toddler Dose||285
8601363|NCT00366899|9637479|FG001|COMPLETED|Toddler Dose||281
8601364|NCT00366899|9637478|FG000|NOT COMPLETED|Toddler Dose||2
8601365|NCT00366899|9637479|FG001|NOT COMPLETED|Toddler Dose||1
8601366|NCT00367003|9637511|FG000|STARTED|Overall Study||37
8601367|NCT00367003|9637511|FG000|COMPLETED|Overall Study||28
8601368|NCT00367003|9637511|FG000|NOT COMPLETED|Overall Study||9
8601369|NCT00367016|9637517|FG000|STARTED|Overall Study||3
8601370|NCT00367016|9637518|FG001|STARTED|Overall Study||3
8601371|NCT00367016|9637517|FG000|First Intervention|Overall Study||3
8601372|NCT00367016|9637518|FG001|First Intervention|Overall Study||3
8601373|NCT00367016|9637517|FG000|Second Intervention|Overall Study||3
8601374|NCT00367016|9637518|FG001|Second Intervention|Overall Study||3
8601375|NCT00367016|9637517|FG000|COMPLETED|Overall Study||3
8601376|NCT00367016|9637518|FG001|COMPLETED|Overall Study||3
8601377|NCT00367016|9637517|FG000|NOT COMPLETED|Overall Study||0
8601378|NCT00367016|9637518|FG001|NOT COMPLETED|Overall Study||0
8601379|NCT00367055|9637528|FG000|STARTED|Overall Study||43
8601380|NCT00367055|9637529|FG001|STARTED|Overall Study||41
8601381|NCT00367055|9637528|FG000|COMPLETED|Overall Study||32
8601382|NCT00367055|9637529|FG001|COMPLETED|Overall Study||30
8601383|NCT00367055|9637528|FG000|NOT COMPLETED|Overall Study||11
8601384|NCT00367055|9637529|FG001|NOT COMPLETED|Overall Study||11
8601385|NCT00367133|9637538|FG000|STARTED|2 Years|Number of Eyes|330
8601386|NCT00367133|9637539|FG001|STARTED|2 Years|Number of Eyes|256
8601387|NCT00367133|9637540|FG002|STARTED|2 Years|Number of Eyes|254
8601388|NCT00367133|9637538|FG000|COMPLETED|2 Years||272
8601389|NCT00367133|9637539|FG001|COMPLETED|2 Years||220
8601390|NCT00367133|9637540|FG002|COMPLETED|2 Years||205
8601391|NCT00367133|9637538|FG000|NOT COMPLETED|2 Years||58
8601392|NCT00367133|9637539|FG001|NOT COMPLETED|2 Years||36
8601393|NCT00367133|9637540|FG002|NOT COMPLETED|2 Years||49
8601394|NCT00367133|9637538|FG000|STARTED|3 Years|Since trial ended early, includes only those with potential for 3 year follow-up -excludes deaths|143
8601395|NCT00367133|9637539|FG001|STARTED|3 Years|Since trial ended early, includes only those with potential for 3 year follow-up -excludes deaths|116
8601396|NCT00367133|9637540|FG002|STARTED|3 Years|Since trial ended early, includes only those with potential for 3 year follow-up -excludes deaths|116
8601397|NCT00367133|9637538|FG000|COMPLETED|3 Years||115
8601398|NCT00367133|9637539|FG001|COMPLETED|3 Years||93
8601399|NCT00367133|9637540|FG002|COMPLETED|3 Years||98
8601400|NCT00367133|9637538|FG000|NOT COMPLETED|3 Years||28
8601401|NCT00367133|9637539|FG001|NOT COMPLETED|3 Years||23
8601402|NCT00367133|9637540|FG002|NOT COMPLETED|3 Years||18
8601403|NCT00367237|9637550|FG000|STARTED|Overall Study|Number of subjects randomized|57
8601404|NCT00367237|9637551|FG001|STARTED|Overall Study|Number of subjects randomized|58
8601405|NCT00367237|9637550|FG000|COMPLETED|Overall Study||47
8601406|NCT00367237|9637551|FG001|COMPLETED|Overall Study||47
8601407|NCT00367237|9637550|FG000|NOT COMPLETED|Overall Study||10
8601408|NCT00367237|9637551|FG001|NOT COMPLETED|Overall Study||11
8601409|NCT00367341|9637559|FG000|STARTED|Overall Study||42
8601410|NCT00367341|9637560|FG001|STARTED|Overall Study||40
8601411|NCT00367341|9637559|FG000|COMPLETED|Overall Study||40
8601412|NCT00367341|9637560|FG001|COMPLETED|Overall Study||40
8601413|NCT00367341|9637559|FG000|NOT COMPLETED|Overall Study||2
8601414|NCT00367341|9637560|FG001|NOT COMPLETED|Overall Study||0
8601415|NCT00367380|9637569|FG000|STARTED|Overall Study||6
8601416|NCT00367380|9637570|FG001|STARTED|Overall Study||6
8601417|NCT00367380|9637571|FG002|STARTED|Overall Study||6
8601418|NCT00367380|9637569|FG000|COMPLETED|Overall Study||6
8601419|NCT00367380|9637570|FG001|COMPLETED|Overall Study||6
8601420|NCT00367380|9637571|FG002|COMPLETED|Overall Study||6
8601421|NCT00367380|9637569|FG000|NOT COMPLETED|Overall Study||0
8601422|NCT00367380|9637570|FG001|NOT COMPLETED|Overall Study||0
8601423|NCT00367380|9637571|FG002|NOT COMPLETED|Overall Study||0
8601424|NCT00367432|9637579|FG000|STARTED|First Period (16 Weeks)|Eligible subjects from preceding study N01221 [NCT00280696] entered the First Period of N01222|313
8601425|NCT00367432|9637580|FG001|STARTED|First Period (16 Weeks)||0
8601426|NCT00367432|9637579|FG000|COMPLETED|First Period (16 Weeks)||275
8601427|NCT00367432|9637580|FG001|COMPLETED|First Period (16 Weeks)||0
8601428|NCT00367432|9637579|FG000|NOT COMPLETED|First Period (16 Weeks)||38
8601429|NCT00367432|9637580|FG001|NOT COMPLETED|First Period (16 Weeks)||0
8601430|NCT00367432|9637579|FG000|STARTED|Second Period (up to 54 Months)|275 subjects from N01221 [NCT00280696] completed First Period and entered Second Period of N01222|275
8601431|NCT00367432|9637580|FG001|STARTED|Second Period (up to 54 Months)|85 subjects from N01020 [NCT00160615] entered Second Period of N01222|85
8601432|NCT00367432|9637579|FG000|COMPLETED|Second Period (up to 54 Months)||188
8601433|NCT00367432|9637580|FG001|COMPLETED|Second Period (up to 54 Months)||69
8601434|NCT00367432|9637579|FG000|NOT COMPLETED|Second Period (up to 54 Months)||87
8601435|NCT00367432|9637580|FG001|NOT COMPLETED|Second Period (up to 54 Months)||16
8601436|NCT00367458|9637586|FG000|STARTED|First Intervention - 8 Weeks||12
8601437|NCT00367458|9637587|FG001|STARTED|First Intervention - 8 Weeks||12
8601438|NCT00367458|9637586|FG000|COMPLETED|First Intervention - 8 Weeks||10
8601439|NCT00367458|9637587|FG001|COMPLETED|First Intervention - 8 Weeks||12
8601440|NCT00367458|9637586|FG000|NOT COMPLETED|First Intervention - 8 Weeks||2
8601441|NCT00367458|9637587|FG001|NOT COMPLETED|First Intervention - 8 Weeks||0
8601442|NCT00367458|9637586|FG000|STARTED|Washout Period - 4-6 Weeks||10
8601443|NCT00367458|9637587|FG001|STARTED|Washout Period - 4-6 Weeks||12
8601444|NCT00367458|9637586|FG000|COMPLETED|Washout Period - 4-6 Weeks||10
8601445|NCT00367458|9637587|FG001|COMPLETED|Washout Period - 4-6 Weeks||12
8601446|NCT00367458|9637586|FG000|NOT COMPLETED|Washout Period - 4-6 Weeks||0
8601447|NCT00367458|9637587|FG001|NOT COMPLETED|Washout Period - 4-6 Weeks||0
8601448|NCT00367458|9637586|FG000|STARTED|Second Intervention - 8 Weeks||10
8601449|NCT00367458|9637587|FG001|STARTED|Second Intervention - 8 Weeks||12
8601450|NCT00367458|9637586|FG000|COMPLETED|Second Intervention - 8 Weeks||10
8601451|NCT00367458|9637587|FG001|COMPLETED|Second Intervention - 8 Weeks||12
8601452|NCT00367458|9637586|FG000|NOT COMPLETED|Second Intervention - 8 Weeks||0
8601453|NCT00367458|9637587|FG001|NOT COMPLETED|Second Intervention - 8 Weeks||0
8601454|NCT00367484|9637593|FG000|STARTED|Overall Study||460
8601455|NCT00367484|9637593|FG000|COMPLETED|Overall Study|Safety population = 460 Intent To Treat (ITT) population = 458|443
8601456|NCT00367484|9637593|FG000|NOT COMPLETED|Overall Study||17
8601457|NCT00367601|9637597|FG000|STARTED|Overall Study||25
8601458|NCT00367601|9637597|FG000|COMPLETED|Overall Study||25
8601459|NCT00367601|9637597|FG000|NOT COMPLETED|Overall Study||0
8601460|NCT00367640|9637606|FG000|STARTED|Overall Study||157
8601461|NCT00367640|9637607|FG001|STARTED|Overall Study||155
8601462|NCT00367640|9637608|FG002|STARTED|Overall Study||160
8601463|NCT00367640|9637609|FG003|STARTED|Overall Study||156
8601464|NCT00367640|9637606|FG000|COMPLETED|Overall Study||139
8601465|NCT00367640|9637607|FG001|COMPLETED|Overall Study||133
8601466|NCT00367640|9637608|FG002|COMPLETED|Overall Study||141
8601467|NCT00367640|9637609|FG003|COMPLETED|Overall Study||146
8601468|NCT00367640|9637606|FG000|NOT COMPLETED|Overall Study||18
8601469|NCT00367640|9637607|FG001|NOT COMPLETED|Overall Study||22
8601470|NCT00367640|9637608|FG002|NOT COMPLETED|Overall Study||19
8601471|NCT00367640|9637609|FG003|NOT COMPLETED|Overall Study||10
8601472|NCT00367679|9637619|FG000|STARTED|Overall Study||35
8601473|NCT00367679|9637619|FG000|COMPLETED|Overall Study||35
8601474|NCT00367679|9637619|FG000|NOT COMPLETED|Overall Study||0
8601475|NCT00367744|9637627|FG000|STARTED|Overall Study||34
8601476|NCT00367744|9637628|FG001|STARTED|Overall Study||37
8601477|NCT00367744|9637627|FG000|COMPLETED|Overall Study||30
8601478|NCT00367744|9637628|FG001|COMPLETED|Overall Study||32
8601479|NCT00367744|9637627|FG000|NOT COMPLETED|Overall Study||4
8601480|NCT00367744|9637628|FG001|NOT COMPLETED|Overall Study||5
8601481|NCT00367770|9637635|FG000|STARTED|Overall Study||37
8601482|NCT00367770|9637635|FG000|COMPLETED|Overall Study||35
8601483|NCT00367770|9637635|FG000|NOT COMPLETED|Overall Study||2
8601484|NCT00367835|9637641|FG000|STARTED|Overall Study||138
8601485|NCT00367835|9637642|FG001|STARTED|Overall Study||79
8601486|NCT00367835|9637641|FG000|COMPLETED|Overall Study||109
8601487|NCT00367835|9637642|FG001|COMPLETED|Overall Study||48
8601488|NCT00367835|9637641|FG000|NOT COMPLETED|Overall Study||29
8601489|NCT00367835|9637642|FG001|NOT COMPLETED|Overall Study||31
8601490|NCT00367991|9637650|FG000|STARTED|Overall Study||29
8601491|NCT00367991|9637651|FG001|STARTED|Overall Study||15
8601492|NCT00367991|9637650|FG000|COMPLETED|Overall Study||27
8601493|NCT00367991|9637651|FG001|COMPLETED|Overall Study||13
8601494|NCT00367991|9637650|FG000|NOT COMPLETED|Overall Study||2
8601495|NCT00367991|9637651|FG001|NOT COMPLETED|Overall Study||2
8601496|NCT00368069|9637659|FG000|STARTED|Overall Study||79
8601497|NCT00368069|9637660|FG001|STARTED|Overall Study||79
8601498|NCT00368069|9637659|FG000|COMPLETED|Overall Study||71
8601499|NCT00368069|9637660|FG001|COMPLETED|Overall Study||72
8601500|NCT00368069|9637659|FG000|NOT COMPLETED|Overall Study||8
8601501|NCT00368069|9637660|FG001|NOT COMPLETED|Overall Study||7
8601502|NCT00368108|9637669|FG000|STARTED|Overall Study|One subject had stopped medication prior to notifying staff. Remaining results will have 250.|251
8601503|NCT00368108|9637670|FG001|STARTED|Overall Study||251
8601504|NCT00368108|9637671|FG002|STARTED|Overall Study||250
8601505|NCT00368108|9637669|FG000|COMPLETED|Overall Study||187
8601506|NCT00368108|9637670|FG001|COMPLETED|Overall Study||198
8601507|NCT00368108|9637671|FG002|COMPLETED|Overall Study||182
8601508|NCT00368108|9637669|FG000|NOT COMPLETED|Overall Study||64
8601509|NCT00368108|9637670|FG001|NOT COMPLETED|Overall Study||53
8601510|NCT00368108|9637671|FG002|NOT COMPLETED|Overall Study||68
8601511|NCT00368251|9637682|FG000|STARTED|Overall Study||18
8601512|NCT00368251|9637683|FG001|STARTED|Overall Study||20
8601513|NCT00368251|9637684|FG002|STARTED|Overall Study||18
8601514|NCT00368251|9637682|FG000|COMPLETED|Overall Study||17
8601515|NCT00368251|9637683|FG001|COMPLETED|Overall Study||20
8601516|NCT00368251|9637684|FG002|COMPLETED|Overall Study||17
8601517|NCT00368251|9637682|FG000|NOT COMPLETED|Overall Study||1
8601518|NCT00368251|9637683|FG001|NOT COMPLETED|Overall Study||0
8601519|NCT00368251|9637684|FG002|NOT COMPLETED|Overall Study||1
8601520|NCT00368277|9637694|FG000|STARTED|Overall Study||457
8601521|NCT00368277|9637695|FG001|STARTED|Overall Study||444
8601522|NCT00368277|9637694|FG000|COMPLETED|Overall Study||344
8601523|NCT00368277|9637695|FG001|COMPLETED|Overall Study||336
8601524|NCT00368277|9637694|FG000|NOT COMPLETED|Overall Study||113
8601525|NCT00368277|9637695|FG001|NOT COMPLETED|Overall Study||108
8601526|NCT00368290|9637703|FG000|STARTED|Overall Study||47
8601527|NCT00368290|9637704|FG001|STARTED|Overall Study||47
8601528|NCT00368290|9637703|FG000|COMPLETED|Overall Study||34
8601529|NCT00368290|9637704|FG001|COMPLETED|Overall Study||37
8601530|NCT00368290|9637703|FG000|NOT COMPLETED|Overall Study||13
8601531|NCT00368290|9637704|FG001|NOT COMPLETED|Overall Study||10
8601532|NCT00368316|9637712|FG000|STARTED|Overall Study||1434
8601533|NCT00368316|9637713|FG001|STARTED|Overall Study||1365
8601534|NCT00368316|9637712|FG000|COMPLETED|Overall Study||1392
8601535|NCT00368316|9637713|FG001|COMPLETED|Overall Study||1319
8601536|NCT00368316|9637712|FG000|NOT COMPLETED|Overall Study||42
8601537|NCT00368316|9637713|FG001|NOT COMPLETED|Overall Study||46
8601538|NCT00368355|9637721|FG000|STARTED|Overall Study||18
8601539|NCT00368355|9637722|FG001|STARTED|Overall Study||28
8601540|NCT00368355|9637721|FG000|COMPLETED|Overall Study||7
8601541|NCT00368355|9637722|FG001|COMPLETED|Overall Study||11
8601542|NCT00368355|9637721|FG000|NOT COMPLETED|Overall Study||11
8601543|NCT00368355|9637722|FG001|NOT COMPLETED|Overall Study||17
8601544|NCT00368459|9637730|FG000|STARTED|Overall Study||21
8601545|NCT00368459|9637731|FG001|STARTED|Overall Study||21
8601546|NCT00368459|9637730|FG000|COMPLETED|Overall Study||19
8601547|NCT00368459|9637731|FG001|COMPLETED|Overall Study||20
8601548|NCT00368459|9637730|FG000|NOT COMPLETED|Overall Study||2
8601549|NCT00368459|9637731|FG001|NOT COMPLETED|Overall Study||1
8601550|NCT00368472|9637737|FG000|STARTED|Overall Study||138
8601551|NCT00368472|9637737|FG000|COMPLETED|Overall Study||33
8601552|NCT00368472|9637737|FG000|NOT COMPLETED|Overall Study||105
8601553|NCT00368537|9637743|FG000|STARTED|Randomization||281
8601554|NCT00368537|9637744|FG001|STARTED|Randomization||269
8601555|NCT00368537|9637743|FG000|COMPLETED|Randomization||268
8601556|NCT00368537|9637744|FG001|COMPLETED|Randomization||263
8601557|NCT00368537|9637743|FG000|NOT COMPLETED|Randomization||13
8601558|NCT00368537|9637744|FG001|NOT COMPLETED|Randomization||6
8601559|NCT00368537|9637743|FG000|STARTED|Baseline Participants||268
8601560|NCT00368537|9637744|FG001|STARTED|Baseline Participants||263
8601561|NCT00368537|9637743|FG000|COMPLETED|Baseline Participants||244
8601562|NCT00368537|9637744|FG001|COMPLETED|Baseline Participants||239
8601563|NCT00368537|9637743|FG000|NOT COMPLETED|Baseline Participants||24
8601564|NCT00368537|9637744|FG001|NOT COMPLETED|Baseline Participants||24
8601565|NCT00368550|9637752|FG000|STARTED|Overall Study||63
8601566|NCT00368550|9637753|FG001|STARTED|Overall Study||71
8601567|NCT00368550|9637752|FG000|COMPLETED|Overall Study||35
8601568|NCT00368550|9637753|FG001|COMPLETED|Overall Study||48
8601569|NCT00368550|9637752|FG000|NOT COMPLETED|Overall Study||28
8601570|NCT00368550|9637753|FG001|NOT COMPLETED|Overall Study||23
8601571|NCT00368641|9637761|FG000|STARTED|Overall Study||6
8601572|NCT00368641|9637762|FG001|STARTED|Overall Study||6
8601573|NCT00368641|9637761|FG000|COMPLETED|Overall Study|study was terminated prior to completion of treatment period|0
8601574|NCT00368641|9637762|FG001|COMPLETED|Overall Study|study was terminated prior to completion of treatment period|0
8601575|NCT00368641|9637761|FG000|NOT COMPLETED|Overall Study||6
8601576|NCT00368641|9637762|FG001|NOT COMPLETED|Overall Study||6
8601577|NCT00368745|9637770|FG000|STARTED|Randomized to Double-blind Treatment||57
8601578|NCT00368745|9637771|FG001|STARTED|Randomized to Double-blind Treatment||51
8601579|NCT00368745|9637770|FG000|COMPLETED|Randomized to Double-blind Treatment|One subject did not return following randomization; study drug not dispensed.|56
8601580|NCT00368745|9637771|FG001|COMPLETED|Randomized to Double-blind Treatment|One subject did not want to participate in study.|50
8601581|NCT00368745|9637770|FG000|NOT COMPLETED|Randomized to Double-blind Treatment||1
8601582|NCT00368745|9637771|FG001|NOT COMPLETED|Randomized to Double-blind Treatment||1
8601583|NCT00368745|9637770|FG000|STARTED|Double-blind Treatment Period||56
8601584|NCT00368745|9637771|FG001|STARTED|Double-blind Treatment Period||50
8601585|NCT00368745|9637770|FG000|COMPLETED|Double-blind Treatment Period||30
8601586|NCT00368745|9637771|FG001|COMPLETED|Double-blind Treatment Period||19
8601587|NCT00368745|9637770|FG000|NOT COMPLETED|Double-blind Treatment Period||26
8601588|NCT00368745|9637771|FG001|NOT COMPLETED|Double-blind Treatment Period||31
8601589|NCT00368849|9637777|FG000|STARTED|Overall Study||10
8601590|NCT00368849|9637778|FG001|STARTED|Overall Study||10
8601591|NCT00368849|9637777|FG000|COMPLETED|Overall Study||10
8601592|NCT00368849|9637778|FG001|COMPLETED|Overall Study||8
8601593|NCT00368849|9637777|FG000|NOT COMPLETED|Overall Study||0
8601594|NCT00368849|9637778|FG001|NOT COMPLETED|Overall Study||2
8601595|NCT00368875|9637785|FG000|STARTED|Overall Study||6
8601596|NCT00368875|9637786|FG001|STARTED|Overall Study||48
8601597|NCT00368875|9637785|FG000|COMPLETED|Overall Study||0
8601598|NCT00368875|9637786|FG001|COMPLETED|Overall Study||0
8601599|NCT00368875|9637785|FG000|NOT COMPLETED|Overall Study||6
8601600|NCT00368875|9637786|FG001|NOT COMPLETED|Overall Study||48
8601601|NCT00368927|9637794|FG000|STARTED|Overall Study||31
8601602|NCT00368927|9637795|FG001|STARTED|Overall Study||30
8601603|NCT00368927|9637794|FG000|COMPLETED|Overall Study||26
8601604|NCT00368927|9637795|FG001|COMPLETED|Overall Study||27
8601605|NCT00368927|9637794|FG000|NOT COMPLETED|Overall Study||5
8601606|NCT00368927|9637795|FG001|NOT COMPLETED|Overall Study||3
8601607|NCT00368940|9637803|FG000|STARTED|Intention-to-Treat||37
8601608|NCT00368940|9637804|FG001|STARTED|Intention-to-Treat||37
8601609|NCT00368940|9637803|FG000|COMPLETED|Intention-to-Treat||37
8601610|NCT00368940|9637804|FG001|COMPLETED|Intention-to-Treat||37
8601611|NCT00368940|9637803|FG000|NOT COMPLETED|Intention-to-Treat||0
8601612|NCT00368940|9637804|FG001|NOT COMPLETED|Intention-to-Treat||0
8601613|NCT00368940|9637803|FG000|STARTED|Completed 12-wk Treatment||37
8601614|NCT00368940|9637804|FG001|STARTED|Completed 12-wk Treatment||37
8601615|NCT00368940|9637803|FG000|COMPLETED|Completed 12-wk Treatment||31
8601616|NCT00368940|9637804|FG001|COMPLETED|Completed 12-wk Treatment||32
8601617|NCT00368940|9637803|FG000|NOT COMPLETED|Completed 12-wk Treatment||6
8601618|NCT00368940|9637804|FG001|NOT COMPLETED|Completed 12-wk Treatment||5
8601619|NCT00368966|9637813|FG000|STARTED|Infant Series||315
8601620|NCT00368966|9637814|FG001|STARTED|Infant Series||304
8601621|NCT00368966|9637813|FG000|Vaccinated Dose 1|Infant Series||314
8601622|NCT00368966|9637814|FG001|Vaccinated Dose 1|Infant Series|1 randomized to 7vPnC but given 13vPnC vaccine; 1 was withdrawn before receiving 7vPnC vaccine|302
8601623|NCT00368966|9637813|FG000|Vaccinated Dose 2|Infant Series|1 randomized but incorrectly given 7vPnC|307
8601624|NCT00368966|9637814|FG001|Vaccinated Dose 2|Infant Series||298
8601625|NCT00368966|9637813|FG000|Vaccinated Dose 3|Infant Series||301
8601626|NCT00368966|9637814|FG001|Vaccinated Dose 3|Infant Series|1 randomized but incorrectly given 13vPnC|296
8601627|NCT00368966|9637813|FG000|COMPLETED|Infant Series||299
8601628|NCT00368966|9637814|FG001|COMPLETED|Infant Series||294
8601629|NCT00368966|9637813|FG000|NOT COMPLETED|Infant Series||16
8601630|NCT00368966|9637814|FG001|NOT COMPLETED|Infant Series||10
8601631|NCT00368966|9637813|FG000|STARTED|After Infant||299
8601632|NCT00368966|9637814|FG001|STARTED|After Infant||294
8601633|NCT00368966|9637813|FG000|COMPLETED|After Infant||293
8601634|NCT00368966|9637814|FG001|COMPLETED|After Infant||289
8601635|NCT00368966|9637813|FG000|NOT COMPLETED|After Infant||6
8601636|NCT00368966|9637814|FG001|NOT COMPLETED|After Infant||5
8601637|NCT00368966|9637813|FG000|STARTED|Toddler Dose||293
8601638|NCT00368966|9637814|FG001|STARTED|Toddler Dose||289
8601639|NCT00368966|9637813|FG000|COMPLETED|Toddler Dose||292
8601640|NCT00368966|9637814|FG001|COMPLETED|Toddler Dose||286
8601641|NCT00368966|9637813|FG000|NOT COMPLETED|Toddler Dose||1
8601642|NCT00368966|9637814|FG001|NOT COMPLETED|Toddler Dose||3
8601643|NCT00368979|9637847|FG000|STARTED|Overall Study||185
8601644|NCT00368979|9637848|FG001|STARTED|Overall Study||193
8601645|NCT00368979|9637847|FG000|COMPLETED|Overall Study||160
8601646|NCT00368979|9637848|FG001|COMPLETED|Overall Study||163
8601647|NCT00368979|9637847|FG000|NOT COMPLETED|Overall Study||25
8601648|NCT00368979|9637848|FG001|NOT COMPLETED|Overall Study||30
8601649|NCT00368992|9637854|FG000|STARTED|Overall Study||110
8601650|NCT00368992|9637854|FG000|COMPLETED|Overall Study||0
8601651|NCT00368992|9637854|FG000|NOT COMPLETED|Overall Study||110
8601652|NCT00369122|9637859|FG000|STARTED|Overall Study||60
8601653|NCT00369122|9637859|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|49
8601654|NCT00369122|9637859|FG000|NOT COMPLETED|Overall Study||11
8601655|NCT00369161|9637865|FG000|STARTED|Overall Study|"Started indicates randomized and safety population."|109
8601656|NCT00369161|9637866|FG001|STARTED|Overall Study||119
8601657|NCT00369161|9637865|FG000|Intention to Treat (ITT)|Overall Study||107
8601658|NCT00369161|9637866|FG001|Intention to Treat (ITT)|Overall Study||117
8601659|NCT00369161|9637865|FG000|COMPLETED|Overall Study||82
8601660|NCT00369161|9637866|FG001|COMPLETED|Overall Study||95
8601661|NCT00369161|9637865|FG000|NOT COMPLETED|Overall Study||27
8601662|NCT00369161|9637866|FG001|NOT COMPLETED|Overall Study||24
8601663|NCT00369226|9637874|FG000|STARTED|Phase I (45 Days)||13
8601664|NCT00369226|9637875|FG001|STARTED|Phase I (45 Days)||0
8601665|NCT00369226|9637874|FG000|COMPLETED|Phase I (45 Days)|Once MTD established, additional 10 patients were accrued at MTD to better estimate toxicity.|13
8601666|NCT00369226|9637875|FG001|COMPLETED|Phase I (45 Days)||0
8601667|NCT00369226|9637874|FG000|NOT COMPLETED|Phase I (45 Days)||0
8601668|NCT00369226|9637875|FG001|NOT COMPLETED|Phase I (45 Days)||0
8601669|NCT00369226|9637874|FG000|STARTED|Phase II (45 Days)||0
8601670|NCT00369226|9637875|FG001|STARTED|Phase II (45 Days)||32
8601671|NCT00369226|9637874|FG000|COMPLETED|Phase II (45 Days)||0
8601672|NCT00369226|9637875|FG001|COMPLETED|Phase II (45 Days)|This includes 10 patients treated at candidate MTD in Phase I.|32
8601673|NCT00369226|9637874|FG000|NOT COMPLETED|Phase II (45 Days)||0
8601674|NCT00369226|9637875|FG001|NOT COMPLETED|Phase II (45 Days)||0
8601675|NCT00369278|9637886|FG000|STARTED|Overall Study||63
8601676|NCT00369278|9637887|FG001|STARTED|Overall Study||65
8601677|NCT00369278|9637886|FG000|COMPLETED|Overall Study||39
8601678|NCT00369278|9637887|FG001|COMPLETED|Overall Study||44
8601679|NCT00369278|9637886|FG000|NOT COMPLETED|Overall Study||24
8601680|NCT00369278|9637887|FG001|NOT COMPLETED|Overall Study||21
8628585|NCT00525161|9668093|FG000|COMPLETED|Overall Study||10
8628586|NCT00525161|9668093|FG000|NOT COMPLETED|Overall Study||1
8629573|NCT00530946|9669353|FG000|STARTED|Overall Study||43
8629574|NCT00530946|9669354|FG001|STARTED|Overall Study||41
8629575|NCT00530946|9669355|FG002|STARTED|Overall Study||41
8629576|NCT00530946|9669356|FG003|STARTED|Overall Study||40
8629577|NCT00530946|9669353|FG000|COMPLETED|Overall Study||41
8629578|NCT00530946|9669354|FG001|COMPLETED|Overall Study||39
8629579|NCT00530946|9669355|FG002|COMPLETED|Overall Study||40
8629580|NCT00530946|9669356|FG003|COMPLETED|Overall Study||38
8629581|NCT00530946|9669353|FG000|NOT COMPLETED|Overall Study||2
8629582|NCT00530946|9669354|FG001|NOT COMPLETED|Overall Study||2
8629583|NCT00530946|9669355|FG002|NOT COMPLETED|Overall Study||1
8629584|NCT00530946|9669356|FG003|NOT COMPLETED|Overall Study||2
8629585|NCT00531011|9669368|FG000|STARTED|Overall Study||103
8629586|NCT00531011|9669369|FG001|STARTED|Overall Study||97
8629587|NCT00531011|9669368|FG000|COMPLETED|Overall Study||99
8629588|NCT00531011|9669369|FG001|COMPLETED|Overall Study||90
8629589|NCT00531011|9669368|FG000|NOT COMPLETED|Overall Study||4
8629590|NCT00531011|9669369|FG001|NOT COMPLETED|Overall Study||7
8629591|NCT00531050|9669381|FG000|STARTED|Part 1: Period 1||4
8629592|NCT00531050|9669382|FG001|STARTED|Part 1: Period 1||5
8629593|NCT00531050|9669383|FG002|STARTED|Part 1: Period 1||4
8629594|NCT00531050|9669384|FG003|STARTED|Part 1: Period 1||5
8629595|NCT00531050|9669385|FG004|STARTED|Part 1: Period 1||4
8629596|NCT00531050|9669386|FG005|STARTED|Part 1: Period 1||5
8629597|NCT00531050|9669381|FG000|COMPLETED|Part 1: Period 1||4
8629598|NCT00531050|9669382|FG001|COMPLETED|Part 1: Period 1||4
8629599|NCT00531050|9669383|FG002|COMPLETED|Part 1: Period 1||4
8629600|NCT00531050|9669384|FG003|COMPLETED|Part 1: Period 1||4
8629601|NCT00531050|9669385|FG004|COMPLETED|Part 1: Period 1||4
8629602|NCT00531050|9669386|FG005|COMPLETED|Part 1: Period 1||5
8629603|NCT00531050|9669381|FG000|NOT COMPLETED|Part 1: Period 1||0
8629604|NCT00531050|9669382|FG001|NOT COMPLETED|Part 1: Period 1||1
8629605|NCT00531050|9669383|FG002|NOT COMPLETED|Part 1: Period 1||0
8629606|NCT00531050|9669384|FG003|NOT COMPLETED|Part 1: Period 1||1
8629607|NCT00531050|9669385|FG004|NOT COMPLETED|Part 1: Period 1||0
8629608|NCT00531050|9669386|FG005|NOT COMPLETED|Part 1: Period 1||0
8629609|NCT00531050|9669381|FG000|STARTED|Part 1: Period 2||4
8714198|NCT00979069|9761065|FG000|STARTED|Overall Study||10
8714199|NCT00979069|9761066|FG001|STARTED|Overall Study||10
8714200|NCT00979069|9761065|FG000|COMPLETED|Overall Study||10
8714201|NCT00979069|9761066|FG001|COMPLETED|Overall Study||8
8714202|NCT00979069|9761065|FG000|NOT COMPLETED|Overall Study||0
8714203|NCT00979069|9761066|FG001|NOT COMPLETED|Overall Study||2
8714204|NCT00979121|9761074|FG000|STARTED|Overall Study||379
8714205|NCT00979121|9761075|FG001|STARTED|Overall Study||366
8601681|NCT00369343|9637895|FG000|STARTED|Double-blind Phase||256
8601682|NCT00369343|9637896|FG001|STARTED|Double-blind Phase||125
8601683|NCT00369343|9637895|FG000|COMPLETED|Double-blind Phase||212
8601684|NCT00369343|9637896|FG001|COMPLETED|Double-blind Phase||109
8601685|NCT00369343|9637895|FG000|NOT COMPLETED|Double-blind Phase||44
8601686|NCT00369343|9637896|FG001|NOT COMPLETED|Double-blind Phase||16
8601687|NCT00369343|9637895|FG000|STARTED|Open-label Phase||212
8601688|NCT00369343|9637896|FG001|STARTED|Open-label Phase||109
8601689|NCT00369343|9637895|FG000|COMPLETED|Open-label Phase||155
8601690|NCT00369343|9637896|FG001|COMPLETED|Open-label Phase||79
8601691|NCT00369343|9637895|FG000|NOT COMPLETED|Open-label Phase||57
8601692|NCT00369343|9637896|FG001|NOT COMPLETED|Open-label Phase||30
8601693|NCT00369382|9637911|FG000|STARTED|Overall Study||59
8601694|NCT00369382|9637912|FG001|STARTED|Overall Study||57
8601695|NCT00369382|9637911|FG000|Received Treatment|Overall Study||57
8601696|NCT00369382|9637912|FG001|Received Treatment|Overall Study||57
8601697|NCT00369382|9637911|FG000|Completed Assigned Treatment Regimen|Overall Study||48
8601698|NCT00369382|9637912|FG001|Completed Assigned Treatment Regimen|Overall Study||33
8813193|NCT01524627|9866348|FG000|STARTED|Overall Study||22
8813194|NCT01524627|9866349|FG001|STARTED|Overall Study||21
8813195|NCT01524627|9866348|FG000|COMPLETED|Overall Study||21
8813196|NCT01524627|9866349|FG001|COMPLETED|Overall Study||19
8813197|NCT01524627|9866348|FG000|NOT COMPLETED|Overall Study||1
8813198|NCT01524627|9866349|FG001|NOT COMPLETED|Overall Study||2
8813199|NCT01524679|9866357|FG000|STARTED|Overall Study||112
8601699|NCT00369382|9637911|FG000|COMPLETED|Overall Study||49
8601700|NCT00369382|9637912|FG001|COMPLETED|Overall Study||54
8601701|NCT00369382|9637911|FG000|NOT COMPLETED|Overall Study||10
8601702|NCT00369382|9637912|FG001|NOT COMPLETED|Overall Study||3
8601703|NCT00369486|9637924|FG000|STARTED|4-Week Visit|Number of eyes|38
8601704|NCT00369486|9637925|FG001|STARTED|4-Week Visit|Number of eyes|21
8601705|NCT00369486|9637926|FG002|STARTED|4-Week Visit|Number of eyes|23
8601706|NCT00369486|9637927|FG003|STARTED|4-Week Visit|Number of eyes|22
8601707|NCT00369486|9637928|FG004|STARTED|4-Week Visit|Number of eyes|25
8601708|NCT00369486|9637924|FG000|COMPLETED|4-Week Visit|Number of eyes|36
8601709|NCT00369486|9637925|FG001|COMPLETED|4-Week Visit|Number of eyes;|19
8601710|NCT00369486|9637926|FG002|COMPLETED|4-Week Visit|Number of eyes|22
8601711|NCT00369486|9637927|FG003|COMPLETED|4-Week Visit|Number of eyes|20
8601712|NCT00369486|9637928|FG004|COMPLETED|4-Week Visit|Number of eyes|24
8601713|NCT00369486|9637924|FG000|NOT COMPLETED|4-Week Visit||2
8601714|NCT00369486|9637925|FG001|NOT COMPLETED|4-Week Visit||2
8601715|NCT00369486|9637926|FG002|NOT COMPLETED|4-Week Visit||1
8601716|NCT00369486|9637927|FG003|NOT COMPLETED|4-Week Visit||2
8601717|NCT00369486|9637928|FG004|NOT COMPLETED|4-Week Visit||1
8601718|NCT00369486|9637924|FG000|STARTED|8-Week Visit|Number of eyes|38
8601719|NCT00369486|9637925|FG001|STARTED|8-Week Visit|Number of eyes|21
8601720|NCT00369486|9637926|FG002|STARTED|8-Week Visit|Number of eyes|22
8601721|NCT00369486|9637927|FG003|STARTED|8-Week Visit|Number of eyes|22
8601722|NCT00369486|9637928|FG004|STARTED|8-Week Visit|Number of eyes|25
8601723|NCT00369486|9637924|FG000|COMPLETED|8-Week Visit|Number of eyes|38
8601724|NCT00369486|9637925|FG001|COMPLETED|8-Week Visit|Number of eyes|20
8601725|NCT00369486|9637926|FG002|COMPLETED|8-Week Visit|Number of eyes|22
8601726|NCT00369486|9637927|FG003|COMPLETED|8-Week Visit|Number of eyes|21
8601727|NCT00369486|9637928|FG004|COMPLETED|8-Week Visit|Number of eyes|24
8601728|NCT00369486|9637924|FG000|NOT COMPLETED|8-Week Visit||0
8601729|NCT00369486|9637925|FG001|NOT COMPLETED|8-Week Visit||1
8601730|NCT00369486|9637926|FG002|NOT COMPLETED|8-Week Visit||0
8601731|NCT00369486|9637927|FG003|NOT COMPLETED|8-Week Visit||1
8601732|NCT00369486|9637928|FG004|NOT COMPLETED|8-Week Visit||1
8601733|NCT00369486|9637924|FG000|STARTED|17-Week Visit|Number of eyes|38
8601734|NCT00369486|9637925|FG001|STARTED|17-Week Visit|Number of eyes|21
8601735|NCT00369486|9637926|FG002|STARTED|17-Week Visit|Number of eyes|23
8601736|NCT00369486|9637927|FG003|STARTED|17-Week Visit|Number of eyes|22
8601737|NCT00369486|9637928|FG004|STARTED|17-Week Visit|Number of eyes|25
8601738|NCT00369486|9637924|FG000|COMPLETED|17-Week Visit|Number of eyes|38
8601739|NCT00369486|9637925|FG001|COMPLETED|17-Week Visit|Number of eyes|21
8601740|NCT00369486|9637926|FG002|COMPLETED|17-Week Visit|Number of eyes|22
8601741|NCT00369486|9637927|FG003|COMPLETED|17-Week Visit|Number of eyes|21
8601742|NCT00369486|9637928|FG004|COMPLETED|17-Week Visit|Number of eyes|24
8601743|NCT00369486|9637924|FG000|NOT COMPLETED|17-Week Visit||0
8601744|NCT00369486|9637925|FG001|NOT COMPLETED|17-Week Visit||0
8601745|NCT00369486|9637926|FG002|NOT COMPLETED|17-Week Visit||1
8601746|NCT00369486|9637927|FG003|NOT COMPLETED|17-Week Visit||1
8714206|NCT00979121|9761074|FG000|COMPLETED|Overall Study||379
8813200|NCT01524679|9866358|FG001|STARTED|Overall Study||58
8714207|NCT00979121|9761075|FG001|COMPLETED|Overall Study||366
8714208|NCT00979121|9761074|FG000|NOT COMPLETED|Overall Study||0
8813201|NCT01524679|9866357|FG000|COMPLETED|Overall Study||89
8813202|NCT01524679|9866358|FG001|COMPLETED|Overall Study||49
8601747|NCT00369486|9637928|FG004|NOT COMPLETED|17-Week Visit||1
8601748|NCT00369486|9637924|FG000|STARTED|34-Week Visit|Number of eyes|38
8601749|NCT00369486|9637925|FG001|STARTED|34-Week Visit|Number of eyes|21
8601750|NCT00369486|9637926|FG002|STARTED|34-Week Visit|Number of eyes|23
8601751|NCT00369486|9637927|FG003|STARTED|34-Week Visit|Number of eyes|22
8601752|NCT00369486|9637928|FG004|STARTED|34-Week Visit|Number of eyes that|25
8601753|NCT00369486|9637924|FG000|COMPLETED|34-Week Visit|Number of eyes|38
8601754|NCT00369486|9637925|FG001|COMPLETED|34-Week Visit|Number of eyes|20
8601755|NCT00369486|9637926|FG002|COMPLETED|34-Week Visit|Number of eyes|22
8601756|NCT00369486|9637927|FG003|COMPLETED|34-Week Visit|Number of eyes|19
8601757|NCT00369486|9637928|FG004|COMPLETED|34-Week Visit|Number of eyes|22
8601758|NCT00369486|9637924|FG000|NOT COMPLETED|34-Week Visit||0
8601759|NCT00369486|9637925|FG001|NOT COMPLETED|34-Week Visit||1
8601760|NCT00369486|9637926|FG002|NOT COMPLETED|34-Week Visit||1
8601761|NCT00369486|9637927|FG003|NOT COMPLETED|34-Week Visit||3
8601762|NCT00369486|9637928|FG004|NOT COMPLETED|34-Week Visit||3
8601763|NCT00369512|9637940|FG000|STARTED|Overall Study||15
8601764|NCT00369512|9637940|FG000|COMPLETED|Overall Study||15
8601765|NCT00369512|9637940|FG000|NOT COMPLETED|Overall Study||0
8601766|NCT00369564|9637946|FG000|STARTED|Overall Study||127
8601767|NCT00369564|9637947|FG001|STARTED|Overall Study||123
8601768|NCT00369564|9637946|FG000|COMPLETED|Overall Study||84
8601769|NCT00369564|9637947|FG001|COMPLETED|Overall Study||100
8601770|NCT00369564|9637946|FG000|NOT COMPLETED|Overall Study||43
8601771|NCT00369564|9637947|FG001|NOT COMPLETED|Overall Study||23
8601772|NCT00369577|9637960|FG000|STARTED|Overall Study||43
8601773|NCT00369577|9637961|FG001|STARTED|Overall Study||45
8601774|NCT00369577|9637962|FG002|STARTED|Overall Study||41
8601775|NCT00369577|9637960|FG000|COMPLETED|Overall Study||43
8601776|NCT00369577|9637961|FG001|COMPLETED|Overall Study||45
8601777|NCT00369577|9637962|FG002|COMPLETED|Overall Study||40
8601778|NCT00369577|9637960|FG000|NOT COMPLETED|Overall Study||0
8601779|NCT00369577|9637961|FG001|NOT COMPLETED|Overall Study||0
8601780|NCT00369577|9637962|FG002|NOT COMPLETED|Overall Study||1
8601781|NCT00369590|9637972|FG000|STARTED|Overall Study||16
8601782|NCT00369590|9637973|FG001|STARTED|Overall Study||42
8601783|NCT00369590|9637972|FG000|COMPLETED|Overall Study||16
8601784|NCT00369590|9637973|FG001|COMPLETED|Overall Study||42
8601785|NCT00369590|9637972|FG000|NOT COMPLETED|Overall Study||0
8601786|NCT00369590|9637973|FG001|NOT COMPLETED|Overall Study||0
8601787|NCT00369629|9637978|FG000|STARTED|Treated 2 Cycles/Reached First Response||6
8601788|NCT00369629|9637979|FG001|STARTED|Treated 2 Cycles/Reached First Response||3
8601789|NCT00369629|9637980|FG002|STARTED|Treated 2 Cycles/Reached First Response||5
8601790|NCT00369629|9637981|FG003|STARTED|Treated 2 Cycles/Reached First Response|No patients were enrolled at this dose level as the study closed early due to lack of funding.|0
8601791|NCT00369629|9637978|FG000|COMPLETED|Treated 2 Cycles/Reached First Response||4
8601792|NCT00369629|9637979|FG001|COMPLETED|Treated 2 Cycles/Reached First Response||2
8601793|NCT00369629|9637980|FG002|COMPLETED|Treated 2 Cycles/Reached First Response||3
8601794|NCT00369629|9637981|FG003|COMPLETED|Treated 2 Cycles/Reached First Response||0
8601795|NCT00369629|9637978|FG000|NOT COMPLETED|Treated 2 Cycles/Reached First Response||2
8601796|NCT00369629|9637979|FG001|NOT COMPLETED|Treated 2 Cycles/Reached First Response||1
8601797|NCT00369629|9637980|FG002|NOT COMPLETED|Treated 2 Cycles/Reached First Response||2
8601798|NCT00369629|9637981|FG003|NOT COMPLETED|Treated 2 Cycles/Reached First Response||0
8601799|NCT00369629|9637978|FG000|STARTED|Moved on to 4 More Cycles||4
8601800|NCT00369629|9637979|FG001|STARTED|Moved on to 4 More Cycles||2
8601801|NCT00369629|9637980|FG002|STARTED|Moved on to 4 More Cycles||3
8601802|NCT00369629|9637981|FG003|STARTED|Moved on to 4 More Cycles||0
8601803|NCT00369629|9637978|FG000|COMPLETED|Moved on to 4 More Cycles||4
8601804|NCT00369629|9637979|FG001|COMPLETED|Moved on to 4 More Cycles||2
8601805|NCT00369629|9637980|FG002|COMPLETED|Moved on to 4 More Cycles||2
8601806|NCT00369629|9637981|FG003|COMPLETED|Moved on to 4 More Cycles||0
8601807|NCT00369629|9637978|FG000|NOT COMPLETED|Moved on to 4 More Cycles||0
8601808|NCT00369629|9637979|FG001|NOT COMPLETED|Moved on to 4 More Cycles||0
8601809|NCT00369629|9637980|FG002|NOT COMPLETED|Moved on to 4 More Cycles||1
8601810|NCT00369629|9637981|FG003|NOT COMPLETED|Moved on to 4 More Cycles||0
8601811|NCT00369629|9637978|FG000|STARTED|Completed 4 More Cycles||4
8601812|NCT00369629|9637979|FG001|STARTED|Completed 4 More Cycles||2
8601813|NCT00369629|9637980|FG002|STARTED|Completed 4 More Cycles||2
8601814|NCT00369629|9637981|FG003|STARTED|Completed 4 More Cycles||0
8601815|NCT00369629|9637978|FG000|COMPLETED|Completed 4 More Cycles||0
8601816|NCT00369629|9637979|FG001|COMPLETED|Completed 4 More Cycles||0
8601817|NCT00369629|9637980|FG002|COMPLETED|Completed 4 More Cycles||0
8601818|NCT00369629|9637981|FG003|COMPLETED|Completed 4 More Cycles||0
8601819|NCT00369629|9637978|FG000|NOT COMPLETED|Completed 4 More Cycles||4
8601820|NCT00369629|9637979|FG001|NOT COMPLETED|Completed 4 More Cycles||2
8601821|NCT00369629|9637980|FG002|NOT COMPLETED|Completed 4 More Cycles||2
8601822|NCT00369629|9637981|FG003|NOT COMPLETED|Completed 4 More Cycles||0
8601823|NCT00369629|9637978|FG000|STARTED|Follow up for 1 Year|All patients treated on study go into the follow up period|6
8601824|NCT00369629|9637979|FG001|STARTED|Follow up for 1 Year||3
8601825|NCT00369629|9637980|FG002|STARTED|Follow up for 1 Year||5
8601826|NCT00369629|9637981|FG003|STARTED|Follow up for 1 Year||0
8601827|NCT00369629|9637978|FG000|COMPLETED|Follow up for 1 Year||4
8601828|NCT00369629|9637979|FG001|COMPLETED|Follow up for 1 Year||1
8601829|NCT00369629|9637980|FG002|COMPLETED|Follow up for 1 Year||2
8601830|NCT00369629|9637981|FG003|COMPLETED|Follow up for 1 Year||0
8601831|NCT00369629|9637978|FG000|NOT COMPLETED|Follow up for 1 Year||2
8601832|NCT00369629|9637979|FG001|NOT COMPLETED|Follow up for 1 Year||2
8601833|NCT00369629|9637980|FG002|NOT COMPLETED|Follow up for 1 Year||3
8601834|NCT00369629|9637981|FG003|NOT COMPLETED|Follow up for 1 Year||0
8601835|NCT00369655|9637991|FG000|STARTED|Overall Study||21
8601836|NCT00369655|9637991|FG000|COMPLETED|Overall Study||19
8601837|NCT00369655|9637991|FG000|NOT COMPLETED|Overall Study||2
8601838|NCT00369668|9637998|FG000|STARTED|Overall Study|Original number of participants to be recruited for each group.|10
8601839|NCT00369668|9637999|FG001|STARTED|Overall Study||10
8601840|NCT00369668|9638000|FG002|STARTED|Overall Study||10
8601841|NCT00369668|9637998|FG000|COMPLETED|Overall Study||6
8601842|NCT00369668|9637999|FG001|COMPLETED|Overall Study||5
8601843|NCT00369668|9638000|FG002|COMPLETED|Overall Study||3
8601844|NCT00369668|9637998|FG000|NOT COMPLETED|Overall Study||4
8601845|NCT00369668|9637999|FG001|NOT COMPLETED|Overall Study||5
8601846|NCT00369668|9638000|FG002|NOT COMPLETED|Overall Study||7
8601847|NCT00369681|9638011|FG000|STARTED|Overall Study||50
8601848|NCT00369681|9638011|FG000|COMPLETED|Overall Study||49
8601849|NCT00369681|9638011|FG000|NOT COMPLETED|Overall Study||1
8601850|NCT00369707|9638015|FG000|STARTED|Induction Part A (1 Cycle -35 Days)||42
8601851|NCT00369707|9638015|FG000|COMPLETED|Induction Part A (1 Cycle -35 Days)||42
8601852|NCT00369707|9638015|FG000|NOT COMPLETED|Induction Part A (1 Cycle -35 Days)||0
8601853|NCT00369707|9638015|FG000|STARTED|Induction Part B (2 Cycles)||42
8601854|NCT00369707|9638015|FG000|COMPLETED|Induction Part B (2 Cycles)||35
8601855|NCT00369707|9638015|FG000|NOT COMPLETED|Induction Part B (2 Cycles)||7
8601856|NCT00369707|9638015|FG000|STARTED|Maintenance Period (up to 4 Cycles)||35
8601857|NCT00369707|9638015|FG000|COMPLETED|Maintenance Period (up to 4 Cycles)||27
8601858|NCT00369707|9638015|FG000|NOT COMPLETED|Maintenance Period (up to 4 Cycles)||8
8601859|NCT00369707|9638015|FG000|STARTED|Follow up for 2 Years After Treatment||41
8601860|NCT00369707|9638015|FG000|COMPLETED|Follow up for 2 Years After Treatment||38
8601861|NCT00369707|9638015|FG000|NOT COMPLETED|Follow up for 2 Years After Treatment||3
8601862|NCT00369746|9638021|FG000|STARTED|Overall Study||138
8601863|NCT00369746|9638022|FG001|STARTED|Overall Study||536
8601864|NCT00369746|9638021|FG000|COMPLETED|Overall Study||138
8601865|NCT00369746|9638022|FG001|COMPLETED|Overall Study||536
8601866|NCT00369746|9638021|FG000|NOT COMPLETED|Overall Study||0
8601867|NCT00369746|9638022|FG001|NOT COMPLETED|Overall Study||0
8601868|NCT00369785|9638030|FG000|STARTED|Overall Study||99
8601869|NCT00369785|9638031|FG001|STARTED|Overall Study||99
8714209|NCT00979121|9761075|FG001|NOT COMPLETED|Overall Study||0
8714210|NCT00979134|9761090|FG000|STARTED|Overall Study||43
8714211|NCT00979134|9761091|FG001|STARTED|Overall Study||6
8714212|NCT00979134|9761092|FG002|STARTED|Overall Study||45
8714213|NCT00979134|9761090|FG000|COMPLETED|Overall Study|At DCO|10
8714214|NCT00979134|9761091|FG001|COMPLETED|Overall Study|At DCO|0
8601870|NCT00369785|9638030|FG000|COMPLETED|Overall Study||72
8601871|NCT00369785|9638031|FG001|COMPLETED|Overall Study||74
8601872|NCT00369785|9638030|FG000|NOT COMPLETED|Overall Study||27
8601873|NCT00369785|9638031|FG001|NOT COMPLETED|Overall Study||25
8601874|NCT00369824|9638043|FG000|STARTED|Overall Study||212
8601875|NCT00369824|9638044|FG001|STARTED|Overall Study||214
8601876|NCT00369824|9638045|FG002|STARTED|Overall Study||214
8601877|NCT00369824|9638046|FG003|STARTED|Overall Study||214
8601878|NCT00369824|9638047|FG004|STARTED|Overall Study||214
8601879|NCT00369824|9638048|FG005|STARTED|Overall Study||215
8601880|NCT00369824|9638043|FG000|COMPLETED|Overall Study||197
8601881|NCT00369824|9638044|FG001|COMPLETED|Overall Study||195
8601882|NCT00369824|9638045|FG002|COMPLETED|Overall Study||202
8601883|NCT00369824|9638046|FG003|COMPLETED|Overall Study||199
8601884|NCT00369824|9638047|FG004|COMPLETED|Overall Study||196
8601885|NCT00369824|9638048|FG005|COMPLETED|Overall Study||204
8601886|NCT00369824|9638043|FG000|NOT COMPLETED|Overall Study||15
8601887|NCT00369824|9638044|FG001|NOT COMPLETED|Overall Study||19
8601888|NCT00369824|9638045|FG002|NOT COMPLETED|Overall Study||12
8601889|NCT00369824|9638046|FG003|NOT COMPLETED|Overall Study||15
8601890|NCT00369824|9638047|FG004|NOT COMPLETED|Overall Study||18
8601891|NCT00369824|9638048|FG005|NOT COMPLETED|Overall Study||11
8601892|NCT00369915|9638064|FG000|STARTED|Overall Study||10
8601893|NCT00369915|9638065|FG001|STARTED|Overall Study||7
8601894|NCT00369915|9638064|FG000|COMPLETED|Overall Study||4
8601895|NCT00369915|9638065|FG001|COMPLETED|Overall Study||4
8601896|NCT00369915|9638064|FG000|NOT COMPLETED|Overall Study||6
8601897|NCT00369915|9638065|FG001|NOT COMPLETED|Overall Study||3
8601898|NCT00369928|9638074|FG000|STARTED|Overall Study||85
8601899|NCT00369928|9638075|FG001|STARTED|Overall Study||85
8601900|NCT00369928|9638076|FG002|STARTED|Overall Study||86
8601901|NCT00369928|9638074|FG000|COMPLETED|Overall Study||77
8601902|NCT00369928|9638075|FG001|COMPLETED|Overall Study||69
8601903|NCT00369928|9638076|FG002|COMPLETED|Overall Study||66
8601904|NCT00369928|9638074|FG000|NOT COMPLETED|Overall Study||8
8601905|NCT00369928|9638075|FG001|NOT COMPLETED|Overall Study||16
8601906|NCT00369928|9638076|FG002|NOT COMPLETED|Overall Study||20
8601907|NCT00369941|9638086|FG000|STARTED|Overall Study||282
8601908|NCT00369941|9638087|FG001|STARTED|Overall Study||284
8601909|NCT00369941|9638086|FG000|Treated|Overall Study||281
8601910|NCT00369941|9638087|FG001|Treated|Overall Study||282
8601911|NCT00369941|9638086|FG000|COMPLETED|Overall Study||210
8601912|NCT00369941|9638087|FG001|COMPLETED|Overall Study||184
8601913|NCT00369941|9638086|FG000|NOT COMPLETED|Overall Study||72
8601914|NCT00369941|9638087|FG001|NOT COMPLETED|Overall Study||100
8601915|NCT00369967|9638096|FG000|STARTED|Overall Study||31
8601916|NCT00369967|9638097|FG001|STARTED|Overall Study||17
8601917|NCT00369967|9638096|FG000|COMPLETED|Overall Study||8
8601918|NCT00369967|9638097|FG001|COMPLETED|Overall Study||5
8601919|NCT00369967|9638096|FG000|NOT COMPLETED|Overall Study||23
8601920|NCT00369967|9638097|FG001|NOT COMPLETED|Overall Study||12
8601921|NCT00370032|9638109|FG000|STARTED|Treatment Period 1|Safety Population - all subjects who took at least one dose of study medication.|24
8601922|NCT00370032|9638110|FG001|STARTED|Treatment Period 1|Safety Population - all subjects who took at least one dose of study medication.|25
8601923|NCT00370032|9638109|FG000|COMPLETED|Treatment Period 1||24
8601924|NCT00370032|9638110|FG001|COMPLETED|Treatment Period 1||24
8601925|NCT00370032|9638109|FG000|NOT COMPLETED|Treatment Period 1||0
8601926|NCT00370032|9638110|FG001|NOT COMPLETED|Treatment Period 1||1
8601927|NCT00370032|9638109|FG000|STARTED|Washout Period||24
8601928|NCT00370032|9638110|FG001|STARTED|Washout Period||24
8601929|NCT00370032|9638109|FG000|COMPLETED|Washout Period||23
8601930|NCT00370032|9638110|FG001|COMPLETED|Washout Period||22
8601931|NCT00370032|9638109|FG000|NOT COMPLETED|Washout Period||1
8601932|NCT00370032|9638110|FG001|NOT COMPLETED|Washout Period||2
8601933|NCT00370032|9638109|FG000|STARTED|Treatment Period 2||23
8601934|NCT00370032|9638110|FG001|STARTED|Treatment Period 2||22
8601935|NCT00370032|9638109|FG000|COMPLETED|Treatment Period 2||23
8601936|NCT00370032|9638110|FG001|COMPLETED|Treatment Period 2||22
8601937|NCT00370032|9638109|FG000|NOT COMPLETED|Treatment Period 2||0
8601938|NCT00370032|9638110|FG001|NOT COMPLETED|Treatment Period 2||0
8601939|NCT00370032|9638109|FG000|STARTED|Follow-up Period||23
8601940|NCT00370032|9638110|FG001|STARTED|Follow-up Period||22
8601941|NCT00370032|9638109|FG000|COMPLETED|Follow-up Period||22
8601942|NCT00370032|9638110|FG001|COMPLETED|Follow-up Period||22
8601943|NCT00370032|9638109|FG000|NOT COMPLETED|Follow-up Period||1
8601944|NCT00370032|9638110|FG001|NOT COMPLETED|Follow-up Period||0
8601945|NCT00370071|9638125|FG000|STARTED|Overall Study||39
8601946|NCT00370071|9638125|FG000|COMPLETED|Overall Study||37
8601947|NCT00370071|9638125|FG000|NOT COMPLETED|Overall Study||2
8601948|NCT00370149|9638131|FG000|STARTED|Overall Study||165
8601949|NCT00370149|9638132|FG001|STARTED|Overall Study||161
8601950|NCT00370149|9638131|FG000|COMPLETED|Overall Study||146
8601951|NCT00370149|9638132|FG001|COMPLETED|Overall Study||142
8601952|NCT00370149|9638131|FG000|NOT COMPLETED|Overall Study||19
8601953|NCT00370149|9638132|FG001|NOT COMPLETED|Overall Study||19
8601954|NCT00370292|9638143|FG000|STARTED|Overall Study||19
8601955|NCT00370292|9638143|FG000|COMPLETED|Overall Study||6
8601956|NCT00370292|9638143|FG000|NOT COMPLETED|Overall Study||13
8628587|NCT00525174|9668099|FG000|STARTED|Overall Study||97
8628588|NCT00525174|9668100|FG001|STARTED|Overall Study||89
8628589|NCT00525174|9668099|FG000|COMPLETED|Overall Study||88
8628590|NCT00525174|9668100|FG001|COMPLETED|Overall Study||81
8628591|NCT00525174|9668099|FG000|NOT COMPLETED|Overall Study||9
8628592|NCT00525174|9668100|FG001|NOT COMPLETED|Overall Study||8
8628593|NCT00525265|9668108|FG000|STARTED|Overall Study||10
8628594|NCT00525265|9668109|FG001|STARTED|Overall Study||10
8628595|NCT00525265|9668108|FG000|COMPLETED|Overall Study||9
8628596|NCT00525265|9668109|FG001|COMPLETED|Overall Study||10
8628597|NCT00525265|9668108|FG000|NOT COMPLETED|Overall Study||1
8628598|NCT00525265|9668109|FG001|NOT COMPLETED|Overall Study||0
8628599|NCT00525421|9668117|FG000|STARTED|Overall Study|Enrollment started october 2007|10
8628600|NCT00525421|9668118|FG001|STARTED|Overall Study||10
8628601|NCT00525421|9668117|FG000|COMPLETED|Overall Study||10
8628602|NCT00525421|9668118|FG001|COMPLETED|Overall Study||10
8628603|NCT00525421|9668117|FG000|NOT COMPLETED|Overall Study||0
8628604|NCT00525421|9668118|FG001|NOT COMPLETED|Overall Study||0
8628605|NCT00525499|9668128|FG000|STARTED|Overall Study||47
8628606|NCT00525499|9668129|FG001|STARTED|Overall Study||46
8628607|NCT00525499|9668130|FG002|STARTED|Overall Study||47
8628608|NCT00525499|9668131|FG003|STARTED|Overall Study||46
8628609|NCT00525499|9668128|FG000|COMPLETED|Overall Study||40
8628610|NCT00525499|9668129|FG001|COMPLETED|Overall Study||39
8628611|NCT00525499|9668130|FG002|COMPLETED|Overall Study||40
8628612|NCT00525499|9668131|FG003|COMPLETED|Overall Study||39
8628613|NCT00525499|9668128|FG000|NOT COMPLETED|Overall Study||7
8628614|NCT00525499|9668129|FG001|NOT COMPLETED|Overall Study||7
8628615|NCT00525499|9668130|FG002|NOT COMPLETED|Overall Study||7
8628616|NCT00525499|9668131|FG003|NOT COMPLETED|Overall Study||7
8628617|NCT00525512|9668143|FG000|STARTED|Double-Blind Phase||259
8628618|NCT00525512|9668144|FG001|STARTED|Double-Blind Phase||260
8628619|NCT00525512|9668145|FG002|STARTED|Double-Blind Phase||0
8628620|NCT00525512|9668146|FG003|STARTED|Double-Blind Phase||0
8628621|NCT00525512|9668143|FG000|COMPLETED|Double-Blind Phase||163
8628622|NCT00525512|9668144|FG001|COMPLETED|Double-Blind Phase||194
8628623|NCT00525512|9668145|FG002|COMPLETED|Double-Blind Phase||0
8628624|NCT00525512|9668146|FG003|COMPLETED|Double-Blind Phase||0
8628625|NCT00525512|9668143|FG000|NOT COMPLETED|Double-Blind Phase||96
8628626|NCT00525512|9668144|FG001|NOT COMPLETED|Double-Blind Phase||66
8628627|NCT00525512|9668145|FG002|NOT COMPLETED|Double-Blind Phase||0
8628628|NCT00525512|9668146|FG003|NOT COMPLETED|Double-Blind Phase||0
8628629|NCT00525512|9668143|FG000|STARTED|Open-Label Phase||0
8628630|NCT00525512|9668144|FG001|STARTED|Open-Label Phase||0
8628631|NCT00525512|9668145|FG002|STARTED|Open-Label Phase||164
8628632|NCT00525512|9668146|FG003|STARTED|Open-Label Phase||194
8601957|NCT04876274|9638156|FG000|STARTED|Overall Study||91
8601958|NCT04876274|9638157|FG001|STARTED|Overall Study||90
8601959|NCT04876274|9638156|FG000|COMPLETED|Overall Study||82
8601960|NCT04876274|9638157|FG001|COMPLETED|Overall Study||78
8601961|NCT04876274|9638156|FG000|NOT COMPLETED|Overall Study||9
8601962|NCT04876274|9638157|FG001|NOT COMPLETED|Overall Study||12
8601963|NCT04656691|9638163|FG000|STARTED|Overall Study||139
8601964|NCT04656691|9638163|FG000|COMPLETED|Overall Study||138
8601965|NCT04656691|9638163|FG000|NOT COMPLETED|Overall Study||1
8601966|NCT04615299|9638169|FG000|STARTED|Overall Study||36
8601967|NCT04615299|9638170|FG001|STARTED|Overall Study||36
8601968|NCT04615299|9638169|FG000|COMPLETED|Overall Study||36
8601969|NCT04615299|9638170|FG001|COMPLETED|Overall Study||36
8601970|NCT04615299|9638169|FG000|NOT COMPLETED|Overall Study||0
8601971|NCT04615299|9638170|FG001|NOT COMPLETED|Overall Study||0
8601972|NCT04555096|9638178|FG000|STARTED|Overall Study||9
8601973|NCT04555096|9638179|FG001|STARTED|Overall Study||7
8601974|NCT04555096|9638178|FG000|COMPLETED|Overall Study||4
8601975|NCT04555096|9638179|FG001|COMPLETED|Overall Study||2
8601976|NCT04555096|9638178|FG000|NOT COMPLETED|Overall Study||5
8601977|NCT04555096|9638179|FG001|NOT COMPLETED|Overall Study||5
8601978|NCT04150341|9638185|FG000|STARTED|Overall Study||4
8601979|NCT04150341|9638186|FG001|STARTED|Overall Study||4
8601980|NCT04150341|9638187|FG002|STARTED|Overall Study||4
8601981|NCT04150341|9638188|FG003|STARTED|Overall Study||4
8601982|NCT04150341|9638189|FG004|STARTED|Overall Study||4
8601983|NCT04150341|9638190|FG005|STARTED|Overall Study||4
8601984|NCT04150341|9638185|FG000|COMPLETED|Overall Study||4
8601985|NCT04150341|9638186|FG001|COMPLETED|Overall Study||4
8601986|NCT04150341|9638187|FG002|COMPLETED|Overall Study||3
8601987|NCT04150341|9638188|FG003|COMPLETED|Overall Study||4
8601988|NCT04150341|9638189|FG004|COMPLETED|Overall Study||3
8601989|NCT04150341|9638190|FG005|COMPLETED|Overall Study||4
8601990|NCT04150341|9638185|FG000|NOT COMPLETED|Overall Study||0
8601991|NCT04150341|9638186|FG001|NOT COMPLETED|Overall Study||0
8601992|NCT04150341|9638187|FG002|NOT COMPLETED|Overall Study||1
8601993|NCT04150341|9638188|FG003|NOT COMPLETED|Overall Study||0
8601994|NCT04150341|9638189|FG004|NOT COMPLETED|Overall Study||1
8601995|NCT04150341|9638190|FG005|NOT COMPLETED|Overall Study||0
8601996|NCT04115839|9638203|FG000|STARTED|Main Study (Up to 16 Weeks)||36
8601997|NCT04115839|9638204|FG001|STARTED|Main Study (Up to 16 Weeks)||34
8601998|NCT04115839|9638205|FG002|STARTED|Main Study (Up to 16 Weeks)||36
8601999|NCT04115839|9638206|FG003|STARTED|Main Study (Up to 16 Weeks)||0
8602000|NCT04115839|9638207|FG004|STARTED|Main Study (Up to 16 Weeks)||0
8602001|NCT04115839|9638208|FG005|STARTED|Main Study (Up to 16 Weeks)||0
8602002|NCT04115839|9638209|FG006|STARTED|Main Study (Up to 16 Weeks)||0
8602003|NCT04115839|9638203|FG000|COMPLETED|Main Study (Up to 16 Weeks)||18
8602004|NCT04115839|9638204|FG001|COMPLETED|Main Study (Up to 16 Weeks)||20
8602005|NCT04115839|9638205|FG002|COMPLETED|Main Study (Up to 16 Weeks)||18
8602006|NCT04115839|9638206|FG003|COMPLETED|Main Study (Up to 16 Weeks)||0
8602007|NCT04115839|9638207|FG004|COMPLETED|Main Study (Up to 16 Weeks)||0
8602008|NCT04115839|9638208|FG005|COMPLETED|Main Study (Up to 16 Weeks)||0
8602009|NCT04115839|9638209|FG006|COMPLETED|Main Study (Up to 16 Weeks)||0
8602010|NCT04115839|9638203|FG000|NOT COMPLETED|Main Study (Up to 16 Weeks)||18
8602011|NCT04115839|9638204|FG001|NOT COMPLETED|Main Study (Up to 16 Weeks)||14
8602012|NCT04115839|9638205|FG002|NOT COMPLETED|Main Study (Up to 16 Weeks)||18
8602013|NCT04115839|9638206|FG003|NOT COMPLETED|Main Study (Up to 16 Weeks)||0
8602014|NCT04115839|9638207|FG004|NOT COMPLETED|Main Study (Up to 16 Weeks)||0
8602015|NCT04115839|9638208|FG005|NOT COMPLETED|Main Study (Up to 16 Weeks)||0
8602016|NCT04115839|9638209|FG006|NOT COMPLETED|Main Study (Up to 16 Weeks)||0
8602017|NCT04115839|9638203|FG000|STARTED|LTE Phase (After Week 16 to Week 63)|Participants who completed main study were randomised in LTE phase to receive filgotinib 200 mg or 100 mg.|0
8602018|NCT04115839|9638204|FG001|STARTED|LTE Phase (After Week 16 to Week 63)|Participants who completed main study were randomised in LTE phase to receive filgotinib 200 mg or 100 mg.|0
8602019|NCT04115839|9638205|FG002|STARTED|LTE Phase (After Week 16 to Week 63)|18 participants who completed main study did not enter LTE phase.|0
8602020|NCT04115839|9638206|FG003|STARTED|LTE Phase (After Week 16 to Week 63)|Participants who completed main study were randomised in LTE phase to receive filgotinib 200 mg or 100 mg.|18
8602021|NCT04115839|9638207|FG004|STARTED|LTE Phase (After Week 16 to Week 63)|Participants who completed main study were randomised in LTE phase to receive filgotinib 200 mg or 100 mg.|20
8602022|NCT04115839|9638208|FG005|STARTED|LTE Phase (After Week 16 to Week 63)|10 participants who received placebo and completed main study were randomised in LTE phase to receive filgotinib 200 mg.|10
8602023|NCT04115839|9638209|FG006|STARTED|LTE Phase (After Week 16 to Week 63)|8 participants who received placebo and completed main study were randomised in LTE phase to receive filgotinib 100 mg.|8
8602024|NCT04115839|9638203|FG000|COMPLETED|LTE Phase (After Week 16 to Week 63)||0
8602025|NCT04115839|9638204|FG001|COMPLETED|LTE Phase (After Week 16 to Week 63)||0
8602026|NCT04115839|9638205|FG002|COMPLETED|LTE Phase (After Week 16 to Week 63)||0
8602027|NCT04115839|9638206|FG003|COMPLETED|LTE Phase (After Week 16 to Week 63)||0
8602028|NCT04115839|9638207|FG004|COMPLETED|LTE Phase (After Week 16 to Week 63)||0
8602029|NCT04115839|9638208|FG005|COMPLETED|LTE Phase (After Week 16 to Week 63)||0
8602030|NCT04115839|9638209|FG006|COMPLETED|LTE Phase (After Week 16 to Week 63)||0
8602031|NCT04115839|9638203|FG000|NOT COMPLETED|LTE Phase (After Week 16 to Week 63)||0
8602032|NCT04115839|9638204|FG001|NOT COMPLETED|LTE Phase (After Week 16 to Week 63)||0
8602033|NCT04115839|9638205|FG002|NOT COMPLETED|LTE Phase (After Week 16 to Week 63)||0
8602034|NCT04115839|9638206|FG003|NOT COMPLETED|LTE Phase (After Week 16 to Week 63)||18
8602035|NCT04115839|9638207|FG004|NOT COMPLETED|LTE Phase (After Week 16 to Week 63)||20
8602036|NCT04115839|9638208|FG005|NOT COMPLETED|LTE Phase (After Week 16 to Week 63)||10
8602037|NCT04115839|9638209|FG006|NOT COMPLETED|LTE Phase (After Week 16 to Week 63)||8
8628633|NCT00525512|9668143|FG000|COMPLETED|Open-Label Phase||0
8628634|NCT00525512|9668144|FG001|COMPLETED|Open-Label Phase||0
8628635|NCT00525512|9668145|FG002|COMPLETED|Open-Label Phase||158
8628636|NCT00525512|9668146|FG003|COMPLETED|Open-Label Phase||189
8628637|NCT00525512|9668143|FG000|NOT COMPLETED|Open-Label Phase||0
8628638|NCT00525512|9668144|FG001|NOT COMPLETED|Open-Label Phase||0
8628639|NCT00525512|9668145|FG002|NOT COMPLETED|Open-Label Phase||6
8628640|NCT00525512|9668146|FG003|NOT COMPLETED|Open-Label Phase||5
8628641|NCT00525525|9668160|FG000|STARTED|Overall Study||59
8628642|NCT00525525|9668161|FG001|STARTED|Overall Study||15
8628643|NCT00525525|9668160|FG000|COMPLETED|Overall Study||59
8628644|NCT00525525|9668161|FG001|COMPLETED|Overall Study||15
8628645|NCT00525525|9668160|FG000|NOT COMPLETED|Overall Study||0
8628646|NCT00525525|9668161|FG001|NOT COMPLETED|Overall Study||0
8628647|NCT00525590|9668167|FG000|STARTED|Overall Study||59
8628648|NCT00525590|9668167|FG000|COMPLETED|Overall Study||14
8628649|NCT00525590|9668167|FG000|NOT COMPLETED|Overall Study||45
8628650|NCT00525603|9668171|FG000|STARTED|Overall Study||60
8628651|NCT00525603|9668171|FG000|COMPLETED|Overall Study||60
8628652|NCT00525603|9668171|FG000|NOT COMPLETED|Overall Study||0
8628653|NCT00525629|9668175|FG000|STARTED|First Intervention||20
8628654|NCT00525629|9668176|FG001|STARTED|First Intervention||20
8628655|NCT00525629|9668175|FG000|COMPLETED|First Intervention||15
8628656|NCT00525629|9668176|FG001|COMPLETED|First Intervention||15
8628657|NCT00525629|9668175|FG000|NOT COMPLETED|First Intervention||5
8628658|NCT00525629|9668176|FG001|NOT COMPLETED|First Intervention||5
8628659|NCT00525629|9668175|FG000|STARTED|Washout||15
8628660|NCT00525629|9668176|FG001|STARTED|Washout||15
8628661|NCT00525629|9668175|FG000|COMPLETED|Washout||15
8628662|NCT00525629|9668176|FG001|COMPLETED|Washout||15
8628663|NCT00525629|9668175|FG000|NOT COMPLETED|Washout||0
8628664|NCT00525629|9668176|FG001|NOT COMPLETED|Washout||0
8628665|NCT00525629|9668175|FG000|STARTED|Second Intervention||15
8628666|NCT00525629|9668176|FG001|STARTED|Second Intervention||15
8628667|NCT00525629|9668175|FG000|COMPLETED|Second Intervention||0
8628668|NCT00525629|9668176|FG001|COMPLETED|Second Intervention||0
8628669|NCT00525629|9668175|FG000|NOT COMPLETED|Second Intervention||15
8628670|NCT00525629|9668176|FG001|NOT COMPLETED|Second Intervention||15
8628671|NCT00525733|9668184|FG000|STARTED|Overall Study||14
8628672|NCT00525733|9668185|FG001|STARTED|Overall Study||26
8628673|NCT00525733|9668184|FG000|COMPLETED|Overall Study||11
8628674|NCT00525733|9668185|FG001|COMPLETED|Overall Study||23
8628675|NCT00525733|9668184|FG000|NOT COMPLETED|Overall Study||3
8628676|NCT00525733|9668185|FG001|NOT COMPLETED|Overall Study||3
8628677|NCT00525785|9668191|FG000|STARTED|Overall Study||58
8628678|NCT00525785|9668191|FG000|COMPLETED|Overall Study||55
8628679|NCT00525785|9668191|FG000|NOT COMPLETED|Overall Study||3
8628680|NCT00525798|9668197|FG000|STARTED|Overall Study||2334
8628681|NCT00525798|9668198|FG001|STARTED|Overall Study||2331
8628682|NCT00525798|9668197|FG000|COMPLETED|Overall Study||1578
8628683|NCT00525798|9668198|FG001|COMPLETED|Overall Study||1732
8628684|NCT00525798|9668197|FG000|NOT COMPLETED|Overall Study||756
8628685|NCT00525798|9668198|FG001|NOT COMPLETED|Overall Study||599
8628686|NCT00525824|9668208|FG000|STARTED|Overall Study|Randomized population|214
8628687|NCT00525824|9668209|FG001|STARTED|Overall Study|Randomized population|214
8628688|NCT00525824|9668210|FG002|STARTED|Overall Study|Randomized population|202
8628689|NCT00525824|9668211|FG003|STARTED|Overall Study|Randomized population|203
8628690|NCT00525824|9668208|FG000|COMPLETED|Overall Study||195
8628691|NCT00525824|9668209|FG001|COMPLETED|Overall Study||186
8628692|NCT00525824|9668210|FG002|COMPLETED|Overall Study||183
8628693|NCT00525824|9668211|FG003|COMPLETED|Overall Study||188
8628694|NCT00525824|9668208|FG000|NOT COMPLETED|Overall Study||19
8628695|NCT00525824|9668209|FG001|NOT COMPLETED|Overall Study||28
8628696|NCT00525824|9668210|FG002|NOT COMPLETED|Overall Study||19
8628697|NCT00525824|9668211|FG003|NOT COMPLETED|Overall Study||15
8628698|NCT00525837|9668225|FG000|STARTED|Overall Study||18
8628699|NCT00525837|9668225|FG000|COMPLETED|Overall Study||14
8628700|NCT00525837|9668225|FG000|NOT COMPLETED|Overall Study||4
8628701|NCT00525876|9668232|FG000|STARTED|Overall Study||16
8628702|NCT00525876|9668233|FG001|STARTED|Overall Study||20
8628703|NCT00525876|9668232|FG000|COMPLETED|Overall Study||16
8628704|NCT00525876|9668233|FG001|COMPLETED|Overall Study||20
8628705|NCT00525876|9668232|FG000|NOT COMPLETED|Overall Study||0
8628706|NCT00525876|9668233|FG001|NOT COMPLETED|Overall Study||0
8628707|NCT00525902|9668239|FG000|STARTED|Overall Study||31
8628708|NCT00525902|9668239|FG000|10 Weeks|Overall Study||30
8628709|NCT00525902|9668239|FG000|50 Weeks|Overall Study||12
8628710|NCT00525902|9668239|FG000|COMPLETED|Overall Study||30
8628711|NCT00525902|9668239|FG000|NOT COMPLETED|Overall Study||1
8628712|NCT00525915|9668245|FG000|STARTED|Overall Study||63
8628713|NCT00525915|9668246|FG001|STARTED|Overall Study||63
8628714|NCT00525915|9668245|FG000|COMPLETED|Overall Study|Participants who underwent surgery.|55
8628715|NCT00525915|9668246|FG001|COMPLETED|Overall Study||54
8628716|NCT00525915|9668245|FG000|NOT COMPLETED|Overall Study||8
8628717|NCT00525915|9668246|FG001|NOT COMPLETED|Overall Study||9
8628718|NCT00526058|9668254|FG000|STARTED|Period: First Intervention||9
8602038|NCT04078126|9638234|FG000|STARTED|Period 1||18
8602039|NCT04078126|9638235|FG001|STARTED|Period 1||17
8602040|NCT04078126|9638234|FG000|COMPLETED|Period 1||18
8602041|NCT04078126|9638235|FG001|COMPLETED|Period 1||17
8602042|NCT04078126|9638234|FG000|NOT COMPLETED|Period 1||0
8602043|NCT04078126|9638235|FG001|NOT COMPLETED|Period 1||0
8602044|NCT04078126|9638234|FG000|STARTED|Washout||18
8602045|NCT04078126|9638235|FG001|STARTED|Washout||17
8602046|NCT04078126|9638234|FG000|COMPLETED|Washout||18
8602047|NCT04078126|9638235|FG001|COMPLETED|Washout||15
8602048|NCT04078126|9638234|FG000|NOT COMPLETED|Washout||0
8602049|NCT04078126|9638235|FG001|NOT COMPLETED|Washout||2
8602050|NCT04078126|9638234|FG000|STARTED|Period 2||18
8602051|NCT04078126|9638235|FG001|STARTED|Period 2||15
8602052|NCT04078126|9638234|FG000|COMPLETED|Period 2||17
8602053|NCT04078126|9638235|FG001|COMPLETED|Period 2||14
8602054|NCT04078126|9638234|FG000|NOT COMPLETED|Period 2||1
8602055|NCT04078126|9638235|FG001|NOT COMPLETED|Period 2||1
8602056|NCT03825341|9638243|FG000|STARTED|Overall Study||0
8602057|NCT03825341|9638244|FG001|STARTED|Overall Study||1
8602058|NCT03825341|9638243|FG000|COMPLETED|Overall Study||0
8602059|NCT03825341|9638244|FG001|COMPLETED|Overall Study||0
8602060|NCT03825341|9638243|FG000|NOT COMPLETED|Overall Study||0
8602061|NCT03825341|9638244|FG001|NOT COMPLETED|Overall Study||1
8602062|NCT03751631|9638252|FG000|STARTED|Overall Study||10
8602063|NCT03751631|9638253|FG001|STARTED|Overall Study||11
8602064|NCT03751631|9638254|FG002|STARTED|Overall Study||11
8602065|NCT03751631|9638255|FG003|STARTED|Overall Study||11
8602066|NCT03751631|9638256|FG004|STARTED|Overall Study||10
8602067|NCT03751631|9638257|FG005|STARTED|Overall Study||11
8602068|NCT03751631|9638252|FG000|Received 1st Drug in Sequence|Overall Study||10
8602069|NCT03751631|9638253|FG001|Received 1st Drug in Sequence|Overall Study||11
8602070|NCT03751631|9638254|FG002|Received 1st Drug in Sequence|Overall Study||11
8602071|NCT03751631|9638255|FG003|Received 1st Drug in Sequence|Overall Study||11
8602072|NCT03751631|9638256|FG004|Received 1st Drug in Sequence|Overall Study||10
8602073|NCT03751631|9638257|FG005|Received 1st Drug in Sequence|Overall Study||11
8602074|NCT03751631|9638252|FG000|Received 2nd Drug in Sequence|Overall Study||10
8602075|NCT03751631|9638253|FG001|Received 2nd Drug in Sequence|Overall Study||11
8602076|NCT03751631|9638254|FG002|Received 2nd Drug in Sequence|Overall Study||10
8602077|NCT03751631|9638255|FG003|Received 2nd Drug in Sequence|Overall Study||10
8602078|NCT03751631|9638256|FG004|Received 2nd Drug in Sequence|Overall Study||10
8602079|NCT03751631|9638257|FG005|Received 2nd Drug in Sequence|Overall Study||11
8602080|NCT03751631|9638252|FG000|Received 3rd Drug in Sequence|Overall Study||10
8602081|NCT03751631|9638253|FG001|Received 3rd Drug in Sequence|Overall Study||11
8602082|NCT03751631|9638254|FG002|Received 3rd Drug in Sequence|Overall Study||10
8602083|NCT03751631|9638255|FG003|Received 3rd Drug in Sequence|Overall Study||10
8602084|NCT03751631|9638256|FG004|Received 3rd Drug in Sequence|Overall Study||10
8602085|NCT03751631|9638257|FG005|Received 3rd Drug in Sequence|Overall Study||11
8602086|NCT03751631|9638252|FG000|COMPLETED|Overall Study||10
8602087|NCT03751631|9638253|FG001|COMPLETED|Overall Study||11
8602088|NCT03751631|9638254|FG002|COMPLETED|Overall Study||10
8602089|NCT03751631|9638255|FG003|COMPLETED|Overall Study||10
8602090|NCT03751631|9638256|FG004|COMPLETED|Overall Study||10
8602091|NCT03751631|9638257|FG005|COMPLETED|Overall Study||11
8602092|NCT03751631|9638252|FG000|NOT COMPLETED|Overall Study||0
8602093|NCT03751631|9638253|FG001|NOT COMPLETED|Overall Study||0
8602094|NCT03751631|9638254|FG002|NOT COMPLETED|Overall Study||1
8602095|NCT03751631|9638255|FG003|NOT COMPLETED|Overall Study||1
8602096|NCT03751631|9638256|FG004|NOT COMPLETED|Overall Study||0
8602097|NCT03751631|9638257|FG005|NOT COMPLETED|Overall Study||0
8602098|NCT03751098|9638268|FG000|STARTED|Overall Study||37
8602099|NCT03751098|9638269|FG001|STARTED|Overall Study||33
8602100|NCT03751098|9638268|FG000|COMPLETED|Overall Study||37
8602101|NCT03751098|9638269|FG001|COMPLETED|Overall Study||32
8602102|NCT03751098|9638268|FG000|NOT COMPLETED|Overall Study||0
8602103|NCT03751098|9638269|FG001|NOT COMPLETED|Overall Study||1
8602104|NCT03673345|9638285|FG000|STARTED|Overall Study||5
8602105|NCT03673345|9638286|FG001|STARTED|Overall Study||3
8602106|NCT03673345|9638287|FG002|STARTED|Overall Study||57
8602107|NCT03673345|9638288|FG003|STARTED|Overall Study||12
8602108|NCT03673345|9638289|FG004|STARTED|Overall Study||21
8602109|NCT03673345|9638290|FG005|STARTED|Overall Study||7
8602110|NCT03673345|9638291|FG006|STARTED|Overall Study||20
8602111|NCT03673345|9638292|FG007|STARTED|Overall Study||0
8602112|NCT03673345|9638285|FG000|COMPLETED|Overall Study||3
8602113|NCT03673345|9638286|FG001|COMPLETED|Overall Study||3
8602114|NCT03673345|9638287|FG002|COMPLETED|Overall Study||48
8602115|NCT03673345|9638288|FG003|COMPLETED|Overall Study||7
8602116|NCT03673345|9638289|FG004|COMPLETED|Overall Study||19
8602117|NCT03673345|9638290|FG005|COMPLETED|Overall Study||6
8602118|NCT03673345|9638291|FG006|COMPLETED|Overall Study||20
8602119|NCT03673345|9638292|FG007|COMPLETED|Overall Study||0
8602120|NCT03673345|9638285|FG000|NOT COMPLETED|Overall Study||2
8602121|NCT03673345|9638286|FG001|NOT COMPLETED|Overall Study||0
8602122|NCT03673345|9638287|FG002|NOT COMPLETED|Overall Study||9
8602123|NCT03673345|9638288|FG003|NOT COMPLETED|Overall Study||5
8602124|NCT03673345|9638289|FG004|NOT COMPLETED|Overall Study||2
8602125|NCT03673345|9638290|FG005|NOT COMPLETED|Overall Study||1
8602126|NCT03673345|9638291|FG006|NOT COMPLETED|Overall Study||0
8602127|NCT03673345|9638292|FG007|NOT COMPLETED|Overall Study||0
8602128|NCT03418675|9638312|FG000|STARTED|Overall Study||40
8602129|NCT03418675|9638313|FG001|STARTED|Overall Study||40
8602130|NCT03418675|9638312|FG000|Completed All Baseline Measures|Overall Study||37
8602131|NCT03418675|9638313|FG001|Completed All Baseline Measures|Overall Study||40
8602132|NCT03418675|9638312|FG000|Completed One-post Randomization Visit|Overall Study||34
8602133|NCT03418675|9638313|FG001|Completed One-post Randomization Visit|Overall Study||35
8602134|NCT03418675|9638312|FG000|COMPLETED|Overall Study||25
8602135|NCT03418675|9638313|FG001|COMPLETED|Overall Study||30
8602136|NCT03418675|9638312|FG000|NOT COMPLETED|Overall Study||15
8602137|NCT03418675|9638313|FG001|NOT COMPLETED|Overall Study||10
8602138|NCT03367910|9638319|FG000|STARTED|Overall Study||1
8602139|NCT03367910|9638319|FG000|COMPLETED|Overall Study||1
8602140|NCT03367910|9638319|FG000|NOT COMPLETED|Overall Study||0
8602141|NCT03329690|9638328|FG000|STARTED|Overall Study||126
8602142|NCT03329690|9638329|FG001|STARTED|Overall Study||55
8602143|NCT03329690|9638330|FG002|STARTED|Overall Study||7
8602144|NCT03329690|9638331|FG003|STARTED|Overall Study||21
8602145|NCT03329690|9638332|FG004|STARTED|Overall Study||24
8602146|NCT03329690|9638328|FG000|Received Treatment|Overall Study||125
8602147|NCT03329690|9638329|FG001|Received Treatment|Overall Study||55
8602148|NCT03329690|9638330|FG002|Received Treatment|Overall Study||7
8602149|NCT03329690|9638331|FG003|Received Treatment|Overall Study||20
8602150|NCT03329690|9638332|FG004|Received Treatment|Overall Study||24
8602151|NCT03329690|9638328|FG000|COMPLETED|Overall Study||0
8602152|NCT03329690|9638329|FG001|COMPLETED|Overall Study||0
8602153|NCT03329690|9638330|FG002|COMPLETED|Overall Study||0
8602154|NCT03329690|9638331|FG003|COMPLETED|Overall Study||0
8602155|NCT03329690|9638332|FG004|COMPLETED|Overall Study||0
8602156|NCT03329690|9638328|FG000|NOT COMPLETED|Overall Study||126
8602157|NCT03329690|9638329|FG001|NOT COMPLETED|Overall Study||55
8602158|NCT03329690|9638330|FG002|NOT COMPLETED|Overall Study||7
8602159|NCT03329690|9638331|FG003|NOT COMPLETED|Overall Study||21
8602160|NCT03329690|9638332|FG004|NOT COMPLETED|Overall Study||24
8602161|NCT03320564|9638350|FG000|STARTED|Overall Study||2
8602162|NCT03320564|9638350|FG000|COMPLETED|Overall Study||1
8602163|NCT03320564|9638350|FG000|NOT COMPLETED|Overall Study||1
8602164|NCT03302234|9638356|FG000|STARTED|Overall Study||284
8602165|NCT03302234|9638357|FG001|STARTED|Overall Study||284
8602166|NCT03302234|9638356|FG000|COMPLETED|Overall Study||146
8602167|NCT03302234|9638357|FG001|COMPLETED|Overall Study||147
8602168|NCT03302234|9638356|FG000|NOT COMPLETED|Overall Study||138
8602169|NCT03302234|9638357|FG001|NOT COMPLETED|Overall Study||137
8602170|NCT03235817|9638367|FG000|STARTED|Overall Study||13
8602171|NCT03235817|9638368|FG001|STARTED|Overall Study||13
8602172|NCT03235817|9638369|FG002|STARTED|Overall Study||13
8602173|NCT03235817|9638367|FG000|COMPLETED|Overall Study||10
8602174|NCT03235817|9638368|FG001|COMPLETED|Overall Study||12
8602175|NCT03235817|9638369|FG002|COMPLETED|Overall Study||11
8602176|NCT03235817|9638367|FG000|NOT COMPLETED|Overall Study||3
8602177|NCT03235817|9638368|FG001|NOT COMPLETED|Overall Study||1
8602178|NCT03235817|9638369|FG002|NOT COMPLETED|Overall Study||2
8602179|NCT03165955|9638378|FG000|STARTED|Screening/Baseline||31
8602180|NCT03165955|9638378|FG000|COMPLETED|Screening/Baseline||28
8602181|NCT03165955|9638378|FG000|NOT COMPLETED|Screening/Baseline||3
8602182|NCT03165955|9638378|FG000|STARTED|Treatment||28
8602183|NCT03165955|9638378|FG000|COMPLETED|Treatment||20
8602184|NCT03165955|9638378|FG000|NOT COMPLETED|Treatment||8
8602185|NCT03133793|9638386|FG000|STARTED|Overall Study||39
8602186|NCT03133793|9638387|FG001|STARTED|Overall Study||39
8602187|NCT03133793|9638388|FG002|STARTED|Overall Study||37
8602188|NCT03133793|9638389|FG003|STARTED|Overall Study||38
8602189|NCT03133793|9638386|FG000|COMPLETED|Overall Study||38
8602190|NCT03133793|9638387|FG001|COMPLETED|Overall Study||35
8602191|NCT03133793|9638388|FG002|COMPLETED|Overall Study||33
8602192|NCT03133793|9638389|FG003|COMPLETED|Overall Study||33
8602193|NCT03133793|9638386|FG000|NOT COMPLETED|Overall Study||1
8602194|NCT03133793|9638387|FG001|NOT COMPLETED|Overall Study||4
8602195|NCT03133793|9638388|FG002|NOT COMPLETED|Overall Study||4
8602196|NCT03133793|9638389|FG003|NOT COMPLETED|Overall Study||5
8628719|NCT00526058|9668255|FG001|STARTED|Period: First Intervention||9
8628720|NCT00526058|9668254|FG000|COMPLETED|Period: First Intervention||9
8628721|NCT00526058|9668255|FG001|COMPLETED|Period: First Intervention||9
8628722|NCT00526058|9668254|FG000|NOT COMPLETED|Period: First Intervention||0
8628723|NCT00526058|9668255|FG001|NOT COMPLETED|Period: First Intervention||0
8628724|NCT00526058|9668254|FG000|STARTED|Period: Second Intervention||9
8628725|NCT00526058|9668255|FG001|STARTED|Period: Second Intervention||9
8628726|NCT00526058|9668254|FG000|COMPLETED|Period: Second Intervention||9
8628727|NCT00526058|9668255|FG001|COMPLETED|Period: Second Intervention||9
8628728|NCT00526058|9668254|FG000|NOT COMPLETED|Period: Second Intervention||0
8628729|NCT00526058|9668255|FG001|NOT COMPLETED|Period: Second Intervention||0
8628730|NCT00526071|9668261|FG000|STARTED|Overall Study||23
8628731|NCT00526071|9668261|FG000|Safety Population|Overall Study||23
8628732|NCT00526071|9668261|FG000|Pharmacodynamic (PD) Population|Overall Study||23
8628733|NCT00526071|9668261|FG000|Amenable Population; Men|Overall Study||11
8628734|NCT00526071|9668261|FG000|Amenable Population; Women|Overall Study||5
8628735|NCT00526071|9668261|FG000|Non-amenable Population; Men|Overall Study||3
8628736|NCT00526071|9668261|FG000|Non-amenable Population; Women|Overall Study||4
8628737|NCT00526071|9668261|FG000|COMPLETED|Overall Study||17
8628738|NCT00526071|9668261|FG000|NOT COMPLETED|Overall Study||6
8629610|NCT00531050|9669382|FG001|STARTED|Part 1: Period 2||4
8602197|NCT03103542|9638403|FG000|STARTED|Overall Study|18 - screened 16 - enrolled|16
8602198|NCT03103542|9638403|FG000|COMPLETED|Overall Study||9
8602199|NCT03103542|9638403|FG000|NOT COMPLETED|Overall Study||7
8602200|NCT03086317|9638410|FG000|STARTED|Overall Study||10
8602201|NCT03086317|9638411|FG001|STARTED|Overall Study||8
8602202|NCT03086317|9638410|FG000|COMPLETED|Overall Study||10
8602203|NCT03086317|9638411|FG001|COMPLETED|Overall Study||8
8602204|NCT03086317|9638410|FG000|NOT COMPLETED|Overall Study||0
8602205|NCT03086317|9638411|FG001|NOT COMPLETED|Overall Study||0
8602206|NCT03063203|9638417|FG000|STARTED|Overall Study||17
8602207|NCT03063203|9638417|FG000|COMPLETED|Overall Study||3
8602208|NCT03063203|9638417|FG000|NOT COMPLETED|Overall Study||14
8602209|NCT02676765|9638430|FG000|STARTED|Overall Study||10
8602210|NCT02676765|9638431|FG001|STARTED|Overall Study||10
8602211|NCT02676765|9638430|FG000|COMPLETED|Overall Study||10
8602212|NCT02676765|9638431|FG001|COMPLETED|Overall Study||9
8602213|NCT02676765|9638430|FG000|NOT COMPLETED|Overall Study||0
8602214|NCT02676765|9638431|FG001|NOT COMPLETED|Overall Study||1
8602215|NCT02539563|9638439|FG000|STARTED|Overall Study||45
8602216|NCT02539563|9638440|FG001|STARTED|Overall Study||56
8602217|NCT02539563|9638439|FG000|COMPLETED|Overall Study||39
8602218|NCT02539563|9638440|FG001|COMPLETED|Overall Study||42
8602219|NCT02539563|9638439|FG000|NOT COMPLETED|Overall Study||6
8602220|NCT02539563|9638440|FG001|NOT COMPLETED|Overall Study||14
8602221|NCT02422446|9638448|FG000|STARTED|Overall Study||1
8602222|NCT02422446|9638449|FG001|STARTED|Overall Study||1
8602223|NCT02422446|9638448|FG000|COMPLETED|Overall Study||1
8602224|NCT02422446|9638449|FG001|COMPLETED|Overall Study||1
8602225|NCT02422446|9638448|FG000|NOT COMPLETED|Overall Study||0
8602226|NCT02422446|9638449|FG001|NOT COMPLETED|Overall Study||0
8602227|NCT02362451|9638457|FG000|STARTED|Overall Study||6
8602228|NCT02362451|9638458|FG001|STARTED|Overall Study||1
8602229|NCT02362451|9638457|FG000|COMPLETED|Overall Study||2
8602230|NCT02362451|9638458|FG001|COMPLETED|Overall Study||0
8602231|NCT02362451|9638457|FG000|NOT COMPLETED|Overall Study||4
8602232|NCT02362451|9638458|FG001|NOT COMPLETED|Overall Study||1
8714215|NCT00979134|9761092|FG002|COMPLETED|Overall Study|At DCO|5
8714216|NCT00979134|9761090|FG000|NOT COMPLETED|Overall Study||33
8714217|NCT00979134|9761091|FG001|NOT COMPLETED|Overall Study||6
8602233|NCT02282020|9638466|FG000|STARTED|Overall Study||178
8602234|NCT02282020|9638467|FG001|STARTED|Overall Study||88
8602235|NCT02282020|9638466|FG000|Received Treatment|Overall Study||178
8602236|NCT02282020|9638467|FG001|Received Treatment|Overall Study||76
8602237|NCT02282020|9638466|FG000|COMPLETED|Overall Study||43
8602238|NCT02282020|9638467|FG001|COMPLETED|Overall Study||1
8602239|NCT02282020|9638466|FG000|NOT COMPLETED|Overall Study||135
8602240|NCT02282020|9638467|FG001|NOT COMPLETED|Overall Study||87
8602241|NCT02271230|9638477|FG000|STARTED|Overall Study||6463
8602242|NCT02271230|9638478|FG001|STARTED|Overall Study||6464
8602243|NCT02271230|9638479|FG002|STARTED|Overall Study||6470
8602244|NCT02271230|9638480|FG003|STARTED|Overall Study||6474
8602245|NCT02271230|9638477|FG000|COMPLETED|Overall Study||6463
8602246|NCT02271230|9638478|FG001|COMPLETED|Overall Study||6464
8602247|NCT02271230|9638479|FG002|COMPLETED|Overall Study||6470
8602248|NCT02271230|9638480|FG003|COMPLETED|Overall Study||6474
8602249|NCT02271230|9638477|FG000|NOT COMPLETED|Overall Study||0
8602250|NCT02271230|9638478|FG001|NOT COMPLETED|Overall Study||0
8602251|NCT02271230|9638479|FG002|NOT COMPLETED|Overall Study||0
8602252|NCT02271230|9638480|FG003|NOT COMPLETED|Overall Study||0
8602253|NCT02180724|9638492|FG000|STARTED|Overall Study||92
8602254|NCT02180724|9638493|FG001|STARTED|Overall Study||14
8602255|NCT02180724|9638492|FG000|Enrolled|Overall Study||92
8602256|NCT02180724|9638493|FG001|Enrolled|Overall Study||14
8602257|NCT02180724|9638492|FG000|Received Study Medication|Overall Study||92
8602258|NCT02180724|9638493|FG001|Received Study Medication|Overall Study||14
8602259|NCT02180724|9638492|FG000|Discontinued Study|Overall Study||14
8602260|NCT02180724|9638493|FG001|Discontinued Study|Overall Study||3
8602261|NCT02180724|9638492|FG000|Discontinued Treatment|Overall Study||23
8602262|NCT02180724|9638493|FG001|Discontinued Treatment|Overall Study||7
8602263|NCT02180724|9638492|FG000|COMPLETED|Overall Study||0
8602264|NCT02180724|9638493|FG001|COMPLETED|Overall Study||0
8602265|NCT02180724|9638492|FG000|NOT COMPLETED|Overall Study||92
8602266|NCT02180724|9638493|FG001|NOT COMPLETED|Overall Study||14
8602267|NCT02038777|9638507|FG000|STARTED|Overall Study||3
8602268|NCT02038777|9638508|FG001|STARTED|Overall Study||5
8602269|NCT02038777|9638509|FG002|STARTED|Overall Study||6
8602270|NCT02038777|9638510|FG003|STARTED|Overall Study||6
8602271|NCT02038777|9638511|FG004|STARTED|Overall Study||6
8602272|NCT02038777|9638512|FG005|STARTED|Overall Study||6
8602273|NCT02038777|9638513|FG006|STARTED|Overall Study||1
8602274|NCT02038777|9638514|FG007|STARTED|Overall Study||15
8602275|NCT02038777|9638507|FG000|Treated (Safety Set)|Overall Study||3
8602276|NCT02038777|9638508|FG001|Treated (Safety Set)|Overall Study||4
8714218|NCT00979134|9761092|FG002|NOT COMPLETED|Overall Study||40
8602277|NCT02038777|9638509|FG002|Treated (Safety Set)|Overall Study||6
8602278|NCT02038777|9638510|FG003|Treated (Safety Set)|Overall Study||6
8602279|NCT02038777|9638511|FG004|Treated (Safety Set)|Overall Study||6
8602280|NCT02038777|9638512|FG005|Treated (Safety Set)|Overall Study||6
8602281|NCT02038777|9638513|FG006|Treated (Safety Set)|Overall Study||1
8602282|NCT02038777|9638514|FG007|Treated (Safety Set)|Overall Study||15
8602283|NCT02038777|9638507|FG000|COMPLETED|Overall Study||2
8602284|NCT02038777|9638508|FG001|COMPLETED|Overall Study||1
8602285|NCT02038777|9638509|FG002|COMPLETED|Overall Study||3
8602286|NCT02038777|9638510|FG003|COMPLETED|Overall Study||2
8602287|NCT02038777|9638511|FG004|COMPLETED|Overall Study||3
8602288|NCT02038777|9638512|FG005|COMPLETED|Overall Study||2
8602289|NCT02038777|9638513|FG006|COMPLETED|Overall Study||1
8602290|NCT02038777|9638514|FG007|COMPLETED|Overall Study||5
8602291|NCT02038777|9638507|FG000|NOT COMPLETED|Overall Study||1
8602292|NCT02038777|9638508|FG001|NOT COMPLETED|Overall Study||4
8602293|NCT02038777|9638509|FG002|NOT COMPLETED|Overall Study||3
8602294|NCT02038777|9638510|FG003|NOT COMPLETED|Overall Study||4
8602295|NCT02038777|9638511|FG004|NOT COMPLETED|Overall Study||3
8602296|NCT02038777|9638512|FG005|NOT COMPLETED|Overall Study||4
8602297|NCT02038777|9638513|FG006|NOT COMPLETED|Overall Study||0
8602298|NCT02038777|9638514|FG007|NOT COMPLETED|Overall Study||10
8602299|NCT01996449|9638533|FG000|STARTED|Period 1: First Drug||6
8602300|NCT01996449|9638534|FG001|STARTED|Period 1: First Drug||8
8602301|NCT01996449|9638533|FG000|COMPLETED|Period 1: First Drug||6
8602302|NCT01996449|9638534|FG001|COMPLETED|Period 1: First Drug||8
8602303|NCT01996449|9638533|FG000|NOT COMPLETED|Period 1: First Drug||0
8602304|NCT01996449|9638534|FG001|NOT COMPLETED|Period 1: First Drug||0
8602305|NCT01996449|9638533|FG000|STARTED|Period 2: Second Drug||6
8602306|NCT01996449|9638534|FG001|STARTED|Period 2: Second Drug||8
8602307|NCT01996449|9638533|FG000|COMPLETED|Period 2: Second Drug||6
8602308|NCT01996449|9638534|FG001|COMPLETED|Period 2: Second Drug||8
8602309|NCT01996449|9638533|FG000|NOT COMPLETED|Period 2: Second Drug||0
8602310|NCT01996449|9638534|FG001|NOT COMPLETED|Period 2: Second Drug||0
8602311|NCT01927419|9638544|FG000|STARTED|Pre-Treatment Period||95
8602312|NCT01927419|9638545|FG001|STARTED|Pre-Treatment Period||47
8602313|NCT01927419|9638544|FG000|COMPLETED|Pre-Treatment Period||94
8602314|NCT01927419|9638545|FG001|COMPLETED|Pre-Treatment Period||46
8602315|NCT01927419|9638544|FG000|NOT COMPLETED|Pre-Treatment Period||1
8602316|NCT01927419|9638545|FG001|NOT COMPLETED|Pre-Treatment Period||1
8602317|NCT01927419|9638544|FG000|STARTED|Treatment Period||94
8602318|NCT01927419|9638545|FG001|STARTED|Treatment Period||46
8602319|NCT01927419|9638544|FG000|COMPLETED|Treatment Period||0
8602320|NCT01927419|9638545|FG001|COMPLETED|Treatment Period||0
8602321|NCT01927419|9638544|FG000|NOT COMPLETED|Treatment Period||94
8602322|NCT01927419|9638545|FG001|NOT COMPLETED|Treatment Period||46
8602323|NCT01924533|9638553|FG000|STARTED|Overall Study||263
8602324|NCT01924533|9638554|FG001|STARTED|Overall Study||262
8602325|NCT01924533|9638553|FG000|COMPLETED|Overall Study||74
8602326|NCT01924533|9638554|FG001|COMPLETED|Overall Study||57
8602327|NCT01924533|9638553|FG000|NOT COMPLETED|Overall Study||189
8602328|NCT01924533|9638554|FG001|NOT COMPLETED|Overall Study||205
8602329|NCT01856140|9638562|FG000|STARTED|Overall Study||6
8602330|NCT01856140|9638563|FG001|STARTED|Overall Study||6
8602331|NCT01856140|9638562|FG000|COMPLETED|Overall Study||6
8602332|NCT01856140|9638563|FG001|COMPLETED|Overall Study||6
8602333|NCT01856140|9638562|FG000|NOT COMPLETED|Overall Study||0
8602334|NCT01856140|9638563|FG001|NOT COMPLETED|Overall Study||0
8602335|NCT01773395|9638571|FG000|STARTED|Overall Study||64
8602336|NCT01773395|9638572|FG001|STARTED|Overall Study||59
8602337|NCT01773395|9638571|FG000|COMPLETED|Overall Study||30
8602338|NCT01773395|9638572|FG001|COMPLETED|Overall Study||27
8602339|NCT01773395|9638571|FG000|NOT COMPLETED|Overall Study||34
8602340|NCT01773395|9638572|FG001|NOT COMPLETED|Overall Study||32
8602341|NCT01711879|9638580|FG000|STARTED|Overall Study||3
8602342|NCT01711879|9638581|FG001|STARTED|Overall Study||4
8602343|NCT01711879|9638580|FG000|COMPLETED|Overall Study||2
8602344|NCT01711879|9638581|FG001|COMPLETED|Overall Study||4
8602345|NCT01711879|9638580|FG000|NOT COMPLETED|Overall Study||1
8602346|NCT01711879|9638581|FG001|NOT COMPLETED|Overall Study||0
8602347|NCT01697267|9638591|FG000|STARTED|Overall Study||85
8602348|NCT01697267|9638592|FG001|STARTED|Overall Study||85
8602349|NCT01697267|9638591|FG000|Month 24|Overall Study||78
8602350|NCT01697267|9638592|FG001|Month 24|Overall Study||78
8602351|NCT01697267|9638591|FG000|COMPLETED|Overall Study||71
8602352|NCT01697267|9638592|FG001|COMPLETED|Overall Study||70
8602353|NCT01697267|9638591|FG000|NOT COMPLETED|Overall Study||14
8602354|NCT01697267|9638592|FG001|NOT COMPLETED|Overall Study||15
8602355|NCT01527149|9638598|FG000|STARTED|Overall Study||37
8602356|NCT01527149|9638598|FG000|COMPLETED|Overall Study||35
8602357|NCT01527149|9638598|FG000|NOT COMPLETED|Overall Study||2
8602358|NCT01388920|9638605|FG000|STARTED|Overall Study||1
8602359|NCT01388920|9638606|FG001|STARTED|Overall Study||1
8602360|NCT01388920|9638607|FG002|STARTED|Overall Study||0
8602361|NCT01388920|9638605|FG000|COMPLETED|Overall Study||1
8602362|NCT01388920|9638606|FG001|COMPLETED|Overall Study||1
8602363|NCT01388920|9638607|FG002|COMPLETED|Overall Study||0
8602364|NCT01388920|9638605|FG000|NOT COMPLETED|Overall Study||0
8602365|NCT01388920|9638606|FG001|NOT COMPLETED|Overall Study||0
8602366|NCT01388920|9638607|FG002|NOT COMPLETED|Overall Study||0
8602367|NCT01164202|9638617|FG000|STARTED|Overall Study||39
8602368|NCT01164202|9638618|FG001|STARTED|Overall Study||39
8602369|NCT01164202|9638617|FG000|COMPLETED|Overall Study||38
8602370|NCT01164202|9638618|FG001|COMPLETED|Overall Study||39
8602371|NCT01164202|9638617|FG000|NOT COMPLETED|Overall Study||1
8602372|NCT01164202|9638618|FG001|NOT COMPLETED|Overall Study||0
8628739|NCT00526097|9668271|FG000|STARTED|Overall Study|Started: Participant was randomised and took at least one dose of randomised study medication|121
8602373|NCT00554840|9638628|FG000|STARTED|Overall Study||4
8602374|NCT00554840|9638629|FG001|STARTED|Overall Study||5
8602375|NCT00554840|9638628|FG000|COMPLETED|Overall Study||4
8602376|NCT00554840|9638629|FG001|COMPLETED|Overall Study||4
8602377|NCT00554840|9638628|FG000|NOT COMPLETED|Overall Study||0
8602378|NCT00554840|9638629|FG001|NOT COMPLETED|Overall Study||1
8602379|NCT00003656|9638639|FG000|STARTED|Overall Study||12
8602380|NCT00003656|9638640|FG001|STARTED|Overall Study||14
8602381|NCT00003656|9638639|FG000|COMPLETED|Overall Study||12
8602382|NCT00003656|9638640|FG001|COMPLETED|Overall Study||13
8602383|NCT00003656|9638639|FG000|NOT COMPLETED|Overall Study||0
8602384|NCT00003656|9638640|FG001|NOT COMPLETED|Overall Study||1
8602385|NCT00370331|9638649|FG000|STARTED|Overall Study||62
8602386|NCT00370331|9638650|FG001|STARTED|Overall Study||135
8602387|NCT00370331|9638649|FG000|COMPLETED|Overall Study||55
8602388|NCT00370331|9638650|FG001|COMPLETED|Overall Study||112
8602389|NCT00370331|9638649|FG000|NOT COMPLETED|Overall Study||7
8602390|NCT00370331|9638650|FG001|NOT COMPLETED|Overall Study||23
8602391|NCT00370396|9638659|FG000|STARTED|Overall Study||737
8602392|NCT00370396|9638660|FG001|STARTED|Overall Study||92
8602393|NCT00370396|9638661|FG002|STARTED|Overall Study||283
8602394|NCT00370396|9638659|FG000|COMPLETED|Overall Study||726
8602395|NCT00370396|9638660|FG001|COMPLETED|Overall Study||91
8602396|NCT00370396|9638661|FG002|COMPLETED|Overall Study||282
8602397|NCT00370396|9638659|FG000|NOT COMPLETED|Overall Study||11
8602398|NCT00370396|9638660|FG001|NOT COMPLETED|Overall Study||1
8602399|NCT00370396|9638661|FG002|NOT COMPLETED|Overall Study||1
8602400|NCT00370552|9638672|FG000|STARTED|Overall Study|Randomized|46
8602401|NCT00370552|9638673|FG001|STARTED|Overall Study|Randomized|45
8602402|NCT00370552|9638674|FG002|STARTED|Overall Study|Randomized|32
8602403|NCT00370552|9638672|FG000|COMPLETED|Overall Study||0
8602404|NCT00370552|9638673|FG001|COMPLETED|Overall Study||0
8602405|NCT00370552|9638674|FG002|COMPLETED|Overall Study||0
8602406|NCT00370552|9638672|FG000|NOT COMPLETED|Overall Study||46
8602407|NCT00370552|9638673|FG001|NOT COMPLETED|Overall Study||45
8602408|NCT00370552|9638674|FG002|NOT COMPLETED|Overall Study||32
8602409|NCT00370682|9638685|FG000|STARTED|Overall Study||40
8602410|NCT00370682|9638686|FG001|STARTED|Overall Study||40
8602411|NCT00370682|9638687|FG002|STARTED|Overall Study||40
8602412|NCT00370682|9638685|FG000|COMPLETED|Overall Study||40
8602413|NCT00370682|9638686|FG001|COMPLETED|Overall Study||37
8602414|NCT00370682|9638687|FG002|COMPLETED|Overall Study||39
8602415|NCT00370682|9638685|FG000|NOT COMPLETED|Overall Study||0
8602416|NCT00370682|9638686|FG001|NOT COMPLETED|Overall Study||3
8602417|NCT00370682|9638687|FG002|NOT COMPLETED|Overall Study||1
8602418|NCT00370838|9638701|FG000|STARTED|Period 1 (Days 8-50)||7
8602419|NCT00370838|9638702|FG001|STARTED|Period 1 (Days 8-50)||3
8602420|NCT00370838|9638701|FG000|COMPLETED|Period 1 (Days 8-50)||7
8602421|NCT00370838|9638702|FG001|COMPLETED|Period 1 (Days 8-50)||3
8602422|NCT00370838|9638701|FG000|NOT COMPLETED|Period 1 (Days 8-50)||0
8602423|NCT00370838|9638702|FG001|NOT COMPLETED|Period 1 (Days 8-50)||0
8602424|NCT00370838|9638701|FG000|STARTED|Washout (Days 51-64)||7
8602425|NCT00370838|9638702|FG001|STARTED|Washout (Days 51-64)||3
8602426|NCT00370838|9638701|FG000|COMPLETED|Washout (Days 51-64)||7
8602427|NCT00370838|9638702|FG001|COMPLETED|Washout (Days 51-64)||3
8602428|NCT00370838|9638701|FG000|NOT COMPLETED|Washout (Days 51-64)||0
8602429|NCT00370838|9638702|FG001|NOT COMPLETED|Washout (Days 51-64)||0
8602430|NCT00370838|9638701|FG000|STARTED|Period 2 (Days 65-107)||7
8602431|NCT00370838|9638702|FG001|STARTED|Period 2 (Days 65-107)||3
8602432|NCT00370838|9638701|FG000|COMPLETED|Period 2 (Days 65-107)||7
8602433|NCT00370838|9638702|FG001|COMPLETED|Period 2 (Days 65-107)||3
8602434|NCT00370838|9638701|FG000|NOT COMPLETED|Period 2 (Days 65-107)||0
8602435|NCT00370838|9638702|FG001|NOT COMPLETED|Period 2 (Days 65-107)||0
8602436|NCT00370838|9638701|FG000|STARTED|Taper||7
8602437|NCT00370838|9638702|FG001|STARTED|Taper||3
8602438|NCT00370838|9638701|FG000|COMPLETED|Taper||7
8602439|NCT00370838|9638702|FG001|COMPLETED|Taper||3
8602440|NCT00370838|9638701|FG000|NOT COMPLETED|Taper||0
8602441|NCT00370838|9638702|FG001|NOT COMPLETED|Taper||0
8602442|NCT00370994|9638710|FG000|STARTED|Overall Study|Sample size was 200, due to the difficulties of recruiting we changed to 120|60
8602443|NCT00370994|9638711|FG001|STARTED|Overall Study||60
8602444|NCT00370994|9638710|FG000|COMPLETED|Overall Study||60
8602445|NCT00370994|9638711|FG001|COMPLETED|Overall Study||60
8602446|NCT00370994|9638710|FG000|NOT COMPLETED|Overall Study||0
8602447|NCT00370994|9638711|FG001|NOT COMPLETED|Overall Study||0
8602448|NCT00371137|9638720|FG000|STARTED|Overall Study||183
8602449|NCT00371137|9638721|FG001|STARTED|Overall Study||182
8602450|NCT00371137|9638722|FG002|STARTED|Overall Study||183
8602451|NCT00371137|9638720|FG000|Treated|Overall Study||183
8602452|NCT00371137|9638721|FG001|Treated|Overall Study||182
8602453|NCT00371137|9638722|FG002|Treated|Overall Study||182
8602454|NCT00371137|9638720|FG000|COMPLETED|Overall Study||111
8602455|NCT00371137|9638721|FG001|COMPLETED|Overall Study||119
8602456|NCT00371137|9638722|FG002|COMPLETED|Overall Study||104
8602457|NCT00371137|9638720|FG000|NOT COMPLETED|Overall Study||72
8602458|NCT00371137|9638721|FG001|NOT COMPLETED|Overall Study||63
8602459|NCT00371137|9638722|FG002|NOT COMPLETED|Overall Study||79
8602460|NCT00371150|9638732|FG000|STARTED|Overall Study||40
8602461|NCT00371150|9638733|FG001|STARTED|Overall Study||6
8602462|NCT00371150|9638732|FG000|Discontinued Prior to Week 48 Visit|Overall Study||1
8602463|NCT00371150|9638733|FG001|Discontinued Prior to Week 48 Visit|Overall Study||1
8602464|NCT00371150|9638732|FG000|Discontinued at or After Week 48 Visit|Overall Study||2
8602465|NCT00371150|9638733|FG001|Discontinued at or After Week 48 Visit|Overall Study||1
8602466|NCT00371150|9638732|FG000|COMPLETED|Overall Study|"Completion of treatment means received treatment through Week 52"|37
8602467|NCT00371150|9638733|FG001|COMPLETED|Overall Study|"Completion of treatment means received treatment through Week 52"|4
8602468|NCT00371150|9638732|FG000|NOT COMPLETED|Overall Study||3
8602469|NCT00371150|9638733|FG001|NOT COMPLETED|Overall Study||2
8602470|NCT00371176|9638745|FG000|STARTED|Overall Study||13
8602471|NCT00371176|9638746|FG001|STARTED|Overall Study||13
8602472|NCT00371176|9638745|FG000|Completed Treatment|Overall Study||10
8602473|NCT00371176|9638746|FG001|Completed Treatment|Overall Study||9
8602474|NCT00371176|9638745|FG000|COMPLETED|Overall Study||8
8602475|NCT00371176|9638746|FG001|COMPLETED|Overall Study||5
8602476|NCT00371176|9638745|FG000|NOT COMPLETED|Overall Study||5
8602477|NCT00371176|9638746|FG001|NOT COMPLETED|Overall Study||8
8602478|NCT00371254|9638754|FG000|STARTED|Overall Study|Number of participants treated|23
8602479|NCT00371254|9638755|FG001|STARTED|Overall Study|Number of participants treated|21
8602480|NCT00371254|9638754|FG000|COMPLETED|Overall Study|Number of participants remained on study till the study drug could be tolerated|0
8602481|NCT00371254|9638755|FG001|COMPLETED|Overall Study|Number of participants remained on study till the study drug could be tolerated|0
8602482|NCT00371254|9638754|FG000|NOT COMPLETED|Overall Study||23
8602483|NCT00371254|9638755|FG001|NOT COMPLETED|Overall Study||21
8602484|NCT00371267|9638763|FG000|STARTED|Overall Study||48
8602485|NCT00371267|9638764|FG001|STARTED|Overall Study||50
8602486|NCT00371267|9638763|FG000|COMPLETED|Overall Study||39
8602487|NCT00371267|9638764|FG001|COMPLETED|Overall Study||32
8602488|NCT00371267|9638763|FG000|NOT COMPLETED|Overall Study||9
8602489|NCT00371267|9638764|FG001|NOT COMPLETED|Overall Study||18
8602490|NCT00371293|9638773|FG000|STARTED|Overall Study||58
8602491|NCT00371293|9638774|FG001|STARTED|Overall Study||61
8602492|NCT00371293|9638775|FG002|STARTED|Overall Study||62
8602493|NCT00371293|9638773|FG000|COMPLETED|Overall Study||48
8602494|NCT00371293|9638774|FG001|COMPLETED|Overall Study||42
8602495|NCT00371293|9638775|FG002|COMPLETED|Overall Study||46
8602496|NCT00371293|9638773|FG000|NOT COMPLETED|Overall Study||10
8602497|NCT00371293|9638774|FG001|NOT COMPLETED|Overall Study||19
8602498|NCT00371293|9638775|FG002|NOT COMPLETED|Overall Study||16
8602499|NCT00371345|9638786|FG000|STARTED|Overall Study||24
8602500|NCT00371345|9638787|FG001|STARTED|Overall Study||46
8602501|NCT00371345|9638786|FG000|COMPLETED|Overall Study||0
8602502|NCT00371345|9638787|FG001|COMPLETED|Overall Study||0
8602503|NCT00371345|9638786|FG000|NOT COMPLETED|Overall Study||24
8602504|NCT00371345|9638787|FG001|NOT COMPLETED|Overall Study||46
8602505|NCT00371397|9638807|FG000|STARTED|Session 1||5
8602506|NCT00371397|9638808|FG001|STARTED|Session 1||7
8602507|NCT00371397|9638809|FG002|STARTED|Session 1||5
8602508|NCT00371397|9638810|FG003|STARTED|Session 1||2
8602509|NCT00371397|9638811|FG004|STARTED|Session 1||3
8602510|NCT00371397|9638812|FG005|STARTED|Session 1||4
8602511|NCT00371397|9638813|FG006|STARTED|Session 1||4
8602512|NCT00371397|9638814|FG007|STARTED|Session 1||5
8602513|NCT00371397|9638815|FG008|STARTED|Session 1||6
8602514|NCT00371397|9638816|FG009|STARTED|Session 1||5
8602515|NCT00371397|9638817|FG010|STARTED|Session 1||4
8602516|NCT00371397|9638818|FG011|STARTED|Session 1||2
8602517|NCT00371397|9638807|FG000|COMPLETED|Session 1||4
8602518|NCT00371397|9638808|FG001|COMPLETED|Session 1||7
8602519|NCT00371397|9638809|FG002|COMPLETED|Session 1||5
8602520|NCT00371397|9638810|FG003|COMPLETED|Session 1||2
8602521|NCT00371397|9638811|FG004|COMPLETED|Session 1||3
8602522|NCT00371397|9638812|FG005|COMPLETED|Session 1||4
8602523|NCT00371397|9638813|FG006|COMPLETED|Session 1||4
8602524|NCT00371397|9638814|FG007|COMPLETED|Session 1||4
8602525|NCT00371397|9638815|FG008|COMPLETED|Session 1||6
8602526|NCT00371397|9638816|FG009|COMPLETED|Session 1||5
8602527|NCT00371397|9638817|FG010|COMPLETED|Session 1||4
8602528|NCT00371397|9638818|FG011|COMPLETED|Session 1||2
8602529|NCT00371397|9638807|FG000|NOT COMPLETED|Session 1||1
8602530|NCT00371397|9638808|FG001|NOT COMPLETED|Session 1||0
8602531|NCT00371397|9638809|FG002|NOT COMPLETED|Session 1||0
8602532|NCT00371397|9638810|FG003|NOT COMPLETED|Session 1||0
8602533|NCT00371397|9638811|FG004|NOT COMPLETED|Session 1||0
8602534|NCT00371397|9638812|FG005|NOT COMPLETED|Session 1||0
8602535|NCT00371397|9638813|FG006|NOT COMPLETED|Session 1||0
8602536|NCT00371397|9638814|FG007|NOT COMPLETED|Session 1||1
8602537|NCT00371397|9638815|FG008|NOT COMPLETED|Session 1||0
8602538|NCT00371397|9638816|FG009|NOT COMPLETED|Session 1||0
8602539|NCT00371397|9638817|FG010|NOT COMPLETED|Session 1||0
8602540|NCT00371397|9638818|FG011|NOT COMPLETED|Session 1||0
8602541|NCT00371397|9638807|FG000|STARTED|Session 2||4
8602542|NCT00371397|9638808|FG001|STARTED|Session 2||7
8602543|NCT00371397|9638809|FG002|STARTED|Session 2||5
8602544|NCT00371397|9638810|FG003|STARTED|Session 2||2
8602545|NCT00371397|9638811|FG004|STARTED|Session 2||3
8602546|NCT00371397|9638812|FG005|STARTED|Session 2||4
8602547|NCT00371397|9638813|FG006|STARTED|Session 2||4
8602548|NCT00371397|9638814|FG007|STARTED|Session 2||4
8602549|NCT00371397|9638815|FG008|STARTED|Session 2||6
8602550|NCT00371397|9638816|FG009|STARTED|Session 2||5
8602551|NCT00371397|9638817|FG010|STARTED|Session 2||4
8602552|NCT00371397|9638818|FG011|STARTED|Session 2||2
8602553|NCT00371397|9638807|FG000|COMPLETED|Session 2||4
8602554|NCT00371397|9638808|FG001|COMPLETED|Session 2||7
8602555|NCT00371397|9638809|FG002|COMPLETED|Session 2||5
8602556|NCT00371397|9638810|FG003|COMPLETED|Session 2||2
8602557|NCT00371397|9638811|FG004|COMPLETED|Session 2||3
8602558|NCT00371397|9638812|FG005|COMPLETED|Session 2||4
8602559|NCT00371397|9638813|FG006|COMPLETED|Session 2||4
8602560|NCT00371397|9638814|FG007|COMPLETED|Session 2||4
8602561|NCT00371397|9638815|FG008|COMPLETED|Session 2||6
8602562|NCT00371397|9638816|FG009|COMPLETED|Session 2||5
8602563|NCT00371397|9638817|FG010|COMPLETED|Session 2||4
8602564|NCT00371397|9638818|FG011|COMPLETED|Session 2||2
8602565|NCT00371397|9638807|FG000|NOT COMPLETED|Session 2||0
8602566|NCT00371397|9638808|FG001|NOT COMPLETED|Session 2||0
8602567|NCT00371397|9638809|FG002|NOT COMPLETED|Session 2||0
8602568|NCT00371397|9638810|FG003|NOT COMPLETED|Session 2||0
8602569|NCT00371397|9638811|FG004|NOT COMPLETED|Session 2||0
8602570|NCT00371397|9638812|FG005|NOT COMPLETED|Session 2||0
8602571|NCT00371397|9638813|FG006|NOT COMPLETED|Session 2||0
8602572|NCT00371397|9638814|FG007|NOT COMPLETED|Session 2||0
8602573|NCT00371397|9638815|FG008|NOT COMPLETED|Session 2||0
8602574|NCT00371397|9638816|FG009|NOT COMPLETED|Session 2||0
8602575|NCT00371397|9638817|FG010|NOT COMPLETED|Session 2||0
8602576|NCT00371397|9638818|FG011|NOT COMPLETED|Session 2||0
8602577|NCT00371397|9638807|FG000|STARTED|Session 3||4
8602578|NCT00371397|9638808|FG001|STARTED|Session 3||7
8602579|NCT00371397|9638809|FG002|STARTED|Session 3||5
8602580|NCT00371397|9638810|FG003|STARTED|Session 3||2
8602581|NCT00371397|9638811|FG004|STARTED|Session 3||3
8602582|NCT00371397|9638812|FG005|STARTED|Session 3||4
8602583|NCT00371397|9638813|FG006|STARTED|Session 3||4
8602584|NCT00371397|9638814|FG007|STARTED|Session 3||4
8602585|NCT00371397|9638815|FG008|STARTED|Session 3||6
8602586|NCT00371397|9638816|FG009|STARTED|Session 3||5
8602587|NCT00371397|9638817|FG010|STARTED|Session 3||4
8602588|NCT00371397|9638818|FG011|STARTED|Session 3||2
8602589|NCT00371397|9638807|FG000|COMPLETED|Session 3||4
8602590|NCT00371397|9638808|FG001|COMPLETED|Session 3||7
8602591|NCT00371397|9638809|FG002|COMPLETED|Session 3||5
8602592|NCT00371397|9638810|FG003|COMPLETED|Session 3||2
8602593|NCT00371397|9638811|FG004|COMPLETED|Session 3||3
8602594|NCT00371397|9638812|FG005|COMPLETED|Session 3||4
8602595|NCT00371397|9638813|FG006|COMPLETED|Session 3||4
8602596|NCT00371397|9638814|FG007|COMPLETED|Session 3||4
8602597|NCT00371397|9638815|FG008|COMPLETED|Session 3||6
8602598|NCT00371397|9638816|FG009|COMPLETED|Session 3||5
8602599|NCT00371397|9638817|FG010|COMPLETED|Session 3||4
8602600|NCT00371397|9638818|FG011|COMPLETED|Session 3||2
8602601|NCT00371397|9638807|FG000|NOT COMPLETED|Session 3||0
8602602|NCT00371397|9638808|FG001|NOT COMPLETED|Session 3||0
8602603|NCT00371397|9638809|FG002|NOT COMPLETED|Session 3||0
8602604|NCT00371397|9638810|FG003|NOT COMPLETED|Session 3||0
8602605|NCT00371397|9638811|FG004|NOT COMPLETED|Session 3||0
8602606|NCT00371397|9638812|FG005|NOT COMPLETED|Session 3||0
8602607|NCT00371397|9638813|FG006|NOT COMPLETED|Session 3||0
8602608|NCT00371397|9638814|FG007|NOT COMPLETED|Session 3||0
8602609|NCT00371397|9638815|FG008|NOT COMPLETED|Session 3||0
8602610|NCT00371397|9638816|FG009|NOT COMPLETED|Session 3||0
8602611|NCT00371397|9638817|FG010|NOT COMPLETED|Session 3||0
8602612|NCT00371397|9638818|FG011|NOT COMPLETED|Session 3||0
8602613|NCT00371436|9638826|FG000|STARTED|Overall Study||92
8602614|NCT00371436|9638827|FG001|STARTED|Overall Study||89
8602615|NCT00371436|9638826|FG000|COMPLETED|Overall Study||58
8602616|NCT00371436|9638827|FG001|COMPLETED|Overall Study||68
8602617|NCT00371436|9638826|FG000|NOT COMPLETED|Overall Study||34
8602618|NCT00371436|9638827|FG001|NOT COMPLETED|Overall Study||21
8602619|NCT00371449|9638833|FG000|STARTED|Overall Study||120
8602620|NCT00371449|9638833|FG000|COMPLETED|Overall Study||120
8602621|NCT00371449|9638833|FG000|NOT COMPLETED|Overall Study||0
8602622|NCT00371540|9638841|FG000|STARTED|Overall Study||112
8602623|NCT00371540|9638842|FG001|STARTED|Overall Study||96
8602624|NCT00371540|9638841|FG000|COMPLETED|Overall Study||102
8602625|NCT00371540|9638842|FG001|COMPLETED|Overall Study||87
8602626|NCT00371540|9638841|FG000|NOT COMPLETED|Overall Study||10
8602627|NCT00371540|9638842|FG001|NOT COMPLETED|Overall Study||9
8602628|NCT00371566|9638850|FG000|STARTED|Treatment Phase||36
8602629|NCT00371566|9638851|FG001|STARTED|Treatment Phase||71
8602630|NCT00371566|9638850|FG000|COMPLETED|Treatment Phase||36
8602631|NCT00371566|9638851|FG001|COMPLETED|Treatment Phase|1 screen failure included in the ITT population|68
8602632|NCT00371566|9638850|FG000|NOT COMPLETED|Treatment Phase||0
8602633|NCT00371566|9638851|FG001|NOT COMPLETED|Treatment Phase||3
8602634|NCT00371566|9638850|FG000|STARTED|Chemoradiation Phase||36
8602635|NCT00371566|9638851|FG001|STARTED|Chemoradiation Phase||68
8602636|NCT00371566|9638850|FG000|COMPLETED|Chemoradiation Phase||31
8602637|NCT00371566|9638851|FG001|COMPLETED|Chemoradiation Phase||65
8602638|NCT00371566|9638850|FG000|NOT COMPLETED|Chemoradiation Phase||5
8602639|NCT00371566|9638851|FG001|NOT COMPLETED|Chemoradiation Phase||3
8602640|NCT00371566|9638850|FG000|STARTED|Follow Up Phase||31
8602641|NCT00371566|9638851|FG001|STARTED|Follow Up Phase||65
8602642|NCT00371566|9638850|FG000|COMPLETED|Follow Up Phase||28
8602643|NCT00371566|9638851|FG001|COMPLETED|Follow Up Phase||58
8602644|NCT00371566|9638850|FG000|NOT COMPLETED|Follow Up Phase||3
8602645|NCT00371566|9638851|FG001|NOT COMPLETED|Follow Up Phase||7
8602646|NCT00371631|9638857|FG000|STARTED|Overall Study||13
8602647|NCT00371631|9638857|FG000|COMPLETED|Overall Study||13
8602648|NCT00371631|9638857|FG000|NOT COMPLETED|Overall Study||0
8602649|NCT00371644|9638863|FG000|STARTED|Overall Study||72
8602650|NCT00371644|9638864|FG001|STARTED|Overall Study||57
8602651|NCT00371644|9638863|FG000|COMPLETED|Overall Study||44
8602652|NCT00371644|9638864|FG001|COMPLETED|Overall Study||44
8602653|NCT00371644|9638863|FG000|NOT COMPLETED|Overall Study||28
8602654|NCT00371644|9638864|FG001|NOT COMPLETED|Overall Study||13
8602655|NCT00371683|9638872|FG000|STARTED|DB Treatment Period-Randomized Patients||1599
8602656|NCT00371683|9638873|FG001|STARTED|DB Treatment Period-Randomized Patients||1596
8602657|NCT00371683|9638872|FG000|COMPLETED|DB Treatment Period-Randomized Patients||1509
8602658|NCT00371683|9638873|FG001|COMPLETED|DB Treatment Period-Randomized Patients||1489
8602659|NCT00371683|9638872|FG000|NOT COMPLETED|DB Treatment Period-Randomized Patients||90
8602660|NCT00371683|9638873|FG001|NOT COMPLETED|DB Treatment Period-Randomized Patients||107
8602661|NCT00371683|9638872|FG000|STARTED|Follow-Up Period - Randomized Patients||1553
8602662|NCT00371683|9638873|FG001|STARTED|Follow-Up Period - Randomized Patients||1533
8602663|NCT00371683|9638872|FG000|COMPLETED|Follow-Up Period - Randomized Patients||1492
8602664|NCT00371683|9638873|FG001|COMPLETED|Follow-Up Period - Randomized Patients||1461
8602665|NCT00371683|9638872|FG000|NOT COMPLETED|Follow-Up Period - Randomized Patients||61
8602666|NCT00371683|9638873|FG001|NOT COMPLETED|Follow-Up Period - Randomized Patients||72
8602667|NCT00371761|9638891|FG000|STARTED|Overall Study||13
8602668|NCT00371761|9638892|FG001|STARTED|Overall Study||12
8602669|NCT00371761|9638891|FG000|COMPLETED|Overall Study||5
8602670|NCT00371761|9638892|FG001|COMPLETED|Overall Study||2
8602671|NCT00371761|9638891|FG000|NOT COMPLETED|Overall Study||8
8602672|NCT00371761|9638892|FG001|NOT COMPLETED|Overall Study||10
8602673|NCT00371787|9638900|FG000|STARTED|Overall Study||26
8602674|NCT00371787|9638901|FG001|STARTED|Overall Study||12
8602675|NCT00371787|9638900|FG000|COMPLETED|Overall Study||23
8602676|NCT00371787|9638901|FG001|COMPLETED|Overall Study||11
8602677|NCT00371787|9638900|FG000|NOT COMPLETED|Overall Study||3
8602678|NCT00371787|9638901|FG001|NOT COMPLETED|Overall Study||1
8602679|NCT00371826|9638910|FG000|STARTED|Core Phase (12 Months)|"Started indicates patients in Randomized, Intent to treat (ITT) and Safety set."|49
8602680|NCT00371826|9638911|FG001|STARTED|Core Phase (12 Months)||47
8602681|NCT00371826|9638912|FG002|STARTED|Core Phase (12 Months)||30
8602682|NCT00371826|9638910|FG000|Modified Intent to Treat (mITT)- Add|Core Phase (12 Months)||46
8602683|NCT00371826|9638911|FG001|Modified Intent to Treat (mITT)- Add|Core Phase (12 Months)||44
8602684|NCT00371826|9638912|FG002|Modified Intent to Treat (mITT)- Add|Core Phase (12 Months)||20
8602685|NCT00371826|9638910|FG000|Modified Intent to Treat (mITT)|Core Phase (12 Months)||27
8602686|NCT00371826|9638911|FG001|Modified Intent to Treat (mITT)|Core Phase (12 Months)||39
8602687|NCT00371826|9638912|FG002|Modified Intent to Treat (mITT)|Core Phase (12 Months)||6
8602688|NCT00371826|9638910|FG000|COMPLETED|Core Phase (12 Months)|"Completed means patients were still on study medication by month 12."|25
8602689|NCT00371826|9638911|FG001|COMPLETED|Core Phase (12 Months)||39
8602690|NCT00371826|9638912|FG002|COMPLETED|Core Phase (12 Months)||6
8602691|NCT00371826|9638910|FG000|NOT COMPLETED|Core Phase (12 Months)||24
8602692|NCT00371826|9638911|FG001|NOT COMPLETED|Core Phase (12 Months)||8
8602693|NCT00371826|9638912|FG002|NOT COMPLETED|Core Phase (12 Months)||24
8602694|NCT00371826|9638910|FG000|STARTED|Extension Phase (24 Months)|2 patients who completed 12 month core did not wish to continue in extension.|23
8602695|NCT00371826|9638911|FG001|STARTED|Extension Phase (24 Months)||39
8602696|NCT00371826|9638912|FG002|STARTED|Extension Phase (24 Months)|One patient completed core, did not wish to continue to extension.|5
8602697|NCT00371826|9638910|FG000|Intention to Treat - Extenstion (ITT-Ex)|Extension Phase (24 Months)||23
8602698|NCT00371826|9638911|FG001|Intention to Treat - Extenstion (ITT-Ex)|Extension Phase (24 Months)||39
8602699|NCT00371826|9638912|FG002|Intention to Treat - Extenstion (ITT-Ex)|Extension Phase (24 Months)|One patient entered extension, was withdrawn (no efficacy data in extension) due to DMC suggestion|4
8602700|NCT00371826|9638910|FG000|Safety Set|Extension Phase (24 Months)|One patient randomized to this arm, was treated with the control regimen (CNI+MPA+Steroid)|22
8602701|NCT00371826|9638911|FG001|Safety Set|Extension Phase (24 Months)|One patient mis-randomised to 1st arm but treated in this arm, evaluated for safety in this arm.|40
8602702|NCT00371826|9638912|FG002|Safety Set|Extension Phase (24 Months)|Patient withdrawn as per DMC suggestion had no efficacy data, but was included in safety set.|5
8602703|NCT00371826|9638910|FG000|COMPLETED|Extension Phase (24 Months)||18
8602704|NCT00371826|9638911|FG001|COMPLETED|Extension Phase (24 Months)||29
8602705|NCT00371826|9638912|FG002|COMPLETED|Extension Phase (24 Months)||3
8602706|NCT00371826|9638910|FG000|NOT COMPLETED|Extension Phase (24 Months)||5
8602707|NCT00371826|9638911|FG001|NOT COMPLETED|Extension Phase (24 Months)||10
8602708|NCT00371826|9638912|FG002|NOT COMPLETED|Extension Phase (24 Months)||2
8602709|NCT00371839|9638923|FG000|STARTED|Overall Study||49
8602710|NCT00371839|9638924|FG001|STARTED|Overall Study||20
8602711|NCT00371839|9638925|FG002|STARTED|Overall Study||9
8602712|NCT00371839|9638923|FG000|COMPLETED|Overall Study||32
8602713|NCT00371839|9638924|FG001|COMPLETED|Overall Study||13
8602714|NCT00371839|9638925|FG002|COMPLETED|Overall Study||7
8602715|NCT00371839|9638923|FG000|NOT COMPLETED|Overall Study||17
8602716|NCT00371839|9638924|FG001|NOT COMPLETED|Overall Study||7
8602717|NCT00371839|9638925|FG002|NOT COMPLETED|Overall Study||2
8602718|NCT00371865|9638933|FG000|STARTED|Overall Study||57
8602719|NCT00371865|9638934|FG001|STARTED|Overall Study||57
8602720|NCT00371865|9638933|FG000|COMPLETED|Overall Study|7 withdrew before starting the intervention. 8 withdrew after starting the intervention.|42
8602721|NCT00371865|9638934|FG001|COMPLETED|Overall Study|8 withdrew before starting the intervention. 6 withdrew after starting the intervention.|43
8602722|NCT00371865|9638933|FG000|NOT COMPLETED|Overall Study||15
8602723|NCT00371865|9638934|FG001|NOT COMPLETED|Overall Study||14
8602724|NCT00372060|9638942|FG000|STARTED|Period I - Double-blind (Weeks 0-12)|The planned number of enrolled patients was 130. The actual number of enrolled patients was 134.|66
8602725|NCT00372060|9638943|FG001|STARTED|Period I - Double-blind (Weeks 0-12)||68
8602726|NCT00372060|9638942|FG000|COMPLETED|Period I - Double-blind (Weeks 0-12)||63
8602727|NCT00372060|9638943|FG001|COMPLETED|Period I - Double-blind (Weeks 0-12)||67
8602728|NCT00372060|9638942|FG000|NOT COMPLETED|Period I - Double-blind (Weeks 0-12)||3
8602729|NCT00372060|9638943|FG001|NOT COMPLETED|Period I - Double-blind (Weeks 0-12)||1
8602730|NCT00372060|9638942|FG000|STARTED|Period II - Open-label (Weeks 12-52)||63
8602731|NCT00372060|9638943|FG001|STARTED|Period II - Open-label (Weeks 12-52)||67
8602732|NCT00372060|9638942|FG000|COMPLETED|Period II - Open-label (Weeks 12-52)||49
8602733|NCT00372060|9638943|FG001|COMPLETED|Period II - Open-label (Weeks 12-52)||59
8602734|NCT00372060|9638942|FG000|NOT COMPLETED|Period II - Open-label (Weeks 12-52)||14
8602735|NCT00372060|9638943|FG001|NOT COMPLETED|Period II - Open-label (Weeks 12-52)||8
8602736|NCT00372112|9638956|FG000|STARTED|Overall Study||17
8602737|NCT00372112|9638957|FG001|STARTED|Overall Study||16
8602738|NCT00372112|9638958|FG002|STARTED|Overall Study||17
8602739|NCT00372112|9638959|FG003|STARTED|Overall Study||18
8602740|NCT00372112|9638956|FG000|COMPLETED|Overall Study||16
8602741|NCT00372112|9638957|FG001|COMPLETED|Overall Study||15
8602742|NCT00372112|9638958|FG002|COMPLETED|Overall Study||13
8602743|NCT00372112|9638959|FG003|COMPLETED|Overall Study||14
8602744|NCT00372112|9638956|FG000|NOT COMPLETED|Overall Study||1
8602745|NCT00372112|9638957|FG001|NOT COMPLETED|Overall Study||1
8602746|NCT00372112|9638958|FG002|NOT COMPLETED|Overall Study||4
8602747|NCT00372112|9638959|FG003|NOT COMPLETED|Overall Study||4
8602748|NCT00372190|9638974|FG000|STARTED|Overall Study|95 were allocated to mesh group, however 2 never underwent any surgery|93
8602749|NCT00372190|9638975|FG001|STARTED|Overall Study|99 were allocated to conventional arm, however 2 never underwent any surgery|97
8602750|NCT00372190|9638974|FG000|COMPLETED|Overall Study||90
8602751|NCT00372190|9638975|FG001|COMPLETED|Overall Study||96
8602752|NCT00372190|9638974|FG000|NOT COMPLETED|Overall Study||3
8602753|NCT00372190|9638975|FG001|NOT COMPLETED|Overall Study||1
8602754|NCT00372255|9638985|FG000|STARTED|Overall Study||110
8602755|NCT00372255|9638986|FG001|STARTED|Overall Study||114
8602756|NCT00372255|9638985|FG000|COMPLETED|Overall Study||108
8602757|NCT00372255|9638986|FG001|COMPLETED|Overall Study||113
8602758|NCT00372255|9638985|FG000|NOT COMPLETED|Overall Study||2
8602759|NCT00372255|9638986|FG001|NOT COMPLETED|Overall Study||1
8602760|NCT00372385|9638997|FG000|STARTED|Overall Study||82
8602761|NCT00372385|9638998|FG001|STARTED|Overall Study||81
8602762|NCT00372385|9638999|FG002|STARTED|Overall Study||82
8602763|NCT00372385|9639000|FG003|STARTED|Overall Study||78
8602764|NCT00372385|9638997|FG000|COMPLETED|Overall Study||49
8602765|NCT00372385|9638998|FG001|COMPLETED|Overall Study||61
8602766|NCT00372385|9638999|FG002|COMPLETED|Overall Study||72
8602767|NCT00372385|9639000|FG003|COMPLETED|Overall Study||70
8602768|NCT00372385|9638997|FG000|NOT COMPLETED|Overall Study||33
8602769|NCT00372385|9638998|FG001|NOT COMPLETED|Overall Study||20
8602770|NCT00372385|9638999|FG002|NOT COMPLETED|Overall Study||10
8602771|NCT00372385|9639000|FG003|NOT COMPLETED|Overall Study||8
8602772|NCT00372411|9639014|FG000|STARTED|Overall Study||49
8602773|NCT00372411|9639015|FG001|STARTED|Overall Study||50
8602774|NCT00372411|9639016|FG002|STARTED|Overall Study||28
8602775|NCT00372411|9639014|FG000|COMPLETED|Overall Study||44
8602776|NCT00372411|9639015|FG001|COMPLETED|Overall Study||42
8602777|NCT00372411|9639016|FG002|COMPLETED|Overall Study||25
8602778|NCT00372411|9639014|FG000|NOT COMPLETED|Overall Study||5
8602779|NCT00372411|9639015|FG001|NOT COMPLETED|Overall Study||8
8602780|NCT00372411|9639016|FG002|NOT COMPLETED|Overall Study||3
8714219|NCT00979199|9761105|FG000|STARTED|Overall Study||697
8714220|NCT00979199|9761105|FG000|COMPLETED|Overall Study||475
8714221|NCT00979199|9761105|FG000|NOT COMPLETED|Overall Study||222
8714222|NCT00979212|9761111|FG000|STARTED|Overall Study||24
8714223|NCT00979212|9761112|FG001|STARTED|Overall Study||47
8602781|NCT00372424|9639024|FG000|STARTED|Overall Study||26
8602782|NCT00372424|9639024|FG000|Treated|Overall Study||25
8602783|NCT00372424|9639024|FG000|COMPLETED|Overall Study||0
8602784|NCT00372424|9639024|FG000|NOT COMPLETED|Overall Study||26
8602785|NCT00372489|9639028|FG000|STARTED|Overall Study||81
8602786|NCT00372489|9639028|FG000|COMPLETED|Overall Study||2
8602787|NCT00372489|9639028|FG000|NOT COMPLETED|Overall Study||79
8602788|NCT00372528|9639032|FG000|STARTED|Overall Study||21
8602789|NCT00372528|9639032|FG000|COMPLETED|Overall Study||0
8602790|NCT00372528|9639032|FG000|NOT COMPLETED|Overall Study||21
8602791|NCT00372567|9639039|FG000|STARTED|Phase 1 Sub-study||0
8602792|NCT00372567|9639040|FG001|STARTED|Phase 1 Sub-study||0
8602793|NCT00372567|9639041|FG002|STARTED|Phase 1 Sub-study||12
8602794|NCT00372567|9639039|FG000|COMPLETED|Phase 1 Sub-study||0
8602795|NCT00372567|9639040|FG001|COMPLETED|Phase 1 Sub-study||0
8602796|NCT00372567|9639041|FG002|COMPLETED|Phase 1 Sub-study||12
8602797|NCT00372567|9639039|FG000|NOT COMPLETED|Phase 1 Sub-study||0
8602798|NCT00372567|9639040|FG001|NOT COMPLETED|Phase 1 Sub-study||0
8602799|NCT00372567|9639041|FG002|NOT COMPLETED|Phase 1 Sub-study||0
8602800|NCT00372567|9639039|FG000|STARTED|Phase 3 Study||31
8602801|NCT00372567|9639040|FG001|STARTED|Phase 3 Study||26
8602802|NCT00372567|9639041|FG002|STARTED|Phase 3 Study||12
8602803|NCT00372567|9639039|FG000|Received Treatment|Phase 3 Study||31
8602804|NCT00372567|9639040|FG001|Received Treatment|Phase 3 Study||25
8725193|NCT01029704|9772385|FG007|COMPLETED|Overall Study||22
8602805|NCT00372567|9639041|FG002|Received Treatment|Phase 3 Study||12
8602806|NCT00372567|9639039|FG000|COMPLETED|Phase 3 Study||0
8602807|NCT00372567|9639040|FG001|COMPLETED|Phase 3 Study||0
8714224|NCT00979212|9761111|FG000|COMPLETED|Overall Study|Subjects with data available for primary analysis are considered to have completed the study.|22
8725194|NCT01029704|9772386|FG008|COMPLETED|Overall Study||25
8602808|NCT00372567|9639041|FG002|COMPLETED|Phase 3 Study||0
8602809|NCT00372567|9639039|FG000|NOT COMPLETED|Phase 3 Study||31
8602810|NCT00372567|9639040|FG001|NOT COMPLETED|Phase 3 Study||26
8602811|NCT00372567|9639041|FG002|NOT COMPLETED|Phase 3 Study||12
8602812|NCT00372593|9639052|FG000|STARTED|Overall Study||531
8602813|NCT00372593|9639053|FG001|STARTED|Overall Study||532
8602814|NCT00372593|9639054|FG002|STARTED|Overall Study||7
8602815|NCT00372593|9639052|FG000|COMPLETED|Overall Study||327
8602816|NCT00372593|9639053|FG001|COMPLETED|Overall Study||334
8602817|NCT00372593|9639054|FG002|COMPLETED|Overall Study||3
8602818|NCT00372593|9639052|FG000|NOT COMPLETED|Overall Study||204
8602819|NCT00372593|9639053|FG001|NOT COMPLETED|Overall Study||198
8602820|NCT00372593|9639054|FG002|NOT COMPLETED|Overall Study||4
8602821|NCT00372619|9639070|FG000|STARTED|Overall Study||8
8602822|NCT00372619|9639071|FG001|STARTED|Overall Study||2
8602823|NCT00372619|9639072|FG002|STARTED|Overall Study||3
8602824|NCT00372619|9639073|FG003|STARTED|Overall Study||10
8602825|NCT00372619|9639074|FG004|STARTED|Overall Study||7
8602826|NCT00372619|9639075|FG005|STARTED|Overall Study||42
8602827|NCT00372619|9639076|FG006|STARTED|Overall Study||2
8602828|NCT00372619|9639070|FG000|COMPLETED|Overall Study||8
8602829|NCT00372619|9639071|FG001|COMPLETED|Overall Study||2
8602830|NCT00372619|9639072|FG002|COMPLETED|Overall Study||3
8602831|NCT00372619|9639073|FG003|COMPLETED|Overall Study||10
8602832|NCT00372619|9639074|FG004|COMPLETED|Overall Study||7
8602833|NCT00372619|9639075|FG005|COMPLETED|Overall Study||39
8602834|NCT00372619|9639076|FG006|COMPLETED|Overall Study||2
8602835|NCT00372619|9639070|FG000|NOT COMPLETED|Overall Study||0
8602836|NCT00372619|9639071|FG001|NOT COMPLETED|Overall Study||0
8602837|NCT00372619|9639072|FG002|NOT COMPLETED|Overall Study||0
8602838|NCT00372619|9639073|FG003|NOT COMPLETED|Overall Study||0
8602839|NCT00372619|9639074|FG004|NOT COMPLETED|Overall Study||0
8602840|NCT00372619|9639075|FG005|NOT COMPLETED|Overall Study||3
8602841|NCT00372619|9639076|FG006|NOT COMPLETED|Overall Study||0
8602842|NCT00372697|9639094|FG000|STARTED|Overall Study||16
8602843|NCT00372697|9639095|FG001|STARTED|Overall Study||12
8602844|NCT00372697|9639094|FG000|COMPLETED|Overall Study||15
8602845|NCT00372697|9639095|FG001|COMPLETED|Overall Study||11
8602846|NCT00372697|9639094|FG000|NOT COMPLETED|Overall Study||1
8602847|NCT00372697|9639095|FG001|NOT COMPLETED|Overall Study||1
8602848|NCT00372775|9639101|FG000|STARTED|Overall Study||66
8602849|NCT00372775|9639101|FG000|Received Treatment|Overall Study||64
8602850|NCT00372775|9639101|FG000|COMPLETED|Overall Study||3
8602851|NCT00372775|9639101|FG000|NOT COMPLETED|Overall Study||63
8602852|NCT00372905|9639105|FG000|STARTED|Cohort 1: Dose Level 1.0mg/m2||3
8602853|NCT00372905|9639106|FG001|STARTED|Cohort 1: Dose Level 1.0mg/m2||0
8602854|NCT00372905|9639107|FG002|STARTED|Cohort 1: Dose Level 1.0mg/m2||0
8602855|NCT00372905|9639108|FG003|STARTED|Cohort 1: Dose Level 1.0mg/m2||0
8602856|NCT00372905|9639105|FG000|Registered to Study|Cohort 1: Dose Level 1.0mg/m2||3
8602857|NCT00372905|9639106|FG001|Registered to Study|Cohort 1: Dose Level 1.0mg/m2||0
8602858|NCT00372905|9639107|FG002|Registered to Study|Cohort 1: Dose Level 1.0mg/m2||0
8602859|NCT00372905|9639108|FG003|Registered to Study|Cohort 1: Dose Level 1.0mg/m2||0
8602860|NCT00372905|9639105|FG000|Treated 1 Cycle of Induction Therapy|Cohort 1: Dose Level 1.0mg/m2||3
8602861|NCT00372905|9639106|FG001|Treated 1 Cycle of Induction Therapy|Cohort 1: Dose Level 1.0mg/m2||0
8602862|NCT00372905|9639107|FG002|Treated 1 Cycle of Induction Therapy|Cohort 1: Dose Level 1.0mg/m2||0
8602863|NCT00372905|9639108|FG003|Treated 1 Cycle of Induction Therapy|Cohort 1: Dose Level 1.0mg/m2||0
8602864|NCT00372905|9639105|FG000|Completed 3 Cycles of Consolidation|Cohort 1: Dose Level 1.0mg/m2||1
8602865|NCT00372905|9639106|FG001|Completed 3 Cycles of Consolidation|Cohort 1: Dose Level 1.0mg/m2||0
8602866|NCT00372905|9639107|FG002|Completed 3 Cycles of Consolidation|Cohort 1: Dose Level 1.0mg/m2||0
8602867|NCT00372905|9639108|FG003|Completed 3 Cycles of Consolidation|Cohort 1: Dose Level 1.0mg/m2||0
8602868|NCT00372905|9639105|FG000|COMPLETED|Cohort 1: Dose Level 1.0mg/m2||1
8602869|NCT00372905|9639106|FG001|COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
8602870|NCT00372905|9639107|FG002|COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
8602871|NCT00372905|9639108|FG003|COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
8602872|NCT00372905|9639105|FG000|NOT COMPLETED|Cohort 1: Dose Level 1.0mg/m2||2
8602873|NCT00372905|9639106|FG001|NOT COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
8602874|NCT00372905|9639107|FG002|NOT COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
8602875|NCT00372905|9639108|FG003|NOT COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
8602876|NCT00372905|9639105|FG000|STARTED|Cohort 2: Dose Level 1.3mg/m2||0
8602877|NCT00372905|9639106|FG001|STARTED|Cohort 2: Dose Level 1.3mg/m2||3
8602878|NCT00372905|9639107|FG002|STARTED|Cohort 2: Dose Level 1.3mg/m2||0
8602879|NCT00372905|9639108|FG003|STARTED|Cohort 2: Dose Level 1.3mg/m2||0
8602880|NCT00372905|9639105|FG000|Registered to Study|Cohort 2: Dose Level 1.3mg/m2||0
8602881|NCT00372905|9639106|FG001|Registered to Study|Cohort 2: Dose Level 1.3mg/m2||3
8602882|NCT00372905|9639107|FG002|Registered to Study|Cohort 2: Dose Level 1.3mg/m2||0
8602883|NCT00372905|9639108|FG003|Registered to Study|Cohort 2: Dose Level 1.3mg/m2||0
8602884|NCT00372905|9639105|FG000|Treated 1 Cycle of Induction Therapy|Cohort 2: Dose Level 1.3mg/m2||0
8602885|NCT00372905|9639106|FG001|Treated 1 Cycle of Induction Therapy|Cohort 2: Dose Level 1.3mg/m2||3
8602886|NCT00372905|9639107|FG002|Treated 1 Cycle of Induction Therapy|Cohort 2: Dose Level 1.3mg/m2||0
8602887|NCT00372905|9639108|FG003|Treated 1 Cycle of Induction Therapy|Cohort 2: Dose Level 1.3mg/m2||0
8602888|NCT00372905|9639105|FG000|Completed 3 Cycles of Consolidation|Cohort 2: Dose Level 1.3mg/m2||0
8602889|NCT00372905|9639106|FG001|Completed 3 Cycles of Consolidation|Cohort 2: Dose Level 1.3mg/m2||3
8602890|NCT00372905|9639107|FG002|Completed 3 Cycles of Consolidation|Cohort 2: Dose Level 1.3mg/m2||0
8602891|NCT00372905|9639108|FG003|Completed 3 Cycles of Consolidation|Cohort 2: Dose Level 1.3mg/m2||0
8602892|NCT00372905|9639105|FG000|COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
8602893|NCT00372905|9639106|FG001|COMPLETED|Cohort 2: Dose Level 1.3mg/m2||3
8602894|NCT00372905|9639107|FG002|COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
8602895|NCT00372905|9639108|FG003|COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
8602896|NCT00372905|9639105|FG000|NOT COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
8602897|NCT00372905|9639106|FG001|NOT COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
8602898|NCT00372905|9639107|FG002|NOT COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
8602899|NCT00372905|9639108|FG003|NOT COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
8602900|NCT00372905|9639105|FG000|STARTED|Cohort 3: Dose Level 1.6mg/m2||0
8602901|NCT00372905|9639106|FG001|STARTED|Cohort 3: Dose Level 1.6mg/m2||0
8602902|NCT00372905|9639107|FG002|STARTED|Cohort 3: Dose Level 1.6mg/m2||4
8602903|NCT00372905|9639108|FG003|STARTED|Cohort 3: Dose Level 1.6mg/m2||0
8602904|NCT00372905|9639105|FG000|Registered|Cohort 3: Dose Level 1.6mg/m2||0
8602905|NCT00372905|9639106|FG001|Registered|Cohort 3: Dose Level 1.6mg/m2||0
8602906|NCT00372905|9639107|FG002|Registered|Cohort 3: Dose Level 1.6mg/m2||4
8602907|NCT00372905|9639108|FG003|Registered|Cohort 3: Dose Level 1.6mg/m2||0
8602908|NCT00372905|9639105|FG000|Treated 1 Cycle of Induction Therapy|Cohort 3: Dose Level 1.6mg/m2||0
8602909|NCT00372905|9639106|FG001|Treated 1 Cycle of Induction Therapy|Cohort 3: Dose Level 1.6mg/m2||0
8602910|NCT00372905|9639107|FG002|Treated 1 Cycle of Induction Therapy|Cohort 3: Dose Level 1.6mg/m2||3
8602911|NCT00372905|9639108|FG003|Treated 1 Cycle of Induction Therapy|Cohort 3: Dose Level 1.6mg/m2||0
8602912|NCT00372905|9639105|FG000|Completed 3 Cycles of Consolidation|Cohort 3: Dose Level 1.6mg/m2||0
8602913|NCT00372905|9639106|FG001|Completed 3 Cycles of Consolidation|Cohort 3: Dose Level 1.6mg/m2||0
8602914|NCT00372905|9639107|FG002|Completed 3 Cycles of Consolidation|Cohort 3: Dose Level 1.6mg/m2||1
8602915|NCT00372905|9639108|FG003|Completed 3 Cycles of Consolidation|Cohort 3: Dose Level 1.6mg/m2||0
8602916|NCT00372905|9639105|FG000|COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
8602917|NCT00372905|9639106|FG001|COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
8602918|NCT00372905|9639107|FG002|COMPLETED|Cohort 3: Dose Level 1.6mg/m2||1
8602919|NCT00372905|9639108|FG003|COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
8602920|NCT00372905|9639105|FG000|NOT COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
8602921|NCT00372905|9639106|FG001|NOT COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
8602922|NCT00372905|9639107|FG002|NOT COMPLETED|Cohort 3: Dose Level 1.6mg/m2||3
8602923|NCT00372905|9639108|FG003|NOT COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
8602924|NCT00372905|9639105|FG000|STARTED|Expansion Phase at Dose 1.3mg/m2||0
8602925|NCT00372905|9639106|FG001|STARTED|Expansion Phase at Dose 1.3mg/m2||0
8602926|NCT00372905|9639107|FG002|STARTED|Expansion Phase at Dose 1.3mg/m2||0
8602927|NCT00372905|9639108|FG003|STARTED|Expansion Phase at Dose 1.3mg/m2||8
8602928|NCT00372905|9639105|FG000|Registration|Expansion Phase at Dose 1.3mg/m2||0
8602929|NCT00372905|9639106|FG001|Registration|Expansion Phase at Dose 1.3mg/m2||0
8602930|NCT00372905|9639107|FG002|Registration|Expansion Phase at Dose 1.3mg/m2||0
8602931|NCT00372905|9639108|FG003|Registration|Expansion Phase at Dose 1.3mg/m2||8
8602932|NCT00372905|9639105|FG000|Treated 1 Cycle Induction Therapy|Expansion Phase at Dose 1.3mg/m2||0
8602933|NCT00372905|9639106|FG001|Treated 1 Cycle Induction Therapy|Expansion Phase at Dose 1.3mg/m2||0
8602934|NCT00372905|9639107|FG002|Treated 1 Cycle Induction Therapy|Expansion Phase at Dose 1.3mg/m2||0
8602935|NCT00372905|9639108|FG003|Treated 1 Cycle Induction Therapy|Expansion Phase at Dose 1.3mg/m2||8
8602936|NCT00372905|9639105|FG000|Completed 3 Cycles of Consolidation|Expansion Phase at Dose 1.3mg/m2||0
8602937|NCT00372905|9639106|FG001|Completed 3 Cycles of Consolidation|Expansion Phase at Dose 1.3mg/m2||0
8602938|NCT00372905|9639107|FG002|Completed 3 Cycles of Consolidation|Expansion Phase at Dose 1.3mg/m2||0
8602939|NCT00372905|9639108|FG003|Completed 3 Cycles of Consolidation|Expansion Phase at Dose 1.3mg/m2||6
8602940|NCT00372905|9639105|FG000|COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
8602941|NCT00372905|9639106|FG001|COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
8602942|NCT00372905|9639107|FG002|COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
8602943|NCT00372905|9639108|FG003|COMPLETED|Expansion Phase at Dose 1.3mg/m2||6
8602944|NCT00372905|9639105|FG000|NOT COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
8602945|NCT00372905|9639106|FG001|NOT COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
8602946|NCT00372905|9639107|FG002|NOT COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
8602947|NCT00372905|9639108|FG003|NOT COMPLETED|Expansion Phase at Dose 1.3mg/m2||2
8602948|NCT00372905|9639105|FG000|STARTED|Follow up Until Relapse or Progression|All patients that are treated on study move into the follow up phase at the completion of therapy.|3
8602949|NCT00372905|9639106|FG001|STARTED|Follow up Until Relapse or Progression||3
8602950|NCT00372905|9639107|FG002|STARTED|Follow up Until Relapse or Progression||3
8602951|NCT00372905|9639108|FG003|STARTED|Follow up Until Relapse or Progression||8
8602952|NCT00372905|9639105|FG000|COMPLETED|Follow up Until Relapse or Progression||3
8602953|NCT00372905|9639106|FG001|COMPLETED|Follow up Until Relapse or Progression||2
8725195|NCT01029704|9772378|FG000|NOT COMPLETED|Overall Study||0
8602954|NCT00372905|9639107|FG002|COMPLETED|Follow up Until Relapse or Progression||3
8602955|NCT00372905|9639108|FG003|COMPLETED|Follow up Until Relapse or Progression||5
8602956|NCT00372905|9639105|FG000|NOT COMPLETED|Follow up Until Relapse or Progression||0
8602957|NCT00372905|9639106|FG001|NOT COMPLETED|Follow up Until Relapse or Progression||1
8602958|NCT00372905|9639107|FG002|NOT COMPLETED|Follow up Until Relapse or Progression||0
8602959|NCT00372905|9639108|FG003|NOT COMPLETED|Follow up Until Relapse or Progression||3
8602960|NCT00372957|9639121|FG000|STARTED|Overall Study||10
8602961|NCT00372957|9639122|FG001|STARTED|Overall Study||10
8602962|NCT00372957|9639123|FG002|STARTED|Overall Study||10
8725196|NCT01029704|9772379|FG001|NOT COMPLETED|Overall Study||0
8725197|NCT01029704|9772380|FG002|NOT COMPLETED|Overall Study||0
8602963|NCT00372957|9639121|FG000|COMPLETED|Overall Study||10
8602964|NCT00372957|9639122|FG001|COMPLETED|Overall Study||10
8602965|NCT00372957|9639123|FG002|COMPLETED|Overall Study||10
8602966|NCT00372957|9639121|FG000|NOT COMPLETED|Overall Study||0
8602967|NCT00372957|9639122|FG001|NOT COMPLETED|Overall Study||0
8602968|NCT00372957|9639123|FG002|NOT COMPLETED|Overall Study||0
8602969|NCT00372970|9639135|FG000|STARTED|Overall Study||16
8602970|NCT00372970|9639136|FG001|STARTED|Overall Study||16
8602971|NCT00372970|9639135|FG000|COMPLETED|Overall Study||16
8602972|NCT00372970|9639136|FG001|COMPLETED|Overall Study||16
8602973|NCT00372970|9639135|FG000|NOT COMPLETED|Overall Study||0
8602974|NCT00372970|9639136|FG001|NOT COMPLETED|Overall Study||0
8602975|NCT00372996|9639144|FG000|STARTED|Overall Study||79
8602976|NCT00372996|9639145|FG001|STARTED|Overall Study||36
8602977|NCT00372996|9639146|FG002|STARTED|Overall Study||61
8602978|NCT00372996|9639147|FG003|STARTED|Overall Study||43
8602979|NCT00372996|9639144|FG000|COMPLETED|Overall Study||42
8602980|NCT00372996|9639145|FG001|COMPLETED|Overall Study||22
8602981|NCT00372996|9639146|FG002|COMPLETED|Overall Study||33
8602982|NCT00372996|9639147|FG003|COMPLETED|Overall Study||23
8602983|NCT00372996|9639144|FG000|NOT COMPLETED|Overall Study||37
8602984|NCT00372996|9639145|FG001|NOT COMPLETED|Overall Study||14
8602985|NCT00372996|9639146|FG002|NOT COMPLETED|Overall Study||28
8602986|NCT00372996|9639147|FG003|NOT COMPLETED|Overall Study||20
8602987|NCT00373113|9639159|FG000|STARTED|Overall Study||238
8602988|NCT00373113|9639160|FG001|STARTED|Overall Study||244
8602989|NCT00373113|9639159|FG000|Received Treatment|Overall Study||238
8602990|NCT00373113|9639160|FG001|Received Treatment|Overall Study||240
8602991|NCT00373113|9639159|FG000|COMPLETED|Overall Study||0
8602992|NCT00373113|9639160|FG001|COMPLETED|Overall Study||0
8602993|NCT00373113|9639159|FG000|NOT COMPLETED|Overall Study||238
8602994|NCT00373113|9639160|FG001|NOT COMPLETED|Overall Study||244
8602995|NCT00373256|9639168|FG000|STARTED|Overall Study||241
8602996|NCT00373256|9639169|FG001|STARTED|Overall Study||247
8602997|NCT00373256|9639168|FG000|Treated|Overall Study||235
8602998|NCT00373256|9639169|FG001|Treated|Overall Study||236
8602999|NCT00373256|9639168|FG000|COMPLETED|Overall Study||0
8603000|NCT00373256|9639169|FG001|COMPLETED|Overall Study||0
8603001|NCT00373256|9639168|FG000|NOT COMPLETED|Overall Study||241
8603002|NCT00373256|9639169|FG001|NOT COMPLETED|Overall Study||247
8603003|NCT00373269|9639177|FG000|STARTED|Overall Study||11
8603004|NCT00373269|9639178|FG001|STARTED|Overall Study||10
8603005|NCT00373269|9639177|FG000|COMPLETED|Overall Study||11
8603006|NCT00373269|9639178|FG001|COMPLETED|Overall Study||10
8603007|NCT00373269|9639177|FG000|NOT COMPLETED|Overall Study||0
8603008|NCT00373269|9639178|FG001|NOT COMPLETED|Overall Study||0
8603009|NCT00373295|9639184|FG000|STARTED|Intervention 1 (8 Days)||2
8603010|NCT00373295|9639185|FG001|STARTED|Intervention 1 (8 Days)||3
8603011|NCT00373295|9639186|FG002|STARTED|Intervention 1 (8 Days)||1
8603012|NCT00373295|9639187|FG003|STARTED|Intervention 1 (8 Days)||2
8603013|NCT00373295|9639188|FG004|STARTED|Intervention 1 (8 Days)||3
8603014|NCT00373295|9639189|FG005|STARTED|Intervention 1 (8 Days)||2
8603015|NCT00373295|9639184|FG000|COMPLETED|Intervention 1 (8 Days)||2
8603016|NCT00373295|9639185|FG001|COMPLETED|Intervention 1 (8 Days)||1
8603017|NCT00373295|9639186|FG002|COMPLETED|Intervention 1 (8 Days)||1
8603018|NCT00373295|9639187|FG003|COMPLETED|Intervention 1 (8 Days)||2
8603019|NCT00373295|9639188|FG004|COMPLETED|Intervention 1 (8 Days)||2
8603020|NCT00373295|9639189|FG005|COMPLETED|Intervention 1 (8 Days)||2
8603021|NCT00373295|9639184|FG000|NOT COMPLETED|Intervention 1 (8 Days)||0
8603022|NCT00373295|9639185|FG001|NOT COMPLETED|Intervention 1 (8 Days)||2
8603023|NCT00373295|9639186|FG002|NOT COMPLETED|Intervention 1 (8 Days)||0
8603024|NCT00373295|9639187|FG003|NOT COMPLETED|Intervention 1 (8 Days)||0
8603025|NCT00373295|9639188|FG004|NOT COMPLETED|Intervention 1 (8 Days)||1
8603026|NCT00373295|9639189|FG005|NOT COMPLETED|Intervention 1 (8 Days)||0
8603027|NCT00373295|9639184|FG000|STARTED|Intervention 2 (8 Days)||2
8603028|NCT00373295|9639185|FG001|STARTED|Intervention 2 (8 Days)||1
8603029|NCT00373295|9639186|FG002|STARTED|Intervention 2 (8 Days)||1
8603030|NCT00373295|9639187|FG003|STARTED|Intervention 2 (8 Days)||2
8603031|NCT00373295|9639188|FG004|STARTED|Intervention 2 (8 Days)||2
8603032|NCT00373295|9639189|FG005|STARTED|Intervention 2 (8 Days)||2
8603033|NCT00373295|9639184|FG000|COMPLETED|Intervention 2 (8 Days)||2
8603034|NCT00373295|9639185|FG001|COMPLETED|Intervention 2 (8 Days)||1
8603035|NCT00373295|9639186|FG002|COMPLETED|Intervention 2 (8 Days)||1
8603036|NCT00373295|9639187|FG003|COMPLETED|Intervention 2 (8 Days)||2
8603037|NCT00373295|9639188|FG004|COMPLETED|Intervention 2 (8 Days)||2
8603038|NCT00373295|9639189|FG005|COMPLETED|Intervention 2 (8 Days)||2
8603039|NCT00373295|9639184|FG000|NOT COMPLETED|Intervention 2 (8 Days)||0
8603040|NCT00373295|9639185|FG001|NOT COMPLETED|Intervention 2 (8 Days)||0
8603041|NCT00373295|9639186|FG002|NOT COMPLETED|Intervention 2 (8 Days)||0
8603042|NCT00373295|9639187|FG003|NOT COMPLETED|Intervention 2 (8 Days)||0
8603043|NCT00373295|9639188|FG004|NOT COMPLETED|Intervention 2 (8 Days)||0
8603044|NCT00373295|9639189|FG005|NOT COMPLETED|Intervention 2 (8 Days)||0
8603045|NCT00373295|9639184|FG000|STARTED|Intervention 3 (8 Days)||2
8603046|NCT00373295|9639185|FG001|STARTED|Intervention 3 (8 Days)||1
8603047|NCT00373295|9639186|FG002|STARTED|Intervention 3 (8 Days)||1
8603048|NCT00373295|9639187|FG003|STARTED|Intervention 3 (8 Days)||2
8603049|NCT00373295|9639188|FG004|STARTED|Intervention 3 (8 Days)||2
8603050|NCT00373295|9639189|FG005|STARTED|Intervention 3 (8 Days)||2
8603051|NCT00373295|9639184|FG000|COMPLETED|Intervention 3 (8 Days)||2
8603052|NCT00373295|9639185|FG001|COMPLETED|Intervention 3 (8 Days)||1
8603053|NCT00373295|9639186|FG002|COMPLETED|Intervention 3 (8 Days)||1
8603054|NCT00373295|9639187|FG003|COMPLETED|Intervention 3 (8 Days)||2
8603055|NCT00373295|9639188|FG004|COMPLETED|Intervention 3 (8 Days)||2
8603056|NCT00373295|9639189|FG005|COMPLETED|Intervention 3 (8 Days)||2
8603057|NCT00373295|9639184|FG000|NOT COMPLETED|Intervention 3 (8 Days)||0
8714225|NCT00979212|9761112|FG001|COMPLETED|Overall Study|Subjects with data available for primary analysis are considered to have completed the study.|39
8714226|NCT00979212|9761111|FG000|NOT COMPLETED|Overall Study||2
8714227|NCT00979212|9761112|FG001|NOT COMPLETED|Overall Study||8
8714228|NCT00979303|9761120|FG000|STARTED|Overall Study||37
8714229|NCT00979303|9761121|FG001|STARTED|Overall Study||37
8714230|NCT00979303|9761120|FG000|COMPLETED|Overall Study||37
8714231|NCT00979303|9761121|FG001|COMPLETED|Overall Study||37
8714232|NCT00979303|9761120|FG000|NOT COMPLETED|Overall Study||0
8714233|NCT00979303|9761121|FG001|NOT COMPLETED|Overall Study||0
8603058|NCT00373295|9639185|FG001|NOT COMPLETED|Intervention 3 (8 Days)||0
8603059|NCT00373295|9639186|FG002|NOT COMPLETED|Intervention 3 (8 Days)||0
8603060|NCT00373295|9639187|FG003|NOT COMPLETED|Intervention 3 (8 Days)||0
8603061|NCT00373295|9639188|FG004|NOT COMPLETED|Intervention 3 (8 Days)||0
8603062|NCT00373295|9639189|FG005|NOT COMPLETED|Intervention 3 (8 Days)||0
8603063|NCT00373334|9639200|FG000|STARTED|Overall Study||43
8603064|NCT00373334|9639201|FG001|STARTED|Overall Study||50
8603065|NCT00373334|9639202|FG002|STARTED|Overall Study||45
8603066|NCT00373334|9639200|FG000|COMPLETED|Overall Study||33
8603067|NCT00373334|9639201|FG001|COMPLETED|Overall Study||32
8603068|NCT00373334|9639202|FG002|COMPLETED|Overall Study||32
8603069|NCT00373334|9639200|FG000|NOT COMPLETED|Overall Study||10
8714234|NCT00979407|9761129|FG000|STARTED|Overall Study||167
8714235|NCT00979407|9761130|FG001|STARTED|Overall Study||167
8714236|NCT00979407|9761129|FG000|COMPLETED|Overall Study||161
8714237|NCT00979407|9761130|FG001|COMPLETED|Overall Study||160
8714238|NCT00979407|9761129|FG000|NOT COMPLETED|Overall Study||6
8714239|NCT00979407|9761130|FG001|NOT COMPLETED|Overall Study||7
8603070|NCT00373334|9639201|FG001|NOT COMPLETED|Overall Study||18
8603071|NCT00373334|9639202|FG002|NOT COMPLETED|Overall Study||13
8603072|NCT00373360|9639210|FG000|STARTED|Overall Study||10
8603073|NCT00373360|9639210|FG000|COMPLETED|Overall Study||10
8603074|NCT00373360|9639210|FG000|NOT COMPLETED|Overall Study||0
8603075|NCT00373386|9639214|FG000|STARTED|Overall Study||9
8603076|NCT00373386|9639214|FG000|COMPLETED|Overall Study||9
8603077|NCT00373386|9639214|FG000|NOT COMPLETED|Overall Study||0
8603078|NCT00373399|9639220|FG000|STARTED|Overall Study||5
8603079|NCT00373399|9639221|FG001|STARTED|Overall Study||7
8603080|NCT00373399|9639222|FG002|STARTED|Overall Study||4
8603081|NCT00373399|9639223|FG003|STARTED|Overall Study||6
8603082|NCT00373399|9639224|FG004|STARTED|Overall Study||7
8603083|NCT00373399|9639225|FG005|STARTED|Overall Study||7
8603084|NCT00373399|9639220|FG000|COMPLETED|Overall Study||5
8603085|NCT00373399|9639221|FG001|COMPLETED|Overall Study||7
8603086|NCT00373399|9639222|FG002|COMPLETED|Overall Study||4
8603087|NCT00373399|9639223|FG003|COMPLETED|Overall Study||6
8603088|NCT00373399|9639224|FG004|COMPLETED|Overall Study||7
8603089|NCT00373399|9639225|FG005|COMPLETED|Overall Study||7
8603090|NCT00373399|9639220|FG000|NOT COMPLETED|Overall Study||0
8603091|NCT00373399|9639221|FG001|NOT COMPLETED|Overall Study||0
8603092|NCT00373399|9639222|FG002|NOT COMPLETED|Overall Study||0
8603093|NCT00373399|9639223|FG003|NOT COMPLETED|Overall Study||0
8603094|NCT00373399|9639224|FG004|NOT COMPLETED|Overall Study||0
8603095|NCT00373399|9639225|FG005|NOT COMPLETED|Overall Study||0
8603096|NCT00373425|9639238|FG000|STARTED|Overall Study||623
8603097|NCT00373425|9639239|FG001|STARTED|Overall Study||350
8603098|NCT00373425|9639240|FG002|STARTED|Overall Study||134
8603099|NCT00373425|9639241|FG003|STARTED|Overall Study||11
8603100|NCT00373425|9639242|FG004|STARTED|Overall Study||132
8603101|NCT00373425|9639238|FG000|Received Treatment|Overall Study||612
8603102|NCT00373425|9639239|FG001|Received Treatment|Overall Study||342
8603103|NCT00373425|9639240|FG002|Received Treatment|Overall Study||134
8603104|NCT00373425|9639241|FG003|Received Treatment|Overall Study||7
8603105|NCT00373425|9639242|FG004|Received Treatment|Overall Study||132
8603106|NCT00373425|9639238|FG000|COMPLETED|Overall Study|Completed 2 years of study treatment|253
8603107|NCT00373425|9639239|FG001|COMPLETED|Overall Study|Completed 2 years of study treatment|197
8603108|NCT00373425|9639240|FG002|COMPLETED|Overall Study|Completed 2 years of study treatment|0
8603109|NCT00373425|9639241|FG003|COMPLETED|Overall Study|Completed 2 years of study treatment|0
8714240|NCT00979420|9761142|FG000|STARTED|Overall Study||178
8714241|NCT00979420|9761143|FG001|STARTED|Overall Study||57
8714242|NCT00979420|9761144|FG002|STARTED|Overall Study||60
8714243|NCT00979420|9761145|FG003|STARTED|Overall Study||61
8603110|NCT00373425|9639242|FG004|COMPLETED|Overall Study|Completed 2 years of study treatment|60
8603111|NCT00373425|9639238|FG000|NOT COMPLETED|Overall Study||370
8603112|NCT00373425|9639239|FG001|NOT COMPLETED|Overall Study||153
8603113|NCT00373425|9639240|FG002|NOT COMPLETED|Overall Study||134
8603114|NCT00373425|9639241|FG003|NOT COMPLETED|Overall Study||11
8603115|NCT00373425|9639242|FG004|NOT COMPLETED|Overall Study||72
8603116|NCT00373490|9639253|FG000|STARTED|Overall Study||10
8603117|NCT00373490|9639254|FG001|STARTED|Overall Study||6
8603118|NCT00373490|9639253|FG000|COMPLETED|Overall Study||1
8603119|NCT00373490|9639254|FG001|COMPLETED|Overall Study||0
8603120|NCT00373490|9639253|FG000|NOT COMPLETED|Overall Study||9
8603121|NCT00373490|9639254|FG001|NOT COMPLETED|Overall Study||6
8603122|NCT00373529|9639260|FG000|STARTED|Overall Study||116
8603123|NCT00373529|9639260|FG000|Full Analysis Set|Overall Study|3 Failed Independent Confirmation of AML; 1 consent violation|112
8603124|NCT00373529|9639260|FG000|COMPLETED|Overall Study|Completed: initiated full 6 cycles of treatment. Not Completed: initiated <6 cycles of treatment|8
8603125|NCT00373529|9639260|FG000|NOT COMPLETED|Overall Study||108
8603126|NCT00373685|9639266|FG000|STARTED|Overall Study||4035
8603127|NCT00373685|9639267|FG001|STARTED|Overall Study||4032
8603128|NCT00373685|9639266|FG000|Treated|Overall Study||3984
8603129|NCT00373685|9639267|FG001|Treated|Overall Study||3955
8603130|NCT00373685|9639266|FG000|COMPLETED|Overall Study||2596
8603131|NCT00373685|9639267|FG001|COMPLETED|Overall Study||2611
8603132|NCT00373685|9639266|FG000|NOT COMPLETED|Overall Study||1439
8603133|NCT00373685|9639267|FG001|NOT COMPLETED|Overall Study||1421
8603134|NCT00373698|9639275|FG000|STARTED|Overall Study||96
8603135|NCT00373698|9639276|FG001|STARTED|Overall Study||99
8603136|NCT00373698|9639275|FG000|COMPLETED|Overall Study||85
8603137|NCT00373698|9639276|FG001|COMPLETED|Overall Study||99
8603138|NCT00373698|9639275|FG000|NOT COMPLETED|Overall Study||11
8603139|NCT00373698|9639276|FG001|NOT COMPLETED|Overall Study||0
8603140|NCT00373880|9639284|FG000|STARTED|Overall Study||26
8603141|NCT00373880|9639284|FG000|COMPLETED|Overall Study||8
8603142|NCT00373880|9639284|FG000|NOT COMPLETED|Overall Study||18
8603143|NCT00373958|9639298|FG000|STARTED|Infant Series|One participant was prerandomized but not consented.|334
8603144|NCT00373958|9639299|FG001|STARTED|Infant Series||332
8603145|NCT00373958|9639298|FG000|Vaccinated Dose 1|Infant Series||332
8603146|NCT00373958|9639299|FG001|Vaccinated Dose 1|Infant Series||331
8603147|NCT00373958|9639298|FG000|Vaccinated Dose 2|Infant Series||309
8603148|NCT00373958|9639299|FG001|Vaccinated Dose 2|Infant Series||305
8603149|NCT00373958|9639298|FG000|Vaccinated Dose 3|Infant Series||298
8603150|NCT00373958|9639299|FG001|Vaccinated Dose 3|Infant Series||300
8603151|NCT00373958|9639298|FG000|COMPLETED|Infant Series||294
8603152|NCT00373958|9639299|FG001|COMPLETED|Infant Series||290
8603153|NCT00373958|9639298|FG000|NOT COMPLETED|Infant Series||40
8603154|NCT00373958|9639299|FG001|NOT COMPLETED|Infant Series||42
8603155|NCT00373958|9639298|FG000|STARTED|Toddler Dose||294
8603156|NCT00373958|9639299|FG001|STARTED|Toddler Dose||290
8603157|NCT00373958|9639298|FG000|Withdrawn After Infant Series|Toddler Dose||22
8603158|NCT00373958|9639299|FG001|Withdrawn After Infant Series|Toddler Dose||25
8603159|NCT00373958|9639298|FG000|Vaccinated Toddler Dose|Toddler Dose||272
8603160|NCT00373958|9639299|FG001|Vaccinated Toddler Dose|Toddler Dose||265
8603161|NCT00373958|9639298|FG000|COMPLETED|Toddler Dose||264
8603162|NCT00373958|9639299|FG001|COMPLETED|Toddler Dose||252
8603163|NCT00373958|9639298|FG000|NOT COMPLETED|Toddler Dose||30
8603164|NCT00373958|9639299|FG001|NOT COMPLETED|Toddler Dose||38
8603165|NCT00374088|9639330|FG000|STARTED|Overall Study||10
8603166|NCT00374088|9639331|FG001|STARTED|Overall Study||11
8603167|NCT00374088|9639330|FG000|COMPLETED|Overall Study||9
8603168|NCT00374088|9639331|FG001|COMPLETED|Overall Study||10
8603169|NCT00374088|9639330|FG000|NOT COMPLETED|Overall Study||1
8603170|NCT00374088|9639331|FG001|NOT COMPLETED|Overall Study||1
8603171|NCT00374127|9639337|FG000|STARTED|Overall Study||35
8603172|NCT00374127|9639337|FG000|COMPLETED|Overall Study||24
8603173|NCT00374127|9639337|FG000|NOT COMPLETED|Overall Study||11
8603174|NCT00374140|9639347|FG000|STARTED|Overall Study||40
8603175|NCT00374140|9639347|FG000|COMPLETED|Overall Study||38
8603176|NCT00374140|9639347|FG000|NOT COMPLETED|Overall Study||2
8603177|NCT00374231|9639351|FG000|STARTED|Overall Study||40
8603178|NCT00374231|9639351|FG000|COMPLETED|Overall Study||40
8603179|NCT00374231|9639351|FG000|NOT COMPLETED|Overall Study||0
8603180|NCT00374244|9639358|FG000|STARTED|Overall Study||14
8603181|NCT00374244|9639359|FG001|STARTED|Overall Study||14
8603182|NCT00374244|9639358|FG000|COMPLETED|Overall Study||14
8603183|NCT00374244|9639359|FG001|COMPLETED|Overall Study||14
8603184|NCT00374244|9639358|FG000|NOT COMPLETED|Overall Study||0
8603185|NCT00374244|9639359|FG001|NOT COMPLETED|Overall Study||0
8603186|NCT00374322|9639367|FG000|STARTED|Overall Study||1579
8603187|NCT00374322|9639368|FG001|STARTED|Overall Study||1582
8603188|NCT00374322|9639367|FG000|Received >=1 Dose of Study Treatment|Overall Study||1571
8603189|NCT00374322|9639368|FG001|Received >=1 Dose of Study Treatment|Overall Study||1576
8603190|NCT00374322|9639367|FG000|COMPLETED|Overall Study||322
8603191|NCT00374322|9639368|FG001|COMPLETED|Overall Study||278
8603192|NCT00374322|9639367|FG000|NOT COMPLETED|Overall Study||1257
8603193|NCT00374322|9639368|FG001|NOT COMPLETED|Overall Study||1304
8603194|NCT00374335|9639375|FG000|STARTED|Overall Study||261
8603195|NCT00374335|9639375|FG000|COMPLETED|Overall Study||261
8603196|NCT00374335|9639375|FG000|NOT COMPLETED|Overall Study||0
8603197|NCT00374452|9639381|FG000|STARTED|Overall Study||34
8603198|NCT00374452|9639382|FG001|STARTED|Overall Study||48
8603199|NCT00374452|9639381|FG000|Intervention Started|Overall Study||30
8603200|NCT00374452|9639382|FG001|Intervention Started|Overall Study||46
8603201|NCT00374452|9639381|FG000|COMPLETED|Overall Study||29
8603202|NCT00374452|9639382|FG001|COMPLETED|Overall Study||43
8603203|NCT00374452|9639381|FG000|NOT COMPLETED|Overall Study||5
8603204|NCT00374452|9639382|FG001|NOT COMPLETED|Overall Study||5
8603205|NCT00374556|9639390|FG000|STARTED|Overall Study||14
8603206|NCT00374556|9639391|FG001|STARTED|Overall Study||16
8603207|NCT00374556|9639390|FG000|COMPLETED|Overall Study||13
8603208|NCT00374556|9639391|FG001|COMPLETED|Overall Study||15
8603209|NCT00374556|9639390|FG000|NOT COMPLETED|Overall Study||1
8603210|NCT00374556|9639391|FG001|NOT COMPLETED|Overall Study||1
8603211|NCT00374803|9639399|FG000|STARTED|Overall Study||22
8603212|NCT00374803|9639400|FG001|STARTED|Overall Study||23
8603213|NCT00374803|9639399|FG000|COMPLETED|Overall Study||22
8603214|NCT00374803|9639400|FG001|COMPLETED|Overall Study||23
8603215|NCT00374803|9639399|FG000|NOT COMPLETED|Overall Study||0
8603216|NCT00374803|9639400|FG001|NOT COMPLETED|Overall Study||0
8603217|NCT00374842|9639411|FG000|STARTED|Overall Study||100
8603218|NCT00374842|9639412|FG001|STARTED|Overall Study||100
8603219|NCT00374842|9639413|FG002|STARTED|Overall Study||100
8603220|NCT00374842|9639411|FG000|COMPLETED|Overall Study||100
8603221|NCT00374842|9639412|FG001|COMPLETED|Overall Study||100
8603222|NCT00374842|9639413|FG002|COMPLETED|Overall Study||100
8603223|NCT00374842|9639411|FG000|NOT COMPLETED|Overall Study||0
8603224|NCT00374842|9639412|FG001|NOT COMPLETED|Overall Study||0
8603225|NCT00374842|9639413|FG002|NOT COMPLETED|Overall Study||0
8603226|NCT00374868|9639423|FG000|STARTED|Overall Study||38
8603227|NCT00374868|9639423|FG000|COMPLETED|Overall Study||2
8603228|NCT00374868|9639423|FG000|NOT COMPLETED|Overall Study||36
8603229|NCT00374907|9639429|FG000|STARTED|12-Week Short-term Period||20
8603230|NCT00374907|9639430|FG001|STARTED|12-Week Short-term Period||16
8603231|NCT00374907|9639429|FG000|COMPLETED|12-Week Short-term Period||17
8603232|NCT00374907|9639430|FG001|COMPLETED|12-Week Short-term Period||15
8603233|NCT00374907|9639429|FG000|NOT COMPLETED|12-Week Short-term Period||3
8603234|NCT00374907|9639430|FG001|NOT COMPLETED|12-Week Short-term Period||1
8603235|NCT00374907|9639429|FG000|STARTED|116-Week Short-term + Long-term Period||20
8603236|NCT00374907|9639430|FG001|STARTED|116-Week Short-term + Long-term Period||16
8603237|NCT00374907|9639429|FG000|Completed 12-week Short Term Period|116-Week Short-term + Long-term Period||17
8603238|NCT00374907|9639430|FG001|Completed 12-week Short Term Period|116-Week Short-term + Long-term Period||15
8603239|NCT00374907|9639429|FG000|COMPLETED|116-Week Short-term + Long-term Period||7
8603240|NCT00374907|9639430|FG001|COMPLETED|116-Week Short-term + Long-term Period||2
8603241|NCT00374907|9639429|FG000|NOT COMPLETED|116-Week Short-term + Long-term Period||13
8603242|NCT00374907|9639430|FG001|NOT COMPLETED|116-Week Short-term + Long-term Period||14
8603243|NCT00375167|9639440|FG000|STARTED|Overall Study|Clients were already receiving ACT services and this continued after study completion|16
8603244|NCT00375167|9639441|FG001|STARTED|Overall Study|Participants were already clients of ACT and continued receiving services following this period|17
8603245|NCT00375167|9639440|FG000|COMPLETED|Overall Study||16
8603246|NCT00375167|9639441|FG001|COMPLETED|Overall Study||17
8603247|NCT00375167|9639440|FG000|NOT COMPLETED|Overall Study||0
8603248|NCT00375167|9639441|FG001|NOT COMPLETED|Overall Study||0
8603249|NCT00375219|9639452|FG000|STARTED|Overall Study||62
8603250|NCT00375219|9639453|FG001|STARTED|Overall Study||20
8603251|NCT00375219|9639454|FG002|STARTED|Overall Study||21
8603252|NCT00375219|9639452|FG000|COMPLETED|Overall Study||3
8603253|NCT00375219|9639453|FG001|COMPLETED|Overall Study||0
8603254|NCT00375219|9639454|FG002|COMPLETED|Overall Study||0
8603255|NCT00375219|9639452|FG000|NOT COMPLETED|Overall Study||59
8603256|NCT00375219|9639453|FG001|NOT COMPLETED|Overall Study||20
8603257|NCT00375219|9639454|FG002|NOT COMPLETED|Overall Study||21
8603258|NCT00375427|9639463|FG000|STARTED|Overall Study|Total enrollment was 430 but five patients were screened but not treated.|209
8603259|NCT00375427|9639464|FG001|STARTED|Overall Study||216
8603260|NCT00375427|9639463|FG000|COMPLETED|Overall Study||149
8603261|NCT00375427|9639464|FG001|COMPLETED|Overall Study||142
8603262|NCT00375427|9639463|FG000|NOT COMPLETED|Overall Study||60
8603263|NCT00375427|9639464|FG001|NOT COMPLETED|Overall Study||74
8603264|NCT00375492|9639472|FG000|STARTED|Overall Study||96
8603265|NCT00375492|9639473|FG001|STARTED|Overall Study||98
8603266|NCT00375492|9639472|FG000|COMPLETED|Overall Study||70
8603267|NCT00375492|9639473|FG001|COMPLETED|Overall Study||72
8603268|NCT00375492|9639472|FG000|NOT COMPLETED|Overall Study||26
8603269|NCT00375492|9639473|FG001|NOT COMPLETED|Overall Study||26
8603270|NCT00375505|9639481|FG000|STARTED|Overall Study||36
8603271|NCT00375505|9639482|FG001|STARTED|Overall Study||34
8603272|NCT00375505|9639481|FG000|COMPLETED|Overall Study||35
8603273|NCT00375505|9639482|FG001|COMPLETED|Overall Study||32
8603274|NCT00375505|9639481|FG000|NOT COMPLETED|Overall Study||1
8603275|NCT00375505|9639482|FG001|NOT COMPLETED|Overall Study||2
8603276|NCT00375518|9639490|FG000|STARTED|Overall Study||80
8603277|NCT00375518|9639491|FG001|STARTED|Overall Study||82
8603278|NCT00375518|9639490|FG000|COMPLETED|Overall Study||72
8603279|NCT00375518|9639491|FG001|COMPLETED|Overall Study||65
8603280|NCT00375518|9639490|FG000|NOT COMPLETED|Overall Study||8
8603281|NCT00375518|9639491|FG001|NOT COMPLETED|Overall Study||17
8603282|NCT00375609|9639500|FG000|STARTED|Overall Study||88
8603283|NCT00375609|9639501|FG001|STARTED|Overall Study||84
8603284|NCT00375609|9639502|FG002|STARTED|Overall Study||43
8603285|NCT00375609|9639500|FG000|COMPLETED|Overall Study||84
8603286|NCT00375609|9639501|FG001|COMPLETED|Overall Study||77
8603287|NCT00375609|9639502|FG002|COMPLETED|Overall Study||42
8603288|NCT00375609|9639500|FG000|NOT COMPLETED|Overall Study||4
8603289|NCT00375609|9639501|FG001|NOT COMPLETED|Overall Study||7
8603290|NCT00375609|9639502|FG002|NOT COMPLETED|Overall Study||1
8603291|NCT00375674|9639512|FG000|STARTED|Overall Study||309
8603292|NCT00375674|9639513|FG001|STARTED|Overall Study||306
8603293|NCT00375674|9639512|FG000|Intent-to-Treat Population|Overall Study||309
8603294|NCT00375674|9639513|FG001|Intent-to-Treat Population|Overall Study||306
8813203|NCT01524679|9866357|FG000|NOT COMPLETED|Overall Study||23
8813204|NCT01524679|9866358|FG001|NOT COMPLETED|Overall Study||9
8813205|NCT01524692|9866364|FG000|STARTED|Overall Study||35
8813206|NCT01524692|9866364|FG000|COMPLETED|Overall Study||32
8813207|NCT01524692|9866364|FG000|NOT COMPLETED|Overall Study||3
8813208|NCT01524770|9866369|FG000|STARTED|First Intervention||26
8603295|NCT00375674|9639512|FG000|As-Treated Population|Overall Study|3 were randomized but not treated: 2 refused treatment & 1 withdrew before receiving study drug|306
8603296|NCT00375674|9639513|FG001|As-Treated Population|Overall Study|2 were randomized but not treated: 1 was screening failure & 1 discontinued due to new liver lesions|304
8603297|NCT00375674|9639512|FG000|COMPLETED|Overall Study||165
8603298|NCT00375674|9639513|FG001|COMPLETED|Overall Study||165
8603299|NCT00375674|9639512|FG000|NOT COMPLETED|Overall Study||144
8603300|NCT00375674|9639513|FG001|NOT COMPLETED|Overall Study||141
8603301|NCT00375713|9639521|FG000|STARTED|Overall Study|Randomized population (N=232).|232
8603302|NCT00375713|9639522|FG001|STARTED|Overall Study|Randomized population (N=234).|234
8603303|NCT00375713|9639521|FG000|COMPLETED|Overall Study|20 Patients were not treated or discontinued after randomization in Levocetirizine group.|212
8603304|NCT00375713|9639522|FG001|COMPLETED|Overall Study|23 Patients were not treated or discontinued after randomization in Cetirizine group.|211
8603305|NCT00375713|9639521|FG000|NOT COMPLETED|Overall Study||20
8603306|NCT00375713|9639522|FG001|NOT COMPLETED|Overall Study||23
8603307|NCT00375752|9639530|FG000|STARTED|Overall Study||79
8603308|NCT00375752|9639531|FG001|STARTED|Overall Study||89
8603309|NCT00375752|9639530|FG000|COMPLETED|Overall Study||67
8603310|NCT00375752|9639531|FG001|COMPLETED|Overall Study||74
8603311|NCT00375752|9639530|FG000|NOT COMPLETED|Overall Study||12
8603312|NCT00375752|9639531|FG001|NOT COMPLETED|Overall Study||15
8603313|NCT00375830|9639540|FG000|STARTED|Overall Study||10
8603314|NCT00375830|9639541|FG001|STARTED|Overall Study||30
8603315|NCT00375830|9639542|FG002|STARTED|Overall Study||74
8603316|NCT00375830|9639540|FG000|COMPLETED|Overall Study||10
8603317|NCT00375830|9639541|FG001|COMPLETED|Overall Study||30
8603318|NCT00375830|9639542|FG002|COMPLETED|Overall Study||74
8603319|NCT00375830|9639540|FG000|NOT COMPLETED|Overall Study||0
8603320|NCT00375830|9639541|FG001|NOT COMPLETED|Overall Study||0
8603321|NCT00375830|9639542|FG002|NOT COMPLETED|Overall Study||0
8603322|NCT00375934|9639564|FG000|STARTED|Overall Study||99
8603323|NCT00375934|9639565|FG001|STARTED|Overall Study||101
8603324|NCT00375934|9639564|FG000|COMPLETED|Overall Study||96
8603325|NCT00375934|9639565|FG001|COMPLETED|Overall Study||95
8603326|NCT00375934|9639564|FG000|NOT COMPLETED|Overall Study||3
8603327|NCT00375934|9639565|FG001|NOT COMPLETED|Overall Study||6
8603328|NCT00375973|9639573|FG000|STARTED|Overall Study||30
8603329|NCT00375973|9639574|FG001|STARTED|Overall Study||30
8603330|NCT00375973|9639573|FG000|COMPLETED|Overall Study||20
8603331|NCT00375973|9639574|FG001|COMPLETED|Overall Study||28
8603332|NCT00375973|9639573|FG000|NOT COMPLETED|Overall Study||10
8603333|NCT00375973|9639574|FG001|NOT COMPLETED|Overall Study||2
8603334|NCT00375999|9639580|FG000|STARTED|Overall Study||34
8603335|NCT00375999|9639580|FG000|COMPLETED|Overall Study||32
8603336|NCT00375999|9639580|FG000|NOT COMPLETED|Overall Study||2
8603337|NCT00376168|9639586|FG000|STARTED|Overall Study||16
8603338|NCT00376168|9639587|FG001|STARTED|Overall Study|One patient randomized but not treated|16
8603339|NCT00376168|9639586|FG000|COMPLETED|Overall Study||14
8603340|NCT00376168|9639587|FG001|COMPLETED|Overall Study||15
8603341|NCT00376168|9639586|FG000|NOT COMPLETED|Overall Study||2
8603342|NCT00376168|9639587|FG001|NOT COMPLETED|Overall Study||1
8603343|NCT00376220|9639595|FG000|STARTED|Overall Study||47
8603344|NCT00376220|9639596|FG001|STARTED|Overall Study||47
8603345|NCT00376220|9639595|FG000|COMPLETED|Overall Study||37
8603346|NCT00376220|9639596|FG001|COMPLETED|Overall Study||35
8603347|NCT00376220|9639595|FG000|NOT COMPLETED|Overall Study||10
8603348|NCT00376220|9639596|FG001|NOT COMPLETED|Overall Study||12
8603349|NCT00376246|9639602|FG000|STARTED|First Intervention (2 Weeks)||14
8603350|NCT00376246|9639603|FG001|STARTED|First Intervention (2 Weeks)||14
8603351|NCT00376246|9639602|FG000|COMPLETED|First Intervention (2 Weeks)||10
8603352|NCT00376246|9639603|FG001|COMPLETED|First Intervention (2 Weeks)||12
8603353|NCT00376246|9639602|FG000|NOT COMPLETED|First Intervention (2 Weeks)||4
8603354|NCT00376246|9639603|FG001|NOT COMPLETED|First Intervention (2 Weeks)||2
8603355|NCT00376246|9639602|FG000|STARTED|Washout (2 Weeks)||10
8603356|NCT00376246|9639603|FG001|STARTED|Washout (2 Weeks)||12
8603357|NCT00376246|9639602|FG000|COMPLETED|Washout (2 Weeks)||10
8603358|NCT00376246|9639603|FG001|COMPLETED|Washout (2 Weeks)||12
8603359|NCT00376246|9639602|FG000|NOT COMPLETED|Washout (2 Weeks)||0
8603360|NCT00376246|9639603|FG001|NOT COMPLETED|Washout (2 Weeks)||0
8603361|NCT00376246|9639602|FG000|STARTED|Second Intervention (2 Weeks)||10
8813209|NCT01524770|9866370|FG001|STARTED|First Intervention||24
8813210|NCT01524770|9866369|FG000|Received at Least 1 Dose of Study Drug|First Intervention||26
8603362|NCT00376246|9639603|FG001|STARTED|Second Intervention (2 Weeks)||12
8603363|NCT00376246|9639602|FG000|COMPLETED|Second Intervention (2 Weeks)||10
8603364|NCT00376246|9639603|FG001|COMPLETED|Second Intervention (2 Weeks)||12
8603365|NCT00376246|9639602|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0
8603366|NCT00376246|9639603|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0
8603367|NCT00376259|9639613|FG000|STARTED|Overall Study||22
8603368|NCT00376259|9639614|FG001|STARTED|Overall Study||21
8603369|NCT00376259|9639613|FG000|Received Study Drug|Overall Study||21
8603370|NCT00376259|9639614|FG001|Received Study Drug|Overall Study||21
8603371|NCT00376259|9639613|FG000|COMPLETED|Overall Study||0
8603372|NCT00376259|9639614|FG001|COMPLETED|Overall Study||0
8603373|NCT00376259|9639613|FG000|NOT COMPLETED|Overall Study||22
8603374|NCT00376259|9639614|FG001|NOT COMPLETED|Overall Study||21
8603375|NCT00376363|9639622|FG000|STARTED|Overall Study||143
8603376|NCT00376363|9639623|FG001|STARTED|Overall Study||133
8603377|NCT00376363|9639622|FG000|COMPLETED|Overall Study||87
8603378|NCT00376363|9639623|FG001|COMPLETED|Overall Study||87
8603379|NCT00376363|9639622|FG000|NOT COMPLETED|Overall Study||56
8603380|NCT00376363|9639623|FG001|NOT COMPLETED|Overall Study||46
8603381|NCT00376506|9639631|FG000|STARTED|Overall Study||4
8603382|NCT00376506|9639632|FG001|STARTED|Overall Study||6
8603383|NCT00376506|9639631|FG000|COMPLETED|Overall Study||4
8603384|NCT00376506|9639632|FG001|COMPLETED|Overall Study||4
8603385|NCT00376506|9639631|FG000|NOT COMPLETED|Overall Study||0
8603386|NCT00376506|9639632|FG001|NOT COMPLETED|Overall Study||2
8603387|NCT00376532|9639643|FG000|STARTED|Overall Study|Subjects with an event were enrolled beginning 09/14/2006.|31
8603388|NCT00376532|9639644|FG001|STARTED|Overall Study|Subjects without an event were enrolled beginning 09/15/2006.|32
8603389|NCT00376532|9639643|FG000|COMPLETED|Overall Study|Last event subject enrolled 2/22/2008|25
8603390|NCT00376532|9639644|FG001|COMPLETED|Overall Study|Last non-event subject enrolled 3/18/2008.|26
8603391|NCT00376532|9639643|FG000|NOT COMPLETED|Overall Study||6
8603392|NCT00376532|9639644|FG001|NOT COMPLETED|Overall Study||6
8603393|NCT00376558|9639652|FG000|STARTED|Overall Study||25
8603394|NCT00376558|9639653|FG001|STARTED|Overall Study||25
8603395|NCT00376558|9639652|FG000|COMPLETED|Overall Study||25
8603396|NCT00376558|9639653|FG001|COMPLETED|Overall Study||25
8603397|NCT00376558|9639652|FG000|NOT COMPLETED|Overall Study||0
8603398|NCT00376558|9639653|FG001|NOT COMPLETED|Overall Study||0
8603399|NCT00376597|9639662|FG000|STARTED|Overall Study||253
8603400|NCT00376597|9639663|FG001|STARTED|Overall Study||315
8603401|NCT00376597|9639662|FG000|COMPLETED|Overall Study||242
8603402|NCT00376597|9639663|FG001|COMPLETED|Overall Study||312
8603403|NCT00376597|9639662|FG000|NOT COMPLETED|Overall Study||11
8603404|NCT00376597|9639663|FG001|NOT COMPLETED|Overall Study||3
8628740|NCT00526097|9668272|FG001|STARTED|Overall Study|Started: Participant was randomised and took at least one dose of randomised study medication|247
8628741|NCT00526097|9668271|FG000|COMPLETED|Overall Study|Completed: Participant without premature discontinuation in the randomised treatment period|106
8628742|NCT00526097|9668272|FG001|COMPLETED|Overall Study|Completed: Participant without premature discontinuation in the randomised treatment period|191
8628743|NCT00526097|9668271|FG000|NOT COMPLETED|Overall Study||15
8628744|NCT00526097|9668272|FG001|NOT COMPLETED|Overall Study||56
8628745|NCT00526110|9668280|FG000|STARTED|Overall Study||53
8628746|NCT00526110|9668281|FG001|STARTED|Overall Study||45
8628747|NCT00526110|9668280|FG000|COMPLETED|Overall Study||51
8628748|NCT00526110|9668281|FG001|COMPLETED|Overall Study||4
8628749|NCT00526110|9668280|FG000|NOT COMPLETED|Overall Study||2
8628750|NCT00526110|9668281|FG001|NOT COMPLETED|Overall Study||41
8628751|NCT00526123|9668289|FG000|STARTED|Overall Study|Intent-to-Treat population|303
8628752|NCT00526123|9668290|FG001|STARTED|Overall Study|Intent-to-Treat population|296
8628753|NCT00526123|9668289|FG000|COMPLETED|Overall Study||39
8628754|NCT00526123|9668290|FG001|COMPLETED|Overall Study||50
8628755|NCT00526123|9668289|FG000|NOT COMPLETED|Overall Study||264
8628756|NCT00526123|9668290|FG001|NOT COMPLETED|Overall Study||246
8628757|NCT00526162|9668296|FG000|STARTED|Overall Study||83
8628758|NCT00526162|9668296|FG000|COMPLETED|Overall Study||80
8628759|NCT00526162|9668296|FG000|NOT COMPLETED|Overall Study||3
8628760|NCT00526188|9668304|FG000|STARTED|Overall Study||234
8628761|NCT00526188|9668304|FG000|COMPLETED|Overall Study||234
8628762|NCT00526188|9668304|FG000|NOT COMPLETED|Overall Study||0
8628763|NCT00526292|9668308|FG000|STARTED|Overall Study||6
8628764|NCT00526292|9668308|FG000|COMPLETED|Overall Study||6
8628765|NCT00526292|9668308|FG000|NOT COMPLETED|Overall Study||0
8628766|NCT00526474|9668314|FG000|STARTED|Overall Study||13224
8628767|NCT00526474|9668315|FG001|STARTED|Overall Study||13225
8628768|NCT00526474|9668314|FG000|Received Study Drug|Overall Study||13166
8628769|NCT00526474|9668315|FG001|Received Study Drug|Overall Study||13186
8628770|NCT00526474|9668314|FG000|COMPLETED|Overall Study||12932
8628771|NCT00526474|9668315|FG001|COMPLETED|Overall Study||12953
8628772|NCT00526474|9668314|FG000|NOT COMPLETED|Overall Study||292
8628773|NCT00526474|9668315|FG001|NOT COMPLETED|Overall Study||272
8628774|NCT00526591|9668323|FG000|STARTED|Overall Study||8
8628775|NCT00526591|9668324|FG001|STARTED|Overall Study||9
8628776|NCT00526591|9668323|FG000|COMPLETED|Overall Study||8
8628777|NCT00526591|9668324|FG001|COMPLETED|Overall Study||9
8628778|NCT00526591|9668323|FG000|NOT COMPLETED|Overall Study||0
8628779|NCT00526591|9668324|FG001|NOT COMPLETED|Overall Study||0
8628780|NCT00526630|9668332|FG000|STARTED|First Intervention Period - 12 Weeks||12
8628781|NCT00526630|9668333|FG001|STARTED|First Intervention Period - 12 Weeks||11
8603405|NCT00376675|9639673|FG000|STARTED|Overall Study||69
8603406|NCT00376675|9639674|FG001|STARTED|Overall Study||70
8603407|NCT00376675|9639673|FG000|COMPLETED|Overall Study||49
8603408|NCT00376675|9639674|FG001|COMPLETED|Overall Study||56
8603409|NCT00376675|9639673|FG000|NOT COMPLETED|Overall Study||20
8603410|NCT00376675|9639674|FG001|NOT COMPLETED|Overall Study||14
8603411|NCT00376688|9639680|FG000|STARTED|Overall Study||31
8603412|NCT00376688|9639680|FG000|COMPLETED|Overall Study||27
8603413|NCT00376688|9639680|FG000|NOT COMPLETED|Overall Study||4
8603414|NCT00376805|9639684|FG000|STARTED|Overall Study||6
8603415|NCT00376805|9639684|FG000|COMPLETED|Overall Study||6
8603416|NCT00376805|9639684|FG000|NOT COMPLETED|Overall Study||0
8603417|NCT00376935|9639692|FG000|STARTED|Overall Study||25
8603418|NCT00376935|9639693|FG001|STARTED|Overall Study||25
8603419|NCT00376935|9639694|FG002|STARTED|Overall Study||25
8603420|NCT00376935|9639695|FG003|STARTED|Overall Study||24
8603421|NCT00376935|9639692|FG000|COMPLETED|Overall Study||25
8603422|NCT00376935|9639693|FG001|COMPLETED|Overall Study||25
8603423|NCT00376935|9639694|FG002|COMPLETED|Overall Study||25
8603424|NCT00376935|9639695|FG003|COMPLETED|Overall Study||24
8603425|NCT00376935|9639692|FG000|NOT COMPLETED|Overall Study||0
8603426|NCT00376935|9639693|FG001|NOT COMPLETED|Overall Study||0
8603427|NCT00376935|9639694|FG002|NOT COMPLETED|Overall Study||0
8603428|NCT00376935|9639695|FG003|NOT COMPLETED|Overall Study||0
8603429|NCT00376948|9639705|FG000|STARTED|Overall Study||20
8603430|NCT00376948|9639705|FG000|COMPLETED|Overall Study||20
8603431|NCT00376948|9639705|FG000|NOT COMPLETED|Overall Study||0
8603432|NCT00376961|9639709|FG000|STARTED|Initial Registration||68
8603433|NCT00376961|9639710|FG001|STARTED|Initial Registration||0
8603434|NCT00376961|9639709|FG000|Eligible|Initial Registration||65
8603435|NCT00376961|9639710|FG001|Eligible|Initial Registration||0
8603436|NCT00376961|9639709|FG000|COMPLETED|Initial Registration||61
8603437|NCT00376961|9639710|FG001|COMPLETED|Initial Registration||0
8603438|NCT00376961|9639709|FG000|NOT COMPLETED|Initial Registration||7
8603439|NCT00376961|9639710|FG001|NOT COMPLETED|Initial Registration||0
8603440|NCT00376961|9639709|FG000|STARTED|Maintenance||0
8603441|NCT00376961|9639710|FG001|STARTED|Maintenance||50
8603442|NCT00376961|9639709|FG000|Eligible|Maintenance||0
8603443|NCT00376961|9639710|FG001|Eligible|Maintenance||47
8603444|NCT00376961|9639709|FG000|COMPLETED|Maintenance||0
8603445|NCT00376961|9639710|FG001|COMPLETED|Maintenance||27
8603446|NCT00376961|9639709|FG000|NOT COMPLETED|Maintenance||0
8603447|NCT00376961|9639710|FG001|NOT COMPLETED|Maintenance||23
8603448|NCT00377156|9639720|FG000|STARTED|Overall Study||111
8603449|NCT00377156|9639721|FG001|STARTED|Overall Study||102
8603450|NCT00377156|9639720|FG000|COMPLETED|Overall Study||63
8603451|NCT00377156|9639721|FG001|COMPLETED|Overall Study||48
8603452|NCT00377156|9639720|FG000|NOT COMPLETED|Overall Study||48
8603453|NCT00377156|9639721|FG001|NOT COMPLETED|Overall Study||54
8603454|NCT00377234|9639731|FG000|STARTED|Overall Study||180
8603455|NCT00377234|9639732|FG001|STARTED|Overall Study||176
8603456|NCT00377234|9639731|FG000|Randomized|Overall Study||180
8603457|NCT00377234|9639732|FG001|Randomized|Overall Study||176
8603458|NCT00377234|9639731|FG000|Did Not Receive Study Treatment|Overall Study||3
8603459|NCT00377234|9639732|FG001|Did Not Receive Study Treatment|Overall Study||2
8603460|NCT00377234|9639731|FG000|Received Treatment|Overall Study||177
8603461|NCT00377234|9639732|FG001|Received Treatment|Overall Study||174
8603462|NCT00377234|9639731|FG000|Safety Analysis Set: Period 1|Overall Study||177
8603463|NCT00377234|9639732|FG001|Safety Analysis Set: Period 1|Overall Study||174
8603464|NCT00377234|9639731|FG000|Safety Analysis Set: Period 2|Overall Study||153
8603465|NCT00377234|9639732|FG001|Safety Analysis Set: Period 2|Overall Study||150
8603466|NCT00377234|9639731|FG000|Safety Analysis Set: Ibandronate|Overall Study||177
8603467|NCT00377234|9639732|FG001|Safety Analysis Set: Ibandronate|Overall Study||150
8603468|NCT00377234|9639731|FG000|Safety Analysis Set: Risedronate|Overall Study||153
8603469|NCT00377234|9639732|FG001|Safety Analysis Set: Risedronate|Overall Study||174
8603470|NCT00377234|9639731|FG000|COMPLETED|Overall Study||146
8603471|NCT00377234|9639732|FG001|COMPLETED|Overall Study||145
8603472|NCT00377234|9639731|FG000|NOT COMPLETED|Overall Study||34
8603473|NCT00377234|9639732|FG001|NOT COMPLETED|Overall Study||31
8603474|NCT00377260|9639746|FG000|STARTED|Overall Study||144
8603475|NCT00377260|9639747|FG001|STARTED|Overall Study||147
8603476|NCT00377260|9639746|FG000|COMPLETED|Overall Study|A child is considered a completer if he/she had at least one visit after the end of therapy.|142
8603477|NCT00377260|9639747|FG001|COMPLETED|Overall Study|A child is considered a completer if he/she had at least one visit after the end of therapy.|142
8603478|NCT00377260|9639746|FG000|NOT COMPLETED|Overall Study||2
8603479|NCT00377260|9639747|FG001|NOT COMPLETED|Overall Study||5
8603480|NCT00377299|9639755|FG000|STARTED|Overall Study||32
8603481|NCT00377299|9639756|FG001|STARTED|Overall Study||28
8603482|NCT00377299|9639755|FG000|COMPLETED|Overall Study||13
8603483|NCT00377299|9639756|FG001|COMPLETED|Overall Study||4
8603484|NCT00377299|9639755|FG000|NOT COMPLETED|Overall Study||19
8603485|NCT00377299|9639756|FG001|NOT COMPLETED|Overall Study||24
8603486|NCT00377312|9639765|FG000|STARTED|Overall Study||6
8603487|NCT00377312|9639766|FG001|STARTED|Overall Study||5
8603488|NCT00377312|9639765|FG000|COMPLETED|Overall Study||5
8603489|NCT00377312|9639766|FG001|COMPLETED|Overall Study||4
8603490|NCT00377312|9639765|FG000|NOT COMPLETED|Overall Study||1
8603491|NCT00377312|9639766|FG001|NOT COMPLETED|Overall Study||1
8603492|NCT00377364|9639774|FG000|STARTED|Overall Study||16
8603493|NCT00377364|9639775|FG001|STARTED|Overall Study||14
8603494|NCT00377364|9639774|FG000|COMPLETED|Overall Study||14
8603495|NCT00377364|9639775|FG001|COMPLETED|Overall Study||14
8603496|NCT00377364|9639774|FG000|NOT COMPLETED|Overall Study||2
8603497|NCT00377364|9639775|FG001|NOT COMPLETED|Overall Study||0
8603498|NCT00377403|9639785|FG000|STARTED|Overall Study||85
8603499|NCT00377403|9639786|FG001|STARTED|Overall Study||81
8603500|NCT00377403|9639785|FG000|Day -3 Assessment|Overall Study||81
8603501|NCT00377403|9639786|FG001|Day -3 Assessment|Overall Study||74
8603502|NCT00377403|9639785|FG000|Day 7 Assessment|Overall Study||80
8603503|NCT00377403|9639786|FG001|Day 7 Assessment|Overall Study||75
8603504|NCT00377403|9639785|FG000|Day 10 Assessment|Overall Study||81
8603505|NCT00377403|9639786|FG001|Day 10 Assessment|Overall Study||71
8603506|NCT00377403|9639785|FG000|Day 28 Assessment|Overall Study||82
8603507|NCT00377403|9639786|FG001|Day 28 Assessment|Overall Study||77
8603508|NCT00377403|9639785|FG000|COMPLETED|Overall Study|The number varied by day of follow-up from 80 to 82 in the intervention group.|81
8603509|NCT00377403|9639786|FG001|COMPLETED|Overall Study|The number varied by day of follow-up from 71 to 77 in the symptomatic treatment only group.|74
8603510|NCT00377403|9639785|FG000|NOT COMPLETED|Overall Study||4
8603511|NCT00377403|9639786|FG001|NOT COMPLETED|Overall Study||7
8603512|NCT00377429|9639792|FG000|STARTED|Overall Study|Treated|47
8603513|NCT00377429|9639792|FG000|COMPLETED|Overall Study|Completed main study|32
8603514|NCT00377429|9639792|FG000|NOT COMPLETED|Overall Study||15
8603515|NCT00377520|9639796|FG000|STARTED|Overall Study||27
8603516|NCT00377520|9639796|FG000|COMPLETED|Overall Study|Completed means the patient was evaluable for response.|26
8603517|NCT00377520|9639796|FG000|NOT COMPLETED|Overall Study||1
8603518|NCT00377572|9639802|FG000|STARTED|Overall Study||208
8603519|NCT00377572|9639803|FG001|STARTED|Overall Study||211
8603520|NCT00377572|9639802|FG000|COMPLETED|Overall Study||155
8603521|NCT00377572|9639803|FG001|COMPLETED|Overall Study||157
8603522|NCT00377572|9639802|FG000|NOT COMPLETED|Overall Study||53
8603523|NCT00377572|9639803|FG001|NOT COMPLETED|Overall Study||54
8603524|NCT00377611|9639811|FG000|STARTED|Overall Study||1047
8603525|NCT00377611|9639812|FG001|STARTED|Overall Study||2007
8603526|NCT00377611|9639811|FG000|COMPLETED|Overall Study||1025
8603527|NCT00377611|9639812|FG001|COMPLETED|Overall Study||1974
8603528|NCT00377611|9639811|FG000|NOT COMPLETED|Overall Study||22
8603529|NCT00377611|9639812|FG001|NOT COMPLETED|Overall Study||33
8603530|NCT00377637|9639823|FG000|STARTED|Induction Phase|Intent-To-Treat|185
8603531|NCT00377637|9639824|FG001|STARTED|Induction Phase|Intent-To-Treat|185
8603532|NCT00377637|9639825|FG002|STARTED|Induction Phase||0
8603533|NCT00377637|9639826|FG003|STARTED|Induction Phase||0
8603534|NCT00377637|9639823|FG000|Safety Population|Induction Phase||180
8603535|NCT00377637|9639824|FG001|Safety Population|Induction Phase||184
8603536|NCT00377637|9639825|FG002|Safety Population|Induction Phase||0
8603537|NCT00377637|9639826|FG003|Safety Population|Induction Phase||0
8603538|NCT00377637|9639823|FG000|COMPLETED|Induction Phase||156
8603539|NCT00377637|9639824|FG001|COMPLETED|Induction Phase||150
8603540|NCT00377637|9639825|FG002|COMPLETED|Induction Phase||0
8603541|NCT00377637|9639826|FG003|COMPLETED|Induction Phase||0
8603542|NCT00377637|9639823|FG000|NOT COMPLETED|Induction Phase||29
8603543|NCT00377637|9639824|FG001|NOT COMPLETED|Induction Phase||35
8603544|NCT00377637|9639825|FG002|NOT COMPLETED|Induction Phase||0
8603545|NCT00377637|9639826|FG003|NOT COMPLETED|Induction Phase||0
8603546|NCT00377637|9639823|FG000|STARTED|Maintenance Phase||0
8603547|NCT00377637|9639824|FG001|STARTED|Maintenance Phase||0
8603548|NCT00377637|9639825|FG002|STARTED|Maintenance Phase||116
8603549|NCT00377637|9639826|FG003|STARTED|Maintenance Phase||111
8603550|NCT00377637|9639823|FG000|COMPLETED|Maintenance Phase||0
8603551|NCT00377637|9639824|FG001|COMPLETED|Maintenance Phase||0
8603552|NCT00377637|9639825|FG002|COMPLETED|Maintenance Phase||73
8603553|NCT00377637|9639826|FG003|COMPLETED|Maintenance Phase||54
8603554|NCT00377637|9639823|FG000|NOT COMPLETED|Maintenance Phase||0
8603555|NCT00377637|9639824|FG001|NOT COMPLETED|Maintenance Phase||0
8603556|NCT00377637|9639825|FG002|NOT COMPLETED|Maintenance Phase||43
8603557|NCT00377637|9639826|FG003|NOT COMPLETED|Maintenance Phase||57
8603558|NCT00377676|9639842|FG000|STARTED|Overall Study|25 subjects did not receive study drug - thus 3070 were randomized and received drug|2054
8603559|NCT00377676|9639843|FG001|STARTED|Overall Study||1016
8603560|NCT00377676|9639842|FG000|COMPLETED|Overall Study||1093
8603561|NCT00377676|9639843|FG001|COMPLETED|Overall Study||694
8603562|NCT00377676|9639842|FG000|NOT COMPLETED|Overall Study||961
8603563|NCT00377676|9639843|FG001|NOT COMPLETED|Overall Study||322
8603564|NCT00377741|9639851|FG000|STARTED|Overall Study||16
8603565|NCT00377741|9639852|FG001|STARTED|Overall Study||15
8603566|NCT00377741|9639851|FG000|COMPLETED|Overall Study||16
8603567|NCT00377741|9639852|FG001|COMPLETED|Overall Study||15
8603568|NCT00377741|9639851|FG000|NOT COMPLETED|Overall Study||0
8603569|NCT00377741|9639852|FG001|NOT COMPLETED|Overall Study||0
8603570|NCT00377819|9639860|FG000|STARTED|Overall Study||251
8603571|NCT00377819|9639861|FG001|STARTED|Overall Study||253
8603572|NCT00377819|9639860|FG000|Received Study Medication|Overall Study||249
8603573|NCT00377819|9639861|FG001|Received Study Medication|Overall Study||253
8603574|NCT00377819|9639860|FG000|COMPLETED|Overall Study||238
8603575|NCT00377819|9639861|FG001|COMPLETED|Overall Study||243
8603576|NCT00377819|9639860|FG000|NOT COMPLETED|Overall Study||13
8603577|NCT00377819|9639861|FG001|NOT COMPLETED|Overall Study||10
8603578|NCT00377832|9639869|FG000|STARTED|Overall Study||7
8603579|NCT00377832|9639870|FG001|STARTED|Overall Study||6
8603580|NCT00377832|9639869|FG000|COMPLETED|Overall Study||7
8603581|NCT00377832|9639870|FG001|COMPLETED|Overall Study||6
8603582|NCT00377832|9639869|FG000|NOT COMPLETED|Overall Study||0
8603583|NCT00377832|9639870|FG001|NOT COMPLETED|Overall Study||0
8603584|NCT00377858|9639881|FG000|STARTED|Overall Study||242
8603585|NCT00377858|9639882|FG001|STARTED|Overall Study||242
8603586|NCT00377858|9639881|FG000|Had at Least One Post-Baseline Value|Overall Study||239
8603587|NCT00377858|9639882|FG001|Had at Least One Post-Baseline Value|Overall Study||240
8603588|NCT00377858|9639881|FG000|COMPLETED|Overall Study||211
8603589|NCT00377858|9639882|FG001|COMPLETED|Overall Study||215
8603590|NCT00377858|9639881|FG000|NOT COMPLETED|Overall Study||31
8603591|NCT00377858|9639882|FG001|NOT COMPLETED|Overall Study||27
8603592|NCT00377962|9639890|FG000|STARTED|Core Study: 0-12 Months||140
8603593|NCT00377962|9639891|FG001|STARTED|Core Study: 0-12 Months||142
8603594|NCT00377962|9639890|FG000|COMPLETED|Core Study: 0-12 Months||112
8603595|NCT00377962|9639891|FG001|COMPLETED|Core Study: 0-12 Months||133
8603596|NCT00377962|9639890|FG000|NOT COMPLETED|Core Study: 0-12 Months||28
8603597|NCT00377962|9639891|FG001|NOT COMPLETED|Core Study: 0-12 Months||9
8603598|NCT00377962|9639890|FG000|STARTED|Extension Study: 12-24 Months||108
8603599|NCT00377962|9639891|FG001|STARTED|Extension Study: 12-24 Months||127
8603600|NCT00377962|9639890|FG000|COMPLETED|Extension Study: 12-24 Months||98
8603601|NCT00377962|9639891|FG001|COMPLETED|Extension Study: 12-24 Months||123
8603602|NCT00377962|9639890|FG000|NOT COMPLETED|Extension Study: 12-24 Months||10
8603603|NCT00377962|9639891|FG001|NOT COMPLETED|Extension Study: 12-24 Months||4
8603604|NCT00378014|9639905|FG000|STARTED|Core (Randomization to Month 11)||101
8603605|NCT00378014|9639906|FG001|STARTED|Core (Randomization to Month 11)||102
8603606|NCT00378014|9639905|FG000|Intent-to-treat (ITT) Population|Core (Randomization to Month 11)|ITT contained all randomized patients who had at least one post baseline GFR measurement.|96
8603607|NCT00378014|9639906|FG001|Intent-to-treat (ITT) Population|Core (Randomization to Month 11)|ITT contained all randomized patients who had at least one post baseline GFR measurement.|98
8603608|NCT00378014|9639905|FG000|COMPLETED|Core (Randomization to Month 11)||87
8603609|NCT00378014|9639906|FG001|COMPLETED|Core (Randomization to Month 11)||90
8603610|NCT00378014|9639905|FG000|NOT COMPLETED|Core (Randomization to Month 11)||14
8603611|NCT00378014|9639906|FG001|NOT COMPLETED|Core (Randomization to Month 11)||12
8603612|NCT00378014|9639905|FG000|STARTED|Extension (Month 12 to Month 59)||41
8603613|NCT00378014|9639906|FG001|STARTED|Extension (Month 12 to Month 59)||40
8603614|NCT00378014|9639905|FG000|COMPLETED|Extension (Month 12 to Month 59)||27
8603615|NCT00378014|9639906|FG001|COMPLETED|Extension (Month 12 to Month 59)||26
8603616|NCT00378014|9639905|FG000|NOT COMPLETED|Extension (Month 12 to Month 59)||14
8603617|NCT00378014|9639906|FG001|NOT COMPLETED|Extension (Month 12 to Month 59)||14
8603618|NCT00378079|9639917|FG000|STARTED|Overall Study||70
8603619|NCT00378079|9639918|FG001|STARTED|Overall Study||70
8603620|NCT00378079|9639919|FG002|STARTED|Overall Study||71
8603621|NCT00378079|9639917|FG000|COMPLETED|Overall Study||64
8603622|NCT00378079|9639918|FG001|COMPLETED|Overall Study||69
8603623|NCT00378079|9639919|FG002|COMPLETED|Overall Study||71
8603624|NCT00378079|9639917|FG000|NOT COMPLETED|Overall Study||6
8603625|NCT00378079|9639918|FG001|NOT COMPLETED|Overall Study||1
8603626|NCT00378079|9639919|FG002|NOT COMPLETED|Overall Study||0
8603627|NCT00378105|9639929|FG000|STARTED|Overall Study|Out of 33 enrolled, two patients went off study before start of therapy.|31
8603628|NCT00378105|9639930|FG001|STARTED|Overall Study||35
8603629|NCT00378105|9639929|FG000|COMPLETED|Overall Study||11
8603630|NCT00378105|9639930|FG001|COMPLETED|Overall Study||5
8603631|NCT00378105|9639929|FG000|NOT COMPLETED|Overall Study||20
8603632|NCT00378105|9639930|FG001|NOT COMPLETED|Overall Study||30
8603633|NCT00378209|9639937|FG000|STARTED|Overall Study|1 patient who never started treatment was excluded in the analysis.|64
8603634|NCT00378209|9639937|FG000|COMPLETED|Overall Study|This included patients who completed at least 8 cycles of combination therapy with all drugs.|42
8603635|NCT00378209|9639937|FG000|NOT COMPLETED|Overall Study||22
8603636|NCT00378326|9639942|FG000|STARTED|Overall Study||26
8603637|NCT00378326|9639942|FG000|COMPLETED|Overall Study||26
8603638|NCT00378326|9639942|FG000|NOT COMPLETED|Overall Study||0
8603639|NCT00378352|9639950|FG000|STARTED|Dose Escalation 15,000 Units||20
8603640|NCT00378352|9639951|FG001|STARTED|Dose Escalation 15,000 Units||0
8603641|NCT00378352|9639952|FG002|STARTED|Dose Escalation 15,000 Units||0
8603642|NCT00378352|9639953|FG003|STARTED|Dose Escalation 15,000 Units||11
8603643|NCT00378352|9639954|FG004|STARTED|Dose Escalation 15,000 Units||0
8603644|NCT00378352|9639955|FG005|STARTED|Dose Escalation 15,000 Units||0
8603645|NCT00378352|9639950|FG000|Safety Analysis|Dose Escalation 15,000 Units||19
8603646|NCT00378352|9639951|FG001|Safety Analysis|Dose Escalation 15,000 Units||0
8603647|NCT00378352|9639952|FG002|Safety Analysis|Dose Escalation 15,000 Units||0
8603648|NCT00378352|9639953|FG003|Safety Analysis|Dose Escalation 15,000 Units||11
8603649|NCT00378352|9639954|FG004|Safety Analysis|Dose Escalation 15,000 Units||0
8603650|NCT00378352|9639955|FG005|Safety Analysis|Dose Escalation 15,000 Units||0
8603651|NCT00378352|9639950|FG000|COMPLETED|Dose Escalation 15,000 Units||15
8603652|NCT00378352|9639951|FG001|COMPLETED|Dose Escalation 15,000 Units||0
8603653|NCT00378352|9639952|FG002|COMPLETED|Dose Escalation 15,000 Units||0
8603654|NCT00378352|9639953|FG003|COMPLETED|Dose Escalation 15,000 Units||10
8603655|NCT00378352|9639954|FG004|COMPLETED|Dose Escalation 15,000 Units||0
8603656|NCT00378352|9639955|FG005|COMPLETED|Dose Escalation 15,000 Units||0
8603657|NCT00378352|9639950|FG000|NOT COMPLETED|Dose Escalation 15,000 Units||5
8603658|NCT00378352|9639951|FG001|NOT COMPLETED|Dose Escalation 15,000 Units||0
8603659|NCT00378352|9639952|FG002|NOT COMPLETED|Dose Escalation 15,000 Units||0
8603660|NCT00378352|9639953|FG003|NOT COMPLETED|Dose Escalation 15,000 Units||1
8603661|NCT00378352|9639954|FG004|NOT COMPLETED|Dose Escalation 15,000 Units||0
8603662|NCT00378352|9639955|FG005|NOT COMPLETED|Dose Escalation 15,000 Units||0
8603663|NCT00378352|9639950|FG000|STARTED|Dose Escalation 30,000 Units||0
8603664|NCT00378352|9639951|FG001|STARTED|Dose Escalation 30,000 Units||19
8603665|NCT00378352|9639952|FG002|STARTED|Dose Escalation 30,000 Units||0
8603666|NCT00378352|9639953|FG003|STARTED|Dose Escalation 30,000 Units||11
8603667|NCT00378352|9639954|FG004|STARTED|Dose Escalation 30,000 Units||0
8603668|NCT00378352|9639955|FG005|STARTED|Dose Escalation 30,000 Units||0
8603669|NCT00378352|9639950|FG000|Safety Analysis|Dose Escalation 30,000 Units||0
8603670|NCT00378352|9639951|FG001|Safety Analysis|Dose Escalation 30,000 Units|One participant randomized to 60,000 units received 30,000 units|20
8603671|NCT00378352|9639952|FG002|Safety Analysis|Dose Escalation 30,000 Units||0
8603672|NCT00378352|9639953|FG003|Safety Analysis|Dose Escalation 30,000 Units||11
8603673|NCT00378352|9639954|FG004|Safety Analysis|Dose Escalation 30,000 Units||0
8603674|NCT00378352|9639955|FG005|Safety Analysis|Dose Escalation 30,000 Units||0
8603675|NCT00378352|9639950|FG000|COMPLETED|Dose Escalation 30,000 Units||0
8603676|NCT00378352|9639951|FG001|COMPLETED|Dose Escalation 30,000 Units||16
8603677|NCT00378352|9639952|FG002|COMPLETED|Dose Escalation 30,000 Units||0
8603678|NCT00378352|9639953|FG003|COMPLETED|Dose Escalation 30,000 Units||9
8603679|NCT00378352|9639954|FG004|COMPLETED|Dose Escalation 30,000 Units||0
8603680|NCT00378352|9639955|FG005|COMPLETED|Dose Escalation 30,000 Units||0
8603681|NCT00378352|9639950|FG000|NOT COMPLETED|Dose Escalation 30,000 Units||0
8603682|NCT00378352|9639951|FG001|NOT COMPLETED|Dose Escalation 30,000 Units||3
8603683|NCT00378352|9639952|FG002|NOT COMPLETED|Dose Escalation 30,000 Units||0
8603684|NCT00378352|9639953|FG003|NOT COMPLETED|Dose Escalation 30,000 Units||2
8603685|NCT00378352|9639954|FG004|NOT COMPLETED|Dose Escalation 30,000 Units||0
8603686|NCT00378352|9639955|FG005|NOT COMPLETED|Dose Escalation 30,000 Units||0
8603687|NCT00378352|9639950|FG000|STARTED|Dose Escalation 60,000 Units||0
8714244|NCT00979420|9761142|FG000|COMPLETED|Overall Study||171
8714245|NCT00979420|9761143|FG001|COMPLETED|Overall Study||57
8714246|NCT00979420|9761144|FG002|COMPLETED|Overall Study||59
8603688|NCT00378352|9639951|FG001|STARTED|Dose Escalation 60,000 Units||0
8603689|NCT00378352|9639952|FG002|STARTED|Dose Escalation 60,000 Units||20
8603690|NCT00378352|9639953|FG003|STARTED|Dose Escalation 60,000 Units||11
8603691|NCT00378352|9639954|FG004|STARTED|Dose Escalation 60,000 Units||0
8603692|NCT00378352|9639955|FG005|STARTED|Dose Escalation 60,000 Units||0
8603693|NCT00378352|9639950|FG000|Safety Analysis|Dose Escalation 60,000 Units||0
8603694|NCT00378352|9639951|FG001|Safety Analysis|Dose Escalation 60,000 Units||0
8603695|NCT00378352|9639952|FG002|Safety Analysis|Dose Escalation 60,000 Units||19
8603696|NCT00378352|9639953|FG003|Safety Analysis|Dose Escalation 60,000 Units||11
8603697|NCT00378352|9639954|FG004|Safety Analysis|Dose Escalation 60,000 Units||0
8603698|NCT00378352|9639955|FG005|Safety Analysis|Dose Escalation 60,000 Units||0
8603699|NCT00378352|9639950|FG000|COMPLETED|Dose Escalation 60,000 Units||0
8603700|NCT00378352|9639951|FG001|COMPLETED|Dose Escalation 60,000 Units||0
8603701|NCT00378352|9639952|FG002|COMPLETED|Dose Escalation 60,000 Units||17
8603702|NCT00378352|9639953|FG003|COMPLETED|Dose Escalation 60,000 Units||10
8603703|NCT00378352|9639954|FG004|COMPLETED|Dose Escalation 60,000 Units||0
8603704|NCT00378352|9639955|FG005|COMPLETED|Dose Escalation 60,000 Units||0
8603705|NCT00378352|9639950|FG000|NOT COMPLETED|Dose Escalation 60,000 Units||0
8603706|NCT00378352|9639951|FG001|NOT COMPLETED|Dose Escalation 60,000 Units||0
8603707|NCT00378352|9639952|FG002|NOT COMPLETED|Dose Escalation 60,000 Units||3
8603708|NCT00378352|9639953|FG003|NOT COMPLETED|Dose Escalation 60,000 Units||1
8603709|NCT00378352|9639954|FG004|NOT COMPLETED|Dose Escalation 60,000 Units||0
8603710|NCT00378352|9639955|FG005|NOT COMPLETED|Dose Escalation 60,000 Units||0
8603711|NCT00378352|9639950|FG000|STARTED|Efficacy Phase||0
8603712|NCT00378352|9639951|FG001|STARTED|Efficacy Phase||0
8603713|NCT00378352|9639952|FG002|STARTED|Efficacy Phase||0
8603714|NCT00378352|9639953|FG003|STARTED|Efficacy Phase||0
8603715|NCT00378352|9639954|FG004|STARTED|Efficacy Phase||65
8603716|NCT00378352|9639955|FG005|STARTED|Efficacy Phase||66
8603717|NCT00378352|9639950|FG000|Safety Analysis|Efficacy Phase||0
8603718|NCT00378352|9639951|FG001|Safety Analysis|Efficacy Phase||0
8603719|NCT00378352|9639952|FG002|Safety Analysis|Efficacy Phase||0
8603720|NCT00378352|9639953|FG003|Safety Analysis|Efficacy Phase||0
8603721|NCT00378352|9639954|FG004|Safety Analysis|Efficacy Phase|Two participants randomized to placebo received 60,000 units Epoetin alfa|67
8603722|NCT00378352|9639955|FG005|Safety Analysis|Efficacy Phase||64
8603723|NCT00378352|9639950|FG000|COMPLETED|Efficacy Phase||0
8603724|NCT00378352|9639951|FG001|COMPLETED|Efficacy Phase||0
8603725|NCT00378352|9639952|FG002|COMPLETED|Efficacy Phase||0
8603726|NCT00378352|9639953|FG003|COMPLETED|Efficacy Phase||0
8603727|NCT00378352|9639954|FG004|COMPLETED|Efficacy Phase||54
8603728|NCT00378352|9639955|FG005|COMPLETED|Efficacy Phase||59
8603729|NCT00378352|9639950|FG000|NOT COMPLETED|Efficacy Phase||0
8603730|NCT00378352|9639951|FG001|NOT COMPLETED|Efficacy Phase||0
8603731|NCT00378352|9639952|FG002|NOT COMPLETED|Efficacy Phase||0
8603732|NCT00378352|9639953|FG003|NOT COMPLETED|Efficacy Phase||0
8603733|NCT00378352|9639954|FG004|NOT COMPLETED|Efficacy Phase||11
8603734|NCT00378352|9639955|FG005|NOT COMPLETED|Efficacy Phase||7
8714247|NCT00979420|9761145|FG003|COMPLETED|Overall Study||59
8714248|NCT00979420|9761142|FG000|NOT COMPLETED|Overall Study||7
8603735|NCT00378508|9639965|FG000|STARTED|Overall Study||29
8603736|NCT00378508|9639966|FG001|STARTED|Overall Study||34
8603737|NCT00378508|9639965|FG000|Randomized|Overall Study||29
8603738|NCT00378508|9639966|FG001|Randomized|Overall Study||34
8603739|NCT00378508|9639965|FG000|Received Intervention/Placebo|Overall Study||28
8603740|NCT00378508|9639966|FG001|Received Intervention/Placebo|Overall Study||31
8603741|NCT00378508|9639965|FG000|COMPLETED|Overall Study||27
8603742|NCT00378508|9639966|FG001|COMPLETED|Overall Study||31
8603743|NCT00378508|9639965|FG000|NOT COMPLETED|Overall Study||2
8603744|NCT00378508|9639966|FG001|NOT COMPLETED|Overall Study||3
8603745|NCT00378534|9639975|FG000|STARTED|Overall Study||58
8603746|NCT00378534|9639976|FG001|STARTED|Overall Study||58
8603747|NCT00378534|9639975|FG000|COMPLETED|Overall Study||55
8603748|NCT00378534|9639976|FG001|COMPLETED|Overall Study||58
8603749|NCT00378534|9639975|FG000|NOT COMPLETED|Overall Study||3
8603750|NCT00378534|9639976|FG001|NOT COMPLETED|Overall Study||0
8603751|NCT00378560|9639983|FG000|STARTED|Overall Study||509
8603752|NCT00378560|9639984|FG001|STARTED|Overall Study||512
8603753|NCT00378560|9639983|FG000|Vaccinated|Overall Study||509
8603754|NCT00378560|9639984|FG001|Vaccinated|Overall Study||512
8603755|NCT00378560|9639983|FG000|COMPLETED|Overall Study||453
8603756|NCT00378560|9639984|FG001|COMPLETED|Overall Study||454
8603757|NCT00378560|9639983|FG000|NOT COMPLETED|Overall Study||56
8603758|NCT00378560|9639984|FG001|NOT COMPLETED|Overall Study||58
8603759|NCT00378573|9639990|FG000|STARTED|Treatment Period||17
8603760|NCT00378573|9639990|FG000|COMPLETED|Treatment Period|Patients who did not complete treatment moved directly to the follow-up phase of the study.|0
8603761|NCT00378573|9639990|FG000|NOT COMPLETED|Treatment Period||17
8603762|NCT00378573|9639990|FG000|STARTED|Follow-up||17
8603763|NCT00378573|9639990|FG000|COMPLETED|Follow-up||3
8603764|NCT00378573|9639990|FG000|NOT COMPLETED|Follow-up||14
8603765|NCT00378599|9639994|FG000|STARTED|Overall Study||125
8603766|NCT00378599|9639994|FG000|COMPLETED|Overall Study||73
8603767|NCT00378599|9639994|FG000|NOT COMPLETED|Overall Study||52
8603768|NCT00378703|9640002|FG000|STARTED|Overall Study|Number of patients randomized to this treatment arm.|89
8603769|NCT00378703|9640003|FG001|STARTED|Overall Study|Number of patients randomized to this treatment arm.|91
8603770|NCT00378703|9640004|FG002|STARTED|Overall Study|Number of patients randomized to this treatment arm.|90
8603771|NCT00378703|9640005|FG003|STARTED|Overall Study|Number of patients randomized to this treatment arm.|91
8813211|NCT01524770|9866370|FG001|Received at Least 1 Dose of Study Drug|First Intervention||24
8813212|NCT01524770|9866369|FG000|COMPLETED|First Intervention||23
8813213|NCT01524770|9866370|FG001|COMPLETED|First Intervention||23
8813214|NCT01524770|9866369|FG000|NOT COMPLETED|First Intervention||3
8603772|NCT00378703|9640002|FG000|Treated|Overall Study|Number of patients included in the toxicity analysis.|88
8603773|NCT00378703|9640003|FG001|Treated|Overall Study|Number of patients included in the toxicity analysis.|86
8603774|NCT00378703|9640004|FG002|Treated|Overall Study|Number of patients included in the toxicity analysis.|90
8603775|NCT00378703|9640005|FG003|Treated|Overall Study|Number of patients included in the toxicity analysis.|91
8603776|NCT00378703|9640002|FG000|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|84
8603777|NCT00378703|9640003|FG001|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|80
8603778|NCT00378703|9640004|FG002|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|83
8603779|NCT00378703|9640005|FG003|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|84
8603780|NCT00378703|9640002|FG000|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
8603781|NCT00378703|9640003|FG001|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
8603782|NCT00378703|9640004|FG002|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
8603783|NCT00378703|9640005|FG003|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
8603784|NCT00378703|9640002|FG000|NOT COMPLETED|Overall Study||89
8603785|NCT00378703|9640003|FG001|NOT COMPLETED|Overall Study||91
8603786|NCT00378703|9640004|FG002|NOT COMPLETED|Overall Study||90
8603787|NCT00378703|9640005|FG003|NOT COMPLETED|Overall Study||91
8603788|NCT00378898|9640017|FG000|STARTED|Overall Study||22
8603789|NCT00378898|9640018|FG001|STARTED|Overall Study||17
8603790|NCT00378898|9640017|FG000|COMPLETED|Overall Study||11
8603791|NCT00378898|9640018|FG001|COMPLETED|Overall Study||11
8603792|NCT00378898|9640017|FG000|NOT COMPLETED|Overall Study||11
8603793|NCT00378898|9640018|FG001|NOT COMPLETED|Overall Study||6
8603794|NCT00379080|9640029|FG000|STARTED|Overall Study||6
8603795|NCT00379080|9640030|FG001|STARTED|Overall Study||19
8714249|NCT00979420|9761143|FG001|NOT COMPLETED|Overall Study||0
8714250|NCT00979420|9761144|FG002|NOT COMPLETED|Overall Study||1
8714251|NCT00979420|9761145|FG003|NOT COMPLETED|Overall Study||2
8714252|NCT00979459|9761153|FG000|STARTED|First Intervention||6
8603796|NCT00379080|9640031|FG002|STARTED|Overall Study||31
8603797|NCT00379080|9640029|FG000|COMPLETED|Overall Study||6
8603798|NCT00379080|9640030|FG001|COMPLETED|Overall Study||15
8603799|NCT00379080|9640031|FG002|COMPLETED|Overall Study||31
8603800|NCT00379080|9640029|FG000|NOT COMPLETED|Overall Study||0
8603801|NCT00379080|9640030|FG001|NOT COMPLETED|Overall Study||4
8603802|NCT00379080|9640031|FG002|NOT COMPLETED|Overall Study||0
8603803|NCT00379145|9640054|FG000|STARTED|Overall Study||20
8714253|NCT00979459|9761154|FG001|STARTED|First Intervention||6
8714254|NCT00979459|9761153|FG000|COMPLETED|First Intervention||6
8603804|NCT00379145|9640054|FG000|COMPLETED|Overall Study||20
8603805|NCT00379145|9640054|FG000|NOT COMPLETED|Overall Study||0
8603806|NCT00379197|9640063|FG000|STARTED|Overall Study||13
8603807|NCT00379197|9640063|FG000|COMPLETED|Overall Study||8
8603808|NCT00379197|9640063|FG000|NOT COMPLETED|Overall Study||5
8603809|NCT00379210|9640070|FG000|STARTED|Overall Study||30
8603810|NCT00379210|9640071|FG001|STARTED|Overall Study||30
8603811|NCT00379210|9640070|FG000|COMPLETED|Overall Study||20
8603812|NCT00379210|9640071|FG001|COMPLETED|Overall Study||23
8603813|NCT00379210|9640070|FG000|NOT COMPLETED|Overall Study||10
8603814|NCT00379210|9640071|FG001|NOT COMPLETED|Overall Study||7
8603815|NCT00379236|9640079|FG000|STARTED|Double-blind||293
8603816|NCT00379236|9640080|FG001|STARTED|Double-blind||295
8603817|NCT00379236|9640081|FG002|STARTED|Double-blind||0
8603818|NCT00379236|9640079|FG000|COMPLETED|Double-blind|Data could not be retrieved for two participants|257
8603819|NCT00379236|9640080|FG001|COMPLETED|Double-blind|Data could not be retrieved for two participants|259
8603820|NCT00379236|9640081|FG002|COMPLETED|Double-blind||0
8603821|NCT00379236|9640079|FG000|NOT COMPLETED|Double-blind||36
8603822|NCT00379236|9640080|FG001|NOT COMPLETED|Double-blind||36
8603823|NCT00379236|9640081|FG002|NOT COMPLETED|Double-blind||0
8603824|NCT00379236|9640079|FG000|STARTED|Open-label Extension||0
8603825|NCT00379236|9640080|FG001|STARTED|Open-label Extension||0
8603826|NCT00379236|9640081|FG002|STARTED|Open-label Extension||433
8603827|NCT00379236|9640079|FG000|COMPLETED|Open-label Extension||0
8603828|NCT00379236|9640080|FG001|COMPLETED|Open-label Extension||0
8603829|NCT00379236|9640081|FG002|COMPLETED|Open-label Extension||378
8603830|NCT00379236|9640079|FG000|NOT COMPLETED|Open-label Extension||0
8603831|NCT00379236|9640080|FG001|NOT COMPLETED|Open-label Extension||0
8603832|NCT00379236|9640081|FG002|NOT COMPLETED|Open-label Extension||55
8603833|NCT00379353|9640095|FG000|STARTED|Overall Study||16
8603834|NCT00379353|9640096|FG001|STARTED|Overall Study||15
8603835|NCT00379353|9640095|FG000|COMPLETED|Overall Study||5
8603836|NCT00379353|9640096|FG001|COMPLETED|Overall Study||9
8603837|NCT00379353|9640095|FG000|NOT COMPLETED|Overall Study||11
8603838|NCT00379353|9640096|FG001|NOT COMPLETED|Overall Study||6
8603839|NCT00379574|9640112|FG000|STARTED|Overall Study|Phase I (9) + Phase II (40)|49
8603840|NCT00379574|9640112|FG000|COMPLETED|Overall Study|Phase I (9) + Phase II (40)|49
8714255|NCT00979459|9761154|FG001|COMPLETED|First Intervention||6
8714256|NCT00979459|9761153|FG000|NOT COMPLETED|First Intervention||0
8714257|NCT00979459|9761154|FG001|NOT COMPLETED|First Intervention||0
8714258|NCT00979459|9761153|FG000|STARTED|7-day Washout Period||6
8603841|NCT00379574|9640112|FG000|NOT COMPLETED|Overall Study||0
8603842|NCT00379587|9640116|FG000|STARTED|Overall Study||65
8603843|NCT00379587|9640116|FG000|COMPLETED|Overall Study||63
8603844|NCT00379587|9640116|FG000|NOT COMPLETED|Overall Study||2
8603845|NCT00379639|9640125|FG000|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|7
8603846|NCT00379639|9640126|FG001|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|7
8603847|NCT00379639|9640127|FG002|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|10
8603848|NCT00379639|9640128|FG003|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|6
8603849|NCT00379639|9640129|FG004|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|6
8603850|NCT00379639|9640125|FG000|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|6
8603851|NCT00379639|9640126|FG001|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|7
8603852|NCT00379639|9640127|FG002|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|7
8603853|NCT00379639|9640128|FG003|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|4
8603854|NCT00379639|9640129|FG004|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|3
8603855|NCT00379639|9640125|FG000|Completed 6 Cycles of Therapy|Overall Study||4
8603856|NCT00379639|9640126|FG001|Completed 6 Cycles of Therapy|Overall Study||2
8603857|NCT00379639|9640127|FG002|Completed 6 Cycles of Therapy|Overall Study||1
8603858|NCT00379639|9640128|FG003|Completed 6 Cycles of Therapy|Overall Study||0
8603859|NCT00379639|9640129|FG004|Completed 6 Cycles of Therapy|Overall Study||0
8603860|NCT00379639|9640125|FG000|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|4
8603861|NCT00379639|9640126|FG001|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|2
8603862|NCT00379639|9640127|FG002|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|1
8603863|NCT00379639|9640128|FG003|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|0
8603864|NCT00379639|9640129|FG004|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|0
8603865|NCT00379639|9640125|FG000|NOT COMPLETED|Overall Study||3
8603866|NCT00379639|9640126|FG001|NOT COMPLETED|Overall Study||5
8603867|NCT00379639|9640127|FG002|NOT COMPLETED|Overall Study||9
8603868|NCT00379639|9640128|FG003|NOT COMPLETED|Overall Study||6
8603869|NCT00379639|9640129|FG004|NOT COMPLETED|Overall Study||6
8714259|NCT00979459|9761154|FG001|STARTED|7-day Washout Period||6
8714260|NCT00979459|9761153|FG000|COMPLETED|7-day Washout Period||6
8714261|NCT00979459|9761154|FG001|COMPLETED|7-day Washout Period||6
8603870|NCT00379769|9640145|FG000|STARTED|Main Study||1117
8603871|NCT00379769|9640146|FG001|STARTED|Main Study||1105
8603872|NCT00379769|9640147|FG002|STARTED|Main Study||1103
8603873|NCT00379769|9640148|FG003|STARTED|Main Study||1122
8603874|NCT00379769|9640149|FG004|STARTED|Main Study||0
8603875|NCT00379769|9640150|FG005|STARTED|Main Study||0
8603876|NCT00379769|9640145|FG000|COMPLETED|Main Study||939
8603877|NCT00379769|9640146|FG001|COMPLETED|Main Study||906
8603878|NCT00379769|9640147|FG002|COMPLETED|Main Study||896
8603879|NCT00379769|9640148|FG003|COMPLETED|Main Study||892
8603880|NCT00379769|9640149|FG004|COMPLETED|Main Study||0
8603881|NCT00379769|9640150|FG005|COMPLETED|Main Study||0
8603882|NCT00379769|9640145|FG000|NOT COMPLETED|Main Study||178
8603883|NCT00379769|9640146|FG001|NOT COMPLETED|Main Study||199
8603884|NCT00379769|9640147|FG002|NOT COMPLETED|Main Study||207
8603885|NCT00379769|9640148|FG003|NOT COMPLETED|Main Study||230
8603886|NCT00379769|9640149|FG004|NOT COMPLETED|Main Study||0
8603887|NCT00379769|9640150|FG005|NOT COMPLETED|Main Study||0
8603888|NCT00379769|9640145|FG000|STARTED|Observational Follow-up||0
8603889|NCT00379769|9640146|FG001|STARTED|Observational Follow-up||0
8603890|NCT00379769|9640147|FG002|STARTED|Observational Follow-up||0
8603891|NCT00379769|9640148|FG003|STARTED|Observational Follow-up||0
8603892|NCT00379769|9640149|FG004|STARTED|Observational Follow-up|"665 from RSG in Addition to Background MET arm; 615 from RGS in Addition to Background SU arm."|1280
8603893|NCT00379769|9640150|FG005|STARTED|Observational Follow-up|"647 from SU in Addition to Background MET arm; 603 from MET in Addition to Background SU arm."|1250
8603894|NCT00379769|9640145|FG000|COMPLETED|Observational Follow-up||0
8603895|NCT00379769|9640146|FG001|COMPLETED|Observational Follow-up||0
8603896|NCT00379769|9640147|FG002|COMPLETED|Observational Follow-up||0
8603897|NCT00379769|9640148|FG003|COMPLETED|Observational Follow-up||0
8603898|NCT00379769|9640149|FG004|COMPLETED|Observational Follow-up||1131
8603899|NCT00379769|9640150|FG005|COMPLETED|Observational Follow-up||1102
8603900|NCT00379769|9640145|FG000|NOT COMPLETED|Observational Follow-up||0
8603901|NCT00379769|9640146|FG001|NOT COMPLETED|Observational Follow-up||0
8603902|NCT00379769|9640147|FG002|NOT COMPLETED|Observational Follow-up||0
8603903|NCT00379769|9640148|FG003|NOT COMPLETED|Observational Follow-up||0
8603904|NCT00379769|9640149|FG004|NOT COMPLETED|Observational Follow-up||149
8603905|NCT00379769|9640150|FG005|NOT COMPLETED|Observational Follow-up||148
8603906|NCT00379795|9640182|FG000|STARTED|Overall Study||526
8603907|NCT00379795|9640183|FG001|STARTED|Overall Study||74
8603908|NCT00379795|9640184|FG002|STARTED|Overall Study||116
8603909|NCT00379795|9640185|FG003|STARTED|Overall Study||74
8603910|NCT00379795|9640186|FG004|STARTED|Overall Study||63
8603911|NCT00379795|9640182|FG000|Received Ranibizumab in Extension Study|Overall Study||377
8603912|NCT00379795|9640183|FG001|Received Ranibizumab in Extension Study|Overall Study||41
8603913|NCT00379795|9640184|FG002|Received Ranibizumab in Extension Study|Overall Study||113
8603914|NCT00379795|9640185|FG003|Received Ranibizumab in Extension Study|Overall Study||55
8603915|NCT00379795|9640186|FG004|Received Ranibizumab in Extension Study|Overall Study||0
8603916|NCT00379795|9640182|FG000|COMPLETED|Overall Study||50
8603917|NCT00379795|9640183|FG001|COMPLETED|Overall Study||23
8603918|NCT00379795|9640184|FG002|COMPLETED|Overall Study||23
8603919|NCT00379795|9640185|FG003|COMPLETED|Overall Study||6
8603920|NCT00379795|9640186|FG004|COMPLETED|Overall Study||14
8603921|NCT00379795|9640182|FG000|NOT COMPLETED|Overall Study||476
8603922|NCT00379795|9640183|FG001|NOT COMPLETED|Overall Study||51
8603923|NCT00379795|9640184|FG002|NOT COMPLETED|Overall Study||93
8603924|NCT00379795|9640185|FG003|NOT COMPLETED|Overall Study||68
8603925|NCT00379795|9640186|FG004|NOT COMPLETED|Overall Study||49
8603926|NCT00379808|9640201|FG000|STARTED|Intervention Period 1 (4 Weeks)||11
8603927|NCT00379808|9640202|FG001|STARTED|Intervention Period 1 (4 Weeks)||11
8603928|NCT00379808|9640201|FG000|COMPLETED|Intervention Period 1 (4 Weeks)||11
8603929|NCT00379808|9640202|FG001|COMPLETED|Intervention Period 1 (4 Weeks)||11
8603930|NCT00379808|9640201|FG000|NOT COMPLETED|Intervention Period 1 (4 Weeks)||0
8603931|NCT00379808|9640202|FG001|NOT COMPLETED|Intervention Period 1 (4 Weeks)||0
8603932|NCT00379808|9640201|FG000|STARTED|Intervention Period 2 (4 Weeks)||11
8603933|NCT00379808|9640202|FG001|STARTED|Intervention Period 2 (4 Weeks)||11
8603934|NCT00379808|9640201|FG000|COMPLETED|Intervention Period 2 (4 Weeks)||11
8603935|NCT00379808|9640202|FG001|COMPLETED|Intervention Period 2 (4 Weeks)||10
8603936|NCT00379808|9640201|FG000|NOT COMPLETED|Intervention Period 2 (4 Weeks)||0
8603937|NCT00379808|9640202|FG001|NOT COMPLETED|Intervention Period 2 (4 Weeks)||1
8603938|NCT00379821|9640212|FG000|STARTED|Overall Study||160
8603939|NCT00379821|9640213|FG001|STARTED|Overall Study||160
8603940|NCT00379821|9640214|FG002|STARTED|Overall Study||160
8603941|NCT00379821|9640215|FG003|STARTED|Overall Study||160
8603942|NCT00379821|9640212|FG000|COMPLETED|Overall Study||87
8603943|NCT00379821|9640213|FG001|COMPLETED|Overall Study||71
8603944|NCT00379821|9640214|FG002|COMPLETED|Overall Study||93
8603945|NCT00379821|9640215|FG003|COMPLETED|Overall Study||81
8603946|NCT00379821|9640212|FG000|NOT COMPLETED|Overall Study||73
8603947|NCT00379821|9640213|FG001|NOT COMPLETED|Overall Study||89
8603948|NCT00379821|9640214|FG002|NOT COMPLETED|Overall Study||67
8603949|NCT00379821|9640215|FG003|NOT COMPLETED|Overall Study||79
8603950|NCT00379834|9640232|FG000|STARTED|Overall Study||10
8603951|NCT00379834|9640232|FG000|COMPLETED|Overall Study||8
8603952|NCT00379834|9640232|FG000|NOT COMPLETED|Overall Study||2
8603953|NCT00379899|9640238|FG000|STARTED|Overall Study||180
8603954|NCT00379899|9640239|FG001|STARTED|Overall Study||180
8603955|NCT00379899|9640238|FG000|COMPLETED|Overall Study||140
8603956|NCT00379899|9640239|FG001|COMPLETED|Overall Study||140
8603957|NCT00379899|9640238|FG000|NOT COMPLETED|Overall Study||40
8603958|NCT00379899|9640239|FG001|NOT COMPLETED|Overall Study||40
8603959|NCT00379912|9640247|FG000|STARTED|Overall Study||7
8603960|NCT00379912|9640248|FG001|STARTED|Overall Study||8
8603961|NCT00379912|9640247|FG000|COMPLETED|Overall Study||6
8603962|NCT00379912|9640248|FG001|COMPLETED|Overall Study||8
8603963|NCT00379912|9640247|FG000|NOT COMPLETED|Overall Study||1
8603964|NCT00379912|9640248|FG001|NOT COMPLETED|Overall Study||0
8603965|NCT00380029|9640260|FG000|STARTED|Overall Study||20
8603966|NCT00380029|9640260|FG000|COMPLETED|Overall Study||20
8603967|NCT00380029|9640260|FG000|NOT COMPLETED|Overall Study||0
8603968|NCT00380068|9640268|FG000|STARTED|Overall Study||224
8603969|NCT00380068|9640268|FG000|COMPLETED|Overall Study||155
8603970|NCT00380068|9640268|FG000|NOT COMPLETED|Overall Study||69
8603971|NCT00380081|9640278|FG000|STARTED|Overall Study||14
8603972|NCT00380081|9640279|FG001|STARTED|Overall Study||13
8603973|NCT00380081|9640280|FG002|STARTED|Overall Study||13
8603974|NCT00380081|9640281|FG003|STARTED|Overall Study||15
8603975|NCT00380081|9640282|FG004|STARTED|Overall Study||13
8603976|NCT00380081|9640283|FG005|STARTED|Overall Study||14
8603977|NCT00380081|9640278|FG000|COMPLETED|Overall Study||14
8603978|NCT00380081|9640279|FG001|COMPLETED|Overall Study||13
8603979|NCT00380081|9640280|FG002|COMPLETED|Overall Study||13
8603980|NCT00380081|9640281|FG003|COMPLETED|Overall Study||15
8603981|NCT00380081|9640282|FG004|COMPLETED|Overall Study||12
8603982|NCT00380081|9640283|FG005|COMPLETED|Overall Study||13
8603983|NCT00380081|9640278|FG000|NOT COMPLETED|Overall Study||0
8603984|NCT00380081|9640279|FG001|NOT COMPLETED|Overall Study||0
8603985|NCT00380081|9640280|FG002|NOT COMPLETED|Overall Study||0
8603986|NCT00380081|9640281|FG003|NOT COMPLETED|Overall Study||0
8603987|NCT00380081|9640282|FG004|NOT COMPLETED|Overall Study||1
8603988|NCT00380081|9640283|FG005|NOT COMPLETED|Overall Study||1
8603989|NCT00380250|9640293|FG000|STARTED|Overall Study||396
8603990|NCT00380250|9640294|FG001|STARTED|Overall Study||194
8603991|NCT00380250|9640293|FG000|COMPLETED|Overall Study||297
8603992|NCT00380250|9640294|FG001|COMPLETED|Overall Study||139
8603993|NCT00380250|9640293|FG000|NOT COMPLETED|Overall Study||99
8603994|NCT00380250|9640294|FG001|NOT COMPLETED|Overall Study||55
8603995|NCT00380367|9640300|FG000|STARTED|Overall Study||110
8603996|NCT00380367|9640300|FG000|COMPLETED|Overall Study||108
8603997|NCT00380367|9640300|FG000|NOT COMPLETED|Overall Study||2
8603998|NCT00380393|9640306|FG000|STARTED|Month 8 (Cross-sectional Visit)||447
8603999|NCT00380393|9640307|FG001|STARTED|Month 8 (Cross-sectional Visit)||447
8604000|NCT00380393|9640306|FG000|COMPLETED|Month 8 (Cross-sectional Visit)||398
8604001|NCT00380393|9640307|FG001|COMPLETED|Month 8 (Cross-sectional Visit)||407
8604002|NCT00380393|9640306|FG000|NOT COMPLETED|Month 8 (Cross-sectional Visit)||49
8604003|NCT00380393|9640307|FG001|NOT COMPLETED|Month 8 (Cross-sectional Visit)||40
8604004|NCT00380393|9640306|FG000|STARTED|Month 14||447
8604005|NCT00380393|9640307|FG001|STARTED|Month 14||447
8604006|NCT00380393|9640306|FG000|COMPLETED|Month 14||390
8604007|NCT00380393|9640307|FG001|COMPLETED|Month 14||391
8604008|NCT00380393|9640306|FG000|NOT COMPLETED|Month 14||57
8604009|NCT00380393|9640307|FG001|NOT COMPLETED|Month 14||56
8604010|NCT00380588|9640315|FG000|STARTED|Overall Study||42
8604011|NCT00380588|9640316|FG001|STARTED|Overall Study||42
8604012|NCT00380588|9640315|FG000|Received at Least One Dose of Study Drug|Overall Study||41
8604013|NCT00380588|9640316|FG001|Received at Least One Dose of Study Drug|Overall Study||42
8604014|NCT00380588|9640315|FG000|COMPLETED|Overall Study|Treatment period reached 48 week maximum.|3
8604015|NCT00380588|9640316|FG001|COMPLETED|Overall Study|Treatment period reached 48 week maximum.|2
8604016|NCT00380588|9640315|FG000|NOT COMPLETED|Overall Study||39
8604017|NCT00380588|9640316|FG001|NOT COMPLETED|Overall Study||40
8604018|NCT00380692|9640324|FG000|STARTED|Study Period II - Double Blind||48
8604019|NCT00380692|9640325|FG001|STARTED|Study Period II - Double Blind||49
8604020|NCT00380692|9640324|FG000|COMPLETED|Study Period II - Double Blind||43
8604021|NCT00380692|9640325|FG001|COMPLETED|Study Period II - Double Blind||46
8604022|NCT00380692|9640324|FG000|NOT COMPLETED|Study Period II - Double Blind||5
8604023|NCT00380692|9640325|FG001|NOT COMPLETED|Study Period II - Double Blind||3
8604024|NCT00380692|9640324|FG000|STARTED|Study Period III - Open Label|One patient who completed Study Period II did not enter Study Period III.|42
8604025|NCT00380692|9640325|FG001|STARTED|Study Period III - Open Label||46
8604026|NCT00380692|9640324|FG000|COMPLETED|Study Period III - Open Label||36
8604027|NCT00380692|9640325|FG001|COMPLETED|Study Period III - Open Label||34
8604028|NCT00380692|9640324|FG000|NOT COMPLETED|Study Period III - Open Label||6
8604029|NCT00380692|9640325|FG001|NOT COMPLETED|Study Period III - Open Label||12
8604030|NCT00380718|9640331|FG000|STARTED|Overall Study||33
8604031|NCT00380718|9640331|FG000|Received at Least One Dose of Study Drug|Overall Study||33
8604032|NCT00380718|9640331|FG000|Received Escalated Dose in Cycle 2|Overall Study||25
8604033|NCT00380718|9640331|FG000|COMPLETED|Overall Study||15
8604034|NCT00380718|9640331|FG000|NOT COMPLETED|Overall Study||18
8604035|NCT00380744|9640342|FG000|STARTED|Overall Study||20
8604036|NCT00380744|9640343|FG001|STARTED|Overall Study||4
8604037|NCT00380744|9640344|FG002|STARTED|Overall Study||20
8604038|NCT00380744|9640345|FG003|STARTED|Overall Study||4
8604039|NCT00380744|9640346|FG004|STARTED|Overall Study||23
8604040|NCT00380744|9640347|FG005|STARTED|Overall Study||25
8604041|NCT00380744|9640348|FG006|STARTED|Overall Study||25
8604042|NCT00380744|9640342|FG000|Received at Least 1 Dose of Study Drug|Overall Study||20
8604043|NCT00380744|9640343|FG001|Received at Least 1 Dose of Study Drug|Overall Study||4
8604044|NCT00380744|9640344|FG002|Received at Least 1 Dose of Study Drug|Overall Study||20
8604045|NCT00380744|9640345|FG003|Received at Least 1 Dose of Study Drug|Overall Study||4
8604046|NCT00380744|9640346|FG004|Received at Least 1 Dose of Study Drug|Overall Study||23
8604047|NCT00380744|9640347|FG005|Received at Least 1 Dose of Study Drug|Overall Study||25
8604048|NCT00380744|9640348|FG006|Received at Least 1 Dose of Study Drug|Overall Study||25
8714262|NCT00979459|9761153|FG000|NOT COMPLETED|7-day Washout Period||0
8714263|NCT00979459|9761154|FG001|NOT COMPLETED|7-day Washout Period||0
8714264|NCT00979459|9761153|FG000|STARTED|Second Intervention||6
8714265|NCT00979459|9761154|FG001|STARTED|Second Intervention||6
8714266|NCT00979459|9761153|FG000|COMPLETED|Second Intervention||6
8604049|NCT00380744|9640342|FG000|COMPLETED|Overall Study||19
8604050|NCT00380744|9640343|FG001|COMPLETED|Overall Study||4
8604051|NCT00380744|9640344|FG002|COMPLETED|Overall Study||20
8604052|NCT00380744|9640345|FG003|COMPLETED|Overall Study||4
8604053|NCT00380744|9640346|FG004|COMPLETED|Overall Study||23
8604054|NCT00380744|9640347|FG005|COMPLETED|Overall Study||25
8604055|NCT00380744|9640348|FG006|COMPLETED|Overall Study||24
8604056|NCT00380744|9640342|FG000|NOT COMPLETED|Overall Study||1
8604057|NCT00380744|9640343|FG001|NOT COMPLETED|Overall Study||0
8604058|NCT00380744|9640344|FG002|NOT COMPLETED|Overall Study||0
8604059|NCT00380744|9640345|FG003|NOT COMPLETED|Overall Study||0
8604060|NCT00380744|9640346|FG004|NOT COMPLETED|Overall Study||0
8604061|NCT00380744|9640347|FG005|NOT COMPLETED|Overall Study||0
8604062|NCT00380744|9640348|FG006|NOT COMPLETED|Overall Study||1
8604063|NCT00380861|9640367|FG000|STARTED|Overall Study||93
8604064|NCT00380861|9640368|FG001|STARTED|Overall Study|Two subjects received the PFC Sigma RP-F device but not the RP and their results are not included.|91
8604065|NCT00380861|9640367|FG000|COMPLETED|Overall Study||75
8604066|NCT00380861|9640368|FG001|COMPLETED|Overall Study||74
8604067|NCT00380861|9640367|FG000|NOT COMPLETED|Overall Study||18
8604068|NCT00380861|9640368|FG001|NOT COMPLETED|Overall Study||17
8604069|NCT00380874|9640376|FG000|STARTED|Overall Study||32
8604070|NCT00380874|9640377|FG001|STARTED|Overall Study||29
8604071|NCT00380874|9640376|FG000|COMPLETED|Overall Study||19
8604072|NCT00380874|9640377|FG001|COMPLETED|Overall Study||19
8604073|NCT00380874|9640376|FG000|NOT COMPLETED|Overall Study||13
8604074|NCT00380874|9640377|FG001|NOT COMPLETED|Overall Study||10
8604075|NCT00380978|9640385|FG000|STARTED|Overall Study||408
8604076|NCT00380978|9640386|FG001|STARTED|Overall Study||410
8604077|NCT00380978|9640385|FG000|COMPLETED|Overall Study||406
8604078|NCT00380978|9640386|FG001|COMPLETED|Overall Study||400
8604079|NCT00380978|9640385|FG000|NOT COMPLETED|Overall Study||2
8604080|NCT00380978|9640386|FG001|NOT COMPLETED|Overall Study||10
8604081|NCT00381004|9640392|FG000|STARTED|Overall Study||60
8604082|NCT00381004|9640392|FG000|COMPLETED|Overall Study||60
8604083|NCT00381004|9640392|FG000|NOT COMPLETED|Overall Study||0
8604084|NCT00381043|9640398|FG000|STARTED|Overall Study||51
8604085|NCT00381043|9640399|FG001|STARTED|Overall Study||49
8604086|NCT00381043|9640398|FG000|COMPLETED|Overall Study||39
8604087|NCT00381043|9640399|FG001|COMPLETED|Overall Study||41
8604088|NCT00381043|9640398|FG000|NOT COMPLETED|Overall Study||12
8604089|NCT00381043|9640399|FG001|NOT COMPLETED|Overall Study||8
8604090|NCT00381095|9640407|FG000|STARTED|Overall Study||72
8604091|NCT00381095|9640408|FG001|STARTED|Overall Study||80
8604092|NCT00381095|9640407|FG000|COMPLETED|Overall Study||59
8604093|NCT00381095|9640408|FG001|COMPLETED|Overall Study||59
8604094|NCT00381095|9640407|FG000|NOT COMPLETED|Overall Study||13
8604095|NCT00381095|9640408|FG001|NOT COMPLETED|Overall Study||21
8604096|NCT00381238|9640414|FG000|STARTED|Overall Study||33
8604097|NCT00381238|9640414|FG000|COMPLETED|Overall Study||21
8604098|NCT00381238|9640414|FG000|NOT COMPLETED|Overall Study||12
8604099|NCT00381303|9640420|FG000|STARTED|Overall Study||287
8604100|NCT00381303|9640421|FG001|STARTED|Overall Study||142
8604101|NCT00381303|9640420|FG000|COMPLETED|Overall Study||193
8604102|NCT00381303|9640421|FG001|COMPLETED|Overall Study||109
8604103|NCT00381303|9640420|FG000|NOT COMPLETED|Overall Study||94
8604104|NCT00381303|9640421|FG001|NOT COMPLETED|Overall Study||33
8604105|NCT00381550|9640439|FG000|STARTED|Overall Study||35
8604106|NCT00381550|9640439|FG000|COMPLETED|Overall Study||35
8604107|NCT00381550|9640439|FG000|NOT COMPLETED|Overall Study||0
8604108|NCT00381563|9640445|FG000|STARTED|Overall Study||41
8604109|NCT00381563|9640446|FG001|STARTED|Overall Study||39
8604110|NCT00381563|9640445|FG000|COMPLETED|Overall Study||34
8604111|NCT00381563|9640446|FG001|COMPLETED|Overall Study||33
8604112|NCT00381563|9640445|FG000|NOT COMPLETED|Overall Study||7
8604113|NCT00381563|9640446|FG001|NOT COMPLETED|Overall Study||6
8604114|NCT00381615|9640455|FG000|STARTED|Overall Study||48
8604115|NCT00381615|9640456|FG001|STARTED|Overall Study||50
8604116|NCT00381615|9640457|FG002|STARTED|Overall Study||25
8604117|NCT00381615|9640458|FG003|STARTED|Overall Study||24
8604118|NCT00381615|9640455|FG000|COMPLETED|Overall Study||44
8604119|NCT00381615|9640456|FG001|COMPLETED|Overall Study||45
8604120|NCT00381615|9640457|FG002|COMPLETED|Overall Study||24
8604121|NCT00381615|9640458|FG003|COMPLETED|Overall Study||22
8604122|NCT00381615|9640455|FG000|NOT COMPLETED|Overall Study||4
8604123|NCT00381615|9640456|FG001|NOT COMPLETED|Overall Study||5
8604124|NCT00381615|9640457|FG002|NOT COMPLETED|Overall Study||1
8604125|NCT00381615|9640458|FG003|NOT COMPLETED|Overall Study||2
8714267|NCT00979459|9761154|FG001|COMPLETED|Second Intervention||6
8604126|NCT00381628|9640474|FG000|STARTED|Overall Study||18
8604127|NCT00381628|9640475|FG001|STARTED|Overall Study||27
8604128|NCT00381628|9640476|FG002|STARTED|Overall Study||0
8604129|NCT00381628|9640477|FG003|STARTED|Overall Study||14
8604130|NCT00381628|9640474|FG000|COMPLETED|Overall Study||18
8604131|NCT00381628|9640475|FG001|COMPLETED|Overall Study||27
8604132|NCT00381628|9640476|FG002|COMPLETED|Overall Study||0
8604133|NCT00381628|9640477|FG003|COMPLETED|Overall Study||14
8604134|NCT00381628|9640474|FG000|NOT COMPLETED|Overall Study||0
8604135|NCT00381628|9640475|FG001|NOT COMPLETED|Overall Study||0
8604136|NCT00381628|9640476|FG002|NOT COMPLETED|Overall Study||0
8604137|NCT00381628|9640477|FG003|NOT COMPLETED|Overall Study||0
8604138|NCT00381680|9640489|FG000|STARTED|Overall Study||206
8604139|NCT00381680|9640490|FG001|STARTED|Overall Study||69
8604140|NCT00381680|9640489|FG000|COMPLETED|Overall Study||81
8604141|NCT00381680|9640490|FG001|COMPLETED|Overall Study||19
8604142|NCT00381680|9640489|FG000|NOT COMPLETED|Overall Study||125
8604143|NCT00381680|9640490|FG001|NOT COMPLETED|Overall Study||50
8604144|NCT00381693|9640500|FG000|STARTED|Overall Study||10
8604145|NCT00381693|9640500|FG000|COMPLETED|Overall Study||2
8604146|NCT00381693|9640500|FG000|NOT COMPLETED|Overall Study||8
8604147|NCT00381706|9640510|FG000|STARTED|Overall Study||82
8604148|NCT00381706|9640511|FG001|STARTED|Overall Study||83
8604149|NCT00381706|9640512|FG002|STARTED|Overall Study||80
8604150|NCT00381706|9640510|FG000|COMPLETED|Overall Study||75
8604151|NCT00381706|9640511|FG001|COMPLETED|Overall Study||81
8604152|NCT00381706|9640512|FG002|COMPLETED|Overall Study||79
8604153|NCT00381706|9640510|FG000|NOT COMPLETED|Overall Study||7
8604154|NCT00381706|9640511|FG001|NOT COMPLETED|Overall Study||2
8604155|NCT00381706|9640512|FG002|NOT COMPLETED|Overall Study||1
8604156|NCT00381797|9640531|FG000|STARTED|Overall Study||18
8604157|NCT00381797|9640532|FG001|STARTED|Overall Study||17
8604158|NCT00381797|9640533|FG002|STARTED|Overall Study||10
8604159|NCT00381797|9640534|FG003|STARTED|Overall Study||15
8604160|NCT00381797|9640535|FG004|STARTED|Overall Study||37
8604161|NCT00381797|9640531|FG000|COMPLETED|Overall Study||17
8604162|NCT00381797|9640532|FG001|COMPLETED|Overall Study||16
8604163|NCT00381797|9640533|FG002|COMPLETED|Overall Study||10
8604164|NCT00381797|9640534|FG003|COMPLETED|Overall Study||14
8604165|NCT00381797|9640535|FG004|COMPLETED|Overall Study||35
8604166|NCT00381797|9640531|FG000|NOT COMPLETED|Overall Study||1
8604167|NCT00381797|9640532|FG001|NOT COMPLETED|Overall Study||1
8604168|NCT00381797|9640533|FG002|NOT COMPLETED|Overall Study||0
8604169|NCT00381797|9640534|FG003|NOT COMPLETED|Overall Study||1
8604170|NCT00381797|9640535|FG004|NOT COMPLETED|Overall Study||2
8604171|NCT00381810|9640568|FG000|STARTED|Treatment and Safety Follow-up||31
8604172|NCT00381810|9640568|FG000|COMPLETED|Treatment and Safety Follow-up||16
8604173|NCT00381810|9640568|FG000|NOT COMPLETED|Treatment and Safety Follow-up||15
8604174|NCT00381810|9640568|FG000|STARTED|B Cell Follow-up|Participants only entered the B cell follow-up period if their peripheral B cells were depleted.|7
8604175|NCT00381810|9640568|FG000|COMPLETED|B Cell Follow-up||0
8604176|NCT00381810|9640568|FG000|NOT COMPLETED|B Cell Follow-up||7
8604177|NCT00381849|9640574|FG000|STARTED|First Intervention||10
8604178|NCT00381849|9640575|FG001|STARTED|First Intervention||10
8604179|NCT00381849|9640574|FG000|COMPLETED|First Intervention||10
8604180|NCT00381849|9640575|FG001|COMPLETED|First Intervention||10
8604181|NCT00381849|9640574|FG000|NOT COMPLETED|First Intervention||0
8604182|NCT00381849|9640575|FG001|NOT COMPLETED|First Intervention||0
8604183|NCT00381849|9640574|FG000|STARTED|Wash Out||10
8604184|NCT00381849|9640575|FG001|STARTED|Wash Out||10
8604185|NCT00381849|9640574|FG000|COMPLETED|Wash Out||10
8604186|NCT00381849|9640575|FG001|COMPLETED|Wash Out||9
8604187|NCT00381849|9640574|FG000|NOT COMPLETED|Wash Out||0
8604188|NCT00381849|9640575|FG001|NOT COMPLETED|Wash Out||1
8604189|NCT00381849|9640574|FG000|STARTED|Second Intervention||10
8604190|NCT00381849|9640575|FG001|STARTED|Second Intervention||9
8604191|NCT00381849|9640574|FG000|COMPLETED|Second Intervention||10
8604192|NCT00381849|9640575|FG001|COMPLETED|Second Intervention||9
8604193|NCT00381849|9640574|FG000|NOT COMPLETED|Second Intervention||0
8604194|NCT00381849|9640575|FG001|NOT COMPLETED|Second Intervention||0
8604195|NCT00381849|9640574|FG000|STARTED|Open-label||10
8604196|NCT00381849|9640575|FG001|STARTED|Open-label||9
8604197|NCT00381849|9640574|FG000|COMPLETED|Open-label||10
8604198|NCT00381849|9640575|FG001|COMPLETED|Open-label||9
8604199|NCT00381849|9640574|FG000|NOT COMPLETED|Open-label||0
8604200|NCT00381849|9640575|FG001|NOT COMPLETED|Open-label||0
8604201|NCT00381862|9640581|FG000|STARTED|Overall Study||54
8604202|NCT00381862|9640581|FG000|COMPLETED|Overall Study||44
8604203|NCT00381862|9640581|FG000|NOT COMPLETED|Overall Study||10
8604204|NCT00381888|9640585|FG000|STARTED|Overall Study||44
8604205|NCT00381888|9640585|FG000|COMPLETED|Overall Study||27
8604206|NCT00381888|9640585|FG000|NOT COMPLETED|Overall Study||17
8604207|NCT00381940|9640589|FG000|STARTED|Overall Study||26
8604208|NCT00381940|9640589|FG000|COMPLETED|Overall Study||21
8604209|NCT00381940|9640589|FG000|NOT COMPLETED|Overall Study||5
8604210|NCT00381966|9640593|FG000|STARTED|Overall Study||5
8604211|NCT00381966|9640593|FG000|COMPLETED|Overall Study||5
8604212|NCT00381966|9640593|FG000|NOT COMPLETED|Overall Study||0
8604213|NCT00382018|9640601|FG000|STARTED|Overall Study||276
8604214|NCT00382018|9640602|FG001|STARTED|Overall Study||165
8604215|NCT00382018|9640603|FG002|STARTED|Overall Study||64
8604216|NCT00382018|9640604|FG003|STARTED|Overall Study||59
8629611|NCT00531050|9669383|FG002|STARTED|Part 1: Period 2||4
8604217|NCT00382018|9640601|FG000|COMPLETED|Overall Study|This group of patients did not receive protocol treatment.|276
8604218|NCT00382018|9640602|FG001|COMPLETED|Overall Study||0
8604219|NCT00382018|9640603|FG002|COMPLETED|Overall Study||0
8604220|NCT00382018|9640604|FG003|COMPLETED|Overall Study||0
8604221|NCT00382018|9640601|FG000|NOT COMPLETED|Overall Study||0
8604222|NCT00382018|9640602|FG001|NOT COMPLETED|Overall Study||165
8604223|NCT00382018|9640603|FG002|NOT COMPLETED|Overall Study||64
8604224|NCT00382018|9640604|FG003|NOT COMPLETED|Overall Study||59
8604225|NCT00382031|9640619|FG000|STARTED|Overall Study|Of the 191 randomized patients 189 received at least one infusion of zalutumumab|191
8604226|NCT00382031|9640620|FG001|STARTED|Overall Study|Of the 95 randomized patients 94 attended Visit2.|95
8604227|NCT00382031|9640619|FG000|COMPLETED|Overall Study||191
8604228|NCT00382031|9640620|FG001|COMPLETED|Overall Study||95
8604229|NCT00382031|9640619|FG000|NOT COMPLETED|Overall Study||0
8604230|NCT00382031|9640620|FG001|NOT COMPLETED|Overall Study||0
8604231|NCT00382070|9640628|FG000|STARTED|Overall Study||1983
8604232|NCT00382070|9640629|FG001|STARTED|Overall Study||1983
8604233|NCT00382070|9640628|FG000|COMPLETED|Overall Study||1950
8604234|NCT00382070|9640629|FG001|COMPLETED|Overall Study||1953
8604235|NCT00382070|9640628|FG000|NOT COMPLETED|Overall Study||33
8604236|NCT00382070|9640629|FG001|NOT COMPLETED|Overall Study||30
8604237|NCT00382109|9640637|FG000|STARTED|Overall Study||76
8604238|NCT00382109|9640638|FG001|STARTED|Overall Study||70
8604239|NCT00382109|9640637|FG000|COMPLETED|Overall Study||64
8604240|NCT00382109|9640638|FG001|COMPLETED|Overall Study||66
8604241|NCT00382109|9640637|FG000|NOT COMPLETED|Overall Study||12
8604242|NCT00382109|9640638|FG001|NOT COMPLETED|Overall Study||4
8604243|NCT00382148|9640649|FG000|STARTED|Overall Study||4
8604244|NCT00382148|9640650|FG001|STARTED|Overall Study||7
8604245|NCT00382148|9640649|FG000|COMPLETED|Overall Study||3
8604246|NCT00382148|9640650|FG001|COMPLETED|Overall Study||7
8604247|NCT00382148|9640649|FG000|NOT COMPLETED|Overall Study||1
8604248|NCT00382148|9640650|FG001|NOT COMPLETED|Overall Study||0
8604249|NCT00382174|9640658|FG000|STARTED|Overall Study||18
8604250|NCT00382174|9640659|FG001|STARTED|Overall Study||54
8604251|NCT00382174|9640660|FG002|STARTED|Overall Study||72
8604252|NCT00382174|9640658|FG000|COMPLETED|Overall Study||14
8604253|NCT00382174|9640659|FG001|COMPLETED|Overall Study||37
8604254|NCT00382174|9640660|FG002|COMPLETED|Overall Study||51
8604255|NCT00382174|9640658|FG000|NOT COMPLETED|Overall Study||4
8604256|NCT00382174|9640659|FG001|NOT COMPLETED|Overall Study||17
8604257|NCT00382174|9640660|FG002|NOT COMPLETED|Overall Study||21
8604258|NCT00382265|9640670|FG000|STARTED|Overall Study||267
8604259|NCT00382265|9640671|FG001|STARTED|Overall Study||245
8604260|NCT00382265|9640670|FG000|COMPLETED|Overall Study||258
8604261|NCT00382265|9640671|FG001|COMPLETED|Overall Study||239
8604262|NCT00382265|9640670|FG000|NOT COMPLETED|Overall Study||9
8604263|NCT00382265|9640671|FG001|NOT COMPLETED|Overall Study||6
8604264|NCT00382291|9640684|FG000|STARTED|Overall Study||18
8604265|NCT00382291|9640685|FG001|STARTED|Overall Study||17
8604266|NCT00382291|9640686|FG002|STARTED|Overall Study||21
8604267|NCT00382291|9640684|FG000|COMPLETED|Overall Study||14
8604268|NCT00382291|9640685|FG001|COMPLETED|Overall Study||10
8604269|NCT00382291|9640686|FG002|COMPLETED|Overall Study||13
8604270|NCT00382291|9640684|FG000|NOT COMPLETED|Overall Study||4
8604271|NCT00382291|9640685|FG001|NOT COMPLETED|Overall Study||7
8604272|NCT00382291|9640686|FG002|NOT COMPLETED|Overall Study||8
8604273|NCT00382408|9640698|FG000|STARTED|Overall Study||3031
8604274|NCT00382408|9640699|FG001|STARTED|Overall Study||1009
8604275|NCT00382408|9640698|FG000|COMPLETED|Overall Study||2887
8604276|NCT00382408|9640699|FG001|COMPLETED|Overall Study||955
8604277|NCT00382408|9640698|FG000|NOT COMPLETED|Overall Study||144
8604278|NCT00382408|9640699|FG001|NOT COMPLETED|Overall Study||54
8604279|NCT00382590|9640707|FG000|STARTED|Overall Study||4
8604280|NCT00382590|9640708|FG001|STARTED|Overall Study||6
8604281|NCT00382590|9640707|FG000|COMPLETED|Overall Study||4
8604282|NCT00382590|9640708|FG001|COMPLETED|Overall Study||6
8604283|NCT00382590|9640707|FG000|NOT COMPLETED|Overall Study||0
8604284|NCT00382590|9640708|FG001|NOT COMPLETED|Overall Study||0
8604285|NCT00382720|9640717|FG000|STARTED|Overall Study||79
8604286|NCT00382720|9640718|FG001|STARTED|Overall Study||89
8604287|NCT00382720|9640719|FG002|STARTED|Overall Study||86
8604288|NCT00382720|9640717|FG000|Administered Non-Optimal Dose (Part I)|Overall Study||10
8604289|NCT00382720|9640718|FG001|Administered Non-Optimal Dose (Part I)|Overall Study||11
8604290|NCT00382720|9640719|FG002|Administered Non-Optimal Dose (Part I)|Overall Study||0
8604291|NCT00382720|9640717|FG000|Administered Optimal Dose (Parts I & II)|Overall Study||78
8604292|NCT00382720|9640718|FG001|Administered Optimal Dose (Parts I & II)|Overall Study||88
8604293|NCT00382720|9640719|FG002|Administered Optimal Dose (Parts I & II)|Overall Study||82
8604294|NCT00382720|9640717|FG000|Full Analysis Population (FAP)|Overall Study|ITT who received at least one dose of study medication|78
8604295|NCT00382720|9640718|FG001|Full Analysis Population (FAP)|Overall Study|ITT who received at least one dose of study medication|88
8604296|NCT00382720|9640719|FG002|Full Analysis Population (FAP)|Overall Study|ITT who received at least one dose of study medication|82
8604297|NCT00382720|9640717|FG000|COMPLETED|Overall Study||0
8604298|NCT00382720|9640718|FG001|COMPLETED|Overall Study||0
8604299|NCT00382720|9640719|FG002|COMPLETED|Overall Study||0
8604300|NCT00382720|9640717|FG000|NOT COMPLETED|Overall Study||79
8604301|NCT00382720|9640718|FG001|NOT COMPLETED|Overall Study||89
8604302|NCT00382720|9640719|FG002|NOT COMPLETED|Overall Study||86
8604303|NCT00382733|9640727|FG000|STARTED|Overall Study||3
8604304|NCT00382733|9640728|FG001|STARTED|Overall Study||4
8604305|NCT00382733|9640729|FG002|STARTED|Overall Study||3
8604306|NCT00382733|9640730|FG003|STARTED|Overall Study||14
8604307|NCT00382733|9640731|FG004|STARTED|Overall Study||2
8604308|NCT00382733|9640727|FG000|COMPLETED|Overall Study||3
8604309|NCT00382733|9640728|FG001|COMPLETED|Overall Study|1 subject withdrew consent before completing Cycle 1 - that subject was replaced|3
8604310|NCT00382733|9640729|FG002|COMPLETED|Overall Study||3
8604311|NCT00382733|9640730|FG003|COMPLETED|Overall Study||14
8604312|NCT00382733|9640731|FG004|COMPLETED|Overall Study||2
8604313|NCT00382733|9640727|FG000|NOT COMPLETED|Overall Study||0
8604314|NCT00382733|9640728|FG001|NOT COMPLETED|Overall Study||1
8604315|NCT00382733|9640729|FG002|NOT COMPLETED|Overall Study||0
8604316|NCT00382733|9640730|FG003|NOT COMPLETED|Overall Study||0
8604317|NCT00382733|9640731|FG004|NOT COMPLETED|Overall Study||0
8604318|NCT00382785|9640746|FG000|STARTED|Overall Study||25
8604319|NCT00382785|9640747|FG001|STARTED|Overall Study||26
8604320|NCT00382785|9640746|FG000|COMPLETED|Overall Study||25
8604321|NCT00382785|9640747|FG001|COMPLETED|Overall Study||26
8604322|NCT00382785|9640746|FG000|NOT COMPLETED|Overall Study||0
8604323|NCT00382785|9640747|FG001|NOT COMPLETED|Overall Study||0
8604324|NCT00382824|9640755|FG000|STARTED|Overall Study||32
8604325|NCT00382824|9640756|FG001|STARTED|Overall Study||29
8604326|NCT00382824|9640755|FG000|COMPLETED|Overall Study||20
8604327|NCT00382824|9640756|FG001|COMPLETED|Overall Study||16
8604328|NCT00382824|9640755|FG000|NOT COMPLETED|Overall Study||12
8604329|NCT00382824|9640756|FG001|NOT COMPLETED|Overall Study||13
8604330|NCT00382863|9640764|FG000|STARTED|Overall Study||96
8604331|NCT00382863|9640765|FG001|STARTED|Overall Study||114
8604332|NCT00382863|9640764|FG000|COMPLETED|Overall Study||81
8604333|NCT00382863|9640765|FG001|COMPLETED|Overall Study||78
8604334|NCT00382863|9640764|FG000|NOT COMPLETED|Overall Study||15
8604335|NCT00382863|9640765|FG001|NOT COMPLETED|Overall Study||36
8628782|NCT00526630|9668332|FG000|COMPLETED|First Intervention Period - 12 Weeks||12
8628783|NCT00526630|9668333|FG001|COMPLETED|First Intervention Period - 12 Weeks||8
8628784|NCT00526630|9668332|FG000|NOT COMPLETED|First Intervention Period - 12 Weeks||0
8628785|NCT00526630|9668333|FG001|NOT COMPLETED|First Intervention Period - 12 Weeks||3
8628786|NCT00526630|9668332|FG000|STARTED|Second Intervention Period - 12 Weeks||12
8628787|NCT00526630|9668333|FG001|STARTED|Second Intervention Period - 12 Weeks||8
8628788|NCT00526630|9668332|FG000|COMPLETED|Second Intervention Period - 12 Weeks||10
8628789|NCT00526630|9668333|FG001|COMPLETED|Second Intervention Period - 12 Weeks||7
8628790|NCT00526630|9668332|FG000|NOT COMPLETED|Second Intervention Period - 12 Weeks||2
8628791|NCT00526630|9668333|FG001|NOT COMPLETED|Second Intervention Period - 12 Weeks||1
8628792|NCT00526656|9668341|FG000|STARTED|Overall Study||9
8628793|NCT00526656|9668341|FG000|COMPLETED|Overall Study||7
8628794|NCT00526656|9668341|FG000|NOT COMPLETED|Overall Study||2
8628795|NCT00526669|9668346|FG000|STARTED|7-Day Run-in Monotherapy Treatment Phase||67
8628796|NCT00526669|9668347|FG001|STARTED|7-Day Run-in Monotherapy Treatment Phase||0
8628797|NCT00526669|9668346|FG000|COMPLETED|7-Day Run-in Monotherapy Treatment Phase||67
8628798|NCT00526669|9668347|FG001|COMPLETED|7-Day Run-in Monotherapy Treatment Phase||0
8628799|NCT00526669|9668346|FG000|NOT COMPLETED|7-Day Run-in Monotherapy Treatment Phase||0
8628800|NCT00526669|9668347|FG001|NOT COMPLETED|7-Day Run-in Monotherapy Treatment Phase||0
8628801|NCT00526669|9668346|FG000|STARTED|Combined Treatment Phase||0
8628802|NCT00526669|9668347|FG001|STARTED|Combined Treatment Phase||67
8628803|NCT00526669|9668346|FG000|COMPLETED|Combined Treatment Phase||0
8628804|NCT00526669|9668347|FG001|COMPLETED|Combined Treatment Phase||59
8628805|NCT00526669|9668346|FG000|NOT COMPLETED|Combined Treatment Phase||0
8628806|NCT00526669|9668347|FG001|NOT COMPLETED|Combined Treatment Phase||8
8628807|NCT00526799|9668355|FG000|STARTED|Overall Study||16
8628808|NCT00526799|9668356|FG001|STARTED|Overall Study||14
8628809|NCT00526799|9668355|FG000|COMPLETED|Overall Study||15
8628810|NCT00526799|9668356|FG001|COMPLETED|Overall Study||13
8628811|NCT00526799|9668355|FG000|NOT COMPLETED|Overall Study||1
8628812|NCT00526799|9668356|FG001|NOT COMPLETED|Overall Study||1
8628813|NCT00526890|9668362|FG000|STARTED|Overall Study||16
8628814|NCT00526890|9668362|FG000|COMPLETED|Overall Study||14
8628815|NCT00526890|9668362|FG000|NOT COMPLETED|Overall Study||2
8628816|NCT00526994|9668369|FG000|STARTED|Overall Study||909
8628817|NCT00526994|9668370|FG001|STARTED|Overall Study||893
8628818|NCT00526994|9668371|FG002|STARTED|Overall Study||898
8628819|NCT00526994|9668369|FG000|COMPLETED|Overall Study||801
8628820|NCT00526994|9668370|FG001|COMPLETED|Overall Study||772
8628821|NCT00526994|9668371|FG002|COMPLETED|Overall Study||791
8628822|NCT00526994|9668369|FG000|NOT COMPLETED|Overall Study||108
8628823|NCT00526994|9668370|FG001|NOT COMPLETED|Overall Study||121
8628824|NCT00526994|9668371|FG002|NOT COMPLETED|Overall Study||107
8628825|NCT00527072|9668379|FG000|STARTED|Overall Study||215
8628826|NCT00527072|9668379|FG000|COMPLETED|Overall Study||179
8628827|NCT00527072|9668379|FG000|NOT COMPLETED|Overall Study||36
8628828|NCT00527098|9668386|FG000|STARTED|Overall Study||36
8628829|NCT00527098|9668387|FG001|STARTED|Overall Study||83
8628830|NCT00527098|9668386|FG000|COMPLETED|Overall Study||36
8628831|NCT00527098|9668387|FG001|COMPLETED|Overall Study||83
8628832|NCT00527098|9668386|FG000|NOT COMPLETED|Overall Study||0
8628833|NCT00527098|9668387|FG001|NOT COMPLETED|Overall Study||0
8628834|NCT00527111|9668394|FG000|STARTED|Overall Study||70
8628835|NCT00527111|9668395|FG001|STARTED|Overall Study||69
8604336|NCT00382928|9640773|FG000|STARTED|Overall Study||97
8604337|NCT00382928|9640774|FG001|STARTED|Overall Study||95
8604338|NCT00382928|9640773|FG000|COMPLETED|Overall Study||97
8604339|NCT00382928|9640774|FG001|COMPLETED|Overall Study||95
8604340|NCT00382928|9640773|FG000|NOT COMPLETED|Overall Study||0
8604341|NCT00382928|9640774|FG001|NOT COMPLETED|Overall Study||0
8604342|NCT00382967|9640787|FG000|STARTED|Overall Study|135 subjects enrolled at the start of the study, however, 13 subjects withdrew prior to dosing.|122
8604343|NCT00382967|9640788|FG001|STARTED|Overall Study||138
8604344|NCT00382967|9640787|FG000|COMPLETED|Overall Study|Patient lost to followup and the data was not recorded.|121
8604345|NCT00382967|9640788|FG001|COMPLETED|Overall Study|Subject dosed in error, should not have received Datscan product|137
8604346|NCT00382967|9640787|FG000|NOT COMPLETED|Overall Study||1
8604347|NCT00382967|9640788|FG001|NOT COMPLETED|Overall Study||1
8604348|NCT00382993|9640794|FG000|STARTED|Migraine Attack 1 (Period 1)||84
8604349|NCT00382993|9640795|FG001|STARTED|Migraine Attack 1 (Period 1)||85
8604350|NCT00382993|9640794|FG000|COMPLETED|Migraine Attack 1 (Period 1)|Participant considered to have completed period if treated a migraine with investigational product.|70
8604351|NCT00382993|9640795|FG001|COMPLETED|Migraine Attack 1 (Period 1)||67
8604352|NCT00382993|9640794|FG000|NOT COMPLETED|Migraine Attack 1 (Period 1)||14
8604353|NCT00382993|9640795|FG001|NOT COMPLETED|Migraine Attack 1 (Period 1)||18
8604354|NCT00382993|9640794|FG000|STARTED|Migraine Attack 2 (Period 2)||70
8604355|NCT00382993|9640795|FG001|STARTED|Migraine Attack 2 (Period 2)||67
8604356|NCT00382993|9640794|FG000|COMPLETED|Migraine Attack 2 (Period 2)||68
8604357|NCT00382993|9640795|FG001|COMPLETED|Migraine Attack 2 (Period 2)||63
8604358|NCT00382993|9640794|FG000|NOT COMPLETED|Migraine Attack 2 (Period 2)||2
8604359|NCT00382993|9640795|FG001|NOT COMPLETED|Migraine Attack 2 (Period 2)||4
8604360|NCT00383019|9640803|FG000|STARTED|Overall Study||144
8604361|NCT00383019|9640804|FG001|STARTED|Overall Study||145
8604362|NCT00383019|9640803|FG000|COMPLETED|Overall Study||139
8604363|NCT00383019|9640804|FG001|COMPLETED|Overall Study||143
8604364|NCT00383019|9640803|FG000|NOT COMPLETED|Overall Study||5
8714268|NCT00979459|9761153|FG000|NOT COMPLETED|Second Intervention||0
8714269|NCT00979459|9761154|FG001|NOT COMPLETED|Second Intervention||0
8714270|NCT00979576|9761165|FG000|STARTED|Combination Treatment Phase||3
8714271|NCT00979576|9761166|FG001|STARTED|Combination Treatment Phase||6
8714272|NCT00979576|9761167|FG002|STARTED|Combination Treatment Phase||9
8714273|NCT00979576|9761165|FG000|COMPLETED|Combination Treatment Phase||0
8714274|NCT00979576|9761166|FG001|COMPLETED|Combination Treatment Phase||0
8714275|NCT00979576|9761167|FG002|COMPLETED|Combination Treatment Phase||0
8714276|NCT00979576|9761165|FG000|NOT COMPLETED|Combination Treatment Phase||3
8714277|NCT00979576|9761166|FG001|NOT COMPLETED|Combination Treatment Phase||6
8714278|NCT00979576|9761167|FG002|NOT COMPLETED|Combination Treatment Phase||9
8714279|NCT00979576|9761165|FG000|STARTED|Combination Followed by Monotherapy||0
8604365|NCT00383019|9640804|FG001|NOT COMPLETED|Overall Study||2
8604366|NCT00383071|9640814|FG000|STARTED|Overall Study||25
8604367|NCT00383071|9640815|FG001|STARTED|Overall Study||25
8604368|NCT00383071|9640816|FG002|STARTED|Overall Study||51
8604369|NCT00383071|9640817|FG003|STARTED|Overall Study||25
8604370|NCT00383071|9640814|FG000|COMPLETED|Overall Study||25
8604371|NCT00383071|9640815|FG001|COMPLETED|Overall Study||21
8714280|NCT00979576|9761166|FG001|STARTED|Combination Followed by Monotherapy||2
8714281|NCT00979576|9761167|FG002|STARTED|Combination Followed by Monotherapy||1
8714282|NCT00979576|9761165|FG000|COMPLETED|Combination Followed by Monotherapy||0
8714283|NCT00979576|9761166|FG001|COMPLETED|Combination Followed by Monotherapy||0
8714284|NCT00979576|9761167|FG002|COMPLETED|Combination Followed by Monotherapy||0
8714285|NCT00979576|9761165|FG000|NOT COMPLETED|Combination Followed by Monotherapy||0
8714286|NCT00979576|9761166|FG001|NOT COMPLETED|Combination Followed by Monotherapy||2
8714287|NCT00979576|9761167|FG002|NOT COMPLETED|Combination Followed by Monotherapy||1
8724878|NCT01028560|9772180|FG000|STARTED|Overall Study|4 of 27 withdrew consent immediately after randomization and are excluded from outcome analysis|27
8724879|NCT01028560|9772181|FG001|STARTED|Overall Study|4 of 31 withdrew consent immediately after randomization and are excluded from outcome analysis|31
8724880|NCT01028560|9772180|FG000|Started Study Protocol|Overall Study||23
8724881|NCT01028560|9772181|FG001|Started Study Protocol|Overall Study||27
8724882|NCT01028560|9772180|FG000|COMPLETED|Overall Study||17
8724883|NCT01028560|9772181|FG001|COMPLETED|Overall Study||13
8724884|NCT01028560|9772180|FG000|NOT COMPLETED|Overall Study||10
8724885|NCT01028560|9772181|FG001|NOT COMPLETED|Overall Study||18
8724886|NCT01028651|9772188|FG000|STARTED|Overall Study||13
8724887|NCT01028651|9772188|FG000|COMPLETED|Overall Study||10
8724888|NCT01028651|9772188|FG000|NOT COMPLETED|Overall Study||3
8724889|NCT01028677|9772196|FG000|STARTED|Overall Study||10
8724890|NCT01028677|9772197|FG001|STARTED|Overall Study||7
8724891|NCT01028677|9772196|FG000|COMPLETED|Overall Study||8
8724892|NCT01028677|9772197|FG001|COMPLETED|Overall Study||6
8724893|NCT01028677|9772196|FG000|NOT COMPLETED|Overall Study||2
8724894|NCT01028677|9772197|FG001|NOT COMPLETED|Overall Study||1
8724895|NCT01028820|9772203|FG000|STARTED|Overall Study||13
8604372|NCT00383071|9640816|FG002|COMPLETED|Overall Study||44
8724896|NCT01028820|9772203|FG000|COMPLETED|Overall Study||12
8724897|NCT01028820|9772203|FG000|NOT COMPLETED|Overall Study||1
8724898|NCT01028911|9772210|FG000|STARTED|Overall Study||7
8724899|NCT01028911|9772211|FG001|STARTED|Overall Study||2
8724900|NCT01028911|9772210|FG000|COMPLETED|Overall Study||7
8724901|NCT01028911|9772211|FG001|COMPLETED|Overall Study||2
8604373|NCT00383071|9640817|FG003|COMPLETED|Overall Study||22
8604374|NCT00383071|9640814|FG000|NOT COMPLETED|Overall Study||0
8604375|NCT00383071|9640815|FG001|NOT COMPLETED|Overall Study||4
8604376|NCT00383071|9640816|FG002|NOT COMPLETED|Overall Study||7
8604377|NCT00383071|9640817|FG003|NOT COMPLETED|Overall Study||3
8604378|NCT00383084|9640829|FG000|STARTED|Overall Study||46
8604379|NCT00383084|9640830|FG001|STARTED|Overall Study||38
8604380|NCT00383084|9640829|FG000|COMPLETED|Overall Study||34
8604381|NCT00383084|9640830|FG001|COMPLETED|Overall Study||28
8604382|NCT00383084|9640829|FG000|NOT COMPLETED|Overall Study||12
8604383|NCT00383084|9640830|FG001|NOT COMPLETED|Overall Study||10
8604384|NCT00383110|9640838|FG000|STARTED|Overall Study||150
8604385|NCT00383110|9640839|FG001|STARTED|Overall Study||150
8604386|NCT00383110|9640838|FG000|COMPLETED|Overall Study||150
8604387|NCT00383110|9640839|FG001|COMPLETED|Overall Study||150
8604388|NCT00383110|9640838|FG000|NOT COMPLETED|Overall Study||0
8604389|NCT00383110|9640839|FG001|NOT COMPLETED|Overall Study||0
8604390|NCT00383123|9640848|FG000|STARTED|Overall Study||2115
8604391|NCT00383123|9640849|FG001|STARTED|Overall Study||1210
8604392|NCT00383123|9640848|FG000|COMPLETED|Overall Study||2004
8604393|NCT00383123|9640849|FG001|COMPLETED|Overall Study||1124
8604394|NCT00383123|9640848|FG000|NOT COMPLETED|Overall Study||111
8604395|NCT00383123|9640849|FG001|NOT COMPLETED|Overall Study||86
8604396|NCT00383149|9640855|FG000|STARTED|Overall Study||54
8604397|NCT00383149|9640855|FG000|COMPLETED|Overall Study||0
8604398|NCT00383149|9640855|FG000|NOT COMPLETED|Overall Study||54
8604399|NCT00383162|9640861|FG000|STARTED|Migraine Attack 1 (Period 1)||87
8604400|NCT00383162|9640862|FG001|STARTED|Migraine Attack 1 (Period 1)||86
8604401|NCT00383162|9640861|FG000|COMPLETED|Migraine Attack 1 (Period 1)|Participants completing a period treated a migraine with investigational product.|67
8604402|NCT00383162|9640862|FG001|COMPLETED|Migraine Attack 1 (Period 1)|Participants not completing did not take investigational product.|73
8604403|NCT00383162|9640861|FG000|NOT COMPLETED|Migraine Attack 1 (Period 1)||20
8604404|NCT00383162|9640862|FG001|NOT COMPLETED|Migraine Attack 1 (Period 1)||13
8604405|NCT00383162|9640861|FG000|STARTED|Migraine Attack 2 (Period 2)||67
8604406|NCT00383162|9640862|FG001|STARTED|Migraine Attack 2 (Period 2)||73
8604407|NCT00383162|9640861|FG000|COMPLETED|Migraine Attack 2 (Period 2)||65
8604408|NCT00383162|9640862|FG001|COMPLETED|Migraine Attack 2 (Period 2)||66
8604409|NCT00383162|9640861|FG000|NOT COMPLETED|Migraine Attack 2 (Period 2)||2
8604410|NCT00383162|9640862|FG001|NOT COMPLETED|Migraine Attack 2 (Period 2)||7
8604411|NCT00383188|9640873|FG000|STARTED|Overall Study||69
8604412|NCT00383188|9640874|FG001|STARTED|Overall Study||74
8604413|NCT00383188|9640875|FG002|STARTED|Overall Study||44
8604414|NCT00383188|9640876|FG003|STARTED|Overall Study||40
8604415|NCT00383188|9640877|FG004|STARTED|Overall Study||75
8604416|NCT00383188|9640873|FG000|COMPLETED|Overall Study||52
8604417|NCT00383188|9640874|FG001|COMPLETED|Overall Study||63
8604418|NCT00383188|9640875|FG002|COMPLETED|Overall Study||31
8604419|NCT00383188|9640876|FG003|COMPLETED|Overall Study||28
8604420|NCT00383188|9640877|FG004|COMPLETED|Overall Study||52
8604421|NCT00383188|9640873|FG000|NOT COMPLETED|Overall Study||17
8604422|NCT00383188|9640874|FG001|NOT COMPLETED|Overall Study||11
8604423|NCT00383188|9640875|FG002|NOT COMPLETED|Overall Study||13
8604424|NCT00383188|9640876|FG003|NOT COMPLETED|Overall Study||12
8604425|NCT00383188|9640877|FG004|NOT COMPLETED|Overall Study||23
8604426|NCT00383266|9640891|FG000|STARTED|Overall Study||9
8604427|NCT00383266|9640891|FG000|COMPLETED|Overall Study||9
8604428|NCT00383266|9640891|FG000|NOT COMPLETED|Overall Study||0
8604429|NCT00383292|9640898|FG000|STARTED|Overall Study||68
8604430|NCT00383292|9640899|FG001|STARTED|Overall Study||32
8604431|NCT00383292|9640900|FG002|STARTED|Overall Study||30
8604432|NCT00383292|9640898|FG000|Received at Least One Dose of Study Drug|Overall Study||68
8604433|NCT00383292|9640899|FG001|Received at Least One Dose of Study Drug|Overall Study||32
8604434|NCT00383292|9640900|FG002|Received at Least One Dose of Study Drug|Overall Study||30
8604435|NCT00383292|9640898|FG000|COMPLETED|Overall Study||53
8604436|NCT00383292|9640899|FG001|COMPLETED|Overall Study||26
8604437|NCT00383292|9640900|FG002|COMPLETED|Overall Study||22
8604438|NCT00383292|9640898|FG000|NOT COMPLETED|Overall Study||15
8604439|NCT00383292|9640899|FG001|NOT COMPLETED|Overall Study||6
8604440|NCT00383292|9640900|FG002|NOT COMPLETED|Overall Study||8
8604441|NCT00383331|9640911|FG000|STARTED|Overall Study||10
8604442|NCT00383331|9640912|FG001|STARTED|Overall Study||9
8604443|NCT00383331|9640911|FG000|COMPLETED|Overall Study||10
8604444|NCT00383331|9640912|FG001|COMPLETED|Overall Study||8
8604445|NCT00383331|9640911|FG000|NOT COMPLETED|Overall Study||0
8604446|NCT00383331|9640912|FG001|NOT COMPLETED|Overall Study||1
8604447|NCT00383448|9640918|FG000|STARTED|Overall Study||38
8604448|NCT00383448|9640918|FG000|COMPLETED|Overall Study||38
8604449|NCT00383448|9640918|FG000|NOT COMPLETED|Overall Study||0
8604450|NCT00383500|9640926|FG000|STARTED|Overall Study||27
8604451|NCT00383500|9640927|FG001|STARTED|Overall Study||24
8604452|NCT00383500|9640928|FG002|STARTED|Overall Study||24
8604453|NCT00383500|9640926|FG000|COMPLETED|Overall Study||19
8604454|NCT00383500|9640927|FG001|COMPLETED|Overall Study||21
8604455|NCT00383500|9640928|FG002|COMPLETED|Overall Study||22
8604456|NCT00383500|9640926|FG000|NOT COMPLETED|Overall Study||8
8604457|NCT00383500|9640927|FG001|NOT COMPLETED|Overall Study||3
8604458|NCT00383500|9640928|FG002|NOT COMPLETED|Overall Study||2
8604459|NCT00383565|9640937|FG000|STARTED|Overall Study||9
8604460|NCT00383565|9640937|FG000|COMPLETED|Overall Study||9
8604461|NCT00383565|9640937|FG000|NOT COMPLETED|Overall Study||0
8604462|NCT00383643|9640944|FG000|STARTED|Overall Study||18
8604463|NCT00383643|9640945|FG001|STARTED|Overall Study||16
8604464|NCT00383643|9640946|FG002|STARTED|Overall Study||14
8604465|NCT00383643|9640944|FG000|COMPLETED|Overall Study||17
8604466|NCT00383643|9640945|FG001|COMPLETED|Overall Study||15
8604467|NCT00383643|9640946|FG002|COMPLETED|Overall Study||13
8604468|NCT00383643|9640944|FG000|NOT COMPLETED|Overall Study||1
8604469|NCT00383643|9640945|FG001|NOT COMPLETED|Overall Study||1
8604470|NCT00383643|9640946|FG002|NOT COMPLETED|Overall Study||1
8604471|NCT00383747|9640956|FG000|STARTED|Visit 1||14
8604472|NCT00383747|9640957|FG001|STARTED|Visit 1||14
8604473|NCT00383747|9640958|FG002|STARTED|Visit 1||16
8604474|NCT00383747|9640959|FG003|STARTED|Visit 1||16
8604475|NCT00383747|9640956|FG000|COMPLETED|Visit 1||14
8604476|NCT00383747|9640957|FG001|COMPLETED|Visit 1||14
8604477|NCT00383747|9640958|FG002|COMPLETED|Visit 1||16
8604478|NCT00383747|9640959|FG003|COMPLETED|Visit 1||16
8604479|NCT00383747|9640956|FG000|NOT COMPLETED|Visit 1||0
8604480|NCT00383747|9640957|FG001|NOT COMPLETED|Visit 1||0
8604481|NCT00383747|9640958|FG002|NOT COMPLETED|Visit 1||0
8604482|NCT00383747|9640959|FG003|NOT COMPLETED|Visit 1||0
8604483|NCT00383747|9640956|FG000|STARTED|Visit 2||14
8604484|NCT00383747|9640957|FG001|STARTED|Visit 2||14
8604485|NCT00383747|9640958|FG002|STARTED|Visit 2||16
8604486|NCT00383747|9640959|FG003|STARTED|Visit 2||16
8604487|NCT00383747|9640956|FG000|COMPLETED|Visit 2||14
8604488|NCT00383747|9640957|FG001|COMPLETED|Visit 2||14
8604489|NCT00383747|9640958|FG002|COMPLETED|Visit 2||16
8604490|NCT00383747|9640959|FG003|COMPLETED|Visit 2||16
8604491|NCT00383747|9640956|FG000|NOT COMPLETED|Visit 2||0
8604492|NCT00383747|9640957|FG001|NOT COMPLETED|Visit 2||0
8604493|NCT00383747|9640958|FG002|NOT COMPLETED|Visit 2||0
8604494|NCT00383747|9640959|FG003|NOT COMPLETED|Visit 2||0
8604495|NCT00383760|9640972|FG000|STARTED|Overall Study||15
8604496|NCT00383760|9640972|FG000|COMPLETED|Overall Study||15
8604497|NCT00383760|9640972|FG000|NOT COMPLETED|Overall Study||0
8604498|NCT00383786|9640979|FG000|STARTED|Overall Study||22
8604499|NCT00383786|9640980|FG001|STARTED|Overall Study||25
8604500|NCT00383786|9640979|FG000|COMPLETED|Overall Study||18
8604501|NCT00383786|9640980|FG001|COMPLETED|Overall Study||13
8604502|NCT00383786|9640979|FG000|NOT COMPLETED|Overall Study||4
8604503|NCT00383786|9640980|FG001|NOT COMPLETED|Overall Study||12
8604504|NCT00383942|9640988|FG000|STARTED|Overall Study||40
8604505|NCT00383942|9640989|FG001|STARTED|Overall Study||40
8604506|NCT00383942|9640988|FG000|COMPLETED|Overall Study||40
8604507|NCT00383942|9640989|FG001|COMPLETED|Overall Study||40
8604508|NCT00383942|9640988|FG000|NOT COMPLETED|Overall Study||0
8604509|NCT00383942|9640989|FG001|NOT COMPLETED|Overall Study||0
8604510|NCT00384033|9640999|FG000|STARTED|Overall Study||164
8604511|NCT00384033|9641000|FG001|STARTED|Overall Study||155
8604512|NCT00384033|9641001|FG002|STARTED|Overall Study||160
8604513|NCT00384033|9641002|FG003|STARTED|Overall Study||159
8604514|NCT00384033|9640999|FG000|Treated|Overall Study||161
8604515|NCT00384033|9641000|FG001|Treated|Overall Study||148
8604516|NCT00384033|9641001|FG002|Treated|Overall Study||150
8604517|NCT00384033|9641002|FG003|Treated|Overall Study||157
8604518|NCT00384033|9640999|FG000|COMPLETED|Overall Study||123
8604519|NCT00384033|9641000|FG001|COMPLETED|Overall Study||120
8604520|NCT00384033|9641001|FG002|COMPLETED|Overall Study||117
8604521|NCT00384033|9641002|FG003|COMPLETED|Overall Study||119
8604522|NCT00384033|9640999|FG000|NOT COMPLETED|Overall Study||41
8604523|NCT00384033|9641000|FG001|NOT COMPLETED|Overall Study||35
8604524|NCT00384033|9641001|FG002|NOT COMPLETED|Overall Study||43
8604525|NCT00384033|9641002|FG003|NOT COMPLETED|Overall Study||40
8604526|NCT00384059|9641014|FG000|STARTED|Infant Series||141
8604527|NCT00384059|9641015|FG001|STARTED|Infant Series||145
8604528|NCT00384059|9641014|FG000|Vaccinated Dose 1|Infant Series||139
8604529|NCT00384059|9641015|FG001|Vaccinated Dose 1|Infant Series||139
8604530|NCT00384059|9641014|FG000|Vaccinated Dose 2|Infant Series||136
8604531|NCT00384059|9641015|FG001|Vaccinated Dose 2|Infant Series||135
8604532|NCT00384059|9641014|FG000|COMPLETED|Infant Series||135
8604533|NCT00384059|9641015|FG001|COMPLETED|Infant Series||132
8604534|NCT00384059|9641014|FG000|NOT COMPLETED|Infant Series||6
8604535|NCT00384059|9641015|FG001|NOT COMPLETED|Infant Series||13
8604536|NCT00384059|9641014|FG000|STARTED|After Infant Series||135
8604537|NCT00384059|9641015|FG001|STARTED|After Infant Series||132
8604538|NCT00384059|9641014|FG000|COMPLETED|After Infant Series||131
8604539|NCT00384059|9641015|FG001|COMPLETED|After Infant Series||122
8604540|NCT00384059|9641014|FG000|NOT COMPLETED|After Infant Series||4
8604541|NCT00384059|9641015|FG001|NOT COMPLETED|After Infant Series||10
8604542|NCT00384059|9641014|FG000|STARTED|Toddler Dose||131
8604543|NCT00384059|9641015|FG001|STARTED|Toddler Dose||122
8604544|NCT00384059|9641014|FG000|COMPLETED|Toddler Dose||130
8604545|NCT00384059|9641015|FG001|COMPLETED|Toddler Dose||120
8604546|NCT00384059|9641014|FG000|NOT COMPLETED|Toddler Dose||1
8604547|NCT00384059|9641015|FG001|NOT COMPLETED|Toddler Dose||2
8604548|NCT00384085|9641045|FG000|STARTED|Overall Study|Randomized|195
8604549|NCT00384085|9641046|FG001|STARTED|Overall Study|Randomized|196
8604550|NCT00384085|9641047|FG002|STARTED|Overall Study|Randomized|197
8604551|NCT00384085|9641045|FG000|Intent-To-Treat (ITT)|Overall Study||195
8604552|NCT00384085|9641046|FG001|Intent-To-Treat (ITT)|Overall Study||196
8604553|NCT00384085|9641047|FG002|Intent-To-Treat (ITT)|Overall Study||197
8604554|NCT00384085|9641045|FG000|Treated (Safety Population)|Overall Study||194
8604555|NCT00384085|9641046|FG001|Treated (Safety Population)|Overall Study||194
8604556|NCT00384085|9641047|FG002|Treated (Safety Population)|Overall Study||194
8604557|NCT00384085|9641045|FG000|Intent-To-Treat (Excluding nonGCP Sites)|Overall Study||187
8604558|NCT00384085|9641046|FG001|Intent-To-Treat (Excluding nonGCP Sites)|Overall Study||186
8604559|NCT00384085|9641047|FG002|Intent-To-Treat (Excluding nonGCP Sites)|Overall Study||189
8604560|NCT00384085|9641045|FG000|COMPLETED|Overall Study|Based on the entire ITT population|156
8604561|NCT00384085|9641046|FG001|COMPLETED|Overall Study|Based on the entire ITT population|150
8604562|NCT00384085|9641047|FG002|COMPLETED|Overall Study|Based on the entire ITT population|141
8604563|NCT00384085|9641045|FG000|NOT COMPLETED|Overall Study||39
8604564|NCT00384085|9641046|FG001|NOT COMPLETED|Overall Study||46
8604565|NCT00384085|9641047|FG002|NOT COMPLETED|Overall Study||56
8604566|NCT00384176|9641060|FG000|STARTED|Overall Study||709
8604567|NCT00384176|9641061|FG001|STARTED|Overall Study||713
8604568|NCT00384176|9641062|FG002|STARTED|Overall Study||192
8604569|NCT00384176|9641060|FG000|COMPLETED|Overall Study||397
8604570|NCT00384176|9641061|FG001|COMPLETED|Overall Study||394
8813215|NCT01524770|9866370|FG001|NOT COMPLETED|First Intervention||1
8813216|NCT01524770|9866369|FG000|STARTED|Washout Period of at Least 28 Days||23
8604571|NCT00384176|9641062|FG002|COMPLETED|Overall Study||60
8604572|NCT00384176|9641060|FG000|NOT COMPLETED|Overall Study||312
8604573|NCT00384176|9641061|FG001|NOT COMPLETED|Overall Study||319
8604574|NCT00384176|9641062|FG002|NOT COMPLETED|Overall Study||132
8604575|NCT00384189|9641074|FG000|STARTED|Overall Study||305
8604576|NCT00384189|9641075|FG001|STARTED|Overall Study||312
8604577|NCT00384189|9641076|FG002|STARTED|Overall Study||313
8604578|NCT00384189|9641077|FG003|STARTED|Overall Study||150
8604579|NCT00384189|9641074|FG000|Randomized, Not Treated|Overall Study||1
8604580|NCT00384189|9641075|FG001|Randomized, Not Treated|Overall Study||0
8604581|NCT00384189|9641076|FG002|Randomized, Not Treated|Overall Study||2
8604582|NCT00384189|9641077|FG003|Randomized, Not Treated|Overall Study||4
8604583|NCT00384189|9641074|FG000|Actual Treatment Received|Overall Study|1 participant randomized to 160 μg who actually received 40 μg is included.|305
8604584|NCT00384189|9641075|FG001|Actual Treatment Received|Overall Study||312
8604585|NCT00384189|9641076|FG002|Actual Treatment Received|Overall Study|1 participants in the 160 μg arm actually received 40 μg and is moved to that arm.|310
8604586|NCT00384189|9641077|FG003|Actual Treatment Received|Overall Study||146
8604587|NCT00384189|9641074|FG000|COMPLETED|Overall Study||255
8604588|NCT00384189|9641075|FG001|COMPLETED|Overall Study||255
8604589|NCT00384189|9641076|FG002|COMPLETED|Overall Study||255
8604590|NCT00384189|9641077|FG003|COMPLETED|Overall Study||110
8604591|NCT00384189|9641074|FG000|NOT COMPLETED|Overall Study||50
8604592|NCT00384189|9641075|FG001|NOT COMPLETED|Overall Study||57
8604593|NCT00384189|9641076|FG002|NOT COMPLETED|Overall Study||58
8604594|NCT00384189|9641077|FG003|NOT COMPLETED|Overall Study||40
8604595|NCT00384241|9641089|FG000|STARTED|Overall Study||500
8604596|NCT00384241|9641090|FG001|STARTED|Overall Study||599
8604597|NCT00384241|9641089|FG000|COMPLETED|Overall Study||500
8604598|NCT00384241|9641090|FG001|COMPLETED|Overall Study||599
8604599|NCT00384241|9641089|FG000|NOT COMPLETED|Overall Study||0
8604600|NCT00384241|9641090|FG001|NOT COMPLETED|Overall Study||0
8604601|NCT00384332|9641097|FG000|STARTED|Overall Study||13
8604602|NCT00384332|9641098|FG001|STARTED|Overall Study||10
8604603|NCT00384332|9641097|FG000|COMPLETED|Overall Study||9
8604604|NCT00384332|9641098|FG001|COMPLETED|Overall Study||10
8604605|NCT00384332|9641097|FG000|NOT COMPLETED|Overall Study||4
8604606|NCT00384332|9641098|FG001|NOT COMPLETED|Overall Study||0
8604607|NCT00384397|9641109|FG000|STARTED|Overall Study||407
8604608|NCT00384397|9641110|FG001|STARTED|Overall Study||293
8604609|NCT00384397|9641111|FG002|STARTED|Overall Study||418
8604610|NCT00384397|9641109|FG000|COMPLETED|Overall Study||375
8604611|NCT00384397|9641110|FG001|COMPLETED|Overall Study||247
8604612|NCT00384397|9641111|FG002|COMPLETED|Overall Study||385
8604613|NCT00384397|9641109|FG000|NOT COMPLETED|Overall Study||32
8604614|NCT00384397|9641110|FG001|NOT COMPLETED|Overall Study||46
8604615|NCT00384397|9641111|FG002|NOT COMPLETED|Overall Study||33
8604616|NCT00384449|9641119|FG000|STARTED|Overall Study||1
8604617|NCT00384449|9641119|FG000|COMPLETED|Overall Study||1
8604618|NCT00384449|9641119|FG000|NOT COMPLETED|Overall Study||0
8604619|NCT00384670|9641123|FG000|STARTED|Overall Study||7
8604620|NCT00384670|9641123|FG000|COMPLETED|Overall Study||7
8604621|NCT00384670|9641123|FG000|NOT COMPLETED|Overall Study||0
8604622|NCT00384748|9641129|FG000|STARTED|Overall Study||25
8604623|NCT00384748|9641130|FG001|STARTED|Overall Study||23
8604624|NCT00384748|9641129|FG000|COMPLETED|Overall Study||25
8604625|NCT00384748|9641130|FG001|COMPLETED|Overall Study||23
8604626|NCT00384748|9641129|FG000|NOT COMPLETED|Overall Study||0
8604627|NCT00384748|9641130|FG001|NOT COMPLETED|Overall Study||0
8604628|NCT00384774|9641143|FG000|STARTED|Overall Study||42
8604629|NCT00384774|9641144|FG001|STARTED|Overall Study||4
8604630|NCT00384774|9641145|FG002|STARTED|Overall Study||12
8714288|NCT00979602|9761178|FG000|STARTED|Overall Study||2025
8714289|NCT00979602|9761179|FG001|STARTED|Overall Study||2023
8714290|NCT00979602|9761178|FG000|COMPLETED|Overall Study||1880
8604631|NCT00384774|9641146|FG003|STARTED|Overall Study||24
8604632|NCT00384774|9641147|FG004|STARTED|Overall Study||28
8604633|NCT00384774|9641148|FG005|STARTED|Overall Study||16
8604634|NCT00384774|9641149|FG006|STARTED|Overall Study||4
8604635|NCT00384774|9641143|FG000|Received at Least 1 Dose of Study Drug|Overall Study||42
8714291|NCT00979602|9761179|FG001|COMPLETED|Overall Study||1890
8604636|NCT00384774|9641144|FG001|Received at Least 1 Dose of Study Drug|Overall Study||4
8604637|NCT00384774|9641145|FG002|Received at Least 1 Dose of Study Drug|Overall Study||12
8604638|NCT00384774|9641146|FG003|Received at Least 1 Dose of Study Drug|Overall Study||24
8604639|NCT00384774|9641147|FG004|Received at Least 1 Dose of Study Drug|Overall Study||28
8604640|NCT00384774|9641148|FG005|Received at Least 1 Dose of Study Drug|Overall Study||16
8604641|NCT00384774|9641149|FG006|Received at Least 1 Dose of Study Drug|Overall Study||4
8604642|NCT00384774|9641143|FG000|COMPLETED|Overall Study||42
8604643|NCT00384774|9641144|FG001|COMPLETED|Overall Study||4
8604644|NCT00384774|9641145|FG002|COMPLETED|Overall Study||12
8604645|NCT00384774|9641146|FG003|COMPLETED|Overall Study||24
8604646|NCT00384774|9641147|FG004|COMPLETED|Overall Study||28
8604647|NCT00384774|9641148|FG005|COMPLETED|Overall Study||16
8604648|NCT00384774|9641149|FG006|COMPLETED|Overall Study||4
8604649|NCT00384774|9641143|FG000|NOT COMPLETED|Overall Study||0
8604650|NCT00384774|9641144|FG001|NOT COMPLETED|Overall Study||0
8604651|NCT00384774|9641145|FG002|NOT COMPLETED|Overall Study||0
8604652|NCT00384774|9641146|FG003|NOT COMPLETED|Overall Study||0
8604653|NCT00384774|9641147|FG004|NOT COMPLETED|Overall Study||0
8604654|NCT00384774|9641148|FG005|NOT COMPLETED|Overall Study||0
8604655|NCT00384774|9641149|FG006|NOT COMPLETED|Overall Study||0
8604656|NCT00384813|9641167|FG000|STARTED|Overall Study||23
8604657|NCT00384813|9641168|FG001|STARTED|Overall Study||20
8604658|NCT00384813|9641167|FG000|COMPLETED|Overall Study||21
8604659|NCT00384813|9641168|FG001|COMPLETED|Overall Study||20
8604660|NCT00384813|9641167|FG000|NOT COMPLETED|Overall Study||2
8604661|NCT00384813|9641168|FG001|NOT COMPLETED|Overall Study||0
8604662|NCT00384839|9641174|FG000|STARTED|Overall Study||36
8604663|NCT00384839|9641174|FG000|COMPLETED|Overall Study||28
8604664|NCT00384839|9641174|FG000|NOT COMPLETED|Overall Study||8
8604665|NCT00384865|9641182|FG000|STARTED|Overall Study||16
8604666|NCT00384865|9641183|FG001|STARTED|Overall Study||16
8604667|NCT00384865|9641184|FG002|STARTED|Overall Study||16
8604668|NCT00384865|9641185|FG003|STARTED|Overall Study||16
8604669|NCT00384865|9641182|FG000|Completed Six Month Assessment|Overall Study||11
8604670|NCT00384865|9641183|FG001|Completed Six Month Assessment|Overall Study||12
8604671|NCT00384865|9641184|FG002|Completed Six Month Assessment|Overall Study||15
8604672|NCT00384865|9641185|FG003|Completed Six Month Assessment|Overall Study||11
8604673|NCT00384865|9641182|FG000|COMPLETED|Overall Study||16
8604674|NCT00384865|9641183|FG001|COMPLETED|Overall Study||16
8604675|NCT00384865|9641184|FG002|COMPLETED|Overall Study||16
8604676|NCT00384865|9641185|FG003|COMPLETED|Overall Study||16
8604677|NCT00384865|9641182|FG000|NOT COMPLETED|Overall Study||0
8604678|NCT00384865|9641183|FG001|NOT COMPLETED|Overall Study||0
8604679|NCT00384865|9641184|FG002|NOT COMPLETED|Overall Study||0
8604680|NCT00384865|9641185|FG003|NOT COMPLETED|Overall Study||0
8604681|NCT00384930|9641200|FG000|STARTED|Overall Study||212
8604682|NCT00384930|9641201|FG001|STARTED|Overall Study||209
8604683|NCT00384930|9641202|FG002|STARTED|Overall Study||212
8604684|NCT00384930|9641203|FG003|STARTED|Overall Study||216
8604685|NCT00384930|9641204|FG004|STARTED|Overall Study||209
8604686|NCT00384930|9641200|FG000|Received Double-Blind Study Drug|Overall Study||211
8604687|NCT00384930|9641201|FG001|Received Double-Blind Study Drug|Overall Study||208
8604688|NCT00384930|9641202|FG002|Received Double-Blind Study Drug|Overall Study||212
8604689|NCT00384930|9641203|FG003|Received Double-Blind Study Drug|Overall Study||216
8604690|NCT00384930|9641204|FG004|Received Double-Blind Study Drug|Overall Study||209
8604691|NCT00384930|9641200|FG000|COMPLETED|Overall Study||185
8604692|NCT00384930|9641201|FG001|COMPLETED|Overall Study||182
8604693|NCT00384930|9641202|FG002|COMPLETED|Overall Study||182
8604694|NCT00384930|9641203|FG003|COMPLETED|Overall Study||175
8604695|NCT00384930|9641204|FG004|COMPLETED|Overall Study||162
8604696|NCT00384930|9641200|FG000|NOT COMPLETED|Overall Study||27
8604697|NCT00384930|9641201|FG001|NOT COMPLETED|Overall Study||27
8604698|NCT00384930|9641202|FG002|NOT COMPLETED|Overall Study||30
8604699|NCT00384930|9641203|FG003|NOT COMPLETED|Overall Study||41
8604700|NCT00384930|9641204|FG004|NOT COMPLETED|Overall Study||47
8604701|NCT00384956|9641219|FG000|STARTED|Overall Study||25
8604702|NCT00384956|9641219|FG000|COMPLETED|Overall Study||22
8604703|NCT00384956|9641219|FG000|NOT COMPLETED|Overall Study||3
8604704|NCT00385008|9641225|FG000|STARTED|Overall Study||10
8604705|NCT00385008|9641226|FG001|STARTED|Overall Study||10
8604706|NCT00385008|9641225|FG000|In Absence of Migraine|Overall Study||10
8604707|NCT00385008|9641226|FG001|In Absence of Migraine|Overall Study||10
8604708|NCT00385008|9641225|FG000|In Presence of Migraine|Overall Study||5
8604709|NCT00385008|9641226|FG001|In Presence of Migraine|Overall Study||5
8604710|NCT00385008|9641225|FG000|COMPLETED|Overall Study||10
8604711|NCT00385008|9641226|FG001|COMPLETED|Overall Study||10
8604712|NCT00385008|9641225|FG000|NOT COMPLETED|Overall Study||0
8604713|NCT00385008|9641226|FG001|NOT COMPLETED|Overall Study||0
8604714|NCT00385138|9641235|FG000|STARTED|Overall Study||2695
8604715|NCT00385138|9641236|FG001|STARTED|Overall Study||2669
8604716|NCT00385138|9641235|FG000|Intent-to-treat (ITT)|Overall Study|All patients randomized excluding two (2) who withdrew consent for using study data.|2693
8604717|NCT00385138|9641236|FG001|Intent-to-treat (ITT)|Overall Study||2669
8604718|NCT00385138|9641235|FG000|Modified Intent-to-treat (mITT)|Overall Study|Excludes 37 patients who either did not receive study drug or have PCI.|2656
8604719|NCT00385138|9641236|FG001|Modified Intent-to-treat (mITT)|Overall Study|Excludes 24 patients who either did not received study drug or have PCI.|2645
8628836|NCT00527111|9668394|FG000|COMPLETED|Overall Study||50
8604720|NCT00385138|9641235|FG000|Safety Population|Overall Study|Includes all randomized patients who received at least one dose of study drug.|2662
8604721|NCT00385138|9641236|FG001|Safety Population|Overall Study|Includes all randomized patients who received at least one dose of study drug.|2650
8604722|NCT00385138|9641235|FG000|COMPLETED|Overall Study|"Completed means patient completed scheduled visits or developed a primary endpoint event."|2665
8604723|NCT00385138|9641236|FG001|COMPLETED|Overall Study|"Completed means patient completed scheduled visits or developed a primary endpoint event."|2641
8604724|NCT00385138|9641235|FG000|NOT COMPLETED|Overall Study||30
8604725|NCT00385138|9641236|FG001|NOT COMPLETED|Overall Study||28
8604726|NCT00385203|9641244|FG000|STARTED|Overall Study||26
8604727|NCT00385203|9641245|FG001|STARTED|Overall Study||10
8604728|NCT00385203|9641244|FG000|COMPLETED|Overall Study||0
8604729|NCT00385203|9641245|FG001|COMPLETED|Overall Study||3
8604730|NCT00385203|9641244|FG000|NOT COMPLETED|Overall Study||26
8604731|NCT00385203|9641245|FG001|NOT COMPLETED|Overall Study||7
8604732|NCT00385216|9641252|FG000|STARTED|First Intervention||11
8604733|NCT00385216|9641253|FG001|STARTED|First Intervention||9
8604734|NCT00385216|9641252|FG000|COMPLETED|First Intervention||11
8604735|NCT00385216|9641253|FG001|COMPLETED|First Intervention||9
8604736|NCT00385216|9641252|FG000|NOT COMPLETED|First Intervention||0
8604737|NCT00385216|9641253|FG001|NOT COMPLETED|First Intervention||0
8604738|NCT00385216|9641252|FG000|STARTED|Second Intervention||11
8604739|NCT00385216|9641253|FG001|STARTED|Second Intervention||9
8604740|NCT00385216|9641252|FG000|COMPLETED|Second Intervention||11
8604741|NCT00385216|9641253|FG001|COMPLETED|Second Intervention||9
8604742|NCT00385216|9641252|FG000|NOT COMPLETED|Second Intervention||0
8604743|NCT00385216|9641253|FG001|NOT COMPLETED|Second Intervention||0
8604744|NCT00385255|9641261|FG000|STARTED|Overall Study||860
8604745|NCT00385255|9641262|FG001|STARTED|Overall Study||858
8604746|NCT00385255|9641261|FG000|≥ 65 Years of Age (YOA) Cohort|Overall Study||112
8604747|NCT00385255|9641262|FG001|≥ 65 Years of Age (YOA) Cohort|Overall Study||109
8604748|NCT00385255|9641261|FG000|19-64 Years of Age (YOA) Cohort|Overall Study||748
8604749|NCT00385255|9641262|FG001|19-64 Years of Age (YOA) Cohort|Overall Study||749
8604750|NCT00385255|9641261|FG000|COMPLETED|Overall Study||839
8604751|NCT00385255|9641262|FG001|COMPLETED|Overall Study||785
8604752|NCT00385255|9641261|FG000|NOT COMPLETED|Overall Study||21
8604753|NCT00385255|9641262|FG001|NOT COMPLETED|Overall Study||73
8604754|NCT00385268|9641274|FG000|STARTED|Overall Study||34
8604755|NCT00385268|9641275|FG001|STARTED|Overall Study||26
8604756|NCT00385268|9641274|FG000|COMPLETED|Overall Study||18
8604757|NCT00385268|9641275|FG001|COMPLETED|Overall Study||18
8604758|NCT00385268|9641274|FG000|NOT COMPLETED|Overall Study||16
8604759|NCT00385268|9641275|FG001|NOT COMPLETED|Overall Study||8
8604760|NCT00385541|9641283|FG000|STARTED|Overall Study||25
8604761|NCT00385541|9641284|FG001|STARTED|Overall Study||25
8604762|NCT00385541|9641283|FG000|COMPLETED|Overall Study||25
8604763|NCT00385541|9641284|FG001|COMPLETED|Overall Study||24
8604764|NCT00385541|9641283|FG000|NOT COMPLETED|Overall Study||0
8604765|NCT00385541|9641284|FG001|NOT COMPLETED|Overall Study||1
8604766|NCT00385580|9641292|FG000|STARTED|Overall Study|Number of participants treated.|48
8604767|NCT00385580|9641293|FG001|STARTED|Overall Study|Number of participants treated.|47
8604768|NCT00385580|9641292|FG000|COMPLETED|Overall Study|Completed=off study. Major reasons for being off study are disease progression, and study toxicity.|48
8604769|NCT00385580|9641293|FG001|COMPLETED|Overall Study|Completed=off study. Major reasons for being off study are disease progression, and study toxicity.|47
8604770|NCT00385580|9641292|FG000|NOT COMPLETED|Overall Study||0
8604771|NCT00385580|9641293|FG001|NOT COMPLETED|Overall Study||0
8604772|NCT00385593|9641311|FG000|STARTED|Overall Study||328
8604773|NCT00385593|9641312|FG001|STARTED|Overall Study||326
8604774|NCT00385593|9641311|FG000|COMPLETED|Overall Study||270
8604775|NCT00385593|9641312|FG001|COMPLETED|Overall Study||289
8604776|NCT00385593|9641311|FG000|NOT COMPLETED|Overall Study||58
8604777|NCT00385593|9641312|FG001|NOT COMPLETED|Overall Study||37
8604778|NCT00385671|9641321|FG000|STARTED|Overall Study||134
8604779|NCT00385671|9641322|FG001|STARTED|Overall Study||138
8604780|NCT00385671|9641323|FG002|STARTED|Overall Study||135
8604781|NCT00385671|9641321|FG000|COMPLETED|Overall Study||96
8604782|NCT00385671|9641322|FG001|COMPLETED|Overall Study||87
8604783|NCT00385671|9641323|FG002|COMPLETED|Overall Study||99
8604784|NCT00385671|9641321|FG000|NOT COMPLETED|Overall Study||38
8604785|NCT00385671|9641322|FG001|NOT COMPLETED|Overall Study||51
8604786|NCT00385671|9641323|FG002|NOT COMPLETED|Overall Study||36
8604787|NCT00385684|9641333|FG000|STARTED|FIRST INTERVENTION OF PHASE A||6
8604788|NCT00385684|9641334|FG001|STARTED|FIRST INTERVENTION OF PHASE A||5
8604789|NCT00385684|9641333|FG000|COMPLETED|FIRST INTERVENTION OF PHASE A||5
8604790|NCT00385684|9641334|FG001|COMPLETED|FIRST INTERVENTION OF PHASE A||5
8604791|NCT00385684|9641333|FG000|NOT COMPLETED|FIRST INTERVENTION OF PHASE A||1
8604792|NCT00385684|9641334|FG001|NOT COMPLETED|FIRST INTERVENTION OF PHASE A||0
8604793|NCT00385684|9641333|FG000|STARTED|SECOND INTERVENTION OF PHASE A||5
8604794|NCT00385684|9641334|FG001|STARTED|SECOND INTERVENTION OF PHASE A||5
8604795|NCT00385684|9641333|FG000|COMPLETED|SECOND INTERVENTION OF PHASE A||5
8604796|NCT00385684|9641334|FG001|COMPLETED|SECOND INTERVENTION OF PHASE A||3
8604797|NCT00385684|9641333|FG000|NOT COMPLETED|SECOND INTERVENTION OF PHASE A||0
8604798|NCT00385684|9641334|FG001|NOT COMPLETED|SECOND INTERVENTION OF PHASE A||2
8604799|NCT00385684|9641333|FG000|STARTED|PHASE B||5
8604800|NCT00385684|9641334|FG001|STARTED|PHASE B||3
8604801|NCT00385684|9641333|FG000|COMPLETED|PHASE B||5
8604802|NCT00385684|9641334|FG001|COMPLETED|PHASE B||3
8604803|NCT00385684|9641333|FG000|NOT COMPLETED|PHASE B||0
8604804|NCT00385684|9641334|FG001|NOT COMPLETED|PHASE B||0
8604805|NCT00385723|9641343|FG000|STARTED|Overall Study||46
8604806|NCT00385723|9641344|FG001|STARTED|Overall Study||46
8604807|NCT00385723|9641345|FG002|STARTED|Overall Study||46
8604808|NCT00385723|9641343|FG000|COMPLETED|Overall Study||44
8604809|NCT00385723|9641344|FG001|COMPLETED|Overall Study||45
8604810|NCT00385723|9641345|FG002|COMPLETED|Overall Study||44
8604811|NCT00385723|9641343|FG000|NOT COMPLETED|Overall Study||2
8604812|NCT00385723|9641344|FG001|NOT COMPLETED|Overall Study||1
8604813|NCT00385723|9641345|FG002|NOT COMPLETED|Overall Study||2
8604814|NCT00385736|9641356|FG000|STARTED|Efficacy Analysis Set - Induction|Enrolled under Amendment 3 or 4 of the protocol.|130
8604815|NCT00385736|9641357|FG001|STARTED|Efficacy Analysis Set - Induction|Enrolled under Amendment 3 or 4 of the protocol.|130
8604816|NCT00385736|9641358|FG002|STARTED|Efficacy Analysis Set - Induction|Enrolled under Amendment 3 or 4 of the protocol.|130
8604817|NCT00385736|9641356|FG000|COMPLETED|Efficacy Analysis Set - Induction|Completed Week 8 of the study.|121
8604818|NCT00385736|9641357|FG001|COMPLETED|Efficacy Analysis Set - Induction|Completed Week 8 of the study.|118
8604819|NCT00385736|9641358|FG002|COMPLETED|Efficacy Analysis Set - Induction|Completed Week 8 of the study.|121
8604820|NCT00385736|9641356|FG000|NOT COMPLETED|Efficacy Analysis Set - Induction||9
8604821|NCT00385736|9641357|FG001|NOT COMPLETED|Efficacy Analysis Set - Induction||12
8604822|NCT00385736|9641358|FG002|NOT COMPLETED|Efficacy Analysis Set - Induction||9
8604823|NCT00385736|9641356|FG000|STARTED|Efficacy Analysis Set - Maintenance|Includes all subjects with confirmed UC enrolled since the start of the study|222
8604824|NCT00385736|9641357|FG001|STARTED|Efficacy Analysis Set - Maintenance|Includes all subjects with confirmed UC enrolled since the start of the study|130
8604825|NCT00385736|9641358|FG002|STARTED|Efficacy Analysis Set - Maintenance|Includes all subjects with confirmed UC enrolled since the start of the study|223
8604826|NCT00385736|9641356|FG000|COMPLETED|Efficacy Analysis Set - Maintenance||153
8604827|NCT00385736|9641357|FG001|COMPLETED|Efficacy Analysis Set - Maintenance||86
8604828|NCT00385736|9641358|FG002|COMPLETED|Efficacy Analysis Set - Maintenance||143
8604829|NCT00385736|9641356|FG000|NOT COMPLETED|Efficacy Analysis Set - Maintenance||69
8604830|NCT00385736|9641357|FG001|NOT COMPLETED|Efficacy Analysis Set - Maintenance||44
8604831|NCT00385736|9641358|FG002|NOT COMPLETED|Efficacy Analysis Set - Maintenance||80
8604832|NCT00385736|9641356|FG000|STARTED|Safety Analysis Set|Includes all subjects enrolled since the start of the study.|223
8604833|NCT00385736|9641357|FG001|STARTED|Safety Analysis Set|Includes all subjects enrolled since the start of the study.|130
8604834|NCT00385736|9641358|FG002|STARTED|Safety Analysis Set|Includes all subjects enrolled since the start of the study.|223
8604835|NCT00385736|9641356|FG000|COMPLETED|Safety Analysis Set||153
8604836|NCT00385736|9641357|FG001|COMPLETED|Safety Analysis Set||86
8604837|NCT00385736|9641358|FG002|COMPLETED|Safety Analysis Set||143
8604838|NCT00385736|9641356|FG000|NOT COMPLETED|Safety Analysis Set||70
8604839|NCT00385736|9641357|FG001|NOT COMPLETED|Safety Analysis Set||44
8604840|NCT00385736|9641358|FG002|NOT COMPLETED|Safety Analysis Set||80
8604841|NCT00385762|9641369|FG000|STARTED|Overall Study||35
8604842|NCT00385762|9641369|FG000|COMPLETED|Overall Study||33
8604843|NCT00385762|9641369|FG000|NOT COMPLETED|Overall Study||2
8604844|NCT00385788|9641375|FG000|STARTED|Overall Study||12
8604845|NCT00385788|9641376|FG001|STARTED|Overall Study||40
8604846|NCT00385788|9641375|FG000|COMPLETED|Overall Study||12
8604847|NCT00385788|9641376|FG001|COMPLETED|Overall Study||40
8604848|NCT00385788|9641375|FG000|NOT COMPLETED|Overall Study||0
8604849|NCT00385788|9641376|FG001|NOT COMPLETED|Overall Study||0
8604850|NCT00385801|9641384|FG000|STARTED|Overall Study||15
8604851|NCT00385801|9641385|FG001|STARTED|Overall Study||16
8604852|NCT00385801|9641384|FG000|COMPLETED|Overall Study||6
8604853|NCT00385801|9641385|FG001|COMPLETED|Overall Study||8
8604854|NCT00385801|9641384|FG000|NOT COMPLETED|Overall Study||9
8604855|NCT00385801|9641385|FG001|NOT COMPLETED|Overall Study||8
8604856|NCT00385827|9641395|FG000|STARTED|Part 1||9
8604857|NCT00385827|9641396|FG001|STARTED|Part 1||0
8604858|NCT00385827|9641397|FG002|STARTED|Part 1||0
8604859|NCT00385827|9641395|FG000|Treated|Part 1||9
8604860|NCT00385827|9641396|FG001|Treated|Part 1||0
8604861|NCT00385827|9641397|FG002|Treated|Part 1||0
8604862|NCT00385827|9641395|FG000|COMPLETED|Part 1||0
8604863|NCT00385827|9641396|FG001|COMPLETED|Part 1||0
8604864|NCT00385827|9641397|FG002|COMPLETED|Part 1||0
8604865|NCT00385827|9641395|FG000|NOT COMPLETED|Part 1||9
8604866|NCT00385827|9641396|FG001|NOT COMPLETED|Part 1||0
8604867|NCT00385827|9641397|FG002|NOT COMPLETED|Part 1||0
8604868|NCT00385827|9641395|FG000|STARTED|Part 2||0
8604869|NCT00385827|9641396|FG001|STARTED|Part 2||49
8604870|NCT00385827|9641397|FG002|STARTED|Part 2||48
8604871|NCT00385827|9641395|FG000|Treated|Part 2||0
8604872|NCT00385827|9641396|FG001|Treated|Part 2||47
8604873|NCT00385827|9641397|FG002|Treated|Part 2||46
8604874|NCT00385827|9641395|FG000|COMPLETED|Part 2||0
8604875|NCT00385827|9641396|FG001|COMPLETED|Part 2||16
8604876|NCT00385827|9641397|FG002|COMPLETED|Part 2||0
8604877|NCT00385827|9641395|FG000|NOT COMPLETED|Part 2||0
8604878|NCT00385827|9641396|FG001|NOT COMPLETED|Part 2||33
8604879|NCT00385827|9641397|FG002|NOT COMPLETED|Part 2||48
8604880|NCT00385840|9641409|FG000|STARTED|Overall Study||133
8604881|NCT00385840|9641410|FG001|STARTED|Overall Study||545
8604882|NCT00385840|9641409|FG000|COMPLETED|Overall Study||129
8604883|NCT00385840|9641410|FG001|COMPLETED|Overall Study||531
8604884|NCT00385840|9641409|FG000|NOT COMPLETED|Overall Study||4
8604885|NCT00385840|9641410|FG001|NOT COMPLETED|Overall Study||14
8714292|NCT00979602|9761178|FG000|NOT COMPLETED|Overall Study||145
8714293|NCT00979602|9761179|FG001|NOT COMPLETED|Overall Study||133
8604886|NCT00385918|9641418|FG000|STARTED|Feasibility & Baseline Measurement Phase||0
8604887|NCT00385918|9641419|FG001|STARTED|Feasibility & Baseline Measurement Phase||0
8604888|NCT00385918|9641420|FG002|STARTED|Feasibility & Baseline Measurement Phase|Total # of subjects screened.The screening occurred before randomization.|35
8604889|NCT00385918|9641418|FG000|Number Eligible|Feasibility & Baseline Measurement Phase||0
8604890|NCT00385918|9641419|FG001|Number Eligible|Feasibility & Baseline Measurement Phase||0
8604891|NCT00385918|9641420|FG002|Number Eligible|Feasibility & Baseline Measurement Phase|8 subjects failed screening.|27
8604892|NCT00385918|9641418|FG000|Completed Baseline Tests|Feasibility & Baseline Measurement Phase||0
8604893|NCT00385918|9641419|FG001|Completed Baseline Tests|Feasibility & Baseline Measurement Phase||0
8604894|NCT00385918|9641420|FG002|Completed Baseline Tests|Feasibility & Baseline Measurement Phase|6 subjects did not complete all baseline tests.|21
8604895|NCT00385918|9641418|FG000|COMPLETED|Feasibility & Baseline Measurement Phase||0
8604896|NCT00385918|9641419|FG001|COMPLETED|Feasibility & Baseline Measurement Phase||0
8604897|NCT00385918|9641420|FG002|COMPLETED|Feasibility & Baseline Measurement Phase||21
8604898|NCT00385918|9641418|FG000|NOT COMPLETED|Feasibility & Baseline Measurement Phase||0
8604899|NCT00385918|9641419|FG001|NOT COMPLETED|Feasibility & Baseline Measurement Phase||0
8604900|NCT00385918|9641420|FG002|NOT COMPLETED|Feasibility & Baseline Measurement Phase||14
8604901|NCT00385918|9641418|FG000|STARTED|Intervention Phase After Randomization|Participant successfully completed screening; this is the number in the Lokomat training arm.|15
8604902|NCT00385918|9641419|FG001|STARTED|Intervention Phase After Randomization|Participants successfully completed screening; this is the number in the home stretching arm.|6
8604903|NCT00385918|9641420|FG002|STARTED|Intervention Phase After Randomization||0
8604904|NCT00385918|9641418|FG000|COMPLETED|Intervention Phase After Randomization|Participants completed the 3-month training intervention|12
8604905|NCT00385918|9641419|FG001|COMPLETED|Intervention Phase After Randomization|Participants completed the 3-month home-base intervention|6
8604906|NCT00385918|9641420|FG002|COMPLETED|Intervention Phase After Randomization||0
8604907|NCT00385918|9641418|FG000|NOT COMPLETED|Intervention Phase After Randomization||3
8604908|NCT00385918|9641419|FG001|NOT COMPLETED|Intervention Phase After Randomization||0
8604909|NCT00385918|9641420|FG002|NOT COMPLETED|Intervention Phase After Randomization||0
8604910|NCT00385944|9641429|FG000|STARTED|Loading Dose||0
8604911|NCT00385944|9641430|FG001|STARTED|Loading Dose||0
8604912|NCT00385944|9641431|FG002|STARTED|Loading Dose||56
8604913|NCT00385944|9641429|FG000|COMPLETED|Loading Dose||0
8604914|NCT00385944|9641430|FG001|COMPLETED|Loading Dose||0
8604915|NCT00385944|9641431|FG002|COMPLETED|Loading Dose||56
8604916|NCT00385944|9641429|FG000|NOT COMPLETED|Loading Dose||0
8604917|NCT00385944|9641430|FG001|NOT COMPLETED|Loading Dose||0
8604918|NCT00385944|9641431|FG002|NOT COMPLETED|Loading Dose||0
8604919|NCT00385944|9641429|FG000|STARTED|1st Maintenance Dose Period||29
8604920|NCT00385944|9641430|FG001|STARTED|1st Maintenance Dose Period|Two patients withdrew from the study after randomization but prior to receiving the 1st MD.|25
8604921|NCT00385944|9641431|FG002|STARTED|1st Maintenance Dose Period||0
8604922|NCT00385944|9641429|FG000|COMPLETED|1st Maintenance Dose Period||25
8604923|NCT00385944|9641430|FG001|COMPLETED|1st Maintenance Dose Period||24
8604924|NCT00385944|9641431|FG002|COMPLETED|1st Maintenance Dose Period||0
8604925|NCT00385944|9641429|FG000|NOT COMPLETED|1st Maintenance Dose Period||4
8604926|NCT00385944|9641430|FG001|NOT COMPLETED|1st Maintenance Dose Period||1
8604927|NCT00385944|9641431|FG002|NOT COMPLETED|1st Maintenance Dose Period||0
8604928|NCT00385944|9641429|FG000|STARTED|2nd Maintenance Dose Period|1 patient discontinued prior to the 2nd MD Period (Sponsor decision due to early study termination)|24
8604929|NCT00385944|9641430|FG001|STARTED|2nd Maintenance Dose Period|2 patients discontinued prior to the 2nd MD Period (Sponsor decision due to early study termination)|22
8604930|NCT00385944|9641431|FG002|STARTED|2nd Maintenance Dose Period||0
8604931|NCT00385944|9641429|FG000|COMPLETED|2nd Maintenance Dose Period||22
8604932|NCT00385944|9641430|FG001|COMPLETED|2nd Maintenance Dose Period||19
8604933|NCT00385944|9641431|FG002|COMPLETED|2nd Maintenance Dose Period||0
8604934|NCT00385944|9641429|FG000|NOT COMPLETED|2nd Maintenance Dose Period||2
8604935|NCT00385944|9641430|FG001|NOT COMPLETED|2nd Maintenance Dose Period||3
8604936|NCT00385944|9641431|FG002|NOT COMPLETED|2nd Maintenance Dose Period||0
8604937|NCT00385996|9641446|FG000|STARTED|Overall Study||22
8604938|NCT00385996|9641446|FG000|COMPLETED|Overall Study||22
8604939|NCT00385996|9641446|FG000|NOT COMPLETED|Overall Study||0
8604940|NCT00386009|9641453|FG000|STARTED|Overall Study||101
8604941|NCT00386009|9641454|FG001|STARTED|Overall Study||99
8604942|NCT00386009|9641453|FG000|COMPLETED|Overall Study||92
8604943|NCT00386009|9641454|FG001|COMPLETED|Overall Study||89
8604944|NCT00386009|9641453|FG000|NOT COMPLETED|Overall Study||9
8604945|NCT00386009|9641454|FG001|NOT COMPLETED|Overall Study||10
8604946|NCT00386022|9641462|FG000|STARTED|Baseline||10
8604947|NCT00386022|9641463|FG001|STARTED|Baseline||9
8604948|NCT00386022|9641462|FG000|All Doses of GnRH|Baseline||10
8604949|NCT00386022|9641463|FG001|All Doses of GnRH|Baseline||9
8604950|NCT00386022|9641462|FG000|COMPLETED|Baseline||10
8604951|NCT00386022|9641463|FG001|COMPLETED|Baseline||9
8604952|NCT00386022|9641462|FG000|NOT COMPLETED|Baseline||0
8604953|NCT00386022|9641463|FG001|NOT COMPLETED|Baseline||0
8604954|NCT00386022|9641462|FG000|STARTED|Plus Estrogen||10
8604955|NCT00386022|9641463|FG001|STARTED|Plus Estrogen||9
8604956|NCT00386022|9641462|FG000|Estrogen Patch|Plus Estrogen||8
8604957|NCT00386022|9641463|FG001|Estrogen Patch|Plus Estrogen||9
8604958|NCT00386022|9641462|FG000|All Doses GnRH|Plus Estrogen||8
8604959|NCT00386022|9641463|FG001|All Doses GnRH|Plus Estrogen||8
8604960|NCT00386022|9641462|FG000|COMPLETED|Plus Estrogen||8
8604961|NCT00386022|9641463|FG001|COMPLETED|Plus Estrogen||8
8604962|NCT00386022|9641462|FG000|NOT COMPLETED|Plus Estrogen||2
8604963|NCT00386022|9641463|FG001|NOT COMPLETED|Plus Estrogen||1
8604964|NCT00386100|9641473|FG000|STARTED|Overall Study||340
8604965|NCT00386100|9641474|FG001|STARTED|Overall Study||348
8604966|NCT00386100|9641473|FG000|COMPLETED|Overall Study||186
8604967|NCT00386100|9641474|FG001|COMPLETED|Overall Study||217
8604968|NCT00386100|9641473|FG000|NOT COMPLETED|Overall Study||154
8604969|NCT00386100|9641474|FG001|NOT COMPLETED|Overall Study||131
8604970|NCT00386152|9641483|FG000|STARTED|Overall Study|number of subjects treated|75
8604971|NCT00386152|9641484|FG001|STARTED|Overall Study|number of subjects treated|77
8604972|NCT00386152|9641485|FG002|STARTED|Overall Study|number of subjects treated|75
8604973|NCT00386152|9641483|FG000|COMPLETED|Overall Study||31
8604974|NCT00386152|9641484|FG001|COMPLETED|Overall Study||37
8604975|NCT00386152|9641485|FG002|COMPLETED|Overall Study||42
8604976|NCT00386152|9641483|FG000|NOT COMPLETED|Overall Study||44
8604977|NCT00386152|9641484|FG001|NOT COMPLETED|Overall Study||40
8604978|NCT00386152|9641485|FG002|NOT COMPLETED|Overall Study||33
8604979|NCT00386243|9641495|FG000|STARTED|Overall Study||121
8604980|NCT00386243|9641496|FG001|STARTED|Overall Study||121
8604981|NCT00386243|9641495|FG000|COMPLETED|Overall Study||114
8604982|NCT00386243|9641496|FG001|COMPLETED|Overall Study||108
8604983|NCT00386243|9641495|FG000|NOT COMPLETED|Overall Study||7
8604984|NCT00386243|9641496|FG001|NOT COMPLETED|Overall Study||13
8604985|NCT00386256|9641506|FG000|STARTED|Overall Study||16
8604986|NCT00386256|9641507|FG001|STARTED|Overall Study||15
8604987|NCT00386256|9641508|FG002|STARTED|Overall Study||4
8604988|NCT00386256|9641509|FG003|STARTED|Overall Study||3
8604989|NCT00386256|9641506|FG000|COMPLETED|Overall Study||16
8604990|NCT00386256|9641507|FG001|COMPLETED|Overall Study||15
8604991|NCT00386256|9641508|FG002|COMPLETED|Overall Study||4
8604992|NCT00386256|9641509|FG003|COMPLETED|Overall Study||3
8604993|NCT00386256|9641506|FG000|NOT COMPLETED|Overall Study||0
8604994|NCT00386256|9641507|FG001|NOT COMPLETED|Overall Study||0
8604995|NCT00386256|9641508|FG002|NOT COMPLETED|Overall Study||0
8604996|NCT00386256|9641509|FG003|NOT COMPLETED|Overall Study||0
8604997|NCT00386308|9641521|FG000|STARTED|Overall Study||123
8604998|NCT00386308|9641522|FG001|STARTED|Overall Study||73
8604999|NCT00386308|9641521|FG000|Intent to Treat Population|Overall Study||117
8605000|NCT00386308|9641522|FG001|Intent to Treat Population|Overall Study||72
8605001|NCT00386308|9641521|FG000|Modified Intent to Treat Population|Overall Study||115
8605002|NCT00386308|9641522|FG001|Modified Intent to Treat Population|Overall Study||72
8605003|NCT00386308|9641521|FG000|COMPLETED|Overall Study||94
8605004|NCT00386308|9641522|FG001|COMPLETED|Overall Study||54
8605005|NCT00386308|9641521|FG000|NOT COMPLETED|Overall Study||29
8605006|NCT00386308|9641522|FG001|NOT COMPLETED|Overall Study||19
8605007|NCT00386334|9641530|FG000|STARTED|Double Blind Period||194
8605008|NCT00386334|9641531|FG001|STARTED|Double Blind Period||194
8605009|NCT00386334|9641530|FG000|COMPLETED|Double Blind Period||148
8605010|NCT00386334|9641531|FG001|COMPLETED|Double Blind Period||147
8605011|NCT00386334|9641530|FG000|NOT COMPLETED|Double Blind Period||46
8605012|NCT00386334|9641531|FG001|NOT COMPLETED|Double Blind Period||47
8605013|NCT00386334|9641530|FG000|STARTED|Follow up:2 Week Placebo, 2 Week no Drug|Two subjects withdrew consent prior to starting the follow up period.|146
8605014|NCT00386334|9641531|FG001|STARTED|Follow up:2 Week Placebo, 2 Week no Drug|Two subjects withdrew consent prior to starting the follow up period.|145
8605015|NCT00386334|9641530|FG000|COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||143
8605016|NCT00386334|9641531|FG001|COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||144
8605017|NCT00386334|9641530|FG000|NOT COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||3
8605018|NCT00386334|9641531|FG001|NOT COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||1
8605019|NCT00386360|9641539|FG000|STARTED|Overall Study||49
8605020|NCT00386360|9641540|FG001|STARTED|Overall Study||112
8605021|NCT00386360|9641539|FG000|Intent to Treat Population (ITT)|Overall Study|Includes all patients randomized and took at least one dose of study drug.|49
8605022|NCT00386360|9641540|FG001|Intent to Treat Population (ITT)|Overall Study||110
8605023|NCT00386360|9641539|FG000|Primary Efficacy|Overall Study|Per-protocol patients with evaluable BVTV (trabecular bone volume/tissue volume) at baseline & M12.|36
8605024|NCT00386360|9641540|FG001|Primary Efficacy|Overall Study||77
8605025|NCT00386360|9641539|FG000|COMPLETED|Overall Study||40
8605026|NCT00386360|9641540|FG001|COMPLETED|Overall Study||95
8605027|NCT00386360|9641539|FG000|NOT COMPLETED|Overall Study||9
8605028|NCT00386360|9641540|FG001|NOT COMPLETED|Overall Study||17
8605029|NCT00386425|9641549|FG000|STARTED|Overall Study|51 severe protein C deficiency; 176 moderate protein C deficiency|227
8605030|NCT00386425|9641550|FG001|STARTED|Overall Study|33 severe protein C deficiency; 173 moderate protein C deficiency|206
8605031|NCT00386425|9641551|FG002|STARTED|Overall Study||53
8605032|NCT00386425|9641549|FG000|Received Study Drug|Overall Study||227
8605033|NCT00386425|9641550|FG001|Received Study Drug|Overall Study||206
8605034|NCT00386425|9641551|FG002|Received Study Drug|Overall Study||53
8605035|NCT00386425|9641549|FG000|COMPLETED|Overall Study|51 severe protein C deficiency; 173 moderate protein C deficiency|224
8605036|NCT00386425|9641550|FG001|COMPLETED|Overall Study|33 severe protein C deficiency; 172 moderate protein C deficiency|205
8605037|NCT00386425|9641551|FG002|COMPLETED|Overall Study||53
8605038|NCT00386425|9641549|FG000|NOT COMPLETED|Overall Study||3
8605039|NCT00386425|9641550|FG001|NOT COMPLETED|Overall Study||1
8605040|NCT00386425|9641551|FG002|NOT COMPLETED|Overall Study||0
8605041|NCT00386477|9641565|FG000|STARTED|Overall Study||155
8605042|NCT00386477|9641566|FG001|STARTED|Overall Study||145
8605043|NCT00386477|9641565|FG000|COMPLETED|Overall Study||155
8605044|NCT00386477|9641566|FG001|COMPLETED|Overall Study||145
8605045|NCT00386477|9641565|FG000|NOT COMPLETED|Overall Study||0
8605046|NCT00386477|9641566|FG001|NOT COMPLETED|Overall Study||0
8605047|NCT00386607|9641572|FG000|STARTED|Core||601
8605048|NCT00386607|9641573|FG001|STARTED|Core||0
8605049|NCT00386607|9641572|FG000|COMPLETED|Core||486
8605050|NCT00386607|9641573|FG001|COMPLETED|Core||0
8605051|NCT00386607|9641572|FG000|NOT COMPLETED|Core||115
8605052|NCT00386607|9641573|FG001|NOT COMPLETED|Core||0
8605053|NCT00386607|9641572|FG000|STARTED|Extension||0
8605054|NCT00386607|9641573|FG001|STARTED|Extension||162
8605055|NCT00386607|9641572|FG000|COMPLETED|Extension||0
8605056|NCT00386607|9641573|FG001|COMPLETED|Extension||145
8605057|NCT00386607|9641572|FG000|NOT COMPLETED|Extension||0
8605058|NCT00386607|9641573|FG001|NOT COMPLETED|Extension||17
8605059|NCT00386776|9641585|FG000|STARTED|Overall Study||40
8605060|NCT00386776|9641585|FG000|COMPLETED|Overall Study||32
8605061|NCT00386776|9641585|FG000|NOT COMPLETED|Overall Study||8
8605062|NCT00386880|9641591|FG000|STARTED|Overall Study||30
8605063|NCT00386880|9641592|FG001|STARTED|Overall Study||8
8605064|NCT00386880|9641591|FG000|COMPLETED|Overall Study||30
8605065|NCT00386880|9641592|FG001|COMPLETED|Overall Study||8
8605066|NCT00386880|9641591|FG000|NOT COMPLETED|Overall Study||0
8605067|NCT00386880|9641592|FG001|NOT COMPLETED|Overall Study||0
8605068|NCT00387010|9641597|FG000|STARTED|Dose Titration Period||218
8605069|NCT00387010|9641597|FG000|COMPLETED|Dose Titration Period||180
8605070|NCT00387010|9641597|FG000|NOT COMPLETED|Dose Titration Period||38
8605071|NCT00387010|9641597|FG000|STARTED|Treatment Period||180
8605072|NCT00387010|9641597|FG000|Full Analysis Set|Treatment Period|FAS: treated patients with at least 1 paired baseline and post baseline efficacy assessment|175
8605073|NCT00387010|9641597|FG000|COMPLETED|Treatment Period||169
8605074|NCT00387010|9641597|FG000|NOT COMPLETED|Treatment Period||11
8605075|NCT00387023|9641601|FG000|STARTED|Overall Study||12
8605076|NCT00387023|9641601|FG000|COMPLETED|Overall Study||12
8605077|NCT00387023|9641601|FG000|NOT COMPLETED|Overall Study||0
8605078|NCT00387036|9641605|FG000|STARTED|2-Week First Intervention||6
8605079|NCT00387036|9641606|FG001|STARTED|2-Week First Intervention||6
8605080|NCT00387036|9641605|FG000|COMPLETED|2-Week First Intervention||6
8605081|NCT00387036|9641606|FG001|COMPLETED|2-Week First Intervention||6
8605082|NCT00387036|9641605|FG000|NOT COMPLETED|2-Week First Intervention||0
8605083|NCT00387036|9641606|FG001|NOT COMPLETED|2-Week First Intervention||0
8605084|NCT00387036|9641605|FG000|STARTED|2-Week Placebo Washout||6
8605085|NCT00387036|9641606|FG001|STARTED|2-Week Placebo Washout||6
8605086|NCT00387036|9641605|FG000|COMPLETED|2-Week Placebo Washout||6
8605087|NCT00387036|9641606|FG001|COMPLETED|2-Week Placebo Washout||6
8605088|NCT00387036|9641605|FG000|NOT COMPLETED|2-Week Placebo Washout||0
8605089|NCT00387036|9641606|FG001|NOT COMPLETED|2-Week Placebo Washout||0
8605090|NCT00387036|9641605|FG000|STARTED|2-Week Crossover Second Intervention||6
8605091|NCT00387036|9641606|FG001|STARTED|2-Week Crossover Second Intervention||6
8605092|NCT00387036|9641605|FG000|COMPLETED|2-Week Crossover Second Intervention||6
8605093|NCT00387036|9641606|FG001|COMPLETED|2-Week Crossover Second Intervention||6
8605094|NCT00387036|9641605|FG000|NOT COMPLETED|2-Week Crossover Second Intervention||0
8605095|NCT00387036|9641606|FG001|NOT COMPLETED|2-Week Crossover Second Intervention||0
8628837|NCT00527111|9668395|FG001|COMPLETED|Overall Study||47
8628838|NCT00527111|9668394|FG000|NOT COMPLETED|Overall Study||20
8628839|NCT00527111|9668395|FG001|NOT COMPLETED|Overall Study||22
8628840|NCT00527124|9668403|FG000|STARTED|Overall Study||29
8628841|NCT00527124|9668404|FG001|STARTED|Overall Study||28
8628842|NCT00527124|9668403|FG000|COMPLETED|Overall Study||29
8628843|NCT00527124|9668404|FG001|COMPLETED|Overall Study||28
8628844|NCT00527124|9668403|FG000|NOT COMPLETED|Overall Study||0
8628845|NCT00527124|9668404|FG001|NOT COMPLETED|Overall Study||0
8628846|NCT00527319|9668413|FG000|STARTED|Overall Study||12
8628847|NCT00527319|9668414|FG001|STARTED|Overall Study||12
8628848|NCT00527319|9668415|FG002|STARTED|Overall Study||13
8628849|NCT00527319|9668413|FG000|COMPLETED|Overall Study||6
8628850|NCT00527319|9668414|FG001|COMPLETED|Overall Study||8
8628851|NCT00527319|9668415|FG002|COMPLETED|Overall Study||7
8628852|NCT00527319|9668413|FG000|NOT COMPLETED|Overall Study||6
8628853|NCT00527319|9668414|FG001|NOT COMPLETED|Overall Study||4
8628854|NCT00527319|9668415|FG002|NOT COMPLETED|Overall Study||6
8628855|NCT00527332|9668425|FG000|STARTED|Overall Study||91
8628856|NCT00527332|9668426|FG001|STARTED|Overall Study||89
8628857|NCT00527332|9668425|FG000|COMPLETED|Overall Study||82
8628858|NCT00527332|9668426|FG001|COMPLETED|Overall Study||80
8628859|NCT00527332|9668425|FG000|NOT COMPLETED|Overall Study||9
8628860|NCT00527332|9668426|FG001|NOT COMPLETED|Overall Study||9
8628861|NCT00527397|9668432|FG000|STARTED|Overall Study||24
8628862|NCT00527397|9668432|FG000|COMPLETED|Overall Study||0
8628863|NCT00527397|9668432|FG000|NOT COMPLETED|Overall Study||24
8628864|NCT00527423|9668439|FG000|STARTED|Overall Study||157
8628865|NCT00527423|9668439|FG000|COMPLETED|Overall Study||120
8628866|NCT00527423|9668439|FG000|NOT COMPLETED|Overall Study||37
8628867|NCT00527475|9668447|FG000|STARTED|Overall Study||30
8628868|NCT00527475|9668448|FG001|STARTED|Overall Study||30
8628869|NCT00527475|9668447|FG000|COMPLETED|Overall Study||27
8628870|NCT00527475|9668448|FG001|COMPLETED|Overall Study||29
8605096|NCT00387088|9641614|FG000|STARTED|Overall Study||1989
8605097|NCT00387088|9641615|FG001|STARTED|Overall Study||2002
8605098|NCT00387088|9641614|FG000|COMPLETED|Overall Study||1671
8605099|NCT00387088|9641615|FG001|COMPLETED|Overall Study||1629
8605100|NCT00387088|9641614|FG000|NOT COMPLETED|Overall Study||318
8605101|NCT00387088|9641615|FG001|NOT COMPLETED|Overall Study||373
8605102|NCT00387127|9641623|FG000|STARTED|Overall Study||33
8605103|NCT00387127|9641624|FG001|STARTED|Overall Study||34
8605104|NCT00387127|9641623|FG000|COMPLETED|Overall Study||0
8605105|NCT00387127|9641624|FG001|COMPLETED|Overall Study||0
8605106|NCT00387127|9641623|FG000|NOT COMPLETED|Overall Study||33
8605107|NCT00387127|9641624|FG001|NOT COMPLETED|Overall Study||34
8605108|NCT00387153|9641632|FG000|STARTED|Overall Study||8
8605109|NCT00387153|9641632|FG000|COMPLETED|Overall Study||0
8605110|NCT00387153|9641632|FG000|NOT COMPLETED|Overall Study||8
8605111|NCT00387335|9641638|FG000|STARTED|Overall Study||15
8605112|NCT00387335|9641639|FG001|STARTED|Overall Study||7
8605113|NCT00387335|9641638|FG000|COMPLETED|Overall Study||15
8605114|NCT00387335|9641639|FG001|COMPLETED|Overall Study||7
8605115|NCT00387335|9641638|FG000|NOT COMPLETED|Overall Study||0
8605116|NCT00387335|9641639|FG001|NOT COMPLETED|Overall Study||0
8605117|NCT00387348|9641648|FG000|STARTED|Overall Study||8
8605118|NCT00387348|9641649|FG001|STARTED|Overall Study||5
8605119|NCT00387348|9641650|FG002|STARTED|Overall Study||11
8605120|NCT00387348|9641648|FG000|COMPLETED|Overall Study||5
8605121|NCT00387348|9641649|FG001|COMPLETED|Overall Study||2
8605122|NCT00387348|9641650|FG002|COMPLETED|Overall Study||7
8605123|NCT00387348|9641648|FG000|NOT COMPLETED|Overall Study||3
8605124|NCT00387348|9641649|FG001|NOT COMPLETED|Overall Study||3
8605125|NCT00387348|9641650|FG002|NOT COMPLETED|Overall Study||4
8605126|NCT00387426|9641663|FG000|STARTED|Overall Study||14
8605127|NCT00387426|9641663|FG000|COMPLETED|Overall Study||0
8605128|NCT00387426|9641663|FG000|NOT COMPLETED|Overall Study||14
8605129|NCT00387465|9641670|FG000|STARTED|Overall Study||3
8605130|NCT00387465|9641671|FG001|STARTED|Overall Study||7
8605131|NCT00387465|9641672|FG002|STARTED|Overall Study||35
8605132|NCT00387465|9641670|FG000|COMPLETED|Overall Study||3
8605133|NCT00387465|9641671|FG001|COMPLETED|Overall Study||6
8605134|NCT00387465|9641672|FG002|COMPLETED|Overall Study||35
8605135|NCT00387465|9641670|FG000|NOT COMPLETED|Overall Study||0
8605136|NCT00387465|9641671|FG001|NOT COMPLETED|Overall Study||1
8605137|NCT00387465|9641672|FG002|NOT COMPLETED|Overall Study||0
8605138|NCT00387621|9641683|FG000|STARTED|First Intervention||29
8605139|NCT00387621|9641684|FG001|STARTED|First Intervention||29
8605140|NCT00387621|9641683|FG000|COMPLETED|First Intervention||29
8605141|NCT00387621|9641684|FG001|COMPLETED|First Intervention||29
8605142|NCT00387621|9641683|FG000|NOT COMPLETED|First Intervention||0
8605143|NCT00387621|9641684|FG001|NOT COMPLETED|First Intervention||0
8605144|NCT00387621|9641683|FG000|STARTED|Washout Period of 2 Weeks||29
8605145|NCT00387621|9641684|FG001|STARTED|Washout Period of 2 Weeks||29
8605146|NCT00387621|9641683|FG000|COMPLETED|Washout Period of 2 Weeks||29
8605147|NCT00387621|9641684|FG001|COMPLETED|Washout Period of 2 Weeks||29
8605148|NCT00387621|9641683|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
8605149|NCT00387621|9641684|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
8605150|NCT00387621|9641683|FG000|STARTED|Second Intervention||29
8605151|NCT00387621|9641684|FG001|STARTED|Second Intervention||29
8605152|NCT00387621|9641683|FG000|COMPLETED|Second Intervention||29
8605153|NCT00387621|9641684|FG001|COMPLETED|Second Intervention||29
8605154|NCT00387621|9641683|FG000|NOT COMPLETED|Second Intervention||0
8605155|NCT00387621|9641684|FG001|NOT COMPLETED|Second Intervention||0
8605156|NCT00387647|9641696|FG000|STARTED|Overall Study||24
8605157|NCT00387647|9641696|FG000|COMPLETED|Overall Study||6
8605158|NCT00387647|9641696|FG000|NOT COMPLETED|Overall Study||18
8605159|NCT00387660|9641702|FG000|STARTED|Overall Study||40
8605160|NCT00387660|9641703|FG001|STARTED|Overall Study||40
8605161|NCT00387660|9641702|FG000|COMPLETED|Overall Study||40
8605162|NCT00387660|9641703|FG001|COMPLETED|Overall Study||40
8605163|NCT00387660|9641702|FG000|NOT COMPLETED|Overall Study||0
8605164|NCT00387660|9641703|FG001|NOT COMPLETED|Overall Study||0
8605165|NCT00387712|9641711|FG000|STARTED|Overall Study||47
8605166|NCT00387712|9641712|FG001|STARTED|Overall Study||52
8605167|NCT00387712|9641711|FG000|COMPLETED|Overall Study||18
8605168|NCT00387712|9641712|FG001|COMPLETED|Overall Study||16
8605169|NCT00387712|9641711|FG000|NOT COMPLETED|Overall Study||29
8605170|NCT00387712|9641712|FG001|NOT COMPLETED|Overall Study||36
8605171|NCT00387725|9641722|FG000|STARTED|Overall Study||21
8605172|NCT00387725|9641723|FG001|STARTED|Overall Study||16
8605173|NCT00387725|9641724|FG002|STARTED|Overall Study||45
8605174|NCT00387725|9641725|FG003|STARTED|Overall Study||45
8605175|NCT00387725|9641722|FG000|COMPLETED|Overall Study||20
8605176|NCT00387725|9641723|FG001|COMPLETED|Overall Study||15
8605177|NCT00387725|9641724|FG002|COMPLETED|Overall Study||43
8605178|NCT00387725|9641725|FG003|COMPLETED|Overall Study||43
8605179|NCT00387725|9641722|FG000|NOT COMPLETED|Overall Study||1
8605180|NCT00387725|9641723|FG001|NOT COMPLETED|Overall Study||1
8605181|NCT00387725|9641724|FG002|NOT COMPLETED|Overall Study||2
8605182|NCT00387725|9641725|FG003|NOT COMPLETED|Overall Study||2
8605183|NCT00387751|9641735|FG000|STARTED|Overall Study||14
8605184|NCT00387751|9641735|FG000|COMPLETED|Overall Study||14
8605185|NCT00387751|9641735|FG000|NOT COMPLETED|Overall Study||0
8605186|NCT00387764|9641741|FG000|STARTED|Overall Study||80
8628871|NCT00527475|9668447|FG000|NOT COMPLETED|Overall Study||3
8605187|NCT00387764|9641741|FG000|COMPLETED|Overall Study|Participants completed treatment (until disease progression), but may not have completed the study.|49
8605188|NCT00387764|9641741|FG000|NOT COMPLETED|Overall Study||31
8605189|NCT00387790|9641745|FG000|STARTED|Overall Study||64
8605190|NCT00387790|9641745|FG000|COMPLETED|Overall Study||50
8605191|NCT00387790|9641745|FG000|NOT COMPLETED|Overall Study||14
8605192|NCT00387829|9641751|FG000|STARTED|Safety Population||178
8605193|NCT00387829|9641752|FG001|STARTED|Safety Population||169
8605194|NCT00387829|9641751|FG000|COMPLETED|Safety Population||139
8605195|NCT00387829|9641752|FG001|COMPLETED|Safety Population||136
8605196|NCT00387829|9641751|FG000|NOT COMPLETED|Safety Population||39
8605197|NCT00387829|9641752|FG001|NOT COMPLETED|Safety Population||33
8605198|NCT00387829|9641751|FG000|STARTED|Intent-to-treat Population||177
8605199|NCT00387829|9641752|FG001|STARTED|Intent-to-treat Population||166
8605200|NCT00387829|9641751|FG000|COMPLETED|Intent-to-treat Population||139
8605201|NCT00387829|9641752|FG001|COMPLETED|Intent-to-treat Population||136
8605202|NCT00387829|9641751|FG000|NOT COMPLETED|Intent-to-treat Population||38
8605203|NCT00387829|9641752|FG001|NOT COMPLETED|Intent-to-treat Population||30
8605204|NCT00387881|9641760|FG000|STARTED|Overall Study||334
8605205|NCT00387881|9641761|FG001|STARTED|Overall Study||345
8605206|NCT00387881|9641760|FG000|COMPLETED|Overall Study||245
8605207|NCT00387881|9641761|FG001|COMPLETED|Overall Study||243
8605208|NCT00387881|9641760|FG000|NOT COMPLETED|Overall Study||89
8605209|NCT00387881|9641761|FG001|NOT COMPLETED|Overall Study||102
8605210|NCT00387894|9641767|FG000|STARTED|Overall Study||6
8605211|NCT00387894|9641767|FG000|COMPLETED|Overall Study||5
8605212|NCT00387894|9641767|FG000|NOT COMPLETED|Overall Study||1
8605213|NCT00387959|9641771|FG000|STARTED|Overall Study||17
8605214|NCT00387959|9641771|FG000|COMPLETED|Overall Study||16
8605215|NCT00387959|9641771|FG000|NOT COMPLETED|Overall Study||1
8605216|NCT00388037|9641775|FG000|STARTED|Overall Study||31
8605217|NCT00388037|9641775|FG000|COMPLETED|Overall Study||30
8605218|NCT00388037|9641775|FG000|NOT COMPLETED|Overall Study||1
8605219|NCT00388154|9641779|FG000|STARTED|Overall Study||21
8605220|NCT00388154|9641779|FG000|COMPLETED|Overall Study||20
8605221|NCT00388154|9641779|FG000|NOT COMPLETED|Overall Study||1
8605222|NCT00388297|9641787|FG000|STARTED|Overall Study||339
8605223|NCT00388297|9641788|FG001|STARTED|Overall Study||338
8605224|NCT00388297|9641789|FG002|STARTED|Overall Study||265
8605225|NCT00388297|9641790|FG003|STARTED|Overall Study||261
8605226|NCT00388297|9641787|FG000|COMPLETED|Overall Study||323
8605227|NCT00388297|9641788|FG001|COMPLETED|Overall Study||326
8605228|NCT00388297|9641789|FG002|COMPLETED|Overall Study||254
8605229|NCT00388297|9641790|FG003|COMPLETED|Overall Study||253
8605230|NCT00388297|9641787|FG000|NOT COMPLETED|Overall Study||16
8605231|NCT00388297|9641788|FG001|NOT COMPLETED|Overall Study||12
8605232|NCT00388297|9641789|FG002|NOT COMPLETED|Overall Study||11
8605233|NCT00388297|9641790|FG003|NOT COMPLETED|Overall Study||8
8605234|NCT00388349|9641800|FG000|STARTED|Phase I Dose Escalation||3
8605235|NCT00388349|9641801|FG001|STARTED|Phase I Dose Escalation||4
8605236|NCT00388349|9641800|FG000|COMPLETED|Phase I Dose Escalation||3
8605237|NCT00388349|9641801|FG001|COMPLETED|Phase I Dose Escalation||1
8605238|NCT00388349|9641800|FG000|NOT COMPLETED|Phase I Dose Escalation||0
8605239|NCT00388349|9641801|FG001|NOT COMPLETED|Phase I Dose Escalation||3
8605240|NCT00388349|9641800|FG000|STARTED|Phase 2 Dose Expansion|Includes the three phase 1 participants who received 1250 mg/m2 gemcitabine (MTD)|139
8605241|NCT00388349|9641801|FG001|STARTED|Phase 2 Dose Expansion|No participants were treated in Phase 2 at 1500 mg/m2 gemcitabine (MTD exceeded)|0
8605242|NCT00388349|9641800|FG000|COMPLETED|Phase 2 Dose Expansion||139
8605243|NCT00388349|9641801|FG001|COMPLETED|Phase 2 Dose Expansion||0
8605244|NCT00388349|9641800|FG000|NOT COMPLETED|Phase 2 Dose Expansion||0
8605245|NCT00388349|9641801|FG001|NOT COMPLETED|Phase 2 Dose Expansion||0
8628872|NCT00527475|9668448|FG001|NOT COMPLETED|Overall Study||1
8628873|NCT00527488|9668458|FG000|STARTED|Overall Study||13
8628874|NCT00527488|9668459|FG001|STARTED|Overall Study||13
8628875|NCT00527488|9668460|FG002|STARTED|Overall Study||13
8628876|NCT00527488|9668461|FG003|STARTED|Overall Study||13
8628877|NCT00527488|9668458|FG000|COMPLETED|Overall Study||13
8628878|NCT00527488|9668459|FG001|COMPLETED|Overall Study||12
8628879|NCT00527488|9668460|FG002|COMPLETED|Overall Study||12
8628880|NCT00527488|9668461|FG003|COMPLETED|Overall Study||13
8628881|NCT00527488|9668458|FG000|NOT COMPLETED|Overall Study||0
8628882|NCT00527488|9668459|FG001|NOT COMPLETED|Overall Study||1
8628883|NCT00527488|9668460|FG002|NOT COMPLETED|Overall Study||1
8628884|NCT00527488|9668461|FG003|NOT COMPLETED|Overall Study||0
8628885|NCT00527514|9668471|FG000|STARTED|Weeks 1-3: Amlodipine (Aml) 5mg||185
8628886|NCT00527514|9668471|FG000|COMPLETED|Weeks 1-3: Amlodipine (Aml) 5mg|1 participant dropped out. 2 participants were subsequently mis-titrated to the third regimen.|184
8628887|NCT00527514|9668471|FG000|NOT COMPLETED|Weeks 1-3: Amlodipine (Aml) 5mg||1
8628888|NCT00527514|9668471|FG000|STARTED|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|184 -2 who were mis-titrated -2 who met blood pressure goal = 180|180
8628889|NCT00527514|9668471|FG000|COMPLETED|Weeks 4-6: Aml 5mg+Olmesartan 20 mg||178
8628890|NCT00527514|9668471|FG000|NOT COMPLETED|Weeks 4-6: Aml 5mg+Olmesartan 20 mg||2
8628891|NCT00527514|9668471|FG000|STARTED|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|178 -19 who met blood pressure goal + 2 who were mis-titrated = 161|161
8628892|NCT00527514|9668471|FG000|COMPLETED|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg||158
8628893|NCT00527514|9668471|FG000|NOT COMPLETED|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg||3
8628894|NCT00527514|9668471|FG000|STARTED|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|158 -24 who met blood pressure goal = 134|134
8605246|NCT00388362|9641809|FG000|STARTED|Enrolled||36
8605247|NCT00388362|9641809|FG000|COMPLETED|Enrolled||23
8605248|NCT00388362|9641809|FG000|NOT COMPLETED|Enrolled||13
8605249|NCT00388362|9641809|FG000|STARTED|Remained on Study Median of 514 Days||23
8605250|NCT00388362|9641809|FG000|COMPLETED|Remained on Study Median of 514 Days||21
8605251|NCT00388362|9641809|FG000|NOT COMPLETED|Remained on Study Median of 514 Days||2
8605252|NCT00388414|9641815|FG000|STARTED|First Intervention (8 Weeks)||7
8605253|NCT00388414|9641816|FG001|STARTED|First Intervention (8 Weeks)||7
8605254|NCT00388414|9641815|FG000|COMPLETED|First Intervention (8 Weeks)||7
8605255|NCT00388414|9641816|FG001|COMPLETED|First Intervention (8 Weeks)||7
8605256|NCT00388414|9641815|FG000|NOT COMPLETED|First Intervention (8 Weeks)||0
8605257|NCT00388414|9641816|FG001|NOT COMPLETED|First Intervention (8 Weeks)||0
8605258|NCT00388414|9641815|FG000|STARTED|Washout (1 Week)||7
8605259|NCT00388414|9641816|FG001|STARTED|Washout (1 Week)||7
8605260|NCT00388414|9641815|FG000|COMPLETED|Washout (1 Week)||7
8605261|NCT00388414|9641816|FG001|COMPLETED|Washout (1 Week)||7
8605262|NCT00388414|9641815|FG000|NOT COMPLETED|Washout (1 Week)||0
8605263|NCT00388414|9641816|FG001|NOT COMPLETED|Washout (1 Week)||0
8605264|NCT00388414|9641815|FG000|STARTED|Second Intervention (8 Weeks)||7
8605265|NCT00388414|9641816|FG001|STARTED|Second Intervention (8 Weeks)||7
8605266|NCT00388414|9641815|FG000|COMPLETED|Second Intervention (8 Weeks)||7
8605267|NCT00388414|9641816|FG001|COMPLETED|Second Intervention (8 Weeks)||7
8605268|NCT00388414|9641815|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||0
8605269|NCT00388414|9641816|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||0
8605270|NCT00388453|9641827|FG000|STARTED|Overall Study||20
8605271|NCT00388453|9641828|FG001|STARTED|Overall Study||17
8605272|NCT00388453|9641829|FG002|STARTED|Overall Study||10
8605273|NCT00388453|9641827|FG000|COMPLETED|Overall Study||20
8605274|NCT00388453|9641828|FG001|COMPLETED|Overall Study||17
8605275|NCT00388453|9641829|FG002|COMPLETED|Overall Study||10
8605276|NCT00388453|9641827|FG000|NOT COMPLETED|Overall Study||0
8605277|NCT00388453|9641828|FG001|NOT COMPLETED|Overall Study||0
8605278|NCT00388453|9641829|FG002|NOT COMPLETED|Overall Study||0
8605279|NCT00388505|9641839|FG000|STARTED|Overall Study|Randomized patients who received any amount of study medication|308
8605280|NCT00388505|9641840|FG001|STARTED|Overall Study|Randomized patients who received any amount of study medication|209
8605281|NCT00388505|9641839|FG000|COMPLETED|Overall Study||225
8605282|NCT00388505|9641840|FG001|COMPLETED|Overall Study||171
8605283|NCT00388505|9641839|FG000|NOT COMPLETED|Overall Study||83
8605284|NCT00388505|9641840|FG001|NOT COMPLETED|Overall Study||38
8605285|NCT00388583|9641848|FG000|STARTED|Overall Study||407
8605286|NCT00388583|9641849|FG001|STARTED|Overall Study||410
8605287|NCT00388583|9641848|FG000|COMPLETED|Overall Study||401
8605288|NCT00388583|9641849|FG001|COMPLETED|Overall Study||406
8605289|NCT00388583|9641848|FG000|NOT COMPLETED|Overall Study||6
8605290|NCT00388583|9641849|FG001|NOT COMPLETED|Overall Study||4
8605291|NCT00388674|9641857|FG000|STARTED|Initial Treatment||6216
8605292|NCT00388674|9641858|FG001|STARTED|Initial Treatment||6162
8605293|NCT00388674|9641857|FG000|COMPLETED|Initial Treatment|Completed=Reason of 'successful treatment', 'other: successful treatment' or 'other: end of study'|4388
8605294|NCT00388674|9641858|FG001|COMPLETED|Initial Treatment|"Completed=discontinued initial treatment reason of successful treatment or end of study"|3576
8605295|NCT00388674|9641857|FG000|NOT COMPLETED|Initial Treatment||1828
8605296|NCT00388674|9641858|FG001|NOT COMPLETED|Initial Treatment||2586
8605297|NCT00388674|9641857|FG000|STARTED|End of Study||6216
8605298|NCT00388674|9641858|FG001|STARTED|End of Study||6162
8605299|NCT00388674|9641857|FG000|COMPLETED|End of Study|Completed=Reason of 'other: end of study'|4482
8605300|NCT00388674|9641858|FG001|COMPLETED|End of Study|Completed=Reason of 'other: end of study'|3993
8605301|NCT00388674|9641857|FG000|NOT COMPLETED|End of Study||1734
8605302|NCT00388674|9641858|FG001|NOT COMPLETED|End of Study||2169
8605303|NCT00388726|9641866|FG000|STARTED|Overall Study||508
8605304|NCT00388726|9641867|FG001|STARTED|Overall Study||254
8605305|NCT00388726|9641866|FG000|COMPLETED|Overall Study||24
8605306|NCT00388726|9641867|FG001|COMPLETED|Overall Study||10
8605307|NCT00388726|9641866|FG000|NOT COMPLETED|Overall Study||484
8605308|NCT00388726|9641867|FG001|NOT COMPLETED|Overall Study||244
8605309|NCT00388804|9641875|FG000|STARTED|Overall Study||17
8605310|NCT00388804|9641876|FG001|STARTED|Overall Study||21
8605311|NCT00388804|9641875|FG000|COMPLETED|Overall Study||17
8605312|NCT00388804|9641876|FG001|COMPLETED|Overall Study||21
8605313|NCT00388804|9641875|FG000|NOT COMPLETED|Overall Study||0
8605314|NCT00388804|9641876|FG001|NOT COMPLETED|Overall Study||0
8605315|NCT00388947|9641882|FG000|STARTED|Overall Study||1590
8605316|NCT00388947|9641882|FG000|COMPLETED|Overall Study|47 patients excluded because no AMS prolapse device was noted.|1543
8605317|NCT00388947|9641882|FG000|NOT COMPLETED|Overall Study||47
8605318|NCT00388973|9641888|FG000|STARTED|Overall Study|Randomized|166
8605319|NCT00388973|9641889|FG001|STARTED|Overall Study|Randomized|172
8605320|NCT00388973|9641888|FG000|Completed Study|Overall Study||110
8605321|NCT00388973|9641889|FG001|Completed Study|Overall Study||114
8605322|NCT00388973|9641888|FG000|COMPLETED|Overall Study|Completed 9-week treatment and 2 week follow-up|110
8605323|NCT00388973|9641889|FG001|COMPLETED|Overall Study|Completed 9-week treatment and 2 week follow-up|114
8605324|NCT00388973|9641888|FG000|NOT COMPLETED|Overall Study||56
8605325|NCT00388973|9641889|FG001|NOT COMPLETED|Overall Study||58
8605326|NCT00389064|9641897|FG000|STARTED|Overall Study||223
8605327|NCT00389064|9641898|FG001|STARTED|Overall Study||227
8605328|NCT00389064|9641897|FG000|COMPLETED|Overall Study||178
8605329|NCT00389064|9641898|FG001|COMPLETED|Overall Study||168
8605330|NCT00389064|9641897|FG000|NOT COMPLETED|Overall Study||45
8605331|NCT00389064|9641898|FG001|NOT COMPLETED|Overall Study||59
8605332|NCT00389168|9641906|FG000|STARTED|Overall Study||56
8605333|NCT00389168|9641907|FG001|STARTED|Overall Study||58
8605334|NCT00389168|9641906|FG000|COMPLETED|Overall Study||47
8605335|NCT00389168|9641907|FG001|COMPLETED|Overall Study||53
8605336|NCT00389168|9641906|FG000|NOT COMPLETED|Overall Study||9
8605337|NCT00389168|9641907|FG001|NOT COMPLETED|Overall Study||5
8605338|NCT00389207|9641916|FG000|STARTED|Overall Study|3 patients were randomized to NVP QD but not treated and so not part of the Full Analysis Set (FAS)|188
8605339|NCT00389207|9641917|FG001|STARTED|Overall Study|4 patients were randomized to NVP BID but not treated and so are not part of the FAS|188
8605340|NCT00389207|9641918|FG002|STARTED|Overall Study||193
8605341|NCT00389207|9641916|FG000|COMPLETED|Overall Study||125
8605342|NCT00389207|9641917|FG001|COMPLETED|Overall Study||116
8605343|NCT00389207|9641918|FG002|COMPLETED|Overall Study||152
8605344|NCT00389207|9641916|FG000|NOT COMPLETED|Overall Study||63
8605345|NCT00389207|9641917|FG001|NOT COMPLETED|Overall Study||72
8605346|NCT00389207|9641918|FG002|NOT COMPLETED|Overall Study||41
8605347|NCT00389324|9641931|FG000|STARTED|Run-In Phase||21
8605348|NCT00389324|9641931|FG000|COMPLETED|Run-In Phase||18
8605349|NCT00389324|9641931|FG000|NOT COMPLETED|Run-In Phase||3
8605350|NCT00389324|9641931|FG000|STARTED|Intravenous Phase|18 subjects entered from the Run-in Phase and 14 new participants entered directly|32
8605351|NCT00389324|9641931|FG000|COMPLETED|Intravenous Phase||32
8605352|NCT00389324|9641931|FG000|NOT COMPLETED|Intravenous Phase||0
8605353|NCT00389324|9641931|FG000|STARTED|Subcutaneous Phase||32
8605354|NCT00389324|9641931|FG000|COMPLETED|Subcutaneous Phase||25
8605355|NCT00389324|9641931|FG000|NOT COMPLETED|Subcutaneous Phase||7
8605356|NCT00389441|9641938|FG000|STARTED|Overall Study||52
8605357|NCT00389441|9641938|FG000|COMPLETED|Overall Study||0
8605358|NCT00389441|9641938|FG000|NOT COMPLETED|Overall Study||52
8605359|NCT00389467|9641946|FG000|STARTED|Overall Study||34
8605360|NCT00389467|9641947|FG001|STARTED|Overall Study||34
8605361|NCT00389467|9641948|FG002|STARTED|Overall Study||30
8605362|NCT00389467|9641949|FG003|STARTED|Overall Study||20
8605363|NCT00389467|9641946|FG000|COMPLETED|Overall Study||34
8605364|NCT00389467|9641947|FG001|COMPLETED|Overall Study||34
8605365|NCT00389467|9641948|FG002|COMPLETED|Overall Study||30
8605366|NCT00389467|9641949|FG003|COMPLETED|Overall Study||20
8605367|NCT00389467|9641946|FG000|NOT COMPLETED|Overall Study||0
8605368|NCT00389467|9641947|FG001|NOT COMPLETED|Overall Study||0
8605369|NCT00389467|9641948|FG002|NOT COMPLETED|Overall Study||0
8605370|NCT00389467|9641949|FG003|NOT COMPLETED|Overall Study||0
8605371|NCT00389493|9641963|FG000|STARTED|Overall Study||40
8605372|NCT00389493|9641964|FG001|STARTED|Overall Study||40
8605373|NCT00389493|9641965|FG002|STARTED|Overall Study||20
8605374|NCT00389493|9641963|FG000|COMPLETED|Overall Study||37
8605375|NCT00389493|9641964|FG001|COMPLETED|Overall Study||32
8605376|NCT00389493|9641965|FG002|COMPLETED|Overall Study||17
8605377|NCT00389493|9641963|FG000|NOT COMPLETED|Overall Study||3
8605378|NCT00389493|9641964|FG001|NOT COMPLETED|Overall Study||8
8605379|NCT00389493|9641965|FG002|NOT COMPLETED|Overall Study||3
8605380|NCT00389519|9641980|FG000|STARTED|Placebo Run-In||422
8605381|NCT00389519|9641981|FG001|STARTED|Placebo Run-In||0
8605382|NCT00389519|9641982|FG002|STARTED|Placebo Run-In||0
8605383|NCT00389519|9641983|FG003|STARTED|Placebo Run-In||0
8605384|NCT00389519|9641980|FG000|COMPLETED|Placebo Run-In||244
8605385|NCT00389519|9641981|FG001|COMPLETED|Placebo Run-In||0
8605386|NCT00389519|9641982|FG002|COMPLETED|Placebo Run-In||0
8605387|NCT00389519|9641983|FG003|COMPLETED|Placebo Run-In||0
8605388|NCT00389519|9641980|FG000|NOT COMPLETED|Placebo Run-In||178
8605389|NCT00389519|9641981|FG001|NOT COMPLETED|Placebo Run-In||0
8605390|NCT00389519|9641982|FG002|NOT COMPLETED|Placebo Run-In||0
8605391|NCT00389519|9641983|FG003|NOT COMPLETED|Placebo Run-In||0
8605392|NCT00389519|9641980|FG000|STARTED|Randomized||83
8605393|NCT00389519|9641981|FG001|STARTED|Randomized||41
8605394|NCT00389519|9641982|FG002|STARTED|Randomized||40
8605395|NCT00389519|9641983|FG003|STARTED|Randomized||80
8605396|NCT00389519|9641980|FG000|COMPLETED|Randomized||81
8605397|NCT00389519|9641981|FG001|COMPLETED|Randomized||41
8605398|NCT00389519|9641982|FG002|COMPLETED|Randomized||40
8605399|NCT00389519|9641983|FG003|COMPLETED|Randomized||80
8605400|NCT00389519|9641980|FG000|NOT COMPLETED|Randomized||2
8605401|NCT00389519|9641981|FG001|NOT COMPLETED|Randomized||0
8605402|NCT00389519|9641982|FG002|NOT COMPLETED|Randomized||0
8605403|NCT00389519|9641983|FG003|NOT COMPLETED|Randomized||0
8605404|NCT00389519|9641980|FG000|STARTED|Treated||81
8605405|NCT00389519|9641981|FG001|STARTED|Treated||41
8605406|NCT00389519|9641982|FG002|STARTED|Treated||40
8605407|NCT00389519|9641983|FG003|STARTED|Treated||80
8605408|NCT00389519|9641980|FG000|COMPLETED|Treated||79
8605409|NCT00389519|9641981|FG001|COMPLETED|Treated||40
8605410|NCT00389519|9641982|FG002|COMPLETED|Treated||40
8605411|NCT00389519|9641983|FG003|COMPLETED|Treated||76
8605412|NCT00389519|9641980|FG000|NOT COMPLETED|Treated||2
8605413|NCT00389519|9641981|FG001|NOT COMPLETED|Treated||1
8605414|NCT00389519|9641982|FG002|NOT COMPLETED|Treated||0
8605415|NCT00389519|9641983|FG003|NOT COMPLETED|Treated||4
8605416|NCT00389532|9641995|FG000|STARTED|Overall Study||60
8605417|NCT00389532|9641996|FG001|STARTED|Overall Study||56
8605418|NCT00389532|9641995|FG000|COMPLETED|Overall Study|3 of the participants did not have valid post-vaccination serological results|60
8605419|NCT00389532|9641996|FG001|COMPLETED|Overall Study||56
8605420|NCT00389532|9641995|FG000|NOT COMPLETED|Overall Study||0
8605421|NCT00389532|9641996|FG001|NOT COMPLETED|Overall Study||0
8605422|NCT00389597|9642006|FG000|STARTED|Overall Study||164
8605423|NCT00389597|9642007|FG001|STARTED|Overall Study||81
8605424|NCT00389597|9642008|FG002|STARTED|Overall Study||225
8605425|NCT00389597|9642009|FG003|STARTED|Overall Study||105
8605426|NCT00389597|9642006|FG000|24 mo|Overall Study||156
8605427|NCT00389597|9642007|FG001|24 mo|Overall Study||75
8605428|NCT00389597|9642008|FG002|24 mo|Overall Study||221
8605429|NCT00389597|9642009|FG003|24 mo|Overall Study||99
8605430|NCT00389597|9642006|FG000|COMPLETED|Overall Study||156
8605431|NCT00389597|9642007|FG001|COMPLETED|Overall Study||75
8605432|NCT00389597|9642008|FG002|COMPLETED|Overall Study||221
8605433|NCT00389597|9642009|FG003|COMPLETED|Overall Study||99
8605434|NCT00389597|9642006|FG000|NOT COMPLETED|Overall Study||8
8605435|NCT00389597|9642007|FG001|NOT COMPLETED|Overall Study||6
8605436|NCT00389597|9642008|FG002|NOT COMPLETED|Overall Study||4
8605437|NCT00389597|9642009|FG003|NOT COMPLETED|Overall Study||6
8605438|NCT00389805|9642021|FG000|STARTED|Phase I||15
8605439|NCT00389805|9642022|FG001|STARTED|Phase I||12
8605440|NCT00389805|9642021|FG000|COMPLETED|Phase I||15
8605441|NCT00389805|9642022|FG001|COMPLETED|Phase I||12
8605442|NCT00389805|9642021|FG000|NOT COMPLETED|Phase I||0
8605443|NCT00389805|9642022|FG001|NOT COMPLETED|Phase I||0
8605444|NCT00389805|9642021|FG000|STARTED|Phase II|The Phase II study was not conducted.|0
8605445|NCT00389805|9642022|FG001|STARTED|Phase II|The Phase II study was not conducted.|0
8605446|NCT00389805|9642021|FG000|COMPLETED|Phase II||0
8605447|NCT00389805|9642022|FG001|COMPLETED|Phase II||0
8605448|NCT00389805|9642021|FG000|NOT COMPLETED|Phase II||0
8605449|NCT00389805|9642022|FG001|NOT COMPLETED|Phase II||0
8605450|NCT00389818|9642028|FG000|STARTED|Overall Study||43
8605451|NCT00389818|9642028|FG000|COMPLETED|Overall Study||40
8605452|NCT00389818|9642028|FG000|NOT COMPLETED|Overall Study||3
8605453|NCT00389831|9642034|FG000|STARTED|Overall Study||10
8605454|NCT00389831|9642035|FG001|STARTED|Overall Study||34
8605455|NCT00389831|9642034|FG000|COMPLETED|Overall Study||10
8605456|NCT00389831|9642035|FG001|COMPLETED|Overall Study||27
8605457|NCT00389831|9642034|FG000|NOT COMPLETED|Overall Study||0
8605458|NCT00389831|9642035|FG001|NOT COMPLETED|Overall Study||7
8605459|NCT00389857|9642055|FG000|STARTED|Overall Study||14
8605460|NCT00389857|9642056|FG001|STARTED|Overall Study||17
8605461|NCT00389857|9642055|FG000|COMPLETED|Overall Study||14
8605462|NCT00389857|9642056|FG001|COMPLETED|Overall Study||17
8605463|NCT00389857|9642055|FG000|NOT COMPLETED|Overall Study||0
8605464|NCT00389857|9642056|FG001|NOT COMPLETED|Overall Study||0
8605465|NCT00389974|9642062|FG000|STARTED|Overall Study||19
8605466|NCT00389974|9642062|FG000|COMPLETED|Overall Study||19
8605467|NCT00389974|9642062|FG000|NOT COMPLETED|Overall Study||0
8605468|NCT00390013|9642069|FG000|STARTED|Phase 1||0
8605469|NCT00390013|9642070|FG001|STARTED|Phase 1||0
8605470|NCT00390013|9642071|FG002|STARTED|Phase 1||2
8605471|NCT00390013|9642072|FG003|STARTED|Phase 1||2
8605472|NCT00390013|9642069|FG000|COMPLETED|Phase 1||0
8605473|NCT00390013|9642070|FG001|COMPLETED|Phase 1||0
8605474|NCT00390013|9642071|FG002|COMPLETED|Phase 1||2
8605475|NCT00390013|9642072|FG003|COMPLETED|Phase 1||1
8605476|NCT00390013|9642069|FG000|NOT COMPLETED|Phase 1||0
8605477|NCT00390013|9642070|FG001|NOT COMPLETED|Phase 1||0
8605478|NCT00390013|9642071|FG002|NOT COMPLETED|Phase 1||0
8605479|NCT00390013|9642072|FG003|NOT COMPLETED|Phase 1||1
8605480|NCT00390013|9642069|FG000|STARTED|Phase 2 First Treatment||3
8605481|NCT00390013|9642070|FG001|STARTED|Phase 2 First Treatment||2
8605482|NCT00390013|9642071|FG002|STARTED|Phase 2 First Treatment||0
8605483|NCT00390013|9642072|FG003|STARTED|Phase 2 First Treatment||0
8605484|NCT00390013|9642069|FG000|COMPLETED|Phase 2 First Treatment||2
8605485|NCT00390013|9642070|FG001|COMPLETED|Phase 2 First Treatment||1
8605486|NCT00390013|9642071|FG002|COMPLETED|Phase 2 First Treatment||0
8605487|NCT00390013|9642072|FG003|COMPLETED|Phase 2 First Treatment||0
8605488|NCT00390013|9642069|FG000|NOT COMPLETED|Phase 2 First Treatment||1
8605489|NCT00390013|9642070|FG001|NOT COMPLETED|Phase 2 First Treatment||1
8605490|NCT00390013|9642071|FG002|NOT COMPLETED|Phase 2 First Treatment||0
8605491|NCT00390013|9642072|FG003|NOT COMPLETED|Phase 2 First Treatment||0
8605492|NCT00390013|9642069|FG000|STARTED|Phase 2 Second Treatment||2
8605493|NCT00390013|9642070|FG001|STARTED|Phase 2 Second Treatment||1
8605494|NCT00390013|9642071|FG002|STARTED|Phase 2 Second Treatment||0
8605495|NCT00390013|9642072|FG003|STARTED|Phase 2 Second Treatment||0
8605496|NCT00390013|9642069|FG000|COMPLETED|Phase 2 Second Treatment||2
8605497|NCT00390013|9642070|FG001|COMPLETED|Phase 2 Second Treatment||1
8605498|NCT00390013|9642071|FG002|COMPLETED|Phase 2 Second Treatment||0
8605499|NCT00390013|9642072|FG003|COMPLETED|Phase 2 Second Treatment||0
8605500|NCT00390013|9642069|FG000|NOT COMPLETED|Phase 2 Second Treatment||0
8605501|NCT00390013|9642070|FG001|NOT COMPLETED|Phase 2 Second Treatment||0
8605502|NCT00390013|9642071|FG002|NOT COMPLETED|Phase 2 Second Treatment||0
8605503|NCT00390013|9642072|FG003|NOT COMPLETED|Phase 2 Second Treatment||0
8605504|NCT00390182|9642078|FG000|STARTED|Overall Study||38
8605505|NCT00390182|9642078|FG000|COMPLETED|Overall Study||33
8605506|NCT00390182|9642078|FG000|NOT COMPLETED|Overall Study||5
8605507|NCT00390221|9642085|FG000|STARTED|Overall Study||204
8605508|NCT00390221|9642086|FG001|STARTED|Overall Study||208
8605509|NCT00390221|9642087|FG002|STARTED|Overall Study||209
8605510|NCT00390221|9642085|FG000|COMPLETED|Overall Study||186
8605511|NCT00390221|9642086|FG001|COMPLETED|Overall Study||188
8605512|NCT00390221|9642087|FG002|COMPLETED|Overall Study||194
8605513|NCT00390221|9642085|FG000|NOT COMPLETED|Overall Study||18
8605514|NCT00390221|9642086|FG001|NOT COMPLETED|Overall Study||20
8605515|NCT00390221|9642087|FG002|NOT COMPLETED|Overall Study||15
8605516|NCT00390234|9642096|FG000|STARTED|Overall Study||63
8605517|NCT00390234|9642096|FG000|COMPLETED|Overall Study||63
8605518|NCT00390234|9642096|FG000|NOT COMPLETED|Overall Study||0
8605519|NCT00390299|9642106|FG000|STARTED|Overall Study||4
8605520|NCT00390299|9642107|FG001|STARTED|Overall Study||3
8605521|NCT00390299|9642108|FG002|STARTED|Overall Study||3
8605522|NCT00390299|9642109|FG003|STARTED|Overall Study||3
8605523|NCT00390299|9642110|FG004|STARTED|Overall Study||10
8605524|NCT00390299|9642106|FG000|COMPLETED|Overall Study||3
8605525|NCT00390299|9642107|FG001|COMPLETED|Overall Study||3
8605526|NCT00390299|9642108|FG002|COMPLETED|Overall Study||3
8605527|NCT00390299|9642109|FG003|COMPLETED|Overall Study||3
8605528|NCT00390299|9642110|FG004|COMPLETED|Overall Study||10
8605529|NCT00390299|9642106|FG000|NOT COMPLETED|Overall Study||1
8605530|NCT00390299|9642107|FG001|NOT COMPLETED|Overall Study||0
8605531|NCT00390299|9642108|FG002|NOT COMPLETED|Overall Study||0
8605532|NCT00390299|9642109|FG003|NOT COMPLETED|Overall Study||0
8605533|NCT00390299|9642110|FG004|NOT COMPLETED|Overall Study||0
8605534|NCT00390364|9642124|FG000|STARTED|Overall Study||1
8605535|NCT00390364|9642124|FG000|COMPLETED|Overall Study||1
8605536|NCT00390364|9642124|FG000|NOT COMPLETED|Overall Study||0
8605537|NCT00390416|9642128|FG000|STARTED|Overall Study||48
8605538|NCT00390416|9642128|FG000|COMPLETED|Overall Study||44
8605539|NCT00390416|9642128|FG000|NOT COMPLETED|Overall Study||4
8605540|NCT00390429|9642135|FG000|STARTED|Overall Study||5
8605541|NCT00390429|9642136|FG001|STARTED|Overall Study||12
8605542|NCT00390429|9642137|FG002|STARTED|Overall Study||25
8605543|NCT00390429|9642138|FG003|STARTED|Overall Study||39
8605544|NCT00390429|9642135|FG000|COMPLETED|Overall Study||5
8605545|NCT00390429|9642136|FG001|COMPLETED|Overall Study||12
8605546|NCT00390429|9642137|FG002|COMPLETED|Overall Study||25
8605547|NCT00390429|9642138|FG003|COMPLETED|Overall Study||39
8605548|NCT00390429|9642135|FG000|NOT COMPLETED|Overall Study||0
8605549|NCT00390429|9642136|FG001|NOT COMPLETED|Overall Study||0
8605550|NCT00390429|9642137|FG002|NOT COMPLETED|Overall Study||0
8605551|NCT00390429|9642138|FG003|NOT COMPLETED|Overall Study||0
8605552|NCT00390455|9642151|FG000|STARTED|Overall Study||148
8605553|NCT00390455|9642152|FG001|STARTED|Overall Study||147
8605554|NCT00390455|9642151|FG000|COMPLETED|Overall Study||116
8605555|NCT00390455|9642152|FG001|COMPLETED|Overall Study||124
8605556|NCT00390455|9642151|FG000|NOT COMPLETED|Overall Study||32
8605557|NCT00390455|9642152|FG001|NOT COMPLETED|Overall Study||23
8605558|NCT00390468|9642158|FG000|STARTED|Overall Study||18
8605559|NCT00390468|9642158|FG000|COMPLETED|Overall Study||15
8605560|NCT00390468|9642158|FG000|NOT COMPLETED|Overall Study||3
8605561|NCT00390546|9642164|FG000|STARTED|Overall Study||33
8605562|NCT00390546|9642165|FG001|STARTED|Overall Study||39
8605563|NCT00390546|9642164|FG000|COMPLETED|Overall Study||27
8605564|NCT00390546|9642165|FG001|COMPLETED|Overall Study||34
8605565|NCT00390546|9642164|FG000|NOT COMPLETED|Overall Study||6
8605566|NCT00390546|9642165|FG001|NOT COMPLETED|Overall Study||5
8605567|NCT00390559|9642172|FG000|STARTED|Overall Study||124
8605568|NCT00390559|9642172|FG000|Received PlaceboP/Active C|Overall Study||93
8605569|NCT00390559|9642172|FG000|ActiveP/ActiveC|Overall Study||87
8605570|NCT00390559|9642172|FG000|PlaceboP/PlaceboC|Overall Study||93
8605571|NCT00390559|9642172|FG000|ActiveP/PlaceboC|Overall Study||90
8605572|NCT00390559|9642172|FG000|COMPLETED|Overall Study||80
8605573|NCT00390559|9642172|FG000|NOT COMPLETED|Overall Study||44
8605574|NCT00390572|9642184|FG000|STARTED|Overall Study||68
8605575|NCT00390572|9642185|FG001|STARTED|Overall Study||69
8605576|NCT00390572|9642184|FG000|COMPLETED|Overall Study||60
8605577|NCT00390572|9642185|FG001|COMPLETED|Overall Study||64
8605578|NCT00390572|9642184|FG000|NOT COMPLETED|Overall Study||8
8605579|NCT00390572|9642185|FG001|NOT COMPLETED|Overall Study||5
8605580|NCT00390611|9642193|FG000|STARTED|6 Cycles of Study Treatment||43
8605581|NCT00390611|9642194|FG001|STARTED|6 Cycles of Study Treatment||42
8605582|NCT00390611|9642193|FG000|COMPLETED|6 Cycles of Study Treatment||34
8605583|NCT00390611|9642194|FG001|COMPLETED|6 Cycles of Study Treatment||37
8605584|NCT00390611|9642193|FG000|NOT COMPLETED|6 Cycles of Study Treatment||9
8605585|NCT00390611|9642194|FG001|NOT COMPLETED|6 Cycles of Study Treatment||5
8605586|NCT00390611|9642193|FG000|STARTED|Maintenance Sorafenib to Month 12|11 patients came off-study between the end of cycle 6 and the start of maintenance|23
8605587|NCT00390611|9642194|FG001|STARTED|Maintenance Sorafenib to Month 12|Patients in the Paclitaxel/carboplatin arm did not recieve maintenance sorafenib|0
8605588|NCT00390611|9642193|FG000|COMPLETED|Maintenance Sorafenib to Month 12||13
8605589|NCT00390611|9642194|FG001|COMPLETED|Maintenance Sorafenib to Month 12||0
8605590|NCT00390611|9642193|FG000|NOT COMPLETED|Maintenance Sorafenib to Month 12||10
8605591|NCT00390611|9642194|FG001|NOT COMPLETED|Maintenance Sorafenib to Month 12||0
8605592|NCT00390689|9642205|FG000|STARTED|Overall Study||48
8605593|NCT00390689|9642206|FG001|STARTED|Overall Study||53
8605594|NCT00390689|9642207|FG002|STARTED|Overall Study||53
8605595|NCT00390689|9642205|FG000|COMPLETED|Overall Study||43
8605596|NCT00390689|9642206|FG001|COMPLETED|Overall Study||48
8605597|NCT00390689|9642207|FG002|COMPLETED|Overall Study||50
8605598|NCT00390689|9642205|FG000|NOT COMPLETED|Overall Study||5
8605599|NCT00390689|9642206|FG001|NOT COMPLETED|Overall Study||5
8605600|NCT00390689|9642207|FG002|NOT COMPLETED|Overall Study||3
8605601|NCT00390780|9642226|FG000|STARTED|Overall Study||291
8605602|NCT00390780|9642227|FG001|STARTED|Overall Study||287
8605603|NCT00390780|9642226|FG000|Treatment|Overall Study|One patient randomized to miconazole lost study drug, never started treatment, and was discontinued.|290
8605604|NCT00390780|9642227|FG001|Treatment|Overall Study||287
8605605|NCT00390780|9642226|FG000|COMPLETED|Overall Study||268
8605606|NCT00390780|9642227|FG001|COMPLETED|Overall Study||260
8605607|NCT00390780|9642226|FG000|NOT COMPLETED|Overall Study||23
8605608|NCT00390780|9642227|FG001|NOT COMPLETED|Overall Study||27
8605609|NCT00390806|9642235|FG000|STARTED|Overall Study||236
8605610|NCT00390806|9642236|FG001|STARTED|Overall Study||236
8605611|NCT00390806|9642235|FG000|Ongoing|Overall Study||4
8605612|NCT00390806|9642236|FG001|Ongoing|Overall Study||2
8605613|NCT00390806|9642235|FG000|COMPLETED|Overall Study||206
8605614|NCT00390806|9642236|FG001|COMPLETED|Overall Study||204
8605615|NCT00390806|9642235|FG000|NOT COMPLETED|Overall Study||30
8605616|NCT00390806|9642236|FG001|NOT COMPLETED|Overall Study||32
8605617|NCT00390858|9642244|FG000|STARTED|Overall Study|20 participants started the Core Study|20
8605618|NCT00390858|9642245|FG001|STARTED|Overall Study|20 Participants started the Core Study|20
8605619|NCT00390858|9642244|FG000|Completed Core & Entered Extension Study|Overall Study||19
8605620|NCT00390858|9642245|FG001|Completed Core & Entered Extension Study|Overall Study||20
8605621|NCT00390858|9642244|FG000|COMPLETED|Overall Study|11 participants Completed the Extension Study|11
8605622|NCT00390858|9642245|FG001|COMPLETED|Overall Study|13 Participants completed the Extension Study|13
8605623|NCT00390858|9642244|FG000|NOT COMPLETED|Overall Study||9
8605624|NCT00390858|9642245|FG001|NOT COMPLETED|Overall Study||7
8605625|NCT00390884|9642253|FG000|STARTED|Overall Study||116
8605626|NCT00390884|9642254|FG001|STARTED|Overall Study||57
8605627|NCT00390884|9642253|FG000|COMPLETED|Overall Study||114
8605628|NCT00390884|9642254|FG001|COMPLETED|Overall Study||55
8605629|NCT00390884|9642253|FG000|NOT COMPLETED|Overall Study||2
8605630|NCT00390884|9642254|FG001|NOT COMPLETED|Overall Study||2
8605631|NCT00390910|9642263|FG000|STARTED|Overall Study||50
8605632|NCT00390910|9642264|FG001|STARTED|Overall Study||87
8605633|NCT00390910|9642265|FG002|STARTED|Overall Study||149
8605634|NCT00390910|9642263|FG000|COMPLETED|Overall Study||48
8605635|NCT00390910|9642264|FG001|COMPLETED|Overall Study||83
8605636|NCT00390910|9642265|FG002|COMPLETED|Overall Study||139
8605637|NCT00390910|9642263|FG000|NOT COMPLETED|Overall Study||2
8605638|NCT00390910|9642264|FG001|NOT COMPLETED|Overall Study||4
8605639|NCT00390910|9642265|FG002|NOT COMPLETED|Overall Study||10
8605640|NCT00390949|9642277|FG000|STARTED|Overall Study||4662
8605641|NCT00390949|9642278|FG001|STARTED|Overall Study||4792
8605642|NCT00390949|9642277|FG000|COMPLETED|Overall Study||2564
8605643|NCT00390949|9642278|FG001|COMPLETED|Overall Study||2664
8605644|NCT00390949|9642277|FG000|NOT COMPLETED|Overall Study||2098
8605645|NCT00390949|9642278|FG001|NOT COMPLETED|Overall Study||2128
8605646|NCT00391027|9642286|FG000|STARTED|Overall Study|Full Analysis Set = 134; 1 subject excluded; missing a baseline or postbaseline HbA1c measurement.|135
8605647|NCT00391027|9642287|FG001|STARTED|Overall Study|Full Analysis Set = 121; 1 subject excluded; missing a baseline or postbaseline HbA1c measurement.|122
8605648|NCT00391027|9642286|FG000|COMPLETED|Overall Study||110
8605649|NCT00391027|9642287|FG001|COMPLETED|Overall Study||110
8605650|NCT00391027|9642286|FG000|NOT COMPLETED|Overall Study||25
8605651|NCT00391027|9642287|FG001|NOT COMPLETED|Overall Study||12
8605652|NCT00391053|9642297|FG000|STARTED|Overall Study||857
8605653|NCT00391053|9642298|FG001|STARTED|Overall Study||848
8605654|NCT00391053|9642299|FG002|STARTED|Overall Study||870
8605655|NCT00391053|9642300|FG003|STARTED|Overall Study||1262
8605656|NCT00391053|9642297|FG000|COMPLETED|Overall Study||848
8605657|NCT00391053|9642298|FG001|COMPLETED|Overall Study||847
8605658|NCT00391053|9642299|FG002|COMPLETED|Overall Study||868
8605659|NCT00391053|9642300|FG003|COMPLETED|Overall Study||1252
8605660|NCT00391053|9642297|FG000|NOT COMPLETED|Overall Study||9
8605661|NCT00391053|9642298|FG001|NOT COMPLETED|Overall Study||1
8605662|NCT00391053|9642299|FG002|NOT COMPLETED|Overall Study||2
8605663|NCT00391053|9642300|FG003|NOT COMPLETED|Overall Study||10
8605664|NCT00391079|9642312|FG000|STARTED|Overall Study||167
8605665|NCT00391079|9642313|FG001|STARTED|Overall Study||172
8605666|NCT00391079|9642312|FG000|COMPLETED|Overall Study||141
8605667|NCT00391079|9642313|FG001|COMPLETED|Overall Study||156
8605668|NCT00391079|9642312|FG000|NOT COMPLETED|Overall Study||26
8605669|NCT00391079|9642313|FG001|NOT COMPLETED|Overall Study||16
8605670|NCT00391092|9642321|FG000|STARTED|Overall Study||208
8605671|NCT00391092|9642322|FG001|STARTED|Overall Study||216
8605672|NCT00391092|9642321|FG000|Received Treatment|Overall Study||206
8605673|NCT00391092|9642322|FG001|Received Treatment|Overall Study||215
8605674|NCT00391092|9642321|FG000|COMPLETED|Overall Study|This was using a data cutoff of 30 June 2011.|0
8605675|NCT00391092|9642322|FG001|COMPLETED|Overall Study|This was using a data cutoff of 30 June 2011.|0
8605676|NCT00391092|9642321|FG000|NOT COMPLETED|Overall Study||208
8605677|NCT00391092|9642322|FG001|NOT COMPLETED|Overall Study||216
8605678|NCT00391118|9642331|FG000|STARTED|Overall Study||11
8605679|NCT00391118|9642332|FG001|STARTED|Overall Study||69
8605680|NCT00391118|9642333|FG002|STARTED|Overall Study||73
8605681|NCT00391118|9642331|FG000|Received ≥1 Dose of Assigned Study Drug|Overall Study||11
8605682|NCT00391118|9642332|FG001|Received ≥1 Dose of Assigned Study Drug|Overall Study||67
8605683|NCT00391118|9642333|FG002|Received ≥1 Dose of Assigned Study Drug|Overall Study||72
8605684|NCT00391118|9642331|FG000|COMPLETED|Overall Study||0
8605685|NCT00391118|9642332|FG001|COMPLETED|Overall Study||14
8605686|NCT00391118|9642333|FG002|COMPLETED|Overall Study||15
8605687|NCT00391118|9642331|FG000|NOT COMPLETED|Overall Study||11
8605688|NCT00391118|9642332|FG001|NOT COMPLETED|Overall Study||55
8605689|NCT00391118|9642333|FG002|NOT COMPLETED|Overall Study||58
8605690|NCT00391222|9642347|FG000|STARTED|Period II (Open-label Risperidone LAI)||0
8605691|NCT00391222|9642348|FG001|STARTED|Period II (Open-label Risperidone LAI)||0
8605692|NCT00391222|9642349|FG002|STARTED|Period II (Open-label Risperidone LAI)||0
8605693|NCT00391222|9642350|FG003|STARTED|Period II (Open-label Risperidone LAI)|The 25 patients at the site of Dr. Parikh were excluded from the analysis due to GCP non-compliance|560
8605694|NCT00391222|9642347|FG000|COMPLETED|Period II (Open-label Risperidone LAI)||0
8605695|NCT00391222|9642348|FG001|COMPLETED|Period II (Open-label Risperidone LAI)||0
8605696|NCT00391222|9642349|FG002|COMPLETED|Period II (Open-label Risperidone LAI)||0
8605697|NCT00391222|9642350|FG003|COMPLETED|Period II (Open-label Risperidone LAI)||398
8605698|NCT00391222|9642347|FG000|NOT COMPLETED|Period II (Open-label Risperidone LAI)||0
8605699|NCT00391222|9642348|FG001|NOT COMPLETED|Period II (Open-label Risperidone LAI)||0
8605700|NCT00391222|9642349|FG002|NOT COMPLETED|Period II (Open-label Risperidone LAI)||0
8605701|NCT00391222|9642350|FG003|NOT COMPLETED|Period II (Open-label Risperidone LAI)||162
8605702|NCT00391222|9642347|FG000|STARTED|Period III (Double-Blind Treatment)|Patients were randomized to one of 3 arms in Period III, after completing open-label Period II|132
8605703|NCT00391222|9642348|FG001|STARTED|Period III (Double-Blind Treatment)|Patients were randomized to one of 3 arms in Period III, after completing open-label Period II|135
8605704|NCT00391222|9642349|FG002|STARTED|Period III (Double-Blind Treatment)|Patients were randomized to one of 3 arms in Period III, after completing open-label Period II|131
8605705|NCT00391222|9642350|FG003|STARTED|Period III (Double-Blind Treatment)||0
8605706|NCT00391222|9642347|FG000|COMPLETED|Period III (Double-Blind Treatment)||104
8605707|NCT00391222|9642348|FG001|COMPLETED|Period III (Double-Blind Treatment)||113
8605708|NCT00391222|9642349|FG002|COMPLETED|Period III (Double-Blind Treatment)||108
8605709|NCT00391222|9642350|FG003|COMPLETED|Period III (Double-Blind Treatment)||0
8605710|NCT00391222|9642347|FG000|NOT COMPLETED|Period III (Double-Blind Treatment)||28
8605711|NCT00391222|9642348|FG001|NOT COMPLETED|Period III (Double-Blind Treatment)||22
8605712|NCT00391222|9642349|FG002|NOT COMPLETED|Period III (Double-Blind Treatment)||23
8605713|NCT00391222|9642350|FG003|NOT COMPLETED|Period III (Double-Blind Treatment)||0
8605714|NCT00391274|9642362|FG000|STARTED|Overall Study||107
8605715|NCT00391274|9642363|FG001|STARTED|Overall Study||104
8605716|NCT00391274|9642362|FG000|Received at Least One Dose of Study Drug|Overall Study||106
8605717|NCT00391274|9642363|FG001|Received at Least One Dose of Study Drug|Overall Study||102
8605718|NCT00391274|9642362|FG000|COMPLETED|Overall Study||46
8605719|NCT00391274|9642363|FG001|COMPLETED|Overall Study||47
8605720|NCT00391274|9642362|FG000|NOT COMPLETED|Overall Study||61
8605721|NCT00391274|9642363|FG001|NOT COMPLETED|Overall Study||57
8605722|NCT00391391|9642373|FG000|STARTED|Overall Study|1 participant was not vaccinated.|98
8605723|NCT00391391|9642374|FG001|STARTED|Overall Study||97
8605724|NCT00391391|9642375|FG002|STARTED|Overall Study|1 participant was not vaccinated.|161
8605725|NCT00391391|9642376|FG003|STARTED|Overall Study|1 participant was not vaccinated.|164
8605726|NCT00391391|9642373|FG000|COMPLETED|Overall Study||89
8605727|NCT00391391|9642374|FG001|COMPLETED|Overall Study||87
8605728|NCT00391391|9642375|FG002|COMPLETED|Overall Study||138
8605729|NCT00391391|9642376|FG003|COMPLETED|Overall Study||145
8605730|NCT00391391|9642373|FG000|NOT COMPLETED|Overall Study||9
8605731|NCT00391391|9642374|FG001|NOT COMPLETED|Overall Study||10
8605732|NCT00391391|9642375|FG002|NOT COMPLETED|Overall Study||23
8605733|NCT00391391|9642376|FG003|NOT COMPLETED|Overall Study||19
8605734|NCT00391443|9642388|FG000|STARTED|Overall Study|1 patient in the bosentan arm did not receive treatment & was excluded from the Safety Population.|209
8605735|NCT00391443|9642389|FG001|STARTED|Overall Study||407
8605736|NCT00391443|9642388|FG000|COMPLETED|Overall Study||209
8605737|NCT00391443|9642389|FG001|COMPLETED|Overall Study||407
8605738|NCT00391443|9642388|FG000|NOT COMPLETED|Overall Study||0
8605739|NCT00391443|9642389|FG001|NOT COMPLETED|Overall Study||0
8605740|NCT00391469|9642399|FG000|STARTED|Overall Study||688
8605741|NCT00391469|9642400|FG001|STARTED|Overall Study||671
8605742|NCT00391469|9642399|FG000|COMPLETED|Overall Study|5 patients were found to be incarcerated at time of randomization, thus data was not included|688
8605743|NCT00391469|9642400|FG001|COMPLETED|Overall Study||671
8605744|NCT00391469|9642399|FG000|NOT COMPLETED|Overall Study||0
8605745|NCT00391469|9642400|FG001|NOT COMPLETED|Overall Study||0
8605746|NCT00391586|9642408|FG000|STARTED|Overall Study||45
8605747|NCT00391586|9642408|FG000|Received First-line Erlotinib|Overall Study|These patients received at least one dose of on-study first-line erlotinib|43
8628895|NCT00527514|9668471|FG000|COMPLETED|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg||132
8714294|NCT00979615|9761199|FG000|STARTED|Overall Study||63
8714295|NCT00979615|9761200|FG001|STARTED|Overall Study||66
8714296|NCT00979615|9761199|FG000|COMPLETED|Overall Study||57
8714297|NCT00979615|9761200|FG001|COMPLETED|Overall Study||58
8714298|NCT00979615|9761199|FG000|NOT COMPLETED|Overall Study||6
8714299|NCT00979615|9761200|FG001|NOT COMPLETED|Overall Study||8
8714300|NCT00979628|9761209|FG000|STARTED|Overall Study||153
8714301|NCT00979628|9761210|FG001|STARTED|Overall Study||142
8714302|NCT00979628|9761211|FG002|STARTED|Overall Study||80
8714303|NCT00979628|9761209|FG000|COMPLETED|Overall Study||144
8714304|NCT00979628|9761210|FG001|COMPLETED|Overall Study||133
8714305|NCT00979628|9761211|FG002|COMPLETED|Overall Study||74
8714306|NCT00979628|9761209|FG000|NOT COMPLETED|Overall Study||9
8714307|NCT00979628|9761210|FG001|NOT COMPLETED|Overall Study||9
8605748|NCT00391586|9642408|FG000|Received Platinum-based Chemotherapy|Overall Study|Total number of patients who received platinum-based chemotherapy after erlotinib treatment|10
8605749|NCT00391586|9642408|FG000|COMPLETED|Overall Study|These patients received at least 2 cycles of erlotinib|21
8605750|NCT00391586|9642408|FG000|NOT COMPLETED|Overall Study||24
8605751|NCT00391599|9642414|FG000|STARTED|Overall Study||65
8605752|NCT00391599|9642415|FG001|STARTED|Overall Study||65
8605753|NCT00391599|9642414|FG000|COMPLETED|Overall Study||65
8605754|NCT00391599|9642415|FG001|COMPLETED|Overall Study||65
8605755|NCT00391599|9642414|FG000|NOT COMPLETED|Overall Study||0
8605756|NCT00391599|9642415|FG001|NOT COMPLETED|Overall Study||0
8605757|NCT00391625|9642423|FG000|STARTED|Baseline||10
8605758|NCT00391625|9642423|FG000|COMPLETED|Baseline||10
8605759|NCT00391625|9642423|FG000|NOT COMPLETED|Baseline||0
8605760|NCT00391625|9642423|FG000|STARTED|Month 14||10
8605761|NCT00391625|9642423|FG000|COMPLETED|Month 14||9
8605762|NCT00391625|9642423|FG000|NOT COMPLETED|Month 14||1
8605763|NCT00391625|9642423|FG000|STARTED|Month 50||9
8605764|NCT00391625|9642423|FG000|COMPLETED|Month 50||8
8605765|NCT00391625|9642423|FG000|NOT COMPLETED|Month 50||1
8605766|NCT00391625|9642423|FG000|STARTED|Month 84||8
8605767|NCT00391625|9642423|FG000|COMPLETED|Month 84||8
8605768|NCT00391625|9642423|FG000|NOT COMPLETED|Month 84||0
8605769|NCT00391716|9642453|FG000|STARTED|Overall Study||54
8605770|NCT00391716|9642454|FG001|STARTED|Overall Study||47
8605771|NCT00391716|9642455|FG002|STARTED|Overall Study||49
8605772|NCT00391716|9642453|FG000|COMPLETED|Overall Study||27
8605773|NCT00391716|9642454|FG001|COMPLETED|Overall Study||28
8605774|NCT00391716|9642455|FG002|COMPLETED|Overall Study||30
8605775|NCT00391716|9642453|FG000|NOT COMPLETED|Overall Study||27
8605776|NCT00391716|9642454|FG001|NOT COMPLETED|Overall Study||19
8605777|NCT00391716|9642455|FG002|NOT COMPLETED|Overall Study||19
8605778|NCT00391768|9642470|FG000|STARTED|Overall Study||12
8605779|NCT00391768|9642471|FG001|STARTED|Overall Study||3
8605780|NCT00391768|9642472|FG002|STARTED|Overall Study||7
8605781|NCT00391768|9642473|FG003|STARTED|Overall Study||8
8605782|NCT00391768|9642474|FG004|STARTED|Overall Study||24
8605783|NCT00391768|9642475|FG005|STARTED|Overall Study||10
8605784|NCT00391768|9642476|FG006|STARTED|Overall Study||23
8605785|NCT00391768|9642470|FG000|COMPLETED|Overall Study||12
8605786|NCT00391768|9642471|FG001|COMPLETED|Overall Study||3
8605787|NCT00391768|9642472|FG002|COMPLETED|Overall Study||6
8605788|NCT00391768|9642473|FG003|COMPLETED|Overall Study||7
8605789|NCT00391768|9642474|FG004|COMPLETED|Overall Study||22
8605790|NCT00391768|9642475|FG005|COMPLETED|Overall Study||7
8605791|NCT00391768|9642476|FG006|COMPLETED|Overall Study||19
8605792|NCT00391768|9642470|FG000|NOT COMPLETED|Overall Study||0
8605793|NCT00391768|9642471|FG001|NOT COMPLETED|Overall Study||0
8605794|NCT00391768|9642472|FG002|NOT COMPLETED|Overall Study||1
8605795|NCT00391768|9642473|FG003|NOT COMPLETED|Overall Study||1
8605796|NCT00391768|9642474|FG004|NOT COMPLETED|Overall Study||2
8605797|NCT00391768|9642475|FG005|NOT COMPLETED|Overall Study||3
8605798|NCT00391768|9642476|FG006|NOT COMPLETED|Overall Study||4
8605799|NCT00391807|9642510|FG000|STARTED|Overall Study||1683
8605800|NCT00391807|9642510|FG000|COMPLETED|Overall Study||968
8605801|NCT00391807|9642510|FG000|NOT COMPLETED|Overall Study||715
8605802|NCT00391846|9642516|FG000|STARTED|Overall Study|Of the 127 randomised patients 8 were discontinued|127
8605803|NCT00391846|9642517|FG001|STARTED|Overall Study|Of th 125 randomised patients 7 were discontinued|125
8605804|NCT00391846|9642516|FG000|COMPLETED|Overall Study|119 completed patients includes 4 CV related deaths|119
8605805|NCT00391846|9642517|FG001|COMPLETED|Overall Study|118 completed patients includes 5 CV related deaths|118
8605806|NCT00391846|9642516|FG000|NOT COMPLETED|Overall Study||8
8605807|NCT00391846|9642517|FG001|NOT COMPLETED|Overall Study||7
8605808|NCT00391872|9642525|FG000|STARTED|Overall Study||9333
8605809|NCT00391872|9642526|FG001|STARTED|Overall Study||9291
8605810|NCT00391872|9642525|FG000|COMPLETED|Overall Study||9026
8605811|NCT00391872|9642526|FG001|COMPLETED|Overall Study||9036
8605812|NCT00391872|9642525|FG000|NOT COMPLETED|Overall Study||307
8605813|NCT00391872|9642526|FG001|NOT COMPLETED|Overall Study||255
8605814|NCT00391898|9642534|FG000|STARTED|Overall Study|Safety population for Levodopa/carbidopa/entacapone is 45, for Levodopa/carbidopa, per randomized.|46
8605815|NCT00391898|9642535|FG001|STARTED|Overall Study||49
8605816|NCT00391898|9642534|FG000|COMPLETED|Overall Study||35
8605817|NCT00391898|9642535|FG001|COMPLETED|Overall Study||39
8605818|NCT00391898|9642534|FG000|NOT COMPLETED|Overall Study||11
8605819|NCT00391898|9642535|FG001|NOT COMPLETED|Overall Study||10
8605820|NCT00391976|9642544|FG000|STARTED|Overall Study|Started indicates all patients who were enrolled at Visit 1|45
8605821|NCT00391976|9642545|FG001|STARTED|Overall Study||43
8605822|NCT00391976|9642546|FG002|STARTED|Overall Study||35
8605823|NCT00391976|9642544|FG000|Randomized|Overall Study|Randomization occurred after 28 days of treatment & negative antibody test aeruginosa antibody test|45
8605824|NCT00391976|9642545|FG001|Randomized|Overall Study||43
8605825|NCT00391976|9642546|FG002|Randomized|Overall Study||0
8605826|NCT00391976|9642544|FG000|Safety Population|Overall Study|Patients who were enrolled and received at least one dose of study medication.|44
8605827|NCT00391976|9642545|FG001|Safety Population|Overall Study||43
8605828|NCT00391976|9642546|FG002|Safety Population|Overall Study||35
8605829|NCT00391976|9642544|FG000|COMPLETED|Overall Study||18
8605830|NCT00391976|9642545|FG001|COMPLETED|Overall Study||18
8605831|NCT00391976|9642546|FG002|COMPLETED|Overall Study||0
8605832|NCT00391976|9642544|FG000|NOT COMPLETED|Overall Study||27
8605833|NCT00391976|9642545|FG001|NOT COMPLETED|Overall Study||25
8605834|NCT00391976|9642546|FG002|NOT COMPLETED|Overall Study||35
8605835|NCT00391989|9642556|FG000|STARTED|Overall Study||55
8605836|NCT00391989|9642556|FG000|COMPLETED|Overall Study||53
8605837|NCT00391989|9642556|FG000|NOT COMPLETED|Overall Study||2
8605838|NCT00392015|9642566|FG000|STARTED|Overall Study||6
8714308|NCT00979628|9761211|FG002|NOT COMPLETED|Overall Study||6
8714309|NCT00979654|9761222|FG000|STARTED|Overall Study||103
8714310|NCT00979654|9761222|FG000|COMPLETED|Overall Study||67
8714311|NCT00979654|9761222|FG000|NOT COMPLETED|Overall Study||36
8714312|NCT00979732|9761228|FG000|STARTED|Overall Study||15
8714313|NCT00979732|9761229|FG001|STARTED|Overall Study||18
8714314|NCT00979732|9761228|FG000|COMPLETED|Overall Study||12
8714315|NCT00979732|9761229|FG001|COMPLETED|Overall Study||17
8714316|NCT00979732|9761228|FG000|NOT COMPLETED|Overall Study||3
8605839|NCT00392015|9642567|FG001|STARTED|Overall Study||6
8605840|NCT00392015|9642568|FG002|STARTED|Overall Study||20
8605841|NCT00392015|9642569|FG003|STARTED|Overall Study||6
8605842|NCT00392015|9642570|FG004|STARTED|Overall Study||15
8605843|NCT00392015|9642571|FG005|STARTED|Overall Study||6
8605844|NCT00392015|9642566|FG000|COMPLETED|Overall Study||4
8605845|NCT00392015|9642567|FG001|COMPLETED|Overall Study||6
8605846|NCT00392015|9642568|FG002|COMPLETED|Overall Study||16
8605847|NCT00392015|9642569|FG003|COMPLETED|Overall Study||5
8605848|NCT00392015|9642570|FG004|COMPLETED|Overall Study||12
8605849|NCT00392015|9642571|FG005|COMPLETED|Overall Study||6
8605850|NCT00392015|9642566|FG000|NOT COMPLETED|Overall Study||2
8605851|NCT00392015|9642567|FG001|NOT COMPLETED|Overall Study||0
8605852|NCT00392015|9642568|FG002|NOT COMPLETED|Overall Study||4
8605853|NCT00392015|9642569|FG003|NOT COMPLETED|Overall Study||1
8605854|NCT00392015|9642570|FG004|NOT COMPLETED|Overall Study||3
8605855|NCT00392015|9642571|FG005|NOT COMPLETED|Overall Study||0
8605856|NCT00392041|9642592|FG000|STARTED|First 4 Weeks||19
8605857|NCT00392041|9642593|FG001|STARTED|First 4 Weeks||17
8605858|NCT00392041|9642592|FG000|COMPLETED|First 4 Weeks||11
8605859|NCT00392041|9642593|FG001|COMPLETED|First 4 Weeks||14
8605860|NCT00392041|9642592|FG000|NOT COMPLETED|First 4 Weeks||8
8605861|NCT00392041|9642593|FG001|NOT COMPLETED|First 4 Weeks||3
8605862|NCT00392041|9642592|FG000|STARTED|Weeks 5 - 12||11
8605863|NCT00392041|9642593|FG001|STARTED|Weeks 5 - 12||14
8605864|NCT00392041|9642592|FG000|COMPLETED|Weeks 5 - 12||7
8605865|NCT00392041|9642593|FG001|COMPLETED|Weeks 5 - 12||9
8605866|NCT00392041|9642592|FG000|NOT COMPLETED|Weeks 5 - 12||4
8605867|NCT00392041|9642593|FG001|NOT COMPLETED|Weeks 5 - 12||5
8605868|NCT00392054|9642601|FG000|STARTED|Overall Study|All participants randomized are included in final analysis|66
8605869|NCT00392054|9642602|FG001|STARTED|Overall Study|All participants randomized are included in final analysis|61
8605870|NCT00392054|9642601|FG000|Received Allocated Intervention|Overall Study||65
8605871|NCT00392054|9642602|FG001|Received Allocated Intervention|Overall Study||60
8605872|NCT00392054|9642601|FG000|COMPLETED|Overall Study||66
8605873|NCT00392054|9642602|FG001|COMPLETED|Overall Study||61
8605874|NCT00392054|9642601|FG000|NOT COMPLETED|Overall Study||0
8605875|NCT00392054|9642602|FG001|NOT COMPLETED|Overall Study||0
8605876|NCT00392171|9642612|FG000|STARTED|Overall Study||120
8605877|NCT00392171|9642612|FG000|COMPLETED|Overall Study||15
8605878|NCT00392171|9642612|FG000|NOT COMPLETED|Overall Study||105
8605879|NCT00392197|9642618|FG000|STARTED|Overall Study||48
8605880|NCT00392197|9642619|FG001|STARTED|Overall Study||63
8605881|NCT00392197|9642618|FG000|COMPLETED|Overall Study||27
8605882|NCT00392197|9642619|FG001|COMPLETED|Overall Study||33
8605883|NCT00392197|9642618|FG000|NOT COMPLETED|Overall Study||21
8605884|NCT00392197|9642619|FG001|NOT COMPLETED|Overall Study||30
8605885|NCT00392210|9642627|FG000|STARTED|First Voiding Trial||36
8605886|NCT00392210|9642628|FG001|STARTED|First Voiding Trial||33
8605887|NCT00392210|9642627|FG000|COMPLETED|First Voiding Trial||34
8605888|NCT00392210|9642628|FG001|COMPLETED|First Voiding Trial||31
8605889|NCT00392210|9642627|FG000|NOT COMPLETED|First Voiding Trial||2
8605890|NCT00392210|9642628|FG001|NOT COMPLETED|First Voiding Trial||2
8605891|NCT00392210|9642627|FG000|STARTED|Second Voiding Trial||34
8605892|NCT00392210|9642628|FG001|STARTED|Second Voiding Trial||31
8605893|NCT00392210|9642627|FG000|COMPLETED|Second Voiding Trial||34
8605894|NCT00392210|9642628|FG001|COMPLETED|Second Voiding Trial||31
8605895|NCT00392210|9642627|FG000|NOT COMPLETED|Second Voiding Trial||0
8605896|NCT00392210|9642628|FG001|NOT COMPLETED|Second Voiding Trial||0
8605897|NCT00392223|9642636|FG000|STARTED|Overall Study||58
8605898|NCT00392223|9642637|FG001|STARTED|Overall Study||60
8714317|NCT00979732|9761229|FG001|NOT COMPLETED|Overall Study||1
8714318|NCT00979745|9761237|FG000|STARTED|Overall Study||38
8714319|NCT00979745|9761238|FG001|STARTED|Overall Study||36
8714320|NCT00979745|9761237|FG000|COMPLETED|Overall Study||34
8714321|NCT00979745|9761238|FG001|COMPLETED|Overall Study||34
8714322|NCT00979745|9761237|FG000|NOT COMPLETED|Overall Study||4
8714323|NCT00979745|9761238|FG001|NOT COMPLETED|Overall Study||2
8714324|NCT00979875|9761244|FG000|STARTED|Intervention 1||2
8714325|NCT00979875|9761245|FG001|STARTED|Intervention 1||2
8605899|NCT00392223|9642636|FG000|COMPLETED|Overall Study||49
8605900|NCT00392223|9642637|FG001|COMPLETED|Overall Study||47
8605901|NCT00392223|9642636|FG000|NOT COMPLETED|Overall Study||9
8605902|NCT00392223|9642637|FG001|NOT COMPLETED|Overall Study||13
8714326|NCT00979875|9761246|FG002|STARTED|Intervention 1||3
8714327|NCT00979875|9761247|FG003|STARTED|Intervention 1||2
8714328|NCT00979875|9761248|FG004|STARTED|Intervention 1||3
8714329|NCT00979875|9761249|FG005|STARTED|Intervention 1||2
8605903|NCT00392236|9642645|FG000|STARTED|Overall Study|1 subject post randomization was found to not meet inclusion criteria|20
8605904|NCT00392236|9642646|FG001|STARTED|Overall Study|1 subject post randomization was found to not meet inclusion criteria|18
8605905|NCT00392236|9642645|FG000|COMPLETED|Overall Study|Defined as having adherence data for month 6 of the study.|8
8605906|NCT00392236|9642646|FG001|COMPLETED|Overall Study|Defined as having adherence data for month 6 of the study.|12
8605907|NCT00392236|9642645|FG000|NOT COMPLETED|Overall Study||12
8605908|NCT00392236|9642646|FG001|NOT COMPLETED|Overall Study||6
8605909|NCT00392288|9642655|FG000|STARTED|Overall Study|Number of randomized subjects is different to number of ITT population in Outcome Measures.|175
8605910|NCT00392288|9642656|FG001|STARTED|Overall Study|Number of randomized subjects is different to number of ITT population in Outcome Measures.|177
8605911|NCT00392288|9642657|FG002|STARTED|Overall Study|Number of randomized subjects is different to number of ITT population in Outcome Measures.|176
8605912|NCT00392288|9642655|FG000|Treatment Period|Overall Study||172
8605913|NCT00392288|9642656|FG001|Treatment Period|Overall Study||174
8605914|NCT00392288|9642657|FG002|Treatment Period|Overall Study||175
8605915|NCT00392288|9642655|FG000|COMPLETED|Overall Study|ITT set = 163 patients|143
8605916|NCT00392288|9642656|FG001|COMPLETED|Overall Study|ITT set = 166 patients|155
8605917|NCT00392288|9642657|FG002|COMPLETED|Overall Study|ITT set = 172 patients|159
8605918|NCT00392288|9642655|FG000|NOT COMPLETED|Overall Study||32
8605919|NCT00392288|9642656|FG001|NOT COMPLETED|Overall Study||22
8605920|NCT00392288|9642657|FG002|NOT COMPLETED|Overall Study||17
8605921|NCT00392379|9642667|FG000|STARTED|Overall Study|Medication period|136
8605922|NCT00392379|9642668|FG001|STARTED|Overall Study|Medication period|134
8605923|NCT00392379|9642667|FG000|COMPLETED|Overall Study|Medication period|114
8605924|NCT00392379|9642668|FG001|COMPLETED|Overall Study|Medication period|96
8605925|NCT00392379|9642667|FG000|NOT COMPLETED|Overall Study||22
8605926|NCT00392379|9642668|FG001|NOT COMPLETED|Overall Study||38
8605927|NCT00392392|9642674|FG000|STARTED|Overall Study||29
8605928|NCT00392392|9642674|FG000|COMPLETED|Overall Study||9
8605929|NCT00392392|9642674|FG000|NOT COMPLETED|Overall Study||20
8605930|NCT00392444|9642678|FG000|STARTED|Overall Study||39
8605931|NCT00392444|9642678|FG000|COMPLETED|Overall Study||39
8605932|NCT00392444|9642678|FG000|NOT COMPLETED|Overall Study||0
8605933|NCT00392496|9642682|FG000|STARTED|Overall Study||19
8605934|NCT00392496|9642682|FG000|COMPLETED|Overall Study||19
8605935|NCT00392496|9642682|FG000|NOT COMPLETED|Overall Study||0
8605936|NCT00392665|9642688|FG000|STARTED|Overall Study||18
8605937|NCT00392665|9642689|FG001|STARTED|Overall Study||18
8605938|NCT00392665|9642688|FG000|COMPLETED|Overall Study||1
8605939|NCT00392665|9642689|FG001|COMPLETED|Overall Study||3
8605940|NCT00392665|9642688|FG000|NOT COMPLETED|Overall Study||17
8605941|NCT00392665|9642689|FG001|NOT COMPLETED|Overall Study||15
8605942|NCT00392678|9642699|FG000|STARTED|Overall Study||27
8605943|NCT00392678|9642700|FG001|STARTED|Overall Study||27
8605944|NCT00392678|9642701|FG002|STARTED|Overall Study||27
8605945|NCT00392678|9642702|FG003|STARTED|Overall Study||27
8605946|NCT00392678|9642699|FG000|COMPLETED|Overall Study||27
8605947|NCT00392678|9642700|FG001|COMPLETED|Overall Study||26
8605948|NCT00392678|9642701|FG002|COMPLETED|Overall Study||25
8605949|NCT00392678|9642702|FG003|COMPLETED|Overall Study||26
8605950|NCT00392678|9642699|FG000|NOT COMPLETED|Overall Study||0
8605951|NCT00392678|9642700|FG001|NOT COMPLETED|Overall Study||1
8605952|NCT00392678|9642701|FG002|NOT COMPLETED|Overall Study||2
8605953|NCT00392678|9642702|FG003|NOT COMPLETED|Overall Study||1
8605954|NCT00392704|9642721|FG000|STARTED|Neoadjuvant Chemotherapy||60
8605955|NCT00392704|9642721|FG000|COMPLETED|Neoadjuvant Chemotherapy||54
8605956|NCT00392704|9642721|FG000|NOT COMPLETED|Neoadjuvant Chemotherapy||6
8605957|NCT00392704|9642721|FG000|STARTED|Combined Modality Therapy||54
8605958|NCT00392704|9642721|FG000|COMPLETED|Combined Modality Therapy||49
8605959|NCT00392704|9642721|FG000|NOT COMPLETED|Combined Modality Therapy||5
8605960|NCT00392769|9642725|FG000|STARTED|Overall Study||33
8605961|NCT00392769|9642725|FG000|COMPLETED|Overall Study||23
8605962|NCT00392769|9642725|FG000|NOT COMPLETED|Overall Study||10
8605963|NCT00392782|9642729|FG000|STARTED|Overall Study||24
8605964|NCT00392782|9642729|FG000|COMPLETED|Overall Study||24
8605965|NCT00392782|9642729|FG000|NOT COMPLETED|Overall Study||0
8605966|NCT00392808|9642737|FG000|STARTED|Overall Study||87
8605967|NCT00392808|9642738|FG001|STARTED|Overall Study||89
8605968|NCT00392808|9642739|FG002|STARTED|Overall Study||109
8605969|NCT00392808|9642740|FG003|STARTED|Overall Study||104
8605970|NCT00392808|9642737|FG000|COMPLETED|Overall Study||81
8605971|NCT00392808|9642738|FG001|COMPLETED|Overall Study||86
8605972|NCT00392808|9642739|FG002|COMPLETED|Overall Study||107
8605973|NCT00392808|9642740|FG003|COMPLETED|Overall Study||100
8605974|NCT00392808|9642737|FG000|NOT COMPLETED|Overall Study||6
8605975|NCT00392808|9642738|FG001|NOT COMPLETED|Overall Study||3
8605976|NCT00392808|9642739|FG002|NOT COMPLETED|Overall Study||2
8605977|NCT00392808|9642740|FG003|NOT COMPLETED|Overall Study||4
8605978|NCT00392834|9642752|FG000|STARTED|Overall Study||2
8605979|NCT00392834|9642753|FG001|STARTED|Overall Study||32
8605980|NCT00392834|9642752|FG000|COMPLETED|Overall Study||2
8605981|NCT00392834|9642753|FG001|COMPLETED|Overall Study||32
8605982|NCT00392834|9642752|FG000|NOT COMPLETED|Overall Study||0
8605983|NCT00392834|9642753|FG001|NOT COMPLETED|Overall Study||0
8605984|NCT00392925|9642763|FG000|STARTED|4 Week Lead-In Period - Non-Randomized||177
8605985|NCT00392925|9642764|FG001|STARTED|4 Week Lead-In Period - Non-Randomized||0
8605986|NCT00392925|9642765|FG002|STARTED|4 Week Lead-In Period - Non-Randomized||0
8605987|NCT00392925|9642766|FG003|STARTED|4 Week Lead-In Period - Non-Randomized||0
8714330|NCT00979875|9761244|FG000|Received at Least 1 Dose of Study Drug|Intervention 1||2
8714331|NCT00979875|9761245|FG001|Received at Least 1 Dose of Study Drug|Intervention 1||2
8714332|NCT00979875|9761246|FG002|Received at Least 1 Dose of Study Drug|Intervention 1||3
8714333|NCT00979875|9761247|FG003|Received at Least 1 Dose of Study Drug|Intervention 1||2
8714334|NCT00979875|9761248|FG004|Received at Least 1 Dose of Study Drug|Intervention 1||3
8714335|NCT00979875|9761249|FG005|Received at Least 1 Dose of Study Drug|Intervention 1||2
8714336|NCT00979875|9761244|FG000|COMPLETED|Intervention 1||2
8714337|NCT00979875|9761245|FG001|COMPLETED|Intervention 1||2
8714338|NCT00979875|9761246|FG002|COMPLETED|Intervention 1||3
8714339|NCT00979875|9761247|FG003|COMPLETED|Intervention 1||2
8714340|NCT00979875|9761248|FG004|COMPLETED|Intervention 1||3
8714341|NCT00979875|9761249|FG005|COMPLETED|Intervention 1||2
8605988|NCT00392925|9642763|FG000|COMPLETED|4 Week Lead-In Period - Non-Randomized||139
8605989|NCT00392925|9642764|FG001|COMPLETED|4 Week Lead-In Period - Non-Randomized||0
8605990|NCT00392925|9642765|FG002|COMPLETED|4 Week Lead-In Period - Non-Randomized||0
8605991|NCT00392925|9642766|FG003|COMPLETED|4 Week Lead-In Period - Non-Randomized||0
8605992|NCT00392925|9642763|FG000|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||38
8605993|NCT00392925|9642764|FG001|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||0
8605994|NCT00392925|9642765|FG002|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||0
8605995|NCT00392925|9642766|FG003|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||0
8605996|NCT00392925|9642763|FG000|STARTED|Randomization to Treatment Group Period||0
8605997|NCT00392925|9642764|FG001|STARTED|Randomization to Treatment Group Period||27
8605998|NCT00392925|9642765|FG002|STARTED|Randomization to Treatment Group Period||56
8605999|NCT00392925|9642766|FG003|STARTED|Randomization to Treatment Group Period||56
8606000|NCT00392925|9642763|FG000|COMPLETED|Randomization to Treatment Group Period||0
8606001|NCT00392925|9642764|FG001|COMPLETED|Randomization to Treatment Group Period|AT Week 20|19
8606002|NCT00392925|9642765|FG002|COMPLETED|Randomization to Treatment Group Period|At Week 20|37
8606003|NCT00392925|9642766|FG003|COMPLETED|Randomization to Treatment Group Period|At Week 20|38
8606004|NCT00392925|9642763|FG000|NOT COMPLETED|Randomization to Treatment Group Period||0
8606005|NCT00392925|9642764|FG001|NOT COMPLETED|Randomization to Treatment Group Period||8
8606006|NCT00392925|9642765|FG002|NOT COMPLETED|Randomization to Treatment Group Period||19
8606007|NCT00392925|9642766|FG003|NOT COMPLETED|Randomization to Treatment Group Period||18
8606008|NCT00392951|9642782|FG000|STARTED|Overall Study||30
8606009|NCT00392951|9642782|FG000|COMPLETED|Overall Study||30
8606010|NCT00392951|9642782|FG000|NOT COMPLETED|Overall Study||0
8606011|NCT00392990|9642788|FG000|STARTED|Treatment on Study||20
8606012|NCT00392990|9642789|FG001|STARTED|Treatment on Study||5
8606013|NCT00392990|9642788|FG000|COMPLETED|Treatment on Study||17
8606014|NCT00392990|9642789|FG001|COMPLETED|Treatment on Study||4
8606015|NCT00392990|9642788|FG000|NOT COMPLETED|Treatment on Study||3
8606016|NCT00392990|9642789|FG001|NOT COMPLETED|Treatment on Study||1
8606017|NCT00392990|9642788|FG000|STARTED|Follow up for 2 Years||20
8606018|NCT00392990|9642789|FG001|STARTED|Follow up for 2 Years||5
8606019|NCT00392990|9642788|FG000|COMPLETED|Follow up for 2 Years||16
8606020|NCT00392990|9642789|FG001|COMPLETED|Follow up for 2 Years||5
8606021|NCT00392990|9642788|FG000|NOT COMPLETED|Follow up for 2 Years||4
8606022|NCT00392990|9642789|FG001|NOT COMPLETED|Follow up for 2 Years||0
8606023|NCT00393029|9642797|FG000|STARTED|Overall Study||2
8606024|NCT00393029|9642798|FG001|STARTED|Overall Study||10
8714342|NCT00979875|9761244|FG000|NOT COMPLETED|Intervention 1||0
8714343|NCT00979875|9761245|FG001|NOT COMPLETED|Intervention 1||0
8714344|NCT00979875|9761246|FG002|NOT COMPLETED|Intervention 1||0
8714345|NCT00979875|9761247|FG003|NOT COMPLETED|Intervention 1||0
8714346|NCT00979875|9761248|FG004|NOT COMPLETED|Intervention 1||0
8714347|NCT00979875|9761249|FG005|NOT COMPLETED|Intervention 1||0
8714348|NCT00979875|9761244|FG000|STARTED|Washout 1 (3 to 14 Days)||2
8714349|NCT00979875|9761245|FG001|STARTED|Washout 1 (3 to 14 Days)||2
8714350|NCT00979875|9761246|FG002|STARTED|Washout 1 (3 to 14 Days)||3
8714351|NCT00979875|9761247|FG003|STARTED|Washout 1 (3 to 14 Days)||2
8714352|NCT00979875|9761248|FG004|STARTED|Washout 1 (3 to 14 Days)||3
8714353|NCT00979875|9761249|FG005|STARTED|Washout 1 (3 to 14 Days)||2
8606025|NCT00393029|9642797|FG000|COMPLETED|Overall Study||2
8606026|NCT00393029|9642798|FG001|COMPLETED|Overall Study||9
8606027|NCT00393029|9642797|FG000|NOT COMPLETED|Overall Study||0
8606028|NCT00393029|9642798|FG001|NOT COMPLETED|Overall Study||1
8606029|NCT00393042|9642805|FG000|STARTED|First Intervention||31
8606030|NCT00393042|9642806|FG001|STARTED|First Intervention||33
8606031|NCT00393042|9642805|FG000|Completed the Placebo Dosage|First Intervention||27
8606032|NCT00393042|9642806|FG001|Completed the Placebo Dosage|First Intervention||29
8606033|NCT00393042|9642805|FG000|Completed 10mg Dosage|First Intervention||29
8606034|NCT00393042|9642806|FG001|Completed 10mg Dosage|First Intervention||29
8606035|NCT00393042|9642805|FG000|Completed 20 mg Dosage|First Intervention||26
8606036|NCT00393042|9642806|FG001|Completed 20 mg Dosage|First Intervention||28
8606037|NCT00393042|9642805|FG000|Completed 25/30mg Dosage|First Intervention||27
8714354|NCT00979875|9761244|FG000|COMPLETED|Washout 1 (3 to 14 Days)||2
8714355|NCT00979875|9761245|FG001|COMPLETED|Washout 1 (3 to 14 Days)||2
8714356|NCT00979875|9761246|FG002|COMPLETED|Washout 1 (3 to 14 Days)||3
8714357|NCT00979875|9761247|FG003|COMPLETED|Washout 1 (3 to 14 Days)||2
8714358|NCT00979875|9761248|FG004|COMPLETED|Washout 1 (3 to 14 Days)||3
8714359|NCT00979875|9761249|FG005|COMPLETED|Washout 1 (3 to 14 Days)||2
8606038|NCT00393042|9642806|FG001|Completed 25/30mg Dosage|First Intervention||27
8606039|NCT00393042|9642805|FG000|COMPLETED|First Intervention||26
8606040|NCT00393042|9642806|FG001|COMPLETED|First Intervention||27
8606041|NCT00393042|9642805|FG000|NOT COMPLETED|First Intervention||5
8606042|NCT00393042|9642806|FG001|NOT COMPLETED|First Intervention||6
8606043|NCT00393042|9642805|FG000|STARTED|Second Intervetion||26
8606044|NCT00393042|9642806|FG001|STARTED|Second Intervetion||27
8606045|NCT00393042|9642805|FG000|Completed Placebo Dosage|Second Intervetion||25
8606046|NCT00393042|9642806|FG001|Completed Placebo Dosage|Second Intervetion||21
8606047|NCT00393042|9642805|FG000|Completed 10 mg Dosage|Second Intervetion||26
8606048|NCT00393042|9642806|FG001|Completed 10 mg Dosage|Second Intervetion||24
8606049|NCT00393042|9642805|FG000|Completed the 20mg Dosage|Second Intervetion||24
8606050|NCT00393042|9642806|FG001|Completed the 20mg Dosage|Second Intervetion||21
8606051|NCT00393042|9642805|FG000|Completed 25/30 mg Dosage|Second Intervetion||24
8606052|NCT00393042|9642806|FG001|Completed 25/30 mg Dosage|Second Intervetion||20
8606053|NCT00393042|9642805|FG000|COMPLETED|Second Intervetion||24
8606054|NCT00393042|9642806|FG001|COMPLETED|Second Intervetion||19
8606055|NCT00393042|9642805|FG000|NOT COMPLETED|Second Intervetion||2
8606056|NCT00393042|9642806|FG001|NOT COMPLETED|Second Intervetion||8
8606057|NCT00393094|9642860|FG000|STARTED|Period1Bevacizumab & Irinotecan Patients||31
8606058|NCT00393094|9642860|FG000|COMPLETED|Period1Bevacizumab & Irinotecan Patients||30
8606059|NCT00393094|9642860|FG000|NOT COMPLETED|Period1Bevacizumab & Irinotecan Patients||1
8606060|NCT00393094|9642860|FG000|STARTED|Disease Progression After Trtmt: Onstudy||30
8606061|NCT00393094|9642860|FG000|COMPLETED|Disease Progression After Trtmt: Onstudy||29
8606062|NCT00393094|9642860|FG000|NOT COMPLETED|Disease Progression After Trtmt: Onstudy||1
8606063|NCT00393367|9642868|FG000|STARTED|Overall Study||91
8606064|NCT00393367|9642869|FG001|STARTED|Overall Study||88
8606065|NCT00393367|9642868|FG000|COMPLETED|Overall Study||89
8606066|NCT00393367|9642869|FG001|COMPLETED|Overall Study||81
8606067|NCT00393367|9642868|FG000|NOT COMPLETED|Overall Study||2
8606068|NCT00393367|9642869|FG001|NOT COMPLETED|Overall Study||7
8606069|NCT00393380|9642877|FG000|STARTED|Overall Study||13
8606070|NCT00393380|9642877|FG000|COMPLETED|Overall Study||13
8606071|NCT00393380|9642877|FG000|NOT COMPLETED|Overall Study||0
8606072|NCT00393458|9642885|FG000|STARTED|Overall Study||437
8606073|NCT00393458|9642886|FG001|STARTED|Overall Study||428
8606074|NCT00393458|9642887|FG002|STARTED|Overall Study||435
8606075|NCT00393458|9642888|FG003|STARTED|Overall Study||432
8606076|NCT00393458|9642885|FG000|Exposed to Study Medication or Placebo|Overall Study||437
8606077|NCT00393458|9642886|FG001|Exposed to Study Medication or Placebo|Overall Study||425
8606078|NCT00393458|9642887|FG002|Exposed to Study Medication or Placebo|Overall Study||434
8606079|NCT00393458|9642888|FG003|Exposed to Study Medication or Placebo|Overall Study||432
8606080|NCT00393458|9642885|FG000|COMPLETED|Overall Study||338
8606081|NCT00393458|9642886|FG001|COMPLETED|Overall Study||326
8606082|NCT00393458|9642887|FG002|COMPLETED|Overall Study||323
8606083|NCT00393458|9642888|FG003|COMPLETED|Overall Study||295
8606084|NCT00393458|9642885|FG000|NOT COMPLETED|Overall Study||99
8606085|NCT00393458|9642886|FG001|NOT COMPLETED|Overall Study||102
8606086|NCT00393458|9642887|FG002|NOT COMPLETED|Overall Study||112
8606087|NCT00393458|9642888|FG003|NOT COMPLETED|Overall Study||137
8606088|NCT00393484|9642900|FG000|STARTED|Double-blind Period (Day 1 to Week 96)|Number treated|56
8606089|NCT00393484|9642901|FG001|STARTED|Double-blind Period (Day 1 to Week 96)|Number treated|64
8606090|NCT00393484|9642900|FG000|Participants Excluded From Analysis|Double-blind Period (Day 1 to Week 96)||1
8606091|NCT00393484|9642901|FG001|Participants Excluded From Analysis|Double-blind Period (Day 1 to Week 96)||1
8606092|NCT00393484|9642900|FG000|COMPLETED|Double-blind Period (Day 1 to Week 96)||54
8606093|NCT00393484|9642901|FG001|COMPLETED|Double-blind Period (Day 1 to Week 96)||52
8606094|NCT00393484|9642900|FG000|NOT COMPLETED|Double-blind Period (Day 1 to Week 96)||2
8606095|NCT00393484|9642901|FG001|NOT COMPLETED|Double-blind Period (Day 1 to Week 96)||12
8606096|NCT00393484|9642900|FG000|STARTED|Open-label Period (Weeks 96 to 240)||48
8606097|NCT00393484|9642901|FG001|STARTED|Open-label Period (Weeks 96 to 240)||44
8606098|NCT00393484|9642900|FG000|Withdrew Consent|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|6
8606099|NCT00393484|9642901|FG001|Withdrew Consent|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|6
8606100|NCT00393484|9642900|FG000|Lack of Efficacy|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|0
8606101|NCT00393484|9642901|FG001|Lack of Efficacy|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|2
8606102|NCT00393484|9642900|FG000|COMPLETED|Open-label Period (Weeks 96 to 240)||40
8606103|NCT00393484|9642901|FG001|COMPLETED|Open-label Period (Weeks 96 to 240)||21
8606104|NCT00393484|9642900|FG000|NOT COMPLETED|Open-label Period (Weeks 96 to 240)||8
8606105|NCT00393484|9642901|FG001|NOT COMPLETED|Open-label Period (Weeks 96 to 240)||23
8606106|NCT00393510|9642911|FG000|STARTED|Overall Study||40
8606107|NCT00393510|9642912|FG001|STARTED|Overall Study||40
8606108|NCT00393510|9642911|FG000|COMPLETED|Overall Study||37
8606109|NCT00393510|9642912|FG001|COMPLETED|Overall Study||31
8606110|NCT00393510|9642911|FG000|NOT COMPLETED|Overall Study||3
8606111|NCT00393510|9642912|FG001|NOT COMPLETED|Overall Study||9
8606112|NCT00393523|9642923|FG000|STARTED|Overall Study||376
8606113|NCT00393523|9642924|FG001|STARTED|Overall Study||375
8606114|NCT00393523|9642925|FG002|STARTED|Overall Study||353
8606115|NCT00393523|9642926|FG003|STARTED|Overall Study||354
8606116|NCT00393523|9642927|FG004|STARTED|Overall Study||20
8606117|NCT00393523|9642923|FG000|Vaccination Visit 1|Overall Study||374
8606118|NCT00393523|9642924|FG001|Vaccination Visit 1|Overall Study||375
8606119|NCT00393523|9642925|FG002|Vaccination Visit 1|Overall Study||349
8606120|NCT00393523|9642926|FG003|Vaccination Visit 1|Overall Study||352
8606121|NCT00393523|9642927|FG004|Vaccination Visit 1|Overall Study||20
8606122|NCT00393523|9642923|FG000|COMPLETED|Overall Study||364
8606123|NCT00393523|9642924|FG001|COMPLETED|Overall Study||366
8606124|NCT00393523|9642925|FG002|COMPLETED|Overall Study||349
8606125|NCT00393523|9642926|FG003|COMPLETED|Overall Study||348
8606126|NCT00393523|9642927|FG004|COMPLETED|Overall Study||19
8606127|NCT00393523|9642923|FG000|NOT COMPLETED|Overall Study||12
8606128|NCT00393523|9642924|FG001|NOT COMPLETED|Overall Study||9
8606129|NCT00393523|9642925|FG002|NOT COMPLETED|Overall Study||4
8606130|NCT00393523|9642926|FG003|NOT COMPLETED|Overall Study||6
8606131|NCT00393523|9642927|FG004|NOT COMPLETED|Overall Study||1
8606132|NCT00393705|9642940|FG000|STARTED|Overall Study||151
8606133|NCT00393705|9642941|FG001|STARTED|Overall Study||151
8606134|NCT00393705|9642940|FG000|Received at Least One Dose of Study Drug|Overall Study||139
8606135|NCT00393705|9642941|FG001|Received at Least One Dose of Study Drug|Overall Study||139
8606136|NCT00393705|9642940|FG000|COMPLETED|Overall Study||128
8606137|NCT00393705|9642941|FG001|COMPLETED|Overall Study||128
8606138|NCT00393705|9642940|FG000|NOT COMPLETED|Overall Study||23
8606139|NCT00393705|9642941|FG001|NOT COMPLETED|Overall Study||23
8628896|NCT00527514|9668471|FG000|NOT COMPLETED|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg||2
8628897|NCT00527566|9668482|FG000|STARTED|Overall Study||10
8628898|NCT00527566|9668482|FG000|COMPLETED|Overall Study||10
8628899|NCT00527566|9668482|FG000|NOT COMPLETED|Overall Study||0
8628900|NCT00527592|9668488|FG000|STARTED|Overall Study||54
8628901|NCT00527592|9668488|FG000|COMPLETED|Overall Study||54
8628902|NCT00527592|9668488|FG000|NOT COMPLETED|Overall Study||0
8628903|NCT00527605|9668496|FG000|STARTED|Overall Study||126
8628904|NCT00527605|9668497|FG001|STARTED|Overall Study||127
8628905|NCT00527605|9668496|FG000|COMPLETED|Overall Study||113
8628906|NCT00527605|9668497|FG001|COMPLETED|Overall Study||116
8628907|NCT00527605|9668496|FG000|NOT COMPLETED|Overall Study||13
8628908|NCT00527605|9668497|FG001|NOT COMPLETED|Overall Study||11
8628909|NCT00527618|9668503|FG000|STARTED|Week 1-12 (First Intervention)|Acyclovir|16
8628910|NCT00527618|9668504|FG001|STARTED|Week 1-12 (First Intervention)|Valacyclovir; one participant was removed from the study due to urticaria after 2.5 weeks|18
8628911|NCT00527618|9668503|FG000|COMPLETED|Week 1-12 (First Intervention)|Acyclovir|13
8628912|NCT00527618|9668504|FG001|COMPLETED|Week 1-12 (First Intervention)|Valacyclovir|16
8628913|NCT00527618|9668503|FG000|NOT COMPLETED|Week 1-12 (First Intervention)||3
8628914|NCT00527618|9668504|FG001|NOT COMPLETED|Week 1-12 (First Intervention)||2
8628915|NCT00527618|9668503|FG000|STARTED|Week 13-14 (Washout)||13
8628916|NCT00527618|9668504|FG001|STARTED|Week 13-14 (Washout)||16
8628917|NCT00527618|9668503|FG000|COMPLETED|Week 13-14 (Washout)||12
8628918|NCT00527618|9668504|FG001|COMPLETED|Week 13-14 (Washout)||16
8628919|NCT00527618|9668503|FG000|NOT COMPLETED|Week 13-14 (Washout)||1
8628920|NCT00527618|9668504|FG001|NOT COMPLETED|Week 13-14 (Washout)||0
8628921|NCT00527618|9668503|FG000|STARTED|Week 15-18 (Second Intervention)|Valacyclovir|12
8628922|NCT00527618|9668504|FG001|STARTED|Week 15-18 (Second Intervention)|Acyclovir|16
8628923|NCT00527618|9668503|FG000|COMPLETED|Week 15-18 (Second Intervention)|Valacyclovir|12
8628924|NCT00527618|9668504|FG001|COMPLETED|Week 15-18 (Second Intervention)|Acyclovir|13
8628925|NCT00527618|9668503|FG000|NOT COMPLETED|Week 15-18 (Second Intervention)||0
8628926|NCT00527618|9668504|FG001|NOT COMPLETED|Week 15-18 (Second Intervention)||3
8628927|NCT00527644|9668511|FG000|STARTED|Overall Study||14
8628928|NCT00527644|9668511|FG000|COMPLETED|Overall Study||14
8628929|NCT00527644|9668511|FG000|NOT COMPLETED|Overall Study||0
8628930|NCT00527722|9668517|FG000|STARTED|Overall Study||22
8628931|NCT00527722|9668518|FG001|STARTED|Overall Study||25
8628932|NCT00527722|9668517|FG000|COMPLETED|Overall Study||22
8628933|NCT00527722|9668518|FG001|COMPLETED|Overall Study||25
8628934|NCT00527722|9668517|FG000|NOT COMPLETED|Overall Study||0
8628935|NCT00527722|9668518|FG001|NOT COMPLETED|Overall Study||0
8628936|NCT00527735|9668527|FG000|STARTED|Overall Study|Treated|113
8628937|NCT00527735|9668528|FG001|STARTED|Overall Study|Treated|109
8628938|NCT00527735|9668529|FG002|STARTED|Overall Study|Treated|109
8628939|NCT00527735|9668527|FG000|COMPLETED|Overall Study|Still on treatment|5
8628940|NCT00527735|9668528|FG001|COMPLETED|Overall Study|Still on treatment|2
8628941|NCT00527735|9668529|FG002|COMPLETED|Overall Study|Still on treatment|2
8628942|NCT00527735|9668527|FG000|NOT COMPLETED|Overall Study||108
8628943|NCT00527735|9668528|FG001|NOT COMPLETED|Overall Study||107
8628944|NCT00527735|9668529|FG002|NOT COMPLETED|Overall Study||107
8628945|NCT00527787|9668551|FG000|STARTED|Overall Study||218
8628946|NCT00527787|9668552|FG001|STARTED|Overall Study|Safety and Intent-to-treat population (>=1 dose drug + no baseline ulcer) N=216|216
8628947|NCT00527787|9668551|FG000|COMPLETED|Overall Study||180
8628948|NCT00527787|9668552|FG001|COMPLETED|Overall Study||153
8628949|NCT00527787|9668551|FG000|NOT COMPLETED|Overall Study||38
8628950|NCT00527787|9668552|FG001|NOT COMPLETED|Overall Study||63
8628951|NCT00527826|9668560|FG000|STARTED|Overall Study|All Patients Population was used for Participant Flow section.|108
8628952|NCT00527826|9668561|FG001|STARTED|Overall Study||106
8628953|NCT00527826|9668560|FG000|COMPLETED|Overall Study||87
8628954|NCT00527826|9668561|FG001|COMPLETED|Overall Study||80
8628955|NCT00527826|9668560|FG000|NOT COMPLETED|Overall Study||21
8628956|NCT00527826|9668561|FG001|NOT COMPLETED|Overall Study||26
8606140|NCT00393718|9642949|FG000|STARTED|Overall Study||268
8606141|NCT00393718|9642950|FG001|STARTED|Overall Study||132
8606142|NCT00393718|9642949|FG000|COMPLETED|Overall Study||225
8606143|NCT00393718|9642950|FG001|COMPLETED|Overall Study||110
8606144|NCT00393718|9642949|FG000|NOT COMPLETED|Overall Study||43
8606145|NCT00393718|9642950|FG001|NOT COMPLETED|Overall Study||22
8606146|NCT00393796|9642958|FG000|STARTED|Double Blind Period||26
8606147|NCT00393796|9642959|FG001|STARTED|Double Blind Period||28
8606148|NCT00393796|9642958|FG000|COMPLETED|Double Blind Period||26
8606149|NCT00393796|9642959|FG001|COMPLETED|Double Blind Period||28
8606150|NCT00393796|9642958|FG000|NOT COMPLETED|Double Blind Period||0
8606151|NCT00393796|9642959|FG001|NOT COMPLETED|Double Blind Period||0
8606152|NCT00393796|9642958|FG000|STARTED|Open Label Period - Placebo to SUTENT||0
8606153|NCT00393796|9642959|FG001|STARTED|Open Label Period - Placebo to SUTENT||16
8606154|NCT00393796|9642958|FG000|COMPLETED|Open Label Period - Placebo to SUTENT||0
8606155|NCT00393796|9642959|FG001|COMPLETED|Open Label Period - Placebo to SUTENT||16
8606156|NCT00393796|9642958|FG000|NOT COMPLETED|Open Label Period - Placebo to SUTENT||0
8606157|NCT00393796|9642959|FG001|NOT COMPLETED|Open Label Period - Placebo to SUTENT||0
8606158|NCT00393848|9642969|FG000|STARTED|Overall Study||16
8606159|NCT00393848|9642970|FG001|STARTED|Overall Study||9
8606160|NCT00393848|9642971|FG002|STARTED|Overall Study||6
8606161|NCT00393848|9642972|FG003|STARTED|Overall Study||9
8606162|NCT00393848|9642969|FG000|COMPLETED|Overall Study||16
8606163|NCT00393848|9642970|FG001|COMPLETED|Overall Study||9
8606164|NCT00393848|9642971|FG002|COMPLETED|Overall Study||4
8606165|NCT00393848|9642972|FG003|COMPLETED|Overall Study||8
8606166|NCT00393848|9642969|FG000|NOT COMPLETED|Overall Study||0
8606167|NCT00393848|9642970|FG001|NOT COMPLETED|Overall Study||0
8606168|NCT00393848|9642971|FG002|NOT COMPLETED|Overall Study||2
8606169|NCT00393848|9642972|FG003|NOT COMPLETED|Overall Study||1
8606170|NCT00393861|9642983|FG000|STARTED|Overall Study||29
8606171|NCT00393861|9642983|FG000|COMPLETED|Overall Study||3
8606172|NCT00393861|9642983|FG000|NOT COMPLETED|Overall Study||26
8606173|NCT00393874|9642990|FG000|STARTED|Overall Study||18
8606174|NCT00393874|9642991|FG001|STARTED|Overall Study||17
8606175|NCT00393874|9642992|FG002|STARTED|Overall Study||15
8606176|NCT00393874|9642990|FG000|COMPLETED|Overall Study||15
8606177|NCT00393874|9642991|FG001|COMPLETED|Overall Study||13
8606178|NCT00393874|9642992|FG002|COMPLETED|Overall Study||13
8606179|NCT00393874|9642990|FG000|NOT COMPLETED|Overall Study||3
8606180|NCT00393874|9642991|FG001|NOT COMPLETED|Overall Study||4
8606181|NCT00393874|9642992|FG002|NOT COMPLETED|Overall Study||2
8606182|NCT00393887|9643005|FG000|STARTED|Overall Study||50
8606183|NCT00393887|9643006|FG001|STARTED|Overall Study||50
8606184|NCT00393887|9643005|FG000|1 Year|Overall Study||45
8606185|NCT00393887|9643006|FG001|1 Year|Overall Study||50
8606186|NCT00393887|9643005|FG000|COMPLETED|Overall Study||34
8606187|NCT00393887|9643006|FG001|COMPLETED|Overall Study||41
8606188|NCT00393887|9643005|FG000|NOT COMPLETED|Overall Study||16
8606189|NCT00393887|9643006|FG001|NOT COMPLETED|Overall Study||9
8606190|NCT00393913|9643012|FG000|STARTED|Initial Assessment||144
8606191|NCT00393913|9643012|FG000|COMPLETED|Initial Assessment||107
8606192|NCT00393913|9643012|FG000|NOT COMPLETED|Initial Assessment||37
8606193|NCT00393913|9643012|FG000|STARTED|CPAP|Excludes normal volunteers without OSA|100
8606194|NCT00393913|9643012|FG000|COMPLETED|CPAP||93
8606195|NCT00393913|9643012|FG000|NOT COMPLETED|CPAP||7
8606196|NCT00393913|9643012|FG000|STARTED|CPAP Withdrawal|Includes only subjects with good CPAP adherence|42
8606197|NCT00393913|9643012|FG000|CPAP Compliance|CPAP Withdrawal|Only subjects with sufficient CPAP complaince (>4 hrs/night) were included.|42
8606198|NCT00393913|9643012|FG000|COMPLETED|CPAP Withdrawal||42
8606199|NCT00393913|9643012|FG000|NOT COMPLETED|CPAP Withdrawal||0
8606200|NCT00393939|9643019|FG000|STARTED|Overall Study||296
8606201|NCT00393939|9643020|FG001|STARTED|Overall Study||297
8606202|NCT00393939|9643019|FG000|Treated|Overall Study||295
8606203|NCT00393939|9643020|FG001|Treated|Overall Study||293
8606204|NCT00393939|9643019|FG000|COMPLETED|Overall Study||0
8606205|NCT00393939|9643020|FG001|COMPLETED|Overall Study||0
8606206|NCT00393939|9643019|FG000|NOT COMPLETED|Overall Study||296
8606207|NCT00393939|9643020|FG001|NOT COMPLETED|Overall Study||297
8606208|NCT00393978|9643028|FG000|STARTED|Overall Study||37
8606209|NCT00393978|9643029|FG001|STARTED|Overall Study||38
8606210|NCT00393978|9643028|FG000|COMPLETED|Overall Study||21
8606211|NCT00393978|9643029|FG001|COMPLETED|Overall Study||18
8606212|NCT00393978|9643028|FG000|NOT COMPLETED|Overall Study||16
8606213|NCT00393978|9643029|FG001|NOT COMPLETED|Overall Study||20
8606214|NCT00394082|9643035|FG000|STARTED|Overall Study||50
8606215|NCT00394082|9643035|FG000|At Least One Response Assessment|Overall Study||43
8606216|NCT00394082|9643035|FG000|COMPLETED|Overall Study|Treatment completed upon disease progression|24
8606217|NCT00394082|9643035|FG000|NOT COMPLETED|Overall Study||26
8606218|NCT00394095|9643041|FG000|STARTED|Overall Study||17
8606219|NCT00394095|9643042|FG001|STARTED|Overall Study||14
8606220|NCT00394095|9643041|FG000|Screened|Overall Study||17
8606221|NCT00394095|9643042|FG001|Screened|Overall Study||14
8606222|NCT00394095|9643041|FG000|COMPLETED|Overall Study||16
8606223|NCT00394095|9643042|FG001|COMPLETED|Overall Study||14
8606224|NCT00394095|9643041|FG000|NOT COMPLETED|Overall Study||1
8606225|NCT00394095|9643042|FG001|NOT COMPLETED|Overall Study||0
8606226|NCT00394212|9643051|FG000|STARTED|Overall Study|2 subjects assigned to suturing underwent sham procedure, results based on Intent-To-Treat (ITT)|50
8606227|NCT00394212|9643052|FG001|STARTED|Overall Study||27
8606228|NCT00394212|9643051|FG000|6 Week Follow-up|Overall Study||45
8606229|NCT00394212|9643052|FG001|6 Week Follow-up|Overall Study||26
8606230|NCT00394212|9643051|FG000|3 Month Follow-up|Overall Study||45
8606231|NCT00394212|9643052|FG001|3 Month Follow-up|Overall Study||26
8606232|NCT00394212|9643051|FG000|6 Month Follow-up|Overall Study||43
8606233|NCT00394212|9643052|FG001|6 Month Follow-up|Overall Study||26
8606234|NCT00394212|9643051|FG000|COMPLETED|Overall Study||43
8606235|NCT00394212|9643052|FG001|COMPLETED|Overall Study||26
8606236|NCT00394212|9643051|FG000|NOT COMPLETED|Overall Study||7
8606237|NCT00394212|9643052|FG001|NOT COMPLETED|Overall Study||1
8606238|NCT00394251|9643060|FG000|STARTED|Overall Study||98
8606239|NCT00394251|9643061|FG001|STARTED|Overall Study||99
8606240|NCT00394251|9643060|FG000|At Least One Dose of Taxane|Overall Study||93
8606241|NCT00394251|9643061|FG001|At Least One Dose of Taxane|Overall Study||93
8606242|NCT00394251|9643060|FG000|COMPLETED|Overall Study||61
8606243|NCT00394251|9643061|FG001|COMPLETED|Overall Study||61
8606244|NCT00394251|9643060|FG000|NOT COMPLETED|Overall Study||37
8606245|NCT00394251|9643061|FG001|NOT COMPLETED|Overall Study||38
8606246|NCT00394277|9643075|FG000|STARTED|Overall Study||195
8606247|NCT00394277|9643076|FG001|STARTED|Overall Study||196
8606248|NCT00394277|9643077|FG002|STARTED|Overall Study||393
8606249|NCT00394277|9643078|FG003|STARTED|Overall Study||391
8606250|NCT00394277|9643075|FG000|COMPLETED|Overall Study||137
8606251|NCT00394277|9643076|FG001|COMPLETED|Overall Study||136
8606252|NCT00394277|9643077|FG002|COMPLETED|Overall Study||273
8606253|NCT00394277|9643078|FG003|COMPLETED|Overall Study||266
8606254|NCT00394277|9643075|FG000|NOT COMPLETED|Overall Study||58
8606255|NCT00394277|9643076|FG001|NOT COMPLETED|Overall Study||60
8606256|NCT00394277|9643077|FG002|NOT COMPLETED|Overall Study||120
8606257|NCT00394277|9643078|FG003|NOT COMPLETED|Overall Study||125
8606258|NCT00394329|9643092|FG000|STARTED|Overall Study||71
8606259|NCT00394329|9643093|FG001|STARTED|Overall Study||72
8606260|NCT00394329|9643094|FG002|STARTED|Overall Study||71
8606261|NCT00394329|9643095|FG003|STARTED|Overall Study||74
8606262|NCT00394329|9643092|FG000|COMPLETED|Overall Study||63
8606263|NCT00394329|9643093|FG001|COMPLETED|Overall Study||63
8606264|NCT00394329|9643094|FG002|COMPLETED|Overall Study||58
8606265|NCT00394329|9643095|FG003|COMPLETED|Overall Study||50
8606266|NCT00394329|9643092|FG000|NOT COMPLETED|Overall Study||8
8606267|NCT00394329|9643093|FG001|NOT COMPLETED|Overall Study||9
8606268|NCT00394329|9643094|FG002|NOT COMPLETED|Overall Study||13
8606269|NCT00394329|9643095|FG003|NOT COMPLETED|Overall Study||24
8606270|NCT00394433|9643111|FG000|STARTED|Overall Study||38
8606271|NCT00394433|9643111|FG000|Evaluable and Treated|Overall Study||35
8606272|NCT00394433|9643111|FG000|COMPLETED|Overall Study||35
8606273|NCT00394433|9643111|FG000|NOT COMPLETED|Overall Study||3
8606274|NCT00394472|9643117|FG000|STARTED|Overall Study||122
8606275|NCT00394472|9643118|FG001|STARTED|Overall Study||122
8606276|NCT00394472|9643117|FG000|COMPLETED|Overall Study||113
8606277|NCT00394472|9643118|FG001|COMPLETED|Overall Study||111
8606278|NCT00394472|9643117|FG000|NOT COMPLETED|Overall Study||9
8606279|NCT00394472|9643118|FG001|NOT COMPLETED|Overall Study||11
8606280|NCT00394524|9643126|FG000|STARTED|Overall Study||80
8606281|NCT00394524|9643127|FG001|STARTED|Overall Study||80
8606282|NCT00394524|9643126|FG000|COMPLETED|Overall Study||77
8606283|NCT00394524|9643127|FG001|COMPLETED|Overall Study||76
8606284|NCT00394524|9643126|FG000|NOT COMPLETED|Overall Study||3
8606285|NCT00394524|9643127|FG001|NOT COMPLETED|Overall Study||4
8606286|NCT00394589|9643138|FG000|STARTED|Overall Study||14
8606287|NCT00394589|9643139|FG001|STARTED|Overall Study||11
8606288|NCT00394589|9643140|FG002|STARTED|Overall Study||18
8606289|NCT00394589|9643138|FG000|COMPLETED|Overall Study||6
8606290|NCT00394589|9643139|FG001|COMPLETED|Overall Study||8
8606291|NCT00394589|9643140|FG002|COMPLETED|Overall Study||11
8606292|NCT00394589|9643138|FG000|NOT COMPLETED|Overall Study||8
8606293|NCT00394589|9643139|FG001|NOT COMPLETED|Overall Study||3
8606294|NCT00394589|9643140|FG002|NOT COMPLETED|Overall Study||7
8606295|NCT00394654|9643150|FG000|STARTED|Overall Study||15
8606296|NCT00394654|9643151|FG001|STARTED|Overall Study||15
8606297|NCT00394654|9643150|FG000|COMPLETED|Overall Study||13
8606298|NCT00394654|9643151|FG001|COMPLETED|Overall Study||15
8606299|NCT00394654|9643150|FG000|NOT COMPLETED|Overall Study||2
8606300|NCT00394654|9643151|FG001|NOT COMPLETED|Overall Study||0
8606301|NCT00394706|9643165|FG000|STARTED|Overall Study||1819
8606302|NCT00394706|9643166|FG001|STARTED|Overall Study||1862
8606303|NCT00394706|9643167|FG002|STARTED|Overall Study||1624
8606304|NCT00394706|9643168|FG003|STARTED|Overall Study||1633
8606305|NCT00394706|9643169|FG004|STARTED|Overall Study||1636
8606306|NCT00394706|9643170|FG005|STARTED|Overall Study||1384
8606307|NCT00394706|9643171|FG006|STARTED|Overall Study||929
8606308|NCT00394706|9643172|FG007|STARTED|Overall Study||851
8606309|NCT00394706|9643165|FG000|COMPLETED|Overall Study||1815
8606310|NCT00394706|9643166|FG001|COMPLETED|Overall Study||1860
8606311|NCT00394706|9643167|FG002|COMPLETED|Overall Study||1615
8606312|NCT00394706|9643168|FG003|COMPLETED|Overall Study||1632
8606313|NCT00394706|9643169|FG004|COMPLETED|Overall Study||1634
8606314|NCT00394706|9643170|FG005|COMPLETED|Overall Study||1377
8606315|NCT00394706|9643171|FG006|COMPLETED|Overall Study||926
8606316|NCT00394706|9643172|FG007|COMPLETED|Overall Study||851
8606317|NCT00394706|9643165|FG000|NOT COMPLETED|Overall Study||4
8606318|NCT00394706|9643166|FG001|NOT COMPLETED|Overall Study||2
8606319|NCT00394706|9643167|FG002|NOT COMPLETED|Overall Study||9
8606320|NCT00394706|9643168|FG003|NOT COMPLETED|Overall Study||1
8606321|NCT00394706|9643169|FG004|NOT COMPLETED|Overall Study||2
8606322|NCT00394706|9643170|FG005|NOT COMPLETED|Overall Study||7
8606323|NCT00394706|9643171|FG006|NOT COMPLETED|Overall Study||3
8606324|NCT00394706|9643172|FG007|NOT COMPLETED|Overall Study||0
8606325|NCT00394771|9643190|FG000|STARTED|Overall Study|Safety population of treated participants|140
8606326|NCT00394771|9643191|FG001|STARTED|Overall Study|Safety population of treated participants|136
8606327|NCT00394771|9643192|FG002|STARTED|Overall Study|Safety population of treated participants|143
8606328|NCT00394771|9643193|FG003|STARTED|Overall Study|Safety population of treated participants|148
8606329|NCT00394771|9643190|FG000|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|110
8606330|NCT00394771|9643191|FG001|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|110
8606331|NCT00394771|9643192|FG002|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|108
8606332|NCT00394771|9643193|FG003|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|120
8606333|NCT00394771|9643190|FG000|COMPLETED|Overall Study||99
8606334|NCT00394771|9643191|FG001|COMPLETED|Overall Study||102
8606335|NCT00394771|9643192|FG002|COMPLETED|Overall Study||96
8606336|NCT00394771|9643193|FG003|COMPLETED|Overall Study||109
8606337|NCT00394771|9643190|FG000|NOT COMPLETED|Overall Study||41
8606338|NCT00394771|9643191|FG001|NOT COMPLETED|Overall Study||34
8606339|NCT00394771|9643192|FG002|NOT COMPLETED|Overall Study||47
8606340|NCT00394771|9643193|FG003|NOT COMPLETED|Overall Study||39
8606341|NCT00394836|9643205|FG000|STARTED|Teatment or Follow-up Phase||30
8606342|NCT00394836|9643206|FG001|STARTED|Teatment or Follow-up Phase||86
8606343|NCT00394836|9643205|FG000|Early Follow-up Entry|Teatment or Follow-up Phase|Did not complete treatment.|4
8606344|NCT00394836|9643206|FG001|Early Follow-up Entry|Teatment or Follow-up Phase|Did not complete treatment.|8
8606345|NCT00394836|9643205|FG000|COMPLETED|Teatment or Follow-up Phase||2
8606346|NCT00394836|9643206|FG001|COMPLETED|Teatment or Follow-up Phase||8
8606347|NCT00394836|9643205|FG000|NOT COMPLETED|Teatment or Follow-up Phase||28
8606348|NCT00394836|9643206|FG001|NOT COMPLETED|Teatment or Follow-up Phase||78
8606349|NCT00394836|9643205|FG000|STARTED|Extended Follow-up Phase (2-5 Years)|Not all participants went into extended follow up per protocol.|20
8606350|NCT00394836|9643206|FG001|STARTED|Extended Follow-up Phase (2-5 Years)|Not all participants went into extended follow up per protocol.|58
8606351|NCT00394836|9643205|FG000|COMPLETED|Extended Follow-up Phase (2-5 Years)||0
8606352|NCT00394836|9643206|FG001|COMPLETED|Extended Follow-up Phase (2-5 Years)||5
8606353|NCT00394836|9643205|FG000|NOT COMPLETED|Extended Follow-up Phase (2-5 Years)||20
8606354|NCT00394836|9643206|FG001|NOT COMPLETED|Extended Follow-up Phase (2-5 Years)||53
8606355|NCT00394888|9643217|FG000|STARTED|Overall Study||108
8606356|NCT00394888|9643218|FG001|STARTED|Overall Study||48
8606357|NCT00394888|9643219|FG002|STARTED|Overall Study||201
8606358|NCT00394888|9643217|FG000|COMPLETED|Overall Study||108
8606359|NCT00394888|9643218|FG001|COMPLETED|Overall Study||48
8606360|NCT00394888|9643219|FG002|COMPLETED|Overall Study||201
8606361|NCT00394888|9643217|FG000|NOT COMPLETED|Overall Study||0
8606362|NCT00394888|9643218|FG001|NOT COMPLETED|Overall Study||0
8606363|NCT00394888|9643219|FG002|NOT COMPLETED|Overall Study||0
8606364|NCT00394901|9643229|FG000|STARTED|Baseline Phase|Subjects randomized|98
8606365|NCT00394901|9643230|FG001|STARTED|Baseline Phase|Subjects randomized|87
8606366|NCT00394901|9643231|FG002|STARTED|Baseline Phase|Subjects randomized|90
8606367|NCT00394901|9643232|FG003|STARTED|Baseline Phase|Subjects randomized|97
8606368|NCT00394901|9643229|FG000|COMPLETED|Baseline Phase||98
8606369|NCT00394901|9643230|FG001|COMPLETED|Baseline Phase||87
8606370|NCT00394901|9643231|FG002|COMPLETED|Baseline Phase||89
8606371|NCT00394901|9643232|FG003|COMPLETED|Baseline Phase||97
8606372|NCT00394901|9643229|FG000|NOT COMPLETED|Baseline Phase||0
8606373|NCT00394901|9643230|FG001|NOT COMPLETED|Baseline Phase||0
8606374|NCT00394901|9643231|FG002|NOT COMPLETED|Baseline Phase||1
8606375|NCT00394901|9643232|FG003|NOT COMPLETED|Baseline Phase||0
8606376|NCT00394901|9643229|FG000|STARTED|Double-blind Phase|Subjects treated with the study drug.|98
8606377|NCT00394901|9643230|FG001|STARTED|Double-blind Phase|Subjects treated with the study drug.|87
8606378|NCT00394901|9643231|FG002|STARTED|Double-blind Phase|Subjects treated with the study drug.|89
8606379|NCT00394901|9643232|FG003|STARTED|Double-blind Phase|Subjects treated with the study drug.|97
8606380|NCT00394901|9643229|FG000|COMPLETED|Double-blind Phase||83
8606381|NCT00394901|9643230|FG001|COMPLETED|Double-blind Phase||73
8606382|NCT00394901|9643231|FG002|COMPLETED|Double-blind Phase||71
8606383|NCT00394901|9643232|FG003|COMPLETED|Double-blind Phase||70
8606384|NCT00394901|9643229|FG000|NOT COMPLETED|Double-blind Phase||15
8606385|NCT00394901|9643230|FG001|NOT COMPLETED|Double-blind Phase||14
8606386|NCT00394901|9643231|FG002|NOT COMPLETED|Double-blind Phase||18
8606387|NCT00394901|9643232|FG003|NOT COMPLETED|Double-blind Phase||27
8606388|NCT00394914|9643247|FG000|STARTED|Screening Period||311
8606389|NCT00394914|9643248|FG001|STARTED|Screening Period||0
8606390|NCT00394914|9643249|FG002|STARTED|Screening Period||0
8606391|NCT00394914|9643247|FG000|COMPLETED|Screening Period||311
8606392|NCT00394914|9643248|FG001|COMPLETED|Screening Period||0
8606393|NCT00394914|9643249|FG002|COMPLETED|Screening Period||0
8606394|NCT00394914|9643247|FG000|NOT COMPLETED|Screening Period||0
8606395|NCT00394914|9643248|FG001|NOT COMPLETED|Screening Period||0
8606396|NCT00394914|9643249|FG002|NOT COMPLETED|Screening Period||0
8606397|NCT00394914|9643247|FG000|STARTED|Pre-exposure Period||311
8606398|NCT00394914|9643248|FG001|STARTED|Pre-exposure Period||0
8606399|NCT00394914|9643249|FG002|STARTED|Pre-exposure Period||0
8606400|NCT00394914|9643247|FG000|COMPLETED|Pre-exposure Period||311
8606401|NCT00394914|9643248|FG001|COMPLETED|Pre-exposure Period||0
8606402|NCT00394914|9643249|FG002|COMPLETED|Pre-exposure Period||0
8606403|NCT00394914|9643247|FG000|NOT COMPLETED|Pre-exposure Period||0
8606404|NCT00394914|9643248|FG001|NOT COMPLETED|Pre-exposure Period||0
8606405|NCT00394914|9643249|FG002|NOT COMPLETED|Pre-exposure Period||0
8606406|NCT00394914|9643247|FG000|STARTED|Treatment Period||0
8606407|NCT00394914|9643248|FG001|STARTED|Treatment Period||154
8606408|NCT00394914|9643249|FG002|STARTED|Treatment Period||157
8606409|NCT00394914|9643247|FG000|COMPLETED|Treatment Period||0
8606410|NCT00394914|9643248|FG001|COMPLETED|Treatment Period||144
8606411|NCT00394914|9643249|FG002|COMPLETED|Treatment Period||151
8606412|NCT00394914|9643247|FG000|NOT COMPLETED|Treatment Period||0
8606413|NCT00394914|9643248|FG001|NOT COMPLETED|Treatment Period||10
8606414|NCT00394914|9643249|FG002|NOT COMPLETED|Treatment Period||6
8606415|NCT00394953|9643257|FG000|STARTED|First Treatment Period||245
8606416|NCT00394953|9643258|FG001|STARTED|First Treatment Period||244
8606417|NCT00394953|9643257|FG000|COMPLETED|First Treatment Period||216
8606418|NCT00394953|9643258|FG001|COMPLETED|First Treatment Period||222
8606419|NCT00394953|9643257|FG000|NOT COMPLETED|First Treatment Period||29
8606420|NCT00394953|9643258|FG001|NOT COMPLETED|First Treatment Period||22
8606421|NCT00394953|9643257|FG000|STARTED|Second Treatment Period||216
8606422|NCT00394953|9643258|FG001|STARTED|Second Treatment Period||222
8606423|NCT00394953|9643257|FG000|COMPLETED|Second Treatment Period||187
9064274|NCT04318535|10124573|FG002|NOT COMPLETED|Treatment Period 1 (Day -1 to Day 5)||0
9064275|NCT04318535|10124571|FG000|STARTED|Period1washout(Atleast 7 Days Post-dose)||12
9064276|NCT04318535|10124572|FG001|STARTED|Period1washout(Atleast 7 Days Post-dose)||12
9064277|NCT04318535|10124573|FG002|STARTED|Period1washout(Atleast 7 Days Post-dose)||12
9064278|NCT04318535|10124571|FG000|COMPLETED|Period1washout(Atleast 7 Days Post-dose)||12
9064279|NCT04318535|10124572|FG001|COMPLETED|Period1washout(Atleast 7 Days Post-dose)||12
9064280|NCT04318535|10124573|FG002|COMPLETED|Period1washout(Atleast 7 Days Post-dose)||12
9064281|NCT04318535|10124571|FG000|NOT COMPLETED|Period1washout(Atleast 7 Days Post-dose)||0
9064282|NCT04318535|10124572|FG001|NOT COMPLETED|Period1washout(Atleast 7 Days Post-dose)||0
9064283|NCT04318535|10124573|FG002|NOT COMPLETED|Period1washout(Atleast 7 Days Post-dose)||0
9064284|NCT04318535|10124571|FG000|STARTED|Treatment Period 2 (Day 7 to Day 12)||12
9064285|NCT04318535|10124572|FG001|STARTED|Treatment Period 2 (Day 7 to Day 12)||12
9064286|NCT04318535|10124573|FG002|STARTED|Treatment Period 2 (Day 7 to Day 12)||12
9064287|NCT04318535|10124571|FG000|COMPLETED|Treatment Period 2 (Day 7 to Day 12)||12
9064288|NCT04318535|10124572|FG001|COMPLETED|Treatment Period 2 (Day 7 to Day 12)||12
8606424|NCT00394953|9643258|FG001|COMPLETED|Second Treatment Period||148
8606425|NCT00394953|9643257|FG000|NOT COMPLETED|Second Treatment Period||29
8606426|NCT00394953|9643258|FG001|NOT COMPLETED|Second Treatment Period||74
8606427|NCT00395018|9643264|FG000|STARTED|On-Treatment|Started = treated (participants who received at least 1 dose of study therapy)|65
8606428|NCT00395018|9643264|FG000|DISCONTINUED PRIOR TO WEEK 72 VISIT|On-Treatment||10
8606429|NCT00395018|9643264|FG000|DISCONTINUED AT OR AFTER WEEK 72 VISIT|On-Treatment||0
8606430|NCT00395018|9643264|FG000|COMPLETED|On-Treatment|"Completed means received treatment through Week 72"|55
8606431|NCT00395018|9643264|FG000|NOT COMPLETED|On-Treatment||10
8606432|NCT00395018|9643264|FG000|STARTED|Off-Treatment Follow-up|Treated participants who discontinued =<72 weeks and did not start other anti-HBV therapy|5
8606433|NCT00395018|9643264|FG000|COMPLETED|Off-Treatment Follow-up|"Completed means completed the study"|1
8606434|NCT00395018|9643264|FG000|NOT COMPLETED|Off-Treatment Follow-up||4
8606435|NCT00395044|9643270|FG000|STARTED|Overall Study||25
8606436|NCT00395044|9643271|FG001|STARTED|Overall Study||25
8606437|NCT00395044|9643270|FG000|COMPLETED|Overall Study||7
8606438|NCT00395044|9643271|FG001|COMPLETED|Overall Study||11
8606439|NCT00395044|9643270|FG000|NOT COMPLETED|Overall Study||18
8606440|NCT00395044|9643271|FG001|NOT COMPLETED|Overall Study||14
8606441|NCT00395057|9643281|FG000|STARTED|Overall Study||34
8606442|NCT00395057|9643282|FG001|STARTED|Overall Study||35
8606443|NCT00395057|9643283|FG002|STARTED|Overall Study||35
8606444|NCT00395057|9643284|FG003|STARTED|Overall Study||34
8606445|NCT00395057|9643281|FG000|COMPLETED|Overall Study||2
8606446|NCT00395057|9643282|FG001|COMPLETED|Overall Study||1
8606447|NCT00395057|9643283|FG002|COMPLETED|Overall Study||2
8606448|NCT00395057|9643284|FG003|COMPLETED|Overall Study||1
8606449|NCT00395057|9643281|FG000|NOT COMPLETED|Overall Study||32
8606450|NCT00395057|9643282|FG001|NOT COMPLETED|Overall Study||34
8606451|NCT00395057|9643283|FG002|NOT COMPLETED|Overall Study||33
8606452|NCT00395057|9643284|FG003|NOT COMPLETED|Overall Study||33
8606453|NCT00395083|9643296|FG000|STARTED|Overall Study||217
8606454|NCT00395083|9643297|FG001|STARTED|Overall Study||209
8606455|NCT00395083|9643296|FG000|COMPLETED|Overall Study||207
8606456|NCT00395083|9643297|FG001|COMPLETED|Overall Study||201
8606457|NCT00395083|9643296|FG000|NOT COMPLETED|Overall Study||10
8606458|NCT00395083|9643297|FG001|NOT COMPLETED|Overall Study||8
8606459|NCT00395135|9643305|FG000|STARTED|Year 1||1595
8606460|NCT00395135|9643306|FG001|STARTED|Year 1||1587
8606461|NCT00395135|9643307|FG002|STARTED|Year 1||0
8606462|NCT00395135|9643308|FG003|STARTED|Year 1||0
8606463|NCT00395135|9643309|FG004|STARTED|Year 1||0
8606464|NCT00395135|9643305|FG000|COMPLETED|Year 1||883
8606465|NCT00395135|9643306|FG001|COMPLETED|Year 1||716
8606466|NCT00395135|9643307|FG002|COMPLETED|Year 1||0
8606467|NCT00395135|9643308|FG003|COMPLETED|Year 1||0
8606468|NCT00395135|9643309|FG004|COMPLETED|Year 1||0
8606469|NCT00395135|9643305|FG000|NOT COMPLETED|Year 1||712
8606470|NCT00395135|9643306|FG001|NOT COMPLETED|Year 1||871
8606471|NCT00395135|9643307|FG002|NOT COMPLETED|Year 1||0
8606472|NCT00395135|9643308|FG003|NOT COMPLETED|Year 1||0
8606473|NCT00395135|9643309|FG004|NOT COMPLETED|Year 1||0
8606474|NCT00395135|9643305|FG000|STARTED|Year 2||0
8606475|NCT00395135|9643306|FG001|STARTED|Year 2||0
8606476|NCT00395135|9643307|FG002|STARTED|Year 2||573
8606477|NCT00395135|9643308|FG003|STARTED|Year 2||283
8606478|NCT00395135|9643309|FG004|STARTED|Year 2||697
8606479|NCT00395135|9643305|FG000|COMPLETED|Year 2||0
8606480|NCT00395135|9643306|FG001|COMPLETED|Year 2||0
8606481|NCT00395135|9643307|FG002|COMPLETED|Year 2||426
8606482|NCT00395135|9643308|FG003|COMPLETED|Year 2||195
8606483|NCT00395135|9643309|FG004|COMPLETED|Year 2||507
8606484|NCT00395135|9643305|FG000|NOT COMPLETED|Year 2||0
8606485|NCT00395135|9643306|FG001|NOT COMPLETED|Year 2||0
8606486|NCT00395135|9643307|FG002|NOT COMPLETED|Year 2||147
8606487|NCT00395135|9643308|FG003|NOT COMPLETED|Year 2||88
8606488|NCT00395135|9643309|FG004|NOT COMPLETED|Year 2||190
8606489|NCT00395161|9643325|FG000|STARTED|Overall Study||149
8606490|NCT00395161|9643326|FG001|STARTED|Overall Study||144
8606491|NCT00395161|9643325|FG000|COMPLETED|Overall Study||149
8606492|NCT00395161|9643326|FG001|COMPLETED|Overall Study||144
8606493|NCT00395161|9643325|FG000|NOT COMPLETED|Overall Study||0
8606494|NCT00395161|9643326|FG001|NOT COMPLETED|Overall Study||0
8606495|NCT00395226|9643336|FG000|STARTED|Overall Study||26
8714360|NCT00979875|9761244|FG000|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
8714361|NCT00979875|9761245|FG001|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
8714362|NCT00979875|9761246|FG002|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
8714363|NCT00979875|9761247|FG003|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
8714364|NCT00979875|9761248|FG004|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
8714365|NCT00979875|9761249|FG005|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
8714366|NCT00979875|9761244|FG000|STARTED|Intervention 2||2
8714367|NCT00979875|9761245|FG001|STARTED|Intervention 2||2
8714368|NCT00979875|9761246|FG002|STARTED|Intervention 2||3
8714369|NCT00979875|9761247|FG003|STARTED|Intervention 2||2
8714370|NCT00979875|9761248|FG004|STARTED|Intervention 2||3
8714371|NCT00979875|9761249|FG005|STARTED|Intervention 2||2
8714372|NCT00979875|9761244|FG000|COMPLETED|Intervention 2||2
8714373|NCT00979875|9761245|FG001|COMPLETED|Intervention 2||2
8714374|NCT00979875|9761246|FG002|COMPLETED|Intervention 2||3
8714375|NCT00979875|9761247|FG003|COMPLETED|Intervention 2||2
8714376|NCT00979875|9761248|FG004|COMPLETED|Intervention 2||3
8714377|NCT00979875|9761249|FG005|COMPLETED|Intervention 2||2
8714378|NCT00979875|9761244|FG000|NOT COMPLETED|Intervention 2||0
8714379|NCT00979875|9761245|FG001|NOT COMPLETED|Intervention 2||0
8714380|NCT00979875|9761246|FG002|NOT COMPLETED|Intervention 2||0
8714381|NCT00979875|9761247|FG003|NOT COMPLETED|Intervention 2||0
8714382|NCT00979875|9761248|FG004|NOT COMPLETED|Intervention 2||0
8714383|NCT00979875|9761249|FG005|NOT COMPLETED|Intervention 2||0
8714384|NCT00979875|9761244|FG000|STARTED|Washout 2 (3 to 14 Days)||2
8714385|NCT00979875|9761245|FG001|STARTED|Washout 2 (3 to 14 Days)||2
8714386|NCT00979875|9761246|FG002|STARTED|Washout 2 (3 to 14 Days)||3
8714387|NCT00979875|9761247|FG003|STARTED|Washout 2 (3 to 14 Days)||2
8714388|NCT00979875|9761248|FG004|STARTED|Washout 2 (3 to 14 Days)||3
8714389|NCT00979875|9761249|FG005|STARTED|Washout 2 (3 to 14 Days)||2
8714390|NCT00979875|9761244|FG000|COMPLETED|Washout 2 (3 to 14 Days)||2
8714391|NCT00979875|9761245|FG001|COMPLETED|Washout 2 (3 to 14 Days)||2
8714392|NCT00979875|9761246|FG002|COMPLETED|Washout 2 (3 to 14 Days)||3
8714393|NCT00979875|9761247|FG003|COMPLETED|Washout 2 (3 to 14 Days)||2
8714394|NCT00979875|9761248|FG004|COMPLETED|Washout 2 (3 to 14 Days)||3
8714395|NCT00979875|9761249|FG005|COMPLETED|Washout 2 (3 to 14 Days)||2
8714396|NCT00979875|9761244|FG000|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
8714397|NCT00979875|9761245|FG001|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
8714398|NCT00979875|9761246|FG002|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
8714399|NCT00979875|9761247|FG003|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
8714400|NCT00979875|9761248|FG004|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
8714401|NCT00979875|9761249|FG005|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
8714402|NCT00979875|9761244|FG000|STARTED|Intervention 3||2
8606496|NCT00395226|9643337|FG001|STARTED|Overall Study||27
8606497|NCT00395226|9643336|FG000|COMPLETED|Overall Study||22
8714403|NCT00979875|9761245|FG001|STARTED|Intervention 3||2
8714404|NCT00979875|9761246|FG002|STARTED|Intervention 3||3
8714405|NCT00979875|9761247|FG003|STARTED|Intervention 3||2
8714406|NCT00979875|9761248|FG004|STARTED|Intervention 3||3
8714407|NCT00979875|9761249|FG005|STARTED|Intervention 3||2
8714408|NCT00979875|9761244|FG000|COMPLETED|Intervention 3||2
8714409|NCT00979875|9761245|FG001|COMPLETED|Intervention 3||2
8714410|NCT00979875|9761246|FG002|COMPLETED|Intervention 3||3
8714411|NCT00979875|9761247|FG003|COMPLETED|Intervention 3||2
8714412|NCT00979875|9761248|FG004|COMPLETED|Intervention 3||3
8714413|NCT00979875|9761249|FG005|COMPLETED|Intervention 3||2
8714414|NCT00979875|9761244|FG000|NOT COMPLETED|Intervention 3||0
8714415|NCT00979875|9761245|FG001|NOT COMPLETED|Intervention 3||0
8714416|NCT00979875|9761246|FG002|NOT COMPLETED|Intervention 3||0
8714417|NCT00979875|9761247|FG003|NOT COMPLETED|Intervention 3||0
8714418|NCT00979875|9761248|FG004|NOT COMPLETED|Intervention 3||0
8714419|NCT00979875|9761249|FG005|NOT COMPLETED|Intervention 3||0
8606498|NCT00395226|9643337|FG001|COMPLETED|Overall Study||22
8606499|NCT00395226|9643336|FG000|NOT COMPLETED|Overall Study||4
8606500|NCT00395226|9643337|FG001|NOT COMPLETED|Overall Study||5
8714420|NCT00979940|9761265|FG000|STARTED|Overall Study||32
8606501|NCT00395291|9643343|FG000|STARTED|First Intervention||17
8606502|NCT00395291|9643344|FG001|STARTED|First Intervention||9
8606503|NCT00395291|9643343|FG000|COMPLETED|First Intervention||15
8606504|NCT00395291|9643344|FG001|COMPLETED|First Intervention||9
8606505|NCT00395291|9643343|FG000|NOT COMPLETED|First Intervention||2
8606506|NCT00395291|9643344|FG001|NOT COMPLETED|First Intervention||0
8606507|NCT00395291|9643343|FG000|STARTED|Washout Period for 30 Days||15
8606508|NCT00395291|9643344|FG001|STARTED|Washout Period for 30 Days||9
8606509|NCT00395291|9643343|FG000|COMPLETED|Washout Period for 30 Days||13
8606510|NCT00395291|9643344|FG001|COMPLETED|Washout Period for 30 Days||9
8606511|NCT00395291|9643343|FG000|NOT COMPLETED|Washout Period for 30 Days||2
8606512|NCT00395291|9643344|FG001|NOT COMPLETED|Washout Period for 30 Days||0
8606513|NCT00395291|9643343|FG000|STARTED|Second Intervention||13
8606514|NCT00395291|9643344|FG001|STARTED|Second Intervention||9
8606515|NCT00395291|9643343|FG000|COMPLETED|Second Intervention||13
8606516|NCT00395291|9643344|FG001|COMPLETED|Second Intervention||9
8606517|NCT00395291|9643343|FG000|NOT COMPLETED|Second Intervention||0
8606518|NCT00395291|9643344|FG001|NOT COMPLETED|Second Intervention||0
8606519|NCT00395304|9643350|FG000|STARTED|Treatment Period 1||31
8606520|NCT00395304|9643351|FG001|STARTED|Treatment Period 1||30
8606521|NCT00395304|9643352|FG002|STARTED|Treatment Period 1||30
8606522|NCT00395304|9643353|FG003|STARTED|Treatment Period 1||31
8606523|NCT00395304|9643354|FG004|STARTED|Treatment Period 1||28
8606524|NCT00395304|9643355|FG005|STARTED|Treatment Period 1||32
8606525|NCT00395304|9643350|FG000|COMPLETED|Treatment Period 1||30
8606526|NCT00395304|9643351|FG001|COMPLETED|Treatment Period 1||26
8606527|NCT00395304|9643352|FG002|COMPLETED|Treatment Period 1||30
8606528|NCT00395304|9643353|FG003|COMPLETED|Treatment Period 1||28
8606529|NCT00395304|9643354|FG004|COMPLETED|Treatment Period 1||27
8606530|NCT00395304|9643355|FG005|COMPLETED|Treatment Period 1||30
8606531|NCT00395304|9643350|FG000|NOT COMPLETED|Treatment Period 1||1
8606532|NCT00395304|9643351|FG001|NOT COMPLETED|Treatment Period 1||4
8606533|NCT00395304|9643352|FG002|NOT COMPLETED|Treatment Period 1||0
8606534|NCT00395304|9643353|FG003|NOT COMPLETED|Treatment Period 1||3
8606535|NCT00395304|9643354|FG004|NOT COMPLETED|Treatment Period 1||1
8606536|NCT00395304|9643355|FG005|NOT COMPLETED|Treatment Period 1||2
8606537|NCT00395304|9643350|FG000|STARTED|Treatment Period 2||30
8606538|NCT00395304|9643351|FG001|STARTED|Treatment Period 2||26
8606539|NCT00395304|9643352|FG002|STARTED|Treatment Period 2||30
8606540|NCT00395304|9643353|FG003|STARTED|Treatment Period 2||28
8606541|NCT00395304|9643354|FG004|STARTED|Treatment Period 2||27
8606542|NCT00395304|9643355|FG005|STARTED|Treatment Period 2||30
8606543|NCT00395304|9643350|FG000|COMPLETED|Treatment Period 2||30
8606544|NCT00395304|9643351|FG001|COMPLETED|Treatment Period 2||22
8606545|NCT00395304|9643352|FG002|COMPLETED|Treatment Period 2||29
8606546|NCT00395304|9643353|FG003|COMPLETED|Treatment Period 2||27
8606547|NCT00395304|9643354|FG004|COMPLETED|Treatment Period 2||27
8606548|NCT00395304|9643355|FG005|COMPLETED|Treatment Period 2||28
8606549|NCT00395304|9643350|FG000|NOT COMPLETED|Treatment Period 2||0
8606550|NCT00395304|9643351|FG001|NOT COMPLETED|Treatment Period 2||4
8606551|NCT00395304|9643352|FG002|NOT COMPLETED|Treatment Period 2||1
8606552|NCT00395304|9643353|FG003|NOT COMPLETED|Treatment Period 2||1
8606553|NCT00395304|9643354|FG004|NOT COMPLETED|Treatment Period 2||0
8606554|NCT00395304|9643355|FG005|NOT COMPLETED|Treatment Period 2||2
8606555|NCT00395304|9643350|FG000|STARTED|Treatment Period 3||30
8606556|NCT00395304|9643351|FG001|STARTED|Treatment Period 3||22
8606557|NCT00395304|9643352|FG002|STARTED|Treatment Period 3||29
8606558|NCT00395304|9643353|FG003|STARTED|Treatment Period 3||27
8606559|NCT00395304|9643354|FG004|STARTED|Treatment Period 3||27
8606560|NCT00395304|9643355|FG005|STARTED|Treatment Period 3||28
8606561|NCT00395304|9643350|FG000|COMPLETED|Treatment Period 3||29
8606562|NCT00395304|9643351|FG001|COMPLETED|Treatment Period 3||20
8606563|NCT00395304|9643352|FG002|COMPLETED|Treatment Period 3||29
8606564|NCT00395304|9643353|FG003|COMPLETED|Treatment Period 3||25
8606565|NCT00395304|9643354|FG004|COMPLETED|Treatment Period 3||27
8606566|NCT00395304|9643355|FG005|COMPLETED|Treatment Period 3||27
8606567|NCT00395304|9643350|FG000|NOT COMPLETED|Treatment Period 3||1
8606568|NCT00395304|9643351|FG001|NOT COMPLETED|Treatment Period 3||2
8606569|NCT00395304|9643352|FG002|NOT COMPLETED|Treatment Period 3||0
8606570|NCT00395304|9643353|FG003|NOT COMPLETED|Treatment Period 3||2
8606571|NCT00395304|9643354|FG004|NOT COMPLETED|Treatment Period 3||0
8714421|NCT00979940|9761266|FG001|STARTED|Overall Study||28
8714422|NCT00979940|9761265|FG000|COMPLETED|Overall Study||32
8714423|NCT00979940|9761266|FG001|COMPLETED|Overall Study||28
8714424|NCT00979940|9761265|FG000|NOT COMPLETED|Overall Study||0
8714425|NCT00979940|9761266|FG001|NOT COMPLETED|Overall Study||0
8714426|NCT00979953|9761276|FG000|STARTED|Overall Study||101
8714427|NCT00979953|9761277|FG001|STARTED|Overall Study||99
8606572|NCT00395304|9643355|FG005|NOT COMPLETED|Treatment Period 3||1
8606573|NCT00395343|9643364|FG000|STARTED|Overall Study||322
8606574|NCT00395343|9643365|FG001|STARTED|Overall Study||319
8606575|NCT00395343|9643364|FG000|COMPLETED|Overall Study||281
8606576|NCT00395343|9643365|FG001|COMPLETED|Overall Study||283
8714428|NCT00979953|9761278|FG002|STARTED|Overall Study||104
8714429|NCT00979953|9761279|FG003|STARTED|Overall Study||104
8714430|NCT00979953|9761276|FG000|Received at Least 1 Dose of Study Drug|Overall Study||101
8714431|NCT00979953|9761277|FG001|Received at Least 1 Dose of Study Drug|Overall Study||99
8606577|NCT00395343|9643364|FG000|NOT COMPLETED|Overall Study||41
8606578|NCT00395343|9643365|FG001|NOT COMPLETED|Overall Study||36
8606579|NCT00395447|9643373|FG000|STARTED|Overall Study||1031
8606580|NCT00395447|9643374|FG001|STARTED|Overall Study||713
8606581|NCT00395447|9643373|FG000|COMPLETED|Overall Study||910
8606582|NCT00395447|9643374|FG001|COMPLETED|Overall Study||602
8606583|NCT00395447|9643373|FG000|NOT COMPLETED|Overall Study||121
8606584|NCT00395447|9643374|FG001|NOT COMPLETED|Overall Study||111
8606585|NCT00395460|9643382|FG000|STARTED|Overall Study||72
8606586|NCT00395460|9643383|FG001|STARTED|Overall Study||75
8606587|NCT00395460|9643382|FG000|Received Treatment|Overall Study|1 participant withdrew consent prior to study drug injection and did not receive any study drug.|71
8606588|NCT00395460|9643383|FG001|Received Treatment|Overall Study||75
8606589|NCT00395460|9643382|FG000|COMPLETED|Overall Study||71
8606590|NCT00395460|9643383|FG001|COMPLETED|Overall Study||75
8606591|NCT00395460|9643382|FG000|NOT COMPLETED|Overall Study||1
8606592|NCT00395460|9643383|FG001|NOT COMPLETED|Overall Study||0
8606593|NCT00395486|9643391|FG000|STARTED|Overall Study|Randomized subjects|132
8606594|NCT00395486|9643392|FG001|STARTED|Overall Study|Randomized subjects|126
8606595|NCT00395486|9643391|FG000|COMPLETED|Overall Study|Completed subjects|126
8606596|NCT00395486|9643392|FG001|COMPLETED|Overall Study|Completed subjects|121
8606597|NCT00395486|9643391|FG000|NOT COMPLETED|Overall Study||6
8606598|NCT00395486|9643392|FG001|NOT COMPLETED|Overall Study||5
8606599|NCT00395512|9643402|FG000|STARTED|Overall Study||164
8606600|NCT00395512|9643403|FG001|STARTED|Overall Study||163
8606601|NCT00395512|9643404|FG002|STARTED|Overall Study||164
8606602|NCT00395512|9643405|FG003|STARTED|Overall Study||164
8606603|NCT00395512|9643402|FG000|Safety Set|Overall Study||164
8606604|NCT00395512|9643403|FG001|Safety Set|Overall Study||163
8606605|NCT00395512|9643404|FG002|Safety Set|Overall Study||164
8606606|NCT00395512|9643405|FG003|Safety Set|Overall Study|1 participant was lost to follow-up post visit 1. It is unknown if they took any study medication.|163
8606607|NCT00395512|9643402|FG000|COMPLETED|Overall Study||126
8606608|NCT00395512|9643403|FG001|COMPLETED|Overall Study||126
8606609|NCT00395512|9643404|FG002|COMPLETED|Overall Study||136
8606610|NCT00395512|9643405|FG003|COMPLETED|Overall Study||126
8606611|NCT00395512|9643402|FG000|NOT COMPLETED|Overall Study||38
8606612|NCT00395512|9643403|FG001|NOT COMPLETED|Overall Study||37
8606613|NCT00395512|9643404|FG002|NOT COMPLETED|Overall Study||28
8606614|NCT00395512|9643405|FG003|NOT COMPLETED|Overall Study||38
8606615|NCT00395538|9643418|FG000|STARTED|Overall Study||8
8606616|NCT00395538|9643419|FG001|STARTED|Overall Study||15
8606617|NCT00395538|9643420|FG002|STARTED|Overall Study||23
8606618|NCT00395538|9643418|FG000|Signed Consent to the New Protocol|Overall Study||7
8606619|NCT00395538|9643419|FG001|Signed Consent to the New Protocol|Overall Study||5
8606620|NCT00395538|9643420|FG002|Signed Consent to the New Protocol|Overall Study||23
8606621|NCT00395538|9643418|FG000|Received HPTH on New Protocol|Overall Study||7
8606622|NCT00395538|9643419|FG001|Received HPTH on New Protocol|Overall Study||5
8606623|NCT00395538|9643420|FG002|Received HPTH on New Protocol|Overall Study||19
8606624|NCT00395538|9643418|FG000|Randomized to Bone Biopsy Year 1|Overall Study||0
8606625|NCT00395538|9643419|FG001|Randomized to Bone Biopsy Year 1|Overall Study||1
8606626|NCT00395538|9643420|FG002|Randomized to Bone Biopsy Year 1|Overall Study||5
8606627|NCT00395538|9643418|FG000|Randomized to Bone Biopsy Year 2|Overall Study||0
8606628|NCT00395538|9643419|FG001|Randomized to Bone Biopsy Year 2|Overall Study||2
8606629|NCT00395538|9643420|FG002|Randomized to Bone Biopsy Year 2|Overall Study||6
8606630|NCT00395538|9643418|FG000|Randomized to Bone Biospy Year 4|Overall Study||0
8606631|NCT00395538|9643419|FG001|Randomized to Bone Biospy Year 4|Overall Study||2
8606632|NCT00395538|9643420|FG002|Randomized to Bone Biospy Year 4|Overall Study||8
8714432|NCT00979953|9761278|FG002|Received at Least 1 Dose of Study Drug|Overall Study||104
8714433|NCT00979953|9761279|FG003|Received at Least 1 Dose of Study Drug|Overall Study||104
8714434|NCT00979953|9761276|FG000|COMPLETED|Overall Study||93
8714435|NCT00979953|9761277|FG001|COMPLETED|Overall Study||94
8714436|NCT00979953|9761278|FG002|COMPLETED|Overall Study||82
8714437|NCT00979953|9761279|FG003|COMPLETED|Overall Study||97
8714438|NCT00979953|9761276|FG000|NOT COMPLETED|Overall Study||8
8714439|NCT00979953|9761277|FG001|NOT COMPLETED|Overall Study||5
8714440|NCT00979953|9761278|FG002|NOT COMPLETED|Overall Study||22
8714441|NCT00979953|9761279|FG003|NOT COMPLETED|Overall Study||7
8714442|NCT00979992|9761289|FG000|STARTED|Overall Study||35
8714443|NCT00979992|9761289|FG000|COMPLETED|Overall Study||30
8714444|NCT00979992|9761289|FG000|NOT COMPLETED|Overall Study||5
8714445|NCT00980005|9761295|FG000|STARTED|Overall Study||1055
8714446|NCT00980005|9761296|FG001|STARTED|Overall Study||1061
8714447|NCT00980005|9761295|FG000|COMPLETED|Overall Study||1008
8714448|NCT00980005|9761296|FG001|COMPLETED|Overall Study||998
8714449|NCT00980005|9761295|FG000|NOT COMPLETED|Overall Study||47
8714450|NCT00980005|9761296|FG001|NOT COMPLETED|Overall Study||63
8714451|NCT00980018|9761306|FG000|STARTED|Overall Study||52
8606633|NCT00395538|9643418|FG000|Completed Bone Biopsy Year 1|Overall Study||0
8714452|NCT00980018|9761306|FG000|COMPLETED|Overall Study||40
8714453|NCT00980018|9761306|FG000|NOT COMPLETED|Overall Study||12
8714454|NCT00980044|9761313|FG000|STARTED|Overall Study||17
8714455|NCT00980044|9761314|FG001|STARTED|Overall Study||19
8714456|NCT00980044|9761315|FG002|STARTED|Overall Study||17
8714457|NCT00980044|9761313|FG000|COMPLETED|Overall Study||12
8714458|NCT00980044|9761314|FG001|COMPLETED|Overall Study||12
8714459|NCT00980044|9761315|FG002|COMPLETED|Overall Study||12
8606634|NCT00395538|9643419|FG001|Completed Bone Biopsy Year 1|Overall Study||1
8606635|NCT00395538|9643420|FG002|Completed Bone Biopsy Year 1|Overall Study||4
8606636|NCT00395538|9643418|FG000|Completed Bone Biopsy Year 2|Overall Study||0
8606637|NCT00395538|9643419|FG001|Completed Bone Biopsy Year 2|Overall Study||2
8606638|NCT00395538|9643420|FG002|Completed Bone Biopsy Year 2|Overall Study||3
8606639|NCT00395538|9643418|FG000|Completed Bone Biopsy Year 4|Overall Study||0
8606640|NCT00395538|9643419|FG001|Completed Bone Biopsy Year 4|Overall Study||1
8606641|NCT00395538|9643420|FG002|Completed Bone Biopsy Year 4|Overall Study||1
8606642|NCT00395538|9643418|FG000|COMPLETED|Overall Study||5
8606643|NCT00395538|9643419|FG001|COMPLETED|Overall Study||2
8606644|NCT00395538|9643420|FG002|COMPLETED|Overall Study||0
8714460|NCT00980044|9761313|FG000|NOT COMPLETED|Overall Study||5
8714461|NCT00980044|9761314|FG001|NOT COMPLETED|Overall Study||7
8714462|NCT00980044|9761315|FG002|NOT COMPLETED|Overall Study||5
8714463|NCT00980057|9761328|FG000|STARTED|Overall Study||318
8714464|NCT00980057|9761329|FG001|STARTED|Overall Study||160
8606645|NCT00395538|9643418|FG000|NOT COMPLETED|Overall Study||3
8606646|NCT00395538|9643419|FG001|NOT COMPLETED|Overall Study||13
8606647|NCT00395538|9643420|FG002|NOT COMPLETED|Overall Study||23
8606648|NCT00395629|9643431|FG000|STARTED|Core Study||11
8606649|NCT00395629|9643432|FG001|STARTED|Core Study||15
8606650|NCT00395629|9643433|FG002|STARTED|Core Study||23
8606651|NCT00395629|9643431|FG000|COMPLETED|Core Study||10
8606652|NCT00395629|9643432|FG001|COMPLETED|Core Study||11
8606653|NCT00395629|9643433|FG002|COMPLETED|Core Study||16
8606654|NCT00395629|9643431|FG000|NOT COMPLETED|Core Study||1
8606655|NCT00395629|9643432|FG001|NOT COMPLETED|Core Study||4
8606656|NCT00395629|9643433|FG002|NOT COMPLETED|Core Study||7
8606657|NCT00395629|9643431|FG000|STARTED|Extension Study||9
8606658|NCT00395629|9643432|FG001|STARTED|Extension Study||6
8606659|NCT00395629|9643433|FG002|STARTED|Extension Study||11
8606660|NCT00395629|9643431|FG000|COMPLETED|Extension Study||9
8606661|NCT00395629|9643432|FG001|COMPLETED|Extension Study||6
8606662|NCT00395629|9643433|FG002|COMPLETED|Extension Study||8
8606663|NCT00395629|9643431|FG000|NOT COMPLETED|Extension Study||0
8606664|NCT00395629|9643432|FG001|NOT COMPLETED|Extension Study||0
8606665|NCT00395629|9643433|FG002|NOT COMPLETED|Extension Study||3
8606666|NCT00395642|9643444|FG000|STARTED|Overall Study||66
8606667|NCT00395642|9643444|FG000|COMPLETED|Overall Study||53
8606668|NCT00395642|9643444|FG000|NOT COMPLETED|Overall Study||13
8606669|NCT00395694|9643450|FG000|STARTED|Escalation Phase + Maintenance Phase||51
8606670|NCT00395694|9643451|FG001|STARTED|Escalation Phase + Maintenance Phase||51
8606671|NCT00395694|9643450|FG000|COMPLETED|Escalation Phase + Maintenance Phase||50
8606672|NCT00395694|9643451|FG001|COMPLETED|Escalation Phase + Maintenance Phase||49
8606673|NCT00395694|9643450|FG000|NOT COMPLETED|Escalation Phase + Maintenance Phase||1
8606674|NCT00395694|9643451|FG001|NOT COMPLETED|Escalation Phase + Maintenance Phase||2
8606675|NCT00395694|9643450|FG000|STARTED|Continuation Phase|One participant completing the Escalation/Maintenance Phase did not start the Continuation Phase.|49
8606676|NCT00395694|9643451|FG001|STARTED|Continuation Phase|One participant completing the Escalation/Maintenance Phase did not start the Continuation Phase.|48
8606677|NCT00395694|9643450|FG000|COMPLETED|Continuation Phase||34
8606678|NCT00395694|9643451|FG001|COMPLETED|Continuation Phase||35
8606679|NCT00395694|9643450|FG000|NOT COMPLETED|Continuation Phase||15
8606680|NCT00395694|9643451|FG001|NOT COMPLETED|Continuation Phase||13
8606681|NCT00395733|9643462|FG000|STARTED|Period 1||41
8606682|NCT00395733|9643463|FG001|STARTED|Period 1||42
8606683|NCT00395733|9643462|FG000|COMPLETED|Period 1||41
8606684|NCT00395733|9643463|FG001|COMPLETED|Period 1||42
8606685|NCT00395733|9643462|FG000|NOT COMPLETED|Period 1||0
8606686|NCT00395733|9643463|FG001|NOT COMPLETED|Period 1||0
8606687|NCT00395733|9643462|FG000|STARTED|Period 2||41
8606688|NCT00395733|9643463|FG001|STARTED|Period 2||42
8606689|NCT00395733|9643462|FG000|COMPLETED|Period 2||39
8606690|NCT00395733|9643463|FG001|COMPLETED|Period 2||37
8606691|NCT00395733|9643462|FG000|NOT COMPLETED|Period 2||2
8606692|NCT00395733|9643463|FG001|NOT COMPLETED|Period 2||5
8606693|NCT00395746|9643472|FG000|STARTED|Overall Study|Exposed to study drug|88
8606694|NCT00395746|9643473|FG001|STARTED|Overall Study|Exposed to study drug|88
8606695|NCT00395746|9643474|FG002|STARTED|Overall Study|Exposed to study drug|88
8606696|NCT00395746|9643472|FG000|COMPLETED|Overall Study|Completed 52 weeks treatment|78
8606697|NCT00395746|9643473|FG001|COMPLETED|Overall Study|Completed 52 weeks treatment|84
8606698|NCT00395746|9643474|FG002|COMPLETED|Overall Study|Completed 52 weeks treatment|66
8606699|NCT00395746|9643472|FG000|NOT COMPLETED|Overall Study||10
8606700|NCT00395746|9643473|FG001|NOT COMPLETED|Overall Study||4
8606701|NCT00395746|9643474|FG002|NOT COMPLETED|Overall Study||22
8606702|NCT00395850|9643486|FG000|STARTED|Pre-randomization Baseline/Induction|Pre-randomization and disulfiram (disulf) administration|118
8606703|NCT00395850|9643487|FG001|STARTED|Pre-randomization Baseline/Induction||0
8606704|NCT00395850|9643488|FG002|STARTED|Pre-randomization Baseline/Induction||0
8606705|NCT00395850|9643489|FG003|STARTED|Pre-randomization Baseline/Induction||0
8606706|NCT00395850|9643486|FG000|COMPLETED|Pre-randomization Baseline/Induction||107
8606707|NCT00395850|9643487|FG001|COMPLETED|Pre-randomization Baseline/Induction||0
8606708|NCT00395850|9643488|FG002|COMPLETED|Pre-randomization Baseline/Induction||0
8606709|NCT00395850|9643489|FG003|COMPLETED|Pre-randomization Baseline/Induction||0
8606710|NCT00395850|9643486|FG000|NOT COMPLETED|Pre-randomization Baseline/Induction||11
8714465|NCT00980057|9761328|FG000|COMPLETED|Overall Study||299
8606711|NCT00395850|9643487|FG001|NOT COMPLETED|Pre-randomization Baseline/Induction||0
8606712|NCT00395850|9643488|FG002|NOT COMPLETED|Pre-randomization Baseline/Induction||0
8606713|NCT00395850|9643489|FG003|NOT COMPLETED|Pre-randomization Baseline/Induction||0
8606714|NCT00395850|9643486|FG000|STARTED|Randomization to Disulfiram/ Pre-admin||27
8606715|NCT00395850|9643487|FG001|STARTED|Randomization to Disulfiram/ Pre-admin||25
8606716|NCT00395850|9643488|FG002|STARTED|Randomization to Disulfiram/ Pre-admin||30
8606717|NCT00395850|9643489|FG003|STARTED|Randomization to Disulfiram/ Pre-admin||25
8606718|NCT00395850|9643486|FG000|COMPLETED|Randomization to Disulfiram/ Pre-admin||22
8606719|NCT00395850|9643487|FG001|COMPLETED|Randomization to Disulfiram/ Pre-admin||23
8606720|NCT00395850|9643488|FG002|COMPLETED|Randomization to Disulfiram/ Pre-admin||24
8606721|NCT00395850|9643489|FG003|COMPLETED|Randomization to Disulfiram/ Pre-admin||21
8606722|NCT00395850|9643486|FG000|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||5
8606723|NCT00395850|9643487|FG001|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||2
8606724|NCT00395850|9643488|FG002|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||6
8606725|NCT00395850|9643489|FG003|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||4
8606726|NCT00395850|9643486|FG000|STARTED|Disulfiram/Placebo Treatment|Received >= 1 disulfiram dose. Two baseline/randomized subjects dropped out before receiving disulf|20
8606727|NCT00395850|9643487|FG001|STARTED|Disulfiram/Placebo Treatment|Received at least one dose of disulfiram|23
8606728|NCT00395850|9643488|FG002|STARTED|Disulfiram/Placebo Treatment|Received at least one dose of disulfiram|24
8606729|NCT00395850|9643489|FG003|STARTED|Disulfiram/Placebo Treatment|Received at least one dose of disulfiram|21
8606730|NCT00395850|9643486|FG000|COMPLETED|Disulfiram/Placebo Treatment||11
8606731|NCT00395850|9643487|FG001|COMPLETED|Disulfiram/Placebo Treatment||9
8606732|NCT00395850|9643488|FG002|COMPLETED|Disulfiram/Placebo Treatment||5
8606733|NCT00395850|9643489|FG003|COMPLETED|Disulfiram/Placebo Treatment||8
8606734|NCT00395850|9643486|FG000|NOT COMPLETED|Disulfiram/Placebo Treatment||9
8606735|NCT00395850|9643487|FG001|NOT COMPLETED|Disulfiram/Placebo Treatment||14
8714466|NCT00980057|9761329|FG001|COMPLETED|Overall Study||155
8714467|NCT00980057|9761328|FG000|NOT COMPLETED|Overall Study||19
8714468|NCT00980057|9761329|FG001|NOT COMPLETED|Overall Study||5
8714469|NCT00980148|9761338|FG000|STARTED|Overall Study||284
8714470|NCT00980148|9761339|FG001|STARTED|Overall Study||283
8714471|NCT00980148|9761338|FG000|COMPLETED|Overall Study|Completed primary evaluation at study visit # 2 (day 28 after therapy started)|155
8606736|NCT00395850|9643488|FG002|NOT COMPLETED|Disulfiram/Placebo Treatment||19
8606737|NCT00395850|9643489|FG003|NOT COMPLETED|Disulfiram/Placebo Treatment||13
8606738|NCT00395863|9643501|FG000|STARTED|Overall Study||23
8606739|NCT00395863|9643502|FG001|STARTED|Overall Study||23
8606740|NCT00395863|9643501|FG000|COMPLETED|Overall Study||21
8606741|NCT00395863|9643502|FG001|COMPLETED|Overall Study||20
8606742|NCT00395863|9643501|FG000|NOT COMPLETED|Overall Study||2
8606743|NCT00395863|9643502|FG001|NOT COMPLETED|Overall Study||3
8606744|NCT00395876|9643513|FG000|STARTED|Overall Study||50
8606745|NCT00395876|9643514|FG001|STARTED|Overall Study||50
8606746|NCT00395876|9643513|FG000|COMPLETED|Overall Study||47
8606747|NCT00395876|9643514|FG001|COMPLETED|Overall Study||50
8606748|NCT00395876|9643513|FG000|NOT COMPLETED|Overall Study||3
8606749|NCT00395876|9643514|FG001|NOT COMPLETED|Overall Study||0
8606750|NCT00395967|9643520|FG000|STARTED|Treatment Period||5
8606751|NCT00395967|9643520|FG000|COMPLETED|Treatment Period|Failed mobilization due to <2 fold yield after one day of plerixafor treatment|4
8606752|NCT00395967|9643520|FG000|NOT COMPLETED|Treatment Period||1
8606753|NCT00395967|9643520|FG000|STARTED|Follow-up Period|Participants who had transplants.|5
8606754|NCT00395967|9643520|FG000|COMPLETED|Follow-up Period||3
8606755|NCT00395967|9643520|FG000|NOT COMPLETED|Follow-up Period||2
8606756|NCT00395993|9643526|FG000|STARTED|Overall Study||246
8606757|NCT00395993|9643527|FG001|STARTED|Overall Study||231
8606758|NCT00395993|9643526|FG000|COMPLETED|Overall Study||211
8606759|NCT00395993|9643527|FG001|COMPLETED|Overall Study||212
8606760|NCT00395993|9643526|FG000|NOT COMPLETED|Overall Study||35
8606761|NCT00395993|9643527|FG001|NOT COMPLETED|Overall Study||19
8606762|NCT00396006|9643533|FG000|STARTED|Overall Study||13
8606763|NCT00396006|9643533|FG000|COMPLETED|Overall Study||13
8606764|NCT00396006|9643533|FG000|NOT COMPLETED|Overall Study||0
8606765|NCT00396019|9643541|FG000|STARTED|Overall Study||27
8606766|NCT00396019|9643542|FG001|STARTED|Overall Study||29
8606767|NCT00396019|9643543|FG002|STARTED|Overall Study||30
8606768|NCT00396019|9643541|FG000|COMPLETED|Overall Study||27
8606769|NCT00396019|9643542|FG001|COMPLETED|Overall Study||26
8606770|NCT00396019|9643543|FG002|COMPLETED|Overall Study||29
8606771|NCT00396019|9643541|FG000|NOT COMPLETED|Overall Study||0
8606772|NCT00396019|9643542|FG001|NOT COMPLETED|Overall Study||3
8606773|NCT00396019|9643543|FG002|NOT COMPLETED|Overall Study||1
8606774|NCT00396032|9643554|FG000|STARTED|Overall Study||74
8606775|NCT00396032|9643555|FG001|STARTED|Overall Study||76
8606776|NCT00396032|9643554|FG000|COMPLETED|Overall Study||70
8606777|NCT00396032|9643555|FG001|COMPLETED|Overall Study||71
8606778|NCT00396032|9643554|FG000|NOT COMPLETED|Overall Study||4
8606779|NCT00396032|9643555|FG001|NOT COMPLETED|Overall Study||5
8606780|NCT00396084|9643567|FG000|STARTED|Overall Study||10
8606781|NCT00396084|9643568|FG001|STARTED|Overall Study||10
8606782|NCT00396084|9643569|FG002|STARTED|Overall Study||10
8606783|NCT00396084|9643570|FG003|STARTED|Overall Study||10
8606784|NCT00396084|9643571|FG004|STARTED|Overall Study||10
8606785|NCT00396084|9643572|FG005|STARTED|Overall Study||20
8606786|NCT00396084|9643567|FG000|COMPLETED|Overall Study||10
8606787|NCT00396084|9643568|FG001|COMPLETED|Overall Study||10
8606788|NCT00396084|9643569|FG002|COMPLETED|Overall Study||10
8606789|NCT00396084|9643570|FG003|COMPLETED|Overall Study||9
8606790|NCT00396084|9643571|FG004|COMPLETED|Overall Study||9
8606791|NCT00396084|9643572|FG005|COMPLETED|Overall Study||18
8606792|NCT00396084|9643567|FG000|NOT COMPLETED|Overall Study||0
8606793|NCT00396084|9643568|FG001|NOT COMPLETED|Overall Study||0
8606794|NCT00396084|9643569|FG002|NOT COMPLETED|Overall Study||0
8606795|NCT00396084|9643570|FG003|NOT COMPLETED|Overall Study||1
8606796|NCT00396084|9643571|FG004|NOT COMPLETED|Overall Study||1
8606797|NCT00396084|9643572|FG005|NOT COMPLETED|Overall Study||2
8606798|NCT00396097|9643592|FG000|STARTED|Overall Study|4 participants randomized to Individualized Dose, received Standard Dose throughout the study.|114
8606799|NCT00396097|9643593|FG001|STARTED|Overall Study||202
8606800|NCT00396097|9643592|FG000|COMPLETED|Overall Study||88
8606801|NCT00396097|9643593|FG001|COMPLETED|Overall Study||156
8606802|NCT00396097|9643592|FG000|NOT COMPLETED|Overall Study||26
8606803|NCT00396097|9643593|FG001|NOT COMPLETED|Overall Study||46
8606804|NCT00396136|9643603|FG000|STARTED|Overall Study||221
8606805|NCT00396136|9643603|FG000|COMPLETED|Overall Study||96
8606806|NCT00396136|9643603|FG000|NOT COMPLETED|Overall Study||125
8606807|NCT00396162|9643609|FG000|STARTED|Overall Study||39
8606808|NCT00396162|9643610|FG001|STARTED|Overall Study||38
8606809|NCT00396162|9643609|FG000|COMPLETED|Overall Study||37
8606810|NCT00396162|9643610|FG001|COMPLETED|Overall Study||35
8606811|NCT00396162|9643609|FG000|NOT COMPLETED|Overall Study||2
8606812|NCT00396162|9643610|FG001|NOT COMPLETED|Overall Study||3
8606813|NCT00396201|9643620|FG000|STARTED|Treatment Period||22
8606814|NCT00396201|9643620|FG000|COMPLETED|Treatment Period|Completed refers to completed all treatment visits.|22
8606815|NCT00396201|9643620|FG000|NOT COMPLETED|Treatment Period||0
8606816|NCT00396201|9643620|FG000|STARTED|Follow-up Period|Participants who had transplants. One had insufficient collection of cells so no transplant.|21
8606817|NCT00396201|9643620|FG000|COMPLETED|Follow-up Period|Follow-up visit 12 months post-transplant|21
8606818|NCT00396201|9643620|FG000|NOT COMPLETED|Follow-up Period||0
8606819|NCT00396253|9643625|FG000|STARTED|Overall Study||223
8606820|NCT00396253|9643625|FG000|COMPLETED|Overall Study||210
8606821|NCT00396253|9643625|FG000|NOT COMPLETED|Overall Study||13
8606822|NCT00396266|9643631|FG000|STARTED|Overall Study||8
8606823|NCT00396266|9643632|FG001|STARTED|Overall Study||14
8606824|NCT00396266|9643631|FG000|COMPLETED|Overall Study||8
8606825|NCT00396266|9643632|FG001|COMPLETED|Overall Study||14
8606826|NCT00396266|9643631|FG000|NOT COMPLETED|Overall Study||0
8606827|NCT00396266|9643632|FG001|NOT COMPLETED|Overall Study||0
8606828|NCT00396279|9643642|FG000|STARTED|Overall Study||37
8606829|NCT00396279|9643642|FG000|COMPLETED|Overall Study|Defined as participants with a complete resection|7
8606830|NCT00396279|9643642|FG000|NOT COMPLETED|Overall Study||30
8606831|NCT00396292|9643648|FG000|STARTED|Overall Study||174
8606832|NCT00396292|9643649|FG001|STARTED|Overall Study||178
8606833|NCT00396292|9643648|FG000|COMPLETED|Overall Study||165
8606834|NCT00396292|9643649|FG001|COMPLETED|Overall Study||162
8606835|NCT00396292|9643648|FG000|NOT COMPLETED|Overall Study||9
8606836|NCT00396292|9643649|FG001|NOT COMPLETED|Overall Study||16
8606837|NCT00396318|9643655|FG000|STARTED|At Least One Dose of Tenecteplase (MITT)||246
8606838|NCT00396318|9643655|FG000|COMPLETED|At Least One Dose of Tenecteplase (MITT)||241
8606839|NCT00396318|9643655|FG000|NOT COMPLETED|At Least One Dose of Tenecteplase (MITT)||5
8606840|NCT00396318|9643655|FG000|STARTED|48- to 96-Hour Follow-Up Period||246
8606841|NCT00396318|9643655|FG000|COMPLETED|48- to 96-Hour Follow-Up Period||241
8606842|NCT00396318|9643655|FG000|NOT COMPLETED|48- to 96-Hour Follow-Up Period||5
8606843|NCT00396318|9643655|FG000|STARTED|7-Day Post-Treatment Contact||241
8606844|NCT00396318|9643655|FG000|COMPLETED|7-Day Post-Treatment Contact||240
8606845|NCT00396318|9643655|FG000|NOT COMPLETED|7-Day Post-Treatment Contact||1
8606846|NCT00396331|9643663|FG000|STARTED|Overall Study||100
8606847|NCT00396331|9643663|FG000|Number of Participants Treated|Overall Study||100
8606848|NCT00396331|9643663|FG000|Number of Participants Transplanted|Overall Study|7 participants had two transplants|87
8606849|NCT00396331|9643663|FG000|COMPLETED|Overall Study||68
8606850|NCT00396331|9643663|FG000|NOT COMPLETED|Overall Study||32
8606851|NCT00396383|9643675|FG000|STARTED|Overall Study||9
8606852|NCT00396383|9643675|FG000|COMPLETED|Overall Study||6
8606853|NCT00396383|9643675|FG000|NOT COMPLETED|Overall Study||3
8606854|NCT00396409|9643681|FG000|STARTED|Period 1 - 2007||65
8606855|NCT00396409|9643682|FG001|STARTED|Period 1 - 2007||63
8606856|NCT00396409|9643681|FG000|COMPLETED|Period 1 - 2007||62
8606857|NCT00396409|9643682|FG001|COMPLETED|Period 1 - 2007||57
8606858|NCT00396409|9643681|FG000|NOT COMPLETED|Period 1 - 2007||3
8606859|NCT00396409|9643682|FG001|NOT COMPLETED|Period 1 - 2007||6
8606860|NCT00396409|9643681|FG000|STARTED|Between Period 1 and Period 2||62
8606861|NCT00396409|9643682|FG001|STARTED|Between Period 1 and Period 2||57
8606862|NCT00396409|9643681|FG000|COMPLETED|Between Period 1 and Period 2||59
8606863|NCT00396409|9643682|FG001|COMPLETED|Between Period 1 and Period 2||55
8606864|NCT00396409|9643681|FG000|NOT COMPLETED|Between Period 1 and Period 2||3
8606865|NCT00396409|9643682|FG001|NOT COMPLETED|Between Period 1 and Period 2||2
8606866|NCT00396409|9643681|FG000|STARTED|Period 2 - 2008||59
8606867|NCT00396409|9643682|FG001|STARTED|Period 2 - 2008||55
8606868|NCT00396409|9643681|FG000|COMPLETED|Period 2 - 2008||52
8606869|NCT00396409|9643682|FG001|COMPLETED|Period 2 - 2008||53
8606870|NCT00396409|9643681|FG000|NOT COMPLETED|Period 2 - 2008||7
8606871|NCT00396409|9643682|FG001|NOT COMPLETED|Period 2 - 2008||2
8606872|NCT00396565|9643693|FG000|STARTED|Overall Study||136
8606873|NCT00396565|9643694|FG001|STARTED|Overall Study||138
8606874|NCT00396565|9643695|FG002|STARTED|Overall Study||47
8606875|NCT00396565|9643693|FG000|COMPLETED|Overall Study||88
8606876|NCT00396565|9643694|FG001|COMPLETED|Overall Study||47
8606877|NCT00396565|9643695|FG002|COMPLETED|Overall Study||30
8606878|NCT00396565|9643693|FG000|NOT COMPLETED|Overall Study||48
8606879|NCT00396565|9643694|FG001|NOT COMPLETED|Overall Study||91
8606880|NCT00396565|9643695|FG002|NOT COMPLETED|Overall Study||17
8606881|NCT00396591|9643703|FG000|STARTED|Overall Study||16
8606882|NCT00396591|9643703|FG000|COMPLETED|Overall Study||0
8606883|NCT00396591|9643703|FG000|NOT COMPLETED|Overall Study||16
8606884|NCT00396630|9643709|FG000|STARTED|Overall Study||100
8606885|NCT00396630|9643710|FG001|STARTED|Overall Study||100
8606886|NCT00396630|9643709|FG000|COMPLETED|Overall Study|Completed Visit 4 (Week 17).|95
8606887|NCT00396630|9643710|FG001|COMPLETED|Overall Study|Completed Visit 4 (Week 17).|95
8606888|NCT00396630|9643709|FG000|NOT COMPLETED|Overall Study||5
8606889|NCT00396630|9643710|FG001|NOT COMPLETED|Overall Study||5
8606890|NCT00396656|9643717|FG000|STARTED|First Treatment Period||15
8606891|NCT00396656|9643718|FG001|STARTED|First Treatment Period||15
8606892|NCT00396656|9643717|FG000|COMPLETED|First Treatment Period||15
8606893|NCT00396656|9643718|FG001|COMPLETED|First Treatment Period||13
8606894|NCT00396656|9643717|FG000|NOT COMPLETED|First Treatment Period||0
8606895|NCT00396656|9643718|FG001|NOT COMPLETED|First Treatment Period||2
8606896|NCT00396656|9643717|FG000|STARTED|Second Treatment Period||15
8606897|NCT00396656|9643718|FG001|STARTED|Second Treatment Period||13
8606898|NCT00396656|9643717|FG000|COMPLETED|Second Treatment Period||15
8606899|NCT00396656|9643718|FG001|COMPLETED|Second Treatment Period||12
8606900|NCT00396656|9643717|FG000|NOT COMPLETED|Second Treatment Period||0
8606901|NCT00396656|9643718|FG001|NOT COMPLETED|Second Treatment Period||1
8606902|NCT00396812|9643724|FG000|STARTED|Overall Study||4
8606903|NCT00396812|9643724|FG000|COMPLETED|Overall Study|4 subjects completed treatment, but 1 subject terminated early due to disease progression|3
8606904|NCT00396812|9643724|FG000|NOT COMPLETED|Overall Study||1
8606905|NCT00396877|9643730|FG000|STARTED|Overall Study|Randomized|439
8606906|NCT00396877|9643731|FG001|STARTED|Overall Study|Randomized|467
8606907|NCT00396877|9643730|FG000|Treated|Overall Study||436
8606908|NCT00396877|9643731|FG001|Treated|Overall Study||464
8606909|NCT00396877|9643730|FG000|Completed Treatment|Overall Study||356
8606910|NCT00396877|9643731|FG001|Completed Treatment|Overall Study||352
8606911|NCT00396877|9643730|FG000|COMPLETED|Overall Study|Completed follow-up|433
8606912|NCT00396877|9643731|FG001|COMPLETED|Overall Study|Completed follow-up|459
8606913|NCT00396877|9643730|FG000|NOT COMPLETED|Overall Study||6
8606914|NCT00396877|9643731|FG001|NOT COMPLETED|Overall Study||8
8606915|NCT00396981|9643739|FG000|STARTED|Overall Study||311
8606916|NCT00396981|9643740|FG001|STARTED|Overall Study||315
8606917|NCT00396981|9643739|FG000|COMPLETED|Overall Study||296
8606918|NCT00396981|9643740|FG001|COMPLETED|Overall Study||306
8606919|NCT00396981|9643739|FG000|NOT COMPLETED|Overall Study||15
8606920|NCT00396981|9643740|FG001|NOT COMPLETED|Overall Study||9
8606921|NCT00397020|9643748|FG000|STARTED|Overall Study||14
8606922|NCT00397020|9643749|FG001|STARTED|Overall Study||16
8606923|NCT00397020|9643748|FG000|COMPLETED|Overall Study||13
8606924|NCT00397020|9643749|FG001|COMPLETED|Overall Study||15
8606925|NCT00397020|9643748|FG000|NOT COMPLETED|Overall Study||1
8606926|NCT00397020|9643749|FG001|NOT COMPLETED|Overall Study||1
8606927|NCT00397033|9643758|FG000|STARTED|Overall Study||107
8606928|NCT00397033|9643759|FG001|STARTED|Overall Study||109
8606929|NCT00397033|9643760|FG002|STARTED|Overall Study||100
8606930|NCT00397033|9643758|FG000|Safety Population: >= 1 Dose of Drug|Overall Study||107
8606931|NCT00397033|9643759|FG001|Safety Population: >= 1 Dose of Drug|Overall Study||108
8606932|NCT00397033|9643760|FG002|Safety Population: >= 1 Dose of Drug|Overall Study||98
8606933|NCT00397033|9643758|FG000|ITT Population|Overall Study||107
8606934|NCT00397033|9643759|FG001|ITT Population|Overall Study||105
8606935|NCT00397033|9643760|FG002|ITT Population|Overall Study||98
8606936|NCT00397033|9643758|FG000|COMPLETED|Overall Study||63
8606937|NCT00397033|9643759|FG001|COMPLETED|Overall Study||72
8606938|NCT00397033|9643760|FG002|COMPLETED|Overall Study||77
8606939|NCT00397033|9643758|FG000|NOT COMPLETED|Overall Study||44
8606940|NCT00397033|9643759|FG001|NOT COMPLETED|Overall Study||37
8606941|NCT00397033|9643760|FG002|NOT COMPLETED|Overall Study||23
8606942|NCT00397046|9643772|FG000|STARTED|Overall Study||3
8606943|NCT00397046|9643773|FG001|STARTED|Overall Study||3
8606944|NCT00397046|9643774|FG002|STARTED|Overall Study||10
8606945|NCT00397046|9643775|FG003|STARTED|Overall Study||5
8606946|NCT00397046|9643772|FG000|COMPLETED|Overall Study||0
8606947|NCT00397046|9643773|FG001|COMPLETED|Overall Study||0
8606948|NCT00397046|9643774|FG002|COMPLETED|Overall Study||0
8606949|NCT00397046|9643775|FG003|COMPLETED|Overall Study||0
8606950|NCT00397046|9643772|FG000|NOT COMPLETED|Overall Study||3
8606951|NCT00397046|9643773|FG001|NOT COMPLETED|Overall Study||3
8606952|NCT00397046|9643774|FG002|NOT COMPLETED|Overall Study||10
8606953|NCT00397046|9643775|FG003|NOT COMPLETED|Overall Study||5
8606954|NCT00397150|9643788|FG000|STARTED|Overall Study||1323
8606955|NCT00397150|9643789|FG001|STARTED|Overall Study||1256
8606956|NCT00397150|9643788|FG000|COMPLETED|Overall Study||1188
8606957|NCT00397150|9643789|FG001|COMPLETED|Overall Study||1111
8606958|NCT00397150|9643788|FG000|NOT COMPLETED|Overall Study||135
8606959|NCT00397150|9643789|FG001|NOT COMPLETED|Overall Study||145
8606960|NCT00397189|9643797|FG000|STARTED|3 Weeks Period||394
8606961|NCT00397189|9643798|FG001|STARTED|3 Weeks Period||395
8606962|NCT00397189|9643797|FG000|COMPLETED|3 Weeks Period|out of 373, 360 were included in the ITT population detailed in the Baseline Characteristics.|373
8606963|NCT00397189|9643798|FG001|COMPLETED|3 Weeks Period|out of 373, 362 were included in the ITT population detailed in the Baseline Characteristics|373
8606964|NCT00397189|9643797|FG000|NOT COMPLETED|3 Weeks Period||21
8606965|NCT00397189|9643798|FG001|NOT COMPLETED|3 Weeks Period||22
8606966|NCT00397189|9643797|FG000|STARTED|Extension Period|Not all completers continued to extension as only patients who wished to proceed were randomized.|534
8606967|NCT00397189|9643798|FG001|STARTED|Extension Period|Please note randomization ratio in extension is 3:1|177
8606968|NCT00397189|9643797|FG000|COMPLETED|Extension Period||421
8606969|NCT00397189|9643798|FG001|COMPLETED|Extension Period||134
8606970|NCT00397189|9643797|FG000|NOT COMPLETED|Extension Period||113
8606971|NCT00397189|9643798|FG001|NOT COMPLETED|Extension Period||43
8606972|NCT00397215|9643810|FG000|STARTED|Month 0 (Day 0)||165
8606973|NCT00397215|9643811|FG001|STARTED|Month 0 (Day 0)||61
8606974|NCT00397215|9643812|FG002|STARTED|Month 0 (Day 0)||159
8606975|NCT00397215|9643813|FG003|STARTED|Month 0 (Day 0)||52
8606976|NCT00397215|9643810|FG000|COMPLETED|Month 0 (Day 0)||158
8606977|NCT00397215|9643811|FG001|COMPLETED|Month 0 (Day 0)||56
8606978|NCT00397215|9643812|FG002|COMPLETED|Month 0 (Day 0)||153
8606979|NCT00397215|9643813|FG003|COMPLETED|Month 0 (Day 0)||48
8606980|NCT00397215|9643810|FG000|NOT COMPLETED|Month 0 (Day 0)||7
8606981|NCT00397215|9643811|FG001|NOT COMPLETED|Month 0 (Day 0)||5
8606982|NCT00397215|9643812|FG002|NOT COMPLETED|Month 0 (Day 0)||6
8606983|NCT00397215|9643813|FG003|NOT COMPLETED|Month 0 (Day 0)||4
8606984|NCT00397215|9643810|FG000|STARTED|Month 6 (Day 180)||164
8606985|NCT00397215|9643811|FG001|STARTED|Month 6 (Day 180)||58
8606986|NCT00397215|9643812|FG002|STARTED|Month 6 (Day 180)||158
8606987|NCT00397215|9643813|FG003|STARTED|Month 6 (Day 180)||51
8606988|NCT00397215|9643810|FG000|COMPLETED|Month 6 (Day 180)||162
8606989|NCT00397215|9643811|FG001|COMPLETED|Month 6 (Day 180)||55
8606990|NCT00397215|9643812|FG002|COMPLETED|Month 6 (Day 180)||153
8606991|NCT00397215|9643813|FG003|COMPLETED|Month 6 (Day 180)||51
8606992|NCT00397215|9643810|FG000|NOT COMPLETED|Month 6 (Day 180)||2
8606993|NCT00397215|9643811|FG001|NOT COMPLETED|Month 6 (Day 180)||3
8606994|NCT00397215|9643812|FG002|NOT COMPLETED|Month 6 (Day 180)||5
8606995|NCT00397215|9643813|FG003|NOT COMPLETED|Month 6 (Day 180)||0
8606996|NCT00397215|9643810|FG000|STARTED|Month 12 (Day 360)||130
8606997|NCT00397215|9643811|FG001|STARTED|Month 12 (Day 360)||48
8606998|NCT00397215|9643812|FG002|STARTED|Month 12 (Day 360)||125
8606999|NCT00397215|9643813|FG003|STARTED|Month 12 (Day 360)||42
8607000|NCT00397215|9643810|FG000|COMPLETED|Month 12 (Day 360)||130
8607001|NCT00397215|9643811|FG001|COMPLETED|Month 12 (Day 360)||48
8607002|NCT00397215|9643812|FG002|COMPLETED|Month 12 (Day 360)||125
8607003|NCT00397215|9643813|FG003|COMPLETED|Month 12 (Day 360)||42
8607004|NCT00397215|9643810|FG000|NOT COMPLETED|Month 12 (Day 360)||0
8607005|NCT00397215|9643811|FG001|NOT COMPLETED|Month 12 (Day 360)||0
8607006|NCT00397215|9643812|FG002|NOT COMPLETED|Month 12 (Day 360)||0
8607007|NCT00397215|9643813|FG003|NOT COMPLETED|Month 12 (Day 360)||0
8607008|NCT00397215|9643810|FG000|STARTED|Month 24 (Day 720)||122
8607009|NCT00397215|9643811|FG001|STARTED|Month 24 (Day 720)||45
8607010|NCT00397215|9643812|FG002|STARTED|Month 24 (Day 720)||117
8607011|NCT00397215|9643813|FG003|STARTED|Month 24 (Day 720)||36
8607012|NCT00397215|9643810|FG000|COMPLETED|Month 24 (Day 720)||122
8607013|NCT00397215|9643811|FG001|COMPLETED|Month 24 (Day 720)||45
8607014|NCT00397215|9643812|FG002|COMPLETED|Month 24 (Day 720)||117
8607015|NCT00397215|9643813|FG003|COMPLETED|Month 24 (Day 720)||36
8607016|NCT00397215|9643810|FG000|NOT COMPLETED|Month 24 (Day 720)||0
8607017|NCT00397215|9643811|FG001|NOT COMPLETED|Month 24 (Day 720)||0
8607018|NCT00397215|9643812|FG002|NOT COMPLETED|Month 24 (Day 720)||0
8607019|NCT00397215|9643813|FG003|NOT COMPLETED|Month 24 (Day 720)||0
8607020|NCT00397462|9643829|FG000|STARTED|Overall Study||16
8607021|NCT00397462|9643830|FG001|STARTED|Overall Study||13
8607022|NCT00397462|9643831|FG002|STARTED|Overall Study||15
8607023|NCT00397462|9643829|FG000|COMPLETED|Overall Study||16
8607024|NCT00397462|9643830|FG001|COMPLETED|Overall Study||13
8607025|NCT00397462|9643831|FG002|COMPLETED|Overall Study||15
8607026|NCT00397462|9643829|FG000|NOT COMPLETED|Overall Study||0
8607027|NCT00397462|9643830|FG001|NOT COMPLETED|Overall Study||0
8607028|NCT00397462|9643831|FG002|NOT COMPLETED|Overall Study||0
8607029|NCT00397488|9643839|FG000|STARTED|Overall Study||78
8607030|NCT00397488|9643839|FG000|COMPLETED|Overall Study||71
8607031|NCT00397488|9643839|FG000|NOT COMPLETED|Overall Study||7
8607032|NCT00397514|9643843|FG000|STARTED|Overall Study||34
8607033|NCT00397514|9643843|FG000|COMPLETED|Overall Study||25
8607034|NCT00397514|9643843|FG000|NOT COMPLETED|Overall Study||9
8607035|NCT00397540|9643855|FG000|STARTED|Overall Study||60
8607036|NCT00397540|9643856|FG001|STARTED|Overall Study||85
8607037|NCT00397540|9643855|FG000|COMPLETED|Overall Study||59
8607038|NCT00397540|9643856|FG001|COMPLETED|Overall Study||85
8607039|NCT00397540|9643855|FG000|NOT COMPLETED|Overall Study||1
8607040|NCT00397540|9643856|FG001|NOT COMPLETED|Overall Study||0
8607041|NCT00397579|9643863|FG000|STARTED|Overall Study||11
8607042|NCT00397579|9643863|FG000|COMPLETED|Overall Study||11
8607043|NCT00397579|9643863|FG000|NOT COMPLETED|Overall Study||0
8607044|NCT00397631|9643869|FG000|STARTED|Overall Study|Randomization ratio was 1:1|261
8607045|NCT00397631|9643870|FG001|STARTED|Overall Study||259
8607046|NCT00397631|9643869|FG000|COMPLETED|Overall Study||231
8607047|NCT00397631|9643870|FG001|COMPLETED|Overall Study||215
8607048|NCT00397631|9643869|FG000|NOT COMPLETED|Overall Study||30
8607049|NCT00397631|9643870|FG001|NOT COMPLETED|Overall Study||44
8607050|NCT00397813|9643882|FG000|STARTED|Overall Study||36
8607051|NCT00397813|9643883|FG001|STARTED|Overall Study||0
8607052|NCT00397813|9643884|FG002|STARTED|Overall Study||0
8607053|NCT00397813|9643885|FG003|STARTED|Overall Study||12
8607054|NCT00397813|9643886|FG004|STARTED|Overall Study||5
8607055|NCT00397813|9643887|FG005|STARTED|Overall Study||24
8607056|NCT00397813|9643882|FG000|COMPLETED|Overall Study||36
8607057|NCT00397813|9643883|FG001|COMPLETED|Overall Study||0
8607058|NCT00397813|9643884|FG002|COMPLETED|Overall Study||0
8607059|NCT00397813|9643885|FG003|COMPLETED|Overall Study||12
8607060|NCT00397813|9643886|FG004|COMPLETED|Overall Study||5
8607061|NCT00397813|9643887|FG005|COMPLETED|Overall Study||24
8607062|NCT00397813|9643882|FG000|NOT COMPLETED|Overall Study||0
8607063|NCT00397813|9643883|FG001|NOT COMPLETED|Overall Study||0
8607064|NCT00397813|9643884|FG002|NOT COMPLETED|Overall Study||0
8607065|NCT00397813|9643885|FG003|NOT COMPLETED|Overall Study||0
8607066|NCT00397813|9643886|FG004|NOT COMPLETED|Overall Study||0
8607067|NCT00397813|9643887|FG005|NOT COMPLETED|Overall Study||0
8607068|NCT00397839|9643903|FG000|STARTED|Overall Study||48
8607069|NCT00397839|9643904|FG001|STARTED|Overall Study||87
8607070|NCT00397839|9643903|FG000|COMPLETED|Overall Study||41
8607071|NCT00397839|9643904|FG001|COMPLETED|Overall Study||69
8607072|NCT00397839|9643903|FG000|NOT COMPLETED|Overall Study||7
8607073|NCT00397839|9643904|FG001|NOT COMPLETED|Overall Study||18
8607074|NCT00397878|9643910|FG000|STARTED|Overall Study||10
8607075|NCT00397878|9643910|FG000|COMPLETED|Overall Study||10
8607076|NCT00397878|9643910|FG000|NOT COMPLETED|Overall Study||0
8607077|NCT00397891|9643919|FG000|STARTED|Overall Study||6
8607078|NCT00397891|9643920|FG001|STARTED|Overall Study||6
8607079|NCT00397891|9643921|FG002|STARTED|Overall Study||6
8607080|NCT00397891|9643922|FG003|STARTED|Overall Study||6
8607081|NCT00397891|9643923|FG004|STARTED|Overall Study||8
8607082|NCT00397891|9643919|FG000|COMPLETED|Overall Study||5
8607083|NCT00397891|9643920|FG001|COMPLETED|Overall Study||6
8607084|NCT00397891|9643921|FG002|COMPLETED|Overall Study||6
8607085|NCT00397891|9643922|FG003|COMPLETED|Overall Study||6
8607086|NCT00397891|9643923|FG004|COMPLETED|Overall Study||7
8607087|NCT00397891|9643919|FG000|NOT COMPLETED|Overall Study||1
8607088|NCT00397891|9643920|FG001|NOT COMPLETED|Overall Study||0
8607089|NCT00397891|9643921|FG002|NOT COMPLETED|Overall Study||0
8607090|NCT00397891|9643922|FG003|NOT COMPLETED|Overall Study||0
8607091|NCT00397891|9643923|FG004|NOT COMPLETED|Overall Study||1
8607092|NCT00397904|9643935|FG000|STARTED|Overall Study||16
8607093|NCT00397904|9643935|FG000|COMPLETED|Overall Study||16
8607094|NCT00397904|9643935|FG000|NOT COMPLETED|Overall Study||0
8607095|NCT00397930|9643941|FG000|STARTED|Overall Study||206
8607096|NCT00397930|9643942|FG001|STARTED|Overall Study||204
8607097|NCT00397930|9643941|FG000|COMPLETED|Overall Study||168
8607098|NCT00397930|9643942|FG001|COMPLETED|Overall Study||153
8607099|NCT00397930|9643941|FG000|NOT COMPLETED|Overall Study||38
8607100|NCT00397930|9643942|FG001|NOT COMPLETED|Overall Study||51
8607101|NCT00397943|9643953|FG000|STARTED|Overall Study||40
8607102|NCT00397943|9643954|FG001|STARTED|Overall Study||40
8607103|NCT00397943|9643955|FG002|STARTED|Overall Study||10
8607104|NCT00397943|9643956|FG003|STARTED|Overall Study||10
8607105|NCT00397943|9643957|FG004|STARTED|Overall Study||10
8607106|NCT00397943|9643953|FG000|COMPLETED|Overall Study||28
8607107|NCT00397943|9643954|FG001|COMPLETED|Overall Study||31
8607108|NCT00397943|9643955|FG002|COMPLETED|Overall Study||10
8607109|NCT00397943|9643956|FG003|COMPLETED|Overall Study||10
8607110|NCT00397943|9643957|FG004|COMPLETED|Overall Study||10
8607111|NCT00397943|9643953|FG000|NOT COMPLETED|Overall Study||12
8607112|NCT00397943|9643954|FG001|NOT COMPLETED|Overall Study||9
8607113|NCT00397943|9643955|FG002|NOT COMPLETED|Overall Study||0
8607114|NCT00397943|9643956|FG003|NOT COMPLETED|Overall Study||0
8607115|NCT00397943|9643957|FG004|NOT COMPLETED|Overall Study||0
8607116|NCT00397982|9643969|FG000|STARTED|Overall Study||17
8607117|NCT00397982|9643969|FG000|COMPLETED|Overall Study||13
8607118|NCT00397982|9643969|FG000|NOT COMPLETED|Overall Study||4
8607119|NCT00398047|9643974|FG000|STARTED|Overall Study||3
8607120|NCT00398047|9643974|FG000|COMPLETED|Overall Study|all three patients progressed before completing|0
8607121|NCT00398047|9643974|FG000|NOT COMPLETED|Overall Study||3
8607122|NCT00398073|9643981|FG000|STARTED|Overall Study||18
8607123|NCT00398073|9643982|FG001|STARTED|Overall Study||17
8607124|NCT00398073|9643981|FG000|COMPLETED|Overall Study||17
8607125|NCT00398073|9643982|FG001|COMPLETED|Overall Study||17
8607126|NCT00398073|9643981|FG000|NOT COMPLETED|Overall Study||1
8607127|NCT00398073|9643982|FG001|NOT COMPLETED|Overall Study||0
8607128|NCT00398086|9643991|FG000|STARTED|Overall Study||20
8607129|NCT00398086|9643992|FG001|STARTED|Overall Study||44
8607130|NCT00398086|9643993|FG002|STARTED|Overall Study||3
8607131|NCT00398086|9643991|FG000|Phase 1, Dose Escalation Population|Overall Study||20
8607132|NCT00398086|9643992|FG001|Phase 1, Dose Escalation Population|Overall Study||7
8607133|NCT00398086|9643993|FG002|Phase 1, Dose Escalation Population|Overall Study||3
8607134|NCT00398086|9643991|FG000|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease.|11
8607135|NCT00398086|9643992|FG001|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease.|21
8607136|NCT00398086|9643993|FG002|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease.|1
8607137|NCT00398086|9643991|FG000|NOT COMPLETED|Overall Study||9
8607138|NCT00398086|9643992|FG001|NOT COMPLETED|Overall Study||23
8607139|NCT00398086|9643993|FG002|NOT COMPLETED|Overall Study||2
8607140|NCT00398112|9644001|FG000|STARTED|Overall Study||18
8607141|NCT00398112|9644001|FG000|COMPLETED|Overall Study||0
8607142|NCT00398112|9644001|FG000|NOT COMPLETED|Overall Study||18
8607143|NCT00398138|9644005|FG000|STARTED|Overall Study||12
8607144|NCT00398138|9644005|FG000|COMPLETED|Overall Study||10
8607145|NCT00398138|9644005|FG000|NOT COMPLETED|Overall Study||2
8628957|NCT00527878|9668570|FG000|STARTED|Intervention 1||7
8628958|NCT00527878|9668571|FG001|STARTED|Intervention 1||7
8628959|NCT00527878|9668570|FG000|COMPLETED|Intervention 1||5
8628960|NCT00527878|9668571|FG001|COMPLETED|Intervention 1||4
8628961|NCT00527878|9668570|FG000|NOT COMPLETED|Intervention 1||2
8628962|NCT00527878|9668571|FG001|NOT COMPLETED|Intervention 1||3
8628963|NCT00527878|9668570|FG000|STARTED|Intervention 2||5
8628964|NCT00527878|9668571|FG001|STARTED|Intervention 2||4
8628965|NCT00527878|9668570|FG000|COMPLETED|Intervention 2||5
8628966|NCT00527878|9668571|FG001|COMPLETED|Intervention 2||4
8628967|NCT00527878|9668570|FG000|NOT COMPLETED|Intervention 2||0
8628968|NCT00527878|9668571|FG001|NOT COMPLETED|Intervention 2||0
8628969|NCT00527904|9668577|FG000|STARTED|Overall Study||239
8628970|NCT00527904|9668577|FG000|COMPLETED|Overall Study||143
8628971|NCT00527904|9668577|FG000|NOT COMPLETED|Overall Study||96
8628972|NCT00527943|9668583|FG000|STARTED|Overall Study||6471
8628973|NCT00527943|9668584|FG001|STARTED|Overall Study||6473
8628974|NCT00527943|9668583|FG000|Received Treatment|Overall Study||6441
8628975|NCT00527943|9668584|FG001|Received Treatment|Overall Study||6446
8628976|NCT00527943|9668583|FG000|COMPLETED|Overall Study||6311
8628977|NCT00527943|9668584|FG001|COMPLETED|Overall Study||6327
8628978|NCT00527943|9668583|FG000|NOT COMPLETED|Overall Study||160
8628979|NCT00527943|9668584|FG001|NOT COMPLETED|Overall Study||146
8628980|NCT00528021|9668594|FG000|STARTED|Overall Study||59
8628981|NCT00528021|9668595|FG001|STARTED|Overall Study||59
8628982|NCT00528021|9668596|FG002|STARTED|Overall Study||56
8628983|NCT00528021|9668597|FG003|STARTED|Overall Study||56
8628984|NCT00528021|9668594|FG000|COMPLETED|Overall Study||42
8628985|NCT00528021|9668595|FG001|COMPLETED|Overall Study||46
8628986|NCT00528021|9668596|FG002|COMPLETED|Overall Study||49
8628987|NCT00528021|9668597|FG003|COMPLETED|Overall Study||47
8628988|NCT00528021|9668594|FG000|NOT COMPLETED|Overall Study||17
8628989|NCT00528021|9668595|FG001|NOT COMPLETED|Overall Study||13
8628990|NCT00528021|9668596|FG002|NOT COMPLETED|Overall Study||7
8628991|NCT00528021|9668597|FG003|NOT COMPLETED|Overall Study||9
8628992|NCT00528112|9668609|FG000|STARTED|Treatment up to 3 Years||1432
8628993|NCT00528112|9668610|FG001|STARTED|Treatment up to 3 Years||1453
8628994|NCT00528112|9668609|FG000|Participants Received Treatment|Treatment up to 3 Years|Full analysis set/Safety population|1432
8628995|NCT00528112|9668610|FG001|Participants Received Treatment|Treatment up to 3 Years|Full analysis set/Safety population|1452
8628996|NCT00528112|9668609|FG000|COMPLETED|Treatment up to 3 Years||819
8628997|NCT00528112|9668610|FG001|COMPLETED|Treatment up to 3 Years||870
8628998|NCT00528112|9668609|FG000|NOT COMPLETED|Treatment up to 3 Years||613
8628999|NCT00528112|9668610|FG001|NOT COMPLETED|Treatment up to 3 Years||583
8629000|NCT00528112|9668609|FG000|STARTED|Extension Phase|Only subjects in the LCS16 groups could participate in the extension phase|0
8629001|NCT00528112|9668610|FG001|STARTED|Extension Phase||707
8629002|NCT00528112|9668609|FG000|COMPLETED|Extension Phase||0
8629003|NCT00528112|9668610|FG001|COMPLETED|Extension Phase||550
8629004|NCT00528112|9668609|FG000|NOT COMPLETED|Extension Phase||0
8629005|NCT00528112|9668610|FG001|NOT COMPLETED|Extension Phase||157
8629006|NCT00528190|9668620|FG000|STARTED|Overall Study||18
8629007|NCT00528190|9668621|FG001|STARTED|Overall Study||17
8629008|NCT00528190|9668620|FG000|COMPLETED|Overall Study||18
8629009|NCT00528190|9668621|FG001|COMPLETED|Overall Study||16
8629010|NCT00528190|9668620|FG000|NOT COMPLETED|Overall Study||0
8629011|NCT00528190|9668621|FG001|NOT COMPLETED|Overall Study||1
8629012|NCT00528268|9668629|FG000|STARTED|Overall Study||6
8629013|NCT00528268|9668630|FG001|STARTED|Overall Study||8
8629014|NCT00528268|9668629|FG000|COMPLETED|Overall Study||5
8629015|NCT00528268|9668630|FG001|COMPLETED|Overall Study||7
8629016|NCT00528268|9668629|FG000|NOT COMPLETED|Overall Study||1
8629017|NCT00528268|9668630|FG001|NOT COMPLETED|Overall Study||1
8629018|NCT00528372|9668645|FG000|STARTED|Short-term (ST) Period (Day 1-Week 24)||75
8629019|NCT00528372|9668646|FG001|STARTED|Short-term (ST) Period (Day 1-Week 24)||65
8629020|NCT00528372|9668647|FG002|STARTED|Short-term (ST) Period (Day 1-Week 24)||64
8629021|NCT00528372|9668648|FG003|STARTED|Short-term (ST) Period (Day 1-Week 24)||70
8629022|NCT00528372|9668649|FG004|STARTED|Short-term (ST) Period (Day 1-Week 24)||67
8629023|NCT00528372|9668650|FG005|STARTED|Short-term (ST) Period (Day 1-Week 24)||68
8629024|NCT00528372|9668651|FG006|STARTED|Short-term (ST) Period (Day 1-Week 24)||76
8629025|NCT00528372|9668652|FG007|STARTED|Short-term (ST) Period (Day 1-Week 24)||34
8629026|NCT00528372|9668653|FG008|STARTED|Short-term (ST) Period (Day 1-Week 24)||39
8629027|NCT00528372|9668645|FG000|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||63
8629028|NCT00528372|9668646|FG001|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||60
8629029|NCT00528372|9668647|FG002|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||52
8629030|NCT00528372|9668648|FG003|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||57
8629031|NCT00528372|9668649|FG004|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||58
8629032|NCT00528372|9668650|FG005|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||57
8629033|NCT00528372|9668651|FG006|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||65
8629034|NCT00528372|9668652|FG007|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||28
8607146|NCT00398216|9644014|FG000|STARTED|Overall Study||192
8607147|NCT00398216|9644015|FG001|STARTED|Overall Study||170
8607148|NCT00398216|9644016|FG002|STARTED|Overall Study||185
8607149|NCT00398216|9644017|FG003|STARTED|Overall Study||177
8607150|NCT00398216|9644018|FG004|STARTED|Overall Study||172
8607151|NCT00398216|9644014|FG000|COMPLETED|Overall Study||181
8607152|NCT00398216|9644015|FG001|COMPLETED|Overall Study||151
8607153|NCT00398216|9644016|FG002|COMPLETED|Overall Study||164
8607154|NCT00398216|9644017|FG003|COMPLETED|Overall Study||155
8607155|NCT00398216|9644018|FG004|COMPLETED|Overall Study||157
8607156|NCT00398216|9644014|FG000|NOT COMPLETED|Overall Study||11
8607157|NCT00398216|9644015|FG001|NOT COMPLETED|Overall Study||19
8607158|NCT00398216|9644016|FG002|NOT COMPLETED|Overall Study||21
8607159|NCT00398216|9644017|FG003|NOT COMPLETED|Overall Study||22
8607160|NCT00398216|9644018|FG004|NOT COMPLETED|Overall Study||15
8607161|NCT00398320|9644030|FG000|STARTED|Overall Study||40
8607162|NCT00398320|9644030|FG000|COMPLETED|Overall Study||34
8607163|NCT00398320|9644030|FG000|NOT COMPLETED|Overall Study||6
8607164|NCT00398398|9644034|FG000|STARTED|Overall Study||44
8607165|NCT00398398|9644034|FG000|COMPLETED|Overall Study||44
8607166|NCT00398398|9644034|FG000|NOT COMPLETED|Overall Study||0
8607167|NCT00398411|9644040|FG000|STARTED|Overall Study||34
8607168|NCT00398411|9644041|FG001|STARTED|Overall Study||32
8607169|NCT00398411|9644040|FG000|COMPLETED|Overall Study||34
8607170|NCT00398411|9644041|FG001|COMPLETED|Overall Study||31
8607171|NCT00398411|9644040|FG000|NOT COMPLETED|Overall Study||0
8607172|NCT00398411|9644041|FG001|NOT COMPLETED|Overall Study||1
8607173|NCT00398476|9644047|FG000|STARTED|Treatment Period 1||63
8607174|NCT00398476|9644048|FG001|STARTED|Treatment Period 1||64
8607175|NCT00398476|9644047|FG000|COMPLETED|Treatment Period 1||63
8607176|NCT00398476|9644048|FG001|COMPLETED|Treatment Period 1||64
8607177|NCT00398476|9644047|FG000|NOT COMPLETED|Treatment Period 1||0
8607178|NCT00398476|9644048|FG001|NOT COMPLETED|Treatment Period 1||0
8607179|NCT00398476|9644047|FG000|STARTED|Washout Period (20 Minutes)||63
8607180|NCT00398476|9644048|FG001|STARTED|Washout Period (20 Minutes)||64
8607181|NCT00398476|9644047|FG000|COMPLETED|Washout Period (20 Minutes)||63
8607182|NCT00398476|9644048|FG001|COMPLETED|Washout Period (20 Minutes)||64
8607183|NCT00398476|9644047|FG000|NOT COMPLETED|Washout Period (20 Minutes)||0
8607184|NCT00398476|9644048|FG001|NOT COMPLETED|Washout Period (20 Minutes)||0
8607185|NCT00398476|9644047|FG000|STARTED|Treatment Period 2||63
8607186|NCT00398476|9644048|FG001|STARTED|Treatment Period 2||64
8607187|NCT00398476|9644047|FG000|COMPLETED|Treatment Period 2||63
8607188|NCT00398476|9644048|FG001|COMPLETED|Treatment Period 2||64
8607189|NCT00398476|9644047|FG000|NOT COMPLETED|Treatment Period 2||0
8607190|NCT00398476|9644048|FG001|NOT COMPLETED|Treatment Period 2||0
8607191|NCT00398567|9644059|FG000|STARTED|Overall Study||4
8607192|NCT00398567|9644060|FG001|STARTED|Overall Study||4
8607193|NCT00398567|9644061|FG002|STARTED|Overall Study||37
8607194|NCT00398567|9644059|FG000|COMPLETED|Overall Study||0
8607195|NCT00398567|9644060|FG001|COMPLETED|Overall Study||0
8607196|NCT00398567|9644061|FG002|COMPLETED|Overall Study||3
8607197|NCT00398567|9644059|FG000|NOT COMPLETED|Overall Study||4
8607198|NCT00398567|9644060|FG001|NOT COMPLETED|Overall Study||4
8607199|NCT00398567|9644061|FG002|NOT COMPLETED|Overall Study||34
8607200|NCT00398632|9644067|FG000|STARTED|Overall Study||6
8607201|NCT00398632|9644067|FG000|COMPLETED|Overall Study|2/6 subjects withdrew at end of week 6; 1 for lack of efficacy, 1 because of time constraints.|4
8607202|NCT00398632|9644067|FG000|NOT COMPLETED|Overall Study||2
8607203|NCT00398866|9644075|FG000|STARTED|Overall Study||66
8607204|NCT00398866|9644076|FG001|STARTED|Overall Study||68
8607205|NCT00398866|9644077|FG002|STARTED|Overall Study||66
8607206|NCT00398866|9644075|FG000|COMPLETED|Overall Study||52
8607207|NCT00398866|9644076|FG001|COMPLETED|Overall Study||60
8607208|NCT00398866|9644077|FG002|COMPLETED|Overall Study||58
8607209|NCT00398866|9644075|FG000|NOT COMPLETED|Overall Study||14
8607210|NCT00398866|9644076|FG001|NOT COMPLETED|Overall Study||8
8607211|NCT00398866|9644077|FG002|NOT COMPLETED|Overall Study||8
8607212|NCT00398918|9644086|FG000|STARTED|Overall Study||10
8607213|NCT00398918|9644086|FG000|COMPLETED|Overall Study||10
8607214|NCT00398918|9644086|FG000|NOT COMPLETED|Overall Study||0
8607215|NCT00398983|9644092|FG000|STARTED|Overall Study||20
8607216|NCT00398983|9644093|FG001|STARTED|Overall Study||25
8607217|NCT00398983|9644092|FG000|COMPLETED|Overall Study||20
8607218|NCT00398983|9644093|FG001|COMPLETED|Overall Study||25
8607219|NCT00398983|9644092|FG000|NOT COMPLETED|Overall Study||0
8607220|NCT00398983|9644093|FG001|NOT COMPLETED|Overall Study||0
8607221|NCT00399035|9644102|FG000|STARTED|Overall Study||502
8607222|NCT00399035|9644103|FG001|STARTED|Overall Study||216
8607223|NCT00399035|9644104|FG002|STARTED|Overall Study||358
8607224|NCT00399035|9644102|FG000|COMPLETED|Overall Study||189
8607225|NCT00399035|9644103|FG001|COMPLETED|Overall Study||58
8607226|NCT00399035|9644104|FG002|COMPLETED|Overall Study||106
8607227|NCT00399035|9644102|FG000|NOT COMPLETED|Overall Study||313
8607228|NCT00399035|9644103|FG001|NOT COMPLETED|Overall Study||158
8607229|NCT00399035|9644104|FG002|NOT COMPLETED|Overall Study||252
8607230|NCT00399308|9644114|FG000|STARTED|Overall Study||13
8607231|NCT00399308|9644115|FG001|STARTED|Overall Study||15
8607232|NCT00399308|9644116|FG002|STARTED|Overall Study||12
8607233|NCT00399308|9644114|FG000|COMPLETED|Overall Study||13
8607234|NCT00399308|9644115|FG001|COMPLETED|Overall Study||15
8607235|NCT00399308|9644116|FG002|COMPLETED|Overall Study|One patient withdrew: did not want to comply with study requirements|11
8607236|NCT00399308|9644114|FG000|NOT COMPLETED|Overall Study||0
8607237|NCT00399308|9644115|FG001|NOT COMPLETED|Overall Study||0
8607238|NCT00399308|9644116|FG002|NOT COMPLETED|Overall Study||1
8607239|NCT00399360|9644128|FG000|STARTED|Overall Study||11
8607240|NCT00399360|9644129|FG001|STARTED|Overall Study||11
8607241|NCT00399360|9644130|FG002|STARTED|Overall Study||13
8607242|NCT00399360|9644131|FG003|STARTED|Overall Study||15
8607243|NCT00399360|9644128|FG000|COMPLETED|Overall Study||9
8607244|NCT00399360|9644129|FG001|COMPLETED|Overall Study||8
8607245|NCT00399360|9644130|FG002|COMPLETED|Overall Study||10
8607246|NCT00399360|9644131|FG003|COMPLETED|Overall Study||9
8607247|NCT00399360|9644128|FG000|NOT COMPLETED|Overall Study||2
8607248|NCT00399360|9644129|FG001|NOT COMPLETED|Overall Study||3
8607249|NCT00399360|9644130|FG002|NOT COMPLETED|Overall Study||3
8607250|NCT00399360|9644131|FG003|NOT COMPLETED|Overall Study||6
8607251|NCT00399490|9644146|FG000|STARTED|Overall Study||281
8607252|NCT00399490|9644146|FG000|COMPLETED|Overall Study||183
8607253|NCT00399490|9644146|FG000|NOT COMPLETED|Overall Study||98
8607254|NCT00399516|9644152|FG000|STARTED|Overall Study||21
8607255|NCT00399516|9644152|FG000|COMPLETED|Overall Study||19
8607256|NCT00399516|9644152|FG000|NOT COMPLETED|Overall Study||2
8607257|NCT00399529|9644156|FG000|STARTED|Overall Study||22
8607258|NCT00399529|9644156|FG000|COMPLETED|Overall Study||20
8607259|NCT00399529|9644156|FG000|NOT COMPLETED|Overall Study||2
8607260|NCT00399542|9644163|FG000|STARTED|Overall Study||387
8607261|NCT00399542|9644164|FG001|STARTED|Overall Study||194
8607262|NCT00399542|9644163|FG000|COMPLETED|Overall Study||303
8607263|NCT00399542|9644164|FG001|COMPLETED|Overall Study||151
8607264|NCT00399542|9644163|FG000|NOT COMPLETED|Overall Study||84
8607265|NCT00399542|9644164|FG001|NOT COMPLETED|Overall Study||43
8607266|NCT00399568|9644172|FG000|STARTED|Overall Study||166
8607267|NCT00399568|9644173|FG001|STARTED|Overall Study||165
8607268|NCT00399568|9644172|FG000|COMPLETED|Overall Study||154
8607269|NCT00399568|9644173|FG001|COMPLETED|Overall Study||156
8607270|NCT00399568|9644172|FG000|NOT COMPLETED|Overall Study||12
8607271|NCT00399568|9644173|FG001|NOT COMPLETED|Overall Study||9
8607272|NCT00399763|9644183|FG000|STARTED|Overall Study||35
8607273|NCT00399763|9644184|FG001|STARTED|Overall Study||35
8607274|NCT00399763|9644183|FG000|COMPLETED|Overall Study||33
8607275|NCT00399763|9644184|FG001|COMPLETED|Overall Study||32
8607276|NCT00399763|9644183|FG000|NOT COMPLETED|Overall Study||2
8607277|NCT00399763|9644184|FG001|NOT COMPLETED|Overall Study||3
8607278|NCT00399802|9644192|FG000|STARTED|Overall Study||14
8607279|NCT00399802|9644193|FG001|STARTED|Overall Study||29
8607280|NCT00399802|9644192|FG000|COMPLETED|Overall Study||14
8607281|NCT00399802|9644193|FG001|COMPLETED|Overall Study||26
8607282|NCT00399802|9644192|FG000|NOT COMPLETED|Overall Study||0
8607283|NCT00399802|9644193|FG001|NOT COMPLETED|Overall Study||3
8607284|NCT00399880|9644201|FG000|STARTED|Overall Study||65
8607285|NCT00399880|9644202|FG001|STARTED|Overall Study||65
8607286|NCT00399880|9644201|FG000|COMPLETED|Overall Study||65
8607287|NCT00399880|9644202|FG001|COMPLETED|Overall Study||65
8607288|NCT00399880|9644201|FG000|NOT COMPLETED|Overall Study||0
8607289|NCT00399880|9644202|FG001|NOT COMPLETED|Overall Study||0
8607290|NCT00399893|9644210|FG000|STARTED|Overall Study||2
8607291|NCT00399893|9644211|FG001|STARTED|Overall Study||3
8607292|NCT00399893|9644210|FG000|COMPLETED|Overall Study|Participant withdrew after 3 months but was included in results|1
8607293|NCT00399893|9644211|FG001|COMPLETED|Overall Study||3
8607294|NCT00399893|9644210|FG000|NOT COMPLETED|Overall Study||1
8607295|NCT00399893|9644211|FG001|NOT COMPLETED|Overall Study||0
8607296|NCT00400153|9644220|FG000|STARTED|Overall Study||486
8607297|NCT00400153|9644221|FG001|STARTED|Overall Study||491
8607298|NCT00400153|9644222|FG002|STARTED|Overall Study||483
8607299|NCT00400153|9644220|FG000|COMPLETED|Overall Study||438
8607300|NCT00400153|9644221|FG001|COMPLETED|Overall Study||436
8607301|NCT00400153|9644222|FG002|COMPLETED|Overall Study||422
8607302|NCT00400153|9644220|FG000|NOT COMPLETED|Overall Study||48
8607303|NCT00400153|9644221|FG001|NOT COMPLETED|Overall Study||55
8607304|NCT00400153|9644222|FG002|NOT COMPLETED|Overall Study||61
8607305|NCT00400179|9644237|FG000|STARTED|Overall Study|Signed informed consent form and randomized|527
8607306|NCT00400179|9644238|FG001|STARTED|Overall Study||526
8607307|NCT00400179|9644237|FG000|COMPLETED|Overall Study|Received Treatment|521
8607308|NCT00400179|9644238|FG001|COMPLETED|Overall Study||508
8607309|NCT00400179|9644237|FG000|NOT COMPLETED|Overall Study||6
8607310|NCT00400179|9644238|FG001|NOT COMPLETED|Overall Study||18
8607311|NCT00400205|9644244|FG000|STARTED|Overall Study||14
8607312|NCT00400205|9644244|FG000|COMPLETED|Overall Study||9
8607313|NCT00400205|9644244|FG000|NOT COMPLETED|Overall Study||5
8607314|NCT00400400|9644251|FG000|STARTED|Overall Study||200
8607315|NCT00400400|9644252|FG001|STARTED|Overall Study||200
8607316|NCT00400400|9644251|FG000|Intent-to-Treat Population|Overall Study|Participants who received study drug.|199
8607317|NCT00400400|9644252|FG001|Intent-to-Treat Population|Overall Study||197
8607318|NCT00400400|9644251|FG000|COMPLETED|Overall Study||186
8607319|NCT00400400|9644252|FG001|COMPLETED|Overall Study||185
8607320|NCT00400400|9644251|FG000|NOT COMPLETED|Overall Study||14
8607321|NCT00400400|9644252|FG001|NOT COMPLETED|Overall Study||15
8607322|NCT00400439|9644260|FG000|STARTED|Overall Study||52
8607323|NCT00400439|9644261|FG001|STARTED|Overall Study||25
8607324|NCT00400439|9644260|FG000|COMPLETED|Overall Study||47
8607325|NCT00400439|9644261|FG001|COMPLETED|Overall Study||23
8607326|NCT00400439|9644260|FG000|NOT COMPLETED|Overall Study||5
8607327|NCT00400439|9644261|FG001|NOT COMPLETED|Overall Study||2
8607328|NCT00400517|9644267|FG000|STARTED|Overall Study|1 pt w/d consent. 1 pt found to have unresectable dx at time of sx and is exc. in tissue analysis.|28
8607329|NCT00400517|9644267|FG000|COMPLETED|Overall Study||26
8607330|NCT00400517|9644267|FG000|NOT COMPLETED|Overall Study||2
8607331|NCT00400569|9644271|FG000|STARTED|Overall Study||48
8607332|NCT00400569|9644271|FG000|COMPLETED|Overall Study||47
8607333|NCT00400569|9644271|FG000|NOT COMPLETED|Overall Study||1
8607334|NCT00400634|9644280|FG000|STARTED|Overall Study||38
8607335|NCT00400634|9644281|FG001|STARTED|Overall Study||20
8607336|NCT00400634|9644280|FG000|COMPLETED|Overall Study||34
8607337|NCT00400634|9644281|FG001|COMPLETED|Overall Study||19
8607338|NCT00400634|9644280|FG000|NOT COMPLETED|Overall Study||4
8714472|NCT00980148|9761339|FG001|COMPLETED|Overall Study|Completed primary evaluation at study visit # 2 (day 28 after therapy started)|155
8714473|NCT00980148|9761338|FG000|NOT COMPLETED|Overall Study||129
8714474|NCT00980148|9761339|FG001|NOT COMPLETED|Overall Study||128
8714475|NCT00980174|9761347|FG000|STARTED|Overall Study||121
8714476|NCT00980174|9761348|FG001|STARTED|Overall Study||121
8714477|NCT00980174|9761347|FG000|COMPLETED|Overall Study||117
8714478|NCT00980174|9761348|FG001|COMPLETED|Overall Study||111
8714479|NCT00980174|9761347|FG000|NOT COMPLETED|Overall Study||4
8714480|NCT00980174|9761348|FG001|NOT COMPLETED|Overall Study||10
8714481|NCT00980200|9761354|FG000|STARTED|7-day Treatment Period 1||15
8714482|NCT00980200|9761355|FG001|STARTED|7-day Treatment Period 1||14
8714483|NCT00980200|9761356|FG002|STARTED|7-day Treatment Period 1||15
8714484|NCT00980200|9761357|FG003|STARTED|7-day Treatment Period 1||16
8714485|NCT00980200|9761358|FG004|STARTED|7-day Treatment Period 1||15
8714486|NCT00980200|9761354|FG000|COMPLETED|7-day Treatment Period 1||15
8714487|NCT00980200|9761355|FG001|COMPLETED|7-day Treatment Period 1||13
8714488|NCT00980200|9761356|FG002|COMPLETED|7-day Treatment Period 1||15
8714489|NCT00980200|9761357|FG003|COMPLETED|7-day Treatment Period 1||16
8714490|NCT00980200|9761358|FG004|COMPLETED|7-day Treatment Period 1||15
8714491|NCT00980200|9761354|FG000|NOT COMPLETED|7-day Treatment Period 1||0
8714492|NCT00980200|9761355|FG001|NOT COMPLETED|7-day Treatment Period 1||1
8714493|NCT00980200|9761356|FG002|NOT COMPLETED|7-day Treatment Period 1||0
8714494|NCT00980200|9761357|FG003|NOT COMPLETED|7-day Treatment Period 1||0
8714495|NCT00980200|9761358|FG004|NOT COMPLETED|7-day Treatment Period 1||0
8714496|NCT00980200|9761354|FG000|STARTED|7-day Washout Period 1||15
8714497|NCT00980200|9761355|FG001|STARTED|7-day Washout Period 1||13
8714498|NCT00980200|9761356|FG002|STARTED|7-day Washout Period 1||15
8714499|NCT00980200|9761357|FG003|STARTED|7-day Washout Period 1||16
8714500|NCT00980200|9761358|FG004|STARTED|7-day Washout Period 1||15
8714501|NCT00980200|9761354|FG000|COMPLETED|7-day Washout Period 1||15
8714502|NCT00980200|9761355|FG001|COMPLETED|7-day Washout Period 1||13
8714503|NCT00980200|9761356|FG002|COMPLETED|7-day Washout Period 1||15
8714504|NCT00980200|9761357|FG003|COMPLETED|7-day Washout Period 1||16
8714505|NCT00980200|9761358|FG004|COMPLETED|7-day Washout Period 1||15
8714506|NCT00980200|9761354|FG000|NOT COMPLETED|7-day Washout Period 1||0
8714507|NCT00980200|9761355|FG001|NOT COMPLETED|7-day Washout Period 1||0
8714508|NCT00980200|9761356|FG002|NOT COMPLETED|7-day Washout Period 1||0
8714509|NCT00980200|9761357|FG003|NOT COMPLETED|7-day Washout Period 1||0
8714510|NCT00980200|9761358|FG004|NOT COMPLETED|7-day Washout Period 1||0
8714511|NCT00980200|9761354|FG000|STARTED|7-day Treatment Period 2||15
8714512|NCT00980200|9761355|FG001|STARTED|7-day Treatment Period 2||13
8714513|NCT00980200|9761356|FG002|STARTED|7-day Treatment Period 2||15
8714514|NCT00980200|9761357|FG003|STARTED|7-day Treatment Period 2||16
8714515|NCT00980200|9761358|FG004|STARTED|7-day Treatment Period 2||15
8714516|NCT00980200|9761354|FG000|COMPLETED|7-day Treatment Period 2||15
8714517|NCT00980200|9761355|FG001|COMPLETED|7-day Treatment Period 2||13
8714518|NCT00980200|9761356|FG002|COMPLETED|7-day Treatment Period 2||15
8714519|NCT00980200|9761357|FG003|COMPLETED|7-day Treatment Period 2||16
8714520|NCT00980200|9761358|FG004|COMPLETED|7-day Treatment Period 2||15
8714521|NCT00980200|9761354|FG000|NOT COMPLETED|7-day Treatment Period 2||0
8714522|NCT00980200|9761355|FG001|NOT COMPLETED|7-day Treatment Period 2||0
8714523|NCT00980200|9761356|FG002|NOT COMPLETED|7-day Treatment Period 2||0
8714524|NCT00980200|9761357|FG003|NOT COMPLETED|7-day Treatment Period 2||0
8714525|NCT00980200|9761358|FG004|NOT COMPLETED|7-day Treatment Period 2||0
8714526|NCT00980200|9761354|FG000|STARTED|7-day Washout Period 2||15
8714527|NCT00980200|9761355|FG001|STARTED|7-day Washout Period 2||13
8714528|NCT00980200|9761356|FG002|STARTED|7-day Washout Period 2||15
8714529|NCT00980200|9761357|FG003|STARTED|7-day Washout Period 2||16
8714530|NCT00980200|9761358|FG004|STARTED|7-day Washout Period 2||15
8714531|NCT00980200|9761354|FG000|COMPLETED|7-day Washout Period 2||15
8607339|NCT00400634|9644281|FG001|NOT COMPLETED|Overall Study||1
8607340|NCT00400686|9644287|FG000|STARTED|Overall Study||31
8607341|NCT00400686|9644287|FG000|COMPLETED|Overall Study||31
8607342|NCT00400686|9644287|FG000|NOT COMPLETED|Overall Study||0
8607343|NCT00400712|9644293|FG000|STARTED|Overall Study||52
8607344|NCT00400712|9644294|FG001|STARTED|Overall Study||51
8607345|NCT00400712|9644293|FG000|COMPLETED|Overall Study||35
8714532|NCT00980200|9761355|FG001|COMPLETED|7-day Washout Period 2||13
8607346|NCT00400712|9644294|FG001|COMPLETED|Overall Study||35
8607347|NCT00400712|9644293|FG000|NOT COMPLETED|Overall Study||17
8607348|NCT00400712|9644294|FG001|NOT COMPLETED|Overall Study||16
8607349|NCT00400764|9644307|FG000|STARTED|Phase Ib||6
8607350|NCT00400764|9644308|FG001|STARTED|Phase Ib||6
8714533|NCT00980200|9761356|FG002|COMPLETED|7-day Washout Period 2||15
8607351|NCT00400764|9644309|FG002|STARTED|Phase Ib||0
8607352|NCT00400764|9644310|FG003|STARTED|Phase Ib||0
8607353|NCT00400764|9644311|FG004|STARTED|Phase Ib||0
8607354|NCT00400764|9644307|FG000|Treated|Phase Ib||6
8607355|NCT00400764|9644308|FG001|Treated|Phase Ib||6
8607356|NCT00400764|9644309|FG002|Treated|Phase Ib||0
8607357|NCT00400764|9644310|FG003|Treated|Phase Ib||0
8607358|NCT00400764|9644311|FG004|Treated|Phase Ib||0
8607359|NCT00400764|9644307|FG000|COMPLETED|Phase Ib|One patient reported as discontinued due to an AE should have been reported as death.|0
8607360|NCT00400764|9644308|FG001|COMPLETED|Phase Ib||2
8607361|NCT00400764|9644309|FG002|COMPLETED|Phase Ib||0
8607362|NCT00400764|9644310|FG003|COMPLETED|Phase Ib||0
8607363|NCT00400764|9644311|FG004|COMPLETED|Phase Ib||0
8607364|NCT00400764|9644307|FG000|NOT COMPLETED|Phase Ib||6
8607365|NCT00400764|9644308|FG001|NOT COMPLETED|Phase Ib||4
8607366|NCT00400764|9644309|FG002|NOT COMPLETED|Phase Ib||0
8607367|NCT00400764|9644310|FG003|NOT COMPLETED|Phase Ib||0
8607368|NCT00400764|9644311|FG004|NOT COMPLETED|Phase Ib||0
8607369|NCT00400764|9644307|FG000|STARTED|Phase II||0
8607370|NCT00400764|9644308|FG001|STARTED|Phase II||0
8607371|NCT00400764|9644309|FG002|STARTED|Phase II||23
8607372|NCT00400764|9644310|FG003|STARTED|Phase II||26
8714534|NCT00980200|9761357|FG003|COMPLETED|7-day Washout Period 2||16
8714535|NCT00980200|9761358|FG004|COMPLETED|7-day Washout Period 2||15
8714536|NCT00980200|9761354|FG000|NOT COMPLETED|7-day Washout Period 2||0
8714537|NCT00980200|9761355|FG001|NOT COMPLETED|7-day Washout Period 2||0
8714538|NCT00980200|9761356|FG002|NOT COMPLETED|7-day Washout Period 2||0
8714539|NCT00980200|9761357|FG003|NOT COMPLETED|7-day Washout Period 2||0
8607373|NCT00400764|9644311|FG004|STARTED|Phase II||11
8607374|NCT00400764|9644307|FG000|Treated|Phase II||0
8607375|NCT00400764|9644308|FG001|Treated|Phase II||0
8714540|NCT00980200|9761358|FG004|NOT COMPLETED|7-day Washout Period 2||0
8714541|NCT00980200|9761354|FG000|STARTED|7-day Treatment Period 3||15
8714542|NCT00980200|9761355|FG001|STARTED|7-day Treatment Period 3||13
8714543|NCT00980200|9761356|FG002|STARTED|7-day Treatment Period 3||15
8714544|NCT00980200|9761357|FG003|STARTED|7-day Treatment Period 3||16
8714545|NCT00980200|9761358|FG004|STARTED|7-day Treatment Period 3||15
8714546|NCT00980200|9761354|FG000|COMPLETED|7-day Treatment Period 3||15
8714547|NCT00980200|9761355|FG001|COMPLETED|7-day Treatment Period 3||12
8714548|NCT00980200|9761356|FG002|COMPLETED|7-day Treatment Period 3||15
8714549|NCT00980200|9761357|FG003|COMPLETED|7-day Treatment Period 3||16
8714550|NCT00980200|9761358|FG004|COMPLETED|7-day Treatment Period 3||14
8714551|NCT00980200|9761354|FG000|NOT COMPLETED|7-day Treatment Period 3||0
8714552|NCT00980200|9761355|FG001|NOT COMPLETED|7-day Treatment Period 3||1
8714553|NCT00980200|9761356|FG002|NOT COMPLETED|7-day Treatment Period 3||0
8714554|NCT00980200|9761357|FG003|NOT COMPLETED|7-day Treatment Period 3||0
8714555|NCT00980200|9761358|FG004|NOT COMPLETED|7-day Treatment Period 3||1
8714556|NCT00980200|9761354|FG000|STARTED|7-day Washout Period 3||15
8714557|NCT00980200|9761355|FG001|STARTED|7-day Washout Period 3||12
8714558|NCT00980200|9761356|FG002|STARTED|7-day Washout Period 3||15
8714559|NCT00980200|9761357|FG003|STARTED|7-day Washout Period 3||16
8714560|NCT00980200|9761358|FG004|STARTED|7-day Washout Period 3||14
8714561|NCT00980200|9761354|FG000|COMPLETED|7-day Washout Period 3||15
8714562|NCT00980200|9761355|FG001|COMPLETED|7-day Washout Period 3||12
8714563|NCT00980200|9761356|FG002|COMPLETED|7-day Washout Period 3||15
8714564|NCT00980200|9761357|FG003|COMPLETED|7-day Washout Period 3||16
8714565|NCT00980200|9761358|FG004|COMPLETED|7-day Washout Period 3||14
8714566|NCT00980200|9761354|FG000|NOT COMPLETED|7-day Washout Period 3||0
8714567|NCT00980200|9761355|FG001|NOT COMPLETED|7-day Washout Period 3||0
8714568|NCT00980200|9761356|FG002|NOT COMPLETED|7-day Washout Period 3||0
8714569|NCT00980200|9761357|FG003|NOT COMPLETED|7-day Washout Period 3||0
8714570|NCT00980200|9761358|FG004|NOT COMPLETED|7-day Washout Period 3||0
8714571|NCT00980200|9761354|FG000|STARTED|7-day Treatment Period 4||15
8714572|NCT00980200|9761355|FG001|STARTED|7-day Treatment Period 4||12
8714573|NCT00980200|9761356|FG002|STARTED|7-day Treatment Period 4||15
8607376|NCT00400764|9644309|FG002|Treated|Phase II|One patient in the Rituximab arm withdrew prior to treatment|22
8607377|NCT00400764|9644310|FG003|Treated|Phase II||26
8607378|NCT00400764|9644311|FG004|Treated|Phase II||11
8607379|NCT00400764|9644307|FG000|COMPLETED|Phase II||0
8607380|NCT00400764|9644308|FG001|COMPLETED|Phase II||0
8607381|NCT00400764|9644309|FG002|COMPLETED|Phase II||0
8607382|NCT00400764|9644310|FG003|COMPLETED|Phase II||0
8714574|NCT00980200|9761357|FG003|STARTED|7-day Treatment Period 4||16
8714575|NCT00980200|9761358|FG004|STARTED|7-day Treatment Period 4||14
8714576|NCT00980200|9761354|FG000|COMPLETED|7-day Treatment Period 4||15
8714577|NCT00980200|9761355|FG001|COMPLETED|7-day Treatment Period 4||12
8714578|NCT00980200|9761356|FG002|COMPLETED|7-day Treatment Period 4||15
8714579|NCT00980200|9761357|FG003|COMPLETED|7-day Treatment Period 4||16
8714580|NCT00980200|9761358|FG004|COMPLETED|7-day Treatment Period 4||14
8714581|NCT00980200|9761354|FG000|NOT COMPLETED|7-day Treatment Period 4||0
8607383|NCT00400764|9644311|FG004|COMPLETED|Phase II||0
8607384|NCT00400764|9644307|FG000|NOT COMPLETED|Phase II||0
8607385|NCT00400764|9644308|FG001|NOT COMPLETED|Phase II||0
8607386|NCT00400764|9644309|FG002|NOT COMPLETED|Phase II||23
8607387|NCT00400764|9644310|FG003|NOT COMPLETED|Phase II||26
8714582|NCT00980200|9761355|FG001|NOT COMPLETED|7-day Treatment Period 4||0
8714583|NCT00980200|9761356|FG002|NOT COMPLETED|7-day Treatment Period 4||0
8607388|NCT00400764|9644311|FG004|NOT COMPLETED|Phase II||11
8607389|NCT00400803|9644328|FG000|STARTED|Overall Study||35
8714584|NCT00980200|9761357|FG003|NOT COMPLETED|7-day Treatment Period 4||0
8714585|NCT00980200|9761358|FG004|NOT COMPLETED|7-day Treatment Period 4||0
8607390|NCT00400803|9644328|FG000|COMPLETED|Overall Study||35
8607391|NCT00400803|9644328|FG000|NOT COMPLETED|Overall Study||0
8607392|NCT00400829|9644336|FG000|STARTED|Overall Study||66
8607393|NCT00400829|9644336|FG000|COMPLETED|Overall Study||66
8607394|NCT00400829|9644336|FG000|NOT COMPLETED|Overall Study||0
8607395|NCT00400881|9644342|FG000|STARTED|Overall Study||62
8607396|NCT00400881|9644343|FG001|STARTED|Overall Study||60
8607397|NCT00400881|9644342|FG000|COMPLETED|Overall Study||62
8607398|NCT00400881|9644343|FG001|COMPLETED|Overall Study||60
8607399|NCT00400881|9644342|FG000|NOT COMPLETED|Overall Study||0
8607400|NCT00400881|9644343|FG001|NOT COMPLETED|Overall Study||0
8607401|NCT00400946|9644355|FG000|STARTED|Overall Study||231
8607402|NCT00400946|9644356|FG001|STARTED|Overall Study||232
8607403|NCT00400946|9644357|FG002|STARTED|Overall Study||42
8607404|NCT00400946|9644358|FG003|STARTED|Overall Study||51
8607405|NCT00400946|9644359|FG004|STARTED|Overall Study||244
8607406|NCT00400946|9644355|FG000|Evaluable for CNS Directed-Treatment|Overall Study||231
8607407|NCT00400946|9644356|FG001|Evaluable for CNS Directed-Treatment|Overall Study||232
8607408|NCT00400946|9644357|FG002|Evaluable for CNS Directed-Treatment|Overall Study||42
8607409|NCT00400946|9644358|FG003|Evaluable for CNS Directed-Treatment|Overall Study||21
8607410|NCT00400946|9644359|FG004|Evaluable for CNS Directed-Treatment|Overall Study||227
8607411|NCT00400946|9644355|FG000|Evaluable for Day 18 Marrow Morphology|Overall Study||158
8607412|NCT00400946|9644356|FG001|Evaluable for Day 18 Marrow Morphology|Overall Study||161
8607413|NCT00400946|9644357|FG002|Evaluable for Day 18 Marrow Morphology|Overall Study||19
8607414|NCT00400946|9644358|FG003|Evaluable for Day 18 Marrow Morphology|Overall Study||13
8607415|NCT00400946|9644359|FG004|Evaluable for Day 18 Marrow Morphology|Overall Study||152
8607416|NCT00400946|9644355|FG000|Evaluable for Day 32 MRD|Overall Study||166
8607417|NCT00400946|9644356|FG001|Evaluable for Day 32 MRD|Overall Study||167
8607418|NCT00400946|9644357|FG002|Evaluable for Day 32 MRD|Overall Study||33
8607419|NCT00400946|9644358|FG003|Evaluable for Day 32 MRD|Overall Study||12
8607420|NCT00400946|9644359|FG004|Evaluable for Day 32 MRD|Overall Study||168
8607421|NCT00400946|9644355|FG000|Eligible and Treated|Overall Study||231
8607422|NCT00400946|9644356|FG001|Eligible and Treated|Overall Study||232
8607423|NCT00400946|9644357|FG002|Eligible and Treated|Overall Study||42
8607424|NCT00400946|9644358|FG003|Eligible and Treated|Overall Study||46
8607425|NCT00400946|9644359|FG004|Eligible and Treated|Overall Study||243
8607426|NCT00400946|9644355|FG000|COMPLETED|Overall Study||217
8714586|NCT00980200|9761354|FG000|STARTED|7-day Washout Period 4||15
8714587|NCT00980200|9761355|FG001|STARTED|7-day Washout Period 4||12
8714588|NCT00980200|9761356|FG002|STARTED|7-day Washout Period 4||15
8714589|NCT00980200|9761357|FG003|STARTED|7-day Washout Period 4||16
8714590|NCT00980200|9761358|FG004|STARTED|7-day Washout Period 4||14
8714591|NCT00980200|9761354|FG000|COMPLETED|7-day Washout Period 4||15
8714592|NCT00980200|9761355|FG001|COMPLETED|7-day Washout Period 4||12
8714593|NCT00980200|9761356|FG002|COMPLETED|7-day Washout Period 4||15
8714594|NCT00980200|9761357|FG003|COMPLETED|7-day Washout Period 4||16
8714595|NCT00980200|9761358|FG004|COMPLETED|7-day Washout Period 4||14
8714596|NCT00980200|9761354|FG000|NOT COMPLETED|7-day Washout Period 4||0
8714597|NCT00980200|9761355|FG001|NOT COMPLETED|7-day Washout Period 4||0
8714598|NCT00980200|9761356|FG002|NOT COMPLETED|7-day Washout Period 4||0
8714599|NCT00980200|9761357|FG003|NOT COMPLETED|7-day Washout Period 4||0
8714600|NCT00980200|9761358|FG004|NOT COMPLETED|7-day Washout Period 4||0
8714601|NCT00980200|9761354|FG000|STARTED|7-day Treatment Period 5||15
8714602|NCT00980200|9761355|FG001|STARTED|7-day Treatment Period 5||12
8714603|NCT00980200|9761356|FG002|STARTED|7-day Treatment Period 5||15
8714604|NCT00980200|9761357|FG003|STARTED|7-day Treatment Period 5||16
8714605|NCT00980200|9761358|FG004|STARTED|7-day Treatment Period 5||14
8714606|NCT00980200|9761354|FG000|COMPLETED|7-day Treatment Period 5||15
8714607|NCT00980200|9761355|FG001|COMPLETED|7-day Treatment Period 5||12
8714608|NCT00980200|9761356|FG002|COMPLETED|7-day Treatment Period 5||15
8714609|NCT00980200|9761357|FG003|COMPLETED|7-day Treatment Period 5||16
8714610|NCT00980200|9761358|FG004|COMPLETED|7-day Treatment Period 5||14
8714611|NCT00980200|9761354|FG000|NOT COMPLETED|7-day Treatment Period 5||0
8714612|NCT00980200|9761355|FG001|NOT COMPLETED|7-day Treatment Period 5||0
8714613|NCT00980200|9761356|FG002|NOT COMPLETED|7-day Treatment Period 5||0
8714614|NCT00980200|9761357|FG003|NOT COMPLETED|7-day Treatment Period 5||0
8714615|NCT00980200|9761358|FG004|NOT COMPLETED|7-day Treatment Period 5||0
8714616|NCT00980278|9761372|FG000|STARTED|Overall Study||13
8714617|NCT00980278|9761373|FG001|STARTED|Overall Study||13
8714618|NCT00980278|9761372|FG000|COMPLETED|Overall Study||11
8714619|NCT00980278|9761373|FG001|COMPLETED|Overall Study||13
8714620|NCT00980278|9761372|FG000|NOT COMPLETED|Overall Study||2
8714621|NCT00980278|9761373|FG001|NOT COMPLETED|Overall Study||0
8714622|NCT00980330|9761386|FG000|STARTED|Overall Study||66
8714623|NCT00980330|9761387|FG001|STARTED|Overall Study||65
8714624|NCT00980330|9761388|FG002|STARTED|Overall Study||66
8714625|NCT00980330|9761389|FG003|STARTED|Overall Study||66
8607427|NCT00400946|9644356|FG001|COMPLETED|Overall Study||221
8607428|NCT00400946|9644357|FG002|COMPLETED|Overall Study||40
8607429|NCT00400946|9644358|FG003|COMPLETED|Overall Study||4
8607430|NCT00400946|9644359|FG004|COMPLETED|Overall Study||206
8714626|NCT00980330|9761390|FG004|STARTED|Overall Study||68
8714627|NCT00980330|9761391|FG005|STARTED|Overall Study||65
8607431|NCT00400946|9644355|FG000|NOT COMPLETED|Overall Study||14
8607432|NCT00400946|9644356|FG001|NOT COMPLETED|Overall Study||11
8607433|NCT00400946|9644357|FG002|NOT COMPLETED|Overall Study||2
8607434|NCT00400946|9644358|FG003|NOT COMPLETED|Overall Study||47
8607435|NCT00400946|9644359|FG004|NOT COMPLETED|Overall Study||38
8607436|NCT00400985|9644377|FG000|STARTED|Overall Study||501
8607437|NCT00400985|9644377|FG000|COMPLETED|Overall Study||449
8607438|NCT00400985|9644377|FG000|NOT COMPLETED|Overall Study||52
8607439|NCT00401102|9644381|FG000|STARTED|Overall Study||12
8607440|NCT00401102|9644381|FG000|COMPLETED|Overall Study||5
8607441|NCT00401102|9644381|FG000|NOT COMPLETED|Overall Study||7
8607442|NCT00401193|9644388|FG000|STARTED|Overall Study||118
8607443|NCT00401193|9644389|FG001|STARTED|Overall Study||117
8607444|NCT00401193|9644390|FG002|STARTED|Overall Study||69
8607445|NCT00401193|9644388|FG000|Intent to Treat Population|Overall Study||115
8607446|NCT00401193|9644389|FG001|Intent to Treat Population|Overall Study||115
8607447|NCT00401193|9644390|FG002|Intent to Treat Population|Overall Study||67
8607448|NCT00401193|9644388|FG000|Modified Intent to Treat Population|Overall Study||112
8607449|NCT00401193|9644389|FG001|Modified Intent to Treat Population|Overall Study||115
8607450|NCT00401193|9644390|FG002|Modified Intent to Treat Population|Overall Study||67
8607451|NCT00401193|9644388|FG000|COMPLETED|Overall Study||103
8607452|NCT00401193|9644389|FG001|COMPLETED|Overall Study||106
8607453|NCT00401193|9644390|FG002|COMPLETED|Overall Study||63
8607454|NCT00401193|9644388|FG000|NOT COMPLETED|Overall Study||15
8607455|NCT00401193|9644389|FG001|NOT COMPLETED|Overall Study||11
8607456|NCT00401193|9644390|FG002|NOT COMPLETED|Overall Study||6
8607457|NCT00401245|9644403|FG000|STARTED|Double Blind Titration Phase||126
8607458|NCT00401245|9644404|FG001|STARTED|Double Blind Titration Phase||121
8607459|NCT00401245|9644405|FG002|STARTED|Double Blind Titration Phase||124
8607460|NCT00401245|9644406|FG003|STARTED|Double Blind Titration Phase||122
8607461|NCT00401245|9644407|FG004|STARTED|Double Blind Titration Phase||0
8607462|NCT00401245|9644408|FG005|STARTED|Double Blind Titration Phase||0
8714628|NCT00980330|9761392|FG006|STARTED|Overall Study||66
8714629|NCT00980330|9761386|FG000|COMPLETED|Overall Study||61
8714630|NCT00980330|9761387|FG001|COMPLETED|Overall Study||60
8714631|NCT00980330|9761388|FG002|COMPLETED|Overall Study||58
8714632|NCT00980330|9761389|FG003|COMPLETED|Overall Study||61
8714633|NCT00980330|9761390|FG004|COMPLETED|Overall Study||63
8714634|NCT00980330|9761391|FG005|COMPLETED|Overall Study||61
8714635|NCT00980330|9761392|FG006|COMPLETED|Overall Study||59
8714636|NCT00980330|9761386|FG000|NOT COMPLETED|Overall Study||5
8714637|NCT00980330|9761387|FG001|NOT COMPLETED|Overall Study||5
8714638|NCT00980330|9761388|FG002|NOT COMPLETED|Overall Study||8
8714639|NCT00980330|9761389|FG003|NOT COMPLETED|Overall Study||5
8714640|NCT00980330|9761390|FG004|NOT COMPLETED|Overall Study||5
8714641|NCT00980330|9761391|FG005|NOT COMPLETED|Overall Study||4
8714642|NCT00980330|9761392|FG006|NOT COMPLETED|Overall Study||7
8714643|NCT00980343|9761411|FG000|STARTED|Overall Study||21
8714644|NCT00980343|9761412|FG001|STARTED|Overall Study||23
8714645|NCT00980343|9761411|FG000|COMPLETED|Overall Study||20
8714646|NCT00980343|9761412|FG001|COMPLETED|Overall Study||20
8714647|NCT00980343|9761411|FG000|NOT COMPLETED|Overall Study||1
8714648|NCT00980343|9761412|FG001|NOT COMPLETED|Overall Study||3
8714649|NCT00980395|9761419|FG000|STARTED|Overall Study||24
8714650|NCT00980395|9761419|FG000|COMPLETED|Overall Study||24
8714651|NCT00980395|9761419|FG000|NOT COMPLETED|Overall Study||0
8714652|NCT00980590|9761425|FG000|STARTED|Overall Study||50
8714653|NCT00980590|9761426|FG001|STARTED|Overall Study||50
8714654|NCT00980590|9761425|FG000|COMPLETED|Overall Study||50
8714655|NCT00980590|9761426|FG001|COMPLETED|Overall Study||50
8714656|NCT00980590|9761425|FG000|NOT COMPLETED|Overall Study||0
8714657|NCT00980590|9761426|FG001|NOT COMPLETED|Overall Study||0
8714658|NCT00980642|9761434|FG000|STARTED|Overall Study||36
8714659|NCT00980642|9761435|FG001|STARTED|Overall Study||20
8714660|NCT00980642|9761434|FG000|COMPLETED|Overall Study||36
8714661|NCT00980642|9761435|FG001|COMPLETED|Overall Study||20
8714662|NCT00980642|9761434|FG000|NOT COMPLETED|Overall Study||0
8714663|NCT00980642|9761435|FG001|NOT COMPLETED|Overall Study||0
8714664|NCT00980655|9761444|FG000|STARTED|Overall Study||61
8714665|NCT00980655|9761445|FG001|STARTED|Overall Study||190
8714666|NCT00980655|9761444|FG000|Vaccinated 13vPnC Dose 1|Overall Study||59
8714667|NCT00980655|9761445|FG001|Vaccinated 13vPnC Dose 1|Overall Study||188
8714668|NCT00980655|9761444|FG000|Vaccinated 13vPnC Dose 2|Overall Study||55
8714669|NCT00980655|9761445|FG001|Vaccinated 13vPnC Dose 2|Overall Study||176
8714670|NCT00980655|9761444|FG000|Vaccinated 13vPnC Dose 3|Overall Study||54
8714671|NCT00980655|9761445|FG001|Vaccinated 13vPnC Dose 3|Overall Study||167
8714672|NCT00980655|9761444|FG000|Vaccinated 13vPnC Dose 4|Overall Study||46
8714673|NCT00980655|9761445|FG001|Vaccinated 13vPnC Dose 4|Overall Study||146
8714674|NCT00980655|9761444|FG000|Vaccinated 23vPS Dose|Overall Study||45
8714675|NCT00980655|9761445|FG001|Vaccinated 23vPS Dose|Overall Study||140
8714676|NCT00980655|9761444|FG000|COMPLETED|Overall Study||45
8714677|NCT00980655|9761445|FG001|COMPLETED|Overall Study||139
8607463|NCT00401245|9644409|FG006|STARTED|Double Blind Titration Phase||0
8607464|NCT00401245|9644410|FG007|STARTED|Double Blind Titration Phase||0
8607465|NCT00401245|9644403|FG000|COMPLETED|Double Blind Titration Phase||122
8714678|NCT00980655|9761444|FG000|NOT COMPLETED|Overall Study||16
8714679|NCT00980655|9761445|FG001|NOT COMPLETED|Overall Study||51
8714680|NCT00980681|9761456|FG000|STARTED|TOF MRA|Out of the 13 enrolled patients, three did not receive treatment|10
8607466|NCT00401245|9644404|FG001|COMPLETED|Double Blind Titration Phase||118
8607467|NCT00401245|9644405|FG002|COMPLETED|Double Blind Titration Phase||118
8607468|NCT00401245|9644406|FG003|COMPLETED|Double Blind Titration Phase||107
8607469|NCT00401245|9644407|FG004|COMPLETED|Double Blind Titration Phase||0
8607470|NCT00401245|9644408|FG005|COMPLETED|Double Blind Titration Phase||0
8607471|NCT00401245|9644409|FG006|COMPLETED|Double Blind Titration Phase||0
8607472|NCT00401245|9644410|FG007|COMPLETED|Double Blind Titration Phase||0
8607473|NCT00401245|9644403|FG000|NOT COMPLETED|Double Blind Titration Phase||4
8607474|NCT00401245|9644404|FG001|NOT COMPLETED|Double Blind Titration Phase||3
8607475|NCT00401245|9644405|FG002|NOT COMPLETED|Double Blind Titration Phase||6
8607476|NCT00401245|9644406|FG003|NOT COMPLETED|Double Blind Titration Phase||15
8607477|NCT00401245|9644407|FG004|NOT COMPLETED|Double Blind Titration Phase||0
8607478|NCT00401245|9644408|FG005|NOT COMPLETED|Double Blind Titration Phase||0
8607479|NCT00401245|9644409|FG006|NOT COMPLETED|Double Blind Titration Phase||0
8607480|NCT00401245|9644410|FG007|NOT COMPLETED|Double Blind Titration Phase||0
8607481|NCT00401245|9644403|FG000|STARTED|Between Titration and Open Label Phase||122
8607482|NCT00401245|9644404|FG001|STARTED|Between Titration and Open Label Phase||118
8607483|NCT00401245|9644405|FG002|STARTED|Between Titration and Open Label Phase||118
8607484|NCT00401245|9644406|FG003|STARTED|Between Titration and Open Label Phase||107
8607485|NCT00401245|9644407|FG004|STARTED|Between Titration and Open Label Phase||0
8607486|NCT00401245|9644408|FG005|STARTED|Between Titration and Open Label Phase||0
8607487|NCT00401245|9644409|FG006|STARTED|Between Titration and Open Label Phase||0
8607488|NCT00401245|9644410|FG007|STARTED|Between Titration and Open Label Phase||0
8607489|NCT00401245|9644403|FG000|COMPLETED|Between Titration and Open Label Phase||122
8607490|NCT00401245|9644404|FG001|COMPLETED|Between Titration and Open Label Phase||116
8607491|NCT00401245|9644405|FG002|COMPLETED|Between Titration and Open Label Phase||118
8607492|NCT00401245|9644406|FG003|COMPLETED|Between Titration and Open Label Phase||105
8607493|NCT00401245|9644407|FG004|COMPLETED|Between Titration and Open Label Phase||0
8607494|NCT00401245|9644408|FG005|COMPLETED|Between Titration and Open Label Phase||0
8607495|NCT00401245|9644409|FG006|COMPLETED|Between Titration and Open Label Phase||0
8607496|NCT00401245|9644410|FG007|COMPLETED|Between Titration and Open Label Phase||0
8607497|NCT00401245|9644403|FG000|NOT COMPLETED|Between Titration and Open Label Phase||0
8607498|NCT00401245|9644404|FG001|NOT COMPLETED|Between Titration and Open Label Phase||2
8607499|NCT00401245|9644405|FG002|NOT COMPLETED|Between Titration and Open Label Phase||0
8607500|NCT00401245|9644406|FG003|NOT COMPLETED|Between Titration and Open Label Phase||2
8607501|NCT00401245|9644407|FG004|NOT COMPLETED|Between Titration and Open Label Phase||0
8607502|NCT00401245|9644408|FG005|NOT COMPLETED|Between Titration and Open Label Phase||0
8607503|NCT00401245|9644409|FG006|NOT COMPLETED|Between Titration and Open Label Phase||0
8607504|NCT00401245|9644410|FG007|NOT COMPLETED|Between Titration and Open Label Phase||0
8607505|NCT00401245|9644403|FG000|STARTED|Open Label Phase||122
8607506|NCT00401245|9644404|FG001|STARTED|Open Label Phase||116
8607507|NCT00401245|9644405|FG002|STARTED|Open Label Phase||118
8607508|NCT00401245|9644406|FG003|STARTED|Open Label Phase||105
8607509|NCT00401245|9644407|FG004|STARTED|Open Label Phase||0
8607510|NCT00401245|9644408|FG005|STARTED|Open Label Phase||0
8607511|NCT00401245|9644409|FG006|STARTED|Open Label Phase||0
8607512|NCT00401245|9644410|FG007|STARTED|Open Label Phase||0
8607513|NCT00401245|9644403|FG000|COMPLETED|Open Label Phase||101
8607514|NCT00401245|9644404|FG001|COMPLETED|Open Label Phase||81
8607515|NCT00401245|9644405|FG002|COMPLETED|Open Label Phase||95
8607516|NCT00401245|9644406|FG003|COMPLETED|Open Label Phase||84
8607517|NCT00401245|9644407|FG004|COMPLETED|Open Label Phase||0
8607518|NCT00401245|9644408|FG005|COMPLETED|Open Label Phase||0
8607519|NCT00401245|9644409|FG006|COMPLETED|Open Label Phase||0
8607520|NCT00401245|9644410|FG007|COMPLETED|Open Label Phase||0
8607521|NCT00401245|9644403|FG000|NOT COMPLETED|Open Label Phase||21
8607522|NCT00401245|9644404|FG001|NOT COMPLETED|Open Label Phase||35
8607523|NCT00401245|9644405|FG002|NOT COMPLETED|Open Label Phase||23
8607524|NCT00401245|9644406|FG003|NOT COMPLETED|Open Label Phase||21
8714681|NCT00980681|9761456|FG000|COMPLETED|TOF MRA||10
8714682|NCT00980681|9761456|FG000|NOT COMPLETED|TOF MRA||0
8714683|NCT00980681|9761456|FG000|STARTED|Dotarem MRA|Out of the 13 enrolled patients, three did not receive treatment|10
8714684|NCT00980681|9761456|FG000|COMPLETED|Dotarem MRA||10
8714685|NCT00980681|9761456|FG000|NOT COMPLETED|Dotarem MRA||0
8714686|NCT00980746|9761468|FG000|STARTED|Overall Study||85
8714687|NCT00980746|9761469|FG001|STARTED|Overall Study||89
8714688|NCT00980746|9761470|FG002|STARTED|Overall Study||95
8714689|NCT00980746|9761471|FG003|STARTED|Overall Study||100
8714690|NCT00980746|9761472|FG004|STARTED|Overall Study||92
8714691|NCT00980746|9761473|FG005|STARTED|Overall Study||96
8714692|NCT00980746|9761468|FG000|Randomized|Overall Study||85
8714693|NCT00980746|9761469|FG001|Randomized|Overall Study||89
8714694|NCT00980746|9761470|FG002|Randomized|Overall Study||95
8714695|NCT00980746|9761471|FG003|Randomized|Overall Study||100
8607525|NCT00401245|9644407|FG004|NOT COMPLETED|Open Label Phase||0
8607526|NCT00401245|9644408|FG005|NOT COMPLETED|Open Label Phase||0
8607527|NCT00401245|9644409|FG006|NOT COMPLETED|Open Label Phase||0
8607528|NCT00401245|9644410|FG007|NOT COMPLETED|Open Label Phase||0
8714696|NCT00980746|9761472|FG004|Randomized|Overall Study||92
8714697|NCT00980746|9761473|FG005|Randomized|Overall Study||96
8714698|NCT00980746|9761468|FG000|Safety Population|Overall Study||85
8714699|NCT00980746|9761469|FG001|Safety Population|Overall Study||89
8607529|NCT00401245|9644403|FG000|STARTED|Double Blind Tapering Phase||0
8607530|NCT00401245|9644404|FG001|STARTED|Double Blind Tapering Phase||0
8607531|NCT00401245|9644405|FG002|STARTED|Double Blind Tapering Phase||0
8607532|NCT00401245|9644406|FG003|STARTED|Double Blind Tapering Phase||0
8607533|NCT00401245|9644407|FG004|STARTED|Double Blind Tapering Phase||101
8607534|NCT00401245|9644408|FG005|STARTED|Double Blind Tapering Phase||94
8607535|NCT00401245|9644409|FG006|STARTED|Double Blind Tapering Phase||87
8607536|NCT00401245|9644410|FG007|STARTED|Double Blind Tapering Phase||102
8607537|NCT00401245|9644403|FG000|COMPLETED|Double Blind Tapering Phase||0
8607538|NCT00401245|9644404|FG001|COMPLETED|Double Blind Tapering Phase||0
8607539|NCT00401245|9644405|FG002|COMPLETED|Double Blind Tapering Phase||0
8607540|NCT00401245|9644406|FG003|COMPLETED|Double Blind Tapering Phase||0
8607541|NCT00401245|9644407|FG004|COMPLETED|Double Blind Tapering Phase||97
8607542|NCT00401245|9644408|FG005|COMPLETED|Double Blind Tapering Phase||90
8607543|NCT00401245|9644409|FG006|COMPLETED|Double Blind Tapering Phase||80
8607544|NCT00401245|9644410|FG007|COMPLETED|Double Blind Tapering Phase||95
8607545|NCT00401245|9644403|FG000|NOT COMPLETED|Double Blind Tapering Phase||0
8607546|NCT00401245|9644404|FG001|NOT COMPLETED|Double Blind Tapering Phase||0
8607547|NCT00401245|9644405|FG002|NOT COMPLETED|Double Blind Tapering Phase||0
8607548|NCT00401245|9644406|FG003|NOT COMPLETED|Double Blind Tapering Phase||0
8607549|NCT00401245|9644407|FG004|NOT COMPLETED|Double Blind Tapering Phase||4
8607550|NCT00401245|9644408|FG005|NOT COMPLETED|Double Blind Tapering Phase||4
8607551|NCT00401245|9644409|FG006|NOT COMPLETED|Double Blind Tapering Phase||7
8607552|NCT00401245|9644410|FG007|NOT COMPLETED|Double Blind Tapering Phase||7
8607553|NCT00401258|9644430|FG000|STARTED|Overall Study||15
8607554|NCT00401258|9644430|FG000|COMPLETED|Overall Study||8
8607555|NCT00401258|9644430|FG000|NOT COMPLETED|Overall Study||7
8607556|NCT00401375|9644437|FG000|STARTED|Overall Study||174
8607557|NCT00401375|9644438|FG001|STARTED|Overall Study||176
8607558|NCT00401375|9644439|FG002|STARTED|Overall Study||174
8607559|NCT00401375|9644437|FG000|Received at Least 1 Dose of Study Drug|Overall Study||171
8607560|NCT00401375|9644438|FG001|Received at Least 1 Dose of Study Drug|Overall Study||173
8607561|NCT00401375|9644439|FG002|Received at Least 1 Dose of Study Drug|Overall Study||171
8607562|NCT00401375|9644437|FG000|COMPLETED|Overall Study||152
8607563|NCT00401375|9644438|FG001|COMPLETED|Overall Study||151
8607564|NCT00401375|9644439|FG002|COMPLETED|Overall Study||149
8607565|NCT00401375|9644437|FG000|NOT COMPLETED|Overall Study||22
8607566|NCT00401375|9644438|FG001|NOT COMPLETED|Overall Study||25
8607567|NCT00401375|9644439|FG002|NOT COMPLETED|Overall Study||25
8607568|NCT00401401|9644451|FG000|STARTED|Overall Study||6
8607569|NCT00401401|9644452|FG001|STARTED|Overall Study||6
8607570|NCT00401401|9644453|FG002|STARTED|Overall Study||6
8607571|NCT00401401|9644454|FG003|STARTED|Overall Study||12
8607572|NCT00401401|9644451|FG000|COMPLETED|Overall Study||6
8607573|NCT00401401|9644452|FG001|COMPLETED|Overall Study||6
8607574|NCT00401401|9644453|FG002|COMPLETED|Overall Study||5
8607575|NCT00401401|9644454|FG003|COMPLETED|Overall Study||9
8607576|NCT00401401|9644451|FG000|NOT COMPLETED|Overall Study||0
8607577|NCT00401401|9644452|FG001|NOT COMPLETED|Overall Study||0
8607578|NCT00401401|9644453|FG002|NOT COMPLETED|Overall Study||1
8607579|NCT00401401|9644454|FG003|NOT COMPLETED|Overall Study||3
8607580|NCT00401414|9644471|FG000|STARTED|Overall Study||118
8607581|NCT00401414|9644472|FG001|STARTED|Overall Study||147
8607582|NCT00401414|9644473|FG002|STARTED|Overall Study||79
8607583|NCT00401414|9644471|FG000|COMPLETED|Overall Study||118
8607584|NCT00401414|9644472|FG001|COMPLETED|Overall Study||147
8607585|NCT00401414|9644473|FG002|COMPLETED|Overall Study||79
8607586|NCT00401414|9644471|FG000|NOT COMPLETED|Overall Study||0
8607587|NCT00401414|9644472|FG001|NOT COMPLETED|Overall Study||0
8607588|NCT00401414|9644473|FG002|NOT COMPLETED|Overall Study||0
8607589|NCT00401518|9644486|FG000|STARTED|Overall Study||46
8607590|NCT00401518|9644487|FG001|STARTED|Overall Study||227
8607591|NCT00401518|9644488|FG002|STARTED|Overall Study||117
8607592|NCT00401518|9644486|FG000|COMPLETED|Overall Study||40
8607593|NCT00401518|9644487|FG001|COMPLETED|Overall Study||190
8607594|NCT00401518|9644488|FG002|COMPLETED|Overall Study||94
8607595|NCT00401518|9644486|FG000|NOT COMPLETED|Overall Study||6
8607596|NCT00401518|9644487|FG001|NOT COMPLETED|Overall Study||37
8607597|NCT00401518|9644488|FG002|NOT COMPLETED|Overall Study||23
8607598|NCT00401531|9644498|FG000|STARTED|Overall Study||206
8607599|NCT00401531|9644499|FG001|STARTED|Overall Study||206
8607600|NCT00401531|9644498|FG000|COMPLETED|Overall Study||197
8607601|NCT00401531|9644499|FG001|COMPLETED|Overall Study||196
8607602|NCT00401531|9644498|FG000|NOT COMPLETED|Overall Study||9
8607603|NCT00401531|9644499|FG001|NOT COMPLETED|Overall Study||10
8607604|NCT00401544|9644509|FG000|STARTED|Overall Study|Randomized and treated|56
8607605|NCT00401544|9644510|FG001|STARTED|Overall Study|Randomized and treated|62
8607606|NCT00401544|9644511|FG002|STARTED|Overall Study|Randomized and treated|60
8607607|NCT00401544|9644512|FG003|STARTED|Overall Study|Randomized and treated|60
8607608|NCT00401544|9644509|FG000|COMPLETED|Overall Study||38
8607609|NCT00401544|9644510|FG001|COMPLETED|Overall Study||44
8607610|NCT00401544|9644511|FG002|COMPLETED|Overall Study||48
8607611|NCT00401544|9644512|FG003|COMPLETED|Overall Study||44
8607612|NCT00401544|9644509|FG000|NOT COMPLETED|Overall Study||18
8607613|NCT00401544|9644510|FG001|NOT COMPLETED|Overall Study||18
8607614|NCT00401544|9644511|FG002|NOT COMPLETED|Overall Study||12
8607615|NCT00401544|9644512|FG003|NOT COMPLETED|Overall Study||16
8607616|NCT00401622|9644529|FG000|STARTED|Overall Study||160
8607617|NCT00401622|9644530|FG001|STARTED|Overall Study||160
8607618|NCT00401622|9644529|FG000|COMPLETED|Overall Study||126
8607619|NCT00401622|9644530|FG001|COMPLETED|Overall Study||117
8607620|NCT00401622|9644529|FG000|NOT COMPLETED|Overall Study||34
8607621|NCT00401622|9644530|FG001|NOT COMPLETED|Overall Study||43
8607622|NCT00401726|9644538|FG000|STARTED|Overall Study||269
8607623|NCT00401726|9644539|FG001|STARTED|Overall Study||268
8607624|NCT00401726|9644538|FG000|COMPLETED|Overall Study||172
8607625|NCT00401726|9644539|FG001|COMPLETED|Overall Study||156
8607626|NCT00401726|9644538|FG000|NOT COMPLETED|Overall Study||97
8607627|NCT00401726|9644539|FG001|NOT COMPLETED|Overall Study||112
8607628|NCT00401752|9644547|FG000|STARTED|Overall Study||107
8607629|NCT00401752|9644548|FG001|STARTED|Overall Study||112
8607630|NCT00401752|9644547|FG000|Number of Patients Received Treatment|Overall Study||107
8607631|NCT00401752|9644548|FG001|Number of Patients Received Treatment|Overall Study||111
8607632|NCT00401752|9644547|FG000|Patients Included in ITT Population|Overall Study||106
8607633|NCT00401752|9644548|FG001|Patients Included in ITT Population|Overall Study||111
8607634|NCT00401752|9644547|FG000|Patients Included in Safety Population|Overall Study||107
8607635|NCT00401752|9644548|FG001|Patients Included in Safety Population|Overall Study||110
8607636|NCT00401752|9644547|FG000|Patients Included in Per-Protocol Popula|Overall Study||100
8607637|NCT00401752|9644548|FG001|Patients Included in Per-Protocol Popula|Overall Study||99
8607638|NCT00401752|9644547|FG000|COMPLETED|Overall Study||97
8607639|NCT00401752|9644548|FG001|COMPLETED|Overall Study||94
8607640|NCT00401752|9644547|FG000|NOT COMPLETED|Overall Study||10
8607641|NCT00401752|9644548|FG001|NOT COMPLETED|Overall Study||18
8607642|NCT00401778|9644557|FG000|STARTED|Overall Study||10
8607643|NCT00401778|9644558|FG001|STARTED|Overall Study||12
8607644|NCT00401778|9644559|FG002|STARTED|Overall Study||11
8607645|NCT00401778|9644557|FG000|COMPLETED|Overall Study||9
8607646|NCT00401778|9644558|FG001|COMPLETED|Overall Study||11
8607647|NCT00401778|9644559|FG002|COMPLETED|Overall Study||10
8607648|NCT00401778|9644557|FG000|NOT COMPLETED|Overall Study||1
8607649|NCT00401778|9644558|FG001|NOT COMPLETED|Overall Study||1
8607650|NCT00401778|9644559|FG002|NOT COMPLETED|Overall Study||1
8607651|NCT00401817|9644567|FG000|STARTED|Overall Study||11
8607652|NCT00401817|9644567|FG000|COMPLETED|Overall Study||11
8607653|NCT00401817|9644567|FG000|NOT COMPLETED|Overall Study||0
8714700|NCT00980746|9761470|FG002|Safety Population|Overall Study||95
8714701|NCT00980746|9761471|FG003|Safety Population|Overall Study||100
8714702|NCT00980746|9761472|FG004|Safety Population|Overall Study||92
8714703|NCT00980746|9761473|FG005|Safety Population|Overall Study||96
8714704|NCT00980746|9761468|FG000|Per-protocol|Overall Study||55
8714705|NCT00980746|9761469|FG001|Per-protocol|Overall Study||66
8714706|NCT00980746|9761470|FG002|Per-protocol|Overall Study||73
8714707|NCT00980746|9761471|FG003|Per-protocol|Overall Study||62
8607654|NCT00401830|9644574|FG000|STARTED|Overall Study||81
8607655|NCT00401830|9644575|FG001|STARTED|Overall Study||78
8607656|NCT00401830|9644574|FG000|COMPLETED|Overall Study||50
8607657|NCT00401830|9644575|FG001|COMPLETED|Overall Study||46
8607658|NCT00401830|9644574|FG000|NOT COMPLETED|Overall Study||31
8607659|NCT00401830|9644575|FG001|NOT COMPLETED|Overall Study||32
8607660|NCT00401843|9644584|FG000|STARTED|Overall Study||21
8607661|NCT00401843|9644585|FG001|STARTED|Overall Study||144
8607662|NCT00401843|9644586|FG002|STARTED|Overall Study||142
8607663|NCT00401843|9644584|FG000|Treated|Overall Study||21
8607664|NCT00401843|9644585|FG001|Treated|Overall Study||142
8607665|NCT00401843|9644586|FG002|Treated|Overall Study||139
8714708|NCT00980746|9761472|FG004|Per-protocol|Overall Study||73
8714709|NCT00980746|9761473|FG005|Per-protocol|Overall Study||74
8714710|NCT00980746|9761468|FG000|COMPLETED|Overall Study||58
8714711|NCT00980746|9761469|FG001|COMPLETED|Overall Study||67
8714712|NCT00980746|9761470|FG002|COMPLETED|Overall Study||75
8714713|NCT00980746|9761471|FG003|COMPLETED|Overall Study||64
8714714|NCT00980746|9761472|FG004|COMPLETED|Overall Study||75
8714715|NCT00980746|9761473|FG005|COMPLETED|Overall Study||78
8714716|NCT00980746|9761468|FG000|NOT COMPLETED|Overall Study||27
8714717|NCT00980746|9761469|FG001|NOT COMPLETED|Overall Study||22
8714718|NCT00980746|9761470|FG002|NOT COMPLETED|Overall Study||20
8714719|NCT00980746|9761471|FG003|NOT COMPLETED|Overall Study||36
8714720|NCT00980746|9761472|FG004|NOT COMPLETED|Overall Study||17
8714721|NCT00980746|9761473|FG005|NOT COMPLETED|Overall Study||18
8607666|NCT00401843|9644584|FG000|COMPLETED|Overall Study||0
8607667|NCT00401843|9644585|FG001|COMPLETED|Overall Study||0
8607668|NCT00401843|9644586|FG002|COMPLETED|Overall Study||0
8607669|NCT00401843|9644584|FG000|NOT COMPLETED|Overall Study||21
8607670|NCT00401843|9644585|FG001|NOT COMPLETED|Overall Study||144
8607671|NCT00401843|9644586|FG002|NOT COMPLETED|Overall Study||142
8714722|NCT00980785|9761489|FG000|STARTED|Overall Study||6
8714723|NCT00980785|9761490|FG001|STARTED|Overall Study||8
8714724|NCT00980785|9761489|FG000|COMPLETED|Overall Study||6
8714725|NCT00980785|9761490|FG001|COMPLETED|Overall Study||8
8714726|NCT00980785|9761489|FG000|NOT COMPLETED|Overall Study||0
8714727|NCT00980785|9761490|FG001|NOT COMPLETED|Overall Study||0
8714728|NCT00980798|9761498|FG000|STARTED|Overall Study||149
8714729|NCT00980798|9761499|FG001|STARTED|Overall Study||139
8607672|NCT00401882|9644598|FG000|STARTED|Overall Study||2
8607673|NCT00401882|9644599|FG001|STARTED|Overall Study||5
8607674|NCT00401882|9644598|FG000|COMPLETED|Overall Study||2
8607675|NCT00401882|9644599|FG001|COMPLETED|Overall Study||5
8714730|NCT00980798|9761498|FG000|COMPLETED|Overall Study||116
8607676|NCT00401882|9644598|FG000|NOT COMPLETED|Overall Study||0
8607677|NCT00401882|9644599|FG001|NOT COMPLETED|Overall Study||0
8607678|NCT00401960|9644613|FG000|STARTED|Overall Study||5
8607679|NCT00401960|9644614|FG001|STARTED|Overall Study||1
8607680|NCT00401960|9644613|FG000|COMPLETED|Overall Study||0
8607681|NCT00401960|9644614|FG001|COMPLETED|Overall Study||1
8607682|NCT00401960|9644613|FG000|NOT COMPLETED|Overall Study||5
8607683|NCT00401960|9644614|FG001|NOT COMPLETED|Overall Study||0
8607684|NCT00401973|9644625|FG000|STARTED|Overall Study||50
8607685|NCT00401973|9644626|FG001|STARTED|Overall Study||76
8607686|NCT00401973|9644627|FG002|STARTED|Overall Study||73
8607687|NCT00401973|9644625|FG000|COMPLETED|Overall Study||39
8607688|NCT00401973|9644626|FG001|COMPLETED|Overall Study||50
8607689|NCT00401973|9644627|FG002|COMPLETED|Overall Study||50
8607690|NCT00401973|9644625|FG000|NOT COMPLETED|Overall Study||11
8607691|NCT00401973|9644626|FG001|NOT COMPLETED|Overall Study||26
8607692|NCT00401973|9644627|FG002|NOT COMPLETED|Overall Study||23
8607693|NCT00401986|9644637|FG000|STARTED|Overall Study||14
8607694|NCT00401986|9644637|FG000|COMPLETED|Overall Study||12
8607695|NCT00401986|9644637|FG000|NOT COMPLETED|Overall Study||2
8607696|NCT00402025|9644649|FG000|STARTED|Overall Study||3
8607697|NCT00402025|9644650|FG001|STARTED|Overall Study||4
8607698|NCT00402025|9644651|FG002|STARTED|Overall Study||10
8607699|NCT00402025|9644649|FG000|COMPLETED|Overall Study||1
8607700|NCT00402025|9644650|FG001|COMPLETED|Overall Study||1
8607701|NCT00402025|9644651|FG002|COMPLETED|Overall Study||0
8607702|NCT00402025|9644649|FG000|NOT COMPLETED|Overall Study||2
8607703|NCT00402025|9644650|FG001|NOT COMPLETED|Overall Study||3
8607704|NCT00402025|9644651|FG002|NOT COMPLETED|Overall Study||10
8607705|NCT00402051|9644661|FG000|STARTED|Overall Study||66
8607706|NCT00402051|9644662|FG001|STARTED|Overall Study||67
8607707|NCT00402051|9644661|FG000|Received Treatment|Overall Study||65
8607708|NCT00402051|9644662|FG001|Received Treatment|Overall Study||65
8607709|NCT00402051|9644661|FG000|COMPLETED|Overall Study|Completed 6 treatment cycles and 30 days of follow-up after last dose of study drug|28
8607710|NCT00402051|9644662|FG001|COMPLETED|Overall Study|Completed 6 treatment cycles and 30 days of follow-up after last dose of study drug|32
8607711|NCT00402051|9644661|FG000|NOT COMPLETED|Overall Study||38
8607712|NCT00402051|9644662|FG001|NOT COMPLETED|Overall Study||35
8607713|NCT00402103|9644670|FG000|STARTED|Overall Study||470
8607714|NCT00402103|9644671|FG001|STARTED|Overall Study||86
8607715|NCT00402103|9644670|FG000|COMPLETED|Overall Study||379
8607716|NCT00402103|9644671|FG001|COMPLETED|Overall Study||73
8607717|NCT00402103|9644670|FG000|NOT COMPLETED|Overall Study||91
8607718|NCT00402103|9644671|FG001|NOT COMPLETED|Overall Study||13
8607719|NCT00402116|9644684|FG000|STARTED|Overall Study||6
8607720|NCT00402116|9644685|FG001|STARTED|Overall Study||6
8607721|NCT00402116|9644686|FG002|STARTED|Overall Study||60
8607722|NCT00402116|9644684|FG000|COMPLETED|Overall Study||3
8607723|NCT00402116|9644685|FG001|COMPLETED|Overall Study||0
8607724|NCT00402116|9644686|FG002|COMPLETED|Overall Study||5
8607725|NCT00402116|9644684|FG000|NOT COMPLETED|Overall Study||3
8607726|NCT00402116|9644685|FG001|NOT COMPLETED|Overall Study||6
8607727|NCT00402116|9644686|FG002|NOT COMPLETED|Overall Study||55
8607728|NCT00402168|9644716|FG000|STARTED|Randomized||84
8607729|NCT00402168|9644717|FG001|STARTED|Randomized||89
8607730|NCT00402168|9644716|FG000|COMPLETED|Randomized||83
8607731|NCT00402168|9644717|FG001|COMPLETED|Randomized||88
8607732|NCT00402168|9644716|FG000|NOT COMPLETED|Randomized||1
8607733|NCT00402168|9644717|FG001|NOT COMPLETED|Randomized||1
8607734|NCT00402168|9644716|FG000|STARTED|Treatment (up to 12 Months)||83
8607735|NCT00402168|9644717|FG001|STARTED|Treatment (up to 12 Months)||88
8607736|NCT00402168|9644716|FG000|COMPLETED|Treatment (up to 12 Months)||81
8607737|NCT00402168|9644717|FG001|COMPLETED|Treatment (up to 12 Months)||86
8607738|NCT00402168|9644716|FG000|NOT COMPLETED|Treatment (up to 12 Months)||2
8607739|NCT00402168|9644717|FG001|NOT COMPLETED|Treatment (up to 12 Months)||2
8607740|NCT00402168|9644716|FG000|STARTED|Long Term (LT)||81
8607741|NCT00402168|9644717|FG001|STARTED|Long Term (LT)|5 completed 12 months, did not enter long term: 1 AE, 1 lack of efficacy, 3 other(non-specified).|81
8607742|NCT00402168|9644716|FG000|COMPLETED|Long Term (LT)||70
8607743|NCT00402168|9644717|FG001|COMPLETED|Long Term (LT)||64
8607744|NCT00402168|9644716|FG000|NOT COMPLETED|Long Term (LT)||11
8607745|NCT00402168|9644717|FG001|NOT COMPLETED|Long Term (LT)||17
8607746|NCT00402168|9644716|FG000|STARTED|Switched From CNI to Belatacept in LT|Participants switched from CNI to Belatacept during LT period.|38
8607747|NCT00402168|9644717|FG001|STARTED|Switched From CNI to Belatacept in LT|Out of 81 starting LT period in CNI group, 38 switched from CNI to Belatacept during the LT period.|0
8607748|NCT00402168|9644716|FG000|COMPLETED|Switched From CNI to Belatacept in LT||32
8607749|NCT00402168|9644717|FG001|COMPLETED|Switched From CNI to Belatacept in LT||0
8607750|NCT00402168|9644716|FG000|NOT COMPLETED|Switched From CNI to Belatacept in LT||6
8607751|NCT00402168|9644717|FG001|NOT COMPLETED|Switched From CNI to Belatacept in LT||0
8607752|NCT00402194|9644733|FG000|STARTED|Overall Study||9
8607753|NCT00402194|9644734|FG001|STARTED|Overall Study||8
8607754|NCT00402194|9644733|FG000|COMPLETED|Overall Study||9
8607755|NCT00402194|9644734|FG001|COMPLETED|Overall Study||8
8607756|NCT00402194|9644733|FG000|NOT COMPLETED|Overall Study||0
8607757|NCT00402194|9644734|FG001|NOT COMPLETED|Overall Study||0
8607758|NCT00402233|9644744|FG000|STARTED|Overall Study||77
8607759|NCT00402233|9644745|FG001|STARTED|Overall Study||80
8607760|NCT00402233|9644746|FG002|STARTED|Overall Study||81
8607761|NCT00402233|9644747|FG003|STARTED|Overall Study||73
8607762|NCT00402233|9644744|FG000|COMPLETED|Overall Study||72
8607763|NCT00402233|9644745|FG001|COMPLETED|Overall Study||70
8607764|NCT00402233|9644746|FG002|COMPLETED|Overall Study||70
8607765|NCT00402233|9644747|FG003|COMPLETED|Overall Study||62
8607766|NCT00402233|9644744|FG000|NOT COMPLETED|Overall Study||5
8607767|NCT00402233|9644745|FG001|NOT COMPLETED|Overall Study||10
8607768|NCT00402233|9644746|FG002|NOT COMPLETED|Overall Study||11
8607769|NCT00402233|9644747|FG003|NOT COMPLETED|Overall Study||11
8607770|NCT00402246|9644759|FG000|STARTED|Overall Study||1014
8607771|NCT00402246|9644760|FG001|STARTED|Overall Study||983
8607772|NCT00402246|9644759|FG000|COMPLETED|Overall Study||794
8607773|NCT00402246|9644760|FG001|COMPLETED|Overall Study||749
8607774|NCT00402246|9644759|FG000|NOT COMPLETED|Overall Study||220
8607775|NCT00402246|9644760|FG001|NOT COMPLETED|Overall Study||234
8607776|NCT00402285|9644771|FG000|STARTED|Overall Study||29
8607777|NCT00402285|9644772|FG001|STARTED|Overall Study||27
8607778|NCT00402285|9644773|FG002|STARTED|Overall Study||28
8607779|NCT00402285|9644771|FG000|COMPLETED|Overall Study||22
8607780|NCT00402285|9644772|FG001|COMPLETED|Overall Study||21
8607781|NCT00402285|9644773|FG002|COMPLETED|Overall Study||26
8607782|NCT00402285|9644771|FG000|NOT COMPLETED|Overall Study||7
8607783|NCT00402285|9644772|FG001|NOT COMPLETED|Overall Study||6
8607784|NCT00402285|9644773|FG002|NOT COMPLETED|Overall Study||2
8607785|NCT00402298|9644781|FG000|STARTED|Overall Study||3
8607786|NCT00402298|9644782|FG001|STARTED|Overall Study||2
8607787|NCT00402298|9644781|FG000|COMPLETED|Overall Study||2
8607788|NCT00402298|9644782|FG001|COMPLETED|Overall Study||2
8714731|NCT00980798|9761499|FG001|COMPLETED|Overall Study||84
8714732|NCT00980798|9761498|FG000|NOT COMPLETED|Overall Study||33
8714733|NCT00980798|9761499|FG001|NOT COMPLETED|Overall Study||55
8714734|NCT00980980|9761508|FG000|STARTED|Overall Study||16
8714735|NCT00980980|9761509|FG001|STARTED|Overall Study||14
8714736|NCT00980980|9761510|FG002|STARTED|Overall Study||13
8714737|NCT00980980|9761508|FG000|COMPLETED|Overall Study||16
8714738|NCT00980980|9761509|FG001|COMPLETED|Overall Study||13
8714739|NCT00980980|9761510|FG002|COMPLETED|Overall Study||13
8714740|NCT00980980|9761508|FG000|NOT COMPLETED|Overall Study||0
8714741|NCT00980980|9761509|FG001|NOT COMPLETED|Overall Study||1
8714742|NCT00980980|9761510|FG002|NOT COMPLETED|Overall Study||0
8714743|NCT00981019|9761521|FG000|STARTED|Overall Study||778
8714744|NCT00981019|9761521|FG000|COMPLETED|Overall Study||301
8813217|NCT01524770|9866370|FG001|STARTED|Washout Period of at Least 28 Days||23
8813218|NCT01524770|9866369|FG000|COMPLETED|Washout Period of at Least 28 Days||23
8813219|NCT01524770|9866370|FG001|COMPLETED|Washout Period of at Least 28 Days||23
8813220|NCT01524770|9866369|FG000|NOT COMPLETED|Washout Period of at Least 28 Days||0
8813221|NCT01524770|9866370|FG001|NOT COMPLETED|Washout Period of at Least 28 Days||0
8813222|NCT01524770|9866369|FG000|STARTED|Second Intervention||23
8813223|NCT01524770|9866370|FG001|STARTED|Second Intervention||23
8813224|NCT01524770|9866369|FG000|COMPLETED|Second Intervention||23
8813225|NCT01524770|9866370|FG001|COMPLETED|Second Intervention||23
8813226|NCT01524770|9866369|FG000|NOT COMPLETED|Second Intervention||0
8714745|NCT00981019|9761521|FG000|NOT COMPLETED|Overall Study||477
8714746|NCT00981045|9761527|FG000|STARTED|Overall Study||1290
8714747|NCT00981045|9761528|FG001|STARTED|Overall Study||1294
8714748|NCT00981045|9761527|FG000|COMPLETED|Overall Study||1276
8714749|NCT00981045|9761528|FG001|COMPLETED|Overall Study||1285
8714750|NCT00981045|9761527|FG000|NOT COMPLETED|Overall Study||14
8714751|NCT00981045|9761528|FG001|NOT COMPLETED|Overall Study||9
8714752|NCT00981084|9761536|FG000|STARTED|First Intervention (One Day)||16
8714753|NCT00981084|9761537|FG001|STARTED|First Intervention (One Day)||17
8714754|NCT00981084|9761536|FG000|COMPLETED|First Intervention (One Day)||16
8714755|NCT00981084|9761537|FG001|COMPLETED|First Intervention (One Day)||17
8714756|NCT00981084|9761536|FG000|NOT COMPLETED|First Intervention (One Day)||0
8714757|NCT00981084|9761537|FG001|NOT COMPLETED|First Intervention (One Day)||0
8714758|NCT00981084|9761536|FG000|STARTED|Washout Period (7 Days)||16
8714759|NCT00981084|9761537|FG001|STARTED|Washout Period (7 Days)||17
8714760|NCT00981084|9761536|FG000|COMPLETED|Washout Period (7 Days)||16
8714761|NCT00981084|9761537|FG001|COMPLETED|Washout Period (7 Days)||17
8714762|NCT00981084|9761536|FG000|NOT COMPLETED|Washout Period (7 Days)||0
8714763|NCT00981084|9761537|FG001|NOT COMPLETED|Washout Period (7 Days)||0
8714764|NCT00981084|9761536|FG000|STARTED|Second Intervention (One Day)||16
8714765|NCT00981084|9761537|FG001|STARTED|Second Intervention (One Day)||17
8714766|NCT00981084|9761536|FG000|COMPLETED|Second Intervention (One Day)||16
8714767|NCT00981084|9761537|FG001|COMPLETED|Second Intervention (One Day)||17
8714768|NCT00981084|9761536|FG000|NOT COMPLETED|Second Intervention (One Day)||0
8714769|NCT00981084|9761537|FG001|NOT COMPLETED|Second Intervention (One Day)||0
8714770|NCT00981084|9761536|FG000|STARTED|Post Intervention (Data Analysis)||16
8714771|NCT00981084|9761537|FG001|STARTED|Post Intervention (Data Analysis)||17
8714772|NCT00981084|9761536|FG000|COMPLETED|Post Intervention (Data Analysis)||14
8714773|NCT00981084|9761537|FG001|COMPLETED|Post Intervention (Data Analysis)||16
8714774|NCT00981084|9761536|FG000|NOT COMPLETED|Post Intervention (Data Analysis)||2
8813227|NCT01524770|9866370|FG001|NOT COMPLETED|Second Intervention||0
8607789|NCT00402298|9644781|FG000|NOT COMPLETED|Overall Study||1
8607790|NCT00402298|9644782|FG001|NOT COMPLETED|Overall Study||0
8607791|NCT00402324|9644790|FG000|STARTED|Overall Study||101
8607792|NCT00402324|9644791|FG001|STARTED|Overall Study||101
8607793|NCT00402324|9644790|FG000|COMPLETED|Overall Study||58
8607794|NCT00402324|9644791|FG001|COMPLETED|Overall Study||60
8607795|NCT00402324|9644790|FG000|NOT COMPLETED|Overall Study||43
8607796|NCT00402324|9644791|FG001|NOT COMPLETED|Overall Study||41
8607797|NCT00402337|9644802|FG000|STARTED|Overall Study||59
8607798|NCT00402337|9644803|FG001|STARTED|Overall Study||57
8607799|NCT00402337|9644804|FG002|STARTED|Overall Study||62
8607800|NCT00402337|9644805|FG003|STARTED|Overall Study||63
8607801|NCT00402337|9644806|FG004|STARTED|Overall Study||69
8607802|NCT00402337|9644802|FG000|COMPLETED|Overall Study||54
8607803|NCT00402337|9644803|FG001|COMPLETED|Overall Study||51
8607804|NCT00402337|9644804|FG002|COMPLETED|Overall Study||58
8607805|NCT00402337|9644805|FG003|COMPLETED|Overall Study||51
8607806|NCT00402337|9644806|FG004|COMPLETED|Overall Study||61
8607807|NCT00402337|9644802|FG000|NOT COMPLETED|Overall Study||5
8607808|NCT00402337|9644803|FG001|NOT COMPLETED|Overall Study||6
8607809|NCT00402337|9644804|FG002|NOT COMPLETED|Overall Study||4
8607810|NCT00402337|9644805|FG003|NOT COMPLETED|Overall Study||12
8607811|NCT00402337|9644806|FG004|NOT COMPLETED|Overall Study||8
8607812|NCT00402363|9644822|FG000|STARTED|Overall Study||266
8607813|NCT00402363|9644823|FG001|STARTED|Overall Study||276
8607814|NCT00402363|9644824|FG002|STARTED|Overall Study||66
8607815|NCT00402363|9644825|FG003|STARTED|Overall Study||55
8607816|NCT00402363|9644822|FG000|COMPLETED|Overall Study||233
8607817|NCT00402363|9644823|FG001|COMPLETED|Overall Study||246
8607818|NCT00402363|9644824|FG002|COMPLETED|Overall Study||60
8607819|NCT00402363|9644825|FG003|COMPLETED|Overall Study||45
8607820|NCT00402363|9644822|FG000|NOT COMPLETED|Overall Study||33
8607821|NCT00402363|9644823|FG001|NOT COMPLETED|Overall Study||30
8607822|NCT00402363|9644824|FG002|NOT COMPLETED|Overall Study||6
8607823|NCT00402363|9644825|FG003|NOT COMPLETED|Overall Study||10
8607824|NCT00402597|9644846|FG000|STARTED|Overall Study||1153
8607825|NCT00402597|9644847|FG001|STARTED|Overall Study||307
8607826|NCT00402597|9644848|FG002|STARTED|Overall Study||1046
8607827|NCT00402597|9644849|FG003|STARTED|Overall Study||353
8607828|NCT00402597|9644850|FG004|STARTED|Overall Study||603
8607829|NCT00402597|9644846|FG000|COMPLETED|Overall Study||962
8607830|NCT00402597|9644847|FG001|COMPLETED|Overall Study||261
8607831|NCT00402597|9644848|FG002|COMPLETED|Overall Study||834
8607832|NCT00402597|9644849|FG003|COMPLETED|Overall Study||279
8607833|NCT00402597|9644850|FG004|COMPLETED|Overall Study||479
8607834|NCT00402597|9644846|FG000|NOT COMPLETED|Overall Study||191
8607835|NCT00402597|9644847|FG001|NOT COMPLETED|Overall Study||46
8607836|NCT00402597|9644848|FG002|NOT COMPLETED|Overall Study||212
8607837|NCT00402597|9644849|FG003|NOT COMPLETED|Overall Study||74
8607838|NCT00402597|9644850|FG004|NOT COMPLETED|Overall Study||124
8607839|NCT00402649|9644862|FG000|STARTED|Overall Study||35
8607840|NCT00402649|9644862|FG000|COMPLETED|Overall Study||33
8607841|NCT00402649|9644862|FG000|NOT COMPLETED|Overall Study||2
8607842|NCT00402688|9644869|FG000|STARTED|Overall Study||81
8607843|NCT00402688|9644870|FG001|STARTED|Overall Study||81
8607844|NCT00402688|9644871|FG002|STARTED|Overall Study||80
8607845|NCT00402688|9644869|FG000|COMPLETED|Overall Study||60
8607846|NCT00402688|9644870|FG001|COMPLETED|Overall Study||65
8607847|NCT00402688|9644871|FG002|COMPLETED|Overall Study||65
8607848|NCT00402688|9644869|FG000|NOT COMPLETED|Overall Study||21
8607849|NCT00402688|9644870|FG001|NOT COMPLETED|Overall Study||16
8607850|NCT00402688|9644871|FG002|NOT COMPLETED|Overall Study||15
8607851|NCT00402714|9644881|FG000|STARTED|Overall Study||3
8607852|NCT00402714|9644882|FG001|STARTED|Overall Study||11
8607853|NCT00402714|9644881|FG000|COMPLETED|Overall Study||3
8607854|NCT00402714|9644882|FG001|COMPLETED|Overall Study||11
8607855|NCT00402714|9644881|FG000|NOT COMPLETED|Overall Study||0
8607856|NCT00402714|9644882|FG001|NOT COMPLETED|Overall Study||0
8607857|NCT00402727|9644892|FG000|STARTED|Overall Study||432
8607858|NCT00402727|9644893|FG001|STARTED|Overall Study||381
8607859|NCT00402727|9644892|FG000|Achieving End Of Treatment (EOT)|Overall Study||408
8607860|NCT00402727|9644893|FG001|Achieving End Of Treatment (EOT)|Overall Study||355
8607861|NCT00402727|9644892|FG000|Achieving Test Of Cure (TOC)|Overall Study||390
8607862|NCT00402727|9644893|FG001|Achieving Test Of Cure (TOC)|Overall Study||347
8607863|NCT00402727|9644892|FG000|COMPLETED|Overall Study||390
8607864|NCT00402727|9644893|FG001|COMPLETED|Overall Study||347
8607865|NCT00402727|9644892|FG000|NOT COMPLETED|Overall Study||42
8607866|NCT00402727|9644893|FG001|NOT COMPLETED|Overall Study||34
8607867|NCT00402740|9644899|FG000|STARTED|Overall Study||322
8607868|NCT00402740|9644899|FG000|COMPLETED|Overall Study||242
8607869|NCT00402740|9644899|FG000|NOT COMPLETED|Overall Study||80
8607870|NCT00402779|9644909|FG000|STARTED|Overall Study||152
8607871|NCT00402779|9644910|FG001|STARTED|Overall Study||151
8607872|NCT00402779|9644909|FG000|COMPLETED|Overall Study||75
8607873|NCT00402779|9644910|FG001|COMPLETED|Overall Study||75
8607874|NCT00402779|9644909|FG000|NOT COMPLETED|Overall Study||77
8607875|NCT00402779|9644910|FG001|NOT COMPLETED|Overall Study||76
8607876|NCT00402831|9644918|FG000|STARTED|Overall Study||202
8607877|NCT00402831|9644919|FG001|STARTED|Overall Study||203
8607878|NCT00402831|9644918|FG000|ProQuad® Dose 1 (Day 1)|Overall Study||202
8607879|NCT00402831|9644919|FG001|ProQuad® Dose 1 (Day 1)|Overall Study||203
8607880|NCT00402831|9644918|FG000|ProQuad® Dose 1 (Day 30)|Overall Study||202
8607881|NCT00402831|9644919|FG001|ProQuad® Dose 1 (Day 30)|Overall Study||203
8607882|NCT00402831|9644918|FG000|COMPLETED|Overall Study||201
8607883|NCT00402831|9644919|FG001|COMPLETED|Overall Study||200
8607884|NCT00402831|9644918|FG000|NOT COMPLETED|Overall Study||1
8607885|NCT00402831|9644919|FG001|NOT COMPLETED|Overall Study||3
8607886|NCT00402896|9644927|FG000|STARTED|Overall Study||20
8607887|NCT00402896|9644927|FG000|COMPLETED|Overall Study||20
8607888|NCT00402896|9644927|FG000|NOT COMPLETED|Overall Study||0
8607889|NCT00402987|9644935|FG000|STARTED|Overall Study||90
8607890|NCT00402987|9644936|FG001|STARTED|Overall Study||45
8607891|NCT00402987|9644937|FG002|STARTED|Overall Study||45
8607892|NCT00402987|9644938|FG003|STARTED|Overall Study||89
8607893|NCT00402987|9644935|FG000|COMPLETED|Overall Study||90
8607894|NCT00402987|9644936|FG001|COMPLETED|Overall Study||45
8607895|NCT00402987|9644937|FG002|COMPLETED|Overall Study||44
8607896|NCT00402987|9644938|FG003|COMPLETED|Overall Study||89
8607897|NCT00402987|9644935|FG000|NOT COMPLETED|Overall Study||0
8607898|NCT00402987|9644936|FG001|NOT COMPLETED|Overall Study||0
8607899|NCT00402987|9644937|FG002|NOT COMPLETED|Overall Study||1
8607900|NCT00402987|9644938|FG003|NOT COMPLETED|Overall Study||0
8607901|NCT00403117|9644962|FG000|STARTED|Overall Study||49
8607902|NCT00403117|9644962|FG000|COMPLETED|Overall Study||29
8607903|NCT00403117|9644962|FG000|NOT COMPLETED|Overall Study||20
8607904|NCT00403130|9644993|FG000|STARTED|2 Years From Start of Treatment||31
8607905|NCT00403130|9644993|FG000|COMPLETED|2 Years From Start of Treatment||26
8607906|NCT00403130|9644993|FG000|NOT COMPLETED|2 Years From Start of Treatment||5
8607907|NCT00403130|9644993|FG000|STARTED|Survival Follow-up up to 6 Years||26
8607908|NCT00403130|9644993|FG000|COMPLETED|Survival Follow-up up to 6 Years||16
8607909|NCT00403130|9644993|FG000|NOT COMPLETED|Survival Follow-up up to 6 Years||10
8607910|NCT00403234|9645001|FG000|STARTED|Overall Study||2
8607911|NCT00403234|9645002|FG001|STARTED|Overall Study||3
8607912|NCT00403234|9645003|FG002|STARTED|Overall Study||3
8607913|NCT00403234|9645004|FG003|STARTED|Overall Study||2
8607914|NCT00403234|9645001|FG000|COMPLETED|Overall Study||1
8607915|NCT00403234|9645002|FG001|COMPLETED|Overall Study||2
8607916|NCT00403234|9645003|FG002|COMPLETED|Overall Study||2
8607917|NCT00403234|9645004|FG003|COMPLETED|Overall Study||2
8607918|NCT00403234|9645001|FG000|NOT COMPLETED|Overall Study||1
8607919|NCT00403234|9645002|FG001|NOT COMPLETED|Overall Study||1
8607920|NCT00403234|9645003|FG002|NOT COMPLETED|Overall Study||1
8607921|NCT00403234|9645004|FG003|NOT COMPLETED|Overall Study||0
8607922|NCT00403260|9645016|FG000|STARTED|Overall Study|Patients randomized and treated.|848
8607923|NCT00403260|9645017|FG001|STARTED|Overall Study|Patients randomized and treated.|423
8607924|NCT00403260|9645016|FG000|COMPLETED|Overall Study||723
8607925|NCT00403260|9645017|FG001|COMPLETED|Overall Study||357
8607926|NCT00403260|9645016|FG000|NOT COMPLETED|Overall Study||125
8607927|NCT00403260|9645017|FG001|NOT COMPLETED|Overall Study||66
8607928|NCT00403273|9645025|FG000|STARTED|Overall Study||25
8607929|NCT00403273|9645026|FG001|STARTED|Overall Study||29
8607930|NCT00403273|9645025|FG000|COMPLETED|Overall Study||22
8607931|NCT00403273|9645026|FG001|COMPLETED|Overall Study||25
8607932|NCT00403273|9645025|FG000|NOT COMPLETED|Overall Study||3
8607933|NCT00403273|9645026|FG001|NOT COMPLETED|Overall Study||4
8607934|NCT00403390|9645036|FG000|STARTED|Overall Study||16
8607935|NCT00403390|9645037|FG001|STARTED|Overall Study||18
8607936|NCT00403390|9645036|FG000|COMPLETED|Overall Study||13
8607937|NCT00403390|9645037|FG001|COMPLETED|Overall Study||18
8607938|NCT00403390|9645036|FG000|NOT COMPLETED|Overall Study||3
8607939|NCT00403390|9645037|FG001|NOT COMPLETED|Overall Study||0
8607940|NCT00403403|9645045|FG000|STARTED|Overall Study||50
8607941|NCT00403403|9645046|FG001|STARTED|Overall Study||52
8607942|NCT00403403|9645045|FG000|Safety-Evaluable Patients|Overall Study||47
8607943|NCT00403403|9645046|FG001|Safety-Evaluable Patients|Overall Study||51
8607944|NCT00403403|9645045|FG000|COMPLETED|Overall Study||50
8607945|NCT00403403|9645046|FG001|COMPLETED|Overall Study||52
8607946|NCT00403403|9645045|FG000|NOT COMPLETED|Overall Study||0
8607947|NCT00403403|9645046|FG001|NOT COMPLETED|Overall Study||0
8607948|NCT00403455|9645052|FG000|STARTED|Overall Study||38
8607949|NCT00403455|9645052|FG000|COMPLETED|Overall Study||37
8607950|NCT00403455|9645052|FG000|NOT COMPLETED|Overall Study||1
8607951|NCT00403481|9645056|FG000|STARTED|Olmesartan Medoxomil (Olm) 20 mg||192
8607952|NCT00403481|9645056|FG000|COMPLETED|Olmesartan Medoxomil (Olm) 20 mg||186
8607953|NCT00403481|9645056|FG000|NOT COMPLETED|Olmesartan Medoxomil (Olm) 20 mg||6
8607954|NCT00403481|9645056|FG000|STARTED|Olm 40 mg|186 -4 met their blood pressure goal (remained on olmesartan 20 mg) = 182|182
8607955|NCT00403481|9645056|FG000|COMPLETED|Olm 40 mg||177
8607956|NCT00403481|9645056|FG000|NOT COMPLETED|Olm 40 mg||5
8607957|NCT00403481|9645056|FG000|STARTED|Olm 40 mg + Hydrochlorothiazide 12.5 mg|177 -4 met their blood pressure goal (remained on olmesartan 40 mg)= 173|173
8607958|NCT00403481|9645056|FG000|COMPLETED|Olm 40 mg + Hydrochlorothiazide 12.5 mg||168
8607959|NCT00403481|9645056|FG000|NOT COMPLETED|Olm 40 mg + Hydrochlorothiazide 12.5 mg||5
8607960|NCT00403481|9645056|FG000|STARTED|Olm 40 mg + Hydrochlorothiazide 25 mg|168 -24 met their blood pressure goal (remained on olmesartan 40 mg/hydrochlorothiazide 12.5mg)= 144|144
8607961|NCT00403481|9645056|FG000|COMPLETED|Olm 40 mg + Hydrochlorothiazide 25 mg||142
8607962|NCT00403481|9645056|FG000|NOT COMPLETED|Olm 40 mg + Hydrochlorothiazide 25 mg||2
8607963|NCT00403494|9645065|FG000|STARTED|Overall Study||96
8607964|NCT00403494|9645066|FG001|STARTED|Overall Study||94
8607965|NCT00403494|9645065|FG000|Intent to Treat|Overall Study||87
8607966|NCT00403494|9645066|FG001|Intent to Treat|Overall Study||83
8607967|NCT00403494|9645065|FG000|Per-protocol|Overall Study||69
8607968|NCT00403494|9645066|FG001|Per-protocol|Overall Study||69
8607969|NCT00403494|9645065|FG000|Safety Population|Overall Study||97
8607970|NCT00403494|9645066|FG001|Safety Population|Overall Study||91
8607971|NCT00403494|9645065|FG000|COMPLETED|Overall Study||81
8607972|NCT00403494|9645066|FG001|COMPLETED|Overall Study||80
8607973|NCT00403494|9645065|FG000|NOT COMPLETED|Overall Study||15
8607974|NCT00403494|9645066|FG001|NOT COMPLETED|Overall Study||14
8607975|NCT00403546|9645076|FG000|STARTED|Signed Informed Consent/Open-Label||131
8607976|NCT00403546|9645077|FG001|STARTED|Signed Informed Consent/Open-Label||0
8607977|NCT00403546|9645078|FG002|STARTED|Signed Informed Consent/Open-Label||0
8607978|NCT00403546|9645076|FG000|COMPLETED|Signed Informed Consent/Open-Label||103
8607979|NCT00403546|9645077|FG001|COMPLETED|Signed Informed Consent/Open-Label||0
8607980|NCT00403546|9645078|FG002|COMPLETED|Signed Informed Consent/Open-Label||0
8607981|NCT00403546|9645076|FG000|NOT COMPLETED|Signed Informed Consent/Open-Label||28
8607982|NCT00403546|9645077|FG001|NOT COMPLETED|Signed Informed Consent/Open-Label||0
8607983|NCT00403546|9645078|FG002|NOT COMPLETED|Signed Informed Consent/Open-Label||0
8607984|NCT00403546|9645076|FG000|STARTED|Screening Phase||103
8607985|NCT00403546|9645077|FG001|STARTED|Screening Phase||0
8607986|NCT00403546|9645078|FG002|STARTED|Screening Phase||0
8607987|NCT00403546|9645076|FG000|COMPLETED|Screening Phase|All participants who completed Screening were randomized to the High-Dose and Placebo arms.|75
8607988|NCT00403546|9645077|FG001|COMPLETED|Screening Phase||0
8607989|NCT00403546|9645078|FG002|COMPLETED|Screening Phase||0
8607990|NCT00403546|9645076|FG000|NOT COMPLETED|Screening Phase||28
8607991|NCT00403546|9645077|FG001|NOT COMPLETED|Screening Phase||0
8607992|NCT00403546|9645078|FG002|NOT COMPLETED|Screening Phase||0
8607993|NCT00403546|9645076|FG000|STARTED|Randomized Trial|All participants who completed Screening were randomized to the High-Dose and Placebo arms.|0
8607994|NCT00403546|9645077|FG001|STARTED|Randomized Trial||38
8607995|NCT00403546|9645078|FG002|STARTED|Randomized Trial||37
8607996|NCT00403546|9645076|FG000|COMPLETED|Randomized Trial||0
8607997|NCT00403546|9645077|FG001|COMPLETED|Randomized Trial||21
8607998|NCT00403546|9645078|FG002|COMPLETED|Randomized Trial||21
8607999|NCT00403546|9645076|FG000|NOT COMPLETED|Randomized Trial||0
8608000|NCT00403546|9645077|FG001|NOT COMPLETED|Randomized Trial||17
8608001|NCT00403546|9645078|FG002|NOT COMPLETED|Randomized Trial||16
8608002|NCT00403585|9645087|FG000|STARTED|Initial Treatment Phase||104
8608003|NCT00403585|9645087|FG000|COMPLETED|Initial Treatment Phase||102
8608004|NCT00403585|9645087|FG000|NOT COMPLETED|Initial Treatment Phase||2
8608005|NCT00403585|9645087|FG000|STARTED|Open-Label Phase; Extension Study|80 of 102 participants completing Study 103814 enrolled in extension (22 didn't continue medication)|80
8608006|NCT00403585|9645087|FG000|COMPLETED|Open-Label Phase; Extension Study||74
8608007|NCT00403585|9645087|FG000|NOT COMPLETED|Open-Label Phase; Extension Study||6
8608008|NCT00403754|9645091|FG000|STARTED|Core Treatment Period 1||11
8608009|NCT00403754|9645092|FG001|STARTED|Core Treatment Period 1||10
8608010|NCT00403754|9645093|FG002|STARTED|Core Treatment Period 1||9
8608011|NCT00403754|9645094|FG003|STARTED|Core Treatment Period 1||11
8608012|NCT00403754|9645091|FG000|COMPLETED|Core Treatment Period 1||11
8608013|NCT00403754|9645092|FG001|COMPLETED|Core Treatment Period 1||9
8608014|NCT00403754|9645093|FG002|COMPLETED|Core Treatment Period 1||9
8608015|NCT00403754|9645094|FG003|COMPLETED|Core Treatment Period 1||11
8608016|NCT00403754|9645091|FG000|NOT COMPLETED|Core Treatment Period 1||0
8608017|NCT00403754|9645092|FG001|NOT COMPLETED|Core Treatment Period 1||1
8608018|NCT00403754|9645093|FG002|NOT COMPLETED|Core Treatment Period 1||0
8608019|NCT00403754|9645094|FG003|NOT COMPLETED|Core Treatment Period 1||0
8608020|NCT00403754|9645091|FG000|STARTED|Core Treatment Period 2||11
8608021|NCT00403754|9645092|FG001|STARTED|Core Treatment Period 2||9
8608022|NCT00403754|9645093|FG002|STARTED|Core Treatment Period 2||9
8608023|NCT00403754|9645094|FG003|STARTED|Core Treatment Period 2||11
8608024|NCT00403754|9645091|FG000|COMPLETED|Core Treatment Period 2||11
8608025|NCT00403754|9645092|FG001|COMPLETED|Core Treatment Period 2||9
8608026|NCT00403754|9645093|FG002|COMPLETED|Core Treatment Period 2||8
8608027|NCT00403754|9645094|FG003|COMPLETED|Core Treatment Period 2||11
8608028|NCT00403754|9645091|FG000|NOT COMPLETED|Core Treatment Period 2||0
8608029|NCT00403754|9645092|FG001|NOT COMPLETED|Core Treatment Period 2||0
8608030|NCT00403754|9645093|FG002|NOT COMPLETED|Core Treatment Period 2||1
8608031|NCT00403754|9645094|FG003|NOT COMPLETED|Core Treatment Period 2||0
8608032|NCT00403754|9645091|FG000|STARTED|Core Treatment Period 3||11
8608033|NCT00403754|9645092|FG001|STARTED|Core Treatment Period 3||9
8608034|NCT00403754|9645093|FG002|STARTED|Core Treatment Period 3||8
8608035|NCT00403754|9645094|FG003|STARTED|Core Treatment Period 3||11
8608036|NCT00403754|9645091|FG000|COMPLETED|Core Treatment Period 3||11
8608037|NCT00403754|9645092|FG001|COMPLETED|Core Treatment Period 3||9
8608038|NCT00403754|9645093|FG002|COMPLETED|Core Treatment Period 3||8
8608039|NCT00403754|9645094|FG003|COMPLETED|Core Treatment Period 3||11
8608040|NCT00403754|9645091|FG000|NOT COMPLETED|Core Treatment Period 3||0
8608041|NCT00403754|9645092|FG001|NOT COMPLETED|Core Treatment Period 3||0
8608042|NCT00403754|9645093|FG002|NOT COMPLETED|Core Treatment Period 3||0
8608043|NCT00403754|9645094|FG003|NOT COMPLETED|Core Treatment Period 3||0
8608044|NCT00403754|9645091|FG000|STARTED|Core Treatment Period 4||11
8608045|NCT00403754|9645092|FG001|STARTED|Core Treatment Period 4||9
8608046|NCT00403754|9645093|FG002|STARTED|Core Treatment Period 4||8
8608047|NCT00403754|9645094|FG003|STARTED|Core Treatment Period 4||11
8608048|NCT00403754|9645091|FG000|COMPLETED|Core Treatment Period 4||11
8608049|NCT00403754|9645092|FG001|COMPLETED|Core Treatment Period 4||9
8608050|NCT00403754|9645093|FG002|COMPLETED|Core Treatment Period 4||8
8608051|NCT00403754|9645094|FG003|COMPLETED|Core Treatment Period 4||11
8608052|NCT00403754|9645091|FG000|NOT COMPLETED|Core Treatment Period 4||0
8608053|NCT00403754|9645092|FG001|NOT COMPLETED|Core Treatment Period 4||0
8608054|NCT00403754|9645093|FG002|NOT COMPLETED|Core Treatment Period 4||0
8608055|NCT00403754|9645094|FG003|NOT COMPLETED|Core Treatment Period 4||0
8608056|NCT00403754|9645091|FG000|STARTED|Open Label: Salmeterol||11
8608057|NCT00403754|9645092|FG001|STARTED|Open Label: Salmeterol||9
8608058|NCT00403754|9645093|FG002|STARTED|Open Label: Salmeterol||8
8608059|NCT00403754|9645094|FG003|STARTED|Open Label: Salmeterol||11
8608060|NCT00403754|9645091|FG000|COMPLETED|Open Label: Salmeterol||11
8608061|NCT00403754|9645092|FG001|COMPLETED|Open Label: Salmeterol||9
8608062|NCT00403754|9645093|FG002|COMPLETED|Open Label: Salmeterol||8
8608063|NCT00403754|9645094|FG003|COMPLETED|Open Label: Salmeterol||11
8608064|NCT00403754|9645091|FG000|NOT COMPLETED|Open Label: Salmeterol||0
8608065|NCT00403754|9645092|FG001|NOT COMPLETED|Open Label: Salmeterol||0
8608066|NCT00403754|9645093|FG002|NOT COMPLETED|Open Label: Salmeterol||0
8608067|NCT00403754|9645094|FG003|NOT COMPLETED|Open Label: Salmeterol||0
8608068|NCT00403767|9645108|FG000|STARTED|Overall Study||7111
8608069|NCT00403767|9645109|FG001|STARTED|Overall Study||7125
8608070|NCT00403767|9645108|FG000|COMPLETED|Overall Study||4591
8608071|NCT00403767|9645109|FG001|COMPLETED|Overall Study||4657
8608072|NCT00403767|9645108|FG000|NOT COMPLETED|Overall Study||2520
8608073|NCT00403767|9645109|FG001|NOT COMPLETED|Overall Study||2468
8608074|NCT00403845|9645115|FG000|STARTED|Treatment Period 1||12
8608075|NCT00403845|9645116|FG001|STARTED|Treatment Period 1||13
8608076|NCT00403845|9645117|FG002|STARTED|Treatment Period 1||11
8608077|NCT00403845|9645118|FG003|STARTED|Treatment Period 1||14
8608078|NCT00403845|9645115|FG000|COMPLETED|Treatment Period 1||11
8608079|NCT00403845|9645116|FG001|COMPLETED|Treatment Period 1||13
8608080|NCT00403845|9645117|FG002|COMPLETED|Treatment Period 1||11
8608081|NCT00403845|9645118|FG003|COMPLETED|Treatment Period 1||13
8608082|NCT00403845|9645115|FG000|NOT COMPLETED|Treatment Period 1||1
8608083|NCT00403845|9645116|FG001|NOT COMPLETED|Treatment Period 1||0
8608084|NCT00403845|9645117|FG002|NOT COMPLETED|Treatment Period 1||0
8608085|NCT00403845|9645118|FG003|NOT COMPLETED|Treatment Period 1||1
8608086|NCT00403845|9645115|FG000|STARTED|Treatment Period 2||11
8608087|NCT00403845|9645116|FG001|STARTED|Treatment Period 2||13
8608088|NCT00403845|9645117|FG002|STARTED|Treatment Period 2||11
8608089|NCT00403845|9645118|FG003|STARTED|Treatment Period 2||13
8608090|NCT00403845|9645115|FG000|COMPLETED|Treatment Period 2||10
8608091|NCT00403845|9645116|FG001|COMPLETED|Treatment Period 2||13
8608092|NCT00403845|9645117|FG002|COMPLETED|Treatment Period 2||11
8608093|NCT00403845|9645118|FG003|COMPLETED|Treatment Period 2||13
8608094|NCT00403845|9645115|FG000|NOT COMPLETED|Treatment Period 2||1
8608095|NCT00403845|9645116|FG001|NOT COMPLETED|Treatment Period 2||0
8608096|NCT00403845|9645117|FG002|NOT COMPLETED|Treatment Period 2||0
8608097|NCT00403845|9645118|FG003|NOT COMPLETED|Treatment Period 2||0
8608098|NCT00403845|9645115|FG000|STARTED|Treatment Period 3||10
8714775|NCT00981084|9761537|FG001|NOT COMPLETED|Post Intervention (Data Analysis)||1
8608099|NCT00403845|9645116|FG001|STARTED|Treatment Period 3||13
8608100|NCT00403845|9645117|FG002|STARTED|Treatment Period 3||11
8608101|NCT00403845|9645118|FG003|STARTED|Treatment Period 3||13
8608102|NCT00403845|9645115|FG000|COMPLETED|Treatment Period 3||10
8608103|NCT00403845|9645116|FG001|COMPLETED|Treatment Period 3||13
8608104|NCT00403845|9645117|FG002|COMPLETED|Treatment Period 3||11
8608105|NCT00403845|9645118|FG003|COMPLETED|Treatment Period 3||11
8608106|NCT00403845|9645115|FG000|NOT COMPLETED|Treatment Period 3||0
8608107|NCT00403845|9645116|FG001|NOT COMPLETED|Treatment Period 3||0
8608108|NCT00403845|9645117|FG002|NOT COMPLETED|Treatment Period 3||0
8608109|NCT00403845|9645118|FG003|NOT COMPLETED|Treatment Period 3||2
8608110|NCT00403845|9645115|FG000|STARTED|Treatment Period 4||10
8608111|NCT00403845|9645116|FG001|STARTED|Treatment Period 4||13
8608112|NCT00403845|9645117|FG002|STARTED|Treatment Period 4||11
8608113|NCT00403845|9645118|FG003|STARTED|Treatment Period 4||11
8608114|NCT00403845|9645115|FG000|COMPLETED|Treatment Period 4||10
8608115|NCT00403845|9645116|FG001|COMPLETED|Treatment Period 4||13
8608116|NCT00403845|9645117|FG002|COMPLETED|Treatment Period 4||11
8608117|NCT00403845|9645118|FG003|COMPLETED|Treatment Period 4||11
8608118|NCT00403845|9645115|FG000|NOT COMPLETED|Treatment Period 4||0
8608119|NCT00403845|9645116|FG001|NOT COMPLETED|Treatment Period 4||0
8608120|NCT00403845|9645117|FG002|NOT COMPLETED|Treatment Period 4||0
8608121|NCT00403845|9645118|FG003|NOT COMPLETED|Treatment Period 4||0
8608122|NCT00404066|9645128|FG000|STARTED|Overall Study|1 subject started but withdrew after adriamycin+cytoxan, but before study drugs lapatinib+docetaxel.|21
8608123|NCT00404066|9645128|FG000|COMPLETED|Overall Study||18
8608124|NCT00404066|9645128|FG000|NOT COMPLETED|Overall Study||3
8608125|NCT00404079|9645134|FG000|STARTED|Overall Study||125
8608126|NCT00404079|9645135|FG001|STARTED|Overall Study||125
8608127|NCT00404079|9645134|FG000|COMPLETED|Overall Study||103
8608128|NCT00404079|9645135|FG001|COMPLETED|Overall Study||105
8608129|NCT00404079|9645134|FG000|NOT COMPLETED|Overall Study||22
8608130|NCT00404079|9645135|FG001|NOT COMPLETED|Overall Study||20
8608131|NCT00404092|9645145|FG000|STARTED|Overall Study||9
8714776|NCT00981149|9761547|FG000|STARTED|Overall Study||12
8608132|NCT00404092|9645146|FG001|STARTED|Overall Study||8
8608133|NCT00404092|9645147|FG002|STARTED|Overall Study||9
8608134|NCT00404092|9645148|FG003|STARTED|Overall Study||20
8608135|NCT00404092|9645145|FG000|COMPLETED|Overall Study||8
8608136|NCT00404092|9645146|FG001|COMPLETED|Overall Study||8
8608137|NCT00404092|9645147|FG002|COMPLETED|Overall Study||8
8608138|NCT00404092|9645148|FG003|COMPLETED|Overall Study||20
8608139|NCT00404092|9645145|FG000|NOT COMPLETED|Overall Study||1
8608140|NCT00404092|9645146|FG001|NOT COMPLETED|Overall Study||0
8608141|NCT00404092|9645147|FG002|NOT COMPLETED|Overall Study||1
8608142|NCT00404092|9645148|FG003|NOT COMPLETED|Overall Study||0
8629035|NCT00528372|9668653|FG008|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||34
8629036|NCT00528372|9668645|FG000|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||12
8629037|NCT00528372|9668646|FG001|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||5
8629038|NCT00528372|9668647|FG002|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||12
8629039|NCT00528372|9668648|FG003|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||13
8629040|NCT00528372|9668649|FG004|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||9
8629041|NCT00528372|9668650|FG005|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||11
8629042|NCT00528372|9668651|FG006|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||11
8629043|NCT00528372|9668652|FG007|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||6
8629044|NCT00528372|9668653|FG008|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||5
8629045|NCT00528372|9668645|FG000|STARTED|Long-term (LT) Period (Weeks 24-102)||62
8629046|NCT00528372|9668646|FG001|STARTED|Long-term (LT) Period (Weeks 24-102)||59
8629047|NCT00528372|9668647|FG002|STARTED|Long-term (LT) Period (Weeks 24-102)||51
8629048|NCT00528372|9668648|FG003|STARTED|Long-term (LT) Period (Weeks 24-102)||56
8629049|NCT00528372|9668649|FG004|STARTED|Long-term (LT) Period (Weeks 24-102)||58
8629050|NCT00528372|9668650|FG005|STARTED|Long-term (LT) Period (Weeks 24-102)||57
8629051|NCT00528372|9668651|FG006|STARTED|Long-term (LT) Period (Weeks 24-102)||65
8629052|NCT00528372|9668652|FG007|STARTED|Long-term (LT) Period (Weeks 24-102)||28
8629053|NCT00528372|9668653|FG008|STARTED|Long-term (LT) Period (Weeks 24-102)|1 patient completed ST phase but withdrew for sponsor administrative reason before start of LT phase|33
8629054|NCT00528372|9668645|FG000|COMPLETED|Long-term (LT) Period (Weeks 24-102)||42
8629055|NCT00528372|9668646|FG001|COMPLETED|Long-term (LT) Period (Weeks 24-102)||40
8629056|NCT00528372|9668647|FG002|COMPLETED|Long-term (LT) Period (Weeks 24-102)||43
8629057|NCT00528372|9668648|FG003|COMPLETED|Long-term (LT) Period (Weeks 24-102)||42
8629058|NCT00528372|9668649|FG004|COMPLETED|Long-term (LT) Period (Weeks 24-102)||37
8629059|NCT00528372|9668650|FG005|COMPLETED|Long-term (LT) Period (Weeks 24-102)||42
8629060|NCT00528372|9668651|FG006|COMPLETED|Long-term (LT) Period (Weeks 24-102)||48
8629061|NCT00528372|9668652|FG007|COMPLETED|Long-term (LT) Period (Weeks 24-102)||22
8629062|NCT00528372|9668653|FG008|COMPLETED|Long-term (LT) Period (Weeks 24-102)||27
8629063|NCT00528372|9668645|FG000|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||20
8629064|NCT00528372|9668646|FG001|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||19
8629065|NCT00528372|9668647|FG002|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||8
8629066|NCT00528372|9668648|FG003|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||14
8629067|NCT00528372|9668649|FG004|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||21
8629068|NCT00528372|9668650|FG005|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||15
8629069|NCT00528372|9668651|FG006|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||17
8629070|NCT00528372|9668652|FG007|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||6
8629071|NCT00528372|9668653|FG008|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||6
8629072|NCT00528398|9668699|FG000|STARTED|Overall Study||111
8629073|NCT00528398|9668699|FG000|COMPLETED|Overall Study||111
8629074|NCT00528398|9668699|FG000|NOT COMPLETED|Overall Study||0
8629075|NCT00528411|9668706|FG000|STARTED|Overall Study||57
8629076|NCT00528411|9668707|FG001|STARTED|Overall Study||54
8629077|NCT00528411|9668708|FG002|STARTED|Overall Study||12
8629078|NCT00528411|9668706|FG000|COMPLETED|Overall Study||52
8629079|NCT00528411|9668707|FG001|COMPLETED|Overall Study||51
8629080|NCT00528411|9668708|FG002|COMPLETED|Overall Study||11
8629081|NCT00528411|9668706|FG000|NOT COMPLETED|Overall Study||5
8629082|NCT00528411|9668707|FG001|NOT COMPLETED|Overall Study||3
8629083|NCT00528411|9668708|FG002|NOT COMPLETED|Overall Study||1
8629084|NCT00528424|9668716|FG000|STARTED|Overall Study||286
8629085|NCT00528424|9668716|FG000|COMPLETED|Overall Study||257
8629086|NCT00528424|9668716|FG000|NOT COMPLETED|Overall Study||29
8629087|NCT00528450|9668720|FG000|STARTED|Overall Study||1
8629088|NCT00528450|9668720|FG000|COMPLETED|Overall Study||1
8629089|NCT00528450|9668720|FG000|NOT COMPLETED|Overall Study||0
8629090|NCT00528528|9668728|FG000|STARTED|Overall Study||40
8629091|NCT00528528|9668729|FG001|STARTED|Overall Study||42
8629092|NCT00528528|9668730|FG002|STARTED|Overall Study||40
8629093|NCT00528528|9668731|FG003|STARTED|Overall Study||39
8629094|NCT00528528|9668728|FG000|Ongoing at Time of Cut-off|Overall Study||0
8629095|NCT00528528|9668729|FG001|Ongoing at Time of Cut-off|Overall Study||0
8629096|NCT00528528|9668730|FG002|Ongoing at Time of Cut-off|Overall Study||1
8629097|NCT00528528|9668731|FG003|Ongoing at Time of Cut-off|Overall Study||0
8629098|NCT00528528|9668728|FG000|COMPLETED|Overall Study||37
8629099|NCT00528528|9668729|FG001|COMPLETED|Overall Study||39
8629100|NCT00528528|9668730|FG002|COMPLETED|Overall Study||37
8629101|NCT00528528|9668731|FG003|COMPLETED|Overall Study||36
8629102|NCT00528528|9668728|FG000|NOT COMPLETED|Overall Study||3
8629103|NCT00528528|9668729|FG001|NOT COMPLETED|Overall Study||3
8629104|NCT00528528|9668730|FG002|NOT COMPLETED|Overall Study||3
8629105|NCT00528528|9668731|FG003|NOT COMPLETED|Overall Study||3
8629106|NCT00528541|9668745|FG000|STARTED|Overall Study||75
8629107|NCT00528541|9668746|FG001|STARTED|Overall Study||70
8629108|NCT00528541|9668745|FG000|COMPLETED|Overall Study||73
8629109|NCT00528541|9668746|FG001|COMPLETED|Overall Study||69
8629110|NCT00528541|9668745|FG000|NOT COMPLETED|Overall Study||2
8629111|NCT00528541|9668746|FG001|NOT COMPLETED|Overall Study||1
8629112|NCT00528567|9668754|FG000|STARTED|Overall Study||1301
8629113|NCT00528567|9668755|FG001|STARTED|Overall Study||1290
8608143|NCT00404235|9645160|FG000|STARTED|Overall Study||35
8608144|NCT00404235|9645161|FG001|STARTED|Overall Study||41
8608145|NCT00404235|9645160|FG000|COMPLETED|Overall Study||34
8608146|NCT00404235|9645161|FG001|COMPLETED|Overall Study||39
8608147|NCT00404235|9645160|FG000|NOT COMPLETED|Overall Study||1
8608148|NCT00404235|9645161|FG001|NOT COMPLETED|Overall Study||2
8608149|NCT00404248|9645170|FG000|STARTED|Overall Study||3
8608150|NCT00404248|9645171|FG001|STARTED|Overall Study||4
8608151|NCT00404248|9645172|FG002|STARTED|Overall Study||5
8608152|NCT00404248|9645173|FG003|STARTED|Overall Study||2
8608153|NCT00404248|9645174|FG004|STARTED|Overall Study||3
8608154|NCT00404248|9645175|FG005|STARTED|Overall Study||3
8608155|NCT00404248|9645176|FG006|STARTED|Overall Study||6
8608156|NCT00404248|9645177|FG007|STARTED|Overall Study||6
8608157|NCT00404248|9645178|FG008|STARTED|Overall Study||3
8608158|NCT00404248|9645170|FG000|COMPLETED|Overall Study||3
8608159|NCT00404248|9645171|FG001|COMPLETED|Overall Study||3
8608160|NCT00404248|9645172|FG002|COMPLETED|Overall Study||5
8608161|NCT00404248|9645173|FG003|COMPLETED|Overall Study||2
8608162|NCT00404248|9645174|FG004|COMPLETED|Overall Study||3
8608163|NCT00404248|9645175|FG005|COMPLETED|Overall Study||3
8608164|NCT00404248|9645176|FG006|COMPLETED|Overall Study||6
8608165|NCT00404248|9645177|FG007|COMPLETED|Overall Study||6
8608166|NCT00404248|9645178|FG008|COMPLETED|Overall Study||3
8608167|NCT00404248|9645170|FG000|NOT COMPLETED|Overall Study||0
8608168|NCT00404248|9645171|FG001|NOT COMPLETED|Overall Study||1
8608169|NCT00404248|9645172|FG002|NOT COMPLETED|Overall Study||0
8608170|NCT00404248|9645173|FG003|NOT COMPLETED|Overall Study||0
8608171|NCT00404248|9645174|FG004|NOT COMPLETED|Overall Study||0
8608172|NCT00404248|9645175|FG005|NOT COMPLETED|Overall Study||0
8608173|NCT00404248|9645176|FG006|NOT COMPLETED|Overall Study||0
8608174|NCT00404248|9645177|FG007|NOT COMPLETED|Overall Study||0
8608175|NCT00404248|9645178|FG008|NOT COMPLETED|Overall Study||0
8608176|NCT00404352|9645207|FG000|STARTED|Double Blind (up to 24 Month)||171
8608177|NCT00404352|9645208|FG001|STARTED|Double Blind (up to 24 Month)||175
8608178|NCT00404352|9645209|FG002|STARTED|Double Blind (up to 24 Month)||171
8608179|NCT00404352|9645210|FG003|STARTED|Double Blind (up to 24 Month)||0
8608180|NCT00404352|9645211|FG004|STARTED|Double Blind (up to 24 Month)||0
8608181|NCT00404352|9645212|FG005|STARTED|Double Blind (up to 24 Month)||0
8608182|NCT00404352|9645213|FG006|STARTED|Double Blind (up to 24 Month)||0
8608183|NCT00404352|9645214|FG007|STARTED|Double Blind (up to 24 Month)||0
8608184|NCT00404352|9645215|FG008|STARTED|Double Blind (up to 24 Month)||0
8608185|NCT00404352|9645207|FG000|Treated|Double Blind (up to 24 Month)||171
8608186|NCT00404352|9645208|FG001|Treated|Double Blind (up to 24 Month)||173
8608187|NCT00404352|9645209|FG002|Treated|Double Blind (up to 24 Month)||171
8608188|NCT00404352|9645210|FG003|Treated|Double Blind (up to 24 Month)||0
8608189|NCT00404352|9645211|FG004|Treated|Double Blind (up to 24 Month)||0
8608190|NCT00404352|9645212|FG005|Treated|Double Blind (up to 24 Month)||0
8714777|NCT00981149|9761548|FG001|STARTED|Overall Study||12
8714778|NCT00981149|9761547|FG000|COMPLETED|Overall Study||10
8714779|NCT00981149|9761548|FG001|COMPLETED|Overall Study||9
8714780|NCT00981149|9761547|FG000|NOT COMPLETED|Overall Study||2
8714781|NCT00981149|9761548|FG001|NOT COMPLETED|Overall Study||3
8714782|NCT00981175|9761557|FG000|STARTED|Primary Dose Vaccination||101
8714783|NCT00981175|9761558|FG001|STARTED|Primary Dose Vaccination||101
8714784|NCT00981175|9761557|FG000|COMPLETED|Primary Dose Vaccination||98
8714785|NCT00981175|9761558|FG001|COMPLETED|Primary Dose Vaccination||99
8714786|NCT00981175|9761557|FG000|NOT COMPLETED|Primary Dose Vaccination||3
8714787|NCT00981175|9761558|FG001|NOT COMPLETED|Primary Dose Vaccination||2
8714788|NCT00981175|9761557|FG000|STARTED|Booster Dose Vaccination|A sub-set of participants in the group received the booster ChimeriVax™-JE vaccine.|55
8714789|NCT00981175|9761558|FG001|STARTED|Booster Dose Vaccination|A sub-set of participants in the group received the booster ChimeriVax™-JE vaccine.|43
8714790|NCT00981175|9761557|FG000|COMPLETED|Booster Dose Vaccination||53
8714791|NCT00981175|9761558|FG001|COMPLETED|Booster Dose Vaccination||40
8714792|NCT00981175|9761557|FG000|NOT COMPLETED|Booster Dose Vaccination||2
8714793|NCT00981175|9761558|FG001|NOT COMPLETED|Booster Dose Vaccination||3
8714794|NCT00981214|9761571|FG000|STARTED|Overall Study||19
8714795|NCT00981214|9761571|FG000|COMPLETED|Overall Study||19
8714796|NCT00981214|9761571|FG000|NOT COMPLETED|Overall Study||0
8714797|NCT00981227|9761581|FG000|STARTED|Overall Study||102
8714798|NCT00981227|9761582|FG001|STARTED|Overall Study||94
8714799|NCT00981227|9761583|FG002|STARTED|Overall Study||94
8714800|NCT00981227|9761584|FG003|STARTED|Overall Study||94
8714801|NCT00981227|9761585|FG004|STARTED|Overall Study||90
8714802|NCT00981227|9761586|FG005|STARTED|Overall Study||93
8714803|NCT00981227|9761581|FG000|Randomized|Overall Study||102
8714804|NCT00981227|9761582|FG001|Randomized|Overall Study||94
8714805|NCT00981227|9761583|FG002|Randomized|Overall Study||94
8714806|NCT00981227|9761584|FG003|Randomized|Overall Study||94
8714807|NCT00981227|9761585|FG004|Randomized|Overall Study||90
8714808|NCT00981227|9761586|FG005|Randomized|Overall Study||93
8608191|NCT00404352|9645213|FG006|Treated|Double Blind (up to 24 Month)||0
8608192|NCT00404352|9645214|FG007|Treated|Double Blind (up to 24 Month)||0
8608193|NCT00404352|9645215|FG008|Treated|Double Blind (up to 24 Month)||0
8608194|NCT00404352|9645207|FG000|COMPLETED|Double Blind (up to 24 Month)||119
8714809|NCT00981227|9761581|FG000|Safety Population|Overall Study||102
8714810|NCT00981227|9761582|FG001|Safety Population|Overall Study||94
8714811|NCT00981227|9761583|FG002|Safety Population|Overall Study||94
8608195|NCT00404352|9645208|FG001|COMPLETED|Double Blind (up to 24 Month)||128
8608196|NCT00404352|9645209|FG002|COMPLETED|Double Blind (up to 24 Month)||92
8608197|NCT00404352|9645210|FG003|COMPLETED|Double Blind (up to 24 Month)||0
8608198|NCT00404352|9645211|FG004|COMPLETED|Double Blind (up to 24 Month)||0
8608199|NCT00404352|9645212|FG005|COMPLETED|Double Blind (up to 24 Month)||0
8608200|NCT00404352|9645213|FG006|COMPLETED|Double Blind (up to 24 Month)||0
8608201|NCT00404352|9645214|FG007|COMPLETED|Double Blind (up to 24 Month)||0
8608202|NCT00404352|9645215|FG008|COMPLETED|Double Blind (up to 24 Month)||0
8608203|NCT00404352|9645207|FG000|NOT COMPLETED|Double Blind (up to 24 Month)||52
8608204|NCT00404352|9645208|FG001|NOT COMPLETED|Double Blind (up to 24 Month)||47
8608205|NCT00404352|9645209|FG002|NOT COMPLETED|Double Blind (up to 24 Month)||79
8608206|NCT00404352|9645210|FG003|NOT COMPLETED|Double Blind (up to 24 Month)||0
8608207|NCT00404352|9645211|FG004|NOT COMPLETED|Double Blind (up to 24 Month)||0
8608208|NCT00404352|9645212|FG005|NOT COMPLETED|Double Blind (up to 24 Month)||0
8608209|NCT00404352|9645213|FG006|NOT COMPLETED|Double Blind (up to 24 Month)||0
8608210|NCT00404352|9645214|FG007|NOT COMPLETED|Double Blind (up to 24 Month)||0
8608211|NCT00404352|9645215|FG008|NOT COMPLETED|Double Blind (up to 24 Month)||0
8608212|NCT00404352|9645207|FG000|STARTED|Open Label (up to 24 Month)||0
8714812|NCT00981227|9761584|FG003|Safety Population|Overall Study||94
8714813|NCT00981227|9761585|FG004|Safety Population|Overall Study||90
8714814|NCT00981227|9761586|FG005|Safety Population|Overall Study||93
8714815|NCT00981227|9761581|FG000|Per-Protocol|Overall Study||69
8714816|NCT00981227|9761582|FG001|Per-Protocol|Overall Study||72
8714817|NCT00981227|9761583|FG002|Per-Protocol|Overall Study||67
8714818|NCT00981227|9761584|FG003|Per-Protocol|Overall Study||68
8714819|NCT00981227|9761585|FG004|Per-Protocol|Overall Study||50
8608213|NCT00404352|9645208|FG001|STARTED|Open Label (up to 24 Month)||0
8608214|NCT00404352|9645209|FG002|STARTED|Open Label (up to 24 Month)||0
8608215|NCT00404352|9645210|FG003|STARTED|Open Label (up to 24 Month)|From DB period, 31 participants converted to CDMS and switched to OL period in this study|31
8608216|NCT00404352|9645211|FG004|STARTED|Open Label (up to 24 Month)|From DB period, 30 participants converted to CDMS and switched to OL period in this study|30
8608217|NCT00404352|9645212|FG005|STARTED|Open Label (up to 24 Month)|From DB period, 59 participants converted to CDMS and switched to OL period in this study|59
8608218|NCT00404352|9645213|FG006|STARTED|Open Label (up to 24 Month)||0
8608219|NCT00404352|9645214|FG007|STARTED|Open Label (up to 24 Month)||0
8608220|NCT00404352|9645215|FG008|STARTED|Open Label (up to 24 Month)||0
8608221|NCT00404352|9645207|FG000|COMPLETED|Open Label (up to 24 Month)||0
8608222|NCT00404352|9645208|FG001|COMPLETED|Open Label (up to 24 Month)||0
8608223|NCT00404352|9645209|FG002|COMPLETED|Open Label (up to 24 Month)||0
8608224|NCT00404352|9645210|FG003|COMPLETED|Open Label (up to 24 Month)||28
8608225|NCT00404352|9645211|FG004|COMPLETED|Open Label (up to 24 Month)||28
8608226|NCT00404352|9645212|FG005|COMPLETED|Open Label (up to 24 Month)||52
8608227|NCT00404352|9645213|FG006|COMPLETED|Open Label (up to 24 Month)||0
8608228|NCT00404352|9645214|FG007|COMPLETED|Open Label (up to 24 Month)||0
8608229|NCT00404352|9645215|FG008|COMPLETED|Open Label (up to 24 Month)||0
8608230|NCT00404352|9645207|FG000|NOT COMPLETED|Open Label (up to 24 Month)||0
8714820|NCT00981227|9761586|FG005|Per-Protocol|Overall Study||70
8714821|NCT00981227|9761581|FG000|COMPLETED|Overall Study||80
8714822|NCT00981227|9761582|FG001|COMPLETED|Overall Study||75
8714823|NCT00981227|9761583|FG002|COMPLETED|Overall Study||73
8714824|NCT00981227|9761584|FG003|COMPLETED|Overall Study||73
8714825|NCT00981227|9761585|FG004|COMPLETED|Overall Study||60
8714826|NCT00981227|9761586|FG005|COMPLETED|Overall Study||75
8714827|NCT00981227|9761581|FG000|NOT COMPLETED|Overall Study||22
8714828|NCT00981227|9761582|FG001|NOT COMPLETED|Overall Study||19
8714829|NCT00981227|9761583|FG002|NOT COMPLETED|Overall Study||21
8714830|NCT00981227|9761584|FG003|NOT COMPLETED|Overall Study||21
8714831|NCT00981227|9761585|FG004|NOT COMPLETED|Overall Study||30
8714832|NCT00981227|9761586|FG005|NOT COMPLETED|Overall Study||18
8714833|NCT00981253|9761606|FG000|STARTED|Overall Study||76
8714834|NCT00981253|9761607|FG001|STARTED|Overall Study||75
8714835|NCT00981253|9761606|FG000|COMPLETED|Overall Study||73
8714836|NCT00981253|9761607|FG001|COMPLETED|Overall Study||72
8714837|NCT00981253|9761606|FG000|NOT COMPLETED|Overall Study||3
8714838|NCT00981253|9761607|FG001|NOT COMPLETED|Overall Study||3
8714839|NCT00981292|9761620|FG000|STARTED|Day 1||7
8714840|NCT00981292|9761621|FG001|STARTED|Day 1||4
8714841|NCT00981292|9761622|FG002|STARTED|Day 1||6
8714842|NCT00981292|9761623|FG003|STARTED|Day 1||4
8714843|NCT00981292|9761624|FG004|STARTED|Day 1||4
8714844|NCT00981292|9761625|FG005|STARTED|Day 1||7
8714845|NCT00981292|9761620|FG000|COMPLETED|Day 1||6
8714846|NCT00981292|9761621|FG001|COMPLETED|Day 1||4
8714847|NCT00981292|9761622|FG002|COMPLETED|Day 1||6
8714848|NCT00981292|9761623|FG003|COMPLETED|Day 1||4
8714849|NCT00981292|9761624|FG004|COMPLETED|Day 1||4
8608231|NCT00404352|9645208|FG001|NOT COMPLETED|Open Label (up to 24 Month)||0
8714850|NCT00981292|9761625|FG005|COMPLETED|Day 1||5
8714851|NCT00981292|9761620|FG000|NOT COMPLETED|Day 1||1
8714852|NCT00981292|9761621|FG001|NOT COMPLETED|Day 1||0
8714853|NCT00981292|9761622|FG002|NOT COMPLETED|Day 1||0
8714854|NCT00981292|9761623|FG003|NOT COMPLETED|Day 1||0
8714855|NCT00981292|9761624|FG004|NOT COMPLETED|Day 1||0
8714856|NCT00981292|9761625|FG005|NOT COMPLETED|Day 1||2
8714857|NCT00981292|9761620|FG000|STARTED|Day 2||6
8714858|NCT00981292|9761621|FG001|STARTED|Day 2||4
8714859|NCT00981292|9761622|FG002|STARTED|Day 2||6
8608232|NCT00404352|9645209|FG002|NOT COMPLETED|Open Label (up to 24 Month)||0
8608233|NCT00404352|9645210|FG003|NOT COMPLETED|Open Label (up to 24 Month)||3
8608234|NCT00404352|9645211|FG004|NOT COMPLETED|Open Label (up to 24 Month)||2
8608235|NCT00404352|9645212|FG005|NOT COMPLETED|Open Label (up to 24 Month)||7
8608236|NCT00404352|9645213|FG006|NOT COMPLETED|Open Label (up to 24 Month)||0
8608237|NCT00404352|9645214|FG007|NOT COMPLETED|Open Label (up to 24 Month)||0
8608238|NCT00404352|9645215|FG008|NOT COMPLETED|Open Label (up to 24 Month)||0
8608239|NCT00404352|9645207|FG000|STARTED|Open Label Extension (up to 36 Months)||0
8608240|NCT00404352|9645208|FG001|STARTED|Open Label Extension (up to 36 Months)||0
8608241|NCT00404352|9645209|FG002|STARTED|Open Label Extension (up to 36 Months)||0
8608242|NCT00404352|9645210|FG003|STARTED|Open Label Extension (up to 36 Months)||0
8608243|NCT00404352|9645211|FG004|STARTED|Open Label Extension (up to 36 Months)||0
8608244|NCT00404352|9645212|FG005|STARTED|Open Label Extension (up to 36 Months)||0
8608245|NCT00404352|9645213|FG006|STARTED|Open Label Extension (up to 36 Months)|4 participants who did not convert to CDMS in 24 months and gave consent to enroll in OLE period|4
8608246|NCT00404352|9645214|FG007|STARTED|Open Label Extension (up to 36 Months)|5 participants who did not convert to CDMS in 24 months and gave consent to enroll in OLE period|5
8608247|NCT00404352|9645215|FG008|STARTED|Open Label Extension (up to 36 Months)|11 participants who did not convert to CDMS in 24 months and gave consent to enroll in OLE period|11
8608248|NCT00404352|9645207|FG000|COMPLETED|Open Label Extension (up to 36 Months)||0
8608249|NCT00404352|9645208|FG001|COMPLETED|Open Label Extension (up to 36 Months)||0
8608250|NCT00404352|9645209|FG002|COMPLETED|Open Label Extension (up to 36 Months)||0
8608251|NCT00404352|9645210|FG003|COMPLETED|Open Label Extension (up to 36 Months)||0
8608252|NCT00404352|9645211|FG004|COMPLETED|Open Label Extension (up to 36 Months)||0
8608253|NCT00404352|9645212|FG005|COMPLETED|Open Label Extension (up to 36 Months)||0
8608254|NCT00404352|9645213|FG006|COMPLETED|Open Label Extension (up to 36 Months)||3
8608255|NCT00404352|9645214|FG007|COMPLETED|Open Label Extension (up to 36 Months)||4
8608256|NCT00404352|9645215|FG008|COMPLETED|Open Label Extension (up to 36 Months)||9
8608257|NCT00404352|9645207|FG000|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
8608258|NCT00404352|9645208|FG001|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
8629114|NCT00528567|9668754|FG000|Intention to Treat|Overall Study||1301
8714860|NCT00981292|9761623|FG003|STARTED|Day 2||4
8714861|NCT00981292|9761624|FG004|STARTED|Day 2||4
8714862|NCT00981292|9761625|FG005|STARTED|Day 2||5
8714863|NCT00981292|9761620|FG000|COMPLETED|Day 2||4
8714864|NCT00981292|9761621|FG001|COMPLETED|Day 2||4
8714865|NCT00981292|9761622|FG002|COMPLETED|Day 2||6
8714866|NCT00981292|9761623|FG003|COMPLETED|Day 2||4
8714867|NCT00981292|9761624|FG004|COMPLETED|Day 2||4
8714868|NCT00981292|9761625|FG005|COMPLETED|Day 2||5
8714869|NCT00981292|9761620|FG000|NOT COMPLETED|Day 2||2
8714870|NCT00981292|9761621|FG001|NOT COMPLETED|Day 2||0
8714871|NCT00981292|9761622|FG002|NOT COMPLETED|Day 2||0
8714872|NCT00981292|9761623|FG003|NOT COMPLETED|Day 2||0
8813228|NCT01524783|9866378|FG000|STARTED|Blinded Period||205
8813229|NCT01524783|9866379|FG001|STARTED|Blinded Period||97
8813230|NCT01524783|9866380|FG002|STARTED|Blinded Period||0
8813231|NCT01524783|9866378|FG000|COMPLETED|Blinded Period||26
8813232|NCT01524783|9866379|FG001|COMPLETED|Blinded Period||6
8813233|NCT01524783|9866380|FG002|COMPLETED|Blinded Period||0
8813234|NCT01524783|9866378|FG000|NOT COMPLETED|Blinded Period||179
8813235|NCT01524783|9866379|FG001|NOT COMPLETED|Blinded Period||91
8813236|NCT01524783|9866380|FG002|NOT COMPLETED|Blinded Period||0
8813237|NCT01524783|9866378|FG000|STARTED|Open-label Period||26
8813238|NCT01524783|9866379|FG001|STARTED|Open-label Period||0
8813239|NCT01524783|9866380|FG002|STARTED|Open-label Period||6
8813240|NCT01524783|9866378|FG000|COMPLETED|Open-label Period||0
8813241|NCT01524783|9866379|FG001|COMPLETED|Open-label Period||0
8813242|NCT01524783|9866380|FG002|COMPLETED|Open-label Period||0
8813243|NCT01524783|9866378|FG000|NOT COMPLETED|Open-label Period||26
8813244|NCT01524783|9866379|FG001|NOT COMPLETED|Open-label Period||0
8813245|NCT01524783|9866380|FG002|NOT COMPLETED|Open-label Period||6
8813246|NCT01524796|9866392|FG000|STARTED|Overall Study||128
8813247|NCT01524796|9866392|FG000|COMPLETED|Overall Study||100
8813248|NCT01524796|9866392|FG000|NOT COMPLETED|Overall Study||28
8813249|NCT01524887|9866399|FG000|STARTED|Overall Study||85
8813250|NCT01524887|9866400|FG001|STARTED|Overall Study||90
8813251|NCT01524887|9866401|FG002|STARTED|Overall Study||86
8813252|NCT01524887|9866399|FG000|Received Treatment|Overall Study||83
8813253|NCT01524887|9866400|FG001|Received Treatment|Overall Study||85
8813254|NCT01524887|9866401|FG002|Received Treatment|Overall Study||83
8813255|NCT01524887|9866399|FG000|COMPLETED|Overall Study|No subject completed the study as Baxter Healthcare terminated the study early.|0
8813256|NCT01524887|9866400|FG001|COMPLETED|Overall Study|No subject completed the study as Baxter Healthcare terminated the study early.|0
8813257|NCT01524887|9866401|FG002|COMPLETED|Overall Study|No subject completed the study as Baxter Healthcare terminated the study early.|0
8813258|NCT01524887|9866399|FG000|NOT COMPLETED|Overall Study||85
8813259|NCT01524887|9866400|FG001|NOT COMPLETED|Overall Study||90
8813260|NCT01524887|9866401|FG002|NOT COMPLETED|Overall Study||86
8813261|NCT01524900|9866414|FG000|STARTED|Overall Study||49
8714873|NCT00981292|9761624|FG004|NOT COMPLETED|Day 2||0
8813262|NCT01524900|9866415|FG001|STARTED|Overall Study||246
8813263|NCT01524900|9866416|FG002|STARTED|Overall Study||30
8813264|NCT01524900|9866417|FG003|STARTED|Overall Study||22
8813265|NCT01524900|9866418|FG004|STARTED|Overall Study||40
8813266|NCT01524900|9866414|FG000|COMPLETED|Overall Study||43
8813267|NCT01524900|9866415|FG001|COMPLETED|Overall Study||232
8608259|NCT00404352|9645209|FG002|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
8608260|NCT00404352|9645210|FG003|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
8608261|NCT00404352|9645211|FG004|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
8608262|NCT00404352|9645212|FG005|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
8608263|NCT00404352|9645213|FG006|NOT COMPLETED|Open Label Extension (up to 36 Months)||1
8608264|NCT00404352|9645214|FG007|NOT COMPLETED|Open Label Extension (up to 36 Months)||1
8608265|NCT00404352|9645215|FG008|NOT COMPLETED|Open Label Extension (up to 36 Months)||2
8608266|NCT00404495|9645234|FG000|STARTED|Overall Study||66
8608267|NCT00404495|9645235|FG001|STARTED|Overall Study||17
8608268|NCT00404495|9645234|FG000|COMPLETED|Overall Study||22
8608269|NCT00404495|9645235|FG001|COMPLETED|Overall Study||6
8608270|NCT00404495|9645234|FG000|NOT COMPLETED|Overall Study||44
8608271|NCT00404495|9645235|FG001|NOT COMPLETED|Overall Study||11
8608272|NCT00404547|9645243|FG000|STARTED|Overall Study||762
8608273|NCT00404547|9645244|FG001|STARTED|Overall Study||359
8608274|NCT00404547|9645243|FG000|COMPLETED|Overall Study||672
8608275|NCT00404547|9645244|FG001|COMPLETED|Overall Study||334
8608276|NCT00404547|9645243|FG000|NOT COMPLETED|Overall Study||90
8608277|NCT00404547|9645244|FG001|NOT COMPLETED|Overall Study||25
8608278|NCT00404651|9645254|FG000|STARTED|Overall Study||340
8608279|NCT00404651|9645255|FG001|STARTED|Overall Study||343
8608280|NCT00404651|9645256|FG002|STARTED|Overall Study||339
8608281|NCT00404651|9645257|FG003|STARTED|Overall Study||167
8608282|NCT00404651|9645254|FG000|COMPLETED|Overall Study||301
8608283|NCT00404651|9645255|FG001|COMPLETED|Overall Study||315
8608284|NCT00404651|9645256|FG002|COMPLETED|Overall Study||294
8608285|NCT00404651|9645257|FG003|COMPLETED|Overall Study||146
8608286|NCT00404651|9645254|FG000|NOT COMPLETED|Overall Study||39
8608287|NCT00404651|9645255|FG001|NOT COMPLETED|Overall Study||28
8608288|NCT00404651|9645256|FG002|NOT COMPLETED|Overall Study||45
8608289|NCT00404651|9645257|FG003|NOT COMPLETED|Overall Study||21
8608290|NCT00404755|9645267|FG000|STARTED|Phase I (Bupropion)|3 went directly into Phase II (intolerant of bupropion), 1 withdrew consent and 4 did not return|17
8608291|NCT00404755|9645267|FG000|COMPLETED|Phase I (Bupropion)||13
8608292|NCT00404755|9645267|FG000|NOT COMPLETED|Phase I (Bupropion)||4
8608293|NCT00404755|9645267|FG000|STARTED|Phase II (Escitalopram)||11
8608294|NCT00404755|9645267|FG000|COMPLETED|Phase II (Escitalopram)||9
8608295|NCT00404755|9645267|FG000|NOT COMPLETED|Phase II (Escitalopram)||2
8608296|NCT00404755|9645267|FG000|STARTED|Phase III (Imipramine)||3
8608297|NCT00404755|9645267|FG000|COMPLETED|Phase III (Imipramine)||3
8608298|NCT00404755|9645267|FG000|NOT COMPLETED|Phase III (Imipramine)||0
8608299|NCT00404768|9645279|FG000|STARTED|Part A and B||20
8608300|NCT00404768|9645280|FG001|STARTED|Part A and B||9
8608301|NCT00404768|9645281|FG002|STARTED|Part A and B||0
8608302|NCT00404768|9645282|FG003|STARTED|Part A and B||0
8608303|NCT00404768|9645279|FG000|COMPLETED|Part A and B||19
8608304|NCT00404768|9645280|FG001|COMPLETED|Part A and B||8
8608305|NCT00404768|9645281|FG002|COMPLETED|Part A and B||0
8608306|NCT00404768|9645282|FG003|COMPLETED|Part A and B||0
8608307|NCT00404768|9645279|FG000|NOT COMPLETED|Part A and B||1
8608308|NCT00404768|9645280|FG001|NOT COMPLETED|Part A and B||1
8608309|NCT00404768|9645281|FG002|NOT COMPLETED|Part A and B||0
8608310|NCT00404768|9645282|FG003|NOT COMPLETED|Part A and B||0
8608311|NCT00404768|9645279|FG000|STARTED|Part C||0
8608312|NCT00404768|9645280|FG001|STARTED|Part C||0
8608313|NCT00404768|9645281|FG002|STARTED|Part C||30
8608314|NCT00404768|9645282|FG003|STARTED|Part C||34
8608315|NCT00404768|9645279|FG000|COMPLETED|Part C||0
8608316|NCT00404768|9645280|FG001|COMPLETED|Part C||0
8608317|NCT00404768|9645281|FG002|COMPLETED|Part C||22
8608318|NCT00404768|9645282|FG003|COMPLETED|Part C||20
8608319|NCT00404768|9645279|FG000|NOT COMPLETED|Part C||0
8608320|NCT00404768|9645280|FG001|NOT COMPLETED|Part C||0
8608321|NCT00404768|9645281|FG002|NOT COMPLETED|Part C||8
8608322|NCT00404768|9645282|FG003|NOT COMPLETED|Part C||14
8608323|NCT00404820|9645299|FG000|STARTED|Overall Study||408
8608324|NCT00404820|9645300|FG001|STARTED|Overall Study||196
8608325|NCT00404820|9645299|FG000|Started Treatment|Overall Study||408
8608326|NCT00404820|9645300|FG001|Started Treatment|Overall Study|The reason why 2 patients did not start treatment is unavailable.|194
8608327|NCT00404820|9645299|FG000|COMPLETED|Overall Study||389
8608328|NCT00404820|9645300|FG001|COMPLETED|Overall Study||172
8608329|NCT00404820|9645299|FG000|NOT COMPLETED|Overall Study||19
8608330|NCT00404820|9645300|FG001|NOT COMPLETED|Overall Study||24
8608331|NCT00404924|9645308|FG000|STARTED|Overall Study|randomised patients|617
8608332|NCT00404924|9645309|FG001|STARTED|Overall Study|randomised patients|307
8608333|NCT00404924|9645308|FG000|COMPLETED|Overall Study|ongoing study treatment at data cut-off|14
8608334|NCT00404924|9645309|FG001|COMPLETED|Overall Study|ongoing study treatment at data cut-off|1
8608335|NCT00404924|9645308|FG000|NOT COMPLETED|Overall Study||603
8608336|NCT00404924|9645309|FG001|NOT COMPLETED|Overall Study||306
8608337|NCT00405067|9645318|FG000|STARTED|Overall Study||28
8608338|NCT00405067|9645319|FG001|STARTED|Overall Study||28
8608339|NCT00405067|9645320|FG002|STARTED|Overall Study||29
8608340|NCT00405067|9645318|FG000|COMPLETED|Overall Study||24
8608341|NCT00405067|9645319|FG001|COMPLETED|Overall Study||19
8608342|NCT00405067|9645320|FG002|COMPLETED|Overall Study||24
8608343|NCT00405067|9645318|FG000|NOT COMPLETED|Overall Study||4
8608344|NCT00405067|9645319|FG001|NOT COMPLETED|Overall Study||9
8608345|NCT00405067|9645320|FG002|NOT COMPLETED|Overall Study||5
8608346|NCT00405275|9645330|FG000|STARTED|Overall Study||178
8608347|NCT00405275|9645331|FG001|STARTED|Overall Study||175
8608348|NCT00405275|9645330|FG000|24 Weeks (Total)|Overall Study||163
8608349|NCT00405275|9645331|FG001|24 Weeks (Total)|Overall Study||165
8608350|NCT00405275|9645330|FG000|24 Week (no Switch)|Overall Study||119
8608351|NCT00405275|9645331|FG001|24 Week (no Switch)|Overall Study||121
8608352|NCT00405275|9645330|FG000|24 Week (Switch)|Overall Study||44
8608353|NCT00405275|9645331|FG001|24 Week (Switch)|Overall Study||44
8608354|NCT00405275|9645330|FG000|COMPLETED|Overall Study||155
8608355|NCT00405275|9645331|FG001|COMPLETED|Overall Study||156
8608356|NCT00405275|9645330|FG000|NOT COMPLETED|Overall Study||23
8608357|NCT00405275|9645331|FG001|NOT COMPLETED|Overall Study||19
8608358|NCT00405288|9645339|FG000|STARTED|Overall Study||204
8608359|NCT00405288|9645340|FG001|STARTED|Overall Study||204
8608360|NCT00405288|9645339|FG000|COMPLETED|Overall Study||204
8608361|NCT00405288|9645340|FG001|COMPLETED|Overall Study||204
8608362|NCT00405288|9645339|FG000|NOT COMPLETED|Overall Study||0
8608363|NCT00405288|9645340|FG001|NOT COMPLETED|Overall Study||0
8608364|NCT00405353|9645346|FG000|STARTED|Overall Study||10
8608365|NCT00405353|9645346|FG000|COMPLETED|Overall Study||10
8608366|NCT00405353|9645346|FG000|NOT COMPLETED|Overall Study||0
8608367|NCT00405392|9645352|FG000|STARTED|Overall Study||183
8608368|NCT00405392|9645353|FG001|STARTED|Overall Study||182
8608369|NCT00405392|9645352|FG000|COMPLETED|Overall Study||153
8608370|NCT00405392|9645353|FG001|COMPLETED|Overall Study||155
8608371|NCT00405392|9645352|FG000|NOT COMPLETED|Overall Study||30
8608372|NCT00405392|9645353|FG001|NOT COMPLETED|Overall Study||27
8608373|NCT00405509|9645361|FG000|STARTED|Overall Study||11
8608374|NCT00405509|9645362|FG001|STARTED|Overall Study||22
8608375|NCT00405509|9645361|FG000|COMPLETED|Overall Study||11
8608376|NCT00405509|9645362|FG001|COMPLETED|Overall Study||22
8608377|NCT00405509|9645361|FG000|NOT COMPLETED|Overall Study||0
8608378|NCT00405509|9645362|FG001|NOT COMPLETED|Overall Study||0
8608379|NCT00405522|9645370|FG000|STARTED|Overall Study||17
8608380|NCT00405522|9645371|FG001|STARTED|Overall Study||17
8608381|NCT00405522|9645370|FG000|COMPLETED|Overall Study||17
8608382|NCT00405522|9645371|FG001|COMPLETED|Overall Study||17
8608383|NCT00405522|9645370|FG000|NOT COMPLETED|Overall Study||0
8608384|NCT00405522|9645371|FG001|NOT COMPLETED|Overall Study||0
8608385|NCT00405548|9645379|FG000|STARTED|Overall Study||28
8608386|NCT00405548|9645380|FG001|STARTED|Overall Study||13
8608387|NCT00405548|9645379|FG000|COMPLETED|Overall Study||24
8608388|NCT00405548|9645380|FG001|COMPLETED|Overall Study||12
8608389|NCT00405548|9645379|FG000|NOT COMPLETED|Overall Study||4
8608390|NCT00405548|9645380|FG001|NOT COMPLETED|Overall Study||1
8608391|NCT00405587|9645390|FG000|STARTED|Overall Study||26
8608392|NCT00405587|9645391|FG001|STARTED|Overall Study||30
8608393|NCT00405587|9645392|FG002|STARTED|Overall Study||32
8608394|NCT00405587|9645393|FG003|STARTED|Overall Study||21
8608395|NCT00405587|9645390|FG000|COMPLETED|Overall Study||0
8608396|NCT00405587|9645391|FG001|COMPLETED|Overall Study||2
8608397|NCT00405587|9645392|FG002|COMPLETED|Overall Study||10
8608398|NCT00405587|9645393|FG003|COMPLETED|Overall Study||1
8608399|NCT00405587|9645390|FG000|NOT COMPLETED|Overall Study||26
8608400|NCT00405587|9645391|FG001|NOT COMPLETED|Overall Study||28
8608401|NCT00405587|9645392|FG002|NOT COMPLETED|Overall Study||22
8608402|NCT00405587|9645393|FG003|NOT COMPLETED|Overall Study||20
8608403|NCT00405639|9645431|FG000|STARTED|Overall Study||25
8608404|NCT00405639|9645432|FG001|STARTED|Overall Study||12
8608405|NCT00405639|9645431|FG000|COMPLETED|Overall Study||22
8608406|NCT00405639|9645432|FG001|COMPLETED|Overall Study||12
8608407|NCT00405639|9645431|FG000|NOT COMPLETED|Overall Study||3
8608408|NCT00405639|9645432|FG001|NOT COMPLETED|Overall Study||0
8608409|NCT00405652|9645438|FG000|STARTED|Overall Study||34
8608410|NCT00405652|9645438|FG000|COMPLETED|Overall Study||30
8608411|NCT00405652|9645438|FG000|NOT COMPLETED|Overall Study||4
8608412|NCT00405704|9645444|FG000|STARTED|Overall Study||302
8608413|NCT00405704|9645445|FG001|STARTED|Overall Study||305
8608414|NCT00405704|9645444|FG000|Completed Outcome Renal Scan|Overall Study||227
8608415|NCT00405704|9645445|FG001|Completed Outcome Renal Scan|Overall Study||235
8608416|NCT00405704|9645444|FG000|Completed Assessments for New Scarring|Overall Study||220
8608417|NCT00405704|9645445|FG001|Completed Assessments for New Scarring|Overall Study||227
8608418|NCT00405704|9645444|FG000|Outcome Stool Assessed|Overall Study||203
8608419|NCT00405704|9645445|FG001|Outcome Stool Assessed|Overall Study||210
8608420|NCT00405704|9645444|FG000|Recurrent UTI With E. Coli|Overall Study||30
8608421|NCT00405704|9645445|FG001|Recurrent UTI With E. Coli|Overall Study||57
8608422|NCT00405704|9645444|FG000|Recurrent UTI With TMP-SMZ Panel|Overall Study||38
8608423|NCT00405704|9645445|FG001|Recurrent UTI With TMP-SMZ Panel|Overall Study||69
8608424|NCT00405704|9645444|FG000|COMPLETED|Overall Study||261
8608425|NCT00405704|9645445|FG001|COMPLETED|Overall Study||259
8608426|NCT00405704|9645444|FG000|NOT COMPLETED|Overall Study||41
8608427|NCT00405704|9645445|FG001|NOT COMPLETED|Overall Study||46
8608428|NCT00405756|9645455|FG000|STARTED|Double-blind Treatment|Intent to treat population of all randomized participants|152
8608429|NCT00405756|9645456|FG001|STARTED|Double-blind Treatment||153
8608430|NCT00405756|9645457|FG002|STARTED|Double-blind Treatment||154
8608431|NCT00405756|9645455|FG000|Safety Population|Double-blind Treatment|Participants who took at least one dose of study drug.|150
8608432|NCT00405756|9645456|FG001|Safety Population|Double-blind Treatment||152
8608433|NCT00405756|9645457|FG002|Safety Population|Double-blind Treatment||153
8608434|NCT00405756|9645455|FG000|COMPLETED|Double-blind Treatment|Double-blind Treatment Period had no defined completion.|0
8608435|NCT00405756|9645456|FG001|COMPLETED|Double-blind Treatment||0
8608436|NCT00405756|9645457|FG002|COMPLETED|Double-blind Treatment||0
8608437|NCT00405756|9645455|FG000|NOT COMPLETED|Double-blind Treatment||152
8608438|NCT00405756|9645456|FG001|NOT COMPLETED|Double-blind Treatment||153
8608439|NCT00405756|9645457|FG002|NOT COMPLETED|Double-blind Treatment||154
8608440|NCT00405756|9645455|FG000|STARTED|Open-label Extension||19
8608441|NCT00405756|9645456|FG001|STARTED|Open-label Extension||47
8608442|NCT00405756|9645457|FG002|STARTED|Open-label Extension||72
8608443|NCT00405756|9645455|FG000|COMPLETED|Open-label Extension|Participants continue until disease progression or other reason for discontinuing.|0
8608444|NCT00405756|9645456|FG001|COMPLETED|Open-label Extension||0
8608445|NCT00405756|9645457|FG002|COMPLETED|Open-label Extension||0
8608446|NCT00405756|9645455|FG000|NOT COMPLETED|Open-label Extension||19
8608447|NCT00405756|9645456|FG001|NOT COMPLETED|Open-label Extension||47
8608448|NCT00405756|9645457|FG002|NOT COMPLETED|Open-label Extension||72
8608449|NCT00405756|9645455|FG000|STARTED|Follow-up|66 participants from Double-blind and 9 from the Open Label Extension|75
8608450|NCT00405756|9645456|FG001|STARTED|Follow-up|65 participants from the Double-blind and 25 from the Open Label Extension|90
8608451|NCT00405756|9645457|FG002|STARTED|Follow-up|52 participants from the Double-blind and 36 from the Open Label Extension|88
8608452|NCT00405756|9645455|FG000|COMPLETED|Follow-up||0
8608453|NCT00405756|9645456|FG001|COMPLETED|Follow-up||0
8608454|NCT00405756|9645457|FG002|COMPLETED|Follow-up||0
8608455|NCT00405756|9645455|FG000|NOT COMPLETED|Follow-up||75
8608456|NCT00405756|9645456|FG001|NOT COMPLETED|Follow-up||90
8608457|NCT00405756|9645457|FG002|NOT COMPLETED|Follow-up||88
8608458|NCT00405821|9645467|FG000|STARTED|Overall Study||220
8608459|NCT00405821|9645468|FG001|STARTED|Overall Study||220
8608460|NCT00405821|9645467|FG000|COMPLETED|Overall Study||198
8608461|NCT00405821|9645468|FG001|COMPLETED|Overall Study||198
8608462|NCT00405821|9645467|FG000|NOT COMPLETED|Overall Study||22
8608463|NCT00405821|9645468|FG001|NOT COMPLETED|Overall Study||22
8608464|NCT00405912|9645477|FG000|STARTED|Overall Study||39
8608465|NCT00405912|9645478|FG001|STARTED|Overall Study||40
8608466|NCT00405912|9645479|FG002|STARTED|Overall Study||39
8608467|NCT00405912|9645477|FG000|COMPLETED|Overall Study||23
8608468|NCT00405912|9645478|FG001|COMPLETED|Overall Study||21
8608469|NCT00405912|9645479|FG002|COMPLETED|Overall Study||23
8608470|NCT00405912|9645477|FG000|NOT COMPLETED|Overall Study||16
8608471|NCT00405912|9645478|FG001|NOT COMPLETED|Overall Study||19
8608472|NCT00405912|9645479|FG002|NOT COMPLETED|Overall Study||16
8608473|NCT00405938|9645489|FG000|STARTED|Overall Study||38
8608474|NCT00405938|9645490|FG001|STARTED|Overall Study||41
8608475|NCT00405938|9645489|FG000|COMPLETED|Overall Study||38
8608476|NCT00405938|9645490|FG001|COMPLETED|Overall Study||41
8608477|NCT00405938|9645489|FG000|NOT COMPLETED|Overall Study||0
8714874|NCT00981292|9761625|FG005|NOT COMPLETED|Day 2||0
8714875|NCT00981292|9761620|FG000|STARTED|Day 3||4
8714876|NCT00981292|9761621|FG001|STARTED|Day 3||4
8714877|NCT00981292|9761622|FG002|STARTED|Day 3||6
8714878|NCT00981292|9761623|FG003|STARTED|Day 3||4
8608478|NCT00405938|9645490|FG001|NOT COMPLETED|Overall Study||0
8608479|NCT00406029|9645501|FG000|STARTED|Overall Study||49
8608480|NCT00406029|9645502|FG001|STARTED|Overall Study||49
8608481|NCT00406029|9645503|FG002|STARTED|Overall Study||49
8608482|NCT00406029|9645504|FG003|STARTED|Overall Study||57
8608483|NCT00406029|9645505|FG004|STARTED|Overall Study||49
8608484|NCT00406029|9645501|FG000|Treated|Overall Study||49
8608485|NCT00406029|9645502|FG001|Treated|Overall Study||49
8608486|NCT00406029|9645503|FG002|Treated|Overall Study||47
8608487|NCT00406029|9645504|FG003|Treated|Overall Study||54
8608488|NCT00406029|9645505|FG004|Treated|Overall Study||47
8608489|NCT00406029|9645501|FG000|COMPLETED|Overall Study||33
8608490|NCT00406029|9645502|FG001|COMPLETED|Overall Study||41
8608491|NCT00406029|9645503|FG002|COMPLETED|Overall Study||39
8608492|NCT00406029|9645504|FG003|COMPLETED|Overall Study||40
8608493|NCT00406029|9645505|FG004|COMPLETED|Overall Study||41
8608494|NCT00406029|9645501|FG000|NOT COMPLETED|Overall Study||16
8608495|NCT00406029|9645502|FG001|NOT COMPLETED|Overall Study||8
8608496|NCT00406029|9645503|FG002|NOT COMPLETED|Overall Study||10
8608497|NCT00406029|9645504|FG003|NOT COMPLETED|Overall Study||17
8608498|NCT00406029|9645505|FG004|NOT COMPLETED|Overall Study||8
8608499|NCT00406107|9645519|FG000|STARTED|Overall Study||15
8608500|NCT00406107|9645520|FG001|STARTED|Overall Study||5
8608501|NCT00406107|9645519|FG000|COMPLETED|Overall Study||14
8608502|NCT00406107|9645520|FG001|COMPLETED|Overall Study||4
8608503|NCT00406107|9645519|FG000|NOT COMPLETED|Overall Study||1
8608504|NCT00406107|9645520|FG001|NOT COMPLETED|Overall Study||1
8608505|NCT00406133|9645531|FG000|STARTED|Phase 1 (First 26 Week Period)||165
8714879|NCT00981292|9761624|FG004|STARTED|Day 3||4
8714880|NCT00981292|9761625|FG005|STARTED|Day 3||5
8714881|NCT00981292|9761620|FG000|COMPLETED|Day 3||4
8714882|NCT00981292|9761621|FG001|COMPLETED|Day 3||4
8714883|NCT00981292|9761622|FG002|COMPLETED|Day 3||6
8714884|NCT00981292|9761623|FG003|COMPLETED|Day 3||4
8714885|NCT00981292|9761624|FG004|COMPLETED|Day 3||4
8608506|NCT00406133|9645532|FG001|STARTED|Phase 1 (First 26 Week Period)||157
8608507|NCT00406133|9645533|FG002|STARTED|Phase 1 (First 26 Week Period)||67
8608508|NCT00406133|9645534|FG003|STARTED|Phase 1 (First 26 Week Period)||62
8608509|NCT00406133|9645531|FG000|COMPLETED|Phase 1 (First 26 Week Period)||162
8608510|NCT00406133|9645532|FG001|COMPLETED|Phase 1 (First 26 Week Period)||155
8714886|NCT00981292|9761625|FG005|COMPLETED|Day 3||4
8714887|NCT00981292|9761620|FG000|NOT COMPLETED|Day 3||0
8608511|NCT00406133|9645533|FG002|COMPLETED|Phase 1 (First 26 Week Period)||67
8608512|NCT00406133|9645534|FG003|COMPLETED|Phase 1 (First 26 Week Period)||60
8608513|NCT00406133|9645531|FG000|NOT COMPLETED|Phase 1 (First 26 Week Period)||3
8608514|NCT00406133|9645532|FG001|NOT COMPLETED|Phase 1 (First 26 Week Period)||2
8608515|NCT00406133|9645533|FG002|NOT COMPLETED|Phase 1 (First 26 Week Period)||0
8608516|NCT00406133|9645534|FG003|NOT COMPLETED|Phase 1 (First 26 Week Period)||2
8608517|NCT00406133|9645531|FG000|STARTED|Phase 2 (Second 26 Week Period)|3 subjects completed phase 1 but elected not to go into phase 2.|159
8608518|NCT00406133|9645532|FG001|STARTED|Phase 2 (Second 26 Week Period)||155
8608519|NCT00406133|9645533|FG002|STARTED|Phase 2 (Second 26 Week Period)||67
8608520|NCT00406133|9645534|FG003|STARTED|Phase 2 (Second 26 Week Period)||60
8608521|NCT00406133|9645531|FG000|COMPLETED|Phase 2 (Second 26 Week Period)||157
8608522|NCT00406133|9645532|FG001|COMPLETED|Phase 2 (Second 26 Week Period)||152
8608523|NCT00406133|9645533|FG002|COMPLETED|Phase 2 (Second 26 Week Period)||67
8608524|NCT00406133|9645534|FG003|COMPLETED|Phase 2 (Second 26 Week Period)||60
8608525|NCT00406133|9645531|FG000|NOT COMPLETED|Phase 2 (Second 26 Week Period)||2
8608526|NCT00406133|9645532|FG001|NOT COMPLETED|Phase 2 (Second 26 Week Period)||3
8608527|NCT00406133|9645533|FG002|NOT COMPLETED|Phase 2 (Second 26 Week Period)||0
8608528|NCT00406133|9645534|FG003|NOT COMPLETED|Phase 2 (Second 26 Week Period)||0
8608529|NCT00406276|9645549|FG000|STARTED|Overall Study||28
8608530|NCT00406276|9645549|FG000|COMPLETED|Overall Study||24
8608531|NCT00406276|9645549|FG000|NOT COMPLETED|Overall Study||4
8608532|NCT00406315|9645554|FG000|STARTED|Overall Study|Started = Treated|241
8608533|NCT00406315|9645554|FG000|COMPLETED|Overall Study||100
8608534|NCT00406315|9645554|FG000|NOT COMPLETED|Overall Study||141
8608535|NCT00406354|9645561|FG000|STARTED|All Randomized Patients||60
8608536|NCT00406354|9645562|FG001|STARTED|All Randomized Patients||61
8608537|NCT00406354|9645563|FG002|STARTED|All Randomized Patients||60
8608538|NCT00406354|9645561|FG000|COMPLETED|All Randomized Patients||60
8608539|NCT00406354|9645562|FG001|COMPLETED|All Randomized Patients||61
8608540|NCT00406354|9645563|FG002|COMPLETED|All Randomized Patients|One patient was randomized but never received study treatment.|59
8608541|NCT00406354|9645561|FG000|NOT COMPLETED|All Randomized Patients||0
8608542|NCT00406354|9645562|FG001|NOT COMPLETED|All Randomized Patients||0
8608543|NCT00406354|9645563|FG002|NOT COMPLETED|All Randomized Patients||1
8608544|NCT00406354|9645561|FG000|STARTED|All Randomized and Treated Patients||60
8608545|NCT00406354|9645562|FG001|STARTED|All Randomized and Treated Patients||61
8608546|NCT00406354|9645563|FG002|STARTED|All Randomized and Treated Patients||59
8608547|NCT00406354|9645561|FG000|COMPLETED|All Randomized and Treated Patients||44
8608548|NCT00406354|9645562|FG001|COMPLETED|All Randomized and Treated Patients||48
8608549|NCT00406354|9645563|FG002|COMPLETED|All Randomized and Treated Patients||37
8608550|NCT00406354|9645561|FG000|NOT COMPLETED|All Randomized and Treated Patients||16
8608551|NCT00406354|9645562|FG001|NOT COMPLETED|All Randomized and Treated Patients||13
8608552|NCT00406354|9645563|FG002|NOT COMPLETED|All Randomized and Treated Patients||22
8608553|NCT00406367|9645573|FG000|STARTED|Main Period - 6 to 20 Weeks||75
8608554|NCT00406367|9645574|FG001|STARTED|Main Period - 6 to 20 Weeks||34
8608555|NCT00406367|9645573|FG000|COMPLETED|Main Period - 6 to 20 Weeks||70
8608556|NCT00406367|9645574|FG001|COMPLETED|Main Period - 6 to 20 Weeks||32
8608557|NCT00406367|9645573|FG000|NOT COMPLETED|Main Period - 6 to 20 Weeks||5
8608558|NCT00406367|9645574|FG001|NOT COMPLETED|Main Period - 6 to 20 Weeks||2
8608559|NCT00406367|9645573|FG000|STARTED|Open-Label Ext. Period - up to 68 Weeks||102
8608560|NCT00406367|9645574|FG001|STARTED|Open-Label Ext. Period - up to 68 Weeks|In the Open-Label Extension Period no placebo treatment arm was given.|0
8608561|NCT00406367|9645573|FG000|COMPLETED|Open-Label Ext. Period - up to 68 Weeks||82
8608562|NCT00406367|9645574|FG001|COMPLETED|Open-Label Ext. Period - up to 68 Weeks||0
8608563|NCT00406367|9645573|FG000|NOT COMPLETED|Open-Label Ext. Period - up to 68 Weeks||20
8608564|NCT00406367|9645574|FG001|NOT COMPLETED|Open-Label Ext. Period - up to 68 Weeks||0
8608565|NCT00406393|9645582|FG000|STARTED|Overall Study||151
8608566|NCT00406393|9645583|FG001|STARTED|Overall Study||153
8608567|NCT00406393|9645582|FG000|COMPLETED|Overall Study||149
8608568|NCT00406393|9645583|FG001|COMPLETED|Overall Study||152
8608569|NCT00406393|9645582|FG000|NOT COMPLETED|Overall Study||2
8608570|NCT00406393|9645583|FG001|NOT COMPLETED|Overall Study||1
8608571|NCT00406419|9645592|FG000|STARTED|Overall Study||324
8608572|NCT00406419|9645593|FG001|STARTED|Overall Study||344
8608573|NCT00406419|9645594|FG002|STARTED|Overall Study||347
8608574|NCT00406419|9645592|FG000|COMPLETED|Overall Study||0
8608575|NCT00406419|9645593|FG001|COMPLETED|Overall Study||0
8608576|NCT00406419|9645594|FG002|COMPLETED|Overall Study||0
8608577|NCT00406419|9645592|FG000|NOT COMPLETED|Overall Study||324
8608578|NCT00406419|9645593|FG001|NOT COMPLETED|Overall Study||344
8608579|NCT00406419|9645594|FG002|NOT COMPLETED|Overall Study||347
8608580|NCT00406640|9645604|FG000|STARTED|Acute Phase||296
8608581|NCT00406640|9645605|FG001|STARTED|Acute Phase||299
8608582|NCT00406640|9645604|FG000|COMPLETED|Acute Phase||245
8608583|NCT00406640|9645605|FG001|COMPLETED|Acute Phase||256
8608584|NCT00406640|9645604|FG000|NOT COMPLETED|Acute Phase||51
8608585|NCT00406640|9645605|FG001|NOT COMPLETED|Acute Phase||43
8608586|NCT00406640|9645604|FG000|STARTED|DB Continuation Phase for Responders||172
8608587|NCT00406640|9645605|FG001|STARTED|DB Continuation Phase for Responders||188
8608588|NCT00406640|9645604|FG000|COMPLETED|DB Continuation Phase for Responders||139
8608589|NCT00406640|9645605|FG001|COMPLETED|DB Continuation Phase for Responders||151
8608590|NCT00406640|9645604|FG000|NOT COMPLETED|DB Continuation Phase for Responders||33
8608591|NCT00406640|9645605|FG001|NOT COMPLETED|DB Continuation Phase for Responders||37
8608592|NCT00406640|9645604|FG000|STARTED|OL Extension Phase for Non-Responders||69
8608593|NCT00406640|9645605|FG001|STARTED|OL Extension Phase for Non-Responders||60
8608594|NCT00406640|9645604|FG000|COMPLETED|OL Extension Phase for Non-Responders||47
8608595|NCT00406640|9645605|FG001|COMPLETED|OL Extension Phase for Non-Responders||36
8608596|NCT00406640|9645604|FG000|NOT COMPLETED|OL Extension Phase for Non-Responders||22
8608597|NCT00406640|9645605|FG001|NOT COMPLETED|OL Extension Phase for Non-Responders||24
8608598|NCT00406653|9645621|FG000|STARTED|Induction Period||65
8608599|NCT00406653|9645622|FG001|STARTED|Induction Period||128
8608600|NCT00406653|9645623|FG002|STARTED|Induction Period||130
8608601|NCT00406653|9645624|FG003|STARTED|Induction Period||128
8608602|NCT00406653|9645625|FG004|STARTED|Induction Period||0
8608603|NCT00406653|9645626|FG005|STARTED|Induction Period||0
8608604|NCT00406653|9645627|FG006|STARTED|Induction Period||0
8608605|NCT00406653|9645621|FG000|COMPLETED|Induction Period||50
8608606|NCT00406653|9645622|FG001|COMPLETED|Induction Period||94
8608607|NCT00406653|9645623|FG002|COMPLETED|Induction Period||112
8608608|NCT00406653|9645624|FG003|COMPLETED|Induction Period||102
8608609|NCT00406653|9645625|FG004|COMPLETED|Induction Period||0
8608610|NCT00406653|9645626|FG005|COMPLETED|Induction Period||0
8608611|NCT00406653|9645627|FG006|COMPLETED|Induction Period||0
8608612|NCT00406653|9645621|FG000|NOT COMPLETED|Induction Period||15
8608613|NCT00406653|9645622|FG001|NOT COMPLETED|Induction Period||34
8608614|NCT00406653|9645623|FG002|NOT COMPLETED|Induction Period||18
8608615|NCT00406653|9645624|FG003|NOT COMPLETED|Induction Period||26
8608616|NCT00406653|9645625|FG004|NOT COMPLETED|Induction Period||0
8608617|NCT00406653|9645626|FG005|NOT COMPLETED|Induction Period||0
8608618|NCT00406653|9645627|FG006|NOT COMPLETED|Induction Period||0
8608619|NCT00406653|9645621|FG000|STARTED|Maintenance Period||0
8608620|NCT00406653|9645622|FG001|STARTED|Maintenance Period||0
8608621|NCT00406653|9645623|FG002|STARTED|Maintenance Period||0
8608622|NCT00406653|9645624|FG003|STARTED|Maintenance Period||0
8608623|NCT00406653|9645625|FG004|STARTED|Maintenance Period|At end of IP, 44 participants met response criteria and were randomly assigned to abatacept in MP.|44
8608624|NCT00406653|9645626|FG005|STARTED|Maintenance Period|At end of IP, 46 participants met response criteria and were randomly assigned to placebo in MP.|46
8608625|NCT00406653|9645627|FG006|STARTED|Maintenance Period||0
8608626|NCT00406653|9645621|FG000|COMPLETED|Maintenance Period||0
8608627|NCT00406653|9645622|FG001|COMPLETED|Maintenance Period||0
8608628|NCT00406653|9645623|FG002|COMPLETED|Maintenance Period||0
8608629|NCT00406653|9645624|FG003|COMPLETED|Maintenance Period||0
8608630|NCT00406653|9645625|FG004|COMPLETED|Maintenance Period||14
8608631|NCT00406653|9645626|FG005|COMPLETED|Maintenance Period||10
8608632|NCT00406653|9645627|FG006|COMPLETED|Maintenance Period||0
8608633|NCT00406653|9645621|FG000|NOT COMPLETED|Maintenance Period||0
8608634|NCT00406653|9645622|FG001|NOT COMPLETED|Maintenance Period||0
8608635|NCT00406653|9645623|FG002|NOT COMPLETED|Maintenance Period||0
8608636|NCT00406653|9645624|FG003|NOT COMPLETED|Maintenance Period||0
8608637|NCT00406653|9645625|FG004|NOT COMPLETED|Maintenance Period||30
8608638|NCT00406653|9645626|FG005|NOT COMPLETED|Maintenance Period||36
8608639|NCT00406653|9645627|FG006|NOT COMPLETED|Maintenance Period||0
8608640|NCT00406653|9645621|FG000|STARTED|Open-Label Period||0
8608641|NCT00406653|9645622|FG001|STARTED|Open-Label Period||0
8608642|NCT00406653|9645623|FG002|STARTED|Open-Label Period||0
8608643|NCT00406653|9645624|FG003|STARTED|Open-Label Period||0
8608644|NCT00406653|9645625|FG004|STARTED|Open-Label Period||0
8608645|NCT00406653|9645626|FG005|STARTED|Open-Label Period||0
8608646|NCT00406653|9645627|FG006|STARTED|Open-Label Period|All completing IP but failing response criteria and those completing or relapsing on MP entered OL.|324
8608647|NCT00406653|9645621|FG000|COMPLETED|Open-Label Period||0
8608648|NCT00406653|9645622|FG001|COMPLETED|Open-Label Period||0
8608649|NCT00406653|9645623|FG002|COMPLETED|Open-Label Period||0
8608650|NCT00406653|9645624|FG003|COMPLETED|Open-Label Period||0
8608651|NCT00406653|9645625|FG004|COMPLETED|Open-Label Period||0
8608652|NCT00406653|9645626|FG005|COMPLETED|Open-Label Period||0
8608653|NCT00406653|9645627|FG006|COMPLETED|Open-Label Period||0
8608654|NCT00406653|9645621|FG000|NOT COMPLETED|Open-Label Period||0
8608655|NCT00406653|9645622|FG001|NOT COMPLETED|Open-Label Period||0
8608656|NCT00406653|9645623|FG002|NOT COMPLETED|Open-Label Period||0
8608657|NCT00406653|9645624|FG003|NOT COMPLETED|Open-Label Period||0
8608658|NCT00406653|9645625|FG004|NOT COMPLETED|Open-Label Period||0
8608659|NCT00406653|9645626|FG005|NOT COMPLETED|Open-Label Period||0
8608660|NCT00406653|9645627|FG006|NOT COMPLETED|Open-Label Period||324
8608661|NCT00406692|9645647|FG000|STARTED|Overall Study||16
8608662|NCT00406692|9645647|FG000|COMPLETED|Overall Study||9
8608663|NCT00406692|9645647|FG000|NOT COMPLETED|Overall Study||7
8608664|NCT00406718|9645654|FG000|STARTED|Overall Study||47
8608665|NCT00406718|9645655|FG001|STARTED|Overall Study||48
8608666|NCT00406718|9645656|FG002|STARTED|Overall Study||47
8608667|NCT00406718|9645654|FG000|COMPLETED|Overall Study||43
8608668|NCT00406718|9645655|FG001|COMPLETED|Overall Study||34
8608669|NCT00406718|9645656|FG002|COMPLETED|Overall Study||39
8608670|NCT00406718|9645654|FG000|NOT COMPLETED|Overall Study||4
8608671|NCT00406718|9645655|FG001|NOT COMPLETED|Overall Study||14
8608672|NCT00406718|9645656|FG002|NOT COMPLETED|Overall Study||8
8608673|NCT00406848|9645668|FG000|STARTED|Overall Study|Represents full safety analysis population. Efficacy analysis population (c,d,e) N=204.|249
8629115|NCT00528567|9668755|FG001|Intention to Treat|Overall Study||1290
8608674|NCT00406848|9645669|FG001|STARTED|Overall Study|Represents full safety analysis population. Efficacy analysis population (c,d,e) N=95.|121
8714888|NCT00981292|9761621|FG001|NOT COMPLETED|Day 3||0
8714889|NCT00981292|9761622|FG002|NOT COMPLETED|Day 3||0
8714890|NCT00981292|9761623|FG003|NOT COMPLETED|Day 3||0
8714891|NCT00981292|9761624|FG004|NOT COMPLETED|Day 3||0
8608675|NCT00406848|9645668|FG000|COMPLETED|Overall Study||156
8608676|NCT00406848|9645669|FG001|COMPLETED|Overall Study||67
8608677|NCT00406848|9645668|FG000|NOT COMPLETED|Overall Study||93
8608678|NCT00406848|9645669|FG001|NOT COMPLETED|Overall Study||54
8608679|NCT00407030|9645681|FG000|STARTED|Main Period - 8 to 20 Weeks||81
8608680|NCT00407030|9645682|FG001|STARTED|Main Period - 8 to 20 Weeks||78
8608681|NCT00407030|9645683|FG002|STARTED|Main Period - 8 to 20 Weeks||74
8608682|NCT00407030|9645681|FG000|COMPLETED|Main Period - 8 to 20 Weeks||76
8608683|NCT00407030|9645682|FG001|COMPLETED|Main Period - 8 to 20 Weeks||75
8608684|NCT00407030|9645683|FG002|COMPLETED|Main Period - 8 to 20 Weeks||68
8608685|NCT00407030|9645681|FG000|NOT COMPLETED|Main Period - 8 to 20 Weeks||5
8608686|NCT00407030|9645682|FG001|NOT COMPLETED|Main Period - 8 to 20 Weeks||3
8608687|NCT00407030|9645683|FG002|NOT COMPLETED|Main Period - 8 to 20 Weeks||6
8608688|NCT00407030|9645681|FG000|STARTED|Extension Period - up to 68 Weeks|2 subjects did not enter the Ext. Period, 3 subjects never expressed any need for a new injection|111
8608689|NCT00407030|9645682|FG001|STARTED|Extension Period - up to 68 Weeks|2 subjects did not enter the Ext. Period, 3 subjects never expressed any need for a new injection|103
8608690|NCT00407030|9645683|FG002|STARTED|Extension Period - up to 68 Weeks|After the Main Period all patients were randomly assigned to the 2 active treatment arms.|0
8608691|NCT00407030|9645681|FG000|COMPLETED|Extension Period - up to 68 Weeks||84
8608692|NCT00407030|9645682|FG001|COMPLETED|Extension Period - up to 68 Weeks||74
8608693|NCT00407030|9645683|FG002|COMPLETED|Extension Period - up to 68 Weeks||0
8608694|NCT00407030|9645681|FG000|NOT COMPLETED|Extension Period - up to 68 Weeks||27
8608695|NCT00407030|9645682|FG001|NOT COMPLETED|Extension Period - up to 68 Weeks||29
8608696|NCT00407030|9645683|FG002|NOT COMPLETED|Extension Period - up to 68 Weeks||0
8608697|NCT00407355|9645695|FG000|STARTED|Overall Study||20
8608698|NCT00407355|9645696|FG001|STARTED|Overall Study||20
8608699|NCT00407355|9645695|FG000|COMPLETED|Overall Study||10
8608700|NCT00407355|9645696|FG001|COMPLETED|Overall Study||9
8608701|NCT00407355|9645695|FG000|NOT COMPLETED|Overall Study||10
8608702|NCT00407355|9645696|FG001|NOT COMPLETED|Overall Study||11
8608703|NCT00407381|9645705|FG000|STARTED|Overall Study||42
8608704|NCT00407381|9645706|FG001|STARTED|Overall Study||42
8608705|NCT00407381|9645707|FG002|STARTED|Overall Study||42
8608706|NCT00407381|9645705|FG000|COMPLETED|Overall Study||39
8608707|NCT00407381|9645706|FG001|COMPLETED|Overall Study||38
8608708|NCT00407381|9645707|FG002|COMPLETED|Overall Study||40
8608709|NCT00407381|9645705|FG000|NOT COMPLETED|Overall Study||3
8608710|NCT00407381|9645706|FG001|NOT COMPLETED|Overall Study||4
8608711|NCT00407381|9645707|FG002|NOT COMPLETED|Overall Study||2
8608712|NCT00407420|9645717|FG000|STARTED|Overall Study||54
8608713|NCT00407420|9645718|FG001|STARTED|Overall Study||52
8608714|NCT00407420|9645717|FG000|COMPLETED|Overall Study||45
8608715|NCT00407420|9645718|FG001|COMPLETED|Overall Study||46
8608716|NCT00407420|9645717|FG000|NOT COMPLETED|Overall Study||9
8608717|NCT00407420|9645718|FG001|NOT COMPLETED|Overall Study||6
8608718|NCT00407485|9645726|FG000|STARTED|Overall Study||22
8608719|NCT00407485|9645726|FG000|COMPLETED|Overall Study||22
8608720|NCT00407485|9645726|FG000|NOT COMPLETED|Overall Study||0
8608721|NCT00407511|9645731|FG000|STARTED|Overall Study||121
8608722|NCT00407511|9645731|FG000|COMPLETED|Overall Study||99
8608723|NCT00407511|9645731|FG000|NOT COMPLETED|Overall Study||22
8608724|NCT00407537|9645737|FG000|STARTED|Overall Study||779
8629116|NCT00528567|9668754|FG000|Safety Population|Overall Study||1288
8714892|NCT00981292|9761625|FG005|NOT COMPLETED|Day 3||1
8714893|NCT00981305|9761639|FG000|STARTED|Overall Study||69
8714894|NCT00981305|9761640|FG001|STARTED|Overall Study||67
8714895|NCT00981305|9761639|FG000|COMPLETED|Overall Study||50
8714896|NCT00981305|9761640|FG001|COMPLETED|Overall Study||57
8714897|NCT00981305|9761639|FG000|NOT COMPLETED|Overall Study||19
8714898|NCT00981305|9761640|FG001|NOT COMPLETED|Overall Study||10
8714899|NCT00981409|9761648|FG000|STARTED|Overall Study||30
8714900|NCT00981409|9761649|FG001|STARTED|Overall Study||11
8714901|NCT00981409|9761648|FG000|COMPLETED|Overall Study||24
8714902|NCT00981409|9761649|FG001|COMPLETED|Overall Study||10
8714903|NCT00981409|9761648|FG000|NOT COMPLETED|Overall Study||6
8714904|NCT00981409|9761649|FG001|NOT COMPLETED|Overall Study||1
8714905|NCT00981435|9761658|FG000|STARTED|Overall Study||31
8714906|NCT00981435|9761659|FG001|STARTED|Overall Study||29
8714907|NCT00981435|9761660|FG002|STARTED|Overall Study||37
8714908|NCT00981435|9761658|FG000|COMPLETED|Overall Study||31
8714909|NCT00981435|9761659|FG001|COMPLETED|Overall Study||29
8714910|NCT00981435|9761660|FG002|COMPLETED|Overall Study||37
8714911|NCT00981435|9761658|FG000|NOT COMPLETED|Overall Study||0
8714912|NCT00981435|9761659|FG001|NOT COMPLETED|Overall Study||0
8714913|NCT00981435|9761660|FG002|NOT COMPLETED|Overall Study||0
8714914|NCT00981461|9761670|FG000|STARTED|Overall Study||48
8714915|NCT00981461|9761671|FG001|STARTED|Overall Study||24
8714916|NCT00981461|9761670|FG000|COMPLETED|Overall Study||43
8714917|NCT00981461|9761671|FG001|COMPLETED|Overall Study||22
8714918|NCT00981461|9761670|FG000|NOT COMPLETED|Overall Study||5
8714919|NCT00981461|9761671|FG001|NOT COMPLETED|Overall Study||2
8714920|NCT00981474|9761679|FG000|STARTED|Overall Study||228
8714921|NCT00981474|9761680|FG001|STARTED|Overall Study||232
8608725|NCT00407537|9645738|FG001|STARTED|Overall Study|4 participants assigned to Caduet treatment received usual care only during the study|682
8608726|NCT00407537|9645737|FG000|Eligible for Efficacy Analysis|Overall Study||760
8608727|NCT00407537|9645738|FG001|Eligible for Efficacy Analysis|Overall Study||657
8608728|NCT00407537|9645737|FG000|COMPLETED|Overall Study||686
8608729|NCT00407537|9645738|FG001|COMPLETED|Overall Study||638
8608730|NCT00407537|9645737|FG000|NOT COMPLETED|Overall Study||93
8714922|NCT00981474|9761679|FG000|COMPLETED|Overall Study||228
8714923|NCT00981474|9761680|FG001|COMPLETED|Overall Study||232
8714924|NCT00981474|9761679|FG000|NOT COMPLETED|Overall Study||0
8714925|NCT00981474|9761680|FG001|NOT COMPLETED|Overall Study||0
8714926|NCT00981526|9761690|FG000|STARTED|Overall Study||26
8714927|NCT00981526|9761691|FG001|STARTED|Overall Study||28
8714928|NCT00981526|9761690|FG000|COMPLETED|Overall Study||22
8714929|NCT00981526|9761691|FG001|COMPLETED|Overall Study||22
8714930|NCT00981526|9761690|FG000|NOT COMPLETED|Overall Study||4
8714931|NCT00981526|9761691|FG001|NOT COMPLETED|Overall Study||6
8608731|NCT00407537|9645738|FG001|NOT COMPLETED|Overall Study||44
8608732|NCT00407550|9645746|FG000|STARTED|Overall Study||10
8608733|NCT00407550|9645747|FG001|STARTED|Overall Study||9
8608734|NCT00407550|9645746|FG000|COMPLETED|Overall Study||7
8608735|NCT00407550|9645747|FG001|COMPLETED|Overall Study||5
8608736|NCT00407550|9645746|FG000|NOT COMPLETED|Overall Study||3
8608737|NCT00407550|9645747|FG001|NOT COMPLETED|Overall Study||4
8608738|NCT00407563|9645753|FG000|STARTED|Overall Study||48
8608739|NCT00407563|9645753|FG000|COMPLETED|Overall Study|One patient remains on study treatment.|47
8608740|NCT00407563|9645753|FG000|NOT COMPLETED|Overall Study||1
8608741|NCT00407654|9645757|FG000|STARTED|Overall Study||75
8608742|NCT00407654|9645757|FG000|COMPLETED|Overall Study||75
8608743|NCT00407654|9645757|FG000|NOT COMPLETED|Overall Study||0
8608744|NCT00407745|9645764|FG000|STARTED|Overall Study||112
8608745|NCT00407745|9645765|FG001|STARTED|Overall Study||108
8608746|NCT00407745|9645764|FG000|Treated|Overall Study||112
8608747|NCT00407745|9645765|FG001|Treated|Overall Study||107
8608748|NCT00407745|9645764|FG000|COMPLETED|Overall Study||93
8608749|NCT00407745|9645765|FG001|COMPLETED|Overall Study||91
8608750|NCT00407745|9645764|FG000|NOT COMPLETED|Overall Study||19
8608751|NCT00407745|9645765|FG001|NOT COMPLETED|Overall Study||17
8608752|NCT00407758|9645771|FG000|STARTED|Overall Study||28
8608753|NCT00407758|9645771|FG000|COMPLETED|Overall Study||27
8608754|NCT00407758|9645771|FG000|NOT COMPLETED|Overall Study||1
8608755|NCT00407797|9645775|FG000|STARTED|Overall Study||136
8608756|NCT00407797|9645775|FG000|Full Analysis Set|Overall Study|At least 1 dose of study medication and had a baseline and at least 1 post-baseline measurement.|135
8608757|NCT00407797|9645775|FG000|COMPLETED|Overall Study||118
8608758|NCT00407797|9645775|FG000|NOT COMPLETED|Overall Study||18
8608759|NCT00407888|9645779|FG000|STARTED|Overall Study||60
8608760|NCT00407888|9645779|FG000|COMPLETED|Overall Study||60
8608761|NCT00407888|9645779|FG000|NOT COMPLETED|Overall Study||0
8608762|NCT00407966|9645783|FG000|STARTED|Overall Study||45
8608763|NCT00407966|9645783|FG000|CR|Overall Study||30
8608764|NCT00407966|9645783|FG000|COMPLETED|Overall Study||45
8714932|NCT00981578|9761699|FG000|STARTED|Overall Study||17
8714933|NCT00981578|9761699|FG000|COMPLETED|Overall Study||14
8714934|NCT00981578|9761699|FG000|NOT COMPLETED|Overall Study||3
8714935|NCT00981630|9761707|FG000|STARTED|Overall Study||32
8714936|NCT00981630|9761708|FG001|STARTED|Overall Study||32
8714937|NCT00981630|9761709|FG002|STARTED|Overall Study||32
8714938|NCT00981630|9761710|FG003|STARTED|Overall Study||32
8714939|NCT00981630|9761707|FG000|COMPLETED|Overall Study||32
8714940|NCT00981630|9761708|FG001|COMPLETED|Overall Study||32
8714941|NCT00981630|9761709|FG002|COMPLETED|Overall Study||32
8714942|NCT00981630|9761710|FG003|COMPLETED|Overall Study||32
8714943|NCT00981630|9761707|FG000|NOT COMPLETED|Overall Study||0
8714944|NCT00981630|9761708|FG001|NOT COMPLETED|Overall Study||0
8714945|NCT00981630|9761709|FG002|NOT COMPLETED|Overall Study||0
8714946|NCT00981630|9761710|FG003|NOT COMPLETED|Overall Study||0
8714947|NCT00981669|9761722|FG000|STARTED|Overall Study||40
8714948|NCT00981669|9761723|FG001|STARTED|Overall Study||40
8714949|NCT00981669|9761722|FG000|COMPLETED|Overall Study||39
8714950|NCT00981669|9761723|FG001|COMPLETED|Overall Study||40
8714951|NCT00981669|9761722|FG000|NOT COMPLETED|Overall Study||1
8714952|NCT00981669|9761723|FG001|NOT COMPLETED|Overall Study||0
8714953|NCT00981682|9761729|FG000|STARTED|Overall Study||376
8714954|NCT00981682|9761729|FG000|COMPLETED|Overall Study||234
8714955|NCT00981682|9761729|FG000|NOT COMPLETED|Overall Study||142
8714956|NCT00981747|9761733|FG000|STARTED|Losartan||12
8714957|NCT00981747|9761733|FG000|Started Losartan|Losartan||12
8714958|NCT00981747|9761733|FG000|Completed Losartan|Losartan|Only 9 were analyzed because only 9 completed all four interventions.|10
8714959|NCT00981747|9761733|FG000|COMPLETED|Losartan|Only 9 were analyzed because only 9 completed all four interventions.|10
8714960|NCT00981747|9761733|FG000|NOT COMPLETED|Losartan||2
8714961|NCT00981747|9761733|FG000|STARTED|Placebo Oral Tablet||10
8714962|NCT00981747|9761733|FG000|Started Placebo Oral Tablet|Placebo Oral Tablet||10
8608765|NCT00407966|9645783|FG000|NOT COMPLETED|Overall Study||0
8714963|NCT00981747|9761733|FG000|Completed Placebo Oral Tablet|Placebo Oral Tablet||9
8714964|NCT00981747|9761733|FG000|COMPLETED|Placebo Oral Tablet||9
8608766|NCT00408070|9645787|FG000|STARTED|Overall Study||5
8608767|NCT00408070|9645787|FG000|COMPLETED|Overall Study||5
8608768|NCT00408070|9645787|FG000|NOT COMPLETED|Overall Study||0
8714965|NCT00981747|9761733|FG000|NOT COMPLETED|Placebo Oral Tablet||1
8608769|NCT00408200|9645793|FG000|STARTED|Overall Study||57
8608770|NCT00408200|9645794|FG001|STARTED|Overall Study||53
8608771|NCT00408200|9645793|FG000|COMPLETED|Overall Study||57
8608772|NCT00408200|9645794|FG001|COMPLETED|Overall Study||53
8608773|NCT00408200|9645793|FG000|NOT COMPLETED|Overall Study||0
8608774|NCT00408200|9645794|FG001|NOT COMPLETED|Overall Study||0
8608775|NCT00408317|9645800|FG000|STARTED|First Intervention Period||14
8608776|NCT00408317|9645801|FG001|STARTED|First Intervention Period||17
8608777|NCT00408317|9645800|FG000|COMPLETED|First Intervention Period||14
8608778|NCT00408317|9645801|FG001|COMPLETED|First Intervention Period||16
8608779|NCT00408317|9645800|FG000|NOT COMPLETED|First Intervention Period||0
8608780|NCT00408317|9645801|FG001|NOT COMPLETED|First Intervention Period||1
8608781|NCT00408317|9645800|FG000|STARTED|Second Intervention Period||14
8608782|NCT00408317|9645801|FG001|STARTED|Second Intervention Period||16
8608783|NCT00408317|9645800|FG000|COMPLETED|Second Intervention Period||12
8608784|NCT00408317|9645801|FG001|COMPLETED|Second Intervention Period||14
8608785|NCT00408317|9645800|FG000|NOT COMPLETED|Second Intervention Period||2
8608786|NCT00408317|9645801|FG001|NOT COMPLETED|Second Intervention Period||2
8608787|NCT00408408|9645813|FG000|STARTED|Overall Study||201
8608788|NCT00408408|9645814|FG001|STARTED|Overall Study||199
8608789|NCT00408408|9645815|FG002|STARTED|Overall Study||204
8608790|NCT00408408|9645816|FG003|STARTED|Overall Study||201
8608791|NCT00408408|9645817|FG004|STARTED|Overall Study||197
8608792|NCT00408408|9645818|FG005|STARTED|Overall Study||204
8608793|NCT00408408|9645813|FG000|COMPLETED|Overall Study||199
8608794|NCT00408408|9645814|FG001|COMPLETED|Overall Study||196
8608795|NCT00408408|9645815|FG002|COMPLETED|Overall Study||204
8608796|NCT00408408|9645816|FG003|COMPLETED|Overall Study||194
8608797|NCT00408408|9645817|FG004|COMPLETED|Overall Study||192
8608798|NCT00408408|9645818|FG005|COMPLETED|Overall Study||201
8608799|NCT00408408|9645813|FG000|NOT COMPLETED|Overall Study||2
8608800|NCT00408408|9645814|FG001|NOT COMPLETED|Overall Study||3
8608801|NCT00408408|9645815|FG002|NOT COMPLETED|Overall Study||0
8608802|NCT00408408|9645816|FG003|NOT COMPLETED|Overall Study||7
8608803|NCT00408408|9645817|FG004|NOT COMPLETED|Overall Study||5
8608804|NCT00408408|9645818|FG005|NOT COMPLETED|Overall Study||3
8608805|NCT00408421|9645834|FG000|STARTED|Treatment Initial Randomization||120
8714966|NCT00981747|9761733|FG000|STARTED|Sildenafil||9
8714967|NCT00981747|9761733|FG000|Started Sildenafil|Sildenafil||9
8714968|NCT00981747|9761733|FG000|Completed Sildenafil|Sildenafil||9
8714969|NCT00981747|9761733|FG000|COMPLETED|Sildenafil||9
8714970|NCT00981747|9761733|FG000|NOT COMPLETED|Sildenafil||0
8714971|NCT00981747|9761733|FG000|STARTED|Sildenafil and Losartan||9
8714972|NCT00981747|9761733|FG000|Started Sildenafil and Losartan|Sildenafil and Losartan||9
8714973|NCT00981747|9761733|FG000|Completed Sildenafil and Losartan|Sildenafil and Losartan||9
8714974|NCT00981747|9761733|FG000|COMPLETED|Sildenafil and Losartan||9
8714975|NCT00981747|9761733|FG000|NOT COMPLETED|Sildenafil and Losartan||0
8714976|NCT00981799|9761747|FG000|STARTED|Overall Study||6
8714977|NCT00981799|9761748|FG001|STARTED|Overall Study||7
8714978|NCT00981799|9761749|FG002|STARTED|Overall Study||10
8714979|NCT00981799|9761750|FG003|STARTED|Overall Study||0
8714980|NCT00981799|9761747|FG000|COMPLETED|Overall Study||5
8714981|NCT00981799|9761748|FG001|COMPLETED|Overall Study||6
8714982|NCT00981799|9761749|FG002|COMPLETED|Overall Study||10
8714983|NCT00981799|9761750|FG003|COMPLETED|Overall Study||0
8714984|NCT00981799|9761747|FG000|NOT COMPLETED|Overall Study||1
8714985|NCT00981799|9761748|FG001|NOT COMPLETED|Overall Study||1
8714986|NCT00981799|9761749|FG002|NOT COMPLETED|Overall Study||0
8714987|NCT00981799|9761750|FG003|NOT COMPLETED|Overall Study||0
8714988|NCT00981812|9761761|FG000|STARTED|Overall Study||20
8714989|NCT00981812|9761761|FG000|COMPLETED|Overall Study||20
8714990|NCT00981812|9761761|FG000|NOT COMPLETED|Overall Study||0
8714991|NCT00981825|9761767|FG000|STARTED|First Intervention||11
8714992|NCT00981825|9761768|FG001|STARTED|First Intervention||11
8714993|NCT00981825|9761767|FG000|COMPLETED|First Intervention||11
8714994|NCT00981825|9761768|FG001|COMPLETED|First Intervention||11
8714995|NCT00981825|9761767|FG000|NOT COMPLETED|First Intervention||0
8714996|NCT00981825|9761768|FG001|NOT COMPLETED|First Intervention||0
8714997|NCT00981825|9761767|FG000|STARTED|Washout After 1st Intervention||11
8714998|NCT00981825|9761768|FG001|STARTED|Washout After 1st Intervention||11
8608806|NCT00408421|9645835|FG001|STARTED|Treatment Initial Randomization||111
8608807|NCT00408421|9645836|FG002|STARTED|Treatment Initial Randomization||0
8608808|NCT00408421|9645834|FG000|COMPLETED|Treatment Initial Randomization|Pre-Re-Randomization (Visit 4)|103
8608809|NCT00408421|9645835|FG001|COMPLETED|Treatment Initial Randomization|Pre-Re-Randomization (Visit 4)|89
8608810|NCT00408421|9645836|FG002|COMPLETED|Treatment Initial Randomization|Patients weren't randomized to Duloxetine 120 mg until Visit 4.|0
8608811|NCT00408421|9645834|FG000|NOT COMPLETED|Treatment Initial Randomization||17
8608812|NCT00408421|9645835|FG001|NOT COMPLETED|Treatment Initial Randomization||22
8608813|NCT00408421|9645836|FG002|NOT COMPLETED|Treatment Initial Randomization||0
8608814|NCT00408421|9645834|FG000|STARTED|Treatment Re-Randomization||103
8608815|NCT00408421|9645835|FG001|STARTED|Treatment Re-Randomization||46
8714999|NCT00981825|9761767|FG000|COMPLETED|Washout After 1st Intervention||11
8715000|NCT00981825|9761768|FG001|COMPLETED|Washout After 1st Intervention||11
8715001|NCT00981825|9761767|FG000|NOT COMPLETED|Washout After 1st Intervention||0
8715002|NCT00981825|9761768|FG001|NOT COMPLETED|Washout After 1st Intervention||0
8715003|NCT00981825|9761767|FG000|STARTED|Second Intervention||11
8715004|NCT00981825|9761768|FG001|STARTED|Second Intervention||11
8608816|NCT00408421|9645836|FG002|STARTED|Treatment Re-Randomization||43
8608817|NCT00408421|9645834|FG000|COMPLETED|Treatment Re-Randomization||96
8608818|NCT00408421|9645835|FG001|COMPLETED|Treatment Re-Randomization||39
8608819|NCT00408421|9645836|FG002|COMPLETED|Treatment Re-Randomization||38
8608820|NCT00408421|9645834|FG000|NOT COMPLETED|Treatment Re-Randomization||7
8608821|NCT00408421|9645835|FG001|NOT COMPLETED|Treatment Re-Randomization||7
8608822|NCT00408421|9645836|FG002|NOT COMPLETED|Treatment Re-Randomization||5
8608823|NCT00408434|9645851|FG000|STARTED|Overall Study||6
8608824|NCT00408434|9645852|FG001|STARTED|Overall Study||3
8608825|NCT00408434|9645853|FG002|STARTED|Overall Study||6
8608826|NCT00408434|9645854|FG003|STARTED|Overall Study||3
8608827|NCT00408434|9645855|FG004|STARTED|Overall Study||6
8608828|NCT00408434|9645856|FG005|STARTED|Overall Study||3
8608829|NCT00408434|9645857|FG006|STARTED|Overall Study||4
8608830|NCT00408434|9645851|FG000|COMPLETED|Overall Study||0
8608831|NCT00408434|9645852|FG001|COMPLETED|Overall Study||0
8608832|NCT00408434|9645853|FG002|COMPLETED|Overall Study||0
8608833|NCT00408434|9645854|FG003|COMPLETED|Overall Study||0
8608834|NCT00408434|9645855|FG004|COMPLETED|Overall Study||0
8608835|NCT00408434|9645856|FG005|COMPLETED|Overall Study||0
8715005|NCT00981825|9761767|FG000|COMPLETED|Second Intervention||11
8715006|NCT00981825|9761768|FG001|COMPLETED|Second Intervention||11
8715007|NCT00981825|9761767|FG000|NOT COMPLETED|Second Intervention||0
8715008|NCT00981825|9761768|FG001|NOT COMPLETED|Second Intervention||0
8715009|NCT00982007|9761778|FG000|STARTED|Overall Study||250
8715010|NCT00982007|9761779|FG001|STARTED|Overall Study||257
8715011|NCT00982007|9761780|FG002|STARTED|Overall Study||253
8715012|NCT00982007|9761781|FG003|STARTED|Overall Study||251
8715013|NCT00982007|9761778|FG000|COMPLETED|Overall Study||246
8715014|NCT00982007|9761779|FG001|COMPLETED|Overall Study||253
8715015|NCT00982007|9761780|FG002|COMPLETED|Overall Study||253
8715016|NCT00982007|9761781|FG003|COMPLETED|Overall Study||245
8715017|NCT00982007|9761778|FG000|NOT COMPLETED|Overall Study||4
8715018|NCT00982007|9761779|FG001|NOT COMPLETED|Overall Study||4
8715019|NCT00982007|9761780|FG002|NOT COMPLETED|Overall Study||0
8715020|NCT00982007|9761781|FG003|NOT COMPLETED|Overall Study||6
8715021|NCT00982020|9761793|FG000|STARTED|Overall Study||102
8715022|NCT00982020|9761794|FG001|STARTED|Overall Study||101
8715023|NCT00982020|9761793|FG000|Received at Least 1 Dose of Study Drug|Overall Study||102
8715024|NCT00982020|9761794|FG001|Received at Least 1 Dose of Study Drug|Overall Study||101
8608836|NCT00408434|9645857|FG006|COMPLETED|Overall Study||0
8608837|NCT00408434|9645851|FG000|NOT COMPLETED|Overall Study||6
8608838|NCT00408434|9645852|FG001|NOT COMPLETED|Overall Study||3
8608839|NCT00408434|9645853|FG002|NOT COMPLETED|Overall Study||6
8608840|NCT00408434|9645854|FG003|NOT COMPLETED|Overall Study||3
8608841|NCT00408434|9645855|FG004|NOT COMPLETED|Overall Study||6
8608842|NCT00408434|9645856|FG005|NOT COMPLETED|Overall Study||3
8608843|NCT00408434|9645857|FG006|NOT COMPLETED|Overall Study||4
8608844|NCT00408460|9645874|FG000|STARTED|Overall Study||34
8608845|NCT00408460|9645874|FG000|COMPLETED|Overall Study||34
8608846|NCT00408460|9645874|FG000|NOT COMPLETED|Overall Study||0
8608847|NCT00408499|9645878|FG000|STARTED|Phase 1: Dose Levels 1-4||4
8608848|NCT00408499|9645879|FG001|STARTED|Phase 1: Dose Levels 1-4||7
8608849|NCT00408499|9645880|FG002|STARTED|Phase 1: Dose Levels 1-4||3
8608850|NCT00408499|9645881|FG003|STARTED|Phase 1: Dose Levels 1-4||6
8608851|NCT00408499|9645882|FG004|STARTED|Phase 1: Dose Levels 1-4||0
8608852|NCT00408499|9645878|FG000|COMPLETED|Phase 1: Dose Levels 1-4||2
8608853|NCT00408499|9645879|FG001|COMPLETED|Phase 1: Dose Levels 1-4||5
8715025|NCT00982020|9761793|FG000|COMPLETED|Overall Study||45
8715026|NCT00982020|9761794|FG001|COMPLETED|Overall Study||37
8715027|NCT00982020|9761793|FG000|NOT COMPLETED|Overall Study||57
8715028|NCT00982020|9761794|FG001|NOT COMPLETED|Overall Study||64
8608854|NCT00408499|9645880|FG002|COMPLETED|Phase 1: Dose Levels 1-4||2
8608855|NCT00408499|9645881|FG003|COMPLETED|Phase 1: Dose Levels 1-4||6
8608856|NCT00408499|9645882|FG004|COMPLETED|Phase 1: Dose Levels 1-4||0
8608857|NCT00408499|9645878|FG000|NOT COMPLETED|Phase 1: Dose Levels 1-4||2
8608858|NCT00408499|9645879|FG001|NOT COMPLETED|Phase 1: Dose Levels 1-4||2
8608859|NCT00408499|9645880|FG002|NOT COMPLETED|Phase 1: Dose Levels 1-4||1
8608860|NCT00408499|9645881|FG003|NOT COMPLETED|Phase 1: Dose Levels 1-4||0
8608861|NCT00408499|9645882|FG004|NOT COMPLETED|Phase 1: Dose Levels 1-4||0
8608862|NCT00408499|9645878|FG000|STARTED|Phase II- MTD Expansion||0
8608863|NCT00408499|9645879|FG001|STARTED|Phase II- MTD Expansion||0
8608864|NCT00408499|9645880|FG002|STARTED|Phase II- MTD Expansion||0
8608865|NCT00408499|9645881|FG003|STARTED|Phase II- MTD Expansion||0
8608866|NCT00408499|9645882|FG004|STARTED|Phase II- MTD Expansion||44
8608867|NCT00408499|9645878|FG000|COMPLETED|Phase II- MTD Expansion||0
8608868|NCT00408499|9645879|FG001|COMPLETED|Phase II- MTD Expansion||0
8608869|NCT00408499|9645880|FG002|COMPLETED|Phase II- MTD Expansion||0
8608870|NCT00408499|9645881|FG003|COMPLETED|Phase II- MTD Expansion||0
8715029|NCT00982033|9761807|FG000|STARTED|Overall Study||25
8715030|NCT00982033|9761808|FG001|STARTED|Overall Study||27
8715031|NCT00982033|9761807|FG000|COMPLETED|Overall Study||25
8715032|NCT00982033|9761808|FG001|COMPLETED|Overall Study||27
8715033|NCT00982033|9761807|FG000|NOT COMPLETED|Overall Study||0
8715034|NCT00982033|9761808|FG001|NOT COMPLETED|Overall Study||0
8715035|NCT00982072|9761816|FG000|STARTED|Overall Study||25
8715036|NCT00982072|9761817|FG001|STARTED|Overall Study||27
8715037|NCT00982072|9761816|FG000|COMPLETED|Overall Study||25
8715038|NCT00982072|9761817|FG001|COMPLETED|Overall Study||25
8608871|NCT00408499|9645882|FG004|COMPLETED|Phase II- MTD Expansion||24
8608872|NCT00408499|9645878|FG000|NOT COMPLETED|Phase II- MTD Expansion||0
8608873|NCT00408499|9645879|FG001|NOT COMPLETED|Phase II- MTD Expansion||0
8608874|NCT00408499|9645880|FG002|NOT COMPLETED|Phase II- MTD Expansion||0
8608875|NCT00408499|9645881|FG003|NOT COMPLETED|Phase II- MTD Expansion||0
8608876|NCT00408499|9645882|FG004|NOT COMPLETED|Phase II- MTD Expansion||20
8608877|NCT00408564|9645891|FG000|STARTED|Overall Study||39
8608878|NCT00408564|9645891|FG000|COMPLETED|Overall Study||39
8608879|NCT00408564|9645891|FG000|NOT COMPLETED|Overall Study||0
8608880|NCT00408590|9645898|FG000|STARTED|Overall Study||3
8608881|NCT00408590|9645899|FG001|STARTED|Overall Study||3
8608882|NCT00408590|9645900|FG002|STARTED|Overall Study||3
8608883|NCT00408590|9645901|FG003|STARTED|Overall Study||3
8608884|NCT00408590|9645902|FG004|STARTED|Overall Study||3
8608885|NCT00408590|9645903|FG005|STARTED|Overall Study||3
8608886|NCT00408590|9645904|FG006|STARTED|Overall Study||3
8608887|NCT00408590|9645905|FG007|STARTED|Overall Study||3
8608888|NCT00408590|9645906|FG008|STARTED|Overall Study||13
8608889|NCT00408590|9645898|FG000|COMPLETED|Overall Study||3
8608890|NCT00408590|9645899|FG001|COMPLETED|Overall Study||3
8608891|NCT00408590|9645900|FG002|COMPLETED|Overall Study||3
8608892|NCT00408590|9645901|FG003|COMPLETED|Overall Study||3
8608893|NCT00408590|9645902|FG004|COMPLETED|Overall Study||3
8608894|NCT00408590|9645903|FG005|COMPLETED|Overall Study||3
8608895|NCT00408590|9645904|FG006|COMPLETED|Overall Study||3
8608896|NCT00408590|9645905|FG007|COMPLETED|Overall Study||3
8608897|NCT00408590|9645906|FG008|COMPLETED|Overall Study||13
8608898|NCT00408590|9645898|FG000|NOT COMPLETED|Overall Study||0
8608899|NCT00408590|9645899|FG001|NOT COMPLETED|Overall Study||0
8608900|NCT00408590|9645900|FG002|NOT COMPLETED|Overall Study||0
8608901|NCT00408590|9645901|FG003|NOT COMPLETED|Overall Study||0
8608902|NCT00408590|9645902|FG004|NOT COMPLETED|Overall Study||0
8608903|NCT00408590|9645903|FG005|NOT COMPLETED|Overall Study||0
8608904|NCT00408590|9645904|FG006|NOT COMPLETED|Overall Study||0
8608905|NCT00408590|9645905|FG007|NOT COMPLETED|Overall Study||0
8608906|NCT00408590|9645906|FG008|NOT COMPLETED|Overall Study||0
8608907|NCT00408603|9645924|FG000|STARTED|Overall Study||69
8608908|NCT00408603|9645925|FG001|STARTED|Overall Study||39
8608909|NCT00408603|9645926|FG002|STARTED|Overall Study||75
8608910|NCT00408603|9645924|FG000|COMPLETED|Overall Study||65
8608911|NCT00408603|9645925|FG001|COMPLETED|Overall Study||37
8608912|NCT00408603|9645926|FG002|COMPLETED|Overall Study||35
8715039|NCT00982072|9761816|FG000|NOT COMPLETED|Overall Study||0
8715040|NCT00982072|9761817|FG001|NOT COMPLETED|Overall Study||2
8715041|NCT00982137|9761827|FG000|STARTED|Overall Study||36
8715042|NCT00982137|9761828|FG001|STARTED|Overall Study||36
8715043|NCT00982137|9761829|FG002|STARTED|Overall Study||18
8715044|NCT00982137|9761830|FG003|STARTED|Overall Study||18
8715045|NCT00982137|9761827|FG000|COMPLETED|Overall Study||36
8715046|NCT00982137|9761828|FG001|COMPLETED|Overall Study||35
8715047|NCT00982137|9761829|FG002|COMPLETED|Overall Study||18
8715048|NCT00982137|9761830|FG003|COMPLETED|Overall Study||17
8715049|NCT00982137|9761827|FG000|NOT COMPLETED|Overall Study||0
8715050|NCT00982137|9761828|FG001|NOT COMPLETED|Overall Study||1
8715051|NCT00982137|9761829|FG002|NOT COMPLETED|Overall Study||0
8715052|NCT00982137|9761830|FG003|NOT COMPLETED|Overall Study||1
8715053|NCT00982189|9761851|FG000|STARTED|Overall Study||10
8715054|NCT00982189|9761852|FG001|STARTED|Overall Study||9
8715055|NCT00982189|9761853|FG002|STARTED|Overall Study||9
8715056|NCT00982189|9761854|FG003|STARTED|Overall Study||9
8715057|NCT00982189|9761851|FG000|COMPLETED|Overall Study||10
8715058|NCT00982189|9761852|FG001|COMPLETED|Overall Study||9
8715059|NCT00982189|9761853|FG002|COMPLETED|Overall Study||9
8715060|NCT00982189|9761854|FG003|COMPLETED|Overall Study||9
8715061|NCT00982189|9761851|FG000|NOT COMPLETED|Overall Study||0
8608913|NCT00408603|9645924|FG000|NOT COMPLETED|Overall Study||4
8608914|NCT00408603|9645925|FG001|NOT COMPLETED|Overall Study||2
8608915|NCT00408603|9645926|FG002|NOT COMPLETED|Overall Study||40
8608916|NCT00408629|9645938|FG000|STARTED|Overall Study|10 ADA recipients from 3 noncompliant clinical sites in Safety, but not in Efficacy analyses (248).|258
8608917|NCT00408629|9645939|FG001|STARTED|Overall Study|14 PLB recipients from 3 noncompliant clinical sites in Safety, but not in Efficacy analyses (246).|260
8608918|NCT00408629|9645938|FG000|COMPLETED|Overall Study|1 ADA recipient did not receive study drug and discontinued due to other reasons.|161
8608919|NCT00408629|9645939|FG001|COMPLETED|Overall Study||135
8608920|NCT00408629|9645938|FG000|NOT COMPLETED|Overall Study||97
8608921|NCT00408629|9645939|FG001|NOT COMPLETED|Overall Study||125
8608922|NCT00408681|9645946|FG000|STARTED|Overall Study||20
8608923|NCT00408681|9645946|FG000|COMPLETED|Overall Study|Completion was defined as administration of the study product for at least 28 days.|11
8608924|NCT00408681|9645946|FG000|NOT COMPLETED|Overall Study||9
8608925|NCT00408694|9645951|FG000|STARTED|Overall Study||46
8608926|NCT00408694|9645951|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|44
8608927|NCT00408694|9645951|FG000|NOT COMPLETED|Overall Study||2
8608928|NCT00408876|9645959|FG000|STARTED|Overall Study||59
8608929|NCT00408876|9645960|FG001|STARTED|Overall Study||116
8715062|NCT00982189|9761852|FG001|NOT COMPLETED|Overall Study||0
8715063|NCT00982189|9761853|FG002|NOT COMPLETED|Overall Study||0
8715064|NCT00982189|9761854|FG003|NOT COMPLETED|Overall Study||0
8715065|NCT00982228|9761868|FG000|STARTED|Main: Week 0 to 52 (NN1250-3583)||472
8715066|NCT00982228|9761869|FG001|STARTED|Main: Week 0 to 52 (NN1250-3583)||157
8608930|NCT00408876|9645961|FG002|STARTED|Overall Study||112
8608931|NCT00408876|9645962|FG003|STARTED|Overall Study||117
8608932|NCT00408876|9645959|FG000|COMPLETED|Overall Study||43
8608933|NCT00408876|9645960|FG001|COMPLETED|Overall Study||80
8608934|NCT00408876|9645961|FG002|COMPLETED|Overall Study||62
8608935|NCT00408876|9645962|FG003|COMPLETED|Overall Study||82
8608936|NCT00408876|9645959|FG000|NOT COMPLETED|Overall Study||16
8608937|NCT00408876|9645960|FG001|NOT COMPLETED|Overall Study||36
8608938|NCT00408876|9645961|FG002|NOT COMPLETED|Overall Study||50
8715067|NCT00982228|9761868|FG000|Full Analysis Set|Main: Week 0 to 52 (NN1250-3583)||472
8715068|NCT00982228|9761869|FG001|Full Analysis Set|Main: Week 0 to 52 (NN1250-3583)||157
8715069|NCT00982228|9761868|FG000|Exposed|Main: Week 0 to 52 (NN1250-3583)||472
8715070|NCT00982228|9761869|FG001|Exposed|Main: Week 0 to 52 (NN1250-3583)|Three subjects withdrew prior to exposure to trial drug|154
8715071|NCT00982228|9761868|FG000|COMPLETED|Main: Week 0 to 52 (NN1250-3583)||404
8715072|NCT00982228|9761869|FG001|COMPLETED|Main: Week 0 to 52 (NN1250-3583)||137
8715073|NCT00982228|9761868|FG000|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3583)||68
8715074|NCT00982228|9761869|FG001|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3583)||20
8715075|NCT00982228|9761868|FG000|STARTED|Extension: Week 53 to 104 (NN1250-3644)|Fifty-three subjects from the main trial did not continue into the extension|351
8715076|NCT00982228|9761869|FG001|STARTED|Extension: Week 53 to 104 (NN1250-3644)|Nineteen subjects from the main trial did not continue into the extension|118
8715077|NCT00982228|9761868|FG000|COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||330
8715078|NCT00982228|9761869|FG001|COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||113
8715079|NCT00982228|9761868|FG000|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||21
8715080|NCT00982228|9761869|FG001|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||5
8715081|NCT00982280|9761875|FG000|STARTED|Observation Period||82
8715082|NCT00982280|9761875|FG000|COMPLETED|Observation Period||63
8715083|NCT00982280|9761875|FG000|NOT COMPLETED|Observation Period||19
8715084|NCT00982280|9761875|FG000|STARTED|Titration and Optimal Dose Period||63
8715085|NCT00982280|9761875|FG000|COMPLETED|Titration and Optimal Dose Period||55
8715086|NCT00982280|9761875|FG000|NOT COMPLETED|Titration and Optimal Dose Period||8
8715087|NCT00982280|9761875|FG000|STARTED|Maintenance Period||55
8715088|NCT00982280|9761875|FG000|COMPLETED|Maintenance Period||54
8715089|NCT00982280|9761875|FG000|NOT COMPLETED|Maintenance Period||1
8715090|NCT00982319|9761882|FG000|STARTED|Overall Study||17
8715091|NCT00982319|9761883|FG001|STARTED|Overall Study||17
8715092|NCT00982319|9761882|FG000|COMPLETED|Overall Study||15
8715093|NCT00982319|9761883|FG001|COMPLETED|Overall Study||15
8715094|NCT00982319|9761882|FG000|NOT COMPLETED|Overall Study||2
8715095|NCT00982319|9761883|FG001|NOT COMPLETED|Overall Study||2
8715096|NCT00982345|9761889|FG000|STARTED|Overall Study||20
8715097|NCT00982345|9761889|FG000|COMPLETED|Overall Study||18
8715098|NCT00982345|9761889|FG000|NOT COMPLETED|Overall Study||2
8715099|NCT00982397|9761895|FG000|STARTED|Phase I||236
8715100|NCT00982397|9761896|FG001|STARTED|Phase I||0
8715101|NCT00982397|9761895|FG000|COMPLETED|Phase I||236
8715102|NCT00982397|9761896|FG001|COMPLETED|Phase I||0
8715103|NCT00982397|9761895|FG000|NOT COMPLETED|Phase I||0
8715104|NCT00982397|9761896|FG001|NOT COMPLETED|Phase I||0
8715105|NCT00982397|9761895|FG000|STARTED|Phase II/Overall Study||2019
8715106|NCT00982397|9761896|FG001|STARTED|Phase II/Overall Study||751
8715107|NCT00982397|9761895|FG000|Secondary Prevention Randomized 18/24NID|Phase II/Overall Study||231
8715108|NCT00982397|9761896|FG001|Secondary Prevention Randomized 18/24NID|Phase II/Overall Study||122
8715109|NCT00982397|9761895|FG000|Secondary Prevention Randomized 30/40NID|Phase II/Overall Study||221
8715110|NCT00982397|9761896|FG001|Secondary Prevention Randomized 30/40NID|Phase II/Overall Study||131
8715111|NCT00982397|9761895|FG000|COMPLETED|Phase II/Overall Study||2019
8715112|NCT00982397|9761896|FG001|COMPLETED|Phase II/Overall Study||751
8715113|NCT00982397|9761895|FG000|NOT COMPLETED|Phase II/Overall Study||0
8715114|NCT00982397|9761896|FG001|NOT COMPLETED|Phase II/Overall Study||0
8715115|NCT00982410|9761907|FG000|STARTED|3-month Follow-up Assessment||65
8715116|NCT00982410|9761908|FG001|STARTED|3-month Follow-up Assessment||66
8715117|NCT00982410|9761907|FG000|COMPLETED|3-month Follow-up Assessment||56
8715118|NCT00982410|9761908|FG001|COMPLETED|3-month Follow-up Assessment||53
8715119|NCT00982410|9761907|FG000|NOT COMPLETED|3-month Follow-up Assessment||9
8715120|NCT00982410|9761908|FG001|NOT COMPLETED|3-month Follow-up Assessment||13
8715121|NCT00982410|9761907|FG000|STARTED|6-month Follow-up Assessment|n=65 : intent to treat. Some persons missed follow-up assessment without withdrawing from study.|65
8715122|NCT00982410|9761908|FG001|STARTED|6-month Follow-up Assessment|n=2 persons withdrew before 3-mo. f/u, reducing pool of participants to N=64 with intent to treat.|64
8715123|NCT00982410|9761907|FG000|COMPLETED|6-month Follow-up Assessment||59
8715124|NCT00982410|9761908|FG001|COMPLETED|6-month Follow-up Assessment||53
8715125|NCT00982410|9761907|FG000|NOT COMPLETED|6-month Follow-up Assessment||6
8715126|NCT00982410|9761908|FG001|NOT COMPLETED|6-month Follow-up Assessment||11
8608939|NCT00408876|9645962|FG003|NOT COMPLETED|Overall Study||35
8608940|NCT00408902|9645972|FG000|STARTED|Overall Study||10
8608941|NCT00408902|9645972|FG000|COMPLETED|Overall Study||0
8608942|NCT00408902|9645972|FG000|NOT COMPLETED|Overall Study||10
8608943|NCT00408928|9645977|FG000|STARTED|Overall Study||11
8608944|NCT00408928|9645977|FG000|COMPLETED|Overall Study||8
8608945|NCT00408928|9645977|FG000|NOT COMPLETED|Overall Study||3
8715127|NCT00982410|9761907|FG000|STARTED|12-month Follow-up Assessment|n=65 : intent to treat. Some persons missed follow-up assessment without withdrawing from study.|65
8608946|NCT00408993|9645983|FG000|STARTED|Overall Study||106
8608947|NCT00408993|9645984|FG001|STARTED|Overall Study||109
8608948|NCT00408993|9645983|FG000|COMPLETED|Overall Study||87
8608949|NCT00408993|9645984|FG001|COMPLETED|Overall Study||92
8608950|NCT00408993|9645983|FG000|NOT COMPLETED|Overall Study||19
8715128|NCT00982410|9761908|FG001|STARTED|12-month Follow-up Assessment|n=2 persons withdrew before 3-mo. f/u, reducing pool of participants to N=64 with intent to treat.|64
8715129|NCT00982410|9761907|FG000|COMPLETED|12-month Follow-up Assessment||56
8715130|NCT00982410|9761908|FG001|COMPLETED|12-month Follow-up Assessment||55
8715131|NCT00982410|9761907|FG000|NOT COMPLETED|12-month Follow-up Assessment||9
8715132|NCT00982410|9761908|FG001|NOT COMPLETED|12-month Follow-up Assessment||9
8715133|NCT00982423|9761917|FG000|STARTED|Overall Study||13
8608951|NCT00408993|9645984|FG001|NOT COMPLETED|Overall Study||17
8608952|NCT00409006|9645996|FG000|STARTED|Overall Study||39
8608953|NCT00409006|9645997|FG001|STARTED|Overall Study||31
8608954|NCT00409006|9645996|FG000|COMPLETED|Overall Study||19
8608955|NCT00409006|9645997|FG001|COMPLETED|Overall Study||19
8608956|NCT00409006|9645996|FG000|NOT COMPLETED|Overall Study||20
8608957|NCT00409006|9645997|FG001|NOT COMPLETED|Overall Study||12
8608958|NCT00409175|9646005|FG000|STARTED|Overall Study||65
8608959|NCT00409175|9646006|FG001|STARTED|Overall Study||63
8608960|NCT00409175|9646005|FG000|COMPLETED|Overall Study||47
8715134|NCT00982423|9761918|FG001|STARTED|Overall Study||19
8715135|NCT00982423|9761917|FG000|COMPLETED|Overall Study||13
8715136|NCT00982423|9761918|FG001|COMPLETED|Overall Study||19
8715137|NCT00982423|9761917|FG000|NOT COMPLETED|Overall Study||0
8715138|NCT00982423|9761918|FG001|NOT COMPLETED|Overall Study||0
8715139|NCT00982488|9761930|FG000|STARTED|Overall Study|Received treatment|185
8715140|NCT00982488|9761931|FG001|STARTED|Overall Study|Received treatment|14
8715141|NCT00982488|9761932|FG002|STARTED|Overall Study|Received treatment|34
8715142|NCT00982488|9761933|FG003|STARTED|Overall Study|Received treatment|3
8715143|NCT00982488|9761934|FG004|STARTED|Overall Study|Received treatment|1
8715144|NCT00982488|9761930|FG000|COMPLETED|Overall Study|Still receiving treatment|0
8715145|NCT00982488|9761931|FG001|COMPLETED|Overall Study|Still receiving treatment|0
8715146|NCT00982488|9761932|FG002|COMPLETED|Overall Study|Still receiving treatment|0
8715147|NCT00982488|9761933|FG003|COMPLETED|Overall Study|Still receiving treatment|0
8715148|NCT00982488|9761934|FG004|COMPLETED|Overall Study|Still receiving treatment|0
8715149|NCT00982488|9761930|FG000|NOT COMPLETED|Overall Study||185
8715150|NCT00982488|9761931|FG001|NOT COMPLETED|Overall Study||14
8715151|NCT00982488|9761932|FG002|NOT COMPLETED|Overall Study||34
8715152|NCT00982488|9761933|FG003|NOT COMPLETED|Overall Study||3
8715153|NCT00982488|9761934|FG004|NOT COMPLETED|Overall Study||1
8715154|NCT00982553|9761946|FG000|STARTED|Phase1||14
8715155|NCT00982553|9761946|FG000|COMPLETED|Phase1||14
8715156|NCT00982553|9761946|FG000|NOT COMPLETED|Phase1||0
8715157|NCT00982553|9761946|FG000|STARTED|Phase2||14
8715158|NCT00982553|9761946|FG000|COMPLETED|Phase2||14
8715159|NCT00982553|9761946|FG000|NOT COMPLETED|Phase2||0
8715160|NCT00982553|9761946|FG000|STARTED|Phase3||14
8715161|NCT00982553|9761946|FG000|COMPLETED|Phase3||14
8715162|NCT00982553|9761946|FG000|NOT COMPLETED|Phase3||0
8715163|NCT00982592|9761957|FG000|STARTED|Overall Study||64
8715164|NCT00982592|9761958|FG001|STARTED|Overall Study||60
8715165|NCT00982592|9761957|FG000|Treatment Received|Overall Study||63
8715166|NCT00982592|9761958|FG001|Treatment Received|Overall Study||52
8715167|NCT00982592|9761957|FG000|COMPLETED|Overall Study|patients who were off treatment due to disease progression|33
8715168|NCT00982592|9761958|FG001|COMPLETED|Overall Study|patients who were off treatment due to disease progression|27
8715169|NCT00982592|9761957|FG000|NOT COMPLETED|Overall Study||31
8715170|NCT00982592|9761958|FG001|NOT COMPLETED|Overall Study||33
8715171|NCT00982644|9761966|FG000|STARTED|Main: Week 0 to 52 (NN1250-3579)||773
8715172|NCT00982644|9761967|FG001|STARTED|Main: Week 0 to 52 (NN1250-3579)||257
8715173|NCT00982644|9761966|FG000|Full Analysis Set|Main: Week 0 to 52 (NN1250-3579)||773
8715174|NCT00982644|9761967|FG001|Full Analysis Set|Main: Week 0 to 52 (NN1250-3579)||257
8715175|NCT00982644|9761966|FG000|Exposed|Main: Week 0 to 52 (NN1250-3579)|7 subjects were withdrawn prior to exposure to trial products|766
8715176|NCT00982644|9761967|FG001|Exposed|Main: Week 0 to 52 (NN1250-3579)||257
8715177|NCT00982644|9761966|FG000|COMPLETED|Main: Week 0 to 52 (NN1250-3579)||607
8715178|NCT00982644|9761967|FG001|COMPLETED|Main: Week 0 to 52 (NN1250-3579)||197
8715179|NCT00982644|9761966|FG000|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3579)||166
8715180|NCT00982644|9761967|FG001|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3579)||60
8715181|NCT00982644|9761966|FG000|STARTED|Extension: Week 53 to 104 (NN1250-3643)|Fifty-six subjects did not continue into extension trial|551
8715182|NCT00982644|9761967|FG001|STARTED|Extension: Week 53 to 104 (NN1250-3643)|Twenty-three subjects did not continue into extension trial|174
8715183|NCT00982644|9761966|FG000|COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||505
8715184|NCT00982644|9761967|FG001|COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||154
8715185|NCT00982644|9761966|FG000|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||46
8715186|NCT00982644|9761967|FG001|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||20
8715187|NCT00982657|9761977|FG000|STARTED|Overall Study||12
8715188|NCT00982657|9761978|FG001|STARTED|Overall Study||3
8715189|NCT00982657|9761979|FG002|STARTED|Overall Study||3
8608961|NCT00409175|9646006|FG001|COMPLETED|Overall Study||44
8608962|NCT00409175|9646005|FG000|NOT COMPLETED|Overall Study||18
8608963|NCT00409175|9646006|FG001|NOT COMPLETED|Overall Study||19
8608964|NCT00409188|9646014|FG000|STARTED|Overall Study||1006
8608965|NCT00409188|9646015|FG001|STARTED|Overall Study||507
8608966|NCT00409188|9646014|FG000|COMPLETED|Overall Study||623
8608967|NCT00409188|9646015|FG001|COMPLETED|Overall Study||332
8608968|NCT00409188|9646014|FG000|NOT COMPLETED|Overall Study||383
8608969|NCT00409188|9646015|FG001|NOT COMPLETED|Overall Study||175
8608970|NCT00409240|9646023|FG000|STARTED|Overall Study||53
8608971|NCT00409240|9646024|FG001|STARTED|Overall Study||50
8608972|NCT00409240|9646023|FG000|COMPLETED|Overall Study||50
8608973|NCT00409240|9646024|FG001|COMPLETED|Overall Study||49
8608974|NCT00409240|9646023|FG000|NOT COMPLETED|Overall Study||3
8608975|NCT00409240|9646024|FG001|NOT COMPLETED|Overall Study||1
8608976|NCT00409292|9646030|FG000|STARTED|Overall Study||33
8608977|NCT00409292|9646030|FG000|COMPLETED|Overall Study||33
8608978|NCT00409292|9646030|FG000|NOT COMPLETED|Overall Study||0
8608979|NCT00409409|9646038|FG000|STARTED|Overall Study||139
8608980|NCT00409409|9646039|FG001|STARTED|Overall Study||139
8608981|NCT00409409|9646038|FG000|COMPLETED|Overall Study||131
8715190|NCT00982657|9761980|FG003|STARTED|Overall Study||16
8715191|NCT00982657|9761977|FG000|COMPLETED|Overall Study||11
8715192|NCT00982657|9761978|FG001|COMPLETED|Overall Study||3
8715193|NCT00982657|9761979|FG002|COMPLETED|Overall Study||1
8715194|NCT00982657|9761980|FG003|COMPLETED|Overall Study||7
8715195|NCT00982657|9761977|FG000|NOT COMPLETED|Overall Study||1
8715196|NCT00982657|9761978|FG001|NOT COMPLETED|Overall Study||0
8715197|NCT00982657|9761979|FG002|NOT COMPLETED|Overall Study||2
8715198|NCT00982657|9761980|FG003|NOT COMPLETED|Overall Study||9
8715199|NCT00982735|9762000|FG000|STARTED|Overall Study||987
8715200|NCT00982735|9762000|FG000|COMPLETED|Overall Study||757
8715201|NCT00982735|9762000|FG000|NOT COMPLETED|Overall Study||230
8715202|NCT00982865|9762008|FG000|STARTED|Overall Study||49
8715203|NCT00982865|9762009|FG001|STARTED|Overall Study||82
8715204|NCT00982865|9762010|FG002|STARTED|Overall Study||15
8715205|NCT00982865|9762011|FG003|STARTED|Overall Study||34
8715206|NCT00982865|9762008|FG000|COMPLETED|Overall Study||49
8715207|NCT00982865|9762009|FG001|COMPLETED|Overall Study||82
8715208|NCT00982865|9762010|FG002|COMPLETED|Overall Study||15
8715209|NCT00982865|9762011|FG003|COMPLETED|Overall Study||34
8715210|NCT00982865|9762008|FG000|NOT COMPLETED|Overall Study||0
8715211|NCT00982865|9762009|FG001|NOT COMPLETED|Overall Study||0
8715212|NCT00982865|9762010|FG002|NOT COMPLETED|Overall Study||0
8715213|NCT00982865|9762011|FG003|NOT COMPLETED|Overall Study||0
8715214|NCT00982878|9762058|FG000|STARTED|Overall Study||13
8715215|NCT00982878|9762058|FG000|COMPLETED|Overall Study||12
8715216|NCT00982878|9762058|FG000|NOT COMPLETED|Overall Study||1
8715217|NCT00982930|9762062|FG000|STARTED|Overall Study||55
8715218|NCT00982930|9762062|FG000|COMPLETED|Overall Study||51
8715219|NCT00982930|9762062|FG000|NOT COMPLETED|Overall Study||4
8715220|NCT00983073|9762066|FG000|STARTED|Observation Period||224
8715221|NCT00983073|9762066|FG000|COMPLETED|Observation Period|24 participants not eligible to be dosed.|200
8715222|NCT00983073|9762066|FG000|NOT COMPLETED|Observation Period||24
8715223|NCT00983073|9762066|FG000|STARTED|Titration and Optimal Dose Period||200
8715224|NCT00983073|9762066|FG000|COMPLETED|Titration and Optimal Dose Period||160
8715225|NCT00983073|9762066|FG000|NOT COMPLETED|Titration and Optimal Dose Period||40
8715226|NCT00983073|9762066|FG000|STARTED|Maintenance Period||160
8715227|NCT00983073|9762066|FG000|COMPLETED|Maintenance Period||144
8715228|NCT00983073|9762066|FG000|NOT COMPLETED|Maintenance Period||16
8715229|NCT00983216|9762071|FG000|STARTED|Colchicine Alone||24
8715230|NCT00983216|9762071|FG000|COMPLETED|Colchicine Alone||24
8715231|NCT00983216|9762071|FG000|NOT COMPLETED|Colchicine Alone||0
8715232|NCT00983216|9762071|FG000|STARTED|14 Day Washout Period||24
8715233|NCT00983216|9762071|FG000|COMPLETED|14 Day Washout Period||24
8715234|NCT00983216|9762071|FG000|NOT COMPLETED|14 Day Washout Period||0
8715235|NCT00983216|9762071|FG000|STARTED|Ketoconazole Alone||24
8715236|NCT00983216|9762071|FG000|COMPLETED|Ketoconazole Alone||24
8715237|NCT00983216|9762071|FG000|NOT COMPLETED|Ketoconazole Alone||0
8715238|NCT00983216|9762071|FG000|STARTED|Colchicine With Ketoconazole||24
8715239|NCT00983216|9762071|FG000|COMPLETED|Colchicine With Ketoconazole||24
8715240|NCT00983216|9762071|FG000|NOT COMPLETED|Colchicine With Ketoconazole||0
8715241|NCT00983242|9762078|FG000|STARTED|Colchicine Alone||24
8715242|NCT00983242|9762078|FG000|COMPLETED|Colchicine Alone||24
8715243|NCT00983242|9762078|FG000|NOT COMPLETED|Colchicine Alone||0
8715244|NCT00983242|9762078|FG000|STARTED|14 Day Washout Period||24
8715245|NCT00983242|9762078|FG000|COMPLETED|14 Day Washout Period||24
8715246|NCT00983242|9762078|FG000|NOT COMPLETED|14 Day Washout Period||0
8715247|NCT00983242|9762078|FG000|STARTED|Verapamil HCl ER Alone||24
8715248|NCT00983242|9762078|FG000|COMPLETED|Verapamil HCl ER Alone||24
8715249|NCT00983242|9762078|FG000|NOT COMPLETED|Verapamil HCl ER Alone||0
8715250|NCT00983242|9762078|FG000|STARTED|Colchicine With Verapamil HCl ER||24
8715251|NCT00983242|9762078|FG000|COMPLETED|Colchicine With Verapamil HCl ER||24
8608982|NCT00409409|9646039|FG001|COMPLETED|Overall Study||135
8608983|NCT00409409|9646038|FG000|NOT COMPLETED|Overall Study||8
8608984|NCT00409409|9646039|FG001|NOT COMPLETED|Overall Study||4
8608985|NCT00409539|9646050|FG000|STARTED|Overall Study||111
8715252|NCT00983242|9762078|FG000|NOT COMPLETED|Colchicine With Verapamil HCl ER||0
8715253|NCT00983281|9762087|FG000|STARTED|Overall Study||805
8715254|NCT00983281|9762088|FG001|STARTED|Overall Study||909
8715255|NCT00983281|9762087|FG000|COMPLETED|Overall Study||805
8715256|NCT00983281|9762088|FG001|COMPLETED|Overall Study||909
8608986|NCT00409539|9646051|FG001|STARTED|Overall Study||111
8608987|NCT00409539|9646052|FG002|STARTED|Overall Study||109
8608988|NCT00409539|9646053|FG003|STARTED|Overall Study||109
8715257|NCT00983281|9762087|FG000|NOT COMPLETED|Overall Study||0
8715258|NCT00983281|9762088|FG001|NOT COMPLETED|Overall Study||0
8608989|NCT00409539|9646054|FG004|STARTED|Overall Study||110
8608990|NCT00409539|9646050|FG000|COMPLETED|Overall Study||100
8608991|NCT00409539|9646051|FG001|COMPLETED|Overall Study||100
8608992|NCT00409539|9646052|FG002|COMPLETED|Overall Study||95
8608993|NCT00409539|9646053|FG003|COMPLETED|Overall Study||97
8608994|NCT00409539|9646054|FG004|COMPLETED|Overall Study||85
8608995|NCT00409539|9646050|FG000|NOT COMPLETED|Overall Study||11
8608996|NCT00409539|9646051|FG001|NOT COMPLETED|Overall Study||11
8608997|NCT00409539|9646052|FG002|NOT COMPLETED|Overall Study||14
8608998|NCT00409539|9646053|FG003|NOT COMPLETED|Overall Study||12
8608999|NCT00409539|9646054|FG004|NOT COMPLETED|Overall Study||25
8609000|NCT00409565|9646066|FG000|STARTED|Overall Study||46
8609001|NCT00409565|9646066|FG000|Overall Response Rate|Overall Study||7
8609002|NCT00409565|9646066|FG000|COMPLETED|Overall Study||45
8609003|NCT00409565|9646066|FG000|NOT COMPLETED|Overall Study||1
8609004|NCT00409578|9646074|FG000|STARTED|Overall Study||280
8609005|NCT00409578|9646075|FG001|STARTED|Overall Study||271
8609006|NCT00409578|9646076|FG002|STARTED|Overall Study||269
8609007|NCT00409578|9646077|FG003|STARTED|Overall Study||281
8715259|NCT00983294|9762094|FG000|STARTED|Colchicine Alone||24
8715260|NCT00983294|9762094|FG000|COMPLETED|Colchicine Alone||24
8715261|NCT00983294|9762094|FG000|NOT COMPLETED|Colchicine Alone||0
8715262|NCT00983294|9762094|FG000|STARTED|14 Day Washout Period||24
8715263|NCT00983294|9762094|FG000|COMPLETED|14 Day Washout Period|two subjects withdrew consent due to personal reasons|22
8715264|NCT00983294|9762094|FG000|NOT COMPLETED|14 Day Washout Period||2
8715265|NCT00983294|9762094|FG000|STARTED|Azithromycin Alone||22
8715266|NCT00983294|9762094|FG000|COMPLETED|Azithromycin Alone||22
8715267|NCT00983294|9762094|FG000|NOT COMPLETED|Azithromycin Alone||0
8715268|NCT00983294|9762094|FG000|STARTED|Colchicine With Azithromycin||22
8715269|NCT00983294|9762094|FG000|COMPLETED|Colchicine With Azithromycin|withdrawn by sponsor on Day 21 due to vomiting on Day 15, prior to azithromycin dosing(1)|21
8715270|NCT00983294|9762094|FG000|NOT COMPLETED|Colchicine With Azithromycin||1
8715271|NCT00983307|9762101|FG000|STARTED|Overall Study||17
8715272|NCT00983307|9762101|FG000|COMPLETED|Overall Study||17
8715273|NCT00983307|9762101|FG000|NOT COMPLETED|Overall Study||0
8715274|NCT00983346|9762105|FG000|STARTED|Overall Study||17
8715275|NCT00983346|9762105|FG000|COMPLETED|Overall Study||17
8715276|NCT00983346|9762105|FG000|NOT COMPLETED|Overall Study||0
8715277|NCT00983359|9762109|FG000|STARTED|Overall Study||40
8715278|NCT00983359|9762109|FG000|Not Eligible for Analysis|Overall Study||1
8715279|NCT00983359|9762109|FG000|COMPLETED|Overall Study||39
8715280|NCT00983359|9762109|FG000|NOT COMPLETED|Overall Study||1
8715281|NCT00983372|9762113|FG000|STARTED|Colchicine Alone||24
8715282|NCT00983372|9762113|FG000|COMPLETED|Colchicine Alone||24
8715283|NCT00983372|9762113|FG000|NOT COMPLETED|Colchicine Alone||0
8715284|NCT00983372|9762113|FG000|STARTED|14 Day Washout Period||24
8715285|NCT00983372|9762113|FG000|COMPLETED|14 Day Washout Period|subject withdrew consent due to schedule conflict - during washout period or diltiazem alone|23
8715286|NCT00983372|9762113|FG000|NOT COMPLETED|14 Day Washout Period||1
8715287|NCT00983372|9762113|FG000|STARTED|Diltiazem ER Alone||23
8715288|NCT00983372|9762113|FG000|COMPLETED|Diltiazem ER Alone|two subjects dropped due to missed diltiazem ER dose; one subject dropped due to vomitting|20
8715289|NCT00983372|9762113|FG000|NOT COMPLETED|Diltiazem ER Alone||3
8715290|NCT00983372|9762113|FG000|STARTED|Colchicine With Diltiazem ER||20
8715291|NCT00983372|9762113|FG000|COMPLETED|Colchicine With Diltiazem ER||20
8715292|NCT00983372|9762113|FG000|NOT COMPLETED|Colchicine With Diltiazem ER||0
8715293|NCT00983385|9762120|FG000|STARTED|Observation Period||208
8715294|NCT00983385|9762120|FG000|COMPLETED|Observation Period||176
8715295|NCT00983385|9762120|FG000|NOT COMPLETED|Observation Period||32
8715296|NCT00983385|9762120|FG000|STARTED|Titration and Optimal Dose Period||176
8715297|NCT00983385|9762120|FG000|COMPLETED|Titration and Optimal Dose Period||140
8715298|NCT00983385|9762120|FG000|NOT COMPLETED|Titration and Optimal Dose Period||36
8715299|NCT00983385|9762120|FG000|STARTED|Maintenance Period||140
8715300|NCT00983385|9762120|FG000|COMPLETED|Maintenance Period||117
8715301|NCT00983385|9762120|FG000|NOT COMPLETED|Maintenance Period||23
8715302|NCT00983476|9762142|FG000|STARTED|Overall Study||95
8715303|NCT00983476|9762143|FG001|STARTED|Overall Study||93
8715304|NCT00983476|9762144|FG002|STARTED|Overall Study||88
8715305|NCT00983476|9762142|FG000|6 Month Follow up Assessment|Overall Study||71
8715306|NCT00983476|9762143|FG001|6 Month Follow up Assessment|Overall Study||62
8715307|NCT00983476|9762144|FG002|6 Month Follow up Assessment|Overall Study||74
8715308|NCT00983476|9762142|FG000|COMPLETED|Overall Study||78
8715309|NCT00983476|9762143|FG001|COMPLETED|Overall Study||71
8715310|NCT00983476|9762144|FG002|COMPLETED|Overall Study||88
8715311|NCT00983476|9762142|FG000|NOT COMPLETED|Overall Study||17
8715312|NCT00983476|9762143|FG001|NOT COMPLETED|Overall Study||22
8715313|NCT00983476|9762144|FG002|NOT COMPLETED|Overall Study||0
8715314|NCT00983489|9762161|FG000|STARTED|Overall Study||511
8715315|NCT00983489|9762162|FG001|STARTED|Overall Study||453
8715316|NCT00983489|9762163|FG002|STARTED|Overall Study||447
8609008|NCT00409578|9646074|FG000|COMPLETED|Overall Study||228
8609009|NCT00409578|9646075|FG001|COMPLETED|Overall Study||201
8609010|NCT00409578|9646076|FG002|COMPLETED|Overall Study||215
8609011|NCT00409578|9646077|FG003|COMPLETED|Overall Study||214
8609012|NCT00409578|9646074|FG000|NOT COMPLETED|Overall Study||52
8609013|NCT00409578|9646075|FG001|NOT COMPLETED|Overall Study||70
8609014|NCT00409578|9646076|FG002|NOT COMPLETED|Overall Study||54
8609015|NCT00409578|9646077|FG003|NOT COMPLETED|Overall Study||67
8609016|NCT00409617|9646087|FG000|STARTED|Overall Study||945
8609017|NCT00409617|9646087|FG000|COMPLETED|Overall Study||785
8609018|NCT00409617|9646087|FG000|NOT COMPLETED|Overall Study||160
8609019|NCT00409682|9646094|FG000|STARTED|Open-label Induction Period||192
8609020|NCT00409682|9646095|FG001|STARTED|Open-label Induction Period||0
8609021|NCT00409682|9646096|FG002|STARTED|Open-label Induction Period||0
8609022|NCT00409682|9646094|FG000|COMPLETED|Open-label Induction Period||188
8609023|NCT00409682|9646095|FG001|COMPLETED|Open-label Induction Period||0
8609024|NCT00409682|9646096|FG002|COMPLETED|Open-label Induction Period||0
8609025|NCT00409682|9646094|FG000|NOT COMPLETED|Open-label Induction Period||4
8609026|NCT00409682|9646095|FG001|NOT COMPLETED|Open-label Induction Period||0
8609027|NCT00409682|9646096|FG002|NOT COMPLETED|Open-label Induction Period||0
8609028|NCT00409682|9646094|FG000|STARTED|EOW Double-blind Maintenance Period||0
8609029|NCT00409682|9646095|FG001|STARTED|EOW Double-blind Maintenance Period||95
8609030|NCT00409682|9646096|FG002|STARTED|EOW Double-blind Maintenance Period||93
8609031|NCT00409682|9646094|FG000|COMPLETED|EOW Double-blind Maintenance Period||0
8609032|NCT00409682|9646095|FG001|COMPLETED|EOW Double-blind Maintenance Period||58
8609033|NCT00409682|9646096|FG002|COMPLETED|EOW Double-blind Maintenance Period||66
8609034|NCT00409682|9646094|FG000|NOT COMPLETED|EOW Double-blind Maintenance Period||0
8609035|NCT00409682|9646095|FG001|NOT COMPLETED|EOW Double-blind Maintenance Period||37
8715317|NCT00983489|9762161|FG000|COMPLETED|Overall Study||326
8715318|NCT00983489|9762162|FG001|COMPLETED|Overall Study||168
8715319|NCT00983489|9762163|FG002|COMPLETED|Overall Study||135
8715320|NCT00983489|9762161|FG000|NOT COMPLETED|Overall Study||185
8715321|NCT00983489|9762162|FG001|NOT COMPLETED|Overall Study||285
8715322|NCT00983489|9762163|FG002|NOT COMPLETED|Overall Study||312
8715323|NCT00983515|9762171|FG000|STARTED|Colchicine Alone||24
8715324|NCT00983515|9762171|FG000|COMPLETED|Colchicine Alone||24
8715325|NCT00983515|9762171|FG000|NOT COMPLETED|Colchicine Alone||0
8715326|NCT00983515|9762171|FG000|STARTED|14 Day Washout Period||24
8715327|NCT00983515|9762171|FG000|COMPLETED|14 Day Washout Period||24
8715328|NCT00983515|9762171|FG000|NOT COMPLETED|14 Day Washout Period||0
8715329|NCT00983515|9762171|FG000|STARTED|Ritonavir Alone||24
8715330|NCT00983515|9762171|FG000|COMPLETED|Ritonavir Alone||18
8715331|NCT00983515|9762171|FG000|NOT COMPLETED|Ritonavir Alone||6
8715332|NCT00983515|9762171|FG000|STARTED|Colchicine With Ritonavir||18
8715333|NCT00983515|9762171|FG000|COMPLETED|Colchicine With Ritonavir|pharmacokinetic data included since parameters could be estimated for both dosing conditions|17
8715334|NCT00983515|9762171|FG000|NOT COMPLETED|Colchicine With Ritonavir||1
8715335|NCT00983528|9762178|FG000|STARTED|Overall Study||6
8715336|NCT00983528|9762178|FG000|COMPLETED|Overall Study||0
8715337|NCT00983528|9762178|FG000|NOT COMPLETED|Overall Study||6
8715338|NCT00983541|9762182|FG000|STARTED|Overall Study||1
8715339|NCT00983541|9762182|FG000|COMPLETED|Overall Study||1
8715340|NCT00983541|9762182|FG000|NOT COMPLETED|Overall Study||0
8715341|NCT00983580|9762188|FG000|STARTED|Overall Study||54
8715342|NCT00983580|9762189|FG001|STARTED|Overall Study||53
8715343|NCT00983580|9762188|FG000|COMPLETED|Overall Study||49
8715344|NCT00983580|9762189|FG001|COMPLETED|Overall Study||49
8715345|NCT00983580|9762188|FG000|NOT COMPLETED|Overall Study||5
8715346|NCT00983580|9762189|FG001|NOT COMPLETED|Overall Study||4
8715347|NCT00983619|9762208|FG000|STARTED|Overall Study||3
8715348|NCT00983619|9762209|FG001|STARTED|Overall Study||4
8715349|NCT00983619|9762210|FG002|STARTED|Overall Study||3
8715350|NCT00983619|9762211|FG003|STARTED|Overall Study||6
8715351|NCT00983619|9762212|FG004|STARTED|Overall Study||3
8715352|NCT00983619|9762213|FG005|STARTED|Overall Study||76
8715353|NCT00983619|9762214|FG006|STARTED|Overall Study||3
8715354|NCT00983619|9762215|FG007|STARTED|Overall Study||3
8715355|NCT00983619|9762216|FG008|STARTED|Overall Study||1
8715356|NCT00983619|9762217|FG009|STARTED|Overall Study||3
8715357|NCT00983619|9762218|FG010|STARTED|Overall Study||17
8715358|NCT00983619|9762219|FG011|STARTED|Overall Study||14
8715359|NCT00983619|9762208|FG000|COMPLETED|Overall Study||0
8715360|NCT00983619|9762209|FG001|COMPLETED|Overall Study||0
8715361|NCT00983619|9762210|FG002|COMPLETED|Overall Study||0
8715362|NCT00983619|9762211|FG003|COMPLETED|Overall Study||1
8715363|NCT00983619|9762212|FG004|COMPLETED|Overall Study||0
8715364|NCT00983619|9762213|FG005|COMPLETED|Overall Study||9
8715365|NCT00983619|9762214|FG006|COMPLETED|Overall Study||0
8715366|NCT00983619|9762215|FG007|COMPLETED|Overall Study||1
8715367|NCT00983619|9762216|FG008|COMPLETED|Overall Study||0
8715368|NCT00983619|9762217|FG009|COMPLETED|Overall Study||0
8715369|NCT00983619|9762218|FG010|COMPLETED|Overall Study||6
8715370|NCT00983619|9762219|FG011|COMPLETED|Overall Study||3
8715371|NCT00983619|9762208|FG000|NOT COMPLETED|Overall Study||3
8715372|NCT00983619|9762209|FG001|NOT COMPLETED|Overall Study||4
8715373|NCT00983619|9762210|FG002|NOT COMPLETED|Overall Study||3
8715374|NCT00983619|9762211|FG003|NOT COMPLETED|Overall Study||5
8609036|NCT00409682|9646096|FG002|NOT COMPLETED|EOW Double-blind Maintenance Period||27
8609037|NCT00409708|9646105|FG000|STARTED|Treatment|A total of 142 participants were screened for the study but only 109 were randomized to treatment|53
8715375|NCT00983619|9762212|FG004|NOT COMPLETED|Overall Study||3
8715376|NCT00983619|9762213|FG005|NOT COMPLETED|Overall Study||67
8715377|NCT00983619|9762214|FG006|NOT COMPLETED|Overall Study||3
8715378|NCT00983619|9762215|FG007|NOT COMPLETED|Overall Study||2
8715379|NCT00983619|9762216|FG008|NOT COMPLETED|Overall Study||1
8715380|NCT00983619|9762217|FG009|NOT COMPLETED|Overall Study||3
8715381|NCT00983619|9762218|FG010|NOT COMPLETED|Overall Study||11
8715382|NCT00983619|9762219|FG011|NOT COMPLETED|Overall Study||11
8715383|NCT00983749|9762267|FG000|STARTED|Acute Phase (Enrollment to Hospital DC)||13
8715384|NCT00983749|9762268|FG001|STARTED|Acute Phase (Enrollment to Hospital DC)||10
8715385|NCT00983749|9762267|FG000|COMPLETED|Acute Phase (Enrollment to Hospital DC)||13
8715386|NCT00983749|9762268|FG001|COMPLETED|Acute Phase (Enrollment to Hospital DC)||10
8715387|NCT00983749|9762267|FG000|NOT COMPLETED|Acute Phase (Enrollment to Hospital DC)||0
8715388|NCT00983749|9762268|FG001|NOT COMPLETED|Acute Phase (Enrollment to Hospital DC)||0
8715389|NCT00983749|9762267|FG000|STARTED|Follow-up Phase (Hospital DC to 30 Days)||13
8715390|NCT00983749|9762268|FG001|STARTED|Follow-up Phase (Hospital DC to 30 Days)||10
8715391|NCT00983749|9762267|FG000|COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||12
8715392|NCT00983749|9762268|FG001|COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||7
8715393|NCT00983749|9762267|FG000|NOT COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||1
8715394|NCT00983749|9762268|FG001|NOT COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||3
8715395|NCT00983801|9762274|FG000|STARTED|Overall Study|Participants who received treatment.|52
8715396|NCT00983801|9762274|FG000|COMPLETED|Overall Study|Participants who were taken off treatment.|52
8715397|NCT00983801|9762274|FG000|NOT COMPLETED|Overall Study||0
8715398|NCT00983827|9762278|FG000|STARTED|Overall Study||8
8715399|NCT00983827|9762278|FG000|COMPLETED|Overall Study||7
8715400|NCT00983827|9762278|FG000|NOT COMPLETED|Overall Study||1
8715401|NCT00983853|9762288|FG000|STARTED|Overall Study||7
8715402|NCT00983853|9762289|FG001|STARTED|Overall Study|1 subject was randomized but not dosed|7
8715403|NCT00983853|9762290|FG002|STARTED|Overall Study|1 subject was randomized but not dosed|17
8715404|NCT00983853|9762291|FG003|STARTED|Overall Study||8
8715405|NCT00983853|9762292|FG004|STARTED|Overall Study||15
8715406|NCT00983853|9762293|FG005|STARTED|Overall Study||8
8715407|NCT00983853|9762288|FG000|COMPLETED|Overall Study||6
8715408|NCT00983853|9762289|FG001|COMPLETED|Overall Study||5
8715409|NCT00983853|9762290|FG002|COMPLETED|Overall Study||14
8715410|NCT00983853|9762291|FG003|COMPLETED|Overall Study||6
8715411|NCT00983853|9762292|FG004|COMPLETED|Overall Study||12
8715412|NCT00983853|9762293|FG005|COMPLETED|Overall Study||7
8715413|NCT00983853|9762288|FG000|NOT COMPLETED|Overall Study||1
8715414|NCT00983853|9762289|FG001|NOT COMPLETED|Overall Study||2
8715415|NCT00983853|9762290|FG002|NOT COMPLETED|Overall Study||3
8715416|NCT00983853|9762291|FG003|NOT COMPLETED|Overall Study||2
8715417|NCT00983853|9762292|FG004|NOT COMPLETED|Overall Study||3
8715418|NCT00983853|9762293|FG005|NOT COMPLETED|Overall Study||1
8715419|NCT00983892|9762311|FG000|STARTED|Overall Study||66
8715420|NCT00983892|9762312|FG001|STARTED|Overall Study||68
8715421|NCT00983892|9762311|FG000|COMPLETED|Overall Study||56
8715422|NCT00983892|9762312|FG001|COMPLETED|Overall Study||56
8715423|NCT00983892|9762311|FG000|NOT COMPLETED|Overall Study||10
8715424|NCT00983892|9762312|FG001|NOT COMPLETED|Overall Study||12
8715425|NCT00983905|9762318|FG000|STARTED|Theophylline Alone||30
8715426|NCT00983905|9762318|FG000|COMPLETED|Theophylline Alone|withdrawn by sponsor due to vomiting(1)|29
8715427|NCT00983905|9762318|FG000|NOT COMPLETED|Theophylline Alone||1
8715428|NCT00983905|9762318|FG000|STARTED|4 Day Washout Period||29
8715429|NCT00983905|9762318|FG000|COMPLETED|4 Day Washout Period||29
8715430|NCT00983905|9762318|FG000|NOT COMPLETED|4 Day Washout Period||0
8715431|NCT00983905|9762318|FG000|STARTED|Colchicine Alone||29
8715432|NCT00983905|9762318|FG000|COMPLETED|Colchicine Alone|withdrawn by sponsor due to: diarrhea(1); vomiting and diarrhea(1)|27
8715433|NCT00983905|9762318|FG000|NOT COMPLETED|Colchicine Alone||2
8715434|NCT00983905|9762318|FG000|STARTED|Theophylline With Colchicine||27
8715435|NCT00983905|9762318|FG000|COMPLETED|Theophylline With Colchicine||27
8715436|NCT00983905|9762318|FG000|NOT COMPLETED|Theophylline With Colchicine||0
8715437|NCT00983918|9762329|FG000|STARTED|Overall Study||20
8715438|NCT00983918|9762330|FG001|STARTED|Overall Study||20
8715439|NCT00983918|9762331|FG002|STARTED|Overall Study||20
8715440|NCT00983918|9762332|FG003|STARTED|Overall Study||20
8715441|NCT00983918|9762329|FG000|COMPLETED|Overall Study||20
8715442|NCT00983918|9762330|FG001|COMPLETED|Overall Study||18
8715443|NCT00983918|9762331|FG002|COMPLETED|Overall Study||18
8715444|NCT00983918|9762332|FG003|COMPLETED|Overall Study||18
8715445|NCT00983918|9762329|FG000|NOT COMPLETED|Overall Study||0
8715446|NCT00983918|9762330|FG001|NOT COMPLETED|Overall Study||2
8715447|NCT00983918|9762331|FG002|NOT COMPLETED|Overall Study||2
8715448|NCT00983918|9762332|FG003|NOT COMPLETED|Overall Study||2
8715449|NCT00983931|9762342|FG000|STARTED|Colchicine Alone||24
8715450|NCT00983931|9762342|FG000|COMPLETED|Colchicine Alone||24
8715451|NCT00983931|9762342|FG000|NOT COMPLETED|Colchicine Alone||0
8715452|NCT00983931|9762342|FG000|STARTED|14 Day Washout Period||24
8715453|NCT00983931|9762342|FG000|COMPLETED|14 Day Washout Period|one subject withdrawn due to creatine kinase out of range|23
8715454|NCT00983931|9762342|FG000|NOT COMPLETED|14 Day Washout Period||1
8715455|NCT00983931|9762342|FG000|STARTED|Colchicine With Cyclosporine||23
8715456|NCT00983931|9762342|FG000|COMPLETED|Colchicine With Cyclosporine||23
8715457|NCT00983931|9762342|FG000|NOT COMPLETED|Colchicine With Cyclosporine||0
8715458|NCT00983957|9762348|FG000|STARTED|Overall Study||20
8715459|NCT00983957|9762348|FG000|Treatment A|Overall Study||20
8715460|NCT00983957|9762348|FG000|Treatment B|Overall Study||20
8715461|NCT00983957|9762348|FG000|Treatment C|Overall Study||18
8715462|NCT00983957|9762348|FG000|COMPLETED|Overall Study||18
8715463|NCT00983957|9762348|FG000|NOT COMPLETED|Overall Study||2
8724902|NCT01028911|9772210|FG000|NOT COMPLETED|Overall Study||0
8724903|NCT01028911|9772211|FG001|NOT COMPLETED|Overall Study||0
8609038|NCT00409708|9646106|FG001|STARTED|Treatment||56
8609039|NCT00409708|9646105|FG000|COMPLETED|Treatment||38
8609040|NCT00409708|9646106|FG001|COMPLETED|Treatment||39
8609041|NCT00409708|9646105|FG000|NOT COMPLETED|Treatment||15
8609042|NCT00409708|9646106|FG001|NOT COMPLETED|Treatment||17
8609043|NCT00409708|9646105|FG000|STARTED|Washout||38
8609044|NCT00409708|9646106|FG001|STARTED|Washout||39
8609045|NCT00409708|9646105|FG000|COMPLETED|Washout||17
8609046|NCT00409708|9646106|FG001|COMPLETED|Washout||29
8609047|NCT00409708|9646105|FG000|NOT COMPLETED|Washout||21
8609048|NCT00409708|9646106|FG001|NOT COMPLETED|Washout||10
8609049|NCT00409747|9646112|FG000|STARTED|Overall Study||11
8609050|NCT00409747|9646112|FG000|COMPLETED|Overall Study||10
8609051|NCT00409747|9646112|FG000|NOT COMPLETED|Overall Study||1
8609052|NCT00409786|9646116|FG000|STARTED|Overall Study||50
8609053|NCT00409786|9646116|FG000|COMPLETED|Overall Study||47
8609054|NCT00409786|9646116|FG000|NOT COMPLETED|Overall Study||3
8609055|NCT00409825|9646120|FG000|STARTED|Overall Study||61
8609056|NCT00409825|9646120|FG000|COMPLETED|Overall Study||61
8609057|NCT00409825|9646120|FG000|NOT COMPLETED|Overall Study||0
8609058|NCT00409838|9646126|FG000|STARTED|Short-term Period|Randomized|56
8609059|NCT00409838|9646127|FG001|STARTED|Short-term Period|Randomized|57
8609060|NCT00409838|9646126|FG000|Treated (Baseline) Population|Short-term Period||55
8609061|NCT00409838|9646127|FG001|Treated (Baseline) Population|Short-term Period||57
8609062|NCT00409838|9646126|FG000|COMPLETED|Short-term Period||53
8609063|NCT00409838|9646127|FG001|COMPLETED|Short-term Period|Participants who received placebo in this period received abatacept in next period.|52
8609064|NCT00409838|9646126|FG000|NOT COMPLETED|Short-term Period||3
8609065|NCT00409838|9646127|FG001|NOT COMPLETED|Short-term Period||5
8609066|NCT00409838|9646126|FG000|STARTED|Long-term Extension Period||105
8609067|NCT00409838|9646127|FG001|STARTED|Long-term Extension Period||0
8609068|NCT00409838|9646126|FG000|COMPLETED|Long-term Extension Period||87
8609069|NCT00409838|9646127|FG001|COMPLETED|Long-term Extension Period||0
8609070|NCT00409838|9646126|FG000|NOT COMPLETED|Long-term Extension Period||18
8609071|NCT00409838|9646127|FG001|NOT COMPLETED|Long-term Extension Period||0
8609072|NCT00410046|9646150|FG000|STARTED|Overall Study||84
8609073|NCT00410046|9646150|FG000|COMPLETED|Overall Study||79
8609074|NCT00410046|9646150|FG000|NOT COMPLETED|Overall Study||5
8609075|NCT00410059|9646155|FG000|STARTED|Overall Study||59
8609076|NCT00410059|9646155|FG000|COMPLETED|Overall Study||59
8609077|NCT00410059|9646155|FG000|NOT COMPLETED|Overall Study||0
8609078|NCT00410072|9646161|FG000|STARTED|Day 1 to Week 48|Number of participants randomized and treated; 4 more were randomized but not treated.|182
8609079|NCT00410072|9646162|FG001|STARTED|Day 1 to Week 48|Number of participants randomized and treated; 1 more was randomized but not treated.|197
8609080|NCT00410072|9646161|FG000|COMPLETED|Day 1 to Week 48||176
8609081|NCT00410072|9646162|FG001|COMPLETED|Day 1 to Week 48||185
8609082|NCT00410072|9646161|FG000|NOT COMPLETED|Day 1 to Week 48||6
8609083|NCT00410072|9646162|FG001|NOT COMPLETED|Day 1 to Week 48||12
8609084|NCT00410072|9646161|FG000|STARTED|After Week 48 to Week 96||176
8609085|NCT00410072|9646162|FG001|STARTED|After Week 48 to Week 96||185
8609086|NCT00410072|9646161|FG000|COMPLETED|After Week 48 to Week 96||170
8609087|NCT00410072|9646162|FG001|COMPLETED|After Week 48 to Week 96||174
8609088|NCT00410072|9646161|FG000|NOT COMPLETED|After Week 48 to Week 96||6
8609089|NCT00410072|9646162|FG001|NOT COMPLETED|After Week 48 to Week 96||11
8609090|NCT00410124|9646170|FG000|STARTED|Core Phase Double Blind (15 Months)|Started indicates randomized (FAS) and treated|277
8609091|NCT00410124|9646171|FG001|STARTED|Core Phase Double Blind (15 Months)||139
8609092|NCT00410124|9646170|FG000|Ongoing|Core Phase Double Blind (15 Months)||13
8609093|NCT00410124|9646171|FG001|Ongoing|Core Phase Double Blind (15 Months)||4
8609094|NCT00410124|9646170|FG000|Completed Double Blind Treatment|Core Phase Double Blind (15 Months)||62
8609095|NCT00410124|9646171|FG001|Completed Double Blind Treatment|Core Phase Double Blind (15 Months)||2
8609096|NCT00410124|9646170|FG000|COMPLETED|Core Phase Double Blind (15 Months)|Patients ongoing/completed double blind phase had option entering extension phase continuing RAD001.|75
8609097|NCT00410124|9646171|FG001|COMPLETED|Core Phase Double Blind (15 Months)|All patients ongoing/completed/not completed in core had option to enter extension taking RAD001.|6
8609098|NCT00410124|9646170|FG000|NOT COMPLETED|Core Phase Double Blind (15 Months)||202
8609099|NCT00410124|9646171|FG001|NOT COMPLETED|Core Phase Double Blind (15 Months)||133
8609100|NCT00410124|9646170|FG000|STARTED|Extension Phase - Open Label (45 Months)||67
8609101|NCT00410124|9646171|FG001|STARTED|Extension Phase - Open Label (45 Months)|Patients on placebo in core received RAD001 in extension phase.|111
8609102|NCT00410124|9646170|FG000|COMPLETED|Extension Phase - Open Label (45 Months)||0
8609103|NCT00410124|9646171|FG001|COMPLETED|Extension Phase - Open Label (45 Months)||0
8609104|NCT00410124|9646170|FG000|NOT COMPLETED|Extension Phase - Open Label (45 Months)||67
8609105|NCT00410124|9646171|FG001|NOT COMPLETED|Extension Phase - Open Label (45 Months)||111
8609106|NCT00410150|9646183|FG000|STARTED|Overall Study||22
8609107|NCT00410150|9646184|FG001|STARTED|Overall Study||20
8609108|NCT00410150|9646183|FG000|COMPLETED|Overall Study|2 study withdrawals (analyzed by intention-to-treat)|20
8609109|NCT00410150|9646184|FG001|COMPLETED|Overall Study|3 study withdrawals (analyzed by intention-to-treat0|17
8609110|NCT00410150|9646183|FG000|NOT COMPLETED|Overall Study||2
8609111|NCT00410150|9646184|FG001|NOT COMPLETED|Overall Study||3
8609112|NCT00410163|9646192|FG000|STARTED|Treatment and Follow-up Phase (2 Years)||31
8609113|NCT00410163|9646193|FG001|STARTED|Treatment and Follow-up Phase (2 Years)||30
8609114|NCT00410163|9646192|FG000|COMPLETED|Treatment and Follow-up Phase (2 Years)||19
8609115|NCT00410163|9646193|FG001|COMPLETED|Treatment and Follow-up Phase (2 Years)||19
8609116|NCT00410163|9646192|FG000|NOT COMPLETED|Treatment and Follow-up Phase (2 Years)||12
8609117|NCT00410163|9646193|FG001|NOT COMPLETED|Treatment and Follow-up Phase (2 Years)||11
8609118|NCT00410163|9646192|FG000|STARTED|Extended Follow-up (FU) Phase (2-5 Years|Participants who withdrew from the Treatment Phase were eligible to enter the Extended FU Phase.|20
8609119|NCT00410163|9646193|FG001|STARTED|Extended Follow-up (FU) Phase (2-5 Years|Participants who withdrew from the Treatment Phase were eligible to enter the Extended FU Phase.|21
8609120|NCT00410163|9646192|FG000|COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||10
8609121|NCT00410163|9646193|FG001|COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||11
8609122|NCT00410163|9646192|FG000|NOT COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||10
8609123|NCT00410163|9646193|FG001|NOT COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||10
8609124|NCT00410189|9646203|FG000|STARTED|Overall Study||54
8609125|NCT00410189|9646203|FG000|COMPLETED|Overall Study||54
8609126|NCT00410189|9646203|FG000|NOT COMPLETED|Overall Study||0
8609127|NCT00410202|9646210|FG000|STARTED|On-Treatment||138
8609128|NCT00410202|9646211|FG001|STARTED|On-Treatment||140
8609129|NCT00410202|9646212|FG002|STARTED|On-Treatment||137
8609130|NCT00410202|9646210|FG000|Discontinued Prior to Week 48 Visit|On-Treatment||4
8609131|NCT00410202|9646211|FG001|Discontinued Prior to Week 48 Visit|On-Treatment||2
8609132|NCT00410202|9646212|FG002|Discontinued Prior to Week 48 Visit|On-Treatment||2
8609133|NCT00410202|9646210|FG000|Discontinued at or After Week 48 Visit|On-Treatment||2
8609134|NCT00410202|9646211|FG001|Discontinued at or After Week 48 Visit|On-Treatment||6
8609135|NCT00410202|9646212|FG002|Discontinued at or After Week 48 Visit|On-Treatment||3
8609136|NCT00410202|9646210|FG000|COMPLETED|On-Treatment|Completed the 100 week dosing|63
8609137|NCT00410202|9646211|FG001|COMPLETED|On-Treatment|Completed the 100 week dosing|61
8609138|NCT00410202|9646212|FG002|COMPLETED|On-Treatment|Completed the 100 week dosing|66
8609139|NCT00410202|9646210|FG000|NOT COMPLETED|On-Treatment||75
8609140|NCT00410202|9646211|FG001|NOT COMPLETED|On-Treatment||79
8609141|NCT00410202|9646212|FG002|NOT COMPLETED|On-Treatment||71
8609142|NCT00410202|9646210|FG000|STARTED|Off-treatment Follow up||15
8609143|NCT00410202|9646211|FG001|STARTED|Off-treatment Follow up||8
8609144|NCT00410202|9646212|FG002|STARTED|Off-treatment Follow up||14
8609145|NCT00410202|9646210|FG000|COMPLETED|Off-treatment Follow up||1
8609146|NCT00410202|9646211|FG001|COMPLETED|Off-treatment Follow up||0
8609147|NCT00410202|9646212|FG002|COMPLETED|Off-treatment Follow up||2
8609148|NCT00410202|9646210|FG000|NOT COMPLETED|Off-treatment Follow up||14
8609149|NCT00410202|9646211|FG001|NOT COMPLETED|Off-treatment Follow up||8
8609150|NCT00410202|9646212|FG002|NOT COMPLETED|Off-treatment Follow up||12
8609151|NCT00410280|9646223|FG000|STARTED|Overall Study||14
8609152|NCT00410280|9646224|FG001|STARTED|Overall Study||13
8609153|NCT00410280|9646223|FG000|COMPLETED|Overall Study||14
8609154|NCT00410280|9646224|FG001|COMPLETED|Overall Study||13
8609155|NCT00410280|9646223|FG000|NOT COMPLETED|Overall Study||0
8609156|NCT00410280|9646224|FG001|NOT COMPLETED|Overall Study||0
8609157|NCT00410384|9646233|FG000|STARTED|Overall Study||275
8609158|NCT00410384|9646234|FG001|STARTED|Overall Study||271
8609159|NCT00410384|9646235|FG002|STARTED|Overall Study||273
8609160|NCT00410384|9646233|FG000|COMPLETED|Overall Study||186
8609161|NCT00410384|9646234|FG001|COMPLETED|Overall Study||199
8609162|NCT00410384|9646235|FG002|COMPLETED|Overall Study||191
8609163|NCT00410384|9646233|FG000|NOT COMPLETED|Overall Study||89
8609164|NCT00410384|9646234|FG001|NOT COMPLETED|Overall Study||72
8609165|NCT00410384|9646235|FG002|NOT COMPLETED|Overall Study||82
8609166|NCT00410410|9646249|FG000|STARTED|Induction Period (IP)||141
8609167|NCT00410410|9646250|FG001|STARTED|Induction Period (IP)||139
8609168|NCT00410410|9646251|FG002|STARTED|Induction Period (IP)||70
8609169|NCT00410410|9646252|FG003|STARTED|Induction Period (IP)||140
8609170|NCT00410410|9646253|FG004|STARTED|Induction Period (IP)||51
8609171|NCT00410410|9646254|FG005|STARTED|Induction Period (IP)||50
8609172|NCT00410410|9646255|FG006|STARTED|Induction Period (IP)||0
8609173|NCT00410410|9646256|FG007|STARTED|Induction Period (IP)||0
8609174|NCT00410410|9646257|FG008|STARTED|Induction Period (IP)||0
8609175|NCT00410410|9646249|FG000|COMPLETED|Induction Period (IP)||106
8609176|NCT00410410|9646250|FG001|COMPLETED|Induction Period (IP)||104
8609177|NCT00410410|9646251|FG002|COMPLETED|Induction Period (IP)||53
8609178|NCT00410410|9646252|FG003|COMPLETED|Induction Period (IP)||120
8609179|NCT00410410|9646253|FG004|COMPLETED|Induction Period (IP)||19
8715464|NCT00983983|9762361|FG000|STARTED|Overall Study||8
8715465|NCT00983983|9762362|FG001|STARTED|Overall Study||9
8715466|NCT00983983|9762363|FG002|STARTED|Overall Study||7
8715467|NCT00983983|9762361|FG000|COMPLETED|Overall Study||6
8715468|NCT00983983|9762362|FG001|COMPLETED|Overall Study||8
8715469|NCT00983983|9762363|FG002|COMPLETED|Overall Study||6
8715470|NCT00983983|9762361|FG000|NOT COMPLETED|Overall Study||2
8715471|NCT00983983|9762362|FG001|NOT COMPLETED|Overall Study||1
8715472|NCT00983983|9762363|FG002|NOT COMPLETED|Overall Study||1
8715473|NCT00984009|9762372|FG000|STARTED|Colchicine Alone||22
8715474|NCT00984009|9762372|FG000|COMPLETED|Colchicine Alone||22
8609180|NCT00410410|9646254|FG005|COMPLETED|Induction Period (IP)||21
8609181|NCT00410410|9646255|FG006|COMPLETED|Induction Period (IP)||0
8609182|NCT00410410|9646256|FG007|COMPLETED|Induction Period (IP)||0
8715475|NCT00984009|9762372|FG000|NOT COMPLETED|Colchicine Alone||0
8715476|NCT00984009|9762372|FG000|STARTED|14 Day Washout Period||22
8609183|NCT00410410|9646257|FG008|COMPLETED|Induction Period (IP)||0
8609184|NCT00410410|9646249|FG000|NOT COMPLETED|Induction Period (IP)||35
8609185|NCT00410410|9646250|FG001|NOT COMPLETED|Induction Period (IP)||35
8609186|NCT00410410|9646251|FG002|NOT COMPLETED|Induction Period (IP)||17
8609187|NCT00410410|9646252|FG003|NOT COMPLETED|Induction Period (IP)||20
8609188|NCT00410410|9646253|FG004|NOT COMPLETED|Induction Period (IP)||32
8609189|NCT00410410|9646254|FG005|NOT COMPLETED|Induction Period (IP)||29
8609190|NCT00410410|9646255|FG006|NOT COMPLETED|Induction Period (IP)||0
8609191|NCT00410410|9646256|FG007|NOT COMPLETED|Induction Period (IP)||0
8609192|NCT00410410|9646257|FG008|NOT COMPLETED|Induction Period (IP)||0
8609193|NCT00410410|9646249|FG000|STARTED|Maintenance Period (MP)||0
8609194|NCT00410410|9646250|FG001|STARTED|Maintenance Period (MP)||0
8609195|NCT00410410|9646251|FG002|STARTED|Maintenance Period (MP)||0
8609196|NCT00410410|9646252|FG003|STARTED|Maintenance Period (MP)||0
8609197|NCT00410410|9646253|FG004|STARTED|Maintenance Period (MP)||0
8609198|NCT00410410|9646254|FG005|STARTED|Maintenance Period (MP)||0
8609199|NCT00410410|9646255|FG006|STARTED|Maintenance Period (MP)|At end of IP, 65 participants met response criteria and were randomly assigned to abatacept in MP.|65
8609200|NCT00410410|9646256|FG007|STARTED|Maintenance Period (MP)|At end of IP, 66 participants met response criteria and were randomly assigned to placebo in MP.|66
8609201|NCT00410410|9646257|FG008|STARTED|Maintenance Period (MP)||0
8609202|NCT00410410|9646249|FG000|COMPLETED|Maintenance Period (MP)||0
8609203|NCT00410410|9646250|FG001|COMPLETED|Maintenance Period (MP)||0
8609204|NCT00410410|9646251|FG002|COMPLETED|Maintenance Period (MP)||0
8609205|NCT00410410|9646252|FG003|COMPLETED|Maintenance Period (MP)||0
8609206|NCT00410410|9646253|FG004|COMPLETED|Maintenance Period (MP)||0
8609207|NCT00410410|9646254|FG005|COMPLETED|Maintenance Period (MP)||0
8609208|NCT00410410|9646255|FG006|COMPLETED|Maintenance Period (MP)||15
8609209|NCT00410410|9646256|FG007|COMPLETED|Maintenance Period (MP)||11
8609210|NCT00410410|9646257|FG008|COMPLETED|Maintenance Period (MP)||0
8609211|NCT00410410|9646249|FG000|NOT COMPLETED|Maintenance Period (MP)||0
8609212|NCT00410410|9646250|FG001|NOT COMPLETED|Maintenance Period (MP)||0
8609213|NCT00410410|9646251|FG002|NOT COMPLETED|Maintenance Period (MP)||0
8609214|NCT00410410|9646252|FG003|NOT COMPLETED|Maintenance Period (MP)||0
8609215|NCT00410410|9646253|FG004|NOT COMPLETED|Maintenance Period (MP)||0
8609216|NCT00410410|9646254|FG005|NOT COMPLETED|Maintenance Period (MP)||0
8609217|NCT00410410|9646255|FG006|NOT COMPLETED|Maintenance Period (MP)||50
8609218|NCT00410410|9646256|FG007|NOT COMPLETED|Maintenance Period (MP)||55
8609219|NCT00410410|9646257|FG008|NOT COMPLETED|Maintenance Period (MP)||0
8609220|NCT00410410|9646249|FG000|STARTED|Open-Label Period (OL)||0
8609221|NCT00410410|9646250|FG001|STARTED|Open-Label Period (OL)||0
8609222|NCT00410410|9646251|FG002|STARTED|Open-Label Period (OL)||0
8609223|NCT00410410|9646252|FG003|STARTED|Open-Label Period (OL)||0
8609224|NCT00410410|9646253|FG004|STARTED|Open-Label Period (OL)||0
8609225|NCT00410410|9646254|FG005|STARTED|Open-Label Period (OL)||0
8609226|NCT00410410|9646255|FG006|STARTED|Open-Label Period (OL)||0
8609227|NCT00410410|9646256|FG007|STARTED|Open-Label Period (OL)||0
8609228|NCT00410410|9646257|FG008|STARTED|Open-Label Period (OL)|349 entered OL (those who completed IP but failed response criteria, or completed/relapsed on MP).|349
8609229|NCT00410410|9646249|FG000|COMPLETED|Open-Label Period (OL)||0
8609230|NCT00410410|9646250|FG001|COMPLETED|Open-Label Period (OL)||0
8609231|NCT00410410|9646251|FG002|COMPLETED|Open-Label Period (OL)||0
8609232|NCT00410410|9646252|FG003|COMPLETED|Open-Label Period (OL)||0
8609233|NCT00410410|9646253|FG004|COMPLETED|Open-Label Period (OL)||0
8609234|NCT00410410|9646254|FG005|COMPLETED|Open-Label Period (OL)||0
8609235|NCT00410410|9646255|FG006|COMPLETED|Open-Label Period (OL)||0
8609236|NCT00410410|9646256|FG007|COMPLETED|Open-Label Period (OL)||0
8609237|NCT00410410|9646257|FG008|COMPLETED|Open-Label Period (OL)||0
8609238|NCT00410410|9646249|FG000|NOT COMPLETED|Open-Label Period (OL)||0
8609239|NCT00410410|9646250|FG001|NOT COMPLETED|Open-Label Period (OL)||0
8609240|NCT00410410|9646251|FG002|NOT COMPLETED|Open-Label Period (OL)||0
8609241|NCT00410410|9646252|FG003|NOT COMPLETED|Open-Label Period (OL)||0
8609242|NCT00410410|9646253|FG004|NOT COMPLETED|Open-Label Period (OL)||0
8609243|NCT00410410|9646254|FG005|NOT COMPLETED|Open-Label Period (OL)||0
8609244|NCT00410410|9646255|FG006|NOT COMPLETED|Open-Label Period (OL)||0
8609245|NCT00410410|9646256|FG007|NOT COMPLETED|Open-Label Period (OL)||0
8609246|NCT00410410|9646257|FG008|NOT COMPLETED|Open-Label Period (OL)||349
8629117|NCT00528567|9668755|FG001|Safety Population|Overall Study||1271
8629118|NCT00528567|9668754|FG000|COMPLETED|Overall Study||870
8629119|NCT00528567|9668755|FG001|COMPLETED|Overall Study||982
8629120|NCT00528567|9668754|FG000|NOT COMPLETED|Overall Study||431
8629121|NCT00528567|9668755|FG001|NOT COMPLETED|Overall Study||308
8629122|NCT00528580|9668770|FG000|STARTED|Overall Study||34
8629123|NCT00528580|9668771|FG001|STARTED|Overall Study||34
8629124|NCT00528580|9668770|FG000|COMPLETED|Overall Study||34
8629125|NCT00528580|9668771|FG001|COMPLETED|Overall Study||34
8629126|NCT00528580|9668770|FG000|NOT COMPLETED|Overall Study||0
8629127|NCT00528580|9668771|FG001|NOT COMPLETED|Overall Study||0
8629128|NCT00528606|9668779|FG000|STARTED|Overall Study||204
8629129|NCT00528606|9668780|FG001|STARTED|Overall Study||104
8629130|NCT00528606|9668779|FG000|COMPLETED|Overall Study||191
8629131|NCT00528606|9668780|FG001|COMPLETED|Overall Study||100
8629132|NCT00528606|9668779|FG000|NOT COMPLETED|Overall Study||13
8629133|NCT00528606|9668780|FG001|NOT COMPLETED|Overall Study||4
8629134|NCT00528645|9668786|FG000|STARTED|Overall Study||23
8629135|NCT00528645|9668786|FG000|COMPLETED|Overall Study||20
8609247|NCT00410423|9646292|FG000|STARTED|Phase 1 - Dose Level 1||3
8609248|NCT00410423|9646293|FG001|STARTED|Phase 1 - Dose Level 1||0
8609249|NCT00410423|9646294|FG002|STARTED|Phase 1 - Dose Level 1||0
8609250|NCT00410423|9646295|FG003|STARTED|Phase 1 - Dose Level 1||0
8609251|NCT00410423|9646292|FG000|COMPLETED|Phase 1 - Dose Level 1||3
8609252|NCT00410423|9646293|FG001|COMPLETED|Phase 1 - Dose Level 1||0
8609253|NCT00410423|9646294|FG002|COMPLETED|Phase 1 - Dose Level 1||0
8609254|NCT00410423|9646295|FG003|COMPLETED|Phase 1 - Dose Level 1||0
8609255|NCT00410423|9646292|FG000|NOT COMPLETED|Phase 1 - Dose Level 1||0
8609256|NCT00410423|9646293|FG001|NOT COMPLETED|Phase 1 - Dose Level 1||0
8609257|NCT00410423|9646294|FG002|NOT COMPLETED|Phase 1 - Dose Level 1||0
8609258|NCT00410423|9646295|FG003|NOT COMPLETED|Phase 1 - Dose Level 1||0
8609259|NCT00410423|9646292|FG000|STARTED|Phase 1 - Dose Level 2||0
8609260|NCT00410423|9646293|FG001|STARTED|Phase 1 - Dose Level 2||5
8609261|NCT00410423|9646294|FG002|STARTED|Phase 1 - Dose Level 2||0
8609262|NCT00410423|9646295|FG003|STARTED|Phase 1 - Dose Level 2||0
8609263|NCT00410423|9646292|FG000|COMPLETED|Phase 1 - Dose Level 2||0
8609264|NCT00410423|9646293|FG001|COMPLETED|Phase 1 - Dose Level 2||5
8609265|NCT00410423|9646294|FG002|COMPLETED|Phase 1 - Dose Level 2||0
8609266|NCT00410423|9646295|FG003|COMPLETED|Phase 1 - Dose Level 2||0
8609267|NCT00410423|9646292|FG000|NOT COMPLETED|Phase 1 - Dose Level 2||0
8609268|NCT00410423|9646293|FG001|NOT COMPLETED|Phase 1 - Dose Level 2||0
8609269|NCT00410423|9646294|FG002|NOT COMPLETED|Phase 1 - Dose Level 2||0
8609270|NCT00410423|9646295|FG003|NOT COMPLETED|Phase 1 - Dose Level 2||0
8609271|NCT00410423|9646292|FG000|STARTED|Phase 1 - Dose Level 3||0
8609272|NCT00410423|9646293|FG001|STARTED|Phase 1 - Dose Level 3||0
8609273|NCT00410423|9646294|FG002|STARTED|Phase 1 - Dose Level 3||3
8609274|NCT00410423|9646295|FG003|STARTED|Phase 1 - Dose Level 3||0
8609275|NCT00410423|9646292|FG000|COMPLETED|Phase 1 - Dose Level 3||0
8609276|NCT00410423|9646293|FG001|COMPLETED|Phase 1 - Dose Level 3||0
8609277|NCT00410423|9646294|FG002|COMPLETED|Phase 1 - Dose Level 3||3
8609278|NCT00410423|9646295|FG003|COMPLETED|Phase 1 - Dose Level 3||0
8609279|NCT00410423|9646292|FG000|NOT COMPLETED|Phase 1 - Dose Level 3||0
8609280|NCT00410423|9646293|FG001|NOT COMPLETED|Phase 1 - Dose Level 3||0
8609281|NCT00410423|9646294|FG002|NOT COMPLETED|Phase 1 - Dose Level 3||0
8609282|NCT00410423|9646295|FG003|NOT COMPLETED|Phase 1 - Dose Level 3||0
8609283|NCT00410423|9646292|FG000|STARTED|Phase 2||0
8609284|NCT00410423|9646293|FG001|STARTED|Phase 2||0
8609285|NCT00410423|9646294|FG002|STARTED|Phase 2||0
8609286|NCT00410423|9646295|FG003|STARTED|Phase 2||44
8609287|NCT00410423|9646292|FG000|COMPLETED|Phase 2||0
8609288|NCT00410423|9646293|FG001|COMPLETED|Phase 2||0
8609289|NCT00410423|9646294|FG002|COMPLETED|Phase 2||0
8609290|NCT00410423|9646295|FG003|COMPLETED|Phase 2||44
8609291|NCT00410423|9646292|FG000|NOT COMPLETED|Phase 2||0
8609292|NCT00410423|9646293|FG001|NOT COMPLETED|Phase 2||0
8609293|NCT00410423|9646294|FG002|NOT COMPLETED|Phase 2||0
8609294|NCT00410423|9646295|FG003|NOT COMPLETED|Phase 2||0
8609295|NCT00410488|9646304|FG000|STARTED|Overall Study||16
8609296|NCT00410488|9646305|FG001|STARTED|Overall Study||34
8609297|NCT00410488|9646304|FG000|COMPLETED|Overall Study||16
8609298|NCT00410488|9646305|FG001|COMPLETED|Overall Study||34
8609299|NCT00410488|9646304|FG000|NOT COMPLETED|Overall Study||0
8609300|NCT00410488|9646305|FG001|NOT COMPLETED|Overall Study||0
8609301|NCT00410514|9646313|FG000|STARTED|Overall Study||65
8609302|NCT00410514|9646314|FG001|STARTED|Overall Study||70
8609303|NCT00410514|9646315|FG002|STARTED|Overall Study||65
8609304|NCT00410514|9646313|FG000|Safety Analysis Set (SAF)|Overall Study|All patients who received at least 1 dose of double-blind study drug.|65
8609305|NCT00410514|9646314|FG001|Safety Analysis Set (SAF)|Overall Study|All patients who received at least 1 dose of double-blind study drug.|70
8609306|NCT00410514|9646315|FG002|Safety Analysis Set (SAF)|Overall Study|All patients who received at least 1 dose of double-blind study drug.|65
8609307|NCT00410514|9646313|FG000|Full Analysis Set (FAS)|Overall Study|SAF patients with both Qmax & PdetQmax measurements at baseline and 1 or both measured postbaseline.|63
8609308|NCT00410514|9646314|FG001|Full Analysis Set (FAS)|Overall Study|SAF patients with both Qmax & PdetQmax measurements at baseline and 1 or both measured postbaseline.|64
8609309|NCT00410514|9646315|FG002|Full Analysis Set (FAS)|Overall Study|SAF patients with both Qmax & PdetQmax measurements at baseline and 1 or both measured postbaseline.|58
8609310|NCT00410514|9646313|FG000|COMPLETED|Overall Study||63
8609311|NCT00410514|9646314|FG001|COMPLETED|Overall Study||67
8609312|NCT00410514|9646315|FG002|COMPLETED|Overall Study||58
8609313|NCT00410514|9646313|FG000|NOT COMPLETED|Overall Study||2
8609314|NCT00410514|9646314|FG001|NOT COMPLETED|Overall Study||3
8609315|NCT00410514|9646315|FG002|NOT COMPLETED|Overall Study||7
8609316|NCT00410605|9646323|FG000|STARTED|Overall Study||39
8609317|NCT00410605|9646323|FG000|COMPLETED|Overall Study||14
8609318|NCT00410605|9646323|FG000|NOT COMPLETED|Overall Study||25
8609319|NCT00410761|9646329|FG000|STARTED|Overall Study|randomised patients|231
8609320|NCT00410761|9646330|FG001|STARTED|Overall Study|randomised patients|100
8609321|NCT00410761|9646329|FG000|COMPLETED|Overall Study|ongoing study treatment at data cut-off|111
8609322|NCT00410761|9646330|FG001|COMPLETED|Overall Study|ongoing study treatment at data cut-off|28
8609323|NCT00410761|9646329|FG000|NOT COMPLETED|Overall Study||120
8609324|NCT00410761|9646330|FG001|NOT COMPLETED|Overall Study||72
8609325|NCT00410813|9646338|FG000|STARTED|Overall Study||43
8609326|NCT00410813|9646339|FG001|STARTED|Overall Study||42
8609327|NCT00410813|9646338|FG000|Eligible|Overall Study||41
8609328|NCT00410813|9646339|FG001|Eligible|Overall Study||38
8629136|NCT00528645|9668786|FG000|NOT COMPLETED|Overall Study||3
8609329|NCT00410813|9646338|FG000|COMPLETED|Overall Study|Patients treated until progression.|0
8609330|NCT00410813|9646339|FG001|COMPLETED|Overall Study||0
8609331|NCT00410813|9646338|FG000|NOT COMPLETED|Overall Study||43
8609332|NCT00410813|9646339|FG001|NOT COMPLETED|Overall Study||42
8609333|NCT00410826|9646370|FG000|STARTED|Overall Study||105
8609334|NCT00410826|9646371|FG001|STARTED|Overall Study||99
8609335|NCT00410826|9646370|FG000|COMPLETED|Overall Study||96
8609336|NCT00410826|9646371|FG001|COMPLETED|Overall Study||95
8609337|NCT00410826|9646370|FG000|NOT COMPLETED|Overall Study||9
8609338|NCT00410826|9646371|FG001|NOT COMPLETED|Overall Study||4
8609339|NCT00410891|9646377|FG000|STARTED|Overall Study||129
8609340|NCT00410891|9646377|FG000|COMPLETED|Overall Study||129
8609341|NCT00410891|9646377|FG000|NOT COMPLETED|Overall Study||0
8609342|NCT00410904|9646383|FG000|STARTED|Overall Study||40
8609343|NCT00410904|9646384|FG001|STARTED|Overall Study||20
8609344|NCT00410904|9646383|FG000|COMPLETED|Overall Study||40
8609345|NCT00410904|9646384|FG001|COMPLETED|Overall Study||20
8609346|NCT00410904|9646383|FG000|NOT COMPLETED|Overall Study||0
8609347|NCT00410904|9646384|FG001|NOT COMPLETED|Overall Study||0
8609348|NCT00411086|9646391|FG000|STARTED|Overall Study||52
8609349|NCT00411086|9646391|FG000|COMPLETED|Overall Study||52
8609350|NCT00411086|9646391|FG000|NOT COMPLETED|Overall Study||0
8609351|NCT00411151|9646395|FG000|STARTED|Overall Study||52
8609352|NCT00411151|9646395|FG000|COMPLETED|Overall Study||5
8609353|NCT00411151|9646395|FG000|NOT COMPLETED|Overall Study||47
8609354|NCT00411216|9646401|FG000|STARTED|Overall Study||13
8609355|NCT00411216|9646402|FG001|STARTED|Overall Study||10
8609356|NCT00411216|9646401|FG000|COMPLETED|Overall Study||13
8609357|NCT00411216|9646402|FG001|COMPLETED|Overall Study||8
8609358|NCT00411216|9646401|FG000|NOT COMPLETED|Overall Study||0
8609359|NCT00411216|9646402|FG001|NOT COMPLETED|Overall Study||2
8609360|NCT00411398|9646408|FG000|STARTED|Overall Study||15
8609361|NCT00411398|9646408|FG000|COMPLETED|Overall Study||10
8609362|NCT00411398|9646408|FG000|NOT COMPLETED|Overall Study||5
8609363|NCT00411411|9646414|FG000|STARTED|Overall Study||24
8609364|NCT00411411|9646415|FG001|STARTED|Overall Study||25
8609365|NCT00411411|9646414|FG000|COMPLETED|Overall Study||24
8609366|NCT00411411|9646415|FG001|COMPLETED|Overall Study||25
8609367|NCT00411411|9646414|FG000|NOT COMPLETED|Overall Study||0
8609368|NCT00411411|9646415|FG001|NOT COMPLETED|Overall Study||0
8609369|NCT00411450|9646422|FG000|STARTED|Overall Study||116
8609370|NCT00411450|9646422|FG000|Received Treatment|Overall Study||115
8609371|NCT00411450|9646422|FG000|COMPLETED|Overall Study|Ended second-line treatment|113
8609372|NCT00411450|9646422|FG000|NOT COMPLETED|Overall Study||3
8609373|NCT00411463|9646430|FG000|STARTED|Overall Study||14
8609374|NCT00411463|9646431|FG001|STARTED|Overall Study||11
8609375|NCT00411463|9646430|FG000|COMPLETED|Overall Study||11
8609376|NCT00411463|9646431|FG001|COMPLETED|Overall Study||8
8609377|NCT00411463|9646430|FG000|NOT COMPLETED|Overall Study||3
8609378|NCT00411463|9646431|FG001|NOT COMPLETED|Overall Study||3
8609379|NCT00411554|9646442|FG000|STARTED|Overall Study|Study enrolled slightly more than the target of N=155|163
8609380|NCT00411554|9646443|FG001|STARTED|Overall Study|Study enrolled slightly more than the target of N=155|156
8609381|NCT00411554|9646442|FG000|COMPLETED|Overall Study||155
8609382|NCT00411554|9646443|FG001|COMPLETED|Overall Study||147
8609383|NCT00411554|9646442|FG000|NOT COMPLETED|Overall Study||8
8609384|NCT00411554|9646443|FG001|NOT COMPLETED|Overall Study||9
8609385|NCT00411619|9646449|FG000|STARTED|Overall Study||28
8609386|NCT00411619|9646449|FG000|COMPLETED|Overall Study||22
8609387|NCT00411619|9646449|FG000|NOT COMPLETED|Overall Study||6
8609388|NCT00411632|9646454|FG000|STARTED|Overall Study||37
8609389|NCT00411632|9646454|FG000|COMPLETED|Overall Study||36
8609390|NCT00411632|9646454|FG000|NOT COMPLETED|Overall Study||1
8609391|NCT00411645|9646460|FG000|STARTED|Overall Study||227
8609392|NCT00411645|9646461|FG001|STARTED|Overall Study||454
8609393|NCT00411645|9646460|FG000|COMPLETED|Overall Study||146
8609394|NCT00411645|9646461|FG001|COMPLETED|Overall Study||290
8609395|NCT00411645|9646460|FG000|NOT COMPLETED|Overall Study||81
8609396|NCT00411645|9646461|FG001|NOT COMPLETED|Overall Study||164
8609397|NCT00411671|9646468|FG000|STARTED|Overall Study||105
8609398|NCT00411671|9646468|FG000|COMPLETED|Overall Study||85
8609399|NCT00411671|9646468|FG000|NOT COMPLETED|Overall Study||20
8609400|NCT00411684|9646472|FG000|STARTED|Overall Study||1533
8609401|NCT00411684|9646472|FG000|COMPLETED|Overall Study||1241
8609402|NCT00411684|9646472|FG000|NOT COMPLETED|Overall Study||292
8609403|NCT00411749|9646478|FG000|STARTED|Overall Study||82
8609404|NCT00411749|9646479|FG001|STARTED|Overall Study||25
8609405|NCT00411749|9646478|FG000|Vaccinated|Overall Study||82
8609406|NCT00411749|9646479|FG001|Vaccinated|Overall Study||25
8609407|NCT00411749|9646478|FG000|COMPLETED|Overall Study|Completed at 24 month after vaccination series (Month 30). Subjects were followed until Month 30|82
8609408|NCT00411749|9646479|FG001|COMPLETED|Overall Study|Completed at 1 month after vaccination series (Month 7). Subjects were followed until Month 7|25
8609409|NCT00411749|9646478|FG000|NOT COMPLETED|Overall Study||0
8609410|NCT00411749|9646479|FG001|NOT COMPLETED|Overall Study||0
8609411|NCT00411762|9646489|FG000|STARTED|Overall Study||25
8609412|NCT00411762|9646489|FG000|COMPLETED|Overall Study||20
8609413|NCT00411762|9646489|FG000|NOT COMPLETED|Overall Study||5
8609414|NCT00411788|9646493|FG000|STARTED|Overall Study||11
8609415|NCT00411788|9646493|FG000|COMPLETED|Overall Study||9
8609416|NCT00411788|9646493|FG000|NOT COMPLETED|Overall Study||2
8609417|NCT00412061|9646499|FG000|STARTED|Double Blind Phase||216
8609418|NCT00412061|9646500|FG001|STARTED|Double Blind Phase||213
8609419|NCT00412061|9646499|FG000|Safety Set|Double Blind Phase|1 patient did not provide at laest one valid post baseline safety assessment.|215
8609420|NCT00412061|9646500|FG001|Safety Set|Double Blind Phase|1 pt randomized never took drug Another randomized did not have valid post BL safety assessment|211
8609421|NCT00412061|9646499|FG000|COMPLETED|Double Blind Phase||0
8609422|NCT00412061|9646500|FG001|COMPLETED|Double Blind Phase||0
8609423|NCT00412061|9646499|FG000|NOT COMPLETED|Double Blind Phase||216
8609424|NCT00412061|9646500|FG001|NOT COMPLETED|Double Blind Phase||213
8609425|NCT00412061|9646499|FG000|STARTED|Open Label Phase||0
8609426|NCT00412061|9646500|FG001|STARTED|Open Label Phase||170
8609427|NCT00412061|9646499|FG000|COMPLETED|Open Label Phase||0
8609428|NCT00412061|9646500|FG001|COMPLETED|Open Label Phase||0
8609429|NCT00412061|9646499|FG000|NOT COMPLETED|Open Label Phase||0
8609430|NCT00412061|9646500|FG001|NOT COMPLETED|Open Label Phase||170
8609431|NCT00412074|9646512|FG000|STARTED|Overall Study||199
8609432|NCT00412074|9646513|FG001|STARTED|Overall Study||66
8609433|NCT00412074|9646514|FG002|STARTED|Overall Study||195
8609434|NCT00412074|9646512|FG000|COMPLETED|Overall Study||122
8609435|NCT00412074|9646513|FG001|COMPLETED|Overall Study||44
8609436|NCT00412074|9646514|FG002|COMPLETED|Overall Study||128
8609437|NCT00412074|9646512|FG000|NOT COMPLETED|Overall Study||77
8609438|NCT00412074|9646513|FG001|NOT COMPLETED|Overall Study||22
8609439|NCT00412074|9646514|FG002|NOT COMPLETED|Overall Study||67
8609440|NCT00412087|9646527|FG000|STARTED|Overall Study||134
8609441|NCT00412087|9646528|FG001|STARTED|Overall Study||131
8609442|NCT00412087|9646527|FG000|COMPLETED|Overall Study||72
8609443|NCT00412087|9646528|FG001|COMPLETED|Overall Study||66
8609444|NCT00412087|9646527|FG000|NOT COMPLETED|Overall Study||62
8609445|NCT00412087|9646528|FG001|NOT COMPLETED|Overall Study||65
8609446|NCT00412113|9646536|FG000|STARTED|Overall Study|15-January-2007|123
8609447|NCT00412113|9646537|FG001|STARTED|Overall Study|15-January-2007|122
8609448|NCT00412113|9646536|FG000|Received Treatment|Overall Study|One subject assigned to Norvasc and TLC did not receive treatment and was excluded from all analyses|122
8609449|NCT00412113|9646537|FG001|Received Treatment|Overall Study||122
8609450|NCT00412113|9646536|FG000|COMPLETED|Overall Study|15-April-2008|111
8609451|NCT00412113|9646537|FG001|COMPLETED|Overall Study|15-April-2008|107
8609452|NCT00412113|9646536|FG000|NOT COMPLETED|Overall Study||12
8609453|NCT00412113|9646537|FG001|NOT COMPLETED|Overall Study||15
8609454|NCT00412217|9646545|FG000|STARTED|Overall Study||46
8609455|NCT00412217|9646546|FG001|STARTED|Overall Study||48
8609456|NCT00412217|9646545|FG000|COMPLETED|Overall Study||0
8609457|NCT00412217|9646546|FG001|COMPLETED|Overall Study||0
8609458|NCT00412217|9646545|FG000|NOT COMPLETED|Overall Study||46
8609459|NCT00412217|9646546|FG001|NOT COMPLETED|Overall Study||48
8609460|NCT00412243|9646552|FG000|STARTED|Overall Study||50
8609461|NCT00412243|9646552|FG000|COMPLETED|Overall Study||50
8609462|NCT00412243|9646552|FG000|NOT COMPLETED|Overall Study||0
8609463|NCT00412360|9646558|FG000|STARTED|Overall Study||113
8609464|NCT00412360|9646559|FG001|STARTED|Overall Study||111
8609465|NCT00412360|9646558|FG000|COMPLETED|Overall Study||112
8609466|NCT00412360|9646559|FG001|COMPLETED|Overall Study||108
8609467|NCT00412360|9646558|FG000|NOT COMPLETED|Overall Study||1
8609468|NCT00412360|9646559|FG001|NOT COMPLETED|Overall Study||3
8609469|NCT00412373|9646567|FG000|STARTED|Overall Study|Number of Subjects in Intent-to-Treat Analysis Set.|93
8609470|NCT00412373|9646568|FG001|STARTED|Overall Study|Number of Subjects Intent-to-Treat Analysis Set.|211
8609471|NCT00412373|9646567|FG000|COMPLETED|Overall Study|Number of Subjects Who Completed Double-Blind Treatment.|52
8609472|NCT00412373|9646568|FG001|COMPLETED|Overall Study|Number of Subjects Who Completed Double-Blind Treatment..|134
8609473|NCT00412373|9646567|FG000|NOT COMPLETED|Overall Study||41
8609474|NCT00412373|9646568|FG001|NOT COMPLETED|Overall Study||77
8609475|NCT00412425|9646576|FG000|STARTED|Overall Study||15
8609476|NCT00412425|9646577|FG001|STARTED|Overall Study||15
8609477|NCT00412425|9646576|FG000|COMPLETED|Overall Study||15
8609478|NCT00412425|9646577|FG001|COMPLETED|Overall Study||15
8609479|NCT00412425|9646576|FG000|NOT COMPLETED|Overall Study||0
8609480|NCT00412425|9646577|FG001|NOT COMPLETED|Overall Study||0
8609481|NCT00412451|9646587|FG000|STARTED|Overall Study||8
8609482|NCT00412451|9646588|FG001|STARTED|Overall Study||15
8609483|NCT00412451|9646589|FG002|STARTED|Overall Study||15
8609484|NCT00412451|9646590|FG003|STARTED|Overall Study||13
8609485|NCT00412451|9646587|FG000|COMPLETED|Overall Study||8
8609486|NCT00412451|9646588|FG001|COMPLETED|Overall Study||15
8609487|NCT00412451|9646589|FG002|COMPLETED|Overall Study||14
8609488|NCT00412451|9646590|FG003|COMPLETED|Overall Study||11
8609489|NCT00412451|9646587|FG000|NOT COMPLETED|Overall Study||0
8609490|NCT00412451|9646588|FG001|NOT COMPLETED|Overall Study||0
8609491|NCT00412451|9646589|FG002|NOT COMPLETED|Overall Study||1
8609492|NCT00412451|9646590|FG003|NOT COMPLETED|Overall Study||2
8609493|NCT00412464|9646600|FG000|STARTED|Overall Study|Age Groups: 1-5 Years (10); 6-12 Years (7); 13-18 years (7)|24
8609494|NCT00412464|9646600|FG000|COMPLETED|Overall Study|Age Groups: 1-5 Years (10); 6-12 Years (7); 13-18 years (7)|24
8609495|NCT00412464|9646600|FG000|NOT COMPLETED|Overall Study||0
8609496|NCT00412516|9646607|FG000|STARTED|Overall Study||93
8609497|NCT00412516|9646608|FG001|STARTED|Overall Study||212
8609498|NCT00412516|9646609|FG002|STARTED|Overall Study||214
8609499|NCT00412516|9646607|FG000|COMPLETED|Overall Study||93
8609500|NCT00412516|9646608|FG001|COMPLETED|Overall Study||212
8609501|NCT00412516|9646609|FG002|COMPLETED|Overall Study||214
8609502|NCT00412516|9646607|FG000|NOT COMPLETED|Overall Study||0
8609503|NCT00412516|9646608|FG001|NOT COMPLETED|Overall Study||0
8609504|NCT00412516|9646609|FG002|NOT COMPLETED|Overall Study||0
8609505|NCT00412529|9646619|FG000|STARTED|Overall Study||23
8609506|NCT00412529|9646620|FG001|STARTED|Overall Study||21
8609507|NCT00412529|9646619|FG000|COMPLETED|Overall Study||23
8609508|NCT00412529|9646620|FG001|COMPLETED|Overall Study||21
8609509|NCT00412529|9646619|FG000|NOT COMPLETED|Overall Study||0
8609510|NCT00412529|9646620|FG001|NOT COMPLETED|Overall Study||0
8609511|NCT00412542|9646628|FG000|STARTED|Overall Study||33
8609512|NCT00412542|9646629|FG001|STARTED|Overall Study||45
8609513|NCT00412542|9646628|FG000|COMPLETED|Overall Study||33
8609514|NCT00412542|9646629|FG001|COMPLETED|Overall Study||42
8609515|NCT00412542|9646628|FG000|NOT COMPLETED|Overall Study||0
8609516|NCT00412542|9646629|FG001|NOT COMPLETED|Overall Study||3
8609517|NCT00412607|9646633|FG000|STARTED|Overall Study||249
8609518|NCT00412607|9646633|FG000|Started Study Catheter|Overall Study||233
8609519|NCT00412607|9646633|FG000|COMPLETED|Overall Study||145
8609520|NCT00412607|9646633|FG000|NOT COMPLETED|Overall Study||104
8609521|NCT00412737|9646642|FG000|STARTED|Overall Study||237
8609522|NCT00412737|9646643|FG001|STARTED|Overall Study||238
8609523|NCT00412737|9646642|FG000|COMPLETED|Overall Study||221
8609524|NCT00412737|9646643|FG001|COMPLETED|Overall Study||232
8609525|NCT00412737|9646642|FG000|NOT COMPLETED|Overall Study||16
8609526|NCT00412737|9646643|FG001|NOT COMPLETED|Overall Study||6
8609527|NCT00412750|9646652|FG000|STARTED|Overall Study||50
8609528|NCT00412750|9646653|FG001|STARTED|Overall Study||55
8609529|NCT00412750|9646654|FG002|STARTED|Overall Study||54
8609530|NCT00412750|9646652|FG000|COMPLETED|Overall Study||19
8609531|NCT00412750|9646653|FG001|COMPLETED|Overall Study||34
8609532|NCT00412750|9646654|FG002|COMPLETED|Overall Study||31
8609533|NCT00412750|9646652|FG000|NOT COMPLETED|Overall Study||31
8609534|NCT00412750|9646653|FG001|NOT COMPLETED|Overall Study||21
8609535|NCT00412750|9646654|FG002|NOT COMPLETED|Overall Study||23
8609536|NCT00412841|9646666|FG000|STARTED|Overall Study||22
8609537|NCT00412841|9646667|FG001|STARTED|Overall Study||21
8609538|NCT00412841|9646666|FG000|COMPLETED|Overall Study||12
8609539|NCT00412841|9646667|FG001|COMPLETED|Overall Study||16
8609540|NCT00412841|9646666|FG000|NOT COMPLETED|Overall Study||10
8609541|NCT00412841|9646667|FG001|NOT COMPLETED|Overall Study||5
8609542|NCT00412854|9646676|FG000|STARTED|Overall Study||330
8609543|NCT00412854|9646677|FG001|STARTED|Overall Study||330
8609544|NCT00412854|9646676|FG000|COMPLETED|Overall Study||316
8609545|NCT00412854|9646677|FG001|COMPLETED|Overall Study||314
8609546|NCT00412854|9646676|FG000|NOT COMPLETED|Overall Study||14
8609547|NCT00412854|9646677|FG001|NOT COMPLETED|Overall Study||16
8609548|NCT00412867|9646683|FG000|STARTED|Overall Study||58
8609549|NCT00412867|9646683|FG000|COMPLETED|Overall Study||58
8609550|NCT00412867|9646683|FG000|NOT COMPLETED|Overall Study||0
8609551|NCT00412893|9646690|FG000|STARTED|Overall Study||263
8609552|NCT00412893|9646691|FG001|STARTED|Overall Study||264
8609553|NCT00412893|9646690|FG000|Received Treatment|Overall Study|One participant randomized to this group received voriconazole treatment for the first 7 days|258
8609554|NCT00412893|9646691|FG001|Received Treatment|Overall Study||258
8609555|NCT00412893|9646690|FG000|COMPLETED|Overall Study|Defined as completed treatment|118
8609556|NCT00412893|9646691|FG001|COMPLETED|Overall Study|Defined as completed treatment|120
8609557|NCT00412893|9646690|FG000|NOT COMPLETED|Overall Study||145
8609558|NCT00412893|9646691|FG001|NOT COMPLETED|Overall Study||144
8609559|NCT00412958|9646701|FG000|STARTED|Overall Study||29
8609560|NCT00412958|9646702|FG001|STARTED|Overall Study||33
8609561|NCT00412958|9646703|FG002|STARTED|Overall Study||32
8609562|NCT00412958|9646704|FG003|STARTED|Overall Study||31
8609563|NCT00412958|9646701|FG000|COMPLETED|Overall Study||26
8609564|NCT00412958|9646702|FG001|COMPLETED|Overall Study||29
8609565|NCT00412958|9646703|FG002|COMPLETED|Overall Study||32
8609566|NCT00412958|9646704|FG003|COMPLETED|Overall Study||30
8609567|NCT00412958|9646701|FG000|NOT COMPLETED|Overall Study||3
8609568|NCT00412958|9646702|FG001|NOT COMPLETED|Overall Study||4
8609569|NCT00412958|9646703|FG002|NOT COMPLETED|Overall Study||0
8609570|NCT00412958|9646704|FG003|NOT COMPLETED|Overall Study||1
8609571|NCT00412971|9646716|FG000|STARTED|Overall Study||115
8609572|NCT00412971|9646717|FG001|STARTED|Overall Study||118
8609573|NCT00412971|9646716|FG000|COMPLETED|Overall Study||85
8609574|NCT00412971|9646717|FG001|COMPLETED|Overall Study||108
8609575|NCT00412971|9646716|FG000|NOT COMPLETED|Overall Study||30
8609576|NCT00412971|9646717|FG001|NOT COMPLETED|Overall Study||10
8609577|NCT00412984|9646725|FG000|STARTED|Overall Study|Randomized participants|9120
8609578|NCT00412984|9646726|FG001|STARTED|Overall Study|Randomized participants|9081
8609579|NCT00412984|9646725|FG000|COMPLETED|Overall Study||6810
8609580|NCT00412984|9646726|FG001|COMPLETED|Overall Study||6588
8609581|NCT00412984|9646725|FG000|NOT COMPLETED|Overall Study||2310
8609582|NCT00412984|9646726|FG001|NOT COMPLETED|Overall Study||2493
8609583|NCT00413010|9646734|FG000|STARTED|Overall Study||180
8609584|NCT00413010|9646735|FG001|STARTED|Overall Study||176
8609585|NCT00413010|9646734|FG000|COMPLETED|Overall Study||108
8609586|NCT00413010|9646735|FG001|COMPLETED|Overall Study||113
8609587|NCT00413010|9646734|FG000|NOT COMPLETED|Overall Study||72
8609588|NCT00413010|9646735|FG001|NOT COMPLETED|Overall Study||63
8609589|NCT00413036|9646741|FG000|STARTED|Overall Study||217
8609590|NCT00413036|9646741|FG000|COMPLETED|Overall Study|Participants remain on study drug until progressive disease or unacceptable adverse events develop.|0
8609591|NCT00413036|9646741|FG000|NOT COMPLETED|Overall Study||217
8609592|NCT00413049|9646747|FG000|STARTED|Overall Study||349
8609593|NCT00413049|9646748|FG001|STARTED|Overall Study||349
8609594|NCT00413049|9646747|FG000|COMPLETED|Overall Study||325
8609595|NCT00413049|9646748|FG001|COMPLETED|Overall Study||331
8609596|NCT00413049|9646747|FG000|NOT COMPLETED|Overall Study||24
8609597|NCT00413049|9646748|FG001|NOT COMPLETED|Overall Study||18
8609598|NCT00413153|9646756|FG000|STARTED|Overall Study||7
8609599|NCT00413153|9646757|FG001|STARTED|Overall Study||8
8609600|NCT00413153|9646756|FG000|COMPLETED|Overall Study||5
8609601|NCT00413153|9646757|FG001|COMPLETED|Overall Study||7
8609602|NCT00413153|9646756|FG000|NOT COMPLETED|Overall Study||2
8609603|NCT00413153|9646757|FG001|NOT COMPLETED|Overall Study||1
8609604|NCT00413166|9646766|FG000|STARTED|Overall Study||57
8609605|NCT00413166|9646767|FG001|STARTED|Overall Study||5
8609606|NCT00413166|9646768|FG002|STARTED|Overall Study||16
8609607|NCT00413166|9646766|FG000|COMPLETED|Overall Study||57
8609608|NCT00413166|9646767|FG001|COMPLETED|Overall Study||5
8609609|NCT00413166|9646768|FG002|COMPLETED|Overall Study||16
8609610|NCT00413166|9646766|FG000|NOT COMPLETED|Overall Study||0
8609611|NCT00413166|9646767|FG001|NOT COMPLETED|Overall Study||0
8609612|NCT00413166|9646768|FG002|NOT COMPLETED|Overall Study||0
8609613|NCT00413192|9646780|FG000|STARTED|Overall Study||37
8609614|NCT00413192|9646781|FG001|STARTED|Overall Study||40
8609615|NCT00413192|9646782|FG002|STARTED|Overall Study||19
8609616|NCT00413192|9646783|FG003|STARTED|Overall Study||32
8609617|NCT00413192|9646780|FG000|COMPLETED|Overall Study||0
8609618|NCT00413192|9646781|FG001|COMPLETED|Overall Study||0
8609619|NCT00413192|9646782|FG002|COMPLETED|Overall Study||0
8609620|NCT00413192|9646783|FG003|COMPLETED|Overall Study||0
8609621|NCT00413192|9646780|FG000|NOT COMPLETED|Overall Study||37
8609622|NCT00413192|9646781|FG001|NOT COMPLETED|Overall Study||40
8609623|NCT00413192|9646782|FG002|NOT COMPLETED|Overall Study||19
8609624|NCT00413192|9646783|FG003|NOT COMPLETED|Overall Study||32
8609625|NCT00413218|9646795|FG000|STARTED|Overall Study||223
8609626|NCT00413218|9646796|FG001|STARTED|Overall Study||227
8609627|NCT00413218|9646795|FG000|Intent to Treat Population (ITT)|Overall Study||221
8609628|NCT00413218|9646796|FG001|Intent to Treat Population (ITT)|Overall Study||219
8609629|NCT00413218|9646795|FG000|COMPLETED|Overall Study||120
8609630|NCT00413218|9646796|FG001|COMPLETED|Overall Study||131
8609631|NCT00413218|9646795|FG000|NOT COMPLETED|Overall Study||103
8609632|NCT00413218|9646796|FG001|NOT COMPLETED|Overall Study||96
8609633|NCT00413231|9646803|FG000|STARTED|0 to 30-day Post Treatment||160
8609634|NCT00413231|9646803|FG000|COMPLETED|0 to 30-day Post Treatment||152
8609635|NCT00413231|9646803|FG000|NOT COMPLETED|0 to 30-day Post Treatment||8
8609636|NCT00413231|9646803|FG000|STARTED|30-day to 365-day Post Treatment||152
8609637|NCT00413231|9646803|FG000|COMPLETED|30-day to 365-day Post Treatment||139
8609638|NCT00413231|9646803|FG000|NOT COMPLETED|30-day to 365-day Post Treatment||13
8609639|NCT00413231|9646803|FG000|STARTED|365-day to 60-month Post Treatment||139
8609640|NCT00413231|9646803|FG000|COMPLETED|365-day to 60-month Post Treatment||93
8609641|NCT00413231|9646803|FG000|NOT COMPLETED|365-day to 60-month Post Treatment||46
8609642|NCT00413244|9646810|FG000|STARTED|Overall Study||31
8609643|NCT00413244|9646811|FG001|STARTED|Overall Study||20
8609644|NCT00413244|9646810|FG000|COMPLETED|Overall Study||21
8609645|NCT00413244|9646811|FG001|COMPLETED|Overall Study||19
8609646|NCT00413244|9646810|FG000|NOT COMPLETED|Overall Study||10
8609647|NCT00413244|9646811|FG001|NOT COMPLETED|Overall Study||1
8609648|NCT00413283|9646821|FG000|STARTED|Overall Study||12
8609649|NCT00413283|9646822|FG001|STARTED|Overall Study||16
8609650|NCT00413283|9646823|FG002|STARTED|Overall Study||18
8609651|NCT00413283|9646824|FG003|STARTED|Overall Study||17
8609652|NCT00413283|9646821|FG000|Received Study Drug|Overall Study||12
8609653|NCT00413283|9646822|FG001|Received Study Drug|Overall Study||16
8609654|NCT00413283|9646823|FG002|Received Study Drug|Overall Study||18
8609655|NCT00413283|9646824|FG003|Received Study Drug|Overall Study||16
8609656|NCT00413283|9646821|FG000|COMPLETED|Overall Study||11
8609657|NCT00413283|9646822|FG001|COMPLETED|Overall Study||13
8609658|NCT00413283|9646823|FG002|COMPLETED|Overall Study||16
8609659|NCT00413283|9646824|FG003|COMPLETED|Overall Study||13
8609660|NCT00413283|9646821|FG000|NOT COMPLETED|Overall Study||1
8609661|NCT00413283|9646822|FG001|NOT COMPLETED|Overall Study||3
8609662|NCT00413283|9646823|FG002|NOT COMPLETED|Overall Study||2
8609663|NCT00413283|9646824|FG003|NOT COMPLETED|Overall Study||4
8609664|NCT00413335|9646836|FG000|STARTED|Overall Study||12
8609665|NCT00413335|9646837|FG001|STARTED|Overall Study||9
8609666|NCT00413335|9646836|FG000|COMPLETED|Overall Study||12
8609667|NCT00413335|9646837|FG001|COMPLETED|Overall Study||9
8609668|NCT00413335|9646836|FG000|NOT COMPLETED|Overall Study||0
8609669|NCT00413335|9646837|FG001|NOT COMPLETED|Overall Study||0
8609670|NCT00413374|9646845|FG000|STARTED|Overall Study||40
8609671|NCT00413374|9646846|FG001|STARTED|Overall Study||80
8609672|NCT00413374|9646845|FG000|COMPLETED|Overall Study||34
8609673|NCT00413374|9646846|FG001|COMPLETED|Overall Study||80
8609674|NCT00413374|9646845|FG000|NOT COMPLETED|Overall Study||6
8609675|NCT00413374|9646846|FG001|NOT COMPLETED|Overall Study||0
8609676|NCT00413400|9646857|FG000|STARTED|Overall Study||24
8609677|NCT00413400|9646858|FG001|STARTED|Overall Study||16
8609678|NCT00413400|9646857|FG000|3 Month Visit|Overall Study||22
8609679|NCT00413400|9646858|FG001|3 Month Visit|Overall Study||12
8609680|NCT00413400|9646857|FG000|COMPLETED|Overall Study||22
8609681|NCT00413400|9646858|FG001|COMPLETED|Overall Study||12
8609682|NCT00413400|9646857|FG000|NOT COMPLETED|Overall Study||2
8609683|NCT00413400|9646858|FG001|NOT COMPLETED|Overall Study||4
8609684|NCT00413413|9646867|FG000|STARTED|Single-Blind|In single-blind period participants were only enrolled to Valsartan 80 mg arm.|0
8609685|NCT00413413|9646868|FG001|STARTED|Single-Blind||1134
8609686|NCT00413413|9646869|FG002|STARTED|Single-Blind|In single-blind period participants were only enrolled to Valsartan 80 mg arm.|0
8609687|NCT00413413|9646867|FG000|COMPLETED|Single-Blind||0
8609688|NCT00413413|9646868|FG001|COMPLETED|Single-Blind||918
8609689|NCT00413413|9646869|FG002|COMPLETED|Single-Blind||0
8609690|NCT00413413|9646867|FG000|NOT COMPLETED|Single-Blind||0
8609691|NCT00413413|9646868|FG001|NOT COMPLETED|Single-Blind||216
8609692|NCT00413413|9646869|FG002|NOT COMPLETED|Single-Blind||0
8609693|NCT00413413|9646867|FG000|STARTED|Double-Blind||308
8609694|NCT00413413|9646868|FG001|STARTED|Double-Blind||307
8609695|NCT00413413|9646869|FG002|STARTED|Double-Blind||303
8609696|NCT00413413|9646867|FG000|COMPLETED|Double-Blind||293
8609697|NCT00413413|9646868|FG001|COMPLETED|Double-Blind||293
8609698|NCT00413413|9646869|FG002|COMPLETED|Double-Blind||285
8609699|NCT00413413|9646867|FG000|NOT COMPLETED|Double-Blind||15
8609700|NCT00413413|9646868|FG001|NOT COMPLETED|Double-Blind||14
8609701|NCT00413413|9646869|FG002|NOT COMPLETED|Double-Blind||18
8609702|NCT00413478|9646877|FG000|STARTED|Overall Study||9
8609703|NCT00413478|9646877|FG000|COMPLETED|Overall Study||9
8609704|NCT00413478|9646877|FG000|NOT COMPLETED|Overall Study||0
8609705|NCT00413582|9646883|FG000|STARTED|Overall Study|all enrolled completed|55
8609706|NCT00413582|9646884|FG001|STARTED|Overall Study|all enrolled completed|55
8609707|NCT00413582|9646883|FG000|Completion of Study|Overall Study|all enrolled completed|55
8609708|NCT00413582|9646884|FG001|Completion of Study|Overall Study|all enrolled completed|55
8609709|NCT00413582|9646883|FG000|COMPLETED|Overall Study|all enrolled completed|55
8609710|NCT00413582|9646884|FG001|COMPLETED|Overall Study|all enrolled completed|55
8609711|NCT00413582|9646883|FG000|NOT COMPLETED|Overall Study||0
8609712|NCT00413582|9646884|FG001|NOT COMPLETED|Overall Study||0
8609713|NCT00413634|9646892|FG000|STARTED|Overall Study||12
8609714|NCT00413634|9646893|FG001|STARTED|Overall Study||12
8609715|NCT00413634|9646892|FG000|COMPLETED|Overall Study||12
8609716|NCT00413634|9646893|FG001|COMPLETED|Overall Study||12
8609717|NCT00413634|9646892|FG000|NOT COMPLETED|Overall Study||0
8609718|NCT00413634|9646893|FG001|NOT COMPLETED|Overall Study||0
8609719|NCT00413660|9646908|FG000|STARTED|Up To Week 12||71
8609720|NCT00413660|9646909|FG001|STARTED|Up To Week 12||68
8609721|NCT00413660|9646910|FG002|STARTED|Up To Week 12||71
8609722|NCT00413660|9646911|FG003|STARTED|Up To Week 12||75
8609723|NCT00413660|9646912|FG004|STARTED|Up To Week 12||75
8609724|NCT00413660|9646913|FG005|STARTED|Up To Week 12||80
8609725|NCT00413660|9646914|FG006|STARTED|Up To Week 12||69
8609726|NCT00413660|9646915|FG007|STARTED|Up To Week 12||0
8609727|NCT00413660|9646916|FG008|STARTED|Up To Week 12||0
8609728|NCT00413660|9646917|FG009|STARTED|Up To Week 12||0
8609729|NCT00413660|9646918|FG010|STARTED|Up To Week 12||0
8609730|NCT00413660|9646908|FG000|Treated|Up To Week 12||70
8609731|NCT00413660|9646909|FG001|Treated|Up To Week 12||68
8609732|NCT00413660|9646910|FG002|Treated|Up To Week 12||71
8609733|NCT00413660|9646911|FG003|Treated|Up To Week 12||74
8609734|NCT00413660|9646912|FG004|Treated|Up To Week 12||75
8609735|NCT00413660|9646913|FG005|Treated|Up To Week 12||80
8609736|NCT00413660|9646914|FG006|Treated|Up To Week 12||69
8609737|NCT00413660|9646915|FG007|Treated|Up To Week 12||0
8609738|NCT00413660|9646916|FG008|Treated|Up To Week 12||0
8609739|NCT00413660|9646917|FG009|Treated|Up To Week 12||0
8609740|NCT00413660|9646918|FG010|Treated|Up To Week 12||0
8609741|NCT00413660|9646908|FG000|COMPLETED|Up To Week 12||64
8609742|NCT00413660|9646909|FG001|COMPLETED|Up To Week 12||61
8609743|NCT00413660|9646910|FG002|COMPLETED|Up To Week 12||64
8609744|NCT00413660|9646911|FG003|COMPLETED|Up To Week 12||67
8609745|NCT00413660|9646912|FG004|COMPLETED|Up To Week 12||66
8609746|NCT00413660|9646913|FG005|COMPLETED|Up To Week 12||70
8609747|NCT00413660|9646914|FG006|COMPLETED|Up To Week 12||58
8609748|NCT00413660|9646915|FG007|COMPLETED|Up To Week 12||0
8609749|NCT00413660|9646916|FG008|COMPLETED|Up To Week 12||0
8609750|NCT00413660|9646917|FG009|COMPLETED|Up To Week 12||0
8609751|NCT00413660|9646918|FG010|COMPLETED|Up To Week 12||0
8609752|NCT00413660|9646908|FG000|NOT COMPLETED|Up To Week 12||7
8813268|NCT01524900|9866416|FG002|COMPLETED|Overall Study||29
8813269|NCT01524900|9866417|FG003|COMPLETED|Overall Study||21
8609753|NCT00413660|9646909|FG001|NOT COMPLETED|Up To Week 12||7
8609754|NCT00413660|9646910|FG002|NOT COMPLETED|Up To Week 12||7
8609755|NCT00413660|9646911|FG003|NOT COMPLETED|Up To Week 12||8
8715477|NCT00984009|9762372|FG000|COMPLETED|14 Day Washout Period||22
8715478|NCT00984009|9762372|FG000|NOT COMPLETED|14 Day Washout Period||0
8609756|NCT00413660|9646912|FG004|NOT COMPLETED|Up To Week 12||9
8609757|NCT00413660|9646913|FG005|NOT COMPLETED|Up To Week 12||10
8609758|NCT00413660|9646914|FG006|NOT COMPLETED|Up To Week 12||11
8609759|NCT00413660|9646915|FG007|NOT COMPLETED|Up To Week 12||0
8609760|NCT00413660|9646916|FG008|NOT COMPLETED|Up To Week 12||0
8609761|NCT00413660|9646917|FG009|NOT COMPLETED|Up To Week 12||0
8609762|NCT00413660|9646918|FG010|NOT COMPLETED|Up To Week 12||0
8609763|NCT00413660|9646908|FG000|STARTED|Post Week 12||43
8609764|NCT00413660|9646909|FG001|STARTED|Post Week 12||48
8609765|NCT00413660|9646910|FG002|STARTED|Post Week 12||64
8609766|NCT00413660|9646911|FG003|STARTED|Post Week 12||67
8609767|NCT00413660|9646912|FG004|STARTED|Post Week 12||66
8715479|NCT00984009|9762372|FG000|STARTED|Grapefruit Juice Alone||22
8609768|NCT00413660|9646913|FG005|STARTED|Post Week 12||57
8609769|NCT00413660|9646914|FG006|STARTED|Post Week 12||40
8609770|NCT00413660|9646915|FG007|STARTED|Post Week 12||21
8609771|NCT00413660|9646916|FG008|STARTED|Post Week 12||13
8813270|NCT01524900|9866418|FG004|COMPLETED|Overall Study||40
8813271|NCT01524900|9866414|FG000|NOT COMPLETED|Overall Study||6
8813272|NCT01524900|9866415|FG001|NOT COMPLETED|Overall Study||14
8609772|NCT00413660|9646917|FG009|STARTED|Post Week 12||13
8609773|NCT00413660|9646918|FG010|STARTED|Post Week 12||18
8813273|NCT01524900|9866416|FG002|NOT COMPLETED|Overall Study||1
8813274|NCT01524900|9866417|FG003|NOT COMPLETED|Overall Study||1
8813275|NCT01524900|9866418|FG004|NOT COMPLETED|Overall Study||0
8813276|NCT01524913|9866434|FG000|STARTED|Overall Study||35
8609774|NCT00413660|9646908|FG000|COMPLETED|Post Week 12||40
8609775|NCT00413660|9646909|FG001|COMPLETED|Post Week 12||44
8609776|NCT00413660|9646910|FG002|COMPLETED|Post Week 12||56
8609777|NCT00413660|9646911|FG003|COMPLETED|Post Week 12||66
8609778|NCT00413660|9646912|FG004|COMPLETED|Post Week 12||60
8609779|NCT00413660|9646913|FG005|COMPLETED|Post Week 12||54
8609780|NCT00413660|9646914|FG006|COMPLETED|Post Week 12||37
8609781|NCT00413660|9646915|FG007|COMPLETED|Post Week 12||21
8609782|NCT00413660|9646916|FG008|COMPLETED|Post Week 12||13
8609783|NCT00413660|9646917|FG009|COMPLETED|Post Week 12||12
8609784|NCT00413660|9646918|FG010|COMPLETED|Post Week 12||17
8609785|NCT00413660|9646908|FG000|NOT COMPLETED|Post Week 12||3
8609786|NCT00413660|9646909|FG001|NOT COMPLETED|Post Week 12||4
8609787|NCT00413660|9646910|FG002|NOT COMPLETED|Post Week 12||8
8609788|NCT00413660|9646911|FG003|NOT COMPLETED|Post Week 12||1
8609789|NCT00413660|9646912|FG004|NOT COMPLETED|Post Week 12||6
8609790|NCT00413660|9646913|FG005|NOT COMPLETED|Post Week 12||3
8609791|NCT00413660|9646914|FG006|NOT COMPLETED|Post Week 12||3
8609792|NCT00413660|9646915|FG007|NOT COMPLETED|Post Week 12||0
8609793|NCT00413660|9646916|FG008|NOT COMPLETED|Post Week 12||0
8609794|NCT00413660|9646917|FG009|NOT COMPLETED|Post Week 12||1
8609795|NCT00413660|9646918|FG010|NOT COMPLETED|Post Week 12||1
8609796|NCT00413777|9646950|FG000|STARTED|Fixed-dose Period||22
8609797|NCT00413777|9646951|FG001|STARTED|Fixed-dose Period||24
8609798|NCT00413777|9646950|FG000|COMPLETED|Fixed-dose Period||18
8609799|NCT00413777|9646951|FG001|COMPLETED|Fixed-dose Period||21
8609800|NCT00413777|9646950|FG000|NOT COMPLETED|Fixed-dose Period||4
8609801|NCT00413777|9646951|FG001|NOT COMPLETED|Fixed-dose Period||3
8609802|NCT00413777|9646950|FG000|STARTED|Extension Period||17
8609803|NCT00413777|9646951|FG001|STARTED|Extension Period||18
8609804|NCT00413777|9646950|FG000|COMPLETED|Extension Period||17
8609805|NCT00413777|9646951|FG001|COMPLETED|Extension Period||18
8609806|NCT00413777|9646950|FG000|NOT COMPLETED|Extension Period||0
8609807|NCT00413777|9646951|FG001|NOT COMPLETED|Extension Period||0
8609808|NCT00413894|9646957|FG000|STARTED|Overall Study||424
8609809|NCT00413894|9646957|FG000|COMPLETED|Overall Study||344
8609810|NCT00413894|9646957|FG000|NOT COMPLETED|Overall Study||80
8609811|NCT00413920|9646966|FG000|STARTED|Overall Study||112
8609812|NCT00413920|9646967|FG001|STARTED|Overall Study||110
8609813|NCT00413920|9646966|FG000|COMPLETED|Overall Study||84
8609814|NCT00413920|9646967|FG001|COMPLETED|Overall Study||82
8609815|NCT00413920|9646966|FG000|NOT COMPLETED|Overall Study||28
8609816|NCT00413920|9646967|FG001|NOT COMPLETED|Overall Study||28
8609817|NCT00413959|9646973|FG000|STARTED|Overall Study||12
8609818|NCT00413959|9646973|FG000|COMPLETED|Overall Study||11
8609819|NCT00413959|9646973|FG000|NOT COMPLETED|Overall Study||1
8609820|NCT00414011|9646977|FG000|STARTED|Overall Study||40
8609821|NCT00414011|9646977|FG000|COMPLETED|Overall Study||35
8609822|NCT00414011|9646977|FG000|NOT COMPLETED|Overall Study||5
8609823|NCT00414050|9646986|FG000|STARTED|Overall Study||431
8609824|NCT00414050|9646987|FG001|STARTED|Overall Study||427
8609825|NCT00414050|9646988|FG002|STARTED|Overall Study||429
8609826|NCT00414050|9646989|FG003|STARTED|Overall Study||431
8609827|NCT00414050|9646986|FG000|Received Vaccination 1|Overall Study||431
8609828|NCT00414050|9646987|FG001|Received Vaccination 1|Overall Study||426
8609829|NCT00414050|9646988|FG002|Received Vaccination 1|Overall Study||429
8609830|NCT00414050|9646989|FG003|Received Vaccination 1|Overall Study||431
8609831|NCT00414050|9646986|FG000|Received Vaccination 2|Overall Study||425
8609832|NCT00414050|9646987|FG001|Received Vaccination 2|Overall Study||421
8609833|NCT00414050|9646988|FG002|Received Vaccination 2|Overall Study||425
8609834|NCT00414050|9646989|FG003|Received Vaccination 2|Overall Study||425
8609835|NCT00414050|9646986|FG000|Received Vaccination 3|Overall Study||424
8609836|NCT00414050|9646987|FG001|Received Vaccination 3|Overall Study||419
8609837|NCT00414050|9646988|FG002|Received Vaccination 3|Overall Study||425
8609838|NCT00414050|9646989|FG003|Received Vaccination 3|Overall Study||424
8609839|NCT00414050|9646986|FG000|COMPLETED|Overall Study||422
8609840|NCT00414050|9646987|FG001|COMPLETED|Overall Study||419
8609841|NCT00414050|9646988|FG002|COMPLETED|Overall Study||423
8609842|NCT00414050|9646989|FG003|COMPLETED|Overall Study||423
8609843|NCT00414050|9646986|FG000|NOT COMPLETED|Overall Study||9
8609844|NCT00414050|9646987|FG001|NOT COMPLETED|Overall Study||8
8609845|NCT00414050|9646988|FG002|NOT COMPLETED|Overall Study||6
8813277|NCT01524913|9866435|FG001|STARTED|Overall Study||36
8609846|NCT00414050|9646989|FG003|NOT COMPLETED|Overall Study||8
8813278|NCT01524913|9866436|FG002|STARTED|Overall Study||31
8609847|NCT00414076|9647001|FG000|STARTED|Overall Study||4
8609848|NCT00414076|9647002|FG001|STARTED|Overall Study||5
8609849|NCT00414076|9647001|FG000|COMPLETED|Overall Study||1
8609850|NCT00414076|9647002|FG001|COMPLETED|Overall Study||0
8609851|NCT00414076|9647001|FG000|NOT COMPLETED|Overall Study||3
8609852|NCT00414076|9647002|FG001|NOT COMPLETED|Overall Study||5
8609853|NCT00414167|9647010|FG000|STARTED|Overall Study||31
8609854|NCT00414167|9647011|FG001|STARTED|Overall Study||30
8609855|NCT00414167|9647010|FG000|COMPLETED|Overall Study||27
8609856|NCT00414167|9647011|FG001|COMPLETED|Overall Study||27
8609857|NCT00414167|9647010|FG000|NOT COMPLETED|Overall Study||4
8609858|NCT00414167|9647011|FG001|NOT COMPLETED|Overall Study||3
8609859|NCT00414206|9647022|FG000|STARTED|Overall Study||115
8609860|NCT00414206|9647023|FG001|STARTED|Overall Study||114
8609861|NCT00414206|9647024|FG002|STARTED|Overall Study||114
8609862|NCT00414206|9647022|FG000|COMPLETED|Overall Study||57
8609863|NCT00414206|9647023|FG001|COMPLETED|Overall Study||58
8609864|NCT00414206|9647024|FG002|COMPLETED|Overall Study||59
8609865|NCT00414206|9647022|FG000|NOT COMPLETED|Overall Study||58
8609866|NCT00414206|9647023|FG001|NOT COMPLETED|Overall Study||56
8609867|NCT00414206|9647024|FG002|NOT COMPLETED|Overall Study||55
8609868|NCT00414271|9647032|FG000|STARTED|Overall Study||18
8609869|NCT00414271|9647032|FG000|COMPLETED|Overall Study||18
8609870|NCT00414271|9647032|FG000|NOT COMPLETED|Overall Study||0
8609871|NCT00414310|9647038|FG000|STARTED|Overall Study||71
8609872|NCT00414310|9647039|FG001|STARTED|Overall Study||79
8609873|NCT00414310|9647038|FG000|COMPLETED|Overall Study||70
8609874|NCT00414310|9647039|FG001|COMPLETED|Overall Study||79
8609875|NCT00414310|9647038|FG000|NOT COMPLETED|Overall Study||1
8609876|NCT00414310|9647039|FG001|NOT COMPLETED|Overall Study||0
8609877|NCT00414388|9647047|FG000|STARTED|Overall Study||22
8609878|NCT00414388|9647047|FG000|COMPLETED|Overall Study||21
8609879|NCT00414388|9647047|FG000|NOT COMPLETED|Overall Study||1
8609880|NCT00414440|9647054|FG000|STARTED|Core Period|Core period|214
8609881|NCT00414440|9647055|FG001|STARTED|Core Period|Core period|217
8609882|NCT00414440|9647054|FG000|COMPLETED|Core Period|Core period|144
8609883|NCT00414440|9647055|FG001|COMPLETED|Core Period|Core period|185
8609884|NCT00414440|9647054|FG000|NOT COMPLETED|Core Period||70
8609885|NCT00414440|9647055|FG001|NOT COMPLETED|Core Period||32
8609886|NCT00414440|9647054|FG000|STARTED|Extension Period|Extension|214
8609887|NCT00414440|9647055|FG001|STARTED|Extension Period|Extension|217
8609888|NCT00414440|9647054|FG000|COMPLETED|Extension Period|Extension|64
8609889|NCT00414440|9647055|FG001|COMPLETED|Extension Period|Extension|77
8609890|NCT00414440|9647054|FG000|NOT COMPLETED|Extension Period||150
8609891|NCT00414440|9647055|FG001|NOT COMPLETED|Extension Period||140
8609892|NCT00414466|9647065|FG000|STARTED|Overall Study||44
8609893|NCT00414466|9647066|FG001|STARTED|Overall Study||42
8609894|NCT00414466|9647067|FG002|STARTED|Overall Study||41
8609895|NCT00414466|9647068|FG003|STARTED|Overall Study||43
8609896|NCT00414466|9647065|FG000|COMPLETED|Overall Study||42
8609897|NCT00414466|9647066|FG001|COMPLETED|Overall Study||42
8609898|NCT00414466|9647067|FG002|COMPLETED|Overall Study||40
8609899|NCT00414466|9647068|FG003|COMPLETED|Overall Study||42
8609900|NCT00414466|9647065|FG000|NOT COMPLETED|Overall Study||2
8609901|NCT00414466|9647066|FG001|NOT COMPLETED|Overall Study||0
8609902|NCT00414466|9647067|FG002|NOT COMPLETED|Overall Study||1
8609903|NCT00414466|9647068|FG003|NOT COMPLETED|Overall Study||1
8609904|NCT00414518|9647083|FG000|STARTED|Overall Study||7
8609905|NCT00414518|9647084|FG001|STARTED|Overall Study||9
8609906|NCT00414518|9647083|FG000|COMPLETED|Overall Study||7
8609907|NCT00414518|9647084|FG001|COMPLETED|Overall Study||9
8609908|NCT00414518|9647083|FG000|NOT COMPLETED|Overall Study||0
8609909|NCT00414518|9647084|FG001|NOT COMPLETED|Overall Study||0
8609910|NCT00414544|9647094|FG000|STARTED|Overall Study||145
8609911|NCT00414544|9647094|FG000|COMPLETED|Overall Study||131
8609912|NCT00414544|9647094|FG000|NOT COMPLETED|Overall Study||14
8609913|NCT00414596|9647100|FG000|STARTED|Overall Study|December 2006|20
8609914|NCT00414596|9647100|FG000|COMPLETED|Overall Study|April 2007|18
8609915|NCT00414596|9647100|FG000|NOT COMPLETED|Overall Study||2
8609916|NCT00414609|9647106|FG000|STARTED|Core Study||397
8609917|NCT00414609|9647107|FG001|STARTED|Core Study||423
8609918|NCT00414609|9647108|FG002|STARTED|Core Study||0
8609919|NCT00414609|9647106|FG000|Received Study Drug|Core Study||397
8609920|NCT00414609|9647107|FG001|Received Study Drug|Core Study||422
8609921|NCT00414609|9647108|FG002|Received Study Drug|Core Study||0
8609922|NCT00414609|9647106|FG000|Echocardiogram Evaluable Set|Core Study||330
8609923|NCT00414609|9647107|FG001|Echocardiogram Evaluable Set|Core Study||343
8609924|NCT00414609|9647108|FG002|Echocardiogram Evaluable Set|Core Study||0
8609925|NCT00414609|9647106|FG000|COMPLETED|Core Study||363
8609926|NCT00414609|9647107|FG001|COMPLETED|Core Study||378
8609927|NCT00414609|9647108|FG002|COMPLETED|Core Study||0
8609928|NCT00414609|9647106|FG000|NOT COMPLETED|Core Study||34
8609929|NCT00414609|9647107|FG001|NOT COMPLETED|Core Study||45
8609930|NCT00414609|9647108|FG002|NOT COMPLETED|Core Study||0
8609931|NCT00414609|9647106|FG000|STARTED|Extension Study||0
8609932|NCT00414609|9647107|FG001|STARTED|Extension Study||0
8609933|NCT00414609|9647108|FG002|STARTED|Extension Study|Patients of both core arms who completed core study and signed informed consent form for extension.|422
8609934|NCT00414609|9647106|FG000|Echocardiogram (ECHO) Analysis Set|Extension Study||0
8609935|NCT00414609|9647107|FG001|Echocardiogram (ECHO) Analysis Set|Extension Study||0
8609936|NCT00414609|9647108|FG002|Echocardiogram (ECHO) Analysis Set|Extension Study||400
8609937|NCT00414609|9647106|FG000|COMPLETED|Extension Study||0
8609938|NCT00414609|9647107|FG001|COMPLETED|Extension Study||0
8609939|NCT00414609|9647108|FG002|COMPLETED|Extension Study||365
8609940|NCT00414609|9647106|FG000|NOT COMPLETED|Extension Study||0
8609941|NCT00414609|9647107|FG001|NOT COMPLETED|Extension Study||0
8609942|NCT00414609|9647108|FG002|NOT COMPLETED|Extension Study||57
8609943|NCT00414635|9647119|FG000|STARTED|Overall Study||30
8609944|NCT00414635|9647120|FG001|STARTED|Overall Study||30
8609945|NCT00414635|9647119|FG000|COMPLETED|Overall Study||25
8609946|NCT00414635|9647120|FG001|COMPLETED|Overall Study||28
8609947|NCT00414635|9647119|FG000|NOT COMPLETED|Overall Study||5
8609948|NCT00414635|9647120|FG001|NOT COMPLETED|Overall Study||2
8609949|NCT00414661|9647130|FG000|STARTED|Overall Study||48
8609950|NCT00414661|9647131|FG001|STARTED|Overall Study||89
8609951|NCT00414661|9647132|FG002|STARTED|Overall Study||22
8609952|NCT00414661|9647133|FG003|STARTED|Overall Study||3
8609953|NCT00414661|9647130|FG000|COMPLETED|Overall Study||34
8609954|NCT00414661|9647131|FG001|COMPLETED|Overall Study||75
8609955|NCT00414661|9647132|FG002|COMPLETED|Overall Study||20
8609956|NCT00414661|9647133|FG003|COMPLETED|Overall Study||0
8609957|NCT00414661|9647130|FG000|NOT COMPLETED|Overall Study||14
8609958|NCT00414661|9647131|FG001|NOT COMPLETED|Overall Study||14
8609959|NCT00414661|9647132|FG002|NOT COMPLETED|Overall Study||2
8609960|NCT00414661|9647133|FG003|NOT COMPLETED|Overall Study||3
8609961|NCT00414700|9647145|FG000|STARTED|Overall Study||57
8609962|NCT00414700|9647146|FG001|STARTED|Overall Study||61
8609963|NCT00414700|9647145|FG000|COMPLETED|Overall Study||51
8609964|NCT00414700|9647146|FG001|COMPLETED|Overall Study||58
8609965|NCT00414700|9647145|FG000|NOT COMPLETED|Overall Study||6
8609966|NCT00414700|9647146|FG001|NOT COMPLETED|Overall Study||3
8609967|NCT00414726|9647154|FG000|STARTED|Overall Study||43
8609968|NCT00414726|9647155|FG001|STARTED|Overall Study||42
8609969|NCT00414726|9647154|FG000|COMPLETED|Overall Study||43
8609970|NCT00414726|9647155|FG001|COMPLETED|Overall Study||41
8609971|NCT00414726|9647154|FG000|NOT COMPLETED|Overall Study||0
8609972|NCT00414726|9647155|FG001|NOT COMPLETED|Overall Study||1
8609973|NCT00414765|9647163|FG000|STARTED|Overall Study||7
8609974|NCT00414765|9647164|FG001|STARTED|Overall Study||19
8609975|NCT00414765|9647163|FG000|Completed Study|Overall Study||7
8609976|NCT00414765|9647164|FG001|Completed Study|Overall Study||18
8609977|NCT00414765|9647163|FG000|Completed Cycle 1|Overall Study||7
8609978|NCT00414765|9647164|FG001|Completed Cycle 1|Overall Study||19
8609979|NCT00414765|9647163|FG000|Completed Cycle 2|Overall Study||4
8609980|NCT00414765|9647164|FG001|Completed Cycle 2|Overall Study||16
8609981|NCT00414765|9647163|FG000|COMPLETED|Overall Study||1
8609982|NCT00414765|9647164|FG001|COMPLETED|Overall Study||8
8609983|NCT00414765|9647163|FG000|NOT COMPLETED|Overall Study||6
8609984|NCT00414765|9647164|FG001|NOT COMPLETED|Overall Study||11
8609985|NCT00414817|9647172|FG000|STARTED|Overall Study||7033
8609986|NCT00414817|9647173|FG001|STARTED|Overall Study||7031
8609987|NCT00414817|9647172|FG000|Never Started on ICS|Overall Study|Not initial users of ICS and not starting during study, hence don't qualify for analysis sample.|1465
8609988|NCT00414817|9647173|FG001|Never Started on ICS|Overall Study|Not initial users of ICS and not starting during study, hence don't qualify for analysis sample.|1392
8609989|NCT00414817|9647172|FG000|Died or Left Health Plan|Overall Study|These individuals died or terminated Health Plan membership prior to ever qualifying for a call.|451
8609990|NCT00414817|9647173|FG001|Died or Left Health Plan|Overall Study|These individuals died or terminated Health Plan membership prior to ever qualifying for a call.|417
8609991|NCT00414817|9647172|FG000|Adherent ICS User|Overall Study|Fully adherent ICS users who never qualified for an intervention call.|922
8609992|NCT00414817|9647173|FG001|Adherent ICS User|Overall Study|Fully adherent ICS users who never qualified for an intervention call.|900
8609993|NCT00414817|9647172|FG000|Daily Oral Steroid User|Overall Study|qualified for analysis sample, but excluded due to subsequent determination of oral steroid use.|117
8609994|NCT00414817|9647173|FG001|Daily Oral Steroid User|Overall Study|qualified for analysis sample, but excluded due to subsequent determination of oral steroid use.|123
8609995|NCT00414817|9647172|FG000|<3 Months Follow-up|Overall Study|qualified for analysis sample, but excluded since follow-up too short to assess adherence reliably.|175
8609996|NCT00414817|9647173|FG001|<3 Months Follow-up|Overall Study|qualified for analysis sample, but excluded since follow-up too short to assess adherence reliably.|184
8609997|NCT00414817|9647172|FG000|COMPLETED|Overall Study|Qualified for primary analysis (3171 prior ICS users) or secondary analysis (732 new users) samples.|3903
8609998|NCT00414817|9647173|FG001|COMPLETED|Overall Study|Qualified for primary analysis (3260 prior ICS users) or secondary analysis (755 new users) samples.|4015
8609999|NCT00414817|9647172|FG000|NOT COMPLETED|Overall Study||3130
8610000|NCT00414817|9647173|FG001|NOT COMPLETED|Overall Study||3016
8610001|NCT00414908|9647181|FG000|STARTED|Overall Study||25
8610002|NCT00414908|9647182|FG001|STARTED|Overall Study||29
8610003|NCT00414908|9647181|FG000|COMPLETED|Overall Study||24
8610004|NCT00414908|9647182|FG001|COMPLETED|Overall Study||28
8610005|NCT00414908|9647181|FG000|NOT COMPLETED|Overall Study||1
8610006|NCT00414908|9647182|FG001|NOT COMPLETED|Overall Study||1
8610007|NCT00414960|9647192|FG000|STARTED|Overall Study||25
8610008|NCT00414960|9647193|FG001|STARTED|Overall Study||15
8610009|NCT00414960|9647192|FG000|Received at Least One Dose of Study Drug|Overall Study||24
8610010|NCT00414960|9647193|FG001|Received at Least One Dose of Study Drug|Overall Study||15
8610011|NCT00414960|9647192|FG000|COMPLETED|Overall Study||18
8610012|NCT00414960|9647193|FG001|COMPLETED|Overall Study||14
8610013|NCT00414960|9647192|FG000|NOT COMPLETED|Overall Study||7
8610014|NCT00414960|9647193|FG001|NOT COMPLETED|Overall Study||1
8610015|NCT00414973|9647203|FG000|STARTED|Overall Study||218
8610016|NCT00414973|9647204|FG001|STARTED|Overall Study||109
8715480|NCT00984009|9762372|FG000|COMPLETED|Grapefruit Juice Alone|one subject dropped due to missed a.m. serving of grapefruit juice on Day 16|21
8715481|NCT00984009|9762372|FG000|NOT COMPLETED|Grapefruit Juice Alone||1
8715482|NCT00984009|9762372|FG000|STARTED|Colchicine With Grapefruit Juice||21
8715483|NCT00984009|9762372|FG000|COMPLETED|Colchicine With Grapefruit Juice||21
8715484|NCT00984009|9762372|FG000|NOT COMPLETED|Colchicine With Grapefruit Juice||0
8715485|NCT00984022|9762381|FG000|STARTED|Overall Study||43
8715486|NCT00984022|9762382|FG001|STARTED|Overall Study||49
8715487|NCT00984022|9762381|FG000|COMPLETED|Overall Study||33
8715488|NCT00984022|9762382|FG001|COMPLETED|Overall Study||35
8610017|NCT00414973|9647205|FG002|STARTED|Overall Study||24
8610018|NCT00414973|9647206|FG003|STARTED|Overall Study||11
8610019|NCT00414973|9647203|FG000|COMPLETED|Overall Study||190
8610020|NCT00414973|9647204|FG001|COMPLETED|Overall Study||99
8610021|NCT00414973|9647205|FG002|COMPLETED|Overall Study||21
8610022|NCT00414973|9647206|FG003|COMPLETED|Overall Study||11
8610023|NCT00414973|9647203|FG000|NOT COMPLETED|Overall Study||28
8610024|NCT00414973|9647204|FG001|NOT COMPLETED|Overall Study||10
8610025|NCT00414973|9647205|FG002|NOT COMPLETED|Overall Study||3
8610026|NCT00414973|9647206|FG003|NOT COMPLETED|Overall Study||0
8610027|NCT00415051|9647216|FG000|STARTED|Overall Study||20
8610028|NCT00415051|9647216|FG000|COMPLETED|Overall Study||19
8610029|NCT00415051|9647216|FG000|NOT COMPLETED|Overall Study||1
8610030|NCT00415168|9647220|FG000|STARTED|Overall Study||53
8610031|NCT00415168|9647220|FG000|Completed Treatment|Overall Study||15
8610032|NCT00415168|9647220|FG000|COMPLETED|Overall Study||1
8610033|NCT00415168|9647220|FG000|NOT COMPLETED|Overall Study||52
8610034|NCT00415194|9647226|FG000|STARTED|Overall Study||398
8610035|NCT00415194|9647227|FG001|STARTED|Overall Study||397
8610036|NCT00415194|9647226|FG000|Received at Least 1 Dose of Study Drug|Overall Study||392
8610037|NCT00415194|9647227|FG001|Received at Least 1 Dose of Study Drug|Overall Study||385
8610038|NCT00415194|9647226|FG000|COMPLETED|Overall Study||70
8610039|NCT00415194|9647227|FG001|COMPLETED|Overall Study||55
8610040|NCT00415194|9647226|FG000|NOT COMPLETED|Overall Study||328
8610041|NCT00415194|9647227|FG001|NOT COMPLETED|Overall Study||342
8610042|NCT00415363|9647235|FG000|STARTED|Overall Study||55
8610043|NCT00415363|9647236|FG001|STARTED|Overall Study||54
8610044|NCT00415363|9647235|FG000|Safety Population|Overall Study||54
8610045|NCT00415363|9647236|FG001|Safety Population|Overall Study||53
8610046|NCT00415363|9647235|FG000|COMPLETED|Overall Study||0
8610047|NCT00415363|9647236|FG001|COMPLETED|Overall Study||0
8610048|NCT00415363|9647235|FG000|NOT COMPLETED|Overall Study||55
8610049|NCT00415363|9647236|FG001|NOT COMPLETED|Overall Study||54
8610050|NCT00415493|9647245|FG000|STARTED|Overall Study||12
8610051|NCT00415493|9647246|FG001|STARTED|Overall Study||12
8610052|NCT00415493|9647245|FG000|COMPLETED|Overall Study||12
8610053|NCT00415493|9647246|FG001|COMPLETED|Overall Study||12
8610054|NCT00415493|9647245|FG000|NOT COMPLETED|Overall Study||0
8610055|NCT00415493|9647246|FG001|NOT COMPLETED|Overall Study||0
8610056|NCT00415506|9647254|FG000|STARTED|Overall Study||12
8610057|NCT00415506|9647255|FG001|STARTED|Overall Study||10
8610058|NCT00415506|9647254|FG000|COMPLETED|Overall Study||9
8610059|NCT00415506|9647255|FG001|COMPLETED|Overall Study||9
8610060|NCT00415506|9647254|FG000|NOT COMPLETED|Overall Study||3
8610061|NCT00415506|9647255|FG001|NOT COMPLETED|Overall Study||1
8629137|NCT00528788|9668791|FG000|STARTED|Overall Study||24
8629138|NCT00528788|9668791|FG000|COMPLETED|Overall Study||20
8629139|NCT00528788|9668791|FG000|NOT COMPLETED|Overall Study||4
8715489|NCT00984022|9762381|FG000|NOT COMPLETED|Overall Study||10
8715490|NCT00984022|9762382|FG001|NOT COMPLETED|Overall Study||14
8813279|NCT01524913|9866434|FG000|COMPLETED|Overall Study||31
8813280|NCT01524913|9866435|FG001|COMPLETED|Overall Study||36
8813281|NCT01524913|9866436|FG002|COMPLETED|Overall Study||31
8813282|NCT01524913|9866434|FG000|NOT COMPLETED|Overall Study||4
8813283|NCT01524913|9866435|FG001|NOT COMPLETED|Overall Study||0
8813284|NCT01524913|9866436|FG002|NOT COMPLETED|Overall Study||0
8813285|NCT01524978|9866455|FG000|STARTED|Overall Study||62
8813286|NCT01524978|9866456|FG001|STARTED|Overall Study||4
8813287|NCT01524978|9866457|FG002|STARTED|Overall Study||10
8813288|NCT01524978|9866458|FG003|STARTED|Overall Study||27
8813289|NCT01524978|9866459|FG004|STARTED|Overall Study||9
8813290|NCT01524978|9866460|FG005|STARTED|Overall Study||9
8813291|NCT01524978|9866461|FG006|STARTED|Overall Study||26
8813292|NCT01524978|9866462|FG007|STARTED|Overall Study||12
8813293|NCT01524978|9866463|FG008|STARTED|Overall Study||12
8813294|NCT01524978|9866464|FG009|STARTED|Overall Study||9
8813295|NCT01524978|9866465|FG010|STARTED|Overall Study||28
8813296|NCT01524978|9866455|FG000|COMPLETED|Overall Study||0
8813297|NCT01524978|9866456|FG001|COMPLETED|Overall Study||0
8813298|NCT01524978|9866457|FG002|COMPLETED|Overall Study||0
8813299|NCT01524978|9866458|FG003|COMPLETED|Overall Study||0
8813300|NCT01524978|9866459|FG004|COMPLETED|Overall Study||0
8629140|NCT00528801|9668797|FG000|STARTED|Overall Study||160
8629141|NCT00528801|9668798|FG001|STARTED|Overall Study||52
8813301|NCT01524978|9866460|FG005|COMPLETED|Overall Study||0
8813302|NCT01524978|9866461|FG006|COMPLETED|Overall Study||0
8813303|NCT01524978|9866462|FG007|COMPLETED|Overall Study||0
8629142|NCT00528801|9668797|FG000|COMPLETED|Overall Study||133
8715491|NCT00984061|9762388|FG000|STARTED|Colchicine Alone||24
8813304|NCT01524978|9866463|FG008|COMPLETED|Overall Study||0
8629143|NCT00528801|9668798|FG001|COMPLETED|Overall Study||41
8629144|NCT00528801|9668797|FG000|NOT COMPLETED|Overall Study||27
8813305|NCT01524978|9866464|FG009|COMPLETED|Overall Study||0
8813306|NCT01524978|9866465|FG010|COMPLETED|Overall Study||0
8813307|NCT01524978|9866455|FG000|NOT COMPLETED|Overall Study||62
8813308|NCT01524978|9866456|FG001|NOT COMPLETED|Overall Study||4
8813309|NCT01524978|9866457|FG002|NOT COMPLETED|Overall Study||10
8813310|NCT01524978|9866458|FG003|NOT COMPLETED|Overall Study||27
8813311|NCT01524978|9866459|FG004|NOT COMPLETED|Overall Study||9
8813312|NCT01524978|9866460|FG005|NOT COMPLETED|Overall Study||9
8813313|NCT01524978|9866461|FG006|NOT COMPLETED|Overall Study||26
8813314|NCT01524978|9866462|FG007|NOT COMPLETED|Overall Study||12
8813315|NCT01524978|9866463|FG008|NOT COMPLETED|Overall Study||12
8813316|NCT01524978|9866464|FG009|NOT COMPLETED|Overall Study||9
8813317|NCT01524978|9866465|FG010|NOT COMPLETED|Overall Study||28
8813318|NCT01524991|9866480|FG000|STARTED|Overall Study||36
8813319|NCT01524991|9866480|FG000|COMPLETED|Overall Study||2
8610062|NCT00415519|9647263|FG000|STARTED|Overall Study||13
8610063|NCT00415519|9647264|FG001|STARTED|Overall Study||12
8610064|NCT00415519|9647263|FG000|COMPLETED|Overall Study||9
8610065|NCT00415519|9647264|FG001|COMPLETED|Overall Study||12
8610066|NCT00415519|9647263|FG000|NOT COMPLETED|Overall Study||4
8610067|NCT00415519|9647264|FG001|NOT COMPLETED|Overall Study||0
8610068|NCT00415532|9647272|FG000|STARTED|Treatment Period||77
8610069|NCT00415532|9647273|FG001|STARTED|Treatment Period||157
8610070|NCT00415532|9647272|FG000|Received Treatment|Treatment Period||75
8610071|NCT00415532|9647273|FG001|Received Treatment|Treatment Period||154
8610072|NCT00415532|9647272|FG000|Switched to Romiplostim Group|Treatment Period||2
8610073|NCT00415532|9647273|FG001|Switched to Romiplostim Group|Treatment Period||0
8610074|NCT00415532|9647272|FG000|COMPLETED|Treatment Period||60
8610075|NCT00415532|9647273|FG001|COMPLETED|Treatment Period||142
8610076|NCT00415532|9647272|FG000|NOT COMPLETED|Treatment Period||17
8610077|NCT00415532|9647273|FG001|NOT COMPLETED|Treatment Period||15
8610078|NCT00415532|9647272|FG000|STARTED|Safety Follow Up Period|Participants who completed the treatment period were not required to participate in this follow-up|43
8610079|NCT00415532|9647273|FG001|STARTED|Safety Follow Up Period|Participants who completed the treatment period were not required to participate in this follow-up|30
8610080|NCT00415532|9647272|FG000|COMPLETED|Safety Follow Up Period||34
8610081|NCT00415532|9647273|FG001|COMPLETED|Safety Follow Up Period||18
8610082|NCT00415532|9647272|FG000|NOT COMPLETED|Safety Follow Up Period||9
8610083|NCT00415532|9647273|FG001|NOT COMPLETED|Safety Follow Up Period||12
8610084|NCT00415597|9647279|FG000|STARTED|Enrollment||467
8610085|NCT00415597|9647279|FG000|COMPLETED|Enrollment||465
8610086|NCT00415597|9647279|FG000|NOT COMPLETED|Enrollment||2
8610087|NCT00415597|9647279|FG000|STARTED|Treatment||465
8610088|NCT00415597|9647279|FG000|COMPLETED|Treatment||160
8610089|NCT00415597|9647279|FG000|NOT COMPLETED|Treatment||305
8610090|NCT00415610|9647286|FG000|STARTED|Overall Study||18
8610091|NCT00415610|9647287|FG001|STARTED|Overall Study||20
8610092|NCT00415610|9647288|FG002|STARTED|Overall Study||22
8610093|NCT00415610|9647286|FG000|COMPLETED|Overall Study||15
8610094|NCT00415610|9647287|FG001|COMPLETED|Overall Study||18
8610095|NCT00415610|9647288|FG002|COMPLETED|Overall Study||17
8610096|NCT00415610|9647286|FG000|NOT COMPLETED|Overall Study||3
8610097|NCT00415610|9647287|FG001|NOT COMPLETED|Overall Study||2
8610098|NCT00415610|9647288|FG002|NOT COMPLETED|Overall Study||5
8610099|NCT00415636|9647302|FG000|STARTED|Overall Study||3
8610100|NCT00415636|9647303|FG001|STARTED|Overall Study||3
8610101|NCT00415636|9647304|FG002|STARTED|Overall Study||3
8610102|NCT00415636|9647305|FG003|STARTED|Overall Study||13
8610103|NCT00415636|9647306|FG004|STARTED|Overall Study||6
8610104|NCT00415636|9647307|FG005|STARTED|Overall Study||3
8610105|NCT00415636|9647302|FG000|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|2
8610106|NCT00415636|9647303|FG001|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|3
8610107|NCT00415636|9647304|FG002|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|2
8610108|NCT00415636|9647305|FG003|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|7
8610109|NCT00415636|9647306|FG004|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|4
8610110|NCT00415636|9647307|FG005|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|1
8610111|NCT00415636|9647302|FG000|NOT COMPLETED|Overall Study||1
8610112|NCT00415636|9647303|FG001|NOT COMPLETED|Overall Study||0
8610113|NCT00415636|9647304|FG002|NOT COMPLETED|Overall Study||1
8610114|NCT00415636|9647305|FG003|NOT COMPLETED|Overall Study||6
8610115|NCT00415636|9647306|FG004|NOT COMPLETED|Overall Study||2
8610116|NCT00415636|9647307|FG005|NOT COMPLETED|Overall Study||2
8610117|NCT00415857|9647331|FG000|STARTED|Overall Study||2
8610118|NCT00415857|9647332|FG001|STARTED|Overall Study||3
8610119|NCT00415857|9647331|FG000|COMPLETED|Overall Study||2
8610120|NCT00415857|9647332|FG001|COMPLETED|Overall Study||3
8610121|NCT00415857|9647331|FG000|NOT COMPLETED|Overall Study||0
8610122|NCT00415857|9647332|FG001|NOT COMPLETED|Overall Study||0
8813320|NCT01524991|9866480|FG000|NOT COMPLETED|Overall Study||34
8813321|NCT01525082|9866484|FG000|STARTED|Overall Study||20
8610123|NCT00415870|9647340|FG000|STARTED|Overall Study||32
8610124|NCT00415870|9647341|FG001|STARTED|Overall Study||33
8610125|NCT00415870|9647340|FG000|COMPLETED|Overall Study||26
8610126|NCT00415870|9647341|FG001|COMPLETED|Overall Study||26
8610127|NCT00415870|9647340|FG000|NOT COMPLETED|Overall Study||6
8813322|NCT01525082|9866484|FG000|COMPLETED|Overall Study||19
8813323|NCT01525082|9866484|FG000|NOT COMPLETED|Overall Study||1
8610128|NCT00415870|9647341|FG001|NOT COMPLETED|Overall Study||7
8610129|NCT00415909|9647347|FG000|STARTED|Overall Study||3
8610130|NCT00415909|9647347|FG000|COMPLETED|Overall Study||0
8610131|NCT00415909|9647347|FG000|NOT COMPLETED|Overall Study||3
8610132|NCT00416078|9647353|FG000|STARTED|Overall Study||29
8610133|NCT00416078|9647354|FG001|STARTED|Overall Study||24
8610134|NCT00416078|9647353|FG000|COMPLETED|Overall Study||18
8610135|NCT00416078|9647354|FG001|COMPLETED|Overall Study||16
8610136|NCT00416078|9647353|FG000|NOT COMPLETED|Overall Study||11
8610137|NCT00416078|9647354|FG001|NOT COMPLETED|Overall Study||8
8610138|NCT00416182|9647362|FG000|STARTED|Overall Study||8
8610139|NCT00416182|9647363|FG001|STARTED|Overall Study||8
8610140|NCT00416182|9647362|FG000|COMPLETED|Overall Study||5
8610141|NCT00416182|9647363|FG001|COMPLETED|Overall Study||6
8610142|NCT00416182|9647362|FG000|NOT COMPLETED|Overall Study||3
8610143|NCT00416182|9647363|FG001|NOT COMPLETED|Overall Study||2
8610144|NCT00416195|9647377|FG000|STARTED|Overall Study||10
8610145|NCT00416195|9647378|FG001|STARTED|Overall Study||38
8610146|NCT00416195|9647377|FG000|COMPLETED|Overall Study||8
8610147|NCT00416195|9647378|FG001|COMPLETED|Overall Study||34
8610148|NCT00416195|9647377|FG000|NOT COMPLETED|Overall Study||2
8610149|NCT00416195|9647378|FG001|NOT COMPLETED|Overall Study||4
8610150|NCT00416312|9647384|FG000|STARTED|Overall Study||9
8610151|NCT00416312|9647384|FG000|Conventional Dosimetry|Overall Study||9
8610152|NCT00416312|9647384|FG000|Patient-specific Dosimetry|Overall Study||9
8610153|NCT00416312|9647384|FG000|COMPLETED|Overall Study||7
8610154|NCT00416312|9647384|FG000|NOT COMPLETED|Overall Study||2
8610155|NCT00416455|9647390|FG000|STARTED|Overall Study|This is a diagnostic imaging study.|169
8610156|NCT00416455|9647391|FG001|STARTED|Overall Study|This is a diagnostic imaging study.|215
8610157|NCT00416455|9647390|FG000|COMPLETED|Overall Study|Number of patients with adequate imaging and pathology|153
8610158|NCT00416455|9647391|FG001|COMPLETED|Overall Study|Number of patients with adequate imaging and pathology|207
8610159|NCT00416455|9647390|FG000|NOT COMPLETED|Overall Study||16
8610160|NCT00416455|9647391|FG001|NOT COMPLETED|Overall Study||8
8610161|NCT00416494|9647410|FG000|STARTED|Overall Study||19
8610162|NCT00416494|9647411|FG001|STARTED|Overall Study||31
8610163|NCT00416494|9647410|FG000|COMPLETED|Overall Study||19
8610164|NCT00416494|9647411|FG001|COMPLETED|Overall Study||31
8610165|NCT00416494|9647410|FG000|NOT COMPLETED|Overall Study||0
8610166|NCT00416494|9647411|FG001|NOT COMPLETED|Overall Study||0
8610167|NCT00416520|9647419|FG000|STARTED|Open-label Period||165
8610168|NCT00416520|9647420|FG001|STARTED|Open-label Period||171
8610169|NCT00416520|9647421|FG002|STARTED|Open-label Period||0
8610170|NCT00416520|9647422|FG003|STARTED|Open-label Period||0
8610171|NCT00416520|9647419|FG000|COMPLETED|Open-label Period||105
8610172|NCT00416520|9647420|FG001|COMPLETED|Open-label Period||139
8610173|NCT00416520|9647421|FG002|COMPLETED|Open-label Period||0
8610174|NCT00416520|9647422|FG003|COMPLETED|Open-label Period||0
8610175|NCT00416520|9647419|FG000|NOT COMPLETED|Open-label Period||60
8610176|NCT00416520|9647420|FG001|NOT COMPLETED|Open-label Period||32
8610177|NCT00416520|9647421|FG002|NOT COMPLETED|Open-label Period||0
8610178|NCT00416520|9647422|FG003|NOT COMPLETED|Open-label Period||0
8610179|NCT00416520|9647419|FG000|STARTED|Placebo-controlled Withdrawal Period||0
8610180|NCT00416520|9647420|FG001|STARTED|Placebo-controlled Withdrawal Period||0
8610181|NCT00416520|9647421|FG002|STARTED|Placebo-controlled Withdrawal Period||50
8610182|NCT00416520|9647422|FG003|STARTED|Placebo-controlled Withdrawal Period||54
8610183|NCT00416520|9647419|FG000|COMPLETED|Placebo-controlled Withdrawal Period||0
8610184|NCT00416520|9647420|FG001|COMPLETED|Placebo-controlled Withdrawal Period||0
8610185|NCT00416520|9647421|FG002|COMPLETED|Placebo-controlled Withdrawal Period||49
8610186|NCT00416520|9647422|FG003|COMPLETED|Placebo-controlled Withdrawal Period||49
8610187|NCT00416520|9647419|FG000|NOT COMPLETED|Placebo-controlled Withdrawal Period||0
8610188|NCT00416520|9647420|FG001|NOT COMPLETED|Placebo-controlled Withdrawal Period||0
8610189|NCT00416520|9647421|FG002|NOT COMPLETED|Placebo-controlled Withdrawal Period||1
8610190|NCT00416520|9647422|FG003|NOT COMPLETED|Placebo-controlled Withdrawal Period||5
8610191|NCT00416572|9647435|FG000|STARTED|Overall Study||83
8610192|NCT00416572|9647436|FG001|STARTED|Overall Study||85
8610193|NCT00416572|9647437|FG002|STARTED|Overall Study||84
8610194|NCT00416572|9647435|FG000|COMPLETED|Overall Study||70
8610195|NCT00416572|9647436|FG001|COMPLETED|Overall Study||78
8610196|NCT00416572|9647437|FG002|COMPLETED|Overall Study||76
8610197|NCT00416572|9647435|FG000|NOT COMPLETED|Overall Study||13
8610198|NCT00416572|9647436|FG001|NOT COMPLETED|Overall Study||7
8610199|NCT00416572|9647437|FG002|NOT COMPLETED|Overall Study||8
8610200|NCT00416598|9647445|FG000|STARTED|Induction & Intensification||546
8610201|NCT00416598|9647445|FG000|COMPLETED|Induction & Intensification||134
8610202|NCT00416598|9647445|FG000|NOT COMPLETED|Induction & Intensification||412
8610203|NCT00416598|9647445|FG000|STARTED|Decitabine Maintenance||134
8610204|NCT00416598|9647445|FG000|COMPLETED|Decitabine Maintenance||62
8610205|NCT00416598|9647445|FG000|NOT COMPLETED|Decitabine Maintenance||72
8610206|NCT00416624|9647453|FG000|STARTED|Overall Study||61
8610207|NCT00416624|9647454|FG001|STARTED|Overall Study||60
8610208|NCT00416624|9647455|FG002|STARTED|Overall Study||58
8610209|NCT00416624|9647456|FG003|STARTED|Overall Study||57
8610210|NCT00416624|9647453|FG000|COMPLETED|Overall Study||39
8610211|NCT00416624|9647454|FG001|COMPLETED|Overall Study||33
8610212|NCT00416624|9647455|FG002|COMPLETED|Overall Study||40
8610213|NCT00416624|9647456|FG003|COMPLETED|Overall Study||40
8610214|NCT00416624|9647453|FG000|NOT COMPLETED|Overall Study||22
8610215|NCT00416624|9647454|FG001|NOT COMPLETED|Overall Study||27
8610216|NCT00416624|9647455|FG002|NOT COMPLETED|Overall Study||18
8610217|NCT00416624|9647456|FG003|NOT COMPLETED|Overall Study||17
8610218|NCT00416715|9647466|FG000|STARTED|Overall Study||100
8610219|NCT00416715|9647466|FG000|COMPLETED|Overall Study||85
8610220|NCT00416715|9647466|FG000|NOT COMPLETED|Overall Study||15
8610221|NCT00416793|9647473|FG000|STARTED|Overall Study||9
8610222|NCT00416793|9647473|FG000|COMPLETED|Overall Study||9
8610223|NCT00416793|9647473|FG000|NOT COMPLETED|Overall Study||0
8715492|NCT00984061|9762388|FG000|COMPLETED|Colchicine Alone||24
8715493|NCT00984061|9762388|FG000|NOT COMPLETED|Colchicine Alone||0
8715494|NCT00984061|9762388|FG000|STARTED|21 Day Washout Period||24
8610224|NCT00416884|9647477|FG000|STARTED|Overall Study||1
8610225|NCT00416884|9647477|FG000|COMPLETED|Overall Study||0
8610226|NCT00416884|9647477|FG000|NOT COMPLETED|Overall Study||1
8610227|NCT00416949|9647481|FG000|STARTED|Overall Study||9
8610228|NCT00416949|9647481|FG000|COMPLETED|Overall Study||4
8610229|NCT00416949|9647481|FG000|NOT COMPLETED|Overall Study||5
8610230|NCT00417027|9647488|FG000|STARTED|Overall Study||66
8610231|NCT00417027|9647489|FG001|STARTED|Overall Study||65
8610232|NCT00417027|9647490|FG002|STARTED|Overall Study||59
8610233|NCT00417027|9647488|FG000|COMPLETED|Overall Study||66
8610234|NCT00417027|9647489|FG001|COMPLETED|Overall Study||60
8610235|NCT00417027|9647490|FG002|COMPLETED|Overall Study||54
8610236|NCT00417027|9647488|FG000|NOT COMPLETED|Overall Study||0
8610237|NCT00417027|9647489|FG001|NOT COMPLETED|Overall Study||5
8610238|NCT00417027|9647490|FG002|NOT COMPLETED|Overall Study||5
8610239|NCT00417079|9647500|FG000|STARTED|Overall Study|Randomized patients|377
8610240|NCT00417079|9647501|FG001|STARTED|Overall Study|Randomized patients|378
8610241|NCT00417079|9647500|FG000|COMPLETED|Overall Study|Randomized patients|46
8610242|NCT00417079|9647501|FG001|COMPLETED|Overall Study|Randomized patients|105
8610243|NCT00417079|9647500|FG000|NOT COMPLETED|Overall Study||331
8610244|NCT00417079|9647501|FG001|NOT COMPLETED|Overall Study||273
8610245|NCT00417170|9647509|FG000|STARTED|Overall Study|"Started indicates Safety population."|23
8610246|NCT00417170|9647510|FG001|STARTED|Overall Study||25
8610247|NCT00417170|9647509|FG000|Pharmacodynamics Population|Overall Study||21
8610248|NCT00417170|9647510|FG001|Pharmacodynamics Population|Overall Study||23
8610249|NCT00417170|9647509|FG000|COMPLETED|Overall Study||21
8610250|NCT00417170|9647510|FG001|COMPLETED|Overall Study||22
8610251|NCT00417170|9647509|FG000|NOT COMPLETED|Overall Study||2
8610252|NCT00417170|9647510|FG001|NOT COMPLETED|Overall Study||3
8610253|NCT00417274|9647516|FG000|STARTED|Overall Study||31
8610254|NCT00417274|9647516|FG000|COMPLETED|Overall Study||31
8610255|NCT00417274|9647516|FG000|NOT COMPLETED|Overall Study||0
8610256|NCT00417417|9647522|FG000|STARTED|Overall Study||4
8610257|NCT00417417|9647523|FG001|STARTED|Overall Study||6
8610258|NCT00417417|9647522|FG000|COMPLETED|Overall Study||4
8610259|NCT00417417|9647523|FG001|COMPLETED|Overall Study||6
8610260|NCT00417417|9647522|FG000|NOT COMPLETED|Overall Study||0
8610261|NCT00417417|9647523|FG001|NOT COMPLETED|Overall Study||0
8610262|NCT00417482|9647534|FG000|STARTED|Phase B 1st 16 Weeks|Risperidone 16 weeks.|32
8610263|NCT00417482|9647535|FG001|STARTED|Phase B 1st 16 Weeks|Risperidone 16 weeks.|38
8610264|NCT00417482|9647536|FG002|STARTED|Phase B 1st 16 Weeks|Placebo 16 weeks.|40
8610265|NCT00417482|9647534|FG000|COMPLETED|Phase B 1st 16 Weeks||13
8610266|NCT00417482|9647535|FG001|COMPLETED|Phase B 1st 16 Weeks||27
8610267|NCT00417482|9647536|FG002|COMPLETED|Phase B 1st 16 Weeks||13
8610268|NCT00417482|9647534|FG000|NOT COMPLETED|Phase B 1st 16 Weeks||19
8610269|NCT00417482|9647535|FG001|NOT COMPLETED|Phase B 1st 16 Weeks||11
8610270|NCT00417482|9647536|FG002|NOT COMPLETED|Phase B 1st 16 Weeks||27
8610271|NCT00417482|9647534|FG000|STARTED|Phase B 2nd 16 Weeks|Risperidone for 16 weeks.|13
8610272|NCT00417482|9647535|FG001|STARTED|Phase B 2nd 16 Weeks|Placebo for 16 weeks.|27
8610273|NCT00417482|9647536|FG002|STARTED|Phase B 2nd 16 Weeks|Placebo for 16 weeks.|13
8610274|NCT00417482|9647534|FG000|COMPLETED|Phase B 2nd 16 Weeks||10
8610275|NCT00417482|9647535|FG001|COMPLETED|Phase B 2nd 16 Weeks||14
8610276|NCT00417482|9647536|FG002|COMPLETED|Phase B 2nd 16 Weeks||10
8610277|NCT00417482|9647534|FG000|NOT COMPLETED|Phase B 2nd 16 Weeks||3
8610278|NCT00417482|9647535|FG001|NOT COMPLETED|Phase B 2nd 16 Weeks||13
8610279|NCT00417482|9647536|FG002|NOT COMPLETED|Phase B 2nd 16 Weeks||3
8610280|NCT00417612|9647552|FG000|STARTED|Overall Study||22
8610281|NCT00417612|9647553|FG001|STARTED|Overall Study||11
8610282|NCT00417612|9647552|FG000|COMPLETED|Overall Study||19
8610283|NCT00417612|9647553|FG001|COMPLETED|Overall Study||8
8610284|NCT00417612|9647552|FG000|NOT COMPLETED|Overall Study||3
8610285|NCT00417612|9647553|FG001|NOT COMPLETED|Overall Study||3
8610286|NCT00417859|9647563|FG000|STARTED|Overall Study||26
8610287|NCT00417859|9647564|FG001|STARTED|Overall Study||30
8610288|NCT00417859|9647563|FG000|COMPLETED|Overall Study||26
8610289|NCT00417859|9647564|FG001|COMPLETED|Overall Study||29
8610290|NCT00417859|9647563|FG000|NOT COMPLETED|Overall Study||0
8610291|NCT00417859|9647564|FG001|NOT COMPLETED|Overall Study||1
8610292|NCT00417885|9647572|FG000|STARTED|Overall Study||6
8610293|NCT00417885|9647572|FG000|COMPLETED|Overall Study||0
8715495|NCT00984061|9762388|FG000|COMPLETED|21 Day Washout Period||24
8610294|NCT00417885|9647572|FG000|NOT COMPLETED|Overall Study||6
8610295|NCT00417963|9647576|FG000|STARTED|Overall Study|79 participants were enrolled in the roll-in cohort and 407 in the pivotal cohort.|486
8715496|NCT00984061|9762388|FG000|NOT COMPLETED|21 Day Washout Period||0
8610296|NCT00417963|9647576|FG000|COMPLETED|Overall Study|79 subjects completed in the roll-in cohort and 371 in the pivotal cohort.|445
8610297|NCT00417963|9647576|FG000|NOT COMPLETED|Overall Study||41
8610298|NCT00417976|9647585|FG000|STARTED|Overall Study||42
8610299|NCT00417976|9647585|FG000|COMPLETED|Overall Study||39
8610300|NCT00417976|9647585|FG000|NOT COMPLETED|Overall Study||3
8610301|NCT00417989|9647592|FG000|STARTED|Overall Study|Intent to Treat include safety population & subjects with baseline & 1 post baseline A1C measurement|244
8610302|NCT00417989|9647593|FG001|STARTED|Overall Study||241
8610303|NCT00417989|9647592|FG000|COMPLETED|Overall Study||224
8610304|NCT00417989|9647593|FG001|COMPLETED|Overall Study||219
8610305|NCT00417989|9647592|FG000|NOT COMPLETED|Overall Study||20
8610306|NCT00417989|9647593|FG001|NOT COMPLETED|Overall Study||22
8610307|NCT00418015|9647605|FG000|STARTED|Overall Study||144
8610308|NCT00418015|9647606|FG001|STARTED|Overall Study||46
8610309|NCT00418015|9647607|FG002|STARTED|Overall Study||78
8610310|NCT00418015|9647608|FG003|STARTED|Overall Study||25
8610311|NCT00418015|9647605|FG000|COMPLETED|Overall Study||144
8610312|NCT00418015|9647606|FG001|COMPLETED|Overall Study||46
8610313|NCT00418015|9647607|FG002|COMPLETED|Overall Study||78
8610314|NCT00418015|9647608|FG003|COMPLETED|Overall Study||25
8610315|NCT00418015|9647605|FG000|NOT COMPLETED|Overall Study||0
8610316|NCT00418015|9647606|FG001|NOT COMPLETED|Overall Study||0
8610317|NCT00418015|9647607|FG002|NOT COMPLETED|Overall Study||0
8610318|NCT00418015|9647608|FG003|NOT COMPLETED|Overall Study||0
8610319|NCT00418028|9647620|FG000|STARTED|Overall Study||97
8610320|NCT00418028|9647621|FG001|STARTED|Overall Study||98
8610321|NCT00418028|9647620|FG000|COMPLETED|Overall Study||95
8610322|NCT00418028|9647621|FG001|COMPLETED|Overall Study||97
8610323|NCT00418028|9647620|FG000|NOT COMPLETED|Overall Study||2
8610324|NCT00418028|9647621|FG001|NOT COMPLETED|Overall Study||1
8610325|NCT00418093|9647627|FG000|STARTED|Overall Study||19
8610326|NCT00418093|9647627|FG000|Completed Study|Overall Study||19
8610327|NCT00418093|9647627|FG000|COMPLETED|Overall Study||19
8610328|NCT00418093|9647627|FG000|NOT COMPLETED|Overall Study||0
8610329|NCT00418184|9647633|FG000|STARTED|Double-blind Phase||137
8610330|NCT00418184|9647634|FG001|STARTED|Double-blind Phase||63
8610331|NCT00418184|9647633|FG000|COMPLETED|Double-blind Phase||110
8610332|NCT00418184|9647634|FG001|COMPLETED|Double-blind Phase||52
8610333|NCT00418184|9647633|FG000|NOT COMPLETED|Double-blind Phase||27
8610334|NCT00418184|9647634|FG001|NOT COMPLETED|Double-blind Phase||11
8610335|NCT00418184|9647633|FG000|STARTED|Open-label Phase|3 were not included due to low compliance in the double blind phase, 5 didn't want to participate.|102
8610336|NCT00418184|9647634|FG001|STARTED|Open-label Phase|1 was not included due to low compliance in the double blind phase, 3 didn't want to participate.|48
8610337|NCT00418184|9647633|FG000|COMPLETED|Open-label Phase|5 dropped out|97
8610338|NCT00418184|9647634|FG001|COMPLETED|Open-label Phase|5 dropped out|43
8610339|NCT00418184|9647633|FG000|NOT COMPLETED|Open-label Phase||5
8610340|NCT00418184|9647634|FG001|NOT COMPLETED|Open-label Phase||5
8610341|NCT00418262|9647640|FG000|STARTED|Visits 1 (Baseline) Thru 5||27
8610342|NCT00418262|9647640|FG000|COMPLETED|Visits 1 (Baseline) Thru 5||25
8610343|NCT00418262|9647640|FG000|NOT COMPLETED|Visits 1 (Baseline) Thru 5||2
8610344|NCT00418262|9647640|FG000|STARTED|Visits 5 Thru 8||25
8610345|NCT00418262|9647640|FG000|COMPLETED|Visits 5 Thru 8||16
8610346|NCT00418262|9647640|FG000|NOT COMPLETED|Visits 5 Thru 8||9
8610347|NCT00418262|9647640|FG000|STARTED|Visits 8 Thru 10||16
8610348|NCT00418262|9647640|FG000|COMPLETED|Visits 8 Thru 10||11
8610349|NCT00418262|9647640|FG000|NOT COMPLETED|Visits 8 Thru 10||5
8610350|NCT00418314|9647650|FG000|STARTED|Overall Study||817
8610351|NCT00418314|9647651|FG001|STARTED|Overall Study||830
8610352|NCT00418314|9647650|FG000|COMPLETED|Overall Study||816
8610353|NCT00418314|9647651|FG001|COMPLETED|Overall Study||828
8610354|NCT00418314|9647650|FG000|NOT COMPLETED|Overall Study||1
8610355|NCT00418314|9647651|FG001|NOT COMPLETED|Overall Study||2
8610356|NCT00418379|9647660|FG000|STARTED|Year 1||207
8610357|NCT00418379|9647661|FG001|STARTED|Year 1||207
8610358|NCT00418379|9647662|FG002|STARTED|Year 1||219
8610359|NCT00418379|9647660|FG000|COMPLETED|Year 1||189
8610360|NCT00418379|9647661|FG001|COMPLETED|Year 1||179
8610361|NCT00418379|9647662|FG002|COMPLETED|Year 1||204
8610362|NCT00418379|9647660|FG000|NOT COMPLETED|Year 1||18
8610363|NCT00418379|9647661|FG001|NOT COMPLETED|Year 1||28
8610364|NCT00418379|9647662|FG002|NOT COMPLETED|Year 1||15
8610365|NCT00418379|9647660|FG000|STARTED|Year 2|22 patients withdrew between Year 1 and Year 2 treatment periods.|167
8610366|NCT00418379|9647661|FG001|STARTED|Year 2|20 patients withdrew between Year 1 and Year 2 treatment periods.|159
8610367|NCT00418379|9647662|FG002|STARTED|Year 2|22 patients withdrew between Year 1 and Year 2 treatment periods.|182
8610368|NCT00418379|9647660|FG000|COMPLETED|Year 2||159
8610369|NCT00418379|9647661|FG001|COMPLETED|Year 2||155
8610370|NCT00418379|9647662|FG002|COMPLETED|Year 2||172
8610371|NCT00418379|9647660|FG000|NOT COMPLETED|Year 2||8
8610372|NCT00418379|9647661|FG001|NOT COMPLETED|Year 2||4
8610373|NCT00418379|9647662|FG002|NOT COMPLETED|Year 2||10
8610374|NCT00418379|9647660|FG000|STARTED|Year 3|8 patients withdrew between Year 2 and Year 3 treatment periods.|151
8610375|NCT00418379|9647661|FG001|STARTED|Year 3|7 patients withdrew between Year 2 and Year 3 treatment periods.|148
8610376|NCT00418379|9647662|FG002|STARTED|Year 3|6 patients withdrew between Year 2 and Year 3 treatment periods.|166
8610377|NCT00418379|9647660|FG000|COMPLETED|Year 3||148
8610378|NCT00418379|9647661|FG001|COMPLETED|Year 3||146
8610379|NCT00418379|9647662|FG002|COMPLETED|Year 3||163
8610380|NCT00418379|9647660|FG000|NOT COMPLETED|Year 3||3
8610381|NCT00418379|9647661|FG001|NOT COMPLETED|Year 3||2
8610382|NCT00418379|9647662|FG002|NOT COMPLETED|Year 3||3
8610383|NCT00418379|9647660|FG000|STARTED|Year 4|3 patients withdrew between Year 3 and Year 4 study periods.|145
8610384|NCT00418379|9647661|FG001|STARTED|Year 4|5 patients withdrew between Year 3 and Year 4 study periods.|141
8610385|NCT00418379|9647662|FG002|STARTED|Year 4|7 patients withdrew between Year 3 and Year 4 study periods.|156
8610386|NCT00418379|9647660|FG000|COMPLETED|Year 4||142
8610387|NCT00418379|9647661|FG001|COMPLETED|Year 4||136
8610388|NCT00418379|9647662|FG002|COMPLETED|Year 4||154
8610389|NCT00418379|9647660|FG000|NOT COMPLETED|Year 4||3
8610390|NCT00418379|9647661|FG001|NOT COMPLETED|Year 4||5
8610391|NCT00418379|9647662|FG002|NOT COMPLETED|Year 4||2
8610392|NCT00418379|9647660|FG000|STARTED|Year 5|14 patients withdrew between Year 4 and Year 5 study periods.|128
8610393|NCT00418379|9647661|FG001|STARTED|Year 5|16 patients withdrew between Year 4 and Year 5 study periods.|120
8610394|NCT00418379|9647662|FG002|STARTED|Year 5|20 patients withdrew between Year 4 and Year 5 study periods.|134
8610395|NCT00418379|9647660|FG000|COMPLETED|Year 5||126
8610396|NCT00418379|9647661|FG001|COMPLETED|Year 5||115
8610397|NCT00418379|9647662|FG002|COMPLETED|Year 5||131
8610398|NCT00418379|9647660|FG000|NOT COMPLETED|Year 5||2
8610399|NCT00418379|9647661|FG001|NOT COMPLETED|Year 5||5
8610400|NCT00418379|9647662|FG002|NOT COMPLETED|Year 5||3
8610401|NCT00418457|9647672|FG000|STARTED|Overall Study||1065
8610402|NCT00418457|9647673|FG001|STARTED|Overall Study||1043
8610403|NCT00418457|9647672|FG000|COMPLETED|Overall Study||1065
8610404|NCT00418457|9647673|FG001|COMPLETED|Overall Study||1043
8610405|NCT00418457|9647672|FG000|NOT COMPLETED|Overall Study||0
8610406|NCT00418457|9647673|FG001|NOT COMPLETED|Overall Study||0
8610407|NCT00418522|9647681|FG000|STARTED|Overall Study||219
8610408|NCT00418522|9647682|FG001|STARTED|Overall Study||194
8610409|NCT00418522|9647681|FG000|Received Treatment|Overall Study||212
8610410|NCT00418522|9647682|FG001|Received Treatment|Overall Study||190
8610411|NCT00418522|9647681|FG000|COMPLETED|Overall Study||136
8610412|NCT00418522|9647682|FG001|COMPLETED|Overall Study||152
8610413|NCT00418522|9647681|FG000|NOT COMPLETED|Overall Study||83
8610414|NCT00418522|9647682|FG001|NOT COMPLETED|Overall Study||42
8610415|NCT00418561|9647691|FG000|STARTED|Overall Study||4
8610416|NCT00418561|9647692|FG001|STARTED|Overall Study||5
8610417|NCT00418561|9647693|FG002|STARTED|Overall Study||4
8610418|NCT00418561|9647691|FG000|COMPLETED|Overall Study||4
8610419|NCT00418561|9647692|FG001|COMPLETED|Overall Study||4
8610420|NCT00418561|9647693|FG002|COMPLETED|Overall Study||4
8610421|NCT00418561|9647691|FG000|NOT COMPLETED|Overall Study||0
8610422|NCT00418561|9647692|FG001|NOT COMPLETED|Overall Study||1
8610423|NCT00418561|9647693|FG002|NOT COMPLETED|Overall Study||0
8610424|NCT00418574|9647703|FG000|STARTED|Overall Study||593
8610425|NCT00418574|9647704|FG001|STARTED|Overall Study||295
8610426|NCT00418574|9647703|FG000|TREATED|Overall Study||592
8610427|NCT00418574|9647704|FG001|TREATED|Overall Study||294
8610428|NCT00418574|9647703|FG000|COMPLETED|Overall Study||545
8610429|NCT00418574|9647704|FG001|COMPLETED|Overall Study||272
8610430|NCT00418574|9647703|FG000|NOT COMPLETED|Overall Study||48
8610431|NCT00418574|9647704|FG001|NOT COMPLETED|Overall Study||23
8610432|NCT00418665|9647713|FG000|STARTED|Treatment Period||12
8610433|NCT00418665|9647714|FG001|STARTED|Treatment Period||14
8610434|NCT00418665|9647715|FG002|STARTED|Treatment Period||13
8610435|NCT00418665|9647713|FG000|Received Study Medication|Treatment Period||11
8610436|NCT00418665|9647714|FG001|Received Study Medication|Treatment Period||13
8610437|NCT00418665|9647715|FG002|Received Study Medication|Treatment Period||13
8610438|NCT00418665|9647713|FG000|COMPLETED|Treatment Period||7
8610439|NCT00418665|9647714|FG001|COMPLETED|Treatment Period||8
8610440|NCT00418665|9647715|FG002|COMPLETED|Treatment Period||9
8610441|NCT00418665|9647713|FG000|NOT COMPLETED|Treatment Period||5
8610442|NCT00418665|9647714|FG001|NOT COMPLETED|Treatment Period||6
8610443|NCT00418665|9647715|FG002|NOT COMPLETED|Treatment Period||4
8610444|NCT00418665|9647713|FG000|STARTED|Treatment Extension||7
8610445|NCT00418665|9647714|FG001|STARTED|Treatment Extension||8
8610446|NCT00418665|9647715|FG002|STARTED|Treatment Extension||9
8610447|NCT00418665|9647713|FG000|COMPLETED|Treatment Extension||1
8610448|NCT00418665|9647714|FG001|COMPLETED|Treatment Extension||4
8610449|NCT00418665|9647715|FG002|COMPLETED|Treatment Extension||7
8610450|NCT00418665|9647713|FG000|NOT COMPLETED|Treatment Extension||6
8610451|NCT00418665|9647714|FG001|NOT COMPLETED|Treatment Extension||4
8610452|NCT00418665|9647715|FG002|NOT COMPLETED|Treatment Extension||2
8610453|NCT00418691|9647726|FG000|STARTED|Overall Study||11
8610454|NCT00418691|9647727|FG001|STARTED|Overall Study||12
8610455|NCT00418691|9647728|FG002|STARTED|Overall Study||10
8610456|NCT00418691|9647726|FG000|COMPLETED|Overall Study||9
8610457|NCT00418691|9647727|FG001|COMPLETED|Overall Study||10
8610458|NCT00418691|9647728|FG002|COMPLETED|Overall Study||5
8610459|NCT00418691|9647726|FG000|NOT COMPLETED|Overall Study||2
8610460|NCT00418691|9647727|FG001|NOT COMPLETED|Overall Study||2
8610461|NCT00418691|9647728|FG002|NOT COMPLETED|Overall Study||5
8610462|NCT00418717|9647736|FG000|STARTED|Treatment Period A - Weeks 1-4||42
8610463|NCT00418717|9647736|FG000|COMPLETED|Treatment Period A - Weeks 1-4||41
8610464|NCT00418717|9647736|FG000|NOT COMPLETED|Treatment Period A - Weeks 1-4||1
8610465|NCT00418717|9647736|FG000|STARTED|Treatment Period B - Weeks 5-12||41
8610466|NCT00418717|9647736|FG000|COMPLETED|Treatment Period B - Weeks 5-12||39
8610467|NCT00418717|9647736|FG000|NOT COMPLETED|Treatment Period B - Weeks 5-12||2
8610468|NCT00418886|9647742|FG000|STARTED|Overall Study|randomised patients|256
8610469|NCT00418886|9647743|FG001|STARTED|Overall Study|randomised patients|278
8610470|NCT00418886|9647742|FG000|COMPLETED|Overall Study|ongoing study treatment at data cut-off|30
8610471|NCT00418886|9647743|FG001|COMPLETED|Overall Study|ongoing study treatment at data cut-off|23
8610472|NCT00418886|9647742|FG000|NOT COMPLETED|Overall Study||226
8610473|NCT00418886|9647743|FG001|NOT COMPLETED|Overall Study||255
8610474|NCT00418938|9647751|FG000|STARTED|Overall Study||133
8610475|NCT00418938|9647752|FG001|STARTED|Overall Study||131
8610476|NCT00418938|9647751|FG000|COMPLETED|Overall Study||109
8610477|NCT00418938|9647752|FG001|COMPLETED|Overall Study||108
8610478|NCT00418938|9647751|FG000|NOT COMPLETED|Overall Study||24
8610479|NCT00418938|9647752|FG001|NOT COMPLETED|Overall Study||23
8610480|NCT00418951|9647761|FG000|STARTED|Overall Study||39
8610481|NCT00418951|9647762|FG001|STARTED|Overall Study||33
8610482|NCT00418951|9647763|FG002|STARTED|Overall Study||40
8610483|NCT00418951|9647761|FG000|COMPLETED|Overall Study||39
8610484|NCT00418951|9647762|FG001|COMPLETED|Overall Study||33
8610485|NCT00418951|9647763|FG002|COMPLETED|Overall Study||40
8610486|NCT00418951|9647761|FG000|NOT COMPLETED|Overall Study||0
8610487|NCT00418951|9647762|FG001|NOT COMPLETED|Overall Study||0
8610488|NCT00418951|9647763|FG002|NOT COMPLETED|Overall Study||0
8610489|NCT00418964|9647774|FG000|STARTED|Overall Study||22
8610490|NCT00418964|9647775|FG001|STARTED|Overall Study||20
8610491|NCT00418964|9647776|FG002|STARTED|Overall Study||20
8610492|NCT00418964|9647774|FG000|COMPLETED|Overall Study||21
8610493|NCT00418964|9647775|FG001|COMPLETED|Overall Study||17
8610494|NCT00418964|9647776|FG002|COMPLETED|Overall Study||14
8610495|NCT00418964|9647774|FG000|NOT COMPLETED|Overall Study||1
8610496|NCT00418964|9647775|FG001|NOT COMPLETED|Overall Study||3
8610497|NCT00418964|9647776|FG002|NOT COMPLETED|Overall Study||6
8610498|NCT00418977|9647786|FG000|STARTED|Overall Study||43
8610499|NCT00418977|9647787|FG001|STARTED|Overall Study||16
8610500|NCT00418977|9647786|FG000|COMPLETED|Overall Study||40
8610501|NCT00418977|9647787|FG001|COMPLETED|Overall Study||13
8610502|NCT00418977|9647786|FG000|NOT COMPLETED|Overall Study||3
8610503|NCT00418977|9647787|FG001|NOT COMPLETED|Overall Study||3
8610504|NCT00419003|9647795|FG000|STARTED|Phase I, Ketamine Infusion||13
8610505|NCT00419003|9647796|FG001|STARTED|Phase I, Ketamine Infusion||13
8610506|NCT00419003|9647795|FG000|COMPLETED|Phase I, Ketamine Infusion||7
8610507|NCT00419003|9647796|FG001|COMPLETED|Phase I, Ketamine Infusion||7
8610508|NCT00419003|9647795|FG000|NOT COMPLETED|Phase I, Ketamine Infusion||6
8610509|NCT00419003|9647796|FG001|NOT COMPLETED|Phase I, Ketamine Infusion||6
8610510|NCT00419003|9647795|FG000|STARTED|Phase 2, Riluzole/Placebo Follow-Up|14 completers of phase I didn't split up evenly (same way as phase I) in the riluzole/placebo phase.|6
8610511|NCT00419003|9647796|FG001|STARTED|Phase 2, Riluzole/Placebo Follow-Up|14 completers of phase I didn't split up evenly (same way as phase I) in the riluzole/placebo phase.|8
8610512|NCT00419003|9647795|FG000|COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||5
8610513|NCT00419003|9647796|FG001|COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||8
8610514|NCT00419003|9647795|FG000|NOT COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||1
8610515|NCT00419003|9647796|FG001|NOT COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||0
8610516|NCT00419094|9647807|FG000|STARTED|Overall Study|Number started refers to number randomized; 303 subjects were screened/enrolled and 228 randomized.|57
8610517|NCT00419094|9647808|FG001|STARTED|Overall Study||171
8610518|NCT00419094|9647807|FG000|COMPLETED|Overall Study||50
8610519|NCT00419094|9647808|FG001|COMPLETED|Overall Study||141
8610520|NCT00419094|9647807|FG000|NOT COMPLETED|Overall Study||7
8610521|NCT00419094|9647808|FG001|NOT COMPLETED|Overall Study||30
8610522|NCT00419120|9647814|FG000|STARTED|Primary Study Period||10
8610523|NCT00419120|9647814|FG000|COMPLETED|Primary Study Period||10
8610524|NCT00419120|9647814|FG000|NOT COMPLETED|Primary Study Period||0
8610525|NCT00419120|9647814|FG000|STARTED|Long Term Follow up Period|10 patients are being followed in long term follow up.|10
8610526|NCT00419120|9647814|FG000|COMPLETED|Long Term Follow up Period||0
8610527|NCT00419120|9647814|FG000|NOT COMPLETED|Long Term Follow up Period||10
8610528|NCT00419159|9647820|FG000|STARTED|Overall Study|Full Analysis Set|99
8610529|NCT00419159|9647821|FG001|STARTED|Overall Study||100
8610530|NCT00419159|9647820|FG000|COMPLETED|Overall Study||0
8610531|NCT00419159|9647821|FG001|COMPLETED|Overall Study||0
8610532|NCT00419159|9647820|FG000|NOT COMPLETED|Overall Study||99
8610533|NCT00419159|9647821|FG001|NOT COMPLETED|Overall Study||100
8610534|NCT00419263|9647838|FG000|STARTED|Overall Study||115
8610535|NCT00419263|9647839|FG001|STARTED|Overall Study||114
8610536|NCT00419263|9647840|FG002|STARTED|Overall Study||115
8610537|NCT00419263|9647838|FG000|COMPLETED|Overall Study||112
8610538|NCT00419263|9647839|FG001|COMPLETED|Overall Study||112
8610539|NCT00419263|9647840|FG002|COMPLETED|Overall Study||112
8610540|NCT00419263|9647838|FG000|NOT COMPLETED|Overall Study||3
8610541|NCT00419263|9647839|FG001|NOT COMPLETED|Overall Study||2
8610542|NCT00419263|9647840|FG002|NOT COMPLETED|Overall Study||3
8610543|NCT00419315|9647851|FG000|STARTED|Overall Study||85
8610544|NCT00419315|9647852|FG001|STARTED|Overall Study||78
8610545|NCT00419315|9647851|FG000|COMPLETED|Overall Study||85
8610546|NCT00419315|9647852|FG001|COMPLETED|Overall Study||78
8610547|NCT00419315|9647851|FG000|NOT COMPLETED|Overall Study||0
8610548|NCT00419315|9647852|FG001|NOT COMPLETED|Overall Study||0
8610549|NCT00419341|9647858|FG000|STARTED|Wash in/Wash Out Period||49
8610550|NCT00419341|9647858|FG000|COMPLETED|Wash in/Wash Out Period||38
8610551|NCT00419341|9647858|FG000|NOT COMPLETED|Wash in/Wash Out Period||11
8610552|NCT00419341|9647858|FG000|STARTED|Efficacy Period||38
8610553|NCT00419341|9647858|FG000|COMPLETED|Efficacy Period||28
8610554|NCT00419341|9647858|FG000|NOT COMPLETED|Efficacy Period||10
8610555|NCT00419380|9647866|FG000|STARTED|Overall Study||19
8610556|NCT00419380|9647867|FG001|STARTED|Overall Study||22
8610557|NCT00419380|9647866|FG000|COMPLETED|Overall Study||18
8610558|NCT00419380|9647867|FG001|COMPLETED|Overall Study||12
8610559|NCT00419380|9647866|FG000|NOT COMPLETED|Overall Study||1
8610560|NCT00419380|9647867|FG001|NOT COMPLETED|Overall Study||10
8610561|NCT00419393|9647873|FG000|STARTED|Overall Study|One subject did not receive medication|190
8610562|NCT00419393|9647873|FG000|COMPLETED|Overall Study||166
8610563|NCT00419393|9647873|FG000|NOT COMPLETED|Overall Study||24
8610564|NCT00419445|9647880|FG000|STARTED|Overall Study||8
8610565|NCT00419445|9647881|FG001|STARTED|Overall Study||16
8610566|NCT00419445|9647882|FG002|STARTED|Overall Study||8
8610567|NCT00419445|9647880|FG000|COMPLETED|Overall Study||7
8610568|NCT00419445|9647881|FG001|COMPLETED|Overall Study||14
8610569|NCT00419445|9647882|FG002|COMPLETED|Overall Study||7
8610570|NCT00419445|9647880|FG000|NOT COMPLETED|Overall Study||1
8610571|NCT00419445|9647881|FG001|NOT COMPLETED|Overall Study||2
8610572|NCT00419445|9647882|FG002|NOT COMPLETED|Overall Study||1
8610573|NCT00419562|9647892|FG000|STARTED|Overall Study||283
8610574|NCT00419562|9647893|FG001|STARTED|Overall Study||277
8610575|NCT00419562|9647892|FG000|COMPLETED|Overall Study||250
8610576|NCT00419562|9647893|FG001|COMPLETED|Overall Study||246
8610577|NCT00419562|9647892|FG000|NOT COMPLETED|Overall Study||33
8610578|NCT00419562|9647893|FG001|NOT COMPLETED|Overall Study||31
8610579|NCT00419666|9647899|FG000|STARTED|Overall Study||25
8610580|NCT00419666|9647899|FG000|COMPLETED|Overall Study||25
8610581|NCT00419666|9647899|FG000|NOT COMPLETED|Overall Study||0
8610582|NCT00419744|9647906|FG000|STARTED|Overall Study||407
8610583|NCT00419744|9647907|FG001|STARTED|Overall Study||408
8610584|NCT00419744|9647908|FG002|STARTED|Overall Study||404
8610585|NCT00419744|9647906|FG000|COMPLETED|Overall Study||290
8610586|NCT00419744|9647907|FG001|COMPLETED|Overall Study||290
8610587|NCT00419744|9647908|FG002|COMPLETED|Overall Study||271
8610588|NCT00419744|9647906|FG000|NOT COMPLETED|Overall Study||117
8610589|NCT00419744|9647907|FG001|NOT COMPLETED|Overall Study||118
8610590|NCT00419744|9647908|FG002|NOT COMPLETED|Overall Study||133
8610591|NCT00419757|9647918|FG000|STARTED|Overall Study|Randomized patients|127
8610592|NCT00419757|9647919|FG001|STARTED|Overall Study|Randomized patients|123
8610593|NCT00419757|9647918|FG000|COMPLETED|Overall Study|Randomized patients|109
8610594|NCT00419757|9647919|FG001|COMPLETED|Overall Study|Randomized patients|102
8610595|NCT00419757|9647918|FG000|NOT COMPLETED|Overall Study||18
8610596|NCT00419757|9647919|FG001|NOT COMPLETED|Overall Study||21
8610597|NCT00419770|9647929|FG000|STARTED|Overall Study||11
8610598|NCT00419770|9647930|FG001|STARTED|Overall Study||9
8610599|NCT00419770|9647929|FG000|COMPLETED|Overall Study||6
8610600|NCT00419770|9647930|FG001|COMPLETED|Overall Study||8
8610601|NCT00419770|9647929|FG000|NOT COMPLETED|Overall Study||5
8610602|NCT00419770|9647930|FG001|NOT COMPLETED|Overall Study||1
8610603|NCT00419926|9647938|FG000|STARTED|Overall Study|Intention to treat population, 150 is safety population.|155
8610604|NCT00419926|9647939|FG001|STARTED|Overall Study|Intention to treat population, 154 is safety population.|158
8610605|NCT00419926|9647938|FG000|COMPLETED|Overall Study||141
8610606|NCT00419926|9647939|FG001|COMPLETED|Overall Study||148
8610607|NCT00419926|9647938|FG000|NOT COMPLETED|Overall Study||14
8610608|NCT00419926|9647939|FG001|NOT COMPLETED|Overall Study||10
8610609|NCT00419952|9647947|FG000|STARTED|Overall Study||377
8610610|NCT00419952|9647948|FG001|STARTED|Overall Study||365
8610611|NCT00419952|9647947|FG000|COMPLETED|Overall Study||228
8928249|NCT02279498|9989406|FG001|NOT COMPLETED|Overall Study||4
8928250|NCT02279524|9989416|FG000|STARTED|Overall Study||98
8928251|NCT02279524|9989417|FG001|STARTED|Overall Study||101
8928252|NCT02279524|9989418|FG002|STARTED|Overall Study||48
8928253|NCT02279524|9989416|FG000|COMPLETED|Overall Study||88
8928254|NCT02279524|9989417|FG001|COMPLETED|Overall Study||90
8928255|NCT02279524|9989418|FG002|COMPLETED|Overall Study||41
8928256|NCT02279524|9989416|FG000|NOT COMPLETED|Overall Study||10
8928257|NCT02279524|9989417|FG001|NOT COMPLETED|Overall Study||11
8928258|NCT02279524|9989418|FG002|NOT COMPLETED|Overall Study||7
8928259|NCT02279641|9989428|FG000|STARTED|Overall Study||6
8928260|NCT02279641|9989429|FG001|STARTED|Overall Study||6
8610612|NCT00419952|9647948|FG001|COMPLETED|Overall Study||240
8610613|NCT00419952|9647947|FG000|NOT COMPLETED|Overall Study||149
8610614|NCT00419952|9647948|FG001|NOT COMPLETED|Overall Study||125
8610615|NCT00420004|9647957|FG000|STARTED|Overall Study||269
8610616|NCT00420004|9647958|FG001|STARTED|Overall Study||138
8610617|NCT00420004|9647959|FG002|STARTED|Overall Study||62
8610618|NCT00420004|9647957|FG000|Received at Least 1 Dose of Study Drug|Overall Study|Participants who received >=1 dose of study drug and had baseline and post-baseline data available|249
8610619|NCT00420004|9647958|FG001|Received at Least 1 Dose of Study Drug|Overall Study|Participants who received >=1 dose of study drug and had baseline and post-baseline data available|122
8610620|NCT00420004|9647959|FG002|Received at Least 1 Dose of Study Drug|Overall Study|Participants who received >=1 dose of study drug and had baseline and post-baseline data available|54
8610621|NCT00420004|9647957|FG000|COMPLETED|Overall Study||140
8610622|NCT00420004|9647958|FG001|COMPLETED|Overall Study||67
8610623|NCT00420004|9647959|FG002|COMPLETED|Overall Study||30
8610624|NCT00420004|9647957|FG000|NOT COMPLETED|Overall Study||129
8610625|NCT00420004|9647958|FG001|NOT COMPLETED|Overall Study||71
8610626|NCT00420004|9647959|FG002|NOT COMPLETED|Overall Study||32
8610627|NCT00420017|9647973|FG000|STARTED|Overall Study||40
8610628|NCT00420017|9647974|FG001|STARTED|Overall Study||40
8610629|NCT00420017|9647973|FG000|COMPLETED|Overall Study|40 completed analysis|38
8610630|NCT00420017|9647974|FG001|COMPLETED|Overall Study||40
8610631|NCT00420017|9647973|FG000|NOT COMPLETED|Overall Study||2
8610632|NCT00420017|9647974|FG001|NOT COMPLETED|Overall Study||0
8610633|NCT00420056|9647980|FG000|STARTED|Overall Study||17
8610634|NCT00420056|9647980|FG000|COMPLETED|Overall Study||0
8610635|NCT00420056|9647980|FG000|NOT COMPLETED|Overall Study||17
8610636|NCT00420095|9647986|FG000|STARTED|Overall Study||57
8610637|NCT00420095|9647987|FG001|STARTED|Overall Study||60
8610638|NCT00420095|9647986|FG000|COMPLETED|Overall Study||54
8610639|NCT00420095|9647987|FG001|COMPLETED|Overall Study||59
8610640|NCT00420095|9647986|FG000|NOT COMPLETED|Overall Study||3
8610641|NCT00420095|9647987|FG001|NOT COMPLETED|Overall Study||1
8610642|NCT00420147|9647995|FG000|STARTED|Overall Study||19
8610643|NCT00420147|9647996|FG001|STARTED|Overall Study||19
8610644|NCT00420147|9647995|FG000|COMPLETED|Overall Study||19
8610645|NCT00420147|9647996|FG001|COMPLETED|Overall Study||19
8610646|NCT00420147|9647995|FG000|NOT COMPLETED|Overall Study||0
8610647|NCT00420147|9647996|FG001|NOT COMPLETED|Overall Study||0
8610648|NCT00420199|9648004|FG000|STARTED|Overall Study||27
8610649|NCT00420199|9648005|FG001|STARTED|Overall Study||23
8610650|NCT00420199|9648004|FG000|COMPLETED|Overall Study||26
8610651|NCT00420199|9648005|FG001|COMPLETED|Overall Study||23
8610652|NCT00420199|9648004|FG000|NOT COMPLETED|Overall Study||1
8610653|NCT00420199|9648005|FG001|NOT COMPLETED|Overall Study||0
8610654|NCT00420212|9648019|FG000|STARTED|Overall Study|408 participants were dosed; 410 participants were randomized|408
8610655|NCT00420212|9648020|FG001|STARTED|Overall Study|410 participants were dosed; 411 participants were randomized|410
8610656|NCT00420212|9648021|FG002|STARTED|Overall Study|416 participants were dosed; 416 participants were randomized|416
8610657|NCT00420212|9648019|FG000|COMPLETED|Overall Study||317
8610658|NCT00420212|9648020|FG001|COMPLETED|Overall Study||315
8610659|NCT00420212|9648021|FG002|COMPLETED|Overall Study||320
8610660|NCT00420212|9648019|FG000|NOT COMPLETED|Overall Study||91
8610661|NCT00420212|9648020|FG001|NOT COMPLETED|Overall Study||95
8610662|NCT00420212|9648021|FG002|NOT COMPLETED|Overall Study||96
8610663|NCT00420238|9648034|FG000|STARTED|12 Week Double-Blind Treatment Period 1||39
8610664|NCT00420238|9648035|FG001|STARTED|12 Week Double-Blind Treatment Period 1||43
8610665|NCT00420238|9648034|FG000|COMPLETED|12 Week Double-Blind Treatment Period 1||38
8610666|NCT00420238|9648035|FG001|COMPLETED|12 Week Double-Blind Treatment Period 1||39
8610667|NCT00420238|9648034|FG000|NOT COMPLETED|12 Week Double-Blind Treatment Period 1||1
8610668|NCT00420238|9648035|FG001|NOT COMPLETED|12 Week Double-Blind Treatment Period 1||4
8610669|NCT00420238|9648034|FG000|STARTED|12 Week Open-Label Treatment Period 2||38
8610670|NCT00420238|9648035|FG001|STARTED|12 Week Open-Label Treatment Period 2||39
8610671|NCT00420238|9648034|FG000|COMPLETED|12 Week Open-Label Treatment Period 2||36
8610672|NCT00420238|9648035|FG001|COMPLETED|12 Week Open-Label Treatment Period 2||38
8610673|NCT00420238|9648034|FG000|NOT COMPLETED|12 Week Open-Label Treatment Period 2||2
8610674|NCT00420238|9648035|FG001|NOT COMPLETED|12 Week Open-Label Treatment Period 2||1
8610675|NCT00420290|9648049|FG000|STARTED|Overall Study||11
8610676|NCT00420290|9648050|FG001|STARTED|Overall Study||11
8610677|NCT00420290|9648049|FG000|COMPLETED|Overall Study||7
8610678|NCT00420290|9648050|FG001|COMPLETED|Overall Study||7
8610679|NCT00420290|9648049|FG000|NOT COMPLETED|Overall Study||4
8610680|NCT00420290|9648050|FG001|NOT COMPLETED|Overall Study||4
8610681|NCT00420303|9648058|FG000|STARTED|Overall Study||12
8610682|NCT00420303|9648059|FG001|STARTED|Overall Study||12
8610683|NCT00420303|9648058|FG000|COMPLETED|Overall Study||11
8610684|NCT00420303|9648059|FG001|COMPLETED|Overall Study||8
8610685|NCT00420303|9648058|FG000|NOT COMPLETED|Overall Study||1
8610686|NCT00420303|9648059|FG001|NOT COMPLETED|Overall Study||4
8610687|NCT00420316|9648067|FG000|STARTED|Overall Study||1082
8610688|NCT00420316|9648068|FG001|STARTED|Overall Study||531
8610689|NCT00420316|9648067|FG000|COMPLETED|Overall Study||1070
8610690|NCT00420316|9648068|FG001|COMPLETED|Overall Study||522
8610691|NCT00420316|9648067|FG000|NOT COMPLETED|Overall Study||12
8610692|NCT00420316|9648068|FG001|NOT COMPLETED|Overall Study||9
8610693|NCT00420342|9648077|FG000|STARTED|Overall Study||30
8610694|NCT00420342|9648078|FG001|STARTED|Overall Study||33
8610695|NCT00420342|9648079|FG002|STARTED|Overall Study||29
8610696|NCT00420342|9648077|FG000|Received Treatment|Overall Study|1 subject did not confirm if she ever took the study medication.|29
8610697|NCT00420342|9648078|FG001|Received Treatment|Overall Study|1 subject did not confirm if she ever took the study medication.|32
8610698|NCT00420342|9648079|FG002|Received Treatment|Overall Study||29
8610699|NCT00420342|9648077|FG000|COMPLETED|Overall Study||29
8610700|NCT00420342|9648078|FG001|COMPLETED|Overall Study||31
8610701|NCT00420342|9648079|FG002|COMPLETED|Overall Study||28
8610702|NCT00420342|9648077|FG000|NOT COMPLETED|Overall Study||1
8610703|NCT00420342|9648078|FG001|NOT COMPLETED|Overall Study||2
8610704|NCT00420342|9648079|FG002|NOT COMPLETED|Overall Study||1
8610705|NCT00420381|9648087|FG000|STARTED|Overall Study||28
8610706|NCT00420381|9648087|FG000|Received at Least One Dose of Study Drug|Overall Study||27
8610707|NCT00420381|9648087|FG000|COMPLETED|Overall Study||27
8610708|NCT00420381|9648087|FG000|NOT COMPLETED|Overall Study||1
8610709|NCT00420407|9648093|FG000|STARTED|Overall Study||41
8610710|NCT00420407|9648094|FG001|STARTED|Overall Study||40
8610711|NCT00420407|9648093|FG000|COMPLETED|Overall Study||37
8610712|NCT00420407|9648094|FG001|COMPLETED|Overall Study||34
8610713|NCT00420407|9648093|FG000|NOT COMPLETED|Overall Study||4
8610714|NCT00420407|9648094|FG001|NOT COMPLETED|Overall Study||6
8610715|NCT00420420|9648103|FG000|STARTED|Overall Study|Number of patients randomized.|73
8610716|NCT00420420|9648104|FG001|STARTED|Overall Study|Number of patients randomized.|71
8610717|NCT00420420|9648103|FG000|COMPLETED|Overall Study|One patient from the MK-0249 arm discontinued the trial due to an AE prior to receiving study drug.|65
8610718|NCT00420420|9648104|FG001|COMPLETED|Overall Study||67
8610719|NCT00420420|9648103|FG000|NOT COMPLETED|Overall Study||8
8610720|NCT00420420|9648104|FG001|NOT COMPLETED|Overall Study||4
8610721|NCT00420459|9648110|FG000|STARTED|Overall Study||12
8610722|NCT00420459|9648110|FG000|COMPLETED|Overall Study||12
8610723|NCT00420459|9648110|FG000|NOT COMPLETED|Overall Study||0
8610724|NCT00420511|9648118|FG000|STARTED|Overall Study||10
8610725|NCT00420511|9648119|FG001|STARTED|Overall Study||11
8610726|NCT00420511|9648118|FG000|COMPLETED|Overall Study||8
8610727|NCT00420511|9648119|FG001|COMPLETED|Overall Study||10
8610728|NCT00420511|9648118|FG000|NOT COMPLETED|Overall Study||2
8610729|NCT00420511|9648119|FG001|NOT COMPLETED|Overall Study||1
8610730|NCT00420628|9648129|FG000|STARTED|Overall Study||72
8610731|NCT00420628|9648130|FG001|STARTED|Overall Study||36
8610732|NCT00420628|9648129|FG000|COMPLETED|Overall Study||63
8610733|NCT00420628|9648130|FG001|COMPLETED|Overall Study||32
8610734|NCT00420628|9648129|FG000|NOT COMPLETED|Overall Study||9
8610735|NCT00420628|9648130|FG001|NOT COMPLETED|Overall Study||4
8610736|NCT00420641|9648139|FG000|STARTED|Overall Study||160
8610737|NCT00420641|9648140|FG001|STARTED|Overall Study||172
8610738|NCT00420641|9648141|FG002|STARTED|Overall Study||172
8610739|NCT00420641|9648139|FG000|COMPLETED|Overall Study||115
8610740|NCT00420641|9648140|FG001|COMPLETED|Overall Study||100
8610741|NCT00420641|9648141|FG002|COMPLETED|Overall Study||128
8610742|NCT00420641|9648139|FG000|NOT COMPLETED|Overall Study||45
8610743|NCT00420641|9648140|FG001|NOT COMPLETED|Overall Study||72
8610744|NCT00420641|9648141|FG002|NOT COMPLETED|Overall Study||44
8610745|NCT00420745|9648151|FG000|STARTED|Overall Study||670
8610746|NCT00420745|9648152|FG001|STARTED|Overall Study||339
8610747|NCT00420745|9648151|FG000|COMPLETED|Overall Study||655
8610748|NCT00420745|9648152|FG001|COMPLETED|Overall Study||333
8610749|NCT00420745|9648151|FG000|NOT COMPLETED|Overall Study||15
8610750|NCT00420745|9648152|FG001|NOT COMPLETED|Overall Study||6
8610751|NCT00420771|9648160|FG000|STARTED|Overall Study||8
8610752|NCT00420771|9648161|FG001|STARTED|Overall Study||11
8610753|NCT00420771|9648160|FG000|COMPLETED|Overall Study||5
8610754|NCT00420771|9648161|FG001|COMPLETED|Overall Study||7
8610755|NCT00420771|9648160|FG000|NOT COMPLETED|Overall Study||3
8610756|NCT00420771|9648161|FG001|NOT COMPLETED|Overall Study||4
8610757|NCT00420784|9648171|FG000|STARTED|Overall Study||115
8610758|NCT00420784|9648172|FG001|STARTED|Overall Study||113
8610759|NCT00420784|9648173|FG002|STARTED|Overall Study||111
8610760|NCT00420784|9648174|FG003|STARTED|Overall Study||114
8610761|NCT00420784|9648171|FG000|COMPLETED|Overall Study||86
8610762|NCT00420784|9648172|FG001|COMPLETED|Overall Study||55
8610763|NCT00420784|9648173|FG002|COMPLETED|Overall Study||58
8610764|NCT00420784|9648174|FG003|COMPLETED|Overall Study||36
8610765|NCT00420784|9648171|FG000|NOT COMPLETED|Overall Study||29
8610766|NCT00420784|9648172|FG001|NOT COMPLETED|Overall Study||58
8610767|NCT00420784|9648173|FG002|NOT COMPLETED|Overall Study||53
8610768|NCT00420784|9648174|FG003|NOT COMPLETED|Overall Study||78
8610769|NCT00420849|9648185|FG000|STARTED|Overall Study||587
8610770|NCT00420849|9648185|FG000|COMPLETED|Overall Study|Participants completed the study upon commercial availability of lenalidomide|256
8610771|NCT00420849|9648185|FG000|NOT COMPLETED|Overall Study||331
8610772|NCT00420927|9648199|FG000|STARTED|Period 1||515
8610773|NCT00420927|9648200|FG001|STARTED|Period 1||517
8610774|NCT00420927|9648201|FG002|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
8610775|NCT00420927|9648202|FG003|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
8610776|NCT00420927|9648203|FG004|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
8610777|NCT00420927|9648204|FG005|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
8610778|NCT00420927|9648205|FG006|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
8610779|NCT00420927|9648199|FG000|COMPLETED|Period 1||466
8610780|NCT00420927|9648200|FG001|COMPLETED|Period 1||460
8610781|NCT00420927|9648201|FG002|COMPLETED|Period 1||0
8610782|NCT00420927|9648202|FG003|COMPLETED|Period 1||0
8610783|NCT00420927|9648203|FG004|COMPLETED|Period 1||0
8610784|NCT00420927|9648204|FG005|COMPLETED|Period 1||0
8610785|NCT00420927|9648205|FG006|COMPLETED|Period 1||0
8610786|NCT00420927|9648199|FG000|NOT COMPLETED|Period 1||49
8610787|NCT00420927|9648200|FG001|NOT COMPLETED|Period 1||57
8610788|NCT00420927|9648201|FG002|NOT COMPLETED|Period 1||0
8610789|NCT00420927|9648202|FG003|NOT COMPLETED|Period 1||0
8610790|NCT00420927|9648203|FG004|NOT COMPLETED|Period 1||0
8610791|NCT00420927|9648204|FG005|NOT COMPLETED|Period 1||0
8610792|NCT00420927|9648205|FG006|NOT COMPLETED|Period 1||0
8610793|NCT00420927|9648199|FG000|STARTED|Period 2|This treatment group is not relevant to Period 2.|0
8610794|NCT00420927|9648200|FG001|STARTED|Period 2|This treatment group is not relevant to Period 2.|0
8610795|NCT00420927|9648201|FG002|STARTED|Period 2||102
8610796|NCT00420927|9648202|FG003|STARTED|Period 2||105
8610797|NCT00420927|9648203|FG004|STARTED|Period 2||259
8610798|NCT00420927|9648204|FG005|STARTED|Period 2||112
8610799|NCT00420927|9648205|FG006|STARTED|Period 2||348
8610800|NCT00420927|9648199|FG000|COMPLETED|Period 2||0
8610801|NCT00420927|9648200|FG001|COMPLETED|Period 2||0
8610802|NCT00420927|9648201|FG002|COMPLETED|Period 2||89
8610803|NCT00420927|9648202|FG003|COMPLETED|Period 2||95
8610804|NCT00420927|9648203|FG004|COMPLETED|Period 2||216
8715497|NCT00984061|9762388|FG000|STARTED|Clarithromycin Alone||24
8715498|NCT00984061|9762388|FG000|COMPLETED|Clarithromycin Alone|One subject was dropped due to noncompliance with outpatient clarithromycin regimen.|23
8715499|NCT00984061|9762388|FG000|NOT COMPLETED|Clarithromycin Alone||1
8715500|NCT00984061|9762388|FG000|STARTED|Colchicine With Clarithromycin||23
8715501|NCT00984061|9762388|FG000|COMPLETED|Colchicine With Clarithromycin||23
8715502|NCT00984061|9762388|FG000|NOT COMPLETED|Colchicine With Clarithromycin||0
8610805|NCT00420927|9648204|FG005|COMPLETED|Period 2||97
8610806|NCT00420927|9648205|FG006|COMPLETED|Period 2||295
8610807|NCT00420927|9648199|FG000|NOT COMPLETED|Period 2||0
8610808|NCT00420927|9648200|FG001|NOT COMPLETED|Period 2||0
8610809|NCT00420927|9648201|FG002|NOT COMPLETED|Period 2||13
8610810|NCT00420927|9648202|FG003|NOT COMPLETED|Period 2||10
8610811|NCT00420927|9648203|FG004|NOT COMPLETED|Period 2||43
8610812|NCT00420927|9648204|FG005|NOT COMPLETED|Period 2||15
8610813|NCT00420927|9648205|FG006|NOT COMPLETED|Period 2||53
8610814|NCT00420992|9648221|FG000|STARTED|Titration Phase|All patients received ALO-01 during open-label titration phase|547
8610815|NCT00420992|9648222|FG001|STARTED|Titration Phase||0
8610816|NCT00420992|9648221|FG000|COMPLETED|Titration Phase||344
8610817|NCT00420992|9648222|FG001|COMPLETED|Titration Phase||0
8610818|NCT00420992|9648221|FG000|NOT COMPLETED|Titration Phase||203
8610819|NCT00420992|9648222|FG001|NOT COMPLETED|Titration Phase||0
8610820|NCT00420992|9648221|FG000|STARTED|Maintenance Phase||171
8610821|NCT00420992|9648222|FG001|STARTED|Maintenance Phase||173
8610822|NCT00420992|9648221|FG000|COMPLETED|Maintenance Phase||110
8610823|NCT00420992|9648222|FG001|COMPLETED|Maintenance Phase||98
8610824|NCT00420992|9648221|FG000|NOT COMPLETED|Maintenance Phase||61
8610825|NCT00420992|9648222|FG001|NOT COMPLETED|Maintenance Phase||75
8610826|NCT00421148|9648249|FG000|STARTED|Overall Study||2
8610827|NCT00421148|9648250|FG001|STARTED|Overall Study||2
8610828|NCT00421148|9648251|FG002|STARTED|Overall Study||2
8610829|NCT00421148|9648252|FG003|STARTED|Overall Study||1
8610830|NCT00421148|9648253|FG004|STARTED|Overall Study||1
8610831|NCT00421148|9648254|FG005|STARTED|Overall Study||5
8610832|NCT00421148|9648255|FG006|STARTED|Overall Study||6
8610833|NCT00421148|9648256|FG007|STARTED|Overall Study||5
8610834|NCT00421148|9648257|FG008|STARTED|Overall Study||5
8610835|NCT00421148|9648258|FG009|STARTED|Overall Study||5
8610836|NCT00421148|9648259|FG010|STARTED|Overall Study||6
8610837|NCT00421148|9648260|FG011|STARTED|Overall Study||6
8610838|NCT00421148|9648261|FG012|STARTED|Overall Study||6
8610839|NCT00421148|9648262|FG013|STARTED|Overall Study||6
8610840|NCT00421148|9648263|FG014|STARTED|Overall Study||6
8610841|NCT00421148|9648264|FG015|STARTED|Overall Study||6
8610842|NCT00421148|9648265|FG016|STARTED|Overall Study||6
8610843|NCT00421148|9648266|FG017|STARTED|Overall Study||6
8610844|NCT00421148|9648267|FG018|STARTED|Overall Study||6
8610845|NCT00421148|9648268|FG019|STARTED|Overall Study||6
8610846|NCT00421148|9648249|FG000|Treated|Overall Study||2
8610847|NCT00421148|9648250|FG001|Treated|Overall Study||2
8610848|NCT00421148|9648251|FG002|Treated|Overall Study||2
8610849|NCT00421148|9648252|FG003|Treated|Overall Study||1
8610850|NCT00421148|9648253|FG004|Treated|Overall Study||1
8610851|NCT00421148|9648254|FG005|Treated|Overall Study|1 additional participant discontinued prior to receiving study treatment|4
8610852|NCT00421148|9648255|FG006|Treated|Overall Study||6
8610853|NCT00421148|9648256|FG007|Treated|Overall Study||5
8610854|NCT00421148|9648257|FG008|Treated|Overall Study||5
8610855|NCT00421148|9648258|FG009|Treated|Overall Study|Includes 1 participant who was inadvertently randomized to group but was an adolescent|5
8610856|NCT00421148|9648259|FG010|Treated|Overall Study||6
8610857|NCT00421148|9648260|FG011|Treated|Overall Study|Includes 1 participant who was inadvertently randomized to group but received 5 mg/kg sugammadex|6
8610858|NCT00421148|9648261|FG012|Treated|Overall Study||6
8610859|NCT00421148|9648262|FG013|Treated|Overall Study||6
8610860|NCT00421148|9648263|FG014|Treated|Overall Study||6
8610861|NCT00421148|9648264|FG015|Treated|Overall Study||6
8610862|NCT00421148|9648265|FG016|Treated|Overall Study||6
8610863|NCT00421148|9648266|FG017|Treated|Overall Study|1 additional participant discontinued prior to receiving study treatment|5
8610864|NCT00421148|9648267|FG018|Treated|Overall Study|1 additional participant discontinued prior to receiving study treatment|5
8610865|NCT00421148|9648268|FG019|Treated|Overall Study||6
8610866|NCT00421148|9648249|FG000|COMPLETED|Overall Study||2
8610867|NCT00421148|9648250|FG001|COMPLETED|Overall Study||2
8610868|NCT00421148|9648251|FG002|COMPLETED|Overall Study||2
8610869|NCT00421148|9648252|FG003|COMPLETED|Overall Study||1
8610870|NCT00421148|9648253|FG004|COMPLETED|Overall Study||1
8610871|NCT00421148|9648254|FG005|COMPLETED|Overall Study||4
8610872|NCT00421148|9648255|FG006|COMPLETED|Overall Study||6
8610873|NCT00421148|9648256|FG007|COMPLETED|Overall Study||5
8610874|NCT00421148|9648257|FG008|COMPLETED|Overall Study||5
8610875|NCT00421148|9648258|FG009|COMPLETED|Overall Study||5
8610876|NCT00421148|9648259|FG010|COMPLETED|Overall Study||6
8610877|NCT00421148|9648260|FG011|COMPLETED|Overall Study||6
8610878|NCT00421148|9648261|FG012|COMPLETED|Overall Study||6
8610879|NCT00421148|9648262|FG013|COMPLETED|Overall Study||6
8610880|NCT00421148|9648263|FG014|COMPLETED|Overall Study||6
8610881|NCT00421148|9648264|FG015|COMPLETED|Overall Study||6
8610882|NCT00421148|9648265|FG016|COMPLETED|Overall Study||6
8610883|NCT00421148|9648266|FG017|COMPLETED|Overall Study||4
8610884|NCT00421148|9648267|FG018|COMPLETED|Overall Study||5
8610885|NCT00421148|9648268|FG019|COMPLETED|Overall Study||6
8610886|NCT00421148|9648249|FG000|NOT COMPLETED|Overall Study||0
8610887|NCT00421148|9648250|FG001|NOT COMPLETED|Overall Study||0
8610888|NCT00421148|9648251|FG002|NOT COMPLETED|Overall Study||0
8610889|NCT00421148|9648252|FG003|NOT COMPLETED|Overall Study||0
8610890|NCT00421148|9648253|FG004|NOT COMPLETED|Overall Study||0
8610891|NCT00421148|9648254|FG005|NOT COMPLETED|Overall Study||1
8610892|NCT00421148|9648255|FG006|NOT COMPLETED|Overall Study||0
8610893|NCT00421148|9648256|FG007|NOT COMPLETED|Overall Study||0
8610894|NCT00421148|9648257|FG008|NOT COMPLETED|Overall Study||0
8610895|NCT00421148|9648258|FG009|NOT COMPLETED|Overall Study||0
8610896|NCT00421148|9648259|FG010|NOT COMPLETED|Overall Study||0
8610897|NCT00421148|9648260|FG011|NOT COMPLETED|Overall Study||0
8610898|NCT00421148|9648261|FG012|NOT COMPLETED|Overall Study||0
8610899|NCT00421148|9648262|FG013|NOT COMPLETED|Overall Study||0
8610900|NCT00421148|9648263|FG014|NOT COMPLETED|Overall Study||0
8610901|NCT00421148|9648264|FG015|NOT COMPLETED|Overall Study||0
8610902|NCT00421148|9648265|FG016|NOT COMPLETED|Overall Study||0
8610903|NCT00421148|9648266|FG017|NOT COMPLETED|Overall Study||2
8610904|NCT00421148|9648267|FG018|NOT COMPLETED|Overall Study||1
8610905|NCT00421148|9648268|FG019|NOT COMPLETED|Overall Study||0
8610906|NCT00421174|9648312|FG000|STARTED|Overall Study||18
8610907|NCT00421174|9648313|FG001|STARTED|Overall Study||19
8610908|NCT00421174|9648312|FG000|COMPLETED|Overall Study||16
8610909|NCT00421174|9648313|FG001|COMPLETED|Overall Study||18
8610910|NCT00421174|9648312|FG000|NOT COMPLETED|Overall Study||2
8610911|NCT00421174|9648313|FG001|NOT COMPLETED|Overall Study||1
8610912|NCT00421304|9648322|FG000|STARTED|Overall Study||40
8610913|NCT00421304|9648323|FG001|STARTED|Overall Study||39
8610914|NCT00421304|9648324|FG002|STARTED|Overall Study||39
8610915|NCT00421304|9648322|FG000|COMPLETED|Overall Study||32
8610916|NCT00421304|9648323|FG001|COMPLETED|Overall Study||35
8610917|NCT00421304|9648324|FG002|COMPLETED|Overall Study||31
8610918|NCT00421304|9648322|FG000|NOT COMPLETED|Overall Study||8
8610919|NCT00421304|9648323|FG001|NOT COMPLETED|Overall Study||4
8610920|NCT00421304|9648324|FG002|NOT COMPLETED|Overall Study||8
8610921|NCT00421343|9648334|FG000|STARTED|Overall Study||29
8610922|NCT00421343|9648334|FG000|COMPLETED|Overall Study||23
8610923|NCT00421343|9648334|FG000|NOT COMPLETED|Overall Study||6
8610924|NCT00421408|9648340|FG000|STARTED|Overall Study||102
8610925|NCT00421408|9648341|FG001|STARTED|Overall Study||106
8610926|NCT00421408|9648340|FG000|COMPLETED|Overall Study||60
8610927|NCT00421408|9648341|FG001|COMPLETED|Overall Study||61
8610928|NCT00421408|9648340|FG000|NOT COMPLETED|Overall Study||42
8610929|NCT00421408|9648341|FG001|NOT COMPLETED|Overall Study||45
8629145|NCT00528801|9668798|FG001|NOT COMPLETED|Overall Study||11
8629146|NCT00528840|9668804|FG000|STARTED|Overall Study||201
8629147|NCT00528840|9668804|FG000|COMPLETED|Overall Study||168
8629148|NCT00528840|9668804|FG000|NOT COMPLETED|Overall Study||33
8629149|NCT00528866|9668808|FG000|STARTED|Overall Study||80
8629150|NCT00528866|9668808|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|74
8629151|NCT00528866|9668808|FG000|NOT COMPLETED|Overall Study||6
8629152|NCT00528879|9668817|FG000|STARTED|Short-term Period (Day 1 to Week 24)||137
8629153|NCT00528879|9668818|FG001|STARTED|Short-term Period (Day 1 to Week 24)||137
8629154|NCT00528879|9668819|FG002|STARTED|Short-term Period (Day 1 to Week 24)||137
8629155|NCT00528879|9668820|FG003|STARTED|Short-term Period (Day 1 to Week 24)||135
8629156|NCT00528879|9668817|FG000|Completed the Period|Short-term Period (Day 1 to Week 24)||119
8629157|NCT00528879|9668818|FG001|Completed the Period|Short-term Period (Day 1 to Week 24)||121
8629158|NCT00528879|9668819|FG002|Completed the Period|Short-term Period (Day 1 to Week 24)||122
8629159|NCT00528879|9668820|FG003|Completed the Period|Short-term Period (Day 1 to Week 24)||121
8629160|NCT00528879|9668817|FG000|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|115
8629161|NCT00528879|9668818|FG001|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|120
8629162|NCT00528879|9668819|FG002|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|122
8629163|NCT00528879|9668820|FG003|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|119
8629164|NCT00528879|9668817|FG000|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||22
8629165|NCT00528879|9668818|FG001|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||17
8629166|NCT00528879|9668819|FG002|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||15
8629167|NCT00528879|9668820|FG003|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||16
8629168|NCT00528879|9668817|FG000|STARTED|Long-term Period (Weeks 24 to 102)||115
8629169|NCT00528879|9668818|FG001|STARTED|Long-term Period (Weeks 24 to 102)||120
8629170|NCT00528879|9668819|FG002|STARTED|Long-term Period (Weeks 24 to 102)||122
8629171|NCT00528879|9668820|FG003|STARTED|Long-term Period (Weeks 24 to 102)||119
8629172|NCT00528879|9668817|FG000|COMPLETED|Long-term Period (Weeks 24 to 102)||73
8629173|NCT00528879|9668818|FG001|COMPLETED|Long-term Period (Weeks 24 to 102)||82
8629174|NCT00528879|9668819|FG002|COMPLETED|Long-term Period (Weeks 24 to 102)||89
8629175|NCT00528879|9668820|FG003|COMPLETED|Long-term Period (Weeks 24 to 102)||95
8629176|NCT00528879|9668817|FG000|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||42
8629177|NCT00528879|9668818|FG001|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||38
8629178|NCT00528879|9668819|FG002|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||33
8629179|NCT00528879|9668820|FG003|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||24
8629180|NCT00528931|9668830|FG000|STARTED|Overall Study||16
8610930|NCT00421603|9648349|FG000|STARTED|Overall Study||39
8610931|NCT00421603|9648350|FG001|STARTED|Overall Study||42
8610932|NCT00421603|9648349|FG000|COMPLETED|Overall Study|Completed all 14 week sof trial|28
8610933|NCT00421603|9648350|FG001|COMPLETED|Overall Study|Completed all 14 week sof trial|30
8610934|NCT00421603|9648349|FG000|NOT COMPLETED|Overall Study||11
8610935|NCT00421603|9648350|FG001|NOT COMPLETED|Overall Study||12
8610936|NCT00421707|9648358|FG000|STARTED|Period 1: Treatment Period 1||67
8610937|NCT00421707|9648359|FG001|STARTED|Period 1: Treatment Period 1||65
8610938|NCT00421707|9648358|FG000|COMPLETED|Period 1: Treatment Period 1||56
8610939|NCT00421707|9648359|FG001|COMPLETED|Period 1: Treatment Period 1||56
8610940|NCT00421707|9648358|FG000|NOT COMPLETED|Period 1: Treatment Period 1||11
8610941|NCT00421707|9648359|FG001|NOT COMPLETED|Period 1: Treatment Period 1||9
8610942|NCT00421707|9648358|FG000|STARTED|Period 2: Washout||56
8610943|NCT00421707|9648359|FG001|STARTED|Period 2: Washout||56
8610944|NCT00421707|9648358|FG000|COMPLETED|Period 2: Washout||55
8610945|NCT00421707|9648359|FG001|COMPLETED|Period 2: Washout||52
8610946|NCT00421707|9648358|FG000|NOT COMPLETED|Period 2: Washout||1
8610947|NCT00421707|9648359|FG001|NOT COMPLETED|Period 2: Washout||4
8610948|NCT00421707|9648358|FG000|STARTED|Period 3:Treatment Period 2||55
8610949|NCT00421707|9648359|FG001|STARTED|Period 3:Treatment Period 2||52
8610950|NCT00421707|9648358|FG000|COMPLETED|Period 3:Treatment Period 2||53
8610951|NCT00421707|9648359|FG001|COMPLETED|Period 3:Treatment Period 2||49
8610952|NCT00421707|9648358|FG000|NOT COMPLETED|Period 3:Treatment Period 2||2
8610953|NCT00421707|9648359|FG001|NOT COMPLETED|Period 3:Treatment Period 2||3
8610954|NCT00421733|9648371|FG000|STARTED|Overall Study||93
8610955|NCT00421733|9648372|FG001|STARTED|Overall Study||95
8610956|NCT00421733|9648373|FG002|STARTED|Overall Study||93
8610957|NCT00421733|9648371|FG000|COMPLETED|Overall Study||78
8610958|NCT00421733|9648372|FG001|COMPLETED|Overall Study||69
8610959|NCT00421733|9648373|FG002|COMPLETED|Overall Study||73
8610960|NCT00421733|9648371|FG000|NOT COMPLETED|Overall Study||15
8610961|NCT00421733|9648372|FG001|NOT COMPLETED|Overall Study||26
8610962|NCT00421733|9648373|FG002|NOT COMPLETED|Overall Study||20
8610963|NCT00421889|9648394|FG000|STARTED|Overall Study||5
8610964|NCT00421889|9648395|FG001|STARTED|Overall Study||5
8610965|NCT00421889|9648396|FG002|STARTED|Overall Study||3
8610966|NCT00421889|9648397|FG003|STARTED|Overall Study||4
8610967|NCT00421889|9648398|FG004|STARTED|Overall Study||6
8610968|NCT00421889|9648399|FG005|STARTED|Overall Study||35
8610969|NCT00421889|9648400|FG006|STARTED|Overall Study||4
8610970|NCT00421889|9648401|FG007|STARTED|Overall Study||3
8610971|NCT00421889|9648402|FG008|STARTED|Overall Study||15
8610972|NCT00421889|9648394|FG000|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 5.20|0
8610973|NCT00421889|9648395|FG001|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 8.20|0
8610974|NCT00421889|9648396|FG002|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 3.33|0
8610975|NCT00421889|9648397|FG003|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 9.25|0
8610976|NCT00421889|9648398|FG004|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 5.00|0
8610977|NCT00421889|9648399|FG005|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 7.69|0
8610978|NCT00421889|9648400|FG006|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 5.50|0
8610979|NCT00421889|9648401|FG007|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 3.33|1
8610980|NCT00421889|9648402|FG008|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 4.27|4
8610981|NCT00421889|9648394|FG000|NOT COMPLETED|Overall Study||5
8610982|NCT00421889|9648395|FG001|NOT COMPLETED|Overall Study||5
8610983|NCT00421889|9648396|FG002|NOT COMPLETED|Overall Study||3
8610984|NCT00421889|9648397|FG003|NOT COMPLETED|Overall Study||4
8610985|NCT00421889|9648398|FG004|NOT COMPLETED|Overall Study||6
8610986|NCT00421889|9648399|FG005|NOT COMPLETED|Overall Study||35
8610987|NCT00421889|9648400|FG006|NOT COMPLETED|Overall Study||4
8610988|NCT00421889|9648401|FG007|NOT COMPLETED|Overall Study||2
8610989|NCT00421889|9648402|FG008|NOT COMPLETED|Overall Study||11
8610990|NCT00421928|9648429|FG000|STARTED|Overall Study|2 randomly assigned to this treatment group did not receive drug|344
8610991|NCT00421928|9648430|FG001|STARTED|Overall Study|2 randomly assigned to this treatment group did not receive drug. One subject was enrolled twice.|342
8610992|NCT00421928|9648431|FG002|STARTED|Overall Study|2 randomly assigned to this treatment group did not receive drug|337
8610993|NCT00421928|9648429|FG000|COMPLETED|Overall Study||181
8610994|NCT00421928|9648430|FG001|COMPLETED|Overall Study||118
8610995|NCT00421928|9648431|FG002|COMPLETED|Overall Study||203
8610996|NCT00421928|9648429|FG000|NOT COMPLETED|Overall Study||163
8610997|NCT00421928|9648430|FG001|NOT COMPLETED|Overall Study||224
8610998|NCT00421928|9648431|FG002|NOT COMPLETED|Overall Study||134
8610999|NCT00421993|9648443|FG000|STARTED|Overall Study||419
8611000|NCT00421993|9648444|FG001|STARTED|Overall Study||418
8611001|NCT00421993|9648445|FG002|STARTED|Overall Study||415
8611002|NCT00421993|9648446|FG003|STARTED|Overall Study||418
8611003|NCT00421993|9648443|FG000|COMPLETED|Overall Study||366
8611004|NCT00421993|9648444|FG001|COMPLETED|Overall Study||369
8611005|NCT00421993|9648445|FG002|COMPLETED|Overall Study||363
8611006|NCT00421993|9648446|FG003|COMPLETED|Overall Study||361
8611007|NCT00421993|9648443|FG000|NOT COMPLETED|Overall Study||53
8611008|NCT00421993|9648444|FG001|NOT COMPLETED|Overall Study||49
8611009|NCT00421993|9648445|FG002|NOT COMPLETED|Overall Study||52
8611010|NCT00421993|9648446|FG003|NOT COMPLETED|Overall Study||57
8611011|NCT00422032|9648458|FG000|STARTED|Overall Study||37
8611012|NCT00422032|9648459|FG001|STARTED|Overall Study||21
8611013|NCT00422032|9648458|FG000|COMPLETED|Overall Study||37
8611014|NCT00422032|9648459|FG001|COMPLETED|Overall Study||21
8611015|NCT00422032|9648458|FG000|NOT COMPLETED|Overall Study||0
8611016|NCT00422032|9648459|FG001|NOT COMPLETED|Overall Study||0
8611017|NCT00422058|9648471|FG000|STARTED|Double-Blind, Week 0-20||98
8611018|NCT00422058|9648472|FG001|STARTED|Double-Blind, Week 0-20||95
8611019|NCT00422058|9648473|FG002|STARTED|Double-Blind, Week 0-20||90
8611020|NCT00422058|9648474|FG003|STARTED|Double-Blind, Week 0-20||93
8611021|NCT00422058|9648475|FG004|STARTED|Double-Blind, Week 0-20||93
8611022|NCT00422058|9648476|FG005|STARTED|Double-Blind, Week 0-20||95
8611023|NCT00422058|9648471|FG000|COMPLETED|Double-Blind, Week 0-20||79
8611024|NCT00422058|9648472|FG001|COMPLETED|Double-Blind, Week 0-20||85
8611025|NCT00422058|9648473|FG002|COMPLETED|Double-Blind, Week 0-20||74
8611026|NCT00422058|9648474|FG003|COMPLETED|Double-Blind, Week 0-20||73
8611027|NCT00422058|9648475|FG004|COMPLETED|Double-Blind, Week 0-20||82
8611028|NCT00422058|9648476|FG005|COMPLETED|Double-Blind, Week 0-20||79
8611029|NCT00422058|9648471|FG000|NOT COMPLETED|Double-Blind, Week 0-20||19
8611030|NCT00422058|9648472|FG001|NOT COMPLETED|Double-Blind, Week 0-20||10
8611031|NCT00422058|9648473|FG002|NOT COMPLETED|Double-Blind, Week 0-20||16
8611032|NCT00422058|9648474|FG003|NOT COMPLETED|Double-Blind, Week 0-20||20
8611033|NCT00422058|9648475|FG004|NOT COMPLETED|Double-Blind, Week 0-20||11
8611034|NCT00422058|9648476|FG005|NOT COMPLETED|Double-Blind, Week 0-20||16
8611035|NCT00422058|9648471|FG000|STARTED|Open-Label Extension, Week 20-104||79
8611036|NCT00422058|9648472|FG001|STARTED|Open-Label Extension, Week 20-104||85
8611037|NCT00422058|9648473|FG002|STARTED|Open-Label Extension, Week 20-104||74
8611038|NCT00422058|9648474|FG003|STARTED|Open-Label Extension, Week 20-104||73
8611039|NCT00422058|9648475|FG004|STARTED|Open-Label Extension, Week 20-104||82
8611040|NCT00422058|9648476|FG005|STARTED|Open-Label Extension, Week 20-104||79
8611041|NCT00422058|9648471|FG000|Enrolled in Extension|Open-Label Extension, Week 20-104||67
8611042|NCT00422058|9648472|FG001|Enrolled in Extension|Open-Label Extension, Week 20-104||68
8611043|NCT00422058|9648473|FG002|Enrolled in Extension|Open-Label Extension, Week 20-104||59
8611044|NCT00422058|9648474|FG003|Enrolled in Extension|Open-Label Extension, Week 20-104||65
8611045|NCT00422058|9648475|FG004|Enrolled in Extension|Open-Label Extension, Week 20-104||72
8611046|NCT00422058|9648476|FG005|Enrolled in Extension|Open-Label Extension, Week 20-104||67
8611047|NCT00422058|9648471|FG000|COMPLETED|Open-Label Extension, Week 20-104||47
8611048|NCT00422058|9648472|FG001|COMPLETED|Open-Label Extension, Week 20-104||46
8611049|NCT00422058|9648473|FG002|COMPLETED|Open-Label Extension, Week 20-104||38
8611050|NCT00422058|9648474|FG003|COMPLETED|Open-Label Extension, Week 20-104||45
8611051|NCT00422058|9648475|FG004|COMPLETED|Open-Label Extension, Week 20-104||47
8611052|NCT00422058|9648476|FG005|COMPLETED|Open-Label Extension, Week 20-104||45
8611053|NCT00422058|9648471|FG000|NOT COMPLETED|Open-Label Extension, Week 20-104||32
8611054|NCT00422058|9648472|FG001|NOT COMPLETED|Open-Label Extension, Week 20-104||39
8611055|NCT00422058|9648473|FG002|NOT COMPLETED|Open-Label Extension, Week 20-104||36
8611056|NCT00422058|9648474|FG003|NOT COMPLETED|Open-Label Extension, Week 20-104||28
8611057|NCT00422058|9648475|FG004|NOT COMPLETED|Open-Label Extension, Week 20-104||35
8611058|NCT00422058|9648476|FG005|NOT COMPLETED|Open-Label Extension, Week 20-104||34
8611059|NCT00422084|9648492|FG000|STARTED|Overall Study||849
8611060|NCT00422084|9648493|FG001|STARTED|Overall Study||423
8611061|NCT00422084|9648492|FG000|COMPLETED|Overall Study||751
8611062|NCT00422084|9648493|FG001|COMPLETED|Overall Study||347
8611063|NCT00422084|9648492|FG000|NOT COMPLETED|Overall Study||98
8611064|NCT00422084|9648493|FG001|NOT COMPLETED|Overall Study||76
8611065|NCT00422097|9648505|FG000|STARTED|Dose Level 1||3
8611066|NCT00422097|9648506|FG001|STARTED|Dose Level 1||0
8611067|NCT00422097|9648507|FG002|STARTED|Dose Level 1||0
8611068|NCT00422097|9648508|FG003|STARTED|Dose Level 1||0
8611069|NCT00422097|9648509|FG004|STARTED|Dose Level 1||0
8611070|NCT00422097|9648510|FG005|STARTED|Dose Level 1||0
8611071|NCT00422097|9648511|FG006|STARTED|Dose Level 1||0
8611072|NCT00422097|9648512|FG007|STARTED|Dose Level 1||0
8611073|NCT00422097|9648505|FG000|COMPLETED|Dose Level 1||3
8611074|NCT00422097|9648506|FG001|COMPLETED|Dose Level 1||0
8611075|NCT00422097|9648507|FG002|COMPLETED|Dose Level 1||0
8611076|NCT00422097|9648508|FG003|COMPLETED|Dose Level 1||0
8611077|NCT00422097|9648509|FG004|COMPLETED|Dose Level 1||0
8611078|NCT00422097|9648510|FG005|COMPLETED|Dose Level 1||0
8611079|NCT00422097|9648511|FG006|COMPLETED|Dose Level 1||0
8611080|NCT00422097|9648512|FG007|COMPLETED|Dose Level 1||0
8611081|NCT00422097|9648505|FG000|NOT COMPLETED|Dose Level 1||0
8611082|NCT00422097|9648506|FG001|NOT COMPLETED|Dose Level 1||0
8611083|NCT00422097|9648507|FG002|NOT COMPLETED|Dose Level 1||0
8611084|NCT00422097|9648508|FG003|NOT COMPLETED|Dose Level 1||0
8611085|NCT00422097|9648509|FG004|NOT COMPLETED|Dose Level 1||0
8611086|NCT00422097|9648510|FG005|NOT COMPLETED|Dose Level 1||0
8611087|NCT00422097|9648511|FG006|NOT COMPLETED|Dose Level 1||0
8611088|NCT00422097|9648512|FG007|NOT COMPLETED|Dose Level 1||0
8611089|NCT00422097|9648505|FG000|STARTED|Dose Level 2||0
8611090|NCT00422097|9648506|FG001|STARTED|Dose Level 2||6
8611091|NCT00422097|9648507|FG002|STARTED|Dose Level 2||0
8611092|NCT00422097|9648508|FG003|STARTED|Dose Level 2||0
8611093|NCT00422097|9648509|FG004|STARTED|Dose Level 2||0
8611094|NCT00422097|9648510|FG005|STARTED|Dose Level 2||0
8611095|NCT00422097|9648511|FG006|STARTED|Dose Level 2||0
8611096|NCT00422097|9648512|FG007|STARTED|Dose Level 2||0
8611097|NCT00422097|9648505|FG000|COMPLETED|Dose Level 2||0
8611098|NCT00422097|9648506|FG001|COMPLETED|Dose Level 2||5
8611099|NCT00422097|9648507|FG002|COMPLETED|Dose Level 2||0
8611100|NCT00422097|9648508|FG003|COMPLETED|Dose Level 2||0
8611101|NCT00422097|9648509|FG004|COMPLETED|Dose Level 2||0
8611102|NCT00422097|9648510|FG005|COMPLETED|Dose Level 2||0
8611103|NCT00422097|9648511|FG006|COMPLETED|Dose Level 2||0
8611104|NCT00422097|9648512|FG007|COMPLETED|Dose Level 2||0
8611105|NCT00422097|9648505|FG000|NOT COMPLETED|Dose Level 2||0
8611106|NCT00422097|9648506|FG001|NOT COMPLETED|Dose Level 2||1
8611107|NCT00422097|9648507|FG002|NOT COMPLETED|Dose Level 2||0
8611108|NCT00422097|9648508|FG003|NOT COMPLETED|Dose Level 2||0
8611109|NCT00422097|9648509|FG004|NOT COMPLETED|Dose Level 2||0
8611110|NCT00422097|9648510|FG005|NOT COMPLETED|Dose Level 2||0
8611111|NCT00422097|9648511|FG006|NOT COMPLETED|Dose Level 2||0
8611112|NCT00422097|9648512|FG007|NOT COMPLETED|Dose Level 2||0
8611113|NCT00422097|9648505|FG000|STARTED|Dose Level 3||0
8611114|NCT00422097|9648506|FG001|STARTED|Dose Level 3||0
8611115|NCT00422097|9648507|FG002|STARTED|Dose Level 3||3
8611116|NCT00422097|9648508|FG003|STARTED|Dose Level 3||0
8611117|NCT00422097|9648509|FG004|STARTED|Dose Level 3||0
8611118|NCT00422097|9648510|FG005|STARTED|Dose Level 3||0
8611119|NCT00422097|9648511|FG006|STARTED|Dose Level 3||0
8611120|NCT00422097|9648512|FG007|STARTED|Dose Level 3||0
8611121|NCT00422097|9648505|FG000|COMPLETED|Dose Level 3||0
8611122|NCT00422097|9648506|FG001|COMPLETED|Dose Level 3||0
8611123|NCT00422097|9648507|FG002|COMPLETED|Dose Level 3||3
8611124|NCT00422097|9648508|FG003|COMPLETED|Dose Level 3||0
8611125|NCT00422097|9648509|FG004|COMPLETED|Dose Level 3||0
8611126|NCT00422097|9648510|FG005|COMPLETED|Dose Level 3||0
8611127|NCT00422097|9648511|FG006|COMPLETED|Dose Level 3||0
8611128|NCT00422097|9648512|FG007|COMPLETED|Dose Level 3||0
8611129|NCT00422097|9648505|FG000|NOT COMPLETED|Dose Level 3||0
8611130|NCT00422097|9648506|FG001|NOT COMPLETED|Dose Level 3||0
8611131|NCT00422097|9648507|FG002|NOT COMPLETED|Dose Level 3||0
8611132|NCT00422097|9648508|FG003|NOT COMPLETED|Dose Level 3||0
8611133|NCT00422097|9648509|FG004|NOT COMPLETED|Dose Level 3||0
8611134|NCT00422097|9648510|FG005|NOT COMPLETED|Dose Level 3||0
8611135|NCT00422097|9648511|FG006|NOT COMPLETED|Dose Level 3||0
8611136|NCT00422097|9648512|FG007|NOT COMPLETED|Dose Level 3||0
8611137|NCT00422097|9648505|FG000|STARTED|Dose Level 4||0
8611138|NCT00422097|9648506|FG001|STARTED|Dose Level 4||0
8611139|NCT00422097|9648507|FG002|STARTED|Dose Level 4||0
8611140|NCT00422097|9648508|FG003|STARTED|Dose Level 4||3
8611141|NCT00422097|9648509|FG004|STARTED|Dose Level 4||0
8611142|NCT00422097|9648510|FG005|STARTED|Dose Level 4||0
8611143|NCT00422097|9648511|FG006|STARTED|Dose Level 4||0
8611144|NCT00422097|9648512|FG007|STARTED|Dose Level 4||0
8611145|NCT00422097|9648505|FG000|COMPLETED|Dose Level 4||0
8611146|NCT00422097|9648506|FG001|COMPLETED|Dose Level 4||0
8611147|NCT00422097|9648507|FG002|COMPLETED|Dose Level 4||0
8611148|NCT00422097|9648508|FG003|COMPLETED|Dose Level 4||3
8611149|NCT00422097|9648509|FG004|COMPLETED|Dose Level 4||0
8611150|NCT00422097|9648510|FG005|COMPLETED|Dose Level 4||0
8611151|NCT00422097|9648511|FG006|COMPLETED|Dose Level 4||0
8611152|NCT00422097|9648512|FG007|COMPLETED|Dose Level 4||0
8611153|NCT00422097|9648505|FG000|NOT COMPLETED|Dose Level 4||0
8611154|NCT00422097|9648506|FG001|NOT COMPLETED|Dose Level 4||0
8611155|NCT00422097|9648507|FG002|NOT COMPLETED|Dose Level 4||0
8611156|NCT00422097|9648508|FG003|NOT COMPLETED|Dose Level 4||0
8611157|NCT00422097|9648509|FG004|NOT COMPLETED|Dose Level 4||0
8611158|NCT00422097|9648510|FG005|NOT COMPLETED|Dose Level 4||0
8611159|NCT00422097|9648511|FG006|NOT COMPLETED|Dose Level 4||0
8611160|NCT00422097|9648512|FG007|NOT COMPLETED|Dose Level 4||0
8611161|NCT00422097|9648505|FG000|STARTED|Dose Level 5||0
8611162|NCT00422097|9648506|FG001|STARTED|Dose Level 5||0
8611163|NCT00422097|9648507|FG002|STARTED|Dose Level 5||0
8611164|NCT00422097|9648508|FG003|STARTED|Dose Level 5||0
8611165|NCT00422097|9648509|FG004|STARTED|Dose Level 5||23
8611166|NCT00422097|9648510|FG005|STARTED|Dose Level 5||0
8611167|NCT00422097|9648511|FG006|STARTED|Dose Level 5||0
8611168|NCT00422097|9648512|FG007|STARTED|Dose Level 5||0
8611169|NCT00422097|9648505|FG000|COMPLETED|Dose Level 5||0
8611170|NCT00422097|9648506|FG001|COMPLETED|Dose Level 5||0
8611171|NCT00422097|9648507|FG002|COMPLETED|Dose Level 5||0
8611172|NCT00422097|9648508|FG003|COMPLETED|Dose Level 5||0
8611173|NCT00422097|9648509|FG004|COMPLETED|Dose Level 5||23
8611174|NCT00422097|9648510|FG005|COMPLETED|Dose Level 5||0
8611175|NCT00422097|9648511|FG006|COMPLETED|Dose Level 5||0
8611176|NCT00422097|9648512|FG007|COMPLETED|Dose Level 5||0
8611177|NCT00422097|9648505|FG000|NOT COMPLETED|Dose Level 5||0
8611178|NCT00422097|9648506|FG001|NOT COMPLETED|Dose Level 5||0
8611179|NCT00422097|9648507|FG002|NOT COMPLETED|Dose Level 5||0
8611180|NCT00422097|9648508|FG003|NOT COMPLETED|Dose Level 5||0
8611181|NCT00422097|9648509|FG004|NOT COMPLETED|Dose Level 5||0
8611182|NCT00422097|9648510|FG005|NOT COMPLETED|Dose Level 5||0
8611183|NCT00422097|9648511|FG006|NOT COMPLETED|Dose Level 5||0
8611184|NCT00422097|9648512|FG007|NOT COMPLETED|Dose Level 5||0
8611185|NCT00422097|9648505|FG000|STARTED|Dose Level 6||0
8611186|NCT00422097|9648506|FG001|STARTED|Dose Level 6||0
8611187|NCT00422097|9648507|FG002|STARTED|Dose Level 6||0
8611188|NCT00422097|9648508|FG003|STARTED|Dose Level 6||0
8611189|NCT00422097|9648509|FG004|STARTED|Dose Level 6||0
8611190|NCT00422097|9648510|FG005|STARTED|Dose Level 6||6
8611191|NCT00422097|9648511|FG006|STARTED|Dose Level 6||0
8611192|NCT00422097|9648512|FG007|STARTED|Dose Level 6||0
8611193|NCT00422097|9648505|FG000|COMPLETED|Dose Level 6||0
8611194|NCT00422097|9648506|FG001|COMPLETED|Dose Level 6||0
8611195|NCT00422097|9648507|FG002|COMPLETED|Dose Level 6||0
8611196|NCT00422097|9648508|FG003|COMPLETED|Dose Level 6||0
8611197|NCT00422097|9648509|FG004|COMPLETED|Dose Level 6||0
8611198|NCT00422097|9648510|FG005|COMPLETED|Dose Level 6||6
8611199|NCT00422097|9648511|FG006|COMPLETED|Dose Level 6||0
8611200|NCT00422097|9648512|FG007|COMPLETED|Dose Level 6||0
8611201|NCT00422097|9648505|FG000|NOT COMPLETED|Dose Level 6||0
8611202|NCT00422097|9648506|FG001|NOT COMPLETED|Dose Level 6||0
8611203|NCT00422097|9648507|FG002|NOT COMPLETED|Dose Level 6||0
8611204|NCT00422097|9648508|FG003|NOT COMPLETED|Dose Level 6||0
8611205|NCT00422097|9648509|FG004|NOT COMPLETED|Dose Level 6||0
8611206|NCT00422097|9648510|FG005|NOT COMPLETED|Dose Level 6||0
8611207|NCT00422097|9648511|FG006|NOT COMPLETED|Dose Level 6||0
8611208|NCT00422097|9648512|FG007|NOT COMPLETED|Dose Level 6||0
8611209|NCT00422097|9648505|FG000|STARTED|Ixabepilone With Famotidine or Food||0
8611210|NCT00422097|9648506|FG001|STARTED|Ixabepilone With Famotidine or Food||0
8611211|NCT00422097|9648507|FG002|STARTED|Ixabepilone With Famotidine or Food||0
8611212|NCT00422097|9648508|FG003|STARTED|Ixabepilone With Famotidine or Food||0
8611213|NCT00422097|9648509|FG004|STARTED|Ixabepilone With Famotidine or Food||0
8611214|NCT00422097|9648510|FG005|STARTED|Ixabepilone With Famotidine or Food||0
8611215|NCT00422097|9648511|FG006|STARTED|Ixabepilone With Famotidine or Food||8
8611216|NCT00422097|9648512|FG007|STARTED|Ixabepilone With Famotidine or Food||7
8611217|NCT00422097|9648505|FG000|COMPLETED|Ixabepilone With Famotidine or Food||0
8611218|NCT00422097|9648506|FG001|COMPLETED|Ixabepilone With Famotidine or Food||0
8611219|NCT00422097|9648507|FG002|COMPLETED|Ixabepilone With Famotidine or Food||0
8611220|NCT00422097|9648508|FG003|COMPLETED|Ixabepilone With Famotidine or Food||0
8611221|NCT00422097|9648509|FG004|COMPLETED|Ixabepilone With Famotidine or Food||0
8611222|NCT00422097|9648510|FG005|COMPLETED|Ixabepilone With Famotidine or Food||0
8611223|NCT00422097|9648511|FG006|COMPLETED|Ixabepilone With Famotidine or Food||8
8611224|NCT00422097|9648512|FG007|COMPLETED|Ixabepilone With Famotidine or Food||7
8611225|NCT00422097|9648505|FG000|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
8611226|NCT00422097|9648506|FG001|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
8611227|NCT00422097|9648507|FG002|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
8611228|NCT00422097|9648508|FG003|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
8611229|NCT00422097|9648509|FG004|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
8611230|NCT00422097|9648510|FG005|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
8611231|NCT00422097|9648511|FG006|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
8611232|NCT00422097|9648512|FG007|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
8611233|NCT00422162|9648538|FG000|STARTED|Overall Study||167
8611234|NCT00422162|9648539|FG001|STARTED|Overall Study||172
8611235|NCT00422162|9648538|FG000|Received Treatment|Overall Study||167
8611236|NCT00422162|9648539|FG001|Received Treatment|Overall Study||171
8611237|NCT00422162|9648538|FG000|COMPLETED|Overall Study||143
8611238|NCT00422162|9648539|FG001|COMPLETED|Overall Study||142
8611239|NCT00422162|9648538|FG000|NOT COMPLETED|Overall Study||24
8611240|NCT00422162|9648539|FG001|NOT COMPLETED|Overall Study||30
8611241|NCT00422201|9648555|FG000|STARTED|Overall Study||18
8611242|NCT00422201|9648555|FG000|COMPLETED|Overall Study||7
8611243|NCT00422201|9648555|FG000|NOT COMPLETED|Overall Study||11
8611244|NCT00422227|9648562|FG000|STARTED|Overall Study||197
8611245|NCT00422227|9648563|FG001|STARTED|Overall Study||103
8611246|NCT00422227|9648562|FG000|COMPLETED|Overall Study||193
8611247|NCT00422227|9648563|FG001|COMPLETED|Overall Study||88
8611248|NCT00422227|9648562|FG000|NOT COMPLETED|Overall Study||4
8611249|NCT00422227|9648563|FG001|NOT COMPLETED|Overall Study||15
8611250|NCT00422279|9648571|FG000|STARTED|Overall Study||2
8611251|NCT00422279|9648572|FG001|STARTED|Overall Study||2
8611252|NCT00422279|9648571|FG000|24 Month After Loading Period|Overall Study||2
8611253|NCT00422279|9648572|FG001|24 Month After Loading Period|Overall Study||2
8611254|NCT00422279|9648571|FG000|COMPLETED|Overall Study||2
8611255|NCT00422279|9648572|FG001|COMPLETED|Overall Study||2
8611256|NCT00422279|9648571|FG000|NOT COMPLETED|Overall Study||0
8611257|NCT00422279|9648572|FG001|NOT COMPLETED|Overall Study||0
8611258|NCT00422292|9648584|FG000|STARTED|Overall Study||257
8611259|NCT00422292|9648585|FG001|STARTED|Overall Study||664
8611260|NCT00422292|9648586|FG002|STARTED|Overall Study||246
8611261|NCT00422292|9648587|FG003|STARTED|Overall Study||476
8611262|NCT00422292|9648584|FG000|COMPLETED|Overall Study||239
8611263|NCT00422292|9648585|FG001|COMPLETED|Overall Study||598
8611264|NCT00422292|9648586|FG002|COMPLETED|Overall Study||224
8611265|NCT00422292|9648587|FG003|COMPLETED|Overall Study||452
8611266|NCT00422292|9648584|FG000|NOT COMPLETED|Overall Study||18
8611267|NCT00422292|9648585|FG001|NOT COMPLETED|Overall Study||66
8611268|NCT00422292|9648586|FG002|NOT COMPLETED|Overall Study||22
8611269|NCT00422292|9648587|FG003|NOT COMPLETED|Overall Study||24
8611270|NCT00422383|9648602|FG000|STARTED|Overall Study||134
8611271|NCT00422383|9648603|FG001|STARTED|Overall Study||120
8611272|NCT00422383|9648604|FG002|STARTED|Overall Study||93
8611273|NCT00422383|9648605|FG003|STARTED|Overall Study||6
8611274|NCT00422383|9648606|FG004|STARTED|Overall Study||25
8611275|NCT00422383|9648602|FG000|COMPLETED|Overall Study||119
8611276|NCT00422383|9648603|FG001|COMPLETED|Overall Study||106
8611277|NCT00422383|9648604|FG002|COMPLETED|Overall Study||89
8611278|NCT00422383|9648605|FG003|COMPLETED|Overall Study||4
8611279|NCT00422383|9648606|FG004|COMPLETED|Overall Study||22
8611280|NCT00422383|9648602|FG000|NOT COMPLETED|Overall Study||15
8611281|NCT00422383|9648603|FG001|NOT COMPLETED|Overall Study||14
8611282|NCT00422383|9648604|FG002|NOT COMPLETED|Overall Study||4
8611283|NCT00422383|9648605|FG003|NOT COMPLETED|Overall Study||2
8611284|NCT00422383|9648606|FG004|NOT COMPLETED|Overall Study||3
8611285|NCT00422422|9648624|FG000|STARTED|Overall Study||100
8611286|NCT00422422|9648624|FG000|COMPLETED|Overall Study||90
8611287|NCT00422422|9648624|FG000|NOT COMPLETED|Overall Study||10
8611288|NCT00422448|9648630|FG000|STARTED|Overall Study|22 prospectively enrolled during study period and 21 retrospectively enrolled|43
8611289|NCT00422448|9648630|FG000|COMPLETED|Overall Study||43
8611290|NCT00422448|9648630|FG000|NOT COMPLETED|Overall Study||0
8611291|NCT00422461|9648638|FG000|STARTED|Overall Study||35
8611292|NCT00422461|9648639|FG001|STARTED|Overall Study||35
8611293|NCT00422461|9648640|FG002|STARTED|Overall Study||32
8611294|NCT00422461|9648641|FG003|STARTED|Overall Study||33
8611295|NCT00422461|9648638|FG000|Treated|Overall Study||34
8611296|NCT00422461|9648639|FG001|Treated|Overall Study||34
8611297|NCT00422461|9648640|FG002|Treated|Overall Study||32
8611298|NCT00422461|9648641|FG003|Treated|Overall Study||33
8611299|NCT00422461|9648638|FG000|Full Analysis Set|Overall Study||34
8611300|NCT00422461|9648639|FG001|Full Analysis Set|Overall Study||34
8611301|NCT00422461|9648640|FG002|Full Analysis Set|Overall Study||31
8611302|NCT00422461|9648641|FG003|Full Analysis Set|Overall Study||33
8611303|NCT00422461|9648638|FG000|COMPLETED|Overall Study||32
8611304|NCT00422461|9648639|FG001|COMPLETED|Overall Study||32
8611305|NCT00422461|9648640|FG002|COMPLETED|Overall Study||31
8611306|NCT00422461|9648641|FG003|COMPLETED|Overall Study||30
8611307|NCT00422461|9648638|FG000|NOT COMPLETED|Overall Study||3
8611308|NCT00422461|9648639|FG001|NOT COMPLETED|Overall Study||3
8611309|NCT00422461|9648640|FG002|NOT COMPLETED|Overall Study||1
8611310|NCT00422461|9648641|FG003|NOT COMPLETED|Overall Study||3
8611311|NCT00422513|9648653|FG000|STARTED|Overall Study||130
8611312|NCT00422513|9648654|FG001|STARTED|Overall Study||130
8611313|NCT00422513|9648653|FG000|COMPLETED|Overall Study||23
8611314|NCT00422513|9648654|FG001|COMPLETED|Overall Study||24
8611315|NCT00422513|9648653|FG000|NOT COMPLETED|Overall Study||107
8611316|NCT00422513|9648654|FG001|NOT COMPLETED|Overall Study||106
8611317|NCT00422591|9648660|FG000|STARTED|Overall Study||175
8611318|NCT00422591|9648660|FG000|COMPLETED|Overall Study||169
8611319|NCT00422591|9648660|FG000|NOT COMPLETED|Overall Study||6
8611320|NCT00422656|9648664|FG000|STARTED|Overall Study||37
8611321|NCT00422656|9648664|FG000|COMPLETED|Overall Study||37
8611322|NCT00422656|9648664|FG000|NOT COMPLETED|Overall Study||0
8611323|NCT00422695|9648670|FG000|STARTED|Overall Study||105
8611324|NCT00422695|9648671|FG001|STARTED|Overall Study||38
8611325|NCT00422695|9648670|FG000|COMPLETED|Overall Study||105
8611326|NCT00422695|9648671|FG001|COMPLETED|Overall Study||38
8611327|NCT00422695|9648670|FG000|NOT COMPLETED|Overall Study||0
8611328|NCT00422695|9648671|FG001|NOT COMPLETED|Overall Study||0
8611329|NCT00422734|9648679|FG000|STARTED|Overall Study||78
8611330|NCT00422734|9648680|FG001|STARTED|Overall Study||264
8611331|NCT00422734|9648679|FG000|COMPLETED|Overall Study||64
8611332|NCT00422734|9648680|FG001|COMPLETED|Overall Study||243
8611333|NCT00422734|9648679|FG000|NOT COMPLETED|Overall Study||14
8611334|NCT00422734|9648680|FG001|NOT COMPLETED|Overall Study||21
8611335|NCT00422799|9648686|FG000|STARTED|Overall Study||63
8611336|NCT00422799|9648686|FG000|COMPLETED|Overall Study||50
8611337|NCT00422799|9648686|FG000|NOT COMPLETED|Overall Study||13
8611338|NCT00422812|9648694|FG000|STARTED|Overall Study||98
8611339|NCT00422812|9648695|FG001|STARTED|Overall Study||104
8611340|NCT00422812|9648696|FG002|STARTED|Overall Study||93
8611341|NCT00422812|9648697|FG003|STARTED|Overall Study||105
8611342|NCT00422812|9648694|FG000|COMPLETED|Overall Study||98
8611343|NCT00422812|9648695|FG001|COMPLETED|Overall Study||103
8611344|NCT00422812|9648696|FG002|COMPLETED|Overall Study||91
8611345|NCT00422812|9648697|FG003|COMPLETED|Overall Study||103
8611346|NCT00422812|9648694|FG000|NOT COMPLETED|Overall Study||0
8611347|NCT00422812|9648695|FG001|NOT COMPLETED|Overall Study||1
8611348|NCT00422812|9648696|FG002|NOT COMPLETED|Overall Study||2
8611349|NCT00422812|9648697|FG003|NOT COMPLETED|Overall Study||2
8611350|NCT00422903|9648709|FG000|STARTED|Overall Study||49
8611351|NCT00422903|9648710|FG001|STARTED|Overall Study||43
8611352|NCT00422903|9648709|FG000|COMPLETED|Overall Study||45
8611353|NCT00422903|9648710|FG001|COMPLETED|Overall Study||38
8611354|NCT00422903|9648709|FG000|NOT COMPLETED|Overall Study||4
8611355|NCT00422903|9648710|FG001|NOT COMPLETED|Overall Study||5
8611356|NCT00423046|9648718|FG000|STARTED|Overall Study||553
8611357|NCT00423046|9648719|FG001|STARTED|Overall Study||553
8611358|NCT00423046|9648718|FG000|COMPLETED|Overall Study|Completed until Month 60|213
8611359|NCT00423046|9648719|FG001|COMPLETED|Overall Study|Completed until Month 60|208
8611360|NCT00423046|9648718|FG000|NOT COMPLETED|Overall Study||340
8611361|NCT00423046|9648719|FG001|NOT COMPLETED|Overall Study||345
8611362|NCT00423085|9648730|FG000|STARTED|24-Week Double-Blind Treatment Phase||288
8611363|NCT00423085|9648731|FG001|STARTED|24-Week Double-Blind Treatment Phase||284
8611364|NCT00423085|9648732|FG002|STARTED|24-Week Double-Blind Treatment Phase||287
8611365|NCT00423085|9648733|FG003|STARTED|24-Week Double-Blind Treatment Phase||0
8611366|NCT00423085|9648730|FG000|COMPLETED|24-Week Double-Blind Treatment Phase||242
8611367|NCT00423085|9648731|FG001|COMPLETED|24-Week Double-Blind Treatment Phase||220
8611368|NCT00423085|9648732|FG002|COMPLETED|24-Week Double-Blind Treatment Phase||228
8611369|NCT00423085|9648733|FG003|COMPLETED|24-Week Double-Blind Treatment Phase||0
8611370|NCT00423085|9648730|FG000|NOT COMPLETED|24-Week Double-Blind Treatment Phase||46
8611371|NCT00423085|9648731|FG001|NOT COMPLETED|24-Week Double-Blind Treatment Phase||64
8611372|NCT00423085|9648732|FG002|NOT COMPLETED|24-Week Double-Blind Treatment Phase||59
8611373|NCT00423085|9648733|FG003|NOT COMPLETED|24-Week Double-Blind Treatment Phase||0
8611374|NCT00423085|9648730|FG000|STARTED|52-Week Open-Label Extension Phase||0
8611375|NCT00423085|9648731|FG001|STARTED|52-Week Open-Label Extension Phase||0
8611376|NCT00423085|9648732|FG002|STARTED|52-Week Open-Label Extension Phase||0
8611377|NCT00423085|9648733|FG003|STARTED|52-Week Open-Label Extension Phase|Patients who completed the 24-wk treatment phase were eligible to enroll in the open-label extension|637
8611378|NCT00423085|9648730|FG000|COMPLETED|52-Week Open-Label Extension Phase||0
8611379|NCT00423085|9648731|FG001|COMPLETED|52-Week Open-Label Extension Phase||0
8611380|NCT00423085|9648732|FG002|COMPLETED|52-Week Open-Label Extension Phase||0
8611381|NCT00423085|9648733|FG003|COMPLETED|52-Week Open-Label Extension Phase||474
8611382|NCT00423085|9648730|FG000|NOT COMPLETED|52-Week Open-Label Extension Phase||0
8611383|NCT00423085|9648731|FG001|NOT COMPLETED|52-Week Open-Label Extension Phase||0
8611384|NCT00423085|9648732|FG002|NOT COMPLETED|52-Week Open-Label Extension Phase||0
8611385|NCT00423085|9648733|FG003|NOT COMPLETED|52-Week Open-Label Extension Phase||163
8611386|NCT00423098|9648745|FG000|STARTED|Overall Study|Total number of patients screened was 90, but the total number of randomized patients was 81.|42
8611387|NCT00423098|9648746|FG001|STARTED|Overall Study||39
8611388|NCT00423098|9648745|FG000|COMPLETED|Overall Study|Completed 24 weeks of study medication.|39
8611389|NCT00423098|9648746|FG001|COMPLETED|Overall Study||35
8611390|NCT00423098|9648745|FG000|NOT COMPLETED|Overall Study||3
8611391|NCT00423098|9648746|FG001|NOT COMPLETED|Overall Study||4
8611392|NCT00423137|9648756|FG000|STARTED|Overall Study||11
8611393|NCT00423137|9648757|FG001|STARTED|Overall Study||12
8611394|NCT00423137|9648758|FG002|STARTED|Overall Study||13
8611395|NCT00423137|9648759|FG003|STARTED|Overall Study||12
8611396|NCT00423137|9648756|FG000|COMPLETED|Overall Study||10
8611397|NCT00423137|9648757|FG001|COMPLETED|Overall Study||12
8611398|NCT00423137|9648758|FG002|COMPLETED|Overall Study||7
8611399|NCT00423137|9648759|FG003|COMPLETED|Overall Study||10
8611400|NCT00423137|9648756|FG000|NOT COMPLETED|Overall Study||1
8611401|NCT00423137|9648757|FG001|NOT COMPLETED|Overall Study||0
8611402|NCT00423137|9648758|FG002|NOT COMPLETED|Overall Study||6
8611403|NCT00423137|9648759|FG003|NOT COMPLETED|Overall Study||2
8611404|NCT00423150|9648772|FG000|STARTED|Overall Study||86
8611405|NCT00423150|9648772|FG000|COMPLETED|Overall Study||0
8611406|NCT00423150|9648772|FG000|NOT COMPLETED|Overall Study||86
8611407|NCT00423189|9648779|FG000|STARTED|Overall Study||2
8611408|NCT00423189|9648780|FG001|STARTED|Overall Study||3
8611409|NCT00423189|9648781|FG002|STARTED|Overall Study||2
8611410|NCT00423189|9648779|FG000|COMPLETED|Overall Study||2
8611411|NCT00423189|9648780|FG001|COMPLETED|Overall Study||2
8611412|NCT00423189|9648781|FG002|COMPLETED|Overall Study||2
8611413|NCT00423189|9648779|FG000|NOT COMPLETED|Overall Study||0
8611414|NCT00423189|9648780|FG001|NOT COMPLETED|Overall Study||1
8611415|NCT00423189|9648781|FG002|NOT COMPLETED|Overall Study||0
8611416|NCT00423267|9648796|FG000|STARTED|Period A||9
8611417|NCT00423267|9648797|FG001|STARTED|Period A||7
8611418|NCT00423267|9648796|FG000|COMPLETED|Period A||7
8611419|NCT00423267|9648797|FG001|COMPLETED|Period A||6
8611420|NCT00423267|9648796|FG000|NOT COMPLETED|Period A||2
8611421|NCT00423267|9648797|FG001|NOT COMPLETED|Period A||1
8611422|NCT00423267|9648796|FG000|STARTED|Period B||12
8611423|NCT00423267|9648797|FG001|STARTED|Period B||0
8611424|NCT00423267|9648796|FG000|COMPLETED|Period B||12
8611425|NCT00423267|9648797|FG001|COMPLETED|Period B||0
8611426|NCT00423267|9648796|FG000|NOT COMPLETED|Period B||0
8611427|NCT00423267|9648797|FG001|NOT COMPLETED|Period B||0
8611428|NCT00423293|9648805|FG000|STARTED|Overall Study||63
8611429|NCT00423293|9648805|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|52
8611430|NCT00423293|9648805|FG000|NOT COMPLETED|Overall Study||11
8611431|NCT00423319|9648811|FG000|STARTED|Overall Study|Randomized|2708
8611432|NCT00423319|9648812|FG001|STARTED|Overall Study|Randomized|2699
8611433|NCT00423319|9648811|FG000|Participants Who Received Treatment|Overall Study||2673
8611434|NCT00423319|9648812|FG001|Participants Who Received Treatment|Overall Study||2659
8611435|NCT00423319|9648811|FG000|COMPLETED|Overall Study||2484
8611436|NCT00423319|9648812|FG001|COMPLETED|Overall Study||2447
8611437|NCT00423319|9648811|FG000|NOT COMPLETED|Overall Study||224
8611438|NCT00423319|9648812|FG001|NOT COMPLETED|Overall Study||252
8611439|NCT00423332|9648821|FG000|STARTED|Overall Study|Randomised|53
8611440|NCT00423332|9648822|FG001|STARTED|Overall Study|Number randomised|18
8611441|NCT00423332|9648821|FG000|Continuing After Unblinding|Overall Study|Number starting/ continuing AZD2171 after unblinding|44
8611442|NCT00423332|9648822|FG001|Continuing After Unblinding|Overall Study|Number starting/ continuing AZD2171 after unblinding|14
8611443|NCT00423332|9648821|FG000|Ongoing at Data Cut Off (8th March 2009)|Overall Study|Number ongoing at data cut off (8th March 2009)|22
8611444|NCT00423332|9648822|FG001|Ongoing at Data Cut Off (8th March 2009)|Overall Study|Number ongoing at data cut off (8th March 2009)|4
8611445|NCT00423332|9648821|FG000|COMPLETED|Overall Study|Number completing 12 weeks blinded randomised treatment|44
8611446|NCT00423332|9648822|FG001|COMPLETED|Overall Study|Number completing 12 weeks blinded randomised treatment|11
8611447|NCT00423332|9648821|FG000|NOT COMPLETED|Overall Study||9
8611448|NCT00423332|9648822|FG001|NOT COMPLETED|Overall Study||7
8611449|NCT00423358|9648831|FG000|STARTED|Overall Study||11
8611450|NCT00423358|9648832|FG001|STARTED|Overall Study||11
8611451|NCT00423358|9648831|FG000|COMPLETED|Overall Study||11
8611452|NCT00423358|9648832|FG001|COMPLETED|Overall Study||11
8611453|NCT00423358|9648831|FG000|NOT COMPLETED|Overall Study||0
8611454|NCT00423358|9648832|FG001|NOT COMPLETED|Overall Study||0
8611455|NCT00423436|9648840|FG000|STARTED|Overall Study||35
8611456|NCT00423436|9648841|FG001|STARTED|Overall Study||33
8611457|NCT00423436|9648840|FG000|COMPLETED|Overall Study||35
8611458|NCT00423436|9648841|FG001|COMPLETED|Overall Study||33
8611459|NCT00423436|9648840|FG000|NOT COMPLETED|Overall Study||0
8611460|NCT00423436|9648841|FG001|NOT COMPLETED|Overall Study||0
8611461|NCT00423449|9648847|FG000|STARTED|Overall Study||4
8611462|NCT00423449|9648848|FG001|STARTED|Overall Study||6
8611463|NCT00423449|9648849|FG002|STARTED|Overall Study||17
8611464|NCT00423449|9648850|FG003|STARTED|Overall Study||27
8611465|NCT00423449|9648851|FG004|STARTED|Overall Study||7
8611466|NCT00423449|9648847|FG000|COMPLETED|Overall Study||1
8611467|NCT00423449|9648848|FG001|COMPLETED|Overall Study||2
8611468|NCT00423449|9648849|FG002|COMPLETED|Overall Study||2
8611469|NCT00423449|9648850|FG003|COMPLETED|Overall Study||5
8611470|NCT00423449|9648851|FG004|COMPLETED|Overall Study||0
8611471|NCT00423449|9648847|FG000|NOT COMPLETED|Overall Study||3
8611472|NCT00423449|9648848|FG001|NOT COMPLETED|Overall Study||4
8611473|NCT00423449|9648849|FG002|NOT COMPLETED|Overall Study||15
8611474|NCT00423449|9648850|FG003|NOT COMPLETED|Overall Study||22
8611475|NCT00423449|9648851|FG004|NOT COMPLETED|Overall Study||7
8611476|NCT00423592|9648864|FG000|STARTED|Overall Study|Enrolled|36
8611477|NCT00423592|9648864|FG000|Completed Preliminary Analysis Cut-off|Overall Study|Preliminary analysis cut-off at Week 12 for primary/secondary endpoint analysis|34
8611478|NCT00423592|9648864|FG000|COMPLETED|Overall Study|Completed study|29
8611479|NCT00423592|9648864|FG000|NOT COMPLETED|Overall Study||7
8611480|NCT00423605|9648868|FG000|STARTED|Overall Study||560
8611481|NCT00423605|9648868|FG000|COMPLETED|Overall Study||319
8611482|NCT00423605|9648868|FG000|NOT COMPLETED|Overall Study||241
8611483|NCT00423657|9648874|FG000|STARTED|Overall Study||342
8611484|NCT00423657|9648875|FG001|STARTED|Overall Study||338
8611485|NCT00423657|9648874|FG000|COMPLETED|Overall Study||316
8611486|NCT00423657|9648875|FG001|COMPLETED|Overall Study||313
8611487|NCT00423657|9648874|FG000|NOT COMPLETED|Overall Study||26
8611488|NCT00423657|9648875|FG001|NOT COMPLETED|Overall Study||25
8611489|NCT00423670|9648888|FG000|STARTED|Treatment Period||104
8611490|NCT00423670|9648889|FG001|STARTED|Treatment Period||107
8611491|NCT00423670|9648890|FG002|STARTED|Treatment Period||103
8611492|NCT00423670|9648891|FG003|STARTED|Treatment Period||103
8611493|NCT00423670|9648892|FG004|STARTED|Treatment Period||103
8611494|NCT00423670|9648893|FG005|STARTED|Treatment Period||16
8611495|NCT00423670|9648894|FG006|STARTED|Treatment Period||59
8611496|NCT00423670|9648895|FG007|STARTED|Treatment Period|Arm 8 were Arm 1 participants that were positive for HCV-RNA at TW 24 and had the option to switch.|36
8611497|NCT00423670|9648888|FG000|COMPLETED|Treatment Period||52
8611498|NCT00423670|9648889|FG001|COMPLETED|Treatment Period||77
8611499|NCT00423670|9648890|FG002|COMPLETED|Treatment Period||76
8611500|NCT00423670|9648891|FG003|COMPLETED|Treatment Period||63
8611501|NCT00423670|9648892|FG004|COMPLETED|Treatment Period||76
8611502|NCT00423670|9648893|FG005|COMPLETED|Treatment Period||8
8611503|NCT00423670|9648894|FG006|COMPLETED|Treatment Period||28
8611504|NCT00423670|9648895|FG007|COMPLETED|Treatment Period||15
8611505|NCT00423670|9648888|FG000|NOT COMPLETED|Treatment Period||52
8611506|NCT00423670|9648889|FG001|NOT COMPLETED|Treatment Period||30
8611507|NCT00423670|9648890|FG002|NOT COMPLETED|Treatment Period||27
8611508|NCT00423670|9648891|FG003|NOT COMPLETED|Treatment Period||40
8611509|NCT00423670|9648892|FG004|NOT COMPLETED|Treatment Period||27
8611510|NCT00423670|9648893|FG005|NOT COMPLETED|Treatment Period||8
8611511|NCT00423670|9648894|FG006|NOT COMPLETED|Treatment Period||31
8611512|NCT00423670|9648895|FG007|NOT COMPLETED|Treatment Period||21
8611513|NCT00423670|9648888|FG000|STARTED|Follow-up Period||97
8611514|NCT00423670|9648889|FG001|STARTED|Follow-up Period||100
8611515|NCT00423670|9648890|FG002|STARTED|Follow-up Period||96
8611516|NCT00423670|9648891|FG003|STARTED|Follow-up Period||96
8611517|NCT00423670|9648892|FG004|STARTED|Follow-up Period||91
8611518|NCT00423670|9648893|FG005|STARTED|Follow-up Period||14
8611519|NCT00423670|9648894|FG006|STARTED|Follow-up Period||50
8611520|NCT00423670|9648895|FG007|STARTED|Follow-up Period||35
8611521|NCT00423670|9648888|FG000|COMPLETED|Follow-up Period||94
8611522|NCT00423670|9648889|FG001|COMPLETED|Follow-up Period||84
8611523|NCT00423670|9648890|FG002|COMPLETED|Follow-up Period||85
8611524|NCT00423670|9648891|FG003|COMPLETED|Follow-up Period||91
8611525|NCT00423670|9648892|FG004|COMPLETED|Follow-up Period||89
8611526|NCT00423670|9648893|FG005|COMPLETED|Follow-up Period||14
8611527|NCT00423670|9648894|FG006|COMPLETED|Follow-up Period||41
8611528|NCT00423670|9648895|FG007|COMPLETED|Follow-up Period||32
8611529|NCT00423670|9648888|FG000|NOT COMPLETED|Follow-up Period||3
8611530|NCT00423670|9648889|FG001|NOT COMPLETED|Follow-up Period||16
8611531|NCT00423670|9648890|FG002|NOT COMPLETED|Follow-up Period||11
8611532|NCT00423670|9648891|FG003|NOT COMPLETED|Follow-up Period||5
8611533|NCT00423670|9648892|FG004|NOT COMPLETED|Follow-up Period||2
8611534|NCT00423670|9648893|FG005|NOT COMPLETED|Follow-up Period||0
8611535|NCT00423670|9648894|FG006|NOT COMPLETED|Follow-up Period||9
8611536|NCT00423670|9648895|FG007|NOT COMPLETED|Follow-up Period||3
8611537|NCT00423683|9648918|FG000|STARTED|Overall Study||31
8611538|NCT00423683|9648919|FG001|STARTED|Overall Study||33
8611539|NCT00423683|9648918|FG000|COMPLETED|Overall Study||30
8611540|NCT00423683|9648919|FG001|COMPLETED|Overall Study||33
8611541|NCT00423683|9648918|FG000|NOT COMPLETED|Overall Study||1
8611542|NCT00423683|9648919|FG001|NOT COMPLETED|Overall Study||0
8611543|NCT00423722|9648929|FG000|STARTED|Overall Study||63
8611544|NCT00423722|9648930|FG001|STARTED|Overall Study||66
8611545|NCT00423722|9648929|FG000|COMPLETED|Overall Study||49
8611546|NCT00423722|9648930|FG001|COMPLETED|Overall Study||53
8611547|NCT00423722|9648929|FG000|NOT COMPLETED|Overall Study||14
8611548|NCT00423722|9648930|FG001|NOT COMPLETED|Overall Study||13
8611549|NCT00423735|9648945|FG000|STARTED|Overall Study||29
8611550|NCT00423735|9648946|FG001|STARTED|Overall Study||35
8611551|NCT00423735|9648947|FG002|STARTED|Overall Study||0
8611552|NCT00423735|9648945|FG000|COMPLETED|Overall Study||21
8611553|NCT00423735|9648946|FG001|COMPLETED|Overall Study||29
8611554|NCT00423735|9648947|FG002|COMPLETED|Overall Study||0
8611555|NCT00423735|9648945|FG000|NOT COMPLETED|Overall Study||8
8611556|NCT00423735|9648946|FG001|NOT COMPLETED|Overall Study||6
8611557|NCT00423735|9648947|FG002|NOT COMPLETED|Overall Study||0
8611558|NCT00423800|9648959|FG000|STARTED|Overall Study||3
8611559|NCT00423800|9648960|FG001|STARTED|Overall Study||2
8611560|NCT00423800|9648959|FG000|COMPLETED|Overall Study||3
8611561|NCT00423800|9648960|FG001|COMPLETED|Overall Study||1
8611562|NCT00423800|9648959|FG000|NOT COMPLETED|Overall Study||0
8611563|NCT00423800|9648960|FG001|NOT COMPLETED|Overall Study||1
8611564|NCT00423813|9648970|FG000|STARTED|Overall Study||188
8611565|NCT00423813|9648971|FG001|STARTED|Overall Study||195
8611566|NCT00423813|9648972|FG002|STARTED|Overall Study||190
8611567|NCT00423813|9648970|FG000|Treated|Overall Study||188
8611568|NCT00423813|9648971|FG001|Treated|Overall Study||194
8611569|NCT00423813|9648972|FG002|Treated|Overall Study||189
8611570|NCT00423813|9648970|FG000|COMPLETED|Overall Study||131
8611571|NCT00423813|9648971|FG001|COMPLETED|Overall Study||129
8611572|NCT00423813|9648972|FG002|COMPLETED|Overall Study||116
8611573|NCT00423813|9648970|FG000|NOT COMPLETED|Overall Study||57
8611574|NCT00423813|9648971|FG001|NOT COMPLETED|Overall Study||66
8611575|NCT00423813|9648972|FG002|NOT COMPLETED|Overall Study||74
8611576|NCT00423852|9648980|FG000|STARTED|Overall Study||26
8611577|NCT00423852|9648980|FG000|COMPLETED|Overall Study||23
8611578|NCT00423852|9648980|FG000|NOT COMPLETED|Overall Study||3
8611579|NCT00423878|9648986|FG000|STARTED|Overall Study||109
8611580|NCT00423878|9648987|FG001|STARTED|Overall Study||106
8611581|NCT00423878|9648986|FG000|COMPLETED|Overall Study||89
8611582|NCT00423878|9648987|FG001|COMPLETED|Overall Study||98
8611583|NCT00423878|9648986|FG000|NOT COMPLETED|Overall Study||20
8611584|NCT00423878|9648987|FG001|NOT COMPLETED|Overall Study||8
8611585|NCT00423891|9648996|FG000|STARTED|Enrolled||35
8611586|NCT00423891|9648997|FG001|STARTED|Enrolled||21
8611587|NCT00423891|9648998|FG002|STARTED|Enrolled||8
8611588|NCT00423891|9648996|FG000|COMPLETED|Enrolled||24
8611589|NCT00423891|9648997|FG001|COMPLETED|Enrolled||19
8611590|NCT00423891|9648998|FG002|COMPLETED|Enrolled||5
8611591|NCT00423891|9648996|FG000|NOT COMPLETED|Enrolled||11
8611592|NCT00423891|9648997|FG001|NOT COMPLETED|Enrolled||2
8611593|NCT00423891|9648998|FG002|NOT COMPLETED|Enrolled||3
8611594|NCT00423891|9648996|FG000|STARTED|Treatment||24
8611595|NCT00423891|9648997|FG001|STARTED|Treatment||19
8611596|NCT00423891|9648998|FG002|STARTED|Treatment||5
8611597|NCT00423891|9648996|FG000|COMPLETED|Treatment||22
8611598|NCT00423891|9648997|FG001|COMPLETED|Treatment||19
8611599|NCT00423891|9648998|FG002|COMPLETED|Treatment||5
8611600|NCT00423891|9648996|FG000|NOT COMPLETED|Treatment||2
8611601|NCT00423891|9648997|FG001|NOT COMPLETED|Treatment||0
8611602|NCT00423891|9648998|FG002|NOT COMPLETED|Treatment||0
8611603|NCT00423891|9648996|FG000|STARTED|Post-Dosing Follow Up||22
8813324|NCT01525173|9866493|FG000|STARTED|Overall Study||70
8813325|NCT01525173|9866494|FG001|STARTED|Overall Study||67
8813326|NCT01525173|9866493|FG000|COMPLETED|Overall Study||63
8611604|NCT00423891|9648997|FG001|STARTED|Post-Dosing Follow Up||18
8611605|NCT00423891|9648998|FG002|STARTED|Post-Dosing Follow Up||5
8611606|NCT00423891|9648996|FG000|COMPLETED|Post-Dosing Follow Up||20
8611607|NCT00423891|9648997|FG001|COMPLETED|Post-Dosing Follow Up||15
8611608|NCT00423891|9648998|FG002|COMPLETED|Post-Dosing Follow Up||3
8611609|NCT00423891|9648996|FG000|NOT COMPLETED|Post-Dosing Follow Up||2
8611610|NCT00423891|9648997|FG001|NOT COMPLETED|Post-Dosing Follow Up||3
8611611|NCT00423891|9648998|FG002|NOT COMPLETED|Post-Dosing Follow Up||2
8611612|NCT00423917|9649008|FG000|STARTED|Overall Study||36
8611613|NCT00423917|9649008|FG000|COMPLETED|Overall Study||33
8611614|NCT00423917|9649008|FG000|NOT COMPLETED|Overall Study||3
8611615|NCT00423930|9649012|FG000|STARTED|Overall Study||44
8611616|NCT00423930|9649012|FG000|COMPLETED|Overall Study||42
8611617|NCT00423930|9649012|FG000|NOT COMPLETED|Overall Study||2
8611618|NCT00423943|9649018|FG000|STARTED|Overall Study||19
8611619|NCT00423943|9649019|FG001|STARTED|Overall Study||14
8611620|NCT00423943|9649018|FG000|COMPLETED|Overall Study||16
8611621|NCT00423943|9649019|FG001|COMPLETED|Overall Study||13
8611622|NCT00423943|9649018|FG000|NOT COMPLETED|Overall Study||3
8611623|NCT00423943|9649019|FG001|NOT COMPLETED|Overall Study||1
8611624|NCT00424021|9649029|FG000|STARTED|NCT00046319 Study Period||16
8611625|NCT00424021|9649030|FG001|STARTED|NCT00046319 Study Period||19
8611626|NCT00424021|9649031|FG002|STARTED|NCT00046319 Study Period||16
8611627|NCT00424021|9649032|FG003|STARTED|NCT00046319 Study Period||13
8611628|NCT00424021|9649029|FG000|COMPLETED|NCT00046319 Study Period||15
8611629|NCT00424021|9649030|FG001|COMPLETED|NCT00046319 Study Period||16
8611630|NCT00424021|9649031|FG002|COMPLETED|NCT00046319 Study Period||15
8611631|NCT00424021|9649032|FG003|COMPLETED|NCT00046319 Study Period||12
8611632|NCT00424021|9649029|FG000|NOT COMPLETED|NCT00046319 Study Period||1
8611633|NCT00424021|9649030|FG001|NOT COMPLETED|NCT00046319 Study Period||3
8611634|NCT00424021|9649031|FG002|NOT COMPLETED|NCT00046319 Study Period||1
8611635|NCT00424021|9649032|FG003|NOT COMPLETED|NCT00046319 Study Period||1
8611636|NCT00424021|9649029|FG000|STARTED|AMB-220-E Study Period||2
8611637|NCT00424021|9649030|FG001|STARTED|AMB-220-E Study Period||7
8611638|NCT00424021|9649031|FG002|STARTED|AMB-220-E Study Period||19
8611639|NCT00424021|9649032|FG003|STARTED|AMB-220-E Study Period||26
8611640|NCT00424021|9649029|FG000|COMPLETED|AMB-220-E Study Period||1
8611641|NCT00424021|9649030|FG001|COMPLETED|AMB-220-E Study Period||5
8611642|NCT00424021|9649031|FG002|COMPLETED|AMB-220-E Study Period||14
8611643|NCT00424021|9649032|FG003|COMPLETED|AMB-220-E Study Period||16
8611644|NCT00424021|9649029|FG000|NOT COMPLETED|AMB-220-E Study Period||1
8611645|NCT00424021|9649030|FG001|NOT COMPLETED|AMB-220-E Study Period||2
8611646|NCT00424021|9649031|FG002|NOT COMPLETED|AMB-220-E Study Period||5
8611647|NCT00424021|9649032|FG003|NOT COMPLETED|AMB-220-E Study Period||10
8611648|NCT00424047|9649051|FG000|STARTED|Blinded Treatment (Up to 03 Aug 2005)||176
8611649|NCT00424047|9649052|FG001|STARTED|Blinded Treatment (Up to 03 Aug 2005)||175
8611650|NCT00424047|9649051|FG000|Safety Population|Blinded Treatment (Up to 03 Aug 2005)|Includes those who took at least one dose of study medication regimen|176
8611651|NCT00424047|9649052|FG001|Safety Population|Blinded Treatment (Up to 03 Aug 2005)|Includes those who took at least one dose of study medication regimen|175
8611652|NCT00424047|9649051|FG000|Evaluable Population|Blinded Treatment (Up to 03 Aug 2005)|1 participant excluded because they had no baseline M-protein assessment|175
8611653|NCT00424047|9649052|FG001|Evaluable Population|Blinded Treatment (Up to 03 Aug 2005)|4 participants excluded because they had no baseline M-protein assessment|171
8611654|NCT00424047|9649051|FG000|COMPLETED|Blinded Treatment (Up to 03 Aug 2005)|54 participants ongoing and continuing on lenalidomide/dexamethasone treatment|54
8611655|NCT00424047|9649052|FG001|COMPLETED|Blinded Treatment (Up to 03 Aug 2005)|Ongoing and includes 15 participants who crossed over to lenalidomide/dexamethasone after unblinding|19
8611656|NCT00424047|9649051|FG000|NOT COMPLETED|Blinded Treatment (Up to 03 Aug 2005)||122
8611657|NCT00424047|9649052|FG001|NOT COMPLETED|Blinded Treatment (Up to 03 Aug 2005)||156
8611658|NCT00424047|9649051|FG000|STARTED|On Study at Time of Unblinding|Refers to original treatment group assignment in the study.|176
8611659|NCT00424047|9649052|FG001|STARTED|On Study at Time of Unblinding||175
8611660|NCT00424047|9649051|FG000|COMPLETED|On Study at Time of Unblinding|Participants completed = those continuing on long term Lenalidomide and dexamethasone|21
8611661|NCT00424047|9649052|FG001|COMPLETED|On Study at Time of Unblinding|Participants completed = those continuing on long term dexamethasone|8
8611662|NCT00424047|9649051|FG000|NOT COMPLETED|On Study at Time of Unblinding||155
8611663|NCT00424047|9649052|FG001|NOT COMPLETED|On Study at Time of Unblinding||167
8611664|NCT00424047|9649051|FG000|STARTED|Long Term Extension (Up to 25 Jun 2013)||21
8611665|NCT00424047|9649052|FG001|STARTED|Long Term Extension (Up to 25 Jun 2013)|2 participants opted to receive dex alone, 3 crossed over to Len/Dex and 3 added Len at a later date|8
8611666|NCT00424047|9649051|FG000|COMPLETED|Long Term Extension (Up to 25 Jun 2013)||0
8611667|NCT00424047|9649052|FG001|COMPLETED|Long Term Extension (Up to 25 Jun 2013)||0
8611668|NCT00424047|9649051|FG000|NOT COMPLETED|Long Term Extension (Up to 25 Jun 2013)||21
8611669|NCT00424047|9649052|FG001|NOT COMPLETED|Long Term Extension (Up to 25 Jun 2013)||8
8611670|NCT00424177|9649063|FG000|STARTED|Cycle 1: Eltrombopag 50 mg Starting Dose||66
8611671|NCT00424177|9649063|FG000|COMPLETED|Cycle 1: Eltrombopag 50 mg Starting Dose||55
8611672|NCT00424177|9649063|FG000|NOT COMPLETED|Cycle 1: Eltrombopag 50 mg Starting Dose||11
8611673|NCT00424177|9649063|FG000|STARTED|Cycle 2: Eltrombopag 50 or 75 mg||55
8611674|NCT00424177|9649063|FG000|COMPLETED|Cycle 2: Eltrombopag 50 or 75 mg||51
8611675|NCT00424177|9649063|FG000|NOT COMPLETED|Cycle 2: Eltrombopag 50 or 75 mg||4
8611676|NCT00424177|9649063|FG000|STARTED|Cycle 3: Eltrombopag 50 or 75 mg||51
8611677|NCT00424177|9649063|FG000|COMPLETED|Cycle 3: Eltrombopag 50 or 75 mg||48
8611678|NCT00424177|9649063|FG000|NOT COMPLETED|Cycle 3: Eltrombopag 50 or 75 mg||3
8611679|NCT00424190|9649077|FG000|STARTED|Overall Study||351
8611680|NCT00424190|9649078|FG001|STARTED|Overall Study||347
8611681|NCT00424190|9649077|FG000|COMPLETED|Overall Study||329
8611682|NCT00424190|9649078|FG001|COMPLETED|Overall Study||317
8611683|NCT00424190|9649077|FG000|NOT COMPLETED|Overall Study||22
8611684|NCT00424190|9649078|FG001|NOT COMPLETED|Overall Study||30
8611685|NCT00424255|9649086|FG000|STARTED|Overall Study||342
8611686|NCT00424255|9649087|FG001|STARTED|Overall Study||346
8611687|NCT00424255|9649086|FG000|COMPLETED|Overall Study||0
8611688|NCT00424255|9649087|FG001|COMPLETED|Overall Study||0
8611689|NCT00424255|9649086|FG000|NOT COMPLETED|Overall Study||342
8611690|NCT00424255|9649087|FG001|NOT COMPLETED|Overall Study||346
8611691|NCT00424268|9649095|FG000|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|371
8611692|NCT00424268|9649096|FG001|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|372
8611693|NCT00424268|9649095|FG000|COMPLETED|Overall Study||309
8611694|NCT00424268|9649096|FG001|COMPLETED|Overall Study||333
8611695|NCT00424268|9649095|FG000|NOT COMPLETED|Overall Study||62
8611696|NCT00424268|9649096|FG001|NOT COMPLETED|Overall Study||39
8611697|NCT00424294|9649104|FG000|STARTED|Overall Study||36
8611698|NCT00424294|9649105|FG001|STARTED|Overall Study||34
8611699|NCT00424294|9649104|FG000|Treated|Overall Study||35
8611700|NCT00424294|9649105|FG001|Treated|Overall Study||34
8611701|NCT00424294|9649104|FG000|COMPLETED|Overall Study||28
8611702|NCT00424294|9649105|FG001|COMPLETED|Overall Study||19
8611703|NCT00424294|9649104|FG000|NOT COMPLETED|Overall Study||8
8611704|NCT00424294|9649105|FG001|NOT COMPLETED|Overall Study||15
8611705|NCT00424346|9649115|FG000|STARTED|Core Study||71
8611706|NCT00424346|9649116|FG001|STARTED|Core Study||64
8611707|NCT00424346|9649117|FG002|STARTED|Core Study||69
8611708|NCT00424346|9649118|FG003|STARTED|Core Study||70
8611709|NCT00424346|9649115|FG000|COMPLETED|Core Study||62
8611710|NCT00424346|9649116|FG001|COMPLETED|Core Study||56
8611711|NCT00424346|9649117|FG002|COMPLETED|Core Study||65
8611712|NCT00424346|9649118|FG003|COMPLETED|Core Study||63
8611713|NCT00424346|9649115|FG000|NOT COMPLETED|Core Study||9
8611714|NCT00424346|9649116|FG001|NOT COMPLETED|Core Study||8
8611715|NCT00424346|9649117|FG002|NOT COMPLETED|Core Study||4
8611716|NCT00424346|9649118|FG003|NOT COMPLETED|Core Study||7
8611717|NCT00424346|9649115|FG000|STARTED|Extension Phase|Participants are represented in the Canakinumab 300 mg q2wk treatment group.|0
8611718|NCT00424346|9649116|FG001|STARTED|Extension Phase|Includes participants who completed the Core phase in the Canakinumab 600 mg IV + 300 mg q2wk group.|110
8611719|NCT00424346|9649117|FG002|STARTED|Extension Phase||59
8611720|NCT00424346|9649118|FG003|STARTED|Extension Phase||58
8611721|NCT00424346|9649115|FG000|COMPLETED|Extension Phase||0
8611722|NCT00424346|9649116|FG001|COMPLETED|Extension Phase||8
8611723|NCT00424346|9649117|FG002|COMPLETED|Extension Phase||4
8611724|NCT00424346|9649118|FG003|COMPLETED|Extension Phase||3
8611725|NCT00424346|9649115|FG000|NOT COMPLETED|Extension Phase||0
8611726|NCT00424346|9649116|FG001|NOT COMPLETED|Extension Phase||102
8611727|NCT00424346|9649117|FG002|NOT COMPLETED|Extension Phase||55
8611728|NCT00424346|9649118|FG003|NOT COMPLETED|Extension Phase||55
8611729|NCT00424372|9649131|FG000|STARTED|Overall Study||126
8611730|NCT00424372|9649131|FG000|COMPLETED|Overall Study||95
8611731|NCT00424372|9649131|FG000|NOT COMPLETED|Overall Study||31
8611732|NCT00424385|9649135|FG000|STARTED|Cohort 0||12
8611733|NCT00424385|9649135|FG000|COMPLETED|Cohort 0||6
8611734|NCT00424385|9649135|FG000|NOT COMPLETED|Cohort 0||6
8611735|NCT00424385|9649135|FG000|STARTED|Cohort 1||5
8611736|NCT00424385|9649135|FG000|COMPLETED|Cohort 1||4
8611737|NCT00424385|9649135|FG000|NOT COMPLETED|Cohort 1||1
8611738|NCT00424398|9649144|FG000|STARTED|Overall Study||35
8611739|NCT00424398|9649145|FG001|STARTED|Overall Study||36
8611740|NCT00424398|9649146|FG002|STARTED|Overall Study||36
8611741|NCT00424398|9649144|FG000|COMPLETED|Overall Study||32
8611742|NCT00424398|9649145|FG001|COMPLETED|Overall Study||35
8611743|NCT00424398|9649146|FG002|COMPLETED|Overall Study||36
8611744|NCT00424398|9649144|FG000|NOT COMPLETED|Overall Study||3
8611745|NCT00424398|9649145|FG001|NOT COMPLETED|Overall Study||1
8611746|NCT00424398|9649146|FG002|NOT COMPLETED|Overall Study||0
8611747|NCT00424463|9649157|FG000|STARTED|Overall Study||45
8611748|NCT00424463|9649158|FG001|STARTED|Overall Study||48
8611749|NCT00424463|9649159|FG002|STARTED|Overall Study||88
8611750|NCT00424463|9649157|FG000|COMPLETED|Overall Study||38
8611751|NCT00424463|9649158|FG001|COMPLETED|Overall Study||34
8611752|NCT00424463|9649159|FG002|COMPLETED|Overall Study||72
8611753|NCT00424463|9649157|FG000|NOT COMPLETED|Overall Study||7
8611754|NCT00424463|9649158|FG001|NOT COMPLETED|Overall Study||14
8611755|NCT00424463|9649159|FG002|NOT COMPLETED|Overall Study||16
8611756|NCT00424476|9649170|FG000|STARTED|Overall Study||287
8611757|NCT00424476|9649171|FG001|STARTED|Overall Study||288
8611758|NCT00424476|9649172|FG002|STARTED|Overall Study||290
8611759|NCT00424476|9649170|FG000|COMPLETED|Overall Study||226
8611760|NCT00424476|9649171|FG001|COMPLETED|Overall Study||240
8611761|NCT00424476|9649172|FG002|COMPLETED|Overall Study||241
8611762|NCT00424476|9649170|FG000|NOT COMPLETED|Overall Study||61
8611763|NCT00424476|9649171|FG001|NOT COMPLETED|Overall Study||48
8611764|NCT00424476|9649172|FG002|NOT COMPLETED|Overall Study||49
8611765|NCT00424489|9649180|FG000|STARTED|Overall Study||9
8611766|NCT00424489|9649180|FG000|COMPLETED|Overall Study||6
8611767|NCT00424489|9649180|FG000|NOT COMPLETED|Overall Study||3
8611768|NCT00424502|9649184|FG000|STARTED|Overall Study||20
8611769|NCT00424502|9649184|FG000|COMPLETED|Overall Study||20
8611770|NCT00424502|9649184|FG000|NOT COMPLETED|Overall Study||0
8611771|NCT00424515|9649190|FG000|STARTED|Overall Study||11
8611772|NCT00424515|9649191|FG001|STARTED|Overall Study||13
8611773|NCT00424515|9649190|FG000|COMPLETED|Overall Study||0
8611774|NCT00424515|9649191|FG001|COMPLETED|Overall Study||0
8611775|NCT00424515|9649190|FG000|NOT COMPLETED|Overall Study||11
8611776|NCT00424515|9649191|FG001|NOT COMPLETED|Overall Study||13
8611777|NCT00424528|9649200|FG000|STARTED|Overall Study||76
8611778|NCT00424528|9649201|FG001|STARTED|Overall Study||80
8611779|NCT00424528|9649202|FG002|STARTED|Overall Study||78
8611780|NCT00424528|9649200|FG000|COMPLETED|Overall Study||71
8611781|NCT00424528|9649201|FG001|COMPLETED|Overall Study||76
8611782|NCT00424528|9649202|FG002|COMPLETED|Overall Study||74
8611783|NCT00424528|9649200|FG000|NOT COMPLETED|Overall Study||5
8611784|NCT00424528|9649201|FG001|NOT COMPLETED|Overall Study||4
8611785|NCT00424528|9649202|FG002|NOT COMPLETED|Overall Study||4
8611786|NCT00424554|9649212|FG000|STARTED|Overall Study||34
8611787|NCT00424554|9649213|FG001|STARTED|Overall Study||6
8611788|NCT00424554|9649212|FG000|COMPLETED|Overall Study||34
8611789|NCT00424554|9649213|FG001|COMPLETED|Overall Study||6
8611790|NCT00424554|9649212|FG000|NOT COMPLETED|Overall Study||0
8611791|NCT00424554|9649213|FG001|NOT COMPLETED|Overall Study||0
8611792|NCT00424593|9649221|FG000|STARTED|Acute Double-Blind Period||115
8611793|NCT00424593|9649222|FG001|STARTED|Acute Double-Blind Period||121
8611794|NCT00424593|9649221|FG000|COMPLETED|Acute Double-Blind Period||84
8611795|NCT00424593|9649222|FG001|COMPLETED|Acute Double-Blind Period||98
8611796|NCT00424593|9649221|FG000|NOT COMPLETED|Acute Double-Blind Period||31
8611797|NCT00424593|9649222|FG001|NOT COMPLETED|Acute Double-Blind Period||23
8611798|NCT00424593|9649221|FG000|STARTED|Dose-Blind Extension Period|83 duloxetine patients from the acute phase entered the dose-blind period.|181
8611799|NCT00424593|9649222|FG001|STARTED|Dose-Blind Extension Period|98 placebo patients from acute phase entered dose-blind period and received duloxetine.|0
8611800|NCT00424593|9649221|FG000|COMPLETED|Dose-Blind Extension Period||117
8611801|NCT00424593|9649222|FG001|COMPLETED|Dose-Blind Extension Period||0
8611802|NCT00424593|9649221|FG000|NOT COMPLETED|Dose-Blind Extension Period||64
8611803|NCT00424593|9649222|FG001|NOT COMPLETED|Dose-Blind Extension Period||0
8611804|NCT00424619|9649231|FG000|STARTED|Baseline||22
8611805|NCT00424619|9649232|FG001|STARTED|Baseline||22
8611806|NCT00424619|9649233|FG002|STARTED|Baseline|n=21 but one participant was lost as a screen failure|21
8611807|NCT00424619|9649231|FG000|COMPLETED|Baseline||22
8611808|NCT00424619|9649232|FG001|COMPLETED|Baseline||22
8611809|NCT00424619|9649233|FG002|COMPLETED|Baseline||20
8611810|NCT00424619|9649231|FG000|NOT COMPLETED|Baseline||0
8611811|NCT00424619|9649232|FG001|NOT COMPLETED|Baseline||0
8611812|NCT00424619|9649233|FG002|NOT COMPLETED|Baseline||1
8611813|NCT00424619|9649231|FG000|STARTED|4 Week||18
8611814|NCT00424619|9649232|FG001|STARTED|4 Week||17
8611815|NCT00424619|9649233|FG002|STARTED|4 Week||17
8611816|NCT00424619|9649231|FG000|COMPLETED|4 Week||18
8611817|NCT00424619|9649232|FG001|COMPLETED|4 Week||17
8611818|NCT00424619|9649233|FG002|COMPLETED|4 Week||17
8611819|NCT00424619|9649231|FG000|NOT COMPLETED|4 Week||0
8611820|NCT00424619|9649232|FG001|NOT COMPLETED|4 Week||0
8611821|NCT00424619|9649233|FG002|NOT COMPLETED|4 Week||0
8611822|NCT00424619|9649231|FG000|STARTED|3 Month||12
8611823|NCT00424619|9649232|FG001|STARTED|3 Month||18
8611824|NCT00424619|9649233|FG002|STARTED|3 Month||17
8611825|NCT00424619|9649231|FG000|COMPLETED|3 Month||12
8611826|NCT00424619|9649232|FG001|COMPLETED|3 Month||18
8611827|NCT00424619|9649233|FG002|COMPLETED|3 Month||17
8611828|NCT00424619|9649231|FG000|NOT COMPLETED|3 Month||0
8611829|NCT00424619|9649232|FG001|NOT COMPLETED|3 Month||0
8611830|NCT00424619|9649233|FG002|NOT COMPLETED|3 Month||0
8611831|NCT00424632|9649243|FG000|STARTED|Overall Study||1
8611832|NCT00424632|9649244|FG001|STARTED|Overall Study||1
8611833|NCT00424632|9649245|FG002|STARTED|Overall Study||1
8611834|NCT00424632|9649246|FG003|STARTED|Overall Study||4
8611835|NCT00424632|9649247|FG004|STARTED|Overall Study||3
8611836|NCT00424632|9649248|FG005|STARTED|Overall Study||15
8611837|NCT00424632|9649249|FG006|STARTED|Overall Study||7
8611838|NCT00424632|9649250|FG007|STARTED|Overall Study||3
8611839|NCT00424632|9649251|FG008|STARTED|Overall Study||16
8611840|NCT00424632|9649252|FG009|STARTED|Overall Study||6
8611841|NCT00424632|9649243|FG000|COMPLETED|Overall Study||0
8611842|NCT00424632|9649244|FG001|COMPLETED|Overall Study||0
8611843|NCT00424632|9649245|FG002|COMPLETED|Overall Study||0
8611844|NCT00424632|9649246|FG003|COMPLETED|Overall Study||0
8611845|NCT00424632|9649247|FG004|COMPLETED|Overall Study||0
8611846|NCT00424632|9649248|FG005|COMPLETED|Overall Study||0
8611847|NCT00424632|9649249|FG006|COMPLETED|Overall Study||0
8611848|NCT00424632|9649250|FG007|COMPLETED|Overall Study||0
8611849|NCT00424632|9649251|FG008|COMPLETED|Overall Study||0
8611850|NCT00424632|9649252|FG009|COMPLETED|Overall Study||0
8611851|NCT00424632|9649243|FG000|NOT COMPLETED|Overall Study||1
8611852|NCT00424632|9649244|FG001|NOT COMPLETED|Overall Study||1
8611853|NCT00424632|9649245|FG002|NOT COMPLETED|Overall Study||1
8611854|NCT00424632|9649246|FG003|NOT COMPLETED|Overall Study||4
8611855|NCT00424632|9649247|FG004|NOT COMPLETED|Overall Study||3
8611856|NCT00424632|9649248|FG005|NOT COMPLETED|Overall Study||15
8611857|NCT00424632|9649249|FG006|NOT COMPLETED|Overall Study||7
8611858|NCT00424632|9649250|FG007|NOT COMPLETED|Overall Study||3
8611859|NCT00424632|9649251|FG008|NOT COMPLETED|Overall Study||16
8611860|NCT00424632|9649252|FG009|NOT COMPLETED|Overall Study||6
8611861|NCT00424749|9649283|FG000|STARTED|Overall Study||4
8611862|NCT00424749|9649283|FG000|COMPLETED|Overall Study||3
8611863|NCT00424749|9649283|FG000|NOT COMPLETED|Overall Study||1
8611864|NCT00424762|9649289|FG000|STARTED|Overall Study||74
8611865|NCT00424762|9649290|FG001|STARTED|Overall Study||76
8611866|NCT00424762|9649289|FG000|COMPLETED|Overall Study||54
8611867|NCT00424762|9649290|FG001|COMPLETED|Overall Study||54
8611868|NCT00424762|9649289|FG000|NOT COMPLETED|Overall Study||20
8611869|NCT00424762|9649290|FG001|NOT COMPLETED|Overall Study||22
8611870|NCT00424775|9649296|FG000|STARTED|Overall Study||3
8611871|NCT00424775|9649297|FG001|STARTED|Overall Study||0
8611872|NCT00424775|9649296|FG000|COMPLETED|Overall Study||0
8611873|NCT00424775|9649297|FG001|COMPLETED|Overall Study||0
8611874|NCT00424775|9649296|FG000|NOT COMPLETED|Overall Study||3
8611875|NCT00424775|9649297|FG001|NOT COMPLETED|Overall Study||0
8611876|NCT00424827|9649301|FG000|STARTED|Overall Study||11
8611877|NCT00424827|9649301|FG000|COMPLETED|Overall Study||10
8611878|NCT00424827|9649301|FG000|NOT COMPLETED|Overall Study||1
8611879|NCT00424840|9649306|FG000|STARTED|Overall Study||3
8611880|NCT00424840|9649307|FG001|STARTED|Overall Study||4
8611881|NCT00424840|9649308|FG002|STARTED|Overall Study||5
8611882|NCT00424840|9649306|FG000|COMPLETED|Overall Study||3
8611883|NCT00424840|9649307|FG001|COMPLETED|Overall Study||4
8611884|NCT00424840|9649308|FG002|COMPLETED|Overall Study||5
8611885|NCT00424840|9649306|FG000|NOT COMPLETED|Overall Study||0
8611886|NCT00424840|9649307|FG001|NOT COMPLETED|Overall Study||0
8611887|NCT00424840|9649308|FG002|NOT COMPLETED|Overall Study||0
8611888|NCT00425061|9649321|FG000|STARTED|Overall Study||16
8611889|NCT00425061|9649322|FG001|STARTED|Overall Study||17
8611890|NCT00425061|9649323|FG002|STARTED|Overall Study||16
8611891|NCT00425061|9649324|FG003|STARTED|Overall Study||16
8611892|NCT00425061|9649325|FG004|STARTED|Overall Study||45
8611893|NCT00425061|9649326|FG005|STARTED|Overall Study||4
8611894|NCT00425061|9649327|FG006|STARTED|Overall Study||45
8611895|NCT00425061|9649321|FG000|COMPLETED|Overall Study||14
8611896|NCT00425061|9649322|FG001|COMPLETED|Overall Study||15
8611897|NCT00425061|9649323|FG002|COMPLETED|Overall Study||16
8611898|NCT00425061|9649324|FG003|COMPLETED|Overall Study||14
8611899|NCT00425061|9649325|FG004|COMPLETED|Overall Study||19
8611900|NCT00425061|9649326|FG005|COMPLETED|Overall Study||0
8611901|NCT00425061|9649327|FG006|COMPLETED|Overall Study||26
8611902|NCT00425061|9649321|FG000|NOT COMPLETED|Overall Study||2
8611903|NCT00425061|9649322|FG001|NOT COMPLETED|Overall Study||2
8611904|NCT00425061|9649323|FG002|NOT COMPLETED|Overall Study||0
8611905|NCT00425061|9649324|FG003|NOT COMPLETED|Overall Study||2
8611906|NCT00425061|9649325|FG004|NOT COMPLETED|Overall Study||26
8611907|NCT00425061|9649326|FG005|NOT COMPLETED|Overall Study||4
8611908|NCT00425061|9649327|FG006|NOT COMPLETED|Overall Study||19
8611909|NCT00425113|9649347|FG000|STARTED|Overall Study||17
8611910|NCT00425113|9649348|FG001|STARTED|Overall Study||18
8611911|NCT00425113|9649347|FG000|Exposed to Study Drug|Overall Study||16
8611912|NCT00425113|9649348|FG001|Exposed to Study Drug|Overall Study||17
8611913|NCT00425113|9649347|FG000|COMPLETED|Overall Study|Included in modified intent-to-treat analysis|15
8611914|NCT00425113|9649348|FG001|COMPLETED|Overall Study|Included in modified intent-to-treat analysis|16
8611915|NCT00425113|9649347|FG000|NOT COMPLETED|Overall Study||2
8611916|NCT00425113|9649348|FG001|NOT COMPLETED|Overall Study||2
8611917|NCT00425269|9649357|FG000|STARTED|Overall Study||101
8611918|NCT00425269|9649358|FG001|STARTED|Overall Study||97
8611919|NCT00425269|9649357|FG000|COMPLETED|Overall Study||82
8611920|NCT00425269|9649358|FG001|COMPLETED|Overall Study||77
8611921|NCT00425269|9649357|FG000|NOT COMPLETED|Overall Study||19
8611922|NCT00425269|9649358|FG001|NOT COMPLETED|Overall Study||20
8611923|NCT00425308|9649366|FG000|STARTED|Overall Study||15
8611924|NCT00425308|9649367|FG001|STARTED|Overall Study||15
8611925|NCT00425308|9649366|FG000|COMPLETED|Overall Study||11
8611926|NCT00425308|9649367|FG001|COMPLETED|Overall Study||14
8611927|NCT00425308|9649366|FG000|NOT COMPLETED|Overall Study||4
8611928|NCT00425308|9649367|FG001|NOT COMPLETED|Overall Study||1
8611929|NCT00425373|9649382|FG000|STARTED|Overall Study||159
8611930|NCT00425373|9649383|FG001|STARTED|Overall Study||167
8611931|NCT00425373|9649384|FG002|STARTED|Overall Study||160
8611932|NCT00425373|9649385|FG003|STARTED|Overall Study||162
8611933|NCT00425373|9649386|FG004|STARTED|Overall Study||169
8611934|NCT00425373|9649387|FG005|STARTED|Overall Study||163
8611935|NCT00425373|9649388|FG006|STARTED|Overall Study||161
8611936|NCT00425373|9649389|FG007|STARTED|Overall Study||161
8611937|NCT00425373|9649390|FG008|STARTED|Overall Study||166
8611938|NCT00425373|9649382|FG000|COMPLETED|Overall Study||154
8611939|NCT00425373|9649383|FG001|COMPLETED|Overall Study||164
8611940|NCT00425373|9649384|FG002|COMPLETED|Overall Study||157
8611941|NCT00425373|9649385|FG003|COMPLETED|Overall Study||160
8611942|NCT00425373|9649386|FG004|COMPLETED|Overall Study||159
8611943|NCT00425373|9649387|FG005|COMPLETED|Overall Study||154
8611944|NCT00425373|9649388|FG006|COMPLETED|Overall Study||154
8611945|NCT00425373|9649389|FG007|COMPLETED|Overall Study||151
8611946|NCT00425373|9649390|FG008|COMPLETED|Overall Study||148
8611947|NCT00425373|9649382|FG000|NOT COMPLETED|Overall Study||5
8611948|NCT00425373|9649383|FG001|NOT COMPLETED|Overall Study||3
8611949|NCT00425373|9649384|FG002|NOT COMPLETED|Overall Study||3
8611950|NCT00425373|9649385|FG003|NOT COMPLETED|Overall Study||2
8611951|NCT00425373|9649386|FG004|NOT COMPLETED|Overall Study||10
8611952|NCT00425373|9649387|FG005|NOT COMPLETED|Overall Study||9
8611953|NCT00425373|9649388|FG006|NOT COMPLETED|Overall Study||7
8611954|NCT00425373|9649389|FG007|NOT COMPLETED|Overall Study||10
8611955|NCT00425373|9649390|FG008|NOT COMPLETED|Overall Study||18
8611956|NCT00425386|9649410|FG000|STARTED|Overall Study||46
8611957|NCT00425386|9649410|FG000|COMPLETED|Overall Study||43
8611958|NCT00425386|9649410|FG000|NOT COMPLETED|Overall Study||3
8611959|NCT00425477|9649414|FG000|STARTED|Overall Study||26
8611960|NCT00425477|9649414|FG000|COMPLETED|Overall Study||13
8611961|NCT00425477|9649414|FG000|NOT COMPLETED|Overall Study||13
8611962|NCT00425503|9649418|FG000|STARTED|Overall Study||40
8611963|NCT00425503|9649418|FG000|COMPLETED|Overall Study||37
8611964|NCT00425503|9649418|FG000|NOT COMPLETED|Overall Study||3
8611965|NCT00425555|9649424|FG000|STARTED|Overall Study||79
8611966|NCT00425555|9649425|FG001|STARTED|Overall Study||60
8611967|NCT00425555|9649424|FG000|COMPLETED|Overall Study||0
8611968|NCT00425555|9649425|FG001|COMPLETED|Overall Study||0
8611969|NCT00425555|9649424|FG000|NOT COMPLETED|Overall Study||79
8611970|NCT00425555|9649425|FG001|NOT COMPLETED|Overall Study||60
8611971|NCT00425607|9649434|FG000|STARTED|Overall Study||29
8611972|NCT00425607|9649434|FG000|Received Treatment|Overall Study||28
8611973|NCT00425607|9649434|FG000|COMPLETED|Overall Study||27
8611974|NCT00425607|9649434|FG000|NOT COMPLETED|Overall Study||2
8611975|NCT00425672|9649438|FG000|STARTED|Overall Study||15
8611976|NCT00425672|9649438|FG000|COMPLETED|Overall Study||14
8611977|NCT00425672|9649438|FG000|NOT COMPLETED|Overall Study||1
8611978|NCT00425698|9649444|FG000|STARTED|Overall Study||44
8611979|NCT00425698|9649445|FG001|STARTED|Overall Study||44
8611980|NCT00425698|9649444|FG000|COMPLETED|Overall Study||41
8611981|NCT00425698|9649445|FG001|COMPLETED|Overall Study||42
8611982|NCT00425698|9649444|FG000|NOT COMPLETED|Overall Study||3
8611983|NCT00425698|9649445|FG001|NOT COMPLETED|Overall Study||2
8611984|NCT00425750|9649451|FG000|STARTED|Overall Study||25
8611985|NCT00425750|9649451|FG000|COMPLETED|Overall Study||0
8611986|NCT00425750|9649451|FG000|NOT COMPLETED|Overall Study||25
8611987|NCT00425802|9649455|FG000|STARTED|Overall Study||61
8611988|NCT00425802|9649455|FG000|COMPLETED|Overall Study||61
8611989|NCT00425802|9649455|FG000|NOT COMPLETED|Overall Study||0
8611990|NCT00425854|9649461|FG000|STARTED|Overall Study|Treated|29
8611991|NCT00425854|9649462|FG001|STARTED|Overall Study|Treated|21
8611992|NCT00425854|9649461|FG000|COMPLETED|Overall Study|On treatment at analysis cut-off date (30 Sep 2009)|0
8611993|NCT00425854|9649462|FG001|COMPLETED|Overall Study|On treatment at analysis cut-off date (30 Sep 2009)|0
8611994|NCT00425854|9649461|FG000|NOT COMPLETED|Overall Study||29
8611995|NCT00425854|9649462|FG001|NOT COMPLETED|Overall Study||21
8611996|NCT00425945|9649471|FG000|STARTED|Overall Study||64
8611997|NCT00425945|9649472|FG001|STARTED|Overall Study||66
8611998|NCT00425945|9649471|FG000|COMPLETED|Overall Study||60
8611999|NCT00425945|9649472|FG001|COMPLETED|Overall Study||61
8612000|NCT00425945|9649471|FG000|NOT COMPLETED|Overall Study||4
8612001|NCT00425945|9649472|FG001|NOT COMPLETED|Overall Study||5
8612002|NCT00426127|9649480|FG000|STARTED|Overall Study||2
8612003|NCT00426127|9649480|FG000|COMPLETED|Overall Study||0
8612004|NCT00426127|9649480|FG000|NOT COMPLETED|Overall Study||2
8612005|NCT00426153|9649486|FG000|STARTED|Overall Study|Participants were randomized in a 2:1 ratio, Octreotide LAR depot: Placebo|28
8612006|NCT00426153|9649487|FG001|STARTED|Overall Study||14
8612007|NCT00426153|9649486|FG000|COMPLETED|Overall Study||28
8612008|NCT00426153|9649487|FG001|COMPLETED|Overall Study||14
8612009|NCT00426153|9649486|FG000|NOT COMPLETED|Overall Study||0
8612010|NCT00426153|9649487|FG001|NOT COMPLETED|Overall Study||0
8612011|NCT00426231|9649495|FG000|STARTED|Overall Study||36
8612012|NCT00426231|9649496|FG001|STARTED|Overall Study||37
8612013|NCT00426231|9649495|FG000|COMPLETED|Overall Study|For the 6 month endpoint|27
8612014|NCT00426231|9649496|FG001|COMPLETED|Overall Study|For the 6-month endpoint|25
8612015|NCT00426231|9649495|FG000|NOT COMPLETED|Overall Study||9
8612016|NCT00426231|9649496|FG001|NOT COMPLETED|Overall Study||12
8629181|NCT00528931|9668830|FG000|COMPLETED|Overall Study||15
8629182|NCT00528931|9668830|FG000|NOT COMPLETED|Overall Study||1
8629183|NCT00528957|9668837|FG000|STARTED|Randomized Phase (Baseline to Week 48)||48
8629184|NCT00528957|9668838|FG001|STARTED|Randomized Phase (Baseline to Week 48)||49
8629185|NCT00528957|9668837|FG000|COMPLETED|Randomized Phase (Baseline to Week 48)||44
8629186|NCT00528957|9668838|FG001|COMPLETED|Randomized Phase (Baseline to Week 48)||48
8629187|NCT00528957|9668837|FG000|NOT COMPLETED|Randomized Phase (Baseline to Week 48)||4
8629188|NCT00528957|9668838|FG001|NOT COMPLETED|Randomized Phase (Baseline to Week 48)||1
8629189|NCT00528957|9668837|FG000|STARTED|First Extension (Week 48 to Week 144)|Six participants completed the 48-week randomized phase and did not enroll in the first extension.|38
8629190|NCT00528957|9668838|FG001|STARTED|First Extension (Week 48 to Week 144)|Seven participants completed the 48-week randomized phase and did not enroll in the first extension.|41
8629191|NCT00528957|9668837|FG000|COMPLETED|First Extension (Week 48 to Week 144)||35
8629192|NCT00528957|9668838|FG001|COMPLETED|First Extension (Week 48 to Week 144)||40
8629193|NCT00528957|9668837|FG000|NOT COMPLETED|First Extension (Week 48 to Week 144)||3
8629194|NCT00528957|9668838|FG001|NOT COMPLETED|First Extension (Week 48 to Week 144)||1
8629195|NCT00528957|9668837|FG000|STARTED|Second Extension (Week 144 to Week 240)|One participant completed the first extension and did not enroll in the second extension.|34
8629196|NCT00528957|9668838|FG001|STARTED|Second Extension (Week 144 to Week 240)||40
8629197|NCT00528957|9668837|FG000|COMPLETED|Second Extension (Week 144 to Week 240)||27
8629198|NCT00528957|9668838|FG001|COMPLETED|Second Extension (Week 144 to Week 240)||37
8629199|NCT00528957|9668837|FG000|NOT COMPLETED|Second Extension (Week 144 to Week 240)||7
8629200|NCT00528957|9668838|FG001|NOT COMPLETED|Second Extension (Week 144 to Week 240)||3
8629201|NCT00528957|9668837|FG000|STARTED|Third Extension (Week 240 to Week 336)||27
8629202|NCT00528957|9668838|FG001|STARTED|Third Extension (Week 240 to Week 336)||37
8629203|NCT00528957|9668837|FG000|COMPLETED|Third Extension (Week 240 to Week 336)||21
8629204|NCT00528957|9668838|FG001|COMPLETED|Third Extension (Week 240 to Week 336)||27
8629205|NCT00528957|9668837|FG000|NOT COMPLETED|Third Extension (Week 240 to Week 336)||6
8629206|NCT00528957|9668838|FG001|NOT COMPLETED|Third Extension (Week 240 to Week 336)||10
8629207|NCT00528957|9668837|FG000|STARTED|Long-Term Extension (Week 336 and On)|Two participants completed the third extension and did not enroll in the long-term extension.|19
8629208|NCT00528957|9668838|FG001|STARTED|Long-Term Extension (Week 336 and On)|Two participants completed the third extension and did not enroll in the long-term extension.|25
8629209|NCT00528957|9668837|FG000|COMPLETED|Long-Term Extension (Week 336 and On)||9
8629210|NCT00528957|9668838|FG001|COMPLETED|Long-Term Extension (Week 336 and On)||8
8629211|NCT00528957|9668837|FG000|NOT COMPLETED|Long-Term Extension (Week 336 and On)||10
8629212|NCT00528957|9668838|FG001|NOT COMPLETED|Long-Term Extension (Week 336 and On)||17
8629213|NCT00528970|9668857|FG000|STARTED|Overall Study||124
8629214|NCT00528970|9668858|FG001|STARTED|Overall Study||125
8629215|NCT00528970|9668859|FG002|STARTED|Overall Study||125
8629216|NCT00528970|9668857|FG000|Received at Least 1 Dose of Study Drug|Overall Study||124
8612017|NCT00426270|9649502|FG000|STARTED|Overall Study||116
8612018|NCT00426270|9649502|FG000|COMPLETED|Overall Study||110
8612019|NCT00426270|9649502|FG000|NOT COMPLETED|Overall Study||6
8612020|NCT00426283|9649508|FG000|STARTED|Overall Study||28
8612021|NCT00426283|9649509|FG001|STARTED|Overall Study||14
8612022|NCT00426283|9649508|FG000|COMPLETED|Overall Study||23
8612023|NCT00426283|9649509|FG001|COMPLETED|Overall Study||13
8612024|NCT00426283|9649508|FG000|NOT COMPLETED|Overall Study||5
9064289|NCT04318535|10124573|FG002|COMPLETED|Treatment Period 2 (Day 7 to Day 12)||12
9064290|NCT04318535|10124571|FG000|NOT COMPLETED|Treatment Period 2 (Day 7 to Day 12)||0
9064291|NCT04318535|10124572|FG001|NOT COMPLETED|Treatment Period 2 (Day 7 to Day 12)||0
9064292|NCT04318535|10124573|FG002|NOT COMPLETED|Treatment Period 2 (Day 7 to Day 12)||0
9064293|NCT04318535|10124571|FG000|STARTED|Period2washout(Atleast 7 Days Post-dose)||12
9064294|NCT04318535|10124572|FG001|STARTED|Period2washout(Atleast 7 Days Post-dose)||12
9064295|NCT04318535|10124573|FG002|STARTED|Period2washout(Atleast 7 Days Post-dose)||12
9064296|NCT04318535|10124571|FG000|COMPLETED|Period2washout(Atleast 7 Days Post-dose)||12
8612025|NCT00426283|9649509|FG001|NOT COMPLETED|Overall Study||1
8612026|NCT00426361|9649522|FG000|STARTED|Overall Study||248
8612027|NCT00426361|9649523|FG001|STARTED|Overall Study||255
8612028|NCT00426361|9649524|FG002|STARTED|Overall Study||248
8612029|NCT00426361|9649522|FG000|COMPLETED|Overall Study||244
8612030|NCT00426361|9649523|FG001|COMPLETED|Overall Study||250
8612031|NCT00426361|9649524|FG002|COMPLETED|Overall Study||243
8612032|NCT00426361|9649522|FG000|NOT COMPLETED|Overall Study||4
8612033|NCT00426361|9649523|FG001|NOT COMPLETED|Overall Study||5
8612034|NCT00426361|9649524|FG002|NOT COMPLETED|Overall Study||5
8612035|NCT00426517|9649536|FG000|STARTED|Overall Study||7
8612036|NCT00426517|9649537|FG001|STARTED|Overall Study||36
8612037|NCT00426517|9649538|FG002|STARTED|Overall Study||3
8612038|NCT00426517|9649539|FG003|STARTED|Overall Study||2
8612039|NCT00426517|9649536|FG000|COMPLETED|Overall Study||7
8612040|NCT00426517|9649537|FG001|COMPLETED|Overall Study||36
8612041|NCT00426517|9649538|FG002|COMPLETED|Overall Study||3
8612042|NCT00426517|9649539|FG003|COMPLETED|Overall Study||2
8612043|NCT00426517|9649536|FG000|NOT COMPLETED|Overall Study||0
8612044|NCT00426517|9649537|FG001|NOT COMPLETED|Overall Study||0
8612045|NCT00426517|9649538|FG002|NOT COMPLETED|Overall Study||0
8612046|NCT00426517|9649539|FG003|NOT COMPLETED|Overall Study||0
8612047|NCT00426556|9649553|FG000|STARTED|Phase I - Core Phase||6
8612048|NCT00426556|9649554|FG001|STARTED|Phase I - Core Phase||17
8612049|NCT00426556|9649555|FG002|STARTED|Phase I - Core Phase||10
8612050|NCT00426556|9649556|FG003|STARTED|Phase I - Core Phase||0
8612051|NCT00426556|9649553|FG000|COMPLETED|Phase I - Core Phase||5
8612052|NCT00426556|9649554|FG001|COMPLETED|Phase I - Core Phase||7
8612053|NCT00426556|9649555|FG002|COMPLETED|Phase I - Core Phase||7
8612054|NCT00426556|9649556|FG003|COMPLETED|Phase I - Core Phase||0
8612055|NCT00426556|9649553|FG000|NOT COMPLETED|Phase I - Core Phase||1
8612056|NCT00426556|9649554|FG001|NOT COMPLETED|Phase I - Core Phase||10
8612057|NCT00426556|9649555|FG002|NOT COMPLETED|Phase I - Core Phase||3
8612058|NCT00426556|9649556|FG003|NOT COMPLETED|Phase I - Core Phase||0
8612059|NCT00426556|9649553|FG000|STARTED|Phase I - Extension Phase||5
8612060|NCT00426556|9649554|FG001|STARTED|Phase I - Extension Phase||7
8612061|NCT00426556|9649555|FG002|STARTED|Phase I - Extension Phase||7
8612062|NCT00426556|9649556|FG003|STARTED|Phase I - Extension Phase||0
8612063|NCT00426556|9649553|FG000|COMPLETED|Phase I - Extension Phase||0
8612064|NCT00426556|9649554|FG001|COMPLETED|Phase I - Extension Phase||1
8612065|NCT00426556|9649555|FG002|COMPLETED|Phase I - Extension Phase||0
8612066|NCT00426556|9649556|FG003|COMPLETED|Phase I - Extension Phase||0
8612067|NCT00426556|9649553|FG000|NOT COMPLETED|Phase I - Extension Phase||5
8612068|NCT00426556|9649554|FG001|NOT COMPLETED|Phase I - Extension Phase||6
8612069|NCT00426556|9649555|FG002|NOT COMPLETED|Phase I - Extension Phase||7
8612070|NCT00426556|9649556|FG003|NOT COMPLETED|Phase I - Extension Phase||0
8612071|NCT00426556|9649553|FG000|STARTED|Phase II - Core Phase||0
8612072|NCT00426556|9649554|FG001|STARTED|Phase II - Core Phase||0
8612073|NCT00426556|9649555|FG002|STARTED|Phase II - Core Phase||0
8612074|NCT00426556|9649556|FG003|STARTED|Phase II - Core Phase||55
8612075|NCT00426556|9649553|FG000|COMPLETED|Phase II - Core Phase||0
8612076|NCT00426556|9649554|FG001|COMPLETED|Phase II - Core Phase||0
8612077|NCT00426556|9649555|FG002|COMPLETED|Phase II - Core Phase||0
8612078|NCT00426556|9649556|FG003|COMPLETED|Phase II - Core Phase||28
8612079|NCT00426556|9649553|FG000|NOT COMPLETED|Phase II - Core Phase||0
8612080|NCT00426556|9649554|FG001|NOT COMPLETED|Phase II - Core Phase||0
8612081|NCT00426556|9649555|FG002|NOT COMPLETED|Phase II - Core Phase||0
8612082|NCT00426556|9649556|FG003|NOT COMPLETED|Phase II - Core Phase||27
8612083|NCT00426556|9649553|FG000|STARTED|Phase II - Extension Phase||0
8612084|NCT00426556|9649554|FG001|STARTED|Phase II - Extension Phase||0
8612085|NCT00426556|9649555|FG002|STARTED|Phase II - Extension Phase||0
8612086|NCT00426556|9649556|FG003|STARTED|Phase II - Extension Phase|4 patients did not enter the Extension phase.|24
8612087|NCT00426556|9649553|FG000|COMPLETED|Phase II - Extension Phase||0
8612088|NCT00426556|9649554|FG001|COMPLETED|Phase II - Extension Phase||0
8612089|NCT00426556|9649555|FG002|COMPLETED|Phase II - Extension Phase||0
8612090|NCT00426556|9649556|FG003|COMPLETED|Phase II - Extension Phase|Completed means 'Ongoing'|1
8612091|NCT00426556|9649553|FG000|NOT COMPLETED|Phase II - Extension Phase||0
8612092|NCT00426556|9649554|FG001|NOT COMPLETED|Phase II - Extension Phase||0
9064297|NCT04318535|10124572|FG001|COMPLETED|Period2washout(Atleast 7 Days Post-dose)||11
8612093|NCT00426556|9649555|FG002|NOT COMPLETED|Phase II - Extension Phase||0
8612094|NCT00426556|9649556|FG003|NOT COMPLETED|Phase II - Extension Phase||23
8612095|NCT00426660|9649566|FG000|STARTED|Overall Study||1047
8612096|NCT00426660|9649566|FG000|Treated|Overall Study||1032
8612097|NCT00426660|9649566|FG000|Safety Analysis Set|Overall Study||1032
8612098|NCT00426660|9649566|FG000|COMPLETED|Overall Study||916
8612099|NCT00426660|9649566|FG000|NOT COMPLETED|Overall Study||131
8612100|NCT00426751|9649572|FG000|STARTED|Overall Study||226
8612101|NCT00426751|9649573|FG001|STARTED|Overall Study||203
8612102|NCT00426751|9649572|FG000|COMPLETED|Overall Study||204
8612103|NCT00426751|9649573|FG001|COMPLETED|Overall Study||183
8612104|NCT00426751|9649572|FG000|NOT COMPLETED|Overall Study||22
8612105|NCT00426751|9649573|FG001|NOT COMPLETED|Overall Study||20
8612106|NCT00426764|9649579|FG000|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|131
8612107|NCT00426764|9649579|FG000|Discontinued Prior to or During Cycle 6|Overall Study||98
8612108|NCT00426764|9649579|FG000|Discontinued at End of or After Cycle 6|Overall Study||33
8612109|NCT00426764|9649579|FG000|COMPLETED|Overall Study||0
8612110|NCT00426764|9649579|FG000|NOT COMPLETED|Overall Study||131
8612111|NCT00426842|9649589|FG000|STARTED|Overall Study||11
8612112|NCT00426842|9649589|FG000|COMPLETED|Overall Study||10
8612113|NCT00426842|9649589|FG000|NOT COMPLETED|Overall Study||1
8612114|NCT00426855|9649595|FG000|STARTED|Overall Study||12
8612115|NCT00426855|9649595|FG000|COMPLETED|Overall Study||12
8612116|NCT00426855|9649595|FG000|NOT COMPLETED|Overall Study||0
8612117|NCT00427011|9649599|FG000|STARTED|Overall Study||25
8612118|NCT00427011|9649599|FG000|COMPLETED|Overall Study||0
8612119|NCT00427011|9649599|FG000|NOT COMPLETED|Overall Study||25
8612120|NCT00427037|9649606|FG000|STARTED|Overall Study||17
8612121|NCT00427037|9649607|FG001|STARTED|Overall Study||17
8612122|NCT00427037|9649606|FG000|COMPLETED|Overall Study||10
8612123|NCT00427037|9649607|FG001|COMPLETED|Overall Study||10
8612124|NCT00427037|9649606|FG000|NOT COMPLETED|Overall Study||7
8612125|NCT00427037|9649607|FG001|NOT COMPLETED|Overall Study||7
8612126|NCT00427297|9649617|FG000|STARTED|Overall Study||17
8612127|NCT00427297|9649618|FG001|STARTED|Overall Study||17
8612128|NCT00427297|9649617|FG000|COMPLETED|Overall Study||17
8612129|NCT00427297|9649618|FG001|COMPLETED|Overall Study||17
8612130|NCT00427297|9649617|FG000|NOT COMPLETED|Overall Study||0
8612131|NCT00427297|9649618|FG001|NOT COMPLETED|Overall Study||0
8612132|NCT00427336|9649624|FG000|STARTED|Overall Study||9
8612133|NCT00427336|9649624|FG000|COMPLETED|Overall Study||9
8612134|NCT00427336|9649624|FG000|NOT COMPLETED|Overall Study||0
8612135|NCT00427349|9649628|FG000|STARTED|Overall Study||46
8612136|NCT00427349|9649628|FG000|Eligible|Overall Study||45
8612137|NCT00427349|9649628|FG000|Treated|Overall Study||45
8612138|NCT00427349|9649628|FG000|Eligible and Treated|Overall Study||44
8612139|NCT00427349|9649628|FG000|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity|0
8612140|NCT00427349|9649628|FG000|NOT COMPLETED|Overall Study||46
8612141|NCT00427557|9649632|FG000|STARTED|Overall Study||30
8612142|NCT00427557|9649632|FG000|COMPLETED|Overall Study||30
8612143|NCT00427557|9649632|FG000|NOT COMPLETED|Overall Study||0
8612144|NCT00427635|9649638|FG000|STARTED|Treatment Phase|Randomised|26
8612145|NCT00427635|9649639|FG001|STARTED|Treatment Phase|Randomised|26
8612146|NCT00427635|9649638|FG000|COMPLETED|Treatment Phase|ITT population. One voluntary discontinuation by parent/guardian|25
8612147|NCT00427635|9649639|FG001|COMPLETED|Treatment Phase|ITT population|26
8612148|NCT00427635|9649638|FG000|NOT COMPLETED|Treatment Phase||1
8612149|NCT00427635|9649639|FG001|NOT COMPLETED|Treatment Phase||0
8612150|NCT00427635|9649638|FG000|STARTED|Study Completion to Safety Follow-up||25
8612151|NCT00427635|9649639|FG001|STARTED|Study Completion to Safety Follow-up||26
8612152|NCT00427635|9649638|FG000|COMPLETED|Study Completion to Safety Follow-up||25
8612153|NCT00427635|9649639|FG001|COMPLETED|Study Completion to Safety Follow-up|One participant lost to follow-up|25
8612154|NCT00427635|9649638|FG000|NOT COMPLETED|Study Completion to Safety Follow-up||0
8612155|NCT00427635|9649639|FG001|NOT COMPLETED|Study Completion to Safety Follow-up||1
8612156|NCT00427648|9649647|FG000|STARTED|Overall Study||12
8612157|NCT00427648|9649648|FG001|STARTED|Overall Study||10
8612158|NCT00427648|9649647|FG000|COMPLETED|Overall Study||11
8612159|NCT00427648|9649648|FG001|COMPLETED|Overall Study||7
8612160|NCT00427648|9649647|FG000|NOT COMPLETED|Overall Study||1
8612161|NCT00427648|9649648|FG001|NOT COMPLETED|Overall Study||3
8612162|NCT00427661|9649656|FG000|STARTED|Overall Study||8
8612163|NCT00427661|9649656|FG000|COMPLETED|Overall Study||8
8612164|NCT00427661|9649656|FG000|NOT COMPLETED|Overall Study||0
8612165|NCT00427700|9649663|FG000|STARTED|Overall Study||40
8612166|NCT00427700|9649664|FG001|STARTED|Overall Study||42
8612167|NCT00427700|9649663|FG000|COMPLETED|Overall Study||37
8612168|NCT00427700|9649664|FG001|COMPLETED|Overall Study||31
8612169|NCT00427700|9649663|FG000|NOT COMPLETED|Overall Study||3
8612170|NCT00427700|9649664|FG001|NOT COMPLETED|Overall Study||11
8612171|NCT00427765|9649671|FG000|STARTED|Overall Study||164
8612172|NCT00427765|9649671|FG000|COMPLETED|Overall Study||164
8612173|NCT00427765|9649671|FG000|NOT COMPLETED|Overall Study||0
8612174|NCT00427778|9649675|FG000|STARTED|First Intervention (4 Weeks)||14
8612175|NCT00427778|9649676|FG001|STARTED|First Intervention (4 Weeks)||15
8612176|NCT00427778|9649675|FG000|COMPLETED|First Intervention (4 Weeks)||10
8612177|NCT00427778|9649676|FG001|COMPLETED|First Intervention (4 Weeks)||14
8612178|NCT00427778|9649675|FG000|NOT COMPLETED|First Intervention (4 Weeks)||4
8612179|NCT00427778|9649676|FG001|NOT COMPLETED|First Intervention (4 Weeks)||1
8612180|NCT00427778|9649675|FG000|STARTED|Wash Out (2 Weeks)||10
8612181|NCT00427778|9649676|FG001|STARTED|Wash Out (2 Weeks)||14
8612182|NCT00427778|9649675|FG000|COMPLETED|Wash Out (2 Weeks)||10
8612183|NCT00427778|9649676|FG001|COMPLETED|Wash Out (2 Weeks)||14
8612184|NCT00427778|9649675|FG000|NOT COMPLETED|Wash Out (2 Weeks)||0
8612185|NCT00427778|9649676|FG001|NOT COMPLETED|Wash Out (2 Weeks)||0
8612186|NCT00427778|9649675|FG000|STARTED|Second Intervention (4 Weeks)||10
8612187|NCT00427778|9649676|FG001|STARTED|Second Intervention (4 Weeks)||14
8612188|NCT00427778|9649675|FG000|COMPLETED|Second Intervention (4 Weeks)||10
8612189|NCT00427778|9649676|FG001|COMPLETED|Second Intervention (4 Weeks)||14
8612190|NCT00427778|9649675|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0
8612191|NCT00427778|9649676|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||0
8612192|NCT00427791|9649697|FG000|STARTED|Overall Study||10
8612193|NCT00427791|9649698|FG001|STARTED|Overall Study||13
8612194|NCT00427791|9649697|FG000|COMPLETED|Overall Study||10
8612195|NCT00427791|9649698|FG001|COMPLETED|Overall Study||13
8612196|NCT00427791|9649697|FG000|NOT COMPLETED|Overall Study||0
8612197|NCT00427791|9649698|FG001|NOT COMPLETED|Overall Study||0
8612198|NCT00427804|9649706|FG000|STARTED|Overall Study||4
8612199|NCT00427804|9649707|FG001|STARTED|Overall Study||5
8612200|NCT00427804|9649706|FG000|COMPLETED|Overall Study||4
8612201|NCT00427804|9649707|FG001|COMPLETED|Overall Study||5
8612202|NCT00427804|9649706|FG000|NOT COMPLETED|Overall Study||0
8612203|NCT00427804|9649707|FG001|NOT COMPLETED|Overall Study||0
8612204|NCT00427895|9649717|FG000|STARTED|Between 6-Month Follow-up - Year 1||411
8612205|NCT00427895|9649718|FG001|STARTED|Between 6-Month Follow-up - Year 1||411
8612206|NCT00427895|9649719|FG002|STARTED|Between 6-Month Follow-up - Year 1||392
8612207|NCT00427895|9649720|FG003|STARTED|Between 6-Month Follow-up - Year 1||854
8612208|NCT00427895|9649721|FG004|STARTED|Between 6-Month Follow-up - Year 1||0
8612209|NCT00427895|9649722|FG005|STARTED|Between 6-Month Follow-up - Year 1||0
8612210|NCT00427895|9649723|FG006|STARTED|Between 6-Month Follow-up - Year 1||0
8612211|NCT00427895|9649724|FG007|STARTED|Between 6-Month Follow-up - Year 1||0
8612212|NCT00427895|9649717|FG000|COMPLETED|Between 6-Month Follow-up - Year 1||411
8612213|NCT00427895|9649718|FG001|COMPLETED|Between 6-Month Follow-up - Year 1||411
8612214|NCT00427895|9649719|FG002|COMPLETED|Between 6-Month Follow-up - Year 1||392
8612215|NCT00427895|9649720|FG003|COMPLETED|Between 6-Month Follow-up - Year 1||502
8612216|NCT00427895|9649721|FG004|COMPLETED|Between 6-Month Follow-up - Year 1||0
8612217|NCT00427895|9649722|FG005|COMPLETED|Between 6-Month Follow-up - Year 1||0
8612218|NCT00427895|9649723|FG006|COMPLETED|Between 6-Month Follow-up - Year 1||0
8612219|NCT00427895|9649724|FG007|COMPLETED|Between 6-Month Follow-up - Year 1||0
8612220|NCT00427895|9649717|FG000|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
8612221|NCT00427895|9649718|FG001|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
8612222|NCT00427895|9649719|FG002|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
8612223|NCT00427895|9649720|FG003|NOT COMPLETED|Between 6-Month Follow-up - Year 1||352
8612224|NCT00427895|9649721|FG004|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
8612225|NCT00427895|9649722|FG005|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
8612226|NCT00427895|9649723|FG006|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
8612227|NCT00427895|9649724|FG007|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
8612228|NCT00427895|9649717|FG000|STARTED|Vax 2/Year 3 to 4||0
8612229|NCT00427895|9649718|FG001|STARTED|Vax 2/Year 3 to 4||0
8612230|NCT00427895|9649719|FG002|STARTED|Vax 2/Year 3 to 4||0
8612231|NCT00427895|9649720|FG003|STARTED|Vax 2/Year 3 to 4||0
8612232|NCT00427895|9649721|FG004|STARTED|Vax 2/Year 3 to 4||108
8612233|NCT00427895|9649722|FG005|STARTED|Vax 2/Year 3 to 4||108
8612234|NCT00427895|9649723|FG006|STARTED|Vax 2/Year 3 to 4||189
8612235|NCT00427895|9649724|FG007|STARTED|Vax 2/Year 3 to 4||214
8612236|NCT00427895|9649717|FG000|COMPLETED|Vax 2/Year 3 to 4||0
8612237|NCT00427895|9649718|FG001|COMPLETED|Vax 2/Year 3 to 4||0
8612238|NCT00427895|9649719|FG002|COMPLETED|Vax 2/Year 3 to 4||0
8612239|NCT00427895|9649720|FG003|COMPLETED|Vax 2/Year 3 to 4||0
8612240|NCT00427895|9649721|FG004|COMPLETED|Vax 2/Year 3 to 4||107
8612241|NCT00427895|9649722|FG005|COMPLETED|Vax 2/Year 3 to 4||108
8612242|NCT00427895|9649723|FG006|COMPLETED|Vax 2/Year 3 to 4||189
8612243|NCT00427895|9649724|FG007|COMPLETED|Vax 2/Year 3 to 4||212
8612244|NCT00427895|9649717|FG000|NOT COMPLETED|Vax 2/Year 3 to 4||0
8612245|NCT00427895|9649718|FG001|NOT COMPLETED|Vax 2/Year 3 to 4||0
8612246|NCT00427895|9649719|FG002|NOT COMPLETED|Vax 2/Year 3 to 4||0
8612247|NCT00427895|9649720|FG003|NOT COMPLETED|Vax 2/Year 3 to 4||0
8612248|NCT00427895|9649721|FG004|NOT COMPLETED|Vax 2/Year 3 to 4||1
8612249|NCT00427895|9649722|FG005|NOT COMPLETED|Vax 2/Year 3 to 4||0
8612250|NCT00427895|9649723|FG006|NOT COMPLETED|Vax 2/Year 3 to 4||0
8612251|NCT00427895|9649724|FG007|NOT COMPLETED|Vax 2/Year 3 to 4||2
8612252|NCT00427895|9649717|FG000|STARTED|Vax 1 Baseline/6-Month Follow-up||418
8612253|NCT00427895|9649718|FG001|STARTED|Vax 1 Baseline/6-Month Follow-up||417
8612254|NCT00427895|9649719|FG002|STARTED|Vax 1 Baseline/6-Month Follow-up||406
8612255|NCT00427895|9649720|FG003|STARTED|Vax 1 Baseline/6-Month Follow-up||900
8612256|NCT00427895|9649721|FG004|STARTED|Vax 1 Baseline/6-Month Follow-up||0
8612257|NCT00427895|9649722|FG005|STARTED|Vax 1 Baseline/6-Month Follow-up||0
8612258|NCT00427895|9649723|FG006|STARTED|Vax 1 Baseline/6-Month Follow-up||0
8612259|NCT00427895|9649724|FG007|STARTED|Vax 1 Baseline/6-Month Follow-up||0
8612260|NCT00427895|9649717|FG000|Vaccinated|Vax 1 Baseline/6-Month Follow-up||417
8612261|NCT00427895|9649718|FG001|Vaccinated|Vax 1 Baseline/6-Month Follow-up||414
8612262|NCT00427895|9649719|FG002|Vaccinated|Vax 1 Baseline/6-Month Follow-up||404
8612263|NCT00427895|9649720|FG003|Vaccinated|Vax 1 Baseline/6-Month Follow-up||899
8612264|NCT00427895|9649721|FG004|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
8612265|NCT00427895|9649722|FG005|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
8612266|NCT00427895|9649723|FG006|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
8612267|NCT00427895|9649724|FG007|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
8612268|NCT00427895|9649717|FG000|COMPLETED|Vax 1 Baseline/6-Month Follow-up||411
8612269|NCT00427895|9649718|FG001|COMPLETED|Vax 1 Baseline/6-Month Follow-up||411
8612270|NCT00427895|9649719|FG002|COMPLETED|Vax 1 Baseline/6-Month Follow-up||392
8612271|NCT00427895|9649720|FG003|COMPLETED|Vax 1 Baseline/6-Month Follow-up||854
8612272|NCT00427895|9649721|FG004|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
8612273|NCT00427895|9649722|FG005|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
8612274|NCT00427895|9649723|FG006|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
8612275|NCT00427895|9649724|FG007|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
8612276|NCT00427895|9649717|FG000|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||7
8612277|NCT00427895|9649718|FG001|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||6
8612278|NCT00427895|9649719|FG002|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||14
8612279|NCT00427895|9649720|FG003|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||46
8612280|NCT00427895|9649721|FG004|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
8612281|NCT00427895|9649722|FG005|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
8612282|NCT00427895|9649723|FG006|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
8612283|NCT00427895|9649724|FG007|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
8612284|NCT00427895|9649717|FG000|STARTED|Vax 1/Year 1 Follow-up||411
8612285|NCT00427895|9649718|FG001|STARTED|Vax 1/Year 1 Follow-up||411
8612286|NCT00427895|9649719|FG002|STARTED|Vax 1/Year 1 Follow-up||392
8612287|NCT00427895|9649720|FG003|STARTED|Vax 1/Year 1 Follow-up||502
8612288|NCT00427895|9649721|FG004|STARTED|Vax 1/Year 1 Follow-up||0
8612289|NCT00427895|9649722|FG005|STARTED|Vax 1/Year 1 Follow-up||0
8612290|NCT00427895|9649723|FG006|STARTED|Vax 1/Year 1 Follow-up||0
8612291|NCT00427895|9649724|FG007|STARTED|Vax 1/Year 1 Follow-up||0
8612292|NCT00427895|9649717|FG000|COMPLETED|Vax 1/Year 1 Follow-up||404
8612293|NCT00427895|9649718|FG001|COMPLETED|Vax 1/Year 1 Follow-up||396
8612294|NCT00427895|9649719|FG002|COMPLETED|Vax 1/Year 1 Follow-up||373
8612295|NCT00427895|9649720|FG003|COMPLETED|Vax 1/Year 1 Follow-up||469
8612296|NCT00427895|9649721|FG004|COMPLETED|Vax 1/Year 1 Follow-up||0
8612297|NCT00427895|9649722|FG005|COMPLETED|Vax 1/Year 1 Follow-up||0
8612298|NCT00427895|9649723|FG006|COMPLETED|Vax 1/Year 1 Follow-up||0
8612299|NCT00427895|9649724|FG007|COMPLETED|Vax 1/Year 1 Follow-up||0
8612300|NCT00427895|9649717|FG000|NOT COMPLETED|Vax 1/Year 1 Follow-up||7
8612301|NCT00427895|9649718|FG001|NOT COMPLETED|Vax 1/Year 1 Follow-up||15
8612302|NCT00427895|9649719|FG002|NOT COMPLETED|Vax 1/Year 1 Follow-up||19
8612303|NCT00427895|9649720|FG003|NOT COMPLETED|Vax 1/Year 1 Follow-up||33
8612304|NCT00427895|9649721|FG004|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
8612305|NCT00427895|9649722|FG005|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
8612306|NCT00427895|9649723|FG006|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
8612307|NCT00427895|9649724|FG007|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
8612308|NCT00427895|9649717|FG000|STARTED|Between Year 1 - Vax 2/Year 3 to 4||404
8612309|NCT00427895|9649718|FG001|STARTED|Between Year 1 - Vax 2/Year 3 to 4||396
8612310|NCT00427895|9649719|FG002|STARTED|Between Year 1 - Vax 2/Year 3 to 4||373
8612311|NCT00427895|9649720|FG003|STARTED|Between Year 1 - Vax 2/Year 3 to 4||469
8612312|NCT00427895|9649721|FG004|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
8612313|NCT00427895|9649722|FG005|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
8612314|NCT00427895|9649723|FG006|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
8612315|NCT00427895|9649724|FG007|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
8612316|NCT00427895|9649717|FG000|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||216
8612317|NCT00427895|9649718|FG001|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||189
8612318|NCT00427895|9649719|FG002|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||214
8612319|NCT00427895|9649720|FG003|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
8612320|NCT00427895|9649721|FG004|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
8612321|NCT00427895|9649722|FG005|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
8612322|NCT00427895|9649723|FG006|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
8612323|NCT00427895|9649724|FG007|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
8612324|NCT00427895|9649717|FG000|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||188
8612325|NCT00427895|9649718|FG001|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||207
8612326|NCT00427895|9649719|FG002|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||159
8612327|NCT00427895|9649720|FG003|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||469
8612328|NCT00427895|9649721|FG004|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
8612329|NCT00427895|9649722|FG005|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
8612330|NCT00427895|9649723|FG006|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
8612331|NCT00427895|9649724|FG007|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
8612332|NCT00427908|9649767|FG000|STARTED|Primary Phase||229
8612333|NCT00427908|9649768|FG001|STARTED|Primary Phase||231
8612334|NCT00427908|9649769|FG002|STARTED|Primary Phase||75
8612335|NCT00427908|9649770|FG003|STARTED|Primary Phase||78
8612336|NCT00427908|9649767|FG000|COMPLETED|Primary Phase||224
8612337|NCT00427908|9649768|FG001|COMPLETED|Primary Phase||228
8612338|NCT00427908|9649769|FG002|COMPLETED|Primary Phase||72
8612339|NCT00427908|9649770|FG003|COMPLETED|Primary Phase||78
8612340|NCT00427908|9649767|FG000|NOT COMPLETED|Primary Phase||5
8612341|NCT00427908|9649768|FG001|NOT COMPLETED|Primary Phase||3
8612342|NCT00427908|9649769|FG002|NOT COMPLETED|Primary Phase||3
8612343|NCT00427908|9649770|FG003|NOT COMPLETED|Primary Phase||0
8612344|NCT00427908|9649767|FG000|STARTED|Persistence Phase Year 1||222
8612345|NCT00427908|9649768|FG001|STARTED|Persistence Phase Year 1||221
8612346|NCT00427908|9649769|FG002|STARTED|Persistence Phase Year 1||71
8612347|NCT00427908|9649770|FG003|STARTED|Persistence Phase Year 1||78
8612348|NCT00427908|9649767|FG000|COMPLETED|Persistence Phase Year 1||222
8612349|NCT00427908|9649768|FG001|COMPLETED|Persistence Phase Year 1||221
8612350|NCT00427908|9649769|FG002|COMPLETED|Persistence Phase Year 1||71
8612351|NCT00427908|9649770|FG003|COMPLETED|Persistence Phase Year 1||78
8612352|NCT00427908|9649767|FG000|NOT COMPLETED|Persistence Phase Year 1||0
8612353|NCT00427908|9649768|FG001|NOT COMPLETED|Persistence Phase Year 1||0
8612354|NCT00427908|9649769|FG002|NOT COMPLETED|Persistence Phase Year 1||0
8612355|NCT00427908|9649770|FG003|NOT COMPLETED|Persistence Phase Year 1||0
8612356|NCT00427908|9649767|FG000|STARTED|Persistence Phase Year 2||208
8612357|NCT00427908|9649768|FG001|STARTED|Persistence Phase Year 2||215
8612358|NCT00427908|9649769|FG002|STARTED|Persistence Phase Year 2||53
8612359|NCT00427908|9649770|FG003|STARTED|Persistence Phase Year 2||61
8612360|NCT00427908|9649767|FG000|COMPLETED|Persistence Phase Year 2||208
8612361|NCT00427908|9649768|FG001|COMPLETED|Persistence Phase Year 2||215
8612362|NCT00427908|9649769|FG002|COMPLETED|Persistence Phase Year 2||53
8612363|NCT00427908|9649770|FG003|COMPLETED|Persistence Phase Year 2||61
8612364|NCT00427908|9649767|FG000|NOT COMPLETED|Persistence Phase Year 2||0
8612365|NCT00427908|9649768|FG001|NOT COMPLETED|Persistence Phase Year 2||0
8612366|NCT00427908|9649769|FG002|NOT COMPLETED|Persistence Phase Year 2||0
8612367|NCT00427908|9649770|FG003|NOT COMPLETED|Persistence Phase Year 2||0
8612368|NCT00427908|9649767|FG000|STARTED|Persistence Phase Year 3||185
8612369|NCT00427908|9649768|FG001|STARTED|Persistence Phase Year 3||201
8612370|NCT00427908|9649769|FG002|STARTED|Persistence Phase Year 3||38
8612371|NCT00427908|9649770|FG003|STARTED|Persistence Phase Year 3||38
8612372|NCT00427908|9649767|FG000|COMPLETED|Persistence Phase Year 3||185
8612373|NCT00427908|9649768|FG001|COMPLETED|Persistence Phase Year 3||201
8612374|NCT00427908|9649769|FG002|COMPLETED|Persistence Phase Year 3||38
8612375|NCT00427908|9649770|FG003|COMPLETED|Persistence Phase Year 3||38
8612376|NCT00427908|9649767|FG000|NOT COMPLETED|Persistence Phase Year 3||0
8612377|NCT00427908|9649768|FG001|NOT COMPLETED|Persistence Phase Year 3||0
8612378|NCT00427908|9649769|FG002|NOT COMPLETED|Persistence Phase Year 3||0
8612379|NCT00427908|9649770|FG003|NOT COMPLETED|Persistence Phase Year 3||0
8612380|NCT00427908|9649767|FG000|STARTED|Persistence Phase Year 4||165
8612381|NCT00427908|9649768|FG001|STARTED|Persistence Phase Year 4||192
8612382|NCT00427908|9649769|FG002|STARTED|Persistence Phase Year 4||34
8612383|NCT00427908|9649770|FG003|STARTED|Persistence Phase Year 4||32
8612384|NCT00427908|9649767|FG000|COMPLETED|Persistence Phase Year 4||165
8612385|NCT00427908|9649768|FG001|COMPLETED|Persistence Phase Year 4||192
8612386|NCT00427908|9649769|FG002|COMPLETED|Persistence Phase Year 4||34
8612387|NCT00427908|9649770|FG003|COMPLETED|Persistence Phase Year 4||32
8612388|NCT00427908|9649767|FG000|NOT COMPLETED|Persistence Phase Year 4||0
8612389|NCT00427908|9649768|FG001|NOT COMPLETED|Persistence Phase Year 4||0
8612390|NCT00427908|9649769|FG002|NOT COMPLETED|Persistence Phase Year 4||0
8612391|NCT00427908|9649770|FG003|NOT COMPLETED|Persistence Phase Year 4||0
8612392|NCT00427908|9649767|FG000|STARTED|Persistence Phase Year 5||52
8612393|NCT00427908|9649768|FG001|STARTED|Persistence Phase Year 5||99
8612394|NCT00427908|9649769|FG002|STARTED|Persistence Phase Year 5||12
8612395|NCT00427908|9649770|FG003|STARTED|Persistence Phase Year 5||13
8612396|NCT00427908|9649767|FG000|COMPLETED|Persistence Phase Year 5||52
8612397|NCT00427908|9649768|FG001|COMPLETED|Persistence Phase Year 5||99
8612398|NCT00427908|9649769|FG002|COMPLETED|Persistence Phase Year 5||12
8612399|NCT00427908|9649770|FG003|COMPLETED|Persistence Phase Year 5||13
8612400|NCT00427908|9649767|FG000|NOT COMPLETED|Persistence Phase Year 5||0
8612401|NCT00427908|9649768|FG001|NOT COMPLETED|Persistence Phase Year 5||0
8612402|NCT00427908|9649769|FG002|NOT COMPLETED|Persistence Phase Year 5||0
8612403|NCT00427908|9649770|FG003|NOT COMPLETED|Persistence Phase Year 5||0
8612404|NCT00427921|9649805|FG000|STARTED|Overall Study||304
8612405|NCT00427921|9649805|FG000|COMPLETED|Overall Study||254
8612406|NCT00427921|9649805|FG000|NOT COMPLETED|Overall Study||50
8612407|NCT00427934|9649813|FG000|STARTED|Overall Study||8
8612408|NCT00427934|9649814|FG001|STARTED|Overall Study||8
8612409|NCT00427934|9649815|FG002|STARTED|Overall Study||78
8612410|NCT00427934|9649816|FG003|STARTED|Overall Study||34
8612411|NCT00427934|9649813|FG000|Treated|Overall Study||8
8612412|NCT00427934|9649814|FG001|Treated|Overall Study||8
8612413|NCT00427934|9649815|FG002|Treated|Overall Study||77
8612414|NCT00427934|9649816|FG003|Treated|Overall Study||33
8612415|NCT00427934|9649813|FG000|COMPLETED|Overall Study||7
8612416|NCT00427934|9649814|FG001|COMPLETED|Overall Study||8
8612417|NCT00427934|9649815|FG002|COMPLETED|Overall Study||55
8612418|NCT00427934|9649816|FG003|COMPLETED|Overall Study||19
8612419|NCT00427934|9649813|FG000|NOT COMPLETED|Overall Study||1
8612420|NCT00427934|9649814|FG001|NOT COMPLETED|Overall Study||0
8612421|NCT00427934|9649815|FG002|NOT COMPLETED|Overall Study||23
8612422|NCT00427934|9649816|FG003|NOT COMPLETED|Overall Study||15
8612423|NCT00427960|9649830|FG000|STARTED|Overall Study||30
8612424|NCT00427960|9649831|FG001|STARTED|Overall Study||25
8612425|NCT00427960|9649830|FG000|COMPLETED|Overall Study||28
8612426|NCT00427960|9649831|FG001|COMPLETED|Overall Study||21
8612427|NCT00427960|9649830|FG000|NOT COMPLETED|Overall Study||2
8612428|NCT00427960|9649831|FG001|NOT COMPLETED|Overall Study||4
8612429|NCT00427973|9649837|FG000|STARTED|Overall Study||17
8612430|NCT00427973|9649837|FG000|COMPLETED|Overall Study||17
8612431|NCT00427973|9649837|FG000|NOT COMPLETED|Overall Study||0
8612432|NCT00427999|9649841|FG000|STARTED|Overall Study||65
8612433|NCT00427999|9649841|FG000|Intent to Treat (ITT)|Overall Study||61
8612434|NCT00427999|9649841|FG000|Extension Follow-up|Overall Study||19
8612435|NCT00427999|9649841|FG000|COMPLETED|Overall Study||33
8612436|NCT00427999|9649841|FG000|NOT COMPLETED|Overall Study||32
8612437|NCT00428077|9649846|FG000|STARTED|Overall Study||4
8612438|NCT00428077|9649846|FG000|COMPLETED|Overall Study||4
8612439|NCT00428077|9649846|FG000|NOT COMPLETED|Overall Study||0
8612440|NCT00428090|9649854|FG000|STARTED|Overall Study||165
8612441|NCT00428090|9649855|FG001|STARTED|Overall Study||166
8612442|NCT00428090|9649856|FG002|STARTED|Overall Study||165
8612443|NCT00428090|9649857|FG003|STARTED|Overall Study||83
8612444|NCT00428090|9649854|FG000|COMPLETED|Overall Study||131
8612445|NCT00428090|9649855|FG001|COMPLETED|Overall Study||135
8612446|NCT00428090|9649856|FG002|COMPLETED|Overall Study||127
8612447|NCT00428090|9649857|FG003|COMPLETED|Overall Study||55
8612448|NCT00428090|9649854|FG000|NOT COMPLETED|Overall Study||34
8612449|NCT00428090|9649855|FG001|NOT COMPLETED|Overall Study||31
8612450|NCT00428090|9649856|FG002|NOT COMPLETED|Overall Study||38
8612451|NCT00428090|9649857|FG003|NOT COMPLETED|Overall Study||28
8612452|NCT00428116|9649877|FG000|STARTED|Overall Study||21
8612453|NCT00428116|9649878|FG001|STARTED|Overall Study||21
8612454|NCT00428116|9649877|FG000|COMPLETED|Overall Study||18
8612455|NCT00428116|9649878|FG001|COMPLETED|Overall Study||21
8612456|NCT00428116|9649877|FG000|NOT COMPLETED|Overall Study||3
8612457|NCT00428116|9649878|FG001|NOT COMPLETED|Overall Study||0
8612458|NCT00428220|9649885|FG000|STARTED|Overall Study||223
8612459|NCT00428220|9649885|FG000|COMPLETED|Overall Study||0
8612460|NCT00428220|9649885|FG000|NOT COMPLETED|Overall Study||223
8612461|NCT00428246|9649903|FG000|STARTED|Overall Study||8
8612462|NCT00428246|9649904|FG001|STARTED|Overall Study||8
8612463|NCT00428246|9649905|FG002|STARTED|Overall Study||8
8612464|NCT00428246|9649903|FG000|COMPLETED|Overall Study||7
8612465|NCT00428246|9649904|FG001|COMPLETED|Overall Study||8
8612466|NCT00428246|9649905|FG002|COMPLETED|Overall Study||7
8612467|NCT00428246|9649903|FG000|NOT COMPLETED|Overall Study||1
8612468|NCT00428246|9649904|FG001|NOT COMPLETED|Overall Study||0
8612469|NCT00428246|9649905|FG002|NOT COMPLETED|Overall Study||1
8612470|NCT00428298|9649915|FG000|STARTED|Overall Study||30
8612471|NCT00428298|9649916|FG001|STARTED|Overall Study||30
8612472|NCT00428298|9649915|FG000|Second RBANS at Study Exit|Overall Study||3
8612473|NCT00428298|9649916|FG001|Second RBANS at Study Exit|Overall Study||3
8612474|NCT00428298|9649915|FG000|COMPLETED|Overall Study||16
8612475|NCT00428298|9649916|FG001|COMPLETED|Overall Study||19
8612476|NCT00428298|9649915|FG000|NOT COMPLETED|Overall Study||14
8612477|NCT00428298|9649916|FG001|NOT COMPLETED|Overall Study||11
8612478|NCT00428389|9649926|FG000|STARTED|Core Phase||131
8612479|NCT00428389|9649927|FG001|STARTED|Core Phase||131
8612480|NCT00428389|9649926|FG000|Intent-to-treat Population|Core Phase||131
8612481|NCT00428389|9649927|FG001|Intent-to-treat Population|Core Phase|1 patient was discontinued from the study the same day as randomization & excluded from all analyses|130
8612482|NCT00428389|9649926|FG000|COMPLETED|Core Phase||120
8612483|NCT00428389|9649927|FG001|COMPLETED|Core Phase||120
8612484|NCT00428389|9649926|FG000|NOT COMPLETED|Core Phase||11
8612485|NCT00428389|9649927|FG001|NOT COMPLETED|Core Phase||11
8612486|NCT00428389|9649926|FG000|STARTED|Extension Phase|Participants were required to sign a separate informed consent prior to entering the extension phase|117
8612487|NCT00428389|9649927|FG001|STARTED|Extension Phase||117
8612488|NCT00428389|9649926|FG000|COMPLETED|Extension Phase||85
8612489|NCT00428389|9649927|FG001|COMPLETED|Extension Phase||91
8612490|NCT00428389|9649926|FG000|NOT COMPLETED|Extension Phase||32
8612491|NCT00428389|9649927|FG001|NOT COMPLETED|Extension Phase||26
8612492|NCT00428441|9649933|FG000|STARTED|Overall Study||75
8612493|NCT00428441|9649933|FG000|COMPLETED|Overall Study||74
8612494|NCT00428441|9649933|FG000|NOT COMPLETED|Overall Study||1
8612495|NCT00428584|9649939|FG000|STARTED|Comparative Phase||65
8612496|NCT00428584|9649940|FG001|STARTED|Comparative Phase||64
8612497|NCT00428584|9649939|FG000|COMPLETED|Comparative Phase|Comparator Phase - new formulation of rebif and Betaseron|56
8612498|NCT00428584|9649940|FG001|COMPLETED|Comparative Phase||63
8612499|NCT00428584|9649939|FG000|NOT COMPLETED|Comparative Phase||9
8612500|NCT00428584|9649940|FG001|NOT COMPLETED|Comparative Phase||1
8612501|NCT00428584|9649939|FG000|STARTED|Extension Phase|Extension Phase - new formulation of rebif to new formulation of rebif|56
8612502|NCT00428584|9649940|FG001|STARTED|Extension Phase||63
8612503|NCT00428584|9649939|FG000|COMPLETED|Extension Phase||35
8612504|NCT00428584|9649940|FG001|COMPLETED|Extension Phase||34
8612505|NCT00428584|9649939|FG000|NOT COMPLETED|Extension Phase||21
8612506|NCT00428584|9649940|FG001|NOT COMPLETED|Extension Phase||29
8612507|NCT00428597|9649952|FG000|STARTED|Overall Study||86
8612508|NCT00428597|9649953|FG001|STARTED|Overall Study||85
8612509|NCT00428597|9649952|FG000|Received Treatment|Overall Study||83
8612510|NCT00428597|9649953|FG001|Received Treatment|Overall Study||82
8612511|NCT00428597|9649952|FG000|COMPLETED|Overall Study||0
8612512|NCT00428597|9649953|FG001|COMPLETED|Overall Study||0
8612513|NCT00428597|9649952|FG000|NOT COMPLETED|Overall Study||86
8612514|NCT00428597|9649953|FG001|NOT COMPLETED|Overall Study||85
8612515|NCT00428610|9649962|FG000|STARTED|Overall Study||53
8612516|NCT00428610|9649963|FG001|STARTED|Overall Study||18
8612517|NCT00428610|9649964|FG002|STARTED|Overall Study||32
8612518|NCT00428610|9649962|FG000|Received at Least One Dose of Study Drug|Overall Study||53
8612519|NCT00428610|9649963|FG001|Received at Least One Dose of Study Drug|Overall Study||18
8612520|NCT00428610|9649964|FG002|Received at Least One Dose of Study Drug|Overall Study||32
8612521|NCT00428610|9649962|FG000|COMPLETED|Overall Study||0
8612522|NCT00428610|9649963|FG001|COMPLETED|Overall Study||0
8612523|NCT00428610|9649964|FG002|COMPLETED|Overall Study||0
8612524|NCT00428610|9649962|FG000|NOT COMPLETED|Overall Study||53
8612525|NCT00428610|9649963|FG001|NOT COMPLETED|Overall Study||18
8612526|NCT00428610|9649964|FG002|NOT COMPLETED|Overall Study||32
8612527|NCT00428714|9649974|FG000|STARTED|Overall Study||31
8612528|NCT00428714|9649975|FG001|STARTED|Overall Study||42
8612529|NCT00428714|9649974|FG000|Received at Least 1 Dose of Study Drug|Overall Study||31
8612530|NCT00428714|9649975|FG001|Received at Least 1 Dose of Study Drug|Overall Study||42
8612531|NCT00428714|9649974|FG000|COMPLETED|Overall Study||0
8612532|NCT00428714|9649975|FG001|COMPLETED|Overall Study||0
8612533|NCT00428714|9649974|FG000|NOT COMPLETED|Overall Study||31
8612534|NCT00428714|9649975|FG001|NOT COMPLETED|Overall Study||42
8612535|NCT00428792|9649984|FG000|STARTED|Overall Study||80
8612536|NCT00428792|9649985|FG001|STARTED|Overall Study||70
8612537|NCT00428792|9649984|FG000|COMPLETED|Overall Study|Information is not available during which cross-over period patients discontinued.|79
8612538|NCT00428792|9649985|FG001|COMPLETED|Overall Study|Information is not available during which cross-over period patients discontinued.|66
8612539|NCT00428792|9649984|FG000|NOT COMPLETED|Overall Study||1
8612540|NCT00428792|9649985|FG001|NOT COMPLETED|Overall Study||4
8612541|NCT00428844|9649994|FG000|STARTED|Completed Study Drug Treatment||25
8612542|NCT00428844|9649995|FG001|STARTED|Completed Study Drug Treatment||24
8612543|NCT00428844|9649996|FG002|STARTED|Completed Study Drug Treatment||26
8612544|NCT00428844|9649994|FG000|Received First Dose|Completed Study Drug Treatment||25
8612545|NCT00428844|9649995|FG001|Received First Dose|Completed Study Drug Treatment||24
8612546|NCT00428844|9649996|FG002|Received First Dose|Completed Study Drug Treatment||25
8612547|NCT00428844|9649994|FG000|COMPLETED|Completed Study Drug Treatment||23
8612548|NCT00428844|9649995|FG001|COMPLETED|Completed Study Drug Treatment||18
8612549|NCT00428844|9649996|FG002|COMPLETED|Completed Study Drug Treatment||19
8612550|NCT00428844|9649994|FG000|NOT COMPLETED|Completed Study Drug Treatment||2
8612551|NCT00428844|9649995|FG001|NOT COMPLETED|Completed Study Drug Treatment||6
8612552|NCT00428844|9649996|FG002|NOT COMPLETED|Completed Study Drug Treatment||7
8612553|NCT00428844|9649994|FG000|STARTED|Completed Test of Cure (TOC) Visit||23
8612554|NCT00428844|9649995|FG001|STARTED|Completed Test of Cure (TOC) Visit||18
8612555|NCT00428844|9649996|FG002|STARTED|Completed Test of Cure (TOC) Visit||19
8612556|NCT00428844|9649994|FG000|COMPLETED|Completed Test of Cure (TOC) Visit||20
8612557|NCT00428844|9649995|FG001|COMPLETED|Completed Test of Cure (TOC) Visit||16
8612558|NCT00428844|9649996|FG002|COMPLETED|Completed Test of Cure (TOC) Visit||17
8612559|NCT00428844|9649994|FG000|NOT COMPLETED|Completed Test of Cure (TOC) Visit||3
8612560|NCT00428844|9649995|FG001|NOT COMPLETED|Completed Test of Cure (TOC) Visit||2
8612561|NCT00428844|9649996|FG002|NOT COMPLETED|Completed Test of Cure (TOC) Visit||2
8612562|NCT00428922|9650004|FG000|STARTED|Overall Study||26
8612563|NCT00428922|9650004|FG000|COMPLETED|Overall Study||26
8612564|NCT00428922|9650004|FG000|NOT COMPLETED|Overall Study||0
8612565|NCT00428948|9650010|FG000|STARTED|Overall Study||961
8612566|NCT00428948|9650011|FG001|STARTED|Overall Study||484
8612567|NCT00428948|9650010|FG000|Received Treatment|Overall Study||961
8612568|NCT00428948|9650011|FG001|Received Treatment|Overall Study||483
8612569|NCT00428948|9650010|FG000|COMPLETED|Overall Study||740
8612570|NCT00428948|9650011|FG001|COMPLETED|Overall Study||417
8612571|NCT00428948|9650010|FG000|NOT COMPLETED|Overall Study||221
8612572|NCT00428948|9650011|FG001|NOT COMPLETED|Overall Study||67
8612573|NCT00428974|9650021|FG000|STARTED|Overall Study|one patient was randomized but never received study treatment|25
8612574|NCT00428974|9650022|FG001|STARTED|Overall Study||17
8612575|NCT00428974|9650023|FG002|STARTED|Overall Study||15
8612576|NCT00428974|9650024|FG003|STARTED|Overall Study||19
8612577|NCT00428974|9650021|FG000|COMPLETED|Overall Study||17
8612578|NCT00428974|9650022|FG001|COMPLETED|Overall Study||17
8612579|NCT00428974|9650023|FG002|COMPLETED|Overall Study||14
8612580|NCT00428974|9650024|FG003|COMPLETED|Overall Study||16
8612581|NCT00428974|9650021|FG000|NOT COMPLETED|Overall Study||8
8612582|NCT00428974|9650022|FG001|NOT COMPLETED|Overall Study||0
8612583|NCT00428974|9650023|FG002|NOT COMPLETED|Overall Study||1
8612584|NCT00428974|9650024|FG003|NOT COMPLETED|Overall Study||3
8612585|NCT00429104|9650035|FG000|STARTED|Overall Study||18
8612586|NCT00429104|9650035|FG000|COMPLETED|Overall Study||17
8612587|NCT00429104|9650035|FG000|NOT COMPLETED|Overall Study||1
8612588|NCT00429143|9650039|FG000|STARTED|Overall Study||27
8612589|NCT00429143|9650039|FG000|COMPLETED|Overall Study||27
8612590|NCT00429143|9650039|FG000|NOT COMPLETED|Overall Study||0
8612591|NCT00429169|9650045|FG000|STARTED|Overall Study||38
8612592|NCT00429169|9650046|FG001|STARTED|Overall Study||40
8612593|NCT00429169|9650045|FG000|COMPLETED|Overall Study|2 subjects excluded due to re-diagnosis/ineligibility.|36
8612594|NCT00429169|9650046|FG001|COMPLETED|Overall Study|2 subjects excluded: re-diagnosis/ineligibility (1), and did not return after randomization (1).|38
8612595|NCT00429169|9650045|FG000|NOT COMPLETED|Overall Study||2
8612596|NCT00429169|9650046|FG001|NOT COMPLETED|Overall Study||2
8612597|NCT00429182|9650054|FG000|STARTED|Overall Study||32
8612598|NCT00429182|9650054|FG000|COMPLETED|Overall Study||25
8612599|NCT00429182|9650054|FG000|NOT COMPLETED|Overall Study||7
8612600|NCT00429273|9650061|FG000|STARTED|Overall Study||68
8612601|NCT00429273|9650062|FG001|STARTED|Overall Study||69
8612602|NCT00429273|9650063|FG002|STARTED|Overall Study||70
8612603|NCT00429273|9650061|FG000|COMPLETED|Overall Study||60
8612604|NCT00429273|9650062|FG001|COMPLETED|Overall Study||61
8612605|NCT00429273|9650063|FG002|COMPLETED|Overall Study||61
8612606|NCT00429273|9650061|FG000|NOT COMPLETED|Overall Study||8
8612607|NCT00429273|9650062|FG001|NOT COMPLETED|Overall Study||8
8612608|NCT00429273|9650063|FG002|NOT COMPLETED|Overall Study||9
8612609|NCT00429299|9650074|FG000|STARTED|Overall Study||36
8612610|NCT00429299|9650075|FG001|STARTED|Overall Study||39
8612611|NCT00429299|9650076|FG002|STARTED|Overall Study||46
8612612|NCT00429299|9650074|FG000|COMPLETED|Overall Study||32
8612613|NCT00429299|9650075|FG001|COMPLETED|Overall Study||32
8612614|NCT00429299|9650076|FG002|COMPLETED|Overall Study||42
8612615|NCT00429299|9650074|FG000|NOT COMPLETED|Overall Study||4
8612616|NCT00429299|9650075|FG001|NOT COMPLETED|Overall Study||7
8612617|NCT00429299|9650076|FG002|NOT COMPLETED|Overall Study||4
8612618|NCT00429364|9650086|FG000|STARTED|Overall Study||303
8612619|NCT00429364|9650087|FG001|STARTED|Overall Study||305
8612620|NCT00429364|9650086|FG000|COMPLETED|Overall Study||271
8612621|NCT00429364|9650087|FG001|COMPLETED|Overall Study||272
8612622|NCT00429364|9650086|FG000|NOT COMPLETED|Overall Study||32
8612623|NCT00429364|9650087|FG001|NOT COMPLETED|Overall Study||33
8612624|NCT00429403|9650095|FG000|STARTED|Overall Study||1
8612625|NCT00429403|9650096|FG001|STARTED|Overall Study||0
8612626|NCT00429403|9650095|FG000|COMPLETED|Overall Study||1
8612627|NCT00429403|9650096|FG001|COMPLETED|Overall Study||0
8612628|NCT00429403|9650095|FG000|NOT COMPLETED|Overall Study||0
8612629|NCT00429403|9650096|FG001|NOT COMPLETED|Overall Study||0
8612630|NCT00429416|9650102|FG000|STARTED|Overall Study||14
8612631|NCT00429416|9650102|FG000|COMPLETED|Overall Study||13
8612632|NCT00429416|9650102|FG000|NOT COMPLETED|Overall Study||1
8612633|NCT00429494|9650106|FG000|STARTED|Overall Study||59
8612634|NCT00429494|9650106|FG000|COMPLETED|Overall Study||44
8612635|NCT00429494|9650106|FG000|NOT COMPLETED|Overall Study||15
8612636|NCT00429507|9650110|FG000|STARTED|Overall Study||12
8612637|NCT00429507|9650110|FG000|COMPLETED|Overall Study||12
8612638|NCT00429507|9650110|FG000|NOT COMPLETED|Overall Study||0
8612639|NCT00429572|9650114|FG000|STARTED|Overall Study||19
8612640|NCT00429572|9650114|FG000|COMPLETED|Overall Study||18
8612641|NCT00429572|9650114|FG000|NOT COMPLETED|Overall Study||1
8612642|NCT00429585|9650120|FG000|STARTED|Overall Study||52
8612643|NCT00429585|9650121|FG001|STARTED|Overall Study||47
8612644|NCT00429585|9650120|FG000|COMPLETED|Overall Study||22
8612645|NCT00429585|9650121|FG001|COMPLETED|Overall Study||27
8612646|NCT00429585|9650120|FG000|NOT COMPLETED|Overall Study||30
8612647|NCT00429585|9650121|FG001|NOT COMPLETED|Overall Study||20
8612648|NCT00429663|9650129|FG000|STARTED|Overall Study||76
8612649|NCT00429663|9650130|FG001|STARTED|Overall Study||80
8612650|NCT00429663|9650129|FG000|COMPLETED|Overall Study||40
8612651|NCT00429663|9650130|FG001|COMPLETED|Overall Study||41
8612652|NCT00429663|9650129|FG000|NOT COMPLETED|Overall Study||36
8612653|NCT00429663|9650130|FG001|NOT COMPLETED|Overall Study||39
8612654|NCT00429702|9650138|FG000|STARTED|Overall Study||3
8612655|NCT00429702|9650139|FG001|STARTED|Overall Study||4
8612656|NCT00429702|9650138|FG000|COMPLETED|Overall Study||3
8612657|NCT00429702|9650139|FG001|COMPLETED|Overall Study||4
8612658|NCT00429702|9650138|FG000|NOT COMPLETED|Overall Study||0
8612659|NCT00429702|9650139|FG001|NOT COMPLETED|Overall Study||0
8612660|NCT00429793|9650145|FG000|STARTED|Overall Study||60
8612661|NCT00429793|9650145|FG000|COMPLETED|Overall Study||54
8612662|NCT00429793|9650145|FG000|NOT COMPLETED|Overall Study||6
8612663|NCT00429949|9650154|FG000|STARTED|Overall Study||21
8612664|NCT00429949|9650154|FG000|COMPLETED|Overall Study||21
8612665|NCT00429949|9650154|FG000|NOT COMPLETED|Overall Study||0
8612666|NCT00430183|9650162|FG000|STARTED|Overall Study||391
8612667|NCT00430183|9650163|FG001|STARTED|Overall Study||397
8612668|NCT00430183|9650162|FG000|COMPLETED|Overall Study||391
8612669|NCT00430183|9650163|FG001|COMPLETED|Overall Study||397
8612670|NCT00430183|9650162|FG000|NOT COMPLETED|Overall Study||0
8612671|NCT00430183|9650163|FG001|NOT COMPLETED|Overall Study||0
8612672|NCT00430248|9650172|FG000|STARTED|Overall Study||757
8612673|NCT00430248|9650173|FG001|STARTED|Overall Study||756
8612674|NCT00430248|9650174|FG002|STARTED|Overall Study||756
8612675|NCT00430248|9650172|FG000|COMPLETED|Overall Study||632
8612676|NCT00430248|9650173|FG001|COMPLETED|Overall Study||598
8612677|NCT00430248|9650174|FG002|COMPLETED|Overall Study||621
8612678|NCT00430248|9650172|FG000|NOT COMPLETED|Overall Study||125
8612679|NCT00430248|9650173|FG001|NOT COMPLETED|Overall Study||158
8612680|NCT00430248|9650174|FG002|NOT COMPLETED|Overall Study||135
8612681|NCT00430300|9650186|FG000|STARTED|Overall Study||17
8612682|NCT00430300|9650187|FG001|STARTED|Overall Study||18
8612683|NCT00430300|9650188|FG002|STARTED|Overall Study||35
8612684|NCT00430300|9650189|FG003|STARTED|Overall Study||17
8612685|NCT00430300|9650186|FG000|COMPLETED|Overall Study||15
8612686|NCT00430300|9650187|FG001|COMPLETED|Overall Study||16
8612687|NCT00430300|9650188|FG002|COMPLETED|Overall Study||29
8612688|NCT00430300|9650189|FG003|COMPLETED|Overall Study||15
8612689|NCT00430300|9650186|FG000|NOT COMPLETED|Overall Study||2
8612690|NCT00430300|9650187|FG001|NOT COMPLETED|Overall Study||2
8612691|NCT00430300|9650188|FG002|NOT COMPLETED|Overall Study||6
8612692|NCT00430300|9650189|FG003|NOT COMPLETED|Overall Study||2
8612693|NCT00430352|9650199|FG000|STARTED|Overall Study||545
8612694|NCT00430352|9650199|FG000|COMPLETED|Overall Study||407
8612695|NCT00430352|9650199|FG000|NOT COMPLETED|Overall Study||138
8612696|NCT00430482|9650205|FG000|STARTED|Completed Treatment||41
8612697|NCT00430482|9650206|FG001|STARTED|Completed Treatment||37
8612698|NCT00430482|9650205|FG000|Completed ASI at Midpoint|Completed Treatment||35
8612699|NCT00430482|9650206|FG001|Completed ASI at Midpoint|Completed Treatment||29
8612700|NCT00430482|9650205|FG000|COMPLETED|Completed Treatment||34
8612701|NCT00430482|9650206|FG001|COMPLETED|Completed Treatment||26
8612702|NCT00430482|9650205|FG000|NOT COMPLETED|Completed Treatment||7
8612703|NCT00430482|9650206|FG001|NOT COMPLETED|Completed Treatment||11
8612704|NCT00430482|9650205|FG000|STARTED|Completed 2 Follow-Up Visits||34
8612705|NCT00430482|9650206|FG001|STARTED|Completed 2 Follow-Up Visits||26
8612706|NCT00430482|9650205|FG000|Completed ASI at Follow-Up #1|Completed 2 Follow-Up Visits||27
8612707|NCT00430482|9650206|FG001|Completed ASI at Follow-Up #1|Completed 2 Follow-Up Visits||20
8612708|NCT00430482|9650205|FG000|Completed ASI at Follow-Up #2|Completed 2 Follow-Up Visits||29
8612709|NCT00430482|9650206|FG001|Completed ASI at Follow-Up #2|Completed 2 Follow-Up Visits||20
8612710|NCT00430482|9650205|FG000|COMPLETED|Completed 2 Follow-Up Visits||29
8612711|NCT00430482|9650206|FG001|COMPLETED|Completed 2 Follow-Up Visits||20
8612712|NCT00430482|9650205|FG000|NOT COMPLETED|Completed 2 Follow-Up Visits||5
8612713|NCT00430482|9650206|FG001|NOT COMPLETED|Completed 2 Follow-Up Visits||6
8612714|NCT00430495|9650216|FG000|STARTED|Overall Study||64
8612715|NCT00430495|9650217|FG001|STARTED|Overall Study||66
8612716|NCT00430495|9650218|FG002|STARTED|Overall Study||62
8612717|NCT00430495|9650219|FG003|STARTED|Overall Study||64
8612718|NCT00430495|9650216|FG000|Treated|Overall Study||62
8612719|NCT00430495|9650217|FG001|Treated|Overall Study||66
8612720|NCT00430495|9650218|FG002|Treated|Overall Study||62
8612721|NCT00430495|9650219|FG003|Treated|Overall Study||64
8612722|NCT00430495|9650216|FG000|COMPLETED|Overall Study||50
8612723|NCT00430495|9650217|FG001|COMPLETED|Overall Study||59
8612724|NCT00430495|9650218|FG002|COMPLETED|Overall Study||49
8612725|NCT00430495|9650219|FG003|COMPLETED|Overall Study||60
8612726|NCT00430495|9650216|FG000|NOT COMPLETED|Overall Study||14
8612727|NCT00430495|9650217|FG001|NOT COMPLETED|Overall Study||7
8612728|NCT00430495|9650218|FG002|NOT COMPLETED|Overall Study||13
8612729|NCT00430495|9650219|FG003|NOT COMPLETED|Overall Study||4
8612730|NCT00430521|9650237|FG000|STARTED|Overall Study||63
8612731|NCT00430521|9650238|FG001|STARTED|Overall Study||66
8612732|NCT00430521|9650239|FG002|STARTED|Overall Study||64
8612733|NCT00430521|9650240|FG003|STARTED|Overall Study||63
8612734|NCT00430521|9650241|FG004|STARTED|Overall Study||64
8612735|NCT00430521|9650242|FG005|STARTED|Overall Study||64
8612736|NCT00430521|9650243|FG006|STARTED|Overall Study||65
8612737|NCT00430521|9650244|FG007|STARTED|Overall Study||63
8612738|NCT00430521|9650237|FG000|COMPLETED|Overall Study||52
8612739|NCT00430521|9650238|FG001|COMPLETED|Overall Study||57
8612740|NCT00430521|9650239|FG002|COMPLETED|Overall Study||61
8612741|NCT00430521|9650240|FG003|COMPLETED|Overall Study||55
8612742|NCT00430521|9650241|FG004|COMPLETED|Overall Study||59
8612743|NCT00430521|9650242|FG005|COMPLETED|Overall Study||59
8612744|NCT00430521|9650243|FG006|COMPLETED|Overall Study||55
8612745|NCT00430521|9650244|FG007|COMPLETED|Overall Study||51
8612746|NCT00430521|9650237|FG000|NOT COMPLETED|Overall Study||11
8612747|NCT00430521|9650238|FG001|NOT COMPLETED|Overall Study||9
8612748|NCT00430521|9650239|FG002|NOT COMPLETED|Overall Study||3
8612749|NCT00430521|9650240|FG003|NOT COMPLETED|Overall Study||8
8612750|NCT00430521|9650241|FG004|NOT COMPLETED|Overall Study||5
8612751|NCT00430521|9650242|FG005|NOT COMPLETED|Overall Study||5
8612752|NCT00430521|9650243|FG006|NOT COMPLETED|Overall Study||10
8612753|NCT00430521|9650244|FG007|NOT COMPLETED|Overall Study||12
8612754|NCT00430573|9650275|FG000|STARTED|Overall Study||10
8612755|NCT00430573|9650275|FG000|COMPLETED|Overall Study|Only 5 took study drug on at least one occasion and 8 completed the baseline ASI.|5
8612756|NCT00430573|9650275|FG000|NOT COMPLETED|Overall Study||5
8612757|NCT00430625|9650282|FG000|STARTED|Overall Study||13
8612758|NCT00430625|9650283|FG001|STARTED|Overall Study||12
8612759|NCT00430625|9650282|FG000|COMPLETED|Overall Study||13
8612760|NCT00430625|9650283|FG001|COMPLETED|Overall Study||12
8612761|NCT00430625|9650282|FG000|NOT COMPLETED|Overall Study||0
8612762|NCT00430625|9650283|FG001|NOT COMPLETED|Overall Study||0
8612763|NCT00430638|9650292|FG000|STARTED|Overall Study||138
8612764|NCT00430638|9650293|FG001|STARTED|Overall Study|2 participants were erroneously assigned to olmesartan 40 mg instead of 20 mg|140
8612765|NCT00430638|9650292|FG000|COMPLETED|Overall Study||60
8612766|NCT00430638|9650293|FG001|COMPLETED|Overall Study||92
8612767|NCT00430638|9650292|FG000|NOT COMPLETED|Overall Study||78
8612768|NCT00430638|9650293|FG001|NOT COMPLETED|Overall Study||48
8612769|NCT00430677|9650306|FG000|STARTED|Short-term Period|1 participant died before receiving the first dose of study medication|99
8612770|NCT00430677|9650307|FG001|STARTED|Short-term Period|1 participant took infliximab on day 1 and was discontinued before receiving study medication.|99
8612771|NCT00430677|9650308|FG002|STARTED|Short-term Period||100
8612772|NCT00430677|9650306|FG000|COMPLETED|Short-term Period|Completed the short-term period|76
8612773|NCT00430677|9650307|FG001|COMPLETED|Short-term Period|Completed the short-term period|74
8612774|NCT00430677|9650308|FG002|COMPLETED|Short-term Period|Completed the short-term period|78
8612775|NCT00430677|9650306|FG000|NOT COMPLETED|Short-term Period||23
8612776|NCT00430677|9650307|FG001|NOT COMPLETED|Short-term Period||25
8612777|NCT00430677|9650308|FG002|NOT COMPLETED|Short-term Period||22
8612778|NCT00430677|9650306|FG000|STARTED|Long-term Extension Period||70
8612779|NCT00430677|9650307|FG001|STARTED|Long-term Extension Period||67
8612780|NCT00430677|9650308|FG002|STARTED|Long-term Extension Period||74
8612781|NCT00430677|9650306|FG000|COMPLETED|Long-term Extension Period|Completed the long-term extension period|10
8612782|NCT00430677|9650307|FG001|COMPLETED|Long-term Extension Period|Completed the long-term extension period|9
8612783|NCT00430677|9650308|FG002|COMPLETED|Long-term Extension Period|Completed the long-term extension period|11
8612784|NCT00430677|9650306|FG000|NOT COMPLETED|Long-term Extension Period||60
8612785|NCT00430677|9650307|FG001|NOT COMPLETED|Long-term Extension Period||58
8612786|NCT00430677|9650308|FG002|NOT COMPLETED|Long-term Extension Period||63
8612787|NCT00430716|9650337|FG000|STARTED|Double Blind Phase||42
8612788|NCT00430716|9650338|FG001|STARTED|Double Blind Phase||43
8612789|NCT00430716|9650339|FG002|STARTED|Double Blind Phase||45
8612790|NCT00430716|9650337|FG000|Treated|Double Blind Phase||41
8612791|NCT00430716|9650338|FG001|Treated|Double Blind Phase||43
8612792|NCT00430716|9650339|FG002|Treated|Double Blind Phase||45
8612793|NCT00430716|9650337|FG000|COMPLETED|Double Blind Phase||36
8612794|NCT00430716|9650338|FG001|COMPLETED|Double Blind Phase||38
8612795|NCT00430716|9650339|FG002|COMPLETED|Double Blind Phase||39
8612796|NCT00430716|9650337|FG000|NOT COMPLETED|Double Blind Phase||6
8612797|NCT00430716|9650338|FG001|NOT COMPLETED|Double Blind Phase||5
8612798|NCT00430716|9650339|FG002|NOT COMPLETED|Double Blind Phase||6
8612799|NCT00430716|9650337|FG000|STARTED|Open Label Phase||36
8612800|NCT00430716|9650338|FG001|STARTED|Open Label Phase||38
8612801|NCT00430716|9650339|FG002|STARTED|Open Label Phase||39
8612802|NCT00430716|9650337|FG000|COMPLETED|Open Label Phase||27
8612803|NCT00430716|9650338|FG001|COMPLETED|Open Label Phase||31
8612804|NCT00430716|9650339|FG002|COMPLETED|Open Label Phase||32
8612805|NCT00430716|9650337|FG000|NOT COMPLETED|Open Label Phase||9
8612806|NCT00430716|9650338|FG001|NOT COMPLETED|Open Label Phase||7
8612807|NCT00430716|9650339|FG002|NOT COMPLETED|Open Label Phase||7
8612808|NCT00430755|9650347|FG000|STARTED|Overall Study||98
8612809|NCT00430755|9650347|FG000|COMPLETED|Overall Study||45
8612810|NCT00430755|9650347|FG000|NOT COMPLETED|Overall Study||53
8612811|NCT00430768|9650354|FG000|STARTED|Overall Study||3
8612812|NCT00430768|9650355|FG001|STARTED|Overall Study||3
8612813|NCT00430768|9650356|FG002|STARTED|Overall Study||3
8612814|NCT00430768|9650354|FG000|COMPLETED|Overall Study||3
8612815|NCT00430768|9650355|FG001|COMPLETED|Overall Study||3
8612816|NCT00430768|9650356|FG002|COMPLETED|Overall Study||3
8612817|NCT00430768|9650354|FG000|NOT COMPLETED|Overall Study||0
8612818|NCT00430768|9650355|FG001|NOT COMPLETED|Overall Study||0
8612819|NCT00430768|9650356|FG002|NOT COMPLETED|Overall Study||0
8612820|NCT00430781|9650373|FG000|STARTED|Interim Analysis; 11 February 2008||59
8612821|NCT00430781|9650374|FG001|STARTED|Interim Analysis; 11 February 2008||58
8612822|NCT00430781|9650375|FG002|STARTED|Interim Analysis; 11 February 2008||60
8612823|NCT00430781|9650373|FG000|Ongoing|Interim Analysis; 11 February 2008||23
8612824|NCT00430781|9650374|FG001|Ongoing|Interim Analysis; 11 February 2008||20
8612825|NCT00430781|9650375|FG002|Ongoing|Interim Analysis; 11 February 2008||25
8612826|NCT00430781|9650373|FG000|COMPLETED|Interim Analysis; 11 February 2008||0
8612827|NCT00430781|9650374|FG001|COMPLETED|Interim Analysis; 11 February 2008||0
8612828|NCT00430781|9650375|FG002|COMPLETED|Interim Analysis; 11 February 2008||0
8612829|NCT00430781|9650373|FG000|NOT COMPLETED|Interim Analysis; 11 February 2008||59
8612830|NCT00430781|9650374|FG001|NOT COMPLETED|Interim Analysis; 11 February 2008||58
8612831|NCT00430781|9650375|FG002|NOT COMPLETED|Interim Analysis; 11 February 2008||60
8612832|NCT00430781|9650373|FG000|STARTED|Final Analysis; 31 July 2008||0
8612833|NCT00430781|9650374|FG001|STARTED|Final Analysis; 31 July 2008||78
8612834|NCT00430781|9650375|FG002|STARTED|Final Analysis; 31 July 2008||74
8612835|NCT00430781|9650373|FG000|Ongoing|Final Analysis; 31 July 2008||0
8612836|NCT00430781|9650374|FG001|Ongoing|Final Analysis; 31 July 2008||29
8612837|NCT00430781|9650375|FG002|Ongoing|Final Analysis; 31 July 2008||32
8612838|NCT00430781|9650373|FG000|COMPLETED|Final Analysis; 31 July 2008||0
8612839|NCT00430781|9650374|FG001|COMPLETED|Final Analysis; 31 July 2008||39
8612840|NCT00430781|9650375|FG002|COMPLETED|Final Analysis; 31 July 2008||26
8715503|NCT00984126|9762399|FG000|STARTED|Overall Study||27
8715504|NCT00984126|9762400|FG001|STARTED|Overall Study||28
8715505|NCT00984126|9762401|FG002|STARTED|Overall Study||23
8715506|NCT00984126|9762402|FG003|STARTED|Overall Study||135
8715507|NCT00984126|9762399|FG000|COMPLETED|Overall Study||20
8715508|NCT00984126|9762400|FG001|COMPLETED|Overall Study||20
8612841|NCT00430781|9650373|FG000|NOT COMPLETED|Final Analysis; 31 July 2008||0
8612842|NCT00430781|9650374|FG001|NOT COMPLETED|Final Analysis; 31 July 2008||39
8612843|NCT00430781|9650375|FG002|NOT COMPLETED|Final Analysis; 31 July 2008||48
8612844|NCT00430781|9650373|FG000|STARTED|End-of-Study Analysis; 28 July 2011|Enrollment continued in this arm after data cut for Interim Analysis and before arm closed.|77
8612845|NCT00430781|9650374|FG001|STARTED|End-of-Study Analysis; 28 July 2011|1 participant randomized to lapatinib (final analysis table) actually received combination therapy.|77
8612846|NCT00430781|9650375|FG002|STARTED|End-of-Study Analysis; 28 July 2011||74
8612847|NCT00430781|9650373|FG000|COMPLETED|End-of-Study Analysis; 28 July 2011||53
8612848|NCT00430781|9650374|FG001|COMPLETED|End-of-Study Analysis; 28 July 2011||59
8715509|NCT00984126|9762401|FG002|COMPLETED|Overall Study||16
8715510|NCT00984126|9762402|FG003|COMPLETED|Overall Study||76
8612849|NCT00430781|9650375|FG002|COMPLETED|End-of-Study Analysis; 28 July 2011||54
8612850|NCT00430781|9650373|FG000|NOT COMPLETED|End-of-Study Analysis; 28 July 2011||24
8612851|NCT00430781|9650374|FG001|NOT COMPLETED|End-of-Study Analysis; 28 July 2011||18
8612852|NCT00430781|9650375|FG002|NOT COMPLETED|End-of-Study Analysis; 28 July 2011||20
8612853|NCT00430937|9650388|FG000|STARTED|Overall Study|Additional 5 participants were randomized; however, they were not exposed to study drug by mistake.|97
8612854|NCT00430937|9650389|FG001|STARTED|Overall Study||92
8612855|NCT00430937|9650388|FG000|COMPLETED|Overall Study||70
8612856|NCT00430937|9650389|FG001|COMPLETED|Overall Study||64
8612857|NCT00430937|9650388|FG000|NOT COMPLETED|Overall Study||27
8612858|NCT00430937|9650389|FG001|NOT COMPLETED|Overall Study||28
8612859|NCT00430989|9650397|FG000|STARTED|Overall Study||3543
8612860|NCT00430989|9650398|FG001|STARTED|Overall Study||3569
8612861|NCT00430989|9650397|FG000|COMPLETED|Overall Study||3483
8612862|NCT00430989|9650398|FG001|COMPLETED|Overall Study||3509
8612863|NCT00430989|9650397|FG000|NOT COMPLETED|Overall Study||60
8612864|NCT00430989|9650398|FG001|NOT COMPLETED|Overall Study||60
8612865|NCT00431041|9650408|FG000|STARTED|Overall Study|Data represents Intention To Treat(ITT) Population: All randomized subjects|68
8612866|NCT00431041|9650409|FG001|STARTED|Overall Study|Data represents ITT Population: All randomized subjects|64
8612867|NCT00431041|9650408|FG000|COMPLETED|Overall Study||52
8612868|NCT00431041|9650409|FG001|COMPLETED|Overall Study||40
8612869|NCT00431041|9650408|FG000|NOT COMPLETED|Overall Study||16
8612870|NCT00431041|9650409|FG001|NOT COMPLETED|Overall Study||24
8612871|NCT00431067|9650415|FG000|STARTED|Overall Study|52 patients screened, 41 treated|41
8612872|NCT00431067|9650415|FG000|COMPLETED|Overall Study|On treatment at analysis cut-off date (22-Sep-2009)|0
8612873|NCT00431067|9650415|FG000|NOT COMPLETED|Overall Study||41
8612874|NCT00431132|9650419|FG000|STARTED|Overall Study||336
8612875|NCT00431132|9650419|FG000|COMPLETED|Overall Study||292
8612876|NCT00431132|9650419|FG000|NOT COMPLETED|Overall Study||44
8612877|NCT00431184|9650425|FG000|STARTED|1st Intervention (Day 1)||10
8612878|NCT00431184|9650426|FG001|STARTED|1st Intervention (Day 1)||9
8612879|NCT00431184|9650425|FG000|COMPLETED|1st Intervention (Day 1)||10
8612880|NCT00431184|9650426|FG001|COMPLETED|1st Intervention (Day 1)||9
8612881|NCT00431184|9650425|FG000|NOT COMPLETED|1st Intervention (Day 1)||0
8612882|NCT00431184|9650426|FG001|NOT COMPLETED|1st Intervention (Day 1)||0
8612883|NCT00431184|9650425|FG000|STARTED|Second Intervention (Day 2)||10
8612884|NCT00431184|9650426|FG001|STARTED|Second Intervention (Day 2)||9
8612885|NCT00431184|9650425|FG000|COMPLETED|Second Intervention (Day 2)||10
8612886|NCT00431184|9650426|FG001|COMPLETED|Second Intervention (Day 2)||9
8612887|NCT00431184|9650425|FG000|NOT COMPLETED|Second Intervention (Day 2)||0
8612888|NCT00431184|9650426|FG001|NOT COMPLETED|Second Intervention (Day 2)||0
8612889|NCT00431444|9650436|FG000|STARTED|Overall Study||56
8612890|NCT00431444|9650437|FG001|STARTED|Overall Study|"Initially 110 randomized, 1 participant of Raloxifene group never took study drug."|53
8612891|NCT00431444|9650436|FG000|COMPLETED|Overall Study||51
8612892|NCT00431444|9650437|FG001|COMPLETED|Overall Study||46
8612893|NCT00431444|9650436|FG000|NOT COMPLETED|Overall Study||5
8612894|NCT00431444|9650437|FG001|NOT COMPLETED|Overall Study||7
8612895|NCT00431496|9650443|FG000|STARTED|Overall Study||71
8612896|NCT00431496|9650443|FG000|COMPLETED|Overall Study||60
8612897|NCT00431496|9650443|FG000|NOT COMPLETED|Overall Study||11
8612898|NCT00431626|9650449|FG000|STARTED|Overall Study||4
8612899|NCT00431626|9650450|FG001|STARTED|Overall Study||0
8612900|NCT00431626|9650449|FG000|COMPLETED|Overall Study||4
8612901|NCT00431626|9650450|FG001|COMPLETED|Overall Study||0
8612902|NCT00431626|9650449|FG000|NOT COMPLETED|Overall Study||0
8612903|NCT00431626|9650450|FG001|NOT COMPLETED|Overall Study||0
8612904|NCT00431834|9650456|FG000|STARTED|Overall Study||75
8612905|NCT00431834|9650456|FG000|COMPLETED|Overall Study||62
8612906|NCT00431834|9650456|FG000|NOT COMPLETED|Overall Study||13
8612907|NCT00431847|9650467|FG000|STARTED|Overall Study||132
8612908|NCT00431847|9650468|FG001|STARTED|Overall Study||45
8612909|NCT00431847|9650469|FG002|STARTED|Overall Study||24
8612910|NCT00431847|9650470|FG003|STARTED|Overall Study||184
8612911|NCT00431847|9650471|FG004|STARTED|Overall Study||1
8612912|NCT00431847|9650467|FG000|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|126
8612913|NCT00431847|9650468|FG001|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|42
8612914|NCT00431847|9650469|FG002|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|20
8612915|NCT00431847|9650470|FG003|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|170
8612916|NCT00431847|9650471|FG004|COMPLETED|Overall Study||0
8612917|NCT00431847|9650467|FG000|NOT COMPLETED|Overall Study||6
8612918|NCT00431847|9650468|FG001|NOT COMPLETED|Overall Study||3
8612919|NCT00431847|9650469|FG002|NOT COMPLETED|Overall Study||4
8612920|NCT00431847|9650470|FG003|NOT COMPLETED|Overall Study||14
8612921|NCT00431847|9650471|FG004|NOT COMPLETED|Overall Study||1
8612922|NCT00431951|9650485|FG000|STARTED|Overall Study||8
8612923|NCT00431951|9650486|FG001|STARTED|Overall Study||8
8612924|NCT00431951|9650487|FG002|STARTED|Overall Study||8
8612925|NCT00431951|9650488|FG003|STARTED|Overall Study||6
8612926|NCT00431951|9650485|FG000|COMPLETED|Overall Study||7
8612927|NCT00431951|9650486|FG001|COMPLETED|Overall Study||6
8612928|NCT00431951|9650487|FG002|COMPLETED|Overall Study||6
8612929|NCT00431951|9650488|FG003|COMPLETED|Overall Study||4
8612930|NCT00431951|9650485|FG000|NOT COMPLETED|Overall Study||1
8612931|NCT00431951|9650486|FG001|NOT COMPLETED|Overall Study||2
8612932|NCT00431951|9650487|FG002|NOT COMPLETED|Overall Study||2
8612933|NCT00431951|9650488|FG003|NOT COMPLETED|Overall Study||2
8612934|NCT00431964|9650504|FG000|STARTED|Overall Study||131
8612935|NCT00431964|9650505|FG001|STARTED|Overall Study||132
8612936|NCT00431964|9650504|FG000|Randomized/Received Drug|Overall Study||131
8612937|NCT00431964|9650505|FG001|Randomized/Received Drug|Overall Study||129
8612938|NCT00431964|9650504|FG000|Did Not Receive Drug|Overall Study||0
8612939|NCT00431964|9650505|FG001|Did Not Receive Drug|Overall Study||3
8612940|NCT00431964|9650504|FG000|Withdrew From Study|Overall Study||6
8612941|NCT00431964|9650505|FG001|Withdrew From Study|Overall Study||5
8612942|NCT00431964|9650504|FG000|COMPLETED|Overall Study||125
8612943|NCT00431964|9650505|FG001|COMPLETED|Overall Study||124
8612944|NCT00431964|9650504|FG000|NOT COMPLETED|Overall Study||6
8612945|NCT00431964|9650505|FG001|NOT COMPLETED|Overall Study||8
8612946|NCT00432042|9650514|FG000|STARTED|Overall Study|Number randomized.|479
8612947|NCT00432042|9650515|FG001|STARTED|Overall Study|Number randomized.|235
8612948|NCT00432042|9650516|FG002|STARTED|Overall Study|Number randomized.|241
8612949|NCT00432042|9650514|FG000|Vaccinated|Overall Study||477
8612950|NCT00432042|9650515|FG001|Vaccinated|Overall Study||235
8612951|NCT00432042|9650516|FG002|Vaccinated|Overall Study||240
8612952|NCT00432042|9650514|FG000|COMPLETED|Overall Study||472
8612953|NCT00432042|9650515|FG001|COMPLETED|Overall Study||234
8612954|NCT00432042|9650516|FG002|COMPLETED|Overall Study||239
8612955|NCT00432042|9650514|FG000|NOT COMPLETED|Overall Study||7
8612956|NCT00432042|9650515|FG001|NOT COMPLETED|Overall Study||1
8612957|NCT00432042|9650516|FG002|NOT COMPLETED|Overall Study||2
8612958|NCT00432159|9650529|FG000|STARTED|Overall Study||185
8612959|NCT00432159|9650530|FG001|STARTED|Overall Study||167
8612960|NCT00432159|9650531|FG002|STARTED|Overall Study||39
8612961|NCT00432159|9650532|FG003|STARTED|Overall Study||20
8612962|NCT00432159|9650533|FG004|STARTED|Overall Study||89
8612963|NCT00432159|9650529|FG000|COMPLETED|Overall Study|Actual (Complete efficacy)|163
8612964|NCT00432159|9650530|FG001|COMPLETED|Overall Study|Actual (Complete efficacy)|137
8612965|NCT00432159|9650531|FG002|COMPLETED|Overall Study|Actual (Complete efficacy)|35
8612966|NCT00432159|9650532|FG003|COMPLETED|Overall Study|Actual (Complete efficacy)|15
8612967|NCT00432159|9650533|FG004|COMPLETED|Overall Study|Actual (Complete efficacy)|79
8612968|NCT00432159|9650529|FG000|NOT COMPLETED|Overall Study||22
8612969|NCT00432159|9650530|FG001|NOT COMPLETED|Overall Study||30
8612970|NCT00432159|9650531|FG002|NOT COMPLETED|Overall Study||4
8612971|NCT00432159|9650532|FG003|NOT COMPLETED|Overall Study||5
8612972|NCT00432159|9650533|FG004|NOT COMPLETED|Overall Study||10
8612973|NCT00432172|9650549|FG000|STARTED|Overall Study||47
8612974|NCT00432172|9650550|FG001|STARTED|Overall Study||48
8612975|NCT00432172|9650551|FG002|STARTED|Overall Study||46
8612976|NCT00432172|9650552|FG003|STARTED|Overall Study||48
8612977|NCT00432172|9650549|FG000|COMPLETED|Overall Study||41
8612978|NCT00432172|9650550|FG001|COMPLETED|Overall Study||41
8612979|NCT00432172|9650551|FG002|COMPLETED|Overall Study||35
8612980|NCT00432172|9650552|FG003|COMPLETED|Overall Study||41
8612981|NCT00432172|9650549|FG000|NOT COMPLETED|Overall Study||6
8612982|NCT00432172|9650550|FG001|NOT COMPLETED|Overall Study||7
8612983|NCT00432172|9650551|FG002|NOT COMPLETED|Overall Study||11
8612984|NCT00432172|9650552|FG003|NOT COMPLETED|Overall Study||7
8612985|NCT00432237|9650568|FG000|STARTED|Overall Study|1 patient in the MK0974 50 mg group was treated but withdrew consent.|244
8612986|NCT00432237|9650569|FG001|STARTED|Overall Study||485
8612987|NCT00432237|9650570|FG002|STARTED|Overall Study|1 patient in the MK0974 300 mg group was treated but withdrew consent.|484
8612988|NCT00432237|9650571|FG003|STARTED|Overall Study||490
8612989|NCT00432237|9650568|FG000|Completed--With Data|Overall Study||176
8612990|NCT00432237|9650569|FG001|Completed--With Data|Overall Study||381
8612991|NCT00432237|9650570|FG002|Completed--With Data|Overall Study||370
8612992|NCT00432237|9650571|FG003|Completed--With Data|Overall Study||365
8612993|NCT00432237|9650568|FG000|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|1
8612994|NCT00432237|9650569|FG001|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|3
8612995|NCT00432237|9650570|FG002|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|5
8612996|NCT00432237|9650571|FG003|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|1
8612997|NCT00432237|9650568|FG000|COMPLETED|Overall Study||177
8612998|NCT00432237|9650569|FG001|COMPLETED|Overall Study||384
8612999|NCT00432237|9650570|FG002|COMPLETED|Overall Study||375
8613000|NCT00432237|9650571|FG003|COMPLETED|Overall Study||366
8613001|NCT00432237|9650568|FG000|NOT COMPLETED|Overall Study||67
8613002|NCT00432237|9650569|FG001|NOT COMPLETED|Overall Study||101
8613003|NCT00432237|9650570|FG002|NOT COMPLETED|Overall Study||109
8613004|NCT00432237|9650571|FG003|NOT COMPLETED|Overall Study||124
8613005|NCT00432276|9650583|FG000|STARTED|Overall Study||404
8613006|NCT00432276|9650584|FG001|STARTED|Overall Study||399
8613007|NCT00432276|9650583|FG000|Per Protocol Set|Overall Study|Patients who received at least 1 dose of study medication and who had no major protocol violations.|303
8613008|NCT00432276|9650584|FG001|Per Protocol Set|Overall Study||306
8613009|NCT00432276|9650583|FG000|COMPLETED|Overall Study||283
8613010|NCT00432276|9650584|FG001|COMPLETED|Overall Study||243
8613011|NCT00432276|9650583|FG000|NOT COMPLETED|Overall Study||121
8613012|NCT00432276|9650584|FG001|NOT COMPLETED|Overall Study||156
8613013|NCT00432341|9650592|FG000|STARTED|Overall Study||24
8613014|NCT00432341|9650593|FG001|STARTED|Overall Study||30
8613015|NCT00432341|9650592|FG000|COMPLETED|Overall Study||24
8613016|NCT00432341|9650593|FG001|COMPLETED|Overall Study||30
8613017|NCT00432341|9650592|FG000|NOT COMPLETED|Overall Study||0
8613018|NCT00432341|9650593|FG001|NOT COMPLETED|Overall Study||0
8613019|NCT00432380|9650602|FG000|STARTED|Overall Study||150
8613020|NCT00432380|9650603|FG001|STARTED|Overall Study||150
8613021|NCT00432380|9650604|FG002|STARTED|Overall Study||75
8613022|NCT00432380|9650602|FG000|COMPLETED|Overall Study||146
8613023|NCT00432380|9650603|FG001|COMPLETED|Overall Study||146
8613024|NCT00432380|9650604|FG002|COMPLETED|Overall Study||74
8613025|NCT00432380|9650602|FG000|NOT COMPLETED|Overall Study||4
8613026|NCT00432380|9650603|FG001|NOT COMPLETED|Overall Study||4
8613027|NCT00432380|9650604|FG002|NOT COMPLETED|Overall Study||1
8629217|NCT00528970|9668858|FG001|Received at Least 1 Dose of Study Drug|Overall Study||125
8629218|NCT00528970|9668859|FG002|Received at Least 1 Dose of Study Drug|Overall Study||124
8629219|NCT00528970|9668857|FG000|COMPLETED|Overall Study||110
8629220|NCT00528970|9668858|FG001|COMPLETED|Overall Study||110
8629221|NCT00528970|9668859|FG002|COMPLETED|Overall Study||105
8629222|NCT00528970|9668857|FG000|NOT COMPLETED|Overall Study||14
8629223|NCT00528970|9668858|FG001|NOT COMPLETED|Overall Study||15
8629224|NCT00528970|9668859|FG002|NOT COMPLETED|Overall Study||20
8629225|NCT00528996|9668872|FG000|STARTED|Overall Study||429
8629226|NCT00528996|9668873|FG001|STARTED|Overall Study||419
8629227|NCT00528996|9668874|FG002|STARTED|Overall Study||415
8629228|NCT00528996|9668875|FG003|STARTED|Overall Study||390
8629229|NCT00528996|9668876|FG004|STARTED|Overall Study||427
8629230|NCT00528996|9668872|FG000|COMPLETED|Overall Study||365
8629231|NCT00528996|9668873|FG001|COMPLETED|Overall Study||395
8629232|NCT00528996|9668874|FG002|COMPLETED|Overall Study||372
8629233|NCT00528996|9668875|FG003|COMPLETED|Overall Study||340
8629234|NCT00528996|9668876|FG004|COMPLETED|Overall Study||390
8629235|NCT00528996|9668872|FG000|NOT COMPLETED|Overall Study||64
8629236|NCT00528996|9668873|FG001|NOT COMPLETED|Overall Study||24
8629237|NCT00528996|9668874|FG002|NOT COMPLETED|Overall Study||43
8629238|NCT00528996|9668875|FG003|NOT COMPLETED|Overall Study||50
8629239|NCT00528996|9668876|FG004|NOT COMPLETED|Overall Study||37
8629240|NCT00529035|9668891|FG000|STARTED|Overall Study|29 enrolled|29
8629241|NCT00529035|9668891|FG000|COMPLETED|Overall Study|28 evaluable, 1 patient withdrew participation and was not evaluable|28
8629242|NCT00529035|9668891|FG000|NOT COMPLETED|Overall Study||1
8629243|NCT00529087|9668905|FG000|STARTED|Overall Study||150
8629244|NCT00529087|9668906|FG001|STARTED|Overall Study||148
8629245|NCT00529087|9668907|FG002|STARTED|Overall Study||162
8629246|NCT00529087|9668905|FG000|COMPLETED|Overall Study||122
8629247|NCT00529087|9668906|FG001|COMPLETED|Overall Study||120
8629248|NCT00529087|9668907|FG002|COMPLETED|Overall Study||146
8629249|NCT00529087|9668905|FG000|NOT COMPLETED|Overall Study||28
8629250|NCT00529087|9668906|FG001|NOT COMPLETED|Overall Study||28
8629251|NCT00529087|9668907|FG002|NOT COMPLETED|Overall Study||16
8629252|NCT00529100|9668928|FG000|STARTED|Overall Study||16
8629253|NCT00529100|9668929|FG001|STARTED|Overall Study||33
8629254|NCT00529100|9668928|FG000|Received at Least 1 Dose of Study Drug|Overall Study||16
8629255|NCT00529100|9668929|FG001|Received at Least 1 Dose of Study Drug|Overall Study||33
8629256|NCT00529100|9668928|FG000|COMPLETED|Overall Study||16
8629257|NCT00529100|9668929|FG001|COMPLETED|Overall Study||24
8629258|NCT00529100|9668928|FG000|NOT COMPLETED|Overall Study||0
8629259|NCT00529100|9668929|FG001|NOT COMPLETED|Overall Study||9
8629260|NCT00529126|9668943|FG000|STARTED|Overall Study||25
8629261|NCT00529126|9668944|FG001|STARTED|Overall Study||25
8629262|NCT00529126|9668945|FG002|STARTED|Overall Study||24
8629263|NCT00529126|9668946|FG003|STARTED|Overall Study||26
8629264|NCT00529126|9668943|FG000|COMPLETED|Overall Study||25
8629265|NCT00529126|9668944|FG001|COMPLETED|Overall Study||25
8629266|NCT00529126|9668945|FG002|COMPLETED|Overall Study||24
8629267|NCT00529126|9668946|FG003|COMPLETED|Overall Study||26
8629268|NCT00529126|9668943|FG000|NOT COMPLETED|Overall Study||0
8629269|NCT00529126|9668944|FG001|NOT COMPLETED|Overall Study||0
8629270|NCT00529126|9668945|FG002|NOT COMPLETED|Overall Study||0
8629271|NCT00529126|9668946|FG003|NOT COMPLETED|Overall Study||0
8629272|NCT00529191|9668958|FG000|STARTED|Overall Study||27
8629273|NCT00529191|9668959|FG001|STARTED|Overall Study||13
8629274|NCT00529191|9668958|FG000|COMPLETED|Overall Study||24
8629275|NCT00529191|9668959|FG001|COMPLETED|Overall Study||13
8629276|NCT00529191|9668958|FG000|NOT COMPLETED|Overall Study||3
8629277|NCT00529191|9668959|FG001|NOT COMPLETED|Overall Study||0
8629278|NCT00529204|9668974|FG000|STARTED|Overall Study||1
8629279|NCT00529204|9668974|FG000|COMPLETED|Overall Study||1
8629280|NCT00529204|9668974|FG000|NOT COMPLETED|Overall Study||0
8629281|NCT00529217|9668978|FG000|STARTED|Overall Study||12
8629282|NCT00529217|9668978|FG000|COMPLETED|Overall Study||8
8629283|NCT00529217|9668978|FG000|NOT COMPLETED|Overall Study||4
8629284|NCT00529243|9668983|FG000|STARTED|Overall Study||52
8629285|NCT00529243|9668983|FG000|COMPLETED|Overall Study||49
8629286|NCT00529243|9668983|FG000|NOT COMPLETED|Overall Study||3
8629287|NCT00529308|9668989|FG000|STARTED|Overall Study||9
8629288|NCT00529308|9668990|FG001|STARTED|Overall Study||11
8629289|NCT00529308|9668989|FG000|COMPLETED|Overall Study||8
8629290|NCT00529308|9668990|FG001|COMPLETED|Overall Study||10
8629291|NCT00529308|9668989|FG000|NOT COMPLETED|Overall Study||1
8629292|NCT00529308|9668990|FG001|NOT COMPLETED|Overall Study||1
8613028|NCT00432458|9650615|FG000|STARTED|Overall Study||35
8613029|NCT00432458|9650616|FG001|STARTED|Overall Study||33
8613030|NCT00432458|9650615|FG000|COMPLETED|Overall Study||30
8613031|NCT00432458|9650616|FG001|COMPLETED|Overall Study||32
8613032|NCT00432458|9650615|FG000|NOT COMPLETED|Overall Study||5
8613033|NCT00432458|9650616|FG001|NOT COMPLETED|Overall Study||1
8613034|NCT00432562|9650624|FG000|STARTED|Overall Study||16
8613035|NCT00432562|9650625|FG001|STARTED|Overall Study||15
8613036|NCT00432562|9650624|FG000|COMPLETED|Overall Study||13
8613037|NCT00432562|9650625|FG001|COMPLETED|Overall Study||15
8613038|NCT00432562|9650624|FG000|NOT COMPLETED|Overall Study||3
8613039|NCT00432562|9650625|FG001|NOT COMPLETED|Overall Study||0
8613040|NCT00432601|9650633|FG000|STARTED|Time 1 to Time 2||510
8613041|NCT00432601|9650634|FG001|STARTED|Time 1 to Time 2||512
8613042|NCT00432601|9650633|FG000|COMPLETED|Time 1 to Time 2|There is large drop-off as only one-third of subjects enrolled were eligible to continue the study|141
8613043|NCT00432601|9650634|FG001|COMPLETED|Time 1 to Time 2|There is large drop-off as only one-third of subjects enrolled were eligible to continue the study|144
8613044|NCT00432601|9650633|FG000|NOT COMPLETED|Time 1 to Time 2||369
8613045|NCT00432601|9650634|FG001|NOT COMPLETED|Time 1 to Time 2||368
8613046|NCT00432601|9650633|FG000|STARTED|Time 2 to Time 3||141
8613047|NCT00432601|9650634|FG001|STARTED|Time 2 to Time 3||144
8613048|NCT00432601|9650633|FG000|COMPLETED|Time 2 to Time 3||122
8613049|NCT00432601|9650634|FG001|COMPLETED|Time 2 to Time 3||122
8613050|NCT00432601|9650633|FG000|NOT COMPLETED|Time 2 to Time 3||19
8613051|NCT00432601|9650634|FG001|NOT COMPLETED|Time 2 to Time 3||22
8613052|NCT00432666|9650642|FG000|STARTED|Main Period||73
8613053|NCT00432666|9650643|FG001|STARTED|Main Period||75
8613054|NCT00432666|9650642|FG000|COMPLETED|Main Period||71
8613055|NCT00432666|9650643|FG001|COMPLETED|Main Period||74
8613056|NCT00432666|9650642|FG000|NOT COMPLETED|Main Period||2
8613057|NCT00432666|9650643|FG001|NOT COMPLETED|Main Period||1
8613058|NCT00432666|9650642|FG000|STARTED|Open-Label Extension Period||145
8613059|NCT00432666|9650643|FG001|STARTED|Open-Label Extension Period|In the Open-Label Extension Period no placebo treatment arm was given.|0
8613060|NCT00432666|9650642|FG000|COMPLETED|Open-Label Extension Period||120
8613061|NCT00432666|9650643|FG001|COMPLETED|Open-Label Extension Period||0
8613062|NCT00432666|9650642|FG000|NOT COMPLETED|Open-Label Extension Period||25
8613063|NCT00432666|9650643|FG001|NOT COMPLETED|Open-Label Extension Period||0
8613064|NCT00432679|9650651|FG000|STARTED|Overall Study||74
8613065|NCT00432679|9650652|FG001|STARTED|Overall Study||75
8613066|NCT00432679|9650651|FG000|COMPLETED|Overall Study||69
8613067|NCT00432679|9650652|FG001|COMPLETED|Overall Study||72
8613068|NCT00432679|9650651|FG000|NOT COMPLETED|Overall Study||5
8613069|NCT00432679|9650652|FG001|NOT COMPLETED|Overall Study||3
8613070|NCT00432744|9650660|FG000|STARTED|Months 0-6||12
8613071|NCT00432744|9650661|FG001|STARTED|Months 0-6||12
8613072|NCT00432744|9650660|FG000|COMPLETED|Months 0-6||7
8613073|NCT00432744|9650661|FG001|COMPLETED|Months 0-6|"One patient in period 1 other reason for loss became too disabled to complete the 6 month test."|8
8613074|NCT00432744|9650660|FG000|NOT COMPLETED|Months 0-6||5
8613075|NCT00432744|9650661|FG001|NOT COMPLETED|Months 0-6||4
8613076|NCT00432744|9650660|FG000|STARTED|Months 7 - 12||7
8613077|NCT00432744|9650661|FG001|STARTED|Months 7 - 12||8
8613078|NCT00432744|9650660|FG000|COMPLETED|Months 7 - 12||6
8613079|NCT00432744|9650661|FG001|COMPLETED|Months 7 - 12||7
8613080|NCT00432744|9650660|FG000|NOT COMPLETED|Months 7 - 12||1
8613081|NCT00432744|9650661|FG001|NOT COMPLETED|Months 7 - 12||1
8613082|NCT00432809|9650670|FG000|STARTED|1 Year Follow-up||50
8613083|NCT00432809|9650671|FG001|STARTED|1 Year Follow-up||50
8613084|NCT00432809|9650672|FG002|STARTED|1 Year Follow-up||50
8613085|NCT00432809|9650670|FG000|COMPLETED|1 Year Follow-up||41
8613086|NCT00432809|9650671|FG001|COMPLETED|1 Year Follow-up||50
8613087|NCT00432809|9650672|FG002|COMPLETED|1 Year Follow-up||49
8613088|NCT00432809|9650670|FG000|NOT COMPLETED|1 Year Follow-up||9
8613089|NCT00432809|9650671|FG001|NOT COMPLETED|1 Year Follow-up||0
8613090|NCT00432809|9650672|FG002|NOT COMPLETED|1 Year Follow-up||1
8613091|NCT00432809|9650670|FG000|STARTED|2 Year Sub-study||20
8613092|NCT00432809|9650671|FG001|STARTED|2 Year Sub-study||20
8613093|NCT00432809|9650672|FG002|STARTED|2 Year Sub-study||20
8613094|NCT00432809|9650670|FG000|COMPLETED|2 Year Sub-study||17
8613095|NCT00432809|9650671|FG001|COMPLETED|2 Year Sub-study||18
8613096|NCT00432809|9650672|FG002|COMPLETED|2 Year Sub-study||19
8613097|NCT00432809|9650670|FG000|NOT COMPLETED|2 Year Sub-study||3
8613098|NCT00432809|9650671|FG001|NOT COMPLETED|2 Year Sub-study||2
8613099|NCT00432809|9650672|FG002|NOT COMPLETED|2 Year Sub-study||1
8613100|NCT00432835|9650682|FG000|STARTED|Overall Study||28
8613101|NCT00432835|9650683|FG001|STARTED|Overall Study||30
8613102|NCT00432835|9650682|FG000|Completed 1st Intervention|Overall Study||22
8613103|NCT00432835|9650683|FG001|Completed 1st Intervention|Overall Study||23
8613104|NCT00432835|9650682|FG000|Completed 2nd Intervention|Overall Study||22
8613105|NCT00432835|9650683|FG001|Completed 2nd Intervention|Overall Study||23
8613106|NCT00432835|9650682|FG000|COMPLETED|Overall Study|These 22 patients completed the entire 8 day protocol.|22
8613107|NCT00432835|9650683|FG001|COMPLETED|Overall Study|These 23 patients completed the entire 8 day protocol.|23
8613108|NCT00432835|9650682|FG000|NOT COMPLETED|Overall Study||6
8613109|NCT00432835|9650683|FG001|NOT COMPLETED|Overall Study||7
8613110|NCT00432965|9650691|FG000|STARTED|Overall Study||169
8613111|NCT00432965|9650692|FG001|STARTED|Overall Study||166
8613112|NCT00432965|9650691|FG000|COMPLETED|Overall Study||75
8613113|NCT00432965|9650692|FG001|COMPLETED|Overall Study||80
8613114|NCT00432965|9650691|FG000|NOT COMPLETED|Overall Study||94
8613115|NCT00432965|9650692|FG001|NOT COMPLETED|Overall Study||86
8613116|NCT00432991|9650700|FG000|STARTED|Overall Study||22
8613117|NCT00432991|9650701|FG001|STARTED|Overall Study||31
8613118|NCT00432991|9650700|FG000|COMPLETED|Overall Study||15
8613119|NCT00432991|9650701|FG001|COMPLETED|Overall Study||19
8613120|NCT00432991|9650700|FG000|NOT COMPLETED|Overall Study||7
8613121|NCT00432991|9650701|FG001|NOT COMPLETED|Overall Study||12
8613122|NCT00433004|9650709|FG000|STARTED|Overall Study||27
8613123|NCT00433004|9650710|FG001|STARTED|Overall Study||23
8613124|NCT00433004|9650709|FG000|COMPLETED|Overall Study||22
8613125|NCT00433004|9650710|FG001|COMPLETED|Overall Study||16
8613126|NCT00433004|9650709|FG000|NOT COMPLETED|Overall Study||5
8613127|NCT00433004|9650710|FG001|NOT COMPLETED|Overall Study||7
8613128|NCT00433017|9650718|FG000|STARTED|Overall Study||122
8613129|NCT00433017|9650719|FG001|STARTED|Overall Study||133
8613130|NCT00433017|9650718|FG000|Completed 12 Month Phase|Overall Study||114
8613131|NCT00433017|9650719|FG001|Completed 12 Month Phase|Overall Study||126
8613132|NCT00433017|9650718|FG000|COMPLETED|Overall Study||26
8613133|NCT00433017|9650719|FG001|COMPLETED|Overall Study||32
8613134|NCT00433017|9650718|FG000|NOT COMPLETED|Overall Study||96
8613135|NCT00433017|9650719|FG001|NOT COMPLETED|Overall Study||101
8613136|NCT00433147|9650729|FG000|STARTED|Overall Study||7
8613137|NCT00433147|9650730|FG001|STARTED|Overall Study||7
8613138|NCT00433147|9650731|FG002|STARTED|Overall Study||9
8613139|NCT00433147|9650732|FG003|STARTED|Overall Study||7
8613140|NCT00433147|9650729|FG000|Safety Population|Overall Study||7
8613141|NCT00433147|9650730|FG001|Safety Population|Overall Study||7
8613142|NCT00433147|9650731|FG002|Safety Population|Overall Study||9
8613143|NCT00433147|9650732|FG003|Safety Population|Overall Study||7
8613144|NCT00433147|9650729|FG000|PD Population|Overall Study||7
8613145|NCT00433147|9650730|FG001|PD Population|Overall Study||6
8613146|NCT00433147|9650731|FG002|PD Population|Overall Study||9
8613147|NCT00433147|9650732|FG003|PD Population|Overall Study||7
8613148|NCT00433147|9650729|FG000|Received at Least One Dose of Study Drug|Overall Study||7
8613149|NCT00433147|9650730|FG001|Received at Least One Dose of Study Drug|Overall Study||7
8613150|NCT00433147|9650731|FG002|Received at Least One Dose of Study Drug|Overall Study||9
8613151|NCT00433147|9650732|FG003|Received at Least One Dose of Study Drug|Overall Study||7
8613152|NCT00433147|9650729|FG000|COMPLETED|Overall Study||7
8613153|NCT00433147|9650730|FG001|COMPLETED|Overall Study||6
8613154|NCT00433147|9650731|FG002|COMPLETED|Overall Study||9
8613155|NCT00433147|9650732|FG003|COMPLETED|Overall Study||7
8613156|NCT00433147|9650729|FG000|NOT COMPLETED|Overall Study||0
8613157|NCT00433147|9650730|FG001|NOT COMPLETED|Overall Study||1
8613158|NCT00433147|9650731|FG002|NOT COMPLETED|Overall Study||0
8613159|NCT00433147|9650732|FG003|NOT COMPLETED|Overall Study||0
8613160|NCT00433160|9650744|FG000|STARTED|52-Week Double-Blind (DB) Period||137
8613161|NCT00433160|9650745|FG001|STARTED|52-Week Double-Blind (DB) Period||70
8613162|NCT00433160|9650744|FG000|Received Treatment|52-Week Double-Blind (DB) Period||136
8613163|NCT00433160|9650745|FG001|Received Treatment|52-Week Double-Blind (DB) Period||68
8613164|NCT00433160|9650744|FG000|COMPLETED|52-Week Double-Blind (DB) Period||120
8613165|NCT00433160|9650745|FG001|COMPLETED|52-Week Double-Blind (DB) Period||60
8613166|NCT00433160|9650744|FG000|NOT COMPLETED|52-Week Double-Blind (DB) Period||17
8613167|NCT00433160|9650745|FG001|NOT COMPLETED|52-Week Double-Blind (DB) Period||10
8613168|NCT00433160|9650744|FG000|STARTED|76 Weeks, 24-Week Open Label (OL) Period|One participant did not continue to first OL period due to adverse event after completing DB period.|119
8613169|NCT00433160|9650745|FG001|STARTED|76 Weeks, 24-Week Open Label (OL) Period|One participant did not continue to first OL period due to adverse event after completing DB period.|59
8613170|NCT00433160|9650744|FG000|Received Treatment|76 Weeks, 24-Week Open Label (OL) Period||119
8613171|NCT00433160|9650745|FG001|Received Treatment|76 Weeks, 24-Week Open Label (OL) Period||59
8613172|NCT00433160|9650744|FG000|COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||113
8613173|NCT00433160|9650745|FG001|COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||55
8613174|NCT00433160|9650744|FG000|NOT COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||6
8613175|NCT00433160|9650745|FG001|NOT COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||4
8613176|NCT00433160|9650744|FG000|STARTED|104 Weeks, 28-Week OL Period|Eleven participants withdrew at end of first OL period and did not continue on to second OL period.|102
8613177|NCT00433160|9650745|FG001|STARTED|104 Weeks, 28-Week OL Period|Five participants withdrew at end of first OL period and did not continue on to second OL period.|50
8613178|NCT00433160|9650744|FG000|Received Treatment|104 Weeks, 28-Week OL Period||102
8613179|NCT00433160|9650745|FG001|Received Treatment|104 Weeks, 28-Week OL Period||50
8613180|NCT00433160|9650744|FG000|COMPLETED|104 Weeks, 28-Week OL Period||92
8613181|NCT00433160|9650745|FG001|COMPLETED|104 Weeks, 28-Week OL Period||47
8613182|NCT00433160|9650744|FG000|NOT COMPLETED|104 Weeks, 28-Week OL Period||10
8613183|NCT00433160|9650745|FG001|NOT COMPLETED|104 Weeks, 28-Week OL Period||3
8613184|NCT00433199|9650757|FG000|STARTED|Double-Blind Period||40
8613185|NCT00433199|9650758|FG001|STARTED|Double-Blind Period||234
8613186|NCT00433199|9650757|FG000|COMPLETED|Double-Blind Period||28
8613187|NCT00433199|9650758|FG001|COMPLETED|Double-Blind Period||168
8613188|NCT00433199|9650757|FG000|NOT COMPLETED|Double-Blind Period||12
8613189|NCT00433199|9650758|FG001|NOT COMPLETED|Double-Blind Period||66
8613190|NCT00433199|9650757|FG000|STARTED|Open-Label Period||0
8613191|NCT00433199|9650758|FG001|STARTED|Open-Label Period||219
8613192|NCT00433199|9650757|FG000|COMPLETED|Open-Label Period||0
8613193|NCT00433199|9650758|FG001|COMPLETED|Open-Label Period||185
8613194|NCT00433199|9650757|FG000|NOT COMPLETED|Open-Label Period||0
8613195|NCT00433199|9650758|FG001|NOT COMPLETED|Open-Label Period||34
8613196|NCT00433290|9650771|FG000|STARTED|Overall Study||128
8613197|NCT00433290|9650772|FG001|STARTED|Overall Study||128
8613198|NCT00433290|9650771|FG000|COMPLETED|Overall Study||93
8613199|NCT00433290|9650772|FG001|COMPLETED|Overall Study||111
8613200|NCT00433290|9650771|FG000|NOT COMPLETED|Overall Study||35
8613201|NCT00433290|9650772|FG001|NOT COMPLETED|Overall Study||17
8613202|NCT00433329|9650778|FG000|STARTED|Overall Study||100
8613203|NCT00433329|9650778|FG000|COMPLETED|Overall Study||79
8613204|NCT00433329|9650778|FG000|NOT COMPLETED|Overall Study||21
8613205|NCT00433381|9650784|FG000|STARTED|Overall Study||63
8613206|NCT00433381|9650785|FG001|STARTED|Overall Study||60
8613207|NCT00433381|9650784|FG000|COMPLETED|Overall Study|Subjects contributing data to [the primary] analysis are considered to have completed the study.|60
8613208|NCT00433381|9650785|FG001|COMPLETED|Overall Study||57
8613209|NCT00433381|9650784|FG000|NOT COMPLETED|Overall Study||3
8613210|NCT00433381|9650785|FG001|NOT COMPLETED|Overall Study||3
8613211|NCT00433446|9650799|FG000|STARTED|Overall Study||62
8613212|NCT00433446|9650799|FG000|Eligible|Overall Study||53
8613213|NCT00433446|9650799|FG000|Eligible and Began Protocol Therapy|Overall Study||53
8613214|NCT00433446|9650799|FG000|COMPLETED|Overall Study||1
8613215|NCT00433446|9650799|FG000|NOT COMPLETED|Overall Study||61
8613216|NCT00433537|9650803|FG000|STARTED|Step 1 - VcR-CVAD Induction||45
8613217|NCT00433537|9650804|FG001|STARTED|Step 1 - VcR-CVAD Induction||22
8613218|NCT00433537|9650805|FG002|STARTED|Step 1 - VcR-CVAD Induction||10
8613219|NCT00433537|9650803|FG000|Eligible and Treated|Step 1 - VcR-CVAD Induction||44
8613220|NCT00433537|9650804|FG001|Eligible and Treated|Step 1 - VcR-CVAD Induction||22
8613221|NCT00433537|9650805|FG002|Eligible and Treated|Step 1 - VcR-CVAD Induction||9
8613222|NCT00433537|9650803|FG000|COMPLETED|Step 1 - VcR-CVAD Induction||44
8613223|NCT00433537|9650804|FG001|COMPLETED|Step 1 - VcR-CVAD Induction||22
8613224|NCT00433537|9650805|FG002|COMPLETED|Step 1 - VcR-CVAD Induction||1
8613225|NCT00433537|9650803|FG000|NOT COMPLETED|Step 1 - VcR-CVAD Induction||1
8613226|NCT00433537|9650804|FG001|NOT COMPLETED|Step 1 - VcR-CVAD Induction||0
8613227|NCT00433537|9650805|FG002|NOT COMPLETED|Step 1 - VcR-CVAD Induction||9
8613228|NCT00433537|9650803|FG000|STARTED|Step 2 - Maintenance Rituximab or ASCT|This included all treated patients regardless of eligibility.|45
8613229|NCT00433537|9650804|FG001|STARTED|Step 2 - Maintenance Rituximab or ASCT||22
8613230|NCT00433537|9650805|FG002|STARTED|Step 2 - Maintenance Rituximab or ASCT|One patient completed VcR-CVAD and then withdrew from the study.|0
8613231|NCT00433537|9650803|FG000|Eligible and Treated|Step 2 - Maintenance Rituximab or ASCT||44
8613232|NCT00433537|9650804|FG001|Eligible and Treated|Step 2 - Maintenance Rituximab or ASCT||22
8613233|NCT00433537|9650805|FG002|Eligible and Treated|Step 2 - Maintenance Rituximab or ASCT||0
8613234|NCT00433537|9650803|FG000|COMPLETED|Step 2 - Maintenance Rituximab or ASCT||29
8613235|NCT00433537|9650804|FG001|COMPLETED|Step 2 - Maintenance Rituximab or ASCT||22
8613236|NCT00433537|9650805|FG002|COMPLETED|Step 2 - Maintenance Rituximab or ASCT||0
8613237|NCT00433537|9650803|FG000|NOT COMPLETED|Step 2 - Maintenance Rituximab or ASCT||16
8613238|NCT00433537|9650804|FG001|NOT COMPLETED|Step 2 - Maintenance Rituximab or ASCT||0
8613239|NCT00433537|9650805|FG002|NOT COMPLETED|Step 2 - Maintenance Rituximab or ASCT||0
8613240|NCT00433550|9650815|FG000|STARTED|Overall Study||17
8613241|NCT00433550|9650816|FG001|STARTED|Overall Study||10
8613242|NCT00433550|9650817|FG002|STARTED|Overall Study||6
8613243|NCT00433550|9650815|FG000|COMPLETED|Overall Study||17
8613244|NCT00433550|9650816|FG001|COMPLETED|Overall Study||10
8613245|NCT00433550|9650817|FG002|COMPLETED|Overall Study||6
8613246|NCT00433550|9650815|FG000|NOT COMPLETED|Overall Study||0
8613247|NCT00433550|9650816|FG001|NOT COMPLETED|Overall Study||0
8613248|NCT00433550|9650817|FG002|NOT COMPLETED|Overall Study||0
8613249|NCT00433654|9650827|FG000|STARTED|Overall Study||258
8613250|NCT00433654|9650828|FG001|STARTED|Overall Study||206
8613251|NCT00433654|9650827|FG000|COMPLETED|Overall Study|Subjects completing the 4-month follow-up.|243
8613252|NCT00433654|9650828|FG001|COMPLETED|Overall Study|Subjects completing the 4-month follow-up.|201
8613253|NCT00433654|9650827|FG000|NOT COMPLETED|Overall Study||15
8613254|NCT00433654|9650828|FG001|NOT COMPLETED|Overall Study||5
8613255|NCT00433745|9650840|FG000|STARTED|Overall Study||4
8613256|NCT00433745|9650840|FG000|COMPLETED|Overall Study||4
8613257|NCT00433745|9650840|FG000|NOT COMPLETED|Overall Study||0
8613258|NCT00433771|9650845|FG000|STARTED|Overall Study|74 enrolled patients(signed an Informed Consent Form)were screened.58 were eligible(intent to treat)|74
8613259|NCT00433771|9650845|FG000|COMPLETED|Overall Study|55 out of 58 patients were evaluable(had a stent placed and had at least 1 week of follow up)|55
8613260|NCT00433771|9650845|FG000|NOT COMPLETED|Overall Study||19
8613261|NCT00433836|9650851|FG000|STARTED|Overall Study||151
8613262|NCT00433836|9650852|FG001|STARTED|Overall Study||149
8613263|NCT00433836|9650851|FG000|COMPLETED|Overall Study||138
8613264|NCT00433836|9650852|FG001|COMPLETED|Overall Study||143
8613265|NCT00433836|9650851|FG000|NOT COMPLETED|Overall Study||13
8613266|NCT00433836|9650852|FG001|NOT COMPLETED|Overall Study||6
8613267|NCT00433914|9650860|FG000|STARTED|Overall Study||30
8613268|NCT00433914|9650861|FG001|STARTED|Overall Study||30
8613269|NCT00433914|9650860|FG000|COMPLETED|Overall Study||30
8613270|NCT00433914|9650861|FG001|COMPLETED|Overall Study||27
8613271|NCT00433914|9650860|FG000|NOT COMPLETED|Overall Study||0
8613272|NCT00433914|9650861|FG001|NOT COMPLETED|Overall Study||3
8613273|NCT00433966|9650869|FG000|STARTED|Pharmacology Intervention/Randomization||1800
8613274|NCT00433966|9650870|FG001|STARTED|Pharmacology Intervention/Randomization||1802
8613275|NCT00433966|9650871|FG002|STARTED|Pharmacology Intervention/Randomization||0
8613276|NCT00433966|9650872|FG003|STARTED|Pharmacology Intervention/Randomization||0
8613277|NCT00433966|9650869|FG000|30-Day Follow-up|Pharmacology Intervention/Randomization||1787
8613278|NCT00433966|9650870|FG001|30-Day Follow-up|Pharmacology Intervention/Randomization||1791
8613279|NCT00433966|9650871|FG002|30-Day Follow-up|Pharmacology Intervention/Randomization||0
8613280|NCT00433966|9650872|FG003|30-Day Follow-up|Pharmacology Intervention/Randomization||0
8613281|NCT00433966|9650869|FG000|1-Year Follow-up|Pharmacology Intervention/Randomization||1696
8613282|NCT00433966|9650870|FG001|1-Year Follow-up|Pharmacology Intervention/Randomization||1702
8613283|NCT00433966|9650871|FG002|1-Year Follow-up|Pharmacology Intervention/Randomization||0
8613284|NCT00433966|9650872|FG003|1-Year Follow-up|Pharmacology Intervention/Randomization||0
8613285|NCT00433966|9650869|FG000|3-Year Follow-up|Pharmacology Intervention/Randomization||1634
8613286|NCT00433966|9650870|FG001|3-Year Follow-up|Pharmacology Intervention/Randomization||1628
8613287|NCT00433966|9650871|FG002|3-Year Follow-up|Pharmacology Intervention/Randomization||0
8613288|NCT00433966|9650872|FG003|3-Year Follow-up|Pharmacology Intervention/Randomization||0
8613289|NCT00433966|9650869|FG000|COMPLETED|Pharmacology Intervention/Randomization||1634
8613290|NCT00433966|9650870|FG001|COMPLETED|Pharmacology Intervention/Randomization||1628
8613291|NCT00433966|9650871|FG002|COMPLETED|Pharmacology Intervention/Randomization||0
8613292|NCT00433966|9650872|FG003|COMPLETED|Pharmacology Intervention/Randomization||0
8613293|NCT00433966|9650869|FG000|NOT COMPLETED|Pharmacology Intervention/Randomization||166
8613294|NCT00433966|9650870|FG001|NOT COMPLETED|Pharmacology Intervention/Randomization||174
8613295|NCT00433966|9650871|FG002|NOT COMPLETED|Pharmacology Intervention/Randomization||0
8613296|NCT00433966|9650872|FG003|NOT COMPLETED|Pharmacology Intervention/Randomization||0
8613297|NCT00433966|9650869|FG000|STARTED|Stent Intervention/Randomization||0
8613298|NCT00433966|9650870|FG001|STARTED|Stent Intervention/Randomization||0
8613299|NCT00433966|9650871|FG002|STARTED|Stent Intervention/Randomization||2257
8613300|NCT00433966|9650872|FG003|STARTED|Stent Intervention/Randomization||749
8613301|NCT00433966|9650869|FG000|1-Year Follow-up|Stent Intervention/Randomization||0
8613302|NCT00433966|9650870|FG001|1-Year Follow-up|Stent Intervention/Randomization||0
8613303|NCT00433966|9650871|FG002|1-Year Follow-up|Stent Intervention/Randomization||2186
8613304|NCT00433966|9650872|FG003|1-Year Follow-up|Stent Intervention/Randomization||715
8715511|NCT00984126|9762399|FG000|NOT COMPLETED|Overall Study||7
8715512|NCT00984126|9762400|FG001|NOT COMPLETED|Overall Study||8
8715513|NCT00984126|9762401|FG002|NOT COMPLETED|Overall Study||7
8715514|NCT00984126|9762402|FG003|NOT COMPLETED|Overall Study||59
8715515|NCT00984139|9762421|FG000|STARTED|Overall Study||306
8715516|NCT00984139|9762421|FG000|COMPLETED|Overall Study||306
8613305|NCT00433966|9650869|FG000|3-Year Follow-up|Stent Intervention/Randomization||0
8613306|NCT00433966|9650870|FG001|3-Year Follow-up|Stent Intervention/Randomization||0
8613307|NCT00433966|9650871|FG002|3-Year Follow-up|Stent Intervention/Randomization||2103
8613308|NCT00433966|9650872|FG003|3-Year Follow-up|Stent Intervention/Randomization||687
8613309|NCT00433966|9650869|FG000|COMPLETED|Stent Intervention/Randomization||0
8613310|NCT00433966|9650870|FG001|COMPLETED|Stent Intervention/Randomization||0
8613311|NCT00433966|9650871|FG002|COMPLETED|Stent Intervention/Randomization||2103
8613312|NCT00433966|9650872|FG003|COMPLETED|Stent Intervention/Randomization||687
8613313|NCT00433966|9650869|FG000|NOT COMPLETED|Stent Intervention/Randomization||0
8613314|NCT00433966|9650870|FG001|NOT COMPLETED|Stent Intervention/Randomization||0
8613315|NCT00433966|9650871|FG002|NOT COMPLETED|Stent Intervention/Randomization||154
8613316|NCT00433966|9650872|FG003|NOT COMPLETED|Stent Intervention/Randomization||62
8613317|NCT00433992|9650884|FG000|STARTED|Overall Study||28
8613318|NCT00433992|9650885|FG001|STARTED|Overall Study||28
8613319|NCT00433992|9650884|FG000|COMPLETED|Overall Study||19
8613320|NCT00433992|9650885|FG001|COMPLETED|Overall Study||20
8613321|NCT00433992|9650884|FG000|NOT COMPLETED|Overall Study||9
8613322|NCT00433992|9650885|FG001|NOT COMPLETED|Overall Study||8
8613323|NCT00434018|9650897|FG000|STARTED|Overall Study||69
8613324|NCT00434018|9650898|FG001|STARTED|Overall Study||69
8613325|NCT00434018|9650897|FG000|COMPLETED|Overall Study||52
8613326|NCT00434018|9650898|FG001|COMPLETED|Overall Study||57
8613327|NCT00434018|9650897|FG000|NOT COMPLETED|Overall Study||17
8613328|NCT00434018|9650898|FG001|NOT COMPLETED|Overall Study||12
8613329|NCT00434057|9650905|FG000|STARTED|Overall Study||1383
8613330|NCT00434057|9650905|FG000|COMPLETED|Overall Study|One patient withdrew from the study after signing the Informed Consent Form|1382
8613331|NCT00434057|9650905|FG000|NOT COMPLETED|Overall Study||1
8613332|NCT00434109|9650909|FG000|STARTED|Overall Study||39
8613333|NCT00434109|9650909|FG000|COMPLETED|Overall Study|Patients completing the maximum eight cycles of sunitinib.|21
8613334|NCT00434109|9650909|FG000|NOT COMPLETED|Overall Study||18
8613335|NCT00434122|9650915|FG000|STARTED|Overall Study|Randomised|42
8613336|NCT00434122|9650916|FG001|STARTED|Overall Study|Randomised|43
8613337|NCT00434122|9650915|FG000|Intention-to-treat (ITT) Population|Overall Study|All randomised and exposed subjects not withdrawn before Stimulation Day 1.|39
8613338|NCT00434122|9650916|FG001|Intention-to-treat (ITT) Population|Overall Study|All randomised and exposed subjects not withdrawn before Stimulation Day 1.|39
8613339|NCT00434122|9650915|FG000|COMPLETED|Overall Study||36
8613340|NCT00434122|9650916|FG001|COMPLETED|Overall Study||36
8613341|NCT00434122|9650915|FG000|NOT COMPLETED|Overall Study||6
8715517|NCT00984139|9762421|FG000|NOT COMPLETED|Overall Study||0
8613342|NCT00434122|9650916|FG001|NOT COMPLETED|Overall Study||7
8613343|NCT00434148|9650926|FG000|STARTED|Overall Study|"Started indicates Full Analysis Set. Patients randomized and treated."|82
8613344|NCT00434148|9650927|FG001|STARTED|Overall Study||80
8613345|NCT00434148|9650926|FG000|Completed Month 12|Overall Study||39
8613346|NCT00434148|9650927|FG001|Completed Month 12|Overall Study||39
8613347|NCT00434148|9650926|FG000|Completed m. 12; Did Not Enter Extension|Overall Study||13
8613348|NCT00434148|9650927|FG001|Completed m. 12; Did Not Enter Extension|Overall Study||7
8613349|NCT00434148|9650926|FG000|Completed Month 12; Entered Extension|Overall Study||26
8613350|NCT00434148|9650927|FG001|Completed Month 12; Entered Extension|Overall Study||32
8613351|NCT00434148|9650926|FG000|COMPLETED|Overall Study||13
8613352|NCT00434148|9650927|FG001|COMPLETED|Overall Study||7
8613353|NCT00434148|9650926|FG000|NOT COMPLETED|Overall Study||69
8613354|NCT00434148|9650927|FG001|NOT COMPLETED|Overall Study||73
8613355|NCT00434161|9650936|FG000|STARTED|Overall Study||109
8613356|NCT00434161|9650937|FG001|STARTED|Overall Study||57
8613357|NCT00434161|9650938|FG002|STARTED|Overall Study||115
8613358|NCT00434161|9650936|FG000|COMPLETED|Overall Study||99
8613359|NCT00434161|9650937|FG001|COMPLETED|Overall Study||54
8613360|NCT00434161|9650938|FG002|COMPLETED|Overall Study||104
8613361|NCT00434161|9650936|FG000|NOT COMPLETED|Overall Study||10
8613362|NCT00434161|9650937|FG001|NOT COMPLETED|Overall Study||3
8613363|NCT00434161|9650938|FG002|NOT COMPLETED|Overall Study||11
8613364|NCT00434213|9650953|FG000|STARTED|Overall Study||309
8613365|NCT00434213|9650953|FG000|COMPLETED|Overall Study||260
8613366|NCT00434213|9650953|FG000|NOT COMPLETED|Overall Study||49
8613367|NCT00434252|9650959|FG000|STARTED|Overall Study||71
8613368|NCT00434252|9650960|FG001|STARTED|Overall Study||143
8613369|NCT00434252|9650959|FG000|Treated|Overall Study|One patient died and one patient withdrew prior to receiving study treatment|69
8613370|NCT00434252|9650960|FG001|Treated|Overall Study||143
8613371|NCT00434252|9650959|FG000|COMPLETED|Overall Study|Continuing study drug treatment at the time of the data cutoff.|7
8613372|NCT00434252|9650960|FG001|COMPLETED|Overall Study|Continuing study drug treatment at the time of the data cutoff.|12
8613373|NCT00434252|9650959|FG000|NOT COMPLETED|Overall Study||64
8613374|NCT00434252|9650960|FG001|NOT COMPLETED|Overall Study||131
8613375|NCT00434278|9650968|FG000|STARTED|Overall Study||14
8613376|NCT00434278|9650969|FG001|STARTED|Overall Study||13
8613377|NCT00434278|9650968|FG000|COMPLETED|Overall Study||12
8613378|NCT00434278|9650969|FG001|COMPLETED|Overall Study||13
8613379|NCT00434278|9650968|FG000|NOT COMPLETED|Overall Study||2
8613380|NCT00434278|9650969|FG001|NOT COMPLETED|Overall Study||0
8613381|NCT00434304|9650975|FG000|STARTED|Overall Study||62
8613382|NCT00434304|9650975|FG000|COMPLETED|Overall Study||42
8613383|NCT00434304|9650975|FG000|NOT COMPLETED|Overall Study||20
8613384|NCT00434330|9650986|FG000|STARTED|Overall Study||15
8613385|NCT00434330|9650987|FG001|STARTED|Overall Study||15
8613386|NCT00434330|9650988|FG002|STARTED|Overall Study||16
8613387|NCT00434330|9650989|FG003|STARTED|Overall Study||15
8613388|NCT00434330|9650990|FG004|STARTED|Overall Study||15
8613389|NCT00434330|9650991|FG005|STARTED|Overall Study||15
8613390|NCT00434330|9650986|FG000|COMPLETED|Overall Study||14
8613391|NCT00434330|9650987|FG001|COMPLETED|Overall Study||15
8613392|NCT00434330|9650988|FG002|COMPLETED|Overall Study||13
8613393|NCT00434330|9650989|FG003|COMPLETED|Overall Study||13
8613394|NCT00434330|9650990|FG004|COMPLETED|Overall Study||14
8613395|NCT00434330|9650991|FG005|COMPLETED|Overall Study||14
8613396|NCT00434330|9650986|FG000|NOT COMPLETED|Overall Study||1
8613397|NCT00434330|9650987|FG001|NOT COMPLETED|Overall Study||0
8613398|NCT00434330|9650988|FG002|NOT COMPLETED|Overall Study||3
8613399|NCT00434330|9650989|FG003|NOT COMPLETED|Overall Study||2
8613400|NCT00434330|9650990|FG004|NOT COMPLETED|Overall Study||1
8613401|NCT00434330|9650991|FG005|NOT COMPLETED|Overall Study||1
8613402|NCT00434356|9651007|FG000|STARTED|Overall Study||23
8613403|NCT00434356|9651008|FG001|STARTED|Overall Study||23
8613404|NCT00434356|9651007|FG000|COMPLETED|Overall Study||0
8613405|NCT00434356|9651008|FG001|COMPLETED|Overall Study||0
8613406|NCT00434356|9651007|FG000|NOT COMPLETED|Overall Study||23
8613407|NCT00434356|9651008|FG001|NOT COMPLETED|Overall Study||23
8613408|NCT00434421|9651014|FG000|STARTED|Overall Study||28
8613409|NCT00434421|9651014|FG000|COMPLETED|Overall Study||26
8613410|NCT00434421|9651014|FG000|NOT COMPLETED|Overall Study||2
8613411|NCT00434434|9651021|FG000|STARTED|Overall Study||23
8613412|NCT00434434|9651022|FG001|STARTED|Overall Study||24
8613413|NCT00434434|9651023|FG002|STARTED|Overall Study||14
8613414|NCT00434434|9651021|FG000|COMPLETED|Overall Study||21
8613415|NCT00434434|9651022|FG001|COMPLETED|Overall Study||24
8613416|NCT00434434|9651023|FG002|COMPLETED|Overall Study||13
8613417|NCT00434434|9651021|FG000|NOT COMPLETED|Overall Study||2
8613418|NCT00434434|9651022|FG001|NOT COMPLETED|Overall Study||0
8613419|NCT00434434|9651023|FG002|NOT COMPLETED|Overall Study||1
8613420|NCT00434512|9651037|FG000|STARTED|Overall Study||10
8613421|NCT00434512|9651038|FG001|STARTED|Overall Study||10
8613422|NCT00434512|9651039|FG002|STARTED|Overall Study||10
8613423|NCT00434512|9651040|FG003|STARTED|Overall Study||50
8613424|NCT00434512|9651041|FG004|STARTED|Overall Study||50
8613425|NCT00434512|9651042|FG005|STARTED|Overall Study||50
8613426|NCT00434512|9651037|FG000|COMPLETED|Overall Study||10
8613427|NCT00434512|9651038|FG001|COMPLETED|Overall Study||9
8613428|NCT00434512|9651039|FG002|COMPLETED|Overall Study||10
8613429|NCT00434512|9651040|FG003|COMPLETED|Overall Study||49
8613430|NCT00434512|9651041|FG004|COMPLETED|Overall Study||49
8613431|NCT00434512|9651042|FG005|COMPLETED|Overall Study||49
8613432|NCT00434512|9651037|FG000|NOT COMPLETED|Overall Study||0
8613433|NCT00434512|9651038|FG001|NOT COMPLETED|Overall Study||1
8613434|NCT00434512|9651039|FG002|NOT COMPLETED|Overall Study||0
8613435|NCT00434512|9651040|FG003|NOT COMPLETED|Overall Study||1
8613436|NCT00434512|9651041|FG004|NOT COMPLETED|Overall Study||1
8613437|NCT00434512|9651042|FG005|NOT COMPLETED|Overall Study||1
8613438|NCT00434577|9651065|FG000|STARTED|Months 0-3||164
8613439|NCT00434577|9651066|FG001|STARTED|Months 0-3||166
8613440|NCT00434577|9651067|FG002|STARTED|Months 0-3||165
8613441|NCT00434577|9651068|FG003|STARTED|Months 0-3||165
8613442|NCT00434577|9651069|FG004|STARTED|Months 0-3||54
8715518|NCT00984165|9762429|FG000|STARTED|Overall Study||9
8715519|NCT00984165|9762430|FG001|STARTED|Overall Study||1
8715520|NCT00984165|9762431|FG002|STARTED|Overall Study||4
8613443|NCT00434577|9651065|FG000|COMPLETED|Months 0-3||161
8613444|NCT00434577|9651066|FG001|COMPLETED|Months 0-3||164
8613445|NCT00434577|9651067|FG002|COMPLETED|Months 0-3||161
8613446|NCT00434577|9651068|FG003|COMPLETED|Months 0-3||164
8613447|NCT00434577|9651069|FG004|COMPLETED|Months 0-3||51
8613448|NCT00434577|9651065|FG000|NOT COMPLETED|Months 0-3||3
8613449|NCT00434577|9651066|FG001|NOT COMPLETED|Months 0-3||2
8613450|NCT00434577|9651067|FG002|NOT COMPLETED|Months 0-3||4
8613451|NCT00434577|9651068|FG003|NOT COMPLETED|Months 0-3||1
8613452|NCT00434577|9651069|FG004|NOT COMPLETED|Months 0-3||3
8613453|NCT00434577|9651065|FG000|STARTED|Month 12||156
8613454|NCT00434577|9651066|FG001|STARTED|Month 12||159
8613455|NCT00434577|9651067|FG002|STARTED|Month 12||159
8613456|NCT00434577|9651068|FG003|STARTED|Month 12||161
8613457|NCT00434577|9651069|FG004|STARTED|Month 12||50
8613458|NCT00434577|9651065|FG000|COMPLETED|Month 12||156
8613459|NCT00434577|9651066|FG001|COMPLETED|Month 12||159
8613460|NCT00434577|9651067|FG002|COMPLETED|Month 12||159
8613461|NCT00434577|9651068|FG003|COMPLETED|Month 12||161
8613462|NCT00434577|9651069|FG004|COMPLETED|Month 12||50
8613463|NCT00434577|9651065|FG000|NOT COMPLETED|Month 12||0
8613464|NCT00434577|9651066|FG001|NOT COMPLETED|Month 12||0
8613465|NCT00434577|9651067|FG002|NOT COMPLETED|Month 12||0
8613466|NCT00434577|9651068|FG003|NOT COMPLETED|Month 12||0
8613467|NCT00434577|9651069|FG004|NOT COMPLETED|Month 12||0
8613468|NCT00434577|9651065|FG000|STARTED|Month 24||150
8613469|NCT00434577|9651066|FG001|STARTED|Month 24||155
8613470|NCT00434577|9651067|FG002|STARTED|Month 24||154
8613471|NCT00434577|9651068|FG003|STARTED|Month 24||157
8613472|NCT00434577|9651069|FG004|STARTED|Month 24||49
8613473|NCT00434577|9651065|FG000|COMPLETED|Month 24||150
8613474|NCT00434577|9651066|FG001|COMPLETED|Month 24||155
8613475|NCT00434577|9651067|FG002|COMPLETED|Month 24||154
8613476|NCT00434577|9651068|FG003|COMPLETED|Month 24||157
8613477|NCT00434577|9651069|FG004|COMPLETED|Month 24||49
8613478|NCT00434577|9651065|FG000|NOT COMPLETED|Month 24||0
8613479|NCT00434577|9651066|FG001|NOT COMPLETED|Month 24||0
8613480|NCT00434577|9651067|FG002|NOT COMPLETED|Month 24||0
8613481|NCT00434577|9651068|FG003|NOT COMPLETED|Month 24||0
8613482|NCT00434577|9651069|FG004|NOT COMPLETED|Month 24||0
8613483|NCT00434577|9651065|FG000|STARTED|Month 36||147
8613484|NCT00434577|9651066|FG001|STARTED|Month 36||147
8613485|NCT00434577|9651067|FG002|STARTED|Month 36||150
8613486|NCT00434577|9651068|FG003|STARTED|Month 36||155
8613487|NCT00434577|9651069|FG004|STARTED|Month 36||47
8715521|NCT00984165|9762432|FG003|STARTED|Overall Study||4
8715522|NCT00984165|9762429|FG000|COMPLETED|Overall Study||2
8715523|NCT00984165|9762430|FG001|COMPLETED|Overall Study||0
8715524|NCT00984165|9762431|FG002|COMPLETED|Overall Study||4
8715525|NCT00984165|9762432|FG003|COMPLETED|Overall Study||0
8715526|NCT00984165|9762429|FG000|NOT COMPLETED|Overall Study||7
8715527|NCT00984165|9762430|FG001|NOT COMPLETED|Overall Study||1
8715528|NCT00984165|9762431|FG002|NOT COMPLETED|Overall Study||0
8715529|NCT00984165|9762432|FG003|NOT COMPLETED|Overall Study||4
8715530|NCT00984204|9762443|FG000|STARTED|Overall Study||188
8715531|NCT00984204|9762443|FG000|COMPLETED|Overall Study|"Seven subjects of the ten Lack of efficacy were acute failures that had no block after 30 min"|173
8715532|NCT00984204|9762443|FG000|NOT COMPLETED|Overall Study||15
8715533|NCT00984256|9762449|FG000|STARTED|Overall Study||6
8715534|NCT00984256|9762450|FG001|STARTED|Overall Study||30
8715535|NCT00984256|9762449|FG000|COMPLETED|Overall Study||6
8715536|NCT00984256|9762450|FG001|COMPLETED|Overall Study||29
8715537|NCT00984256|9762449|FG000|NOT COMPLETED|Overall Study||0
8613488|NCT00434577|9651065|FG000|COMPLETED|Month 36||147
8613489|NCT00434577|9651066|FG001|COMPLETED|Month 36||147
8715538|NCT00984256|9762450|FG001|NOT COMPLETED|Overall Study||1
8613490|NCT00434577|9651067|FG002|COMPLETED|Month 36||150
8613491|NCT00434577|9651068|FG003|COMPLETED|Month 36||155
8613492|NCT00434577|9651069|FG004|COMPLETED|Month 36||47
8613493|NCT00434577|9651065|FG000|NOT COMPLETED|Month 36||0
8613494|NCT00434577|9651066|FG001|NOT COMPLETED|Month 36||0
8613495|NCT00434577|9651067|FG002|NOT COMPLETED|Month 36||0
8613496|NCT00434577|9651068|FG003|NOT COMPLETED|Month 36||0
8613497|NCT00434577|9651069|FG004|NOT COMPLETED|Month 36||0
8613498|NCT00434642|9651083|FG000|STARTED|Blinded Treatment Phase||242
8715539|NCT00984282|9762467|FG000|STARTED|Double Blind Treatment||207
8715540|NCT00984282|9762468|FG001|STARTED|Double Blind Treatment||210
8724904|NCT01028937|9772217|FG000|STARTED|Overall Study||6
8613499|NCT00434642|9651084|FG001|STARTED|Blinded Treatment Phase||242
8613500|NCT00434642|9651083|FG000|COMPLETED|Blinded Treatment Phase||0
8613501|NCT00434642|9651084|FG001|COMPLETED|Blinded Treatment Phase||13
8613502|NCT00434642|9651083|FG000|NOT COMPLETED|Blinded Treatment Phase||242
8613503|NCT00434642|9651084|FG001|NOT COMPLETED|Blinded Treatment Phase||229
8613504|NCT00434642|9651083|FG000|STARTED|Open-label Treatment Phase||0
8613505|NCT00434642|9651084|FG001|STARTED|Open-label Treatment Phase|One participant did not continue into the open-label treatment phase.|12
8613506|NCT00434642|9651083|FG000|COMPLETED|Open-label Treatment Phase||0
8613507|NCT00434642|9651084|FG001|COMPLETED|Open-label Treatment Phase||1
8613508|NCT00434642|9651083|FG000|NOT COMPLETED|Open-label Treatment Phase||0
8613509|NCT00434642|9651084|FG001|NOT COMPLETED|Open-label Treatment Phase||11
8613510|NCT00434759|9651092|FG000|STARTED|Overall Study||46
8613511|NCT00434759|9651093|FG001|STARTED|Overall Study||43
8613512|NCT00434759|9651092|FG000|COMPLETED|Overall Study||22
8613513|NCT00434759|9651093|FG001|COMPLETED|Overall Study||38
8613514|NCT00434759|9651092|FG000|NOT COMPLETED|Overall Study||24
8613515|NCT00434759|9651093|FG001|NOT COMPLETED|Overall Study||5
8613516|NCT00434876|9651103|FG000|STARTED|Overall Study||11
8613517|NCT00434876|9651104|FG001|STARTED|Overall Study||11
8613518|NCT00434876|9651103|FG000|COMPLETED|Overall Study||10
8613519|NCT00434876|9651104|FG001|COMPLETED|Overall Study||10
8613520|NCT00434876|9651103|FG000|NOT COMPLETED|Overall Study||1
8613521|NCT00434876|9651104|FG001|NOT COMPLETED|Overall Study||1
8613522|NCT00434954|9651112|FG000|STARTED|Overall Study||248
8613523|NCT00434954|9651113|FG001|STARTED|Overall Study||246
8613524|NCT00434954|9651112|FG000|Started - Previous Treatment MET Only|Overall Study||182
8613525|NCT00434954|9651113|FG001|Started - Previous Treatment MET Only|Overall Study||181
8613526|NCT00434954|9651112|FG000|Started - Previous Treatment MET + SU|Overall Study||66
8613527|NCT00434954|9651113|FG001|Started - Previous Treatment MET + SU|Overall Study||65
8613528|NCT00434954|9651112|FG000|Full Analysis Set (FAS) Overall|Overall Study|FAS=received >=1 dose of study drug. Adverse event data reported for Overall FAS.|247
8613529|NCT00434954|9651113|FG001|Full Analysis Set (FAS) Overall|Overall Study|FAS=received >=1 dose of study drug. Adverse event data reported for Overall FAS.|233
8613530|NCT00434954|9651112|FG000|FAS - Previous Treatment MET Only|Overall Study|"Baseline and efficacy data reported for FAS-Previous Treatment MET Only group."|181
8613531|NCT00434954|9651113|FG001|FAS - Previous Treatment MET Only|Overall Study|"Baseline and efficacy data reported for FAS-Previous Treatment MET Only group."|173
8613532|NCT00434954|9651112|FG000|FAS - Previous Treatment MET + SU|Overall Study||66
8613533|NCT00434954|9651113|FG001|FAS - Previous Treatment MET + SU|Overall Study||60
8613534|NCT00434954|9651112|FG000|Completed - Previous Treatment MET Only|Overall Study||135
8613535|NCT00434954|9651113|FG001|Completed - Previous Treatment MET Only|Overall Study||137
8613536|NCT00434954|9651112|FG000|Completed - Previous Treatment MET + SU|Overall Study||31
8613537|NCT00434954|9651113|FG001|Completed - Previous Treatment MET + SU|Overall Study||38
8613538|NCT00434954|9651112|FG000|COMPLETED|Overall Study||166
8613539|NCT00434954|9651113|FG001|COMPLETED|Overall Study||175
8613540|NCT00434954|9651112|FG000|NOT COMPLETED|Overall Study||82
8613541|NCT00434954|9651113|FG001|NOT COMPLETED|Overall Study||71
8613542|NCT00434967|9651123|FG000|STARTED|Overall Study||97
8613543|NCT00434967|9651124|FG001|STARTED|Overall Study||465
8613544|NCT00434967|9651125|FG002|STARTED|Overall Study||470
8613545|NCT00434967|9651126|FG003|STARTED|Overall Study||492
8613546|NCT00434967|9651123|FG000|COMPLETED|Overall Study||90
8613547|NCT00434967|9651124|FG001|COMPLETED|Overall Study||457
8613548|NCT00434967|9651125|FG002|COMPLETED|Overall Study||461
8613549|NCT00434967|9651126|FG003|COMPLETED|Overall Study||478
8613550|NCT00434967|9651123|FG000|NOT COMPLETED|Overall Study||7
8613551|NCT00434967|9651124|FG001|NOT COMPLETED|Overall Study||8
8613552|NCT00434967|9651125|FG002|NOT COMPLETED|Overall Study||9
8613553|NCT00434967|9651126|FG003|NOT COMPLETED|Overall Study||14
8613554|NCT00434993|9651138|FG000|STARTED|Overall Study||152
8613555|NCT00434993|9651139|FG001|STARTED|Overall Study||130
8613556|NCT00434993|9651138|FG000|COMPLETED|Overall Study||152
8613557|NCT00434993|9651139|FG001|COMPLETED|Overall Study||130
8613558|NCT00434993|9651138|FG000|NOT COMPLETED|Overall Study||0
8613559|NCT00434993|9651139|FG001|NOT COMPLETED|Overall Study||0
8613560|NCT00435019|9651147|FG000|STARTED|Overall Study|Randomised|177
8613561|NCT00435019|9651148|FG001|STARTED|Overall Study|Randomised|171
8613562|NCT00435019|9651147|FG000|Exposed to Study Drug|Overall Study||177
8613563|NCT00435019|9651148|FG001|Exposed to Study Drug|Overall Study|One subject withdrew before receiving study drug, and thus not included in the full analysis set.|170
8613564|NCT00435019|9651147|FG000|COMPLETED|Overall Study||164
8613565|NCT00435019|9651148|FG001|COMPLETED|Overall Study||161
8613566|NCT00435019|9651147|FG000|NOT COMPLETED|Overall Study||13
8613567|NCT00435019|9651148|FG001|NOT COMPLETED|Overall Study||10
8613568|NCT00435045|9651156|FG000|STARTED|Weeks 1-8 / 10 mg Dose Level||123
8613569|NCT00435045|9651157|FG001|STARTED|Weeks 1-8 / 10 mg Dose Level||122
8613570|NCT00435045|9651156|FG000|COMPLETED|Weeks 1-8 / 10 mg Dose Level||118
8613571|NCT00435045|9651157|FG001|COMPLETED|Weeks 1-8 / 10 mg Dose Level||118
8613572|NCT00435045|9651156|FG000|NOT COMPLETED|Weeks 1-8 / 10 mg Dose Level||5
8613573|NCT00435045|9651157|FG001|NOT COMPLETED|Weeks 1-8 / 10 mg Dose Level||4
8613574|NCT00435045|9651156|FG000|STARTED|Weeks 9-12 / 20mg Dose Level||118
8613575|NCT00435045|9651157|FG001|STARTED|Weeks 9-12 / 20mg Dose Level||118
8613576|NCT00435045|9651156|FG000|COMPLETED|Weeks 9-12 / 20mg Dose Level||113
8613577|NCT00435045|9651157|FG001|COMPLETED|Weeks 9-12 / 20mg Dose Level||113
8613578|NCT00435045|9651156|FG000|NOT COMPLETED|Weeks 9-12 / 20mg Dose Level||5
8613579|NCT00435045|9651157|FG001|NOT COMPLETED|Weeks 9-12 / 20mg Dose Level||5
8613580|NCT00435045|9651156|FG000|STARTED|Weeks 13-16 / 40mg Dose Level||113
8613581|NCT00435045|9651157|FG001|STARTED|Weeks 13-16 / 40mg Dose Level||113
8613582|NCT00435045|9651156|FG000|COMPLETED|Weeks 13-16 / 40mg Dose Level||108
8613583|NCT00435045|9651157|FG001|COMPLETED|Weeks 13-16 / 40mg Dose Level||111
8613584|NCT00435045|9651156|FG000|NOT COMPLETED|Weeks 13-16 / 40mg Dose Level||5
8613585|NCT00435045|9651157|FG001|NOT COMPLETED|Weeks 13-16 / 40mg Dose Level||2
8613586|NCT00435162|9651166|FG000|STARTED|Period 1 (6 Weeks)||15
8613587|NCT00435162|9651167|FG001|STARTED|Period 1 (6 Weeks)||15
8613588|NCT00435162|9651168|FG002|STARTED|Period 1 (6 Weeks)||6
8613589|NCT00435162|9651169|FG003|STARTED|Period 1 (6 Weeks)||8
8613590|NCT00435162|9651170|FG004|STARTED|Period 1 (6 Weeks)||15
8613591|NCT00435162|9651171|FG005|STARTED|Period 1 (6 Weeks)||15
8613592|NCT00435162|9651166|FG000|COMPLETED|Period 1 (6 Weeks)||15
8613593|NCT00435162|9651167|FG001|COMPLETED|Period 1 (6 Weeks)||15
8613594|NCT00435162|9651168|FG002|COMPLETED|Period 1 (6 Weeks)||6
8613595|NCT00435162|9651169|FG003|COMPLETED|Period 1 (6 Weeks)||8
8613596|NCT00435162|9651170|FG004|COMPLETED|Period 1 (6 Weeks)||15
8613597|NCT00435162|9651171|FG005|COMPLETED|Period 1 (6 Weeks)||15
8613598|NCT00435162|9651166|FG000|NOT COMPLETED|Period 1 (6 Weeks)||0
8613599|NCT00435162|9651167|FG001|NOT COMPLETED|Period 1 (6 Weeks)||0
8613600|NCT00435162|9651168|FG002|NOT COMPLETED|Period 1 (6 Weeks)||0
8613601|NCT00435162|9651169|FG003|NOT COMPLETED|Period 1 (6 Weeks)||0
8613602|NCT00435162|9651170|FG004|NOT COMPLETED|Period 1 (6 Weeks)||0
8613603|NCT00435162|9651171|FG005|NOT COMPLETED|Period 1 (6 Weeks)||0
8613604|NCT00435162|9651166|FG000|STARTED|Period 2 (2 Weeks)||15
8613605|NCT00435162|9651167|FG001|STARTED|Period 2 (2 Weeks)||15
8613606|NCT00435162|9651168|FG002|STARTED|Period 2 (2 Weeks)||6
8613607|NCT00435162|9651169|FG003|STARTED|Period 2 (2 Weeks)||8
8613608|NCT00435162|9651170|FG004|STARTED|Period 2 (2 Weeks)||15
8613609|NCT00435162|9651171|FG005|STARTED|Period 2 (2 Weeks)||15
8613610|NCT00435162|9651166|FG000|COMPLETED|Period 2 (2 Weeks)||15
8613611|NCT00435162|9651167|FG001|COMPLETED|Period 2 (2 Weeks)||14
8613612|NCT00435162|9651168|FG002|COMPLETED|Period 2 (2 Weeks)||6
8613613|NCT00435162|9651169|FG003|COMPLETED|Period 2 (2 Weeks)||8
8613614|NCT00435162|9651170|FG004|COMPLETED|Period 2 (2 Weeks)||15
8613615|NCT00435162|9651171|FG005|COMPLETED|Period 2 (2 Weeks)||15
8613616|NCT00435162|9651166|FG000|NOT COMPLETED|Period 2 (2 Weeks)||0
8613617|NCT00435162|9651167|FG001|NOT COMPLETED|Period 2 (2 Weeks)||1
8613618|NCT00435162|9651168|FG002|NOT COMPLETED|Period 2 (2 Weeks)||0
8613619|NCT00435162|9651169|FG003|NOT COMPLETED|Period 2 (2 Weeks)||0
8613620|NCT00435162|9651170|FG004|NOT COMPLETED|Period 2 (2 Weeks)||0
8613621|NCT00435162|9651171|FG005|NOT COMPLETED|Period 2 (2 Weeks)||0
8613622|NCT00435188|9651186|FG000|STARTED|Overall Study||199
8613623|NCT00435188|9651187|FG001|STARTED|Overall Study||199
8613624|NCT00435188|9651186|FG000|COMPLETED|Overall Study||177
8613625|NCT00435188|9651187|FG001|COMPLETED|Overall Study||176
8613626|NCT00435188|9651186|FG000|NOT COMPLETED|Overall Study||22
8613627|NCT00435188|9651187|FG001|NOT COMPLETED|Overall Study||23
8613628|NCT00435370|9651197|FG000|STARTED|Overall Study||90
8613629|NCT00435370|9651198|FG001|STARTED|Overall Study|The recruitment restarted in August, 2010.|89
8613630|NCT00435370|9651197|FG000|COMPLETED|Overall Study||68
8613631|NCT00435370|9651198|FG001|COMPLETED|Overall Study|The entire recruitment has been completed in December, 2011.|69
8613632|NCT00435370|9651197|FG000|NOT COMPLETED|Overall Study||22
8613633|NCT00435370|9651198|FG001|NOT COMPLETED|Overall Study||20
8613634|NCT00435409|9651206|FG000|STARTED|Overall Study||221
8613635|NCT00435409|9651207|FG001|STARTED|Overall Study||143
8613636|NCT00435409|9651208|FG002|STARTED|Overall Study||78
8613637|NCT00435409|9651206|FG000|Treated|Overall Study||217
8613638|NCT00435409|9651207|FG001|Treated|Overall Study||139
8613639|NCT00435409|9651208|FG002|Treated|Overall Study||78
8613640|NCT00435409|9651206|FG000|COMPLETED|Overall Study||0
8613641|NCT00435409|9651207|FG001|COMPLETED|Overall Study||0
8613642|NCT00435409|9651208|FG002|COMPLETED|Overall Study||0
8613643|NCT00435409|9651206|FG000|NOT COMPLETED|Overall Study||221
8613644|NCT00435409|9651207|FG001|NOT COMPLETED|Overall Study||143
8613645|NCT00435409|9651208|FG002|NOT COMPLETED|Overall Study||78
8613646|NCT00435461|9651217|FG000|STARTED|Overall Study||313
8613647|NCT00435461|9651218|FG001|STARTED|Overall Study||312
8613648|NCT00435461|9651219|FG002|STARTED|Overall Study||311
8613649|NCT00435461|9651217|FG000|COMPLETED|Overall Study||290
8613650|NCT00435461|9651218|FG001|COMPLETED|Overall Study||298
8613651|NCT00435461|9651219|FG002|COMPLETED|Overall Study||287
8613652|NCT00435461|9651217|FG000|NOT COMPLETED|Overall Study||23
8613653|NCT00435461|9651218|FG001|NOT COMPLETED|Overall Study||14
8613654|NCT00435461|9651219|FG002|NOT COMPLETED|Overall Study||24
8613655|NCT00435487|9651229|FG000|STARTED|Overall Study|87 subjects were randomized however one additional subject originally randomized to UFH was treated.|88
8613656|NCT00435487|9651230|FG001|STARTED|Overall Study||86
8613657|NCT00435487|9651229|FG000|TREATED|Overall Study|One additional subject originally randomized to Unfractioned Heparin was treated with Dalteparin.|88
8613658|NCT00435487|9651230|FG001|TREATED|Overall Study|One subject was mistakenly treated with Dalteparin, two subjects withdrew consent before treatment.|83
8613659|NCT00435487|9651229|FG000|COMPLETED|Overall Study||76
8613660|NCT00435487|9651230|FG001|COMPLETED|Overall Study||71
8613661|NCT00435487|9651229|FG000|NOT COMPLETED|Overall Study||12
8613662|NCT00435487|9651230|FG001|NOT COMPLETED|Overall Study||15
8613663|NCT00435539|9651241|FG000|STARTED|Overall Study||12
8613664|NCT00435539|9651242|FG001|STARTED|Overall Study||13
8613665|NCT00435539|9651243|FG002|STARTED|Overall Study||11
8613666|NCT00435539|9651244|FG003|STARTED|Overall Study||12
8613667|NCT00435539|9651245|FG004|STARTED|Overall Study||12
8613668|NCT00435539|9651241|FG000|COMPLETED|Overall Study||12
8613669|NCT00435539|9651242|FG001|COMPLETED|Overall Study||13
8813327|NCT01525173|9866494|FG001|COMPLETED|Overall Study||62
8813328|NCT01525173|9866493|FG000|NOT COMPLETED|Overall Study||7
8613670|NCT00435539|9651243|FG002|COMPLETED|Overall Study||11
8613671|NCT00435539|9651244|FG003|COMPLETED|Overall Study||12
8613672|NCT00435539|9651245|FG004|COMPLETED|Overall Study||12
8613673|NCT00435539|9651241|FG000|NOT COMPLETED|Overall Study||0
8613674|NCT00435539|9651242|FG001|NOT COMPLETED|Overall Study||0
8613675|NCT00435539|9651243|FG002|NOT COMPLETED|Overall Study||0
8613676|NCT00435539|9651244|FG003|NOT COMPLETED|Overall Study||0
8613677|NCT00435539|9651245|FG004|NOT COMPLETED|Overall Study||0
8613678|NCT00435591|9651260|FG000|STARTED|Overall Study||30
8613679|NCT00435591|9651261|FG001|STARTED|Overall Study||31
8613680|NCT00435591|9651262|FG002|STARTED|Overall Study||30
8613681|NCT00435591|9651263|FG003|STARTED|Overall Study||30
8613682|NCT00435591|9651260|FG000|Safety Analysis Set|Overall Study||28
8613683|NCT00435591|9651261|FG001|Safety Analysis Set|Overall Study||30
8613684|NCT00435591|9651262|FG002|Safety Analysis Set|Overall Study||30
8613685|NCT00435591|9651263|FG003|Safety Analysis Set|Overall Study||29
8613686|NCT00435591|9651260|FG000|Full Analysis Set|Overall Study||28
8613687|NCT00435591|9651261|FG001|Full Analysis Set|Overall Study||29
8613688|NCT00435591|9651262|FG002|Full Analysis Set|Overall Study||30
8613689|NCT00435591|9651263|FG003|Full Analysis Set|Overall Study||29
8613690|NCT00435591|9651260|FG000|End of Treatment|Overall Study||25
8613691|NCT00435591|9651261|FG001|End of Treatment|Overall Study||27
8613692|NCT00435591|9651262|FG002|End of Treatment|Overall Study||27
8613693|NCT00435591|9651263|FG003|End of Treatment|Overall Study||23
8613694|NCT00435591|9651260|FG000|COMPLETED|Overall Study||23
8613695|NCT00435591|9651261|FG001|COMPLETED|Overall Study||27
8613696|NCT00435591|9651262|FG002|COMPLETED|Overall Study||25
8613697|NCT00435591|9651263|FG003|COMPLETED|Overall Study||19
8613698|NCT00435591|9651260|FG000|NOT COMPLETED|Overall Study||7
8613699|NCT00435591|9651261|FG001|NOT COMPLETED|Overall Study||4
8613700|NCT00435591|9651262|FG002|NOT COMPLETED|Overall Study||5
8613701|NCT00435591|9651263|FG003|NOT COMPLETED|Overall Study||11
8613702|NCT00435812|9651278|FG000|STARTED|Overall Study||1820
8613703|NCT00435812|9651279|FG001|STARTED|Overall Study||608
8613704|NCT00435812|9651278|FG000|COMPLETED|Overall Study||1757
8613705|NCT00435812|9651279|FG001|COMPLETED|Overall Study||590
8613706|NCT00435812|9651278|FG000|NOT COMPLETED|Overall Study||63
8613707|NCT00435812|9651279|FG001|NOT COMPLETED|Overall Study||18
8613708|NCT00435825|9651289|FG000|STARTED|Overall Study||141
8613709|NCT00435825|9651290|FG001|STARTED|Overall Study||136
8613710|NCT00435825|9651291|FG002|STARTED|Overall Study||138
8613711|NCT00435825|9651292|FG003|STARTED|Overall Study||136
8613712|NCT00435825|9651289|FG000|Received Study Drug|Overall Study||140
8613713|NCT00435825|9651290|FG001|Received Study Drug|Overall Study||136
8613714|NCT00435825|9651291|FG002|Received Study Drug|Overall Study||136
8613715|NCT00435825|9651292|FG003|Received Study Drug|Overall Study||136
8613716|NCT00435825|9651289|FG000|Entered Follow-up|Overall Study||140
8613717|NCT00435825|9651290|FG001|Entered Follow-up|Overall Study||132
8613718|NCT00435825|9651291|FG002|Entered Follow-up|Overall Study||135
8613719|NCT00435825|9651292|FG003|Entered Follow-up|Overall Study||133
8613720|NCT00435825|9651289|FG000|Completed 24 Weeks Treatment|Overall Study||128
8613721|NCT00435825|9651290|FG001|Completed 24 Weeks Treatment|Overall Study||126
8613722|NCT00435825|9651291|FG002|Completed 24 Weeks Treatment|Overall Study||134
8613723|NCT00435825|9651292|FG003|Completed 24 Weeks Treatment|Overall Study||131
8613724|NCT00435825|9651289|FG000|Completed 48 Weeks Treatment|Overall Study||0
8613725|NCT00435825|9651290|FG001|Completed 48 Weeks Treatment|Overall Study||0
8613726|NCT00435825|9651291|FG002|Completed 48 Weeks Treatment|Overall Study||124
8613727|NCT00435825|9651292|FG003|Completed 48 Weeks Treatment|Overall Study||117
8613728|NCT00435825|9651289|FG000|COMPLETED|Overall Study|Completed is the number of participants who received study treatment and completed follow-up.|123
8613729|NCT00435825|9651290|FG001|COMPLETED|Overall Study||124
8613730|NCT00435825|9651291|FG002|COMPLETED|Overall Study||127
8613731|NCT00435825|9651292|FG003|COMPLETED|Overall Study||120
8613732|NCT00435825|9651289|FG000|NOT COMPLETED|Overall Study||18
8613733|NCT00435825|9651290|FG001|NOT COMPLETED|Overall Study||12
8613734|NCT00435825|9651291|FG002|NOT COMPLETED|Overall Study||11
8613735|NCT00435825|9651292|FG003|NOT COMPLETED|Overall Study||16
8613736|NCT00435929|9651304|FG000|STARTED|Overall Study||7
8613737|NCT00435929|9651305|FG001|STARTED|Overall Study||9
8613738|NCT00435929|9651304|FG000|COMPLETED|Overall Study||7
8613739|NCT00435929|9651305|FG001|COMPLETED|Overall Study||9
8613740|NCT00435929|9651304|FG000|NOT COMPLETED|Overall Study||0
8613741|NCT00435929|9651305|FG001|NOT COMPLETED|Overall Study||0
8613742|NCT00435942|9651313|FG000|STARTED|Overall Study||120
8613743|NCT00435942|9651314|FG001|STARTED|Overall Study||60
8613744|NCT00435942|9651313|FG000|COMPLETED|Overall Study||97
8613745|NCT00435942|9651314|FG001|COMPLETED|Overall Study||33
8613746|NCT00435942|9651313|FG000|NOT COMPLETED|Overall Study||23
8613747|NCT00435942|9651314|FG001|NOT COMPLETED|Overall Study||27
8613748|NCT00435994|9651323|FG000|STARTED|Overall Study||22
8613749|NCT00435994|9651324|FG001|STARTED|Overall Study||25
8813329|NCT01525173|9866494|FG001|NOT COMPLETED|Overall Study||5
8613750|NCT00435994|9651325|FG002|STARTED|Overall Study||12
8629293|NCT00529373|9668998|FG000|STARTED|Base Study||8043
8613751|NCT00435994|9651323|FG000|COMPLETED|Overall Study|7 of the subjects were consented and did not complete the study procedures.|15
8613752|NCT00435994|9651324|FG001|COMPLETED|Overall Study||25
8613753|NCT00435994|9651325|FG002|COMPLETED|Overall Study||12
8613754|NCT00435994|9651323|FG000|NOT COMPLETED|Overall Study||7
8613755|NCT00435994|9651324|FG001|NOT COMPLETED|Overall Study||0
8613756|NCT00435994|9651325|FG002|NOT COMPLETED|Overall Study||0
8613757|NCT00436007|9651337|FG000|STARTED|Overall Study||170
8613758|NCT00436007|9651338|FG001|STARTED|Overall Study||170
8613759|NCT00436007|9651339|FG002|STARTED|Overall Study||171
8613760|NCT00436007|9651337|FG000|COMPLETED|Overall Study||151
8613761|NCT00436007|9651338|FG001|COMPLETED|Overall Study||156
8613762|NCT00436007|9651339|FG002|COMPLETED|Overall Study||148
8613763|NCT00436007|9651337|FG000|NOT COMPLETED|Overall Study||19
8613764|NCT00436007|9651338|FG001|NOT COMPLETED|Overall Study||14
8613765|NCT00436007|9651339|FG002|NOT COMPLETED|Overall Study||23
8613766|NCT00436046|9651355|FG000|STARTED|Overall Study||32
8613767|NCT00436046|9651356|FG001|STARTED|Overall Study||32
8613768|NCT00436046|9651357|FG002|STARTED|Overall Study||31
8613769|NCT00436046|9651355|FG000|COMPLETED|Overall Study||32
8613770|NCT00436046|9651356|FG001|COMPLETED|Overall Study||32
8613771|NCT00436046|9651357|FG002|COMPLETED|Overall Study||31
8613772|NCT00436046|9651355|FG000|NOT COMPLETED|Overall Study||0
8613773|NCT00436046|9651356|FG001|NOT COMPLETED|Overall Study||0
8613774|NCT00436046|9651357|FG002|NOT COMPLETED|Overall Study||0
8613775|NCT00436163|9651365|FG000|STARTED|Overall Study||39
8613776|NCT00436163|9651365|FG000|COMPLETED|Overall Study||36
8613777|NCT00436163|9651365|FG000|NOT COMPLETED|Overall Study||3
8613778|NCT00436215|9651370|FG000|STARTED|Overall Study||55
8613779|NCT00436215|9651370|FG000|COMPLETED|Overall Study||51
8613780|NCT00436215|9651370|FG000|NOT COMPLETED|Overall Study||4
8613781|NCT00436280|9651374|FG000|STARTED|Period 1: Induction||68
8613782|NCT00436280|9651374|FG000|Received at Least 1 Dose of Study Drug|Period 1: Induction||68
8613783|NCT00436280|9651374|FG000|COMPLETED|Period 1: Induction||40
8613784|NCT00436280|9651374|FG000|NOT COMPLETED|Period 1: Induction||28
8613785|NCT00436280|9651374|FG000|STARTED|Period 2: Consolidation||40
8613786|NCT00436280|9651374|FG000|COMPLETED|Period 2: Consolidation||23
8613787|NCT00436280|9651374|FG000|NOT COMPLETED|Period 2: Consolidation||17
8613788|NCT00436280|9651374|FG000|STARTED|Period 3: Maintenance||23
8715541|NCT00984282|9762467|FG000|Received Treatment|Double Blind Treatment|Subjects at Risk/Safety Population - in RG1 (RG= Reporting Group for Safety Data)|207
8715542|NCT00984282|9762468|FG001|Received Treatment|Double Blind Treatment|Subjects at Risk/Safety Population - in RG2 (RG= Reporting Group for Safety Data)|209
8715543|NCT00984282|9762467|FG000|COMPLETED|Double Blind Treatment||103
8715544|NCT00984282|9762468|FG001|COMPLETED|Double Blind Treatment||172
8715545|NCT00984282|9762467|FG000|NOT COMPLETED|Double Blind Treatment||104
8715546|NCT00984282|9762468|FG001|NOT COMPLETED|Double Blind Treatment||38
8613789|NCT00436280|9651374|FG000|COMPLETED|Period 3: Maintenance||5
8613790|NCT00436280|9651374|FG000|NOT COMPLETED|Period 3: Maintenance||18
8613791|NCT00436332|9651378|FG000|STARTED|Overall Study||84
8613792|NCT00436332|9651378|FG000|Eligible|Overall Study||82
8613793|NCT00436332|9651378|FG000|Eligible and Began Protocol Therapy|Overall Study||79
8613794|NCT00436332|9651378|FG000|COMPLETED|Overall Study||1
8928261|NCT02279641|9989428|FG000|COMPLETED|Overall Study||6
8928262|NCT02279641|9989429|FG001|COMPLETED|Overall Study||6
8928263|NCT02279641|9989428|FG000|NOT COMPLETED|Overall Study||0
8928264|NCT02279641|9989429|FG001|NOT COMPLETED|Overall Study||0
8928265|NCT02279667|9989448|FG000|STARTED|Overall Study||6
8613795|NCT00436332|9651378|FG000|NOT COMPLETED|Overall Study||83
8613796|NCT00436345|9651384|FG000|STARTED|Overall Study||21
8613797|NCT00436345|9651385|FG001|STARTED|Overall Study||18
8613798|NCT00436345|9651384|FG000|COMPLETED|Overall Study||18
8613799|NCT00436345|9651385|FG001|COMPLETED|Overall Study||18
8613800|NCT00436345|9651384|FG000|NOT COMPLETED|Overall Study||3
8613801|NCT00436345|9651385|FG001|NOT COMPLETED|Overall Study||0
8613802|NCT00436436|9651392|FG000|STARTED|Overall Study||12
8613803|NCT00436436|9651392|FG000|COMPLETED|Overall Study||0
8613804|NCT00436436|9651392|FG000|NOT COMPLETED|Overall Study||12
8613805|NCT00436475|9651400|FG000|STARTED|Overall Study||23
8613806|NCT00436475|9651401|FG001|STARTED|Overall Study||23
8613807|NCT00436475|9651402|FG002|STARTED|Overall Study||22
8613808|NCT00436475|9651403|FG003|STARTED|Overall Study||24
8613809|NCT00436475|9651400|FG000|COMPLETED|Overall Study||23
8715547|NCT00984282|9762467|FG000|STARTED|Open-label Treatment||86
8715548|NCT00984282|9762468|FG001|STARTED|Open-label Treatment||161
8724905|NCT01028937|9772217|FG000|COMPLETED|Overall Study||6
8928266|NCT02279667|9989449|FG001|STARTED|Overall Study||6
8928267|NCT02279667|9989450|FG002|STARTED|Overall Study||6
8613810|NCT00436475|9651401|FG001|COMPLETED|Overall Study||22
8613811|NCT00436475|9651402|FG002|COMPLETED|Overall Study||21
8613812|NCT00436475|9651403|FG003|COMPLETED|Overall Study||22
8613813|NCT00436475|9651400|FG000|NOT COMPLETED|Overall Study||0
8613814|NCT00436475|9651401|FG001|NOT COMPLETED|Overall Study||1
8613815|NCT00436475|9651402|FG002|NOT COMPLETED|Overall Study||1
8613816|NCT00436475|9651403|FG003|NOT COMPLETED|Overall Study||2
8613817|NCT00436501|9651415|FG000|STARTED|Complete Study Participation|Phase 1 opened on January 17, 2007 and closed to new patient entry on March 7, 2008.|9
8613818|NCT00436501|9651416|FG001|STARTED|Complete Study Participation|After toxicity observations, Phase 2 opened June 4, 2008 and closed September 27, 2010.|49
8613819|NCT00436501|9651415|FG000|COMPLETED|Complete Study Participation||9
8613820|NCT00436501|9651416|FG001|COMPLETED|Complete Study Participation||49
8613821|NCT00436501|9651415|FG000|NOT COMPLETED|Complete Study Participation||0
8613822|NCT00436501|9651416|FG001|NOT COMPLETED|Complete Study Participation||0
8613823|NCT00436501|9651415|FG000|STARTED|Phase 1: VEGF Trap Escalating Dose|Phase 1 opened on January 17, 2007 and closed to new patient entry on March 7, 2008.|9
8613824|NCT00436501|9651416|FG001|STARTED|Phase 1: VEGF Trap Escalating Dose|Participants registered in next period.|0
8613825|NCT00436501|9651415|FG000|COMPLETED|Phase 1: VEGF Trap Escalating Dose||9
8613826|NCT00436501|9651416|FG001|COMPLETED|Phase 1: VEGF Trap Escalating Dose||0
8613827|NCT00436501|9651415|FG000|NOT COMPLETED|Phase 1: VEGF Trap Escalating Dose||0
8613828|NCT00436501|9651416|FG001|NOT COMPLETED|Phase 1: VEGF Trap Escalating Dose||0
8613829|NCT00436501|9651415|FG000|STARTED|Phase 2: MTD VEGF Trap + Docetaxel||0
8613830|NCT00436501|9651416|FG001|STARTED|Phase 2: MTD VEGF Trap + Docetaxel|After toxicity observations Phase 2 opened June 4, 2008 and closed to entry September 27, 2010.|49
8613831|NCT00436501|9651415|FG000|COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||0
8613832|NCT00436501|9651416|FG001|COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||46
8613833|NCT00436501|9651415|FG000|NOT COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||0
8613834|NCT00436501|9651416|FG001|NOT COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||3
8613835|NCT00436553|9651426|FG000|STARTED|Overall Study|"The table shows 12 month data. Started indicates Randomized set of population."|104
8613836|NCT00436553|9651427|FG001|STARTED|Overall Study||105
8613837|NCT00436553|9651428|FG002|STARTED|Overall Study||112
8613838|NCT00436553|9651426|FG000|COMPLETED|Overall Study|Completed the 12 month study phase.|91
8613839|NCT00436553|9651427|FG001|COMPLETED|Overall Study||93
8613840|NCT00436553|9651428|FG002|COMPLETED|Overall Study||102
8613841|NCT00436553|9651426|FG000|NOT COMPLETED|Overall Study||13
8613842|NCT00436553|9651427|FG001|NOT COMPLETED|Overall Study||12
8613843|NCT00436553|9651428|FG002|NOT COMPLETED|Overall Study||10
8613844|NCT00436566|9651436|FG000|STARTED|Overall Study||112
8613845|NCT00436566|9651436|FG000|COMPLETED|Overall Study||109
8613846|NCT00436566|9651436|FG000|NOT COMPLETED|Overall Study||3
8613847|NCT00436605|9651440|FG000|STARTED|Overall Study||39
8613848|NCT00436605|9651440|FG000|COMPLETED|Overall Study||36
8613849|NCT00436605|9651440|FG000|NOT COMPLETED|Overall Study||3
8613850|NCT00436618|9651447|FG000|STARTED|Overall Study||114
8613851|NCT00436618|9651448|FG001|STARTED|Overall Study||55
8613852|NCT00436618|9651449|FG002|STARTED|Overall Study||107
8613853|NCT00436618|9651447|FG000|COMPLETED|Overall Study||84
8613854|NCT00436618|9651448|FG001|COMPLETED|Overall Study||28
8613855|NCT00436618|9651449|FG002|COMPLETED|Overall Study||46
8613856|NCT00436618|9651447|FG000|NOT COMPLETED|Overall Study||30
8613857|NCT00436618|9651448|FG001|NOT COMPLETED|Overall Study||27
8613858|NCT00436618|9651449|FG002|NOT COMPLETED|Overall Study||61
8613859|NCT00436644|9651457|FG000|STARTED|Overall Study||18
8613860|NCT00436644|9651457|FG000|COMPLETED|Overall Study||15
8613861|NCT00436644|9651457|FG000|NOT COMPLETED|Overall Study||3
8613862|NCT00436748|9651463|FG000|STARTED|Overall Study||59
8613863|NCT00436748|9651464|FG001|STARTED|Overall Study||57
8613864|NCT00436748|9651463|FG000|Received Treatment|Overall Study||58
8613865|NCT00436748|9651464|FG001|Received Treatment|Overall Study||56
8613866|NCT00436748|9651463|FG000|COMPLETED|Overall Study||48
8613867|NCT00436748|9651464|FG001|COMPLETED|Overall Study||45
8613868|NCT00436748|9651463|FG000|NOT COMPLETED|Overall Study||11
8613869|NCT00436748|9651464|FG001|NOT COMPLETED|Overall Study||12
8613870|NCT00436852|9651472|FG000|STARTED|Overall Study||45
8613871|NCT00436852|9651473|FG001|STARTED|Overall Study||47
8613872|NCT00436852|9651472|FG000|COMPLETED|Overall Study||10
8613873|NCT00436852|9651473|FG001|COMPLETED|Overall Study||2
8613874|NCT00436852|9651472|FG000|NOT COMPLETED|Overall Study||35
8613875|NCT00436852|9651473|FG001|NOT COMPLETED|Overall Study||45
8613876|NCT00436904|9651482|FG000|STARTED|Overall Study||30
8613877|NCT00436904|9651482|FG000|COMPLETED|Overall Study||30
8613878|NCT00436904|9651482|FG000|NOT COMPLETED|Overall Study||0
8613879|NCT00436917|9651486|FG000|STARTED|Overall Study|7 participants (1 cancellation, 1 major violation, 5 ineligibles) were excluded from all analysis.|53
8613880|NCT00436917|9651486|FG000|COMPLETED|Overall Study||32
8613881|NCT00436917|9651486|FG000|NOT COMPLETED|Overall Study||21
8613882|NCT00436956|9651490|FG000|STARTED|Overall Study||36
8613883|NCT00436956|9651491|FG001|STARTED|Overall Study||23
8613884|NCT00436956|9651490|FG000|COMPLETED|Overall Study|One pt was not evaluable due to a cord compression on day 2 of therapy; was removed from the trial.|35
8613885|NCT00436956|9651491|FG001|COMPLETED|Overall Study||23
8613886|NCT00436956|9651490|FG000|NOT COMPLETED|Overall Study||1
8613887|NCT00436956|9651491|FG001|NOT COMPLETED|Overall Study||0
8613888|NCT00436969|9651500|FG000|STARTED|Overall Study||88
8613889|NCT00436969|9651501|FG001|STARTED|Overall Study||186
8613890|NCT00436969|9651500|FG000|Randomized But Not Treated|Overall Study||1
8613891|NCT00436969|9651501|FG001|Randomized But Not Treated|Overall Study||3
8613892|NCT00436969|9651500|FG000|COMPLETED|Overall Study||66
8613893|NCT00436969|9651501|FG001|COMPLETED|Overall Study||134
8613894|NCT00436969|9651500|FG000|NOT COMPLETED|Overall Study||22
8613895|NCT00436969|9651501|FG001|NOT COMPLETED|Overall Study||52
8613896|NCT00436982|9651509|FG000|STARTED|Overall Study||30
8613897|NCT00436982|9651510|FG001|STARTED|Overall Study||30
8613898|NCT00436982|9651509|FG000|COMPLETED|Overall Study||26
8613899|NCT00436982|9651510|FG001|COMPLETED|Overall Study||26
8613900|NCT00436982|9651509|FG000|NOT COMPLETED|Overall Study||4
8613901|NCT00436982|9651510|FG001|NOT COMPLETED|Overall Study||4
8613902|NCT00437034|9651520|FG000|STARTED|Overall Study||6
8613903|NCT00437034|9651520|FG000|COMPLETED|Overall Study||0
8613904|NCT00437034|9651520|FG000|NOT COMPLETED|Overall Study||6
8613905|NCT00437073|9651526|FG000|STARTED|Overall Study||13
8613906|NCT00437073|9651527|FG001|STARTED|Overall Study||9
8613907|NCT00437073|9651526|FG000|COMPLETED|Overall Study||12
8613908|NCT00437073|9651527|FG001|COMPLETED|Overall Study||8
8613909|NCT00437073|9651526|FG000|NOT COMPLETED|Overall Study||1
8613910|NCT00437073|9651527|FG001|NOT COMPLETED|Overall Study||1
8613911|NCT00437125|9651533|FG000|STARTED|Overall Study||151
8613912|NCT00437125|9651533|FG000|COMPLETED|Overall Study||119
8613913|NCT00437125|9651533|FG000|NOT COMPLETED|Overall Study||32
8613914|NCT00437203|9651547|FG000|STARTED|Overall Study||6
8613915|NCT00437203|9651548|FG001|STARTED|Overall Study||8
8613916|NCT00437203|9651549|FG002|STARTED|Overall Study||3
8613917|NCT00437203|9651550|FG003|STARTED|Overall Study||3
8613918|NCT00437203|9651551|FG004|STARTED|Overall Study||3
8613919|NCT00437203|9651552|FG005|STARTED|Overall Study||3
8613920|NCT00437203|9651553|FG006|STARTED|Overall Study||7
8613921|NCT00437203|9651554|FG007|STARTED|Overall Study||3
8613922|NCT00437203|9651555|FG008|STARTED|Overall Study||3
8613923|NCT00437203|9651556|FG009|STARTED|Overall Study||4
8613924|NCT00437203|9651547|FG000|COMPLETED|Overall Study||0
8715549|NCT00984282|9762467|FG000|Received Treatment|Open-label Treatment|Subjects at Risk/Safety Population - in RG3 (RG= Reporting Group for Safety Data)|86
8715550|NCT00984282|9762468|FG001|Received Treatment|Open-label Treatment|Subjects at Risk/Safety Population - in RG4 (RG= Reporting Group for Safety Data)|161
8715551|NCT00984282|9762467|FG000|COMPLETED|Open-label Treatment||0
8715552|NCT00984282|9762468|FG001|COMPLETED|Open-label Treatment||0
8715553|NCT00984282|9762467|FG000|NOT COMPLETED|Open-label Treatment||86
8715554|NCT00984282|9762468|FG001|NOT COMPLETED|Open-label Treatment||161
8715555|NCT00984282|9762467|FG000|STARTED|Long Term Follow-up|Participants entered long-term follow-up if terminated double-blind or open-label periods|72
8715556|NCT00984282|9762468|FG001|STARTED|Long Term Follow-up|Participants entered long-term follow-up if terminated double-blind or open-label periods|124
8715557|NCT00984282|9762467|FG000|COMPLETED|Long Term Follow-up||3
8715558|NCT00984282|9762468|FG001|COMPLETED|Long Term Follow-up||4
8715559|NCT00984282|9762467|FG000|NOT COMPLETED|Long Term Follow-up||69
8715560|NCT00984282|9762468|FG001|NOT COMPLETED|Long Term Follow-up||120
8715561|NCT00984295|9762479|FG000|STARTED|Overall Study|2 patients were incorrectly vaccinated and are excluded from this table.|949
8715562|NCT00984295|9762480|FG001|STARTED|Overall Study||485
8715563|NCT00984295|9762481|FG002|STARTED|Overall Study||479
8715564|NCT00984295|9762479|FG000|Visit 1|Overall Study||949
8613925|NCT00437203|9651548|FG001|COMPLETED|Overall Study||0
8613926|NCT00437203|9651549|FG002|COMPLETED|Overall Study||0
8613927|NCT00437203|9651550|FG003|COMPLETED|Overall Study||0
8613928|NCT00437203|9651551|FG004|COMPLETED|Overall Study||0
8613929|NCT00437203|9651552|FG005|COMPLETED|Overall Study||0
8613930|NCT00437203|9651553|FG006|COMPLETED|Overall Study||0
8613931|NCT00437203|9651554|FG007|COMPLETED|Overall Study||0
8613932|NCT00437203|9651555|FG008|COMPLETED|Overall Study||0
8613933|NCT00437203|9651556|FG009|COMPLETED|Overall Study||0
8613934|NCT00437203|9651547|FG000|NOT COMPLETED|Overall Study||6
8613935|NCT00437203|9651548|FG001|NOT COMPLETED|Overall Study||8
8613936|NCT00437203|9651549|FG002|NOT COMPLETED|Overall Study||3
8613937|NCT00437203|9651550|FG003|NOT COMPLETED|Overall Study||3
8613938|NCT00437203|9651551|FG004|NOT COMPLETED|Overall Study||3
8613939|NCT00437203|9651552|FG005|NOT COMPLETED|Overall Study||3
8613940|NCT00437203|9651553|FG006|NOT COMPLETED|Overall Study||7
8613941|NCT00437203|9651554|FG007|NOT COMPLETED|Overall Study||3
8613942|NCT00437203|9651555|FG008|NOT COMPLETED|Overall Study||3
8613943|NCT00437203|9651556|FG009|NOT COMPLETED|Overall Study||4
8613944|NCT00437268|9651589|FG000|STARTED|Overall Study||13
8613945|NCT00437268|9651590|FG001|STARTED|Overall Study||13
8613946|NCT00437268|9651589|FG000|Received at Least 1 Dose of Study Drug|Overall Study||13
8613947|NCT00437268|9651590|FG001|Received at Least 1 Dose of Study Drug|Overall Study||13
8613948|NCT00437268|9651589|FG000|Protocol Qualified (PQ) Participant|Overall Study|PQ population: randomized participants without an immune reaction to cetuximab after the first dose|13
8613949|NCT00437268|9651590|FG001|Protocol Qualified (PQ) Participant|Overall Study|PQ population: randomized participants without an immune reaction to cetuximab after the first dose|12
8613950|NCT00437268|9651589|FG000|COMPLETED|Overall Study||0
8613951|NCT00437268|9651590|FG001|COMPLETED|Overall Study||0
8613952|NCT00437268|9651589|FG000|NOT COMPLETED|Overall Study||13
8613953|NCT00437268|9651590|FG001|NOT COMPLETED|Overall Study||13
8613954|NCT00437281|9651618|FG000|STARTED|Overall Study||3
8613955|NCT00437281|9651619|FG001|STARTED|Overall Study||3
8613956|NCT00437281|9651620|FG002|STARTED|Overall Study||3
8613957|NCT00437281|9651621|FG003|STARTED|Overall Study||3
8613958|NCT00437281|9651622|FG004|STARTED|Overall Study||4
8613959|NCT00437281|9651623|FG005|STARTED|Overall Study||4
8613960|NCT00437281|9651624|FG006|STARTED|Overall Study||3
8613961|NCT00437281|9651625|FG007|STARTED|Overall Study||3
8613962|NCT00437281|9651626|FG008|STARTED|Overall Study||3
8613963|NCT00437281|9651627|FG009|STARTED|Overall Study||5
8613964|NCT00437281|9651628|FG010|STARTED|Overall Study||3
8613965|NCT00437281|9651629|FG011|STARTED|Overall Study||3
8613966|NCT00437281|9651630|FG012|STARTED|Overall Study||2
8613967|NCT00437281|9651631|FG013|STARTED|Overall Study||3
8613968|NCT00437281|9651632|FG014|STARTED|Overall Study||5
8613969|NCT00437281|9651633|FG015|STARTED|Overall Study||3
8613970|NCT00437281|9651634|FG016|STARTED|Overall Study||3
8613971|NCT00437281|9651635|FG017|STARTED|Overall Study||4
8613972|NCT00437281|9651636|FG018|STARTED|Overall Study||2
8613973|NCT00437281|9651637|FG019|STARTED|Overall Study||3
8613974|NCT00437281|9651618|FG000|COMPLETED|Overall Study||3
8715565|NCT00984295|9762480|FG001|Visit 1|Overall Study||485
8715566|NCT00984295|9762481|FG002|Visit 1|Overall Study||479
8613975|NCT00437281|9651619|FG001|COMPLETED|Overall Study||3
8613976|NCT00437281|9651620|FG002|COMPLETED|Overall Study||3
8613977|NCT00437281|9651621|FG003|COMPLETED|Overall Study||2
8613978|NCT00437281|9651622|FG004|COMPLETED|Overall Study||4
8613979|NCT00437281|9651623|FG005|COMPLETED|Overall Study||3
8613980|NCT00437281|9651624|FG006|COMPLETED|Overall Study||3
8613981|NCT00437281|9651625|FG007|COMPLETED|Overall Study||3
8613982|NCT00437281|9651626|FG008|COMPLETED|Overall Study||3
8613983|NCT00437281|9651627|FG009|COMPLETED|Overall Study||4
8613984|NCT00437281|9651628|FG010|COMPLETED|Overall Study||3
8613985|NCT00437281|9651629|FG011|COMPLETED|Overall Study||3
8613986|NCT00437281|9651630|FG012|COMPLETED|Overall Study||2
8613987|NCT00437281|9651631|FG013|COMPLETED|Overall Study||2
8613988|NCT00437281|9651632|FG014|COMPLETED|Overall Study||4
8613989|NCT00437281|9651633|FG015|COMPLETED|Overall Study||3
8613990|NCT00437281|9651634|FG016|COMPLETED|Overall Study||3
8613991|NCT00437281|9651635|FG017|COMPLETED|Overall Study||4
8613992|NCT00437281|9651636|FG018|COMPLETED|Overall Study||1
8613993|NCT00437281|9651637|FG019|COMPLETED|Overall Study||2
8613994|NCT00437281|9651618|FG000|NOT COMPLETED|Overall Study||0
8613995|NCT00437281|9651619|FG001|NOT COMPLETED|Overall Study||0
8613996|NCT00437281|9651620|FG002|NOT COMPLETED|Overall Study||0
8613997|NCT00437281|9651621|FG003|NOT COMPLETED|Overall Study||1
8613998|NCT00437281|9651622|FG004|NOT COMPLETED|Overall Study||0
8613999|NCT00437281|9651623|FG005|NOT COMPLETED|Overall Study||1
8614000|NCT00437281|9651624|FG006|NOT COMPLETED|Overall Study||0
8614001|NCT00437281|9651625|FG007|NOT COMPLETED|Overall Study||0
8614002|NCT00437281|9651626|FG008|NOT COMPLETED|Overall Study||0
8614003|NCT00437281|9651627|FG009|NOT COMPLETED|Overall Study||1
8614004|NCT00437281|9651628|FG010|NOT COMPLETED|Overall Study||0
8614005|NCT00437281|9651629|FG011|NOT COMPLETED|Overall Study||0
8614006|NCT00437281|9651630|FG012|NOT COMPLETED|Overall Study||0
8614007|NCT00437281|9651631|FG013|NOT COMPLETED|Overall Study||1
8614008|NCT00437281|9651632|FG014|NOT COMPLETED|Overall Study||1
8614009|NCT00437281|9651633|FG015|NOT COMPLETED|Overall Study||0
8614010|NCT00437281|9651634|FG016|NOT COMPLETED|Overall Study||0
8614011|NCT00437281|9651635|FG017|NOT COMPLETED|Overall Study||0
8614012|NCT00437281|9651636|FG018|NOT COMPLETED|Overall Study||1
8614013|NCT00437281|9651637|FG019|NOT COMPLETED|Overall Study||1
8614014|NCT00437294|9651711|FG000|STARTED|Overall Study||43
8614015|NCT00437294|9651712|FG001|STARTED|Overall Study||43
8614016|NCT00437294|9651711|FG000|Received at Least 1 Dose of Study Drug|Overall Study||42
8614017|NCT00437294|9651712|FG001|Received at Least 1 Dose of Study Drug|Overall Study||43
8614018|NCT00437294|9651711|FG000|COMPLETED|Overall Study||0
8614019|NCT00437294|9651712|FG001|COMPLETED|Overall Study||0
8614020|NCT00437294|9651711|FG000|NOT COMPLETED|Overall Study||43
8614021|NCT00437294|9651712|FG001|NOT COMPLETED|Overall Study||43
8614022|NCT00437489|9651726|FG000|STARTED|Overall Study||25
8614023|NCT00437489|9651727|FG001|STARTED|Overall Study||24
8614024|NCT00437489|9651726|FG000|COMPLETED|Overall Study|2 subjects completed prior to study termination.|2
8614025|NCT00437489|9651727|FG001|COMPLETED|Overall Study|2 subjects completed prior to study termination.|2
8614026|NCT00437489|9651726|FG000|NOT COMPLETED|Overall Study||23
8614027|NCT00437489|9651727|FG001|NOT COMPLETED|Overall Study||22
8614028|NCT00437645|9651735|FG000|STARTED|Overall Study||592
8614029|NCT00437645|9651736|FG001|STARTED|Overall Study||591
8614030|NCT00437645|9651735|FG000|COMPLETED|Overall Study||557
8614031|NCT00437645|9651736|FG001|COMPLETED|Overall Study||476
8614032|NCT00437645|9651735|FG000|NOT COMPLETED|Overall Study||35
8614033|NCT00437645|9651736|FG001|NOT COMPLETED|Overall Study||115
8614034|NCT00437658|9651745|FG000|STARTED|Treatment Period (24 Weeks)||84
8614035|NCT00437658|9651746|FG001|STARTED|Treatment Period (24 Weeks)||84
8614036|NCT00437658|9651747|FG002|STARTED|Treatment Period (24 Weeks)||84
8614037|NCT00437658|9651745|FG000|Received Study Drug|Treatment Period (24 Weeks)||84
8614038|NCT00437658|9651746|FG001|Received Study Drug|Treatment Period (24 Weeks)||84
8614039|NCT00437658|9651747|FG002|Received Study Drug|Treatment Period (24 Weeks)||84
8614040|NCT00437658|9651745|FG000|COMPLETED|Treatment Period (24 Weeks)||56
8614041|NCT00437658|9651746|FG001|COMPLETED|Treatment Period (24 Weeks)||62
8614042|NCT00437658|9651747|FG002|COMPLETED|Treatment Period (24 Weeks)||51
8614043|NCT00437658|9651745|FG000|NOT COMPLETED|Treatment Period (24 Weeks)||28
8614044|NCT00437658|9651746|FG001|NOT COMPLETED|Treatment Period (24 Weeks)||22
8715567|NCT00984295|9762479|FG000|Visit 2|Overall Study||909
8715568|NCT00984295|9762480|FG001|Visit 2|Overall Study||468
8715569|NCT00984295|9762481|FG002|Visit 2|Overall Study||453
8715570|NCT00984295|9762479|FG000|COMPLETED|Overall Study||884
8715571|NCT00984295|9762480|FG001|COMPLETED|Overall Study||453
8715572|NCT00984295|9762481|FG002|COMPLETED|Overall Study||442
8614045|NCT00437658|9651747|FG002|NOT COMPLETED|Treatment Period (24 Weeks)||33
8614046|NCT00437658|9651745|FG000|STARTED|Post-treatment Period (24 Weeks)||56
8614047|NCT00437658|9651746|FG001|STARTED|Post-treatment Period (24 Weeks)||62
8614048|NCT00437658|9651747|FG002|STARTED|Post-treatment Period (24 Weeks)||51
8614049|NCT00437658|9651745|FG000|COMPLETED|Post-treatment Period (24 Weeks)||32
8614050|NCT00437658|9651746|FG001|COMPLETED|Post-treatment Period (24 Weeks)||54
8715573|NCT00984295|9762479|FG000|NOT COMPLETED|Overall Study||65
8715574|NCT00984295|9762480|FG001|NOT COMPLETED|Overall Study||32
8614051|NCT00437658|9651747|FG002|COMPLETED|Post-treatment Period (24 Weeks)||37
8614052|NCT00437658|9651745|FG000|NOT COMPLETED|Post-treatment Period (24 Weeks)||24
8614053|NCT00437658|9651746|FG001|NOT COMPLETED|Post-treatment Period (24 Weeks)||8
8614054|NCT00437658|9651747|FG002|NOT COMPLETED|Post-treatment Period (24 Weeks)||14
8614055|NCT00437983|9651757|FG000|STARTED|Overall Study||79
8614056|NCT00437983|9651758|FG001|STARTED|Overall Study||78
8614057|NCT00437983|9651757|FG000|COMPLETED|Overall Study||66
8614058|NCT00437983|9651758|FG001|COMPLETED|Overall Study||65
8614059|NCT00437983|9651757|FG000|NOT COMPLETED|Overall Study||13
8614060|NCT00437983|9651758|FG001|NOT COMPLETED|Overall Study||13
8614061|NCT00438100|9651766|FG000|STARTED|Overall Study||73
8614062|NCT00438100|9651767|FG001|STARTED|Overall Study||69
8614063|NCT00438100|9651766|FG000|COMPLETED|Overall Study||71
8614064|NCT00438100|9651767|FG001|COMPLETED|Overall Study||65
8614065|NCT00438100|9651766|FG000|NOT COMPLETED|Overall Study||2
8614066|NCT00438100|9651767|FG001|NOT COMPLETED|Overall Study||4
8614067|NCT00438191|9651775|FG000|STARTED|Overall Study||43
8614068|NCT00438191|9651776|FG001|STARTED|Overall Study||40
8614069|NCT00438191|9651775|FG000|COMPLETED|Overall Study||32
8614070|NCT00438191|9651776|FG001|COMPLETED|Overall Study||26
8614071|NCT00438191|9651775|FG000|NOT COMPLETED|Overall Study||11
8614072|NCT00438191|9651776|FG001|NOT COMPLETED|Overall Study||14
8629294|NCT00529373|9668999|FG001|STARTED|Base Study||8028
8629295|NCT00529373|9668998|FG000|COMPLETED|Base Study||4297
8629296|NCT00529373|9668999|FG001|COMPLETED|Base Study||3960
8629297|NCT00529373|9668998|FG000|NOT COMPLETED|Base Study||3746
8629298|NCT00529373|9668999|FG001|NOT COMPLETED|Base Study||4068
8629299|NCT00529373|9668998|FG000|STARTED|First Extension Study||4297
8629300|NCT00529373|9668999|FG001|STARTED|First Extension Study||3960
8629301|NCT00529373|9668998|FG000|COMPLETED|First Extension Study||3144
8629302|NCT00529373|9668999|FG001|COMPLETED|First Extension Study||2309
8629303|NCT00529373|9668998|FG000|NOT COMPLETED|First Extension Study||1153
8629304|NCT00529373|9668999|FG001|NOT COMPLETED|First Extension Study||1651
8629305|NCT00529373|9668998|FG000|STARTED|Second Extension Study||3144
8629306|NCT00529373|9668999|FG001|STARTED|Second Extension Study||2309
8629307|NCT00529373|9668998|FG000|COMPLETED|Second Extension Study||2844
8629308|NCT00529373|9668999|FG001|COMPLETED|Second Extension Study||2112
8629309|NCT00529373|9668998|FG000|NOT COMPLETED|Second Extension Study||300
8629310|NCT00529373|9668999|FG001|NOT COMPLETED|Second Extension Study||197
8629311|NCT00529386|9669013|FG000|STARTED|Overall Study|Study has been discontinued|7
8629312|NCT00529386|9669013|FG000|COMPLETED|Overall Study|Study discontinued after 7 patients enrolled and analyzed|6
8629313|NCT00529386|9669013|FG000|NOT COMPLETED|Overall Study||1
8629314|NCT00529399|9669020|FG000|STARTED|Overall Study||48
8629315|NCT00529399|9669021|FG001|STARTED|Overall Study||49
8629316|NCT00529399|9669022|FG002|STARTED|Overall Study||48
8629317|NCT00529399|9669020|FG000|COMPLETED|Overall Study||46
8629318|NCT00529399|9669021|FG001|COMPLETED|Overall Study||48
8629319|NCT00529399|9669022|FG002|COMPLETED|Overall Study||46
8629320|NCT00529399|9669020|FG000|NOT COMPLETED|Overall Study||2
8629321|NCT00529399|9669021|FG001|NOT COMPLETED|Overall Study||1
8629322|NCT00529399|9669022|FG002|NOT COMPLETED|Overall Study||2
8629323|NCT00529451|9669034|FG000|STARTED|Overall Study||331
8629324|NCT00529451|9669035|FG001|STARTED|Overall Study||323
8629325|NCT00529451|9669036|FG002|STARTED|Overall Study||332
8629326|NCT00529451|9669037|FG003|STARTED|Overall Study||330
8629327|NCT00529451|9669034|FG000|COMPLETED|Overall Study||294
8629328|NCT00529451|9669035|FG001|COMPLETED|Overall Study||275
8629329|NCT00529451|9669036|FG002|COMPLETED|Overall Study||292
8629330|NCT00529451|9669037|FG003|COMPLETED|Overall Study||299
8629331|NCT00529451|9669034|FG000|NOT COMPLETED|Overall Study||37
8629332|NCT00529451|9669035|FG001|NOT COMPLETED|Overall Study||48
8629333|NCT00529451|9669036|FG002|NOT COMPLETED|Overall Study||40
8629334|NCT00529451|9669037|FG003|NOT COMPLETED|Overall Study||31
8629335|NCT00529516|9669053|FG000|STARTED|Overall Study||475
8715575|NCT00984295|9762481|FG002|NOT COMPLETED|Overall Study||37
8715576|NCT00984308|9762491|FG000|STARTED|Overall Study||110
8715577|NCT00984308|9762492|FG001|STARTED|Overall Study||115
8715578|NCT00984308|9762491|FG000|COMPLETED|Overall Study||92
8715579|NCT00984308|9762492|FG001|COMPLETED|Overall Study||109
8715580|NCT00984308|9762491|FG000|NOT COMPLETED|Overall Study||18
8715581|NCT00984308|9762492|FG001|NOT COMPLETED|Overall Study||6
8715582|NCT00984334|9762503|FG000|STARTED|Overall Study||8
8715583|NCT00984334|9762504|FG001|STARTED|Overall Study||8
8715584|NCT00984334|9762505|FG002|STARTED|Overall Study||8
8629336|NCT00529516|9669054|FG001|STARTED|Overall Study||488
8629337|NCT00529516|9669055|FG002|STARTED|Overall Study||289
8715585|NCT00984334|9762506|FG003|STARTED|Overall Study||8
8715586|NCT00984334|9762507|FG004|STARTED|Overall Study||8
8715587|NCT00984334|9762503|FG000|COMPLETED|Overall Study||7
8629338|NCT00529516|9669053|FG000|COMPLETED|Overall Study||472
8629339|NCT00529516|9669054|FG001|COMPLETED|Overall Study||486
8629340|NCT00529516|9669055|FG002|COMPLETED|Overall Study||288
8629341|NCT00529516|9669053|FG000|NOT COMPLETED|Overall Study||3
8629342|NCT00529516|9669054|FG001|NOT COMPLETED|Overall Study||2
8629343|NCT00529516|9669055|FG002|NOT COMPLETED|Overall Study||1
8629344|NCT00529529|9669066|FG000|STARTED|Overall Study||268
8629345|NCT00529529|9669067|FG001|STARTED|Overall Study||268
8629346|NCT00529529|9669068|FG002|STARTED|Overall Study||269
8629347|NCT00529529|9669066|FG000|COMPLETED|Overall Study||225
8715588|NCT00984334|9762504|FG001|COMPLETED|Overall Study||7
8715589|NCT00984334|9762505|FG002|COMPLETED|Overall Study||8
8614073|NCT00438204|9651782|FG000|STARTED|Overall Study||39
8614074|NCT00438204|9651782|FG000|COMPLETED|Overall Study||39
8614075|NCT00438204|9651782|FG000|NOT COMPLETED|Overall Study||0
8614076|NCT00438256|9651787|FG000|STARTED|Overall Study||3
8614077|NCT00438256|9651788|FG001|STARTED|Overall Study||3
8614078|NCT00438256|9651789|FG002|STARTED|Overall Study||3
8614079|NCT00438256|9651790|FG003|STARTED|Overall Study||41
8614080|NCT00438256|9651787|FG000|Surgical Resection|Overall Study||1
8614081|NCT00438256|9651788|FG001|Surgical Resection|Overall Study||2
8614082|NCT00438256|9651789|FG002|Surgical Resection|Overall Study||2
8614083|NCT00438256|9651790|FG003|Surgical Resection|Overall Study||34
8614084|NCT00438256|9651787|FG000|COMPLETED|Overall Study||1
8614085|NCT00438256|9651788|FG001|COMPLETED|Overall Study||2
8614086|NCT00438256|9651789|FG002|COMPLETED|Overall Study||2
8614087|NCT00438256|9651790|FG003|COMPLETED|Overall Study||32
8614088|NCT00438256|9651787|FG000|NOT COMPLETED|Overall Study||2
8614089|NCT00438256|9651788|FG001|NOT COMPLETED|Overall Study||1
8614090|NCT00438256|9651789|FG002|NOT COMPLETED|Overall Study||1
8614091|NCT00438256|9651790|FG003|NOT COMPLETED|Overall Study||9
8614092|NCT00438360|9651805|FG000|STARTED|Overall Study|"Started indicates randomized patients."|162
8614093|NCT00438360|9651806|FG001|STARTED|Overall Study||81
8614094|NCT00438360|9651805|FG000|Intention to Treat (ITT) Population|Overall Study|These numbers are different from those started (randomized) as 2 pts from each arm never took drug.|160
8614095|NCT00438360|9651806|FG001|Intention to Treat (ITT) Population|Overall Study||79
8614096|NCT00438360|9651805|FG000|COMPLETED|Overall Study||90
8614097|NCT00438360|9651806|FG001|COMPLETED|Overall Study||38
8614098|NCT00438360|9651805|FG000|NOT COMPLETED|Overall Study||72
8614099|NCT00438360|9651806|FG001|NOT COMPLETED|Overall Study||43
8614100|NCT00438399|9651815|FG000|STARTED|Overall Study||38
8614101|NCT00438399|9651816|FG001|STARTED|Overall Study||40
8614102|NCT00438399|9651817|FG002|STARTED|Overall Study||35
8614103|NCT00438399|9651818|FG003|STARTED|Overall Study||36
8614104|NCT00438399|9651819|FG004|STARTED|Overall Study||33
8614105|NCT00438399|9651820|FG005|STARTED|Overall Study||37
8614106|NCT00438399|9651815|FG000|TREATED & ANALYZED|Overall Study||30
8614107|NCT00438399|9651816|FG001|TREATED & ANALYZED|Overall Study||32
8614108|NCT00438399|9651817|FG002|TREATED & ANALYZED|Overall Study||28
8614109|NCT00438399|9651818|FG003|TREATED & ANALYZED|Overall Study||32
8614110|NCT00438399|9651819|FG004|TREATED & ANALYZED|Overall Study||30
8614111|NCT00438399|9651820|FG005|TREATED & ANALYZED|Overall Study||31
8614112|NCT00438399|9651815|FG000|COMPLETED|Overall Study||30
8614113|NCT00438399|9651816|FG001|COMPLETED|Overall Study||32
8614114|NCT00438399|9651817|FG002|COMPLETED|Overall Study||28
8614115|NCT00438399|9651818|FG003|COMPLETED|Overall Study||32
8614116|NCT00438399|9651819|FG004|COMPLETED|Overall Study||30
8614117|NCT00438399|9651820|FG005|COMPLETED|Overall Study||31
8614118|NCT00438399|9651815|FG000|NOT COMPLETED|Overall Study||8
8614119|NCT00438399|9651816|FG001|NOT COMPLETED|Overall Study||8
8614120|NCT00438399|9651817|FG002|NOT COMPLETED|Overall Study||7
8614121|NCT00438399|9651818|FG003|NOT COMPLETED|Overall Study||4
8614122|NCT00438399|9651819|FG004|NOT COMPLETED|Overall Study||3
8614123|NCT00438399|9651820|FG005|NOT COMPLETED|Overall Study||6
8614124|NCT00438451|9651832|FG000|STARTED|Overall Study||122
8614125|NCT00438451|9651833|FG001|STARTED|Overall Study||121
8614126|NCT00438451|9651834|FG002|STARTED|Overall Study||118
8614127|NCT00438451|9651832|FG000|Safety Population|Overall Study||122
8614128|NCT00438451|9651833|FG001|Safety Population|Overall Study||121
8614129|NCT00438451|9651834|FG002|Safety Population|Overall Study||117
8614130|NCT00438451|9651832|FG000|ITT Population|Overall Study||122
8614131|NCT00438451|9651833|FG001|ITT Population|Overall Study||120
8614132|NCT00438451|9651834|FG002|ITT Population|Overall Study||117
8614133|NCT00438451|9651832|FG000|Maintenance Phase (Week 7-58)|Overall Study||93
8614134|NCT00438451|9651833|FG001|Maintenance Phase (Week 7-58)|Overall Study||89
8614135|NCT00438451|9651834|FG002|Maintenance Phase (Week 7-58)|Overall Study||93
8614136|NCT00438451|9651832|FG000|COMPLETED|Overall Study||75
8614137|NCT00438451|9651833|FG001|COMPLETED|Overall Study||55
8614138|NCT00438451|9651834|FG002|COMPLETED|Overall Study||65
8614139|NCT00438451|9651832|FG000|NOT COMPLETED|Overall Study||47
8614140|NCT00438451|9651833|FG001|NOT COMPLETED|Overall Study||66
8614141|NCT00438451|9651834|FG002|NOT COMPLETED|Overall Study||53
8614142|NCT00438464|9651844|FG000|STARTED|Overall Study||103
8614143|NCT00438464|9651845|FG001|STARTED|Overall Study||101
8614144|NCT00438464|9651844|FG000|Received Assigned Intervention|Overall Study||89
8614145|NCT00438464|9651845|FG001|Received Assigned Intervention|Overall Study||94
8614146|NCT00438464|9651844|FG000|COMPLETED|Overall Study||89
8614147|NCT00438464|9651845|FG001|COMPLETED|Overall Study||94
8614148|NCT00438464|9651844|FG000|NOT COMPLETED|Overall Study||14
8614149|NCT00438464|9651845|FG001|NOT COMPLETED|Overall Study||7
8614150|NCT00438490|9651865|FG000|STARTED|Overall Study||12
8614151|NCT00438490|9651866|FG001|STARTED|Overall Study||9
8614152|NCT00438490|9651865|FG000|COMPLETED|Overall Study||12
8614153|NCT00438490|9651866|FG001|COMPLETED|Overall Study||9
8614154|NCT00438490|9651865|FG000|NOT COMPLETED|Overall Study||0
8614155|NCT00438490|9651866|FG001|NOT COMPLETED|Overall Study||0
8614156|NCT00438633|9651878|FG000|STARTED|Overall Study||32
8614157|NCT00438633|9651879|FG001|STARTED|Overall Study||31
8614158|NCT00438633|9651878|FG000|3-month Follow-up|Overall Study||26
8614159|NCT00438633|9651879|FG001|3-month Follow-up|Overall Study||24
8614160|NCT00438633|9651878|FG000|COMPLETED|Overall Study||16
8614161|NCT00438633|9651879|FG001|COMPLETED|Overall Study||14
8614162|NCT00438633|9651878|FG000|NOT COMPLETED|Overall Study||16
8614163|NCT00438633|9651879|FG001|NOT COMPLETED|Overall Study||17
8614164|NCT00438659|9651887|FG000|STARTED|Overall Study||90
8614165|NCT00438659|9651888|FG001|STARTED|Overall Study||86
8614166|NCT00438659|9651887|FG000|COMPLETED|Overall Study||84
8614167|NCT00438659|9651888|FG001|COMPLETED|Overall Study||82
8614168|NCT00438659|9651887|FG000|NOT COMPLETED|Overall Study||6
8614169|NCT00438659|9651888|FG001|NOT COMPLETED|Overall Study||4
8614170|NCT00438672|9651897|FG000|STARTED|Overall Study||31
8614171|NCT00438672|9651898|FG001|STARTED|Overall Study||33
8614172|NCT00438672|9651897|FG000|COMPLETED|Overall Study||24
8614173|NCT00438672|9651898|FG001|COMPLETED|Overall Study||24
8614174|NCT00438672|9651897|FG000|NOT COMPLETED|Overall Study||7
8614175|NCT00438672|9651898|FG001|NOT COMPLETED|Overall Study||9
8614176|NCT00438750|9651906|FG000|STARTED|Overall Study||48
8614177|NCT00438750|9651907|FG001|STARTED|Overall Study||46
8614178|NCT00438750|9651906|FG000|COMPLETED|Overall Study||39
8614179|NCT00438750|9651907|FG001|COMPLETED|Overall Study||37
8614180|NCT00438750|9651906|FG000|NOT COMPLETED|Overall Study||9
8614181|NCT00438750|9651907|FG001|NOT COMPLETED|Overall Study||9
8614182|NCT00438802|9651916|FG000|STARTED|Overall Study||6
8614183|NCT00438802|9651917|FG001|STARTED|Overall Study||8
8614184|NCT00438802|9651918|FG002|STARTED|Overall Study||9
8614185|NCT00438802|9651916|FG000|COMPLETED|Overall Study||6
8614186|NCT00438802|9651917|FG001|COMPLETED|Overall Study||8
8614187|NCT00438802|9651918|FG002|COMPLETED|Overall Study||9
8614188|NCT00438802|9651916|FG000|NOT COMPLETED|Overall Study||0
8614189|NCT00438802|9651917|FG001|NOT COMPLETED|Overall Study||0
8614190|NCT00438802|9651918|FG002|NOT COMPLETED|Overall Study||0
8614191|NCT00438815|9651928|FG000|STARTED|Overall Study||113
8614192|NCT00438815|9651928|FG000|COMPLETED|Overall Study||43
8614193|NCT00438815|9651928|FG000|NOT COMPLETED|Overall Study||70
8614194|NCT00438854|9651932|FG000|STARTED|Overall Study||15
8614195|NCT00438854|9651932|FG000|COMPLETED|Overall Study||15
8614196|NCT00438854|9651932|FG000|NOT COMPLETED|Overall Study||0
8614197|NCT00438880|9651938|FG000|STARTED|Overall Study||30
8614198|NCT00438880|9651939|FG001|STARTED|Overall Study||8
8614199|NCT00438880|9651938|FG000|COMPLETED|Overall Study||30
8614200|NCT00438880|9651939|FG001|COMPLETED|Overall Study||8
8614201|NCT00438880|9651938|FG000|NOT COMPLETED|Overall Study||0
8614202|NCT00438880|9651939|FG001|NOT COMPLETED|Overall Study||0
8614203|NCT00438932|9651949|FG000|STARTED|Overall Study||4
8614204|NCT00438932|9651950|FG001|STARTED|Overall Study||4
8614205|NCT00438932|9651951|FG002|STARTED|Overall Study||4
8614206|NCT00438932|9651952|FG003|STARTED|Overall Study||4
8614207|NCT00438932|9651949|FG000|COMPLETED|Overall Study||4
8614208|NCT00438932|9651950|FG001|COMPLETED|Overall Study||4
8614209|NCT00438932|9651951|FG002|COMPLETED|Overall Study||4
8614210|NCT00438932|9651952|FG003|COMPLETED|Overall Study||4
8614211|NCT00438932|9651949|FG000|NOT COMPLETED|Overall Study||0
8614212|NCT00438932|9651950|FG001|NOT COMPLETED|Overall Study||0
8614213|NCT00438932|9651951|FG002|NOT COMPLETED|Overall Study||0
8614214|NCT00438932|9651952|FG003|NOT COMPLETED|Overall Study||0
8614215|NCT00438971|9651962|FG000|STARTED|Overall Study||17
8614216|NCT00438971|9651962|FG000|COMPLETED|Overall Study||15
8614217|NCT00438971|9651962|FG000|NOT COMPLETED|Overall Study||2
8614218|NCT00439140|9651970|FG000|STARTED|Treatment Cycle 1||15
8614219|NCT00439140|9651971|FG001|STARTED|Treatment Cycle 1||14
8614220|NCT00439140|9651972|FG002|STARTED|Treatment Cycle 1||12
8614221|NCT00439140|9651970|FG000|COMPLETED|Treatment Cycle 1||14
8614222|NCT00439140|9651971|FG001|COMPLETED|Treatment Cycle 1||10
8614223|NCT00439140|9651972|FG002|COMPLETED|Treatment Cycle 1|5 patients did not enter Cycle 2. 6 patients received botulinum toxin Type A in Cycle 2.|11
8614224|NCT00439140|9651970|FG000|NOT COMPLETED|Treatment Cycle 1||1
8614225|NCT00439140|9651971|FG001|NOT COMPLETED|Treatment Cycle 1||4
8614226|NCT00439140|9651972|FG002|NOT COMPLETED|Treatment Cycle 1||1
8614227|NCT00439140|9651970|FG000|STARTED|Treatment Cycle 2|8 patients from the 200U arm plus 5 patients from the placebo arm in Cycle 1 entered Cycle 2.|13
8614228|NCT00439140|9651971|FG001|STARTED|Treatment Cycle 2|6 patients from the 300U arm plus 1 patient from the placebo arm in Cycle 1 entered Cycle 2.|7
8614229|NCT00439140|9651972|FG002|STARTED|Treatment Cycle 2|No patients received placebo in Cycle 2.|0
8614230|NCT00439140|9651970|FG000|COMPLETED|Treatment Cycle 2||11
8614231|NCT00439140|9651971|FG001|COMPLETED|Treatment Cycle 2||6
8614232|NCT00439140|9651972|FG002|COMPLETED|Treatment Cycle 2||0
8614233|NCT00439140|9651970|FG000|NOT COMPLETED|Treatment Cycle 2||2
8614234|NCT00439140|9651971|FG001|NOT COMPLETED|Treatment Cycle 2||1
8614235|NCT00439140|9651972|FG002|NOT COMPLETED|Treatment Cycle 2||0
8614236|NCT00439179|9651984|FG000|STARTED|Overall Study|1 with biliary|3
8614237|NCT00439179|9651985|FG001|STARTED|Overall Study|2 with biliary|13
8614238|NCT00439179|9651986|FG002|STARTED|Overall Study|2 with biliary|6
8614239|NCT00439179|9651987|FG003|STARTED|Overall Study|2 with biliry|5
8614240|NCT00439179|9651984|FG000|COMPLETED|Overall Study||3
8614241|NCT00439179|9651985|FG001|COMPLETED|Overall Study||11
8614242|NCT00439179|9651986|FG002|COMPLETED|Overall Study||6
8614243|NCT00439179|9651987|FG003|COMPLETED|Overall Study||5
8614244|NCT00439179|9651984|FG000|NOT COMPLETED|Overall Study||0
8614245|NCT00439179|9651985|FG001|NOT COMPLETED|Overall Study||2
8614246|NCT00439179|9651986|FG002|NOT COMPLETED|Overall Study||0
8614247|NCT00439179|9651987|FG003|NOT COMPLETED|Overall Study||0
8614248|NCT00439218|9652000|FG000|STARTED|Cohort 1 (500 mg/kg/Day)||4
8629348|NCT00529529|9669067|FG001|COMPLETED|Overall Study||225
8614249|NCT00439218|9652000|FG000|COMPLETED|Cohort 1 (500 mg/kg/Day)|3 subjects completed the study in Cohort 1. Cohort 2 was then opened for new enrollments.|3
8614250|NCT00439218|9652000|FG000|NOT COMPLETED|Cohort 1 (500 mg/kg/Day)||1
8614251|NCT00439218|9652000|FG000|STARTED|Cohort 2 (500 mg/kg/Day)|One new subject was enrolled into the study after Cohort 1 completed the study.|1
8614252|NCT00439218|9652000|FG000|COMPLETED|Cohort 2 (500 mg/kg/Day)||1
8614253|NCT00439218|9652000|FG000|NOT COMPLETED|Cohort 2 (500 mg/kg/Day)||0
8614254|NCT00439231|9652004|FG000|STARTED|Overall Study||33
8614255|NCT00439231|9652004|FG000|COMPLETED|Overall Study|5 subjects had a partial response, 0 complete response, 28 completed off study,|5
8614256|NCT00439231|9652004|FG000|NOT COMPLETED|Overall Study||28
8614257|NCT00439244|9652011|FG000|STARTED|Overall Study|"Started indicates randomized as well as intent to treat (ITT) population enrolled to study."|137
8715590|NCT00984334|9762506|FG003|COMPLETED|Overall Study||7
8715591|NCT00984334|9762507|FG004|COMPLETED|Overall Study||7
8715592|NCT00984334|9762503|FG000|NOT COMPLETED|Overall Study||1
8715593|NCT00984334|9762504|FG001|NOT COMPLETED|Overall Study||1
8715594|NCT00984334|9762505|FG002|NOT COMPLETED|Overall Study||0
8715595|NCT00984334|9762506|FG003|NOT COMPLETED|Overall Study||1
8614258|NCT00439244|9652012|FG001|STARTED|Overall Study||137
8614259|NCT00439244|9652013|FG002|STARTED|Overall Study||138
8614260|NCT00439244|9652011|FG000|Safety Population|Overall Study|Total safety population is 411. One patient was randomized, but never received any study medication.|137
8614261|NCT00439244|9652012|FG001|Safety Population|Overall Study||137
8614262|NCT00439244|9652013|FG002|Safety Population|Overall Study||137
8614263|NCT00439244|9652011|FG000|COMPLETED|Overall Study||126
8614264|NCT00439244|9652012|FG001|COMPLETED|Overall Study||131
8614265|NCT00439244|9652013|FG002|COMPLETED|Overall Study||131
8614266|NCT00439244|9652011|FG000|NOT COMPLETED|Overall Study||11
8614267|NCT00439244|9652012|FG001|NOT COMPLETED|Overall Study||6
8614268|NCT00439244|9652013|FG002|NOT COMPLETED|Overall Study||7
8614269|NCT00439270|9652026|FG000|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
8614270|NCT00439270|9652027|FG001|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
8614271|NCT00439270|9652028|FG002|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
8614272|NCT00439270|9652029|FG003|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|4
8614273|NCT00439270|9652030|FG004|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
8614274|NCT00439270|9652026|FG000|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
8614275|NCT00439270|9652027|FG001|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
8614276|NCT00439270|9652028|FG002|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
8614277|NCT00439270|9652029|FG003|COMPLETED|Phase 1 (18.1 Months)|Remained on study|4
8614278|NCT00439270|9652030|FG004|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
8614279|NCT00439270|9652026|FG000|NOT COMPLETED|Phase 1 (18.1 Months)||3
8614280|NCT00439270|9652027|FG001|NOT COMPLETED|Phase 1 (18.1 Months)||3
8614281|NCT00439270|9652028|FG002|NOT COMPLETED|Phase 1 (18.1 Months)||3
8614282|NCT00439270|9652029|FG003|NOT COMPLETED|Phase 1 (18.1 Months)||0
8614283|NCT00439270|9652030|FG004|NOT COMPLETED|Phase 1 (18.1 Months)||3
8614284|NCT00439270|9652026|FG000|STARTED|Phase 2 (51.6 Months)||0
8614285|NCT00439270|9652027|FG001|STARTED|Phase 2 (51.6 Months)||0
8614286|NCT00439270|9652028|FG002|STARTED|Phase 2 (51.6 Months)||0
8614287|NCT00439270|9652029|FG003|STARTED|Phase 2 (51.6 Months)|Includes 4 patients who completed Phase 1|34
8614288|NCT00439270|9652030|FG004|STARTED|Phase 2 (51.6 Months)||0
8614289|NCT00439270|9652026|FG000|COMPLETED|Phase 2 (51.6 Months)||0
8614290|NCT00439270|9652027|FG001|COMPLETED|Phase 2 (51.6 Months)||0
8614291|NCT00439270|9652028|FG002|COMPLETED|Phase 2 (51.6 Months)||0
8614292|NCT00439270|9652029|FG003|COMPLETED|Phase 2 (51.6 Months)||0
8614293|NCT00439270|9652030|FG004|COMPLETED|Phase 2 (51.6 Months)||0
8614294|NCT00439270|9652026|FG000|NOT COMPLETED|Phase 2 (51.6 Months)||0
8614295|NCT00439270|9652027|FG001|NOT COMPLETED|Phase 2 (51.6 Months)||0
8614296|NCT00439270|9652028|FG002|NOT COMPLETED|Phase 2 (51.6 Months)||0
8614297|NCT00439270|9652029|FG003|NOT COMPLETED|Phase 2 (51.6 Months)||34
8614298|NCT00439270|9652030|FG004|NOT COMPLETED|Phase 2 (51.6 Months)||0
8614299|NCT00439296|9652051|FG000|STARTED|Overall Study||5
8614300|NCT00439296|9652052|FG001|STARTED|Overall Study||4
8614301|NCT00439296|9652051|FG000|Treatment Course 1|Overall Study||5
8614302|NCT00439296|9652052|FG001|Treatment Course 1|Overall Study||3
8614303|NCT00439296|9652051|FG000|Treatment Course 2|Overall Study||1
8614304|NCT00439296|9652052|FG001|Treatment Course 2|Overall Study||1
8614305|NCT00439296|9652051|FG000|COMPLETED|Overall Study||5
8614306|NCT00439296|9652052|FG001|COMPLETED|Overall Study||4
8614307|NCT00439296|9652051|FG000|NOT COMPLETED|Overall Study||0
8614308|NCT00439296|9652052|FG001|NOT COMPLETED|Overall Study||0
8614309|NCT00439309|9652060|FG000|STARTED|Treatment||54
8614310|NCT00439309|9652061|FG001|STARTED|Treatment||15
8614311|NCT00439309|9652060|FG000|COMPLETED|Treatment||54
8614312|NCT00439309|9652061|FG001|COMPLETED|Treatment||15
8614313|NCT00439309|9652060|FG000|NOT COMPLETED|Treatment||0
8614314|NCT00439309|9652061|FG001|NOT COMPLETED|Treatment||0
8614315|NCT00439309|9652060|FG000|STARTED|Follow-Up||54
8614316|NCT00439309|9652061|FG001|STARTED|Follow-Up||15
8715596|NCT00984334|9762507|FG004|NOT COMPLETED|Overall Study||1
8715597|NCT00984542|9762519|FG000|STARTED|Overall Study||50
8715598|NCT00984542|9762519|FG000|COMPLETED|Overall Study||9
8715599|NCT00984542|9762519|FG000|NOT COMPLETED|Overall Study||41
8715600|NCT00984568|9762526|FG000|STARTED|Overall Study||15
8715601|NCT00984568|9762527|FG001|STARTED|Overall Study||13
8715602|NCT00984568|9762526|FG000|COMPLETED|Overall Study||7
8614317|NCT00439309|9652060|FG000|COMPLETED|Follow-Up||51
8614318|NCT00439309|9652061|FG001|COMPLETED|Follow-Up||13
8614319|NCT00439309|9652060|FG000|NOT COMPLETED|Follow-Up||3
8614320|NCT00439309|9652061|FG001|NOT COMPLETED|Follow-Up||2
8614321|NCT00439335|9652069|FG000|STARTED|Overall Study||113
8614322|NCT00439335|9652070|FG001|STARTED|Overall Study||114
8614323|NCT00439335|9652069|FG000|COMPLETED|Overall Study||111
8614324|NCT00439335|9652070|FG001|COMPLETED|Overall Study||114
8614325|NCT00439335|9652069|FG000|NOT COMPLETED|Overall Study||2
8614326|NCT00439335|9652070|FG001|NOT COMPLETED|Overall Study||0
8614327|NCT00439374|9652078|FG000|STARTED|Overall Study||327
8715603|NCT00984568|9762527|FG001|COMPLETED|Overall Study||7
8715604|NCT00984568|9762526|FG000|NOT COMPLETED|Overall Study||8
8715605|NCT00984568|9762527|FG001|NOT COMPLETED|Overall Study||6
8715606|NCT00984594|9762535|FG000|STARTED|Overall Study||2
8715607|NCT00984594|9762536|FG001|STARTED|Overall Study|One patient withdrew consent and left the study before treatment.|2
8715608|NCT00984594|9762535|FG000|COMPLETED|Overall Study||1
8715609|NCT00984594|9762536|FG001|COMPLETED|Overall Study||1
8715610|NCT00984594|9762535|FG000|NOT COMPLETED|Overall Study||1
8614328|NCT00439374|9652079|FG001|STARTED|Overall Study||330
8614329|NCT00439374|9652078|FG000|COMPLETED|Overall Study||327
8614330|NCT00439374|9652079|FG001|COMPLETED|Overall Study||330
8614331|NCT00439374|9652078|FG000|NOT COMPLETED|Overall Study||0
8614332|NCT00439374|9652079|FG001|NOT COMPLETED|Overall Study||0
8614333|NCT00439413|9652087|FG000|STARTED|Overall Study||121
8614334|NCT00439413|9652088|FG001|STARTED|Overall Study||125
8614335|NCT00439413|9652087|FG000|COMPLETED|Overall Study||90
8614336|NCT00439413|9652088|FG001|COMPLETED|Overall Study||88
8614337|NCT00439413|9652087|FG000|NOT COMPLETED|Overall Study||31
8614338|NCT00439413|9652088|FG001|NOT COMPLETED|Overall Study||37
8614339|NCT00439465|9652096|FG000|STARTED|Overall Study||23
8614340|NCT00439465|9652096|FG000|COMPLETED|Overall Study||19
8614341|NCT00439465|9652096|FG000|NOT COMPLETED|Overall Study||4
8614342|NCT00439517|9652105|FG000|STARTED|Overall Study||152
8614343|NCT00439517|9652106|FG001|STARTED|Overall Study||150
8614344|NCT00439517|9652105|FG000|COMPLETED|Overall Study||150
8614345|NCT00439517|9652106|FG001|COMPLETED|Overall Study||150
8614346|NCT00439517|9652105|FG000|NOT COMPLETED|Overall Study||2
8614347|NCT00439517|9652106|FG001|NOT COMPLETED|Overall Study||0
8614348|NCT00439556|9652115|FG000|STARTED|Overall Study||36
8614349|NCT00439556|9652116|FG001|STARTED|Overall Study||4
8614350|NCT00439556|9652117|FG002|STARTED|Overall Study||0
8614351|NCT00439556|9652115|FG000|COMPLETED|Overall Study||36
8614352|NCT00439556|9652116|FG001|COMPLETED|Overall Study||3
8614353|NCT00439556|9652117|FG002|COMPLETED|Overall Study||0
8614354|NCT00439556|9652115|FG000|NOT COMPLETED|Overall Study||0
8614355|NCT00439556|9652116|FG001|NOT COMPLETED|Overall Study||1
8614356|NCT00439556|9652117|FG002|NOT COMPLETED|Overall Study||0
8614357|NCT00439608|9652126|FG000|STARTED|Overall Study||60
8614358|NCT00439608|9652126|FG000|COMPLETED|Overall Study||60
8614359|NCT00439608|9652126|FG000|NOT COMPLETED|Overall Study||0
8614360|NCT00439647|9652132|FG000|STARTED|Overall Study|"Started indicates intent to treat (ITT) and safety set."|588
8614361|NCT00439647|9652133|FG001|STARTED|Overall Study||611
8614362|NCT00439647|9652132|FG000|Modified Intent to Treat (mITT)|Overall Study||553
8614363|NCT00439647|9652133|FG001|Modified Intent to Treat (mITT)|Overall Study||574
8614364|NCT00439647|9652132|FG000|COMPLETED|Overall Study||530
8614365|NCT00439647|9652133|FG001|COMPLETED|Overall Study||540
8614366|NCT00439647|9652132|FG000|NOT COMPLETED|Overall Study||58
8614367|NCT00439647|9652133|FG001|NOT COMPLETED|Overall Study||71
8614368|NCT00439673|9652139|FG000|STARTED|Overall Study||62
8614369|NCT00439673|9652139|FG000|COMPLETED|Overall Study||26
8614370|NCT00439673|9652139|FG000|NOT COMPLETED|Overall Study||36
8614371|NCT00439725|9652145|FG000|STARTED|Treatment Period||602
8614372|NCT00439725|9652146|FG001|STARTED|Treatment Period||595
8614373|NCT00439725|9652145|FG000|Participants Received Treatment|Treatment Period|Safety population|598
8614374|NCT00439725|9652146|FG001|Participants Received Treatment|Treatment Period|Safety population|590
8614375|NCT00439725|9652145|FG000|COMPLETED|Treatment Period||366
8614376|NCT00439725|9652146|FG001|COMPLETED|Treatment Period||349
8715611|NCT00984594|9762536|FG001|NOT COMPLETED|Overall Study||1
8715612|NCT00984620|9762546|FG000|STARTED|Overall Study||81
8715613|NCT00984620|9762547|FG001|STARTED|Overall Study||79
8715614|NCT00984620|9762546|FG000|COMPLETED|Overall Study||75
8715615|NCT00984620|9762547|FG001|COMPLETED|Overall Study||67
8614377|NCT00439725|9652145|FG000|NOT COMPLETED|Treatment Period||236
8614378|NCT00439725|9652146|FG001|NOT COMPLETED|Treatment Period||246
8614379|NCT00439725|9652145|FG000|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|577
8614380|NCT00439725|9652146|FG001|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|560
8614381|NCT00439725|9652145|FG000|COMPLETED|Observational Period||569
8614382|NCT00439725|9652146|FG001|COMPLETED|Observational Period||553
8614383|NCT00439725|9652145|FG000|NOT COMPLETED|Observational Period||8
8614384|NCT00439725|9652146|FG001|NOT COMPLETED|Observational Period||7
8614385|NCT00439777|9652154|FG000|STARTED|Treatment Period||2420
8614386|NCT00439777|9652155|FG001|STARTED|Treatment Period||2413
8614387|NCT00439777|9652154|FG000|Participants Received Treatment|Treatment Period||2412
8614388|NCT00439777|9652155|FG001|Participants Received Treatment|Treatment Period||2405
8614389|NCT00439777|9652154|FG000|COMPLETED|Treatment Period||2001
8715616|NCT00984620|9762546|FG000|NOT COMPLETED|Overall Study||6
8614390|NCT00439777|9652155|FG001|COMPLETED|Treatment Period||1954
8614391|NCT00439777|9652154|FG000|NOT COMPLETED|Treatment Period||419
8614392|NCT00439777|9652155|FG001|NOT COMPLETED|Treatment Period||459
8614393|NCT00439777|9652154|FG000|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|2206
8614394|NCT00439777|9652155|FG001|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|2197
8614395|NCT00439777|9652154|FG000|COMPLETED|Observational Period||2165
8614396|NCT00439777|9652155|FG001|COMPLETED|Observational Period||2156
8614397|NCT00439777|9652154|FG000|NOT COMPLETED|Observational Period||41
8614398|NCT00439777|9652155|FG001|NOT COMPLETED|Observational Period||41
8614399|NCT00439946|9652161|FG000|STARTED|Overall Study||8
8614400|NCT00439946|9652161|FG000|COMPLETED|Overall Study||8
8614401|NCT00439946|9652161|FG000|NOT COMPLETED|Overall Study||0
8614402|NCT00440011|9652167|FG000|STARTED|Overall Study||131
8614403|NCT00440011|9652168|FG001|STARTED|Overall Study||135
8614404|NCT00440011|9652167|FG000|COMPLETED|Overall Study||127
8614405|NCT00440011|9652168|FG001|COMPLETED|Overall Study||132
8614406|NCT00440011|9652167|FG000|NOT COMPLETED|Overall Study||4
8614407|NCT00440011|9652168|FG001|NOT COMPLETED|Overall Study||3
8614408|NCT00440037|9652174|FG000|STARTED|Overall Study||44
8614409|NCT00440037|9652174|FG000|COMPLETED|Overall Study||35
8614410|NCT00440037|9652174|FG000|NOT COMPLETED|Overall Study||9
8614411|NCT00440050|9652180|FG000|STARTED|Overall Study||164
8614412|NCT00440050|9652181|FG001|STARTED|Overall Study||238
8614413|NCT00440050|9652180|FG000|COMPLETED|Overall Study||124
8614414|NCT00440050|9652181|FG001|COMPLETED|Overall Study||171
8614415|NCT00440050|9652180|FG000|NOT COMPLETED|Overall Study||40
8614416|NCT00440050|9652181|FG001|NOT COMPLETED|Overall Study||67
8614417|NCT00440115|9652190|FG000|STARTED|Overall Study||251
8614418|NCT00440115|9652191|FG001|STARTED|Overall Study||249
8614419|NCT00440115|9652192|FG002|STARTED|Overall Study||250
8614420|NCT00440115|9652190|FG000|COMPLETED|Overall Study||244
8614421|NCT00440115|9652191|FG001|COMPLETED|Overall Study||238
8614422|NCT00440115|9652192|FG002|COMPLETED|Overall Study||244
8614423|NCT00440115|9652190|FG000|NOT COMPLETED|Overall Study||7
8614424|NCT00440115|9652191|FG001|NOT COMPLETED|Overall Study||11
8614425|NCT00440115|9652192|FG002|NOT COMPLETED|Overall Study||6
8614426|NCT00440180|9652202|FG000|STARTED|Overall Study||10
8614427|NCT00440180|9652203|FG001|STARTED|Overall Study||10
8614428|NCT00440180|9652202|FG000|COMPLETED|Overall Study||10
8614429|NCT00440180|9652203|FG001|COMPLETED|Overall Study||10
8614430|NCT00440180|9652202|FG000|NOT COMPLETED|Overall Study||0
8614431|NCT00440180|9652203|FG001|NOT COMPLETED|Overall Study||0
8614432|NCT00440193|9652211|FG000|STARTED|Treatment Period||1731
8614433|NCT00440193|9652212|FG001|STARTED|Treatment Period||1718
8614434|NCT00440193|9652211|FG000|Participants Received Treatment|Treatment Period||1718
8614435|NCT00440193|9652212|FG001|Participants Received Treatment|Treatment Period||1711
8614436|NCT00440193|9652211|FG000|COMPLETED|Treatment Period||1426
8614437|NCT00440193|9652212|FG001|COMPLETED|Treatment Period||1367
8614438|NCT00440193|9652211|FG000|NOT COMPLETED|Treatment Period||305
8614439|NCT00440193|9652212|FG001|NOT COMPLETED|Treatment Period||351
8614440|NCT00440193|9652211|FG000|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|1425
8614441|NCT00440193|9652212|FG001|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|1407
8614442|NCT00440193|9652211|FG000|COMPLETED|Observational Period||1380
8614443|NCT00440193|9652212|FG001|COMPLETED|Observational Period||1369
8614444|NCT00440193|9652211|FG000|NOT COMPLETED|Observational Period||45
8614445|NCT00440193|9652212|FG001|NOT COMPLETED|Observational Period||38
8614446|NCT00440232|9652220|FG000|STARTED|Overall Study||36
8614447|NCT00440232|9652221|FG001|STARTED|Overall Study||38
8614448|NCT00440232|9652220|FG000|COMPLETED|Overall Study||33
8614449|NCT00440232|9652221|FG001|COMPLETED|Overall Study||34
8614450|NCT00440232|9652220|FG000|NOT COMPLETED|Overall Study||3
8614451|NCT00440232|9652221|FG001|NOT COMPLETED|Overall Study||4
8614452|NCT00440297|9652229|FG000|STARTED|Overall Study||139
8614453|NCT00440297|9652230|FG001|STARTED|Overall Study||138
8614454|NCT00440297|9652229|FG000|Vaccination Visit 1|Overall Study||138
8614455|NCT00440297|9652230|FG001|Vaccination Visit 1|Overall Study||138
8614456|NCT00440297|9652229|FG000|Vaccination Visit 2|Overall Study||136
8614457|NCT00440297|9652230|FG001|Vaccination Visit 2|Overall Study||134
8614458|NCT00440297|9652229|FG000|Vaccination Visit 3|Overall Study||124
8614459|NCT00440297|9652230|FG001|Vaccination Visit 3|Overall Study||125
8614460|NCT00440297|9652229|FG000|Vaccination Visit 4|Overall Study||116
8614461|NCT00440297|9652230|FG001|Vaccination Visit 4|Overall Study||122
8614462|NCT00440297|9652229|FG000|COMPLETED|Overall Study||116
8614463|NCT00440297|9652230|FG001|COMPLETED|Overall Study||120
8614464|NCT00440297|9652229|FG000|NOT COMPLETED|Overall Study||23
8614465|NCT00440297|9652230|FG001|NOT COMPLETED|Overall Study||18
8614466|NCT00440310|9652238|FG000|STARTED|Overall Study||244
8614467|NCT00440310|9652239|FG001|STARTED|Overall Study||239
8614468|NCT00440310|9652238|FG000|Treated|Overall Study||222
8614469|NCT00440310|9652239|FG001|Treated|Overall Study||232
8614470|NCT00440310|9652238|FG000|COMPLETED|Overall Study||216
8614471|NCT00440310|9652239|FG001|COMPLETED|Overall Study||209
8614472|NCT00440310|9652238|FG000|NOT COMPLETED|Overall Study||28
8614473|NCT00440310|9652239|FG001|NOT COMPLETED|Overall Study||30
8614474|NCT00440401|9652247|FG000|STARTED|Overall Study||59
8614475|NCT00440401|9652248|FG001|STARTED|Overall Study||60
8614476|NCT00440401|9652247|FG000|COMPLETED|Overall Study||55
8614477|NCT00440401|9652248|FG001|COMPLETED|Overall Study||54
8614478|NCT00440401|9652247|FG000|NOT COMPLETED|Overall Study||4
8614479|NCT00440401|9652248|FG001|NOT COMPLETED|Overall Study||6
8614480|NCT00440466|9652257|FG000|STARTED|Overall Study||108
8614481|NCT00440466|9652258|FG001|STARTED|Overall Study||107
8614482|NCT00440466|9652259|FG002|STARTED|Overall Study||215
8614483|NCT00440466|9652257|FG000|COMPLETED|Overall Study||95
8614484|NCT00440466|9652258|FG001|COMPLETED|Overall Study||92
8614485|NCT00440466|9652259|FG002|COMPLETED|Overall Study||174
8614486|NCT00440466|9652257|FG000|NOT COMPLETED|Overall Study||13
8614487|NCT00440466|9652258|FG001|NOT COMPLETED|Overall Study||15
8614488|NCT00440466|9652259|FG002|NOT COMPLETED|Overall Study||41
8614489|NCT00440505|9652267|FG000|STARTED|First Intervention||5
8614490|NCT00440505|9652268|FG001|STARTED|First Intervention||2
8614491|NCT00440505|9652269|FG002|STARTED|First Intervention||1
8614492|NCT00440505|9652270|FG003|STARTED|First Intervention||2
8614493|NCT00440505|9652271|FG004|STARTED|First Intervention||5
8614494|NCT00440505|9652272|FG005|STARTED|First Intervention||5
8614495|NCT00440505|9652267|FG000|COMPLETED|First Intervention||5
8614496|NCT00440505|9652268|FG001|COMPLETED|First Intervention||2
8614497|NCT00440505|9652269|FG002|COMPLETED|First Intervention||1
8614498|NCT00440505|9652270|FG003|COMPLETED|First Intervention||2
8614499|NCT00440505|9652271|FG004|COMPLETED|First Intervention||5
8614500|NCT00440505|9652272|FG005|COMPLETED|First Intervention||5
8614501|NCT00440505|9652267|FG000|NOT COMPLETED|First Intervention||0
8614502|NCT00440505|9652268|FG001|NOT COMPLETED|First Intervention||0
8614503|NCT00440505|9652269|FG002|NOT COMPLETED|First Intervention||0
8614504|NCT00440505|9652270|FG003|NOT COMPLETED|First Intervention||0
8614505|NCT00440505|9652271|FG004|NOT COMPLETED|First Intervention||0
8614506|NCT00440505|9652272|FG005|NOT COMPLETED|First Intervention||0
8614507|NCT00440505|9652267|FG000|STARTED|Second Intervention||5
8614508|NCT00440505|9652268|FG001|STARTED|Second Intervention||2
8614509|NCT00440505|9652269|FG002|STARTED|Second Intervention||1
8614510|NCT00440505|9652270|FG003|STARTED|Second Intervention||2
8614511|NCT00440505|9652271|FG004|STARTED|Second Intervention||5
8614512|NCT00440505|9652272|FG005|STARTED|Second Intervention||5
8614513|NCT00440505|9652267|FG000|COMPLETED|Second Intervention||5
8614514|NCT00440505|9652268|FG001|COMPLETED|Second Intervention||2
8614515|NCT00440505|9652269|FG002|COMPLETED|Second Intervention||1
8614516|NCT00440505|9652270|FG003|COMPLETED|Second Intervention||2
8614517|NCT00440505|9652271|FG004|COMPLETED|Second Intervention||5
8614518|NCT00440505|9652272|FG005|COMPLETED|Second Intervention||5
8614519|NCT00440505|9652267|FG000|NOT COMPLETED|Second Intervention||0
8614520|NCT00440505|9652268|FG001|NOT COMPLETED|Second Intervention||0
8614521|NCT00440505|9652269|FG002|NOT COMPLETED|Second Intervention||0
8614522|NCT00440505|9652270|FG003|NOT COMPLETED|Second Intervention||0
8614523|NCT00440505|9652271|FG004|NOT COMPLETED|Second Intervention||0
8614524|NCT00440505|9652272|FG005|NOT COMPLETED|Second Intervention||0
8614525|NCT00440505|9652267|FG000|STARTED|Third Intervention||5
8614526|NCT00440505|9652268|FG001|STARTED|Third Intervention||2
8614527|NCT00440505|9652269|FG002|STARTED|Third Intervention||1
8614528|NCT00440505|9652270|FG003|STARTED|Third Intervention||2
8614529|NCT00440505|9652271|FG004|STARTED|Third Intervention||5
8614530|NCT00440505|9652272|FG005|STARTED|Third Intervention||5
8614531|NCT00440505|9652267|FG000|COMPLETED|Third Intervention||5
8614532|NCT00440505|9652268|FG001|COMPLETED|Third Intervention||2
8614533|NCT00440505|9652269|FG002|COMPLETED|Third Intervention||1
8614534|NCT00440505|9652270|FG003|COMPLETED|Third Intervention||1
8614535|NCT00440505|9652271|FG004|COMPLETED|Third Intervention||5
8614536|NCT00440505|9652272|FG005|COMPLETED|Third Intervention||5
8614537|NCT00440505|9652267|FG000|NOT COMPLETED|Third Intervention||0
8614538|NCT00440505|9652268|FG001|NOT COMPLETED|Third Intervention||0
8614539|NCT00440505|9652269|FG002|NOT COMPLETED|Third Intervention||0
8614540|NCT00440505|9652270|FG003|NOT COMPLETED|Third Intervention||1
8614541|NCT00440505|9652271|FG004|NOT COMPLETED|Third Intervention||0
8614542|NCT00440505|9652272|FG005|NOT COMPLETED|Third Intervention||0
8614543|NCT00440518|9652283|FG000|STARTED|Randomized /Titration Period||72
8614544|NCT00440518|9652284|FG001|STARTED|Randomized /Titration Period||72
8614545|NCT00440518|9652285|FG002|STARTED|Randomized /Titration Period||74
8614546|NCT00440518|9652283|FG000|COMPLETED|Randomized /Titration Period||59
8614547|NCT00440518|9652284|FG001|COMPLETED|Randomized /Titration Period||63
8614548|NCT00440518|9652285|FG002|COMPLETED|Randomized /Titration Period||70
8614549|NCT00440518|9652283|FG000|NOT COMPLETED|Randomized /Titration Period||13
8614550|NCT00440518|9652284|FG001|NOT COMPLETED|Randomized /Titration Period||9
8614551|NCT00440518|9652285|FG002|NOT COMPLETED|Randomized /Titration Period||4
8614552|NCT00440518|9652283|FG000|STARTED|Maintenance and Safety Follow-up Periods||59
8614553|NCT00440518|9652284|FG001|STARTED|Maintenance and Safety Follow-up Periods||63
8614554|NCT00440518|9652285|FG002|STARTED|Maintenance and Safety Follow-up Periods||70
8614555|NCT00440518|9652283|FG000|COMPLETED|Maintenance and Safety Follow-up Periods||52
8614556|NCT00440518|9652284|FG001|COMPLETED|Maintenance and Safety Follow-up Periods||51
8715617|NCT00984620|9762547|FG001|NOT COMPLETED|Overall Study||12
8715618|NCT00984659|9762559|FG000|STARTED|2-week Run-in Period||418
8614557|NCT00440518|9652285|FG002|COMPLETED|Maintenance and Safety Follow-up Periods||55
8614558|NCT00440518|9652283|FG000|NOT COMPLETED|Maintenance and Safety Follow-up Periods||7
8715619|NCT00984659|9762560|FG001|STARTED|2-week Run-in Period||0
8715620|NCT00984659|9762561|FG002|STARTED|2-week Run-in Period||0
8614559|NCT00440518|9652284|FG001|NOT COMPLETED|Maintenance and Safety Follow-up Periods||12
8614560|NCT00440518|9652285|FG002|NOT COMPLETED|Maintenance and Safety Follow-up Periods||15
8614561|NCT00440557|9652296|FG000|STARTED|Overall Study|Safety population defined as all subjects who received at least 1 injection of study drug.|123
8614562|NCT00440557|9652297|FG001|STARTED|Overall Study|Safety population defined as all subjects who received at least 1 injection of study drug.|125
8614563|NCT00440557|9652298|FG002|STARTED|Overall Study|Safety population defined as all subjects who received at least 1 injection of study drug.|125
8614564|NCT00440557|9652296|FG000|COMPLETED|Overall Study||98
8614565|NCT00440557|9652297|FG001|COMPLETED|Overall Study||96
8614566|NCT00440557|9652298|FG002|COMPLETED|Overall Study||90
8614567|NCT00440557|9652296|FG000|NOT COMPLETED|Overall Study||25
8614568|NCT00440557|9652297|FG001|NOT COMPLETED|Overall Study||29
8614569|NCT00440557|9652298|FG002|NOT COMPLETED|Overall Study||35
8614570|NCT00440596|9652308|FG000|STARTED|Overall Study||28
8614571|NCT00440596|9652309|FG001|STARTED|Overall Study||28
8614572|NCT00440596|9652308|FG000|COMPLETED|Overall Study||21
8614573|NCT00440596|9652309|FG001|COMPLETED|Overall Study||17
8614574|NCT00440596|9652308|FG000|NOT COMPLETED|Overall Study||7
8614575|NCT00440596|9652309|FG001|NOT COMPLETED|Overall Study||11
8614576|NCT00440700|9652320|FG000|STARTED|Overall Study||122
8614577|NCT00440700|9652321|FG001|STARTED|Overall Study||118
8614578|NCT00440700|9652322|FG002|STARTED|Overall Study||124
8614579|NCT00440700|9652320|FG000|COMPLETED|Overall Study||114
8614580|NCT00440700|9652321|FG001|COMPLETED|Overall Study||110
8614581|NCT00440700|9652322|FG002|COMPLETED|Overall Study||120
8614582|NCT00440700|9652320|FG000|NOT COMPLETED|Overall Study||8
8614583|NCT00440700|9652321|FG001|NOT COMPLETED|Overall Study||8
8614584|NCT00440700|9652322|FG002|NOT COMPLETED|Overall Study||4
8614585|NCT00440726|9652333|FG000|STARTED|Phase 1||4
8614586|NCT00440726|9652334|FG001|STARTED|Phase 1||6
8614587|NCT00440726|9652335|FG002|STARTED|Phase 1||0
8614588|NCT00440726|9652333|FG000|COMPLETED|Phase 1||3
8614589|NCT00440726|9652334|FG001|COMPLETED|Phase 1||5
8614590|NCT00440726|9652335|FG002|COMPLETED|Phase 1||0
8614591|NCT00440726|9652333|FG000|NOT COMPLETED|Phase 1||1
8614592|NCT00440726|9652334|FG001|NOT COMPLETED|Phase 1||1
8614593|NCT00440726|9652335|FG002|NOT COMPLETED|Phase 1||0
8614594|NCT00440726|9652333|FG000|STARTED|Phase 2||0
8614595|NCT00440726|9652334|FG001|STARTED|Phase 2||0
8614596|NCT00440726|9652335|FG002|STARTED|Phase 2||22
8614597|NCT00440726|9652333|FG000|COMPLETED|Phase 2||0
8614598|NCT00440726|9652334|FG001|COMPLETED|Phase 2||0
8614599|NCT00440726|9652335|FG002|COMPLETED|Phase 2||20
8614600|NCT00440726|9652333|FG000|NOT COMPLETED|Phase 2||0
8614601|NCT00440726|9652334|FG001|NOT COMPLETED|Phase 2||0
8614602|NCT00440726|9652335|FG002|NOT COMPLETED|Phase 2||2
8614603|NCT00440830|9652350|FG000|STARTED|Overall Study||20
8614604|NCT00440830|9652351|FG001|STARTED|Overall Study||8
8614605|NCT00440830|9652352|FG002|STARTED|Overall Study||30
8614606|NCT00440830|9652353|FG003|STARTED|Overall Study||10
8614607|NCT00440830|9652350|FG000|COMPLETED|Overall Study||20
8614608|NCT00440830|9652351|FG001|COMPLETED|Overall Study||8
8614609|NCT00440830|9652352|FG002|COMPLETED|Overall Study||30
8614610|NCT00440830|9652353|FG003|COMPLETED|Overall Study||10
8614611|NCT00440830|9652350|FG000|NOT COMPLETED|Overall Study||0
8614612|NCT00440830|9652351|FG001|NOT COMPLETED|Overall Study||0
8614613|NCT00440830|9652352|FG002|NOT COMPLETED|Overall Study||0
8614614|NCT00440830|9652353|FG003|NOT COMPLETED|Overall Study||0
8614615|NCT00440947|9652367|FG000|STARTED|36-Week Induction Phase||515
8614616|NCT00440947|9652368|FG001|STARTED|36-Week Induction Phase||0
8614617|NCT00440947|9652369|FG002|STARTED|36-Week Induction Phase||0
8614618|NCT00440947|9652370|FG003|STARTED|36-Week Induction Phase||0
8614619|NCT00440947|9652371|FG004|STARTED|36-Week Induction Phase||0
8614620|NCT00440947|9652367|FG000|COMPLETED|36-Week Induction Phase|23 PAR without confirmed HIV-RNA<50c/mL prior to Wk 36 couldn't be randomized but weren't withdrawn.|442
8614621|NCT00440947|9652368|FG001|COMPLETED|36-Week Induction Phase||0
8614622|NCT00440947|9652369|FG002|COMPLETED|36-Week Induction Phase||0
8614623|NCT00440947|9652370|FG003|COMPLETED|36-Week Induction Phase||0
8614624|NCT00440947|9652371|FG004|COMPLETED|36-Week Induction Phase||0
8614625|NCT00440947|9652367|FG000|NOT COMPLETED|36-Week Induction Phase||73
8614626|NCT00440947|9652368|FG001|NOT COMPLETED|36-Week Induction Phase||0
8614627|NCT00440947|9652369|FG002|NOT COMPLETED|36-Week Induction Phase||0
8614628|NCT00440947|9652370|FG003|NOT COMPLETED|36-Week Induction Phase||0
8614629|NCT00440947|9652371|FG004|NOT COMPLETED|36-Week Induction Phase||0
8614630|NCT00440947|9652367|FG000|STARTED|48-Week Randomization Phase||0
8614631|NCT00440947|9652368|FG001|STARTED|48-Week Randomization Phase||210
8614632|NCT00440947|9652369|FG002|STARTED|48-Week Randomization Phase||209
8614633|NCT00440947|9652370|FG003|STARTED|48-Week Randomization Phase||0
8614634|NCT00440947|9652371|FG004|STARTED|48-Week Randomization Phase||0
8614635|NCT00440947|9652367|FG000|COMPLETED|48-Week Randomization Phase||0
8614636|NCT00440947|9652368|FG001|COMPLETED|48-Week Randomization Phase||194
8614637|NCT00440947|9652369|FG002|COMPLETED|48-Week Randomization Phase||185
8614638|NCT00440947|9652370|FG003|COMPLETED|48-Week Randomization Phase||0
8614639|NCT00440947|9652371|FG004|COMPLETED|48-Week Randomization Phase||0
8614640|NCT00440947|9652367|FG000|NOT COMPLETED|48-Week Randomization Phase||0
8614641|NCT00440947|9652368|FG001|NOT COMPLETED|48-Week Randomization Phase||16
8614642|NCT00440947|9652369|FG002|NOT COMPLETED|48-Week Randomization Phase||24
8614643|NCT00440947|9652370|FG003|NOT COMPLETED|48-Week Randomization Phase||0
8614644|NCT00440947|9652371|FG004|NOT COMPLETED|48-Week Randomization Phase||0
8614645|NCT00440947|9652367|FG000|STARTED|Optional 60-Week Extension Phase||0
8614646|NCT00440947|9652368|FG001|STARTED|Optional 60-Week Extension Phase||0
8614647|NCT00440947|9652369|FG002|STARTED|Optional 60-Week Extension Phase||0
8614648|NCT00440947|9652370|FG003|STARTED|Optional 60-Week Extension Phase||189
8614649|NCT00440947|9652371|FG004|STARTED|Optional 60-Week Extension Phase||180
8614650|NCT00440947|9652367|FG000|COMPLETED|Optional 60-Week Extension Phase||0
8614651|NCT00440947|9652368|FG001|COMPLETED|Optional 60-Week Extension Phase||0
8614652|NCT00440947|9652369|FG002|COMPLETED|Optional 60-Week Extension Phase||0
8614653|NCT00440947|9652370|FG003|COMPLETED|Optional 60-Week Extension Phase||160
8614654|NCT00440947|9652371|FG004|COMPLETED|Optional 60-Week Extension Phase||154
8614655|NCT00440947|9652367|FG000|NOT COMPLETED|Optional 60-Week Extension Phase||0
8614656|NCT00440947|9652368|FG001|NOT COMPLETED|Optional 60-Week Extension Phase||0
8614657|NCT00440947|9652369|FG002|NOT COMPLETED|Optional 60-Week Extension Phase||0
8614658|NCT00440947|9652370|FG003|NOT COMPLETED|Optional 60-Week Extension Phase||29
8614659|NCT00440947|9652371|FG004|NOT COMPLETED|Optional 60-Week Extension Phase||26
8614660|NCT00440999|9652385|FG000|STARTED|Overall Study||228
8614661|NCT00440999|9652386|FG001|STARTED|Overall Study||228
8614662|NCT00440999|9652385|FG000|COMPLETED|Overall Study||193
8614663|NCT00440999|9652386|FG001|COMPLETED|Overall Study||187
8614664|NCT00440999|9652385|FG000|NOT COMPLETED|Overall Study||35
8614665|NCT00440999|9652386|FG001|NOT COMPLETED|Overall Study||41
8614666|NCT00441012|9652396|FG000|STARTED|Overall Study||270
8614667|NCT00441012|9652397|FG001|STARTED|Overall Study||276
8614668|NCT00441012|9652396|FG000|Vaccination Visit 1|Overall Study|1 participant was randomized but not vaccinated in the Modified Process Vaccine group|269
8614669|NCT00441012|9652397|FG001|Vaccination Visit 1|Overall Study|3 participants were vaccinated but were never randomized in the COMVAX™ group|276
8614670|NCT00441012|9652396|FG000|Vaccination Visit 2|Overall Study||267
8614671|NCT00441012|9652397|FG001|Vaccination Visit 2|Overall Study||272
8614672|NCT00441012|9652396|FG000|Vaccination Visit 3|Overall Study||265
8614673|NCT00441012|9652397|FG001|Vaccination Visit 3|Overall Study||269
8614674|NCT00441012|9652396|FG000|COMPLETED|Overall Study||252
8614675|NCT00441012|9652397|FG001|COMPLETED|Overall Study||263
8614676|NCT00441012|9652396|FG000|NOT COMPLETED|Overall Study||18
8614677|NCT00441012|9652397|FG001|NOT COMPLETED|Overall Study||13
8614678|NCT00441064|9652405|FG000|STARTED|Overall Study||69
8614679|NCT00441064|9652406|FG001|STARTED|Overall Study||63
8614680|NCT00441064|9652405|FG000|Safety Population (SP)|Overall Study||69
8614681|NCT00441064|9652406|FG001|Safety Population (SP)|Overall Study||63
8614682|NCT00441064|9652405|FG000|Intent-to-treat (ITT) Population|Overall Study||61
8614683|NCT00441064|9652406|FG001|Intent-to-treat (ITT) Population|Overall Study||57
8614684|NCT00441064|9652405|FG000|COMPLETED|Overall Study||59
8614685|NCT00441064|9652406|FG001|COMPLETED|Overall Study||56
8614686|NCT00441064|9652405|FG000|NOT COMPLETED|Overall Study||10
8614687|NCT00441064|9652406|FG001|NOT COMPLETED|Overall Study||7
8614688|NCT00441090|9652417|FG000|STARTED|Overall Study||15
8614689|NCT00441090|9652418|FG001|STARTED|Overall Study||15
8614690|NCT00441090|9652419|FG002|STARTED|Overall Study||14
8614691|NCT00441090|9652420|FG003|STARTED|Overall Study||15
8614692|NCT00441090|9652421|FG004|STARTED|Overall Study||5
8614693|NCT00441090|9652417|FG000|COMPLETED|Overall Study||13
8614694|NCT00441090|9652418|FG001|COMPLETED|Overall Study||14
8614695|NCT00441090|9652419|FG002|COMPLETED|Overall Study||12
8614696|NCT00441090|9652420|FG003|COMPLETED|Overall Study||13
8614697|NCT00441090|9652421|FG004|COMPLETED|Overall Study||5
8614698|NCT00441090|9652417|FG000|NOT COMPLETED|Overall Study||2
8614699|NCT00441090|9652418|FG001|NOT COMPLETED|Overall Study||1
8614700|NCT00441090|9652419|FG002|NOT COMPLETED|Overall Study||2
8614701|NCT00441090|9652420|FG003|NOT COMPLETED|Overall Study||2
8614702|NCT00441090|9652421|FG004|NOT COMPLETED|Overall Study||0
8715621|NCT00984659|9762562|FG003|STARTED|2-week Run-in Period||0
8715622|NCT00984659|9762559|FG000|COMPLETED|2-week Run-in Period||366
8715623|NCT00984659|9762560|FG001|COMPLETED|2-week Run-in Period||0
8715624|NCT00984659|9762561|FG002|COMPLETED|2-week Run-in Period||0
8715625|NCT00984659|9762562|FG003|COMPLETED|2-week Run-in Period||0
8715626|NCT00984659|9762559|FG000|NOT COMPLETED|2-week Run-in Period||52
8715627|NCT00984659|9762560|FG001|NOT COMPLETED|2-week Run-in Period||0
8715628|NCT00984659|9762561|FG002|NOT COMPLETED|2-week Run-in Period||0
8715629|NCT00984659|9762562|FG003|NOT COMPLETED|2-week Run-in Period||0
8715630|NCT00984659|9762559|FG000|STARTED|6-week Double-blind Treatment Period||0
8614703|NCT00441103|9652435|FG000|STARTED|Overall Study|Intent to treat (ITT) population: all participants who received at least one dose of study drug.|120
8614704|NCT00441103|9652436|FG001|STARTED|Overall Study|Intent to treat (ITT) population: all participants who received at least one dose of study drug.|60
8614705|NCT00441103|9652435|FG000|COMPLETED|Overall Study||109
8614706|NCT00441103|9652436|FG001|COMPLETED|Overall Study||56
8614707|NCT00441103|9652435|FG000|NOT COMPLETED|Overall Study||11
8614708|NCT00441103|9652436|FG001|NOT COMPLETED|Overall Study||4
8614709|NCT00441116|9652445|FG000|STARTED|Overall Study||76
8614710|NCT00441116|9652446|FG001|STARTED|Overall Study||77
8614711|NCT00441116|9652445|FG000|COMPLETED|Overall Study||73
8614712|NCT00441116|9652446|FG001|COMPLETED|Overall Study||75
8614713|NCT00441116|9652445|FG000|NOT COMPLETED|Overall Study||3
8715631|NCT00984659|9762560|FG001|STARTED|6-week Double-blind Treatment Period||75
8715632|NCT00984659|9762561|FG002|STARTED|6-week Double-blind Treatment Period||152
8614714|NCT00441116|9652446|FG001|NOT COMPLETED|Overall Study||2
8614715|NCT00441129|9652454|FG000|STARTED|Overall Study||60
8614716|NCT00441129|9652455|FG001|STARTED|Overall Study||55
8614717|NCT00441129|9652454|FG000|COMPLETED|Overall Study||54
8614718|NCT00441129|9652455|FG001|COMPLETED|Overall Study||41
8614719|NCT00441129|9652454|FG000|NOT COMPLETED|Overall Study||6
8614720|NCT00441129|9652455|FG001|NOT COMPLETED|Overall Study||14
8614721|NCT00441142|9652465|FG000|STARTED|Overall Study||6
8614722|NCT00441142|9652466|FG001|STARTED|Overall Study||7
8614723|NCT00441142|9652467|FG002|STARTED|Overall Study||29
8614724|NCT00441142|9652468|FG003|STARTED|Overall Study||69
8614725|NCT00441142|9652465|FG000|COMPLETED|Overall Study||0
8614726|NCT00441142|9652466|FG001|COMPLETED|Overall Study||0
8614727|NCT00441142|9652467|FG002|COMPLETED|Overall Study||7
8614728|NCT00441142|9652468|FG003|COMPLETED|Overall Study||1
8614729|NCT00441142|9652465|FG000|NOT COMPLETED|Overall Study||6
8614730|NCT00441142|9652466|FG001|NOT COMPLETED|Overall Study||7
8614731|NCT00441142|9652467|FG002|NOT COMPLETED|Overall Study||22
8614732|NCT00441142|9652468|FG003|NOT COMPLETED|Overall Study||68
8614733|NCT00441168|9652482|FG000|STARTED|Treatment Period||17
8614734|NCT00441168|9652483|FG001|STARTED|Treatment Period||13
8614735|NCT00441168|9652482|FG000|TREATED|Treatment Period||16
8614736|NCT00441168|9652483|FG001|TREATED|Treatment Period||13
8614737|NCT00441168|9652482|FG000|COMPLETED|Treatment Period||6
8614738|NCT00441168|9652483|FG001|COMPLETED|Treatment Period||7
8614739|NCT00441168|9652482|FG000|NOT COMPLETED|Treatment Period||11
8614740|NCT00441168|9652483|FG001|NOT COMPLETED|Treatment Period||6
8614741|NCT00441168|9652482|FG000|STARTED|Follow-up Period|Subjects who did not complete the treatment period could be entered into the follow-up period|17
8614742|NCT00441168|9652483|FG001|STARTED|Follow-up Period|Subjects who did not complete the treatment period could be entered into the follow-up period|13
8614743|NCT00441168|9652482|FG000|COMPLETED|Follow-up Period||5
8614744|NCT00441168|9652483|FG001|COMPLETED|Follow-up Period||4
8614745|NCT00441168|9652482|FG000|NOT COMPLETED|Follow-up Period||12
8614746|NCT00441168|9652483|FG001|NOT COMPLETED|Follow-up Period||9
8614747|NCT00441259|9652491|FG000|STARTED|Overall Study||48
8614748|NCT00441259|9652492|FG001|STARTED|Overall Study||48
8614749|NCT00441259|9652491|FG000|COMPLETED|Overall Study||48
8614750|NCT00441259|9652492|FG001|COMPLETED|Overall Study||48
8614751|NCT00441259|9652491|FG000|NOT COMPLETED|Overall Study||0
8614752|NCT00441259|9652492|FG001|NOT COMPLETED|Overall Study||0
8614753|NCT00441285|9652503|FG000|STARTED|Overall Study||16
8614754|NCT00441285|9652504|FG001|STARTED|Overall Study||16
8614755|NCT00441285|9652505|FG002|STARTED|Overall Study||41
8614756|NCT00441285|9652506|FG003|STARTED|Overall Study||40
8614757|NCT00441285|9652507|FG004|STARTED|Overall Study||43
8614758|NCT00441285|9652503|FG000|COMPLETED|Overall Study||16
8614759|NCT00441285|9652504|FG001|COMPLETED|Overall Study||16
8614760|NCT00441285|9652505|FG002|COMPLETED|Overall Study||41
8614761|NCT00441285|9652506|FG003|COMPLETED|Overall Study||40
8614762|NCT00441285|9652507|FG004|COMPLETED|Overall Study||43
8614763|NCT00441285|9652503|FG000|NOT COMPLETED|Overall Study||0
8614764|NCT00441285|9652504|FG001|NOT COMPLETED|Overall Study||0
8614765|NCT00441285|9652505|FG002|NOT COMPLETED|Overall Study||0
8614766|NCT00441285|9652506|FG003|NOT COMPLETED|Overall Study||0
8614767|NCT00441285|9652507|FG004|NOT COMPLETED|Overall Study||0
8614768|NCT00441337|9652523|FG000|STARTED|Overall Study||6
8614769|NCT00441337|9652524|FG001|STARTED|Overall Study||6
8614770|NCT00441337|9652525|FG002|STARTED|Overall Study||6
8614771|NCT00441337|9652526|FG003|STARTED|Overall Study||21
8614772|NCT00441337|9652523|FG000|COMPLETED|Overall Study||0
8614773|NCT00441337|9652524|FG001|COMPLETED|Overall Study||0
8614774|NCT00441337|9652525|FG002|COMPLETED|Overall Study||0
8614775|NCT00441337|9652526|FG003|COMPLETED|Overall Study||0
8614776|NCT00441337|9652523|FG000|NOT COMPLETED|Overall Study||6
8614777|NCT00441337|9652524|FG001|NOT COMPLETED|Overall Study||6
8614778|NCT00441337|9652525|FG002|NOT COMPLETED|Overall Study||6
8614779|NCT00441337|9652526|FG003|NOT COMPLETED|Overall Study||21
8614780|NCT00441350|9652546|FG000|STARTED|Phase A: Randomization to Week 8||285
8614781|NCT00441350|9652547|FG001|STARTED|Phase A: Randomization to Week 8||561
8614782|NCT00441350|9652548|FG002|STARTED|Phase A: Randomization to Week 8||0
8614783|NCT00441350|9652549|FG003|STARTED|Phase A: Randomization to Week 8||0
8614784|NCT00441350|9652550|FG004|STARTED|Phase A: Randomization to Week 8||0
8614785|NCT00441350|9652551|FG005|STARTED|Phase A: Randomization to Week 8||0
8614786|NCT00441350|9652546|FG000|COMPLETED|Phase A: Randomization to Week 8||268
8614787|NCT00441350|9652547|FG001|COMPLETED|Phase A: Randomization to Week 8||524
8614788|NCT00441350|9652548|FG002|COMPLETED|Phase A: Randomization to Week 8||0
8614789|NCT00441350|9652549|FG003|COMPLETED|Phase A: Randomization to Week 8||0
8614790|NCT00441350|9652550|FG004|COMPLETED|Phase A: Randomization to Week 8||0
8614791|NCT00441350|9652551|FG005|COMPLETED|Phase A: Randomization to Week 8||0
8614792|NCT00441350|9652546|FG000|NOT COMPLETED|Phase A: Randomization to Week 8||17
8614793|NCT00441350|9652547|FG001|NOT COMPLETED|Phase A: Randomization to Week 8||37
8614794|NCT00441350|9652548|FG002|NOT COMPLETED|Phase A: Randomization to Week 8||0
8614795|NCT00441350|9652549|FG003|NOT COMPLETED|Phase A: Randomization to Week 8||0
8614796|NCT00441350|9652550|FG004|NOT COMPLETED|Phase A: Randomization to Week 8||0
8614797|NCT00441350|9652551|FG005|NOT COMPLETED|Phase A: Randomization to Week 8||0
8614798|NCT00441350|9652546|FG000|STARTED|Phase B: Week 8 to Week 16||0
8614799|NCT00441350|9652547|FG001|STARTED|Phase B: Week 8 to Week 16||0
8614800|NCT00441350|9652548|FG002|STARTED|Phase B: Week 8 to Week 16||129
8614801|NCT00441350|9652549|FG003|STARTED|Phase B: Week 8 to Week 16||139
8614802|NCT00441350|9652550|FG004|STARTED|Phase B: Week 8 to Week 16||336
8614803|NCT00441350|9652551|FG005|STARTED|Phase B: Week 8 to Week 16||188
8614804|NCT00441350|9652546|FG000|COMPLETED|Phase B: Week 8 to Week 16||0
8614805|NCT00441350|9652547|FG001|COMPLETED|Phase B: Week 8 to Week 16||0
8614806|NCT00441350|9652548|FG002|COMPLETED|Phase B: Week 8 to Week 16||128
8614807|NCT00441350|9652549|FG003|COMPLETED|Phase B: Week 8 to Week 16||137
8614808|NCT00441350|9652550|FG004|COMPLETED|Phase B: Week 8 to Week 16||333
8614809|NCT00441350|9652551|FG005|COMPLETED|Phase B: Week 8 to Week 16||186
8614810|NCT00441350|9652546|FG000|NOT COMPLETED|Phase B: Week 8 to Week 16||0
8614811|NCT00441350|9652547|FG001|NOT COMPLETED|Phase B: Week 8 to Week 16||0
8614812|NCT00441350|9652548|FG002|NOT COMPLETED|Phase B: Week 8 to Week 16||1
8614813|NCT00441350|9652549|FG003|NOT COMPLETED|Phase B: Week 8 to Week 16||2
8614814|NCT00441350|9652550|FG004|NOT COMPLETED|Phase B: Week 8 to Week 16||3
8614815|NCT00441350|9652551|FG005|NOT COMPLETED|Phase B: Week 8 to Week 16||2
8614816|NCT00441363|9652567|FG000|STARTED|Overall Study||32
8614817|NCT00441363|9652568|FG001|STARTED|Overall Study||34
8614818|NCT00441363|9652567|FG000|COMPLETED|Overall Study|no subject withdrew early since the trial was terminated|15
8614819|NCT00441363|9652568|FG001|COMPLETED|Overall Study||19
8614820|NCT00441363|9652567|FG000|NOT COMPLETED|Overall Study||17
8614821|NCT00441363|9652568|FG001|NOT COMPLETED|Overall Study||15
8614822|NCT00441441|9652576|FG000|STARTED|Overall Study||173
8614823|NCT00441441|9652577|FG001|STARTED|Overall Study||177
8614824|NCT00441441|9652576|FG000|COMPLETED|Overall Study||162
8614825|NCT00441441|9652577|FG001|COMPLETED|Overall Study||163
8614826|NCT00441441|9652576|FG000|NOT COMPLETED|Overall Study||11
8614827|NCT00441441|9652577|FG001|NOT COMPLETED|Overall Study||14
8614828|NCT00441467|9652597|FG000|STARTED|Overall Study||22
8614829|NCT00441467|9652597|FG000|2 Cycles|Overall Study||17
8614830|NCT00441467|9652597|FG000|4 Cycles|Overall Study||7
8614831|NCT00441467|9652597|FG000|COMPLETED|Overall Study||4
8614832|NCT00441467|9652597|FG000|NOT COMPLETED|Overall Study||18
8614833|NCT00441480|9652603|FG000|STARTED|Overall Study||46
8614834|NCT00441480|9652604|FG001|STARTED|Overall Study||45
8614835|NCT00441480|9652603|FG000|COMPLETED|Overall Study||43
8614836|NCT00441480|9652604|FG001|COMPLETED|Overall Study||41
8614837|NCT00441480|9652603|FG000|NOT COMPLETED|Overall Study||3
8614838|NCT00441480|9652604|FG001|NOT COMPLETED|Overall Study||4
8614839|NCT00441545|9652610|FG000|STARTED|First Intervention||95
8614840|NCT00441545|9652611|FG001|STARTED|First Intervention||87
8614841|NCT00441545|9652610|FG000|COMPLETED|First Intervention||77
8614842|NCT00441545|9652611|FG001|COMPLETED|First Intervention||75
8614843|NCT00441545|9652610|FG000|NOT COMPLETED|First Intervention||18
8614844|NCT00441545|9652611|FG001|NOT COMPLETED|First Intervention||12
8614845|NCT00441545|9652610|FG000|STARTED|Washout||77
8614846|NCT00441545|9652611|FG001|STARTED|Washout||75
8614847|NCT00441545|9652610|FG000|COMPLETED|Washout||77
8614848|NCT00441545|9652611|FG001|COMPLETED|Washout||75
8614849|NCT00441545|9652610|FG000|NOT COMPLETED|Washout||0
8614850|NCT00441545|9652611|FG001|NOT COMPLETED|Washout||0
8614851|NCT00441545|9652610|FG000|STARTED|Second Intervention||77
8614852|NCT00441545|9652611|FG001|STARTED|Second Intervention||75
8614853|NCT00441545|9652610|FG000|COMPLETED|Second Intervention||65
8614854|NCT00441545|9652611|FG001|COMPLETED|Second Intervention||68
8614855|NCT00441545|9652610|FG000|NOT COMPLETED|Second Intervention||12
8614856|NCT00441545|9652611|FG001|NOT COMPLETED|Second Intervention||7
8614857|NCT00441558|9652617|FG000|STARTED|Overall Study||1723
8614858|NCT00441558|9652617|FG000|COMPLETED|Overall Study||667
8614859|NCT00441558|9652617|FG000|NOT COMPLETED|Overall Study||1056
8614860|NCT00441584|9652621|FG000|STARTED|Overall Study||117
8614861|NCT00441584|9652621|FG000|COMPLETED|Overall Study||12
8614862|NCT00441584|9652621|FG000|NOT COMPLETED|Overall Study||105
8614863|NCT00441701|9652635|FG000|STARTED|Overall Study||22
8614864|NCT00441701|9652636|FG001|STARTED|Overall Study||11
8614865|NCT00441701|9652637|FG002|STARTED|Overall Study||22
8715633|NCT00984659|9762562|FG003|STARTED|6-week Double-blind Treatment Period||139
8715634|NCT00984659|9762559|FG000|COMPLETED|6-week Double-blind Treatment Period||0
8715635|NCT00984659|9762560|FG001|COMPLETED|6-week Double-blind Treatment Period||69
8715636|NCT00984659|9762561|FG002|COMPLETED|6-week Double-blind Treatment Period||141
8715637|NCT00984659|9762562|FG003|COMPLETED|6-week Double-blind Treatment Period||126
8715638|NCT00984659|9762559|FG000|NOT COMPLETED|6-week Double-blind Treatment Period||0
8715639|NCT00984659|9762560|FG001|NOT COMPLETED|6-week Double-blind Treatment Period||6
8715640|NCT00984659|9762561|FG002|NOT COMPLETED|6-week Double-blind Treatment Period||11
8715641|NCT00984659|9762562|FG003|NOT COMPLETED|6-week Double-blind Treatment Period||13
8715642|NCT00984698|9762571|FG000|STARTED|Overall Study||21
8715643|NCT00984698|9762572|FG001|STARTED|Overall Study||22
8715644|NCT00984698|9762571|FG000|COMPLETED|Overall Study||18
8715645|NCT00984698|9762572|FG001|COMPLETED|Overall Study||14
8715646|NCT00984698|9762571|FG000|NOT COMPLETED|Overall Study||3
8715647|NCT00984698|9762572|FG001|NOT COMPLETED|Overall Study||8
8813330|NCT01525225|9866500|FG000|STARTED|Enrollment||4
8614866|NCT00441701|9652638|FG003|STARTED|Overall Study||11
8614867|NCT00441701|9652639|FG004|STARTED|Overall Study||22
8614868|NCT00441701|9652640|FG005|STARTED|Overall Study||11
8715648|NCT00984815|9762578|FG000|STARTED|Overall Study||86
8715649|NCT00984815|9762578|FG000|COMPLETED|Overall Study||56
8813331|NCT01525225|9866500|FG000|COMPLETED|Enrollment||2
8614869|NCT00441701|9652641|FG006|STARTED|Overall Study||0
8614870|NCT00441701|9652642|FG007|STARTED|Overall Study||0
8614871|NCT00441701|9652643|FG008|STARTED|Overall Study||0
8614872|NCT00441701|9652644|FG009|STARTED|Overall Study||0
8614873|NCT00441701|9652635|FG000|COMPLETED|Overall Study||17
8614874|NCT00441701|9652636|FG001|COMPLETED|Overall Study||7
8614875|NCT00441701|9652637|FG002|COMPLETED|Overall Study||18
8614876|NCT00441701|9652638|FG003|COMPLETED|Overall Study||8
8614877|NCT00441701|9652639|FG004|COMPLETED|Overall Study||20
8614878|NCT00441701|9652640|FG005|COMPLETED|Overall Study||8
8614879|NCT00441701|9652641|FG006|COMPLETED|Overall Study||0
8614880|NCT00441701|9652642|FG007|COMPLETED|Overall Study||0
8614881|NCT00441701|9652643|FG008|COMPLETED|Overall Study||0
8614882|NCT00441701|9652644|FG009|COMPLETED|Overall Study||0
8614883|NCT00441701|9652635|FG000|NOT COMPLETED|Overall Study||5
8614884|NCT00441701|9652636|FG001|NOT COMPLETED|Overall Study||4
8614885|NCT00441701|9652637|FG002|NOT COMPLETED|Overall Study||4
8614886|NCT00441701|9652638|FG003|NOT COMPLETED|Overall Study||3
8614887|NCT00441701|9652639|FG004|NOT COMPLETED|Overall Study||2
8614888|NCT00441701|9652640|FG005|NOT COMPLETED|Overall Study||3
8614889|NCT00441701|9652641|FG006|NOT COMPLETED|Overall Study||0
8614890|NCT00441701|9652642|FG007|NOT COMPLETED|Overall Study||0
8614891|NCT00441701|9652643|FG008|NOT COMPLETED|Overall Study||0
8614892|NCT00441701|9652644|FG009|NOT COMPLETED|Overall Study||0
8614893|NCT00441727|9652665|FG000|STARTED|Overall Study|ITT/randomised|817
8614894|NCT00441727|9652666|FG001|STARTED|Overall Study|ITT/randomised|804
8614895|NCT00441727|9652667|FG002|STARTED|Overall Study|ITT/randomised|805
8614896|NCT00441727|9652665|FG000|COMPLETED|Overall Study|ITT/randomised|711
8614897|NCT00441727|9652666|FG001|COMPLETED|Overall Study|ITT/randomised|686
8614898|NCT00441727|9652667|FG002|COMPLETED|Overall Study|ITT/randomised|637
8614899|NCT00441727|9652665|FG000|NOT COMPLETED|Overall Study||106
8614900|NCT00441727|9652666|FG001|NOT COMPLETED|Overall Study||118
8614901|NCT00441727|9652667|FG002|NOT COMPLETED|Overall Study||168
8614902|NCT00441766|9652684|FG000|STARTED|Overall Study||53
8614903|NCT00441766|9652685|FG001|STARTED|Overall Study||53
8614904|NCT00441766|9652686|FG002|STARTED|Overall Study||53
8614905|NCT00441766|9652687|FG003|STARTED|Overall Study||54
8614906|NCT00441766|9652684|FG000|COMPLETED|Overall Study||39
8614907|NCT00441766|9652685|FG001|COMPLETED|Overall Study||46
8614908|NCT00441766|9652686|FG002|COMPLETED|Overall Study||44
8614909|NCT00441766|9652687|FG003|COMPLETED|Overall Study||48
8614910|NCT00441766|9652684|FG000|NOT COMPLETED|Overall Study||14
8614911|NCT00441766|9652685|FG001|NOT COMPLETED|Overall Study||7
8614912|NCT00441766|9652686|FG002|NOT COMPLETED|Overall Study||9
8614913|NCT00441766|9652687|FG003|NOT COMPLETED|Overall Study||6
8614914|NCT00441792|9652699|FG000|STARTED|Overall Study||59
8614915|NCT00441792|9652700|FG001|STARTED|Overall Study||63
8614916|NCT00441792|9652699|FG000|COMPLETED|Overall Study||59
8614917|NCT00441792|9652700|FG001|COMPLETED|Overall Study|2 patients lost to follow up in Etomidate arm due to transfer to outside hospital.|61
8614918|NCT00441792|9652699|FG000|NOT COMPLETED|Overall Study||0
8614919|NCT00441792|9652700|FG001|NOT COMPLETED|Overall Study||2
8614920|NCT00441883|9652711|FG000|STARTED|Overall Study||43
8614921|NCT00441883|9652712|FG001|STARTED|Overall Study||32
8614922|NCT00441883|9652713|FG002|STARTED|Overall Study||28
8614923|NCT00441883|9652714|FG003|STARTED|Overall Study||28
8614924|NCT00441883|9652715|FG004|STARTED|Overall Study||45
8614925|NCT00441883|9652711|FG000|ITT Population|Overall Study||43
8614926|NCT00441883|9652712|FG001|ITT Population|Overall Study||30
8614927|NCT00441883|9652713|FG002|ITT Population|Overall Study||30
8614928|NCT00441883|9652714|FG003|ITT Population|Overall Study||30
8614929|NCT00441883|9652715|FG004|ITT Population|Overall Study||43
8614930|NCT00441883|9652711|FG000|Per Protocol Population|Overall Study||38
8715650|NCT00984815|9762578|FG000|NOT COMPLETED|Overall Study||30
8715651|NCT00984867|9762584|FG000|STARTED|Overall Study|Of the 226 randomized and treated participants only 224 were included in the full analysis set.|226
8715652|NCT00984867|9762585|FG001|STARTED|Overall Study|Of the 225 randomized and treated participants only 223 were included in the full analysis set.|225
8715653|NCT00984867|9762584|FG000|COMPLETED|Overall Study||203
8715654|NCT00984867|9762585|FG001|COMPLETED|Overall Study||208
8715655|NCT00984867|9762584|FG000|NOT COMPLETED|Overall Study||23
8715656|NCT00984867|9762585|FG001|NOT COMPLETED|Overall Study||17
8715657|NCT00985010|9762595|FG000|STARTED|Overall Study||4
8715658|NCT00985010|9762596|FG001|STARTED|Overall Study||5
8715659|NCT00985010|9762595|FG000|COMPLETED|Overall Study||4
8715660|NCT00985010|9762596|FG001|COMPLETED|Overall Study||5
8715661|NCT00985010|9762595|FG000|NOT COMPLETED|Overall Study||0
8715662|NCT00985010|9762596|FG001|NOT COMPLETED|Overall Study||0
8715663|NCT00985088|9762610|FG000|STARTED|Overall Study||222
8715664|NCT00985088|9762611|FG001|STARTED|Overall Study||114
8715665|NCT00985088|9762612|FG002|STARTED|Overall Study||112
8715666|NCT00985088|9762613|FG003|STARTED|Overall Study||221
8715667|NCT00985088|9762614|FG004|STARTED|Overall Study||223
8715668|NCT00985088|9762615|FG005|STARTED|Overall Study||115
8614931|NCT00441883|9652712|FG001|Per Protocol Population|Overall Study||29
8614932|NCT00441883|9652713|FG002|Per Protocol Population|Overall Study||25
8614933|NCT00441883|9652714|FG003|Per Protocol Population|Overall Study||24
8614934|NCT00441883|9652715|FG004|Per Protocol Population|Overall Study||38
8614935|NCT00441883|9652711|FG000|Safety Population|Overall Study||43
8614936|NCT00441883|9652712|FG001|Safety Population|Overall Study||32
8614937|NCT00441883|9652713|FG002|Safety Population|Overall Study||28
8715669|NCT00985088|9762616|FG006|STARTED|Overall Study||111
8715670|NCT00985088|9762617|FG007|STARTED|Overall Study||222
8614938|NCT00441883|9652714|FG003|Safety Population|Overall Study||28
8614939|NCT00441883|9652715|FG004|Safety Population|Overall Study||45
8614940|NCT00441883|9652711|FG000|COMPLETED|Overall Study||42
8614941|NCT00441883|9652712|FG001|COMPLETED|Overall Study||32
8614942|NCT00441883|9652713|FG002|COMPLETED|Overall Study||28
8614943|NCT00441883|9652714|FG003|COMPLETED|Overall Study||28
8614944|NCT00441883|9652715|FG004|COMPLETED|Overall Study||43
8614945|NCT00441883|9652711|FG000|NOT COMPLETED|Overall Study||1
8614946|NCT00441883|9652712|FG001|NOT COMPLETED|Overall Study||0
8614947|NCT00441883|9652713|FG002|NOT COMPLETED|Overall Study||0
8614948|NCT00441883|9652714|FG003|NOT COMPLETED|Overall Study||0
8614949|NCT00441883|9652715|FG004|NOT COMPLETED|Overall Study||2
8614950|NCT00441974|9652727|FG000|STARTED|Overall Study||1470
8614951|NCT00441974|9652727|FG000|COMPLETED|Overall Study||1342
8614952|NCT00441974|9652727|FG000|NOT COMPLETED|Overall Study||128
8614953|NCT00442013|9652736|FG000|STARTED|Overall Study||157
8614954|NCT00442013|9652737|FG001|STARTED|Overall Study||149
8614955|NCT00442013|9652736|FG000|COMPLETED|Overall Study||131
8614956|NCT00442013|9652737|FG001|COMPLETED|Overall Study||132
8614957|NCT00442013|9652736|FG000|NOT COMPLETED|Overall Study||26
8614958|NCT00442013|9652737|FG001|NOT COMPLETED|Overall Study||17
8614959|NCT00442169|9652750|FG000|STARTED|Part 1||17
8614960|NCT00442169|9652751|FG001|STARTED|Part 1||24
8614961|NCT00442169|9652752|FG002|STARTED|Part 1||40
8614962|NCT00442169|9652753|FG003|STARTED|Part 1||31
8614963|NCT00442169|9652754|FG004|STARTED|Part 1|Participants in Part 2 are not the same as those in Part 1|0
8614964|NCT00442169|9652755|FG005|STARTED|Part 1|Participants in Part 2 are not the same as those in Part 1|0
8614965|NCT00442169|9652750|FG000|COMPLETED|Part 1||17
8614966|NCT00442169|9652751|FG001|COMPLETED|Part 1||24
8614967|NCT00442169|9652752|FG002|COMPLETED|Part 1||40
8614968|NCT00442169|9652753|FG003|COMPLETED|Part 1||31
8614969|NCT00442169|9652754|FG004|COMPLETED|Part 1||0
8614970|NCT00442169|9652755|FG005|COMPLETED|Part 1||0
8614971|NCT00442169|9652750|FG000|NOT COMPLETED|Part 1||0
8614972|NCT00442169|9652751|FG001|NOT COMPLETED|Part 1||0
8614973|NCT00442169|9652752|FG002|NOT COMPLETED|Part 1||0
8614974|NCT00442169|9652753|FG003|NOT COMPLETED|Part 1||0
8614975|NCT00442169|9652754|FG004|NOT COMPLETED|Part 1||0
8614976|NCT00442169|9652755|FG005|NOT COMPLETED|Part 1||0
8614977|NCT00442169|9652750|FG000|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
8614978|NCT00442169|9652751|FG001|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
8614979|NCT00442169|9652752|FG002|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
8614980|NCT00442169|9652753|FG003|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
8614981|NCT00442169|9652754|FG004|STARTED|Part 2||25
8614982|NCT00442169|9652755|FG005|STARTED|Part 2||57
8614983|NCT00442169|9652750|FG000|COMPLETED|Part 2||0
8614984|NCT00442169|9652751|FG001|COMPLETED|Part 2||0
8614985|NCT00442169|9652752|FG002|COMPLETED|Part 2||0
8614986|NCT00442169|9652753|FG003|COMPLETED|Part 2||0
8614987|NCT00442169|9652754|FG004|COMPLETED|Part 2||25
8614988|NCT00442169|9652755|FG005|COMPLETED|Part 2||57
8614989|NCT00442169|9652750|FG000|NOT COMPLETED|Part 2||0
8614990|NCT00442169|9652751|FG001|NOT COMPLETED|Part 2||0
8614991|NCT00442169|9652752|FG002|NOT COMPLETED|Part 2||0
8614992|NCT00442169|9652753|FG003|NOT COMPLETED|Part 2||0
8614993|NCT00442169|9652754|FG004|NOT COMPLETED|Part 2||0
8614994|NCT00442169|9652755|FG005|NOT COMPLETED|Part 2||0
8614995|NCT00442286|9652772|FG000|STARTED|Overall Study||181
8614996|NCT00442286|9652773|FG001|STARTED|Overall Study||84
8614997|NCT00442286|9652772|FG000|6 Months|Overall Study||177
8614998|NCT00442286|9652773|FG001|6 Months|Overall Study||83
8614999|NCT00442286|9652772|FG000|12 Months|Overall Study||174
8615000|NCT00442286|9652773|FG001|12 Months|Overall Study||82
8615001|NCT00442286|9652772|FG000|COMPLETED|Overall Study||174
8615002|NCT00442286|9652773|FG001|COMPLETED|Overall Study||82
8615003|NCT00442286|9652772|FG000|NOT COMPLETED|Overall Study||7
8615004|NCT00442286|9652773|FG001|NOT COMPLETED|Overall Study||2
8615005|NCT00442364|9652781|FG000|STARTED|Overall Study||60
8615006|NCT00442364|9652781|FG000|COMPLETED|Overall Study||60
8715671|NCT00985088|9762610|FG000|COMPLETED|Overall Study||211
8715672|NCT00985088|9762611|FG001|COMPLETED|Overall Study||112
8715673|NCT00985088|9762612|FG002|COMPLETED|Overall Study||108
8715674|NCT00985088|9762613|FG003|COMPLETED|Overall Study||214
8615007|NCT00442364|9652781|FG000|NOT COMPLETED|Overall Study||0
8615008|NCT00442416|9652787|FG000|STARTED|Overall Study||39
8615009|NCT00442416|9652788|FG001|STARTED|Overall Study||41
8615010|NCT00442416|9652787|FG000|COMPLETED|Overall Study||2
8615011|NCT00442416|9652788|FG001|COMPLETED|Overall Study||2
8615012|NCT00442416|9652787|FG000|NOT COMPLETED|Overall Study||37
8615013|NCT00442416|9652788|FG001|NOT COMPLETED|Overall Study||39
8615014|NCT00442468|9652794|FG000|STARTED|Overall Study||1283
8615015|NCT00442468|9652794|FG000|COMPLETED|Overall Study||1100
8615016|NCT00442468|9652794|FG000|NOT COMPLETED|Overall Study||183
8615017|NCT00442507|9652798|FG000|STARTED|Overall Study||6
8615018|NCT00442507|9652798|FG000|COMPLETED|Overall Study||6
8615019|NCT00442507|9652798|FG000|NOT COMPLETED|Overall Study||0
8615020|NCT00442572|9652804|FG000|STARTED|Overall Study||17
8615021|NCT00442572|9652805|FG001|STARTED|Overall Study||4
8615022|NCT00442572|9652804|FG000|COMPLETED|Overall Study||9
8615023|NCT00442572|9652805|FG001|COMPLETED|Overall Study||1
8615024|NCT00442572|9652804|FG000|NOT COMPLETED|Overall Study||8
8615025|NCT00442572|9652805|FG001|NOT COMPLETED|Overall Study||3
8715675|NCT00985088|9762614|FG004|COMPLETED|Overall Study||214
8615026|NCT00442598|9652815|FG000|STARTED|Overall Study||7
8615027|NCT00442598|9652816|FG001|STARTED|Overall Study||10
8615028|NCT00442598|9652817|FG002|STARTED|Overall Study||0
8615029|NCT00442598|9652815|FG000|Two Cycles|Overall Study||5
8615030|NCT00442598|9652816|FG001|Two Cycles|Overall Study||6
8615031|NCT00442598|9652817|FG002|Two Cycles|Overall Study||0
8615032|NCT00442598|9652815|FG000|COMPLETED|Overall Study||1
8615033|NCT00442598|9652816|FG001|COMPLETED|Overall Study||2
8615034|NCT00442598|9652817|FG002|COMPLETED|Overall Study||0
8615035|NCT00442598|9652815|FG000|NOT COMPLETED|Overall Study||6
8615036|NCT00442598|9652816|FG001|NOT COMPLETED|Overall Study||8
8615037|NCT00442598|9652817|FG002|NOT COMPLETED|Overall Study||0
8615038|NCT00442611|9652826|FG000|STARTED|Overall Study||7
8615039|NCT00442611|9652827|FG001|STARTED|Overall Study||3
8615040|NCT00442611|9652826|FG000|COMPLETED|Overall Study||6
8615041|NCT00442611|9652827|FG001|COMPLETED|Overall Study||3
8615042|NCT00442611|9652826|FG000|NOT COMPLETED|Overall Study||1
8615043|NCT00442611|9652827|FG001|NOT COMPLETED|Overall Study||0
8615044|NCT00442689|9652836|FG000|STARTED|Overall Study||21
8615045|NCT00442689|9652837|FG001|STARTED|Overall Study||24
8615046|NCT00442689|9652838|FG002|STARTED|Overall Study||22
8615047|NCT00442689|9652836|FG000|COMPLETED|Overall Study||11
8615048|NCT00442689|9652837|FG001|COMPLETED|Overall Study||13
8615049|NCT00442689|9652838|FG002|COMPLETED|Overall Study||13
8615050|NCT00442689|9652836|FG000|NOT COMPLETED|Overall Study||10
8615051|NCT00442689|9652837|FG001|NOT COMPLETED|Overall Study||11
8615052|NCT00442689|9652838|FG002|NOT COMPLETED|Overall Study||9
8615053|NCT00442702|9652848|FG000|STARTED|Titration Period||114
8615054|NCT00442702|9652849|FG001|STARTED|Titration Period||114
8615055|NCT00442702|9652848|FG000|Safety Population|Titration Period|One patient was randomized to darbepoetin alfa but treated by mistake with Mircera|115
8615056|NCT00442702|9652849|FG001|Safety Population|Titration Period||113
8615057|NCT00442702|9652848|FG000|COMPLETED|Titration Period||102
8615058|NCT00442702|9652849|FG001|COMPLETED|Titration Period||111
8615059|NCT00442702|9652848|FG000|NOT COMPLETED|Titration Period||12
8615060|NCT00442702|9652849|FG001|NOT COMPLETED|Titration Period||3
8615061|NCT00442702|9652848|FG000|STARTED|Evaluation Period||102
8615062|NCT00442702|9652849|FG001|STARTED|Evaluation Period||111
8615063|NCT00442702|9652848|FG000|COMPLETED|Evaluation Period||97
8615064|NCT00442702|9652849|FG001|COMPLETED|Evaluation Period||107
8615065|NCT00442702|9652848|FG000|NOT COMPLETED|Evaluation Period||5
8615066|NCT00442702|9652849|FG001|NOT COMPLETED|Evaluation Period||4
8615067|NCT00442767|9652855|FG000|STARTED|Overall Study||8
8615068|NCT00442767|9652855|FG000|COMPLETED|Overall Study||8
8615069|NCT00442767|9652855|FG000|NOT COMPLETED|Overall Study||0
8615070|NCT00442936|9652865|FG000|STARTED|Overall Study||333
8615071|NCT00442936|9652866|FG001|STARTED|Overall Study||354
8615072|NCT00442936|9652867|FG002|STARTED|Overall Study||345
8615073|NCT00442936|9652868|FG003|STARTED|Overall Study||348
8615074|NCT00442936|9652865|FG000|COMPLETED|Overall Study||332
8615075|NCT00442936|9652866|FG001|COMPLETED|Overall Study||354
8615076|NCT00442936|9652867|FG002|COMPLETED|Overall Study||344
8615077|NCT00442936|9652868|FG003|COMPLETED|Overall Study||347
8615078|NCT00442936|9652865|FG000|NOT COMPLETED|Overall Study||1
8615079|NCT00442936|9652866|FG001|NOT COMPLETED|Overall Study||0
8615080|NCT00442936|9652867|FG002|NOT COMPLETED|Overall Study||1
8615081|NCT00442936|9652868|FG003|NOT COMPLETED|Overall Study||1
8615082|NCT00442962|9652878|FG000|STARTED|Overall Study||54
8615083|NCT00442962|9652878|FG000|Primary Outcome Evaluation|Overall Study|Primary outcome evaluation at week 24.|52
8615084|NCT00442962|9652878|FG000|COMPLETED|Overall Study|Completed 48 weeks of follow-up.|46
8615085|NCT00442962|9652878|FG000|NOT COMPLETED|Overall Study||8
8615086|NCT00443053|9652884|FG000|STARTED|Overall Study||1502
8615087|NCT00443053|9652885|FG001|STARTED|Overall Study||1500
8615088|NCT00443053|9652884|FG000|COMPLETED|Overall Study||1481
8615089|NCT00443053|9652885|FG001|COMPLETED|Overall Study||1467
8615090|NCT00443053|9652884|FG000|NOT COMPLETED|Overall Study||21
8615091|NCT00443053|9652885|FG001|NOT COMPLETED|Overall Study||33
8615092|NCT00443079|9652893|FG000|STARTED|Overall Study||3
8615093|NCT00443079|9652894|FG001|STARTED|Overall Study||3
8615094|NCT00443079|9652893|FG000|COMPLETED|Overall Study||3
8615095|NCT00443079|9652894|FG001|COMPLETED|Overall Study||2
8615096|NCT00443079|9652893|FG000|NOT COMPLETED|Overall Study||0
8615097|NCT00443079|9652894|FG001|NOT COMPLETED|Overall Study||1
8615098|NCT00443118|9652905|FG000|STARTED|Overall Study||515
8615099|NCT00443118|9652906|FG001|STARTED|Overall Study||291
8615100|NCT00443118|9652907|FG002|STARTED|Overall Study||226
8615101|NCT00443118|9652905|FG000|COMPLETED|Overall Study||511
8615102|NCT00443118|9652906|FG001|COMPLETED|Overall Study||290
8615103|NCT00443118|9652907|FG002|COMPLETED|Overall Study||226
8615104|NCT00443118|9652905|FG000|NOT COMPLETED|Overall Study||4
8615105|NCT00443118|9652906|FG001|NOT COMPLETED|Overall Study||1
8615106|NCT00443118|9652907|FG002|NOT COMPLETED|Overall Study||0
8629349|NCT00529529|9669068|FG002|COMPLETED|Overall Study||238
8629350|NCT00529529|9669066|FG000|NOT COMPLETED|Overall Study||43
8629351|NCT00529529|9669067|FG001|NOT COMPLETED|Overall Study||43
8629352|NCT00529529|9669068|FG002|NOT COMPLETED|Overall Study||31
8629353|NCT00529542|9669078|FG000|STARTED|Overall Study||9
8629354|NCT00529542|9669079|FG001|STARTED|Overall Study||11
8629355|NCT00529542|9669078|FG000|COMPLETED|Overall Study||8
8629356|NCT00529542|9669079|FG001|COMPLETED|Overall Study||10
8629357|NCT00529542|9669078|FG000|NOT COMPLETED|Overall Study||1
8615107|NCT00443209|9652935|FG000|STARTED|Months 1 to 12 Treatment Period||712
8615108|NCT00443209|9652936|FG001|STARTED|Months 1 to 12 Treatment Period||356
8615109|NCT00443209|9652935|FG000|Treated|Months 1 to 12 Treatment Period||641
8615110|NCT00443209|9652936|FG001|Treated|Months 1 to 12 Treatment Period||313
8615111|NCT00443209|9652935|FG000|COMPLETED|Months 1 to 12 Treatment Period|Trial terminated used for participants not completing 12 months of treatment due to trial completion|367
8615112|NCT00443209|9652936|FG001|COMPLETED|Months 1 to 12 Treatment Period|Trial terminated used for participants not completing 12 months of treatment due to trial completion|202
8615113|NCT00443209|9652935|FG000|NOT COMPLETED|Months 1 to 12 Treatment Period||345
8615114|NCT00443209|9652936|FG001|NOT COMPLETED|Months 1 to 12 Treatment Period||154
8615115|NCT00443209|9652935|FG000|STARTED|Months 13 to 18 Treatment Period|The Months 13 to 18 Treatment Period.was optional. 181 participants chose not to continue.|186
8615116|NCT00443209|9652936|FG001|STARTED|Months 13 to 18 Treatment Period|The Months 13 to 18 Treatment Period was optional. 116 participants chose not to continue.|86
8615117|NCT00443209|9652935|FG000|COMPLETED|Months 13 to 18 Treatment Period|Trial terminated used for participants not completing 18 months of treatment due to trial completion|87
8615118|NCT00443209|9652936|FG001|COMPLETED|Months 13 to 18 Treatment Period|Trial terminated used for participants not completing 18 months of treatment due to trial completion|39
8615119|NCT00443209|9652935|FG000|NOT COMPLETED|Months 13 to 18 Treatment Period||99
8615120|NCT00443209|9652936|FG001|NOT COMPLETED|Months 13 to 18 Treatment Period||47
8615121|NCT00443261|9652942|FG000|STARTED|Overall Study||1
8615122|NCT00443261|9652942|FG000|Accrual in 10 Months|Overall Study|Patient died due to progressive disease after cycle 1 of treatment|1
8615123|NCT00443261|9652942|FG000|COMPLETED|Overall Study|Study terminated due to poor accrual and only patient enrolled died|0
8615124|NCT00443261|9652942|FG000|NOT COMPLETED|Overall Study||1
8615125|NCT00443352|9652946|FG000|STARTED|Overall Study||27
8615126|NCT00443352|9652946|FG000|COMPLETED|Overall Study||22
8615127|NCT00443352|9652946|FG000|NOT COMPLETED|Overall Study||5
8615128|NCT00443430|9652952|FG000|STARTED|Overall Study||43
8615129|NCT00443430|9652953|FG001|STARTED|Overall Study||42
8615130|NCT00443430|9652952|FG000|COMPLETED|Overall Study||39
8615131|NCT00443430|9652953|FG001|COMPLETED|Overall Study||38
8615132|NCT00443430|9652952|FG000|NOT COMPLETED|Overall Study||4
8615133|NCT00443430|9652953|FG001|NOT COMPLETED|Overall Study||4
8615134|NCT00443456|9652959|FG000|STARTED|Overall Study||134
8615135|NCT00443456|9652959|FG000|COMPLETED|Overall Study||116
8615136|NCT00443456|9652959|FG000|NOT COMPLETED|Overall Study||18
8615137|NCT00443534|9652967|FG000|STARTED|Overall Study||123
8615138|NCT00443534|9652967|FG000|Treated|Overall Study||122
8615139|NCT00443534|9652967|FG000|COMPLETED|Overall Study||0
8615140|NCT00443534|9652967|FG000|NOT COMPLETED|Overall Study||123
8615141|NCT00443547|9652975|FG000|STARTED|Overall Study|Enrolled and Treated Per Protocol|89
8615142|NCT00443547|9652976|FG001|STARTED|Overall Study|Enrolled and Treated Per Protocol|88
8615143|NCT00443547|9652977|FG002|STARTED|Overall Study|Enrolled and Treated Per Protocol|48
8615144|NCT00443547|9652978|FG003|STARTED|Overall Study|Enrolled and Treated Per Protocol|6
8615145|NCT00443547|9652975|FG000|Evaluated at 12 Months|Overall Study||58
8615146|NCT00443547|9652976|FG001|Evaluated at 12 Months|Overall Study||55
8615147|NCT00443547|9652977|FG002|Evaluated at 12 Months|Overall Study||37
8615148|NCT00443547|9652978|FG003|Evaluated at 12 Months|Overall Study||5
8615149|NCT00443547|9652975|FG000|COMPLETED|Overall Study||44
8615150|NCT00443547|9652976|FG001|COMPLETED|Overall Study||46
8615151|NCT00443547|9652977|FG002|COMPLETED|Overall Study||27
8615152|NCT00443547|9652978|FG003|COMPLETED|Overall Study||4
8615153|NCT00443547|9652975|FG000|NOT COMPLETED|Overall Study||45
8615154|NCT00443547|9652976|FG001|NOT COMPLETED|Overall Study||42
8615155|NCT00443547|9652977|FG002|NOT COMPLETED|Overall Study||21
8615156|NCT00443547|9652978|FG003|NOT COMPLETED|Overall Study||2
8615157|NCT00443560|9652990|FG000|STARTED|Overall Study||1081
8615158|NCT00443560|9652991|FG001|STARTED|Overall Study||1081
8615159|NCT00443560|9652990|FG000|COMPLETED|Overall Study||1021
8615160|NCT00443560|9652991|FG001|COMPLETED|Overall Study||1051
8615161|NCT00443560|9652990|FG000|NOT COMPLETED|Overall Study||60
8615162|NCT00443560|9652991|FG001|NOT COMPLETED|Overall Study||30
8615163|NCT00443599|9652999|FG000|STARTED|Overall Study|Randomly Assigned to Tight Glycemic Control|496
8615164|NCT00443599|9653000|FG001|STARTED|Overall Study|Randomly Assigned to Standard Care|493
8615165|NCT00443599|9652999|FG000|COMPLETED|Overall Study|Included in per-protocol analysis|490
8615166|NCT00443599|9653000|FG001|COMPLETED|Overall Study|Included in per-protocol analysis|490
8615167|NCT00443599|9652999|FG000|NOT COMPLETED|Overall Study||6
8615168|NCT00443599|9653000|FG001|NOT COMPLETED|Overall Study||3
8615169|NCT00443651|9653008|FG000|STARTED|Overall Study||401
8615170|NCT00443651|9653009|FG001|STARTED|Overall Study||176
8615171|NCT00443651|9653008|FG000|Week 24|Overall Study||376
8615172|NCT00443651|9653009|FG001|Week 24|Overall Study||160
8615173|NCT00443651|9653008|FG000|Week 48|Overall Study||338
8615174|NCT00443651|9653009|FG001|Week 48|Overall Study||134
8615175|NCT00443651|9653008|FG000|COMPLETED|Overall Study|Completed the study or the safety follow-up period.|306
8615176|NCT00443651|9653009|FG001|COMPLETED|Overall Study|Completed the study or the safety follow-up period.|118
8615177|NCT00443651|9653008|FG000|NOT COMPLETED|Overall Study||95
8615178|NCT00443651|9653009|FG001|NOT COMPLETED|Overall Study||58
8615179|NCT00443703|9653017|FG000|STARTED|Overall Study||177
8615180|NCT00443703|9653018|FG001|STARTED|Overall Study||175
8615181|NCT00443703|9653017|FG000|Treated|Overall Study||174
8615182|NCT00443703|9653018|FG001|Treated|Overall Study||174
8615183|NCT00443703|9653017|FG000|COMPLETED|Overall Study||149
8615184|NCT00443703|9653018|FG001|COMPLETED|Overall Study||157
8615185|NCT00443703|9653017|FG000|NOT COMPLETED|Overall Study||28
8615186|NCT00443703|9653018|FG001|NOT COMPLETED|Overall Study||18
8615187|NCT00443729|9653026|FG000|STARTED|Overall Study||176
8615188|NCT00443729|9653027|FG001|STARTED|Overall Study||179
8615189|NCT00443729|9653026|FG000|Treated|Overall Study||176
8615190|NCT00443729|9653027|FG001|Treated|Overall Study||178
8615191|NCT00443729|9653026|FG000|COMPLETED|Overall Study||166
8615192|NCT00443729|9653027|FG001|COMPLETED|Overall Study||172
8615193|NCT00443729|9653026|FG000|NOT COMPLETED|Overall Study||10
8615194|NCT00443729|9653027|FG001|NOT COMPLETED|Overall Study||7
8615195|NCT00443755|9653035|FG000|STARTED|Overall Study||14
8615196|NCT00443755|9653036|FG001|STARTED|Overall Study||14
8615197|NCT00443755|9653035|FG000|COMPLETED|Overall Study||12
8615198|NCT00443755|9653036|FG001|COMPLETED|Overall Study||13
8615199|NCT00443755|9653035|FG000|NOT COMPLETED|Overall Study||2
8615200|NCT00443755|9653036|FG001|NOT COMPLETED|Overall Study||1
8615201|NCT00443781|9653042|FG000|STARTED|Overall Study||62
8615202|NCT00443781|9653042|FG000|COMPLETED|Overall Study||37
8615203|NCT00443781|9653042|FG000|NOT COMPLETED|Overall Study||25
8615204|NCT00443820|9653050|FG000|STARTED|Overall Study||133
8615205|NCT00443820|9653051|FG001|STARTED|Overall Study||130
8615206|NCT00443820|9653052|FG002|STARTED|Overall Study||135
8615207|NCT00443820|9653053|FG003|STARTED|Overall Study||128
8615208|NCT00443820|9653050|FG000|Safety Population|Overall Study|Participants who received study drug and had at least one post-baseline safety assessment.|131
8615209|NCT00443820|9653051|FG001|Safety Population|Overall Study||129
8615210|NCT00443820|9653052|FG002|Safety Population|Overall Study||134
8615211|NCT00443820|9653053|FG003|Safety Population|Overall Study||126
8615212|NCT00443820|9653050|FG000|COMPLETED|Overall Study||112
8615213|NCT00443820|9653051|FG001|COMPLETED|Overall Study|A participant from this gr. discont'ed due to renal failure, was counted as an AE and also as a SAE.|111
8615214|NCT00443820|9653052|FG002|COMPLETED|Overall Study||117
8615215|NCT00443820|9653053|FG003|COMPLETED|Overall Study||111
8615216|NCT00443820|9653050|FG000|NOT COMPLETED|Overall Study||21
8615217|NCT00443820|9653051|FG001|NOT COMPLETED|Overall Study||19
8615218|NCT00443820|9653052|FG002|NOT COMPLETED|Overall Study||18
8615219|NCT00443820|9653053|FG003|NOT COMPLETED|Overall Study||17
8615220|NCT00443846|9653065|FG000|STARTED|Overall Study||124
8615221|NCT00443846|9653066|FG001|STARTED|Overall Study||123
8615222|NCT00443846|9653065|FG000|Vaccinated|Overall Study||116
8615223|NCT00443846|9653066|FG001|Vaccinated|Overall Study||123
8615224|NCT00443846|9653065|FG000|COMPLETED|Overall Study||113
8615225|NCT00443846|9653066|FG001|COMPLETED|Overall Study||117
8615226|NCT00443846|9653065|FG000|NOT COMPLETED|Overall Study||11
8615227|NCT00443846|9653066|FG001|NOT COMPLETED|Overall Study||6
8615228|NCT00443872|9653072|FG000|STARTED|Overall Study||77
8615229|NCT00443872|9653072|FG000|COMPLETED|Overall Study||60
8615230|NCT00443872|9653072|FG000|NOT COMPLETED|Overall Study||17
8615231|NCT00443898|9653089|FG000|STARTED|Overall Study||126
8615232|NCT00443898|9653090|FG001|STARTED|Overall Study||128
8615233|NCT00443898|9653091|FG002|STARTED|Overall Study||136
8615234|NCT00443898|9653092|FG003|STARTED|Overall Study||128
8615235|NCT00443898|9653089|FG000|COMPLETED|Overall Study||102
8615236|NCT00443898|9653090|FG001|COMPLETED|Overall Study||103
8615237|NCT00443898|9653091|FG002|COMPLETED|Overall Study||107
8615238|NCT00443898|9653092|FG003|COMPLETED|Overall Study||110
8615239|NCT00443898|9653089|FG000|NOT COMPLETED|Overall Study||24
8615240|NCT00443898|9653090|FG001|NOT COMPLETED|Overall Study||25
8615241|NCT00443898|9653091|FG002|NOT COMPLETED|Overall Study||29
8615242|NCT00443898|9653092|FG003|NOT COMPLETED|Overall Study||18
8615243|NCT00444028|9653108|FG000|STARTED|Overall Study||14
8615244|NCT00444028|9653109|FG001|STARTED|Overall Study||7
8615245|NCT00444028|9653110|FG002|STARTED|Overall Study||8
8615246|NCT00444028|9653111|FG003|STARTED|Overall Study||6
8615247|NCT00444028|9653112|FG004|STARTED|Overall Study||7
8615248|NCT00444028|9653113|FG005|STARTED|Overall Study||8
8615249|NCT00444028|9653108|FG000|COMPLETED|Overall Study||14
8615250|NCT00444028|9653109|FG001|COMPLETED|Overall Study||7
8615251|NCT00444028|9653110|FG002|COMPLETED|Overall Study||8
8615252|NCT00444028|9653111|FG003|COMPLETED|Overall Study||6
8615253|NCT00444028|9653112|FG004|COMPLETED|Overall Study||7
8615254|NCT00444028|9653113|FG005|COMPLETED|Overall Study||8
8615255|NCT00444028|9653108|FG000|NOT COMPLETED|Overall Study||0
8615256|NCT00444028|9653109|FG001|NOT COMPLETED|Overall Study||0
8615257|NCT00444028|9653110|FG002|NOT COMPLETED|Overall Study||0
8615258|NCT00444028|9653111|FG003|NOT COMPLETED|Overall Study||0
8615259|NCT00444028|9653112|FG004|NOT COMPLETED|Overall Study||0
8615260|NCT00444028|9653113|FG005|NOT COMPLETED|Overall Study||0
8615261|NCT00444067|9653128|FG000|STARTED|Overall Study||74
8615262|NCT00444067|9653129|FG001|STARTED|Overall Study||24
8615263|NCT00444067|9653128|FG000|COMPLETED|Overall Study||74
8615264|NCT00444067|9653129|FG001|COMPLETED|Overall Study||23
8615265|NCT00444067|9653128|FG000|NOT COMPLETED|Overall Study||0
8615266|NCT00444067|9653129|FG001|NOT COMPLETED|Overall Study||1
8615267|NCT00444080|9653137|FG000|STARTED|Overall Study||61
8615268|NCT00444080|9653138|FG001|STARTED|Overall Study||59
8615269|NCT00444080|9653137|FG000|COMPLETED|Overall Study||61
8615270|NCT00444080|9653138|FG001|COMPLETED|Overall Study||59
8615271|NCT00444080|9653137|FG000|NOT COMPLETED|Overall Study||0
8615272|NCT00444080|9653138|FG001|NOT COMPLETED|Overall Study||0
8615273|NCT00444106|9653150|FG000|STARTED|Overall Study||159
8615274|NCT00444106|9653151|FG001|STARTED|Overall Study||53
8615275|NCT00444106|9653152|FG002|STARTED|Overall Study||53
8615276|NCT00444106|9653150|FG000|Completed Treatment Period|Overall Study||159
8615277|NCT00444106|9653151|FG001|Completed Treatment Period|Overall Study||53
8615278|NCT00444106|9653152|FG002|Completed Treatment Period|Overall Study||53
8615279|NCT00444106|9653150|FG000|COMPLETED|Overall Study||157
8615280|NCT00444106|9653151|FG001|COMPLETED|Overall Study||52
8615281|NCT00444106|9653152|FG002|COMPLETED|Overall Study||52
8615282|NCT00444106|9653150|FG000|NOT COMPLETED|Overall Study||2
8615283|NCT00444106|9653151|FG001|NOT COMPLETED|Overall Study||1
8615284|NCT00444106|9653152|FG002|NOT COMPLETED|Overall Study||1
8615285|NCT00444145|9653163|FG000|STARTED|Overall Study||38
8615286|NCT00444145|9653163|FG000|COMPLETED|Overall Study||19
8615287|NCT00444145|9653163|FG000|NOT COMPLETED|Overall Study||19
8615288|NCT00444275|9653170|FG000|STARTED|Initial Treatment Phase||2156
8615289|NCT00444275|9653171|FG001|STARTED|Initial Treatment Phase||873
8615290|NCT00444275|9653172|FG002|STARTED|Initial Treatment Phase||0
8615291|NCT00444275|9653173|FG003|STARTED|Initial Treatment Phase||0
8615292|NCT00444275|9653174|FG004|STARTED|Initial Treatment Phase||0
8615293|NCT00444275|9653170|FG000|COMPLETED|Initial Treatment Phase||1908
8615294|NCT00444275|9653171|FG001|COMPLETED|Initial Treatment Phase||777
8615295|NCT00444275|9653172|FG002|COMPLETED|Initial Treatment Phase||0
8615296|NCT00444275|9653173|FG003|COMPLETED|Initial Treatment Phase||0
8615297|NCT00444275|9653174|FG004|COMPLETED|Initial Treatment Phase||0
8615298|NCT00444275|9653170|FG000|NOT COMPLETED|Initial Treatment Phase||248
8615299|NCT00444275|9653171|FG001|NOT COMPLETED|Initial Treatment Phase||96
8615300|NCT00444275|9653172|FG002|NOT COMPLETED|Initial Treatment Phase||0
8615301|NCT00444275|9653173|FG003|NOT COMPLETED|Initial Treatment Phase||0
8615302|NCT00444275|9653174|FG004|NOT COMPLETED|Initial Treatment Phase||0
8615303|NCT00444275|9653170|FG000|STARTED|Maintenance Treatment Phase||0
8615304|NCT00444275|9653171|FG001|STARTED|Maintenance Treatment Phase||0
8615305|NCT00444275|9653172|FG002|STARTED|Maintenance Treatment Phase||908
8615306|NCT00444275|9653173|FG003|STARTED|Maintenance Treatment Phase||897
8615307|NCT00444275|9653174|FG004|STARTED|Maintenance Treatment Phase||880
8615308|NCT00444275|9653170|FG000|COMPLETED|Maintenance Treatment Phase||0
8615309|NCT00444275|9653171|FG001|COMPLETED|Maintenance Treatment Phase||0
8615310|NCT00444275|9653172|FG002|COMPLETED|Maintenance Treatment Phase||747
8615311|NCT00444275|9653173|FG003|COMPLETED|Maintenance Treatment Phase||764
8615312|NCT00444275|9653174|FG004|COMPLETED|Maintenance Treatment Phase||701
8615313|NCT00444275|9653170|FG000|NOT COMPLETED|Maintenance Treatment Phase||0
8615314|NCT00444275|9653171|FG001|NOT COMPLETED|Maintenance Treatment Phase||0
8615315|NCT00444275|9653172|FG002|NOT COMPLETED|Maintenance Treatment Phase||161
8615316|NCT00444275|9653173|FG003|NOT COMPLETED|Maintenance Treatment Phase||133
8615317|NCT00444275|9653174|FG004|NOT COMPLETED|Maintenance Treatment Phase||179
8615318|NCT00444457|9653193|FG000|STARTED|Infant Series||489
8615319|NCT00444457|9653194|FG001|STARTED|Infant Series||488
8615320|NCT00444457|9653195|FG002|STARTED|Infant Series||489
8615321|NCT00444457|9653196|FG003|STARTED|Infant Series||246
8615322|NCT00444457|9653193|FG000|Vaccinated Dose 1|Infant Series||486
8615323|NCT00444457|9653194|FG001|Vaccinated Dose 1|Infant Series||484
8615324|NCT00444457|9653195|FG002|Vaccinated Dose 1|Infant Series||485
8615325|NCT00444457|9653196|FG003|Vaccinated Dose 1|Infant Series||244
8615326|NCT00444457|9653193|FG000|Vaccinated Dose 2|Infant Series||455
8615327|NCT00444457|9653194|FG001|Vaccinated Dose 2|Infant Series||447
8615328|NCT00444457|9653195|FG002|Vaccinated Dose 2|Infant Series||455
8615329|NCT00444457|9653196|FG003|Vaccinated Dose 2|Infant Series||228
8615330|NCT00444457|9653193|FG000|Vaccinated Dose 3|Infant Series||442
8615331|NCT00444457|9653194|FG001|Vaccinated Dose 3|Infant Series||435
8615332|NCT00444457|9653195|FG002|Vaccinated Dose 3|Infant Series||438
8615333|NCT00444457|9653196|FG003|Vaccinated Dose 3|Infant Series||225
8615334|NCT00444457|9653193|FG000|COMPLETED|Infant Series||435
8615335|NCT00444457|9653194|FG001|COMPLETED|Infant Series||427
8615336|NCT00444457|9653195|FG002|COMPLETED|Infant Series||428
8615337|NCT00444457|9653196|FG003|COMPLETED|Infant Series||218
8615338|NCT00444457|9653193|FG000|NOT COMPLETED|Infant Series||54
8615339|NCT00444457|9653194|FG001|NOT COMPLETED|Infant Series||61
8615340|NCT00444457|9653195|FG002|NOT COMPLETED|Infant Series||61
8615341|NCT00444457|9653196|FG003|NOT COMPLETED|Infant Series||28
8615342|NCT00444457|9653193|FG000|STARTED|After Infant Series||435
8615343|NCT00444457|9653194|FG001|STARTED|After Infant Series||427
8615344|NCT00444457|9653195|FG002|STARTED|After Infant Series||427
8615345|NCT00444457|9653196|FG003|STARTED|After Infant Series||218
8615346|NCT00444457|9653193|FG000|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|415
8615347|NCT00444457|9653194|FG001|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|397
8615348|NCT00444457|9653195|FG002|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|408
8615349|NCT00444457|9653196|FG003|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|208
8615350|NCT00444457|9653193|FG000|NOT COMPLETED|After Infant Series||20
8615351|NCT00444457|9653194|FG001|NOT COMPLETED|After Infant Series||30
8615352|NCT00444457|9653195|FG002|NOT COMPLETED|After Infant Series||19
8615353|NCT00444457|9653196|FG003|NOT COMPLETED|After Infant Series||10
8615354|NCT00444457|9653193|FG000|STARTED|Toddler Dose|Vaccinated toddler dose|415
8615355|NCT00444457|9653194|FG001|STARTED|Toddler Dose|Vaccinated toddler dose|397
8615356|NCT00444457|9653195|FG002|STARTED|Toddler Dose|Vaccinated toddler dose|408
8615357|NCT00444457|9653196|FG003|STARTED|Toddler Dose|Vaccinated toddler dose|208
8615358|NCT00444457|9653193|FG000|COMPLETED|Toddler Dose||408
8615359|NCT00444457|9653194|FG001|COMPLETED|Toddler Dose||391
8715676|NCT00985088|9762615|FG005|COMPLETED|Overall Study||108
8715677|NCT00985088|9762616|FG006|COMPLETED|Overall Study||107
8715678|NCT00985088|9762617|FG007|COMPLETED|Overall Study||216
8715679|NCT00985088|9762610|FG000|NOT COMPLETED|Overall Study||11
8715680|NCT00985088|9762611|FG001|NOT COMPLETED|Overall Study||2
8715681|NCT00985088|9762612|FG002|NOT COMPLETED|Overall Study||4
8715682|NCT00985088|9762613|FG003|NOT COMPLETED|Overall Study||7
8615360|NCT00444457|9653195|FG002|COMPLETED|Toddler Dose||404
8615361|NCT00444457|9653196|FG003|COMPLETED|Toddler Dose||200
8615362|NCT00444457|9653193|FG000|NOT COMPLETED|Toddler Dose||7
8615363|NCT00444457|9653194|FG001|NOT COMPLETED|Toddler Dose||6
8615364|NCT00444457|9653195|FG002|NOT COMPLETED|Toddler Dose||4
8615365|NCT00444457|9653196|FG003|NOT COMPLETED|Toddler Dose||8
8615366|NCT00444535|9653217|FG000|STARTED|Overall Study||52
8615367|NCT00444535|9653217|FG000|COMPLETED|Overall Study||39
8615368|NCT00444535|9653217|FG000|NOT COMPLETED|Overall Study||13
8615369|NCT00444587|9653223|FG000|STARTED|Overall Study||93
8615370|NCT00444587|9653224|FG001|STARTED|Overall Study||16
8615371|NCT00444587|9653223|FG000|COMPLETED|Overall Study||10
8615372|NCT00444587|9653224|FG001|COMPLETED|Overall Study||1
8615373|NCT00444587|9653223|FG000|NOT COMPLETED|Overall Study||83
8615374|NCT00444587|9653224|FG001|NOT COMPLETED|Overall Study||15
8615375|NCT00444600|9653236|FG000|STARTED|Overall Study|Number of eyes|293
8615376|NCT00444600|9653237|FG001|STARTED|Overall Study|Number of eyes|187
8615377|NCT00444600|9653238|FG002|STARTED|Overall Study|Number of eyes|188
8615378|NCT00444600|9653239|FG003|STARTED|Overall Study|Number of eyes|186
8615379|NCT00444600|9653236|FG000|COMPLETED|Overall Study|Number of eyes|274
8615380|NCT00444600|9653237|FG001|COMPLETED|Overall Study|Number of eyes|171
8615381|NCT00444600|9653238|FG002|COMPLETED|Overall Study|Number of eyes|178
8615382|NCT00444600|9653239|FG003|COMPLETED|Overall Study|Number of eyes|176
8615383|NCT00444600|9653236|FG000|NOT COMPLETED|Overall Study||19
8615384|NCT00444600|9653237|FG001|NOT COMPLETED|Overall Study||16
8615385|NCT00444600|9653238|FG002|NOT COMPLETED|Overall Study||10
8615386|NCT00444600|9653239|FG003|NOT COMPLETED|Overall Study||10
8615387|NCT00444626|9653255|FG000|STARTED|Initial Treatment Period||140
8615388|NCT00444626|9653255|FG000|COMPLETED|Initial Treatment Period||128
8615389|NCT00444626|9653255|FG000|NOT COMPLETED|Initial Treatment Period||12
8615390|NCT00444626|9653255|FG000|STARTED|Repeat Treatment Period|23 subjects withdrew after completing the Initial Treatment and did not enter the Repeat Treatment|105
8615391|NCT00444626|9653255|FG000|COMPLETED|Repeat Treatment Period||105
8615392|NCT00444626|9653255|FG000|NOT COMPLETED|Repeat Treatment Period||0
8615393|NCT00444678|9653268|FG000|STARTED|Overall Study||36
8615394|NCT00444678|9653268|FG000|COMPLETED|Overall Study||5
8615395|NCT00444678|9653268|FG000|NOT COMPLETED|Overall Study||31
8615396|NCT00444795|9653272|FG000|STARTED|Overall Study||620
8615397|NCT00444795|9653272|FG000|COMPLETED|Overall Study|Refer to the Safety Analysis Set.|617
8615398|NCT00444795|9653272|FG000|NOT COMPLETED|Overall Study||3
8615399|NCT00444821|9653278|FG000|STARTED|Overall Study||362
8615400|NCT00444821|9653279|FG001|STARTED|Overall Study||366
8615401|NCT00444821|9653278|FG000|Received AAA Repair|Overall Study|Crossed over to AAA repair|122
8615402|NCT00444821|9653279|FG001|Received AAA Repair|Overall Study|Underwent AAA repair per protocol|326
8615403|NCT00444821|9653278|FG000|COMPLETED|Overall Study||0
8615404|NCT00444821|9653279|FG001|COMPLETED|Overall Study||0
8615405|NCT00444821|9653278|FG000|NOT COMPLETED|Overall Study||362
8615406|NCT00444821|9653279|FG001|NOT COMPLETED|Overall Study||366
8615407|NCT00444912|9653287|FG000|STARTED|Overall Study||15
8715683|NCT00985088|9762614|FG004|NOT COMPLETED|Overall Study||9
8615408|NCT00444912|9653288|FG001|STARTED|Overall Study||15
8615409|NCT00444912|9653287|FG000|Received Plerixafor|Overall Study||15
8615410|NCT00444912|9653288|FG001|Received Plerixafor|Overall Study||15
8615411|NCT00444912|9653287|FG000|Received Transplant|Overall Study||14
8615412|NCT00444912|9653288|FG001|Received Transplant|Overall Study||14
8615413|NCT00444912|9653287|FG000|COMPLETED|Overall Study||12
8615414|NCT00444912|9653288|FG001|COMPLETED|Overall Study||13
8615415|NCT00444912|9653287|FG000|NOT COMPLETED|Overall Study||3
8615416|NCT00444912|9653288|FG001|NOT COMPLETED|Overall Study||2
8615417|NCT00444925|9653297|FG000|STARTED|Single-blind Placebo Run-In Period||2446
8615418|NCT00444925|9653298|FG001|STARTED|Single-blind Placebo Run-In Period||0
8615419|NCT00444925|9653299|FG002|STARTED|Single-blind Placebo Run-In Period||0
8615420|NCT00444925|9653297|FG000|COMPLETED|Single-blind Placebo Run-In Period|progressed to randomization in double-blind treatment period|1712
8615421|NCT00444925|9653298|FG001|COMPLETED|Single-blind Placebo Run-In Period||0
8615422|NCT00444925|9653299|FG002|COMPLETED|Single-blind Placebo Run-In Period||0
8615423|NCT00444925|9653297|FG000|NOT COMPLETED|Single-blind Placebo Run-In Period||734
8615424|NCT00444925|9653298|FG001|NOT COMPLETED|Single-blind Placebo Run-In Period||0
8615425|NCT00444925|9653299|FG002|NOT COMPLETED|Single-blind Placebo Run-In Period||0
8615426|NCT00444925|9653297|FG000|STARTED|Randomized to Double-blind Treatment||337
8715684|NCT00985088|9762615|FG005|NOT COMPLETED|Overall Study||7
8715685|NCT00985088|9762616|FG006|NOT COMPLETED|Overall Study||4
8715686|NCT00985088|9762617|FG007|NOT COMPLETED|Overall Study||6
8715687|NCT00985114|9762647|FG000|STARTED|Overall Study|38 randomized, 34 received the device|34
8615427|NCT00444925|9653298|FG001|STARTED|Randomized to Double-blind Treatment||690
8615428|NCT00444925|9653299|FG002|STARTED|Randomized to Double-blind Treatment||685
8615429|NCT00444925|9653297|FG000|COMPLETED|Randomized to Double-blind Treatment||334
8615430|NCT00444925|9653298|FG001|COMPLETED|Randomized to Double-blind Treatment||684
8615431|NCT00444925|9653299|FG002|COMPLETED|Randomized to Double-blind Treatment||679
8615432|NCT00444925|9653297|FG000|NOT COMPLETED|Randomized to Double-blind Treatment||3
8615433|NCT00444925|9653298|FG001|NOT COMPLETED|Randomized to Double-blind Treatment||6
8615434|NCT00444925|9653299|FG002|NOT COMPLETED|Randomized to Double-blind Treatment||6
8615435|NCT00444925|9653297|FG000|STARTED|Double-blind Treatment Period||334
8615436|NCT00444925|9653298|FG001|STARTED|Double-blind Treatment Period||684
8615437|NCT00444925|9653299|FG002|STARTED|Double-blind Treatment Period||679
8615438|NCT00444925|9653297|FG000|COMPLETED|Double-blind Treatment Period||304
8615439|NCT00444925|9653298|FG001|COMPLETED|Double-blind Treatment Period||628
8615440|NCT00444925|9653299|FG002|COMPLETED|Double-blind Treatment Period||598
8615441|NCT00444925|9653297|FG000|NOT COMPLETED|Double-blind Treatment Period||30
8615442|NCT00444925|9653298|FG001|NOT COMPLETED|Double-blind Treatment Period||56
8615443|NCT00444925|9653299|FG002|NOT COMPLETED|Double-blind Treatment Period||81
8615444|NCT00444951|9653310|FG000|STARTED|Overall Study||145
8615445|NCT00444951|9653311|FG001|STARTED|Overall Study||142
8615446|NCT00444951|9653312|FG002|STARTED|Overall Study||163
8615447|NCT00444951|9653310|FG000|COMPLETED|Overall Study||140
8615448|NCT00444951|9653311|FG001|COMPLETED|Overall Study||136
8615449|NCT00444951|9653312|FG002|COMPLETED|Overall Study||160
8615450|NCT00444951|9653310|FG000|NOT COMPLETED|Overall Study||5
8615451|NCT00444951|9653311|FG001|NOT COMPLETED|Overall Study||6
8615452|NCT00444951|9653312|FG002|NOT COMPLETED|Overall Study||3
8615453|NCT00444964|9653320|FG000|STARTED|Overall Study||11
8615454|NCT00444964|9653320|FG000|COMPLETED|Overall Study||11
8615455|NCT00444964|9653320|FG000|NOT COMPLETED|Overall Study||0
8615456|NCT00445003|9653327|FG000|STARTED|Overall Study||123
8615457|NCT00445003|9653328|FG001|STARTED|Overall Study||113
8615458|NCT00445003|9653329|FG002|STARTED|Overall Study||109
8615459|NCT00445003|9653327|FG000|COMPLETED|Overall Study||118
8615460|NCT00445003|9653328|FG001|COMPLETED|Overall Study||103
8615461|NCT00445003|9653329|FG002|COMPLETED|Overall Study||105
8615462|NCT00445003|9653327|FG000|NOT COMPLETED|Overall Study||5
8615463|NCT00445003|9653328|FG001|NOT COMPLETED|Overall Study||10
8615464|NCT00445003|9653329|FG002|NOT COMPLETED|Overall Study||4
8615465|NCT00445068|9653337|FG000|STARTED|Overall Study||38
8615466|NCT00445068|9653337|FG000|COMPLETED|Overall Study||2
8615467|NCT00445068|9653337|FG000|NOT COMPLETED|Overall Study||36
8615468|NCT00445146|9653341|FG000|STARTED|Overall Study||192
8615469|NCT00445146|9653341|FG000|COMPLETED|Overall Study||73
8615470|NCT00445146|9653341|FG000|NOT COMPLETED|Overall Study||119
8615471|NCT00445211|9653347|FG000|STARTED|Overall Study||23
8615472|NCT00445211|9653348|FG001|STARTED|Overall Study||23
8615473|NCT00445211|9653347|FG000|COMPLETED|Overall Study||23
8615474|NCT00445211|9653348|FG001|COMPLETED|Overall Study||23
8615475|NCT00445211|9653347|FG000|NOT COMPLETED|Overall Study||0
8615476|NCT00445211|9653348|FG001|NOT COMPLETED|Overall Study||0
8615477|NCT00445224|9653356|FG000|STARTED|Specific Exercises||17
8615478|NCT00445224|9653357|FG001|STARTED|Specific Exercises||16
8615479|NCT00445224|9653356|FG000|Baseline|Specific Exercises||17
8615480|NCT00445224|9653357|FG001|Baseline|Specific Exercises||16
8615481|NCT00445224|9653356|FG000|4 Weeks|Specific Exercises|Participants withdrew due to time conflicts|14
8615482|NCT00445224|9653357|FG001|4 Weeks|Specific Exercises|Participants withdrew due to time conflicts|13
8615483|NCT00445224|9653356|FG000|COMPLETED|Specific Exercises|No adverse event occurred|13
8615484|NCT00445224|9653357|FG001|COMPLETED|Specific Exercises|No adverse event occurred|13
8615485|NCT00445224|9653356|FG000|NOT COMPLETED|Specific Exercises||4
8615486|NCT00445224|9653357|FG001|NOT COMPLETED|Specific Exercises||3
8615487|NCT00445224|9653356|FG000|STARTED|Combined Exercises||13
8615488|NCT00445224|9653357|FG001|STARTED|Combined Exercises||13
8615489|NCT00445224|9653356|FG000|COMPLETED|Combined Exercises||13
8615490|NCT00445224|9653357|FG001|COMPLETED|Combined Exercises||13
8615491|NCT00445224|9653356|FG000|NOT COMPLETED|Combined Exercises||0
8615492|NCT00445224|9653357|FG001|NOT COMPLETED|Combined Exercises||0
8615493|NCT00445263|9653365|FG000|STARTED|Overall Study||83
8615494|NCT00445263|9653366|FG001|STARTED|Overall Study||87
8615495|NCT00445263|9653365|FG000|COMPLETED|Overall Study||83
8615496|NCT00445263|9653366|FG001|COMPLETED|Overall Study||86
8615497|NCT00445263|9653365|FG000|NOT COMPLETED|Overall Study||0
8615498|NCT00445263|9653366|FG001|NOT COMPLETED|Overall Study||1
8715688|NCT00985114|9762648|FG001|STARTED|Overall Study||39
8715689|NCT00985114|9762647|FG000|Diet + Lifestyle Counseling Cross-over|Overall Study||0
8715690|NCT00985114|9762648|FG001|Diet + Lifestyle Counseling Cross-over|Overall Study|Received device for intended period of 12 months with 6 months follow up|28
8715691|NCT00985114|9762647|FG000|COMPLETED|Overall Study||33
8715692|NCT00985114|9762648|FG001|COMPLETED|Overall Study||37
8715693|NCT00985114|9762647|FG000|NOT COMPLETED|Overall Study||1
8715694|NCT00985114|9762648|FG001|NOT COMPLETED|Overall Study||2
8715695|NCT00985140|9762654|FG000|STARTED|Overall Study||15
8715696|NCT00985140|9762654|FG000|COMPLETED|Overall Study||15
8715697|NCT00985140|9762654|FG000|NOT COMPLETED|Overall Study||0
8615499|NCT00445302|9653376|FG000|STARTED|Overall Study||6
8615500|NCT00445302|9653377|FG001|STARTED|Overall Study||5
8615501|NCT00445302|9653378|FG002|STARTED|Overall Study||6
8615502|NCT00445302|9653379|FG003|STARTED|Overall Study||6
8615503|NCT00445302|9653376|FG000|COMPLETED|Overall Study||6
8615504|NCT00445302|9653377|FG001|COMPLETED|Overall Study||5
8615505|NCT00445302|9653378|FG002|COMPLETED|Overall Study||6
8615506|NCT00445302|9653379|FG003|COMPLETED|Overall Study||6
8615507|NCT00445302|9653376|FG000|NOT COMPLETED|Overall Study||0
8615508|NCT00445302|9653377|FG001|NOT COMPLETED|Overall Study||0
8615509|NCT00445302|9653378|FG002|NOT COMPLETED|Overall Study||0
8615510|NCT00445302|9653379|FG003|NOT COMPLETED|Overall Study||0
8615511|NCT00445315|9653394|FG000|STARTED|Overall Study||6
8615512|NCT00445315|9653395|FG001|STARTED|Overall Study||6
8615513|NCT00445315|9653396|FG002|STARTED|Overall Study||6
8615514|NCT00445315|9653397|FG003|STARTED|Overall Study||6
8615515|NCT00445315|9653398|FG004|STARTED|Overall Study||8
8615516|NCT00445315|9653394|FG000|COMPLETED|Overall Study||6
8615517|NCT00445315|9653395|FG001|COMPLETED|Overall Study||6
8615518|NCT00445315|9653396|FG002|COMPLETED|Overall Study||6
8615519|NCT00445315|9653397|FG003|COMPLETED|Overall Study||6
8615520|NCT00445315|9653398|FG004|COMPLETED|Overall Study||8
8615521|NCT00445315|9653394|FG000|NOT COMPLETED|Overall Study||0
8615522|NCT00445315|9653395|FG001|NOT COMPLETED|Overall Study||0
8615523|NCT00445315|9653396|FG002|NOT COMPLETED|Overall Study||0
8615524|NCT00445315|9653397|FG003|NOT COMPLETED|Overall Study||0
8615525|NCT00445315|9653398|FG004|NOT COMPLETED|Overall Study||0
8615526|NCT00445328|9653413|FG000|STARTED|Overall Study||42
8615527|NCT00445328|9653414|FG001|STARTED|Overall Study||42
8715698|NCT00985153|9762662|FG000|STARTED|Overall Study||985
8715699|NCT00985153|9762663|FG001|STARTED|Overall Study||968
8715700|NCT00985153|9762664|FG002|STARTED|Overall Study||962
8715701|NCT00985153|9762665|FG003|STARTED|Overall Study||1012
8715702|NCT00985153|9762662|FG000|Vaccinated at Visit 1|Overall Study||985
8615528|NCT00445328|9653413|FG000|Received Treatment|Overall Study|1 subject discontinued after enrollment but prior to study treatment.|41
8615529|NCT00445328|9653414|FG001|Received Treatment|Overall Study||42
8615530|NCT00445328|9653413|FG000|COMPLETED|Overall Study||39
8615531|NCT00445328|9653414|FG001|COMPLETED|Overall Study||36
8615532|NCT00445328|9653413|FG000|NOT COMPLETED|Overall Study||3
8615533|NCT00445328|9653414|FG001|NOT COMPLETED|Overall Study||6
8615534|NCT00445341|9653420|FG000|STARTED|Overall Study||28
8615535|NCT00445341|9653420|FG000|COMPLETED|Overall Study||26
8615536|NCT00445341|9653420|FG000|NOT COMPLETED|Overall Study||2
8615537|NCT00445432|9653427|FG000|STARTED|Through Week 52 of NCT00445432 (M06-837)||25
8615538|NCT00445432|9653428|FG001|STARTED|Through Week 52 of NCT00445432 (M06-837)||25
8615539|NCT00445432|9653429|FG002|STARTED|Through Week 52 of NCT00445432 (M06-837)||32
8615540|NCT00445432|9653430|FG003|STARTED|Through Week 52 of NCT00445432 (M06-837)|This treatment group is not applicable for this period.|0
8615541|NCT00445432|9653427|FG000|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||10
8615542|NCT00445432|9653428|FG001|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||2
8615543|NCT00445432|9653429|FG002|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||21
8615544|NCT00445432|9653430|FG003|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||0
8615545|NCT00445432|9653427|FG000|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||15
8615546|NCT00445432|9653428|FG001|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||23
8615547|NCT00445432|9653429|FG002|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||11
8615548|NCT00445432|9653430|FG003|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||0
8615549|NCT00445432|9653427|FG000|STARTED|148 Weeks of Adalimumab Treatment|This group is not applicable for this period.|0
8615550|NCT00445432|9653428|FG001|STARTED|148 Weeks of Adalimumab Treatment|This group is not applicable for this period.|0
8615551|NCT00445432|9653429|FG002|STARTED|148 Weeks of Adalimumab Treatment|This group is not applicable for this period.|0
8615552|NCT00445432|9653430|FG003|STARTED|148 Weeks of Adalimumab Treatment|3 participants discontinued while receiving double-blind placebo and never received any adalimumab|79
8615553|NCT00445432|9653427|FG000|COMPLETED|148 Weeks of Adalimumab Treatment||0
8615554|NCT00445432|9653428|FG001|COMPLETED|148 Weeks of Adalimumab Treatment||0
8615555|NCT00445432|9653429|FG002|COMPLETED|148 Weeks of Adalimumab Treatment||0
8615556|NCT00445432|9653430|FG003|COMPLETED|148 Weeks of Adalimumab Treatment||35
8615557|NCT00445432|9653427|FG000|NOT COMPLETED|148 Weeks of Adalimumab Treatment||0
8615558|NCT00445432|9653428|FG001|NOT COMPLETED|148 Weeks of Adalimumab Treatment||0
8615559|NCT00445432|9653429|FG002|NOT COMPLETED|148 Weeks of Adalimumab Treatment||0
8615560|NCT00445432|9653430|FG003|NOT COMPLETED|148 Weeks of Adalimumab Treatment||44
8615561|NCT00445458|9653445|FG000|STARTED|Overall Study||3
8615562|NCT00445458|9653446|FG001|STARTED|Overall Study||5
8615563|NCT00445458|9653447|FG002|STARTED|Overall Study||71
8615564|NCT00445458|9653448|FG003|STARTED|Overall Study||31
8615565|NCT00445458|9653445|FG000|COMPLETED|Overall Study||0
8615566|NCT00445458|9653446|FG001|COMPLETED|Overall Study||0
8615567|NCT00445458|9653447|FG002|COMPLETED|Overall Study||3
8615568|NCT00445458|9653448|FG003|COMPLETED|Overall Study||3
8615569|NCT00445458|9653445|FG000|NOT COMPLETED|Overall Study||3
8615570|NCT00445458|9653446|FG001|NOT COMPLETED|Overall Study||5
8615571|NCT00445458|9653447|FG002|NOT COMPLETED|Overall Study||68
8615572|NCT00445458|9653448|FG003|NOT COMPLETED|Overall Study||28
8615573|NCT00445484|9653463|FG000|STARTED|Overall Study||11
8615574|NCT00445484|9653464|FG001|STARTED|Overall Study||11
8615575|NCT00445484|9653463|FG000|COMPLETED|Overall Study||7
8615576|NCT00445484|9653464|FG001|COMPLETED|Overall Study||10
8615577|NCT00445484|9653463|FG000|NOT COMPLETED|Overall Study||4
8615578|NCT00445484|9653464|FG001|NOT COMPLETED|Overall Study||1
8615579|NCT00445549|9653470|FG000|STARTED|Overall Study||12
8615580|NCT00445549|9653470|FG000|COMPLETED|Overall Study||0
8615581|NCT00445549|9653470|FG000|NOT COMPLETED|Overall Study||12
8615582|NCT00445588|9653474|FG000|STARTED|Overall Study||56
8615583|NCT00445588|9653474|FG000|COMPLETED|Overall Study||56
8715703|NCT00985153|9762663|FG001|Vaccinated at Visit 1|Overall Study||968
8715704|NCT00985153|9762664|FG002|Vaccinated at Visit 1|Overall Study||962
8715705|NCT00985153|9762665|FG003|Vaccinated at Visit 1|Overall Study||1012
8715706|NCT00985153|9762662|FG000|COMPLETED|Overall Study||950
8715707|NCT00985153|9762663|FG001|COMPLETED|Overall Study||924
8715708|NCT00985153|9762664|FG002|COMPLETED|Overall Study||918
8715709|NCT00985153|9762665|FG003|COMPLETED|Overall Study||965
8715710|NCT00985153|9762662|FG000|NOT COMPLETED|Overall Study||35
8715711|NCT00985153|9762663|FG001|NOT COMPLETED|Overall Study||44
8715712|NCT00985153|9762664|FG002|NOT COMPLETED|Overall Study||44
8715713|NCT00985153|9762665|FG003|NOT COMPLETED|Overall Study||47
8715714|NCT00985166|9762678|FG000|STARTED|Overall Study|Two randomized subjects withdrew consent before vaccination: no demographic information available.|401
8615584|NCT00445588|9653474|FG000|NOT COMPLETED|Overall Study||0
8615585|NCT00445601|9653481|FG000|STARTED|Overall Study||201
8615586|NCT00445601|9653482|FG001|STARTED|Overall Study||205
8615587|NCT00445601|9653481|FG000|Received TURBT|Overall Study||190
8615588|NCT00445601|9653482|FG001|Received TURBT|Overall Study||193
8615589|NCT00445601|9653481|FG000|COMPLETED|Overall Study||168
8615590|NCT00445601|9653482|FG001|COMPLETED|Overall Study||177
8615591|NCT00445601|9653481|FG000|NOT COMPLETED|Overall Study||33
8615592|NCT00445601|9653482|FG001|NOT COMPLETED|Overall Study||28
8615593|NCT00445679|9653496|FG000|STARTED|Overall Study||203
8615594|NCT00445679|9653497|FG001|STARTED|Overall Study||203
8615595|NCT00445679|9653498|FG002|STARTED|Overall Study||205
8615596|NCT00445679|9653499|FG003|STARTED|Overall Study||196
8615597|NCT00445679|9653496|FG000|COMPLETED|Overall Study||155
8615598|NCT00445679|9653497|FG001|COMPLETED|Overall Study||157
8615599|NCT00445679|9653498|FG002|COMPLETED|Overall Study||139
8615600|NCT00445679|9653499|FG003|COMPLETED|Overall Study||149
8615601|NCT00445679|9653496|FG000|NOT COMPLETED|Overall Study||48
8615602|NCT00445679|9653497|FG001|NOT COMPLETED|Overall Study||46
8615603|NCT00445679|9653498|FG002|NOT COMPLETED|Overall Study||66
8615604|NCT00445679|9653499|FG003|NOT COMPLETED|Overall Study||47
8615605|NCT00445692|9653509|FG000|STARTED|Overall Study||31
8615606|NCT00445692|9653509|FG000|COMPLETED|Overall Study||15
8615607|NCT00445692|9653509|FG000|NOT COMPLETED|Overall Study||16
8615608|NCT00445705|9653519|FG000|STARTED|Overall Study||53
8615609|NCT00445705|9653520|FG001|STARTED|Overall Study||53
8615610|NCT00445705|9653521|FG002|STARTED|Overall Study||52
8615611|NCT00445705|9653522|FG003|STARTED|Overall Study||53
8615612|NCT00445705|9653519|FG000|COMPLETED|Overall Study||44
8615613|NCT00445705|9653520|FG001|COMPLETED|Overall Study||42
8615614|NCT00445705|9653521|FG002|COMPLETED|Overall Study||41
8615615|NCT00445705|9653522|FG003|COMPLETED|Overall Study||39
8615616|NCT00445705|9653519|FG000|NOT COMPLETED|Overall Study||9
8615617|NCT00445705|9653520|FG001|NOT COMPLETED|Overall Study||11
8615618|NCT00445705|9653521|FG002|NOT COMPLETED|Overall Study||11
8615619|NCT00445705|9653522|FG003|NOT COMPLETED|Overall Study||14
8615620|NCT00445744|9653532|FG000|STARTED|Overall Study||52
8615621|NCT00445744|9653532|FG000|COMPLETED|Overall Study||51
8615622|NCT00445744|9653532|FG000|NOT COMPLETED|Overall Study||1
8615623|NCT00445770|9653539|FG000|STARTED|Overall Study||176
8615624|NCT00445770|9653540|FG001|STARTED|Overall Study||192
8615625|NCT00445770|9653541|FG002|STARTED|Overall Study||182
8615626|NCT00445770|9653539|FG000|COMPLETED|Overall Study||123
8615627|NCT00445770|9653540|FG001|COMPLETED|Overall Study||157
8615628|NCT00445770|9653541|FG002|COMPLETED|Overall Study||151
8615629|NCT00445770|9653539|FG000|NOT COMPLETED|Overall Study||53
8615630|NCT00445770|9653540|FG001|NOT COMPLETED|Overall Study||35
8715715|NCT00985166|9762679|FG001|STARTED|Overall Study||205
8715716|NCT00985166|9762680|FG002|STARTED|Overall Study||195
8715717|NCT00985166|9762678|FG000|Vaccinated at Visit 1|Overall Study||399
8715718|NCT00985166|9762679|FG001|Vaccinated at Visit 1|Overall Study||205
8715719|NCT00985166|9762680|FG002|Vaccinated at Visit 1|Overall Study||195
8715720|NCT00985166|9762678|FG000|COMPLETED|Overall Study||392
8715721|NCT00985166|9762679|FG001|COMPLETED|Overall Study||201
8715722|NCT00985166|9762680|FG002|COMPLETED|Overall Study||188
8715723|NCT00985166|9762678|FG000|NOT COMPLETED|Overall Study||9
8715724|NCT00985166|9762679|FG001|NOT COMPLETED|Overall Study||4
8715725|NCT00985166|9762680|FG002|NOT COMPLETED|Overall Study||7
8715726|NCT00985192|9762690|FG000|STARTED|Overall Study||49
8715727|NCT00985192|9762690|FG000|COMPLETED|Overall Study||45
8715728|NCT00985192|9762690|FG000|NOT COMPLETED|Overall Study||4
8715729|NCT00985231|9762696|FG000|STARTED|Overall Study||133
8715730|NCT00985231|9762697|FG001|STARTED|Overall Study||132
8715731|NCT00985231|9762696|FG000|COMPLETED|Overall Study||130
8715732|NCT00985231|9762697|FG001|COMPLETED|Overall Study||129
8615631|NCT00445770|9653541|FG002|NOT COMPLETED|Overall Study||31
8615632|NCT00445848|9653551|FG000|STARTED|Overall Study||85
8615633|NCT00445848|9653551|FG000|COMPLETED|Overall Study||0
8615634|NCT00445848|9653551|FG000|NOT COMPLETED|Overall Study||85
8715733|NCT00985231|9762696|FG000|NOT COMPLETED|Overall Study||3
8615635|NCT00445887|9653557|FG000|STARTED|Overall Study||33
8615636|NCT00445887|9653558|FG001|STARTED|Overall Study||31
8615637|NCT00445887|9653557|FG000|COMPLETED|Overall Study||33
8615638|NCT00445887|9653558|FG001|COMPLETED|Overall Study||31
8615639|NCT00445887|9653557|FG000|NOT COMPLETED|Overall Study||0
8615640|NCT00445887|9653558|FG001|NOT COMPLETED|Overall Study||0
8615641|NCT00445939|9653577|FG000|STARTED|Period A - Week 0 - Week 4||33
8615642|NCT00445939|9653578|FG001|STARTED|Period A - Week 0 - Week 4||34
8615643|NCT00445939|9653579|FG002|STARTED|Period A - Week 0 - Week 4||23
8715734|NCT00985231|9762697|FG001|NOT COMPLETED|Overall Study||3
8615644|NCT00445939|9653580|FG003|STARTED|Period A - Week 0 - Week 4||0
8615645|NCT00445939|9653577|FG000|COMPLETED|Period A - Week 0 - Week 4|23 rated as responders and 9 rated as non-responders in evaluation on Week 4.|32
8615646|NCT00445939|9653578|FG001|COMPLETED|Period A - Week 0 - Week 4|20 rated as responders and 12 rated as non-responders in evaluation on Week 4.|32
8615647|NCT00445939|9653579|FG002|COMPLETED|Period A - Week 0 - Week 4|7 rated as responders and 16 rated as non-responders in evaluation on Week 4.|23
8615648|NCT00445939|9653580|FG003|COMPLETED|Period A - Week 0 - Week 4||0
8615649|NCT00445939|9653577|FG000|NOT COMPLETED|Period A - Week 0 - Week 4||1
8615650|NCT00445939|9653578|FG001|NOT COMPLETED|Period A - Week 0 - Week 4||2
8615651|NCT00445939|9653579|FG002|NOT COMPLETED|Period A - Week 0 - Week 4||0
8615652|NCT00445939|9653580|FG003|NOT COMPLETED|Period A - Week 0 - Week 4||0
8615653|NCT00445939|9653577|FG000|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous 16 placebo subjects allocated to 160/80 mg group.|16
8615654|NCT00445939|9653578|FG001|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous 80/40 mg subjects allocated to 40/40 mg group.|0
8615655|NCT00445939|9653579|FG002|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous placebo subjects allocated to 160/80 mg group.|0
8615656|NCT00445939|9653580|FG003|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous 160/80 and 80/40 subjects allocated to 40/40 group.|21
8615657|NCT00445939|9653577|FG000|COMPLETED|Period B - Week 4 - Week 8||14
8615658|NCT00445939|9653578|FG001|COMPLETED|Period B - Week 4 - Week 8||0
8615659|NCT00445939|9653579|FG002|COMPLETED|Period B - Week 4 - Week 8||0
8615660|NCT00445939|9653580|FG003|COMPLETED|Period B - Week 4 - Week 8||20
8615661|NCT00445939|9653577|FG000|NOT COMPLETED|Period B - Week 4 - Week 8||2
8615662|NCT00445939|9653578|FG001|NOT COMPLETED|Period B - Week 4 - Week 8||0
8615663|NCT00445939|9653579|FG002|NOT COMPLETED|Period B - Week 4 - Week 8||0
8615664|NCT00445939|9653580|FG003|NOT COMPLETED|Period B - Week 4 - Week 8||1
8615665|NCT00445978|9653600|FG000|STARTED|Week 0 - Week 4 (2.5 mg/kg/Day)||32
8615666|NCT00445978|9653600|FG000|COMPLETED|Week 0 - Week 4 (2.5 mg/kg/Day)||29
8615667|NCT00445978|9653600|FG000|NOT COMPLETED|Week 0 - Week 4 (2.5 mg/kg/Day)||3
8615668|NCT00445978|9653600|FG000|STARTED|Week 4 - Week 8 (5 mg/kg/Day)||29
8615669|NCT00445978|9653600|FG000|Received Escalated Dose|Week 4 - Week 8 (5 mg/kg/Day)||29
8615670|NCT00445978|9653600|FG000|COMPLETED|Week 4 - Week 8 (5 mg/kg/Day)||25
8615671|NCT00445978|9653600|FG000|NOT COMPLETED|Week 4 - Week 8 (5 mg/kg/Day)||4
8615672|NCT00445978|9653600|FG000|STARTED|Week 8 - Week 12 (10 mg/kg/Day)||25
8615673|NCT00445978|9653600|FG000|Received Escalated Dose|Week 8 - Week 12 (10 mg/kg/Day)||25
8615674|NCT00445978|9653600|FG000|COMPLETED|Week 8 - Week 12 (10 mg/kg/Day)||24
8615675|NCT00445978|9653600|FG000|NOT COMPLETED|Week 8 - Week 12 (10 mg/kg/Day)||1
8615676|NCT00445978|9653600|FG000|STARTED|Week 12 - Week 16 (20 mg/kg/Day)||24
8615677|NCT00445978|9653600|FG000|Received Escalated Dose|Week 12 - Week 16 (20 mg/kg/Day)||21
8615678|NCT00445978|9653600|FG000|COMPLETED|Week 12 - Week 16 (20 mg/kg/Day)||23
8615679|NCT00445978|9653600|FG000|NOT COMPLETED|Week 12 - Week 16 (20 mg/kg/Day)||1
8615680|NCT00446030|9653613|FG000|STARTED|TREATMENT (up to 52 Weeks)||93
8615681|NCT00446030|9653614|FG001|STARTED|TREATMENT (up to 52 Weeks)||34
8615682|NCT00446030|9653613|FG000|RECEIVED TREATMENT|TREATMENT (up to 52 Weeks)||92
8615683|NCT00446030|9653614|FG001|RECEIVED TREATMENT|TREATMENT (up to 52 Weeks)||34
8615684|NCT00446030|9653613|FG000|COMPLETED|TREATMENT (up to 52 Weeks)|Participants who completed treatment|49
8615685|NCT00446030|9653614|FG001|COMPLETED|TREATMENT (up to 52 Weeks)|Participants who completed treatment|25
8615686|NCT00446030|9653613|FG000|NOT COMPLETED|TREATMENT (up to 52 Weeks)||44
8615687|NCT00446030|9653614|FG001|NOT COMPLETED|TREATMENT (up to 52 Weeks)||9
8615688|NCT00446030|9653613|FG000|STARTED|FOLLOW-UP (up to 2-years)|All participants, including those who discontinued treatment, continued to the follow-up period.|93
8615689|NCT00446030|9653614|FG001|STARTED|FOLLOW-UP (up to 2-years)||34
8615690|NCT00446030|9653613|FG000|COMPLETED|FOLLOW-UP (up to 2-years)||63
8615691|NCT00446030|9653614|FG001|COMPLETED|FOLLOW-UP (up to 2-years)||25
8615692|NCT00446030|9653613|FG000|NOT COMPLETED|FOLLOW-UP (up to 2-years)||30
8615693|NCT00446030|9653614|FG001|NOT COMPLETED|FOLLOW-UP (up to 2-years)||9
8615694|NCT00446095|9653625|FG000|STARTED|Phase II (8 Weeks)||23
8615695|NCT00446095|9653626|FG001|STARTED|Phase II (8 Weeks)||21
8615696|NCT00446095|9653627|FG002|STARTED|Phase II (8 Weeks)||24
8615697|NCT00446095|9653628|FG003|STARTED|Phase II (8 Weeks)||0
8615698|NCT00446095|9653629|FG004|STARTED|Phase II (8 Weeks)||0
8615699|NCT00446095|9653625|FG000|COMPLETED|Phase II (8 Weeks)||11
8615700|NCT00446095|9653626|FG001|COMPLETED|Phase II (8 Weeks)||18
8615701|NCT00446095|9653627|FG002|COMPLETED|Phase II (8 Weeks)||21
8615702|NCT00446095|9653628|FG003|COMPLETED|Phase II (8 Weeks)||0
8615703|NCT00446095|9653629|FG004|COMPLETED|Phase II (8 Weeks)||0
8615704|NCT00446095|9653625|FG000|NOT COMPLETED|Phase II (8 Weeks)||12
8615705|NCT00446095|9653626|FG001|NOT COMPLETED|Phase II (8 Weeks)||3
8615706|NCT00446095|9653627|FG002|NOT COMPLETED|Phase II (8 Weeks)||3
8615707|NCT00446095|9653628|FG003|NOT COMPLETED|Phase II (8 Weeks)||0
8615708|NCT00446095|9653629|FG004|NOT COMPLETED|Phase II (8 Weeks)||0
8615709|NCT00446095|9653625|FG000|STARTED|Phase I (28 Days)||0
8615710|NCT00446095|9653626|FG001|STARTED|Phase I (28 Days)||0
8615711|NCT00446095|9653627|FG002|STARTED|Phase I (28 Days)||0
8615712|NCT00446095|9653628|FG003|STARTED|Phase I (28 Days)||6
8615713|NCT00446095|9653629|FG004|STARTED|Phase I (28 Days)||7
8615714|NCT00446095|9653625|FG000|COMPLETED|Phase I (28 Days)||0
8615715|NCT00446095|9653626|FG001|COMPLETED|Phase I (28 Days)||0
8615716|NCT00446095|9653627|FG002|COMPLETED|Phase I (28 Days)||0
8615717|NCT00446095|9653628|FG003|COMPLETED|Phase I (28 Days)||5
8615718|NCT00446095|9653629|FG004|COMPLETED|Phase I (28 Days)||4
8615719|NCT00446095|9653625|FG000|NOT COMPLETED|Phase I (28 Days)||0
8615720|NCT00446095|9653626|FG001|NOT COMPLETED|Phase I (28 Days)||0
8615721|NCT00446095|9653627|FG002|NOT COMPLETED|Phase I (28 Days)||0
8615722|NCT00446095|9653628|FG003|NOT COMPLETED|Phase I (28 Days)||1
8615723|NCT00446095|9653629|FG004|NOT COMPLETED|Phase I (28 Days)||3
8615724|NCT00446134|9653644|FG000|STARTED|Overall Study|Includes 2 patients who did not receive study drug and was not included in any other analysis|69
8615725|NCT00446134|9653645|FG001|STARTED|Overall Study||70
8615726|NCT00446134|9653646|FG002|STARTED|Overall Study|Includes 1 patient who did not receive study drug and was not included in any other analysis|69
8615727|NCT00446134|9653647|FG003|STARTED|Overall Study||70
8615728|NCT00446134|9653644|FG000|COMPLETED|Overall Study||35
8615729|NCT00446134|9653645|FG001|COMPLETED|Overall Study||25
8615730|NCT00446134|9653646|FG002|COMPLETED|Overall Study||26
8615731|NCT00446134|9653647|FG003|COMPLETED|Overall Study||25
8615732|NCT00446134|9653644|FG000|NOT COMPLETED|Overall Study||34
8615733|NCT00446134|9653645|FG001|NOT COMPLETED|Overall Study||45
8615734|NCT00446134|9653646|FG002|NOT COMPLETED|Overall Study||43
8615735|NCT00446134|9653647|FG003|NOT COMPLETED|Overall Study||45
8615736|NCT00446147|9653659|FG000|STARTED|Overall Study||195
8615737|NCT00446147|9653660|FG001|STARTED|Overall Study||194
8615738|NCT00446147|9653659|FG000|COMPLETED|Overall Study||180
8615739|NCT00446147|9653660|FG001|COMPLETED|Overall Study||180
8615740|NCT00446147|9653659|FG000|NOT COMPLETED|Overall Study||15
8615741|NCT00446147|9653660|FG001|NOT COMPLETED|Overall Study||14
8615742|NCT00446199|9653670|FG000|STARTED|Overall Study||183
8615743|NCT00446199|9653671|FG001|STARTED|Overall Study||184
8615744|NCT00446199|9653672|FG002|STARTED|Overall Study||185
8615745|NCT00446199|9653673|FG003|STARTED|Overall Study||183
8615746|NCT00446199|9653670|FG000|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|181
8615747|NCT00446199|9653671|FG001|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|183
8615748|NCT00446199|9653672|FG002|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|182
8615749|NCT00446199|9653673|FG003|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|180
8615750|NCT00446199|9653670|FG000|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|178
8615751|NCT00446199|9653671|FG001|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|177
8615752|NCT00446199|9653672|FG002|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|179
8615753|NCT00446199|9653673|FG003|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|176
8615754|NCT00446199|9653670|FG000|COMPLETED|Overall Study||160
8615755|NCT00446199|9653671|FG001|COMPLETED|Overall Study||164
8615756|NCT00446199|9653672|FG002|COMPLETED|Overall Study||158
8615757|NCT00446199|9653673|FG003|COMPLETED|Overall Study||153
8615758|NCT00446199|9653670|FG000|NOT COMPLETED|Overall Study||23
8615759|NCT00446199|9653671|FG001|NOT COMPLETED|Overall Study||20
8615760|NCT00446199|9653672|FG002|NOT COMPLETED|Overall Study||27
8615761|NCT00446199|9653673|FG003|NOT COMPLETED|Overall Study||30
8615762|NCT00446251|9653683|FG000|STARTED|Overall Study|14 subjects were enrolled in this Rituximab-mycophenolic mofetil group.|14
8615763|NCT00446251|9653683|FG000|COMPLETED|Overall Study||9
8615764|NCT00446251|9653683|FG000|NOT COMPLETED|Overall Study||5
8615765|NCT00446264|9653687|FG000|STARTED|Overall Study||14
8615766|NCT00446264|9653687|FG000|COMPLETED|Overall Study||14
8615767|NCT00446264|9653687|FG000|NOT COMPLETED|Overall Study||0
8615768|NCT00446290|9653691|FG000|STARTED|Overall Study||22
8615769|NCT00446290|9653691|FG000|COMPLETED|Overall Study||22
8615770|NCT00446290|9653691|FG000|NOT COMPLETED|Overall Study||0
8615771|NCT00446446|9653695|FG000|STARTED|Overall Study||52
8615772|NCT00446446|9653695|FG000|COMPLETED|Overall Study|Participants who completed the 60-day safety visit|28
8615773|NCT00446446|9653695|FG000|NOT COMPLETED|Overall Study||24
8615774|NCT00446459|9653699|FG000|STARTED|8 Months|34 subjects received any amount of MMF.|34
8615775|NCT00446459|9653699|FG000|COMPLETED|8 Months|22 subjects were on study at month 8.|22
8615776|NCT00446459|9653699|FG000|NOT COMPLETED|8 Months||12
8615777|NCT00446459|9653699|FG000|STARTED|12 Months|22 subjects remained on-study at month 8|22
8615778|NCT00446459|9653699|FG000|COMPLETED|12 Months|4 subjects remained at month 12|4
8615779|NCT00446459|9653699|FG000|NOT COMPLETED|12 Months||18
8615780|NCT00446511|9653707|FG000|STARTED|Overall Study||21
8615781|NCT00446511|9653708|FG001|STARTED|Overall Study||17
8615782|NCT00446511|9653709|FG002|STARTED|Overall Study||103
8615783|NCT00446511|9653710|FG003|STARTED|Overall Study||109
8615784|NCT00446511|9653707|FG000|COMPLETED|Overall Study||11
8615785|NCT00446511|9653708|FG001|COMPLETED|Overall Study||15
8615786|NCT00446511|9653709|FG002|COMPLETED|Overall Study||96
8615787|NCT00446511|9653710|FG003|COMPLETED|Overall Study||103
8615788|NCT00446511|9653707|FG000|NOT COMPLETED|Overall Study||10
8615789|NCT00446511|9653708|FG001|NOT COMPLETED|Overall Study||2
8615790|NCT00446511|9653709|FG002|NOT COMPLETED|Overall Study||7
8615791|NCT00446511|9653710|FG003|NOT COMPLETED|Overall Study||6
8615792|NCT00446550|9653724|FG000|STARTED|Overall Study||11
8615793|NCT00446550|9653725|FG001|STARTED|Overall Study||8
8615794|NCT00446550|9653724|FG000|Safety Population|Overall Study||11
8615795|NCT00446550|9653725|FG001|Safety Population|Overall Study||8
8615796|NCT00446550|9653724|FG000|PD Population|Overall Study||11
8615797|NCT00446550|9653725|FG001|PD Population|Overall Study||8
8615798|NCT00446550|9653724|FG000|COMPLETED|Overall Study||10
8615799|NCT00446550|9653725|FG001|COMPLETED|Overall Study||8
8615800|NCT00446550|9653724|FG000|NOT COMPLETED|Overall Study||1
8615801|NCT00446550|9653725|FG001|NOT COMPLETED|Overall Study||0
8615802|NCT00446563|9653734|FG000|STARTED|Overall Study||43
8615803|NCT00446563|9653735|FG001|STARTED|Overall Study||47
8615804|NCT00446563|9653734|FG000|COMPLETED|Overall Study||36
8615805|NCT00446563|9653735|FG001|COMPLETED|Overall Study||38
8615806|NCT00446563|9653734|FG000|NOT COMPLETED|Overall Study||7
8615807|NCT00446563|9653735|FG001|NOT COMPLETED|Overall Study||9
8615808|NCT00446641|9653743|FG000|STARTED|Overall Study||125
8615809|NCT00446641|9653744|FG001|STARTED|Overall Study||119
8615810|NCT00446641|9653743|FG000|COMPLETED|Overall Study||108
8615811|NCT00446641|9653744|FG001|COMPLETED|Overall Study||109
8615812|NCT00446641|9653743|FG000|NOT COMPLETED|Overall Study||17
8615813|NCT00446641|9653744|FG001|NOT COMPLETED|Overall Study||10
8615814|NCT00446654|9653752|FG000|STARTED|Overall Study||21
8615815|NCT00446654|9653753|FG001|STARTED|Overall Study||22
8615816|NCT00446654|9653752|FG000|COMPLETED|Overall Study||19
8615817|NCT00446654|9653753|FG001|COMPLETED|Overall Study||22
8615818|NCT00446654|9653752|FG000|NOT COMPLETED|Overall Study||2
8615819|NCT00446654|9653753|FG001|NOT COMPLETED|Overall Study||0
8615820|NCT00446797|9653761|FG000|STARTED|Overall Study||141
8615821|NCT00446797|9653762|FG001|STARTED|Overall Study||137
8615822|NCT00446797|9653761|FG000|COMPLETED|Overall Study||133
8615823|NCT00446797|9653762|FG001|COMPLETED|Overall Study||125
8615824|NCT00446797|9653761|FG000|NOT COMPLETED|Overall Study||8
8615825|NCT00446797|9653762|FG001|NOT COMPLETED|Overall Study||12
8615826|NCT00446849|9653768|FG000|STARTED|Acute Phase||138
8615827|NCT00446849|9653768|FG000|COMPLETED|Acute Phase||56
8615828|NCT00446849|9653768|FG000|NOT COMPLETED|Acute Phase||82
8615829|NCT00446849|9653768|FG000|STARTED|Maintenance Phase||208
8615830|NCT00446849|9653768|FG000|COMPLETED|Maintenance Phase||138
8615831|NCT00446849|9653768|FG000|NOT COMPLETED|Maintenance Phase||70
8615832|NCT00446966|9653775|FG000|STARTED|Overall Study||130
8615833|NCT00446966|9653776|FG001|STARTED|Overall Study||130
8615834|NCT00446966|9653775|FG000|COMPLETED|Overall Study||120
8615835|NCT00446966|9653776|FG001|COMPLETED|Overall Study||123
8615836|NCT00446966|9653775|FG000|NOT COMPLETED|Overall Study||10
8615837|NCT00446966|9653776|FG001|NOT COMPLETED|Overall Study||7
8615838|NCT00446992|9653782|FG000|STARTED|Overall Study|Beginning of Intervention|30
8615839|NCT00446992|9653782|FG000|COMPLETED|Overall Study|Intervention Completion|14
8615840|NCT00446992|9653782|FG000|NOT COMPLETED|Overall Study||16
8615841|NCT00447005|9653786|FG000|STARTED|Overall Study||12
8615842|NCT00447005|9653786|FG000|COMPLETED|Overall Study||0
8715735|NCT00985257|9762703|FG000|STARTED|Overall Study||123
8715736|NCT00985257|9762703|FG000|COMPLETED|Overall Study||123
8715737|NCT00985257|9762703|FG000|NOT COMPLETED|Overall Study||0
8715738|NCT00985426|9762709|FG000|STARTED|Overall Study||258
8715739|NCT00985426|9762710|FG001|STARTED|Overall Study||263
8715740|NCT00985426|9762709|FG000|COMPLETED|Overall Study||215
8715741|NCT00985426|9762710|FG001|COMPLETED|Overall Study||219
8715742|NCT00985426|9762709|FG000|NOT COMPLETED|Overall Study||43
8715743|NCT00985426|9762710|FG001|NOT COMPLETED|Overall Study||44
8715744|NCT00985439|9762720|FG000|STARTED|Overall Study||49
8715745|NCT00985439|9762721|FG001|STARTED|Overall Study||51
8715746|NCT00985439|9762722|FG002|STARTED|Overall Study||51
8715747|NCT00985439|9762723|FG003|STARTED|Overall Study||51
8715748|NCT00985439|9762720|FG000|COMPLETED|Overall Study||49
8715749|NCT00985439|9762721|FG001|COMPLETED|Overall Study||51
8715750|NCT00985439|9762722|FG002|COMPLETED|Overall Study||50
8715751|NCT00985439|9762723|FG003|COMPLETED|Overall Study||51
8715752|NCT00985439|9762720|FG000|NOT COMPLETED|Overall Study||0
8715753|NCT00985439|9762721|FG001|NOT COMPLETED|Overall Study||0
8715754|NCT00985439|9762722|FG002|NOT COMPLETED|Overall Study||1
8715755|NCT00985439|9762723|FG003|NOT COMPLETED|Overall Study||0
8615843|NCT00447005|9653786|FG000|NOT COMPLETED|Overall Study||12
8615844|NCT00447057|9653794|FG000|STARTED|Overall Study||83
8615845|NCT00447057|9653795|FG001|STARTED|Overall Study||76
8615846|NCT00447057|9653796|FG002|STARTED|Overall Study||19
8615847|NCT00447057|9653797|FG003|STARTED|Overall Study||26
8615848|NCT00447057|9653794|FG000|COMPLETED|Overall Study||0
8615849|NCT00447057|9653795|FG001|COMPLETED|Overall Study||3
8615850|NCT00447057|9653796|FG002|COMPLETED|Overall Study||0
8615851|NCT00447057|9653797|FG003|COMPLETED|Overall Study||0
8615852|NCT00447057|9653794|FG000|NOT COMPLETED|Overall Study||83
8615853|NCT00447057|9653795|FG001|NOT COMPLETED|Overall Study||73
8615854|NCT00447057|9653796|FG002|NOT COMPLETED|Overall Study||19
8615855|NCT00447057|9653797|FG003|NOT COMPLETED|Overall Study||26
8615856|NCT00447083|9653807|FG000|STARTED|Phase I||10
8615857|NCT00447083|9653808|FG001|STARTED|Phase I||9
8715756|NCT00985465|9762735|FG000|STARTED|Overall Study||141
8715757|NCT00985465|9762736|FG001|STARTED|Overall Study||69
8715758|NCT00985465|9762735|FG000|COMPLETED|Overall Study||140
8715759|NCT00985465|9762736|FG001|COMPLETED|Overall Study||66
8715760|NCT00985465|9762735|FG000|NOT COMPLETED|Overall Study||1
8715761|NCT00985465|9762736|FG001|NOT COMPLETED|Overall Study||3
8715762|NCT00985491|9762743|FG000|STARTED|Overall Study|46 subjects underwent an attempted implantation procedure|46
8715763|NCT00985491|9762743|FG000|Received Device|Overall Study||43
8615858|NCT00447083|9653809|FG002|STARTED|Phase I||0
8615859|NCT00447083|9653810|FG003|STARTED|Phase I||0
8615860|NCT00447083|9653807|FG000|COMPLETED|Phase I|2 participants did not acclimate to phase II|10
8615861|NCT00447083|9653808|FG001|COMPLETED|Phase I|1 participant did not acclimate to phase II|9
8615862|NCT00447083|9653809|FG002|COMPLETED|Phase I||0
8615863|NCT00447083|9653810|FG003|COMPLETED|Phase I||0
8615864|NCT00447083|9653807|FG000|NOT COMPLETED|Phase I||0
8615865|NCT00447083|9653808|FG001|NOT COMPLETED|Phase I||0
8615866|NCT00447083|9653809|FG002|NOT COMPLETED|Phase I||0
8615867|NCT00447083|9653810|FG003|NOT COMPLETED|Phase I||0
8615868|NCT00447083|9653807|FG000|STARTED|Phase II|Participants in this group will then be randomized to a phase 2 group in phase2|0
8615869|NCT00447083|9653808|FG001|STARTED|Phase II|Participants in this group will then be randomized to a phase 2 group in phase2|0
8615870|NCT00447083|9653809|FG002|STARTED|Phase II|Only 8 participants qualified from the end of phase 1|8
8615871|NCT00447083|9653810|FG003|STARTED|Phase II|Only 8 participants qualified from the end of phase 1|8
8615872|NCT00447083|9653807|FG000|COMPLETED|Phase II||0
8615873|NCT00447083|9653808|FG001|COMPLETED|Phase II||0
8615874|NCT00447083|9653809|FG002|COMPLETED|Phase II||7
8615875|NCT00447083|9653810|FG003|COMPLETED|Phase II||7
8615876|NCT00447083|9653807|FG000|NOT COMPLETED|Phase II||0
8615877|NCT00447083|9653808|FG001|NOT COMPLETED|Phase II||0
8615878|NCT00447083|9653809|FG002|NOT COMPLETED|Phase II||1
8615879|NCT00447083|9653810|FG003|NOT COMPLETED|Phase II||1
8615880|NCT00447226|9653818|FG000|STARTED|12-Week Open-label Phase||0
8615881|NCT00447226|9653819|FG001|STARTED|12-Week Open-label Phase||32
8615882|NCT00447226|9653818|FG000|COMPLETED|12-Week Open-label Phase||0
8615883|NCT00447226|9653819|FG001|COMPLETED|12-Week Open-label Phase||7
8615884|NCT00447226|9653818|FG000|NOT COMPLETED|12-Week Open-label Phase||0
8615885|NCT00447226|9653819|FG001|NOT COMPLETED|12-Week Open-label Phase||25
8615886|NCT00447226|9653818|FG000|STARTED|Double-blind Phase||4
8715764|NCT00985491|9762743|FG000|COMPLETED|Overall Study|43 subjects received a device, 27 subjects completed 12 month implant period|27
8715765|NCT00985491|9762743|FG000|NOT COMPLETED|Overall Study||19
8715766|NCT00985504|9762750|FG000|STARTED|Acute Treatment Period||244
8715767|NCT00985504|9762751|FG001|STARTED|Acute Treatment Period||239
8715768|NCT00985504|9762750|FG000|COMPLETED|Acute Treatment Period||229
8715769|NCT00985504|9762751|FG001|COMPLETED|Acute Treatment Period||227
8715770|NCT00985504|9762750|FG000|NOT COMPLETED|Acute Treatment Period||15
8715771|NCT00985504|9762751|FG001|NOT COMPLETED|Acute Treatment Period||12
8715772|NCT00985504|9762750|FG000|STARTED|Optimization Period||229
8715773|NCT00985504|9762751|FG001|STARTED|Optimization Period||227
8715774|NCT00985504|9762750|FG000|COMPLETED|Optimization Period||203
8715775|NCT00985504|9762751|FG001|COMPLETED|Optimization Period||204
8715776|NCT00985504|9762750|FG000|NOT COMPLETED|Optimization Period||26
8715777|NCT00985504|9762751|FG001|NOT COMPLETED|Optimization Period||23
8715778|NCT00985517|9762761|FG000|STARTED|Overall Study||3
8715779|NCT00985517|9762762|FG001|STARTED|Overall Study||3
8715780|NCT00985517|9762763|FG002|STARTED|Overall Study||24
8715781|NCT00985517|9762764|FG003|STARTED|Overall Study||27
8715782|NCT00985517|9762761|FG000|COMPLETED|Overall Study||3
8715783|NCT00985517|9762762|FG001|COMPLETED|Overall Study||3
8715784|NCT00985517|9762763|FG002|COMPLETED|Overall Study||23
8715785|NCT00985517|9762764|FG003|COMPLETED|Overall Study||24
8715786|NCT00985517|9762761|FG000|NOT COMPLETED|Overall Study||0
8715787|NCT00985517|9762762|FG001|NOT COMPLETED|Overall Study||0
8715788|NCT00985517|9762763|FG002|NOT COMPLETED|Overall Study||1
8715789|NCT00985517|9762764|FG003|NOT COMPLETED|Overall Study||3
8715790|NCT00985543|9762775|FG000|STARTED|Overall Study||22
8715791|NCT00985543|9762775|FG000|COMPLETED|Overall Study||22
8715792|NCT00985543|9762775|FG000|NOT COMPLETED|Overall Study||0
8715793|NCT00985621|9762785|FG000|STARTED|Overall Study||142
8715794|NCT00985621|9762786|FG001|STARTED|Overall Study||161
8715795|NCT00985621|9762787|FG002|STARTED|Overall Study||152
8715796|NCT00985621|9762788|FG003|STARTED|Overall Study||159
8715797|NCT00985621|9762785|FG000|Treated|Overall Study||141
8715798|NCT00985621|9762786|FG001|Treated|Overall Study||161
8715799|NCT00985621|9762787|FG002|Treated|Overall Study||150
8715800|NCT00985621|9762788|FG003|Treated|Overall Study||158
8715801|NCT00985621|9762785|FG000|COMPLETED|Overall Study||28
8615887|NCT00447226|9653819|FG001|STARTED|Double-blind Phase||3
8615888|NCT00447226|9653818|FG000|COMPLETED|Double-blind Phase||0
8615889|NCT00447226|9653819|FG001|COMPLETED|Double-blind Phase||0
8615890|NCT00447226|9653818|FG000|NOT COMPLETED|Double-blind Phase||4
8615891|NCT00447226|9653819|FG001|NOT COMPLETED|Double-blind Phase||3
8615892|NCT00447265|9653834|FG000|STARTED|Overall Study||1
8615893|NCT00447265|9653835|FG001|STARTED|Overall Study||0
8615894|NCT00447265|9653834|FG000|COMPLETED|Overall Study|The participant completed treatment and discontinued follow-up at week 39 after randomization|0
8615895|NCT00447265|9653835|FG001|COMPLETED|Overall Study||0
8615896|NCT00447265|9653834|FG000|NOT COMPLETED|Overall Study||1
8615897|NCT00447265|9653835|FG001|NOT COMPLETED|Overall Study||0
8615898|NCT00447278|9653841|FG000|STARTED|Period II (6 Month Open-Label)||199
8615899|NCT00447278|9653842|FG001|STARTED|Period II (6 Month Open-Label)||200
8615900|NCT00447278|9653841|FG000|Received at Least One Dose of Study Drug|Period II (6 Month Open-Label)||199
8715802|NCT00985621|9762786|FG001|COMPLETED|Overall Study||30
8715803|NCT00985621|9762787|FG002|COMPLETED|Overall Study||29
8715804|NCT00985621|9762788|FG003|COMPLETED|Overall Study||22
8715805|NCT00985621|9762785|FG000|NOT COMPLETED|Overall Study||114
8715806|NCT00985621|9762786|FG001|NOT COMPLETED|Overall Study||131
8615901|NCT00447278|9653842|FG001|Received at Least One Dose of Study Drug|Period II (6 Month Open-Label)|1 patient withdrew due to parent/guardian decision prior to receiving study drug.|199
8615902|NCT00447278|9653841|FG000|COMPLETED|Period II (6 Month Open-Label)||157
8615903|NCT00447278|9653842|FG001|COMPLETED|Period II (6 Month Open-Label)||171
8615904|NCT00447278|9653841|FG000|NOT COMPLETED|Period II (6 Month Open-Label)||42
8615905|NCT00447278|9653842|FG001|NOT COMPLETED|Period II (6 Month Open-Label)||29
8615906|NCT00447278|9653841|FG000|STARTED|Period III (Optional 6 Month Extension)|18 choose not to enter this optional period.|139
8615907|NCT00447278|9653842|FG001|STARTED|Period III (Optional 6 Month Extension)|16 choose not to enter this optional period.|155
8615908|NCT00447278|9653841|FG000|COMPLETED|Period III (Optional 6 Month Extension)||109
8615909|NCT00447278|9653842|FG001|COMPLETED|Period III (Optional 6 Month Extension)||140
8615910|NCT00447278|9653841|FG000|NOT COMPLETED|Period III (Optional 6 Month Extension)||30
8615911|NCT00447278|9653842|FG001|NOT COMPLETED|Period III (Optional 6 Month Extension)||15
8615912|NCT00447330|9653849|FG000|STARTED|Overall Study|2 subjects signed the ICF, but were withdrawn from study prior to receiving any study drug|60
8615913|NCT00447330|9653849|FG000|COMPLETED|Overall Study||58
8615914|NCT00447330|9653849|FG000|NOT COMPLETED|Overall Study||2
8615915|NCT00447382|9653856|FG000|STARTED|Overall Study||164
8615916|NCT00447382|9653857|FG001|STARTED|Overall Study||166
8615917|NCT00447382|9653856|FG000|COMPLETED|Overall Study||158
8615918|NCT00447382|9653857|FG001|COMPLETED|Overall Study||160
8615919|NCT00447382|9653856|FG000|NOT COMPLETED|Overall Study||6
8615920|NCT00447382|9653857|FG001|NOT COMPLETED|Overall Study||6
8615921|NCT00447499|9653863|FG000|STARTED|Overall Study||59
8615922|NCT00447499|9653863|FG000|COMPLETED|Overall Study||52
8615923|NCT00447499|9653863|FG000|NOT COMPLETED|Overall Study||7
8615924|NCT00447590|9653869|FG000|STARTED|Overall Study|153 participants were treated with the LAP-BAND System.|153
8615925|NCT00447590|9653869|FG000|COMPLETED|Overall Study|Completing the study was defined as the number of participants in the study at month 60 (5 years).|93
8615926|NCT00447590|9653869|FG000|NOT COMPLETED|Overall Study||60
8615927|NCT00447694|9653873|FG000|STARTED|Overall Study||28
8615928|NCT00447694|9653873|FG000|COMPLETED|Overall Study||22
8615929|NCT00447694|9653873|FG000|NOT COMPLETED|Overall Study||6
8615930|NCT00447772|9653877|FG000|STARTED|Overall Study||516
8615931|NCT00447772|9653877|FG000|COMPLETED|Overall Study||489
8615932|NCT00447772|9653877|FG000|NOT COMPLETED|Overall Study||27
8615933|NCT00447876|9653886|FG000|STARTED|Overall Study||20
8615934|NCT00447876|9653887|FG001|STARTED|Overall Study||20
8615935|NCT00447876|9653886|FG000|COMPLETED|Overall Study||17
8615936|NCT00447876|9653887|FG001|COMPLETED|Overall Study||16
8615937|NCT00447876|9653886|FG000|NOT COMPLETED|Overall Study||3
8615938|NCT00447876|9653887|FG001|NOT COMPLETED|Overall Study||4
8615939|NCT00447902|9653895|FG000|STARTED|Overall Study||5
8615940|NCT00447902|9653896|FG001|STARTED|Overall Study||6
8615941|NCT00447902|9653895|FG000|COMPLETED|Overall Study||1
8615942|NCT00447902|9653896|FG001|COMPLETED|Overall Study||0
8615943|NCT00447902|9653895|FG000|NOT COMPLETED|Overall Study||4
8615944|NCT00447902|9653896|FG001|NOT COMPLETED|Overall Study||6
8615945|NCT00448019|9653902|FG000|STARTED|Overall Study||64
8615946|NCT00448019|9653902|FG000|COMPLETED|Overall Study||57
8615947|NCT00448019|9653902|FG000|NOT COMPLETED|Overall Study||7
8615948|NCT00448123|9653908|FG000|STARTED|Overall Study||62
8615949|NCT00448123|9653909|FG001|STARTED|Overall Study||65
8615950|NCT00448123|9653908|FG000|COMPLETED|Overall Study||47
8615951|NCT00448123|9653909|FG001|COMPLETED|Overall Study||53
8615952|NCT00448123|9653908|FG000|NOT COMPLETED|Overall Study||15
8615953|NCT00448123|9653909|FG001|NOT COMPLETED|Overall Study||12
8615954|NCT00448136|9653920|FG000|STARTED|Overall Study||34
8615955|NCT00448136|9653921|FG001|STARTED|Overall Study||49
8615956|NCT00448136|9653920|FG000|COMPLETED|Overall Study||30
8615957|NCT00448136|9653921|FG001|COMPLETED|Overall Study||41
8615958|NCT00448136|9653920|FG000|NOT COMPLETED|Overall Study||4
8615959|NCT00448136|9653921|FG001|NOT COMPLETED|Overall Study||8
8615960|NCT00448175|9653929|FG000|STARTED|12 Weeks PTNS vs. Drug||50
8615961|NCT00448175|9653930|FG001|STARTED|12 Weeks PTNS vs. Drug||50
8615962|NCT00448175|9653929|FG000|COMPLETED|12 Weeks PTNS vs. Drug||41
8615963|NCT00448175|9653930|FG001|COMPLETED|12 Weeks PTNS vs. Drug||43
8615964|NCT00448175|9653929|FG000|NOT COMPLETED|12 Weeks PTNS vs. Drug||9
8615965|NCT00448175|9653930|FG001|NOT COMPLETED|12 Weeks PTNS vs. Drug||7
8615966|NCT00448175|9653929|FG000|STARTED|Continued PTNS Through 12 Months||35
8615967|NCT00448175|9653930|FG001|STARTED|Continued PTNS Through 12 Months||0
8615968|NCT00448175|9653929|FG000|COMPLETED|Continued PTNS Through 12 Months||25
8615969|NCT00448175|9653930|FG001|COMPLETED|Continued PTNS Through 12 Months||0
8615970|NCT00448175|9653929|FG000|NOT COMPLETED|Continued PTNS Through 12 Months||10
8615971|NCT00448175|9653930|FG001|NOT COMPLETED|Continued PTNS Through 12 Months||0
8615972|NCT00448201|9653936|FG000|STARTED|Overall Study||71
8615973|NCT00448201|9653936|FG000|COMPLETED|Overall Study||71
8615974|NCT00448201|9653936|FG000|NOT COMPLETED|Overall Study||0
8715807|NCT00985621|9762787|FG002|NOT COMPLETED|Overall Study||123
8715808|NCT00985621|9762788|FG003|NOT COMPLETED|Overall Study||137
8715809|NCT00985673|9762806|FG000|STARTED|Overall Study||102
8615975|NCT00448227|9653942|FG000|STARTED|Overall Study||18
8615976|NCT00448227|9653942|FG000|COMPLETED|Overall Study||18
8615977|NCT00448227|9653942|FG000|NOT COMPLETED|Overall Study||0
8629358|NCT00529542|9669079|FG001|NOT COMPLETED|Overall Study||1
8715810|NCT00985673|9762807|FG001|STARTED|Overall Study||104
8715811|NCT00985673|9762808|FG002|STARTED|Overall Study||102
8715812|NCT00985673|9762809|FG003|STARTED|Overall Study||100
8615978|NCT00448279|9653951|FG000|STARTED|Overall Study||29
8615979|NCT00448279|9653952|FG001|STARTED|Overall Study||29
8615980|NCT00448279|9653951|FG000|COMPLETED|Overall Study||0
8615981|NCT00448279|9653952|FG001|COMPLETED|Overall Study||0
8615982|NCT00448279|9653951|FG000|NOT COMPLETED|Overall Study||29
8615983|NCT00448279|9653952|FG001|NOT COMPLETED|Overall Study||29
8615984|NCT00448344|9653960|FG000|STARTED|Overall Study||235
8615985|NCT00448344|9653961|FG001|STARTED|Overall Study||236
8615986|NCT00448344|9653960|FG000|COMPLETED|Overall Study||205
8615987|NCT00448344|9653961|FG001|COMPLETED|Overall Study||200
8615988|NCT00448344|9653960|FG000|NOT COMPLETED|Overall Study||30
8615989|NCT00448344|9653961|FG001|NOT COMPLETED|Overall Study||36
8615990|NCT00448357|9653967|FG000|STARTED|Overall Study||54
8615991|NCT00448357|9653967|FG000|COMPLETED|Overall Study||54
8615992|NCT00448357|9653967|FG000|NOT COMPLETED|Overall Study||0
8615993|NCT00448435|9653983|FG000|STARTED|Treatment Period I - 4 Weeks||26
8615994|NCT00448435|9653984|FG001|STARTED|Treatment Period I - 4 Weeks||25
8615995|NCT00448435|9653983|FG000|COMPLETED|Treatment Period I - 4 Weeks||26
8615996|NCT00448435|9653984|FG001|COMPLETED|Treatment Period I - 4 Weeks||25
8615997|NCT00448435|9653983|FG000|NOT COMPLETED|Treatment Period I - 4 Weeks||0
8615998|NCT00448435|9653984|FG001|NOT COMPLETED|Treatment Period I - 4 Weeks||0
8615999|NCT00448435|9653983|FG000|STARTED|Washout Period - 2 Weeks||26
8616000|NCT00448435|9653984|FG001|STARTED|Washout Period - 2 Weeks||25
8616001|NCT00448435|9653983|FG000|COMPLETED|Washout Period - 2 Weeks||25
8616002|NCT00448435|9653984|FG001|COMPLETED|Washout Period - 2 Weeks||25
8616003|NCT00448435|9653983|FG000|NOT COMPLETED|Washout Period - 2 Weeks||1
8616004|NCT00448435|9653984|FG001|NOT COMPLETED|Washout Period - 2 Weeks||0
8616005|NCT00448435|9653983|FG000|STARTED|Treatment Period II - 4 Weeks||25
8616006|NCT00448435|9653984|FG001|STARTED|Treatment Period II - 4 Weeks||25
8616007|NCT00448435|9653983|FG000|COMPLETED|Treatment Period II - 4 Weeks||25
8616008|NCT00448435|9653984|FG001|COMPLETED|Treatment Period II - 4 Weeks||25
8616009|NCT00448435|9653983|FG000|NOT COMPLETED|Treatment Period II - 4 Weeks||0
8616010|NCT00448435|9653984|FG001|NOT COMPLETED|Treatment Period II - 4 Weeks||0
8616011|NCT00448435|9653983|FG000|STARTED|Extension Period - 20 Weeks||50
8616012|NCT00448435|9653984|FG001|STARTED|Extension Period - 20 Weeks||0
8616013|NCT00448435|9653983|FG000|COMPLETED|Extension Period - 20 Weeks||50
8616014|NCT00448435|9653984|FG001|COMPLETED|Extension Period - 20 Weeks||0
8616015|NCT00448435|9653983|FG000|NOT COMPLETED|Extension Period - 20 Weeks||0
8616016|NCT00448435|9653984|FG001|NOT COMPLETED|Extension Period - 20 Weeks||0
8616017|NCT00448448|9653995|FG000|STARTED|Overall Study||246
8616018|NCT00448448|9653996|FG001|STARTED|Overall Study||137
8616019|NCT00448448|9653995|FG000|COMPLETED|Overall Study||146
8616020|NCT00448448|9653996|FG001|COMPLETED|Overall Study||96
8616021|NCT00448448|9653995|FG000|NOT COMPLETED|Overall Study||100
8616022|NCT00448448|9653996|FG001|NOT COMPLETED|Overall Study||41
8616023|NCT00448539|9654004|FG000|STARTED|Overall Study||134
8616024|NCT00448539|9654005|FG001|STARTED|Overall Study||152
8616025|NCT00448539|9654004|FG000|COMPLETED|Overall Study||0
8616026|NCT00448539|9654005|FG001|COMPLETED|Overall Study||0
8715813|NCT00985673|9762810|FG004|STARTED|Overall Study||101
8715814|NCT00985673|9762811|FG005|STARTED|Overall Study||102
8715815|NCT00985673|9762806|FG000|COMPLETED|Overall Study||95
8715816|NCT00985673|9762807|FG001|COMPLETED|Overall Study||93
8715817|NCT00985673|9762808|FG002|COMPLETED|Overall Study||90
8715818|NCT00985673|9762809|FG003|COMPLETED|Overall Study||88
8715819|NCT00985673|9762810|FG004|COMPLETED|Overall Study||93
8715820|NCT00985673|9762811|FG005|COMPLETED|Overall Study||96
8715821|NCT00985673|9762806|FG000|NOT COMPLETED|Overall Study||7
8715822|NCT00985673|9762807|FG001|NOT COMPLETED|Overall Study||11
8715823|NCT00985673|9762808|FG002|NOT COMPLETED|Overall Study||12
8715824|NCT00985673|9762809|FG003|NOT COMPLETED|Overall Study||12
8715825|NCT00985673|9762810|FG004|NOT COMPLETED|Overall Study||8
8715826|NCT00985673|9762811|FG005|NOT COMPLETED|Overall Study||6
8715827|NCT00985686|9762830|FG000|STARTED|Overall Study||18
8715828|NCT00985686|9762831|FG001|STARTED|Overall Study||16
8715829|NCT00985686|9762832|FG002|STARTED|Overall Study||13
8715830|NCT00985686|9762833|FG003|STARTED|Overall Study||16
8715831|NCT00985686|9762830|FG000|Visit 1: Baseline Data Collection|Overall Study||18
8715832|NCT00985686|9762831|FG001|Visit 1: Baseline Data Collection|Overall Study||15
8715833|NCT00985686|9762832|FG002|Visit 1: Baseline Data Collection|Overall Study||13
8715834|NCT00985686|9762833|FG003|Visit 1: Baseline Data Collection|Overall Study||16
8715835|NCT00985686|9762830|FG000|Visit 2: Data Collection at 8 Weeks|Overall Study||18
8715836|NCT00985686|9762831|FG001|Visit 2: Data Collection at 8 Weeks|Overall Study||15
8715837|NCT00985686|9762832|FG002|Visit 2: Data Collection at 8 Weeks|Overall Study||13
8715838|NCT00985686|9762833|FG003|Visit 2: Data Collection at 8 Weeks|Overall Study||16
8715839|NCT00985686|9762830|FG000|Visit 3: Data Collection at 16 Weeks|Overall Study||17
8715840|NCT00985686|9762831|FG001|Visit 3: Data Collection at 16 Weeks|Overall Study||15
8715841|NCT00985686|9762832|FG002|Visit 3: Data Collection at 16 Weeks|Overall Study||13
8715842|NCT00985686|9762833|FG003|Visit 3: Data Collection at 16 Weeks|Overall Study||16
8715843|NCT00985686|9762830|FG000|Visit 4: Data Collection at 24 Weeks|Overall Study||17
8616027|NCT00448539|9654004|FG000|NOT COMPLETED|Overall Study||134
8616028|NCT00448539|9654005|FG001|NOT COMPLETED|Overall Study||152
8616029|NCT00448591|9654011|FG000|STARTED|Overall Study||2296
8616030|NCT00448591|9654011|FG000|COMPLETED|Overall Study||0
8616031|NCT00448591|9654011|FG000|NOT COMPLETED|Overall Study||2296
8616032|NCT00448669|9654019|FG000|STARTED|Overall Study||611
8616033|NCT00448669|9654020|FG001|STARTED|Overall Study||608
8616034|NCT00448669|9654019|FG000|COMPLETED|Overall Study||393
8616035|NCT00448669|9654020|FG001|COMPLETED|Overall Study||410
8616036|NCT00448669|9654019|FG000|NOT COMPLETED|Overall Study||218
8616037|NCT00448669|9654020|FG001|NOT COMPLETED|Overall Study||198
8616038|NCT00448708|9654030|FG000|STARTED|Overall Study||112
8616039|NCT00448708|9654031|FG001|STARTED|Overall Study||110
8616040|NCT00448708|9654030|FG000|COMPLETED|Overall Study||77
8616041|NCT00448708|9654031|FG001|COMPLETED|Overall Study||79
8616042|NCT00448708|9654030|FG000|NOT COMPLETED|Overall Study||35
8616043|NCT00448708|9654031|FG001|NOT COMPLETED|Overall Study||31
8616044|NCT00448747|9654039|FG000|STARTED|Overall Study||53
8616045|NCT00448747|9654040|FG001|STARTED|Overall Study||48
8616046|NCT00448747|9654039|FG000|Received First Drug Administration|Overall Study||53
8616047|NCT00448747|9654040|FG001|Received First Drug Administration|Overall Study||48
8616048|NCT00448747|9654039|FG000|Received Second Drug Administration|Overall Study||42
8616049|NCT00448747|9654040|FG001|Received Second Drug Administration|Overall Study||10
8616050|NCT00448747|9654039|FG000|Received AEZS-130|Overall Study||52
8616051|NCT00448747|9654040|FG001|Received AEZS-130|Overall Study||48
8616052|NCT00448747|9654039|FG000|Received L-ARG-GHRH|Overall Study||43
8616053|NCT00448747|9654040|FG001|Received L-ARG-GHRH|Overall Study||10
8616054|NCT00448747|9654039|FG000|Received L-ARG-GHRH and AEZS-130|Overall Study||42
8616055|NCT00448747|9654040|FG001|Received L-ARG-GHRH and AEZS-130|Overall Study||10
8616056|NCT00448747|9654039|FG000|Per Protocol Population (PPS)|Overall Study||50
8616057|NCT00448747|9654040|FG001|Per Protocol Population (PPS)|Overall Study||48
8616058|NCT00448747|9654039|FG000|COMPLETED|Overall Study||52
8616059|NCT00448747|9654040|FG001|COMPLETED|Overall Study||48
8616060|NCT00448747|9654039|FG000|NOT COMPLETED|Overall Study||1
8616061|NCT00448747|9654040|FG001|NOT COMPLETED|Overall Study||0
8616062|NCT00448760|9654056|FG000|STARTED|Overall Study||29
8616063|NCT00448760|9654056|FG000|COMPLETED|Overall Study||26
8616064|NCT00448760|9654056|FG000|NOT COMPLETED|Overall Study||3
8616065|NCT00448812|9654062|FG000|STARTED|Year 1||45
8616066|NCT00448812|9654063|FG001|STARTED|Year 1||24
8616067|NCT00448812|9654062|FG000|COMPLETED|Year 1||45
8616068|NCT00448812|9654063|FG001|COMPLETED|Year 1||24
8616069|NCT00448812|9654062|FG000|NOT COMPLETED|Year 1||0
8616070|NCT00448812|9654063|FG001|NOT COMPLETED|Year 1||0
8616071|NCT00448812|9654062|FG000|STARTED|Year 2||45
8616072|NCT00448812|9654063|FG001|STARTED|Year 2||24
8616073|NCT00448812|9654062|FG000|COMPLETED|Year 2||41
8616074|NCT00448812|9654063|FG001|COMPLETED|Year 2||23
8616075|NCT00448812|9654062|FG000|NOT COMPLETED|Year 2||4
8616076|NCT00448812|9654063|FG001|NOT COMPLETED|Year 2||1
8616077|NCT00448812|9654062|FG000|STARTED|Year 3||45
8616078|NCT00448812|9654063|FG001|STARTED|Year 3||24
8616079|NCT00448812|9654062|FG000|COMPLETED|Year 3||41
8616080|NCT00448812|9654063|FG001|COMPLETED|Year 3||21
8616081|NCT00448812|9654062|FG000|NOT COMPLETED|Year 3||4
8616082|NCT00448812|9654063|FG001|NOT COMPLETED|Year 3||3
8616083|NCT00448812|9654062|FG000|STARTED|Year 4||43
8616084|NCT00448812|9654063|FG001|STARTED|Year 4|Control group subjects exited from study after completing Year 3 evaluation.|0
8616085|NCT00448812|9654062|FG000|COMPLETED|Year 4||43
8616086|NCT00448812|9654063|FG001|COMPLETED|Year 4|Control group subjects exited from study after completing Year 3 evaluation.|0
8715844|NCT00985686|9762831|FG001|Visit 4: Data Collection at 24 Weeks|Overall Study||15
8715845|NCT00985686|9762832|FG002|Visit 4: Data Collection at 24 Weeks|Overall Study||13
8715846|NCT00985686|9762833|FG003|Visit 4: Data Collection at 24 Weeks|Overall Study||14
8715847|NCT00985686|9762830|FG000|COMPLETED|Overall Study||17
8715848|NCT00985686|9762831|FG001|COMPLETED|Overall Study||15
8715849|NCT00985686|9762832|FG002|COMPLETED|Overall Study||13
8715850|NCT00985686|9762833|FG003|COMPLETED|Overall Study||14
8715851|NCT00985686|9762830|FG000|NOT COMPLETED|Overall Study||1
8715852|NCT00985686|9762831|FG001|NOT COMPLETED|Overall Study||1
8715853|NCT00985686|9762832|FG002|NOT COMPLETED|Overall Study||0
8715854|NCT00985686|9762833|FG003|NOT COMPLETED|Overall Study||2
8715855|NCT00985712|9762843|FG000|STARTED|Overall Study||133
8715856|NCT00985712|9762844|FG001|STARTED|Overall Study||130
8715857|NCT00985712|9762843|FG000|Received at Least One Dose of Study Drug|Overall Study||131
8715858|NCT00985712|9762844|FG001|Received at Least One Dose of Study Drug|Overall Study||130
8715859|NCT00985712|9762843|FG000|Full Analysis Set (FAS)|Overall Study|Participants completed baseline and had at least 1 post-baseline measurement for efficacy analysis.|128
8715860|NCT00985712|9762844|FG001|Full Analysis Set (FAS)|Overall Study|Participants completed baseline and had at least 1 post-baseline measurement for efficacy analysis.|129
8715861|NCT00985712|9762843|FG000|COMPLETED|Overall Study||127
8715862|NCT00985712|9762844|FG001|COMPLETED|Overall Study||123
8715863|NCT00985712|9762843|FG000|NOT COMPLETED|Overall Study||6
8715864|NCT00985712|9762844|FG001|NOT COMPLETED|Overall Study||7
8715865|NCT00985725|9762852|FG000|STARTED|Overall Study||71
8715866|NCT00985725|9762853|FG001|STARTED|Overall Study||72
8715867|NCT00985725|9762852|FG000|COMPLETED|Overall Study||60
8715868|NCT00985725|9762853|FG001|COMPLETED|Overall Study||59
8616087|NCT00448812|9654062|FG000|NOT COMPLETED|Year 4||0
8616088|NCT00448812|9654063|FG001|NOT COMPLETED|Year 4||0
8616089|NCT00448812|9654062|FG000|STARTED|Year 5||43
8616090|NCT00448812|9654063|FG001|STARTED|Year 5|Control group subjects exited from study after completing Year 3 evaluation.|0
8616091|NCT00448812|9654062|FG000|COMPLETED|Year 5||42
8616092|NCT00448812|9654063|FG001|COMPLETED|Year 5|Control group subjects exited from study after completing Year 3 evaluation.|0
8616093|NCT00448812|9654062|FG000|NOT COMPLETED|Year 5||1
8616094|NCT00448812|9654063|FG001|NOT COMPLETED|Year 5||0
8616095|NCT00448864|9654084|FG000|STARTED|Overall Study||27
8616096|NCT00448864|9654085|FG001|STARTED|Overall Study||29
8616097|NCT00448864|9654086|FG002|STARTED|Overall Study||19
8616098|NCT00448864|9654084|FG000|Received at Least 1 Dose of Study Drug|Overall Study||26
8616099|NCT00448864|9654085|FG001|Received at Least 1 Dose of Study Drug|Overall Study||25
8616100|NCT00448864|9654086|FG002|Received at Least 1 Dose of Study Drug|Overall Study||18
8616101|NCT00448864|9654084|FG000|Started Post-operative Period|Overall Study||26
8616102|NCT00448864|9654085|FG001|Started Post-operative Period|Overall Study||25
8616103|NCT00448864|9654086|FG002|Started Post-operative Period|Overall Study||18
8616104|NCT00448864|9654084|FG000|Completed Post-operative Period|Overall Study||26
8616105|NCT00448864|9654085|FG001|Completed Post-operative Period|Overall Study||25
8616106|NCT00448864|9654086|FG002|Completed Post-operative Period|Overall Study||18
8616107|NCT00448864|9654084|FG000|COMPLETED|Overall Study||22
8616108|NCT00448864|9654085|FG001|COMPLETED|Overall Study||24
8616109|NCT00448864|9654086|FG002|COMPLETED|Overall Study||18
8616110|NCT00448864|9654084|FG000|NOT COMPLETED|Overall Study||5
8616111|NCT00448864|9654085|FG001|NOT COMPLETED|Overall Study||5
8616112|NCT00448864|9654086|FG002|NOT COMPLETED|Overall Study||1
8616113|NCT00448916|9654100|FG000|STARTED|Overall Study||16
8616114|NCT00448916|9654101|FG001|STARTED|Overall Study||15
8616115|NCT00448916|9654102|FG002|STARTED|Overall Study||12
8616116|NCT00448916|9654103|FG003|STARTED|Overall Study||11
8616117|NCT00448916|9654100|FG000|COMPLETED|Overall Study||9
8616118|NCT00448916|9654101|FG001|COMPLETED|Overall Study||9
8616119|NCT00448916|9654102|FG002|COMPLETED|Overall Study||6
8616120|NCT00448916|9654103|FG003|COMPLETED|Overall Study||5
8616121|NCT00448916|9654100|FG000|NOT COMPLETED|Overall Study||7
8616122|NCT00448916|9654101|FG001|NOT COMPLETED|Overall Study||6
8616123|NCT00448916|9654102|FG002|NOT COMPLETED|Overall Study||6
8616124|NCT00448916|9654103|FG003|NOT COMPLETED|Overall Study||6
8616125|NCT00449007|9654117|FG000|STARTED|Overall Study||2
8616126|NCT00449007|9654118|FG001|STARTED|Overall Study||3
8616127|NCT00449007|9654117|FG000|COMPLETED|Overall Study||2
8616128|NCT00449007|9654118|FG001|COMPLETED|Overall Study||3
8616129|NCT00449007|9654117|FG000|NOT COMPLETED|Overall Study||0
8616130|NCT00449007|9654118|FG001|NOT COMPLETED|Overall Study||0
8616131|NCT00449033|9654128|FG000|STARTED|Treatment Period||452
8616132|NCT00449033|9654129|FG001|STARTED|Treatment Period|Reasons for not treated: Adverse event (N=1); Consent withdrawn (N=1); Reason missing (N=1)|452
8616133|NCT00449033|9654128|FG000|Received Treatment|Treatment Period||452
8616134|NCT00449033|9654129|FG001|Received Treatment|Treatment Period||449
8616135|NCT00449033|9654128|FG000|COMPLETED|Treatment Period||0
8616136|NCT00449033|9654129|FG001|COMPLETED|Treatment Period||0
8616137|NCT00449033|9654128|FG000|NOT COMPLETED|Treatment Period||452
8616138|NCT00449033|9654129|FG001|NOT COMPLETED|Treatment Period||452
8616139|NCT00449033|9654128|FG000|STARTED|Follow-up Period|425 entered, comprising 452 randomized less 21 deaths & 6 ongoing on treatment|425
8616140|NCT00449033|9654129|FG001|STARTED|Follow-up Period|434 entered, comprising 452 randomized less 12 deaths, 2 lost to follow-up & 4 ongoing on treatment|434
8616141|NCT00449033|9654128|FG000|COMPLETED|Follow-up Period||0
8616142|NCT00449033|9654129|FG001|COMPLETED|Follow-up Period||0
8616143|NCT00449033|9654128|FG000|NOT COMPLETED|Follow-up Period||425
8616144|NCT00449033|9654129|FG001|NOT COMPLETED|Follow-up Period||434
8616145|NCT00449046|9654135|FG000|STARTED|Overall Study||40
8616146|NCT00449046|9654135|FG000|COMPLETED|Overall Study||40
8616147|NCT00449046|9654135|FG000|NOT COMPLETED|Overall Study||0
8616148|NCT00449072|9654141|FG000|STARTED|Overall Study||148
8616149|NCT00449072|9654142|FG001|STARTED|Overall Study||151
8616150|NCT00449072|9654141|FG000|COMPLETED|Overall Study||107
8616151|NCT00449072|9654142|FG001|COMPLETED|Overall Study||109
8616152|NCT00449072|9654141|FG000|NOT COMPLETED|Overall Study||41
8616153|NCT00449072|9654142|FG001|NOT COMPLETED|Overall Study||42
8616154|NCT00449150|9654151|FG000|STARTED|Overall Study||219
8616155|NCT00449150|9654152|FG001|STARTED|Overall Study||230
8616156|NCT00449150|9654153|FG002|STARTED|Overall Study||218
8616157|NCT00449150|9654151|FG000|COMPLETED|Overall Study|Subjects could have more than one reason for not completing.|173
8616158|NCT00449150|9654152|FG001|COMPLETED|Overall Study|Subjects could have more than one reason for not completing.|177
8616159|NCT00449150|9654153|FG002|COMPLETED|Overall Study|Subjects could have more than one reason for not completing.|171
8616160|NCT00449150|9654151|FG000|NOT COMPLETED|Overall Study||46
8616161|NCT00449150|9654152|FG001|NOT COMPLETED|Overall Study||53
8616162|NCT00449150|9654153|FG002|NOT COMPLETED|Overall Study||47
8616163|NCT00449163|9654164|FG000|STARTED|Overall Study||25
8616164|NCT00449163|9654164|FG000|COMPLETED|Overall Study||22
8616165|NCT00449163|9654164|FG000|NOT COMPLETED|Overall Study||3
8616166|NCT00449176|9654171|FG000|STARTED|Overall Study|3 randomly assigned to this treatment group did not take drug (of 321 subjects initially randomized)|318
8616167|NCT00449176|9654172|FG001|STARTED|Overall Study|6 randomly assigned to this treatment group did not take drug (of 334 subjects initially randomized)|328
8616168|NCT00449176|9654173|FG002|STARTED|Overall Study|5 randomly assigned to this group did not receive drug, 2 enrolled twice(of 326 subjects randomized)|319
8616169|NCT00449176|9654171|FG000|COMPLETED|Overall Study||166
8616170|NCT00449176|9654172|FG001|COMPLETED|Overall Study||133
8616171|NCT00449176|9654173|FG002|COMPLETED|Overall Study||152
8616172|NCT00449176|9654171|FG000|NOT COMPLETED|Overall Study||152
8616173|NCT00449176|9654172|FG001|NOT COMPLETED|Overall Study||195
8616174|NCT00449176|9654173|FG002|NOT COMPLETED|Overall Study||167
8616175|NCT00449540|9654183|FG000|STARTED|Pretreatment Phase||267
8616176|NCT00449540|9654184|FG001|STARTED|Pretreatment Phase||0
8616177|NCT00449540|9654185|FG002|STARTED|Pretreatment Phase||0
8616178|NCT00449540|9654183|FG000|COMPLETED|Pretreatment Phase||201
8616179|NCT00449540|9654184|FG001|COMPLETED|Pretreatment Phase||0
8616180|NCT00449540|9654185|FG002|COMPLETED|Pretreatment Phase||0
8616181|NCT00449540|9654183|FG000|NOT COMPLETED|Pretreatment Phase||66
8616182|NCT00449540|9654184|FG001|NOT COMPLETED|Pretreatment Phase||0
8616183|NCT00449540|9654185|FG002|NOT COMPLETED|Pretreatment Phase||0
8616184|NCT00449540|9654183|FG000|STARTED|Treatment Phase||0
8616185|NCT00449540|9654184|FG001|STARTED|Treatment Phase||102
8616186|NCT00449540|9654185|FG002|STARTED|Treatment Phase||99
8616187|NCT00449540|9654183|FG000|COMPLETED|Treatment Phase||0
8616188|NCT00449540|9654184|FG001|COMPLETED|Treatment Phase||82
8616189|NCT00449540|9654185|FG002|COMPLETED|Treatment Phase||82
8616190|NCT00449540|9654183|FG000|NOT COMPLETED|Treatment Phase||0
8616191|NCT00449540|9654184|FG001|NOT COMPLETED|Treatment Phase||20
8616192|NCT00449540|9654185|FG002|NOT COMPLETED|Treatment Phase||17
8616193|NCT00449644|9654197|FG000|STARTED|Overall Study||23
8616194|NCT00449644|9654198|FG001|STARTED|Overall Study||24
8616195|NCT00449644|9654199|FG002|STARTED|Overall Study||79
8616196|NCT00449644|9654200|FG003|STARTED|Overall Study||81
8616197|NCT00449644|9654197|FG000|Rollover|Overall Study||0
8616198|NCT00449644|9654198|FG001|Rollover|Overall Study||0
8616199|NCT00449644|9654199|FG002|Rollover|Overall Study||0
8616200|NCT00449644|9654200|FG003|Rollover|Overall Study||1
8616201|NCT00449644|9654197|FG000|COMPLETED|Overall Study||13
8616202|NCT00449644|9654198|FG001|COMPLETED|Overall Study||11
8616203|NCT00449644|9654199|FG002|COMPLETED|Overall Study||50
8616204|NCT00449644|9654200|FG003|COMPLETED|Overall Study|After Week 24, 1 patient rolled over to treatment with TMC207 and was not completed or discontinued.|49
8616205|NCT00449644|9654197|FG000|NOT COMPLETED|Overall Study||10
8616206|NCT00449644|9654198|FG001|NOT COMPLETED|Overall Study||13
8616207|NCT00449644|9654199|FG002|NOT COMPLETED|Overall Study||29
8616208|NCT00449644|9654200|FG003|NOT COMPLETED|Overall Study||32
8616209|NCT00449670|9654215|FG000|STARTED|Primary Phase (Study no.109630)||961
8616210|NCT00449670|9654216|FG001|STARTED|Primary Phase (Study no.109630)||245
8616211|NCT00449670|9654215|FG000|COMPLETED|Primary Phase (Study no.109630)||947
8616212|NCT00449670|9654216|FG001|COMPLETED|Primary Phase (Study no.109630)||243
8616213|NCT00449670|9654215|FG000|NOT COMPLETED|Primary Phase (Study no.109630)||14
8616214|NCT00449670|9654216|FG001|NOT COMPLETED|Primary Phase (Study no.109630)||2
8616215|NCT00449670|9654215|FG000|STARTED|Booster Phase (Study no.109873)||265
8616216|NCT00449670|9654216|FG001|STARTED|Booster Phase (Study no.109873)||236
8616217|NCT00449670|9654215|FG000|COMPLETED|Booster Phase (Study no.109873)||265
8616218|NCT00449670|9654216|FG001|COMPLETED|Booster Phase (Study no.109873)||233
8616219|NCT00449670|9654215|FG000|NOT COMPLETED|Booster Phase (Study no.109873)||0
8616220|NCT00449670|9654216|FG001|NOT COMPLETED|Booster Phase (Study no.109873)||3
8616221|NCT00449696|9654231|FG000|STARTED|Overall Study||251
8616222|NCT00449696|9654232|FG001|STARTED|Overall Study||128
8616223|NCT00449696|9654231|FG000|Received Injection|Overall Study||249
8616224|NCT00449696|9654232|FG001|Received Injection|Overall Study||128
8813332|NCT01525225|9866500|FG000|NOT COMPLETED|Enrollment||2
8813333|NCT01525225|9866500|FG000|STARTED|Treated||2
8813334|NCT01525225|9866500|FG000|COMPLETED|Treated||2
8616225|NCT00449696|9654231|FG000|Analyzed Participants|Overall Study|2 subjects removed from ITT analyses because of no post treatment data (pre-defined criteria).|247
8616226|NCT00449696|9654232|FG001|Analyzed Participants|Overall Study||128
8616227|NCT00449696|9654231|FG000|COMPLETED|Overall Study||231
8616228|NCT00449696|9654232|FG001|COMPLETED|Overall Study||119
8616229|NCT00449696|9654231|FG000|NOT COMPLETED|Overall Study||20
8715869|NCT00985725|9762852|FG000|NOT COMPLETED|Overall Study||11
8715870|NCT00985725|9762853|FG001|NOT COMPLETED|Overall Study||13
8715871|NCT00985751|9762864|FG000|STARTED|Overall Study||51
8715872|NCT00985751|9762865|FG001|STARTED|Overall Study||52
8715873|NCT00985751|9762866|FG002|STARTED|Overall Study||52
8715874|NCT00985751|9762867|FG003|STARTED|Overall Study||51
8715875|NCT00985751|9762868|FG004|STARTED|Overall Study||51
8715876|NCT00985751|9762864|FG000|COMPLETED|Overall Study||51
8715877|NCT00985751|9762865|FG001|COMPLETED|Overall Study||52
8715878|NCT00985751|9762866|FG002|COMPLETED|Overall Study||52
8813335|NCT01525225|9866500|FG000|NOT COMPLETED|Treated||0
8813336|NCT01525238|9866507|FG000|STARTED|Overall Study||8
8813337|NCT01525238|9866508|FG001|STARTED|Overall Study||8
8813338|NCT01525238|9866509|FG002|STARTED|Overall Study||8
8813339|NCT01525238|9866507|FG000|COMPLETED|Overall Study||7
8813340|NCT01525238|9866508|FG001|COMPLETED|Overall Study||8
8813341|NCT01525238|9866509|FG002|COMPLETED|Overall Study||8
8813342|NCT01525238|9866507|FG000|NOT COMPLETED|Overall Study||1
8813343|NCT01525238|9866508|FG001|NOT COMPLETED|Overall Study||0
8616230|NCT00449696|9654232|FG001|NOT COMPLETED|Overall Study||9
8616231|NCT00449748|9654238|FG000|STARTED|Overall Study||10
8616232|NCT00449748|9654238|FG000|COMPLETED|Overall Study||10
8616233|NCT00449748|9654238|FG000|NOT COMPLETED|Overall Study||0
8813344|NCT01525238|9866509|FG002|NOT COMPLETED|Overall Study||0
8813345|NCT01525407|9866519|FG000|STARTED|Overall Study||41
8813346|NCT01525407|9866520|FG001|STARTED|Overall Study||42
8715879|NCT00985751|9762867|FG003|COMPLETED|Overall Study||51
8715880|NCT00985751|9762868|FG004|COMPLETED|Overall Study||50
8715881|NCT00985751|9762864|FG000|NOT COMPLETED|Overall Study||0
8715882|NCT00985751|9762865|FG001|NOT COMPLETED|Overall Study||0
8616234|NCT00449761|9654242|FG000|STARTED|Overall Study||27
8616235|NCT00449761|9654242|FG000|COMPLETED|Overall Study||9
8616236|NCT00449761|9654242|FG000|NOT COMPLETED|Overall Study||18
8616237|NCT00449787|9654249|FG000|STARTED|Overall Study||203
8616238|NCT00449787|9654250|FG001|STARTED|Overall Study||198
8616239|NCT00449787|9654249|FG000|COMPLETED|Overall Study||98
8616240|NCT00449787|9654250|FG001|COMPLETED|Overall Study||98
8616241|NCT00449787|9654249|FG000|NOT COMPLETED|Overall Study||105
8616242|NCT00449787|9654250|FG001|NOT COMPLETED|Overall Study||100
8616243|NCT00449865|9654260|FG000|STARTED|Overall Study||867
8616244|NCT00449865|9654261|FG001|STARTED|Overall Study||874
8616245|NCT00449865|9654260|FG000|Completed Year 1|Overall Study|867 Expected at Year 1|802
8616246|NCT00449865|9654261|FG001|Completed Year 1|Overall Study|874 Expected at Year 1|822
8616247|NCT00449865|9654260|FG000|Completed Year 2|Overall Study|867 Expected at Year 2|768
8616248|NCT00449865|9654261|FG001|Completed Year 2|Overall Study|874 Expected at Year 2|766
8616249|NCT00449865|9654260|FG000|Completed Year 3|Overall Study|867 Expected at Year 3|719
8616250|NCT00449865|9654261|FG001|Completed Year 3|Overall Study|874 Expected at Year 3|715
8616251|NCT00449865|9654260|FG000|Completed Year 4|Overall Study|679 Expected at Year 4|521
8616252|NCT00449865|9654261|FG001|Completed Year 4|Overall Study|686 Expected at Year 4|523
8616253|NCT00449865|9654260|FG000|COMPLETED|Overall Study|478 Expected at Year 5|345
8616254|NCT00449865|9654261|FG001|COMPLETED|Overall Study|477 Expected at Year 5|340
8616255|NCT00449865|9654260|FG000|NOT COMPLETED|Overall Study||522
8616256|NCT00449865|9654261|FG001|NOT COMPLETED|Overall Study||534
8616257|NCT00449930|9654269|FG000|STARTED|Overall Study||528
8616258|NCT00449930|9654270|FG001|STARTED|Overall Study||522
8616259|NCT00449930|9654269|FG000|COMPLETED|Overall Study||467
8616260|NCT00449930|9654270|FG001|COMPLETED|Overall Study||447
8616261|NCT00449930|9654269|FG000|NOT COMPLETED|Overall Study||61
8616262|NCT00449930|9654270|FG001|NOT COMPLETED|Overall Study||75
8616263|NCT00449956|9654279|FG000|STARTED|Overall Study||189
8616264|NCT00449956|9654280|FG001|STARTED|Overall Study||92
8715883|NCT00985751|9762866|FG002|NOT COMPLETED|Overall Study||0
8715884|NCT00985751|9762867|FG003|NOT COMPLETED|Overall Study||0
8715885|NCT00985751|9762868|FG004|NOT COMPLETED|Overall Study||1
8715886|NCT00985790|9762885|FG000|STARTED|Overall Study|95 were primed and 203 were unprimed subjects.|298
8715887|NCT00985790|9762886|FG001|STARTED|Overall Study|97 were primed and 204 were unprimed subjects.|301
8715888|NCT00985790|9762885|FG000|COMPLETED|Overall Study||291
8715889|NCT00985790|9762886|FG001|COMPLETED|Overall Study||293
8715890|NCT00985790|9762885|FG000|NOT COMPLETED|Overall Study||7
8715891|NCT00985790|9762886|FG001|NOT COMPLETED|Overall Study||8
8715892|NCT00985829|9762897|FG000|STARTED|Overall Study||28
8715893|NCT00985829|9762897|FG000|COMPLETED|Overall Study||28
8715894|NCT00985829|9762897|FG000|NOT COMPLETED|Overall Study||0
8715895|NCT00985907|9762902|FG000|STARTED|Overall Study||13
8715896|NCT00985907|9762902|FG000|COMPLETED|Overall Study||0
8715897|NCT00985907|9762902|FG000|NOT COMPLETED|Overall Study||13
8715898|NCT00985946|9762906|FG000|STARTED|Overall Study|Eighty-seven percent (n=13) were evaluable for response.|15
8715899|NCT00985946|9762906|FG000|COMPLETED|Overall Study||8
8715900|NCT00985946|9762906|FG000|NOT COMPLETED|Overall Study||7
8715901|NCT00985959|9762913|FG000|STARTED|Overall Study|Number of participants treated|6
8715902|NCT00985959|9762914|FG001|STARTED|Overall Study|Number of participants treated|6
8715903|NCT00985959|9762915|FG002|STARTED|Overall Study|Number of participants treated|87
8715904|NCT00985959|9762913|FG000|COMPLETED|Overall Study|Completed all 9 cycles|3
8715905|NCT00985959|9762914|FG001|COMPLETED|Overall Study|Completed all 9 cycles|3
8715906|NCT00985959|9762915|FG002|COMPLETED|Overall Study||28
8715907|NCT00985959|9762913|FG000|NOT COMPLETED|Overall Study||3
8715908|NCT00985959|9762914|FG001|NOT COMPLETED|Overall Study||3
8715909|NCT00985959|9762915|FG002|NOT COMPLETED|Overall Study||59
8715910|NCT00985985|9762933|FG000|STARTED|Overall Study||241
8715911|NCT00985985|9762934|FG001|STARTED|Overall Study||242
8715912|NCT00985985|9762935|FG002|STARTED|Overall Study||120
8715913|NCT00985985|9762936|FG003|STARTED|Overall Study||120
8715914|NCT00985985|9762933|FG000|Safety Population|Overall Study||241
8715915|NCT00985985|9762934|FG001|Safety Population|Overall Study||242
8715916|NCT00985985|9762935|FG002|Safety Population|Overall Study||119
8715917|NCT00985985|9762936|FG003|Safety Population|Overall Study||118
8715918|NCT00985985|9762933|FG000|Full Analysis Set (FAS) Population|Overall Study||241
8715919|NCT00985985|9762934|FG001|Full Analysis Set (FAS) Population|Overall Study||242
8715920|NCT00985985|9762935|FG002|Full Analysis Set (FAS) Population|Overall Study||120
8715921|NCT00985985|9762936|FG003|Full Analysis Set (FAS) Population|Overall Study|One participant withdrew consent and was not included as the FAS population.|119
8715922|NCT00985985|9762933|FG000|COMPLETED|Overall Study||217
8715923|NCT00985985|9762934|FG001|COMPLETED|Overall Study||218
8715924|NCT00985985|9762935|FG002|COMPLETED|Overall Study||109
8715925|NCT00985985|9762936|FG003|COMPLETED|Overall Study||107
8715926|NCT00985985|9762933|FG000|NOT COMPLETED|Overall Study||24
8715927|NCT00985985|9762934|FG001|NOT COMPLETED|Overall Study||24
8715928|NCT00985985|9762935|FG002|NOT COMPLETED|Overall Study||11
8715929|NCT00985985|9762936|FG003|NOT COMPLETED|Overall Study||13
8715930|NCT00986102|9762955|FG000|STARTED|Overall Study|Number of participants who received study medication|53
8715931|NCT00986102|9762956|FG001|STARTED|Overall Study|Number of participants who received study medication|77
8616265|NCT00449956|9654281|FG002|STARTED|Overall Study||193
8616266|NCT00449956|9654279|FG000|COMPLETED|Overall Study||179
8616267|NCT00449956|9654280|FG001|COMPLETED|Overall Study||88
8616268|NCT00449956|9654281|FG002|COMPLETED|Overall Study||184
8616269|NCT00449956|9654279|FG000|NOT COMPLETED|Overall Study||10
8616270|NCT00449956|9654280|FG001|NOT COMPLETED|Overall Study||4
8616271|NCT00449956|9654281|FG002|NOT COMPLETED|Overall Study||9
8616272|NCT00450073|9654292|FG000|STARTED|Overall Study||10
8616273|NCT00450073|9654293|FG001|STARTED|Overall Study||10
8616274|NCT00450073|9654294|FG002|STARTED|Overall Study||10
8616275|NCT00450073|9654292|FG000|COMPLETED|Overall Study||9
8616276|NCT00450073|9654293|FG001|COMPLETED|Overall Study||10
8616277|NCT00450073|9654294|FG002|COMPLETED|Overall Study||9
8616278|NCT00450073|9654292|FG000|NOT COMPLETED|Overall Study||1
8616279|NCT00450073|9654293|FG001|NOT COMPLETED|Overall Study||0
8616280|NCT00450073|9654294|FG002|NOT COMPLETED|Overall Study||1
8616281|NCT00450112|9654304|FG000|STARTED|Overall Study||125
8616282|NCT00450112|9654305|FG001|STARTED|Overall Study||77
8616283|NCT00450112|9654304|FG000|Received Injection|Overall Study||125
8616284|NCT00450112|9654305|FG001|Received Injection|Overall Study||74
8616285|NCT00450112|9654304|FG000|Analyzed Participants|Overall Study|3 subjects removed from ITT analyses because of no post treatment data (pre-defined criteria).|122
8616286|NCT00450112|9654305|FG001|Analyzed Participants|Overall Study||74
8616287|NCT00450112|9654304|FG000|COMPLETED|Overall Study||112
8616288|NCT00450112|9654305|FG001|COMPLETED|Overall Study||71
8616289|NCT00450112|9654304|FG000|NOT COMPLETED|Overall Study||13
8616290|NCT00450112|9654305|FG001|NOT COMPLETED|Overall Study||6
8616291|NCT00450177|9654313|FG000|STARTED|Overall Study||97
8616292|NCT00450177|9654314|FG001|STARTED|Overall Study||103
8616293|NCT00450177|9654313|FG000|COMPLETED|Overall Study||88
8616294|NCT00450177|9654314|FG001|COMPLETED|Overall Study||92
8616295|NCT00450177|9654313|FG000|NOT COMPLETED|Overall Study||9
8616296|NCT00450177|9654314|FG001|NOT COMPLETED|Overall Study||11
8616297|NCT00450190|9654320|FG000|STARTED|Overall Study||20
8616298|NCT00450190|9654320|FG000|COMPLETED|Overall Study||18
8616299|NCT00450190|9654320|FG000|NOT COMPLETED|Overall Study||2
8616300|NCT00450216|9654326|FG000|STARTED|Overall Study||607
8616301|NCT00450216|9654327|FG001|STARTED|Overall Study||299
8616302|NCT00450216|9654326|FG000|COMPLETED|Overall Study||433
8616303|NCT00450216|9654327|FG001|COMPLETED|Overall Study||170
8616304|NCT00450216|9654326|FG000|NOT COMPLETED|Overall Study||174
8616305|NCT00450216|9654327|FG001|NOT COMPLETED|Overall Study||129
8616306|NCT00450242|9654335|FG000|STARTED|Overall Study||7
8616307|NCT00450242|9654336|FG001|STARTED|Overall Study||7
8616308|NCT00450242|9654335|FG000|COMPLETED|Overall Study||4
8616309|NCT00450242|9654336|FG001|COMPLETED|Overall Study||6
8616310|NCT00450242|9654335|FG000|NOT COMPLETED|Overall Study||3
8616311|NCT00450242|9654336|FG001|NOT COMPLETED|Overall Study||1
8616312|NCT00450255|9654344|FG000|STARTED|Overall Study||41
8616313|NCT00450255|9654344|FG000|COMPLETED|Overall Study||40
8616314|NCT00450255|9654344|FG000|NOT COMPLETED|Overall Study||1
8616315|NCT00450294|9654349|FG000|STARTED|Overall Study||10
8616316|NCT00450294|9654349|FG000|COMPLETED|Overall Study||10
8616317|NCT00450294|9654349|FG000|NOT COMPLETED|Overall Study||0
8616318|NCT00450372|9654354|FG000|STARTED|Overall Study||38
8616319|NCT00450372|9654354|FG000|COMPLETED|Overall Study||37
8616320|NCT00450372|9654354|FG000|NOT COMPLETED|Overall Study||1
8616321|NCT00450385|9654361|FG000|STARTED|Overall Study||57
8616322|NCT00450385|9654361|FG000|COMPLETED|Overall Study||44
8616323|NCT00450385|9654361|FG000|NOT COMPLETED|Overall Study||13
8616324|NCT00450411|9654366|FG000|STARTED|Overall Study||100
8616325|NCT00450411|9654366|FG000|Eligible and Started Protocol Treatment|Overall Study||92
8616326|NCT00450411|9654366|FG000|COMPLETED|Overall Study||92
8616327|NCT00450411|9654366|FG000|NOT COMPLETED|Overall Study||8
8616328|NCT00450424|9654372|FG000|STARTED|Overall Study||122
8616329|NCT00450424|9654373|FG001|STARTED|Overall Study||117
8616330|NCT00450424|9654372|FG000|COMPLETED|Overall Study||102
8616331|NCT00450424|9654373|FG001|COMPLETED|Overall Study||106
8616332|NCT00450424|9654372|FG000|NOT COMPLETED|Overall Study||20
8616333|NCT00450424|9654373|FG001|NOT COMPLETED|Overall Study||11
8616334|NCT00450437|9654381|FG000|STARTED|Overall Study||1640
8616335|NCT00450437|9654382|FG001|STARTED|Overall Study||540
8616336|NCT00450437|9654383|FG002|STARTED|Overall Study||1023
8616337|NCT00450437|9654384|FG003|STARTED|Overall Study||336
8616338|NCT00450437|9654381|FG000|COMPLETED|Overall Study||1594
8616339|NCT00450437|9654382|FG001|COMPLETED|Overall Study||524
8616340|NCT00450437|9654383|FG002|COMPLETED|Overall Study||999
8616341|NCT00450437|9654384|FG003|COMPLETED|Overall Study||325
8616342|NCT00450437|9654381|FG000|NOT COMPLETED|Overall Study||46
8616343|NCT00450437|9654382|FG001|NOT COMPLETED|Overall Study||16
8616344|NCT00450437|9654383|FG002|NOT COMPLETED|Overall Study||24
8616345|NCT00450437|9654384|FG003|NOT COMPLETED|Overall Study||11
8616346|NCT00450463|9654400|FG000|STARTED|Initial Drug Administration||33
8616347|NCT00450463|9654401|FG001|STARTED|Initial Drug Administration||31
8616348|NCT00450463|9654400|FG000|COMPLETED|Initial Drug Administration||33
8616349|NCT00450463|9654401|FG001|COMPLETED|Initial Drug Administration||31
8616350|NCT00450463|9654400|FG000|NOT COMPLETED|Initial Drug Administration||0
8616351|NCT00450463|9654401|FG001|NOT COMPLETED|Initial Drug Administration||0
8616352|NCT00450463|9654400|FG000|STARTED|Progressed to Receive Vaccine Alone||11
8616353|NCT00450463|9654401|FG001|STARTED|Progressed to Receive Vaccine Alone||0
8616354|NCT00450463|9654400|FG000|COMPLETED|Progressed to Receive Vaccine Alone||11
8616355|NCT00450463|9654401|FG001|COMPLETED|Progressed to Receive Vaccine Alone||0
8616356|NCT00450463|9654400|FG000|NOT COMPLETED|Progressed to Receive Vaccine Alone||0
8616357|NCT00450463|9654401|FG001|NOT COMPLETED|Progressed to Receive Vaccine Alone||0
8616358|NCT00450580|9654412|FG000|STARTED|Overall Study||106
8616359|NCT00450580|9654413|FG001|STARTED|Overall Study||106
8616360|NCT00450580|9654412|FG000|COMPLETED|Overall Study||90
8616361|NCT00450580|9654413|FG001|COMPLETED|Overall Study||90
8616362|NCT00450580|9654412|FG000|NOT COMPLETED|Overall Study||16
8616363|NCT00450580|9654413|FG001|NOT COMPLETED|Overall Study||16
8616364|NCT00450619|9654421|FG000|STARTED|Overall Study||22
8616365|NCT00450619|9654422|FG001|STARTED|Overall Study||22
8616366|NCT00450619|9654421|FG000|COMPLETED|Overall Study||18
8616367|NCT00450619|9654422|FG001|COMPLETED|Overall Study||21
8616368|NCT00450619|9654421|FG000|NOT COMPLETED|Overall Study||4
8616369|NCT00450619|9654422|FG001|NOT COMPLETED|Overall Study||1
8616370|NCT00450658|9654431|FG000|STARTED|Overall Study||415
8616371|NCT00450658|9654432|FG001|STARTED|Overall Study||212
8616372|NCT00450658|9654431|FG000|COMPLETED|Overall Study||272
8616373|NCT00450658|9654432|FG001|COMPLETED|Overall Study||122
8616374|NCT00450658|9654431|FG000|NOT COMPLETED|Overall Study||143
8616375|NCT00450658|9654432|FG001|NOT COMPLETED|Overall Study||90
8616376|NCT00450723|9654438|FG000|STARTED|Overall Study||39
8616377|NCT00450723|9654438|FG000|COMPLETED|Overall Study||34
8616378|NCT00450723|9654438|FG000|NOT COMPLETED|Overall Study||5
8616379|NCT00450749|9654446|FG000|STARTED|Overall Study||3
8616380|NCT00450749|9654447|FG001|STARTED|Overall Study||3
8616381|NCT00450749|9654448|FG002|STARTED|Overall Study||4
8616382|NCT00450749|9654446|FG000|COMPLETED|Overall Study||3
8616383|NCT00450749|9654447|FG001|COMPLETED|Overall Study||2
8616384|NCT00450749|9654448|FG002|COMPLETED|Overall Study||2
8616385|NCT00450749|9654446|FG000|NOT COMPLETED|Overall Study||0
8616386|NCT00450749|9654447|FG001|NOT COMPLETED|Overall Study||1
8616387|NCT00450749|9654448|FG002|NOT COMPLETED|Overall Study||2
8616388|NCT00450801|9654456|FG000|STARTED|Overall Study||22
8616389|NCT00450801|9654456|FG000|COMPLETED|Overall Study||21
8616390|NCT00450801|9654456|FG000|NOT COMPLETED|Overall Study||1
8616391|NCT00450814|9654475|FG000|STARTED|Overall Study||3
8616392|NCT00450814|9654476|FG001|STARTED|Overall Study||3
8616393|NCT00450814|9654477|FG002|STARTED|Overall Study||3
8616394|NCT00450814|9654478|FG003|STARTED|Overall Study||4
8616395|NCT00450814|9654479|FG004|STARTED|Overall Study||4
8616396|NCT00450814|9654480|FG005|STARTED|Overall Study||7
8616397|NCT00450814|9654481|FG006|STARTED|Overall Study||3
8616398|NCT00450814|9654482|FG007|STARTED|Overall Study||3
8616399|NCT00450814|9654483|FG008|STARTED|Overall Study||2
8616400|NCT00450814|9654484|FG009|STARTED|Overall Study||12
8616401|NCT00450814|9654485|FG010|STARTED|Overall Study||4
8616402|NCT00450814|9654475|FG000|COMPLETED|Overall Study||3
8616403|NCT00450814|9654476|FG001|COMPLETED|Overall Study||3
8616404|NCT00450814|9654477|FG002|COMPLETED|Overall Study||3
8616405|NCT00450814|9654478|FG003|COMPLETED|Overall Study||3
8616406|NCT00450814|9654479|FG004|COMPLETED|Overall Study||3
8616407|NCT00450814|9654480|FG005|COMPLETED|Overall Study||6
8616408|NCT00450814|9654481|FG006|COMPLETED|Overall Study||3
8616409|NCT00450814|9654482|FG007|COMPLETED|Overall Study||3
8616410|NCT00450814|9654483|FG008|COMPLETED|Overall Study||2
8616411|NCT00450814|9654484|FG009|COMPLETED|Overall Study||11
8616412|NCT00450814|9654485|FG010|COMPLETED|Overall Study||4
8616413|NCT00450814|9654475|FG000|NOT COMPLETED|Overall Study||0
8616414|NCT00450814|9654476|FG001|NOT COMPLETED|Overall Study||0
8616415|NCT00450814|9654477|FG002|NOT COMPLETED|Overall Study||0
8715932|NCT00986102|9762957|FG002|STARTED|Overall Study|Number of participants who received study medication|19
8715933|NCT00986102|9762958|FG003|STARTED|Overall Study|Number of participants who received study medication|67
8715934|NCT00986102|9762955|FG000|COMPLETED|Overall Study||52
8715935|NCT00986102|9762956|FG001|COMPLETED|Overall Study||75
8715936|NCT00986102|9762957|FG002|COMPLETED|Overall Study||19
8715937|NCT00986102|9762958|FG003|COMPLETED|Overall Study||66
8715938|NCT00986102|9762955|FG000|NOT COMPLETED|Overall Study||1
8715939|NCT00986102|9762956|FG001|NOT COMPLETED|Overall Study||2
8715940|NCT00986102|9762957|FG002|NOT COMPLETED|Overall Study||0
8715941|NCT00986102|9762958|FG003|NOT COMPLETED|Overall Study||1
8715942|NCT00986154|9762970|FG000|STARTED|Overall Study||4143
8715943|NCT00986154|9762971|FG001|STARTED|Overall Study||4149
8715944|NCT00986154|9762970|FG000|Safety Analysis Set (Received Drug)|Overall Study||4118
8715945|NCT00986154|9762971|FG001|Safety Analysis Set (Received Drug)|Overall Study||4122
8715946|NCT00986154|9762970|FG000|COMPLETED|Overall Study||3937
8715947|NCT00986154|9762971|FG001|COMPLETED|Overall Study||3955
8715948|NCT00986154|9762970|FG000|NOT COMPLETED|Overall Study||206
8715949|NCT00986154|9762971|FG001|NOT COMPLETED|Overall Study||194
8616416|NCT00450814|9654478|FG003|NOT COMPLETED|Overall Study||1
8616417|NCT00450814|9654479|FG004|NOT COMPLETED|Overall Study||1
8616418|NCT00450814|9654480|FG005|NOT COMPLETED|Overall Study||1
8616419|NCT00450814|9654481|FG006|NOT COMPLETED|Overall Study||0
8616420|NCT00450814|9654482|FG007|NOT COMPLETED|Overall Study||0
8616421|NCT00450814|9654483|FG008|NOT COMPLETED|Overall Study||0
8715950|NCT00986180|9762979|FG000|STARTED|Overall Study||321
8715951|NCT00986180|9762980|FG001|STARTED|Overall Study||324
8715952|NCT00986180|9762979|FG000|COMPLETED|Overall Study||277
8616422|NCT00450814|9654484|FG009|NOT COMPLETED|Overall Study||1
8616423|NCT00450814|9654485|FG010|NOT COMPLETED|Overall Study||0
8616424|NCT00450866|9654510|FG000|STARTED|Overall Study||45
8616425|NCT00450866|9654511|FG001|STARTED|Overall Study||10
8616426|NCT00450866|9654510|FG000|COMPLETED|Overall Study||38
8616427|NCT00450866|9654511|FG001|COMPLETED|Overall Study||7
8616428|NCT00450866|9654510|FG000|NOT COMPLETED|Overall Study||7
8616429|NCT00450866|9654511|FG001|NOT COMPLETED|Overall Study||3
8616430|NCT00450983|9654517|FG000|STARTED|Overall Study||1
8616431|NCT00450983|9654517|FG000|COMPLETED|Overall Study||1
8616432|NCT00450983|9654517|FG000|NOT COMPLETED|Overall Study||0
8616433|NCT00451035|9654521|FG000|STARTED|Overall Study||29
8616434|NCT00451035|9654521|FG000|COMPLETED|Overall Study||12
8616435|NCT00451035|9654521|FG000|NOT COMPLETED|Overall Study||17
8616436|NCT00451048|9654526|FG000|STARTED|Overall Study||10
8616437|NCT00451048|9654526|FG000|COMPLETED|Overall Study||10
8616438|NCT00451048|9654526|FG000|NOT COMPLETED|Overall Study||0
8616439|NCT00451178|9654532|FG000|STARTED|Chemotherapy (Up To Six 21-Day Cycles)||58
8616440|NCT00451178|9654533|FG001|STARTED|Chemotherapy (Up To Six 21-Day Cycles)||43
8616441|NCT00451178|9654532|FG000|Received At Least 1 Dose Study Treatment|Chemotherapy (Up To Six 21-Day Cycles)||57
8616442|NCT00451178|9654533|FG001|Received At Least 1 Dose Study Treatment|Chemotherapy (Up To Six 21-Day Cycles)||43
8616443|NCT00451178|9654532|FG000|COMPLETED|Chemotherapy (Up To Six 21-Day Cycles)||40
8616444|NCT00451178|9654533|FG001|COMPLETED|Chemotherapy (Up To Six 21-Day Cycles)||26
8616445|NCT00451178|9654532|FG000|NOT COMPLETED|Chemotherapy (Up To Six 21-Day Cycles)||18
8616446|NCT00451178|9654533|FG001|NOT COMPLETED|Chemotherapy (Up To Six 21-Day Cycles)||17
8616447|NCT00451178|9654532|FG000|STARTED|Prior to Maintenance Therapy||40
8616448|NCT00451178|9654533|FG001|STARTED|Prior to Maintenance Therapy|R-CHOP participants were excluded from maintenance therapy and went directly to long-term follow-up.|0
8616449|NCT00451178|9654532|FG000|COMPLETED|Prior to Maintenance Therapy||36
8616450|NCT00451178|9654533|FG001|COMPLETED|Prior to Maintenance Therapy||0
8616451|NCT00451178|9654532|FG000|NOT COMPLETED|Prior to Maintenance Therapy||4
8616452|NCT00451178|9654533|FG001|NOT COMPLETED|Prior to Maintenance Therapy||0
8616453|NCT00451178|9654532|FG000|STARTED|Maintenance Therapy (up to 3 Years)||36
8616454|NCT00451178|9654533|FG001|STARTED|Maintenance Therapy (up to 3 Years)|R-CHOP participants were excluded from maintenance therapy and went directly to long-term follow-up.|0
8616455|NCT00451178|9654532|FG000|COMPLETED|Maintenance Therapy (up to 3 Years)||6
8616456|NCT00451178|9654533|FG001|COMPLETED|Maintenance Therapy (up to 3 Years)||0
8616457|NCT00451178|9654532|FG000|NOT COMPLETED|Maintenance Therapy (up to 3 Years)||30
8616458|NCT00451178|9654533|FG001|NOT COMPLETED|Maintenance Therapy (up to 3 Years)||0
8616459|NCT00451178|9654532|FG000|STARTED|Long-Term Follow-Up (Up to 2 Years)||6
8616460|NCT00451178|9654533|FG001|STARTED|Long-Term Follow-Up (Up to 2 Years)||26
8616461|NCT00451178|9654532|FG000|COMPLETED|Long-Term Follow-Up (Up to 2 Years)||0
8616462|NCT00451178|9654533|FG001|COMPLETED|Long-Term Follow-Up (Up to 2 Years)||0
8616463|NCT00451178|9654532|FG000|NOT COMPLETED|Long-Term Follow-Up (Up to 2 Years)||6
8616464|NCT00451178|9654533|FG001|NOT COMPLETED|Long-Term Follow-Up (Up to 2 Years)||26
8616465|NCT00451191|9654545|FG000|STARTED|Overall Study||68
8616466|NCT00451191|9654546|FG001|STARTED|Overall Study||66
8616467|NCT00451191|9654545|FG000|COMPLETED|Overall Study||53
8616468|NCT00451191|9654546|FG001|COMPLETED|Overall Study||55
8616469|NCT00451191|9654545|FG000|NOT COMPLETED|Overall Study||15
8616470|NCT00451191|9654546|FG001|NOT COMPLETED|Overall Study||11
8616471|NCT00451204|9654554|FG000|STARTED|Overall Study||82
8616472|NCT00451204|9654555|FG001|STARTED|Overall Study||76
8616473|NCT00451204|9654554|FG000|COMPLETED|Overall Study|60 completed the study but 3 stopped study drug(s) early|60
8616474|NCT00451204|9654555|FG001|COMPLETED|Overall Study||56
8616475|NCT00451204|9654554|FG000|NOT COMPLETED|Overall Study||22
8616476|NCT00451204|9654555|FG001|NOT COMPLETED|Overall Study||20
8616477|NCT00451217|9654568|FG000|STARTED|Overall Study||49
8616478|NCT00451217|9654569|FG001|STARTED|Overall Study||49
8616479|NCT00451217|9654570|FG002|STARTED|Overall Study||51
8616480|NCT00451217|9654571|FG003|STARTED|Overall Study||49
8616481|NCT00451217|9654568|FG000|Treated|Overall Study||48
8616482|NCT00451217|9654569|FG001|Treated|Overall Study||48
8616483|NCT00451217|9654570|FG002|Treated|Overall Study||48
8616484|NCT00451217|9654571|FG003|Treated|Overall Study||45
8616485|NCT00451217|9654568|FG000|COMPLETED|Overall Study||47
8616486|NCT00451217|9654569|FG001|COMPLETED|Overall Study||47
8616487|NCT00451217|9654570|FG002|COMPLETED|Overall Study||47
8715953|NCT00986180|9762980|FG001|COMPLETED|Overall Study||268
8715954|NCT00986180|9762979|FG000|NOT COMPLETED|Overall Study||44
8715955|NCT00986180|9762980|FG001|NOT COMPLETED|Overall Study||56
8715956|NCT00986232|9762990|FG000|STARTED|Overall Study||387
8715957|NCT00986232|9762991|FG001|STARTED|Overall Study|Excludes 1 patient who was randomized to receive ProQuad (Middle Dose), but was not vaccinated.|393
8715958|NCT00986232|9762992|FG002|STARTED|Overall Study||381
8715959|NCT00986232|9762993|FG003|STARTED|Overall Study|Excludes 1 patient who was randomized to receive M-M-R™ II + PUVV, but was not vaccinated.|390
8715960|NCT00986232|9762990|FG000|Vaccination Visit 1|Overall Study||387
8715961|NCT00986232|9762991|FG001|Vaccination Visit 1|Overall Study||393
8715962|NCT00986232|9762992|FG002|Vaccination Visit 1|Overall Study||381
8715963|NCT00986232|9762993|FG003|Vaccination Visit 1|Overall Study||390
8715964|NCT00986232|9762990|FG000|Vaccination Visit 2|Overall Study||360
8715965|NCT00986232|9762991|FG001|Vaccination Visit 2|Overall Study||365
8715966|NCT00986232|9762992|FG002|Vaccination Visit 2|Overall Study||360
8715967|NCT00986232|9762993|FG003|Vaccination Visit 2|Overall Study||0
8715968|NCT00986232|9762990|FG000|COMPLETED|Overall Study||336
8715969|NCT00986232|9762991|FG001|COMPLETED|Overall Study||343
8715970|NCT00986232|9762992|FG002|COMPLETED|Overall Study||346
8715971|NCT00986232|9762993|FG003|COMPLETED|Overall Study||370
8715972|NCT00986232|9762990|FG000|NOT COMPLETED|Overall Study||51
8715973|NCT00986232|9762991|FG001|NOT COMPLETED|Overall Study||50
8616488|NCT00451217|9654571|FG003|COMPLETED|Overall Study||44
8616489|NCT00451217|9654568|FG000|NOT COMPLETED|Overall Study||2
8616490|NCT00451217|9654569|FG001|NOT COMPLETED|Overall Study||2
8616491|NCT00451217|9654570|FG002|NOT COMPLETED|Overall Study||4
8616492|NCT00451217|9654571|FG003|NOT COMPLETED|Overall Study||5
8616493|NCT00451282|9654583|FG000|STARTED|Overall Study||46
8616494|NCT00451282|9654584|FG001|STARTED|Overall Study||39
8616495|NCT00451282|9654583|FG000|COMPLETED|Overall Study||40
8616496|NCT00451282|9654584|FG001|COMPLETED|Overall Study||34
8616497|NCT00451282|9654583|FG000|NOT COMPLETED|Overall Study||6
8616498|NCT00451282|9654584|FG001|NOT COMPLETED|Overall Study||5
8616499|NCT00451321|9654598|FG000|STARTED|Overall Study||8
8616500|NCT00451321|9654599|FG001|STARTED|Overall Study||15
8616501|NCT00451321|9654600|FG002|STARTED|Overall Study||18
8616502|NCT00451321|9654601|FG003|STARTED|Overall Study||19
8616503|NCT00451321|9654602|FG004|STARTED|Overall Study||7
8616504|NCT00451321|9654603|FG005|STARTED|Overall Study||9
8616505|NCT00451321|9654604|FG006|STARTED|Overall Study||6
8616506|NCT00451321|9654605|FG007|STARTED|Overall Study||6
8616507|NCT00451321|9654598|FG000|COMPLETED|Overall Study||1
8616508|NCT00451321|9654599|FG001|COMPLETED|Overall Study||10
8616509|NCT00451321|9654600|FG002|COMPLETED|Overall Study||0
8616510|NCT00451321|9654601|FG003|COMPLETED|Overall Study||7
8616511|NCT00451321|9654602|FG004|COMPLETED|Overall Study||0
8616512|NCT00451321|9654603|FG005|COMPLETED|Overall Study||0
8715974|NCT00986232|9762992|FG002|NOT COMPLETED|Overall Study||35
8715975|NCT00986232|9762993|FG003|NOT COMPLETED|Overall Study||20
8715976|NCT00986245|9763009|FG000|STARTED|First Intervention||41
8715977|NCT00986245|9763010|FG001|STARTED|First Intervention||41
8715978|NCT00986245|9763009|FG000|COMPLETED|First Intervention||31
8715979|NCT00986245|9763010|FG001|COMPLETED|First Intervention||33
8715980|NCT00986245|9763009|FG000|NOT COMPLETED|First Intervention||10
8715981|NCT00986245|9763010|FG001|NOT COMPLETED|First Intervention||8
8715982|NCT00986245|9763009|FG000|STARTED|Second Intervention||31
8715983|NCT00986245|9763010|FG001|STARTED|Second Intervention||33
8715984|NCT00986245|9763009|FG000|COMPLETED|Second Intervention||29
8715985|NCT00986245|9763010|FG001|COMPLETED|Second Intervention||32
8715986|NCT00986245|9763009|FG000|NOT COMPLETED|Second Intervention||2
8715987|NCT00986245|9763010|FG001|NOT COMPLETED|Second Intervention||1
8715988|NCT00986258|9763021|FG000|STARTED|Observation Period||136
8715989|NCT00986258|9763021|FG000|COMPLETED|Observation Period||125
8715990|NCT00986258|9763021|FG000|NOT COMPLETED|Observation Period||11
8715991|NCT00986258|9763021|FG000|STARTED|Titration and Optimal Dose Period||125
8715992|NCT00986258|9763021|FG000|COMPLETED|Titration and Optimal Dose Period||102
8715993|NCT00986258|9763021|FG000|NOT COMPLETED|Titration and Optimal Dose Period||23
8715994|NCT00986258|9763021|FG000|STARTED|Maintenance Period||102
8715995|NCT00986258|9763021|FG000|COMPLETED|Maintenance Period||93
8715996|NCT00986258|9763021|FG000|NOT COMPLETED|Maintenance Period||9
8715997|NCT00986349|9763035|FG000|STARTED|Overall Study|attempted implant procedures|23
8715998|NCT00986349|9763035|FG000|Successful Implant Procedure|Overall Study|successful device implant procedure|20
8715999|NCT00986349|9763035|FG000|Early Explant|Overall Study||4
8716000|NCT00986349|9763035|FG000|COMPLETED|Overall Study||16
8716001|NCT00986349|9763035|FG000|NOT COMPLETED|Overall Study||7
8716002|NCT00986362|9763050|FG000|STARTED|Overall Study|16 eyes randomized and treated (in 15 subjects).|16
8716003|NCT00986362|9763051|FG001|STARTED|Overall Study|8 eyes randomized and treated (in 8 subjects).|8
8716004|NCT00986362|9763050|FG000|COMPLETED|Overall Study|14 eyes completed the study (in 14 subjects).|14
8716005|NCT00986362|9763051|FG001|COMPLETED|Overall Study|7 eyes completed the study (in 7 subjects).|7
8716006|NCT00986362|9763050|FG000|NOT COMPLETED|Overall Study||2
8716007|NCT00986362|9763051|FG001|NOT COMPLETED|Overall Study||1
8716008|NCT00986401|9763059|FG000|STARTED|Period 1||22
8716009|NCT00986401|9763060|FG001|STARTED|Period 1||22
8716010|NCT00986401|9763059|FG000|COMPLETED|Period 1||22
8716011|NCT00986401|9763060|FG001|COMPLETED|Period 1||21
8716012|NCT00986401|9763059|FG000|NOT COMPLETED|Period 1||0
8716013|NCT00986401|9763060|FG001|NOT COMPLETED|Period 1||1
8716014|NCT00986401|9763059|FG000|STARTED|Period 2||22
8716015|NCT00986401|9763060|FG001|STARTED|Period 2||21
8716016|NCT00986401|9763059|FG000|COMPLETED|Period 2||22
8716017|NCT00986401|9763060|FG001|COMPLETED|Period 2||21
8716018|NCT00986401|9763059|FG000|NOT COMPLETED|Period 2||0
8716019|NCT00986401|9763060|FG001|NOT COMPLETED|Period 2||0
8716020|NCT00986427|9763071|FG000|STARTED|Overall Study||12
8716021|NCT00986427|9763072|FG001|STARTED|Overall Study||12
8716022|NCT00986427|9763071|FG000|COMPLETED|Overall Study||8
8716023|NCT00986427|9763072|FG001|COMPLETED|Overall Study||12
8716024|NCT00986427|9763071|FG000|NOT COMPLETED|Overall Study||4
8716025|NCT00986427|9763072|FG001|NOT COMPLETED|Overall Study||0
8716026|NCT00986440|9763084|FG000|STARTED|Overall Study||41
8616513|NCT00451321|9654604|FG006|COMPLETED|Overall Study||0
8616514|NCT00451321|9654605|FG007|COMPLETED|Overall Study||0
8616515|NCT00451321|9654598|FG000|NOT COMPLETED|Overall Study||7
8616516|NCT00451321|9654599|FG001|NOT COMPLETED|Overall Study||5
8616517|NCT00451321|9654600|FG002|NOT COMPLETED|Overall Study||18
8616518|NCT00451321|9654601|FG003|NOT COMPLETED|Overall Study||12
8616519|NCT00451321|9654602|FG004|NOT COMPLETED|Overall Study||7
8716027|NCT00986440|9763085|FG001|STARTED|Overall Study||43
8616520|NCT00451321|9654603|FG005|NOT COMPLETED|Overall Study||9
8616521|NCT00451321|9654604|FG006|NOT COMPLETED|Overall Study||6
8616522|NCT00451321|9654605|FG007|NOT COMPLETED|Overall Study||6
8616523|NCT00451451|9654627|FG000|STARTED|Overall Study|363 participants were dosed; 363 participants were randomized|363
8616524|NCT00451451|9654628|FG001|STARTED|Overall Study|359 participants were dosed; 362 participants were randomized|359
8616525|NCT00451451|9654629|FG002|STARTED|Overall Study|345 participants were dosed; 345 participants were randomized|345
8616526|NCT00451451|9654630|FG003|STARTED|Overall Study|350 participants were dosed; 360 participants were randomized|350
8616527|NCT00451451|9654627|FG000|COMPLETED|Overall Study||278
8616528|NCT00451451|9654628|FG001|COMPLETED|Overall Study||284
8616529|NCT00451451|9654629|FG002|COMPLETED|Overall Study||273
8616530|NCT00451451|9654630|FG003|COMPLETED|Overall Study||292
8616531|NCT00451451|9654627|FG000|NOT COMPLETED|Overall Study||85
8616532|NCT00451451|9654628|FG001|NOT COMPLETED|Overall Study||75
8616533|NCT00451451|9654629|FG002|NOT COMPLETED|Overall Study||72
8616534|NCT00451451|9654630|FG003|NOT COMPLETED|Overall Study||58
8616535|NCT00451555|9654645|FG000|STARTED|Overall Study||96
8616536|NCT00451555|9654646|FG001|STARTED|Overall Study||60
8616537|NCT00451555|9654645|FG000|Received at Least One Dose of Study Drug|Overall Study||94
8616538|NCT00451555|9654646|FG001|Received at Least One Dose of Study Drug|Overall Study||58
8616539|NCT00451555|9654645|FG000|Enzastaurin Twice Daily Dosing (BID)|Overall Study||39
8616540|NCT00451555|9654646|FG001|Enzastaurin Twice Daily Dosing (BID)|Overall Study||0
8616541|NCT00451555|9654645|FG000|Enzastaurin Once Daily Dosing (QD)|Overall Study||55
8616542|NCT00451555|9654646|FG001|Enzastaurin Once Daily Dosing (QD)|Overall Study||0
8616543|NCT00451555|9654645|FG000|Progressive Disease|Overall Study||75
8616544|NCT00451555|9654646|FG001|Progressive Disease|Overall Study||54
8616545|NCT00451555|9654645|FG000|Death|Overall Study||2
8616546|NCT00451555|9654646|FG001|Death|Overall Study||0
8616547|NCT00451555|9654645|FG000|COMPLETED|Overall Study||83
8616548|NCT00451555|9654646|FG001|COMPLETED|Overall Study||56
8616549|NCT00451555|9654645|FG000|NOT COMPLETED|Overall Study||13
8616550|NCT00451555|9654646|FG001|NOT COMPLETED|Overall Study||4
8616551|NCT00451698|9654663|FG000|STARTED|Overall Study||3
8616552|NCT00451698|9654664|FG001|STARTED|Overall Study||6
8616553|NCT00451698|9654663|FG000|COMPLETED|Overall Study||3
8616554|NCT00451698|9654664|FG001|COMPLETED|Overall Study||6
8616555|NCT00451698|9654663|FG000|NOT COMPLETED|Overall Study||0
8616556|NCT00451698|9654664|FG001|NOT COMPLETED|Overall Study||0
8616557|NCT00451906|9654672|FG000|STARTED|Overall Study||2252
8616558|NCT00451906|9654672|FG000|COMPLETED|Overall Study||13
8616559|NCT00451906|9654672|FG000|NOT COMPLETED|Overall Study||2239
8616560|NCT00451958|9654680|FG000|STARTED|CS21 (NCT00295750)|CS21 intention-to-treat (ITT) population.|210
8616561|NCT00451958|9654681|FG001|STARTED|CS21 (NCT00295750)|CS21 ITT population.|206
8616562|NCT00451958|9654682|FG002|STARTED|CS21 (NCT00295750)|Participants were switched from the leuprolide 7.5 mg group when CS21 was completed.|0
8616563|NCT00451958|9654683|FG003|STARTED|CS21 (NCT00295750)|Participants were switched from the leuprolide 7.5 mg group when CS21 was completed.|0
8616564|NCT00451958|9654684|FG004|STARTED|CS21 (NCT00295750)||204
8716028|NCT00986440|9763084|FG000|Randomized, But Not Dosed|Overall Study||0
8716029|NCT00986440|9763085|FG001|Randomized, But Not Dosed|Overall Study||1
8716030|NCT00986440|9763084|FG000|COMPLETED|Overall Study||0
8716031|NCT00986440|9763085|FG001|COMPLETED|Overall Study||0
8716032|NCT00986440|9763084|FG000|NOT COMPLETED|Overall Study||41
8716033|NCT00986440|9763085|FG001|NOT COMPLETED|Overall Study||43
8616565|NCT00451958|9654680|FG000|COMPLETED|CS21 (NCT00295750)||169
8616566|NCT00451958|9654681|FG001|COMPLETED|CS21 (NCT00295750)||163
8616567|NCT00451958|9654682|FG002|COMPLETED|CS21 (NCT00295750)||0
8616568|NCT00451958|9654683|FG003|COMPLETED|CS21 (NCT00295750)||0
8616569|NCT00451958|9654684|FG004|COMPLETED|CS21 (NCT00295750)||172
8616570|NCT00451958|9654680|FG000|NOT COMPLETED|CS21 (NCT00295750)||41
8616571|NCT00451958|9654681|FG001|NOT COMPLETED|CS21 (NCT00295750)||43
8616572|NCT00451958|9654682|FG002|NOT COMPLETED|CS21 (NCT00295750)||0
8616573|NCT00451958|9654683|FG003|NOT COMPLETED|CS21 (NCT00295750)||0
8616574|NCT00451958|9654684|FG004|NOT COMPLETED|CS21 (NCT00295750)||32
8616575|NCT00451958|9654680|FG000|STARTED|CS21A (NCT00451958)|CS21A intention-to-treat (ITT) population.|125
8616576|NCT00451958|9654681|FG001|STARTED|CS21A (NCT00451958)|CS21A ITT population.|126
8716034|NCT00986453|9763091|FG000|STARTED|Overall Study||45
8716035|NCT00986453|9763091|FG000|COMPLETED|Overall Study||43
8716036|NCT00986453|9763091|FG000|NOT COMPLETED|Overall Study||2
8716037|NCT00986479|9763099|FG000|STARTED|Period 1||12
8716038|NCT00986479|9763100|FG001|STARTED|Period 1||10
8716039|NCT00986479|9763099|FG000|COMPLETED|Period 1||10
8716040|NCT00986479|9763100|FG001|COMPLETED|Period 1||10
8716041|NCT00986479|9763099|FG000|NOT COMPLETED|Period 1||2
8716042|NCT00986479|9763100|FG001|NOT COMPLETED|Period 1||0
8716043|NCT00986479|9763099|FG000|STARTED|Period 2||10
8716044|NCT00986479|9763100|FG001|STARTED|Period 2||10
8716045|NCT00986479|9763099|FG000|COMPLETED|Period 2||10
8716046|NCT00986479|9763100|FG001|COMPLETED|Period 2||10
8716047|NCT00986479|9763099|FG000|NOT COMPLETED|Period 2||0
8716048|NCT00986479|9763100|FG001|NOT COMPLETED|Period 2||0
8716049|NCT00986544|9763108|FG000|STARTED|Overall Study||53
8716050|NCT00986544|9763109|FG001|STARTED|Overall Study||53
8716051|NCT00986544|9763108|FG000|COMPLETED|Overall Study||53
8716052|NCT00986544|9763109|FG001|COMPLETED|Overall Study||53
8716053|NCT00986544|9763108|FG000|NOT COMPLETED|Overall Study||0
8716054|NCT00986544|9763109|FG001|NOT COMPLETED|Overall Study||0
8616577|NCT00451958|9654682|FG002|STARTED|CS21A (NCT00451958)|CS21A ITT population.|69
8629359|NCT00529555|9669088|FG000|STARTED|Overall Study||200
8716055|NCT00986570|9763116|FG000|STARTED|Overall Study||121
8616578|NCT00451958|9654683|FG003|STARTED|CS21A (NCT00451958)|One of the enrolled participants never received any treatment, i.e. the CS21A ITT population=65.|66
8616579|NCT00451958|9654684|FG004|STARTED|CS21A (NCT00451958)|Participants were switched to the degarelix groups when CS21 was completed.|0
8616580|NCT00451958|9654680|FG000|COMPLETED|CS21A (NCT00451958)||60
8616581|NCT00451958|9654681|FG001|COMPLETED|CS21A (NCT00451958)||49
8616582|NCT00451958|9654682|FG002|COMPLETED|CS21A (NCT00451958)||27
8616583|NCT00451958|9654683|FG003|COMPLETED|CS21A (NCT00451958)||27
8616584|NCT00451958|9654684|FG004|COMPLETED|CS21A (NCT00451958)||0
8616585|NCT00451958|9654680|FG000|NOT COMPLETED|CS21A (NCT00451958)||65
8616586|NCT00451958|9654681|FG001|NOT COMPLETED|CS21A (NCT00451958)||77
8616587|NCT00451958|9654682|FG002|NOT COMPLETED|CS21A (NCT00451958)||42
8616588|NCT00451958|9654683|FG003|NOT COMPLETED|CS21A (NCT00451958)||39
8616589|NCT00451958|9654684|FG004|NOT COMPLETED|CS21A (NCT00451958)||0
8616590|NCT00452114|9654700|FG000|STARTED|Overall Study||15
8716056|NCT00986570|9763116|FG000|COMPLETED|Overall Study||114
8716057|NCT00986570|9763116|FG000|NOT COMPLETED|Overall Study||7
8716058|NCT00986583|9763122|FG000|STARTED|Overall Study||38
8716059|NCT00986583|9763123|FG001|STARTED|Overall Study||32
8716060|NCT00986583|9763122|FG000|COMPLETED|Overall Study||38
8716061|NCT00986583|9763123|FG001|COMPLETED|Overall Study||32
8616591|NCT00452114|9654701|FG001|STARTED|Overall Study||13
8616592|NCT00452114|9654700|FG000|COMPLETED|Overall Study||12
8616593|NCT00452114|9654701|FG001|COMPLETED|Overall Study||10
8616594|NCT00452114|9654700|FG000|NOT COMPLETED|Overall Study||3
8616595|NCT00452114|9654701|FG001|NOT COMPLETED|Overall Study||3
8616596|NCT00452335|9654710|FG000|STARTED|Overall Study||27
8616597|NCT00452335|9654711|FG001|STARTED|Overall Study||65
8616598|NCT00452335|9654712|FG002|STARTED|Overall Study||32
8616599|NCT00452335|9654710|FG000|COMPLETED|Overall Study||25
8616600|NCT00452335|9654711|FG001|COMPLETED|Overall Study||61
8616601|NCT00452335|9654712|FG002|COMPLETED|Overall Study||23
8616602|NCT00452335|9654710|FG000|NOT COMPLETED|Overall Study||2
8716062|NCT00986583|9763122|FG000|NOT COMPLETED|Overall Study||0
8716063|NCT00986583|9763123|FG001|NOT COMPLETED|Overall Study||0
8716064|NCT00986674|9763133|FG000|STARTED|Overall Study||47
8716065|NCT00986674|9763134|FG001|STARTED|Overall Study||45
8716066|NCT00986674|9763135|FG002|STARTED|Overall Study||48
8716067|NCT00986674|9763133|FG000|Treated|Overall Study||43
8716068|NCT00986674|9763134|FG001|Treated|Overall Study||42
8716069|NCT00986674|9763135|FG002|Treated|Overall Study||47
8716070|NCT00986674|9763133|FG000|Eligible and Treated|Overall Study||39
8716071|NCT00986674|9763134|FG001|Eligible and Treated|Overall Study||41
8716072|NCT00986674|9763135|FG002|Eligible and Treated|Overall Study||47
8716073|NCT00986674|9763133|FG000|COMPLETED|Overall Study||0
8716074|NCT00986674|9763134|FG001|COMPLETED|Overall Study||0
8716075|NCT00986674|9763135|FG002|COMPLETED|Overall Study||0
8716076|NCT00986674|9763133|FG000|NOT COMPLETED|Overall Study||47
8716077|NCT00986674|9763134|FG001|NOT COMPLETED|Overall Study||45
8716078|NCT00986674|9763135|FG002|NOT COMPLETED|Overall Study||48
8716079|NCT00986830|9763143|FG000|STARTED|Overall Study||74
8716080|NCT00986830|9763143|FG000|Treated|Overall Study||69
8716081|NCT00986830|9763143|FG000|COMPLETED|Overall Study||66
8716082|NCT00986830|9763143|FG000|NOT COMPLETED|Overall Study||8
8716083|NCT00986856|9763149|FG000|STARTED|Overall Study||42
8716084|NCT00986856|9763150|FG001|STARTED|Overall Study||16
8716085|NCT00986856|9763149|FG000|COMPLETED|Overall Study||42
8716086|NCT00986856|9763150|FG001|COMPLETED|Overall Study||16
8716087|NCT00986856|9763149|FG000|NOT COMPLETED|Overall Study||0
8716088|NCT00986856|9763150|FG001|NOT COMPLETED|Overall Study||0
8716089|NCT00986921|9763158|FG000|STARTED|Overall Study||25
8716090|NCT00986921|9763159|FG001|STARTED|Overall Study||25
8716091|NCT00986921|9763158|FG000|COMPLETED|Overall Study||24
8716092|NCT00986921|9763159|FG001|COMPLETED|Overall Study||25
8716093|NCT00986921|9763158|FG000|NOT COMPLETED|Overall Study||1
8716094|NCT00986921|9763159|FG001|NOT COMPLETED|Overall Study||0
8716095|NCT00986973|9763168|FG000|STARTED|Overall Study||6
8716096|NCT00986973|9763168|FG000|COMPLETED|Overall Study|One subject was withdrawn from the study due to poor compliance with KUVAN therapy.|5
8716097|NCT00986973|9763168|FG000|NOT COMPLETED|Overall Study||1
8716098|NCT00986986|9763175|FG000|STARTED|Overall Study||10
8716099|NCT00986986|9763176|FG001|STARTED|Overall Study||10
8716100|NCT00986986|9763175|FG000|COMPLETED|Overall Study||10
8716101|NCT00986986|9763176|FG001|COMPLETED|Overall Study||9
8716102|NCT00986986|9763175|FG000|NOT COMPLETED|Overall Study||0
8716103|NCT00986986|9763176|FG001|NOT COMPLETED|Overall Study||1
8716104|NCT00987337|9763186|FG000|STARTED|Overall Study||96
8716105|NCT00987337|9763187|FG001|STARTED|Overall Study||96
8716106|NCT00987337|9763188|FG002|STARTED|Overall Study||96
8716107|NCT00987337|9763186|FG000|COMPLETED|Overall Study||39
8716108|NCT00987337|9763187|FG001|COMPLETED|Overall Study||41
8716109|NCT00987337|9763188|FG002|COMPLETED|Overall Study||45
8716110|NCT00987337|9763186|FG000|NOT COMPLETED|Overall Study||57
8616603|NCT00452335|9654711|FG001|NOT COMPLETED|Overall Study||4
8616604|NCT00452335|9654712|FG002|NOT COMPLETED|Overall Study||9
8616605|NCT00452348|9654725|FG000|STARTED|Overall Study||310
8716111|NCT00987337|9763187|FG001|NOT COMPLETED|Overall Study||55
8716112|NCT00987337|9763188|FG002|NOT COMPLETED|Overall Study||51
8716113|NCT00987389|9763200|FG000|STARTED|Overall Study||176
8716114|NCT00987389|9763201|FG001|STARTED|Overall Study||176
8716115|NCT00987389|9763202|FG002|STARTED|Overall Study||175
8716116|NCT00987389|9763203|FG003|STARTED|Overall Study||177
8616606|NCT00452348|9654726|FG001|STARTED|Overall Study||318
8616607|NCT00452348|9654725|FG000|COMPLETED|Overall Study||231
8616608|NCT00452348|9654726|FG001|COMPLETED|Overall Study||234
8616609|NCT00452348|9654725|FG000|NOT COMPLETED|Overall Study||79
8616610|NCT00452348|9654726|FG001|NOT COMPLETED|Overall Study||84
8616611|NCT00452374|9654732|FG000|STARTED|Overall Study||48
8616612|NCT00452374|9654732|FG000|COMPLETED|Overall Study||48
8616613|NCT00452374|9654732|FG000|NOT COMPLETED|Overall Study||0
8616614|NCT00452387|9654736|FG000|STARTED|Overall Study||22
8616615|NCT00452387|9654736|FG000|COMPLETED|Overall Study||22
8616616|NCT00452387|9654736|FG000|NOT COMPLETED|Overall Study||0
8616617|NCT00452400|9654747|FG000|STARTED|Overall Study||79
8616618|NCT00452400|9654748|FG001|STARTED|Overall Study||81
8616619|NCT00452400|9654749|FG002|STARTED|Overall Study||80
8616620|NCT00452400|9654750|FG003|STARTED|Overall Study||86
8616621|NCT00452400|9654751|FG004|STARTED|Overall Study||79
8616622|NCT00452400|9654747|FG000|COMPLETED|Overall Study||74
8616623|NCT00452400|9654748|FG001|COMPLETED|Overall Study||80
8616624|NCT00452400|9654749|FG002|COMPLETED|Overall Study||73
8616625|NCT00452400|9654750|FG003|COMPLETED|Overall Study||85
8616626|NCT00452400|9654751|FG004|COMPLETED|Overall Study||76
8616627|NCT00452400|9654747|FG000|NOT COMPLETED|Overall Study||5
8716117|NCT00987389|9763200|FG000|COMPLETED|Overall Study||167
8716118|NCT00987389|9763201|FG001|COMPLETED|Overall Study||168
8716119|NCT00987389|9763202|FG002|COMPLETED|Overall Study||167
8716120|NCT00987389|9763203|FG003|COMPLETED|Overall Study||174
8716121|NCT00987389|9763200|FG000|NOT COMPLETED|Overall Study||9
8716122|NCT00987389|9763201|FG001|NOT COMPLETED|Overall Study||8
8716123|NCT00987389|9763202|FG002|NOT COMPLETED|Overall Study||8
8716124|NCT00987389|9763203|FG003|NOT COMPLETED|Overall Study||3
8716125|NCT00987402|9763213|FG000|STARTED|Overall Study|January 2007, with crossover every 2 months|1682
8716126|NCT00987402|9763214|FG001|STARTED|Overall Study|January 2007 with crossover every 2 months|1635
8716127|NCT00987402|9763213|FG000|COMPLETED|Overall Study|86 patients did not have some data, and could not be evaluated|1596
8716128|NCT00987402|9763214|FG001|COMPLETED|Overall Study|98 patients did not have sufficient data|1537
8716129|NCT00987402|9763213|FG000|NOT COMPLETED|Overall Study||86
8716130|NCT00987402|9763214|FG001|NOT COMPLETED|Overall Study||98
8716131|NCT00987415|9763222|FG000|STARTED|Overall Study||128
8716132|NCT00987415|9763223|FG001|STARTED|Overall Study||125
8716133|NCT00987415|9763222|FG000|COMPLETED|Overall Study||119
8716134|NCT00987415|9763223|FG001|COMPLETED|Overall Study||116
8716135|NCT00987415|9763222|FG000|NOT COMPLETED|Overall Study||9
8716136|NCT00987415|9763223|FG001|NOT COMPLETED|Overall Study||9
8716137|NCT00987467|9763229|FG000|STARTED|Overall Study||12
8716138|NCT00987467|9763229|FG000|COMPLETED|Overall Study||10
8716139|NCT00987467|9763229|FG000|NOT COMPLETED|Overall Study||2
8716140|NCT00987480|9763234|FG000|STARTED|Overall Study||45
8716141|NCT00987480|9763234|FG000|COMPLETED|Overall Study||45
8716142|NCT00987480|9763234|FG000|NOT COMPLETED|Overall Study||0
8716143|NCT00987558|9763238|FG000|STARTED|Overall Study||13
8716144|NCT00987558|9763239|FG001|STARTED|Overall Study||17
8716145|NCT00987558|9763238|FG000|Simvastatin|Overall Study||13
8716146|NCT00987558|9763239|FG001|Simvastatin|Overall Study||12
8716147|NCT00987558|9763238|FG000|Washout|Overall Study||13
8716148|NCT00987558|9763239|FG001|Washout|Overall Study||12
8716149|NCT00987558|9763238|FG000|Eslicarbazepine Acetate + Simvastatin|Overall Study||13
8716150|NCT00987558|9763239|FG001|Eslicarbazepine Acetate + Simvastatin|Overall Study||17
8716151|NCT00987558|9763238|FG000|COMPLETED|Overall Study||12
8716152|NCT00987558|9763239|FG001|COMPLETED|Overall Study||12
8716153|NCT00987558|9763238|FG000|NOT COMPLETED|Overall Study||1
8716154|NCT00987558|9763239|FG001|NOT COMPLETED|Overall Study||5
8716155|NCT00987623|9763248|FG000|STARTED|Overall Study||145
8716156|NCT00987623|9763249|FG001|STARTED|Overall Study||154
8716157|NCT00987623|9763248|FG000|COMPLETED|Overall Study||140
8716158|NCT00987623|9763249|FG001|COMPLETED|Overall Study||151
8716159|NCT00987623|9763248|FG000|NOT COMPLETED|Overall Study||5
8716160|NCT00987623|9763249|FG001|NOT COMPLETED|Overall Study||3
8716161|NCT00987727|9763257|FG000|STARTED|Overall Study||41
8716162|NCT00987727|9763258|FG001|STARTED|Overall Study||41
8716163|NCT00987727|9763257|FG000|COMPLETED|Overall Study||36
8716164|NCT00987727|9763258|FG001|COMPLETED|Overall Study||34
8716165|NCT00987727|9763257|FG000|NOT COMPLETED|Overall Study||5
8716166|NCT00987727|9763258|FG001|NOT COMPLETED|Overall Study||7
8716167|NCT00987831|9763267|FG000|STARTED|Overall Study|41 patients improved after depomedrol, if not improved, treated and moved to Group B|41
8716168|NCT00987831|9763268|FG001|STARTED|Overall Study|52 healthy controls donated biomarkers on two occasions in order to verify biomarkers ranges|55
8716169|NCT00987831|9763269|FG002|STARTED|Overall Study|Anyone who entered this arm completed it the same day|62
8716170|NCT00987831|9763267|FG000|COMPLETED|Overall Study|40 patients completed in 6 months. 1 patient did not meet completion definition in 12 months.|40
8716171|NCT00987831|9763268|FG001|COMPLETED|Overall Study|all controls returned for two visits|52
8616628|NCT00452400|9654748|FG001|NOT COMPLETED|Overall Study||1
8616629|NCT00452400|9654749|FG002|NOT COMPLETED|Overall Study||7
8616630|NCT00452400|9654750|FG003|NOT COMPLETED|Overall Study||1
8616631|NCT00452400|9654751|FG004|NOT COMPLETED|Overall Study||3
8616632|NCT00452413|9654766|FG000|STARTED|Overall Study||4
8616633|NCT00452413|9654767|FG001|STARTED|Overall Study||12
8616634|NCT00452413|9654768|FG002|STARTED|Overall Study||49
8616635|NCT00452413|9654766|FG000|Received at Least 1 Dose of Study Drug|Overall Study||4
8616636|NCT00452413|9654767|FG001|Received at Least 1 Dose of Study Drug|Overall Study||12
8616637|NCT00452413|9654768|FG002|Received at Least 1 Dose of Study Drug|Overall Study||49
8616638|NCT00452413|9654766|FG000|COMPLETED|Overall Study||0
8716172|NCT00987831|9763269|FG002|COMPLETED|Overall Study|Anyone who entered this arm completed it the same day|62
8716173|NCT00987831|9763267|FG000|NOT COMPLETED|Overall Study||1
8716174|NCT00987831|9763268|FG001|NOT COMPLETED|Overall Study||3
8616639|NCT00452413|9654767|FG001|COMPLETED|Overall Study||0
8616640|NCT00452413|9654768|FG002|COMPLETED|Overall Study||0
8616641|NCT00452413|9654766|FG000|NOT COMPLETED|Overall Study||4
8616642|NCT00452413|9654767|FG001|NOT COMPLETED|Overall Study||12
8616643|NCT00452413|9654768|FG002|NOT COMPLETED|Overall Study||49
8616644|NCT00452426|9654779|FG000|STARTED|Overall Study||496
8616645|NCT00452426|9654780|FG001|STARTED|Overall Study||504
8616646|NCT00452426|9654779|FG000|COMPLETED|Overall Study||489
8616647|NCT00452426|9654780|FG001|COMPLETED|Overall Study||493
8616648|NCT00452426|9654779|FG000|NOT COMPLETED|Overall Study||7
8616649|NCT00452426|9654780|FG001|NOT COMPLETED|Overall Study||11
8616650|NCT00452439|9654788|FG000|STARTED|Overall Study||36
8616651|NCT00452439|9654789|FG001|STARTED|Overall Study||36
8616652|NCT00452439|9654788|FG000|COMPLETED|Overall Study||22
8616653|NCT00452439|9654789|FG001|COMPLETED|Overall Study||29
8616654|NCT00452439|9654788|FG000|NOT COMPLETED|Overall Study||14
8616655|NCT00452439|9654789|FG001|NOT COMPLETED|Overall Study||7
8616656|NCT00452452|9654798|FG000|STARTED|Overall Study||90
8616657|NCT00452452|9654799|FG001|STARTED|Overall Study||112
8716175|NCT00987831|9763269|FG002|NOT COMPLETED|Overall Study||0
8716176|NCT00987935|9763287|FG000|STARTED|Overall Study||4
8716177|NCT00987935|9763288|FG001|STARTED|Overall Study||3
8716178|NCT00987935|9763289|FG002|STARTED|Overall Study||3
8716179|NCT00987935|9763290|FG003|STARTED|Overall Study||3
8716180|NCT00987935|9763291|FG004|STARTED|Overall Study||7
8716181|NCT00987935|9763292|FG005|STARTED|Overall Study||3
8716182|NCT00987935|9763293|FG006|STARTED|Overall Study||16
8716183|NCT00987935|9763294|FG007|STARTED|Overall Study||63
8716184|NCT00987935|9763295|FG008|STARTED|Overall Study||32
8716185|NCT00987935|9763287|FG000|COMPLETED|Overall Study||0
8716186|NCT00987935|9763288|FG001|COMPLETED|Overall Study||0
8716187|NCT00987935|9763289|FG002|COMPLETED|Overall Study||0
8716188|NCT00987935|9763290|FG003|COMPLETED|Overall Study||0
8716189|NCT00987935|9763291|FG004|COMPLETED|Overall Study||0
8716190|NCT00987935|9763292|FG005|COMPLETED|Overall Study||0
8716191|NCT00987935|9763293|FG006|COMPLETED|Overall Study|On-treatment at analysis cut-off date (16 July 2014).|1
8716192|NCT00987935|9763294|FG007|COMPLETED|Overall Study|On-treatment at analysis cut-off date (16 July 2014).|1
8928268|NCT02279667|9989448|FG000|COMPLETED|Overall Study||6
8928269|NCT02279667|9989449|FG001|COMPLETED|Overall Study||6
8928270|NCT02279667|9989450|FG002|COMPLETED|Overall Study||6
8928271|NCT02279667|9989448|FG000|NOT COMPLETED|Overall Study||0
8616658|NCT00452452|9654800|FG002|STARTED|Overall Study||153
8616659|NCT00452452|9654798|FG000|Vaccinated Dose 1|Overall Study||90
8716193|NCT00987935|9763295|FG008|COMPLETED|Overall Study||0
8716194|NCT00987935|9763287|FG000|NOT COMPLETED|Overall Study||4
8716195|NCT00987935|9763288|FG001|NOT COMPLETED|Overall Study||3
8716196|NCT00987935|9763289|FG002|NOT COMPLETED|Overall Study||3
8716197|NCT00987935|9763290|FG003|NOT COMPLETED|Overall Study||3
8716198|NCT00987935|9763291|FG004|NOT COMPLETED|Overall Study||7
8716199|NCT00987935|9763292|FG005|NOT COMPLETED|Overall Study||3
8716200|NCT00987935|9763293|FG006|NOT COMPLETED|Overall Study||15
8716201|NCT00987935|9763294|FG007|NOT COMPLETED|Overall Study||62
8716202|NCT00987935|9763295|FG008|NOT COMPLETED|Overall Study||32
8716203|NCT00987948|9763321|FG000|STARTED|Overall Study||15
8716204|NCT00987948|9763321|FG000|COMPLETED|Overall Study||12
8716205|NCT00987948|9763321|FG000|NOT COMPLETED|Overall Study||3
8716206|NCT00988000|9763328|FG000|STARTED|Overall Study||49
8716207|NCT00988000|9763329|FG001|STARTED|Overall Study||51
8716208|NCT00988000|9763330|FG002|STARTED|Overall Study||57
8716209|NCT00988000|9763328|FG000|COMPLETED|Overall Study||49
8716210|NCT00988000|9763329|FG001|COMPLETED|Overall Study||51
8716211|NCT00988000|9763330|FG002|COMPLETED|Overall Study||57
8716212|NCT00988000|9763328|FG000|NOT COMPLETED|Overall Study||0
8716213|NCT00988000|9763329|FG001|NOT COMPLETED|Overall Study||0
8716214|NCT00988000|9763330|FG002|NOT COMPLETED|Overall Study||0
8716215|NCT00988013|9763344|FG000|STARTED|Overall Study||3
8716216|NCT00988013|9763345|FG001|STARTED|Overall Study||3
8716217|NCT00988013|9763346|FG002|STARTED|Overall Study||6
8716218|NCT00988013|9763347|FG003|STARTED|Overall Study||2
8716219|NCT00988013|9763344|FG000|COMPLETED|Overall Study||3
8716220|NCT00988013|9763345|FG001|COMPLETED|Overall Study||3
8716221|NCT00988013|9763346|FG002|COMPLETED|Overall Study||6
8716222|NCT00988013|9763347|FG003|COMPLETED|Overall Study||2
8716223|NCT00988013|9763344|FG000|NOT COMPLETED|Overall Study||0
8616660|NCT00452452|9654799|FG001|Vaccinated Dose 1|Overall Study||112
8616661|NCT00452452|9654800|FG002|Vaccinated Dose 1|Overall Study||152
8716224|NCT00988013|9763345|FG001|NOT COMPLETED|Overall Study||0
8616662|NCT00452452|9654798|FG000|Vaccinated Dose 2|Overall Study||90
8716225|NCT00988013|9763346|FG002|NOT COMPLETED|Overall Study||0
8716226|NCT00988013|9763347|FG003|NOT COMPLETED|Overall Study||0
8716227|NCT00988065|9763362|FG000|STARTED|Overall Study|Randomized to double-blind treatment|148
8716228|NCT00988065|9763363|FG001|STARTED|Overall Study|Randomized to double-blind treatment|150
8716229|NCT00988065|9763364|FG002|STARTED|Overall Study|Randomized to double-blind treatment|150
8928272|NCT02279667|9989449|FG001|NOT COMPLETED|Overall Study||0
8716230|NCT00988065|9763362|FG000|Received First Randomized Dose|Overall Study||148
8716231|NCT00988065|9763363|FG001|Received First Randomized Dose|Overall Study||150
8716232|NCT00988065|9763364|FG002|Received First Randomized Dose|Overall Study||150
8716233|NCT00988065|9763362|FG000|Received Second Randomized Dose|Overall Study||139
8716234|NCT00988065|9763363|FG001|Received Second Randomized Dose|Overall Study||135
8716235|NCT00988065|9763364|FG002|Received Second Randomized Dose|Overall Study||145
8716236|NCT00988065|9763362|FG000|Received Third Randomized Dose|Overall Study||135
8716237|NCT00988065|9763363|FG001|Received Third Randomized Dose|Overall Study||127
8716238|NCT00988065|9763364|FG002|Received Third Randomized Dose|Overall Study||135
8716239|NCT00988065|9763362|FG000|COMPLETED|Overall Study||135
8716240|NCT00988065|9763363|FG001|COMPLETED|Overall Study||127
8716241|NCT00988065|9763364|FG002|COMPLETED|Overall Study||135
8716242|NCT00988065|9763362|FG000|NOT COMPLETED|Overall Study||13
8716243|NCT00988065|9763363|FG001|NOT COMPLETED|Overall Study||23
8716244|NCT00988065|9763364|FG002|NOT COMPLETED|Overall Study||15
9064298|NCT04318535|10124573|FG002|COMPLETED|Period2washout(Atleast 7 Days Post-dose)||12
9064299|NCT04318535|10124571|FG000|NOT COMPLETED|Period2washout(Atleast 7 Days Post-dose)||0
9064300|NCT04318535|10124572|FG001|NOT COMPLETED|Period2washout(Atleast 7 Days Post-dose)||1
9064301|NCT04318535|10124573|FG002|NOT COMPLETED|Period2washout(Atleast 7 Days Post-dose)||0
9064302|NCT04318535|10124571|FG000|STARTED|Treatment Period 3 (Day 17 to Day 22)||12
9064303|NCT04318535|10124572|FG001|STARTED|Treatment Period 3 (Day 17 to Day 22)||11
9064304|NCT04318535|10124573|FG002|STARTED|Treatment Period 3 (Day 17 to Day 22)||12
9064305|NCT04318535|10124571|FG000|COMPLETED|Treatment Period 3 (Day 17 to Day 22)||12
9064306|NCT04318535|10124572|FG001|COMPLETED|Treatment Period 3 (Day 17 to Day 22)||11
9064307|NCT04318535|10124573|FG002|COMPLETED|Treatment Period 3 (Day 17 to Day 22)||12
9064308|NCT04318535|10124571|FG000|NOT COMPLETED|Treatment Period 3 (Day 17 to Day 22)||0
9064309|NCT04318535|10124572|FG001|NOT COMPLETED|Treatment Period 3 (Day 17 to Day 22)||0
9064310|NCT04318535|10124573|FG002|NOT COMPLETED|Treatment Period 3 (Day 17 to Day 22)||0
9064311|NCT04316260|10124584|FG000|STARTED|Overall Study||34
9064312|NCT04316260|10124585|FG001|STARTED|Overall Study||17
9064313|NCT04316260|10124584|FG000|COMPLETED|Overall Study||34
9064314|NCT04316260|10124585|FG001|COMPLETED|Overall Study||17
9064315|NCT04316260|10124584|FG000|NOT COMPLETED|Overall Study||0
9064316|NCT04316260|10124585|FG001|NOT COMPLETED|Overall Study||0
9064317|NCT04314037|10124594|FG000|STARTED|Treatment Period 1||18
9064318|NCT04314037|10124595|FG001|STARTED|Treatment Period 1||18
9064319|NCT04314037|10124594|FG000|COMPLETED|Treatment Period 1||18
9064320|NCT04314037|10124595|FG001|COMPLETED|Treatment Period 1||18
9064321|NCT04314037|10124594|FG000|NOT COMPLETED|Treatment Period 1||0
9064322|NCT04314037|10124595|FG001|NOT COMPLETED|Treatment Period 1||0
9064323|NCT04314037|10124594|FG000|STARTED|Treatment Period 2||18
9064324|NCT04314037|10124595|FG001|STARTED|Treatment Period 2||18
9064325|NCT04314037|10124594|FG000|COMPLETED|Treatment Period 2||17
9064326|NCT04314037|10124595|FG001|COMPLETED|Treatment Period 2||18
9064327|NCT04314037|10124594|FG000|NOT COMPLETED|Treatment Period 2||1
9064328|NCT04314037|10124595|FG001|NOT COMPLETED|Treatment Period 2||0
9064329|NCT04314037|10124594|FG000|STARTED|Treatment Period 3||17
9064330|NCT04314037|10124595|FG001|STARTED|Treatment Period 3||18
9064331|NCT04314037|10124594|FG000|COMPLETED|Treatment Period 3||16
9064332|NCT04314037|10124595|FG001|COMPLETED|Treatment Period 3||17
9064333|NCT04314037|10124594|FG000|NOT COMPLETED|Treatment Period 3||1
9064334|NCT04314037|10124595|FG001|NOT COMPLETED|Treatment Period 3||1
9064335|NCT04314037|10124594|FG000|STARTED|Treatment Period 4||16
9064336|NCT04314037|10124595|FG001|STARTED|Treatment Period 4||17
9064337|NCT04314037|10124594|FG000|COMPLETED|Treatment Period 4||16
9064338|NCT04314037|10124595|FG001|COMPLETED|Treatment Period 4||17
9064339|NCT04314037|10124594|FG000|NOT COMPLETED|Treatment Period 4||0
8716245|NCT00988091|9763374|FG000|STARTED|Double-blind Period||298
8716246|NCT00988091|9763375|FG001|STARTED|Double-blind Period||298
8716247|NCT00988091|9763374|FG000|Intent to Treat Population|Double-blind Period|ITT population excludes participants from one site which was closed for non-compliance.|294
8716248|NCT00988091|9763375|FG001|Intent to Treat Population|Double-blind Period|ITT population excludes participants from one site which was closed for non-compliance.|295
8716249|NCT00988091|9763374|FG000|COMPLETED|Double-blind Period||255
8716250|NCT00988091|9763375|FG001|COMPLETED|Double-blind Period||251
8716251|NCT00988091|9763374|FG000|NOT COMPLETED|Double-blind Period||43
8716252|NCT00988091|9763375|FG001|NOT COMPLETED|Double-blind Period||47
8716253|NCT00988091|9763374|FG000|STARTED|Open-label Period|Participation in the Open-label period was optional.|229
8716254|NCT00988091|9763375|FG001|STARTED|Open-label Period|Participation in the Open-label period was optional.|225
9064340|NCT04314037|10124595|FG001|NOT COMPLETED|Treatment Period 4||0
9064341|NCT04315298|10124626|FG000|STARTED|Overall Study||90
9064342|NCT04315298|10124627|FG001|STARTED|Overall Study||187
9064343|NCT04315298|10124628|FG002|STARTED|Overall Study||180
9064344|NCT04315298|10124629|FG003|STARTED|Overall Study||170
9064345|NCT04315298|10124630|FG004|STARTED|Overall Study||242
9064346|NCT04315298|10124631|FG005|STARTED|Overall Study||338
9064347|NCT04315298|10124632|FG006|STARTED|Overall Study||70
9064348|NCT04315298|10124633|FG007|STARTED|Overall Study||140
9064349|NCT04315298|10124634|FG008|STARTED|Overall Study||137
9064350|NCT04315298|10124635|FG009|STARTED|Overall Study||46
9064351|NCT04315298|10124636|FG010|STARTED|Overall Study||95
9064352|NCT04315298|10124637|FG011|STARTED|Overall Study||92
9064353|NCT04315298|10124638|FG012|STARTED|Overall Study||8
9064354|NCT04315298|10124639|FG013|STARTED|Overall Study||12
9064355|NCT04315298|10124640|FG014|STARTED|Overall Study||15
9064356|NCT04315298|10124641|FG015|STARTED|Overall Study||15
9064357|NCT04315298|10124642|FG016|STARTED|Overall Study||16
9064358|NCT04315298|10124643|FG017|STARTED|Overall Study||6
9064359|NCT04315298|10124644|FG018|STARTED|Overall Study||2
9064360|NCT04315298|10124626|FG000|COMPLETED|Overall Study||61
9064361|NCT04315298|10124627|FG001|COMPLETED|Overall Study||117
9064362|NCT04315298|10124628|FG002|COMPLETED|Overall Study||125
9064363|NCT04315298|10124629|FG003|COMPLETED|Overall Study||101
9064364|NCT04315298|10124630|FG004|COMPLETED|Overall Study||157
9064365|NCT04315298|10124631|FG005|COMPLETED|Overall Study||209
9064366|NCT04315298|10124632|FG006|COMPLETED|Overall Study||52
9064367|NCT04315298|10124633|FG007|COMPLETED|Overall Study||111
9064368|NCT04315298|10124634|FG008|COMPLETED|Overall Study||101
9064369|NCT04315298|10124635|FG009|COMPLETED|Overall Study||29
9064370|NCT04315298|10124636|FG010|COMPLETED|Overall Study||53
9064371|NCT04315298|10124637|FG011|COMPLETED|Overall Study||51
9064372|NCT04315298|10124638|FG012|COMPLETED|Overall Study||5
9064373|NCT04315298|10124639|FG013|COMPLETED|Overall Study||8
9064374|NCT04315298|10124640|FG014|COMPLETED|Overall Study||9
9064375|NCT04315298|10124641|FG015|COMPLETED|Overall Study||9
9064376|NCT04315298|10124642|FG016|COMPLETED|Overall Study||13
9064377|NCT04315298|10124643|FG017|COMPLETED|Overall Study||5
9064378|NCT04315298|10124644|FG018|COMPLETED|Overall Study||2
9064379|NCT04315298|10124626|FG000|NOT COMPLETED|Overall Study||29
9064380|NCT04315298|10124627|FG001|NOT COMPLETED|Overall Study||70
9064381|NCT04315298|10124628|FG002|NOT COMPLETED|Overall Study||55
9064382|NCT04315298|10124629|FG003|NOT COMPLETED|Overall Study||69
9064383|NCT04315298|10124630|FG004|NOT COMPLETED|Overall Study||85
9064384|NCT04315298|10124631|FG005|NOT COMPLETED|Overall Study||129
9064385|NCT04315298|10124632|FG006|NOT COMPLETED|Overall Study||18
9064386|NCT04315298|10124633|FG007|NOT COMPLETED|Overall Study||29
9064387|NCT04315298|10124634|FG008|NOT COMPLETED|Overall Study||36
9064388|NCT04315298|10124635|FG009|NOT COMPLETED|Overall Study||17
9064389|NCT04315298|10124636|FG010|NOT COMPLETED|Overall Study||42
9064390|NCT04315298|10124637|FG011|NOT COMPLETED|Overall Study||41
9064391|NCT04315298|10124638|FG012|NOT COMPLETED|Overall Study||3
8716255|NCT00988091|9763374|FG000|COMPLETED|Open-label Period||208
8716256|NCT00988091|9763375|FG001|COMPLETED|Open-label Period||192
8716257|NCT00988091|9763374|FG000|NOT COMPLETED|Open-label Period||21
8716258|NCT00988091|9763375|FG001|NOT COMPLETED|Open-label Period||33
8716259|NCT00988117|9763382|FG000|STARTED|4.6 mg/24 Hours From Baseline to Week 4||15
8716260|NCT00988117|9763382|FG000|COMPLETED|4.6 mg/24 Hours From Baseline to Week 4||14
8716261|NCT00988117|9763382|FG000|NOT COMPLETED|4.6 mg/24 Hours From Baseline to Week 4||1
8716262|NCT00988117|9763382|FG000|STARTED|9.5 mg/24 Hours From Week 4 to 12||14
8716263|NCT00988117|9763382|FG000|COMPLETED|9.5 mg/24 Hours From Week 4 to 12||12
8716264|NCT00988117|9763382|FG000|NOT COMPLETED|9.5 mg/24 Hours From Week 4 to 12||2
8716265|NCT00988143|9763390|FG000|STARTED|Overall Study||220
8716266|NCT00988143|9763391|FG001|STARTED|Overall Study||190
8716267|NCT00988143|9763392|FG002|STARTED|Overall Study||190
8716268|NCT00988143|9763390|FG000|COMPLETED|Overall Study||220
8716269|NCT00988143|9763391|FG001|COMPLETED|Overall Study||190
8716270|NCT00988143|9763392|FG002|COMPLETED|Overall Study||190
8716271|NCT00988143|9763390|FG000|NOT COMPLETED|Overall Study||0
8716272|NCT00988143|9763391|FG001|NOT COMPLETED|Overall Study||0
8716273|NCT00988143|9763392|FG002|NOT COMPLETED|Overall Study||0
8716274|NCT00988156|9763402|FG000|STARTED|Overall Study||149
8716275|NCT00988156|9763403|FG001|STARTED|Overall Study||155
8716276|NCT00988156|9763402|FG000|Intention-to-Treat Set (ITT)|Overall Study||129
8716277|NCT00988156|9763403|FG001|Intention-to-Treat Set (ITT)|Overall Study||134
8716278|NCT00988156|9763402|FG000|Per Protocol Set (PP)|Overall Study||101
8716279|NCT00988156|9763403|FG001|Per Protocol Set (PP)|Overall Study||97
8716280|NCT00988156|9763402|FG000|Safety Set|Overall Study||129
8716281|NCT00988156|9763403|FG001|Safety Set|Overall Study||134
8716282|NCT00988156|9763402|FG000|COMPLETED|Overall Study||132
8716283|NCT00988156|9763403|FG001|COMPLETED|Overall Study||135
8716284|NCT00988156|9763402|FG000|NOT COMPLETED|Overall Study||17
8716285|NCT00988156|9763403|FG001|NOT COMPLETED|Overall Study||20
8716286|NCT00988169|9763409|FG000|STARTED|Overall Study||6
8716287|NCT00988169|9763409|FG000|COMPLETED|Overall Study||5
8813347|NCT01525407|9866519|FG000|COMPLETED|Overall Study||38
9064392|NCT04315298|10124639|FG013|NOT COMPLETED|Overall Study||4
9064393|NCT04315298|10124640|FG014|NOT COMPLETED|Overall Study||6
9064394|NCT04315298|10124641|FG015|NOT COMPLETED|Overall Study||6
9064395|NCT04315298|10124642|FG016|NOT COMPLETED|Overall Study||3
9064396|NCT04315298|10124643|FG017|NOT COMPLETED|Overall Study||1
9064397|NCT04315298|10124644|FG018|NOT COMPLETED|Overall Study||0
9064398|NCT04313647|10124716|FG000|STARTED|Overall Study||3
9064399|NCT04313647|10124717|FG001|STARTED|Overall Study||3
9064400|NCT04313647|10124718|FG002|STARTED|Overall Study||6
9064401|NCT04313647|10124719|FG003|STARTED|Overall Study||6
9064402|NCT04313647|10124720|FG004|STARTED|Overall Study||6
9064403|NCT04313647|10124716|FG000|COMPLETED|Overall Study||3
9064404|NCT04313647|10124717|FG001|COMPLETED|Overall Study||3
8716288|NCT00988169|9763409|FG000|NOT COMPLETED|Overall Study||1
8716289|NCT00988208|9763415|FG000|STARTED|Overall Study||526
8813348|NCT01525407|9866520|FG001|COMPLETED|Overall Study||38
9064405|NCT04313647|10124718|FG002|COMPLETED|Overall Study||6
9064406|NCT04313647|10124719|FG003|COMPLETED|Overall Study||6
8716290|NCT00988208|9763416|FG001|STARTED|Overall Study||533
8716291|NCT00988208|9763415|FG000|Treated|Overall Study||521
9064407|NCT04313647|10124720|FG004|COMPLETED|Overall Study||6
9064408|NCT04313647|10124716|FG000|NOT COMPLETED|Overall Study||0
9064409|NCT04313647|10124717|FG001|NOT COMPLETED|Overall Study||0
9064410|NCT04313647|10124718|FG002|NOT COMPLETED|Overall Study||0
9064411|NCT04313647|10124719|FG003|NOT COMPLETED|Overall Study||0
9064412|NCT04313647|10124720|FG004|NOT COMPLETED|Overall Study||0
9064413|NCT04310085|10124739|FG000|STARTED|Overall Study||8
9064414|NCT04310085|10124740|FG001|STARTED|Overall Study||8
9064415|NCT04310085|10124739|FG000|COMPLETED|Overall Study||8
9064416|NCT04310085|10124740|FG001|COMPLETED|Overall Study||8
9064417|NCT04310085|10124739|FG000|NOT COMPLETED|Overall Study||0
9064418|NCT04310085|10124740|FG001|NOT COMPLETED|Overall Study||0
9064419|NCT04309617|10124746|FG000|STARTED|Overall Study||618
9064420|NCT04309617|10124746|FG000|Modified High Risk of Recurrence|Overall Study||136
9064421|NCT04309617|10124746|FG000|COMPLETED|Overall Study||618
9064422|NCT04309617|10124746|FG000|NOT COMPLETED|Overall Study||0
9064423|NCT04308239|10124754|FG000|STARTED|Pre-intervention Evaluation (1 Week)||20
9064424|NCT04308239|10124755|FG001|STARTED|Pre-intervention Evaluation (1 Week)||14
9064425|NCT04308239|10124754|FG000|COMPLETED|Pre-intervention Evaluation (1 Week)|No withdrawals. These participants just missed this evaluation but stayed in study.|17
9064426|NCT04308239|10124755|FG001|COMPLETED|Pre-intervention Evaluation (1 Week)|No withdrawals. These participants just missed this evaluation but stayed in study.|11
9064427|NCT04308239|10124754|FG000|NOT COMPLETED|Pre-intervention Evaluation (1 Week)||3
9064428|NCT04308239|10124755|FG001|NOT COMPLETED|Pre-intervention Evaluation (1 Week)||3
9064429|NCT04308239|10124754|FG000|STARTED|Intervention (2 Weeks)||20
9064430|NCT04308239|10124755|FG001|STARTED|Intervention (2 Weeks)||14
9064431|NCT04308239|10124754|FG000|COMPLETED|Intervention (2 Weeks)||20
9064432|NCT04308239|10124755|FG001|COMPLETED|Intervention (2 Weeks)||14
9064433|NCT04308239|10124754|FG000|NOT COMPLETED|Intervention (2 Weeks)||0
9064434|NCT04308239|10124755|FG001|NOT COMPLETED|Intervention (2 Weeks)||0
9064435|NCT04308239|10124754|FG000|STARTED|Post-intervention Evaluation (1 Week)||20
9064436|NCT04308239|10124755|FG001|STARTED|Post-intervention Evaluation (1 Week)||14
9064437|NCT04308239|10124754|FG000|COMPLETED|Post-intervention Evaluation (1 Week)||19
9064438|NCT04308239|10124755|FG001|COMPLETED|Post-intervention Evaluation (1 Week)||10
9064439|NCT04308239|10124754|FG000|NOT COMPLETED|Post-intervention Evaluation (1 Week)||1
9064440|NCT04308239|10124755|FG001|NOT COMPLETED|Post-intervention Evaluation (1 Week)||4
9064441|NCT04308668|10124767|FG000|STARTED|Overall Study||658
9064442|NCT04308668|10124768|FG001|STARTED|Overall Study||654
9064443|NCT04308668|10124767|FG000|COMPLETED|Overall Study||622
9064444|NCT04308668|10124768|FG001|COMPLETED|Overall Study||612
9064445|NCT04308668|10124767|FG000|NOT COMPLETED|Overall Study||36
9064446|NCT04308668|10124768|FG001|NOT COMPLETED|Overall Study||42
9064447|NCT04307940|10124777|FG000|STARTED|Overall Study||90
9064448|NCT04307940|10124778|FG001|STARTED|Overall Study||87
9064449|NCT04307940|10124779|FG002|STARTED|Overall Study||44
9064450|NCT04307940|10124777|FG000|COMPLETED|Overall Study||85
9064451|NCT04307940|10124778|FG001|COMPLETED|Overall Study||84
9064452|NCT04307940|10124779|FG002|COMPLETED|Overall Study||42
9064453|NCT04307940|10124777|FG000|NOT COMPLETED|Overall Study||5
9064454|NCT04307940|10124778|FG001|NOT COMPLETED|Overall Study||3
9064455|NCT04307940|10124779|FG002|NOT COMPLETED|Overall Study||2
9064456|NCT04302545|10124789|FG000|STARTED|Overall Study||107
9064457|NCT04302545|10124790|FG001|STARTED|Overall Study||107
9064458|NCT04302545|10124789|FG000|COMPLETED|Overall Study||104
9064459|NCT04302545|10124790|FG001|COMPLETED|Overall Study||103
9064460|NCT04302545|10124789|FG000|NOT COMPLETED|Overall Study||3
9064461|NCT04302545|10124790|FG001|NOT COMPLETED|Overall Study||4
9064462|NCT04297631|10124807|FG000|STARTED|Overall Study||20
9064463|NCT04297631|10124807|FG000|COMPLETED|Overall Study||20
9064464|NCT04297631|10124807|FG000|NOT COMPLETED|Overall Study||0
9064465|NCT04297241|10124812|FG000|STARTED|Overall Study||20
9064466|NCT04297241|10124812|FG000|COMPLETED|Overall Study||15
9064467|NCT04297241|10124812|FG000|NOT COMPLETED|Overall Study||5
9064468|NCT04296448|10124828|FG000|STARTED|Overall Study||98
9064469|NCT04296448|10124829|FG001|STARTED|Overall Study||99
9064470|NCT04296448|10124828|FG000|COMPLETED|Overall Study||98
9064471|NCT04296448|10124829|FG001|COMPLETED|Overall Study||99
9064472|NCT04296448|10124828|FG000|NOT COMPLETED|Overall Study||0
9064473|NCT04296448|10124829|FG001|NOT COMPLETED|Overall Study||0
9064474|NCT04296227|10124835|FG000|STARTED|Overall Study||85
9064475|NCT04296227|10124835|FG000|COMPLETED|Overall Study||85
9064476|NCT04296227|10124835|FG000|NOT COMPLETED|Overall Study||0
9064477|NCT04295356|10124841|FG000|STARTED|Overall Study||93
9064478|NCT04295356|10124842|FG001|STARTED|Overall Study||87
9064479|NCT04295356|10124841|FG000|COMPLETED|Overall Study||92
9064480|NCT04295356|10124842|FG001|COMPLETED|Overall Study||83
9064481|NCT04295356|10124841|FG000|NOT COMPLETED|Overall Study||1
9064482|NCT04295356|10124842|FG001|NOT COMPLETED|Overall Study||4
9064483|NCT04292639|10124848|FG000|STARTED|Overall Study||20
9064484|NCT04292639|10124848|FG000|COMPLETED|Overall Study||20
9064485|NCT04292639|10124848|FG000|NOT COMPLETED|Overall Study||0
9064486|NCT04292535|10124866|FG000|STARTED|Overall Study||8
9064487|NCT04292535|10124867|FG001|STARTED|Overall Study||8
9064488|NCT04292535|10124868|FG002|STARTED|Overall Study||9
9064489|NCT04292535|10124869|FG003|STARTED|Overall Study||8
9064490|NCT04292535|10124870|FG004|STARTED|Overall Study||8
9064491|NCT04292535|10124871|FG005|STARTED|Overall Study||9
9064492|NCT04292535|10124872|FG006|STARTED|Overall Study||8
9064493|NCT04292535|10124873|FG007|STARTED|Overall Study||10
8616663|NCT00452452|9654799|FG001|Vaccinated Dose 2|Overall Study||112
8616664|NCT00452452|9654800|FG002|Vaccinated Dose 2|Overall Study||0
8616665|NCT00452452|9654798|FG000|Vaccinated Dose 3|Overall Study||89
8616666|NCT00452452|9654799|FG001|Vaccinated Dose 3|Overall Study||0
8616667|NCT00452452|9654800|FG002|Vaccinated Dose 3|Overall Study||0
8616668|NCT00452452|9654798|FG000|COMPLETED|Overall Study||88
8616669|NCT00452452|9654799|FG001|COMPLETED|Overall Study||112
8616670|NCT00452452|9654800|FG002|COMPLETED|Overall Study||152
8616671|NCT00452452|9654798|FG000|NOT COMPLETED|Overall Study||2
8616672|NCT00452452|9654799|FG001|NOT COMPLETED|Overall Study||0
8616673|NCT00452452|9654800|FG002|NOT COMPLETED|Overall Study||1
8616674|NCT00452530|9654816|FG000|STARTED|Overall Study|Randomized|1528
8616675|NCT00452530|9654817|FG001|STARTED|Overall Study|Randomized|1529
8616676|NCT00452530|9654816|FG000|Received Treatment|Overall Study||1501
8616677|NCT00452530|9654817|FG001|Received Treatment|Overall Study||1508
8716292|NCT00988208|9763416|FG001|Treated|Overall Study||525
8716293|NCT00988208|9763415|FG000|COMPLETED|Overall Study|DP Completed = kept on treatment with docetaxel/prednisone; Placebo was discontinued in DP arm|95
8716294|NCT00988208|9763416|FG001|COMPLETED|Overall Study|DPL Completed = kept on treatment with docetaxel/prednisone; Lenalidomide discontinued in DPL arm|95
8716295|NCT00988208|9763415|FG000|NOT COMPLETED|Overall Study||431
8716296|NCT00988208|9763416|FG001|NOT COMPLETED|Overall Study||438
8716297|NCT00988221|9763425|FG000|STARTED|Part I||35
8716298|NCT00988221|9763426|FG001|STARTED|Part I||34
8716299|NCT00988221|9763427|FG002|STARTED|Part I||119
8716300|NCT00988221|9763428|FG003|STARTED|Part I|No patients received placebo in Part I of this study.|0
8716301|NCT00988221|9763425|FG000|COMPLETED|Part I||31
8716302|NCT00988221|9763426|FG001|COMPLETED|Part I||24
8716303|NCT00988221|9763427|FG002|COMPLETED|Part I||111
8716304|NCT00988221|9763428|FG003|COMPLETED|Part I||0
8716305|NCT00988221|9763425|FG000|NOT COMPLETED|Part I||4
8716306|NCT00988221|9763426|FG001|NOT COMPLETED|Part I||10
8716307|NCT00988221|9763427|FG002|NOT COMPLETED|Part I||8
8716308|NCT00988221|9763428|FG003|NOT COMPLETED|Part I||0
8716309|NCT00988221|9763425|FG000|STARTED|Part II|Some of the patients in this group in Part I were randomized to receive placebo in Part II.|16
8716310|NCT00988221|9763426|FG001|STARTED|Part II|Some of the patients in this group in Part I were randomized to receive placebo in Part II.|11
8716311|NCT00988221|9763427|FG002|STARTED|Part II|Some of the patients in this group in Part I were randomized to receive placebo in Part II.|55
8716312|NCT00988221|9763428|FG003|STARTED|Part II||84
8716313|NCT00988221|9763425|FG000|COMPLETED|Part II||15
8716314|NCT00988221|9763426|FG001|COMPLETED|Part II||11
8716315|NCT00988221|9763427|FG002|COMPLETED|Part II|One participant who did not complete Part II was available to continue in the study and did.|52
8716316|NCT00988221|9763428|FG003|COMPLETED|Part II||81
8716317|NCT00988221|9763425|FG000|NOT COMPLETED|Part II||1
8716318|NCT00988221|9763426|FG001|NOT COMPLETED|Part II||0
8716319|NCT00988221|9763427|FG002|NOT COMPLETED|Part II||3
8716320|NCT00988221|9763428|FG003|NOT COMPLETED|Part II||3
8716321|NCT00988221|9763425|FG000|STARTED|Part III||30
8716322|NCT00988221|9763426|FG001|STARTED|Part III||24
8716323|NCT00988221|9763427|FG002|STARTED|Part III||106
8716324|NCT00988221|9763428|FG003|STARTED|Part III|No patients received placebo in Part III of this study.|0
8716325|NCT00988221|9763425|FG000|COMPLETED|Part III||29
8716326|NCT00988221|9763426|FG001|COMPLETED|Part III||23
8716327|NCT00988221|9763427|FG002|COMPLETED|Part III||103
8716328|NCT00988221|9763428|FG003|COMPLETED|Part III||0
8716329|NCT00988221|9763425|FG000|NOT COMPLETED|Part III||1
8716330|NCT00988221|9763426|FG001|NOT COMPLETED|Part III||1
8716331|NCT00988221|9763427|FG002|NOT COMPLETED|Part III||3
8716332|NCT00988221|9763428|FG003|NOT COMPLETED|Part III||0
8716333|NCT00988325|9763450|FG000|STARTED|Overall Study||40
8716334|NCT00988325|9763451|FG001|STARTED|Overall Study||20
8716335|NCT00988325|9763452|FG002|STARTED|Overall Study||5
8716336|NCT00988325|9763450|FG000|COMPLETED|Overall Study||40
8716337|NCT00988325|9763451|FG001|COMPLETED|Overall Study||20
8716338|NCT00988325|9763452|FG002|COMPLETED|Overall Study||5
8716339|NCT00988325|9763450|FG000|NOT COMPLETED|Overall Study||0
8716340|NCT00988325|9763451|FG001|NOT COMPLETED|Overall Study||0
8716341|NCT00988325|9763452|FG002|NOT COMPLETED|Overall Study||0
8716342|NCT00988351|9763466|FG000|STARTED|Overall Study||78
8716343|NCT00988351|9763467|FG001|STARTED|Overall Study||78
8716344|NCT00988351|9763466|FG000|CPAP Titration|Overall Study|8 declined CPAP treatment|78
8716345|NCT00988351|9763467|FG001|CPAP Titration|Overall Study|no titration needed|78
8716346|NCT00988351|9763466|FG000|PAP Setup|Overall Study|CPAP treatment started|70
8716347|NCT00988351|9763467|FG001|PAP Setup|Overall Study|APAP treatment started|78
8716348|NCT00988351|9763466|FG000|Clinic Visit|Overall Study|6 lost to follow-up or no show for clinic|64
8716349|NCT00988351|9763467|FG001|Clinic Visit|Overall Study|9 lost to follow-up or no show for clinic|69
8716350|NCT00988351|9763466|FG000|Using CPAP or APAP|Overall Study|5 not using CPAP (use < 1/2 hour per night)|59
8716351|NCT00988351|9763467|FG001|Using CPAP or APAP|Overall Study|3 not using APAP (less than 1/2 hour per night)|66
8716352|NCT00988351|9763466|FG000|COMPLETED|Overall Study||59
8716353|NCT00988351|9763467|FG001|COMPLETED|Overall Study||66
8716354|NCT00988351|9763466|FG000|NOT COMPLETED|Overall Study||19
8616678|NCT00452530|9654816|FG000|Evaluable Participants|Overall Study||907
8616679|NCT00452530|9654817|FG001|Evaluable Participants|Overall Study||921
8616680|NCT00452530|9654816|FG000|Primary Participants|Overall Study||976
8616681|NCT00452530|9654817|FG001|Primary Participants|Overall Study||997
8616682|NCT00452530|9654816|FG000|COMPLETED|Overall Study||1392
8616683|NCT00452530|9654817|FG001|COMPLETED|Overall Study||1393
8616684|NCT00452530|9654816|FG000|NOT COMPLETED|Overall Study||136
8716355|NCT00988351|9763467|FG001|NOT COMPLETED|Overall Study||12
8716356|NCT00988429|9763476|FG000|STARTED|Overall Study||226
8716357|NCT00988429|9763477|FG001|STARTED|Overall Study||216
8716358|NCT00988429|9763478|FG002|STARTED|Overall Study||211
8716359|NCT00988429|9763476|FG000|Safety Population|Overall Study||224
8716360|NCT00988429|9763477|FG001|Safety Population|Overall Study||216
8716361|NCT00988429|9763478|FG002|Safety Population|Overall Study||210
8716362|NCT00988429|9763476|FG000|Intention-to-treat (ITT) Population|Overall Study||220
8716363|NCT00988429|9763477|FG001|Intention-to-treat (ITT) Population|Overall Study||215
8716364|NCT00988429|9763478|FG002|Intention-to-treat (ITT) Population|Overall Study||205
8716365|NCT00988429|9763476|FG000|COMPLETED|Overall Study||189
8716366|NCT00988429|9763477|FG001|COMPLETED|Overall Study||173
8716367|NCT00988429|9763478|FG002|COMPLETED|Overall Study||142
8716368|NCT00988429|9763476|FG000|NOT COMPLETED|Overall Study||37
8716369|NCT00988429|9763477|FG001|NOT COMPLETED|Overall Study||43
8716370|NCT00988429|9763478|FG002|NOT COMPLETED|Overall Study||69
8716371|NCT00988442|9763489|FG000|STARTED|Overall Study||30
8716372|NCT00988442|9763490|FG001|STARTED|Overall Study||29
8716373|NCT00988442|9763489|FG000|COMPLETED|Overall Study||0
8616685|NCT00452530|9654817|FG001|NOT COMPLETED|Overall Study||136
8616686|NCT00452543|9654829|FG000|STARTED|Overall Study||12
8716374|NCT00988442|9763490|FG001|COMPLETED|Overall Study||1
8716375|NCT00988442|9763489|FG000|NOT COMPLETED|Overall Study||30
8716376|NCT00988442|9763490|FG001|NOT COMPLETED|Overall Study||28
8716377|NCT00988533|9763499|FG000|STARTED|Overall Study||30
8716378|NCT00988533|9763499|FG000|COMPLETED|Overall Study||27
8716379|NCT00988533|9763499|FG000|NOT COMPLETED|Overall Study||3
8716380|NCT00988559|9763507|FG000|STARTED|Overall Study||10
8716381|NCT00988559|9763508|FG001|STARTED|Overall Study||11
8716382|NCT00988559|9763509|FG002|STARTED|Overall Study||11
8716383|NCT00988559|9763510|FG003|STARTED|Overall Study||7
8716384|NCT00988559|9763507|FG000|COMPLETED|Overall Study||9
8716385|NCT00988559|9763508|FG001|COMPLETED|Overall Study||9
8716386|NCT00988559|9763509|FG002|COMPLETED|Overall Study||9
8716387|NCT00988559|9763510|FG003|COMPLETED|Overall Study||6
8716388|NCT00988559|9763507|FG000|NOT COMPLETED|Overall Study||1
8716389|NCT00988559|9763508|FG001|NOT COMPLETED|Overall Study||2
8716390|NCT00988559|9763509|FG002|NOT COMPLETED|Overall Study||2
8716391|NCT00988559|9763510|FG003|NOT COMPLETED|Overall Study||1
8716392|NCT00988598|9763522|FG000|STARTED|Overall Study||10
8716393|NCT00988598|9763523|FG001|STARTED|Overall Study||5
8716394|NCT00988598|9763522|FG000|COMPLETED|Overall Study||8
8716395|NCT00988598|9763523|FG001|COMPLETED|Overall Study||5
8716396|NCT00988598|9763522|FG000|NOT COMPLETED|Overall Study||2
8716397|NCT00988598|9763523|FG001|NOT COMPLETED|Overall Study||0
8724906|NCT01028937|9772217|FG000|NOT COMPLETED|Overall Study||0
8724907|NCT01029054|9772221|FG000|STARTED|Phase I||4
8724908|NCT01029054|9772222|FG001|STARTED|Phase I||13
8616687|NCT00452543|9654830|FG001|STARTED|Overall Study||11
8616688|NCT00452543|9654829|FG000|COMPLETED|Overall Study||7
8616689|NCT00452543|9654830|FG001|COMPLETED|Overall Study||5
8616690|NCT00452543|9654829|FG000|NOT COMPLETED|Overall Study||5
8616691|NCT00452543|9654830|FG001|NOT COMPLETED|Overall Study||6
8616692|NCT00452673|9654840|FG000|STARTED|Dose Escalation Period||7
8616693|NCT00452673|9654841|FG001|STARTED|Dose Escalation Period||9
8616694|NCT00452673|9654842|FG002|STARTED|Dose Escalation Period||6
8616695|NCT00452673|9654843|FG003|STARTED|Dose Escalation Period||9
8616696|NCT00452673|9654844|FG004|STARTED|Dose Escalation Period||0
8616697|NCT00452673|9654840|FG000|COMPLETED|Dose Escalation Period||0
8616698|NCT00452673|9654841|FG001|COMPLETED|Dose Escalation Period||0
8616699|NCT00452673|9654842|FG002|COMPLETED|Dose Escalation Period||0
8616700|NCT00452673|9654843|FG003|COMPLETED|Dose Escalation Period||0
8616701|NCT00452673|9654844|FG004|COMPLETED|Dose Escalation Period||0
8616702|NCT00452673|9654840|FG000|NOT COMPLETED|Dose Escalation Period||7
8616703|NCT00452673|9654841|FG001|NOT COMPLETED|Dose Escalation Period||9
8616704|NCT00452673|9654842|FG002|NOT COMPLETED|Dose Escalation Period||6
8616705|NCT00452673|9654843|FG003|NOT COMPLETED|Dose Escalation Period||9
8616706|NCT00452673|9654844|FG004|NOT COMPLETED|Dose Escalation Period||0
8616707|NCT00452673|9654840|FG000|STARTED|Dose Expansion Period||0
8616708|NCT00452673|9654841|FG001|STARTED|Dose Expansion Period||0
8616709|NCT00452673|9654842|FG002|STARTED|Dose Expansion Period||0
8616710|NCT00452673|9654843|FG003|STARTED|Dose Expansion Period||0
8616711|NCT00452673|9654844|FG004|STARTED|Dose Expansion Period|The last dose level arm in the escalation period was selected for the dose expansion period.|21
8616712|NCT00452673|9654840|FG000|COMPLETED|Dose Expansion Period||0
8616713|NCT00452673|9654841|FG001|COMPLETED|Dose Expansion Period||0
8616714|NCT00452673|9654842|FG002|COMPLETED|Dose Expansion Period||0
8616715|NCT00452673|9654843|FG003|COMPLETED|Dose Expansion Period||0
8616716|NCT00452673|9654844|FG004|COMPLETED|Dose Expansion Period||0
8616717|NCT00452673|9654840|FG000|NOT COMPLETED|Dose Expansion Period||0
8616718|NCT00452673|9654841|FG001|NOT COMPLETED|Dose Expansion Period||0
8616719|NCT00452673|9654842|FG002|NOT COMPLETED|Dose Expansion Period||0
8724909|NCT01029054|9772223|FG002|STARTED|Phase I||18
8724910|NCT01029054|9772221|FG000|COMPLETED|Phase I||4
8724911|NCT01029054|9772222|FG001|COMPLETED|Phase I||13
8724912|NCT01029054|9772223|FG002|COMPLETED|Phase I||18
8724913|NCT01029054|9772221|FG000|NOT COMPLETED|Phase I||0
8724914|NCT01029054|9772222|FG001|NOT COMPLETED|Phase I||0
8616720|NCT00452673|9654843|FG003|NOT COMPLETED|Dose Expansion Period||0
8616721|NCT00452673|9654844|FG004|NOT COMPLETED|Dose Expansion Period||21
8616722|NCT00452699|9654857|FG000|STARTED|Overall Study||306
8616723|NCT00452699|9654858|FG001|STARTED|Overall Study||315
8616724|NCT00452699|9654857|FG000|COMPLETED|Overall Study||225
8616725|NCT00452699|9654858|FG001|COMPLETED|Overall Study||242
8616726|NCT00452699|9654857|FG000|NOT COMPLETED|Overall Study||81
8616727|NCT00452699|9654858|FG001|NOT COMPLETED|Overall Study||73
8616728|NCT00452790|9654866|FG000|STARTED|Infant Series||354
8616729|NCT00452790|9654867|FG001|STARTED|Infant Series||355
8616730|NCT00452790|9654866|FG000|Vaccinated Dose 1|Infant Series||353
8616731|NCT00452790|9654867|FG001|Vaccinated Dose 1|Infant Series||353
8616732|NCT00452790|9654866|FG000|Vaccinated Dose 2|Infant Series||300
8616733|NCT00452790|9654867|FG001|Vaccinated Dose 2|Infant Series||300
8616734|NCT00452790|9654866|FG000|Vaccinated Dose 3|Infant Series||221
8616735|NCT00452790|9654867|FG001|Vaccinated Dose 3|Infant Series||218
8616736|NCT00452790|9654866|FG000|COMPLETED|Infant Series||219
8616737|NCT00452790|9654867|FG001|COMPLETED|Infant Series||214
8616738|NCT00452790|9654866|FG000|NOT COMPLETED|Infant Series||135
8616739|NCT00452790|9654867|FG001|NOT COMPLETED|Infant Series||141
8616740|NCT00452790|9654866|FG000|STARTED|After Infant Series||219
8616741|NCT00452790|9654867|FG001|STARTED|After Infant Series||214
8616742|NCT00452790|9654866|FG000|COMPLETED|After Infant Series||198
8616743|NCT00452790|9654867|FG001|COMPLETED|After Infant Series||200
8616744|NCT00452790|9654866|FG000|NOT COMPLETED|After Infant Series||21
8616745|NCT00452790|9654867|FG001|NOT COMPLETED|After Infant Series||14
8616746|NCT00452790|9654866|FG000|STARTED|Toddler Dose||198
8616747|NCT00452790|9654867|FG001|STARTED|Toddler Dose||200
8616748|NCT00452790|9654866|FG000|COMPLETED|Toddler Dose||198
8616749|NCT00452790|9654867|FG001|COMPLETED|Toddler Dose||198
8616750|NCT00452790|9654866|FG000|NOT COMPLETED|Toddler Dose||0
8616751|NCT00452790|9654867|FG001|NOT COMPLETED|Toddler Dose||2
8616752|NCT00452868|9654877|FG000|STARTED|Overall Study||13
8616753|NCT00452868|9654877|FG000|COMPLETED|Overall Study||11
8616754|NCT00452868|9654877|FG000|NOT COMPLETED|Overall Study||2
8616755|NCT00453102|9654881|FG000|STARTED|Overall Study||18
8616756|NCT00453102|9654881|FG000|COMPLETED|Overall Study||16
8616757|NCT00453102|9654881|FG000|NOT COMPLETED|Overall Study||2
8616758|NCT00453154|9654888|FG000|STARTED|Combination Chemotherapy||12
8616759|NCT00453154|9654889|FG001|STARTED|Combination Chemotherapy||144
8616760|NCT00453154|9654890|FG002|STARTED|Combination Chemotherapy||0
8616761|NCT00453154|9654891|FG003|STARTED|Combination Chemotherapy||0
8616762|NCT00453154|9654888|FG000|COMPLETED|Combination Chemotherapy||12
8616763|NCT00453154|9654889|FG001|COMPLETED|Combination Chemotherapy||95
8616764|NCT00453154|9654890|FG002|COMPLETED|Combination Chemotherapy||0
8616765|NCT00453154|9654891|FG003|COMPLETED|Combination Chemotherapy||0
8616766|NCT00453154|9654888|FG000|NOT COMPLETED|Combination Chemotherapy||0
8616767|NCT00453154|9654889|FG001|NOT COMPLETED|Combination Chemotherapy||49
8616768|NCT00453154|9654890|FG002|NOT COMPLETED|Combination Chemotherapy||0
8616769|NCT00453154|9654891|FG003|NOT COMPLETED|Combination Chemotherapy||0
8616770|NCT00453154|9654888|FG000|STARTED|Double BIind Maintenance||0
8716398|NCT00988637|9763531|FG000|STARTED|Overall Study||70
8716399|NCT00988637|9763532|FG001|STARTED|Overall Study||68
8716400|NCT00988637|9763531|FG000|COMPLETED|Overall Study||67
8716401|NCT00988637|9763532|FG001|COMPLETED|Overall Study||65
8716402|NCT00988637|9763531|FG000|NOT COMPLETED|Overall Study||3
8716403|NCT00988637|9763532|FG001|NOT COMPLETED|Overall Study||3
8716404|NCT00988832|9763538|FG000|STARTED|Overall Study||380
8716405|NCT00988832|9763538|FG000|COMPLETED|Overall Study||380
8716406|NCT00988832|9763538|FG000|NOT COMPLETED|Overall Study||0
8716407|NCT00988858|9763545|FG000|STARTED|Overall Study||55
8716408|NCT00988858|9763545|FG000|COMPLETED|Overall Study||45
8716409|NCT00988858|9763545|FG000|NOT COMPLETED|Overall Study||10
8716410|NCT00988884|9763551|FG000|STARTED|Overall Study||621
8716411|NCT00988884|9763552|FG001|STARTED|Overall Study||620
8716412|NCT00988884|9763551|FG000|COMPLETED|Overall Study||586
8716413|NCT00988884|9763552|FG001|COMPLETED|Overall Study||584
8716414|NCT00988884|9763551|FG000|NOT COMPLETED|Overall Study||35
8716415|NCT00988884|9763552|FG001|NOT COMPLETED|Overall Study||36
8716416|NCT00989014|9763562|FG000|STARTED|Overall Study||31
8716417|NCT00989014|9763563|FG001|STARTED|Overall Study||31
8716418|NCT00989014|9763564|FG002|STARTED|Overall Study||28
8716419|NCT00989014|9763565|FG003|STARTED|Overall Study||32
8716420|NCT00989014|9763562|FG000|COMPLETED|Overall Study||31
8716421|NCT00989014|9763563|FG001|COMPLETED|Overall Study||31
8716422|NCT00989014|9763564|FG002|COMPLETED|Overall Study||28
8716423|NCT00989014|9763565|FG003|COMPLETED|Overall Study||32
8716424|NCT00989014|9763562|FG000|NOT COMPLETED|Overall Study||0
8716425|NCT00989014|9763563|FG001|NOT COMPLETED|Overall Study||0
8716426|NCT00989014|9763564|FG002|NOT COMPLETED|Overall Study||0
8716427|NCT00989014|9763565|FG003|NOT COMPLETED|Overall Study||0
8716428|NCT00989092|9763577|FG000|STARTED|Overall Study||228
8716429|NCT00989092|9763578|FG001|STARTED|Overall Study||59
8716430|NCT00989092|9763577|FG000|Treated With Darbepoetin Alfa|Overall Study||226
8716431|NCT00989092|9763578|FG001|Treated With Darbepoetin Alfa|Overall Study||33
8716432|NCT00989092|9763577|FG000|COMPLETED|Overall Study||138
8716433|NCT00989092|9763578|FG001|COMPLETED|Overall Study||31
8716434|NCT00989092|9763577|FG000|NOT COMPLETED|Overall Study||90
8616771|NCT00453154|9654889|FG001|STARTED|Double BIind Maintenance||0
8616772|NCT00453154|9654890|FG002|STARTED|Double BIind Maintenance||46
8616773|NCT00453154|9654891|FG003|STARTED|Double BIind Maintenance||49
8616774|NCT00453154|9654888|FG000|COMPLETED|Double BIind Maintenance||0
8616775|NCT00453154|9654889|FG001|COMPLETED|Double BIind Maintenance||0
8616776|NCT00453154|9654890|FG002|COMPLETED|Double BIind Maintenance||0
8616777|NCT00453154|9654891|FG003|COMPLETED|Double BIind Maintenance||0
8616778|NCT00453154|9654888|FG000|NOT COMPLETED|Double BIind Maintenance||0
8616779|NCT00453154|9654889|FG001|NOT COMPLETED|Double BIind Maintenance||0
8616780|NCT00453154|9654890|FG002|NOT COMPLETED|Double BIind Maintenance||46
8616781|NCT00453154|9654891|FG003|NOT COMPLETED|Double BIind Maintenance||49
8616782|NCT00453154|9654888|FG000|STARTED|Open Label Sunitinib Crossover||0
8616783|NCT00453154|9654889|FG001|STARTED|Open Label Sunitinib Crossover||0
8616784|NCT00453154|9654890|FG002|STARTED|Open Label Sunitinib Crossover||18
8616785|NCT00453154|9654891|FG003|STARTED|Open Label Sunitinib Crossover||0
8616786|NCT00453154|9654888|FG000|COMPLETED|Open Label Sunitinib Crossover||0
8616787|NCT00453154|9654889|FG001|COMPLETED|Open Label Sunitinib Crossover||0
8616788|NCT00453154|9654890|FG002|COMPLETED|Open Label Sunitinib Crossover||18
8616789|NCT00453154|9654891|FG003|COMPLETED|Open Label Sunitinib Crossover||0
8616790|NCT00453154|9654888|FG000|NOT COMPLETED|Open Label Sunitinib Crossover||0
8616791|NCT00453154|9654889|FG001|NOT COMPLETED|Open Label Sunitinib Crossover||0
8616792|NCT00453154|9654890|FG002|NOT COMPLETED|Open Label Sunitinib Crossover||0
8616793|NCT00453154|9654891|FG003|NOT COMPLETED|Open Label Sunitinib Crossover||0
8616794|NCT00453180|9654902|FG000|STARTED|Overall Study||16
8616795|NCT00453180|9654903|FG001|STARTED|Overall Study||15
8616796|NCT00453180|9654902|FG000|COMPLETED|Overall Study||13
8616797|NCT00453180|9654903|FG001|COMPLETED|Overall Study||12
8616798|NCT00453180|9654902|FG000|NOT COMPLETED|Overall Study||3
8616799|NCT00453180|9654903|FG001|NOT COMPLETED|Overall Study||3
8616800|NCT00453193|9654909|FG000|STARTED|Overall Study||24
8616801|NCT00453193|9654909|FG000|COMPLETED|Overall Study||24
8616802|NCT00453193|9654909|FG000|NOT COMPLETED|Overall Study||0
8616803|NCT00453206|9654913|FG000|STARTED|Overall Study||66
8616804|NCT00453206|9654913|FG000|COMPLETED|Overall Study||65
8616805|NCT00453206|9654913|FG000|NOT COMPLETED|Overall Study||1
8616806|NCT00453310|9654917|FG000|STARTED|Overall Study||10
8616807|NCT00453310|9654917|FG000|COMPLETED|Overall Study||0
8616808|NCT00453310|9654917|FG000|NOT COMPLETED|Overall Study||10
8616809|NCT00453336|9654921|FG000|STARTED|Overall Study||45
8616810|NCT00453336|9654921|FG000|COMPLETED|Overall Study||45
8616811|NCT00453336|9654921|FG000|NOT COMPLETED|Overall Study||0
8616812|NCT00453349|9654927|FG000|STARTED|Randomized||228
8616813|NCT00453349|9654928|FG001|STARTED|Randomized||232
8616814|NCT00453349|9654927|FG000|COMPLETED|Randomized||203
8616815|NCT00453349|9654928|FG001|COMPLETED|Randomized||209
8716435|NCT00989092|9763578|FG001|NOT COMPLETED|Overall Study||28
8716436|NCT00989157|9763587|FG000|STARTED|Overall Study||10
8716437|NCT00989157|9763588|FG001|STARTED|Overall Study||10
8716438|NCT00989157|9763587|FG000|COMPLETED|Overall Study||10
8716439|NCT00989157|9763588|FG001|COMPLETED|Overall Study||10
8716440|NCT00989157|9763587|FG000|NOT COMPLETED|Overall Study||0
8716441|NCT00989157|9763588|FG001|NOT COMPLETED|Overall Study||0
8716442|NCT00989196|9763596|FG000|STARTED|PK Crossover Period||10
8716443|NCT00989196|9763597|FG001|STARTED|PK Crossover Period||12
8716444|NCT00989196|9763596|FG000|COMPLETED|PK Crossover Period||10
8716445|NCT00989196|9763597|FG001|COMPLETED|PK Crossover Period||12
8716446|NCT00989196|9763596|FG000|NOT COMPLETED|PK Crossover Period||0
8716447|NCT00989196|9763597|FG001|NOT COMPLETED|PK Crossover Period||0
8716448|NCT00989196|9763596|FG000|STARTED|Treatment Period||10
8716449|NCT00989196|9763597|FG001|STARTED|Treatment Period||12
8716450|NCT00989196|9763596|FG000|COMPLETED|Treatment Period||9
8716451|NCT00989196|9763597|FG001|COMPLETED|Treatment Period||12
8716452|NCT00989196|9763596|FG000|NOT COMPLETED|Treatment Period||1
8716453|NCT00989196|9763597|FG001|NOT COMPLETED|Treatment Period||0
8716454|NCT00989235|9763605|FG000|STARTED|Overall Study||58
8716455|NCT00989235|9763606|FG001|STARTED|Overall Study||50
8716456|NCT00989235|9763605|FG000|Number Rescued to Open-Label Treatment|Overall Study||4
8716457|NCT00989235|9763606|FG001|Number Rescued to Open-Label Treatment|Overall Study|Of these, 1 was discontinued from open-label treatment (lost to follow-up).|4
8716458|NCT00989235|9763605|FG000|Number Completing Double-Blind Treatment|Overall Study||51
8716459|NCT00989235|9763606|FG001|Number Completing Double-Blind Treatment|Overall Study||41
8716460|NCT00989235|9763605|FG000|COMPLETED|Overall Study||55
8716461|NCT00989235|9763606|FG001|COMPLETED|Overall Study||44
8716462|NCT00989235|9763605|FG000|NOT COMPLETED|Overall Study||3
8716463|NCT00989235|9763606|FG001|NOT COMPLETED|Overall Study||6
8716464|NCT00989261|9763617|FG000|STARTED|Overall Study||157
8616816|NCT00453349|9654927|FG000|NOT COMPLETED|Randomized||25
8716465|NCT00989261|9763618|FG001|STARTED|Overall Study||176
8716466|NCT00989261|9763617|FG000|COMPLETED|Overall Study||142
8716467|NCT00989261|9763618|FG001|COMPLETED|Overall Study||154
8716468|NCT00989261|9763617|FG000|NOT COMPLETED|Overall Study||15
8716469|NCT00989261|9763618|FG001|NOT COMPLETED|Overall Study||22
8616817|NCT00453349|9654928|FG001|NOT COMPLETED|Randomized||23
8616818|NCT00453349|9654927|FG000|STARTED|Reaching of Primary Endpoint (TOC)|Subjects who attended the TOC visit or at least had a clinical evaluation at TOC|225
8629360|NCT00529555|9669089|FG001|STARTED|Overall Study||202
8716470|NCT00989287|9763626|FG000|STARTED|Overall Study||65
8716471|NCT00989287|9763627|FG001|STARTED|Overall Study||66
8716472|NCT00989287|9763626|FG000|COMPLETED|Overall Study||64
8716473|NCT00989287|9763627|FG001|COMPLETED|Overall Study||65
8616819|NCT00453349|9654928|FG001|STARTED|Reaching of Primary Endpoint (TOC)|i.e. the ITT population|230
8616820|NCT00453349|9654927|FG000|Valid for Primary Efficacy Analysis|Reaching of Primary Endpoint (TOC)||194
8616821|NCT00453349|9654928|FG001|Valid for Primary Efficacy Analysis|Reaching of Primary Endpoint (TOC)||190
8616822|NCT00453349|9654927|FG000|COMPLETED|Reaching of Primary Endpoint (TOC)|All PP patients and ITT patients with a clinical response with no missing information|215
8616823|NCT00453349|9654928|FG001|COMPLETED|Reaching of Primary Endpoint (TOC)||219
8616824|NCT00453349|9654927|FG000|NOT COMPLETED|Reaching of Primary Endpoint (TOC)||10
8616825|NCT00453349|9654928|FG001|NOT COMPLETED|Reaching of Primary Endpoint (TOC)||11
8616826|NCT00453349|9654927|FG000|STARTED|Completed Study||228
8716474|NCT00989287|9763626|FG000|NOT COMPLETED|Overall Study||1
8716475|NCT00989287|9763627|FG001|NOT COMPLETED|Overall Study||1
8716476|NCT00989573|9763649|FG000|STARTED|Overall Study||65
8716477|NCT00989573|9763650|FG001|STARTED|Overall Study||63
8716478|NCT00989573|9763651|FG002|STARTED|Overall Study||63
8716479|NCT00989573|9763649|FG000|COMPLETED|Overall Study||52
8716480|NCT00989573|9763650|FG001|COMPLETED|Overall Study||41
8716481|NCT00989573|9763651|FG002|COMPLETED|Overall Study||55
8716482|NCT00989573|9763649|FG000|NOT COMPLETED|Overall Study||13
8716483|NCT00989573|9763650|FG001|NOT COMPLETED|Overall Study||22
8716484|NCT00989573|9763651|FG002|NOT COMPLETED|Overall Study||8
8716485|NCT00989586|9763661|FG000|STARTED|Overall Study||18
8716486|NCT00989586|9763662|FG001|STARTED|Overall Study||17
8716487|NCT00989586|9763661|FG000|COMPLETED|Overall Study||18
8716488|NCT00989586|9763662|FG001|COMPLETED|Overall Study||17
8716489|NCT00989586|9763661|FG000|NOT COMPLETED|Overall Study||0
8716490|NCT00989586|9763662|FG001|NOT COMPLETED|Overall Study||0
8716491|NCT00989612|9763669|FG000|STARTED|Overall Study||100
8716492|NCT00989612|9763669|FG000|COMPLETED|Overall Study||100
8716493|NCT00989612|9763669|FG000|NOT COMPLETED|Overall Study||0
8716494|NCT00989664|9763675|FG000|STARTED|Dosimetric and Therapeutic Treatment||61
8716495|NCT00989664|9763675|FG000|COMPLETED|Dosimetric and Therapeutic Treatment||0
8716496|NCT00989664|9763675|FG000|NOT COMPLETED|Dosimetric and Therapeutic Treatment||61
8716497|NCT00989664|9763675|FG000|STARTED|Long-Term Follow-Up|14 of the 61 participants withdrawing from Study BEX104504 enrolled in the LTFU study.|14
8716498|NCT00989664|9763675|FG000|COMPLETED|Long-Term Follow-Up||11
8716499|NCT00989664|9763675|FG000|NOT COMPLETED|Long-Term Follow-Up||3
8716500|NCT00989768|9763681|FG000|STARTED|Overall Study|All patients received both treatments. They are their own controls|29
8716501|NCT00989768|9763681|FG000|COMPLETED|Overall Study||28
8716502|NCT00989768|9763681|FG000|NOT COMPLETED|Overall Study||1
8716503|NCT00989781|9763691|FG000|STARTED|Ovarian Response to hCG||21
8716504|NCT00989781|9763692|FG001|STARTED|Ovarian Response to hCG||20
8716505|NCT00989781|9763691|FG000|COMPLETED|Ovarian Response to hCG||18
8716506|NCT00989781|9763692|FG001|COMPLETED|Ovarian Response to hCG||18
8716507|NCT00989781|9763691|FG000|NOT COMPLETED|Ovarian Response to hCG||3
8716508|NCT00989781|9763692|FG001|NOT COMPLETED|Ovarian Response to hCG||2
8716509|NCT00989781|9763691|FG000|STARTED|Adrenal Response ot ACTH|15 subjects that completed part 1 elected to participate in Part 2|18
8716510|NCT00989781|9763692|FG001|STARTED|Adrenal Response ot ACTH|15 subjects that completed part 1 elected to participate in Part 2|18
8716511|NCT00989781|9763691|FG000|COMPLETED|Adrenal Response ot ACTH|Of 18 eligible, 15 consented. 2 dropped out and 13 completed study|13
8716512|NCT00989781|9763692|FG001|COMPLETED|Adrenal Response ot ACTH|Of 18 eligible, 15 consented and completed study|15
8716513|NCT00989781|9763691|FG000|NOT COMPLETED|Adrenal Response ot ACTH||5
8716514|NCT00989781|9763692|FG001|NOT COMPLETED|Adrenal Response ot ACTH||3
8716515|NCT00989833|9763702|FG000|STARTED|Overall Study||21
8716516|NCT00989833|9763703|FG001|STARTED|Overall Study||22
8716517|NCT00989833|9763704|FG002|STARTED|Overall Study||23
8716518|NCT00989833|9763702|FG000|COMPLETED|Overall Study||19
8716519|NCT00989833|9763703|FG001|COMPLETED|Overall Study||19
8716520|NCT00989833|9763704|FG002|COMPLETED|Overall Study||21
8716521|NCT00989833|9763702|FG000|NOT COMPLETED|Overall Study||2
8716522|NCT00989833|9763703|FG001|NOT COMPLETED|Overall Study||3
8716523|NCT00989833|9763704|FG002|NOT COMPLETED|Overall Study||2
8716524|NCT00989911|9763712|FG000|STARTED|Overall Study||10
8716525|NCT00989911|9763712|FG000|COMPLETED|Overall Study||7
8716526|NCT00989911|9763712|FG000|NOT COMPLETED|Overall Study||3
8716527|NCT00989950|9763720|FG000|STARTED|Open Label Dose Optimization||6
8716528|NCT00989950|9763721|FG001|STARTED|Open Label Dose Optimization||9
8716529|NCT00989950|9763722|FG002|STARTED|Open Label Dose Optimization||4
8716530|NCT00989950|9763723|FG003|STARTED|Open Label Dose Optimization||7
8716531|NCT00989950|9763720|FG000|COMPLETED|Open Label Dose Optimization||6
8716532|NCT00989950|9763721|FG001|COMPLETED|Open Label Dose Optimization||9
8716533|NCT00989950|9763722|FG002|COMPLETED|Open Label Dose Optimization||4
8716534|NCT00989950|9763723|FG003|COMPLETED|Open Label Dose Optimization||7
8716535|NCT00989950|9763720|FG000|NOT COMPLETED|Open Label Dose Optimization||0
8716536|NCT00989950|9763721|FG001|NOT COMPLETED|Open Label Dose Optimization||0
8716537|NCT00989950|9763722|FG002|NOT COMPLETED|Open Label Dose Optimization||0
8716538|NCT00989950|9763723|FG003|NOT COMPLETED|Open Label Dose Optimization||0
8716539|NCT00989950|9763720|FG000|STARTED|Randomized Phase||6
8716540|NCT00989950|9763721|FG001|STARTED|Randomized Phase||9
8716541|NCT00989950|9763722|FG002|STARTED|Randomized Phase||4
8716542|NCT00989950|9763723|FG003|STARTED|Randomized Phase||7
8716543|NCT00989950|9763720|FG000|COMPLETED|Randomized Phase||5
8716544|NCT00989950|9763721|FG001|COMPLETED|Randomized Phase||8
8716545|NCT00989950|9763722|FG002|COMPLETED|Randomized Phase||4
8616827|NCT00453349|9654928|FG001|STARTED|Completed Study||232
8616828|NCT00453349|9654927|FG000|Completed Study Treatment|Completed Study|25 terminated prematurely|203
8616829|NCT00453349|9654928|FG001|Completed Study Treatment|Completed Study|23 terminated prematurely|209
8616830|NCT00453349|9654927|FG000|COMPLETED|Completed Study|had follow-up assessment or alternative antibiotic assessment|201
8716546|NCT00989950|9763723|FG003|COMPLETED|Randomized Phase||7
8716547|NCT00989950|9763720|FG000|NOT COMPLETED|Randomized Phase||1
8716548|NCT00989950|9763721|FG001|NOT COMPLETED|Randomized Phase||1
8716549|NCT00989950|9763722|FG002|NOT COMPLETED|Randomized Phase||0
8716550|NCT00989950|9763723|FG003|NOT COMPLETED|Randomized Phase||0
8716551|NCT00989963|9763736|FG000|STARTED|Overall Study||12
8716552|NCT00989963|9763737|FG001|STARTED|Overall Study||12
8716553|NCT00989963|9763738|FG002|STARTED|Overall Study||12
8716554|NCT00989963|9763736|FG000|Safety Population|Overall Study|1 participant randomized to MTD received FD 60 ug; was included in FD 60 ug arm for this population|13
8716555|NCT00989963|9763737|FG001|Safety Population|Overall Study||12
8716556|NCT00989963|9763738|FG002|Safety Population|Overall Study|1 participant randomized to MTD received FD 60 ug; was included in FD 60 ug arm for this population|11
8716557|NCT00989963|9763736|FG000|Per-Protocol Population|Overall Study|1 participant randomized to MTD received FD 60 ug; was included in FD 60 ug arm for this population|12
8716558|NCT00989963|9763737|FG001|Per-Protocol Population|Overall Study||11
8716559|NCT00989963|9763738|FG002|Per-Protocol Population|Overall Study|1 participant randomized to MTD received FD 60 ug; was included in FD 60 ug arm for this population|10
8716560|NCT00989963|9763736|FG000|COMPLETED|Overall Study||11
8716561|NCT00989963|9763737|FG001|COMPLETED|Overall Study||11
8716562|NCT00989963|9763738|FG002|COMPLETED|Overall Study||11
8716563|NCT00989963|9763736|FG000|NOT COMPLETED|Overall Study||1
8716564|NCT00989963|9763737|FG001|NOT COMPLETED|Overall Study||1
8716565|NCT00989963|9763738|FG002|NOT COMPLETED|Overall Study||1
8716566|NCT00989989|9763749|FG000|STARTED|Overall Study||132
8716567|NCT00989989|9763750|FG001|STARTED|Overall Study||133
8716568|NCT00989989|9763751|FG002|STARTED|Overall Study||131
8716569|NCT00989989|9763749|FG000|COMPLETED|Overall Study||114
8716570|NCT00989989|9763750|FG001|COMPLETED|Overall Study||123
8716571|NCT00989989|9763751|FG002|COMPLETED|Overall Study||108
8716572|NCT00989989|9763749|FG000|NOT COMPLETED|Overall Study||18
8716573|NCT00989989|9763750|FG001|NOT COMPLETED|Overall Study||10
8716574|NCT00989989|9763751|FG002|NOT COMPLETED|Overall Study||23
8716575|NCT00990093|9763759|FG000|STARTED|Test Period 1 (1-14 Days)||19
8716576|NCT00990093|9763760|FG001|STARTED|Test Period 1 (1-14 Days)||17
8716577|NCT00990093|9763759|FG000|COMPLETED|Test Period 1 (1-14 Days)||15
8716578|NCT00990093|9763760|FG001|COMPLETED|Test Period 1 (1-14 Days)||15
8616831|NCT00453349|9654928|FG001|COMPLETED|Completed Study|had follow-up assessment or alternative antibiotic assessment|198
8616832|NCT00453349|9654927|FG000|NOT COMPLETED|Completed Study||27
8616833|NCT00453349|9654928|FG001|NOT COMPLETED|Completed Study||34
8616834|NCT00453362|9654934|FG000|STARTED|Overall Study|14 participants consented but did not receive drug and are not represented in the baseline data|88
8616835|NCT00453362|9654934|FG000|Treated With Erlotinib|Overall Study||74
8616836|NCT00453362|9654934|FG000|FDG-PET Evaluable|Overall Study|Participants who completed all FDG-PET scans through day 56.|51
8616837|NCT00453362|9654934|FG000|FLT-PET Evaluable|Overall Study|Participants who completed all FLT-PET scans through day 56.|50
8616838|NCT00453362|9654934|FG000|COMPLETED|Overall Study||1
8616839|NCT00453362|9654934|FG000|NOT COMPLETED|Overall Study||87
8616840|NCT00453388|9654954|FG000|STARTED|Overall Study||0
8616841|NCT00453388|9654955|FG001|STARTED|Overall Study||5
8616842|NCT00453388|9654956|FG002|STARTED|Overall Study||1
8616843|NCT00453388|9654957|FG003|STARTED|Overall Study||0
8616844|NCT00453388|9654954|FG000|COMPLETED|Overall Study||0
8616845|NCT00453388|9654955|FG001|COMPLETED|Overall Study||5
8616846|NCT00453388|9654956|FG002|COMPLETED|Overall Study||1
8616847|NCT00453388|9654957|FG003|COMPLETED|Overall Study||0
8616848|NCT00453388|9654954|FG000|NOT COMPLETED|Overall Study||0
8616849|NCT00453388|9654955|FG001|NOT COMPLETED|Overall Study||0
8616850|NCT00453388|9654956|FG002|NOT COMPLETED|Overall Study||0
8616851|NCT00453388|9654957|FG003|NOT COMPLETED|Overall Study||0
8616852|NCT00453479|9654970|FG000|STARTED|Overall Study||6
8616853|NCT00453479|9654971|FG001|STARTED|Overall Study||9
8616854|NCT00453479|9654972|FG002|STARTED|Overall Study||8
8616855|NCT00453479|9654970|FG000|COMPLETED|Overall Study||6
8616856|NCT00453479|9654971|FG001|COMPLETED|Overall Study||9
8616857|NCT00453479|9654972|FG002|COMPLETED|Overall Study||8
8616858|NCT00453479|9654970|FG000|NOT COMPLETED|Overall Study||0
8616859|NCT00453479|9654971|FG001|NOT COMPLETED|Overall Study||0
8616860|NCT00453479|9654972|FG002|NOT COMPLETED|Overall Study||0
8616861|NCT00453895|9654982|FG000|STARTED|Overall Study||39
8616862|NCT00453895|9654982|FG000|COMPLETED|Overall Study||39
8616863|NCT00453895|9654982|FG000|NOT COMPLETED|Overall Study||0
8616864|NCT00453921|9654990|FG000|STARTED|Overall Study||19
8616865|NCT00453921|9654991|FG001|STARTED|Overall Study||18
8616866|NCT00453921|9654992|FG002|STARTED|Overall Study||20
8616867|NCT00453921|9654993|FG003|STARTED|Overall Study||19
8616868|NCT00453921|9654990|FG000|COMPLETED|Overall Study||18
8616869|NCT00453921|9654991|FG001|COMPLETED|Overall Study||17
8616870|NCT00453921|9654992|FG002|COMPLETED|Overall Study||18
8616871|NCT00453921|9654993|FG003|COMPLETED|Overall Study||18
8716579|NCT00990093|9763759|FG000|NOT COMPLETED|Test Period 1 (1-14 Days)||4
8716580|NCT00990093|9763760|FG001|NOT COMPLETED|Test Period 1 (1-14 Days)||2
8716581|NCT00990093|9763759|FG000|STARTED|Test Period 2 (15-28 Days)||15
8616872|NCT00453921|9654990|FG000|NOT COMPLETED|Overall Study||1
8716582|NCT00990093|9763760|FG001|STARTED|Test Period 2 (15-28 Days)||15
8716583|NCT00990093|9763759|FG000|COMPLETED|Test Period 2 (15-28 Days)||13
8716584|NCT00990093|9763760|FG001|COMPLETED|Test Period 2 (15-28 Days)||14
8716585|NCT00990093|9763759|FG000|NOT COMPLETED|Test Period 2 (15-28 Days)||2
8716586|NCT00990093|9763760|FG001|NOT COMPLETED|Test Period 2 (15-28 Days)||1
8716587|NCT00990106|9763768|FG000|STARTED|Overall Study||32
8716588|NCT00990106|9763769|FG001|STARTED|Overall Study||35
8716589|NCT00990106|9763768|FG000|COMPLETED|Overall Study||23
8716590|NCT00990106|9763769|FG001|COMPLETED|Overall Study||23
8716591|NCT00990106|9763768|FG000|NOT COMPLETED|Overall Study||9
8716592|NCT00990106|9763769|FG001|NOT COMPLETED|Overall Study||12
8716593|NCT00990184|9763775|FG000|STARTED|Overall Study||21
8716594|NCT00990184|9763775|FG000|COMPLETED|Overall Study||20
8716595|NCT00990184|9763775|FG000|NOT COMPLETED|Overall Study||1
8716596|NCT00990236|9763783|FG000|STARTED|Overall Study||89
8716597|NCT00990236|9763784|FG001|STARTED|Overall Study||96
8716598|NCT00990236|9763783|FG000|COMPLETED|Overall Study||89
8716599|NCT00990236|9763784|FG001|COMPLETED|Overall Study||96
8716600|NCT00990236|9763783|FG000|NOT COMPLETED|Overall Study||0
8716601|NCT00990236|9763784|FG001|NOT COMPLETED|Overall Study||0
8716602|NCT00990249|9763790|FG000|STARTED|Overall Study||120
8716603|NCT00990249|9763790|FG000|COMPLETED|Overall Study||107
8716604|NCT00990249|9763790|FG000|NOT COMPLETED|Overall Study||13
8716605|NCT00990288|9763796|FG000|STARTED|Overall Study||97
8716606|NCT00990288|9763797|FG001|STARTED|Overall Study||99
8716607|NCT00990288|9763796|FG000|COMPLETED|Overall Study||97
8716608|NCT00990288|9763797|FG001|COMPLETED|Overall Study||99
8716609|NCT00990288|9763796|FG000|NOT COMPLETED|Overall Study||0
8716610|NCT00990288|9763797|FG001|NOT COMPLETED|Overall Study||0
8716611|NCT00990314|9763803|FG000|STARTED|Overall Study||31
8716612|NCT00990314|9763803|FG000|COMPLETED|Overall Study||19
8716613|NCT00990314|9763803|FG000|NOT COMPLETED|Overall Study||12
8716614|NCT00990340|9763809|FG000|STARTED|First 14-day Treatment||27
8716615|NCT00990340|9763810|FG001|STARTED|First 14-day Treatment||25
8716616|NCT00990340|9763809|FG000|COMPLETED|First 14-day Treatment||21
8716617|NCT00990340|9763810|FG001|COMPLETED|First 14-day Treatment||21
8716618|NCT00990340|9763809|FG000|NOT COMPLETED|First 14-day Treatment||6
8716619|NCT00990340|9763810|FG001|NOT COMPLETED|First 14-day Treatment||4
8716620|NCT00990340|9763809|FG000|STARTED|Second 14-day Treatment||21
8716621|NCT00990340|9763810|FG001|STARTED|Second 14-day Treatment||21
8716622|NCT00990340|9763809|FG000|COMPLETED|Second 14-day Treatment||21
8716623|NCT00990340|9763810|FG001|COMPLETED|Second 14-day Treatment||21
8716624|NCT00990340|9763809|FG000|NOT COMPLETED|Second 14-day Treatment||0
8716625|NCT00990340|9763810|FG001|NOT COMPLETED|Second 14-day Treatment||0
8716626|NCT00990509|9763820|FG000|STARTED|Overall Study||5
8716627|NCT00990509|9763821|FG001|STARTED|Overall Study||9
8716628|NCT00990509|9763820|FG000|COMPLETED|Overall Study||5
8716629|NCT00990509|9763821|FG001|COMPLETED|Overall Study||8
8716630|NCT00990509|9763820|FG000|NOT COMPLETED|Overall Study||0
8716631|NCT00990509|9763821|FG001|NOT COMPLETED|Overall Study||1
8716632|NCT00990561|9763829|FG000|STARTED|Period 1||20
8716633|NCT00990561|9763830|FG001|STARTED|Period 1||20
8716634|NCT00990561|9763831|FG002|STARTED|Period 1||0
8716635|NCT00990561|9763832|FG003|STARTED|Period 1||0
8716636|NCT00990561|9763829|FG000|COMPLETED|Period 1||20
8716637|NCT00990561|9763830|FG001|COMPLETED|Period 1||19
8716638|NCT00990561|9763831|FG002|COMPLETED|Period 1||0
8616873|NCT00453921|9654991|FG001|NOT COMPLETED|Overall Study||1
8616874|NCT00453921|9654992|FG002|NOT COMPLETED|Overall Study||2
8616875|NCT00453921|9654993|FG003|NOT COMPLETED|Overall Study||1
8616876|NCT00453973|9655009|FG000|STARTED|Overall Study||51
8616877|NCT00453973|9655010|FG001|STARTED|Overall Study||63
8616878|NCT00453973|9655009|FG000|COMPLETED|Overall Study||0
8616879|NCT00453973|9655010|FG001|COMPLETED|Overall Study||15
8616880|NCT00453973|9655009|FG000|NOT COMPLETED|Overall Study||51
8616881|NCT00453973|9655010|FG001|NOT COMPLETED|Overall Study||48
8616882|NCT00453986|9655021|FG000|STARTED|Overall Study||311
8616883|NCT00453986|9655022|FG001|STARTED|Overall Study||311
8616884|NCT00453986|9655023|FG002|STARTED|Overall Study||313
8616885|NCT00453986|9655024|FG003|STARTED|Overall Study||312
8616886|NCT00453986|9655025|FG004|STARTED|Overall Study||105
8616887|NCT00453986|9655021|FG000|COMPLETED|Overall Study||305
8616888|NCT00453986|9655022|FG001|COMPLETED|Overall Study||306
8716639|NCT00990561|9763832|FG003|COMPLETED|Period 1||0
8716640|NCT00990561|9763829|FG000|NOT COMPLETED|Period 1||0
8716641|NCT00990561|9763830|FG001|NOT COMPLETED|Period 1||1
8716642|NCT00990561|9763831|FG002|NOT COMPLETED|Period 1||0
8716643|NCT00990561|9763832|FG003|NOT COMPLETED|Period 1||0
8616889|NCT00453986|9655023|FG002|COMPLETED|Overall Study||307
8616890|NCT00453986|9655024|FG003|COMPLETED|Overall Study||310
8616891|NCT00453986|9655025|FG004|COMPLETED|Overall Study||105
8616892|NCT00453986|9655021|FG000|NOT COMPLETED|Overall Study||6
8616893|NCT00453986|9655022|FG001|NOT COMPLETED|Overall Study||5
8716644|NCT00990561|9763829|FG000|STARTED|Period 2||0
8716645|NCT00990561|9763830|FG001|STARTED|Period 2||0
8716646|NCT00990561|9763831|FG002|STARTED|Period 2||20
8716647|NCT00990561|9763832|FG003|STARTED|Period 2||19
8716648|NCT00990561|9763829|FG000|COMPLETED|Period 2||0
8716649|NCT00990561|9763830|FG001|COMPLETED|Period 2||0
8716650|NCT00990561|9763831|FG002|COMPLETED|Period 2||20
8716651|NCT00990561|9763832|FG003|COMPLETED|Period 2||17
8616894|NCT00453986|9655023|FG002|NOT COMPLETED|Overall Study||6
8616895|NCT00453986|9655024|FG003|NOT COMPLETED|Overall Study||2
8616896|NCT00453986|9655025|FG004|NOT COMPLETED|Overall Study||0
8616897|NCT00453999|9655044|FG000|STARTED|Overall Study||45
8616898|NCT00453999|9655045|FG001|STARTED|Overall Study||46
8616899|NCT00453999|9655046|FG002|STARTED|Overall Study||46
8616900|NCT00453999|9655044|FG000|COMPLETED|Overall Study||40
8616901|NCT00453999|9655045|FG001|COMPLETED|Overall Study||41
8716652|NCT00990561|9763829|FG000|NOT COMPLETED|Period 2||0
8716653|NCT00990561|9763830|FG001|NOT COMPLETED|Period 2||0
8716654|NCT00990561|9763831|FG002|NOT COMPLETED|Period 2||0
8716655|NCT00990561|9763832|FG003|NOT COMPLETED|Period 2||2
8716656|NCT00990652|9763838|FG000|STARTED|Pre-surgical Bortezomib||10
8716657|NCT00990652|9763838|FG000|COMPLETED|Pre-surgical Bortezomib||9
8716658|NCT00990652|9763838|FG000|NOT COMPLETED|Pre-surgical Bortezomib||1
8716659|NCT00990652|9763838|FG000|STARTED|Surgical Resection||9
8716660|NCT00990652|9763838|FG000|COMPLETED|Surgical Resection||9
8716661|NCT00990652|9763838|FG000|NOT COMPLETED|Surgical Resection||0
8716662|NCT00990652|9763838|FG000|STARTED|Post-sugery Bortezomib + Temozolomide||9
8716663|NCT00990652|9763838|FG000|COMPLETED|Post-sugery Bortezomib + Temozolomide||8
8716664|NCT00990652|9763838|FG000|NOT COMPLETED|Post-sugery Bortezomib + Temozolomide||1
8716665|NCT00990665|9763843|FG000|STARTED|Overall Study||178
8716666|NCT00990665|9763843|FG000|COMPLETED|Overall Study||130
8716667|NCT00990665|9763843|FG000|NOT COMPLETED|Overall Study||48
8716668|NCT00990704|9763851|FG000|STARTED|Overall Study||14
8716669|NCT00990704|9763852|FG001|STARTED|Overall Study||33
8716670|NCT00990704|9763851|FG000|COMPLETED|Overall Study||13
8716671|NCT00990704|9763852|FG001|COMPLETED|Overall Study||31
8716672|NCT00990704|9763851|FG000|NOT COMPLETED|Overall Study||1
8716673|NCT00990704|9763852|FG001|NOT COMPLETED|Overall Study||2
8716674|NCT00990769|9763860|FG000|STARTED|Overall Study|Signed consent and assigned to High-normal BIS|22
8716675|NCT00990769|9763861|FG001|STARTED|Overall Study|Signed consent and assigned to Low-normal BIS|18
8716676|NCT00990769|9763860|FG000|COMPLETED|Overall Study||22
8716677|NCT00990769|9763861|FG001|COMPLETED|Overall Study||18
8716678|NCT00990769|9763860|FG000|NOT COMPLETED|Overall Study||0
8716679|NCT00990769|9763861|FG001|NOT COMPLETED|Overall Study||0
8716680|NCT00990782|9763867|FG000|STARTED|Overall Study||93
8716681|NCT00990782|9763867|FG000|COMPLETED|Overall Study||88
8716682|NCT00990782|9763867|FG000|NOT COMPLETED|Overall Study||5
8716683|NCT00990821|9763885|FG000|STARTED|Overall Study||14
8716684|NCT00990821|9763886|FG001|STARTED|Overall Study||16
8716685|NCT00990821|9763887|FG002|STARTED|Overall Study||14
8716686|NCT00990821|9763888|FG003|STARTED|Overall Study||8
8813349|NCT01525407|9866519|FG000|NOT COMPLETED|Overall Study||3
8813350|NCT01525407|9866520|FG001|NOT COMPLETED|Overall Study||4
8813351|NCT01525420|9866528|FG000|STARTED|Overall Study||59
8813352|NCT01525420|9866529|FG001|STARTED|Overall Study||62
8813353|NCT01525420|9866528|FG000|COMPLETED|Overall Study||43
8813354|NCT01525420|9866529|FG001|COMPLETED|Overall Study||38
8813355|NCT01525420|9866528|FG000|NOT COMPLETED|Overall Study||16
8813356|NCT01525420|9866529|FG001|NOT COMPLETED|Overall Study||24
8813357|NCT01525550|9866537|FG000|STARTED|Overall Study||61
8813358|NCT01525550|9866538|FG001|STARTED|Overall Study||45
8813359|NCT01525550|9866537|FG000|COMPLETED|Overall Study||0
8813360|NCT01525550|9866538|FG001|COMPLETED|Overall Study||0
8813361|NCT01525550|9866537|FG000|NOT COMPLETED|Overall Study||61
8813362|NCT01525550|9866538|FG001|NOT COMPLETED|Overall Study||45
8813363|NCT01525563|9866544|FG000|STARTED|Overall Study||1000
8813364|NCT01525563|9866544|FG000|End of Treatment|Overall Study|Only patients who had cycle regularization at end of treatment were allowed to continue.|910
8813365|NCT01525563|9866544|FG000|3 Months Follow-up|Overall Study|Only patients who had cycle regularization at end of treatment were allowed to continue.|838
8813366|NCT01525563|9866544|FG000|COMPLETED|Overall Study|6 Months Follow-up|788
8813367|NCT01525563|9866544|FG000|NOT COMPLETED|Overall Study||212
8813368|NCT01525589|9866551|FG000|STARTED|Overall Study||56
8813369|NCT01525589|9866552|FG001|STARTED|Overall Study||20
8813370|NCT01525589|9866553|FG002|STARTED|Overall Study||35
8813371|NCT01525589|9866551|FG000|COMPLETED|Overall Study||0
8813372|NCT01525589|9866552|FG001|COMPLETED|Overall Study||0
8813373|NCT01525589|9866553|FG002|COMPLETED|Overall Study||0
8813374|NCT01525589|9866551|FG000|NOT COMPLETED|Overall Study||56
8813375|NCT01525589|9866552|FG001|NOT COMPLETED|Overall Study||20
8813376|NCT01525589|9866553|FG002|NOT COMPLETED|Overall Study||35
8813377|NCT01525602|9866569|FG000|STARTED|Overall Study||9
8616902|NCT00453999|9655046|FG002|COMPLETED|Overall Study||43
8616903|NCT00453999|9655044|FG000|NOT COMPLETED|Overall Study||5
8616904|NCT00453999|9655045|FG001|NOT COMPLETED|Overall Study||5
8616905|NCT00453999|9655046|FG002|NOT COMPLETED|Overall Study||3
8813378|NCT01525602|9866570|FG001|STARTED|Overall Study||3
8813379|NCT01525602|9866571|FG002|STARTED|Overall Study||3
8813380|NCT01525602|9866572|FG003|STARTED|Overall Study||6
8813381|NCT01525602|9866573|FG004|STARTED|Overall Study||33
8813382|NCT01525602|9866574|FG005|STARTED|Overall Study||7
8813383|NCT01525602|9866575|FG006|STARTED|Overall Study||6
8716687|NCT00990821|9763889|FG004|STARTED|Overall Study||17
8813384|NCT01525602|9866576|FG007|STARTED|Overall Study||7
8616906|NCT00454051|9655057|FG000|STARTED|Overall Study||20
8716688|NCT00990821|9763890|FG005|STARTED|Overall Study||17
8716689|NCT00990821|9763891|FG006|STARTED|Overall Study||12
8813385|NCT01525602|9866569|FG000|COMPLETED|Overall Study||0
8813386|NCT01525602|9866570|FG001|COMPLETED|Overall Study||0
8616907|NCT00454051|9655058|FG001|STARTED|Overall Study||11
8616908|NCT00454051|9655057|FG000|COMPLETED|Overall Study||17
8616909|NCT00454051|9655058|FG001|COMPLETED|Overall Study||8
8616910|NCT00454051|9655057|FG000|NOT COMPLETED|Overall Study||3
8616911|NCT00454051|9655058|FG001|NOT COMPLETED|Overall Study||3
8629361|NCT00529555|9669090|FG002|STARTED|Overall Study||200
8629362|NCT00529555|9669088|FG000|COMPLETED|Overall Study||171
8629363|NCT00529555|9669089|FG001|COMPLETED|Overall Study||172
8629364|NCT00529555|9669090|FG002|COMPLETED|Overall Study||174
8629365|NCT00529555|9669088|FG000|NOT COMPLETED|Overall Study||29
8629366|NCT00529555|9669089|FG001|NOT COMPLETED|Overall Study||30
8629367|NCT00529555|9669090|FG002|NOT COMPLETED|Overall Study||26
8629368|NCT00529568|9669100|FG000|STARTED|Open-label Pre-Antiviral Treatment Phase||805
8629369|NCT00529568|9669101|FG001|STARTED|Open-label Pre-Antiviral Treatment Phase||0
8629370|NCT00529568|9669102|FG002|STARTED|Open-label Pre-Antiviral Treatment Phase||0
8629371|NCT00529568|9669100|FG000|COMPLETED|Open-label Pre-Antiviral Treatment Phase||759
8629372|NCT00529568|9669101|FG001|COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
8629373|NCT00529568|9669102|FG002|COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
8629374|NCT00529568|9669100|FG000|NOT COMPLETED|Open-label Pre-Antiviral Treatment Phase||46
8629375|NCT00529568|9669101|FG001|NOT COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
8629376|NCT00529568|9669102|FG002|NOT COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
8629377|NCT00529568|9669100|FG000|STARTED|Double-bilnd Antiviral Treatment Phase||0
8629378|NCT00529568|9669101|FG001|STARTED|Double-bilnd Antiviral Treatment Phase||253
8629379|NCT00529568|9669102|FG002|STARTED|Double-bilnd Antiviral Treatment Phase||506
8629380|NCT00529568|9669100|FG000|COMPLETED|Double-bilnd Antiviral Treatment Phase||0
8629381|NCT00529568|9669101|FG001|COMPLETED|Double-bilnd Antiviral Treatment Phase||205
8629382|NCT00529568|9669102|FG002|COMPLETED|Double-bilnd Antiviral Treatment Phase||404
8629383|NCT00529568|9669100|FG000|NOT COMPLETED|Double-bilnd Antiviral Treatment Phase||0
8629384|NCT00529568|9669101|FG001|NOT COMPLETED|Double-bilnd Antiviral Treatment Phase||48
8629385|NCT00529568|9669102|FG002|NOT COMPLETED|Double-bilnd Antiviral Treatment Phase||102
8629386|NCT00529633|9669113|FG000|STARTED|Overall Study||2
8629387|NCT00529633|9669114|FG001|STARTED|Overall Study||2
8629388|NCT00529633|9669113|FG000|COMPLETED|Overall Study||1
8629389|NCT00529633|9669114|FG001|COMPLETED|Overall Study||1
8629390|NCT00529633|9669113|FG000|NOT COMPLETED|Overall Study||1
8629391|NCT00529633|9669114|FG001|NOT COMPLETED|Overall Study||1
8629392|NCT00529659|9669122|FG000|STARTED|Overall Study||81
8629393|NCT00529659|9669123|FG001|STARTED|Overall Study||89
8629394|NCT00529659|9669122|FG000|COMPLETED|Overall Study||70
8629395|NCT00529659|9669123|FG001|COMPLETED|Overall Study||66
8629396|NCT00529659|9669122|FG000|NOT COMPLETED|Overall Study||11
8629397|NCT00529659|9669123|FG001|NOT COMPLETED|Overall Study||23
8629612|NCT00531050|9669384|FG003|STARTED|Part 1: Period 2||4
8629613|NCT00531050|9669385|FG004|STARTED|Part 1: Period 2||4
8629614|NCT00531050|9669386|FG005|STARTED|Part 1: Period 2||5
8629615|NCT00531050|9669381|FG000|COMPLETED|Part 1: Period 2||4
8629616|NCT00531050|9669382|FG001|COMPLETED|Part 1: Period 2||4
8629617|NCT00531050|9669383|FG002|COMPLETED|Part 1: Period 2||4
8629618|NCT00531050|9669384|FG003|COMPLETED|Part 1: Period 2||4
8629619|NCT00531050|9669385|FG004|COMPLETED|Part 1: Period 2||4
8629620|NCT00531050|9669386|FG005|COMPLETED|Part 1: Period 2||5
8629621|NCT00531050|9669381|FG000|NOT COMPLETED|Part 1: Period 2||0
8629622|NCT00531050|9669382|FG001|NOT COMPLETED|Part 1: Period 2||0
8629623|NCT00531050|9669383|FG002|NOT COMPLETED|Part 1: Period 2||0
8629624|NCT00531050|9669384|FG003|NOT COMPLETED|Part 1: Period 2||0
8629625|NCT00531050|9669385|FG004|NOT COMPLETED|Part 1: Period 2||0
8629626|NCT00531050|9669386|FG005|NOT COMPLETED|Part 1: Period 2||0
8629627|NCT00531050|9669381|FG000|STARTED|Part 1: Period 3||4
8629628|NCT00531050|9669382|FG001|STARTED|Part 1: Period 3||4
8629629|NCT00531050|9669383|FG002|STARTED|Part 1: Period 3||4
8629630|NCT00531050|9669384|FG003|STARTED|Part 1: Period 3||4
8629631|NCT00531050|9669385|FG004|STARTED|Part 1: Period 3||4
8629632|NCT00531050|9669386|FG005|STARTED|Part 1: Period 3||5
8629633|NCT00531050|9669381|FG000|COMPLETED|Part 1: Period 3||3
8629634|NCT00531050|9669382|FG001|COMPLETED|Part 1: Period 3||4
8629635|NCT00531050|9669383|FG002|COMPLETED|Part 1: Period 3||4
8629636|NCT00531050|9669384|FG003|COMPLETED|Part 1: Period 3||4
8629637|NCT00531050|9669385|FG004|COMPLETED|Part 1: Period 3||4
8629638|NCT00531050|9669386|FG005|COMPLETED|Part 1: Period 3||5
8629639|NCT00531050|9669381|FG000|NOT COMPLETED|Part 1: Period 3||1
8629640|NCT00531050|9669382|FG001|NOT COMPLETED|Part 1: Period 3||0
8629641|NCT00531050|9669383|FG002|NOT COMPLETED|Part 1: Period 3||0
8629642|NCT00531050|9669384|FG003|NOT COMPLETED|Part 1: Period 3||0
8629643|NCT00531050|9669385|FG004|NOT COMPLETED|Part 1: Period 3||0
8629644|NCT00531050|9669386|FG005|NOT COMPLETED|Part 1: Period 3||0
8629645|NCT00531050|9669381|FG000|STARTED|Part 2: Period 1||3
8629646|NCT00531050|9669382|FG001|STARTED|Part 2: Period 1||4
8629647|NCT00531050|9669383|FG002|STARTED|Part 2: Period 1||4
8629648|NCT00531050|9669384|FG003|STARTED|Part 2: Period 1||4
8629649|NCT00531050|9669385|FG004|STARTED|Part 2: Period 1||4
8629650|NCT00531050|9669386|FG005|STARTED|Part 2: Period 1||5
8629651|NCT00531050|9669381|FG000|COMPLETED|Part 2: Period 1||3
8629652|NCT00531050|9669382|FG001|COMPLETED|Part 2: Period 1||4
8629653|NCT00531050|9669383|FG002|COMPLETED|Part 2: Period 1||4
8629654|NCT00531050|9669384|FG003|COMPLETED|Part 2: Period 1||4
8629655|NCT00531050|9669385|FG004|COMPLETED|Part 2: Period 1||4
8629656|NCT00531050|9669386|FG005|COMPLETED|Part 2: Period 1||4
8616912|NCT00454116|9655067|FG000|STARTED|Overall Study|randomised patients|35
8616913|NCT00454116|9655068|FG001|STARTED|Overall Study|randomised patients|36
8616914|NCT00454116|9655069|FG002|STARTED|Overall Study|randomised patients|35
8616915|NCT00454116|9655067|FG000|COMPLETED|Overall Study|ongoing study treatment at data cut-off|8
8616916|NCT00454116|9655068|FG001|COMPLETED|Overall Study|ongoing study treatment at data cut-off|7
8616917|NCT00454116|9655069|FG002|COMPLETED|Overall Study|ongoing study treatment at data cut-off|7
8616918|NCT00454116|9655067|FG000|NOT COMPLETED|Overall Study||27
8616919|NCT00454116|9655068|FG001|NOT COMPLETED|Overall Study||29
8616920|NCT00454116|9655069|FG002|NOT COMPLETED|Overall Study||28
8616921|NCT00454142|9655077|FG000|STARTED|Overall Study||33
8616922|NCT00454142|9655077|FG000|COMPLETED|Overall Study||32
8616923|NCT00454142|9655077|FG000|NOT COMPLETED|Overall Study||1
8616924|NCT00454181|9655085|FG000|STARTED|Overall Study||45
8616925|NCT00454181|9655086|FG001|STARTED|Overall Study||14
8616926|NCT00454181|9655085|FG000|COMPLETED|Overall Study||30
8616927|NCT00454181|9655086|FG001|COMPLETED|Overall Study||11
8616928|NCT00454181|9655085|FG000|NOT COMPLETED|Overall Study||15
8716690|NCT00990821|9763892|FG007|STARTED|Overall Study||14
8716691|NCT00990821|9763893|FG008|STARTED|Overall Study||12
8716692|NCT00990821|9763894|FG009|STARTED|Overall Study||14
8716693|NCT00990821|9763895|FG010|STARTED|Overall Study||12
8716694|NCT00990821|9763896|FG011|STARTED|Overall Study||14
8716695|NCT00990821|9763897|FG012|STARTED|Overall Study||12
8716696|NCT00990821|9763898|FG013|STARTED|Overall Study||12
8716697|NCT00990821|9763885|FG000|COMPLETED|Overall Study||14
8716698|NCT00990821|9763886|FG001|COMPLETED|Overall Study||14
8716699|NCT00990821|9763887|FG002|COMPLETED|Overall Study||14
8716700|NCT00990821|9763888|FG003|COMPLETED|Overall Study||8
8716701|NCT00990821|9763889|FG004|COMPLETED|Overall Study||14
8716702|NCT00990821|9763890|FG005|COMPLETED|Overall Study||14
8716703|NCT00990821|9763891|FG006|COMPLETED|Overall Study||11
8716704|NCT00990821|9763892|FG007|COMPLETED|Overall Study||14
8716705|NCT00990821|9763893|FG008|COMPLETED|Overall Study||12
8716706|NCT00990821|9763894|FG009|COMPLETED|Overall Study||13
8716707|NCT00990821|9763895|FG010|COMPLETED|Overall Study||9
8716708|NCT00990821|9763896|FG011|COMPLETED|Overall Study||9
8716709|NCT00990821|9763897|FG012|COMPLETED|Overall Study||10
8716710|NCT00990821|9763898|FG013|COMPLETED|Overall Study||11
8716711|NCT00990821|9763885|FG000|NOT COMPLETED|Overall Study||0
8716712|NCT00990821|9763886|FG001|NOT COMPLETED|Overall Study||2
8716713|NCT00990821|9763887|FG002|NOT COMPLETED|Overall Study||0
8716714|NCT00990821|9763888|FG003|NOT COMPLETED|Overall Study||0
8716715|NCT00990821|9763889|FG004|NOT COMPLETED|Overall Study||3
8716716|NCT00990821|9763890|FG005|NOT COMPLETED|Overall Study||3
8716717|NCT00990821|9763891|FG006|NOT COMPLETED|Overall Study||1
8716718|NCT00990821|9763892|FG007|NOT COMPLETED|Overall Study||0
8716719|NCT00990821|9763893|FG008|NOT COMPLETED|Overall Study||0
8716720|NCT00990821|9763894|FG009|NOT COMPLETED|Overall Study||1
8716721|NCT00990821|9763895|FG010|NOT COMPLETED|Overall Study||3
8716722|NCT00990821|9763896|FG011|NOT COMPLETED|Overall Study||5
8716723|NCT00990821|9763897|FG012|NOT COMPLETED|Overall Study||2
8716724|NCT00990821|9763898|FG013|NOT COMPLETED|Overall Study||1
8716725|NCT00990938|9763921|FG000|STARTED|Overall Study||3
8716726|NCT00990938|9763922|FG001|STARTED|Overall Study||12
8716727|NCT00990938|9763923|FG002|STARTED|Overall Study||12
8716728|NCT00990938|9763924|FG003|STARTED|Overall Study||12
8716729|NCT00990938|9763925|FG004|STARTED|Overall Study||12
8716730|NCT00990938|9763926|FG005|STARTED|Overall Study||12
8716731|NCT00990938|9763921|FG000|COMPLETED|Overall Study||3
8716732|NCT00990938|9763922|FG001|COMPLETED|Overall Study||12
8716733|NCT00990938|9763923|FG002|COMPLETED|Overall Study||12
8716734|NCT00990938|9763924|FG003|COMPLETED|Overall Study||12
8716735|NCT00990938|9763925|FG004|COMPLETED|Overall Study||12
8716736|NCT00990938|9763926|FG005|COMPLETED|Overall Study||12
8716737|NCT00990938|9763921|FG000|NOT COMPLETED|Overall Study||0
8716738|NCT00990938|9763922|FG001|NOT COMPLETED|Overall Study||0
8716739|NCT00990938|9763923|FG002|NOT COMPLETED|Overall Study||0
8813387|NCT01525602|9866571|FG002|COMPLETED|Overall Study||0
8813388|NCT01525602|9866572|FG003|COMPLETED|Overall Study||0
8813389|NCT01525602|9866573|FG004|COMPLETED|Overall Study||0
8813390|NCT01525602|9866574|FG005|COMPLETED|Overall Study||0
8813391|NCT01525602|9866575|FG006|COMPLETED|Overall Study||0
8813392|NCT01525602|9866576|FG007|COMPLETED|Overall Study||0
8813393|NCT01525602|9866569|FG000|NOT COMPLETED|Overall Study||9
8813394|NCT01525602|9866570|FG001|NOT COMPLETED|Overall Study||3
8616929|NCT00454181|9655086|FG001|NOT COMPLETED|Overall Study||3
8616930|NCT00454194|9655094|FG000|STARTED|Overall Study||47
8716740|NCT00990938|9763924|FG003|NOT COMPLETED|Overall Study||0
8716741|NCT00990938|9763925|FG004|NOT COMPLETED|Overall Study||0
8716742|NCT00990938|9763926|FG005|NOT COMPLETED|Overall Study||0
8716743|NCT00990964|9763940|FG000|STARTED|Overall Study|Total number of subjects enrolled|2014
8716744|NCT00990964|9763940|FG000|Attain Family Study System Attempt|Overall Study|Total number of subjects with an Attain Family lead attempt after an Attain Family catheter attempt|1917
8716745|NCT00990964|9763940|FG000|COMPLETED|Overall Study|Total number of subjects with successful Attain Family lead using Attain Family catheter|1802
8716746|NCT00990964|9763940|FG000|NOT COMPLETED|Overall Study||212
8716747|NCT00991029|9763947|FG000|STARTED|Overall Study||2432
8716748|NCT00991029|9763948|FG001|STARTED|Overall Study||2449
8813395|NCT01525602|9866571|FG002|NOT COMPLETED|Overall Study||3
8813396|NCT01525602|9866572|FG003|NOT COMPLETED|Overall Study||6
8616931|NCT00454194|9655095|FG001|STARTED|Overall Study||51
8616932|NCT00454194|9655094|FG000|COMPLETED|Overall Study||25
8616933|NCT00454194|9655095|FG001|COMPLETED|Overall Study||37
8616934|NCT00454194|9655094|FG000|NOT COMPLETED|Overall Study||22
8616935|NCT00454194|9655095|FG001|NOT COMPLETED|Overall Study||14
8616936|NCT00454207|9655103|FG000|STARTED|Overall Study||21
8616937|NCT00454207|9655104|FG001|STARTED|Overall Study||23
8616938|NCT00454207|9655103|FG000|COMPLETED|Overall Study|19 participants completed Part I period. 17 of 19 participants continued from part I into Part II.|17
8716749|NCT00991029|9763947|FG000|COMPLETED|Overall Study||2276
8716750|NCT00991029|9763948|FG001|COMPLETED|Overall Study||2281
8716751|NCT00991029|9763947|FG000|NOT COMPLETED|Overall Study||156
8716752|NCT00991029|9763948|FG001|NOT COMPLETED|Overall Study||168
8716753|NCT00991081|9763956|FG000|STARTED|Phase I, Formative Research||20
8716754|NCT00991081|9763957|FG001|STARTED|Phase I, Formative Research||0
8716755|NCT00991081|9763958|FG002|STARTED|Phase I, Formative Research||0
8716756|NCT00991081|9763956|FG000|COMPLETED|Phase I, Formative Research|The 10 smokers interviewed were not enrolled in the Phase II RCT.|20
8716757|NCT00991081|9763957|FG001|COMPLETED|Phase I, Formative Research||0
8716758|NCT00991081|9763958|FG002|COMPLETED|Phase I, Formative Research||0
8716759|NCT00991081|9763956|FG000|NOT COMPLETED|Phase I, Formative Research||0
8716760|NCT00991081|9763957|FG001|NOT COMPLETED|Phase I, Formative Research||0
8716761|NCT00991081|9763958|FG002|NOT COMPLETED|Phase I, Formative Research||0
8716762|NCT00991081|9763956|FG000|STARTED|Phase II, Randomized Control Trial||0
8716763|NCT00991081|9763957|FG001|STARTED|Phase II, Randomized Control Trial|Phase I interview participants were not enrolled in the Phase II RCT.|17
8716764|NCT00991081|9763958|FG002|STARTED|Phase II, Randomized Control Trial|Phase I interview participants were not enrolled in the Phase II RCT.|19
8716765|NCT00991081|9763956|FG000|Received First Clinical Call|Phase II, Randomized Control Trial||0
8716766|NCT00991081|9763957|FG001|Received First Clinical Call|Phase II, Randomized Control Trial||16
8716767|NCT00991081|9763958|FG002|Received First Clinical Call|Phase II, Randomized Control Trial||17
8716768|NCT00991081|9763956|FG000|COMPLETED|Phase II, Randomized Control Trial||0
8716769|NCT00991081|9763957|FG001|COMPLETED|Phase II, Randomized Control Trial||15
8716770|NCT00991081|9763958|FG002|COMPLETED|Phase II, Randomized Control Trial||15
8716771|NCT00991081|9763956|FG000|NOT COMPLETED|Phase II, Randomized Control Trial||0
8716772|NCT00991081|9763957|FG001|NOT COMPLETED|Phase II, Randomized Control Trial||2
8716773|NCT00991081|9763958|FG002|NOT COMPLETED|Phase II, Randomized Control Trial||4
8716774|NCT00991185|9763964|FG000|STARTED|Overall Study||8
8716775|NCT00991185|9763964|FG000|COMPLETED|Overall Study||8
8716776|NCT00991185|9763964|FG000|NOT COMPLETED|Overall Study||0
8716777|NCT00991276|9763974|FG000|STARTED|First Intervention Period||15
8716778|NCT00991276|9763975|FG001|STARTED|First Intervention Period||13
8716779|NCT00991276|9763976|FG002|STARTED|First Intervention Period||14
8716780|NCT00991276|9763977|FG003|STARTED|First Intervention Period||15
8716781|NCT00991276|9763978|FG004|STARTED|First Intervention Period||15
8716782|NCT00991276|9763979|FG005|STARTED|First Intervention Period||13
8716783|NCT00991276|9763974|FG000|COMPLETED|First Intervention Period||15
8716784|NCT00991276|9763975|FG001|COMPLETED|First Intervention Period||10
8716785|NCT00991276|9763976|FG002|COMPLETED|First Intervention Period||14
8716786|NCT00991276|9763977|FG003|COMPLETED|First Intervention Period||11
8716787|NCT00991276|9763978|FG004|COMPLETED|First Intervention Period||11
8716788|NCT00991276|9763979|FG005|COMPLETED|First Intervention Period||12
8716789|NCT00991276|9763974|FG000|NOT COMPLETED|First Intervention Period||0
8716790|NCT00991276|9763975|FG001|NOT COMPLETED|First Intervention Period||3
8716791|NCT00991276|9763976|FG002|NOT COMPLETED|First Intervention Period||0
8716792|NCT00991276|9763977|FG003|NOT COMPLETED|First Intervention Period||4
8716793|NCT00991276|9763978|FG004|NOT COMPLETED|First Intervention Period||4
8716794|NCT00991276|9763979|FG005|NOT COMPLETED|First Intervention Period||1
8716795|NCT00991276|9763974|FG000|STARTED|Placebo Wash-out Period (7 Days)||15
8716796|NCT00991276|9763975|FG001|STARTED|Placebo Wash-out Period (7 Days)||10
8716797|NCT00991276|9763976|FG002|STARTED|Placebo Wash-out Period (7 Days)||14
8716798|NCT00991276|9763977|FG003|STARTED|Placebo Wash-out Period (7 Days)||11
8716799|NCT00991276|9763978|FG004|STARTED|Placebo Wash-out Period (7 Days)||11
8716800|NCT00991276|9763979|FG005|STARTED|Placebo Wash-out Period (7 Days)||12
8716801|NCT00991276|9763974|FG000|COMPLETED|Placebo Wash-out Period (7 Days)||15
8716802|NCT00991276|9763975|FG001|COMPLETED|Placebo Wash-out Period (7 Days)||10
8716803|NCT00991276|9763976|FG002|COMPLETED|Placebo Wash-out Period (7 Days)||14
8716804|NCT00991276|9763977|FG003|COMPLETED|Placebo Wash-out Period (7 Days)||11
8716805|NCT00991276|9763978|FG004|COMPLETED|Placebo Wash-out Period (7 Days)||11
8716806|NCT00991276|9763979|FG005|COMPLETED|Placebo Wash-out Period (7 Days)||12
8716807|NCT00991276|9763974|FG000|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
8716808|NCT00991276|9763975|FG001|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
8616939|NCT00454207|9655104|FG001|COMPLETED|Overall Study||21
8616940|NCT00454207|9655103|FG000|NOT COMPLETED|Overall Study||4
8616941|NCT00454207|9655104|FG001|NOT COMPLETED|Overall Study||2
8616942|NCT00454246|9655125|FG000|STARTED|Overall Study||73
8616943|NCT00454246|9655126|FG001|STARTED|Overall Study||29
8616944|NCT00454246|9655127|FG002|STARTED|Overall Study||9
8616945|NCT00454246|9655125|FG000|COMPLETED|Overall Study||0
8616946|NCT00454246|9655126|FG001|COMPLETED|Overall Study||0
8616947|NCT00454246|9655127|FG002|COMPLETED|Overall Study||0
8616948|NCT00454246|9655125|FG000|NOT COMPLETED|Overall Study||73
8616949|NCT00454246|9655126|FG001|NOT COMPLETED|Overall Study||29
8616950|NCT00454246|9655127|FG002|NOT COMPLETED|Overall Study||9
8616951|NCT00454324|9655137|FG000|STARTED|Overall Study||14
8616952|NCT00454324|9655138|FG001|STARTED|Overall Study||13
8616953|NCT00454324|9655137|FG000|COMPLETED|Overall Study||14
8616954|NCT00454324|9655138|FG001|COMPLETED|Overall Study||13
8616955|NCT00454324|9655137|FG000|NOT COMPLETED|Overall Study||0
8616956|NCT00454324|9655138|FG001|NOT COMPLETED|Overall Study||0
8716809|NCT00991276|9763976|FG002|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
8716810|NCT00991276|9763977|FG003|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
8716811|NCT00991276|9763978|FG004|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
8716812|NCT00991276|9763979|FG005|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
8716813|NCT00991276|9763974|FG000|STARTED|Second Intervention Period||15
8716814|NCT00991276|9763975|FG001|STARTED|Second Intervention Period||10
8716815|NCT00991276|9763976|FG002|STARTED|Second Intervention Period||14
8716816|NCT00991276|9763977|FG003|STARTED|Second Intervention Period||11
8716817|NCT00991276|9763978|FG004|STARTED|Second Intervention Period||11
8716818|NCT00991276|9763979|FG005|STARTED|Second Intervention Period||12
8716819|NCT00991276|9763974|FG000|COMPLETED|Second Intervention Period||14
8716820|NCT00991276|9763975|FG001|COMPLETED|Second Intervention Period||8
8716821|NCT00991276|9763976|FG002|COMPLETED|Second Intervention Period||14
8716822|NCT00991276|9763977|FG003|COMPLETED|Second Intervention Period||9
8716823|NCT00991276|9763978|FG004|COMPLETED|Second Intervention Period||10
8716824|NCT00991276|9763979|FG005|COMPLETED|Second Intervention Period||11
8716825|NCT00991276|9763974|FG000|NOT COMPLETED|Second Intervention Period||1
8716826|NCT00991276|9763975|FG001|NOT COMPLETED|Second Intervention Period||2
8716827|NCT00991276|9763976|FG002|NOT COMPLETED|Second Intervention Period||0
8716828|NCT00991276|9763977|FG003|NOT COMPLETED|Second Intervention Period||2
8716829|NCT00991276|9763978|FG004|NOT COMPLETED|Second Intervention Period||1
8716830|NCT00991276|9763979|FG005|NOT COMPLETED|Second Intervention Period||1
8716831|NCT00991276|9763974|FG000|STARTED|Placebo Wash-out Period (7 Days)||14
8716832|NCT00991276|9763975|FG001|STARTED|Placebo Wash-out Period (7 Days)||8
8716833|NCT00991276|9763976|FG002|STARTED|Placebo Wash-out Period (7 Days)||14
8716834|NCT00991276|9763977|FG003|STARTED|Placebo Wash-out Period (7 Days)||9
8716835|NCT00991276|9763978|FG004|STARTED|Placebo Wash-out Period (7 Days)||10
8716836|NCT00991276|9763979|FG005|STARTED|Placebo Wash-out Period (7 Days)||11
8716837|NCT00991276|9763974|FG000|COMPLETED|Placebo Wash-out Period (7 Days)||14
8716838|NCT00991276|9763975|FG001|COMPLETED|Placebo Wash-out Period (7 Days)||8
8716839|NCT00991276|9763976|FG002|COMPLETED|Placebo Wash-out Period (7 Days)||14
8716840|NCT00991276|9763977|FG003|COMPLETED|Placebo Wash-out Period (7 Days)||9
8716841|NCT00991276|9763978|FG004|COMPLETED|Placebo Wash-out Period (7 Days)||10
8716842|NCT00991276|9763979|FG005|COMPLETED|Placebo Wash-out Period (7 Days)||11
8716843|NCT00991276|9763974|FG000|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
8716844|NCT00991276|9763975|FG001|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
8716845|NCT00991276|9763976|FG002|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
8716846|NCT00991276|9763977|FG003|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
8716847|NCT00991276|9763978|FG004|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
8716848|NCT00991276|9763979|FG005|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
8716849|NCT00991276|9763974|FG000|STARTED|Third Intervention Period||14
8716850|NCT00991276|9763975|FG001|STARTED|Third Intervention Period||8
8716851|NCT00991276|9763976|FG002|STARTED|Third Intervention Period||14
8716852|NCT00991276|9763977|FG003|STARTED|Third Intervention Period||9
8716853|NCT00991276|9763978|FG004|STARTED|Third Intervention Period||10
8716854|NCT00991276|9763979|FG005|STARTED|Third Intervention Period||11
8716855|NCT00991276|9763974|FG000|COMPLETED|Third Intervention Period||13
8716856|NCT00991276|9763975|FG001|COMPLETED|Third Intervention Period||8
8716857|NCT00991276|9763976|FG002|COMPLETED|Third Intervention Period||13
8716858|NCT00991276|9763977|FG003|COMPLETED|Third Intervention Period||8
8716859|NCT00991276|9763978|FG004|COMPLETED|Third Intervention Period||10
8716860|NCT00991276|9763979|FG005|COMPLETED|Third Intervention Period||10
8716861|NCT00991276|9763974|FG000|NOT COMPLETED|Third Intervention Period||1
8716862|NCT00991276|9763975|FG001|NOT COMPLETED|Third Intervention Period||0
8716863|NCT00991276|9763976|FG002|NOT COMPLETED|Third Intervention Period||1
8716864|NCT00991276|9763977|FG003|NOT COMPLETED|Third Intervention Period||1
8716865|NCT00991276|9763978|FG004|NOT COMPLETED|Third Intervention Period||0
8716866|NCT00991276|9763979|FG005|NOT COMPLETED|Third Intervention Period||1
8716867|NCT00991289|9763988|FG000|STARTED|Overall Study|68 participants enrolled, one was found to have been ineligible and was excluded.|67
8716868|NCT00991289|9763988|FG000|COMPLETED Week 16|Overall Study|Completed 16 weeks of the study (the primary endpoint time point). The study continued to Week 76.|61
8716869|NCT00991289|9763988|FG000|COMPLETED|Overall Study|Completed study.|55
8716870|NCT00991289|9763988|FG000|NOT COMPLETED|Overall Study||12
8716871|NCT00991302|9763994|FG000|STARTED|Overall Study||86
8716872|NCT00991302|9763995|FG001|STARTED|Overall Study||86
8616957|NCT00454363|9655146|FG000|STARTED|Overall Study||20
8616958|NCT00454363|9655147|FG001|STARTED|Overall Study||31
8616959|NCT00454363|9655146|FG000|COMPLETED|Overall Study||15
8716873|NCT00991302|9763994|FG000|COMPLETED|Overall Study||72
8716874|NCT00991302|9763995|FG001|COMPLETED|Overall Study||73
8716875|NCT00991302|9763994|FG000|NOT COMPLETED|Overall Study||14
8716876|NCT00991302|9763995|FG001|NOT COMPLETED|Overall Study||13
8716877|NCT00991341|9764003|FG000|STARTED|Overall Study||742
8716878|NCT00991341|9764004|FG001|STARTED|Overall Study||739
8716879|NCT00991341|9764003|FG000|COMPLETED|Overall Study||538
8716880|NCT00991341|9764004|FG001|COMPLETED|Overall Study||560
8716881|NCT00991341|9764003|FG000|NOT COMPLETED|Overall Study||204
8716882|NCT00991341|9764004|FG001|NOT COMPLETED|Overall Study||179
8716883|NCT00991406|9764010|FG000|STARTED|Overall Study||9
8716884|NCT00991406|9764010|FG000|COMPLETED|Overall Study|One participant did not respond to FES due to tone.|8
8716885|NCT00991406|9764010|FG000|NOT COMPLETED|Overall Study||1
8716886|NCT00991458|9764017|FG000|STARTED|Overall Study||207
8716887|NCT00991458|9764018|FG001|STARTED|Overall Study||209
8716888|NCT00991458|9764019|FG002|STARTED|Overall Study||205
8716889|NCT00991458|9764017|FG000|COMPLETED|Overall Study||187
8716890|NCT00991458|9764018|FG001|COMPLETED|Overall Study||181
8716891|NCT00991458|9764019|FG002|COMPLETED|Overall Study||180
8716892|NCT00991458|9764017|FG000|NOT COMPLETED|Overall Study||20
8716893|NCT00991458|9764018|FG001|NOT COMPLETED|Overall Study||28
8716894|NCT00991458|9764019|FG002|NOT COMPLETED|Overall Study||25
8716895|NCT00991510|9764029|FG000|STARTED|Period I (Days 1-14)||22
8716896|NCT00991510|9764030|FG001|STARTED|Period I (Days 1-14)||21
8716897|NCT00991510|9764029|FG000|COMPLETED|Period I (Days 1-14)||21
8716898|NCT00991510|9764030|FG001|COMPLETED|Period I (Days 1-14)||21
8716899|NCT00991510|9764029|FG000|NOT COMPLETED|Period I (Days 1-14)||1
8716900|NCT00991510|9764030|FG001|NOT COMPLETED|Period I (Days 1-14)||0
8716901|NCT00991510|9764029|FG000|STARTED|Period II (Days 15-28)||21
8716902|NCT00991510|9764030|FG001|STARTED|Period II (Days 15-28)||21
8716903|NCT00991510|9764029|FG000|COMPLETED|Period II (Days 15-28)||21
8716904|NCT00991510|9764030|FG001|COMPLETED|Period II (Days 15-28)||21
8716905|NCT00991510|9764029|FG000|NOT COMPLETED|Period II (Days 15-28)||0
8716906|NCT00991510|9764030|FG001|NOT COMPLETED|Period II (Days 15-28)||0
8716907|NCT00991510|9764029|FG000|STARTED|Period III (Days 29-112)||21
8716908|NCT00991510|9764030|FG001|STARTED|Period III (Days 29-112)||21
8716909|NCT00991510|9764029|FG000|COMPLETED|Period III (Days 29-112)||20
8716910|NCT00991510|9764030|FG001|COMPLETED|Period III (Days 29-112)||20
8716911|NCT00991510|9764029|FG000|NOT COMPLETED|Period III (Days 29-112)||1
8716912|NCT00991510|9764030|FG001|NOT COMPLETED|Period III (Days 29-112)||1
8716913|NCT00991809|9764042|FG000|STARTED|Overall Study||12
8716914|NCT00991809|9764043|FG001|STARTED|Overall Study||10
8716915|NCT00991809|9764042|FG000|COMPLETED|Overall Study||8
8716916|NCT00991809|9764043|FG001|COMPLETED|Overall Study||4
8716917|NCT00991809|9764042|FG000|NOT COMPLETED|Overall Study||4
8716918|NCT00991809|9764043|FG001|NOT COMPLETED|Overall Study||6
8716919|NCT00991939|9764053|FG000|STARTED|Overall Study||5
8716920|NCT00991939|9764054|FG001|STARTED|Overall Study||3
8716921|NCT00991939|9764053|FG000|COMPLETED|Overall Study||0
8716922|NCT00991939|9764054|FG001|COMPLETED|Overall Study||1
8716923|NCT00991939|9764053|FG000|NOT COMPLETED|Overall Study||5
8716924|NCT00991939|9764054|FG001|NOT COMPLETED|Overall Study||2
8716925|NCT00991952|9764064|FG000|STARTED|Overall Study||13
8716926|NCT00991952|9764065|FG001|STARTED|Overall Study||6
8716927|NCT00991952|9764064|FG000|COMPLETED|Overall Study||13
8716928|NCT00991952|9764065|FG001|COMPLETED|Overall Study||5
8716929|NCT00991952|9764064|FG000|NOT COMPLETED|Overall Study||0
8716930|NCT00991952|9764065|FG001|NOT COMPLETED|Overall Study||1
8716931|NCT00992017|9764071|FG000|STARTED|Overall Study|Two additional women were enrolled but left the clinic before vaccine was administered.|128
8716932|NCT00992017|9764071|FG000|Received Both Study Vaccinations|Overall Study||124
8716933|NCT00992017|9764071|FG000|Received Only One Study Vaccination|Overall Study|Reasons: delivered and LFU; moved; no transportation; ineligible - blood transfusion at delivery|4
8716934|NCT00992017|9764071|FG000|COMPLETED|Overall Study||118
8716935|NCT00992017|9764071|FG000|NOT COMPLETED|Overall Study||10
8716936|NCT00992056|9764082|FG000|STARTED|Treatment Period 1 (6 Weeks)||12
8716937|NCT00992056|9764083|FG001|STARTED|Treatment Period 1 (6 Weeks)||12
8716938|NCT00992056|9764082|FG000|COMPLETED|Treatment Period 1 (6 Weeks)|February 2012|11
8716939|NCT00992056|9764083|FG001|COMPLETED|Treatment Period 1 (6 Weeks)||10
8716940|NCT00992056|9764082|FG000|NOT COMPLETED|Treatment Period 1 (6 Weeks)||1
8716941|NCT00992056|9764083|FG001|NOT COMPLETED|Treatment Period 1 (6 Weeks)||2
8716942|NCT00992056|9764082|FG000|STARTED|Washout Period (2 Weeks)||11
8716943|NCT00992056|9764083|FG001|STARTED|Washout Period (2 Weeks)||10
8716944|NCT00992056|9764082|FG000|COMPLETED|Washout Period (2 Weeks)||10
8716945|NCT00992056|9764083|FG001|COMPLETED|Washout Period (2 Weeks)||10
8716946|NCT00992056|9764082|FG000|NOT COMPLETED|Washout Period (2 Weeks)||1
8716947|NCT00992056|9764083|FG001|NOT COMPLETED|Washout Period (2 Weeks)||0
8716948|NCT00992056|9764082|FG000|STARTED|Treatment Period 2 (6 Weeks)||10
8716949|NCT00992056|9764083|FG001|STARTED|Treatment Period 2 (6 Weeks)||10
8716950|NCT00992056|9764082|FG000|COMPLETED|Treatment Period 2 (6 Weeks)||10
8716951|NCT00992056|9764083|FG001|COMPLETED|Treatment Period 2 (6 Weeks)||10
8716952|NCT00992056|9764082|FG000|NOT COMPLETED|Treatment Period 2 (6 Weeks)||0
8716953|NCT00992056|9764083|FG001|NOT COMPLETED|Treatment Period 2 (6 Weeks)||0
8716954|NCT00992108|9764091|FG000|STARTED|Overall Study||7
8716955|NCT00992108|9764092|FG001|STARTED|Overall Study||10
8716956|NCT00992108|9764091|FG000|COMPLETED|Overall Study||7
8716957|NCT00992108|9764092|FG001|COMPLETED|Overall Study||9
8716958|NCT00992108|9764091|FG000|NOT COMPLETED|Overall Study||0
8716959|NCT00992108|9764092|FG001|NOT COMPLETED|Overall Study||1
8716960|NCT00992186|9764098|FG000|STARTED|Overall Study||46
8716961|NCT00992186|9764098|FG000|COMPLETED|Overall Study||0
8716962|NCT00992186|9764098|FG000|NOT COMPLETED|Overall Study||46
8716963|NCT00992225|9764103|FG000|STARTED|Overall Study||43
8716964|NCT00992225|9764103|FG000|Received at Least One Dose of Study Drug|Overall Study||33
8716965|NCT00992225|9764103|FG000|COMPLETED|Overall Study||33
8716966|NCT00992225|9764103|FG000|NOT COMPLETED|Overall Study||10
8716967|NCT00992264|9764123|FG000|STARTED|Overall Study||116
8716968|NCT00992264|9764124|FG001|STARTED|Overall Study||116
8716969|NCT00992264|9764125|FG002|STARTED|Overall Study||117
8716970|NCT00992264|9764126|FG003|STARTED|Overall Study||117
8716971|NCT00992264|9764127|FG004|STARTED|Overall Study||117
8716972|NCT00992264|9764128|FG005|STARTED|Overall Study||117
8716973|NCT00992264|9764129|FG006|STARTED|Overall Study||116
8716974|NCT00992264|9764130|FG007|STARTED|Overall Study||117
8716975|NCT00992264|9764131|FG008|STARTED|Overall Study||116
8716976|NCT00992264|9764132|FG009|STARTED|Overall Study||116
8716977|NCT00992264|9764133|FG010|STARTED|Overall Study||117
8716978|NCT00992264|9764134|FG011|STARTED|Overall Study||117
8716979|NCT00992264|9764135|FG012|STARTED|Overall Study||116
8716980|NCT00992264|9764136|FG013|STARTED|Overall Study||117
8716981|NCT00992264|9764137|FG014|STARTED|Overall Study||117
8716982|NCT00992264|9764138|FG015|STARTED|Overall Study||116
8716983|NCT00992264|9764123|FG000|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
8716984|NCT00992264|9764124|FG001|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
8716985|NCT00992264|9764125|FG002|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
8716986|NCT00992264|9764126|FG003|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
8716987|NCT00992264|9764127|FG004|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
8716988|NCT00992264|9764128|FG005|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
8716989|NCT00992264|9764129|FG006|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
8716990|NCT00992264|9764130|FG007|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
8716991|NCT00992264|9764131|FG008|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
8716992|NCT00992264|9764132|FG009|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
8716993|NCT00992264|9764133|FG010|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
8716994|NCT00992264|9764134|FG011|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
8716995|NCT00992264|9764135|FG012|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
8716996|NCT00992264|9764136|FG013|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
8716997|NCT00992264|9764137|FG014|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
8716998|NCT00992264|9764138|FG015|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
8716999|NCT00992264|9764123|FG000|NOT COMPLETED|Overall Study||0
8717000|NCT00992264|9764124|FG001|NOT COMPLETED|Overall Study||0
8717001|NCT00992264|9764125|FG002|NOT COMPLETED|Overall Study||0
8717002|NCT00992264|9764126|FG003|NOT COMPLETED|Overall Study||0
8717003|NCT00992264|9764127|FG004|NOT COMPLETED|Overall Study||0
8717004|NCT00992264|9764128|FG005|NOT COMPLETED|Overall Study||0
8717005|NCT00992264|9764129|FG006|NOT COMPLETED|Overall Study||0
8717006|NCT00992264|9764130|FG007|NOT COMPLETED|Overall Study||0
8717007|NCT00992264|9764131|FG008|NOT COMPLETED|Overall Study||0
8717008|NCT00992264|9764132|FG009|NOT COMPLETED|Overall Study||0
8717009|NCT00992264|9764133|FG010|NOT COMPLETED|Overall Study||0
8717010|NCT00992264|9764134|FG011|NOT COMPLETED|Overall Study||0
8717011|NCT00992264|9764135|FG012|NOT COMPLETED|Overall Study||0
8717012|NCT00992264|9764136|FG013|NOT COMPLETED|Overall Study||0
8717013|NCT00992264|9764137|FG014|NOT COMPLETED|Overall Study||0
8717014|NCT00992264|9764138|FG015|NOT COMPLETED|Overall Study||0
8717015|NCT00992394|9764151|FG000|STARTED|Overall Study||88
8717016|NCT00992394|9764152|FG001|STARTED|Overall Study||86
8717017|NCT00992394|9764151|FG000|Safety Population|Overall Study||87
8717018|NCT00992394|9764152|FG001|Safety Population|Overall Study||84
8717019|NCT00992394|9764151|FG000|mITT Population|Overall Study||86
8717020|NCT00992394|9764152|FG001|mITT Population|Overall Study||84
8717021|NCT00992394|9764151|FG000|COMPLETED|Overall Study||64
8717022|NCT00992394|9764152|FG001|COMPLETED|Overall Study||72
8717023|NCT00992394|9764151|FG000|NOT COMPLETED|Overall Study||24
8717024|NCT00992394|9764152|FG001|NOT COMPLETED|Overall Study||14
8717025|NCT00992407|9764160|FG000|STARTED|Overall Study||37
8616960|NCT00454363|9655147|FG001|COMPLETED|Overall Study||29
8616961|NCT00454363|9655146|FG000|NOT COMPLETED|Overall Study||5
8616962|NCT00454363|9655147|FG001|NOT COMPLETED|Overall Study||2
8616963|NCT00454532|9655156|FG000|STARTED|Overall Study||11
8616964|NCT00454532|9655157|FG001|STARTED|Overall Study||6
8616965|NCT00454532|9655158|FG002|STARTED|Overall Study||3
8616966|NCT00454532|9655159|FG003|STARTED|Overall Study||7
8616967|NCT00454532|9655156|FG000|COMPLETED|Overall Study||11
8616968|NCT00454532|9655157|FG001|COMPLETED|Overall Study||6
8616969|NCT00454532|9655158|FG002|COMPLETED|Overall Study||3
8616970|NCT00454532|9655159|FG003|COMPLETED|Overall Study||7
8616971|NCT00454532|9655156|FG000|NOT COMPLETED|Overall Study||0
8616972|NCT00454532|9655157|FG001|NOT COMPLETED|Overall Study||0
8616973|NCT00454532|9655158|FG002|NOT COMPLETED|Overall Study||0
8616974|NCT00454532|9655159|FG003|NOT COMPLETED|Overall Study||0
8717026|NCT00992407|9764161|FG001|STARTED|Overall Study||38
8717027|NCT00992407|9764160|FG000|Treated|Overall Study||20
8717028|NCT00992407|9764161|FG001|Treated|Overall Study||25
8717029|NCT00992407|9764160|FG000|COMPLETED|Overall Study||6
8717030|NCT00992407|9764161|FG001|COMPLETED|Overall Study||14
8717031|NCT00992407|9764160|FG000|NOT COMPLETED|Overall Study||31
8717032|NCT00992407|9764161|FG001|NOT COMPLETED|Overall Study||24
8717033|NCT00992433|9764172|FG000|STARTED|Overall Study||95
8717034|NCT00992433|9764173|FG001|STARTED|Overall Study||97
8717035|NCT00992433|9764172|FG000|COMPLETED|Overall Study||91
8717036|NCT00992433|9764173|FG001|COMPLETED|Overall Study||90
8717037|NCT00992433|9764172|FG000|NOT COMPLETED|Overall Study||4
8717038|NCT00992433|9764173|FG001|NOT COMPLETED|Overall Study||7
8717039|NCT00992446|9764179|FG000|STARTED|Overall Study||27
8717040|NCT00992446|9764179|FG000|COMPLETED|Overall Study||19
8717041|NCT00992446|9764179|FG000|NOT COMPLETED|Overall Study||8
8717042|NCT00992459|9764185|FG000|STARTED|Overall Study|All patients received HPN 100 placebo in Arm A (+ concomitant active NaPBA)|22
8717043|NCT00992459|9764186|FG001|STARTED|Overall Study|All patients received NaPBA placebo in Arm B (+ concomitant active HPN 100)|24
8717044|NCT00992459|9764185|FG000|COMPLETED|Overall Study|Totals enrolled and completed in Arm A NaPBA treatment + HPN 100 Placebo are not mutually exclusive.|21
8717045|NCT00992459|9764186|FG001|COMPLETED|Overall Study|Totals enrolled and completed in Arm B HPN 100 treatment + NaPBA Placebo are not mutually exclusive.|23
8928273|NCT02279667|9989450|FG002|NOT COMPLETED|Overall Study||0
8717046|NCT00992459|9764185|FG000|NOT COMPLETED|Overall Study||1
8717047|NCT00992459|9764186|FG001|NOT COMPLETED|Overall Study||1
8717048|NCT00992511|9764196|FG000|STARTED|Overall Study||76
8717049|NCT00992511|9764197|FG001|STARTED|Overall Study||73
8717050|NCT00992511|9764198|FG002|STARTED|Overall Study||76
8717051|NCT00992511|9764199|FG003|STARTED|Overall Study||75
8717052|NCT00992511|9764196|FG000|COMPLETED|Overall Study||74
8717053|NCT00992511|9764197|FG001|COMPLETED|Overall Study||73
8717054|NCT00992511|9764198|FG002|COMPLETED|Overall Study||74
8717055|NCT00992511|9764199|FG003|COMPLETED|Overall Study||70
8717056|NCT00992511|9764196|FG000|NOT COMPLETED|Overall Study||2
8717057|NCT00992511|9764197|FG001|NOT COMPLETED|Overall Study||0
8717058|NCT00992511|9764198|FG002|NOT COMPLETED|Overall Study||2
8717059|NCT00992511|9764199|FG003|NOT COMPLETED|Overall Study||5
8717060|NCT00992589|9764209|FG000|STARTED|Open-Label Phase||344
8717061|NCT00992589|9764210|FG001|STARTED|Open-Label Phase||0
8717062|NCT00992589|9764211|FG002|STARTED|Open-Label Phase||0
8717063|NCT00992589|9764212|FG003|STARTED|Open-Label Phase||0
8717064|NCT00992589|9764209|FG000|COMPLETED|Open-Label Phase||267
8717065|NCT00992589|9764210|FG001|COMPLETED|Open-Label Phase||0
8717066|NCT00992589|9764211|FG002|COMPLETED|Open-Label Phase||0
8717067|NCT00992589|9764212|FG003|COMPLETED|Open-Label Phase||0
8717068|NCT00992589|9764209|FG000|NOT COMPLETED|Open-Label Phase||77
8717069|NCT00992589|9764210|FG001|NOT COMPLETED|Open-Label Phase||0
8717070|NCT00992589|9764211|FG002|NOT COMPLETED|Open-Label Phase||0
8717071|NCT00992589|9764212|FG003|NOT COMPLETED|Open-Label Phase||0
8717072|NCT00992589|9764209|FG000|STARTED|Double-Blind Phase||0
8717073|NCT00992589|9764210|FG001|STARTED|Double-Blind Phase||89
8717074|NCT00992589|9764211|FG002|STARTED|Double-Blind Phase||90
8717075|NCT00992589|9764212|FG003|STARTED|Double-Blind Phase||88
8717076|NCT00992589|9764209|FG000|COMPLETED|Double-Blind Phase||0
8717077|NCT00992589|9764210|FG001|COMPLETED|Double-Blind Phase||76
8717078|NCT00992589|9764211|FG002|COMPLETED|Double-Blind Phase||77
8717079|NCT00992589|9764212|FG003|COMPLETED|Double-Blind Phase||78
8717080|NCT00992589|9764209|FG000|NOT COMPLETED|Double-Blind Phase||0
8717081|NCT00992589|9764210|FG001|NOT COMPLETED|Double-Blind Phase||13
8717082|NCT00992589|9764211|FG002|NOT COMPLETED|Double-Blind Phase||13
8717083|NCT00992589|9764212|FG003|NOT COMPLETED|Double-Blind Phase||10
8717084|NCT00992602|9764230|FG000|STARTED|Overall Study||3
8717085|NCT00992602|9764230|FG000|COMPLETED|Overall Study||0
8717086|NCT00992602|9764230|FG000|NOT COMPLETED|Overall Study||3
8717087|NCT00992719|9764237|FG000|STARTED|Overall Study||28
8717088|NCT00992719|9764238|FG001|STARTED|Overall Study||28
8717089|NCT00992719|9764239|FG002|STARTED|Overall Study||28
8717090|NCT00992719|9764237|FG000|COMPLETED|Overall Study||27
8717091|NCT00992719|9764238|FG001|COMPLETED|Overall Study||27
8717092|NCT00992719|9764239|FG002|COMPLETED|Overall Study||28
8717093|NCT00992719|9764237|FG000|NOT COMPLETED|Overall Study||1
8717094|NCT00992719|9764238|FG001|NOT COMPLETED|Overall Study||1
8717095|NCT00992719|9764239|FG002|NOT COMPLETED|Overall Study||0
8717096|NCT00992784|9764250|FG000|STARTED|Overall Study||180
8717097|NCT00992784|9764251|FG001|STARTED|Overall Study||104
8717098|NCT00992784|9764252|FG002|STARTED|Overall Study||86
8717099|NCT00992784|9764250|FG000|COMPLETED|Overall Study||177
8717100|NCT00992784|9764251|FG001|COMPLETED|Overall Study||102
8717101|NCT00992784|9764252|FG002|COMPLETED|Overall Study||85
8717102|NCT00992784|9764250|FG000|NOT COMPLETED|Overall Study||3
8717103|NCT00992784|9764251|FG001|NOT COMPLETED|Overall Study||2
8717104|NCT00992784|9764252|FG002|NOT COMPLETED|Overall Study||1
8717105|NCT00992836|9764260|FG000|STARTED|Overall Study||155
8717106|NCT00992836|9764260|FG000|Received Both Study Vaccinations|Overall Study||150
8717107|NCT00992836|9764260|FG000|COMPLETED|Overall Study||150
8717108|NCT00992836|9764260|FG000|NOT COMPLETED|Overall Study||5
8717109|NCT00992927|9764272|FG000|STARTED|Overall Study||32
8717110|NCT00992927|9764273|FG001|STARTED|Overall Study||22
8717111|NCT00992927|9764272|FG000|COMPLETED|Overall Study||32
8928274|NCT02279732|9989461|FG000|STARTED|Overall Study||98
8717112|NCT00992927|9764273|FG001|COMPLETED|Overall Study||22
8717113|NCT00992927|9764272|FG000|NOT COMPLETED|Overall Study||0
8717114|NCT00992927|9764273|FG001|NOT COMPLETED|Overall Study||0
8717115|NCT00992992|9764279|FG000|STARTED|Overall Study||25
8717116|NCT00992992|9764279|FG000|COMPLETED|Overall Study||0
8717117|NCT00992992|9764279|FG000|NOT COMPLETED|Overall Study||25
8717118|NCT00993031|9764285|FG000|STARTED|Overall Study||195
8717119|NCT00993031|9764286|FG001|STARTED|Overall Study||194
8717120|NCT00993031|9764285|FG000|Delivered|Overall Study||187
8717121|NCT00993031|9764286|FG001|Delivered|Overall Study||190
8717122|NCT00993031|9764285|FG000|COMPLETED|Overall Study||173
8717123|NCT00993031|9764286|FG001|COMPLETED|Overall Study||175
8717124|NCT00993031|9764285|FG000|NOT COMPLETED|Overall Study||22
8717125|NCT00993031|9764286|FG001|NOT COMPLETED|Overall Study||19
8717126|NCT00993044|9764296|FG000|STARTED|Irinotecan 30 mg||6
8717127|NCT00993044|9764296|FG000|COMPLETED|Irinotecan 30 mg||6
8717128|NCT00993044|9764296|FG000|NOT COMPLETED|Irinotecan 30 mg||0
8717129|NCT00993044|9764296|FG000|STARTED|Irinotecan 50 mg||7
8717130|NCT00993044|9764296|FG000|COMPLETED|Irinotecan 50 mg||6
8717131|NCT00993044|9764296|FG000|NOT COMPLETED|Irinotecan 50 mg||1
8717132|NCT00993148|9764301|FG000|STARTED|Overall Study||25
8717133|NCT00993148|9764301|FG000|COMPLETED|Overall Study||22
8717134|NCT00993148|9764301|FG000|NOT COMPLETED|Overall Study||3
8717135|NCT00993187|9764307|FG000|STARTED|Overall Study||147
8717136|NCT00993187|9764308|FG001|STARTED|Overall Study||145
8717137|NCT00993187|9764307|FG000|Received at Least 1 Dose of Study Drug|Overall Study||146
8717138|NCT00993187|9764308|FG001|Received at Least 1 Dose of Study Drug|Overall Study||144
8717139|NCT00993187|9764307|FG000|COMPLETED|Overall Study||121
8717140|NCT00993187|9764308|FG001|COMPLETED|Overall Study||108
8717141|NCT00993187|9764307|FG000|NOT COMPLETED|Overall Study||26
8717142|NCT00993187|9764308|FG001|NOT COMPLETED|Overall Study||37
8717143|NCT00993200|9764316|FG000|STARTED|Overall Study||13
8717144|NCT00993200|9764317|FG001|STARTED|Overall Study||13
8717145|NCT00993200|9764316|FG000|COMPLETED|Overall Study||13
8717146|NCT00993200|9764317|FG001|COMPLETED|Overall Study||13
8717147|NCT00993200|9764316|FG000|NOT COMPLETED|Overall Study||0
8717148|NCT00993200|9764317|FG001|NOT COMPLETED|Overall Study||0
8717149|NCT00993226|9764328|FG000|STARTED|Overall Study||61
8717150|NCT00993226|9764329|FG001|STARTED|Overall Study||27
8717151|NCT00993226|9764330|FG002|STARTED|Overall Study||27
8717152|NCT00993226|9764328|FG000|COMPLETED|Overall Study||60
8717153|NCT00993226|9764329|FG001|COMPLETED|Overall Study||26
8717154|NCT00993226|9764330|FG002|COMPLETED|Overall Study||27
8717155|NCT00993226|9764328|FG000|NOT COMPLETED|Overall Study||1
8717156|NCT00993226|9764329|FG001|NOT COMPLETED|Overall Study||1
8717157|NCT00993226|9764330|FG002|NOT COMPLETED|Overall Study||0
8717158|NCT00993265|9764340|FG000|STARTED|Overall Study||20
8717159|NCT00993265|9764341|FG001|STARTED|Overall Study||19
8717160|NCT00993265|9764340|FG000|COMPLETED|Overall Study||16
8717161|NCT00993265|9764341|FG001|COMPLETED|Overall Study||19
8717162|NCT00993265|9764340|FG000|NOT COMPLETED|Overall Study||4
8717163|NCT00993265|9764341|FG001|NOT COMPLETED|Overall Study||0
8717164|NCT00993291|9764347|FG000|STARTED|Overall Study||20
8717165|NCT00993291|9764347|FG000|COMPLETED|Overall Study||19
8717166|NCT00993291|9764347|FG000|NOT COMPLETED|Overall Study||1
8717167|NCT00993317|9764353|FG000|STARTED|Overall Study||42
8717168|NCT00993317|9764354|FG001|STARTED|Overall Study||85
8717169|NCT00993317|9764353|FG000|COMPLETED|Overall Study||21
8717170|NCT00993317|9764354|FG001|COMPLETED|Overall Study||60
8717171|NCT00993317|9764353|FG000|NOT COMPLETED|Overall Study||21
8717172|NCT00993317|9764354|FG001|NOT COMPLETED|Overall Study||25
8717173|NCT00993421|9764367|FG000|STARTED|Overall Study||49
8717174|NCT00993421|9764368|FG001|STARTED|Overall Study||49
8717175|NCT00993421|9764369|FG002|STARTED|Overall Study||48
8717176|NCT00993421|9764370|FG003|STARTED|Overall Study||49
8717177|NCT00993421|9764371|FG004|STARTED|Overall Study||52
8717178|NCT00993421|9764372|FG005|STARTED|Overall Study||50
8717179|NCT00993421|9764373|FG006|STARTED|Overall Study||46
8717180|NCT00993421|9764367|FG000|COMPLETED|Overall Study||5
8717181|NCT00993421|9764368|FG001|COMPLETED|Overall Study||4
8717182|NCT00993421|9764369|FG002|COMPLETED|Overall Study||5
8717183|NCT00993421|9764370|FG003|COMPLETED|Overall Study||4
8717184|NCT00993421|9764371|FG004|COMPLETED|Overall Study||6
8717185|NCT00993421|9764372|FG005|COMPLETED|Overall Study||4
8717186|NCT00993421|9764373|FG006|COMPLETED|Overall Study||4
8717187|NCT00993421|9764367|FG000|NOT COMPLETED|Overall Study||44
8717188|NCT00993421|9764368|FG001|NOT COMPLETED|Overall Study||45
8717189|NCT00993421|9764369|FG002|NOT COMPLETED|Overall Study||43
8717190|NCT00993421|9764370|FG003|NOT COMPLETED|Overall Study||45
8717191|NCT00993421|9764371|FG004|NOT COMPLETED|Overall Study||46
8717192|NCT00993421|9764372|FG005|NOT COMPLETED|Overall Study||46
8717193|NCT00993421|9764373|FG006|NOT COMPLETED|Overall Study||42
8717194|NCT00993473|9764391|FG000|STARTED|Overall Study|61 patients randomized to Lantus but 62 patients treated with Lantus due to a dispensation's error|61
8717195|NCT00993473|9764392|FG001|STARTED|Overall Study|64 patients randomized to NPH but only 63 patients treated with NPH due to a dispensation's error|64
8717196|NCT00993473|9764391|FG000|COMPLETED|Overall Study||57
8717197|NCT00993473|9764392|FG001|COMPLETED|Overall Study||54
8717198|NCT00993473|9764391|FG000|NOT COMPLETED|Overall Study||4
8717199|NCT00993473|9764392|FG001|NOT COMPLETED|Overall Study||10
8717200|NCT00993499|9764404|FG000|STARTED|Run-in Period (8 Days)||13
8717201|NCT00993499|9764405|FG001|STARTED|Run-in Period (8 Days)||12
8717202|NCT00993499|9764406|FG002|STARTED|Run-in Period (8 Days)||10
8717203|NCT00993499|9764407|FG003|STARTED|Run-in Period (8 Days)||3
8717204|NCT00993499|9764408|FG004|STARTED|Run-in Period (8 Days)||3
8717205|NCT00993499|9764409|FG005|STARTED|Run-in Period (8 Days)||3
8717206|NCT00993499|9764404|FG000|COMPLETED|Run-in Period (8 Days)||12
8717207|NCT00993499|9764405|FG001|COMPLETED|Run-in Period (8 Days)||9
8717208|NCT00993499|9764406|FG002|COMPLETED|Run-in Period (8 Days)||9
8717209|NCT00993499|9764407|FG003|COMPLETED|Run-in Period (8 Days)||3
8717210|NCT00993499|9764408|FG004|COMPLETED|Run-in Period (8 Days)||3
8717211|NCT00993499|9764409|FG005|COMPLETED|Run-in Period (8 Days)||3
8717212|NCT00993499|9764404|FG000|NOT COMPLETED|Run-in Period (8 Days)||1
8717213|NCT00993499|9764405|FG001|NOT COMPLETED|Run-in Period (8 Days)||3
8717214|NCT00993499|9764406|FG002|NOT COMPLETED|Run-in Period (8 Days)||1
8717215|NCT00993499|9764407|FG003|NOT COMPLETED|Run-in Period (8 Days)||0
8717216|NCT00993499|9764408|FG004|NOT COMPLETED|Run-in Period (8 Days)||0
8717217|NCT00993499|9764409|FG005|NOT COMPLETED|Run-in Period (8 Days)||0
8717218|NCT00993499|9764404|FG000|STARTED|Discontinued Before Starting Course 3||12
8717219|NCT00993499|9764405|FG001|STARTED|Discontinued Before Starting Course 3||9
8717220|NCT00993499|9764406|FG002|STARTED|Discontinued Before Starting Course 3||9
8717221|NCT00993499|9764407|FG003|STARTED|Discontinued Before Starting Course 3||3
8717222|NCT00993499|9764408|FG004|STARTED|Discontinued Before Starting Course 3||3
8717223|NCT00993499|9764409|FG005|STARTED|Discontinued Before Starting Course 3||3
8717224|NCT00993499|9764404|FG000|COMPLETED|Discontinued Before Starting Course 3||8
8717225|NCT00993499|9764405|FG001|COMPLETED|Discontinued Before Starting Course 3||5
8717226|NCT00993499|9764406|FG002|COMPLETED|Discontinued Before Starting Course 3||6
8717227|NCT00993499|9764407|FG003|COMPLETED|Discontinued Before Starting Course 3||2
8717228|NCT00993499|9764408|FG004|COMPLETED|Discontinued Before Starting Course 3||3
8717229|NCT00993499|9764409|FG005|COMPLETED|Discontinued Before Starting Course 3||3
8717230|NCT00993499|9764404|FG000|NOT COMPLETED|Discontinued Before Starting Course 3||4
8717231|NCT00993499|9764405|FG001|NOT COMPLETED|Discontinued Before Starting Course 3||4
8717232|NCT00993499|9764406|FG002|NOT COMPLETED|Discontinued Before Starting Course 3||3
8717233|NCT00993499|9764407|FG003|NOT COMPLETED|Discontinued Before Starting Course 3||1
8717234|NCT00993499|9764408|FG004|NOT COMPLETED|Discontinued Before Starting Course 3||0
8717235|NCT00993499|9764409|FG005|NOT COMPLETED|Discontinued Before Starting Course 3||0
8717236|NCT00993499|9764404|FG000|STARTED|Discontinued After Starting Course 3||12
8717237|NCT00993499|9764405|FG001|STARTED|Discontinued After Starting Course 3||9
8717238|NCT00993499|9764406|FG002|STARTED|Discontinued After Starting Course 3||9
8717239|NCT00993499|9764407|FG003|STARTED|Discontinued After Starting Course 3||3
8717240|NCT00993499|9764408|FG004|STARTED|Discontinued After Starting Course 3||3
8717241|NCT00993499|9764409|FG005|STARTED|Discontinued After Starting Course 3||3
8717242|NCT00993499|9764404|FG000|COMPLETED|Discontinued After Starting Course 3||4
8717243|NCT00993499|9764405|FG001|COMPLETED|Discontinued After Starting Course 3||4
8717244|NCT00993499|9764406|FG002|COMPLETED|Discontinued After Starting Course 3||3
8717245|NCT00993499|9764407|FG003|COMPLETED|Discontinued After Starting Course 3||1
8717246|NCT00993499|9764408|FG004|COMPLETED|Discontinued After Starting Course 3||0
8717247|NCT00993499|9764409|FG005|COMPLETED|Discontinued After Starting Course 3||0
8717248|NCT00993499|9764404|FG000|NOT COMPLETED|Discontinued After Starting Course 3||8
8717249|NCT00993499|9764405|FG001|NOT COMPLETED|Discontinued After Starting Course 3||5
8717250|NCT00993499|9764406|FG002|NOT COMPLETED|Discontinued After Starting Course 3||6
8717251|NCT00993499|9764407|FG003|NOT COMPLETED|Discontinued After Starting Course 3||2
8717252|NCT00993499|9764408|FG004|NOT COMPLETED|Discontinued After Starting Course 3||3
8717253|NCT00993499|9764409|FG005|NOT COMPLETED|Discontinued After Starting Course 3||3
8717254|NCT00993616|9764423|FG000|STARTED|Overall Study||29
8717255|NCT00993616|9764423|FG000|COMPLETED|Overall Study|Number of eligible and evaluable participants|27
8717256|NCT00993616|9764423|FG000|NOT COMPLETED|Overall Study||2
8717257|NCT00993655|9764436|FG000|STARTED|Overall Study||101
8717258|NCT00993655|9764437|FG001|STARTED|Overall Study||72
8717259|NCT00993655|9764438|FG002|STARTED|Overall Study||102
8717260|NCT00993655|9764436|FG000|COMPLETED|Overall Study||101
8717261|NCT00993655|9764437|FG001|COMPLETED|Overall Study||72
8717262|NCT00993655|9764438|FG002|COMPLETED|Overall Study||102
8717263|NCT00993655|9764436|FG000|NOT COMPLETED|Overall Study||0
8717264|NCT00993655|9764437|FG001|NOT COMPLETED|Overall Study||0
8717265|NCT00993655|9764438|FG002|NOT COMPLETED|Overall Study||0
8717266|NCT00993668|9764451|FG000|STARTED|Single-Blind Period||114
8717267|NCT00993668|9764452|FG001|STARTED|Single-Blind Period||110
8717268|NCT00993668|9764451|FG000|COMPLETED|Single-Blind Period||110
8717269|NCT00993668|9764452|FG001|COMPLETED|Single-Blind Period||107
8717270|NCT00993668|9764451|FG000|NOT COMPLETED|Single-Blind Period||4
8717271|NCT00993668|9764452|FG001|NOT COMPLETED|Single-Blind Period||3
8717272|NCT00993668|9764451|FG000|STARTED|Open-Label Period|1 subject chose not to enter the optional open-label period|109
8717273|NCT00993668|9764452|FG001|STARTED|Open-Label Period|1 subject chose not to enter the optional open-label period|106
8717274|NCT00993668|9764451|FG000|COMPLETED|Open-Label Period||86
8717275|NCT00993668|9764452|FG001|COMPLETED|Open-Label Period||91
8717276|NCT00993668|9764451|FG000|NOT COMPLETED|Open-Label Period||23
8717277|NCT00993668|9764452|FG001|NOT COMPLETED|Open-Label Period||15
8717278|NCT00993798|9764462|FG000|STARTED|Overall Study||53
8717279|NCT00993798|9764463|FG001|STARTED|Overall Study||25
8717280|NCT00993798|9764464|FG002|STARTED|Overall Study||29
8717281|NCT00993798|9764465|FG003|STARTED|Overall Study||0
8717282|NCT00993798|9764466|FG004|STARTED|Overall Study||0
8717283|NCT00993798|9764462|FG000|COMPLETED|Overall Study||53
8717284|NCT00993798|9764463|FG001|COMPLETED|Overall Study||25
8717285|NCT00993798|9764464|FG002|COMPLETED|Overall Study||29
8717286|NCT00993798|9764465|FG003|COMPLETED|Overall Study||0
8717287|NCT00993798|9764466|FG004|COMPLETED|Overall Study||0
8717288|NCT00993798|9764462|FG000|NOT COMPLETED|Overall Study||0
8717289|NCT00993798|9764463|FG001|NOT COMPLETED|Overall Study||0
8717290|NCT00993798|9764464|FG002|NOT COMPLETED|Overall Study||0
8717291|NCT00993798|9764465|FG003|NOT COMPLETED|Overall Study||0
8717292|NCT00993798|9764466|FG004|NOT COMPLETED|Overall Study||0
8717293|NCT00993824|9764476|FG000|STARTED|Overall Study||11
8717294|NCT00993824|9764477|FG001|STARTED|Overall Study||10
8717295|NCT00993824|9764476|FG000|COMPLETED|Overall Study||11
8717296|NCT00993824|9764477|FG001|COMPLETED|Overall Study||10
8717297|NCT00993824|9764476|FG000|NOT COMPLETED|Overall Study||0
8717298|NCT00993824|9764477|FG001|NOT COMPLETED|Overall Study||0
8717299|NCT00993915|9764485|FG000|STARTED|Overall Study||687
8717300|NCT00993915|9764485|FG000|COMPLETED|Overall Study||678
8717301|NCT00993915|9764485|FG000|NOT COMPLETED|Overall Study||9
8717302|NCT00993928|9764491|FG000|STARTED|Overall Study||48
8717303|NCT00993928|9764492|FG001|STARTED|Overall Study||45
8717304|NCT00993928|9764491|FG000|COMPLETED|Overall Study||43
8717305|NCT00993928|9764492|FG001|COMPLETED|Overall Study||38
8717306|NCT00993928|9764491|FG000|NOT COMPLETED|Overall Study||5
8717307|NCT00993928|9764492|FG001|NOT COMPLETED|Overall Study||7
8717308|NCT00993954|9764504|FG000|STARTED|Overall Study||145
8717309|NCT00993954|9764505|FG001|STARTED|Overall Study||123
8717310|NCT00993954|9764504|FG000|COMPLETED|Overall Study||124
8717311|NCT00993954|9764505|FG001|COMPLETED|Overall Study||121
8717312|NCT00993954|9764504|FG000|NOT COMPLETED|Overall Study||21
8717313|NCT00993954|9764505|FG001|NOT COMPLETED|Overall Study||2
8717314|NCT00993967|9764511|FG000|STARTED|Overall Study||200
8717315|NCT00993967|9764511|FG000|COMPLETED|Overall Study||139
8717316|NCT00993967|9764511|FG000|NOT COMPLETED|Overall Study||61
8717317|NCT00994110|9764517|FG000|STARTED|Overall Study||217
8717318|NCT00994110|9764518|FG001|STARTED|Overall Study||222
8717319|NCT00994110|9764517|FG000|COMPLETED|Overall Study||152
8717320|NCT00994110|9764518|FG001|COMPLETED|Overall Study||148
8717321|NCT00994110|9764517|FG000|NOT COMPLETED|Overall Study||65
8717322|NCT00994110|9764518|FG001|NOT COMPLETED|Overall Study||74
8717323|NCT00994123|9764527|FG000|STARTED|Overall Study||33
8717324|NCT00994123|9764528|FG001|STARTED|Overall Study||85
8717325|NCT00994123|9764529|FG002|STARTED|Overall Study||44
8717326|NCT00994123|9764527|FG000|COMPLETED|Overall Study||33
8717327|NCT00994123|9764528|FG001|COMPLETED|Overall Study||85
8717328|NCT00994123|9764529|FG002|COMPLETED|Overall Study||44
8717329|NCT00994123|9764527|FG000|NOT COMPLETED|Overall Study||0
8717330|NCT00994123|9764528|FG001|NOT COMPLETED|Overall Study||0
8717331|NCT00994123|9764529|FG002|NOT COMPLETED|Overall Study||0
8717332|NCT00994175|9764548|FG000|STARTED|First Intervention||6
8717333|NCT00994175|9764549|FG001|STARTED|First Intervention||9
8717334|NCT00994175|9764548|FG000|COMPLETED|First Intervention||4
8717335|NCT00994175|9764549|FG001|COMPLETED|First Intervention||8
8717336|NCT00994175|9764548|FG000|NOT COMPLETED|First Intervention||2
8717337|NCT00994175|9764549|FG001|NOT COMPLETED|First Intervention||1
8717338|NCT00994175|9764548|FG000|STARTED|Second Intervention||4
8717339|NCT00994175|9764549|FG001|STARTED|Second Intervention||8
8717340|NCT00994175|9764548|FG000|COMPLETED|Second Intervention||4
8717341|NCT00994175|9764549|FG001|COMPLETED|Second Intervention||8
8717342|NCT00994175|9764548|FG000|NOT COMPLETED|Second Intervention||0
8717343|NCT00994175|9764549|FG001|NOT COMPLETED|Second Intervention||0
8717344|NCT00994214|9764559|FG000|STARTED|ITT (Intention-to-Treat) - Part A||19
8717345|NCT00994214|9764560|FG001|STARTED|ITT (Intention-to-Treat) - Part A||19
8717346|NCT00994214|9764561|FG002|STARTED|ITT (Intention-to-Treat) - Part A||18
8717347|NCT00994214|9764562|FG003|STARTED|ITT (Intention-to-Treat) - Part A||20
8717348|NCT00994214|9764559|FG000|COMPLETED|ITT (Intention-to-Treat) - Part A||5
8717349|NCT00994214|9764560|FG001|COMPLETED|ITT (Intention-to-Treat) - Part A||6
8717350|NCT00994214|9764561|FG002|COMPLETED|ITT (Intention-to-Treat) - Part A||5
8717351|NCT00994214|9764562|FG003|COMPLETED|ITT (Intention-to-Treat) - Part A||5
8717352|NCT00994214|9764559|FG000|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||14
8717353|NCT00994214|9764560|FG001|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||13
8717354|NCT00994214|9764561|FG002|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||13
8717355|NCT00994214|9764562|FG003|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||15
8717356|NCT00994214|9764559|FG000|STARTED|ITT (Intention-to-Treat) - Part B|1 subject did not enter Part B Arm A|4
8717357|NCT00994214|9764560|FG001|STARTED|ITT (Intention-to-Treat) - Part B|3 subjects did not enter Part B Arm B|3
8717358|NCT00994214|9764561|FG002|STARTED|ITT (Intention-to-Treat) - Part B|3 subjects did not enter Part B Arm C|2
8717359|NCT00994214|9764562|FG003|STARTED|ITT (Intention-to-Treat) - Part B|2 subjects did not enter Part B Arm D|3
8717360|NCT00994214|9764559|FG000|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
8717361|NCT00994214|9764560|FG001|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
8717362|NCT00994214|9764561|FG002|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
8717363|NCT00994214|9764562|FG003|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
8717364|NCT00994214|9764559|FG000|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||3
8717365|NCT00994214|9764560|FG001|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||0
8717366|NCT00994214|9764561|FG002|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||0
8717367|NCT00994214|9764562|FG003|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||0
8717368|NCT00994214|9764559|FG000|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||1
8717369|NCT00994214|9764560|FG001|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||3
8717370|NCT00994214|9764561|FG002|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||0
8717371|NCT00994214|9764562|FG003|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||0
8717372|NCT00994214|9764559|FG000|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||0
8717373|NCT00994214|9764560|FG001|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||0
8717374|NCT00994214|9764561|FG002|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||2
8717375|NCT00994214|9764562|FG003|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||3
8717376|NCT00994214|9764559|FG000|COMPLETED|ITT (Intention-to-Treat) - Part B||0
8717377|NCT00994214|9764560|FG001|COMPLETED|ITT (Intention-to-Treat) - Part B||0
8717378|NCT00994214|9764561|FG002|COMPLETED|ITT (Intention-to-Treat) - Part B||0
8717379|NCT00994214|9764562|FG003|COMPLETED|ITT (Intention-to-Treat) - Part B||0
8717380|NCT00994214|9764559|FG000|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||4
8717381|NCT00994214|9764560|FG001|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||3
8717382|NCT00994214|9764561|FG002|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||2
8717383|NCT00994214|9764562|FG003|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||3
8717384|NCT00994240|9764592|FG000|STARTED|Overall Study||41
8717385|NCT00994240|9764593|FG001|STARTED|Overall Study||44
8717386|NCT00994240|9764592|FG000|COMPLETED|Overall Study||35
8717387|NCT00994240|9764593|FG001|COMPLETED|Overall Study||39
8717388|NCT00994240|9764592|FG000|NOT COMPLETED|Overall Study||6
8717389|NCT00994240|9764593|FG001|NOT COMPLETED|Overall Study||5
8717390|NCT00994279|9764601|FG000|STARTED|Overall Study||22
8717391|NCT00994279|9764602|FG001|STARTED|Overall Study||18
8717392|NCT00994279|9764601|FG000|COMPLETED|Overall Study||18
8717393|NCT00994279|9764602|FG001|COMPLETED|Overall Study||13
8717394|NCT00994279|9764601|FG000|NOT COMPLETED|Overall Study||4
8717395|NCT00994279|9764602|FG001|NOT COMPLETED|Overall Study||5
8717396|NCT00994318|9764611|FG000|STARTED|Overall Study||155
8717397|NCT00994318|9764612|FG001|STARTED|Overall Study||154
8717398|NCT00994318|9764613|FG002|STARTED|Overall Study||317
8717399|NCT00994318|9764611|FG000|COMPLETED|Overall Study||133
8717400|NCT00994318|9764612|FG001|COMPLETED|Overall Study||136
8717401|NCT00994318|9764613|FG002|COMPLETED|Overall Study||250
8717402|NCT00994318|9764611|FG000|NOT COMPLETED|Overall Study||22
8717403|NCT00994318|9764612|FG001|NOT COMPLETED|Overall Study||18
8717404|NCT00994318|9764613|FG002|NOT COMPLETED|Overall Study||67
8724915|NCT01029054|9772223|FG002|NOT COMPLETED|Phase I||0
8724916|NCT01029054|9772221|FG000|STARTED|Phase II||0
8724917|NCT01029054|9772222|FG001|STARTED|Phase II||0
8724918|NCT01029054|9772223|FG002|STARTED|Phase II|35 participants were enrolled in Ph I. 18 additional participants were enrolled in Ph II at the MTD.|18
8724919|NCT01029054|9772221|FG000|COMPLETED|Phase II||0
8724920|NCT01029054|9772222|FG001|COMPLETED|Phase II||0
8724921|NCT01029054|9772223|FG002|COMPLETED|Phase II||18
8724922|NCT01029054|9772221|FG000|NOT COMPLETED|Phase II||0
8724923|NCT01029054|9772222|FG001|NOT COMPLETED|Phase II||0
8724924|NCT01029054|9772223|FG002|NOT COMPLETED|Phase II||0
8724925|NCT01029262|9772229|FG000|STARTED|Overall Study||79
8724926|NCT01029262|9772230|FG001|STARTED|Overall Study||160
8724927|NCT01029262|9772229|FG000|COMPLETED|Overall Study||0
8724928|NCT01029262|9772230|FG001|COMPLETED|Overall Study||0
8724929|NCT01029262|9772229|FG000|NOT COMPLETED|Overall Study||79
8724930|NCT01029262|9772230|FG001|NOT COMPLETED|Overall Study||160
8724931|NCT01029340|9772246|FG000|STARTED|Part A Treatment Period||14
8724932|NCT01029340|9772247|FG001|STARTED|Part A Treatment Period||14
8724933|NCT01029340|9772248|FG002|STARTED|Part A Treatment Period||0
8724934|NCT01029340|9772249|FG003|STARTED|Part A Treatment Period||0
8724935|NCT01029340|9772250|FG004|STARTED|Part A Treatment Period||0
8724936|NCT01029340|9772251|FG005|STARTED|Part A Treatment Period||0
8724937|NCT01029340|9772246|FG000|Participants Received Treatment|Part A Treatment Period||14
8724938|NCT01029340|9772247|FG001|Participants Received Treatment|Part A Treatment Period||14
8724939|NCT01029340|9772248|FG002|Participants Received Treatment|Part A Treatment Period||0
8724940|NCT01029340|9772249|FG003|Participants Received Treatment|Part A Treatment Period||0
8724941|NCT01029340|9772250|FG004|Participants Received Treatment|Part A Treatment Period||0
8724942|NCT01029340|9772251|FG005|Participants Received Treatment|Part A Treatment Period||0
8724943|NCT01029340|9772246|FG000|Safety Population|Part A Treatment Period|One excluded because receiving Kogenate FS twice.|13
8724944|NCT01029340|9772247|FG001|Safety Population|Part A Treatment Period||14
8724945|NCT01029340|9772248|FG002|Safety Population|Part A Treatment Period||0
8724946|NCT01029340|9772249|FG003|Safety Population|Part A Treatment Period||0
8724947|NCT01029340|9772250|FG004|Safety Population|Part A Treatment Period||0
8724948|NCT01029340|9772251|FG005|Safety Population|Part A Treatment Period||0
8813397|NCT01525602|9866573|FG004|NOT COMPLETED|Overall Study||33
8813398|NCT01525602|9866574|FG005|NOT COMPLETED|Overall Study||7
8724949|NCT01029340|9772246|FG000|COMPLETED|Part A Treatment Period||14
8724950|NCT01029340|9772247|FG001|COMPLETED|Part A Treatment Period||14
8724951|NCT01029340|9772248|FG002|COMPLETED|Part A Treatment Period||0
8724952|NCT01029340|9772249|FG003|COMPLETED|Part A Treatment Period||0
8724953|NCT01029340|9772250|FG004|COMPLETED|Part A Treatment Period||0
8724954|NCT01029340|9772251|FG005|COMPLETED|Part A Treatment Period||0
8813399|NCT01525602|9866575|FG006|NOT COMPLETED|Overall Study||6
8717405|NCT00994422|9764623|FG000|STARTED|Overall Study||192
8717406|NCT00994422|9764624|FG001|STARTED|Overall Study||55
8717407|NCT00994422|9764623|FG000|COMPLETED|Overall Study||185
8717408|NCT00994422|9764624|FG001|COMPLETED|Overall Study||54
8717409|NCT00994422|9764623|FG000|NOT COMPLETED|Overall Study||7
8717410|NCT00994422|9764624|FG001|NOT COMPLETED|Overall Study||1
8717411|NCT00994448|9764634|FG000|STARTED|Overall Study||12
8717412|NCT00994448|9764635|FG001|STARTED|Overall Study||7
8717413|NCT00994448|9764634|FG000|COMPLETED|Overall Study||4
8717414|NCT00994448|9764635|FG001|COMPLETED|Overall Study||5
8717415|NCT00994448|9764634|FG000|NOT COMPLETED|Overall Study||8
8717416|NCT00994448|9764635|FG001|NOT COMPLETED|Overall Study||2
8717417|NCT00994461|9764644|FG000|STARTED|Overall Study||76
8717418|NCT00994461|9764645|FG001|STARTED|Overall Study||76
8717419|NCT00994461|9764646|FG002|STARTED|Overall Study|One subject was randomized but did not receive study drug.|37
8717420|NCT00994461|9764644|FG000|COMPLETED|Overall Study||74
8717421|NCT00994461|9764645|FG001|COMPLETED|Overall Study||75
8717422|NCT00994461|9764646|FG002|COMPLETED|Overall Study||37
8717423|NCT00994461|9764644|FG000|NOT COMPLETED|Overall Study||2
8717424|NCT00994461|9764645|FG001|NOT COMPLETED|Overall Study||1
8717425|NCT00994461|9764646|FG002|NOT COMPLETED|Overall Study||0
8717426|NCT00994604|9764654|FG000|STARTED|Overall Study||51
8717427|NCT00994604|9764654|FG000|COMPLETED|Overall Study||45
8717428|NCT00994604|9764654|FG000|NOT COMPLETED|Overall Study||6
8717429|NCT00994643|9764661|FG000|STARTED|Overall Study||11
8717430|NCT00994643|9764661|FG000|COMPLETED|Overall Study||10
8717431|NCT00994643|9764661|FG000|NOT COMPLETED|Overall Study||1
8717432|NCT00994682|9764667|FG000|STARTED|Double Bilnd||51
8717433|NCT00994682|9764668|FG001|STARTED|Double Bilnd||50
8717434|NCT00994682|9764667|FG000|COMPLETED|Double Bilnd||42
8717435|NCT00994682|9764668|FG001|COMPLETED|Double Bilnd||41
8717436|NCT00994682|9764667|FG000|NOT COMPLETED|Double Bilnd||9
8717437|NCT00994682|9764668|FG001|NOT COMPLETED|Double Bilnd||9
8717438|NCT00994682|9764667|FG000|STARTED|Pioglitazone Open Label||42
8717439|NCT00994682|9764668|FG001|STARTED|Pioglitazone Open Label||41
8717440|NCT00994682|9764667|FG000|COMPLETED|Pioglitazone Open Label||29
8717441|NCT00994682|9764668|FG001|COMPLETED|Pioglitazone Open Label||34
8717442|NCT00994682|9764667|FG000|NOT COMPLETED|Pioglitazone Open Label||13
8717443|NCT00994682|9764668|FG001|NOT COMPLETED|Pioglitazone Open Label||7
8717444|NCT00994760|9764678|FG000|STARTED|Overall Study||131
8717445|NCT00994760|9764678|FG000|COMPLETED|Overall Study||107
8717446|NCT00994760|9764678|FG000|NOT COMPLETED|Overall Study||24
8717447|NCT00994890|9764699|FG000|STARTED|Overall Study||231
8717448|NCT00994890|9764700|FG001|STARTED|Overall Study||222
8717449|NCT00994890|9764701|FG002|STARTED|Overall Study||226
8717450|NCT00994890|9764699|FG000|Treated|Overall Study||230
8717451|NCT00994890|9764700|FG001|Treated|Overall Study||222
8717452|NCT00994890|9764701|FG002|Treated|Overall Study||226
8717453|NCT00994890|9764699|FG000|COMPLETED|Overall Study||0
8717454|NCT00994890|9764700|FG001|COMPLETED|Overall Study||0
8717455|NCT00994890|9764701|FG002|COMPLETED|Overall Study||0
8717456|NCT00994890|9764699|FG000|NOT COMPLETED|Overall Study||231
8717457|NCT00994890|9764700|FG001|NOT COMPLETED|Overall Study||222
8717458|NCT00994890|9764701|FG002|NOT COMPLETED|Overall Study||226
8717459|NCT00994929|9764709|FG000|STARTED|Overall Study||9
8717460|NCT00994929|9764709|FG000|COMPLETED|Overall Study||9
8717461|NCT00994929|9764709|FG000|NOT COMPLETED|Overall Study||0
8717462|NCT00995007|9764716|FG000|STARTED|Overall Study||56
8717463|NCT00995007|9764717|FG001|STARTED|Overall Study||56
8717464|NCT00995007|9764716|FG000|Crossover to Vandetanib|Overall Study||42
8717465|NCT00995007|9764717|FG001|Crossover to Vandetanib|Overall Study||0
8717466|NCT00995007|9764716|FG000|COMPLETED|Overall Study||39
8717467|NCT00995007|9764717|FG001|COMPLETED|Overall Study||54
8717468|NCT00995007|9764716|FG000|NOT COMPLETED|Overall Study||17
8717469|NCT00995007|9764717|FG001|NOT COMPLETED|Overall Study||2
8717470|NCT00995020|9764734|FG000|STARTED|Overall Study||51
8717471|NCT00995020|9764735|FG001|STARTED|Overall Study||52
8717472|NCT00995020|9764734|FG000|COMPLETED|Overall Study|"Reasons for not completed:~margin analysis not performed specimen fragmentation thermal damage"|48
8717473|NCT00995020|9764735|FG001|COMPLETED|Overall Study|"Reasons for not completed:~margin analysis not performed specimen fragmentation thermal damage"|45
8717474|NCT00995020|9764734|FG000|NOT COMPLETED|Overall Study||3
8717475|NCT00995020|9764735|FG001|NOT COMPLETED|Overall Study||7
8717476|NCT00995072|9764745|FG000|STARTED|Overall Study||10
8717477|NCT00995072|9764746|FG001|STARTED|Overall Study||15
8717478|NCT00995072|9764745|FG000|COMPLETED|Overall Study||9
8717479|NCT00995072|9764746|FG001|COMPLETED|Overall Study||12
8717480|NCT00995072|9764745|FG000|NOT COMPLETED|Overall Study||1
8717481|NCT00995072|9764746|FG001|NOT COMPLETED|Overall Study||3
8717482|NCT00995085|9764752|FG000|STARTED|Overall Study||43
8717483|NCT00995085|9764752|FG000|COMPLETED|Overall Study||38
8717484|NCT00995085|9764752|FG000|NOT COMPLETED|Overall Study||5
8717485|NCT00995215|9764756|FG000|STARTED|Overall Study||6
8717486|NCT00995215|9764756|FG000|COMPLETED|Overall Study||6
8717487|NCT00995215|9764756|FG000|NOT COMPLETED|Overall Study||0
8717488|NCT00995345|9764766|FG000|STARTED|Overall Study||81
8717489|NCT00995345|9764767|FG001|STARTED|Overall Study||81
8717490|NCT00995345|9764768|FG002|STARTED|Overall Study||80
8717491|NCT00995345|9764769|FG003|STARTED|Overall Study||81
8717492|NCT00995345|9764770|FG004|STARTED|Overall Study||80
8717493|NCT00995345|9764766|FG000|COMPLETED|Overall Study||70
8717494|NCT00995345|9764767|FG001|COMPLETED|Overall Study||74
8717495|NCT00995345|9764768|FG002|COMPLETED|Overall Study||73
8717496|NCT00995345|9764769|FG003|COMPLETED|Overall Study||76
8717497|NCT00995345|9764770|FG004|COMPLETED|Overall Study||75
8717498|NCT00995345|9764766|FG000|NOT COMPLETED|Overall Study||11
8717499|NCT00995345|9764767|FG001|NOT COMPLETED|Overall Study||7
8717500|NCT00995345|9764768|FG002|NOT COMPLETED|Overall Study||7
8717501|NCT00995345|9764769|FG003|NOT COMPLETED|Overall Study||5
8717502|NCT00995345|9764770|FG004|NOT COMPLETED|Overall Study||5
8717503|NCT00995371|9764784|FG000|STARTED|Prior to ESI Cross-over, 6 Weeks||21
8717504|NCT00995371|9764785|FG001|STARTED|Prior to ESI Cross-over, 6 Weeks||17
8717505|NCT00995371|9764784|FG000|COMPLETED|Prior to ESI Cross-over, 6 Weeks||21
8717506|NCT00995371|9764785|FG001|COMPLETED|Prior to ESI Cross-over, 6 Weeks||17
8717507|NCT00995371|9764784|FG000|NOT COMPLETED|Prior to ESI Cross-over, 6 Weeks||0
8717508|NCT00995371|9764785|FG001|NOT COMPLETED|Prior to ESI Cross-over, 6 Weeks||0
8717509|NCT00995371|9764784|FG000|STARTED|After ESI Cross-over to Mild, 26 Weeks||21
8717510|NCT00995371|9764785|FG001|STARTED|After ESI Cross-over to Mild, 26 Weeks||17
8717511|NCT00995371|9764784|FG000|COMPLETED|After ESI Cross-over to Mild, 26 Weeks|All 21 completed Wk 6 Intent to Treat analysis. Sixteen reported Week 26 outcomes.|16
8717512|NCT00995371|9764785|FG001|COMPLETED|After ESI Cross-over to Mild, 26 Weeks|All 17 completed Wk 6 Intent to Treat analysis prior to x-over. After x-over 12 reported Wk 26|12
8717513|NCT00995371|9764784|FG000|NOT COMPLETED|After ESI Cross-over to Mild, 26 Weeks||5
8717514|NCT00995371|9764785|FG001|NOT COMPLETED|After ESI Cross-over to Mild, 26 Weeks||5
8717515|NCT00995410|9764793|FG000|STARTED|Overall Study||380
8717516|NCT00995410|9764793|FG000|Treated|Overall Study||379
8717517|NCT00995410|9764793|FG000|COMPLETED|Overall Study||292
8717518|NCT00995410|9764793|FG000|NOT COMPLETED|Overall Study||88
8717519|NCT00995436|9764800|FG000|STARTED|Overall Study|25|25
8717520|NCT00995436|9764801|FG001|STARTED|Overall Study||27
8717521|NCT00995436|9764802|FG002|STARTED|Overall Study||26
8717522|NCT00995436|9764800|FG000|COMPLETED|Overall Study||23
8717523|NCT00995436|9764801|FG001|COMPLETED|Overall Study||22
8717524|NCT00995436|9764802|FG002|COMPLETED|Overall Study||26
8717525|NCT00995436|9764800|FG000|NOT COMPLETED|Overall Study||2
8717526|NCT00995436|9764801|FG001|NOT COMPLETED|Overall Study||5
8717527|NCT00995436|9764802|FG002|NOT COMPLETED|Overall Study||0
8717528|NCT00995449|9764814|FG000|STARTED|Overall Study||0
8717529|NCT00995449|9764815|FG001|STARTED|Overall Study||0
8717530|NCT00995449|9764816|FG002|STARTED|Overall Study||7
8717531|NCT00995449|9764817|FG003|STARTED|Overall Study||2
8717532|NCT00995449|9764814|FG000|COMPLETED|Overall Study||0
8717533|NCT00995449|9764815|FG001|COMPLETED|Overall Study||0
8717534|NCT00995449|9764816|FG002|COMPLETED|Overall Study||5
8717535|NCT00995449|9764817|FG003|COMPLETED|Overall Study||2
8717536|NCT00995449|9764814|FG000|NOT COMPLETED|Overall Study||0
8717537|NCT00995449|9764815|FG001|NOT COMPLETED|Overall Study||0
8717538|NCT00995449|9764816|FG002|NOT COMPLETED|Overall Study||2
8717539|NCT00995449|9764817|FG003|NOT COMPLETED|Overall Study||0
8717540|NCT00995475|9764825|FG000|STARTED|First Intervention||9
8717541|NCT00995475|9764826|FG001|STARTED|First Intervention||9
8717542|NCT00995475|9764825|FG000|COMPLETED|First Intervention||9
8717543|NCT00995475|9764826|FG001|COMPLETED|First Intervention||9
8717544|NCT00995475|9764825|FG000|NOT COMPLETED|First Intervention||0
8717545|NCT00995475|9764826|FG001|NOT COMPLETED|First Intervention||0
8717546|NCT00995475|9764825|FG000|STARTED|Wash-out Two Week||9
8717547|NCT00995475|9764826|FG001|STARTED|Wash-out Two Week||9
8717548|NCT00995475|9764825|FG000|COMPLETED|Wash-out Two Week||9
8717549|NCT00995475|9764826|FG001|COMPLETED|Wash-out Two Week||9
8717550|NCT00995475|9764825|FG000|NOT COMPLETED|Wash-out Two Week||0
8717551|NCT00995475|9764826|FG001|NOT COMPLETED|Wash-out Two Week||0
8717552|NCT00995475|9764825|FG000|STARTED|Second Intervention||9
8717553|NCT00995475|9764826|FG001|STARTED|Second Intervention||9
8717554|NCT00995475|9764825|FG000|COMPLETED|Second Intervention||9
8717555|NCT00995475|9764826|FG001|COMPLETED|Second Intervention||9
8717556|NCT00995475|9764825|FG000|NOT COMPLETED|Second Intervention||0
8717557|NCT00995475|9764826|FG001|NOT COMPLETED|Second Intervention||0
8717558|NCT00995488|9764832|FG000|STARTED|Overall Study||16
8717559|NCT00995488|9764832|FG000|COMPLETED|Overall Study||15
8717560|NCT00995488|9764832|FG000|NOT COMPLETED|Overall Study||1
8717561|NCT00995501|9764844|FG000|STARTED|Overall Study||52
8717562|NCT00995501|9764845|FG001|STARTED|Overall Study||51
8717563|NCT00995501|9764846|FG002|STARTED|Overall Study||47
8717564|NCT00995501|9764847|FG003|STARTED|Overall Study||46
8717565|NCT00995501|9764848|FG004|STARTED|Overall Study||46
8717566|NCT00995501|9764849|FG005|STARTED|Overall Study||44
8717567|NCT00995501|9764850|FG006|STARTED|Overall Study||49
8717568|NCT00995501|9764851|FG007|STARTED|Overall Study||46
8717569|NCT00995501|9764844|FG000|COMPLETED|Overall Study||52
8717570|NCT00995501|9764845|FG001|COMPLETED|Overall Study||51
8717571|NCT00995501|9764846|FG002|COMPLETED|Overall Study||47
8717572|NCT00995501|9764847|FG003|COMPLETED|Overall Study||46
8717573|NCT00995501|9764848|FG004|COMPLETED|Overall Study||46
8717574|NCT00995501|9764849|FG005|COMPLETED|Overall Study||44
8717575|NCT00995501|9764850|FG006|COMPLETED|Overall Study||49
8717576|NCT00995501|9764851|FG007|COMPLETED|Overall Study||46
8717577|NCT00995501|9764844|FG000|NOT COMPLETED|Overall Study||0
8717578|NCT00995501|9764845|FG001|NOT COMPLETED|Overall Study||0
8717579|NCT00995501|9764846|FG002|NOT COMPLETED|Overall Study||0
8717580|NCT00995501|9764847|FG003|NOT COMPLETED|Overall Study||0
8717581|NCT00995501|9764848|FG004|NOT COMPLETED|Overall Study||0
8717582|NCT00995501|9764849|FG005|NOT COMPLETED|Overall Study||0
8717583|NCT00995501|9764850|FG006|NOT COMPLETED|Overall Study||0
8717584|NCT00995501|9764851|FG007|NOT COMPLETED|Overall Study||0
8717585|NCT00995553|9764871|FG000|STARTED|Overall Study||40
8717586|NCT00995553|9764872|FG001|STARTED|Overall Study||41
8717587|NCT00995553|9764871|FG000|COMPLETED|Overall Study||38
8717588|NCT00995553|9764872|FG001|COMPLETED|Overall Study||35
8717589|NCT00995553|9764871|FG000|NOT COMPLETED|Overall Study||2
8717590|NCT00995553|9764872|FG001|NOT COMPLETED|Overall Study||6
8717591|NCT00995566|9764878|FG000|STARTED|Overall Study||54
8717592|NCT00995566|9764878|FG000|COMPLETED|Overall Study||0
8717593|NCT00995566|9764878|FG000|NOT COMPLETED|Overall Study||54
8717594|NCT00995670|9764885|FG000|STARTED|Overall Study||26
8717595|NCT00995670|9764886|FG001|STARTED|Overall Study||16
8717596|NCT00995670|9764887|FG002|STARTED|Overall Study||17
8717597|NCT00995670|9764885|FG000|COMPLETED|Overall Study|These 26 subjects underwent a total of 58 studies to determine the effect of dose of glucose on I/R.|25
8717598|NCT00995670|9764886|FG001|COMPLETED|Overall Study|These 16 subjects underwent a total of 25 studies on the effect of Vitamin C.|16
8717599|NCT00995670|9764887|FG002|COMPLETED|Overall Study|These 17 volunteers underwent 33 studies on the effect of statins, glucose, and glucose & statins.|14
8717600|NCT00995670|9764885|FG000|NOT COMPLETED|Overall Study||1
8717601|NCT00995670|9764886|FG001|NOT COMPLETED|Overall Study||0
8717602|NCT00995670|9764887|FG002|NOT COMPLETED|Overall Study||3
8717603|NCT00995709|9764898|FG000|STARTED|Overall Study||39
8717604|NCT00995709|9764899|FG001|STARTED|Overall Study||40
8717605|NCT00995709|9764900|FG002|STARTED|Overall Study||39
8717606|NCT00995709|9764898|FG000|COMPLETED|Overall Study||32
8717607|NCT00995709|9764899|FG001|COMPLETED|Overall Study|patient in the 300 mg monthly group was randomized,was not eligible,never received study medication|31
8717608|NCT00995709|9764900|FG002|COMPLETED|Overall Study||34
8717609|NCT00995709|9764898|FG000|NOT COMPLETED|Overall Study||7
8717610|NCT00995709|9764899|FG001|NOT COMPLETED|Overall Study||9
8717611|NCT00995709|9764900|FG002|NOT COMPLETED|Overall Study||5
8717612|NCT00995722|9764910|FG000|STARTED|Double Blinded: 16 Weeks||6
8717613|NCT00995722|9764911|FG001|STARTED|Double Blinded: 16 Weeks||5
8717614|NCT00995722|9764910|FG000|COMPLETED|Double Blinded: 16 Weeks||5
8717615|NCT00995722|9764911|FG001|COMPLETED|Double Blinded: 16 Weeks||4
8717616|NCT00995722|9764910|FG000|NOT COMPLETED|Double Blinded: 16 Weeks||1
8717617|NCT00995722|9764911|FG001|NOT COMPLETED|Double Blinded: 16 Weeks||1
8717618|NCT00995722|9764910|FG000|STARTED|Overall Study: 36 Weeks||5
8717619|NCT00995722|9764911|FG001|STARTED|Overall Study: 36 Weeks||4
8717620|NCT00995722|9764910|FG000|COMPLETED|Overall Study: 36 Weeks||3
8717621|NCT00995722|9764911|FG001|COMPLETED|Overall Study: 36 Weeks||2
8717622|NCT00995722|9764910|FG000|NOT COMPLETED|Overall Study: 36 Weeks||2
8717623|NCT00995722|9764911|FG001|NOT COMPLETED|Overall Study: 36 Weeks||2
8717624|NCT00995761|9764917|FG000|STARTED|Overall Study||48
8717625|NCT00995761|9764917|FG000|COMPLETED|Overall Study||48
8813400|NCT01525602|9866576|FG007|NOT COMPLETED|Overall Study||7
8813401|NCT01525615|9866604|FG000|STARTED|Overall Study||132
8813402|NCT01525615|9866605|FG001|STARTED|Overall Study||133
8813403|NCT01525615|9866606|FG002|STARTED|Overall Study||139
8813404|NCT01525615|9866604|FG000|COMPLETED|Overall Study||118
8813405|NCT01525615|9866605|FG001|COMPLETED|Overall Study||126
8813406|NCT01525615|9866606|FG002|COMPLETED|Overall Study||133
8813407|NCT01525615|9866604|FG000|NOT COMPLETED|Overall Study||14
8813408|NCT01525615|9866605|FG001|NOT COMPLETED|Overall Study||7
8813409|NCT01525615|9866606|FG002|NOT COMPLETED|Overall Study||6
8813410|NCT01525628|9866619|FG000|STARTED|Overall Study||16
8813411|NCT01525628|9866620|FG001|STARTED|Overall Study||19
8813412|NCT01525628|9866621|FG002|STARTED|Overall Study||16
8813413|NCT01525628|9866622|FG003|STARTED|Overall Study||14
8813414|NCT01525628|9866623|FG004|STARTED|Overall Study||7
8813415|NCT01525628|9866619|FG000|COMPLETED|Overall Study||14
8813416|NCT01525628|9866620|FG001|COMPLETED|Overall Study||14
8813417|NCT01525628|9866621|FG002|COMPLETED|Overall Study||11
8813418|NCT01525628|9866622|FG003|COMPLETED|Overall Study||10
8813419|NCT01525628|9866623|FG004|COMPLETED|Overall Study||4
8813420|NCT01525628|9866619|FG000|NOT COMPLETED|Overall Study||2
8813421|NCT01525628|9866620|FG001|NOT COMPLETED|Overall Study||5
8813422|NCT01525628|9866621|FG002|NOT COMPLETED|Overall Study||5
8813423|NCT01525628|9866622|FG003|NOT COMPLETED|Overall Study||4
8813424|NCT01525628|9866623|FG004|NOT COMPLETED|Overall Study||3
8813425|NCT01525641|9866637|FG000|STARTED|Overall Study||615
8813426|NCT01525641|9866637|FG000|COMPLETED|Overall Study||435
8813427|NCT01525641|9866637|FG000|NOT COMPLETED|Overall Study||180
8813428|NCT01525667|9866644|FG000|STARTED|Overall Study||7
8813429|NCT01525667|9866645|FG001|STARTED|Overall Study||6
8813430|NCT01525667|9866646|FG002|STARTED|Overall Study||7
8813431|NCT01525667|9866644|FG000|COMPLETED|Overall Study||7
8813432|NCT01525667|9866645|FG001|COMPLETED|Overall Study||6
8813433|NCT01525667|9866646|FG002|COMPLETED|Overall Study||7
8813434|NCT01525667|9866644|FG000|NOT COMPLETED|Overall Study||0
8717626|NCT00995761|9764917|FG000|NOT COMPLETED|Overall Study||0
8717627|NCT00995774|9764923|FG000|STARTED|Training Period 1||7
8717628|NCT00995774|9764924|FG001|STARTED|Training Period 1||5
8813435|NCT01525667|9866645|FG001|NOT COMPLETED|Overall Study||0
8813436|NCT01525667|9866646|FG002|NOT COMPLETED|Overall Study||0
8813437|NCT01525849|9866658|FG000|STARTED|Overall Study||76
8813438|NCT01525849|9866659|FG001|STARTED|Overall Study||75
8813439|NCT01525849|9866658|FG000|Treated|Overall Study|2 withdrew before treatment: 1 didn't want balloon dilation, 1 unrelated medical issue.|74
8616975|NCT00454584|9655172|FG000|STARTED|Controlled Period||347
8616976|NCT00454584|9655173|FG001|STARTED|Controlled Period||209
8616977|NCT00454584|9655174|FG002|STARTED|Controlled Period||347
8717629|NCT00995774|9764923|FG000|COMPLETED|Training Period 1||7
8717630|NCT00995774|9764924|FG001|COMPLETED|Training Period 1||5
8717631|NCT00995774|9764923|FG000|NOT COMPLETED|Training Period 1||0
8717632|NCT00995774|9764924|FG001|NOT COMPLETED|Training Period 1||0
8717633|NCT00995774|9764923|FG000|STARTED|Washout Period||7
8717634|NCT00995774|9764924|FG001|STARTED|Washout Period||5
8717635|NCT00995774|9764923|FG000|COMPLETED|Washout Period||7
8717636|NCT00995774|9764924|FG001|COMPLETED|Washout Period||5
8717637|NCT00995774|9764923|FG000|NOT COMPLETED|Washout Period||0
8717638|NCT00995774|9764924|FG001|NOT COMPLETED|Washout Period||0
8717639|NCT00995774|9764923|FG000|STARTED|Training Period 2||7
8717640|NCT00995774|9764924|FG001|STARTED|Training Period 2||5
8717641|NCT00995774|9764923|FG000|COMPLETED|Training Period 2||5
8717642|NCT00995774|9764924|FG001|COMPLETED|Training Period 2||5
8717643|NCT00995774|9764923|FG000|NOT COMPLETED|Training Period 2||2
8717644|NCT00995774|9764924|FG001|NOT COMPLETED|Training Period 2||0
8717645|NCT00995865|9764933|FG000|STARTED|Overall Study||24
8717646|NCT00995865|9764934|FG001|STARTED|Overall Study||24
8717647|NCT00995865|9764935|FG002|STARTED|Overall Study||12
8717648|NCT00995865|9764933|FG000|COMPLETED|Overall Study||22
8717649|NCT00995865|9764934|FG001|COMPLETED|Overall Study||24
8717650|NCT00995865|9764935|FG002|COMPLETED|Overall Study||11
8717651|NCT00995865|9764933|FG000|NOT COMPLETED|Overall Study||2
8717652|NCT00995865|9764934|FG001|NOT COMPLETED|Overall Study||0
8717653|NCT00995865|9764935|FG002|NOT COMPLETED|Overall Study||1
8717654|NCT00995904|9764948|FG000|STARTED|Visit 2 (Randomization)||4
8717655|NCT00995904|9764949|FG001|STARTED|Visit 2 (Randomization)||3
8717656|NCT00995904|9764950|FG002|STARTED|Visit 2 (Randomization)||4
8717657|NCT00995904|9764951|FG003|STARTED|Visit 2 (Randomization)||5
8717658|NCT00995904|9764952|FG004|STARTED|Visit 2 (Randomization)||5
8717659|NCT00995904|9764953|FG005|STARTED|Visit 2 (Randomization)||4
8717660|NCT00995904|9764948|FG000|COMPLETED|Visit 2 (Randomization)||4
8717661|NCT00995904|9764949|FG001|COMPLETED|Visit 2 (Randomization)||3
8717662|NCT00995904|9764950|FG002|COMPLETED|Visit 2 (Randomization)||4
8717663|NCT00995904|9764951|FG003|COMPLETED|Visit 2 (Randomization)||5
8717664|NCT00995904|9764952|FG004|COMPLETED|Visit 2 (Randomization)||5
8717665|NCT00995904|9764953|FG005|COMPLETED|Visit 2 (Randomization)||4
8717666|NCT00995904|9764948|FG000|NOT COMPLETED|Visit 2 (Randomization)||0
8717667|NCT00995904|9764949|FG001|NOT COMPLETED|Visit 2 (Randomization)||0
8717668|NCT00995904|9764950|FG002|NOT COMPLETED|Visit 2 (Randomization)||0
8717669|NCT00995904|9764951|FG003|NOT COMPLETED|Visit 2 (Randomization)||0
8717670|NCT00995904|9764952|FG004|NOT COMPLETED|Visit 2 (Randomization)||0
8717671|NCT00995904|9764953|FG005|NOT COMPLETED|Visit 2 (Randomization)||0
8717672|NCT00995904|9764948|FG000|STARTED|Visit 3||4
8717673|NCT00995904|9764949|FG001|STARTED|Visit 3||3
8717674|NCT00995904|9764950|FG002|STARTED|Visit 3||4
8717675|NCT00995904|9764951|FG003|STARTED|Visit 3||5
8717676|NCT00995904|9764952|FG004|STARTED|Visit 3||5
8717677|NCT00995904|9764953|FG005|STARTED|Visit 3|One subject was withdrawn from the study after completion of Visit 2 but prior to Visit 3.|3
8717678|NCT00995904|9764948|FG000|COMPLETED|Visit 3||4
8717679|NCT00995904|9764949|FG001|COMPLETED|Visit 3||3
8717680|NCT00995904|9764950|FG002|COMPLETED|Visit 3||4
8717681|NCT00995904|9764951|FG003|COMPLETED|Visit 3||5
8717682|NCT00995904|9764952|FG004|COMPLETED|Visit 3||5
8717683|NCT00995904|9764953|FG005|COMPLETED|Visit 3||3
8717684|NCT00995904|9764948|FG000|NOT COMPLETED|Visit 3||0
8717685|NCT00995904|9764949|FG001|NOT COMPLETED|Visit 3||0
8717686|NCT00995904|9764950|FG002|NOT COMPLETED|Visit 3||0
8717687|NCT00995904|9764951|FG003|NOT COMPLETED|Visit 3||0
8717688|NCT00995904|9764952|FG004|NOT COMPLETED|Visit 3||0
8717689|NCT00995904|9764953|FG005|NOT COMPLETED|Visit 3||0
8717690|NCT00995904|9764948|FG000|STARTED|Visit 4||4
8717691|NCT00995904|9764949|FG001|STARTED|Visit 4||3
8717692|NCT00995904|9764950|FG002|STARTED|Visit 4||4
8616978|NCT00454584|9655175|FG003|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
8616979|NCT00454584|9655176|FG004|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
8616980|NCT00454584|9655177|FG005|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
8616981|NCT00454584|9655172|FG000|COMPLETED|Controlled Period||336
8616982|NCT00454584|9655173|FG001|COMPLETED|Controlled Period||201
8616983|NCT00454584|9655174|FG002|COMPLETED|Controlled Period||342
8616984|NCT00454584|9655175|FG003|COMPLETED|Controlled Period||0
8616985|NCT00454584|9655176|FG004|COMPLETED|Controlled Period||0
8616986|NCT00454584|9655177|FG005|COMPLETED|Controlled Period||0
8616987|NCT00454584|9655172|FG000|NOT COMPLETED|Controlled Period||11
8616988|NCT00454584|9655173|FG001|NOT COMPLETED|Controlled Period||8
8616989|NCT00454584|9655174|FG002|NOT COMPLETED|Controlled Period||5
8616990|NCT00454584|9655175|FG003|NOT COMPLETED|Controlled Period||0
8717693|NCT00995904|9764951|FG003|STARTED|Visit 4||5
8717694|NCT00995904|9764952|FG004|STARTED|Visit 4||5
8717695|NCT00995904|9764953|FG005|STARTED|Visit 4||3
8717696|NCT00995904|9764948|FG000|COMPLETED|Visit 4||4
8717697|NCT00995904|9764949|FG001|COMPLETED|Visit 4||3
8717698|NCT00995904|9764950|FG002|COMPLETED|Visit 4||4
8717699|NCT00995904|9764951|FG003|COMPLETED|Visit 4||5
8717700|NCT00995904|9764952|FG004|COMPLETED|Visit 4||5
8717701|NCT00995904|9764953|FG005|COMPLETED|Visit 4||3
8717702|NCT00995904|9764948|FG000|NOT COMPLETED|Visit 4||0
8717703|NCT00995904|9764949|FG001|NOT COMPLETED|Visit 4||0
8717704|NCT00995904|9764950|FG002|NOT COMPLETED|Visit 4||0
8717705|NCT00995904|9764951|FG003|NOT COMPLETED|Visit 4||0
8717706|NCT00995904|9764952|FG004|NOT COMPLETED|Visit 4||0
8717707|NCT00995904|9764953|FG005|NOT COMPLETED|Visit 4||0
8717708|NCT00995904|9764948|FG000|STARTED|Follow-up Visit (Final Visit)||4
8717709|NCT00995904|9764949|FG001|STARTED|Follow-up Visit (Final Visit)||3
8717710|NCT00995904|9764950|FG002|STARTED|Follow-up Visit (Final Visit)||4
8717711|NCT00995904|9764951|FG003|STARTED|Follow-up Visit (Final Visit)||5
8717712|NCT00995904|9764952|FG004|STARTED|Follow-up Visit (Final Visit)||5
8717713|NCT00995904|9764953|FG005|STARTED|Follow-up Visit (Final Visit)||3
8717714|NCT00995904|9764948|FG000|COMPLETED|Follow-up Visit (Final Visit)||4
8717715|NCT00995904|9764949|FG001|COMPLETED|Follow-up Visit (Final Visit)||3
8717716|NCT00995904|9764950|FG002|COMPLETED|Follow-up Visit (Final Visit)||4
8717717|NCT00995904|9764951|FG003|COMPLETED|Follow-up Visit (Final Visit)||5
8717718|NCT00995904|9764952|FG004|COMPLETED|Follow-up Visit (Final Visit)||5
8717719|NCT00995904|9764953|FG005|COMPLETED|Follow-up Visit (Final Visit)||3
8717720|NCT00995904|9764948|FG000|NOT COMPLETED|Follow-up Visit (Final Visit)||0
8717721|NCT00995904|9764949|FG001|NOT COMPLETED|Follow-up Visit (Final Visit)||0
8717722|NCT00995904|9764950|FG002|NOT COMPLETED|Follow-up Visit (Final Visit)||0
8717723|NCT00995904|9764951|FG003|NOT COMPLETED|Follow-up Visit (Final Visit)||0
8717724|NCT00995904|9764952|FG004|NOT COMPLETED|Follow-up Visit (Final Visit)||0
8717725|NCT00995904|9764953|FG005|NOT COMPLETED|Follow-up Visit (Final Visit)||0
8717726|NCT00995930|9764966|FG000|STARTED|Overall Study||94
8717727|NCT00995930|9764967|FG001|STARTED|Overall Study||95
8717728|NCT00995930|9764966|FG000|Safety Analysis Set|Overall Study||94
8717729|NCT00995930|9764967|FG001|Safety Analysis Set|Overall Study||95
8717730|NCT00995930|9764966|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||0
8717731|NCT00995930|9764967|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||95
8717732|NCT00995930|9764966|FG000|Pharmacodynamic (PD) Analysis Set|Overall Study||92
8717733|NCT00995930|9764967|FG001|Pharmacodynamic (PD) Analysis Set|Overall Study||92
8717734|NCT00995930|9764966|FG000|Imaging Analysis Set|Overall Study||92
8717735|NCT00995930|9764967|FG001|Imaging Analysis Set|Overall Study||92
8717736|NCT00995930|9764966|FG000|COMPLETED|Overall Study||73
8717737|NCT00995930|9764967|FG001|COMPLETED|Overall Study||67
8717738|NCT00995930|9764966|FG000|NOT COMPLETED|Overall Study||21
8717739|NCT00995930|9764967|FG001|NOT COMPLETED|Overall Study||28
8717740|NCT00996034|9764974|FG000|STARTED|Overall Study||14
8717741|NCT00996034|9764974|FG000|COMPLETED|Overall Study||11
8717742|NCT00996034|9764974|FG000|NOT COMPLETED|Overall Study||3
8717743|NCT00996125|9764980|FG000|STARTED|Overall Study||374
8717744|NCT00996125|9764981|FG001|STARTED|Overall Study||376
8717745|NCT00996125|9764980|FG000|COMPLETED|Overall Study||369
8717746|NCT00996125|9764981|FG001|COMPLETED|Overall Study||365
8717747|NCT00996125|9764980|FG000|NOT COMPLETED|Overall Study||5
8717748|NCT00996125|9764981|FG001|NOT COMPLETED|Overall Study||11
8717749|NCT00996164|9764989|FG000|STARTED|Overall Study||543
8717750|NCT00996164|9764990|FG001|STARTED|Overall Study||547
8717751|NCT00996164|9764989|FG000|COMPLETED|Overall Study||408
8717752|NCT00996164|9764990|FG001|COMPLETED|Overall Study||446
8717753|NCT00996164|9764989|FG000|NOT COMPLETED|Overall Study||135
8717754|NCT00996164|9764990|FG001|NOT COMPLETED|Overall Study||101
8717755|NCT00996203|9764996|FG000|STARTED|Overall Study||201
8717756|NCT00996203|9764996|FG000|COMPLETED|Overall Study||194
8717757|NCT00996203|9764996|FG000|NOT COMPLETED|Overall Study||7
8717758|NCT00996216|9765001|FG000|STARTED|Part 1 (Pre-Antiviral Treatment Phase)||27
8717759|NCT00996216|9765001|FG000|COMPLETED|Part 1 (Pre-Antiviral Treatment Phase)||26
8717760|NCT00996216|9765001|FG000|NOT COMPLETED|Part 1 (Pre-Antiviral Treatment Phase)||1
8717761|NCT00996216|9765001|FG000|STARTED|Part 2 (Antiviral Treatment Phase)|One participant who completed Part 1 didn't qualify to begin antiviral treatment in Part 2.|25
8717762|NCT00996216|9765001|FG000|COMPLETED|Part 2 (Antiviral Treatment Phase)||21
8717763|NCT00996216|9765001|FG000|NOT COMPLETED|Part 2 (Antiviral Treatment Phase)||4
8717764|NCT00996281|9765008|FG000|STARTED|Overall Study||418
8717765|NCT00996281|9765009|FG001|STARTED|Overall Study||419
8717766|NCT00996281|9765008|FG000|COMPLETED|Overall Study||287
8717767|NCT00996281|9765009|FG001|COMPLETED|Overall Study||330
8717768|NCT00996281|9765008|FG000|NOT COMPLETED|Overall Study||131
8616991|NCT00454584|9655176|FG004|NOT COMPLETED|Controlled Period||0
8616992|NCT00454584|9655177|FG005|NOT COMPLETED|Controlled Period||0
8616993|NCT00454584|9655172|FG000|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
8616994|NCT00454584|9655173|FG001|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
8616995|NCT00454584|9655174|FG002|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
8616996|NCT00454584|9655175|FG003|STARTED|After Controlled Period||336
8616997|NCT00454584|9655176|FG004|STARTED|After Controlled Period||201
8616998|NCT00454584|9655177|FG005|STARTED|After Controlled Period||342
8616999|NCT00454584|9655172|FG000|COMPLETED|After Controlled Period||0
8617000|NCT00454584|9655173|FG001|COMPLETED|After Controlled Period||0
8617001|NCT00454584|9655174|FG002|COMPLETED|After Controlled Period||0
8617002|NCT00454584|9655175|FG003|COMPLETED|After Controlled Period||310
8617003|NCT00454584|9655176|FG004|COMPLETED|After Controlled Period||189
8617004|NCT00454584|9655177|FG005|COMPLETED|After Controlled Period||310
8717769|NCT00996281|9765009|FG001|NOT COMPLETED|Overall Study||89
8717770|NCT00996307|9765019|FG000|STARTED|Overall Study||164
8617005|NCT00454584|9655172|FG000|NOT COMPLETED|After Controlled Period||0
8717771|NCT00996307|9765020|FG001|STARTED|Overall Study||165
8928275|NCT02279732|9989462|FG001|STARTED|Overall Study||106
8928276|NCT02279732|9989461|FG000|COMPLETED|Overall Study||0
8928277|NCT02279732|9989462|FG001|COMPLETED|Overall Study||0
8928278|NCT02279732|9989461|FG000|NOT COMPLETED|Overall Study||98
8928279|NCT02279732|9989462|FG001|NOT COMPLETED|Overall Study||106
8928280|NCT02279862|9989470|FG000|STARTED|Overall Study||26
8928281|NCT02279862|9989471|FG001|STARTED|Overall Study||27
8928282|NCT02279862|9989470|FG000|Treated|Overall Study||25
8928283|NCT02279862|9989471|FG001|Treated|Overall Study||26
8928284|NCT02279862|9989470|FG000|COMPLETED|Overall Study|Completed treatment in induction period|0
8928285|NCT02279862|9989471|FG001|COMPLETED|Overall Study|Completed treatment in induction period|2
8928286|NCT02279862|9989470|FG000|NOT COMPLETED|Overall Study||26
8928287|NCT02279862|9989471|FG001|NOT COMPLETED|Overall Study||25
8928288|NCT02280044|9989479|FG000|STARTED|Overall Study||15
8928289|NCT02280044|9989480|FG001|STARTED|Overall Study||15
8928290|NCT02280044|9989479|FG000|COMPLETED|Overall Study||15
8928291|NCT02280044|9989480|FG001|COMPLETED|Overall Study||13
8928292|NCT02280044|9989479|FG000|NOT COMPLETED|Overall Study||0
8928293|NCT02280044|9989480|FG001|NOT COMPLETED|Overall Study||2
8928294|NCT02280096|9989488|FG000|STARTED|Overall Study||13
8928295|NCT02280096|9989489|FG001|STARTED|Overall Study||11
8928296|NCT02280096|9989488|FG000|COMPLETED|Overall Study||11
8928297|NCT02280096|9989489|FG001|COMPLETED|Overall Study||10
8928298|NCT02280096|9989488|FG000|NOT COMPLETED|Overall Study||2
8928299|NCT02280096|9989489|FG001|NOT COMPLETED|Overall Study||1
8928300|NCT02280122|9989506|FG000|STARTED|Overall Study||15
8928301|NCT02280122|9989507|FG001|STARTED|Overall Study||15
8928302|NCT02280122|9989508|FG002|STARTED|Overall Study||30
8928303|NCT02280122|9989506|FG000|COMPLETED|Overall Study||15
8928304|NCT02280122|9989507|FG001|COMPLETED|Overall Study||15
8928305|NCT02280122|9989508|FG002|COMPLETED|Overall Study||30
8928306|NCT02280122|9989506|FG000|NOT COMPLETED|Overall Study||0
8928307|NCT02280122|9989507|FG001|NOT COMPLETED|Overall Study||0
8928308|NCT02280122|9989508|FG002|NOT COMPLETED|Overall Study||0
8928309|NCT02280187|9989514|FG000|STARTED|Overall Study||400
8928310|NCT02280187|9989514|FG000|COMPLETED|Overall Study||182
8928311|NCT02280187|9989514|FG000|NOT COMPLETED|Overall Study||218
8928312|NCT02280200|9989520|FG000|STARTED|Overall Study||15
8928313|NCT02280200|9989521|FG001|STARTED|Overall Study||13
8928314|NCT02280200|9989520|FG000|COMPLETED|Overall Study||12
8928315|NCT02280200|9989521|FG001|COMPLETED|Overall Study||10
8928316|NCT02280200|9989520|FG000|NOT COMPLETED|Overall Study||3
8928317|NCT02280200|9989521|FG001|NOT COMPLETED|Overall Study||3
8928318|NCT02280226|9989527|FG000|STARTED|Overall Study||17
8928319|NCT02280226|9989527|FG000|COMPLETED|Overall Study||17
8928320|NCT02280226|9989527|FG000|NOT COMPLETED|Overall Study||0
8928321|NCT02280291|9989535|FG000|STARTED|Overall Study||25
8928322|NCT02280291|9989536|FG001|STARTED|Overall Study||25
8928323|NCT02280291|9989537|FG002|STARTED|Overall Study||24
8928324|NCT02280291|9989538|FG003|STARTED|Overall Study||26
8928325|NCT02280291|9989535|FG000|COMPLETED|Overall Study||21
8928326|NCT02280291|9989536|FG001|COMPLETED|Overall Study||23
8928327|NCT02280291|9989537|FG002|COMPLETED|Overall Study||21
8928328|NCT02280291|9989538|FG003|COMPLETED|Overall Study||18
8928329|NCT02280291|9989535|FG000|NOT COMPLETED|Overall Study||4
8928330|NCT02280291|9989536|FG001|NOT COMPLETED|Overall Study||2
8928331|NCT02280291|9989537|FG002|NOT COMPLETED|Overall Study||3
8928332|NCT02280291|9989538|FG003|NOT COMPLETED|Overall Study||8
8928333|NCT02280304|9989552|FG000|STARTED|Overall Study||19
8928334|NCT02280304|9989553|FG001|STARTED|Overall Study||18
8928335|NCT02280304|9989552|FG000|COMPLETED|Overall Study||12
8928336|NCT02280304|9989553|FG001|COMPLETED|Overall Study|A non completer received the allocated intervention before being lost to follow-up.|10
8928337|NCT02280304|9989552|FG000|NOT COMPLETED|Overall Study||7
8928338|NCT02280304|9989553|FG001|NOT COMPLETED|Overall Study||8
8928339|NCT02280317|9989571|FG000|STARTED|Overall Study|Patients receiving at least one dose.|1
8928340|NCT02280317|9989572|FG001|STARTED|Overall Study|Patients receiving at least one dose.|1
8928341|NCT02280317|9989573|FG002|STARTED|Overall Study|Patients receiving at least one dose.|3
8928342|NCT02280317|9989574|FG003|STARTED|Overall Study|Patients receiving at least one dose.|5
8928343|NCT02280317|9989575|FG004|STARTED|Overall Study|Patients receiving at least one dose.|2
8928344|NCT02280317|9989571|FG000|COMPLETED|Overall Study|Patients completing six cycles.|1
8928345|NCT02280317|9989572|FG001|COMPLETED|Overall Study|Patients completing six cycles.|1
8928346|NCT02280317|9989573|FG002|COMPLETED|Overall Study|Patients completing six cycles.|0
8928347|NCT02280317|9989574|FG003|COMPLETED|Overall Study|Patients completing six cycles.|2
8617006|NCT00454584|9655173|FG001|NOT COMPLETED|After Controlled Period||0
8617007|NCT00454584|9655174|FG002|NOT COMPLETED|After Controlled Period||0
8617008|NCT00454584|9655175|FG003|NOT COMPLETED|After Controlled Period||26
8617009|NCT00454584|9655176|FG004|NOT COMPLETED|After Controlled Period||12
8617010|NCT00454584|9655177|FG005|NOT COMPLETED|After Controlled Period||32
8617011|NCT00454636|9655195|FG000|STARTED|Overall Study||41
8617012|NCT00454636|9655196|FG001|STARTED|Overall Study||32
8928348|NCT02280317|9989575|FG004|COMPLETED|Overall Study|Patients completing six cycles.|0
8617013|NCT00454636|9655197|FG002|STARTED|Overall Study||27
8617014|NCT00454636|9655198|FG003|STARTED|Overall Study||58
8928349|NCT02280317|9989571|FG000|NOT COMPLETED|Overall Study||0
8928350|NCT02280317|9989572|FG001|NOT COMPLETED|Overall Study||0
8928351|NCT02280317|9989573|FG002|NOT COMPLETED|Overall Study||3
8928352|NCT02280317|9989574|FG003|NOT COMPLETED|Overall Study||3
8928353|NCT02280317|9989575|FG004|NOT COMPLETED|Overall Study||2
8928354|NCT02280408|9989602|FG000|STARTED|Overall Study||10
8928355|NCT02280408|9989603|FG001|STARTED|Overall Study||10
8928356|NCT02280408|9989604|FG002|STARTED|Overall Study||10
8928357|NCT02280408|9989605|FG003|STARTED|Overall Study||9
8928358|NCT02280408|9989602|FG000|Vaccination 1|Overall Study||10
8928359|NCT02280408|9989603|FG001|Vaccination 1|Overall Study||10
8928360|NCT02280408|9989604|FG002|Vaccination 1|Overall Study||10
8928361|NCT02280408|9989605|FG003|Vaccination 1|Overall Study||9
8928362|NCT02280408|9989602|FG000|Vaccination 2|Overall Study||10
8928363|NCT02280408|9989603|FG001|Vaccination 2|Overall Study||10
8928364|NCT02280408|9989604|FG002|Vaccination 2|Overall Study||10
8928365|NCT02280408|9989605|FG003|Vaccination 2|Overall Study||9
8928366|NCT02280408|9989602|FG000|COMPLETED|Overall Study||10
8928367|NCT02280408|9989603|FG001|COMPLETED|Overall Study||8
8928368|NCT02280408|9989604|FG002|COMPLETED|Overall Study||10
8928369|NCT02280408|9989605|FG003|COMPLETED|Overall Study||9
8928370|NCT02280408|9989602|FG000|NOT COMPLETED|Overall Study||0
8928371|NCT02280408|9989603|FG001|NOT COMPLETED|Overall Study||2
8928372|NCT02280408|9989604|FG002|NOT COMPLETED|Overall Study||0
8928373|NCT02280408|9989605|FG003|NOT COMPLETED|Overall Study||0
8928374|NCT02280421|9989617|FG000|STARTED|First Intervention(2 Weeks)||12
8928375|NCT02280421|9989618|FG001|STARTED|First Intervention(2 Weeks)||12
8928376|NCT02280421|9989617|FG000|Received Intervention|First Intervention(2 Weeks)||12
8928377|NCT02280421|9989618|FG001|Received Intervention|First Intervention(2 Weeks)||12
8928378|NCT02280421|9989617|FG000|COMPLETED|First Intervention(2 Weeks)||12
8928379|NCT02280421|9989618|FG001|COMPLETED|First Intervention(2 Weeks)||12
8928380|NCT02280421|9989617|FG000|NOT COMPLETED|First Intervention(2 Weeks)||0
8928381|NCT02280421|9989618|FG001|NOT COMPLETED|First Intervention(2 Weeks)||0
8928382|NCT02280421|9989617|FG000|STARTED|Washout (2 Weeks)||12
8928383|NCT02280421|9989618|FG001|STARTED|Washout (2 Weeks)||12
8928384|NCT02280421|9989617|FG000|COMPLETED|Washout (2 Weeks)||11
8928385|NCT02280421|9989618|FG001|COMPLETED|Washout (2 Weeks)||11
8928386|NCT02280421|9989617|FG000|NOT COMPLETED|Washout (2 Weeks)||1
8928387|NCT02280421|9989618|FG001|NOT COMPLETED|Washout (2 Weeks)||1
8928388|NCT02280421|9989617|FG000|STARTED|Second Intervention(2 Weeks)||12
8928389|NCT02280421|9989618|FG001|STARTED|Second Intervention(2 Weeks)||12
8928390|NCT02280421|9989617|FG000|Received Intervention|Second Intervention(2 Weeks)||12
8928391|NCT02280421|9989618|FG001|Received Intervention|Second Intervention(2 Weeks)||12
8928392|NCT02280421|9989617|FG000|COMPLETED|Second Intervention(2 Weeks)||12
8928393|NCT02280421|9989618|FG001|COMPLETED|Second Intervention(2 Weeks)||12
8928394|NCT02280421|9989617|FG000|NOT COMPLETED|Second Intervention(2 Weeks)||0
8928395|NCT02280421|9989618|FG001|NOT COMPLETED|Second Intervention(2 Weeks)||0
8928396|NCT02280473|9989638|FG000|STARTED|Overall Study||94
8928397|NCT02280473|9989639|FG001|STARTED|Overall Study||94
8928398|NCT02280473|9989638|FG000|COMPLETED|Overall Study||93
8928399|NCT02280473|9989639|FG001|COMPLETED|Overall Study||91
8928400|NCT02280473|9989638|FG000|NOT COMPLETED|Overall Study||1
8928401|NCT02280473|9989639|FG001|NOT COMPLETED|Overall Study||3
8928402|NCT02280499|9989645|FG000|STARTED|Overall Study||87
8928403|NCT02280499|9989645|FG000|COMPLETED|Overall Study||26
8928404|NCT02280499|9989645|FG000|NOT COMPLETED|Overall Study||61
8928405|NCT02280655|9989651|FG000|STARTED|Overall Study||25
8928406|NCT02280655|9989652|FG001|STARTED|Overall Study||18
8928407|NCT02280655|9989651|FG000|COMPLETED|Overall Study||25
8928408|NCT02280655|9989652|FG001|COMPLETED|Overall Study||18
8928409|NCT02280655|9989651|FG000|NOT COMPLETED|Overall Study||0
8928410|NCT02280655|9989652|FG001|NOT COMPLETED|Overall Study||0
8928411|NCT02280811|9989663|FG000|STARTED|Drug Administration||1
8928412|NCT02280811|9989664|FG001|STARTED|Drug Administration||2
8928413|NCT02280811|9989665|FG002|STARTED|Drug Administration||1
8928414|NCT02280811|9989666|FG003|STARTED|Drug Administration||6
8928415|NCT02280811|9989667|FG004|STARTED|Drug Administration||2
8928416|NCT02280811|9989663|FG000|COMPLETED|Drug Administration||1
8928417|NCT02280811|9989664|FG001|COMPLETED|Drug Administration||2
8928418|NCT02280811|9989665|FG002|COMPLETED|Drug Administration||1
8928419|NCT02280811|9989666|FG003|COMPLETED|Drug Administration||6
8928420|NCT02280811|9989667|FG004|COMPLETED|Drug Administration||2
8928421|NCT02280811|9989663|FG000|NOT COMPLETED|Drug Administration||0
8928422|NCT02280811|9989664|FG001|NOT COMPLETED|Drug Administration||0
8928423|NCT02280811|9989665|FG002|NOT COMPLETED|Drug Administration||0
8928424|NCT02280811|9989666|FG003|NOT COMPLETED|Drug Administration||0
8928425|NCT02280811|9989667|FG004|NOT COMPLETED|Drug Administration||0
8928426|NCT02280811|9989663|FG000|STARTED|Retreated at the MTD||0
8928427|NCT02280811|9989664|FG001|STARTED|Retreated at the MTD||0
8928428|NCT02280811|9989665|FG002|STARTED|Retreated at the MTD||0
8928429|NCT02280811|9989666|FG003|STARTED|Retreated at the MTD||0
8928430|NCT02280811|9989667|FG004|STARTED|Retreated at the MTD|Patient originally started in Grp1(HPV-16 E6mTCR PBL 1x10^9+HD IL-2) and was retreated at the MTD.|1
8928431|NCT02280811|9989663|FG000|COMPLETED|Retreated at the MTD||0
8928432|NCT02280811|9989664|FG001|COMPLETED|Retreated at the MTD||0
8928433|NCT02280811|9989665|FG002|COMPLETED|Retreated at the MTD||0
8928434|NCT02280811|9989666|FG003|COMPLETED|Retreated at the MTD||0
8928435|NCT02280811|9989667|FG004|COMPLETED|Retreated at the MTD||1
8928436|NCT02280811|9989663|FG000|NOT COMPLETED|Retreated at the MTD||0
8928437|NCT02280811|9989664|FG001|NOT COMPLETED|Retreated at the MTD||0
8928438|NCT02280811|9989665|FG002|NOT COMPLETED|Retreated at the MTD||0
8928439|NCT02280811|9989666|FG003|NOT COMPLETED|Retreated at the MTD||0
8928440|NCT02280811|9989667|FG004|NOT COMPLETED|Retreated at the MTD||0
8928441|NCT02280863|9989683|FG000|STARTED|Android Platform||8
8928442|NCT02280863|9989684|FG001|STARTED|Android Platform||0
8928443|NCT02280863|9989683|FG000|COMPLETED|Android Platform||8
8928444|NCT02280863|9989684|FG001|COMPLETED|Android Platform||0
8928445|NCT02280863|9989683|FG000|NOT COMPLETED|Android Platform||0
8928446|NCT02280863|9989684|FG001|NOT COMPLETED|Android Platform||0
8928447|NCT02280863|9989683|FG000|STARTED|Integrated Platform|One additional participant was enrolled for part 2.|9
8928448|NCT02280863|9989684|FG001|STARTED|Integrated Platform||15
8928449|NCT02280863|9989683|FG000|COMPLETED|Integrated Platform||9
8928450|NCT02280863|9989684|FG001|COMPLETED|Integrated Platform||14
8928451|NCT02280863|9989683|FG000|NOT COMPLETED|Integrated Platform||0
8928452|NCT02280863|9989684|FG001|NOT COMPLETED|Integrated Platform||1
8928453|NCT02281136|9989694|FG000|STARTED|Overall Study||29
8928454|NCT02281136|9989694|FG000|COMPLETED|Overall Study||29
8928455|NCT02281136|9989694|FG000|NOT COMPLETED|Overall Study||0
8928456|NCT02281318|9989700|FG000|STARTED|Overall Study||277
8928457|NCT02281318|9989701|FG001|STARTED|Overall Study||274
8928458|NCT02281318|9989700|FG000|COMPLETED|Overall Study||263
8928459|NCT02281318|9989701|FG001|COMPLETED|Overall Study||269
8928460|NCT02281318|9989700|FG000|NOT COMPLETED|Overall Study||14
8928461|NCT02281318|9989701|FG001|NOT COMPLETED|Overall Study||5
8928462|NCT02281344|9989707|FG000|STARTED|Overall Study||6
8928463|NCT02281344|9989707|FG000|COMPLETED|Overall Study||6
8928464|NCT02281344|9989707|FG000|NOT COMPLETED|Overall Study||0
8928465|NCT02281357|9989713|FG000|STARTED|Overall Study||70
8928466|NCT02281357|9989714|FG001|STARTED|Overall Study||70
8928467|NCT02281357|9989713|FG000|COMPLETED|Overall Study||63
8928468|NCT02281357|9989714|FG001|COMPLETED|Overall Study||66
8928469|NCT02281357|9989713|FG000|NOT COMPLETED|Overall Study||7
8928470|NCT02281357|9989714|FG001|NOT COMPLETED|Overall Study||4
8928471|NCT02281409|9989724|FG000|STARTED|Overall Study||3
8928472|NCT02281409|9989725|FG001|STARTED|Overall Study||3
8617015|NCT00454636|9655195|FG000|COMPLETED|Overall Study||10
8617016|NCT00454636|9655196|FG001|COMPLETED|Overall Study||9
8617017|NCT00454636|9655197|FG002|COMPLETED|Overall Study||7
8928473|NCT02281409|9989726|FG002|STARTED|Overall Study||5
8928474|NCT02281409|9989727|FG003|STARTED|Overall Study||6
8928475|NCT02281409|9989724|FG000|COMPLETED|Overall Study||3
8928476|NCT02281409|9989725|FG001|COMPLETED|Overall Study||3
8928477|NCT02281409|9989726|FG002|COMPLETED|Overall Study||5
8928478|NCT02281409|9989727|FG003|COMPLETED|Overall Study||6
8928479|NCT02281409|9989724|FG000|NOT COMPLETED|Overall Study||0
8928480|NCT02281409|9989725|FG001|NOT COMPLETED|Overall Study||0
8928481|NCT02281409|9989726|FG002|NOT COMPLETED|Overall Study||0
8928482|NCT02281409|9989727|FG003|NOT COMPLETED|Overall Study||0
8928483|NCT02281422|9989743|FG000|STARTED|Overall Study||8
8928484|NCT02281422|9989744|FG001|STARTED|Overall Study||8
8928485|NCT02281422|9989745|FG002|STARTED|Overall Study||8
8928486|NCT02281422|9989746|FG003|STARTED|Overall Study||8
8928487|NCT02281422|9989747|FG004|STARTED|Overall Study||8
8928488|NCT02281422|9989743|FG000|COMPLETED|Overall Study||8
8928489|NCT02281422|9989744|FG001|COMPLETED|Overall Study||8
8928490|NCT02281422|9989745|FG002|COMPLETED|Overall Study||8
8928491|NCT02281422|9989746|FG003|COMPLETED|Overall Study||8
8928492|NCT02281422|9989747|FG004|COMPLETED|Overall Study||8
8928493|NCT02281422|9989743|FG000|NOT COMPLETED|Overall Study||0
8928494|NCT02281422|9989744|FG001|NOT COMPLETED|Overall Study||0
8928495|NCT02281422|9989745|FG002|NOT COMPLETED|Overall Study||0
8928496|NCT02281422|9989746|FG003|NOT COMPLETED|Overall Study||0
8928497|NCT02281422|9989747|FG004|NOT COMPLETED|Overall Study||0
8928498|NCT02281448|9989761|FG000|STARTED|Overall Study||10
8928499|NCT02281448|9989762|FG001|STARTED|Overall Study||10
8928500|NCT02281448|9989761|FG000|COMPLETED|Overall Study||8
8928501|NCT02281448|9989762|FG001|COMPLETED|Overall Study||9
8928502|NCT02281448|9989761|FG000|NOT COMPLETED|Overall Study||2
8928503|NCT02281448|9989762|FG001|NOT COMPLETED|Overall Study||1
8928504|NCT02281526|9989770|FG000|STARTED|Overall Study||9
8928505|NCT02281526|9989771|FG001|STARTED|Overall Study||8
8928506|NCT02281526|9989770|FG000|COMPLETED|Overall Study||8
8928507|NCT02281526|9989771|FG001|COMPLETED|Overall Study||8
8928508|NCT02281526|9989770|FG000|NOT COMPLETED|Overall Study||1
8928509|NCT02281526|9989771|FG001|NOT COMPLETED|Overall Study||0
8928510|NCT02281552|9989779|FG000|STARTED|Overall Study||104
8928511|NCT02281552|9989780|FG001|STARTED|Overall Study||105
8617018|NCT00454636|9655198|FG003|COMPLETED|Overall Study||26
8617019|NCT00454636|9655195|FG000|NOT COMPLETED|Overall Study||31
8617020|NCT00454636|9655196|FG001|NOT COMPLETED|Overall Study||23
8617021|NCT00454636|9655197|FG002|NOT COMPLETED|Overall Study||20
8617022|NCT00454636|9655198|FG003|NOT COMPLETED|Overall Study||32
8928512|NCT02281552|9989779|FG000|COMPLETED|Overall Study||100
8928513|NCT02281552|9989780|FG001|COMPLETED|Overall Study||95
8928514|NCT02281552|9989779|FG000|NOT COMPLETED|Overall Study||4
8928515|NCT02281552|9989780|FG001|NOT COMPLETED|Overall Study||10
8928516|NCT02281591|9989790|FG000|STARTED|Overall Study||8
8928517|NCT02281591|9989791|FG001|STARTED|Overall Study||8
8928518|NCT02281591|9989792|FG002|STARTED|Overall Study||8
8928519|NCT02281591|9989793|FG003|STARTED|Overall Study||8
8928520|NCT02281591|9989790|FG000|COMPLETED|Overall Study||8
8617023|NCT00454649|9655218|FG000|STARTED|Overall Study||3
8617024|NCT00454649|9655219|FG001|STARTED|Overall Study||5
8617025|NCT00454649|9655220|FG002|STARTED|Overall Study||20
8928521|NCT02281591|9989791|FG001|COMPLETED|Overall Study||8
8928522|NCT02281591|9989792|FG002|COMPLETED|Overall Study||8
8928523|NCT02281591|9989793|FG003|COMPLETED|Overall Study||8
8928524|NCT02281591|9989790|FG000|NOT COMPLETED|Overall Study||0
8928525|NCT02281591|9989791|FG001|NOT COMPLETED|Overall Study||0
8928526|NCT02281591|9989792|FG002|NOT COMPLETED|Overall Study||0
8928527|NCT02281591|9989793|FG003|NOT COMPLETED|Overall Study||0
8928528|NCT02281760|9989803|FG000|STARTED|Overall Study||6
8928529|NCT02281760|9989803|FG000|COMPLETED|Overall Study||5
8928530|NCT02281760|9989803|FG000|NOT COMPLETED|Overall Study||1
8928531|NCT02281773|9989812|FG000|STARTED|Overall Study||87
8928532|NCT02281773|9989813|FG001|STARTED|Overall Study|Started are the treated patients|85
8928533|NCT02281773|9989814|FG002|STARTED|Overall Study||85
8928534|NCT02281773|9989815|FG003|STARTED|Overall Study||86
8928535|NCT02281773|9989816|FG004|STARTED|Overall Study|Started are the treated patients|173
8928536|NCT02281773|9989812|FG000|COMPLETED|Overall Study||76
8928537|NCT02281773|9989813|FG001|COMPLETED|Overall Study||70
8928538|NCT02281773|9989814|FG002|COMPLETED|Overall Study||67
8928539|NCT02281773|9989815|FG003|COMPLETED|Overall Study||65
8928540|NCT02281773|9989816|FG004|COMPLETED|Overall Study||143
8928541|NCT02281773|9989812|FG000|NOT COMPLETED|Overall Study||11
8928542|NCT02281773|9989813|FG001|NOT COMPLETED|Overall Study||15
8928543|NCT02281773|9989814|FG002|NOT COMPLETED|Overall Study||18
8928544|NCT02281773|9989815|FG003|NOT COMPLETED|Overall Study||21
8928545|NCT02281773|9989816|FG004|NOT COMPLETED|Overall Study||30
8928546|NCT02281851|9989830|FG000|STARTED|Overall Study||4
8928547|NCT02281851|9989831|FG001|STARTED|Overall Study||10
8928548|NCT02281851|9989830|FG000|COMPLETED|Overall Study||4
8928549|NCT02281851|9989831|FG001|COMPLETED|Overall Study||10
8928550|NCT02281851|9989830|FG000|NOT COMPLETED|Overall Study||0
8928551|NCT02281851|9989831|FG001|NOT COMPLETED|Overall Study||0
8928552|NCT02282111|9989839|FG000|STARTED|Overall Study||26
8928553|NCT02282111|9989840|FG001|STARTED|Overall Study||30
8928554|NCT02282111|9989839|FG000|COMPLETED|Overall Study||19
8928555|NCT02282111|9989840|FG001|COMPLETED|Overall Study||22
8928556|NCT02282111|9989839|FG000|NOT COMPLETED|Overall Study||7
8928557|NCT02282111|9989840|FG001|NOT COMPLETED|Overall Study||8
8928558|NCT02282163|9989846|FG000|STARTED|Overall Study||13
8928559|NCT02282163|9989846|FG000|COMPLETED|Overall Study||12
8928560|NCT02282163|9989846|FG000|NOT COMPLETED|Overall Study||1
8928561|NCT02282293|9989861|FG000|STARTED|Overall Study||100
8928562|NCT02282293|9989862|FG001|STARTED|Overall Study||100
8928563|NCT02282293|9989861|FG000|COMPLETED|Overall Study||97
8928564|NCT02282293|9989862|FG001|COMPLETED|Overall Study||97
8928565|NCT02282293|9989861|FG000|NOT COMPLETED|Overall Study||3
8928566|NCT02282293|9989862|FG001|NOT COMPLETED|Overall Study||3
8928567|NCT02282514|9989868|FG000|STARTED|Overall Study||23
8928568|NCT02282514|9989868|FG000|COMPLETED|Overall Study||23
8928569|NCT02282514|9989868|FG000|NOT COMPLETED|Overall Study||0
8928570|NCT02282527|9989874|FG000|STARTED|Overall Study||16
8928571|NCT02282527|9989875|FG001|STARTED|Overall Study||16
8928572|NCT02282527|9989874|FG000|COMPLETED|Overall Study||15
8928573|NCT02282527|9989875|FG001|COMPLETED|Overall Study||15
8928574|NCT02282527|9989874|FG000|NOT COMPLETED|Overall Study||1
8928575|NCT02282527|9989875|FG001|NOT COMPLETED|Overall Study||1
8928576|NCT02282605|9989887|FG000|STARTED|Overall Study||27
8928577|NCT02282605|9989888|FG001|STARTED|Overall Study||12
8928578|NCT02282605|9989889|FG002|STARTED|Overall Study||24
8928579|NCT02282605|9989887|FG000|COMPLETED|Overall Study||24
8928580|NCT02282605|9989888|FG001|COMPLETED|Overall Study||12
8928581|NCT02282605|9989889|FG002|COMPLETED|Overall Study||24
8928582|NCT02282605|9989887|FG000|NOT COMPLETED|Overall Study||3
8928583|NCT02282605|9989888|FG001|NOT COMPLETED|Overall Study||0
8928584|NCT02282605|9989889|FG002|NOT COMPLETED|Overall Study||0
8928585|NCT02282631|9989899|FG000|STARTED|Overall Study|The two dropouts happened on the 2nd and 3rd weeks post-baseline, respectively|14
8928586|NCT02282631|9989900|FG001|STARTED|Overall Study||15
8928587|NCT02282631|9989899|FG000|COMPLETED|Overall Study||12
8928588|NCT02282631|9989900|FG001|COMPLETED|Overall Study||15
8928589|NCT02282631|9989899|FG000|NOT COMPLETED|Overall Study||2
8928590|NCT02282631|9989900|FG001|NOT COMPLETED|Overall Study||0
8928591|NCT02282722|9989914|FG000|STARTED|Overall Study||94
8928592|NCT02282722|9989915|FG001|STARTED|Overall Study||92
8928593|NCT02282722|9989914|FG000|2-week Assessment|Overall Study||79
8928594|NCT02282722|9989915|FG001|2-week Assessment|Overall Study||75
8928595|NCT02282722|9989914|FG000|3-month Assessment|Overall Study||71
8928596|NCT02282722|9989915|FG001|3-month Assessment|Overall Study||73
8617026|NCT00454649|9655221|FG003|STARTED|Overall Study||7
8617027|NCT00454649|9655222|FG004|STARTED|Overall Study||1
8617028|NCT00454649|9655223|FG005|STARTED|Overall Study||7
8617029|NCT00454649|9655224|FG006|STARTED|Overall Study||9
8617030|NCT00454649|9655225|FG007|STARTED|Overall Study||19
8928597|NCT02282722|9989914|FG000|COMPLETED|Overall Study||71
8928598|NCT02282722|9989915|FG001|COMPLETED|Overall Study||73
8617031|NCT00454649|9655226|FG008|STARTED|Overall Study||21
8928599|NCT02282722|9989914|FG000|NOT COMPLETED|Overall Study||23
8928600|NCT02282722|9989915|FG001|NOT COMPLETED|Overall Study||19
8928601|NCT02282813|9989924|FG000|STARTED|Overall Study|ITT Population|103
8928602|NCT02282813|9989925|FG001|STARTED|Overall Study|ITT Population - not randomized or randomized to CTAP101 monotherapy|153
8928603|NCT02282813|9989926|FG002|STARTED|Overall Study|Randomization to take adjunctive treatment in addition to CTAP101 capsules began after week 12.|42
8928604|NCT02282813|9989924|FG000|COMPLETED|Overall Study||91
8928605|NCT02282813|9989925|FG001|COMPLETED|Overall Study||130
8928606|NCT02282813|9989926|FG002|COMPLETED|Overall Study||39
8928607|NCT02282813|9989924|FG000|NOT COMPLETED|Overall Study||12
8928608|NCT02282813|9989925|FG001|NOT COMPLETED|Overall Study||23
8928609|NCT02282813|9989926|FG002|NOT COMPLETED|Overall Study||3
8928610|NCT02282904|9989936|FG000|STARTED|Overall Study||7
8928611|NCT02282904|9989936|FG000|COMPLETED|Overall Study|Patient accrual was stopped early, and the protocol closed after completing followup|7
8928612|NCT02282904|9989936|FG000|NOT COMPLETED|Overall Study||0
8928613|NCT02282930|9989940|FG000|STARTED|Overall Study||20
8928614|NCT02282930|9989940|FG000|COMPLETED|Overall Study||19
8928615|NCT02282930|9989940|FG000|NOT COMPLETED|Overall Study||1
8928616|NCT02282982|9989944|FG000|STARTED|Overall Study||359
8928617|NCT02282982|9989944|FG000|Attended Visit 1|Overall Study||359
8928618|NCT02282982|9989944|FG000|Attended Visit 2|Overall Study||341
8928619|NCT02282982|9989944|FG000|Attended Visit 3|Overall Study||298
8928620|NCT02282982|9989944|FG000|Attended Visit 4|Overall Study||194
8928621|NCT02282982|9989944|FG000|Attended Visit 5|Overall Study||83
8928622|NCT02282982|9989944|FG000|Attended Follow-up Visit|Overall Study||349
8928623|NCT02282982|9989944|FG000|COMPLETED|Overall Study||153
8928624|NCT02282982|9989944|FG000|NOT COMPLETED|Overall Study||206
8928625|NCT02283268|9989948|FG000|STARTED|Overall Study||15
8928626|NCT02283268|9989948|FG000|COMPLETED|Overall Study||14
8928627|NCT02283268|9989948|FG000|NOT COMPLETED|Overall Study||1
8948228|NCT02428413|10010575|FG000|COMPLETED|Overall Study||56
8948229|NCT02428413|10010576|FG001|COMPLETED|Overall Study||52
8948230|NCT02428413|10010575|FG000|NOT COMPLETED|Overall Study||8
8948231|NCT02428413|10010576|FG001|NOT COMPLETED|Overall Study||9
8948232|NCT02428478|10010582|FG000|STARTED|First Study Night||9
8948233|NCT02428478|10010583|FG001|STARTED|First Study Night||8
8948234|NCT02428478|10010582|FG000|COMPLETED|First Study Night||9
8948235|NCT02428478|10010583|FG001|COMPLETED|First Study Night||8
8948236|NCT02428478|10010582|FG000|NOT COMPLETED|First Study Night||0
8948237|NCT02428478|10010583|FG001|NOT COMPLETED|First Study Night||0
8948238|NCT02428478|10010582|FG000|STARTED|Second Study Night|1 participant did not return for the second study night|8
8948239|NCT02428478|10010583|FG001|STARTED|Second Study Night|2 participants did not return for the second study night|6
8948240|NCT02428478|10010582|FG000|COMPLETED|Second Study Night||8
8948241|NCT02428478|10010583|FG001|COMPLETED|Second Study Night||6
8948242|NCT02428478|10010582|FG000|NOT COMPLETED|Second Study Night||0
8948243|NCT02428478|10010583|FG001|NOT COMPLETED|Second Study Night||0
8948244|NCT02428595|10010589|FG000|STARTED|Fitting||137
8948245|NCT02428595|10010589|FG000|COMPLETED|Fitting||73
8948246|NCT02428595|10010589|FG000|NOT COMPLETED|Fitting||64
8948247|NCT02428595|10010589|FG000|STARTED|Treatment||73
8948248|NCT02428595|10010589|FG000|COMPLETED|Treatment||54
8948249|NCT02428595|10010589|FG000|NOT COMPLETED|Treatment||19
8948250|NCT02428608|10010602|FG000|STARTED|Overall Study||570
8948251|NCT02428608|10010602|FG000|COMPLETED|Overall Study||487
8948252|NCT02428608|10010602|FG000|NOT COMPLETED|Overall Study||83
8948253|NCT02428699|10010607|FG000|STARTED|Period 1||25
8948254|NCT02428699|10010608|FG001|STARTED|Period 1||25
8948255|NCT02428699|10010607|FG000|COMPLETED|Period 1||25
8948256|NCT02428699|10010608|FG001|COMPLETED|Period 1||25
8948257|NCT02428699|10010607|FG000|NOT COMPLETED|Period 1||0
8948258|NCT02428699|10010608|FG001|NOT COMPLETED|Period 1||0
8948259|NCT02428699|10010607|FG000|STARTED|Washout Period 1||25
8948260|NCT02428699|10010608|FG001|STARTED|Washout Period 1||25
8948261|NCT02428699|10010607|FG000|COMPLETED|Washout Period 1||24
8948262|NCT02428699|10010608|FG001|COMPLETED|Washout Period 1||23
8948263|NCT02428699|10010607|FG000|NOT COMPLETED|Washout Period 1||1
8948264|NCT02428699|10010608|FG001|NOT COMPLETED|Washout Period 1||2
8948265|NCT02428699|10010607|FG000|STARTED|Period 2||24
8948266|NCT02428699|10010608|FG001|STARTED|Period 2||23
8948267|NCT02428699|10010607|FG000|COMPLETED|Period 2||24
8948268|NCT02428699|10010608|FG001|COMPLETED|Period 2||23
8948269|NCT02428699|10010607|FG000|NOT COMPLETED|Period 2||0
8948270|NCT02428699|10010608|FG001|NOT COMPLETED|Period 2||0
8948271|NCT02428855|10010619|FG000|STARTED|Overall Study||8
8948272|NCT02428855|10010619|FG000|COMPLETED|Overall Study||6
8948273|NCT02428855|10010619|FG000|NOT COMPLETED|Overall Study||2
8948274|NCT02429115|10010629|FG000|STARTED|Overall Study||52
8948275|NCT02429115|10010630|FG001|STARTED|Overall Study||52
8948276|NCT02429115|10010631|FG002|STARTED|Overall Study||51
8948277|NCT02429115|10010632|FG003|STARTED|Overall Study||29
8617032|NCT00454649|9655227|FG009|STARTED|Overall Study||6
8617033|NCT00454649|9655218|FG000|COMPLETED|Overall Study||0
8948278|NCT02429115|10010633|FG004|STARTED|Overall Study||29
8948279|NCT02429115|10010634|FG005|STARTED|Overall Study||28
8948280|NCT02429115|10010629|FG000|COMPLETED|Overall Study||40
8948281|NCT02429115|10010630|FG001|COMPLETED|Overall Study||42
8948282|NCT02429115|10010631|FG002|COMPLETED|Overall Study||35
8948283|NCT02429115|10010632|FG003|COMPLETED|Overall Study||21
8617034|NCT00454649|9655219|FG001|COMPLETED|Overall Study||1
8948284|NCT02429115|10010633|FG004|COMPLETED|Overall Study||22
8948285|NCT02429115|10010634|FG005|COMPLETED|Overall Study||27
8948286|NCT02429115|10010629|FG000|NOT COMPLETED|Overall Study||12
8948287|NCT02429115|10010630|FG001|NOT COMPLETED|Overall Study||10
8617035|NCT00454649|9655220|FG002|COMPLETED|Overall Study||1
8948288|NCT02429115|10010631|FG002|NOT COMPLETED|Overall Study||16
8928628|NCT02283294|9989962|FG000|STARTED|Overall Study||41
8928629|NCT02283294|9989963|FG001|STARTED|Overall Study||47
8928630|NCT02283294|9989962|FG000|Received Allocated Treatment Intervention|Overall Study||38
8928631|NCT02283294|9989963|FG001|Received Allocated Treatment Intervention|Overall Study||31
8928632|NCT02283294|9989962|FG000|COMPLETED|Overall Study||38
8928633|NCT02283294|9989963|FG001|COMPLETED|Overall Study||39
8928634|NCT02283294|9989962|FG000|NOT COMPLETED|Overall Study||3
8928635|NCT02283294|9989963|FG001|NOT COMPLETED|Overall Study||8
8928636|NCT02283333|9989972|FG000|STARTED|Overall Study||77
8928637|NCT02283333|9989973|FG001|STARTED|Overall Study||78
8928638|NCT02283333|9989972|FG000|COMPLETED|Overall Study||63
8928639|NCT02283333|9989973|FG001|COMPLETED|Overall Study||64
8928640|NCT02283333|9989972|FG000|NOT COMPLETED|Overall Study||14
8928641|NCT02283333|9989973|FG001|NOT COMPLETED|Overall Study||14
8928642|NCT02283411|9989979|FG000|STARTED|Overall Study||156
8928643|NCT02283411|9989979|FG000|COMPLETED|Overall Study||125
8928644|NCT02283411|9989979|FG000|NOT COMPLETED|Overall Study||31
8617036|NCT00454649|9655221|FG003|COMPLETED|Overall Study||1
8617037|NCT00454649|9655222|FG004|COMPLETED|Overall Study||0
8617038|NCT00454649|9655223|FG005|COMPLETED|Overall Study||0
8617039|NCT00454649|9655224|FG006|COMPLETED|Overall Study||0
8617040|NCT00454649|9655225|FG007|COMPLETED|Overall Study||0
8617041|NCT00454649|9655226|FG008|COMPLETED|Overall Study||1
8617042|NCT00454649|9655227|FG009|COMPLETED|Overall Study||1
8617043|NCT00454649|9655218|FG000|NOT COMPLETED|Overall Study||3
8617044|NCT00454649|9655219|FG001|NOT COMPLETED|Overall Study||4
8617045|NCT00454649|9655220|FG002|NOT COMPLETED|Overall Study||19
8617046|NCT00454649|9655221|FG003|NOT COMPLETED|Overall Study||6
8617047|NCT00454649|9655222|FG004|NOT COMPLETED|Overall Study||1
8617048|NCT00454649|9655223|FG005|NOT COMPLETED|Overall Study||7
8617049|NCT00454649|9655224|FG006|NOT COMPLETED|Overall Study||9
8617050|NCT00454649|9655225|FG007|NOT COMPLETED|Overall Study||19
8928645|NCT02283528|9989985|FG000|STARTED|Overall Study||26
8928646|NCT02283528|9989986|FG001|STARTED|Overall Study||24
8928647|NCT02283528|9989985|FG000|COMPLETED|Overall Study||26
8928648|NCT02283528|9989986|FG001|COMPLETED|Overall Study||24
8928649|NCT02283528|9989985|FG000|NOT COMPLETED|Overall Study||0
8928650|NCT02283528|9989986|FG001|NOT COMPLETED|Overall Study||0
8928651|NCT02283658|9989992|FG000|STARTED|Overall Study||20
8928652|NCT02283658|9989992|FG000|COMPLETED|Overall Study||19
8928653|NCT02283658|9989992|FG000|NOT COMPLETED|Overall Study||1
8928654|NCT02283749|9989996|FG000|STARTED|Overall Study||5
8928655|NCT02283749|9989996|FG000|COMPLETED|Overall Study||5
8928656|NCT02283749|9989996|FG000|NOT COMPLETED|Overall Study||0
8928657|NCT02283762|9990002|FG000|STARTED|Main Treatment Phase (MT)||60
8928658|NCT02283762|9990003|FG001|STARTED|Main Treatment Phase (MT)||61
8928659|NCT02283762|9990002|FG000|COMPLETED|Main Treatment Phase (MT)||42
8928660|NCT02283762|9990003|FG001|COMPLETED|Main Treatment Phase (MT)||46
8928661|NCT02283762|9990002|FG000|NOT COMPLETED|Main Treatment Phase (MT)||18
8928662|NCT02283762|9990003|FG001|NOT COMPLETED|Main Treatment Phase (MT)||15
8928663|NCT02283762|9990002|FG000|STARTED|Long-term Extension Phase (LTE)||42
8928664|NCT02283762|9990003|FG001|STARTED|Long-term Extension Phase (LTE)|Of the 46 patients who completed the main treatment phase, 1 patient did not enter the LTE phase|45
8928665|NCT02283762|9990002|FG000|COMPLETED|Long-term Extension Phase (LTE)||32
8928666|NCT02283762|9990003|FG001|COMPLETED|Long-term Extension Phase (LTE)||31
8928667|NCT02283762|9990002|FG000|NOT COMPLETED|Long-term Extension Phase (LTE)||10
8928668|NCT02283762|9990003|FG001|NOT COMPLETED|Long-term Extension Phase (LTE)||14
8928669|NCT02283788|9990015|FG000|STARTED|Overall Study||17
8928670|NCT02283788|9990016|FG001|STARTED|Overall Study||17
8928671|NCT02283788|9990017|FG002|STARTED|Overall Study||17
8928672|NCT02283788|9990018|FG003|STARTED|Overall Study||16
8928673|NCT02283788|9990015|FG000|COMPLETED|Overall Study||16
8928674|NCT02283788|9990016|FG001|COMPLETED|Overall Study||13
8928675|NCT02283788|9990017|FG002|COMPLETED|Overall Study||12
8928676|NCT02283788|9990018|FG003|COMPLETED|Overall Study||14
8928677|NCT02283788|9990015|FG000|NOT COMPLETED|Overall Study||1
8928678|NCT02283788|9990016|FG001|NOT COMPLETED|Overall Study||4
8928679|NCT02283788|9990017|FG002|NOT COMPLETED|Overall Study||5
8928680|NCT02283788|9990018|FG003|NOT COMPLETED|Overall Study||2
8617051|NCT00454649|9655226|FG008|NOT COMPLETED|Overall Study||20
8617052|NCT00454649|9655227|FG009|NOT COMPLETED|Overall Study||5
8617053|NCT00454779|9655270|FG000|STARTED|First-line Treatment Phase||56
8617054|NCT00454779|9655271|FG001|STARTED|First-line Treatment Phase||57
8617055|NCT00454779|9655270|FG000|Received Study Medication|First-line Treatment Phase||56
8617056|NCT00454779|9655271|FG001|Received Study Medication|First-line Treatment Phase||55
8928681|NCT02283814|9990030|FG000|STARTED|Overall Study||16
8928682|NCT02283814|9990031|FG001|STARTED|Overall Study||16
8928683|NCT02283814|9990030|FG000|COMPLETED|Overall Study||13
8928684|NCT02283814|9990031|FG001|COMPLETED|Overall Study||14
8928685|NCT02283814|9990030|FG000|NOT COMPLETED|Overall Study||3
8928686|NCT02283814|9990031|FG001|NOT COMPLETED|Overall Study||2
8928687|NCT02283827|9990039|FG000|STARTED|Overall Study||16
8928688|NCT02283827|9990040|FG001|STARTED|Overall Study||16
8928689|NCT02283827|9990039|FG000|COMPLETED|Overall Study||15
8928690|NCT02283827|9990040|FG001|COMPLETED|Overall Study||13
8928691|NCT02283827|9990039|FG000|NOT COMPLETED|Overall Study||1
8928692|NCT02283827|9990040|FG001|NOT COMPLETED|Overall Study||3
8928693|NCT02283840|9990055|FG000|STARTED|Overall Study||20
8928694|NCT02283840|9990056|FG001|STARTED|Overall Study||20
8928695|NCT02283840|9990057|FG002|STARTED|Overall Study||20
8928696|NCT02283840|9990055|FG000|COMPLETED|Overall Study||20
8928697|NCT02283840|9990056|FG001|COMPLETED|Overall Study||19
8928698|NCT02283840|9990057|FG002|COMPLETED|Overall Study||20
8928699|NCT02283840|9990055|FG000|NOT COMPLETED|Overall Study||0
8928700|NCT02283840|9990056|FG001|NOT COMPLETED|Overall Study||1
8928701|NCT02283840|9990057|FG002|NOT COMPLETED|Overall Study||0
8928702|NCT02284009|9990070|FG000|STARTED|Overall Study||17
8928703|NCT02284009|9990071|FG001|STARTED|Overall Study||50
8928704|NCT02284009|9990070|FG000|COMPLETED|Overall Study||11
8928705|NCT02284009|9990071|FG001|COMPLETED|Overall Study||40
8928706|NCT02284009|9990070|FG000|NOT COMPLETED|Overall Study||6
8928707|NCT02284009|9990071|FG001|NOT COMPLETED|Overall Study||10
8928708|NCT02284126|9990081|FG000|STARTED|Overall Study||552
8928709|NCT02284126|9990082|FG001|STARTED|Overall Study||551
8928710|NCT02284126|9990081|FG000|COMPLETED|Overall Study||484
8928711|NCT02284126|9990082|FG001|COMPLETED|Overall Study||489
8928712|NCT02284126|9990081|FG000|NOT COMPLETED|Overall Study||68
8928713|NCT02284126|9990082|FG001|NOT COMPLETED|Overall Study||62
8928714|NCT02284165|9990091|FG000|STARTED|Overall Study||36448
8928715|NCT02284165|9990092|FG001|STARTED|Overall Study||40272
8928716|NCT02284165|9990093|FG002|STARTED|Overall Study||70996
8928717|NCT02284165|9990091|FG000|COMPLETED|Overall Study||36448
8928718|NCT02284165|9990092|FG001|COMPLETED|Overall Study||40272
8928719|NCT02284165|9990093|FG002|COMPLETED|Overall Study||70996
8928720|NCT02284165|9990091|FG000|NOT COMPLETED|Overall Study||0
8928721|NCT02284165|9990092|FG001|NOT COMPLETED|Overall Study||0
8928722|NCT02284165|9990093|FG002|NOT COMPLETED|Overall Study||0
8928723|NCT02284178|9990101|FG000|STARTED|Overall Study||255
8928724|NCT02284178|9990102|FG001|STARTED|Overall Study||258
8928725|NCT02284178|9990101|FG000|COMPLETED|Overall Study||206
8928726|NCT02284178|9990102|FG001|COMPLETED|Overall Study||204
8928727|NCT02284178|9990101|FG000|NOT COMPLETED|Overall Study||49
8928728|NCT02284178|9990102|FG001|NOT COMPLETED|Overall Study||54
8928729|NCT02284243|9990110|FG000|STARTED|Overall Study||84
8928730|NCT02284243|9990111|FG001|STARTED|Overall Study||84
8928731|NCT02284243|9990110|FG000|COMPLETED|Overall Study||80
8928732|NCT02284243|9990111|FG001|COMPLETED|Overall Study||81
8928733|NCT02284243|9990110|FG000|NOT COMPLETED|Overall Study||4
8928734|NCT02284243|9990111|FG001|NOT COMPLETED|Overall Study||3
8928735|NCT02284347|9990117|FG000|STARTED|Overall Study||51
8928736|NCT02284347|9990117|FG000|COMPLETED|Overall Study||48
8928737|NCT02284347|9990117|FG000|NOT COMPLETED|Overall Study||3
8928738|NCT02284386|9990121|FG000|STARTED|Overall Study||15
8928739|NCT02284386|9990121|FG000|COMPLETED|Overall Study||15
8928740|NCT02284386|9990121|FG000|NOT COMPLETED|Overall Study||0
8928741|NCT02284399|9990127|FG000|STARTED|Overall Study||1414
8617057|NCT00454779|9655270|FG000|COMPLETED|First-line Treatment Phase|Disease progression (radiographically determined) or death|51
8617058|NCT00454779|9655271|FG001|COMPLETED|First-line Treatment Phase|Disease progression (radiographically determined) or death|49
8928742|NCT02284399|9990128|FG001|STARTED|Overall Study||3074
8928743|NCT02284399|9990127|FG000|COMPLETED|Overall Study||1414
8928744|NCT02284399|9990128|FG001|COMPLETED|Overall Study||3074
8928745|NCT02284399|9990127|FG000|NOT COMPLETED|Overall Study||0
8928746|NCT02284399|9990128|FG001|NOT COMPLETED|Overall Study||0
8928747|NCT02284464|9990138|FG000|STARTED|Overall Study||52
8928748|NCT02284464|9990139|FG001|STARTED|Overall Study||53
8928749|NCT02284464|9990138|FG000|COMPLETED|Overall Study||39
8928750|NCT02284464|9990139|FG001|COMPLETED|Overall Study||36
8928751|NCT02284464|9990138|FG000|NOT COMPLETED|Overall Study||13
8928752|NCT02284464|9990139|FG001|NOT COMPLETED|Overall Study||17
8928753|NCT02284516|9990147|FG000|STARTED|Overall Study||356
8928754|NCT02284516|9990148|FG001|STARTED|Overall Study||355
8928755|NCT02284516|9990147|FG000|Safety Population|Overall Study|Two placebo participants were considered for Lifitegrast arm; Placebo safety analysis set (N= 354).|354
8928756|NCT02284516|9990148|FG001|Safety Population|Overall Study|Two placebo participants were included in Lifitegrast arm for safety analysis set (N=357).|357
8928757|NCT02284516|9990147|FG000|COMPLETED|Overall Study||318
8928758|NCT02284516|9990148|FG001|COMPLETED|Overall Study||319
8928759|NCT02284516|9990147|FG000|NOT COMPLETED|Overall Study||38
8928760|NCT02284516|9990148|FG001|NOT COMPLETED|Overall Study||36
8928761|NCT02284555|9990154|FG000|STARTED|Overall Study||12
8928762|NCT02284555|9990154|FG000|COMPLETED|Overall Study||12
8928763|NCT02284555|9990154|FG000|NOT COMPLETED|Overall Study||0
8928764|NCT02284828|9990158|FG000|STARTED|Overall Study||26
8928765|NCT02284828|9990158|FG000|COMPLETED|Overall Study||22
8928766|NCT02284828|9990158|FG000|NOT COMPLETED|Overall Study||4
8928767|NCT02284854|9990167|FG000|STARTED|Overall Study||23
8928768|NCT02284854|9990168|FG001|STARTED|Overall Study||20
8928769|NCT02284854|9990167|FG000|COMPLETED|Overall Study||18
8928770|NCT02284854|9990168|FG001|COMPLETED|Overall Study||20
8928771|NCT02284854|9990167|FG000|NOT COMPLETED|Overall Study||5
8928772|NCT02284854|9990168|FG001|NOT COMPLETED|Overall Study||0
8928773|NCT02284867|9990183|FG000|STARTED|Overall Study||30
8928774|NCT02284867|9990184|FG001|STARTED|Overall Study||30
8928775|NCT02284867|9990183|FG000|COMPLETED|Overall Study||30
8928776|NCT02284867|9990184|FG001|COMPLETED|Overall Study||30
8928777|NCT02284867|9990183|FG000|NOT COMPLETED|Overall Study||0
8928778|NCT02284867|9990184|FG001|NOT COMPLETED|Overall Study||0
8928779|NCT02284880|9990192|FG000|STARTED|Overall Study||11
8928780|NCT02284880|9990193|FG001|STARTED|Overall Study||9
8928781|NCT02284880|9990194|FG002|STARTED|Overall Study||10
8928782|NCT02284880|9990195|FG003|STARTED|Overall Study||10
8928783|NCT02284880|9990192|FG000|First Period (4 Days)|Overall Study||11
8928784|NCT02284880|9990193|FG001|First Period (4 Days)|Overall Study||9
8928785|NCT02284880|9990194|FG002|First Period (4 Days)|Overall Study||10
8928786|NCT02284880|9990195|FG003|First Period (4 Days)|Overall Study||10
8928787|NCT02284880|9990192|FG000|Wash-out Period (7 Days)|Overall Study||11
8928788|NCT02284880|9990193|FG001|Wash-out Period (7 Days)|Overall Study||9
8928789|NCT02284880|9990194|FG002|Wash-out Period (7 Days)|Overall Study||10
8928790|NCT02284880|9990195|FG003|Wash-out Period (7 Days)|Overall Study||10
8928791|NCT02284880|9990192|FG000|Second Period (4 Days)|Overall Study||11
8928792|NCT02284880|9990193|FG001|Second Period (4 Days)|Overall Study||9
8928793|NCT02284880|9990194|FG002|Second Period (4 Days)|Overall Study||8
8928794|NCT02284880|9990195|FG003|Second Period (4 Days)|Overall Study||10
8928795|NCT02284880|9990192|FG000|COMPLETED|Overall Study||11
8928796|NCT02284880|9990193|FG001|COMPLETED|Overall Study||9
8928797|NCT02284880|9990194|FG002|COMPLETED|Overall Study||8
8928798|NCT02284880|9990195|FG003|COMPLETED|Overall Study||10
8928799|NCT02284880|9990192|FG000|NOT COMPLETED|Overall Study||0
8928800|NCT02284880|9990193|FG001|NOT COMPLETED|Overall Study||0
8928801|NCT02284880|9990194|FG002|NOT COMPLETED|Overall Study||2
8928802|NCT02284880|9990195|FG003|NOT COMPLETED|Overall Study||0
8928803|NCT02284893|9990207|FG000|STARTED|26 Week (Short Term)||232
8928804|NCT02284893|9990208|FG001|STARTED|26 Week (Short Term)||229
8928805|NCT02284893|9990207|FG000|COMPLETED|26 Week (Short Term)||213
8928806|NCT02284893|9990208|FG001|COMPLETED|26 Week (Short Term)||198
8928807|NCT02284893|9990207|FG000|NOT COMPLETED|26 Week (Short Term)||19
8928808|NCT02284893|9990208|FG001|NOT COMPLETED|26 Week (Short Term)||31
8928809|NCT02284893|9990207|FG000|STARTED|52 Week (Long Term)||209
8928810|NCT02284893|9990208|FG001|STARTED|52 Week (Long Term)||193
8928811|NCT02284893|9990207|FG000|COMPLETED|52 Week (Long Term)||198
8928812|NCT02284893|9990208|FG001|COMPLETED|52 Week (Long Term)||180
8928813|NCT02284893|9990207|FG000|NOT COMPLETED|52 Week (Long Term)||11
8928814|NCT02284893|9990208|FG001|NOT COMPLETED|52 Week (Long Term)||13
8928815|NCT02285010|9990216|FG000|STARTED|Overall Study||63
8928816|NCT02285010|9990217|FG001|STARTED|Overall Study||62
8928817|NCT02285010|9990216|FG000|COMPLETED|Overall Study||58
8928818|NCT02285010|9990217|FG001|COMPLETED|Overall Study||61
8928819|NCT02285010|9990216|FG000|NOT COMPLETED|Overall Study||5
8928820|NCT02285010|9990217|FG001|NOT COMPLETED|Overall Study||1
8928821|NCT02285023|9990223|FG000|STARTED|Overall Study||166
8928822|NCT02285023|9990223|FG000|COMPLETED|Overall Study||166
8928823|NCT02285023|9990223|FG000|NOT COMPLETED|Overall Study||0
8928824|NCT02285153|9990235|FG000|STARTED|Overall Study||7
8928825|NCT02285153|9990236|FG001|STARTED|Overall Study||8
8928826|NCT02285153|9990235|FG000|COMPLETED|Overall Study||6
8928827|NCT02285153|9990236|FG001|COMPLETED|Overall Study||8
8928828|NCT02285153|9990235|FG000|NOT COMPLETED|Overall Study||1
8928829|NCT02285153|9990236|FG001|NOT COMPLETED|Overall Study||0
8928830|NCT02285283|9990244|FG000|STARTED|Overall Study||29
8928831|NCT02285283|9990245|FG001|STARTED|Overall Study||29
8928832|NCT02285283|9990244|FG000|COMPLETED|Overall Study||25
8928833|NCT02285283|9990245|FG001|COMPLETED|Overall Study||20
8928834|NCT02285283|9990244|FG000|NOT COMPLETED|Overall Study||4
8928835|NCT02285283|9990245|FG001|NOT COMPLETED|Overall Study||9
8928836|NCT02285361|9990251|FG000|STARTED|Overall Study||1272
8928837|NCT02285361|9990251|FG000|COMPLETED|Overall Study||1221
8928838|NCT02285361|9990251|FG000|NOT COMPLETED|Overall Study||51
8928839|NCT02285634|9990259|FG000|STARTED|Overall Study||15
8928840|NCT02285634|9990260|FG001|STARTED|Overall Study||20
8928841|NCT02285634|9990261|FG002|STARTED|Overall Study||15
8928842|NCT02285634|9990262|FG003|STARTED|Overall Study||18
8928843|NCT02285634|9990259|FG000|COMPLETED|Overall Study||15
8928844|NCT02285634|9990260|FG001|COMPLETED|Overall Study||20
8928845|NCT02285634|9990261|FG002|COMPLETED|Overall Study||11
8928846|NCT02285634|9990262|FG003|COMPLETED|Overall Study||17
8928847|NCT02285634|9990259|FG000|NOT COMPLETED|Overall Study||0
8928848|NCT02285634|9990260|FG001|NOT COMPLETED|Overall Study||0
8928849|NCT02285634|9990261|FG002|NOT COMPLETED|Overall Study||4
8928850|NCT02285634|9990262|FG003|NOT COMPLETED|Overall Study||1
8928851|NCT02285777|9990275|FG000|STARTED|Overall Study||95
8928852|NCT02285777|9990276|FG001|STARTED|Overall Study||94
8928853|NCT02285777|9990275|FG000|COMPLETED|Overall Study||90
8928854|NCT02285777|9990276|FG001|COMPLETED|Overall Study||91
8928855|NCT02285777|9990275|FG000|NOT COMPLETED|Overall Study||5
8928856|NCT02285777|9990276|FG001|NOT COMPLETED|Overall Study||3
8928857|NCT02285855|9990284|FG000|STARTED|Overall Study||16
8928858|NCT02285855|9990285|FG001|STARTED|Overall Study||2
8928859|NCT02285855|9990284|FG000|Randomized|Overall Study||16
8928860|NCT02285855|9990285|FG001|Randomized|Overall Study||2
8928861|NCT02285855|9990284|FG000|COMPLETED|Overall Study||14
8928862|NCT02285855|9990285|FG001|COMPLETED|Overall Study||1
8928863|NCT02285855|9990284|FG000|NOT COMPLETED|Overall Study||2
8928864|NCT02285855|9990285|FG001|NOT COMPLETED|Overall Study||1
8928865|NCT02285907|9990291|FG000|STARTED|Overall Study||21
8928866|NCT02285907|9990291|FG000|Began 1st Intervention|Overall Study||21
8928867|NCT02285907|9990291|FG000|Began 2nd Intervention|Overall Study||21
8928868|NCT02285907|9990291|FG000|Began 3rd Intervention|Overall Study||21
8928869|NCT02285907|9990291|FG000|Began 4th Intervention|Overall Study||21
8928870|NCT02285907|9990291|FG000|COMPLETED|Overall Study||21
8928871|NCT02285907|9990291|FG000|NOT COMPLETED|Overall Study||0
8928872|NCT02285920|9990308|FG000|STARTED|Overall Study||51
8928873|NCT02285920|9990309|FG001|STARTED|Overall Study||27
8928874|NCT02285920|9990310|FG002|STARTED|Overall Study||26
8928875|NCT02285920|9990311|FG003|STARTED|Overall Study||25
8928876|NCT02285920|9990308|FG000|COMPLETED|Overall Study||47
8928877|NCT02285920|9990309|FG001|COMPLETED|Overall Study||23
8617059|NCT00454779|9655270|FG000|NOT COMPLETED|First-line Treatment Phase||5
8928878|NCT02285920|9990310|FG002|COMPLETED|Overall Study||21
8928879|NCT02285920|9990311|FG003|COMPLETED|Overall Study||24
8928880|NCT02285920|9990308|FG000|NOT COMPLETED|Overall Study||4
8928881|NCT02285920|9990309|FG001|NOT COMPLETED|Overall Study||4
8928882|NCT02285920|9990310|FG002|NOT COMPLETED|Overall Study||5
8928883|NCT02285920|9990311|FG003|NOT COMPLETED|Overall Study||1
8928884|NCT02285998|9990323|FG000|STARTED|Overall Study||4474
8928885|NCT02285998|9990324|FG001|STARTED|Overall Study||4489
8928886|NCT02285998|9990323|FG000|COMPLETED|Overall Study||4228
8928887|NCT02285998|9990324|FG001|COMPLETED|Overall Study||4236
8928888|NCT02285998|9990323|FG000|NOT COMPLETED|Overall Study||246
8928889|NCT02285998|9990324|FG001|NOT COMPLETED|Overall Study||253
8928890|NCT02286102|9990332|FG000|STARTED|Overall Study||36
8928891|NCT02286102|9990333|FG001|STARTED|Overall Study||34
8928892|NCT02286102|9990332|FG000|COMPLETED|Overall Study||35
8928893|NCT02286102|9990333|FG001|COMPLETED|Overall Study||33
8928894|NCT02286102|9990332|FG000|NOT COMPLETED|Overall Study||1
8928895|NCT02286102|9990333|FG001|NOT COMPLETED|Overall Study||1
9064494|NCT04292535|10124874|FG008|STARTED|Overall Study||8
9064495|NCT04292535|10124875|FG009|STARTED|Overall Study||8
9064496|NCT04292535|10124876|FG010|STARTED|Overall Study||7
9064497|NCT04292535|10124877|FG011|STARTED|Overall Study||7
9064498|NCT04292535|10124878|FG012|STARTED|Overall Study||9
9064499|NCT04292535|10124879|FG013|STARTED|Overall Study||9
9064500|NCT04292535|10124866|FG000|COMPLETED|Overall Study||8
9064501|NCT04292535|10124867|FG001|COMPLETED|Overall Study||8
9064502|NCT04292535|10124868|FG002|COMPLETED|Overall Study||9
9064503|NCT04292535|10124869|FG003|COMPLETED|Overall Study||8
9064504|NCT04292535|10124870|FG004|COMPLETED|Overall Study||8
9064505|NCT04292535|10124871|FG005|COMPLETED|Overall Study||9
9064506|NCT04292535|10124872|FG006|COMPLETED|Overall Study||8
9064507|NCT04292535|10124873|FG007|COMPLETED|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL (n = 1)|8
9064508|NCT04292535|10124874|FG008|COMPLETED|Overall Study||8
9064509|NCT04292535|10124875|FG009|COMPLETED|Overall Study||8
9064510|NCT04292535|10124876|FG010|COMPLETED|Overall Study||7
9064511|NCT04292535|10124877|FG011|COMPLETED|Overall Study||6
9064512|NCT04292535|10124878|FG012|COMPLETED|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL (n = 1)|8
9064513|NCT04292535|10124879|FG013|COMPLETED|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL (n = 1) Condition stopped due to Report of Dizziness (n = 1)|7
9064514|NCT04292535|10124866|FG000|NOT COMPLETED|Overall Study||0
9064515|NCT04292535|10124867|FG001|NOT COMPLETED|Overall Study||0
9064516|NCT04292535|10124868|FG002|NOT COMPLETED|Overall Study||0
9064517|NCT04292535|10124869|FG003|NOT COMPLETED|Overall Study||0
9064518|NCT04292535|10124870|FG004|NOT COMPLETED|Overall Study||0
9064519|NCT04292535|10124871|FG005|NOT COMPLETED|Overall Study||0
9064520|NCT04292535|10124872|FG006|NOT COMPLETED|Overall Study||0
9064521|NCT04292535|10124873|FG007|NOT COMPLETED|Overall Study||2
9064522|NCT04292535|10124874|FG008|NOT COMPLETED|Overall Study||0
9064523|NCT04292535|10124875|FG009|NOT COMPLETED|Overall Study||0
9064524|NCT04292535|10124876|FG010|NOT COMPLETED|Overall Study||0
9064525|NCT04292535|10124877|FG011|NOT COMPLETED|Overall Study||1
9064526|NCT04292535|10124878|FG012|NOT COMPLETED|Overall Study||1
9064527|NCT04292535|10124879|FG013|NOT COMPLETED|Overall Study||2
9064528|NCT04292171|10124911|FG000|STARTED|Overall Study||109
9064529|NCT04292171|10124912|FG001|STARTED|Overall Study||110
9064530|NCT04292171|10124911|FG000|COMPLETED|Overall Study||107
9064531|NCT04292171|10124912|FG001|COMPLETED|Overall Study||109
9064532|NCT04292171|10124911|FG000|NOT COMPLETED|Overall Study||2
9064533|NCT04292171|10124912|FG001|NOT COMPLETED|Overall Study||1
9064534|NCT04292899|10124922|FG000|STARTED|Overall Study||200
9064535|NCT04292899|10124923|FG001|STARTED|Overall Study||197
9064536|NCT04292899|10124924|FG002|STARTED|Overall Study||844
9064537|NCT04292899|10124925|FG003|STARTED|Overall Study||3597
9064538|NCT04292899|10124922|FG000|COMPLETED|Overall Study||168
9064539|NCT04292899|10124923|FG001|COMPLETED|Overall Study||164
9064540|NCT04292899|10124924|FG002|COMPLETED|Overall Study||621
8617060|NCT00454779|9655271|FG001|NOT COMPLETED|First-line Treatment Phase||8
8617061|NCT00454779|9655270|FG000|STARTED|Second-line Treatment Phase|Subjects in this arm do not have second-line treatment period|0
8617062|NCT00454779|9655271|FG001|STARTED|Second-line Treatment Phase|Second-line Panitumumab Monotherapy|30
8928896|NCT02286193|9990339|FG000|STARTED|Overall Study||622
8928897|NCT02286193|9990339|FG000|COMPLETED|Overall Study||418
8928898|NCT02286193|9990339|FG000|NOT COMPLETED|Overall Study||204
8928899|NCT02286466|9990346|FG000|STARTED|Overall Study||72
8928900|NCT02286466|9990347|FG001|STARTED|Overall Study||73
9064541|NCT04292899|10124925|FG003|COMPLETED|Overall Study||2952
9064542|NCT04292899|10124922|FG000|NOT COMPLETED|Overall Study||32
9064543|NCT04292899|10124923|FG001|NOT COMPLETED|Overall Study||33
8928901|NCT02286466|9990346|FG000|Baseline Clinician Assessment|Overall Study||72
8928902|NCT02286466|9990347|FG001|Baseline Clinician Assessment|Overall Study||72
8928903|NCT02286466|9990346|FG000|Post Self-report|Overall Study||67
9064544|NCT04292899|10124924|FG002|NOT COMPLETED|Overall Study||223
9064545|NCT04292899|10124925|FG003|NOT COMPLETED|Overall Study||645
9064546|NCT04292730|10124937|FG000|STARTED|Overall Study||199
8928904|NCT02286466|9990347|FG001|Post Self-report|Overall Study||68
8928905|NCT02286466|9990346|FG000|COMPLETED|Overall Study||65
8617063|NCT00454779|9655270|FG000|COMPLETED|Second-line Treatment Phase|Disease progression (radiographically determined) or death|0
8617064|NCT00454779|9655271|FG001|COMPLETED|Second-line Treatment Phase|Disease progression (radiographically determined) or death|27
8617065|NCT00454779|9655270|FG000|NOT COMPLETED|Second-line Treatment Phase||0
8617066|NCT00454779|9655271|FG001|NOT COMPLETED|Second-line Treatment Phase||3
8617067|NCT00454805|9655279|FG000|STARTED|Overall Study|Randomised|31
8617068|NCT00454805|9655280|FG001|STARTED|Overall Study|Randomised|31
8617069|NCT00454805|9655279|FG000|COMPLETED|Overall Study|Ongoing at data cut-off|5
8617070|NCT00454805|9655280|FG001|COMPLETED|Overall Study|Ongoing at data cut-off|8
8617071|NCT00454805|9655279|FG000|NOT COMPLETED|Overall Study||26
8617072|NCT00454805|9655280|FG001|NOT COMPLETED|Overall Study||23
8928906|NCT02286466|9990347|FG001|COMPLETED|Overall Study||63
8928907|NCT02286466|9990346|FG000|NOT COMPLETED|Overall Study||7
8928908|NCT02286466|9990347|FG001|NOT COMPLETED|Overall Study||10
8928909|NCT02286518|9990367|FG000|STARTED|All Parts (16 Days)||6
8928910|NCT02286518|9990368|FG001|STARTED|All Parts (16 Days)||6
8928911|NCT02286518|9990369|FG002|STARTED|All Parts (16 Days)||6
8928912|NCT02286518|9990370|FG003|STARTED|All Parts (16 Days)||6
8928913|NCT02286518|9990371|FG004|STARTED|All Parts (16 Days)||6
8928914|NCT02286518|9990372|FG005|STARTED|All Parts (16 Days)||6
8928915|NCT02286518|9990373|FG006|STARTED|All Parts (16 Days)||6
8928916|NCT02286518|9990374|FG007|STARTED|All Parts (16 Days)||6
8928917|NCT02286518|9990375|FG008|STARTED|All Parts (16 Days)||6
8928918|NCT02286518|9990376|FG009|STARTED|All Parts (16 Days)||4
8928919|NCT02286518|9990377|FG010|STARTED|All Parts (16 Days)||6
8928920|NCT02286518|9990378|FG011|STARTED|All Parts (16 Days)||6
8928921|NCT02286518|9990379|FG012|STARTED|All Parts (16 Days)||6
8928922|NCT02286518|9990380|FG013|STARTED|All Parts (16 Days)||6
8928923|NCT02286518|9990367|FG000|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
8928924|NCT02286518|9990368|FG001|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
8928925|NCT02286518|9990369|FG002|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
8928926|NCT02286518|9990370|FG003|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
8928927|NCT02286518|9990371|FG004|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
8928928|NCT02286518|9990372|FG005|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
8928929|NCT02286518|9990373|FG006|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
8928930|NCT02286518|9990374|FG007|COMPLETED|All Parts (16 Days)|Only participants of Part 2 continued in next period.|6
8928931|NCT02286518|9990375|FG008|COMPLETED|All Parts (16 Days)|Only participants of Part 2 would continue in next period.|6
8928932|NCT02286518|9990376|FG009|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|4
8928933|NCT02286518|9990377|FG010|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
8928934|NCT02286518|9990378|FG011|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
8928935|NCT02286518|9990379|FG012|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
8928936|NCT02286518|9990380|FG013|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
8928937|NCT02286518|9990367|FG000|NOT COMPLETED|All Parts (16 Days)||0
8928938|NCT02286518|9990368|FG001|NOT COMPLETED|All Parts (16 Days)||0
8928939|NCT02286518|9990369|FG002|NOT COMPLETED|All Parts (16 Days)||0
8928940|NCT02286518|9990370|FG003|NOT COMPLETED|All Parts (16 Days)||0
8928941|NCT02286518|9990371|FG004|NOT COMPLETED|All Parts (16 Days)||0
8928942|NCT02286518|9990372|FG005|NOT COMPLETED|All Parts (16 Days)||0
8928943|NCT02286518|9990373|FG006|NOT COMPLETED|All Parts (16 Days)||0
8928944|NCT02286518|9990374|FG007|NOT COMPLETED|All Parts (16 Days)||0
8928945|NCT02286518|9990375|FG008|NOT COMPLETED|All Parts (16 Days)||0
8928946|NCT02286518|9990376|FG009|NOT COMPLETED|All Parts (16 Days)||0
8928947|NCT02286518|9990377|FG010|NOT COMPLETED|All Parts (16 Days)||0
8928948|NCT02286518|9990378|FG011|NOT COMPLETED|All Parts (16 Days)||0
8928949|NCT02286518|9990379|FG012|NOT COMPLETED|All Parts (16 Days)||0
8928950|NCT02286518|9990380|FG013|NOT COMPLETED|All Parts (16 Days)||0
8928951|NCT02286518|9990367|FG000|STARTED|Washout Crossover Period(Part 2:14 Days)||0
8928952|NCT02286518|9990368|FG001|STARTED|Washout Crossover Period(Part 2:14 Days)||0
8928953|NCT02286518|9990369|FG002|STARTED|Washout Crossover Period(Part 2:14 Days)||0
8928954|NCT02286518|9990370|FG003|STARTED|Washout Crossover Period(Part 2:14 Days)||0
8928955|NCT02286518|9990371|FG004|STARTED|Washout Crossover Period(Part 2:14 Days)||0
8928956|NCT02286518|9990372|FG005|STARTED|Washout Crossover Period(Part 2:14 Days)||0
8928957|NCT02286518|9990373|FG006|STARTED|Washout Crossover Period(Part 2:14 Days)||0
8928958|NCT02286518|9990374|FG007|STARTED|Washout Crossover Period(Part 2:14 Days)||6
8928959|NCT02286518|9990375|FG008|STARTED|Washout Crossover Period(Part 2:14 Days)||6
8928960|NCT02286518|9990376|FG009|STARTED|Washout Crossover Period(Part 2:14 Days)||0
8928961|NCT02286518|9990377|FG010|STARTED|Washout Crossover Period(Part 2:14 Days)||0
8948289|NCT02429115|10010632|FG003|NOT COMPLETED|Overall Study||8
8617073|NCT00454818|9655294|FG000|STARTED|Phase I: Open-label Dose-escalation||3
8928962|NCT02286518|9990378|FG011|STARTED|Washout Crossover Period(Part 2:14 Days)||0
8928963|NCT02286518|9990379|FG012|STARTED|Washout Crossover Period(Part 2:14 Days)||0
8928964|NCT02286518|9990380|FG013|STARTED|Washout Crossover Period(Part 2:14 Days)||0
8928965|NCT02286518|9990367|FG000|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8928966|NCT02286518|9990368|FG001|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8928967|NCT02286518|9990369|FG002|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8928968|NCT02286518|9990370|FG003|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8928969|NCT02286518|9990371|FG004|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8928970|NCT02286518|9990372|FG005|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8928971|NCT02286518|9990373|FG006|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8928972|NCT02286518|9990374|FG007|COMPLETED|Washout Crossover Period(Part 2:14 Days)||6
9064547|NCT04292730|10124938|FG001|STARTED|Overall Study||197
9064548|NCT04292730|10124939|FG002|STARTED|Overall Study||200
9064549|NCT04292730|10124940|FG003|STARTED|Overall Study||517
9064550|NCT04292730|10124937|FG000|COMPLETED|Overall Study||179
9064551|NCT04292730|10124938|FG001|COMPLETED|Overall Study||176
9064552|NCT04292730|10124939|FG002|COMPLETED|Overall Study||178
9064553|NCT04292730|10124940|FG003|COMPLETED|Overall Study||437
9064554|NCT04292730|10124937|FG000|NOT COMPLETED|Overall Study||20
9064555|NCT04292730|10124938|FG001|NOT COMPLETED|Overall Study||21
9064556|NCT04292730|10124939|FG002|NOT COMPLETED|Overall Study||22
9064557|NCT04292730|10124940|FG003|NOT COMPLETED|Overall Study||80
9064558|NCT04290676|10124949|FG000|STARTED|Overall Study||527
9064559|NCT04290676|10124949|FG000|COMPLETED|Overall Study||527
9064560|NCT04290676|10124949|FG000|NOT COMPLETED|Overall Study||0
9064561|NCT04290039|10124956|FG000|STARTED|Period 1 (Visit 1; Day 1)||5
9064562|NCT04290039|10124957|FG001|STARTED|Period 1 (Visit 1; Day 1)||5
9064563|NCT04290039|10124958|FG002|STARTED|Period 1 (Visit 1; Day 1)||5
9064564|NCT04290039|10124956|FG000|COMPLETED|Period 1 (Visit 1; Day 1)||5
9064565|NCT04290039|10124957|FG001|COMPLETED|Period 1 (Visit 1; Day 1)||5
9064566|NCT04290039|10124958|FG002|COMPLETED|Period 1 (Visit 1; Day 1)||5
9064567|NCT04290039|10124956|FG000|NOT COMPLETED|Period 1 (Visit 1; Day 1)||0
9064568|NCT04290039|10124957|FG001|NOT COMPLETED|Period 1 (Visit 1; Day 1)||0
9064569|NCT04290039|10124958|FG002|NOT COMPLETED|Period 1 (Visit 1; Day 1)||0
9064570|NCT04290039|10124956|FG000|STARTED|Period 2 (Visit 2; Day 8)||5
9064571|NCT04290039|10124957|FG001|STARTED|Period 2 (Visit 2; Day 8)||5
9064572|NCT04290039|10124958|FG002|STARTED|Period 2 (Visit 2; Day 8)||5
9064573|NCT04290039|10124956|FG000|COMPLETED|Period 2 (Visit 2; Day 8)||5
9064574|NCT04290039|10124957|FG001|COMPLETED|Period 2 (Visit 2; Day 8)||5
9064575|NCT04290039|10124958|FG002|COMPLETED|Period 2 (Visit 2; Day 8)||5
9064576|NCT04290039|10124956|FG000|NOT COMPLETED|Period 2 (Visit 2; Day 8)||0
9064577|NCT04290039|10124957|FG001|NOT COMPLETED|Period 2 (Visit 2; Day 8)||0
9064578|NCT04290039|10124958|FG002|NOT COMPLETED|Period 2 (Visit 2; Day 8)||0
9064579|NCT04290039|10124956|FG000|STARTED|Period 3 (Visit 3; Day 15)||5
9064580|NCT04290039|10124957|FG001|STARTED|Period 3 (Visit 3; Day 15)||4
9064581|NCT04290039|10124958|FG002|STARTED|Period 3 (Visit 3; Day 15)||5
9064582|NCT04290039|10124956|FG000|COMPLETED|Period 3 (Visit 3; Day 15)||5
9064583|NCT04290039|10124957|FG001|COMPLETED|Period 3 (Visit 3; Day 15)||4
9064584|NCT04290039|10124958|FG002|COMPLETED|Period 3 (Visit 3; Day 15)||5
9064585|NCT04290039|10124956|FG000|NOT COMPLETED|Period 3 (Visit 3; Day 15)||0
9064586|NCT04290039|10124957|FG001|NOT COMPLETED|Period 3 (Visit 3; Day 15)||0
9064587|NCT04290039|10124958|FG002|NOT COMPLETED|Period 3 (Visit 3; Day 15)||0
9064588|NCT04289623|10124973|FG000|STARTED|Wave 1 Emails||6782
9064589|NCT04289623|10124974|FG001|STARTED|Wave 1 Emails||6764
9064590|NCT04289623|10124975|FG002|STARTED|Wave 1 Emails|Participants who did not respond to the intervention in Wave 1 were randomly assigned to this intervention or the testimonial (rank-and-file) email in Wave 2.|0
9064591|NCT04289623|10124976|FG003|STARTED|Wave 1 Emails|Participants who did not respond to the intervention in Wave 1 were randomly assigned to this intervention or the testimonial (medical expert) email in Wave 2.|0
9064592|NCT04289623|10124977|FG004|STARTED|Wave 1 Emails|A planned Wave 3 of the study was not conducted due to COVID-19-related changes in the program being offered as part of the intervention.|0
9064593|NCT04289623|10124978|FG005|STARTED|Wave 1 Emails|A planned Wave 3 of the study was not conducted due to COVID-19-related changes in the program being offered as part of the intervention.|0
9064594|NCT04289623|10124973|FG000|COMPLETED|Wave 1 Emails||6514
9064595|NCT04289623|10124974|FG001|COMPLETED|Wave 1 Emails||6507
9064596|NCT04289623|10124975|FG002|COMPLETED|Wave 1 Emails||0
9064597|NCT04289623|10124976|FG003|COMPLETED|Wave 1 Emails||0
9064598|NCT04289623|10124977|FG004|COMPLETED|Wave 1 Emails||0
9064599|NCT04289623|10124978|FG005|COMPLETED|Wave 1 Emails||0
9064600|NCT04289623|10124973|FG000|NOT COMPLETED|Wave 1 Emails||268
9064601|NCT04289623|10124974|FG001|NOT COMPLETED|Wave 1 Emails||257
9064602|NCT04289623|10124975|FG002|NOT COMPLETED|Wave 1 Emails||0
9064603|NCT04289623|10124976|FG003|NOT COMPLETED|Wave 1 Emails||0
9064604|NCT04289623|10124977|FG004|NOT COMPLETED|Wave 1 Emails||0
9064605|NCT04289623|10124978|FG005|NOT COMPLETED|Wave 1 Emails||0
9064606|NCT04289623|10124973|FG000|STARTED|Wave 2 Emails|Participants were already sent this intervention or the loss frame email in Wave 1.|0
9064607|NCT04289623|10124974|FG001|STARTED|Wave 2 Emails|Participants were already sent this intervention or the standard email in Wave 1.|0
9064608|NCT04289623|10124975|FG002|STARTED|Wave 2 Emails|Participants who did not respond to the intervention in Wave 1 were randomly assigned to these groups in Wave 2.|6099
8928973|NCT02286518|9990375|FG008|COMPLETED|Washout Crossover Period(Part 2:14 Days)||6
8928974|NCT02286518|9990376|FG009|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8928975|NCT02286518|9990377|FG010|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8928976|NCT02286518|9990378|FG011|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8928977|NCT02286518|9990379|FG012|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8928978|NCT02286518|9990380|FG013|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8928979|NCT02286518|9990367|FG000|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8928980|NCT02286518|9990368|FG001|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8928981|NCT02286518|9990369|FG002|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8928982|NCT02286518|9990370|FG003|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8928983|NCT02286518|9990371|FG004|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8928984|NCT02286518|9990372|FG005|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8928985|NCT02286518|9990373|FG006|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8928986|NCT02286518|9990374|FG007|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8928987|NCT02286518|9990375|FG008|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8928988|NCT02286518|9990376|FG009|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8928989|NCT02286518|9990377|FG010|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8617074|NCT00454818|9655295|FG001|STARTED|Phase I: Open-label Dose-escalation||3
8617075|NCT00454818|9655296|FG002|STARTED|Phase I: Open-label Dose-escalation||3
8617076|NCT00454818|9655297|FG003|STARTED|Phase I: Open-label Dose-escalation||3
8617077|NCT00454818|9655298|FG004|STARTED|Phase I: Open-label Dose-escalation||0
8928990|NCT02286518|9990378|FG011|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8928991|NCT02286518|9990379|FG012|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8928992|NCT02286518|9990380|FG013|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8928993|NCT02286518|9990367|FG000|STARTED|Crossover Treatment (Part 2: 3 Days)||0
8928994|NCT02286518|9990368|FG001|STARTED|Crossover Treatment (Part 2: 3 Days)||0
8928995|NCT02286518|9990369|FG002|STARTED|Crossover Treatment (Part 2: 3 Days)||0
8928996|NCT02286518|9990370|FG003|STARTED|Crossover Treatment (Part 2: 3 Days)||0
8928997|NCT02286518|9990371|FG004|STARTED|Crossover Treatment (Part 2: 3 Days)||0
8928998|NCT02286518|9990372|FG005|STARTED|Crossover Treatment (Part 2: 3 Days)||0
8928999|NCT02286518|9990373|FG006|STARTED|Crossover Treatment (Part 2: 3 Days)||0
8929000|NCT02286518|9990374|FG007|STARTED|Crossover Treatment (Part 2: 3 Days)||6
8929001|NCT02286518|9990375|FG008|STARTED|Crossover Treatment (Part 2: 3 Days)||6
8929002|NCT02286518|9990376|FG009|STARTED|Crossover Treatment (Part 2: 3 Days)||0
8929003|NCT02286518|9990377|FG010|STARTED|Crossover Treatment (Part 2: 3 Days)||0
8929004|NCT02286518|9990378|FG011|STARTED|Crossover Treatment (Part 2: 3 Days)||0
8929005|NCT02286518|9990379|FG012|STARTED|Crossover Treatment (Part 2: 3 Days)||0
8929006|NCT02286518|9990380|FG013|STARTED|Crossover Treatment (Part 2: 3 Days)||0
8929007|NCT02286518|9990367|FG000|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8929008|NCT02286518|9990368|FG001|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8929009|NCT02286518|9990369|FG002|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8929010|NCT02286518|9990370|FG003|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8929011|NCT02286518|9990371|FG004|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8929012|NCT02286518|9990372|FG005|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8929013|NCT02286518|9990373|FG006|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8929014|NCT02286518|9990374|FG007|COMPLETED|Crossover Treatment (Part 2: 3 Days)||6
8929015|NCT02286518|9990375|FG008|COMPLETED|Crossover Treatment (Part 2: 3 Days)||6
8929016|NCT02286518|9990376|FG009|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8929017|NCT02286518|9990377|FG010|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8929018|NCT02286518|9990378|FG011|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8929019|NCT02286518|9990379|FG012|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8929020|NCT02286518|9990380|FG013|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8929021|NCT02286518|9990367|FG000|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8929022|NCT02286518|9990368|FG001|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8929023|NCT02286518|9990369|FG002|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8929024|NCT02286518|9990370|FG003|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8929025|NCT02286518|9990371|FG004|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8929026|NCT02286518|9990372|FG005|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8929027|NCT02286518|9990373|FG006|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8929028|NCT02286518|9990374|FG007|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8929029|NCT02286518|9990375|FG008|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8929030|NCT02286518|9990376|FG009|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8929031|NCT02286518|9990377|FG010|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8929032|NCT02286518|9990378|FG011|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8929033|NCT02286518|9990379|FG012|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8929034|NCT02286518|9990380|FG013|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8929035|NCT02286713|9990428|FG000|STARTED|One Week Follow-Up||259
8929036|NCT02286713|9990429|FG001|STARTED|One Week Follow-Up||257
8929037|NCT02286713|9990428|FG000|COMPLETED|One Week Follow-Up||235
8929038|NCT02286713|9990429|FG001|COMPLETED|One Week Follow-Up||233
8929039|NCT02286713|9990428|FG000|NOT COMPLETED|One Week Follow-Up||24
8929040|NCT02286713|9990429|FG001|NOT COMPLETED|One Week Follow-Up||24
8929041|NCT02286713|9990428|FG000|STARTED|Three Month Follow-Up||252
8929042|NCT02286713|9990429|FG001|STARTED|Three Month Follow-Up||254
8929043|NCT02286713|9990428|FG000|COMPLETED|Three Month Follow-Up||224
8929044|NCT02286713|9990429|FG001|COMPLETED|Three Month Follow-Up||228
8929045|NCT02286713|9990428|FG000|NOT COMPLETED|Three Month Follow-Up||28
8929046|NCT02286713|9990429|FG001|NOT COMPLETED|Three Month Follow-Up||26
8929047|NCT02286713|9990428|FG000|STARTED|Six Month Follow-Up||250
8929048|NCT02286713|9990429|FG001|STARTED|Six Month Follow-Up||252
8929049|NCT02286713|9990428|FG000|COMPLETED|Six Month Follow-Up||218
8929050|NCT02286713|9990429|FG001|COMPLETED|Six Month Follow-Up||225
8929051|NCT02286713|9990428|FG000|NOT COMPLETED|Six Month Follow-Up||32
8929052|NCT02286713|9990429|FG001|NOT COMPLETED|Six Month Follow-Up||27
8929053|NCT02286726|9990438|FG000|STARTED|Overall Study||16
8929054|NCT02286726|9990439|FG001|STARTED|Overall Study||24
8929055|NCT02286726|9990440|FG002|STARTED|Overall Study||16
8929056|NCT02286726|9990438|FG000|COMPLETED|Overall Study||16
8929057|NCT02286726|9990439|FG001|COMPLETED|Overall Study||24
8929058|NCT02286726|9990440|FG002|COMPLETED|Overall Study||16
8929059|NCT02286726|9990438|FG000|NOT COMPLETED|Overall Study||0
8929060|NCT02286726|9990439|FG001|NOT COMPLETED|Overall Study||0
8929061|NCT02286726|9990440|FG002|NOT COMPLETED|Overall Study||0
8929062|NCT02286843|9990448|FG000|STARTED|Overall Study||49
8929063|NCT02286843|9990448|FG000|COMPLETED|Overall Study||43
8929064|NCT02286843|9990448|FG000|NOT COMPLETED|Overall Study||6
8929065|NCT02286895|9990454|FG000|STARTED|Randomized and Vaccinated||300
8929066|NCT02286895|9990455|FG001|STARTED|Randomized and Vaccinated||300
8929067|NCT02286895|9990454|FG000|COMPLETED|Randomized and Vaccinated||300
8929068|NCT02286895|9990455|FG001|COMPLETED|Randomized and Vaccinated||300
8929069|NCT02286895|9990454|FG000|NOT COMPLETED|Randomized and Vaccinated||0
8929070|NCT02286895|9990455|FG001|NOT COMPLETED|Randomized and Vaccinated||0
8929071|NCT02286895|9990454|FG000|STARTED|Assessed for Measles Seroconversion||300
8929072|NCT02286895|9990455|FG001|STARTED|Assessed for Measles Seroconversion||300
8929073|NCT02286895|9990454|FG000|COMPLETED|Assessed for Measles Seroconversion||252
8929074|NCT02286895|9990455|FG001|COMPLETED|Assessed for Measles Seroconversion||261
8929075|NCT02286895|9990454|FG000|NOT COMPLETED|Assessed for Measles Seroconversion||48
8929076|NCT02286895|9990455|FG001|NOT COMPLETED|Assessed for Measles Seroconversion||39
8929077|NCT02286921|9990463|FG000|STARTED|Overall Study||94
8929078|NCT02286921|9990464|FG001|STARTED|Overall Study||101
8929079|NCT02286921|9990463|FG000|COMPLETED|Overall Study||94
9064609|NCT04289623|10124976|FG003|STARTED|Wave 2 Emails|Participants who did not respond to the intervention in Wave 1 were randomly assigned to these groups in Wave 2.|6117
9064610|NCT04289623|10124977|FG004|STARTED|Wave 2 Emails|A planned Wave 3 of the study was not conducted due to COVID-19-related changes in the program being offered as part of the intervention.|0
9064611|NCT04289623|10124978|FG005|STARTED|Wave 2 Emails|A planned Wave 3 of the study was not conducted due to COVID-19-related changes in the program being offered as part of the intervention.|0
9064612|NCT04289623|10124973|FG000|COMPLETED|Wave 2 Emails||0
9064613|NCT04289623|10124974|FG001|COMPLETED|Wave 2 Emails||0
9064614|NCT04289623|10124975|FG002|COMPLETED|Wave 2 Emails||6099
9064615|NCT04289623|10124976|FG003|COMPLETED|Wave 2 Emails||6117
9064616|NCT04289623|10124977|FG004|COMPLETED|Wave 2 Emails||0
9064617|NCT04289623|10124978|FG005|COMPLETED|Wave 2 Emails||0
9064618|NCT04289623|10124973|FG000|NOT COMPLETED|Wave 2 Emails||0
8617078|NCT00454818|9655294|FG000|COMPLETED|Phase I: Open-label Dose-escalation||2
8617079|NCT00454818|9655295|FG001|COMPLETED|Phase I: Open-label Dose-escalation||2
8617080|NCT00454818|9655296|FG002|COMPLETED|Phase I: Open-label Dose-escalation||2
8929080|NCT02286921|9990464|FG001|COMPLETED|Overall Study||101
8929081|NCT02286921|9990463|FG000|NOT COMPLETED|Overall Study||0
8929082|NCT02286921|9990464|FG001|NOT COMPLETED|Overall Study||0
8929083|NCT02286947|9990470|FG000|STARTED|Overall Study||24
8929084|NCT02286947|9990470|FG000|COMPLETED|Overall Study||22
8929085|NCT02286947|9990470|FG000|NOT COMPLETED|Overall Study||2
8929086|NCT02286960|9990478|FG000|STARTED|Overall Study||19
8929087|NCT02286960|9990479|FG001|STARTED|Overall Study||17
8929088|NCT02286960|9990478|FG000|COMPLETED|Overall Study||16
8929089|NCT02286960|9990479|FG001|COMPLETED|Overall Study||14
8929090|NCT02286960|9990478|FG000|NOT COMPLETED|Overall Study||3
8929091|NCT02286960|9990479|FG001|NOT COMPLETED|Overall Study||3
8929092|NCT02287038|9990487|FG000|STARTED|Overall Study||23
8929093|NCT02287038|9990488|FG001|STARTED|Overall Study||21
8929094|NCT02287038|9990487|FG000|COMPLETED|Overall Study||18
8929095|NCT02287038|9990488|FG001|COMPLETED|Overall Study||18
8929096|NCT02287038|9990487|FG000|NOT COMPLETED|Overall Study||5
8929097|NCT02287038|9990488|FG001|NOT COMPLETED|Overall Study||3
8617081|NCT00454818|9655297|FG003|COMPLETED|Phase I: Open-label Dose-escalation||2
8617082|NCT00454818|9655298|FG004|COMPLETED|Phase I: Open-label Dose-escalation||0
8617083|NCT00454818|9655294|FG000|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
8617084|NCT00454818|9655295|FG001|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
8929098|NCT02287350|9990496|FG000|STARTED|Overall Study||51
8929099|NCT02287350|9990496|FG000|COMPLETED|Overall Study||48
8929100|NCT02287350|9990496|FG000|NOT COMPLETED|Overall Study||3
8929101|NCT02287376|9990500|FG000|STARTED|Overall Study||25
8929102|NCT02287376|9990500|FG000|COMPLETED|Overall Study||25
8929103|NCT02287376|9990500|FG000|NOT COMPLETED|Overall Study||0
8929104|NCT02287402|9990504|FG000|STARTED|Treatment Period||197
8929105|NCT02287402|9990504|FG000|COMPLETED|Treatment Period||170
8929106|NCT02287402|9990504|FG000|NOT COMPLETED|Treatment Period||27
8929107|NCT02287402|9990504|FG000|STARTED|Follow-up|64 participants who completed the Treatment Period did not continue to Follow-up.|106
8929108|NCT02287402|9990504|FG000|COMPLETED|Follow-up||103
8929109|NCT02287402|9990504|FG000|NOT COMPLETED|Follow-up||3
8929110|NCT02287415|9990508|FG000|STARTED|Overall Study||13
8929111|NCT02287415|9990508|FG000|COMPLETED|Overall Study||13
8929112|NCT02287415|9990508|FG000|NOT COMPLETED|Overall Study||0
8929113|NCT02287467|9990514|FG000|STARTED|Overall Study||168
8929114|NCT02287467|9990515|FG001|STARTED|Overall Study||161
8929115|NCT02287467|9990514|FG000|COMPLETED|Overall Study||156
8929116|NCT02287467|9990515|FG001|COMPLETED|Overall Study||152
8929117|NCT02287467|9990514|FG000|NOT COMPLETED|Overall Study||12
8929118|NCT02287467|9990515|FG001|NOT COMPLETED|Overall Study||9
8929119|NCT02287610|9990524|FG000|STARTED|Overall Study||64
8929120|NCT02287610|9990524|FG000|Per Protocol Follow-Up|Overall Study||56
8929121|NCT02287610|9990524|FG000|COMPLETED|Overall Study||48
8929122|NCT02287610|9990524|FG000|NOT COMPLETED|Overall Study||16
8929123|NCT02287623|9990530|FG000|STARTED|Overall Study||30
8929124|NCT02287623|9990531|FG001|STARTED|Overall Study||30
8929125|NCT02287623|9990530|FG000|COMPLETED|Overall Study||30
8929126|NCT02287623|9990531|FG001|COMPLETED|Overall Study||29
8929127|NCT02287623|9990530|FG000|NOT COMPLETED|Overall Study||0
8929128|NCT02287623|9990531|FG001|NOT COMPLETED|Overall Study||1
8929129|NCT02287675|9990539|FG000|STARTED|Overall Study||22
8929130|NCT02287675|9990540|FG001|STARTED|Overall Study||18
8929131|NCT02287675|9990539|FG000|COMPLETED|Overall Study||22
8929132|NCT02287675|9990540|FG001|COMPLETED|Overall Study||18
8929133|NCT02287675|9990539|FG000|NOT COMPLETED|Overall Study||0
8929134|NCT02287675|9990540|FG001|NOT COMPLETED|Overall Study||0
8929135|NCT02287688|9990546|FG000|STARTED|Overall Study||138
8929136|NCT02287688|9990546|FG000|COMPLETED|Overall Study||138
8929137|NCT02287688|9990546|FG000|NOT COMPLETED|Overall Study||0
8929138|NCT02287779|9990558|FG000|STARTED|Overall Study||21
8929139|NCT02287779|9990559|FG001|STARTED|Overall Study||9
8929140|NCT02287779|9990560|FG002|STARTED|Overall Study||9
8929141|NCT02287779|9990561|FG003|STARTED|Overall Study||9
8929142|NCT02287779|9990562|FG004|STARTED|Overall Study||9
8929143|NCT02287779|9990563|FG005|STARTED|Overall Study||9
8929144|NCT02287779|9990564|FG006|STARTED|Overall Study||9
8929145|NCT02287779|9990565|FG007|STARTED|Overall Study||9
8929146|NCT02287779|9990558|FG000|COMPLETED|Overall Study||21
8929147|NCT02287779|9990559|FG001|COMPLETED|Overall Study||9
8929148|NCT02287779|9990560|FG002|COMPLETED|Overall Study||9
8929149|NCT02287779|9990561|FG003|COMPLETED|Overall Study||9
8929150|NCT02287779|9990562|FG004|COMPLETED|Overall Study||9
8929151|NCT02287779|9990563|FG005|COMPLETED|Overall Study||9
8929152|NCT02287779|9990564|FG006|COMPLETED|Overall Study||9
8929153|NCT02287779|9990565|FG007|COMPLETED|Overall Study||9
8929154|NCT02287779|9990558|FG000|NOT COMPLETED|Overall Study||0
8929155|NCT02287779|9990559|FG001|NOT COMPLETED|Overall Study||0
8929156|NCT02287779|9990560|FG002|NOT COMPLETED|Overall Study||0
8929157|NCT02287779|9990561|FG003|NOT COMPLETED|Overall Study||0
8929158|NCT02287779|9990562|FG004|NOT COMPLETED|Overall Study||0
8929159|NCT02287779|9990563|FG005|NOT COMPLETED|Overall Study||0
8929160|NCT02287779|9990564|FG006|NOT COMPLETED|Overall Study||0
8929161|NCT02287779|9990565|FG007|NOT COMPLETED|Overall Study||0
8929162|NCT02287818|9990589|FG000|STARTED|Overall Study||60
8929163|NCT02287818|9990590|FG001|STARTED|Overall Study||67
8929164|NCT02287818|9990589|FG000|COMPLETED|Overall Study||53
8929165|NCT02287818|9990590|FG001|COMPLETED|Overall Study||54
8929166|NCT02287818|9990589|FG000|NOT COMPLETED|Overall Study||7
8929167|NCT02287818|9990590|FG001|NOT COMPLETED|Overall Study||13
8929168|NCT02287883|9990598|FG000|STARTED|Overall Study||1081
8929169|NCT02287883|9990599|FG001|STARTED|Overall Study||1095
8929170|NCT02287883|9990598|FG000|One-year Follow-up Survey|Overall Study||622
8929171|NCT02287883|9990599|FG001|One-year Follow-up Survey|Overall Study||669
8929172|NCT02287883|9990598|FG000|COMPLETED|Overall Study||622
8929173|NCT02287883|9990599|FG001|COMPLETED|Overall Study||669
8929174|NCT02287883|9990598|FG000|NOT COMPLETED|Overall Study||459
8929175|NCT02287883|9990599|FG001|NOT COMPLETED|Overall Study||426
8929176|NCT02287896|9990607|FG000|STARTED|Screening Visit V1||36
8929177|NCT02287896|9990608|FG001|STARTED|Screening Visit V1||26
8929178|NCT02287896|9990607|FG000|COMPLETED|Screening Visit V1||36
8929179|NCT02287896|9990608|FG001|COMPLETED|Screening Visit V1||26
8929180|NCT02287896|9990607|FG000|NOT COMPLETED|Screening Visit V1||0
8929181|NCT02287896|9990608|FG001|NOT COMPLETED|Screening Visit V1||0
8929182|NCT02287896|9990607|FG000|STARTED|First Injection Visit||36
8929183|NCT02287896|9990608|FG001|STARTED|First Injection Visit||26
8929184|NCT02287896|9990607|FG000|COMPLETED|First Injection Visit||36
8929185|NCT02287896|9990608|FG001|COMPLETED|First Injection Visit||26
8929186|NCT02287896|9990607|FG000|NOT COMPLETED|First Injection Visit||0
8929187|NCT02287896|9990608|FG001|NOT COMPLETED|First Injection Visit||0
8929188|NCT02287896|9990607|FG000|STARTED|Second Injection Visit||36
8929189|NCT02287896|9990608|FG001|STARTED|Second Injection Visit||26
8929190|NCT02287896|9990607|FG000|COMPLETED|Second Injection Visit||36
9064619|NCT04289623|10124974|FG001|NOT COMPLETED|Wave 2 Emails||0
8929191|NCT02287896|9990608|FG001|COMPLETED|Second Injection Visit||25
8929192|NCT02287896|9990607|FG000|NOT COMPLETED|Second Injection Visit||0
8929193|NCT02287896|9990608|FG001|NOT COMPLETED|Second Injection Visit||1
9064620|NCT04289623|10124975|FG002|NOT COMPLETED|Wave 2 Emails||0
8929194|NCT02287909|9990624|FG000|STARTED|Overall Study||20
8929195|NCT02287909|9990625|FG001|STARTED|Overall Study||20
8929196|NCT02287909|9990626|FG002|STARTED|Overall Study||20
8929197|NCT02287909|9990627|FG003|STARTED|Overall Study||20
9064621|NCT04289623|10124976|FG003|NOT COMPLETED|Wave 2 Emails||0
8929198|NCT02287909|9990624|FG000|COMPLETED|Overall Study||18
8929199|NCT02287909|9990625|FG001|COMPLETED|Overall Study||19
8929200|NCT02287909|9990626|FG002|COMPLETED|Overall Study||20
8929201|NCT02287909|9990627|FG003|COMPLETED|Overall Study||19
8929202|NCT02287909|9990624|FG000|NOT COMPLETED|Overall Study||2
8929203|NCT02287909|9990625|FG001|NOT COMPLETED|Overall Study||1
8929204|NCT02287909|9990626|FG002|NOT COMPLETED|Overall Study||0
8929205|NCT02287909|9990627|FG003|NOT COMPLETED|Overall Study||1
8929206|NCT02287922|9990641|FG000|STARTED|Overall Study||62
8929207|NCT02287922|9990642|FG001|STARTED|Overall Study||62
8929208|NCT02287922|9990643|FG002|STARTED|Overall Study||63
8929209|NCT02287922|9990644|FG003|STARTED|Overall Study||64
8929210|NCT02287922|9990641|FG000|COMPLETED|Overall Study||59
8929211|NCT02287922|9990642|FG001|COMPLETED|Overall Study||60
8929212|NCT02287922|9990643|FG002|COMPLETED|Overall Study||56
8929213|NCT02287922|9990644|FG003|COMPLETED|Overall Study||57
8929214|NCT02287922|9990641|FG000|NOT COMPLETED|Overall Study||3
8929215|NCT02287922|9990642|FG001|NOT COMPLETED|Overall Study||2
8929216|NCT02287922|9990643|FG002|NOT COMPLETED|Overall Study||7
8929217|NCT02287922|9990644|FG003|NOT COMPLETED|Overall Study||7
8929218|NCT02288091|9990655|FG000|STARTED|Overall Study||32
8929219|NCT02288091|9990655|FG000|Randomized/Treated|Overall Study||25
8929220|NCT02288091|9990655|FG000|COMPLETED|Overall Study||24
8929221|NCT02288091|9990655|FG000|NOT COMPLETED|Overall Study||8
8929222|NCT02288156|9990663|FG000|STARTED|Overall Study||20
8929223|NCT02288156|9990664|FG001|STARTED|Overall Study||20
8929224|NCT02288156|9990665|FG002|STARTED|Overall Study||20
8929225|NCT02288156|9990666|FG003|STARTED|Overall Study||20
8929226|NCT02288156|9990663|FG000|COMPLETED|Overall Study||16
8929227|NCT02288156|9990664|FG001|COMPLETED|Overall Study||16
8929228|NCT02288156|9990665|FG002|COMPLETED|Overall Study||18
8929229|NCT02288156|9990666|FG003|COMPLETED|Overall Study||18
8929230|NCT02288156|9990663|FG000|NOT COMPLETED|Overall Study||4
8929231|NCT02288156|9990664|FG001|NOT COMPLETED|Overall Study||4
8929232|NCT02288156|9990665|FG002|NOT COMPLETED|Overall Study||2
8929233|NCT02288156|9990666|FG003|NOT COMPLETED|Overall Study||2
8929234|NCT02288182|9990680|FG000|STARTED|Overall Study||25
8929235|NCT02288182|9990681|FG001|STARTED|Overall Study||27
8929236|NCT02288182|9990680|FG000|COMPLETED|Overall Study||25
8929237|NCT02288182|9990681|FG001|COMPLETED|Overall Study||25
8929238|NCT02288182|9990680|FG000|NOT COMPLETED|Overall Study||0
8929239|NCT02288182|9990681|FG001|NOT COMPLETED|Overall Study||2
8929240|NCT02288273|9990691|FG000|STARTED|Overall Study||61
8929241|NCT02288273|9990692|FG001|STARTED|Overall Study||56
8929242|NCT02288273|9990691|FG000|COMPLETED|Overall Study||53
8929243|NCT02288273|9990692|FG001|COMPLETED|Overall Study||48
8929244|NCT02288273|9990691|FG000|NOT COMPLETED|Overall Study||8
8929245|NCT02288273|9990692|FG001|NOT COMPLETED|Overall Study||8
8929246|NCT02288312|9990701|FG000|STARTED|Overall Study||6
8929247|NCT02288312|9990702|FG001|STARTED|Overall Study||6
8929248|NCT02288312|9990703|FG002|STARTED|Overall Study||6
8929249|NCT02288312|9990701|FG000|COMPLETED|Overall Study||5
8929250|NCT02288312|9990702|FG001|COMPLETED|Overall Study||6
8929251|NCT02288312|9990703|FG002|COMPLETED|Overall Study||6
8929252|NCT02288312|9990701|FG000|NOT COMPLETED|Overall Study||1
8929253|NCT02288312|9990702|FG001|NOT COMPLETED|Overall Study||0
8929254|NCT02288312|9990703|FG002|NOT COMPLETED|Overall Study||0
8929255|NCT02288325|9990711|FG000|STARTED|Run-in Period||644
8929256|NCT02288325|9990712|FG001|STARTED|Run-in Period||0
8929257|NCT02288325|9990713|FG002|STARTED|Run-in Period||0
8929258|NCT02288325|9990711|FG000|COMPLETED|Run-in Period||499
8929259|NCT02288325|9990712|FG001|COMPLETED|Run-in Period||0
8929260|NCT02288325|9990713|FG002|COMPLETED|Run-in Period||0
8929261|NCT02288325|9990711|FG000|NOT COMPLETED|Run-in Period||145
8929262|NCT02288325|9990712|FG001|NOT COMPLETED|Run-in Period||0
8929263|NCT02288325|9990713|FG002|NOT COMPLETED|Run-in Period||0
8929264|NCT02288325|9990711|FG000|STARTED|Stabilization Period|70 participants did not enter Stabilization Period (69 did not meet entry criteria; 1 other reason)|429
8929265|NCT02288325|9990712|FG001|STARTED|Stabilization Period||0
8929266|NCT02288325|9990713|FG002|STARTED|Stabilization Period||0
8929267|NCT02288325|9990711|FG000|COMPLETED|Stabilization Period||331
8929268|NCT02288325|9990712|FG001|COMPLETED|Stabilization Period||0
8929269|NCT02288325|9990713|FG002|COMPLETED|Stabilization Period||0
8929270|NCT02288325|9990711|FG000|NOT COMPLETED|Stabilization Period||98
8929271|NCT02288325|9990712|FG001|NOT COMPLETED|Stabilization Period||0
8929272|NCT02288325|9990713|FG002|NOT COMPLETED|Stabilization Period||0
8929273|NCT02288325|9990711|FG000|STARTED|Double-blind Treatment Period||0
8929274|NCT02288325|9990712|FG001|STARTED|Double-blind Treatment Period|7 participants did not enter Double-Blind Period (2 did not meet entry criteria; 5 other reasons)|159
8929275|NCT02288325|9990713|FG002|STARTED|Double-blind Treatment Period|7 participants did not enter Double-Blind Period (2 did not meet entry criteria; 5 other reasons)|165
8929276|NCT02288325|9990711|FG000|COMPLETED|Double-blind Treatment Period||0
8929277|NCT02288325|9990712|FG001|COMPLETED|Double-blind Treatment Period||135
8929278|NCT02288325|9990713|FG002|COMPLETED|Double-blind Treatment Period||139
8929279|NCT02288325|9990711|FG000|NOT COMPLETED|Double-blind Treatment Period||0
8929280|NCT02288325|9990712|FG001|NOT COMPLETED|Double-blind Treatment Period||24
8929281|NCT02288325|9990713|FG002|NOT COMPLETED|Double-blind Treatment Period||26
8929282|NCT02288364|9990722|FG000|STARTED|Overall Study||42
8929283|NCT02288364|9990723|FG001|STARTED|Overall Study||44
8929284|NCT02288364|9990722|FG000|COMPLETED|Overall Study||42
8929285|NCT02288364|9990723|FG001|COMPLETED|Overall Study||44
8929286|NCT02288364|9990722|FG000|NOT COMPLETED|Overall Study||0
8929287|NCT02288364|9990723|FG001|NOT COMPLETED|Overall Study||0
8929288|NCT02288377|9990731|FG000|STARTED|Overall Study||26
8929289|NCT02288377|9990732|FG001|STARTED|Overall Study||27
8929290|NCT02288377|9990731|FG000|COMPLETED|Overall Study||25
8929291|NCT02288377|9990732|FG001|COMPLETED|Overall Study||27
8929292|NCT02288377|9990731|FG000|NOT COMPLETED|Overall Study||1
8929293|NCT02288377|9990732|FG001|NOT COMPLETED|Overall Study||0
8929294|NCT02288559|9990742|FG000|STARTED|Overall Study||10
8929295|NCT02288559|9990743|FG001|STARTED|Overall Study||11
8929296|NCT02288559|9990744|FG002|STARTED|Overall Study||46
8929297|NCT02288559|9990745|FG003|STARTED|Overall Study||22
8929298|NCT02288559|9990742|FG000|COMPLETED|Overall Study||9
8929299|NCT02288559|9990743|FG001|COMPLETED|Overall Study||10
8929300|NCT02288559|9990744|FG002|COMPLETED|Overall Study||35
8929301|NCT02288559|9990745|FG003|COMPLETED|Overall Study||20
8929302|NCT02288559|9990742|FG000|NOT COMPLETED|Overall Study||1
8929303|NCT02288559|9990743|FG001|NOT COMPLETED|Overall Study||1
8929304|NCT02288559|9990744|FG002|NOT COMPLETED|Overall Study||11
8929305|NCT02288559|9990745|FG003|NOT COMPLETED|Overall Study||2
8929306|NCT02288819|9990757|FG000|STARTED|Overall Study||50
8929307|NCT02288819|9990757|FG000|COMPLETED|Overall Study||50
8929308|NCT02288819|9990757|FG000|NOT COMPLETED|Overall Study||0
8929309|NCT02289079|9990763|FG000|STARTED|Overall Study||30
8929310|NCT02289079|9990764|FG001|STARTED|Overall Study||30
8929311|NCT02289079|9990763|FG000|COMPLETED|Overall Study||28
8929312|NCT02289079|9990764|FG001|COMPLETED|Overall Study||29
8929313|NCT02289079|9990763|FG000|NOT COMPLETED|Overall Study||2
8929314|NCT02289079|9990764|FG001|NOT COMPLETED|Overall Study||1
8929315|NCT02289105|9990772|FG000|STARTED|Overall Study||642
8929316|NCT02289105|9990773|FG001|STARTED|Overall Study||637
8929317|NCT02289105|9990772|FG000|COMPLETED|Overall Study||642
8929318|NCT02289105|9990773|FG001|COMPLETED|Overall Study||637
8929319|NCT02289105|9990772|FG000|NOT COMPLETED|Overall Study||0
8929320|NCT02289105|9990773|FG001|NOT COMPLETED|Overall Study||0
8929321|NCT02289157|9990781|FG000|STARTED|Overall Study||222
8929322|NCT02289157|9990782|FG001|STARTED|Overall Study||219
8929323|NCT02289157|9990781|FG000|No Post op Check or Follow up Phone Call|Overall Study||2
8929324|NCT02289157|9990782|FG001|No Post op Check or Follow up Phone Call|Overall Study||4
8929325|NCT02289157|9990781|FG000|COMPLETED|Overall Study||222
8929326|NCT02289157|9990782|FG001|COMPLETED|Overall Study||219
8929327|NCT02289157|9990781|FG000|NOT COMPLETED|Overall Study||0
8929328|NCT02289157|9990782|FG001|NOT COMPLETED|Overall Study||0
8929329|NCT02289222|9990788|FG000|STARTED|Overall Study||48
8929330|NCT02289222|9990788|FG000|COMPLETED|Overall Study||48
8929331|NCT02289222|9990788|FG000|NOT COMPLETED|Overall Study||0
8929332|NCT02289352|9990795|FG000|STARTED|Overall Study||199
8929333|NCT02289352|9990796|FG001|STARTED|Overall Study||199
8929334|NCT02289352|9990797|FG002|STARTED|Overall Study||64
8929335|NCT02289352|9990795|FG000|Safety Population|Overall Study||199
8929336|NCT02289352|9990796|FG001|Safety Population|Overall Study||199
8929337|NCT02289352|9990797|FG002|Safety Population|Overall Study||64
8929338|NCT02289352|9990795|FG000|mITT Population|Overall Study||191
8929339|NCT02289352|9990796|FG001|mITT Population|Overall Study||193
8929340|NCT02289352|9990797|FG002|mITT Population|Overall Study||58
8929341|NCT02289352|9990795|FG000|PP Population|Overall Study||173
8929342|NCT02289352|9990796|FG001|PP Population|Overall Study||173
8929343|NCT02289352|9990797|FG002|PP Population|Overall Study||54
8929344|NCT02289352|9990795|FG000|COMPLETED|Overall Study||198
8929345|NCT02289352|9990796|FG001|COMPLETED|Overall Study||198
8929346|NCT02289352|9990797|FG002|COMPLETED|Overall Study||64
8929347|NCT02289352|9990795|FG000|NOT COMPLETED|Overall Study||1
8929348|NCT02289352|9990796|FG001|NOT COMPLETED|Overall Study||1
8929349|NCT02289352|9990797|FG002|NOT COMPLETED|Overall Study||0
8929350|NCT02289417|9990809|FG000|STARTED|Placebo-Controlled Phase Weeks 0-12||58
8929351|NCT02289417|9990810|FG001|STARTED|Placebo-Controlled Phase Weeks 0-12||57
8929352|NCT02289417|9990811|FG002|STARTED|Placebo-Controlled Phase Weeks 0-12||55
8929353|NCT02289417|9990812|FG003|STARTED|Placebo-Controlled Phase Weeks 0-12||0
8929354|NCT02289417|9990813|FG004|STARTED|Placebo-Controlled Phase Weeks 0-12||0
8929355|NCT02289417|9990814|FG005|STARTED|Placebo-Controlled Phase Weeks 0-12||0
8929356|NCT02289417|9990815|FG006|STARTED|Placebo-Controlled Phase Weeks 0-12||0
8929357|NCT02289417|9990816|FG007|STARTED|Placebo-Controlled Phase Weeks 0-12||0
8929358|NCT02289417|9990817|FG008|STARTED|Placebo-Controlled Phase Weeks 0-12||0
8929359|NCT02289417|9990809|FG000|COMPLETED|Placebo-Controlled Phase Weeks 0-12||51
8929360|NCT02289417|9990810|FG001|COMPLETED|Placebo-Controlled Phase Weeks 0-12||53
8929361|NCT02289417|9990811|FG002|COMPLETED|Placebo-Controlled Phase Weeks 0-12||52
8929362|NCT02289417|9990812|FG003|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
8929363|NCT02289417|9990813|FG004|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
8929364|NCT02289417|9990814|FG005|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
8929365|NCT02289417|9990815|FG006|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
8929366|NCT02289417|9990816|FG007|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
8929367|NCT02289417|9990817|FG008|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
8929368|NCT02289417|9990809|FG000|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||7
8929369|NCT02289417|9990810|FG001|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||4
8929370|NCT02289417|9990811|FG002|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||3
8929371|NCT02289417|9990812|FG003|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
8929372|NCT02289417|9990813|FG004|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
8929373|NCT02289417|9990814|FG005|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
8929374|NCT02289417|9990815|FG006|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
8929375|NCT02289417|9990816|FG007|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
8929376|NCT02289417|9990817|FG008|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
8929377|NCT02289417|9990809|FG000|STARTED|Active Treatment Phase Weeks 12-52||0
8929378|NCT02289417|9990810|FG001|STARTED|Active Treatment Phase Weeks 12-52||41
8929379|NCT02289417|9990811|FG002|STARTED|Active Treatment Phase Weeks 12-52||42
8929380|NCT02289417|9990812|FG003|STARTED|Active Treatment Phase Weeks 12-52||26
8929381|NCT02289417|9990813|FG004|STARTED|Active Treatment Phase Weeks 12-52||25
8929382|NCT02289417|9990814|FG005|STARTED|Active Treatment Phase Weeks 12-52|1 participant went only to Week 20|12
8929383|NCT02289417|9990815|FG006|STARTED|Active Treatment Phase Weeks 12-52|Week 12 TMS were missing for 3 participants|7
8929384|NCT02289417|9990816|FG007|STARTED|Active Treatment Phase Weeks 12-52||0
8929385|NCT02289417|9990817|FG008|STARTED|Active Treatment Phase Weeks 12-52||0
8929386|NCT02289417|9990809|FG000|COMPLETED|Active Treatment Phase Weeks 12-52||0
8929387|NCT02289417|9990810|FG001|COMPLETED|Active Treatment Phase Weeks 12-52||39
8929388|NCT02289417|9990811|FG002|COMPLETED|Active Treatment Phase Weeks 12-52||32
8929389|NCT02289417|9990812|FG003|COMPLETED|Active Treatment Phase Weeks 12-52||17
8929390|NCT02289417|9990813|FG004|COMPLETED|Active Treatment Phase Weeks 12-52||20
8929391|NCT02289417|9990814|FG005|COMPLETED|Active Treatment Phase Weeks 12-52||7
8929392|NCT02289417|9990815|FG006|COMPLETED|Active Treatment Phase Weeks 12-52||5
8929393|NCT02289417|9990816|FG007|COMPLETED|Active Treatment Phase Weeks 12-52||0
8617085|NCT00454818|9655296|FG002|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
8617086|NCT00454818|9655297|FG003|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
8929394|NCT02289417|9990817|FG008|COMPLETED|Active Treatment Phase Weeks 12-52||0
8929395|NCT02289417|9990809|FG000|NOT COMPLETED|Active Treatment Phase Weeks 12-52||0
8929396|NCT02289417|9990810|FG001|NOT COMPLETED|Active Treatment Phase Weeks 12-52||2
8929397|NCT02289417|9990811|FG002|NOT COMPLETED|Active Treatment Phase Weeks 12-52||10
8929398|NCT02289417|9990812|FG003|NOT COMPLETED|Active Treatment Phase Weeks 12-52||9
8929399|NCT02289417|9990813|FG004|NOT COMPLETED|Active Treatment Phase Weeks 12-52||5
8929400|NCT02289417|9990814|FG005|NOT COMPLETED|Active Treatment Phase Weeks 12-52||5
8929401|NCT02289417|9990815|FG006|NOT COMPLETED|Active Treatment Phase Weeks 12-52||2
8929402|NCT02289417|9990816|FG007|NOT COMPLETED|Active Treatment Phase Weeks 12-52||0
8929403|NCT02289417|9990817|FG008|NOT COMPLETED|Active Treatment Phase Weeks 12-52||0
8929404|NCT02289417|9990809|FG000|STARTED|Extension Phase Weeks 52-104||0
8929405|NCT02289417|9990810|FG001|STARTED|Extension Phase Weeks 52-104||0
8929406|NCT02289417|9990811|FG002|STARTED|Extension Phase Weeks 52-104||0
8929407|NCT02289417|9990812|FG003|STARTED|Extension Phase Weeks 52-104||0
8929408|NCT02289417|9990813|FG004|STARTED|Extension Phase Weeks 52-104||0
8929409|NCT02289417|9990814|FG005|STARTED|Extension Phase Weeks 52-104||0
8929410|NCT02289417|9990815|FG006|STARTED|Extension Phase Weeks 52-104||0
8929411|NCT02289417|9990816|FG007|STARTED|Extension Phase Weeks 52-104||45
8929412|NCT02289417|9990817|FG008|STARTED|Extension Phase Weeks 52-104||54
8929413|NCT02289417|9990809|FG000|COMPLETED|Extension Phase Weeks 52-104||0
8929414|NCT02289417|9990810|FG001|COMPLETED|Extension Phase Weeks 52-104||0
8929415|NCT02289417|9990811|FG002|COMPLETED|Extension Phase Weeks 52-104||0
8929416|NCT02289417|9990812|FG003|COMPLETED|Extension Phase Weeks 52-104||0
8929417|NCT02289417|9990813|FG004|COMPLETED|Extension Phase Weeks 52-104||0
8929418|NCT02289417|9990814|FG005|COMPLETED|Extension Phase Weeks 52-104||0
8929419|NCT02289417|9990815|FG006|COMPLETED|Extension Phase Weeks 52-104||0
8929420|NCT02289417|9990816|FG007|COMPLETED|Extension Phase Weeks 52-104||38
8929421|NCT02289417|9990817|FG008|COMPLETED|Extension Phase Weeks 52-104||48
8929422|NCT02289417|9990809|FG000|NOT COMPLETED|Extension Phase Weeks 52-104||0
8929423|NCT02289417|9990810|FG001|NOT COMPLETED|Extension Phase Weeks 52-104||0
8929424|NCT02289417|9990811|FG002|NOT COMPLETED|Extension Phase Weeks 52-104||0
8929425|NCT02289417|9990812|FG003|NOT COMPLETED|Extension Phase Weeks 52-104||0
8929426|NCT02289417|9990813|FG004|NOT COMPLETED|Extension Phase Weeks 52-104||0
8929427|NCT02289417|9990814|FG005|NOT COMPLETED|Extension Phase Weeks 52-104||0
8929428|NCT02289417|9990815|FG006|NOT COMPLETED|Extension Phase Weeks 52-104||0
8929429|NCT02289417|9990816|FG007|NOT COMPLETED|Extension Phase Weeks 52-104||7
8929430|NCT02289417|9990817|FG008|NOT COMPLETED|Extension Phase Weeks 52-104||6
8929431|NCT02289456|9990833|FG000|STARTED|Induction Period||40
8929432|NCT02289456|9990833|FG000|Treated Population|Induction Period||40
8929433|NCT02289456|9990833|FG000|COMPLETED|Induction Period||16
8929434|NCT02289456|9990833|FG000|NOT COMPLETED|Induction Period||24
8929435|NCT02289456|9990833|FG000|STARTED|Monotherapy Period||16
8929436|NCT02289456|9990833|FG000|COMPLETED|Monotherapy Period||0
8929437|NCT02289456|9990833|FG000|NOT COMPLETED|Monotherapy Period||16
8929438|NCT02289469|9990844|FG000|STARTED|Overall Study||250
8929439|NCT02289469|9990845|FG001|STARTED|Overall Study||244
8929440|NCT02289469|9990844|FG000|COMPLETED|Overall Study||244
8929441|NCT02289469|9990845|FG001|COMPLETED|Overall Study||244
8929442|NCT02289469|9990844|FG000|NOT COMPLETED|Overall Study||6
8929443|NCT02289469|9990845|FG001|NOT COMPLETED|Overall Study||0
8929444|NCT02289690|9990861|FG000|STARTED|Overall Study||4
8929445|NCT02289690|9990862|FG001|STARTED|Overall Study||3
8929446|NCT02289690|9990863|FG002|STARTED|Overall Study||4
8617087|NCT00454818|9655298|FG004|NOT COMPLETED|Phase I: Open-label Dose-escalation||0
8617088|NCT00454818|9655294|FG000|STARTED|Phase 2: Randomized Double-blind||0
8617089|NCT00454818|9655295|FG001|STARTED|Phase 2: Randomized Double-blind||8
8617090|NCT00454818|9655296|FG002|STARTED|Phase 2: Randomized Double-blind||8
8929447|NCT02289690|9990864|FG003|STARTED|Overall Study||3
8929448|NCT02289690|9990865|FG004|STARTED|Overall Study||8
8929449|NCT02289690|9990866|FG005|STARTED|Overall Study||14
8929450|NCT02289690|9990867|FG006|STARTED|Overall Study||4
8929451|NCT02289690|9990868|FG007|STARTED|Overall Study||61
8929452|NCT02289690|9990869|FG008|STARTED|Overall Study||59
8929453|NCT02289690|9990870|FG009|STARTED|Overall Study||61
8929454|NCT02289690|9990861|FG000|Received Study Drug|Overall Study||4
8929455|NCT02289690|9990862|FG001|Received Study Drug|Overall Study||3
8929456|NCT02289690|9990863|FG002|Received Study Drug|Overall Study||4
8929457|NCT02289690|9990864|FG003|Received Study Drug|Overall Study||3
8929458|NCT02289690|9990865|FG004|Received Study Drug|Overall Study||8
8929459|NCT02289690|9990866|FG005|Received Study Drug|Overall Study||14
8929460|NCT02289690|9990867|FG006|Received Study Drug|Overall Study||4
8929461|NCT02289690|9990868|FG007|Received Study Drug|Overall Study||60
8929462|NCT02289690|9990869|FG008|Received Study Drug|Overall Study||58
8929463|NCT02289690|9990870|FG009|Received Study Drug|Overall Study||60
8929464|NCT02289690|9990861|FG000|COMPLETED|Overall Study||0
8929465|NCT02289690|9990862|FG001|COMPLETED|Overall Study||0
8929466|NCT02289690|9990863|FG002|COMPLETED|Overall Study||0
8929467|NCT02289690|9990864|FG003|COMPLETED|Overall Study||0
8929468|NCT02289690|9990865|FG004|COMPLETED|Overall Study||0
8929469|NCT02289690|9990866|FG005|COMPLETED|Overall Study||0
8717772|NCT00996307|9765021|FG002|STARTED|Overall Study||160
8929470|NCT02289690|9990867|FG006|COMPLETED|Overall Study||0
8929471|NCT02289690|9990868|FG007|COMPLETED|Overall Study||0
8929472|NCT02289690|9990869|FG008|COMPLETED|Overall Study||0
8929473|NCT02289690|9990870|FG009|COMPLETED|Overall Study||0
8929474|NCT02289690|9990861|FG000|NOT COMPLETED|Overall Study||4
8929475|NCT02289690|9990862|FG001|NOT COMPLETED|Overall Study||3
8929476|NCT02289690|9990863|FG002|NOT COMPLETED|Overall Study||4
8929477|NCT02289690|9990864|FG003|NOT COMPLETED|Overall Study||3
8929478|NCT02289690|9990865|FG004|NOT COMPLETED|Overall Study||8
8929479|NCT02289690|9990866|FG005|NOT COMPLETED|Overall Study||14
8929480|NCT02289690|9990867|FG006|NOT COMPLETED|Overall Study||4
8929481|NCT02289690|9990868|FG007|NOT COMPLETED|Overall Study||61
8929482|NCT02289690|9990869|FG008|NOT COMPLETED|Overall Study||59
8929483|NCT02289690|9990870|FG009|NOT COMPLETED|Overall Study||61
8929484|NCT02289729|9990906|FG000|STARTED|Overall Study||59
8929485|NCT02289729|9990906|FG000|COMPLETED|Overall Study||53
8929486|NCT02289729|9990906|FG000|NOT COMPLETED|Overall Study||6
8929487|NCT02289742|9990912|FG000|STARTED|First Wear Period||11
8929488|NCT02289742|9990913|FG001|STARTED|First Wear Period||12
8929489|NCT02289742|9990914|FG002|STARTED|First Wear Period||12
8929490|NCT02289742|9990915|FG003|STARTED|First Wear Period||10
8929491|NCT02289742|9990912|FG000|Treated|First Wear Period||11
8929492|NCT02289742|9990913|FG001|Treated|First Wear Period||11
8929493|NCT02289742|9990914|FG002|Treated|First Wear Period||12
8929494|NCT02289742|9990915|FG003|Treated|First Wear Period||9
8929495|NCT02289742|9990912|FG000|COMPLETED|First Wear Period||11
8929496|NCT02289742|9990913|FG001|COMPLETED|First Wear Period||11
8929497|NCT02289742|9990914|FG002|COMPLETED|First Wear Period||11
8929498|NCT02289742|9990915|FG003|COMPLETED|First Wear Period||9
8929499|NCT02289742|9990912|FG000|NOT COMPLETED|First Wear Period||0
8929500|NCT02289742|9990913|FG001|NOT COMPLETED|First Wear Period||1
8929501|NCT02289742|9990914|FG002|NOT COMPLETED|First Wear Period||1
8929502|NCT02289742|9990915|FG003|NOT COMPLETED|First Wear Period||1
8929503|NCT02289742|9990912|FG000|STARTED|Second Wear Period||11
8929504|NCT02289742|9990913|FG001|STARTED|Second Wear Period||11
8929505|NCT02289742|9990914|FG002|STARTED|Second Wear Period||11
8929506|NCT02289742|9990915|FG003|STARTED|Second Wear Period||9
8929507|NCT02289742|9990912|FG000|COMPLETED|Second Wear Period||11
8929508|NCT02289742|9990913|FG001|COMPLETED|Second Wear Period||11
8929509|NCT02289742|9990914|FG002|COMPLETED|Second Wear Period||11
8929510|NCT02289742|9990915|FG003|COMPLETED|Second Wear Period||9
8929511|NCT02289742|9990912|FG000|NOT COMPLETED|Second Wear Period||0
8929512|NCT02289742|9990913|FG001|NOT COMPLETED|Second Wear Period||0
8929513|NCT02289742|9990914|FG002|NOT COMPLETED|Second Wear Period||0
8929514|NCT02289742|9990915|FG003|NOT COMPLETED|Second Wear Period||0
8929515|NCT02289742|9990912|FG000|STARTED|Third Wear Period||11
8929516|NCT02289742|9990913|FG001|STARTED|Third Wear Period||11
8929517|NCT02289742|9990914|FG002|STARTED|Third Wear Period||11
8929518|NCT02289742|9990915|FG003|STARTED|Third Wear Period||9
8929519|NCT02289742|9990912|FG000|COMPLETED|Third Wear Period||11
8929520|NCT02289742|9990913|FG001|COMPLETED|Third Wear Period||10
8929521|NCT02289742|9990914|FG002|COMPLETED|Third Wear Period||11
8929522|NCT02289742|9990915|FG003|COMPLETED|Third Wear Period||8
8929523|NCT02289742|9990912|FG000|NOT COMPLETED|Third Wear Period||0
8929524|NCT02289742|9990913|FG001|NOT COMPLETED|Third Wear Period||1
8929525|NCT02289742|9990914|FG002|NOT COMPLETED|Third Wear Period||0
8929526|NCT02289742|9990915|FG003|NOT COMPLETED|Third Wear Period||1
8929527|NCT02289755|9990929|FG000|STARTED|Baseline Period [No Treatment, 3 Days]||16
8929528|NCT02289755|9990929|FG000|COMPLETED|Baseline Period [No Treatment, 3 Days]||16
8929529|NCT02289755|9990929|FG000|NOT COMPLETED|Baseline Period [No Treatment, 3 Days]||0
8929530|NCT02289755|9990929|FG000|STARTED|ALLN-177 Treatment Period [4 Days]||16
8929531|NCT02289755|9990929|FG000|COMPLETED|ALLN-177 Treatment Period [4 Days]||16
8929532|NCT02289755|9990929|FG000|NOT COMPLETED|ALLN-177 Treatment Period [4 Days]||0
8929533|NCT02289755|9990929|FG000|STARTED|Follow up Period [4 Days]||16
8929534|NCT02289755|9990929|FG000|COMPLETED|Follow up Period [4 Days]||16
8929535|NCT02289755|9990929|FG000|NOT COMPLETED|Follow up Period [4 Days]||0
8929536|NCT02289820|9990940|FG000|STARTED|Overall Study||39
8929537|NCT02289820|9990941|FG001|STARTED|Overall Study||20
8929538|NCT02289820|9990942|FG002|STARTED|Overall Study||44
8929539|NCT02289820|9990943|FG003|STARTED|Overall Study||39
8929540|NCT02289820|9990944|FG004|STARTED|Overall Study||40
8929541|NCT02289820|9990945|FG005|STARTED|Overall Study||40
8929542|NCT02289820|9990946|FG006|STARTED|Overall Study||39
8929543|NCT02289820|9990940|FG000|COMPLETED|Overall Study||37
8929544|NCT02289820|9990941|FG001|COMPLETED|Overall Study||18
8929545|NCT02289820|9990942|FG002|COMPLETED|Overall Study||38
8929546|NCT02289820|9990943|FG003|COMPLETED|Overall Study||37
8929547|NCT02289820|9990944|FG004|COMPLETED|Overall Study||40
8929548|NCT02289820|9990945|FG005|COMPLETED|Overall Study||39
8929549|NCT02289820|9990946|FG006|COMPLETED|Overall Study||37
8929550|NCT02289820|9990940|FG000|NOT COMPLETED|Overall Study||2
8929551|NCT02289820|9990941|FG001|NOT COMPLETED|Overall Study||2
8929552|NCT02289820|9990942|FG002|NOT COMPLETED|Overall Study||6
8929553|NCT02289820|9990943|FG003|NOT COMPLETED|Overall Study||2
8929554|NCT02289820|9990944|FG004|NOT COMPLETED|Overall Study||0
8929555|NCT02289820|9990945|FG005|NOT COMPLETED|Overall Study||1
8929556|NCT02289820|9990946|FG006|NOT COMPLETED|Overall Study||2
8929557|NCT02289833|9990968|FG000|STARTED|Overall Study||29
8929558|NCT02289833|9990969|FG001|STARTED|Overall Study||20
8929559|NCT02289833|9990968|FG000|COMPLETED|Overall Study||2
8929560|NCT02289833|9990969|FG001|COMPLETED|Overall Study||3
8929561|NCT02289833|9990968|FG000|NOT COMPLETED|Overall Study||27
8929562|NCT02289833|9990969|FG001|NOT COMPLETED|Overall Study||17
8929563|NCT02289898|9990980|FG000|STARTED|Overall Study||68
8929564|NCT02289898|9990981|FG001|STARTED|Overall Study||71
8929565|NCT02289898|9990982|FG002|STARTED|Overall Study||65
8929566|NCT02289898|9990980|FG000|COMPLETED|Overall Study||16
8929567|NCT02289898|9990981|FG001|COMPLETED|Overall Study||18
8929568|NCT02289898|9990982|FG002|COMPLETED|Overall Study||9
8929569|NCT02289898|9990980|FG000|NOT COMPLETED|Overall Study||52
8929570|NCT02289898|9990981|FG001|NOT COMPLETED|Overall Study||53
8929571|NCT02289898|9990982|FG002|NOT COMPLETED|Overall Study||56
8929572|NCT02289950|9990991|FG000|STARTED|Overall Study||142
8929573|NCT02289950|9990992|FG001|STARTED|Overall Study||72
8929574|NCT02289950|9990991|FG000|Treated|Overall Study|1 participant randomized to placebo group but was treated with farletuzumab, and was analyzed in the farletuzumab group in safety analysis set.|140
8929575|NCT02289950|9990992|FG001|Treated|Overall Study||71
8929576|NCT02289950|9990991|FG000|COMPLETED|Overall Study||0
8929577|NCT02289950|9990992|FG001|COMPLETED|Overall Study||0
8929578|NCT02289950|9990991|FG000|NOT COMPLETED|Overall Study||142
8929579|NCT02289950|9990992|FG001|NOT COMPLETED|Overall Study||72
8929580|NCT02289963|9991000|FG000|STARTED|Overall Study|Randomized|102
8929581|NCT02289963|9991001|FG001|STARTED|Overall Study|Randomized|97
8929582|NCT02289963|9991000|FG000|Treated|Overall Study||102
8929583|NCT02289963|9991001|FG001|Treated|Overall Study||97
8929584|NCT02289963|9991000|FG000|COMPLETED|Overall Study||97
8929585|NCT02289963|9991001|FG001|COMPLETED|Overall Study||87
8929586|NCT02289963|9991000|FG000|NOT COMPLETED|Overall Study||5
8617091|NCT00454818|9655297|FG003|STARTED|Phase 2: Randomized Double-blind||9
8617092|NCT00454818|9655298|FG004|STARTED|Phase 2: Randomized Double-blind||14
8617093|NCT00454818|9655294|FG000|COMPLETED|Phase 2: Randomized Double-blind||0
8717773|NCT00996307|9765022|FG003|STARTED|Overall Study||165
8717774|NCT00996307|9765019|FG000|COMPLETED|Overall Study||144
8717775|NCT00996307|9765020|FG001|COMPLETED|Overall Study||148
9064622|NCT04289623|10124977|FG004|NOT COMPLETED|Wave 2 Emails||0
8717776|NCT00996307|9765021|FG002|COMPLETED|Overall Study||146
8717777|NCT00996307|9765022|FG003|COMPLETED|Overall Study||144
8929587|NCT02289963|9991001|FG001|NOT COMPLETED|Overall Study||10
8929588|NCT02289989|9991009|FG000|STARTED|Overall Study||0
8929589|NCT02289989|9991010|FG001|STARTED|Overall Study||1
8929590|NCT02289989|9991009|FG000|COMPLETED|Overall Study||0
8929591|NCT02289989|9991010|FG001|COMPLETED|Overall Study||1
8929592|NCT02289989|9991009|FG000|NOT COMPLETED|Overall Study||0
8929593|NCT02289989|9991010|FG001|NOT COMPLETED|Overall Study||0
8929594|NCT02290028|9991016|FG000|STARTED|Overall Study||2226
8929595|NCT02290028|9991016|FG000|COMPLETED|Overall Study||0
8929596|NCT02290028|9991016|FG000|NOT COMPLETED|Overall Study||2226
8929597|NCT02290106|9991025|FG000|STARTED|Overall Study||25
8929598|NCT02290106|9991026|FG001|STARTED|Overall Study||25
9064623|NCT04289623|10124978|FG005|NOT COMPLETED|Wave 2 Emails||0
9064624|NCT04276207|10124992|FG000|STARTED|Period 1||15
8617094|NCT00454818|9655295|FG001|COMPLETED|Phase 2: Randomized Double-blind||6
8617095|NCT00454818|9655296|FG002|COMPLETED|Phase 2: Randomized Double-blind||5
8617096|NCT00454818|9655297|FG003|COMPLETED|Phase 2: Randomized Double-blind||8
8617097|NCT00454818|9655298|FG004|COMPLETED|Phase 2: Randomized Double-blind||10
8617098|NCT00454818|9655294|FG000|NOT COMPLETED|Phase 2: Randomized Double-blind||0
8617099|NCT00454818|9655295|FG001|NOT COMPLETED|Phase 2: Randomized Double-blind||2
8929599|NCT02290106|9991025|FG000|COMPLETED|Overall Study||24
8929600|NCT02290106|9991026|FG001|COMPLETED|Overall Study||23
8929601|NCT02290106|9991025|FG000|NOT COMPLETED|Overall Study||1
8929602|NCT02290106|9991026|FG001|NOT COMPLETED|Overall Study||2
9064625|NCT04276207|10124993|FG001|STARTED|Period 1||17
8929603|NCT02290184|9991034|FG000|STARTED|Overall Study||22
8929604|NCT02290184|9991035|FG001|STARTED|Overall Study||23
8929605|NCT02290184|9991034|FG000|3-month Follow-up|Overall Study|Completed initial 3-month intervention and now transition to a 3-month maintenance phase|22
8929606|NCT02290184|9991035|FG001|3-month Follow-up|Overall Study|Completed initial 3-month control period and transition to receive the 3-month intervention|23
8929607|NCT02290184|9991034|FG000|COMPLETED|Overall Study|6-month follow-up visit - completed the 3-month maintenance phase and completed study|22
8929608|NCT02290184|9991035|FG001|COMPLETED|Overall Study|6-month follow up visit - completed 3-month intervention and competed study|23
8929609|NCT02290184|9991034|FG000|NOT COMPLETED|Overall Study||0
8929610|NCT02290184|9991035|FG001|NOT COMPLETED|Overall Study||0
8929611|NCT02290223|9991049|FG000|STARTED|Baseline||189
8929612|NCT02290223|9991050|FG001|STARTED|Baseline||187
8929613|NCT02290223|9991049|FG000|COMPLETED|Baseline||189
8929614|NCT02290223|9991050|FG001|COMPLETED|Baseline||187
8929615|NCT02290223|9991049|FG000|NOT COMPLETED|Baseline||0
8929616|NCT02290223|9991050|FG001|NOT COMPLETED|Baseline||0
8929617|NCT02290223|9991049|FG000|STARTED|6 Months||189
8929618|NCT02290223|9991050|FG001|STARTED|6 Months||187
8929619|NCT02290223|9991049|FG000|COMPLETED|6 Months||173
8929620|NCT02290223|9991050|FG001|COMPLETED|6 Months||181
8929621|NCT02290223|9991049|FG000|NOT COMPLETED|6 Months||16
8929622|NCT02290223|9991050|FG001|NOT COMPLETED|6 Months||6
8929623|NCT02290223|9991049|FG000|STARTED|12 Months|All participants were contacted at 12 mo, unless deceased or withdrawn (n=7).|182
8929624|NCT02290223|9991050|FG001|STARTED|12 Months|All participants were contacted at 12 mo, unless deceased or withdrawn (n=0).|187
8929625|NCT02290223|9991049|FG000|COMPLETED|12 Months||166
8929626|NCT02290223|9991050|FG001|COMPLETED|12 Months||176
8929627|NCT02290223|9991049|FG000|NOT COMPLETED|12 Months||16
8929628|NCT02290223|9991050|FG001|NOT COMPLETED|12 Months||11
8929629|NCT02290340|9991060|FG000|STARTED|Overall Study||18
8929630|NCT02290340|9991061|FG001|STARTED|Overall Study||8
8929631|NCT02290340|9991062|FG002|STARTED|Overall Study||31
8929632|NCT02290340|9991063|FG003|STARTED|Overall Study||32
8929633|NCT02290340|9991060|FG000|COMPLETED|Overall Study||16
8929634|NCT02290340|9991061|FG001|COMPLETED|Overall Study||8
8929635|NCT02290340|9991062|FG002|COMPLETED|Overall Study||31
8929636|NCT02290340|9991063|FG003|COMPLETED|Overall Study||30
8929637|NCT02290340|9991060|FG000|NOT COMPLETED|Overall Study||2
8929638|NCT02290340|9991061|FG001|NOT COMPLETED|Overall Study||0
8929639|NCT02290340|9991062|FG002|NOT COMPLETED|Overall Study||0
8929640|NCT02290340|9991063|FG003|NOT COMPLETED|Overall Study||2
8929641|NCT02290405|9991078|FG000|STARTED|Overall Study||36
8929642|NCT02290405|9991079|FG001|STARTED|Overall Study||53
8929643|NCT02290405|9991078|FG000|COMPLETED|Overall Study||35
8929644|NCT02290405|9991079|FG001|COMPLETED|Overall Study||53
8929645|NCT02290405|9991078|FG000|NOT COMPLETED|Overall Study||1
8929646|NCT02290405|9991079|FG001|NOT COMPLETED|Overall Study||0
8929647|NCT02290444|9991087|FG000|STARTED|Overall Study||30
8929648|NCT02290444|9991088|FG001|STARTED|Overall Study||34
8929649|NCT02290444|9991087|FG000|COMPLETED|Overall Study||29
8929650|NCT02290444|9991088|FG001|COMPLETED|Overall Study||32
8929651|NCT02290444|9991087|FG000|NOT COMPLETED|Overall Study||1
8929652|NCT02290444|9991088|FG001|NOT COMPLETED|Overall Study||2
8948290|NCT02429115|10010633|FG004|NOT COMPLETED|Overall Study||7
8948291|NCT02429115|10010634|FG005|NOT COMPLETED|Overall Study||1
8948292|NCT02429258|10010650|FG000|STARTED|Overall Study||50
8948293|NCT02429258|10010651|FG001|STARTED|Overall Study||50
8617100|NCT00454818|9655296|FG002|NOT COMPLETED|Phase 2: Randomized Double-blind||3
8617101|NCT00454818|9655297|FG003|NOT COMPLETED|Phase 2: Randomized Double-blind||1
8617102|NCT00454818|9655298|FG004|NOT COMPLETED|Phase 2: Randomized Double-blind||4
8617103|NCT00454857|9655315|FG000|STARTED|Overall Study||326
8617104|NCT00454857|9655315|FG000|Completed Retrospective Chart Review|Overall Study||324
8948294|NCT02429258|10010650|FG000|COMPLETED|Overall Study||48
8948295|NCT02429258|10010651|FG001|COMPLETED|Overall Study||49
8948296|NCT02429258|10010650|FG000|NOT COMPLETED|Overall Study||2
8948297|NCT02429258|10010651|FG001|NOT COMPLETED|Overall Study||1
8948298|NCT02429310|10010659|FG000|STARTED|Overall Study||22
8948299|NCT02429310|10010660|FG001|STARTED|Overall Study||20
8948300|NCT02429310|10010659|FG000|COMPLETED|Overall Study||20
8948301|NCT02429310|10010660|FG001|COMPLETED|Overall Study||17
8948302|NCT02429310|10010659|FG000|NOT COMPLETED|Overall Study||2
8948303|NCT02429310|10010660|FG001|NOT COMPLETED|Overall Study||3
8948304|NCT02429427|10010668|FG000|STARTED|Overall Study||1763
8948305|NCT02429427|10010669|FG001|STARTED|Overall Study||876
8948306|NCT02429427|10010668|FG000|COMPLETED|Overall Study||1392
8948307|NCT02429427|10010669|FG001|COMPLETED|Overall Study||697
8948308|NCT02429427|10010668|FG000|NOT COMPLETED|Overall Study||371
8948309|NCT02429427|10010669|FG001|NOT COMPLETED|Overall Study||179
8948310|NCT02429778|10010677|FG000|STARTED|Overall Study||20
8948311|NCT02429778|10010678|FG001|STARTED|Overall Study||20
8948312|NCT02429778|10010677|FG000|COMPLETED|Overall Study||13
8948313|NCT02429778|10010678|FG001|COMPLETED|Overall Study||20
8948314|NCT02429778|10010677|FG000|NOT COMPLETED|Overall Study||7
8948315|NCT02429778|10010678|FG001|NOT COMPLETED|Overall Study||0
8948316|NCT02429856|10010686|FG000|STARTED|Overall Study||49
8948317|NCT02429856|10010687|FG001|STARTED|Overall Study||51
8948318|NCT02429856|10010686|FG000|COMPLETED|Overall Study||30
8948319|NCT02429856|10010687|FG001|COMPLETED|Overall Study||32
8948320|NCT02429856|10010686|FG000|NOT COMPLETED|Overall Study||19
8948321|NCT02429856|10010687|FG001|NOT COMPLETED|Overall Study||19
8929653|NCT02290509|9991096|FG000|STARTED|Overall Study||1011
8929654|NCT02290509|9991097|FG001|STARTED|Overall Study||339
8929655|NCT02290509|9991096|FG000|COMPLETED|Overall Study||962
8929656|NCT02290509|9991097|FG001|COMPLETED|Overall Study||325
8929657|NCT02290509|9991096|FG000|NOT COMPLETED|Overall Study||49
8929658|NCT02290509|9991097|FG001|NOT COMPLETED|Overall Study||14
8929659|NCT02290574|9991103|FG000|STARTED|Overall Study||14
8929660|NCT02290574|9991103|FG000|COMPLETED|Overall Study||13
8929661|NCT02290574|9991103|FG000|NOT COMPLETED|Overall Study||1
8929662|NCT02290613|9991110|FG000|STARTED|Overall Study||19
8929663|NCT02290613|9991111|FG001|STARTED|Overall Study||19
8929664|NCT02290613|9991110|FG000|COMPLETED|Overall Study||17
8929665|NCT02290613|9991111|FG001|COMPLETED|Overall Study||15
8929666|NCT02290613|9991110|FG000|NOT COMPLETED|Overall Study||2
8617105|NCT00454857|9655315|FG000|Completed ≥1 Observational Study Visit|Overall Study||319
8617106|NCT00454857|9655315|FG000|COMPLETED|Overall Study||272
8617107|NCT00454857|9655315|FG000|NOT COMPLETED|Overall Study||54
8617108|NCT00454909|9655322|FG000|STARTED|Overall Study||587
8929667|NCT02290613|9991111|FG001|NOT COMPLETED|Overall Study||4
8929668|NCT02290691|9991119|FG000|STARTED|Overall Study||496
8929669|NCT02290691|9991120|FG001|STARTED|Overall Study||488
8929670|NCT02290691|9991119|FG000|COMPLETED|Overall Study||488
8929671|NCT02290691|9991120|FG001|COMPLETED|Overall Study||479
8617109|NCT00454909|9655323|FG001|STARTED|Overall Study||197
8617110|NCT00454909|9655324|FG002|STARTED|Overall Study||88
8617111|NCT00454909|9655322|FG000|COMPLETED|Overall Study||580
8617112|NCT00454909|9655323|FG001|COMPLETED|Overall Study||194
8617113|NCT00454909|9655324|FG002|COMPLETED|Overall Study||86
8617114|NCT00454909|9655322|FG000|NOT COMPLETED|Overall Study||7
8929672|NCT02290691|9991119|FG000|NOT COMPLETED|Overall Study||8
8929673|NCT02290691|9991120|FG001|NOT COMPLETED|Overall Study||9
8929674|NCT02290821|9991128|FG000|STARTED|Overall Study||109
8929675|NCT02290821|9991129|FG001|STARTED|Overall Study||106
8929676|NCT02290821|9991128|FG000|COMPLETED|Overall Study||103
8929677|NCT02290821|9991129|FG001|COMPLETED|Overall Study||103
8929678|NCT02290821|9991128|FG000|NOT COMPLETED|Overall Study||6
8929679|NCT02290821|9991129|FG001|NOT COMPLETED|Overall Study||3
8929680|NCT02290873|9991138|FG000|STARTED|Overall Study||298
8929681|NCT02290873|9991139|FG001|STARTED|Overall Study||60
8929682|NCT02290873|9991140|FG002|STARTED|Overall Study||103
8929683|NCT02290873|9991138|FG000|Modified Intention to Treat (mITT)|Overall Study||296
8929684|NCT02290873|9991139|FG001|Modified Intention to Treat (mITT)|Overall Study||60
8929685|NCT02290873|9991140|FG002|Modified Intention to Treat (mITT)|Overall Study||102
8929686|NCT02290873|9991138|FG000|Safety Population|Overall Study||296
8929687|NCT02290873|9991139|FG001|Safety Population|Overall Study||60
8929688|NCT02290873|9991140|FG002|Safety Population|Overall Study||102
8929689|NCT02290873|9991138|FG000|COMPLETED|Overall Study||296
8929690|NCT02290873|9991139|FG001|COMPLETED|Overall Study||59
8929691|NCT02290873|9991140|FG002|COMPLETED|Overall Study||101
8929692|NCT02290873|9991138|FG000|NOT COMPLETED|Overall Study||2
8929693|NCT02290873|9991139|FG001|NOT COMPLETED|Overall Study||1
8929694|NCT02290873|9991140|FG002|NOT COMPLETED|Overall Study||2
8929695|NCT02290925|9991151|FG000|STARTED|First Period of Three Months||62
8929696|NCT02290925|9991152|FG001|STARTED|First Period of Three Months||71
8929697|NCT02290925|9991151|FG000|COMPLETED|First Period of Three Months||58
8929698|NCT02290925|9991152|FG001|COMPLETED|First Period of Three Months||69
8929699|NCT02290925|9991151|FG000|NOT COMPLETED|First Period of Three Months||4
8929700|NCT02290925|9991152|FG001|NOT COMPLETED|First Period of Three Months||2
8929701|NCT02290925|9991151|FG000|STARTED|Second Period of 3 Months||58
8929702|NCT02290925|9991152|FG001|STARTED|Second Period of 3 Months||69
8929703|NCT02290925|9991151|FG000|COMPLETED|Second Period of 3 Months||57
8929704|NCT02290925|9991152|FG001|COMPLETED|Second Period of 3 Months||65
8929705|NCT02290925|9991151|FG000|NOT COMPLETED|Second Period of 3 Months||1
8617115|NCT00454909|9655323|FG001|NOT COMPLETED|Overall Study||3
8617116|NCT00454909|9655324|FG002|NOT COMPLETED|Overall Study||2
8617117|NCT00454987|9655336|FG000|STARTED|Booster Period (NCT00258700)||359
8617118|NCT00454987|9655337|FG001|STARTED|Booster Period (NCT00258700)||117
8617119|NCT00454987|9655338|FG002|STARTED|Booster Period (NCT00258700)||0
8617120|NCT00454987|9655336|FG000|COMPLETED|Booster Period (NCT00258700)||357
8617121|NCT00454987|9655337|FG001|COMPLETED|Booster Period (NCT00258700)||116
8617122|NCT00454987|9655338|FG002|COMPLETED|Booster Period (NCT00258700)||0
8929706|NCT02290925|9991152|FG001|NOT COMPLETED|Second Period of 3 Months||4
8929707|NCT02291016|9991162|FG000|STARTED|Visit 1||2
8929708|NCT02291016|9991163|FG001|STARTED|Visit 1||5
8929709|NCT02291016|9991162|FG000|COMPLETED|Visit 1||2
8617123|NCT00454987|9655336|FG000|NOT COMPLETED|Booster Period (NCT00258700)||2
8617124|NCT00454987|9655337|FG001|NOT COMPLETED|Booster Period (NCT00258700)||1
8617125|NCT00454987|9655338|FG002|NOT COMPLETED|Booster Period (NCT00258700)||0
8617126|NCT00454987|9655336|FG000|STARTED|Year 1 (NCT00454987)||221
8929710|NCT02291016|9991163|FG001|COMPLETED|Visit 1||5
8929711|NCT02291016|9991162|FG000|NOT COMPLETED|Visit 1||0
8929712|NCT02291016|9991163|FG001|NOT COMPLETED|Visit 1||0
8929713|NCT02291016|9991162|FG000|STARTED|Visit 2||2
8929714|NCT02291016|9991163|FG001|STARTED|Visit 2||5
8929715|NCT02291016|9991162|FG000|COMPLETED|Visit 2|Patients did not meet visit 2 FEV1 criteria ( 15% or closer to value at visit 1)|1
8929716|NCT02291016|9991163|FG001|COMPLETED|Visit 2||5
8929717|NCT02291016|9991162|FG000|NOT COMPLETED|Visit 2||1
8929718|NCT02291016|9991163|FG001|NOT COMPLETED|Visit 2||0
8929719|NCT02291029|9991176|FG000|STARTED|Overall Study||8
8929720|NCT02291029|9991177|FG001|STARTED|Overall Study||4
8929721|NCT02291029|9991178|FG002|STARTED|Overall Study||21
8929722|NCT02291029|9991179|FG003|STARTED|Overall Study||11
8929723|NCT02291029|9991180|FG004|STARTED|Overall Study||13
8929724|NCT02291029|9991181|FG005|STARTED|Overall Study||12
8929725|NCT02291029|9991176|FG000|COMPLETED|Overall Study||8
8929726|NCT02291029|9991177|FG001|COMPLETED|Overall Study||3
8929727|NCT02291029|9991178|FG002|COMPLETED|Overall Study||20
8929728|NCT02291029|9991179|FG003|COMPLETED|Overall Study||11
8929729|NCT02291029|9991180|FG004|COMPLETED|Overall Study||13
8717778|NCT00996307|9765019|FG000|NOT COMPLETED|Overall Study||20
8929730|NCT02291029|9991181|FG005|COMPLETED|Overall Study||12
8929731|NCT02291029|9991176|FG000|NOT COMPLETED|Overall Study||0
8929732|NCT02291029|9991177|FG001|NOT COMPLETED|Overall Study||1
8929733|NCT02291029|9991178|FG002|NOT COMPLETED|Overall Study||1
8929734|NCT02291029|9991179|FG003|NOT COMPLETED|Overall Study||0
8929735|NCT02291029|9991180|FG004|NOT COMPLETED|Overall Study||0
8929736|NCT02291029|9991181|FG005|NOT COMPLETED|Overall Study||0
8929737|NCT02291133|9991195|FG000|STARTED|Overall Study||25
8929738|NCT02291133|9991195|FG000|COMPLETED|Overall Study||24
8929739|NCT02291133|9991195|FG000|NOT COMPLETED|Overall Study||1
8929740|NCT02291237|9991201|FG000|STARTED|Overall Study||86
8929741|NCT02291237|9991202|FG001|STARTED|Overall Study||86
8929742|NCT02291237|9991201|FG000|COMPLETED|Overall Study||0
8929743|NCT02291237|9991202|FG001|COMPLETED|Overall Study||0
8929744|NCT02291237|9991201|FG000|NOT COMPLETED|Overall Study||86
8717779|NCT00996307|9765020|FG001|NOT COMPLETED|Overall Study||17
8717780|NCT00996307|9765021|FG002|NOT COMPLETED|Overall Study||14
8717781|NCT00996307|9765022|FG003|NOT COMPLETED|Overall Study||21
8717782|NCT00996346|9765053|FG000|STARTED|Overall Study||6
8717783|NCT00996346|9765054|FG001|STARTED|Overall Study||8
8717784|NCT00996346|9765055|FG002|STARTED|Overall Study||3
8717785|NCT00996346|9765053|FG000|COMPLETED|Overall Study||6
8717786|NCT00996346|9765054|FG001|COMPLETED|Overall Study||8
8717787|NCT00996346|9765055|FG002|COMPLETED|Overall Study||3
8717788|NCT00996346|9765053|FG000|NOT COMPLETED|Overall Study||0
8717789|NCT00996346|9765054|FG001|NOT COMPLETED|Overall Study||0
8717790|NCT00996346|9765055|FG002|NOT COMPLETED|Overall Study||0
8929745|NCT02291237|9991202|FG001|NOT COMPLETED|Overall Study||86
8929746|NCT02291289|9991212|FG000|STARTED|Induction Treatment||60
8929747|NCT02291289|9991213|FG001|STARTED|Induction Treatment||0
8929748|NCT02291289|9991214|FG002|STARTED|Induction Treatment||0
8929749|NCT02291289|9991215|FG003|STARTED|Induction Treatment||445
8929750|NCT02291289|9991216|FG004|STARTED|Induction Treatment||0
8929751|NCT02291289|9991217|FG005|STARTED|Induction Treatment||0
8929752|NCT02291289|9991218|FG006|STARTED|Induction Treatment||5
8929753|NCT02291289|9991219|FG007|STARTED|Induction Treatment||0
8929754|NCT02291289|9991220|FG008|STARTED|Induction Treatment||0
8929755|NCT02291289|9991221|FG009|STARTED|Induction Treatment||99
8929756|NCT02291289|9991222|FG010|STARTED|Induction Treatment||0
8929757|NCT02291289|9991223|FG011|STARTED|Induction Treatment||0
8929758|NCT02291289|9991212|FG000|COMPLETED|Induction Treatment||58
8929759|NCT02291289|9991213|FG001|COMPLETED|Induction Treatment||0
8929760|NCT02291289|9991214|FG002|COMPLETED|Induction Treatment||0
8929761|NCT02291289|9991215|FG003|COMPLETED|Induction Treatment||436
8929762|NCT02291289|9991216|FG004|COMPLETED|Induction Treatment||0
8929763|NCT02291289|9991217|FG005|COMPLETED|Induction Treatment||0
8929764|NCT02291289|9991218|FG006|COMPLETED|Induction Treatment||5
8929765|NCT02291289|9991219|FG007|COMPLETED|Induction Treatment||0
8929766|NCT02291289|9991220|FG008|COMPLETED|Induction Treatment||0
8929767|NCT02291289|9991221|FG009|COMPLETED|Induction Treatment||98
8929768|NCT02291289|9991222|FG010|COMPLETED|Induction Treatment||0
8929769|NCT02291289|9991223|FG011|COMPLETED|Induction Treatment||0
8929770|NCT02291289|9991212|FG000|NOT COMPLETED|Induction Treatment||2
8929771|NCT02291289|9991213|FG001|NOT COMPLETED|Induction Treatment||0
8929772|NCT02291289|9991214|FG002|NOT COMPLETED|Induction Treatment||0
8929773|NCT02291289|9991215|FG003|NOT COMPLETED|Induction Treatment||9
8929774|NCT02291289|9991216|FG004|NOT COMPLETED|Induction Treatment||0
8929775|NCT02291289|9991217|FG005|NOT COMPLETED|Induction Treatment||0
8929776|NCT02291289|9991218|FG006|NOT COMPLETED|Induction Treatment||0
8929777|NCT02291289|9991219|FG007|NOT COMPLETED|Induction Treatment||0
8717791|NCT00996372|9765063|FG000|STARTED|Overall Study||468
8717792|NCT00996372|9765064|FG001|STARTED|Overall Study||481
8929778|NCT02291289|9991220|FG008|NOT COMPLETED|Induction Treatment||0
8929779|NCT02291289|9991221|FG009|NOT COMPLETED|Induction Treatment||1
8929780|NCT02291289|9991222|FG010|NOT COMPLETED|Induction Treatment||0
8717793|NCT00996372|9765063|FG000|COMPLETED|Overall Study||365
8717794|NCT00996372|9765064|FG001|COMPLETED|Overall Study||397
8929781|NCT02291289|9991223|FG011|NOT COMPLETED|Induction Treatment||0
8929782|NCT02291289|9991212|FG000|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|0
8929783|NCT02291289|9991213|FG001|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|40
8929784|NCT02291289|9991214|FG002|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|20
8929785|NCT02291289|9991215|FG003|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|0
8929786|NCT02291289|9991216|FG004|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|297
8929787|NCT02291289|9991217|FG005|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|148
8929788|NCT02291289|9991218|FG006|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|0
8929789|NCT02291289|9991219|FG007|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|3
8929790|NCT02291289|9991220|FG008|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|2
8929791|NCT02291289|9991221|FG009|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|0
8929792|NCT02291289|9991222|FG010|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|65
8929793|NCT02291289|9991223|FG011|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|34
8929794|NCT02291289|9991212|FG000|Dosed|Maintenance Treatment Phase||0
8929795|NCT02291289|9991213|FG001|Dosed|Maintenance Treatment Phase||40
8929796|NCT02291289|9991214|FG002|Dosed|Maintenance Treatment Phase||18
8929797|NCT02291289|9991215|FG003|Dosed|Maintenance Treatment Phase||0
8929798|NCT02291289|9991216|FG004|Dosed|Maintenance Treatment Phase||293
8929799|NCT02291289|9991217|FG005|Dosed|Maintenance Treatment Phase||143
8929800|NCT02291289|9991218|FG006|Dosed|Maintenance Treatment Phase||0
8929801|NCT02291289|9991219|FG007|Dosed|Maintenance Treatment Phase||3
8929802|NCT02291289|9991220|FG008|Dosed|Maintenance Treatment Phase||2
8929803|NCT02291289|9991221|FG009|Dosed|Maintenance Treatment Phase||0
8929804|NCT02291289|9991222|FG010|Dosed|Maintenance Treatment Phase||64
8929805|NCT02291289|9991223|FG011|Dosed|Maintenance Treatment Phase||34
8929806|NCT02291289|9991212|FG000|COMPLETED|Maintenance Treatment Phase||0
8929807|NCT02291289|9991213|FG001|COMPLETED|Maintenance Treatment Phase||16
8929808|NCT02291289|9991214|FG002|COMPLETED|Maintenance Treatment Phase||4
8929809|NCT02291289|9991215|FG003|COMPLETED|Maintenance Treatment Phase||0
8929810|NCT02291289|9991216|FG004|COMPLETED|Maintenance Treatment Phase||45
8929811|NCT02291289|9991217|FG005|COMPLETED|Maintenance Treatment Phase||19
8929812|NCT02291289|9991218|FG006|COMPLETED|Maintenance Treatment Phase||0
8929813|NCT02291289|9991219|FG007|COMPLETED|Maintenance Treatment Phase||1
8929814|NCT02291289|9991220|FG008|COMPLETED|Maintenance Treatment Phase||0
8929815|NCT02291289|9991221|FG009|COMPLETED|Maintenance Treatment Phase||0
8929816|NCT02291289|9991222|FG010|COMPLETED|Maintenance Treatment Phase||34
8929817|NCT02291289|9991223|FG011|COMPLETED|Maintenance Treatment Phase||18
8929818|NCT02291289|9991212|FG000|NOT COMPLETED|Maintenance Treatment Phase||0
8929819|NCT02291289|9991213|FG001|NOT COMPLETED|Maintenance Treatment Phase||24
8929820|NCT02291289|9991214|FG002|NOT COMPLETED|Maintenance Treatment Phase||16
8929821|NCT02291289|9991215|FG003|NOT COMPLETED|Maintenance Treatment Phase||0
8929822|NCT02291289|9991216|FG004|NOT COMPLETED|Maintenance Treatment Phase||252
8929823|NCT02291289|9991217|FG005|NOT COMPLETED|Maintenance Treatment Phase||129
8929824|NCT02291289|9991218|FG006|NOT COMPLETED|Maintenance Treatment Phase||0
8929825|NCT02291289|9991219|FG007|NOT COMPLETED|Maintenance Treatment Phase||2
8929826|NCT02291289|9991220|FG008|NOT COMPLETED|Maintenance Treatment Phase||2
8929827|NCT02291289|9991221|FG009|NOT COMPLETED|Maintenance Treatment Phase||0
8929828|NCT02291289|9991222|FG010|NOT COMPLETED|Maintenance Treatment Phase||31
8929829|NCT02291289|9991223|FG011|NOT COMPLETED|Maintenance Treatment Phase||16
8929830|NCT02291302|9991252|FG000|STARTED|Overall Study||59
8929831|NCT02291302|9991253|FG001|STARTED|Overall Study||59
8929832|NCT02291302|9991254|FG002|STARTED|Overall Study||59
8929833|NCT02291302|9991255|FG003|STARTED|Overall Study||59
8813440|NCT01525849|9866659|FG001|Treated|Overall Study|14 withdrew before treatment: 8 didn't want FESS, 1 too busy, 2 medical issues, 3 excl. criteria.|61
8813441|NCT01525849|9866658|FG000|6-Months|Overall Study||73
8813442|NCT01525849|9866659|FG001|6-Months|Overall Study||60
8813443|NCT01525849|9866658|FG000|COMPLETED|Overall Study||71
8813444|NCT01525849|9866659|FG001|COMPLETED|Overall Study||59
8813445|NCT01525849|9866658|FG000|NOT COMPLETED|Overall Study||5
8813446|NCT01525849|9866659|FG001|NOT COMPLETED|Overall Study||16
8813447|NCT01525862|9866665|FG000|STARTED|Overall Study||21
8813448|NCT01525862|9866665|FG000|COMPLETED|Overall Study||21
8813449|NCT01525862|9866665|FG000|NOT COMPLETED|Overall Study||0
8813450|NCT01525875|9866671|FG000|STARTED|Placebo-controlled Period||22
8813451|NCT01525875|9866672|FG001|STARTED|Placebo-controlled Period||22
8813452|NCT01525875|9866671|FG000|COMPLETED|Placebo-controlled Period||21
8813453|NCT01525875|9866672|FG001|COMPLETED|Placebo-controlled Period||20
8813454|NCT01525875|9866671|FG000|NOT COMPLETED|Placebo-controlled Period||1
8813455|NCT01525875|9866672|FG001|NOT COMPLETED|Placebo-controlled Period||2
8813456|NCT01525875|9866671|FG000|STARTED|Open-label Period||21
8813457|NCT01525875|9866672|FG001|STARTED|Open-label Period||20
8813458|NCT01525875|9866671|FG000|COMPLETED|Open-label Period||21
8813459|NCT01525875|9866672|FG001|COMPLETED|Open-label Period||18
8813460|NCT01525875|9866671|FG000|NOT COMPLETED|Open-label Period||0
8813461|NCT01525875|9866672|FG001|NOT COMPLETED|Open-label Period||2
8813462|NCT01526057|9866681|FG000|STARTED|Overall Study||73
8813463|NCT01526057|9866682|FG001|STARTED|Overall Study||74
8813464|NCT01526057|9866683|FG002|STARTED|Overall Study||73
8929834|NCT02291302|9991252|FG000|COMPLETED|Overall Study||59
8929835|NCT02291302|9991253|FG001|COMPLETED|Overall Study||59
8929836|NCT02291302|9991254|FG002|COMPLETED|Overall Study||59
8813465|NCT01526057|9866681|FG000|COMPLETED|Overall Study||64
8813466|NCT01526057|9866682|FG001|COMPLETED|Overall Study||71
8929837|NCT02291302|9991255|FG003|COMPLETED|Overall Study||59
8929838|NCT02291302|9991252|FG000|NOT COMPLETED|Overall Study||0
8929839|NCT02291302|9991253|FG001|NOT COMPLETED|Overall Study||0
8929840|NCT02291302|9991254|FG002|NOT COMPLETED|Overall Study||0
8929841|NCT02291302|9991255|FG003|NOT COMPLETED|Overall Study||0
8929842|NCT02291419|9991267|FG000|STARTED|Overall Study||1
8929843|NCT02291419|9991268|FG001|STARTED|Overall Study||5
8929844|NCT02291419|9991267|FG000|COMPLETED|Overall Study||0
8929845|NCT02291419|9991268|FG001|COMPLETED|Overall Study||0
8929846|NCT02291419|9991267|FG000|NOT COMPLETED|Overall Study||1
8929847|NCT02291419|9991268|FG001|NOT COMPLETED|Overall Study||5
8929848|NCT02291432|9991274|FG000|STARTED|Overall Study||25
8929849|NCT02291432|9991274|FG000|Muscle Biopsy|Overall Study||25
8929850|NCT02291432|9991274|FG000|AMDC Injection|Overall Study||23
8929851|NCT02291432|9991274|FG000|1-Month Follow Up|Overall Study||23
8929852|NCT02291432|9991274|FG000|3-Month Follow Up|Overall Study||23
8929853|NCT02291432|9991274|FG000|6-Month Follow Up|Overall Study||23
8929854|NCT02291432|9991274|FG000|12-Month Follow Up|Overall Study||23
8929855|NCT02291432|9991274|FG000|COMPLETED|Overall Study||23
8929856|NCT02291432|9991274|FG000|NOT COMPLETED|Overall Study||2
8929857|NCT02291510|9991282|FG000|STARTED|Overall Study||5
8929858|NCT02291510|9991283|FG001|STARTED|Overall Study||5
8929859|NCT02291510|9991284|FG002|STARTED|Overall Study||5
8929860|NCT02291510|9991285|FG003|STARTED|Overall Study||5
8929861|NCT02291510|9991282|FG000|Completed Treatment A|Overall Study||5
8929862|NCT02291510|9991283|FG001|Completed Treatment A|Overall Study||5
8929863|NCT02291510|9991284|FG002|Completed Treatment A|Overall Study||5
8929864|NCT02291510|9991285|FG003|Completed Treatment A|Overall Study||5
8929865|NCT02291510|9991282|FG000|Completed Treatment B|Overall Study||5
8929866|NCT02291510|9991283|FG001|Completed Treatment B|Overall Study||5
8929867|NCT02291510|9991284|FG002|Completed Treatment B|Overall Study||5
8929868|NCT02291510|9991285|FG003|Completed Treatment B|Overall Study||4
9064626|NCT04276207|10124992|FG000|Received at Least One Dose of Study Drug|Period 1||15
9064627|NCT04276207|10124993|FG001|Received at Least One Dose of Study Drug|Period 1||17
9064628|NCT04276207|10124992|FG000|COMPLETED|Period 1||15
9064629|NCT04276207|10124993|FG001|COMPLETED|Period 1||16
9064630|NCT04276207|10124992|FG000|NOT COMPLETED|Period 1||0
9064631|NCT04276207|10124993|FG001|NOT COMPLETED|Period 1||1
9064632|NCT04276207|10124992|FG000|STARTED|Washout (3- 14 Days)||15
9064633|NCT04276207|10124993|FG001|STARTED|Washout (3- 14 Days)||16
8617127|NCT00454987|9655337|FG001|STARTED|Year 1 (NCT00454987)||67
8617128|NCT00454987|9655338|FG002|STARTED|Year 1 (NCT00454987)||0
8617129|NCT00454987|9655336|FG000|COMPLETED|Year 1 (NCT00454987)||221
8617130|NCT00454987|9655337|FG001|COMPLETED|Year 1 (NCT00454987)||67
8617131|NCT00454987|9655338|FG002|COMPLETED|Year 1 (NCT00454987)||0
9064634|NCT04276207|10124992|FG000|COMPLETED|Washout (3- 14 Days)||15
9064635|NCT04276207|10124993|FG001|COMPLETED|Washout (3- 14 Days)||16
9064636|NCT04276207|10124992|FG000|NOT COMPLETED|Washout (3- 14 Days)||0
9064637|NCT04276207|10124993|FG001|NOT COMPLETED|Washout (3- 14 Days)||0
9064638|NCT04276207|10124992|FG000|STARTED|Period 2||15
9064639|NCT04276207|10124993|FG001|STARTED|Period 2||16
9064640|NCT04276207|10124992|FG000|COMPLETED|Period 2||15
9064641|NCT04276207|10124993|FG001|COMPLETED|Period 2||16
9064642|NCT04276207|10124992|FG000|NOT COMPLETED|Period 2||0
9064643|NCT04276207|10124993|FG001|NOT COMPLETED|Period 2||0
9064644|NCT04289714|10125002|FG000|STARTED|Overall Study||14
9064645|NCT04289714|10125003|FG001|STARTED|Overall Study||11
9064646|NCT04289714|10125004|FG002|STARTED|Overall Study||10
9064647|NCT04289714|10125002|FG000|COMPLETED|Overall Study||8
9064648|NCT04289714|10125003|FG001|COMPLETED|Overall Study||6
9064649|NCT04289714|10125004|FG002|COMPLETED|Overall Study||4
9064650|NCT04289714|10125002|FG000|NOT COMPLETED|Overall Study||6
8929869|NCT02291510|9991282|FG000|Completed Treatment C|Overall Study||5
8929870|NCT02291510|9991283|FG001|Completed Treatment C|Overall Study||5
9064651|NCT04289714|10125003|FG001|NOT COMPLETED|Overall Study||5
9064652|NCT04289714|10125004|FG002|NOT COMPLETED|Overall Study||6
8617132|NCT00454987|9655336|FG000|NOT COMPLETED|Year 1 (NCT00454987)||0
8929871|NCT02291510|9991284|FG002|Completed Treatment C|Overall Study||5
8929872|NCT02291510|9991285|FG003|Completed Treatment C|Overall Study||4
8929873|NCT02291510|9991282|FG000|Completed Treatment D|Overall Study||5
8929874|NCT02291510|9991283|FG001|Completed Treatment D|Overall Study||5
8929875|NCT02291510|9991284|FG002|Completed Treatment D|Overall Study||5
8929876|NCT02291510|9991285|FG003|Completed Treatment D|Overall Study||5
8929877|NCT02291510|9991282|FG000|COMPLETED|Overall Study||5
8929878|NCT02291510|9991283|FG001|COMPLETED|Overall Study||5
8929879|NCT02291510|9991284|FG002|COMPLETED|Overall Study||5
8929880|NCT02291510|9991285|FG003|COMPLETED|Overall Study||4
8929881|NCT02291510|9991282|FG000|NOT COMPLETED|Overall Study||0
8929882|NCT02291510|9991283|FG001|NOT COMPLETED|Overall Study||0
8929883|NCT02291510|9991284|FG002|NOT COMPLETED|Overall Study||0
8929884|NCT02291510|9991285|FG003|NOT COMPLETED|Overall Study||1
8929885|NCT02291549|9991297|FG000|STARTED|Overall Study||201
8929886|NCT02291549|9991298|FG001|STARTED|Overall Study||99
8717795|NCT00996372|9765063|FG000|NOT COMPLETED|Overall Study||103
8717796|NCT00996372|9765064|FG001|NOT COMPLETED|Overall Study||84
8717797|NCT00996437|9765074|FG000|STARTED|Overall Study||125
8717798|NCT00996437|9765075|FG001|STARTED|Overall Study||136
8717799|NCT00996437|9765074|FG000|COMPLETED|Overall Study||120
8717800|NCT00996437|9765075|FG001|COMPLETED|Overall Study||129
8717801|NCT00996437|9765074|FG000|NOT COMPLETED|Overall Study||5
8717802|NCT00996437|9765075|FG001|NOT COMPLETED|Overall Study||7
8717803|NCT00996476|9765086|FG000|STARTED|Overall Study||27
8717804|NCT00996476|9765087|FG001|STARTED|Overall Study||26
8717805|NCT00996476|9765088|FG002|STARTED|Overall Study||13
8717806|NCT00996476|9765089|FG003|STARTED|Overall Study||13
8929887|NCT02291549|9991297|FG000|COMPLETED|Overall Study||200
8929888|NCT02291549|9991298|FG001|COMPLETED|Overall Study||98
8929889|NCT02291549|9991297|FG000|NOT COMPLETED|Overall Study||1
8929890|NCT02291549|9991298|FG001|NOT COMPLETED|Overall Study||1
8929891|NCT02291601|9991306|FG000|STARTED|Abdomen||638
8929892|NCT02291601|9991307|FG001|STARTED|Abdomen||108
8617133|NCT00454987|9655337|FG001|NOT COMPLETED|Year 1 (NCT00454987)||0
8617134|NCT00454987|9655338|FG002|NOT COMPLETED|Year 1 (NCT00454987)||0
8617135|NCT00454987|9655336|FG000|STARTED|Year 2 (NCT00454987)||235
8617136|NCT00454987|9655337|FG001|STARTED|Year 2 (NCT00454987)||77
8617137|NCT00454987|9655338|FG002|STARTED|Year 2 (NCT00454987)||74
8617138|NCT00454987|9655336|FG000|COMPLETED|Year 2 (NCT00454987)||235
8617139|NCT00454987|9655337|FG001|COMPLETED|Year 2 (NCT00454987)||77
8617140|NCT00454987|9655338|FG002|COMPLETED|Year 2 (NCT00454987)||74
8717807|NCT00996476|9765090|FG004|STARTED|Overall Study||13
8717808|NCT00996476|9765086|FG000|COMPLETED|Overall Study||26
8717809|NCT00996476|9765087|FG001|COMPLETED|Overall Study||23
8717810|NCT00996476|9765088|FG002|COMPLETED|Overall Study||12
8929893|NCT02291601|9991308|FG002|STARTED|Abdomen||642
8929894|NCT02291601|9991306|FG000|COMPLETED|Abdomen|638 participants received CHG cloth|305
8929895|NCT02291601|9991307|FG001|COMPLETED|Abdomen|108 participants received vehicle|54
8929896|NCT02291601|9991308|FG002|COMPLETED|Abdomen|642 participants received comparator CHG|303
8929897|NCT02291601|9991306|FG000|NOT COMPLETED|Abdomen||333
8617141|NCT00454987|9655336|FG000|NOT COMPLETED|Year 2 (NCT00454987)||0
8617142|NCT00454987|9655337|FG001|NOT COMPLETED|Year 2 (NCT00454987)||0
8617143|NCT00454987|9655338|FG002|NOT COMPLETED|Year 2 (NCT00454987)||0
8617144|NCT00454987|9655336|FG000|STARTED|Year 4 (NCT00454987)||206
8617145|NCT00454987|9655337|FG001|STARTED|Year 4 (NCT00454987)||62
8717811|NCT00996476|9765089|FG003|COMPLETED|Overall Study||13
8717812|NCT00996476|9765090|FG004|COMPLETED|Overall Study||11
8717813|NCT00996476|9765086|FG000|NOT COMPLETED|Overall Study||1
8717814|NCT00996476|9765087|FG001|NOT COMPLETED|Overall Study||3
8717815|NCT00996476|9765088|FG002|NOT COMPLETED|Overall Study||1
8929898|NCT02291601|9991307|FG001|NOT COMPLETED|Abdomen||54
8929899|NCT02291601|9991308|FG002|NOT COMPLETED|Abdomen||339
8929900|NCT02291601|9991306|FG000|STARTED|Groin||520
8929901|NCT02291601|9991307|FG001|STARTED|Groin||93
8929902|NCT02291601|9991308|FG002|STARTED|Groin||515
8929903|NCT02291601|9991306|FG000|COMPLETED|Groin|520 participants received CHG cloth|337
8929904|NCT02291601|9991307|FG001|COMPLETED|Groin|93 participants received vehicle|63
8929905|NCT02291601|9991308|FG002|COMPLETED|Groin|515 participants received Comparator CHG|338
8929906|NCT02291601|9991306|FG000|NOT COMPLETED|Groin||183
8929907|NCT02291601|9991307|FG001|NOT COMPLETED|Groin||30
8929908|NCT02291601|9991308|FG002|NOT COMPLETED|Groin||177
8929909|NCT02291614|9991330|FG000|STARTED|Overall Study||3
8929910|NCT02291614|9991331|FG001|STARTED|Overall Study||3
8929911|NCT02291614|9991332|FG002|STARTED|Overall Study||3
8929912|NCT02291614|9991333|FG003|STARTED|Overall Study||5
8929913|NCT02291614|9991334|FG004|STARTED|Overall Study||3
8929914|NCT02291614|9991335|FG005|STARTED|Overall Study||3
8929915|NCT02291614|9991336|FG006|STARTED|Overall Study||6
8929916|NCT02291614|9991337|FG007|STARTED|Overall Study||3
8929917|NCT02291614|9991338|FG008|STARTED|Overall Study||3
8929918|NCT02291614|9991339|FG009|STARTED|Overall Study||11
8929919|NCT02291614|9991340|FG010|STARTED|Overall Study||2
8929920|NCT02291614|9991330|FG000|Received AMG 211|Overall Study||3
8929921|NCT02291614|9991331|FG001|Received AMG 211|Overall Study||3
8813467|NCT01526057|9866683|FG002|COMPLETED|Overall Study||67
8813468|NCT01526057|9866681|FG000|NOT COMPLETED|Overall Study||9
8813469|NCT01526057|9866682|FG001|NOT COMPLETED|Overall Study||3
8813470|NCT01526057|9866683|FG002|NOT COMPLETED|Overall Study||6
8813471|NCT01526148|9866693|FG000|STARTED|Overall Study||18
8813472|NCT01526148|9866694|FG001|STARTED|Overall Study||24
8813473|NCT01526148|9866693|FG000|COMPLETED|Overall Study||4
8813474|NCT01526148|9866694|FG001|COMPLETED|Overall Study||11
8813475|NCT01526148|9866693|FG000|NOT COMPLETED|Overall Study||14
8813476|NCT01526148|9866694|FG001|NOT COMPLETED|Overall Study||13
8813477|NCT01526213|9866706|FG000|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
8813478|NCT01526213|9866707|FG001|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
8813479|NCT01526213|9866708|FG002|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
8813480|NCT01526213|9866709|FG003|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
8813481|NCT01526213|9866710|FG004|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
8813482|NCT01526213|9866711|FG005|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to (and completed) one of six sequences.|3
8813483|NCT01526213|9866706|FG000|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
8813484|NCT01526213|9866707|FG001|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
8813485|NCT01526213|9866708|FG002|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
8813486|NCT01526213|9866709|FG003|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
8813487|NCT01526213|9866710|FG004|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
8813488|NCT01526213|9866711|FG005|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
8813489|NCT01526213|9866706|FG000|NOT COMPLETED|Period 1 (5 Days)||0
8813490|NCT01526213|9866707|FG001|NOT COMPLETED|Period 1 (5 Days)||0
8813491|NCT01526213|9866708|FG002|NOT COMPLETED|Period 1 (5 Days)||0
8813492|NCT01526213|9866709|FG003|NOT COMPLETED|Period 1 (5 Days)||0
8813493|NCT01526213|9866710|FG004|NOT COMPLETED|Period 1 (5 Days)||0
8813494|NCT01526213|9866711|FG005|NOT COMPLETED|Period 1 (5 Days)||0
8813495|NCT01526213|9866706|FG000|STARTED|Washout 1 (10 Days)||3
8813496|NCT01526213|9866707|FG001|STARTED|Washout 1 (10 Days)||3
8813497|NCT01526213|9866708|FG002|STARTED|Washout 1 (10 Days)||3
8813498|NCT01526213|9866709|FG003|STARTED|Washout 1 (10 Days)||3
8813499|NCT01526213|9866710|FG004|STARTED|Washout 1 (10 Days)||3
8813500|NCT01526213|9866711|FG005|STARTED|Washout 1 (10 Days)||3
8813501|NCT01526213|9866706|FG000|COMPLETED|Washout 1 (10 Days)||3
8813502|NCT01526213|9866707|FG001|COMPLETED|Washout 1 (10 Days)||3
8813503|NCT01526213|9866708|FG002|COMPLETED|Washout 1 (10 Days)||3
8813504|NCT01526213|9866709|FG003|COMPLETED|Washout 1 (10 Days)||3
8813505|NCT01526213|9866710|FG004|COMPLETED|Washout 1 (10 Days)||3
8813506|NCT01526213|9866711|FG005|COMPLETED|Washout 1 (10 Days)||3
8813507|NCT01526213|9866706|FG000|NOT COMPLETED|Washout 1 (10 Days)||0
8813508|NCT01526213|9866707|FG001|NOT COMPLETED|Washout 1 (10 Days)||0
8813509|NCT01526213|9866708|FG002|NOT COMPLETED|Washout 1 (10 Days)||0
8813510|NCT01526213|9866709|FG003|NOT COMPLETED|Washout 1 (10 Days)||0
8813511|NCT01526213|9866710|FG004|NOT COMPLETED|Washout 1 (10 Days)||0
8813512|NCT01526213|9866711|FG005|NOT COMPLETED|Washout 1 (10 Days)||0
8813513|NCT01526213|9866706|FG000|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
8813514|NCT01526213|9866707|FG001|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
8813515|NCT01526213|9866708|FG002|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
8813516|NCT01526213|9866709|FG003|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
8813517|NCT01526213|9866710|FG004|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
8813518|NCT01526213|9866711|FG005|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
8929922|NCT02291614|9991332|FG002|Received AMG 211|Overall Study||3
8929923|NCT02291614|9991333|FG003|Received AMG 211|Overall Study||5
8929924|NCT02291614|9991334|FG004|Received AMG 211|Overall Study||3
8929925|NCT02291614|9991335|FG005|Received AMG 211|Overall Study||3
8929926|NCT02291614|9991336|FG006|Received AMG 211|Overall Study||6
8929927|NCT02291614|9991337|FG007|Received AMG 211|Overall Study||3
8929928|NCT02291614|9991338|FG008|Received AMG 211|Overall Study||3
8929929|NCT02291614|9991339|FG009|Received AMG 211|Overall Study||10
8929930|NCT02291614|9991340|FG010|Received AMG 211|Overall Study||2
8929931|NCT02291614|9991330|FG000|COMPLETED|Overall Study||3
8929932|NCT02291614|9991331|FG001|COMPLETED|Overall Study||2
8929933|NCT02291614|9991332|FG002|COMPLETED|Overall Study||2
8929934|NCT02291614|9991333|FG003|COMPLETED|Overall Study||4
8929935|NCT02291614|9991334|FG004|COMPLETED|Overall Study||2
8929936|NCT02291614|9991335|FG005|COMPLETED|Overall Study||2
8929937|NCT02291614|9991336|FG006|COMPLETED|Overall Study||5
8929938|NCT02291614|9991337|FG007|COMPLETED|Overall Study||2
8929939|NCT02291614|9991338|FG008|COMPLETED|Overall Study||3
8929940|NCT02291614|9991339|FG009|COMPLETED|Overall Study||9
8929941|NCT02291614|9991340|FG010|COMPLETED|Overall Study||0
8929942|NCT02291614|9991330|FG000|NOT COMPLETED|Overall Study||0
8929943|NCT02291614|9991331|FG001|NOT COMPLETED|Overall Study||1
8929944|NCT02291614|9991332|FG002|NOT COMPLETED|Overall Study||1
8929945|NCT02291614|9991333|FG003|NOT COMPLETED|Overall Study||1
8929946|NCT02291614|9991334|FG004|NOT COMPLETED|Overall Study||1
8929947|NCT02291614|9991335|FG005|NOT COMPLETED|Overall Study||1
8929948|NCT02291614|9991336|FG006|NOT COMPLETED|Overall Study||1
8929949|NCT02291614|9991337|FG007|NOT COMPLETED|Overall Study||1
8929950|NCT02291614|9991338|FG008|NOT COMPLETED|Overall Study||0
8929951|NCT02291614|9991339|FG009|NOT COMPLETED|Overall Study||2
8929952|NCT02291614|9991340|FG010|NOT COMPLETED|Overall Study||2
8929953|NCT02291679|9991373|FG000|STARTED|Overall Study||401
8929954|NCT02291679|9991374|FG001|STARTED|Overall Study||411
8929955|NCT02291679|9991375|FG002|STARTED|Overall Study||411
8929956|NCT02291679|9991373|FG000|COMPLETED|Overall Study||357
8929957|NCT02291679|9991374|FG001|COMPLETED|Overall Study||369
8929958|NCT02291679|9991375|FG002|COMPLETED|Overall Study||352
8929959|NCT02291679|9991373|FG000|NOT COMPLETED|Overall Study||44
8929960|NCT02291679|9991374|FG001|NOT COMPLETED|Overall Study||42
8929961|NCT02291679|9991375|FG002|NOT COMPLETED|Overall Study||59
8929962|NCT02291718|9991385|FG000|STARTED|Overall Study||50
8929963|NCT02291718|9991386|FG001|STARTED|Overall Study||50
8929964|NCT02291718|9991387|FG002|STARTED|Overall Study||50
8929965|NCT02291718|9991385|FG000|COMPLETED|Overall Study||50
8929966|NCT02291718|9991386|FG001|COMPLETED|Overall Study||50
8929967|NCT02291718|9991387|FG002|COMPLETED|Overall Study||50
8929968|NCT02291718|9991385|FG000|NOT COMPLETED|Overall Study||0
8929969|NCT02291718|9991386|FG001|NOT COMPLETED|Overall Study||0
8929970|NCT02291718|9991387|FG002|NOT COMPLETED|Overall Study||0
8929971|NCT02291861|9991399|FG000|STARTED|Overall Study||74
8929972|NCT02291861|9991400|FG001|STARTED|Overall Study||75
8929973|NCT02291861|9991401|FG002|STARTED|Overall Study||74
8929974|NCT02291861|9991402|FG003|STARTED|Overall Study||75
8929975|NCT02291861|9991399|FG000|Safety Population|Overall Study||72
8929976|NCT02291861|9991400|FG001|Safety Population|Overall Study||74
8929977|NCT02291861|9991401|FG002|Safety Population|Overall Study||73
8929978|NCT02291861|9991402|FG003|Safety Population|Overall Study||74
8929979|NCT02291861|9991399|FG000|Modified Intent to Treat Pop (mITT)|Overall Study||58
8929980|NCT02291861|9991400|FG001|Modified Intent to Treat Pop (mITT)|Overall Study||60
8929981|NCT02291861|9991401|FG002|Modified Intent to Treat Pop (mITT)|Overall Study||49
8929982|NCT02291861|9991402|FG003|Modified Intent to Treat Pop (mITT)|Overall Study||55
8929983|NCT02291861|9991399|FG000|COMPLETED|Overall Study||67
8929984|NCT02291861|9991400|FG001|COMPLETED|Overall Study||67
8929985|NCT02291861|9991401|FG002|COMPLETED|Overall Study||65
8929986|NCT02291861|9991402|FG003|COMPLETED|Overall Study||65
8929987|NCT02291861|9991399|FG000|NOT COMPLETED|Overall Study||7
8929988|NCT02291861|9991400|FG001|NOT COMPLETED|Overall Study||8
8929989|NCT02291861|9991401|FG002|NOT COMPLETED|Overall Study||9
8929990|NCT02291861|9991402|FG003|NOT COMPLETED|Overall Study||10
8929991|NCT02291913|9991412|FG000|STARTED|Overall Study||48
8929992|NCT02291913|9991412|FG000|COMPLETED|Overall Study||0
8929993|NCT02291913|9991412|FG000|NOT COMPLETED|Overall Study||48
8929994|NCT02292082|9991418|FG000|STARTED|Overall Study||56
8929995|NCT02292082|9991419|FG001|STARTED|Overall Study||55
8929996|NCT02292082|9991418|FG000|COMPLETED|Overall Study||56
8929997|NCT02292082|9991419|FG001|COMPLETED|Overall Study||55
8929998|NCT02292082|9991418|FG000|NOT COMPLETED|Overall Study||0
8929999|NCT02292082|9991419|FG001|NOT COMPLETED|Overall Study||0
8930000|NCT02292186|9991425|FG000|STARTED|Overall Study||25
8930001|NCT02292186|9991425|FG000|COMPLETED|Overall Study||7
8930002|NCT02292186|9991425|FG000|NOT COMPLETED|Overall Study||18
8930003|NCT02292212|9991429|FG000|STARTED|Pre-ViE Phase||17
8930004|NCT02292212|9991429|FG000|COMPLETED|Pre-ViE Phase||17
8930005|NCT02292212|9991429|FG000|NOT COMPLETED|Pre-ViE Phase||0
8930006|NCT02292212|9991429|FG000|STARTED|ViE Phase||17
8930007|NCT02292212|9991429|FG000|COMPLETED|ViE Phase||14
8930008|NCT02292212|9991429|FG000|NOT COMPLETED|ViE Phase||3
8930009|NCT02292212|9991429|FG000|STARTED|Post-ViE Phase||14
8930010|NCT02292212|9991429|FG000|COMPLETED|Post-ViE Phase||14
8930011|NCT02292212|9991429|FG000|NOT COMPLETED|Post-ViE Phase||0
8930012|NCT02292433|9991443|FG000|STARTED|First Intervention Period (7 Days)||4
8930013|NCT02292433|9991444|FG001|STARTED|First Intervention Period (7 Days)||4
8930014|NCT02292433|9991445|FG002|STARTED|First Intervention Period (7 Days)||4
8930015|NCT02292433|9991443|FG000|COMPLETED|First Intervention Period (7 Days)||4
8930016|NCT02292433|9991444|FG001|COMPLETED|First Intervention Period (7 Days)||4
8930017|NCT02292433|9991445|FG002|COMPLETED|First Intervention Period (7 Days)||4
8930018|NCT02292433|9991443|FG000|NOT COMPLETED|First Intervention Period (7 Days)||0
8930019|NCT02292433|9991444|FG001|NOT COMPLETED|First Intervention Period (7 Days)||0
8930020|NCT02292433|9991445|FG002|NOT COMPLETED|First Intervention Period (7 Days)||0
8930021|NCT02292433|9991443|FG000|STARTED|First Washout Period (7 to 14 Days)||4
8930022|NCT02292433|9991444|FG001|STARTED|First Washout Period (7 to 14 Days)||4
8930023|NCT02292433|9991445|FG002|STARTED|First Washout Period (7 to 14 Days)||4
8930024|NCT02292433|9991443|FG000|COMPLETED|First Washout Period (7 to 14 Days)||4
8930025|NCT02292433|9991444|FG001|COMPLETED|First Washout Period (7 to 14 Days)||4
8930026|NCT02292433|9991445|FG002|COMPLETED|First Washout Period (7 to 14 Days)||4
8930027|NCT02292433|9991443|FG000|NOT COMPLETED|First Washout Period (7 to 14 Days)||0
8930028|NCT02292433|9991444|FG001|NOT COMPLETED|First Washout Period (7 to 14 Days)||0
8930029|NCT02292433|9991445|FG002|NOT COMPLETED|First Washout Period (7 to 14 Days)||0
8930030|NCT02292433|9991443|FG000|STARTED|Second Intervention Period (7 Days)||4
8930031|NCT02292433|9991444|FG001|STARTED|Second Intervention Period (7 Days)||4
8930032|NCT02292433|9991445|FG002|STARTED|Second Intervention Period (7 Days)||4
8930033|NCT02292433|9991443|FG000|COMPLETED|Second Intervention Period (7 Days)||4
8930034|NCT02292433|9991444|FG001|COMPLETED|Second Intervention Period (7 Days)||4
8930035|NCT02292433|9991445|FG002|COMPLETED|Second Intervention Period (7 Days)||4
8930036|NCT02292433|9991443|FG000|NOT COMPLETED|Second Intervention Period (7 Days)||0
8930037|NCT02292433|9991444|FG001|NOT COMPLETED|Second Intervention Period (7 Days)||0
8930038|NCT02292433|9991445|FG002|NOT COMPLETED|Second Intervention Period (7 Days)||0
8930039|NCT02292433|9991443|FG000|STARTED|Second Washout Period (7 to 14 Days)||4
8930040|NCT02292433|9991444|FG001|STARTED|Second Washout Period (7 to 14 Days)||4
8930041|NCT02292433|9991445|FG002|STARTED|Second Washout Period (7 to 14 Days)||4
8930042|NCT02292433|9991443|FG000|COMPLETED|Second Washout Period (7 to 14 Days)||4
8930043|NCT02292433|9991444|FG001|COMPLETED|Second Washout Period (7 to 14 Days)||4
8930044|NCT02292433|9991445|FG002|COMPLETED|Second Washout Period (7 to 14 Days)||4
8930045|NCT02292433|9991443|FG000|NOT COMPLETED|Second Washout Period (7 to 14 Days)||0
8930046|NCT02292433|9991444|FG001|NOT COMPLETED|Second Washout Period (7 to 14 Days)||0
8930047|NCT02292433|9991445|FG002|NOT COMPLETED|Second Washout Period (7 to 14 Days)||0
8930048|NCT02292433|9991443|FG000|STARTED|Third Intervention Period (7 Days)||4
8930049|NCT02292433|9991444|FG001|STARTED|Third Intervention Period (7 Days)||4
8930050|NCT02292433|9991445|FG002|STARTED|Third Intervention Period (7 Days)||4
8930051|NCT02292433|9991443|FG000|COMPLETED|Third Intervention Period (7 Days)||4
8930052|NCT02292433|9991444|FG001|COMPLETED|Third Intervention Period (7 Days)||4
8930053|NCT02292433|9991445|FG002|COMPLETED|Third Intervention Period (7 Days)||4
8930054|NCT02292433|9991443|FG000|NOT COMPLETED|Third Intervention Period (7 Days)||0
8930055|NCT02292433|9991444|FG001|NOT COMPLETED|Third Intervention Period (7 Days)||0
8930056|NCT02292433|9991445|FG002|NOT COMPLETED|Third Intervention Period (7 Days)||0
8930057|NCT02292446|9991453|FG000|STARTED|Overall Study||161
8930058|NCT02292446|9991453|FG000|COMPLETED|Overall Study||141
8930059|NCT02292446|9991453|FG000|NOT COMPLETED|Overall Study||20
8930060|NCT02292537|9991462|FG000|STARTED|Overall Study||42
8930061|NCT02292537|9991463|FG001|STARTED|Overall Study||84
8930062|NCT02292537|9991462|FG000|Completed Treatment|Overall Study||42
8930063|NCT02292537|9991463|FG001|Completed Treatment|Overall Study|1 participant completed the study but did not complete treatments due to early study closure|83
8930064|NCT02292537|9991462|FG000|COMPLETED|Overall Study||42
8930065|NCT02292537|9991463|FG001|COMPLETED|Overall Study||84
8930066|NCT02292537|9991462|FG000|NOT COMPLETED|Overall Study||0
8930067|NCT02292537|9991463|FG001|NOT COMPLETED|Overall Study||0
8930068|NCT02292719|9991475|FG000|STARTED|Overall Study||9
8930069|NCT02292719|9991476|FG001|STARTED|Overall Study||11
8930070|NCT02292719|9991477|FG002|STARTED|Overall Study||10
8930071|NCT02292719|9991478|FG003|STARTED|Overall Study||9
8930072|NCT02292719|9991479|FG004|STARTED|Overall Study||21
8930073|NCT02292719|9991480|FG005|STARTED|Overall Study||10
8930074|NCT02292719|9991475|FG000|COMPLETED|Overall Study||9
8930075|NCT02292719|9991476|FG001|COMPLETED|Overall Study||11
8930076|NCT02292719|9991477|FG002|COMPLETED|Overall Study||9
8930077|NCT02292719|9991478|FG003|COMPLETED|Overall Study||8
8930078|NCT02292719|9991479|FG004|COMPLETED|Overall Study||20
8930079|NCT02292719|9991480|FG005|COMPLETED|Overall Study||10
8930080|NCT02292719|9991475|FG000|NOT COMPLETED|Overall Study||0
8930081|NCT02292719|9991476|FG001|NOT COMPLETED|Overall Study||0
8930082|NCT02292719|9991477|FG002|NOT COMPLETED|Overall Study||1
8930083|NCT02292719|9991478|FG003|NOT COMPLETED|Overall Study||1
8930084|NCT02292719|9991479|FG004|NOT COMPLETED|Overall Study||1
8930085|NCT02292719|9991480|FG005|NOT COMPLETED|Overall Study||0
8930086|NCT02292771|9991496|FG000|STARTED|Overall Study||47
8930087|NCT02292771|9991497|FG001|STARTED|Overall Study||50
8930088|NCT02292771|9991496|FG000|COMPLETED|Overall Study||43
8930089|NCT02292771|9991497|FG001|COMPLETED|Overall Study||48
8930090|NCT02292771|9991496|FG000|NOT COMPLETED|Overall Study||4
8930091|NCT02292771|9991497|FG001|NOT COMPLETED|Overall Study||2
8930092|NCT02292784|9991510|FG000|STARTED|Overall Study||5
8930093|NCT02292784|9991511|FG001|STARTED|Overall Study||44
9064653|NCT04288752|10125014|FG000|STARTED|Overall Study|88 Participants were randomized to the VR101 group. However, one randomized participant (AR33) was unable to place the device and was immediately terminated from the study, prior to any post-randomization data collection. Therefore, 87 participants assigned to the VR101 group entered the treatment phase.|87
9064654|NCT04288752|10125015|FG001|STARTED|Overall Study||88
9064655|NCT04288752|10125014|FG000|COMPLETED|Overall Study||81
8717816|NCT00996476|9765089|FG003|NOT COMPLETED|Overall Study||0
8717817|NCT00996476|9765090|FG004|NOT COMPLETED|Overall Study||2
8717818|NCT00996489|9765107|FG000|STARTED|Overall Study||459
8717819|NCT00996489|9765107|FG000|COMPLETED|Overall Study||298
8717820|NCT00996489|9765107|FG000|NOT COMPLETED|Overall Study||161
8717821|NCT00996580|9765111|FG000|STARTED|Overall Study||3597
8717822|NCT00996580|9765111|FG000|Pregnancy Intent-to-Treat Population|Overall Study||3019
8717823|NCT00996580|9765111|FG000|COMPLETED|Overall Study||2144
8717824|NCT00996580|9765111|FG000|NOT COMPLETED|Overall Study||1453
8717825|NCT00996593|9765118|FG000|STARTED|Dosimetric and Therapeutic Treatment||43
8717826|NCT00996593|9765118|FG000|COMPLETED|Dosimetric and Therapeutic Treatment||0
8717827|NCT00996593|9765118|FG000|NOT COMPLETED|Dosimetric and Therapeutic Treatment||43
8717828|NCT00996593|9765118|FG000|STARTED|Long-Term Follow-Up|9 of the 40 participants withdrawing from Study BEX104507 enrolled in long-term follow-up study.|9
8717829|NCT00996593|9765118|FG000|COMPLETED|Long-Term Follow-Up||6
8717830|NCT00996593|9765118|FG000|NOT COMPLETED|Long-Term Follow-Up||3
8717831|NCT00996606|9765122|FG000|STARTED|Overall Study||58
8717832|NCT00996606|9765122|FG000|COMPLETED|Overall Study||50
8717833|NCT00996606|9765122|FG000|NOT COMPLETED|Overall Study||8
8717834|NCT00996632|9765128|FG000|STARTED|Overall Study||38
8717835|NCT00996632|9765129|FG001|STARTED|Overall Study||56
8717836|NCT00996632|9765128|FG000|COMPLETED|Overall Study||38
8617146|NCT00454987|9655338|FG002|STARTED|Year 4 (NCT00454987)||0
8617147|NCT00454987|9655336|FG000|COMPLETED|Year 4 (NCT00454987)||206
8617148|NCT00454987|9655337|FG001|COMPLETED|Year 4 (NCT00454987)||62
8617149|NCT00454987|9655338|FG002|COMPLETED|Year 4 (NCT00454987)||0
8717837|NCT00996632|9765129|FG001|COMPLETED|Overall Study||56
8717838|NCT00996632|9765128|FG000|NOT COMPLETED|Overall Study||0
8717839|NCT00996632|9765129|FG001|NOT COMPLETED|Overall Study||0
8717840|NCT00996658|9765137|FG000|STARTED|Overall Study||92
8717841|NCT00996658|9765138|FG001|STARTED|Overall Study||186
8717842|NCT00996658|9765137|FG000|COMPLETED|Overall Study||76
8717843|NCT00996658|9765138|FG001|COMPLETED|Overall Study||165
8717844|NCT00996658|9765137|FG000|NOT COMPLETED|Overall Study||16
8717845|NCT00996658|9765138|FG001|NOT COMPLETED|Overall Study||21
9064656|NCT04288752|10125015|FG001|COMPLETED|Overall Study||85
9064657|NCT04288752|10125014|FG000|NOT COMPLETED|Overall Study||6
9064658|NCT04288752|10125015|FG001|NOT COMPLETED|Overall Study||3
9064659|NCT04287517|10125023|FG000|STARTED|Overall Study||19
9064660|NCT04287517|10125024|FG001|STARTED|Overall Study||19
9064661|NCT04287517|10125023|FG000|COMPLETED|Overall Study||18
9064662|NCT04287517|10125024|FG001|COMPLETED|Overall Study||18
9064663|NCT04287517|10125023|FG000|NOT COMPLETED|Overall Study||1
9064664|NCT04287517|10125024|FG001|NOT COMPLETED|Overall Study||1
9064665|NCT04287036|10125030|FG000|STARTED|Period 1||13
9064666|NCT04287036|10125031|FG001|STARTED|Period 1||12
9064667|NCT04287036|10125030|FG000|COMPLETED|Period 1||13
9064668|NCT04287036|10125031|FG001|COMPLETED|Period 1||12
9064669|NCT04287036|10125030|FG000|NOT COMPLETED|Period 1||0
9064670|NCT04287036|10125031|FG001|NOT COMPLETED|Period 1||0
9064671|NCT04287036|10125030|FG000|STARTED|Period 2||13
9064672|NCT04287036|10125031|FG001|STARTED|Period 2||12
9064673|NCT04287036|10125030|FG000|COMPLETED|Period 2||13
9064674|NCT04287036|10125031|FG001|COMPLETED|Period 2||12
9064675|NCT04287036|10125030|FG000|NOT COMPLETED|Period 2||0
9064676|NCT04287036|10125031|FG001|NOT COMPLETED|Period 2||0
9064677|NCT04286412|10125037|FG000|STARTED|Overall Study||25
9064678|NCT04286412|10125037|FG000|COMPLETED|Overall Study||25
9064679|NCT04286412|10125037|FG000|NOT COMPLETED|Overall Study||0
9064680|NCT04285411|10125041|FG000|STARTED|Overall Study||10
9064681|NCT04285411|10125041|FG000|COMPLETED|Overall Study||10
9064682|NCT04285411|10125041|FG000|NOT COMPLETED|Overall Study||0
9064683|NCT04284930|10125049|FG000|STARTED|Overall Study||8
9064684|NCT04284930|10125050|FG001|STARTED|Overall Study||5
9064685|NCT04284930|10125051|FG002|STARTED|Overall Study||8
9064686|NCT04284930|10125049|FG000|COMPLETED|Overall Study||8
9064687|NCT04284930|10125050|FG001|COMPLETED|Overall Study||5
9064688|NCT04284930|10125051|FG002|COMPLETED|Overall Study||8
9064689|NCT04284930|10125049|FG000|NOT COMPLETED|Overall Study||0
9064690|NCT04284930|10125050|FG001|NOT COMPLETED|Overall Study||0
8617150|NCT00454987|9655336|FG000|NOT COMPLETED|Year 4 (NCT00454987)||0
8617151|NCT00454987|9655337|FG001|NOT COMPLETED|Year 4 (NCT00454987)||0
8617152|NCT00454987|9655338|FG002|NOT COMPLETED|Year 4 (NCT00454987)||0
8617153|NCT00455013|9655350|FG000|STARTED|Short Term Period|35 randomized, 33 transplanted and treated.|33
8617154|NCT00455013|9655351|FG001|STARTED|Short Term Period|27 randomized, 26 transplanted and treated.|26
8617155|NCT00455013|9655352|FG002|STARTED|Short Term Period|31 randomized, 30 transplanted and treated|30
8617156|NCT00455013|9655350|FG000|COMPLETED|Short Term Period|5 discontinued belatacept by Month 6 (1 more by Month 12), 2 switched from MMF to sirolimus.|27
8617157|NCT00455013|9655351|FG001|COMPLETED|Short Term Period|5 discontinued belatacept by Month 6; 10 additional switched from sirolimus to MMF.|21
8629398|NCT00529789|9669129|FG000|STARTED|Study Period II/III||72
8717846|NCT00996736|9765146|FG000|STARTED|Overall Study||162
9064691|NCT04284930|10125051|FG002|NOT COMPLETED|Overall Study||0
8930094|NCT02292784|9991512|FG002|STARTED|Overall Study||49
8930095|NCT02292784|9991510|FG000|COMPLETED|Overall Study||4
8930096|NCT02292784|9991511|FG001|COMPLETED|Overall Study||24
8930097|NCT02292784|9991512|FG002|COMPLETED|Overall Study||28
8930098|NCT02292784|9991510|FG000|NOT COMPLETED|Overall Study||1
8930099|NCT02292784|9991511|FG001|NOT COMPLETED|Overall Study||20
8617158|NCT00455013|9655352|FG002|COMPLETED|Short Term Period|1 discontinued tacrolimus by Month 6 and 2 discontinued by Month 12 (1 more by Month 12)|28
8617159|NCT00455013|9655350|FG000|NOT COMPLETED|Short Term Period||6
8617160|NCT00455013|9655351|FG001|NOT COMPLETED|Short Term Period||5
8617161|NCT00455013|9655352|FG002|NOT COMPLETED|Short Term Period||2
8930100|NCT02292784|9991512|FG002|NOT COMPLETED|Overall Study||21
8930101|NCT02292849|9991523|FG000|STARTED|Overall Study||11
8930102|NCT02292849|9991524|FG001|STARTED|Overall Study||8
8930103|NCT02292849|9991525|FG002|STARTED|Overall Study||10
8930104|NCT02292849|9991523|FG000|COMPLETED|Overall Study||7
8930105|NCT02292849|9991524|FG001|COMPLETED|Overall Study||6
8930106|NCT02292849|9991525|FG002|COMPLETED|Overall Study||8
8930107|NCT02292849|9991523|FG000|NOT COMPLETED|Overall Study||4
8930108|NCT02292849|9991524|FG001|NOT COMPLETED|Overall Study||2
8930109|NCT02292849|9991525|FG002|NOT COMPLETED|Overall Study||2
8930110|NCT02292927|9991535|FG000|STARTED|Overall Study||13
8930111|NCT02292927|9991536|FG001|STARTED|Overall Study||12
8930112|NCT02292927|9991535|FG000|COMPLETED|Overall Study||0
8930113|NCT02292927|9991536|FG001|COMPLETED|Overall Study||5
8930114|NCT02292927|9991535|FG000|NOT COMPLETED|Overall Study||13
8930115|NCT02292927|9991536|FG001|NOT COMPLETED|Overall Study||7
8930116|NCT02292940|9991547|FG000|STARTED|Overall Study||165477
8930117|NCT02292940|9991548|FG001|STARTED|Overall Study||3000
8930118|NCT02292940|9991547|FG000|COMPLETED|Overall Study||165477
8930119|NCT02292940|9991548|FG001|COMPLETED|Overall Study||1824
8930120|NCT02292940|9991547|FG000|NOT COMPLETED|Overall Study||0
8930121|NCT02292940|9991548|FG001|NOT COMPLETED|Overall Study||1176
8930122|NCT02293044|9991555|FG000|STARTED|Overall Study||15
8930123|NCT02293044|9991555|FG000|COMPLETED|Overall Study||15
8930124|NCT02293044|9991555|FG000|NOT COMPLETED|Overall Study||0
8930125|NCT02293096|9991559|FG000|STARTED|Overall Study||140
8930126|NCT02293096|9991559|FG000|COMPLETED|Overall Study||140
8930127|NCT02293096|9991559|FG000|NOT COMPLETED|Overall Study||0
8930128|NCT02293395|9991565|FG000|STARTED|Overall Study||1519
8930129|NCT02293395|9991566|FG001|STARTED|Overall Study||1518
8930130|NCT02293395|9991565|FG000|Treated|Overall Study||1510
8930131|NCT02293395|9991566|FG001|Treated|Overall Study||1506
8930132|NCT02293395|9991565|FG000|COMPLETED|Overall Study||1510
8930133|NCT02293395|9991566|FG001|COMPLETED|Overall Study||1511
8930134|NCT02293395|9991565|FG000|NOT COMPLETED|Overall Study||9
8930135|NCT02293395|9991566|FG001|NOT COMPLETED|Overall Study||7
8930136|NCT02293460|9991572|FG000|STARTED|Overall Study||43
8930137|NCT02293460|9991572|FG000|COMPLETED|Overall Study||37
8930138|NCT02293460|9991572|FG000|NOT COMPLETED|Overall Study||6
8930139|NCT02293499|9991579|FG000|STARTED|Baseline - Enrollment||152
8930140|NCT02293499|9991580|FG001|STARTED|Baseline - Enrollment||168
8930141|NCT02293499|9991581|FG002|STARTED|Baseline - Enrollment||51
8930142|NCT02293499|9991579|FG000|COMPLETED|Baseline - Enrollment||152
8930143|NCT02293499|9991580|FG001|COMPLETED|Baseline - Enrollment||168
8930144|NCT02293499|9991581|FG002|COMPLETED|Baseline - Enrollment||51
8930145|NCT02293499|9991579|FG000|NOT COMPLETED|Baseline - Enrollment||0
8930146|NCT02293499|9991580|FG001|NOT COMPLETED|Baseline - Enrollment||0
8930147|NCT02293499|9991581|FG002|NOT COMPLETED|Baseline - Enrollment||0
8930148|NCT02293499|9991579|FG000|STARTED|Training - Peer Leaders Only|Participant number carried over from previous time point.|0
8930149|NCT02293499|9991580|FG001|STARTED|Training - Peer Leaders Only|Participant number carried over from previous time point.|0
8930150|NCT02293499|9991581|FG002|STARTED|Training - Peer Leaders Only||51
8930151|NCT02293499|9991579|FG000|COMPLETED|Training - Peer Leaders Only||0
8930152|NCT02293499|9991580|FG001|COMPLETED|Training - Peer Leaders Only||0
8930153|NCT02293499|9991581|FG002|COMPLETED|Training - Peer Leaders Only||41
8930154|NCT02293499|9991579|FG000|NOT COMPLETED|Training - Peer Leaders Only||0
8930155|NCT02293499|9991580|FG001|NOT COMPLETED|Training - Peer Leaders Only||0
8930156|NCT02293499|9991581|FG002|NOT COMPLETED|Training - Peer Leaders Only||10
8617162|NCT00455013|9655350|FG000|STARTED|Long Term Extension (LTE)||27
8930157|NCT02293499|9991579|FG000|STARTED|Intervention - Camp|By design, they did not participate in the previous period.|152
8930158|NCT02293499|9991580|FG001|STARTED|Intervention - Camp|By design, they did not participate in the previous period.|168
8930159|NCT02293499|9991581|FG002|STARTED|Intervention - Camp||41
8930160|NCT02293499|9991579|FG000|COMPLETED|Intervention - Camp||125
8930161|NCT02293499|9991580|FG001|COMPLETED|Intervention - Camp||134
8930162|NCT02293499|9991581|FG002|COMPLETED|Intervention - Camp||35
8930163|NCT02293499|9991579|FG000|NOT COMPLETED|Intervention - Camp||27
8930164|NCT02293499|9991580|FG001|NOT COMPLETED|Intervention - Camp||34
8930165|NCT02293499|9991581|FG002|NOT COMPLETED|Intervention - Camp||6
8930166|NCT02293499|9991579|FG000|STARTED|3 Month Follow Up||149
8930167|NCT02293499|9991580|FG001|STARTED|3 Month Follow Up||162
8930168|NCT02293499|9991581|FG002|STARTED|3 Month Follow Up||39
8930169|NCT02293499|9991579|FG000|COMPLETED|3 Month Follow Up||134
8930170|NCT02293499|9991580|FG001|COMPLETED|3 Month Follow Up||147
8930171|NCT02293499|9991581|FG002|COMPLETED|3 Month Follow Up||29
8930172|NCT02293499|9991579|FG000|NOT COMPLETED|3 Month Follow Up||15
8930173|NCT02293499|9991580|FG001|NOT COMPLETED|3 Month Follow Up||15
8930174|NCT02293499|9991581|FG002|NOT COMPLETED|3 Month Follow Up||10
8930175|NCT02293499|9991579|FG000|STARTED|6 Month Follow Up||148
8930176|NCT02293499|9991580|FG001|STARTED|6 Month Follow Up||162
8930177|NCT02293499|9991581|FG002|STARTED|6 Month Follow Up||35
8930178|NCT02293499|9991579|FG000|COMPLETED|6 Month Follow Up||131
8930179|NCT02293499|9991580|FG001|COMPLETED|6 Month Follow Up||135
8930180|NCT02293499|9991581|FG002|COMPLETED|6 Month Follow Up||28
8930181|NCT02293499|9991579|FG000|NOT COMPLETED|6 Month Follow Up||17
8930182|NCT02293499|9991580|FG001|NOT COMPLETED|6 Month Follow Up||27
8930183|NCT02293499|9991581|FG002|NOT COMPLETED|6 Month Follow Up||7
8717847|NCT00996736|9765147|FG001|STARTED|Overall Study||161
8717848|NCT00996736|9765146|FG000|3-week Visit|Overall Study|149 visited within pre-specified 3-week window (2.5-5 weeks); 6 had a second visit not within window|155
8717849|NCT00996736|9765147|FG001|3-week Visit|Overall Study|144 visited within pre-specified 3-week window (2.5-5 weeks); 7 had a second visit not within window|151
8813519|NCT01526213|9866706|FG000|COMPLETED|Period 2 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
8930184|NCT02293499|9991579|FG000|STARTED|9 Month Follow Up||148
8930185|NCT02293499|9991580|FG001|STARTED|9 Month Follow Up||162
8930186|NCT02293499|9991581|FG002|STARTED|9 Month Follow Up||34
8717850|NCT00996736|9765146|FG000|3-month Visit|Overall Study||146
8717851|NCT00996736|9765147|FG001|3-month Visit|Overall Study||146
8813520|NCT01526213|9866707|FG001|COMPLETED|Period 2 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
8813521|NCT01526213|9866708|FG002|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
8813522|NCT01526213|9866709|FG003|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
8813523|NCT01526213|9866710|FG004|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
8813524|NCT01526213|9866711|FG005|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
8813525|NCT01526213|9866706|FG000|NOT COMPLETED|Period 2 (5 Days)||0
8813526|NCT01526213|9866707|FG001|NOT COMPLETED|Period 2 (5 Days)||0
8813527|NCT01526213|9866708|FG002|NOT COMPLETED|Period 2 (5 Days)||0
8813528|NCT01526213|9866709|FG003|NOT COMPLETED|Period 2 (5 Days)||0
8813529|NCT01526213|9866710|FG004|NOT COMPLETED|Period 2 (5 Days)||0
8813530|NCT01526213|9866711|FG005|NOT COMPLETED|Period 2 (5 Days)||0
8813531|NCT01526213|9866706|FG000|STARTED|Washout 2 (10 Days)||3
8813532|NCT01526213|9866707|FG001|STARTED|Washout 2 (10 Days)||3
8813533|NCT01526213|9866708|FG002|STARTED|Washout 2 (10 Days)||3
8813534|NCT01526213|9866709|FG003|STARTED|Washout 2 (10 Days)||3
8813535|NCT01526213|9866710|FG004|STARTED|Washout 2 (10 Days)||3
8813536|NCT01526213|9866711|FG005|STARTED|Washout 2 (10 Days)||3
8813537|NCT01526213|9866706|FG000|COMPLETED|Washout 2 (10 Days)||3
8813538|NCT01526213|9866707|FG001|COMPLETED|Washout 2 (10 Days)||3
8813539|NCT01526213|9866708|FG002|COMPLETED|Washout 2 (10 Days)||3
8813540|NCT01526213|9866709|FG003|COMPLETED|Washout 2 (10 Days)||3
8813541|NCT01526213|9866710|FG004|COMPLETED|Washout 2 (10 Days)||3
8813542|NCT01526213|9866711|FG005|COMPLETED|Washout 2 (10 Days)||3
8813543|NCT01526213|9866706|FG000|NOT COMPLETED|Washout 2 (10 Days)||0
8813544|NCT01526213|9866707|FG001|NOT COMPLETED|Washout 2 (10 Days)||0
8813545|NCT01526213|9866708|FG002|NOT COMPLETED|Washout 2 (10 Days)||0
8813546|NCT01526213|9866709|FG003|NOT COMPLETED|Washout 2 (10 Days)||0
8813547|NCT01526213|9866710|FG004|NOT COMPLETED|Washout 2 (10 Days)||0
8813548|NCT01526213|9866711|FG005|NOT COMPLETED|Washout 2 (10 Days)||0
8813549|NCT01526213|9866706|FG000|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
8813550|NCT01526213|9866707|FG001|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
8813551|NCT01526213|9866708|FG002|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
8813552|NCT01526213|9866709|FG003|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
8813553|NCT01526213|9866710|FG004|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
8813554|NCT01526213|9866711|FG005|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
8813555|NCT01526213|9866706|FG000|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
8813556|NCT01526213|9866707|FG001|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
8813557|NCT01526213|9866708|FG002|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
8813558|NCT01526213|9866709|FG003|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
8813559|NCT01526213|9866710|FG004|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
8813560|NCT01526213|9866711|FG005|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
8813561|NCT01526213|9866706|FG000|NOT COMPLETED|Period 3 (5 Days)||0
8813562|NCT01526213|9866707|FG001|NOT COMPLETED|Period 3 (5 Days)||0
8813563|NCT01526213|9866708|FG002|NOT COMPLETED|Period 3 (5 Days)||0
8813564|NCT01526213|9866709|FG003|NOT COMPLETED|Period 3 (5 Days)||0
8813565|NCT01526213|9866710|FG004|NOT COMPLETED|Period 3 (5 Days)||0
8813566|NCT01526213|9866711|FG005|NOT COMPLETED|Period 3 (5 Days)||0
8930187|NCT02293499|9991579|FG000|COMPLETED|9 Month Follow Up||122
8717852|NCT00996736|9765146|FG000|COMPLETED|Overall Study||141
8717853|NCT00996736|9765147|FG001|COMPLETED|Overall Study||143
8930188|NCT02293499|9991580|FG001|COMPLETED|9 Month Follow Up||134
8930189|NCT02293499|9991581|FG002|COMPLETED|9 Month Follow Up||30
8930190|NCT02293499|9991579|FG000|NOT COMPLETED|9 Month Follow Up||26
8930191|NCT02293499|9991580|FG001|NOT COMPLETED|9 Month Follow Up||28
8930192|NCT02293499|9991581|FG002|NOT COMPLETED|9 Month Follow Up||4
8930193|NCT02293499|9991579|FG000|STARTED|12 Month Follow Up||146
8930194|NCT02293499|9991580|FG001|STARTED|12 Month Follow Up||162
8930195|NCT02293499|9991581|FG002|STARTED|12 Month Follow Up||34
8930196|NCT02293499|9991579|FG000|COMPLETED|12 Month Follow Up||120
8930197|NCT02293499|9991580|FG001|COMPLETED|12 Month Follow Up||136
8930198|NCT02293499|9991581|FG002|COMPLETED|12 Month Follow Up||28
8930199|NCT02293499|9991579|FG000|NOT COMPLETED|12 Month Follow Up||26
8930200|NCT02293499|9991580|FG001|NOT COMPLETED|12 Month Follow Up||26
8930201|NCT02293499|9991581|FG002|NOT COMPLETED|12 Month Follow Up||6
8930202|NCT02293499|9991579|FG000|STARTED|15 Month Follow Up||146
8930203|NCT02293499|9991580|FG001|STARTED|15 Month Follow Up||161
8930204|NCT02293499|9991581|FG002|STARTED|15 Month Follow Up||34
8930205|NCT02293499|9991579|FG000|COMPLETED|15 Month Follow Up||124
8930206|NCT02293499|9991580|FG001|COMPLETED|15 Month Follow Up||139
8930207|NCT02293499|9991581|FG002|COMPLETED|15 Month Follow Up||27
8930208|NCT02293499|9991579|FG000|NOT COMPLETED|15 Month Follow Up||22
8930209|NCT02293499|9991580|FG001|NOT COMPLETED|15 Month Follow Up||22
8930210|NCT02293499|9991581|FG002|NOT COMPLETED|15 Month Follow Up||7
8930211|NCT02293512|9991594|FG000|STARTED|Overall Study||10
8930212|NCT02293512|9991595|FG001|STARTED|Overall Study||10
8930213|NCT02293512|9991596|FG002|STARTED|Overall Study||10
8930214|NCT02293512|9991597|FG003|STARTED|Overall Study||10
8930215|NCT02293512|9991594|FG000|COMPLETED|Overall Study||6
8930216|NCT02293512|9991595|FG001|COMPLETED|Overall Study||4
8930217|NCT02293512|9991596|FG002|COMPLETED|Overall Study||7
8930218|NCT02293512|9991597|FG003|COMPLETED|Overall Study||8
8930219|NCT02293512|9991594|FG000|NOT COMPLETED|Overall Study||4
8930220|NCT02293512|9991595|FG001|NOT COMPLETED|Overall Study||6
8930221|NCT02293512|9991596|FG002|NOT COMPLETED|Overall Study||3
8930222|NCT02293512|9991597|FG003|NOT COMPLETED|Overall Study||2
8930223|NCT02293538|9991609|FG000|STARTED|Overall Study||73
8930224|NCT02293538|9991610|FG001|STARTED|Overall Study||71
8930225|NCT02293538|9991609|FG000|COMPLETED|Overall Study||72
8930226|NCT02293538|9991610|FG001|COMPLETED|Overall Study||69
8930227|NCT02293538|9991609|FG000|NOT COMPLETED|Overall Study||1
8930228|NCT02293538|9991610|FG001|NOT COMPLETED|Overall Study||2
8930229|NCT02293798|9991617|FG000|STARTED|Overall Study|2 units of SERI Mesh placed in each patient|13
8930230|NCT02293798|9991617|FG000|COMPLETED|Overall Study|2 units of SERI Mesh placed in each patient|13
8930231|NCT02293798|9991617|FG000|NOT COMPLETED|Overall Study||0
8930232|NCT02293837|9991625|FG000|STARTED|Overall Study||54
8930233|NCT02293837|9991626|FG001|STARTED|Overall Study||27
8930234|NCT02293837|9991627|FG002|STARTED|Overall Study|1 randomized adult was never treated|35
8930235|NCT02293837|9991628|FG003|STARTED|Overall Study||20
8930236|NCT02293837|9991625|FG000|COMPLETED|Overall Study||51
8930237|NCT02293837|9991626|FG001|COMPLETED|Overall Study||23
8930238|NCT02293837|9991627|FG002|COMPLETED|Overall Study||31
8930239|NCT02293837|9991628|FG003|COMPLETED|Overall Study||19
8930240|NCT02293837|9991625|FG000|NOT COMPLETED|Overall Study||3
8930241|NCT02293837|9991626|FG001|NOT COMPLETED|Overall Study||4
8930242|NCT02293837|9991627|FG002|NOT COMPLETED|Overall Study||4
8930243|NCT02293837|9991628|FG003|NOT COMPLETED|Overall Study||1
8930244|NCT02293863|9991645|FG000|STARTED|Overall Study||56
8930245|NCT02293863|9991646|FG001|STARTED|Overall Study||55
8930246|NCT02293863|9991647|FG002|STARTED|Overall Study||47
8930247|NCT02293863|9991645|FG000|COMPLETED|Overall Study||47
8930248|NCT02293863|9991646|FG001|COMPLETED|Overall Study||42
8930249|NCT02293863|9991647|FG002|COMPLETED|Overall Study||38
8930250|NCT02293863|9991645|FG000|NOT COMPLETED|Overall Study||9
8930251|NCT02293863|9991646|FG001|NOT COMPLETED|Overall Study||13
8930252|NCT02293863|9991647|FG002|NOT COMPLETED|Overall Study||9
8930253|NCT02293902|9991660|FG000|STARTED|Double-Blind Period (Up to Week 24)||82
8930254|NCT02293902|9991661|FG001|STARTED|Double-Blind Period (Up to Week 24)||81
8930255|NCT02293902|9991662|FG002|STARTED|Double-Blind Period (Up to Week 24)||80
8930256|NCT02293902|9991663|FG003|STARTED|Double-Blind Period (Up to Week 24)||0
8930257|NCT02293902|9991664|FG004|STARTED|Double-Blind Period (Up to Week 24)||0
8930258|NCT02293902|9991660|FG000|Treated|Double-Blind Period (Up to Week 24)||81
8930259|NCT02293902|9991661|FG001|Treated|Double-Blind Period (Up to Week 24)||81
8930260|NCT02293902|9991662|FG002|Treated|Double-Blind Period (Up to Week 24)||80
8930261|NCT02293902|9991663|FG003|Treated|Double-Blind Period (Up to Week 24)||0
8930262|NCT02293902|9991664|FG004|Treated|Double-Blind Period (Up to Week 24)||0
8930263|NCT02293902|9991660|FG000|Rescued|Double-Blind Period (Up to Week 24)||44
8930264|NCT02293902|9991661|FG001|Rescued|Double-Blind Period (Up to Week 24)||6
8930265|NCT02293902|9991662|FG002|Rescued|Double-Blind Period (Up to Week 24)||8
8930266|NCT02293902|9991663|FG003|Rescued|Double-Blind Period (Up to Week 24)||0
8930267|NCT02293902|9991664|FG004|Rescued|Double-Blind Period (Up to Week 24)||0
8930268|NCT02293902|9991660|FG000|COMPLETED|Double-Blind Period (Up to Week 24)|42 rescued and 29 not rescued completed.|71
8930269|NCT02293902|9991661|FG001|COMPLETED|Double-Blind Period (Up to Week 24)|6 rescued and 68 not rescued completed.|74
8930270|NCT02293902|9991662|FG002|COMPLETED|Double-Blind Period (Up to Week 24)|8 rescued and 62 not rescued completed.|70
8930271|NCT02293902|9991663|FG003|COMPLETED|Double-Blind Period (Up to Week 24)||0
8930272|NCT02293902|9991664|FG004|COMPLETED|Double-Blind Period (Up to Week 24)||0
8930273|NCT02293902|9991660|FG000|NOT COMPLETED|Double-Blind Period (Up to Week 24)||11
8930274|NCT02293902|9991661|FG001|NOT COMPLETED|Double-Blind Period (Up to Week 24)||7
8930275|NCT02293902|9991662|FG002|NOT COMPLETED|Double-Blind Period (Up to Week 24)||10
8930276|NCT02293902|9991663|FG003|NOT COMPLETED|Double-Blind Period (Up to Week 24)||0
8930277|NCT02293902|9991664|FG004|NOT COMPLETED|Double-Blind Period (Up to Week 24)||0
8930278|NCT02293902|9991660|FG000|STARTED|Single-Blind Period (Week 25 to Week 52)||0
8930279|NCT02293902|9991661|FG001|STARTED|Single-Blind Period (Week 25 to Week 52)|68 participants not rescued continued same treatment and 6 rescued continued open label treatment.|74
8930280|NCT02293902|9991662|FG002|STARTED|Single-Blind Period (Week 25 to Week 52)|62 participants not rescued continued same treatment and 8 rescued continued open label treatment.|70
8930281|NCT02293902|9991663|FG003|STARTED|Single-Blind Period (Week 25 to Week 52)|14 participants not rescued were switched and 20 rescued continued open label treatment.|34
8930282|NCT02293902|9991664|FG004|STARTED|Single-Blind Period (Week 25 to Week 52)|15 participants not rescued were switched and 22 rescued continued open label treatment.|37
8930283|NCT02293902|9991660|FG000|COMPLETED|Single-Blind Period (Week 25 to Week 52)||0
8930284|NCT02293902|9991661|FG001|COMPLETED|Single-Blind Period (Week 25 to Week 52)|5 rescued and 61 not rescued completed.|66
8930285|NCT02293902|9991662|FG002|COMPLETED|Single-Blind Period (Week 25 to Week 52)|8 rescued and 60 not rescued completed.|68
8930286|NCT02293902|9991663|FG003|COMPLETED|Single-Blind Period (Week 25 to Week 52)|20 rescued and 13 not rescued completed.|33
8930287|NCT02293902|9991664|FG004|COMPLETED|Single-Blind Period (Week 25 to Week 52)|18 rescued and 13 not rescued completed.|31
8930288|NCT02293902|9991660|FG000|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||0
8930289|NCT02293902|9991661|FG001|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||8
8930290|NCT02293902|9991662|FG002|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||2
8930291|NCT02293902|9991663|FG003|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||1
8930292|NCT02293902|9991664|FG004|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||6
8930293|NCT02293993|9991686|FG000|STARTED|Course 1 (DLT Evaluation Period)||4
8930294|NCT02293993|9991687|FG001|STARTED|Course 1 (DLT Evaluation Period)||6
8930295|NCT02293993|9991688|FG002|STARTED|Course 1 (DLT Evaluation Period)||7
8930296|NCT02293993|9991689|FG003|STARTED|Course 1 (DLT Evaluation Period)||4
8930297|NCT02293993|9991686|FG000|COMPLETED|Course 1 (DLT Evaluation Period)||3
8930298|NCT02293993|9991687|FG001|COMPLETED|Course 1 (DLT Evaluation Period)||6
8930299|NCT02293993|9991688|FG002|COMPLETED|Course 1 (DLT Evaluation Period)||7
8930300|NCT02293993|9991689|FG003|COMPLETED|Course 1 (DLT Evaluation Period)||3
8930301|NCT02293993|9991686|FG000|NOT COMPLETED|Course 1 (DLT Evaluation Period)||1
8930302|NCT02293993|9991687|FG001|NOT COMPLETED|Course 1 (DLT Evaluation Period)||0
8930303|NCT02293993|9991688|FG002|NOT COMPLETED|Course 1 (DLT Evaluation Period)||0
8930304|NCT02293993|9991689|FG003|NOT COMPLETED|Course 1 (DLT Evaluation Period)||1
8930305|NCT02293993|9991686|FG000|STARTED|Course ≥2 (Extended Treatment Period)||2
8930306|NCT02293993|9991687|FG001|STARTED|Course ≥2 (Extended Treatment Period)||5
8930307|NCT02293993|9991688|FG002|STARTED|Course ≥2 (Extended Treatment Period)||6
8930308|NCT02293993|9991689|FG003|STARTED|Course ≥2 (Extended Treatment Period)||3
8930309|NCT02293993|9991686|FG000|COMPLETED|Course ≥2 (Extended Treatment Period)||0
8930310|NCT02293993|9991687|FG001|COMPLETED|Course ≥2 (Extended Treatment Period)||0
8930311|NCT02293993|9991688|FG002|COMPLETED|Course ≥2 (Extended Treatment Period)||1
8930312|NCT02293993|9991689|FG003|COMPLETED|Course ≥2 (Extended Treatment Period)||2
8930313|NCT02293993|9991686|FG000|NOT COMPLETED|Course ≥2 (Extended Treatment Period)||2
8930314|NCT02293993|9991687|FG001|NOT COMPLETED|Course ≥2 (Extended Treatment Period)||5
8930315|NCT02293993|9991688|FG002|NOT COMPLETED|Course ≥2 (Extended Treatment Period)||5
8930316|NCT02293993|9991689|FG003|NOT COMPLETED|Course ≥2 (Extended Treatment Period)||1
8930317|NCT02294019|9991707|FG000|STARTED|Overall Study||738
8930318|NCT02294019|9991707|FG000|COMPLETED|Overall Study||635
8930319|NCT02294019|9991707|FG000|NOT COMPLETED|Overall Study||103
8930320|NCT02294058|9991714|FG000|STARTED|Overall Study||448
8930321|NCT02294058|9991715|FG001|STARTED|Overall Study||451
8930322|NCT02294058|9991716|FG002|STARTED|Overall Study||447
8930323|NCT02294058|9991714|FG000|Safety Population|Overall Study||445
8930324|NCT02294058|9991715|FG001|Safety Population|Overall Study||453
8930325|NCT02294058|9991716|FG002|Safety Population|Overall Study||448
8930326|NCT02294058|9991714|FG000|COMPLETED|Overall Study||412
8930327|NCT02294058|9991715|FG001|COMPLETED|Overall Study||425
8930328|NCT02294058|9991716|FG002|COMPLETED|Overall Study||418
8930329|NCT02294058|9991714|FG000|NOT COMPLETED|Overall Study||36
8930330|NCT02294058|9991715|FG001|NOT COMPLETED|Overall Study||26
8930331|NCT02294058|9991716|FG002|NOT COMPLETED|Overall Study||29
8930332|NCT02294175|9991727|FG000|STARTED|Overall Study||23
8930333|NCT02294175|9991728|FG001|STARTED|Overall Study||22
8930334|NCT02294175|9991727|FG000|COMPLETED|Overall Study||18
8930335|NCT02294175|9991728|FG001|COMPLETED|Overall Study||16
8617163|NCT00455013|9655351|FG001|STARTED|Long Term Extension (LTE)|2 Participants chose not to enter the LTE.|19
8617164|NCT00455013|9655352|FG002|STARTED|Long Term Extension (LTE)|1 Participant chose not to enter the LTE.|27
8617165|NCT00455013|9655350|FG000|COMPLETED|Long Term Extension (LTE)||25
8617166|NCT00455013|9655351|FG001|COMPLETED|Long Term Extension (LTE)||16
8617167|NCT00455013|9655352|FG002|COMPLETED|Long Term Extension (LTE)||20
8617168|NCT00455013|9655350|FG000|NOT COMPLETED|Long Term Extension (LTE)||2
8617169|NCT00455013|9655351|FG001|NOT COMPLETED|Long Term Extension (LTE)||3
8617170|NCT00455013|9655352|FG002|NOT COMPLETED|Long Term Extension (LTE)||7
8930336|NCT02294175|9991727|FG000|NOT COMPLETED|Overall Study||5
8930337|NCT02294175|9991728|FG001|NOT COMPLETED|Overall Study||6
8930338|NCT02294227|9991737|FG000|STARTED|Overall Study||114
8930339|NCT02294227|9991738|FG001|STARTED|Overall Study||113
8930340|NCT02294227|9991739|FG002|STARTED|Overall Study||114
8930341|NCT02294227|9991737|FG000|COMPLETED|Overall Study||89
8930342|NCT02294227|9991738|FG001|COMPLETED|Overall Study||88
8930343|NCT02294227|9991739|FG002|COMPLETED|Overall Study||95
8930344|NCT02294227|9991737|FG000|NOT COMPLETED|Overall Study||25
8930345|NCT02294227|9991738|FG001|NOT COMPLETED|Overall Study||25
8930346|NCT02294227|9991739|FG002|NOT COMPLETED|Overall Study||19
8930347|NCT02294253|9991749|FG000|STARTED|Overall Study||30
8930348|NCT02294253|9991749|FG000|COMPLETED|Overall Study||15
8930349|NCT02294253|9991749|FG000|NOT COMPLETED|Overall Study||15
8930350|NCT02294318|9991755|FG000|STARTED|Overall Study||24
8930351|NCT02294318|9991756|FG001|STARTED|Overall Study||23
8930352|NCT02294318|9991755|FG000|COMPLETED|Overall Study||21
8930353|NCT02294318|9991756|FG001|COMPLETED|Overall Study||21
8930354|NCT02294318|9991755|FG000|NOT COMPLETED|Overall Study||3
8930355|NCT02294318|9991756|FG001|NOT COMPLETED|Overall Study||2
8930356|NCT02294396|9991766|FG000|STARTED|Overall Study||167
8930357|NCT02294396|9991767|FG001|STARTED|Overall Study||161
8930358|NCT02294396|9991768|FG002|STARTED|Overall Study||161
8930359|NCT02294396|9991769|FG003|STARTED|Overall Study||160
8930360|NCT02294396|9991766|FG000|COMPLETED|Overall Study||127
8930361|NCT02294396|9991767|FG001|COMPLETED|Overall Study||128
8930362|NCT02294396|9991768|FG002|COMPLETED|Overall Study||126
8930363|NCT02294396|9991769|FG003|COMPLETED|Overall Study||123
8930364|NCT02294396|9991766|FG000|NOT COMPLETED|Overall Study||40
8930365|NCT02294396|9991767|FG001|NOT COMPLETED|Overall Study||33
8930366|NCT02294396|9991768|FG002|NOT COMPLETED|Overall Study||35
8930367|NCT02294396|9991769|FG003|NOT COMPLETED|Overall Study||37
8930368|NCT02294474|9991781|FG000|STARTED|Overall Study||253
8930369|NCT02294474|9991782|FG001|STARTED|Overall Study||252
8930370|NCT02294474|9991781|FG000|COMPLETED|Overall Study||228
8930371|NCT02294474|9991782|FG001|COMPLETED|Overall Study||230
8930372|NCT02294474|9991781|FG000|NOT COMPLETED|Overall Study||25
8930373|NCT02294474|9991782|FG001|NOT COMPLETED|Overall Study||22
8930374|NCT02294604|9991792|FG000|STARTED|Overall Study||80
8930375|NCT02294604|9991793|FG001|STARTED|Overall Study||80
8930376|NCT02294604|9991794|FG002|STARTED|Overall Study||80
8930377|NCT02294604|9991792|FG000|COMPLETED|Overall Study||79
8930378|NCT02294604|9991793|FG001|COMPLETED|Overall Study||77
8930379|NCT02294604|9991794|FG002|COMPLETED|Overall Study||80
8930380|NCT02294604|9991792|FG000|NOT COMPLETED|Overall Study||1
8930381|NCT02294604|9991793|FG001|NOT COMPLETED|Overall Study||3
8930382|NCT02294604|9991794|FG002|NOT COMPLETED|Overall Study||0
8930383|NCT02294630|9991806|FG000|STARTED|Overall Study||37
8930384|NCT02294630|9991807|FG001|STARTED|Overall Study||38
8930385|NCT02294630|9991808|FG002|STARTED|Overall Study||35
8930386|NCT02294630|9991809|FG003|STARTED|Overall Study||39
8930387|NCT02294630|9991806|FG000|COMPLETED|Overall Study||37
8930388|NCT02294630|9991807|FG001|COMPLETED|Overall Study||38
8930389|NCT02294630|9991808|FG002|COMPLETED|Overall Study||35
8930390|NCT02294630|9991809|FG003|COMPLETED|Overall Study||39
8930391|NCT02294630|9991806|FG000|NOT COMPLETED|Overall Study||0
8930392|NCT02294630|9991807|FG001|NOT COMPLETED|Overall Study||0
8930393|NCT02294630|9991808|FG002|NOT COMPLETED|Overall Study||0
8930394|NCT02294630|9991809|FG003|NOT COMPLETED|Overall Study||0
8930395|NCT02294682|9991821|FG000|STARTED|Overall Study||53
8930396|NCT02294682|9991822|FG001|STARTED|Overall Study||53
8930397|NCT02294682|9991821|FG000|COMPLETED|Overall Study||52
8930398|NCT02294682|9991822|FG001|COMPLETED|Overall Study||53
8930399|NCT02294682|9991821|FG000|NOT COMPLETED|Overall Study||1
8930400|NCT02294682|9991822|FG001|NOT COMPLETED|Overall Study||0
8930401|NCT02294734|9991830|FG000|STARTED|Overall Study||63
8617171|NCT00455195|9655362|FG000|STARTED|Double-blind Study AGLU02704|Patients randomized to alglucosidase alfa treatment group in AGLU02704 (NCT00158600).|60
8617172|NCT00455195|9655363|FG001|STARTED|Double-blind Study AGLU02704|See study AGLU02704 (NCT00158600) for results while on placebo.|30
8930402|NCT02294734|9991831|FG001|STARTED|Overall Study||63
8930403|NCT02294734|9991830|FG000|COMPLETED|Overall Study||49
8930404|NCT02294734|9991831|FG001|COMPLETED|Overall Study||55
8930405|NCT02294734|9991830|FG000|NOT COMPLETED|Overall Study||14
8930406|NCT02294734|9991831|FG001|NOT COMPLETED|Overall Study||8
8930407|NCT02294773|9991841|FG000|STARTED|Overall Study||7
8930408|NCT02294773|9991842|FG001|STARTED|Overall Study||6
8930409|NCT02294773|9991841|FG000|COMPLETED|Overall Study||7
8930410|NCT02294773|9991842|FG001|COMPLETED|Overall Study||4
8930411|NCT02294773|9991841|FG000|NOT COMPLETED|Overall Study||0
8930412|NCT02294773|9991842|FG001|NOT COMPLETED|Overall Study||2
8930413|NCT02294786|9991850|FG000|STARTED|Overall Study||30
8930414|NCT02294786|9991851|FG001|STARTED|Overall Study||32
8930415|NCT02294786|9991850|FG000|Safety Population|Overall Study|One subject randomized to Octreotide received only 0.1 mg dose.|29
8930416|NCT02294786|9991851|FG001|Safety Population|Overall Study|The subject was included in the No-Octreotide arm.|33
8930417|NCT02294786|9991850|FG000|ITT Population|Overall Study||30
8930418|NCT02294786|9991851|FG001|ITT Population|Overall Study||32
8930419|NCT02294786|9991850|FG000|COMPLETED|Overall Study||19
8930420|NCT02294786|9991851|FG001|COMPLETED|Overall Study||18
8930421|NCT02294786|9991850|FG000|NOT COMPLETED|Overall Study||11
8930422|NCT02294786|9991851|FG001|NOT COMPLETED|Overall Study||14
8930423|NCT02295020|9991860|FG000|STARTED|Overall Study||20
8930424|NCT02295020|9991861|FG001|STARTED|Overall Study||20
8930425|NCT02295020|9991860|FG000|COMPLETED|Overall Study||17
8930426|NCT02295020|9991861|FG001|COMPLETED|Overall Study||17
8930427|NCT02295020|9991860|FG000|NOT COMPLETED|Overall Study||3
8930428|NCT02295020|9991861|FG001|NOT COMPLETED|Overall Study||3
8930429|NCT02295280|9991875|FG000|STARTED|Overall Study||35
8930430|NCT02295280|9991876|FG001|STARTED|Overall Study||35
8930431|NCT02295280|9991875|FG000|COMPLETED|Overall Study||35
8930432|NCT02295280|9991876|FG001|COMPLETED|Overall Study||34
8930433|NCT02295280|9991875|FG000|NOT COMPLETED|Overall Study||0
8930434|NCT02295280|9991876|FG001|NOT COMPLETED|Overall Study||1
8930435|NCT02295553|9991886|FG000|STARTED|Overall Study||14
8930436|NCT02295553|9991887|FG001|STARTED|Overall Study||14
8930437|NCT02295553|9991888|FG002|STARTED|Overall Study||14
8930438|NCT02295553|9991889|FG003|STARTED|Overall Study||14
8930439|NCT02295553|9991886|FG000|COMPLETED|Overall Study||14
8930440|NCT02295553|9991887|FG001|COMPLETED|Overall Study||14
8930441|NCT02295553|9991888|FG002|COMPLETED|Overall Study||13
8930442|NCT02295553|9991889|FG003|COMPLETED|Overall Study||13
8930443|NCT02295553|9991886|FG000|NOT COMPLETED|Overall Study||0
8930444|NCT02295553|9991887|FG001|NOT COMPLETED|Overall Study||0
8717854|NCT00996736|9765146|FG000|NOT COMPLETED|Overall Study||21
8717855|NCT00996736|9765147|FG001|NOT COMPLETED|Overall Study||18
8717856|NCT00996775|9765155|FG000|STARTED|Overall Study||78
8717857|NCT00996775|9765156|FG001|STARTED|Overall Study||89
8717858|NCT00996775|9765155|FG000|COMPLETED|Overall Study||67
8717859|NCT00996775|9765156|FG001|COMPLETED|Overall Study||75
8930445|NCT02295553|9991888|FG002|NOT COMPLETED|Overall Study||1
8930446|NCT02295553|9991889|FG003|NOT COMPLETED|Overall Study||1
8930447|NCT02295644|9991903|FG000|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
8930448|NCT02295644|9991904|FG001|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
8930449|NCT02295644|9991905|FG002|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
8930450|NCT02295644|9991906|FG003|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
8930451|NCT02295644|9991903|FG000|COMPLETED|Overall Study||7
8930452|NCT02295644|9991904|FG001|COMPLETED|Overall Study||7
8930453|NCT02295644|9991905|FG002|COMPLETED|Overall Study||6
8930454|NCT02295644|9991906|FG003|COMPLETED|Overall Study||5
8930455|NCT02295644|9991903|FG000|NOT COMPLETED|Overall Study||0
8930456|NCT02295644|9991904|FG001|NOT COMPLETED|Overall Study||0
8930457|NCT02295644|9991905|FG002|NOT COMPLETED|Overall Study||1
8930458|NCT02295644|9991906|FG003|NOT COMPLETED|Overall Study||2
8930459|NCT02295735|9991918|FG000|STARTED|Overall Study||238
8930460|NCT02295735|9991919|FG001|STARTED|Overall Study||237
8930461|NCT02295735|9991918|FG000|COMPLETED|Overall Study||212
8930462|NCT02295735|9991919|FG001|COMPLETED|Overall Study||210
8930463|NCT02295735|9991918|FG000|NOT COMPLETED|Overall Study||26
8930464|NCT02295735|9991919|FG001|NOT COMPLETED|Overall Study||27
8930465|NCT02295774|9991925|FG000|STARTED|Overall Study||13
8930466|NCT02295774|9991925|FG000|COMPLETED|Overall Study||10
8930467|NCT02295774|9991925|FG000|NOT COMPLETED|Overall Study||3
8930468|NCT02295995|9991932|FG000|STARTED|Overall Study||36
8930469|NCT02295995|9991933|FG001|STARTED|Overall Study||18
8930470|NCT02295995|9991932|FG000|COMPLETED|Overall Study||31
8930471|NCT02295995|9991933|FG001|COMPLETED|Overall Study||17
8930472|NCT02295995|9991932|FG000|NOT COMPLETED|Overall Study||5
8930473|NCT02295995|9991933|FG001|NOT COMPLETED|Overall Study||1
8930474|NCT02296099|9991942|FG000|STARTED|Overall Study||57
8930475|NCT02296099|9991943|FG001|STARTED|Overall Study||57
8930476|NCT02296099|9991942|FG000|COMPLETED|Overall Study||54
8930477|NCT02296099|9991943|FG001|COMPLETED|Overall Study||55
8930478|NCT02296099|9991942|FG000|NOT COMPLETED|Overall Study||3
8930479|NCT02296099|9991943|FG001|NOT COMPLETED|Overall Study||2
8930480|NCT02296112|9991949|FG000|STARTED|Overall Study||9
8930481|NCT02296112|9991949|FG000|COMPLETED|Overall Study||0
8930482|NCT02296112|9991949|FG000|NOT COMPLETED|Overall Study||9
8930483|NCT02296138|9991960|FG000|STARTED|Overall Study||3952
8930484|NCT02296138|9991961|FG001|STARTED|Overall Study||3951
8930485|NCT02296138|9991960|FG000|Treated|Overall Study||3941
8930486|NCT02296138|9991961|FG001|Treated|Overall Study||3939
8930487|NCT02296138|9991960|FG000|COMPLETED|Overall Study||3291
8930488|NCT02296138|9991961|FG001|COMPLETED|Overall Study||3451
8930489|NCT02296138|9991960|FG000|NOT COMPLETED|Overall Study||661
8930490|NCT02296138|9991961|FG001|NOT COMPLETED|Overall Study||500
8930491|NCT02296164|9991967|FG000|STARTED|Overall Study|2 patients not eligible as were not on Valchlor at time of study start|298
8930492|NCT02296164|9991967|FG000|COMPLETED|Overall Study||188
8930493|NCT02296164|9991967|FG000|NOT COMPLETED|Overall Study||110
8930494|NCT02296190|9991977|FG000|STARTED|Overall Study||35
8930495|NCT02296190|9991978|FG001|STARTED|Overall Study||41
8930496|NCT02296190|9991979|FG002|STARTED|Overall Study||35
8930497|NCT02296190|9991980|FG003|STARTED|Overall Study||43
8717860|NCT00996775|9765155|FG000|NOT COMPLETED|Overall Study||11
8717861|NCT00996775|9765156|FG001|NOT COMPLETED|Overall Study||14
8717862|NCT00996801|9765168|FG000|STARTED|Overall Study||88
8717863|NCT00996801|9765169|FG001|STARTED|Overall Study||88
8717864|NCT00996801|9765170|FG002|STARTED|Overall Study||88
8717865|NCT00996801|9765171|FG003|STARTED|Overall Study||87
8930498|NCT02296190|9991981|FG004|STARTED|Overall Study||36
8930499|NCT02296190|9991982|FG005|STARTED|Overall Study||9
8930500|NCT02296190|9991977|FG000|COMPLETED|Overall Study||21
8930501|NCT02296190|9991978|FG001|COMPLETED|Overall Study||20
8930502|NCT02296190|9991979|FG002|COMPLETED|Overall Study||23
8930503|NCT02296190|9991980|FG003|COMPLETED|Overall Study||20
8930504|NCT02296190|9991981|FG004|COMPLETED|Overall Study||20
8930505|NCT02296190|9991982|FG005|COMPLETED|Overall Study||9
8930506|NCT02296190|9991977|FG000|NOT COMPLETED|Overall Study||14
8930507|NCT02296190|9991978|FG001|NOT COMPLETED|Overall Study||21
8930508|NCT02296190|9991979|FG002|NOT COMPLETED|Overall Study||12
8930509|NCT02296190|9991980|FG003|NOT COMPLETED|Overall Study||23
8930510|NCT02296190|9991981|FG004|NOT COMPLETED|Overall Study||16
8930511|NCT02296190|9991982|FG005|NOT COMPLETED|Overall Study||0
8930512|NCT02296242|9992000|FG000|STARTED|Overall Study||5
8930513|NCT02296242|9992001|FG001|STARTED|Overall Study||6
8930514|NCT02296242|9992002|FG002|STARTED|Overall Study||7
8930515|NCT02296242|9992003|FG003|STARTED|Overall Study||14
8930516|NCT02296242|9992004|FG004|STARTED|Overall Study||21
8930517|NCT02296242|9992000|FG000|COMPLETED|Overall Study||0
8930518|NCT02296242|9992001|FG001|COMPLETED|Overall Study||0
8930519|NCT02296242|9992002|FG002|COMPLETED|Overall Study||0
8930520|NCT02296242|9992003|FG003|COMPLETED|Overall Study||0
8930521|NCT02296242|9992004|FG004|COMPLETED|Overall Study||0
8930522|NCT02296242|9992000|FG000|NOT COMPLETED|Overall Study||5
8930523|NCT02296242|9992001|FG001|NOT COMPLETED|Overall Study||6
8930524|NCT02296242|9992002|FG002|NOT COMPLETED|Overall Study||7
8930525|NCT02296242|9992003|FG003|NOT COMPLETED|Overall Study||14
8930526|NCT02296242|9992004|FG004|NOT COMPLETED|Overall Study||21
8930527|NCT02296320|9992027|FG000|STARTED|Overall Study||102
8930528|NCT02296320|9992028|FG001|STARTED|Overall Study||15
8930529|NCT02296320|9992029|FG002|STARTED|Overall Study||96
8930530|NCT02296320|9992027|FG000|Treated|Overall Study||100
8930531|NCT02296320|9992028|FG001|Treated|Overall Study||15
8930532|NCT02296320|9992029|FG002|Treated|Overall Study||96
8930533|NCT02296320|9992027|FG000|COMPLETED|Overall Study||67
8930534|NCT02296320|9992028|FG001|COMPLETED|Overall Study||10
8930535|NCT02296320|9992029|FG002|COMPLETED|Overall Study||59
8930536|NCT02296320|9992027|FG000|NOT COMPLETED|Overall Study||35
8930537|NCT02296320|9992028|FG001|NOT COMPLETED|Overall Study||5
8930538|NCT02296320|9992029|FG002|NOT COMPLETED|Overall Study||37
8930539|NCT02296346|9992041|FG000|STARTED|Overall Study||7
8930540|NCT02296346|9992042|FG001|STARTED|Overall Study||6
8930541|NCT02296346|9992041|FG000|COMPLETED|Overall Study||2
8930542|NCT02296346|9992042|FG001|COMPLETED|Overall Study||0
8930543|NCT02296346|9992041|FG000|NOT COMPLETED|Overall Study||5
8930544|NCT02296346|9992042|FG001|NOT COMPLETED|Overall Study||6
8930545|NCT02296424|9992052|FG000|STARTED|Part 1|16 patients immediately went into Part II|84
8930546|NCT02296424|9992053|FG001|STARTED|Part 1||98
8813567|NCT01526343|9866722|FG000|STARTED|Overall Study||47
8813568|NCT01526343|9866722|FG000|COMPLETED|Overall Study||47
8930547|NCT02296424|9992054|FG002|STARTED|Part 1||0
8930548|NCT02296424|9992055|FG003|STARTED|Part 1||0
8930549|NCT02296424|9992052|FG000|COMPLETED|Part 1||61
8930550|NCT02296424|9992053|FG001|COMPLETED|Part 1||65
8930551|NCT02296424|9992054|FG002|COMPLETED|Part 1||0
8930552|NCT02296424|9992055|FG003|COMPLETED|Part 1||0
8930553|NCT02296424|9992052|FG000|NOT COMPLETED|Part 1||23
8930554|NCT02296424|9992053|FG001|NOT COMPLETED|Part 1||33
8930555|NCT02296424|9992054|FG002|NOT COMPLETED|Part 1||0
8930556|NCT02296424|9992055|FG003|NOT COMPLETED|Part 1||0
8930557|NCT02296424|9992052|FG000|STARTED|Part 2||0
8930558|NCT02296424|9992053|FG001|STARTED|Part 2||0
8930559|NCT02296424|9992054|FG002|STARTED|Part 2||38
8930560|NCT02296424|9992055|FG003|STARTED|Part 2||37
8930561|NCT02296424|9992052|FG000|COMPLETED|Part 2||0
8930562|NCT02296424|9992053|FG001|COMPLETED|Part 2||0
8717866|NCT00996801|9765172|FG004|STARTED|Overall Study|15-mg arm was discontinued as a result of Protocol Amendment 1.|88
8717867|NCT00996801|9765173|FG005|STARTED|Overall Study||87
8717868|NCT00996801|9765168|FG000|COMPLETED|Overall Study||68
8717869|NCT00996801|9765169|FG001|COMPLETED|Overall Study||72
8717870|NCT00996801|9765170|FG002|COMPLETED|Overall Study||65
8717871|NCT00996801|9765171|FG003|COMPLETED|Overall Study||56
8717872|NCT00996801|9765172|FG004|COMPLETED|Overall Study||0
8717873|NCT00996801|9765173|FG005|COMPLETED|Overall Study||68
8717874|NCT00996801|9765168|FG000|NOT COMPLETED|Overall Study||20
8717875|NCT00996801|9765169|FG001|NOT COMPLETED|Overall Study||16
8930563|NCT02296424|9992054|FG002|COMPLETED|Part 2||35
8930564|NCT02296424|9992055|FG003|COMPLETED|Part 2||37
8930565|NCT02296424|9992052|FG000|NOT COMPLETED|Part 2||0
8930566|NCT02296424|9992053|FG001|NOT COMPLETED|Part 2||0
8930567|NCT02296424|9992054|FG002|NOT COMPLETED|Part 2||3
8930568|NCT02296424|9992055|FG003|NOT COMPLETED|Part 2||0
8717876|NCT00996801|9765170|FG002|NOT COMPLETED|Overall Study||23
8813569|NCT01526343|9866722|FG000|NOT COMPLETED|Overall Study||0
8717877|NCT00996801|9765171|FG003|NOT COMPLETED|Overall Study||31
8717878|NCT00996801|9765172|FG004|NOT COMPLETED|Overall Study||88
8930569|NCT02296476|9992066|FG000|STARTED|Overall Study||6
8930570|NCT02296476|9992067|FG001|STARTED|Overall Study||4
8930571|NCT02296476|9992068|FG002|STARTED|Overall Study||2
8930572|NCT02296476|9992066|FG000|COMPLETED|Overall Study||0
8930573|NCT02296476|9992067|FG001|COMPLETED|Overall Study||0
8930574|NCT02296476|9992068|FG002|COMPLETED|Overall Study||0
8930575|NCT02296476|9992066|FG000|NOT COMPLETED|Overall Study||6
8930576|NCT02296476|9992067|FG001|NOT COMPLETED|Overall Study||4
8930577|NCT02296476|9992068|FG002|NOT COMPLETED|Overall Study||2
8930578|NCT02296502|9992080|FG000|STARTED|Overall Study||248
8930579|NCT02296502|9992081|FG001|STARTED|Overall Study||1
8930580|NCT02296502|9992082|FG002|STARTED|Overall Study||30
8930581|NCT02296502|9992083|FG003|STARTED|Overall Study||160
8930582|NCT02296502|9992080|FG000|COMPLETED|Overall Study||248
8930583|NCT02296502|9992081|FG001|COMPLETED|Overall Study||1
8930584|NCT02296502|9992082|FG002|COMPLETED|Overall Study||30
8930585|NCT02296502|9992083|FG003|COMPLETED|Overall Study||160
8930586|NCT02296502|9992080|FG000|NOT COMPLETED|Overall Study||0
8930587|NCT02296502|9992081|FG001|NOT COMPLETED|Overall Study||0
8930588|NCT02296502|9992082|FG002|NOT COMPLETED|Overall Study||0
8930589|NCT02296502|9992083|FG003|NOT COMPLETED|Overall Study||0
8930590|NCT02296606|9992096|FG000|STARTED|Overall Study||127
8930591|NCT02296606|9992096|FG000|COMPLETED|Overall Study||127
8930592|NCT02296606|9992096|FG000|NOT COMPLETED|Overall Study||0
8930593|NCT02296775|9992103|FG000|STARTED|Treatment and Evaluation||91
8930594|NCT02296775|9992104|FG001|STARTED|Treatment and Evaluation||92
8930595|NCT02296775|9992105|FG002|STARTED|Treatment and Evaluation||93
8930596|NCT02296775|9992103|FG000|COMPLETED|Treatment and Evaluation||87
8930597|NCT02296775|9992104|FG001|COMPLETED|Treatment and Evaluation||84
8930598|NCT02296775|9992105|FG002|COMPLETED|Treatment and Evaluation||83
8930599|NCT02296775|9992103|FG000|NOT COMPLETED|Treatment and Evaluation||4
8930600|NCT02296775|9992104|FG001|NOT COMPLETED|Treatment and Evaluation||8
8930601|NCT02296775|9992105|FG002|NOT COMPLETED|Treatment and Evaluation||10
8930602|NCT02296775|9992103|FG000|STARTED|Recovery and Follow-up||87
8930603|NCT02296775|9992104|FG001|STARTED|Recovery and Follow-up||84
8930604|NCT02296775|9992105|FG002|STARTED|Recovery and Follow-up||83
8930605|NCT02296775|9992103|FG000|COMPLETED|Recovery and Follow-up||82
8930606|NCT02296775|9992104|FG001|COMPLETED|Recovery and Follow-up||79
8930607|NCT02296775|9992105|FG002|COMPLETED|Recovery and Follow-up||79
8930608|NCT02296775|9992103|FG000|NOT COMPLETED|Recovery and Follow-up||5
8930609|NCT02296775|9992104|FG001|NOT COMPLETED|Recovery and Follow-up||5
8930610|NCT02296775|9992105|FG002|NOT COMPLETED|Recovery and Follow-up||4
8930611|NCT02296840|9992115|FG000|STARTED|Overall Study||18
8930612|NCT02296840|9992116|FG001|STARTED|Overall Study||27
8930613|NCT02296840|9992115|FG000|COMPLETED|Overall Study||9
8930614|NCT02296840|9992116|FG001|COMPLETED|Overall Study||8
8930615|NCT02296840|9992115|FG000|NOT COMPLETED|Overall Study||9
8930616|NCT02296840|9992116|FG001|NOT COMPLETED|Overall Study||19
8930617|NCT02296853|9992124|FG000|STARTED|Overall Study||10
8930618|NCT02296853|9992125|FG001|STARTED|Overall Study||10
8930619|NCT02296853|9992124|FG000|COMPLETED|Overall Study||10
8930620|NCT02296853|9992125|FG001|COMPLETED|Overall Study||10
8930621|NCT02296853|9992124|FG000|NOT COMPLETED|Overall Study||0
8930622|NCT02296853|9992125|FG001|NOT COMPLETED|Overall Study||0
8930623|NCT02296892|9992134|FG000|STARTED|Overall Study||310
8930624|NCT02296892|9992135|FG001|STARTED|Overall Study||63
8930625|NCT02296892|9992136|FG002|STARTED|Overall Study||73
8930626|NCT02296892|9992134|FG000|Safety Population|Overall Study||303
8930627|NCT02296892|9992135|FG001|Safety Population|Overall Study||59
8930628|NCT02296892|9992136|FG002|Safety Population|Overall Study||69
8930629|NCT02296892|9992134|FG000|Complete Trial Treatment Period|Overall Study||303
8930630|NCT02296892|9992135|FG001|Complete Trial Treatment Period|Overall Study||59
8930631|NCT02296892|9992136|FG002|Complete Trial Treatment Period|Overall Study||69
8930632|NCT02296892|9992134|FG000|COMPLETED|Overall Study||298
8930633|NCT02296892|9992135|FG001|COMPLETED|Overall Study||59
8930634|NCT02296892|9992136|FG002|COMPLETED|Overall Study||68
8930635|NCT02296892|9992134|FG000|NOT COMPLETED|Overall Study||12
8930636|NCT02296892|9992135|FG001|NOT COMPLETED|Overall Study||4
8930637|NCT02296892|9992136|FG002|NOT COMPLETED|Overall Study||5
8930638|NCT02296931|9992146|FG000|STARTED|Overall Study||10
8930639|NCT02296931|9992147|FG001|STARTED|Overall Study||24
8930640|NCT02296931|9992146|FG000|COMPLETED|Overall Study||10
8930641|NCT02296931|9992147|FG001|COMPLETED|Overall Study||22
8930642|NCT02296931|9992146|FG000|NOT COMPLETED|Overall Study||0
8930643|NCT02296931|9992147|FG001|NOT COMPLETED|Overall Study||2
8930644|NCT02297100|9992155|FG000|STARTED|Overall Study||13
8930645|NCT02297100|9992156|FG001|STARTED|Overall Study||14
8930646|NCT02297100|9992155|FG000|COMPLETED|Overall Study||13
8930647|NCT02297100|9992156|FG001|COMPLETED|Overall Study||14
8930648|NCT02297100|9992155|FG000|NOT COMPLETED|Overall Study||0
8930649|NCT02297100|9992156|FG001|NOT COMPLETED|Overall Study||0
8930650|NCT02297308|9992162|FG000|STARTED|Overall Study||90
8930651|NCT02297308|9992162|FG000|COMPLETED|Overall Study||90
8930652|NCT02297308|9992162|FG000|NOT COMPLETED|Overall Study||0
8930653|NCT02297503|9992169|FG000|STARTED|Overall Study||30
8930654|NCT02297503|9992170|FG001|STARTED|Overall Study||31
8930655|NCT02297503|9992169|FG000|Initial Single Treatment|Overall Study||29
8930656|NCT02297503|9992170|FG001|Initial Single Treatment|Overall Study||31
8930657|NCT02297503|9992169|FG000|First Combined Treatment|Overall Study||28
8930658|NCT02297503|9992170|FG001|First Combined Treatment|Overall Study||28
8930659|NCT02297503|9992169|FG000|Second Combined Treatment|Overall Study||28
9064692|NCT04283773|10125062|FG000|STARTED|Overall Study||22
9064693|NCT04283773|10125063|FG001|STARTED|Overall Study||20
9064694|NCT04283773|10125064|FG002|STARTED|Overall Study||20
8930660|NCT02297503|9992170|FG001|Second Combined Treatment|Overall Study||28
9064695|NCT04283773|10125062|FG000|COMPLETED|Overall Study||22
8930661|NCT02297503|9992169|FG000|COMPLETED|Overall Study||28
8930662|NCT02297503|9992170|FG001|COMPLETED|Overall Study||27
8930663|NCT02297503|9992169|FG000|NOT COMPLETED|Overall Study||2
8930664|NCT02297503|9992170|FG001|NOT COMPLETED|Overall Study||4
9064696|NCT04283773|10125063|FG001|COMPLETED|Overall Study||20
8930665|NCT02297516|9992187|FG000|STARTED|Single Treatment Phase (6 Months)||32
8930666|NCT02297516|9992188|FG001|STARTED|Single Treatment Phase (6 Months)||33
8930667|NCT02297516|9992187|FG000|COMPLETED|Single Treatment Phase (6 Months)||31
8930668|NCT02297516|9992188|FG001|COMPLETED|Single Treatment Phase (6 Months)||31
8930669|NCT02297516|9992187|FG000|NOT COMPLETED|Single Treatment Phase (6 Months)||1
8930670|NCT02297516|9992188|FG001|NOT COMPLETED|Single Treatment Phase (6 Months)||2
8930671|NCT02297516|9992187|FG000|STARTED|Combination Treatment Phase (up to 18 m)||31
8930672|NCT02297516|9992188|FG001|STARTED|Combination Treatment Phase (up to 18 m)||31
8930673|NCT02297516|9992187|FG000|COMPLETED|Combination Treatment Phase (up to 18 m)||31
9064697|NCT04283773|10125064|FG002|COMPLETED|Overall Study||20
9064698|NCT04283773|10125062|FG000|NOT COMPLETED|Overall Study||0
9064699|NCT04283773|10125063|FG001|NOT COMPLETED|Overall Study||0
9064700|NCT04283773|10125064|FG002|NOT COMPLETED|Overall Study||0
9064701|NCT04281901|10125076|FG000|STARTED|Overall Study||12
9064702|NCT04281901|10125077|FG001|STARTED|Overall Study||12
9064703|NCT04281901|10125076|FG000|2. Check-up|Overall Study||11
9064704|NCT04281901|10125077|FG001|2. Check-up|Overall Study||11
9064705|NCT04281901|10125076|FG000|3. Check-up|Overall Study||11
9064706|NCT04281901|10125077|FG001|3. Check-up|Overall Study||11
9064707|NCT04281901|10125076|FG000|COMPLETED|Overall Study||11
9064708|NCT04281901|10125077|FG001|COMPLETED|Overall Study||11
9064709|NCT04281901|10125076|FG000|NOT COMPLETED|Overall Study||1
9064710|NCT04281901|10125077|FG001|NOT COMPLETED|Overall Study||1
9064711|NCT04280653|10125083|FG000|STARTED|Overall Study||15
9064712|NCT04280653|10125083|FG000|COMPLETED|Overall Study||15
9064713|NCT04280653|10125083|FG000|NOT COMPLETED|Overall Study||0
9064714|NCT04277936|10125087|FG000|STARTED|Overall Study||1
9064715|NCT04277936|10125087|FG000|COMPLETED|Overall Study||1
9064716|NCT04277936|10125087|FG000|NOT COMPLETED|Overall Study||0
9064717|NCT04275336|10125094|FG000|STARTED|Overall Study||120
9064718|NCT04275336|10125095|FG001|STARTED|Overall Study||118
9064719|NCT04275336|10125096|FG002|STARTED|Overall Study||116
9064720|NCT04275336|10125094|FG000|COMPLETED|Overall Study||103
9064721|NCT04275336|10125095|FG001|COMPLETED|Overall Study||96
9064722|NCT04275336|10125096|FG002|COMPLETED|Overall Study||100
9064723|NCT04275336|10125094|FG000|NOT COMPLETED|Overall Study||17
9064724|NCT04275336|10125095|FG001|NOT COMPLETED|Overall Study||22
9064725|NCT04275336|10125096|FG002|NOT COMPLETED|Overall Study||16
8930674|NCT02297516|9992188|FG001|COMPLETED|Combination Treatment Phase (up to 18 m)||30
8930675|NCT02297516|9992187|FG000|NOT COMPLETED|Combination Treatment Phase (up to 18 m)||0
8930676|NCT02297516|9992188|FG001|NOT COMPLETED|Combination Treatment Phase (up to 18 m)||1
8930677|NCT02297815|9992203|FG000|STARTED|Overall Study||1604
8930678|NCT02297815|9992204|FG001|STARTED|Overall Study||868
8930679|NCT02297815|9992203|FG000|5-10 Day Interview|Overall Study||1604
8930680|NCT02297815|9992204|FG001|5-10 Day Interview|Overall Study||868
8930681|NCT02297815|9992203|FG000|14-20 Day Interview|Overall Study||1368
8930682|NCT02297815|9992204|FG001|14-20 Day Interview|Overall Study||728
8930683|NCT02297815|9992203|FG000|COMPLETED|Overall Study||1368
8617173|NCT00455195|9655362|FG000|COMPLETED|Double-blind Study AGLU02704||55
8617174|NCT00455195|9655363|FG001|COMPLETED|Double-blind Study AGLU02704||26
8617175|NCT00455195|9655362|FG000|NOT COMPLETED|Double-blind Study AGLU02704||5
8617176|NCT00455195|9655363|FG001|NOT COMPLETED|Double-blind Study AGLU02704||4
8617177|NCT00455195|9655362|FG000|STARTED|Extension Study AGLU03206||55
8617178|NCT00455195|9655363|FG001|STARTED|Extension Study AGLU03206|These 26 participants completed placebo double-blind treatment in the AGLU02704 (NCT00158600) study.|26
8930684|NCT02297815|9992204|FG001|COMPLETED|Overall Study||728
8930685|NCT02297815|9992203|FG000|NOT COMPLETED|Overall Study||236
8930686|NCT02297815|9992204|FG001|NOT COMPLETED|Overall Study||140
8930687|NCT02297841|9992212|FG000|STARTED|Overall Study||209
8930688|NCT02297841|9992212|FG000|Induction Phase|Overall Study||209
8930689|NCT02297841|9992212|FG000|Challenge Phase|Overall Study||201
8930690|NCT02297841|9992212|FG000|COMPLETED|Overall Study||201
8930691|NCT02297841|9992212|FG000|NOT COMPLETED|Overall Study||8
8930692|NCT02298023|9992219|FG000|STARTED|Overall Study||8
8930693|NCT02298023|9992220|FG001|STARTED|Overall Study||8
8930694|NCT02298023|9992221|FG002|STARTED|Overall Study||8
8930695|NCT02298023|9992219|FG000|Intervention|Overall Study|Withdrawal by participant before intervention.|7
8930696|NCT02298023|9992220|FG001|Intervention|Overall Study||8
8930697|NCT02298023|9992221|FG002|Intervention|Overall Study||8
8930698|NCT02298023|9992219|FG000|COMPLETED|Overall Study||7
8930699|NCT02298023|9992220|FG001|COMPLETED|Overall Study||8
8930700|NCT02298023|9992221|FG002|COMPLETED|Overall Study||8
8930701|NCT02298023|9992219|FG000|NOT COMPLETED|Overall Study||1
8930702|NCT02298023|9992220|FG001|NOT COMPLETED|Overall Study||0
8930703|NCT02298023|9992221|FG002|NOT COMPLETED|Overall Study||0
8930704|NCT02298179|9992244|FG000|STARTED|Overall Study||24
8930705|NCT02298179|9992245|FG001|STARTED|Overall Study||24
8930706|NCT02298179|9992246|FG002|STARTED|Overall Study||24
8930707|NCT02298179|9992247|FG003|STARTED|Overall Study||24
8930708|NCT02298179|9992248|FG004|STARTED|Overall Study||24
8930709|NCT02298179|9992249|FG005|STARTED|Overall Study||24
8930710|NCT02298179|9992250|FG006|STARTED|Overall Study||24
8930711|NCT02298179|9992251|FG007|STARTED|Overall Study||24
8930712|NCT02298179|9992252|FG008|STARTED|Overall Study||24
8930713|NCT02298179|9992253|FG009|STARTED|Overall Study||24
8930714|NCT02298179|9992254|FG010|STARTED|Overall Study||24
8930715|NCT02298179|9992255|FG011|STARTED|Overall Study||24
8930716|NCT02298179|9992244|FG000|COMPLETED|Overall Study||24
8930717|NCT02298179|9992245|FG001|COMPLETED|Overall Study||24
8930718|NCT02298179|9992246|FG002|COMPLETED|Overall Study||23
8930719|NCT02298179|9992247|FG003|COMPLETED|Overall Study||24
8930720|NCT02298179|9992248|FG004|COMPLETED|Overall Study||24
8930721|NCT02298179|9992249|FG005|COMPLETED|Overall Study||24
8930722|NCT02298179|9992250|FG006|COMPLETED|Overall Study||24
8930723|NCT02298179|9992251|FG007|COMPLETED|Overall Study||23
8930724|NCT02298179|9992252|FG008|COMPLETED|Overall Study||24
8930725|NCT02298179|9992253|FG009|COMPLETED|Overall Study||24
8930726|NCT02298179|9992254|FG010|COMPLETED|Overall Study||24
8930727|NCT02298179|9992255|FG011|COMPLETED|Overall Study||24
8930728|NCT02298179|9992244|FG000|NOT COMPLETED|Overall Study||0
8930729|NCT02298179|9992245|FG001|NOT COMPLETED|Overall Study||0
8930730|NCT02298179|9992246|FG002|NOT COMPLETED|Overall Study||1
8930731|NCT02298179|9992247|FG003|NOT COMPLETED|Overall Study||0
8930732|NCT02298179|9992248|FG004|NOT COMPLETED|Overall Study||0
8930733|NCT02298179|9992249|FG005|NOT COMPLETED|Overall Study||0
8930734|NCT02298179|9992250|FG006|NOT COMPLETED|Overall Study||0
8930735|NCT02298179|9992251|FG007|NOT COMPLETED|Overall Study||1
8930736|NCT02298179|9992252|FG008|NOT COMPLETED|Overall Study||0
8930737|NCT02298179|9992253|FG009|NOT COMPLETED|Overall Study||0
8930738|NCT02298179|9992254|FG010|NOT COMPLETED|Overall Study||0
8930739|NCT02298179|9992255|FG011|NOT COMPLETED|Overall Study||0
8930740|NCT02298192|9992283|FG000|STARTED|Overall Study||210
8930741|NCT02298192|9992284|FG001|STARTED|Overall Study||210
8930742|NCT02298192|9992283|FG000|COMPLETED|Overall Study||191
8930743|NCT02298192|9992284|FG001|COMPLETED|Overall Study||204
8930744|NCT02298192|9992283|FG000|NOT COMPLETED|Overall Study||19
8930745|NCT02298192|9992284|FG001|NOT COMPLETED|Overall Study||6
8930746|NCT02298322|9992290|FG000|STARTED|Overall Study||60
8930747|NCT02298322|9992290|FG000|COMPLETED|Overall Study||60
8930748|NCT02298322|9992290|FG000|NOT COMPLETED|Overall Study||0
8930749|NCT02298361|9992300|FG000|STARTED|Overall Study||2240
8930750|NCT02298361|9992301|FG001|STARTED|Overall Study||12784
8930751|NCT02298361|9992302|FG002|STARTED|Overall Study||12227
8930752|NCT02298361|9992300|FG000|COMPLETED|Overall Study||2240
8930753|NCT02298361|9992301|FG001|COMPLETED|Overall Study||12784
8930754|NCT02298361|9992302|FG002|COMPLETED|Overall Study||12227
8930755|NCT02298361|9992300|FG000|NOT COMPLETED|Overall Study||0
8930756|NCT02298361|9992301|FG001|NOT COMPLETED|Overall Study||0
8930757|NCT02298361|9992302|FG002|NOT COMPLETED|Overall Study||0
8930758|NCT02298491|9992310|FG000|STARTED|Overall Study||4
8930759|NCT02298491|9992310|FG000|COMPLETED|Overall Study||3
8930760|NCT02298491|9992310|FG000|NOT COMPLETED|Overall Study||1
8930761|NCT02298803|9992316|FG000|STARTED|Overall Study||30
8930762|NCT02298803|9992316|FG000|COMPLETED|Overall Study||30
8930763|NCT02298803|9992316|FG000|NOT COMPLETED|Overall Study||0
8930764|NCT02298842|9992327|FG000|STARTED|First Platelet Donation (Day 0)||44
8930765|NCT02298842|9992328|FG001|STARTED|First Platelet Donation (Day 0)||41
8930766|NCT02298842|9992327|FG000|COMPLETED|First Platelet Donation (Day 0)||38
8930767|NCT02298842|9992328|FG001|COMPLETED|First Platelet Donation (Day 0)||36
8930768|NCT02298842|9992327|FG000|NOT COMPLETED|First Platelet Donation (Day 0)||6
8930769|NCT02298842|9992328|FG001|NOT COMPLETED|First Platelet Donation (Day 0)||5
8930770|NCT02298842|9992327|FG000|STARTED|Second Platelet Donation (Day 6-8)||38
8930771|NCT02298842|9992328|FG001|STARTED|Second Platelet Donation (Day 6-8)||36
8930772|NCT02298842|9992327|FG000|COMPLETED|Second Platelet Donation (Day 6-8)||30
8930773|NCT02298842|9992328|FG001|COMPLETED|Second Platelet Donation (Day 6-8)||30
8930774|NCT02298842|9992327|FG000|NOT COMPLETED|Second Platelet Donation (Day 6-8)||8
8930775|NCT02298842|9992328|FG001|NOT COMPLETED|Second Platelet Donation (Day 6-8)||6
8930776|NCT02298868|9992336|FG000|STARTED|Overall Study||10
8930777|NCT02298868|9992336|FG000|COMPLETED|Overall Study||7
8930778|NCT02298868|9992336|FG000|NOT COMPLETED|Overall Study||3
8948322|NCT02429869|10010695|FG000|STARTED|Overall Study||10
8948323|NCT02429869|10010695|FG000|COMPLETED|Overall Study||10
8948324|NCT02429869|10010695|FG000|NOT COMPLETED|Overall Study||0
8948325|NCT02429934|10010701|FG000|STARTED|Overall Study||15
8948326|NCT02429934|10010702|FG001|STARTED|Overall Study||13
8948327|NCT02429934|10010701|FG000|COMPLETED|Overall Study||11
8948328|NCT02429934|10010702|FG001|COMPLETED|Overall Study||10
8948329|NCT02429934|10010701|FG000|NOT COMPLETED|Overall Study||4
8948330|NCT02429934|10010702|FG001|NOT COMPLETED|Overall Study||3
8948331|NCT02430090|10010713|FG000|STARTED|Overall Study||15
8948332|NCT02430090|10010714|FG001|STARTED|Overall Study||15
8948333|NCT02430090|10010715|FG002|STARTED|Overall Study||15
8948334|NCT02430090|10010713|FG000|COMPLETED|Overall Study||15
8948335|NCT02430090|10010714|FG001|COMPLETED|Overall Study||15
8948336|NCT02430090|10010715|FG002|COMPLETED|Overall Study||15
8948337|NCT02430090|10010713|FG000|NOT COMPLETED|Overall Study||0
8948338|NCT02430090|10010714|FG001|NOT COMPLETED|Overall Study||0
8948339|NCT02430090|10010715|FG002|NOT COMPLETED|Overall Study||0
8948340|NCT02430311|10010725|FG000|STARTED|Part A||20
8948341|NCT02430311|10010726|FG001|STARTED|Part A||16
8948342|NCT02430311|10010725|FG000|Received Olaparib|Part A||20
8948343|NCT02430311|10010726|FG001|Received Olaparib|Part A||16
8948344|NCT02430311|10010725|FG000|Received Paclitaxel|Part A|Cohort 1 patients are planned to receive olaparib monotherapy|0
8948345|NCT02430311|10010726|FG001|Received Paclitaxel|Part A||16
8948346|NCT02430311|10010725|FG000|COMPLETED|Part A||19
8948347|NCT02430311|10010726|FG001|COMPLETED|Part A||15
8948348|NCT02430311|10010725|FG000|NOT COMPLETED|Part A||1
8948349|NCT02430311|10010726|FG001|NOT COMPLETED|Part A||1
8948350|NCT02430311|10010725|FG000|STARTED|Part B||19
8948351|NCT02430311|10010726|FG001|STARTED|Part B||15
8948352|NCT02430311|10010725|FG000|Received Olaparib|Part B||19
8948353|NCT02430311|10010726|FG001|Received Olaparib|Part B||15
8948354|NCT02430311|10010725|FG000|Received Paclitaxel|Part B|Cohort 1 patients are planned to receive olaparib monotherapy|0
8948355|NCT02430311|10010726|FG001|Received Paclitaxel|Part B||14
8948356|NCT02430311|10010725|FG000|COMPLETED|Part B||9
8948357|NCT02430311|10010726|FG001|COMPLETED|Part B||7
8948358|NCT02430311|10010725|FG000|NOT COMPLETED|Part B||10
8948359|NCT02430311|10010726|FG001|NOT COMPLETED|Part B||8
8948360|NCT02430337|10010743|FG000|STARTED|Overall Study||11
8948361|NCT02430337|10010744|FG001|STARTED|Overall Study||20
8948362|NCT02430337|10010743|FG000|COMPLETED|Overall Study||11
8948363|NCT02430337|10010744|FG001|COMPLETED|Overall Study||20
8948364|NCT02430337|10010743|FG000|NOT COMPLETED|Overall Study||0
8948365|NCT02430337|10010744|FG001|NOT COMPLETED|Overall Study||0
8948366|NCT02430389|10010754|FG000|STARTED|Overall Study||10
8948367|NCT02430389|10010755|FG001|STARTED|Overall Study||10
8948368|NCT02430389|10010754|FG000|COMPLETED|Overall Study||10
8948369|NCT02430389|10010755|FG001|COMPLETED|Overall Study||10
8948370|NCT02430389|10010754|FG000|NOT COMPLETED|Overall Study||0
8948371|NCT02430389|10010755|FG001|NOT COMPLETED|Overall Study||0
8617179|NCT00455195|9655362|FG000|COMPLETED|Extension Study AGLU03206||55
8617180|NCT00455195|9655363|FG001|COMPLETED|Extension Study AGLU03206||26
8617181|NCT00455195|9655362|FG000|NOT COMPLETED|Extension Study AGLU03206||0
8617182|NCT00455195|9655363|FG001|NOT COMPLETED|Extension Study AGLU03206||0
8617183|NCT00455312|9655371|FG000|STARTED|Overall Study||15
8617184|NCT00455312|9655372|FG001|STARTED|Overall Study||21
8948372|NCT02430480|10010763|FG000|STARTED|Overall Study||39
8948373|NCT02430480|10010763|FG000|COMPLETED|Overall Study||36
8948374|NCT02430480|10010763|FG000|NOT COMPLETED|Overall Study||3
8948375|NCT02430818|10010772|FG000|STARTED|Overall Study||7
8948376|NCT02430818|10010773|FG001|STARTED|Overall Study||6
8948377|NCT02430818|10010772|FG000|COMPLETED|Overall Study||7
8948378|NCT02430818|10010773|FG001|COMPLETED|Overall Study||6
8948379|NCT02430818|10010772|FG000|NOT COMPLETED|Overall Study||0
8948380|NCT02430818|10010773|FG001|NOT COMPLETED|Overall Study||0
8948381|NCT02430870|10010791|FG000|STARTED|Part 1||6
8948382|NCT02430870|10010792|FG001|STARTED|Part 1||6
8948383|NCT02430870|10010793|FG002|STARTED|Part 1||4
8948384|NCT02430870|10010794|FG003|STARTED|Part 1||0
8948385|NCT02430870|10010795|FG004|STARTED|Part 1||0
8948386|NCT02430870|10010796|FG005|STARTED|Part 1||0
8948387|NCT02430870|10010797|FG006|STARTED|Part 1||0
8930779|NCT02298933|9992340|FG000|STARTED|Overall Study||10
8930780|NCT02298933|9992340|FG000|COMPLETED|Overall Study||10
8930781|NCT02298933|9992340|FG000|NOT COMPLETED|Overall Study||0
8930782|NCT02298946|9992346|FG000|STARTED|Overall Study||8
8930783|NCT02298946|9992347|FG001|STARTED|Overall Study||9
8930784|NCT02298946|9992346|FG000|COMPLETED|Overall Study||4
8930785|NCT02298946|9992347|FG001|COMPLETED|Overall Study||8
8930786|NCT02298946|9992346|FG000|NOT COMPLETED|Overall Study||4
8930787|NCT02298946|9992347|FG001|NOT COMPLETED|Overall Study||1
8930788|NCT02299050|9992354|FG000|STARTED|Overall Study||23
8930789|NCT02299050|9992354|FG000|COMPLETED|Overall Study||15
8930790|NCT02299050|9992354|FG000|NOT COMPLETED|Overall Study||8
8930791|NCT02299076|9992360|FG000|STARTED|Overall Study||230
8930792|NCT02299076|9992361|FG001|STARTED|Overall Study||226
8930793|NCT02299076|9992360|FG000|COMPLETED|Overall Study||210
8930794|NCT02299076|9992361|FG001|COMPLETED|Overall Study||212
8930795|NCT02299076|9992360|FG000|NOT COMPLETED|Overall Study||20
8930796|NCT02299076|9992361|FG001|NOT COMPLETED|Overall Study||14
8930797|NCT02299089|9992371|FG000|STARTED|Overall Study||3
8930798|NCT02299089|9992372|FG001|STARTED|Overall Study||4
8930799|NCT02299089|9992373|FG002|STARTED|Overall Study||1
8930800|NCT02299089|9992374|FG003|STARTED|Overall Study||4
8930801|NCT02299089|9992371|FG000|COMPLETED|Overall Study||3
8930802|NCT02299089|9992372|FG001|COMPLETED|Overall Study||4
8930803|NCT02299089|9992373|FG002|COMPLETED|Overall Study||1
8930804|NCT02299089|9992374|FG003|COMPLETED|Overall Study||4
8930805|NCT02299089|9992371|FG000|NOT COMPLETED|Overall Study||0
8930806|NCT02299089|9992372|FG001|NOT COMPLETED|Overall Study||0
8930807|NCT02299089|9992373|FG002|NOT COMPLETED|Overall Study||0
8930808|NCT02299089|9992374|FG003|NOT COMPLETED|Overall Study||0
8930809|NCT02299141|9992394|FG000|STARTED|Overall Study||20
8930810|NCT02299141|9992394|FG000|COMPLETED|Overall Study||20
8930811|NCT02299141|9992394|FG000|NOT COMPLETED|Overall Study||0
8930812|NCT02299167|9992405|FG000|STARTED|Overall Study||35
8930813|NCT02299167|9992405|FG000|Dural Puncture|Overall Study||24
8930814|NCT02299167|9992405|FG000|Success Rate|Overall Study||24
8930815|NCT02299167|9992405|FG000|Adverse Effects|Overall Study||24
8930816|NCT02299167|9992405|FG000|COMPLETED|Overall Study||24
8930817|NCT02299167|9992405|FG000|NOT COMPLETED|Overall Study||11
8930818|NCT02299258|9992411|FG000|STARTED|Overall Study||32
8930819|NCT02299258|9992412|FG001|STARTED|Overall Study||31
8930820|NCT02299258|9992411|FG000|COMPLETED|Overall Study||31
8930821|NCT02299258|9992412|FG001|COMPLETED|Overall Study||30
8930822|NCT02299258|9992411|FG000|NOT COMPLETED|Overall Study||1
8930823|NCT02299258|9992412|FG001|NOT COMPLETED|Overall Study||1
8930824|NCT02299297|9992418|FG000|STARTED|Overall Study||12
8930825|NCT02299297|9992418|FG000|COMPLETED|Overall Study||11
8930826|NCT02299297|9992418|FG000|NOT COMPLETED|Overall Study||1
8930827|NCT02299336|9992422|FG000|STARTED|Overall Study||60
8930828|NCT02299336|9992422|FG000|COMPLETED|Overall Study||46
8930829|NCT02299336|9992422|FG000|NOT COMPLETED|Overall Study||14
8930830|NCT02299349|9992428|FG000|STARTED|Overall Study||35
8930831|NCT02299349|9992429|FG001|STARTED|Overall Study||35
8930832|NCT02299349|9992428|FG000|COMPLETED|Overall Study||35
8930833|NCT02299349|9992429|FG001|COMPLETED|Overall Study||35
8930834|NCT02299349|9992428|FG000|NOT COMPLETED|Overall Study||0
8930835|NCT02299349|9992429|FG001|NOT COMPLETED|Overall Study||0
8930836|NCT02299375|9992437|FG000|STARTED|Overall Study||94
8930837|NCT02299375|9992438|FG001|STARTED|Overall Study||90
8930838|NCT02299375|9992437|FG000|COMPLETED|Overall Study||14
8930839|NCT02299375|9992438|FG001|COMPLETED|Overall Study||10
8930840|NCT02299375|9992437|FG000|NOT COMPLETED|Overall Study||80
8930841|NCT02299375|9992438|FG001|NOT COMPLETED|Overall Study||80
8930842|NCT02299388|9992447|FG000|STARTED|Overall Study||6
8930843|NCT02299388|9992448|FG001|STARTED|Overall Study||5
8930844|NCT02299388|9992447|FG000|COMPLETED|Overall Study||6
8930845|NCT02299388|9992448|FG001|COMPLETED|Overall Study||4
8930846|NCT02299388|9992447|FG000|NOT COMPLETED|Overall Study||0
8930847|NCT02299388|9992448|FG001|NOT COMPLETED|Overall Study||1
8930848|NCT02299427|9992456|FG000|STARTED|Overall Study||35
8930849|NCT02299427|9992457|FG001|STARTED|Overall Study||34
8930850|NCT02299427|9992456|FG000|COMPLETED|Overall Study||12
8930851|NCT02299427|9992457|FG001|COMPLETED|Overall Study||31
8930852|NCT02299427|9992456|FG000|NOT COMPLETED|Overall Study||23
8930853|NCT02299427|9992457|FG001|NOT COMPLETED|Overall Study||3
8930854|NCT02299479|9992463|FG000|STARTED|Overall Study||20
8930855|NCT02299479|9992463|FG000|COMPLETED|Overall Study||18
8930856|NCT02299479|9992463|FG000|NOT COMPLETED|Overall Study||2
8930857|NCT02299570|9992470|FG000|STARTED|Overall Study||45
8930858|NCT02299570|9992471|FG001|STARTED|Overall Study||44
8930859|NCT02299570|9992472|FG002|STARTED|Overall Study||44
8930860|NCT02299570|9992470|FG000|COMPLETED|Overall Study||31
8930861|NCT02299570|9992471|FG001|COMPLETED|Overall Study||35
8930862|NCT02299570|9992472|FG002|COMPLETED|Overall Study||25
8930863|NCT02299570|9992470|FG000|NOT COMPLETED|Overall Study||14
8930864|NCT02299570|9992471|FG001|NOT COMPLETED|Overall Study||9
8930865|NCT02299570|9992472|FG002|NOT COMPLETED|Overall Study||19
8930866|NCT02299635|9992485|FG000|STARTED|Overall Study||19
8930867|NCT02299635|9992485|FG000|COMPLETED|Overall Study||0
8930868|NCT02299635|9992485|FG000|NOT COMPLETED|Overall Study||19
8930869|NCT02299791|9992491|FG000|STARTED|Overall Study||2053
8930870|NCT02299791|9992492|FG001|STARTED|Overall Study||2803
8930871|NCT02299791|9992491|FG000|COMPLETED|Overall Study||2053
8930872|NCT02299791|9992492|FG001|COMPLETED|Overall Study||2803
8930873|NCT02299791|9992491|FG000|NOT COMPLETED|Overall Study||0
8930874|NCT02299791|9992492|FG001|NOT COMPLETED|Overall Study||0
8930875|NCT02299869|9992502|FG000|STARTED|Overall Study||10
8930876|NCT02299869|9992503|FG001|STARTED|Overall Study||10
8930877|NCT02299869|9992504|FG002|STARTED|Overall Study||10
8930878|NCT02299869|9992505|FG003|STARTED|Overall Study||10
8930879|NCT02299869|9992502|FG000|COMPLETED|Overall Study||10
8930880|NCT02299869|9992503|FG001|COMPLETED|Overall Study||10
8930881|NCT02299869|9992504|FG002|COMPLETED|Overall Study||10
8930882|NCT02299869|9992505|FG003|COMPLETED|Overall Study||10
8930883|NCT02299869|9992502|FG000|NOT COMPLETED|Overall Study||0
8930884|NCT02299869|9992503|FG001|NOT COMPLETED|Overall Study||0
8930885|NCT02299869|9992504|FG002|NOT COMPLETED|Overall Study||0
8930886|NCT02299869|9992505|FG003|NOT COMPLETED|Overall Study||0
8930887|NCT02300025|9992516|FG000|STARTED|Overall Study||10
8930888|NCT02300025|9992517|FG001|STARTED|Overall Study||6
8930889|NCT02300025|9992518|FG002|STARTED|Overall Study||6
8930890|NCT02300025|9992519|FG003|STARTED|Overall Study||6
8930891|NCT02300025|9992516|FG000|COMPLETED|Overall Study||10
8930892|NCT02300025|9992517|FG001|COMPLETED|Overall Study||6
8930893|NCT02300025|9992518|FG002|COMPLETED|Overall Study||6
8930894|NCT02300025|9992519|FG003|COMPLETED|Overall Study||6
8930895|NCT02300025|9992516|FG000|NOT COMPLETED|Overall Study||0
8930896|NCT02300025|9992517|FG001|NOT COMPLETED|Overall Study||0
8930897|NCT02300025|9992518|FG002|NOT COMPLETED|Overall Study||0
8930898|NCT02300025|9992519|FG003|NOT COMPLETED|Overall Study||0
8930899|NCT02300077|9992533|FG000|STARTED|Overall Study||21
8617185|NCT00455312|9655371|FG000|COMPLETED|Overall Study||15
8617186|NCT00455312|9655372|FG001|COMPLETED|Overall Study||20
8617187|NCT00455312|9655371|FG000|NOT COMPLETED|Overall Study||0
8617188|NCT00455312|9655372|FG001|NOT COMPLETED|Overall Study||1
8617189|NCT00455429|9655382|FG000|STARTED|Overall Study||18
8617190|NCT00455429|9655383|FG001|STARTED|Overall Study||15
8617191|NCT00455429|9655384|FG002|STARTED|Overall Study||17
8617192|NCT00455429|9655385|FG003|STARTED|Overall Study||34
8617193|NCT00455429|9655382|FG000|Treated|Overall Study||18
8930900|NCT02300077|9992534|FG001|STARTED|Overall Study||18
8930901|NCT02300077|9992535|FG002|STARTED|Overall Study||21
8930902|NCT02300077|9992533|FG000|COMPLETED|Overall Study||21
8930903|NCT02300077|9992534|FG001|COMPLETED|Overall Study||18
8930904|NCT02300077|9992535|FG002|COMPLETED|Overall Study||21
8930905|NCT02300077|9992533|FG000|NOT COMPLETED|Overall Study||0
8617194|NCT00455429|9655383|FG001|Treated|Overall Study||15
8930906|NCT02300077|9992534|FG001|NOT COMPLETED|Overall Study||0
8930907|NCT02300077|9992535|FG002|NOT COMPLETED|Overall Study||0
8930908|NCT02300103|9992543|FG000|STARTED|Overall Study||69
8930909|NCT02300103|9992543|FG000|COMPLETED|Overall Study||63
8930910|NCT02300103|9992543|FG000|NOT COMPLETED|Overall Study||6
8930911|NCT02300129|9992547|FG000|STARTED|Period 1 Session 1 (Day 1)||11
8930912|NCT02300129|9992548|FG001|STARTED|Period 1 Session 1 (Day 1)||5
8930913|NCT02300129|9992549|FG002|STARTED|Period 1 Session 1 (Day 1)||7
8930914|NCT02300129|9992550|FG003|STARTED|Period 1 Session 1 (Day 1)||11
8930915|NCT02300129|9992547|FG000|COMPLETED|Period 1 Session 1 (Day 1)||11
8930916|NCT02300129|9992548|FG001|COMPLETED|Period 1 Session 1 (Day 1)||5
8930917|NCT02300129|9992549|FG002|COMPLETED|Period 1 Session 1 (Day 1)||7
8930918|NCT02300129|9992550|FG003|COMPLETED|Period 1 Session 1 (Day 1)||11
8930919|NCT02300129|9992547|FG000|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
8930920|NCT02300129|9992548|FG001|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
8930921|NCT02300129|9992549|FG002|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
8930922|NCT02300129|9992550|FG003|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
8930923|NCT02300129|9992547|FG000|STARTED|Period 1 Session 2 (Day 3)||11
8930924|NCT02300129|9992548|FG001|STARTED|Period 1 Session 2 (Day 3)|Withdrawal consent of 1 subject between Day 1 and Day 3|5
8930925|NCT02300129|9992549|FG002|STARTED|Period 1 Session 2 (Day 3)||7
8930926|NCT02300129|9992550|FG003|STARTED|Period 1 Session 2 (Day 3)||11
8930927|NCT02300129|9992547|FG000|COMPLETED|Period 1 Session 2 (Day 3)||11
8930928|NCT02300129|9992548|FG001|COMPLETED|Period 1 Session 2 (Day 3)||4
8930929|NCT02300129|9992549|FG002|COMPLETED|Period 1 Session 2 (Day 3)||7
8930930|NCT02300129|9992550|FG003|COMPLETED|Period 1 Session 2 (Day 3)||11
8930931|NCT02300129|9992547|FG000|NOT COMPLETED|Period 1 Session 2 (Day 3)||0
8617195|NCT00455429|9655384|FG002|Treated|Overall Study||17
8617196|NCT00455429|9655385|FG003|Treated|Overall Study||32
8617197|NCT00455429|9655382|FG000|COMPLETED|Overall Study||16
8930932|NCT02300129|9992548|FG001|NOT COMPLETED|Period 1 Session 2 (Day 3)||1
8930933|NCT02300129|9992549|FG002|NOT COMPLETED|Period 1 Session 2 (Day 3)||0
8930934|NCT02300129|9992550|FG003|NOT COMPLETED|Period 1 Session 2 (Day 3)||0
8930935|NCT02300129|9992547|FG000|STARTED|Period 1 Session 3 (Day 5)||11
8930936|NCT02300129|9992548|FG001|STARTED|Period 1 Session 3 (Day 5)||4
8930937|NCT02300129|9992549|FG002|STARTED|Period 1 Session 3 (Day 5)||7
8930938|NCT02300129|9992550|FG003|STARTED|Period 1 Session 3 (Day 5)||11
8930939|NCT02300129|9992547|FG000|COMPLETED|Period 1 Session 3 (Day 5)||11
8930940|NCT02300129|9992548|FG001|COMPLETED|Period 1 Session 3 (Day 5)||4
8930941|NCT02300129|9992549|FG002|COMPLETED|Period 1 Session 3 (Day 5)||7
8930942|NCT02300129|9992550|FG003|COMPLETED|Period 1 Session 3 (Day 5)||11
8930943|NCT02300129|9992547|FG000|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
8930944|NCT02300129|9992548|FG001|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
8930945|NCT02300129|9992549|FG002|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
8617198|NCT00455429|9655383|FG001|COMPLETED|Overall Study||10
8930946|NCT02300129|9992550|FG003|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
8930947|NCT02300129|9992547|FG000|STARTED|Period 2 Treatment 1 (2 Weeks)||11
8930948|NCT02300129|9992548|FG001|STARTED|Period 2 Treatment 1 (2 Weeks)||4
8617199|NCT00455429|9655384|FG002|COMPLETED|Overall Study||16
8617200|NCT00455429|9655385|FG003|COMPLETED|Overall Study||20
8617201|NCT00455429|9655382|FG000|NOT COMPLETED|Overall Study||2
8617202|NCT00455429|9655383|FG001|NOT COMPLETED|Overall Study||5
8617203|NCT00455429|9655384|FG002|NOT COMPLETED|Overall Study||1
8930949|NCT02300129|9992549|FG002|STARTED|Period 2 Treatment 1 (2 Weeks)||7
8930950|NCT02300129|9992550|FG003|STARTED|Period 2 Treatment 1 (2 Weeks)|Withdrawal consent of 1 subject between the Period 1 and Period 2|11
8930951|NCT02300129|9992547|FG000|COMPLETED|Period 2 Treatment 1 (2 Weeks)||10
8930952|NCT02300129|9992548|FG001|COMPLETED|Period 2 Treatment 1 (2 Weeks)||4
8930953|NCT02300129|9992549|FG002|COMPLETED|Period 2 Treatment 1 (2 Weeks)||7
8930954|NCT02300129|9992550|FG003|COMPLETED|Period 2 Treatment 1 (2 Weeks)||10
8930955|NCT02300129|9992547|FG000|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||1
8930956|NCT02300129|9992548|FG001|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||0
8930957|NCT02300129|9992549|FG002|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||0
8930958|NCT02300129|9992550|FG003|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||1
8930959|NCT02300129|9992547|FG000|STARTED|Period 2 Treatment 2 (2 Weeks)||10
8930960|NCT02300129|9992548|FG001|STARTED|Period 2 Treatment 2 (2 Weeks)||4
8930961|NCT02300129|9992549|FG002|STARTED|Period 2 Treatment 2 (2 Weeks)||7
8930962|NCT02300129|9992550|FG003|STARTED|Period 2 Treatment 2 (2 Weeks)||10
8930963|NCT02300129|9992547|FG000|COMPLETED|Period 2 Treatment 2 (2 Weeks)||10
8930964|NCT02300129|9992548|FG001|COMPLETED|Period 2 Treatment 2 (2 Weeks)||4
8930965|NCT02300129|9992549|FG002|COMPLETED|Period 2 Treatment 2 (2 Weeks)||7
8930966|NCT02300129|9992550|FG003|COMPLETED|Period 2 Treatment 2 (2 Weeks)||10
8930967|NCT02300129|9992547|FG000|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
8930968|NCT02300129|9992548|FG001|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
8930969|NCT02300129|9992549|FG002|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
8930970|NCT02300129|9992550|FG003|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
8930971|NCT02300220|9992562|FG000|STARTED|Overall Study||72
8930972|NCT02300220|9992563|FG001|STARTED|Overall Study||72
8930973|NCT02300220|9992562|FG000|COMPLETED|Overall Study||68
8930974|NCT02300220|9992563|FG001|COMPLETED|Overall Study||65
8930975|NCT02300220|9992562|FG000|NOT COMPLETED|Overall Study||4
8930976|NCT02300220|9992563|FG001|NOT COMPLETED|Overall Study||7
8930977|NCT02300259|9992572|FG000|STARTED|Period 1||16
8930978|NCT02300259|9992573|FG001|STARTED|Period 1||16
8930979|NCT02300259|9992574|FG002|STARTED|Period 1||16
8930980|NCT02300259|9992572|FG000|Received at Least One Dose of Study Drug|Period 1||16
8930981|NCT02300259|9992573|FG001|Received at Least One Dose of Study Drug|Period 1||16
8930982|NCT02300259|9992574|FG002|Received at Least One Dose of Study Drug|Period 1||16
8930983|NCT02300259|9992572|FG000|COMPLETED|Period 1||16
8930984|NCT02300259|9992573|FG001|COMPLETED|Period 1||16
8930985|NCT02300259|9992574|FG002|COMPLETED|Period 1||14
8930986|NCT02300259|9992572|FG000|NOT COMPLETED|Period 1||0
8930987|NCT02300259|9992573|FG001|NOT COMPLETED|Period 1||0
8930988|NCT02300259|9992574|FG002|NOT COMPLETED|Period 1||2
8930989|NCT02300259|9992572|FG000|STARTED|Period 2||16
8930990|NCT02300259|9992573|FG001|STARTED|Period 2|There was no period 2 for Group 2.|0
8930991|NCT02300259|9992574|FG002|STARTED|Period 2||14
8930992|NCT02300259|9992572|FG000|COMPLETED|Period 2||15
8930993|NCT02300259|9992573|FG001|COMPLETED|Period 2||0
8930994|NCT02300259|9992574|FG002|COMPLETED|Period 2||13
8930995|NCT02300259|9992572|FG000|NOT COMPLETED|Period 2||1
8930996|NCT02300259|9992573|FG001|NOT COMPLETED|Period 2||0
8930997|NCT02300259|9992574|FG002|NOT COMPLETED|Period 2||1
8930998|NCT02300285|9992595|FG000|STARTED|Overall Study||3
8930999|NCT02300285|9992596|FG001|STARTED|Overall Study||3
8931000|NCT02300285|9992595|FG000|COMPLETED|Overall Study||3
8931001|NCT02300285|9992596|FG001|COMPLETED|Overall Study||3
8931002|NCT02300285|9992595|FG000|NOT COMPLETED|Overall Study||0
8931003|NCT02300285|9992596|FG001|NOT COMPLETED|Overall Study||0
8931004|NCT02300298|9992602|FG000|STARTED|Disposition for Nintedanib||10
8931005|NCT02300298|9992603|FG001|STARTED|Disposition for Nintedanib||0
8931006|NCT02300298|9992602|FG000|COMPLETED|Disposition for Nintedanib||0
8931007|NCT02300298|9992603|FG001|COMPLETED|Disposition for Nintedanib||0
8931008|NCT02300298|9992602|FG000|NOT COMPLETED|Disposition for Nintedanib||10
8931009|NCT02300298|9992603|FG001|NOT COMPLETED|Disposition for Nintedanib||0
8931010|NCT02300298|9992602|FG000|STARTED|Disposition for Docetaxel||0
8931011|NCT02300298|9992603|FG001|STARTED|Disposition for Docetaxel||10
8931012|NCT02300298|9992602|FG000|COMPLETED|Disposition for Docetaxel||0
8931013|NCT02300298|9992603|FG001|COMPLETED|Disposition for Docetaxel||0
8931014|NCT02300298|9992602|FG000|NOT COMPLETED|Disposition for Docetaxel||0
8931015|NCT02300298|9992603|FG001|NOT COMPLETED|Disposition for Docetaxel||10
8931016|NCT02300311|9992609|FG000|STARTED|Overall Study||69
8931017|NCT02300311|9992610|FG001|STARTED|Overall Study||69
8931018|NCT02300311|9992609|FG000|COMPLETED|Overall Study||50
8617204|NCT00455429|9655385|FG003|NOT COMPLETED|Overall Study||14
8931019|NCT02300311|9992610|FG001|COMPLETED|Overall Study||69
8931020|NCT02300311|9992609|FG000|NOT COMPLETED|Overall Study||19
8931021|NCT02300311|9992610|FG001|NOT COMPLETED|Overall Study||0
8931022|NCT02300545|9992616|FG000|STARTED|Overall Study||56
8931023|NCT02300545|9992616|FG000|COMPLETED|Overall Study||56
8931024|NCT02300545|9992616|FG000|NOT COMPLETED|Overall Study||0
8931025|NCT02300558|9992620|FG000|STARTED|Single Blind Phase (24 Weeks)||41
8931026|NCT02300558|9992620|FG000|COMPLETED|Single Blind Phase (24 Weeks)||35
8931027|NCT02300558|9992620|FG000|NOT COMPLETED|Single Blind Phase (24 Weeks)||6
8931028|NCT02300558|9992620|FG000|STARTED|Open-Label (OL) Extension Phase||32
8931029|NCT02300558|9992620|FG000|COMPLETED|Open-Label (OL) Extension Phase||0
8931030|NCT02300558|9992620|FG000|NOT COMPLETED|Open-Label (OL) Extension Phase||32
8931031|NCT02300610|9992631|FG000|STARTED|Overall Study||3
8931032|NCT02300610|9992632|FG001|STARTED|Overall Study||3
8931033|NCT02300610|9992633|FG002|STARTED|Overall Study||4
8931034|NCT02300610|9992631|FG000|COMPLETED|Overall Study||2
8931035|NCT02300610|9992632|FG001|COMPLETED|Overall Study||3
8931036|NCT02300610|9992633|FG002|COMPLETED|Overall Study||3
8931037|NCT02300610|9992631|FG000|NOT COMPLETED|Overall Study||1
8931038|NCT02300610|9992632|FG001|NOT COMPLETED|Overall Study||0
8931039|NCT02300610|9992633|FG002|NOT COMPLETED|Overall Study||1
8931040|NCT02300727|9992649|FG000|STARTED|Overall Study||0
8931041|NCT02300727|9992650|FG001|STARTED|Overall Study||0
8931042|NCT02300727|9992651|FG002|STARTED|Overall Study||3
8931043|NCT02300727|9992652|FG003|STARTED|Overall Study||3
8931044|NCT02300727|9992653|FG004|STARTED|Overall Study||0
8931045|NCT02300727|9992654|FG005|STARTED|Overall Study||0
8931046|NCT02300727|9992649|FG000|COMPLETED|Overall Study||0
8931047|NCT02300727|9992650|FG001|COMPLETED|Overall Study||0
8931048|NCT02300727|9992651|FG002|COMPLETED|Overall Study||3
8931049|NCT02300727|9992652|FG003|COMPLETED|Overall Study||2
8931050|NCT02300727|9992653|FG004|COMPLETED|Overall Study||0
8931051|NCT02300727|9992654|FG005|COMPLETED|Overall Study||0
8931052|NCT02300727|9992649|FG000|NOT COMPLETED|Overall Study||0
8931053|NCT02300727|9992650|FG001|NOT COMPLETED|Overall Study||0
8931054|NCT02300727|9992651|FG002|NOT COMPLETED|Overall Study||0
8931055|NCT02300727|9992652|FG003|NOT COMPLETED|Overall Study||1
8931056|NCT02300727|9992653|FG004|NOT COMPLETED|Overall Study||0
8931057|NCT02300727|9992654|FG005|NOT COMPLETED|Overall Study||0
8931058|NCT02300987|9992670|FG000|STARTED|Primary Phase : Prior to Cross-over||8
8931059|NCT02300987|9992671|FG001|STARTED|Primary Phase : Prior to Cross-over||2
8931060|NCT02300987|9992670|FG000|COMPLETED|Primary Phase : Prior to Cross-over||2
8931061|NCT02300987|9992671|FG001|COMPLETED|Primary Phase : Prior to Cross-over||0
8931062|NCT02300987|9992670|FG000|NOT COMPLETED|Primary Phase : Prior to Cross-over||6
8931063|NCT02300987|9992671|FG001|NOT COMPLETED|Primary Phase : Prior to Cross-over||2
8931064|NCT02300987|9992670|FG000|STARTED|Secondary Phase : Cross-over to LEE011||1
8931065|NCT02300987|9992671|FG001|STARTED|Secondary Phase : Cross-over to LEE011||2
8931066|NCT02300987|9992670|FG000|COMPLETED|Secondary Phase : Cross-over to LEE011||0
9064726|NCT04272775|10125109|FG000|STARTED|Overall Study||7
9064727|NCT04272775|10125110|FG001|STARTED|Overall Study||7
9064728|NCT04272775|10125109|FG000|COMPLETED|Overall Study||0
9064729|NCT04272775|10125110|FG001|COMPLETED|Overall Study||0
9064730|NCT04272775|10125109|FG000|NOT COMPLETED|Overall Study||7
9064731|NCT04272775|10125110|FG001|NOT COMPLETED|Overall Study||7
9064732|NCT04271020|10125116|FG000|STARTED|Overall Study||12
9064733|NCT04271020|10125116|FG000|COMPLETED|Overall Study||12
9064734|NCT04271020|10125116|FG000|NOT COMPLETED|Overall Study||0
9064735|NCT04274075|10125126|FG000|STARTED|Overall Study||3
9064736|NCT04274075|10125127|FG001|STARTED|Overall Study||3
9064737|NCT04274075|10125128|FG002|STARTED|Overall Study||3
9064738|NCT04274075|10125129|FG003|STARTED|Overall Study||3
9064739|NCT04274075|10125130|FG004|STARTED|Overall Study||3
9064740|NCT04274075|10125131|FG005|STARTED|Overall Study||3
9064741|NCT04274075|10125126|FG000|Completed Treatment Period 1 (9 Days)|Overall Study||3
9064742|NCT04274075|10125127|FG001|Completed Treatment Period 1 (9 Days)|Overall Study||3
9064743|NCT04274075|10125128|FG002|Completed Treatment Period 1 (9 Days)|Overall Study||3
9064744|NCT04274075|10125129|FG003|Completed Treatment Period 1 (9 Days)|Overall Study||3
9064745|NCT04274075|10125130|FG004|Completed Treatment Period 1 (9 Days)|Overall Study||3
9064746|NCT04274075|10125131|FG005|Completed Treatment Period 1 (9 Days)|Overall Study||3
9064747|NCT04274075|10125126|FG000|Completed Treatment Period 2 (9 Days)|Overall Study||3
9064748|NCT04274075|10125127|FG001|Completed Treatment Period 2 (9 Days)|Overall Study||3
9064749|NCT04274075|10125128|FG002|Completed Treatment Period 2 (9 Days)|Overall Study||3
9064750|NCT04274075|10125129|FG003|Completed Treatment Period 2 (9 Days)|Overall Study||3
9064751|NCT04274075|10125130|FG004|Completed Treatment Period 2 (9 Days)|Overall Study||3
9064752|NCT04274075|10125131|FG005|Completed Treatment Period 2 (9 Days)|Overall Study||3
9064753|NCT04274075|10125126|FG000|Completed Treatment Period 3 (9 Days)|Overall Study||3
9064754|NCT04274075|10125127|FG001|Completed Treatment Period 3 (9 Days)|Overall Study||3
9064755|NCT04274075|10125128|FG002|Completed Treatment Period 3 (9 Days)|Overall Study||3
9064756|NCT04274075|10125129|FG003|Completed Treatment Period 3 (9 Days)|Overall Study||3
9064757|NCT04274075|10125130|FG004|Completed Treatment Period 3 (9 Days)|Overall Study||3
9064758|NCT04274075|10125131|FG005|Completed Treatment Period 3 (9 Days)|Overall Study||3
9064759|NCT04274075|10125126|FG000|Completed Follow-up Visit|Overall Study||3
9064760|NCT04274075|10125127|FG001|Completed Follow-up Visit|Overall Study||3
9064761|NCT04274075|10125128|FG002|Completed Follow-up Visit|Overall Study||3
9064762|NCT04274075|10125129|FG003|Completed Follow-up Visit|Overall Study||3
9064763|NCT04274075|10125130|FG004|Completed Follow-up Visit|Overall Study||3
8931067|NCT02300987|9992671|FG001|COMPLETED|Secondary Phase : Cross-over to LEE011||1
8931068|NCT02300987|9992670|FG000|NOT COMPLETED|Secondary Phase : Cross-over to LEE011||1
8931069|NCT02300987|9992671|FG001|NOT COMPLETED|Secondary Phase : Cross-over to LEE011||1
8931070|NCT02301039|9992681|FG000|STARTED|Overall Study||42
8931071|NCT02301039|9992682|FG001|STARTED|Overall Study||42
8931072|NCT02301039|9992683|FG002|STARTED|Overall Study||60
8931073|NCT02301039|9992681|FG000|COMPLETED|Overall Study||42
8931074|NCT02301039|9992682|FG001|COMPLETED|Overall Study||42
8931075|NCT02301039|9992683|FG002|COMPLETED|Overall Study||60
8931076|NCT02301039|9992681|FG000|NOT COMPLETED|Overall Study||0
8931077|NCT02301039|9992682|FG001|NOT COMPLETED|Overall Study||0
8931078|NCT02301039|9992683|FG002|NOT COMPLETED|Overall Study||0
8931079|NCT02301143|9992691|FG000|STARTED|Induction Period||107
8931080|NCT02301143|9992692|FG001|STARTED|Induction Period||0
8931081|NCT02301143|9992691|FG000|COMPLETED|Induction Period||62
8931082|NCT02301143|9992692|FG001|COMPLETED|Induction Period||0
8931083|NCT02301143|9992691|FG000|NOT COMPLETED|Induction Period||45
8931084|NCT02301143|9992692|FG001|NOT COMPLETED|Induction Period||0
8931085|NCT02301143|9992691|FG000|STARTED|Investigator's Choice||0
8931086|NCT02301143|9992692|FG001|STARTED|Investigator's Choice|12 participants continued nab-Paclitaxel/Gemcitabine; 18 started chemoradiation;17 underwent surgery|47
8931087|NCT02301143|9992691|FG000|COMPLETED|Investigator's Choice||0
8931088|NCT02301143|9992692|FG001|COMPLETED|Investigator's Choice|3 participants completed nab-Paclitaxel+Gemcitabine,18 completed chemoradiation,16 had surgery.|37
8931089|NCT02301143|9992691|FG000|NOT COMPLETED|Investigator's Choice||0
8931090|NCT02301143|9992692|FG001|NOT COMPLETED|Investigator's Choice||10
8931091|NCT02301169|9992705|FG000|STARTED|Overall Study||21
8931092|NCT02301169|9992706|FG001|STARTED|Overall Study||21
8931093|NCT02301169|9992705|FG000|COMPLETED|Overall Study||20
8931094|NCT02301169|9992706|FG001|COMPLETED|Overall Study||21
8931095|NCT02301169|9992705|FG000|NOT COMPLETED|Overall Study||1
8931096|NCT02301169|9992706|FG001|NOT COMPLETED|Overall Study||0
8931097|NCT02301299|9992712|FG000|STARTED|Overall Study||1322
8931098|NCT02301299|9992712|FG000|COMPLETED|Overall Study||1322
8931099|NCT02301299|9992712|FG000|NOT COMPLETED|Overall Study||0
8931100|NCT02301364|9992719|FG000|STARTED|Overall Study||4
8931101|NCT02301364|9992719|FG000|COMPLETED|Overall Study||4
8931102|NCT02301364|9992719|FG000|NOT COMPLETED|Overall Study||0
8931103|NCT02301377|9992725|FG000|STARTED|Overall Study||3
8931104|NCT02301377|9992726|FG001|STARTED|Overall Study||2
8931105|NCT02301377|9992725|FG000|COMPLETED|Overall Study||3
8717879|NCT00996801|9765173|FG005|NOT COMPLETED|Overall Study||19
8717880|NCT00996840|9765194|FG000|STARTED|Overall Study||20
8717881|NCT00996840|9765195|FG001|STARTED|Overall Study||9
8931106|NCT02301377|9992726|FG001|COMPLETED|Overall Study||2
8931107|NCT02301377|9992725|FG000|NOT COMPLETED|Overall Study||0
8931108|NCT02301377|9992726|FG001|NOT COMPLETED|Overall Study||0
8931109|NCT02301390|9992734|FG000|STARTED|Overall Study||27
8931110|NCT02301390|9992735|FG001|STARTED|Overall Study||26
8931111|NCT02301390|9992734|FG000|COMPLETED|Overall Study||17
8931112|NCT02301390|9992735|FG001|COMPLETED|Overall Study||13
8931113|NCT02301390|9992734|FG000|NOT COMPLETED|Overall Study||10
8931114|NCT02301390|9992735|FG001|NOT COMPLETED|Overall Study||13
8931115|NCT02301403|9992743|FG000|STARTED|Overall Study||315
8931116|NCT02301403|9992744|FG001|STARTED|Overall Study||308
8931117|NCT02301403|9992743|FG000|COMPLETED|Overall Study||287
8931118|NCT02301403|9992744|FG001|COMPLETED|Overall Study||267
8931119|NCT02301403|9992743|FG000|NOT COMPLETED|Overall Study||28
8931120|NCT02301403|9992744|FG001|NOT COMPLETED|Overall Study||41
8931121|NCT02301416|9992752|FG000|STARTED|Overall Study||25
8931122|NCT02301416|9992753|FG001|STARTED|Overall Study||40
8931123|NCT02301416|9992752|FG000|COMPLETED|Overall Study||15
8931124|NCT02301416|9992753|FG001|COMPLETED|Overall Study||40
8931125|NCT02301416|9992752|FG000|NOT COMPLETED|Overall Study||10
8931126|NCT02301416|9992753|FG001|NOT COMPLETED|Overall Study||0
8931127|NCT02301429|9992759|FG000|STARTED|Overall Study||16
8931128|NCT02301429|9992759|FG000|COMPLETED|Overall Study||13
8931129|NCT02301429|9992759|FG000|NOT COMPLETED|Overall Study||3
8931130|NCT02301546|9992765|FG000|STARTED|Short-term Effectiveness (~13 Weeks)||73
8931131|NCT02301546|9992766|FG001|STARTED|Short-term Effectiveness (~13 Weeks)||73
8931132|NCT02301546|9992765|FG000|COMPLETED|Short-term Effectiveness (~13 Weeks)||55
8931133|NCT02301546|9992766|FG001|COMPLETED|Short-term Effectiveness (~13 Weeks)||58
8931134|NCT02301546|9992765|FG000|NOT COMPLETED|Short-term Effectiveness (~13 Weeks)||18
8931135|NCT02301546|9992766|FG001|NOT COMPLETED|Short-term Effectiveness (~13 Weeks)||15
8931136|NCT02301546|9992765|FG000|STARTED|Long Term Effectiveness (~1 Year)||55
8931137|NCT02301546|9992766|FG001|STARTED|Long Term Effectiveness (~1 Year)||58
8931138|NCT02301546|9992765|FG000|COMPLETED|Long Term Effectiveness (~1 Year)||43
8931139|NCT02301546|9992766|FG001|COMPLETED|Long Term Effectiveness (~1 Year)||51
8931140|NCT02301546|9992765|FG000|NOT COMPLETED|Long Term Effectiveness (~1 Year)||12
8931141|NCT02301546|9992766|FG001|NOT COMPLETED|Long Term Effectiveness (~1 Year)||7
8931142|NCT02301624|9992774|FG000|STARTED|Blind Induction Phase||56
8931143|NCT02301624|9992775|FG001|STARTED|Blind Induction Phase||61
8931144|NCT02301624|9992774|FG000|Received at Least 1 Dose of Study Drug|Blind Induction Phase||56
8931145|NCT02301624|9992775|FG001|Received at Least 1 Dose of Study Drug|Blind Induction Phase||61
8931146|NCT02301624|9992774|FG000|COMPLETED|Blind Induction Phase||55
8931147|NCT02301624|9992775|FG001|COMPLETED|Blind Induction Phase||61
8931148|NCT02301624|9992774|FG000|NOT COMPLETED|Blind Induction Phase||1
8931149|NCT02301624|9992775|FG001|NOT COMPLETED|Blind Induction Phase||0
8931150|NCT02301624|9992774|FG000|STARTED|Open-label Maintenance Phase||55
8717882|NCT00996840|9765196|FG002|STARTED|Overall Study||12
8717883|NCT00996840|9765197|FG003|STARTED|Overall Study||18
8931151|NCT02301624|9992775|FG001|STARTED|Open-label Maintenance Phase||61
8931152|NCT02301624|9992774|FG000|Received at Least 1 Dose of Study Drug|Open-label Maintenance Phase||55
8931153|NCT02301624|9992775|FG001|Received at Least 1 Dose of Study Drug|Open-label Maintenance Phase||61
8931154|NCT02301624|9992774|FG000|COMPLETED|Open-label Maintenance Phase||43
8931155|NCT02301624|9992775|FG001|COMPLETED|Open-label Maintenance Phase||44
8931156|NCT02301624|9992774|FG000|NOT COMPLETED|Open-label Maintenance Phase||12
8931157|NCT02301624|9992775|FG001|NOT COMPLETED|Open-label Maintenance Phase||17
8931158|NCT02301793|9992784|FG000|STARTED|Pre Education Study Period|Nurses had not been randomized|
8931159|NCT02301793|9992785|FG001|STARTED|Pre Education Study Period|Nurses had not been randomized|
8931160|NCT02301793|9992784|FG000|COMPLETED|Pre Education Study Period|Nurses had not been randomized|
8931161|NCT02301793|9992785|FG001|COMPLETED|Pre Education Study Period|Nurses had not been randomized|
8931162|NCT02301793|9992784|FG000|NOT COMPLETED|Pre Education Study Period||
8931163|NCT02301793|9992785|FG001|NOT COMPLETED|Pre Education Study Period||
8931164|NCT02301793|9992784|FG000|STARTED|During and Post Education Study Period||488
8931165|NCT02301793|9992785|FG001|STARTED|During and Post Education Study Period||445
8931166|NCT02301793|9992784|FG000|COMPLETED|During and Post Education Study Period||405
8931167|NCT02301793|9992785|FG001|COMPLETED|During and Post Education Study Period||396
8931168|NCT02301793|9992784|FG000|NOT COMPLETED|During and Post Education Study Period||83
8931169|NCT02301793|9992785|FG001|NOT COMPLETED|During and Post Education Study Period||49
8931170|NCT02301897|9992794|FG000|STARTED|Treatment Course 1||12
8931171|NCT02301897|9992795|FG001|STARTED|Treatment Course 1||17
8931172|NCT02301897|9992796|FG002|STARTED|Treatment Course 1||14
8931173|NCT02301897|9992794|FG000|COMPLETED|Treatment Course 1||9
8931174|NCT02301897|9992795|FG001|COMPLETED|Treatment Course 1||14
8931175|NCT02301897|9992796|FG002|COMPLETED|Treatment Course 1||8
8931176|NCT02301897|9992794|FG000|NOT COMPLETED|Treatment Course 1||3
8931177|NCT02301897|9992795|FG001|NOT COMPLETED|Treatment Course 1||3
8931178|NCT02301897|9992796|FG002|NOT COMPLETED|Treatment Course 1||6
8931179|NCT02301897|9992794|FG000|STARTED|Treatment Course 2||9
8931180|NCT02301897|9992795|FG001|STARTED|Treatment Course 2||14
8931181|NCT02301897|9992796|FG002|STARTED|Treatment Course 2||8
8931182|NCT02301897|9992794|FG000|COMPLETED|Treatment Course 2||8
8931183|NCT02301897|9992795|FG001|COMPLETED|Treatment Course 2||9
8931184|NCT02301897|9992796|FG002|COMPLETED|Treatment Course 2||7
8931185|NCT02301897|9992794|FG000|NOT COMPLETED|Treatment Course 2||1
8931186|NCT02301897|9992795|FG001|NOT COMPLETED|Treatment Course 2||5
8931187|NCT02301897|9992796|FG002|NOT COMPLETED|Treatment Course 2||1
8931188|NCT02301936|9992806|FG000|STARTED|Overall Study||9
8931189|NCT02301936|9992807|FG001|STARTED|Overall Study||1
8931190|NCT02301936|9992806|FG000|COMPLETED|Overall Study||8
8931191|NCT02301936|9992807|FG001|COMPLETED|Overall Study||1
8931192|NCT02301936|9992806|FG000|NOT COMPLETED|Overall Study||1
8931193|NCT02301936|9992807|FG001|NOT COMPLETED|Overall Study||0
8931194|NCT02301975|9992816|FG000|STARTED|Overall Study||504
8931195|NCT02301975|9992817|FG001|STARTED|Overall Study||501
8931196|NCT02301975|9992818|FG002|STARTED|Overall Study||499
8931197|NCT02301975|9992816|FG000|COMPLETED|Overall Study||473
8931198|NCT02301975|9992817|FG001|COMPLETED|Overall Study||476
8931199|NCT02301975|9992818|FG002|COMPLETED|Overall Study||477
8931200|NCT02301975|9992816|FG000|NOT COMPLETED|Overall Study||31
8931201|NCT02301975|9992817|FG001|NOT COMPLETED|Overall Study||25
8931202|NCT02301975|9992818|FG002|NOT COMPLETED|Overall Study||22
8931203|NCT02301988|9992828|FG000|STARTED|Overall Study||76
8931204|NCT02301988|9992829|FG001|STARTED|Overall Study||75
8931205|NCT02301988|9992828|FG000|COMPLETED|Overall Study||66
8931206|NCT02301988|9992829|FG001|COMPLETED|Overall Study||66
8931207|NCT02301988|9992828|FG000|NOT COMPLETED|Overall Study||10
8931208|NCT02301988|9992829|FG001|NOT COMPLETED|Overall Study||9
8931209|NCT02302066|9992839|FG000|STARTED|Overall Study||201
8931210|NCT02302066|9992840|FG001|STARTED|Overall Study||398
8931211|NCT02302066|9992841|FG002|STARTED|Overall Study||1002
8931212|NCT02302066|9992842|FG003|STARTED|Overall Study||199
8931213|NCT02302066|9992839|FG000|Safety Analysis Set|Overall Study||200
8931214|NCT02302066|9992840|FG001|Safety Analysis Set|Overall Study||398
8931215|NCT02302066|9992841|FG002|Safety Analysis Set|Overall Study||998
8931216|NCT02302066|9992842|FG003|Safety Analysis Set|Overall Study||198
8931217|NCT02302066|9992839|FG000|Immunogenicity Subset|Overall Study||92
8931218|NCT02302066|9992840|FG001|Immunogenicity Subset|Overall Study||187
8931219|NCT02302066|9992841|FG002|Immunogenicity Subset|Overall Study||192
8931220|NCT02302066|9992842|FG003|Immunogenicity Subset|Overall Study||94
8931221|NCT02302066|9992839|FG000|Per-Protocol Set (PPS)|Overall Study||83
8931222|NCT02302066|9992840|FG001|Per-Protocol Set (PPS)|Overall Study||171
8931223|NCT02302066|9992841|FG002|Per-Protocol Set (PPS)|Overall Study||174
8931224|NCT02302066|9992842|FG003|Per-Protocol Set (PPS)|Overall Study||81
8931225|NCT02302066|9992839|FG000|COMPLETED|Overall Study||168
8931226|NCT02302066|9992840|FG001|COMPLETED|Overall Study||323
8931227|NCT02302066|9992841|FG002|COMPLETED|Overall Study||830
8931228|NCT02302066|9992842|FG003|COMPLETED|Overall Study||158
8931229|NCT02302066|9992839|FG000|NOT COMPLETED|Overall Study||33
8931230|NCT02302066|9992840|FG001|NOT COMPLETED|Overall Study||75
8931231|NCT02302066|9992841|FG002|NOT COMPLETED|Overall Study||172
8931232|NCT02302066|9992842|FG003|NOT COMPLETED|Overall Study||41
8931233|NCT02302092|9992864|FG000|STARTED|Overall Study||6
8931234|NCT02302092|9992865|FG001|STARTED|Overall Study||7
8931235|NCT02302092|9992864|FG000|COMPLETED|Overall Study||6
8931236|NCT02302092|9992865|FG001|COMPLETED|Overall Study||7
8931237|NCT02302092|9992864|FG000|NOT COMPLETED|Overall Study||0
8931238|NCT02302092|9992865|FG001|NOT COMPLETED|Overall Study||0
8931239|NCT02302157|9992876|FG000|STARTED|Overall Study||3
8931240|NCT02302157|9992877|FG001|STARTED|Overall Study||6
8931241|NCT02302157|9992878|FG002|STARTED|Overall Study||6
8931242|NCT02302157|9992879|FG003|STARTED|Overall Study||6
8931243|NCT02302157|9992880|FG004|STARTED|Overall Study||4
8931244|NCT02302157|9992876|FG000|COMPLETED|Overall Study||3
8931245|NCT02302157|9992877|FG001|COMPLETED|Overall Study||6
8931246|NCT02302157|9992878|FG002|COMPLETED|Overall Study||6
8931247|NCT02302157|9992879|FG003|COMPLETED|Overall Study||6
8931248|NCT02302157|9992880|FG004|COMPLETED|Overall Study||4
8931249|NCT02302157|9992876|FG000|NOT COMPLETED|Overall Study||0
8931250|NCT02302157|9992877|FG001|NOT COMPLETED|Overall Study||0
8931251|NCT02302157|9992878|FG002|NOT COMPLETED|Overall Study||0
8931252|NCT02302157|9992879|FG003|NOT COMPLETED|Overall Study||0
8931253|NCT02302157|9992880|FG004|NOT COMPLETED|Overall Study||0
8931254|NCT02302222|9992899|FG000|STARTED|Overall Study||34
8931255|NCT02302222|9992900|FG001|STARTED|Overall Study||37
8931256|NCT02302222|9992899|FG000|COMPLETED|Overall Study||33
8931257|NCT02302222|9992900|FG001|COMPLETED|Overall Study||31
8931258|NCT02302222|9992899|FG000|NOT COMPLETED|Overall Study||1
8931259|NCT02302222|9992900|FG001|NOT COMPLETED|Overall Study||6
8931260|NCT02302339|9992910|FG000|STARTED|Overall Study||62
8931261|NCT02302339|9992911|FG001|STARTED|Overall Study||34
8931262|NCT02302339|9992912|FG002|STARTED|Overall Study||29
8931263|NCT02302339|9992913|FG003|STARTED|Overall Study||7
8931264|NCT02302339|9992910|FG000|COMPLETED|Overall Study||61
8931265|NCT02302339|9992911|FG001|COMPLETED|Overall Study||32
8931266|NCT02302339|9992912|FG002|COMPLETED|Overall Study||28
8931267|NCT02302339|9992913|FG003|COMPLETED|Overall Study||7
8931268|NCT02302339|9992910|FG000|NOT COMPLETED|Overall Study||1
8931269|NCT02302339|9992911|FG001|NOT COMPLETED|Overall Study||2
8931270|NCT02302339|9992912|FG002|NOT COMPLETED|Overall Study||1
8931271|NCT02302339|9992913|FG003|NOT COMPLETED|Overall Study||0
8931272|NCT02302365|9992924|FG000|STARTED|0-2 Hour Period|Data were collected from 58 WBCD procedures performed in 43 subjects - Full and Safety Analysis Sets|43
8931273|NCT02302365|9992924|FG000|COMPLETED|0-2 Hour Period|The Per-protocol Analysis Set comprised 54 procedures performed in 41 subjects|41
8931274|NCT02302365|9992924|FG000|NOT COMPLETED|0-2 Hour Period||2
8931275|NCT02302365|9992924|FG000|STARTED|0-24 Hour Period|2 of 3 study sites collected additional safety data; 32 pts. 0-24 hour data, 43 pts. 0-2 hour data|32
8931276|NCT02302365|9992924|FG000|COMPLETED|0-24 Hour Period||32
8931277|NCT02302365|9992924|FG000|NOT COMPLETED|0-24 Hour Period||0
8931278|NCT02302716|9992934|FG000|STARTED|Overall Study||249
8931279|NCT02302716|9992935|FG001|STARTED|Overall Study||244
8931280|NCT02302716|9992934|FG000|Received at Least 1 Dose of Study Drug|Overall Study||249
8931281|NCT02302716|9992935|FG001|Received at Least 1 Dose of Study Drug|Overall Study||244
8931282|NCT02302716|9992934|FG000|COMPLETED|Overall Study||230
8931283|NCT02302716|9992935|FG001|COMPLETED|Overall Study||225
8931284|NCT02302716|9992934|FG000|NOT COMPLETED|Overall Study||19
8931285|NCT02302716|9992935|FG001|NOT COMPLETED|Overall Study||19
8931286|NCT02302807|9992943|FG000|STARTED|Overall Study||464
8931287|NCT02302807|9992944|FG001|STARTED|Overall Study||467
8931288|NCT02302807|9992943|FG000|Received Treatment|Overall Study||443
8931289|NCT02302807|9992944|FG001|Received Treatment|Overall Study||459
8931290|NCT02302807|9992943|FG000|COMPLETED|Overall Study|Participants still on chemotherapy were discontinued where that treatment was available locally.|0
8931291|NCT02302807|9992944|FG001|COMPLETED|Overall Study|Participants still receiving atezolizumab had opportunity to continue treatment in extension study.|0
8931292|NCT02302807|9992943|FG000|NOT COMPLETED|Overall Study||464
8931293|NCT02302807|9992944|FG001|NOT COMPLETED|Overall Study||467
8931294|NCT02302846|9992963|FG000|STARTED|Overall Study||5
8931295|NCT02302846|9992963|FG000|COMPLETED|Overall Study||4
8931296|NCT02302846|9992963|FG000|NOT COMPLETED|Overall Study||1
8931297|NCT02303041|9992969|FG000|STARTED|Overall Study||4
8931298|NCT02303041|9992970|FG001|STARTED|Overall Study||6
8931299|NCT02303041|9992969|FG000|COMPLETED|Overall Study||3
8931300|NCT02303041|9992970|FG001|COMPLETED|Overall Study||4
8931301|NCT02303041|9992969|FG000|NOT COMPLETED|Overall Study||1
8931302|NCT02303041|9992970|FG001|NOT COMPLETED|Overall Study||2
8931303|NCT02303093|9992976|FG000|STARTED|Overall Study||344
8931304|NCT02303093|9992976|FG000|COMPLETED|Overall Study||344
8931305|NCT02303093|9992976|FG000|NOT COMPLETED|Overall Study||0
8931306|NCT02303184|9992994|FG000|STARTED|Overall Study||23
8931307|NCT02303184|9992995|FG001|STARTED|Overall Study||23
8931308|NCT02303184|9992994|FG000|COMPLETED|Overall Study||23
8931309|NCT02303184|9992995|FG001|COMPLETED|Overall Study||23
8931310|NCT02303184|9992994|FG000|NOT COMPLETED|Overall Study||0
8931311|NCT02303184|9992995|FG001|NOT COMPLETED|Overall Study||0
8931312|NCT02303262|9993001|FG000|STARTED|Overall Study||20
8931313|NCT02303262|9993001|FG000|COMPLETED|Overall Study||18
8931314|NCT02303262|9993001|FG000|NOT COMPLETED|Overall Study||2
8931315|NCT02303574|9993017|FG000|STARTED|Part 1a (Fasted State)- SAD||6
8931316|NCT02303574|9993018|FG001|STARTED|Part 1a (Fasted State)- SAD||6
8931317|NCT02303574|9993019|FG002|STARTED|Part 1a (Fasted State)- SAD||6
8931318|NCT02303574|9993020|FG003|STARTED|Part 1a (Fasted State)- SAD||6
8931319|NCT02303574|9993021|FG004|STARTED|Part 1a (Fasted State)- SAD||6
8931320|NCT02303574|9993022|FG005|STARTED|Part 1a (Fasted State)- SAD||0
8931321|NCT02303574|9993023|FG006|STARTED|Part 1a (Fasted State)- SAD||0
8931322|NCT02303574|9993024|FG007|STARTED|Part 1a (Fasted State)- SAD||0
8931323|NCT02303574|9993025|FG008|STARTED|Part 1a (Fasted State)- SAD||0
8931324|NCT02303574|9993026|FG009|STARTED|Part 1a (Fasted State)- SAD|Participants received AZD7986 matching placebo on Day 1 in fasted state.|15
8931325|NCT02303574|9993017|FG000|COMPLETED|Part 1a (Fasted State)- SAD||6
8931326|NCT02303574|9993018|FG001|COMPLETED|Part 1a (Fasted State)- SAD||6
8931327|NCT02303574|9993019|FG002|COMPLETED|Part 1a (Fasted State)- SAD||5
8931328|NCT02303574|9993020|FG003|COMPLETED|Part 1a (Fasted State)- SAD||6
8717884|NCT00996840|9765198|FG004|STARTED|Overall Study||18
8717885|NCT00996840|9765194|FG000|COMPLETED|Overall Study||19
8717886|NCT00996840|9765195|FG001|COMPLETED|Overall Study||7
8717887|NCT00996840|9765196|FG002|COMPLETED|Overall Study||11
8717888|NCT00996840|9765197|FG003|COMPLETED|Overall Study||17
8717889|NCT00996840|9765198|FG004|COMPLETED|Overall Study||16
8717890|NCT00996840|9765194|FG000|NOT COMPLETED|Overall Study||1
8717891|NCT00996840|9765195|FG001|NOT COMPLETED|Overall Study||2
8717892|NCT00996840|9765196|FG002|NOT COMPLETED|Overall Study||1
8931329|NCT02303574|9993021|FG004|COMPLETED|Part 1a (Fasted State)- SAD||6
8931330|NCT02303574|9993022|FG005|COMPLETED|Part 1a (Fasted State)- SAD||0
8931331|NCT02303574|9993023|FG006|COMPLETED|Part 1a (Fasted State)- SAD||0
8931332|NCT02303574|9993024|FG007|COMPLETED|Part 1a (Fasted State)- SAD||0
8931333|NCT02303574|9993025|FG008|COMPLETED|Part 1a (Fasted State)- SAD||0
8931334|NCT02303574|9993026|FG009|COMPLETED|Part 1a (Fasted State)- SAD||15
8931335|NCT02303574|9993017|FG000|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
8931336|NCT02303574|9993018|FG001|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
8931337|NCT02303574|9993019|FG002|NOT COMPLETED|Part 1a (Fasted State)- SAD||1
8931338|NCT02303574|9993020|FG003|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
8931339|NCT02303574|9993021|FG004|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
8931340|NCT02303574|9993022|FG005|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
8931341|NCT02303574|9993023|FG006|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
8931342|NCT02303574|9993024|FG007|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
8931343|NCT02303574|9993025|FG008|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
8931344|NCT02303574|9993026|FG009|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
8931345|NCT02303574|9993017|FG000|STARTED|Part 1b (Fed State) - SAD||0
8931346|NCT02303574|9993018|FG001|STARTED|Part 1b (Fed State) - SAD||0
8931347|NCT02303574|9993019|FG002|STARTED|Part 1b (Fed State) - SAD||0
8931348|NCT02303574|9993020|FG003|STARTED|Part 1b (Fed State) - SAD||0
8931349|NCT02303574|9993021|FG004|STARTED|Part 1b (Fed State) - SAD||0
8931350|NCT02303574|9993022|FG005|STARTED|Part 1b (Fed State) - SAD||5
8931351|NCT02303574|9993023|FG006|STARTED|Part 1b (Fed State) - SAD||0
8931352|NCT02303574|9993024|FG007|STARTED|Part 1b (Fed State) - SAD||0
8931353|NCT02303574|9993025|FG008|STARTED|Part 1b (Fed State) - SAD||0
8931354|NCT02303574|9993026|FG009|STARTED|Part 1b (Fed State) - SAD|Participants received AZD7986 matching placebo on Day 1 in fed state.|3
8931355|NCT02303574|9993017|FG000|COMPLETED|Part 1b (Fed State) - SAD||0
8931356|NCT02303574|9993018|FG001|COMPLETED|Part 1b (Fed State) - SAD||0
8931357|NCT02303574|9993019|FG002|COMPLETED|Part 1b (Fed State) - SAD||0
8931358|NCT02303574|9993020|FG003|COMPLETED|Part 1b (Fed State) - SAD||0
8931359|NCT02303574|9993021|FG004|COMPLETED|Part 1b (Fed State) - SAD||0
8931360|NCT02303574|9993022|FG005|COMPLETED|Part 1b (Fed State) - SAD||5
8931361|NCT02303574|9993023|FG006|COMPLETED|Part 1b (Fed State) - SAD||0
8931362|NCT02303574|9993024|FG007|COMPLETED|Part 1b (Fed State) - SAD||0
8931363|NCT02303574|9993025|FG008|COMPLETED|Part 1b (Fed State) - SAD||0
8931364|NCT02303574|9993026|FG009|COMPLETED|Part 1b (Fed State) - SAD||3
8931365|NCT02303574|9993017|FG000|NOT COMPLETED|Part 1b (Fed State) - SAD||0
8931366|NCT02303574|9993018|FG001|NOT COMPLETED|Part 1b (Fed State) - SAD||0
8931367|NCT02303574|9993019|FG002|NOT COMPLETED|Part 1b (Fed State) - SAD||0
8931368|NCT02303574|9993020|FG003|NOT COMPLETED|Part 1b (Fed State) - SAD||0
8931369|NCT02303574|9993021|FG004|NOT COMPLETED|Part 1b (Fed State) - SAD||0
8931370|NCT02303574|9993022|FG005|NOT COMPLETED|Part 1b (Fed State) - SAD||0
8931371|NCT02303574|9993023|FG006|NOT COMPLETED|Part 1b (Fed State) - SAD||0
8931372|NCT02303574|9993024|FG007|NOT COMPLETED|Part 1b (Fed State) - SAD||0
8931373|NCT02303574|9993025|FG008|NOT COMPLETED|Part 1b (Fed State) - SAD||0
8931374|NCT02303574|9993026|FG009|NOT COMPLETED|Part 1b (Fed State) - SAD||0
8931375|NCT02303574|9993017|FG000|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
8931376|NCT02303574|9993018|FG001|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
8931377|NCT02303574|9993019|FG002|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
8931378|NCT02303574|9993020|FG003|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
8931379|NCT02303574|9993021|FG004|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
8931380|NCT02303574|9993022|FG005|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
8931381|NCT02303574|9993023|FG006|STARTED|Part 2 - Multiple Ascending Dose (MAD)||6
8931382|NCT02303574|9993024|FG007|STARTED|Part 2 - Multiple Ascending Dose (MAD)||8
8931383|NCT02303574|9993025|FG008|STARTED|Part 2 - Multiple Ascending Dose (MAD)||10
8931384|NCT02303574|9993026|FG009|STARTED|Part 2 - Multiple Ascending Dose (MAD)|Participants took AZD7986 matching placebo for 28 days (fasted/fed state, based on part 1b results)|12
8931385|NCT02303574|9993017|FG000|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
8931386|NCT02303574|9993018|FG001|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
8931387|NCT02303574|9993019|FG002|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
8717893|NCT00996840|9765197|FG003|NOT COMPLETED|Overall Study||1
8717894|NCT00996840|9765198|FG004|NOT COMPLETED|Overall Study||2
8717895|NCT00996892|9765214|FG000|STARTED|Dose-Escalation Stage 1||4
8717896|NCT00996892|9765215|FG001|STARTED|Dose-Escalation Stage 1||3
8931388|NCT02303574|9993020|FG003|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
8931389|NCT02303574|9993021|FG004|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
8931390|NCT02303574|9993022|FG005|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
8931391|NCT02303574|9993023|FG006|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||6
8931392|NCT02303574|9993024|FG007|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||7
8931393|NCT02303574|9993025|FG008|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||10
8931394|NCT02303574|9993026|FG009|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||12
8931395|NCT02303574|9993017|FG000|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
8931396|NCT02303574|9993018|FG001|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
8931397|NCT02303574|9993019|FG002|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
8931398|NCT02303574|9993020|FG003|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
8931399|NCT02303574|9993021|FG004|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
8931400|NCT02303574|9993022|FG005|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
8931401|NCT02303574|9993023|FG006|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
8931402|NCT02303574|9993024|FG007|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||1
8931403|NCT02303574|9993025|FG008|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
8931404|NCT02303574|9993026|FG009|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
8931405|NCT02303704|9993061|FG000|STARTED|Overall Study||220
8931406|NCT02303704|9993062|FG001|STARTED|Overall Study||228
8931407|NCT02303704|9993061|FG000|COMPLETED|Overall Study||215
8931408|NCT02303704|9993062|FG001|COMPLETED|Overall Study||219
8931409|NCT02303704|9993061|FG000|NOT COMPLETED|Overall Study||5
8931410|NCT02303704|9993062|FG001|NOT COMPLETED|Overall Study||9
8931411|NCT02303743|9993070|FG000|STARTED|Overall Study||108
8931412|NCT02303743|9993071|FG001|STARTED|Overall Study||152
8931413|NCT02303743|9993070|FG000|COMPLETED|Overall Study||108
8931414|NCT02303743|9993071|FG001|COMPLETED|Overall Study||152
8931415|NCT02303743|9993070|FG000|NOT COMPLETED|Overall Study||0
8931416|NCT02303743|9993071|FG001|NOT COMPLETED|Overall Study||0
8931417|NCT02303977|9993077|FG000|STARTED|Overall Study||37
8931418|NCT02303977|9993077|FG000|COMPLETED|Overall Study||37
8931419|NCT02303977|9993077|FG000|NOT COMPLETED|Overall Study||0
8931420|NCT02303990|9993082|FG000|STARTED|Overall Study||59
8931421|NCT02303990|9993082|FG000|COMPLETED|Overall Study||59
8931422|NCT02303990|9993082|FG000|NOT COMPLETED|Overall Study||0
8931423|NCT02304159|9993088|FG000|STARTED|Overall Study||21
8931424|NCT02304159|9993089|FG001|STARTED|Overall Study||18
8931425|NCT02304159|9993088|FG000|COMPLETED|Overall Study||19
8931426|NCT02304159|9993089|FG001|COMPLETED|Overall Study||16
8931427|NCT02304159|9993088|FG000|NOT COMPLETED|Overall Study||2
8931428|NCT02304159|9993089|FG001|NOT COMPLETED|Overall Study||2
8931429|NCT02304380|9993101|FG000|STARTED|Pediatric Claims Data Analysis (Aim 3)||0
8931430|NCT02304380|9993102|FG001|STARTED|Pediatric Claims Data Analysis (Aim 3)||0
8931431|NCT02304380|9993103|FG002|STARTED|Pediatric Claims Data Analysis (Aim 3)||0
8931432|NCT02304380|9993104|FG003|STARTED|Pediatric Claims Data Analysis (Aim 3)||0
8931433|NCT02304380|9993105|FG004|STARTED|Pediatric Claims Data Analysis (Aim 3)||17356
8931434|NCT02304380|9993106|FG005|STARTED|Pediatric Claims Data Analysis (Aim 3)||47026
8931435|NCT02304380|9993101|FG000|COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
8931436|NCT02304380|9993102|FG001|COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
8931437|NCT02304380|9993103|FG002|COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
8931438|NCT02304380|9993104|FG003|COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
8931439|NCT02304380|9993105|FG004|COMPLETED|Pediatric Claims Data Analysis (Aim 3)|2,096 Caregivers of the 17,356 claims were included in the Caregiver Survey.|17356
8931440|NCT02304380|9993106|FG005|COMPLETED|Pediatric Claims Data Analysis (Aim 3)|Not included in any other portion of the study.|47026
8931441|NCT02304380|9993101|FG000|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
8931442|NCT02304380|9993102|FG001|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
8931443|NCT02304380|9993103|FG002|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
8931444|NCT02304380|9993104|FG003|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
8931445|NCT02304380|9993105|FG004|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
8931446|NCT02304380|9993106|FG005|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
8931447|NCT02304380|9993101|FG000|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||0
8931448|NCT02304380|9993102|FG001|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||0
8931449|NCT02304380|9993103|FG002|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||0
8931450|NCT02304380|9993104|FG003|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||2096
8931451|NCT02304380|9993105|FG004|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||0
8931452|NCT02304380|9993106|FG005|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||0
8931453|NCT02304380|9993101|FG000|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
8717897|NCT00996892|9765216|FG002|STARTED|Dose-Escalation Stage 1||3
8717898|NCT00996892|9765217|FG003|STARTED|Dose-Escalation Stage 1||9
8717899|NCT00996892|9765218|FG004|STARTED|Dose-Escalation Stage 1||11
8617205|NCT00455455|9655398|FG000|STARTED|Washout||25
8617206|NCT00455455|9655399|FG001|STARTED|Washout||25
8617207|NCT00455455|9655398|FG000|COMPLETED|Washout||25
8617208|NCT00455455|9655399|FG001|COMPLETED|Washout||24
8617209|NCT00455455|9655398|FG000|NOT COMPLETED|Washout||0
8617210|NCT00455455|9655399|FG001|NOT COMPLETED|Washout||1
8617211|NCT00455455|9655398|FG000|STARTED|First Intervention||25
8617212|NCT00455455|9655399|FG001|STARTED|First Intervention||24
8617213|NCT00455455|9655398|FG000|COMPLETED|First Intervention||25
8617214|NCT00455455|9655399|FG001|COMPLETED|First Intervention||24
8617215|NCT00455455|9655398|FG000|NOT COMPLETED|First Intervention||0
8931454|NCT02304380|9993102|FG001|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
8931455|NCT02304380|9993103|FG002|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
8931456|NCT02304380|9993104|FG003|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)|68 Caregivers/Patients of the 2,062 surveyed were included in the Interviews and Focus Group .|2062
8931457|NCT02304380|9993105|FG004|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
8931458|NCT02304380|9993106|FG005|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
8931459|NCT02304380|9993101|FG000|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
8931460|NCT02304380|9993102|FG001|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
8931461|NCT02304380|9993103|FG002|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
8931462|NCT02304380|9993104|FG003|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||34
8931463|NCT02304380|9993105|FG004|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
8931464|NCT02304380|9993106|FG005|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
8931465|NCT02304380|9993101|FG000|STARTED|Interviews & Focus Groups (Aim 1)||0
8931466|NCT02304380|9993102|FG001|STARTED|Interviews & Focus Groups (Aim 1)||35
8931467|NCT02304380|9993103|FG002|STARTED|Interviews & Focus Groups (Aim 1)||33
8931468|NCT02304380|9993104|FG003|STARTED|Interviews & Focus Groups (Aim 1)||0
8931469|NCT02304380|9993105|FG004|STARTED|Interviews & Focus Groups (Aim 1)||0
8931470|NCT02304380|9993106|FG005|STARTED|Interviews & Focus Groups (Aim 1)||0
8931471|NCT02304380|9993101|FG000|COMPLETED|Interviews & Focus Groups (Aim 1)||0
8931472|NCT02304380|9993102|FG001|COMPLETED|Interviews & Focus Groups (Aim 1)||35
8931473|NCT02304380|9993103|FG002|COMPLETED|Interviews & Focus Groups (Aim 1)||33
8931474|NCT02304380|9993104|FG003|COMPLETED|Interviews & Focus Groups (Aim 1)||0
8931475|NCT02304380|9993105|FG004|COMPLETED|Interviews & Focus Groups (Aim 1)||0
8931476|NCT02304380|9993106|FG005|COMPLETED|Interviews & Focus Groups (Aim 1)||0
8931477|NCT02304380|9993101|FG000|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0
8931478|NCT02304380|9993102|FG001|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0
8931479|NCT02304380|9993103|FG002|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0
8931480|NCT02304380|9993104|FG003|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0
8931481|NCT02304380|9993105|FG004|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0
8931482|NCT02304380|9993106|FG005|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0
8931483|NCT02304380|9993101|FG000|STARTED|ACO Stakeholder Interviews (Aim 1)||24
8931484|NCT02304380|9993102|FG001|STARTED|ACO Stakeholder Interviews (Aim 1)||0
8931485|NCT02304380|9993103|FG002|STARTED|ACO Stakeholder Interviews (Aim 1)||0
8931486|NCT02304380|9993104|FG003|STARTED|ACO Stakeholder Interviews (Aim 1)||0
8931487|NCT02304380|9993105|FG004|STARTED|ACO Stakeholder Interviews (Aim 1)||0
8931488|NCT02304380|9993106|FG005|STARTED|ACO Stakeholder Interviews (Aim 1)||0
8931489|NCT02304380|9993101|FG000|COMPLETED|ACO Stakeholder Interviews (Aim 1)||24
8931490|NCT02304380|9993102|FG001|COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
8931491|NCT02304380|9993103|FG002|COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
8931492|NCT02304380|9993104|FG003|COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
8931493|NCT02304380|9993105|FG004|COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
8931494|NCT02304380|9993106|FG005|COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
8931495|NCT02304380|9993101|FG000|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
8931496|NCT02304380|9993102|FG001|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
8931497|NCT02304380|9993103|FG002|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
8931498|NCT02304380|9993104|FG003|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
8931499|NCT02304380|9993105|FG004|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
8931500|NCT02304380|9993106|FG005|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
8931501|NCT02304406|9993120|FG000|STARTED|Overall Study||449
8931502|NCT02304406|9993120|FG000|COMPLETED|Overall Study||449
8931503|NCT02304406|9993120|FG000|NOT COMPLETED|Overall Study||0
8931504|NCT02304432|9993124|FG000|STARTED|Open Label DCS||2
8931505|NCT02304432|9993125|FG001|STARTED|Open Label DCS||0
8931506|NCT02304432|9993126|FG002|STARTED|Open Label DCS||0
8931507|NCT02304432|9993127|FG003|STARTED|Open Label DCS||0
8931508|NCT02304432|9993124|FG000|COMPLETED|Open Label DCS||2
8931509|NCT02304432|9993125|FG001|COMPLETED|Open Label DCS||0
8931510|NCT02304432|9993126|FG002|COMPLETED|Open Label DCS||0
8931511|NCT02304432|9993127|FG003|COMPLETED|Open Label DCS||0
8931512|NCT02304432|9993124|FG000|NOT COMPLETED|Open Label DCS||0
8931513|NCT02304432|9993125|FG001|NOT COMPLETED|Open Label DCS||0
8931514|NCT02304432|9993126|FG002|NOT COMPLETED|Open Label DCS||0
8931515|NCT02304432|9993127|FG003|NOT COMPLETED|Open Label DCS||0
8931516|NCT02304432|9993124|FG000|STARTED|Double-Blind DCS Placebo Crossover||0
8931517|NCT02304432|9993125|FG001|STARTED|Double-Blind DCS Placebo Crossover||1
8931518|NCT02304432|9993126|FG002|STARTED|Double-Blind DCS Placebo Crossover||1
8931519|NCT02304432|9993127|FG003|STARTED|Double-Blind DCS Placebo Crossover||0
8931520|NCT02304432|9993124|FG000|COMPLETED|Double-Blind DCS Placebo Crossover||0
8931521|NCT02304432|9993125|FG001|COMPLETED|Double-Blind DCS Placebo Crossover||1
8931522|NCT02304432|9993126|FG002|COMPLETED|Double-Blind DCS Placebo Crossover||1
8931523|NCT02304432|9993127|FG003|COMPLETED|Double-Blind DCS Placebo Crossover||0
8931524|NCT02304432|9993124|FG000|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0
8931525|NCT02304432|9993125|FG001|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0
8931526|NCT02304432|9993126|FG002|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0
8931527|NCT02304432|9993127|FG003|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0
8931528|NCT02304432|9993124|FG000|STARTED|Second Open Label DCS||0
8931529|NCT02304432|9993125|FG001|STARTED|Second Open Label DCS||0
8931530|NCT02304432|9993126|FG002|STARTED|Second Open Label DCS||0
8931531|NCT02304432|9993127|FG003|STARTED|Second Open Label DCS||2
8931532|NCT02304432|9993124|FG000|COMPLETED|Second Open Label DCS||0
8931533|NCT02304432|9993125|FG001|COMPLETED|Second Open Label DCS||0
8931534|NCT02304432|9993126|FG002|COMPLETED|Second Open Label DCS||0
8931535|NCT02304432|9993127|FG003|COMPLETED|Second Open Label DCS||2
8931536|NCT02304432|9993124|FG000|NOT COMPLETED|Second Open Label DCS||0
8931537|NCT02304432|9993125|FG001|NOT COMPLETED|Second Open Label DCS||0
8931538|NCT02304432|9993126|FG002|NOT COMPLETED|Second Open Label DCS||0
8931539|NCT02304432|9993127|FG003|NOT COMPLETED|Second Open Label DCS||0
8931540|NCT02304484|9993142|FG000|STARTED|Overall Study||770
8931541|NCT02304484|9993142|FG000|COMPLETED|Overall Study||745
8931542|NCT02304484|9993142|FG000|NOT COMPLETED|Overall Study||25
8617216|NCT00455455|9655399|FG001|NOT COMPLETED|First Intervention||0
8617217|NCT00455455|9655398|FG000|STARTED|Washout||25
8617218|NCT00455455|9655399|FG001|STARTED|Washout||24
8617219|NCT00455455|9655398|FG000|COMPLETED|Washout||24
8617220|NCT00455455|9655399|FG001|COMPLETED|Washout||24
8617221|NCT00455455|9655398|FG000|NOT COMPLETED|Washout||1
8931543|NCT02304705|9993148|FG000|STARTED|Overall Study||16
8931544|NCT02304705|9993149|FG001|STARTED|Overall Study||17
8931545|NCT02304705|9993148|FG000|COMPLETED|Overall Study||12
8931546|NCT02304705|9993149|FG001|COMPLETED|Overall Study||10
8931547|NCT02304705|9993148|FG000|NOT COMPLETED|Overall Study||4
8931548|NCT02304705|9993149|FG001|NOT COMPLETED|Overall Study||7
8931549|NCT02304757|9993157|FG000|STARTED|Overall Study||70
8931550|NCT02304757|9993158|FG001|STARTED|Overall Study||72
8931551|NCT02304757|9993157|FG000|COMPLETED|Overall Study||70
8931552|NCT02304757|9993158|FG001|COMPLETED|Overall Study||72
8931553|NCT02304757|9993157|FG000|NOT COMPLETED|Overall Study||0
8931554|NCT02304757|9993158|FG001|NOT COMPLETED|Overall Study||0
8931555|NCT02304926|9993166|FG000|STARTED|Overall Study||22
8931556|NCT02304926|9993167|FG001|STARTED|Overall Study||20
8931557|NCT02304926|9993166|FG000|COMPLETED|Overall Study||20
8931558|NCT02304926|9993167|FG001|COMPLETED|Overall Study||19
8931559|NCT02304926|9993166|FG000|NOT COMPLETED|Overall Study||2
8931560|NCT02304926|9993167|FG001|NOT COMPLETED|Overall Study||1
8931561|NCT02305017|9993177|FG000|STARTED|Overall Study||14
8931562|NCT02305017|9993178|FG001|STARTED|Overall Study||14
8931563|NCT02305017|9993177|FG000|COMPLETED|Overall Study||14
8931564|NCT02305017|9993178|FG001|COMPLETED|Overall Study||14
8931565|NCT02305017|9993177|FG000|NOT COMPLETED|Overall Study||0
8931566|NCT02305017|9993178|FG001|NOT COMPLETED|Overall Study||0
8931567|NCT02305238|9993191|FG000|STARTED|Overall Study||124
8931568|NCT02305238|9993192|FG001|STARTED|Overall Study||123
8931569|NCT02305238|9993193|FG002|STARTED|Overall Study||8
8931570|NCT02305238|9993191|FG000|Treated|Overall Study||124
8931571|NCT02305238|9993192|FG001|Treated|Overall Study||123
8931572|NCT02305238|9993193|FG002|Treated|Overall Study||7
8931573|NCT02305238|9993191|FG000|Randomized|Overall Study||124
8931574|NCT02305238|9993192|FG001|Randomized|Overall Study||123
8931575|NCT02305238|9993193|FG002|Randomized|Overall Study||0
8931576|NCT02305238|9993191|FG000|BCVA Post-randomization Assessment|Overall Study||123
8931577|NCT02305238|9993192|FG001|BCVA Post-randomization Assessment|Overall Study||123
8931578|NCT02305238|9993193|FG002|BCVA Post-randomization Assessment|Overall Study||0
8931579|NCT02305238|9993191|FG000|COMPLETED|Overall Study||108
8931580|NCT02305238|9993192|FG001|COMPLETED|Overall Study||104
8931581|NCT02305238|9993193|FG002|COMPLETED|Overall Study||0
8931582|NCT02305238|9993191|FG000|NOT COMPLETED|Overall Study||16
8931583|NCT02305238|9993192|FG001|NOT COMPLETED|Overall Study||19
8931584|NCT02305238|9993193|FG002|NOT COMPLETED|Overall Study||8
8931585|NCT02305277|9993206|FG000|STARTED|Overall Study||15
8931586|NCT02305277|9993207|FG001|STARTED|Overall Study||14
8931587|NCT02305277|9993208|FG002|STARTED|Overall Study||14
8931588|NCT02305277|9993209|FG003|STARTED|Overall Study||14
8931589|NCT02305277|9993210|FG004|STARTED|Overall Study||14
8931590|NCT02305277|9993211|FG005|STARTED|Overall Study||14
8931591|NCT02305277|9993206|FG000|Received CM|Overall Study||15
8931592|NCT02305277|9993207|FG001|Received CM|Overall Study||14
8931593|NCT02305277|9993208|FG002|Received CM|Overall Study||14
8931594|NCT02305277|9993209|FG003|Received CM|Overall Study||14
8931595|NCT02305277|9993210|FG004|Received CM|Overall Study||14
8931596|NCT02305277|9993211|FG005|Received CM|Overall Study||14
8617222|NCT00455455|9655399|FG001|NOT COMPLETED|Washout||0
8931597|NCT02305277|9993206|FG000|Received TBM|Overall Study||15
8931598|NCT02305277|9993207|FG001|Received TBM|Overall Study||14
8931599|NCT02305277|9993208|FG002|Received TBM|Overall Study||14
8931600|NCT02305277|9993209|FG003|Received TBM|Overall Study||14
8931601|NCT02305277|9993210|FG004|Received TBM|Overall Study||14
8931602|NCT02305277|9993211|FG005|Received TBM|Overall Study||14
8931603|NCT02305277|9993206|FG000|COMPLETED|Overall Study||14
8931604|NCT02305277|9993207|FG001|COMPLETED|Overall Study||14
8931605|NCT02305277|9993208|FG002|COMPLETED|Overall Study||14
8931606|NCT02305277|9993209|FG003|COMPLETED|Overall Study||14
8931607|NCT02305277|9993210|FG004|COMPLETED|Overall Study||13
8931608|NCT02305277|9993211|FG005|COMPLETED|Overall Study||14
8931609|NCT02305277|9993206|FG000|NOT COMPLETED|Overall Study||1
8931610|NCT02305277|9993207|FG001|NOT COMPLETED|Overall Study||0
8931611|NCT02305277|9993208|FG002|NOT COMPLETED|Overall Study||0
8931612|NCT02305277|9993209|FG003|NOT COMPLETED|Overall Study||0
8931613|NCT02305277|9993210|FG004|NOT COMPLETED|Overall Study||1
8931614|NCT02305277|9993211|FG005|NOT COMPLETED|Overall Study||0
8931615|NCT02305316|9993227|FG000|STARTED|Overall Study||14
8931616|NCT02305316|9993228|FG001|STARTED|Overall Study||14
8931617|NCT02305316|9993227|FG000|COMPLETED|Overall Study||14
8931618|NCT02305316|9993228|FG001|COMPLETED|Overall Study||14
8931619|NCT02305316|9993227|FG000|NOT COMPLETED|Overall Study||0
8931620|NCT02305316|9993228|FG001|NOT COMPLETED|Overall Study||0
8931621|NCT02305329|9993238|FG000|STARTED|Overall Study||14
8931622|NCT02305329|9993239|FG001|STARTED|Overall Study||14
8931623|NCT02305329|9993240|FG002|STARTED|Overall Study||14
8931624|NCT02305329|9993241|FG003|STARTED|Overall Study||14
8931625|NCT02305329|9993238|FG000|Period 1|Overall Study||14
8931626|NCT02305329|9993239|FG001|Period 1|Overall Study||14
8931627|NCT02305329|9993240|FG002|Period 1|Overall Study||14
8931628|NCT02305329|9993241|FG003|Period 1|Overall Study||14
8931629|NCT02305329|9993238|FG000|Period 2|Overall Study||14
8931630|NCT02305329|9993239|FG001|Period 2|Overall Study||13
8931631|NCT02305329|9993240|FG002|Period 2|Overall Study||14
8931632|NCT02305329|9993241|FG003|Period 2|Overall Study||14
8931633|NCT02305329|9993238|FG000|COMPLETED|Overall Study||14
8931634|NCT02305329|9993239|FG001|COMPLETED|Overall Study||13
8931635|NCT02305329|9993240|FG002|COMPLETED|Overall Study||14
8931636|NCT02305329|9993241|FG003|COMPLETED|Overall Study||14
8931637|NCT02305329|9993238|FG000|NOT COMPLETED|Overall Study||0
8931638|NCT02305329|9993239|FG001|NOT COMPLETED|Overall Study||1
8931639|NCT02305329|9993240|FG002|NOT COMPLETED|Overall Study||0
8931640|NCT02305329|9993241|FG003|NOT COMPLETED|Overall Study||0
8931641|NCT02305381|9993254|FG000|STARTED|Overall Study||132
8931642|NCT02305381|9993255|FG001|STARTED|Overall Study||132
8931643|NCT02305381|9993256|FG002|STARTED|Overall Study||133
8931644|NCT02305381|9993254|FG000|Exposed|Overall Study||132
8931645|NCT02305381|9993255|FG001|Exposed|Overall Study||131
8931646|NCT02305381|9993256|FG002|Exposed|Overall Study||133
8931647|NCT02305381|9993254|FG000|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial.|14
8931648|NCT02305381|9993255|FG001|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial|16
8931649|NCT02305381|9993256|FG002|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial.|13
8931650|NCT02305381|9993254|FG000|COMPLETED|Overall Study|Subjects who completed the trial.|127
8931651|NCT02305381|9993255|FG001|COMPLETED|Overall Study|Subjects who completed the trial.|127
8931652|NCT02305381|9993256|FG002|COMPLETED|Overall Study|Subjects who completed the trial.|126
8931653|NCT02305381|9993254|FG000|NOT COMPLETED|Overall Study||5
8931654|NCT02305381|9993255|FG001|NOT COMPLETED|Overall Study||5
8931655|NCT02305381|9993256|FG002|NOT COMPLETED|Overall Study||7
8931656|NCT02305446|9993264|FG000|STARTED|Overall Study||55
8931657|NCT02305446|9993264|FG000|COMPLETED|Overall Study||54
8931658|NCT02305446|9993264|FG000|NOT COMPLETED|Overall Study||1
8931659|NCT02305563|9993273|FG000|STARTED|Treatment Period||3
8931660|NCT02305563|9993274|FG001|STARTED|Treatment Period||3
8931661|NCT02305563|9993275|FG002|STARTED|Treatment Period||26
8931662|NCT02305563|9993276|FG003|STARTED|Treatment Period||14
8931663|NCT02305563|9993277|FG004|STARTED|Treatment Period||24
8931664|NCT02305563|9993273|FG000|COMPLETED|Treatment Period|At the time of the Phase 1 lock, 1 participant was still continuing on treatment|1
8931665|NCT02305563|9993274|FG001|COMPLETED|Treatment Period|At the time of the Phase 1 lock, 1 participant was still continuing on treatment|1
8931666|NCT02305563|9993275|FG002|COMPLETED|Treatment Period||0
8931667|NCT02305563|9993276|FG003|COMPLETED|Treatment Period||0
8931668|NCT02305563|9993277|FG004|COMPLETED|Treatment Period||0
8931669|NCT02305563|9993273|FG000|NOT COMPLETED|Treatment Period||2
8931670|NCT02305563|9993274|FG001|NOT COMPLETED|Treatment Period||2
8931671|NCT02305563|9993275|FG002|NOT COMPLETED|Treatment Period||26
8931672|NCT02305563|9993276|FG003|NOT COMPLETED|Treatment Period||14
8931673|NCT02305563|9993277|FG004|NOT COMPLETED|Treatment Period||24
8931674|NCT02305563|9993273|FG000|STARTED|Follow-up Period||3
8931675|NCT02305563|9993274|FG001|STARTED|Follow-up Period||3
8931676|NCT02305563|9993275|FG002|STARTED|Follow-up Period||11
8931677|NCT02305563|9993276|FG003|STARTED|Follow-up Period||6
8931678|NCT02305563|9993277|FG004|STARTED|Follow-up Period||12
8931679|NCT02305563|9993273|FG000|COMPLETED|Follow-up Period||0
8931680|NCT02305563|9993274|FG001|COMPLETED|Follow-up Period||0
8931681|NCT02305563|9993275|FG002|COMPLETED|Follow-up Period||0
8931682|NCT02305563|9993276|FG003|COMPLETED|Follow-up Period||0
8931683|NCT02305563|9993277|FG004|COMPLETED|Follow-up Period||0
8931684|NCT02305563|9993273|FG000|NOT COMPLETED|Follow-up Period||3
8931685|NCT02305563|9993274|FG001|NOT COMPLETED|Follow-up Period||3
8931686|NCT02305563|9993275|FG002|NOT COMPLETED|Follow-up Period||11
8931687|NCT02305563|9993276|FG003|NOT COMPLETED|Follow-up Period||6
8931688|NCT02305563|9993277|FG004|NOT COMPLETED|Follow-up Period||12
8931689|NCT02305732|9993293|FG000|STARTED|Overall Study||90
8931690|NCT02305732|9993293|FG000|COMPLETED|Overall Study||72
8931691|NCT02305732|9993293|FG000|NOT COMPLETED|Overall Study||18
8931692|NCT02305758|9993300|FG000|STARTED|Overall Study||65
8931693|NCT02305758|9993301|FG001|STARTED|Overall Study||65
8931694|NCT02305758|9993300|FG000|COMPLETED|Overall Study||0
8931695|NCT02305758|9993301|FG001|COMPLETED|Overall Study||0
8931696|NCT02305758|9993300|FG000|NOT COMPLETED|Overall Study||65
8931697|NCT02305758|9993301|FG001|NOT COMPLETED|Overall Study||65
8931698|NCT02305797|9993309|FG000|STARTED|Overall Study||247
8931699|NCT02305797|9993310|FG001|STARTED|Overall Study||248
8931700|NCT02305797|9993309|FG000|COMPLETED|Overall Study||202
8931701|NCT02305797|9993310|FG001|COMPLETED|Overall Study||210
8931702|NCT02305797|9993309|FG000|NOT COMPLETED|Overall Study||45
8617223|NCT00455455|9655398|FG000|STARTED|Second Intervention||24
8617224|NCT00455455|9655399|FG001|STARTED|Second Intervention||24
8617225|NCT00455455|9655398|FG000|COMPLETED|Second Intervention||24
8617226|NCT00455455|9655399|FG001|COMPLETED|Second Intervention||24
8931703|NCT02305797|9993310|FG001|NOT COMPLETED|Overall Study||38
8931704|NCT02305849|9993319|FG000|STARTED|Overall Study||175
8931705|NCT02305849|9993320|FG001|STARTED|Overall Study||174
8931706|NCT02305849|9993321|FG002|STARTED|Overall Study||85
8931707|NCT02305849|9993322|FG003|STARTED|Overall Study||85
8931708|NCT02305849|9993319|FG000|COMPLETED|Overall Study||148
8931709|NCT02305849|9993320|FG001|COMPLETED|Overall Study||146
8931710|NCT02305849|9993321|FG002|COMPLETED|Overall Study||67
8931711|NCT02305849|9993322|FG003|COMPLETED|Overall Study||66
8931712|NCT02305849|9993319|FG000|NOT COMPLETED|Overall Study||27
8931713|NCT02305849|9993320|FG001|NOT COMPLETED|Overall Study||28
8931714|NCT02305849|9993321|FG002|NOT COMPLETED|Overall Study||18
8931715|NCT02305849|9993322|FG003|NOT COMPLETED|Overall Study||19
8931716|NCT02305888|9993356|FG000|STARTED|Overall Study||63
8931717|NCT02305888|9993357|FG001|STARTED|Overall Study||63
8931718|NCT02305888|9993358|FG002|STARTED|Overall Study||63
8931719|NCT02305888|9993356|FG000|COMPLETED|Overall Study||63
8931720|NCT02305888|9993357|FG001|COMPLETED|Overall Study||62
8931721|NCT02305888|9993358|FG002|COMPLETED|Overall Study||62
8931722|NCT02305888|9993356|FG000|NOT COMPLETED|Overall Study||0
8931723|NCT02305888|9993357|FG001|NOT COMPLETED|Overall Study||1
8931724|NCT02305888|9993358|FG002|NOT COMPLETED|Overall Study||1
9064764|NCT04274075|10125131|FG005|Completed Follow-up Visit|Overall Study||3
9064765|NCT04274075|10125126|FG000|COMPLETED|Overall Study||3
9064766|NCT04274075|10125127|FG001|COMPLETED|Overall Study||3
9064767|NCT04274075|10125128|FG002|COMPLETED|Overall Study||3
9064768|NCT04274075|10125129|FG003|COMPLETED|Overall Study||3
9064769|NCT04274075|10125130|FG004|COMPLETED|Overall Study||3
9064770|NCT04274075|10125131|FG005|COMPLETED|Overall Study||3
9064771|NCT04274075|10125126|FG000|NOT COMPLETED|Overall Study||0
9064772|NCT04274075|10125127|FG001|NOT COMPLETED|Overall Study||0
9064773|NCT04274075|10125128|FG002|NOT COMPLETED|Overall Study||0
9064774|NCT04274075|10125129|FG003|NOT COMPLETED|Overall Study||0
9064775|NCT04274075|10125130|FG004|NOT COMPLETED|Overall Study||0
9064776|NCT04274075|10125131|FG005|NOT COMPLETED|Overall Study||0
9064777|NCT04271605|10125142|FG000|STARTED|Overall Study|Baseline questionnaire and examination were done after enrollment.|5
9064778|NCT04271605|10125142|FG000|COMPLETED|Overall Study||0
9064779|NCT04271605|10125142|FG000|NOT COMPLETED|Overall Study||5
9064780|NCT04271761|10125146|FG000|STARTED|Overall Study||14
9064781|NCT04271761|10125146|FG000|COMPLETED|Overall Study||14
9064782|NCT04271761|10125146|FG000|NOT COMPLETED|Overall Study||0
9064783|NCT04268316|10125153|FG000|STARTED|Overall Study||5
9064784|NCT04268316|10125154|FG001|STARTED|Overall Study||4
9064785|NCT04268316|10125155|FG002|STARTED|Overall Study||4
9064786|NCT04268316|10125153|FG000|COMPLETED|Overall Study||3
9064787|NCT04268316|10125154|FG001|COMPLETED|Overall Study||3
9064788|NCT04268316|10125155|FG002|COMPLETED|Overall Study||4
9064789|NCT04268316|10125153|FG000|NOT COMPLETED|Overall Study||2
9064790|NCT04268316|10125154|FG001|NOT COMPLETED|Overall Study||1
9064791|NCT04268316|10125155|FG002|NOT COMPLETED|Overall Study||0
9064792|NCT04269629|10125163|FG000|STARTED|Overall Study|1425 patients were included in the study (=Visit 1)|1425
9064793|NCT04269629|10125163|FG000|Number of Patients Who Performed VIT|Overall Study|Visit 2 was performed with 1342 patients|1342
9064794|NCT04269629|10125163|FG000|COMPLETED|Overall Study|Visit 3 was performed with 1186 patients|1186
9064795|NCT04269629|10125163|FG000|NOT COMPLETED|Overall Study||239
9064796|NCT04267575|10125171|FG000|STARTED|Overall Study||20
8931725|NCT02306265|9993366|FG000|STARTED|Overall Study||250
8931726|NCT02306265|9993366|FG000|COMPLETED|Overall Study||249
8931727|NCT02306265|9993366|FG000|NOT COMPLETED|Overall Study||1
8931728|NCT02306694|9993371|FG000|STARTED|Overall Study||16
8931729|NCT02306694|9993371|FG000|COMPLETED|Overall Study||12
8931730|NCT02306694|9993371|FG000|NOT COMPLETED|Overall Study||4
8931731|NCT02306759|9993377|FG000|STARTED|Overall Study||30
8931732|NCT02306759|9993378|FG001|STARTED|Overall Study||30
8931733|NCT02306759|9993377|FG000|COMPLETED|Overall Study||30
8931734|NCT02306759|9993378|FG001|COMPLETED|Overall Study||30
8931735|NCT02306759|9993377|FG000|NOT COMPLETED|Overall Study||0
8931736|NCT02306759|9993378|FG001|NOT COMPLETED|Overall Study||0
8931737|NCT02306850|9993386|FG000|STARTED|Overall Study||10
8931738|NCT02306850|9993386|FG000|COMPLETED|Overall Study||8
8931739|NCT02306850|9993386|FG000|NOT COMPLETED|Overall Study||2
8931740|NCT02306928|9993391|FG000|STARTED|Overall Study||15
8931741|NCT02306928|9993391|FG000|COMPLETED|Overall Study||15
8931742|NCT02306928|9993391|FG000|NOT COMPLETED|Overall Study||0
8931743|NCT02307123|9993395|FG000|STARTED|Overall Study||483
8931744|NCT02307123|9993395|FG000|COMPLETED|Overall Study||483
8931745|NCT02307123|9993395|FG000|NOT COMPLETED|Overall Study||0
8931746|NCT02307266|9993402|FG000|STARTED|Overall Study||33
8931747|NCT02307266|9993403|FG001|STARTED|Overall Study||33
8931748|NCT02307266|9993404|FG002|STARTED|Overall Study||31
8931749|NCT02307266|9993402|FG000|COMPLETED|Overall Study||25
8931750|NCT02307266|9993403|FG001|COMPLETED|Overall Study||32
8931751|NCT02307266|9993404|FG002|COMPLETED|Overall Study||25
8931752|NCT02307266|9993402|FG000|NOT COMPLETED|Overall Study||8
8931753|NCT02307266|9993403|FG001|NOT COMPLETED|Overall Study||1
9064797|NCT04267575|10125171|FG000|COMPLETED|Overall Study||20
9064798|NCT04267575|10125171|FG000|NOT COMPLETED|Overall Study||0
8931754|NCT02307266|9993404|FG002|NOT COMPLETED|Overall Study||6
8931755|NCT02307318|9993412|FG000|STARTED|Overall Study||51
8931756|NCT02307318|9993412|FG000|COMPLETED|Overall Study||51
8931757|NCT02307318|9993412|FG000|NOT COMPLETED|Overall Study||0
8931758|NCT02307370|9993416|FG000|STARTED|Overall Study||44
8931759|NCT02307370|9993416|FG000|30 Day Follow-up|Overall Study||40
8931760|NCT02307370|9993416|FG000|180 Day Patient Telephone Contact|Overall Study||25
8931761|NCT02307370|9993416|FG000|COMPLETED|Overall Study||25
8931762|NCT02307370|9993416|FG000|NOT COMPLETED|Overall Study||19
8931763|NCT02307513|9993424|FG000|STARTED|Placebo Controlled Phase (Weeks 0-12)||103
8931764|NCT02307513|9993425|FG001|STARTED|Placebo Controlled Phase (Weeks 0-12)||104
8931765|NCT02307513|9993424|FG000|COMPLETED|Placebo Controlled Phase (Weeks 0-12)||83
8931766|NCT02307513|9993425|FG001|COMPLETED|Placebo Controlled Phase (Weeks 0-12)||96
8931767|NCT02307513|9993424|FG000|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-12)||20
8931768|NCT02307513|9993425|FG001|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-12)||8
8931769|NCT02307513|9993424|FG000|STARTED|Active Treatment Phase (Weeks 13-64)||83
8931770|NCT02307513|9993425|FG001|STARTED|Active Treatment Phase (Weeks 13-64)|1 participant completed Week 12; did not enter into active treatment|95
8931771|NCT02307513|9993424|FG000|COMPLETED|Active Treatment Phase (Weeks 13-64)||68
8931772|NCT02307513|9993425|FG001|COMPLETED|Active Treatment Phase (Weeks 13-64)||75
8931773|NCT02307513|9993424|FG000|NOT COMPLETED|Active Treatment Phase (Weeks 13-64)||15
8931774|NCT02307513|9993425|FG001|NOT COMPLETED|Active Treatment Phase (Weeks 13-64)||20
8931775|NCT02307513|9993424|FG000|STARTED|Long-term Extension||2
8931776|NCT02307513|9993425|FG001|STARTED|Long-term Extension||0
8931777|NCT02307513|9993424|FG000|COMPLETED|Long-term Extension||1
8931778|NCT02307513|9993425|FG001|COMPLETED|Long-term Extension||0
8931779|NCT02307513|9993424|FG000|NOT COMPLETED|Long-term Extension||1
8931780|NCT02307513|9993425|FG001|NOT COMPLETED|Long-term Extension||0
8931781|NCT02307526|9993435|FG000|STARTED|Day 1 - No Drug||10
8931782|NCT02307526|9993435|FG000|COMPLETED|Day 1 - No Drug||10
8931783|NCT02307526|9993435|FG000|NOT COMPLETED|Day 1 - No Drug||0
8931784|NCT02307526|9993435|FG000|STARTED|Day 2 - 60 mg of Pyridostigmine||10
8931785|NCT02307526|9993435|FG000|COMPLETED|Day 2 - 60 mg of Pyridostigmine||10
8931786|NCT02307526|9993435|FG000|NOT COMPLETED|Day 2 - 60 mg of Pyridostigmine||0
8948388|NCT02430870|10010798|FG007|STARTED|Part 1||0
8948389|NCT02430870|10010791|FG000|COMPLETED|Part 1||6
8948390|NCT02430870|10010792|FG001|COMPLETED|Part 1||6
8948391|NCT02430870|10010793|FG002|COMPLETED|Part 1||4
8948392|NCT02430870|10010794|FG003|COMPLETED|Part 1||0
8948393|NCT02430870|10010795|FG004|COMPLETED|Part 1||0
8948394|NCT02430870|10010796|FG005|COMPLETED|Part 1||0
8948395|NCT02430870|10010797|FG006|COMPLETED|Part 1||0
8948396|NCT02430870|10010798|FG007|COMPLETED|Part 1||0
8948397|NCT02430870|10010791|FG000|NOT COMPLETED|Part 1||0
8948398|NCT02430870|10010792|FG001|NOT COMPLETED|Part 1||0
8948399|NCT02430870|10010793|FG002|NOT COMPLETED|Part 1||0
8948400|NCT02430870|10010794|FG003|NOT COMPLETED|Part 1||0
8948401|NCT02430870|10010795|FG004|NOT COMPLETED|Part 1||0
8948402|NCT02430870|10010796|FG005|NOT COMPLETED|Part 1||0
8948403|NCT02430870|10010797|FG006|NOT COMPLETED|Part 1||0
8948404|NCT02430870|10010798|FG007|NOT COMPLETED|Part 1||0
8948405|NCT02430870|10010791|FG000|STARTED|Part 2||0
8948406|NCT02430870|10010792|FG001|STARTED|Part 2||0
8948407|NCT02430870|10010793|FG002|STARTED|Part 2||0
8948408|NCT02430870|10010794|FG003|STARTED|Part 2||6
8948409|NCT02430870|10010795|FG004|STARTED|Part 2||6
8948410|NCT02430870|10010796|FG005|STARTED|Part 2||6
8948411|NCT02430870|10010797|FG006|STARTED|Part 2||6
8948412|NCT02430870|10010798|FG007|STARTED|Part 2||8
8948413|NCT02430870|10010791|FG000|COMPLETED|Part 2||0
8948414|NCT02430870|10010792|FG001|COMPLETED|Part 2||0
8948415|NCT02430870|10010793|FG002|COMPLETED|Part 2||0
8948416|NCT02430870|10010794|FG003|COMPLETED|Part 2||6
8948417|NCT02430870|10010795|FG004|COMPLETED|Part 2||6
8948418|NCT02430870|10010796|FG005|COMPLETED|Part 2||6
8948419|NCT02430870|10010797|FG006|COMPLETED|Part 2||5
9064799|NCT04267770|10125177|FG000|STARTED|Overall Study||9
9064800|NCT04267770|10125178|FG001|STARTED|Overall Study||8
8813570|NCT01526356|9866729|FG000|STARTED|Overall Study||59
8813571|NCT01526356|9866730|FG001|STARTED|Overall Study||63
8813572|NCT01526356|9866731|FG002|STARTED|Overall Study||57
8813573|NCT01526356|9866729|FG000|COMPLETED|Overall Study||51
8813574|NCT01526356|9866730|FG001|COMPLETED|Overall Study||53
8813575|NCT01526356|9866731|FG002|COMPLETED|Overall Study||45
8813576|NCT01526356|9866729|FG000|NOT COMPLETED|Overall Study||8
8813577|NCT01526356|9866730|FG001|NOT COMPLETED|Overall Study||10
8813578|NCT01526356|9866731|FG002|NOT COMPLETED|Overall Study||12
8813579|NCT01526538|9866743|FG000|STARTED|Overall Study||30
8813580|NCT01526538|9866744|FG001|STARTED|Overall Study||22
8813581|NCT01526538|9866743|FG000|COMPLETED|Overall Study||21
8813582|NCT01526538|9866744|FG001|COMPLETED|Overall Study||18
8813583|NCT01526538|9866743|FG000|NOT COMPLETED|Overall Study||9
8813584|NCT01526538|9866744|FG001|NOT COMPLETED|Overall Study||4
8813585|NCT01526551|9866752|FG000|STARTED|Overall Study||935
8813586|NCT01526551|9866752|FG000|COMPLETED|Overall Study||511
8948420|NCT02430870|10010798|FG007|COMPLETED|Part 2||7
8948421|NCT02430870|10010791|FG000|NOT COMPLETED|Part 2||0
8948422|NCT02430870|10010792|FG001|NOT COMPLETED|Part 2||0
8948423|NCT02430870|10010793|FG002|NOT COMPLETED|Part 2||0
8948424|NCT02430870|10010794|FG003|NOT COMPLETED|Part 2||0
8948425|NCT02430870|10010795|FG004|NOT COMPLETED|Part 2||0
8948426|NCT02430870|10010796|FG005|NOT COMPLETED|Part 2||0
8948427|NCT02430870|10010797|FG006|NOT COMPLETED|Part 2||1
8931787|NCT02307552|9993441|FG000|STARTED|Overall Study||1
8931788|NCT02307552|9993441|FG000|COMPLETED|Overall Study||1
8931789|NCT02307552|9993441|FG000|NOT COMPLETED|Overall Study||0
8931790|NCT02307682|9993448|FG000|STARTED|Overall Study||360
8931791|NCT02307682|9993449|FG001|STARTED|Overall Study||361
8931792|NCT02307682|9993450|FG002|STARTED|Overall Study||361
8931793|NCT02307682|9993448|FG000|Randomized and Treated|Overall Study||358
8931794|NCT02307682|9993449|FG001|Randomized and Treated|Overall Study||360
8931795|NCT02307682|9993450|FG002|Randomized and Treated|Overall Study||360
8931796|NCT02307682|9993448|FG000|COMPLETED|Overall Study||310
8931797|NCT02307682|9993449|FG001|COMPLETED|Overall Study||304
8931798|NCT02307682|9993450|FG002|COMPLETED|Overall Study||297
8931799|NCT02307682|9993448|FG000|NOT COMPLETED|Overall Study||50
8931800|NCT02307682|9993449|FG001|NOT COMPLETED|Overall Study||57
8931801|NCT02307682|9993450|FG002|NOT COMPLETED|Overall Study||64
8931802|NCT02307838|9993461|FG000|STARTED|Overall Study||56
8931803|NCT02307838|9993462|FG001|STARTED|Overall Study||64
8931804|NCT02307838|9993463|FG002|STARTED|Overall Study||55
8931805|NCT02307838|9993461|FG000|COMPLETED|Overall Study||56
8931806|NCT02307838|9993462|FG001|COMPLETED|Overall Study||64
8931807|NCT02307838|9993463|FG002|COMPLETED|Overall Study||55
8931808|NCT02307838|9993461|FG000|NOT COMPLETED|Overall Study||0
8931809|NCT02307838|9993462|FG001|NOT COMPLETED|Overall Study||0
8931810|NCT02307838|9993463|FG002|NOT COMPLETED|Overall Study||0
8931811|NCT02307916|9993474|FG000|STARTED|Overall Study||42
8931812|NCT02307916|9993475|FG001|STARTED|Overall Study||15
8931813|NCT02307916|9993474|FG000|COMPLETED|Overall Study||40
8931814|NCT02307916|9993475|FG001|COMPLETED|Overall Study||14
8931815|NCT02307916|9993474|FG000|NOT COMPLETED|Overall Study||2
8931816|NCT02307916|9993475|FG001|NOT COMPLETED|Overall Study||1
8931817|NCT02308007|9993484|FG000|STARTED|Overall Study||159
8931818|NCT02308007|9993485|FG001|STARTED|Overall Study||159
8931819|NCT02308007|9993486|FG002|STARTED|Overall Study||157
8931820|NCT02308007|9993484|FG000|COMPLETED|Overall Study||83
8931821|NCT02308007|9993485|FG001|COMPLETED|Overall Study||84
8931822|NCT02308007|9993486|FG002|COMPLETED|Overall Study||82
8931823|NCT02308007|9993484|FG000|NOT COMPLETED|Overall Study||76
8931824|NCT02308007|9993485|FG001|NOT COMPLETED|Overall Study||75
8931825|NCT02308007|9993486|FG002|NOT COMPLETED|Overall Study||75
8931826|NCT02308020|9993500|FG000|STARTED|Overall Study||27
8931827|NCT02308020|9993501|FG001|STARTED|Overall Study||58
8931828|NCT02308020|9993502|FG002|STARTED|Overall Study||9
8931829|NCT02308020|9993503|FG003|STARTED|Overall Study||28
8931830|NCT02308020|9993504|FG004|STARTED|Overall Study||23
8931831|NCT02308020|9993505|FG005|STARTED|Overall Study||17
8931832|NCT02308020|9993500|FG000|Received at Least One Dose of Study Drug|Overall Study||27
8931833|NCT02308020|9993501|FG001|Received at Least One Dose of Study Drug|Overall Study||58
8931834|NCT02308020|9993502|FG002|Received at Least One Dose of Study Drug|Overall Study||9
8931835|NCT02308020|9993503|FG003|Received at Least One Dose of Study Drug|Overall Study||28
8931836|NCT02308020|9993504|FG004|Received at Least One Dose of Study Drug|Overall Study||23
9064801|NCT04267770|10125177|FG000|COMPLETED|Overall Study||9
9064802|NCT04267770|10125178|FG001|COMPLETED|Overall Study||8
9064803|NCT04267770|10125177|FG000|NOT COMPLETED|Overall Study||0
9064804|NCT04267770|10125178|FG001|NOT COMPLETED|Overall Study||0
9064805|NCT04266925|10125186|FG000|STARTED|1 Referee Game (~1 Hour)||23
8717900|NCT00996892|9765219|FG005|STARTED|Dose-Escalation Stage 1||10
8717901|NCT00996892|9765220|FG006|STARTED|Dose-Escalation Stage 1||4
8717902|NCT00996892|9765221|FG007|STARTED|Dose-Escalation Stage 1||0
8717903|NCT00996892|9765222|FG008|STARTED|Dose-Escalation Stage 1||0
9064806|NCT04266925|10125187|FG001|STARTED|1 Referee Game (~1 Hour)||26
9064807|NCT04266925|10125186|FG000|COMPLETED|1 Referee Game (~1 Hour)||23
9064808|NCT04266925|10125187|FG001|COMPLETED|1 Referee Game (~1 Hour)||26
9064809|NCT04266925|10125186|FG000|NOT COMPLETED|1 Referee Game (~1 Hour)||0
9064810|NCT04266925|10125187|FG001|NOT COMPLETED|1 Referee Game (~1 Hour)||0
9064811|NCT04266925|10125186|FG000|STARTED|3 Referee Game (~1 Hour)||23
9064812|NCT04266925|10125187|FG001|STARTED|3 Referee Game (~1 Hour)||26
9064813|NCT04266925|10125186|FG000|COMPLETED|3 Referee Game (~1 Hour)||23
9064814|NCT04266925|10125187|FG001|COMPLETED|3 Referee Game (~1 Hour)||26
9064815|NCT04266925|10125186|FG000|NOT COMPLETED|3 Referee Game (~1 Hour)||0
9064816|NCT04266925|10125187|FG001|NOT COMPLETED|3 Referee Game (~1 Hour)||0
9064817|NCT04263142|10125198|FG000|STARTED|Part 1 Period 1 (Day 1)||9
9064818|NCT04263142|10125199|FG001|STARTED|Part 1 Period 1 (Day 1)||9
9064819|NCT04263142|10125200|FG002|STARTED|Part 1 Period 1 (Day 1)||0
9064820|NCT04263142|10125201|FG003|STARTED|Part 1 Period 1 (Day 1)||0
9064821|NCT04263142|10125202|FG004|STARTED|Part 1 Period 1 (Day 1)||0
9064822|NCT04263142|10125198|FG000|COMPLETED|Part 1 Period 1 (Day 1)||9
9064823|NCT04263142|10125199|FG001|COMPLETED|Part 1 Period 1 (Day 1)||9
9064824|NCT04263142|10125200|FG002|COMPLETED|Part 1 Period 1 (Day 1)||0
9064825|NCT04263142|10125201|FG003|COMPLETED|Part 1 Period 1 (Day 1)||0
8717904|NCT00996892|9765223|FG009|STARTED|Dose-Escalation Stage 1||0
8717905|NCT00996892|9765224|FG010|STARTED|Dose-Escalation Stage 1||0
9064826|NCT04263142|10125202|FG004|COMPLETED|Part 1 Period 1 (Day 1)||0
8931837|NCT02308020|9993505|FG005|Received at Least One Dose of Study Drug|Overall Study||17
8931838|NCT02308020|9993500|FG000|COMPLETED|Overall Study||23
8931839|NCT02308020|9993501|FG001|COMPLETED|Overall Study||38
8931840|NCT02308020|9993502|FG002|COMPLETED|Overall Study||6
8931841|NCT02308020|9993503|FG003|COMPLETED|Overall Study||24
8931842|NCT02308020|9993504|FG004|COMPLETED|Overall Study||19
8931843|NCT02308020|9993505|FG005|COMPLETED|Overall Study||12
8931844|NCT02308020|9993500|FG000|NOT COMPLETED|Overall Study||4
8931845|NCT02308020|9993501|FG001|NOT COMPLETED|Overall Study||20
8931846|NCT02308020|9993502|FG002|NOT COMPLETED|Overall Study||3
8931847|NCT02308020|9993503|FG003|NOT COMPLETED|Overall Study||4
8931848|NCT02308020|9993504|FG004|NOT COMPLETED|Overall Study||4
8931849|NCT02308020|9993505|FG005|NOT COMPLETED|Overall Study||5
8931850|NCT02308033|9993527|FG000|STARTED|Overall Study||102
8931851|NCT02308033|9993528|FG001|STARTED|Overall Study||102
8931852|NCT02308033|9993527|FG000|COMPLETED|Overall Study||76
8931853|NCT02308033|9993528|FG001|COMPLETED|Overall Study||83
8931854|NCT02308033|9993527|FG000|NOT COMPLETED|Overall Study||26
8931855|NCT02308033|9993528|FG001|NOT COMPLETED|Overall Study||19
8931856|NCT02308046|9993536|FG000|STARTED|Overall Study||107
8931857|NCT02308046|9993537|FG001|STARTED|Overall Study||105
8931858|NCT02308046|9993536|FG000|COMPLETED|Overall Study||73
8931859|NCT02308046|9993537|FG001|COMPLETED|Overall Study||67
8931860|NCT02308046|9993536|FG000|NOT COMPLETED|Overall Study||34
8931861|NCT02308046|9993537|FG001|NOT COMPLETED|Overall Study||38
8931862|NCT02308124|9993546|FG000|STARTED|Overall Study||29
8931863|NCT02308124|9993547|FG001|STARTED|Overall Study||29
8931864|NCT02308124|9993548|FG002|STARTED|Overall Study||29
8931865|NCT02308124|9993546|FG000|COMPLETED|Overall Study||23
8931866|NCT02308124|9993547|FG001|COMPLETED|Overall Study||21
8931867|NCT02308124|9993548|FG002|COMPLETED|Overall Study||21
8931868|NCT02308124|9993546|FG000|NOT COMPLETED|Overall Study||6
8931869|NCT02308124|9993547|FG001|NOT COMPLETED|Overall Study||8
8931870|NCT02308124|9993548|FG002|NOT COMPLETED|Overall Study||8
8931871|NCT02308163|9993560|FG000|STARTED|Overall Study||104
8931872|NCT02308163|9993561|FG001|STARTED|Overall Study||102
8931873|NCT02308163|9993562|FG002|STARTED|Overall Study||50
8931874|NCT02308163|9993563|FG003|STARTED|Overall Study||52
8931875|NCT02308163|9993564|FG004|STARTED|Overall Study||201
8931876|NCT02308163|9993560|FG000|COMPLETED|Overall Study||73
8931877|NCT02308163|9993561|FG001|COMPLETED|Overall Study||84
8931878|NCT02308163|9993562|FG002|COMPLETED|Overall Study||36
8931879|NCT02308163|9993563|FG003|COMPLETED|Overall Study||39
8931880|NCT02308163|9993564|FG004|COMPLETED|Overall Study||167
8931881|NCT02308163|9993560|FG000|NOT COMPLETED|Overall Study||31
8931882|NCT02308163|9993561|FG001|NOT COMPLETED|Overall Study||18
8931883|NCT02308163|9993562|FG002|NOT COMPLETED|Overall Study||14
8931884|NCT02308163|9993563|FG003|NOT COMPLETED|Overall Study||13
8931885|NCT02308163|9993564|FG004|NOT COMPLETED|Overall Study||34
8931886|NCT02308189|9993593|FG000|STARTED|Overall Study||17
8931887|NCT02308189|9993594|FG001|STARTED|Overall Study||15
8931888|NCT02308189|9993593|FG000|COMPLETED|Overall Study||16
8931889|NCT02308189|9993594|FG001|COMPLETED|Overall Study||14
8931890|NCT02308189|9993593|FG000|NOT COMPLETED|Overall Study||1
8931891|NCT02308189|9993594|FG001|NOT COMPLETED|Overall Study||1
8931892|NCT02308228|9993602|FG000|STARTED|Overall Study||54
8931893|NCT02308228|9993603|FG001|STARTED|Overall Study||55
8931894|NCT02308228|9993602|FG000|COMPLETED|Overall Study||46
8931895|NCT02308228|9993603|FG001|COMPLETED|Overall Study||48
8931896|NCT02308228|9993602|FG000|NOT COMPLETED|Overall Study||8
8931897|NCT02308228|9993603|FG001|NOT COMPLETED|Overall Study||7
8931898|NCT02308371|9993611|FG000|STARTED|Overall Study|Started enrollment and recruitment 11/26/2014|50
8931899|NCT02308371|9993612|FG001|STARTED|Overall Study|Consider eligible for retrospective enrollment if admitted after 4/1/2012|50
8931900|NCT02308371|9993611|FG000|COMPLETED|Overall Study|Ended enrollment and recruitment 3/1/2016|50
8931901|NCT02308371|9993612|FG001|COMPLETED|Overall Study|Consider eligible for retrospective enrollment if admitted up until 10/15/2012|50
8931902|NCT02308371|9993611|FG000|NOT COMPLETED|Overall Study||0
8931903|NCT02308371|9993612|FG001|NOT COMPLETED|Overall Study||0
8931904|NCT02308501|9993622|FG000|STARTED|Overall Study|25 participants received one drop of Lastacaft in one eye and Tears Naturale in the other eye.|25
8931905|NCT02308501|9993623|FG001|STARTED|Overall Study||25
8931906|NCT02308501|9993622|FG000|Randomized Participant Eyes|Overall Study||25
8931907|NCT02308501|9993623|FG001|Randomized Participant Eyes|Overall Study||25
8931908|NCT02308501|9993622|FG000|COMPLETED|Overall Study||25
8931909|NCT02308501|9993623|FG001|COMPLETED|Overall Study||25
8931910|NCT02308501|9993622|FG000|NOT COMPLETED|Overall Study||0
8931911|NCT02308501|9993623|FG001|NOT COMPLETED|Overall Study||0
8931912|NCT02308540|9993641|FG000|STARTED|Overall Study||17
8931913|NCT02308540|9993642|FG001|STARTED|Overall Study||17
8931914|NCT02308540|9993643|FG002|STARTED|Overall Study||56
8931915|NCT02308540|9993644|FG003|STARTED|Overall Study||56
8931916|NCT02308540|9993645|FG004|STARTED|Overall Study||100
8931917|NCT02308540|9993646|FG005|STARTED|Overall Study||100
8931918|NCT02308540|9993641|FG000|Randomized|Overall Study||17
8931919|NCT02308540|9993642|FG001|Randomized|Overall Study||17
8931920|NCT02308540|9993643|FG002|Randomized|Overall Study||56
8931921|NCT02308540|9993644|FG003|Randomized|Overall Study||56
8931922|NCT02308540|9993645|FG004|Randomized|Overall Study||100
8931923|NCT02308540|9993646|FG005|Randomized|Overall Study||100
8931924|NCT02308540|9993641|FG000|Vaccinated|Overall Study||17
8931925|NCT02308540|9993642|FG001|Vaccinated|Overall Study||17
8931926|NCT02308540|9993643|FG002|Vaccinated|Overall Study||56
8931927|NCT02308540|9993644|FG003|Vaccinated|Overall Study||56
8931928|NCT02308540|9993645|FG004|Vaccinated|Overall Study||100
8931929|NCT02308540|9993646|FG005|Vaccinated|Overall Study||100
8931930|NCT02308540|9993641|FG000|COMPLETED|Overall Study||17
8931931|NCT02308540|9993642|FG001|COMPLETED|Overall Study||17
8931932|NCT02308540|9993643|FG002|COMPLETED|Overall Study||56
8931933|NCT02308540|9993644|FG003|COMPLETED|Overall Study||56
8931934|NCT02308540|9993645|FG004|COMPLETED|Overall Study||100
8931935|NCT02308540|9993646|FG005|COMPLETED|Overall Study||99
8931936|NCT02308540|9993641|FG000|NOT COMPLETED|Overall Study||0
8931937|NCT02308540|9993642|FG001|NOT COMPLETED|Overall Study||0
8931938|NCT02308540|9993643|FG002|NOT COMPLETED|Overall Study||0
8931939|NCT02308540|9993644|FG003|NOT COMPLETED|Overall Study||0
8931940|NCT02308540|9993645|FG004|NOT COMPLETED|Overall Study||0
8931941|NCT02308540|9993646|FG005|NOT COMPLETED|Overall Study||1
8931942|NCT02308696|9993697|FG000|STARTED|Overall Study||222
8931943|NCT02308696|9993698|FG001|STARTED|Overall Study||234
8931944|NCT02308696|9993697|FG000|COMPLETED|Overall Study||169
8931945|NCT02308696|9993698|FG001|COMPLETED|Overall Study||203
8931946|NCT02308696|9993697|FG000|NOT COMPLETED|Overall Study||53
8931947|NCT02308696|9993698|FG001|NOT COMPLETED|Overall Study||31
8931948|NCT02308748|9993704|FG000|STARTED|Period 1||2
8931949|NCT02308748|9993705|FG001|STARTED|Period 1||2
8931950|NCT02308748|9993706|FG002|STARTED|Period 1||2
8931951|NCT02308748|9993707|FG003|STARTED|Period 1||2
8931952|NCT02308748|9993708|FG004|STARTED|Period 1||2
8931953|NCT02308748|9993709|FG005|STARTED|Period 1||3
8931954|NCT02308748|9993710|FG006|STARTED|Period 1||2
8931955|NCT02308748|9993711|FG007|STARTED|Period 1||2
8931956|NCT02308748|9993712|FG008|STARTED|Period 1||2
8931957|NCT02308748|9993713|FG009|STARTED|Period 1||3
8931958|NCT02308748|9993704|FG000|COMPLETED|Period 1||2
8931959|NCT02308748|9993705|FG001|COMPLETED|Period 1||2
8931960|NCT02308748|9993706|FG002|COMPLETED|Period 1|One subject withdraw consent before starting Period 2|1
8931961|NCT02308748|9993707|FG003|COMPLETED|Period 1||2
8931962|NCT02308748|9993708|FG004|COMPLETED|Period 1||2
8931963|NCT02308748|9993709|FG005|COMPLETED|Period 1||3
8931964|NCT02308748|9993710|FG006|COMPLETED|Period 1||2
8931965|NCT02308748|9993711|FG007|COMPLETED|Period 1||2
8931966|NCT02308748|9993712|FG008|COMPLETED|Period 1||2
8931967|NCT02308748|9993713|FG009|COMPLETED|Period 1||3
8931968|NCT02308748|9993704|FG000|NOT COMPLETED|Period 1||0
8931969|NCT02308748|9993705|FG001|NOT COMPLETED|Period 1||0
8931970|NCT02308748|9993706|FG002|NOT COMPLETED|Period 1||1
8931971|NCT02308748|9993707|FG003|NOT COMPLETED|Period 1||0
8931972|NCT02308748|9993708|FG004|NOT COMPLETED|Period 1||0
8931973|NCT02308748|9993709|FG005|NOT COMPLETED|Period 1||0
8931974|NCT02308748|9993710|FG006|NOT COMPLETED|Period 1||0
8931975|NCT02308748|9993711|FG007|NOT COMPLETED|Period 1||0
8931976|NCT02308748|9993712|FG008|NOT COMPLETED|Period 1||0
8931977|NCT02308748|9993713|FG009|NOT COMPLETED|Period 1||0
8931978|NCT02308748|9993704|FG000|STARTED|Period 2||2
8931979|NCT02308748|9993705|FG001|STARTED|Period 2||2
8931980|NCT02308748|9993706|FG002|STARTED|Period 2||1
8931981|NCT02308748|9993707|FG003|STARTED|Period 2||2
8931982|NCT02308748|9993708|FG004|STARTED|Period 2||2
8931983|NCT02308748|9993709|FG005|STARTED|Period 2||3
8931984|NCT02308748|9993710|FG006|STARTED|Period 2||2
8931985|NCT02308748|9993711|FG007|STARTED|Period 2||2
8931986|NCT02308748|9993712|FG008|STARTED|Period 2||2
8931987|NCT02308748|9993713|FG009|STARTED|Period 2||3
8931988|NCT02308748|9993704|FG000|COMPLETED|Period 2||2
8931989|NCT02308748|9993705|FG001|COMPLETED|Period 2||2
8931990|NCT02308748|9993706|FG002|COMPLETED|Period 2||1
8931991|NCT02308748|9993707|FG003|COMPLETED|Period 2||2
8931992|NCT02308748|9993708|FG004|COMPLETED|Period 2||2
8931993|NCT02308748|9993709|FG005|COMPLETED|Period 2||3
8931994|NCT02308748|9993710|FG006|COMPLETED|Period 2||2
8931995|NCT02308748|9993711|FG007|COMPLETED|Period 2||1
8931996|NCT02308748|9993712|FG008|COMPLETED|Period 2||2
8931997|NCT02308748|9993713|FG009|COMPLETED|Period 2||3
8931998|NCT02308748|9993704|FG000|NOT COMPLETED|Period 2||0
8931999|NCT02308748|9993705|FG001|NOT COMPLETED|Period 2||0
8932000|NCT02308748|9993706|FG002|NOT COMPLETED|Period 2||0
8932001|NCT02308748|9993707|FG003|NOT COMPLETED|Period 2||0
8932002|NCT02308748|9993708|FG004|NOT COMPLETED|Period 2||0
8932003|NCT02308748|9993709|FG005|NOT COMPLETED|Period 2||0
8932004|NCT02308748|9993710|FG006|NOT COMPLETED|Period 2||0
8932005|NCT02308748|9993711|FG007|NOT COMPLETED|Period 2||1
8932006|NCT02308748|9993712|FG008|NOT COMPLETED|Period 2||0
8932007|NCT02308748|9993713|FG009|NOT COMPLETED|Period 2||0
8932008|NCT02308748|9993704|FG000|STARTED|Period 3||2
8932009|NCT02308748|9993705|FG001|STARTED|Period 3||2
8932010|NCT02308748|9993706|FG002|STARTED|Period 3||1
8932011|NCT02308748|9993707|FG003|STARTED|Period 3||2
8932012|NCT02308748|9993708|FG004|STARTED|Period 3||2
8932013|NCT02308748|9993709|FG005|STARTED|Period 3||3
8932014|NCT02308748|9993710|FG006|STARTED|Period 3||2
8932015|NCT02308748|9993711|FG007|STARTED|Period 3||1
8932016|NCT02308748|9993712|FG008|STARTED|Period 3||2
8932017|NCT02308748|9993713|FG009|STARTED|Period 3||3
8932018|NCT02308748|9993704|FG000|COMPLETED|Period 3||2
8932019|NCT02308748|9993705|FG001|COMPLETED|Period 3||2
8932020|NCT02308748|9993706|FG002|COMPLETED|Period 3||1
8932021|NCT02308748|9993707|FG003|COMPLETED|Period 3||2
8932022|NCT02308748|9993708|FG004|COMPLETED|Period 3||2
8932023|NCT02308748|9993709|FG005|COMPLETED|Period 3||3
8932024|NCT02308748|9993710|FG006|COMPLETED|Period 3||2
8932025|NCT02308748|9993711|FG007|COMPLETED|Period 3||1
8932026|NCT02308748|9993712|FG008|COMPLETED|Period 3||2
8932027|NCT02308748|9993713|FG009|COMPLETED|Period 3||2
8932028|NCT02308748|9993704|FG000|NOT COMPLETED|Period 3||0
8932029|NCT02308748|9993705|FG001|NOT COMPLETED|Period 3||0
8932030|NCT02308748|9993706|FG002|NOT COMPLETED|Period 3||0
8932031|NCT02308748|9993707|FG003|NOT COMPLETED|Period 3||0
8932032|NCT02308748|9993708|FG004|NOT COMPLETED|Period 3||0
8932033|NCT02308748|9993709|FG005|NOT COMPLETED|Period 3||0
8932034|NCT02308748|9993710|FG006|NOT COMPLETED|Period 3||0
8932035|NCT02308748|9993711|FG007|NOT COMPLETED|Period 3||0
8932036|NCT02308748|9993712|FG008|NOT COMPLETED|Period 3||0
8932037|NCT02308748|9993713|FG009|NOT COMPLETED|Period 3||1
8932038|NCT02308748|9993704|FG000|STARTED|Period 4||2
8932039|NCT02308748|9993705|FG001|STARTED|Period 4||2
8932040|NCT02308748|9993706|FG002|STARTED|Period 4||1
8932041|NCT02308748|9993707|FG003|STARTED|Period 4||2
8932042|NCT02308748|9993708|FG004|STARTED|Period 4||2
8932043|NCT02308748|9993709|FG005|STARTED|Period 4||3
8932044|NCT02308748|9993710|FG006|STARTED|Period 4||2
8932045|NCT02308748|9993711|FG007|STARTED|Period 4||1
8932046|NCT02308748|9993712|FG008|STARTED|Period 4||2
8932047|NCT02308748|9993713|FG009|STARTED|Period 4||2
8932048|NCT02308748|9993704|FG000|COMPLETED|Period 4||2
8932049|NCT02308748|9993705|FG001|COMPLETED|Period 4||2
8932050|NCT02308748|9993706|FG002|COMPLETED|Period 4||1
8932051|NCT02308748|9993707|FG003|COMPLETED|Period 4||2
8932052|NCT02308748|9993708|FG004|COMPLETED|Period 4||2
8932053|NCT02308748|9993709|FG005|COMPLETED|Period 4||3
8932054|NCT02308748|9993710|FG006|COMPLETED|Period 4||2
8932055|NCT02308748|9993711|FG007|COMPLETED|Period 4||1
8932056|NCT02308748|9993712|FG008|COMPLETED|Period 4||2
8932057|NCT02308748|9993713|FG009|COMPLETED|Period 4||2
8932058|NCT02308748|9993704|FG000|NOT COMPLETED|Period 4||0
8932059|NCT02308748|9993705|FG001|NOT COMPLETED|Period 4||0
8932060|NCT02308748|9993706|FG002|NOT COMPLETED|Period 4||0
8932061|NCT02308748|9993707|FG003|NOT COMPLETED|Period 4||0
8932062|NCT02308748|9993708|FG004|NOT COMPLETED|Period 4||0
8932063|NCT02308748|9993709|FG005|NOT COMPLETED|Period 4||0
8932064|NCT02308748|9993710|FG006|NOT COMPLETED|Period 4||0
8932065|NCT02308748|9993711|FG007|NOT COMPLETED|Period 4||0
8932066|NCT02308748|9993712|FG008|NOT COMPLETED|Period 4||0
8932067|NCT02308748|9993713|FG009|NOT COMPLETED|Period 4||0
8932068|NCT02308748|9993704|FG000|STARTED|Period 5||2
8932069|NCT02308748|9993705|FG001|STARTED|Period 5||2
8932070|NCT02308748|9993706|FG002|STARTED|Period 5||1
8932071|NCT02308748|9993707|FG003|STARTED|Period 5||2
8932072|NCT02308748|9993708|FG004|STARTED|Period 5||2
8932073|NCT02308748|9993709|FG005|STARTED|Period 5||3
8932074|NCT02308748|9993710|FG006|STARTED|Period 5||2
8932075|NCT02308748|9993711|FG007|STARTED|Period 5||1
8932076|NCT02308748|9993712|FG008|STARTED|Period 5||2
8932077|NCT02308748|9993713|FG009|STARTED|Period 5||2
8932078|NCT02308748|9993704|FG000|COMPLETED|Period 5||1
8932079|NCT02308748|9993705|FG001|COMPLETED|Period 5||2
8932080|NCT02308748|9993706|FG002|COMPLETED|Period 5||1
8932081|NCT02308748|9993707|FG003|COMPLETED|Period 5||2
8932082|NCT02308748|9993708|FG004|COMPLETED|Period 5||2
8932083|NCT02308748|9993709|FG005|COMPLETED|Period 5||3
8932084|NCT02308748|9993710|FG006|COMPLETED|Period 5||2
8932085|NCT02308748|9993711|FG007|COMPLETED|Period 5||1
8932086|NCT02308748|9993712|FG008|COMPLETED|Period 5||1
8932087|NCT02308748|9993713|FG009|COMPLETED|Period 5||2
8932088|NCT02308748|9993704|FG000|NOT COMPLETED|Period 5||1
8932089|NCT02308748|9993705|FG001|NOT COMPLETED|Period 5||0
8932090|NCT02308748|9993706|FG002|NOT COMPLETED|Period 5||0
8932091|NCT02308748|9993707|FG003|NOT COMPLETED|Period 5||0
8932092|NCT02308748|9993708|FG004|NOT COMPLETED|Period 5||0
8932093|NCT02308748|9993709|FG005|NOT COMPLETED|Period 5||0
8932094|NCT02308748|9993710|FG006|NOT COMPLETED|Period 5||0
8932095|NCT02308748|9993711|FG007|NOT COMPLETED|Period 5||0
8932096|NCT02308748|9993712|FG008|NOT COMPLETED|Period 5||1
8932097|NCT02308748|9993713|FG009|NOT COMPLETED|Period 5||0
8932098|NCT02308787|9993725|FG000|STARTED|Overall Study|Data were collected from 20 PLTD procedures performed in 12 subjects|12
8932099|NCT02308787|9993725|FG000|COMPLETED|Overall Study|Data were collected from 20 PLTD procedures performed in 12 subjects|12
8932100|NCT02308787|9993725|FG000|NOT COMPLETED|Overall Study||0
8932101|NCT02308839|9993729|FG000|STARTED|Overall Study||181
8932102|NCT02308839|9993729|FG000|COMPLETED|Overall Study||72
8932103|NCT02308839|9993729|FG000|NOT COMPLETED|Overall Study||109
8932104|NCT02309099|9993735|FG000|STARTED|Overall Study||7
8932105|NCT02309099|9993736|FG001|STARTED|Overall Study||3
8932106|NCT02309099|9993735|FG000|Cochlear Implantation|Overall Study||7
8932107|NCT02309099|9993736|FG001|Cochlear Implantation|Overall Study||3
8932108|NCT02309099|9993735|FG000|Initial Activation|Overall Study||7
8932109|NCT02309099|9993736|FG001|Initial Activation|Overall Study||3
8932110|NCT02309099|9993735|FG000|Cochlear Implant Use/Follow-Up|Overall Study|5 participants completed cochlear implant use/follow-up (2 did not complete due to adverse event)|5
8932111|NCT02309099|9993736|FG001|Cochlear Implant Use/Follow-Up|Overall Study||3
8932112|NCT02309099|9993735|FG000|COMPLETED|Overall Study|5 participants completed the study (2 did not complete due to adverse event)|5
8932113|NCT02309099|9993736|FG001|COMPLETED|Overall Study||3
8932114|NCT02309099|9993735|FG000|NOT COMPLETED|Overall Study||2
8932115|NCT02309099|9993736|FG001|NOT COMPLETED|Overall Study||0
8932116|NCT02309112|9993745|FG000|STARTED|Overall Study||5
8932117|NCT02309112|9993746|FG001|STARTED|Overall Study||5
8932118|NCT02309112|9993747|FG002|STARTED|Overall Study||5
8932119|NCT02309112|9993745|FG000|Completed Yoga Intervention|Overall Study||4
8932120|NCT02309112|9993746|FG001|Completed Yoga Intervention|Overall Study||5
8932121|NCT02309112|9993747|FG002|Completed Yoga Intervention|Overall Study||4
8932122|NCT02309112|9993745|FG000|COMPLETED|Overall Study||4
8932123|NCT02309112|9993746|FG001|COMPLETED|Overall Study||4
8932124|NCT02309112|9993747|FG002|COMPLETED|Overall Study||4
8932125|NCT02309112|9993745|FG000|NOT COMPLETED|Overall Study||1
8932126|NCT02309112|9993746|FG001|NOT COMPLETED|Overall Study||1
8932127|NCT02309112|9993747|FG002|NOT COMPLETED|Overall Study||1
8932128|NCT02309138|9993759|FG000|STARTED|Overall Study||460
8932129|NCT02309138|9993760|FG001|STARTED|Overall Study||461
8932130|NCT02309138|9993759|FG000|COMPLETED|Overall Study||412
8932131|NCT02309138|9993760|FG001|COMPLETED|Overall Study||443
8932132|NCT02309138|9993759|FG000|NOT COMPLETED|Overall Study||48
8932133|NCT02309138|9993760|FG001|NOT COMPLETED|Overall Study||18
8932134|NCT02309294|9993776|FG000|STARTED|Overall Study||43
8932135|NCT02309294|9993776|FG000|COMPLETED|Overall Study||41
8932136|NCT02309294|9993776|FG000|NOT COMPLETED|Overall Study||2
8932137|NCT02309359|9993785|FG000|STARTED|Overall Study||69
8932138|NCT02309359|9993786|FG001|STARTED|Overall Study||70
8932139|NCT02309359|9993787|FG002|STARTED|Overall Study||68
8932140|NCT02309359|9993788|FG003|STARTED|Overall Study||69
8932141|NCT02309359|9993789|FG004|STARTED|Overall Study||69
8932142|NCT02309359|9993785|FG000|COMPLETED|Overall Study||57
8932143|NCT02309359|9993786|FG001|COMPLETED|Overall Study||62
8932144|NCT02309359|9993787|FG002|COMPLETED|Overall Study||57
8932145|NCT02309359|9993788|FG003|COMPLETED|Overall Study||57
8932146|NCT02309359|9993789|FG004|COMPLETED|Overall Study||60
8932147|NCT02309359|9993785|FG000|NOT COMPLETED|Overall Study||12
8932148|NCT02309359|9993786|FG001|NOT COMPLETED|Overall Study||8
8932149|NCT02309359|9993787|FG002|NOT COMPLETED|Overall Study||11
8932150|NCT02309359|9993788|FG003|NOT COMPLETED|Overall Study||12
8932151|NCT02309359|9993789|FG004|NOT COMPLETED|Overall Study||9
8932152|NCT02309372|9993804|FG000|STARTED|Overall Study||27
8932153|NCT02309372|9993805|FG001|STARTED|Overall Study||27
8932154|NCT02309372|9993804|FG000|COMPLETED|Overall Study||24
9064827|NCT04263142|10125198|FG000|NOT COMPLETED|Part 1 Period 1 (Day 1)||0
9064828|NCT04263142|10125199|FG001|NOT COMPLETED|Part 1 Period 1 (Day 1)||0
9064829|NCT04263142|10125200|FG002|NOT COMPLETED|Part 1 Period 1 (Day 1)||0
8932155|NCT02309372|9993805|FG001|COMPLETED|Overall Study||25
8932156|NCT02309372|9993804|FG000|NOT COMPLETED|Overall Study||3
8932157|NCT02309372|9993805|FG001|NOT COMPLETED|Overall Study||2
8932158|NCT02309411|9993814|FG000|STARTED|Overall Study||25
8932159|NCT02309411|9993815|FG001|STARTED|Overall Study||15
8932160|NCT02309411|9993816|FG002|STARTED|Overall Study||6
8932161|NCT02309411|9993814|FG000|COMPLETED|Overall Study||23
8932162|NCT02309411|9993815|FG001|COMPLETED|Overall Study||14
8932163|NCT02309411|9993816|FG002|COMPLETED|Overall Study||6
8932164|NCT02309411|9993814|FG000|NOT COMPLETED|Overall Study||2
8932165|NCT02309411|9993815|FG001|NOT COMPLETED|Overall Study||1
8932166|NCT02309411|9993816|FG002|NOT COMPLETED|Overall Study||0
8932167|NCT02309489|9993825|FG000|STARTED|Overall Study||583
8932168|NCT02309489|9993826|FG001|STARTED|Overall Study||561
8932169|NCT02309489|9993825|FG000|Follow-up at 3 Months Postpartum|Overall Study||560
8932170|NCT02309489|9993826|FG001|Follow-up at 3 Months Postpartum|Overall Study||541
8932171|NCT02309489|9993825|FG000|COMPLETED|Overall Study||568
8932172|NCT02309489|9993826|FG001|COMPLETED|Overall Study||547
8932173|NCT02309489|9993825|FG000|NOT COMPLETED|Overall Study||15
8932174|NCT02309489|9993826|FG001|NOT COMPLETED|Overall Study||14
8932175|NCT02309515|9993834|FG000|STARTED|Overall Study||5
8932176|NCT02309515|9993835|FG001|STARTED|Overall Study||7
8932177|NCT02309515|9993834|FG000|COMPLETED|Overall Study||5
8932178|NCT02309515|9993835|FG001|COMPLETED|Overall Study||6
8932179|NCT02309515|9993834|FG000|NOT COMPLETED|Overall Study||0
8932180|NCT02309515|9993835|FG001|NOT COMPLETED|Overall Study||1
8932181|NCT02309723|9993844|FG000|STARTED|Overall Study||129
8932182|NCT02309723|9993845|FG001|STARTED|Overall Study||128
8932183|NCT02309723|9993846|FG002|STARTED|Overall Study||129
8932184|NCT02309723|9993844|FG000|COMPLETED|Overall Study||105
8932185|NCT02309723|9993845|FG001|COMPLETED|Overall Study||105
8932186|NCT02309723|9993846|FG002|COMPLETED|Overall Study||105
8932187|NCT02309723|9993844|FG000|NOT COMPLETED|Overall Study||24
8932188|NCT02309723|9993845|FG001|NOT COMPLETED|Overall Study||23
8932189|NCT02309723|9993846|FG002|NOT COMPLETED|Overall Study||24
8932190|NCT02309944|9993856|FG000|STARTED|Overall Study||38
8932191|NCT02309944|9993857|FG001|STARTED|Overall Study||43
8932192|NCT02309944|9993856|FG000|COMPLETED|Overall Study||38
8932193|NCT02309944|9993857|FG001|COMPLETED|Overall Study||43
8932194|NCT02309944|9993856|FG000|NOT COMPLETED|Overall Study||0
8932195|NCT02309944|9993857|FG001|NOT COMPLETED|Overall Study||0
8932196|NCT02310100|9993863|FG000|STARTED|Overall Study|First enrollment|178
8932197|NCT02310100|9993863|FG000|COMPLETED|Overall Study||160
8932198|NCT02310100|9993863|FG000|NOT COMPLETED|Overall Study||18
8932199|NCT02310126|9993870|FG000|STARTED|Period 1 (15 Minutes)||94
8932200|NCT02310126|9993871|FG001|STARTED|Period 1 (15 Minutes)||97
8932201|NCT02310126|9993870|FG000|Hyperopes|Period 1 (15 Minutes)||38
8932202|NCT02310126|9993871|FG001|Hyperopes|Period 1 (15 Minutes)||33
8932203|NCT02310126|9993870|FG000|Myopes|Period 1 (15 Minutes)||56
8932204|NCT02310126|9993871|FG001|Myopes|Period 1 (15 Minutes)||64
8932205|NCT02310126|9993870|FG000|COMPLETED|Period 1 (15 Minutes)||94
8932206|NCT02310126|9993871|FG001|COMPLETED|Period 1 (15 Minutes)||95
8932207|NCT02310126|9993870|FG000|NOT COMPLETED|Period 1 (15 Minutes)||0
8932208|NCT02310126|9993871|FG001|NOT COMPLETED|Period 1 (15 Minutes)||2
8932209|NCT02310126|9993870|FG000|STARTED|Period 2 (15 Minutes)||94
8932210|NCT02310126|9993871|FG001|STARTED|Period 2 (15 Minutes)||95
8932211|NCT02310126|9993870|FG000|Hyperopes|Period 2 (15 Minutes)||38
8932212|NCT02310126|9993871|FG001|Hyperopes|Period 2 (15 Minutes)||32
8932213|NCT02310126|9993870|FG000|Myopes|Period 2 (15 Minutes)||56
8932214|NCT02310126|9993871|FG001|Myopes|Period 2 (15 Minutes)||63
8932215|NCT02310126|9993870|FG000|COMPLETED|Period 2 (15 Minutes)||94
8932216|NCT02310126|9993871|FG001|COMPLETED|Period 2 (15 Minutes)||95
8932217|NCT02310126|9993870|FG000|NOT COMPLETED|Period 2 (15 Minutes)||0
8932218|NCT02310126|9993871|FG001|NOT COMPLETED|Period 2 (15 Minutes)||0
8932219|NCT02310568|9993882|FG000|STARTED|Stage 1 ( 4 Weeks)||15
8932220|NCT02310568|9993883|FG001|STARTED|Stage 1 ( 4 Weeks)||15
8932221|NCT02310568|9993884|FG002|STARTED|Stage 1 ( 4 Weeks)||15
8932222|NCT02310568|9993885|FG003|STARTED|Stage 1 ( 4 Weeks)||24
8932223|NCT02310568|9993886|FG004|STARTED|Stage 1 ( 4 Weeks)||21
8932224|NCT02310568|9993882|FG000|COMPLETED|Stage 1 ( 4 Weeks)||12
8932225|NCT02310568|9993883|FG001|COMPLETED|Stage 1 ( 4 Weeks)||13
8932226|NCT02310568|9993884|FG002|COMPLETED|Stage 1 ( 4 Weeks)||14
8932227|NCT02310568|9993885|FG003|COMPLETED|Stage 1 ( 4 Weeks)||22
8932228|NCT02310568|9993886|FG004|COMPLETED|Stage 1 ( 4 Weeks)||20
8932229|NCT02310568|9993882|FG000|NOT COMPLETED|Stage 1 ( 4 Weeks)||3
8932230|NCT02310568|9993883|FG001|NOT COMPLETED|Stage 1 ( 4 Weeks)||2
8932231|NCT02310568|9993884|FG002|NOT COMPLETED|Stage 1 ( 4 Weeks)||1
8932232|NCT02310568|9993885|FG003|NOT COMPLETED|Stage 1 ( 4 Weeks)||2
8932233|NCT02310568|9993886|FG004|NOT COMPLETED|Stage 1 ( 4 Weeks)||1
8932234|NCT02310568|9993882|FG000|STARTED|Stage 2 (4 Weeks)||12
8932235|NCT02310568|9993883|FG001|STARTED|Stage 2 (4 Weeks)||13
8932236|NCT02310568|9993884|FG002|STARTED|Stage 2 (4 Weeks)||14
8932237|NCT02310568|9993885|FG003|STARTED|Stage 2 (4 Weeks)||22
8932238|NCT02310568|9993886|FG004|STARTED|Stage 2 (4 Weeks)||20
8932239|NCT02310568|9993882|FG000|COMPLETED|Stage 2 (4 Weeks)||11
8932240|NCT02310568|9993883|FG001|COMPLETED|Stage 2 (4 Weeks)||12
8932241|NCT02310568|9993884|FG002|COMPLETED|Stage 2 (4 Weeks)||13
8932242|NCT02310568|9993885|FG003|COMPLETED|Stage 2 (4 Weeks)||17
8932243|NCT02310568|9993886|FG004|COMPLETED|Stage 2 (4 Weeks)||19
8932244|NCT02310568|9993882|FG000|NOT COMPLETED|Stage 2 (4 Weeks)||1
8932245|NCT02310568|9993883|FG001|NOT COMPLETED|Stage 2 (4 Weeks)||1
8932246|NCT02310568|9993884|FG002|NOT COMPLETED|Stage 2 (4 Weeks)||1
8932247|NCT02310568|9993885|FG003|NOT COMPLETED|Stage 2 (4 Weeks)||5
8932248|NCT02310568|9993886|FG004|NOT COMPLETED|Stage 2 (4 Weeks)||1
8932249|NCT02310581|9993908|FG000|STARTED|Overall Study||9
8932250|NCT02310581|9993909|FG001|STARTED|Overall Study||11
8932251|NCT02310581|9993910|FG002|STARTED|Overall Study||10
8932252|NCT02310581|9993911|FG003|STARTED|Overall Study||10
8932253|NCT02310581|9993908|FG000|COMPLETED|Overall Study||6
8932254|NCT02310581|9993909|FG001|COMPLETED|Overall Study||9
8932255|NCT02310581|9993910|FG002|COMPLETED|Overall Study||9
8932256|NCT02310581|9993911|FG003|COMPLETED|Overall Study||9
8932257|NCT02310581|9993908|FG000|NOT COMPLETED|Overall Study||3
8932258|NCT02310581|9993909|FG001|NOT COMPLETED|Overall Study||2
8932259|NCT02310581|9993910|FG002|NOT COMPLETED|Overall Study||1
8932260|NCT02310581|9993911|FG003|NOT COMPLETED|Overall Study||1
8932261|NCT02310646|9993923|FG000|STARTED|First Intervention (Day 1 - Day 7)||109
8932262|NCT02310646|9993924|FG001|STARTED|First Intervention (Day 1 - Day 7)||104
8932263|NCT02310646|9993923|FG000|COMPLETED|First Intervention (Day 1 - Day 7)||107
8932264|NCT02310646|9993924|FG001|COMPLETED|First Intervention (Day 1 - Day 7)||104
8932265|NCT02310646|9993923|FG000|NOT COMPLETED|First Intervention (Day 1 - Day 7)||2
8932266|NCT02310646|9993924|FG001|NOT COMPLETED|First Intervention (Day 1 - Day 7)||0
8932267|NCT02310646|9993923|FG000|STARTED|Second Intervention (Day 8 - Day 14)||107
8932268|NCT02310646|9993924|FG001|STARTED|Second Intervention (Day 8 - Day 14)||104
8932269|NCT02310646|9993923|FG000|COMPLETED|Second Intervention (Day 8 - Day 14)||107
8932270|NCT02310646|9993924|FG001|COMPLETED|Second Intervention (Day 8 - Day 14)||104
8932271|NCT02310646|9993923|FG000|NOT COMPLETED|Second Intervention (Day 8 - Day 14)||0
8932272|NCT02310646|9993924|FG001|NOT COMPLETED|Second Intervention (Day 8 - Day 14)||0
8932273|NCT02310672|9993946|FG000|STARTED|Overall Study||87
8932274|NCT02310672|9993946|FG000|COMPLETED|Overall Study||72
8932275|NCT02310672|9993946|FG000|NOT COMPLETED|Overall Study||15
8932276|NCT02310750|9993961|FG000|STARTED|HP Period 1||7
8932277|NCT02310750|9993962|FG001|STARTED|HP Period 1||6
8932278|NCT02310750|9993963|FG002|STARTED|HP Period 1||6
8932279|NCT02310750|9993964|FG003|STARTED|HP Period 1||6
8932280|NCT02310750|9993965|FG004|STARTED|HP Period 1||8
8932281|NCT02310750|9993966|FG005|STARTED|HP Period 1||8
8932282|NCT02310750|9993967|FG006|STARTED|HP Period 1||13
8932283|NCT02310750|9993968|FG007|STARTED|HP Period 1||0
8932284|NCT02310750|9993969|FG008|STARTED|HP Period 1||0
8932285|NCT02310750|9993970|FG009|STARTED|HP Period 1||0
8932286|NCT02310750|9993971|FG010|STARTED|HP Period 1||2
8932287|NCT02310750|9993972|FG011|STARTED|HP Period 1||2
8932288|NCT02310750|9993973|FG012|STARTED|HP Period 1||2
8932289|NCT02310750|9993974|FG013|STARTED|HP Period 1||2
8932290|NCT02310750|9993975|FG014|STARTED|HP Period 1||2
8932291|NCT02310750|9993976|FG015|STARTED|HP Period 1||2
8932292|NCT02310750|9993961|FG000|COMPLETED|HP Period 1||6
8932293|NCT02310750|9993962|FG001|COMPLETED|HP Period 1||6
8932294|NCT02310750|9993963|FG002|COMPLETED|HP Period 1||6
8932295|NCT02310750|9993964|FG003|COMPLETED|HP Period 1||5
8932296|NCT02310750|9993965|FG004|COMPLETED|HP Period 1||8
8932297|NCT02310750|9993966|FG005|COMPLETED|HP Period 1||8
8932298|NCT02310750|9993967|FG006|COMPLETED|HP Period 1||12
8932299|NCT02310750|9993968|FG007|COMPLETED|HP Period 1||0
8932300|NCT02310750|9993969|FG008|COMPLETED|HP Period 1||0
8932301|NCT02310750|9993970|FG009|COMPLETED|HP Period 1||0
8932302|NCT02310750|9993971|FG010|COMPLETED|HP Period 1||2
8717906|NCT00996892|9765225|FG011|STARTED|Dose-Escalation Stage 1||0
8717907|NCT00996892|9765226|FG012|STARTED|Dose-Escalation Stage 1||0
8717908|NCT00996892|9765227|FG013|STARTED|Dose-Escalation Stage 1||0
8717909|NCT00996892|9765228|FG014|STARTED|Dose-Escalation Stage 1||0
8717910|NCT00996892|9765229|FG015|STARTED|Dose-Escalation Stage 1||0
8717911|NCT00996892|9765230|FG016|STARTED|Dose-Escalation Stage 1||0
8717912|NCT00996892|9765231|FG017|STARTED|Dose-Escalation Stage 1||0
8717913|NCT00996892|9765232|FG018|STARTED|Dose-Escalation Stage 1||0
8717914|NCT00996892|9765233|FG019|STARTED|Dose-Escalation Stage 1||0
8932303|NCT02310750|9993972|FG011|COMPLETED|HP Period 1||2
8932304|NCT02310750|9993973|FG012|COMPLETED|HP Period 1||2
8932305|NCT02310750|9993974|FG013|COMPLETED|HP Period 1||2
8932306|NCT02310750|9993975|FG014|COMPLETED|HP Period 1||2
8932307|NCT02310750|9993976|FG015|COMPLETED|HP Period 1||2
8932308|NCT02310750|9993961|FG000|NOT COMPLETED|HP Period 1||1
8932309|NCT02310750|9993962|FG001|NOT COMPLETED|HP Period 1||0
8932310|NCT02310750|9993963|FG002|NOT COMPLETED|HP Period 1||0
8932311|NCT02310750|9993964|FG003|NOT COMPLETED|HP Period 1||1
8717915|NCT00996892|9765214|FG000|COMPLETED|Dose-Escalation Stage 1||0
8717916|NCT00996892|9765215|FG001|COMPLETED|Dose-Escalation Stage 1||0
8717917|NCT00996892|9765216|FG002|COMPLETED|Dose-Escalation Stage 1||0
8932312|NCT02310750|9993965|FG004|NOT COMPLETED|HP Period 1||0
8932313|NCT02310750|9993966|FG005|NOT COMPLETED|HP Period 1||0
8932314|NCT02310750|9993967|FG006|NOT COMPLETED|HP Period 1||1
8932315|NCT02310750|9993968|FG007|NOT COMPLETED|HP Period 1||0
8932316|NCT02310750|9993969|FG008|NOT COMPLETED|HP Period 1||0
8932317|NCT02310750|9993970|FG009|NOT COMPLETED|HP Period 1||0
8932318|NCT02310750|9993971|FG010|NOT COMPLETED|HP Period 1||0
8932319|NCT02310750|9993972|FG011|NOT COMPLETED|HP Period 1||0
8932320|NCT02310750|9993973|FG012|NOT COMPLETED|HP Period 1||0
8932321|NCT02310750|9993974|FG013|NOT COMPLETED|HP Period 1||0
8932322|NCT02310750|9993975|FG014|NOT COMPLETED|HP Period 1||0
8932323|NCT02310750|9993976|FG015|NOT COMPLETED|HP Period 1||0
8932324|NCT02310750|9993961|FG000|STARTED|HP Washout 1||0
8932325|NCT02310750|9993962|FG001|STARTED|HP Washout 1||0
8932326|NCT02310750|9993963|FG002|STARTED|HP Washout 1||6
8932327|NCT02310750|9993964|FG003|STARTED|HP Washout 1||5
8932328|NCT02310750|9993965|FG004|STARTED|HP Washout 1||8
8932329|NCT02310750|9993966|FG005|STARTED|HP Washout 1||8
8932330|NCT02310750|9993967|FG006|STARTED|HP Washout 1||12
8932331|NCT02310750|9993968|FG007|STARTED|HP Washout 1||0
8932332|NCT02310750|9993969|FG008|STARTED|HP Washout 1||0
8932333|NCT02310750|9993970|FG009|STARTED|HP Washout 1||0
8932334|NCT02310750|9993971|FG010|STARTED|HP Washout 1||2
8932335|NCT02310750|9993972|FG011|STARTED|HP Washout 1||2
8932336|NCT02310750|9993973|FG012|STARTED|HP Washout 1||2
8932337|NCT02310750|9993974|FG013|STARTED|HP Washout 1||2
8932338|NCT02310750|9993975|FG014|STARTED|HP Washout 1||2
8932339|NCT02310750|9993976|FG015|STARTED|HP Washout 1||2
8932340|NCT02310750|9993961|FG000|COMPLETED|HP Washout 1||0
8932341|NCT02310750|9993962|FG001|COMPLETED|HP Washout 1||0
8932342|NCT02310750|9993963|FG002|COMPLETED|HP Washout 1||5
8932343|NCT02310750|9993964|FG003|COMPLETED|HP Washout 1||4
8932344|NCT02310750|9993965|FG004|COMPLETED|HP Washout 1||6
8932345|NCT02310750|9993966|FG005|COMPLETED|HP Washout 1||6
8932346|NCT02310750|9993967|FG006|COMPLETED|HP Washout 1||9
8932347|NCT02310750|9993968|FG007|COMPLETED|HP Washout 1||0
8932348|NCT02310750|9993969|FG008|COMPLETED|HP Washout 1||0
8932349|NCT02310750|9993970|FG009|COMPLETED|HP Washout 1||0
8932350|NCT02310750|9993971|FG010|COMPLETED|HP Washout 1||2
8932351|NCT02310750|9993972|FG011|COMPLETED|HP Washout 1||2
8932352|NCT02310750|9993973|FG012|COMPLETED|HP Washout 1||2
8932353|NCT02310750|9993974|FG013|COMPLETED|HP Washout 1||2
8932354|NCT02310750|9993975|FG014|COMPLETED|HP Washout 1||2
8932355|NCT02310750|9993976|FG015|COMPLETED|HP Washout 1||2
8932356|NCT02310750|9993961|FG000|NOT COMPLETED|HP Washout 1||0
8932357|NCT02310750|9993962|FG001|NOT COMPLETED|HP Washout 1||0
8932358|NCT02310750|9993963|FG002|NOT COMPLETED|HP Washout 1||1
8932359|NCT02310750|9993964|FG003|NOT COMPLETED|HP Washout 1||1
8932360|NCT02310750|9993965|FG004|NOT COMPLETED|HP Washout 1||2
8932361|NCT02310750|9993966|FG005|NOT COMPLETED|HP Washout 1||2
8932362|NCT02310750|9993967|FG006|NOT COMPLETED|HP Washout 1||3
8932363|NCT02310750|9993968|FG007|NOT COMPLETED|HP Washout 1||0
8932364|NCT02310750|9993969|FG008|NOT COMPLETED|HP Washout 1||0
8932365|NCT02310750|9993970|FG009|NOT COMPLETED|HP Washout 1||0
8932366|NCT02310750|9993971|FG010|NOT COMPLETED|HP Washout 1||0
8932367|NCT02310750|9993972|FG011|NOT COMPLETED|HP Washout 1||0
8932368|NCT02310750|9993973|FG012|NOT COMPLETED|HP Washout 1||0
8932369|NCT02310750|9993974|FG013|NOT COMPLETED|HP Washout 1||0
8932370|NCT02310750|9993975|FG014|NOT COMPLETED|HP Washout 1||0
8932371|NCT02310750|9993976|FG015|NOT COMPLETED|HP Washout 1||0
8932372|NCT02310750|9993961|FG000|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
8932373|NCT02310750|9993962|FG001|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
8717918|NCT00996892|9765217|FG003|COMPLETED|Dose-Escalation Stage 1||0
8717919|NCT00996892|9765218|FG004|COMPLETED|Dose-Escalation Stage 1||0
8717920|NCT00996892|9765219|FG005|COMPLETED|Dose-Escalation Stage 1||0
8717921|NCT00996892|9765220|FG006|COMPLETED|Dose-Escalation Stage 1||0
8717922|NCT00996892|9765221|FG007|COMPLETED|Dose-Escalation Stage 1||0
8932374|NCT02310750|9993963|FG002|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||5
8932375|NCT02310750|9993964|FG003|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||4
8932376|NCT02310750|9993965|FG004|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
8932377|NCT02310750|9993966|FG005|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
8932378|NCT02310750|9993967|FG006|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||9
8932379|NCT02310750|9993968|FG007|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||9
8932380|NCT02310750|9993969|FG008|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||14
8932381|NCT02310750|9993970|FG009|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||7
8932382|NCT02310750|9993971|FG010|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
8932383|NCT02310750|9993972|FG011|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
8932384|NCT02310750|9993973|FG012|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
8932385|NCT02310750|9993974|FG013|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
8932386|NCT02310750|9993975|FG014|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
8932387|NCT02310750|9993976|FG015|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
8932388|NCT02310750|9993961|FG000|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
8932389|NCT02310750|9993962|FG001|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
8932390|NCT02310750|9993963|FG002|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||5
8932391|NCT02310750|9993964|FG003|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||3
8932392|NCT02310750|9993965|FG004|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
8932393|NCT02310750|9993966|FG005|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||4
8932394|NCT02310750|9993967|FG006|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||9
8932395|NCT02310750|9993968|FG007|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||7
8932396|NCT02310750|9993969|FG008|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
8932397|NCT02310750|9993970|FG009|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||4
8932398|NCT02310750|9993971|FG010|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
8932399|NCT02310750|9993972|FG011|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
8932400|NCT02310750|9993973|FG012|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
8932401|NCT02310750|9993974|FG013|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
8932402|NCT02310750|9993975|FG014|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
8932403|NCT02310750|9993976|FG015|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
8932404|NCT02310750|9993961|FG000|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
8932405|NCT02310750|9993962|FG001|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
8932406|NCT02310750|9993963|FG002|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
8932407|NCT02310750|9993964|FG003|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||1
8932408|NCT02310750|9993965|FG004|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
8932409|NCT02310750|9993966|FG005|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
8932410|NCT02310750|9993967|FG006|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
8932411|NCT02310750|9993968|FG007|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
8932412|NCT02310750|9993969|FG008|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||8
8932413|NCT02310750|9993970|FG009|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||3
8932414|NCT02310750|9993971|FG010|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
8932415|NCT02310750|9993972|FG011|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
8932416|NCT02310750|9993973|FG012|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
8932417|NCT02310750|9993974|FG013|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
8932418|NCT02310750|9993975|FG014|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
8932419|NCT02310750|9993976|FG015|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
8932420|NCT02310750|9993961|FG000|STARTED|HP Washout 2||0
8932421|NCT02310750|9993962|FG001|STARTED|HP Washout 2||0
8932422|NCT02310750|9993963|FG002|STARTED|HP Washout 2||0
8932423|NCT02310750|9993964|FG003|STARTED|HP Washout 2||0
8932424|NCT02310750|9993965|FG004|STARTED|HP Washout 2||6
8932425|NCT02310750|9993966|FG005|STARTED|HP Washout 2||0
8932426|NCT02310750|9993967|FG006|STARTED|HP Washout 2||9
8932427|NCT02310750|9993968|FG007|STARTED|HP Washout 2||0
8932428|NCT02310750|9993969|FG008|STARTED|HP Washout 2||0
8932429|NCT02310750|9993970|FG009|STARTED|HP Washout 2||0
8932430|NCT02310750|9993971|FG010|STARTED|HP Washout 2||2
8932431|NCT02310750|9993972|FG011|STARTED|HP Washout 2||2
8932432|NCT02310750|9993973|FG012|STARTED|HP Washout 2||2
8932433|NCT02310750|9993974|FG013|STARTED|HP Washout 2||2
8932434|NCT02310750|9993975|FG014|STARTED|HP Washout 2||2
8932435|NCT02310750|9993976|FG015|STARTED|HP Washout 2||2
8932436|NCT02310750|9993961|FG000|COMPLETED|HP Washout 2||0
8932437|NCT02310750|9993962|FG001|COMPLETED|HP Washout 2||0
8932438|NCT02310750|9993963|FG002|COMPLETED|HP Washout 2||0
8932439|NCT02310750|9993964|FG003|COMPLETED|HP Washout 2||0
8932440|NCT02310750|9993965|FG004|COMPLETED|HP Washout 2||5
8932441|NCT02310750|9993966|FG005|COMPLETED|HP Washout 2||0
8932442|NCT02310750|9993967|FG006|COMPLETED|HP Washout 2||2
8932443|NCT02310750|9993968|FG007|COMPLETED|HP Washout 2||0
8932444|NCT02310750|9993969|FG008|COMPLETED|HP Washout 2||0
8932445|NCT02310750|9993970|FG009|COMPLETED|HP Washout 2||0
8932446|NCT02310750|9993971|FG010|COMPLETED|HP Washout 2||2
8932447|NCT02310750|9993972|FG011|COMPLETED|HP Washout 2||2
8932448|NCT02310750|9993973|FG012|COMPLETED|HP Washout 2||2
8932449|NCT02310750|9993974|FG013|COMPLETED|HP Washout 2||2
8932450|NCT02310750|9993975|FG014|COMPLETED|HP Washout 2||2
8932451|NCT02310750|9993976|FG015|COMPLETED|HP Washout 2||2
8932452|NCT02310750|9993961|FG000|NOT COMPLETED|HP Washout 2||0
8932453|NCT02310750|9993962|FG001|NOT COMPLETED|HP Washout 2||0
8932454|NCT02310750|9993963|FG002|NOT COMPLETED|HP Washout 2||0
8932455|NCT02310750|9993964|FG003|NOT COMPLETED|HP Washout 2||0
8932456|NCT02310750|9993965|FG004|NOT COMPLETED|HP Washout 2||1
8932457|NCT02310750|9993966|FG005|NOT COMPLETED|HP Washout 2||0
8932458|NCT02310750|9993967|FG006|NOT COMPLETED|HP Washout 2||7
8932459|NCT02310750|9993968|FG007|NOT COMPLETED|HP Washout 2||0
8932460|NCT02310750|9993969|FG008|NOT COMPLETED|HP Washout 2||0
8932461|NCT02310750|9993970|FG009|NOT COMPLETED|HP Washout 2||0
8932462|NCT02310750|9993971|FG010|NOT COMPLETED|HP Washout 2||0
8932463|NCT02310750|9993972|FG011|NOT COMPLETED|HP Washout 2||0
8932464|NCT02310750|9993973|FG012|NOT COMPLETED|HP Washout 2||0
8932465|NCT02310750|9993974|FG013|NOT COMPLETED|HP Washout 2||0
8932466|NCT02310750|9993975|FG014|NOT COMPLETED|HP Washout 2||0
8932467|NCT02310750|9993976|FG015|NOT COMPLETED|HP Washout 2||0
8932468|NCT02310750|9993961|FG000|STARTED|HP MAD and Fasted/Fed||0
8932469|NCT02310750|9993962|FG001|STARTED|HP MAD and Fasted/Fed||0
8932470|NCT02310750|9993963|FG002|STARTED|HP MAD and Fasted/Fed||0
8932471|NCT02310750|9993964|FG003|STARTED|HP MAD and Fasted/Fed||0
8932472|NCT02310750|9993965|FG004|STARTED|HP MAD and Fasted/Fed||5
8932473|NCT02310750|9993966|FG005|STARTED|HP MAD and Fasted/Fed||0
8932474|NCT02310750|9993967|FG006|STARTED|HP MAD and Fasted/Fed||2
8932475|NCT02310750|9993968|FG007|STARTED|HP MAD and Fasted/Fed||0
8932476|NCT02310750|9993969|FG008|STARTED|HP MAD and Fasted/Fed||0
8932477|NCT02310750|9993970|FG009|STARTED|HP MAD and Fasted/Fed||0
8932478|NCT02310750|9993971|FG010|STARTED|HP MAD and Fasted/Fed||2
8932479|NCT02310750|9993972|FG011|STARTED|HP MAD and Fasted/Fed||2
8932480|NCT02310750|9993973|FG012|STARTED|HP MAD and Fasted/Fed||2
8932481|NCT02310750|9993974|FG013|STARTED|HP MAD and Fasted/Fed||2
8932482|NCT02310750|9993975|FG014|STARTED|HP MAD and Fasted/Fed||2
8932483|NCT02310750|9993976|FG015|STARTED|HP MAD and Fasted/Fed||2
8932484|NCT02310750|9993961|FG000|COMPLETED|HP MAD and Fasted/Fed||0
8932485|NCT02310750|9993962|FG001|COMPLETED|HP MAD and Fasted/Fed||0
8932486|NCT02310750|9993963|FG002|COMPLETED|HP MAD and Fasted/Fed||0
8932487|NCT02310750|9993964|FG003|COMPLETED|HP MAD and Fasted/Fed||0
8932488|NCT02310750|9993965|FG004|COMPLETED|HP MAD and Fasted/Fed||4
8932489|NCT02310750|9993966|FG005|COMPLETED|HP MAD and Fasted/Fed||0
8932490|NCT02310750|9993967|FG006|COMPLETED|HP MAD and Fasted/Fed||2
8932491|NCT02310750|9993968|FG007|COMPLETED|HP MAD and Fasted/Fed||0
8932492|NCT02310750|9993969|FG008|COMPLETED|HP MAD and Fasted/Fed||0
8932493|NCT02310750|9993970|FG009|COMPLETED|HP MAD and Fasted/Fed||0
8932494|NCT02310750|9993971|FG010|COMPLETED|HP MAD and Fasted/Fed||2
8932495|NCT02310750|9993972|FG011|COMPLETED|HP MAD and Fasted/Fed||2
8932496|NCT02310750|9993973|FG012|COMPLETED|HP MAD and Fasted/Fed||2
8932497|NCT02310750|9993974|FG013|COMPLETED|HP MAD and Fasted/Fed||2
8932498|NCT02310750|9993975|FG014|COMPLETED|HP MAD and Fasted/Fed||2
8932499|NCT02310750|9993976|FG015|COMPLETED|HP MAD and Fasted/Fed||2
8932500|NCT02310750|9993961|FG000|NOT COMPLETED|HP MAD and Fasted/Fed||0
8932501|NCT02310750|9993962|FG001|NOT COMPLETED|HP MAD and Fasted/Fed||0
8932502|NCT02310750|9993963|FG002|NOT COMPLETED|HP MAD and Fasted/Fed||0
8932503|NCT02310750|9993964|FG003|NOT COMPLETED|HP MAD and Fasted/Fed||0
8932504|NCT02310750|9993965|FG004|NOT COMPLETED|HP MAD and Fasted/Fed||1
8932505|NCT02310750|9993966|FG005|NOT COMPLETED|HP MAD and Fasted/Fed||0
8932506|NCT02310750|9993967|FG006|NOT COMPLETED|HP MAD and Fasted/Fed||0
8932507|NCT02310750|9993968|FG007|NOT COMPLETED|HP MAD and Fasted/Fed||0
8932508|NCT02310750|9993969|FG008|NOT COMPLETED|HP MAD and Fasted/Fed||0
8932509|NCT02310750|9993970|FG009|NOT COMPLETED|HP MAD and Fasted/Fed||0
8932510|NCT02310750|9993971|FG010|NOT COMPLETED|HP MAD and Fasted/Fed||0
8932511|NCT02310750|9993972|FG011|NOT COMPLETED|HP MAD and Fasted/Fed||0
8932512|NCT02310750|9993973|FG012|NOT COMPLETED|HP MAD and Fasted/Fed||0
8932513|NCT02310750|9993974|FG013|NOT COMPLETED|HP MAD and Fasted/Fed||0
8932514|NCT02310750|9993975|FG014|NOT COMPLETED|HP MAD and Fasted/Fed||0
8932515|NCT02310750|9993976|FG015|NOT COMPLETED|HP MAD and Fasted/Fed||0
8932516|NCT02310763|9994060|FG000|STARTED|Period 1 (Weeks 1 to 48)||41
8932517|NCT02310763|9994061|FG001|STARTED|Period 1 (Weeks 1 to 48)||39
8932518|NCT02310763|9994062|FG002|STARTED|Period 1 (Weeks 1 to 48)||40
8932519|NCT02310763|9994060|FG000|COMPLETED|Period 1 (Weeks 1 to 48)||38
8932520|NCT02310763|9994061|FG001|COMPLETED|Period 1 (Weeks 1 to 48)||37
8932521|NCT02310763|9994062|FG002|COMPLETED|Period 1 (Weeks 1 to 48)||38
8932522|NCT02310763|9994060|FG000|NOT COMPLETED|Period 1 (Weeks 1 to 48)||3
8932523|NCT02310763|9994061|FG001|NOT COMPLETED|Period 1 (Weeks 1 to 48)||2
8932524|NCT02310763|9994062|FG002|NOT COMPLETED|Period 1 (Weeks 1 to 48)||2
8932525|NCT02310763|9994060|FG000|STARTED|Period 2 (Weeks 49 to 96)||38
8932526|NCT02310763|9994061|FG001|STARTED|Period 2 (Weeks 49 to 96)||37
8932527|NCT02310763|9994062|FG002|STARTED|Period 2 (Weeks 49 to 96)||38
8932528|NCT02310763|9994060|FG000|COMPLETED|Period 2 (Weeks 49 to 96)||22
8932529|NCT02310763|9994061|FG001|COMPLETED|Period 2 (Weeks 49 to 96)||21
8932530|NCT02310763|9994062|FG002|COMPLETED|Period 2 (Weeks 49 to 96)||22
8932531|NCT02310763|9994060|FG000|NOT COMPLETED|Period 2 (Weeks 49 to 96)||16
8932532|NCT02310763|9994061|FG001|NOT COMPLETED|Period 2 (Weeks 49 to 96)||16
8932533|NCT02310763|9994062|FG002|NOT COMPLETED|Period 2 (Weeks 49 to 96)||16
8932534|NCT02310776|9994088|FG000|STARTED|Overall Study||501
8932535|NCT02310776|9994088|FG000|COMPLETED|Overall Study||501
8932536|NCT02310776|9994088|FG000|NOT COMPLETED|Overall Study||0
8932537|NCT02310789|9994092|FG000|STARTED|Overall Study||8
8932538|NCT02310789|9994092|FG000|COMPLETED|Overall Study||7
8932539|NCT02310789|9994092|FG000|NOT COMPLETED|Overall Study||1
8932540|NCT02310906|9994100|FG000|STARTED|Part 1: Double Blind Phase (12 Weeks)||4
8932541|NCT02310906|9994101|FG001|STARTED|Part 1: Double Blind Phase (12 Weeks)||8
8932542|NCT02310906|9994102|FG002|STARTED|Part 1: Double Blind Phase (12 Weeks)||0
8932543|NCT02310906|9994103|FG003|STARTED|Part 1: Double Blind Phase (12 Weeks)||0
8932544|NCT02310906|9994100|FG000|Received 4 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
8932545|NCT02310906|9994101|FG001|Received 4 mg/kg|Part 1: Double Blind Phase (12 Weeks)||8
8932546|NCT02310906|9994102|FG002|Received 4 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
8932547|NCT02310906|9994103|FG003|Received 4 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
8932548|NCT02310906|9994100|FG000|Received 10 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
8932549|NCT02310906|9994101|FG001|Received 10 mg/kg|Part 1: Double Blind Phase (12 Weeks)||8
8932550|NCT02310906|9994102|FG002|Received 10 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
8932551|NCT02310906|9994103|FG003|Received 10 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
8932552|NCT02310906|9994100|FG000|Received 20 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
8932553|NCT02310906|9994101|FG001|Received 20 mg/kg|Part 1: Double Blind Phase (12 Weeks)||8
8932554|NCT02310906|9994102|FG002|Received 20 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
8932555|NCT02310906|9994103|FG003|Received 20 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
8932556|NCT02310906|9994100|FG000|Received 30 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
8932557|NCT02310906|9994101|FG001|Received 30 mg/kg|Part 1: Double Blind Phase (12 Weeks)||8
8932558|NCT02310906|9994102|FG002|Received 30 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
8932559|NCT02310906|9994103|FG003|Received 30 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
8932560|NCT02310906|9994100|FG000|COMPLETED|Part 1: Double Blind Phase (12 Weeks)||4
8932561|NCT02310906|9994101|FG001|COMPLETED|Part 1: Double Blind Phase (12 Weeks)||8
8932562|NCT02310906|9994102|FG002|COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0
8932563|NCT02310906|9994103|FG003|COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0
8932564|NCT02310906|9994100|FG000|NOT COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0
8932565|NCT02310906|9994101|FG001|NOT COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0
8932566|NCT02310906|9994102|FG002|NOT COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0
8932567|NCT02310906|9994103|FG003|NOT COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0
8932568|NCT02310906|9994100|FG000|STARTED|Part 2: Open Label Phase (168 Weeks)||0
8932569|NCT02310906|9994101|FG001|STARTED|Part 2: Open Label Phase (168 Weeks)||0
8932570|NCT02310906|9994102|FG002|STARTED|Part 2: Open Label Phase (168 Weeks)|4 participants from Part 1(Placebo) + 8 participants from Part 1(Golodirsen) +13 new participants|25
8932571|NCT02310906|9994103|FG003|STARTED|Part 2: Open Label Phase (168 Weeks)||14
8932572|NCT02310906|9994100|FG000|COMPLETED|Part 2: Open Label Phase (168 Weeks)||0
8932573|NCT02310906|9994101|FG001|COMPLETED|Part 2: Open Label Phase (168 Weeks)||0
8932574|NCT02310906|9994102|FG002|COMPLETED|Part 2: Open Label Phase (168 Weeks)||23
8932575|NCT02310906|9994103|FG003|COMPLETED|Part 2: Open Label Phase (168 Weeks)||6
8932576|NCT02310906|9994100|FG000|NOT COMPLETED|Part 2: Open Label Phase (168 Weeks)||0
8932577|NCT02310906|9994101|FG001|NOT COMPLETED|Part 2: Open Label Phase (168 Weeks)||0
8932578|NCT02310906|9994102|FG002|NOT COMPLETED|Part 2: Open Label Phase (168 Weeks)||2
8932579|NCT02310906|9994103|FG003|NOT COMPLETED|Part 2: Open Label Phase (168 Weeks)||8
8932580|NCT02311153|9994126|FG000|STARTED|Overall Study||53
8932581|NCT02311153|9994127|FG001|STARTED|Overall Study||49
8932582|NCT02311153|9994126|FG000|COMPLETED|Overall Study||48
8932583|NCT02311153|9994127|FG001|COMPLETED|Overall Study||42
8932584|NCT02311153|9994126|FG000|NOT COMPLETED|Overall Study||5
8932585|NCT02311153|9994127|FG001|NOT COMPLETED|Overall Study||7
8932586|NCT02311309|9994136|FG000|STARTED|Overall Study|There were 863 patients with no peroperative bleeding in the 1439 patients studied|541
8932587|NCT02311309|9994137|FG001|STARTED|Overall Study|There were 863 patients with no peroperative bleeding in the 1439 patients studied|35
8932588|NCT02311309|9994138|FG002|STARTED|Overall Study||863
8932589|NCT02311309|9994136|FG000|COMPLETED|Overall Study||541
8932590|NCT02311309|9994137|FG001|COMPLETED|Overall Study||35
8932591|NCT02311309|9994138|FG002|COMPLETED|Overall Study||863
8932592|NCT02311309|9994136|FG000|NOT COMPLETED|Overall Study||0
8932593|NCT02311309|9994137|FG001|NOT COMPLETED|Overall Study||0
8932594|NCT02311309|9994138|FG002|NOT COMPLETED|Overall Study||0
8932595|NCT02311361|9994150|FG000|STARTED|Overall Study||14
8932596|NCT02311361|9994151|FG001|STARTED|Overall Study||11
8932597|NCT02311361|9994152|FG002|STARTED|Overall Study||19
8932598|NCT02311361|9994153|FG003|STARTED|Overall Study||21
8932599|NCT02311361|9994150|FG000|Received Radiation Therapy Only|Overall Study||0
8932600|NCT02311361|9994151|FG001|Received Radiation Therapy Only|Overall Study||1
8932601|NCT02311361|9994152|FG002|Received Radiation Therapy Only|Overall Study||1
8932602|NCT02311361|9994153|FG003|Received Radiation Therapy Only|Overall Study||1
8932603|NCT02311361|9994150|FG000|COMPLETED|Overall Study||14
8932604|NCT02311361|9994151|FG001|COMPLETED|Overall Study||10
8932605|NCT02311361|9994152|FG002|COMPLETED|Overall Study||19
8932606|NCT02311361|9994153|FG003|COMPLETED|Overall Study||20
8932607|NCT02311361|9994150|FG000|NOT COMPLETED|Overall Study||0
8932608|NCT02311361|9994151|FG001|NOT COMPLETED|Overall Study||1
8932609|NCT02311361|9994152|FG002|NOT COMPLETED|Overall Study||0
8932610|NCT02311361|9994153|FG003|NOT COMPLETED|Overall Study||1
8932611|NCT02311478|9994167|FG000|STARTED|Overall Study||79
8932612|NCT02311478|9994167|FG000|IUD Insertion|Overall Study||78
8932613|NCT02311478|9994167|FG000|COMPLETED|Overall Study||72
8932614|NCT02311478|9994167|FG000|NOT COMPLETED|Overall Study||7
8932615|NCT02311881|9994174|FG000|STARTED|Overall Study|Started refers to all randomized participants.|235
8932616|NCT02311881|9994175|FG001|STARTED|Overall Study|Started refers to all randomized participants.|236
8932617|NCT02311881|9994176|FG002|STARTED|Overall Study|Started refers to all randomized participants.|237
8932618|NCT02311881|9994174|FG000|Safety Population|Overall Study|All treated participants: One participant was randomized but did not receive any treatment.|234
8932619|NCT02311881|9994175|FG001|Safety Population|Overall Study|All treated participants: One participant was randomized but did not receive any treatment.|236
8932620|NCT02311881|9994176|FG002|Safety Population|Overall Study|All treated participants: One participant was randomized but did not receive any treatment.|237
8932621|NCT02311881|9994174|FG000|COMPLETED|Overall Study||200
8932622|NCT02311881|9994175|FG001|COMPLETED|Overall Study||193
8932623|NCT02311881|9994176|FG002|COMPLETED|Overall Study||196
8932624|NCT02311881|9994174|FG000|NOT COMPLETED|Overall Study||35
8932625|NCT02311881|9994175|FG001|NOT COMPLETED|Overall Study||43
8932626|NCT02311881|9994176|FG002|NOT COMPLETED|Overall Study||41
8932627|NCT02311894|9994187|FG000|STARTED|Overall Study||82
8932628|NCT02311894|9994187|FG000|Modified ITT Population|Overall Study||81
8932629|NCT02311894|9994187|FG000|COMPLETED|Overall Study||78
8932630|NCT02311894|9994187|FG000|NOT COMPLETED|Overall Study||4
8932631|NCT02311907|9994193|FG000|STARTED|Overall Study||94
8932632|NCT02311907|9994194|FG001|STARTED|Overall Study||91
8932633|NCT02311907|9994193|FG000|COMPLETED|Overall Study||94
8932634|NCT02311907|9994194|FG001|COMPLETED|Overall Study||91
8932635|NCT02311907|9994193|FG000|NOT COMPLETED|Overall Study||0
8932636|NCT02311907|9994194|FG001|NOT COMPLETED|Overall Study||0
8932637|NCT02311933|9994202|FG000|STARTED|Overall Study||41
8932638|NCT02311933|9994203|FG001|STARTED|Overall Study||40
8932639|NCT02311933|9994202|FG000|COMPLETED|Overall Study||41
8932640|NCT02311933|9994203|FG001|COMPLETED|Overall Study||40
8932641|NCT02311933|9994202|FG000|NOT COMPLETED|Overall Study||0
8932642|NCT02311933|9994203|FG001|NOT COMPLETED|Overall Study||0
8932643|NCT02311972|9994211|FG000|STARTED|Overall Study||12
8932644|NCT02311972|9994212|FG001|STARTED|Overall Study||8
8932645|NCT02311972|9994211|FG000|COMPLETED|Overall Study||12
8932646|NCT02311972|9994212|FG001|COMPLETED|Overall Study||8
8932647|NCT02311972|9994211|FG000|NOT COMPLETED|Overall Study||0
8932648|NCT02311972|9994212|FG001|NOT COMPLETED|Overall Study||0
8932649|NCT02312063|9994221|FG000|STARTED|Overall Study||23
8932650|NCT02312063|9994222|FG001|STARTED|Overall Study||25
8932651|NCT02312063|9994221|FG000|COMPLETED|Overall Study||23
8932652|NCT02312063|9994222|FG001|COMPLETED|Overall Study||24
8932653|NCT02312063|9994221|FG000|NOT COMPLETED|Overall Study||0
8932654|NCT02312063|9994222|FG001|NOT COMPLETED|Overall Study||1
8932655|NCT02312154|9994229|FG000|STARTED|Overall Study||25
8932656|NCT02312154|9994229|FG000|COMPLETED|Overall Study||24
8932657|NCT02312154|9994229|FG000|NOT COMPLETED|Overall Study||1
8932658|NCT02312206|9994236|FG000|STARTED|Overall Study||130
8932659|NCT02312206|9994237|FG001|STARTED|Overall Study||130
8932660|NCT02312206|9994236|FG000|Informed Consent Obtained|Overall Study||130
8932661|NCT02312206|9994237|FG001|Informed Consent Obtained|Overall Study||130
8932662|NCT02312206|9994236|FG000|COMPLETED|Overall Study||0
8932663|NCT02312206|9994237|FG001|COMPLETED|Overall Study||0
8932664|NCT02312206|9994236|FG000|NOT COMPLETED|Overall Study||130
8932665|NCT02312206|9994237|FG001|NOT COMPLETED|Overall Study||130
8932666|NCT02312219|9994245|FG000|STARTED|Overall Study||13
8932667|NCT02312219|9994246|FG001|STARTED|Overall Study||22
8932668|NCT02312219|9994245|FG000|COMPLETED|Overall Study||12
8932669|NCT02312219|9994246|FG001|COMPLETED|Overall Study||16
8932670|NCT02312219|9994245|FG000|NOT COMPLETED|Overall Study||1
8932671|NCT02312219|9994246|FG001|NOT COMPLETED|Overall Study||6
8932672|NCT02312310|9994256|FG000|STARTED|Overall Study||53
8932673|NCT02312310|9994257|FG001|STARTED|Overall Study||53
8932674|NCT02312310|9994258|FG002|STARTED|Overall Study||53
8932675|NCT02312310|9994259|FG003|STARTED|Overall Study||52
8932676|NCT02312310|9994256|FG000|COMPLETED|Overall Study||51
8932677|NCT02312310|9994257|FG001|COMPLETED|Overall Study||51
8932678|NCT02312310|9994258|FG002|COMPLETED|Overall Study||50
8932679|NCT02312310|9994259|FG003|COMPLETED|Overall Study||52
8932680|NCT02312310|9994256|FG000|NOT COMPLETED|Overall Study||2
8932681|NCT02312310|9994257|FG001|NOT COMPLETED|Overall Study||2
8932682|NCT02312310|9994258|FG002|NOT COMPLETED|Overall Study||3
8932683|NCT02312310|9994259|FG003|NOT COMPLETED|Overall Study||0
8932684|NCT02312622|9994276|FG000|STARTED|Overall Study||12
8932685|NCT02312622|9994277|FG001|STARTED|Overall Study||3
8932686|NCT02312622|9994278|FG002|STARTED|Overall Study||12
8932687|NCT02312622|9994276|FG000|COMPLETED|Overall Study||12
8932688|NCT02312622|9994277|FG001|COMPLETED|Overall Study||3
8932689|NCT02312622|9994278|FG002|COMPLETED|Overall Study||12
8932690|NCT02312622|9994276|FG000|NOT COMPLETED|Overall Study||0
8932691|NCT02312622|9994277|FG001|NOT COMPLETED|Overall Study||0
8932692|NCT02312622|9994278|FG002|NOT COMPLETED|Overall Study||0
8932693|NCT02312687|9994289|FG000|STARTED|Overall Study||20
8932694|NCT02312687|9994289|FG000|COMPLETED|Overall Study||19
8932695|NCT02312687|9994289|FG000|NOT COMPLETED|Overall Study||1
8932696|NCT02312713|9994296|FG000|STARTED|Overall Study||140
8932697|NCT02312713|9994297|FG001|STARTED|Overall Study||142
8932698|NCT02312713|9994298|FG002|STARTED|Overall Study||68
8932699|NCT02312713|9994296|FG000|COMPLETED|Overall Study||129
8932700|NCT02312713|9994297|FG001|COMPLETED|Overall Study||112
8932701|NCT02312713|9994298|FG002|COMPLETED|Overall Study||63
8932702|NCT02312713|9994296|FG000|NOT COMPLETED|Overall Study||11
8932703|NCT02312713|9994297|FG001|NOT COMPLETED|Overall Study||30
8932704|NCT02312713|9994298|FG002|NOT COMPLETED|Overall Study||5
8932705|NCT02312726|9994306|FG000|STARTED|Overall Study||38
8932706|NCT02312726|9994307|FG001|STARTED|Overall Study||30
8932707|NCT02312726|9994308|FG002|STARTED|Overall Study||67
8932708|NCT02312726|9994306|FG000|COMPLETED|Overall Study||38
8932709|NCT02312726|9994307|FG001|COMPLETED|Overall Study||30
8932710|NCT02312726|9994308|FG002|COMPLETED|Overall Study||0
8932711|NCT02312726|9994306|FG000|NOT COMPLETED|Overall Study||0
8932712|NCT02312726|9994307|FG001|NOT COMPLETED|Overall Study||0
8932713|NCT02312726|9994308|FG002|NOT COMPLETED|Overall Study||67
8932714|NCT02312739|9994317|FG000|STARTED|Overall Study||36
8932715|NCT02312739|9994318|FG001|STARTED|Overall Study||36
8932716|NCT02312739|9994317|FG000|Withdrawn Prior to Procedure|Overall Study||6
8932717|NCT02312739|9994318|FG001|Withdrawn Prior to Procedure|Overall Study||2
8932718|NCT02312739|9994317|FG000|COMPLETED|Overall Study||30
8932719|NCT02312739|9994318|FG001|COMPLETED|Overall Study||34
8932720|NCT02312739|9994317|FG000|NOT COMPLETED|Overall Study||6
8932721|NCT02312739|9994318|FG001|NOT COMPLETED|Overall Study||2
8932722|NCT02312765|9994326|FG000|STARTED|Overall Study||74
8932723|NCT02312765|9994327|FG001|STARTED|Overall Study||72
8932724|NCT02312765|9994326|FG000|COMPLETED|Overall Study||19
8932725|NCT02312765|9994327|FG001|COMPLETED|Overall Study||36
8932726|NCT02312765|9994326|FG000|NOT COMPLETED|Overall Study||55
8932727|NCT02312765|9994327|FG001|NOT COMPLETED|Overall Study||36
8932728|NCT02312856|9994333|FG000|STARTED|Overall Study||34
8932729|NCT02312856|9994333|FG000|COMPLETED|Overall Study||30
8932730|NCT02312856|9994333|FG000|NOT COMPLETED|Overall Study||4
8932731|NCT02312882|9994337|FG000|STARTED|Overall Study||40
8932732|NCT02312882|9994337|FG000|COMPLETED|Overall Study||36
8932733|NCT02312882|9994337|FG000|NOT COMPLETED|Overall Study||4
8932734|NCT02312934|9994343|FG000|STARTED|Overall Study||11
8932735|NCT02312934|9994344|FG001|STARTED|Overall Study||11
8932736|NCT02312934|9994343|FG000|COMPLETED|Overall Study||9
8932737|NCT02312934|9994344|FG001|COMPLETED|Overall Study||11
8932738|NCT02312934|9994343|FG000|NOT COMPLETED|Overall Study||2
8932739|NCT02312934|9994344|FG001|NOT COMPLETED|Overall Study||0
8932740|NCT02312986|9994351|FG000|STARTED|Overall Study||1
8932741|NCT02312986|9994351|FG000|COMPLETED|Overall Study||1
8932742|NCT02312986|9994351|FG000|NOT COMPLETED|Overall Study||0
8932743|NCT02313155|9994357|FG000|STARTED|Overall Study||55
8932744|NCT02313155|9994358|FG001|STARTED|Overall Study||55
8932745|NCT02313155|9994357|FG000|COMPLETED|Overall Study||55
8932746|NCT02313155|9994358|FG001|COMPLETED|Overall Study||54
8932747|NCT02313155|9994357|FG000|NOT COMPLETED|Overall Study||0
8932748|NCT02313155|9994358|FG001|NOT COMPLETED|Overall Study||1
8932749|NCT02313233|9994366|FG000|STARTED|Overall Study||20
8932750|NCT02313233|9994367|FG001|STARTED|Overall Study||21
8932751|NCT02313233|9994366|FG000|COMPLETED|Overall Study||18
8932752|NCT02313233|9994367|FG001|COMPLETED|Overall Study||18
8932753|NCT02313233|9994366|FG000|NOT COMPLETED|Overall Study||2
8932754|NCT02313233|9994367|FG001|NOT COMPLETED|Overall Study||3
8932755|NCT02313454|9994375|FG000|STARTED|Treatment 1||9
8932756|NCT02313454|9994376|FG001|STARTED|Treatment 1||11
8932757|NCT02313454|9994375|FG000|COMPLETED|Treatment 1||9
8932758|NCT02313454|9994376|FG001|COMPLETED|Treatment 1||11
8932759|NCT02313454|9994375|FG000|NOT COMPLETED|Treatment 1||0
8932760|NCT02313454|9994376|FG001|NOT COMPLETED|Treatment 1||0
8717923|NCT00996892|9765222|FG008|COMPLETED|Dose-Escalation Stage 1||0
8717924|NCT00996892|9765223|FG009|COMPLETED|Dose-Escalation Stage 1||0
8717925|NCT00996892|9765224|FG010|COMPLETED|Dose-Escalation Stage 1||0
8717926|NCT00996892|9765225|FG011|COMPLETED|Dose-Escalation Stage 1||0
8717927|NCT00996892|9765226|FG012|COMPLETED|Dose-Escalation Stage 1||0
8717928|NCT00996892|9765227|FG013|COMPLETED|Dose-Escalation Stage 1||0
8717929|NCT00996892|9765228|FG014|COMPLETED|Dose-Escalation Stage 1||0
8717930|NCT00996892|9765229|FG015|COMPLETED|Dose-Escalation Stage 1||0
8717931|NCT00996892|9765230|FG016|COMPLETED|Dose-Escalation Stage 1||0
8932761|NCT02313454|9994375|FG000|STARTED|Treatment 2|1 participant did not receive the second application.|8
8932762|NCT02313454|9994376|FG001|STARTED|Treatment 2|1 participant did not receive the second application.|10
8932763|NCT02313454|9994375|FG000|COMPLETED|Treatment 2||8
8932764|NCT02313454|9994376|FG001|COMPLETED|Treatment 2||10
8932765|NCT02313454|9994375|FG000|NOT COMPLETED|Treatment 2||0
8932766|NCT02313454|9994376|FG001|NOT COMPLETED|Treatment 2||0
8932767|NCT02313506|9994384|FG000|STARTED|Overall Study||17
8932768|NCT02313506|9994385|FG001|STARTED|Overall Study||17
8932769|NCT02313506|9994384|FG000|COMPLETED|Overall Study||17
8932770|NCT02313506|9994385|FG001|COMPLETED|Overall Study||17
8932771|NCT02313506|9994384|FG000|NOT COMPLETED|Overall Study||0
8932772|NCT02313506|9994385|FG001|NOT COMPLETED|Overall Study||0
8932773|NCT02313558|9994394|FG000|STARTED|Overall Study||50
8932774|NCT02313558|9994395|FG001|STARTED|Overall Study||50
8932775|NCT02313558|9994394|FG000|COMPLETED|Overall Study||44
8932776|NCT02313558|9994395|FG001|COMPLETED|Overall Study||46
8717932|NCT00996892|9765231|FG017|COMPLETED|Dose-Escalation Stage 1||0
8717933|NCT00996892|9765232|FG018|COMPLETED|Dose-Escalation Stage 1||0
8932777|NCT02313558|9994394|FG000|NOT COMPLETED|Overall Study||6
8932778|NCT02313558|9994395|FG001|NOT COMPLETED|Overall Study||4
8932779|NCT02313597|9994403|FG000|STARTED|Overall Study||40
8932780|NCT02313597|9994404|FG001|STARTED|Overall Study||40
8932781|NCT02313597|9994403|FG000|COMPLETED|Overall Study||40
8932782|NCT02313597|9994404|FG001|COMPLETED|Overall Study||40
8932783|NCT02313597|9994403|FG000|NOT COMPLETED|Overall Study||0
8717934|NCT00996892|9765233|FG019|COMPLETED|Dose-Escalation Stage 1||0
8717935|NCT00996892|9765214|FG000|NOT COMPLETED|Dose-Escalation Stage 1||4
8932784|NCT02313597|9994404|FG001|NOT COMPLETED|Overall Study||0
8932785|NCT02313675|9994414|FG000|STARTED|Overall Study||11
8932786|NCT02313675|9994415|FG001|STARTED|Overall Study||11
8932787|NCT02313675|9994416|FG002|STARTED|Overall Study||11
8932788|NCT02313675|9994417|FG003|STARTED|Overall Study||11
8932789|NCT02313675|9994414|FG000|COMPLETED|Overall Study||11
8932790|NCT02313675|9994415|FG001|COMPLETED|Overall Study||11
8932791|NCT02313675|9994416|FG002|COMPLETED|Overall Study||11
8932792|NCT02313675|9994417|FG003|COMPLETED|Overall Study||11
8932793|NCT02313675|9994414|FG000|NOT COMPLETED|Overall Study||0
8932794|NCT02313675|9994415|FG001|NOT COMPLETED|Overall Study||0
8932795|NCT02313675|9994416|FG002|NOT COMPLETED|Overall Study||0
8932796|NCT02313675|9994417|FG003|NOT COMPLETED|Overall Study||0
8932797|NCT02313766|9994430|FG000|STARTED|Overall Study||50
8932798|NCT02313766|9994431|FG001|STARTED|Overall Study||50
8932799|NCT02313766|9994432|FG002|STARTED|Overall Study||50
8932800|NCT02313766|9994430|FG000|COMPLETED|Overall Study||49
8932801|NCT02313766|9994431|FG001|COMPLETED|Overall Study||47
8932802|NCT02313766|9994432|FG002|COMPLETED|Overall Study||50
8932803|NCT02313766|9994430|FG000|NOT COMPLETED|Overall Study||1
8932804|NCT02313766|9994431|FG001|NOT COMPLETED|Overall Study||3
8932805|NCT02313766|9994432|FG002|NOT COMPLETED|Overall Study||0
8932806|NCT02313909|9994442|FG000|STARTED|Overall Study||3609
8932807|NCT02313909|9994443|FG001|STARTED|Overall Study||3604
8932808|NCT02313909|9994442|FG000|Treated|Overall Study||3562
8932809|NCT02313909|9994443|FG001|Treated|Overall Study||3559
8932810|NCT02313909|9994442|FG000|COMPLETED|Overall Study||3552
8932811|NCT02313909|9994443|FG001|COMPLETED|Overall Study||3554
8932812|NCT02313909|9994442|FG000|NOT COMPLETED|Overall Study||57
8932813|NCT02313909|9994443|FG001|NOT COMPLETED|Overall Study||50
8932814|NCT02314000|9994451|FG000|STARTED|Overall Study||75
8932815|NCT02314000|9994452|FG001|STARTED|Overall Study||65
8932816|NCT02314000|9994451|FG000|COMPLETED|Overall Study||62
8932817|NCT02314000|9994452|FG001|COMPLETED|Overall Study||57
8932818|NCT02314000|9994451|FG000|NOT COMPLETED|Overall Study||13
8932819|NCT02314000|9994452|FG001|NOT COMPLETED|Overall Study||8
8932820|NCT02314026|9994459|FG000|STARTED|Overall Study||135
8932821|NCT02314026|9994459|FG000|COMPLETED|Overall Study||107
8932822|NCT02314026|9994459|FG000|NOT COMPLETED|Overall Study||28
8932823|NCT02314052|9994463|FG000|STARTED|Cycle One||3
8932824|NCT02314052|9994464|FG001|STARTED|Cycle One||3
8932825|NCT02314052|9994465|FG002|STARTED|Cycle One||3
8932826|NCT02314052|9994466|FG003|STARTED|Cycle One||3
8932827|NCT02314052|9994467|FG004|STARTED|Cycle One||6
8932828|NCT02314052|9994468|FG005|STARTED|Cycle One||3
8932829|NCT02314052|9994463|FG000|COMPLETED|Cycle One||3
8932830|NCT02314052|9994464|FG001|COMPLETED|Cycle One||3
8932831|NCT02314052|9994465|FG002|COMPLETED|Cycle One||3
8932832|NCT02314052|9994466|FG003|COMPLETED|Cycle One||2
8932833|NCT02314052|9994467|FG004|COMPLETED|Cycle One||6
8932834|NCT02314052|9994468|FG005|COMPLETED|Cycle One||3
8932835|NCT02314052|9994463|FG000|NOT COMPLETED|Cycle One||0
8932836|NCT02314052|9994464|FG001|NOT COMPLETED|Cycle One||0
8932837|NCT02314052|9994465|FG002|NOT COMPLETED|Cycle One||0
8932838|NCT02314052|9994466|FG003|NOT COMPLETED|Cycle One||1
8932839|NCT02314052|9994467|FG004|NOT COMPLETED|Cycle One||0
8932840|NCT02314052|9994468|FG005|NOT COMPLETED|Cycle One||0
8932841|NCT02314052|9994463|FG000|STARTED|Cycle Two||3
8932842|NCT02314052|9994464|FG001|STARTED|Cycle Two||3
8932843|NCT02314052|9994465|FG002|STARTED|Cycle Two||3
8932844|NCT02314052|9994466|FG003|STARTED|Cycle Two||2
8932845|NCT02314052|9994467|FG004|STARTED|Cycle Two||6
8932846|NCT02314052|9994468|FG005|STARTED|Cycle Two||3
8932847|NCT02314052|9994463|FG000|COMPLETED|Cycle Two||3
8932848|NCT02314052|9994464|FG001|COMPLETED|Cycle Two||2
8932849|NCT02314052|9994465|FG002|COMPLETED|Cycle Two||2
8932850|NCT02314052|9994466|FG003|COMPLETED|Cycle Two||1
8932851|NCT02314052|9994467|FG004|COMPLETED|Cycle Two||2
8932852|NCT02314052|9994468|FG005|COMPLETED|Cycle Two||3
8932853|NCT02314052|9994463|FG000|NOT COMPLETED|Cycle Two||0
8932854|NCT02314052|9994464|FG001|NOT COMPLETED|Cycle Two||1
8932855|NCT02314052|9994465|FG002|NOT COMPLETED|Cycle Two||1
8932856|NCT02314052|9994466|FG003|NOT COMPLETED|Cycle Two||1
8932857|NCT02314052|9994467|FG004|NOT COMPLETED|Cycle Two||4
8932858|NCT02314052|9994468|FG005|NOT COMPLETED|Cycle Two||0
8932859|NCT02314052|9994463|FG000|STARTED|Cycle Three||3
8932860|NCT02314052|9994464|FG001|STARTED|Cycle Three||2
8932861|NCT02314052|9994465|FG002|STARTED|Cycle Three||2
8932862|NCT02314052|9994466|FG003|STARTED|Cycle Three||1
8932863|NCT02314052|9994467|FG004|STARTED|Cycle Three||2
8932864|NCT02314052|9994468|FG005|STARTED|Cycle Three||3
8932865|NCT02314052|9994463|FG000|COMPLETED|Cycle Three||3
8932866|NCT02314052|9994464|FG001|COMPLETED|Cycle Three|1 of 2 completers in cohort 2 (subject 02-005) only completed 1 of 2 infusions during this cycle|2
8932867|NCT02314052|9994465|FG002|COMPLETED|Cycle Three||2
8932868|NCT02314052|9994466|FG003|COMPLETED|Cycle Three||1
8932869|NCT02314052|9994467|FG004|COMPLETED|Cycle Three||2
8932870|NCT02314052|9994468|FG005|COMPLETED|Cycle Three||3
8932871|NCT02314052|9994463|FG000|NOT COMPLETED|Cycle Three||0
8932872|NCT02314052|9994464|FG001|NOT COMPLETED|Cycle Three||0
8932873|NCT02314052|9994465|FG002|NOT COMPLETED|Cycle Three||0
8932874|NCT02314052|9994466|FG003|NOT COMPLETED|Cycle Three||0
8932875|NCT02314052|9994467|FG004|NOT COMPLETED|Cycle Three||0
8932876|NCT02314052|9994468|FG005|NOT COMPLETED|Cycle Three||0
8932877|NCT02314052|9994463|FG000|STARTED|Cycle Four||3
8932878|NCT02314052|9994464|FG001|STARTED|Cycle Four||2
8932879|NCT02314052|9994465|FG002|STARTED|Cycle Four||2
8932880|NCT02314052|9994466|FG003|STARTED|Cycle Four||1
8932881|NCT02314052|9994467|FG004|STARTED|Cycle Four||2
8932882|NCT02314052|9994468|FG005|STARTED|Cycle Four||3
8932883|NCT02314052|9994463|FG000|COMPLETED|Cycle Four||0
8932884|NCT02314052|9994464|FG001|COMPLETED|Cycle Four||2
8932885|NCT02314052|9994465|FG002|COMPLETED|Cycle Four||1
8932886|NCT02314052|9994466|FG003|COMPLETED|Cycle Four||0
8932887|NCT02314052|9994467|FG004|COMPLETED|Cycle Four||2
8932888|NCT02314052|9994468|FG005|COMPLETED|Cycle Four||0
8932889|NCT02314052|9994463|FG000|NOT COMPLETED|Cycle Four||3
8932890|NCT02314052|9994464|FG001|NOT COMPLETED|Cycle Four||0
8932891|NCT02314052|9994465|FG002|NOT COMPLETED|Cycle Four||1
8932892|NCT02314052|9994466|FG003|NOT COMPLETED|Cycle Four||1
8717936|NCT00996892|9765215|FG001|NOT COMPLETED|Dose-Escalation Stage 1||3
8717937|NCT00996892|9765216|FG002|NOT COMPLETED|Dose-Escalation Stage 1||3
8717938|NCT00996892|9765217|FG003|NOT COMPLETED|Dose-Escalation Stage 1||9
8717939|NCT00996892|9765218|FG004|NOT COMPLETED|Dose-Escalation Stage 1||11
8932893|NCT02314052|9994467|FG004|NOT COMPLETED|Cycle Four||0
8932894|NCT02314052|9994468|FG005|NOT COMPLETED|Cycle Four||3
8932895|NCT02314052|9994463|FG000|STARTED|Cycle Five||0
8932896|NCT02314052|9994464|FG001|STARTED|Cycle Five||2
8932897|NCT02314052|9994465|FG002|STARTED|Cycle Five||1
8932898|NCT02314052|9994466|FG003|STARTED|Cycle Five|subject missed cycle four but returned for cycle 5|1
8932899|NCT02314052|9994467|FG004|STARTED|Cycle Five||2
8932900|NCT02314052|9994468|FG005|STARTED|Cycle Five||0
8932901|NCT02314052|9994463|FG000|COMPLETED|Cycle Five||0
8932902|NCT02314052|9994464|FG001|COMPLETED|Cycle Five||0
8932903|NCT02314052|9994465|FG002|COMPLETED|Cycle Five||0
8932904|NCT02314052|9994466|FG003|COMPLETED|Cycle Five|subject missed cycle four but returned for cycle 5|1
8932905|NCT02314052|9994467|FG004|COMPLETED|Cycle Five||2
8932906|NCT02314052|9994468|FG005|COMPLETED|Cycle Five||0
8932907|NCT02314052|9994463|FG000|NOT COMPLETED|Cycle Five||0
8932908|NCT02314052|9994464|FG001|NOT COMPLETED|Cycle Five||2
8932909|NCT02314052|9994465|FG002|NOT COMPLETED|Cycle Five||1
8932910|NCT02314052|9994466|FG003|NOT COMPLETED|Cycle Five||0
8932911|NCT02314052|9994467|FG004|NOT COMPLETED|Cycle Five||0
8932912|NCT02314052|9994468|FG005|NOT COMPLETED|Cycle Five||0
8932913|NCT02314052|9994463|FG000|STARTED|Cycles 6 -10.5||0
8932914|NCT02314052|9994464|FG001|STARTED|Cycles 6 -10.5||0
8932915|NCT02314052|9994465|FG002|STARTED|Cycles 6 -10.5||0
8932916|NCT02314052|9994466|FG003|STARTED|Cycles 6 -10.5||1
8932917|NCT02314052|9994467|FG004|STARTED|Cycles 6 -10.5||2
8932918|NCT02314052|9994468|FG005|STARTED|Cycles 6 -10.5||0
8932919|NCT02314052|9994463|FG000|COMPLETED|Cycles 6 -10.5||0
8932920|NCT02314052|9994464|FG001|COMPLETED|Cycles 6 -10.5||0
8932921|NCT02314052|9994465|FG002|COMPLETED|Cycles 6 -10.5||0
8932922|NCT02314052|9994466|FG003|COMPLETED|Cycles 6 -10.5||1
8932923|NCT02314052|9994467|FG004|COMPLETED|Cycles 6 -10.5|Subject 02-014 only completed 1 of 2 doses in cycle 6|2
8932924|NCT02314052|9994468|FG005|COMPLETED|Cycles 6 -10.5||0
8932925|NCT02314052|9994463|FG000|NOT COMPLETED|Cycles 6 -10.5||0
8932926|NCT02314052|9994464|FG001|NOT COMPLETED|Cycles 6 -10.5||0
8932927|NCT02314052|9994465|FG002|NOT COMPLETED|Cycles 6 -10.5||0
8932928|NCT02314052|9994466|FG003|NOT COMPLETED|Cycles 6 -10.5||0
8932929|NCT02314052|9994467|FG004|NOT COMPLETED|Cycles 6 -10.5||0
8932930|NCT02314052|9994468|FG005|NOT COMPLETED|Cycles 6 -10.5||0
9064830|NCT04263142|10125201|FG003|NOT COMPLETED|Part 1 Period 1 (Day 1)||0
9064831|NCT04263142|10125202|FG004|NOT COMPLETED|Part 1 Period 1 (Day 1)||0
9064832|NCT04263142|10125198|FG000|STARTED|Part 1 Period 2 (Up to Day 5)||9
9064833|NCT04263142|10125199|FG001|STARTED|Part 1 Period 2 (Up to Day 5)||9
9064834|NCT04263142|10125200|FG002|STARTED|Part 1 Period 2 (Up to Day 5)||0
9064835|NCT04263142|10125201|FG003|STARTED|Part 1 Period 2 (Up to Day 5)||0
9064836|NCT04263142|10125202|FG004|STARTED|Part 1 Period 2 (Up to Day 5)||0
9064837|NCT04263142|10125198|FG000|COMPLETED|Part 1 Period 2 (Up to Day 5)||9
9064838|NCT04263142|10125199|FG001|COMPLETED|Part 1 Period 2 (Up to Day 5)||9
9064839|NCT04263142|10125200|FG002|COMPLETED|Part 1 Period 2 (Up to Day 5)||0
9064840|NCT04263142|10125201|FG003|COMPLETED|Part 1 Period 2 (Up to Day 5)||0
9064841|NCT04263142|10125202|FG004|COMPLETED|Part 1 Period 2 (Up to Day 5)||0
9064842|NCT04263142|10125198|FG000|NOT COMPLETED|Part 1 Period 2 (Up to Day 5)||0
9064843|NCT04263142|10125199|FG001|NOT COMPLETED|Part 1 Period 2 (Up to Day 5)||0
9064844|NCT04263142|10125200|FG002|NOT COMPLETED|Part 1 Period 2 (Up to Day 5)||0
9064845|NCT04263142|10125201|FG003|NOT COMPLETED|Part 1 Period 2 (Up to Day 5)||0
9064846|NCT04263142|10125202|FG004|NOT COMPLETED|Part 1 Period 2 (Up to Day 5)||0
9064847|NCT04263142|10125198|FG000|STARTED|Part 2 Period 1 (Day 1)||0
9064848|NCT04263142|10125199|FG001|STARTED|Part 2 Period 1 (Day 1)||0
9064849|NCT04263142|10125200|FG002|STARTED|Part 2 Period 1 (Day 1)||7
8717940|NCT00996892|9765219|FG005|NOT COMPLETED|Dose-Escalation Stage 1||10
8717941|NCT00996892|9765220|FG006|NOT COMPLETED|Dose-Escalation Stage 1||4
8932931|NCT02314104|9994485|FG000|STARTED|Overall Study||71
8932932|NCT02314104|9994486|FG001|STARTED|Overall Study||78
8932933|NCT02314104|9994487|FG002|STARTED|Overall Study||71
8932934|NCT02314104|9994485|FG000|COMPLETED|Overall Study||57
8932935|NCT02314104|9994486|FG001|COMPLETED|Overall Study||58
8932936|NCT02314104|9994487|FG002|COMPLETED|Overall Study||53
8932937|NCT02314104|9994485|FG000|NOT COMPLETED|Overall Study||14
8932938|NCT02314104|9994486|FG001|NOT COMPLETED|Overall Study||20
8932939|NCT02314104|9994487|FG002|NOT COMPLETED|Overall Study||18
8932940|NCT02314117|9994497|FG000|STARTED|Overall Study||326
8932941|NCT02314117|9994498|FG001|STARTED|Overall Study||319
8932942|NCT02314117|9994497|FG000|Received at Least One Dose of Study Drug|Overall Study||323
8932943|NCT02314117|9994498|FG001|Received at Least One Dose of Study Drug|Overall Study||315
8932944|NCT02314117|9994497|FG000|COMPLETED|Overall Study||314
8932945|NCT02314117|9994498|FG001|COMPLETED|Overall Study||303
8717942|NCT00996892|9765221|FG007|NOT COMPLETED|Dose-Escalation Stage 1||0
8717943|NCT00996892|9765222|FG008|NOT COMPLETED|Dose-Escalation Stage 1||0
8717944|NCT00996892|9765223|FG009|NOT COMPLETED|Dose-Escalation Stage 1||0
8717945|NCT00996892|9765224|FG010|NOT COMPLETED|Dose-Escalation Stage 1||0
8717946|NCT00996892|9765225|FG011|NOT COMPLETED|Dose-Escalation Stage 1||0
8717947|NCT00996892|9765226|FG012|NOT COMPLETED|Dose-Escalation Stage 1||0
8717948|NCT00996892|9765227|FG013|NOT COMPLETED|Dose-Escalation Stage 1||0
8717949|NCT00996892|9765228|FG014|NOT COMPLETED|Dose-Escalation Stage 1||0
8717950|NCT00996892|9765229|FG015|NOT COMPLETED|Dose-Escalation Stage 1||0
8717951|NCT00996892|9765230|FG016|NOT COMPLETED|Dose-Escalation Stage 1||0
8717952|NCT00996892|9765231|FG017|NOT COMPLETED|Dose-Escalation Stage 1||0
8932946|NCT02314117|9994497|FG000|NOT COMPLETED|Overall Study||12
8932947|NCT02314117|9994498|FG001|NOT COMPLETED|Overall Study||16
8932948|NCT02314143|9994508|FG000|STARTED|Overall Study||16
8932949|NCT02314143|9994509|FG001|STARTED|Overall Study||16
8932950|NCT02314143|9994510|FG002|STARTED|Overall Study||16
8932951|NCT02314143|9994508|FG000|COMPLETED|Overall Study||8
8932952|NCT02314143|9994509|FG001|COMPLETED|Overall Study||6
8932953|NCT02314143|9994510|FG002|COMPLETED|Overall Study||7
8932954|NCT02314143|9994508|FG000|NOT COMPLETED|Overall Study||8
8932955|NCT02314143|9994509|FG001|NOT COMPLETED|Overall Study||10
8932956|NCT02314143|9994510|FG002|NOT COMPLETED|Overall Study||9
8932957|NCT02314247|9994521|FG000|STARTED|Overall Study||9
8932958|NCT02314247|9994522|FG001|STARTED|Overall Study||6
8932959|NCT02314247|9994523|FG002|STARTED|Overall Study||1
8932960|NCT02314247|9994521|FG000|COMPLETED|Overall Study||0
8932961|NCT02314247|9994522|FG001|COMPLETED|Overall Study||0
8932962|NCT02314247|9994523|FG002|COMPLETED|Overall Study||0
8932963|NCT02314247|9994521|FG000|NOT COMPLETED|Overall Study||9
8932964|NCT02314247|9994522|FG001|NOT COMPLETED|Overall Study||6
8932965|NCT02314247|9994523|FG002|NOT COMPLETED|Overall Study||1
8932966|NCT02314260|9994533|FG000|STARTED|Overall Study||80
8932967|NCT02314260|9994533|FG000|COMPLETED|Overall Study||80
8932968|NCT02314260|9994533|FG000|NOT COMPLETED|Overall Study||0
8932969|NCT02314403|9994537|FG000|STARTED|Overall Study||2
8932970|NCT02314403|9994537|FG000|COMPLETED|Overall Study||2
8932971|NCT02314403|9994537|FG000|NOT COMPLETED|Overall Study||0
9064850|NCT04263142|10125201|FG003|STARTED|Part 2 Period 1 (Day 1)||7
9064851|NCT04263142|10125202|FG004|STARTED|Part 2 Period 1 (Day 1)||7
9064852|NCT04263142|10125198|FG000|COMPLETED|Part 2 Period 1 (Day 1)||0
9064853|NCT04263142|10125199|FG001|COMPLETED|Part 2 Period 1 (Day 1)||0
9064854|NCT04263142|10125200|FG002|COMPLETED|Part 2 Period 1 (Day 1)||7
9064855|NCT04263142|10125201|FG003|COMPLETED|Part 2 Period 1 (Day 1)||7
9064856|NCT04263142|10125202|FG004|COMPLETED|Part 2 Period 1 (Day 1)||6
9064857|NCT04263142|10125198|FG000|NOT COMPLETED|Part 2 Period 1 (Day 1)||0
9064858|NCT04263142|10125199|FG001|NOT COMPLETED|Part 2 Period 1 (Day 1)||0
9064859|NCT04263142|10125200|FG002|NOT COMPLETED|Part 2 Period 1 (Day 1)||0
9064860|NCT04263142|10125201|FG003|NOT COMPLETED|Part 2 Period 1 (Day 1)||0
9064861|NCT04263142|10125202|FG004|NOT COMPLETED|Part 2 Period 1 (Day 1)||1
9064862|NCT04263142|10125198|FG000|STARTED|Part 2 Period 2 (Day 1)||0
9064863|NCT04263142|10125199|FG001|STARTED|Part 2 Period 2 (Day 1)||0
9064864|NCT04263142|10125200|FG002|STARTED|Part 2 Period 2 (Day 1)||7
9064865|NCT04263142|10125201|FG003|STARTED|Part 2 Period 2 (Day 1)||7
9064866|NCT04263142|10125202|FG004|STARTED|Part 2 Period 2 (Day 1)||6
9064867|NCT04263142|10125198|FG000|COMPLETED|Part 2 Period 2 (Day 1)||0
9064868|NCT04263142|10125199|FG001|COMPLETED|Part 2 Period 2 (Day 1)||0
9064869|NCT04263142|10125200|FG002|COMPLETED|Part 2 Period 2 (Day 1)||7
9064870|NCT04263142|10125201|FG003|COMPLETED|Part 2 Period 2 (Day 1)||7
9064871|NCT04263142|10125202|FG004|COMPLETED|Part 2 Period 2 (Day 1)||5
9064872|NCT04263142|10125198|FG000|NOT COMPLETED|Part 2 Period 2 (Day 1)||0
9064873|NCT04263142|10125199|FG001|NOT COMPLETED|Part 2 Period 2 (Day 1)||0
9064874|NCT04263142|10125200|FG002|NOT COMPLETED|Part 2 Period 2 (Day 1)||0
9064875|NCT04263142|10125201|FG003|NOT COMPLETED|Part 2 Period 2 (Day 1)||0
9064876|NCT04263142|10125202|FG004|NOT COMPLETED|Part 2 Period 2 (Day 1)||1
9064877|NCT04263142|10125198|FG000|STARTED|Part 2 Period 3 (Up to Day 5)||0
9064878|NCT04263142|10125199|FG001|STARTED|Part 2 Period 3 (Up to Day 5)||0
9064879|NCT04263142|10125200|FG002|STARTED|Part 2 Period 3 (Up to Day 5)||7
9064880|NCT04263142|10125201|FG003|STARTED|Part 2 Period 3 (Up to Day 5)||7
9064881|NCT04263142|10125202|FG004|STARTED|Part 2 Period 3 (Up to Day 5)||5
9064882|NCT04263142|10125198|FG000|COMPLETED|Part 2 Period 3 (Up to Day 5)||0
9064883|NCT04263142|10125199|FG001|COMPLETED|Part 2 Period 3 (Up to Day 5)||0
9064884|NCT04263142|10125200|FG002|COMPLETED|Part 2 Period 3 (Up to Day 5)||7
9064885|NCT04263142|10125201|FG003|COMPLETED|Part 2 Period 3 (Up to Day 5)||7
9064886|NCT04263142|10125202|FG004|COMPLETED|Part 2 Period 3 (Up to Day 5)||5
9064887|NCT04263142|10125198|FG000|NOT COMPLETED|Part 2 Period 3 (Up to Day 5)||0
9064888|NCT04263142|10125199|FG001|NOT COMPLETED|Part 2 Period 3 (Up to Day 5)||0
9064889|NCT04263142|10125200|FG002|NOT COMPLETED|Part 2 Period 3 (Up to Day 5)||0
9064890|NCT04263142|10125201|FG003|NOT COMPLETED|Part 2 Period 3 (Up to Day 5)||0
9064891|NCT04263142|10125202|FG004|NOT COMPLETED|Part 2 Period 3 (Up to Day 5)||0
9064892|NCT04256785|10125217|FG000|STARTED|Overall Study||54
8717953|NCT00996892|9765232|FG018|NOT COMPLETED|Dose-Escalation Stage 1||0
8717954|NCT00996892|9765233|FG019|NOT COMPLETED|Dose-Escalation Stage 1||0
8717955|NCT00996892|9765214|FG000|STARTED|Dose-Escalation Stage 1A||0
8932972|NCT02314520|9994543|FG000|STARTED|Overall Study||72
8932973|NCT02314520|9994544|FG001|STARTED|Overall Study||80
8932974|NCT02314520|9994543|FG000|COMPLETED|Overall Study||72
8717956|NCT00996892|9765215|FG001|STARTED|Dose-Escalation Stage 1A||0
8717957|NCT00996892|9765216|FG002|STARTED|Dose-Escalation Stage 1A||0
8717958|NCT00996892|9765217|FG003|STARTED|Dose-Escalation Stage 1A||0
8717959|NCT00996892|9765218|FG004|STARTED|Dose-Escalation Stage 1A||0
8717960|NCT00996892|9765219|FG005|STARTED|Dose-Escalation Stage 1A||0
8932975|NCT02314520|9994544|FG001|COMPLETED|Overall Study||80
8932976|NCT02314520|9994543|FG000|NOT COMPLETED|Overall Study||0
8932977|NCT02314520|9994544|FG001|NOT COMPLETED|Overall Study||0
8932978|NCT02314546|9994553|FG000|STARTED|Overall Study||5
8932979|NCT02314546|9994554|FG001|STARTED|Overall Study||5
8932980|NCT02314546|9994555|FG002|STARTED|Overall Study||5
8932981|NCT02314546|9994553|FG000|COMPLETED|Overall Study||5
8932982|NCT02314546|9994554|FG001|COMPLETED|Overall Study||5
8932983|NCT02314546|9994555|FG002|COMPLETED|Overall Study||5
8932984|NCT02314546|9994553|FG000|NOT COMPLETED|Overall Study||0
8932985|NCT02314546|9994554|FG001|NOT COMPLETED|Overall Study||0
8932986|NCT02314546|9994555|FG002|NOT COMPLETED|Overall Study||0
8932987|NCT02314598|9994564|FG000|STARTED|Overall Study||46
8932988|NCT02314598|9994564|FG000|COMPLETED|Overall Study||46
8932989|NCT02314598|9994564|FG000|NOT COMPLETED|Overall Study||0
8932990|NCT02314637|9994570|FG000|STARTED|Overall Study||151
8932991|NCT02314637|9994571|FG001|STARTED|Overall Study||89
8932992|NCT02314637|9994570|FG000|COMPLETED|Overall Study||135
8932993|NCT02314637|9994571|FG001|COMPLETED|Overall Study||75
8932994|NCT02314637|9994570|FG000|NOT COMPLETED|Overall Study||16
8932995|NCT02314637|9994571|FG001|NOT COMPLETED|Overall Study||14
8932996|NCT02314689|9994577|FG000|STARTED|Overall Study||4
8932997|NCT02314689|9994577|FG000|COMPLETED|Overall Study|Target citrulline level reached with first 4 subjects enrolled at initial IV citrulline of 20 mg/kg|4
8932998|NCT02314689|9994577|FG000|NOT COMPLETED|Overall Study||0
8932999|NCT02314728|9994583|FG000|STARTED|Overall Study||117
8933000|NCT02314728|9994584|FG001|STARTED|Overall Study||113
8933001|NCT02314728|9994583|FG000|COMPLETED|Overall Study||116
8933002|NCT02314728|9994584|FG001|COMPLETED|Overall Study||112
8933003|NCT02314728|9994583|FG000|NOT COMPLETED|Overall Study||1
8933004|NCT02314728|9994584|FG001|NOT COMPLETED|Overall Study||1
8933005|NCT02314780|9994595|FG000|STARTED|Overall Study||9
8933006|NCT02314780|9994596|FG001|STARTED|Overall Study||10
8933007|NCT02314780|9994597|FG002|STARTED|Overall Study||8
8933008|NCT02314780|9994595|FG000|COMPLETED|Overall Study||9
8933009|NCT02314780|9994596|FG001|COMPLETED|Overall Study||7
8933010|NCT02314780|9994597|FG002|COMPLETED|Overall Study||8
8933011|NCT02314780|9994595|FG000|NOT COMPLETED|Overall Study||0
8933012|NCT02314780|9994596|FG001|NOT COMPLETED|Overall Study||3
8933013|NCT02314780|9994597|FG002|NOT COMPLETED|Overall Study||0
8933014|NCT02314936|9994609|FG000|STARTED|Overall Study||48
8933015|NCT02314936|9994610|FG001|STARTED|Overall Study||48
8933016|NCT02314936|9994611|FG002|STARTED|Overall Study||48
8933017|NCT02314936|9994612|FG003|STARTED|Overall Study||48
8933018|NCT02314936|9994609|FG000|COMPLETED|Overall Study||48
8933019|NCT02314936|9994610|FG001|COMPLETED|Overall Study||48
8933020|NCT02314936|9994611|FG002|COMPLETED|Overall Study||46
8933021|NCT02314936|9994612|FG003|COMPLETED|Overall Study||48
8933022|NCT02314936|9994609|FG000|NOT COMPLETED|Overall Study||0
8933023|NCT02314936|9994610|FG001|NOT COMPLETED|Overall Study||0
8933024|NCT02314936|9994611|FG002|NOT COMPLETED|Overall Study||2
8933025|NCT02314936|9994612|FG003|NOT COMPLETED|Overall Study||0
8933026|NCT02315170|9994622|FG000|STARTED|Overall Study||50
8933027|NCT02315170|9994623|FG001|STARTED|Overall Study||50
8933028|NCT02315170|9994622|FG000|COMPLETED|Overall Study||50
8933029|NCT02315170|9994623|FG001|COMPLETED|Overall Study||50
8933030|NCT02315170|9994622|FG000|NOT COMPLETED|Overall Study||0
8933031|NCT02315170|9994623|FG001|NOT COMPLETED|Overall Study||0
8933032|NCT02315261|9994629|FG000|STARTED|Overall Study||364
8933033|NCT02315261|9994629|FG000|COMPLETED|Overall Study||364
8933034|NCT02315261|9994629|FG000|NOT COMPLETED|Overall Study||0
8933035|NCT02315352|9994635|FG000|STARTED|First Intervention (Day 1)||24
8933036|NCT02315352|9994636|FG001|STARTED|First Intervention (Day 1)||24
8933037|NCT02315352|9994637|FG002|STARTED|First Intervention (Day 1)||0
8933038|NCT02315352|9994638|FG003|STARTED|First Intervention (Day 1)||0
8933039|NCT02315352|9994639|FG004|STARTED|First Intervention (Day 1)||0
8717961|NCT00996892|9765220|FG006|STARTED|Dose-Escalation Stage 1A||0
8717962|NCT00996892|9765221|FG007|STARTED|Dose-Escalation Stage 1A||3
8933040|NCT02315352|9994640|FG005|STARTED|First Intervention (Day 1)||0
8933041|NCT02315352|9994641|FG006|STARTED|First Intervention (Day 1)||0
8933042|NCT02315352|9994642|FG007|STARTED|First Intervention (Day 1)||0
8933043|NCT02315352|9994635|FG000|COMPLETED|First Intervention (Day 1)||24
8933044|NCT02315352|9994636|FG001|COMPLETED|First Intervention (Day 1)||24
8933045|NCT02315352|9994637|FG002|COMPLETED|First Intervention (Day 1)||0
8933046|NCT02315352|9994638|FG003|COMPLETED|First Intervention (Day 1)||0
8933047|NCT02315352|9994639|FG004|COMPLETED|First Intervention (Day 1)||0
8933048|NCT02315352|9994640|FG005|COMPLETED|First Intervention (Day 1)||0
8933049|NCT02315352|9994641|FG006|COMPLETED|First Intervention (Day 1)||0
8717963|NCT00996892|9765222|FG008|STARTED|Dose-Escalation Stage 1A||3
8717964|NCT00996892|9765223|FG009|STARTED|Dose-Escalation Stage 1A||4
8717965|NCT00996892|9765224|FG010|STARTED|Dose-Escalation Stage 1A||7
8933050|NCT02315352|9994642|FG007|COMPLETED|First Intervention (Day 1)||0
8933051|NCT02315352|9994635|FG000|NOT COMPLETED|First Intervention (Day 1)||0
8933052|NCT02315352|9994636|FG001|NOT COMPLETED|First Intervention (Day 1)||0
8933053|NCT02315352|9994637|FG002|NOT COMPLETED|First Intervention (Day 1)||0
8933054|NCT02315352|9994638|FG003|NOT COMPLETED|First Intervention (Day 1)||0
8933055|NCT02315352|9994639|FG004|NOT COMPLETED|First Intervention (Day 1)||0
8933056|NCT02315352|9994640|FG005|NOT COMPLETED|First Intervention (Day 1)||0
8933057|NCT02315352|9994641|FG006|NOT COMPLETED|First Intervention (Day 1)||0
8933058|NCT02315352|9994642|FG007|NOT COMPLETED|First Intervention (Day 1)||0
8933059|NCT02315352|9994635|FG000|STARTED|Second Intervention (Day 1)||24
8933060|NCT02315352|9994636|FG001|STARTED|Second Intervention (Day 1)||24
8933061|NCT02315352|9994637|FG002|STARTED|Second Intervention (Day 1)||0
8933062|NCT02315352|9994638|FG003|STARTED|Second Intervention (Day 1)||0
8933063|NCT02315352|9994639|FG004|STARTED|Second Intervention (Day 1)||0
8933064|NCT02315352|9994640|FG005|STARTED|Second Intervention (Day 1)||0
8933065|NCT02315352|9994641|FG006|STARTED|Second Intervention (Day 1)||0
8933066|NCT02315352|9994642|FG007|STARTED|Second Intervention (Day 1)||0
8933067|NCT02315352|9994635|FG000|COMPLETED|Second Intervention (Day 1)|Out of 24 subjects completing this period, 1 discontinued before assignment to any sequence on Day 2|24
8933068|NCT02315352|9994636|FG001|COMPLETED|Second Intervention (Day 1)||24
8933069|NCT02315352|9994637|FG002|COMPLETED|Second Intervention (Day 1)||0
8933070|NCT02315352|9994638|FG003|COMPLETED|Second Intervention (Day 1)||0
8933071|NCT02315352|9994639|FG004|COMPLETED|Second Intervention (Day 1)||0
8933072|NCT02315352|9994640|FG005|COMPLETED|Second Intervention (Day 1)||0
8933073|NCT02315352|9994641|FG006|COMPLETED|Second Intervention (Day 1)||0
8933074|NCT02315352|9994642|FG007|COMPLETED|Second Intervention (Day 1)||0
8933075|NCT02315352|9994635|FG000|NOT COMPLETED|Second Intervention (Day 1)||0
8933076|NCT02315352|9994636|FG001|NOT COMPLETED|Second Intervention (Day 1)||0
8933077|NCT02315352|9994637|FG002|NOT COMPLETED|Second Intervention (Day 1)||0
8933078|NCT02315352|9994638|FG003|NOT COMPLETED|Second Intervention (Day 1)||0
8933079|NCT02315352|9994639|FG004|NOT COMPLETED|Second Intervention (Day 1)||0
8933080|NCT02315352|9994640|FG005|NOT COMPLETED|Second Intervention (Day 1)||0
8933081|NCT02315352|9994641|FG006|NOT COMPLETED|Second Intervention (Day 1)||0
8933082|NCT02315352|9994642|FG007|NOT COMPLETED|Second Intervention (Day 1)||0
8933083|NCT02315352|9994635|FG000|STARTED|Third Intervention (Day 2)||0
8933084|NCT02315352|9994636|FG001|STARTED|Third Intervention (Day 2)||0
8933085|NCT02315352|9994637|FG002|STARTED|Third Intervention (Day 2)||7
8933086|NCT02315352|9994638|FG003|STARTED|Third Intervention (Day 2)||8
8933087|NCT02315352|9994639|FG004|STARTED|Third Intervention (Day 2)||8
8933088|NCT02315352|9994640|FG005|STARTED|Third Intervention (Day 2)||7
8933089|NCT02315352|9994641|FG006|STARTED|Third Intervention (Day 2)||9
8933090|NCT02315352|9994642|FG007|STARTED|Third Intervention (Day 2)||8
8933091|NCT02315352|9994635|FG000|COMPLETED|Third Intervention (Day 2)||0
8933092|NCT02315352|9994636|FG001|COMPLETED|Third Intervention (Day 2)||0
8933093|NCT02315352|9994637|FG002|COMPLETED|Third Intervention (Day 2)||7
8933094|NCT02315352|9994638|FG003|COMPLETED|Third Intervention (Day 2)||8
8933095|NCT02315352|9994639|FG004|COMPLETED|Third Intervention (Day 2)||8
8933096|NCT02315352|9994640|FG005|COMPLETED|Third Intervention (Day 2)||7
8933097|NCT02315352|9994641|FG006|COMPLETED|Third Intervention (Day 2)||9
8933098|NCT02315352|9994642|FG007|COMPLETED|Third Intervention (Day 2)||8
8933099|NCT02315352|9994635|FG000|NOT COMPLETED|Third Intervention (Day 2)||0
8933100|NCT02315352|9994636|FG001|NOT COMPLETED|Third Intervention (Day 2)||0
8933101|NCT02315352|9994637|FG002|NOT COMPLETED|Third Intervention (Day 2)||0
8933102|NCT02315352|9994638|FG003|NOT COMPLETED|Third Intervention (Day 2)||0
8933103|NCT02315352|9994639|FG004|NOT COMPLETED|Third Intervention (Day 2)||0
8933104|NCT02315352|9994640|FG005|NOT COMPLETED|Third Intervention (Day 2)||0
8933105|NCT02315352|9994641|FG006|NOT COMPLETED|Third Intervention (Day 2)||0
8933106|NCT02315352|9994642|FG007|NOT COMPLETED|Third Intervention (Day 2)||0
8933107|NCT02315352|9994635|FG000|STARTED|Fourth Intervention (Day 2)||0
8933108|NCT02315352|9994636|FG001|STARTED|Fourth Intervention (Day 2)||0
8933109|NCT02315352|9994637|FG002|STARTED|Fourth Intervention (Day 2)||7
8933110|NCT02315352|9994638|FG003|STARTED|Fourth Intervention (Day 2)||8
8933111|NCT02315352|9994639|FG004|STARTED|Fourth Intervention (Day 2)||8
8933112|NCT02315352|9994640|FG005|STARTED|Fourth Intervention (Day 2)||7
8933113|NCT02315352|9994641|FG006|STARTED|Fourth Intervention (Day 2)||9
8933114|NCT02315352|9994642|FG007|STARTED|Fourth Intervention (Day 2)||8
8933115|NCT02315352|9994635|FG000|COMPLETED|Fourth Intervention (Day 2)||0
8933116|NCT02315352|9994636|FG001|COMPLETED|Fourth Intervention (Day 2)||0
8933117|NCT02315352|9994637|FG002|COMPLETED|Fourth Intervention (Day 2)||7
8933118|NCT02315352|9994638|FG003|COMPLETED|Fourth Intervention (Day 2)||8
8933119|NCT02315352|9994639|FG004|COMPLETED|Fourth Intervention (Day 2)||8
8933120|NCT02315352|9994640|FG005|COMPLETED|Fourth Intervention (Day 2)||7
8933121|NCT02315352|9994641|FG006|COMPLETED|Fourth Intervention (Day 2)||9
8933122|NCT02315352|9994642|FG007|COMPLETED|Fourth Intervention (Day 2)||8
8933123|NCT02315352|9994635|FG000|NOT COMPLETED|Fourth Intervention (Day 2)||0
8617227|NCT00455455|9655398|FG000|NOT COMPLETED|Second Intervention||0
8617228|NCT00455455|9655399|FG001|NOT COMPLETED|Second Intervention||0
8617229|NCT00455520|9655410|FG000|STARTED|Open Label Tapentadol Extended Release||591
8933124|NCT02315352|9994636|FG001|NOT COMPLETED|Fourth Intervention (Day 2)||0
8933125|NCT02315352|9994637|FG002|NOT COMPLETED|Fourth Intervention (Day 2)||0
8933126|NCT02315352|9994638|FG003|NOT COMPLETED|Fourth Intervention (Day 2)||0
8933127|NCT02315352|9994639|FG004|NOT COMPLETED|Fourth Intervention (Day 2)||0
8933128|NCT02315352|9994640|FG005|NOT COMPLETED|Fourth Intervention (Day 2)||0
8933129|NCT02315352|9994641|FG006|NOT COMPLETED|Fourth Intervention (Day 2)||0
8933130|NCT02315352|9994642|FG007|NOT COMPLETED|Fourth Intervention (Day 2)||0
8933131|NCT02315352|9994635|FG000|STARTED|Fifth Intervention (Day 2)||0
8933132|NCT02315352|9994636|FG001|STARTED|Fifth Intervention (Day 2)||0
8933133|NCT02315352|9994637|FG002|STARTED|Fifth Intervention (Day 2)||7
8933134|NCT02315352|9994638|FG003|STARTED|Fifth Intervention (Day 2)||8
8933135|NCT02315352|9994639|FG004|STARTED|Fifth Intervention (Day 2)||8
8933136|NCT02315352|9994640|FG005|STARTED|Fifth Intervention (Day 2)||7
8933137|NCT02315352|9994641|FG006|STARTED|Fifth Intervention (Day 2)||9
8933138|NCT02315352|9994642|FG007|STARTED|Fifth Intervention (Day 2)||8
8933139|NCT02315352|9994635|FG000|COMPLETED|Fifth Intervention (Day 2)||0
8933140|NCT02315352|9994636|FG001|COMPLETED|Fifth Intervention (Day 2)||0
8933141|NCT02315352|9994637|FG002|COMPLETED|Fifth Intervention (Day 2)||7
8933142|NCT02315352|9994638|FG003|COMPLETED|Fifth Intervention (Day 2)||8
8933143|NCT02315352|9994639|FG004|COMPLETED|Fifth Intervention (Day 2)||8
8933144|NCT02315352|9994640|FG005|COMPLETED|Fifth Intervention (Day 2)||7
8933145|NCT02315352|9994641|FG006|COMPLETED|Fifth Intervention (Day 2)||9
8933146|NCT02315352|9994642|FG007|COMPLETED|Fifth Intervention (Day 2)||8
8933147|NCT02315352|9994635|FG000|NOT COMPLETED|Fifth Intervention (Day 2)||0
8717966|NCT00996892|9765225|FG011|STARTED|Dose-Escalation Stage 1A||9
8717967|NCT00996892|9765226|FG012|STARTED|Dose-Escalation Stage 1A||8
8717968|NCT00996892|9765227|FG013|STARTED|Dose-Escalation Stage 1A||5
8933148|NCT02315352|9994636|FG001|NOT COMPLETED|Fifth Intervention (Day 2)||0
8933149|NCT02315352|9994637|FG002|NOT COMPLETED|Fifth Intervention (Day 2)||0
8933150|NCT02315352|9994638|FG003|NOT COMPLETED|Fifth Intervention (Day 2)||0
8933151|NCT02315352|9994639|FG004|NOT COMPLETED|Fifth Intervention (Day 2)||0
8933152|NCT02315352|9994640|FG005|NOT COMPLETED|Fifth Intervention (Day 2)||0
8933153|NCT02315352|9994641|FG006|NOT COMPLETED|Fifth Intervention (Day 2)||0
8933154|NCT02315352|9994642|FG007|NOT COMPLETED|Fifth Intervention (Day 2)||0
8933155|NCT02315430|9994654|FG000|STARTED|Overall Study||13
8933156|NCT02315430|9994654|FG000|COMPLETED|Overall Study||13
8933157|NCT02315430|9994654|FG000|NOT COMPLETED|Overall Study||0
8933158|NCT02315560|9994658|FG000|STARTED|Overall Study||25
8933159|NCT02315560|9994658|FG000|COMPLETED|Overall Study||22
8933160|NCT02315560|9994658|FG000|NOT COMPLETED|Overall Study||3
8933161|NCT02315625|9994664|FG000|STARTED|First Intervention||14
8933162|NCT02315625|9994665|FG001|STARTED|First Intervention||2
8933163|NCT02315625|9994664|FG000|COMPLETED|First Intervention||13
8933164|NCT02315625|9994665|FG001|COMPLETED|First Intervention||2
8933165|NCT02315625|9994664|FG000|NOT COMPLETED|First Intervention||1
8933166|NCT02315625|9994665|FG001|NOT COMPLETED|First Intervention||0
8933167|NCT02315625|9994664|FG000|STARTED|Second Intervention||13
8933168|NCT02315625|9994665|FG001|STARTED|Second Intervention||2
8933169|NCT02315625|9994664|FG000|COMPLETED|Second Intervention||9
8933170|NCT02315625|9994665|FG001|COMPLETED|Second Intervention||1
8933171|NCT02315625|9994664|FG000|NOT COMPLETED|Second Intervention||4
8933172|NCT02315625|9994665|FG001|NOT COMPLETED|Second Intervention||1
8933173|NCT02315664|9994675|FG000|STARTED|Overall Study||30
8933174|NCT02315664|9994676|FG001|STARTED|Overall Study||31
8933175|NCT02315664|9994675|FG000|COMPLETED|Overall Study||29
8933176|NCT02315664|9994676|FG001|COMPLETED|Overall Study||27
8933177|NCT02315664|9994675|FG000|NOT COMPLETED|Overall Study||1
8717969|NCT00996892|9765228|FG014|STARTED|Dose-Escalation Stage 1A||0
8717970|NCT00996892|9765229|FG015|STARTED|Dose-Escalation Stage 1A||0
8933178|NCT02315664|9994676|FG001|NOT COMPLETED|Overall Study||4
8933179|NCT02315755|9994682|FG000|STARTED|Overall Study||102
8933180|NCT02315755|9994682|FG000|COMPLETED|Overall Study|Participants who died, were considered as 'completed'.|102
8933181|NCT02315755|9994682|FG000|NOT COMPLETED|Overall Study||0
8933182|NCT02315872|9994688|FG000|STARTED|Overall Study||4
8933183|NCT02315872|9994689|FG001|STARTED|Overall Study||4
8933184|NCT02315872|9994688|FG000|COMPLETED|Overall Study||1
8933185|NCT02315872|9994689|FG001|COMPLETED|Overall Study||3
8933186|NCT02315872|9994688|FG000|NOT COMPLETED|Overall Study||3
8933187|NCT02315872|9994689|FG001|NOT COMPLETED|Overall Study||1
8948428|NCT02430870|10010798|FG007|NOT COMPLETED|Part 2||1
8948429|NCT02431052|10010821|FG000|STARTED|Overall Study||53
8948430|NCT02431052|10010822|FG001|STARTED|Overall Study||50
8948431|NCT02431052|10010823|FG002|STARTED|Overall Study||106
8948432|NCT02431052|10010824|FG003|STARTED|Overall Study||110
8948433|NCT02431052|10010825|FG004|STARTED|Overall Study||101
8948434|NCT02431052|10010821|FG000|COMPLETED|Overall Study||42
8948435|NCT02431052|10010822|FG001|COMPLETED|Overall Study||46
8948436|NCT02431052|10010823|FG002|COMPLETED|Overall Study||94
8948437|NCT02431052|10010824|FG003|COMPLETED|Overall Study||94
8948438|NCT02431052|10010825|FG004|COMPLETED|Overall Study||86
8948439|NCT02431052|10010821|FG000|NOT COMPLETED|Overall Study||11
8948440|NCT02431052|10010822|FG001|NOT COMPLETED|Overall Study||4
8948441|NCT02431052|10010823|FG002|NOT COMPLETED|Overall Study||12
8948442|NCT02431052|10010824|FG003|NOT COMPLETED|Overall Study||16
8948443|NCT02431052|10010825|FG004|NOT COMPLETED|Overall Study||15
8948444|NCT02431260|10010856|FG000|STARTED|Overall Study||4
8948445|NCT02431260|10010857|FG001|STARTED|Overall Study||5
8948446|NCT02431260|10010858|FG002|STARTED|Overall Study||6
8717971|NCT00996892|9765230|FG016|STARTED|Dose-Escalation Stage 1A||0
8717972|NCT00996892|9765231|FG017|STARTED|Dose-Escalation Stage 1A||0
8948447|NCT02431260|10010859|FG003|STARTED|Overall Study||5
8948448|NCT02431260|10010860|FG004|STARTED|Overall Study||3
8948449|NCT02431260|10010861|FG005|STARTED|Overall Study||4
8717973|NCT00996892|9765232|FG018|STARTED|Dose-Escalation Stage 1A||0
8933188|NCT02315989|9994695|FG000|STARTED|Overall Study||6
8933189|NCT02315989|9994695|FG000|COMPLETED|Overall Study||6
8933190|NCT02315989|9994695|FG000|NOT COMPLETED|Overall Study||0
8933191|NCT02316171|9994705|FG000|STARTED|Overall Study||4
8933192|NCT02316171|9994706|FG001|STARTED|Overall Study||6
8933193|NCT02316171|9994707|FG002|STARTED|Overall Study||3
8933194|NCT02316171|9994708|FG003|STARTED|Overall Study||3
8933195|NCT02316171|9994705|FG000|COMPLETED|Overall Study||3
8933196|NCT02316171|9994706|FG001|COMPLETED|Overall Study||6
8933197|NCT02316171|9994707|FG002|COMPLETED|Overall Study||3
8933198|NCT02316171|9994708|FG003|COMPLETED|Overall Study||3
8933199|NCT02316171|9994705|FG000|NOT COMPLETED|Overall Study||1
8933200|NCT02316171|9994706|FG001|NOT COMPLETED|Overall Study||0
8933201|NCT02316171|9994707|FG002|NOT COMPLETED|Overall Study||0
8933202|NCT02316171|9994708|FG003|NOT COMPLETED|Overall Study||0
8933203|NCT02316223|9994717|FG000|STARTED|Overall Study||134
8933204|NCT02316223|9994718|FG001|STARTED|Overall Study||133
8933205|NCT02316223|9994719|FG002|STARTED|Overall Study||139
8933206|NCT02316223|9994717|FG000|COMPLETED|Overall Study||90
8933207|NCT02316223|9994718|FG001|COMPLETED|Overall Study||76
8933208|NCT02316223|9994719|FG002|COMPLETED|Overall Study||95
8933209|NCT02316223|9994717|FG000|NOT COMPLETED|Overall Study||44
8933210|NCT02316223|9994718|FG001|NOT COMPLETED|Overall Study||57
8933211|NCT02316223|9994719|FG002|NOT COMPLETED|Overall Study||44
8933212|NCT02316353|9994729|FG000|STARTED|Overall Study|7 subjects assigned to the CSL830 (40) Arm, were titrated up to the 60 IU/kg arm during the study|63
8933213|NCT02316353|9994730|FG001|STARTED|Overall Study||63
8933214|NCT02316353|9994729|FG000|COMPLETED|Overall Study||55
8933215|NCT02316353|9994730|FG001|COMPLETED|Overall Study||55
8933216|NCT02316353|9994729|FG000|NOT COMPLETED|Overall Study||8
8933217|NCT02316353|9994730|FG001|NOT COMPLETED|Overall Study||8
8933218|NCT02316366|9994741|FG000|STARTED|Overall Study||40
8933219|NCT02316366|9994742|FG001|STARTED|Overall Study||40
8933220|NCT02316366|9994741|FG000|COMPLETED|Overall Study||40
8933221|NCT02316366|9994742|FG001|COMPLETED|Overall Study||40
8933222|NCT02316366|9994741|FG000|NOT COMPLETED|Overall Study||0
8933223|NCT02316366|9994742|FG001|NOT COMPLETED|Overall Study||0
8933224|NCT02316470|9994752|FG000|STARTED|Overall Study||148
8933225|NCT02316470|9994753|FG001|STARTED|Overall Study||152
8933226|NCT02316470|9994754|FG002|STARTED|Overall Study||152
8933227|NCT02316470|9994755|FG003|STARTED|Overall Study||48
8933228|NCT02316470|9994752|FG000|COMPLETED|Overall Study||143
8933229|NCT02316470|9994753|FG001|COMPLETED|Overall Study||146
8933230|NCT02316470|9994754|FG002|COMPLETED|Overall Study||147
8933231|NCT02316470|9994755|FG003|COMPLETED|Overall Study||46
8933232|NCT02316470|9994752|FG000|NOT COMPLETED|Overall Study||5
8933233|NCT02316470|9994753|FG001|NOT COMPLETED|Overall Study||6
8933234|NCT02316470|9994754|FG002|NOT COMPLETED|Overall Study||5
8933235|NCT02316470|9994755|FG003|NOT COMPLETED|Overall Study||2
8933236|NCT02316548|9994767|FG000|STARTED|Overall Study|Randomized|6
8933237|NCT02316548|9994768|FG001|STARTED|Overall Study|Randomized|7
8933238|NCT02316548|9994767|FG000|Eligible Population|Overall Study||6
8933239|NCT02316548|9994768|FG001|Eligible Population|Overall Study||6
8933240|NCT02316548|9994767|FG000|Eligible With Disease Assessment|Overall Study||4
8933241|NCT02316548|9994768|FG001|Eligible With Disease Assessment|Overall Study||1
8933242|NCT02316548|9994767|FG000|Eligible With Adverse Event Data|Overall Study||4
8933243|NCT02316548|9994768|FG001|Eligible With Adverse Event Data|Overall Study||2
8933244|NCT02316548|9994767|FG000|COMPLETED|Overall Study|Eligible patients on study until study termination|6
8933245|NCT02316548|9994768|FG001|COMPLETED|Overall Study|Eligible patients on study until study termination|6
8933246|NCT02316548|9994767|FG000|NOT COMPLETED|Overall Study||0
8933247|NCT02316548|9994768|FG001|NOT COMPLETED|Overall Study||1
8933248|NCT02316613|9994774|FG000|STARTED|Overall Study||260
8933249|NCT02316613|9994774|FG000|Safety Population|Overall Study||255
8933250|NCT02316613|9994774|FG000|Overall Population|Overall Study||241
8933251|NCT02316613|9994774|FG000|COMPLETED|Overall Study||156
8933252|NCT02316613|9994774|FG000|NOT COMPLETED|Overall Study||104
8933253|NCT02316678|9994791|FG000|STARTED|Overall Study||1879
8933254|NCT02316678|9994792|FG001|STARTED|Overall Study||7694
8933255|NCT02316678|9994791|FG000|COMPLETED|Overall Study||1879
8933256|NCT02316678|9994792|FG001|COMPLETED|Overall Study||7694
8933257|NCT02316678|9994791|FG000|NOT COMPLETED|Overall Study||0
8933258|NCT02316678|9994792|FG001|NOT COMPLETED|Overall Study||0
8933259|NCT02316717|9994801|FG000|STARTED|Overall Study||43
8933260|NCT02316717|9994802|FG001|STARTED|Overall Study||46
8933261|NCT02316717|9994803|FG002|STARTED|Overall Study||44
8933262|NCT02316717|9994801|FG000|COMPLETED|Overall Study||32
8933263|NCT02316717|9994802|FG001|COMPLETED|Overall Study||39
8933264|NCT02316717|9994803|FG002|COMPLETED|Overall Study||41
8933265|NCT02316717|9994801|FG000|NOT COMPLETED|Overall Study||11
8933266|NCT02316717|9994802|FG001|NOT COMPLETED|Overall Study||7
8933267|NCT02316717|9994803|FG002|NOT COMPLETED|Overall Study||3
8933268|NCT02316769|9994816|FG000|STARTED|Overall Study||33
8933269|NCT02316769|9994817|FG001|STARTED|Overall Study||33
8933270|NCT02316769|9994816|FG000|COMPLETED|Overall Study||31
8933271|NCT02316769|9994817|FG001|COMPLETED|Overall Study||33
8933272|NCT02316769|9994816|FG000|NOT COMPLETED|Overall Study||2
8933273|NCT02316769|9994817|FG001|NOT COMPLETED|Overall Study||0
8933274|NCT02316847|9994825|FG000|STARTED|Overall Study||9
8933275|NCT02316847|9994826|FG001|STARTED|Overall Study||99
8933276|NCT02316847|9994825|FG000|COMPLETED|Overall Study||0
8933277|NCT02316847|9994826|FG001|COMPLETED|Overall Study||13
8933278|NCT02316847|9994825|FG000|NOT COMPLETED|Overall Study||9
8933279|NCT02316847|9994826|FG001|NOT COMPLETED|Overall Study||86
8933280|NCT02317016|9994834|FG000|STARTED|Part A: Day 1-3 (Rosuvastatin Alone)||44
8933281|NCT02317016|9994834|FG000|COMPLETED|Part A: Day 1-3 (Rosuvastatin Alone)||44
8933282|NCT02317016|9994834|FG000|NOT COMPLETED|Part A: Day 1-3 (Rosuvastatin Alone)||0
8933283|NCT02317016|9994834|FG000|STARTED|Part A: Day 4-31 (AZD9291 Alone)||44
8933284|NCT02317016|9994834|FG000|COMPLETED|Part A: Day 4-31 (AZD9291 Alone)||43
8933285|NCT02317016|9994834|FG000|NOT COMPLETED|Part A: Day 4-31 (AZD9291 Alone)||1
8933286|NCT02317016|9994834|FG000|STARTED|Part A: Day 32-34 (Rosuvastatin+AZD9291)||43
8933287|NCT02317016|9994834|FG000|COMPLETED|Part A: Day 32-34 (Rosuvastatin+AZD9291)||41
8933288|NCT02317016|9994834|FG000|NOT COMPLETED|Part A: Day 32-34 (Rosuvastatin+AZD9291)||2
8933289|NCT02317016|9994834|FG000|STARTED|Part B: Day 35 to End Part B (AZD9291)|41 completed Part A + 1 entered Part B without completing Part A (due to AE) = 42 started Part B|42
8933290|NCT02317016|9994834|FG000|COMPLETED|Part B: Day 35 to End Part B (AZD9291)||11
8933291|NCT02317016|9994834|FG000|NOT COMPLETED|Part B: Day 35 to End Part B (AZD9291)||31
8933292|NCT02317042|9994842|FG000|STARTED|Overall Study||11
8933293|NCT02317042|9994843|FG001|STARTED|Overall Study||14
8933294|NCT02317042|9994842|FG000|COMPLETED|Overall Study||11
8933295|NCT02317042|9994843|FG001|COMPLETED|Overall Study||14
8933296|NCT02317042|9994842|FG000|NOT COMPLETED|Overall Study||0
8933297|NCT02317042|9994843|FG001|NOT COMPLETED|Overall Study||0
8933298|NCT02317432|9994853|FG000|STARTED|Overall Study||153
8933299|NCT02317432|9994854|FG001|STARTED|Overall Study||154
8933300|NCT02317432|9994853|FG000|Completed CBT|Overall Study||118
8933301|NCT02317432|9994854|FG001|Completed CBT|Overall Study|Participants in Enhanced Usual Care did not receive CBT sessions.|0
8933302|NCT02317432|9994853|FG000|Completed InVEST|Overall Study||63
8933303|NCT02317432|9994854|FG001|Completed InVEST|Overall Study|Participants in Enhanced Usual Care did not receive InVEST sessions.|0
8933304|NCT02317432|9994853|FG000|Completed CBT + InVEST Exercise|Overall Study||122
8933305|NCT02317432|9994854|FG001|Completed CBT + InVEST Exercise|Overall Study|Participants in Enhanced Usual Care did not receive either CBT or InVEST sessions.|0
8933306|NCT02317432|9994853|FG000|Completed Enhanced Usual Care|Overall Study|Participants in CBT + InVEST exercise did not receive Enhanced Usual Care.|0
8933307|NCT02317432|9994854|FG001|Completed Enhanced Usual Care|Overall Study||148
8933308|NCT02317432|9994853|FG000|COMPLETED|Overall Study||122
8933309|NCT02317432|9994854|FG001|COMPLETED|Overall Study||148
8933310|NCT02317432|9994853|FG000|NOT COMPLETED|Overall Study||31
8933311|NCT02317432|9994854|FG001|NOT COMPLETED|Overall Study||6
8933312|NCT02317510|9994862|FG000|STARTED|Overall Study||25
8933313|NCT02317510|9994863|FG001|STARTED|Overall Study||25
8933314|NCT02317510|9994862|FG000|COMPLETED|Overall Study||25
8933315|NCT02317510|9994863|FG001|COMPLETED|Overall Study||24
8933316|NCT02317510|9994862|FG000|NOT COMPLETED|Overall Study||0
8933317|NCT02317510|9994863|FG001|NOT COMPLETED|Overall Study||1
8933318|NCT02317549|9994874|FG000|STARTED|Overall Study||5
8933319|NCT02317549|9994875|FG001|STARTED|Overall Study||3
8933320|NCT02317549|9994874|FG000|COMPLETED|Overall Study||5
8933321|NCT02317549|9994875|FG001|COMPLETED|Overall Study||3
8933322|NCT02317549|9994874|FG000|NOT COMPLETED|Overall Study||0
8933323|NCT02317549|9994875|FG001|NOT COMPLETED|Overall Study||0
8933324|NCT02317562|9994881|FG000|STARTED|Overall Study||19
8933325|NCT02317562|9994881|FG000|COMPLETED|Overall Study||5
8933326|NCT02317562|9994881|FG000|NOT COMPLETED|Overall Study||14
8933327|NCT02317575|9994885|FG000|STARTED|Period 1||5
8933328|NCT02317575|9994886|FG001|STARTED|Period 1||6
8933329|NCT02317575|9994887|FG002|STARTED|Period 1||6
8933330|NCT02317575|9994888|FG003|STARTED|Period 1||6
8933331|NCT02317575|9994889|FG004|STARTED|Period 1||6
8933332|NCT02317575|9994885|FG000|Received at Least 1 Dose of Study Drug|Period 1||5
8933333|NCT02317575|9994886|FG001|Received at Least 1 Dose of Study Drug|Period 1||5
8933334|NCT02317575|9994887|FG002|Received at Least 1 Dose of Study Drug|Period 1||6
8933335|NCT02317575|9994888|FG003|Received at Least 1 Dose of Study Drug|Period 1||6
8933336|NCT02317575|9994889|FG004|Received at Least 1 Dose of Study Drug|Period 1||6
8933337|NCT02317575|9994885|FG000|COMPLETED|Period 1||4
8933338|NCT02317575|9994886|FG001|COMPLETED|Period 1||5
8933339|NCT02317575|9994887|FG002|COMPLETED|Period 1||6
8933340|NCT02317575|9994888|FG003|COMPLETED|Period 1||6
8933341|NCT02317575|9994889|FG004|COMPLETED|Period 1||6
8933342|NCT02317575|9994885|FG000|NOT COMPLETED|Period 1||1
8933343|NCT02317575|9994886|FG001|NOT COMPLETED|Period 1||1
8933344|NCT02317575|9994887|FG002|NOT COMPLETED|Period 1||0
8933345|NCT02317575|9994888|FG003|NOT COMPLETED|Period 1||0
8933346|NCT02317575|9994889|FG004|NOT COMPLETED|Period 1||0
8933347|NCT02317575|9994885|FG000|STARTED|Period 2||4
8933348|NCT02317575|9994886|FG001|STARTED|Period 2||5
8933349|NCT02317575|9994887|FG002|STARTED|Period 2||6
8933350|NCT02317575|9994888|FG003|STARTED|Period 2||6
8933351|NCT02317575|9994889|FG004|STARTED|Period 2||6
8933352|NCT02317575|9994885|FG000|COMPLETED|Period 2||4
8933353|NCT02317575|9994886|FG001|COMPLETED|Period 2||5
8933354|NCT02317575|9994887|FG002|COMPLETED|Period 2||6
8933355|NCT02317575|9994888|FG003|COMPLETED|Period 2||6
8933356|NCT02317575|9994889|FG004|COMPLETED|Period 2||6
8933357|NCT02317575|9994885|FG000|NOT COMPLETED|Period 2||0
8933358|NCT02317575|9994886|FG001|NOT COMPLETED|Period 2||0
8933359|NCT02317575|9994887|FG002|NOT COMPLETED|Period 2||0
8933360|NCT02317575|9994888|FG003|NOT COMPLETED|Period 2||0
8933361|NCT02317575|9994889|FG004|NOT COMPLETED|Period 2||0
8933362|NCT02317575|9994885|FG000|STARTED|Period 3||4
8933363|NCT02317575|9994886|FG001|STARTED|Period 3||5
8933364|NCT02317575|9994887|FG002|STARTED|Period 3||6
8933365|NCT02317575|9994888|FG003|STARTED|Period 3||6
8933366|NCT02317575|9994889|FG004|STARTED|Period 3||6
8933367|NCT02317575|9994885|FG000|COMPLETED|Period 3||4
8933368|NCT02317575|9994886|FG001|COMPLETED|Period 3||5
8933369|NCT02317575|9994887|FG002|COMPLETED|Period 3||6
8933370|NCT02317575|9994888|FG003|COMPLETED|Period 3||6
8933371|NCT02317575|9994889|FG004|COMPLETED|Period 3||6
8933372|NCT02317575|9994885|FG000|NOT COMPLETED|Period 3||0
8933373|NCT02317575|9994886|FG001|NOT COMPLETED|Period 3||0
8933374|NCT02317575|9994887|FG002|NOT COMPLETED|Period 3||0
8933375|NCT02317575|9994888|FG003|NOT COMPLETED|Period 3||0
8933376|NCT02317575|9994889|FG004|NOT COMPLETED|Period 3||0
8933377|NCT02317575|9994885|FG000|STARTED|Period 4||4
8933378|NCT02317575|9994886|FG001|STARTED|Period 4||5
8933379|NCT02317575|9994887|FG002|STARTED|Period 4||6
8933380|NCT02317575|9994888|FG003|STARTED|Period 4||6
8933381|NCT02317575|9994889|FG004|STARTED|Period 4||6
8933382|NCT02317575|9994885|FG000|COMPLETED|Period 4||4
8933383|NCT02317575|9994886|FG001|COMPLETED|Period 4||5
8933384|NCT02317575|9994887|FG002|COMPLETED|Period 4||6
8933385|NCT02317575|9994888|FG003|COMPLETED|Period 4||6
8933386|NCT02317575|9994889|FG004|COMPLETED|Period 4||6
8933387|NCT02317575|9994885|FG000|NOT COMPLETED|Period 4||0
8933388|NCT02317575|9994886|FG001|NOT COMPLETED|Period 4||0
8933389|NCT02317575|9994887|FG002|NOT COMPLETED|Period 4||0
8933390|NCT02317575|9994888|FG003|NOT COMPLETED|Period 4||0
8933391|NCT02317575|9994889|FG004|NOT COMPLETED|Period 4||0
8933392|NCT02317575|9994885|FG000|STARTED|Period 5||4
8933393|NCT02317575|9994886|FG001|STARTED|Period 5||5
8933394|NCT02317575|9994887|FG002|STARTED|Period 5||6
8933395|NCT02317575|9994888|FG003|STARTED|Period 5||6
8933396|NCT02317575|9994889|FG004|STARTED|Period 5||6
8933397|NCT02317575|9994885|FG000|COMPLETED|Period 5||4
8933398|NCT02317575|9994886|FG001|COMPLETED|Period 5||5
8933399|NCT02317575|9994887|FG002|COMPLETED|Period 5||6
8933400|NCT02317575|9994888|FG003|COMPLETED|Period 5||6
8933401|NCT02317575|9994889|FG004|COMPLETED|Period 5||6
8933402|NCT02317575|9994885|FG000|NOT COMPLETED|Period 5||0
8933403|NCT02317575|9994886|FG001|NOT COMPLETED|Period 5||0
8933404|NCT02317575|9994887|FG002|NOT COMPLETED|Period 5||0
8933405|NCT02317575|9994888|FG003|NOT COMPLETED|Period 5||0
8933406|NCT02317575|9994889|FG004|NOT COMPLETED|Period 5||0
8933407|NCT02317614|9994909|FG000|STARTED|Overall Study||26
8933408|NCT02317614|9994910|FG001|STARTED|Overall Study||25
8933409|NCT02317614|9994909|FG000|COMPLETED|Overall Study||23
8933410|NCT02317614|9994910|FG001|COMPLETED|Overall Study||23
8933411|NCT02317614|9994909|FG000|NOT COMPLETED|Overall Study||3
8933412|NCT02317614|9994910|FG001|NOT COMPLETED|Overall Study||2
8933413|NCT02317692|9994918|FG000|STARTED|Overall Study||69
8933414|NCT02317692|9994919|FG001|STARTED|Overall Study||77
8933415|NCT02317692|9994918|FG000|COMPLETED|Overall Study||63
8933416|NCT02317692|9994919|FG001|COMPLETED|Overall Study||77
8933417|NCT02317692|9994918|FG000|NOT COMPLETED|Overall Study||6
8933418|NCT02317692|9994919|FG001|NOT COMPLETED|Overall Study||0
8933419|NCT02317744|9994927|FG000|STARTED|Overall Study||12
8933420|NCT02317744|9994928|FG001|STARTED|Overall Study||10
8933421|NCT02317744|9994927|FG000|Completed Treatment|Overall Study||10
8933422|NCT02317744|9994928|FG001|Completed Treatment|Overall Study||7
8933423|NCT02317744|9994927|FG000|COMPLETED|Overall Study|One NB participant stopped the treatment but completed assessments.|11
8933424|NCT02317744|9994928|FG001|COMPLETED|Overall Study|One Placebo participant stopped the treatment but completed assessments.|8
8933425|NCT02317744|9994927|FG000|NOT COMPLETED|Overall Study||1
8933426|NCT02317744|9994928|FG001|NOT COMPLETED|Overall Study||2
8933427|NCT02317809|9994934|FG000|STARTED|First Intervention Period (8 Days)||17
8933428|NCT02317809|9994935|FG001|STARTED|First Intervention Period (8 Days)||17
8933429|NCT02317809|9994934|FG000|COMPLETED|First Intervention Period (8 Days)||14
8933430|NCT02317809|9994935|FG001|COMPLETED|First Intervention Period (8 Days)||17
8933431|NCT02317809|9994934|FG000|NOT COMPLETED|First Intervention Period (8 Days)||3
8933432|NCT02317809|9994935|FG001|NOT COMPLETED|First Intervention Period (8 Days)||0
8933433|NCT02317809|9994934|FG000|STARTED|Second Intervention Period (8 Days)||14
8933434|NCT02317809|9994935|FG001|STARTED|Second Intervention Period (8 Days)||17
8933435|NCT02317809|9994934|FG000|COMPLETED|Second Intervention Period (8 Days)||14
8933436|NCT02317809|9994935|FG001|COMPLETED|Second Intervention Period (8 Days)||17
8933437|NCT02317809|9994934|FG000|NOT COMPLETED|Second Intervention Period (8 Days)||0
8933438|NCT02317809|9994935|FG001|NOT COMPLETED|Second Intervention Period (8 Days)||0
8933439|NCT02318134|9994946|FG000|STARTED|Overall Study||30
8933440|NCT02318134|9994947|FG001|STARTED|Overall Study||30
8933441|NCT02318134|9994946|FG000|COMPLETED|Overall Study||28
8933442|NCT02318134|9994947|FG001|COMPLETED|Overall Study||29
8933443|NCT02318134|9994946|FG000|NOT COMPLETED|Overall Study||2
8933444|NCT02318134|9994947|FG001|NOT COMPLETED|Overall Study||1
8933445|NCT02318303|9994962|FG000|STARTED|Overall Study||159
8933446|NCT02318303|9994963|FG001|STARTED|Overall Study||158
8933447|NCT02318303|9994964|FG002|STARTED|Overall Study||160
8933448|NCT02318303|9994965|FG003|STARTED|Overall Study||158
8933449|NCT02318303|9994966|FG004|STARTED|Overall Study||157
8933450|NCT02318303|9994967|FG005|STARTED|Overall Study||159
8933451|NCT02318303|9994968|FG006|STARTED|Overall Study||160
8933452|NCT02318303|9994962|FG000|COMPLETED|Overall Study||155
8933453|NCT02318303|9994963|FG001|COMPLETED|Overall Study||155
8933454|NCT02318303|9994964|FG002|COMPLETED|Overall Study||157
8933455|NCT02318303|9994965|FG003|COMPLETED|Overall Study||155
8933456|NCT02318303|9994966|FG004|COMPLETED|Overall Study||152
8933457|NCT02318303|9994967|FG005|COMPLETED|Overall Study||153
8933458|NCT02318303|9994968|FG006|COMPLETED|Overall Study||158
8933459|NCT02318303|9994962|FG000|NOT COMPLETED|Overall Study||4
8933460|NCT02318303|9994963|FG001|NOT COMPLETED|Overall Study||3
8933461|NCT02318303|9994964|FG002|NOT COMPLETED|Overall Study||3
8933462|NCT02318303|9994965|FG003|NOT COMPLETED|Overall Study||3
8933463|NCT02318303|9994966|FG004|NOT COMPLETED|Overall Study||5
8933464|NCT02318303|9994967|FG005|NOT COMPLETED|Overall Study||6
8933465|NCT02318303|9994968|FG006|NOT COMPLETED|Overall Study||2
8933466|NCT02318368|9994986|FG000|STARTED|Overall Study||7
8933467|NCT02318368|9994987|FG001|STARTED|Overall Study||3
8933468|NCT02318368|9994986|FG000|COMPLETED|Overall Study||0
8933469|NCT02318368|9994987|FG001|COMPLETED|Overall Study||0
8933470|NCT02318368|9994986|FG000|NOT COMPLETED|Overall Study||7
8933471|NCT02318368|9994987|FG001|NOT COMPLETED|Overall Study||3
8933472|NCT02318550|9994993|FG000|STARTED|Overall Study||262
8933473|NCT02318550|9994993|FG000|COMPLETED|Overall Study||262
8933474|NCT02318550|9994993|FG000|NOT COMPLETED|Overall Study||0
8933475|NCT02318602|9995000|FG000|STARTED|Overall Study||9
8933476|NCT02318602|9995001|FG001|STARTED|Overall Study||26
8933477|NCT02318602|9995002|FG002|STARTED|Overall Study||17
8933478|NCT02318602|9995000|FG000|COMPLETED|Overall Study||8
8933479|NCT02318602|9995001|FG001|COMPLETED|Overall Study||22
8933480|NCT02318602|9995002|FG002|COMPLETED|Overall Study||15
8933481|NCT02318602|9995000|FG000|NOT COMPLETED|Overall Study||1
8933482|NCT02318602|9995001|FG001|NOT COMPLETED|Overall Study||4
8933483|NCT02318602|9995002|FG002|NOT COMPLETED|Overall Study||2
8933484|NCT02318667|9995016|FG000|STARTED|Overall Study||38
8933485|NCT02318667|9995016|FG000|COMPLETED|Overall Study||29
8933486|NCT02318667|9995016|FG000|NOT COMPLETED|Overall Study||9
8933487|NCT02318693|9995026|FG000|STARTED|Overall Study||26
8933488|NCT02318693|9995027|FG001|STARTED|Overall Study||27
8933489|NCT02318693|9995026|FG000|Treated|Overall Study||26
8933490|NCT02318693|9995027|FG001|Treated|Overall Study|1 randomized participant did not receive treatment.|26
8933491|NCT02318693|9995026|FG000|COMPLETED|Overall Study||26
8933492|NCT02318693|9995027|FG001|COMPLETED|Overall Study||26
8933493|NCT02318693|9995026|FG000|NOT COMPLETED|Overall Study||0
8933494|NCT02318693|9995027|FG001|NOT COMPLETED|Overall Study||1
8933495|NCT02318706|9995037|FG000|STARTED|Double-blind Phase||334
8933496|NCT02318706|9995038|FG001|STARTED|Double-blind Phase||166
8933497|NCT02318706|9995039|FG002|STARTED|Double-blind Phase||168
8933498|NCT02318706|9995040|FG003|STARTED|Double-blind Phase||166
8933499|NCT02318706|9995041|FG004|STARTED|Double-blind Phase||0
8933500|NCT02318706|9995037|FG000|COMPLETED|Double-blind Phase||309
8933501|NCT02318706|9995038|FG001|COMPLETED|Double-blind Phase||154
8933502|NCT02318706|9995039|FG002|COMPLETED|Double-blind Phase||150
8933503|NCT02318706|9995040|FG003|COMPLETED|Double-blind Phase||142
8933504|NCT02318706|9995041|FG004|COMPLETED|Double-blind Phase||0
8933505|NCT02318706|9995037|FG000|NOT COMPLETED|Double-blind Phase||25
8933506|NCT02318706|9995038|FG001|NOT COMPLETED|Double-blind Phase||12
8933507|NCT02318706|9995039|FG002|NOT COMPLETED|Double-blind Phase||18
8933508|NCT02318706|9995040|FG003|NOT COMPLETED|Double-blind Phase||24
8933509|NCT02318706|9995041|FG004|NOT COMPLETED|Double-blind Phase||0
8933510|NCT02318706|9995037|FG000|STARTED|Open-label Extension Phase||0
8933511|NCT02318706|9995038|FG001|STARTED|Open-label Extension Phase||0
8933512|NCT02318706|9995039|FG002|STARTED|Open-label Extension Phase||0
8933513|NCT02318706|9995040|FG003|STARTED|Open-label Extension Phase||0
8933514|NCT02318706|9995041|FG004|STARTED|Open-label Extension Phase|A portion of participants who completed the double-blind phase enrolled in the open-label extension.|214
8933515|NCT02318706|9995037|FG000|COMPLETED|Open-label Extension Phase||0
8933516|NCT02318706|9995038|FG001|COMPLETED|Open-label Extension Phase||0
8933517|NCT02318706|9995039|FG002|COMPLETED|Open-label Extension Phase||0
8933518|NCT02318706|9995040|FG003|COMPLETED|Open-label Extension Phase||0
8933519|NCT02318706|9995041|FG004|COMPLETED|Open-label Extension Phase||172
8933520|NCT02318706|9995037|FG000|NOT COMPLETED|Open-label Extension Phase||0
8933521|NCT02318706|9995038|FG001|NOT COMPLETED|Open-label Extension Phase||0
8933522|NCT02318706|9995039|FG002|NOT COMPLETED|Open-label Extension Phase||0
8933523|NCT02318706|9995040|FG003|NOT COMPLETED|Open-label Extension Phase||0
8933524|NCT02318706|9995041|FG004|NOT COMPLETED|Open-label Extension Phase||42
8933525|NCT02318719|9995057|FG000|STARTED|Double-blind Phase||304
8933526|NCT02318719|9995058|FG001|STARTED|Double-blind Phase||153
8933527|NCT02318719|9995059|FG002|STARTED|Double-blind Phase||153
8933528|NCT02318719|9995060|FG003|STARTED|Double-blind Phase||155
8933529|NCT02318719|9995061|FG004|STARTED|Double-blind Phase||0
8933530|NCT02318719|9995057|FG000|Did Not Receive Treatment|Double-blind Phase||1
8933531|NCT02318719|9995058|FG001|Did Not Receive Treatment|Double-blind Phase||1
8933532|NCT02318719|9995059|FG002|Did Not Receive Treatment|Double-blind Phase||0
8933533|NCT02318719|9995060|FG003|Did Not Receive Treatment|Double-blind Phase||0
8933534|NCT02318719|9995061|FG004|Did Not Receive Treatment|Double-blind Phase||0
8933535|NCT02318719|9995057|FG000|COMPLETED|Double-blind Phase||266
8933536|NCT02318719|9995058|FG001|COMPLETED|Double-blind Phase||137
8933537|NCT02318719|9995059|FG002|COMPLETED|Double-blind Phase||128
8933538|NCT02318719|9995060|FG003|COMPLETED|Double-blind Phase||140
8933539|NCT02318719|9995061|FG004|COMPLETED|Double-blind Phase||0
8933540|NCT02318719|9995057|FG000|NOT COMPLETED|Double-blind Phase||38
8933541|NCT02318719|9995058|FG001|NOT COMPLETED|Double-blind Phase||16
8933542|NCT02318719|9995059|FG002|NOT COMPLETED|Double-blind Phase||25
8933543|NCT02318719|9995060|FG003|NOT COMPLETED|Double-blind Phase||15
8933544|NCT02318719|9995061|FG004|NOT COMPLETED|Double-blind Phase||0
8933545|NCT02318719|9995057|FG000|STARTED|Open-label Extension Phase||0
8933546|NCT02318719|9995058|FG001|STARTED|Open-label Extension Phase||0
8933547|NCT02318719|9995059|FG002|STARTED|Open-label Extension Phase||0
8933548|NCT02318719|9995060|FG003|STARTED|Open-label Extension Phase||0
8933549|NCT02318719|9995061|FG004|STARTED|Open-label Extension Phase|A portion of participants who completed the double-blind phase enrolled in the open-label extension.|239
8933550|NCT02318719|9995057|FG000|COMPLETED|Open-label Extension Phase||0
8933551|NCT02318719|9995058|FG001|COMPLETED|Open-label Extension Phase||0
8933552|NCT02318719|9995059|FG002|COMPLETED|Open-label Extension Phase||0
8933553|NCT02318719|9995060|FG003|COMPLETED|Open-label Extension Phase||0
8933554|NCT02318719|9995061|FG004|COMPLETED|Open-label Extension Phase||184
8933555|NCT02318719|9995057|FG000|NOT COMPLETED|Open-label Extension Phase||0
8933556|NCT02318719|9995058|FG001|NOT COMPLETED|Open-label Extension Phase||0
8933557|NCT02318719|9995059|FG002|NOT COMPLETED|Open-label Extension Phase||0
8933558|NCT02318719|9995060|FG003|NOT COMPLETED|Open-label Extension Phase||0
8933559|NCT02318719|9995061|FG004|NOT COMPLETED|Open-label Extension Phase||55
8933560|NCT02318797|9995075|FG000|STARTED|Overall Study||516
8933561|NCT02318797|9995076|FG001|STARTED|Overall Study||713
8933562|NCT02318797|9995075|FG000|COMPLETED|Overall Study||428
8933563|NCT02318797|9995076|FG001|COMPLETED|Overall Study||611
8933564|NCT02318797|9995075|FG000|NOT COMPLETED|Overall Study||88
8933565|NCT02318797|9995076|FG001|NOT COMPLETED|Overall Study||102
8933566|NCT02318940|9995084|FG000|STARTED|Overall Study|in the last patient we lost the record.|50
8933567|NCT02318940|9995085|FG001|STARTED|Overall Study||50
8933568|NCT02318940|9995084|FG000|COMPLETED|Overall Study||49
8933569|NCT02318940|9995085|FG001|COMPLETED|Overall Study||50
8933570|NCT02318940|9995084|FG000|NOT COMPLETED|Overall Study||1
8933571|NCT02318940|9995085|FG001|NOT COMPLETED|Overall Study||0
8933572|NCT02318979|9995093|FG000|STARTED|Overall Study||15
8933573|NCT02318979|9995094|FG001|STARTED|Overall Study||15
8933574|NCT02318979|9995093|FG000|COMPLETED|Overall Study||15
8933575|NCT02318979|9995094|FG001|COMPLETED|Overall Study||15
8933576|NCT02318979|9995093|FG000|NOT COMPLETED|Overall Study||0
8933577|NCT02318979|9995094|FG001|NOT COMPLETED|Overall Study||0
8933578|NCT02318992|9995107|FG000|STARTED|Overall Study||27
8933579|NCT02318992|9995108|FG001|STARTED|Overall Study||27
8933580|NCT02318992|9995109|FG002|STARTED|Overall Study||24
8933581|NCT02318992|9995107|FG000|COMPLETED|Overall Study||25
8933582|NCT02318992|9995108|FG001|COMPLETED|Overall Study||25
8933583|NCT02318992|9995109|FG002|COMPLETED|Overall Study||20
8933584|NCT02318992|9995107|FG000|NOT COMPLETED|Overall Study||2
8933585|NCT02318992|9995108|FG001|NOT COMPLETED|Overall Study||2
8933586|NCT02318992|9995109|FG002|NOT COMPLETED|Overall Study||4
8933587|NCT02319031|9995119|FG000|STARTED|Treatment Period||24
8933588|NCT02319031|9995120|FG001|STARTED|Treatment Period||26
8933589|NCT02319031|9995119|FG000|COMPLETED|Treatment Period||23
8933590|NCT02319031|9995120|FG001|COMPLETED|Treatment Period||26
8933591|NCT02319031|9995119|FG000|NOT COMPLETED|Treatment Period||1
8933592|NCT02319031|9995120|FG001|NOT COMPLETED|Treatment Period||0
8933593|NCT02319031|9995119|FG000|STARTED|Follow-Up Period||23
8933594|NCT02319031|9995120|FG001|STARTED|Follow-Up Period||26
8933595|NCT02319031|9995119|FG000|COMPLETED|Follow-Up Period||23
8933596|NCT02319031|9995120|FG001|COMPLETED|Follow-Up Period||26
8933597|NCT02319031|9995119|FG000|NOT COMPLETED|Follow-Up Period||0
8933598|NCT02319031|9995120|FG001|NOT COMPLETED|Follow-Up Period||0
8933599|NCT02319044|9995129|FG000|STARTED|Overall Study||133
8933600|NCT02319044|9995130|FG001|STARTED|Overall Study||67
8933601|NCT02319044|9995131|FG002|STARTED|Overall Study||67
8933602|NCT02319044|9995129|FG000|COMPLETED|Overall Study||11
8933603|NCT02319044|9995130|FG001|COMPLETED|Overall Study||7
8933604|NCT02319044|9995131|FG002|COMPLETED|Overall Study||0
8933605|NCT02319044|9995129|FG000|NOT COMPLETED|Overall Study||122
8933606|NCT02319044|9995130|FG001|NOT COMPLETED|Overall Study||60
8933607|NCT02319044|9995131|FG002|NOT COMPLETED|Overall Study||67
8933608|NCT02319148|9995143|FG000|STARTED|First Intervention Period||22
8933609|NCT02319148|9995144|FG001|STARTED|First Intervention Period||0
8933610|NCT02319148|9995145|FG002|STARTED|First Intervention Period||0
8933611|NCT02319148|9995146|FG003|STARTED|First Intervention Period||0
8933612|NCT02319148|9995143|FG000|COMPLETED|First Intervention Period||22
8933613|NCT02319148|9995144|FG001|COMPLETED|First Intervention Period||0
8933614|NCT02319148|9995145|FG002|COMPLETED|First Intervention Period||0
8933615|NCT02319148|9995146|FG003|COMPLETED|First Intervention Period||0
8933616|NCT02319148|9995143|FG000|NOT COMPLETED|First Intervention Period||0
8933617|NCT02319148|9995144|FG001|NOT COMPLETED|First Intervention Period||0
8933618|NCT02319148|9995145|FG002|NOT COMPLETED|First Intervention Period||0
8933619|NCT02319148|9995146|FG003|NOT COMPLETED|First Intervention Period||0
8933620|NCT02319148|9995143|FG000|STARTED|Washout Period 4 Days||22
8933621|NCT02319148|9995144|FG001|STARTED|Washout Period 4 Days||0
8933622|NCT02319148|9995145|FG002|STARTED|Washout Period 4 Days||0
8933623|NCT02319148|9995146|FG003|STARTED|Washout Period 4 Days||0
8933624|NCT02319148|9995143|FG000|COMPLETED|Washout Period 4 Days||22
8933625|NCT02319148|9995144|FG001|COMPLETED|Washout Period 4 Days||0
8933626|NCT02319148|9995145|FG002|COMPLETED|Washout Period 4 Days||0
8933627|NCT02319148|9995146|FG003|COMPLETED|Washout Period 4 Days||0
8933628|NCT02319148|9995143|FG000|NOT COMPLETED|Washout Period 4 Days||0
8933629|NCT02319148|9995144|FG001|NOT COMPLETED|Washout Period 4 Days||0
8933630|NCT02319148|9995145|FG002|NOT COMPLETED|Washout Period 4 Days||0
8933631|NCT02319148|9995146|FG003|NOT COMPLETED|Washout Period 4 Days||0
8933632|NCT02319148|9995143|FG000|STARTED|Second Intervention Period||0
8933633|NCT02319148|9995144|FG001|STARTED|Second Intervention Period||7
8933634|NCT02319148|9995145|FG002|STARTED|Second Intervention Period||7
8933635|NCT02319148|9995146|FG003|STARTED|Second Intervention Period||8
8933636|NCT02319148|9995143|FG000|COMPLETED|Second Intervention Period||0
8933637|NCT02319148|9995144|FG001|COMPLETED|Second Intervention Period||6
8933638|NCT02319148|9995145|FG002|COMPLETED|Second Intervention Period||6
8933639|NCT02319148|9995146|FG003|COMPLETED|Second Intervention Period||6
8933640|NCT02319148|9995143|FG000|NOT COMPLETED|Second Intervention Period||0
8933641|NCT02319148|9995144|FG001|NOT COMPLETED|Second Intervention Period||1
8933642|NCT02319148|9995145|FG002|NOT COMPLETED|Second Intervention Period||1
8933643|NCT02319148|9995146|FG003|NOT COMPLETED|Second Intervention Period||2
8933644|NCT02319174|9995165|FG000|STARTED|Overall Study||43
8933645|NCT02319174|9995165|FG000|COMPLETED|Overall Study||42
8933646|NCT02319174|9995165|FG000|NOT COMPLETED|Overall Study||1
8933647|NCT02319304|9995170|FG000|STARTED|Overall Study||3
8933648|NCT02319304|9995170|FG000|COMPLETED|Overall Study||2
8933649|NCT02319304|9995170|FG000|NOT COMPLETED|Overall Study||1
8933650|NCT02319317|9995176|FG000|STARTED|Overall Study||31
8933651|NCT02319317|9995177|FG001|STARTED|Overall Study||29
8933652|NCT02319317|9995176|FG000|COMPLETED|Overall Study||31
8933653|NCT02319317|9995177|FG001|COMPLETED|Overall Study||29
8933654|NCT02319317|9995176|FG000|NOT COMPLETED|Overall Study||0
8933655|NCT02319317|9995177|FG001|NOT COMPLETED|Overall Study||0
8933656|NCT02319369|9995196|FG000|STARTED|Overall Study||7
8933657|NCT02319369|9995197|FG001|STARTED|Overall Study||6
8933658|NCT02319369|9995198|FG002|STARTED|Overall Study||11
8933659|NCT02319369|9995199|FG003|STARTED|Overall Study||8
8933660|NCT02319369|9995200|FG004|STARTED|Overall Study||5
8933661|NCT02319369|9995201|FG005|STARTED|Overall Study||7
8933662|NCT02319369|9995202|FG006|STARTED|Overall Study||3
8933663|NCT02319369|9995203|FG007|STARTED|Overall Study||6
8933664|NCT02319369|9995204|FG008|STARTED|Overall Study||4
8933665|NCT02319369|9995205|FG009|STARTED|Overall Study||9
8933666|NCT02319369|9995206|FG010|STARTED|Overall Study||3
8933667|NCT02319369|9995207|FG011|STARTED|Overall Study||4
8933668|NCT02319369|9995208|FG012|STARTED|Overall Study||1
8933669|NCT02319369|9995196|FG000|COMPLETED|Overall Study||7
8933670|NCT02319369|9995197|FG001|COMPLETED|Overall Study||6
8933671|NCT02319369|9995198|FG002|COMPLETED|Overall Study||11
8933672|NCT02319369|9995199|FG003|COMPLETED|Overall Study||8
8933673|NCT02319369|9995200|FG004|COMPLETED|Overall Study||5
8933674|NCT02319369|9995201|FG005|COMPLETED|Overall Study||7
8933675|NCT02319369|9995202|FG006|COMPLETED|Overall Study||3
8933676|NCT02319369|9995203|FG007|COMPLETED|Overall Study||6
8933677|NCT02319369|9995204|FG008|COMPLETED|Overall Study||4
8933678|NCT02319369|9995205|FG009|COMPLETED|Overall Study||9
8933679|NCT02319369|9995206|FG010|COMPLETED|Overall Study||3
8933680|NCT02319369|9995207|FG011|COMPLETED|Overall Study||4
8933681|NCT02319369|9995208|FG012|COMPLETED|Overall Study||1
8933682|NCT02319369|9995196|FG000|NOT COMPLETED|Overall Study||0
8933683|NCT02319369|9995197|FG001|NOT COMPLETED|Overall Study||0
8933684|NCT02319369|9995198|FG002|NOT COMPLETED|Overall Study||0
8933685|NCT02319369|9995199|FG003|NOT COMPLETED|Overall Study||0
8933686|NCT02319369|9995200|FG004|NOT COMPLETED|Overall Study||0
8933687|NCT02319369|9995201|FG005|NOT COMPLETED|Overall Study||0
8933688|NCT02319369|9995202|FG006|NOT COMPLETED|Overall Study||0
8933689|NCT02319369|9995203|FG007|NOT COMPLETED|Overall Study||0
8933690|NCT02319369|9995204|FG008|NOT COMPLETED|Overall Study||0
8933691|NCT02319369|9995205|FG009|NOT COMPLETED|Overall Study||0
8933692|NCT02319369|9995206|FG010|NOT COMPLETED|Overall Study||0
8933693|NCT02319369|9995207|FG011|NOT COMPLETED|Overall Study||0
8933694|NCT02319369|9995208|FG012|NOT COMPLETED|Overall Study||0
8933695|NCT02319486|9995246|FG000|STARTED|Overall Study||26
8933696|NCT02319486|9995246|FG000|COMPLETED|Overall Study||26
8933697|NCT02319486|9995246|FG000|NOT COMPLETED|Overall Study||0
8933698|NCT02319525|9995254|FG000|STARTED|Overall Study||153
8933699|NCT02319525|9995255|FG001|STARTED|Overall Study||148
8933700|NCT02319525|9995254|FG000|Primary Research Completion|Overall Study||151
8933701|NCT02319525|9995255|FG001|Primary Research Completion|Overall Study||147
8933702|NCT02319525|9995254|FG000|COMPLETED|Overall Study||151
8933703|NCT02319525|9995255|FG001|COMPLETED|Overall Study||147
8933704|NCT02319525|9995254|FG000|NOT COMPLETED|Overall Study||2
8933705|NCT02319525|9995255|FG001|NOT COMPLETED|Overall Study||1
8933706|NCT02319642|9995263|FG000|STARTED|Overall Study||95
8933707|NCT02319642|9995264|FG001|STARTED|Overall Study||251
8933708|NCT02319642|9995263|FG000|COMPLETED|Overall Study||91
8933709|NCT02319642|9995264|FG001|COMPLETED|Overall Study||245
8933710|NCT02319642|9995263|FG000|NOT COMPLETED|Overall Study||4
8933711|NCT02319642|9995264|FG001|NOT COMPLETED|Overall Study||6
8933712|NCT02319668|9995274|FG000|STARTED|Overall Study||19
8933713|NCT02319668|9995275|FG001|STARTED|Overall Study||19
8933714|NCT02319668|9995274|FG000|COMPLETED|Overall Study||19
8933715|NCT02319668|9995275|FG001|COMPLETED|Overall Study||17
8933716|NCT02319668|9995274|FG000|NOT COMPLETED|Overall Study||0
8933717|NCT02319668|9995275|FG001|NOT COMPLETED|Overall Study||2
8933718|NCT02319759|9995286|FG000|STARTED|Week 0 - 16||49
8933719|NCT02319759|9995287|FG001|STARTED|Week 0 - 16||0
8933720|NCT02319759|9995288|FG002|STARTED|Week 0 - 16||100
8933721|NCT02319759|9995289|FG003|STARTED|Week 0 - 16||0
8933722|NCT02319759|9995290|FG004|STARTED|Week 0 - 16||0
8933723|NCT02319759|9995286|FG000|COMPLETED|Week 0 - 16||48
8933724|NCT02319759|9995287|FG001|COMPLETED|Week 0 - 16||0
8933725|NCT02319759|9995288|FG002|COMPLETED|Week 0 - 16||99
8933726|NCT02319759|9995289|FG003|COMPLETED|Week 0 - 16||0
8933727|NCT02319759|9995290|FG004|COMPLETED|Week 0 - 16||0
8933728|NCT02319759|9995286|FG000|NOT COMPLETED|Week 0 - 16||1
8933729|NCT02319759|9995287|FG001|NOT COMPLETED|Week 0 - 16||0
8933730|NCT02319759|9995288|FG002|NOT COMPLETED|Week 0 - 16||1
8933731|NCT02319759|9995289|FG003|NOT COMPLETED|Week 0 - 16||0
8933732|NCT02319759|9995290|FG004|NOT COMPLETED|Week 0 - 16||0
8933733|NCT02319759|9995286|FG000|STARTED|Week 16 - 24||31
8933734|NCT02319759|9995287|FG001|STARTED|Week 16 - 24||0
8933735|NCT02319759|9995288|FG002|STARTED|Week 16 - 24||89
8933736|NCT02319759|9995289|FG003|STARTED|Week 16 - 24||17
8933737|NCT02319759|9995290|FG004|STARTED|Week 16 - 24||10
8933738|NCT02319759|9995286|FG000|COMPLETED|Week 16 - 24||29
8933739|NCT02319759|9995287|FG001|COMPLETED|Week 16 - 24||0
8933740|NCT02319759|9995288|FG002|COMPLETED|Week 16 - 24||86
8933741|NCT02319759|9995289|FG003|COMPLETED|Week 16 - 24||17
8933742|NCT02319759|9995290|FG004|COMPLETED|Week 16 - 24||10
8933743|NCT02319759|9995286|FG000|NOT COMPLETED|Week 16 - 24||2
8933744|NCT02319759|9995287|FG001|NOT COMPLETED|Week 16 - 24||0
8933745|NCT02319759|9995288|FG002|NOT COMPLETED|Week 16 - 24||3
8933746|NCT02319759|9995289|FG003|NOT COMPLETED|Week 16 - 24||0
8933747|NCT02319759|9995290|FG004|NOT COMPLETED|Week 16 - 24||0
8933748|NCT02319759|9995286|FG000|STARTED|Week 24 - 56||0
8933749|NCT02319759|9995287|FG001|STARTED|Week 24 - 56||29
8933750|NCT02319759|9995288|FG002|STARTED|Week 24 - 56||86
8933751|NCT02319759|9995289|FG003|STARTED|Week 24 - 56||17
8933752|NCT02319759|9995290|FG004|STARTED|Week 24 - 56||10
8933753|NCT02319759|9995286|FG000|COMPLETED|Week 24 - 56||0
8933754|NCT02319759|9995287|FG001|COMPLETED|Week 24 - 56||28
8933755|NCT02319759|9995288|FG002|COMPLETED|Week 24 - 56||84
8933756|NCT02319759|9995289|FG003|COMPLETED|Week 24 - 56||15
8933757|NCT02319759|9995290|FG004|COMPLETED|Week 24 - 56||8
8933758|NCT02319759|9995286|FG000|NOT COMPLETED|Week 24 - 56||0
8933759|NCT02319759|9995287|FG001|NOT COMPLETED|Week 24 - 56||1
8933760|NCT02319759|9995288|FG002|NOT COMPLETED|Week 24 - 56||2
8933761|NCT02319759|9995289|FG003|NOT COMPLETED|Week 24 - 56||2
8933762|NCT02319759|9995290|FG004|NOT COMPLETED|Week 24 - 56||2
8933763|NCT02319824|9995303|FG000|STARTED|Overall Study||2
8933764|NCT02319824|9995303|FG000|COMPLETED|Overall Study||2
8933765|NCT02319824|9995303|FG000|NOT COMPLETED|Overall Study||0
8933766|NCT02319967|9995311|FG000|STARTED|Overall Study||126
8933767|NCT02319967|9995312|FG001|STARTED|Overall Study||126
8933768|NCT02319967|9995313|FG002|STARTED|Overall Study||121
8933769|NCT02319967|9995311|FG000|COMPLETED|Overall Study||78
8933770|NCT02319967|9995312|FG001|COMPLETED|Overall Study||82
8933771|NCT02319967|9995313|FG002|COMPLETED|Overall Study||76
8933772|NCT02319967|9995311|FG000|NOT COMPLETED|Overall Study||48
8933773|NCT02319967|9995312|FG001|NOT COMPLETED|Overall Study||44
8933774|NCT02319967|9995313|FG002|NOT COMPLETED|Overall Study||45
8933775|NCT02320058|9995323|FG000|STARTED|Overall Study||101
8933776|NCT02320058|9995324|FG001|STARTED|Overall Study||18
8933777|NCT02320058|9995323|FG000|COMPLETED|Overall Study||59
8933778|NCT02320058|9995324|FG001|COMPLETED|Overall Study||5
8933779|NCT02320058|9995323|FG000|NOT COMPLETED|Overall Study||42
8933780|NCT02320058|9995324|FG001|NOT COMPLETED|Overall Study||13
8933781|NCT02320123|9995332|FG000|STARTED|Overall Study||10
8933782|NCT02320123|9995333|FG001|STARTED|Overall Study||12
8933783|NCT02320123|9995332|FG000|COMPLETED|Overall Study||0
8933784|NCT02320123|9995333|FG001|COMPLETED|Overall Study||1
8933785|NCT02320123|9995332|FG000|NOT COMPLETED|Overall Study||10
8933786|NCT02320123|9995333|FG001|NOT COMPLETED|Overall Study||11
8933787|NCT02320149|9995345|FG000|STARTED|Overall Study||483
8933788|NCT02320149|9995346|FG001|STARTED|Overall Study||485
8933789|NCT02320149|9995345|FG000|COMPLETED|Overall Study||420
8933790|NCT02320149|9995346|FG001|COMPLETED|Overall Study||405
8933791|NCT02320149|9995345|FG000|NOT COMPLETED|Overall Study||63
8933792|NCT02320149|9995346|FG001|NOT COMPLETED|Overall Study||80
8933793|NCT02320175|9995354|FG000|STARTED|Overall Study|Patients (n=1574); Parents (n=1222); Physicians (n=478); Nurses (n=264).|3538
8933794|NCT02320175|9995355|FG001|STARTED|Overall Study|Patients (n=1532); Parents (n=926); Physicians (n=311); Nurses (n=171).|2940
8933795|NCT02320175|9995354|FG000|COMPLETED|Overall Study|Patients (n=1574); Parents (n=1222); Physicians (n=478); Nurses (n=264).|3538
8933796|NCT02320175|9995355|FG001|COMPLETED|Overall Study|Patients (n=1532); Parents (n=926); Physicians (n=311); Nurses (n=171).|2940
8933797|NCT02320175|9995354|FG000|NOT COMPLETED|Overall Study||0
8933798|NCT02320175|9995355|FG001|NOT COMPLETED|Overall Study||0
8933799|NCT02320214|9995364|FG000|STARTED|Overall Study||30
8933800|NCT02320214|9995364|FG000|COMPLETED|Overall Study||30
8933801|NCT02320214|9995364|FG000|NOT COMPLETED|Overall Study||0
8933802|NCT02320227|9995368|FG000|STARTED|Overall Study||30
8933803|NCT02320227|9995368|FG000|COMPLETED|Overall Study||30
8933804|NCT02320227|9995368|FG000|NOT COMPLETED|Overall Study||0
8933805|NCT02320253|9995376|FG000|STARTED|Overall Study||69
8933806|NCT02320253|9995377|FG001|STARTED|Overall Study||70
8933807|NCT02320253|9995378|FG002|STARTED|Overall Study||72
8933808|NCT02320253|9995376|FG000|COMPLETED|Overall Study||63
8933809|NCT02320253|9995377|FG001|COMPLETED|Overall Study||68
8933810|NCT02320253|9995378|FG002|COMPLETED|Overall Study||70
8933811|NCT02320253|9995376|FG000|NOT COMPLETED|Overall Study||6
8933812|NCT02320253|9995377|FG001|NOT COMPLETED|Overall Study||2
8933813|NCT02320253|9995378|FG002|NOT COMPLETED|Overall Study||2
8933814|NCT02320487|9995386|FG000|STARTED|Overall Study||102
8933815|NCT02320487|9995386|FG000|COMPLETED|Overall Study|Completed = completed the 6-cycle Treatment Period.|81
8933816|NCT02320487|9995386|FG000|NOT COMPLETED|Overall Study||21
8933817|NCT02320695|9995390|FG000|STARTED|Overall Study||60
8933818|NCT02320695|9995390|FG000|Saline|Overall Study||60
8933819|NCT02320695|9995390|FG000|Alcohol|Overall Study||60
8933820|NCT02320695|9995390|FG000|Pain Relieving Cream|Overall Study||59
8933821|NCT02320695|9995390|FG000|Antibiotic/Pain Relieving Ointment|Overall Study||60
8933822|NCT02320695|9995390|FG000|Original Ointment|Overall Study||60
8933823|NCT02320695|9995390|FG000|Pain Relief Ointment|Overall Study||60
8933824|NCT02320695|9995390|FG000|COMPLETED|Overall Study||60
8933825|NCT02320695|9995390|FG000|NOT COMPLETED|Overall Study||0
8933826|NCT02320721|9995401|FG000|STARTED|Overall Study||508
8933827|NCT02320721|9995402|FG001|STARTED|Overall Study||506
8933828|NCT02320721|9995401|FG000|Treated (Safety Population)|Overall Study||508
8933829|NCT02320721|9995402|FG001|Treated (Safety Population)|Overall Study||505
8933830|NCT02320721|9995401|FG000|COMPLETED|Overall Study||481
8933831|NCT02320721|9995402|FG001|COMPLETED|Overall Study||472
8933832|NCT02320721|9995401|FG000|NOT COMPLETED|Overall Study||27
8933833|NCT02320721|9995402|FG001|NOT COMPLETED|Overall Study||34
8933834|NCT02320812|9995408|FG000|STARTED|Overall Study||28
8933835|NCT02320812|9995408|FG000|COMPLETED|Overall Study||28
8933836|NCT02320812|9995408|FG000|NOT COMPLETED|Overall Study||0
8933837|NCT02320838|9995416|FG000|STARTED|First Intervention (1 Day)||8
8933838|NCT02320838|9995417|FG001|STARTED|First Intervention (1 Day)||8
8933839|NCT02320838|9995418|FG002|STARTED|First Intervention (1 Day)||8
8933840|NCT02320838|9995419|FG003|STARTED|First Intervention (1 Day)||7
8933841|NCT02320838|9995420|FG004|STARTED|First Intervention (1 Day)||7
8933842|NCT02320838|9995416|FG000|COMPLETED|First Intervention (1 Day)||8
8933843|NCT02320838|9995417|FG001|COMPLETED|First Intervention (1 Day)||8
8933844|NCT02320838|9995418|FG002|COMPLETED|First Intervention (1 Day)||8
8933845|NCT02320838|9995419|FG003|COMPLETED|First Intervention (1 Day)||7
8933846|NCT02320838|9995420|FG004|COMPLETED|First Intervention (1 Day)||7
8933847|NCT02320838|9995416|FG000|NOT COMPLETED|First Intervention (1 Day)||0
8933848|NCT02320838|9995417|FG001|NOT COMPLETED|First Intervention (1 Day)||0
8933849|NCT02320838|9995418|FG002|NOT COMPLETED|First Intervention (1 Day)||0
8933850|NCT02320838|9995419|FG003|NOT COMPLETED|First Intervention (1 Day)||0
8933851|NCT02320838|9995420|FG004|NOT COMPLETED|First Intervention (1 Day)||0
8933852|NCT02320838|9995416|FG000|STARTED|Washout (1 Day)||8
8933853|NCT02320838|9995417|FG001|STARTED|Washout (1 Day)||8
8933854|NCT02320838|9995418|FG002|STARTED|Washout (1 Day)||8
8933855|NCT02320838|9995419|FG003|STARTED|Washout (1 Day)||7
8933856|NCT02320838|9995420|FG004|STARTED|Washout (1 Day)||7
8933857|NCT02320838|9995416|FG000|COMPLETED|Washout (1 Day)||8
8933858|NCT02320838|9995417|FG001|COMPLETED|Washout (1 Day)||8
8933859|NCT02320838|9995418|FG002|COMPLETED|Washout (1 Day)||8
8933860|NCT02320838|9995419|FG003|COMPLETED|Washout (1 Day)||7
8933861|NCT02320838|9995420|FG004|COMPLETED|Washout (1 Day)||7
8933862|NCT02320838|9995416|FG000|NOT COMPLETED|Washout (1 Day)||0
8933863|NCT02320838|9995417|FG001|NOT COMPLETED|Washout (1 Day)||0
8933864|NCT02320838|9995418|FG002|NOT COMPLETED|Washout (1 Day)||0
8933865|NCT02320838|9995419|FG003|NOT COMPLETED|Washout (1 Day)||0
8933866|NCT02320838|9995420|FG004|NOT COMPLETED|Washout (1 Day)||0
8933867|NCT02320838|9995416|FG000|STARTED|Second Intervention (1 Day)||8
8933868|NCT02320838|9995417|FG001|STARTED|Second Intervention (1 Day)||8
8933869|NCT02320838|9995418|FG002|STARTED|Second Intervention (1 Day)||8
8933870|NCT02320838|9995419|FG003|STARTED|Second Intervention (1 Day)||7
8933871|NCT02320838|9995420|FG004|STARTED|Second Intervention (1 Day)||7
8933872|NCT02320838|9995416|FG000|COMPLETED|Second Intervention (1 Day)||8
8933873|NCT02320838|9995417|FG001|COMPLETED|Second Intervention (1 Day)||8
8933874|NCT02320838|9995418|FG002|COMPLETED|Second Intervention (1 Day)||8
8933875|NCT02320838|9995419|FG003|COMPLETED|Second Intervention (1 Day)||7
8933876|NCT02320838|9995420|FG004|COMPLETED|Second Intervention (1 Day)||7
8933877|NCT02320838|9995416|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
8933878|NCT02320838|9995417|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
8933879|NCT02320838|9995418|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
8933880|NCT02320838|9995419|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
8933881|NCT02320838|9995420|FG004|NOT COMPLETED|Second Intervention (1 Day)||0
8933882|NCT02320838|9995416|FG000|STARTED|Washout (1 Day)||8
8933883|NCT02320838|9995417|FG001|STARTED|Washout (1 Day)||8
8933884|NCT02320838|9995418|FG002|STARTED|Washout (1 Day)||8
8933885|NCT02320838|9995419|FG003|STARTED|Washout (1 Day)||7
8933886|NCT02320838|9995420|FG004|STARTED|Washout (1 Day)||7
8933887|NCT02320838|9995416|FG000|COMPLETED|Washout (1 Day)||8
8933888|NCT02320838|9995417|FG001|COMPLETED|Washout (1 Day)||8
8933889|NCT02320838|9995418|FG002|COMPLETED|Washout (1 Day)||8
8933890|NCT02320838|9995419|FG003|COMPLETED|Washout (1 Day)||7
8933891|NCT02320838|9995420|FG004|COMPLETED|Washout (1 Day)||7
8933892|NCT02320838|9995416|FG000|NOT COMPLETED|Washout (1 Day)||0
8933893|NCT02320838|9995417|FG001|NOT COMPLETED|Washout (1 Day)||0
8933894|NCT02320838|9995418|FG002|NOT COMPLETED|Washout (1 Day)||0
8933895|NCT02320838|9995419|FG003|NOT COMPLETED|Washout (1 Day)||0
8933896|NCT02320838|9995420|FG004|NOT COMPLETED|Washout (1 Day)||0
8933897|NCT02320838|9995416|FG000|STARTED|Third Intervention (1 Day)||8
8933898|NCT02320838|9995417|FG001|STARTED|Third Intervention (1 Day)||8
8933899|NCT02320838|9995418|FG002|STARTED|Third Intervention (1 Day)||8
8933900|NCT02320838|9995419|FG003|STARTED|Third Intervention (1 Day)||7
8933901|NCT02320838|9995420|FG004|STARTED|Third Intervention (1 Day)||7
8933902|NCT02320838|9995416|FG000|COMPLETED|Third Intervention (1 Day)||8
8933903|NCT02320838|9995417|FG001|COMPLETED|Third Intervention (1 Day)||8
8933904|NCT02320838|9995418|FG002|COMPLETED|Third Intervention (1 Day)||8
8933905|NCT02320838|9995419|FG003|COMPLETED|Third Intervention (1 Day)||7
8933906|NCT02320838|9995420|FG004|COMPLETED|Third Intervention (1 Day)||7
8933907|NCT02320838|9995416|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
8933908|NCT02320838|9995417|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
8617230|NCT00455520|9655411|FG001|STARTED|Open Label Tapentadol Extended Release||0
8617231|NCT00455520|9655410|FG000|COMPLETED|Open Label Tapentadol Extended Release||395
8617232|NCT00455520|9655411|FG001|COMPLETED|Open Label Tapentadol Extended Release||0
8617233|NCT00455520|9655410|FG000|NOT COMPLETED|Open Label Tapentadol Extended Release||196
8617234|NCT00455520|9655411|FG001|NOT COMPLETED|Open Label Tapentadol Extended Release||0
8617235|NCT00455520|9655410|FG000|STARTED|Double Blind Tapentadol ER vs Placebo|2 subjects enrolled two separate times in this study, 1 subject did not receive study medication|196
8933909|NCT02320838|9995418|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
8933910|NCT02320838|9995419|FG003|NOT COMPLETED|Third Intervention (1 Day)||0
8933911|NCT02320838|9995420|FG004|NOT COMPLETED|Third Intervention (1 Day)||0
8933912|NCT02320903|9995431|FG000|STARTED|Overall Study||24
8933913|NCT02320903|9995432|FG001|STARTED|Overall Study||32
8933914|NCT02320903|9995433|FG002|STARTED|Overall Study||32
8933915|NCT02320903|9995431|FG000|COMPLETED|Overall Study||16
8933916|NCT02320903|9995432|FG001|COMPLETED|Overall Study||16
8933917|NCT02320903|9995433|FG002|COMPLETED|Overall Study||16
8933918|NCT02320903|9995431|FG000|NOT COMPLETED|Overall Study||8
8933919|NCT02320903|9995432|FG001|NOT COMPLETED|Overall Study||16
8933920|NCT02320903|9995433|FG002|NOT COMPLETED|Overall Study||16
8933921|NCT02321098|9995445|FG000|STARTED|12 Weeks Treament||26
8933922|NCT02321098|9995446|FG001|STARTED|12 Weeks Treament||24
8933923|NCT02321098|9995447|FG002|STARTED|12 Weeks Treament||0
8933924|NCT02321098|9995445|FG000|COMPLETED|12 Weeks Treament||25
8933925|NCT02321098|9995446|FG001|COMPLETED|12 Weeks Treament||23
8933926|NCT02321098|9995447|FG002|COMPLETED|12 Weeks Treament||0
8933927|NCT02321098|9995445|FG000|NOT COMPLETED|12 Weeks Treament||1
8933928|NCT02321098|9995446|FG001|NOT COMPLETED|12 Weeks Treament||1
9064893|NCT04256785|10125218|FG001|STARTED|Overall Study||56
9064894|NCT04256785|10125217|FG000|COMPLETED|Overall Study||26
9064895|NCT04256785|10125218|FG001|COMPLETED|Overall Study||31
9064896|NCT04256785|10125217|FG000|NOT COMPLETED|Overall Study||28
9064897|NCT04256785|10125218|FG001|NOT COMPLETED|Overall Study||25
9064898|NCT04252092|10125228|FG000|STARTED|Overall Study||15
9064899|NCT04252092|10125229|FG001|STARTED|Overall Study||15
8813587|NCT01526551|9866752|FG000|NOT COMPLETED|Overall Study||424
8813588|NCT01526577|9866761|FG000|STARTED|Overall Study|1 more subject enrolled as a substitute for 1 withdrawn subject before the administration.|49
8813589|NCT01526577|9866762|FG001|STARTED|Overall Study||12
8813590|NCT01526577|9866763|FG002|STARTED|Overall Study|1 more subject enrolled as a substitute for 1 withdrawn subject before the administration.|33
8813591|NCT01526577|9866764|FG003|STARTED|Overall Study|1 more subject enrolled as a substitute for 1 withdrawn subject before the administration.|9
8813592|NCT01526577|9866765|FG004|STARTED|Overall Study|2 more subjects were enrolled as the substitutes for 2 withdrawn subjects before the administration.|10
8813593|NCT01526577|9866761|FG000|COMPLETED|Overall Study||48
8813594|NCT01526577|9866762|FG001|COMPLETED|Overall Study||12
8813595|NCT01526577|9866763|FG002|COMPLETED|Overall Study||32
8813596|NCT01526577|9866764|FG003|COMPLETED|Overall Study||8
8813597|NCT01526577|9866765|FG004|COMPLETED|Overall Study||8
8813598|NCT01526577|9866761|FG000|NOT COMPLETED|Overall Study||1
8813599|NCT01526577|9866762|FG001|NOT COMPLETED|Overall Study||0
8813600|NCT01526577|9866763|FG002|NOT COMPLETED|Overall Study||1
8813601|NCT01526577|9866764|FG003|NOT COMPLETED|Overall Study||1
8813602|NCT01526577|9866765|FG004|NOT COMPLETED|Overall Study||2
8813603|NCT01526629|9866773|FG000|STARTED|Overall Study||354
8813604|NCT01526629|9866773|FG000|COMPLETED|Overall Study||308
8813605|NCT01526629|9866773|FG000|NOT COMPLETED|Overall Study||46
8813606|NCT01526733|9866777|FG000|STARTED|Phase 1||12
8813607|NCT01526733|9866778|FG001|STARTED|Phase 1|One participant discontinued after receiving insulin-sham and before receiving insulin-rHuPH20.|13
9064900|NCT04252092|10125228|FG000|COMPLETED|Overall Study||15
9064901|NCT04252092|10125229|FG001|COMPLETED|Overall Study||15
8813608|NCT01526733|9866777|FG000|Received at Least 1 Dose of Study Drug|Phase 1||12
8813609|NCT01526733|9866778|FG001|Received at Least 1 Dose of Study Drug|Phase 1||13
8933929|NCT02321098|9995447|FG002|NOT COMPLETED|12 Weeks Treament||0
8933930|NCT02321098|9995445|FG000|STARTED|Additional 15 Months Treatment||0
8933931|NCT02321098|9995446|FG001|STARTED|Additional 15 Months Treatment||0
8933932|NCT02321098|9995447|FG002|STARTED|Additional 15 Months Treatment||29
8933933|NCT02321098|9995445|FG000|COMPLETED|Additional 15 Months Treatment||0
8933934|NCT02321098|9995446|FG001|COMPLETED|Additional 15 Months Treatment||0
8933935|NCT02321098|9995447|FG002|COMPLETED|Additional 15 Months Treatment||21
8933936|NCT02321098|9995445|FG000|NOT COMPLETED|Additional 15 Months Treatment||0
8933937|NCT02321098|9995446|FG001|NOT COMPLETED|Additional 15 Months Treatment||0
9064902|NCT04252092|10125228|FG000|NOT COMPLETED|Overall Study||0
8933938|NCT02321098|9995447|FG002|NOT COMPLETED|Additional 15 Months Treatment||8
8933939|NCT02321111|9995456|FG000|STARTED|Infusion1||1
8933940|NCT02321111|9995457|FG001|STARTED|Infusion1||4
8933941|NCT02321111|9995458|FG002|STARTED|Infusion1||4
8933942|NCT02321111|9995459|FG003|STARTED|Infusion1||1
8933943|NCT02321111|9995460|FG004|STARTED|Infusion1||0
8933944|NCT02321111|9995461|FG005|STARTED|Infusion1||0
8933945|NCT02321111|9995456|FG000|COMPLETED|Infusion1||1
8933946|NCT02321111|9995457|FG001|COMPLETED|Infusion1||4
8933947|NCT02321111|9995458|FG002|COMPLETED|Infusion1||4
8933948|NCT02321111|9995459|FG003|COMPLETED|Infusion1||1
8933949|NCT02321111|9995460|FG004|COMPLETED|Infusion1||0
8933950|NCT02321111|9995461|FG005|COMPLETED|Infusion1||0
8933951|NCT02321111|9995456|FG000|NOT COMPLETED|Infusion1||0
8933952|NCT02321111|9995457|FG001|NOT COMPLETED|Infusion1||0
8933953|NCT02321111|9995458|FG002|NOT COMPLETED|Infusion1||0
8933954|NCT02321111|9995459|FG003|NOT COMPLETED|Infusion1||0
8933955|NCT02321111|9995460|FG004|NOT COMPLETED|Infusion1||0
8933956|NCT02321111|9995461|FG005|NOT COMPLETED|Infusion1||0
8933957|NCT02321111|9995456|FG000|STARTED|Washout1 (3-4weeks Between Infusions)||1
8933958|NCT02321111|9995457|FG001|STARTED|Washout1 (3-4weeks Between Infusions)||4
8933959|NCT02321111|9995458|FG002|STARTED|Washout1 (3-4weeks Between Infusions)||4
8717974|NCT00996892|9765233|FG019|STARTED|Dose-Escalation Stage 1A||0
8717975|NCT00996892|9765214|FG000|COMPLETED|Dose-Escalation Stage 1A||0
8717976|NCT00996892|9765215|FG001|COMPLETED|Dose-Escalation Stage 1A||0
8717977|NCT00996892|9765216|FG002|COMPLETED|Dose-Escalation Stage 1A||0
8717978|NCT00996892|9765217|FG003|COMPLETED|Dose-Escalation Stage 1A||0
8933960|NCT02321111|9995459|FG003|STARTED|Washout1 (3-4weeks Between Infusions)||1
8933961|NCT02321111|9995460|FG004|STARTED|Washout1 (3-4weeks Between Infusions)||0
8933962|NCT02321111|9995461|FG005|STARTED|Washout1 (3-4weeks Between Infusions)||0
8933963|NCT02321111|9995456|FG000|COMPLETED|Washout1 (3-4weeks Between Infusions)||1
8933964|NCT02321111|9995457|FG001|COMPLETED|Washout1 (3-4weeks Between Infusions)||4
8933965|NCT02321111|9995458|FG002|COMPLETED|Washout1 (3-4weeks Between Infusions)||4
8933966|NCT02321111|9995459|FG003|COMPLETED|Washout1 (3-4weeks Between Infusions)||1
8933967|NCT02321111|9995460|FG004|COMPLETED|Washout1 (3-4weeks Between Infusions)||0
8933968|NCT02321111|9995461|FG005|COMPLETED|Washout1 (3-4weeks Between Infusions)||0
8933969|NCT02321111|9995456|FG000|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
9064903|NCT04252092|10125229|FG001|NOT COMPLETED|Overall Study||0
9064904|NCT04250987|10125235|FG000|STARTED|Overall Study||12
9064905|NCT04250987|10125235|FG000|COMPLETED|Overall Study||12
9064906|NCT04250987|10125235|FG000|NOT COMPLETED|Overall Study||0
9064907|NCT04249336|10125243|FG000|STARTED|Overall Study||35
9064908|NCT04249336|10125244|FG001|STARTED|Overall Study||35
9064909|NCT04249336|10125245|FG002|STARTED|Overall Study||35
9064910|NCT04249336|10125246|FG003|STARTED|Overall Study||35
9064911|NCT04249336|10125243|FG000|Per Protocol Population Day 3|Overall Study||32
9064912|NCT04249336|10125244|FG001|Per Protocol Population Day 3|Overall Study||32
9064913|NCT04249336|10125245|FG002|Per Protocol Population Day 3|Overall Study||32
9064914|NCT04249336|10125246|FG003|Per Protocol Population Day 3|Overall Study||32
9064915|NCT04249336|10125243|FG000|Per Protocol Population Week 4|Overall Study||33
9064916|NCT04249336|10125244|FG001|Per Protocol Population Week 4|Overall Study||35
9064917|NCT04249336|10125245|FG002|Per Protocol Population Week 4|Overall Study||33
9064918|NCT04249336|10125246|FG003|Per Protocol Population Week 4|Overall Study||34
9064919|NCT04249336|10125243|FG000|COMPLETED|Overall Study||32
9064920|NCT04249336|10125244|FG001|COMPLETED|Overall Study||32
9064921|NCT04249336|10125245|FG002|COMPLETED|Overall Study||32
9064922|NCT04249336|10125246|FG003|COMPLETED|Overall Study||32
9064923|NCT04249336|10125243|FG000|NOT COMPLETED|Overall Study||3
9064924|NCT04249336|10125244|FG001|NOT COMPLETED|Overall Study||3
9064925|NCT04249336|10125245|FG002|NOT COMPLETED|Overall Study||3
9064926|NCT04249336|10125246|FG003|NOT COMPLETED|Overall Study||3
9064927|NCT04249310|10125258|FG000|STARTED|Overall Study||1436
9064928|NCT04249310|10125259|FG001|STARTED|Overall Study||5352
9064929|NCT04249310|10125258|FG000|PS-matched Cohort|Overall Study||1412
9064930|NCT04249310|10125259|FG001|PS-matched Cohort|Overall Study||1412
9064931|NCT04249310|10125258|FG000|hdPS-matched Cohort|Overall Study||1302
9064932|NCT04249310|10125259|FG001|hdPS-matched Cohort|Overall Study||1302
9064933|NCT04249310|10125258|FG000|COMPLETED|Overall Study||1436
9064934|NCT04249310|10125259|FG001|COMPLETED|Overall Study||5352
9064935|NCT04249310|10125258|FG000|NOT COMPLETED|Overall Study||0
9064936|NCT04249310|10125259|FG001|NOT COMPLETED|Overall Study||0
9064937|NCT04247581|10125267|FG000|STARTED|Overall Study||241
9064938|NCT04247581|10125268|FG001|STARTED|Overall Study||305
9064939|NCT04247581|10125267|FG000|COMPLETED|Overall Study||241
9064940|NCT04247581|10125268|FG001|COMPLETED|Overall Study||293
9064941|NCT04247581|10125267|FG000|NOT COMPLETED|Overall Study||0
8717979|NCT00996892|9765218|FG004|COMPLETED|Dose-Escalation Stage 1A||0
8933970|NCT02321111|9995457|FG001|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
9064942|NCT04247581|10125268|FG001|NOT COMPLETED|Overall Study||12
9064943|NCT04247061|10125274|FG000|STARTED|Overall Study|13 Subjects completed the required pre-dental appointment study activities and were scheduled to attend the dental clinic|13
9064944|NCT04247061|10125274|FG000|COMPLETED|Overall Study||4
9064945|NCT04247061|10125274|FG000|NOT COMPLETED|Overall Study||9
8933971|NCT02321111|9995458|FG002|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
8933972|NCT02321111|9995459|FG003|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
8933973|NCT02321111|9995460|FG004|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
8933974|NCT02321111|9995461|FG005|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
8933975|NCT02321111|9995456|FG000|STARTED|Infusion2||1
8933976|NCT02321111|9995457|FG001|STARTED|Infusion2||4
8933977|NCT02321111|9995458|FG002|STARTED|Infusion2||4
8933978|NCT02321111|9995459|FG003|STARTED|Infusion2||1
8933979|NCT02321111|9995460|FG004|STARTED|Infusion2||0
8933980|NCT02321111|9995461|FG005|STARTED|Infusion2||0
8933981|NCT02321111|9995456|FG000|COMPLETED|Infusion2||1
8933982|NCT02321111|9995457|FG001|COMPLETED|Infusion2||4
8933983|NCT02321111|9995458|FG002|COMPLETED|Infusion2||4
8933984|NCT02321111|9995459|FG003|COMPLETED|Infusion2||1
8933985|NCT02321111|9995460|FG004|COMPLETED|Infusion2||0
8933986|NCT02321111|9995461|FG005|COMPLETED|Infusion2||0
8933987|NCT02321111|9995456|FG000|NOT COMPLETED|Infusion2||0
8933988|NCT02321111|9995457|FG001|NOT COMPLETED|Infusion2||0
8933989|NCT02321111|9995458|FG002|NOT COMPLETED|Infusion2||0
8933990|NCT02321111|9995459|FG003|NOT COMPLETED|Infusion2||0
8933991|NCT02321111|9995460|FG004|NOT COMPLETED|Infusion2||0
8933992|NCT02321111|9995461|FG005|NOT COMPLETED|Infusion2||0
8933993|NCT02321111|9995456|FG000|STARTED|Washout2 (3-4weeks Between Infusions)||1
8933994|NCT02321111|9995457|FG001|STARTED|Washout2 (3-4weeks Between Infusions)||4
8933995|NCT02321111|9995458|FG002|STARTED|Washout2 (3-4weeks Between Infusions)||4
8933996|NCT02321111|9995459|FG003|STARTED|Washout2 (3-4weeks Between Infusions)||1
8933997|NCT02321111|9995460|FG004|STARTED|Washout2 (3-4weeks Between Infusions)||0
8933998|NCT02321111|9995461|FG005|STARTED|Washout2 (3-4weeks Between Infusions)||0
8933999|NCT02321111|9995456|FG000|COMPLETED|Washout2 (3-4weeks Between Infusions)||1
8934000|NCT02321111|9995457|FG001|COMPLETED|Washout2 (3-4weeks Between Infusions)||4
8934001|NCT02321111|9995458|FG002|COMPLETED|Washout2 (3-4weeks Between Infusions)||4
8934002|NCT02321111|9995459|FG003|COMPLETED|Washout2 (3-4weeks Between Infusions)||1
8934003|NCT02321111|9995460|FG004|COMPLETED|Washout2 (3-4weeks Between Infusions)||0
8934004|NCT02321111|9995461|FG005|COMPLETED|Washout2 (3-4weeks Between Infusions)||0
8934005|NCT02321111|9995456|FG000|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
8934006|NCT02321111|9995457|FG001|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
8934007|NCT02321111|9995458|FG002|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
8934008|NCT02321111|9995459|FG003|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
8934009|NCT02321111|9995460|FG004|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
8934010|NCT02321111|9995461|FG005|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
8934011|NCT02321111|9995456|FG000|STARTED|Infusion3||1
8934012|NCT02321111|9995457|FG001|STARTED|Infusion3||4
8934013|NCT02321111|9995458|FG002|STARTED|Infusion3||4
8934014|NCT02321111|9995459|FG003|STARTED|Infusion3||1
8934015|NCT02321111|9995460|FG004|STARTED|Infusion3||0
8934016|NCT02321111|9995461|FG005|STARTED|Infusion3||0
8934017|NCT02321111|9995456|FG000|COMPLETED|Infusion3||1
8934018|NCT02321111|9995457|FG001|COMPLETED|Infusion3||4
8934019|NCT02321111|9995458|FG002|COMPLETED|Infusion3||4
8934020|NCT02321111|9995459|FG003|COMPLETED|Infusion3||1
8934021|NCT02321111|9995460|FG004|COMPLETED|Infusion3||0
8934022|NCT02321111|9995461|FG005|COMPLETED|Infusion3||0
8934023|NCT02321111|9995456|FG000|NOT COMPLETED|Infusion3||0
8934024|NCT02321111|9995457|FG001|NOT COMPLETED|Infusion3||0
8934025|NCT02321111|9995458|FG002|NOT COMPLETED|Infusion3||0
8934026|NCT02321111|9995459|FG003|NOT COMPLETED|Infusion3||0
8934027|NCT02321111|9995460|FG004|NOT COMPLETED|Infusion3||0
8934028|NCT02321111|9995461|FG005|NOT COMPLETED|Infusion3||0
8934029|NCT02321319|9995469|FG000|STARTED|Overall Study||5
8934030|NCT02321319|9995469|FG000|COMPLETED|Overall Study||0
8934031|NCT02321319|9995469|FG000|NOT COMPLETED|Overall Study||5
8934032|NCT02321436|9995475|FG000|STARTED|Overall Study||28
8934033|NCT02321436|9995476|FG001|STARTED|Overall Study||14
8934034|NCT02321436|9995475|FG000|COMPLETED|Overall Study||27
8934035|NCT02321436|9995476|FG001|COMPLETED|Overall Study||13
8934036|NCT02321436|9995475|FG000|NOT COMPLETED|Overall Study||1
8934037|NCT02321436|9995476|FG001|NOT COMPLETED|Overall Study||1
8934038|NCT02321462|9995485|FG000|STARTED|Overall Study||147
8934039|NCT02321462|9995486|FG001|STARTED|Overall Study||149
8934040|NCT02321462|9995485|FG000|ITT Population|Overall Study||146
8934041|NCT02321462|9995486|FG001|ITT Population|Overall Study||148
8934042|NCT02321462|9995485|FG000|Treated Patients|Overall Study||147
8934043|NCT02321462|9995486|FG001|Treated Patients|Overall Study||147
8934044|NCT02321462|9995485|FG000|Safety Population|Overall Study||147
8934045|NCT02321462|9995486|FG001|Safety Population|Overall Study||147
8934046|NCT02321462|9995485|FG000|COMPLETED|Overall Study||141
8934047|NCT02321462|9995486|FG001|COMPLETED|Overall Study||146
8934048|NCT02321462|9995485|FG000|NOT COMPLETED|Overall Study||6
8934049|NCT02321462|9995486|FG001|NOT COMPLETED|Overall Study||3
8934050|NCT02321527|9995493|FG000|STARTED|Overall Study||21
8934051|NCT02321527|9995493|FG000|COMPLETED|Overall Study||20
8934052|NCT02321527|9995493|FG000|NOT COMPLETED|Overall Study||1
8934053|NCT02321748|9995499|FG000|STARTED|Overall Study||12
8934054|NCT02321748|9995500|FG001|STARTED|Overall Study||12
8934055|NCT02321748|9995499|FG000|First Intervention (4 Days)|Overall Study||12
8934056|NCT02321748|9995500|FG001|First Intervention (4 Days)|Overall Study||12
8934057|NCT02321748|9995499|FG000|Wasout (2weeks)|Overall Study||12
8934058|NCT02321748|9995500|FG001|Wasout (2weeks)|Overall Study||12
8934059|NCT02321748|9995499|FG000|Second Intervention (4 Days)|Overall Study||12
8934060|NCT02321748|9995500|FG001|Second Intervention (4 Days)|Overall Study||12
8934061|NCT02321748|9995499|FG000|COMPLETED|Overall Study||12
8934062|NCT02321748|9995500|FG001|COMPLETED|Overall Study||12
8934063|NCT02321748|9995499|FG000|NOT COMPLETED|Overall Study||0
8934064|NCT02321748|9995500|FG001|NOT COMPLETED|Overall Study||0
8934065|NCT02321800|9995511|FG000|STARTED|Overall Study||303
8934066|NCT02321800|9995512|FG001|STARTED|Overall Study||149
8934067|NCT02321800|9995511|FG000|Received Study Drug|Overall Study||300
8934068|NCT02321800|9995512|FG001|Received Study Drug|Overall Study||148
8934069|NCT02321800|9995511|FG000|COMPLETED|Overall Study||283
8934070|NCT02321800|9995512|FG001|COMPLETED|Overall Study||138
8934071|NCT02321800|9995511|FG000|NOT COMPLETED|Overall Study||20
8934072|NCT02321800|9995512|FG001|NOT COMPLETED|Overall Study||11
8934073|NCT02321930|9995518|FG000|STARTED|Overall Study||25
8934074|NCT02321930|9995518|FG000|COMPLETED|Overall Study||24
8934075|NCT02321930|9995518|FG000|NOT COMPLETED|Overall Study||1
8934076|NCT02322021|9995526|FG000|STARTED|Core Phase||17
8934077|NCT02322021|9995527|FG001|STARTED|Core Phase||17
8934078|NCT02322021|9995528|FG002|STARTED|Core Phase||19
8934079|NCT02322021|9995529|FG003|STARTED|Core Phase||17
8934080|NCT02322021|9995530|FG004|STARTED|Core Phase||0
8934081|NCT02322021|9995526|FG000|COMPLETED|Core Phase||12
8934082|NCT02322021|9995527|FG001|COMPLETED|Core Phase||9
8934083|NCT02322021|9995528|FG002|COMPLETED|Core Phase||10
8934084|NCT02322021|9995529|FG003|COMPLETED|Core Phase||12
8934085|NCT02322021|9995530|FG004|COMPLETED|Core Phase||0
8934086|NCT02322021|9995526|FG000|NOT COMPLETED|Core Phase||5
8934087|NCT02322021|9995527|FG001|NOT COMPLETED|Core Phase||8
8934088|NCT02322021|9995528|FG002|NOT COMPLETED|Core Phase||9
8934089|NCT02322021|9995529|FG003|NOT COMPLETED|Core Phase||5
8934090|NCT02322021|9995530|FG004|NOT COMPLETED|Core Phase||0
8934091|NCT02322021|9995526|FG000|STARTED|Extension Phase||0
8934092|NCT02322021|9995527|FG001|STARTED|Extension Phase||0
8934093|NCT02322021|9995528|FG002|STARTED|Extension Phase||0
8934094|NCT02322021|9995529|FG003|STARTED|Extension Phase||0
8934095|NCT02322021|9995530|FG004|STARTED|Extension Phase|Participants who completed Core Phase, were eligible and gave consent, entered Extension Phase.|41
8934096|NCT02322021|9995526|FG000|COMPLETED|Extension Phase||0
8934097|NCT02322021|9995527|FG001|COMPLETED|Extension Phase||0
8934098|NCT02322021|9995528|FG002|COMPLETED|Extension Phase||0
8934099|NCT02322021|9995529|FG003|COMPLETED|Extension Phase||0
8934100|NCT02322021|9995530|FG004|COMPLETED|Extension Phase||0
8934101|NCT02322021|9995526|FG000|NOT COMPLETED|Extension Phase||0
8934102|NCT02322021|9995527|FG001|NOT COMPLETED|Extension Phase||0
8934103|NCT02322021|9995528|FG002|NOT COMPLETED|Extension Phase||0
8934104|NCT02322021|9995529|FG003|NOT COMPLETED|Extension Phase||0
8934105|NCT02322021|9995530|FG004|NOT COMPLETED|Extension Phase||41
8934106|NCT02322047|9995549|FG000|STARTED|Overall Study||8
8934107|NCT02322047|9995550|FG001|STARTED|Overall Study||7
8934108|NCT02322047|9995551|FG002|STARTED|Overall Study||7
8934109|NCT02322047|9995552|FG003|STARTED|Overall Study||9
8934110|NCT02322047|9995549|FG000|COMPLETED|Overall Study||6
8934111|NCT02322047|9995550|FG001|COMPLETED|Overall Study||6
8934112|NCT02322047|9995551|FG002|COMPLETED|Overall Study||6
8934113|NCT02322047|9995552|FG003|COMPLETED|Overall Study||7
8934114|NCT02322047|9995549|FG000|NOT COMPLETED|Overall Study||2
8934115|NCT02322047|9995550|FG001|NOT COMPLETED|Overall Study||1
8934116|NCT02322047|9995551|FG002|NOT COMPLETED|Overall Study||1
8934117|NCT02322047|9995552|FG003|NOT COMPLETED|Overall Study||2
8934118|NCT02322125|9995562|FG000|STARTED|Overall Study||12
8934119|NCT02322125|9995562|FG000|COMPLETED|Overall Study||10
8934120|NCT02322125|9995562|FG000|NOT COMPLETED|Overall Study||2
8934121|NCT02322190|9995566|FG000|STARTED|Overall Study||5
8934122|NCT02322190|9995567|FG001|STARTED|Overall Study||0
8934123|NCT02322190|9995566|FG000|COMPLETED|Overall Study||4
8934124|NCT02322190|9995567|FG001|COMPLETED|Overall Study||0
8934125|NCT02322190|9995566|FG000|NOT COMPLETED|Overall Study||1
8934126|NCT02322190|9995567|FG001|NOT COMPLETED|Overall Study||0
8934127|NCT02322216|9995574|FG000|STARTED|Overall Study||126
8934128|NCT02322216|9995575|FG001|STARTED|Overall Study||127
8934129|NCT02322216|9995574|FG000|Treated (Safety Set)|Overall Study||126
8934130|NCT02322216|9995575|FG001|Treated (Safety Set)|Overall Study||126
8934131|NCT02322216|9995574|FG000|Per Protocol Set (PPS)|Overall Study||123
8934132|NCT02322216|9995575|FG001|Per Protocol Set (PPS)|Overall Study||122
8934133|NCT02322216|9995574|FG000|COMPLETED|Overall Study||124
8934134|NCT02322216|9995575|FG001|COMPLETED|Overall Study||123
8934135|NCT02322216|9995574|FG000|NOT COMPLETED|Overall Study||2
8934136|NCT02322216|9995575|FG001|NOT COMPLETED|Overall Study||4
8934137|NCT02322229|9995582|FG000|STARTED|Overall Study||52
8934138|NCT02322229|9995582|FG000|COMPLETED|Overall Study||50
8934139|NCT02322229|9995582|FG000|NOT COMPLETED|Overall Study||2
8934140|NCT02322242|9995589|FG000|STARTED|Overall Study||92
8934141|NCT02322242|9995590|FG001|STARTED|Overall Study||90
8934142|NCT02322242|9995589|FG000|Primary Outcome|Overall Study||92
8934143|NCT02322242|9995590|FG001|Primary Outcome|Overall Study||90
8934144|NCT02322242|9995589|FG000|1 Week Follow-up|Overall Study|2 lost to follow-up for secondary outcomes|90
8934145|NCT02322242|9995590|FG001|1 Week Follow-up|Overall Study|1 lost to follow-up for secondary outcomes|89
8934146|NCT02322242|9995589|FG000|COMPLETED|Overall Study||92
8934147|NCT02322242|9995590|FG001|COMPLETED|Overall Study||90
8934148|NCT02322242|9995589|FG000|NOT COMPLETED|Overall Study||0
8934149|NCT02322242|9995590|FG001|NOT COMPLETED|Overall Study||0
8934150|NCT02322281|9995599|FG000|STARTED|Overall Study||53
8934151|NCT02322281|9995600|FG001|STARTED|Overall Study||22
8934152|NCT02322281|9995601|FG002|STARTED|Overall Study||74
8934153|NCT02322281|9995599|FG000|Crossed Over to Rociletinib 500 mg BID|Overall Study||0
8934154|NCT02322281|9995600|FG001|Crossed Over to Rociletinib 500 mg BID|Overall Study||0
8934155|NCT02322281|9995601|FG002|Crossed Over to Rociletinib 500 mg BID|Overall Study||36
8934156|NCT02322281|9995599|FG000|Crossed Over to Rociletinib 625 mg BID|Overall Study||0
8934157|NCT02322281|9995600|FG001|Crossed Over to Rociletinib 625 mg BID|Overall Study||0
8934158|NCT02322281|9995601|FG002|Crossed Over to Rociletinib 625 mg BID|Overall Study||3
8934159|NCT02322281|9995599|FG000|COMPLETED|Overall Study|Patients who are off study for any reason.|0
8617236|NCT00455520|9655411|FG001|STARTED|Double Blind Tapentadol ER vs Placebo|1 subject enrolled two separate times in this study, 2 subjects did not receive study medication|193
8617237|NCT00455520|9655410|FG000|COMPLETED|Double Blind Tapentadol ER vs Placebo||133
8617238|NCT00455520|9655411|FG001|COMPLETED|Double Blind Tapentadol ER vs Placebo||131
8617239|NCT00455520|9655410|FG000|NOT COMPLETED|Double Blind Tapentadol ER vs Placebo||63
8617240|NCT00455520|9655411|FG001|NOT COMPLETED|Double Blind Tapentadol ER vs Placebo||62
8617241|NCT00455533|9655419|FG000|STARTED|Period One: Initial Chemotherapy||313
8617242|NCT00455533|9655420|FG001|STARTED|Period One: Initial Chemotherapy||0
8617243|NCT00455533|9655421|FG002|STARTED|Period One: Initial Chemotherapy||0
8934160|NCT02322281|9995600|FG001|COMPLETED|Overall Study|Patients who are off study for any reason.|0
8934161|NCT02322281|9995601|FG002|COMPLETED|Overall Study|Patients who are off study for any reason.|0
8934162|NCT02322281|9995599|FG000|NOT COMPLETED|Overall Study||53
8934163|NCT02322281|9995600|FG001|NOT COMPLETED|Overall Study||22
8934164|NCT02322281|9995601|FG002|NOT COMPLETED|Overall Study||74
8934165|NCT02322320|9995614|FG000|STARTED|Overall Study||98
8934166|NCT02322320|9995615|FG001|STARTED|Overall Study||86
8934167|NCT02322320|9995616|FG002|STARTED|Overall Study||89
8934168|NCT02322320|9995614|FG000|COMPLETED|Overall Study||98
8934169|NCT02322320|9995615|FG001|COMPLETED|Overall Study||86
8934170|NCT02322320|9995616|FG002|COMPLETED|Overall Study||89
8934171|NCT02322320|9995614|FG000|NOT COMPLETED|Overall Study||0
8934172|NCT02322320|9995615|FG001|NOT COMPLETED|Overall Study||0
8934173|NCT02322320|9995616|FG002|NOT COMPLETED|Overall Study||0
8934174|NCT02322333|9995626|FG000|STARTED|Overall Study||80
8934175|NCT02322333|9995627|FG001|STARTED|Overall Study||77
8934176|NCT02322333|9995626|FG000|COMPLETED|Overall Study||63
8934177|NCT02322333|9995627|FG001|COMPLETED|Overall Study||61
8934178|NCT02322333|9995626|FG000|NOT COMPLETED|Overall Study||17
8934179|NCT02322333|9995627|FG001|NOT COMPLETED|Overall Study||16
8934180|NCT02322411|9995635|FG000|STARTED|Overall Study||14
8934181|NCT02322411|9995636|FG001|STARTED|Overall Study||16
8934182|NCT02322411|9995635|FG000|Randomized|Overall Study||14
8934183|NCT02322411|9995636|FG001|Randomized|Overall Study||16
8934184|NCT02322411|9995635|FG000|All Baseline Measures Analyzed|Overall Study||13
8934185|NCT02322411|9995636|FG001|All Baseline Measures Analyzed|Overall Study||16
8934186|NCT02322411|9995635|FG000|COMPLETED|Overall Study||9
8934187|NCT02322411|9995636|FG001|COMPLETED|Overall Study||9
8934188|NCT02322411|9995635|FG000|NOT COMPLETED|Overall Study||5
8934189|NCT02322411|9995636|FG001|NOT COMPLETED|Overall Study||7
8934190|NCT02322528|9995642|FG000|STARTED|Overall Study||10
8934191|NCT02322528|9995642|FG000|COMPLETED|Overall Study||10
8934192|NCT02322528|9995642|FG000|NOT COMPLETED|Overall Study||0
8934193|NCT02322749|9995646|FG000|STARTED|Period 1||8
8934194|NCT02322749|9995647|FG001|STARTED|Period 1||8
8934195|NCT02322749|9995648|FG002|STARTED|Period 1||8
8934196|NCT02322749|9995649|FG003|STARTED|Period 1||8
8934197|NCT02322749|9995650|FG004|STARTED|Period 1||8
8934198|NCT02322749|9995651|FG005|STARTED|Period 1||8
8934199|NCT02322749|9995646|FG000|COMPLETED|Period 1||8
8934200|NCT02322749|9995647|FG001|COMPLETED|Period 1||8
8934201|NCT02322749|9995648|FG002|COMPLETED|Period 1||8
8934202|NCT02322749|9995649|FG003|COMPLETED|Period 1||8
8934203|NCT02322749|9995650|FG004|COMPLETED|Period 1||8
8934204|NCT02322749|9995651|FG005|COMPLETED|Period 1||8
8934205|NCT02322749|9995646|FG000|NOT COMPLETED|Period 1||0
8934206|NCT02322749|9995647|FG001|NOT COMPLETED|Period 1||0
8934207|NCT02322749|9995648|FG002|NOT COMPLETED|Period 1||0
8934208|NCT02322749|9995649|FG003|NOT COMPLETED|Period 1||0
8934209|NCT02322749|9995650|FG004|NOT COMPLETED|Period 1||0
8934210|NCT02322749|9995651|FG005|NOT COMPLETED|Period 1||0
8934211|NCT02322749|9995646|FG000|STARTED|Period 2||8
8934212|NCT02322749|9995647|FG001|STARTED|Period 2||8
8934213|NCT02322749|9995648|FG002|STARTED|Period 2||8
8934214|NCT02322749|9995649|FG003|STARTED|Period 2||8
8934215|NCT02322749|9995650|FG004|STARTED|Period 2||8
8934216|NCT02322749|9995651|FG005|STARTED|Period 2||8
8934217|NCT02322749|9995646|FG000|COMPLETED|Period 2||8
8934218|NCT02322749|9995647|FG001|COMPLETED|Period 2||8
8934219|NCT02322749|9995648|FG002|COMPLETED|Period 2||8
8934220|NCT02322749|9995649|FG003|COMPLETED|Period 2||6
8934221|NCT02322749|9995650|FG004|COMPLETED|Period 2||8
8934222|NCT02322749|9995651|FG005|COMPLETED|Period 2||8
8934223|NCT02322749|9995646|FG000|NOT COMPLETED|Period 2||0
8934224|NCT02322749|9995647|FG001|NOT COMPLETED|Period 2||0
8934225|NCT02322749|9995648|FG002|NOT COMPLETED|Period 2||0
8934226|NCT02322749|9995649|FG003|NOT COMPLETED|Period 2||2
8934227|NCT02322749|9995650|FG004|NOT COMPLETED|Period 2||0
8934228|NCT02322749|9995651|FG005|NOT COMPLETED|Period 2||0
8934229|NCT02322749|9995646|FG000|STARTED|Period 3||8
8934230|NCT02322749|9995647|FG001|STARTED|Period 3||8
8934231|NCT02322749|9995648|FG002|STARTED|Period 3||8
8934232|NCT02322749|9995649|FG003|STARTED|Period 3||6
8934233|NCT02322749|9995650|FG004|STARTED|Period 3||8
8934234|NCT02322749|9995651|FG005|STARTED|Period 3||8
8934235|NCT02322749|9995646|FG000|COMPLETED|Period 3||8
8934236|NCT02322749|9995647|FG001|COMPLETED|Period 3||8
8934237|NCT02322749|9995648|FG002|COMPLETED|Period 3||7
8934238|NCT02322749|9995649|FG003|COMPLETED|Period 3||6
8934239|NCT02322749|9995650|FG004|COMPLETED|Period 3||8
8934240|NCT02322749|9995651|FG005|COMPLETED|Period 3||8
8934241|NCT02322749|9995646|FG000|NOT COMPLETED|Period 3||0
8934242|NCT02322749|9995647|FG001|NOT COMPLETED|Period 3||0
8934243|NCT02322749|9995648|FG002|NOT COMPLETED|Period 3||1
8934244|NCT02322749|9995649|FG003|NOT COMPLETED|Period 3||0
8934245|NCT02322749|9995650|FG004|NOT COMPLETED|Period 3||0
8934246|NCT02322749|9995651|FG005|NOT COMPLETED|Period 3||0
8934247|NCT02322775|9995662|FG000|STARTED|Overall Study||106
8934248|NCT02322775|9995663|FG001|STARTED|Overall Study||105
8934249|NCT02322775|9995662|FG000|COMPLETED|Overall Study||101
8934250|NCT02322775|9995663|FG001|COMPLETED|Overall Study||99
8934251|NCT02322775|9995662|FG000|NOT COMPLETED|Overall Study||5
8934252|NCT02322775|9995663|FG001|NOT COMPLETED|Overall Study||6
8934253|NCT02322788|9995669|FG000|STARTED|Visit 3||15
8934254|NCT02322788|9995670|FG001|STARTED|Visit 3||15
8934255|NCT02322788|9995671|FG002|STARTED|Visit 3||14
8934256|NCT02322788|9995672|FG003|STARTED|Visit 3||16
8934257|NCT02322788|9995669|FG000|COMPLETED|Visit 3||15
8934258|NCT02322788|9995670|FG001|COMPLETED|Visit 3||15
8934259|NCT02322788|9995671|FG002|COMPLETED|Visit 3||14
8934260|NCT02322788|9995672|FG003|COMPLETED|Visit 3||16
8934261|NCT02322788|9995669|FG000|NOT COMPLETED|Visit 3||0
8934262|NCT02322788|9995670|FG001|NOT COMPLETED|Visit 3||0
8934263|NCT02322788|9995671|FG002|NOT COMPLETED|Visit 3||0
8934264|NCT02322788|9995672|FG003|NOT COMPLETED|Visit 3||0
8934265|NCT02322788|9995669|FG000|STARTED|Visit 4||15
8934266|NCT02322788|9995670|FG001|STARTED|Visit 4||14
8934267|NCT02322788|9995671|FG002|STARTED|Visit 4||16
8934268|NCT02322788|9995672|FG003|STARTED|Visit 4||15
8934269|NCT02322788|9995669|FG000|COMPLETED|Visit 4||15
8934270|NCT02322788|9995670|FG001|COMPLETED|Visit 4||14
8934271|NCT02322788|9995671|FG002|COMPLETED|Visit 4||16
8934272|NCT02322788|9995672|FG003|COMPLETED|Visit 4||15
8934273|NCT02322788|9995669|FG000|NOT COMPLETED|Visit 4||0
8934274|NCT02322788|9995670|FG001|NOT COMPLETED|Visit 4||0
8934275|NCT02322788|9995671|FG002|NOT COMPLETED|Visit 4||0
8934276|NCT02322788|9995672|FG003|NOT COMPLETED|Visit 4||0
8934277|NCT02322788|9995669|FG000|STARTED|Visit 5||16
8934278|NCT02322788|9995670|FG001|STARTED|Visit 5||15
8934279|NCT02322788|9995671|FG002|STARTED|Visit 5||15
8934280|NCT02322788|9995672|FG003|STARTED|Visit 5||14
8934281|NCT02322788|9995669|FG000|COMPLETED|Visit 5||16
8934282|NCT02322788|9995670|FG001|COMPLETED|Visit 5||15
8934283|NCT02322788|9995671|FG002|COMPLETED|Visit 5||15
8934284|NCT02322788|9995672|FG003|COMPLETED|Visit 5||14
8934285|NCT02322788|9995669|FG000|NOT COMPLETED|Visit 5||0
8934286|NCT02322788|9995670|FG001|NOT COMPLETED|Visit 5||0
8934287|NCT02322788|9995671|FG002|NOT COMPLETED|Visit 5||0
8934288|NCT02322788|9995672|FG003|NOT COMPLETED|Visit 5||0
8934289|NCT02322788|9995669|FG000|STARTED|Visit 6||14
8934290|NCT02322788|9995670|FG001|STARTED|Visit 6||16
8934291|NCT02322788|9995671|FG002|STARTED|Visit 6||15
8934292|NCT02322788|9995672|FG003|STARTED|Visit 6||15
8934293|NCT02322788|9995669|FG000|COMPLETED|Visit 6||14
8934294|NCT02322788|9995670|FG001|COMPLETED|Visit 6||16
8934295|NCT02322788|9995671|FG002|COMPLETED|Visit 6||15
8934296|NCT02322788|9995672|FG003|COMPLETED|Visit 6||15
8934297|NCT02322788|9995669|FG000|NOT COMPLETED|Visit 6||0
8934298|NCT02322788|9995670|FG001|NOT COMPLETED|Visit 6||0
8934299|NCT02322788|9995671|FG002|NOT COMPLETED|Visit 6||0
8934300|NCT02322788|9995672|FG003|NOT COMPLETED|Visit 6||0
8934301|NCT02322814|9995687|FG000|STARTED|Overall Study||16
8934302|NCT02322814|9995688|FG001|STARTED|Overall Study||43
8934303|NCT02322814|9995689|FG002|STARTED|Overall Study||47
8934304|NCT02322814|9995690|FG003|STARTED|Overall Study||32
8717980|NCT00996892|9765219|FG005|COMPLETED|Dose-Escalation Stage 1A||0
8717981|NCT00996892|9765220|FG006|COMPLETED|Dose-Escalation Stage 1A||0
8717982|NCT00996892|9765221|FG007|COMPLETED|Dose-Escalation Stage 1A||0
8934305|NCT02322814|9995691|FG004|STARTED|Overall Study||31
8934306|NCT02322814|9995687|FG000|COMPLETED|Overall Study||0
8934307|NCT02322814|9995688|FG001|COMPLETED|Overall Study||0
8934308|NCT02322814|9995689|FG002|COMPLETED|Overall Study||0
8934309|NCT02322814|9995690|FG003|COMPLETED|Overall Study||0
8934310|NCT02322814|9995691|FG004|COMPLETED|Overall Study||0
8934311|NCT02322814|9995687|FG000|NOT COMPLETED|Overall Study||16
8934312|NCT02322814|9995688|FG001|NOT COMPLETED|Overall Study||43
8934313|NCT02322814|9995689|FG002|NOT COMPLETED|Overall Study||47
8934314|NCT02322814|9995690|FG003|NOT COMPLETED|Overall Study||32
8934315|NCT02322814|9995691|FG004|NOT COMPLETED|Overall Study||31
8934316|NCT02322866|9995704|FG000|STARTED|Overall Study||515
8934317|NCT02322866|9995705|FG001|STARTED|Overall Study||519
8934318|NCT02322866|9995704|FG000|COMPLETED|Overall Study||444
8717983|NCT00996892|9765222|FG008|COMPLETED|Dose-Escalation Stage 1A||0
8934319|NCT02322866|9995705|FG001|COMPLETED|Overall Study||433
8934320|NCT02322866|9995704|FG000|NOT COMPLETED|Overall Study||71
8934321|NCT02322866|9995705|FG001|NOT COMPLETED|Overall Study||86
8934322|NCT02322879|9995713|FG000|STARTED|First Intervention||11
8934323|NCT02322879|9995714|FG001|STARTED|First Intervention||10
8934324|NCT02322879|9995713|FG000|COMPLETED|First Intervention||10
8934325|NCT02322879|9995714|FG001|COMPLETED|First Intervention||10
8934326|NCT02322879|9995713|FG000|NOT COMPLETED|First Intervention||1
8934327|NCT02322879|9995714|FG001|NOT COMPLETED|First Intervention||0
8934328|NCT02322879|9995713|FG000|STARTED|Washout||10
8934329|NCT02322879|9995714|FG001|STARTED|Washout||10
8934330|NCT02322879|9995713|FG000|COMPLETED|Washout||10
8934331|NCT02322879|9995714|FG001|COMPLETED|Washout||10
8934332|NCT02322879|9995713|FG000|NOT COMPLETED|Washout||0
8934333|NCT02322879|9995714|FG001|NOT COMPLETED|Washout||0
8934334|NCT02322879|9995713|FG000|STARTED|Second Intervention||10
8934335|NCT02322879|9995714|FG001|STARTED|Second Intervention||10
8934336|NCT02322879|9995713|FG000|COMPLETED|Second Intervention||10
8934337|NCT02322879|9995714|FG001|COMPLETED|Second Intervention||10
8934338|NCT02322879|9995713|FG000|NOT COMPLETED|Second Intervention||0
8934339|NCT02322879|9995714|FG001|NOT COMPLETED|Second Intervention||0
8934340|NCT02322892|9995722|FG000|STARTED|Overall Study|Number randomized|35
8934341|NCT02322892|9995723|FG001|STARTED|Overall Study|Number randomized|34
8934342|NCT02322892|9995722|FG000|COMPLETED|Overall Study|Received placebo|33
8934343|NCT02322892|9995723|FG001|COMPLETED|Overall Study|Received thiamine|31
8934344|NCT02322892|9995722|FG000|NOT COMPLETED|Overall Study||2
8934345|NCT02322892|9995723|FG001|NOT COMPLETED|Overall Study||3
8934346|NCT02323048|9995734|FG000|STARTED|Overall Study||25
8934347|NCT02323048|9995735|FG001|STARTED|Overall Study||26
8934348|NCT02323048|9995736|FG002|STARTED|Overall Study||23
8934349|NCT02323048|9995737|FG003|STARTED|Overall Study||7
8934350|NCT02323048|9995738|FG004|STARTED|Overall Study||9
8934351|NCT02323048|9995734|FG000|COMPLETED|Overall Study||24
8934352|NCT02323048|9995735|FG001|COMPLETED|Overall Study||24
8934353|NCT02323048|9995736|FG002|COMPLETED|Overall Study||23
8934354|NCT02323048|9995737|FG003|COMPLETED|Overall Study||7
8934355|NCT02323048|9995738|FG004|COMPLETED|Overall Study||9
8934356|NCT02323048|9995734|FG000|NOT COMPLETED|Overall Study||1
8934357|NCT02323048|9995735|FG001|NOT COMPLETED|Overall Study||2
8934358|NCT02323048|9995736|FG002|NOT COMPLETED|Overall Study||0
8934359|NCT02323048|9995737|FG003|NOT COMPLETED|Overall Study||0
8934360|NCT02323048|9995738|FG004|NOT COMPLETED|Overall Study||0
8934361|NCT02323113|9995757|FG000|STARTED|Overall Study||4
8934362|NCT02323113|9995758|FG001|STARTED|Overall Study||7
8934363|NCT02323113|9995759|FG002|STARTED|Overall Study||4
8934364|NCT02323113|9995760|FG003|STARTED|Overall Study||5
8934365|NCT02323113|9995761|FG004|STARTED|Overall Study||9
8934366|NCT02323113|9995762|FG005|STARTED|Overall Study||8
8934367|NCT02323113|9995763|FG006|STARTED|Overall Study||6
8934368|NCT02323113|9995764|FG007|STARTED|Overall Study||0
8934369|NCT02323113|9995757|FG000|COMPLETED|Overall Study||0
8934370|NCT02323113|9995758|FG001|COMPLETED|Overall Study||0
8934371|NCT02323113|9995759|FG002|COMPLETED|Overall Study||0
8934372|NCT02323113|9995760|FG003|COMPLETED|Overall Study||0
8934373|NCT02323113|9995761|FG004|COMPLETED|Overall Study||0
8934374|NCT02323113|9995762|FG005|COMPLETED|Overall Study||0
8934375|NCT02323113|9995763|FG006|COMPLETED|Overall Study||0
8934376|NCT02323113|9995764|FG007|COMPLETED|Overall Study||0
8934377|NCT02323113|9995757|FG000|NOT COMPLETED|Overall Study||4
8934378|NCT02323113|9995758|FG001|NOT COMPLETED|Overall Study||7
8934379|NCT02323113|9995759|FG002|NOT COMPLETED|Overall Study||4
8934380|NCT02323113|9995760|FG003|NOT COMPLETED|Overall Study||5
8934381|NCT02323113|9995761|FG004|NOT COMPLETED|Overall Study||9
8934382|NCT02323113|9995762|FG005|NOT COMPLETED|Overall Study||8
8934383|NCT02323113|9995763|FG006|NOT COMPLETED|Overall Study||6
8934384|NCT02323113|9995764|FG007|NOT COMPLETED|Overall Study||0
8934385|NCT02323204|9995787|FG000|STARTED|Baseline Survey Completion||155
8934386|NCT02323204|9995788|FG001|STARTED|Baseline Survey Completion||155
8934387|NCT02323204|9995789|FG002|STARTED|Baseline Survey Completion||159
8934388|NCT02323204|9995790|FG003|STARTED|Baseline Survey Completion||159
8934389|NCT02323204|9995787|FG000|COMPLETED|Baseline Survey Completion||145
8934390|NCT02323204|9995788|FG001|COMPLETED|Baseline Survey Completion||146
8934391|NCT02323204|9995789|FG002|COMPLETED|Baseline Survey Completion||154
8934392|NCT02323204|9995790|FG003|COMPLETED|Baseline Survey Completion||156
8934393|NCT02323204|9995787|FG000|NOT COMPLETED|Baseline Survey Completion||10
8934394|NCT02323204|9995788|FG001|NOT COMPLETED|Baseline Survey Completion||9
8934395|NCT02323204|9995789|FG002|NOT COMPLETED|Baseline Survey Completion||5
8934396|NCT02323204|9995790|FG003|NOT COMPLETED|Baseline Survey Completion||3
8934397|NCT02323204|9995787|FG000|STARTED|6-week Follow-up Survey Completion||145
8934398|NCT02323204|9995788|FG001|STARTED|6-week Follow-up Survey Completion||146
8934399|NCT02323204|9995789|FG002|STARTED|6-week Follow-up Survey Completion||154
8934400|NCT02323204|9995790|FG003|STARTED|6-week Follow-up Survey Completion||156
8934401|NCT02323204|9995787|FG000|COMPLETED|6-week Follow-up Survey Completion||104
8934402|NCT02323204|9995788|FG001|COMPLETED|6-week Follow-up Survey Completion||110
8934403|NCT02323204|9995789|FG002|COMPLETED|6-week Follow-up Survey Completion||112
8934404|NCT02323204|9995790|FG003|COMPLETED|6-week Follow-up Survey Completion||119
8934405|NCT02323204|9995787|FG000|NOT COMPLETED|6-week Follow-up Survey Completion||41
8934406|NCT02323204|9995788|FG001|NOT COMPLETED|6-week Follow-up Survey Completion||36
8934407|NCT02323204|9995789|FG002|NOT COMPLETED|6-week Follow-up Survey Completion||42
8934408|NCT02323204|9995790|FG003|NOT COMPLETED|6-week Follow-up Survey Completion||37
8934409|NCT02323204|9995787|FG000|STARTED|6-week Follow-up Intervention Booster|Child participants did not receive intervention booster training.|0
8934410|NCT02323204|9995788|FG001|STARTED|6-week Follow-up Intervention Booster|Received intervention-specific booster training via phone between 6-weeks and 1 year post-enrollment|146
8934411|NCT02323204|9995789|FG002|STARTED|6-week Follow-up Intervention Booster|Child participants did not receive intervention booster training.|0
8934412|NCT02323204|9995790|FG003|STARTED|6-week Follow-up Intervention Booster|Received intervention-specific booster training via phone between 6-weeks and 1 year post-enrollment|156
8717984|NCT00996892|9765223|FG009|COMPLETED|Dose-Escalation Stage 1A||0
8717985|NCT00996892|9765224|FG010|COMPLETED|Dose-Escalation Stage 1A||0
8717986|NCT00996892|9765225|FG011|COMPLETED|Dose-Escalation Stage 1A||0
8717987|NCT00996892|9765226|FG012|COMPLETED|Dose-Escalation Stage 1A||0
8717988|NCT00996892|9765227|FG013|COMPLETED|Dose-Escalation Stage 1A||0
8717989|NCT00996892|9765228|FG014|COMPLETED|Dose-Escalation Stage 1A||0
8717990|NCT00996892|9765229|FG015|COMPLETED|Dose-Escalation Stage 1A||0
8717991|NCT00996892|9765230|FG016|COMPLETED|Dose-Escalation Stage 1A||0
8717992|NCT00996892|9765231|FG017|COMPLETED|Dose-Escalation Stage 1A||0
8717993|NCT00996892|9765232|FG018|COMPLETED|Dose-Escalation Stage 1A||0
8717994|NCT00996892|9765233|FG019|COMPLETED|Dose-Escalation Stage 1A||0
8717995|NCT00996892|9765214|FG000|NOT COMPLETED|Dose-Escalation Stage 1A||0
8717996|NCT00996892|9765215|FG001|NOT COMPLETED|Dose-Escalation Stage 1A||0
8717997|NCT00996892|9765216|FG002|NOT COMPLETED|Dose-Escalation Stage 1A||0
8717998|NCT00996892|9765217|FG003|NOT COMPLETED|Dose-Escalation Stage 1A||0
8717999|NCT00996892|9765218|FG004|NOT COMPLETED|Dose-Escalation Stage 1A||0
8718000|NCT00996892|9765219|FG005|NOT COMPLETED|Dose-Escalation Stage 1A||0
8718001|NCT00996892|9765220|FG006|NOT COMPLETED|Dose-Escalation Stage 1A||0
8718002|NCT00996892|9765221|FG007|NOT COMPLETED|Dose-Escalation Stage 1A||3
8718003|NCT00996892|9765222|FG008|NOT COMPLETED|Dose-Escalation Stage 1A||3
8718004|NCT00996892|9765223|FG009|NOT COMPLETED|Dose-Escalation Stage 1A||4
8718005|NCT00996892|9765224|FG010|NOT COMPLETED|Dose-Escalation Stage 1A||7
8718006|NCT00996892|9765225|FG011|NOT COMPLETED|Dose-Escalation Stage 1A||9
8718007|NCT00996892|9765226|FG012|NOT COMPLETED|Dose-Escalation Stage 1A||8
8718008|NCT00996892|9765227|FG013|NOT COMPLETED|Dose-Escalation Stage 1A||5
8718009|NCT00996892|9765228|FG014|NOT COMPLETED|Dose-Escalation Stage 1A||0
8718010|NCT00996892|9765229|FG015|NOT COMPLETED|Dose-Escalation Stage 1A||0
8718011|NCT00996892|9765230|FG016|NOT COMPLETED|Dose-Escalation Stage 1A||0
8718012|NCT00996892|9765231|FG017|NOT COMPLETED|Dose-Escalation Stage 1A||0
8718013|NCT00996892|9765232|FG018|NOT COMPLETED|Dose-Escalation Stage 1A||0
8718014|NCT00996892|9765233|FG019|NOT COMPLETED|Dose-Escalation Stage 1A||0
8718015|NCT00996892|9765214|FG000|STARTED|Dose-Escalation Stage 1B||0
8718016|NCT00996892|9765215|FG001|STARTED|Dose-Escalation Stage 1B||0
8718017|NCT00996892|9765216|FG002|STARTED|Dose-Escalation Stage 1B||0
8718018|NCT00996892|9765217|FG003|STARTED|Dose-Escalation Stage 1B||0
8718019|NCT00996892|9765218|FG004|STARTED|Dose-Escalation Stage 1B||0
8718020|NCT00996892|9765219|FG005|STARTED|Dose-Escalation Stage 1B||0
8718021|NCT00996892|9765220|FG006|STARTED|Dose-Escalation Stage 1B||0
8718022|NCT00996892|9765221|FG007|STARTED|Dose-Escalation Stage 1B||0
8718023|NCT00996892|9765222|FG008|STARTED|Dose-Escalation Stage 1B||0
8718024|NCT00996892|9765223|FG009|STARTED|Dose-Escalation Stage 1B||0
8718025|NCT00996892|9765224|FG010|STARTED|Dose-Escalation Stage 1B||0
8718026|NCT00996892|9765225|FG011|STARTED|Dose-Escalation Stage 1B||0
8718027|NCT00996892|9765226|FG012|STARTED|Dose-Escalation Stage 1B||0
8718028|NCT00996892|9765227|FG013|STARTED|Dose-Escalation Stage 1B||0
8718029|NCT00996892|9765228|FG014|STARTED|Dose-Escalation Stage 1B||4
8718030|NCT00996892|9765229|FG015|STARTED|Dose-Escalation Stage 1B||3
8718031|NCT00996892|9765230|FG016|STARTED|Dose-Escalation Stage 1B||3
8718032|NCT00996892|9765231|FG017|STARTED|Dose-Escalation Stage 1B||5
8718033|NCT00996892|9765232|FG018|STARTED|Dose-Escalation Stage 1B||0
8718034|NCT00996892|9765233|FG019|STARTED|Dose-Escalation Stage 1B||0
8718035|NCT00996892|9765214|FG000|COMPLETED|Dose-Escalation Stage 1B||0
8718036|NCT00996892|9765215|FG001|COMPLETED|Dose-Escalation Stage 1B||0
8718037|NCT00996892|9765216|FG002|COMPLETED|Dose-Escalation Stage 1B||0
8718038|NCT00996892|9765217|FG003|COMPLETED|Dose-Escalation Stage 1B||0
8718039|NCT00996892|9765218|FG004|COMPLETED|Dose-Escalation Stage 1B||0
8718040|NCT00996892|9765219|FG005|COMPLETED|Dose-Escalation Stage 1B||0
8718041|NCT00996892|9765220|FG006|COMPLETED|Dose-Escalation Stage 1B||0
8718042|NCT00996892|9765221|FG007|COMPLETED|Dose-Escalation Stage 1B||0
8718043|NCT00996892|9765222|FG008|COMPLETED|Dose-Escalation Stage 1B||0
8718044|NCT00996892|9765223|FG009|COMPLETED|Dose-Escalation Stage 1B||0
8718045|NCT00996892|9765224|FG010|COMPLETED|Dose-Escalation Stage 1B||0
8718046|NCT00996892|9765225|FG011|COMPLETED|Dose-Escalation Stage 1B||0
8718047|NCT00996892|9765226|FG012|COMPLETED|Dose-Escalation Stage 1B||0
8718048|NCT00996892|9765227|FG013|COMPLETED|Dose-Escalation Stage 1B||0
8718049|NCT00996892|9765228|FG014|COMPLETED|Dose-Escalation Stage 1B||0
8718050|NCT00996892|9765229|FG015|COMPLETED|Dose-Escalation Stage 1B||0
8718051|NCT00996892|9765230|FG016|COMPLETED|Dose-Escalation Stage 1B||0
8718052|NCT00996892|9765231|FG017|COMPLETED|Dose-Escalation Stage 1B||0
8718053|NCT00996892|9765232|FG018|COMPLETED|Dose-Escalation Stage 1B||0
8718054|NCT00996892|9765233|FG019|COMPLETED|Dose-Escalation Stage 1B||0
8718055|NCT00996892|9765214|FG000|NOT COMPLETED|Dose-Escalation Stage 1B||0
8718056|NCT00996892|9765215|FG001|NOT COMPLETED|Dose-Escalation Stage 1B||0
8718057|NCT00996892|9765216|FG002|NOT COMPLETED|Dose-Escalation Stage 1B||0
8718058|NCT00996892|9765217|FG003|NOT COMPLETED|Dose-Escalation Stage 1B||0
8718059|NCT00996892|9765218|FG004|NOT COMPLETED|Dose-Escalation Stage 1B||0
8718060|NCT00996892|9765219|FG005|NOT COMPLETED|Dose-Escalation Stage 1B||0
8718061|NCT00996892|9765220|FG006|NOT COMPLETED|Dose-Escalation Stage 1B||0
8718062|NCT00996892|9765221|FG007|NOT COMPLETED|Dose-Escalation Stage 1B||0
8718063|NCT00996892|9765222|FG008|NOT COMPLETED|Dose-Escalation Stage 1B||0
8718064|NCT00996892|9765223|FG009|NOT COMPLETED|Dose-Escalation Stage 1B||0
8718065|NCT00996892|9765224|FG010|NOT COMPLETED|Dose-Escalation Stage 1B||0
8718066|NCT00996892|9765225|FG011|NOT COMPLETED|Dose-Escalation Stage 1B||0
8718067|NCT00996892|9765226|FG012|NOT COMPLETED|Dose-Escalation Stage 1B||0
8934413|NCT02323204|9995787|FG000|COMPLETED|6-week Follow-up Intervention Booster||0
8934414|NCT02323204|9995788|FG001|COMPLETED|6-week Follow-up Intervention Booster||103
8934415|NCT02323204|9995789|FG002|COMPLETED|6-week Follow-up Intervention Booster||0
8934416|NCT02323204|9995790|FG003|COMPLETED|6-week Follow-up Intervention Booster||120
8934417|NCT02323204|9995787|FG000|NOT COMPLETED|6-week Follow-up Intervention Booster||0
8934418|NCT02323204|9995788|FG001|NOT COMPLETED|6-week Follow-up Intervention Booster||43
8934419|NCT02323204|9995789|FG002|NOT COMPLETED|6-week Follow-up Intervention Booster||0
8934420|NCT02323204|9995790|FG003|NOT COMPLETED|6-week Follow-up Intervention Booster||36
8934421|NCT02323204|9995787|FG000|STARTED|3-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|145
8934422|NCT02323204|9995788|FG001|STARTED|3-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|146
8934423|NCT02323204|9995789|FG002|STARTED|3-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|154
8934424|NCT02323204|9995790|FG003|STARTED|3-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|156
8934425|NCT02323204|9995787|FG000|COMPLETED|3-month Follow-up Survey Completion||91
8934426|NCT02323204|9995788|FG001|COMPLETED|3-month Follow-up Survey Completion||99
8934427|NCT02323204|9995789|FG002|COMPLETED|3-month Follow-up Survey Completion||113
8934428|NCT02323204|9995790|FG003|COMPLETED|3-month Follow-up Survey Completion||112
8934429|NCT02323204|9995787|FG000|NOT COMPLETED|3-month Follow-up Survey Completion||54
8934430|NCT02323204|9995788|FG001|NOT COMPLETED|3-month Follow-up Survey Completion||47
8934431|NCT02323204|9995789|FG002|NOT COMPLETED|3-month Follow-up Survey Completion||41
8934432|NCT02323204|9995790|FG003|NOT COMPLETED|3-month Follow-up Survey Completion||44
8934433|NCT02323204|9995787|FG000|STARTED|6-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|145
8934434|NCT02323204|9995788|FG001|STARTED|6-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|146
8934435|NCT02323204|9995789|FG002|STARTED|6-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|154
8934436|NCT02323204|9995790|FG003|STARTED|6-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|156
8934437|NCT02323204|9995787|FG000|COMPLETED|6-month Follow-up Survey Completion||96
8934438|NCT02323204|9995788|FG001|COMPLETED|6-month Follow-up Survey Completion||96
8934439|NCT02323204|9995789|FG002|COMPLETED|6-month Follow-up Survey Completion||113
8934440|NCT02323204|9995790|FG003|COMPLETED|6-month Follow-up Survey Completion||112
8934441|NCT02323204|9995787|FG000|NOT COMPLETED|6-month Follow-up Survey Completion||49
8934442|NCT02323204|9995788|FG001|NOT COMPLETED|6-month Follow-up Survey Completion||50
8934443|NCT02323204|9995789|FG002|NOT COMPLETED|6-month Follow-up Survey Completion||41
8934444|NCT02323204|9995790|FG003|NOT COMPLETED|6-month Follow-up Survey Completion||44
8934445|NCT02323217|9995800|FG000|STARTED|Overall Study||18
8934446|NCT02323217|9995800|FG000|COMPLETED|Overall Study||18
8934447|NCT02323217|9995800|FG000|NOT COMPLETED|Overall Study||0
8934448|NCT02323334|9995814|FG000|STARTED|Period 1||4
8934449|NCT02323334|9995815|FG001|STARTED|Period 1||4
8934450|NCT02323334|9995816|FG002|STARTED|Period 1||4
8934451|NCT02323334|9995817|FG003|STARTED|Period 1||4
8934452|NCT02323334|9995818|FG004|STARTED|Period 1||4
8934453|NCT02323334|9995819|FG005|STARTED|Period 1||4
8934454|NCT02323334|9995820|FG006|STARTED|Period 1||6
8934455|NCT02323334|9995821|FG007|STARTED|Period 1||6
8934456|NCT02323334|9995822|FG008|STARTED|Period 1||5
8934457|NCT02323334|9995823|FG009|STARTED|Period 1||7
8934458|NCT02323334|9995824|FG010|STARTED|Period 1||5
8934459|NCT02323334|9995825|FG011|STARTED|Period 1||3
8934460|NCT02323334|9995826|FG012|STARTED|Period 1||9
8934461|NCT02323334|9995827|FG013|STARTED|Period 1||9
8934462|NCT02323334|9995828|FG014|STARTED|Period 1||9
8934463|NCT02323334|9995829|FG015|STARTED|Period 1||9
8934464|NCT02323334|9995830|FG016|STARTED|Period 1||2
8934465|NCT02323334|9995814|FG000|Received at Least One Dose of Study Drug|Period 1||4
8934466|NCT02323334|9995815|FG001|Received at Least One Dose of Study Drug|Period 1||4
8934467|NCT02323334|9995816|FG002|Received at Least One Dose of Study Drug|Period 1||4
8934468|NCT02323334|9995817|FG003|Received at Least One Dose of Study Drug|Period 1||4
8934469|NCT02323334|9995818|FG004|Received at Least One Dose of Study Drug|Period 1||4
8934470|NCT02323334|9995819|FG005|Received at Least One Dose of Study Drug|Period 1||4
8934471|NCT02323334|9995820|FG006|Received at Least One Dose of Study Drug|Period 1||6
8934472|NCT02323334|9995821|FG007|Received at Least One Dose of Study Drug|Period 1||6
8934473|NCT02323334|9995822|FG008|Received at Least One Dose of Study Drug|Period 1||5
8934474|NCT02323334|9995823|FG009|Received at Least One Dose of Study Drug|Period 1||7
8934475|NCT02323334|9995824|FG010|Received at Least One Dose of Study Drug|Period 1||5
8934476|NCT02323334|9995825|FG011|Received at Least One Dose of Study Drug|Period 1||3
8934477|NCT02323334|9995826|FG012|Received at Least One Dose of Study Drug|Period 1||9
8934478|NCT02323334|9995827|FG013|Received at Least One Dose of Study Drug|Period 1||9
8934479|NCT02323334|9995828|FG014|Received at Least One Dose of Study Drug|Period 1||9
8934480|NCT02323334|9995829|FG015|Received at Least One Dose of Study Drug|Period 1||9
8934481|NCT02323334|9995830|FG016|Received at Least One Dose of Study Drug|Period 1||2
8718068|NCT00996892|9765227|FG013|NOT COMPLETED|Dose-Escalation Stage 1B||0
8718069|NCT00996892|9765228|FG014|NOT COMPLETED|Dose-Escalation Stage 1B||4
8934482|NCT02323334|9995814|FG000|COMPLETED|Period 1||4
8934483|NCT02323334|9995815|FG001|COMPLETED|Period 1||4
8934484|NCT02323334|9995816|FG002|COMPLETED|Period 1||4
8934485|NCT02323334|9995817|FG003|COMPLETED|Period 1||4
8934486|NCT02323334|9995818|FG004|COMPLETED|Period 1||4
8934487|NCT02323334|9995819|FG005|COMPLETED|Period 1||4
8934488|NCT02323334|9995820|FG006|COMPLETED|Period 1||6
8934489|NCT02323334|9995821|FG007|COMPLETED|Period 1||6
8934490|NCT02323334|9995822|FG008|COMPLETED|Period 1||5
8934491|NCT02323334|9995823|FG009|COMPLETED|Period 1||7
8934492|NCT02323334|9995824|FG010|COMPLETED|Period 1||5
8934493|NCT02323334|9995825|FG011|COMPLETED|Period 1||3
8934494|NCT02323334|9995826|FG012|COMPLETED|Period 1||9
8934495|NCT02323334|9995827|FG013|COMPLETED|Period 1||9
8934496|NCT02323334|9995828|FG014|COMPLETED|Period 1||9
8934497|NCT02323334|9995829|FG015|COMPLETED|Period 1||9
8934498|NCT02323334|9995830|FG016|COMPLETED|Period 1||2
8934499|NCT02323334|9995814|FG000|NOT COMPLETED|Period 1||0
8934500|NCT02323334|9995815|FG001|NOT COMPLETED|Period 1||0
8934501|NCT02323334|9995816|FG002|NOT COMPLETED|Period 1||0
8934502|NCT02323334|9995817|FG003|NOT COMPLETED|Period 1||0
8934503|NCT02323334|9995818|FG004|NOT COMPLETED|Period 1||0
8934504|NCT02323334|9995819|FG005|NOT COMPLETED|Period 1||0
8934505|NCT02323334|9995820|FG006|NOT COMPLETED|Period 1||0
8934506|NCT02323334|9995821|FG007|NOT COMPLETED|Period 1||0
8934507|NCT02323334|9995822|FG008|NOT COMPLETED|Period 1||0
8934508|NCT02323334|9995823|FG009|NOT COMPLETED|Period 1||0
8934509|NCT02323334|9995824|FG010|NOT COMPLETED|Period 1||0
8934510|NCT02323334|9995825|FG011|NOT COMPLETED|Period 1||0
8934511|NCT02323334|9995826|FG012|NOT COMPLETED|Period 1||0
8934512|NCT02323334|9995827|FG013|NOT COMPLETED|Period 1||0
8934513|NCT02323334|9995828|FG014|NOT COMPLETED|Period 1||0
8934514|NCT02323334|9995829|FG015|NOT COMPLETED|Period 1||0
8934515|NCT02323334|9995830|FG016|NOT COMPLETED|Period 1||0
8934516|NCT02323334|9995814|FG000|STARTED|Period 2||4
8934517|NCT02323334|9995815|FG001|STARTED|Period 2||4
8934518|NCT02323334|9995816|FG002|STARTED|Period 2||4
8718070|NCT00996892|9765229|FG015|NOT COMPLETED|Dose-Escalation Stage 1B||3
8718071|NCT00996892|9765230|FG016|NOT COMPLETED|Dose-Escalation Stage 1B||3
8718072|NCT00996892|9765231|FG017|NOT COMPLETED|Dose-Escalation Stage 1B||5
8718073|NCT00996892|9765232|FG018|NOT COMPLETED|Dose-Escalation Stage 1B||0
8718074|NCT00996892|9765233|FG019|NOT COMPLETED|Dose-Escalation Stage 1B||0
8718075|NCT00996892|9765214|FG000|STARTED|Expansion Stage 2||0
8718076|NCT00996892|9765215|FG001|STARTED|Expansion Stage 2||0
8718077|NCT00996892|9765216|FG002|STARTED|Expansion Stage 2||0
8718078|NCT00996892|9765217|FG003|STARTED|Expansion Stage 2||0
8718079|NCT00996892|9765218|FG004|STARTED|Expansion Stage 2||0
8718080|NCT00996892|9765219|FG005|STARTED|Expansion Stage 2||0
8718081|NCT00996892|9765220|FG006|STARTED|Expansion Stage 2||0
8718082|NCT00996892|9765221|FG007|STARTED|Expansion Stage 2||0
8718083|NCT00996892|9765222|FG008|STARTED|Expansion Stage 2||0
8718084|NCT00996892|9765223|FG009|STARTED|Expansion Stage 2||0
8718085|NCT00996892|9765224|FG010|STARTED|Expansion Stage 2||0
8718086|NCT00996892|9765225|FG011|STARTED|Expansion Stage 2||0
8718087|NCT00996892|9765226|FG012|STARTED|Expansion Stage 2||0
8718088|NCT00996892|9765227|FG013|STARTED|Expansion Stage 2||0
8718089|NCT00996892|9765228|FG014|STARTED|Expansion Stage 2||0
8718090|NCT00996892|9765229|FG015|STARTED|Expansion Stage 2||0
8718091|NCT00996892|9765230|FG016|STARTED|Expansion Stage 2||0
8718092|NCT00996892|9765231|FG017|STARTED|Expansion Stage 2||0
8718093|NCT00996892|9765232|FG018|STARTED|Expansion Stage 2||35
8718094|NCT00996892|9765233|FG019|STARTED|Expansion Stage 2||0
8718095|NCT00996892|9765214|FG000|COMPLETED|Expansion Stage 2||0
8718096|NCT00996892|9765215|FG001|COMPLETED|Expansion Stage 2||0
8718097|NCT00996892|9765216|FG002|COMPLETED|Expansion Stage 2||0
8718098|NCT00996892|9765217|FG003|COMPLETED|Expansion Stage 2||0
8718099|NCT00996892|9765218|FG004|COMPLETED|Expansion Stage 2||0
8718100|NCT00996892|9765219|FG005|COMPLETED|Expansion Stage 2||0
8718101|NCT00996892|9765220|FG006|COMPLETED|Expansion Stage 2||0
8718102|NCT00996892|9765221|FG007|COMPLETED|Expansion Stage 2||0
8718103|NCT00996892|9765222|FG008|COMPLETED|Expansion Stage 2||0
8718104|NCT00996892|9765223|FG009|COMPLETED|Expansion Stage 2||0
8718105|NCT00996892|9765224|FG010|COMPLETED|Expansion Stage 2||0
8718106|NCT00996892|9765225|FG011|COMPLETED|Expansion Stage 2||0
8718107|NCT00996892|9765226|FG012|COMPLETED|Expansion Stage 2||0
8718108|NCT00996892|9765227|FG013|COMPLETED|Expansion Stage 2||0
8718109|NCT00996892|9765228|FG014|COMPLETED|Expansion Stage 2||0
8718110|NCT00996892|9765229|FG015|COMPLETED|Expansion Stage 2||0
8934519|NCT02323334|9995817|FG003|STARTED|Period 2||4
8934520|NCT02323334|9995818|FG004|STARTED|Period 2||4
8934521|NCT02323334|9995819|FG005|STARTED|Period 2||4
8934522|NCT02323334|9995820|FG006|STARTED|Period 2||6
8934523|NCT02323334|9995821|FG007|STARTED|Period 2||6
8934524|NCT02323334|9995822|FG008|STARTED|Period 2|Part B was a single period conducted in parallel to Part A and received last dose in Period 1.|0
8934525|NCT02323334|9995823|FG009|STARTED|Period 2|Part B was a single period conducted in parallel to Part A and received last dose in Period 1.|0
8934526|NCT02323334|9995824|FG010|STARTED|Period 2|Part B was a single period conducted in parallel to Part A and received last dose in Period 1.|0
8718111|NCT00996892|9765230|FG016|COMPLETED|Expansion Stage 2||0
8718112|NCT00996892|9765231|FG017|COMPLETED|Expansion Stage 2||0
8718113|NCT00996892|9765232|FG018|COMPLETED|Expansion Stage 2||0
8718114|NCT00996892|9765233|FG019|COMPLETED|Expansion Stage 2||0
8948450|NCT02431260|10010862|FG006|STARTED|Overall Study||4
8934527|NCT02323334|9995825|FG011|STARTED|Period 2|Part B was a single period conducted in parallel to Part A and received last dose in Period 1.|0
8934528|NCT02323334|9995826|FG012|STARTED|Period 2|Part C was a single period conducted in parallel to Part A and received last dose in Period 1.|0
8934529|NCT02323334|9995827|FG013|STARTED|Period 2|Part C was a single period conducted in parallel to Part A and received last dose in Period 1.|0
8934530|NCT02323334|9995828|FG014|STARTED|Period 2|Part C was a single period conducted in parallel to Part A and received last dose in Period 1.|0
8934531|NCT02323334|9995829|FG015|STARTED|Period 2|Part C was a single period conducted in parallel to Part A and received last dose in Period 1.|0
8934532|NCT02323334|9995830|FG016|STARTED|Period 2|Part D was a single period conducted in parallel to Part A and received last dose in Period 1.|0
8934533|NCT02323334|9995814|FG000|COMPLETED|Period 2||4
8934534|NCT02323334|9995815|FG001|COMPLETED|Period 2||4
8934535|NCT02323334|9995816|FG002|COMPLETED|Period 2||4
8934536|NCT02323334|9995817|FG003|COMPLETED|Period 2||4
8934537|NCT02323334|9995818|FG004|COMPLETED|Period 2||4
8934538|NCT02323334|9995819|FG005|COMPLETED|Period 2||4
8934539|NCT02323334|9995820|FG006|COMPLETED|Period 2||6
8934540|NCT02323334|9995821|FG007|COMPLETED|Period 2||6
8934541|NCT02323334|9995822|FG008|COMPLETED|Period 2||0
8934542|NCT02323334|9995823|FG009|COMPLETED|Period 2||0
8934543|NCT02323334|9995824|FG010|COMPLETED|Period 2||0
8934544|NCT02323334|9995825|FG011|COMPLETED|Period 2||0
8934545|NCT02323334|9995826|FG012|COMPLETED|Period 2||0
8934546|NCT02323334|9995827|FG013|COMPLETED|Period 2||0
8934547|NCT02323334|9995828|FG014|COMPLETED|Period 2||0
8934548|NCT02323334|9995829|FG015|COMPLETED|Period 2||0
8934549|NCT02323334|9995830|FG016|COMPLETED|Period 2||0
8934550|NCT02323334|9995814|FG000|NOT COMPLETED|Period 2||0
8934551|NCT02323334|9995815|FG001|NOT COMPLETED|Period 2||0
8934552|NCT02323334|9995816|FG002|NOT COMPLETED|Period 2||0
8934553|NCT02323334|9995817|FG003|NOT COMPLETED|Period 2||0
8934554|NCT02323334|9995818|FG004|NOT COMPLETED|Period 2||0
8934555|NCT02323334|9995819|FG005|NOT COMPLETED|Period 2||0
8934556|NCT02323334|9995820|FG006|NOT COMPLETED|Period 2||0
8934557|NCT02323334|9995821|FG007|NOT COMPLETED|Period 2||0
8934558|NCT02323334|9995822|FG008|NOT COMPLETED|Period 2||0
8934559|NCT02323334|9995823|FG009|NOT COMPLETED|Period 2||0
8934560|NCT02323334|9995824|FG010|NOT COMPLETED|Period 2||0
8934561|NCT02323334|9995825|FG011|NOT COMPLETED|Period 2||0
8934562|NCT02323334|9995826|FG012|NOT COMPLETED|Period 2||0
8934563|NCT02323334|9995827|FG013|NOT COMPLETED|Period 2||0
8934564|NCT02323334|9995828|FG014|NOT COMPLETED|Period 2||0
8934565|NCT02323334|9995829|FG015|NOT COMPLETED|Period 2||0
8934566|NCT02323334|9995830|FG016|NOT COMPLETED|Period 2||0
8934567|NCT02323334|9995814|FG000|STARTED|Period 3||4
8934568|NCT02323334|9995815|FG001|STARTED|Period 3||4
8934569|NCT02323334|9995816|FG002|STARTED|Period 3||4
8934570|NCT02323334|9995817|FG003|STARTED|Period 3||4
8934571|NCT02323334|9995818|FG004|STARTED|Period 3||4
8934572|NCT02323334|9995819|FG005|STARTED|Period 3||4
8934573|NCT02323334|9995820|FG006|STARTED|Period 3|Part A Cohort 3 Food Effect participated in Period 1 and Period 2 only.|0
8934574|NCT02323334|9995821|FG007|STARTED|Period 3|Part A Cohort 3 Food Effect participated in Period 1 and Period 2 only.|0
8934575|NCT02323334|9995822|FG008|STARTED|Period 3||0
8934576|NCT02323334|9995823|FG009|STARTED|Period 3||0
8934577|NCT02323334|9995824|FG010|STARTED|Period 3||0
8934578|NCT02323334|9995825|FG011|STARTED|Period 3||0
8934579|NCT02323334|9995826|FG012|STARTED|Period 3||0
8934580|NCT02323334|9995827|FG013|STARTED|Period 3||0
8934581|NCT02323334|9995828|FG014|STARTED|Period 3||0
8934582|NCT02323334|9995829|FG015|STARTED|Period 3||0
8934583|NCT02323334|9995830|FG016|STARTED|Period 3||0
8934584|NCT02323334|9995814|FG000|COMPLETED|Period 3||3
8934585|NCT02323334|9995815|FG001|COMPLETED|Period 3||4
8934586|NCT02323334|9995816|FG002|COMPLETED|Period 3||3
8934587|NCT02323334|9995817|FG003|COMPLETED|Period 3||4
8934588|NCT02323334|9995818|FG004|COMPLETED|Period 3||4
8718115|NCT00996892|9765214|FG000|NOT COMPLETED|Expansion Stage 2||0
8718116|NCT00996892|9765215|FG001|NOT COMPLETED|Expansion Stage 2||0
8718117|NCT00996892|9765216|FG002|NOT COMPLETED|Expansion Stage 2||0
8718118|NCT00996892|9765217|FG003|NOT COMPLETED|Expansion Stage 2||0
8718119|NCT00996892|9765218|FG004|NOT COMPLETED|Expansion Stage 2||0
8718120|NCT00996892|9765219|FG005|NOT COMPLETED|Expansion Stage 2||0
8718121|NCT00996892|9765220|FG006|NOT COMPLETED|Expansion Stage 2||0
8718122|NCT00996892|9765221|FG007|NOT COMPLETED|Expansion Stage 2||0
8718123|NCT00996892|9765222|FG008|NOT COMPLETED|Expansion Stage 2||0
8718124|NCT00996892|9765223|FG009|NOT COMPLETED|Expansion Stage 2||0
8718125|NCT00996892|9765224|FG010|NOT COMPLETED|Expansion Stage 2||0
8718126|NCT00996892|9765225|FG011|NOT COMPLETED|Expansion Stage 2||0
8718127|NCT00996892|9765226|FG012|NOT COMPLETED|Expansion Stage 2||0
8718128|NCT00996892|9765227|FG013|NOT COMPLETED|Expansion Stage 2||0
8718129|NCT00996892|9765228|FG014|NOT COMPLETED|Expansion Stage 2||0
8718130|NCT00996892|9765229|FG015|NOT COMPLETED|Expansion Stage 2||0
8718131|NCT00996892|9765230|FG016|NOT COMPLETED|Expansion Stage 2||0
8934589|NCT02323334|9995819|FG005|COMPLETED|Period 3||4
8718132|NCT00996892|9765231|FG017|NOT COMPLETED|Expansion Stage 2||0
8934590|NCT02323334|9995820|FG006|COMPLETED|Period 3||0
8934591|NCT02323334|9995821|FG007|COMPLETED|Period 3||0
8934592|NCT02323334|9995822|FG008|COMPLETED|Period 3||0
8934593|NCT02323334|9995823|FG009|COMPLETED|Period 3||0
8934594|NCT02323334|9995824|FG010|COMPLETED|Period 3||0
8934595|NCT02323334|9995825|FG011|COMPLETED|Period 3||0
8934596|NCT02323334|9995826|FG012|COMPLETED|Period 3||0
8934597|NCT02323334|9995827|FG013|COMPLETED|Period 3||0
8934598|NCT02323334|9995828|FG014|COMPLETED|Period 3||0
8934599|NCT02323334|9995829|FG015|COMPLETED|Period 3||0
8934600|NCT02323334|9995830|FG016|COMPLETED|Period 3||0
8934601|NCT02323334|9995814|FG000|NOT COMPLETED|Period 3||1
8934602|NCT02323334|9995815|FG001|NOT COMPLETED|Period 3||0
8934603|NCT02323334|9995816|FG002|NOT COMPLETED|Period 3||1
8934604|NCT02323334|9995817|FG003|NOT COMPLETED|Period 3||0
8934605|NCT02323334|9995818|FG004|NOT COMPLETED|Period 3||0
8934606|NCT02323334|9995819|FG005|NOT COMPLETED|Period 3||0
8934607|NCT02323334|9995820|FG006|NOT COMPLETED|Period 3||0
8934608|NCT02323334|9995821|FG007|NOT COMPLETED|Period 3||0
8934609|NCT02323334|9995822|FG008|NOT COMPLETED|Period 3||0
8934610|NCT02323334|9995823|FG009|NOT COMPLETED|Period 3||0
8934611|NCT02323334|9995824|FG010|NOT COMPLETED|Period 3||0
8934612|NCT02323334|9995825|FG011|NOT COMPLETED|Period 3||0
8934613|NCT02323334|9995826|FG012|NOT COMPLETED|Period 3||0
8934614|NCT02323334|9995827|FG013|NOT COMPLETED|Period 3||0
8934615|NCT02323334|9995828|FG014|NOT COMPLETED|Period 3||0
8934616|NCT02323334|9995829|FG015|NOT COMPLETED|Period 3||0
8934617|NCT02323334|9995830|FG016|NOT COMPLETED|Period 3||0
8934618|NCT02323334|9995814|FG000|STARTED|Period 4||3
8934619|NCT02323334|9995815|FG001|STARTED|Period 4||4
8934620|NCT02323334|9995816|FG002|STARTED|Period 4||3
8934621|NCT02323334|9995817|FG003|STARTED|Period 4||4
8934622|NCT02323334|9995818|FG004|STARTED|Period 4||4
8934623|NCT02323334|9995819|FG005|STARTED|Period 4||4
8934624|NCT02323334|9995820|FG006|STARTED|Period 4||0
8934625|NCT02323334|9995821|FG007|STARTED|Period 4||0
8934626|NCT02323334|9995822|FG008|STARTED|Period 4||0
8934627|NCT02323334|9995823|FG009|STARTED|Period 4||0
8934628|NCT02323334|9995824|FG010|STARTED|Period 4||0
8934629|NCT02323334|9995825|FG011|STARTED|Period 4||0
8934630|NCT02323334|9995826|FG012|STARTED|Period 4||0
8934631|NCT02323334|9995827|FG013|STARTED|Period 4||0
8934632|NCT02323334|9995828|FG014|STARTED|Period 4||0
8934633|NCT02323334|9995829|FG015|STARTED|Period 4||0
8934634|NCT02323334|9995830|FG016|STARTED|Period 4||0
8934635|NCT02323334|9995814|FG000|COMPLETED|Period 4||3
8934636|NCT02323334|9995815|FG001|COMPLETED|Period 4||4
8934637|NCT02323334|9995816|FG002|COMPLETED|Period 4||3
8934638|NCT02323334|9995817|FG003|COMPLETED|Period 4||4
8934639|NCT02323334|9995818|FG004|COMPLETED|Period 4||4
8934640|NCT02323334|9995819|FG005|COMPLETED|Period 4||4
8934641|NCT02323334|9995820|FG006|COMPLETED|Period 4||0
8934642|NCT02323334|9995821|FG007|COMPLETED|Period 4||0
8934643|NCT02323334|9995822|FG008|COMPLETED|Period 4||0
8934644|NCT02323334|9995823|FG009|COMPLETED|Period 4||0
8934645|NCT02323334|9995824|FG010|COMPLETED|Period 4||0
8934646|NCT02323334|9995825|FG011|COMPLETED|Period 4||0
8934647|NCT02323334|9995826|FG012|COMPLETED|Period 4||0
8934648|NCT02323334|9995827|FG013|COMPLETED|Period 4||0
8934649|NCT02323334|9995828|FG014|COMPLETED|Period 4||0
8934650|NCT02323334|9995829|FG015|COMPLETED|Period 4||0
8934651|NCT02323334|9995830|FG016|COMPLETED|Period 4||0
8934652|NCT02323334|9995814|FG000|NOT COMPLETED|Period 4||0
8934653|NCT02323334|9995815|FG001|NOT COMPLETED|Period 4||0
8934654|NCT02323334|9995816|FG002|NOT COMPLETED|Period 4||0
8934655|NCT02323334|9995817|FG003|NOT COMPLETED|Period 4||0
8934656|NCT02323334|9995818|FG004|NOT COMPLETED|Period 4||0
8934657|NCT02323334|9995819|FG005|NOT COMPLETED|Period 4||0
8934658|NCT02323334|9995820|FG006|NOT COMPLETED|Period 4||0
8934659|NCT02323334|9995821|FG007|NOT COMPLETED|Period 4||0
8934660|NCT02323334|9995822|FG008|NOT COMPLETED|Period 4||0
8934661|NCT02323334|9995823|FG009|NOT COMPLETED|Period 4||0
8934662|NCT02323334|9995824|FG010|NOT COMPLETED|Period 4||0
8934663|NCT02323334|9995825|FG011|NOT COMPLETED|Period 4||0
8934664|NCT02323334|9995826|FG012|NOT COMPLETED|Period 4||0
8934665|NCT02323334|9995827|FG013|NOT COMPLETED|Period 4||0
8934666|NCT02323334|9995828|FG014|NOT COMPLETED|Period 4||0
8934667|NCT02323334|9995829|FG015|NOT COMPLETED|Period 4||0
8934668|NCT02323334|9995830|FG016|NOT COMPLETED|Period 4||0
8934669|NCT02323646|9995895|FG000|STARTED|Treatment Course 1||14
8934670|NCT02323646|9995896|FG001|STARTED|Treatment Course 1||13
8934671|NCT02323646|9995897|FG002|STARTED|Treatment Course 1||15
8934672|NCT02323646|9995895|FG000|COMPLETED|Treatment Course 1||11
8934673|NCT02323646|9995896|FG001|COMPLETED|Treatment Course 1||10
8934674|NCT02323646|9995897|FG002|COMPLETED|Treatment Course 1||12
8934675|NCT02323646|9995895|FG000|NOT COMPLETED|Treatment Course 1||3
8934676|NCT02323646|9995896|FG001|NOT COMPLETED|Treatment Course 1||3
8934677|NCT02323646|9995897|FG002|NOT COMPLETED|Treatment Course 1||3
8934678|NCT02323646|9995895|FG000|STARTED|Treatment Course 2||11
8934679|NCT02323646|9995896|FG001|STARTED|Treatment Course 2||10
8934680|NCT02323646|9995897|FG002|STARTED|Treatment Course 2||12
8934681|NCT02323646|9995895|FG000|COMPLETED|Treatment Course 2||10
8934682|NCT02323646|9995896|FG001|COMPLETED|Treatment Course 2||9
8934683|NCT02323646|9995897|FG002|COMPLETED|Treatment Course 2||9
8934684|NCT02323646|9995895|FG000|NOT COMPLETED|Treatment Course 2||1
8934685|NCT02323646|9995896|FG001|NOT COMPLETED|Treatment Course 2||1
8934686|NCT02323646|9995897|FG002|NOT COMPLETED|Treatment Course 2||3
8934687|NCT02323854|9995905|FG000|STARTED|Overall Study||15
8934688|NCT02323854|9995905|FG000|COMPLETED|Overall Study||15
8934689|NCT02323854|9995905|FG000|NOT COMPLETED|Overall Study||0
8934690|NCT02324049|9995909|FG000|STARTED|Part A||11
8934691|NCT02324049|9995909|FG000|Safety Analysis Set|Part A|Participants with informed consent, confirmed MPS IIIB diagnosis, and received any amount of SBC-103|11
8934692|NCT02324049|9995909|FG000|COMPLETED|Part A||11
8934693|NCT02324049|9995909|FG000|NOT COMPLETED|Part A||0
8934694|NCT02324049|9995909|FG000|STARTED|Part B||11
8934695|NCT02324049|9995909|FG000|Safety Analysis Set|Part B||11
8934696|NCT02324049|9995909|FG000|COMPLETED|Part B||11
8934697|NCT02324049|9995909|FG000|NOT COMPLETED|Part B||0
8934698|NCT02324049|9995909|FG000|STARTED|Part C||11
8934699|NCT02324049|9995909|FG000|Safety Analysis Set|Part C||11
8934700|NCT02324049|9995909|FG000|COMPLETED|Part C||0
8934701|NCT02324049|9995909|FG000|NOT COMPLETED|Part C||11
8934702|NCT02324075|9995915|FG000|STARTED|Overall Study||612
8934703|NCT02324075|9995916|FG001|STARTED|Overall Study||614
8934704|NCT02324075|9995915|FG000|COMPLETED|Overall Study||609
8934705|NCT02324075|9995916|FG001|COMPLETED|Overall Study||605
8934706|NCT02324075|9995915|FG000|NOT COMPLETED|Overall Study||3
8934707|NCT02324075|9995916|FG001|NOT COMPLETED|Overall Study||9
8948451|NCT02431260|10010863|FG007|STARTED|Overall Study||3
8948452|NCT02431260|10010864|FG008|STARTED|Overall Study||8
8948453|NCT02431260|10010865|FG009|STARTED|Overall Study||8
8948454|NCT02431260|10010866|FG010|STARTED|Overall Study||4
8948455|NCT02431260|10010867|FG011|STARTED|Overall Study||4
8948456|NCT02431260|10010868|FG012|STARTED|Overall Study||10
8948457|NCT02431260|10010869|FG013|STARTED|Overall Study||1
8948458|NCT02431260|10010856|FG000|COMPLETED|Overall Study||0
8948459|NCT02431260|10010857|FG001|COMPLETED|Overall Study||0
8948460|NCT02431260|10010858|FG002|COMPLETED|Overall Study||0
8948461|NCT02431260|10010859|FG003|COMPLETED|Overall Study||0
8948462|NCT02431260|10010860|FG004|COMPLETED|Overall Study||0
8948463|NCT02431260|10010861|FG005|COMPLETED|Overall Study||0
8948464|NCT02431260|10010862|FG006|COMPLETED|Overall Study||0
8948465|NCT02431260|10010863|FG007|COMPLETED|Overall Study||0
8948466|NCT02431260|10010864|FG008|COMPLETED|Overall Study||0
8948467|NCT02431260|10010865|FG009|COMPLETED|Overall Study||0
8948468|NCT02431260|10010866|FG010|COMPLETED|Overall Study||0
8948469|NCT02431260|10010867|FG011|COMPLETED|Overall Study||0
8948470|NCT02431260|10010868|FG012|COMPLETED|Overall Study||0
8948471|NCT02431260|10010869|FG013|COMPLETED|Overall Study||0
8948472|NCT02431260|10010856|FG000|NOT COMPLETED|Overall Study||4
8948473|NCT02431260|10010857|FG001|NOT COMPLETED|Overall Study||5
8948474|NCT02431260|10010858|FG002|NOT COMPLETED|Overall Study||6
8948475|NCT02431260|10010859|FG003|NOT COMPLETED|Overall Study||5
8948476|NCT02431260|10010860|FG004|NOT COMPLETED|Overall Study||3
8948477|NCT02431260|10010861|FG005|NOT COMPLETED|Overall Study||4
8948478|NCT02431260|10010862|FG006|NOT COMPLETED|Overall Study||4
8948479|NCT02431260|10010863|FG007|NOT COMPLETED|Overall Study||3
8948480|NCT02431260|10010864|FG008|NOT COMPLETED|Overall Study||8
8948481|NCT02431260|10010865|FG009|NOT COMPLETED|Overall Study||8
8948482|NCT02431260|10010866|FG010|NOT COMPLETED|Overall Study||4
8948483|NCT02431260|10010867|FG011|NOT COMPLETED|Overall Study||4
8948484|NCT02431260|10010868|FG012|NOT COMPLETED|Overall Study||10
8948485|NCT02431260|10010869|FG013|NOT COMPLETED|Overall Study||1
8948486|NCT02431273|10010912|FG000|STARTED|TDF (Single IVR)||6
8948487|NCT02431273|10010912|FG000|COMPLETED|TDF (Single IVR)||6
8948488|NCT02431273|10010912|FG000|NOT COMPLETED|TDF (Single IVR)||0
8948489|NCT02431273|10010912|FG000|STARTED|TDF-FTC (Dual IVR)||6
8948490|NCT02431273|10010912|FG000|COMPLETED|TDF-FTC (Dual IVR)||6
8948491|NCT02431273|10010912|FG000|NOT COMPLETED|TDF-FTC (Dual IVR)||0
8948492|NCT02431273|10010912|FG000|STARTED|TDF-FTC-MVC (Triple IVR)||6
8948493|NCT02431273|10010912|FG000|COMPLETED|TDF-FTC-MVC (Triple IVR)||6
8948494|NCT02431273|10010912|FG000|NOT COMPLETED|TDF-FTC-MVC (Triple IVR)||0
8948495|NCT02431299|10010922|FG000|STARTED|Overall Study||236
8948496|NCT02431299|10010923|FG001|STARTED|Overall Study||63
8948497|NCT02431299|10010922|FG000|COMPLETED|Overall Study||183
8948498|NCT02431299|10010923|FG001|COMPLETED|Overall Study||62
8948499|NCT02431299|10010922|FG000|NOT COMPLETED|Overall Study||53
8948500|NCT02431299|10010923|FG001|NOT COMPLETED|Overall Study||1
8948501|NCT02431364|10010934|FG000|STARTED|Overall Study||8
8948502|NCT02431364|10010935|FG001|STARTED|Overall Study||6
8948503|NCT02431364|10010936|FG002|STARTED|Overall Study||6
8948504|NCT02431364|10010937|FG003|STARTED|Overall Study||7
8948505|NCT02431364|10010938|FG004|STARTED|Overall Study||6
8948506|NCT02431364|10010934|FG000|Treated|Overall Study||8
8948507|NCT02431364|10010935|FG001|Treated|Overall Study||6
8948508|NCT02431364|10010936|FG002|Treated|Overall Study||6
8948509|NCT02431364|10010937|FG003|Treated|Overall Study||6
8948510|NCT02431364|10010938|FG004|Treated|Overall Study||6
8948511|NCT02431364|10010934|FG000|COMPLETED|Overall Study||8
8948512|NCT02431364|10010935|FG001|COMPLETED|Overall Study||5
8948513|NCT02431364|10010936|FG002|COMPLETED|Overall Study||6
8948514|NCT02431364|10010937|FG003|COMPLETED|Overall Study||6
8948515|NCT02431364|10010938|FG004|COMPLETED|Overall Study||6
8948516|NCT02431364|10010934|FG000|NOT COMPLETED|Overall Study||0
8948517|NCT02431364|10010935|FG001|NOT COMPLETED|Overall Study||1
8948518|NCT02431364|10010936|FG002|NOT COMPLETED|Overall Study||0
8948519|NCT02431364|10010937|FG003|NOT COMPLETED|Overall Study||1
8948520|NCT02431364|10010938|FG004|NOT COMPLETED|Overall Study||0
8948521|NCT02431455|10010956|FG000|STARTED|Overall Study||112
8948522|NCT02431455|10010957|FG001|STARTED|Overall Study||112
8948523|NCT02431455|10010956|FG000|COMPLETED|Overall Study||112
8948524|NCT02431455|10010957|FG001|COMPLETED|Overall Study||112
8948525|NCT02431455|10010956|FG000|NOT COMPLETED|Overall Study||0
8948526|NCT02431455|10010957|FG001|NOT COMPLETED|Overall Study||0
8948527|NCT02431468|10010966|FG000|STARTED|Overall Study||46
8948528|NCT02431468|10010967|FG001|STARTED|Overall Study||47
8934708|NCT02324153|9995925|FG000|STARTED|Overall Study||41
8934709|NCT02324153|9995926|FG001|STARTED|Overall Study||39
8934710|NCT02324153|9995925|FG000|COMPLETED|Overall Study||33
8934711|NCT02324153|9995926|FG001|COMPLETED|Overall Study||38
8934712|NCT02324153|9995925|FG000|NOT COMPLETED|Overall Study||8
8934713|NCT02324153|9995926|FG001|NOT COMPLETED|Overall Study||1
8934714|NCT02324205|9995932|FG000|STARTED|Overall Study||196
8934715|NCT02324205|9995932|FG000|COMPLETED|Overall Study||159
8934716|NCT02324205|9995932|FG000|NOT COMPLETED|Overall Study||37
8934717|NCT02324270|9995939|FG000|STARTED|Overall Study||218
8934718|NCT02324270|9995940|FG001|STARTED|Overall Study||219
8934719|NCT02324270|9995941|FG002|STARTED|Overall Study||221
8934720|NCT02324270|9995939|FG000|Safety Population|Overall Study||214
8934721|NCT02324270|9995940|FG001|Safety Population|Overall Study||216
8934722|NCT02324270|9995941|FG002|Safety Population|Overall Study||217
8934723|NCT02324270|9995939|FG000|mITT Population|Overall Study||214
8934724|NCT02324270|9995940|FG001|mITT Population|Overall Study||216
8934725|NCT02324270|9995941|FG002|mITT Population|Overall Study||217
8934726|NCT02324270|9995939|FG000|PP Population|Overall Study||180
8934727|NCT02324270|9995940|FG001|PP Population|Overall Study||177
8934728|NCT02324270|9995941|FG002|PP Population|Overall Study||171
8934729|NCT02324270|9995939|FG000|COMPLETED|Overall Study||213
8934730|NCT02324270|9995940|FG001|COMPLETED|Overall Study||212
8934731|NCT02324270|9995941|FG002|COMPLETED|Overall Study||216
8934732|NCT02324270|9995939|FG000|NOT COMPLETED|Overall Study||5
8934733|NCT02324270|9995940|FG001|NOT COMPLETED|Overall Study||7
8934734|NCT02324270|9995941|FG002|NOT COMPLETED|Overall Study||5
8934735|NCT02324335|9995951|FG000|STARTED|Overall Study||30
8934736|NCT02324335|9995952|FG001|STARTED|Overall Study||29
8934737|NCT02324335|9995951|FG000|COMPLETED|Overall Study||21
8934738|NCT02324335|9995952|FG001|COMPLETED|Overall Study||20
8934739|NCT02324335|9995951|FG000|NOT COMPLETED|Overall Study||9
8934740|NCT02324335|9995952|FG001|NOT COMPLETED|Overall Study||9
8934741|NCT02324361|9995960|FG000|STARTED|Overall Study||24
8934742|NCT02324361|9995961|FG001|STARTED|Overall Study||24
8934743|NCT02324361|9995960|FG000|COMPLETED|Overall Study||19
8934744|NCT02324361|9995961|FG001|COMPLETED|Overall Study||22
8934745|NCT02324361|9995960|FG000|NOT COMPLETED|Overall Study||5
8934746|NCT02324361|9995961|FG001|NOT COMPLETED|Overall Study||2
8934747|NCT02324465|9995969|FG000|STARTED|Overall Study||18
8934748|NCT02324465|9995970|FG001|STARTED|Overall Study||22
8934749|NCT02324465|9995969|FG000|COMPLETED|Overall Study||18
8934750|NCT02324465|9995970|FG001|COMPLETED|Overall Study||21
8934751|NCT02324465|9995969|FG000|NOT COMPLETED|Overall Study||0
8934752|NCT02324465|9995970|FG001|NOT COMPLETED|Overall Study||1
8934753|NCT02324504|9995976|FG000|STARTED|Overall Study||60
8934754|NCT02324504|9995976|FG000|COMPLETED|Overall Study||60
8934755|NCT02324504|9995976|FG000|NOT COMPLETED|Overall Study||0
8934756|NCT02324543|9995989|FG000|STARTED|Overall Study||6
8934757|NCT02324543|9995990|FG001|STARTED|Overall Study||6
8934758|NCT02324543|9995991|FG002|STARTED|Overall Study||3
8934759|NCT02324543|9995992|FG003|STARTED|Overall Study||4
8934760|NCT02324543|9995993|FG004|STARTED|Overall Study||4
8934761|NCT02324543|9995994|FG005|STARTED|Overall Study||24
8934762|NCT02324543|9995989|FG000|COMPLETED|Overall Study||6
8934763|NCT02324543|9995990|FG001|COMPLETED|Overall Study||6
8934764|NCT02324543|9995991|FG002|COMPLETED|Overall Study||3
8934765|NCT02324543|9995992|FG003|COMPLETED|Overall Study||4
8934766|NCT02324543|9995993|FG004|COMPLETED|Overall Study||4
8934767|NCT02324543|9995994|FG005|COMPLETED|Overall Study||24
8934768|NCT02324543|9995989|FG000|NOT COMPLETED|Overall Study||0
8934769|NCT02324543|9995990|FG001|NOT COMPLETED|Overall Study||0
8934770|NCT02324543|9995991|FG002|NOT COMPLETED|Overall Study||0
8934771|NCT02324543|9995992|FG003|NOT COMPLETED|Overall Study||0
8934772|NCT02324543|9995993|FG004|NOT COMPLETED|Overall Study||0
8934773|NCT02324543|9995994|FG005|NOT COMPLETED|Overall Study||0
8934774|NCT02324569|9996006|FG000|STARTED|Overall Study||116
8934775|NCT02324569|9996007|FG001|STARTED|Overall Study||124
8934776|NCT02324569|9996006|FG000|COMPLETED|Overall Study||100
8934777|NCT02324569|9996007|FG001|COMPLETED|Overall Study||103
8934778|NCT02324569|9996006|FG000|NOT COMPLETED|Overall Study||16
8934779|NCT02324569|9996007|FG001|NOT COMPLETED|Overall Study||21
8934780|NCT02324660|9996013|FG000|STARTED|Overall Study||169
8934781|NCT02324660|9996013|FG000|COMPLETED|Overall Study||137
8934782|NCT02324660|9996013|FG000|NOT COMPLETED|Overall Study||32
8934783|NCT02324673|9996021|FG000|STARTED|Overall Study||20
8934784|NCT02324673|9996022|FG001|STARTED|Overall Study||20
8934785|NCT02324673|9996023|FG002|STARTED|Overall Study||21
8934786|NCT02324673|9996021|FG000|COMPLETED|Overall Study||20
8934787|NCT02324673|9996022|FG001|COMPLETED|Overall Study||20
8934788|NCT02324673|9996023|FG002|COMPLETED|Overall Study||21
8934789|NCT02324673|9996021|FG000|NOT COMPLETED|Overall Study||0
8934790|NCT02324673|9996022|FG001|NOT COMPLETED|Overall Study||0
8934791|NCT02324673|9996023|FG002|NOT COMPLETED|Overall Study||0
8934792|NCT02324699|9996031|FG000|STARTED|Overall Study||1
8934793|NCT02324699|9996031|FG000|COMPLETED|Overall Study||0
8934794|NCT02324699|9996031|FG000|NOT COMPLETED|Overall Study||1
8934795|NCT02324842|9996038|FG000|STARTED|Overall Study||15
8934796|NCT02324842|9996039|FG001|STARTED|Overall Study||15
8934797|NCT02324842|9996040|FG002|STARTED|Overall Study||15
8934798|NCT02324842|9996038|FG000|COMPLETED|Overall Study||14
8934799|NCT02324842|9996039|FG001|COMPLETED|Overall Study||14
8934800|NCT02324842|9996040|FG002|COMPLETED|Overall Study||13
8934801|NCT02324842|9996038|FG000|NOT COMPLETED|Overall Study||1
8934802|NCT02324842|9996039|FG001|NOT COMPLETED|Overall Study||1
8934803|NCT02324842|9996040|FG002|NOT COMPLETED|Overall Study||2
8934804|NCT02324920|9996050|FG000|STARTED|Overall Study||64
8934805|NCT02324920|9996051|FG001|STARTED|Overall Study||64
8934806|NCT02324920|9996050|FG000|COMPLETED|Overall Study||63
8934807|NCT02324920|9996051|FG001|COMPLETED|Overall Study||64
8934808|NCT02324920|9996050|FG000|NOT COMPLETED|Overall Study||1
8934809|NCT02324920|9996051|FG001|NOT COMPLETED|Overall Study||0
8934810|NCT02324972|9996059|FG000|STARTED|Overall Study||26
8934811|NCT02324972|9996060|FG001|STARTED|Overall Study||28
8934812|NCT02324972|9996059|FG000|COMPLETED|Overall Study||19
8934813|NCT02324972|9996060|FG001|COMPLETED|Overall Study||23
8934814|NCT02324972|9996059|FG000|NOT COMPLETED|Overall Study||7
8934815|NCT02324972|9996060|FG001|NOT COMPLETED|Overall Study||5
8934816|NCT02325219|9996069|FG000|STARTED|Controlled Period (Week 0 - 16)||64
8934817|NCT02325219|9996070|FG001|STARTED|Controlled Period (Week 0 - 16)||65
8934818|NCT02325219|9996071|FG002|STARTED|Controlled Period (Week 0 - 16)||63
8934819|NCT02325219|9996072|FG003|STARTED|Controlled Period (Week 0 - 16)||0
8934820|NCT02325219|9996073|FG004|STARTED|Controlled Period (Week 0 - 16)||0
8934821|NCT02325219|9996069|FG000|COMPLETED|Controlled Period (Week 0 - 16)||52
8934822|NCT02325219|9996070|FG001|COMPLETED|Controlled Period (Week 0 - 16)||63
8934823|NCT02325219|9996071|FG002|COMPLETED|Controlled Period (Week 0 - 16)||62
8934824|NCT02325219|9996072|FG003|COMPLETED|Controlled Period (Week 0 - 16)||0
8934825|NCT02325219|9996073|FG004|COMPLETED|Controlled Period (Week 0 - 16)||0
8934826|NCT02325219|9996069|FG000|NOT COMPLETED|Controlled Period (Week 0 - 16)||12
8934827|NCT02325219|9996070|FG001|NOT COMPLETED|Controlled Period (Week 0 - 16)||2
8934828|NCT02325219|9996071|FG002|NOT COMPLETED|Controlled Period (Week 0 - 16)||1
8934829|NCT02325219|9996072|FG003|NOT COMPLETED|Controlled Period (Week 0 - 16)||0
8934830|NCT02325219|9996073|FG004|NOT COMPLETED|Controlled Period (Week 0 - 16)||0
8934831|NCT02325219|9996069|FG000|STARTED|After Controlled Period (Week 16 - 52)||0
8934832|NCT02325219|9996070|FG001|STARTED|After Controlled Period (Week 16 - 52)||63
8934833|NCT02325219|9996071|FG002|STARTED|After Controlled Period (Week 16 - 52)||62
8934834|NCT02325219|9996072|FG003|STARTED|After Controlled Period (Week 16 - 52)|Participants who completed CP and re-randomized to Guselkumab 50 mg.|26
8934835|NCT02325219|9996073|FG004|STARTED|After Controlled Period (Week 16 - 52)|Participants who completed CP and re-randomized to Guselkumab 100 mg.|26
8934836|NCT02325219|9996069|FG000|COMPLETED|After Controlled Period (Week 16 - 52)||0
8934837|NCT02325219|9996070|FG001|COMPLETED|After Controlled Period (Week 16 - 52)||60
8934838|NCT02325219|9996071|FG002|COMPLETED|After Controlled Period (Week 16 - 52)||62
8934839|NCT02325219|9996072|FG003|COMPLETED|After Controlled Period (Week 16 - 52)||26
8934840|NCT02325219|9996073|FG004|COMPLETED|After Controlled Period (Week 16 - 52)||25
8934841|NCT02325219|9996069|FG000|NOT COMPLETED|After Controlled Period (Week 16 - 52)||0
8934842|NCT02325219|9996070|FG001|NOT COMPLETED|After Controlled Period (Week 16 - 52)||3
8934843|NCT02325219|9996071|FG002|NOT COMPLETED|After Controlled Period (Week 16 - 52)||0
8934844|NCT02325219|9996072|FG003|NOT COMPLETED|After Controlled Period (Week 16 - 52)||0
8934845|NCT02325219|9996073|FG004|NOT COMPLETED|After Controlled Period (Week 16 - 52)||1
8934846|NCT02325401|9996089|FG000|STARTED|Overall Study||6
8934847|NCT02325401|9996090|FG001|STARTED|Overall Study||9
8934848|NCT02325401|9996091|FG002|STARTED|Overall Study||5
8934849|NCT02325401|9996089|FG000|COMPLETED|Overall Study||6
8934850|NCT02325401|9996090|FG001|COMPLETED|Overall Study||8
8934851|NCT02325401|9996091|FG002|COMPLETED|Overall Study||4
8934852|NCT02325401|9996089|FG000|NOT COMPLETED|Overall Study||0
8934853|NCT02325401|9996090|FG001|NOT COMPLETED|Overall Study||1
8934854|NCT02325401|9996091|FG002|NOT COMPLETED|Overall Study||1
8934855|NCT02325414|9996107|FG000|STARTED|Overall Study||30
8934856|NCT02325414|9996108|FG001|STARTED|Overall Study||30
8934857|NCT02325414|9996107|FG000|COMPLETED|Overall Study||22
8934858|NCT02325414|9996108|FG001|COMPLETED|Overall Study||24
9064946|NCT04245202|10125280|FG000|STARTED|Overall Study|After getting consent.|48
9064947|NCT04245202|10125281|FG001|STARTED|Overall Study|After getting consent|39
9064948|NCT04245202|10125280|FG000|COMPLETED|Overall Study||38
9064949|NCT04245202|10125281|FG001|COMPLETED|Overall Study||38
9064950|NCT04245202|10125280|FG000|NOT COMPLETED|Overall Study||10
9064951|NCT04245202|10125281|FG001|NOT COMPLETED|Overall Study||1
9064952|NCT04243369|10125288|FG000|STARTED|Overall Study||30
9064953|NCT04243369|10125288|FG000|COMPLETED|Overall Study||30
9064954|NCT04243369|10125288|FG000|NOT COMPLETED|Overall Study||0
9064955|NCT04241146|10125294|FG000|STARTED|Overall Study||24
9064956|NCT04241146|10125295|FG001|STARTED|Overall Study||28
8934859|NCT02325414|9996107|FG000|NOT COMPLETED|Overall Study||8
8934860|NCT02325414|9996108|FG001|NOT COMPLETED|Overall Study||6
8934861|NCT02325518|9996118|FG000|STARTED|Overall Study||98
8934862|NCT02325518|9996119|FG001|STARTED|Overall Study||103
8934863|NCT02325518|9996118|FG000|Safety Set|Overall Study||98
8934864|NCT02325518|9996119|FG001|Safety Set|Overall Study||103
8934865|NCT02325518|9996118|FG000|Full Analysis Set (FAS)|Overall Study||98
8934866|NCT02325518|9996119|FG001|Full Analysis Set (FAS)|Overall Study||101
8934867|NCT02325518|9996118|FG000|Per Protocol Set (PPS)|Overall Study||92
8934868|NCT02325518|9996119|FG001|Per Protocol Set (PPS)|Overall Study||97
8934869|NCT02325518|9996118|FG000|COMPLETED|Overall Study||94
8934870|NCT02325518|9996119|FG001|COMPLETED|Overall Study||100
8934871|NCT02325518|9996118|FG000|NOT COMPLETED|Overall Study||4
8934872|NCT02325518|9996119|FG001|NOT COMPLETED|Overall Study||3
8934873|NCT02325687|9996129|FG000|STARTED|Overall Study||16
8934874|NCT02325687|9996130|FG001|STARTED|Overall Study||15
8934875|NCT02325687|9996131|FG002|STARTED|Overall Study||19
8934876|NCT02325687|9996129|FG000|COMPLETED|Overall Study||12
8934877|NCT02325687|9996130|FG001|COMPLETED|Overall Study||12
8934878|NCT02325687|9996131|FG002|COMPLETED|Overall Study||13
8934879|NCT02325687|9996129|FG000|NOT COMPLETED|Overall Study||4
8934880|NCT02325687|9996130|FG001|NOT COMPLETED|Overall Study||3
8934881|NCT02325687|9996131|FG002|NOT COMPLETED|Overall Study||6
8934882|NCT02325713|9996155|FG000|STARTED|Intervention Period 1 (2 Days)||2
8934883|NCT02325713|9996156|FG001|STARTED|Intervention Period 1 (2 Days)||2
8934884|NCT02325713|9996157|FG002|STARTED|Intervention Period 1 (2 Days)||2
8934885|NCT02325713|9996158|FG003|STARTED|Intervention Period 1 (2 Days)||2
8934886|NCT02325713|9996159|FG004|STARTED|Intervention Period 1 (2 Days)||2
8934887|NCT02325713|9996160|FG005|STARTED|Intervention Period 1 (2 Days)||2
8934888|NCT02325713|9996161|FG006|STARTED|Intervention Period 1 (2 Days)||2
8934889|NCT02325713|9996162|FG007|STARTED|Intervention Period 1 (2 Days)||2
8934890|NCT02325713|9996163|FG008|STARTED|Intervention Period 1 (2 Days)||2
8934891|NCT02325713|9996164|FG009|STARTED|Intervention Period 1 (2 Days)||2
8934892|NCT02325713|9996165|FG010|STARTED|Intervention Period 1 (2 Days)||2
8934893|NCT02325713|9996166|FG011|STARTED|Intervention Period 1 (2 Days)||2
8934894|NCT02325713|9996167|FG012|STARTED|Intervention Period 1 (2 Days)||2
8934895|NCT02325713|9996168|FG013|STARTED|Intervention Period 1 (2 Days)||2
8934896|NCT02325713|9996169|FG014|STARTED|Intervention Period 1 (2 Days)||2
8934897|NCT02325713|9996170|FG015|STARTED|Intervention Period 1 (2 Days)||2
8934898|NCT02325713|9996155|FG000|COMPLETED|Intervention Period 1 (2 Days)||2
8934899|NCT02325713|9996156|FG001|COMPLETED|Intervention Period 1 (2 Days)||2
8934900|NCT02325713|9996157|FG002|COMPLETED|Intervention Period 1 (2 Days)||2
8934901|NCT02325713|9996158|FG003|COMPLETED|Intervention Period 1 (2 Days)||2
8934902|NCT02325713|9996159|FG004|COMPLETED|Intervention Period 1 (2 Days)||2
8934903|NCT02325713|9996160|FG005|COMPLETED|Intervention Period 1 (2 Days)||2
8934904|NCT02325713|9996161|FG006|COMPLETED|Intervention Period 1 (2 Days)||2
8934905|NCT02325713|9996162|FG007|COMPLETED|Intervention Period 1 (2 Days)||2
8934906|NCT02325713|9996163|FG008|COMPLETED|Intervention Period 1 (2 Days)||2
8934907|NCT02325713|9996164|FG009|COMPLETED|Intervention Period 1 (2 Days)||2
8934908|NCT02325713|9996165|FG010|COMPLETED|Intervention Period 1 (2 Days)||1
8934909|NCT02325713|9996166|FG011|COMPLETED|Intervention Period 1 (2 Days)||2
8934910|NCT02325713|9996167|FG012|COMPLETED|Intervention Period 1 (2 Days)||2
8934911|NCT02325713|9996168|FG013|COMPLETED|Intervention Period 1 (2 Days)||2
9064957|NCT04241146|10125294|FG000|COMPLETED|Overall Study||24
9064958|NCT04241146|10125295|FG001|COMPLETED|Overall Study||28
9064959|NCT04241146|10125294|FG000|NOT COMPLETED|Overall Study||0
9064960|NCT04241146|10125295|FG001|NOT COMPLETED|Overall Study||0
9064961|NCT04240678|10125303|FG000|STARTED|Overall Study||4141
9064962|NCT04240678|10125304|FG001|STARTED|Overall Study||4158
9064963|NCT04240678|10125303|FG000|COMPLETED|Overall Study||4141
9064964|NCT04240678|10125304|FG001|COMPLETED|Overall Study||4158
9064965|NCT04240678|10125303|FG000|NOT COMPLETED|Overall Study||0
9064966|NCT04240678|10125304|FG001|NOT COMPLETED|Overall Study||0
9064967|NCT04238650|10125312|FG000|STARTED|Overall Study||24
9064968|NCT04238650|10125313|FG001|STARTED|Overall Study|One subject was enrolled and randomized to EU Avastin® but the subject was not dosed (subject withdrawal before study drug administration)|25
9064969|NCT04238650|10125312|FG000|COMPLETED|Overall Study||24
9064970|NCT04238650|10125313|FG001|COMPLETED|Overall Study||24
9064971|NCT04238650|10125312|FG000|NOT COMPLETED|Overall Study||0
9064972|NCT04238650|10125313|FG001|NOT COMPLETED|Overall Study||1
9064973|NCT04238663|10125322|FG000|STARTED|Overall Study||38
9064974|NCT04238663|10125323|FG001|STARTED|Overall Study||38
9064975|NCT04238663|10125324|FG002|STARTED|Overall Study||38
9064976|NCT04238663|10125322|FG000|COMPLETED|Overall Study||38
9064977|NCT04238663|10125323|FG001|COMPLETED|Overall Study||37
9064978|NCT04238663|10125324|FG002|COMPLETED|Overall Study||38
9064979|NCT04238663|10125322|FG000|NOT COMPLETED|Overall Study||0
9064980|NCT04238663|10125323|FG001|NOT COMPLETED|Overall Study||1
9064981|NCT04238663|10125324|FG002|NOT COMPLETED|Overall Study||0
9064982|NCT04235582|10125335|FG000|STARTED|Overall Study||12
9064983|NCT04235582|10125336|FG001|STARTED|Overall Study||13
9064984|NCT04235582|10125337|FG002|STARTED|Overall Study||11
9064985|NCT04235582|10125335|FG000|COMPLETED|Overall Study||12
9064986|NCT04235582|10125336|FG001|COMPLETED|Overall Study||12
9064987|NCT04235582|10125337|FG002|COMPLETED|Overall Study||8
9064988|NCT04235582|10125335|FG000|NOT COMPLETED|Overall Study||0
9064989|NCT04235582|10125336|FG001|NOT COMPLETED|Overall Study||1
9064990|NCT04235582|10125337|FG002|NOT COMPLETED|Overall Study||3
9064991|NCT04203225|10125347|FG000|STARTED|Overall Study||21
9064992|NCT04203225|10125348|FG001|STARTED|Overall Study||27
9064993|NCT04203225|10125347|FG000|COMPLETED|Overall Study||21
9064994|NCT04203225|10125348|FG001|COMPLETED|Overall Study||27
9064995|NCT04203225|10125347|FG000|NOT COMPLETED|Overall Study||0
9064996|NCT04203225|10125348|FG001|NOT COMPLETED|Overall Study||0
9064997|NCT04234672|10125354|FG000|STARTED|Treatment Period 1 (Day 1)||6
9064998|NCT04234672|10125354|FG000|COMPLETED|Treatment Period 1 (Day 1)||6
9064999|NCT04234672|10125354|FG000|NOT COMPLETED|Treatment Period 1 (Day 1)||0
9065000|NCT04234672|10125354|FG000|STARTED|Washout Period (Day 2 to 8)||6
9065001|NCT04234672|10125354|FG000|COMPLETED|Washout Period (Day 2 to 8)||6
9065002|NCT04234672|10125354|FG000|NOT COMPLETED|Washout Period (Day 2 to 8)||0
9065003|NCT04234672|10125354|FG000|STARTED|Treatment Period 2(Day9[Day1of Period2])||6
8934912|NCT02325713|9996169|FG014|COMPLETED|Intervention Period 1 (2 Days)||2
8934913|NCT02325713|9996170|FG015|COMPLETED|Intervention Period 1 (2 Days)||2
8934914|NCT02325713|9996155|FG000|NOT COMPLETED|Intervention Period 1 (2 Days)||0
8934915|NCT02325713|9996156|FG001|NOT COMPLETED|Intervention Period 1 (2 Days)||0
8934916|NCT02325713|9996157|FG002|NOT COMPLETED|Intervention Period 1 (2 Days)||0
8934917|NCT02325713|9996158|FG003|NOT COMPLETED|Intervention Period 1 (2 Days)||0
8934918|NCT02325713|9996159|FG004|NOT COMPLETED|Intervention Period 1 (2 Days)||0
8934919|NCT02325713|9996160|FG005|NOT COMPLETED|Intervention Period 1 (2 Days)||0
8934920|NCT02325713|9996161|FG006|NOT COMPLETED|Intervention Period 1 (2 Days)||0
8934921|NCT02325713|9996162|FG007|NOT COMPLETED|Intervention Period 1 (2 Days)||0
8934922|NCT02325713|9996163|FG008|NOT COMPLETED|Intervention Period 1 (2 Days)||0
8934923|NCT02325713|9996164|FG009|NOT COMPLETED|Intervention Period 1 (2 Days)||0
8934924|NCT02325713|9996165|FG010|NOT COMPLETED|Intervention Period 1 (2 Days)||1
8934925|NCT02325713|9996166|FG011|NOT COMPLETED|Intervention Period 1 (2 Days)||0
8934926|NCT02325713|9996167|FG012|NOT COMPLETED|Intervention Period 1 (2 Days)||0
8934927|NCT02325713|9996168|FG013|NOT COMPLETED|Intervention Period 1 (2 Days)||0
8934928|NCT02325713|9996169|FG014|NOT COMPLETED|Intervention Period 1 (2 Days)||0
8934929|NCT02325713|9996170|FG015|NOT COMPLETED|Intervention Period 1 (2 Days)||0
8934930|NCT02325713|9996155|FG000|STARTED|Intervention Period 2 (2 Days)||2
8617244|NCT00455533|9655419|FG000|COMPLETED|Period One: Initial Chemotherapy||295
8617245|NCT00455533|9655420|FG001|COMPLETED|Period One: Initial Chemotherapy||0
8617246|NCT00455533|9655421|FG002|COMPLETED|Period One: Initial Chemotherapy||0
8617247|NCT00455533|9655419|FG000|NOT COMPLETED|Period One: Initial Chemotherapy||18
8617248|NCT00455533|9655420|FG001|NOT COMPLETED|Period One: Initial Chemotherapy||0
8617249|NCT00455533|9655421|FG002|NOT COMPLETED|Period One: Initial Chemotherapy||0
8617250|NCT00455533|9655419|FG000|STARTED|Period Two: Randomized Period||0
8617251|NCT00455533|9655420|FG001|STARTED|Period Two: Randomized Period|148 randomized, 145 randomized and treated with ixabepilone|145
8617252|NCT00455533|9655421|FG002|STARTED|Period Two: Randomized Period|147 randomized, 144 randomized and treated with paclitaxel|144
8617253|NCT00455533|9655419|FG000|COMPLETED|Period Two: Randomized Period||0
8934931|NCT02325713|9996156|FG001|STARTED|Intervention Period 2 (2 Days)||2
8934932|NCT02325713|9996157|FG002|STARTED|Intervention Period 2 (2 Days)||2
8934933|NCT02325713|9996158|FG003|STARTED|Intervention Period 2 (2 Days)||2
8934934|NCT02325713|9996159|FG004|STARTED|Intervention Period 2 (2 Days)||2
8934935|NCT02325713|9996160|FG005|STARTED|Intervention Period 2 (2 Days)||2
8934936|NCT02325713|9996161|FG006|STARTED|Intervention Period 2 (2 Days)||2
8934937|NCT02325713|9996162|FG007|STARTED|Intervention Period 2 (2 Days)||2
8934938|NCT02325713|9996163|FG008|STARTED|Intervention Period 2 (2 Days)||2
8934939|NCT02325713|9996164|FG009|STARTED|Intervention Period 2 (2 Days)||2
8934940|NCT02325713|9996165|FG010|STARTED|Intervention Period 2 (2 Days)||1
8934941|NCT02325713|9996166|FG011|STARTED|Intervention Period 2 (2 Days)||2
8934942|NCT02325713|9996167|FG012|STARTED|Intervention Period 2 (2 Days)||2
8934943|NCT02325713|9996168|FG013|STARTED|Intervention Period 2 (2 Days)||2
8934944|NCT02325713|9996169|FG014|STARTED|Intervention Period 2 (2 Days)||2
8934945|NCT02325713|9996170|FG015|STARTED|Intervention Period 2 (2 Days)||2
8934946|NCT02325713|9996155|FG000|COMPLETED|Intervention Period 2 (2 Days)||1
8934947|NCT02325713|9996156|FG001|COMPLETED|Intervention Period 2 (2 Days)||2
8934948|NCT02325713|9996157|FG002|COMPLETED|Intervention Period 2 (2 Days)||2
8934949|NCT02325713|9996158|FG003|COMPLETED|Intervention Period 2 (2 Days)||2
8934950|NCT02325713|9996159|FG004|COMPLETED|Intervention Period 2 (2 Days)||2
8934951|NCT02325713|9996160|FG005|COMPLETED|Intervention Period 2 (2 Days)||2
8934952|NCT02325713|9996161|FG006|COMPLETED|Intervention Period 2 (2 Days)||2
8934953|NCT02325713|9996162|FG007|COMPLETED|Intervention Period 2 (2 Days)||2
8934954|NCT02325713|9996163|FG008|COMPLETED|Intervention Period 2 (2 Days)||2
8934955|NCT02325713|9996164|FG009|COMPLETED|Intervention Period 2 (2 Days)||2
8934956|NCT02325713|9996165|FG010|COMPLETED|Intervention Period 2 (2 Days)||1
8934957|NCT02325713|9996166|FG011|COMPLETED|Intervention Period 2 (2 Days)||2
8934958|NCT02325713|9996167|FG012|COMPLETED|Intervention Period 2 (2 Days)||2
8934959|NCT02325713|9996168|FG013|COMPLETED|Intervention Period 2 (2 Days)||2
8934960|NCT02325713|9996169|FG014|COMPLETED|Intervention Period 2 (2 Days)||2
8617254|NCT00455533|9655420|FG001|COMPLETED|Period Two: Randomized Period||139
8617255|NCT00455533|9655421|FG002|COMPLETED|Period Two: Randomized Period||138
8617256|NCT00455533|9655419|FG000|NOT COMPLETED|Period Two: Randomized Period||0
8718133|NCT00996892|9765232|FG018|NOT COMPLETED|Expansion Stage 2||35
8718134|NCT00996892|9765233|FG019|NOT COMPLETED|Expansion Stage 2||0
8934961|NCT02325713|9996170|FG015|COMPLETED|Intervention Period 2 (2 Days)||2
8934962|NCT02325713|9996155|FG000|NOT COMPLETED|Intervention Period 2 (2 Days)||1
8934963|NCT02325713|9996156|FG001|NOT COMPLETED|Intervention Period 2 (2 Days)||0
8934964|NCT02325713|9996157|FG002|NOT COMPLETED|Intervention Period 2 (2 Days)||0
8934965|NCT02325713|9996158|FG003|NOT COMPLETED|Intervention Period 2 (2 Days)||0
8934966|NCT02325713|9996159|FG004|NOT COMPLETED|Intervention Period 2 (2 Days)||0
8934967|NCT02325713|9996160|FG005|NOT COMPLETED|Intervention Period 2 (2 Days)||0
8934968|NCT02325713|9996161|FG006|NOT COMPLETED|Intervention Period 2 (2 Days)||0
8934969|NCT02325713|9996162|FG007|NOT COMPLETED|Intervention Period 2 (2 Days)||0
8934970|NCT02325713|9996163|FG008|NOT COMPLETED|Intervention Period 2 (2 Days)||0
8934971|NCT02325713|9996164|FG009|NOT COMPLETED|Intervention Period 2 (2 Days)||0
8617257|NCT00455533|9655420|FG001|NOT COMPLETED|Period Two: Randomized Period||6
8718135|NCT00996892|9765214|FG000|STARTED|Expansion Stage 2A||0
8934972|NCT02325713|9996165|FG010|NOT COMPLETED|Intervention Period 2 (2 Days)||0
8934973|NCT02325713|9996166|FG011|NOT COMPLETED|Intervention Period 2 (2 Days)||0
8934974|NCT02325713|9996167|FG012|NOT COMPLETED|Intervention Period 2 (2 Days)||0
8934975|NCT02325713|9996168|FG013|NOT COMPLETED|Intervention Period 2 (2 Days)||0
8934976|NCT02325713|9996169|FG014|NOT COMPLETED|Intervention Period 2 (2 Days)||0
8934977|NCT02325713|9996170|FG015|NOT COMPLETED|Intervention Period 2 (2 Days)||0
8934978|NCT02325713|9996155|FG000|STARTED|Intervention Period 3 (2 Days)||1
8934979|NCT02325713|9996156|FG001|STARTED|Intervention Period 3 (2 Days)||2
8934980|NCT02325713|9996157|FG002|STARTED|Intervention Period 3 (2 Days)||2
8617258|NCT00455533|9655421|FG002|NOT COMPLETED|Period Two: Randomized Period||6
8617259|NCT00455650|9655431|FG000|STARTED|Week 1||10
8617260|NCT00455650|9655432|FG001|STARTED|Week 1||10
8617261|NCT00455650|9655433|FG002|STARTED|Week 1||10
8617262|NCT00455650|9655434|FG003|STARTED|Week 1||14
8617263|NCT00455650|9655435|FG004|STARTED|Week 1||14
8617264|NCT00455650|9655436|FG005|STARTED|Week 1||13
8934981|NCT02325713|9996158|FG003|STARTED|Intervention Period 3 (2 Days)||2
8934982|NCT02325713|9996159|FG004|STARTED|Intervention Period 3 (2 Days)||2
8934983|NCT02325713|9996160|FG005|STARTED|Intervention Period 3 (2 Days)||2
8934984|NCT02325713|9996161|FG006|STARTED|Intervention Period 3 (2 Days)||2
8934985|NCT02325713|9996162|FG007|STARTED|Intervention Period 3 (2 Days)||2
8934986|NCT02325713|9996163|FG008|STARTED|Intervention Period 3 (2 Days)||2
8934987|NCT02325713|9996164|FG009|STARTED|Intervention Period 3 (2 Days)||2
8934988|NCT02325713|9996165|FG010|STARTED|Intervention Period 3 (2 Days)||1
8934989|NCT02325713|9996166|FG011|STARTED|Intervention Period 3 (2 Days)||2
8934990|NCT02325713|9996167|FG012|STARTED|Intervention Period 3 (2 Days)||2
8934991|NCT02325713|9996168|FG013|STARTED|Intervention Period 3 (2 Days)||2
8934992|NCT02325713|9996169|FG014|STARTED|Intervention Period 3 (2 Days)||2
8934993|NCT02325713|9996170|FG015|STARTED|Intervention Period 3 (2 Days)||2
8934994|NCT02325713|9996155|FG000|COMPLETED|Intervention Period 3 (2 Days)||1
8934995|NCT02325713|9996156|FG001|COMPLETED|Intervention Period 3 (2 Days)||2
8934996|NCT02325713|9996157|FG002|COMPLETED|Intervention Period 3 (2 Days)||2
8934997|NCT02325713|9996158|FG003|COMPLETED|Intervention Period 3 (2 Days)||2
8934998|NCT02325713|9996159|FG004|COMPLETED|Intervention Period 3 (2 Days)||2
8934999|NCT02325713|9996160|FG005|COMPLETED|Intervention Period 3 (2 Days)||2
8935000|NCT02325713|9996161|FG006|COMPLETED|Intervention Period 3 (2 Days)||2
8935001|NCT02325713|9996162|FG007|COMPLETED|Intervention Period 3 (2 Days)||2
8935002|NCT02325713|9996163|FG008|COMPLETED|Intervention Period 3 (2 Days)||2
8935003|NCT02325713|9996164|FG009|COMPLETED|Intervention Period 3 (2 Days)||1
8935004|NCT02325713|9996165|FG010|COMPLETED|Intervention Period 3 (2 Days)||1
8935005|NCT02325713|9996166|FG011|COMPLETED|Intervention Period 3 (2 Days)||2
8935006|NCT02325713|9996167|FG012|COMPLETED|Intervention Period 3 (2 Days)||2
8935007|NCT02325713|9996168|FG013|COMPLETED|Intervention Period 3 (2 Days)||2
8935008|NCT02325713|9996169|FG014|COMPLETED|Intervention Period 3 (2 Days)||2
8935009|NCT02325713|9996170|FG015|COMPLETED|Intervention Period 3 (2 Days)||2
8935010|NCT02325713|9996155|FG000|NOT COMPLETED|Intervention Period 3 (2 Days)||0
8935011|NCT02325713|9996156|FG001|NOT COMPLETED|Intervention Period 3 (2 Days)||0
8935012|NCT02325713|9996157|FG002|NOT COMPLETED|Intervention Period 3 (2 Days)||0
8935013|NCT02325713|9996158|FG003|NOT COMPLETED|Intervention Period 3 (2 Days)||0
8935014|NCT02325713|9996159|FG004|NOT COMPLETED|Intervention Period 3 (2 Days)||0
8935015|NCT02325713|9996160|FG005|NOT COMPLETED|Intervention Period 3 (2 Days)||0
8935016|NCT02325713|9996161|FG006|NOT COMPLETED|Intervention Period 3 (2 Days)||0
8935017|NCT02325713|9996162|FG007|NOT COMPLETED|Intervention Period 3 (2 Days)||0
8935018|NCT02325713|9996163|FG008|NOT COMPLETED|Intervention Period 3 (2 Days)||0
8935019|NCT02325713|9996164|FG009|NOT COMPLETED|Intervention Period 3 (2 Days)||1
8935020|NCT02325713|9996165|FG010|NOT COMPLETED|Intervention Period 3 (2 Days)||0
8935021|NCT02325713|9996166|FG011|NOT COMPLETED|Intervention Period 3 (2 Days)||0
8935022|NCT02325713|9996167|FG012|NOT COMPLETED|Intervention Period 3 (2 Days)||0
8935023|NCT02325713|9996168|FG013|NOT COMPLETED|Intervention Period 3 (2 Days)||0
8935024|NCT02325713|9996169|FG014|NOT COMPLETED|Intervention Period 3 (2 Days)||0
8935025|NCT02325713|9996170|FG015|NOT COMPLETED|Intervention Period 3 (2 Days)||0
8935026|NCT02325713|9996155|FG000|STARTED|Intervention Period 4 (2 Days)||1
8935027|NCT02325713|9996156|FG001|STARTED|Intervention Period 4 (2 Days)||2
8935028|NCT02325713|9996157|FG002|STARTED|Intervention Period 4 (2 Days)||2
8935029|NCT02325713|9996158|FG003|STARTED|Intervention Period 4 (2 Days)||2
8935030|NCT02325713|9996159|FG004|STARTED|Intervention Period 4 (2 Days)||2
8935031|NCT02325713|9996160|FG005|STARTED|Intervention Period 4 (2 Days)||2
8935032|NCT02325713|9996161|FG006|STARTED|Intervention Period 4 (2 Days)||2
8935033|NCT02325713|9996162|FG007|STARTED|Intervention Period 4 (2 Days)||2
8935034|NCT02325713|9996163|FG008|STARTED|Intervention Period 4 (2 Days)||2
8935035|NCT02325713|9996164|FG009|STARTED|Intervention Period 4 (2 Days)||1
8935036|NCT02325713|9996165|FG010|STARTED|Intervention Period 4 (2 Days)||1
8935037|NCT02325713|9996166|FG011|STARTED|Intervention Period 4 (2 Days)||2
8935038|NCT02325713|9996167|FG012|STARTED|Intervention Period 4 (2 Days)||2
8935039|NCT02325713|9996168|FG013|STARTED|Intervention Period 4 (2 Days)||2
8935040|NCT02325713|9996169|FG014|STARTED|Intervention Period 4 (2 Days)||2
8617265|NCT00455650|9655431|FG000|COMPLETED|Week 1||10
8617266|NCT00455650|9655432|FG001|COMPLETED|Week 1||10
8617267|NCT00455650|9655433|FG002|COMPLETED|Week 1||10
8617268|NCT00455650|9655434|FG003|COMPLETED|Week 1||14
8935041|NCT02325713|9996170|FG015|STARTED|Intervention Period 4 (2 Days)||2
8935042|NCT02325713|9996155|FG000|COMPLETED|Intervention Period 4 (2 Days)||1
8935043|NCT02325713|9996156|FG001|COMPLETED|Intervention Period 4 (2 Days)||2
8935044|NCT02325713|9996157|FG002|COMPLETED|Intervention Period 4 (2 Days)||2
8935045|NCT02325713|9996158|FG003|COMPLETED|Intervention Period 4 (2 Days)||2
8935046|NCT02325713|9996159|FG004|COMPLETED|Intervention Period 4 (2 Days)||2
8935047|NCT02325713|9996160|FG005|COMPLETED|Intervention Period 4 (2 Days)||2
8935048|NCT02325713|9996161|FG006|COMPLETED|Intervention Period 4 (2 Days)||2
8935049|NCT02325713|9996162|FG007|COMPLETED|Intervention Period 4 (2 Days)||2
8935050|NCT02325713|9996163|FG008|COMPLETED|Intervention Period 4 (2 Days)||2
8935051|NCT02325713|9996164|FG009|COMPLETED|Intervention Period 4 (2 Days)||1
8935052|NCT02325713|9996165|FG010|COMPLETED|Intervention Period 4 (2 Days)||1
8935053|NCT02325713|9996166|FG011|COMPLETED|Intervention Period 4 (2 Days)||2
8935054|NCT02325713|9996167|FG012|COMPLETED|Intervention Period 4 (2 Days)||2
8935055|NCT02325713|9996168|FG013|COMPLETED|Intervention Period 4 (2 Days)||2
8935056|NCT02325713|9996169|FG014|COMPLETED|Intervention Period 4 (2 Days)||2
8935057|NCT02325713|9996170|FG015|COMPLETED|Intervention Period 4 (2 Days)||2
8935058|NCT02325713|9996155|FG000|NOT COMPLETED|Intervention Period 4 (2 Days)||0
8935059|NCT02325713|9996156|FG001|NOT COMPLETED|Intervention Period 4 (2 Days)||0
8935060|NCT02325713|9996157|FG002|NOT COMPLETED|Intervention Period 4 (2 Days)||0
8935061|NCT02325713|9996158|FG003|NOT COMPLETED|Intervention Period 4 (2 Days)||0
8935062|NCT02325713|9996159|FG004|NOT COMPLETED|Intervention Period 4 (2 Days)||0
8935063|NCT02325713|9996160|FG005|NOT COMPLETED|Intervention Period 4 (2 Days)||0
8935064|NCT02325713|9996161|FG006|NOT COMPLETED|Intervention Period 4 (2 Days)||0
8935065|NCT02325713|9996162|FG007|NOT COMPLETED|Intervention Period 4 (2 Days)||0
8935066|NCT02325713|9996163|FG008|NOT COMPLETED|Intervention Period 4 (2 Days)||0
8935067|NCT02325713|9996164|FG009|NOT COMPLETED|Intervention Period 4 (2 Days)||0
8935068|NCT02325713|9996165|FG010|NOT COMPLETED|Intervention Period 4 (2 Days)||0
8935069|NCT02325713|9996166|FG011|NOT COMPLETED|Intervention Period 4 (2 Days)||0
8935070|NCT02325713|9996167|FG012|NOT COMPLETED|Intervention Period 4 (2 Days)||0
8935071|NCT02325713|9996168|FG013|NOT COMPLETED|Intervention Period 4 (2 Days)||0
8935072|NCT02325713|9996169|FG014|NOT COMPLETED|Intervention Period 4 (2 Days)||0
8935073|NCT02325713|9996170|FG015|NOT COMPLETED|Intervention Period 4 (2 Days)||0
8935074|NCT02325739|9996196|FG000|STARTED|Phase I Part||11
8935075|NCT02325739|9996197|FG001|STARTED|Phase I Part||6
8935076|NCT02325739|9996198|FG002|STARTED|Phase I Part||5
8935077|NCT02325739|9996199|FG003|STARTED|Phase I Part||26
8935078|NCT02325739|9996200|FG004|STARTED|Phase I Part||19
8935079|NCT02325739|9996201|FG005|STARTED|Phase I Part||7
8935080|NCT02325739|9996202|FG006|STARTED|Phase I Part||6
8935081|NCT02325739|9996203|FG007|STARTED|Phase I Part||6
8935082|NCT02325739|9996204|FG008|STARTED|Phase I Part||0
8935083|NCT02325739|9996205|FG009|STARTED|Phase I Part||0
8935084|NCT02325739|9996206|FG010|STARTED|Phase I Part||0
8935085|NCT02325739|9996196|FG000|COMPLETED|Phase I Part||0
8935086|NCT02325739|9996197|FG001|COMPLETED|Phase I Part||0
8935087|NCT02325739|9996198|FG002|COMPLETED|Phase I Part||0
8935088|NCT02325739|9996199|FG003|COMPLETED|Phase I Part||0
8935089|NCT02325739|9996200|FG004|COMPLETED|Phase I Part||0
8935090|NCT02325739|9996201|FG005|COMPLETED|Phase I Part||0
8935091|NCT02325739|9996202|FG006|COMPLETED|Phase I Part||0
8935092|NCT02325739|9996203|FG007|COMPLETED|Phase I Part||0
8935093|NCT02325739|9996204|FG008|COMPLETED|Phase I Part||0
8935094|NCT02325739|9996205|FG009|COMPLETED|Phase I Part||0
8935095|NCT02325739|9996206|FG010|COMPLETED|Phase I Part||0
8935096|NCT02325739|9996196|FG000|NOT COMPLETED|Phase I Part||11
8935097|NCT02325739|9996197|FG001|NOT COMPLETED|Phase I Part||6
8935098|NCT02325739|9996198|FG002|NOT COMPLETED|Phase I Part||5
8935099|NCT02325739|9996199|FG003|NOT COMPLETED|Phase I Part||26
8935100|NCT02325739|9996200|FG004|NOT COMPLETED|Phase I Part||19
8935101|NCT02325739|9996201|FG005|NOT COMPLETED|Phase I Part||7
8935102|NCT02325739|9996202|FG006|NOT COMPLETED|Phase I Part||6
8935103|NCT02325739|9996203|FG007|NOT COMPLETED|Phase I Part||6
8935104|NCT02325739|9996204|FG008|NOT COMPLETED|Phase I Part||0
8935105|NCT02325739|9996205|FG009|NOT COMPLETED|Phase I Part||0
8935106|NCT02325739|9996206|FG010|NOT COMPLETED|Phase I Part||0
8935107|NCT02325739|9996196|FG000|STARTED|Phase II Part||0
8935108|NCT02325739|9996197|FG001|STARTED|Phase II Part||0
8935109|NCT02325739|9996198|FG002|STARTED|Phase II Part||0
8935110|NCT02325739|9996199|FG003|STARTED|Phase II Part||0
8935111|NCT02325739|9996200|FG004|STARTED|Phase II Part||0
8935112|NCT02325739|9996201|FG005|STARTED|Phase II Part||0
8935113|NCT02325739|9996202|FG006|STARTED|Phase II Part||0
8935114|NCT02325739|9996203|FG007|STARTED|Phase II Part||0
8935115|NCT02325739|9996204|FG008|STARTED|Phase II Part||30
8935116|NCT02325739|9996205|FG009|STARTED|Phase II Part||36
8935117|NCT02325739|9996206|FG010|STARTED|Phase II Part||20
8935118|NCT02325739|9996196|FG000|COMPLETED|Phase II Part||0
8935119|NCT02325739|9996197|FG001|COMPLETED|Phase II Part||0
8935120|NCT02325739|9996198|FG002|COMPLETED|Phase II Part||0
8935121|NCT02325739|9996199|FG003|COMPLETED|Phase II Part||0
8935122|NCT02325739|9996200|FG004|COMPLETED|Phase II Part||0
8935123|NCT02325739|9996201|FG005|COMPLETED|Phase II Part||0
8935124|NCT02325739|9996202|FG006|COMPLETED|Phase II Part||0
8935125|NCT02325739|9996203|FG007|COMPLETED|Phase II Part||0
8935126|NCT02325739|9996204|FG008|COMPLETED|Phase II Part||0
8935127|NCT02325739|9996205|FG009|COMPLETED|Phase II Part||0
8935128|NCT02325739|9996206|FG010|COMPLETED|Phase II Part||0
8935129|NCT02325739|9996196|FG000|NOT COMPLETED|Phase II Part||0
8935130|NCT02325739|9996197|FG001|NOT COMPLETED|Phase II Part||0
8935131|NCT02325739|9996198|FG002|NOT COMPLETED|Phase II Part||0
8935132|NCT02325739|9996199|FG003|NOT COMPLETED|Phase II Part||0
8935133|NCT02325739|9996200|FG004|NOT COMPLETED|Phase II Part||0
8935134|NCT02325739|9996201|FG005|NOT COMPLETED|Phase II Part||0
8935135|NCT02325739|9996202|FG006|NOT COMPLETED|Phase II Part||0
8935136|NCT02325739|9996203|FG007|NOT COMPLETED|Phase II Part||0
8935137|NCT02325739|9996204|FG008|NOT COMPLETED|Phase II Part||30
8935138|NCT02325739|9996205|FG009|NOT COMPLETED|Phase II Part||36
8935139|NCT02325739|9996206|FG010|NOT COMPLETED|Phase II Part||20
8935140|NCT02325791|9996255|FG000|STARTED|Overall Study||23
8935141|NCT02325791|9996256|FG001|STARTED|Overall Study||383
8935142|NCT02325791|9996257|FG002|STARTED|Overall Study||385
8935143|NCT02325791|9996258|FG003|STARTED|Overall Study||381
8935144|NCT02325791|9996255|FG000|COMPLETED|Overall Study||23
8935145|NCT02325791|9996256|FG001|COMPLETED|Overall Study||358
8935146|NCT02325791|9996257|FG002|COMPLETED|Overall Study||360
8935147|NCT02325791|9996258|FG003|COMPLETED|Overall Study||355
8935148|NCT02325791|9996255|FG000|NOT COMPLETED|Overall Study||0
8935149|NCT02325791|9996256|FG001|NOT COMPLETED|Overall Study||25
8935150|NCT02325791|9996257|FG002|NOT COMPLETED|Overall Study||25
8935151|NCT02325791|9996258|FG003|NOT COMPLETED|Overall Study||26
8935152|NCT02325856|9996273|FG000|STARTED|Overall Study||148
8935153|NCT02325856|9996274|FG001|STARTED|Overall Study||150
8935154|NCT02325856|9996273|FG000|COMPLETED|Overall Study||128
8935155|NCT02325856|9996274|FG001|COMPLETED|Overall Study||123
8935156|NCT02325856|9996273|FG000|NOT COMPLETED|Overall Study||20
8935157|NCT02325856|9996274|FG001|NOT COMPLETED|Overall Study||27
8935158|NCT02326025|9996282|FG000|STARTED|Overall Study||25
8935159|NCT02326025|9996283|FG001|STARTED|Overall Study||24
8935160|NCT02326025|9996282|FG000|Received at Least 1 Dose of Study Drug|Overall Study||25
8935161|NCT02326025|9996283|FG001|Received at Least 1 Dose of Study Drug|Overall Study||24
8935162|NCT02326025|9996282|FG000|COMPLETED|Overall Study||20
8935163|NCT02326025|9996283|FG001|COMPLETED|Overall Study||19
8935164|NCT02326025|9996282|FG000|NOT COMPLETED|Overall Study||5
8935165|NCT02326025|9996283|FG001|NOT COMPLETED|Overall Study||5
8935166|NCT02326220|9996304|FG000|STARTED|Double-blind Treatment Period|Out of 21 participants, 9 participants entered in open label treatment period|21
8935167|NCT02326220|9996305|FG001|STARTED|Double-blind Treatment Period|Out of 41 participants, 20 participants entered in open label treatment period.|41
8935168|NCT02326220|9996306|FG002|STARTED|Double-blind Treatment Period||0
8935169|NCT02326220|9996304|FG000|COMPLETED|Double-blind Treatment Period||20
8935170|NCT02326220|9996305|FG001|COMPLETED|Double-blind Treatment Period||37
8935171|NCT02326220|9996306|FG002|COMPLETED|Double-blind Treatment Period||0
8935172|NCT02326220|9996304|FG000|NOT COMPLETED|Double-blind Treatment Period||1
8935173|NCT02326220|9996305|FG001|NOT COMPLETED|Double-blind Treatment Period||4
8935174|NCT02326220|9996306|FG002|NOT COMPLETED|Double-blind Treatment Period||0
8935175|NCT02326220|9996304|FG000|STARTED|Open-label Treatment Period||0
8935176|NCT02326220|9996305|FG001|STARTED|Open-label Treatment Period||0
8935177|NCT02326220|9996306|FG002|STARTED|Open-label Treatment Period|29 participants: 9 from Placebo and 20 from Alirocumab 150 mg arm entered in open-label period.|29
8935178|NCT02326220|9996304|FG000|COMPLETED|Open-label Treatment Period||0
8935179|NCT02326220|9996305|FG001|COMPLETED|Open-label Treatment Period||0
8935180|NCT02326220|9996306|FG002|COMPLETED|Open-label Treatment Period||27
8935181|NCT02326220|9996304|FG000|NOT COMPLETED|Open-label Treatment Period||0
8718136|NCT00996892|9765215|FG001|STARTED|Expansion Stage 2A||0
8718137|NCT00996892|9765216|FG002|STARTED|Expansion Stage 2A||0
8718138|NCT00996892|9765217|FG003|STARTED|Expansion Stage 2A||0
8718139|NCT00996892|9765218|FG004|STARTED|Expansion Stage 2A||0
8718140|NCT00996892|9765219|FG005|STARTED|Expansion Stage 2A||0
8718141|NCT00996892|9765220|FG006|STARTED|Expansion Stage 2A||0
8718142|NCT00996892|9765221|FG007|STARTED|Expansion Stage 2A||0
8718143|NCT00996892|9765222|FG008|STARTED|Expansion Stage 2A||0
8718144|NCT00996892|9765223|FG009|STARTED|Expansion Stage 2A||0
8718145|NCT00996892|9765224|FG010|STARTED|Expansion Stage 2A||0
8718146|NCT00996892|9765225|FG011|STARTED|Expansion Stage 2A||0
8718147|NCT00996892|9765226|FG012|STARTED|Expansion Stage 2A||0
8718148|NCT00996892|9765227|FG013|STARTED|Expansion Stage 2A||0
8718149|NCT00996892|9765228|FG014|STARTED|Expansion Stage 2A||0
8718150|NCT00996892|9765229|FG015|STARTED|Expansion Stage 2A||0
8718151|NCT00996892|9765230|FG016|STARTED|Expansion Stage 2A||0
8718152|NCT00996892|9765231|FG017|STARTED|Expansion Stage 2A||0
8718153|NCT00996892|9765232|FG018|STARTED|Expansion Stage 2A||0
8718154|NCT00996892|9765233|FG019|STARTED|Expansion Stage 2A||45
8718155|NCT00996892|9765214|FG000|COMPLETED|Expansion Stage 2A||0
8718156|NCT00996892|9765215|FG001|COMPLETED|Expansion Stage 2A||0
8935182|NCT02326220|9996305|FG001|NOT COMPLETED|Open-label Treatment Period||0
8935183|NCT02326220|9996306|FG002|NOT COMPLETED|Open-label Treatment Period||2
8935184|NCT02326233|9996318|FG000|STARTED|Overall Study||95
8935185|NCT02326233|9996319|FG001|STARTED|Overall Study||95
8935186|NCT02326233|9996318|FG000|COMPLETED|Overall Study||95
8935187|NCT02326233|9996319|FG001|COMPLETED|Overall Study||94
8935188|NCT02326233|9996318|FG000|NOT COMPLETED|Overall Study||0
8935189|NCT02326233|9996319|FG001|NOT COMPLETED|Overall Study||1
8935190|NCT02326272|9996328|FG000|STARTED|Initial Period (Week 0 to Week 16)||49
8718157|NCT00996892|9765216|FG002|COMPLETED|Expansion Stage 2A||0
8935191|NCT02326272|9996329|FG001|STARTED|Initial Period (Week 0 to Week 16)||91
8935192|NCT02326272|9996330|FG002|STARTED|Initial Period (Week 0 to Week 16)||87
8935193|NCT02326272|9996331|FG003|STARTED|Initial Period (Week 0 to Week 16)||0
8935194|NCT02326272|9996332|FG004|STARTED|Initial Period (Week 0 to Week 16)||0
8935195|NCT02326272|9996333|FG005|STARTED|Initial Period (Week 0 to Week 16)||0
8935196|NCT02326272|9996334|FG006|STARTED|Initial Period (Week 0 to Week 16)||0
8935197|NCT02326272|9996335|FG007|STARTED|Initial Period (Week 0 to Week 16)||0
8935198|NCT02326272|9996336|FG008|STARTED|Initial Period (Week 0 to Week 16)||0
8935199|NCT02326272|9996337|FG009|STARTED|Initial Period (Week 0 to Week 16)||0
8935200|NCT02326272|9996338|FG010|STARTED|Initial Period (Week 0 to Week 16)||0
8935201|NCT02326272|9996339|FG011|STARTED|Initial Period (Week 0 to Week 16)||0
8935202|NCT02326272|9996340|FG012|STARTED|Initial Period (Week 0 to Week 16)||0
8935203|NCT02326272|9996341|FG013|STARTED|Initial Period (Week 0 to Week 16)||0
8935204|NCT02326272|9996342|FG014|STARTED|Initial Period (Week 0 to Week 16)||0
8935205|NCT02326272|9996328|FG000|Completed Week 16|Initial Period (Week 0 to Week 16)||45
8935206|NCT02326272|9996329|FG001|Completed Week 16|Initial Period (Week 0 to Week 16)||84
8935207|NCT02326272|9996330|FG002|Completed Week 16|Initial Period (Week 0 to Week 16)||83
8935208|NCT02326272|9996331|FG003|Completed Week 16|Initial Period (Week 0 to Week 16)||0
8935209|NCT02326272|9996332|FG004|Completed Week 16|Initial Period (Week 0 to Week 16)||0
8935210|NCT02326272|9996333|FG005|Completed Week 16|Initial Period (Week 0 to Week 16)||0
8935211|NCT02326272|9996334|FG006|Completed Week 16|Initial Period (Week 0 to Week 16)||0
8935212|NCT02326272|9996335|FG007|Completed Week 16|Initial Period (Week 0 to Week 16)||0
8935213|NCT02326272|9996336|FG008|Completed Week 16|Initial Period (Week 0 to Week 16)||0
8935214|NCT02326272|9996337|FG009|Completed Week 16|Initial Period (Week 0 to Week 16)||0
8935215|NCT02326272|9996338|FG010|Completed Week 16|Initial Period (Week 0 to Week 16)||0
8935216|NCT02326272|9996339|FG011|Completed Week 16|Initial Period (Week 0 to Week 16)||0
8935217|NCT02326272|9996340|FG012|Completed Week 16|Initial Period (Week 0 to Week 16)||0
8935218|NCT02326272|9996341|FG013|Completed Week 16|Initial Period (Week 0 to Week 16)||0
8935219|NCT02326272|9996342|FG014|Completed Week 16|Initial Period (Week 0 to Week 16)||0
8935220|NCT02326272|9996328|FG000|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||45
8935221|NCT02326272|9996329|FG001|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||84
8935222|NCT02326272|9996330|FG002|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||81
8935223|NCT02326272|9996331|FG003|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
8935224|NCT02326272|9996332|FG004|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
8935225|NCT02326272|9996333|FG005|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
8935226|NCT02326272|9996334|FG006|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
8935227|NCT02326272|9996335|FG007|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
8935228|NCT02326272|9996336|FG008|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
8935229|NCT02326272|9996337|FG009|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
8935230|NCT02326272|9996338|FG010|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
8935231|NCT02326272|9996339|FG011|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
8935232|NCT02326272|9996340|FG012|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
8935233|NCT02326272|9996341|FG013|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
8935234|NCT02326272|9996342|FG014|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
8935235|NCT02326272|9996328|FG000|COMPLETED|Initial Period (Week 0 to Week 16)||45
8935236|NCT02326272|9996329|FG001|COMPLETED|Initial Period (Week 0 to Week 16)||84
8935237|NCT02326272|9996330|FG002|COMPLETED|Initial Period (Week 0 to Week 16)||81
8935238|NCT02326272|9996331|FG003|COMPLETED|Initial Period (Week 0 to Week 16)||0
8935239|NCT02326272|9996332|FG004|COMPLETED|Initial Period (Week 0 to Week 16)||0
8935240|NCT02326272|9996333|FG005|COMPLETED|Initial Period (Week 0 to Week 16)||0
8935241|NCT02326272|9996334|FG006|COMPLETED|Initial Period (Week 0 to Week 16)||0
8935242|NCT02326272|9996335|FG007|COMPLETED|Initial Period (Week 0 to Week 16)||0
8935243|NCT02326272|9996336|FG008|COMPLETED|Initial Period (Week 0 to Week 16)||0
8935244|NCT02326272|9996337|FG009|COMPLETED|Initial Period (Week 0 to Week 16)||0
8935245|NCT02326272|9996338|FG010|COMPLETED|Initial Period (Week 0 to Week 16)||0
8935246|NCT02326272|9996339|FG011|COMPLETED|Initial Period (Week 0 to Week 16)||0
8935247|NCT02326272|9996340|FG012|COMPLETED|Initial Period (Week 0 to Week 16)||0
8935248|NCT02326272|9996341|FG013|COMPLETED|Initial Period (Week 0 to Week 16)||0
8935249|NCT02326272|9996342|FG014|COMPLETED|Initial Period (Week 0 to Week 16)||0
8935250|NCT02326272|9996328|FG000|NOT COMPLETED|Initial Period (Week 0 to Week 16)||4
8935251|NCT02326272|9996329|FG001|NOT COMPLETED|Initial Period (Week 0 to Week 16)||7
8935252|NCT02326272|9996330|FG002|NOT COMPLETED|Initial Period (Week 0 to Week 16)||6
8935253|NCT02326272|9996331|FG003|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8935254|NCT02326272|9996332|FG004|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8935255|NCT02326272|9996333|FG005|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8935256|NCT02326272|9996334|FG006|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8935257|NCT02326272|9996335|FG007|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8935258|NCT02326272|9996336|FG008|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8935259|NCT02326272|9996337|FG009|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8935260|NCT02326272|9996338|FG010|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8935261|NCT02326272|9996339|FG011|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8935262|NCT02326272|9996340|FG012|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8935263|NCT02326272|9996341|FG013|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8935264|NCT02326272|9996342|FG014|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8935265|NCT02326272|9996328|FG000|STARTED|Maintenance Period (Week 16 to Week 48)||0
8935266|NCT02326272|9996329|FG001|STARTED|Maintenance Period (Week 16 to Week 48)||0
8935267|NCT02326272|9996330|FG002|STARTED|Maintenance Period (Week 16 to Week 48)||0
8935268|NCT02326272|9996331|FG003|STARTED|Maintenance Period (Week 16 to Week 48)||6
8935269|NCT02326272|9996332|FG004|STARTED|Maintenance Period (Week 16 to Week 48)||5
8935270|NCT02326272|9996333|FG005|STARTED|Maintenance Period (Week 16 to Week 48)||76
8935271|NCT02326272|9996334|FG006|STARTED|Maintenance Period (Week 16 to Week 48)||69
8935272|NCT02326272|9996335|FG007|STARTED|Maintenance Period (Week 16 to Week 48)||34
8935273|NCT02326272|9996336|FG008|STARTED|Maintenance Period (Week 16 to Week 48)||8
8935274|NCT02326272|9996337|FG009|STARTED|Maintenance Period (Week 16 to Week 48)||12
8935275|NCT02326272|9996338|FG010|STARTED|Maintenance Period (Week 16 to Week 48)||0
8935276|NCT02326272|9996339|FG011|STARTED|Maintenance Period (Week 16 to Week 48)||0
8935277|NCT02326272|9996340|FG012|STARTED|Maintenance Period (Week 16 to Week 48)||0
8935278|NCT02326272|9996341|FG013|STARTED|Maintenance Period (Week 16 to Week 48)||0
8935279|NCT02326272|9996342|FG014|STARTED|Maintenance Period (Week 16 to Week 48)||0
8935280|NCT02326272|9996328|FG000|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
8935281|NCT02326272|9996329|FG001|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
8935282|NCT02326272|9996330|FG002|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
8935283|NCT02326272|9996331|FG003|Completed Week 48|Maintenance Period (Week 16 to Week 48)||5
8935284|NCT02326272|9996332|FG004|Completed Week 48|Maintenance Period (Week 16 to Week 48)||3
8935285|NCT02326272|9996333|FG005|Completed Week 48|Maintenance Period (Week 16 to Week 48)||64
8935286|NCT02326272|9996334|FG006|Completed Week 48|Maintenance Period (Week 16 to Week 48)||61
8935287|NCT02326272|9996335|FG007|Completed Week 48|Maintenance Period (Week 16 to Week 48)||27
8935288|NCT02326272|9996336|FG008|Completed Week 48|Maintenance Period (Week 16 to Week 48)||3
8935289|NCT02326272|9996337|FG009|Completed Week 48|Maintenance Period (Week 16 to Week 48)||10
8935290|NCT02326272|9996338|FG010|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
8935291|NCT02326272|9996339|FG011|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
8935292|NCT02326272|9996340|FG012|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
8935293|NCT02326272|9996341|FG013|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
8935294|NCT02326272|9996342|FG014|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
8935295|NCT02326272|9996328|FG000|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8718158|NCT00996892|9765217|FG003|COMPLETED|Expansion Stage 2A||0
8718159|NCT00996892|9765218|FG004|COMPLETED|Expansion Stage 2A||0
8718160|NCT00996892|9765219|FG005|COMPLETED|Expansion Stage 2A||0
8718161|NCT00996892|9765220|FG006|COMPLETED|Expansion Stage 2A||0
8718162|NCT00996892|9765221|FG007|COMPLETED|Expansion Stage 2A||0
8718163|NCT00996892|9765222|FG008|COMPLETED|Expansion Stage 2A||0
8718164|NCT00996892|9765223|FG009|COMPLETED|Expansion Stage 2A||0
8718165|NCT00996892|9765224|FG010|COMPLETED|Expansion Stage 2A||0
8718166|NCT00996892|9765225|FG011|COMPLETED|Expansion Stage 2A||0
8718167|NCT00996892|9765226|FG012|COMPLETED|Expansion Stage 2A||0
8718168|NCT00996892|9765227|FG013|COMPLETED|Expansion Stage 2A||0
8718169|NCT00996892|9765228|FG014|COMPLETED|Expansion Stage 2A||0
8718170|NCT00996892|9765229|FG015|COMPLETED|Expansion Stage 2A||0
8718171|NCT00996892|9765230|FG016|COMPLETED|Expansion Stage 2A||0
8718172|NCT00996892|9765231|FG017|COMPLETED|Expansion Stage 2A||0
8718173|NCT00996892|9765232|FG018|COMPLETED|Expansion Stage 2A||0
8718174|NCT00996892|9765233|FG019|COMPLETED|Expansion Stage 2A||0
8718175|NCT00996892|9765214|FG000|NOT COMPLETED|Expansion Stage 2A||0
8935296|NCT02326272|9996329|FG001|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8935297|NCT02326272|9996330|FG002|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8935298|NCT02326272|9996331|FG003|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||5
8935299|NCT02326272|9996332|FG004|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||3
8935300|NCT02326272|9996333|FG005|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||63
8935301|NCT02326272|9996334|FG006|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||60
8718176|NCT00996892|9765215|FG001|NOT COMPLETED|Expansion Stage 2A||0
8718177|NCT00996892|9765216|FG002|NOT COMPLETED|Expansion Stage 2A||0
8718178|NCT00996892|9765217|FG003|NOT COMPLETED|Expansion Stage 2A||0
8718179|NCT00996892|9765218|FG004|NOT COMPLETED|Expansion Stage 2A||0
8718180|NCT00996892|9765219|FG005|NOT COMPLETED|Expansion Stage 2A||0
8718181|NCT00996892|9765220|FG006|NOT COMPLETED|Expansion Stage 2A||0
8718182|NCT00996892|9765221|FG007|NOT COMPLETED|Expansion Stage 2A||0
8718183|NCT00996892|9765222|FG008|NOT COMPLETED|Expansion Stage 2A||0
8718184|NCT00996892|9765223|FG009|NOT COMPLETED|Expansion Stage 2A||0
8718185|NCT00996892|9765224|FG010|NOT COMPLETED|Expansion Stage 2A||0
8718186|NCT00996892|9765225|FG011|NOT COMPLETED|Expansion Stage 2A||0
8718187|NCT00996892|9765226|FG012|NOT COMPLETED|Expansion Stage 2A||0
8718188|NCT00996892|9765227|FG013|NOT COMPLETED|Expansion Stage 2A||0
8718189|NCT00996892|9765228|FG014|NOT COMPLETED|Expansion Stage 2A||0
8718190|NCT00996892|9765229|FG015|NOT COMPLETED|Expansion Stage 2A||0
8718191|NCT00996892|9765230|FG016|NOT COMPLETED|Expansion Stage 2A||0
8935302|NCT02326272|9996335|FG007|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||27
8935303|NCT02326272|9996336|FG008|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||3
8935304|NCT02326272|9996337|FG009|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||10
8935305|NCT02326272|9996338|FG010|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8935306|NCT02326272|9996339|FG011|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8935307|NCT02326272|9996340|FG012|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8935308|NCT02326272|9996341|FG013|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8935309|NCT02326272|9996342|FG014|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8935310|NCT02326272|9996328|FG000|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8935311|NCT02326272|9996329|FG001|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8935312|NCT02326272|9996330|FG002|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8935313|NCT02326272|9996331|FG003|COMPLETED|Maintenance Period (Week 16 to Week 48)||5
8935314|NCT02326272|9996332|FG004|COMPLETED|Maintenance Period (Week 16 to Week 48)||3
8935315|NCT02326272|9996333|FG005|COMPLETED|Maintenance Period (Week 16 to Week 48)||63
8935316|NCT02326272|9996334|FG006|COMPLETED|Maintenance Period (Week 16 to Week 48)||60
8935317|NCT02326272|9996335|FG007|COMPLETED|Maintenance Period (Week 16 to Week 48)||27
8935318|NCT02326272|9996336|FG008|COMPLETED|Maintenance Period (Week 16 to Week 48)||3
8935319|NCT02326272|9996337|FG009|COMPLETED|Maintenance Period (Week 16 to Week 48)||10
8935320|NCT02326272|9996338|FG010|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8935321|NCT02326272|9996339|FG011|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8935322|NCT02326272|9996340|FG012|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8935323|NCT02326272|9996341|FG013|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8935324|NCT02326272|9996342|FG014|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8935325|NCT02326272|9996328|FG000|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8935326|NCT02326272|9996329|FG001|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8935327|NCT02326272|9996330|FG002|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8935328|NCT02326272|9996331|FG003|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||1
8935329|NCT02326272|9996332|FG004|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2
8935330|NCT02326272|9996333|FG005|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||13
8935331|NCT02326272|9996334|FG006|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||9
8935332|NCT02326272|9996335|FG007|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||7
8935333|NCT02326272|9996336|FG008|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||5
8935334|NCT02326272|9996337|FG009|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2
8935335|NCT02326272|9996338|FG010|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8935336|NCT02326272|9996339|FG011|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8935337|NCT02326272|9996340|FG012|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8935338|NCT02326272|9996341|FG013|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8935339|NCT02326272|9996342|FG014|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8935340|NCT02326272|9996328|FG000|STARTED|Open-label Period (Week 48 to Week 144)||0
8935341|NCT02326272|9996329|FG001|STARTED|Open-label Period (Week 48 to Week 144)||0
8935342|NCT02326272|9996330|FG002|STARTED|Open-label Period (Week 48 to Week 144)||0
8935343|NCT02326272|9996331|FG003|STARTED|Open-label Period (Week 48 to Week 144)||0
8935344|NCT02326272|9996332|FG004|STARTED|Open-label Period (Week 48 to Week 144)||0
8935345|NCT02326272|9996333|FG005|STARTED|Open-label Period (Week 48 to Week 144)||0
8935346|NCT02326272|9996334|FG006|STARTED|Open-label Period (Week 48 to Week 144)||0
8935347|NCT02326272|9996335|FG007|STARTED|Open-label Period (Week 48 to Week 144)||0
8935348|NCT02326272|9996336|FG008|STARTED|Open-label Period (Week 48 to Week 144)||0
8935349|NCT02326272|9996337|FG009|STARTED|Open-label Period (Week 48 to Week 144)||0
8935350|NCT02326272|9996338|FG010|STARTED|Open-label Period (Week 48 to Week 144)||5
8935351|NCT02326272|9996339|FG011|STARTED|Open-label Period (Week 48 to Week 144)||66
8935352|NCT02326272|9996340|FG012|STARTED|Open-label Period (Week 48 to Week 144)||59
8935353|NCT02326272|9996341|FG013|STARTED|Open-label Period (Week 48 to Week 144)||1
8935354|NCT02326272|9996342|FG014|STARTED|Open-label Period (Week 48 to Week 144)||40
8935355|NCT02326272|9996328|FG000|COMPLETED|Open-label Period (Week 48 to Week 144)||0
8935356|NCT02326272|9996329|FG001|COMPLETED|Open-label Period (Week 48 to Week 144)||0
8935357|NCT02326272|9996330|FG002|COMPLETED|Open-label Period (Week 48 to Week 144)||0
8935358|NCT02326272|9996331|FG003|COMPLETED|Open-label Period (Week 48 to Week 144)||0
8935359|NCT02326272|9996332|FG004|COMPLETED|Open-label Period (Week 48 to Week 144)||0
8935360|NCT02326272|9996333|FG005|COMPLETED|Open-label Period (Week 48 to Week 144)||0
8935361|NCT02326272|9996334|FG006|COMPLETED|Open-label Period (Week 48 to Week 144)||0
8935362|NCT02326272|9996335|FG007|COMPLETED|Open-label Period (Week 48 to Week 144)||0
8935363|NCT02326272|9996336|FG008|COMPLETED|Open-label Period (Week 48 to Week 144)||0
8935364|NCT02326272|9996337|FG009|COMPLETED|Open-label Period (Week 48 to Week 144)||0
8935365|NCT02326272|9996338|FG010|COMPLETED|Open-label Period (Week 48 to Week 144)||2
8935366|NCT02326272|9996339|FG011|COMPLETED|Open-label Period (Week 48 to Week 144)||51
8935367|NCT02326272|9996340|FG012|COMPLETED|Open-label Period (Week 48 to Week 144)||48
8935368|NCT02326272|9996341|FG013|COMPLETED|Open-label Period (Week 48 to Week 144)||1
8718192|NCT00996892|9765231|FG017|NOT COMPLETED|Expansion Stage 2A||0
8718193|NCT00996892|9765232|FG018|NOT COMPLETED|Expansion Stage 2A||0
8718194|NCT00996892|9765233|FG019|NOT COMPLETED|Expansion Stage 2A||45
8718195|NCT00996918|9765299|FG000|STARTED|Overall Study||39
8935369|NCT02326272|9996342|FG014|COMPLETED|Open-label Period (Week 48 to Week 144)||31
8935370|NCT02326272|9996328|FG000|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
8935371|NCT02326272|9996329|FG001|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
8935372|NCT02326272|9996330|FG002|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
8935373|NCT02326272|9996331|FG003|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
8935374|NCT02326272|9996332|FG004|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
8935375|NCT02326272|9996333|FG005|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
8935376|NCT02326272|9996334|FG006|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
8935377|NCT02326272|9996335|FG007|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
8935378|NCT02326272|9996336|FG008|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
8935379|NCT02326272|9996337|FG009|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
8935380|NCT02326272|9996338|FG010|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||3
8935381|NCT02326272|9996339|FG011|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||15
8935382|NCT02326272|9996340|FG012|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||11
8935383|NCT02326272|9996341|FG013|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
8935384|NCT02326272|9996342|FG014|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||9
8935385|NCT02326298|9996354|FG000|STARTED|Initial Period (Week 0 to Week 16)||51
8935386|NCT02326298|9996355|FG001|STARTED|Initial Period (Week 0 to Week 16)||95
8935387|NCT02326298|9996356|FG002|STARTED|Initial Period (Week 0 to Week 16)||88
8935388|NCT02326298|9996357|FG003|STARTED|Initial Period (Week 0 to Week 16)||0
8935389|NCT02326298|9996358|FG004|STARTED|Initial Period (Week 0 to Week 16)||0
8935390|NCT02326298|9996359|FG005|STARTED|Initial Period (Week 0 to Week 16)||0
8935391|NCT02326298|9996360|FG006|STARTED|Initial Period (Week 0 to Week 16)||0
8935392|NCT02326298|9996361|FG007|STARTED|Initial Period (Week 0 to Week 16)||0
8935393|NCT02326298|9996362|FG008|STARTED|Initial Period (Week 0 to Week 16)||0
8935394|NCT02326298|9996363|FG009|STARTED|Initial Period (Week 0 to Week 16)||0
8935395|NCT02326298|9996364|FG010|STARTED|Initial Period (Week 0 to Week 16)||0
8935396|NCT02326298|9996365|FG011|STARTED|Initial Period (Week 0 to Week 16)||0
8935397|NCT02326298|9996366|FG012|STARTED|Initial Period (Week 0 to Week 16)||0
8935398|NCT02326298|9996367|FG013|STARTED|Initial Period (Week 0 to Week 16)||0
8935399|NCT02326298|9996354|FG000|Completed Week 16|Initial Period (Week 0 to Week 16)||46
8935400|NCT02326298|9996355|FG001|Completed Week 16|Initial Period (Week 0 to Week 16)||92
8935401|NCT02326298|9996356|FG002|Completed Week 16|Initial Period (Week 0 to Week 16)||87
8935402|NCT02326298|9996357|FG003|Completed Week 16|Initial Period (Week 0 to Week 16)||0
8935403|NCT02326298|9996358|FG004|Completed Week 16|Initial Period (Week 0 to Week 16)||0
8935404|NCT02326298|9996359|FG005|Completed Week 16|Initial Period (Week 0 to Week 16)||0
8935405|NCT02326298|9996360|FG006|Completed Week 16|Initial Period (Week 0 to Week 16)||0
8935406|NCT02326298|9996361|FG007|Completed Week 16|Initial Period (Week 0 to Week 16)||0
8935407|NCT02326298|9996362|FG008|Completed Week 16|Initial Period (Week 0 to Week 16)||0
8935408|NCT02326298|9996363|FG009|Completed Week 16|Initial Period (Week 0 to Week 16)||0
8935409|NCT02326298|9996364|FG010|Completed Week 16|Initial Period (Week 0 to Week 16)||0
8935410|NCT02326298|9996365|FG011|Completed Week 16|Initial Period (Week 0 to Week 16)||0
8935411|NCT02326298|9996366|FG012|Completed Week 16|Initial Period (Week 0 to Week 16)||0
8935412|NCT02326298|9996367|FG013|Completed Week 16|Initial Period (Week 0 to Week 16)||0
8935413|NCT02326298|9996354|FG000|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||46
8935414|NCT02326298|9996355|FG001|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||92
8935415|NCT02326298|9996356|FG002|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||85
8935416|NCT02326298|9996357|FG003|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
8935417|NCT02326298|9996358|FG004|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
8935418|NCT02326298|9996359|FG005|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
8935419|NCT02326298|9996360|FG006|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
8935420|NCT02326298|9996361|FG007|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
8935421|NCT02326298|9996362|FG008|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
8935422|NCT02326298|9996363|FG009|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
8935423|NCT02326298|9996364|FG010|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
8935424|NCT02326298|9996365|FG011|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
8935425|NCT02326298|9996366|FG012|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
8718196|NCT00996918|9765300|FG001|STARTED|Overall Study||66
8718197|NCT00996918|9765301|FG002|STARTED|Overall Study||37
8718198|NCT00996918|9765302|FG003|STARTED|Overall Study||56
8718199|NCT00996918|9765303|FG004|STARTED|Overall Study||4
8718200|NCT00996918|9765299|FG000|Treated|Overall Study||39
8718201|NCT00996918|9765300|FG001|Treated|Overall Study||66
8718202|NCT00996918|9765301|FG002|Treated|Overall Study||37
8718203|NCT00996918|9765302|FG003|Treated|Overall Study||56
8718204|NCT00996918|9765303|FG004|Treated|Overall Study||4
8718205|NCT00996918|9765299|FG000|COMPLETED|Overall Study||0
8718206|NCT00996918|9765300|FG001|COMPLETED|Overall Study||0
8718207|NCT00996918|9765301|FG002|COMPLETED|Overall Study||0
8718208|NCT00996918|9765302|FG003|COMPLETED|Overall Study||0
8718209|NCT00996918|9765303|FG004|COMPLETED|Overall Study||0
8935426|NCT02326298|9996367|FG013|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
8935427|NCT02326298|9996354|FG000|COMPLETED|Initial Period (Week 0 to Week 16)||46
8935428|NCT02326298|9996355|FG001|COMPLETED|Initial Period (Week 0 to Week 16)||92
8935429|NCT02326298|9996356|FG002|COMPLETED|Initial Period (Week 0 to Week 16)||85
8935430|NCT02326298|9996357|FG003|COMPLETED|Initial Period (Week 0 to Week 16)||0
8935431|NCT02326298|9996358|FG004|COMPLETED|Initial Period (Week 0 to Week 16)||0
8935432|NCT02326298|9996359|FG005|COMPLETED|Initial Period (Week 0 to Week 16)||0
8935433|NCT02326298|9996360|FG006|COMPLETED|Initial Period (Week 0 to Week 16)||0
8935434|NCT02326298|9996361|FG007|COMPLETED|Initial Period (Week 0 to Week 16)||0
8935435|NCT02326298|9996362|FG008|COMPLETED|Initial Period (Week 0 to Week 16)||0
8935436|NCT02326298|9996363|FG009|COMPLETED|Initial Period (Week 0 to Week 16)||0
8935437|NCT02326298|9996364|FG010|COMPLETED|Initial Period (Week 0 to Week 16)||0
8935438|NCT02326298|9996365|FG011|COMPLETED|Initial Period (Week 0 to Week 16)||0
8935439|NCT02326298|9996366|FG012|COMPLETED|Initial Period (Week 0 to Week 16)||0
8935440|NCT02326298|9996367|FG013|COMPLETED|Initial Period (Week 0 to Week 16)||0
8935441|NCT02326298|9996354|FG000|NOT COMPLETED|Initial Period (Week 0 to Week 16)||5
8935442|NCT02326298|9996355|FG001|NOT COMPLETED|Initial Period (Week 0 to Week 16)||3
8935443|NCT02326298|9996356|FG002|NOT COMPLETED|Initial Period (Week 0 to Week 16)||3
8935444|NCT02326298|9996357|FG003|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8935445|NCT02326298|9996358|FG004|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8935446|NCT02326298|9996359|FG005|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8935447|NCT02326298|9996360|FG006|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8935448|NCT02326298|9996361|FG007|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8935449|NCT02326298|9996362|FG008|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8935450|NCT02326298|9996363|FG009|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8935451|NCT02326298|9996364|FG010|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8935452|NCT02326298|9996365|FG011|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8935453|NCT02326298|9996366|FG012|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8935454|NCT02326298|9996367|FG013|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8935455|NCT02326298|9996354|FG000|STARTED|Maintenance Period (Week 16 to Week 48)||0
8935456|NCT02326298|9996355|FG001|STARTED|Maintenance Period (Week 16 to Week 48)||0
8935457|NCT02326298|9996356|FG002|STARTED|Maintenance Period (Week 16 to Week 48)||0
8935458|NCT02326298|9996357|FG003|STARTED|Maintenance Period (Week 16 to Week 48)||3
8935459|NCT02326298|9996358|FG004|STARTED|Maintenance Period (Week 16 to Week 48)||5
8935460|NCT02326298|9996359|FG005|STARTED|Maintenance Period (Week 16 to Week 48)||74
8935461|NCT02326298|9996360|FG006|STARTED|Maintenance Period (Week 16 to Week 48)||77
8935462|NCT02326298|9996361|FG007|STARTED|Maintenance Period (Week 16 to Week 48)||38
8935463|NCT02326298|9996362|FG008|STARTED|Maintenance Period (Week 16 to Week 48)||18
8935464|NCT02326298|9996363|FG009|STARTED|Maintenance Period (Week 16 to Week 48)||8
8935465|NCT02326298|9996364|FG010|STARTED|Maintenance Period (Week 16 to Week 48)||0
8935466|NCT02326298|9996365|FG011|STARTED|Maintenance Period (Week 16 to Week 48)||0
8935467|NCT02326298|9996366|FG012|STARTED|Maintenance Period (Week 16 to Week 48)||0
8935468|NCT02326298|9996367|FG013|STARTED|Maintenance Period (Week 16 to Week 48)||0
8935469|NCT02326298|9996354|FG000|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
8935470|NCT02326298|9996355|FG001|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
8935471|NCT02326298|9996356|FG002|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
8935472|NCT02326298|9996357|FG003|Completed Week 48|Maintenance Period (Week 16 to Week 48)||3
8935473|NCT02326298|9996358|FG004|Completed Week 48|Maintenance Period (Week 16 to Week 48)||5
8935474|NCT02326298|9996359|FG005|Completed Week 48|Maintenance Period (Week 16 to Week 48)||71
8935475|NCT02326298|9996360|FG006|Completed Week 48|Maintenance Period (Week 16 to Week 48)||70
8935476|NCT02326298|9996361|FG007|Completed Week 48|Maintenance Period (Week 16 to Week 48)||33
8935477|NCT02326298|9996362|FG008|Completed Week 48|Maintenance Period (Week 16 to Week 48)||13
8935478|NCT02326298|9996363|FG009|Completed Week 48|Maintenance Period (Week 16 to Week 48)||7
8935479|NCT02326298|9996364|FG010|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
8935480|NCT02326298|9996365|FG011|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
8935481|NCT02326298|9996366|FG012|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
8935482|NCT02326298|9996367|FG013|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
8935483|NCT02326298|9996354|FG000|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8935484|NCT02326298|9996355|FG001|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8935485|NCT02326298|9996356|FG002|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8935486|NCT02326298|9996357|FG003|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||3
8935487|NCT02326298|9996358|FG004|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||5
8935488|NCT02326298|9996359|FG005|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||69
8935489|NCT02326298|9996360|FG006|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||70
8935490|NCT02326298|9996361|FG007|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||33
8935491|NCT02326298|9996362|FG008|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||13
8935492|NCT02326298|9996363|FG009|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||7
8935493|NCT02326298|9996364|FG010|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8935494|NCT02326298|9996365|FG011|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8935495|NCT02326298|9996366|FG012|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8935496|NCT02326298|9996367|FG013|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8935497|NCT02326298|9996354|FG000|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8935498|NCT02326298|9996355|FG001|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8935499|NCT02326298|9996356|FG002|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8935500|NCT02326298|9996357|FG003|COMPLETED|Maintenance Period (Week 16 to Week 48)||3
8935501|NCT02326298|9996358|FG004|COMPLETED|Maintenance Period (Week 16 to Week 48)||5
8718210|NCT00996918|9765299|FG000|NOT COMPLETED|Overall Study||39
8718211|NCT00996918|9765300|FG001|NOT COMPLETED|Overall Study||66
8718212|NCT00996918|9765301|FG002|NOT COMPLETED|Overall Study||37
8935502|NCT02326298|9996359|FG005|COMPLETED|Maintenance Period (Week 16 to Week 48)||69
8935503|NCT02326298|9996360|FG006|COMPLETED|Maintenance Period (Week 16 to Week 48)||70
8935504|NCT02326298|9996361|FG007|COMPLETED|Maintenance Period (Week 16 to Week 48)||33
8935505|NCT02326298|9996362|FG008|COMPLETED|Maintenance Period (Week 16 to Week 48)||13
8935506|NCT02326298|9996363|FG009|COMPLETED|Maintenance Period (Week 16 to Week 48)||7
8935507|NCT02326298|9996364|FG010|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8935508|NCT02326298|9996365|FG011|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8935509|NCT02326298|9996366|FG012|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8935510|NCT02326298|9996367|FG013|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8935511|NCT02326298|9996354|FG000|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8935512|NCT02326298|9996355|FG001|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8935513|NCT02326298|9996356|FG002|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8935514|NCT02326298|9996357|FG003|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8935515|NCT02326298|9996358|FG004|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8935516|NCT02326298|9996359|FG005|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||5
8935517|NCT02326298|9996360|FG006|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||7
8935518|NCT02326298|9996361|FG007|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||5
8935519|NCT02326298|9996362|FG008|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||5
8935520|NCT02326298|9996363|FG009|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||1
8935521|NCT02326298|9996364|FG010|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8935522|NCT02326298|9996365|FG011|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8935523|NCT02326298|9996366|FG012|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8935524|NCT02326298|9996367|FG013|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8935525|NCT02326298|9996354|FG000|STARTED|Open-label Period (Week 48 to Week 144)||0
8935526|NCT02326298|9996355|FG001|STARTED|Open-label Period (Week 48 to Week 144)||0
8935527|NCT02326298|9996356|FG002|STARTED|Open-label Period (Week 48 to Week 144)||0
8935528|NCT02326298|9996357|FG003|STARTED|Open-label Period (Week 48 to Week 144)||0
8935529|NCT02326298|9996358|FG004|STARTED|Open-label Period (Week 48 to Week 144)||0
8935530|NCT02326298|9996359|FG005|STARTED|Open-label Period (Week 48 to Week 144)||0
8935531|NCT02326298|9996360|FG006|STARTED|Open-label Period (Week 48 to Week 144)||0
8935532|NCT02326298|9996361|FG007|STARTED|Open-label Period (Week 48 to Week 144)||0
8935533|NCT02326298|9996362|FG008|STARTED|Open-label Period (Week 48 to Week 144)||0
8935534|NCT02326298|9996363|FG009|STARTED|Open-label Period (Week 48 to Week 144)||0
8935535|NCT02326298|9996364|FG010|STARTED|Open-label Period (Week 48 to Week 144)||3
8935536|NCT02326298|9996365|FG011|STARTED|Open-label Period (Week 48 to Week 144)||74
8935537|NCT02326298|9996366|FG012|STARTED|Open-label Period (Week 48 to Week 144)||70
8935538|NCT02326298|9996367|FG013|STARTED|Open-label Period (Week 48 to Week 144)||53
8935539|NCT02326298|9996354|FG000|COMPLETED|Open-label Period (Week 48 to Week 144)||0
8718213|NCT00996918|9765302|FG003|NOT COMPLETED|Overall Study||56
8718214|NCT00996918|9765303|FG004|NOT COMPLETED|Overall Study||4
8718215|NCT00996931|9765315|FG000|STARTED|Overall Study||6
8718216|NCT00996931|9765315|FG000|COMPLETED|Overall Study||6
8718217|NCT00996931|9765315|FG000|NOT COMPLETED|Overall Study||0
8718218|NCT00996944|9765322|FG000|STARTED|Double-blind Treatment Period||22
8718219|NCT00996944|9765323|FG001|STARTED|Double-blind Treatment Period||12
8718220|NCT00996944|9765322|FG000|COMPLETED|Double-blind Treatment Period||12
8718221|NCT00996944|9765323|FG001|COMPLETED|Double-blind Treatment Period||5
8718222|NCT00996944|9765322|FG000|NOT COMPLETED|Double-blind Treatment Period||10
8718223|NCT00996944|9765323|FG001|NOT COMPLETED|Double-blind Treatment Period||7
8718224|NCT00996944|9765322|FG000|STARTED|Long-term Treatment Period||12
8718225|NCT00996944|9765323|FG001|STARTED|Long-term Treatment Period||5
8718226|NCT00996944|9765322|FG000|COMPLETED|Long-term Treatment Period||0
8718227|NCT00996944|9765323|FG001|COMPLETED|Long-term Treatment Period||0
8718228|NCT00996944|9765322|FG000|NOT COMPLETED|Long-term Treatment Period||12
8718229|NCT00996944|9765323|FG001|NOT COMPLETED|Long-term Treatment Period||5
8718230|NCT00996996|9765331|FG000|STARTED|Overall Study||77
8718231|NCT00996996|9765331|FG000|COMPLETED|Overall Study|These participants completed 12 years of follow-up.|44
8718232|NCT00996996|9765331|FG000|NOT COMPLETED|Overall Study||33
8718233|NCT00997035|9765337|FG000|STARTED|3-week Followup Visit||121
8718234|NCT00997035|9765338|FG001|STARTED|3-week Followup Visit||119
8718235|NCT00997035|9765337|FG000|COMPLETED|3-week Followup Visit||112
8718236|NCT00997035|9765338|FG001|COMPLETED|3-week Followup Visit||113
8718237|NCT00997035|9765337|FG000|NOT COMPLETED|3-week Followup Visit||9
8718238|NCT00997035|9765338|FG001|NOT COMPLETED|3-week Followup Visit||6
8718239|NCT00997035|9765337|FG000|STARTED|3-month Follow-up Visit||112
8718240|NCT00997035|9765338|FG001|STARTED|3-month Follow-up Visit||113
8935540|NCT02326298|9996355|FG001|COMPLETED|Open-label Period (Week 48 to Week 144)||0
8935541|NCT02326298|9996356|FG002|COMPLETED|Open-label Period (Week 48 to Week 144)||0
8935542|NCT02326298|9996357|FG003|COMPLETED|Open-label Period (Week 48 to Week 144)||0
8935543|NCT02326298|9996358|FG004|COMPLETED|Open-label Period (Week 48 to Week 144)||0
8935544|NCT02326298|9996359|FG005|COMPLETED|Open-label Period (Week 48 to Week 144)||0
8935545|NCT02326298|9996360|FG006|COMPLETED|Open-label Period (Week 48 to Week 144)||0
8935546|NCT02326298|9996361|FG007|COMPLETED|Open-label Period (Week 48 to Week 144)||0
8935547|NCT02326298|9996362|FG008|COMPLETED|Open-label Period (Week 48 to Week 144)||0
8935548|NCT02326298|9996363|FG009|COMPLETED|Open-label Period (Week 48 to Week 144)||0
8935549|NCT02326298|9996364|FG010|COMPLETED|Open-label Period (Week 48 to Week 144)||3
8935550|NCT02326298|9996365|FG011|COMPLETED|Open-label Period (Week 48 to Week 144)||54
8935551|NCT02326298|9996366|FG012|COMPLETED|Open-label Period (Week 48 to Week 144)||51
8935552|NCT02326298|9996367|FG013|COMPLETED|Open-label Period (Week 48 to Week 144)||44
8935553|NCT02326298|9996354|FG000|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
8935554|NCT02326298|9996355|FG001|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
8935555|NCT02326298|9996356|FG002|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
8935556|NCT02326298|9996357|FG003|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
8935557|NCT02326298|9996358|FG004|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
8935558|NCT02326298|9996359|FG005|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
8935559|NCT02326298|9996360|FG006|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
8935560|NCT02326298|9996361|FG007|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
8935561|NCT02326298|9996362|FG008|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
8935562|NCT02326298|9996363|FG009|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
8935563|NCT02326298|9996364|FG010|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
8935564|NCT02326298|9996365|FG011|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||20
8935565|NCT02326298|9996366|FG012|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||19
8935566|NCT02326298|9996367|FG013|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||9
8935567|NCT02326363|9996378|FG000|STARTED|Overall Study||98
8935568|NCT02326363|9996379|FG001|STARTED|Overall Study||106
8935569|NCT02326363|9996378|FG000|COMPLETED|Overall Study||47
8935570|NCT02326363|9996379|FG001|COMPLETED|Overall Study||50
8935571|NCT02326363|9996378|FG000|NOT COMPLETED|Overall Study||51
8935572|NCT02326363|9996379|FG001|NOT COMPLETED|Overall Study||56
8935573|NCT02326467|9996387|FG000|STARTED|Overall Study||10
8935574|NCT02326467|9996387|FG000|COMPLETED|Overall Study||9
8935575|NCT02326467|9996387|FG000|NOT COMPLETED|Overall Study||1
8935576|NCT02326597|9996394|FG000|STARTED|Overall Study||60
8718241|NCT00997035|9765337|FG000|COMPLETED|3-month Follow-up Visit||100
8718242|NCT00997035|9765338|FG001|COMPLETED|3-month Follow-up Visit||107
8718243|NCT00997035|9765337|FG000|NOT COMPLETED|3-month Follow-up Visit||12
8718244|NCT00997035|9765338|FG001|NOT COMPLETED|3-month Follow-up Visit||6
8718245|NCT00997113|9765356|FG000|STARTED|Overall Study||10
8718246|NCT00997113|9765357|FG001|STARTED|Overall Study||10
8718247|NCT00997113|9765356|FG000|COMPLETED|Overall Study||10
8718248|NCT00997113|9765357|FG001|COMPLETED|Overall Study||10
8935577|NCT02326597|9996395|FG001|STARTED|Overall Study||60
8935578|NCT02326597|9996394|FG000|COMPLETED|Overall Study||18
8935579|NCT02326597|9996395|FG001|COMPLETED|Overall Study||28
8935580|NCT02326597|9996394|FG000|NOT COMPLETED|Overall Study||42
8935581|NCT02326597|9996395|FG001|NOT COMPLETED|Overall Study||32
8935582|NCT02326649|9996403|FG000|STARTED|Overall Study||33
8935583|NCT02326649|9996403|FG000|COMPLETED|Overall Study||21
8935584|NCT02326649|9996403|FG000|NOT COMPLETED|Overall Study||12
8935585|NCT02326805|9996409|FG000|STARTED|Overall Study||106
8935586|NCT02326805|9996410|FG001|STARTED|Overall Study||48
8935587|NCT02326805|9996409|FG000|COMPLETED|Overall Study||103
8935588|NCT02326805|9996410|FG001|COMPLETED|Overall Study||47
8935589|NCT02326805|9996409|FG000|NOT COMPLETED|Overall Study||3
8935590|NCT02326805|9996410|FG001|NOT COMPLETED|Overall Study||1
8935591|NCT02326844|9996416|FG000|STARTED|Overall Study||3
8935592|NCT02326844|9996416|FG000|COMPLETED|Overall Study||3
8935593|NCT02326844|9996416|FG000|NOT COMPLETED|Overall Study||0
8935594|NCT02326883|9996423|FG000|STARTED|Overall Study||6314
8935595|NCT02326883|9996424|FG001|STARTED|Overall Study||6312
8935596|NCT02326883|9996425|FG002|STARTED|Overall Study||6256
8935597|NCT02326883|9996423|FG000|COMPLETED|Overall Study||6230
8935598|NCT02326883|9996424|FG001|COMPLETED|Overall Study||6227
8935599|NCT02326883|9996425|FG002|COMPLETED|Overall Study||6187
8935600|NCT02326883|9996423|FG000|NOT COMPLETED|Overall Study||84
8935601|NCT02326883|9996424|FG001|NOT COMPLETED|Overall Study||85
8935602|NCT02326883|9996425|FG002|NOT COMPLETED|Overall Study||69
8935603|NCT02327013|9996436|FG000|STARTED|Overall Study||49
8935604|NCT02327013|9996437|FG001|STARTED|Overall Study||45
8935605|NCT02327013|9996438|FG002|STARTED|Overall Study||96
8718249|NCT00997113|9765356|FG000|NOT COMPLETED|Overall Study||0
8718250|NCT00997113|9765357|FG001|NOT COMPLETED|Overall Study||0
8718251|NCT00997126|9765365|FG000|STARTED|Overall Study||63
8718252|NCT00997126|9765366|FG001|STARTED|Overall Study||63
8718253|NCT00997126|9765365|FG000|COMPLETED|Overall Study||56
8935606|NCT02327013|9996439|FG003|STARTED|Overall Study||21
8935607|NCT02327013|9996440|FG004|STARTED|Overall Study||16
8935608|NCT02327013|9996436|FG000|COMPLETED|Overall Study||36
8935609|NCT02327013|9996437|FG001|COMPLETED|Overall Study||29
8718254|NCT00997126|9765366|FG001|COMPLETED|Overall Study||52
8718255|NCT00997126|9765365|FG000|NOT COMPLETED|Overall Study||7
8935610|NCT02327013|9996438|FG002|COMPLETED|Overall Study||54
8935611|NCT02327013|9996439|FG003|COMPLETED|Overall Study||20
8935612|NCT02327013|9996440|FG004|COMPLETED|Overall Study||12
8935613|NCT02327013|9996436|FG000|NOT COMPLETED|Overall Study||13
8935614|NCT02327013|9996437|FG001|NOT COMPLETED|Overall Study||16
8935615|NCT02327013|9996438|FG002|NOT COMPLETED|Overall Study||42
8935616|NCT02327013|9996439|FG003|NOT COMPLETED|Overall Study||1
8617269|NCT00455650|9655435|FG004|COMPLETED|Week 1||14
8617270|NCT00455650|9655436|FG005|COMPLETED|Week 1||13
8617271|NCT00455650|9655431|FG000|NOT COMPLETED|Week 1||0
8617272|NCT00455650|9655432|FG001|NOT COMPLETED|Week 1||0
8718256|NCT00997126|9765366|FG001|NOT COMPLETED|Overall Study||11
8718257|NCT00997139|9765372|FG000|STARTED|Overall Study||216
8935617|NCT02327013|9996440|FG004|NOT COMPLETED|Overall Study||4
8935618|NCT02327052|9996460|FG000|STARTED|Overall Study||58
8935619|NCT02327052|9996460|FG000|COMPLETED|Overall Study||58
8935620|NCT02327052|9996460|FG000|NOT COMPLETED|Overall Study||0
8935621|NCT02327117|9996466|FG000|STARTED|Overall Study||45
8935622|NCT02327117|9996467|FG001|STARTED|Overall Study||45
8935623|NCT02327117|9996466|FG000|COMPLETED|Overall Study||45
8935624|NCT02327117|9996467|FG001|COMPLETED|Overall Study||45
8935625|NCT02327117|9996466|FG000|NOT COMPLETED|Overall Study||0
8935626|NCT02327117|9996467|FG001|NOT COMPLETED|Overall Study||0
8935627|NCT02327130|9996473|FG000|STARTED|Overall Study||32
8935628|NCT02327130|9996473|FG000|COMPLETED|Overall Study||20
8935629|NCT02327130|9996473|FG000|NOT COMPLETED|Overall Study||12
8935630|NCT02327143|9996480|FG000|STARTED|Day 1: Time 0 Hrs to 6 Hrs||11
8935631|NCT02327143|9996481|FG001|STARTED|Day 1: Time 0 Hrs to 6 Hrs||0
8935632|NCT02327143|9996480|FG000|COMPLETED|Day 1: Time 0 Hrs to 6 Hrs||11
8935633|NCT02327143|9996481|FG001|COMPLETED|Day 1: Time 0 Hrs to 6 Hrs||0
8935634|NCT02327143|9996480|FG000|NOT COMPLETED|Day 1: Time 0 Hrs to 6 Hrs||0
8935635|NCT02327143|9996481|FG001|NOT COMPLETED|Day 1: Time 0 Hrs to 6 Hrs||0
8935636|NCT02327143|9996480|FG000|STARTED|Day 1: Time 6 Hrs - to Day 9||0
8935637|NCT02327143|9996481|FG001|STARTED|Day 1: Time 6 Hrs - to Day 9||11
8935638|NCT02327143|9996480|FG000|COMPLETED|Day 1: Time 6 Hrs - to Day 9||0
8935639|NCT02327143|9996481|FG001|COMPLETED|Day 1: Time 6 Hrs - to Day 9||11
8718258|NCT00997139|9765372|FG000|Treated for Positive Baseline Culture|Overall Study||30
8718259|NCT00997139|9765372|FG000|COMPLETED|Overall Study||30
8718260|NCT00997139|9765372|FG000|NOT COMPLETED|Overall Study||186
8718261|NCT00997204|9765380|FG000|STARTED|Naive Treatment Phase||25
8718262|NCT00997204|9765381|FG001|STARTED|Naive Treatment Phase|Non-naive patients participated in the study but they were not treated in the naive treatment phase|79
8718263|NCT00997204|9765380|FG000|COMPLETED|Naive Treatment Phase||19
8718264|NCT00997204|9765381|FG001|COMPLETED|Naive Treatment Phase||0
8718265|NCT00997204|9765380|FG000|NOT COMPLETED|Naive Treatment Phase||6
8718266|NCT00997204|9765381|FG001|NOT COMPLETED|Naive Treatment Phase||79
8718267|NCT00997204|9765380|FG000|STARTED|Self-administration Phase||19
8718268|NCT00997204|9765381|FG001|STARTED|Self-administration Phase|1 subject did not self-administered icatibant but had a HCP to perform. the data were not included.|78
8718269|NCT00997204|9765380|FG000|COMPLETED|Self-administration Phase||19
8718270|NCT00997204|9765381|FG001|COMPLETED|Self-administration Phase||77
8718271|NCT00997204|9765380|FG000|NOT COMPLETED|Self-administration Phase||0
8718272|NCT00997204|9765381|FG001|NOT COMPLETED|Self-administration Phase||1
8718273|NCT00997243|9765391|FG000|STARTED|Overall Study||7
8718274|NCT00997243|9765391|FG000|COMPLETED|Overall Study||0
8718275|NCT00997243|9765391|FG000|NOT COMPLETED|Overall Study||7
8718276|NCT00997321|9765397|FG000|STARTED|Overall Study||50
8718277|NCT00997321|9765398|FG001|STARTED|Overall Study||50
8935640|NCT02327143|9996480|FG000|NOT COMPLETED|Day 1: Time 6 Hrs - to Day 9||0
8935641|NCT02327143|9996481|FG001|NOT COMPLETED|Day 1: Time 6 Hrs - to Day 9||0
8935642|NCT02327169|9996502|FG000|STARTED|Overall Study||4
8935643|NCT02327169|9996503|FG001|STARTED|Overall Study||3
8935644|NCT02327169|9996504|FG002|STARTED|Overall Study||7
8935645|NCT02327169|9996505|FG003|STARTED|Overall Study||3
8935646|NCT02327169|9996506|FG004|STARTED|Overall Study||8
8935647|NCT02327169|9996507|FG005|STARTED|Overall Study||4
8617273|NCT00455650|9655433|FG002|NOT COMPLETED|Week 1||0
8617274|NCT00455650|9655434|FG003|NOT COMPLETED|Week 1||0
8617275|NCT00455650|9655435|FG004|NOT COMPLETED|Week 1||0
8617276|NCT00455650|9655436|FG005|NOT COMPLETED|Week 1||0
8617277|NCT00455650|9655431|FG000|STARTED|Week 2||10
8617278|NCT00455650|9655432|FG001|STARTED|Week 2||10
8617279|NCT00455650|9655433|FG002|STARTED|Week 2||10
8617280|NCT00455650|9655434|FG003|STARTED|Week 2||14
8617281|NCT00455650|9655435|FG004|STARTED|Week 2||14
8617282|NCT00455650|9655436|FG005|STARTED|Week 2||13
8718278|NCT00997321|9765397|FG000|COMPLETED|Overall Study||50
8718279|NCT00997321|9765398|FG001|COMPLETED|Overall Study||47
8718280|NCT00997321|9765397|FG000|NOT COMPLETED|Overall Study||0
8935648|NCT02327169|9996508|FG006|STARTED|Overall Study||3
8935649|NCT02327169|9996509|FG007|STARTED|Overall Study||4
8935650|NCT02327169|9996510|FG008|STARTED|Overall Study||6
8935651|NCT02327169|9996511|FG009|STARTED|Overall Study||8
8935652|NCT02327169|9996512|FG010|STARTED|Overall Study||6
8935653|NCT02327169|9996513|FG011|STARTED|Overall Study||7
8935654|NCT02327169|9996514|FG012|STARTED|Overall Study||1
8935655|NCT02327169|9996515|FG013|STARTED|Overall Study||7
8617283|NCT00455650|9655431|FG000|COMPLETED|Week 2||10
8617284|NCT00455650|9655432|FG001|COMPLETED|Week 2||10
8617285|NCT00455650|9655433|FG002|COMPLETED|Week 2||10
8617286|NCT00455650|9655434|FG003|COMPLETED|Week 2||14
8935656|NCT02327169|9996516|FG014|STARTED|Overall Study||10
8935657|NCT02327169|9996502|FG000|COMPLETED|Overall Study||0
8935658|NCT02327169|9996503|FG001|COMPLETED|Overall Study||0
8935659|NCT02327169|9996504|FG002|COMPLETED|Overall Study||0
8935660|NCT02327169|9996505|FG003|COMPLETED|Overall Study||0
8935661|NCT02327169|9996506|FG004|COMPLETED|Overall Study||0
8935662|NCT02327169|9996507|FG005|COMPLETED|Overall Study||0
8935663|NCT02327169|9996508|FG006|COMPLETED|Overall Study||0
8935664|NCT02327169|9996509|FG007|COMPLETED|Overall Study||0
8935665|NCT02327169|9996510|FG008|COMPLETED|Overall Study||0
8935666|NCT02327169|9996511|FG009|COMPLETED|Overall Study||0
8935667|NCT02327169|9996512|FG010|COMPLETED|Overall Study||0
8617287|NCT00455650|9655435|FG004|COMPLETED|Week 2||14
8617288|NCT00455650|9655436|FG005|COMPLETED|Week 2||13
8617289|NCT00455650|9655431|FG000|NOT COMPLETED|Week 2||0
8617290|NCT00455650|9655432|FG001|NOT COMPLETED|Week 2||0
8617291|NCT00455650|9655433|FG002|NOT COMPLETED|Week 2||0
8617292|NCT00455650|9655434|FG003|NOT COMPLETED|Week 2||0
8935668|NCT02327169|9996513|FG011|COMPLETED|Overall Study||0
8935669|NCT02327169|9996514|FG012|COMPLETED|Overall Study||0
8935670|NCT02327169|9996515|FG013|COMPLETED|Overall Study||0
8935671|NCT02327169|9996516|FG014|COMPLETED|Overall Study||0
8935672|NCT02327169|9996502|FG000|NOT COMPLETED|Overall Study||4
8935673|NCT02327169|9996503|FG001|NOT COMPLETED|Overall Study||3
8935674|NCT02327169|9996504|FG002|NOT COMPLETED|Overall Study||7
8935675|NCT02327169|9996505|FG003|NOT COMPLETED|Overall Study||3
8935676|NCT02327169|9996506|FG004|NOT COMPLETED|Overall Study||8
8935677|NCT02327169|9996507|FG005|NOT COMPLETED|Overall Study||4
8935678|NCT02327169|9996508|FG006|NOT COMPLETED|Overall Study||3
8935679|NCT02327169|9996509|FG007|NOT COMPLETED|Overall Study||4
8718281|NCT00997321|9765398|FG001|NOT COMPLETED|Overall Study||3
8718282|NCT00997334|9765410|FG000|STARTED|Overall Study||60
8718283|NCT00997334|9765410|FG000|Eligible for Repeat Biopsy|Overall Study|Patients who experience disease progression on treatment were eligible for repeat biopsy|44
8718284|NCT00997334|9765410|FG000|Evaluable|Overall Study|Patients with tissue available for re-biopsy at time of progression|35
8718285|NCT00997334|9765410|FG000|COMPLETED|Overall Study||35
8718286|NCT00997334|9765410|FG000|NOT COMPLETED|Overall Study||25
8718287|NCT00997373|9765416|FG000|STARTED|Overall Study||28
8718288|NCT00997373|9765417|FG001|STARTED|Overall Study||15
8718289|NCT00997373|9765416|FG000|Received Letrozole|Overall Study||23
8718290|NCT00997373|9765417|FG001|Received Letrozole|Overall Study||0
8718291|NCT00997373|9765416|FG000|Completed Hysterectomy|Overall Study||17
8718292|NCT00997373|9765417|FG001|Completed Hysterectomy|Overall Study||15
8718293|NCT00997373|9765416|FG000|COMPLETED|Overall Study||13
8718294|NCT00997373|9765417|FG001|COMPLETED|Overall Study||15
8718295|NCT00997373|9765416|FG000|NOT COMPLETED|Overall Study||15
8718296|NCT00997373|9765417|FG001|NOT COMPLETED|Overall Study||0
8718297|NCT00997425|9765423|FG000|STARTED|Overall Study||19
8935680|NCT02327169|9996510|FG008|NOT COMPLETED|Overall Study||6
8935681|NCT02327169|9996511|FG009|NOT COMPLETED|Overall Study||8
8935682|NCT02327169|9996512|FG010|NOT COMPLETED|Overall Study||6
8935683|NCT02327169|9996513|FG011|NOT COMPLETED|Overall Study||7
8935684|NCT02327169|9996514|FG012|NOT COMPLETED|Overall Study||1
8935685|NCT02327169|9996515|FG013|NOT COMPLETED|Overall Study||7
8935686|NCT02327169|9996516|FG014|NOT COMPLETED|Overall Study||10
8935687|NCT02327260|9996561|FG000|STARTED|Overall Study||20
8935688|NCT02327260|9996562|FG001|STARTED|Overall Study||24
8935689|NCT02327260|9996563|FG002|STARTED|Overall Study||17
8935690|NCT02327260|9996561|FG000|COMPLETED|Overall Study||14
8935691|NCT02327260|9996562|FG001|COMPLETED|Overall Study||20
8935692|NCT02327260|9996563|FG002|COMPLETED|Overall Study||15
8935693|NCT02327260|9996561|FG000|NOT COMPLETED|Overall Study||6
8935694|NCT02327260|9996562|FG001|NOT COMPLETED|Overall Study||4
8935695|NCT02327260|9996563|FG002|NOT COMPLETED|Overall Study||2
8935696|NCT02327325|9996575|FG000|STARTED|Overall Study||20
8935697|NCT02327325|9996576|FG001|STARTED|Overall Study||20
8935698|NCT02327325|9996577|FG002|STARTED|Overall Study||20
8935699|NCT02327325|9996575|FG000|COMPLETED|Overall Study||19
8935700|NCT02327325|9996576|FG001|COMPLETED|Overall Study||16
8935701|NCT02327325|9996577|FG002|COMPLETED|Overall Study||15
8617293|NCT00455650|9655435|FG004|NOT COMPLETED|Week 2||0
8935702|NCT02327325|9996575|FG000|NOT COMPLETED|Overall Study||1
8935703|NCT02327325|9996576|FG001|NOT COMPLETED|Overall Study||4
8935704|NCT02327325|9996577|FG002|NOT COMPLETED|Overall Study||5
8935705|NCT02327351|9996585|FG000|STARTED|Overall Study||98
8935706|NCT02327351|9996585|FG000|COMPLETED|Overall Study||98
8935707|NCT02327351|9996585|FG000|NOT COMPLETED|Overall Study||0
8617294|NCT00455650|9655436|FG005|NOT COMPLETED|Week 2||0
8617295|NCT00455650|9655431|FG000|STARTED|Week 3||10
8617296|NCT00455650|9655432|FG001|STARTED|Week 3||10
8718298|NCT00997425|9765423|FG000|COMPLETED|Overall Study||19
8935708|NCT02327429|9996593|FG000|STARTED|Overall Study||19
8935709|NCT02327429|9996593|FG000|COMPLETED|Overall Study||17
8935710|NCT02327429|9996593|FG000|NOT COMPLETED|Overall Study||2
8935711|NCT02327741|9996599|FG000|STARTED|Overall Study||502
8935712|NCT02327741|9996600|FG001|STARTED|Overall Study||508
8935713|NCT02327741|9996599|FG000|COMPLETED|Overall Study||502
8935714|NCT02327741|9996600|FG001|COMPLETED|Overall Study||508
8935715|NCT02327741|9996599|FG000|NOT COMPLETED|Overall Study||0
8935716|NCT02327741|9996600|FG001|NOT COMPLETED|Overall Study||0
8935717|NCT02328027|9996608|FG000|STARTED|Overall Study||5
8617297|NCT00455650|9655433|FG002|STARTED|Week 3||10
8935718|NCT02328027|9996609|FG001|STARTED|Overall Study||11
8935719|NCT02328027|9996608|FG000|COMPLETED|Overall Study||5
8935720|NCT02328027|9996609|FG001|COMPLETED|Overall Study||10
8935721|NCT02328027|9996608|FG000|NOT COMPLETED|Overall Study||0
8935722|NCT02328027|9996609|FG001|NOT COMPLETED|Overall Study||1
8935723|NCT02328040|9996616|FG000|STARTED|First Intervention (2 Days)||8
8935724|NCT02328040|9996617|FG001|STARTED|First Intervention (2 Days)||9
8935725|NCT02328040|9996616|FG000|COMPLETED|First Intervention (2 Days)||7
8935726|NCT02328040|9996617|FG001|COMPLETED|First Intervention (2 Days)||8
8935727|NCT02328040|9996616|FG000|NOT COMPLETED|First Intervention (2 Days)||1
8935728|NCT02328040|9996617|FG001|NOT COMPLETED|First Intervention (2 Days)||1
8935729|NCT02328040|9996616|FG000|STARTED|Second Intervention (2 Days)||7
8935730|NCT02328040|9996617|FG001|STARTED|Second Intervention (2 Days)||8
8935731|NCT02328040|9996616|FG000|COMPLETED|Second Intervention (2 Days)||7
8935732|NCT02328040|9996617|FG001|COMPLETED|Second Intervention (2 Days)||8
8935733|NCT02328040|9996616|FG000|NOT COMPLETED|Second Intervention (2 Days)||0
8935734|NCT02328040|9996617|FG001|NOT COMPLETED|Second Intervention (2 Days)||0
8935735|NCT02328326|9996625|FG000|STARTED|Overall Study|3 participant dyads withdrew before 6-month follow up. 3 more care partners withdrew and 1 died.|246
8935736|NCT02328326|9996626|FG001|STARTED|Overall Study|1 participant dyad withdrew from the study between assignment to control arm and 6-month follow up.|232
8935737|NCT02328326|9996625|FG000|6-month Follow Up|Overall Study|We were unable to reach 15 participants. 1 patient died, 1 care partner withdrew before completion.|221
8935738|NCT02328326|9996626|FG001|6-month Follow Up|Overall Study|We were unable to reach 9 participants. 1 patient died, 1 care partner withdrew before completion.|221
8935739|NCT02328326|9996625|FG000|COMPLETED|Overall Study||224
8935740|NCT02328326|9996626|FG001|COMPLETED|Overall Study||224
8935741|NCT02328326|9996625|FG000|NOT COMPLETED|Overall Study||22
8935742|NCT02328326|9996626|FG001|NOT COMPLETED|Overall Study||8
8935743|NCT02328404|9996636|FG000|STARTED|Overall Study||30
8935744|NCT02328404|9996637|FG001|STARTED|Overall Study||30
8935745|NCT02328404|9996636|FG000|COMPLETED|Overall Study||29
8935746|NCT02328404|9996637|FG001|COMPLETED|Overall Study||29
8935747|NCT02328404|9996636|FG000|NOT COMPLETED|Overall Study||1
8935748|NCT02328404|9996637|FG001|NOT COMPLETED|Overall Study||1
8935749|NCT02328547|9996649|FG000|STARTED|First Intervention (12 Weeks)||25
8935750|NCT02328547|9996650|FG001|STARTED|First Intervention (12 Weeks)||23
8935751|NCT02328547|9996649|FG000|COMPLETED|First Intervention (12 Weeks)||22
8935752|NCT02328547|9996650|FG001|COMPLETED|First Intervention (12 Weeks)||23
8935753|NCT02328547|9996649|FG000|NOT COMPLETED|First Intervention (12 Weeks)||3
8935754|NCT02328547|9996650|FG001|NOT COMPLETED|First Intervention (12 Weeks)||0
8935755|NCT02328547|9996649|FG000|STARTED|Second Intervention (12 Weeks)||22
8935756|NCT02328547|9996650|FG001|STARTED|Second Intervention (12 Weeks)||23
8935757|NCT02328547|9996649|FG000|COMPLETED|Second Intervention (12 Weeks)||22
8935758|NCT02328547|9996650|FG001|COMPLETED|Second Intervention (12 Weeks)||23
8935759|NCT02328547|9996649|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||0
8935760|NCT02328547|9996650|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||0
8935761|NCT02328755|9996664|FG000|STARTED|Overall Study||3
8935762|NCT02328755|9996665|FG001|STARTED|Overall Study||33
8935763|NCT02328755|9996664|FG000|COMPLETED|Overall Study|Evaluable for the phase II primary endpoint of relapse at 6-months post-HCT|0
8935764|NCT02328755|9996665|FG001|COMPLETED|Overall Study||31
8935765|NCT02328755|9996664|FG000|NOT COMPLETED|Overall Study||3
8935766|NCT02328755|9996665|FG001|NOT COMPLETED|Overall Study||2
8935767|NCT02328807|9996677|FG000|STARTED|Overall Study||6
8935768|NCT02328807|9996677|FG000|COMPLETED|Overall Study||6
8935769|NCT02328807|9996677|FG000|NOT COMPLETED|Overall Study||0
8935770|NCT02328937|9996683|FG000|STARTED|Period 1||7
8935771|NCT02328937|9996684|FG001|STARTED|Period 1||6
8935772|NCT02328937|9996685|FG002|STARTED|Period 1||7
8935773|NCT02328937|9996686|FG003|STARTED|Period 1||6
8935774|NCT02328937|9996687|FG004|STARTED|Period 1||6
8935775|NCT02328937|9996688|FG005|STARTED|Period 1||6
8935776|NCT02328937|9996683|FG000|COMPLETED|Period 1||7
8935777|NCT02328937|9996684|FG001|COMPLETED|Period 1||6
8935778|NCT02328937|9996685|FG002|COMPLETED|Period 1||7
8935779|NCT02328937|9996686|FG003|COMPLETED|Period 1||5
8935780|NCT02328937|9996687|FG004|COMPLETED|Period 1||6
8935781|NCT02328937|9996688|FG005|COMPLETED|Period 1||6
8935782|NCT02328937|9996683|FG000|NOT COMPLETED|Period 1||0
8935783|NCT02328937|9996684|FG001|NOT COMPLETED|Period 1||0
8935784|NCT02328937|9996685|FG002|NOT COMPLETED|Period 1||0
8935785|NCT02328937|9996686|FG003|NOT COMPLETED|Period 1||1
8935786|NCT02328937|9996687|FG004|NOT COMPLETED|Period 1||0
8935787|NCT02328937|9996688|FG005|NOT COMPLETED|Period 1||0
8935788|NCT02328937|9996683|FG000|STARTED|Period 2||7
8935789|NCT02328937|9996684|FG001|STARTED|Period 2||6
8935790|NCT02328937|9996685|FG002|STARTED|Period 2||7
8935791|NCT02328937|9996686|FG003|STARTED|Period 2||5
8935792|NCT02328937|9996687|FG004|STARTED|Period 2||6
8935793|NCT02328937|9996688|FG005|STARTED|Period 2||6
8935794|NCT02328937|9996683|FG000|COMPLETED|Period 2||7
8935795|NCT02328937|9996684|FG001|COMPLETED|Period 2||6
8935796|NCT02328937|9996685|FG002|COMPLETED|Period 2||6
8935797|NCT02328937|9996686|FG003|COMPLETED|Period 2||5
8935798|NCT02328937|9996687|FG004|COMPLETED|Period 2||6
8935799|NCT02328937|9996688|FG005|COMPLETED|Period 2||6
8935800|NCT02328937|9996683|FG000|NOT COMPLETED|Period 2||0
8935801|NCT02328937|9996684|FG001|NOT COMPLETED|Period 2||0
8935802|NCT02328937|9996685|FG002|NOT COMPLETED|Period 2||1
8935803|NCT02328937|9996686|FG003|NOT COMPLETED|Period 2||0
8935804|NCT02328937|9996687|FG004|NOT COMPLETED|Period 2||0
9065004|NCT04234672|10125354|FG000|COMPLETED|Treatment Period 2(Day9[Day1of Period2])||6
9065005|NCT04234672|10125354|FG000|NOT COMPLETED|Treatment Period 2(Day9[Day1of Period2])||0
9065006|NCT04223635|10125367|FG000|STARTED|Overall Study||8
9065007|NCT04223635|10125368|FG001|STARTED|Overall Study||8
9065008|NCT04223635|10125367|FG000|COMPLETED|Overall Study||8
9065009|NCT04223635|10125368|FG001|COMPLETED|Overall Study||8
9065010|NCT04223635|10125367|FG000|NOT COMPLETED|Overall Study||0
9065011|NCT04223635|10125368|FG001|NOT COMPLETED|Overall Study||0
9065012|NCT04214951|10125376|FG000|STARTED|Overall Study||50
9065013|NCT04214951|10125377|FG001|STARTED|Overall Study||50
9065014|NCT04214951|10125376|FG000|COMPLETED|Overall Study||10
9065015|NCT04214951|10125377|FG001|COMPLETED|Overall Study||10
9065016|NCT04214951|10125376|FG000|NOT COMPLETED|Overall Study||40
9065017|NCT04214951|10125377|FG001|NOT COMPLETED|Overall Study||40
9065018|NCT04234425|10125383|FG000|STARTED|Overall Study||18
9065019|NCT04234425|10125383|FG000|Midpoint-Week 4|Overall Study||18
9065020|NCT04234425|10125383|FG000|COMPLETED|Overall Study||18
9065021|NCT04234425|10125383|FG000|NOT COMPLETED|Overall Study||0
9065022|NCT04232137|10125391|FG000|STARTED|Overall Study||254
9065023|NCT04232137|10125392|FG001|STARTED|Overall Study||185
9065024|NCT04232137|10125391|FG000|COMPLETED|Overall Study||254
9065025|NCT04232137|10125392|FG001|COMPLETED|Overall Study||185
9065026|NCT04232137|10125391|FG000|NOT COMPLETED|Overall Study||0
9065027|NCT04232137|10125392|FG001|NOT COMPLETED|Overall Study||0
9065028|NCT04222699|10125398|FG000|STARTED|Overall Study||28
9065029|NCT04222699|10125398|FG000|COMPLETED|Overall Study||26
9065030|NCT04222699|10125398|FG000|NOT COMPLETED|Overall Study||2
9065031|NCT04208698|10125407|FG000|STARTED|Overall Study||2
9065032|NCT04208698|10125408|FG001|STARTED|Overall Study||0
9065033|NCT04208698|10125409|FG002|STARTED|Overall Study||0
9065034|NCT04208698|10125410|FG003|STARTED|Overall Study||0
9065035|NCT04208698|10125411|FG004|STARTED|Overall Study||0
9065036|NCT04208698|10125407|FG000|COMPLETED|Overall Study||0
9065037|NCT04208698|10125408|FG001|COMPLETED|Overall Study||0
9065038|NCT04208698|10125409|FG002|COMPLETED|Overall Study||0
9065039|NCT04208698|10125410|FG003|COMPLETED|Overall Study||0
9065040|NCT04208698|10125411|FG004|COMPLETED|Overall Study||0
9065041|NCT04208698|10125407|FG000|NOT COMPLETED|Overall Study||2
9065042|NCT04208698|10125408|FG001|NOT COMPLETED|Overall Study||0
9065043|NCT04208698|10125409|FG002|NOT COMPLETED|Overall Study||0
9065044|NCT04208698|10125410|FG003|NOT COMPLETED|Overall Study||0
9065045|NCT04208698|10125411|FG004|NOT COMPLETED|Overall Study||0
9065046|NCT04206293|10125421|FG000|STARTED|Overall Study||11
9065047|NCT04206293|10125421|FG000|COMPLETED|Overall Study||10
9065048|NCT04206293|10125421|FG000|NOT COMPLETED|Overall Study||1
9065049|NCT04228302|10125432|FG000|STARTED|Overall Study||6
9065050|NCT04228302|10125433|FG001|STARTED|Overall Study||6
9065051|NCT04228302|10125434|FG002|STARTED|Overall Study||6
9065052|NCT04228302|10125435|FG003|STARTED|Overall Study||6
9065053|NCT04228302|10125436|FG004|STARTED|Overall Study||6
9065054|NCT04228302|10125437|FG005|STARTED|Overall Study||10
9065055|NCT04228302|10125432|FG000|COMPLETED|Overall Study||6
9065056|NCT04228302|10125433|FG001|COMPLETED|Overall Study||6
9065057|NCT04228302|10125434|FG002|COMPLETED|Overall Study||6
9065058|NCT04228302|10125435|FG003|COMPLETED|Overall Study||6
9065059|NCT04228302|10125436|FG004|COMPLETED|Overall Study||5
9065060|NCT04228302|10125437|FG005|COMPLETED|Overall Study||10
9065061|NCT04228302|10125432|FG000|NOT COMPLETED|Overall Study||0
8718299|NCT00997425|9765423|FG000|NOT COMPLETED|Overall Study||0
8718300|NCT00997438|9765431|FG000|STARTED|Overall Study||21
8718301|NCT00997438|9765432|FG001|STARTED|Overall Study||24
8718302|NCT00997438|9765433|FG002|STARTED|Overall Study||24
8718303|NCT00997438|9765431|FG000|COMPLETED|Overall Study||16
8718304|NCT00997438|9765432|FG001|COMPLETED|Overall Study||21
8718305|NCT00997438|9765433|FG002|COMPLETED|Overall Study||20
8718306|NCT00997438|9765431|FG000|NOT COMPLETED|Overall Study||5
8718307|NCT00997438|9765432|FG001|NOT COMPLETED|Overall Study||3
8718308|NCT00997438|9765433|FG002|NOT COMPLETED|Overall Study||4
8718309|NCT00997503|9765442|FG000|STARTED|Overall Study||4199
8718310|NCT00997503|9765442|FG000|12 Months|Overall Study|4059 subjects evaluable at 12-months (cardiac death/MI within 365 days or completed follow-up)|4059
8718311|NCT00997503|9765442|FG000|COMPLETED|Overall Study||3926
8718312|NCT00997503|9765442|FG000|NOT COMPLETED|Overall Study||273
8718313|NCT00997516|9765451|FG000|STARTED|Short-term Follow-up (Post Operative)||37
8935805|NCT02328937|9996688|FG005|NOT COMPLETED|Period 2||0
8935806|NCT02328937|9996683|FG000|STARTED|Period 3||7
8935807|NCT02328937|9996684|FG001|STARTED|Period 3||6
8935808|NCT02328937|9996685|FG002|STARTED|Period 3||6
8935809|NCT02328937|9996686|FG003|STARTED|Period 3||5
8935810|NCT02328937|9996687|FG004|STARTED|Period 3||6
8935811|NCT02328937|9996688|FG005|STARTED|Period 3||6
8935812|NCT02328937|9996683|FG000|COMPLETED|Period 3||7
8935813|NCT02328937|9996684|FG001|COMPLETED|Period 3||6
8935814|NCT02328937|9996685|FG002|COMPLETED|Period 3||6
8935815|NCT02328937|9996686|FG003|COMPLETED|Period 3||5
8935816|NCT02328937|9996687|FG004|COMPLETED|Period 3||6
8935817|NCT02328937|9996688|FG005|COMPLETED|Period 3||6
8935818|NCT02328937|9996683|FG000|NOT COMPLETED|Period 3||0
8935819|NCT02328937|9996684|FG001|NOT COMPLETED|Period 3||0
8935820|NCT02328937|9996685|FG002|NOT COMPLETED|Period 3||0
8935821|NCT02328937|9996686|FG003|NOT COMPLETED|Period 3||0
9065062|NCT04228302|10125433|FG001|NOT COMPLETED|Overall Study||0
8935822|NCT02328937|9996687|FG004|NOT COMPLETED|Period 3||0
8935823|NCT02328937|9996688|FG005|NOT COMPLETED|Period 3||0
8935824|NCT02329015|9996698|FG000|STARTED|Overall Study||48
8935825|NCT02329015|9996699|FG001|STARTED|Overall Study||64
8935826|NCT02329015|9996698|FG000|COMPLETED|Overall Study||48
8935827|NCT02329015|9996699|FG001|COMPLETED|Overall Study||64
8935828|NCT02329015|9996698|FG000|NOT COMPLETED|Overall Study||0
8935829|NCT02329015|9996699|FG001|NOT COMPLETED|Overall Study||0
8935830|NCT02329223|9996708|FG000|STARTED|Overall Study||73
8935831|NCT02329223|9996709|FG001|STARTED|Overall Study||71
8935832|NCT02329223|9996710|FG002|STARTED|Overall Study||74
8935833|NCT02329223|9996708|FG000|Full Analysis Set|Overall Study||73
8935834|NCT02329223|9996709|FG001|Full Analysis Set|Overall Study||70
8935835|NCT02329223|9996710|FG002|Full Analysis Set|Overall Study||74
8935836|NCT02329223|9996708|FG000|Safety Set|Overall Study||73
8935837|NCT02329223|9996709|FG001|Safety Set|Overall Study||71
8935838|NCT02329223|9996710|FG002|Safety Set|Overall Study||74
8935839|NCT02329223|9996708|FG000|COMPLETED|Overall Study||72
8935840|NCT02329223|9996709|FG001|COMPLETED|Overall Study||68
8935841|NCT02329223|9996710|FG002|COMPLETED|Overall Study||68
8935842|NCT02329223|9996708|FG000|NOT COMPLETED|Overall Study||1
8935843|NCT02329223|9996709|FG001|NOT COMPLETED|Overall Study||3
8935844|NCT02329223|9996710|FG002|NOT COMPLETED|Overall Study||6
8935845|NCT02329431|9996720|FG000|STARTED|Overall Study||92
8935846|NCT02329431|9996721|FG001|STARTED|Overall Study||89
8935847|NCT02329431|9996720|FG000|Baseline Interview|Overall Study||87
8935848|NCT02329431|9996721|FG001|Baseline Interview|Overall Study||85
8935849|NCT02329431|9996720|FG000|COMPLETED|Overall Study||72
8718314|NCT00997516|9765452|FG001|STARTED|Short-term Follow-up (Post Operative)||38
8718315|NCT00997516|9765451|FG000|COMPLETED|Short-term Follow-up (Post Operative)||37
8718316|NCT00997516|9765452|FG001|COMPLETED|Short-term Follow-up (Post Operative)||38
8718317|NCT00997516|9765451|FG000|NOT COMPLETED|Short-term Follow-up (Post Operative)||0
8718318|NCT00997516|9765452|FG001|NOT COMPLETED|Short-term Follow-up (Post Operative)||0
8718319|NCT00997516|9765451|FG000|STARTED|Long-term Follow-up (After 6 Months)||37
8718320|NCT00997516|9765452|FG001|STARTED|Long-term Follow-up (After 6 Months)||38
8718321|NCT00997516|9765451|FG000|COMPLETED|Long-term Follow-up (After 6 Months)||31
8718322|NCT00997516|9765452|FG001|COMPLETED|Long-term Follow-up (After 6 Months)||36
8718323|NCT00997516|9765451|FG000|NOT COMPLETED|Long-term Follow-up (After 6 Months)||6
8718324|NCT00997516|9765452|FG001|NOT COMPLETED|Long-term Follow-up (After 6 Months)||2
8718325|NCT00997555|9765460|FG000|STARTED|Overall Study||13
8718326|NCT00997555|9765461|FG001|STARTED|Overall Study||15
8718327|NCT00997555|9765460|FG000|COMPLETED|Overall Study||13
8718328|NCT00997555|9765461|FG001|COMPLETED|Overall Study||15
8718329|NCT00997555|9765460|FG000|NOT COMPLETED|Overall Study||0
8718330|NCT00997555|9765461|FG001|NOT COMPLETED|Overall Study||0
8718331|NCT00997594|9765469|FG000|STARTED|Overall Study||9
8718332|NCT00997594|9765470|FG001|STARTED|Overall Study||9
8718333|NCT00997594|9765469|FG000|Completion of Ablation Procedure|Overall Study||9
8718334|NCT00997594|9765470|FG001|Completion of Ablation Procedure|Overall Study||9
8718335|NCT00997594|9765469|FG000|COMPLETED|Overall Study||9
8718336|NCT00997594|9765470|FG001|COMPLETED|Overall Study||9
8718337|NCT00997594|9765469|FG000|NOT COMPLETED|Overall Study||0
8718338|NCT00997594|9765470|FG001|NOT COMPLETED|Overall Study||0
8718339|NCT00997620|9765478|FG000|STARTED|Overall Study||19
8718340|NCT00997620|9765479|FG001|STARTED|Overall Study||21
8718341|NCT00997620|9765478|FG000|COMPLETED|Overall Study||19
8718342|NCT00997620|9765479|FG001|COMPLETED|Overall Study||21
8718343|NCT00997620|9765478|FG000|NOT COMPLETED|Overall Study||0
8718344|NCT00997620|9765479|FG001|NOT COMPLETED|Overall Study||0
8718345|NCT00997672|9765490|FG000|STARTED|Overall Study||4
8718346|NCT00997672|9765491|FG001|STARTED|Overall Study||5
8718347|NCT00997672|9765490|FG000|COMPLETED|Overall Study||0
8718348|NCT00997672|9765491|FG001|COMPLETED|Overall Study||1
8718349|NCT00997672|9765490|FG000|NOT COMPLETED|Overall Study||4
8718350|NCT00997672|9765491|FG001|NOT COMPLETED|Overall Study||4
8718351|NCT00997893|9765500|FG000|STARTED|Overall Study||14
8718352|NCT00997893|9765501|FG001|STARTED|Overall Study||13
8718353|NCT00997893|9765502|FG002|STARTED|Overall Study||13
8718354|NCT00997893|9765500|FG000|COMPLETED|Overall Study||12
8718355|NCT00997893|9765501|FG001|COMPLETED|Overall Study||12
8935850|NCT02329431|9996721|FG001|COMPLETED|Overall Study||76
8935851|NCT02329431|9996720|FG000|NOT COMPLETED|Overall Study||20
8935852|NCT02329431|9996721|FG001|NOT COMPLETED|Overall Study||13
8935853|NCT02329587|9996729|FG000|STARTED|Baseline Thru Post-treatment Assessment||5
8935854|NCT02329587|9996730|FG001|STARTED|Baseline Thru Post-treatment Assessment||7
8935855|NCT02329587|9996729|FG000|Completed All Intervention Sessions|Baseline Thru Post-treatment Assessment||3
8935856|NCT02329587|9996730|FG001|Completed All Intervention Sessions|Baseline Thru Post-treatment Assessment||4
8935857|NCT02329587|9996729|FG000|COMPLETED|Baseline Thru Post-treatment Assessment||4
8935858|NCT02329587|9996730|FG001|COMPLETED|Baseline Thru Post-treatment Assessment||6
8718356|NCT00997893|9765502|FG002|COMPLETED|Overall Study||13
8718357|NCT00997893|9765500|FG000|NOT COMPLETED|Overall Study||2
8718358|NCT00997893|9765501|FG001|NOT COMPLETED|Overall Study||1
8718359|NCT00997893|9765502|FG002|NOT COMPLETED|Overall Study||0
8718360|NCT00997932|9765510|FG000|STARTED|Overall Study||29
8718361|NCT00997932|9765510|FG000|COMPLETED|Overall Study||27
8718362|NCT00997932|9765510|FG000|NOT COMPLETED|Overall Study||2
8718363|NCT00997984|9765518|FG000|STARTED|Overall Study||113
8935859|NCT02329587|9996729|FG000|NOT COMPLETED|Baseline Thru Post-treatment Assessment||1
8935860|NCT02329587|9996730|FG001|NOT COMPLETED|Baseline Thru Post-treatment Assessment||1
8935861|NCT02329587|9996729|FG000|STARTED|1-month Follow-up||4
8935862|NCT02329587|9996730|FG001|STARTED|1-month Follow-up||6
8935863|NCT02329587|9996729|FG000|COMPLETED|1-month Follow-up||4
8935864|NCT02329587|9996730|FG001|COMPLETED|1-month Follow-up||5
8935865|NCT02329587|9996729|FG000|NOT COMPLETED|1-month Follow-up||0
8935866|NCT02329587|9996730|FG001|NOT COMPLETED|1-month Follow-up||1
8935867|NCT02329600|9996739|FG000|STARTED|Overall Study||10
8935868|NCT02329600|9996740|FG001|STARTED|Overall Study||15
8935869|NCT02329600|9996741|FG002|STARTED|Overall Study||15
8935870|NCT02329600|9996739|FG000|COMPLETED|Overall Study||10
8935871|NCT02329600|9996740|FG001|COMPLETED|Overall Study||15
8935872|NCT02329600|9996741|FG002|COMPLETED|Overall Study||15
8935873|NCT02329600|9996739|FG000|NOT COMPLETED|Overall Study||0
8935874|NCT02329600|9996740|FG001|NOT COMPLETED|Overall Study||0
8935875|NCT02329600|9996741|FG002|NOT COMPLETED|Overall Study||0
8935876|NCT02329730|9996753|FG000|STARTED|Overall Study||14
8935877|NCT02329730|9996754|FG001|STARTED|Overall Study||14
8935878|NCT02329730|9996755|FG002|STARTED|Overall Study||14
8935879|NCT02329730|9996756|FG003|STARTED|Overall Study||14
8935880|NCT02329730|9996757|FG004|STARTED|Overall Study||14
8935881|NCT02329730|9996758|FG005|STARTED|Overall Study||14
8935882|NCT02329730|9996759|FG006|STARTED|Overall Study||14
8935883|NCT02329730|9996760|FG007|STARTED|Overall Study||14
8935884|NCT02329730|9996761|FG008|STARTED|Overall Study||8
8935885|NCT02329730|9996762|FG009|STARTED|Overall Study||8
8935886|NCT02329730|9996763|FG010|STARTED|Overall Study||8
8935887|NCT02329730|9996764|FG011|STARTED|Overall Study||8
8935888|NCT02329730|9996753|FG000|COMPLETED|Overall Study||14
8935889|NCT02329730|9996754|FG001|COMPLETED|Overall Study||14
8935890|NCT02329730|9996755|FG002|COMPLETED|Overall Study||14
8935891|NCT02329730|9996756|FG003|COMPLETED|Overall Study||14
8935892|NCT02329730|9996757|FG004|COMPLETED|Overall Study||11
8935893|NCT02329730|9996758|FG005|COMPLETED|Overall Study||12
8935894|NCT02329730|9996759|FG006|COMPLETED|Overall Study||13
8935895|NCT02329730|9996760|FG007|COMPLETED|Overall Study||13
8935896|NCT02329730|9996761|FG008|COMPLETED|Overall Study||7
8935897|NCT02329730|9996762|FG009|COMPLETED|Overall Study||7
8935898|NCT02329730|9996763|FG010|COMPLETED|Overall Study||8
8935899|NCT02329730|9996764|FG011|COMPLETED|Overall Study||8
8935900|NCT02329730|9996753|FG000|NOT COMPLETED|Overall Study||0
8935901|NCT02329730|9996754|FG001|NOT COMPLETED|Overall Study||0
8935902|NCT02329730|9996755|FG002|NOT COMPLETED|Overall Study||0
8935903|NCT02329730|9996756|FG003|NOT COMPLETED|Overall Study||0
8935904|NCT02329730|9996757|FG004|NOT COMPLETED|Overall Study||3
8935905|NCT02329730|9996758|FG005|NOT COMPLETED|Overall Study||2
8935906|NCT02329730|9996759|FG006|NOT COMPLETED|Overall Study||1
8935907|NCT02329730|9996760|FG007|NOT COMPLETED|Overall Study||1
8935908|NCT02329730|9996761|FG008|NOT COMPLETED|Overall Study||1
8935909|NCT02329730|9996762|FG009|NOT COMPLETED|Overall Study||1
8935910|NCT02329730|9996763|FG010|NOT COMPLETED|Overall Study||0
8935911|NCT02329730|9996764|FG011|NOT COMPLETED|Overall Study||0
8935912|NCT02329743|9996785|FG000|STARTED|Overall Study||84
8935913|NCT02329743|9996786|FG001|STARTED|Overall Study||87
8617298|NCT00455650|9655434|FG003|STARTED|Week 3||14
8617299|NCT00455650|9655435|FG004|STARTED|Week 3||14
8617300|NCT00455650|9655436|FG005|STARTED|Week 3||13
8617301|NCT00455650|9655431|FG000|COMPLETED|Week 3||10
8617302|NCT00455650|9655432|FG001|COMPLETED|Week 3||10
8617303|NCT00455650|9655433|FG002|COMPLETED|Week 3||10
8617304|NCT00455650|9655434|FG003|COMPLETED|Week 3||14
8617305|NCT00455650|9655435|FG004|COMPLETED|Week 3||14
8617306|NCT00455650|9655436|FG005|COMPLETED|Week 3||13
8617307|NCT00455650|9655431|FG000|NOT COMPLETED|Week 3||0
8617308|NCT00455650|9655432|FG001|NOT COMPLETED|Week 3||0
8617309|NCT00455650|9655433|FG002|NOT COMPLETED|Week 3||0
8617310|NCT00455650|9655434|FG003|NOT COMPLETED|Week 3||0
8617311|NCT00455650|9655435|FG004|NOT COMPLETED|Week 3||0
8617312|NCT00455650|9655436|FG005|NOT COMPLETED|Week 3||0
8617313|NCT00455663|9655449|FG000|STARTED|Overall Study||37
8617314|NCT00455663|9655450|FG001|STARTED|Overall Study||36
8617315|NCT00455663|9655451|FG002|STARTED|Overall Study||32
8935914|NCT02329743|9996787|FG002|STARTED|Overall Study||85
8935915|NCT02329743|9996785|FG000|COMPLETED|Overall Study||78
8935916|NCT02329743|9996786|FG001|COMPLETED|Overall Study||80
8935917|NCT02329743|9996787|FG002|COMPLETED|Overall Study||77
8935918|NCT02329743|9996785|FG000|NOT COMPLETED|Overall Study||6
8935919|NCT02329743|9996786|FG001|NOT COMPLETED|Overall Study||7
8935920|NCT02329743|9996787|FG002|NOT COMPLETED|Overall Study||8
8935921|NCT02329964|9996797|FG000|STARTED|Overall Study||40
8935922|NCT02329964|9996798|FG001|STARTED|Overall Study||40
8935923|NCT02329964|9996797|FG000|COMPLETED|Overall Study||40
8617316|NCT00455663|9655449|FG000|COMPLETED|Overall Study||34
8617317|NCT00455663|9655450|FG001|COMPLETED|Overall Study||32
8935924|NCT02329964|9996798|FG001|COMPLETED|Overall Study||40
8935925|NCT02329964|9996797|FG000|NOT COMPLETED|Overall Study||0
8935926|NCT02329964|9996798|FG001|NOT COMPLETED|Overall Study||0
8935927|NCT02330055|9996806|FG000|STARTED|Overall Study||50
8617318|NCT00455663|9655451|FG002|COMPLETED|Overall Study||29
8617319|NCT00455663|9655449|FG000|NOT COMPLETED|Overall Study||3
8935928|NCT02330055|9996807|FG001|STARTED|Overall Study||49
8935929|NCT02330055|9996806|FG000|COMPLETED|Overall Study||40
8935930|NCT02330055|9996807|FG001|COMPLETED|Overall Study||40
8935931|NCT02330055|9996806|FG000|NOT COMPLETED|Overall Study||10
8935932|NCT02330055|9996807|FG001|NOT COMPLETED|Overall Study||9
8935933|NCT02330081|9996813|FG000|STARTED|Overall Study||22
8935934|NCT02330081|9996813|FG000|COMPLETED|Overall Study||14
8935935|NCT02330081|9996813|FG000|NOT COMPLETED|Overall Study||8
8935936|NCT02330094|9996822|FG000|STARTED|Overall Study||8
8935937|NCT02330094|9996823|FG001|STARTED|Overall Study||8
8935938|NCT02330094|9996822|FG000|COMPLETED|Overall Study||8
8935939|NCT02330094|9996823|FG001|COMPLETED|Overall Study||8
8935940|NCT02330094|9996822|FG000|NOT COMPLETED|Overall Study||0
8935941|NCT02330094|9996823|FG001|NOT COMPLETED|Overall Study||0
8935942|NCT02330172|9996831|FG000|STARTED|Overall Study||22
8935943|NCT02330172|9996832|FG001|STARTED|Overall Study||22
8935944|NCT02330172|9996831|FG000|COMPLETED|Overall Study||19
8935945|NCT02330172|9996832|FG001|COMPLETED|Overall Study||21
8935946|NCT02330172|9996831|FG000|NOT COMPLETED|Overall Study||3
8935947|NCT02330172|9996832|FG001|NOT COMPLETED|Overall Study||1
8935948|NCT02330276|9996841|FG000|STARTED|Overall Study||4
8935949|NCT02330276|9996842|FG001|STARTED|Overall Study||4
8935950|NCT02330276|9996843|FG002|STARTED|Overall Study||4
8935951|NCT02330276|9996841|FG000|COMPLETED|Overall Study||4
8935952|NCT02330276|9996842|FG001|COMPLETED|Overall Study||4
8935953|NCT02330276|9996843|FG002|COMPLETED|Overall Study||4
8935954|NCT02330276|9996841|FG000|NOT COMPLETED|Overall Study||0
8935955|NCT02330276|9996842|FG001|NOT COMPLETED|Overall Study||0
8935956|NCT02330276|9996843|FG002|NOT COMPLETED|Overall Study||0
8935957|NCT02330341|9996853|FG000|STARTED|Overall Study||12
8935958|NCT02330341|9996854|FG001|STARTED|Overall Study||12
8935959|NCT02330341|9996853|FG000|COMPLETED|Overall Study||12
8935960|NCT02330341|9996854|FG001|COMPLETED|Overall Study||11
8935961|NCT02330341|9996853|FG000|NOT COMPLETED|Overall Study||0
8935962|NCT02330341|9996854|FG001|NOT COMPLETED|Overall Study||1
8935963|NCT02330523|9996862|FG000|STARTED|Overall Study||21
8935964|NCT02330523|9996863|FG001|STARTED|Overall Study||19
8935965|NCT02330523|9996862|FG000|COMPLETED|Overall Study||21
8935966|NCT02330523|9996863|FG001|COMPLETED|Overall Study||19
8935967|NCT02330523|9996862|FG000|NOT COMPLETED|Overall Study||0
8935968|NCT02330523|9996863|FG001|NOT COMPLETED|Overall Study||0
8935969|NCT02330549|9996871|FG000|STARTED|Overall Study||20
8935970|NCT02330549|9996872|FG001|STARTED|Overall Study||25
8935971|NCT02330549|9996871|FG000|COMPLETED|Overall Study||16
8935972|NCT02330549|9996872|FG001|COMPLETED|Overall Study||24
8935973|NCT02330549|9996871|FG000|NOT COMPLETED|Overall Study||4
8935974|NCT02330549|9996872|FG001|NOT COMPLETED|Overall Study||1
8935975|NCT02330588|9996883|FG000|STARTED|Overall Study||44
8935976|NCT02330588|9996884|FG001|STARTED|Overall Study||43
8935977|NCT02330588|9996885|FG002|STARTED|Overall Study||46
8935978|NCT02330588|9996886|FG003|STARTED|Overall Study||46
8935979|NCT02330588|9996887|FG004|STARTED|Overall Study||47
8935980|NCT02330588|9996883|FG000|COMPLETED|Overall Study||28
8935981|NCT02330588|9996884|FG001|COMPLETED|Overall Study||25
8935982|NCT02330588|9996885|FG002|COMPLETED|Overall Study||31
8935983|NCT02330588|9996886|FG003|COMPLETED|Overall Study||24
8935984|NCT02330588|9996887|FG004|COMPLETED|Overall Study||28
8935985|NCT02330588|9996883|FG000|NOT COMPLETED|Overall Study||16
8935986|NCT02330588|9996884|FG001|NOT COMPLETED|Overall Study||18
8935987|NCT02330588|9996885|FG002|NOT COMPLETED|Overall Study||15
8935988|NCT02330588|9996886|FG003|NOT COMPLETED|Overall Study||22
8935989|NCT02330588|9996887|FG004|NOT COMPLETED|Overall Study||19
8935990|NCT02330627|9996909|FG000|STARTED|Overall Study||16
8935991|NCT02330627|9996910|FG001|STARTED|Overall Study||13
8935992|NCT02330627|9996909|FG000|COMPLETED|Overall Study||15
8935993|NCT02330627|9996910|FG001|COMPLETED|Overall Study||12
8935994|NCT02330627|9996909|FG000|NOT COMPLETED|Overall Study||1
8935995|NCT02330627|9996910|FG001|NOT COMPLETED|Overall Study||1
8935996|NCT02330978|9996916|FG000|STARTED|The First Patient Included at Study||1
8935997|NCT02330978|9996916|FG000|COMPLETED|The First Patient Included at Study||1
8935998|NCT02330978|9996916|FG000|NOT COMPLETED|The First Patient Included at Study||0
8935999|NCT02330978|9996916|FG000|STARTED|The Second Patient Included at Study||1
8936000|NCT02330978|9996916|FG000|COMPLETED|The Second Patient Included at Study||1
8936001|NCT02330978|9996916|FG000|NOT COMPLETED|The Second Patient Included at Study||0
8936002|NCT02331095|9996922|FG000|STARTED|Overall Study||11
8936003|NCT02331095|9996923|FG001|STARTED|Overall Study||10
8936004|NCT02331095|9996922|FG000|COMPLETED|Overall Study||7
8936005|NCT02331095|9996923|FG001|COMPLETED|Overall Study||9
8936006|NCT02331095|9996922|FG000|NOT COMPLETED|Overall Study||4
8936007|NCT02331095|9996923|FG001|NOT COMPLETED|Overall Study||1
8936008|NCT02331108|9996939|FG000|STARTED|Overall Study||51
8936009|NCT02331108|9996940|FG001|STARTED|Overall Study||52
8936010|NCT02331108|9996941|FG002|STARTED|Overall Study||51
8936011|NCT02331108|9996942|FG003|STARTED|Overall Study||51
8936012|NCT02331108|9996943|FG004|STARTED|Overall Study||52
8936013|NCT02331108|9996944|FG005|STARTED|Overall Study||52
8936014|NCT02331108|9996939|FG000|COMPLETED|Overall Study||50
8936015|NCT02331108|9996940|FG001|COMPLETED|Overall Study||50
8936016|NCT02331108|9996941|FG002|COMPLETED|Overall Study||50
8936017|NCT02331108|9996942|FG003|COMPLETED|Overall Study||50
8936018|NCT02331108|9996943|FG004|COMPLETED|Overall Study||50
8936019|NCT02331108|9996944|FG005|COMPLETED|Overall Study||50
8936020|NCT02331108|9996939|FG000|NOT COMPLETED|Overall Study||1
8936021|NCT02331108|9996940|FG001|NOT COMPLETED|Overall Study||2
8936022|NCT02331108|9996941|FG002|NOT COMPLETED|Overall Study||1
8936023|NCT02331108|9996942|FG003|NOT COMPLETED|Overall Study||1
8936024|NCT02331108|9996943|FG004|NOT COMPLETED|Overall Study||2
8936025|NCT02331108|9996944|FG005|NOT COMPLETED|Overall Study||2
8936026|NCT02331368|9996960|FG000|STARTED|Overall Study||32
8936027|NCT02331368|9996960|FG000|COMPLETED|Overall Study||29
8936028|NCT02331368|9996960|FG000|NOT COMPLETED|Overall Study||3
8936029|NCT02331394|9996964|FG000|STARTED|Overall Study||15
8936030|NCT02331394|9996964|FG000|COMPLETED|Overall Study|14 patients, 1 dropped out|14
8936031|NCT02331394|9996964|FG000|NOT COMPLETED|Overall Study||1
8936032|NCT02331407|9996975|FG000|STARTED|Overall Study||9
8936033|NCT02331407|9996975|FG000|COMPLETED|Overall Study||9
8936034|NCT02331407|9996975|FG000|NOT COMPLETED|Overall Study||0
8936035|NCT02331446|9996983|FG000|STARTED|Overall Study||9
8936036|NCT02331446|9996984|FG001|STARTED|Overall Study||11
8936037|NCT02331446|9996985|FG002|STARTED|Overall Study||11
8936038|NCT02331446|9996986|FG003|STARTED|Overall Study||11
8936039|NCT02331446|9996983|FG000|COMPLETED|Overall Study||5
8936040|NCT02331446|9996984|FG001|COMPLETED|Overall Study||6
8936041|NCT02331446|9996985|FG002|COMPLETED|Overall Study||8
8936042|NCT02331446|9996986|FG003|COMPLETED|Overall Study||8
8936043|NCT02331446|9996983|FG000|NOT COMPLETED|Overall Study||4
8936044|NCT02331446|9996984|FG001|NOT COMPLETED|Overall Study||5
8936045|NCT02331446|9996985|FG002|NOT COMPLETED|Overall Study||3
8936046|NCT02331446|9996986|FG003|NOT COMPLETED|Overall Study||3
8936047|NCT02331589|9996998|FG000|STARTED|Overall Study||39
8936048|NCT02331589|9996999|FG001|STARTED|Overall Study||36
8936049|NCT02331589|9996998|FG000|COMPLETED|Overall Study||34
8936050|NCT02331589|9996999|FG001|COMPLETED|Overall Study||31
8936051|NCT02331589|9996998|FG000|NOT COMPLETED|Overall Study||5
8936052|NCT02331589|9996999|FG001|NOT COMPLETED|Overall Study||5
8936053|NCT02331680|9997008|FG000|STARTED|Overall Study||40
8936054|NCT02331680|9997009|FG001|STARTED|Overall Study||40
8936055|NCT02331680|9997010|FG002|STARTED|Overall Study||44
8936056|NCT02331680|9997008|FG000|COMPLETED|Overall Study||34
8936057|NCT02331680|9997009|FG001|COMPLETED|Overall Study||36
8936058|NCT02331680|9997010|FG002|COMPLETED|Overall Study||29
8936059|NCT02331680|9997008|FG000|NOT COMPLETED|Overall Study||6
8936060|NCT02331680|9997009|FG001|NOT COMPLETED|Overall Study||4
8936061|NCT02331680|9997010|FG002|NOT COMPLETED|Overall Study||15
8936062|NCT02331940|9997020|FG000|STARTED|Overall Study||100
8936063|NCT02331940|9997021|FG001|STARTED|Overall Study||100
8936064|NCT02331940|9997020|FG000|COMPLETED|Overall Study||93
8936065|NCT02331940|9997021|FG001|COMPLETED|Overall Study||95
8936066|NCT02331940|9997020|FG000|NOT COMPLETED|Overall Study||7
8936067|NCT02331940|9997021|FG001|NOT COMPLETED|Overall Study||5
8936068|NCT02331992|9997027|FG000|STARTED|Overall Study||34
8936069|NCT02331992|9997027|FG000|COMPLETED|Overall Study||34
8936070|NCT02331992|9997027|FG000|NOT COMPLETED|Overall Study||0
8936071|NCT02332239|9997033|FG000|STARTED|Overall Study||58
8936072|NCT02332239|9997034|FG001|STARTED|Overall Study||58
8936073|NCT02332239|9997033|FG000|COMPLETED|Overall Study||54
8936074|NCT02332239|9997034|FG001|COMPLETED|Overall Study||52
8936075|NCT02332239|9997033|FG000|NOT COMPLETED|Overall Study||4
8936076|NCT02332239|9997034|FG001|NOT COMPLETED|Overall Study||6
8936077|NCT02332291|9997044|FG000|STARTED|Phase 1: Blinded Escitalopram or Placebo||63
8936078|NCT02332291|9997045|FG001|STARTED|Phase 1: Blinded Escitalopram or Placebo||32
8936079|NCT02332291|9997044|FG000|COMPLETED|Phase 1: Blinded Escitalopram or Placebo||59
8936080|NCT02332291|9997045|FG001|COMPLETED|Phase 1: Blinded Escitalopram or Placebo||23
8936081|NCT02332291|9997044|FG000|NOT COMPLETED|Phase 1: Blinded Escitalopram or Placebo||4
8936082|NCT02332291|9997045|FG001|NOT COMPLETED|Phase 1: Blinded Escitalopram or Placebo||9
8936083|NCT02332291|9997044|FG000|STARTED|Phase 2: Open-Label Bupropion||22
8936084|NCT02332291|9997045|FG001|STARTED|Phase 2: Open-Label Bupropion||19
8936085|NCT02332291|9997044|FG000|COMPLETED|Phase 2: Open-Label Bupropion||19
8936086|NCT02332291|9997045|FG001|COMPLETED|Phase 2: Open-Label Bupropion||11
8936087|NCT02332291|9997044|FG000|NOT COMPLETED|Phase 2: Open-Label Bupropion||3
8936088|NCT02332291|9997045|FG001|NOT COMPLETED|Phase 2: Open-Label Bupropion||8
8936089|NCT02332707|9997073|FG000|STARTED|Overall Study||23
8936090|NCT02332707|9997074|FG001|STARTED|Overall Study||24
8936091|NCT02332707|9997075|FG002|STARTED|Overall Study||16
8936092|NCT02332707|9997076|FG003|STARTED|Overall Study||14
8936093|NCT02332707|9997077|FG004|STARTED|Overall Study||23
8936094|NCT02332707|9997078|FG005|STARTED|Overall Study||23
8936095|NCT02332707|9997079|FG006|STARTED|Overall Study||15
8936096|NCT02332707|9997080|FG007|STARTED|Overall Study||16
8936097|NCT02332707|9997081|FG008|STARTED|Overall Study||48
8936098|NCT02332707|9997082|FG009|STARTED|Overall Study||31
8936099|NCT02332707|9997083|FG010|STARTED|Overall Study||31
8936100|NCT02332707|9997084|FG011|STARTED|Overall Study||35
8936101|NCT02332707|9997085|FG012|STARTED|Overall Study||40
8936102|NCT02332707|9997086|FG013|STARTED|Overall Study||15
8936103|NCT02332707|9997087|FG014|STARTED|Overall Study||16
8936104|NCT02332707|9997088|FG015|STARTED|Overall Study||26
8936105|NCT02332707|9997089|FG016|STARTED|Overall Study||30
8936106|NCT02332707|9997090|FG017|STARTED|Overall Study||16
8936107|NCT02332707|9997073|FG000|COMPLETED|Overall Study||23
8936108|NCT02332707|9997074|FG001|COMPLETED|Overall Study||24
8936109|NCT02332707|9997075|FG002|COMPLETED|Overall Study||15
8936110|NCT02332707|9997076|FG003|COMPLETED|Overall Study||13
8936111|NCT02332707|9997077|FG004|COMPLETED|Overall Study||23
8936112|NCT02332707|9997078|FG005|COMPLETED|Overall Study||22
8936113|NCT02332707|9997079|FG006|COMPLETED|Overall Study||15
8936114|NCT02332707|9997080|FG007|COMPLETED|Overall Study||16
9065063|NCT04228302|10125434|FG002|NOT COMPLETED|Overall Study||0
9065064|NCT04228302|10125435|FG003|NOT COMPLETED|Overall Study||0
9065065|NCT04228302|10125436|FG004|NOT COMPLETED|Overall Study||1
9065066|NCT04228302|10125437|FG005|NOT COMPLETED|Overall Study||0
9065067|NCT04227119|10125451|FG000|STARTED|Overall Study||11
9065068|NCT04227119|10125451|FG000|COMPLETED|Overall Study||11
9065069|NCT04227119|10125451|FG000|NOT COMPLETED|Overall Study||0
9065070|NCT04224753|10125457|FG000|STARTED|Overall Study||51
9065071|NCT04224753|10125457|FG000|COMPLETED|Overall Study||51
9065072|NCT04224753|10125457|FG000|NOT COMPLETED|Overall Study||0
9065073|NCT04218799|10125461|FG000|STARTED|Overall Study||7
9065074|NCT04218799|10125461|FG000|COMPLETED|Overall Study||7
9065075|NCT04218799|10125461|FG000|NOT COMPLETED|Overall Study||0
9065076|NCT04204057|10125465|FG000|STARTED|Overall Study||21
9065077|NCT04204057|10125465|FG000|COMPLETED|Overall Study||21
9065078|NCT04204057|10125465|FG000|NOT COMPLETED|Overall Study||0
9065079|NCT04195594|10125469|FG000|STARTED|Overall Study||14
9065080|NCT04195594|10125469|FG000|COMPLETED|Overall Study||11
9065081|NCT04195594|10125469|FG000|NOT COMPLETED|Overall Study||3
9065082|NCT04223687|10125475|FG000|STARTED|Overall Study||163
9065083|NCT04223687|10125476|FG001|STARTED|Overall Study||163
9065084|NCT04223687|10125475|FG000|COMPLETED|Overall Study||162
9065085|NCT04223687|10125476|FG001|COMPLETED|Overall Study||163
9065086|NCT04223687|10125475|FG000|NOT COMPLETED|Overall Study||1
9065087|NCT04223687|10125476|FG001|NOT COMPLETED|Overall Study||0
9065088|NCT04223232|10125482|FG000|STARTED|Overall Study||6
9065089|NCT04223232|10125482|FG000|COMPLETED|Overall Study||5
9065090|NCT04223232|10125482|FG000|NOT COMPLETED|Overall Study||1
9065091|NCT04189224|10125486|FG000|STARTED|Period 1||23
9065092|NCT04189224|10125487|FG001|STARTED|Period 1||21
9065093|NCT04189224|10125486|FG000|COMPLETED|Period 1||23
9065094|NCT04189224|10125487|FG001|COMPLETED|Period 1||21
9065095|NCT04189224|10125486|FG000|NOT COMPLETED|Period 1||0
9065096|NCT04189224|10125487|FG001|NOT COMPLETED|Period 1||0
9065097|NCT04189224|10125486|FG000|STARTED|Period 2||23
9065098|NCT04189224|10125487|FG001|STARTED|Period 2||21
9065099|NCT04189224|10125486|FG000|COMPLETED|Period 2||23
9065100|NCT04189224|10125487|FG001|COMPLETED|Period 2||20
9065101|NCT04189224|10125486|FG000|NOT COMPLETED|Period 2||0
9065102|NCT04189224|10125487|FG001|NOT COMPLETED|Period 2||1
9065103|NCT04214600|10125495|FG000|STARTED|Overall Study||50
9065104|NCT04214600|10125496|FG001|STARTED|Overall Study||50
9065105|NCT04214600|10125495|FG000|COMPLETED|Overall Study||41
9065106|NCT04214600|10125496|FG001|COMPLETED|Overall Study||36
9065107|NCT04214600|10125495|FG000|NOT COMPLETED|Overall Study||9
9065108|NCT04214600|10125496|FG001|NOT COMPLETED|Overall Study||14
9065109|NCT04202497|10125503|FG000|STARTED|Baseline Scan (Day-1)||7
9065110|NCT04202497|10125504|FG001|STARTED|Baseline Scan (Day-1)||0
9065111|NCT04202497|10125505|FG002|STARTED|Baseline Scan (Day-1)||0
9065112|NCT04202497|10125506|FG003|STARTED|Baseline Scan (Day-1)||0
9065113|NCT04202497|10125503|FG000|COMPLETED|Baseline Scan (Day-1)||6
9065114|NCT04202497|10125504|FG001|COMPLETED|Baseline Scan (Day-1)||0
9065115|NCT04202497|10125505|FG002|COMPLETED|Baseline Scan (Day-1)||0
9065116|NCT04202497|10125506|FG003|COMPLETED|Baseline Scan (Day-1)||0
9065117|NCT04202497|10125503|FG000|NOT COMPLETED|Baseline Scan (Day-1)||1
9065118|NCT04202497|10125504|FG001|NOT COMPLETED|Baseline Scan (Day-1)||0
9065119|NCT04202497|10125505|FG002|NOT COMPLETED|Baseline Scan (Day-1)||0
9065120|NCT04202497|10125506|FG003|NOT COMPLETED|Baseline Scan (Day-1)||0
9065121|NCT04202497|10125503|FG000|STARTED|Treatment Period (Day 1 Through Day 2-3)||0
8617320|NCT00455663|9655450|FG001|NOT COMPLETED|Overall Study||4
8617321|NCT00455663|9655451|FG002|NOT COMPLETED|Overall Study||3
8617322|NCT00455689|9655465|FG000|STARTED|Overall Study||14
8617323|NCT00455689|9655466|FG001|STARTED|Overall Study||6
8936115|NCT02332707|9997081|FG008|COMPLETED|Overall Study||48
8936116|NCT02332707|9997082|FG009|COMPLETED|Overall Study||28
8936117|NCT02332707|9997083|FG010|COMPLETED|Overall Study||29
8936118|NCT02332707|9997084|FG011|COMPLETED|Overall Study||35
8936119|NCT02332707|9997085|FG012|COMPLETED|Overall Study||35
8936120|NCT02332707|9997086|FG013|COMPLETED|Overall Study||15
8936121|NCT02332707|9997087|FG014|COMPLETED|Overall Study||16
8936122|NCT02332707|9997088|FG015|COMPLETED|Overall Study||26
8936123|NCT02332707|9997089|FG016|COMPLETED|Overall Study||30
8936124|NCT02332707|9997090|FG017|COMPLETED|Overall Study||16
8936125|NCT02332707|9997073|FG000|NOT COMPLETED|Overall Study||0
8936126|NCT02332707|9997074|FG001|NOT COMPLETED|Overall Study||0
8936127|NCT02332707|9997075|FG002|NOT COMPLETED|Overall Study||1
9065122|NCT04202497|10125504|FG001|STARTED|Treatment Period (Day 1 Through Day 2-3)|Eligible participants from Baseline Period who received 10 mCi of [18F]MNI-1054 on Day -1.|2
9065123|NCT04202497|10125505|FG002|STARTED|Treatment Period (Day 1 Through Day 2-3)|Eligible participants from Baseline Period who received 10 mCi of [18F]MNI-1054 on Day -1.|2
9065124|NCT04202497|10125506|FG003|STARTED|Treatment Period (Day 1 Through Day 2-3)|Eligible participants from Baseline Period who received 10 mCi of [18F]MNI-1054 on Day -1.|2
8936128|NCT02332707|9997076|FG003|NOT COMPLETED|Overall Study||1
8936129|NCT02332707|9997077|FG004|NOT COMPLETED|Overall Study||0
9065125|NCT04202497|10125503|FG000|COMPLETED|Treatment Period (Day 1 Through Day 2-3)||0
9065126|NCT04202497|10125504|FG001|COMPLETED|Treatment Period (Day 1 Through Day 2-3)||2
9065127|NCT04202497|10125505|FG002|COMPLETED|Treatment Period (Day 1 Through Day 2-3)||2
9065128|NCT04202497|10125506|FG003|COMPLETED|Treatment Period (Day 1 Through Day 2-3)||2
9065129|NCT04202497|10125503|FG000|NOT COMPLETED|Treatment Period (Day 1 Through Day 2-3)||0
8936130|NCT02332707|9997078|FG005|NOT COMPLETED|Overall Study||1
8936131|NCT02332707|9997079|FG006|NOT COMPLETED|Overall Study||0
8936132|NCT02332707|9997080|FG007|NOT COMPLETED|Overall Study||0
8936133|NCT02332707|9997081|FG008|NOT COMPLETED|Overall Study||0
8936134|NCT02332707|9997082|FG009|NOT COMPLETED|Overall Study||3
8936135|NCT02332707|9997083|FG010|NOT COMPLETED|Overall Study||2
8936136|NCT02332707|9997084|FG011|NOT COMPLETED|Overall Study||0
8936137|NCT02332707|9997085|FG012|NOT COMPLETED|Overall Study||5
8936138|NCT02332707|9997086|FG013|NOT COMPLETED|Overall Study||0
8936139|NCT02332707|9997087|FG014|NOT COMPLETED|Overall Study||0
8936140|NCT02332707|9997088|FG015|NOT COMPLETED|Overall Study||0
8936141|NCT02332707|9997089|FG016|NOT COMPLETED|Overall Study||0
8936142|NCT02332707|9997090|FG017|NOT COMPLETED|Overall Study||0
8936143|NCT02332720|9997151|FG000|STARTED|Part A and Part B||21
8936144|NCT02332720|9997152|FG001|STARTED|Part A and Part B||21
8936145|NCT02332720|9997153|FG002|STARTED|Part A and Part B||22
8936146|NCT02332720|9997154|FG003|STARTED|Part A and Part B||22
8936147|NCT02332720|9997155|FG004|STARTED|Part A and Part B||16
8936148|NCT02332720|9997156|FG005|STARTED|Part A and Part B||36
8936149|NCT02332720|9997157|FG006|STARTED|Part A and Part B||37
8936150|NCT02332720|9997158|FG007|STARTED|Part A and Part B||35
8936151|NCT02332720|9997159|FG008|STARTED|Part A and Part B||15
8936152|NCT02332720|9997160|FG009|STARTED|Part A and Part B||14
8936153|NCT02332720|9997161|FG010|STARTED|Part A and Part B||14
8936154|NCT02332720|9997162|FG011|STARTED|Part A and Part B||15
8936155|NCT02332720|9997163|FG012|STARTED|Part A and Part B||16
8936156|NCT02332720|9997164|FG013|STARTED|Part A and Part B||13
8936157|NCT02332720|9997165|FG014|STARTED|Part A and Part B||16
8936158|NCT02332720|9997166|FG015|STARTED|Part A and Part B||14
8936159|NCT02332720|9997167|FG016|STARTED|Part A and Part B||15
8936160|NCT02332720|9997168|FG017|STARTED|Part A and Part B||14
8936161|NCT02332720|9997169|FG018|STARTED|Part A and Part B||21
8936162|NCT02332720|9997170|FG019|STARTED|Part A and Part B||25
8936163|NCT02332720|9997171|FG020|STARTED|Part A and Part B||7
8936164|NCT02332720|9997172|FG021|STARTED|Part A and Part B||0
8936165|NCT02332720|9997173|FG022|STARTED|Part A and Part B||4
8936166|NCT02332720|9997151|FG000|Treated|Part A and Part B||21
8936167|NCT02332720|9997152|FG001|Treated|Part A and Part B||21
8718364|NCT00997984|9765519|FG001|STARTED|Overall Study||113
8718365|NCT00997984|9765520|FG002|STARTED|Overall Study||114
8718366|NCT00997984|9765518|FG000|COMPLETED|Overall Study||76
8718367|NCT00997984|9765519|FG001|COMPLETED|Overall Study||79
8718368|NCT00997984|9765520|FG002|COMPLETED|Overall Study||88
8718369|NCT00997984|9765518|FG000|NOT COMPLETED|Overall Study||37
8718370|NCT00997984|9765519|FG001|NOT COMPLETED|Overall Study||34
8718371|NCT00997984|9765520|FG002|NOT COMPLETED|Overall Study||26
8718372|NCT00998010|9765530|FG000|STARTED|Overall Study||24
8718373|NCT00998010|9765530|FG000|COMPLETED|Overall Study||24
8718374|NCT00998010|9765530|FG000|NOT COMPLETED|Overall Study||0
8718375|NCT00998023|9765536|FG000|STARTED|Overall Study||32
8718376|NCT00998023|9765537|FG001|STARTED|Overall Study||32
8718377|NCT00998023|9765536|FG000|COMPLETED|Overall Study||32
8718378|NCT00998023|9765537|FG001|COMPLETED|Overall Study||32
8718379|NCT00998023|9765536|FG000|NOT COMPLETED|Overall Study||0
8718380|NCT00998023|9765537|FG001|NOT COMPLETED|Overall Study||0
8718381|NCT00998049|9765543|FG000|STARTED|Overall Study||39
8718382|NCT00998049|9765543|FG000|COMPLETED|Overall Study||39
8718383|NCT00998049|9765543|FG000|NOT COMPLETED|Overall Study||0
8718384|NCT00998205|9765547|FG000|STARTED|Overall Study||16
8718385|NCT00998205|9765547|FG000|COMPLETED|Overall Study||16
8718386|NCT00998205|9765547|FG000|NOT COMPLETED|Overall Study||0
8936168|NCT02332720|9997153|FG002|Treated|Part A and Part B||22
8936169|NCT02332720|9997154|FG003|Treated|Part A and Part B||22
8936170|NCT02332720|9997155|FG004|Treated|Part A and Part B||16
8936171|NCT02332720|9997156|FG005|Treated|Part A and Part B||36
8936172|NCT02332720|9997157|FG006|Treated|Part A and Part B||37
8936173|NCT02332720|9997158|FG007|Treated|Part A and Part B||35
8936174|NCT02332720|9997159|FG008|Treated|Part A and Part B||15
8936175|NCT02332720|9997160|FG009|Treated|Part A and Part B||14
8936176|NCT02332720|9997161|FG010|Treated|Part A and Part B||14
8936177|NCT02332720|9997162|FG011|Treated|Part A and Part B||15
8936178|NCT02332720|9997163|FG012|Treated|Part A and Part B||16
8936179|NCT02332720|9997164|FG013|Treated|Part A and Part B||13
8936180|NCT02332720|9997165|FG014|Treated|Part A and Part B||16
8936181|NCT02332720|9997166|FG015|Treated|Part A and Part B||14
8936182|NCT02332720|9997167|FG016|Treated|Part A and Part B||15
8936183|NCT02332720|9997168|FG017|Treated|Part A and Part B||14
8936184|NCT02332720|9997169|FG018|Treated|Part A and Part B||20
8936185|NCT02332720|9997170|FG019|Treated|Part A and Part B||25
8936186|NCT02332720|9997171|FG020|Treated|Part A and Part B||7
8936187|NCT02332720|9997172|FG021|Treated|Part A and Part B||0
8936188|NCT02332720|9997173|FG022|Treated|Part A and Part B||4
8936189|NCT02332720|9997151|FG000|COMPLETED|Part A and Part B||20
8936190|NCT02332720|9997152|FG001|COMPLETED|Part A and Part B||21
8936191|NCT02332720|9997153|FG002|COMPLETED|Part A and Part B||22
8936192|NCT02332720|9997154|FG003|COMPLETED|Part A and Part B||22
8936193|NCT02332720|9997155|FG004|COMPLETED|Part A and Part B||16
8936194|NCT02332720|9997156|FG005|COMPLETED|Part A and Part B||33
8936195|NCT02332720|9997157|FG006|COMPLETED|Part A and Part B||36
8936196|NCT02332720|9997158|FG007|COMPLETED|Part A and Part B||34
8718387|NCT00998296|9765563|FG000|STARTED|Overall Study||6
8718388|NCT00998296|9765564|FG001|STARTED|Overall Study||3
8718389|NCT00998296|9765565|FG002|STARTED|Overall Study||3
8936197|NCT02332720|9997159|FG008|COMPLETED|Part A and Part B||15
8936198|NCT02332720|9997160|FG009|COMPLETED|Part A and Part B||14
8936199|NCT02332720|9997161|FG010|COMPLETED|Part A and Part B||14
8936200|NCT02332720|9997162|FG011|COMPLETED|Part A and Part B||15
8936201|NCT02332720|9997163|FG012|COMPLETED|Part A and Part B||16
8936202|NCT02332720|9997164|FG013|COMPLETED|Part A and Part B||13
8936203|NCT02332720|9997165|FG014|COMPLETED|Part A and Part B||16
8936204|NCT02332720|9997166|FG015|COMPLETED|Part A and Part B||13
8936205|NCT02332720|9997167|FG016|COMPLETED|Part A and Part B||15
8936206|NCT02332720|9997168|FG017|COMPLETED|Part A and Part B||13
8936207|NCT02332720|9997169|FG018|COMPLETED|Part A and Part B||20
8936208|NCT02332720|9997170|FG019|COMPLETED|Part A and Part B||24
8936209|NCT02332720|9997171|FG020|COMPLETED|Part A and Part B||7
8936210|NCT02332720|9997172|FG021|COMPLETED|Part A and Part B||0
8936211|NCT02332720|9997173|FG022|COMPLETED|Part A and Part B||4
8936212|NCT02332720|9997151|FG000|NOT COMPLETED|Part A and Part B||1
8936213|NCT02332720|9997152|FG001|NOT COMPLETED|Part A and Part B||0
8936214|NCT02332720|9997153|FG002|NOT COMPLETED|Part A and Part B||0
8936215|NCT02332720|9997154|FG003|NOT COMPLETED|Part A and Part B||0
8936216|NCT02332720|9997155|FG004|NOT COMPLETED|Part A and Part B||0
8936217|NCT02332720|9997156|FG005|NOT COMPLETED|Part A and Part B||3
8936218|NCT02332720|9997157|FG006|NOT COMPLETED|Part A and Part B||1
8936219|NCT02332720|9997158|FG007|NOT COMPLETED|Part A and Part B||1
8936220|NCT02332720|9997159|FG008|NOT COMPLETED|Part A and Part B||0
8936221|NCT02332720|9997160|FG009|NOT COMPLETED|Part A and Part B||0
8936222|NCT02332720|9997161|FG010|NOT COMPLETED|Part A and Part B||0
8936223|NCT02332720|9997162|FG011|NOT COMPLETED|Part A and Part B||0
8936224|NCT02332720|9997163|FG012|NOT COMPLETED|Part A and Part B||0
8936225|NCT02332720|9997164|FG013|NOT COMPLETED|Part A and Part B||0
8936226|NCT02332720|9997165|FG014|NOT COMPLETED|Part A and Part B||0
8936227|NCT02332720|9997166|FG015|NOT COMPLETED|Part A and Part B||1
8936228|NCT02332720|9997167|FG016|NOT COMPLETED|Part A and Part B||0
8936229|NCT02332720|9997168|FG017|NOT COMPLETED|Part A and Part B||1
8936230|NCT02332720|9997169|FG018|NOT COMPLETED|Part A and Part B||1
8936231|NCT02332720|9997170|FG019|NOT COMPLETED|Part A and Part B||1
8936232|NCT02332720|9997171|FG020|NOT COMPLETED|Part A and Part B||0
8936233|NCT02332720|9997172|FG021|NOT COMPLETED|Part A and Part B||0
8936234|NCT02332720|9997173|FG022|NOT COMPLETED|Part A and Part B||0
8936235|NCT02332720|9997151|FG000|STARTED|Part C|Part A participants who had relapsed were offered the option of retreatment in Part C.|2
8936236|NCT02332720|9997152|FG001|STARTED|Part C|Part A participants who had relapsed were offered the option of retreatment in Part C.|1
8936237|NCT02332720|9997153|FG002|STARTED|Part C|Part A participants who had relapsed were offered the option of retreatment in Part C.|3
8936238|NCT02332720|9997154|FG003|STARTED|Part C|Part A participants who had relapsed were offered the option of retreatment in Part C.|2
8936239|NCT02332720|9997155|FG004|STARTED|Part C|Part B participants were not included in Part C.|0
8936240|NCT02332720|9997156|FG005|STARTED|Part C|Part B participants were not included in Part C.|0
8936241|NCT02332720|9997157|FG006|STARTED|Part C|Part B participants were not included in Part C.|0
8936242|NCT02332720|9997158|FG007|STARTED|Part C|Part B participants were not included in Part C.|0
8936243|NCT02332720|9997159|FG008|STARTED|Part C|Part B participants were not included in Part C.|0
8936244|NCT02332720|9997160|FG009|STARTED|Part C|Part B participants were not included in Part C.|0
8936245|NCT02332720|9997161|FG010|STARTED|Part C|Part B participants were not included in Part C.|0
8936246|NCT02332720|9997162|FG011|STARTED|Part C|Part B participants were not included in Part C.|0
8936247|NCT02332720|9997163|FG012|STARTED|Part C|Part B participants were not included in Part C.|0
8936248|NCT02332720|9997164|FG013|STARTED|Part C|Part B participants were not included in Part C.|0
8936249|NCT02332720|9997165|FG014|STARTED|Part C|Part B participants were not included in Part C.|0
8936250|NCT02332720|9997166|FG015|STARTED|Part C|Part B participants were not included in Part C.|0
8936251|NCT02332720|9997167|FG016|STARTED|Part C|Part B participants were not included in Part C.|0
8936252|NCT02332720|9997168|FG017|STARTED|Part C|Part B participants were not included in Part C.|0
8936253|NCT02332720|9997169|FG018|STARTED|Part C|Part B participants were not included in Part C.|0
8936254|NCT02332720|9997170|FG019|STARTED|Part C|Part B participants were not included in Part C.|0
8936255|NCT02332720|9997171|FG020|STARTED|Part C|Part B participants were not included in Part C.|0
8936256|NCT02332720|9997172|FG021|STARTED|Part C||0
8936257|NCT02332720|9997173|FG022|STARTED|Part C|Part B participants were not included in Part C.|0
8936258|NCT02332720|9997151|FG000|COMPLETED|Part C||2
8936259|NCT02332720|9997152|FG001|COMPLETED|Part C||1
8936260|NCT02332720|9997153|FG002|COMPLETED|Part C||3
8936261|NCT02332720|9997154|FG003|COMPLETED|Part C||2
8936262|NCT02332720|9997155|FG004|COMPLETED|Part C||0
8936263|NCT02332720|9997156|FG005|COMPLETED|Part C||0
8936264|NCT02332720|9997157|FG006|COMPLETED|Part C||0
8936265|NCT02332720|9997158|FG007|COMPLETED|Part C||0
8936266|NCT02332720|9997159|FG008|COMPLETED|Part C||0
8936267|NCT02332720|9997160|FG009|COMPLETED|Part C||0
8936268|NCT02332720|9997161|FG010|COMPLETED|Part C||0
8936269|NCT02332720|9997162|FG011|COMPLETED|Part C||0
8936270|NCT02332720|9997163|FG012|COMPLETED|Part C||0
8936271|NCT02332720|9997164|FG013|COMPLETED|Part C||0
8936272|NCT02332720|9997165|FG014|COMPLETED|Part C||0
8936273|NCT02332720|9997166|FG015|COMPLETED|Part C||0
8936274|NCT02332720|9997167|FG016|COMPLETED|Part C||0
8936275|NCT02332720|9997168|FG017|COMPLETED|Part C||0
8936276|NCT02332720|9997169|FG018|COMPLETED|Part C||0
8936277|NCT02332720|9997170|FG019|COMPLETED|Part C||0
8936278|NCT02332720|9997171|FG020|COMPLETED|Part C||0
8936279|NCT02332720|9997172|FG021|COMPLETED|Part C||0
8936280|NCT02332720|9997173|FG022|COMPLETED|Part C||0
8936281|NCT02332720|9997151|FG000|NOT COMPLETED|Part C||0
8936282|NCT02332720|9997152|FG001|NOT COMPLETED|Part C||0
8936283|NCT02332720|9997153|FG002|NOT COMPLETED|Part C||0
8936284|NCT02332720|9997154|FG003|NOT COMPLETED|Part C||0
8936285|NCT02332720|9997155|FG004|NOT COMPLETED|Part C||0
8936286|NCT02332720|9997156|FG005|NOT COMPLETED|Part C||0
8936287|NCT02332720|9997157|FG006|NOT COMPLETED|Part C||0
8936288|NCT02332720|9997158|FG007|NOT COMPLETED|Part C||0
8936289|NCT02332720|9997159|FG008|NOT COMPLETED|Part C||0
8936290|NCT02332720|9997160|FG009|NOT COMPLETED|Part C||0
8936291|NCT02332720|9997161|FG010|NOT COMPLETED|Part C||0
8936292|NCT02332720|9997162|FG011|NOT COMPLETED|Part C||0
8936293|NCT02332720|9997163|FG012|NOT COMPLETED|Part C||0
8936294|NCT02332720|9997164|FG013|NOT COMPLETED|Part C||0
8936295|NCT02332720|9997165|FG014|NOT COMPLETED|Part C||0
8936296|NCT02332720|9997166|FG015|NOT COMPLETED|Part C||0
8936297|NCT02332720|9997167|FG016|NOT COMPLETED|Part C||0
8936298|NCT02332720|9997168|FG017|NOT COMPLETED|Part C||0
8936299|NCT02332720|9997169|FG018|NOT COMPLETED|Part C||0
8936300|NCT02332720|9997170|FG019|NOT COMPLETED|Part C||0
8936301|NCT02332720|9997171|FG020|NOT COMPLETED|Part C||0
8936302|NCT02332720|9997172|FG021|NOT COMPLETED|Part C||0
8936303|NCT02332720|9997173|FG022|NOT COMPLETED|Part C||0
8936304|NCT02332798|9997238|FG000|STARTED|Overall Study||13
8936305|NCT02332798|9997239|FG001|STARTED|Overall Study||14
8936306|NCT02332798|9997240|FG002|STARTED|Overall Study||12
8813610|NCT01526733|9866777|FG000|COMPLETED|Phase 1||10
8813611|NCT01526733|9866778|FG001|COMPLETED|Phase 1||12
8813612|NCT01526733|9866777|FG000|NOT COMPLETED|Phase 1||2
8813613|NCT01526733|9866778|FG001|NOT COMPLETED|Phase 1||1
8813614|NCT01526733|9866777|FG000|STARTED|Washout Period of 5 to 21 Days||10
8813615|NCT01526733|9866778|FG001|STARTED|Washout Period of 5 to 21 Days||12
8813616|NCT01526733|9866777|FG000|COMPLETED|Washout Period of 5 to 21 Days||10
8813617|NCT01526733|9866778|FG001|COMPLETED|Washout Period of 5 to 21 Days||12
8813618|NCT01526733|9866777|FG000|NOT COMPLETED|Washout Period of 5 to 21 Days||0
8813619|NCT01526733|9866778|FG001|NOT COMPLETED|Washout Period of 5 to 21 Days||0
8813620|NCT01526733|9866777|FG000|STARTED|Phase 2||10
8813621|NCT01526733|9866778|FG001|STARTED|Phase 2||12
8813622|NCT01526733|9866777|FG000|COMPLETED|Phase 2||10
8813623|NCT01526733|9866778|FG001|COMPLETED|Phase 2||12
8813624|NCT01526733|9866777|FG000|NOT COMPLETED|Phase 2||0
8813625|NCT01526733|9866778|FG001|NOT COMPLETED|Phase 2||0
8813626|NCT01526785|9866785|FG000|STARTED|Overall Study||113
8813627|NCT01526785|9866785|FG000|COMPLETED|Overall Study||100
8813628|NCT01526785|9866785|FG000|NOT COMPLETED|Overall Study||13
8813629|NCT01526889|9866791|FG000|STARTED|Treatment Period||18
8813630|NCT01526889|9866792|FG001|STARTED|Treatment Period||7
8813631|NCT01526889|9866791|FG000|COMPLETED|Treatment Period||16
8813632|NCT01526889|9866792|FG001|COMPLETED|Treatment Period||7
8813633|NCT01526889|9866791|FG000|NOT COMPLETED|Treatment Period||2
8813634|NCT01526889|9866792|FG001|NOT COMPLETED|Treatment Period||0
8813635|NCT01526889|9866791|FG000|STARTED|Treatment Extension Period||5
8813636|NCT01526889|9866792|FG001|STARTED|Treatment Extension Period||0
8813637|NCT01526889|9866791|FG000|COMPLETED|Treatment Extension Period||4
8813638|NCT01526889|9866792|FG001|COMPLETED|Treatment Extension Period||0
8813639|NCT01526889|9866791|FG000|NOT COMPLETED|Treatment Extension Period||1
8813640|NCT01526889|9866792|FG001|NOT COMPLETED|Treatment Extension Period||0
8813641|NCT01526902|9866798|FG000|STARTED|Overall Study||25
8813642|NCT01526902|9866799|FG001|STARTED|Overall Study||24
8813643|NCT01526902|9866798|FG000|COMPLETED|Overall Study||25
8813644|NCT01526902|9866799|FG001|COMPLETED|Overall Study||24
8813645|NCT01526902|9866798|FG000|NOT COMPLETED|Overall Study||0
8813646|NCT01526902|9866799|FG001|NOT COMPLETED|Overall Study||0
8813647|NCT01526928|9866811|FG000|STARTED|Overall Study||38
8813648|NCT01526928|9866812|FG001|STARTED|Overall Study||19
8813649|NCT01526928|9866813|FG002|STARTED|Overall Study||209
8813650|NCT01526928|9866814|FG003|STARTED|Overall Study||245
8813651|NCT01526928|9866815|FG004|STARTED|Overall Study||95
8813652|NCT01526928|9866816|FG005|STARTED|Overall Study||6
8813653|NCT01526928|9866811|FG000|Started Phase 1|Overall Study||38
8813654|NCT01526928|9866812|FG001|Started Phase 1|Overall Study||19
8813655|NCT01526928|9866813|FG002|Started Phase 1|Overall Study||18
8813656|NCT01526928|9866814|FG003|Started Phase 1|Overall Study||17
8813657|NCT01526928|9866815|FG004|Started Phase 1|Overall Study||13
8813658|NCT01526928|9866816|FG005|Started Phase 1|Overall Study||6
8813659|NCT01526928|9866811|FG000|Started Phase 2|Overall Study||0
8813660|NCT01526928|9866812|FG001|Started Phase 2|Overall Study||0
8813661|NCT01526928|9866813|FG002|Started Phase 2|Overall Study||191
8813662|NCT01526928|9866814|FG003|Started Phase 2|Overall Study||228
8936307|NCT02332798|9997238|FG000|COMPLETED|Overall Study||12
8936308|NCT02332798|9997239|FG001|COMPLETED|Overall Study||12
8936309|NCT02332798|9997240|FG002|COMPLETED|Overall Study||11
8936310|NCT02332798|9997238|FG000|NOT COMPLETED|Overall Study||1
8936311|NCT02332798|9997239|FG001|NOT COMPLETED|Overall Study||2
8936312|NCT02332798|9997240|FG002|NOT COMPLETED|Overall Study||1
8936313|NCT02332824|9997254|FG000|STARTED|Overall Study||67
8936314|NCT02332824|9997255|FG001|STARTED|Overall Study||67
8936315|NCT02332824|9997256|FG002|STARTED|Overall Study||74
8936316|NCT02332824|9997257|FG003|STARTED|Overall Study||68
8813663|NCT01526928|9866815|FG004|Started Phase 2|Overall Study||82
8813664|NCT01526928|9866816|FG005|Started Phase 2|Overall Study||0
8936317|NCT02332824|9997258|FG004|STARTED|Overall Study||69
8936318|NCT02332824|9997259|FG005|STARTED|Overall Study||70
8936319|NCT02332824|9997254|FG000|COMPLETED|Overall Study||61
8936320|NCT02332824|9997255|FG001|COMPLETED|Overall Study||66
8936321|NCT02332824|9997256|FG002|COMPLETED|Overall Study||72
8936322|NCT02332824|9997257|FG003|COMPLETED|Overall Study||66
8936323|NCT02332824|9997258|FG004|COMPLETED|Overall Study||65
8936324|NCT02332824|9997259|FG005|COMPLETED|Overall Study||69
8936325|NCT02332824|9997254|FG000|NOT COMPLETED|Overall Study||6
8936326|NCT02332824|9997255|FG001|NOT COMPLETED|Overall Study||1
8936327|NCT02332824|9997256|FG002|NOT COMPLETED|Overall Study||2
8936328|NCT02332824|9997257|FG003|NOT COMPLETED|Overall Study||2
8936329|NCT02332824|9997258|FG004|NOT COMPLETED|Overall Study||4
8936330|NCT02332824|9997259|FG005|NOT COMPLETED|Overall Study||1
8936331|NCT02332863|9997275|FG000|STARTED|Overall Study||22
8936332|NCT02332863|9997276|FG001|STARTED|Overall Study||22
8936333|NCT02332863|9997275|FG000|COMPLETED|Overall Study||22
8936334|NCT02332863|9997276|FG001|COMPLETED|Overall Study||22
8936335|NCT02332863|9997275|FG000|NOT COMPLETED|Overall Study||0
8936336|NCT02332863|9997276|FG001|NOT COMPLETED|Overall Study||0
8936337|NCT02332876|9997284|FG000|STARTED|Overall Study||43
8936338|NCT02332876|9997285|FG001|STARTED|Overall Study||44
8936339|NCT02332876|9997284|FG000|COMPLETED|Overall Study||42
8936340|NCT02332876|9997285|FG001|COMPLETED|Overall Study||43
8936341|NCT02332876|9997284|FG000|NOT COMPLETED|Overall Study||1
8936342|NCT02332876|9997285|FG001|NOT COMPLETED|Overall Study||1
8936343|NCT02332889|9997291|FG000|STARTED|Overall Study||1
8936344|NCT02332889|9997291|FG000|COMPLETED|Overall Study||0
8936345|NCT02332889|9997291|FG000|NOT COMPLETED|Overall Study||1
8936346|NCT02332902|9997295|FG000|STARTED|Overall Study||24
8936347|NCT02332902|9997295|FG000|COMPLETED|Overall Study||17
8936348|NCT02332902|9997295|FG000|NOT COMPLETED|Overall Study||7
8936349|NCT02332915|9997301|FG000|STARTED|Overall Study||18
8936350|NCT02332915|9997302|FG001|STARTED|Overall Study||18
8936351|NCT02332915|9997301|FG000|COMPLETED|Overall Study||12
8936352|NCT02332915|9997302|FG001|COMPLETED|Overall Study||12
8936353|NCT02332915|9997301|FG000|NOT COMPLETED|Overall Study||6
8936354|NCT02332915|9997302|FG001|NOT COMPLETED|Overall Study||6
8936355|NCT02333045|9997312|FG000|STARTED|Overall Study||1
8936356|NCT02333045|9997313|FG001|STARTED|Overall Study||3
8936357|NCT02333045|9997312|FG000|COMPLETED|Overall Study||1
8936358|NCT02333045|9997313|FG001|COMPLETED|Overall Study||3
8936359|NCT02333045|9997312|FG000|NOT COMPLETED|Overall Study||0
8936360|NCT02333045|9997313|FG001|NOT COMPLETED|Overall Study||0
8936361|NCT02333071|9997321|FG000|STARTED|Core Study||326
8936362|NCT02333071|9997322|FG001|STARTED|Core Study||327
8936363|NCT02333071|9997321|FG000|Received Intervention|Core Study||319
8936364|NCT02333071|9997322|FG001|Received Intervention|Core Study||324
8936365|NCT02333071|9997321|FG000|COMPLETED|Core Study||274
8936366|NCT02333071|9997322|FG001|COMPLETED|Core Study||190
8936367|NCT02333071|9997321|FG000|NOT COMPLETED|Core Study||52
8936368|NCT02333071|9997322|FG001|NOT COMPLETED|Core Study||137
8936369|NCT02333071|9997321|FG000|STARTED|Open Label Extension||239
8936370|NCT02333071|9997322|FG001|STARTED|Open Label Extension||124
8936371|NCT02333071|9997321|FG000|COMPLETED|Open Label Extension||95
8936372|NCT02333071|9997322|FG001|COMPLETED|Open Label Extension||49
8718390|NCT00998296|9765566|FG003|STARTED|Overall Study||3
8718391|NCT00998296|9765567|FG004|STARTED|Overall Study||8
8718392|NCT00998296|9765568|FG005|STARTED|Overall Study||3
8718393|NCT00998296|9765569|FG006|STARTED|Overall Study||7
8718394|NCT00998296|9765570|FG007|STARTED|Overall Study||6
8718395|NCT00998296|9765571|FG008|STARTED|Overall Study||6
8718396|NCT00998296|9765572|FG009|STARTED|Overall Study||18
8718397|NCT00998296|9765573|FG010|STARTED|Overall Study||7
8718398|NCT00998296|9765563|FG000|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|6
8718399|NCT00998296|9765564|FG001|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|2
8718400|NCT00998296|9765565|FG002|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|3
8718401|NCT00998296|9765566|FG003|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|3
8718402|NCT00998296|9765567|FG004|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|6
8718403|NCT00998296|9765568|FG005|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|3
8718404|NCT00998296|9765569|FG006|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|6
8718405|NCT00998296|9765570|FG007|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|4
8718406|NCT00998296|9765571|FG008|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|4
8718407|NCT00998296|9765572|FG009|COMPLETED|Overall Study||0
8718408|NCT00998296|9765573|FG010|COMPLETED|Overall Study||0
8936373|NCT02333071|9997321|FG000|NOT COMPLETED|Open Label Extension||144
8936374|NCT02333071|9997322|FG001|NOT COMPLETED|Open Label Extension||75
8936375|NCT02333331|9997337|FG000|STARTED|Overall Study||19
8936376|NCT02333331|9997338|FG001|STARTED|Overall Study||18
8936377|NCT02333331|9997339|FG002|STARTED|Overall Study||113
8936378|NCT02333331|9997340|FG003|STARTED|Overall Study||67
8936379|NCT02333331|9997337|FG000|COMPLETED|Overall Study||17
8936380|NCT02333331|9997338|FG001|COMPLETED|Overall Study||12
8936381|NCT02333331|9997339|FG002|COMPLETED|Overall Study||95
8936382|NCT02333331|9997340|FG003|COMPLETED|Overall Study||64
8936383|NCT02333331|9997337|FG000|NOT COMPLETED|Overall Study||2
8936384|NCT02333331|9997338|FG001|NOT COMPLETED|Overall Study||6
8936385|NCT02333331|9997339|FG002|NOT COMPLETED|Overall Study||18
8936386|NCT02333331|9997340|FG003|NOT COMPLETED|Overall Study||3
8936387|NCT02333383|9997350|FG000|STARTED|Overall Study||201
8936388|NCT02333383|9997350|FG000|COMPLETED|Overall Study||160
8936389|NCT02333383|9997350|FG000|NOT COMPLETED|Overall Study||41
8936390|NCT02333487|9997357|FG000|STARTED|Overall Study||6
8936391|NCT02333487|9997358|FG001|STARTED|Overall Study||8
8936392|NCT02333487|9997359|FG002|STARTED|Overall Study||8
8936393|NCT02333487|9997357|FG000|COMPLETED|Overall Study||6
8936394|NCT02333487|9997358|FG001|COMPLETED|Overall Study||6
8936395|NCT02333487|9997359|FG002|COMPLETED|Overall Study||8
8936396|NCT02333487|9997357|FG000|NOT COMPLETED|Overall Study||0
8936397|NCT02333487|9997358|FG001|NOT COMPLETED|Overall Study||2
8936398|NCT02333487|9997359|FG002|NOT COMPLETED|Overall Study||0
8948529|NCT02431468|10010968|FG002|STARTED|Overall Study||48
8948530|NCT02431468|10010966|FG000|COMPLETED|Overall Study||38
8948531|NCT02431468|10010967|FG001|COMPLETED|Overall Study||29
8948532|NCT02431468|10010968|FG002|COMPLETED|Overall Study||39
8948533|NCT02431468|10010966|FG000|NOT COMPLETED|Overall Study||8
8948534|NCT02431468|10010967|FG001|NOT COMPLETED|Overall Study||18
8948535|NCT02431468|10010968|FG002|NOT COMPLETED|Overall Study||9
8948536|NCT02431533|10010984|FG000|STARTED|Overall Study||25
8948537|NCT02431533|10010985|FG001|STARTED|Overall Study||25
8948538|NCT02431533|10010984|FG000|COMPLETED|Overall Study||23
8948539|NCT02431533|10010985|FG001|COMPLETED|Overall Study||22
8948540|NCT02431533|10010984|FG000|NOT COMPLETED|Overall Study||2
8948541|NCT02431533|10010985|FG001|NOT COMPLETED|Overall Study||3
8948542|NCT02431559|10010995|FG000|STARTED|Overall Study||3
8948543|NCT02431559|10010996|FG001|STARTED|Overall Study||4
8718409|NCT00998296|9765563|FG000|NOT COMPLETED|Overall Study||0
8718410|NCT00998296|9765564|FG001|NOT COMPLETED|Overall Study||1
8718411|NCT00998296|9765565|FG002|NOT COMPLETED|Overall Study||0
8718412|NCT00998296|9765566|FG003|NOT COMPLETED|Overall Study||0
8718413|NCT00998296|9765567|FG004|NOT COMPLETED|Overall Study||2
8718414|NCT00998296|9765568|FG005|NOT COMPLETED|Overall Study||0
8718415|NCT00998296|9765569|FG006|NOT COMPLETED|Overall Study||1
8718416|NCT00998296|9765570|FG007|NOT COMPLETED|Overall Study||2
8718417|NCT00998296|9765571|FG008|NOT COMPLETED|Overall Study||2
8718418|NCT00998296|9765572|FG009|NOT COMPLETED|Overall Study||18
8718419|NCT00998296|9765573|FG010|NOT COMPLETED|Overall Study||7
8718420|NCT00998309|9765602|FG000|STARTED|Overall Study||502
8718421|NCT00998309|9765602|FG000|COMPLETED|Overall Study||498
8718422|NCT00998309|9765602|FG000|NOT COMPLETED|Overall Study||4
8718423|NCT00998335|9765656|FG000|STARTED|Initial Treatment (Months 0 - 3)||30
8718424|NCT00998335|9765657|FG001|STARTED|Initial Treatment (Months 0 - 3)||0
8718425|NCT00998335|9765656|FG000|COMPLETED|Initial Treatment (Months 0 - 3)||30
8718426|NCT00998335|9765657|FG001|COMPLETED|Initial Treatment (Months 0 - 3)||0
8718427|NCT00998335|9765656|FG000|NOT COMPLETED|Initial Treatment (Months 0 - 3)||0
8718428|NCT00998335|9765657|FG001|NOT COMPLETED|Initial Treatment (Months 0 - 3)||0
8718429|NCT00998335|9765656|FG000|STARTED|Randomized Period (Months 3 to 6)|"All participants started in the Insulin detemir only arm. At month 3 subjects were randomized 2:1."|8
8718430|NCT00998335|9765657|FG001|STARTED|Randomized Period (Months 3 to 6)|"All participants started in the Insulin detemir only arm. At month 3 subjects were randomized 2:1."|22
8718431|NCT00998335|9765656|FG000|COMPLETED|Randomized Period (Months 3 to 6)||8
8718432|NCT00998335|9765657|FG001|COMPLETED|Randomized Period (Months 3 to 6)||20
8718433|NCT00998335|9765656|FG000|NOT COMPLETED|Randomized Period (Months 3 to 6)||0
8718434|NCT00998335|9765657|FG001|NOT COMPLETED|Randomized Period (Months 3 to 6)||2
8718435|NCT00998374|9765671|FG000|STARTED|Overall Study||39
8718436|NCT00998374|9765672|FG001|STARTED|Overall Study||23
8718437|NCT00998374|9765671|FG000|COMPLETED|Overall Study||27
8718438|NCT00998374|9765672|FG001|COMPLETED|Overall Study||12
8718439|NCT00998374|9765671|FG000|NOT COMPLETED|Overall Study||12
8718440|NCT00998374|9765672|FG001|NOT COMPLETED|Overall Study||11
8718441|NCT00998400|9765682|FG000|STARTED|Overall Study||50
8718442|NCT00998400|9765683|FG001|STARTED|Overall Study||50
8718443|NCT00998400|9765682|FG000|COMPLETED|Overall Study||48
8718444|NCT00998400|9765683|FG001|COMPLETED|Overall Study||48
8718445|NCT00998400|9765682|FG000|NOT COMPLETED|Overall Study||2
8718446|NCT00998400|9765683|FG001|NOT COMPLETED|Overall Study||2
8718447|NCT00998426|9765690|FG000|STARTED|Overall Study||5
8718448|NCT00998426|9765690|FG000|Blood Glucose Monitoring|Overall Study||5
8718449|NCT00998426|9765690|FG000|COMPLETED|Overall Study||5
8718450|NCT00998426|9765690|FG000|NOT COMPLETED|Overall Study||0
8718451|NCT00998517|9765698|FG000|STARTED|Overall Study||888
8718452|NCT00998517|9765699|FG001|STARTED|Overall Study||906
8718453|NCT00998517|9765700|FG002|STARTED|Overall Study||918
8718454|NCT00998517|9765698|FG000|COMPLETED|Overall Study||888
8718455|NCT00998517|9765699|FG001|COMPLETED|Overall Study||906
8718456|NCT00998517|9765700|FG002|COMPLETED|Overall Study||918
8718457|NCT00998517|9765698|FG000|NOT COMPLETED|Overall Study||0
8718458|NCT00998517|9765699|FG001|NOT COMPLETED|Overall Study||0
8718459|NCT00998517|9765700|FG002|NOT COMPLETED|Overall Study||0
8718460|NCT00998582|9765710|FG000|STARTED|Overall Study||13
8718461|NCT00998582|9765711|FG001|STARTED|Overall Study||14
8718462|NCT00998582|9765710|FG000|COMPLETED|Overall Study||13
8948544|NCT02431559|10010997|FG002|STARTED|Overall Study||6
8718463|NCT00998582|9765711|FG001|COMPLETED|Overall Study||14
8718464|NCT00998582|9765710|FG000|NOT COMPLETED|Overall Study||0
8948545|NCT02431559|10010998|FG003|STARTED|Overall Study||40
8948546|NCT02431559|10010995|FG000|COMPLETED|Overall Study||1
8948547|NCT02431559|10010996|FG001|COMPLETED|Overall Study||1
8948548|NCT02431559|10010997|FG002|COMPLETED|Overall Study||2
8948549|NCT02431559|10010998|FG003|COMPLETED|Overall Study||9
8948550|NCT02431559|10010995|FG000|NOT COMPLETED|Overall Study||2
8936399|NCT02333630|9997370|FG000|STARTED|Overall Study||100
8936400|NCT02333630|9997371|FG001|STARTED|Overall Study||100
8936401|NCT02333630|9997370|FG000|COMPLETED|Overall Study||95
8936402|NCT02333630|9997371|FG001|COMPLETED|Overall Study||98
8936403|NCT02333630|9997370|FG000|NOT COMPLETED|Overall Study||5
8936404|NCT02333630|9997371|FG001|NOT COMPLETED|Overall Study||2
8936405|NCT02334059|9997384|FG000|STARTED|Overall Study||37
8936406|NCT02334059|9997385|FG001|STARTED|Overall Study||34
8936407|NCT02334059|9997386|FG002|STARTED|Overall Study||37
8936408|NCT02334059|9997384|FG000|COMPLETED|Overall Study||37
8936409|NCT02334059|9997385|FG001|COMPLETED|Overall Study||34
8936410|NCT02334059|9997386|FG002|COMPLETED|Overall Study||37
8936411|NCT02334059|9997384|FG000|NOT COMPLETED|Overall Study||0
8936412|NCT02334059|9997385|FG001|NOT COMPLETED|Overall Study||0
8936413|NCT02334059|9997386|FG002|NOT COMPLETED|Overall Study||0
8936414|NCT02334215|9997397|FG000|STARTED|Overall Study||75
8936415|NCT02334215|9997398|FG001|STARTED|Overall Study||74
8936416|NCT02334215|9997399|FG002|STARTED|Overall Study||76
8936417|NCT02334215|9997397|FG000|COMPLETED|Overall Study||68
8936418|NCT02334215|9997398|FG001|COMPLETED|Overall Study||68
8936419|NCT02334215|9997399|FG002|COMPLETED|Overall Study||61
8936420|NCT02334215|9997397|FG000|NOT COMPLETED|Overall Study||7
8936421|NCT02334215|9997398|FG001|NOT COMPLETED|Overall Study||6
8936422|NCT02334215|9997399|FG002|NOT COMPLETED|Overall Study||15
8936423|NCT02334267|9997409|FG000|STARTED|Overall Study||6
8936424|NCT02334267|9997410|FG001|STARTED|Overall Study||5
8936425|NCT02334267|9997409|FG000|COMPLETED|Overall Study||5
8936426|NCT02334267|9997410|FG001|COMPLETED|Overall Study||5
8936427|NCT02334267|9997409|FG000|NOT COMPLETED|Overall Study||1
8936428|NCT02334267|9997410|FG001|NOT COMPLETED|Overall Study||0
8936429|NCT02334306|9997424|FG000|STARTED|Double-blind Period||16
8936430|NCT02334306|9997425|FG001|STARTED|Double-blind Period||16
8936431|NCT02334306|9997424|FG000|COMPLETED|Double-blind Period||15
8936432|NCT02334306|9997425|FG001|COMPLETED|Double-blind Period||14
8936433|NCT02334306|9997424|FG000|NOT COMPLETED|Double-blind Period||1
8718465|NCT00998582|9765711|FG001|NOT COMPLETED|Overall Study||0
8718466|NCT00998660|9765720|FG000|STARTED|Overall Study||100
8718467|NCT00998660|9765720|FG000|Implanted|Overall Study||93
8718468|NCT00998660|9765720|FG000|Month 3 Visit|Overall Study||87
8718469|NCT00998660|9765720|FG000|COMPLETED|Overall Study|87 subjects reached the final study visit at Month 6.|87
8718470|NCT00998660|9765720|FG000|NOT COMPLETED|Overall Study||13
8718471|NCT00998764|9765726|FG000|STARTED|Overall Study||216
8718472|NCT00998764|9765727|FG001|STARTED|Overall Study||276
8718473|NCT00998764|9765726|FG000|Treated|Overall Study||215
8718474|NCT00998764|9765727|FG001|Treated|Overall Study||275
8718475|NCT00998764|9765726|FG000|COMPLETED|Overall Study||0
8718476|NCT00998764|9765727|FG001|COMPLETED|Overall Study||2
8718477|NCT00998764|9765726|FG000|NOT COMPLETED|Overall Study||216
8718478|NCT00998764|9765727|FG001|NOT COMPLETED|Overall Study||274
8718479|NCT00998790|9765735|FG000|STARTED|Overall Study||114
8718480|NCT00998790|9765735|FG000|Participants Who Were Treated|Overall Study||113
8718481|NCT00998790|9765735|FG000|COMPLETED|Overall Study||93
8718482|NCT00998790|9765735|FG000|NOT COMPLETED|Overall Study||21
8718483|NCT00998868|9765739|FG000|STARTED|Overall Study|>=10 for each muscle strength per MRC scale, after excluding the cases following exclusion criteria|51
8718484|NCT00998868|9765739|FG000|COMPLETED|Overall Study||51
8718485|NCT00998868|9765739|FG000|NOT COMPLETED|Overall Study||0
8718486|NCT00998881|9765745|FG000|STARTED|Overall Study||104
8718487|NCT00998881|9765746|FG001|STARTED|Overall Study||99
8718488|NCT00998881|9765745|FG000|COMPLETED|Overall Study||96
8718489|NCT00998881|9765746|FG001|COMPLETED|Overall Study||97
8718490|NCT00998881|9765745|FG000|NOT COMPLETED|Overall Study||8
8718491|NCT00998881|9765746|FG001|NOT COMPLETED|Overall Study||2
8718492|NCT00998946|9765752|FG000|STARTED|Overall Study||29
8718493|NCT00998946|9765752|FG000|Safety Population|Overall Study|Safety population included all participants who received at least 1 dose of the study drug.|27
8718494|NCT00998946|9765752|FG000|COMPLETED|Overall Study||20
8718495|NCT00998946|9765752|FG000|NOT COMPLETED|Overall Study||9
8718496|NCT00998985|9765770|FG000|STARTED|Overall Study||5
8718497|NCT00998985|9765771|FG001|STARTED|Overall Study||5
8718498|NCT00998985|9765772|FG002|STARTED|Overall Study||15
8718499|NCT00998985|9765773|FG003|STARTED|Overall Study||5
8718500|NCT00998985|9765774|FG004|STARTED|Overall Study||5
8718501|NCT00998985|9765775|FG005|STARTED|Overall Study||5
8718502|NCT00998985|9765776|FG006|STARTED|Overall Study||5
8718503|NCT00998985|9765777|FG007|STARTED|Overall Study||5
8718504|NCT00998985|9765778|FG008|STARTED|Overall Study||6
8718505|NCT00998985|9765779|FG009|STARTED|Overall Study||5
8718506|NCT00998985|9765780|FG010|STARTED|Overall Study||5
8718507|NCT00998985|9765781|FG011|STARTED|Overall Study||5
8718508|NCT00998985|9765782|FG012|STARTED|Overall Study||5
8718509|NCT00998985|9765783|FG013|STARTED|Overall Study||15
8718510|NCT00998985|9765770|FG000|COMPLETED|Overall Study||5
8718511|NCT00998985|9765771|FG001|COMPLETED|Overall Study||5
8718512|NCT00998985|9765772|FG002|COMPLETED|Overall Study||15
8718513|NCT00998985|9765773|FG003|COMPLETED|Overall Study||5
8718514|NCT00998985|9765774|FG004|COMPLETED|Overall Study||5
8718515|NCT00998985|9765775|FG005|COMPLETED|Overall Study||4
8936434|NCT02334306|9997425|FG001|NOT COMPLETED|Double-blind Period||2
8936435|NCT02334306|9997424|FG000|STARTED|Open-label Period||15
8936436|NCT02334306|9997425|FG001|STARTED|Open-label Period||14
8936437|NCT02334306|9997424|FG000|COMPLETED|Open-label Period||15
8936438|NCT02334306|9997425|FG001|COMPLETED|Open-label Period||14
8936439|NCT02334306|9997424|FG000|NOT COMPLETED|Open-label Period||0
8936440|NCT02334306|9997425|FG001|NOT COMPLETED|Open-label Period||0
8936441|NCT02334358|9997432|FG000|STARTED|Overall Study||503
8936442|NCT02334358|9997432|FG000|COMPLETED|Overall Study||494
8936443|NCT02334358|9997432|FG000|NOT COMPLETED|Overall Study||9
8936444|NCT02334384|9997438|FG000|STARTED|Overall Study||4
8936445|NCT02334384|9997439|FG001|STARTED|Overall Study||2
8936446|NCT02334384|9997438|FG000|COMPLETED|Overall Study||3
8936447|NCT02334384|9997439|FG001|COMPLETED|Overall Study||1
8936448|NCT02334384|9997438|FG000|NOT COMPLETED|Overall Study||1
8936449|NCT02334384|9997439|FG001|NOT COMPLETED|Overall Study||1
8936450|NCT02334423|9997447|FG000|STARTED|Overall Study||246
8936451|NCT02334423|9997448|FG001|STARTED|Overall Study||84
8936452|NCT02334423|9997447|FG000|COMPLETED|Overall Study||236
8936453|NCT02334423|9997448|FG001|COMPLETED|Overall Study||81
8936454|NCT02334423|9997447|FG000|NOT COMPLETED|Overall Study||10
8936455|NCT02334423|9997448|FG001|NOT COMPLETED|Overall Study||3
8936456|NCT02334436|9997456|FG000|STARTED|Overall Study||246
8936457|NCT02334436|9997457|FG001|STARTED|Overall Study||78
8936458|NCT02334436|9997456|FG000|COMPLETED|Overall Study||237
8936459|NCT02334436|9997457|FG001|COMPLETED|Overall Study||77
8936460|NCT02334436|9997456|FG000|NOT COMPLETED|Overall Study||9
8936461|NCT02334436|9997457|FG001|NOT COMPLETED|Overall Study||1
8936462|NCT02334527|9997463|FG000|STARTED|Overall Study||12
8936463|NCT02334527|9997463|FG000|COMPLETED|Overall Study||12
8936464|NCT02334527|9997463|FG000|NOT COMPLETED|Overall Study||0
8936465|NCT02334683|9997473|FG000|STARTED|First 12 Week Period||10
8936466|NCT02334683|9997474|FG001|STARTED|First 12 Week Period||10
8936467|NCT02334683|9997473|FG000|COMPLETED|First 12 Week Period||9
8936468|NCT02334683|9997474|FG001|COMPLETED|First 12 Week Period||10
8936469|NCT02334683|9997473|FG000|NOT COMPLETED|First 12 Week Period||1
8936470|NCT02334683|9997474|FG001|NOT COMPLETED|First 12 Week Period||0
8936471|NCT02334683|9997473|FG000|STARTED|Second 12 Week Period||9
8936472|NCT02334683|9997474|FG001|STARTED|Second 12 Week Period||10
8936473|NCT02334683|9997473|FG000|COMPLETED|Second 12 Week Period||9
8936474|NCT02334683|9997474|FG001|COMPLETED|Second 12 Week Period||9
8936475|NCT02334683|9997473|FG000|NOT COMPLETED|Second 12 Week Period||0
8936476|NCT02334683|9997474|FG001|NOT COMPLETED|Second 12 Week Period||1
8936477|NCT02334748|9997480|FG000|STARTED|Overall Study||31
8936478|NCT02334748|9997480|FG000|COMPLETED|Overall Study||23
8718516|NCT00998985|9765776|FG006|COMPLETED|Overall Study||5
8718517|NCT00998985|9765777|FG007|COMPLETED|Overall Study||5
8718518|NCT00998985|9765778|FG008|COMPLETED|Overall Study||5
8718519|NCT00998985|9765779|FG009|COMPLETED|Overall Study||5
8718520|NCT00998985|9765780|FG010|COMPLETED|Overall Study||5
8718521|NCT00998985|9765781|FG011|COMPLETED|Overall Study||5
8718522|NCT00998985|9765782|FG012|COMPLETED|Overall Study||5
8718523|NCT00998985|9765783|FG013|COMPLETED|Overall Study||15
8718524|NCT00998985|9765770|FG000|NOT COMPLETED|Overall Study||0
8718525|NCT00998985|9765771|FG001|NOT COMPLETED|Overall Study||0
8718526|NCT00998985|9765772|FG002|NOT COMPLETED|Overall Study||0
8718527|NCT00998985|9765773|FG003|NOT COMPLETED|Overall Study||0
8718528|NCT00998985|9765774|FG004|NOT COMPLETED|Overall Study||0
8718529|NCT00998985|9765775|FG005|NOT COMPLETED|Overall Study||1
8718530|NCT00998985|9765776|FG006|NOT COMPLETED|Overall Study||0
8718531|NCT00998985|9765777|FG007|NOT COMPLETED|Overall Study||0
8718532|NCT00998985|9765778|FG008|NOT COMPLETED|Overall Study||1
8718533|NCT00998985|9765779|FG009|NOT COMPLETED|Overall Study||0
8718534|NCT00998985|9765780|FG010|NOT COMPLETED|Overall Study||0
8718535|NCT00998985|9765781|FG011|NOT COMPLETED|Overall Study||0
8718536|NCT00998985|9765782|FG012|NOT COMPLETED|Overall Study||0
8718537|NCT00998985|9765783|FG013|NOT COMPLETED|Overall Study||0
8718538|NCT00999037|9765830|FG000|STARTED|Overall Study||9
8718539|NCT00999037|9765831|FG001|STARTED|Overall Study|20|9
8718540|NCT00999037|9765830|FG000|COMPLETED|Overall Study||9
8718541|NCT00999037|9765831|FG001|COMPLETED|Overall Study||9
8718542|NCT00999037|9765830|FG000|NOT COMPLETED|Overall Study||0
8718543|NCT00999037|9765831|FG001|NOT COMPLETED|Overall Study||0
8718544|NCT00999102|9765839|FG000|STARTED|4 Weeks at Lower Dose of First Drug||16
8718545|NCT00999102|9765840|FG001|STARTED|4 Weeks at Lower Dose of First Drug||17
8718546|NCT00999102|9765839|FG000|COMPLETED|4 Weeks at Lower Dose of First Drug||15
8718547|NCT00999102|9765840|FG001|COMPLETED|4 Weeks at Lower Dose of First Drug||16
8718548|NCT00999102|9765839|FG000|NOT COMPLETED|4 Weeks at Lower Dose of First Drug||1
8718549|NCT00999102|9765840|FG001|NOT COMPLETED|4 Weeks at Lower Dose of First Drug||1
8718550|NCT00999102|9765839|FG000|STARTED|4 Weeks at Higher Dose of First Drug||15
8718551|NCT00999102|9765840|FG001|STARTED|4 Weeks at Higher Dose of First Drug||16
8936479|NCT02334748|9997480|FG000|NOT COMPLETED|Overall Study||8
8936480|NCT02334787|9997488|FG000|STARTED|Overall Study||8
8936481|NCT02334787|9997489|FG001|STARTED|Overall Study||8
8936482|NCT02334787|9997490|FG002|STARTED|Overall Study||8
8936483|NCT02334787|9997491|FG003|STARTED|Overall Study||8
8936484|NCT02334787|9997488|FG000|COMPLETED|Overall Study||8
8936485|NCT02334787|9997489|FG001|COMPLETED|Overall Study||8
8718552|NCT00999102|9765839|FG000|COMPLETED|4 Weeks at Higher Dose of First Drug||15
8718553|NCT00999102|9765840|FG001|COMPLETED|4 Weeks at Higher Dose of First Drug||16
8718554|NCT00999102|9765839|FG000|NOT COMPLETED|4 Weeks at Higher Dose of First Drug||0
8718555|NCT00999102|9765840|FG001|NOT COMPLETED|4 Weeks at Higher Dose of First Drug||0
8936486|NCT02334787|9997490|FG002|COMPLETED|Overall Study||8
8936487|NCT02334787|9997491|FG003|COMPLETED|Overall Study||8
8936488|NCT02334787|9997488|FG000|NOT COMPLETED|Overall Study||0
8936489|NCT02334787|9997489|FG001|NOT COMPLETED|Overall Study||0
8936490|NCT02334787|9997490|FG002|NOT COMPLETED|Overall Study||0
8936491|NCT02334787|9997491|FG003|NOT COMPLETED|Overall Study||0
8936492|NCT02334800|9997511|FG000|STARTED|Overall Study||7
8936493|NCT02334800|9997512|FG001|STARTED|Overall Study||7
8936494|NCT02334800|9997513|FG002|STARTED|Overall Study||7
8936495|NCT02334800|9997514|FG003|STARTED|Overall Study||7
8936496|NCT02334800|9997511|FG000|Received Treatment|Overall Study||7
8936497|NCT02334800|9997512|FG001|Received Treatment|Overall Study||7
8936498|NCT02334800|9997513|FG002|Received Treatment|Overall Study||7
8936499|NCT02334800|9997514|FG003|Received Treatment|Overall Study||7
8936500|NCT02334800|9997511|FG000|COMPLETED|Overall Study||7
8936501|NCT02334800|9997512|FG001|COMPLETED|Overall Study||7
8936502|NCT02334800|9997513|FG002|COMPLETED|Overall Study||7
8936503|NCT02334800|9997514|FG003|COMPLETED|Overall Study||7
8936504|NCT02334800|9997511|FG000|NOT COMPLETED|Overall Study||0
8936505|NCT02334800|9997512|FG001|NOT COMPLETED|Overall Study||0
8936506|NCT02334800|9997513|FG002|NOT COMPLETED|Overall Study||0
8936507|NCT02334800|9997514|FG003|NOT COMPLETED|Overall Study||0
8936508|NCT02334813|9997526|FG000|STARTED|Overall Study||12
8936509|NCT02334813|9997527|FG001|STARTED|Overall Study||14
8936510|NCT02334813|9997526|FG000|COMPLETED|Overall Study||9
8936511|NCT02334813|9997527|FG001|COMPLETED|Overall Study||13
8936512|NCT02334813|9997526|FG000|NOT COMPLETED|Overall Study||3
8936513|NCT02334813|9997527|FG001|NOT COMPLETED|Overall Study||1
8936514|NCT02334982|9997540|FG000|STARTED|Overall Study||6
8936515|NCT02334982|9997541|FG001|STARTED|Overall Study||5
8936516|NCT02334982|9997542|FG002|STARTED|Overall Study||6
8936517|NCT02334982|9997543|FG003|STARTED|Overall Study||6
8936518|NCT02334982|9997544|FG004|STARTED|Overall Study||6
8936519|NCT02334982|9997545|FG005|STARTED|Overall Study||6
8936520|NCT02334982|9997546|FG006|STARTED|Overall Study||12
8936521|NCT02334982|9997540|FG000|COMPLETED|Overall Study||6
8936522|NCT02334982|9997541|FG001|COMPLETED|Overall Study||5
8936523|NCT02334982|9997542|FG002|COMPLETED|Overall Study||6
8936524|NCT02334982|9997543|FG003|COMPLETED|Overall Study||6
8936525|NCT02334982|9997544|FG004|COMPLETED|Overall Study||6
8936526|NCT02334982|9997545|FG005|COMPLETED|Overall Study||6
8936527|NCT02334982|9997546|FG006|COMPLETED|Overall Study||12
8936528|NCT02334982|9997540|FG000|NOT COMPLETED|Overall Study||0
8936529|NCT02334982|9997541|FG001|NOT COMPLETED|Overall Study||0
8936530|NCT02334982|9997542|FG002|NOT COMPLETED|Overall Study||0
8936531|NCT02334982|9997543|FG003|NOT COMPLETED|Overall Study||0
8936532|NCT02334982|9997544|FG004|NOT COMPLETED|Overall Study||0
8936533|NCT02334982|9997545|FG005|NOT COMPLETED|Overall Study||0
8936534|NCT02334982|9997546|FG006|NOT COMPLETED|Overall Study||0
8936535|NCT02335125|9997575|FG000|STARTED|Overall Study||20
8936536|NCT02335125|9997576|FG001|STARTED|Overall Study||20
8936537|NCT02335125|9997575|FG000|COMPLETED|Overall Study||20
8936538|NCT02335125|9997576|FG001|COMPLETED|Overall Study||20
8936539|NCT02335125|9997575|FG000|NOT COMPLETED|Overall Study||0
8936540|NCT02335125|9997576|FG001|NOT COMPLETED|Overall Study||0
8936541|NCT02335216|9997582|FG000|STARTED|Overall Study||22
8936542|NCT02335216|9997582|FG000|Received Trial System|Overall Study||16
8936543|NCT02335216|9997582|FG000|Received Permanent System|Overall Study||13
8936544|NCT02335216|9997582|FG000|COMPLETED|Overall Study||9
8936545|NCT02335216|9997582|FG000|NOT COMPLETED|Overall Study||13
8936546|NCT02335229|9997586|FG000|STARTED|Overall Study||30
8936547|NCT02335229|9997586|FG000|Received Trial System|Overall Study||10
8936548|NCT02335229|9997586|FG000|Received Permanent System|Overall Study||26
8936549|NCT02335229|9997586|FG000|COMPLETED|Overall Study||23
8936550|NCT02335229|9997586|FG000|NOT COMPLETED|Overall Study||7
8936551|NCT02335294|9997596|FG000|STARTED|Overall Study||39
8936552|NCT02335294|9997597|FG001|STARTED|Overall Study||42
8936553|NCT02335294|9997598|FG002|STARTED|Overall Study||19
8936554|NCT02335294|9997599|FG003|STARTED|Overall Study||39
8936555|NCT02335294|9997600|FG004|STARTED|Overall Study||41
8936556|NCT02335294|9997601|FG005|STARTED|Overall Study||20
8936557|NCT02335294|9997596|FG000|COMPLETED|Overall Study||36
8936558|NCT02335294|9997597|FG001|COMPLETED|Overall Study||38
8936559|NCT02335294|9997598|FG002|COMPLETED|Overall Study||18
8936560|NCT02335294|9997599|FG003|COMPLETED|Overall Study||36
8936561|NCT02335294|9997600|FG004|COMPLETED|Overall Study||39
8936562|NCT02335294|9997601|FG005|COMPLETED|Overall Study||19
8936563|NCT02335294|9997596|FG000|NOT COMPLETED|Overall Study||3
8936564|NCT02335294|9997597|FG001|NOT COMPLETED|Overall Study||4
8936565|NCT02335294|9997598|FG002|NOT COMPLETED|Overall Study||1
8936566|NCT02335294|9997599|FG003|NOT COMPLETED|Overall Study||3
8936567|NCT02335294|9997600|FG004|NOT COMPLETED|Overall Study||2
8936568|NCT02335294|9997601|FG005|NOT COMPLETED|Overall Study||1
8936569|NCT02335346|9997615|FG000|STARTED|Overall Study||93
8936570|NCT02335346|9997615|FG000|Received At Least 1 Dose of Study Drug|Overall Study||93
8936571|NCT02335346|9997615|FG000|COMPLETED|Overall Study||81
8936572|NCT02335346|9997615|FG000|NOT COMPLETED|Overall Study||12
8936573|NCT02335450|9997619|FG000|STARTED|Overall Study||5
8936574|NCT02335450|9997619|FG000|COMPLETED|Overall Study||4
8936575|NCT02335450|9997619|FG000|NOT COMPLETED|Overall Study||1
8936576|NCT02335489|9997629|FG000|STARTED|Overall Study||10
8936577|NCT02335489|9997629|FG000|Received Trial System|Overall Study||9
8936578|NCT02335489|9997629|FG000|Receiving Permanent System|Overall Study||8
8936579|NCT02335489|9997629|FG000|COMPLETED|Overall Study||0
8936580|NCT02335489|9997629|FG000|NOT COMPLETED|Overall Study||10
8936581|NCT02335502|9997633|FG000|STARTED|Overall Study||66
8936582|NCT02335502|9997633|FG000|Received Trial System|Overall Study||65
8936583|NCT02335502|9997633|FG000|Receiving Permanent System|Overall Study||56
8936584|NCT02335502|9997633|FG000|COMPLETED|Overall Study||49
8936585|NCT02335502|9997633|FG000|NOT COMPLETED|Overall Study||17
8936586|NCT02335710|9997639|FG000|STARTED|Overall Study||40
8936587|NCT02335710|9997640|FG001|STARTED|Overall Study||10
8936588|NCT02335710|9997639|FG000|COMPLETED|Overall Study||40
8936589|NCT02335710|9997640|FG001|COMPLETED|Overall Study||10
8936590|NCT02335710|9997639|FG000|NOT COMPLETED|Overall Study||0
8936591|NCT02335710|9997640|FG001|NOT COMPLETED|Overall Study||0
8936592|NCT02335905|9997646|FG000|STARTED|Overall Study||11
8936593|NCT02335905|9997646|FG000|COMPLETED|Overall Study||7
8936594|NCT02335905|9997646|FG000|NOT COMPLETED|Overall Study||4
8936595|NCT02335983|9997656|FG000|STARTED|Overall Study||10
8936596|NCT02335983|9997657|FG001|STARTED|Overall Study||12
8936597|NCT02335983|9997658|FG002|STARTED|Overall Study||34
8936598|NCT02335983|9997659|FG003|STARTED|Overall Study||9
8936599|NCT02335983|9997660|FG004|STARTED|Overall Study||9
8936600|NCT02335983|9997661|FG005|STARTED|Overall Study||33
8936601|NCT02335983|9997656|FG000|COMPLETED|Overall Study||2
8936602|NCT02335983|9997657|FG001|COMPLETED|Overall Study||3
8936603|NCT02335983|9997658|FG002|COMPLETED|Overall Study||2
8936604|NCT02335983|9997659|FG003|COMPLETED|Overall Study||0
8936605|NCT02335983|9997660|FG004|COMPLETED|Overall Study||1
8936606|NCT02335983|9997661|FG005|COMPLETED|Overall Study||1
8936607|NCT02335983|9997656|FG000|NOT COMPLETED|Overall Study||8
8936608|NCT02335983|9997657|FG001|NOT COMPLETED|Overall Study||9
8936609|NCT02335983|9997658|FG002|NOT COMPLETED|Overall Study||32
8936610|NCT02335983|9997659|FG003|NOT COMPLETED|Overall Study||9
8936611|NCT02335983|9997660|FG004|NOT COMPLETED|Overall Study||8
8936612|NCT02335983|9997661|FG005|NOT COMPLETED|Overall Study||32
8936613|NCT02336074|9997686|FG000|STARTED|Overall Study||30
8936614|NCT02336074|9997687|FG001|STARTED|Overall Study||30
8936615|NCT02336074|9997686|FG000|COMPLETED|Overall Study||30
8936616|NCT02336074|9997687|FG001|COMPLETED|Overall Study||28
8936617|NCT02336074|9997686|FG000|NOT COMPLETED|Overall Study||0
8936618|NCT02336074|9997687|FG001|NOT COMPLETED|Overall Study||2
8936619|NCT02336165|9997703|FG000|STARTED|Overall Study||40
8936620|NCT02336165|9997704|FG001|STARTED|Overall Study||31
8936621|NCT02336165|9997705|FG002|STARTED|Overall Study||33
8936622|NCT02336165|9997706|FG003|STARTED|Overall Study||33
8936623|NCT02336165|9997707|FG004|STARTED|Overall Study||22
8936624|NCT02336165|9997703|FG000|COMPLETED|Overall Study||6
8936625|NCT02336165|9997704|FG001|COMPLETED|Overall Study||6
8936626|NCT02336165|9997705|FG002|COMPLETED|Overall Study||2
8936627|NCT02336165|9997706|FG003|COMPLETED|Overall Study||2
8936628|NCT02336165|9997707|FG004|COMPLETED|Overall Study||0
8936629|NCT02336165|9997703|FG000|NOT COMPLETED|Overall Study||34
8936630|NCT02336165|9997704|FG001|NOT COMPLETED|Overall Study||25
8936631|NCT02336165|9997705|FG002|NOT COMPLETED|Overall Study||31
8936632|NCT02336165|9997706|FG003|NOT COMPLETED|Overall Study||31
8936633|NCT02336165|9997707|FG004|NOT COMPLETED|Overall Study||22
8936634|NCT02336178|9997723|FG000|STARTED|Overall Study||70
8936635|NCT02336178|9997723|FG000|COMPLETED|Overall Study||66
8936636|NCT02336178|9997723|FG000|NOT COMPLETED|Overall Study||4
8936637|NCT02336282|9997735|FG000|STARTED|Overall Study||33
8936638|NCT02336282|9997735|FG000|COMPLETED|Overall Study||28
8936639|NCT02336282|9997735|FG000|NOT COMPLETED|Overall Study||5
8936640|NCT02336360|9997747|FG000|STARTED|Overall Study||6
8936641|NCT02336360|9997747|FG000|COMPLETED|Overall Study||6
8936642|NCT02336360|9997747|FG000|NOT COMPLETED|Overall Study||0
8936643|NCT02336373|9997751|FG000|STARTED|Overall Study||32
8936644|NCT02336373|9997751|FG000|COMPLETED|Overall Study||14
8936645|NCT02336373|9997751|FG000|NOT COMPLETED|Overall Study||18
8718556|NCT00999102|9765839|FG000|STARTED|4 Weeks at Lower Dose of Second Drug||15
8718557|NCT00999102|9765840|FG001|STARTED|4 Weeks at Lower Dose of Second Drug||16
8718558|NCT00999102|9765839|FG000|COMPLETED|4 Weeks at Lower Dose of Second Drug||15
8718559|NCT00999102|9765840|FG001|COMPLETED|4 Weeks at Lower Dose of Second Drug||16
8718560|NCT00999102|9765839|FG000|NOT COMPLETED|4 Weeks at Lower Dose of Second Drug||0
8718561|NCT00999102|9765840|FG001|NOT COMPLETED|4 Weeks at Lower Dose of Second Drug||0
8718562|NCT00999102|9765839|FG000|STARTED|4 Weeks at Higher Dose of Second Drug||15
8936646|NCT02336438|9997757|FG000|STARTED|Overall Study||11
8936647|NCT02336438|9997757|FG000|COMPLETED|Overall Study||10
8936648|NCT02336438|9997757|FG000|NOT COMPLETED|Overall Study||1
8936649|NCT02336451|9997766|FG000|STARTED|Overall Study||42
8936650|NCT02336451|9997767|FG001|STARTED|Overall Study||40
8936651|NCT02336451|9997768|FG002|STARTED|Overall Study||12
8936652|NCT02336451|9997769|FG003|STARTED|Overall Study||44
8936653|NCT02336451|9997770|FG004|STARTED|Overall Study||18
8936654|NCT02336451|9997766|FG000|COMPLETED|Overall Study||0
8936655|NCT02336451|9997767|FG001|COMPLETED|Overall Study||0
8936656|NCT02336451|9997768|FG002|COMPLETED|Overall Study||0
8936657|NCT02336451|9997769|FG003|COMPLETED|Overall Study||0
8936658|NCT02336451|9997770|FG004|COMPLETED|Overall Study||0
8936659|NCT02336451|9997766|FG000|NOT COMPLETED|Overall Study||42
8936660|NCT02336451|9997767|FG001|NOT COMPLETED|Overall Study||40
8936661|NCT02336451|9997768|FG002|NOT COMPLETED|Overall Study||12
8936662|NCT02336451|9997769|FG003|NOT COMPLETED|Overall Study||44
8936663|NCT02336451|9997770|FG004|NOT COMPLETED|Overall Study||18
8936664|NCT02336555|9997786|FG000|STARTED|Treatment Period 1 (28 Days)||18
8936665|NCT02336555|9997787|FG001|STARTED|Treatment Period 1 (28 Days)||17
8936666|NCT02336555|9997786|FG000|COMPLETED|Treatment Period 1 (28 Days)||16
8936667|NCT02336555|9997787|FG001|COMPLETED|Treatment Period 1 (28 Days)||16
8936668|NCT02336555|9997786|FG000|NOT COMPLETED|Treatment Period 1 (28 Days)||2
8936669|NCT02336555|9997787|FG001|NOT COMPLETED|Treatment Period 1 (28 Days)||1
8936670|NCT02336555|9997786|FG000|STARTED|Treatment Period 2 (28 Days)||16
8936671|NCT02336555|9997787|FG001|STARTED|Treatment Period 2 (28 Days)||16
8936672|NCT02336555|9997786|FG000|COMPLETED|Treatment Period 2 (28 Days)||16
8936673|NCT02336555|9997787|FG001|COMPLETED|Treatment Period 2 (28 Days)||15
8936674|NCT02336555|9997786|FG000|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8936675|NCT02336555|9997787|FG001|NOT COMPLETED|Treatment Period 2 (28 Days)||1
8936676|NCT02336594|9997797|FG000|STARTED|Overall Study||3
8936677|NCT02336594|9997798|FG001|STARTED|Overall Study||4
8936678|NCT02336594|9997799|FG002|STARTED|Overall Study||4
8936679|NCT02336594|9997800|FG003|STARTED|Overall Study||4
8936680|NCT02336594|9997797|FG000|COMPLETED|Overall Study||3
8936681|NCT02336594|9997798|FG001|COMPLETED|Overall Study||4
8936682|NCT02336594|9997799|FG002|COMPLETED|Overall Study||4
8936683|NCT02336594|9997800|FG003|COMPLETED|Overall Study||4
8936684|NCT02336594|9997797|FG000|NOT COMPLETED|Overall Study||0
8936685|NCT02336594|9997798|FG001|NOT COMPLETED|Overall Study||0
8936686|NCT02336594|9997799|FG002|NOT COMPLETED|Overall Study||0
8936687|NCT02336594|9997800|FG003|NOT COMPLETED|Overall Study||0
8936688|NCT02336607|9997817|FG000|STARTED|Overall Study||85
8936689|NCT02336607|9997818|FG001|STARTED|Overall Study||85
8936690|NCT02336607|9997819|FG002|STARTED|Overall Study||92
8936691|NCT02336607|9997820|FG003|STARTED|Overall Study||267
8936692|NCT02336607|9997817|FG000|Patients Included in ITT Population|Overall Study||84
8936693|NCT02336607|9997818|FG001|Patients Included in ITT Population|Overall Study||84
8936694|NCT02336607|9997819|FG002|Patients Included in ITT Population|Overall Study||91
8936695|NCT02336607|9997820|FG003|Patients Included in ITT Population|Overall Study||222
8936696|NCT02336607|9997817|FG000|Patients Included in PP Population|Overall Study||78
8936697|NCT02336607|9997818|FG001|Patients Included in PP Population|Overall Study||75
8936698|NCT02336607|9997819|FG002|Patients Included in PP Population|Overall Study||75
8936699|NCT02336607|9997820|FG003|Patients Included in PP Population|Overall Study||162
8936700|NCT02336607|9997817|FG000|Patients Included in Safety Population|Overall Study||85
8936701|NCT02336607|9997818|FG001|Patients Included in Safety Population|Overall Study||85
8936702|NCT02336607|9997819|FG002|Patients Included in Safety Population|Overall Study||92
8936703|NCT02336607|9997820|FG003|Patients Included in Safety Population|Overall Study||260
8936704|NCT02336607|9997817|FG000|COMPLETED|Overall Study||81
8936705|NCT02336607|9997818|FG001|COMPLETED|Overall Study||75
8718563|NCT00999102|9765840|FG001|STARTED|4 Weeks at Higher Dose of Second Drug||16
8718564|NCT00999102|9765839|FG000|COMPLETED|4 Weeks at Higher Dose of Second Drug||15
8718565|NCT00999102|9765840|FG001|COMPLETED|4 Weeks at Higher Dose of Second Drug||16
8718566|NCT00999102|9765839|FG000|NOT COMPLETED|4 Weeks at Higher Dose of Second Drug||0
8718567|NCT00999102|9765840|FG001|NOT COMPLETED|4 Weeks at Higher Dose of Second Drug||0
8718568|NCT00999141|9765850|FG000|STARTED|Overall Study|Randomized and treated|75
8718569|NCT00999141|9765850|FG000|COMPLETED|Overall Study||75
8718570|NCT00999141|9765850|FG000|NOT COMPLETED|Overall Study||0
8724955|NCT01029340|9772246|FG000|NOT COMPLETED|Part A Treatment Period||0
8724956|NCT01029340|9772247|FG001|NOT COMPLETED|Part A Treatment Period||0
8724957|NCT01029340|9772248|FG002|NOT COMPLETED|Part A Treatment Period||0
8724958|NCT01029340|9772249|FG003|NOT COMPLETED|Part A Treatment Period||0
8724959|NCT01029340|9772250|FG004|NOT COMPLETED|Part A Treatment Period||0
8724960|NCT01029340|9772251|FG005|NOT COMPLETED|Part A Treatment Period||0
8724961|NCT01029340|9772246|FG000|STARTED|Part A Follow up Period||14
8724962|NCT01029340|9772247|FG001|STARTED|Part A Follow up Period||14
8724963|NCT01029340|9772248|FG002|STARTED|Part A Follow up Period||0
8724964|NCT01029340|9772249|FG003|STARTED|Part A Follow up Period||0
8724965|NCT01029340|9772250|FG004|STARTED|Part A Follow up Period||0
8724966|NCT01029340|9772251|FG005|STARTED|Part A Follow up Period||0
8724967|NCT01029340|9772246|FG000|COMPLETED|Part A Follow up Period||14
8724968|NCT01029340|9772247|FG001|COMPLETED|Part A Follow up Period||14
8724969|NCT01029340|9772248|FG002|COMPLETED|Part A Follow up Period||0
8724970|NCT01029340|9772249|FG003|COMPLETED|Part A Follow up Period||0
8724971|NCT01029340|9772250|FG004|COMPLETED|Part A Follow up Period||0
8724972|NCT01029340|9772251|FG005|COMPLETED|Part A Follow up Period||0
8724973|NCT01029340|9772246|FG000|NOT COMPLETED|Part A Follow up Period||0
8724974|NCT01029340|9772247|FG001|NOT COMPLETED|Part A Follow up Period||0
8724975|NCT01029340|9772248|FG002|NOT COMPLETED|Part A Follow up Period||0
8724976|NCT01029340|9772249|FG003|NOT COMPLETED|Part A Follow up Period||0
8724977|NCT01029340|9772250|FG004|NOT COMPLETED|Part A Follow up Period||0
8724978|NCT01029340|9772251|FG005|NOT COMPLETED|Part A Follow up Period||0
8724979|NCT01029340|9772246|FG000|STARTED|Part B Treatment Period||0
8724980|NCT01029340|9772247|FG001|STARTED|Part B Treatment Period||0
8724981|NCT01029340|9772248|FG002|STARTED|Part B Treatment Period|Enrolled 4 participants from Arm 1 and 7 participants from Arm 2|31
8936706|NCT02336607|9997819|FG002|COMPLETED|Overall Study||86
8936707|NCT02336607|9997820|FG003|COMPLETED|Overall Study||180
8936708|NCT02336607|9997817|FG000|NOT COMPLETED|Overall Study||4
8936709|NCT02336607|9997818|FG001|NOT COMPLETED|Overall Study||10
8936710|NCT02336607|9997819|FG002|NOT COMPLETED|Overall Study||6
8936711|NCT02336607|9997820|FG003|NOT COMPLETED|Overall Study||87
8936712|NCT02336737|9997830|FG000|STARTED|Overall Study||160
8936713|NCT02336737|9997830|FG000|COMPLETED|Overall Study||147
8936714|NCT02336737|9997830|FG000|NOT COMPLETED|Overall Study||13
8936715|NCT02336815|9997837|FG000|STARTED|Overall Study||79
8936716|NCT02336815|9997838|FG001|STARTED|Overall Study||123
8936717|NCT02336815|9997837|FG000|COMPLETED|Overall Study||0
8936718|NCT02336815|9997838|FG001|COMPLETED|Overall Study||0
8936719|NCT02336815|9997837|FG000|NOT COMPLETED|Overall Study||79
8936720|NCT02336815|9997838|FG001|NOT COMPLETED|Overall Study||123
8936721|NCT02336958|9997848|FG000|STARTED|Overall Study||20
8936722|NCT02336958|9997849|FG001|STARTED|Overall Study||20
8936723|NCT02336958|9997848|FG000|COMPLETED|Overall Study||20
8936724|NCT02336958|9997849|FG001|COMPLETED|Overall Study||20
8936725|NCT02336958|9997848|FG000|NOT COMPLETED|Overall Study||0
8936726|NCT02336958|9997849|FG001|NOT COMPLETED|Overall Study||0
8936727|NCT02337062|9997857|FG000|STARTED|Overall Study||572
8936728|NCT02337062|9997858|FG001|STARTED|Overall Study||575
8936729|NCT02337062|9997857|FG000|COMPLETED|Overall Study||555
8936730|NCT02337062|9997858|FG001|COMPLETED|Overall Study||556
8936731|NCT02337062|9997857|FG000|NOT COMPLETED|Overall Study||17
8936732|NCT02337062|9997858|FG001|NOT COMPLETED|Overall Study||19
8936733|NCT02337218|9997868|FG000|STARTED|Overall Study||17
8936734|NCT02337218|9997869|FG001|STARTED|Overall Study||11
8936735|NCT02337218|9997868|FG000|COMPLETED|Overall Study||17
8936736|NCT02337218|9997869|FG001|COMPLETED|Overall Study||11
8936737|NCT02337218|9997868|FG000|NOT COMPLETED|Overall Study||0
8936738|NCT02337218|9997869|FG001|NOT COMPLETED|Overall Study||0
8936739|NCT02337361|9997877|FG000|STARTED|Baseline Assessment||99
8936740|NCT02337361|9997878|FG001|STARTED|Baseline Assessment||86
8936741|NCT02337361|9997877|FG000|COMPLETED|Baseline Assessment||99
8936742|NCT02337361|9997878|FG001|COMPLETED|Baseline Assessment||86
8936743|NCT02337361|9997877|FG000|NOT COMPLETED|Baseline Assessment||0
8936744|NCT02337361|9997878|FG001|NOT COMPLETED|Baseline Assessment||0
8936745|NCT02337361|9997877|FG000|STARTED|3-month Follow-up||99
8936746|NCT02337361|9997878|FG001|STARTED|3-month Follow-up||86
8936747|NCT02337361|9997877|FG000|COMPLETED|3-month Follow-up||80
8936748|NCT02337361|9997878|FG001|COMPLETED|3-month Follow-up||72
8936749|NCT02337361|9997877|FG000|NOT COMPLETED|3-month Follow-up||19
8936750|NCT02337361|9997878|FG001|NOT COMPLETED|3-month Follow-up||14
8936751|NCT02337361|9997877|FG000|STARTED|6-month Follow-up||80
8936752|NCT02337361|9997878|FG001|STARTED|6-month Follow-up||72
8936753|NCT02337361|9997877|FG000|COMPLETED|6-month Follow-up||78
8936754|NCT02337361|9997878|FG001|COMPLETED|6-month Follow-up||68
8936755|NCT02337361|9997877|FG000|NOT COMPLETED|6-month Follow-up||2
8936756|NCT02337361|9997878|FG001|NOT COMPLETED|6-month Follow-up||4
8936757|NCT02337387|9997889|FG000|STARTED|Overall Study||14
8936758|NCT02337387|9997890|FG001|STARTED|Overall Study||8
8936759|NCT02337387|9997891|FG002|STARTED|Overall Study||3
8936760|NCT02337387|9997892|FG003|STARTED|Overall Study||3
8936761|NCT02337387|9997889|FG000|Received at Least 1 Dose of Study Drug|Overall Study||14
8936762|NCT02337387|9997890|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8
8936763|NCT02337387|9997891|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
8936764|NCT02337387|9997892|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
8936765|NCT02337387|9997889|FG000|COMPLETED|Overall Study||0
8936766|NCT02337387|9997890|FG001|COMPLETED|Overall Study||0
8936767|NCT02337387|9997891|FG002|COMPLETED|Overall Study||0
8936768|NCT02337387|9997892|FG003|COMPLETED|Overall Study||0
8936769|NCT02337387|9997889|FG000|NOT COMPLETED|Overall Study||14
8936770|NCT02337387|9997890|FG001|NOT COMPLETED|Overall Study||8
8936771|NCT02337387|9997891|FG002|NOT COMPLETED|Overall Study||3
8936772|NCT02337387|9997892|FG003|NOT COMPLETED|Overall Study||3
8936773|NCT02337465|9997902|FG000|STARTED|Overall Study||30
8936774|NCT02337465|9997902|FG000|COMPLETED|Overall Study||30
8936775|NCT02337465|9997902|FG000|NOT COMPLETED|Overall Study||0
8936776|NCT02337478|9997906|FG000|STARTED|Overall Study||5
8936777|NCT02337478|9997906|FG000|COMPLETED|Overall Study||0
8936778|NCT02337478|9997906|FG000|NOT COMPLETED|Overall Study||5
8936779|NCT02337491|9997912|FG000|STARTED|Overall Study||50
8936780|NCT02337491|9997913|FG001|STARTED|Overall Study||30
8936781|NCT02337491|9997912|FG000|COMPLETED|Overall Study||0
8936782|NCT02337491|9997913|FG001|COMPLETED|Overall Study||0
8936783|NCT02337491|9997912|FG000|NOT COMPLETED|Overall Study||50
8936784|NCT02337491|9997913|FG001|NOT COMPLETED|Overall Study||30
8936785|NCT02337517|9997920|FG000|STARTED|Overall Study||6
8936786|NCT02337517|9997920|FG000|COMPLETED|Overall Study||6
8936787|NCT02337517|9997920|FG000|NOT COMPLETED|Overall Study||0
8936788|NCT02337530|9997927|FG000|STARTED|Overall Study||20
8936789|NCT02337530|9997928|FG001|STARTED|Overall Study||21
8936790|NCT02337530|9997929|FG002|STARTED|Overall Study||21
8936791|NCT02337530|9997927|FG000|COMPLETED|Overall Study||20
8936792|NCT02337530|9997928|FG001|COMPLETED|Overall Study||21
8936793|NCT02337530|9997929|FG002|COMPLETED|Overall Study||21
8936794|NCT02337530|9997927|FG000|NOT COMPLETED|Overall Study||0
8936795|NCT02337530|9997928|FG001|NOT COMPLETED|Overall Study||0
8936796|NCT02337530|9997929|FG002|NOT COMPLETED|Overall Study||0
8936797|NCT02337907|9997943|FG000|STARTED|Overall Study||55
8936798|NCT02337907|9997944|FG001|STARTED|Overall Study||53
8936799|NCT02337907|9997945|FG002|STARTED|Overall Study||55
8936800|NCT02337907|9997946|FG003|STARTED|Overall Study||55
8936801|NCT02337907|9997947|FG004|STARTED|Overall Study||106
8936802|NCT02337907|9997948|FG005|STARTED|Overall Study||5
8936803|NCT02337907|9997943|FG000|COMPLETED|Overall Study||51
8936804|NCT02337907|9997944|FG001|COMPLETED|Overall Study||49
8936805|NCT02337907|9997945|FG002|COMPLETED|Overall Study||54
8936806|NCT02337907|9997946|FG003|COMPLETED|Overall Study||51
8936807|NCT02337907|9997947|FG004|COMPLETED|Overall Study||96
8936808|NCT02337907|9997948|FG005|COMPLETED|Overall Study||4
8936809|NCT02337907|9997943|FG000|NOT COMPLETED|Overall Study||4
8936810|NCT02337907|9997944|FG001|NOT COMPLETED|Overall Study||4
8936811|NCT02337907|9997945|FG002|NOT COMPLETED|Overall Study||1
8936812|NCT02337907|9997946|FG003|NOT COMPLETED|Overall Study||4
8936813|NCT02337907|9997947|FG004|NOT COMPLETED|Overall Study||10
8936814|NCT02337907|9997948|FG005|NOT COMPLETED|Overall Study||1
8936815|NCT02337933|9997965|FG000|STARTED|Overall Study||12
8936816|NCT02337933|9997966|FG001|STARTED|Overall Study||12
8936817|NCT02337933|9997965|FG000|COMPLETED|Overall Study||12
8936818|NCT02337933|9997966|FG001|COMPLETED|Overall Study||12
8936819|NCT02337933|9997965|FG000|NOT COMPLETED|Overall Study||0
8936820|NCT02337933|9997966|FG001|NOT COMPLETED|Overall Study||0
8936821|NCT02337946|9997972|FG000|STARTED|Protocol Treatment 1 Period||164
8936822|NCT02337946|9997973|FG001|STARTED|Protocol Treatment 1 Period||0
8936823|NCT02337946|9997974|FG002|STARTED|Protocol Treatment 1 Period||0
8936824|NCT02337946|9997972|FG000|COMPLETED|Protocol Treatment 1 Period||114
8936825|NCT02337946|9997973|FG001|COMPLETED|Protocol Treatment 1 Period||0
8936826|NCT02337946|9997974|FG002|COMPLETED|Protocol Treatment 1 Period||0
8936827|NCT02337946|9997972|FG000|NOT COMPLETED|Protocol Treatment 1 Period||50
8936828|NCT02337946|9997973|FG001|NOT COMPLETED|Protocol Treatment 1 Period||0
8936829|NCT02337946|9997974|FG002|NOT COMPLETED|Protocol Treatment 1 Period||0
8936830|NCT02337946|9997972|FG000|STARTED|In-between Period||114
8936831|NCT02337946|9997973|FG001|STARTED|In-between Period||0
8936832|NCT02337946|9997974|FG002|STARTED|In-between Period||0
8936833|NCT02337946|9997972|FG000|COMPLETED|In-between Period||113
8936834|NCT02337946|9997973|FG001|COMPLETED|In-between Period||0
8936835|NCT02337946|9997974|FG002|COMPLETED|In-between Period||0
8936836|NCT02337946|9997972|FG000|NOT COMPLETED|In-between Period||1
8936837|NCT02337946|9997973|FG001|NOT COMPLETED|In-between Period||0
8936838|NCT02337946|9997974|FG002|NOT COMPLETED|In-between Period||0
8936839|NCT02337946|9997972|FG000|STARTED|Protocol Treatment 2 Period||0
8936840|NCT02337946|9997973|FG001|STARTED|Protocol Treatment 2 Period||56
8936841|NCT02337946|9997974|FG002|STARTED|Protocol Treatment 2 Period||57
8936842|NCT02337946|9997972|FG000|Safety Population|Protocol Treatment 2 Period||0
8936843|NCT02337946|9997973|FG001|Safety Population|Protocol Treatment 2 Period||56
8936844|NCT02337946|9997974|FG002|Safety Population|Protocol Treatment 2 Period||54
8936845|NCT02337946|9997972|FG000|COMPLETED|Protocol Treatment 2 Period||0
8936846|NCT02337946|9997973|FG001|COMPLETED|Protocol Treatment 2 Period||5
8936847|NCT02337946|9997974|FG002|COMPLETED|Protocol Treatment 2 Period||7
8936848|NCT02337946|9997972|FG000|NOT COMPLETED|Protocol Treatment 2 Period||0
8936849|NCT02337946|9997973|FG001|NOT COMPLETED|Protocol Treatment 2 Period||51
8936850|NCT02337946|9997974|FG002|NOT COMPLETED|Protocol Treatment 2 Period||50
8936851|NCT02337959|9997983|FG000|STARTED|Overall Study||10
8936852|NCT02337959|9997984|FG001|STARTED|Overall Study||10
8718571|NCT00999167|9765908|FG000|STARTED|Part A: Open Label Safety run-in||15
8718572|NCT00999167|9765909|FG001|STARTED|Part A: Open Label Safety run-in||0
8718573|NCT00999167|9765910|FG002|STARTED|Part A: Open Label Safety run-in||0
8718574|NCT00999167|9765908|FG000|Received 9 mL BID|Part A: Open Label Safety run-in||15
8718575|NCT00999167|9765909|FG001|Received 9 mL BID|Part A: Open Label Safety run-in||0
8718576|NCT00999167|9765910|FG002|Received 9 mL BID|Part A: Open Label Safety run-in||0
8718577|NCT00999167|9765908|FG000|COMPLETED|Part A: Open Label Safety run-in||8
8718578|NCT00999167|9765909|FG001|COMPLETED|Part A: Open Label Safety run-in||0
8718579|NCT00999167|9765910|FG002|COMPLETED|Part A: Open Label Safety run-in||0
8718580|NCT00999167|9765908|FG000|NOT COMPLETED|Part A: Open Label Safety run-in||7
8718581|NCT00999167|9765909|FG001|NOT COMPLETED|Part A: Open Label Safety run-in||0
8718582|NCT00999167|9765910|FG002|NOT COMPLETED|Part A: Open Label Safety run-in||0
8718583|NCT00999167|9765908|FG000|STARTED|Part B: Randomized, Placebo Controlled||0
8718584|NCT00999167|9765909|FG001|STARTED|Part B: Randomized, Placebo Controlled|4 subjects who participated in Part A enrolled in Part B and remainder were newly enrolled|90
8718585|NCT00999167|9765910|FG002|STARTED|Part B: Randomized, Placebo Controlled||88
8718586|NCT00999167|9765908|FG000|COMPLETED|Part B: Randomized, Placebo Controlled||0
8718587|NCT00999167|9765909|FG001|COMPLETED|Part B: Randomized, Placebo Controlled||55
8718588|NCT00999167|9765910|FG002|COMPLETED|Part B: Randomized, Placebo Controlled||67
8718589|NCT00999167|9765908|FG000|NOT COMPLETED|Part B: Randomized, Placebo Controlled||0
8718590|NCT00999167|9765909|FG001|NOT COMPLETED|Part B: Randomized, Placebo Controlled||35
8718591|NCT00999167|9765910|FG002|NOT COMPLETED|Part B: Randomized, Placebo Controlled||21
8718592|NCT00999466|9765923|FG000|STARTED|Pilot Part||6
8936853|NCT02337959|9997985|FG002|STARTED|Overall Study||7
8936854|NCT02337959|9997983|FG000|COMPLETED|Overall Study||10
8936855|NCT02337959|9997984|FG001|COMPLETED|Overall Study||7
8936856|NCT02337959|9997985|FG002|COMPLETED|Overall Study||7
8936857|NCT02337959|9997983|FG000|NOT COMPLETED|Overall Study||0
8936858|NCT02337959|9997984|FG001|NOT COMPLETED|Overall Study||3
8936859|NCT02337959|9997985|FG002|NOT COMPLETED|Overall Study||0
8936860|NCT02338076|9997993|FG000|STARTED|Overall Study||20
8936861|NCT02338076|9997993|FG000|COMPLETED|Overall Study||20
8936862|NCT02338076|9997993|FG000|NOT COMPLETED|Overall Study||0
8936863|NCT02338154|9997999|FG000|STARTED|Overall Study||516
8936864|NCT02338154|9997999|FG000|Enrolled Cohort (Intent to Treat)|Overall Study||516
8936865|NCT02338154|9997999|FG000|INTUITY (Study Valve Cohort)|Overall Study||493
8936866|NCT02338154|9997999|FG000|COMPLETED|Overall Study||373
8936867|NCT02338154|9997999|FG000|NOT COMPLETED|Overall Study||143
8718593|NCT00999466|9765924|FG001|STARTED|Pilot Part|AZD8848 nasal spray 60 μg group was not participated in the Pilot part|0
8718594|NCT00999466|9765925|FG002|STARTED|Pilot Part||3
8718595|NCT00999466|9765923|FG000|COMPLETED|Pilot Part||6
8813665|NCT01526928|9866811|FG000|COMPLETED|Overall Study||0
8813666|NCT01526928|9866812|FG001|COMPLETED|Overall Study||0
8813667|NCT01526928|9866813|FG002|COMPLETED|Overall Study||0
8813668|NCT01526928|9866814|FG003|COMPLETED|Overall Study||0
8718596|NCT00999466|9765924|FG001|COMPLETED|Pilot Part||0
8718597|NCT00999466|9765925|FG002|COMPLETED|Pilot Part||3
8718598|NCT00999466|9765923|FG000|NOT COMPLETED|Pilot Part||0
8718599|NCT00999466|9765924|FG001|NOT COMPLETED|Pilot Part||0
8718600|NCT00999466|9765925|FG002|NOT COMPLETED|Pilot Part||0
8718601|NCT00999466|9765923|FG000|STARTED|Main Part|AZD8848 nasal spray 30 μg group was not participated in the Main part|0
8718602|NCT00999466|9765924|FG001|STARTED|Main Part||26
8718603|NCT00999466|9765925|FG002|STARTED|Main Part||25
8718604|NCT00999466|9765923|FG000|COMPLETED|Main Part||0
8718605|NCT00999466|9765924|FG001|COMPLETED|Main Part||22
8718606|NCT00999466|9765925|FG002|COMPLETED|Main Part||21
8718607|NCT00999466|9765923|FG000|NOT COMPLETED|Main Part||0
8718608|NCT00999466|9765924|FG001|NOT COMPLETED|Main Part||4
8718609|NCT00999466|9765925|FG002|NOT COMPLETED|Main Part||4
8718610|NCT00999518|9765938|FG000|STARTED|Overall Study||43
8718611|NCT00999518|9765939|FG001|STARTED|Overall Study||42
8718612|NCT00999518|9765940|FG002|STARTED|Overall Study||39
8718613|NCT00999518|9765941|FG003|STARTED|Overall Study||40
8718614|NCT00999518|9765942|FG004|STARTED|Overall Study||41
8718615|NCT00999518|9765938|FG000|Treated|Overall Study||42
8718616|NCT00999518|9765939|FG001|Treated|Overall Study||41
8718617|NCT00999518|9765940|FG002|Treated|Overall Study||37
8718618|NCT00999518|9765941|FG003|Treated|Overall Study||40
8718619|NCT00999518|9765942|FG004|Treated|Overall Study||40
8718620|NCT00999518|9765938|FG000|COMPLETED|Overall Study||19
8718621|NCT00999518|9765939|FG001|COMPLETED|Overall Study||17
8718622|NCT00999518|9765940|FG002|COMPLETED|Overall Study||17
8718623|NCT00999518|9765941|FG003|COMPLETED|Overall Study||18
8718624|NCT00999518|9765942|FG004|COMPLETED|Overall Study||17
8718625|NCT00999518|9765938|FG000|NOT COMPLETED|Overall Study||24
8718626|NCT00999518|9765939|FG001|NOT COMPLETED|Overall Study||25
8718627|NCT00999518|9765940|FG002|NOT COMPLETED|Overall Study||22
8718628|NCT00999518|9765941|FG003|NOT COMPLETED|Overall Study||22
8718629|NCT00999518|9765942|FG004|NOT COMPLETED|Overall Study||24
8718630|NCT00999544|9765958|FG000|STARTED|Overall Study||9
8718631|NCT00999544|9765958|FG000|COMPLETED|Overall Study||8
8718632|NCT00999544|9765958|FG000|NOT COMPLETED|Overall Study||1
8718633|NCT00999596|9765991|FG000|STARTED|Overall Study||107
8718634|NCT00999596|9765991|FG000|New FDA Guideline Released|Overall Study|FDA Guidance: Class II Special Controls Guidance Document: Full-Field Digital Mammography System|6
8718635|NCT00999596|9765991|FG000|COMPLETED|Overall Study|Not all patient images were used for the reader evaluation based on new FDA Guidelines|6
8718636|NCT00999596|9765991|FG000|NOT COMPLETED|Overall Study||101
8718637|NCT00999661|9765996|FG000|STARTED|Overall Study||231
8718638|NCT00999661|9765996|FG000|COMPLETED|Overall Study||161
8718639|NCT00999661|9765996|FG000|NOT COMPLETED|Overall Study||70
8718640|NCT00999687|9766000|FG000|STARTED|First Intervention|16 used the INOE on the right hand,15 used the INOE on the left hand.|31
8718641|NCT00999687|9766000|FG000|COMPLETED|First Intervention||30
8718642|NCT00999687|9766000|FG000|NOT COMPLETED|First Intervention||1
8718643|NCT00999687|9766000|FG000|STARTED|Second Intervention|From week 13 to 24, all participants applied INOE to both hands twice daily.|30
8718644|NCT00999687|9766000|FG000|COMPLETED|Second Intervention||27
8718645|NCT00999687|9766000|FG000|NOT COMPLETED|Second Intervention||3
8718646|NCT00999713|9766008|FG000|STARTED|Overall Study||26
8718647|NCT00999713|9766009|FG001|STARTED|Overall Study||17
8718648|NCT00999713|9766008|FG000|COMPLETED|Overall Study||24
8718649|NCT00999713|9766009|FG001|COMPLETED|Overall Study||17
8718650|NCT00999713|9766008|FG000|NOT COMPLETED|Overall Study||2
8718651|NCT00999713|9766009|FG001|NOT COMPLETED|Overall Study||0
8718652|NCT00999804|9766017|FG000|STARTED|Overall Study||85
8718653|NCT00999804|9766018|FG001|STARTED|Overall Study||43
8718654|NCT00999804|9766017|FG000|COMPLETED|Overall Study||64
8718655|NCT00999804|9766018|FG001|COMPLETED|Overall Study||38
8718656|NCT00999804|9766017|FG000|NOT COMPLETED|Overall Study||21
8718657|NCT00999804|9766018|FG001|NOT COMPLETED|Overall Study||5
8718658|NCT00999830|9766026|FG000|STARTED|Overall Study||14
8718659|NCT00999830|9766027|FG001|STARTED|Overall Study||13
8813669|NCT01526928|9866815|FG004|COMPLETED|Overall Study||0
8718660|NCT00999830|9766026|FG000|COMPLETED|Overall Study||14
8718661|NCT00999830|9766027|FG001|COMPLETED|Overall Study||13
8718662|NCT00999830|9766026|FG000|NOT COMPLETED|Overall Study||0
8718663|NCT00999830|9766027|FG001|NOT COMPLETED|Overall Study||0
8718664|NCT00999908|9766033|FG000|STARTED|Treatment Period 1||19
8718665|NCT00999908|9766034|FG001|STARTED|Treatment Period 1||16
8718666|NCT00999908|9766035|FG002|STARTED|Treatment Period 1||19
8718667|NCT00999908|9766033|FG000|COMPLETED|Treatment Period 1||17
8936868|NCT02338193|9998014|FG000|STARTED|Overall Study||20
8936869|NCT02338193|9998015|FG001|STARTED|Overall Study||21
8936870|NCT02338193|9998016|FG002|STARTED|Overall Study||25
8936871|NCT02338193|9998014|FG000|COMPLETED|Overall Study||17
8718668|NCT00999908|9766034|FG001|COMPLETED|Treatment Period 1||16
8718669|NCT00999908|9766035|FG002|COMPLETED|Treatment Period 1||19
8718670|NCT00999908|9766033|FG000|NOT COMPLETED|Treatment Period 1||2
8718671|NCT00999908|9766034|FG001|NOT COMPLETED|Treatment Period 1||0
8718672|NCT00999908|9766035|FG002|NOT COMPLETED|Treatment Period 1||0
8718673|NCT00999908|9766033|FG000|STARTED|Treatment Period 2||17
8718674|NCT00999908|9766034|FG001|STARTED|Treatment Period 2||16
8718675|NCT00999908|9766035|FG002|STARTED|Treatment Period 2||19
8718676|NCT00999908|9766033|FG000|COMPLETED|Treatment Period 2||16
8718677|NCT00999908|9766034|FG001|COMPLETED|Treatment Period 2||16
8718678|NCT00999908|9766035|FG002|COMPLETED|Treatment Period 2||19
8718679|NCT00999908|9766033|FG000|NOT COMPLETED|Treatment Period 2||1
8718680|NCT00999908|9766034|FG001|NOT COMPLETED|Treatment Period 2||0
8718681|NCT00999908|9766035|FG002|NOT COMPLETED|Treatment Period 2||0
8718682|NCT00999908|9766033|FG000|STARTED|Treatment Period 3||16
8718683|NCT00999908|9766034|FG001|STARTED|Treatment Period 3||16
8718684|NCT00999908|9766035|FG002|STARTED|Treatment Period 3||19
8718685|NCT00999908|9766033|FG000|COMPLETED|Treatment Period 3||16
8718686|NCT00999908|9766034|FG001|COMPLETED|Treatment Period 3||16
8718687|NCT00999908|9766035|FG002|COMPLETED|Treatment Period 3||19
8718688|NCT00999908|9766033|FG000|NOT COMPLETED|Treatment Period 3||0
8718689|NCT00999908|9766034|FG001|NOT COMPLETED|Treatment Period 3||0
8718690|NCT00999908|9766035|FG002|NOT COMPLETED|Treatment Period 3||0
8718691|NCT00999921|9766045|FG000|STARTED|Overall Study||127
8718692|NCT00999921|9766046|FG001|STARTED|Overall Study||129
8718693|NCT00999921|9766045|FG000|COMPLETED|Overall Study||117
8718694|NCT00999921|9766046|FG001|COMPLETED|Overall Study||110
8718695|NCT00999921|9766045|FG000|NOT COMPLETED|Overall Study||10
8718696|NCT00999921|9766046|FG001|NOT COMPLETED|Overall Study||19
8718697|NCT01000025|9766057|FG000|STARTED|Overall Study||480
8718698|NCT01000025|9766058|FG001|STARTED|Overall Study||240
8718699|NCT01000025|9766057|FG000|COMPLETED|Overall Study||12
8718700|NCT01000025|9766058|FG001|COMPLETED|Overall Study||2
8718701|NCT01000025|9766057|FG000|NOT COMPLETED|Overall Study||468
8718702|NCT01000025|9766058|FG001|NOT COMPLETED|Overall Study||238
8718703|NCT01000051|9766066|FG000|STARTED|Overall Study||42
8718704|NCT01000051|9766067|FG001|STARTED|Overall Study||18
8718705|NCT01000051|9766066|FG000|COMPLETED|Overall Study||39
8718706|NCT01000051|9766067|FG001|COMPLETED|Overall Study||17
8718707|NCT01000051|9766066|FG000|NOT COMPLETED|Overall Study||3
8718708|NCT01000051|9766067|FG001|NOT COMPLETED|Overall Study||1
8718709|NCT01000064|9766073|FG000|STARTED|Overall Study||7
8718710|NCT01000064|9766074|FG001|STARTED|Overall Study||6
8718711|NCT01000064|9766073|FG000|COMPLETED|Overall Study||6
8718712|NCT01000064|9766074|FG001|COMPLETED|Overall Study||5
8718713|NCT01000064|9766073|FG000|NOT COMPLETED|Overall Study||1
8718714|NCT01000064|9766074|FG001|NOT COMPLETED|Overall Study||1
8718715|NCT01000155|9766083|FG000|STARTED|Overall Study||5
8718716|NCT01000155|9766083|FG000|COMPLETED|Overall Study||3
8718717|NCT01000155|9766083|FG000|NOT COMPLETED|Overall Study||2
8718718|NCT01000285|9766089|FG000|STARTED|Overall Study||18
8718719|NCT01000285|9766089|FG000|COMPLETED|Overall Study||18
8718720|NCT01000285|9766089|FG000|NOT COMPLETED|Overall Study||0
8718721|NCT01000311|9766105|FG000|STARTED|Overall Study||258
8718722|NCT01000311|9766106|FG001|STARTED|Overall Study||271
8718723|NCT01000311|9766105|FG000|COMPLETED|Overall Study||213
8718724|NCT01000311|9766106|FG001|COMPLETED|Overall Study||201
8718725|NCT01000311|9766105|FG000|NOT COMPLETED|Overall Study||45
8718726|NCT01000311|9766106|FG001|NOT COMPLETED|Overall Study||70
8718727|NCT01000324|9766112|FG000|STARTED|Year 16||40
8718728|NCT01000324|9766112|FG000|COMPLETED|Year 16||40
8718729|NCT01000324|9766112|FG000|NOT COMPLETED|Year 16||0
8718730|NCT01000324|9766112|FG000|STARTED|Year 17||32
8718731|NCT01000324|9766112|FG000|COMPLETED|Year 17||32
8718732|NCT01000324|9766112|FG000|NOT COMPLETED|Year 17||0
8718733|NCT01000324|9766112|FG000|STARTED|Year 18||29
8718734|NCT01000324|9766112|FG000|COMPLETED|Year 18||29
8718735|NCT01000324|9766112|FG000|NOT COMPLETED|Year 18||0
8718736|NCT01000324|9766112|FG000|STARTED|Year 19||28
8718737|NCT01000324|9766112|FG000|COMPLETED|Year 19||28
8718738|NCT01000324|9766112|FG000|NOT COMPLETED|Year 19||0
8718739|NCT01000324|9766112|FG000|STARTED|Year 20||28
8718740|NCT01000324|9766112|FG000|COMPLETED|Year 20||28
8718741|NCT01000324|9766112|FG000|NOT COMPLETED|Year 20||0
8718742|NCT01000337|9766119|FG000|STARTED|Overall Study||34
8718743|NCT01000337|9766120|FG001|STARTED|Overall Study||33
8718744|NCT01000337|9766119|FG000|COMPLETED|Overall Study||30
8718745|NCT01000337|9766120|FG001|COMPLETED|Overall Study||30
8718746|NCT01000337|9766119|FG000|NOT COMPLETED|Overall Study||4
8718747|NCT01000337|9766120|FG001|NOT COMPLETED|Overall Study||3
8718748|NCT01000376|9766128|FG000|STARTED|Cycle 1 Day 1||6
8718749|NCT01000376|9766129|FG001|STARTED|Cycle 1 Day 1||6
8718750|NCT01000376|9766128|FG000|COMPLETED|Cycle 1 Day 1||4
8718751|NCT01000376|9766129|FG001|COMPLETED|Cycle 1 Day 1||6
8718752|NCT01000376|9766128|FG000|NOT COMPLETED|Cycle 1 Day 1||2
8718753|NCT01000376|9766129|FG001|NOT COMPLETED|Cycle 1 Day 1||0
8718754|NCT01000376|9766128|FG000|STARTED|Cycle 1 Day 15||4
8718755|NCT01000376|9766129|FG001|STARTED|Cycle 1 Day 15||6
8718756|NCT01000376|9766128|FG000|COMPLETED|Cycle 1 Day 15||4
8718757|NCT01000376|9766129|FG001|COMPLETED|Cycle 1 Day 15||6
8718758|NCT01000376|9766128|FG000|NOT COMPLETED|Cycle 1 Day 15||0
8718759|NCT01000376|9766129|FG001|NOT COMPLETED|Cycle 1 Day 15||0
8718760|NCT01000480|9766135|FG000|STARTED|Induction Phase||90
8936872|NCT02338193|9998015|FG001|COMPLETED|Overall Study||17
8936873|NCT02338193|9998016|FG002|COMPLETED|Overall Study||15
8936874|NCT02338193|9998014|FG000|NOT COMPLETED|Overall Study||3
8936875|NCT02338193|9998015|FG001|NOT COMPLETED|Overall Study||4
8718761|NCT01000480|9766135|FG000|Received at Least 1 Dose of Either Drug|Induction Phase||90
8718762|NCT01000480|9766135|FG000|Death (Any Cause) or Disease Progression|Induction Phase|Participants who died (any cause) or had disease progression considered to have completed phase.|8
8718763|NCT01000480|9766135|FG000|COMPLETED|Induction Phase||83
8718764|NCT01000480|9766135|FG000|NOT COMPLETED|Induction Phase||7
8718765|NCT01000480|9766135|FG000|STARTED|Concurrent Therapy Phase|Eight participants (pts) who completed Induction Phase, not eligible for Concurrent Therapy Phase.|75
8718766|NCT01000480|9766135|FG000|Death (Any Cause) or Disease Progression|Concurrent Therapy Phase|Pts who died (any cause) or had disease progression considered to have completed the phase.|1
8718767|NCT01000480|9766135|FG000|COMPLETED|Concurrent Therapy Phase||65
8718768|NCT01000480|9766135|FG000|NOT COMPLETED|Concurrent Therapy Phase||10
8718769|NCT01000480|9766135|FG000|STARTED|Follow-Up Period|One pt lost to follow-up during induction, 1 pt died in concurrent therapy, both not enter follow-up|88
8718770|NCT01000480|9766135|FG000|COMPLETED|Follow-Up Period||88
8718771|NCT01000480|9766135|FG000|NOT COMPLETED|Follow-Up Period||0
8718772|NCT01000493|9766141|FG000|STARTED|Overall Study||60
8718773|NCT01000493|9766142|FG001|STARTED|Overall Study||69
8718774|NCT01000493|9766141|FG000|COMPLETED|Overall Study||21
8718775|NCT01000493|9766142|FG001|COMPLETED|Overall Study||14
8718776|NCT01000493|9766141|FG000|NOT COMPLETED|Overall Study||39
8718777|NCT01000493|9766142|FG001|NOT COMPLETED|Overall Study||55
8718778|NCT01000506|9766152|FG000|STARTED|Overall Study||155
8718779|NCT01000506|9766153|FG001|STARTED|Overall Study||153
8718780|NCT01000506|9766154|FG002|STARTED|Overall Study||152
8718781|NCT01000506|9766155|FG003|STARTED|Overall Study||156
8718782|NCT01000506|9766152|FG000|COMPLETED|Overall Study||127
8718783|NCT01000506|9766153|FG001|COMPLETED|Overall Study||129
8718784|NCT01000506|9766154|FG002|COMPLETED|Overall Study||131
8718785|NCT01000506|9766155|FG003|COMPLETED|Overall Study||133
8718786|NCT01000506|9766152|FG000|NOT COMPLETED|Overall Study||28
8718787|NCT01000506|9766153|FG001|NOT COMPLETED|Overall Study||24
8718788|NCT01000506|9766154|FG002|NOT COMPLETED|Overall Study||21
8718789|NCT01000506|9766155|FG003|NOT COMPLETED|Overall Study||23
8718790|NCT01000610|9766165|FG000|STARTED|Overall Study||18
8718791|NCT01000610|9766165|FG000|COMPLETED|Overall Study||12
8718792|NCT01000610|9766165|FG000|NOT COMPLETED|Overall Study||6
8718793|NCT01000636|9766169|FG000|STARTED|Overall Study||9
8718794|NCT01000636|9766169|FG000|COMPLETED|Overall Study||7
8718795|NCT01000636|9766169|FG000|NOT COMPLETED|Overall Study||2
8718796|NCT01000649|9766177|FG000|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|10
8718797|NCT01000649|9766178|FG001|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|19
8718798|NCT01000649|9766179|FG002|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|2
8718799|NCT01000649|9766180|FG003|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|21
8718800|NCT01000649|9766177|FG000|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|10
8718801|NCT01000649|9766178|FG001|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|20
8718802|NCT01000649|9766179|FG002|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|2
8718803|NCT01000649|9766180|FG003|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|21
8718804|NCT01000649|9766177|FG000|COMPLETED|Overall Study||5
8718805|NCT01000649|9766178|FG001|COMPLETED|Overall Study||16
8718806|NCT01000649|9766179|FG002|COMPLETED|Overall Study||0
8718807|NCT01000649|9766180|FG003|COMPLETED|Overall Study||15
8718808|NCT01000649|9766177|FG000|NOT COMPLETED|Overall Study||5
8718809|NCT01000649|9766178|FG001|NOT COMPLETED|Overall Study||3
8718810|NCT01000649|9766179|FG002|NOT COMPLETED|Overall Study||2
8718811|NCT01000649|9766180|FG003|NOT COMPLETED|Overall Study||6
8718812|NCT01000662|9766191|FG000|STARTED|Overall Study||206
8718813|NCT01000662|9766192|FG001|STARTED|Overall Study||206
8718814|NCT01000662|9766191|FG000|COMPLETED|Overall Study||202
8718815|NCT01000662|9766192|FG001|COMPLETED|Overall Study||198
8718816|NCT01000662|9766191|FG000|NOT COMPLETED|Overall Study||4
8718817|NCT01000662|9766192|FG001|NOT COMPLETED|Overall Study||8
8718818|NCT01000727|9766202|FG000|STARTED|Overall Study||6522
8718819|NCT01000727|9766203|FG001|STARTED|Overall Study||6504
8718820|NCT01000727|9766202|FG000|COMPLETED|Overall Study||6347
8718821|NCT01000727|9766203|FG001|COMPLETED|Overall Study||6328
8718822|NCT01000727|9766202|FG000|NOT COMPLETED|Overall Study||175
8718823|NCT01000727|9766203|FG001|NOT COMPLETED|Overall Study||176
8718824|NCT01000805|9766213|FG000|STARTED|Overall Study||262
8718825|NCT01000805|9766214|FG001|STARTED|Overall Study||266
8718826|NCT01000805|9766213|FG000|COMPLETED|Overall Study||192
8718827|NCT01000805|9766214|FG001|COMPLETED|Overall Study||204
8718828|NCT01000805|9766213|FG000|NOT COMPLETED|Overall Study||70
8718829|NCT01000805|9766214|FG001|NOT COMPLETED|Overall Study||62
8718830|NCT01000818|9766221|FG000|STARTED|Raltegravir||18
8718831|NCT01000818|9766221|FG000|COMPLETED|Raltegravir||18
8718832|NCT01000818|9766221|FG000|NOT COMPLETED|Raltegravir||0
8718833|NCT01000818|9766221|FG000|STARTED|Famotidine + Raltegravir||18
8718834|NCT01000818|9766221|FG000|COMPLETED|Famotidine + Raltegravir||18
8936876|NCT02338193|9998016|FG002|NOT COMPLETED|Overall Study||10
8718835|NCT01000818|9766221|FG000|NOT COMPLETED|Famotidine + Raltegravir||0
8718836|NCT01000818|9766221|FG000|STARTED|Omeprazole + Raltegravir||18
8718837|NCT01000818|9766221|FG000|COMPLETED|Omeprazole + Raltegravir||18
8718838|NCT01000818|9766221|FG000|NOT COMPLETED|Omeprazole + Raltegravir||0
8718839|NCT01000961|9766230|FG000|STARTED|Run-in Period of 2-3 Weeks on Cystagon|Part of the Safety analysis set|21
8718840|NCT01000961|9766231|FG001|STARTED|Run-in Period of 2-3 Weeks on Cystagon|Part of the Safety analysis set|22
8718841|NCT01000961|9766230|FG000|COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||21
8718842|NCT01000961|9766231|FG001|COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||22
8718843|NCT01000961|9766230|FG000|NOT COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||0
8718844|NCT01000961|9766231|FG001|NOT COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||0
8718845|NCT01000961|9766230|FG000|STARTED|First Intervention (3 Weeks)||21
8718846|NCT01000961|9766231|FG001|STARTED|First Intervention (3 Weeks)||22
8718847|NCT01000961|9766230|FG000|COMPLETED|First Intervention (3 Weeks)||21
8718848|NCT01000961|9766231|FG001|COMPLETED|First Intervention (3 Weeks)||20
8718849|NCT01000961|9766230|FG000|NOT COMPLETED|First Intervention (3 Weeks)||0
8718850|NCT01000961|9766231|FG001|NOT COMPLETED|First Intervention (3 Weeks)||2
8718851|NCT01000961|9766230|FG000|STARTED|Second Intervention (3 Weeks)||21
8718852|NCT01000961|9766231|FG001|STARTED|Second Intervention (3 Weeks)||20
8718853|NCT01000961|9766230|FG000|COMPLETED|Second Intervention (3 Weeks)|Part of Efficacy analysis set|21
8718854|NCT01000961|9766231|FG001|COMPLETED|Second Intervention (3 Weeks)|Part of Efficacy analysis set|20
8718855|NCT01000961|9766230|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0
8718856|NCT01000961|9766231|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
8718857|NCT01000974|9766242|FG000|STARTED|Primary Vaccination Phase||2963
8718858|NCT01000974|9766243|FG001|STARTED|Primary Vaccination Phase||520
8718859|NCT01000974|9766244|FG002|STARTED|Primary Vaccination Phase||520
8718860|NCT01000974|9766242|FG000|COMPLETED|Primary Vaccination Phase||2625
8718861|NCT01000974|9766243|FG001|COMPLETED|Primary Vaccination Phase||470
8718862|NCT01000974|9766244|FG002|COMPLETED|Primary Vaccination Phase||457
8718863|NCT01000974|9766242|FG000|NOT COMPLETED|Primary Vaccination Phase||338
8718864|NCT01000974|9766243|FG001|NOT COMPLETED|Primary Vaccination Phase||50
8718865|NCT01000974|9766244|FG002|NOT COMPLETED|Primary Vaccination Phase||63
8718866|NCT01000974|9766242|FG000|STARTED|Booster Vaccination Phase||2337
8718867|NCT01000974|9766243|FG001|STARTED|Booster Vaccination Phase||435
8718868|NCT01000974|9766244|FG002|STARTED|Booster Vaccination Phase||400
8718869|NCT01000974|9766242|FG000|COMPLETED|Booster Vaccination Phase||2270
8718870|NCT01000974|9766243|FG001|COMPLETED|Booster Vaccination Phase||423
8718871|NCT01000974|9766244|FG002|COMPLETED|Booster Vaccination Phase||386
8718872|NCT01000974|9766242|FG000|NOT COMPLETED|Booster Vaccination Phase||67
8718873|NCT01000974|9766243|FG001|NOT COMPLETED|Booster Vaccination Phase||12
8718874|NCT01000974|9766244|FG002|NOT COMPLETED|Booster Vaccination Phase||14
8718875|NCT01000987|9766258|FG000|STARTED|Overall Study||12
8718876|NCT01000987|9766259|FG001|STARTED|Overall Study||15
8718877|NCT01000987|9766260|FG002|STARTED|Overall Study||17
8718878|NCT01000987|9766258|FG000|COMPLETED|Overall Study||12
8718879|NCT01000987|9766259|FG001|COMPLETED|Overall Study||15
8718880|NCT01000987|9766260|FG002|COMPLETED|Overall Study||17
8718881|NCT01000987|9766258|FG000|NOT COMPLETED|Overall Study||0
8718882|NCT01000987|9766259|FG001|NOT COMPLETED|Overall Study||0
8718883|NCT01000987|9766260|FG002|NOT COMPLETED|Overall Study||0
8718884|NCT01001052|9766268|FG000|STARTED|Overall Study||20
8718885|NCT01001052|9766269|FG001|STARTED|Overall Study||18
8718886|NCT01001052|9766268|FG000|COMPLETED|Overall Study||20
8718887|NCT01001052|9766269|FG001|COMPLETED|Overall Study||18
8718888|NCT01001052|9766268|FG000|NOT COMPLETED|Overall Study||0
8718889|NCT01001052|9766269|FG001|NOT COMPLETED|Overall Study||0
8718890|NCT01001078|9766277|FG000|STARTED|Overall Study||50
8718891|NCT01001078|9766278|FG001|STARTED|Overall Study||50
8718892|NCT01001078|9766277|FG000|Received Allocated Intervention|Overall Study||46
8718893|NCT01001078|9766278|FG001|Received Allocated Intervention|Overall Study||46
8718894|NCT01001078|9766277|FG000|Received Crossover|Overall Study||2
8718895|NCT01001078|9766278|FG001|Received Crossover|Overall Study||3
8718896|NCT01001078|9766277|FG000|Intubated|Overall Study||2
8718897|NCT01001078|9766278|FG001|Intubated|Overall Study||1
8718898|NCT01001078|9766277|FG000|Lost to Followup Interview|Overall Study|Could not be interviewed.|5
8718899|NCT01001078|9766278|FG001|Lost to Followup Interview|Overall Study|Could not be interviewed.|2
8718900|NCT01001078|9766277|FG000|COMPLETED|Overall Study|Analyzed: 46, excluded from interview analysis: 5|50
8718901|NCT01001078|9766278|FG001|COMPLETED|Overall Study|Analyzed: 46, excluded from interview analysis: 2|50
8718902|NCT01001078|9766277|FG000|NOT COMPLETED|Overall Study||0
8718903|NCT01001078|9766278|FG001|NOT COMPLETED|Overall Study||0
8718904|NCT01001104|9766290|FG000|STARTED|Overall Study||35
8718905|NCT01001104|9766291|FG001|STARTED|Overall Study||37
8718906|NCT01001104|9766292|FG002|STARTED|Overall Study||36
8718907|NCT01001104|9766293|FG003|STARTED|Overall Study||37
8718908|NCT01001104|9766290|FG000|COMPLETED|Overall Study||33
8718909|NCT01001104|9766291|FG001|COMPLETED|Overall Study||36
8718910|NCT01001104|9766292|FG002|COMPLETED|Overall Study||35
8718911|NCT01001104|9766293|FG003|COMPLETED|Overall Study||34
8718912|NCT01001104|9766290|FG000|NOT COMPLETED|Overall Study||2
8718913|NCT01001104|9766291|FG001|NOT COMPLETED|Overall Study||1
8718914|NCT01001104|9766292|FG002|NOT COMPLETED|Overall Study||1
8718915|NCT01001104|9766293|FG003|NOT COMPLETED|Overall Study||3
8718916|NCT01001169|9766308|FG000|STARTED|Overall Study||30
8936877|NCT02338336|9998026|FG000|STARTED|Overall Study||26
8936878|NCT02338336|9998027|FG001|STARTED|Overall Study||17
8936879|NCT02338336|9998028|FG002|STARTED|Overall Study||7
8936880|NCT02338336|9998029|FG003|STARTED|Overall Study||4
8936881|NCT02338336|9998026|FG000|COMPLETED|Overall Study||24
8936882|NCT02338336|9998027|FG001|COMPLETED|Overall Study||17
8936883|NCT02338336|9998028|FG002|COMPLETED|Overall Study||7
8936884|NCT02338336|9998029|FG003|COMPLETED|Overall Study||4
8936885|NCT02338336|9998026|FG000|NOT COMPLETED|Overall Study||2
8936886|NCT02338336|9998027|FG001|NOT COMPLETED|Overall Study||0
8936887|NCT02338336|9998028|FG002|NOT COMPLETED|Overall Study||0
8936888|NCT02338336|9998029|FG003|NOT COMPLETED|Overall Study||0
8936889|NCT02338362|9998037|FG000|STARTED|Overall Study||11
8936890|NCT02338362|9998038|FG001|STARTED|Overall Study||11
8936891|NCT02338362|9998037|FG000|COMPLETED|Overall Study||10
8936892|NCT02338362|9998038|FG001|COMPLETED|Overall Study||10
8936893|NCT02338362|9998037|FG000|NOT COMPLETED|Overall Study||1
8936894|NCT02338362|9998038|FG001|NOT COMPLETED|Overall Study||1
8936895|NCT02338492|9998044|FG000|STARTED|Overall Study||81
8936896|NCT02338492|9998044|FG000|Enrolled|Overall Study||81
8936897|NCT02338492|9998044|FG000|Device Implanted|Overall Study||79
8936898|NCT02338492|9998044|FG000|Treatment Failure|Overall Study||2
8936899|NCT02338492|9998044|FG000|COMPLETED|Overall Study||36
8936900|NCT02338492|9998044|FG000|NOT COMPLETED|Overall Study||45
8936901|NCT02338713|9998048|FG000|STARTED|Overall Study||27
8936902|NCT02338713|9998048|FG000|COMPLETED|Overall Study||27
8936903|NCT02338713|9998048|FG000|NOT COMPLETED|Overall Study||0
8936904|NCT02338843|9998056|FG000|STARTED|Overall Study||163
8936905|NCT02338843|9998057|FG001|STARTED|Overall Study||158
8936906|NCT02338843|9998056|FG000|COMPLETED|Overall Study||119
8936907|NCT02338843|9998057|FG001|COMPLETED|Overall Study||100
8936908|NCT02338843|9998056|FG000|NOT COMPLETED|Overall Study||44
8936909|NCT02338843|9998057|FG001|NOT COMPLETED|Overall Study||58
8936910|NCT02338882|9998065|FG000|STARTED|Overall Study||50
8936911|NCT02338882|9998066|FG001|STARTED|Overall Study||50
8936912|NCT02338882|9998065|FG000|COMPLETED|Overall Study||43
8936913|NCT02338882|9998066|FG001|COMPLETED|Overall Study||47
8936914|NCT02338882|9998065|FG000|NOT COMPLETED|Overall Study||7
8936915|NCT02338882|9998066|FG001|NOT COMPLETED|Overall Study||3
8936916|NCT02338960|9998077|FG000|STARTED|Core Study||306
8936917|NCT02338960|9998078|FG001|STARTED|Core Study||308
8936918|NCT02338960|9998077|FG000|Received Intervention|Core Study||303
8936919|NCT02338960|9998078|FG001|Received Intervention|Core Study||301
8936920|NCT02338960|9998077|FG000|COMPLETED|Core Study||219
8936921|NCT02338960|9998078|FG001|COMPLETED|Core Study||173
8936922|NCT02338960|9998077|FG000|NOT COMPLETED|Core Study||87
8936923|NCT02338960|9998078|FG001|NOT COMPLETED|Core Study||135
8936924|NCT02338960|9998077|FG000|STARTED|Open Label Extension||191
8936925|NCT02338960|9998078|FG001|STARTED|Open Label Extension||130
8936926|NCT02338960|9998077|FG000|COMPLETED|Open Label Extension||77
8936927|NCT02338960|9998078|FG001|COMPLETED|Open Label Extension||51
8936928|NCT02338960|9998077|FG000|NOT COMPLETED|Open Label Extension||114
8936929|NCT02338960|9998078|FG001|NOT COMPLETED|Open Label Extension||79
8936930|NCT02338973|9998089|FG000|STARTED|Overall Study||4
8936931|NCT02338973|9998089|FG000|Rod-cone Dystrophy (RCD)|Overall Study||2
8936932|NCT02338973|9998089|FG000|Enhanced S-Cone Syndrome (ESCS)|Overall Study||2
8936933|NCT02338973|9998089|FG000|COMPLETED|Overall Study||4
8936934|NCT02338973|9998089|FG000|NOT COMPLETED|Overall Study||0
8936935|NCT02338999|9998172|FG000|STARTED|First Intervention||39
8936936|NCT02338999|9998173|FG001|STARTED|First Intervention||41
8936937|NCT02338999|9998172|FG000|COMPLETED|First Intervention||36
8936938|NCT02338999|9998173|FG001|COMPLETED|First Intervention||40
8936939|NCT02338999|9998172|FG000|NOT COMPLETED|First Intervention||3
8936940|NCT02338999|9998173|FG001|NOT COMPLETED|First Intervention||1
8936941|NCT02338999|9998172|FG000|STARTED|Washout Period||36
8936942|NCT02338999|9998173|FG001|STARTED|Washout Period||40
8936943|NCT02338999|9998172|FG000|COMPLETED|Washout Period||36
8936944|NCT02338999|9998173|FG001|COMPLETED|Washout Period||38
8936945|NCT02338999|9998172|FG000|NOT COMPLETED|Washout Period||0
8936946|NCT02338999|9998173|FG001|NOT COMPLETED|Washout Period||2
8936947|NCT02338999|9998172|FG000|STARTED|Second Intervention||36
8936948|NCT02338999|9998173|FG001|STARTED|Second Intervention||38
8936949|NCT02338999|9998172|FG000|COMPLETED|Second Intervention||36
8936950|NCT02338999|9998173|FG001|COMPLETED|Second Intervention||36
8936951|NCT02338999|9998172|FG000|NOT COMPLETED|Second Intervention||0
8936952|NCT02338999|9998173|FG001|NOT COMPLETED|Second Intervention||2
8936953|NCT02339038|9998179|FG000|STARTED|Overall Study||600
8936954|NCT02339038|9998179|FG000|COMPLETED|Overall Study||0
8936955|NCT02339038|9998179|FG000|NOT COMPLETED|Overall Study||600
8936956|NCT02339155|9998185|FG000|STARTED|Overall Study||287
8936957|NCT02339155|9998186|FG001|STARTED|Overall Study||286
8936958|NCT02339155|9998185|FG000|Received Study Treatment|Overall Study||286
8936959|NCT02339155|9998186|FG001|Received Study Treatment|Overall Study||280
8936960|NCT02339155|9998185|FG000|COMPLETED|Overall Study||272
8936961|NCT02339155|9998186|FG001|COMPLETED|Overall Study||265
8936962|NCT02339155|9998185|FG000|NOT COMPLETED|Overall Study||15
8936963|NCT02339155|9998186|FG001|NOT COMPLETED|Overall Study||21
8936964|NCT02339246|9998196|FG000|STARTED|First Intervention (7 Days)||0
8936965|NCT02339246|9998197|FG001|STARTED|First Intervention (7 Days)||0
8936966|NCT02339246|9998198|FG002|STARTED|First Intervention (7 Days)||31
8936967|NCT02339246|9998196|FG000|COMPLETED|First Intervention (7 Days)||0
8936968|NCT02339246|9998197|FG001|COMPLETED|First Intervention (7 Days)||0
8936969|NCT02339246|9998198|FG002|COMPLETED|First Intervention (7 Days)||31
8936970|NCT02339246|9998196|FG000|NOT COMPLETED|First Intervention (7 Days)||0
8936971|NCT02339246|9998197|FG001|NOT COMPLETED|First Intervention (7 Days)||0
8936972|NCT02339246|9998198|FG002|NOT COMPLETED|First Intervention (7 Days)||0
8936973|NCT02339246|9998196|FG000|STARTED|Second Intervention (7 Days)||16
8718917|NCT01001169|9766309|FG001|STARTED|Overall Study||30
8718918|NCT01001169|9766308|FG000|COMPLETED|Overall Study||28
8718919|NCT01001169|9766309|FG001|COMPLETED|Overall Study||29
8718920|NCT01001169|9766308|FG000|NOT COMPLETED|Overall Study||2
8718921|NCT01001169|9766309|FG001|NOT COMPLETED|Overall Study||1
8718922|NCT01001195|9766327|FG000|STARTED|Overall Study||39
8718923|NCT01001195|9766328|FG001|STARTED|Overall Study||41
8718924|NCT01001195|9766329|FG002|STARTED|Overall Study||44
8718925|NCT01001195|9766330|FG003|STARTED|Overall Study||41
8718926|NCT01001195|9766327|FG000|COMPLETED|Overall Study||37
8718927|NCT01001195|9766328|FG001|COMPLETED|Overall Study||39
8718928|NCT01001195|9766329|FG002|COMPLETED|Overall Study||44
8718929|NCT01001195|9766330|FG003|COMPLETED|Overall Study||41
8718930|NCT01001195|9766327|FG000|NOT COMPLETED|Overall Study||2
8718931|NCT01001195|9766328|FG001|NOT COMPLETED|Overall Study||2
8718932|NCT01001195|9766329|FG002|NOT COMPLETED|Overall Study||0
8718933|NCT01001195|9766330|FG003|NOT COMPLETED|Overall Study||0
8718934|NCT01001208|9766342|FG000|STARTED|Overall Study||239
8718935|NCT01001208|9766343|FG001|STARTED|Overall Study||239
8718936|NCT01001208|9766342|FG000|COMPLETED|Overall Study||211
8718937|NCT01001208|9766343|FG001|COMPLETED|Overall Study||206
8718938|NCT01001208|9766342|FG000|NOT COMPLETED|Overall Study||28
8718939|NCT01001208|9766343|FG001|NOT COMPLETED|Overall Study||33
8718940|NCT01001221|9766353|FG000|STARTED|Overall Study||5
8718941|NCT01001221|9766354|FG001|STARTED|Overall Study||5
8718942|NCT01001221|9766355|FG002|STARTED|Overall Study||3
8718943|NCT01001221|9766356|FG003|STARTED|Overall Study||6
8718944|NCT01001221|9766357|FG004|STARTED|Overall Study|Inability to determine the MTD during study part 1|0
8718945|NCT01001221|9766353|FG000|Treated|Overall Study||5
8718946|NCT01001221|9766354|FG001|Treated|Overall Study||5
8718947|NCT01001221|9766355|FG002|Treated|Overall Study||2
8718948|NCT01001221|9766356|FG003|Treated|Overall Study||6
8718949|NCT01001221|9766357|FG004|Treated|Overall Study||0
8718950|NCT01001221|9766353|FG000|Completed 1st Treatment Cycle|Overall Study||5
8718951|NCT01001221|9766354|FG001|Completed 1st Treatment Cycle|Overall Study||5
8718952|NCT01001221|9766355|FG002|Completed 1st Treatment Cycle|Overall Study||2
8718953|NCT01001221|9766356|FG003|Completed 1st Treatment Cycle|Overall Study||6
8718954|NCT01001221|9766357|FG004|Completed 1st Treatment Cycle|Overall Study||0
8718955|NCT01001221|9766353|FG000|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
8718956|NCT01001221|9766354|FG001|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
8718957|NCT01001221|9766355|FG002|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
8718958|NCT01001221|9766356|FG003|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
8718959|NCT01001221|9766357|FG004|COMPLETED|Overall Study||0
8718960|NCT01001221|9766353|FG000|NOT COMPLETED|Overall Study||5
8718961|NCT01001221|9766354|FG001|NOT COMPLETED|Overall Study||5
8718962|NCT01001221|9766355|FG002|NOT COMPLETED|Overall Study||3
8718963|NCT01001221|9766356|FG003|NOT COMPLETED|Overall Study||6
8718964|NCT01001221|9766357|FG004|NOT COMPLETED|Overall Study||0
8718965|NCT01001299|9766368|FG000|STARTED|Overall Study||25
8718966|NCT01001299|9766368|FG000|COMPLETED|Overall Study||0
8718967|NCT01001299|9766368|FG000|NOT COMPLETED|Overall Study||25
8718968|NCT01001325|9766374|FG000|STARTED|Overall Study||234
8718969|NCT01001325|9766375|FG001|STARTED|Overall Study||234
8718970|NCT01001325|9766374|FG000|COMPLETED|Overall Study||216
8718971|NCT01001325|9766375|FG001|COMPLETED|Overall Study||224
8718972|NCT01001325|9766374|FG000|NOT COMPLETED|Overall Study||18
8718973|NCT01001325|9766375|FG001|NOT COMPLETED|Overall Study||10
8718974|NCT01001377|9766383|FG000|STARTED|Overall Study||504
8718975|NCT01001377|9766384|FG001|STARTED|Overall Study||506
8718976|NCT01001377|9766383|FG000|Received Treatment|Overall Study||500
8718977|NCT01001377|9766384|FG001|Received Treatment|Overall Study||499
8718978|NCT01001377|9766383|FG000|COMPLETED|Overall Study|Indicates participants continuing in study|78
8718979|NCT01001377|9766384|FG001|COMPLETED|Overall Study|Indicates participants continuing in study|85
8718980|NCT01001377|9766383|FG000|NOT COMPLETED|Overall Study||426
8718981|NCT01001377|9766384|FG001|NOT COMPLETED|Overall Study||421
8718982|NCT01001403|9766392|FG000|STARTED|Overall Study||31
8718983|NCT01001403|9766393|FG001|STARTED|Overall Study||31
8718984|NCT01001403|9766392|FG000|COMPLETED|Overall Study||31
8718985|NCT01001403|9766393|FG001|COMPLETED|Overall Study||31
8718986|NCT01001403|9766392|FG000|NOT COMPLETED|Overall Study||0
8718987|NCT01001403|9766393|FG001|NOT COMPLETED|Overall Study||0
8718988|NCT01001429|9766401|FG000|STARTED|Overall Study||39
8718989|NCT01001429|9766402|FG001|STARTED|Overall Study||38
8718990|NCT01001429|9766401|FG000|COMPLETED|Overall Study||39
8718991|NCT01001429|9766402|FG001|COMPLETED|Overall Study||37
8718992|NCT01001429|9766401|FG000|NOT COMPLETED|Overall Study||0
8718993|NCT01001429|9766402|FG001|NOT COMPLETED|Overall Study||1
8936974|NCT02339246|9998197|FG001|STARTED|Second Intervention (7 Days)||15
8718994|NCT01001442|9766440|FG000|STARTED|Overall Study||4
8718995|NCT01001442|9766441|FG001|STARTED|Overall Study||3
8936975|NCT02339246|9998198|FG002|STARTED|Second Intervention (7 Days)||0
8718996|NCT01001442|9766442|FG002|STARTED|Overall Study||4
8718997|NCT01001442|9766443|FG003|STARTED|Overall Study||3
8718998|NCT01001442|9766444|FG004|STARTED|Overall Study||4
8718999|NCT01001442|9766445|FG005|STARTED|Overall Study||3
8719000|NCT01001442|9766446|FG006|STARTED|Overall Study||10
8719001|NCT01001442|9766447|FG007|STARTED|Overall Study||4
8719002|NCT01001442|9766440|FG000|COMPLETED|Overall Study||4
8719003|NCT01001442|9766441|FG001|COMPLETED|Overall Study||3
8719004|NCT01001442|9766442|FG002|COMPLETED|Overall Study||4
8719005|NCT01001442|9766443|FG003|COMPLETED|Overall Study||3
8719006|NCT01001442|9766444|FG004|COMPLETED|Overall Study||2
8719007|NCT01001442|9766445|FG005|COMPLETED|Overall Study||3
8719008|NCT01001442|9766446|FG006|COMPLETED|Overall Study||6
8719009|NCT01001442|9766447|FG007|COMPLETED|Overall Study||2
8719010|NCT01001442|9766440|FG000|NOT COMPLETED|Overall Study||0
8719011|NCT01001442|9766441|FG001|NOT COMPLETED|Overall Study||0
8719012|NCT01001442|9766442|FG002|NOT COMPLETED|Overall Study||0
8719013|NCT01001442|9766443|FG003|NOT COMPLETED|Overall Study||0
8719014|NCT01001442|9766444|FG004|NOT COMPLETED|Overall Study||2
8719015|NCT01001442|9766445|FG005|NOT COMPLETED|Overall Study||0
8719016|NCT01001442|9766446|FG006|NOT COMPLETED|Overall Study||4
8719017|NCT01001442|9766447|FG007|NOT COMPLETED|Overall Study||2
8719018|NCT01001494|9766472|FG000|STARTED|Overall Study|280 patients were randomized, but baseline data was missing from 3 patients in one center|277
8719019|NCT01001494|9766473|FG001|STARTED|Overall Study|272 patients were randomized, but baseline data was missing from 3 patients in one center|269
8719020|NCT01001494|9766474|FG002|STARTED|Overall Study|276 patients were randomized, but baseline data was missing from 3 patients in one center|273
8719021|NCT01001494|9766472|FG000|COMPLETED|Overall Study||253
8719022|NCT01001494|9766473|FG001|COMPLETED|Overall Study||252
8719023|NCT01001494|9766474|FG002|COMPLETED|Overall Study||232
8719024|NCT01001494|9766472|FG000|NOT COMPLETED|Overall Study||24
8719025|NCT01001494|9766473|FG001|NOT COMPLETED|Overall Study||17
8719026|NCT01001494|9766474|FG002|NOT COMPLETED|Overall Study||41
8719027|NCT01001520|9766482|FG000|STARTED|Medication Period 1||22
8719028|NCT01001520|9766483|FG001|STARTED|Medication Period 1||24
8719029|NCT01001520|9766482|FG000|COMPLETED|Medication Period 1||18
8719030|NCT01001520|9766483|FG001|COMPLETED|Medication Period 1||17
8719031|NCT01001520|9766482|FG000|NOT COMPLETED|Medication Period 1||4
8719032|NCT01001520|9766483|FG001|NOT COMPLETED|Medication Period 1||7
8719033|NCT01001520|9766482|FG000|STARTED|Washout Period||18
8719034|NCT01001520|9766483|FG001|STARTED|Washout Period||17
8719035|NCT01001520|9766482|FG000|COMPLETED|Washout Period||16
8719036|NCT01001520|9766483|FG001|COMPLETED|Washout Period||16
8719037|NCT01001520|9766482|FG000|NOT COMPLETED|Washout Period||2
8719038|NCT01001520|9766483|FG001|NOT COMPLETED|Washout Period||1
8719039|NCT01001520|9766482|FG000|STARTED|Medication Period 2||16
8719040|NCT01001520|9766483|FG001|STARTED|Medication Period 2||16
8719041|NCT01001520|9766482|FG000|COMPLETED|Medication Period 2||16
8719042|NCT01001520|9766483|FG001|COMPLETED|Medication Period 2||13
8719043|NCT01001520|9766482|FG000|NOT COMPLETED|Medication Period 2||0
8719044|NCT01001520|9766483|FG001|NOT COMPLETED|Medication Period 2||3
8719045|NCT01001546|9766494|FG000|STARTED|Overall Study||206
8719046|NCT01001546|9766495|FG001|STARTED|Overall Study||207
8719047|NCT01001546|9766494|FG000|COMPLETED|Overall Study||206
8719048|NCT01001546|9766495|FG001|COMPLETED|Overall Study||207
8719049|NCT01001546|9766494|FG000|NOT COMPLETED|Overall Study||0
8719050|NCT01001546|9766495|FG001|NOT COMPLETED|Overall Study||0
8719051|NCT01001559|9766503|FG000|STARTED|Overall Study||95
8719052|NCT01001559|9766504|FG001|STARTED|Overall Study||147
8719053|NCT01001559|9766503|FG000|COMPLETED|Overall Study||95
8719054|NCT01001559|9766504|FG001|COMPLETED|Overall Study||147
8719055|NCT01001559|9766503|FG000|NOT COMPLETED|Overall Study||0
8719056|NCT01001559|9766504|FG001|NOT COMPLETED|Overall Study||0
8719057|NCT01001572|9766512|FG000|STARTED|Single-Blind Valsartan 160 mg||932
8719058|NCT01001572|9766513|FG001|STARTED|Single-Blind Valsartan 160 mg|Participants did not enroll into this arm during single blind period.|0
8719059|NCT01001572|9766514|FG002|STARTED|Single-Blind Valsartan 160 mg|Participants did not enroll into this arm during single blind period.|0
8719060|NCT01001572|9766512|FG000|COMPLETED|Single-Blind Valsartan 160 mg||654
8719061|NCT01001572|9766513|FG001|COMPLETED|Single-Blind Valsartan 160 mg||0
8719062|NCT01001572|9766514|FG002|COMPLETED|Single-Blind Valsartan 160 mg||0
8719063|NCT01001572|9766512|FG000|NOT COMPLETED|Single-Blind Valsartan 160 mg||278
8719064|NCT01001572|9766513|FG001|NOT COMPLETED|Single-Blind Valsartan 160 mg||0
8719065|NCT01001572|9766514|FG002|NOT COMPLETED|Single-Blind Valsartan 160 mg||0
8719066|NCT01001572|9766512|FG000|STARTED|Double-Blind Treatment Phase|This arm is only used for single blind period. So, no enrollment during double blind period.|0
8719067|NCT01001572|9766513|FG001|STARTED|Double-Blind Treatment Phase||329
8719068|NCT01001572|9766514|FG002|STARTED|Double-Blind Treatment Phase||325
8719069|NCT01001572|9766512|FG000|Full Analysis Set (FAS)|Double-Blind Treatment Phase||0
8719070|NCT01001572|9766513|FG001|Full Analysis Set (FAS)|Double-Blind Treatment Phase|One patient was excluded from full analysis set for having no post-baseline efficacy assessment.|328
8719071|NCT01001572|9766514|FG002|Full Analysis Set (FAS)|Double-Blind Treatment Phase|Two patients were excluded from full analysis set for having no post-baseline efficacy assessment.|323
8719072|NCT01001572|9766512|FG000|COMPLETED|Double-Blind Treatment Phase||0
8719073|NCT01001572|9766513|FG001|COMPLETED|Double-Blind Treatment Phase||319
8719074|NCT01001572|9766514|FG002|COMPLETED|Double-Blind Treatment Phase||306
8936976|NCT02339246|9998196|FG000|COMPLETED|Second Intervention (7 Days)||16
8719075|NCT01001572|9766512|FG000|NOT COMPLETED|Double-Blind Treatment Phase||0
8719076|NCT01001572|9766513|FG001|NOT COMPLETED|Double-Blind Treatment Phase||10
8719077|NCT01001572|9766514|FG002|NOT COMPLETED|Double-Blind Treatment Phase||19
8719078|NCT01001598|9766520|FG000|STARTED|Overall Study||5
8719079|NCT01001598|9766520|FG000|COMPLETED|Overall Study|3 completed study (2 FA and 1 DC) in 2011|3
8719080|NCT01001598|9766520|FG000|NOT COMPLETED|Overall Study||2
8719081|NCT01001702|9766524|FG000|STARTED|Overall Study||85
8719082|NCT01001702|9766524|FG000|COMPLETED|Overall Study||13
8719083|NCT01001702|9766524|FG000|NOT COMPLETED|Overall Study||72
8719084|NCT01001767|9766530|FG000|STARTED|Overall Study||18
8719085|NCT01001767|9766531|FG001|STARTED|Overall Study||17
8719086|NCT01001767|9766530|FG000|COMPLETED|Overall Study||14
8719087|NCT01001767|9766531|FG001|COMPLETED|Overall Study||17
8719088|NCT01001767|9766530|FG000|NOT COMPLETED|Overall Study||4
8719089|NCT01001767|9766531|FG001|NOT COMPLETED|Overall Study||0
8719090|NCT01001806|9766540|FG000|STARTED|Overall Study||42
8719091|NCT01001806|9766541|FG001|STARTED|Overall Study||42
8719092|NCT01001806|9766542|FG002|STARTED|Overall Study||42
8719093|NCT01001806|9766540|FG000|COMPLETED|Overall Study||42
8719094|NCT01001806|9766541|FG001|COMPLETED|Overall Study||41
8719095|NCT01001806|9766542|FG002|COMPLETED|Overall Study||38
8719096|NCT01001806|9766540|FG000|NOT COMPLETED|Overall Study||0
8719097|NCT01001806|9766541|FG001|NOT COMPLETED|Overall Study||1
8719098|NCT01001806|9766542|FG002|NOT COMPLETED|Overall Study||4
8719099|NCT01001832|9766552|FG000|STARTED|Short-term Period||59
8719100|NCT01001832|9766553|FG001|STARTED|Short-term Period||59
8719101|NCT01001832|9766552|FG000|COMPLETED|Short-term Period||57
8719102|NCT01001832|9766553|FG001|COMPLETED|Short-term Period||56
8719103|NCT01001832|9766552|FG000|NOT COMPLETED|Short-term Period||2
8719104|NCT01001832|9766553|FG001|NOT COMPLETED|Short-term Period||3
8719105|NCT01001832|9766552|FG000|STARTED|Long-term Period|1 participant completed the short term period but discontinued before start of the Long-term Period.|56
8719106|NCT01001832|9766553|FG001|STARTED|Long-term Period||56
8719107|NCT01001832|9766552|FG000|COMPLETED|Long-term Period||52
8719108|NCT01001832|9766553|FG001|COMPLETED|Long-term Period||51
8719109|NCT01001832|9766552|FG000|NOT COMPLETED|Long-term Period||4
8719110|NCT01001832|9766553|FG001|NOT COMPLETED|Long-term Period||5
8719111|NCT01001832|9766552|FG000|STARTED|Follow-up Period||52
8719112|NCT01001832|9766553|FG001|STARTED|Follow-up Period||51
8719113|NCT01001832|9766552|FG000|COMPLETED|Follow-up Period||34
8719114|NCT01001832|9766553|FG001|COMPLETED|Follow-up Period||30
8719115|NCT01001832|9766552|FG000|NOT COMPLETED|Follow-up Period||18
8719116|NCT01001832|9766553|FG001|NOT COMPLETED|Follow-up Period||21
8719117|NCT01001910|9766562|FG000|STARTED|Overall Study|We screened and started 28 patients in the study. However only 22 patients were evaluable for outcome, because 6 patients did not receive adequate number of cycles of treatment for analysis. While we could not evaluate these 6 patients for their outcome, their treatment-cycles were included in the safe analysis.|28
8719118|NCT01001910|9766562|FG000|COMPLETED|Overall Study|6 patients did not receive 3 cycles required for evaluation of response as per protocol s7.1.1|22
8719119|NCT01001910|9766562|FG000|NOT COMPLETED|Overall Study||6
8719120|NCT01001975|9766568|FG000|STARTED|Overall Study||5
8719121|NCT01001975|9766569|FG001|STARTED|Overall Study||5
8719122|NCT01001975|9766568|FG000|COMPLETED|Overall Study||5
8719123|NCT01001975|9766569|FG001|COMPLETED|Overall Study||5
8719124|NCT01001975|9766568|FG000|NOT COMPLETED|Overall Study||0
8719125|NCT01001975|9766569|FG001|NOT COMPLETED|Overall Study||0
8719126|NCT01001988|9766575|FG000|STARTED|Overall Study||596
8719127|NCT01001988|9766575|FG000|COMPLETED|Overall Study||479
8719128|NCT01001988|9766575|FG000|NOT COMPLETED|Overall Study||117
8719129|NCT01002105|9766581|FG000|STARTED|Overall Study||32
8719130|NCT01002105|9766582|FG001|STARTED|Overall Study||32
8719131|NCT01002105|9766581|FG000|COMPLETED|Overall Study||13
8719132|NCT01002105|9766582|FG001|COMPLETED|Overall Study||11
8719133|NCT01002105|9766581|FG000|NOT COMPLETED|Overall Study||19
8719134|NCT01002105|9766582|FG001|NOT COMPLETED|Overall Study||21
8719135|NCT01002118|9766591|FG000|STARTED|Overall Study||1
8719136|NCT01002118|9766591|FG000|Randomized Only Patient|Overall Study||1
8719137|NCT01002118|9766591|FG000|COMPLETED|Overall Study||1
8719138|NCT01002118|9766591|FG000|NOT COMPLETED|Overall Study||0
8719139|NCT01002287|9766597|FG000|STARTED|Overall Study||8
8719140|NCT01002287|9766598|FG001|STARTED|Overall Study||3
8719141|NCT01002287|9766597|FG000|COMPLETED|Overall Study||8
8719142|NCT01002287|9766598|FG001|COMPLETED|Overall Study||3
8719143|NCT01002287|9766597|FG000|NOT COMPLETED|Overall Study||0
8719144|NCT01002287|9766598|FG001|NOT COMPLETED|Overall Study||0
8719145|NCT01002339|9766607|FG000|STARTED|Overall Study||44
8719146|NCT01002339|9766608|FG001|STARTED|Overall Study||43
8719147|NCT01002339|9766609|FG002|STARTED|Overall Study||47
8719148|NCT01002339|9766607|FG000|COMPLETED|Overall Study||44
8719149|NCT01002339|9766608|FG001|COMPLETED|Overall Study||42
8719150|NCT01002339|9766609|FG002|COMPLETED|Overall Study||42
8719151|NCT01002339|9766607|FG000|NOT COMPLETED|Overall Study||0
8719152|NCT01002339|9766608|FG001|NOT COMPLETED|Overall Study||1
8719153|NCT01002339|9766609|FG002|NOT COMPLETED|Overall Study||5
8719154|NCT01002456|9766619|FG000|STARTED|Overall Study||98
8719155|NCT01002456|9766620|FG001|STARTED|Overall Study||122
8719156|NCT01002456|9766619|FG000|COMPLETED|Overall Study||98
8719157|NCT01002456|9766620|FG001|COMPLETED|Overall Study||122
8719158|NCT01002456|9766619|FG000|NOT COMPLETED|Overall Study||0
8719159|NCT01002456|9766620|FG001|NOT COMPLETED|Overall Study||0
8719160|NCT01002482|9766630|FG000|STARTED|Overall Study||1351
8719161|NCT01002482|9766631|FG001|STARTED|Overall Study||1333
8719162|NCT01002482|9766630|FG000|COMPLETED|Overall Study||1336
8719163|NCT01002482|9766631|FG001|COMPLETED|Overall Study||1312
8719164|NCT01002482|9766630|FG000|NOT COMPLETED|Overall Study||15
8719165|NCT01002482|9766631|FG001|NOT COMPLETED|Overall Study||21
8719166|NCT01002547|9766640|FG000|STARTED|Overall Study||32
8719167|NCT01002547|9766641|FG001|STARTED|Overall Study||36
8719168|NCT01002547|9766642|FG002|STARTED|Overall Study||37
8719169|NCT01002547|9766640|FG000|COMPLETED|Overall Study||24
8719170|NCT01002547|9766641|FG001|COMPLETED|Overall Study||33
8719171|NCT01002547|9766642|FG002|COMPLETED|Overall Study||29
8719172|NCT01002547|9766640|FG000|NOT COMPLETED|Overall Study||8
8719173|NCT01002547|9766641|FG001|NOT COMPLETED|Overall Study||3
8719174|NCT01002547|9766642|FG002|NOT COMPLETED|Overall Study||8
8719175|NCT01002573|9766652|FG000|STARTED|Overall Study||58
8719176|NCT01002573|9766653|FG001|STARTED|Overall Study||60
8719177|NCT01002573|9766652|FG000|COMPLETED|Overall Study||47
8719178|NCT01002573|9766653|FG001|COMPLETED|Overall Study||53
8719179|NCT01002573|9766652|FG000|NOT COMPLETED|Overall Study||11
8719180|NCT01002573|9766653|FG001|NOT COMPLETED|Overall Study||7
8719181|NCT01002742|9766661|FG000|STARTED|Overall Study||119
8719182|NCT01002742|9766662|FG001|STARTED|Overall Study||117
8719183|NCT01002742|9766661|FG000|COMPLETED|Overall Study||119
8719184|NCT01002742|9766662|FG001|COMPLETED|Overall Study||116
8719185|NCT01002742|9766661|FG000|NOT COMPLETED|Overall Study||0
8719186|NCT01002742|9766662|FG001|NOT COMPLETED|Overall Study||1
8719187|NCT01002755|9766668|FG000|STARTED|Overall Study||36
8719188|NCT01002755|9766668|FG000|COMPLETED|Overall Study||36
8719189|NCT01002755|9766668|FG000|NOT COMPLETED|Overall Study||0
8719190|NCT01002989|9766672|FG000|STARTED|Overall Study||98
8719191|NCT01002989|9766672|FG000|COMPLETED|Overall Study||93
8719192|NCT01002989|9766672|FG000|NOT COMPLETED|Overall Study||5
8719193|NCT01003067|9766678|FG000|STARTED|Overall Study||136
8719194|NCT01003067|9766679|FG001|STARTED|Overall Study||131
8719195|NCT01003067|9766678|FG000|COMPLETED|Overall Study||103
8719196|NCT01003067|9766679|FG001|COMPLETED|Overall Study||107
8719197|NCT01003067|9766678|FG000|NOT COMPLETED|Overall Study||33
8719198|NCT01003067|9766679|FG001|NOT COMPLETED|Overall Study||24
8719199|NCT01003080|9766687|FG000|STARTED|Overall Study||50
8719200|NCT01003080|9766688|FG001|STARTED|Overall Study||61
8719201|NCT01003080|9766687|FG000|COMPLETED|Overall Study||50
8719202|NCT01003080|9766688|FG001|COMPLETED|Overall Study||61
8719203|NCT01003080|9766687|FG000|NOT COMPLETED|Overall Study||0
8719204|NCT01003080|9766688|FG001|NOT COMPLETED|Overall Study||0
8719205|NCT01003106|9766698|FG000|STARTED|Baseline to Month 6||22
8719206|NCT01003106|9766699|FG001|STARTED|Baseline to Month 6||20
8719207|NCT01003106|9766700|FG002|STARTED|Baseline to Month 6||0
8719208|NCT01003106|9766701|FG003|STARTED|Baseline to Month 6||0
8719209|NCT01003106|9766702|FG004|STARTED|Baseline to Month 6||19
8719210|NCT01003106|9766703|FG005|STARTED|Baseline to Month 6||20
8719211|NCT01003106|9766704|FG006|STARTED|Baseline to Month 6||0
8719212|NCT01003106|9766705|FG007|STARTED|Baseline to Month 6||0
8719213|NCT01003106|9766698|FG000|COMPLETED|Baseline to Month 6||22
8719214|NCT01003106|9766699|FG001|COMPLETED|Baseline to Month 6||20
8719215|NCT01003106|9766700|FG002|COMPLETED|Baseline to Month 6||0
8719216|NCT01003106|9766701|FG003|COMPLETED|Baseline to Month 6||0
8719217|NCT01003106|9766702|FG004|COMPLETED|Baseline to Month 6||19
8719218|NCT01003106|9766703|FG005|COMPLETED|Baseline to Month 6||20
8719219|NCT01003106|9766704|FG006|COMPLETED|Baseline to Month 6||0
8719220|NCT01003106|9766705|FG007|COMPLETED|Baseline to Month 6||0
8719221|NCT01003106|9766698|FG000|NOT COMPLETED|Baseline to Month 6||0
8719222|NCT01003106|9766699|FG001|NOT COMPLETED|Baseline to Month 6||0
8719223|NCT01003106|9766700|FG002|NOT COMPLETED|Baseline to Month 6||0
8719224|NCT01003106|9766701|FG003|NOT COMPLETED|Baseline to Month 6||0
8719225|NCT01003106|9766702|FG004|NOT COMPLETED|Baseline to Month 6||0
8719226|NCT01003106|9766703|FG005|NOT COMPLETED|Baseline to Month 6||0
8719227|NCT01003106|9766704|FG006|NOT COMPLETED|Baseline to Month 6||0
8719228|NCT01003106|9766705|FG007|NOT COMPLETED|Baseline to Month 6||0
8719229|NCT01003106|9766698|FG000|STARTED|Month 6-Month 36||0
8719230|NCT01003106|9766699|FG001|STARTED|Month 6-Month 36||0
8719231|NCT01003106|9766700|FG002|STARTED|Month 6-Month 36||19
8719232|NCT01003106|9766701|FG003|STARTED|Month 6-Month 36||20
8719233|NCT01003106|9766702|FG004|STARTED|Month 6-Month 36||0
8719234|NCT01003106|9766703|FG005|STARTED|Month 6-Month 36||0
8719235|NCT01003106|9766704|FG006|STARTED|Month 6-Month 36||20
8719236|NCT01003106|9766705|FG007|STARTED|Month 6-Month 36||18
8719237|NCT01003106|9766698|FG000|COMPLETED|Month 6-Month 36||0
8719238|NCT01003106|9766699|FG001|COMPLETED|Month 6-Month 36||0
8719239|NCT01003106|9766700|FG002|COMPLETED|Month 6-Month 36||18
8719240|NCT01003106|9766701|FG003|COMPLETED|Month 6-Month 36||20
8719241|NCT01003106|9766702|FG004|COMPLETED|Month 6-Month 36||0
8719242|NCT01003106|9766703|FG005|COMPLETED|Month 6-Month 36||0
8719243|NCT01003106|9766704|FG006|COMPLETED|Month 6-Month 36||19
8719244|NCT01003106|9766705|FG007|COMPLETED|Month 6-Month 36||18
8719245|NCT01003106|9766698|FG000|NOT COMPLETED|Month 6-Month 36||0
8719246|NCT01003106|9766699|FG001|NOT COMPLETED|Month 6-Month 36||0
8719247|NCT01003106|9766700|FG002|NOT COMPLETED|Month 6-Month 36||1
8936977|NCT02339246|9998197|FG001|COMPLETED|Second Intervention (7 Days)||15
8936978|NCT02339246|9998198|FG002|COMPLETED|Second Intervention (7 Days)||0
8936979|NCT02339246|9998196|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
8936980|NCT02339246|9998197|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
8936981|NCT02339246|9998198|FG002|NOT COMPLETED|Second Intervention (7 Days)||0
8936982|NCT02339246|9998196|FG000|STARTED|Third Period (7 Days)||15
8936983|NCT02339246|9998197|FG001|STARTED|Third Period (7 Days)||16
8936984|NCT02339246|9998198|FG002|STARTED|Third Period (7 Days)||0
8936985|NCT02339246|9998196|FG000|COMPLETED|Third Period (7 Days)||15
8936986|NCT02339246|9998197|FG001|COMPLETED|Third Period (7 Days)||16
8936987|NCT02339246|9998198|FG002|COMPLETED|Third Period (7 Days)||0
8936988|NCT02339246|9998196|FG000|NOT COMPLETED|Third Period (7 Days)||0
8936989|NCT02339246|9998197|FG001|NOT COMPLETED|Third Period (7 Days)||0
8936990|NCT02339246|9998198|FG002|NOT COMPLETED|Third Period (7 Days)||0
8936991|NCT02339285|9998209|FG000|STARTED|Overall Study||10
8936992|NCT02339285|9998210|FG001|STARTED|Overall Study||11
8936993|NCT02339285|9998211|FG002|STARTED|Overall Study||11
8936994|NCT02339285|9998209|FG000|Completed Intervention|Overall Study||10
8936995|NCT02339285|9998210|FG001|Completed Intervention|Overall Study||10
8936996|NCT02339285|9998211|FG002|Completed Intervention|Overall Study||10
8936997|NCT02339285|9998209|FG000|2 Week Follow-up|Overall Study||9
8936998|NCT02339285|9998210|FG001|2 Week Follow-up|Overall Study||10
8936999|NCT02339285|9998211|FG002|2 Week Follow-up|Overall Study||10
8937000|NCT02339285|9998209|FG000|4 Week Follow-up Visit|Overall Study||9
8937001|NCT02339285|9998210|FG001|4 Week Follow-up Visit|Overall Study||8
8937002|NCT02339285|9998211|FG002|4 Week Follow-up Visit|Overall Study||9
8937003|NCT02339285|9998209|FG000|COMPLETED|Overall Study||9
8937004|NCT02339285|9998210|FG001|COMPLETED|Overall Study||8
8937005|NCT02339285|9998211|FG002|COMPLETED|Overall Study||9
8937006|NCT02339285|9998209|FG000|NOT COMPLETED|Overall Study||1
9065130|NCT04202497|10125504|FG001|NOT COMPLETED|Treatment Period (Day 1 Through Day 2-3)||0
9065131|NCT04202497|10125505|FG002|NOT COMPLETED|Treatment Period (Day 1 Through Day 2-3)||0
9065132|NCT04202497|10125506|FG003|NOT COMPLETED|Treatment Period (Day 1 Through Day 2-3)||0
9065133|NCT04214080|10125522|FG000|STARTED|Overall Study||20
9065134|NCT04214080|10125523|FG001|STARTED|Overall Study||20
9065135|NCT04214080|10125522|FG000|COMPLETED|Overall Study||20
9065136|NCT04214080|10125523|FG001|COMPLETED|Overall Study||20
9065137|NCT04214080|10125522|FG000|NOT COMPLETED|Overall Study||0
9065138|NCT04214080|10125523|FG001|NOT COMPLETED|Overall Study||0
9065139|NCT04209530|10125533|FG000|STARTED|Overall Study||4
9065140|NCT04209530|10125534|FG001|STARTED|Overall Study||3
9065141|NCT04209530|10125533|FG000|COMPLETED|Overall Study||0
9065142|NCT04209530|10125534|FG001|COMPLETED|Overall Study||0
9065143|NCT04209530|10125533|FG000|NOT COMPLETED|Overall Study||4
9065144|NCT04209530|10125534|FG001|NOT COMPLETED|Overall Study||3
9065145|NCT04209335|10125540|FG000|STARTED|Overall Study||48
9065146|NCT04209335|10125540|FG000|COMPLETED|Overall Study||48
9065147|NCT04209335|10125540|FG000|NOT COMPLETED|Overall Study||0
9065148|NCT04207333|10125547|FG000|STARTED|First Intervention (Single 1-Day Visit)||3
9065149|NCT04207333|10125548|FG001|STARTED|First Intervention (Single 1-Day Visit)||3
9065150|NCT04207333|10125547|FG000|COMPLETED|First Intervention (Single 1-Day Visit)||3
9065151|NCT04207333|10125548|FG001|COMPLETED|First Intervention (Single 1-Day Visit)||3
9065152|NCT04207333|10125547|FG000|NOT COMPLETED|First Intervention (Single 1-Day Visit)||0
9065153|NCT04207333|10125548|FG001|NOT COMPLETED|First Intervention (Single 1-Day Visit)||0
9065154|NCT04207333|10125547|FG000|STARTED|Washout (2-7 Days)||3
9065155|NCT04207333|10125548|FG001|STARTED|Washout (2-7 Days)||3
9065156|NCT04207333|10125547|FG000|COMPLETED|Washout (2-7 Days)||3
9065157|NCT04207333|10125548|FG001|COMPLETED|Washout (2-7 Days)||3
9065158|NCT04207333|10125547|FG000|NOT COMPLETED|Washout (2-7 Days)||0
9065159|NCT04207333|10125548|FG001|NOT COMPLETED|Washout (2-7 Days)||0
8937007|NCT02339285|9998210|FG001|NOT COMPLETED|Overall Study||3
8937008|NCT02339285|9998211|FG002|NOT COMPLETED|Overall Study||2
8937009|NCT02339389|9998219|FG000|STARTED|Overall Study||57
8937010|NCT02339389|9998219|FG000|COMPLETED|Overall Study||41
8937011|NCT02339389|9998219|FG000|NOT COMPLETED|Overall Study||16
8937012|NCT02339415|9998226|FG000|STARTED|First Period||22
8937013|NCT02339415|9998227|FG001|STARTED|First Period||22
8937014|NCT02339415|9998226|FG000|Received at Least One Dose|First Period||21
8937015|NCT02339415|9998227|FG001|Received at Least One Dose|First Period||20
8937016|NCT02339415|9998226|FG000|COMPLETED|First Period||20
8937017|NCT02339415|9998227|FG001|COMPLETED|First Period||20
8937018|NCT02339415|9998226|FG000|NOT COMPLETED|First Period||2
8937019|NCT02339415|9998227|FG001|NOT COMPLETED|First Period||2
8937020|NCT02339415|9998226|FG000|STARTED|Washout||20
8937021|NCT02339415|9998227|FG001|STARTED|Washout||20
8937022|NCT02339415|9998226|FG000|COMPLETED|Washout||20
8937023|NCT02339415|9998227|FG001|COMPLETED|Washout||20
8937024|NCT02339415|9998226|FG000|NOT COMPLETED|Washout||0
8937025|NCT02339415|9998227|FG001|NOT COMPLETED|Washout||0
8937026|NCT02339415|9998226|FG000|STARTED|Second Period||20
8937027|NCT02339415|9998227|FG001|STARTED|Second Period||20
8937028|NCT02339415|9998226|FG000|COMPLETED|Second Period||19
8937029|NCT02339415|9998227|FG001|COMPLETED|Second Period||18
8937030|NCT02339415|9998226|FG000|NOT COMPLETED|Second Period||1
8937031|NCT02339415|9998227|FG001|NOT COMPLETED|Second Period||2
9065160|NCT04207333|10125547|FG000|STARTED|Second Intervention (Single 1-Day Visit)||3
9065161|NCT04207333|10125548|FG001|STARTED|Second Intervention (Single 1-Day Visit)||3
8937032|NCT02339506|9998235|FG000|STARTED|Period 1 (Placebo or Cosyntropin)||12
8937033|NCT02339506|9998236|FG001|STARTED|Period 1 (Placebo or Cosyntropin)||11
8937034|NCT02339506|9998235|FG000|COMPLETED|Period 1 (Placebo or Cosyntropin)||12
8937035|NCT02339506|9998236|FG001|COMPLETED|Period 1 (Placebo or Cosyntropin)||10
8617324|NCT00455689|9655465|FG000|COMPLETED|Overall Study||14
8937036|NCT02339506|9998235|FG000|NOT COMPLETED|Period 1 (Placebo or Cosyntropin)||0
8937037|NCT02339506|9998236|FG001|NOT COMPLETED|Period 1 (Placebo or Cosyntropin)||1
8937038|NCT02339506|9998235|FG000|STARTED|Washout (Period 2)||12
8937039|NCT02339506|9998236|FG001|STARTED|Washout (Period 2)||10
8937040|NCT02339506|9998235|FG000|COMPLETED|Washout (Period 2)||10
8937041|NCT02339506|9998236|FG001|COMPLETED|Washout (Period 2)||10
8937042|NCT02339506|9998235|FG000|NOT COMPLETED|Washout (Period 2)||2
8937043|NCT02339506|9998236|FG001|NOT COMPLETED|Washout (Period 2)||0
8937044|NCT02339506|9998235|FG000|STARTED|Period 3 (Placebo or Cosyntropin)||10
8937045|NCT02339506|9998236|FG001|STARTED|Period 3 (Placebo or Cosyntropin)||10
8937046|NCT02339506|9998235|FG000|COMPLETED|Period 3 (Placebo or Cosyntropin)||10
8937047|NCT02339506|9998236|FG001|COMPLETED|Period 3 (Placebo or Cosyntropin)||10
8937048|NCT02339506|9998235|FG000|NOT COMPLETED|Period 3 (Placebo or Cosyntropin)||0
8937049|NCT02339506|9998236|FG001|NOT COMPLETED|Period 3 (Placebo or Cosyntropin)||0
8937050|NCT02339545|9998242|FG000|STARTED|Overall Study||15
8937051|NCT02339545|9998242|FG000|COMPLETED|Overall Study||15
8937052|NCT02339545|9998242|FG000|NOT COMPLETED|Overall Study||0
8937053|NCT02339558|9998247|FG000|STARTED|Overall Study||45
8937054|NCT02339558|9998247|FG000|COMPLETED|Overall Study||45
8937055|NCT02339558|9998247|FG000|NOT COMPLETED|Overall Study||0
8937056|NCT02339584|9998253|FG000|STARTED|Overall Study||188
8937057|NCT02339584|9998254|FG001|STARTED|Overall Study||191
8937058|NCT02339584|9998253|FG000|COMPLETED|Overall Study||173
8937059|NCT02339584|9998254|FG001|COMPLETED|Overall Study||176
8937060|NCT02339584|9998253|FG000|NOT COMPLETED|Overall Study||15
8937061|NCT02339584|9998254|FG001|NOT COMPLETED|Overall Study||15
8937062|NCT02339831|9998262|FG000|STARTED|Overall Study||58
8937063|NCT02339831|9998263|FG001|STARTED|Overall Study||52
8937064|NCT02339831|9998262|FG000|Lost to Follow Up|Overall Study||20
8937065|NCT02339831|9998263|FG001|Lost to Follow Up|Overall Study||7
8937066|NCT02339831|9998262|FG000|COMPLETED|Overall Study||38
8937067|NCT02339831|9998263|FG001|COMPLETED|Overall Study||45
8937068|NCT02339831|9998262|FG000|NOT COMPLETED|Overall Study||20
8937069|NCT02339831|9998263|FG001|NOT COMPLETED|Overall Study||7
8937070|NCT02339909|9998272|FG000|STARTED|Overall Study||524
8937071|NCT02339909|9998273|FG001|STARTED|Overall Study||375
8937072|NCT02339909|9998274|FG002|STARTED|Overall Study||375
8937073|NCT02339909|9998272|FG000|COMPLETED|Overall Study||435
8937074|NCT02339909|9998273|FG001|COMPLETED|Overall Study||312
8937075|NCT02339909|9998274|FG002|COMPLETED|Overall Study||304
8937076|NCT02339909|9998272|FG000|NOT COMPLETED|Overall Study||89
8937077|NCT02339909|9998273|FG001|NOT COMPLETED|Overall Study||63
8937078|NCT02339909|9998274|FG002|NOT COMPLETED|Overall Study||71
8937079|NCT02340000|9998284|FG000|STARTED|Time Period 1||90
8937080|NCT02340000|9998285|FG001|STARTED|Time Period 1||89
8937081|NCT02340000|9998284|FG000|COMPLETED|Time Period 1||78
8937082|NCT02340000|9998285|FG001|COMPLETED|Time Period 1||74
8937083|NCT02340000|9998284|FG000|NOT COMPLETED|Time Period 1||12
8937084|NCT02340000|9998285|FG001|NOT COMPLETED|Time Period 1||15
8937085|NCT02340000|9998284|FG000|STARTED|Time Period 2||69
8937086|NCT02340000|9998285|FG001|STARTED|Time Period 2||67
8937087|NCT02340000|9998284|FG000|COMPLETED|Time Period 2||50
8937088|NCT02340000|9998285|FG001|COMPLETED|Time Period 2||52
8937089|NCT02340000|9998284|FG000|NOT COMPLETED|Time Period 2||19
8937090|NCT02340000|9998285|FG001|NOT COMPLETED|Time Period 2||15
8937091|NCT02340078|9998298|FG000|STARTED|Overall Study||62
8937092|NCT02340078|9998298|FG000|COMPLETED|Overall Study||61
8937093|NCT02340078|9998298|FG000|NOT COMPLETED|Overall Study||1
8937094|NCT02340091|9998303|FG000|STARTED|Overall Study|All Study Participants|62
8937095|NCT02340091|9998303|FG000|COMPLETED|Overall Study||60
8937096|NCT02340091|9998303|FG000|NOT COMPLETED|Overall Study||2
8937097|NCT02340104|9998308|FG000|STARTED|Overall Study||8
8937098|NCT02340104|9998308|FG000|COMPLETED|Overall Study||8
8937099|NCT02340104|9998308|FG000|NOT COMPLETED|Overall Study||0
8937100|NCT02340156|9998313|FG000|STARTED|Overall Study||1
8937101|NCT02340156|9998313|FG000|COMPLETED|Overall Study||1
8937102|NCT02340156|9998313|FG000|NOT COMPLETED|Overall Study||0
8937103|NCT02340299|9998319|FG000|STARTED|Overall Study||4
8937104|NCT02340299|9998320|FG001|STARTED|Overall Study||2
8937105|NCT02340299|9998319|FG000|COMPLETED|Overall Study||4
8937106|NCT02340299|9998320|FG001|COMPLETED|Overall Study||2
8937107|NCT02340299|9998319|FG000|NOT COMPLETED|Overall Study||0
8937108|NCT02340299|9998320|FG001|NOT COMPLETED|Overall Study||0
8937109|NCT02340338|9998333|FG000|STARTED|Overall Study|2 vaccine + 1 placebo|2
8937110|NCT02340338|9998334|FG001|STARTED|Overall Study|2 vaccine + 1 placebo|2
8937111|NCT02340338|9998335|FG002|STARTED|Overall Study|3 vaccine + 1 placebo|3
8937112|NCT02340338|9998336|FG003|STARTED|Overall Study|9 vaccine + 3 placebo|9
8937113|NCT02340338|9998337|FG004|STARTED|Overall Study|9 vaccine + 3 placebo|9
8937114|NCT02340338|9998338|FG005|STARTED|Overall Study|9 vaccine + 3 placebo|9
8937115|NCT02340338|9998339|FG006|STARTED|Overall Study|Placebos were randomly assigned to dose groups 1-6, included in the 46 participants.|12
8937116|NCT02340338|9998333|FG000|COMPLETED|Overall Study||2
8937117|NCT02340338|9998334|FG001|COMPLETED|Overall Study||2
8617325|NCT00455689|9655466|FG001|COMPLETED|Overall Study||6
8937118|NCT02340338|9998335|FG002|COMPLETED|Overall Study||3
8937119|NCT02340338|9998336|FG003|COMPLETED|Overall Study||9
8937120|NCT02340338|9998337|FG004|COMPLETED|Overall Study||9
8937121|NCT02340338|9998338|FG005|COMPLETED|Overall Study|1 withdrew voluntarily after the first immunization; safety and serum assessment completed.|9
8937122|NCT02340338|9998339|FG006|COMPLETED|Overall Study||12
8937123|NCT02340338|9998333|FG000|NOT COMPLETED|Overall Study||0
8937124|NCT02340338|9998334|FG001|NOT COMPLETED|Overall Study||0
8937125|NCT02340338|9998335|FG002|NOT COMPLETED|Overall Study||0
8937126|NCT02340338|9998336|FG003|NOT COMPLETED|Overall Study||0
8937127|NCT02340338|9998337|FG004|NOT COMPLETED|Overall Study||0
8937128|NCT02340338|9998338|FG005|NOT COMPLETED|Overall Study||0
8937129|NCT02340338|9998339|FG006|NOT COMPLETED|Overall Study||0
8937130|NCT02340520|9998355|FG000|STARTED|Overall Study||11
8937131|NCT02340520|9998355|FG000|COMPLETED|Overall Study||8
8937132|NCT02340520|9998355|FG000|NOT COMPLETED|Overall Study||3
8937133|NCT02340663|9998361|FG000|STARTED|Overall Study||35
8937134|NCT02340663|9998362|FG001|STARTED|Overall Study||32
8937135|NCT02340663|9998361|FG000|Clinical Exam, Impressions|Overall Study||35
8937136|NCT02340663|9998362|FG001|Clinical Exam, Impressions|Overall Study||32
8937137|NCT02340663|9998361|FG000|Splint Delivery, Assessments|Overall Study||33
8937138|NCT02340663|9998362|FG001|Splint Delivery, Assessments|Overall Study||31
8937139|NCT02340663|9998361|FG000|1 Week Follow-up, Assessments|Overall Study||33
8937140|NCT02340663|9998362|FG001|1 Week Follow-up, Assessments|Overall Study||31
8937141|NCT02340663|9998361|FG000|4 Month Follow-up, Assessments|Overall Study||30
8937142|NCT02340663|9998362|FG001|4 Month Follow-up, Assessments|Overall Study||31
8937143|NCT02340663|9998361|FG000|COMPLETED|Overall Study||30
8937144|NCT02340663|9998362|FG001|COMPLETED|Overall Study||31
8937145|NCT02340663|9998361|FG000|NOT COMPLETED|Overall Study||5
8937146|NCT02340663|9998362|FG001|NOT COMPLETED|Overall Study||1
8617326|NCT00455689|9655465|FG000|NOT COMPLETED|Overall Study||0
8617327|NCT00455689|9655466|FG001|NOT COMPLETED|Overall Study||0
8617328|NCT00455702|9655473|FG000|STARTED|Overall Study||19
8617329|NCT00455702|9655474|FG001|STARTED|Overall Study||19
8617330|NCT00455702|9655473|FG000|COMPLETED|Overall Study||16
8617331|NCT00455702|9655474|FG001|COMPLETED|Overall Study||16
8617332|NCT00455702|9655473|FG000|NOT COMPLETED|Overall Study||3
8937147|NCT02340715|9998368|FG000|STARTED|Overall Study|158|158
8937148|NCT02340715|9998368|FG000|COMPLETED|Overall Study|158|158
8937149|NCT02340715|9998368|FG000|NOT COMPLETED|Overall Study||0
8937150|NCT02340767|9998381|FG000|STARTED|Overall Study||28
8937151|NCT02340767|9998382|FG001|STARTED|Overall Study||28
8937152|NCT02340767|9998383|FG002|STARTED|Overall Study||29
8937153|NCT02340767|9998384|FG003|STARTED|Overall Study||500
8937154|NCT02340767|9998385|FG004|STARTED|Overall Study||474
8937155|NCT02340767|9998386|FG005|STARTED|Overall Study||526
8937156|NCT02340767|9998387|FG006|STARTED|Overall Study||525
8937157|NCT02340767|9998388|FG007|STARTED|Overall Study||444
8937158|NCT02340767|9998389|FG008|STARTED|Overall Study||531
8937159|NCT02340767|9998381|FG000|COMPLETED|Overall Study||28
8937160|NCT02340767|9998382|FG001|COMPLETED|Overall Study||28
8937161|NCT02340767|9998383|FG002|COMPLETED|Overall Study||29
8937162|NCT02340767|9998384|FG003|COMPLETED|Overall Study||500
8937163|NCT02340767|9998385|FG004|COMPLETED|Overall Study||474
8937164|NCT02340767|9998386|FG005|COMPLETED|Overall Study||526
8937165|NCT02340767|9998387|FG006|COMPLETED|Overall Study||525
8937166|NCT02340767|9998388|FG007|COMPLETED|Overall Study||444
8937167|NCT02340767|9998389|FG008|COMPLETED|Overall Study||531
8937168|NCT02340767|9998381|FG000|NOT COMPLETED|Overall Study||0
8937169|NCT02340767|9998382|FG001|NOT COMPLETED|Overall Study||0
8937170|NCT02340767|9998383|FG002|NOT COMPLETED|Overall Study||0
8937171|NCT02340767|9998384|FG003|NOT COMPLETED|Overall Study||0
8937172|NCT02340767|9998385|FG004|NOT COMPLETED|Overall Study||0
8937173|NCT02340767|9998386|FG005|NOT COMPLETED|Overall Study||0
8937174|NCT02340767|9998387|FG006|NOT COMPLETED|Overall Study||0
8937175|NCT02340767|9998388|FG007|NOT COMPLETED|Overall Study||0
8937176|NCT02340767|9998389|FG008|NOT COMPLETED|Overall Study||0
8937177|NCT02340780|9998404|FG000|STARTED|Overall Study|A total of 14 patients enrolled, one patient was found ineligible after the enrollment.|14
8937178|NCT02340780|9998404|FG000|COMPLETED|Overall Study||13
8937179|NCT02340780|9998404|FG000|NOT COMPLETED|Overall Study||1
8937180|NCT02340806|9998410|FG000|STARTED|Overall Study||108
8937181|NCT02340806|9998411|FG001|STARTED|Overall Study||112
8937182|NCT02340806|9998410|FG000|COMPLETED|Overall Study||102
8937183|NCT02340806|9998411|FG001|COMPLETED|Overall Study||108
8937184|NCT02340806|9998410|FG000|NOT COMPLETED|Overall Study||6
8617333|NCT00455702|9655474|FG001|NOT COMPLETED|Overall Study||3
8937185|NCT02340806|9998411|FG001|NOT COMPLETED|Overall Study||4
8937186|NCT02340819|9998417|FG000|STARTED|Overall Study||11
8937187|NCT02340819|9998417|FG000|Started Stage 2|Overall Study||11
8937188|NCT02340819|9998417|FG000|Completed Stage 2|Overall Study||9
8937189|NCT02340819|9998417|FG000|Started Stage 3|Overall Study||8
8937190|NCT02340819|9998417|FG000|Completed Stage 3|Overall Study||7
8937191|NCT02340819|9998417|FG000|Started Stage 4|Overall Study||7
8937192|NCT02340819|9998417|FG000|Completed Stage 4|Overall Study||7
8937193|NCT02340819|9998417|FG000|COMPLETED|Overall Study||7
8937194|NCT02340819|9998417|FG000|NOT COMPLETED|Overall Study||4
8937195|NCT02340949|9998423|FG000|STARTED|Overall Study||115
8617334|NCT00455741|9655484|FG000|STARTED|Overall Study||13
8617335|NCT00455741|9655485|FG001|STARTED|Overall Study||12
8937196|NCT02340949|9998424|FG001|STARTED|Overall Study||65
8937197|NCT02340949|9998423|FG000|COMPLETED|Overall Study||99
8937198|NCT02340949|9998424|FG001|COMPLETED|Overall Study||61
8937199|NCT02340949|9998423|FG000|NOT COMPLETED|Overall Study||16
8937200|NCT02340949|9998424|FG001|NOT COMPLETED|Overall Study||4
8937201|NCT02340962|9998432|FG000|STARTED|Overall Study||13
8937202|NCT02340962|9998433|FG001|STARTED|Overall Study||12
8937203|NCT02340962|9998432|FG000|COMPLETED|Overall Study||12
8937204|NCT02340962|9998433|FG001|COMPLETED|Overall Study||12
8937205|NCT02340962|9998432|FG000|NOT COMPLETED|Overall Study||1
8937206|NCT02340962|9998433|FG001|NOT COMPLETED|Overall Study||0
8937207|NCT02340975|9998445|FG000|STARTED|Overall Study||6
8937208|NCT02340975|9998446|FG001|STARTED|Overall Study||27
8937209|NCT02340975|9998447|FG002|STARTED|Overall Study||24
8937210|NCT02340975|9998448|FG003|STARTED|Overall Study||12
8937211|NCT02340975|9998449|FG004|STARTED|Overall Study||25
8937212|NCT02340975|9998450|FG005|STARTED|Overall Study||19
8937213|NCT02340975|9998445|FG000|COMPLETED|Overall Study||0
8937214|NCT02340975|9998446|FG001|COMPLETED|Overall Study||0
8937215|NCT02340975|9998447|FG002|COMPLETED|Overall Study||0
8937216|NCT02340975|9998448|FG003|COMPLETED|Overall Study||0
8937217|NCT02340975|9998449|FG004|COMPLETED|Overall Study||0
8937218|NCT02340975|9998450|FG005|COMPLETED|Overall Study||0
8937219|NCT02340975|9998445|FG000|NOT COMPLETED|Overall Study||6
8937220|NCT02340975|9998446|FG001|NOT COMPLETED|Overall Study||27
8937221|NCT02340975|9998447|FG002|NOT COMPLETED|Overall Study||24
8937222|NCT02340975|9998448|FG003|NOT COMPLETED|Overall Study||12
8937223|NCT02340975|9998449|FG004|NOT COMPLETED|Overall Study||25
8937224|NCT02340975|9998450|FG005|NOT COMPLETED|Overall Study||19
8937225|NCT02341144|9998467|FG000|STARTED|Overall Study||30
8937226|NCT02341144|9998468|FG001|STARTED|Overall Study||31
8937227|NCT02341144|9998467|FG000|COMPLETED|Overall Study||28
8937228|NCT02341144|9998468|FG001|COMPLETED|Overall Study||30
8937229|NCT02341144|9998467|FG000|NOT COMPLETED|Overall Study||2
8937230|NCT02341144|9998468|FG001|NOT COMPLETED|Overall Study||1
8937231|NCT02341417|9998477|FG000|STARTED|Overall Study||13
8937232|NCT02341417|9998478|FG001|STARTED|Overall Study||14
8937233|NCT02341417|9998479|FG002|STARTED|Overall Study||1
8937234|NCT02341417|9998477|FG000|COMPLETED|Overall Study||11
8937235|NCT02341417|9998478|FG001|COMPLETED|Overall Study||12
8937236|NCT02341417|9998479|FG002|COMPLETED|Overall Study||0
8937237|NCT02341417|9998477|FG000|NOT COMPLETED|Overall Study||2
8937238|NCT02341417|9998478|FG001|NOT COMPLETED|Overall Study||2
8937239|NCT02341417|9998479|FG002|NOT COMPLETED|Overall Study||1
8937240|NCT02341456|9998491|FG000|STARTED|Overall Study||7
8937241|NCT02341456|9998492|FG001|STARTED|Overall Study||6
8937242|NCT02341456|9998493|FG002|STARTED|Overall Study||6
8937243|NCT02341456|9998491|FG000|COMPLETED|Overall Study||3
8937244|NCT02341456|9998492|FG001|COMPLETED|Overall Study||0
8937245|NCT02341456|9998493|FG002|COMPLETED|Overall Study||2
8937246|NCT02341456|9998491|FG000|NOT COMPLETED|Overall Study||4
8937247|NCT02341456|9998492|FG001|NOT COMPLETED|Overall Study||6
8937248|NCT02341456|9998493|FG002|NOT COMPLETED|Overall Study||4
9065162|NCT04207333|10125547|FG000|COMPLETED|Second Intervention (Single 1-Day Visit)||3
9065163|NCT04207333|10125548|FG001|COMPLETED|Second Intervention (Single 1-Day Visit)||3
9065164|NCT04207333|10125547|FG000|NOT COMPLETED|Second Intervention (Single 1-Day Visit)||0
9065165|NCT04207333|10125548|FG001|NOT COMPLETED|Second Intervention (Single 1-Day Visit)||0
9065166|NCT04207840|10125554|FG000|STARTED|Treatment Period 1||9
9065167|NCT04207840|10125555|FG001|STARTED|Treatment Period 1||10
9065168|NCT04207840|10125556|FG002|STARTED|Treatment Period 1||9
9065169|NCT04207840|10125554|FG000|COMPLETED|Treatment Period 1||9
9065170|NCT04207840|10125555|FG001|COMPLETED|Treatment Period 1||10
9065171|NCT04207840|10125556|FG002|COMPLETED|Treatment Period 1||9
9065172|NCT04207840|10125554|FG000|NOT COMPLETED|Treatment Period 1||0
9065173|NCT04207840|10125555|FG001|NOT COMPLETED|Treatment Period 1||0
8719248|NCT01003106|9766701|FG003|NOT COMPLETED|Month 6-Month 36||0
8719249|NCT01003106|9766702|FG004|NOT COMPLETED|Month 6-Month 36||0
8719250|NCT01003106|9766703|FG005|NOT COMPLETED|Month 6-Month 36||0
9065174|NCT04207840|10125556|FG002|NOT COMPLETED|Treatment Period 1||0
9065175|NCT04207840|10125554|FG000|STARTED|Washout Period 1 (2-7 Days)||9
9065176|NCT04207840|10125555|FG001|STARTED|Washout Period 1 (2-7 Days)||10
9065177|NCT04207840|10125556|FG002|STARTED|Washout Period 1 (2-7 Days)||9
9065178|NCT04207840|10125554|FG000|COMPLETED|Washout Period 1 (2-7 Days)||9
9065179|NCT04207840|10125555|FG001|COMPLETED|Washout Period 1 (2-7 Days)||10
9065180|NCT04207840|10125556|FG002|COMPLETED|Washout Period 1 (2-7 Days)||8
9065181|NCT04207840|10125554|FG000|NOT COMPLETED|Washout Period 1 (2-7 Days)||0
9065182|NCT04207840|10125555|FG001|NOT COMPLETED|Washout Period 1 (2-7 Days)||0
9065183|NCT04207840|10125556|FG002|NOT COMPLETED|Washout Period 1 (2-7 Days)||1
9065184|NCT04207840|10125554|FG000|STARTED|Treatment Period 2||9
9065185|NCT04207840|10125555|FG001|STARTED|Treatment Period 2||10
9065186|NCT04207840|10125556|FG002|STARTED|Treatment Period 2||8
9065187|NCT04207840|10125554|FG000|COMPLETED|Treatment Period 2||9
9065188|NCT04207840|10125555|FG001|COMPLETED|Treatment Period 2||10
8719251|NCT01003106|9766704|FG006|NOT COMPLETED|Month 6-Month 36||1
8937249|NCT02341482|9998501|FG000|STARTED|Overall Study||13
8937250|NCT02341482|9998501|FG000|COMPLETED|Overall Study||12
8937251|NCT02341482|9998501|FG000|NOT COMPLETED|Overall Study||1
8937252|NCT02341599|9998515|FG000|STARTED|Overall Study||8
8937253|NCT02341599|9998516|FG001|STARTED|Overall Study||8
8937254|NCT02341599|9998517|FG002|STARTED|Overall Study||8
8937255|NCT02341599|9998518|FG003|STARTED|Overall Study||8
8937256|NCT02341599|9998519|FG004|STARTED|Overall Study||8
8937257|NCT02341599|9998515|FG000|COMPLETED|Overall Study||8
8937258|NCT02341599|9998516|FG001|COMPLETED|Overall Study||8
8937259|NCT02341599|9998517|FG002|COMPLETED|Overall Study||8
8937260|NCT02341599|9998518|FG003|COMPLETED|Overall Study||8
8937261|NCT02341599|9998519|FG004|COMPLETED|Overall Study||8
8937262|NCT02341599|9998515|FG000|NOT COMPLETED|Overall Study||0
8937263|NCT02341599|9998516|FG001|NOT COMPLETED|Overall Study||0
8937264|NCT02341599|9998517|FG002|NOT COMPLETED|Overall Study||0
8937265|NCT02341599|9998518|FG003|NOT COMPLETED|Overall Study||0
8937266|NCT02341599|9998519|FG004|NOT COMPLETED|Overall Study||0
8948551|NCT02431559|10010996|FG001|NOT COMPLETED|Overall Study||3
8948552|NCT02431559|10010997|FG002|NOT COMPLETED|Overall Study||4
8948553|NCT02431559|10010998|FG003|NOT COMPLETED|Overall Study||31
8948554|NCT02431572|10011011|FG000|STARTED|Overall Study||1
8948555|NCT02431572|10011012|FG001|STARTED|Overall Study||1
8948556|NCT02431572|10011013|FG002|STARTED|Overall Study||9
8948557|NCT02431572|10011011|FG000|COMPLETED|Overall Study||0
8948558|NCT02431572|10011012|FG001|COMPLETED|Overall Study||1
8948559|NCT02431572|10011013|FG002|COMPLETED|Overall Study||9
8948560|NCT02431572|10011011|FG000|NOT COMPLETED|Overall Study||1
8948561|NCT02431572|10011012|FG001|NOT COMPLETED|Overall Study||0
8948562|NCT02431572|10011013|FG002|NOT COMPLETED|Overall Study||0
8948563|NCT02431598|10011021|FG000|STARTED|Overall Study||6
8948564|NCT02431598|10011022|FG001|STARTED|Overall Study||9
8948565|NCT02431598|10011023|FG002|STARTED|Overall Study||9
8948566|NCT02431598|10011024|FG003|STARTED|Overall Study||7
8948567|NCT02431598|10011025|FG004|STARTED|Overall Study||7
8948568|NCT02431598|10011026|FG005|STARTED|Overall Study||6
8948569|NCT02431598|10011021|FG000|COMPLETED|Overall Study||6
8948570|NCT02431598|10011022|FG001|COMPLETED|Overall Study||9
8948571|NCT02431598|10011023|FG002|COMPLETED|Overall Study||9
8948572|NCT02431598|10011024|FG003|COMPLETED|Overall Study||7
8948573|NCT02431598|10011025|FG004|COMPLETED|Overall Study||7
8948574|NCT02431598|10011026|FG005|COMPLETED|Overall Study||6
8948575|NCT02431598|10011021|FG000|NOT COMPLETED|Overall Study||0
8948576|NCT02431598|10011022|FG001|NOT COMPLETED|Overall Study||0
8948577|NCT02431598|10011023|FG002|NOT COMPLETED|Overall Study||0
8948578|NCT02431598|10011024|FG003|NOT COMPLETED|Overall Study||0
8948579|NCT02431598|10011025|FG004|NOT COMPLETED|Overall Study||0
8948580|NCT02431598|10011026|FG005|NOT COMPLETED|Overall Study||0
8948581|NCT02431637|10011043|FG000|STARTED|Overall Study||6
8948582|NCT02431637|10011043|FG000|COMPLETED|Overall Study||6
8948583|NCT02431637|10011043|FG000|NOT COMPLETED|Overall Study||0
8948584|NCT02431650|10011049|FG000|STARTED|Overall Study||5
8948585|NCT02431650|10011050|FG001|STARTED|Overall Study||6
8948586|NCT02431650|10011049|FG000|COMPLETED|Overall Study||5
8948587|NCT02431650|10011050|FG001|COMPLETED|Overall Study||6
8948588|NCT02431650|10011049|FG000|NOT COMPLETED|Overall Study||0
8948589|NCT02431650|10011050|FG001|NOT COMPLETED|Overall Study||0
8948590|NCT02431676|10011059|FG000|STARTED|Overall Study||40
8948591|NCT02431676|10011060|FG001|STARTED|Overall Study||39
8948592|NCT02431676|10011061|FG002|STARTED|Overall Study||42
8948593|NCT02431676|10011059|FG000|COMPLETED|Overall Study||40
8948594|NCT02431676|10011060|FG001|COMPLETED|Overall Study||38
8948595|NCT02431676|10011061|FG002|COMPLETED|Overall Study||40
8948596|NCT02431676|10011059|FG000|NOT COMPLETED|Overall Study||0
8948597|NCT02431676|10011060|FG001|NOT COMPLETED|Overall Study||1
8948598|NCT02431676|10011061|FG002|NOT COMPLETED|Overall Study||2
8948599|NCT02431741|10011069|FG000|STARTED|Overall Study||14
8948600|NCT02431741|10011069|FG000|COMPLETED|Overall Study||14
8948601|NCT02431741|10011069|FG000|NOT COMPLETED|Overall Study||0
8948602|NCT02431754|10011075|FG000|STARTED|Period 1 (8 Weeks)||85
8948603|NCT02431754|10011076|FG001|STARTED|Period 1 (8 Weeks)||86
8948604|NCT02431754|10011075|FG000|Received at Least One Dose of Study Drug|Period 1 (8 Weeks)||85
8948605|NCT02431754|10011076|FG001|Received at Least One Dose of Study Drug|Period 1 (8 Weeks)||86
8948606|NCT02431754|10011075|FG000|COMPLETED|Period 1 (8 Weeks)||79
8948607|NCT02431754|10011076|FG001|COMPLETED|Period 1 (8 Weeks)||82
8948608|NCT02431754|10011075|FG000|NOT COMPLETED|Period 1 (8 Weeks)||6
8948609|NCT02431754|10011076|FG001|NOT COMPLETED|Period 1 (8 Weeks)||4
8948610|NCT02431754|10011075|FG000|STARTED|Wash-out Period (4 Weeks)||79
8948611|NCT02431754|10011076|FG001|STARTED|Wash-out Period (4 Weeks)||82
8948612|NCT02431754|10011075|FG000|COMPLETED|Wash-out Period (4 Weeks)||75
8948613|NCT02431754|10011076|FG001|COMPLETED|Wash-out Period (4 Weeks)||82
8948614|NCT02431754|10011075|FG000|NOT COMPLETED|Wash-out Period (4 Weeks)||4
8948615|NCT02431754|10011076|FG001|NOT COMPLETED|Wash-out Period (4 Weeks)||0
8948616|NCT02431754|10011075|FG000|STARTED|Period 2 (8 Weeks)||75
8948617|NCT02431754|10011076|FG001|STARTED|Period 2 (8 Weeks)||82
8948618|NCT02431754|10011075|FG000|COMPLETED|Period 2 (8 Weeks)||74
8948619|NCT02431754|10011076|FG001|COMPLETED|Period 2 (8 Weeks)||78
8948620|NCT02431754|10011075|FG000|NOT COMPLETED|Period 2 (8 Weeks)||1
8948621|NCT02431754|10011076|FG001|NOT COMPLETED|Period 2 (8 Weeks)||4
8948622|NCT02431793|10011087|FG000|STARTED|Overall Study||202
8948623|NCT02431793|10011088|FG001|STARTED|Overall Study||243
8948624|NCT02431793|10011089|FG002|STARTED|Overall Study||207
8948625|NCT02431793|10011087|FG000|Completed T1 (3-5 Days Post Enrollment)|Overall Study||136
8948626|NCT02431793|10011088|FG001|Completed T1 (3-5 Days Post Enrollment)|Overall Study||180
8948627|NCT02431793|10011089|FG002|Completed T1 (3-5 Days Post Enrollment)|Overall Study||143
8948628|NCT02431793|10011087|FG000|Completed T2 (7-14 Days Post Enrollment)|Overall Study||95
8948825|NCT02433080|10011308|FG000|STARTED|Overall Study||26
8937267|NCT02341859|9998534|FG000|STARTED|First Intervention (1 Day)||10
8937268|NCT02341859|9998535|FG001|STARTED|First Intervention (1 Day)||9
8937269|NCT02341859|9998534|FG000|COMPLETED|First Intervention (1 Day)||10
8937270|NCT02341859|9998535|FG001|COMPLETED|First Intervention (1 Day)||9
8937271|NCT02341859|9998534|FG000|NOT COMPLETED|First Intervention (1 Day)||0
8937272|NCT02341859|9998535|FG001|NOT COMPLETED|First Intervention (1 Day)||0
8937273|NCT02341859|9998534|FG000|STARTED|Second Intervention (1 Day)||10
8937274|NCT02341859|9998535|FG001|STARTED|Second Intervention (1 Day)||9
8937275|NCT02341859|9998534|FG000|COMPLETED|Second Intervention (1 Day)||10
8937276|NCT02341859|9998535|FG001|COMPLETED|Second Intervention (1 Day)||9
8937277|NCT02341859|9998534|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
8937278|NCT02341859|9998535|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
8937279|NCT02342015|9998548|FG000|STARTED|Overall Study||20
8937280|NCT02342015|9998548|FG000|COMPLETED|Overall Study||20
8937281|NCT02342015|9998548|FG000|NOT COMPLETED|Overall Study||0
8937282|NCT02342171|9998554|FG000|STARTED|Overall Study||99
8937283|NCT02342171|9998555|FG001|STARTED|Overall Study||507
8937284|NCT02342171|9998554|FG000|COMPLETED|Overall Study||84
8937285|NCT02342171|9998555|FG001|COMPLETED|Overall Study||418
8937286|NCT02342171|9998554|FG000|NOT COMPLETED|Overall Study||15
8937287|NCT02342171|9998555|FG001|NOT COMPLETED|Overall Study||89
8937288|NCT02342197|9998562|FG000|STARTED|Overall Study||30
8937289|NCT02342197|9998563|FG001|STARTED|Overall Study||30
8937290|NCT02342197|9998562|FG000|COMPLETED|Overall Study||27
8937291|NCT02342197|9998563|FG001|COMPLETED|Overall Study||28
8937292|NCT02342197|9998562|FG000|NOT COMPLETED|Overall Study||3
8937293|NCT02342197|9998563|FG001|NOT COMPLETED|Overall Study||2
8937294|NCT02342223|9998569|FG000|STARTED|Overall Study||20
8937295|NCT02342223|9998569|FG000|COMPLETED|Overall Study||19
8937296|NCT02342223|9998569|FG000|NOT COMPLETED|Overall Study||1
8937297|NCT02342288|9998575|FG000|STARTED|Overall Study|16 patients were not randomized to either arm.|30
8937298|NCT02342288|9998576|FG001|STARTED|Overall Study|various issues listed below caused removal of subjects|33
8937299|NCT02342288|9998575|FG000|COMPLETED|Overall Study||25
8937300|NCT02342288|9998576|FG001|COMPLETED|Overall Study||27
8937301|NCT02342288|9998575|FG000|NOT COMPLETED|Overall Study||5
8937302|NCT02342288|9998576|FG001|NOT COMPLETED|Overall Study||6
8937303|NCT02342314|9998584|FG000|STARTED|Part A||6
8937304|NCT02342314|9998585|FG001|STARTED|Part A||3
8937305|NCT02342314|9998586|FG002|STARTED|Part A||3
8937306|NCT02342314|9998587|FG003|STARTED|Part A||3
8937307|NCT02342314|9998588|FG004|STARTED|Part A||6
8937308|NCT02342314|9998589|FG005|STARTED|Part A||3
8937309|NCT02342314|9998590|FG006|STARTED|Part A||0
8937310|NCT02342314|9998591|FG007|STARTED|Part A||0
8937311|NCT02342314|9998592|FG008|STARTED|Part A||0
8937312|NCT02342314|9998593|FG009|STARTED|Part A||0
8937313|NCT02342314|9998594|FG010|STARTED|Part A||0
8937314|NCT02342314|9998595|FG011|STARTED|Part A||0
8937315|NCT02342314|9998596|FG012|STARTED|Part A||0
8937316|NCT02342314|9998597|FG013|STARTED|Part A||0
8937317|NCT02342314|9998598|FG014|STARTED|Part A||0
8937318|NCT02342314|9998599|FG015|STARTED|Part A||0
8937319|NCT02342314|9998600|FG016|STARTED|Part A||0
8937320|NCT02342314|9998584|FG000|COMPLETED|Part A||6
8937321|NCT02342314|9998585|FG001|COMPLETED|Part A||3
8937322|NCT02342314|9998586|FG002|COMPLETED|Part A||3
8937323|NCT02342314|9998587|FG003|COMPLETED|Part A||3
8937324|NCT02342314|9998588|FG004|COMPLETED|Part A||6
8937325|NCT02342314|9998589|FG005|COMPLETED|Part A||3
8937326|NCT02342314|9998590|FG006|COMPLETED|Part A||0
8937327|NCT02342314|9998591|FG007|COMPLETED|Part A||0
8937328|NCT02342314|9998592|FG008|COMPLETED|Part A||0
8937329|NCT02342314|9998593|FG009|COMPLETED|Part A||0
8937330|NCT02342314|9998594|FG010|COMPLETED|Part A||0
8937331|NCT02342314|9998595|FG011|COMPLETED|Part A||0
8937332|NCT02342314|9998596|FG012|COMPLETED|Part A||0
8937333|NCT02342314|9998597|FG013|COMPLETED|Part A||0
8937334|NCT02342314|9998598|FG014|COMPLETED|Part A||0
8937335|NCT02342314|9998599|FG015|COMPLETED|Part A||0
8937336|NCT02342314|9998600|FG016|COMPLETED|Part A||0
8937337|NCT02342314|9998584|FG000|NOT COMPLETED|Part A||0
8937338|NCT02342314|9998585|FG001|NOT COMPLETED|Part A||0
8937339|NCT02342314|9998586|FG002|NOT COMPLETED|Part A||0
8937340|NCT02342314|9998587|FG003|NOT COMPLETED|Part A||0
8937341|NCT02342314|9998588|FG004|NOT COMPLETED|Part A||0
8937342|NCT02342314|9998589|FG005|NOT COMPLETED|Part A||0
8937343|NCT02342314|9998590|FG006|NOT COMPLETED|Part A||0
8937344|NCT02342314|9998591|FG007|NOT COMPLETED|Part A||0
8937345|NCT02342314|9998592|FG008|NOT COMPLETED|Part A||0
8937346|NCT02342314|9998593|FG009|NOT COMPLETED|Part A||0
8937347|NCT02342314|9998594|FG010|NOT COMPLETED|Part A||0
8937348|NCT02342314|9998595|FG011|NOT COMPLETED|Part A||0
8937349|NCT02342314|9998596|FG012|NOT COMPLETED|Part A||0
8937350|NCT02342314|9998597|FG013|NOT COMPLETED|Part A||0
8937351|NCT02342314|9998598|FG014|NOT COMPLETED|Part A||0
8937352|NCT02342314|9998599|FG015|NOT COMPLETED|Part A||0
8937353|NCT02342314|9998600|FG016|NOT COMPLETED|Part A||0
8937354|NCT02342314|9998584|FG000|STARTED|Part B|Participants received placebo in Part A.|0
8937355|NCT02342314|9998585|FG001|STARTED|Part B|Participants received LY3143753 in Part A.|0
8937356|NCT02342314|9998586|FG002|STARTED|Part B|Participants received LY3143753 in Part A.|0
8937357|NCT02342314|9998587|FG003|STARTED|Part B|Participants received LY3143753 in Part A.|0
8937358|NCT02342314|9998588|FG004|STARTED|Part B|Participants received LY3143753 in Part A.|0
8937359|NCT02342314|9998589|FG005|STARTED|Part B|Participants received LY3143753 in Part A.|0
8937360|NCT02342314|9998590|FG006|STARTED|Part B|Participants received placebo in Part B.|11
8937361|NCT02342314|9998591|FG007|STARTED|Part B|Participants received LY3185643 in Part B.|3
8937362|NCT02342314|9998592|FG008|STARTED|Part B|Participants received LY3185643 in Part B.|3
8937363|NCT02342314|9998593|FG009|STARTED|Part B|Participants received LY3185643 in Part B.|3
8937364|NCT02342314|9998594|FG010|STARTED|Part B|Participants received LY3185643 in Part B.|3
8937365|NCT02342314|9998595|FG011|STARTED|Part B|Participants received LY3185643 in Part B.|3
8937366|NCT02342314|9998596|FG012|STARTED|Part B|Participants received LY3185643 in Part B.|3
8937367|NCT02342314|9998597|FG013|STARTED|Part B|Participants received LY3185643 in Part B.|3
8937368|NCT02342314|9998598|FG014|STARTED|Part B|Participants received LY3185643 in Part B.|3
8937369|NCT02342314|9998599|FG015|STARTED|Part B|Participants received LY3185643 in Part B.|3
8937370|NCT02342314|9998600|FG016|STARTED|Part B|Participants received rGlucagon in Part B.|6
8937371|NCT02342314|9998584|FG000|COMPLETED|Part B||0
8937372|NCT02342314|9998585|FG001|COMPLETED|Part B||0
8937373|NCT02342314|9998586|FG002|COMPLETED|Part B||0
8937374|NCT02342314|9998587|FG003|COMPLETED|Part B||0
8937375|NCT02342314|9998588|FG004|COMPLETED|Part B||0
8937376|NCT02342314|9998589|FG005|COMPLETED|Part B||0
8937377|NCT02342314|9998590|FG006|COMPLETED|Part B||11
8937378|NCT02342314|9998591|FG007|COMPLETED|Part B||3
8937379|NCT02342314|9998592|FG008|COMPLETED|Part B||3
8937380|NCT02342314|9998593|FG009|COMPLETED|Part B||3
8937381|NCT02342314|9998594|FG010|COMPLETED|Part B||3
8937382|NCT02342314|9998595|FG011|COMPLETED|Part B||3
8937383|NCT02342314|9998596|FG012|COMPLETED|Part B||3
8937384|NCT02342314|9998597|FG013|COMPLETED|Part B||3
8937385|NCT02342314|9998598|FG014|COMPLETED|Part B||3
8937386|NCT02342314|9998599|FG015|COMPLETED|Part B||3
8937387|NCT02342314|9998600|FG016|COMPLETED|Part B||6
8937388|NCT02342314|9998584|FG000|NOT COMPLETED|Part B||0
8937389|NCT02342314|9998585|FG001|NOT COMPLETED|Part B||0
8937390|NCT02342314|9998586|FG002|NOT COMPLETED|Part B||0
8937391|NCT02342314|9998587|FG003|NOT COMPLETED|Part B||0
8937392|NCT02342314|9998588|FG004|NOT COMPLETED|Part B||0
8937393|NCT02342314|9998589|FG005|NOT COMPLETED|Part B||0
8937394|NCT02342314|9998590|FG006|NOT COMPLETED|Part B||0
8937395|NCT02342314|9998591|FG007|NOT COMPLETED|Part B||0
8937396|NCT02342314|9998592|FG008|NOT COMPLETED|Part B||0
8937397|NCT02342314|9998593|FG009|NOT COMPLETED|Part B||0
8937398|NCT02342314|9998594|FG010|NOT COMPLETED|Part B||0
8937399|NCT02342314|9998595|FG011|NOT COMPLETED|Part B||0
8937400|NCT02342314|9998596|FG012|NOT COMPLETED|Part B||0
8937401|NCT02342314|9998597|FG013|NOT COMPLETED|Part B||0
8937402|NCT02342314|9998598|FG014|NOT COMPLETED|Part B||0
8937403|NCT02342314|9998599|FG015|NOT COMPLETED|Part B||0
8937404|NCT02342314|9998600|FG016|NOT COMPLETED|Part B||0
8937405|NCT02342327|9998673|FG000|STARTED|Overall Study||60
8937406|NCT02342327|9998674|FG001|STARTED|Overall Study||62
8937407|NCT02342327|9998673|FG000|Completed Quit Day Visit|Overall Study||54
8937408|NCT02342327|9998674|FG001|Completed Quit Day Visit|Overall Study||53
8937409|NCT02342327|9998673|FG000|COMPLETED|Overall Study||39
8937410|NCT02342327|9998674|FG001|COMPLETED|Overall Study||40
8937411|NCT02342327|9998673|FG000|NOT COMPLETED|Overall Study||21
8937412|NCT02342327|9998674|FG001|NOT COMPLETED|Overall Study||22
8937413|NCT02342379|9998680|FG000|STARTED|Overall Study||35
8937414|NCT02342379|9998680|FG000|COMPLETED|Overall Study||35
8937415|NCT02342379|9998680|FG000|NOT COMPLETED|Overall Study||0
8937416|NCT02342418|9998686|FG000|STARTED|Overall Study||9
8937417|NCT02342418|9998687|FG001|STARTED|Overall Study||10
8937418|NCT02342418|9998686|FG000|COMPLETED|Overall Study||9
8937419|NCT02342418|9998687|FG001|COMPLETED|Overall Study||9
8937420|NCT02342418|9998686|FG000|NOT COMPLETED|Overall Study||0
8937421|NCT02342418|9998687|FG001|NOT COMPLETED|Overall Study||1
8937422|NCT02342535|9998693|FG000|STARTED|Overall Study|30 women who participated in the aerobic exercise class and 38 children.|68
8937423|NCT02342535|9998693|FG000|COMPLETED|Overall Study|30 women in aerobic class and 38 kids in kids exercise class|68
8937424|NCT02342535|9998693|FG000|NOT COMPLETED|Overall Study||0
8937425|NCT02342548|9998700|FG000|STARTED|Overall Study||51
8937426|NCT02342548|9998701|FG001|STARTED|Overall Study||71
8937427|NCT02342548|9998702|FG002|STARTED|Overall Study||66
8937428|NCT02342548|9998700|FG000|COMPLETED|Overall Study||17
8937429|NCT02342548|9998701|FG001|COMPLETED|Overall Study||9
8937430|NCT02342548|9998702|FG002|COMPLETED|Overall Study||23
8937431|NCT02342548|9998700|FG000|NOT COMPLETED|Overall Study||34
8937432|NCT02342548|9998701|FG001|NOT COMPLETED|Overall Study||62
8937433|NCT02342548|9998702|FG002|NOT COMPLETED|Overall Study||43
8937434|NCT02342561|9998710|FG000|STARTED|Overall Study||20
8937435|NCT02342561|9998710|FG000|COMPLETED|Overall Study||20
8937436|NCT02342561|9998710|FG000|NOT COMPLETED|Overall Study||0
8937437|NCT02342639|9998720|FG000|STARTED|Overall Study||19
8937438|NCT02342639|9998721|FG001|STARTED|Overall Study||19
8937439|NCT02342639|9998720|FG000|COMPLETED|Overall Study||17
8937440|NCT02342639|9998721|FG001|COMPLETED|Overall Study||14
8937441|NCT02342639|9998720|FG000|NOT COMPLETED|Overall Study||2
8937442|NCT02342639|9998721|FG001|NOT COMPLETED|Overall Study||5
8937443|NCT02342678|9998731|FG000|STARTED|Overall Study||28
8937444|NCT02342678|9998732|FG001|STARTED|Overall Study||28
8937445|NCT02342678|9998731|FG000|COMPLETED|Overall Study||27
8937446|NCT02342678|9998732|FG001|COMPLETED|Overall Study||23
8937447|NCT02342678|9998731|FG000|NOT COMPLETED|Overall Study||1
8937448|NCT02342678|9998732|FG001|NOT COMPLETED|Overall Study||5
8937449|NCT02342704|9998740|FG000|STARTED|Overall Study|Safety Population: randomized participants who received at least 1 dose of study treatment.|54
8937450|NCT02342704|9998741|FG001|STARTED|Overall Study|Safety Population: randomized participants who received at least 1 dose of study treatment.|54
8937451|NCT02342704|9998740|FG000|COMPLETED|Overall Study||1
8937452|NCT02342704|9998741|FG001|COMPLETED|Overall Study||3
8937453|NCT02342704|9998740|FG000|NOT COMPLETED|Overall Study||53
8937454|NCT02342704|9998741|FG001|NOT COMPLETED|Overall Study||51
8937455|NCT02342743|9998747|FG000|STARTED|Baseline Period||73
8937456|NCT02342743|9998747|FG000|COMPLETED|Baseline Period||58
8937457|NCT02342743|9998747|FG000|NOT COMPLETED|Baseline Period||15
8937458|NCT02342743|9998747|FG000|STARTED|Treatment Period|7 patients didn't meet inclusion criteria for treatment period, evaluated at the end of the baseline|58
8937459|NCT02342743|9998747|FG000|COMPLETED|Treatment Period||47
8937460|NCT02342743|9998747|FG000|NOT COMPLETED|Treatment Period||11
8937461|NCT02342886|9998756|FG000|STARTED|Overall Study||65
8937462|NCT02342886|9998757|FG001|STARTED|Overall Study||71
8937463|NCT02342886|9998758|FG002|STARTED|Overall Study||67
8937464|NCT02342886|9998759|FG003|STARTED|Overall Study||68
8937465|NCT02342886|9998760|FG004|STARTED|Overall Study||13
8937466|NCT02342886|9998756|FG000|Completed Month 12 Follow-Up|Overall Study||43
8937467|NCT02342886|9998757|FG001|Completed Month 12 Follow-Up|Overall Study||52
8937468|NCT02342886|9998758|FG002|Completed Month 12 Follow-Up|Overall Study||49
8937469|NCT02342886|9998759|FG003|Completed Month 12 Follow-Up|Overall Study||57
8937470|NCT02342886|9998760|FG004|Completed Month 12 Follow-Up|Overall Study||10
8937471|NCT02342886|9998756|FG000|Completed Month 24 Follow-Up|Overall Study||40
8937472|NCT02342886|9998757|FG001|Completed Month 24 Follow-Up|Overall Study||47
8937473|NCT02342886|9998758|FG002|Completed Month 24 Follow-Up|Overall Study||46
8937474|NCT02342886|9998759|FG003|Completed Month 24 Follow-Up|Overall Study||53
8937475|NCT02342886|9998760|FG004|Completed Month 24 Follow-Up|Overall Study||10
8937476|NCT02342886|9998756|FG000|COMPLETED|Overall Study||57
8937477|NCT02342886|9998757|FG001|COMPLETED|Overall Study||63
8937478|NCT02342886|9998758|FG002|COMPLETED|Overall Study||52
8937479|NCT02342886|9998759|FG003|COMPLETED|Overall Study||59
8937480|NCT02342886|9998760|FG004|COMPLETED|Overall Study||10
8937481|NCT02342886|9998756|FG000|NOT COMPLETED|Overall Study||8
8937482|NCT02342886|9998757|FG001|NOT COMPLETED|Overall Study||8
8937483|NCT02342886|9998758|FG002|NOT COMPLETED|Overall Study||15
8937484|NCT02342886|9998759|FG003|NOT COMPLETED|Overall Study||9
8937485|NCT02342886|9998760|FG004|NOT COMPLETED|Overall Study||3
8937486|NCT02343003|9998774|FG000|STARTED|Overall Study||76
8937487|NCT02343003|9998775|FG001|STARTED|Overall Study||75
8937488|NCT02343003|9998774|FG000|COMPLETED|Overall Study||58
8937489|NCT02343003|9998775|FG001|COMPLETED|Overall Study||68
8937490|NCT02343003|9998774|FG000|NOT COMPLETED|Overall Study||18
8937491|NCT02343003|9998775|FG001|NOT COMPLETED|Overall Study||7
8937492|NCT02343081|9998783|FG000|STARTED|First Intervention (Day 3)||8
8937493|NCT02343081|9998784|FG001|STARTED|First Intervention (Day 3)||8
8937494|NCT02343081|9998783|FG000|Received Intervention|First Intervention (Day 3)||8
8937495|NCT02343081|9998784|FG001|Received Intervention|First Intervention (Day 3)||8
8937496|NCT02343081|9998783|FG000|COMPLETED|First Intervention (Day 3)||8
8937497|NCT02343081|9998784|FG001|COMPLETED|First Intervention (Day 3)||8
8937498|NCT02343081|9998783|FG000|NOT COMPLETED|First Intervention (Day 3)||0
8937499|NCT02343081|9998784|FG001|NOT COMPLETED|First Intervention (Day 3)||0
8937500|NCT02343081|9998783|FG000|STARTED|Washout (10 Hours)||8
8937501|NCT02343081|9998784|FG001|STARTED|Washout (10 Hours)||8
8937502|NCT02343081|9998783|FG000|COMPLETED|Washout (10 Hours)||8
8937503|NCT02343081|9998784|FG001|COMPLETED|Washout (10 Hours)||8
8937504|NCT02343081|9998783|FG000|NOT COMPLETED|Washout (10 Hours)||0
8937505|NCT02343081|9998784|FG001|NOT COMPLETED|Washout (10 Hours)||0
8937506|NCT02343081|9998783|FG000|STARTED|Second Intervention (Day 4)||8
8937507|NCT02343081|9998784|FG001|STARTED|Second Intervention (Day 4)||8
8937508|NCT02343081|9998783|FG000|Received Intervention|Second Intervention (Day 4)||8
8937509|NCT02343081|9998784|FG001|Received Intervention|Second Intervention (Day 4)||8
8937510|NCT02343081|9998783|FG000|COMPLETED|Second Intervention (Day 4)||8
8937511|NCT02343081|9998784|FG001|COMPLETED|Second Intervention (Day 4)||8
8937512|NCT02343081|9998783|FG000|NOT COMPLETED|Second Intervention (Day 4)||0
9065189|NCT04207840|10125556|FG002|COMPLETED|Treatment Period 2||8
9065190|NCT04207840|10125554|FG000|NOT COMPLETED|Treatment Period 2||0
9065191|NCT04207840|10125555|FG001|NOT COMPLETED|Treatment Period 2||0
9065192|NCT04207840|10125556|FG002|NOT COMPLETED|Treatment Period 2||0
9065193|NCT04207840|10125554|FG000|STARTED|Washout Period 2 (2-7 Days)||9
9065194|NCT04207840|10125555|FG001|STARTED|Washout Period 2 (2-7 Days)||10
9065195|NCT04207840|10125556|FG002|STARTED|Washout Period 2 (2-7 Days)||8
9065196|NCT04207840|10125554|FG000|COMPLETED|Washout Period 2 (2-7 Days)||9
9065197|NCT04207840|10125555|FG001|COMPLETED|Washout Period 2 (2-7 Days)||10
9065198|NCT04207840|10125556|FG002|COMPLETED|Washout Period 2 (2-7 Days)||7
9065199|NCT04207840|10125554|FG000|NOT COMPLETED|Washout Period 2 (2-7 Days)||0
9065200|NCT04207840|10125555|FG001|NOT COMPLETED|Washout Period 2 (2-7 Days)||0
8937513|NCT02343081|9998784|FG001|NOT COMPLETED|Second Intervention (Day 4)||0
8937514|NCT02343276|9998792|FG000|STARTED|Overall Study||164
8937515|NCT02343276|9998793|FG001|STARTED|Overall Study||164
8937516|NCT02343276|9998792|FG000|COMPLETED|Overall Study||164
8937517|NCT02343276|9998793|FG001|COMPLETED|Overall Study||164
8937518|NCT02343276|9998792|FG000|NOT COMPLETED|Overall Study||0
8937519|NCT02343276|9998793|FG001|NOT COMPLETED|Overall Study||0
8937520|NCT02343380|9998801|FG000|STARTED|Overall Study|Morning test (first week)|10
8937521|NCT02343380|9998802|FG001|STARTED|Overall Study|Evening test (first week)|10
8937522|NCT02343380|9998801|FG000|COMPLETED|Overall Study|Evening test (second week)|10
8937523|NCT02343380|9998802|FG001|COMPLETED|Overall Study|Morning test (second week)|10
8937524|NCT02343380|9998801|FG000|NOT COMPLETED|Overall Study||0
8937525|NCT02343380|9998802|FG001|NOT COMPLETED|Overall Study||0
8937526|NCT02343406|9998823|FG000|STARTED|Overall Study||88
8937527|NCT02343406|9998824|FG001|STARTED|Overall Study||86
8937528|NCT02343406|9998825|FG002|STARTED|Overall Study||60
8937529|NCT02343406|9998826|FG003|STARTED|Overall Study||26
8937530|NCT02343406|9998827|FG004|STARTED|Overall Study||6
8937531|NCT02343406|9998823|FG000|COMPLETED|Overall Study||0
8937532|NCT02343406|9998824|FG001|COMPLETED|Overall Study||0
8937533|NCT02343406|9998825|FG002|COMPLETED|Overall Study||2
8937534|NCT02343406|9998826|FG003|COMPLETED|Overall Study||0
8937535|NCT02343406|9998827|FG004|COMPLETED|Overall Study||1
8937536|NCT02343406|9998823|FG000|NOT COMPLETED|Overall Study||88
8937537|NCT02343406|9998824|FG001|NOT COMPLETED|Overall Study||86
8937538|NCT02343406|9998825|FG002|NOT COMPLETED|Overall Study||58
8937539|NCT02343406|9998826|FG003|NOT COMPLETED|Overall Study||26
8937540|NCT02343406|9998827|FG004|NOT COMPLETED|Overall Study||5
8937541|NCT02343458|9998842|FG000|STARTED|Overall Study||555
8937542|NCT02343458|9998843|FG001|STARTED|Overall Study||483
8937543|NCT02343458|9998844|FG002|STARTED|Overall Study||480
8937544|NCT02343458|9998845|FG003|STARTED|Overall Study||238
8937545|NCT02343458|9998842|FG000|COMPLETED|Overall Study||494
8937546|NCT02343458|9998843|FG001|COMPLETED|Overall Study||417
8937547|NCT02343458|9998844|FG002|COMPLETED|Overall Study||417
8937548|NCT02343458|9998845|FG003|COMPLETED|Overall Study||200
8937549|NCT02343458|9998842|FG000|NOT COMPLETED|Overall Study||61
8937550|NCT02343458|9998843|FG001|NOT COMPLETED|Overall Study||66
8937551|NCT02343458|9998844|FG002|NOT COMPLETED|Overall Study||63
8937552|NCT02343458|9998845|FG003|NOT COMPLETED|Overall Study||38
8937553|NCT02343575|9998857|FG000|STARTED|Overall Study||1
8937554|NCT02343575|9998858|FG001|STARTED|Overall Study||2
8937555|NCT02343575|9998857|FG000|COMPLETED|Overall Study||1
8937556|NCT02343575|9998858|FG001|COMPLETED|Overall Study||2
8719252|NCT01003106|9766705|FG007|NOT COMPLETED|Month 6-Month 36||0
8719253|NCT01003184|9766721|FG000|STARTED|Overall Study||111
8719254|NCT01003184|9766722|FG001|STARTED|Overall Study||111
8719255|NCT01003184|9766721|FG000|Full Analysis Set (FAS)|Overall Study||111
8719256|NCT01003184|9766722|FG001|Full Analysis Set (FAS)|Overall Study||105
8719257|NCT01003184|9766721|FG000|COMPLETED|Overall Study||92
8937557|NCT02343575|9998857|FG000|NOT COMPLETED|Overall Study||0
8937558|NCT02343575|9998858|FG001|NOT COMPLETED|Overall Study||0
8937559|NCT02343627|9998866|FG000|STARTED|Overall Study||35
8937560|NCT02343627|9998867|FG001|STARTED|Overall Study||12
8937561|NCT02343627|9998866|FG000|COMPLETED|Overall Study||23
8937562|NCT02343627|9998867|FG001|COMPLETED|Overall Study||11
8937563|NCT02343627|9998866|FG000|NOT COMPLETED|Overall Study||12
8937564|NCT02343627|9998867|FG001|NOT COMPLETED|Overall Study||1
8937565|NCT02343939|9998882|FG000|STARTED|Overall Study||3
8937566|NCT02343939|9998883|FG001|STARTED|Overall Study||50
8937567|NCT02343939|9998884|FG002|STARTED|Overall Study||5
8937568|NCT02343939|9998885|FG003|STARTED|Overall Study||6
8937569|NCT02343939|9998886|FG004|STARTED|Overall Study||8
8937570|NCT02343939|9998887|FG005|STARTED|Overall Study||17
8937571|NCT02343939|9998888|FG006|STARTED|Overall Study||15
8937572|NCT02343939|9998889|FG007|STARTED|Overall Study||37
8937573|NCT02343939|9998890|FG008|STARTED|Overall Study||7
8937574|NCT02343939|9998882|FG000|COMPLETED|Overall Study||0
8937575|NCT02343939|9998883|FG001|COMPLETED|Overall Study||2
8937576|NCT02343939|9998884|FG002|COMPLETED|Overall Study||0
8937577|NCT02343939|9998885|FG003|COMPLETED|Overall Study||0
8937578|NCT02343939|9998886|FG004|COMPLETED|Overall Study||0
8937579|NCT02343939|9998887|FG005|COMPLETED|Overall Study||0
8937580|NCT02343939|9998888|FG006|COMPLETED|Overall Study||0
8719258|NCT01003184|9766722|FG001|COMPLETED|Overall Study||99
8937581|NCT02343939|9998889|FG007|COMPLETED|Overall Study||0
8937582|NCT02343939|9998890|FG008|COMPLETED|Overall Study||0
8937583|NCT02343939|9998882|FG000|NOT COMPLETED|Overall Study||3
8937584|NCT02343939|9998883|FG001|NOT COMPLETED|Overall Study||48
8937585|NCT02343939|9998884|FG002|NOT COMPLETED|Overall Study||5
8937586|NCT02343939|9998885|FG003|NOT COMPLETED|Overall Study||6
8937587|NCT02343939|9998886|FG004|NOT COMPLETED|Overall Study||8
8937588|NCT02343939|9998887|FG005|NOT COMPLETED|Overall Study||17
8937589|NCT02343939|9998888|FG006|NOT COMPLETED|Overall Study||15
8937590|NCT02343939|9998889|FG007|NOT COMPLETED|Overall Study||37
8937591|NCT02343939|9998890|FG008|NOT COMPLETED|Overall Study||7
8937592|NCT02344004|9998926|FG000|STARTED|Overall Study||224
8937593|NCT02344004|9998927|FG001|STARTED|Overall Study||112
8937594|NCT02344004|9998926|FG000|COMPLETED|Overall Study||163
8937595|NCT02344004|9998927|FG001|COMPLETED|Overall Study||98
8937596|NCT02344004|9998926|FG000|NOT COMPLETED|Overall Study||61
8937597|NCT02344004|9998927|FG001|NOT COMPLETED|Overall Study||14
8937598|NCT02344173|9998934|FG000|STARTED|Enrollment||2035
8937599|NCT02344173|9998934|FG000|COMPLETED|Enrollment||2035
8937600|NCT02344173|9998934|FG000|NOT COMPLETED|Enrollment||0
8937601|NCT02344173|9998934|FG000|STARTED|Procedure||2035
8937602|NCT02344173|9998934|FG000|COMPLETED|Procedure||2028
8937603|NCT02344173|9998934|FG000|NOT COMPLETED|Procedure||7
8937604|NCT02344173|9998934|FG000|STARTED|12-month Visit||2028
8937605|NCT02344173|9998934|FG000|COMPLETED|12-month Visit||1932
8937606|NCT02344173|9998934|FG000|NOT COMPLETED|12-month Visit||96
8937607|NCT02344225|9998943|FG000|STARTED|Overall Study||6
8937608|NCT02344225|9998944|FG001|STARTED|Overall Study||3
8937609|NCT02344225|9998945|FG002|STARTED|Overall Study||5
8937610|NCT02344225|9998943|FG000|COMPLETED|Overall Study||6
8937611|NCT02344225|9998944|FG001|COMPLETED|Overall Study||3
8937612|NCT02344225|9998945|FG002|COMPLETED|Overall Study||5
8937613|NCT02344225|9998943|FG000|NOT COMPLETED|Overall Study||0
8937614|NCT02344225|9998944|FG001|NOT COMPLETED|Overall Study||0
8937615|NCT02344225|9998945|FG002|NOT COMPLETED|Overall Study||0
8937616|NCT02344238|9998956|FG000|STARTED|Overall Study||20
8937617|NCT02344238|9998957|FG001|STARTED|Overall Study||20
8937618|NCT02344238|9998958|FG002|STARTED|Overall Study||20
8937619|NCT02344238|9998956|FG000|COMPLETED|Overall Study||20
8937620|NCT02344238|9998957|FG001|COMPLETED|Overall Study||20
8937621|NCT02344238|9998958|FG002|COMPLETED|Overall Study||20
8937622|NCT02344238|9998956|FG000|NOT COMPLETED|Overall Study||0
8937623|NCT02344238|9998957|FG001|NOT COMPLETED|Overall Study||0
8937624|NCT02344238|9998958|FG002|NOT COMPLETED|Overall Study||0
8937625|NCT02344251|9998969|FG000|STARTED|Overall Study||20
8937626|NCT02344251|9998970|FG001|STARTED|Overall Study||20
8937627|NCT02344251|9998969|FG000|COMPLETED|Overall Study||20
8937628|NCT02344251|9998970|FG001|COMPLETED|Overall Study||20
8937629|NCT02344251|9998969|FG000|NOT COMPLETED|Overall Study||0
8937630|NCT02344251|9998970|FG001|NOT COMPLETED|Overall Study||0
8937631|NCT02344316|9998980|FG000|STARTED|Overall Study||13
8937632|NCT02344316|9998981|FG001|STARTED|Overall Study||13
8937633|NCT02344316|9998980|FG000|COMPLETED|Overall Study||12
8937634|NCT02344316|9998981|FG001|COMPLETED|Overall Study||11
8937635|NCT02344316|9998980|FG000|NOT COMPLETED|Overall Study||1
8937636|NCT02344316|9998981|FG001|NOT COMPLETED|Overall Study||2
8937637|NCT02344342|9998994|FG000|STARTED|Overall Study||13
8937638|NCT02344342|9998995|FG001|STARTED|Overall Study||11
8937639|NCT02344342|9998996|FG002|STARTED|Overall Study||14
8937640|NCT02344342|9998997|FG003|STARTED|Overall Study||13
8937641|NCT02344342|9998994|FG000|COMPLETED|Overall Study||2
8937642|NCT02344342|9998995|FG001|COMPLETED|Overall Study||2
8937643|NCT02344342|9998996|FG002|COMPLETED|Overall Study||0
8937644|NCT02344342|9998997|FG003|COMPLETED|Overall Study||3
8937645|NCT02344342|9998994|FG000|NOT COMPLETED|Overall Study||11
8937646|NCT02344342|9998995|FG001|NOT COMPLETED|Overall Study||9
8937647|NCT02344342|9998996|FG002|NOT COMPLETED|Overall Study||14
8937648|NCT02344342|9998997|FG003|NOT COMPLETED|Overall Study||10
8937649|NCT02344407|9999014|FG000|STARTED|Overall Study||500
8937650|NCT02344407|9999015|FG001|STARTED|Overall Study||500
8937651|NCT02344407|9999016|FG002|STARTED|Overall Study||500
8937652|NCT02344407|9999014|FG000|COMPLETED|Overall Study||492
8937653|NCT02344407|9999015|FG001|COMPLETED|Overall Study||491
8937654|NCT02344407|9999016|FG002|COMPLETED|Overall Study||494
8937655|NCT02344407|9999014|FG000|NOT COMPLETED|Overall Study||8
8937656|NCT02344407|9999015|FG001|NOT COMPLETED|Overall Study||9
8937657|NCT02344407|9999016|FG002|NOT COMPLETED|Overall Study||6
8937658|NCT02344576|9999028|FG000|STARTED|Enrollment|Includes 7 patients who agreed to medical record review only and were excluded from further analysis|142
8937659|NCT02344576|9999029|FG001|STARTED|Enrollment|Includes 8 patients who agreed to medical record review only and were excluded from further analysis|121
8937660|NCT02344576|9999030|FG002|STARTED|Enrollment||111
8937661|NCT02344576|9999031|FG003|STARTED|Enrollment||71
8937662|NCT02344576|9999028|FG000|Agreed to Survey Data Collection|Enrollment||135
8937663|NCT02344576|9999029|FG001|Agreed to Survey Data Collection|Enrollment||113
8937664|NCT02344576|9999030|FG002|Agreed to Survey Data Collection|Enrollment||111
8937665|NCT02344576|9999031|FG003|Agreed to Survey Data Collection|Enrollment||71
8937666|NCT02344576|9999028|FG000|COMPLETED|Enrollment||135
8937667|NCT02344576|9999029|FG001|COMPLETED|Enrollment||113
8937668|NCT02344576|9999030|FG002|COMPLETED|Enrollment||111
8937669|NCT02344576|9999031|FG003|COMPLETED|Enrollment||71
8937670|NCT02344576|9999028|FG000|NOT COMPLETED|Enrollment||7
8937671|NCT02344576|9999029|FG001|NOT COMPLETED|Enrollment||8
8937672|NCT02344576|9999030|FG002|NOT COMPLETED|Enrollment||0
8937673|NCT02344576|9999031|FG003|NOT COMPLETED|Enrollment||0
8937674|NCT02344576|9999028|FG000|STARTED|1-Month Follow-Up||135
8937675|NCT02344576|9999029|FG001|STARTED|1-Month Follow-Up||113
8937676|NCT02344576|9999030|FG002|STARTED|1-Month Follow-Up||111
8937677|NCT02344576|9999031|FG003|STARTED|1-Month Follow-Up||71
8937678|NCT02344576|9999028|FG000|Completed 1-Month Survey|1-Month Follow-Up||104
8937679|NCT02344576|9999029|FG001|Completed 1-Month Survey|1-Month Follow-Up||79
8937680|NCT02344576|9999030|FG002|Completed 1-Month Survey|1-Month Follow-Up||89
8937681|NCT02344576|9999031|FG003|Completed 1-Month Survey|1-Month Follow-Up||53
8937682|NCT02344576|9999028|FG000|COMPLETED|1-Month Follow-Up|Includes 13 patients who were still enrolled at 1-month but did not complete the 1-month survey.|117
8937683|NCT02344576|9999029|FG001|COMPLETED|1-Month Follow-Up|Includes 7 patients who were still enrolled at 1-month but did not complete the 1-month survey.|86
8937684|NCT02344576|9999030|FG002|COMPLETED|1-Month Follow-Up|Includes 3 caregivers who were still enrolled at 1-month but did not complete the 1-month survey.|92
8948629|NCT02431793|10011088|FG001|Completed T2 (7-14 Days Post Enrollment)|Overall Study||141
8937685|NCT02344576|9999031|FG003|COMPLETED|1-Month Follow-Up|Includes 5 caregivers who were still enrolled at 1-month but did not complete the 1-month survey.|58
8937686|NCT02344576|9999028|FG000|NOT COMPLETED|1-Month Follow-Up||18
8937687|NCT02344576|9999029|FG001|NOT COMPLETED|1-Month Follow-Up||27
8937688|NCT02344576|9999030|FG002|NOT COMPLETED|1-Month Follow-Up||19
8937689|NCT02344576|9999031|FG003|NOT COMPLETED|1-Month Follow-Up||13
8937690|NCT02344576|9999028|FG000|STARTED|6-Month Follow-Up||117
8937691|NCT02344576|9999029|FG001|STARTED|6-Month Follow-Up||86
8937692|NCT02344576|9999030|FG002|STARTED|6-Month Follow-Up||92
8937693|NCT02344576|9999031|FG003|STARTED|6-Month Follow-Up||58
8937694|NCT02344576|9999028|FG000|Completed 6-Month Survey|6-Month Follow-Up||98
8937695|NCT02344576|9999029|FG001|Completed 6-Month Survey|6-Month Follow-Up||67
8937696|NCT02344576|9999030|FG002|Completed 6-Month Survey|6-Month Follow-Up||78
8937697|NCT02344576|9999031|FG003|Completed 6-Month Survey|6-Month Follow-Up||50
8937698|NCT02344576|9999028|FG000|COMPLETED|6-Month Follow-Up||98
8937699|NCT02344576|9999029|FG001|COMPLETED|6-Month Follow-Up||67
8937700|NCT02344576|9999030|FG002|COMPLETED|6-Month Follow-Up||78
8937701|NCT02344576|9999031|FG003|COMPLETED|6-Month Follow-Up||50
8937702|NCT02344576|9999028|FG000|NOT COMPLETED|6-Month Follow-Up||19
8937703|NCT02344576|9999029|FG001|NOT COMPLETED|6-Month Follow-Up||19
8937704|NCT02344576|9999030|FG002|NOT COMPLETED|6-Month Follow-Up||14
8937705|NCT02344576|9999031|FG003|NOT COMPLETED|6-Month Follow-Up||8
8937706|NCT02344576|9999028|FG000|STARTED|12-Month Medical Record Follow-Up||98
8937707|NCT02344576|9999029|FG001|STARTED|12-Month Medical Record Follow-Up||67
8937708|NCT02344576|9999030|FG002|STARTED|12-Month Medical Record Follow-Up|This period not applicable to caregivers, as medical record review was completed for patients only.|78
8937709|NCT02344576|9999031|FG003|STARTED|12-Month Medical Record Follow-Up|This period not applicable to caregivers, as medical record review was completed for patients only.|50
8937710|NCT02344576|9999028|FG000|COMPLETED|12-Month Medical Record Follow-Up||98
8937711|NCT02344576|9999029|FG001|COMPLETED|12-Month Medical Record Follow-Up||67
8937712|NCT02344576|9999030|FG002|COMPLETED|12-Month Medical Record Follow-Up|This period not applicable to caregivers, as medical record review was completed for patients only.|78
8937713|NCT02344576|9999031|FG003|COMPLETED|12-Month Medical Record Follow-Up|This period not applicable to caregivers, as medical record review was completed for patients only.|50
8937714|NCT02344576|9999028|FG000|NOT COMPLETED|12-Month Medical Record Follow-Up||0
8937715|NCT02344576|9999029|FG001|NOT COMPLETED|12-Month Medical Record Follow-Up||0
8937716|NCT02344576|9999030|FG002|NOT COMPLETED|12-Month Medical Record Follow-Up||0
8937717|NCT02344576|9999031|FG003|NOT COMPLETED|12-Month Medical Record Follow-Up||0
8937718|NCT02344628|9999045|FG000|STARTED|Overall Study||291
8937719|NCT02344628|9999046|FG001|STARTED|Overall Study||292
8937720|NCT02344628|9999045|FG000|COMPLETED|Overall Study|4/52 clinical data was available for 283. Serological data 6/12 for 212. Both were available for 200|200
8937721|NCT02344628|9999046|FG001|COMPLETED|Overall Study|4/52 clinical data was available for 286. Serological data 6/12 for 218. Both were available for 206|206
8937722|NCT02344628|9999045|FG000|NOT COMPLETED|Overall Study||91
8937723|NCT02344628|9999046|FG001|NOT COMPLETED|Overall Study||86
8937724|NCT02344745|9999054|FG000|STARTED|Overall Study||40
8937725|NCT02344745|9999055|FG001|STARTED|Overall Study||40
8937726|NCT02344745|9999054|FG000|COMPLETED|Overall Study||38
8937727|NCT02344745|9999055|FG001|COMPLETED|Overall Study||40
8937728|NCT02344745|9999054|FG000|NOT COMPLETED|Overall Study||2
8937729|NCT02344745|9999055|FG001|NOT COMPLETED|Overall Study||0
8937730|NCT02345031|9999063|FG000|STARTED|Overall Study||38
8937731|NCT02345031|9999064|FG001|STARTED|Overall Study||40
8937732|NCT02345031|9999063|FG000|COMPLETED|Overall Study||37
8937733|NCT02345031|9999064|FG001|COMPLETED|Overall Study||39
8937734|NCT02345031|9999063|FG000|NOT COMPLETED|Overall Study||1
8937735|NCT02345031|9999064|FG001|NOT COMPLETED|Overall Study||1
8937736|NCT02345161|9999074|FG000|STARTED|Overall Study||911
8937737|NCT02345161|9999075|FG001|STARTED|Overall Study||899
8937738|NCT02345161|9999074|FG000|COMPLETED|Overall Study||866
8937739|NCT02345161|9999075|FG001|COMPLETED|Overall Study||842
8937740|NCT02345161|9999074|FG000|NOT COMPLETED|Overall Study||45
8937741|NCT02345161|9999075|FG001|NOT COMPLETED|Overall Study||57
8617336|NCT00455741|9655484|FG000|COMPLETED|Overall Study||13
8617337|NCT00455741|9655485|FG001|COMPLETED|Overall Study||11
8617338|NCT00455741|9655484|FG000|NOT COMPLETED|Overall Study||0
8937742|NCT02345226|9999088|FG000|STARTED|Double-Blind Phase||440
8937743|NCT02345226|9999089|FG001|STARTED|Double-Blind Phase||441
8937744|NCT02345226|9999088|FG000|COMPLETED|Double-Blind Phase||371
8937745|NCT02345226|9999089|FG001|COMPLETED|Double-Blind Phase||370
8937746|NCT02345226|9999088|FG000|NOT COMPLETED|Double-Blind Phase||69
9065201|NCT04207840|10125556|FG002|NOT COMPLETED|Washout Period 2 (2-7 Days)||1
9065202|NCT04207840|10125554|FG000|STARTED|Treatment Period 3||9
9065203|NCT04207840|10125555|FG001|STARTED|Treatment Period 3||10
8937747|NCT02345226|9999089|FG001|NOT COMPLETED|Double-Blind Phase||71
8937748|NCT02345226|9999088|FG000|STARTED|Open-Label Extension Phase|346 participants completed the Double-Blind Phase, but did not enter Open-Label Extension Phase.|25
8937749|NCT02345226|9999089|FG001|STARTED|Open-Label Extension Phase|349 participants completed the Double-Blind Phase, but did not enter Open-Label Extension Phase.|21
8937750|NCT02345226|9999088|FG000|COMPLETED|Open-Label Extension Phase||25
8937751|NCT02345226|9999089|FG001|COMPLETED|Open-Label Extension Phase||20
8937752|NCT02345226|9999088|FG000|NOT COMPLETED|Open-Label Extension Phase||0
8937753|NCT02345226|9999089|FG001|NOT COMPLETED|Open-Label Extension Phase||1
9065204|NCT04207840|10125556|FG002|STARTED|Treatment Period 3||7
9065205|NCT04207840|10125554|FG000|COMPLETED|Treatment Period 3||9
8937754|NCT02345252|9999099|FG000|STARTED|Double-Blind Phase||316
8937755|NCT02345252|9999100|FG001|STARTED|Double-Blind Phase||316
8937756|NCT02345252|9999099|FG000|COMPLETED|Double-Blind Phase||276
8937757|NCT02345252|9999100|FG001|COMPLETED|Double-Blind Phase||267
8937758|NCT02345252|9999099|FG000|NOT COMPLETED|Double-Blind Phase||40
8937759|NCT02345252|9999100|FG001|NOT COMPLETED|Double-Blind Phase||49
8937760|NCT02345252|9999099|FG000|STARTED|Open-Label Extension Phase|257 participants completed the Double-Blind Phase, but did not enter Open-Label Extension Phase.|19
8937761|NCT02345252|9999100|FG001|STARTED|Open-Label Extension Phase|250 participants completed the Double-Blind Phase, but did not enter Open-Label Extension Phase.|17
8937762|NCT02345252|9999099|FG000|COMPLETED|Open-Label Extension Phase||19
8937763|NCT02345252|9999100|FG001|COMPLETED|Open-Label Extension Phase||17
8937764|NCT02345252|9999099|FG000|NOT COMPLETED|Open-Label Extension Phase||0
8937765|NCT02345252|9999100|FG001|NOT COMPLETED|Open-Label Extension Phase||0
8937766|NCT02345330|9999108|FG000|STARTED|Overall Study||4
8937767|NCT02345330|9999108|FG000|COMPLETED|Overall Study||1
8937768|NCT02345330|9999108|FG000|NOT COMPLETED|Overall Study||3
8937769|NCT02345434|9999114|FG000|STARTED|Overall Study||763
8937770|NCT02345434|9999115|FG001|STARTED|Overall Study||762
8937771|NCT02345434|9999114|FG000|COMPLETED|Overall Study||758
8937772|NCT02345434|9999115|FG001|COMPLETED|Overall Study||760
8937773|NCT02345434|9999114|FG000|NOT COMPLETED|Overall Study||5
8937774|NCT02345434|9999115|FG001|NOT COMPLETED|Overall Study||2
8937775|NCT02345486|9999123|FG000|STARTED|Overall Study||454
8937776|NCT02345486|9999124|FG001|STARTED|Overall Study||520
8937777|NCT02345486|9999123|FG000|COMPLETED|Overall Study||454
8937778|NCT02345486|9999124|FG001|COMPLETED|Overall Study||520
8937779|NCT02345486|9999123|FG000|NOT COMPLETED|Overall Study||0
8937780|NCT02345486|9999124|FG001|NOT COMPLETED|Overall Study||0
8937781|NCT02345512|9999130|FG000|STARTED|Overall Study||11
8937782|NCT02345512|9999130|FG000|COMPLETED|Overall Study||9
8937783|NCT02345512|9999130|FG000|NOT COMPLETED|Overall Study||2
8937784|NCT02345642|9999141|FG000|STARTED|Overall Study||10
8937785|NCT02345642|9999142|FG001|STARTED|Overall Study||10
8937786|NCT02345642|9999141|FG000|COMPLETED|Overall Study||10
8937787|NCT02345642|9999142|FG001|COMPLETED|Overall Study||10
8937788|NCT02345642|9999141|FG000|NOT COMPLETED|Overall Study||0
8937789|NCT02345642|9999142|FG001|NOT COMPLETED|Overall Study||0
8937790|NCT02345720|9999148|FG000|STARTED|Overall Study||20
8937791|NCT02345720|9999148|FG000|COMPLETED|Overall Study||20
8937792|NCT02345720|9999148|FG000|NOT COMPLETED|Overall Study||0
8937793|NCT02345811|9999152|FG000|STARTED|First Intervention||17
8937794|NCT02345811|9999153|FG001|STARTED|First Intervention||17
8937795|NCT02345811|9999152|FG000|COMPLETED|First Intervention||16
8937796|NCT02345811|9999153|FG001|COMPLETED|First Intervention||16
8937797|NCT02345811|9999152|FG000|NOT COMPLETED|First Intervention||1
8937798|NCT02345811|9999153|FG001|NOT COMPLETED|First Intervention||1
8937799|NCT02345811|9999152|FG000|STARTED|Second Intervention||16
8937800|NCT02345811|9999153|FG001|STARTED|Second Intervention||16
8937801|NCT02345811|9999152|FG000|COMPLETED|Second Intervention||16
8937802|NCT02345811|9999153|FG001|COMPLETED|Second Intervention||16
8937803|NCT02345811|9999152|FG000|NOT COMPLETED|Second Intervention||0
8937804|NCT02345811|9999153|FG001|NOT COMPLETED|Second Intervention||0
8937805|NCT02345889|9999165|FG000|STARTED|Overall Study||316
8937806|NCT02345889|9999166|FG001|STARTED|Overall Study||316
8937807|NCT02345889|9999167|FG002|STARTED|Overall Study||315
8937808|NCT02345889|9999168|FG003|STARTED|Overall Study||315
8937809|NCT02345889|9999165|FG000|COMPLETED|Overall Study||295
8937810|NCT02345889|9999166|FG001|COMPLETED|Overall Study||299
8937811|NCT02345889|9999167|FG002|COMPLETED|Overall Study||295
8937812|NCT02345889|9999168|FG003|COMPLETED|Overall Study||299
8937813|NCT02345889|9999165|FG000|NOT COMPLETED|Overall Study||21
8937814|NCT02345889|9999166|FG001|NOT COMPLETED|Overall Study||17
8937815|NCT02345889|9999167|FG002|NOT COMPLETED|Overall Study||20
8937816|NCT02345889|9999168|FG003|NOT COMPLETED|Overall Study||16
8937817|NCT02346136|9999180|FG000|STARTED|Overall Study||93
8937818|NCT02346136|9999181|FG001|STARTED|Overall Study||87
8937819|NCT02346136|9999180|FG000|COMPLETED|Overall Study||71
8937820|NCT02346136|9999181|FG001|COMPLETED|Overall Study||64
8617339|NCT00455741|9655485|FG001|NOT COMPLETED|Overall Study||1
8617340|NCT00455858|9655501|FG000|STARTED|Overall Study|Enrolled in study and exposed to study drug|87
8617341|NCT00455858|9655501|FG000|COMPLETED|Overall Study||81
8937821|NCT02346136|9999180|FG000|NOT COMPLETED|Overall Study||22
8937822|NCT02346136|9999181|FG001|NOT COMPLETED|Overall Study||23
8937823|NCT02346240|9999191|FG000|STARTED|Initial Period (Baseline to Week 16)||57
8617342|NCT00455858|9655501|FG000|NOT COMPLETED|Overall Study||6
8937824|NCT02346240|9999192|FG001|STARTED|Initial Period (Baseline to Week 16)||170
8937825|NCT02346240|9999193|FG002|STARTED|Initial Period (Baseline to Week 16)||165
8937826|NCT02346240|9999194|FG003|STARTED|Initial Period (Baseline to Week 16)||167
8937827|NCT02346240|9999195|FG004|STARTED|Initial Period (Baseline to Week 16)||0
8937828|NCT02346240|9999196|FG005|STARTED|Initial Period (Baseline to Week 16)||0
8937829|NCT02346240|9999197|FG006|STARTED|Initial Period (Baseline to Week 16)||0
8937830|NCT02346240|9999198|FG007|STARTED|Initial Period (Baseline to Week 16)||0
8937831|NCT02346240|9999199|FG008|STARTED|Initial Period (Baseline to Week 16)||0
8937832|NCT02346240|9999200|FG009|STARTED|Initial Period (Baseline to Week 16)||0
8937833|NCT02346240|9999201|FG010|STARTED|Initial Period (Baseline to Week 16)||0
8937834|NCT02346240|9999202|FG011|STARTED|Initial Period (Baseline to Week 16)||0
8937835|NCT02346240|9999203|FG012|STARTED|Initial Period (Baseline to Week 16)||0
8937836|NCT02346240|9999204|FG013|STARTED|Initial Period (Baseline to Week 16)||0
8937837|NCT02346240|9999205|FG014|STARTED|Initial Period (Baseline to Week 16)||0
8937838|NCT02346240|9999206|FG015|STARTED|Initial Period (Baseline to Week 16)||0
8937839|NCT02346240|9999207|FG016|STARTED|Initial Period (Baseline to Week 16)||0
8937840|NCT02346240|9999208|FG017|STARTED|Initial Period (Baseline to Week 16)||0
8937841|NCT02346240|9999209|FG018|STARTED|Initial Period (Baseline to Week 16)||0
8937842|NCT02346240|9999210|FG019|STARTED|Initial Period (Baseline to Week 16)||0
8937843|NCT02346240|9999211|FG020|STARTED|Initial Period (Baseline to Week 16)||0
8937844|NCT02346240|9999212|FG021|STARTED|Initial Period (Baseline to Week 16)||0
8937845|NCT02346240|9999213|FG022|STARTED|Initial Period (Baseline to Week 16)||0
8937846|NCT02346240|9999214|FG023|STARTED|Initial Period (Baseline to Week 16)||0
8937847|NCT02346240|9999191|FG000|Completed Week 16|Initial Period (Baseline to Week 16)||55
8937848|NCT02346240|9999192|FG001|Completed Week 16|Initial Period (Baseline to Week 16)||159
8937849|NCT02346240|9999193|FG002|Completed Week 16|Initial Period (Baseline to Week 16)||159
8937850|NCT02346240|9999194|FG003|Completed Week 16|Initial Period (Baseline to Week 16)||162
8937851|NCT02346240|9999195|FG004|Completed Week 16|Initial Period (Baseline to Week 16)||0
8937852|NCT02346240|9999196|FG005|Completed Week 16|Initial Period (Baseline to Week 16)||0
8937853|NCT02346240|9999197|FG006|Completed Week 16|Initial Period (Baseline to Week 16)||0
8937854|NCT02346240|9999198|FG007|Completed Week 16|Initial Period (Baseline to Week 16)||0
8937855|NCT02346240|9999199|FG008|Completed Week 16|Initial Period (Baseline to Week 16)||0
8937856|NCT02346240|9999200|FG009|Completed Week 16|Initial Period (Baseline to Week 16)||0
8937857|NCT02346240|9999201|FG010|Completed Week 16|Initial Period (Baseline to Week 16)||0
8937858|NCT02346240|9999202|FG011|Completed Week 16|Initial Period (Baseline to Week 16)||0
8937859|NCT02346240|9999203|FG012|Completed Week 16|Initial Period (Baseline to Week 16)||0
8937860|NCT02346240|9999204|FG013|Completed Week 16|Initial Period (Baseline to Week 16)||0
8937861|NCT02346240|9999205|FG014|Completed Week 16|Initial Period (Baseline to Week 16)||0
8937862|NCT02346240|9999206|FG015|Completed Week 16|Initial Period (Baseline to Week 16)||0
8937863|NCT02346240|9999207|FG016|Completed Week 16|Initial Period (Baseline to Week 16)||0
8937864|NCT02346240|9999208|FG017|Completed Week 16|Initial Period (Baseline to Week 16)||0
8937865|NCT02346240|9999209|FG018|Completed Week 16|Initial Period (Baseline to Week 16)||0
8937866|NCT02346240|9999210|FG019|Completed Week 16|Initial Period (Baseline to Week 16)||0
8937867|NCT02346240|9999211|FG020|Completed Week 16|Initial Period (Baseline to Week 16)||0
8937868|NCT02346240|9999212|FG021|Completed Week 16|Initial Period (Baseline to Week 16)||0
8937869|NCT02346240|9999213|FG022|Completed Week 16|Initial Period (Baseline to Week 16)||0
8937870|NCT02346240|9999214|FG023|Completed Week 16|Initial Period (Baseline to Week 16)||0
8937871|NCT02346240|9999191|FG000|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||55
8937872|NCT02346240|9999192|FG001|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||159
8937873|NCT02346240|9999193|FG002|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||159
8937874|NCT02346240|9999194|FG003|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||160
8937875|NCT02346240|9999195|FG004|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
8937876|NCT02346240|9999196|FG005|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
8937877|NCT02346240|9999197|FG006|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
8937878|NCT02346240|9999198|FG007|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
8937879|NCT02346240|9999199|FG008|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
8937880|NCT02346240|9999200|FG009|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
8937881|NCT02346240|9999201|FG010|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
8937882|NCT02346240|9999202|FG011|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
8937883|NCT02346240|9999203|FG012|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
8937884|NCT02346240|9999204|FG013|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
8937885|NCT02346240|9999205|FG014|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
8937886|NCT02346240|9999206|FG015|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
8937887|NCT02346240|9999207|FG016|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
8937888|NCT02346240|9999208|FG017|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
8937889|NCT02346240|9999209|FG018|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
8937890|NCT02346240|9999210|FG019|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
8937891|NCT02346240|9999211|FG020|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
8937892|NCT02346240|9999212|FG021|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
8937893|NCT02346240|9999213|FG022|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
8937894|NCT02346240|9999214|FG023|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
8937895|NCT02346240|9999191|FG000|COMPLETED|Initial Period (Baseline to Week 16)||55
8937896|NCT02346240|9999192|FG001|COMPLETED|Initial Period (Baseline to Week 16)||159
8937897|NCT02346240|9999193|FG002|COMPLETED|Initial Period (Baseline to Week 16)||159
8937898|NCT02346240|9999194|FG003|COMPLETED|Initial Period (Baseline to Week 16)||160
8937899|NCT02346240|9999195|FG004|COMPLETED|Initial Period (Baseline to Week 16)||0
8937900|NCT02346240|9999196|FG005|COMPLETED|Initial Period (Baseline to Week 16)||0
8937901|NCT02346240|9999197|FG006|COMPLETED|Initial Period (Baseline to Week 16)||0
8937902|NCT02346240|9999198|FG007|COMPLETED|Initial Period (Baseline to Week 16)||0
8937903|NCT02346240|9999199|FG008|COMPLETED|Initial Period (Baseline to Week 16)||0
8937904|NCT02346240|9999200|FG009|COMPLETED|Initial Period (Baseline to Week 16)||0
8937905|NCT02346240|9999201|FG010|COMPLETED|Initial Period (Baseline to Week 16)||0
8937906|NCT02346240|9999202|FG011|COMPLETED|Initial Period (Baseline to Week 16)||0
8937907|NCT02346240|9999203|FG012|COMPLETED|Initial Period (Baseline to Week 16)||0
8937908|NCT02346240|9999204|FG013|COMPLETED|Initial Period (Baseline to Week 16)||0
8937909|NCT02346240|9999205|FG014|COMPLETED|Initial Period (Baseline to Week 16)||0
8937910|NCT02346240|9999206|FG015|COMPLETED|Initial Period (Baseline to Week 16)||0
8937911|NCT02346240|9999207|FG016|COMPLETED|Initial Period (Baseline to Week 16)||0
8937912|NCT02346240|9999208|FG017|COMPLETED|Initial Period (Baseline to Week 16)||0
8937913|NCT02346240|9999209|FG018|COMPLETED|Initial Period (Baseline to Week 16)||0
8937914|NCT02346240|9999210|FG019|COMPLETED|Initial Period (Baseline to Week 16)||0
8937915|NCT02346240|9999211|FG020|COMPLETED|Initial Period (Baseline to Week 16)||0
8937916|NCT02346240|9999212|FG021|COMPLETED|Initial Period (Baseline to Week 16)||0
8937917|NCT02346240|9999213|FG022|COMPLETED|Initial Period (Baseline to Week 16)||0
8937918|NCT02346240|9999214|FG023|COMPLETED|Initial Period (Baseline to Week 16)||0
8937919|NCT02346240|9999191|FG000|NOT COMPLETED|Initial Period (Baseline to Week 16)||2
8937920|NCT02346240|9999192|FG001|NOT COMPLETED|Initial Period (Baseline to Week 16)||11
8937921|NCT02346240|9999193|FG002|NOT COMPLETED|Initial Period (Baseline to Week 16)||6
8937922|NCT02346240|9999194|FG003|NOT COMPLETED|Initial Period (Baseline to Week 16)||7
8937923|NCT02346240|9999195|FG004|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
8937924|NCT02346240|9999196|FG005|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
8937925|NCT02346240|9999197|FG006|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
8937926|NCT02346240|9999198|FG007|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
8937927|NCT02346240|9999199|FG008|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
8937928|NCT02346240|9999200|FG009|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
8937929|NCT02346240|9999201|FG010|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
8937930|NCT02346240|9999202|FG011|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
8937931|NCT02346240|9999203|FG012|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
8937932|NCT02346240|9999204|FG013|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
8937933|NCT02346240|9999205|FG014|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
8937934|NCT02346240|9999206|FG015|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
8937935|NCT02346240|9999207|FG016|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
8937936|NCT02346240|9999208|FG017|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
8937937|NCT02346240|9999209|FG018|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
8937938|NCT02346240|9999210|FG019|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
8937939|NCT02346240|9999211|FG020|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
8937940|NCT02346240|9999212|FG021|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
8937941|NCT02346240|9999213|FG022|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
8937942|NCT02346240|9999214|FG023|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
8937943|NCT02346240|9999191|FG000|STARTED|Maintenance Period (Week 16 to Week 48)||0
8937944|NCT02346240|9999192|FG001|STARTED|Maintenance Period (Week 16 to Week 48)||0
8937945|NCT02346240|9999193|FG002|STARTED|Maintenance Period (Week 16 to Week 48)||0
8937946|NCT02346240|9999194|FG003|STARTED|Maintenance Period (Week 16 to Week 48)||0
8937947|NCT02346240|9999195|FG004|STARTED|Maintenance Period (Week 16 to Week 48)||2
8937948|NCT02346240|9999196|FG005|STARTED|Maintenance Period (Week 16 to Week 48)||24
8937949|NCT02346240|9999197|FG006|STARTED|Maintenance Period (Week 16 to Week 48)||50
8937950|NCT02346240|9999198|FG007|STARTED|Maintenance Period (Week 16 to Week 48)||22
8937951|NCT02346240|9999199|FG008|STARTED|Maintenance Period (Week 16 to Week 48)||44
8937952|NCT02346240|9999200|FG009|STARTED|Maintenance Period (Week 16 to Week 48)||44
8937953|NCT02346240|9999201|FG010|STARTED|Maintenance Period (Week 16 to Week 48)||25
8937954|NCT02346240|9999202|FG011|STARTED|Maintenance Period (Week 16 to Week 48)||50
8937955|NCT02346240|9999203|FG012|STARTED|Maintenance Period (Week 16 to Week 48)||49
8937956|NCT02346240|9999204|FG013|STARTED|Maintenance Period (Week 16 to Week 48)||53
8937957|NCT02346240|9999205|FG014|STARTED|Maintenance Period (Week 16 to Week 48)||85
8937958|NCT02346240|9999206|FG015|STARTED|Maintenance Period (Week 16 to Week 48)||49
8937959|NCT02346240|9999207|FG016|STARTED|Maintenance Period (Week 16 to Week 48)||36
8937960|NCT02346240|9999208|FG017|STARTED|Maintenance Period (Week 16 to Week 48)||0
8937961|NCT02346240|9999209|FG018|STARTED|Maintenance Period (Week 16 to Week 48)||0
8937962|NCT02346240|9999210|FG019|STARTED|Maintenance Period (Week 16 to Week 48)||0
8937963|NCT02346240|9999211|FG020|STARTED|Maintenance Period (Week 16 to Week 48)||0
8937964|NCT02346240|9999212|FG021|STARTED|Maintenance Period (Week 16 to Week 48)||0
8937965|NCT02346240|9999213|FG022|STARTED|Maintenance Period (Week 16 to Week 48)||0
8937966|NCT02346240|9999214|FG023|STARTED|Maintenance Period (Week 16 to Week 48)||0
8937967|NCT02346240|9999191|FG000|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
8937968|NCT02346240|9999192|FG001|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
8948826|NCT02433080|10011309|FG001|STARTED|Overall Study||28
8617343|NCT00455923|9655507|FG000|STARTED|Overall Study||50
8617344|NCT00455923|9655508|FG001|STARTED|Overall Study||50
8617345|NCT00455923|9655507|FG000|COMPLETED|Overall Study||47
8617346|NCT00455923|9655508|FG001|COMPLETED|Overall Study||47
8617347|NCT00455923|9655507|FG000|NOT COMPLETED|Overall Study||3
8617348|NCT00455923|9655508|FG001|NOT COMPLETED|Overall Study||3
8617349|NCT00455962|9655516|FG000|STARTED|Overall Study||10
8617350|NCT00455962|9655517|FG001|STARTED|Overall Study||13
8617351|NCT00455962|9655516|FG000|COMPLETED|Overall Study||10
8937969|NCT02346240|9999193|FG002|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
8937970|NCT02346240|9999194|FG003|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
8937971|NCT02346240|9999195|FG004|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||2
8937972|NCT02346240|9999196|FG005|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||23
8937973|NCT02346240|9999197|FG006|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||48
8937974|NCT02346240|9999198|FG007|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||20
8937975|NCT02346240|9999199|FG008|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||40
8937976|NCT02346240|9999200|FG009|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||43
8937977|NCT02346240|9999201|FG010|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||23
8937978|NCT02346240|9999202|FG011|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||47
8937979|NCT02346240|9999203|FG012|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||49
8937980|NCT02346240|9999204|FG013|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||46
8937981|NCT02346240|9999205|FG014|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||71
8937982|NCT02346240|9999206|FG015|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||36
8937983|NCT02346240|9999207|FG016|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||30
8937984|NCT02346240|9999208|FG017|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
8937985|NCT02346240|9999209|FG018|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
8937986|NCT02346240|9999210|FG019|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
8937987|NCT02346240|9999211|FG020|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
8937988|NCT02346240|9999212|FG021|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
8937989|NCT02346240|9999213|FG022|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
8937990|NCT02346240|9999214|FG023|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
8937991|NCT02346240|9999191|FG000|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8937992|NCT02346240|9999192|FG001|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8937993|NCT02346240|9999193|FG002|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8937994|NCT02346240|9999194|FG003|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8937995|NCT02346240|9999195|FG004|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||2
8937996|NCT02346240|9999196|FG005|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||23
8937997|NCT02346240|9999197|FG006|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||48
8937998|NCT02346240|9999198|FG007|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||20
8937999|NCT02346240|9999199|FG008|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||40
8938000|NCT02346240|9999200|FG009|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||43
8938001|NCT02346240|9999201|FG010|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||23
8938002|NCT02346240|9999202|FG011|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||47
8938003|NCT02346240|9999203|FG012|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||49
8938004|NCT02346240|9999204|FG013|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||45
8938005|NCT02346240|9999205|FG014|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||68
8938006|NCT02346240|9999206|FG015|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||35
8938007|NCT02346240|9999207|FG016|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||29
8938008|NCT02346240|9999208|FG017|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8938009|NCT02346240|9999209|FG018|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8938010|NCT02346240|9999210|FG019|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8938011|NCT02346240|9999211|FG020|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8938012|NCT02346240|9999212|FG021|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8938013|NCT02346240|9999213|FG022|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8938014|NCT02346240|9999214|FG023|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8938015|NCT02346240|9999191|FG000|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8938016|NCT02346240|9999192|FG001|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8938017|NCT02346240|9999193|FG002|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8938018|NCT02346240|9999194|FG003|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8938019|NCT02346240|9999195|FG004|COMPLETED|Maintenance Period (Week 16 to Week 48)||2
8938020|NCT02346240|9999196|FG005|COMPLETED|Maintenance Period (Week 16 to Week 48)||23
8938021|NCT02346240|9999197|FG006|COMPLETED|Maintenance Period (Week 16 to Week 48)||48
8938022|NCT02346240|9999198|FG007|COMPLETED|Maintenance Period (Week 16 to Week 48)||20
8617352|NCT00455962|9655517|FG001|COMPLETED|Overall Study||13
8617353|NCT00455962|9655516|FG000|NOT COMPLETED|Overall Study||0
8719259|NCT01003184|9766721|FG000|NOT COMPLETED|Overall Study||19
8617354|NCT00455962|9655517|FG001|NOT COMPLETED|Overall Study||0
8938023|NCT02346240|9999199|FG008|COMPLETED|Maintenance Period (Week 16 to Week 48)||40
8938024|NCT02346240|9999200|FG009|COMPLETED|Maintenance Period (Week 16 to Week 48)||43
8938025|NCT02346240|9999201|FG010|COMPLETED|Maintenance Period (Week 16 to Week 48)||23
8938026|NCT02346240|9999202|FG011|COMPLETED|Maintenance Period (Week 16 to Week 48)||47
8938027|NCT02346240|9999203|FG012|COMPLETED|Maintenance Period (Week 16 to Week 48)||49
8938028|NCT02346240|9999204|FG013|COMPLETED|Maintenance Period (Week 16 to Week 48)|1 subject completed the Maintenance Period but did not enter the Open-Label Period.|45
8938029|NCT02346240|9999205|FG014|COMPLETED|Maintenance Period (Week 16 to Week 48)|3 subjects completed the Maintenance Period but did not enter the Open-Label Period.|68
8938030|NCT02346240|9999206|FG015|COMPLETED|Maintenance Period (Week 16 to Week 48)|1 subject completed the Maintenance Period but did not enter the Open-Label Period.|35
8938031|NCT02346240|9999207|FG016|COMPLETED|Maintenance Period (Week 16 to Week 48)|1 subject completed the Maintenance Period but did not enter the Open-Label Period.|29
8938032|NCT02346240|9999208|FG017|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8938033|NCT02346240|9999209|FG018|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8938034|NCT02346240|9999210|FG019|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8938035|NCT02346240|9999211|FG020|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8938036|NCT02346240|9999212|FG021|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8938037|NCT02346240|9999213|FG022|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8938038|NCT02346240|9999214|FG023|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8938039|NCT02346240|9999191|FG000|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8938040|NCT02346240|9999192|FG001|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8938041|NCT02346240|9999193|FG002|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8938042|NCT02346240|9999194|FG003|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8938043|NCT02346240|9999195|FG004|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8938044|NCT02346240|9999196|FG005|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||1
8938045|NCT02346240|9999197|FG006|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2
8938046|NCT02346240|9999198|FG007|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2
8938047|NCT02346240|9999199|FG008|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||4
8938048|NCT02346240|9999200|FG009|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||1
8938049|NCT02346240|9999201|FG010|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2
8938050|NCT02346240|9999202|FG011|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||3
8938051|NCT02346240|9999203|FG012|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8938052|NCT02346240|9999204|FG013|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||8
8938053|NCT02346240|9999205|FG014|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||17
8938054|NCT02346240|9999206|FG015|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||14
8938055|NCT02346240|9999207|FG016|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||7
8938056|NCT02346240|9999208|FG017|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8938057|NCT02346240|9999209|FG018|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8938058|NCT02346240|9999210|FG019|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8938059|NCT02346240|9999211|FG020|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8938060|NCT02346240|9999212|FG021|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8938061|NCT02346240|9999213|FG022|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8938062|NCT02346240|9999214|FG023|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8938063|NCT02346240|9999191|FG000|STARTED|Open-Label Period (Week 48 to Week 144)||0
8938064|NCT02346240|9999192|FG001|STARTED|Open-Label Period (Week 48 to Week 144)||0
8938065|NCT02346240|9999193|FG002|STARTED|Open-Label Period (Week 48 to Week 144)||0
8938066|NCT02346240|9999194|FG003|STARTED|Open-Label Period (Week 48 to Week 144)||0
8938067|NCT02346240|9999195|FG004|STARTED|Open-Label Period (Week 48 to Week 144)||0
8938068|NCT02346240|9999196|FG005|STARTED|Open-Label Period (Week 48 to Week 144)||0
8938069|NCT02346240|9999197|FG006|STARTED|Open-Label Period (Week 48 to Week 144)||0
8938070|NCT02346240|9999198|FG007|STARTED|Open-Label Period (Week 48 to Week 144)||0
8938071|NCT02346240|9999199|FG008|STARTED|Open-Label Period (Week 48 to Week 144)||0
8938072|NCT02346240|9999200|FG009|STARTED|Open-Label Period (Week 48 to Week 144)||0
8938073|NCT02346240|9999201|FG010|STARTED|Open-Label Period (Week 48 to Week 144)||0
8938074|NCT02346240|9999202|FG011|STARTED|Open-Label Period (Week 48 to Week 144)||0
8938075|NCT02346240|9999203|FG012|STARTED|Open-Label Period (Week 48 to Week 144)||0
8938076|NCT02346240|9999204|FG013|STARTED|Open-Label Period (Week 48 to Week 144)||0
8938077|NCT02346240|9999205|FG014|STARTED|Open-Label Period (Week 48 to Week 144)||0
8938078|NCT02346240|9999206|FG015|STARTED|Open-Label Period (Week 48 to Week 144)||0
8938079|NCT02346240|9999207|FG016|STARTED|Open-Label Period (Week 48 to Week 144)||0
8938080|NCT02346240|9999208|FG017|STARTED|Open-Label Period (Week 48 to Week 144)||34
8938081|NCT02346240|9999209|FG018|STARTED|Open-Label Period (Week 48 to Week 144)||122
8938082|NCT02346240|9999210|FG019|STARTED|Open-Label Period (Week 48 to Week 144)||41
8938083|NCT02346240|9999211|FG020|STARTED|Open-Label Period (Week 48 to Week 144)||48
8938084|NCT02346240|9999212|FG021|STARTED|Open-Label Period (Week 48 to Week 144)||177
8938085|NCT02346240|9999213|FG022|STARTED|Open-Label Period (Week 48 to Week 144)||34
8938086|NCT02346240|9999214|FG023|STARTED|Open-Label Period (Week 48 to Week 144)||16
8938087|NCT02346240|9999191|FG000|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8938088|NCT02346240|9999192|FG001|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8938089|NCT02346240|9999193|FG002|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8938090|NCT02346240|9999194|FG003|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8938091|NCT02346240|9999195|FG004|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8938092|NCT02346240|9999196|FG005|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8938093|NCT02346240|9999197|FG006|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8938094|NCT02346240|9999198|FG007|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8938095|NCT02346240|9999199|FG008|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8938096|NCT02346240|9999200|FG009|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8938097|NCT02346240|9999201|FG010|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8938098|NCT02346240|9999202|FG011|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8938099|NCT02346240|9999203|FG012|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8938100|NCT02346240|9999204|FG013|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8938101|NCT02346240|9999205|FG014|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8938102|NCT02346240|9999206|FG015|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8938103|NCT02346240|9999207|FG016|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8938104|NCT02346240|9999208|FG017|COMPLETED|Open-Label Period (Week 48 to Week 144)||31
8938105|NCT02346240|9999209|FG018|COMPLETED|Open-Label Period (Week 48 to Week 144)||105
8938106|NCT02346240|9999210|FG019|COMPLETED|Open-Label Period (Week 48 to Week 144)||34
8938107|NCT02346240|9999211|FG020|COMPLETED|Open-Label Period (Week 48 to Week 144)||45
8938108|NCT02346240|9999212|FG021|COMPLETED|Open-Label Period (Week 48 to Week 144)||146
8938109|NCT02346240|9999213|FG022|COMPLETED|Open-Label Period (Week 48 to Week 144)||27
8938110|NCT02346240|9999214|FG023|COMPLETED|Open-Label Period (Week 48 to Week 144)||8
8938111|NCT02346240|9999191|FG000|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8938112|NCT02346240|9999192|FG001|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8938113|NCT02346240|9999193|FG002|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8938114|NCT02346240|9999194|FG003|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8938115|NCT02346240|9999195|FG004|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8938116|NCT02346240|9999196|FG005|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8938117|NCT02346240|9999197|FG006|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8938118|NCT02346240|9999198|FG007|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8938119|NCT02346240|9999199|FG008|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8938120|NCT02346240|9999200|FG009|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8938121|NCT02346240|9999201|FG010|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8938122|NCT02346240|9999202|FG011|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8938123|NCT02346240|9999203|FG012|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8938124|NCT02346240|9999204|FG013|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8938125|NCT02346240|9999205|FG014|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8938126|NCT02346240|9999206|FG015|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8938127|NCT02346240|9999207|FG016|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8938128|NCT02346240|9999208|FG017|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||3
8938129|NCT02346240|9999209|FG018|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||17
8938130|NCT02346240|9999210|FG019|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||7
8938131|NCT02346240|9999211|FG020|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||3
8938132|NCT02346240|9999212|FG021|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||31
8938133|NCT02346240|9999213|FG022|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||7
8938134|NCT02346240|9999214|FG023|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||8
8938135|NCT02346370|9999239|FG000|STARTED|Overall Study||8
8938136|NCT02346370|9999240|FG001|STARTED|Overall Study||4
8938137|NCT02346370|9999241|FG002|STARTED|Overall Study||4
8938138|NCT02346370|9999239|FG000|COMPLETED|Overall Study||0
8938139|NCT02346370|9999240|FG001|COMPLETED|Overall Study||0
8938140|NCT02346370|9999241|FG002|COMPLETED|Overall Study||0
8938141|NCT02346370|9999239|FG000|NOT COMPLETED|Overall Study||8
8938142|NCT02346370|9999240|FG001|NOT COMPLETED|Overall Study||4
8938143|NCT02346370|9999241|FG002|NOT COMPLETED|Overall Study||4
8938144|NCT02346383|9999251|FG000|STARTED|Overall Study||40
8938145|NCT02346383|9999251|FG000|COMPLETED|Overall Study||40
8938146|NCT02346383|9999251|FG000|NOT COMPLETED|Overall Study||0
8938147|NCT02346461|9999261|FG000|STARTED|Overall Study||6
8938148|NCT02346461|9999262|FG001|STARTED|Overall Study||6
8938149|NCT02346461|9999261|FG000|COMPLETED|Overall Study||6
8938150|NCT02346461|9999262|FG001|COMPLETED|Overall Study||6
8938151|NCT02346461|9999261|FG000|NOT COMPLETED|Overall Study||0
8938152|NCT02346461|9999262|FG001|NOT COMPLETED|Overall Study||0
8938153|NCT02346643|9999269|FG000|STARTED|Overall Study||41
8938154|NCT02346643|9999269|FG000|Received Trial System|Overall Study||29
8938155|NCT02346643|9999269|FG000|Received Permanent System|Overall Study||31
8938156|NCT02346643|9999269|FG000|COMPLETED|Overall Study||6
8719260|NCT01003184|9766722|FG001|NOT COMPLETED|Overall Study||12
8719261|NCT01003210|9766730|FG000|STARTED|Overall Study||105
8719262|NCT01003210|9766731|FG001|STARTED|Overall Study||105
8719263|NCT01003210|9766730|FG000|COMPLETED|Overall Study||104
8719264|NCT01003210|9766731|FG001|COMPLETED|Overall Study||102
8719265|NCT01003210|9766730|FG000|NOT COMPLETED|Overall Study||1
8719266|NCT01003210|9766731|FG001|NOT COMPLETED|Overall Study||3
8938157|NCT02346643|9999269|FG000|NOT COMPLETED|Overall Study||35
8938158|NCT02346708|9999275|FG000|STARTED|Overall Study||24
8938159|NCT02346708|9999276|FG001|STARTED|Overall Study||25
8938160|NCT02346708|9999275|FG000|COMPLETED|Overall Study||22
8938161|NCT02346708|9999276|FG001|COMPLETED|Overall Study||24
8938162|NCT02346708|9999275|FG000|NOT COMPLETED|Overall Study||2
8938163|NCT02346708|9999276|FG001|NOT COMPLETED|Overall Study||1
8719267|NCT01003249|9766737|FG000|STARTED|First Intervention (4 Weeks)||7
8938164|NCT02346721|9999283|FG000|STARTED|Overall Study||111
8938165|NCT02346721|9999283|FG000|COMPLETED|Overall Study||107
8938166|NCT02346721|9999283|FG000|NOT COMPLETED|Overall Study||4
8938167|NCT02346903|9999289|FG000|STARTED|Overall Study||99
8938168|NCT02346903|9999289|FG000|COMPLETED|Overall Study||99
8938169|NCT02346903|9999289|FG000|NOT COMPLETED|Overall Study||0
8938170|NCT02346916|9999293|FG000|STARTED|Overall Study||20
8938171|NCT02346916|9999293|FG000|COMPLETED|Overall Study||20
8938172|NCT02346916|9999293|FG000|NOT COMPLETED|Overall Study||0
8938173|NCT02347072|9999297|FG000|STARTED|Overall Study||80
8938174|NCT02347072|9999297|FG000|GFF MDI 14.4/9.6 µg|Overall Study||75
8938175|NCT02347072|9999297|FG000|Placebo MDI|Overall Study||72
8938176|NCT02347072|9999297|FG000|Spiriva Respimat 5 µg|Overall Study||73
8938177|NCT02347072|9999297|FG000|COMPLETED|Overall Study||62
8938178|NCT02347072|9999297|FG000|NOT COMPLETED|Overall Study||18
8938179|NCT02347085|9999305|FG000|STARTED|Overall Study||43
8938180|NCT02347085|9999305|FG000|GFF MDI 14.4/9.6 µg|Overall Study||40
8938181|NCT02347085|9999305|FG000|Placebo MDI|Overall Study||40
8938182|NCT02347085|9999305|FG000|COMPLETED|Overall Study||33
8938183|NCT02347085|9999305|FG000|NOT COMPLETED|Overall Study||10
8938184|NCT02347098|9999313|FG000|STARTED|Overall Study||63
8938185|NCT02347098|9999314|FG001|STARTED|Overall Study||66
8938186|NCT02347098|9999313|FG000|COMPLETED|Overall Study||56
8938187|NCT02347098|9999314|FG001|COMPLETED|Overall Study||58
8938188|NCT02347098|9999313|FG000|NOT COMPLETED|Overall Study||7
8938189|NCT02347098|9999314|FG001|NOT COMPLETED|Overall Study||8
8938190|NCT02347124|9999322|FG000|STARTED|Overall Study||360
8938191|NCT02347124|9999323|FG001|STARTED|Overall Study||358
8938192|NCT02347124|9999322|FG000|2 Month Follow-up|Overall Study||298
8938193|NCT02347124|9999323|FG001|2 Month Follow-up|Overall Study||275
8938194|NCT02347124|9999322|FG000|COMPLETED|Overall Study||267
8938195|NCT02347124|9999323|FG001|COMPLETED|Overall Study||259
8938196|NCT02347124|9999322|FG000|NOT COMPLETED|Overall Study||93
8938197|NCT02347124|9999323|FG001|NOT COMPLETED|Overall Study||99
8938198|NCT02347176|9999333|FG000|STARTED|Overall Study||51
8938199|NCT02347176|9999334|FG001|STARTED|Overall Study||50
8938200|NCT02347176|9999335|FG002|STARTED|Overall Study||51
8938201|NCT02347176|9999336|FG003|STARTED|Overall Study||52
8938202|NCT02347176|9999333|FG000|COMPLETED|Overall Study||39
8938203|NCT02347176|9999334|FG001|COMPLETED|Overall Study||40
8938204|NCT02347176|9999335|FG002|COMPLETED|Overall Study||43
8938205|NCT02347176|9999336|FG003|COMPLETED|Overall Study||48
8719268|NCT01003249|9766738|FG001|STARTED|First Intervention (4 Weeks)||5
8719269|NCT01003249|9766737|FG000|Received Intervention|First Intervention (4 Weeks)||7
8719270|NCT01003249|9766738|FG001|Received Intervention|First Intervention (4 Weeks)||5
8719271|NCT01003249|9766737|FG000|COMPLETED|First Intervention (4 Weeks)||5
8719272|NCT01003249|9766738|FG001|COMPLETED|First Intervention (4 Weeks)||3
8719273|NCT01003249|9766737|FG000|NOT COMPLETED|First Intervention (4 Weeks)||2
8719274|NCT01003249|9766738|FG001|NOT COMPLETED|First Intervention (4 Weeks)||2
8938206|NCT02347176|9999333|FG000|NOT COMPLETED|Overall Study||12
8938207|NCT02347176|9999334|FG001|NOT COMPLETED|Overall Study||10
8938208|NCT02347176|9999335|FG002|NOT COMPLETED|Overall Study||8
8938209|NCT02347176|9999336|FG003|NOT COMPLETED|Overall Study||4
8938210|NCT02347189|9999346|FG000|STARTED|Overall Study||39
8938211|NCT02347189|9999346|FG000|Catheterized|Overall Study||39
8938212|NCT02347189|9999346|FG000|Implanted|Overall Study||30
8938213|NCT02347189|9999346|FG000|Implanted > 24 Hours|Overall Study||30
8938214|NCT02347189|9999346|FG000|COMPLETED|Overall Study||28
8938215|NCT02347189|9999346|FG000|NOT COMPLETED|Overall Study||11
8938216|NCT02347332|9999363|FG000|STARTED|Overall Study||230
8938217|NCT02347332|9999364|FG001|STARTED|Overall Study||229
8938218|NCT02347332|9999363|FG000|COMPLETED|Overall Study|6 patients: suicide(1), unknown cause(5 - 4 at home +1 in city hospital).|0
8938219|NCT02347332|9999364|FG001|COMPLETED|Overall Study|6 patients: unknown cause(2home), PDsuspect(1home+1hosp), sudden death(1home), hypercapnie(1hosp).|0
8938220|NCT02347332|9999363|FG000|NOT COMPLETED|Overall Study||230
8938221|NCT02347332|9999364|FG001|NOT COMPLETED|Overall Study||229
8938222|NCT02347345|9999373|FG000|STARTED|Overall Study||10
8938223|NCT02347345|9999374|FG001|STARTED|Overall Study||12
8938224|NCT02347345|9999375|FG002|STARTED|Overall Study||12
8938225|NCT02347345|9999373|FG000|COMPLETED|Overall Study||10
8938226|NCT02347345|9999374|FG001|COMPLETED|Overall Study||12
8938227|NCT02347345|9999375|FG002|COMPLETED|Overall Study||12
8938228|NCT02347345|9999373|FG000|NOT COMPLETED|Overall Study||0
8938229|NCT02347345|9999374|FG001|NOT COMPLETED|Overall Study||0
8938230|NCT02347345|9999375|FG002|NOT COMPLETED|Overall Study||0
8938231|NCT02347410|9999386|FG000|STARTED|Overall Study||102
8938232|NCT02347410|9999386|FG000|COMPLETED|Overall Study||98
8938233|NCT02347410|9999386|FG000|NOT COMPLETED|Overall Study||4
8938234|NCT02347488|9999396|FG000|STARTED|Overall Study||30
8938235|NCT02347488|9999396|FG000|COMPLETED|Overall Study||30
8938236|NCT02347488|9999396|FG000|NOT COMPLETED|Overall Study||0
8938237|NCT02347605|9999408|FG000|STARTED|Overall Study||10
8938238|NCT02347605|9999409|FG001|STARTED|Overall Study||10
8938239|NCT02347605|9999410|FG002|STARTED|Overall Study||8
8938240|NCT02347605|9999411|FG003|STARTED|Overall Study||10
8938241|NCT02347605|9999412|FG004|STARTED|Overall Study||9
8938242|NCT02347605|9999413|FG005|STARTED|Overall Study||9
8938243|NCT02347605|9999408|FG000|Completed Lab 1|Overall Study||10
8938244|NCT02347605|9999409|FG001|Completed Lab 1|Overall Study||10
8938245|NCT02347605|9999410|FG002|Completed Lab 1|Overall Study||8
8938246|NCT02347605|9999411|FG003|Completed Lab 1|Overall Study||10
8938247|NCT02347605|9999412|FG004|Completed Lab 1|Overall Study||8
8938248|NCT02347605|9999413|FG005|Completed Lab 1|Overall Study||9
8938249|NCT02347605|9999408|FG000|Completed Lab 2|Overall Study||7
8938250|NCT02347605|9999409|FG001|Completed Lab 2|Overall Study||7
8938251|NCT02347605|9999410|FG002|Completed Lab 2|Overall Study||7
8938252|NCT02347605|9999411|FG003|Completed Lab 2|Overall Study||7
8938253|NCT02347605|9999412|FG004|Completed Lab 2|Overall Study||6
8938254|NCT02347605|9999413|FG005|Completed Lab 2|Overall Study||8
8938255|NCT02347605|9999408|FG000|COMPLETED|Overall Study||7
8938256|NCT02347605|9999409|FG001|COMPLETED|Overall Study||7
8938257|NCT02347605|9999410|FG002|COMPLETED|Overall Study||7
8938258|NCT02347605|9999411|FG003|COMPLETED|Overall Study||6
8938259|NCT02347605|9999412|FG004|COMPLETED|Overall Study||6
8938260|NCT02347605|9999413|FG005|COMPLETED|Overall Study||7
8938261|NCT02347605|9999408|FG000|NOT COMPLETED|Overall Study||3
8938262|NCT02347605|9999409|FG001|NOT COMPLETED|Overall Study||3
8938263|NCT02347605|9999410|FG002|NOT COMPLETED|Overall Study||1
8938264|NCT02347605|9999411|FG003|NOT COMPLETED|Overall Study||4
8938265|NCT02347605|9999412|FG004|NOT COMPLETED|Overall Study||3
8938266|NCT02347605|9999413|FG005|NOT COMPLETED|Overall Study||2
8938267|NCT02347631|9999423|FG000|STARTED|Washout 1 (1 Month)||61
8938268|NCT02347631|9999424|FG001|STARTED|Washout 1 (1 Month)||57
8938269|NCT02347631|9999423|FG000|COMPLETED|Washout 1 (1 Month)||61
8938270|NCT02347631|9999424|FG001|COMPLETED|Washout 1 (1 Month)||57
8938271|NCT02347631|9999423|FG000|NOT COMPLETED|Washout 1 (1 Month)||0
8938272|NCT02347631|9999424|FG001|NOT COMPLETED|Washout 1 (1 Month)||0
8938273|NCT02347631|9999423|FG000|STARTED|First Intervention (2 Months)||61
8938274|NCT02347631|9999424|FG001|STARTED|First Intervention (2 Months)||57
8938275|NCT02347631|9999423|FG000|COMPLETED|First Intervention (2 Months)||54
8938276|NCT02347631|9999424|FG001|COMPLETED|First Intervention (2 Months)||51
8938277|NCT02347631|9999423|FG000|NOT COMPLETED|First Intervention (2 Months)||7
8938278|NCT02347631|9999424|FG001|NOT COMPLETED|First Intervention (2 Months)||6
8938279|NCT02347631|9999423|FG000|STARTED|Washout 2 (1 Month)||54
8938280|NCT02347631|9999424|FG001|STARTED|Washout 2 (1 Month)||51
8938281|NCT02347631|9999423|FG000|COMPLETED|Washout 2 (1 Month)||52
8938282|NCT02347631|9999424|FG001|COMPLETED|Washout 2 (1 Month)||48
8938283|NCT02347631|9999423|FG000|NOT COMPLETED|Washout 2 (1 Month)||2
8938284|NCT02347631|9999424|FG001|NOT COMPLETED|Washout 2 (1 Month)||3
8938285|NCT02347631|9999423|FG000|STARTED|Second Intervention (2 Months)||52
8938286|NCT02347631|9999424|FG001|STARTED|Second Intervention (2 Months)||48
8938287|NCT02347631|9999423|FG000|COMPLETED|Second Intervention (2 Months)||39
8938288|NCT02347631|9999424|FG001|COMPLETED|Second Intervention (2 Months)||44
8938289|NCT02347631|9999423|FG000|NOT COMPLETED|Second Intervention (2 Months)||13
8938290|NCT02347631|9999424|FG001|NOT COMPLETED|Second Intervention (2 Months)||4
8938291|NCT02347657|9999434|FG000|STARTED|Overall Study||259
8938292|NCT02347657|9999435|FG001|STARTED|Overall Study||251
8938293|NCT02347657|9999434|FG000|Treated|Overall Study||258
8938294|NCT02347657|9999435|FG001|Treated|Overall Study||251
8938295|NCT02347657|9999434|FG000|COMPLETED|Overall Study||241
8938296|NCT02347657|9999435|FG001|COMPLETED|Overall Study||236
8938297|NCT02347657|9999434|FG000|NOT COMPLETED|Overall Study||18
8938298|NCT02347657|9999435|FG001|NOT COMPLETED|Overall Study||15
8938299|NCT02347761|9999445|FG000|STARTED|All Collected||218
8938300|NCT02347761|9999446|FG001|STARTED|All Collected||217
8938301|NCT02347761|9999447|FG002|STARTED|All Collected||218
8938302|NCT02347761|9999445|FG000|COMPLETED|All Collected||201
8938303|NCT02347761|9999446|FG001|COMPLETED|All Collected||203
8938304|NCT02347761|9999447|FG002|COMPLETED|All Collected||191
8938305|NCT02347761|9999445|FG000|NOT COMPLETED|All Collected||17
8938306|NCT02347761|9999446|FG001|NOT COMPLETED|All Collected||14
8938307|NCT02347761|9999447|FG002|NOT COMPLETED|All Collected||27
8938308|NCT02347761|9999445|FG000|STARTED|On Study Treatment||218
8938309|NCT02347761|9999446|FG001|STARTED|On Study Treatment||217
8938310|NCT02347761|9999447|FG002|STARTED|On Study Treatment||218
8938311|NCT02347761|9999445|FG000|COMPLETED|On Study Treatment||191
8938312|NCT02347761|9999446|FG001|COMPLETED|On Study Treatment||194
8938313|NCT02347761|9999447|FG002|COMPLETED|On Study Treatment||176
8938314|NCT02347761|9999445|FG000|NOT COMPLETED|On Study Treatment||27
8938315|NCT02347761|9999446|FG001|NOT COMPLETED|On Study Treatment||23
8938316|NCT02347761|9999447|FG002|NOT COMPLETED|On Study Treatment||42
8938317|NCT02347774|9999458|FG000|STARTED|Study Participation||214
8938318|NCT02347774|9999459|FG001|STARTED|Study Participation||214
8938319|NCT02347774|9999460|FG002|STARTED|Study Participation|One subject randomized in error to the placebo arm was never dosed .|213
8938320|NCT02347774|9999458|FG000|COMPLETED|Study Participation||199
8938321|NCT02347774|9999459|FG001|COMPLETED|Study Participation||193
8938322|NCT02347774|9999460|FG002|COMPLETED|Study Participation||188
8938323|NCT02347774|9999458|FG000|NOT COMPLETED|Study Participation||15
8938324|NCT02347774|9999459|FG001|NOT COMPLETED|Study Participation||21
8938325|NCT02347774|9999460|FG002|NOT COMPLETED|Study Participation||25
8938326|NCT02347774|9999458|FG000|STARTED|On Study Treatment||214
8938327|NCT02347774|9999459|FG001|STARTED|On Study Treatment||214
8938328|NCT02347774|9999460|FG002|STARTED|On Study Treatment|One subject randomized in error to the placebo arm was never dosed .|213
8938329|NCT02347774|9999458|FG000|COMPLETED|On Study Treatment||190
8938330|NCT02347774|9999459|FG001|COMPLETED|On Study Treatment||183
8938331|NCT02347774|9999460|FG002|COMPLETED|On Study Treatment||177
8938332|NCT02347774|9999458|FG000|NOT COMPLETED|On Study Treatment||24
8938333|NCT02347774|9999459|FG001|NOT COMPLETED|On Study Treatment||31
8938334|NCT02347774|9999460|FG002|NOT COMPLETED|On Study Treatment||36
8938335|NCT02347787|9999470|FG000|STARTED|6 Month Follow-Up||288
8938336|NCT02347787|9999471|FG001|STARTED|6 Month Follow-Up||304
8938337|NCT02347787|9999470|FG000|COMPLETED|6 Month Follow-Up||222
8938338|NCT02347787|9999471|FG001|COMPLETED|6 Month Follow-Up||248
8938339|NCT02347787|9999470|FG000|NOT COMPLETED|6 Month Follow-Up||66
8938340|NCT02347787|9999471|FG001|NOT COMPLETED|6 Month Follow-Up||56
8938341|NCT02347787|9999470|FG000|STARTED|9 Month Follow-Up||288
8938342|NCT02347787|9999471|FG001|STARTED|9 Month Follow-Up||304
8938343|NCT02347787|9999470|FG000|COMPLETED|9 Month Follow-Up||227
8938344|NCT02347787|9999471|FG001|COMPLETED|9 Month Follow-Up||233
8938345|NCT02347787|9999470|FG000|NOT COMPLETED|9 Month Follow-Up||61
8938346|NCT02347787|9999471|FG001|NOT COMPLETED|9 Month Follow-Up||71
8938347|NCT02347813|9999484|FG000|STARTED|First Intervention, 24 Weeks||6
8938348|NCT02347813|9999485|FG001|STARTED|First Intervention, 24 Weeks||6
8938349|NCT02347813|9999484|FG000|COMPLETED|First Intervention, 24 Weeks||4
8938350|NCT02347813|9999485|FG001|COMPLETED|First Intervention, 24 Weeks||4
8938351|NCT02347813|9999484|FG000|NOT COMPLETED|First Intervention, 24 Weeks||2
8938352|NCT02347813|9999485|FG001|NOT COMPLETED|First Intervention, 24 Weeks||2
8938353|NCT02347813|9999484|FG000|STARTED|Second Intervention, 24 Weeks||4
8938354|NCT02347813|9999485|FG001|STARTED|Second Intervention, 24 Weeks||4
8938355|NCT02347813|9999484|FG000|COMPLETED|Second Intervention, 24 Weeks||4
8938356|NCT02347813|9999485|FG001|COMPLETED|Second Intervention, 24 Weeks||4
8938357|NCT02347813|9999484|FG000|NOT COMPLETED|Second Intervention, 24 Weeks||0
8938358|NCT02347813|9999485|FG001|NOT COMPLETED|Second Intervention, 24 Weeks||0
8938359|NCT02348008|9999493|FG000|STARTED|Overall Study||3
8938360|NCT02348008|9999494|FG001|STARTED|Overall Study||10
8938361|NCT02348008|9999495|FG002|STARTED|Overall Study||48
8938362|NCT02348008|9999493|FG000|COMPLETED|Overall Study||0
8938363|NCT02348008|9999494|FG001|COMPLETED|Overall Study||0
8938364|NCT02348008|9999495|FG002|COMPLETED|Overall Study||29
8938365|NCT02348008|9999493|FG000|NOT COMPLETED|Overall Study||3
8938366|NCT02348008|9999494|FG001|NOT COMPLETED|Overall Study||10
8938367|NCT02348008|9999495|FG002|NOT COMPLETED|Overall Study||19
8938368|NCT02348203|9999503|FG000|STARTED|Overall Study||31
8938369|NCT02348203|9999504|FG001|STARTED|Overall Study||32
8938370|NCT02348203|9999503|FG000|COMPLETED|Overall Study||21
9065206|NCT04207840|10125555|FG001|COMPLETED|Treatment Period 3||10
9065207|NCT04207840|10125556|FG002|COMPLETED|Treatment Period 3||7
9065208|NCT04207840|10125554|FG000|NOT COMPLETED|Treatment Period 3||0
9065209|NCT04207840|10125555|FG001|NOT COMPLETED|Treatment Period 3||0
9065210|NCT04207840|10125556|FG002|NOT COMPLETED|Treatment Period 3||0
9065211|NCT04206800|10125566|FG000|STARTED|Overall Study||4
9065212|NCT04206800|10125567|FG001|STARTED|Overall Study||1
9065213|NCT04206800|10125566|FG000|COMPLETED|Overall Study||4
9065214|NCT04206800|10125567|FG001|COMPLETED|Overall Study||1
9065215|NCT04206800|10125566|FG000|NOT COMPLETED|Overall Study||0
9065216|NCT04206800|10125567|FG001|NOT COMPLETED|Overall Study||0
9065217|NCT04205669|10125575|FG000|STARTED|Overall Study||47
9065218|NCT04205669|10125576|FG001|STARTED|Overall Study||57
9065219|NCT04205669|10125575|FG000|COMPLETED|Overall Study||34
9065220|NCT04205669|10125576|FG001|COMPLETED|Overall Study||45
9065221|NCT04205669|10125575|FG000|NOT COMPLETED|Overall Study||13
9065222|NCT04205669|10125576|FG001|NOT COMPLETED|Overall Study||12
9065223|NCT04198948|10125584|FG000|STARTED|First Period||7
9065224|NCT04198948|10125585|FG001|STARTED|First Period||8
9065225|NCT04198948|10125584|FG000|COMPLETED|First Period||7
9065226|NCT04198948|10125585|FG001|COMPLETED|First Period||8
9065227|NCT04198948|10125584|FG000|NOT COMPLETED|First Period||0
9065228|NCT04198948|10125585|FG001|NOT COMPLETED|First Period||0
9065229|NCT04198948|10125584|FG000|STARTED|Wash-out (10 Days)||7
9065230|NCT04198948|10125585|FG001|STARTED|Wash-out (10 Days)||8
9065231|NCT04198948|10125584|FG000|COMPLETED|Wash-out (10 Days)||7
9065232|NCT04198948|10125585|FG001|COMPLETED|Wash-out (10 Days)||8
9065233|NCT04198948|10125584|FG000|NOT COMPLETED|Wash-out (10 Days)||0
9065234|NCT04198948|10125585|FG001|NOT COMPLETED|Wash-out (10 Days)||0
9065235|NCT04198948|10125584|FG000|STARTED|Second Period||7
8938371|NCT02348203|9999504|FG001|COMPLETED|Overall Study||22
8938372|NCT02348203|9999503|FG000|NOT COMPLETED|Overall Study||10
8938373|NCT02348203|9999504|FG001|NOT COMPLETED|Overall Study||10
9065236|NCT04198948|10125585|FG001|STARTED|Second Period||8
9065237|NCT04198948|10125584|FG000|COMPLETED|Second Period||7
9065238|NCT04198948|10125585|FG001|COMPLETED|Second Period||7
9065239|NCT04198948|10125584|FG000|NOT COMPLETED|Second Period||0
8938374|NCT02348385|9999512|FG000|STARTED|Overall Study||24
8938375|NCT02348385|9999513|FG001|STARTED|Overall Study||25
8938376|NCT02348385|9999512|FG000|COMPLETED|Overall Study||24
8938377|NCT02348385|9999513|FG001|COMPLETED|Overall Study||25
8938378|NCT02348385|9999512|FG000|NOT COMPLETED|Overall Study||0
8938379|NCT02348385|9999513|FG001|NOT COMPLETED|Overall Study||0
8938380|NCT02348489|9999523|FG000|STARTED|Overall Study||408
8938381|NCT02348489|9999524|FG001|STARTED|Overall Study||407
8938382|NCT02348489|9999523|FG000|COMPLETED|Overall Study||55
8938383|NCT02348489|9999524|FG001|COMPLETED|Overall Study||40
8938384|NCT02348489|9999523|FG000|NOT COMPLETED|Overall Study||353
8938385|NCT02348489|9999524|FG001|NOT COMPLETED|Overall Study||367
8938386|NCT02348593|9999536|FG000|STARTED|Overall Study||59
8938387|NCT02348593|9999537|FG001|STARTED|Overall Study||59
9065240|NCT04198948|10125585|FG001|NOT COMPLETED|Second Period||1
8938388|NCT02348593|9999538|FG002|STARTED|Overall Study||59
8938389|NCT02348593|9999539|FG003|STARTED|Overall Study||59
8938390|NCT02348593|9999536|FG000|COMPLETED|Overall Study||49
8938391|NCT02348593|9999537|FG001|COMPLETED|Overall Study||51
8938392|NCT02348593|9999538|FG002|COMPLETED|Overall Study||43
8938393|NCT02348593|9999539|FG003|COMPLETED|Overall Study||52
8719275|NCT01003249|9766737|FG000|STARTED|Washout (3 Weeks)||4
8719276|NCT01003249|9766738|FG001|STARTED|Washout (3 Weeks)||3
8719277|NCT01003249|9766737|FG000|COMPLETED|Washout (3 Weeks)||4
8719278|NCT01003249|9766738|FG001|COMPLETED|Washout (3 Weeks)||3
8719279|NCT01003249|9766737|FG000|NOT COMPLETED|Washout (3 Weeks)||0
8719280|NCT01003249|9766738|FG001|NOT COMPLETED|Washout (3 Weeks)||0
8719281|NCT01003249|9766737|FG000|STARTED|Second Intervention (4 Weeks)||4
8719282|NCT01003249|9766738|FG001|STARTED|Second Intervention (4 Weeks)||3
8719283|NCT01003249|9766737|FG000|COMPLETED|Second Intervention (4 Weeks)||3
8719284|NCT01003249|9766738|FG001|COMPLETED|Second Intervention (4 Weeks)||2
8719285|NCT01003249|9766737|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||1
8938394|NCT02348593|9999536|FG000|NOT COMPLETED|Overall Study||10
8938395|NCT02348593|9999537|FG001|NOT COMPLETED|Overall Study||8
8938396|NCT02348593|9999538|FG002|NOT COMPLETED|Overall Study||16
8938397|NCT02348593|9999539|FG003|NOT COMPLETED|Overall Study||7
8938398|NCT02348606|9999554|FG000|STARTED|Overall Study||58
8938399|NCT02348606|9999555|FG001|STARTED|Overall Study||62
8938400|NCT02348606|9999556|FG002|STARTED|Overall Study||117
8938401|NCT02348606|9999557|FG003|STARTED|Overall Study||118
8938402|NCT02348606|9999558|FG004|STARTED|Overall Study||119
8938403|NCT02348606|9999554|FG000|COMPLETED|Overall Study||49
8938404|NCT02348606|9999555|FG001|COMPLETED|Overall Study||54
8938405|NCT02348606|9999556|FG002|COMPLETED|Overall Study||106
8938406|NCT02348606|9999557|FG003|COMPLETED|Overall Study||94
8938407|NCT02348606|9999558|FG004|COMPLETED|Overall Study||101
8938408|NCT02348606|9999554|FG000|NOT COMPLETED|Overall Study||9
8938409|NCT02348606|9999555|FG001|NOT COMPLETED|Overall Study||8
8938410|NCT02348606|9999556|FG002|NOT COMPLETED|Overall Study||11
8938411|NCT02348606|9999557|FG003|NOT COMPLETED|Overall Study||24
8938412|NCT02348606|9999558|FG004|NOT COMPLETED|Overall Study||18
8938413|NCT02348619|9999570|FG000|STARTED|Titration Phase||174
8938414|NCT02348619|9999571|FG001|STARTED|Titration Phase||0
8938415|NCT02348619|9999570|FG000|COMPLETED|Titration Phase||157
8938416|NCT02348619|9999571|FG001|COMPLETED|Titration Phase||0
8938417|NCT02348619|9999570|FG000|NOT COMPLETED|Titration Phase||17
8938418|NCT02348619|9999571|FG001|NOT COMPLETED|Titration Phase||0
8938419|NCT02348619|9999570|FG000|STARTED|Stable-Dose Phase||157
8938420|NCT02348619|9999571|FG001|STARTED|Stable-Dose Phase||0
8938421|NCT02348619|9999570|FG000|COMPLETED|Stable-Dose Phase||124
8938422|NCT02348619|9999571|FG001|COMPLETED|Stable-Dose Phase||0
8938423|NCT02348619|9999570|FG000|NOT COMPLETED|Stable-Dose Phase||33
8938424|NCT02348619|9999571|FG001|NOT COMPLETED|Stable-Dose Phase||0
8938425|NCT02348619|9999570|FG000|STARTED|Double-Blind Withdrawal Phase||62
8938426|NCT02348619|9999571|FG001|STARTED|Double-Blind Withdrawal Phase||62
8938427|NCT02348619|9999570|FG000|COMPLETED|Double-Blind Withdrawal Phase||60
8938428|NCT02348619|9999571|FG001|COMPLETED|Double-Blind Withdrawal Phase||62
8938429|NCT02348619|9999570|FG000|NOT COMPLETED|Double-Blind Withdrawal Phase||2
8938430|NCT02348619|9999571|FG001|NOT COMPLETED|Double-Blind Withdrawal Phase||0
8938431|NCT02348632|9999577|FG000|STARTED|Open-label Period||643
8938432|NCT02348632|9999578|FG001|STARTED|Open-label Period||0
8938433|NCT02348632|9999577|FG000|COMPLETED|Open-label Period||458
8938434|NCT02348632|9999578|FG001|COMPLETED|Open-label Period||0
8938435|NCT02348632|9999577|FG000|NOT COMPLETED|Open-label Period||185
8938436|NCT02348632|9999578|FG001|NOT COMPLETED|Open-label Period||0
8938437|NCT02348632|9999577|FG000|STARTED|Randomized Withdrawal Period||140
9065241|NCT04206384|10125591|FG000|STARTED|Overall Study||52
9065242|NCT04206384|10125591|FG000|COMPLETED|Overall Study||42
9065243|NCT04206384|10125591|FG000|NOT COMPLETED|Overall Study||10
9065244|NCT04204200|10125598|FG000|STARTED|Overall Study||22
9065245|NCT04204200|10125599|FG001|STARTED|Overall Study||22
9065246|NCT04204200|10125600|FG002|STARTED|Overall Study||22
9065247|NCT04204200|10125598|FG000|COMPLETED|Overall Study||22
9065248|NCT04204200|10125599|FG001|COMPLETED|Overall Study||22
9065249|NCT04204200|10125600|FG002|COMPLETED|Overall Study||22
9065250|NCT04204200|10125598|FG000|NOT COMPLETED|Overall Study||0
9065251|NCT04204200|10125599|FG001|NOT COMPLETED|Overall Study||0
9065252|NCT04204200|10125600|FG002|NOT COMPLETED|Overall Study||0
9065253|NCT04196907|10125608|FG000|STARTED|Overall Study||20
9065254|NCT04196907|10125608|FG000|COMPLETED|Overall Study||20
9065255|NCT04196907|10125608|FG000|NOT COMPLETED|Overall Study||0
9065256|NCT04195893|10125612|FG000|STARTED|First Intervention||27
9065257|NCT04195893|10125613|FG001|STARTED|First Intervention||29
9065258|NCT04195893|10125612|FG000|COMPLETED|First Intervention||27
8938438|NCT02348632|9999578|FG001|STARTED|Randomized Withdrawal Period||142
8938439|NCT02348632|9999577|FG000|COMPLETED|Randomized Withdrawal Period||137
8938440|NCT02348632|9999578|FG001|COMPLETED|Randomized Withdrawal Period||141
8938441|NCT02348632|9999577|FG000|NOT COMPLETED|Randomized Withdrawal Period||3
8938442|NCT02348632|9999578|FG001|NOT COMPLETED|Randomized Withdrawal Period||1
8938443|NCT02348658|9999584|FG000|STARTED|Period 1 (7 Days)||6
8938444|NCT02348658|9999585|FG001|STARTED|Period 1 (7 Days)||6
8938445|NCT02348658|9999584|FG000|COMPLETED|Period 1 (7 Days)||6
9065259|NCT04195893|10125613|FG001|COMPLETED|First Intervention||29
9065260|NCT04195893|10125612|FG000|NOT COMPLETED|First Intervention||0
8938446|NCT02348658|9999585|FG001|COMPLETED|Period 1 (7 Days)||6
8938447|NCT02348658|9999584|FG000|NOT COMPLETED|Period 1 (7 Days)||0
8938448|NCT02348658|9999585|FG001|NOT COMPLETED|Period 1 (7 Days)||0
8938449|NCT02348658|9999584|FG000|STARTED|Washout Period (22 Days)||6
8938450|NCT02348658|9999585|FG001|STARTED|Washout Period (22 Days)||6
8938451|NCT02348658|9999584|FG000|COMPLETED|Washout Period (22 Days)||6
8938452|NCT02348658|9999585|FG001|COMPLETED|Washout Period (22 Days)||6
8938453|NCT02348658|9999584|FG000|NOT COMPLETED|Washout Period (22 Days)||0
8938454|NCT02348658|9999585|FG001|NOT COMPLETED|Washout Period (22 Days)||0
8938455|NCT02348658|9999584|FG000|STARTED|Period 2 (7 Days)||6
8938456|NCT02348658|9999585|FG001|STARTED|Period 2 (7 Days)||6
8938457|NCT02348658|9999584|FG000|COMPLETED|Period 2 (7 Days)||6
8938458|NCT02348658|9999585|FG001|COMPLETED|Period 2 (7 Days)||6
8938459|NCT02348658|9999584|FG000|NOT COMPLETED|Period 2 (7 Days)||0
8938460|NCT02348658|9999585|FG001|NOT COMPLETED|Period 2 (7 Days)||0
8938461|NCT02348684|9999591|FG000|STARTED|Overall Study||20
8938462|NCT02348684|9999591|FG000|COMPLETED|Overall Study||20
8938463|NCT02348684|9999591|FG000|NOT COMPLETED|Overall Study||0
8938464|NCT02348723|9999597|FG000|STARTED|Overall Study||338
8938465|NCT02348723|9999598|FG001|STARTED|Overall Study||338
8938466|NCT02348723|9999597|FG000|COMPLETED|Overall Study||310
8938467|NCT02348723|9999598|FG001|COMPLETED|Overall Study||312
8938468|NCT02348723|9999597|FG000|NOT COMPLETED|Overall Study||28
8938469|NCT02348723|9999598|FG001|NOT COMPLETED|Overall Study||26
8938470|NCT02348775|9999606|FG000|STARTED|Overall Study||8
8938471|NCT02348775|9999607|FG001|STARTED|Overall Study||8
8938472|NCT02348775|9999606|FG000|COMPLETED|Overall Study||8
8938473|NCT02348775|9999607|FG001|COMPLETED|Overall Study||8
8938474|NCT02348775|9999606|FG000|NOT COMPLETED|Overall Study||0
8938475|NCT02348775|9999607|FG001|NOT COMPLETED|Overall Study||0
8938476|NCT02348840|9999617|FG000|STARTED|Overall Study||23
8938477|NCT02348840|9999618|FG001|STARTED|Overall Study||21
8938478|NCT02348840|9999619|FG002|STARTED|Overall Study||425
8938479|NCT02348840|9999620|FG003|STARTED|Overall Study||374
8938480|NCT02348840|9999617|FG000|COMPLETED|Overall Study||21
8938481|NCT02348840|9999618|FG001|COMPLETED|Overall Study||20
8938482|NCT02348840|9999619|FG002|COMPLETED|Overall Study||425
8617355|NCT00455975|9655525|FG000|STARTED|Overall Study||58
8617356|NCT00455975|9655526|FG001|STARTED|Overall Study||61
8617357|NCT00455975|9655525|FG000|COMPLETED|Overall Study||40
8617358|NCT00455975|9655526|FG001|COMPLETED|Overall Study||40
8617359|NCT00455975|9655525|FG000|NOT COMPLETED|Overall Study||18
8617360|NCT00455975|9655526|FG001|NOT COMPLETED|Overall Study||21
8938483|NCT02348840|9999620|FG003|COMPLETED|Overall Study||374
8938484|NCT02348840|9999617|FG000|NOT COMPLETED|Overall Study||2
8938485|NCT02348840|9999618|FG001|NOT COMPLETED|Overall Study||1
8938486|NCT02348840|9999619|FG002|NOT COMPLETED|Overall Study||0
8938487|NCT02348840|9999620|FG003|NOT COMPLETED|Overall Study||0
8938488|NCT02348918|9999639|FG000|STARTED|Overall Study||39
8938489|NCT02348918|9999640|FG001|STARTED|Overall Study||33
8938490|NCT02348918|9999641|FG002|STARTED|Overall Study||42
8938491|NCT02348918|9999642|FG003|STARTED|Overall Study||24
8938492|NCT02348918|9999643|FG004|STARTED|Overall Study||19
8938493|NCT02348918|9999644|FG005|STARTED|Overall Study||17
8938494|NCT02348918|9999645|FG006|STARTED|Overall Study||13
8938495|NCT02348918|9999646|FG007|STARTED|Overall Study||16
8938496|NCT02348918|9999647|FG008|STARTED|Overall Study||15
8938497|NCT02348918|9999639|FG000|COMPLETED|Overall Study||39
8938498|NCT02348918|9999640|FG001|COMPLETED|Overall Study||33
8938499|NCT02348918|9999641|FG002|COMPLETED|Overall Study||42
8938500|NCT02348918|9999642|FG003|COMPLETED|Overall Study||24
8938501|NCT02348918|9999643|FG004|COMPLETED|Overall Study||19
8938502|NCT02348918|9999644|FG005|COMPLETED|Overall Study||17
8938503|NCT02348918|9999645|FG006|COMPLETED|Overall Study||13
8938504|NCT02348918|9999646|FG007|COMPLETED|Overall Study||16
8938505|NCT02348918|9999647|FG008|COMPLETED|Overall Study||15
8617361|NCT00456014|9655532|FG000|STARTED|SSRI Phase||37
8617362|NCT00456014|9655532|FG000|COMPLETED|SSRI Phase||28
8617363|NCT00456014|9655532|FG000|NOT COMPLETED|SSRI Phase||9
8617364|NCT00456014|9655532|FG000|STARTED|Tricyclic Phase|Only non-remitters from phase 1 were eligible for phase 2, and not all those eligible continued.|4
8617365|NCT00456014|9655532|FG000|COMPLETED|Tricyclic Phase||1
8617366|NCT00456014|9655532|FG000|NOT COMPLETED|Tricyclic Phase||3
8617367|NCT00456092|9655541|FG000|STARTED|Extension Phase|The Extension Phase was only open to participants enrolled after amendment 1 was in effect.|46
8617368|NCT00456092|9655542|FG001|STARTED|Extension Phase|The Extension Phase was only open to participants enrolled after amendment 1 was in effect.|40
8617369|NCT00456092|9655543|FG002|STARTED|Extension Phase||0
8617370|NCT00456092|9655544|FG003|STARTED|Extension Phase|The Extension Phase was only open to participants enrolled after amendment 1 was in effect.|20
8617371|NCT00456092|9655545|FG004|STARTED|Extension Phase|The Extension Phase was only open to participants enrolled after amendment 1 was in effect.|20
8617372|NCT00456092|9655541|FG000|COMPLETED|Extension Phase||35
8617373|NCT00456092|9655542|FG001|COMPLETED|Extension Phase||36
8617374|NCT00456092|9655543|FG002|COMPLETED|Extension Phase||0
8617375|NCT00456092|9655544|FG003|COMPLETED|Extension Phase||19
8617376|NCT00456092|9655545|FG004|COMPLETED|Extension Phase||13
8617377|NCT00456092|9655541|FG000|NOT COMPLETED|Extension Phase||11
8617378|NCT00456092|9655542|FG001|NOT COMPLETED|Extension Phase||4
8617379|NCT00456092|9655543|FG002|NOT COMPLETED|Extension Phase||0
8617380|NCT00456092|9655544|FG003|NOT COMPLETED|Extension Phase||1
8938506|NCT02348918|9999639|FG000|NOT COMPLETED|Overall Study||0
8938507|NCT02348918|9999640|FG001|NOT COMPLETED|Overall Study||0
8938508|NCT02348918|9999641|FG002|NOT COMPLETED|Overall Study||0
8938509|NCT02348918|9999642|FG003|NOT COMPLETED|Overall Study||0
8938510|NCT02348918|9999643|FG004|NOT COMPLETED|Overall Study||0
8938511|NCT02348918|9999644|FG005|NOT COMPLETED|Overall Study||0
8938512|NCT02348918|9999645|FG006|NOT COMPLETED|Overall Study||0
8938513|NCT02348918|9999646|FG007|NOT COMPLETED|Overall Study||0
8938514|NCT02348918|9999647|FG008|NOT COMPLETED|Overall Study||0
8938515|NCT02349048|9999669|FG000|STARTED|Overall Study||59
8938516|NCT02349048|9999670|FG001|STARTED|Overall Study||9
8938517|NCT02349048|9999669|FG000|COMPLETED|Overall Study||54
8938518|NCT02349048|9999670|FG001|COMPLETED|Overall Study||9
8938519|NCT02349048|9999669|FG000|NOT COMPLETED|Overall Study||5
8938520|NCT02349048|9999670|FG001|NOT COMPLETED|Overall Study||0
8938521|NCT02349061|9999678|FG000|STARTED|Main Study: PCP (Up to Week 24)||42
8938522|NCT02349061|9999679|FG001|STARTED|Main Study: PCP (Up to Week 24)||60
8938523|NCT02349061|9999680|FG002|STARTED|Main Study: PCP (Up to Week 24)||0
8938524|NCT02349061|9999678|FG000|COMPLETED|Main Study: PCP (Up to Week 24)||33
8719286|NCT01003249|9766738|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||1
8719287|NCT01003275|9766750|FG000|STARTED|Overall Study||11
8719288|NCT01003275|9766751|FG001|STARTED|Overall Study||11
8719289|NCT01003275|9766750|FG000|COMPLETED|Overall Study||10
8719290|NCT01003275|9766751|FG001|COMPLETED|Overall Study||11
8719291|NCT01003275|9766750|FG000|NOT COMPLETED|Overall Study||1
8938525|NCT02349061|9999679|FG001|COMPLETED|Main Study: PCP (Up to Week 24)||56
8938526|NCT02349061|9999680|FG002|COMPLETED|Main Study: PCP (Up to Week 24)||0
8938527|NCT02349061|9999678|FG000|NOT COMPLETED|Main Study: PCP (Up to Week 24)||9
8938528|NCT02349061|9999679|FG001|NOT COMPLETED|Main Study: PCP (Up to Week 24)||4
8938529|NCT02349061|9999680|FG002|NOT COMPLETED|Main Study: PCP (Up to Week 24)||0
8938530|NCT02349061|9999678|FG000|STARTED|Main Study: Week 24 to 56||0
8938531|NCT02349061|9999679|FG001|STARTED|Main Study: Week 24 to 56||56
8938532|NCT02349061|9999680|FG002|STARTED|Main Study: Week 24 to 56||33
8938533|NCT02349061|9999678|FG000|COMPLETED|Main Study: Week 24 to 56||0
8938534|NCT02349061|9999679|FG001|COMPLETED|Main Study: Week 24 to 56||53
8938535|NCT02349061|9999680|FG002|COMPLETED|Main Study: Week 24 to 56||30
8938536|NCT02349061|9999678|FG000|NOT COMPLETED|Main Study: Week 24 to 56||0
8938537|NCT02349061|9999679|FG001|NOT COMPLETED|Main Study: Week 24 to 56||3
8938538|NCT02349061|9999680|FG002|NOT COMPLETED|Main Study: Week 24 to 56||3
8938539|NCT02349061|9999678|FG000|STARTED|Study Extension (Week 56 to Week 120)||0
8938540|NCT02349061|9999679|FG001|STARTED|Study Extension (Week 56 to Week 120)|Who met study extension inclusion criteria received open-label ustekinumab SC through Week 104.|29
8938541|NCT02349061|9999680|FG002|STARTED|Study Extension (Week 56 to Week 120)|Who met study extension inclusion criteria received open-label ustekinumab SC through Week 104.|17
8938542|NCT02349061|9999678|FG000|COMPLETED|Study Extension (Week 56 to Week 120)||0
9065261|NCT04195893|10125613|FG001|NOT COMPLETED|First Intervention||0
9065262|NCT04195893|10125612|FG000|STARTED|Second Intervention||27
9065263|NCT04195893|10125613|FG001|STARTED|Second Intervention||29
9065264|NCT04195893|10125612|FG000|COMPLETED|Second Intervention||26
9065265|NCT04195893|10125613|FG001|COMPLETED|Second Intervention||29
9065266|NCT04195893|10125612|FG000|NOT COMPLETED|Second Intervention||1
9065267|NCT04195893|10125613|FG001|NOT COMPLETED|Second Intervention||0
9065268|NCT04195880|10125621|FG000|STARTED|Overall Study||3205
9065269|NCT04195880|10125622|FG001|STARTED|Overall Study||3338
9065270|NCT04195880|10125621|FG000|COMPLETED|Overall Study||3205
9065271|NCT04195880|10125622|FG001|COMPLETED|Overall Study||3338
9065272|NCT04195880|10125621|FG000|NOT COMPLETED|Overall Study||0
9065273|NCT04195880|10125622|FG001|NOT COMPLETED|Overall Study||0
9065274|NCT04195581|10125628|FG000|STARTED|Comfilcon A With All in One Light||28
9065275|NCT04195581|10125628|FG000|COMPLETED|Comfilcon A With All in One Light||24
9065276|NCT04195581|10125628|FG000|NOT COMPLETED|Comfilcon A With All in One Light||4
9065277|NCT04195581|10125628|FG000|STARTED|Comfilcon A With Hy-Care||30
9065278|NCT04195581|10125628|FG000|COMPLETED|Comfilcon A With Hy-Care||25
9065279|NCT04195581|10125628|FG000|NOT COMPLETED|Comfilcon A With Hy-Care||5
9065280|NCT04195581|10125628|FG000|STARTED|Comfilcon A With Refine One Step||25
9065281|NCT04195581|10125628|FG000|COMPLETED|Comfilcon A With Refine One Step||24
9065282|NCT04195581|10125628|FG000|NOT COMPLETED|Comfilcon A With Refine One Step||1
9065283|NCT04195581|10125628|FG000|STARTED|Fanfilcon A With All in One Light||28
9065284|NCT04195581|10125628|FG000|COMPLETED|Fanfilcon A With All in One Light||27
9065285|NCT04195581|10125628|FG000|NOT COMPLETED|Fanfilcon A With All in One Light||1
9065286|NCT04195581|10125628|FG000|STARTED|Fanfilcon A With Hy-Care||28
9065287|NCT04195581|10125628|FG000|COMPLETED|Fanfilcon A With Hy-Care||25
8719292|NCT01003275|9766751|FG001|NOT COMPLETED|Overall Study||0
9065288|NCT04195581|10125628|FG000|NOT COMPLETED|Fanfilcon A With Hy-Care||3
9065289|NCT04195581|10125628|FG000|STARTED|Fanfilcon A With Refine One Step||29
9065290|NCT04195581|10125628|FG000|COMPLETED|Fanfilcon A With Refine One Step||27
9065291|NCT04195581|10125628|FG000|NOT COMPLETED|Fanfilcon A With Refine One Step||2
9065292|NCT04194151|10125652|FG000|STARTED|Overall Study||32
9065293|NCT04194151|10125653|FG001|STARTED|Overall Study||32
9065294|NCT04194151|10125654|FG002|STARTED|Overall Study||32
9065295|NCT04194151|10125655|FG003|STARTED|Overall Study||32
9065296|NCT04194151|10125656|FG004|STARTED|Overall Study||32
9065297|NCT04194151|10125657|FG005|STARTED|Overall Study||32
9065298|NCT04194151|10125652|FG000|COMPLETED|Overall Study||31
8719293|NCT01003288|9766759|FG000|STARTED|Overall Study||255
8719294|NCT01003288|9766759|FG000|COMPLETED|Overall Study||255
9065299|NCT04194151|10125653|FG001|COMPLETED|Overall Study||30
9065300|NCT04194151|10125654|FG002|COMPLETED|Overall Study||31
9065301|NCT04194151|10125655|FG003|COMPLETED|Overall Study||31
9065302|NCT04194151|10125656|FG004|COMPLETED|Overall Study||32
9065303|NCT04194151|10125657|FG005|COMPLETED|Overall Study||31
9065304|NCT04194151|10125652|FG000|NOT COMPLETED|Overall Study||1
9065305|NCT04194151|10125653|FG001|NOT COMPLETED|Overall Study||2
9065306|NCT04194151|10125654|FG002|NOT COMPLETED|Overall Study||1
9065307|NCT04194151|10125655|FG003|NOT COMPLETED|Overall Study||1
9065308|NCT04194151|10125656|FG004|NOT COMPLETED|Overall Study||0
9065309|NCT04194151|10125657|FG005|NOT COMPLETED|Overall Study||1
9065310|NCT04194008|10125671|FG000|STARTED|Baseline (Run-in) Phase||126
9065311|NCT04194008|10125671|FG000|COMPLETED|Baseline (Run-in) Phase||99
9065312|NCT04194008|10125671|FG000|NOT COMPLETED|Baseline (Run-in) Phase||27
9065313|NCT04194008|10125671|FG000|STARTED|Treatment Phase With Nerivio||99
9065314|NCT04194008|10125671|FG000|COMPLETED|Treatment Phase With Nerivio||91
9065315|NCT04194008|10125671|FG000|NOT COMPLETED|Treatment Phase With Nerivio||8
9065316|NCT04191668|10125675|FG000|STARTED|Overall Study||106
9065317|NCT04191668|10125675|FG000|COMPLETED|Overall Study||106
9065318|NCT04191668|10125675|FG000|NOT COMPLETED|Overall Study||0
9065319|NCT04189081|10125682|FG000|STARTED|Overall Study||46
9065320|NCT04189081|10125683|FG001|STARTED|Overall Study||45
9065321|NCT04189081|10125684|FG002|STARTED|Overall Study||46
9065322|NCT04189081|10125682|FG000|COMPLETED|Overall Study||45
9065323|NCT04189081|10125683|FG001|COMPLETED|Overall Study||45
9065324|NCT04189081|10125684|FG002|COMPLETED|Overall Study||45
9065325|NCT04189081|10125682|FG000|NOT COMPLETED|Overall Study||1
9065326|NCT04189081|10125683|FG001|NOT COMPLETED|Overall Study||0
9065327|NCT04189081|10125684|FG002|NOT COMPLETED|Overall Study||1
9065328|NCT04186780|10125694|FG000|STARTED|Overall Study||36
9065329|NCT04186780|10125695|FG001|STARTED|Overall Study||32
9065330|NCT04186780|10125694|FG000|COMPLETED|Overall Study||22
9065331|NCT04186780|10125695|FG001|COMPLETED|Overall Study||25
9065332|NCT04186780|10125694|FG000|NOT COMPLETED|Overall Study||14
9065333|NCT04186780|10125695|FG001|NOT COMPLETED|Overall Study||7
9065334|NCT04186806|10125705|FG000|STARTED|Period 1: 7 Days||20
9065335|NCT04186806|10125706|FG001|STARTED|Period 1: 7 Days||20
9065336|NCT04186806|10125705|FG000|COMPLETED|Period 1: 7 Days||19
9065337|NCT04186806|10125706|FG001|COMPLETED|Period 1: 7 Days||20
8617381|NCT00456092|9655545|FG004|NOT COMPLETED|Extension Phase||7
8617382|NCT00456092|9655541|FG000|STARTED|Treatment Phase (12 Weeks)||67
9065338|NCT04186806|10125705|FG000|NOT COMPLETED|Period 1: 7 Days||1
9065339|NCT04186806|10125706|FG001|NOT COMPLETED|Period 1: 7 Days||0
9065340|NCT04186806|10125705|FG000|STARTED|Washout Period: at Least 2 Days||19
9065341|NCT04186806|10125706|FG001|STARTED|Washout Period: at Least 2 Days||20
9065342|NCT04186806|10125705|FG000|COMPLETED|Washout Period: at Least 2 Days||19
9065343|NCT04186806|10125706|FG001|COMPLETED|Washout Period: at Least 2 Days||20
9065344|NCT04186806|10125705|FG000|NOT COMPLETED|Washout Period: at Least 2 Days||0
9065345|NCT04186806|10125706|FG001|NOT COMPLETED|Washout Period: at Least 2 Days||0
9065346|NCT04186806|10125705|FG000|STARTED|Period 2: 7 Days||19
9065347|NCT04186806|10125706|FG001|STARTED|Period 2: 7 Days||20
9065348|NCT04186806|10125705|FG000|COMPLETED|Period 2: 7 Days||19
9065349|NCT04186806|10125706|FG001|COMPLETED|Period 2: 7 Days||20
9065350|NCT04186806|10125705|FG000|NOT COMPLETED|Period 2: 7 Days||0
9065351|NCT04186806|10125706|FG001|NOT COMPLETED|Period 2: 7 Days||0
9065352|NCT04186481|10125713|FG000|STARTED|Overall Study||32
9065353|NCT04186481|10125713|FG000|Completed 6 Month Visit|Overall Study||31
9065354|NCT04186481|10125713|FG000|Completed 12 Month Visit|Overall Study||4
9065355|NCT04186481|10125713|FG000|COMPLETED|Overall Study||32
9065356|NCT04186481|10125713|FG000|NOT COMPLETED|Overall Study||0
9065357|NCT04184999|10125719|FG000|STARTED|Overall Study||40
9065358|NCT04184999|10125720|FG001|STARTED|Overall Study||40
9065359|NCT04184999|10125719|FG000|3 Week Tear Film Osmolarity Testing|Overall Study||40
9065360|NCT04184999|10125720|FG001|3 Week Tear Film Osmolarity Testing|Overall Study||40
9065361|NCT04184999|10125719|FG000|COMPLETED|Overall Study||40
9065362|NCT04184999|10125720|FG001|COMPLETED|Overall Study||40
9065363|NCT04184999|10125719|FG000|NOT COMPLETED|Overall Study||0
9065364|NCT04184999|10125720|FG001|NOT COMPLETED|Overall Study||0
8938543|NCT02349061|9999679|FG001|COMPLETED|Study Extension (Week 56 to Week 120)||24
9065365|NCT04184271|10125726|FG000|STARTED|Overall Study||16
9065366|NCT04184271|10125726|FG000|COMPLETED|Overall Study||16
9065367|NCT04184271|10125726|FG000|NOT COMPLETED|Overall Study||0
8617383|NCT00456092|9655542|FG001|STARTED|Treatment Phase (12 Weeks)||69
8617384|NCT00456092|9655543|FG002|STARTED|Treatment Phase (12 Weeks)||68
8617385|NCT00456092|9655544|FG003|STARTED|Treatment Phase (12 Weeks)||0
8938544|NCT02349061|9999680|FG002|COMPLETED|Study Extension (Week 56 to Week 120)||14
8938545|NCT02349061|9999678|FG000|NOT COMPLETED|Study Extension (Week 56 to Week 120)||0
8938546|NCT02349061|9999679|FG001|NOT COMPLETED|Study Extension (Week 56 to Week 120)||5
8938547|NCT02349061|9999680|FG002|NOT COMPLETED|Study Extension (Week 56 to Week 120)||3
8938548|NCT02349152|9999692|FG000|STARTED|Overall Study||60
8617386|NCT00456092|9655545|FG004|STARTED|Treatment Phase (12 Weeks)||0
8617387|NCT00456092|9655541|FG000|COMPLETED|Treatment Phase (12 Weeks)||60
8617388|NCT00456092|9655542|FG001|COMPLETED|Treatment Phase (12 Weeks)||55
8938549|NCT02349152|9999693|FG001|STARTED|Overall Study||56
8938550|NCT02349152|9999692|FG000|COMPLETED|Overall Study||54
9065368|NCT04183231|10125730|FG000|STARTED|Overall Study||16
9065369|NCT04183231|10125730|FG000|COMPLETED|Overall Study||16
8938551|NCT02349152|9999693|FG001|COMPLETED|Overall Study||52
8938552|NCT02349152|9999692|FG000|NOT COMPLETED|Overall Study||6
8938553|NCT02349152|9999693|FG001|NOT COMPLETED|Overall Study||4
8938554|NCT02349178|9999699|FG000|STARTED|Overall Study||6
8938555|NCT02349178|9999699|FG000|COMPLETED|Overall Study||6
8938556|NCT02349178|9999699|FG000|NOT COMPLETED|Overall Study||0
8938557|NCT02349295|9999706|FG000|STARTED|Double Blind Treatment (Week 0-24)||123
8938558|NCT02349295|9999707|FG001|STARTED|Double Blind Treatment (Week 0-24)||122
8938559|NCT02349295|9999708|FG002|STARTED|Double Blind Treatment (Week 0-24)||118
8938560|NCT02349295|9999709|FG003|STARTED|Double Blind Treatment (Week 0-24)||0
8938561|NCT02349295|9999710|FG004|STARTED|Double Blind Treatment (Week 0-24)||0
8938562|NCT02349295|9999711|FG005|STARTED|Double Blind Treatment (Week 0-24)||0
8938563|NCT02349295|9999712|FG006|STARTED|Double Blind Treatment (Week 0-24)||0
8938564|NCT02349295|9999713|FG007|STARTED|Double Blind Treatment (Week 0-24)||0
8938565|NCT02349295|9999714|FG008|STARTED|Double Blind Treatment (Week 0-24)||0
8938566|NCT02349295|9999715|FG009|STARTED|Double Blind Treatment (Week 0-24)||0
8938567|NCT02349295|9999716|FG010|STARTED|Double Blind Treatment (Week 0-24)||0
8938568|NCT02349295|9999717|FG011|STARTED|Double Blind Treatment (Week 0-24)||0
8938569|NCT02349295|9999718|FG012|STARTED|Double Blind Treatment (Week 0-24)||0
8938570|NCT02349295|9999719|FG013|STARTED|Double Blind Treatment (Week 0-24)||0
8938571|NCT02349295|9999706|FG000|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||123
8938572|NCT02349295|9999707|FG001|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||122
8938573|NCT02349295|9999708|FG002|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||118
8938574|NCT02349295|9999709|FG003|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
8938575|NCT02349295|9999710|FG004|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
8938576|NCT02349295|9999711|FG005|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
8938577|NCT02349295|9999712|FG006|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
8938578|NCT02349295|9999713|FG007|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
8938579|NCT02349295|9999714|FG008|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
8938580|NCT02349295|9999715|FG009|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
8938581|NCT02349295|9999716|FG010|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
8938582|NCT02349295|9999717|FG011|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
8938583|NCT02349295|9999718|FG012|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
8938584|NCT02349295|9999719|FG013|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
8938585|NCT02349295|9999706|FG000|COMPLETED|Double Blind Treatment (Week 0-24)||109
8938586|NCT02349295|9999707|FG001|COMPLETED|Double Blind Treatment (Week 0-24)||111
8938587|NCT02349295|9999708|FG002|COMPLETED|Double Blind Treatment (Week 0-24)||94
8938588|NCT02349295|9999709|FG003|COMPLETED|Double Blind Treatment (Week 0-24)||0
8938589|NCT02349295|9999710|FG004|COMPLETED|Double Blind Treatment (Week 0-24)||0
8938590|NCT02349295|9999711|FG005|COMPLETED|Double Blind Treatment (Week 0-24)||0
8938591|NCT02349295|9999712|FG006|COMPLETED|Double Blind Treatment (Week 0-24)||0
8938592|NCT02349295|9999713|FG007|COMPLETED|Double Blind Treatment (Week 0-24)||0
8938593|NCT02349295|9999714|FG008|COMPLETED|Double Blind Treatment (Week 0-24)||0
8938594|NCT02349295|9999715|FG009|COMPLETED|Double Blind Treatment (Week 0-24)||0
8938595|NCT02349295|9999716|FG010|COMPLETED|Double Blind Treatment (Week 0-24)||0
8938596|NCT02349295|9999717|FG011|COMPLETED|Double Blind Treatment (Week 0-24)||0
8938597|NCT02349295|9999718|FG012|COMPLETED|Double Blind Treatment (Week 0-24)||0
8938598|NCT02349295|9999719|FG013|COMPLETED|Double Blind Treatment (Week 0-24)||0
8938599|NCT02349295|9999706|FG000|NOT COMPLETED|Double Blind Treatment (Week 0-24)||14
8938600|NCT02349295|9999707|FG001|NOT COMPLETED|Double Blind Treatment (Week 0-24)||11
8938601|NCT02349295|9999708|FG002|NOT COMPLETED|Double Blind Treatment (Week 0-24)||24
8938602|NCT02349295|9999709|FG003|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
8938603|NCT02349295|9999710|FG004|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
8938604|NCT02349295|9999711|FG005|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
8938605|NCT02349295|9999712|FG006|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
8938606|NCT02349295|9999713|FG007|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
8938607|NCT02349295|9999714|FG008|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
8938608|NCT02349295|9999715|FG009|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
8938609|NCT02349295|9999716|FG010|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
8938610|NCT02349295|9999717|FG011|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
8938611|NCT02349295|9999718|FG012|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
8938612|NCT02349295|9999719|FG013|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
8938613|NCT02349295|9999706|FG000|STARTED|IR (Week 16-24)|Only IR participants were included.|0
8938614|NCT02349295|9999707|FG001|STARTED|IR (Week 16-24)|Only IR participants were included.|0
8938615|NCT02349295|9999708|FG002|STARTED|IR (Week 16-24)|Only IR participants were included.|0
8938616|NCT02349295|9999709|FG003|STARTED|IR (Week 16-24)|IR from ixekizumab 80 mg Q2W only.|17
8938617|NCT02349295|9999710|FG004|STARTED|IR (Week 16-24)|IR from ixekizumab 80 mg Q4W only.|15
8938618|NCT02349295|9999711|FG005|STARTED|IR (Week 16-24)|IR from placebo who re-randomized (1:1) to ixekizumab 80 mg Q2W.|16
8938619|NCT02349295|9999712|FG006|STARTED|IR (Week 16-24)|IR from placebo who re-randomized (1:1) to ixekizumab 80 mg Q4W.|16
8938620|NCT02349295|9999713|FG007|STARTED|IR (Week 16-24)||0
8938621|NCT02349295|9999714|FG008|STARTED|IR (Week 16-24)||0
8938622|NCT02349295|9999715|FG009|STARTED|IR (Week 16-24)||0
8938623|NCT02349295|9999716|FG010|STARTED|IR (Week 16-24)||0
8938624|NCT02349295|9999717|FG011|STARTED|IR (Week 16-24)||0
8938625|NCT02349295|9999718|FG012|STARTED|IR (Week 16-24)||0
8938626|NCT02349295|9999719|FG013|STARTED|IR (Week 16-24)||0
8938627|NCT02349295|9999706|FG000|COMPLETED|IR (Week 16-24)||0
8938628|NCT02349295|9999707|FG001|COMPLETED|IR (Week 16-24)||0
8938629|NCT02349295|9999708|FG002|COMPLETED|IR (Week 16-24)||0
8938630|NCT02349295|9999709|FG003|COMPLETED|IR (Week 16-24)||16
8938631|NCT02349295|9999710|FG004|COMPLETED|IR (Week 16-24)||15
8938632|NCT02349295|9999711|FG005|COMPLETED|IR (Week 16-24)||16
8938633|NCT02349295|9999712|FG006|COMPLETED|IR (Week 16-24)||16
8938634|NCT02349295|9999713|FG007|COMPLETED|IR (Week 16-24)||0
8938635|NCT02349295|9999714|FG008|COMPLETED|IR (Week 16-24)||0
8938636|NCT02349295|9999715|FG009|COMPLETED|IR (Week 16-24)||0
8938637|NCT02349295|9999716|FG010|COMPLETED|IR (Week 16-24)||0
8938638|NCT02349295|9999717|FG011|COMPLETED|IR (Week 16-24)||0
8938639|NCT02349295|9999718|FG012|COMPLETED|IR (Week 16-24)||0
8938640|NCT02349295|9999719|FG013|COMPLETED|IR (Week 16-24)||0
8938641|NCT02349295|9999706|FG000|NOT COMPLETED|IR (Week 16-24)||0
8938642|NCT02349295|9999707|FG001|NOT COMPLETED|IR (Week 16-24)||0
8938643|NCT02349295|9999708|FG002|NOT COMPLETED|IR (Week 16-24)||0
8938644|NCT02349295|9999709|FG003|NOT COMPLETED|IR (Week 16-24)||1
8938645|NCT02349295|9999710|FG004|NOT COMPLETED|IR (Week 16-24)||0
8938646|NCT02349295|9999711|FG005|NOT COMPLETED|IR (Week 16-24)||0
8938647|NCT02349295|9999712|FG006|NOT COMPLETED|IR (Week 16-24)||0
8938648|NCT02349295|9999713|FG007|NOT COMPLETED|IR (Week 16-24)||0
8938649|NCT02349295|9999714|FG008|NOT COMPLETED|IR (Week 16-24)||0
8938650|NCT02349295|9999715|FG009|NOT COMPLETED|IR (Week 16-24)||0
8938651|NCT02349295|9999716|FG010|NOT COMPLETED|IR (Week 16-24)||0
8938652|NCT02349295|9999717|FG011|NOT COMPLETED|IR (Week 16-24)||0
8938653|NCT02349295|9999718|FG012|NOT COMPLETED|IR (Week 16-24)||0
8938654|NCT02349295|9999719|FG013|NOT COMPLETED|IR (Week 16-24)||0
8938655|NCT02349295|9999706|FG000|STARTED|Long-Term Extension Period (Week 24-156)||0
8938656|NCT02349295|9999707|FG001|STARTED|Long-Term Extension Period (Week 24-156)||0
8938657|NCT02349295|9999708|FG002|STARTED|Long-Term Extension Period (Week 24-156)||0
8938658|NCT02349295|9999709|FG003|STARTED|Long-Term Extension Period (Week 24-156)|Only included combined extension participants.|0
8938659|NCT02349295|9999710|FG004|STARTED|Long-Term Extension Period (Week 24-156)|Only included combined extension participants.|0
8938660|NCT02349295|9999711|FG005|STARTED|Long-Term Extension Period (Week 24-156)|Only included combined extension participants.|0
8938661|NCT02349295|9999712|FG006|STARTED|Long-Term Extension Period (Week 24-156)|Only included combined extension participants.|0
8938662|NCT02349295|9999713|FG007|STARTED|Long-Term Extension Period (Week 24-156)|IxeQ2W participants who entered the long-term extension period.|107
8938663|NCT02349295|9999714|FG008|STARTED|Long-Term Extension Period (Week 24-156)|IxeQ4W participants who entered the long-term extension period.|111
8938664|NCT02349295|9999715|FG009|STARTED|Long-Term Extension Period (Week 24-156)|Placebo/IxeQ2W participants who entered the long-term extension period.|46
8938665|NCT02349295|9999716|FG010|STARTED|Long-Term Extension Period (Week 24-156)|Placebo/IxeQ4W participants who entered the long-term extension period.|46
8938666|NCT02349295|9999717|FG011|STARTED|Long-Term Extension Period (Week 24-156)||0
8938667|NCT02349295|9999718|FG012|STARTED|Long-Term Extension Period (Week 24-156)||0
8938668|NCT02349295|9999719|FG013|STARTED|Long-Term Extension Period (Week 24-156)||0
8938669|NCT02349295|9999706|FG000|COMPLETED|Long-Term Extension Period (Week 24-156)||0
8938670|NCT02349295|9999707|FG001|COMPLETED|Long-Term Extension Period (Week 24-156)||0
8938671|NCT02349295|9999708|FG002|COMPLETED|Long-Term Extension Period (Week 24-156)||0
8938672|NCT02349295|9999709|FG003|COMPLETED|Long-Term Extension Period (Week 24-156)||0
8938673|NCT02349295|9999710|FG004|COMPLETED|Long-Term Extension Period (Week 24-156)||0
8938674|NCT02349295|9999711|FG005|COMPLETED|Long-Term Extension Period (Week 24-156)||0
8938675|NCT02349295|9999712|FG006|COMPLETED|Long-Term Extension Period (Week 24-156)||0
8938676|NCT02349295|9999713|FG007|COMPLETED|Long-Term Extension Period (Week 24-156)||55
8938677|NCT02349295|9999714|FG008|COMPLETED|Long-Term Extension Period (Week 24-156)||70
8938678|NCT02349295|9999715|FG009|COMPLETED|Long-Term Extension Period (Week 24-156)||20
8938679|NCT02349295|9999716|FG010|COMPLETED|Long-Term Extension Period (Week 24-156)||23
8938680|NCT02349295|9999717|FG011|COMPLETED|Long-Term Extension Period (Week 24-156)||0
8938681|NCT02349295|9999718|FG012|COMPLETED|Long-Term Extension Period (Week 24-156)||0
8938682|NCT02349295|9999719|FG013|COMPLETED|Long-Term Extension Period (Week 24-156)||0
8938683|NCT02349295|9999706|FG000|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
8938684|NCT02349295|9999707|FG001|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
8938685|NCT02349295|9999708|FG002|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
8938686|NCT02349295|9999709|FG003|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
8938687|NCT02349295|9999710|FG004|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
8938688|NCT02349295|9999711|FG005|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
8938689|NCT02349295|9999712|FG006|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
8938690|NCT02349295|9999713|FG007|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||52
8938691|NCT02349295|9999714|FG008|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||41
8938692|NCT02349295|9999715|FG009|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||26
8938693|NCT02349295|9999716|FG010|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||23
8938694|NCT02349295|9999717|FG011|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
8938695|NCT02349295|9999718|FG012|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
8938696|NCT02349295|9999719|FG013|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
8938697|NCT02349295|9999706|FG000|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
8938698|NCT02349295|9999707|FG001|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
8938699|NCT02349295|9999708|FG002|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
8938700|NCT02349295|9999709|FG003|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
8938701|NCT02349295|9999710|FG004|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
8938702|NCT02349295|9999711|FG005|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
8938703|NCT02349295|9999712|FG006|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
8938704|NCT02349295|9999713|FG007|STARTED|Follow-Up Period (Up to 12-24 Weeks)|Only included post-treatment follow-up participants.|0
8938705|NCT02349295|9999714|FG008|STARTED|Follow-Up Period (Up to 12-24 Weeks)|Only included post-treatment follow-up participants.|0
8938706|NCT02349295|9999715|FG009|STARTED|Follow-Up Period (Up to 12-24 Weeks)|Only included post-treatment follow-up participants.|0
8938707|NCT02349295|9999716|FG010|STARTED|Follow-Up Period (Up to 12-24 Weeks)|Only included post-treatment follow-up participants.|0
8938708|NCT02349295|9999717|FG011|STARTED|Follow-Up Period (Up to 12-24 Weeks)|IxeQ2W participants who entered post-treatment follow-up.|142
8938709|NCT02349295|9999718|FG012|STARTED|Follow-Up Period (Up to 12-24 Weeks)|IxeQ4W participants who entered post-treatment follow-up.|145
8938710|NCT02349295|9999719|FG013|STARTED|Follow-Up Period (Up to 12-24 Weeks)|PBO participants who entered post-treatment follow-up.|17
8938711|NCT02349295|9999706|FG000|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
8938712|NCT02349295|9999707|FG001|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
8938713|NCT02349295|9999708|FG002|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
8938714|NCT02349295|9999709|FG003|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
8938715|NCT02349295|9999710|FG004|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
8938716|NCT02349295|9999711|FG005|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
8938717|NCT02349295|9999712|FG006|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
8938718|NCT02349295|9999713|FG007|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
8938719|NCT02349295|9999714|FG008|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
8938720|NCT02349295|9999715|FG009|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
8938721|NCT02349295|9999716|FG010|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
8938722|NCT02349295|9999717|FG011|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||133
8938723|NCT02349295|9999718|FG012|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||137
8938724|NCT02349295|9999719|FG013|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||16
8938725|NCT02349295|9999706|FG000|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
8938726|NCT02349295|9999707|FG001|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
8938727|NCT02349295|9999708|FG002|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
8938728|NCT02349295|9999709|FG003|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
8938729|NCT02349295|9999710|FG004|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
8938730|NCT02349295|9999711|FG005|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
8938731|NCT02349295|9999712|FG006|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
8938732|NCT02349295|9999713|FG007|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
8938733|NCT02349295|9999714|FG008|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
8938734|NCT02349295|9999715|FG009|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
8938735|NCT02349295|9999716|FG010|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
8938736|NCT02349295|9999717|FG011|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||9
8938737|NCT02349295|9999718|FG012|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||8
8938738|NCT02349295|9999719|FG013|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||1
8938739|NCT02349360|9999746|FG000|STARTED|Overall Study||21
8938740|NCT02349360|9999747|FG001|STARTED|Overall Study||21
8938741|NCT02349360|9999746|FG000|COMPLETED|Overall Study||21
8938742|NCT02349360|9999747|FG001|COMPLETED|Overall Study||20
8938743|NCT02349360|9999746|FG000|NOT COMPLETED|Overall Study||0
8938744|NCT02349360|9999747|FG001|NOT COMPLETED|Overall Study||1
8938745|NCT02349412|9999755|FG000|STARTED|Overall Study||202
8938746|NCT02349412|9999756|FG001|STARTED|Overall Study||203
8938747|NCT02349412|9999755|FG000|Completed Week-12 QOL Assessment Measure|Overall Study||92
8938748|NCT02349412|9999756|FG001|Completed Week-12 QOL Assessment Measure|Overall Study||101
8938749|NCT02349412|9999755|FG000|Completed Week-24 QOL Assessment Measure|Overall Study||68
8938750|NCT02349412|9999756|FG001|Completed Week-24 QOL Assessment Measure|Overall Study||80
8938751|NCT02349412|9999755|FG000|COMPLETED|Overall Study||195
8938752|NCT02349412|9999756|FG001|COMPLETED|Overall Study||196
8938753|NCT02349412|9999755|FG000|NOT COMPLETED|Overall Study||7
8938754|NCT02349412|9999756|FG001|NOT COMPLETED|Overall Study||7
8938755|NCT02349425|9999766|FG000|STARTED|Period 1||15
8938756|NCT02349425|9999767|FG001|STARTED|Period 1||14
8938757|NCT02349425|9999768|FG002|STARTED|Period 1||15
8938758|NCT02349425|9999769|FG003|STARTED|Period 1||15
8938759|NCT02349425|9999766|FG000|COMPLETED|Period 1||14
8938760|NCT02349425|9999767|FG001|COMPLETED|Period 1||13
8938761|NCT02349425|9999768|FG002|COMPLETED|Period 1||15
8938762|NCT02349425|9999769|FG003|COMPLETED|Period 1||15
8938763|NCT02349425|9999766|FG000|NOT COMPLETED|Period 1||1
8938764|NCT02349425|9999767|FG001|NOT COMPLETED|Period 1||1
8938765|NCT02349425|9999768|FG002|NOT COMPLETED|Period 1||0
8938766|NCT02349425|9999769|FG003|NOT COMPLETED|Period 1||0
8938767|NCT02349425|9999766|FG000|STARTED|Period 2||14
8938768|NCT02349425|9999767|FG001|STARTED|Period 2||13
8938769|NCT02349425|9999768|FG002|STARTED|Period 2||15
8938770|NCT02349425|9999769|FG003|STARTED|Period 2||15
8938771|NCT02349425|9999766|FG000|COMPLETED|Period 2||14
8938772|NCT02349425|9999767|FG001|COMPLETED|Period 2||12
8938773|NCT02349425|9999768|FG002|COMPLETED|Period 2||14
8938774|NCT02349425|9999769|FG003|COMPLETED|Period 2||15
8938775|NCT02349425|9999766|FG000|NOT COMPLETED|Period 2||0
8938776|NCT02349425|9999767|FG001|NOT COMPLETED|Period 2||1
8938777|NCT02349425|9999768|FG002|NOT COMPLETED|Period 2||1
8938778|NCT02349425|9999769|FG003|NOT COMPLETED|Period 2||0
8938779|NCT02349438|9999807|FG000|STARTED|Period 1||11
8938780|NCT02349438|9999808|FG001|STARTED|Period 1||10
8938781|NCT02349438|9999807|FG000|COMPLETED|Period 1||11
8938782|NCT02349438|9999808|FG001|COMPLETED|Period 1||10
8938783|NCT02349438|9999807|FG000|NOT COMPLETED|Period 1||0
8938784|NCT02349438|9999808|FG001|NOT COMPLETED|Period 1||0
8938785|NCT02349438|9999807|FG000|STARTED|Period 2||11
8617389|NCT00456092|9655543|FG002|COMPLETED|Treatment Phase (12 Weeks)||50
8617390|NCT00456092|9655544|FG003|COMPLETED|Treatment Phase (12 Weeks)||0
8617391|NCT00456092|9655545|FG004|COMPLETED|Treatment Phase (12 Weeks)||0
8617392|NCT00456092|9655541|FG000|NOT COMPLETED|Treatment Phase (12 Weeks)||7
8617393|NCT00456092|9655542|FG001|NOT COMPLETED|Treatment Phase (12 Weeks)||14
8617394|NCT00456092|9655543|FG002|NOT COMPLETED|Treatment Phase (12 Weeks)||18
8617395|NCT00456092|9655544|FG003|NOT COMPLETED|Treatment Phase (12 Weeks)||0
8617396|NCT00456092|9655545|FG004|NOT COMPLETED|Treatment Phase (12 Weeks)||0
8938786|NCT02349438|9999808|FG001|STARTED|Period 2||10
8938787|NCT02349438|9999807|FG000|COMPLETED|Period 2||11
8938788|NCT02349438|9999808|FG001|COMPLETED|Period 2||10
8938789|NCT02349438|9999807|FG000|NOT COMPLETED|Period 2||0
8938790|NCT02349438|9999808|FG001|NOT COMPLETED|Period 2||0
8948630|NCT02431793|10011089|FG002|Completed T2 (7-14 Days Post Enrollment)|Overall Study||107
8948631|NCT02431793|10011087|FG000|Completed T3 (30 Days Post Enrollment)|Overall Study||85
8948632|NCT02431793|10011088|FG001|Completed T3 (30 Days Post Enrollment)|Overall Study||113
8617397|NCT00456300|9655559|FG000|STARTED|Overall Study||5
8617398|NCT00456300|9655560|FG001|STARTED|Overall Study||4
8617399|NCT00456300|9655559|FG000|COMPLETED|Overall Study||4
8617400|NCT00456300|9655560|FG001|COMPLETED|Overall Study||4
8617401|NCT00456300|9655559|FG000|NOT COMPLETED|Overall Study||1
8617402|NCT00456300|9655560|FG001|NOT COMPLETED|Overall Study||0
8617403|NCT00456365|9655570|FG000|STARTED|Overall Study||56
8617404|NCT00456365|9655571|FG001|STARTED|Overall Study||54
8617405|NCT00456365|9655570|FG000|COMPLETED|Overall Study||49
8617406|NCT00456365|9655571|FG001|COMPLETED|Overall Study||42
8617407|NCT00456365|9655570|FG000|NOT COMPLETED|Overall Study||7
8617408|NCT00456365|9655571|FG001|NOT COMPLETED|Overall Study||12
8617409|NCT00456495|9655579|FG000|STARTED|Overall Study||5
8617410|NCT00456495|9655579|FG000|COMPLETED|Overall Study||3
8617411|NCT00456495|9655579|FG000|NOT COMPLETED|Overall Study||2
8617412|NCT00456508|9655584|FG000|STARTED|Overall Study||147
8617413|NCT00456508|9655584|FG000|COMPLETED|Overall Study||147
8617414|NCT00456508|9655584|FG000|NOT COMPLETED|Overall Study||0
8617415|NCT00456521|9655590|FG000|STARTED|Overall Study||591
8617416|NCT00456521|9655591|FG001|STARTED|Overall Study||202
8617417|NCT00456521|9655590|FG000|COMPLETED|Overall Study||342
8617418|NCT00456521|9655591|FG001|COMPLETED|Overall Study||118
8617419|NCT00456521|9655590|FG000|NOT COMPLETED|Overall Study||249
8617420|NCT00456521|9655591|FG001|NOT COMPLETED|Overall Study||84
8617421|NCT00456547|9655600|FG000|STARTED|Overall Study||12
8617422|NCT00456547|9655601|FG001|STARTED|Overall Study||12
8617423|NCT00456547|9655600|FG000|COMPLETED|Overall Study||12
8617424|NCT00456547|9655601|FG001|COMPLETED|Overall Study||12
8617425|NCT00456547|9655600|FG000|NOT COMPLETED|Overall Study||0
8617426|NCT00456547|9655601|FG001|NOT COMPLETED|Overall Study||0
8617427|NCT00456599|9655607|FG000|STARTED|Overall Study||71
8617428|NCT00456599|9655607|FG000|Completed Cycle 1|Overall Study|Of the 71 patients, 1 was removed for noncompliance; 2 withdrew; 2 did not complete cycle 1.|66
8617429|NCT00456599|9655607|FG000|Initiated Cycle 2|Overall Study|5 patients were removed from study prior to initiation of a second cycle.|61
8617430|NCT00456599|9655607|FG000|Completed Protocol Surgery|Overall Study|Forty-eight patients (71%) underwent laparotomy according to the protocol.|48
8617431|NCT00456599|9655607|FG000|Completed Resection|Overall Study|43 patients underwent resection.|43
8617432|NCT00456599|9655607|FG000|Post-Surgery Adjuvent Therapy|Overall Study|After resection, 26 patients (68%) initiated adjuvant therapy.|26
8617433|NCT00456599|9655607|FG000|Completed 4th Cycle of Chemotherapy|Overall Study|24 patients (63%) completed a fourth cycle of chemotherapy.|24
8617434|NCT00456599|9655607|FG000|COMPLETED|Overall Study||68
8617435|NCT00456599|9655607|FG000|NOT COMPLETED|Overall Study||3
8617436|NCT00456625|9655611|FG000|STARTED|Overall Study||76
8617437|NCT00456625|9655611|FG000|COMPLETED|Overall Study||76
8617438|NCT00456625|9655611|FG000|NOT COMPLETED|Overall Study||0
8617439|NCT00456755|9655617|FG000|STARTED|Overall Study||63
8617440|NCT00456755|9655618|FG001|STARTED|Overall Study||63
8617441|NCT00456755|9655617|FG000|COMPLETED|Overall Study||61
8617442|NCT00456755|9655618|FG001|COMPLETED|Overall Study||62
8617443|NCT00456755|9655617|FG000|NOT COMPLETED|Overall Study||2
8948633|NCT02431793|10011089|FG002|Completed T3 (30 Days Post Enrollment)|Overall Study||93
8948634|NCT02431793|10011087|FG000|COMPLETED|Overall Study||83
8948635|NCT02431793|10011088|FG001|COMPLETED|Overall Study||109
8948636|NCT02431793|10011089|FG002|COMPLETED|Overall Study||90
8948637|NCT02431793|10011087|FG000|NOT COMPLETED|Overall Study||119
8948638|NCT02431793|10011088|FG001|NOT COMPLETED|Overall Study||134
8948639|NCT02431793|10011089|FG002|NOT COMPLETED|Overall Study||117
8617444|NCT00456755|9655618|FG001|NOT COMPLETED|Overall Study||1
8617445|NCT00456807|9655626|FG000|STARTED|Overall Study||53
8617446|NCT00456807|9655627|FG001|STARTED|Overall Study||47
8617447|NCT00456807|9655626|FG000|COMPLETED|Overall Study||52
8617448|NCT00456807|9655627|FG001|COMPLETED|Overall Study||47
8617449|NCT00456807|9655626|FG000|NOT COMPLETED|Overall Study||1
8617450|NCT00456807|9655627|FG001|NOT COMPLETED|Overall Study||0
8617451|NCT00456846|9655635|FG000|STARTED|Overall Study||47
8617452|NCT00456846|9655636|FG001|STARTED|Overall Study||76
8617453|NCT00456846|9655635|FG000|COMPLETED|Overall Study|Treatment considered completed upon disease progression|31
8617454|NCT00456846|9655636|FG001|COMPLETED|Overall Study|Treatment considered completed upon disease progression|48
8617455|NCT00456846|9655635|FG000|NOT COMPLETED|Overall Study||16
8617456|NCT00456846|9655636|FG001|NOT COMPLETED|Overall Study||28
8617457|NCT00456885|9655642|FG000|STARTED|First Treatment Period, 16 Weeks||24
8617458|NCT00456885|9655643|FG001|STARTED|First Treatment Period, 16 Weeks||17
8617459|NCT00456885|9655642|FG000|COMPLETED|First Treatment Period, 16 Weeks||24
8617460|NCT00456885|9655643|FG001|COMPLETED|First Treatment Period, 16 Weeks||17
8617461|NCT00456885|9655642|FG000|NOT COMPLETED|First Treatment Period, 16 Weeks||0
8617462|NCT00456885|9655643|FG001|NOT COMPLETED|First Treatment Period, 16 Weeks||0
8617463|NCT00456885|9655642|FG000|STARTED|Washout, 3 Weeks||24
8617464|NCT00456885|9655643|FG001|STARTED|Washout, 3 Weeks||17
8617465|NCT00456885|9655642|FG000|COMPLETED|Washout, 3 Weeks||24
8617466|NCT00456885|9655643|FG001|COMPLETED|Washout, 3 Weeks||17
8617467|NCT00456885|9655642|FG000|NOT COMPLETED|Washout, 3 Weeks||0
8617468|NCT00456885|9655643|FG001|NOT COMPLETED|Washout, 3 Weeks||0
8617469|NCT00456885|9655642|FG000|STARTED|Second Treatment Period, 16 Weeks||24
8617470|NCT00456885|9655643|FG001|STARTED|Second Treatment Period, 16 Weeks||17
8617471|NCT00456885|9655642|FG000|COMPLETED|Second Treatment Period, 16 Weeks||23
8617472|NCT00456885|9655643|FG001|COMPLETED|Second Treatment Period, 16 Weeks||17
8617473|NCT00456885|9655642|FG000|NOT COMPLETED|Second Treatment Period, 16 Weeks||1
8617474|NCT00456885|9655643|FG001|NOT COMPLETED|Second Treatment Period, 16 Weeks||0
8617475|NCT00457002|9655650|FG000|STARTED|Overall Study||3255
8617476|NCT00457002|9655651|FG001|STARTED|Overall Study||3273
8617477|NCT00457002|9655650|FG000|COMPLETED|Overall Study||2442
8617478|NCT00457002|9655651|FG001|COMPLETED|Overall Study||2516
8617479|NCT00457002|9655650|FG000|NOT COMPLETED|Overall Study||813
8617480|NCT00457002|9655651|FG001|NOT COMPLETED|Overall Study||757
8617481|NCT00457015|9655659|FG000|STARTED|Overall Study||48
8617482|NCT00457015|9655660|FG001|STARTED|Overall Study||48
8617483|NCT00457015|9655659|FG000|COMPLETED|Overall Study||48
8938791|NCT02349451|9999818|FG000|STARTED|Overall Study||24
8938792|NCT02349451|9999819|FG001|STARTED|Overall Study||72
8938793|NCT02349451|9999820|FG002|STARTED|Overall Study||71
8938794|NCT02349451|9999821|FG003|STARTED|Overall Study||73
8938795|NCT02349451|9999818|FG000|COMPLETED|Overall Study||24
8938796|NCT02349451|9999819|FG001|COMPLETED|Overall Study||71
8938797|NCT02349451|9999820|FG002|COMPLETED|Overall Study||69
8938798|NCT02349451|9999821|FG003|COMPLETED|Overall Study||72
8938799|NCT02349451|9999818|FG000|NOT COMPLETED|Overall Study||0
8938800|NCT02349451|9999819|FG001|NOT COMPLETED|Overall Study||1
8938801|NCT02349451|9999820|FG002|NOT COMPLETED|Overall Study||2
8938802|NCT02349451|9999821|FG003|NOT COMPLETED|Overall Study||1
8938803|NCT02349477|9999836|FG000|STARTED|Overall Study||44
8938804|NCT02349477|9999837|FG001|STARTED|Overall Study||46
8938805|NCT02349477|9999836|FG000|COMPLETED|Overall Study||31
8938806|NCT02349477|9999837|FG001|COMPLETED|Overall Study||28
8938807|NCT02349477|9999836|FG000|NOT COMPLETED|Overall Study||13
8938808|NCT02349477|9999837|FG001|NOT COMPLETED|Overall Study||18
8938809|NCT02349542|9999847|FG000|STARTED|Overall Study||20
8938810|NCT02349542|9999847|FG000|COMPLETED|Overall Study||15
8938811|NCT02349542|9999847|FG000|NOT COMPLETED|Overall Study||5
8938812|NCT02349633|9999865|FG000|STARTED|Overall Study||4
8938813|NCT02349633|9999866|FG001|STARTED|Overall Study||3
8938814|NCT02349633|9999867|FG002|STARTED|Overall Study||4
8938815|NCT02349633|9999868|FG003|STARTED|Overall Study||4
8938816|NCT02349633|9999869|FG004|STARTED|Overall Study||3
8938817|NCT02349633|9999870|FG005|STARTED|Overall Study||4
8938818|NCT02349633|9999871|FG006|STARTED|Overall Study||4
8938819|NCT02349633|9999872|FG007|STARTED|Overall Study||29
8938820|NCT02349633|9999873|FG008|STARTED|Overall Study||5
8938821|NCT02349633|9999874|FG009|STARTED|Overall Study||5
8617484|NCT00457015|9655660|FG001|COMPLETED|Overall Study||47
8617485|NCT00457015|9655659|FG000|NOT COMPLETED|Overall Study||0
8617486|NCT00457015|9655660|FG001|NOT COMPLETED|Overall Study||1
8617487|NCT00457197|9655668|FG000|STARTED|Overall Study||45
8617488|NCT00457197|9655669|FG001|STARTED|Overall Study||45
8617489|NCT00457197|9655668|FG000|COMPLETED|Overall Study||44
8617490|NCT00457197|9655669|FG001|COMPLETED|Overall Study||44
8617491|NCT00457197|9655668|FG000|NOT COMPLETED|Overall Study||1
8617492|NCT00457197|9655669|FG001|NOT COMPLETED|Overall Study||1
8617493|NCT00457249|9655677|FG000|STARTED|Overall Study||1170
8938822|NCT02349633|9999875|FG010|STARTED|Overall Study|No participants were enrolled in this cohort/arm prior to study termination.|0
8938823|NCT02349633|9999876|FG011|STARTED|Overall Study|No participants were enrolled in this cohort/arm prior to study termination.|0
8938824|NCT02349633|9999877|FG012|STARTED|Overall Study|No participants were enrolled in this cohort/arm prior to study termination.|0
8938825|NCT02349633|9999878|FG013|STARTED|Overall Study|No participants were enrolled in this cohort/arm prior to study termination.|0
8938826|NCT02349633|9999865|FG000|COMPLETED|Overall Study||4
8938827|NCT02349633|9999866|FG001|COMPLETED|Overall Study||2
8938828|NCT02349633|9999867|FG002|COMPLETED|Overall Study||4
8938829|NCT02349633|9999868|FG003|COMPLETED|Overall Study||2
8938830|NCT02349633|9999869|FG004|COMPLETED|Overall Study||1
8938831|NCT02349633|9999870|FG005|COMPLETED|Overall Study||3
8938832|NCT02349633|9999871|FG006|COMPLETED|Overall Study||3
8938833|NCT02349633|9999872|FG007|COMPLETED|Overall Study||13
8938834|NCT02349633|9999873|FG008|COMPLETED|Overall Study||3
8938835|NCT02349633|9999874|FG009|COMPLETED|Overall Study||0
8938836|NCT02349633|9999875|FG010|COMPLETED|Overall Study||0
8938837|NCT02349633|9999876|FG011|COMPLETED|Overall Study||0
8938838|NCT02349633|9999877|FG012|COMPLETED|Overall Study||0
8938839|NCT02349633|9999878|FG013|COMPLETED|Overall Study||0
8938840|NCT02349633|9999865|FG000|NOT COMPLETED|Overall Study||0
8938841|NCT02349633|9999866|FG001|NOT COMPLETED|Overall Study||1
8938842|NCT02349633|9999867|FG002|NOT COMPLETED|Overall Study||0
8938843|NCT02349633|9999868|FG003|NOT COMPLETED|Overall Study||2
8938844|NCT02349633|9999869|FG004|NOT COMPLETED|Overall Study||2
8938845|NCT02349633|9999870|FG005|NOT COMPLETED|Overall Study||1
8938846|NCT02349633|9999871|FG006|NOT COMPLETED|Overall Study||1
8938847|NCT02349633|9999872|FG007|NOT COMPLETED|Overall Study||16
8938848|NCT02349633|9999873|FG008|NOT COMPLETED|Overall Study||2
8938849|NCT02349633|9999874|FG009|NOT COMPLETED|Overall Study||5
8938850|NCT02349633|9999875|FG010|NOT COMPLETED|Overall Study||0
8938851|NCT02349633|9999876|FG011|NOT COMPLETED|Overall Study||0
8938852|NCT02349633|9999877|FG012|NOT COMPLETED|Overall Study||0
8938853|NCT02349633|9999878|FG013|NOT COMPLETED|Overall Study||0
8938854|NCT02349646|9999939|FG000|STARTED|Overall Study||33
8938855|NCT02349646|9999939|FG000|Received Trial System|Overall Study||24
8938856|NCT02349646|9999939|FG000|Receive Permanent System|Overall Study||27
8938857|NCT02349646|9999939|FG000|COMPLETED|Overall Study||16
8938858|NCT02349646|9999939|FG000|NOT COMPLETED|Overall Study||17
8938859|NCT02349685|9999946|FG000|STARTED|Overall Study||89
8938860|NCT02349685|9999947|FG001|STARTED|Overall Study||89
8938861|NCT02349685|9999948|FG002|STARTED|Overall Study||41
8938862|NCT02349685|9999946|FG000|COMPLETED|Overall Study||84
8938863|NCT02349685|9999947|FG001|COMPLETED|Overall Study||87
8938864|NCT02349685|9999948|FG002|COMPLETED|Overall Study||37
8938865|NCT02349685|9999946|FG000|NOT COMPLETED|Overall Study||5
8938866|NCT02349685|9999947|FG001|NOT COMPLETED|Overall Study||2
8938867|NCT02349685|9999948|FG002|NOT COMPLETED|Overall Study||4
8938868|NCT02349711|9999958|FG000|STARTED|Overall Study||87
8938869|NCT02349711|9999959|FG001|STARTED|Overall Study||86
8938870|NCT02349711|9999958|FG000|COMPLETED|Overall Study||84
8938871|NCT02349711|9999959|FG001|COMPLETED|Overall Study||84
8938872|NCT02349711|9999958|FG000|NOT COMPLETED|Overall Study||3
8938873|NCT02349711|9999959|FG001|NOT COMPLETED|Overall Study||2
8938874|NCT02349789|9999965|FG000|STARTED|Overall Study||11
8938875|NCT02349789|9999965|FG000|COMPLETED|Overall Study||9
8938876|NCT02349789|9999965|FG000|NOT COMPLETED|Overall Study||2
8938877|NCT02350127|9999971|FG000|STARTED|4-Month Assessment||44
8938878|NCT02350127|9999972|FG001|STARTED|4-Month Assessment||44
8938879|NCT02350127|9999971|FG000|Completed Baseline|4-Month Assessment|Withdrew prior to baseline due to time constraints (n=1) and lack of interest (n=1)|42
8938880|NCT02350127|9999972|FG001|Completed Baseline|4-Month Assessment|Withdrew prior to baseline due to health issue (n=1)|43
8938881|NCT02350127|9999971|FG000|COMPLETED|4-Month Assessment||33
8938882|NCT02350127|9999972|FG001|COMPLETED|4-Month Assessment||35
8938883|NCT02350127|9999971|FG000|NOT COMPLETED|4-Month Assessment||11
8938884|NCT02350127|9999972|FG001|NOT COMPLETED|4-Month Assessment||9
8938885|NCT02350127|9999971|FG000|STARTED|8-Month Assessment||33
8938886|NCT02350127|9999972|FG001|STARTED|8-Month Assessment||35
8938887|NCT02350127|9999971|FG000|COMPLETED|8-Month Assessment||27
8938888|NCT02350127|9999972|FG001|COMPLETED|8-Month Assessment||26
8938889|NCT02350127|9999971|FG000|NOT COMPLETED|8-Month Assessment||6
8938890|NCT02350127|9999972|FG001|NOT COMPLETED|8-Month Assessment||9
8938891|NCT02350309|9999985|FG000|STARTED|Treatment Period 1 (2 Days)||12
8938892|NCT02350309|9999986|FG001|STARTED|Treatment Period 1 (2 Days)||11
8938893|NCT02350309|9999987|FG002|STARTED|Treatment Period 1 (2 Days)||11
8938894|NCT02350309|9999988|FG003|STARTED|Treatment Period 1 (2 Days)||11
8938895|NCT02350309|9999989|FG004|STARTED|Treatment Period 1 (2 Days)||12
8938896|NCT02350309|9999990|FG005|STARTED|Treatment Period 1 (2 Days)||12
8938897|NCT02350309|9999985|FG000|COMPLETED|Treatment Period 1 (2 Days)||12
8938898|NCT02350309|9999986|FG001|COMPLETED|Treatment Period 1 (2 Days)||11
8938899|NCT02350309|9999987|FG002|COMPLETED|Treatment Period 1 (2 Days)||10
8938900|NCT02350309|9999988|FG003|COMPLETED|Treatment Period 1 (2 Days)||11
8938901|NCT02350309|9999989|FG004|COMPLETED|Treatment Period 1 (2 Days)||12
8938902|NCT02350309|9999990|FG005|COMPLETED|Treatment Period 1 (2 Days)||12
8938903|NCT02350309|9999985|FG000|NOT COMPLETED|Treatment Period 1 (2 Days)||0
8938904|NCT02350309|9999986|FG001|NOT COMPLETED|Treatment Period 1 (2 Days)||0
8938905|NCT02350309|9999987|FG002|NOT COMPLETED|Treatment Period 1 (2 Days)||1
8938906|NCT02350309|9999988|FG003|NOT COMPLETED|Treatment Period 1 (2 Days)||0
8938907|NCT02350309|9999989|FG004|NOT COMPLETED|Treatment Period 1 (2 Days)||0
8938908|NCT02350309|9999990|FG005|NOT COMPLETED|Treatment Period 1 (2 Days)||0
8938909|NCT02350309|9999985|FG000|STARTED|Washout Period 1 (12-16 Days)||12
8938910|NCT02350309|9999986|FG001|STARTED|Washout Period 1 (12-16 Days)||11
8938911|NCT02350309|9999987|FG002|STARTED|Washout Period 1 (12-16 Days)||10
8938912|NCT02350309|9999988|FG003|STARTED|Washout Period 1 (12-16 Days)||11
8938913|NCT02350309|9999989|FG004|STARTED|Washout Period 1 (12-16 Days)||12
8938914|NCT02350309|9999990|FG005|STARTED|Washout Period 1 (12-16 Days)||12
8938915|NCT02350309|9999985|FG000|COMPLETED|Washout Period 1 (12-16 Days)||12
8938916|NCT02350309|9999986|FG001|COMPLETED|Washout Period 1 (12-16 Days)||11
8938917|NCT02350309|9999987|FG002|COMPLETED|Washout Period 1 (12-16 Days)||10
8938918|NCT02350309|9999988|FG003|COMPLETED|Washout Period 1 (12-16 Days)||11
8938919|NCT02350309|9999989|FG004|COMPLETED|Washout Period 1 (12-16 Days)||12
8938920|NCT02350309|9999990|FG005|COMPLETED|Washout Period 1 (12-16 Days)||12
8938921|NCT02350309|9999985|FG000|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
8938922|NCT02350309|9999986|FG001|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
8938923|NCT02350309|9999987|FG002|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
8938924|NCT02350309|9999988|FG003|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
8617494|NCT00457249|9655678|FG001|STARTED|Overall Study||391
8617495|NCT00457249|9655677|FG000|COMPLETED|Overall Study||1158
8617496|NCT00457249|9655678|FG001|COMPLETED|Overall Study||389
8617497|NCT00457249|9655677|FG000|NOT COMPLETED|Overall Study||12
8938925|NCT02350309|9999989|FG004|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
8938926|NCT02350309|9999990|FG005|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
8938927|NCT02350309|9999985|FG000|STARTED|Treatment Period 2 (2 Days)||12
8938928|NCT02350309|9999986|FG001|STARTED|Treatment Period 2 (2 Days)||11
8938929|NCT02350309|9999987|FG002|STARTED|Treatment Period 2 (2 Days)||10
8938930|NCT02350309|9999988|FG003|STARTED|Treatment Period 2 (2 Days)||11
8938931|NCT02350309|9999989|FG004|STARTED|Treatment Period 2 (2 Days)||12
8938932|NCT02350309|9999990|FG005|STARTED|Treatment Period 2 (2 Days)||12
8938933|NCT02350309|9999985|FG000|COMPLETED|Treatment Period 2 (2 Days)||12
8938934|NCT02350309|9999986|FG001|COMPLETED|Treatment Period 2 (2 Days)||11
8938935|NCT02350309|9999987|FG002|COMPLETED|Treatment Period 2 (2 Days)||10
8938936|NCT02350309|9999988|FG003|COMPLETED|Treatment Period 2 (2 Days)||11
8938937|NCT02350309|9999989|FG004|COMPLETED|Treatment Period 2 (2 Days)||12
8938938|NCT02350309|9999990|FG005|COMPLETED|Treatment Period 2 (2 Days)||12
8938939|NCT02350309|9999985|FG000|NOT COMPLETED|Treatment Period 2 (2 Days)||0
8938940|NCT02350309|9999986|FG001|NOT COMPLETED|Treatment Period 2 (2 Days)||0
8938941|NCT02350309|9999987|FG002|NOT COMPLETED|Treatment Period 2 (2 Days)||0
8938942|NCT02350309|9999988|FG003|NOT COMPLETED|Treatment Period 2 (2 Days)||0
8938943|NCT02350309|9999989|FG004|NOT COMPLETED|Treatment Period 2 (2 Days)||0
8938944|NCT02350309|9999990|FG005|NOT COMPLETED|Treatment Period 2 (2 Days)||0
8938945|NCT02350309|9999985|FG000|STARTED|Washout Period 2 (12-16 Days)||12
8938946|NCT02350309|9999986|FG001|STARTED|Washout Period 2 (12-16 Days)||11
8938947|NCT02350309|9999987|FG002|STARTED|Washout Period 2 (12-16 Days)||10
8938948|NCT02350309|9999988|FG003|STARTED|Washout Period 2 (12-16 Days)||11
8938949|NCT02350309|9999989|FG004|STARTED|Washout Period 2 (12-16 Days)||12
8938950|NCT02350309|9999990|FG005|STARTED|Washout Period 2 (12-16 Days)||12
8938951|NCT02350309|9999985|FG000|COMPLETED|Washout Period 2 (12-16 Days)||12
8938952|NCT02350309|9999986|FG001|COMPLETED|Washout Period 2 (12-16 Days)||11
8938953|NCT02350309|9999987|FG002|COMPLETED|Washout Period 2 (12-16 Days)||10
8938954|NCT02350309|9999988|FG003|COMPLETED|Washout Period 2 (12-16 Days)||11
8938955|NCT02350309|9999989|FG004|COMPLETED|Washout Period 2 (12-16 Days)||12
8938956|NCT02350309|9999990|FG005|COMPLETED|Washout Period 2 (12-16 Days)||12
8938957|NCT02350309|9999985|FG000|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
8938958|NCT02350309|9999986|FG001|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
8617498|NCT00457249|9655678|FG001|NOT COMPLETED|Overall Study||2
8938959|NCT02350309|9999987|FG002|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
8938960|NCT02350309|9999988|FG003|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
8938961|NCT02350309|9999989|FG004|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
8938962|NCT02350309|9999990|FG005|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
8938963|NCT02350309|9999985|FG000|STARTED|Treatment Period 3 (2 Days)||12
8938964|NCT02350309|9999986|FG001|STARTED|Treatment Period 3 (2 Days)||11
8938965|NCT02350309|9999987|FG002|STARTED|Treatment Period 3 (2 Days)||10
8938966|NCT02350309|9999988|FG003|STARTED|Treatment Period 3 (2 Days)||11
8938967|NCT02350309|9999989|FG004|STARTED|Treatment Period 3 (2 Days)||12
8938968|NCT02350309|9999990|FG005|STARTED|Treatment Period 3 (2 Days)||12
8938969|NCT02350309|9999985|FG000|COMPLETED|Treatment Period 3 (2 Days)||12
8938970|NCT02350309|9999986|FG001|COMPLETED|Treatment Period 3 (2 Days)||11
8938971|NCT02350309|9999987|FG002|COMPLETED|Treatment Period 3 (2 Days)||10
8938972|NCT02350309|9999988|FG003|COMPLETED|Treatment Period 3 (2 Days)||11
8938973|NCT02350309|9999989|FG004|COMPLETED|Treatment Period 3 (2 Days)||12
8938974|NCT02350309|9999990|FG005|COMPLETED|Treatment Period 3 (2 Days)||12
8938975|NCT02350309|9999985|FG000|NOT COMPLETED|Treatment Period 3 (2 Days)||0
8938976|NCT02350309|9999986|FG001|NOT COMPLETED|Treatment Period 3 (2 Days)||0
8938977|NCT02350309|9999987|FG002|NOT COMPLETED|Treatment Period 3 (2 Days)||0
8938978|NCT02350309|9999988|FG003|NOT COMPLETED|Treatment Period 3 (2 Days)||0
8938979|NCT02350309|9999989|FG004|NOT COMPLETED|Treatment Period 3 (2 Days)||0
8938980|NCT02350309|9999990|FG005|NOT COMPLETED|Treatment Period 3 (2 Days)||0
8938981|NCT02350309|9999985|FG000|STARTED|Washout Period 3 (12-16 Days)||12
8938982|NCT02350309|9999986|FG001|STARTED|Washout Period 3 (12-16 Days)||11
8938983|NCT02350309|9999987|FG002|STARTED|Washout Period 3 (12-16 Days)||10
8938984|NCT02350309|9999988|FG003|STARTED|Washout Period 3 (12-16 Days)||11
8938985|NCT02350309|9999989|FG004|STARTED|Washout Period 3 (12-16 Days)||12
8938986|NCT02350309|9999990|FG005|STARTED|Washout Period 3 (12-16 Days)||12
8938987|NCT02350309|9999985|FG000|COMPLETED|Washout Period 3 (12-16 Days)||12
8938988|NCT02350309|9999986|FG001|COMPLETED|Washout Period 3 (12-16 Days)||11
8938989|NCT02350309|9999987|FG002|COMPLETED|Washout Period 3 (12-16 Days)||10
8938990|NCT02350309|9999988|FG003|COMPLETED|Washout Period 3 (12-16 Days)||11
8938991|NCT02350309|9999989|FG004|COMPLETED|Washout Period 3 (12-16 Days)||12
8938992|NCT02350309|9999990|FG005|COMPLETED|Washout Period 3 (12-16 Days)||12
8938993|NCT02350309|9999985|FG000|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
8938994|NCT02350309|9999986|FG001|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
8938995|NCT02350309|9999987|FG002|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
8938996|NCT02350309|9999988|FG003|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
8938997|NCT02350309|9999989|FG004|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
8938998|NCT02350309|9999990|FG005|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
8938999|NCT02350309|9999985|FG000|STARTED|Treatment Period 4 (2 Days)||12
8939000|NCT02350309|9999986|FG001|STARTED|Treatment Period 4 (2 Days)||11
8939001|NCT02350309|9999987|FG002|STARTED|Treatment Period 4 (2 Days)||10
8939002|NCT02350309|9999988|FG003|STARTED|Treatment Period 4 (2 Days)||11
8939003|NCT02350309|9999989|FG004|STARTED|Treatment Period 4 (2 Days)||12
8939004|NCT02350309|9999990|FG005|STARTED|Treatment Period 4 (2 Days)||12
8939005|NCT02350309|9999985|FG000|COMPLETED|Treatment Period 4 (2 Days)||12
8939006|NCT02350309|9999986|FG001|COMPLETED|Treatment Period 4 (2 Days)||11
8939007|NCT02350309|9999987|FG002|COMPLETED|Treatment Period 4 (2 Days)||10
8939008|NCT02350309|9999988|FG003|COMPLETED|Treatment Period 4 (2 Days)||11
8939009|NCT02350309|9999989|FG004|COMPLETED|Treatment Period 4 (2 Days)||12
8939010|NCT02350309|9999990|FG005|COMPLETED|Treatment Period 4 (2 Days)||11
8939011|NCT02350309|9999985|FG000|NOT COMPLETED|Treatment Period 4 (2 Days)||0
8939012|NCT02350309|9999986|FG001|NOT COMPLETED|Treatment Period 4 (2 Days)||0
8939013|NCT02350309|9999987|FG002|NOT COMPLETED|Treatment Period 4 (2 Days)||0
8617499|NCT00457301|9655688|FG000|STARTED|Overall Study||105
8617500|NCT00457301|9655689|FG001|STARTED|Overall Study||108
8617501|NCT00457301|9655688|FG000|COMPLETED|Overall Study||82
8617502|NCT00457301|9655689|FG001|COMPLETED|Overall Study||84
8617503|NCT00457301|9655688|FG000|NOT COMPLETED|Overall Study||23
8617504|NCT00457301|9655689|FG001|NOT COMPLETED|Overall Study||24
9065370|NCT04183231|10125730|FG000|NOT COMPLETED|Overall Study||0
9065371|NCT04182958|10125734|FG000|STARTED|Overall Study||8
9065372|NCT04182958|10125734|FG000|COMPLETED|Overall Study||8
9065373|NCT04182958|10125734|FG000|NOT COMPLETED|Overall Study||0
9065374|NCT04179838|10125740|FG000|STARTED|First Intervention (1 Day)||13
9065375|NCT04179838|10125741|FG001|STARTED|First Intervention (1 Day)||16
9065376|NCT04179838|10125740|FG000|COMPLETED|First Intervention (1 Day)||13
9065377|NCT04179838|10125741|FG001|COMPLETED|First Intervention (1 Day)||13
9065378|NCT04179838|10125740|FG000|NOT COMPLETED|First Intervention (1 Day)||0
9065379|NCT04179838|10125741|FG001|NOT COMPLETED|First Intervention (1 Day)||3
9065380|NCT04179838|10125740|FG000|STARTED|Washout (4 Weeks)||13
9065381|NCT04179838|10125741|FG001|STARTED|Washout (4 Weeks)||13
9065382|NCT04179838|10125740|FG000|COMPLETED|Washout (4 Weeks)||13
9065383|NCT04179838|10125741|FG001|COMPLETED|Washout (4 Weeks)||13
9065384|NCT04179838|10125740|FG000|NOT COMPLETED|Washout (4 Weeks)||0
9065385|NCT04179838|10125741|FG001|NOT COMPLETED|Washout (4 Weeks)||0
9065386|NCT04179838|10125740|FG000|STARTED|Second Intervention (1 Day)||13
9065387|NCT04179838|10125741|FG001|STARTED|Second Intervention (1 Day)||13
9065388|NCT04179838|10125740|FG000|COMPLETED|Second Intervention (1 Day)||13
9065389|NCT04179838|10125741|FG001|COMPLETED|Second Intervention (1 Day)||12
9065390|NCT04179838|10125740|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
9065391|NCT04179838|10125741|FG001|NOT COMPLETED|Second Intervention (1 Day)||1
9065392|NCT04179461|10125747|FG000|STARTED|Overall Study||21
9065393|NCT04179461|10125747|FG000|COMPLETED|Overall Study||17
9065394|NCT04179461|10125747|FG000|NOT COMPLETED|Overall Study||4
8939014|NCT02350309|9999988|FG003|NOT COMPLETED|Treatment Period 4 (2 Days)||0
8939015|NCT02350309|9999989|FG004|NOT COMPLETED|Treatment Period 4 (2 Days)||0
8939016|NCT02350309|9999990|FG005|NOT COMPLETED|Treatment Period 4 (2 Days)||1
8939017|NCT02350478|10000007|FG000|STARTED|Overall Study||25
8939018|NCT02350478|10000008|FG001|STARTED|Overall Study||24
8939019|NCT02350478|10000007|FG000|COMPLETED|Overall Study||20
9065395|NCT04179474|10125753|FG000|STARTED|Treatment Period 1 (First Intervention)||20
8939020|NCT02350478|10000008|FG001|COMPLETED|Overall Study||23
8939021|NCT02350478|10000007|FG000|NOT COMPLETED|Overall Study||5
8939022|NCT02350478|10000008|FG001|NOT COMPLETED|Overall Study||1
8939023|NCT02350569|10000014|FG000|STARTED|Main Study (LDV/SOF 4 Weeks)||16
8939024|NCT02350569|10000014|FG000|COMPLETED|Main Study (LDV/SOF 4 Weeks)|1 participant discontinued treatment, but completed follow-up visits and study.|16
8939025|NCT02350569|10000014|FG000|NOT COMPLETED|Main Study (LDV/SOF 4 Weeks)||0
8939026|NCT02350569|10000014|FG000|STARTED|Retreatment (LDV/SOF 12 Weeks)|1 completed treatment (Main Study), experienced virologic failure, and entered Retreatment Phase|1
8939027|NCT02350569|10000014|FG000|COMPLETED|Retreatment (LDV/SOF 12 Weeks)||1
8939028|NCT02350569|10000014|FG000|NOT COMPLETED|Retreatment (LDV/SOF 12 Weeks)||0
8939029|NCT02350647|10000022|FG000|STARTED|Overall Study||32
8939030|NCT02350647|10000023|FG001|STARTED|Overall Study||32
8939031|NCT02350647|10000022|FG000|COMPLETED|Overall Study||26
8939032|NCT02350647|10000023|FG001|COMPLETED|Overall Study||26
8939033|NCT02350647|10000022|FG000|NOT COMPLETED|Overall Study||6
8939034|NCT02350647|10000023|FG001|NOT COMPLETED|Overall Study||6
8939035|NCT02350660|10000031|FG000|STARTED|Overall Study||7
8939036|NCT02350660|10000032|FG001|STARTED|Overall Study||17
8939037|NCT02350660|10000031|FG000|COMPLETED|Overall Study||7
8939038|NCT02350660|10000032|FG001|COMPLETED|Overall Study||17
8939039|NCT02350660|10000031|FG000|NOT COMPLETED|Overall Study||0
8939040|NCT02350660|10000032|FG001|NOT COMPLETED|Overall Study||0
8939041|NCT02350816|10000042|FG000|STARTED|Overall Study||7
8939042|NCT02350816|10000043|FG001|STARTED|Overall Study||6
8939043|NCT02350816|10000044|FG002|STARTED|Overall Study||2
8939044|NCT02350816|10000045|FG003|STARTED|Overall Study||2
8939045|NCT02350816|10000042|FG000|COMPLETED|Overall Study||7
8939046|NCT02350816|10000043|FG001|COMPLETED|Overall Study||6
8939047|NCT02350816|10000044|FG002|COMPLETED|Overall Study||2
8939048|NCT02350816|10000045|FG003|COMPLETED|Overall Study||2
8939049|NCT02350816|10000042|FG000|NOT COMPLETED|Overall Study||0
8939050|NCT02350816|10000043|FG001|NOT COMPLETED|Overall Study||0
8939051|NCT02350816|10000044|FG002|NOT COMPLETED|Overall Study||0
8939052|NCT02350816|10000045|FG003|NOT COMPLETED|Overall Study||0
8939053|NCT02350881|10000055|FG000|STARTED|Overall Study|64 patients were included (6 bilateral)|64
8939054|NCT02350881|10000055|FG000|COMPLETED|Overall Study|64 patients were completed (6 bilateral)|64
9065396|NCT04179474|10125754|FG001|STARTED|Treatment Period 1 (First Intervention)||20
9065397|NCT04179474|10125753|FG000|COMPLETED|Treatment Period 1 (First Intervention)||20
9065398|NCT04179474|10125754|FG001|COMPLETED|Treatment Period 1 (First Intervention)||20
9065399|NCT04179474|10125753|FG000|NOT COMPLETED|Treatment Period 1 (First Intervention)||0
9065400|NCT04179474|10125754|FG001|NOT COMPLETED|Treatment Period 1 (First Intervention)||0
9065401|NCT04179474|10125753|FG000|STARTED|Treatment Period 2 (Second Intervention)|1 participant did not receive Intervention B.|19
9065402|NCT04179474|10125754|FG001|STARTED|Treatment Period 2 (Second Intervention)||20
9065403|NCT04179474|10125753|FG000|COMPLETED|Treatment Period 2 (Second Intervention)||19
9065404|NCT04179474|10125754|FG001|COMPLETED|Treatment Period 2 (Second Intervention)||20
9065405|NCT04179474|10125753|FG000|NOT COMPLETED|Treatment Period 2 (Second Intervention)||0
9065406|NCT04179474|10125754|FG001|NOT COMPLETED|Treatment Period 2 (Second Intervention)||0
9065407|NCT04179474|10125753|FG000|STARTED|Treatment Period 3 (Third Intervention)||19
9065408|NCT04179474|10125754|FG001|STARTED|Treatment Period 3 (Third Intervention)|1 participant did not receive Intervention D.|19
9065409|NCT04179474|10125753|FG000|COMPLETED|Treatment Period 3 (Third Intervention)||19
9065410|NCT04179474|10125754|FG001|COMPLETED|Treatment Period 3 (Third Intervention)||19
9065411|NCT04179474|10125753|FG000|NOT COMPLETED|Treatment Period 3 (Third Intervention)||0
9065412|NCT04179474|10125754|FG001|NOT COMPLETED|Treatment Period 3 (Third Intervention)||0
9065413|NCT04178590|10125775|FG000|STARTED|Overall Study||32
9065414|NCT04178590|10125775|FG000|COMPLETED|Overall Study||30
9065415|NCT04178590|10125775|FG000|NOT COMPLETED|Overall Study||2
9065416|NCT04177862|10125803|FG000|STARTED|Overall Study||35
9065417|NCT04177862|10125804|FG001|STARTED|Overall Study||40
9065418|NCT04177862|10125803|FG000|COMPLETED|Overall Study||33
9065419|NCT04177862|10125804|FG001|COMPLETED|Overall Study||33
9065420|NCT04177862|10125803|FG000|NOT COMPLETED|Overall Study||2
9065421|NCT04177862|10125804|FG001|NOT COMPLETED|Overall Study||7
9065422|NCT04176406|10125811|FG000|STARTED|Overall Study||0
9065423|NCT04176406|10125812|FG001|STARTED|Overall Study||0
9065424|NCT04176406|10125813|FG002|STARTED|Overall Study||0
9065425|NCT04176406|10125814|FG003|STARTED|Overall Study||0
9065426|NCT04176406|10125811|FG000|COMPLETED|Overall Study||0
9065427|NCT04176406|10125812|FG001|COMPLETED|Overall Study||0
9065428|NCT04176406|10125813|FG002|COMPLETED|Overall Study||0
8617505|NCT00457366|9655697|FG000|STARTED|Overall Study||40
8617506|NCT00457366|9655698|FG001|STARTED|Overall Study||32
8617507|NCT00457366|9655697|FG000|COMPLETED|Overall Study||40
8617508|NCT00457366|9655698|FG001|COMPLETED|Overall Study||32
8617509|NCT00457366|9655697|FG000|NOT COMPLETED|Overall Study||0
8939055|NCT02350881|10000055|FG000|NOT COMPLETED|Overall Study||0
8939056|NCT02350998|10000080|FG000|STARTED|Overall Study||33
8939057|NCT02350998|10000080|FG000|COMPLETED|Overall Study||33
9065429|NCT04176406|10125814|FG003|COMPLETED|Overall Study||0
9065430|NCT04176406|10125811|FG000|NOT COMPLETED|Overall Study||0
8617510|NCT00457366|9655698|FG001|NOT COMPLETED|Overall Study||0
8617511|NCT00457392|9655706|FG000|STARTED|Overall Study||480
8617512|NCT00457392|9655707|FG001|STARTED|Overall Study||480
8617513|NCT00457392|9655706|FG000|Treated|Overall Study||473
8939058|NCT02350998|10000080|FG000|NOT COMPLETED|Overall Study||0
8617514|NCT00457392|9655707|FG001|Treated|Overall Study||477
8617515|NCT00457392|9655706|FG000|COMPLETED|Overall Study||0
8617516|NCT00457392|9655707|FG001|COMPLETED|Overall Study||0
8617517|NCT00457392|9655706|FG000|NOT COMPLETED|Overall Study||480
8939059|NCT02351037|10000089|FG000|STARTED|Overall Study||7
8939060|NCT02351037|10000090|FG001|STARTED|Overall Study||21
8939061|NCT02351037|10000091|FG002|STARTED|Overall Study||8
8939062|NCT02351037|10000089|FG000|COMPLETED|Overall Study||7
8939063|NCT02351037|10000090|FG001|COMPLETED|Overall Study||21
8939064|NCT02351037|10000091|FG002|COMPLETED|Overall Study||8
8939065|NCT02351037|10000089|FG000|NOT COMPLETED|Overall Study||0
8939066|NCT02351037|10000090|FG001|NOT COMPLETED|Overall Study||0
8939067|NCT02351037|10000091|FG002|NOT COMPLETED|Overall Study||0
8939068|NCT02351115|10000104|FG000|STARTED|Overall Study||1
8939069|NCT02351115|10000105|FG001|STARTED|Overall Study||1
8939070|NCT02351115|10000106|FG002|STARTED|Overall Study||1
8939071|NCT02351115|10000107|FG003|STARTED|Overall Study||1
8939072|NCT02351115|10000108|FG004|STARTED|Overall Study||1
8939073|NCT02351115|10000104|FG000|COMPLETED|Overall Study||1
8939074|NCT02351115|10000105|FG001|COMPLETED|Overall Study||1
8939075|NCT02351115|10000106|FG002|COMPLETED|Overall Study||1
8939076|NCT02351115|10000107|FG003|COMPLETED|Overall Study||1
8939077|NCT02351115|10000108|FG004|COMPLETED|Overall Study||1
8939078|NCT02351115|10000104|FG000|NOT COMPLETED|Overall Study||0
8939079|NCT02351115|10000105|FG001|NOT COMPLETED|Overall Study||0
8939080|NCT02351115|10000106|FG002|NOT COMPLETED|Overall Study||0
8939081|NCT02351115|10000107|FG003|NOT COMPLETED|Overall Study||0
8939082|NCT02351115|10000108|FG004|NOT COMPLETED|Overall Study||0
8939083|NCT02351167|10000124|FG000|STARTED|Overall Study||275
8939084|NCT02351167|10000125|FG001|STARTED|Overall Study||274
8939085|NCT02351167|10000126|FG002|STARTED|Overall Study||273
8939086|NCT02351167|10000124|FG000|COMPLETED|Overall Study||256
8939087|NCT02351167|10000125|FG001|COMPLETED|Overall Study||256
8939088|NCT02351167|10000126|FG002|COMPLETED|Overall Study||252
8939089|NCT02351167|10000124|FG000|NOT COMPLETED|Overall Study||19
8939090|NCT02351167|10000125|FG001|NOT COMPLETED|Overall Study||18
8939091|NCT02351167|10000126|FG002|NOT COMPLETED|Overall Study||21
8939092|NCT02351258|10000135|FG000|STARTED|Intervention 1 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|
8939093|NCT02351258|10000136|FG001|STARTED|Intervention 1 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|
8939094|NCT02351258|10000135|FG000|COMPLETED|Intervention 1 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|
8939095|NCT02351258|10000136|FG001|COMPLETED|Intervention 1 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|
8939096|NCT02351258|10000135|FG000|NOT COMPLETED|Intervention 1 (12 Months)||
8939097|NCT02351258|10000136|FG001|NOT COMPLETED|Intervention 1 (12 Months)||
8939098|NCT02351258|10000135|FG000|STARTED|Washout (2-3 Months)|Number of participants is not available for this study, only clinic-level data collected.|
8939099|NCT02351258|10000136|FG001|STARTED|Washout (2-3 Months)|Number of participants is not available for this study, only clinic-level data collected.|
8939100|NCT02351258|10000135|FG000|COMPLETED|Washout (2-3 Months)|Number of participants is not available for this study, only clinic-level data collected.|
8939101|NCT02351258|10000136|FG001|COMPLETED|Washout (2-3 Months)|Number of participants is not available for this study, only clinic-level data collected.|
8939102|NCT02351258|10000135|FG000|NOT COMPLETED|Washout (2-3 Months)||
8939103|NCT02351258|10000136|FG001|NOT COMPLETED|Washout (2-3 Months)||
8939104|NCT02351258|10000135|FG000|STARTED|Intervention 2 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|
8939105|NCT02351258|10000136|FG001|STARTED|Intervention 2 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|
8939106|NCT02351258|10000135|FG000|COMPLETED|Intervention 2 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|
8939107|NCT02351258|10000136|FG001|COMPLETED|Intervention 2 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|
8939108|NCT02351258|10000135|FG000|NOT COMPLETED|Intervention 2 (12 Months)||
8939109|NCT02351258|10000136|FG001|NOT COMPLETED|Intervention 2 (12 Months)||
8939110|NCT02351271|10000143|FG000|STARTED|Overall Study||68
8939111|NCT02351271|10000144|FG001|STARTED|Overall Study||62
8939112|NCT02351271|10000143|FG000|COMPLETED|Overall Study||68
8939113|NCT02351271|10000144|FG001|COMPLETED|Overall Study||62
8939114|NCT02351271|10000143|FG000|NOT COMPLETED|Overall Study||0
8939115|NCT02351271|10000144|FG001|NOT COMPLETED|Overall Study||0
8939116|NCT02351349|10000154|FG000|STARTED|Overall Study||6
8939117|NCT02351349|10000155|FG001|STARTED|Overall Study||8
8939118|NCT02351349|10000154|FG000|COMPLETED|Overall Study||4
8939119|NCT02351349|10000155|FG001|COMPLETED|Overall Study||5
8939120|NCT02351349|10000154|FG000|NOT COMPLETED|Overall Study||2
8939121|NCT02351349|10000155|FG001|NOT COMPLETED|Overall Study||3
8939122|NCT02351505|10000166|FG000|STARTED|Overall Study||1
8617518|NCT00457392|9655707|FG001|NOT COMPLETED|Overall Study||480
8939123|NCT02351505|10000166|FG000|COMPLETED|Overall Study||1
8939124|NCT02351505|10000166|FG000|NOT COMPLETED|Overall Study||0
8939125|NCT02351700|10000173|FG000|STARTED|Overall Study||28
8939126|NCT02351700|10000174|FG001|STARTED|Overall Study||34
8939127|NCT02351700|10000173|FG000|COMPLETED|Overall Study||28
8939128|NCT02351700|10000174|FG001|COMPLETED|Overall Study||34
8939129|NCT02351700|10000173|FG000|NOT COMPLETED|Overall Study||0
8939130|NCT02351700|10000174|FG001|NOT COMPLETED|Overall Study||0
8939131|NCT02351739|10000184|FG000|STARTED|Overall Study||38
8939132|NCT02351739|10000185|FG001|STARTED|Overall Study||40
8939133|NCT02351739|10000184|FG000|Enrolled|Overall Study||38
8939134|NCT02351739|10000185|FG001|Enrolled|Overall Study||40
8939135|NCT02351739|10000184|FG000|Received Study Medication|Overall Study||35
8939136|NCT02351739|10000185|FG001|Received Study Medication|Overall Study||40
8939137|NCT02351739|10000184|FG000|Discontinued Study|Overall Study||38
8939138|NCT02351739|10000185|FG001|Discontinued Study|Overall Study||40
8939139|NCT02351739|10000184|FG000|COMPLETED|Overall Study||0
8939140|NCT02351739|10000185|FG001|COMPLETED|Overall Study||0
8939141|NCT02351739|10000184|FG000|NOT COMPLETED|Overall Study||38
8939142|NCT02351739|10000185|FG001|NOT COMPLETED|Overall Study||40
8939143|NCT02351817|10000191|FG000|STARTED|Baseline Period||5
8939144|NCT02351817|10000192|FG001|STARTED|Baseline Period||5
8939145|NCT02351817|10000191|FG000|COMPLETED|Baseline Period||5
8939146|NCT02351817|10000192|FG001|COMPLETED|Baseline Period||5
8939147|NCT02351817|10000191|FG000|NOT COMPLETED|Baseline Period||0
8939148|NCT02351817|10000192|FG001|NOT COMPLETED|Baseline Period||0
8939149|NCT02351817|10000191|FG000|STARTED|Period 1||5
8939150|NCT02351817|10000192|FG001|STARTED|Period 1||5
8939151|NCT02351817|10000191|FG000|COMPLETED|Period 1||4
8939152|NCT02351817|10000192|FG001|COMPLETED|Period 1||2
8939153|NCT02351817|10000191|FG000|NOT COMPLETED|Period 1||1
8939154|NCT02351817|10000192|FG001|NOT COMPLETED|Period 1||3
8939155|NCT02351817|10000191|FG000|STARTED|Period 2|Subjects who did not complete Period 1 as planned were allowed to continue to Period 2|5
8939156|NCT02351817|10000192|FG001|STARTED|Period 2|Subjects who did not complete Period 1 as planned were allowed to continue to Period 2|5
8939157|NCT02351817|10000191|FG000|COMPLETED|Period 2||4
8939158|NCT02351817|10000192|FG001|COMPLETED|Period 2||3
8939159|NCT02351817|10000191|FG000|NOT COMPLETED|Period 2||1
8939160|NCT02351817|10000192|FG001|NOT COMPLETED|Period 2||2
8939161|NCT02351934|10000201|FG000|STARTED|Allocation||62
8939162|NCT02351934|10000202|FG001|STARTED|Allocation||61
8939163|NCT02351934|10000201|FG000|Received Allocation|Allocation||56
8939164|NCT02351934|10000202|FG001|Received Allocation|Allocation||61
8939165|NCT02351934|10000201|FG000|COMPLETED|Allocation||56
8939166|NCT02351934|10000202|FG001|COMPLETED|Allocation||61
8939167|NCT02351934|10000201|FG000|NOT COMPLETED|Allocation||6
8939168|NCT02351934|10000202|FG001|NOT COMPLETED|Allocation||0
8939169|NCT02351934|10000201|FG000|STARTED|Follow-Up||56
8939170|NCT02351934|10000202|FG001|STARTED|Follow-Up||61
8939171|NCT02351934|10000201|FG000|COMPLETED|Follow-Up||44
8939172|NCT02351934|10000202|FG001|COMPLETED|Follow-Up||51
8939173|NCT02351934|10000201|FG000|NOT COMPLETED|Follow-Up||12
8939174|NCT02351934|10000202|FG001|NOT COMPLETED|Follow-Up||10
8939175|NCT02351960|10000210|FG000|STARTED|Overall Study||208
8939176|NCT02351960|10000211|FG001|STARTED|Overall Study||88
8939177|NCT02351960|10000210|FG000|COMPLETED|Overall Study||197
8939178|NCT02351960|10000211|FG001|COMPLETED|Overall Study||76
8939179|NCT02351960|10000210|FG000|NOT COMPLETED|Overall Study||11
8939180|NCT02351960|10000211|FG001|NOT COMPLETED|Overall Study||12
8939181|NCT02352259|10000218|FG000|STARTED|Overall Study||23
8939182|NCT02352259|10000218|FG000|COMPLETED|Overall Study||23
8939183|NCT02352259|10000218|FG000|NOT COMPLETED|Overall Study||0
8939184|NCT02352298|10000222|FG000|STARTED|Overall Study||52
8939185|NCT02352298|10000222|FG000|COMPLETED|Overall Study||52
8939186|NCT02352298|10000222|FG000|NOT COMPLETED|Overall Study||0
8939187|NCT02352363|10000229|FG000|STARTED|Overall Study||278
8939188|NCT02352363|10000230|FG001|STARTED|Overall Study||130
8939189|NCT02352363|10000229|FG000|COMPLETED|Overall Study||271
8939190|NCT02352363|10000230|FG001|COMPLETED|Overall Study||127
8939191|NCT02352363|10000229|FG000|NOT COMPLETED|Overall Study||7
8939192|NCT02352363|10000230|FG001|NOT COMPLETED|Overall Study||3
8939193|NCT02352493|10000254|FG000|STARTED|Overall Study||8
8939194|NCT02352493|10000255|FG001|STARTED|Overall Study||3
8939195|NCT02352493|10000256|FG002|STARTED|Overall Study||3
8939196|NCT02352493|10000257|FG003|STARTED|Overall Study||3
8939197|NCT02352493|10000258|FG004|STARTED|Overall Study||3
8939198|NCT02352493|10000259|FG005|STARTED|Overall Study||3
8939199|NCT02352493|10000260|FG006|STARTED|Overall Study||3
8939200|NCT02352493|10000261|FG007|STARTED|Overall Study||3
8939201|NCT02352493|10000262|FG008|STARTED|Overall Study||3
8939202|NCT02352493|10000263|FG009|STARTED|Overall Study||6
8939203|NCT02352493|10000264|FG010|STARTED|Overall Study||3
8939204|NCT02352493|10000265|FG011|STARTED|Overall Study||3
8939205|NCT02352493|10000266|FG012|STARTED|Overall Study||3
8939206|NCT02352493|10000267|FG013|STARTED|Overall Study||3
8939207|NCT02352493|10000268|FG014|STARTED|Overall Study||3
8939208|NCT02352493|10000269|FG015|STARTED|Overall Study||3
8939209|NCT02352493|10000270|FG016|STARTED|Overall Study||3
8939210|NCT02352493|10000271|FG017|STARTED|Overall Study||3
8939211|NCT02352493|10000254|FG000|COMPLETED|Overall Study||8
8939212|NCT02352493|10000255|FG001|COMPLETED|Overall Study||3
8939213|NCT02352493|10000256|FG002|COMPLETED|Overall Study||3
8939214|NCT02352493|10000257|FG003|COMPLETED|Overall Study||3
8939215|NCT02352493|10000258|FG004|COMPLETED|Overall Study||3
8939216|NCT02352493|10000259|FG005|COMPLETED|Overall Study||3
8939217|NCT02352493|10000260|FG006|COMPLETED|Overall Study||2
8939218|NCT02352493|10000261|FG007|COMPLETED|Overall Study||3
8939219|NCT02352493|10000262|FG008|COMPLETED|Overall Study||1
8939220|NCT02352493|10000263|FG009|COMPLETED|Overall Study||5
8939221|NCT02352493|10000264|FG010|COMPLETED|Overall Study||3
8939222|NCT02352493|10000265|FG011|COMPLETED|Overall Study||3
8939223|NCT02352493|10000266|FG012|COMPLETED|Overall Study||2
8939224|NCT02352493|10000267|FG013|COMPLETED|Overall Study||1
8939225|NCT02352493|10000268|FG014|COMPLETED|Overall Study||2
8939226|NCT02352493|10000269|FG015|COMPLETED|Overall Study||3
8939227|NCT02352493|10000270|FG016|COMPLETED|Overall Study||3
8939228|NCT02352493|10000271|FG017|COMPLETED|Overall Study||3
8939229|NCT02352493|10000254|FG000|NOT COMPLETED|Overall Study||0
8939230|NCT02352493|10000255|FG001|NOT COMPLETED|Overall Study||0
8939231|NCT02352493|10000256|FG002|NOT COMPLETED|Overall Study||0
8939232|NCT02352493|10000257|FG003|NOT COMPLETED|Overall Study||0
8939233|NCT02352493|10000258|FG004|NOT COMPLETED|Overall Study||0
8939234|NCT02352493|10000259|FG005|NOT COMPLETED|Overall Study||0
8939235|NCT02352493|10000260|FG006|NOT COMPLETED|Overall Study||1
8939236|NCT02352493|10000261|FG007|NOT COMPLETED|Overall Study||0
8939237|NCT02352493|10000262|FG008|NOT COMPLETED|Overall Study||2
8939238|NCT02352493|10000263|FG009|NOT COMPLETED|Overall Study||1
8939239|NCT02352493|10000264|FG010|NOT COMPLETED|Overall Study||0
8939240|NCT02352493|10000265|FG011|NOT COMPLETED|Overall Study||0
8939241|NCT02352493|10000266|FG012|NOT COMPLETED|Overall Study||1
8939242|NCT02352493|10000267|FG013|NOT COMPLETED|Overall Study||2
8939243|NCT02352493|10000268|FG014|NOT COMPLETED|Overall Study||1
8939244|NCT02352493|10000269|FG015|NOT COMPLETED|Overall Study||0
8939245|NCT02352493|10000270|FG016|NOT COMPLETED|Overall Study||0
8939246|NCT02352493|10000271|FG017|NOT COMPLETED|Overall Study||0
8939247|NCT02352779|10000329|FG000|STARTED|Overall Study||37
8939248|NCT02352779|10000330|FG001|STARTED|Overall Study||36
8617519|NCT00457418|9655713|FG000|STARTED|Pharmacokinetic (PK) Sampling Phase||32
8617520|NCT00457418|9655713|FG000|COMPLETED|Pharmacokinetic (PK) Sampling Phase||27
8617521|NCT00457418|9655713|FG000|NOT COMPLETED|Pharmacokinetic (PK) Sampling Phase||5
8617522|NCT00457418|9655713|FG000|STARTED|Post PK Maintenance|4 participants didn't complete the PK sampling phase but continued to post PK maintenance treatment.|31
8617523|NCT00457418|9655713|FG000|COMPLETED|Post PK Maintenance||3
8617524|NCT00457418|9655713|FG000|NOT COMPLETED|Post PK Maintenance||28
8939249|NCT02352779|10000331|FG002|STARTED|Overall Study||35
8939250|NCT02352779|10000329|FG000|COMPLETED|Overall Study||29
8939251|NCT02352779|10000330|FG001|COMPLETED|Overall Study||35
8939252|NCT02352779|10000331|FG002|COMPLETED|Overall Study||33
8939253|NCT02352779|10000329|FG000|NOT COMPLETED|Overall Study||8
8939254|NCT02352779|10000330|FG001|NOT COMPLETED|Overall Study||1
8939255|NCT02352779|10000331|FG002|NOT COMPLETED|Overall Study||2
8939256|NCT02352831|10000341|FG000|STARTED|Overall Study||6
8939257|NCT02352831|10000342|FG001|STARTED|Overall Study||10
8939258|NCT02352831|10000341|FG000|COMPLETED|Overall Study||6
8939259|NCT02352831|10000342|FG001|COMPLETED|Overall Study||10
8939260|NCT02352831|10000341|FG000|NOT COMPLETED|Overall Study||0
8939261|NCT02352831|10000342|FG001|NOT COMPLETED|Overall Study||0
8939262|NCT02352844|10000350|FG000|STARTED|Overall Study||12
8939263|NCT02352844|10000350|FG000|COMPLETED|Overall Study||12
8939264|NCT02352844|10000350|FG000|NOT COMPLETED|Overall Study||0
8939265|NCT02352922|10000356|FG000|STARTED|Overall Study||32
8939266|NCT02352922|10000357|FG001|STARTED|Overall Study||32
8939267|NCT02352922|10000356|FG000|COMPLETED|Overall Study|completed POD14 Survey|28
8939268|NCT02352922|10000357|FG001|COMPLETED|Overall Study|Completed POD14 survey|28
8939269|NCT02352922|10000356|FG000|NOT COMPLETED|Overall Study||4
8939270|NCT02352922|10000357|FG001|NOT COMPLETED|Overall Study||4
8939271|NCT02352974|10000363|FG000|STARTED|Main Study||12
8939272|NCT02352974|10000363|FG000|COMPLETED|Main Study||12
8939273|NCT02352974|10000363|FG000|NOT COMPLETED|Main Study||0
8939274|NCT02352974|10000363|FG000|STARTED|Extension|Only 3 out of the 12 patients who completed the main study continued in to the extension period.|3
8939275|NCT02352974|10000363|FG000|COMPLETED|Extension||3
8939276|NCT02352974|10000363|FG000|NOT COMPLETED|Extension||0
8939277|NCT02353091|10000369|FG000|STARTED|Overall Study||13
8939278|NCT02353091|10000370|FG001|STARTED|Overall Study||13
8939279|NCT02353091|10000369|FG000|COMPLETED|Overall Study||13
8939280|NCT02353091|10000370|FG001|COMPLETED|Overall Study||13
8939281|NCT02353091|10000369|FG000|NOT COMPLETED|Overall Study||0
8939282|NCT02353091|10000370|FG001|NOT COMPLETED|Overall Study||0
8939283|NCT02353169|10000389|FG000|STARTED|Overall Study||15
8617525|NCT00457626|9655717|FG000|STARTED|Overall Study||66
8617526|NCT00457626|9655717|FG000|COMPLETED|Overall Study||60
8617527|NCT00457626|9655717|FG000|NOT COMPLETED|Overall Study||6
8629399|NCT00529789|9669129|FG000|COMPLETED|Study Period II/III||48
8939284|NCT02353169|10000390|FG001|STARTED|Overall Study||18
8939285|NCT02353169|10000391|FG002|STARTED|Overall Study||16
8939286|NCT02353169|10000392|FG003|STARTED|Overall Study||15
8939287|NCT02353169|10000389|FG000|COMPLETED|Overall Study||12
8939288|NCT02353169|10000390|FG001|COMPLETED|Overall Study||12
8939289|NCT02353169|10000391|FG002|COMPLETED|Overall Study||12
8939290|NCT02353169|10000392|FG003|COMPLETED|Overall Study||12
8939291|NCT02353169|10000389|FG000|NOT COMPLETED|Overall Study||3
8939292|NCT02353169|10000390|FG001|NOT COMPLETED|Overall Study||6
8939293|NCT02353169|10000391|FG002|NOT COMPLETED|Overall Study||4
8939294|NCT02353169|10000392|FG003|NOT COMPLETED|Overall Study||3
8939295|NCT02353299|10000402|FG000|STARTED|First Intervention (1 Night)||13
8939296|NCT02353299|10000403|FG001|STARTED|First Intervention (1 Night)||13
8939297|NCT02353299|10000404|FG002|STARTED|First Intervention (1 Night)||13
8939298|NCT02353299|10000405|FG003|STARTED|First Intervention (1 Night)||13
8939299|NCT02353299|10000402|FG000|COMPLETED|First Intervention (1 Night)||13
8939300|NCT02353299|10000403|FG001|COMPLETED|First Intervention (1 Night)||13
8939301|NCT02353299|10000404|FG002|COMPLETED|First Intervention (1 Night)||13
8939302|NCT02353299|10000405|FG003|COMPLETED|First Intervention (1 Night)||13
8939303|NCT02353299|10000402|FG000|NOT COMPLETED|First Intervention (1 Night)||0
8617528|NCT00457639|9655721|FG000|STARTED|Intervention 1 (6 Months)|6 months on Cholic Acid and crossover to Placebo for 6 months|9
8617529|NCT00457639|9655722|FG001|STARTED|Intervention 1 (6 Months)|6 months on Placebo and crossover to cholic acid for 6 months|9
8617530|NCT00457639|9655721|FG000|COMPLETED|Intervention 1 (6 Months)|Number of Patients completing Cholic Acid Phase|6
8617531|NCT00457639|9655722|FG001|COMPLETED|Intervention 1 (6 Months)|Number of patients completing Placebo Phase|7
8617532|NCT00457639|9655721|FG000|NOT COMPLETED|Intervention 1 (6 Months)||3
8617533|NCT00457639|9655722|FG001|NOT COMPLETED|Intervention 1 (6 Months)||2
8617534|NCT00457639|9655721|FG000|STARTED|Intervention 2 (6 Months)||6
8617535|NCT00457639|9655722|FG001|STARTED|Intervention 2 (6 Months)||7
8617536|NCT00457639|9655721|FG000|COMPLETED|Intervention 2 (6 Months)||6
8617537|NCT00457639|9655722|FG001|COMPLETED|Intervention 2 (6 Months)||6
8617538|NCT00457639|9655721|FG000|NOT COMPLETED|Intervention 2 (6 Months)||0
8617539|NCT00457639|9655722|FG001|NOT COMPLETED|Intervention 2 (6 Months)||1
8617540|NCT00457665|9655730|FG000|STARTED|12 Months||28
8617541|NCT00457665|9655731|FG001|STARTED|12 Months||28
8617542|NCT00457665|9655730|FG000|COMPLETED|12 Months||20
8617543|NCT00457665|9655731|FG001|COMPLETED|12 Months||19
8617544|NCT00457665|9655730|FG000|NOT COMPLETED|12 Months||8
8617545|NCT00457665|9655731|FG001|NOT COMPLETED|12 Months||9
8617546|NCT00457665|9655730|FG000|STARTED|24 Months||20
8617547|NCT00457665|9655731|FG001|STARTED|24 Months||19
8939304|NCT02353299|10000403|FG001|NOT COMPLETED|First Intervention (1 Night)||0
8939305|NCT02353299|10000404|FG002|NOT COMPLETED|First Intervention (1 Night)||0
8939306|NCT02353299|10000405|FG003|NOT COMPLETED|First Intervention (1 Night)||0
8939307|NCT02353299|10000402|FG000|STARTED|Second Intervention (1 Night)||13
8939308|NCT02353299|10000403|FG001|STARTED|Second Intervention (1 Night)||13
8939309|NCT02353299|10000404|FG002|STARTED|Second Intervention (1 Night)||13
8939310|NCT02353299|10000405|FG003|STARTED|Second Intervention (1 Night)||13
8939311|NCT02353299|10000402|FG000|COMPLETED|Second Intervention (1 Night)||13
8939312|NCT02353299|10000403|FG001|COMPLETED|Second Intervention (1 Night)||13
8939313|NCT02353299|10000404|FG002|COMPLETED|Second Intervention (1 Night)||13
8939314|NCT02353299|10000405|FG003|COMPLETED|Second Intervention (1 Night)||13
8939315|NCT02353299|10000402|FG000|NOT COMPLETED|Second Intervention (1 Night)||0
8939316|NCT02353299|10000403|FG001|NOT COMPLETED|Second Intervention (1 Night)||0
8939317|NCT02353299|10000404|FG002|NOT COMPLETED|Second Intervention (1 Night)||0
8939318|NCT02353299|10000405|FG003|NOT COMPLETED|Second Intervention (1 Night)||0
8939319|NCT02353299|10000402|FG000|STARTED|Third Intervention (1 Night)||13
8939320|NCT02353299|10000403|FG001|STARTED|Third Intervention (1 Night)||13
8617548|NCT00457665|9655730|FG000|COMPLETED|24 Months||15
8617549|NCT00457665|9655731|FG001|COMPLETED|24 Months||11
8617550|NCT00457665|9655730|FG000|NOT COMPLETED|24 Months||5
8617551|NCT00457665|9655731|FG001|NOT COMPLETED|24 Months||8
8617552|NCT00457691|9655739|FG000|STARTED|Overall Study||386
8617553|NCT00457691|9655740|FG001|STARTED|Overall Study||382
8617554|NCT00457691|9655739|FG000|COMPLETED|Overall Study||0
8617555|NCT00457691|9655740|FG001|COMPLETED|Overall Study||0
8617556|NCT00457691|9655739|FG000|NOT COMPLETED|Overall Study||386
8617557|NCT00457691|9655740|FG001|NOT COMPLETED|Overall Study||382
8617558|NCT00457730|9655748|FG000|STARTED|Overall Study||18
8617559|NCT00457730|9655749|FG001|STARTED|Overall Study||20
8617560|NCT00457730|9655748|FG000|COMPLETED|Overall Study||14
8617561|NCT00457730|9655749|FG001|COMPLETED|Overall Study||19
8617562|NCT00457730|9655748|FG000|NOT COMPLETED|Overall Study||4
8617563|NCT00457730|9655749|FG001|NOT COMPLETED|Overall Study||1
8617564|NCT00457743|9655762|FG000|STARTED|Overall Study|Overall study|3
8617565|NCT00457743|9655763|FG001|STARTED|Overall Study|Overall study|30
8617566|NCT00457743|9655764|FG002|STARTED|Overall Study|Overall study|3
8617567|NCT00457743|9655762|FG000|Enrolled in Phase 1|Overall Study||3
8617568|NCT00457743|9655763|FG001|Enrolled in Phase 1|Overall Study||6
8617569|NCT00457743|9655764|FG002|Enrolled in Phase 1|Overall Study||3
8617570|NCT00457743|9655762|FG000|Completed Phase 1|Overall Study||3
8617571|NCT00457743|9655763|FG001|Completed Phase 1|Overall Study||6
8617572|NCT00457743|9655764|FG002|Completed Phase 1|Overall Study||3
8617573|NCT00457743|9655762|FG000|Enrolled in Phase 2|Overall Study|Three subjects who completed Phase 1 entered Phase 2.|3
8617574|NCT00457743|9655763|FG001|Enrolled in Phase 2|Overall Study|Six subjects who completed Phase 1 entered Phase 2, and 24 subjects were newly enrolled.|30
8939321|NCT02353299|10000404|FG002|STARTED|Third Intervention (1 Night)||13
8939322|NCT02353299|10000405|FG003|STARTED|Third Intervention (1 Night)||13
8939323|NCT02353299|10000402|FG000|COMPLETED|Third Intervention (1 Night)||13
8939324|NCT02353299|10000403|FG001|COMPLETED|Third Intervention (1 Night)||13
8939325|NCT02353299|10000404|FG002|COMPLETED|Third Intervention (1 Night)||13
8939326|NCT02353299|10000405|FG003|COMPLETED|Third Intervention (1 Night)||13
8939327|NCT02353299|10000402|FG000|NOT COMPLETED|Third Intervention (1 Night)||0
8939328|NCT02353299|10000403|FG001|NOT COMPLETED|Third Intervention (1 Night)||0
8939329|NCT02353299|10000404|FG002|NOT COMPLETED|Third Intervention (1 Night)||0
8939330|NCT02353299|10000405|FG003|NOT COMPLETED|Third Intervention (1 Night)||0
8939331|NCT02353299|10000402|FG000|STARTED|Fourth Intervention (1 Night)||13
8939332|NCT02353299|10000403|FG001|STARTED|Fourth Intervention (1 Night)|One patient withdrawn from study prior to start of fourth intervention.|12
8939333|NCT02353299|10000404|FG002|STARTED|Fourth Intervention (1 Night)||13
8939334|NCT02353299|10000405|FG003|STARTED|Fourth Intervention (1 Night)||13
8617575|NCT00457743|9655764|FG002|Enrolled in Phase 2|Overall Study|Three subjects who completed Phase 1 entered Phase 2.|3
8939335|NCT02353299|10000402|FG000|COMPLETED|Fourth Intervention (1 Night)||13
8939336|NCT02353299|10000403|FG001|COMPLETED|Fourth Intervention (1 Night)||12
8939337|NCT02353299|10000404|FG002|COMPLETED|Fourth Intervention (1 Night)||13
8939338|NCT02353299|10000405|FG003|COMPLETED|Fourth Intervention (1 Night)||13
8939339|NCT02353299|10000402|FG000|NOT COMPLETED|Fourth Intervention (1 Night)||0
8939340|NCT02353299|10000403|FG001|NOT COMPLETED|Fourth Intervention (1 Night)||0
8939341|NCT02353299|10000404|FG002|NOT COMPLETED|Fourth Intervention (1 Night)||0
8939342|NCT02353299|10000405|FG003|NOT COMPLETED|Fourth Intervention (1 Night)||0
8939343|NCT02353442|10000425|FG000|STARTED|Overall Study||28
8939344|NCT02353442|10000426|FG001|STARTED|Overall Study||31
8939345|NCT02353442|10000425|FG000|COMPLETED|Overall Study||25
8939346|NCT02353442|10000426|FG001|COMPLETED|Overall Study||27
8939347|NCT02353442|10000425|FG000|NOT COMPLETED|Overall Study||3
8939348|NCT02353442|10000426|FG001|NOT COMPLETED|Overall Study||4
8939349|NCT02353754|10000434|FG000|STARTED|Overall Study||12
8939350|NCT02353754|10000435|FG001|STARTED|Overall Study||0
8939351|NCT02353754|10000434|FG000|COMPLETED|Overall Study||10
8939352|NCT02353754|10000435|FG001|COMPLETED|Overall Study||0
8939353|NCT02353754|10000434|FG000|NOT COMPLETED|Overall Study||2
8939354|NCT02353754|10000435|FG001|NOT COMPLETED|Overall Study||0
8939355|NCT02353780|10000444|FG000|STARTED|Overall Study||3
8939356|NCT02353780|10000445|FG001|STARTED|Overall Study||3
8939357|NCT02353780|10000446|FG002|STARTED|Overall Study||3
8939358|NCT02353780|10000444|FG000|COMPLETED|Overall Study||3
8939359|NCT02353780|10000445|FG001|COMPLETED|Overall Study||3
8939360|NCT02353780|10000446|FG002|COMPLETED|Overall Study||3
8939361|NCT02353780|10000444|FG000|NOT COMPLETED|Overall Study||0
8939362|NCT02353780|10000445|FG001|NOT COMPLETED|Overall Study||0
8939363|NCT02353780|10000446|FG002|NOT COMPLETED|Overall Study||0
8939364|NCT02353806|10000454|FG000|STARTED|Overall Study||16
8939365|NCT02353806|10000454|FG000|COMPLETED|Overall Study||6
8939366|NCT02353806|10000454|FG000|NOT COMPLETED|Overall Study||10
8939367|NCT02353871|10000462|FG000|STARTED|Overall Study|Randomised.|125
8939368|NCT02353871|10000463|FG001|STARTED|Overall Study|Randomised. Included a subject who was randomised by mistake (excluded from mITT population).|60
8939369|NCT02353871|10000462|FG000|COMPLETED|Overall Study||122
8939370|NCT02353871|10000463|FG001|COMPLETED|Overall Study||51
8939371|NCT02353871|10000462|FG000|NOT COMPLETED|Overall Study||3
8939372|NCT02353871|10000463|FG001|NOT COMPLETED|Overall Study||9
8939373|NCT02354092|10000471|FG000|STARTED|Overall Study||7
8939374|NCT02354092|10000472|FG001|STARTED|Overall Study||7
8939375|NCT02354092|10000471|FG000|COMPLETED|Overall Study||7
8939376|NCT02354092|10000472|FG001|COMPLETED|Overall Study||7
8939377|NCT02354092|10000471|FG000|NOT COMPLETED|Overall Study||0
8939378|NCT02354092|10000472|FG001|NOT COMPLETED|Overall Study||0
8939379|NCT02354144|10000480|FG000|STARTED|Overall Study||127
8939380|NCT02354144|10000481|FG001|STARTED|Overall Study||128
8939381|NCT02354144|10000480|FG000|COMPLETED|Overall Study|Participants completed all 7 study visits.|48
8939382|NCT02354144|10000481|FG001|COMPLETED|Overall Study|Participants completed all 7 study visits.|51
8939383|NCT02354144|10000480|FG000|NOT COMPLETED|Overall Study||79
8939384|NCT02354144|10000481|FG001|NOT COMPLETED|Overall Study||77
8939385|NCT02354222|10000489|FG000|STARTED|Overall Study||77
8939386|NCT02354222|10000490|FG001|STARTED|Overall Study||77
8939387|NCT02354222|10000489|FG000|COMPLETED|Overall Study||73
8939388|NCT02354222|10000490|FG001|COMPLETED|Overall Study||66
8939389|NCT02354222|10000489|FG000|NOT COMPLETED|Overall Study||4
8939390|NCT02354222|10000490|FG001|NOT COMPLETED|Overall Study||11
8939391|NCT02354235|10000498|FG000|STARTED|Overall Study||70
8939392|NCT02354235|10000499|FG001|STARTED|Overall Study||68
8939393|NCT02354235|10000498|FG000|COMPLETED|Overall Study||67
8939394|NCT02354235|10000499|FG001|COMPLETED|Overall Study||61
8939395|NCT02354235|10000498|FG000|NOT COMPLETED|Overall Study||3
8939396|NCT02354235|10000499|FG001|NOT COMPLETED|Overall Study||7
8939397|NCT02354339|10000507|FG000|STARTED|Overall Study||12
8939398|NCT02354339|10000508|FG001|STARTED|Overall Study||12
8617576|NCT00457743|9655762|FG000|COMPLETED|Overall Study|However, all 3 subjects enrolled were included in analysis (Intent-to treat population).|0
8629400|NCT00529789|9669129|FG000|NOT COMPLETED|Study Period II/III||24
8939399|NCT02354339|10000507|FG000|COMPLETED|Overall Study||12
8939400|NCT02354339|10000508|FG001|COMPLETED|Overall Study||12
8939401|NCT02354339|10000507|FG000|NOT COMPLETED|Overall Study||0
8939402|NCT02354339|10000508|FG001|NOT COMPLETED|Overall Study||0
8939403|NCT02354352|10000516|FG000|STARTED|Overall Study||26
8939404|NCT02354352|10000517|FG001|STARTED|Overall Study||26
8939405|NCT02354352|10000516|FG000|2 Weeks|Overall Study||26
8939406|NCT02354352|10000517|FG001|2 Weeks|Overall Study||25
8939407|NCT02354352|10000516|FG000|1 Month|Overall Study||24
8939408|NCT02354352|10000517|FG001|1 Month|Overall Study||23
8939409|NCT02354352|10000516|FG000|2 Months|Overall Study||24
8939410|NCT02354352|10000517|FG001|2 Months|Overall Study||22
8939411|NCT02354352|10000516|FG000|3 Months|Overall Study||25
8939412|NCT02354352|10000517|FG001|3 Months|Overall Study||23
8939413|NCT02354352|10000516|FG000|6 Months|Overall Study||25
8939414|NCT02354352|10000517|FG001|6 Months|Overall Study||23
8939415|NCT02354352|10000516|FG000|9 Months|Overall Study||25
8939416|NCT02354352|10000517|FG001|9 Months|Overall Study||23
8939417|NCT02354352|10000516|FG000|COMPLETED|Overall Study||23
8939418|NCT02354352|10000517|FG001|COMPLETED|Overall Study||23
8939419|NCT02354352|10000516|FG000|NOT COMPLETED|Overall Study||3
8939420|NCT02354352|10000517|FG001|NOT COMPLETED|Overall Study||3
8939421|NCT02354378|10000525|FG000|STARTED|Overall Study||64
8939422|NCT02354378|10000526|FG001|STARTED|Overall Study||20
8939423|NCT02354378|10000525|FG000|COMPLETED|Overall Study||30
8939424|NCT02354378|10000526|FG001|COMPLETED|Overall Study||16
8939425|NCT02354378|10000525|FG000|NOT COMPLETED|Overall Study||34
8939426|NCT02354378|10000526|FG001|NOT COMPLETED|Overall Study||4
8939427|NCT02354417|10000532|FG000|STARTED|Overall Study||3
8939428|NCT02354417|10000532|FG000|COMPLETED|Overall Study||2
8939429|NCT02354417|10000532|FG000|NOT COMPLETED|Overall Study||1
8939430|NCT02354443|10000536|FG000|STARTED|Overall Study||1
8939431|NCT02354443|10000536|FG000|COMPLETED|Overall Study||1
8939432|NCT02354443|10000536|FG000|NOT COMPLETED|Overall Study||0
8939433|NCT02354482|10000540|FG000|STARTED|Patient Communication and Care||2158
8939434|NCT02354482|10000540|FG000|COMPLETED|Patient Communication and Care||2158
8939435|NCT02354482|10000540|FG000|NOT COMPLETED|Patient Communication and Care||0
8939436|NCT02354482|10000540|FG000|STARTED|Home-Based Trust and Plain Language||1979
8939437|NCT02354482|10000540|FG000|COMPLETED|Home-Based Trust and Plain Language||1979
8939438|NCT02354482|10000540|FG000|NOT COMPLETED|Home-Based Trust and Plain Language||0
8939439|NCT02354482|10000540|FG000|STARTED|Hospital-Based Trust and Plain Language||2090
8939440|NCT02354482|10000540|FG000|COMPLETED|Hospital-Based Trust and Plain Language||2090
8939441|NCT02354482|10000540|FG000|NOT COMPLETED|Hospital-Based Trust and Plain Language||0
8939442|NCT02354482|10000540|FG000|STARTED|Patient/Family Caregiver Assessment||3093
8939443|NCT02354482|10000540|FG000|COMPLETED|Patient/Family Caregiver Assessment||3093
8939444|NCT02354482|10000540|FG000|NOT COMPLETED|Patient/Family Caregiver Assessment||0
8939445|NCT02354482|10000540|FG000|STARTED|Assessment and Teach Back||508
8939446|NCT02354482|10000540|FG000|COMPLETED|Assessment and Teach Back||508
8939447|NCT02354482|10000540|FG000|NOT COMPLETED|Assessment and Teach Back||0
8939448|NCT02354482|10000540|FG000|STARTED|Reference||2042
8939449|NCT02354482|10000540|FG000|COMPLETED|Reference||2042
8939450|NCT02354482|10000540|FG000|NOT COMPLETED|Reference||0
8939451|NCT02354508|10000557|FG000|STARTED|Period 1: Core Phase||41
8939452|NCT02354508|10000558|FG001|STARTED|Period 1: Core Phase||29
8939453|NCT02354508|10000559|FG002|STARTED|Period 1: Core Phase||53
8939454|NCT02354508|10000557|FG000|COMPLETED|Period 1: Core Phase||39
8939455|NCT02354508|10000558|FG001|COMPLETED|Period 1: Core Phase||27
8939456|NCT02354508|10000559|FG002|COMPLETED|Period 1: Core Phase||47
8939457|NCT02354508|10000557|FG000|NOT COMPLETED|Period 1: Core Phase||2
8939458|NCT02354508|10000558|FG001|NOT COMPLETED|Period 1: Core Phase||2
8939459|NCT02354508|10000559|FG002|NOT COMPLETED|Period 1: Core Phase||6
8939460|NCT02354508|10000557|FG000|STARTED|Period 2: Extension Phase|not all patients who completed the Core phase went into the Extension phase|26
8939461|NCT02354508|10000558|FG001|STARTED|Period 2: Extension Phase|not all patients who completed the Core phase went into the Extension phase|23
8939462|NCT02354508|10000559|FG002|STARTED|Period 2: Extension Phase|not all patients who completed the Core phase went into the Extension phase|39
8939463|NCT02354508|10000557|FG000|COMPLETED|Period 2: Extension Phase||20
8939464|NCT02354508|10000558|FG001|COMPLETED|Period 2: Extension Phase||19
8939465|NCT02354508|10000559|FG002|COMPLETED|Period 2: Extension Phase||36
8939466|NCT02354508|10000557|FG000|NOT COMPLETED|Period 2: Extension Phase||6
8939467|NCT02354508|10000558|FG001|NOT COMPLETED|Period 2: Extension Phase||4
8939468|NCT02354508|10000559|FG002|NOT COMPLETED|Period 2: Extension Phase||3
8939469|NCT02354508|10000557|FG000|STARTED|Period 3: Post-treatment Follow up Phase||26
8939470|NCT02354508|10000558|FG001|STARTED|Period 3: Post-treatment Follow up Phase||23
8939471|NCT02354508|10000559|FG002|STARTED|Period 3: Post-treatment Follow up Phase||39
8939472|NCT02354508|10000557|FG000|Entered Post-treatment f/up Discontinued|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, discontinued|4
8939473|NCT02354508|10000558|FG001|Entered Post-treatment f/up Discontinued|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, discontinued|3
8939474|NCT02354508|10000559|FG002|Entered Post-treatment f/up Discontinued|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, discontinued|3
8939475|NCT02354508|10000557|FG000|COMPLETED|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, completed|22
8939476|NCT02354508|10000558|FG001|COMPLETED|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, completed|20
8939477|NCT02354508|10000559|FG002|COMPLETED|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, completed|36
8939478|NCT02354508|10000557|FG000|NOT COMPLETED|Period 3: Post-treatment Follow up Phase||4
8939479|NCT02354508|10000558|FG001|NOT COMPLETED|Period 3: Post-treatment Follow up Phase||3
8939480|NCT02354508|10000559|FG002|NOT COMPLETED|Period 3: Post-treatment Follow up Phase||3
8939481|NCT02354534|10000612|FG000|STARTED|Overall Study||3
8939482|NCT02354534|10000613|FG001|STARTED|Overall Study||9
8939483|NCT02354534|10000614|FG002|STARTED|Overall Study||10
8939484|NCT02354534|10000615|FG003|STARTED|Overall Study||8
8939485|NCT02354534|10000612|FG000|COMPLETED|Overall Study||3
8939486|NCT02354534|10000613|FG001|COMPLETED|Overall Study||9
8939487|NCT02354534|10000614|FG002|COMPLETED|Overall Study||9
8939488|NCT02354534|10000615|FG003|COMPLETED|Overall Study||8
8939489|NCT02354534|10000612|FG000|NOT COMPLETED|Overall Study||0
8939490|NCT02354534|10000613|FG001|NOT COMPLETED|Overall Study||0
8939491|NCT02354534|10000614|FG002|NOT COMPLETED|Overall Study||1
8939492|NCT02354534|10000615|FG003|NOT COMPLETED|Overall Study||0
8939493|NCT02354586|10000625|FG000|STARTED|Overall Study||463
8939494|NCT02354586|10000625|FG000|Ongoing in Study|Overall Study||21
8939495|NCT02354586|10000625|FG000|COMPLETED|Overall Study||122
8939496|NCT02354586|10000625|FG000|NOT COMPLETED|Overall Study||341
8939497|NCT02354599|10000635|FG000|STARTED|Overall Study||6
8939498|NCT02354599|10000636|FG001|STARTED|Overall Study||6
8939499|NCT02354599|10000637|FG002|STARTED|Overall Study||6
8939500|NCT02354599|10000638|FG003|STARTED|Overall Study||6
8939501|NCT02354599|10000639|FG004|STARTED|Overall Study||2
8939502|NCT02354599|10000640|FG005|STARTED|Overall Study||6
8939503|NCT02354599|10000635|FG000|COMPLETED|Overall Study||5
8939504|NCT02354599|10000636|FG001|COMPLETED|Overall Study||5
8939505|NCT02354599|10000637|FG002|COMPLETED|Overall Study||6
8939506|NCT02354599|10000638|FG003|COMPLETED|Overall Study||6
8939507|NCT02354599|10000639|FG004|COMPLETED|Overall Study||2
8939508|NCT02354599|10000640|FG005|COMPLETED|Overall Study||5
8939509|NCT02354599|10000635|FG000|NOT COMPLETED|Overall Study||1
8939510|NCT02354599|10000636|FG001|NOT COMPLETED|Overall Study||1
8939511|NCT02354599|10000637|FG002|NOT COMPLETED|Overall Study||0
8939512|NCT02354599|10000638|FG003|NOT COMPLETED|Overall Study||0
8939513|NCT02354599|10000639|FG004|NOT COMPLETED|Overall Study||0
8939514|NCT02354599|10000640|FG005|NOT COMPLETED|Overall Study||1
8939515|NCT02354690|10000660|FG000|STARTED|Overall Study||13
8939516|NCT02354690|10000660|FG000|COMPLETED|Overall Study||12
8617577|NCT00457743|9655763|FG001|COMPLETED|Overall Study|However, all 30 subjects enrolled were included in analysis(Intent-to treat population).|3
8617578|NCT00457743|9655764|FG002|COMPLETED|Overall Study|However, all 3 subjects enrolled were included in analysis(Intent-to treat population).|0
8617579|NCT00457743|9655762|FG000|NOT COMPLETED|Overall Study||3
8617580|NCT00457743|9655763|FG001|NOT COMPLETED|Overall Study||27
8617581|NCT00457743|9655764|FG002|NOT COMPLETED|Overall Study||3
8617582|NCT00457795|9655773|FG000|STARTED|Overall Study||15
8939517|NCT02354690|10000660|FG000|NOT COMPLETED|Overall Study||1
8939518|NCT02354781|10000664|FG000|STARTED|Overall Study||3
8939519|NCT02354781|10000664|FG000|COMPLETED|Overall Study||3
8939520|NCT02354781|10000664|FG000|NOT COMPLETED|Overall Study||0
8939521|NCT02354833|10000671|FG000|STARTED|Overall Study||38
8939522|NCT02354833|10000672|FG001|STARTED|Overall Study||43
8719295|NCT01003288|9766759|FG000|NOT COMPLETED|Overall Study||0
8719296|NCT01003301|9766766|FG000|STARTED|Overall Study||10
8719297|NCT01003301|9766767|FG001|STARTED|Overall Study||9
8719298|NCT01003301|9766766|FG000|COMPLETED|Overall Study||10
8719299|NCT01003301|9766767|FG001|COMPLETED|Overall Study||9
8719300|NCT01003301|9766766|FG000|NOT COMPLETED|Overall Study||0
8719301|NCT01003301|9766767|FG001|NOT COMPLETED|Overall Study||0
8719302|NCT01003418|9766775|FG000|STARTED|Overall Study||5
8719303|NCT01003418|9766776|FG001|STARTED|Overall Study||3
8719304|NCT01003418|9766775|FG000|COMPLETED|Overall Study||5
8719305|NCT01003418|9766776|FG001|COMPLETED|Overall Study||3
8719306|NCT01003418|9766775|FG000|NOT COMPLETED|Overall Study||0
8719307|NCT01003418|9766776|FG001|NOT COMPLETED|Overall Study||0
8719308|NCT01003639|9766784|FG000|STARTED|Overall Study||86
8719309|NCT01003639|9766785|FG001|STARTED|Overall Study||79
8719310|NCT01003639|9766784|FG000|COMPLETED|Overall Study||69
8719311|NCT01003639|9766785|FG001|COMPLETED|Overall Study||57
8719312|NCT01003639|9766784|FG000|NOT COMPLETED|Overall Study||17
8719313|NCT01003639|9766785|FG001|NOT COMPLETED|Overall Study||22
8719314|NCT01003769|9766791|FG000|STARTED|Overall Study||5
8719315|NCT01003769|9766791|FG000|COMPLETED|Overall Study||5
8719316|NCT01003769|9766791|FG000|NOT COMPLETED|Overall Study||0
8719317|NCT01003886|9766795|FG000|STARTED|Overall Study||989
8939523|NCT02354833|10000671|FG000|COMPLETED|Overall Study||38
8719318|NCT01003886|9766795|FG000|COMPLETED|Overall Study||759
8939524|NCT02354833|10000672|FG001|COMPLETED|Overall Study||43
8939525|NCT02354833|10000671|FG000|NOT COMPLETED|Overall Study||0
8939526|NCT02354833|10000672|FG001|NOT COMPLETED|Overall Study||0
8939527|NCT02354859|10000682|FG000|STARTED|Overall Study||60
8939528|NCT02354859|10000683|FG001|STARTED|Overall Study||59
8939529|NCT02354859|10000682|FG000|COMPLETED|Overall Study||60
8939530|NCT02354859|10000683|FG001|COMPLETED|Overall Study||57
8939531|NCT02354859|10000682|FG000|NOT COMPLETED|Overall Study||0
8617583|NCT00457795|9655773|FG000|COMPLETED|Overall Study||15
8617584|NCT00457795|9655773|FG000|NOT COMPLETED|Overall Study||0
8617585|NCT00457821|9655785|FG000|STARTED|Part 1|Number of subjects randomized|4
8617586|NCT00457821|9655786|FG001|STARTED|Part 1|Number of subjects randomized|4
8719319|NCT01003886|9766795|FG000|NOT COMPLETED|Overall Study||230
8719320|NCT01003899|9766799|FG000|STARTED|Overall Study|enrolled|47
8719321|NCT01003899|9766799|FG000|COMPLETED|Overall Study||0
8939532|NCT02354859|10000683|FG001|NOT COMPLETED|Overall Study||2
8939533|NCT02354924|10000691|FG000|STARTED|Overall Study||40
8939534|NCT02354924|10000692|FG001|STARTED|Overall Study||20
8939535|NCT02354924|10000691|FG000|COMPLETED|Overall Study||40
8719322|NCT01003899|9766799|FG000|NOT COMPLETED|Overall Study||47
8719323|NCT01003938|9766803|FG000|STARTED|Overall Study||6
8719324|NCT01003938|9766803|FG000|COMPLETED|Overall Study||6
8719325|NCT01003938|9766803|FG000|NOT COMPLETED|Overall Study||0
8719326|NCT01003990|9766810|FG000|STARTED|Overall Study||459
8719327|NCT01003990|9766811|FG001|STARTED|Overall Study||154
8719328|NCT01003990|9766812|FG002|STARTED|Overall Study||96
8719329|NCT01003990|9766810|FG000|COMPLETED|Overall Study||367
8719330|NCT01003990|9766811|FG001|COMPLETED|Overall Study||103
8719331|NCT01003990|9766812|FG002|COMPLETED|Overall Study||53
8719332|NCT01003990|9766810|FG000|NOT COMPLETED|Overall Study||92
8719333|NCT01003990|9766811|FG001|NOT COMPLETED|Overall Study||51
8939536|NCT02354924|10000692|FG001|COMPLETED|Overall Study||20
8939537|NCT02354924|10000691|FG000|NOT COMPLETED|Overall Study||0
8939538|NCT02354924|10000692|FG001|NOT COMPLETED|Overall Study||0
8939539|NCT02354976|10000703|FG000|STARTED|Overall Study||25
8939540|NCT02354976|10000704|FG001|STARTED|Overall Study||27
8939541|NCT02354976|10000705|FG002|STARTED|Overall Study||26
8939542|NCT02354976|10000703|FG000|COMPLETED|Overall Study||23
8939543|NCT02354976|10000704|FG001|COMPLETED|Overall Study||26
8939544|NCT02354976|10000705|FG002|COMPLETED|Overall Study||23
8939545|NCT02354976|10000703|FG000|NOT COMPLETED|Overall Study||2
8939546|NCT02354976|10000704|FG001|NOT COMPLETED|Overall Study||1
8617587|NCT00457821|9655787|FG002|STARTED|Part 1|Number of subjects randomized|5
8617588|NCT00457821|9655788|FG003|STARTED|Part 1|Number of subjects randomized|4
8719334|NCT01003990|9766812|FG002|NOT COMPLETED|Overall Study||43
8939547|NCT02354976|10000705|FG002|NOT COMPLETED|Overall Study||3
8939548|NCT02355028|10000715|FG000|STARTED|Overall Study||47
8939549|NCT02355028|10000716|FG001|STARTED|Overall Study||46
8939550|NCT02355028|10000715|FG000|Treated|Overall Study||46
8939551|NCT02355028|10000716|FG001|Treated|Overall Study||45
8939552|NCT02355028|10000715|FG000|COMPLETED|Overall Study||36
8939553|NCT02355028|10000716|FG001|COMPLETED|Overall Study||41
8939554|NCT02355028|10000715|FG000|NOT COMPLETED|Overall Study||11
8939555|NCT02355028|10000716|FG001|NOT COMPLETED|Overall Study||5
8939556|NCT02355067|10000729|FG000|STARTED|Overall Study||20
8939557|NCT02355067|10000730|FG001|STARTED|Overall Study||20
8939558|NCT02355067|10000729|FG000|COMPLETED|Overall Study||12
8939559|NCT02355067|10000730|FG001|COMPLETED|Overall Study||12
8939560|NCT02355067|10000729|FG000|NOT COMPLETED|Overall Study||8
8939561|NCT02355067|10000730|FG001|NOT COMPLETED|Overall Study||8
8939562|NCT02355158|10000736|FG000|STARTED|Overall Study||197
8939563|NCT02355158|10000736|FG000|COMPLETED|Overall Study||47
8939564|NCT02355158|10000736|FG000|NOT COMPLETED|Overall Study||150
8939565|NCT02355210|10000746|FG000|STARTED|Overall Study||19
8939566|NCT02355210|10000747|FG001|STARTED|Overall Study||18
8939567|NCT02355210|10000748|FG002|STARTED|Overall Study||16
8939568|NCT02355210|10000749|FG003|STARTED|Overall Study||17
8939569|NCT02355210|10000750|FG004|STARTED|Overall Study||19
8939570|NCT02355210|10000751|FG005|STARTED|Overall Study||18
8939571|NCT02355210|10000746|FG000|COMPLETED|Overall Study||19
8939572|NCT02355210|10000747|FG001|COMPLETED|Overall Study||18
8939573|NCT02355210|10000748|FG002|COMPLETED|Overall Study||16
8939574|NCT02355210|10000749|FG003|COMPLETED|Overall Study||17
8939575|NCT02355210|10000750|FG004|COMPLETED|Overall Study||19
8939576|NCT02355210|10000751|FG005|COMPLETED|Overall Study||18
8939577|NCT02355210|10000746|FG000|NOT COMPLETED|Overall Study||0
8939578|NCT02355210|10000747|FG001|NOT COMPLETED|Overall Study||0
8939579|NCT02355210|10000748|FG002|NOT COMPLETED|Overall Study||0
8939580|NCT02355210|10000749|FG003|NOT COMPLETED|Overall Study||0
8939581|NCT02355210|10000750|FG004|NOT COMPLETED|Overall Study||0
8939582|NCT02355210|10000751|FG005|NOT COMPLETED|Overall Study||0
8939583|NCT02355275|10000765|FG000|STARTED|Overall Study||22
8939584|NCT02355275|10000765|FG000|COMPLETED|Overall Study||14
8939585|NCT02355275|10000765|FG000|NOT COMPLETED|Overall Study||8
8939586|NCT02355665|10000771|FG000|STARTED|Overall Study||601
8939587|NCT02355665|10000772|FG001|STARTED|Overall Study||597
8939588|NCT02355665|10000771|FG000|COMPLETED|Overall Study||352
8939589|NCT02355665|10000772|FG001|COMPLETED|Overall Study||365
8939590|NCT02355665|10000771|FG000|NOT COMPLETED|Overall Study||249
8939591|NCT02355665|10000772|FG001|NOT COMPLETED|Overall Study||232
8939592|NCT02355691|10000780|FG000|STARTED|Overall Study||7
8939593|NCT02355691|10000781|FG001|STARTED|Overall Study||9
8939594|NCT02355691|10000780|FG000|1st Postop Visit|Overall Study||7
8939595|NCT02355691|10000781|FG001|1st Postop Visit|Overall Study||9
8939596|NCT02355691|10000780|FG000|2nd Postop Visit|Overall Study||7
8617589|NCT00457821|9655789|FG004|STARTED|Part 1|Number of subjects randomized|4
8617590|NCT00457821|9655790|FG005|STARTED|Part 1|Arm in Part 2 only|0
8719335|NCT01004003|9766829|FG000|STARTED|Overall Study||6
8719336|NCT01004003|9766830|FG001|STARTED|Overall Study||3
8719337|NCT01004003|9766831|FG002|STARTED|Overall Study||4
8719338|NCT01004003|9766832|FG003|STARTED|Overall Study||3
8939597|NCT02355691|10000781|FG001|2nd Postop Visit|Overall Study||9
8939598|NCT02355691|10000780|FG000|COMPLETED|Overall Study||0
8939599|NCT02355691|10000781|FG001|COMPLETED|Overall Study||0
8939600|NCT02355691|10000780|FG000|NOT COMPLETED|Overall Study||7
8939601|NCT02355691|10000781|FG001|NOT COMPLETED|Overall Study||9
8939602|NCT02355743|10000787|FG000|STARTED|Overall Study||8
8939603|NCT02355743|10000787|FG000|COMPLETED|Overall Study||6
8939604|NCT02355743|10000787|FG000|NOT COMPLETED|Overall Study||2
8939605|NCT02355821|10000793|FG000|STARTED|Overall Study||57
8939606|NCT02355821|10000794|FG001|STARTED|Overall Study||57
8939607|NCT02355821|10000793|FG000|COMPLETED|Overall Study||57
8939608|NCT02355821|10000794|FG001|COMPLETED|Overall Study||57
8939609|NCT02355821|10000793|FG000|NOT COMPLETED|Overall Study||0
8939610|NCT02355821|10000794|FG001|NOT COMPLETED|Overall Study||0
8939611|NCT02355886|10000802|FG000|STARTED|Overall Study||13
8939612|NCT02355886|10000803|FG001|STARTED|Overall Study||12
8939613|NCT02355886|10000802|FG000|COMPLETED|Overall Study||13
8939614|NCT02355886|10000803|FG001|COMPLETED|Overall Study||12
8939615|NCT02355886|10000802|FG000|NOT COMPLETED|Overall Study||0
8939616|NCT02355886|10000803|FG001|NOT COMPLETED|Overall Study||0
8939617|NCT02355977|10000812|FG000|STARTED|Overall Study||21
8939618|NCT02355977|10000813|FG001|STARTED|Overall Study||26
8939619|NCT02355977|10000814|FG002|STARTED|Overall Study||23
8939620|NCT02355977|10000812|FG000|COMPLETED|Overall Study||21
8939621|NCT02355977|10000813|FG001|COMPLETED|Overall Study||26
8939622|NCT02355977|10000814|FG002|COMPLETED|Overall Study||23
8939623|NCT02355977|10000812|FG000|NOT COMPLETED|Overall Study||0
8939624|NCT02355977|10000813|FG001|NOT COMPLETED|Overall Study||0
8939625|NCT02355977|10000814|FG002|NOT COMPLETED|Overall Study||0
8939626|NCT02356003|10000822|FG000|STARTED|Overall Study||10
8939627|NCT02356003|10000822|FG000|COMPLETED|Overall Study||10
8939628|NCT02356003|10000822|FG000|NOT COMPLETED|Overall Study||0
8939629|NCT02356107|10000827|FG000|STARTED|Overall Study||15
8939630|NCT02356107|10000827|FG000|COMPLETED|Overall Study||12
8939631|NCT02356107|10000827|FG000|NOT COMPLETED|Overall Study||3
8939632|NCT02356198|10000833|FG000|STARTED|Overall Study||104
8939633|NCT02356198|10000834|FG001|STARTED|Overall Study||105
8939634|NCT02356198|10000833|FG000|COMPLETED|Overall Study||102
8939635|NCT02356198|10000834|FG001|COMPLETED|Overall Study||98
8939636|NCT02356198|10000833|FG000|NOT COMPLETED|Overall Study||2
8939637|NCT02356198|10000834|FG001|NOT COMPLETED|Overall Study||7
8939638|NCT02356211|10000842|FG000|STARTED|Overall Study||57
8939639|NCT02356211|10000843|FG001|STARTED|Overall Study||52
8939640|NCT02356211|10000842|FG000|COMPLETED|Overall Study||54
8939641|NCT02356211|10000843|FG001|COMPLETED|Overall Study||42
8939642|NCT02356211|10000842|FG000|NOT COMPLETED|Overall Study||3
8939643|NCT02356211|10000843|FG001|NOT COMPLETED|Overall Study||10
8939644|NCT02356471|10000849|FG000|STARTED|Overall Study||34
8939645|NCT02356471|10000849|FG000|COMPLETED|Overall Study||28
8939646|NCT02356471|10000849|FG000|NOT COMPLETED|Overall Study||6
8939647|NCT02356484|10000853|FG000|STARTED|Overall Study||138
8939648|NCT02356484|10000853|FG000|COMPLETED|Overall Study||138
8939649|NCT02356484|10000853|FG000|NOT COMPLETED|Overall Study||0
8939650|NCT02356562|10000859|FG000|STARTED|Overall Study||22
8719339|NCT01004003|9766833|FG004|STARTED|Overall Study||4
8719340|NCT01004003|9766834|FG005|STARTED|Overall Study||4
8719341|NCT01004003|9766835|FG006|STARTED|Overall Study||8
8939651|NCT02356562|10000860|FG001|STARTED|Overall Study||7
8939652|NCT02356562|10000859|FG000|COMPLETED|Overall Study||20
8939653|NCT02356562|10000860|FG001|COMPLETED|Overall Study||6
8939654|NCT02356562|10000859|FG000|NOT COMPLETED|Overall Study||2
8939655|NCT02356562|10000860|FG001|NOT COMPLETED|Overall Study||1
8939656|NCT02356588|10000869|FG000|STARTED|Overall Study||107
8939657|NCT02356588|10000870|FG001|STARTED|Overall Study||54
8939658|NCT02356588|10000869|FG000|COMPLETED|Overall Study||102
8939659|NCT02356588|10000870|FG001|COMPLETED|Overall Study||41
8939660|NCT02356588|10000869|FG000|NOT COMPLETED|Overall Study||5
8939661|NCT02356588|10000870|FG001|NOT COMPLETED|Overall Study||13
8939662|NCT02356692|10000876|FG000|STARTED|Overall Study||60
8939663|NCT02356692|10000877|FG001|STARTED|Overall Study||60
8939664|NCT02356692|10000876|FG000|COMPLETED|Overall Study||60
8939665|NCT02356692|10000877|FG001|COMPLETED|Overall Study||60
8939666|NCT02356692|10000876|FG000|NOT COMPLETED|Overall Study||0
8939667|NCT02356692|10000877|FG001|NOT COMPLETED|Overall Study||0
8939668|NCT02356783|10000887|FG000|STARTED|Overall Study||16
8939669|NCT02356783|10000888|FG001|STARTED|Overall Study||17
8939670|NCT02356783|10000887|FG000|COMPLETED|Overall Study||15
8939671|NCT02356783|10000888|FG001|COMPLETED|Overall Study||14
8939672|NCT02356783|10000887|FG000|NOT COMPLETED|Overall Study||1
8939673|NCT02356783|10000888|FG001|NOT COMPLETED|Overall Study||3
8939674|NCT02356887|10000894|FG000|STARTED|Overall Study||12
8719342|NCT01004003|9766836|FG007|STARTED|Overall Study||62
8939675|NCT02356887|10000894|FG000|COMPLETED|Overall Study||10
8939676|NCT02356887|10000894|FG000|NOT COMPLETED|Overall Study||2
8939677|NCT02356900|10000906|FG000|STARTED|Overall Study||11
8939678|NCT02356900|10000907|FG001|STARTED|Overall Study||10
8939679|NCT02356900|10000906|FG000|COMPLETED|Overall Study||11
8939680|NCT02356900|10000907|FG001|COMPLETED|Overall Study||10
8939681|NCT02356900|10000906|FG000|NOT COMPLETED|Overall Study||0
8939682|NCT02356900|10000907|FG001|NOT COMPLETED|Overall Study||0
8939683|NCT02357043|10000913|FG000|STARTED|Overall Study||368
8939684|NCT02357043|10000913|FG000|COMPLETED|Overall Study||368
8939685|NCT02357043|10000913|FG000|NOT COMPLETED|Overall Study||0
8939686|NCT02357134|10000921|FG000|STARTED|Overall Study||11
8939687|NCT02357134|10000922|FG001|STARTED|Overall Study||11
8939688|NCT02357134|10000923|FG002|STARTED|Overall Study||12
8939689|NCT02357134|10000924|FG003|STARTED|Overall Study||11
8939690|NCT02357134|10000921|FG000|COMPLETED|Overall Study||10
8939691|NCT02357134|10000922|FG001|COMPLETED|Overall Study||11
8719343|NCT01004003|9766837|FG008|STARTED|Overall Study||31
8939692|NCT02357134|10000923|FG002|COMPLETED|Overall Study||12
8939693|NCT02357134|10000924|FG003|COMPLETED|Overall Study||11
8939694|NCT02357134|10000921|FG000|NOT COMPLETED|Overall Study||1
8939695|NCT02357134|10000922|FG001|NOT COMPLETED|Overall Study||0
8939696|NCT02357134|10000923|FG002|NOT COMPLETED|Overall Study||0
8939697|NCT02357134|10000924|FG003|NOT COMPLETED|Overall Study||0
8939698|NCT02357147|10000936|FG000|STARTED|Combination Treatment Phase||52
8939699|NCT02357147|10000937|FG001|STARTED|Combination Treatment Phase||56
8939700|NCT02357147|10000936|FG000|Treated|Combination Treatment Phase||52
8939701|NCT02357147|10000937|FG001|Treated|Combination Treatment Phase||54
8939702|NCT02357147|10000936|FG000|COMPLETED|Combination Treatment Phase||26
8939703|NCT02357147|10000937|FG001|COMPLETED|Combination Treatment Phase||29
8939704|NCT02357147|10000936|FG000|NOT COMPLETED|Combination Treatment Phase||26
8939705|NCT02357147|10000937|FG001|NOT COMPLETED|Combination Treatment Phase||27
8939706|NCT02357147|10000936|FG000|STARTED|Maintenance Treatment Phase||26
8939707|NCT02357147|10000937|FG001|STARTED|Maintenance Treatment Phase||29
8939708|NCT02357147|10000936|FG000|Treated|Maintenance Treatment Phase||25
8939709|NCT02357147|10000937|FG001|Treated|Maintenance Treatment Phase||29
8939710|NCT02357147|10000936|FG000|COMPLETED|Maintenance Treatment Phase||0
8719344|NCT01004003|9766829|FG000|COMPLETED|Overall Study||0
8939711|NCT02357147|10000937|FG001|COMPLETED|Maintenance Treatment Phase||0
8939712|NCT02357147|10000936|FG000|NOT COMPLETED|Maintenance Treatment Phase||26
8939713|NCT02357147|10000937|FG001|NOT COMPLETED|Maintenance Treatment Phase||29
8939714|NCT02357173|10000950|FG000|STARTED|Overall Study||25
8939715|NCT02357173|10000951|FG001|STARTED|Overall Study||21
8939716|NCT02357173|10000952|FG002|STARTED|Overall Study||22
8939717|NCT02357173|10000950|FG000|COMPLETED|Overall Study||19
8939718|NCT02357173|10000951|FG001|COMPLETED|Overall Study||15
8939719|NCT02357173|10000952|FG002|COMPLETED|Overall Study||16
8939720|NCT02357173|10000950|FG000|NOT COMPLETED|Overall Study||6
8939721|NCT02357173|10000951|FG001|NOT COMPLETED|Overall Study||6
8939722|NCT02357173|10000952|FG002|NOT COMPLETED|Overall Study||6
8939723|NCT02357264|10000962|FG000|STARTED|Overall Study||56
8617591|NCT00457821|9655791|FG006|STARTED|Part 1|Arm in Part 2 only|0
8617592|NCT00457821|9655792|FG007|STARTED|Part 1|Arm in Part 2 only|0
8939724|NCT02357264|10000963|FG001|STARTED|Overall Study||130
8939725|NCT02357264|10000962|FG000|COMPLETED|Overall Study||56
8939726|NCT02357264|10000963|FG001|COMPLETED|Overall Study||130
8939727|NCT02357264|10000962|FG000|NOT COMPLETED|Overall Study||0
8939728|NCT02357264|10000963|FG001|NOT COMPLETED|Overall Study||0
8939729|NCT02357290|10000969|FG000|STARTED|Overall Study||40
8939730|NCT02357290|10000969|FG000|Exposed|Overall Study||26
8939731|NCT02357290|10000969|FG000|COMPLETED|Overall Study||14
8939732|NCT02357290|10000969|FG000|NOT COMPLETED|Overall Study||26
8939733|NCT02357342|10000975|FG000|STARTED|First 6 Months||20
8939734|NCT02357342|10000976|FG001|STARTED|First 6 Months||20
8939735|NCT02357342|10000975|FG000|COMPLETED|First 6 Months|2 patients died. Neither deaths were study drug related.|18
8939736|NCT02357342|10000976|FG001|COMPLETED|First 6 Months||20
8939737|NCT02357342|10000975|FG000|NOT COMPLETED|First 6 Months||2
8939738|NCT02357342|10000976|FG001|NOT COMPLETED|First 6 Months||0
8939739|NCT02357342|10000975|FG000|STARTED|Extension Study||4
8939740|NCT02357342|10000976|FG001|STARTED|Extension Study||9
8939741|NCT02357342|10000975|FG000|COMPLETED|Extension Study||4
8939742|NCT02357342|10000976|FG001|COMPLETED|Extension Study||9
8939743|NCT02357342|10000975|FG000|NOT COMPLETED|Extension Study||0
8939744|NCT02357342|10000976|FG001|NOT COMPLETED|Extension Study||0
8939745|NCT02357368|10000986|FG000|STARTED|Overall Study||19
8939746|NCT02357368|10000987|FG001|STARTED|Overall Study||18
8939747|NCT02357368|10000988|FG002|STARTED|Overall Study||14
8939748|NCT02357368|10000989|FG003|STARTED|Overall Study||8
8939749|NCT02357368|10000986|FG000|COMPLETED|Overall Study||13
8939750|NCT02357368|10000987|FG001|COMPLETED|Overall Study||15
8939751|NCT02357368|10000988|FG002|COMPLETED|Overall Study||13
8939752|NCT02357368|10000989|FG003|COMPLETED|Overall Study||5
8939753|NCT02357368|10000986|FG000|NOT COMPLETED|Overall Study||6
8939754|NCT02357368|10000987|FG001|NOT COMPLETED|Overall Study||3
8939755|NCT02357368|10000988|FG002|NOT COMPLETED|Overall Study||1
8939756|NCT02357368|10000989|FG003|NOT COMPLETED|Overall Study||3
8939757|NCT02357394|10001001|FG000|STARTED|Overall Study||4
8939758|NCT02357394|10001002|FG001|STARTED|Overall Study||3
8939759|NCT02357394|10001001|FG000|COMPLETED|Overall Study||4
8939760|NCT02357394|10001002|FG001|COMPLETED|Overall Study||3
8939761|NCT02357394|10001001|FG000|NOT COMPLETED|Overall Study||0
8939762|NCT02357394|10001002|FG001|NOT COMPLETED|Overall Study||0
8939763|NCT02357420|10001012|FG000|STARTED|Overall Study||104
8939764|NCT02357420|10001013|FG001|STARTED|Overall Study||98
8939765|NCT02357420|10001014|FG002|STARTED|Overall Study||109
8939766|NCT02357420|10001015|FG003|STARTED|Overall Study||82
8939767|NCT02357420|10001012|FG000|Full Analysis Set (FAS)|Overall Study||104
8939768|NCT02357420|10001013|FG001|Full Analysis Set (FAS)|Overall Study||98
8939769|NCT02357420|10001014|FG002|Full Analysis Set (FAS)|Overall Study||109
8939770|NCT02357420|10001015|FG003|Full Analysis Set (FAS)|Overall Study|1 participant from safety set did not enter FAS.|81
8939771|NCT02357420|10001012|FG000|COMPLETED|Overall Study|3 participants who discontinued prematurely were included in completed as they fulfilled Visit 8.|92
8939772|NCT02357420|10001013|FG001|COMPLETED|Overall Study|1 participant who discontinued prematurely was included in completed as he/she fulfilled Visit 8.|86
8939773|NCT02357420|10001014|FG002|COMPLETED|Overall Study|1 participant who discontinued prematurely was included in completed as he/she fulfilled Visit 8.|93
8939774|NCT02357420|10001015|FG003|COMPLETED|Overall Study||63
8939775|NCT02357420|10001012|FG000|NOT COMPLETED|Overall Study||12
8939776|NCT02357420|10001013|FG001|NOT COMPLETED|Overall Study||12
8939777|NCT02357420|10001014|FG002|NOT COMPLETED|Overall Study||16
8939778|NCT02357420|10001015|FG003|NOT COMPLETED|Overall Study||19
8939779|NCT02357459|10001028|FG000|STARTED|Overall Study||161
8939780|NCT02357459|10001029|FG001|STARTED|Overall Study||163
8939781|NCT02357459|10001030|FG002|STARTED|Overall Study||162
8939782|NCT02357459|10001028|FG000|COMPLETED|Overall Study||144
8939783|NCT02357459|10001029|FG001|COMPLETED|Overall Study||149
8939784|NCT02357459|10001030|FG002|COMPLETED|Overall Study||150
8939785|NCT02357459|10001028|FG000|NOT COMPLETED|Overall Study||17
8939786|NCT02357459|10001029|FG001|NOT COMPLETED|Overall Study||14
8939787|NCT02357459|10001030|FG002|NOT COMPLETED|Overall Study||12
8617593|NCT00457821|9655785|FG000|COMPLETED|Part 1||4
8948640|NCT02431806|10011101|FG000|STARTED|Double-blind Treatment Period||142
8948641|NCT02431806|10011102|FG001|STARTED|Double-blind Treatment Period||136
8948642|NCT02431806|10011103|FG002|STARTED|Double-blind Treatment Period||139
8948643|NCT02431806|10011104|FG003|STARTED|Double-blind Treatment Period||135
8948644|NCT02431806|10011101|FG000|Safety Population|Double-blind Treatment Period||141
8948645|NCT02431806|10011102|FG001|Safety Population|Double-blind Treatment Period||134
8948827|NCT02433080|10011308|FG000|8 Weeks|Overall Study||25
8939788|NCT02357485|10001041|FG000|STARTED|Overall Study|6 subjects, 8 knees ( 2 bilateral & 4 unilateral)|6
8939789|NCT02357485|10001041|FG000|COMPLETED|Overall Study||6
8939790|NCT02357485|10001041|FG000|NOT COMPLETED|Overall Study||0
8939791|NCT02357576|10001048|FG000|STARTED|Treatment Period||12
8939792|NCT02357576|10001049|FG001|STARTED|Treatment Period||9
8939793|NCT02357576|10001048|FG000|COMPLETED|Treatment Period||12
8939794|NCT02357576|10001049|FG001|COMPLETED|Treatment Period||7
8939795|NCT02357576|10001048|FG000|NOT COMPLETED|Treatment Period||0
8939796|NCT02357576|10001049|FG001|NOT COMPLETED|Treatment Period||2
8939797|NCT02357576|10001048|FG000|STARTED|Neurodevelopmental Outcome Follow Up|1 patient exited the study after treatment completion and before returning for follow up visits.|11
8939798|NCT02357576|10001049|FG001|STARTED|Neurodevelopmental Outcome Follow Up||7
8939799|NCT02357576|10001048|FG000|COMPLETED|Neurodevelopmental Outcome Follow Up||6
8939800|NCT02357576|10001049|FG001|COMPLETED|Neurodevelopmental Outcome Follow Up||2
8939801|NCT02357576|10001048|FG000|NOT COMPLETED|Neurodevelopmental Outcome Follow Up||5
8939802|NCT02357576|10001049|FG001|NOT COMPLETED|Neurodevelopmental Outcome Follow Up||5
8939803|NCT02357706|10001055|FG000|STARTED|Overall Study||10
8939804|NCT02357706|10001056|FG001|STARTED|Overall Study||10
8939805|NCT02357706|10001055|FG000|COMPLETED|Overall Study||10
8939806|NCT02357706|10001056|FG001|COMPLETED|Overall Study||10
8939807|NCT02357706|10001055|FG000|NOT COMPLETED|Overall Study||0
8939808|NCT02357706|10001056|FG001|NOT COMPLETED|Overall Study||0
8939809|NCT02357758|10001068|FG000|STARTED|Overall Study||25
8939810|NCT02357758|10001069|FG001|STARTED|Overall Study||20
8939811|NCT02357758|10001070|FG002|STARTED|Overall Study||12
8939812|NCT02357758|10001068|FG000|COMPLETED|Overall Study||9
8939813|NCT02357758|10001069|FG001|COMPLETED|Overall Study||20
8939814|NCT02357758|10001070|FG002|COMPLETED|Overall Study||5
8939815|NCT02357758|10001068|FG000|NOT COMPLETED|Overall Study||16
8939816|NCT02357758|10001069|FG001|NOT COMPLETED|Overall Study||0
8939817|NCT02357758|10001070|FG002|NOT COMPLETED|Overall Study||7
8939818|NCT02357836|10001078|FG000|STARTED|Overall Study||13
8939819|NCT02357836|10001078|FG000|COMPLETED|Overall Study||13
8939820|NCT02357836|10001078|FG000|NOT COMPLETED|Overall Study||0
8939821|NCT02357901|10001086|FG000|STARTED|Run-In Period (Days -14 to Day -1)|Received at least one dose of SUBOXONE sublingual film.|665
8939822|NCT02357901|10001087|FG001|STARTED|Run-In Period (Days -14 to Day -1)||0
8939823|NCT02357901|10001088|FG002|STARTED|Run-In Period (Days -14 to Day -1)||0
8939824|NCT02357901|10001089|FG003|STARTED|Run-In Period (Days -14 to Day -1)||0
8939825|NCT02357901|10001086|FG000|COMPLETED|Run-In Period (Days -14 to Day -1)||504
8939826|NCT02357901|10001087|FG001|COMPLETED|Run-In Period (Days -14 to Day -1)||0
8939827|NCT02357901|10001088|FG002|COMPLETED|Run-In Period (Days -14 to Day -1)||0
8939828|NCT02357901|10001089|FG003|COMPLETED|Run-In Period (Days -14 to Day -1)||0
8939829|NCT02357901|10001086|FG000|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||161
8939830|NCT02357901|10001087|FG001|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
8939831|NCT02357901|10001088|FG002|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
8939832|NCT02357901|10001089|FG003|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
8939833|NCT02357901|10001086|FG000|STARTED|Treatment Period (Day 1 to Week 24)||0
8939834|NCT02357901|10001087|FG001|STARTED|Treatment Period (Day 1 to Week 24)||203
8939835|NCT02357901|10001088|FG002|STARTED|Treatment Period (Day 1 to Week 24)||201
8939836|NCT02357901|10001089|FG003|STARTED|Treatment Period (Day 1 to Week 24)||100
8939837|NCT02357901|10001086|FG000|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||0
8939838|NCT02357901|10001087|FG001|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||203
8939839|NCT02357901|10001088|FG002|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||201
8939840|NCT02357901|10001089|FG003|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||100
8939841|NCT02357901|10001086|FG000|Full Analysis Set|Treatment Period (Day 1 to Week 24)||0
8939842|NCT02357901|10001087|FG001|Full Analysis Set|Treatment Period (Day 1 to Week 24)||194
8939843|NCT02357901|10001088|FG002|Full Analysis Set|Treatment Period (Day 1 to Week 24)||196
8939844|NCT02357901|10001089|FG003|Full Analysis Set|Treatment Period (Day 1 to Week 24)||99
8939845|NCT02357901|10001086|FG000|COMPLETED|Treatment Period (Day 1 to Week 24)||0
8939846|NCT02357901|10001087|FG001|COMPLETED|Treatment Period (Day 1 to Week 24)||125
8939847|NCT02357901|10001088|FG002|COMPLETED|Treatment Period (Day 1 to Week 24)||129
8939848|NCT02357901|10001089|FG003|COMPLETED|Treatment Period (Day 1 to Week 24)||34
8939849|NCT02357901|10001086|FG000|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||0
8939850|NCT02357901|10001087|FG001|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||78
8939851|NCT02357901|10001088|FG002|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||72
9065431|NCT04176406|10125812|FG001|NOT COMPLETED|Overall Study||0
9065432|NCT04176406|10125813|FG002|NOT COMPLETED|Overall Study||0
9065433|NCT04176406|10125814|FG003|NOT COMPLETED|Overall Study||0
9065434|NCT04175262|10125825|FG000|STARTED|Overall Study||102
9065435|NCT04175262|10125825|FG000|COMPLETED|Overall Study||102
9065436|NCT04175262|10125825|FG000|NOT COMPLETED|Overall Study||0
9065437|NCT04171102|10125832|FG000|STARTED|Overall Study||4
9065438|NCT04171102|10125833|FG001|STARTED|Overall Study||5
9065439|NCT04171102|10125834|FG002|STARTED|Overall Study||6
9065440|NCT04171102|10125832|FG000|COMPLETED|Overall Study||4
9065441|NCT04171102|10125833|FG001|COMPLETED|Overall Study||5
8939852|NCT02357901|10001089|FG003|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||66
8939853|NCT02357940|10001099|FG000|STARTED|Overall Study||9
8939854|NCT02357940|10001100|FG001|STARTED|Overall Study||32
8939855|NCT02357940|10001099|FG000|COMPLETED|Overall Study||9
8939856|NCT02357940|10001100|FG001|COMPLETED|Overall Study||30
8939857|NCT02357940|10001099|FG000|NOT COMPLETED|Overall Study||0
8939858|NCT02357940|10001100|FG001|NOT COMPLETED|Overall Study||2
8939859|NCT02357979|10001108|FG000|STARTED|Overall Study||60
8939860|NCT02357979|10001109|FG001|STARTED|Overall Study||60
8939861|NCT02357979|10001108|FG000|COMPLETED|Overall Study||55
8939862|NCT02357979|10001109|FG001|COMPLETED|Overall Study||55
8939863|NCT02357979|10001108|FG000|NOT COMPLETED|Overall Study||5
8939864|NCT02357979|10001109|FG001|NOT COMPLETED|Overall Study||5
8939865|NCT02358044|10001117|FG000|STARTED|Overall Study||129
8939866|NCT02358044|10001118|FG001|STARTED|Overall Study||128
8939867|NCT02358044|10001117|FG000|Treated|Overall Study||129
8939868|NCT02358044|10001118|FG001|Treated|Overall Study||126
8939869|NCT02358044|10001117|FG000|COMPLETED|Overall Study|Completed = Completed Follow-up Week 24 (end of study)|127
8939870|NCT02358044|10001118|FG001|COMPLETED|Overall Study|Completed = Completed Follow-up Week 24 (end of study)|121
8939871|NCT02358044|10001117|FG000|NOT COMPLETED|Overall Study||2
8939872|NCT02358044|10001118|FG001|NOT COMPLETED|Overall Study||7
8939873|NCT02358135|10001126|FG000|STARTED|Overall Study||150
8939874|NCT02358135|10001127|FG001|STARTED|Overall Study||150
8939875|NCT02358135|10001126|FG000|Randomized|Overall Study||148
8939876|NCT02358135|10001127|FG001|Randomized|Overall Study||148
8939877|NCT02358135|10001126|FG000|COMPLETED|Overall Study||135
8939878|NCT02358135|10001127|FG001|COMPLETED|Overall Study||131
8939879|NCT02358135|10001126|FG000|NOT COMPLETED|Overall Study||15
8939880|NCT02358135|10001127|FG001|NOT COMPLETED|Overall Study||19
8939881|NCT02358343|10001138|FG000|STARTED|Screening Intervention|90 completed engagement interview|92
8939882|NCT02358343|10001139|FG001|STARTED|Screening Intervention|89 completed control visit|92
8939883|NCT02358343|10001140|FG002|STARTED|Screening Intervention||0
8939884|NCT02358343|10001141|FG003|STARTED|Screening Intervention||0
8939885|NCT02358343|10001142|FG004|STARTED|Screening Intervention||0
8939886|NCT02358343|10001138|FG000|COMPLETED|Screening Intervention||86
8939887|NCT02358343|10001139|FG001|COMPLETED|Screening Intervention||84
8939888|NCT02358343|10001140|FG002|COMPLETED|Screening Intervention||0
8939889|NCT02358343|10001141|FG003|COMPLETED|Screening Intervention||0
8939890|NCT02358343|10001142|FG004|COMPLETED|Screening Intervention||0
8939891|NCT02358343|10001138|FG000|NOT COMPLETED|Screening Intervention||6
8939892|NCT02358343|10001139|FG001|NOT COMPLETED|Screening Intervention||8
8939893|NCT02358343|10001140|FG002|NOT COMPLETED|Screening Intervention||0
8939894|NCT02358343|10001141|FG003|NOT COMPLETED|Screening Intervention||0
8939895|NCT02358343|10001142|FG004|NOT COMPLETED|Screening Intervention||0
8939896|NCT02358343|10001138|FG000|STARTED|Comparative Efficacy Trial / Observation|Participants enrolled in screening intervention enrolled in comparative efficacy trial|0
8939897|NCT02358343|10001139|FG001|STARTED|Comparative Efficacy Trial / Observation|Participants enrolled in screening intervention enrolled in comparative efficacy trial|0
8939898|NCT02358343|10001140|FG002|STARTED|Comparative Efficacy Trial / Observation|44 completed treatment|60
8939899|NCT02358343|10001141|FG003|STARTED|Comparative Efficacy Trial / Observation|47 completed treatment|60
8939900|NCT02358343|10001142|FG004|STARTED|Comparative Efficacy Trial / Observation||20
8939901|NCT02358343|10001138|FG000|COMPLETED|Comparative Efficacy Trial / Observation||0
8939902|NCT02358343|10001139|FG001|COMPLETED|Comparative Efficacy Trial / Observation||0
8939903|NCT02358343|10001140|FG002|COMPLETED|Comparative Efficacy Trial / Observation||55
8939904|NCT02358343|10001141|FG003|COMPLETED|Comparative Efficacy Trial / Observation||58
8939905|NCT02358343|10001142|FG004|COMPLETED|Comparative Efficacy Trial / Observation||18
8939906|NCT02358343|10001138|FG000|NOT COMPLETED|Comparative Efficacy Trial / Observation||0
8939907|NCT02358343|10001139|FG001|NOT COMPLETED|Comparative Efficacy Trial / Observation||0
8939908|NCT02358343|10001140|FG002|NOT COMPLETED|Comparative Efficacy Trial / Observation||5
8939909|NCT02358343|10001141|FG003|NOT COMPLETED|Comparative Efficacy Trial / Observation||2
8939910|NCT02358343|10001142|FG004|NOT COMPLETED|Comparative Efficacy Trial / Observation||2
8939911|NCT02358369|10001156|FG000|STARTED|Pre-Randomization Washout Period||156
8939912|NCT02358369|10001157|FG001|STARTED|Pre-Randomization Washout Period||0
8939913|NCT02358369|10001158|FG002|STARTED|Pre-Randomization Washout Period||0
8939914|NCT02358369|10001159|FG003|STARTED|Pre-Randomization Washout Period||0
8939915|NCT02358369|10001160|FG004|STARTED|Pre-Randomization Washout Period||0
8939916|NCT02358369|10001156|FG000|COMPLETED|Pre-Randomization Washout Period||121
8939917|NCT02358369|10001157|FG001|COMPLETED|Pre-Randomization Washout Period||0
8939918|NCT02358369|10001158|FG002|COMPLETED|Pre-Randomization Washout Period||0
8939919|NCT02358369|10001159|FG003|COMPLETED|Pre-Randomization Washout Period||0
8939920|NCT02358369|10001160|FG004|COMPLETED|Pre-Randomization Washout Period||0
8939921|NCT02358369|10001156|FG000|NOT COMPLETED|Pre-Randomization Washout Period||35
8939922|NCT02358369|10001157|FG001|NOT COMPLETED|Pre-Randomization Washout Period||0
8939923|NCT02358369|10001158|FG002|NOT COMPLETED|Pre-Randomization Washout Period||0
8939924|NCT02358369|10001159|FG003|NOT COMPLETED|Pre-Randomization Washout Period||0
8939925|NCT02358369|10001160|FG004|NOT COMPLETED|Pre-Randomization Washout Period||0
8939926|NCT02358369|10001156|FG000|STARTED|Treatment Period A/B||0
8939927|NCT02358369|10001157|FG001|STARTED|Treatment Period A/B||40
8939928|NCT02358369|10001158|FG002|STARTED|Treatment Period A/B||40
8939929|NCT02358369|10001159|FG003|STARTED|Treatment Period A/B||41
8939930|NCT02358369|10001160|FG004|STARTED|Treatment Period A/B||0
8939931|NCT02358369|10001156|FG000|COMPLETED|Treatment Period A/B||0
8939932|NCT02358369|10001157|FG001|COMPLETED|Treatment Period A/B||38
8939933|NCT02358369|10001158|FG002|COMPLETED|Treatment Period A/B||38
8939934|NCT02358369|10001159|FG003|COMPLETED|Treatment Period A/B||37
8939935|NCT02358369|10001160|FG004|COMPLETED|Treatment Period A/B||0
8939936|NCT02358369|10001156|FG000|NOT COMPLETED|Treatment Period A/B||0
8939937|NCT02358369|10001157|FG001|NOT COMPLETED|Treatment Period A/B||2
8939938|NCT02358369|10001158|FG002|NOT COMPLETED|Treatment Period A/B||2
8939939|NCT02358369|10001159|FG003|NOT COMPLETED|Treatment Period A/B||4
8939940|NCT02358369|10001160|FG004|NOT COMPLETED|Treatment Period A/B||0
8939941|NCT02358369|10001156|FG000|STARTED|Treatment Period C||0
8939942|NCT02358369|10001157|FG001|STARTED|Treatment Period C||0
8939943|NCT02358369|10001158|FG002|STARTED|Treatment Period C||0
8939944|NCT02358369|10001159|FG003|STARTED|Treatment Period C||0
8939945|NCT02358369|10001160|FG004|STARTED|Treatment Period C||113
8939946|NCT02358369|10001156|FG000|COMPLETED|Treatment Period C||0
8939947|NCT02358369|10001157|FG001|COMPLETED|Treatment Period C||0
8939948|NCT02358369|10001158|FG002|COMPLETED|Treatment Period C||0
8939949|NCT02358369|10001159|FG003|COMPLETED|Treatment Period C||0
8939950|NCT02358369|10001160|FG004|COMPLETED|Treatment Period C||106
8939951|NCT02358369|10001156|FG000|NOT COMPLETED|Treatment Period C||0
8939952|NCT02358369|10001157|FG001|NOT COMPLETED|Treatment Period C||0
8939953|NCT02358369|10001158|FG002|NOT COMPLETED|Treatment Period C||0
8939954|NCT02358369|10001159|FG003|NOT COMPLETED|Treatment Period C||0
8939955|NCT02358369|10001160|FG004|NOT COMPLETED|Treatment Period C||7
8939956|NCT02358473|10001170|FG000|STARTED|Overall Study||13
8939957|NCT02358473|10001170|FG000|COMPLETED|Overall Study||0
8939958|NCT02358473|10001170|FG000|NOT COMPLETED|Overall Study||13
8939959|NCT02358603|10001176|FG000|STARTED|Overall Study||40
8939960|NCT02358603|10001177|FG001|STARTED|Overall Study||8
8939961|NCT02358603|10001176|FG000|COMPLETED|Overall Study||40
8939962|NCT02358603|10001177|FG001|COMPLETED|Overall Study||8
8939963|NCT02358603|10001176|FG000|NOT COMPLETED|Overall Study||0
8939964|NCT02358603|10001177|FG001|NOT COMPLETED|Overall Study||0
8939965|NCT02358668|10001186|FG000|STARTED|Overall Study||24
8939966|NCT02358668|10001187|FG001|STARTED|Overall Study||24
8939967|NCT02358668|10001188|FG002|STARTED|Overall Study||12
8939968|NCT02358668|10001186|FG000|COMPLETED|Overall Study||22
8939969|NCT02358668|10001187|FG001|COMPLETED|Overall Study||23
8939970|NCT02358668|10001188|FG002|COMPLETED|Overall Study||12
8939971|NCT02358668|10001186|FG000|NOT COMPLETED|Overall Study||2
8939972|NCT02358668|10001187|FG001|NOT COMPLETED|Overall Study||1
8939973|NCT02358668|10001188|FG002|NOT COMPLETED|Overall Study||0
8939974|NCT02358863|10001196|FG000|STARTED|Overall Study||13
8939975|NCT02358863|10001196|FG000|COMPLETED|Overall Study||10
8939976|NCT02358863|10001196|FG000|NOT COMPLETED|Overall Study||3
8939977|NCT02358876|10001200|FG000|STARTED|Overall Study||32
8939978|NCT02358876|10001200|FG000|COMPLETED|Overall Study|All 32 participants completed the in-clinic portion and 30 out of the 32 completed the home portion.|30
8939979|NCT02358876|10001200|FG000|NOT COMPLETED|Overall Study||2
8939980|NCT02358889|10001207|FG000|STARTED|Overall Study||30
8939981|NCT02358889|10001208|FG001|STARTED|Overall Study||30
8939982|NCT02358889|10001209|FG002|STARTED|Overall Study||28
8617594|NCT00457821|9655786|FG001|COMPLETED|Part 1||4
8617595|NCT00457821|9655787|FG002|COMPLETED|Part 1||4
8617596|NCT00457821|9655788|FG003|COMPLETED|Part 1||4
8617597|NCT00457821|9655789|FG004|COMPLETED|Part 1||4
8617598|NCT00457821|9655790|FG005|COMPLETED|Part 1||0
8939983|NCT02358889|10001207|FG000|COMPLETED|Overall Study||30
8939984|NCT02358889|10001208|FG001|COMPLETED|Overall Study||28
8939985|NCT02358889|10001209|FG002|COMPLETED|Overall Study||27
8939986|NCT02358889|10001207|FG000|NOT COMPLETED|Overall Study||0
8939987|NCT02358889|10001208|FG001|NOT COMPLETED|Overall Study||2
8939988|NCT02358889|10001209|FG002|NOT COMPLETED|Overall Study||1
8939989|NCT02359006|10001219|FG000|STARTED|Overall Study||14
8939990|NCT02359006|10001220|FG001|STARTED|Overall Study||13
8939991|NCT02359006|10001219|FG000|COMPLETED|Overall Study||10
8939992|NCT02359006|10001220|FG001|COMPLETED|Overall Study||10
8939993|NCT02359006|10001219|FG000|NOT COMPLETED|Overall Study||4
8939994|NCT02359006|10001220|FG001|NOT COMPLETED|Overall Study||3
8939995|NCT02359019|10001228|FG000|STARTED|Overall Study||45
8617599|NCT00457821|9655791|FG006|COMPLETED|Part 1||0
8617600|NCT00457821|9655792|FG007|COMPLETED|Part 1||0
8939996|NCT02359019|10001228|FG000|COMPLETED|Overall Study||45
8939997|NCT02359019|10001228|FG000|NOT COMPLETED|Overall Study||0
8939998|NCT02359045|10001234|FG000|STARTED|Overall Study||40
8939999|NCT02359045|10001235|FG001|STARTED|Overall Study||42
8940000|NCT02359045|10001234|FG000|COMPLETED|Overall Study||36
8940001|NCT02359045|10001235|FG001|COMPLETED|Overall Study||39
8940002|NCT02359045|10001234|FG000|NOT COMPLETED|Overall Study||4
8940003|NCT02359045|10001235|FG001|NOT COMPLETED|Overall Study||3
8940004|NCT02359058|10001254|FG000|STARTED|Overall Study||6
8940005|NCT02359058|10001255|FG001|STARTED|Overall Study||6
8940006|NCT02359058|10001256|FG002|STARTED|Overall Study||6
8940007|NCT02359058|10001254|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
8940008|NCT02359058|10001255|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
8940009|NCT02359058|10001256|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
8940010|NCT02359058|10001254|FG000|COMPLETED|Overall Study||6
8940011|NCT02359058|10001255|FG001|COMPLETED|Overall Study||6
8940012|NCT02359058|10001256|FG002|COMPLETED|Overall Study||6
8940013|NCT02359058|10001254|FG000|NOT COMPLETED|Overall Study||0
8940014|NCT02359058|10001255|FG001|NOT COMPLETED|Overall Study||0
8940015|NCT02359058|10001256|FG002|NOT COMPLETED|Overall Study||0
8940016|NCT02359110|10001267|FG000|STARTED|Overall Study||55
8940017|NCT02359110|10001268|FG001|STARTED|Overall Study||54
8940018|NCT02359110|10001267|FG000|COMPLETED|Overall Study||55
8617601|NCT00457821|9655785|FG000|NOT COMPLETED|Part 1||0
8940019|NCT02359110|10001268|FG001|COMPLETED|Overall Study||54
8940020|NCT02359110|10001267|FG000|NOT COMPLETED|Overall Study||0
8940021|NCT02359110|10001268|FG001|NOT COMPLETED|Overall Study||0
8940022|NCT02359305|10001276|FG000|STARTED|Overall Study||34
8940023|NCT02359305|10001277|FG001|STARTED|Overall Study||34
8940024|NCT02359305|10001276|FG000|COMPLETED|Overall Study||34
8940025|NCT02359305|10001277|FG001|COMPLETED|Overall Study||34
8940026|NCT02359305|10001276|FG000|NOT COMPLETED|Overall Study||0
8940027|NCT02359305|10001277|FG001|NOT COMPLETED|Overall Study||0
8940028|NCT02359435|10001285|FG000|STARTED|Overall Study||220
8940029|NCT02359435|10001286|FG001|STARTED|Overall Study||220
8940030|NCT02359435|10001285|FG000|COMPLETED|Overall Study||216
8940031|NCT02359435|10001286|FG001|COMPLETED|Overall Study||216
8940032|NCT02359435|10001285|FG000|NOT COMPLETED|Overall Study||4
8940033|NCT02359435|10001286|FG001|NOT COMPLETED|Overall Study||4
8940034|NCT02359552|10001294|FG000|STARTED|Overall Study||25
8940035|NCT02359552|10001295|FG001|STARTED|Overall Study||25
8940036|NCT02359552|10001294|FG000|COMPLETED|Overall Study||22
8940037|NCT02359552|10001295|FG001|COMPLETED|Overall Study||21
8940038|NCT02359552|10001294|FG000|NOT COMPLETED|Overall Study||3
8940039|NCT02359552|10001295|FG001|NOT COMPLETED|Overall Study||4
8940040|NCT02359851|10001301|FG000|STARTED|Overall Study||5
8940041|NCT02359851|10001301|FG000|COMPLETED|Overall Study||3
8940042|NCT02359851|10001301|FG000|NOT COMPLETED|Overall Study||2
8940043|NCT02359877|10001309|FG000|STARTED|Overall Study||34
8940044|NCT02359877|10001310|FG001|STARTED|Overall Study||6
8940045|NCT02359877|10001311|FG002|STARTED|Overall Study||6
8940046|NCT02359877|10001312|FG003|STARTED|Overall Study||14
8940047|NCT02359877|10001309|FG000|COMPLETED|Overall Study||33
8940048|NCT02359877|10001310|FG001|COMPLETED|Overall Study||6
8940049|NCT02359877|10001311|FG002|COMPLETED|Overall Study||6
8940050|NCT02359877|10001312|FG003|COMPLETED|Overall Study||11
8940051|NCT02359877|10001309|FG000|NOT COMPLETED|Overall Study||1
8940052|NCT02359877|10001310|FG001|NOT COMPLETED|Overall Study||0
8940053|NCT02359877|10001311|FG002|NOT COMPLETED|Overall Study||0
8940054|NCT02359877|10001312|FG003|NOT COMPLETED|Overall Study||3
8940055|NCT02359890|10001340|FG000|STARTED|Overall Study|Patients who enrolled in the study are those who signed informed consent forms.|165
8940056|NCT02359890|10001340|FG000|Safety Population|Overall Study|Enrolled subjects who had the study catheter inserted|159
8940057|NCT02359890|10001340|FG000|mITT Population|Overall Study|Enrolled subjects who met the inclusion/exclusion criteria and had the study catheter inserted|155
8940058|NCT02359890|10001340|FG000|Per-Protocol (PP) Population|Overall Study|Subjects part of mITT population who had undergone RF ablation.|155
8940059|NCT02359890|10001340|FG000|COMPLETED|Overall Study||155
8940060|NCT02359890|10001340|FG000|NOT COMPLETED|Overall Study||10
8940061|NCT02359903|10001346|FG000|STARTED|Overall Study||45
8940062|NCT02359903|10001347|FG001|STARTED|Overall Study||45
8940063|NCT02359903|10001346|FG000|COMPLETED|Overall Study||45
8940064|NCT02359903|10001347|FG001|COMPLETED|Overall Study||43
8940065|NCT02359903|10001346|FG000|NOT COMPLETED|Overall Study||0
8940066|NCT02359903|10001347|FG001|NOT COMPLETED|Overall Study||2
8940067|NCT02359916|10001360|FG000|STARTED|Overall Study|The number of unique individuals in this study is unknown|
8940068|NCT02359916|10001361|FG001|STARTED|Overall Study|The number of unique individuals in this study is unknown|
8940069|NCT02359916|10001362|FG002|STARTED|Overall Study|The number of unique individuals in this study is unknown|
8940070|NCT02359916|10001363|FG003|STARTED|Overall Study|The number of unique individuals in this study is unknown|
8940071|NCT02359916|10001364|FG004|STARTED|Overall Study|The number of unique individuals in this study is unknown|
8940072|NCT02359916|10001365|FG005|STARTED|Overall Study|The number of unique individuals in this study is unknown|
8940073|NCT02359916|10001366|FG006|STARTED|Overall Study|The number of unique individuals in this study is unknown|
8940074|NCT02359916|10001360|FG000|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|
8940075|NCT02359916|10001361|FG001|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|
8617602|NCT00457821|9655786|FG001|NOT COMPLETED|Part 1||0
8940076|NCT02359916|10001362|FG002|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|
8940077|NCT02359916|10001363|FG003|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|
8940078|NCT02359916|10001364|FG004|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|
8940079|NCT02359916|10001365|FG005|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|
8940080|NCT02359916|10001366|FG006|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|
8940081|NCT02359916|10001360|FG000|NOT COMPLETED|Overall Study||
8940082|NCT02359916|10001361|FG001|NOT COMPLETED|Overall Study||
8940083|NCT02359916|10001362|FG002|NOT COMPLETED|Overall Study||
8940084|NCT02359916|10001363|FG003|NOT COMPLETED|Overall Study||
8940085|NCT02359916|10001364|FG004|NOT COMPLETED|Overall Study||
8940086|NCT02359916|10001365|FG005|NOT COMPLETED|Overall Study||
8940087|NCT02359916|10001366|FG006|NOT COMPLETED|Overall Study||
8940088|NCT02359955|10001383|FG000|STARTED|Overall Study||10
8940089|NCT02359955|10001384|FG001|STARTED|Overall Study||10
8940090|NCT02359955|10001383|FG000|COMPLETED|Overall Study||10
8719345|NCT01004003|9766830|FG001|COMPLETED|Overall Study||0
8719346|NCT01004003|9766831|FG002|COMPLETED|Overall Study||0
8719347|NCT01004003|9766832|FG003|COMPLETED|Overall Study||0
8719348|NCT01004003|9766833|FG004|COMPLETED|Overall Study||0
8940091|NCT02359955|10001384|FG001|COMPLETED|Overall Study||10
8940092|NCT02359955|10001383|FG000|NOT COMPLETED|Overall Study||0
8940093|NCT02359955|10001384|FG001|NOT COMPLETED|Overall Study||0
8940094|NCT02360085|10001400|FG000|STARTED|Overall Study||65
8940095|NCT02360085|10001400|FG000|COMPLETED|Overall Study||49
8940096|NCT02360085|10001400|FG000|NOT COMPLETED|Overall Study||16
8940097|NCT02360098|10001413|FG000|STARTED|Overall Study||36
8940098|NCT02360098|10001413|FG000|COMPLETED|Overall Study||29
8940099|NCT02360098|10001413|FG000|NOT COMPLETED|Overall Study||7
8940100|NCT02360124|10001421|FG000|STARTED|Overall Study||108
8940101|NCT02360124|10001422|FG001|STARTED|Overall Study||107
8940102|NCT02360124|10001423|FG002|STARTED|Overall Study||108
8940103|NCT02360124|10001421|FG000|COMPLETED|Overall Study||80
8940104|NCT02360124|10001422|FG001|COMPLETED|Overall Study||95
8940105|NCT02360124|10001423|FG002|COMPLETED|Overall Study||82
8940106|NCT02360124|10001421|FG000|NOT COMPLETED|Overall Study||28
8940107|NCT02360124|10001422|FG001|NOT COMPLETED|Overall Study||12
8940108|NCT02360124|10001423|FG002|NOT COMPLETED|Overall Study||26
8940109|NCT02360215|10001435|FG000|STARTED|Overall Study||257
8940110|NCT02360215|10001436|FG001|STARTED|Overall Study||261
8940111|NCT02360215|10001435|FG000|All Randomized Participants|Overall Study||257
8940112|NCT02360215|10001436|FG001|All Randomized Participants|Overall Study||261
8940113|NCT02360215|10001435|FG000|Started Protocol Treatment|Overall Study||232
8940114|NCT02360215|10001436|FG001|Started Protocol Treatment|Overall Study||223
8940115|NCT02360215|10001435|FG000|MDASI-BT Symptom Score|Overall Study||249
8940116|NCT02360215|10001436|FG001|MDASI-BT Symptom Score|Overall Study||251
8940117|NCT02360215|10001435|FG000|MDASI-BT Intererence Score|Overall Study||248
8940118|NCT02360215|10001436|FG001|MDASI-BT Intererence Score|Overall Study||251
8940119|NCT02360215|10001435|FG000|MDASI-BT Cognitive Factor Score|Overall Study||249
8940120|NCT02360215|10001436|FG001|MDASI-BT Cognitive Factor Score|Overall Study||251
8940121|NCT02360215|10001435|FG000|MDASI-BT Neurologic Factor Score|Overall Study||249
8940122|NCT02360215|10001436|FG001|MDASI-BT Neurologic Factor Score|Overall Study||251
8940123|NCT02360215|10001435|FG000|HVLT-R Total Recall|Overall Study||256
8940124|NCT02360215|10001436|FG001|HVLT-R Total Recall|Overall Study||259
8940125|NCT02360215|10001435|FG000|HVLT-R Delayed Recall|Overall Study||256
8940126|NCT02360215|10001436|FG001|HVLT-R Delayed Recall|Overall Study||259
8940127|NCT02360215|10001435|FG000|HVLT-R Recognition|Overall Study||255
8940128|NCT02360215|10001436|FG001|HVLT-R Recognition|Overall Study||259
8940129|NCT02360215|10001435|FG000|Trail Making Test (TMT) Part A|Overall Study||256
8940130|NCT02360215|10001436|FG001|Trail Making Test (TMT) Part A|Overall Study||260
8940131|NCT02360215|10001435|FG000|TMT Part B|Overall Study||250
8940132|NCT02360215|10001436|FG001|TMT Part B|Overall Study||257
8940133|NCT02360215|10001435|FG000|Controlled Oral Word Association (COWA)|Overall Study||257
8940134|NCT02360215|10001436|FG001|Controlled Oral Word Association (COWA)|Overall Study||261
8940135|NCT02360215|10001435|FG000|Clinical Trial Battery Composite Score|Overall Study||255
8940136|NCT02360215|10001436|FG001|Clinical Trial Battery Composite Score|Overall Study||259
8940137|NCT02360215|10001435|FG000|EQ-5D-5L Index at 2 Months|Overall Study||142
8940138|NCT02360215|10001436|FG001|EQ-5D-5L Index at 2 Months|Overall Study||125
8940139|NCT02360215|10001435|FG000|EQ-5D-5L Index at 4 Months|Overall Study||110
8940140|NCT02360215|10001436|FG001|EQ-5D-5L Index at 4 Months|Overall Study||96
8940141|NCT02360215|10001435|FG000|EQ-5D-5L Index at 6 Months|Overall Study||79
8940142|NCT02360215|10001436|FG001|EQ-5D-5L Index at 6 Months|Overall Study||70
8940143|NCT02360215|10001435|FG000|EQ-5D-5L Index at 12 Months|Overall Study||56
8940144|NCT02360215|10001436|FG001|EQ-5D-5L Index at 12 Months|Overall Study||45
8940145|NCT02360215|10001435|FG000|EQ-5D-5L VAS at 2 Months|Overall Study||139
8940146|NCT02360215|10001436|FG001|EQ-5D-5L VAS at 2 Months|Overall Study||123
8940147|NCT02360215|10001435|FG000|EQ-5D-5L VAS at 4 Months|Overall Study||104
8940148|NCT02360215|10001436|FG001|EQ-5D-5L VAS at 4 Months|Overall Study||193
8940149|NCT02360215|10001435|FG000|EQ-5D-5L VAS at 6 Months|Overall Study||76
8940150|NCT02360215|10001436|FG001|EQ-5D-5L VAS at 6 Months|Overall Study||69
8940151|NCT02360215|10001435|FG000|EQ-5D-5L VAS at 12 Months|Overall Study||57
8940152|NCT02360215|10001436|FG001|EQ-5D-5L VAS at 12 Months|Overall Study||48
8940153|NCT02360215|10001435|FG000|COMPLETED|Overall Study||257
8940154|NCT02360215|10001436|FG001|COMPLETED|Overall Study||261
8940155|NCT02360215|10001435|FG000|NOT COMPLETED|Overall Study||0
8940156|NCT02360215|10001436|FG001|NOT COMPLETED|Overall Study||0
8940157|NCT02360228|10001446|FG000|STARTED|Overall Study||9
8719349|NCT01004003|9766834|FG005|COMPLETED|Overall Study||0
8719350|NCT01004003|9766835|FG006|COMPLETED|Overall Study||0
8940158|NCT02360228|10001447|FG001|STARTED|Overall Study||8
8940159|NCT02360228|10001448|FG002|STARTED|Overall Study||8
8940160|NCT02360228|10001446|FG000|COMPLETED|Overall Study||8
8940161|NCT02360228|10001447|FG001|COMPLETED|Overall Study||7
8940162|NCT02360228|10001448|FG002|COMPLETED|Overall Study||7
8940163|NCT02360228|10001446|FG000|NOT COMPLETED|Overall Study||1
8940164|NCT02360228|10001447|FG001|NOT COMPLETED|Overall Study||1
8940165|NCT02360228|10001448|FG002|NOT COMPLETED|Overall Study||1
8940166|NCT02360280|10001458|FG000|STARTED|Overall Study||28
8940167|NCT02360280|10001459|FG001|STARTED|Overall Study||30
8940168|NCT02360280|10001458|FG000|COMPLETED|Overall Study||25
8940169|NCT02360280|10001459|FG001|COMPLETED|Overall Study||29
8940170|NCT02360280|10001458|FG000|NOT COMPLETED|Overall Study||3
8940171|NCT02360280|10001459|FG001|NOT COMPLETED|Overall Study||1
8940172|NCT02360293|10001467|FG000|STARTED|Overall Study||178
8940173|NCT02360293|10001468|FG001|STARTED|Overall Study||179
8940174|NCT02360293|10001467|FG000|6month f/u Survey|Overall Study||110
8940175|NCT02360293|10001468|FG001|6month f/u Survey|Overall Study||105
8940176|NCT02360293|10001467|FG000|6month Physical Activity|Overall Study||122
8940177|NCT02360293|10001468|FG001|6month Physical Activity|Overall Study||108
8940178|NCT02360293|10001467|FG000|12month f/u Survey|Overall Study||102
8940179|NCT02360293|10001468|FG001|12month f/u Survey|Overall Study||83
8940180|NCT02360293|10001467|FG000|12month Physical Activity|Overall Study||68
8940181|NCT02360293|10001468|FG001|12month Physical Activity|Overall Study||59
8940182|NCT02360293|10001467|FG000|COMPLETED|Overall Study||102
8940183|NCT02360293|10001468|FG001|COMPLETED|Overall Study||83
8940184|NCT02360293|10001467|FG000|NOT COMPLETED|Overall Study||76
8940185|NCT02360293|10001468|FG001|NOT COMPLETED|Overall Study||96
8940186|NCT02360319|10001476|FG000|STARTED|Overall Study||255
8940187|NCT02360319|10001477|FG001|STARTED|Overall Study||234
8940188|NCT02360319|10001476|FG000|COMPLETED|Overall Study||167
8940189|NCT02360319|10001477|FG001|COMPLETED|Overall Study||173
8940190|NCT02360319|10001476|FG000|NOT COMPLETED|Overall Study||88
8940191|NCT02360319|10001477|FG001|NOT COMPLETED|Overall Study||61
8940192|NCT02360371|10001485|FG000|STARTED|Overall Study||13
8940193|NCT02360371|10001486|FG001|STARTED|Overall Study||84
8940194|NCT02360371|10001485|FG000|Placebo (Oral)|Overall Study||13
8940195|NCT02360371|10001486|FG001|Placebo (Oral)|Overall Study||69
8940196|NCT02360371|10001485|FG000|Hydromorphone (Oral) 2mg|Overall Study||13
8940197|NCT02360371|10001486|FG001|Hydromorphone (Oral) 2mg|Overall Study||69
8940198|NCT02360371|10001485|FG000|Hydromorphone (Oral) 4mg|Overall Study||13
8940199|NCT02360371|10001486|FG001|Hydromorphone (Oral) 4mg|Overall Study||69
8940200|NCT02360371|10001485|FG000|Hydromorphone (Oral) 8mg|Overall Study||13
8940201|NCT02360371|10001486|FG001|Hydromorphone (Oral) 8mg|Overall Study||69
8940202|NCT02360371|10001485|FG000|COMPLETED|Overall Study||13
8940203|NCT02360371|10001486|FG001|COMPLETED|Overall Study||69
8940204|NCT02360371|10001485|FG000|NOT COMPLETED|Overall Study||0
8940205|NCT02360371|10001486|FG001|NOT COMPLETED|Overall Study||15
8940206|NCT02360397|10001496|FG000|STARTED|Overall Study||6
8940207|NCT02360397|10001496|FG000|COMPLETED|Overall Study||2
8940208|NCT02360397|10001496|FG000|NOT COMPLETED|Overall Study||4
8940209|NCT02360475|10001505|FG000|STARTED|Overall Study||126
8940210|NCT02360475|10001506|FG001|STARTED|Overall Study||124
8940211|NCT02360475|10001507|FG002|STARTED|Overall Study||125
8940212|NCT02360475|10001508|FG003|STARTED|Overall Study||125
8940213|NCT02360475|10001505|FG000|COMPLETED|Overall Study||122
8940214|NCT02360475|10001506|FG001|COMPLETED|Overall Study||111
8940215|NCT02360475|10001507|FG002|COMPLETED|Overall Study||117
8940216|NCT02360475|10001508|FG003|COMPLETED|Overall Study||120
8940217|NCT02360475|10001505|FG000|NOT COMPLETED|Overall Study||4
8940218|NCT02360475|10001506|FG001|NOT COMPLETED|Overall Study||13
8940219|NCT02360475|10001507|FG002|NOT COMPLETED|Overall Study||8
8940220|NCT02360475|10001508|FG003|NOT COMPLETED|Overall Study||5
8940221|NCT02360488|10001520|FG000|STARTED|Overall Study||62
8940222|NCT02360488|10001521|FG001|STARTED|Overall Study||62
8940223|NCT02360488|10001520|FG000|COMPLETED|Overall Study||59
8940224|NCT02360488|10001521|FG001|COMPLETED|Overall Study||55
8940225|NCT02360488|10001520|FG000|NOT COMPLETED|Overall Study||3
8940226|NCT02360488|10001521|FG001|NOT COMPLETED|Overall Study||7
8940227|NCT02360605|10001529|FG000|STARTED|Overall Study||311
8940228|NCT02360605|10001530|FG001|STARTED|Overall Study||309
8940229|NCT02360605|10001529|FG000|COMPLETED|Overall Study||300
8940230|NCT02360605|10001530|FG001|COMPLETED|Overall Study||291
8940231|NCT02360605|10001529|FG000|NOT COMPLETED|Overall Study||11
8617603|NCT00457821|9655787|FG002|NOT COMPLETED|Part 1||1
8940232|NCT02360605|10001530|FG001|NOT COMPLETED|Overall Study||18
8940233|NCT02360631|10001540|FG000|STARTED|Overall Study||300
8940234|NCT02360631|10001541|FG001|STARTED|Overall Study||200
8940235|NCT02360631|10001540|FG000|Week 12|Overall Study||249
8940236|NCT02360631|10001541|FG001|Week 12|Overall Study||165
8940237|NCT02360631|10001540|FG000|COMPLETED|Overall Study||267
8940238|NCT02360631|10001541|FG001|COMPLETED|Overall Study||174
8940239|NCT02360631|10001540|FG000|NOT COMPLETED|Overall Study||33
8940240|NCT02360631|10001541|FG001|NOT COMPLETED|Overall Study||26
8940241|NCT02360774|10001549|FG000|STARTED|Overall Study||15
8940242|NCT02360774|10001550|FG001|STARTED|Overall Study||15
8940243|NCT02360774|10001549|FG000|COMPLETED|Overall Study||12
8940244|NCT02360774|10001550|FG001|COMPLETED|Overall Study||13
8940245|NCT02360774|10001549|FG000|NOT COMPLETED|Overall Study||3
8940246|NCT02360774|10001550|FG001|NOT COMPLETED|Overall Study||2
8617604|NCT00457821|9655788|FG003|NOT COMPLETED|Part 1||0
8940247|NCT02360995|10001561|FG000|STARTED|Overall Study||43
8940248|NCT02360995|10001562|FG001|STARTED|Overall Study||43
8940249|NCT02360995|10001563|FG002|STARTED|Overall Study||43
8940250|NCT02360995|10001561|FG000|COMPLETED|Overall Study||41
8940251|NCT02360995|10001562|FG001|COMPLETED|Overall Study||42
8940252|NCT02360995|10001563|FG002|COMPLETED|Overall Study||41
8940253|NCT02360995|10001561|FG000|NOT COMPLETED|Overall Study||2
8940254|NCT02360995|10001562|FG001|NOT COMPLETED|Overall Study||1
8940255|NCT02360995|10001563|FG002|NOT COMPLETED|Overall Study||2
8940256|NCT02361216|10001573|FG000|STARTED|3 Day Treatment and 8 Week Follow/up||552
8940257|NCT02361216|10001574|FG001|STARTED|3 Day Treatment and 8 Week Follow/up||177
8940258|NCT02361216|10001573|FG000|COMPLETED|3 Day Treatment and 8 Week Follow/up||541
8940259|NCT02361216|10001574|FG001|COMPLETED|3 Day Treatment and 8 Week Follow/up||158
8940260|NCT02361216|10001573|FG000|NOT COMPLETED|3 Day Treatment and 8 Week Follow/up||11
8940261|NCT02361216|10001574|FG001|NOT COMPLETED|3 Day Treatment and 8 Week Follow/up||19
8940262|NCT02361216|10001573|FG000|STARTED|12-month Follow-up||541
8940263|NCT02361216|10001574|FG001|STARTED|12-month Follow-up|1 of the 158 subjects did not receive treatment and was also excluded from the 12-month follow-up.|157
8940264|NCT02361216|10001573|FG000|COMPLETED|12-month Follow-up||489
8940265|NCT02361216|10001574|FG001|COMPLETED|12-month Follow-up||130
8940266|NCT02361216|10001573|FG000|NOT COMPLETED|12-month Follow-up||52
8940267|NCT02361216|10001574|FG001|NOT COMPLETED|12-month Follow-up||27
8940268|NCT02361307|10001585|FG000|STARTED|Overall Study||18
8940269|NCT02361307|10001586|FG001|STARTED|Overall Study||18
8940270|NCT02361307|10001585|FG000|COMPLETED|Overall Study||18
8940271|NCT02361307|10001586|FG001|COMPLETED|Overall Study||17
8940272|NCT02361307|10001585|FG000|NOT COMPLETED|Overall Study||0
8940273|NCT02361307|10001586|FG001|NOT COMPLETED|Overall Study||1
8940274|NCT02361476|10001594|FG000|STARTED|Overall Study||191
8940275|NCT02361476|10001595|FG001|STARTED|Overall Study||188
8940276|NCT02361476|10001594|FG000|COMPLETED|Overall Study||191
8940277|NCT02361476|10001595|FG001|COMPLETED|Overall Study||188
8940278|NCT02361476|10001594|FG000|NOT COMPLETED|Overall Study||0
8940279|NCT02361476|10001595|FG001|NOT COMPLETED|Overall Study||0
8940280|NCT02361736|10001603|FG000|STARTED|Overall Study||60
8940281|NCT02361736|10001604|FG001|STARTED|Overall Study||60
8940282|NCT02361736|10001603|FG000|COMPLETED|Overall Study||59
8940283|NCT02361736|10001604|FG001|COMPLETED|Overall Study||59
8940284|NCT02361736|10001603|FG000|NOT COMPLETED|Overall Study||1
8940285|NCT02361736|10001604|FG001|NOT COMPLETED|Overall Study||1
8940286|NCT02361762|10001612|FG000|STARTED|Overall Study||35
8940287|NCT02361762|10001613|FG001|STARTED|Overall Study||35
8940288|NCT02361762|10001612|FG000|COMPLETED|Overall Study||35
8940289|NCT02361762|10001613|FG001|COMPLETED|Overall Study||33
8940290|NCT02361762|10001612|FG000|NOT COMPLETED|Overall Study||0
8940291|NCT02361762|10001613|FG001|NOT COMPLETED|Overall Study||2
8940292|NCT02362048|10001621|FG000|STARTED|Overall Study|37 enrolled but only 35 received study medication.|37
8940293|NCT02362048|10001622|FG001|STARTED|Overall Study|40 enrolled but only 38 received study medication.|40
8940294|NCT02362048|10001621|FG000|Enrolled|Overall Study||37
8940295|NCT02362048|10001622|FG001|Enrolled|Overall Study||40
8940296|NCT02362048|10001621|FG000|Received Study Medication|Overall Study||35
8940297|NCT02362048|10001622|FG001|Received Study Medication|Overall Study||38
8940298|NCT02362048|10001621|FG000|Discontinued Study|Overall Study||37
8940299|NCT02362048|10001622|FG001|Discontinued Study|Overall Study||40
8940300|NCT02362048|10001621|FG000|COMPLETED|Overall Study||0
8940301|NCT02362048|10001622|FG001|COMPLETED|Overall Study||0
8940302|NCT02362048|10001621|FG000|NOT COMPLETED|Overall Study||37
8940303|NCT02362048|10001622|FG001|NOT COMPLETED|Overall Study||40
8940304|NCT02362191|10001628|FG000|STARTED|Overall Study||5
8940305|NCT02362191|10001628|FG000|COMPLETED|Overall Study||3
8940306|NCT02362191|10001628|FG000|NOT COMPLETED|Overall Study||2
8940307|NCT02362269|10001634|FG000|STARTED|Overall Study||83
8940308|NCT02362269|10001635|FG001|STARTED|Overall Study||86
8940309|NCT02362269|10001634|FG000|COMPLETED|Overall Study||82
8940310|NCT02362269|10001635|FG001|COMPLETED|Overall Study||80
8940311|NCT02362269|10001634|FG000|NOT COMPLETED|Overall Study||1
8940312|NCT02362269|10001635|FG001|NOT COMPLETED|Overall Study||6
8940313|NCT02362282|10001643|FG000|STARTED|Overall Study||5
8940314|NCT02362282|10001644|FG001|STARTED|Overall Study||7
8940315|NCT02362282|10001643|FG000|COMPLETED|Overall Study||4
8940316|NCT02362282|10001644|FG001|COMPLETED|Overall Study||7
8940317|NCT02362282|10001643|FG000|NOT COMPLETED|Overall Study||1
8940318|NCT02362282|10001644|FG001|NOT COMPLETED|Overall Study||0
8940319|NCT02362321|10001652|FG000|STARTED|Overall Study||10
8940320|NCT02362321|10001653|FG001|STARTED|Overall Study||10
8940321|NCT02362321|10001652|FG000|COMPLETED|Overall Study||6
8940322|NCT02362321|10001653|FG001|COMPLETED|Overall Study||10
8940323|NCT02362321|10001652|FG000|NOT COMPLETED|Overall Study||4
8940324|NCT02362321|10001653|FG001|NOT COMPLETED|Overall Study||0
8940325|NCT02362360|10001659|FG000|STARTED|Period 1||26
8940326|NCT02362360|10001660|FG001|STARTED|Period 1||26
8940327|NCT02362360|10001659|FG000|COMPLETED|Period 1||23
8940328|NCT02362360|10001660|FG001|COMPLETED|Period 1||25
8940329|NCT02362360|10001659|FG000|NOT COMPLETED|Period 1||3
8940330|NCT02362360|10001660|FG001|NOT COMPLETED|Period 1||1
8940331|NCT02362360|10001659|FG000|STARTED|Period 2||23
8940332|NCT02362360|10001660|FG001|STARTED|Period 2||25
8940333|NCT02362360|10001659|FG000|COMPLETED|Period 2||23
8940334|NCT02362360|10001660|FG001|COMPLETED|Period 2||25
8940335|NCT02362360|10001659|FG000|NOT COMPLETED|Period 2||0
8940336|NCT02362360|10001660|FG001|NOT COMPLETED|Period 2||0
8940337|NCT02362373|10001666|FG000|STARTED|Overall Study||20
8940338|NCT02362373|10001666|FG000|COMPLETED|Overall Study||20
8940339|NCT02362373|10001666|FG000|NOT COMPLETED|Overall Study||0
8940340|NCT02362412|10001670|FG000|STARTED|Treatment Period II||9
8940341|NCT02362412|10001671|FG001|STARTED|Treatment Period II||11
9065442|NCT04171102|10125834|FG002|COMPLETED|Overall Study||6
9065443|NCT04171102|10125832|FG000|NOT COMPLETED|Overall Study||0
8940342|NCT02362412|10001670|FG000|TREATED|Treatment Period II||9
8940343|NCT02362412|10001671|FG001|TREATED|Treatment Period II||11
8940344|NCT02362412|10001670|FG000|COMPLETED|Treatment Period II||9
8940345|NCT02362412|10001671|FG001|COMPLETED|Treatment Period II||11
8940346|NCT02362412|10001670|FG000|NOT COMPLETED|Treatment Period II||0
8940347|NCT02362412|10001671|FG001|NOT COMPLETED|Treatment Period II||0
8940348|NCT02362412|10001670|FG000|STARTED|Treatment Period III||9
8940349|NCT02362412|10001671|FG001|STARTED|Treatment Period III||11
8940350|NCT02362412|10001670|FG000|TREATED|Treatment Period III||9
8940351|NCT02362412|10001671|FG001|TREATED|Treatment Period III||11
8940352|NCT02362412|10001670|FG000|COMPLETED|Treatment Period III||9
8940353|NCT02362412|10001671|FG001|COMPLETED|Treatment Period III||10
8940354|NCT02362412|10001670|FG000|NOT COMPLETED|Treatment Period III||0
8940355|NCT02362412|10001671|FG001|NOT COMPLETED|Treatment Period III||1
8940356|NCT02362425|10001687|FG000|STARTED|Phase 1 (up to 6 Months)||53
8940357|NCT02362425|10001688|FG001|STARTED|Phase 1 (up to 6 Months)||10
8940358|NCT02362425|10001689|FG002|STARTED|Phase 1 (up to 6 Months)||0
8940359|NCT02362425|10001690|FG003|STARTED|Phase 1 (up to 6 Months)||0
8940360|NCT02362425|10001687|FG000|COMPLETED|Phase 1 (up to 6 Months)||37
8940361|NCT02362425|10001688|FG001|COMPLETED|Phase 1 (up to 6 Months)||10
8940362|NCT02362425|10001689|FG002|COMPLETED|Phase 1 (up to 6 Months)||0
8940363|NCT02362425|10001690|FG003|COMPLETED|Phase 1 (up to 6 Months)||0
8940364|NCT02362425|10001687|FG000|NOT COMPLETED|Phase 1 (up to 6 Months)||16
8940365|NCT02362425|10001688|FG001|NOT COMPLETED|Phase 1 (up to 6 Months)||0
8940366|NCT02362425|10001689|FG002|NOT COMPLETED|Phase 1 (up to 6 Months)||0
8940367|NCT02362425|10001690|FG003|NOT COMPLETED|Phase 1 (up to 6 Months)||0
8940368|NCT02362425|10001687|FG000|STARTED|Phase 2 (up to 6 Months, Randomized)||0
8940369|NCT02362425|10001688|FG001|STARTED|Phase 2 (up to 6 Months, Randomized)||0
8940370|NCT02362425|10001689|FG002|STARTED|Phase 2 (up to 6 Months, Randomized)||16
8940371|NCT02362425|10001690|FG003|STARTED|Phase 2 (up to 6 Months, Randomized)||17
8940372|NCT02362425|10001687|FG000|COMPLETED|Phase 2 (up to 6 Months, Randomized)||0
8940373|NCT02362425|10001688|FG001|COMPLETED|Phase 2 (up to 6 Months, Randomized)||0
8940374|NCT02362425|10001689|FG002|COMPLETED|Phase 2 (up to 6 Months, Randomized)||15
8940375|NCT02362425|10001690|FG003|COMPLETED|Phase 2 (up to 6 Months, Randomized)||14
8940376|NCT02362425|10001687|FG000|NOT COMPLETED|Phase 2 (up to 6 Months, Randomized)||0
8940377|NCT02362425|10001688|FG001|NOT COMPLETED|Phase 2 (up to 6 Months, Randomized)||0
8940378|NCT02362425|10001689|FG002|NOT COMPLETED|Phase 2 (up to 6 Months, Randomized)||1
8940379|NCT02362425|10001690|FG003|NOT COMPLETED|Phase 2 (up to 6 Months, Randomized)||3
8940380|NCT02362594|10001703|FG000|STARTED|Overall Study||514
8940381|NCT02362594|10001704|FG001|STARTED|Overall Study||505
8940382|NCT02362594|10001703|FG000|Treated|Overall Study||509
8940383|NCT02362594|10001704|FG001|Treated|Overall Study||502
8940384|NCT02362594|10001703|FG000|Continuing Part 1 Adjuvant Therapy|Overall Study||41
8940385|NCT02362594|10001704|FG001|Continuing Part 1 Adjuvant Therapy|Overall Study||21
8940386|NCT02362594|10001703|FG000|COMPLETED|Overall Study||264
8940387|NCT02362594|10001704|FG001|COMPLETED|Overall Study||280
8940388|NCT02362594|10001703|FG000|NOT COMPLETED|Overall Study||250
8940389|NCT02362594|10001704|FG001|NOT COMPLETED|Overall Study||225
8940390|NCT02362646|10001712|FG000|STARTED|Overall Study||106
8940391|NCT02362646|10001713|FG001|STARTED|Overall Study||53
8940392|NCT02362646|10001712|FG000|COMPLETED|Overall Study||68
8940393|NCT02362646|10001713|FG001|COMPLETED|Overall Study||29
8940394|NCT02362646|10001712|FG000|NOT COMPLETED|Overall Study||38
8940395|NCT02362646|10001713|FG001|NOT COMPLETED|Overall Study||24
8940396|NCT02362672|10001723|FG000|STARTED|Titration Phase||1189
8940397|NCT02362672|10001724|FG001|STARTED|Titration Phase||0
8940398|NCT02362672|10001725|FG002|STARTED|Titration Phase||0
8940399|NCT02362672|10001723|FG000|COMPLETED|Titration Phase||610
8940400|NCT02362672|10001724|FG001|COMPLETED|Titration Phase||0
9065444|NCT04171102|10125833|FG001|NOT COMPLETED|Overall Study||0
9065445|NCT04171102|10125834|FG002|NOT COMPLETED|Overall Study||0
9065446|NCT04174638|10125844|FG000|STARTED|Overall Study||32
9065447|NCT04174638|10125845|FG001|STARTED|Overall Study||28
9065448|NCT04174638|10125844|FG000|COMPLETED|Overall Study||32
9065449|NCT04174638|10125845|FG001|COMPLETED|Overall Study||28
9065450|NCT04174638|10125844|FG000|NOT COMPLETED|Overall Study||0
9065451|NCT04174638|10125845|FG001|NOT COMPLETED|Overall Study||0
9065452|NCT04174313|10125856|FG000|STARTED|Overall Study||15
9065453|NCT04174313|10125857|FG001|STARTED|Overall Study||50
9065454|NCT04174313|10125856|FG000|COMPLETED|Overall Study||15
9065455|NCT04174313|10125857|FG001|COMPLETED|Overall Study||50
9065456|NCT04174313|10125856|FG000|NOT COMPLETED|Overall Study||0
9065457|NCT04174313|10125857|FG001|NOT COMPLETED|Overall Study||0
9065458|NCT04173429|10125869|FG000|STARTED|Overall Study||32
9065459|NCT04173429|10125870|FG001|STARTED|Overall Study||32
9065460|NCT04173429|10125869|FG000|Completed the Nadroparin Calcium Therapy and Received Warfarin|Overall Study||32
9065461|NCT04173429|10125870|FG001|Completed the Nadroparin Calcium Therapy and Received Warfarin|Overall Study||0
9065462|NCT04173429|10125869|FG000|COMPLETED|Overall Study||30
9065463|NCT04173429|10125870|FG001|COMPLETED|Overall Study||30
9065464|NCT04173429|10125869|FG000|NOT COMPLETED|Overall Study||2
9065465|NCT04173429|10125870|FG001|NOT COMPLETED|Overall Study||2
9065466|NCT04173741|10125879|FG000|STARTED|Overall Study||23
9065467|NCT04173741|10125880|FG001|STARTED|Overall Study||23
9065468|NCT04173741|10125879|FG000|COMPLETED|Overall Study||22
9065469|NCT04173741|10125880|FG001|COMPLETED|Overall Study||22
8940401|NCT02362672|10001725|FG002|COMPLETED|Titration Phase||0
8940402|NCT02362672|10001723|FG000|NOT COMPLETED|Titration Phase||579
8940403|NCT02362672|10001724|FG001|NOT COMPLETED|Titration Phase||0
8940404|NCT02362672|10001725|FG002|NOT COMPLETED|Titration Phase||0
8940405|NCT02362672|10001723|FG000|STARTED|Double-blind Maintenance Phase||0
8940406|NCT02362672|10001724|FG001|STARTED|Double-blind Maintenance Phase||309
9065470|NCT04173741|10125879|FG000|NOT COMPLETED|Overall Study||1
8940407|NCT02362672|10001725|FG002|STARTED|Double-blind Maintenance Phase||301
8940408|NCT02362672|10001723|FG000|COMPLETED|Double-blind Maintenance Phase||0
8940409|NCT02362672|10001724|FG001|COMPLETED|Double-blind Maintenance Phase||249
8940410|NCT02362672|10001725|FG002|COMPLETED|Double-blind Maintenance Phase||242
8940411|NCT02362672|10001723|FG000|NOT COMPLETED|Double-blind Maintenance Phase||0
8940412|NCT02362672|10001724|FG001|NOT COMPLETED|Double-blind Maintenance Phase||60
8940413|NCT02362672|10001725|FG002|NOT COMPLETED|Double-blind Maintenance Phase||59
8940414|NCT02362724|10001736|FG000|STARTED|Overall Study||59
8940415|NCT02362724|10001737|FG001|STARTED|Overall Study||30
8940416|NCT02362724|10001736|FG000|COMPLETED|Overall Study||53
8940417|NCT02362724|10001737|FG001|COMPLETED|Overall Study||29
8940418|NCT02362724|10001736|FG000|NOT COMPLETED|Overall Study||6
8940419|NCT02362724|10001737|FG001|NOT COMPLETED|Overall Study||1
8940420|NCT02362789|10001745|FG000|STARTED|Run-in Phase (Week 0 to 16)||130
8940421|NCT02362789|10001746|FG001|STARTED|Run-in Phase (Week 0 to 16)||0
8940422|NCT02362789|10001747|FG002|STARTED|Run-in Phase (Week 0 to 16)||0
8940423|NCT02362789|10001745|FG000|COMPLETED|Run-in Phase (Week 0 to 16)||128
8940424|NCT02362789|10001746|FG001|COMPLETED|Run-in Phase (Week 0 to 16)||0
8940425|NCT02362789|10001747|FG002|COMPLETED|Run-in Phase (Week 0 to 16)||0
8940426|NCT02362789|10001745|FG000|NOT COMPLETED|Run-in Phase (Week 0 to 16)||2
8940427|NCT02362789|10001746|FG001|NOT COMPLETED|Run-in Phase (Week 0 to 16)||0
8940428|NCT02362789|10001747|FG002|NOT COMPLETED|Run-in Phase (Week 0 to 16)||0
8940429|NCT02362789|10001745|FG000|STARTED|Randomized Withdrawal (Wk 16 to 32)|N/A. Run-in phase completed.|0
8940430|NCT02362789|10001746|FG001|STARTED|Randomized Withdrawal (Wk 16 to 32)|Subjects achieving PASI reduction by 98-100% vs. baseline during Run-In|42
8940431|NCT02362789|10001747|FG002|STARTED|Randomized Withdrawal (Wk 16 to 32)|Subjects achieving PASI reduction by 98-100% vs. baseline during Run-In|38
8940432|NCT02362789|10001745|FG000|COMPLETED|Randomized Withdrawal (Wk 16 to 32)||0
8940433|NCT02362789|10001746|FG001|COMPLETED|Randomized Withdrawal (Wk 16 to 32)||38
8940434|NCT02362789|10001747|FG002|COMPLETED|Randomized Withdrawal (Wk 16 to 32)||26
8940435|NCT02362789|10001745|FG000|NOT COMPLETED|Randomized Withdrawal (Wk 16 to 32)||0
8940436|NCT02362789|10001746|FG001|NOT COMPLETED|Randomized Withdrawal (Wk 16 to 32)||4
8940437|NCT02362789|10001747|FG002|NOT COMPLETED|Randomized Withdrawal (Wk 16 to 32)||12
8940438|NCT02363270|10001756|FG000|STARTED|Overall Study||24
8940439|NCT02363270|10001757|FG001|STARTED|Overall Study||24
8940440|NCT02363270|10001756|FG000|COMPLETED|Overall Study||24
8940441|NCT02363270|10001757|FG001|COMPLETED|Overall Study||24
8940442|NCT02363270|10001756|FG000|NOT COMPLETED|Overall Study||0
8940443|NCT02363270|10001757|FG001|NOT COMPLETED|Overall Study||0
8940444|NCT02363283|10001763|FG000|STARTED|Overall Study||37
8940445|NCT02363283|10001763|FG000|COMPLETED|Overall Study||35
8940446|NCT02363283|10001763|FG000|NOT COMPLETED|Overall Study||2
8940447|NCT02363322|10001769|FG000|STARTED|Overall Study||36
8940448|NCT02363322|10001770|FG001|STARTED|Overall Study||36
8940449|NCT02363322|10001769|FG000|COMPLETED|Overall Study||35
8940450|NCT02363322|10001770|FG001|COMPLETED|Overall Study||36
8940451|NCT02363322|10001769|FG000|NOT COMPLETED|Overall Study||1
8940452|NCT02363322|10001770|FG001|NOT COMPLETED|Overall Study||0
8940453|NCT02363439|10001776|FG000|STARTED|Overall Study||5
8940454|NCT02363439|10001776|FG000|COMPLETED|Overall Study||1
8940455|NCT02363439|10001776|FG000|NOT COMPLETED|Overall Study||4
8940456|NCT02363478|10001780|FG000|STARTED|Overall Study||30
8940457|NCT02363478|10001780|FG000|COMPLETED|Overall Study||22
8940458|NCT02363478|10001780|FG000|NOT COMPLETED|Overall Study||8
8940459|NCT02363621|10001787|FG000|STARTED|Overall Study||51
8940460|NCT02363621|10001788|FG001|STARTED|Overall Study||50
8940461|NCT02363621|10001787|FG000|COMPLETED|Overall Study||50
8940462|NCT02363621|10001788|FG001|COMPLETED|Overall Study||50
8940463|NCT02363621|10001787|FG000|NOT COMPLETED|Overall Study||1
8940464|NCT02363621|10001788|FG001|NOT COMPLETED|Overall Study||0
8940465|NCT02363686|10001794|FG000|STARTED|Overall Study||248
8940466|NCT02363686|10001794|FG000|COMPLETED|Overall Study||213
8940467|NCT02363686|10001794|FG000|NOT COMPLETED|Overall Study||35
8940468|NCT02363738|10001800|FG000|STARTED|Overall Study||29
8940469|NCT02363738|10001801|FG001|STARTED|Overall Study||31
8940470|NCT02363738|10001800|FG000|COMPLETED|Overall Study||21
8940471|NCT02363738|10001801|FG001|COMPLETED|Overall Study||26
8940472|NCT02363738|10001800|FG000|NOT COMPLETED|Overall Study||8
8940473|NCT02363738|10001801|FG001|NOT COMPLETED|Overall Study||5
8940474|NCT02363803|10001809|FG000|STARTED|Period 1||17
8940475|NCT02363803|10001810|FG001|STARTED|Period 1||17
8940476|NCT02363803|10001809|FG000|COMPLETED|Period 1||17
8940477|NCT02363803|10001810|FG001|COMPLETED|Period 1||17
8940478|NCT02363803|10001809|FG000|NOT COMPLETED|Period 1||0
8940479|NCT02363803|10001810|FG001|NOT COMPLETED|Period 1||0
8940480|NCT02363803|10001809|FG000|STARTED|Period 2||17
8940481|NCT02363803|10001810|FG001|STARTED|Period 2|One participant did not return for Period 2 treatment|16
8940482|NCT02363803|10001809|FG000|COMPLETED|Period 2||17
8940483|NCT02363803|10001810|FG001|COMPLETED|Period 2||16
8940484|NCT02363803|10001809|FG000|NOT COMPLETED|Period 2||0
8940485|NCT02363803|10001810|FG001|NOT COMPLETED|Period 2||0
8940486|NCT02363907|10001822|FG000|STARTED|Overall Study||30
8940487|NCT02363907|10001822|FG000|COMPLETED|Overall Study||30
8940488|NCT02363907|10001822|FG000|NOT COMPLETED|Overall Study||0
8940489|NCT02363933|10001826|FG000|STARTED|Overall Study||8
8940490|NCT02363933|10001826|FG000|COMPLETED|Overall Study||2
8940491|NCT02363933|10001826|FG000|NOT COMPLETED|Overall Study||6
8940492|NCT02363946|10001843|FG000|STARTED|Overall Study||4
8940493|NCT02363946|10001844|FG001|STARTED|Overall Study||4
8940494|NCT02363946|10001845|FG002|STARTED|Overall Study||4
8940495|NCT02363946|10001846|FG003|STARTED|Overall Study||4
8940496|NCT02363946|10001847|FG004|STARTED|Overall Study||4
8940497|NCT02363946|10001848|FG005|STARTED|Overall Study||4
8940498|NCT02363946|10001849|FG006|STARTED|Overall Study||4
8940499|NCT02363946|10001850|FG007|STARTED|Overall Study||4
8940500|NCT02363946|10001851|FG008|STARTED|Overall Study||4
8940501|NCT02363946|10001852|FG009|STARTED|Overall Study||18
8940502|NCT02363946|10001853|FG010|STARTED|Overall Study||4
8940503|NCT02363946|10001854|FG011|STARTED|Overall Study||3
8940504|NCT02363946|10001855|FG012|STARTED|Overall Study||4
8940505|NCT02363946|10001843|FG000|COMPLETED|Overall Study||4
8940506|NCT02363946|10001844|FG001|COMPLETED|Overall Study||4
8940507|NCT02363946|10001845|FG002|COMPLETED|Overall Study||4
8940508|NCT02363946|10001846|FG003|COMPLETED|Overall Study||4
8940509|NCT02363946|10001847|FG004|COMPLETED|Overall Study||4
8940510|NCT02363946|10001848|FG005|COMPLETED|Overall Study||4
8940511|NCT02363946|10001849|FG006|COMPLETED|Overall Study||4
8940512|NCT02363946|10001850|FG007|COMPLETED|Overall Study||3
8940513|NCT02363946|10001851|FG008|COMPLETED|Overall Study||4
8940514|NCT02363946|10001852|FG009|COMPLETED|Overall Study||18
8940515|NCT02363946|10001853|FG010|COMPLETED|Overall Study||4
8940516|NCT02363946|10001854|FG011|COMPLETED|Overall Study||3
8940517|NCT02363946|10001855|FG012|COMPLETED|Overall Study||4
8940518|NCT02363946|10001843|FG000|NOT COMPLETED|Overall Study||0
8940519|NCT02363946|10001844|FG001|NOT COMPLETED|Overall Study||0
8940520|NCT02363946|10001845|FG002|NOT COMPLETED|Overall Study||0
8940521|NCT02363946|10001846|FG003|NOT COMPLETED|Overall Study||0
8940522|NCT02363946|10001847|FG004|NOT COMPLETED|Overall Study||0
8940523|NCT02363946|10001848|FG005|NOT COMPLETED|Overall Study||0
8940524|NCT02363946|10001849|FG006|NOT COMPLETED|Overall Study||0
8940525|NCT02363946|10001850|FG007|NOT COMPLETED|Overall Study||1
8940526|NCT02363946|10001851|FG008|NOT COMPLETED|Overall Study||0
8940527|NCT02363946|10001852|FG009|NOT COMPLETED|Overall Study||0
8940528|NCT02363946|10001853|FG010|NOT COMPLETED|Overall Study||0
8940529|NCT02363946|10001854|FG011|NOT COMPLETED|Overall Study||0
8940530|NCT02363946|10001855|FG012|NOT COMPLETED|Overall Study||0
8940531|NCT02363959|10001885|FG000|STARTED|Overall Study||10
8940532|NCT02363959|10001886|FG001|STARTED|Overall Study||10
8940533|NCT02363959|10001885|FG000|COMPLETED|Overall Study||9
8940534|NCT02363959|10001886|FG001|COMPLETED|Overall Study||10
8940535|NCT02363959|10001885|FG000|NOT COMPLETED|Overall Study||1
8940536|NCT02363959|10001886|FG001|NOT COMPLETED|Overall Study||0
8940537|NCT02363972|10001892|FG000|STARTED|Overall Study||103
8940538|NCT02363972|10001892|FG000|COMPLETED|Overall Study||77
8940539|NCT02363972|10001892|FG000|NOT COMPLETED|Overall Study||26
8940540|NCT02364037|10001898|FG000|STARTED|Overall Study||502
8940541|NCT02364037|10001899|FG001|STARTED|Overall Study||506
8940542|NCT02364037|10001898|FG000|COMPLETED|Overall Study||458
8940543|NCT02364037|10001899|FG001|COMPLETED|Overall Study||453
8940544|NCT02364037|10001898|FG000|NOT COMPLETED|Overall Study||44
8940545|NCT02364037|10001899|FG001|NOT COMPLETED|Overall Study||53
8940546|NCT02364076|10001905|FG000|STARTED|Overall Study||45
8940547|NCT02364076|10001905|FG000|COMPLETED|Overall Study||40
8940548|NCT02364076|10001905|FG000|NOT COMPLETED|Overall Study||5
8940549|NCT02364180|10001909|FG000|STARTED|Overall Study||11
8940550|NCT02364180|10001909|FG000|COMPLETED|Overall Study||10
8940551|NCT02364180|10001909|FG000|NOT COMPLETED|Overall Study||1
8940552|NCT02364271|10001915|FG000|STARTED|Overall Study||479
8940553|NCT02364271|10001916|FG001|STARTED|Overall Study||123
8940554|NCT02364271|10001915|FG000|COMPLETED|Overall Study||479
8940555|NCT02364271|10001916|FG001|COMPLETED|Overall Study||123
8940556|NCT02364271|10001915|FG000|NOT COMPLETED|Overall Study||0
8940557|NCT02364271|10001916|FG001|NOT COMPLETED|Overall Study||0
8940558|NCT02364336|10001925|FG000|STARTED|Overall Study||1
8940559|NCT02364336|10001926|FG001|STARTED|Overall Study||12
8940560|NCT02364336|10001925|FG000|6 Hours Post First Peginterferon Inject|Overall Study||1
8940561|NCT02364336|10001926|FG001|6 Hours Post First Peginterferon Inject|Overall Study||12
8940562|NCT02364336|10001925|FG000|End of Peginterferon Treatment|Overall Study||1
8940563|NCT02364336|10001926|FG001|End of Peginterferon Treatment|Overall Study||11
8940564|NCT02364336|10001925|FG000|24 Weeks After End of Peginterferon|Overall Study||1
8940565|NCT02364336|10001926|FG001|24 Weeks After End of Peginterferon|Overall Study||11
8940566|NCT02364336|10001925|FG000|48 Weeks After End of Peginterferon|Overall Study||1
8940567|NCT02364336|10001926|FG001|48 Weeks After End of Peginterferon|Overall Study||10
8940568|NCT02364336|10001925|FG000|COMPLETED|Overall Study||1
8940569|NCT02364336|10001926|FG001|COMPLETED|Overall Study||11
8940570|NCT02364336|10001925|FG000|NOT COMPLETED|Overall Study||0
8940571|NCT02364336|10001926|FG001|NOT COMPLETED|Overall Study||1
8940572|NCT02364388|10001933|FG000|STARTED|Overall Study||217
8940573|NCT02364388|10001933|FG000|Biopsied|Overall Study||209
8940574|NCT02364388|10001933|FG000|Excluded|Overall Study||8
8940575|NCT02364388|10001933|FG000|COMPLETED|Overall Study||209
8940576|NCT02364388|10001933|FG000|NOT COMPLETED|Overall Study||8
8940577|NCT02364570|10001937|FG000|STARTED|Overall Study||1
8940578|NCT02364570|10001938|FG001|STARTED|Overall Study||1
8940579|NCT02364570|10001939|FG002|STARTED|Overall Study||2
8940580|NCT02364570|10001940|FG003|STARTED|Overall Study||1
8940581|NCT02364570|10001941|FG004|STARTED|Overall Study||1
8940582|NCT02364570|10001942|FG005|STARTED|Overall Study||1
8940583|NCT02364570|10001943|FG006|STARTED|Overall Study||2
8940584|NCT02364570|10001944|FG007|STARTED|Overall Study||1
8940585|NCT02364570|10001945|FG008|STARTED|Overall Study||2
8940586|NCT02364570|10001946|FG009|STARTED|Overall Study||1
8940587|NCT02364570|10001947|FG010|STARTED|Overall Study||1
8940588|NCT02364570|10001948|FG011|STARTED|Overall Study||1
8940589|NCT02364570|10001949|FG012|STARTED|Overall Study||1
8940590|NCT02364570|10001950|FG013|STARTED|Overall Study||2
8940591|NCT02364570|10001951|FG014|STARTED|Overall Study||1
8940592|NCT02364570|10001952|FG015|STARTED|Overall Study||1
8940593|NCT02364570|10001937|FG000|COMPLETED|Overall Study||1
8940594|NCT02364570|10001938|FG001|COMPLETED|Overall Study||1
8940595|NCT02364570|10001939|FG002|COMPLETED|Overall Study||2
8940596|NCT02364570|10001940|FG003|COMPLETED|Overall Study||1
8940597|NCT02364570|10001941|FG004|COMPLETED|Overall Study||1
8940598|NCT02364570|10001942|FG005|COMPLETED|Overall Study||1
8940599|NCT02364570|10001943|FG006|COMPLETED|Overall Study||2
8940600|NCT02364570|10001944|FG007|COMPLETED|Overall Study||1
8940601|NCT02364570|10001945|FG008|COMPLETED|Overall Study||2
8940602|NCT02364570|10001946|FG009|COMPLETED|Overall Study||1
8940603|NCT02364570|10001947|FG010|COMPLETED|Overall Study||1
8940604|NCT02364570|10001948|FG011|COMPLETED|Overall Study||1
8940605|NCT02364570|10001949|FG012|COMPLETED|Overall Study||1
8940606|NCT02364570|10001950|FG013|COMPLETED|Overall Study||2
8940607|NCT02364570|10001951|FG014|COMPLETED|Overall Study||1
8940608|NCT02364570|10001952|FG015|COMPLETED|Overall Study||1
8940609|NCT02364570|10001937|FG000|NOT COMPLETED|Overall Study||0
8940610|NCT02364570|10001938|FG001|NOT COMPLETED|Overall Study||0
8940611|NCT02364570|10001939|FG002|NOT COMPLETED|Overall Study||0
8940612|NCT02364570|10001940|FG003|NOT COMPLETED|Overall Study||0
8940613|NCT02364570|10001941|FG004|NOT COMPLETED|Overall Study||0
8940614|NCT02364570|10001942|FG005|NOT COMPLETED|Overall Study||0
8940615|NCT02364570|10001943|FG006|NOT COMPLETED|Overall Study||0
8940616|NCT02364570|10001944|FG007|NOT COMPLETED|Overall Study||0
8940617|NCT02364570|10001945|FG008|NOT COMPLETED|Overall Study||0
8940618|NCT02364570|10001946|FG009|NOT COMPLETED|Overall Study||0
8940619|NCT02364570|10001947|FG010|NOT COMPLETED|Overall Study||0
8940620|NCT02364570|10001948|FG011|NOT COMPLETED|Overall Study||0
8940621|NCT02364570|10001949|FG012|NOT COMPLETED|Overall Study||0
8940622|NCT02364570|10001950|FG013|NOT COMPLETED|Overall Study||0
8940623|NCT02364570|10001951|FG014|NOT COMPLETED|Overall Study||0
8940624|NCT02364570|10001952|FG015|NOT COMPLETED|Overall Study||0
8940625|NCT02364700|10001962|FG000|STARTED|Overall Study||12
8940626|NCT02364700|10001962|FG000|COMPLETED|Overall Study||12
8940627|NCT02364700|10001962|FG000|NOT COMPLETED|Overall Study||0
8940628|NCT02364778|10001968|FG000|STARTED|Overall Study||30
8940629|NCT02364778|10001968|FG000|COMPLETED|Overall Study||30
8940630|NCT02364778|10001968|FG000|NOT COMPLETED|Overall Study||0
8940631|NCT02364947|10001977|FG000|STARTED|Overall Study||248
8940632|NCT02364947|10001978|FG001|STARTED|Overall Study||184
8940633|NCT02364947|10001979|FG002|STARTED|Overall Study||245
8940634|NCT02364947|10001977|FG000|COMPLETED|Overall Study||189
8940635|NCT02364947|10001978|FG001|COMPLETED|Overall Study||139
8940636|NCT02364947|10001979|FG002|COMPLETED|Overall Study||219
8940637|NCT02364947|10001977|FG000|NOT COMPLETED|Overall Study||59
8940638|NCT02364947|10001978|FG001|NOT COMPLETED|Overall Study||45
8940639|NCT02364947|10001979|FG002|NOT COMPLETED|Overall Study||26
8940640|NCT02364999|10001989|FG000|STARTED|Overall Study||358
8940641|NCT02364999|10001990|FG001|STARTED|Overall Study||361
8940642|NCT02364999|10001989|FG000|Received Treatment|Overall Study||356
8940643|NCT02364999|10001990|FG001|Received Treatment|Overall Study||358
8940644|NCT02364999|10001989|FG000|COMPLETED|Overall Study||193
8940645|NCT02364999|10001990|FG001|COMPLETED|Overall Study||188
9065471|NCT04173741|10125880|FG001|NOT COMPLETED|Overall Study||1
9065472|NCT04169061|10125886|FG000|STARTED|Overall Study||36
9065473|NCT04169061|10125886|FG000|Safety Population|Overall Study||36
9065474|NCT04169061|10125886|FG000|Modified Intent to Treat (mITT) Population|Overall Study||34
9065475|NCT04169061|10125886|FG000|COMPLETED|Overall Study||31
9065476|NCT04169061|10125886|FG000|NOT COMPLETED|Overall Study||5
9065477|NCT04157738|10125892|FG000|STARTED|Overall Study||12
9065478|NCT04157738|10125893|FG001|STARTED|Overall Study||12
9065479|NCT04157738|10125892|FG000|COMPLETED|Overall Study||11
8940646|NCT02364999|10001989|FG000|NOT COMPLETED|Overall Study||165
8940647|NCT02364999|10001990|FG001|NOT COMPLETED|Overall Study||173
8940648|NCT02365064|10001999|FG000|STARTED|Overall Study||31
8940649|NCT02365064|10002000|FG001|STARTED|Overall Study||47
8940650|NCT02365064|10001999|FG000|Included in ITT Analysis|Overall Study||29
8940651|NCT02365064|10002000|FG001|Included in ITT Analysis|Overall Study||32
8940652|NCT02365064|10001999|FG000|COMPLETED|Overall Study||21
8940653|NCT02365064|10002000|FG001|COMPLETED|Overall Study||19
8940654|NCT02365064|10001999|FG000|NOT COMPLETED|Overall Study||10
8940655|NCT02365064|10002000|FG001|NOT COMPLETED|Overall Study||28
8940656|NCT02365285|10002010|FG000|STARTED|Overall Study||7
8940657|NCT02365285|10002011|FG001|STARTED|Overall Study||6
8940658|NCT02365285|10002012|FG002|STARTED|Overall Study||7
8940659|NCT02365285|10002013|FG003|STARTED|Overall Study||3
8940660|NCT02365285|10002010|FG000|COMPLETED|Overall Study||7
9065480|NCT04157738|10125893|FG001|COMPLETED|Overall Study||10
9065481|NCT04157738|10125892|FG000|NOT COMPLETED|Overall Study||1
9065482|NCT04157738|10125893|FG001|NOT COMPLETED|Overall Study||2
8940661|NCT02365285|10002011|FG001|COMPLETED|Overall Study||5
8940662|NCT02365285|10002012|FG002|COMPLETED|Overall Study||6
8940663|NCT02365285|10002013|FG003|COMPLETED|Overall Study||1
8940664|NCT02365285|10002010|FG000|NOT COMPLETED|Overall Study||0
8940665|NCT02365285|10002011|FG001|NOT COMPLETED|Overall Study||1
8940666|NCT02365285|10002012|FG002|NOT COMPLETED|Overall Study||1
8940667|NCT02365285|10002013|FG003|NOT COMPLETED|Overall Study||2
8940668|NCT02365298|10002025|FG000|STARTED|Period 1||14
8940669|NCT02365298|10002026|FG001|STARTED|Period 1||14
8940670|NCT02365298|10002025|FG000|COMPLETED|Period 1||14
8940671|NCT02365298|10002026|FG001|COMPLETED|Period 1||14
8940672|NCT02365298|10002025|FG000|NOT COMPLETED|Period 1||0
8940673|NCT02365298|10002026|FG001|NOT COMPLETED|Period 1||0
8940674|NCT02365298|10002025|FG000|STARTED|Period 2||14
8940675|NCT02365298|10002026|FG001|STARTED|Period 2||14
8940676|NCT02365298|10002025|FG000|COMPLETED|Period 2||12
8940677|NCT02365298|10002026|FG001|COMPLETED|Period 2||12
8940678|NCT02365298|10002025|FG000|NOT COMPLETED|Period 2||2
8940679|NCT02365298|10002026|FG001|NOT COMPLETED|Period 2||2
8940680|NCT02365480|10002034|FG000|STARTED|Overall Study||14
8940681|NCT02365480|10002035|FG001|STARTED|Overall Study||4
8940682|NCT02365480|10002034|FG000|COMPLETED|Overall Study||12
8940683|NCT02365480|10002035|FG001|COMPLETED|Overall Study||4
8940684|NCT02365480|10002034|FG000|NOT COMPLETED|Overall Study||2
8940685|NCT02365480|10002035|FG001|NOT COMPLETED|Overall Study||0
8940686|NCT02365506|10002044|FG000|STARTED|Overall Study||4
8940687|NCT02365506|10002045|FG001|STARTED|Overall Study||4
8940688|NCT02365506|10002046|FG002|STARTED|Overall Study||5
8940689|NCT02365506|10002044|FG000|COMPLETED|Overall Study||4
8940690|NCT02365506|10002045|FG001|COMPLETED|Overall Study||4
8940691|NCT02365506|10002046|FG002|COMPLETED|Overall Study||4
8940692|NCT02365506|10002044|FG000|NOT COMPLETED|Overall Study||0
8940693|NCT02365506|10002045|FG001|NOT COMPLETED|Overall Study||0
8940694|NCT02365506|10002046|FG002|NOT COMPLETED|Overall Study||1
8940695|NCT02365519|10002056|FG000|STARTED|Vehicle Run-In||213
8940696|NCT02365519|10002057|FG001|STARTED|Vehicle Run-In||0
8940697|NCT02365519|10002058|FG002|STARTED|Vehicle Run-In||0
8940698|NCT02365519|10002056|FG000|COMPLETED|Vehicle Run-In||134
8940699|NCT02365519|10002057|FG001|COMPLETED|Vehicle Run-In||0
8940700|NCT02365519|10002058|FG002|COMPLETED|Vehicle Run-In||0
8940701|NCT02365519|10002056|FG000|NOT COMPLETED|Vehicle Run-In||79
8940702|NCT02365519|10002057|FG001|NOT COMPLETED|Vehicle Run-In||0
8940703|NCT02365519|10002058|FG002|NOT COMPLETED|Vehicle Run-In||0
8940704|NCT02365519|10002056|FG000|STARTED|Randomized and Treated||0
8940705|NCT02365519|10002057|FG001|STARTED|Randomized and Treated||69
8940706|NCT02365519|10002058|FG002|STARTED|Randomized and Treated||65
8940707|NCT02365519|10002056|FG000|COMPLETED|Randomized and Treated||0
8940708|NCT02365519|10002057|FG001|COMPLETED|Randomized and Treated||67
8940709|NCT02365519|10002058|FG002|COMPLETED|Randomized and Treated||64
8940710|NCT02365519|10002056|FG000|NOT COMPLETED|Randomized and Treated||0
8940711|NCT02365519|10002057|FG001|NOT COMPLETED|Randomized and Treated||2
8940712|NCT02365519|10002058|FG002|NOT COMPLETED|Randomized and Treated||1
8940713|NCT02365558|10002067|FG000|STARTED|Period 1 (Day 1 Through Day 7)||34
8940714|NCT02365558|10002068|FG001|STARTED|Period 1 (Day 1 Through Day 7)||0
8940715|NCT02365558|10002067|FG000|Received at Least One Dose of Study Drug|Period 1 (Day 1 Through Day 7)||34
8940716|NCT02365558|10002068|FG001|Received at Least One Dose of Study Drug|Period 1 (Day 1 Through Day 7)||0
8940717|NCT02365558|10002067|FG000|COMPLETED|Period 1 (Day 1 Through Day 7)||33
8940718|NCT02365558|10002068|FG001|COMPLETED|Period 1 (Day 1 Through Day 7)||0
8940719|NCT02365558|10002067|FG000|NOT COMPLETED|Period 1 (Day 1 Through Day 7)||1
8940720|NCT02365558|10002068|FG001|NOT COMPLETED|Period 1 (Day 1 Through Day 7)||0
8940721|NCT02365558|10002067|FG000|STARTED|Period 2 (Day 8 Through Day 20)|Participants move to Evacetrapib + Omeprazole for Period 2.|0
8940722|NCT02365558|10002068|FG001|STARTED|Period 2 (Day 8 Through Day 20)|Participants completed Period 1 and entered Evacetrapib + Omeprazole for Period 2.|33
8940723|NCT02365558|10002067|FG000|COMPLETED|Period 2 (Day 8 Through Day 20)||0
8940724|NCT02365558|10002068|FG001|COMPLETED|Period 2 (Day 8 Through Day 20)||32
8940725|NCT02365558|10002067|FG000|NOT COMPLETED|Period 2 (Day 8 Through Day 20)||0
8940726|NCT02365558|10002068|FG001|NOT COMPLETED|Period 2 (Day 8 Through Day 20)||1
8940727|NCT02365584|10002079|FG000|STARTED|Overall Study||21
8940728|NCT02365584|10002080|FG001|STARTED|Overall Study||22
8940729|NCT02365584|10002079|FG000|COMPLETED|Overall Study||9
8940730|NCT02365584|10002080|FG001|COMPLETED|Overall Study||8
8940731|NCT02365584|10002079|FG000|NOT COMPLETED|Overall Study||12
8940732|NCT02365584|10002080|FG001|NOT COMPLETED|Overall Study||14
8948646|NCT02431806|10011103|FG002|Safety Population|Double-blind Treatment Period||138
8948647|NCT02431806|10011104|FG003|Safety Population|Double-blind Treatment Period||134
8948648|NCT02431806|10011101|FG000|COMPLETED|Double-blind Treatment Period||117
8948649|NCT02431806|10011102|FG001|COMPLETED|Double-blind Treatment Period||115
8948650|NCT02431806|10011103|FG002|COMPLETED|Double-blind Treatment Period||107
8948651|NCT02431806|10011104|FG003|COMPLETED|Double-blind Treatment Period||109
8948652|NCT02431806|10011101|FG000|NOT COMPLETED|Double-blind Treatment Period||25
8948653|NCT02431806|10011102|FG001|NOT COMPLETED|Double-blind Treatment Period||21
8948654|NCT02431806|10011103|FG002|NOT COMPLETED|Double-blind Treatment Period||32
8948655|NCT02431806|10011104|FG003|NOT COMPLETED|Double-blind Treatment Period||26
8948656|NCT02431806|10011101|FG000|STARTED|Double-blind Down-taper Period||111
8948657|NCT02431806|10011102|FG001|STARTED|Double-blind Down-taper Period||109
8948658|NCT02431806|10011103|FG002|STARTED|Double-blind Down-taper Period||104
8948659|NCT02431806|10011104|FG003|STARTED|Double-blind Down-taper Period||107
8948660|NCT02431806|10011101|FG000|COMPLETED|Double-blind Down-taper Period||111
8948661|NCT02431806|10011102|FG001|COMPLETED|Double-blind Down-taper Period||109
8948662|NCT02431806|10011103|FG002|COMPLETED|Double-blind Down-taper Period||104
8948663|NCT02431806|10011104|FG003|COMPLETED|Double-blind Down-taper Period||107
8940733|NCT02365636|10002089|FG000|STARTED|Overall Study||100
8940734|NCT02365636|10002090|FG001|STARTED|Overall Study||100
8940735|NCT02365636|10002091|FG002|STARTED|Overall Study||100
8940736|NCT02365636|10002089|FG000|Safety Population|Overall Study||100
8940737|NCT02365636|10002090|FG001|Safety Population|Overall Study|2 terminated prior to treatment due to 1) prohibited concomitant medication 2) exclusion criteria|98
8940738|NCT02365636|10002091|FG002|Safety Population|Overall Study||100
8719351|NCT01004003|9766836|FG007|COMPLETED|Overall Study|On-treatment at analysis cut-off date (15 July 2014).|2
8719352|NCT01004003|9766837|FG008|COMPLETED|Overall Study|On-treatment at analysis cut-off date (15 July 2014).|1
8719353|NCT01004003|9766829|FG000|NOT COMPLETED|Overall Study||6
8719354|NCT01004003|9766830|FG001|NOT COMPLETED|Overall Study||3
8719355|NCT01004003|9766831|FG002|NOT COMPLETED|Overall Study||4
8719356|NCT01004003|9766832|FG003|NOT COMPLETED|Overall Study||3
8719357|NCT01004003|9766833|FG004|NOT COMPLETED|Overall Study||4
8719358|NCT01004003|9766834|FG005|NOT COMPLETED|Overall Study||4
8719359|NCT01004003|9766835|FG006|NOT COMPLETED|Overall Study||8
8719360|NCT01004003|9766836|FG007|NOT COMPLETED|Overall Study||60
8719361|NCT01004003|9766837|FG008|NOT COMPLETED|Overall Study||30
8719362|NCT01004029|9766861|FG000|STARTED|Overall Study||578
8719363|NCT01004029|9766862|FG001|STARTED|Overall Study||1130
8719364|NCT01004029|9766861|FG000|Safety Population|Overall Study||578
8719365|NCT01004029|9766862|FG001|Safety Population|Overall Study||1128
8719366|NCT01004029|9766861|FG000|COMPLETED|Overall Study||530
8719367|NCT01004029|9766862|FG001|COMPLETED|Overall Study||1057
8719368|NCT01004029|9766861|FG000|NOT COMPLETED|Overall Study||48
8719369|NCT01004029|9766862|FG001|NOT COMPLETED|Overall Study||73
8719370|NCT01004042|9766871|FG000|STARTED|Overall Study||25
8940739|NCT02365636|10002089|FG000|Full Analysis Set|Overall Study||100
8940740|NCT02365636|10002090|FG001|Full Analysis Set|Overall Study||98
8940741|NCT02365636|10002091|FG002|Full Analysis Set|Overall Study||100
8940742|NCT02365636|10002089|FG000|COMPLETED|Overall Study||94
8940743|NCT02365636|10002090|FG001|COMPLETED|Overall Study||93
8940744|NCT02365636|10002091|FG002|COMPLETED|Overall Study||97
8940745|NCT02365636|10002089|FG000|NOT COMPLETED|Overall Study||6
8940746|NCT02365636|10002090|FG001|NOT COMPLETED|Overall Study||7
8940747|NCT02365636|10002091|FG002|NOT COMPLETED|Overall Study||3
8940748|NCT02365714|10002099|FG000|STARTED|Overall Study||2
8940749|NCT02365714|10002099|FG000|COMPLETED|Overall Study||2
8940750|NCT02365714|10002099|FG000|NOT COMPLETED|Overall Study||0
8940751|NCT02365870|10002105|FG000|STARTED|Overall Study||1
8940752|NCT02365870|10002106|FG001|STARTED|Overall Study||3
8940753|NCT02365870|10002105|FG000|COMPLETED|Overall Study||1
8940754|NCT02365870|10002106|FG001|COMPLETED|Overall Study||3
8940755|NCT02365870|10002105|FG000|NOT COMPLETED|Overall Study||0
8940756|NCT02365870|10002106|FG001|NOT COMPLETED|Overall Study||0
8940757|NCT02365961|10002114|FG000|STARTED|Overall Study||41
8940758|NCT02365961|10002115|FG001|STARTED|Overall Study||43
8940759|NCT02365961|10002114|FG000|COMPLETED|Overall Study||41
8940760|NCT02365961|10002115|FG001|COMPLETED|Overall Study||43
8940761|NCT02365961|10002114|FG000|NOT COMPLETED|Overall Study||0
8940762|NCT02365961|10002115|FG001|NOT COMPLETED|Overall Study||0
8940763|NCT02366091|10002125|FG000|STARTED|Overall Study||24
8940764|NCT02366091|10002126|FG001|STARTED|Overall Study||23
8940765|NCT02366091|10002127|FG002|STARTED|Overall Study||24
8940766|NCT02366091|10002128|FG003|STARTED|Overall Study||23
8940767|NCT02366091|10002125|FG000|COMPLETED|Overall Study||21
8940768|NCT02366091|10002126|FG001|COMPLETED|Overall Study||16
8940769|NCT02366091|10002127|FG002|COMPLETED|Overall Study||21
8940770|NCT02366091|10002128|FG003|COMPLETED|Overall Study||22
8940771|NCT02366091|10002125|FG000|NOT COMPLETED|Overall Study||3
8940772|NCT02366091|10002126|FG001|NOT COMPLETED|Overall Study||7
8940773|NCT02366091|10002127|FG002|NOT COMPLETED|Overall Study||3
8940774|NCT02366091|10002128|FG003|NOT COMPLETED|Overall Study||1
8940775|NCT02366130|10002138|FG000|STARTED|Overall Study||45
8940776|NCT02366130|10002138|FG000|COMPLETED|Overall Study||36
8940777|NCT02366130|10002138|FG000|NOT COMPLETED|Overall Study||9
8940778|NCT02366143|10002145|FG000|STARTED|Overall Study||400
8940779|NCT02366143|10002146|FG001|STARTED|Overall Study||400
8940780|NCT02366143|10002147|FG002|STARTED|Overall Study||402
8940781|NCT02366143|10002145|FG000|COMPLETED|Overall Study||0
8940782|NCT02366143|10002146|FG001|COMPLETED|Overall Study||0
8940783|NCT02366143|10002147|FG002|COMPLETED|Overall Study||0
8940784|NCT02366143|10002145|FG000|NOT COMPLETED|Overall Study||400
8940785|NCT02366143|10002146|FG001|NOT COMPLETED|Overall Study||400
8940786|NCT02366143|10002147|FG002|NOT COMPLETED|Overall Study||402
8719371|NCT01004042|9766872|FG001|STARTED|Overall Study||25
8940787|NCT02366195|10002159|FG000|STARTED|Overall Study||112
8940788|NCT02366195|10002159|FG000|Received Study Drug|Overall Study||111
8940789|NCT02366195|10002159|FG000|COMPLETED|Overall Study||58
8940790|NCT02366195|10002159|FG000|NOT COMPLETED|Overall Study||54
8940791|NCT02366312|10002165|FG000|STARTED|Overall Study||1
8940792|NCT02366312|10002166|FG001|STARTED|Overall Study||1
8940793|NCT02366312|10002165|FG000|COMPLETED|Overall Study||1
8940794|NCT02366312|10002166|FG001|COMPLETED|Overall Study|The subject did not attend the 2-year post-treatment visit (last visit).|0
8940795|NCT02366312|10002165|FG000|NOT COMPLETED|Overall Study||0
8940796|NCT02366312|10002166|FG001|NOT COMPLETED|Overall Study||1
8940797|NCT02366338|10002175|FG000|STARTED|Overall Study||73
8719372|NCT01004042|9766871|FG000|COMPLETED|Overall Study||21
8719373|NCT01004042|9766872|FG001|COMPLETED|Overall Study||25
8719374|NCT01004042|9766871|FG000|NOT COMPLETED|Overall Study||4
8940798|NCT02366338|10002176|FG001|STARTED|Overall Study||39
8940799|NCT02366338|10002177|FG002|STARTED|Overall Study||36
8940800|NCT02366338|10002175|FG000|COMPLETED|Overall Study||73
8940801|NCT02366338|10002176|FG001|COMPLETED|Overall Study||39
8940802|NCT02366338|10002177|FG002|COMPLETED|Overall Study||36
8940803|NCT02366338|10002175|FG000|NOT COMPLETED|Overall Study||0
8940804|NCT02366338|10002176|FG001|NOT COMPLETED|Overall Study||0
8940805|NCT02366338|10002177|FG002|NOT COMPLETED|Overall Study||0
8940806|NCT02366403|10002187|FG000|STARTED|Overall Study||41
8940807|NCT02366403|10002188|FG001|STARTED|Overall Study||44
8940808|NCT02366403|10002187|FG000|COMPLETED|Overall Study||30
8617605|NCT00457821|9655789|FG004|NOT COMPLETED|Part 1||0
8617606|NCT00457821|9655790|FG005|NOT COMPLETED|Part 1||0
8617607|NCT00457821|9655791|FG006|NOT COMPLETED|Part 1||0
8940809|NCT02366403|10002188|FG001|COMPLETED|Overall Study||29
8940810|NCT02366403|10002187|FG000|NOT COMPLETED|Overall Study||11
8940811|NCT02366403|10002188|FG001|NOT COMPLETED|Overall Study||15
8940812|NCT02366468|10002196|FG000|STARTED|Overall Study||68
8940813|NCT02366468|10002197|FG001|STARTED|Overall Study||67
8940814|NCT02366468|10002196|FG000|Full Analysis Set (FAS)|Overall Study||67
8940815|NCT02366468|10002197|FG001|Full Analysis Set (FAS)|Overall Study||66
8940816|NCT02366468|10002196|FG000|Per Protocol Set (PPS)|Overall Study||62
8940817|NCT02366468|10002197|FG001|Per Protocol Set (PPS)|Overall Study||61
8940818|NCT02366468|10002196|FG000|COMPLETED|Overall Study||62
8940819|NCT02366468|10002197|FG001|COMPLETED|Overall Study||58
8940820|NCT02366468|10002196|FG000|NOT COMPLETED|Overall Study||6
8940821|NCT02366468|10002197|FG001|NOT COMPLETED|Overall Study||9
8940822|NCT02366611|10002205|FG000|STARTED|Overall Study||10
8940823|NCT02366611|10002206|FG001|STARTED|Overall Study||1
8940824|NCT02366611|10002205|FG000|COMPLETED|Overall Study||8
8940825|NCT02366611|10002206|FG001|COMPLETED|Overall Study||1
8940826|NCT02366611|10002205|FG000|NOT COMPLETED|Overall Study||2
8940827|NCT02366611|10002206|FG001|NOT COMPLETED|Overall Study||0
8940828|NCT02366637|10002213|FG000|STARTED|First Intervention Period||7
8940829|NCT02366637|10002214|FG001|STARTED|First Intervention Period||6
8940830|NCT02366637|10002213|FG000|COMPLETED|First Intervention Period||1
8940831|NCT02366637|10002214|FG001|COMPLETED|First Intervention Period||1
8940832|NCT02366637|10002213|FG000|NOT COMPLETED|First Intervention Period||6
8940833|NCT02366637|10002214|FG001|NOT COMPLETED|First Intervention Period||5
8940834|NCT02366637|10002213|FG000|STARTED|Washout Period 28 to 49 Days||1
8940835|NCT02366637|10002214|FG001|STARTED|Washout Period 28 to 49 Days||1
8940836|NCT02366637|10002213|FG000|COMPLETED|Washout Period 28 to 49 Days||1
8940837|NCT02366637|10002214|FG001|COMPLETED|Washout Period 28 to 49 Days||1
8940838|NCT02366637|10002213|FG000|NOT COMPLETED|Washout Period 28 to 49 Days||0
8940839|NCT02366637|10002214|FG001|NOT COMPLETED|Washout Period 28 to 49 Days||0
8940840|NCT02366637|10002213|FG000|STARTED|Second Intervention Period||1
8940841|NCT02366637|10002214|FG001|STARTED|Second Intervention Period||1
8940842|NCT02366637|10002213|FG000|COMPLETED|Second Intervention Period||0
8940843|NCT02366637|10002214|FG001|COMPLETED|Second Intervention Period||0
8940844|NCT02366637|10002213|FG000|NOT COMPLETED|Second Intervention Period||1
8940845|NCT02366637|10002214|FG001|NOT COMPLETED|Second Intervention Period||1
8940846|NCT02366663|10002222|FG000|STARTED|Overall Study||2
8940847|NCT02366663|10002223|FG001|STARTED|Overall Study||1
8940848|NCT02366663|10002222|FG000|COMPLETED|Overall Study||2
8940849|NCT02366663|10002223|FG001|COMPLETED|Overall Study||1
8940850|NCT02366663|10002222|FG000|NOT COMPLETED|Overall Study||0
8940851|NCT02366663|10002223|FG001|NOT COMPLETED|Overall Study||0
8940852|NCT02366689|10002232|FG000|STARTED|Overall Study||60
8940853|NCT02366689|10002233|FG001|STARTED|Overall Study||58
8940854|NCT02366689|10002234|FG002|STARTED|Overall Study||61
8940855|NCT02366689|10002232|FG000|COMPLETED|Overall Study||56
8940856|NCT02366689|10002233|FG001|COMPLETED|Overall Study||55
8940857|NCT02366689|10002234|FG002|COMPLETED|Overall Study||59
8940858|NCT02366689|10002232|FG000|NOT COMPLETED|Overall Study||4
8940859|NCT02366689|10002233|FG001|NOT COMPLETED|Overall Study||3
8940860|NCT02366689|10002234|FG002|NOT COMPLETED|Overall Study||2
8940861|NCT02366767|10002244|FG000|STARTED|Overall Study||11
8940862|NCT02366767|10002245|FG001|STARTED|Overall Study||10
8940863|NCT02366767|10002244|FG000|COMPLETED|Overall Study||10
8940864|NCT02366767|10002245|FG001|COMPLETED|Overall Study||10
8617608|NCT00457821|9655792|FG007|NOT COMPLETED|Part 1||0
8617609|NCT00457821|9655785|FG000|STARTED|Part 2|Arm in Part 1 only|0
8617610|NCT00457821|9655786|FG001|STARTED|Part 2|Arm in Part 1 only|0
8617611|NCT00457821|9655787|FG002|STARTED|Part 2|Arm in Part 1 only|0
8617612|NCT00457821|9655788|FG003|STARTED|Part 2|Arm in Part 1 only|0
8617613|NCT00457821|9655789|FG004|STARTED|Part 2|Arm in Part 1 only|0
8940865|NCT02366767|10002244|FG000|NOT COMPLETED|Overall Study||1
8940866|NCT02366767|10002245|FG001|NOT COMPLETED|Overall Study||0
8617614|NCT00457821|9655790|FG005|STARTED|Part 2|All subjects who received at least 1 dose of study drug (ivacaftor).|8
8617615|NCT00457821|9655791|FG006|STARTED|Part 2|All subjects who received at least 1 dose of study drug (ivacaftor).|7
8617616|NCT00457821|9655792|FG007|STARTED|Part 2|All subjects who received at least 1 dose of study drug (placebo).|5
8940867|NCT02366845|10002253|FG000|STARTED|Overall Study||25
8617617|NCT00457821|9655785|FG000|Completed Study Drug Treatment|Part 2||0
8617618|NCT00457821|9655786|FG001|Completed Study Drug Treatment|Part 2||0
8940868|NCT02366845|10002254|FG001|STARTED|Overall Study||25
8940869|NCT02366845|10002253|FG000|COMPLETED|Overall Study||25
8940870|NCT02366845|10002254|FG001|COMPLETED|Overall Study||25
8940871|NCT02366845|10002253|FG000|NOT COMPLETED|Overall Study||0
8940872|NCT02366845|10002254|FG001|NOT COMPLETED|Overall Study||0
8940873|NCT02366871|10002262|FG000|STARTED|Overall Study||204
8940874|NCT02366871|10002263|FG001|STARTED|Overall Study||196
8940875|NCT02366871|10002262|FG000|COMPLETED|Overall Study||204
8940876|NCT02366871|10002263|FG001|COMPLETED|Overall Study||196
8940877|NCT02366871|10002262|FG000|NOT COMPLETED|Overall Study||0
8940878|NCT02366871|10002263|FG001|NOT COMPLETED|Overall Study||0
8940879|NCT02366910|10002269|FG000|STARTED|Overall Study||26
8940880|NCT02366910|10002269|FG000|COMPLETED|Overall Study||21
8940881|NCT02366910|10002269|FG000|NOT COMPLETED|Overall Study||5
8617619|NCT00457821|9655787|FG002|Completed Study Drug Treatment|Part 2||0
8617620|NCT00457821|9655788|FG003|Completed Study Drug Treatment|Part 2||0
8617621|NCT00457821|9655789|FG004|Completed Study Drug Treatment|Part 2||0
8617622|NCT00457821|9655790|FG005|Completed Study Drug Treatment|Part 2||8
8617623|NCT00457821|9655791|FG006|Completed Study Drug Treatment|Part 2|1 subject missed a 250-mg dose of ivacaftor on Day 28 of Part 2.|7
8617624|NCT00457821|9655792|FG007|Completed Study Drug Treatment|Part 2||4
8940882|NCT02366923|10002275|FG000|STARTED|Overall Study||28
8940883|NCT02366923|10002275|FG000|COMPLETED|Overall Study||22
8940884|NCT02366923|10002275|FG000|NOT COMPLETED|Overall Study||6
8940885|NCT02366936|10002280|FG000|STARTED|Overall Study||32
8940886|NCT02366936|10002280|FG000|COMPLETED|Overall Study||24
8940887|NCT02366936|10002280|FG000|NOT COMPLETED|Overall Study||8
8940888|NCT02367014|10002288|FG000|STARTED|Overall Study||9
8940889|NCT02367014|10002289|FG001|STARTED|Overall Study||9
8940890|NCT02367014|10002290|FG002|STARTED|Overall Study||9
8940891|NCT02367014|10002291|FG003|STARTED|Overall Study||9
8940892|NCT02367014|10002288|FG000|COMPLETED|Overall Study||9
8940893|NCT02367014|10002289|FG001|COMPLETED|Overall Study||9
8940894|NCT02367014|10002290|FG002|COMPLETED|Overall Study||9
8940895|NCT02367014|10002291|FG003|COMPLETED|Overall Study||9
8940896|NCT02367014|10002288|FG000|NOT COMPLETED|Overall Study||0
8940897|NCT02367014|10002289|FG001|NOT COMPLETED|Overall Study||0
8940898|NCT02367014|10002290|FG002|NOT COMPLETED|Overall Study||0
8940899|NCT02367014|10002291|FG003|NOT COMPLETED|Overall Study||0
8940900|NCT02367066|10002305|FG000|STARTED|Overall Study||10
8940901|NCT02367066|10002306|FG001|STARTED|Overall Study||10
8940902|NCT02367066|10002305|FG000|COMPLETED|Overall Study||10
8940903|NCT02367066|10002306|FG001|COMPLETED|Overall Study||10
8940904|NCT02367066|10002305|FG000|NOT COMPLETED|Overall Study||0
8940905|NCT02367066|10002306|FG001|NOT COMPLETED|Overall Study||0
8940906|NCT02367131|10002317|FG000|STARTED|Overall Study|Started are the treated patients|423
8940907|NCT02367131|10002317|FG000|COMPLETED|Overall Study||201
8940908|NCT02367131|10002317|FG000|NOT COMPLETED|Overall Study||222
8940909|NCT02367352|10002321|FG000|STARTED|Overall Study||9
8940910|NCT02367352|10002322|FG001|STARTED|Overall Study||0
8940911|NCT02367352|10002323|FG002|STARTED|Overall Study||0
8940912|NCT02367352|10002321|FG000|COMPLETED|Overall Study||0
8940913|NCT02367352|10002322|FG001|COMPLETED|Overall Study||0
8940914|NCT02367352|10002323|FG002|COMPLETED|Overall Study||0
8940915|NCT02367352|10002321|FG000|NOT COMPLETED|Overall Study||9
8940916|NCT02367352|10002322|FG001|NOT COMPLETED|Overall Study||0
8940917|NCT02367352|10002323|FG002|NOT COMPLETED|Overall Study||0
8940918|NCT02367391|10002331|FG000|STARTED|Overall Study||76
8940919|NCT02367391|10002332|FG001|STARTED|Overall Study||76
8940920|NCT02367391|10002331|FG000|COMPLETED|Overall Study||74
8940921|NCT02367391|10002332|FG001|COMPLETED|Overall Study||76
8940922|NCT02367391|10002331|FG000|NOT COMPLETED|Overall Study||2
8940923|NCT02367391|10002332|FG001|NOT COMPLETED|Overall Study||0
8940924|NCT02367430|10002338|FG000|STARTED|Overall Study||14
8940925|NCT02367430|10002338|FG000|COMPLETED|Overall Study||11
8617625|NCT00457821|9655785|FG000|COMPLETED|Part 2||0
8940926|NCT02367430|10002338|FG000|NOT COMPLETED|Overall Study||3
8940927|NCT02367521|10002344|FG000|STARTED|Overall Study||17
8940928|NCT02367521|10002345|FG001|STARTED|Overall Study||17
8940929|NCT02367521|10002344|FG000|COMPLETED|Overall Study||13
8940930|NCT02367521|10002345|FG001|COMPLETED|Overall Study||17
8940931|NCT02367521|10002344|FG000|NOT COMPLETED|Overall Study||4
8940932|NCT02367521|10002345|FG001|NOT COMPLETED|Overall Study||0
8940933|NCT02367599|10002353|FG000|STARTED|Overall Study||48
8940934|NCT02367599|10002354|FG001|STARTED|Overall Study||48
8940935|NCT02367599|10002353|FG000|COMPLETED|Overall Study||48
8617626|NCT00457821|9655786|FG001|COMPLETED|Part 2||0
8617627|NCT00457821|9655787|FG002|COMPLETED|Part 2||0
8940936|NCT02367599|10002354|FG001|COMPLETED|Overall Study||48
8940937|NCT02367599|10002353|FG000|NOT COMPLETED|Overall Study||0
8940938|NCT02367599|10002354|FG001|NOT COMPLETED|Overall Study||0
8940939|NCT02367716|10002360|FG000|STARTED|Overall Study||121
8940940|NCT02367716|10002360|FG000|COMPLETED|Overall Study||120
8940941|NCT02367716|10002360|FG000|NOT COMPLETED|Overall Study||1
8940942|NCT02367729|10002367|FG000|STARTED|Overall Study||60
8940943|NCT02367729|10002368|FG001|STARTED|Overall Study||55
8940944|NCT02367729|10002367|FG000|COMPLETED|Overall Study||57
8940945|NCT02367729|10002368|FG001|COMPLETED|Overall Study||47
8940946|NCT02367729|10002367|FG000|NOT COMPLETED|Overall Study||3
8940947|NCT02367729|10002368|FG001|NOT COMPLETED|Overall Study||8
8940948|NCT02367781|10002377|FG000|STARTED|Overall Study||483
8940949|NCT02367781|10002378|FG001|STARTED|Overall Study||240
8940950|NCT02367781|10002377|FG000|COMPLETED|Overall Study||0
8940951|NCT02367781|10002378|FG001|COMPLETED|Overall Study||0
8940952|NCT02367781|10002377|FG000|NOT COMPLETED|Overall Study||483
8940953|NCT02367781|10002378|FG001|NOT COMPLETED|Overall Study||240
8940954|NCT02367820|10002390|FG000|STARTED|Overall Study||638
8940955|NCT02367820|10002390|FG000|COMPLETED|Overall Study||402
8940956|NCT02367820|10002390|FG000|NOT COMPLETED|Overall Study||236
8940957|NCT02367833|10002403|FG000|STARTED|Overall Study||9
8940958|NCT02367833|10002404|FG001|STARTED|Overall Study||9
8940959|NCT02367833|10002405|FG002|STARTED|Overall Study||8
8940960|NCT02367833|10002403|FG000|COMPLETED|Overall Study||8
8940961|NCT02367833|10002404|FG001|COMPLETED|Overall Study||8
8940962|NCT02367833|10002405|FG002|COMPLETED|Overall Study||8
8940963|NCT02367833|10002403|FG000|NOT COMPLETED|Overall Study||1
8940964|NCT02367833|10002404|FG001|NOT COMPLETED|Overall Study||1
8940965|NCT02367833|10002405|FG002|NOT COMPLETED|Overall Study||0
8940966|NCT02367859|10002413|FG000|STARTED|Overall Study||1
8940967|NCT02367859|10002413|FG000|COMPLETED|Overall Study||1
8940968|NCT02367859|10002413|FG000|NOT COMPLETED|Overall Study||0
8940969|NCT02367872|10002425|FG000|STARTED|Overall Study||6
8940970|NCT02367872|10002426|FG001|STARTED|Overall Study||6
8940971|NCT02367872|10002427|FG002|STARTED|Overall Study||6
8940972|NCT02367872|10002428|FG003|STARTED|Overall Study||6
8940973|NCT02367872|10002429|FG004|STARTED|Overall Study||6
8940974|NCT02367872|10002430|FG005|STARTED|Overall Study||6
8940975|NCT02367872|10002431|FG006|STARTED|Overall Study||6
8940976|NCT02367872|10002432|FG007|STARTED|Overall Study||6
8940977|NCT02367872|10002425|FG000|COMPLETED|Overall Study||6
8940978|NCT02367872|10002426|FG001|COMPLETED|Overall Study||6
8940979|NCT02367872|10002427|FG002|COMPLETED|Overall Study||6
8940980|NCT02367872|10002428|FG003|COMPLETED|Overall Study||6
8940981|NCT02367872|10002429|FG004|COMPLETED|Overall Study||6
8940982|NCT02367872|10002430|FG005|COMPLETED|Overall Study||6
8940983|NCT02367872|10002431|FG006|COMPLETED|Overall Study||6
8940984|NCT02367872|10002432|FG007|COMPLETED|Overall Study||6
8940985|NCT02367872|10002425|FG000|NOT COMPLETED|Overall Study||0
8940986|NCT02367872|10002426|FG001|NOT COMPLETED|Overall Study||0
8940987|NCT02367872|10002427|FG002|NOT COMPLETED|Overall Study||0
8940988|NCT02367872|10002428|FG003|NOT COMPLETED|Overall Study||0
8940989|NCT02367872|10002429|FG004|NOT COMPLETED|Overall Study||0
8940990|NCT02367872|10002430|FG005|NOT COMPLETED|Overall Study||0
8940991|NCT02367872|10002431|FG006|NOT COMPLETED|Overall Study||0
8940992|NCT02367872|10002432|FG007|NOT COMPLETED|Overall Study||0
8940993|NCT02367885|10002462|FG000|STARTED|Overall Study||33
8940994|NCT02367885|10002463|FG001|STARTED|Overall Study||33
8940995|NCT02367885|10002464|FG002|STARTED|Overall Study||33
8940996|NCT02367885|10002462|FG000|COMPLETED|Overall Study||31
8940997|NCT02367885|10002463|FG001|COMPLETED|Overall Study||33
8940998|NCT02367885|10002464|FG002|COMPLETED|Overall Study||33
8940999|NCT02367885|10002462|FG000|NOT COMPLETED|Overall Study||2
8941000|NCT02367885|10002463|FG001|NOT COMPLETED|Overall Study||0
8941001|NCT02367885|10002464|FG002|NOT COMPLETED|Overall Study||0
8941002|NCT02367911|10002477|FG000|STARTED|Overall Study||71
8941003|NCT02367911|10002478|FG001|STARTED|Overall Study||73
8941004|NCT02367911|10002477|FG000|COMPLETED|Overall Study||66
8941005|NCT02367911|10002478|FG001|COMPLETED|Overall Study||69
8941006|NCT02367911|10002477|FG000|NOT COMPLETED|Overall Study||5
8941007|NCT02367911|10002478|FG001|NOT COMPLETED|Overall Study||4
8941008|NCT02368093|10002486|FG000|STARTED|Overall Study||24
8941009|NCT02368093|10002487|FG001|STARTED|Overall Study||24
8941010|NCT02368093|10002486|FG000|COMPLETED|Overall Study||24
8941011|NCT02368093|10002487|FG001|COMPLETED|Overall Study||24
8941012|NCT02368093|10002486|FG000|NOT COMPLETED|Overall Study||0
8941013|NCT02368093|10002487|FG001|NOT COMPLETED|Overall Study||0
8941014|NCT02368210|10002495|FG000|STARTED|Overall Study||75
8941015|NCT02368210|10002496|FG001|STARTED|Overall Study||76
8941016|NCT02368210|10002495|FG000|COMPLETED|Overall Study||74
8941017|NCT02368210|10002496|FG001|COMPLETED|Overall Study||75
8941018|NCT02368210|10002495|FG000|NOT COMPLETED|Overall Study||1
8941019|NCT02368210|10002496|FG001|NOT COMPLETED|Overall Study||1
8941020|NCT02368314|10002504|FG000|STARTED|Overall Study||64
8941021|NCT02368314|10002505|FG001|STARTED|Overall Study||60
8941022|NCT02368314|10002504|FG000|COMPLETED|Overall Study||61
8941023|NCT02368314|10002505|FG001|COMPLETED|Overall Study||57
8941024|NCT02368314|10002504|FG000|NOT COMPLETED|Overall Study||3
8941025|NCT02368314|10002505|FG001|NOT COMPLETED|Overall Study||3
8941026|NCT02368431|10002513|FG000|STARTED|Overall Study||46
8941027|NCT02368431|10002514|FG001|STARTED|Overall Study||46
8941028|NCT02368431|10002513|FG000|COMPLETED|Overall Study||22
8941029|NCT02368431|10002514|FG001|COMPLETED|Overall Study||27
8941030|NCT02368431|10002513|FG000|NOT COMPLETED|Overall Study||24
8941031|NCT02368431|10002514|FG001|NOT COMPLETED|Overall Study||19
8941032|NCT02368457|10002522|FG000|STARTED|Overall Study||12
8941033|NCT02368457|10002523|FG001|STARTED|Overall Study||12
8941034|NCT02368457|10002522|FG000|COMPLETED|Overall Study||12
8941035|NCT02368457|10002523|FG001|COMPLETED|Overall Study||12
8941036|NCT02368457|10002522|FG000|NOT COMPLETED|Overall Study||0
8941037|NCT02368457|10002523|FG001|NOT COMPLETED|Overall Study||0
8941038|NCT02368691|10002530|FG000|STARTED|Overall Study|32 subjects were enrolled and received at least one dose of study drug|32
8941039|NCT02368691|10002530|FG000|COMPLETED|Overall Study||0
8941040|NCT02368691|10002530|FG000|NOT COMPLETED|Overall Study||32
8941041|NCT02369068|10002536|FG000|STARTED|1 Month||10
8941042|NCT02369068|10002537|FG001|STARTED|1 Month||11
8941043|NCT02369068|10002536|FG000|COMPLETED|1 Month||9
8941044|NCT02369068|10002537|FG001|COMPLETED|1 Month||10
8941045|NCT02369068|10002536|FG000|NOT COMPLETED|1 Month||1
8941046|NCT02369068|10002537|FG001|NOT COMPLETED|1 Month||1
8941047|NCT02369068|10002536|FG000|STARTED|3 Months||9
8941048|NCT02369068|10002537|FG001|STARTED|3 Months||10
8941049|NCT02369068|10002536|FG000|COMPLETED|3 Months||9
8941050|NCT02369068|10002537|FG001|COMPLETED|3 Months||8
8941051|NCT02369068|10002536|FG000|NOT COMPLETED|3 Months||0
8941052|NCT02369068|10002537|FG001|NOT COMPLETED|3 Months||2
8941053|NCT02369068|10002536|FG000|STARTED|6 Months||9
8941054|NCT02369068|10002537|FG001|STARTED|6 Months||8
8941055|NCT02369068|10002536|FG000|COMPLETED|6 Months||9
8941056|NCT02369068|10002537|FG001|COMPLETED|6 Months||7
8941057|NCT02369068|10002536|FG000|NOT COMPLETED|6 Months||0
8941058|NCT02369068|10002537|FG001|NOT COMPLETED|6 Months||1
8941059|NCT02369159|10002545|FG000|STARTED|Overall Study||114
8941060|NCT02369159|10002546|FG001|STARTED|Overall Study||23
8941061|NCT02369159|10002545|FG000|ITT Population|Overall Study||114
8941062|NCT02369159|10002546|FG001|ITT Population|Overall Study||23
8941063|NCT02369159|10002545|FG000|Safety Population|Overall Study||107
8941064|NCT02369159|10002546|FG001|Safety Population|Overall Study||23
8941065|NCT02369159|10002545|FG000|ITTI Population|Overall Study||81
8941066|NCT02369159|10002546|FG001|ITTI Population|Overall Study||16
8941067|NCT02369159|10002545|FG000|E-R Population|Overall Study||80
8941068|NCT02369159|10002546|FG001|E-R Population|Overall Study|Milestone only applied to Peramivir group|0
8941069|NCT02369159|10002545|FG000|COMPLETED|Overall Study||106
8941070|NCT02369159|10002546|FG001|COMPLETED|Overall Study||21
8941071|NCT02369159|10002545|FG000|NOT COMPLETED|Overall Study||8
8941072|NCT02369159|10002546|FG001|NOT COMPLETED|Overall Study||2
8941073|NCT02369172|10002563|FG000|STARTED|Overall Study||24
8941074|NCT02369172|10002563|FG000|COMPLETED|Overall Study||24
8941075|NCT02369172|10002563|FG000|NOT COMPLETED|Overall Study||0
8941076|NCT02369211|10002587|FG000|STARTED|Overall Study||43
8941077|NCT02369211|10002588|FG001|STARTED|Overall Study||43
8941078|NCT02369211|10002587|FG000|COMPLETED|Overall Study||43
8941079|NCT02369211|10002588|FG001|COMPLETED|Overall Study||41
8941080|NCT02369211|10002587|FG000|NOT COMPLETED|Overall Study||0
8941081|NCT02369211|10002588|FG001|NOT COMPLETED|Overall Study||2
8941082|NCT02369341|10002596|FG000|STARTED|Overall Study||63
8941083|NCT02369341|10002597|FG001|STARTED|Overall Study||57
8941084|NCT02369341|10002596|FG000|COMPLETED|Overall Study||62
8941085|NCT02369341|10002597|FG001|COMPLETED|Overall Study||57
8941086|NCT02369341|10002596|FG000|NOT COMPLETED|Overall Study||1
8941087|NCT02369341|10002597|FG001|NOT COMPLETED|Overall Study||0
8941088|NCT02369484|10002607|FG000|STARTED|Overall Study||13
8941089|NCT02369484|10002607|FG000|COMPLETED|Overall Study||13
8941090|NCT02369484|10002607|FG000|NOT COMPLETED|Overall Study||0
8941091|NCT02369510|10002614|FG000|STARTED|Overall Study||23
8941092|NCT02369510|10002615|FG001|STARTED|Overall Study||22
8941093|NCT02369510|10002616|FG002|STARTED|Overall Study||23
8941094|NCT02369510|10002614|FG000|COMPLETED|Overall Study||21
8941095|NCT02369510|10002615|FG001|COMPLETED|Overall Study||19
8941096|NCT02369510|10002616|FG002|COMPLETED|Overall Study||17
8941097|NCT02369510|10002614|FG000|NOT COMPLETED|Overall Study||2
8941098|NCT02369510|10002615|FG001|NOT COMPLETED|Overall Study||3
8941099|NCT02369510|10002616|FG002|NOT COMPLETED|Overall Study||6
8813670|NCT01526928|9866816|FG005|COMPLETED|Overall Study||0
8813671|NCT01526928|9866811|FG000|NOT COMPLETED|Overall Study||38
8813672|NCT01526928|9866812|FG001|NOT COMPLETED|Overall Study||19
8813673|NCT01526928|9866813|FG002|NOT COMPLETED|Overall Study||209
8813674|NCT01526928|9866814|FG003|NOT COMPLETED|Overall Study||245
8813675|NCT01526928|9866815|FG004|NOT COMPLETED|Overall Study||95
8813676|NCT01526928|9866816|FG005|NOT COMPLETED|Overall Study||6
8813677|NCT01527006|9866874|FG000|STARTED|Core Study||22
8813678|NCT01527006|9866875|FG001|STARTED|Core Study||28
8813679|NCT01527006|9866874|FG000|COMPLETED|Core Study||20
8813680|NCT01527006|9866875|FG001|COMPLETED|Core Study||22
8813681|NCT01527006|9866874|FG000|NOT COMPLETED|Core Study||2
8813682|NCT01527006|9866875|FG001|NOT COMPLETED|Core Study||6
8813683|NCT01527006|9866874|FG000|STARTED|Extension Phase|Of the 20 subjects who completed the Core Study, 19 subjects continued into the Extension Phase.|19
8813684|NCT01527006|9866875|FG001|STARTED|Extension Phase||22
8813685|NCT01527006|9866874|FG000|COMPLETED|Extension Phase||13
8813686|NCT01527006|9866875|FG001|COMPLETED|Extension Phase||14
8813687|NCT01527006|9866874|FG000|NOT COMPLETED|Extension Phase||6
8813688|NCT01527006|9866875|FG001|NOT COMPLETED|Extension Phase||8
8941100|NCT02369796|10002629|FG000|STARTED|Overall Study||3
8941101|NCT02369796|10002630|FG001|STARTED|Overall Study||3
8941102|NCT02369796|10002631|FG002|STARTED|Overall Study||3
8941103|NCT02369796|10002632|FG003|STARTED|Overall Study||3
8941104|NCT02369796|10002633|FG004|STARTED|Overall Study||3
8941105|NCT02369796|10002629|FG000|COMPLETED|Overall Study||3
8941106|NCT02369796|10002630|FG001|COMPLETED|Overall Study||3
8941107|NCT02369796|10002631|FG002|COMPLETED|Overall Study||3
8941108|NCT02369796|10002632|FG003|COMPLETED|Overall Study||3
8941109|NCT02369796|10002633|FG004|COMPLETED|Overall Study||3
8941110|NCT02369796|10002629|FG000|NOT COMPLETED|Overall Study||0
8941111|NCT02369796|10002630|FG001|NOT COMPLETED|Overall Study||0
8941112|NCT02369796|10002631|FG002|NOT COMPLETED|Overall Study||0
8941113|NCT02369796|10002632|FG003|NOT COMPLETED|Overall Study||0
8941114|NCT02369796|10002633|FG004|NOT COMPLETED|Overall Study||0
8941115|NCT02369835|10002647|FG000|STARTED|Overall Study||64
8941116|NCT02369835|10002648|FG001|STARTED|Overall Study||68
8941117|NCT02369835|10002647|FG000|COMPLETED|Overall Study|Reasons that participants did not complete for the Primary Outcome are not available.|53
8948664|NCT02431806|10011101|FG000|NOT COMPLETED|Double-blind Down-taper Period||0
8813689|NCT01527045|9866890|FG000|STARTED|Overall Study||30
8813690|NCT01527045|9866891|FG001|STARTED|Overall Study||5
8941118|NCT02369835|10002648|FG001|COMPLETED|Overall Study|Reasons that participants did not complete for the Primary Outcome are not available.|55
8941119|NCT02369835|10002647|FG000|NOT COMPLETED|Overall Study||11
8941120|NCT02369835|10002648|FG001|NOT COMPLETED|Overall Study||13
8941121|NCT02369848|10002654|FG000|STARTED|Overall Study||60
8941122|NCT02369848|10002654|FG000|30 Day Primary Safety Endpoint|Overall Study||58
8941123|NCT02369848|10002654|FG000|12 Month Primary Endpoint|Overall Study||30
8941124|NCT02369848|10002654|FG000|COMPLETED|Overall Study||56
8941125|NCT02369848|10002654|FG000|NOT COMPLETED|Overall Study||4
8941126|NCT02369874|10002661|FG000|STARTED|Overall Study||247
8941127|NCT02369874|10002662|FG001|STARTED|Overall Study||240
8941128|NCT02369874|10002663|FG002|STARTED|Overall Study||249
8941129|NCT02369874|10002661|FG000|Received Treatment|Overall Study||246
8941130|NCT02369874|10002662|FG001|Received Treatment|Overall Study||237
8941131|NCT02369874|10002663|FG002|Received Treatment|Overall Study||240
8941132|NCT02369874|10002661|FG000|COMPLETED|Overall Study||203
8941133|NCT02369874|10002662|FG001|COMPLETED|Overall Study||183
8941134|NCT02369874|10002663|FG002|COMPLETED|Overall Study||188
8941135|NCT02369874|10002661|FG000|NOT COMPLETED|Overall Study||44
8941136|NCT02369874|10002662|FG001|NOT COMPLETED|Overall Study||57
8941137|NCT02369874|10002663|FG002|NOT COMPLETED|Overall Study||61
8941138|NCT02369900|10002673|FG000|STARTED|Overall Study||18
8941139|NCT02369900|10002674|FG001|STARTED|Overall Study||22
8941140|NCT02369900|10002673|FG000|COMPLETED|Overall Study||18
8941141|NCT02369900|10002674|FG001|COMPLETED|Overall Study||22
8941142|NCT02369900|10002673|FG000|NOT COMPLETED|Overall Study||0
8941143|NCT02369900|10002674|FG001|NOT COMPLETED|Overall Study||0
8941144|NCT02370004|10002680|FG000|STARTED|Overall Study||11
8941145|NCT02370004|10002680|FG000|COMPLETED|Overall Study||10
8941146|NCT02370004|10002680|FG000|NOT COMPLETED|Overall Study||1
8941147|NCT02370043|10002689|FG000|STARTED|Overall Study||3
8941148|NCT02370043|10002690|FG001|STARTED|Overall Study||3
8941149|NCT02370043|10002691|FG002|STARTED|Overall Study||3
8941150|NCT02370043|10002692|FG003|STARTED|Overall Study||3
8941151|NCT02370043|10002693|FG004|STARTED|Overall Study||3
8941152|NCT02370043|10002694|FG005|STARTED|Overall Study||4
8941153|NCT02370043|10002689|FG000|COMPLETED|Overall Study||3
8941154|NCT02370043|10002690|FG001|COMPLETED|Overall Study||3
8941155|NCT02370043|10002691|FG002|COMPLETED|Overall Study||3
8941156|NCT02370043|10002692|FG003|COMPLETED|Overall Study||3
8941157|NCT02370043|10002693|FG004|COMPLETED|Overall Study||2
8941158|NCT02370043|10002694|FG005|COMPLETED|Overall Study||3
8941159|NCT02370043|10002689|FG000|NOT COMPLETED|Overall Study||0
8941160|NCT02370043|10002690|FG001|NOT COMPLETED|Overall Study||0
8941161|NCT02370043|10002691|FG002|NOT COMPLETED|Overall Study||0
8941162|NCT02370043|10002692|FG003|NOT COMPLETED|Overall Study||0
8941163|NCT02370043|10002693|FG004|NOT COMPLETED|Overall Study||1
8941164|NCT02370043|10002694|FG005|NOT COMPLETED|Overall Study||1
8941165|NCT02370056|10002724|FG000|STARTED|Overall Study||27
8941166|NCT02370056|10002725|FG001|STARTED|Overall Study||26
8941167|NCT02370056|10002724|FG000|COMPLETED|Overall Study||27
8941168|NCT02370056|10002725|FG001|COMPLETED|Overall Study||26
8941169|NCT02370056|10002724|FG000|NOT COMPLETED|Overall Study||0
8941170|NCT02370056|10002725|FG001|NOT COMPLETED|Overall Study||0
8941171|NCT02370095|10002733|FG000|STARTED|Overall Study||10
8941172|NCT02370095|10002734|FG001|STARTED|Overall Study||4
8941173|NCT02370095|10002733|FG000|COMPLETED|Overall Study||10
8941174|NCT02370095|10002734|FG001|COMPLETED|Overall Study||3
8941175|NCT02370095|10002733|FG000|NOT COMPLETED|Overall Study||0
8941176|NCT02370095|10002734|FG001|NOT COMPLETED|Overall Study||1
8941177|NCT02370121|10002742|FG000|STARTED|Overall Study||12
8941178|NCT02370121|10002743|FG001|STARTED|Overall Study||12
8941179|NCT02370121|10002742|FG000|COMPLETED|Overall Study|One patient did not complete the study due to early withdrawl|11
8941180|NCT02370121|10002743|FG001|COMPLETED|Overall Study|One patient did not complete the study due to early withdrawl|11
8941181|NCT02370121|10002742|FG000|NOT COMPLETED|Overall Study||1
8941182|NCT02370121|10002743|FG001|NOT COMPLETED|Overall Study||1
8941183|NCT02370160|10002749|FG000|STARTED|Overall Study||9
8941184|NCT02370160|10002750|FG001|STARTED|Overall Study||6
8941185|NCT02370160|10002751|FG002|STARTED|Overall Study||3
8941186|NCT02370160|10002749|FG000|COMPLETED|Overall Study||6
8941187|NCT02370160|10002750|FG001|COMPLETED|Overall Study||2
8941188|NCT02370160|10002751|FG002|COMPLETED|Overall Study||2
8941189|NCT02370160|10002749|FG000|NOT COMPLETED|Overall Study||3
8941190|NCT02370160|10002750|FG001|NOT COMPLETED|Overall Study||4
8941191|NCT02370160|10002751|FG002|NOT COMPLETED|Overall Study||1
8941192|NCT02370238|10002766|FG000|STARTED|Overall Study||62
8941193|NCT02370238|10002767|FG001|STARTED|Overall Study||61
8941194|NCT02370238|10002766|FG000|ITT Population|Overall Study||62
8941195|NCT02370238|10002767|FG001|ITT Population|Overall Study||61
8941196|NCT02370238|10002766|FG000|Safety Population|Overall Study||61
8941197|NCT02370238|10002767|FG001|Safety Population|Overall Study||60
8941198|NCT02370238|10002766|FG000|Responsable-evaluable Population|Overall Study||57
8941199|NCT02370238|10002767|FG001|Responsable-evaluable Population|Overall Study||54
8941200|NCT02370238|10002766|FG000|COMPLETED|Overall Study||15
8813691|NCT01527045|9866892|FG002|STARTED|Overall Study||12
8941201|NCT02370238|10002767|FG001|COMPLETED|Overall Study||16
8941202|NCT02370238|10002766|FG000|NOT COMPLETED|Overall Study||47
8813692|NCT01527045|9866890|FG000|COMPLETED|Overall Study||29
8941203|NCT02370238|10002767|FG001|NOT COMPLETED|Overall Study||45
8941204|NCT02370251|10002777|FG000|STARTED|Overall Study||63
8941205|NCT02370251|10002777|FG000|COMPLETED|Overall Study||52
8941206|NCT02370251|10002777|FG000|NOT COMPLETED|Overall Study||11
8941207|NCT02370368|10002783|FG000|STARTED|Overall Study||14
8941208|NCT02370368|10002784|FG001|STARTED|Overall Study||13
8941209|NCT02370368|10002783|FG000|COMPLETED|Overall Study||8
8941210|NCT02370368|10002784|FG001|COMPLETED|Overall Study||7
8941211|NCT02370368|10002783|FG000|NOT COMPLETED|Overall Study||6
8941212|NCT02370368|10002784|FG001|NOT COMPLETED|Overall Study||6
8941213|NCT02370394|10002792|FG000|STARTED|Overall Study||28
8941214|NCT02370394|10002793|FG001|STARTED|Overall Study||25
8941215|NCT02370394|10002792|FG000|COMPLETED|Overall Study||26
8941216|NCT02370394|10002793|FG001|COMPLETED|Overall Study||23
8941217|NCT02370394|10002792|FG000|NOT COMPLETED|Overall Study||2
8941218|NCT02370394|10002793|FG001|NOT COMPLETED|Overall Study||2
8617628|NCT00457821|9655788|FG003|COMPLETED|Part 2||0
8617629|NCT00457821|9655789|FG004|COMPLETED|Part 2||0
8941219|NCT02370407|10002802|FG000|STARTED|Overall Study||20
8941220|NCT02370407|10002803|FG001|STARTED|Overall Study||20
9065483|NCT04156646|10125901|FG000|STARTED|Treatment Period 1 (6 Days)||8
9065484|NCT04156646|10125902|FG001|STARTED|Treatment Period 1 (6 Days)||8
9065485|NCT04156646|10125901|FG000|COMPLETED|Treatment Period 1 (6 Days)||8
9065486|NCT04156646|10125902|FG001|COMPLETED|Treatment Period 1 (6 Days)||8
9065487|NCT04156646|10125901|FG000|NOT COMPLETED|Treatment Period 1 (6 Days)||0
9065488|NCT04156646|10125902|FG001|NOT COMPLETED|Treatment Period 1 (6 Days)||0
9065489|NCT04156646|10125901|FG000|STARTED|Wash-out Period (12- to 21-days)||8
9065490|NCT04156646|10125902|FG001|STARTED|Wash-out Period (12- to 21-days)||8
9065491|NCT04156646|10125901|FG000|COMPLETED|Wash-out Period (12- to 21-days)||8
9065492|NCT04156646|10125902|FG001|COMPLETED|Wash-out Period (12- to 21-days)||8
9065493|NCT04156646|10125901|FG000|NOT COMPLETED|Wash-out Period (12- to 21-days)||0
9065494|NCT04156646|10125902|FG001|NOT COMPLETED|Wash-out Period (12- to 21-days)||0
9065495|NCT04156646|10125901|FG000|STARTED|Treatment Period 2 (6 Days)||8
9065496|NCT04156646|10125902|FG001|STARTED|Treatment Period 2 (6 Days)||8
9065497|NCT04156646|10125901|FG000|COMPLETED|Treatment Period 2 (6 Days)||8
9065498|NCT04156646|10125902|FG001|COMPLETED|Treatment Period 2 (6 Days)||8
9065499|NCT04156646|10125901|FG000|NOT COMPLETED|Treatment Period 2 (6 Days)||0
9065500|NCT04156646|10125902|FG001|NOT COMPLETED|Treatment Period 2 (6 Days)||0
9065501|NCT04156646|10125901|FG000|STARTED|Wash-out Period (12- to 21-days)||8
9065502|NCT04156646|10125902|FG001|STARTED|Wash-out Period (12- to 21-days)||8
9065503|NCT04156646|10125901|FG000|COMPLETED|Wash-out Period (12- to 21-days)||8
9065504|NCT04156646|10125902|FG001|COMPLETED|Wash-out Period (12- to 21-days)||8
9065505|NCT04156646|10125901|FG000|NOT COMPLETED|Wash-out Period (12- to 21-days)||0
9065506|NCT04156646|10125902|FG001|NOT COMPLETED|Wash-out Period (12- to 21-days)||0
9065507|NCT04156646|10125901|FG000|STARTED|Treatment Period 3 (6 Days)||8
9065508|NCT04156646|10125902|FG001|STARTED|Treatment Period 3 (6 Days)||8
9065509|NCT04156646|10125901|FG000|COMPLETED|Treatment Period 3 (6 Days)||8
9065510|NCT04156646|10125902|FG001|COMPLETED|Treatment Period 3 (6 Days)||7
9065511|NCT04156646|10125901|FG000|NOT COMPLETED|Treatment Period 3 (6 Days)||0
9065512|NCT04156646|10125902|FG001|NOT COMPLETED|Treatment Period 3 (6 Days)||1
9065513|NCT04170686|10125913|FG000|STARTED|Screening||74
9065514|NCT04170686|10125914|FG001|STARTED|Screening||72
9065515|NCT04170686|10125913|FG000|COMPLETED|Screening||62
9065516|NCT04170686|10125914|FG001|COMPLETED|Screening||59
9065517|NCT04170686|10125913|FG000|NOT COMPLETED|Screening||12
9065518|NCT04170686|10125914|FG001|NOT COMPLETED|Screening||13
9065519|NCT04170686|10125913|FG000|STARTED|Randomization and Treatment||62
9065520|NCT04170686|10125914|FG001|STARTED|Randomization and Treatment||59
9065521|NCT04170686|10125913|FG000|COMPLETED|Randomization and Treatment||36
9065522|NCT04170686|10125914|FG001|COMPLETED|Randomization and Treatment||44
9065523|NCT04170686|10125913|FG000|NOT COMPLETED|Randomization and Treatment||26
9065524|NCT04170686|10125914|FG001|NOT COMPLETED|Randomization and Treatment||15
9065525|NCT04169113|10125922|FG000|STARTED|Overall Study||52
9065526|NCT04169113|10125923|FG001|STARTED|Overall Study||59
9065527|NCT04169113|10125922|FG000|COMPLETED|Overall Study||47
9065528|NCT04169113|10125923|FG001|COMPLETED|Overall Study||53
9065529|NCT04169113|10125922|FG000|NOT COMPLETED|Overall Study||5
9065530|NCT04169113|10125923|FG001|NOT COMPLETED|Overall Study||6
9065531|NCT04160975|10125935|FG000|STARTED|Overall Study||479
9065532|NCT04160975|10125936|FG001|STARTED|Overall Study||496
9065533|NCT04160975|10125937|FG002|STARTED|Overall Study||478
9065534|NCT04160975|10125938|FG003|STARTED|Overall Study||485
9065535|NCT04160975|10125939|FG004|STARTED|Overall Study||649
9065536|NCT04160975|10125940|FG005|STARTED|Overall Study||658
9065537|NCT04160975|10125935|FG000|COMPLETED|Overall Study||415
9065538|NCT04160975|10125936|FG001|COMPLETED|Overall Study||430
9065539|NCT04160975|10125937|FG002|COMPLETED|Overall Study||417
9065540|NCT04160975|10125938|FG003|COMPLETED|Overall Study||410
8941221|NCT02370407|10002802|FG000|COMPLETED|Overall Study||20
8941222|NCT02370407|10002803|FG001|COMPLETED|Overall Study||20
8941223|NCT02370407|10002802|FG000|NOT COMPLETED|Overall Study||0
8941224|NCT02370407|10002803|FG001|NOT COMPLETED|Overall Study||0
8941225|NCT02370420|10002815|FG000|STARTED|Overall Study||29
8941226|NCT02370420|10002816|FG001|STARTED|Overall Study||27
8941227|NCT02370420|10002815|FG000|COMPLETED|Overall Study||15
8941228|NCT02370420|10002816|FG001|COMPLETED|Overall Study||15
8941229|NCT02370420|10002815|FG000|NOT COMPLETED|Overall Study||14
9065541|NCT04160975|10125939|FG004|COMPLETED|Overall Study||614
9065542|NCT04160975|10125940|FG005|COMPLETED|Overall Study||607
8941230|NCT02370420|10002816|FG001|NOT COMPLETED|Overall Study||12
8941231|NCT02370498|10002824|FG000|STARTED|Overall Study||296
8941232|NCT02370498|10002825|FG001|STARTED|Overall Study||296
8941233|NCT02370498|10002824|FG000|Treated|Overall Study||294
8941234|NCT02370498|10002825|FG001|Treated|Overall Study||276
8941235|NCT02370498|10002824|FG000|PD-L1 Positive Participants|Overall Study||196
8941236|NCT02370498|10002825|FG001|PD-L1 Positive Participants|Overall Study||199
8941237|NCT02370498|10002824|FG000|COMPLETED|Overall Study||0
8941238|NCT02370498|10002825|FG001|COMPLETED|Overall Study||0
8941239|NCT02370498|10002824|FG000|NOT COMPLETED|Overall Study||296
8941240|NCT02370498|10002825|FG001|NOT COMPLETED|Overall Study||296
8941241|NCT02370511|10002834|FG000|STARTED|Overall Study||31
8941242|NCT02370511|10002835|FG001|STARTED|Overall Study||30
8941243|NCT02370511|10002836|FG002|STARTED|Overall Study||30
8941244|NCT02370511|10002834|FG000|COMPLETED|Overall Study||19
8941245|NCT02370511|10002835|FG001|COMPLETED|Overall Study||19
8941246|NCT02370511|10002836|FG002|COMPLETED|Overall Study||29
8941247|NCT02370511|10002834|FG000|NOT COMPLETED|Overall Study||12
8941248|NCT02370511|10002835|FG001|NOT COMPLETED|Overall Study||11
8941249|NCT02370511|10002836|FG002|NOT COMPLETED|Overall Study||1
8941250|NCT02370537|10002847|FG000|STARTED|Part A (Open-label Recruitment)||16
8941251|NCT02370537|10002848|FG001|STARTED|Part A (Open-label Recruitment)||16
8941252|NCT02370537|10002849|FG002|STARTED|Part A (Open-label Recruitment)||283
8941253|NCT02370537|10002847|FG000|COMPLETED|Part A (Open-label Recruitment)||16
8941254|NCT02370537|10002848|FG001|COMPLETED|Part A (Open-label Recruitment)||15
8941255|NCT02370537|10002849|FG002|COMPLETED|Part A (Open-label Recruitment)||282
8941256|NCT02370537|10002847|FG000|NOT COMPLETED|Part A (Open-label Recruitment)||0
8941257|NCT02370537|10002848|FG001|NOT COMPLETED|Part A (Open-label Recruitment)||1
8941258|NCT02370537|10002849|FG002|NOT COMPLETED|Part A (Open-label Recruitment)||1
8941259|NCT02370537|10002847|FG000|STARTED|Part B||16
8941260|NCT02370537|10002848|FG001|STARTED|Part B||15
8941261|NCT02370537|10002849|FG002|STARTED|Part B||282
8941262|NCT02370537|10002847|FG000|Eligible for Randomisation|Part B||15
8941263|NCT02370537|10002848|FG001|Eligible for Randomisation|Part B||13
8941264|NCT02370537|10002849|FG002|Eligible for Randomisation|Part B||23
8941265|NCT02370537|10002847|FG000|Period 1 Sequence AB|Part B||8
8941266|NCT02370537|10002848|FG001|Period 1 Sequence AB|Part B||6
8941267|NCT02370537|10002849|FG002|Period 1 Sequence AB|Part B||11
8941268|NCT02370537|10002847|FG000|Period 1 Sequence BA|Part B||7
8941269|NCT02370537|10002848|FG001|Period 1 Sequence BA|Part B||7
8941270|NCT02370537|10002849|FG002|Period 1 Sequence BA|Part B||12
8941271|NCT02370537|10002847|FG000|Period 2 Sequence AB|Part B||8
8941272|NCT02370537|10002848|FG001|Period 2 Sequence AB|Part B||5
8941273|NCT02370537|10002849|FG002|Period 2 Sequence AB|Part B||11
8941274|NCT02370537|10002847|FG000|Period 2 Sequence BA|Part B||7
8941275|NCT02370537|10002848|FG001|Period 2 Sequence BA|Part B||7
8941276|NCT02370537|10002849|FG002|Period 2 Sequence BA|Part B||12
8941277|NCT02370537|10002847|FG000|COMPLETED|Part B||15
8941278|NCT02370537|10002848|FG001|COMPLETED|Part B||12
8941279|NCT02370537|10002849|FG002|COMPLETED|Part B||23
8941280|NCT02370537|10002847|FG000|NOT COMPLETED|Part B||1
8941281|NCT02370537|10002848|FG001|NOT COMPLETED|Part B||3
8941282|NCT02370537|10002849|FG002|NOT COMPLETED|Part B||259
8941283|NCT02370602|10002872|FG000|STARTED|Overall Study||1
8941284|NCT02370602|10002873|FG001|STARTED|Overall Study||2
8941285|NCT02370602|10002874|FG002|STARTED|Overall Study||2
8941286|NCT02370602|10002875|FG003|STARTED|Overall Study||3
8941287|NCT02370602|10002876|FG004|STARTED|Overall Study||3
8941288|NCT02370602|10002877|FG005|STARTED|Overall Study||2
8617630|NCT00457821|9655790|FG005|COMPLETED|Part 2||8
8617631|NCT00457821|9655791|FG006|COMPLETED|Part 2||7
8617632|NCT00457821|9655792|FG007|COMPLETED|Part 2||4
8617633|NCT00457821|9655785|FG000|NOT COMPLETED|Part 2||0
8617634|NCT00457821|9655786|FG001|NOT COMPLETED|Part 2||0
8617635|NCT00457821|9655787|FG002|NOT COMPLETED|Part 2||0
8941289|NCT02370602|10002872|FG000|COMPLETED|Overall Study||0
8941290|NCT02370602|10002873|FG001|COMPLETED|Overall Study||2
8941291|NCT02370602|10002874|FG002|COMPLETED|Overall Study||2
8941292|NCT02370602|10002875|FG003|COMPLETED|Overall Study||3
8941293|NCT02370602|10002876|FG004|COMPLETED|Overall Study||3
8941294|NCT02370602|10002877|FG005|COMPLETED|Overall Study||2
8941295|NCT02370602|10002872|FG000|NOT COMPLETED|Overall Study||1
8941296|NCT02370602|10002873|FG001|NOT COMPLETED|Overall Study||0
8941297|NCT02370602|10002874|FG002|NOT COMPLETED|Overall Study||0
8941298|NCT02370602|10002875|FG003|NOT COMPLETED|Overall Study||0
8941299|NCT02370602|10002876|FG004|NOT COMPLETED|Overall Study||0
8941300|NCT02370602|10002877|FG005|NOT COMPLETED|Overall Study||0
8941301|NCT02370615|10002896|FG000|STARTED|Overall Study||16
8941302|NCT02370615|10002897|FG001|STARTED|Overall Study||18
8941303|NCT02370615|10002896|FG000|COMPLETED|Overall Study||15
8941304|NCT02370615|10002897|FG001|COMPLETED|Overall Study||18
8941305|NCT02370615|10002896|FG000|NOT COMPLETED|Overall Study||1
8941306|NCT02370615|10002897|FG001|NOT COMPLETED|Overall Study||0
8941307|NCT02370641|10002912|FG000|STARTED|Overall Study||18
8941308|NCT02370641|10002913|FG001|STARTED|Overall Study||8
8617636|NCT00457821|9655788|FG003|NOT COMPLETED|Part 2||0
8941309|NCT02370641|10002912|FG000|COMPLETED|Overall Study||14
8941310|NCT02370641|10002913|FG001|COMPLETED|Overall Study||6
8941311|NCT02370641|10002912|FG000|NOT COMPLETED|Overall Study||4
8941312|NCT02370641|10002913|FG001|NOT COMPLETED|Overall Study||2
8941313|NCT02370667|10002922|FG000|STARTED|Overall Study||10
8941314|NCT02370667|10002923|FG001|STARTED|Overall Study||11
8941315|NCT02370667|10002924|FG002|STARTED|Overall Study||10
8941316|NCT02370667|10002922|FG000|COMPLETED|Overall Study||10
8941317|NCT02370667|10002923|FG001|COMPLETED|Overall Study||10
8941318|NCT02370667|10002924|FG002|COMPLETED|Overall Study||10
8941319|NCT02370667|10002922|FG000|NOT COMPLETED|Overall Study||0
8941320|NCT02370667|10002923|FG001|NOT COMPLETED|Overall Study||1
8941321|NCT02370667|10002924|FG002|NOT COMPLETED|Overall Study||0
8941322|NCT02370693|10002935|FG000|STARTED|Overall Study||3
8941323|NCT02370693|10002936|FG001|STARTED|Overall Study||4
8941324|NCT02370693|10002935|FG000|COMPLETED|Overall Study||2
8941325|NCT02370693|10002936|FG001|COMPLETED|Overall Study||3
8941326|NCT02370693|10002935|FG000|NOT COMPLETED|Overall Study||1
8941327|NCT02370693|10002936|FG001|NOT COMPLETED|Overall Study||1
8941328|NCT02370784|10002944|FG000|STARTED|Overall Study||10
8941329|NCT02370784|10002945|FG001|STARTED|Overall Study||14
8941330|NCT02370784|10002944|FG000|COMPLETED|Overall Study||10
8941331|NCT02370784|10002945|FG001|COMPLETED|Overall Study||13
8941332|NCT02370784|10002944|FG000|NOT COMPLETED|Overall Study||0
8941333|NCT02370784|10002945|FG001|NOT COMPLETED|Overall Study||1
8941334|NCT02370810|10002955|FG000|STARTED|Overall Study||73
8941335|NCT02370810|10002956|FG001|STARTED|Overall Study||73
8941336|NCT02370810|10002955|FG000|COMPLETED|Overall Study||50
8941337|NCT02370810|10002956|FG001|COMPLETED|Overall Study||54
8941338|NCT02370810|10002955|FG000|NOT COMPLETED|Overall Study||23
8941339|NCT02370810|10002956|FG001|NOT COMPLETED|Overall Study||19
8941340|NCT02370914|10002964|FG000|STARTED|Overall Study||84
8941341|NCT02370914|10002964|FG000|COMPLETED|Overall Study||82
8941342|NCT02370914|10002964|FG000|NOT COMPLETED|Overall Study||2
8941343|NCT02371187|10002970|FG000|STARTED|Overall Study||18
8941344|NCT02371187|10002971|FG001|STARTED|Overall Study||19
8941345|NCT02371187|10002970|FG000|COMPLETED|Overall Study||15
8941346|NCT02371187|10002971|FG001|COMPLETED|Overall Study||15
8941347|NCT02371187|10002970|FG000|NOT COMPLETED|Overall Study||3
8941348|NCT02371187|10002971|FG001|NOT COMPLETED|Overall Study||4
8941349|NCT02371252|10002979|FG000|STARTED|Overall Study||70
8941350|NCT02371252|10002980|FG001|STARTED|Overall Study||70
8941351|NCT02371252|10002979|FG000|COMPLETED|Overall Study||70
8941352|NCT02371252|10002980|FG001|COMPLETED|Overall Study||70
8941353|NCT02371252|10002979|FG000|NOT COMPLETED|Overall Study||0
8941354|NCT02371252|10002980|FG001|NOT COMPLETED|Overall Study||0
8941355|NCT02371356|10002991|FG000|STARTED|Overall Study||1320
8941356|NCT02371356|10002992|FG001|STARTED|Overall Study||7354
8941357|NCT02371356|10002993|FG002|STARTED|Overall Study||2804
8941358|NCT02371356|10002994|FG003|STARTED|Overall Study||7423
8941359|NCT02371356|10002995|FG004|STARTED|Overall Study||72183
8941360|NCT02371356|10002991|FG000|COMPLETED|Overall Study||1320
8941361|NCT02371356|10002992|FG001|COMPLETED|Overall Study||7354
8941362|NCT02371356|10002993|FG002|COMPLETED|Overall Study||2804
8941363|NCT02371356|10002994|FG003|COMPLETED|Overall Study||7423
8941364|NCT02371356|10002995|FG004|COMPLETED|Overall Study||72183
8941365|NCT02371356|10002991|FG000|NOT COMPLETED|Overall Study||0
8941366|NCT02371356|10002992|FG001|NOT COMPLETED|Overall Study||0
8941367|NCT02371356|10002993|FG002|NOT COMPLETED|Overall Study||0
8941368|NCT02371356|10002994|FG003|NOT COMPLETED|Overall Study||0
8941369|NCT02371356|10002995|FG004|NOT COMPLETED|Overall Study||0
8941370|NCT02371395|10003007|FG000|STARTED|Overall Study||1000
8941371|NCT02371395|10003007|FG000|COMPLETED|Overall Study||1000
8941372|NCT02371395|10003007|FG000|NOT COMPLETED|Overall Study||0
8941373|NCT02371616|10003013|FG000|STARTED|Overall Study||150
8941374|NCT02371616|10003014|FG001|STARTED|Overall Study||154
8941375|NCT02371616|10003013|FG000|COMPLETED|Overall Study||146
8941376|NCT02371616|10003014|FG001|COMPLETED|Overall Study||147
8941377|NCT02371616|10003013|FG000|NOT COMPLETED|Overall Study||4
8941378|NCT02371616|10003014|FG001|NOT COMPLETED|Overall Study||7
8941379|NCT02371629|10003022|FG000|STARTED|Overall Study||388
8941380|NCT02371629|10003023|FG001|STARTED|Overall Study||388
8941381|NCT02371629|10003022|FG000|COMPLETED|Overall Study||362
8941382|NCT02371629|10003023|FG001|COMPLETED|Overall Study||363
8941383|NCT02371629|10003022|FG000|NOT COMPLETED|Overall Study||26
8941384|NCT02371629|10003023|FG001|NOT COMPLETED|Overall Study||25
8941385|NCT02371668|10003031|FG000|STARTED|Overall Study||49
8941386|NCT02371668|10003032|FG001|STARTED|Overall Study||42
8941387|NCT02371668|10003031|FG000|COMPLETED|Overall Study||49
8941388|NCT02371668|10003032|FG001|COMPLETED|Overall Study||42
8941389|NCT02371668|10003031|FG000|NOT COMPLETED|Overall Study||0
8941390|NCT02371668|10003032|FG001|NOT COMPLETED|Overall Study||0
8941391|NCT02371746|10003045|FG000|STARTED|Overall Study||7
8941392|NCT02371746|10003046|FG001|STARTED|Overall Study||10
8941393|NCT02371746|10003047|FG002|STARTED|Overall Study||2
8941394|NCT02371746|10003048|FG003|STARTED|Overall Study||2
8941395|NCT02371746|10003049|FG004|STARTED|Overall Study||5
8941396|NCT02371746|10003050|FG005|STARTED|Overall Study||6
8941397|NCT02371746|10003051|FG006|STARTED|Overall Study||9
8941398|NCT02371746|10003045|FG000|COMPLETED|Overall Study||7
8941399|NCT02371746|10003046|FG001|COMPLETED|Overall Study||10
8941400|NCT02371746|10003047|FG002|COMPLETED|Overall Study||2
8941401|NCT02371746|10003048|FG003|COMPLETED|Overall Study||2
8941402|NCT02371746|10003049|FG004|COMPLETED|Overall Study||5
8941403|NCT02371746|10003050|FG005|COMPLETED|Overall Study||6
8941404|NCT02371746|10003051|FG006|COMPLETED|Overall Study||8
8941405|NCT02371746|10003045|FG000|NOT COMPLETED|Overall Study||0
8941406|NCT02371746|10003046|FG001|NOT COMPLETED|Overall Study||0
8941407|NCT02371746|10003047|FG002|NOT COMPLETED|Overall Study||0
8941408|NCT02371746|10003048|FG003|NOT COMPLETED|Overall Study||0
8941409|NCT02371746|10003049|FG004|NOT COMPLETED|Overall Study||0
8941410|NCT02371746|10003050|FG005|NOT COMPLETED|Overall Study||0
8941411|NCT02371746|10003051|FG006|NOT COMPLETED|Overall Study||1
8941412|NCT02371759|10003075|FG000|STARTED|Overall Study||32
8941413|NCT02371759|10003076|FG001|STARTED|Overall Study||31
8941414|NCT02371759|10003077|FG002|STARTED|Overall Study||33
8941415|NCT02371759|10003078|FG003|STARTED|Overall Study||31
8941416|NCT02371759|10003079|FG004|STARTED|Overall Study||27
8941417|NCT02371759|10003080|FG005|STARTED|Overall Study||26
8941418|NCT02371759|10003081|FG006|STARTED|Overall Study||25
8941419|NCT02371759|10003082|FG007|STARTED|Overall Study||28
8941420|NCT02371759|10003075|FG000|COMPLETED|Overall Study||29
8941421|NCT02371759|10003076|FG001|COMPLETED|Overall Study||30
8941422|NCT02371759|10003077|FG002|COMPLETED|Overall Study||32
8941423|NCT02371759|10003078|FG003|COMPLETED|Overall Study||31
8941424|NCT02371759|10003079|FG004|COMPLETED|Overall Study||24
8941425|NCT02371759|10003080|FG005|COMPLETED|Overall Study||25
8941426|NCT02371759|10003081|FG006|COMPLETED|Overall Study||25
8941427|NCT02371759|10003082|FG007|COMPLETED|Overall Study||24
8941428|NCT02371759|10003075|FG000|NOT COMPLETED|Overall Study||3
8941429|NCT02371759|10003076|FG001|NOT COMPLETED|Overall Study||1
8941430|NCT02371759|10003077|FG002|NOT COMPLETED|Overall Study||1
8941431|NCT02371759|10003078|FG003|NOT COMPLETED|Overall Study||0
8941432|NCT02371759|10003079|FG004|NOT COMPLETED|Overall Study||3
8941433|NCT02371759|10003080|FG005|NOT COMPLETED|Overall Study||1
8941434|NCT02371759|10003081|FG006|NOT COMPLETED|Overall Study||0
8941435|NCT02371759|10003082|FG007|NOT COMPLETED|Overall Study||4
8941436|NCT02371785|10003100|FG000|STARTED|Overall Study||20
8941437|NCT02371785|10003100|FG000|COMPLETED|Overall Study||20
8941438|NCT02371785|10003100|FG000|NOT COMPLETED|Overall Study||0
8941439|NCT02371850|10003110|FG000|STARTED|Overall Study||10
8941440|NCT02371850|10003110|FG000|COMPLETED|Overall Study||10
8941441|NCT02371850|10003110|FG000|NOT COMPLETED|Overall Study||0
8941442|NCT02371876|10003121|FG000|STARTED|Overall Study||134
8941443|NCT02371876|10003121|FG000|COMPLETED|Overall Study||134
8941444|NCT02371876|10003121|FG000|NOT COMPLETED|Overall Study||0
8941445|NCT02371980|10003129|FG000|STARTED|Open-label Period||1106
8941446|NCT02371980|10003130|FG001|STARTED|Open-label Period||0
8941447|NCT02371980|10003131|FG002|STARTED|Open-label Period||0
8941448|NCT02371980|10003132|FG003|STARTED|Open-label Period||0
8941449|NCT02371980|10003133|FG004|STARTED|Open-label Period||0
8941450|NCT02371980|10003129|FG000|COMPLETED|Open-label Period||580
8941451|NCT02371980|10003130|FG001|COMPLETED|Open-label Period||0
8941452|NCT02371980|10003131|FG002|COMPLETED|Open-label Period||0
8941453|NCT02371980|10003132|FG003|COMPLETED|Open-label Period||0
8941454|NCT02371980|10003133|FG004|COMPLETED|Open-label Period||0
8941455|NCT02371980|10003129|FG000|NOT COMPLETED|Open-label Period||526
8941456|NCT02371980|10003130|FG001|NOT COMPLETED|Open-label Period||0
8941457|NCT02371980|10003131|FG002|NOT COMPLETED|Open-label Period||0
8941458|NCT02371980|10003132|FG003|NOT COMPLETED|Open-label Period||0
8941459|NCT02371980|10003133|FG004|NOT COMPLETED|Open-label Period||0
8941460|NCT02371980|10003129|FG000|STARTED|Double-blind Period||0
8941461|NCT02371980|10003130|FG001|STARTED|Double-blind Period||151
8941462|NCT02371980|10003131|FG002|STARTED|Double-blind Period||140
8941463|NCT02371980|10003132|FG003|STARTED|Double-blind Period||145
8941464|NCT02371980|10003133|FG004|STARTED|Double-blind Period||144
8941465|NCT02371980|10003129|FG000|COMPLETED|Double-blind Period||0
8941466|NCT02371980|10003130|FG001|COMPLETED|Double-blind Period||70
8941467|NCT02371980|10003131|FG002|COMPLETED|Double-blind Period||84
8941468|NCT02371980|10003132|FG003|COMPLETED|Double-blind Period||96
8941469|NCT02371980|10003133|FG004|COMPLETED|Double-blind Period||86
8941470|NCT02371980|10003129|FG000|NOT COMPLETED|Double-blind Period||0
8941471|NCT02371980|10003130|FG001|NOT COMPLETED|Double-blind Period||81
8941472|NCT02371980|10003131|FG002|NOT COMPLETED|Double-blind Period||56
8941473|NCT02371980|10003132|FG003|NOT COMPLETED|Double-blind Period||49
8941474|NCT02371980|10003133|FG004|NOT COMPLETED|Double-blind Period||58
8941475|NCT02372006|10003147|FG000|STARTED|Overall Study||8
8941476|NCT02372006|10003148|FG001|STARTED|Overall Study||9
8941477|NCT02372006|10003149|FG002|STARTED|Overall Study||39
8941478|NCT02372006|10003147|FG000|COMPLETED|Overall Study||0
8941479|NCT02372006|10003148|FG001|COMPLETED|Overall Study||0
8941480|NCT02372006|10003149|FG002|COMPLETED|Overall Study||0
8941481|NCT02372006|10003147|FG000|NOT COMPLETED|Overall Study||8
8941482|NCT02372006|10003148|FG001|NOT COMPLETED|Overall Study||9
8941483|NCT02372006|10003149|FG002|NOT COMPLETED|Overall Study||39
8941484|NCT02372058|10003158|FG000|STARTED|Overall Study||103
8941485|NCT02372058|10003158|FG000|COMPLETED|Overall Study||100
8941486|NCT02372058|10003158|FG000|NOT COMPLETED|Overall Study||3
8941487|NCT02372071|10003164|FG000|STARTED|Overall Study||111
8941488|NCT02372071|10003164|FG000|COMPLETED|Overall Study||93
8941489|NCT02372071|10003164|FG000|NOT COMPLETED|Overall Study||18
8941490|NCT02372097|10003171|FG000|STARTED|First Intervention Period (8 Days)||12
8941491|NCT02372097|10003172|FG001|STARTED|First Intervention Period (8 Days)||12
8941492|NCT02372097|10003171|FG000|COMPLETED|First Intervention Period (8 Days)||12
8941493|NCT02372097|10003172|FG001|COMPLETED|First Intervention Period (8 Days)||12
8941494|NCT02372097|10003171|FG000|NOT COMPLETED|First Intervention Period (8 Days)||0
8941495|NCT02372097|10003172|FG001|NOT COMPLETED|First Intervention Period (8 Days)||0
8941496|NCT02372097|10003171|FG000|STARTED|Wash Out Period (13 Days)||12
8941497|NCT02372097|10003172|FG001|STARTED|Wash Out Period (13 Days)||12
8941498|NCT02372097|10003171|FG000|COMPLETED|Wash Out Period (13 Days)||12
8941499|NCT02372097|10003172|FG001|COMPLETED|Wash Out Period (13 Days)||12
8941500|NCT02372097|10003171|FG000|NOT COMPLETED|Wash Out Period (13 Days)||0
8941501|NCT02372097|10003172|FG001|NOT COMPLETED|Wash Out Period (13 Days)||0
8941502|NCT02372097|10003171|FG000|STARTED|Second Intervention Period (8 Days)||12
8941503|NCT02372097|10003172|FG001|STARTED|Second Intervention Period (8 Days)||12
8941504|NCT02372097|10003171|FG000|COMPLETED|Second Intervention Period (8 Days)||12
8941505|NCT02372097|10003172|FG001|COMPLETED|Second Intervention Period (8 Days)||12
8941506|NCT02372097|10003171|FG000|NOT COMPLETED|Second Intervention Period (8 Days)||0
8941507|NCT02372097|10003172|FG001|NOT COMPLETED|Second Intervention Period (8 Days)||0
8941508|NCT02372136|10003180|FG000|STARTED|Overall Study||62
8941509|NCT02372136|10003181|FG001|STARTED|Overall Study||58
8941510|NCT02372136|10003180|FG000|COMPLETED|Overall Study||59
8941511|NCT02372136|10003181|FG001|COMPLETED|Overall Study||57
8941512|NCT02372136|10003180|FG000|NOT COMPLETED|Overall Study||3
8941513|NCT02372136|10003181|FG001|NOT COMPLETED|Overall Study||1
8941514|NCT02372253|10003191|FG000|STARTED|Overall Study||13
8941515|NCT02372253|10003192|FG001|STARTED|Overall Study||13
8941516|NCT02372253|10003191|FG000|COMPLETED|Overall Study||11
8941517|NCT02372253|10003192|FG001|COMPLETED|Overall Study||13
8941518|NCT02372253|10003191|FG000|NOT COMPLETED|Overall Study||2
8941519|NCT02372253|10003192|FG001|NOT COMPLETED|Overall Study||0
8941520|NCT02372344|10003200|FG000|STARTED|Period 1 (Visit 2)||14
8941521|NCT02372344|10003201|FG001|STARTED|Period 1 (Visit 2)||14
8941522|NCT02372344|10003202|FG002|STARTED|Period 1 (Visit 2)||14
8941523|NCT02372344|10003200|FG000|COMPLETED|Period 1 (Visit 2)||14
8941524|NCT02372344|10003201|FG001|COMPLETED|Period 1 (Visit 2)||14
8941525|NCT02372344|10003202|FG002|COMPLETED|Period 1 (Visit 2)||14
8941526|NCT02372344|10003200|FG000|NOT COMPLETED|Period 1 (Visit 2)||0
8941527|NCT02372344|10003201|FG001|NOT COMPLETED|Period 1 (Visit 2)||0
8941528|NCT02372344|10003202|FG002|NOT COMPLETED|Period 1 (Visit 2)||0
8941529|NCT02372344|10003200|FG000|STARTED|Period 2 (Visit 3)||14
8941530|NCT02372344|10003201|FG001|STARTED|Period 2 (Visit 3)||14
8941531|NCT02372344|10003202|FG002|STARTED|Period 2 (Visit 3)||14
8941532|NCT02372344|10003200|FG000|COMPLETED|Period 2 (Visit 3)||14
8941533|NCT02372344|10003201|FG001|COMPLETED|Period 2 (Visit 3)||14
8941534|NCT02372344|10003202|FG002|COMPLETED|Period 2 (Visit 3)||14
8941535|NCT02372344|10003200|FG000|NOT COMPLETED|Period 2 (Visit 3)||0
8941536|NCT02372344|10003201|FG001|NOT COMPLETED|Period 2 (Visit 3)||0
8941537|NCT02372344|10003202|FG002|NOT COMPLETED|Period 2 (Visit 3)||0
8941538|NCT02372344|10003200|FG000|STARTED|Period 3 (Visit 4)||14
8941539|NCT02372344|10003201|FG001|STARTED|Period 3 (Visit 4)||14
8941540|NCT02372344|10003202|FG002|STARTED|Period 3 (Visit 4)||14
8941541|NCT02372344|10003200|FG000|COMPLETED|Period 3 (Visit 4)||14
8941542|NCT02372344|10003201|FG001|COMPLETED|Period 3 (Visit 4)||14
8941543|NCT02372344|10003202|FG002|COMPLETED|Period 3 (Visit 4)||14
8941544|NCT02372344|10003200|FG000|NOT COMPLETED|Period 3 (Visit 4)||0
8941545|NCT02372344|10003201|FG001|NOT COMPLETED|Period 3 (Visit 4)||0
8941546|NCT02372344|10003202|FG002|NOT COMPLETED|Period 3 (Visit 4)||0
8948665|NCT02431806|10011102|FG001|NOT COMPLETED|Double-blind Down-taper Period||0
8617637|NCT00457821|9655789|FG004|NOT COMPLETED|Part 2||0
8617638|NCT00457821|9655790|FG005|NOT COMPLETED|Part 2||0
8617639|NCT00457821|9655791|FG006|NOT COMPLETED|Part 2||0
8617640|NCT00457821|9655792|FG007|NOT COMPLETED|Part 2||1
8948666|NCT02431806|10011103|FG002|NOT COMPLETED|Double-blind Down-taper Period||0
8948667|NCT02431806|10011104|FG003|NOT COMPLETED|Double-blind Down-taper Period||0
8948668|NCT02432040|10011116|FG000|STARTED|Overall Study||14
8948669|NCT02432040|10011117|FG001|STARTED|Overall Study||14
8948670|NCT02432040|10011116|FG000|COMPLETED|Overall Study||6
8948671|NCT02432040|10011117|FG001|COMPLETED|Overall Study||8
8948672|NCT02432040|10011116|FG000|NOT COMPLETED|Overall Study||8
8948673|NCT02432040|10011117|FG001|NOT COMPLETED|Overall Study||6
8948674|NCT02432105|10011126|FG000|STARTED|Overall Study||164
8948675|NCT02432105|10011127|FG001|STARTED|Overall Study||110
8948676|NCT02432105|10011128|FG002|STARTED|Overall Study||111
8948677|NCT02432105|10011126|FG000|COMPLETED|Overall Study||162
8948678|NCT02432105|10011127|FG001|COMPLETED|Overall Study||108
8948679|NCT02432105|10011128|FG002|COMPLETED|Overall Study||108
8948680|NCT02432105|10011126|FG000|NOT COMPLETED|Overall Study||2
8948681|NCT02432105|10011127|FG001|NOT COMPLETED|Overall Study||2
8948682|NCT02432105|10011128|FG002|NOT COMPLETED|Overall Study||3
8948683|NCT02432144|10011137|FG000|STARTED|Overall Study||12
8948684|NCT02432144|10011137|FG000|COMPLETED|Overall Study||11
8948685|NCT02432144|10011137|FG000|NOT COMPLETED|Overall Study||1
8948686|NCT02432183|10011145|FG000|STARTED|Overall Study||44
8948687|NCT02432183|10011146|FG001|STARTED|Overall Study||47
8948688|NCT02432183|10011147|FG002|STARTED|Overall Study||26
8948689|NCT02432183|10011148|FG003|STARTED|Overall Study||17
8617641|NCT00457977|9655811|FG000|STARTED|Overall Study||90
8948690|NCT02432183|10011145|FG000|COMPLETED|Overall Study||44
8948691|NCT02432183|10011146|FG001|COMPLETED|Overall Study||47
8948692|NCT02432183|10011147|FG002|COMPLETED|Overall Study||26
8948693|NCT02432183|10011148|FG003|COMPLETED|Overall Study||17
8948694|NCT02432183|10011145|FG000|NOT COMPLETED|Overall Study||0
8948695|NCT02432183|10011146|FG001|NOT COMPLETED|Overall Study||0
8948696|NCT02432183|10011147|FG002|NOT COMPLETED|Overall Study||0
8948697|NCT02432183|10011148|FG003|NOT COMPLETED|Overall Study||0
8948698|NCT02432235|10011170|FG000|STARTED|Overall Study||2
8948699|NCT02432235|10011171|FG001|STARTED|Overall Study||2
8617642|NCT00457977|9655812|FG001|STARTED|Overall Study||91
8941547|NCT02372383|10003212|FG000|STARTED|First Intervention (1 Day)||10
8941548|NCT02372383|10003213|FG001|STARTED|First Intervention (1 Day)||11
8941549|NCT02372383|10003214|FG002|STARTED|First Intervention (1 Day)||10
8941550|NCT02372383|10003212|FG000|COMPLETED|First Intervention (1 Day)||10
8941551|NCT02372383|10003213|FG001|COMPLETED|First Intervention (1 Day)||10
8941552|NCT02372383|10003214|FG002|COMPLETED|First Intervention (1 Day)||10
8941553|NCT02372383|10003212|FG000|NOT COMPLETED|First Intervention (1 Day)||0
8941554|NCT02372383|10003213|FG001|NOT COMPLETED|First Intervention (1 Day)||1
8941555|NCT02372383|10003214|FG002|NOT COMPLETED|First Intervention (1 Day)||0
8941556|NCT02372383|10003212|FG000|STARTED|Washout (14 Days)||10
8941557|NCT02372383|10003213|FG001|STARTED|Washout (14 Days)||10
8941558|NCT02372383|10003214|FG002|STARTED|Washout (14 Days)||10
8941559|NCT02372383|10003212|FG000|COMPLETED|Washout (14 Days)||10
8941560|NCT02372383|10003213|FG001|COMPLETED|Washout (14 Days)||10
8941561|NCT02372383|10003214|FG002|COMPLETED|Washout (14 Days)||10
8941562|NCT02372383|10003212|FG000|NOT COMPLETED|Washout (14 Days)||0
8941563|NCT02372383|10003213|FG001|NOT COMPLETED|Washout (14 Days)||0
8941564|NCT02372383|10003214|FG002|NOT COMPLETED|Washout (14 Days)||0
8941565|NCT02372383|10003212|FG000|STARTED|Second Intervention (1 Day)||10
8941566|NCT02372383|10003213|FG001|STARTED|Second Intervention (1 Day)||10
9065543|NCT04160975|10125935|FG000|NOT COMPLETED|Overall Study||64
9065544|NCT04160975|10125936|FG001|NOT COMPLETED|Overall Study||66
8941567|NCT02372383|10003214|FG002|STARTED|Second Intervention (1 Day)||10
8941568|NCT02372383|10003212|FG000|COMPLETED|Second Intervention (1 Day)||10
8941569|NCT02372383|10003213|FG001|COMPLETED|Second Intervention (1 Day)||10
8941570|NCT02372383|10003214|FG002|COMPLETED|Second Intervention (1 Day)||10
8941571|NCT02372383|10003212|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
8941572|NCT02372383|10003213|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
8941573|NCT02372383|10003214|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
8941574|NCT02372396|10003226|FG000|STARTED|Overall Study||17
8941575|NCT02372396|10003227|FG001|STARTED|Overall Study||20
8941576|NCT02372396|10003226|FG000|Began Intervention|Overall Study||14
8941577|NCT02372396|10003227|FG001|Began Intervention|Overall Study||14
8941578|NCT02372396|10003226|FG000|COMPLETED|Overall Study||10
8941579|NCT02372396|10003227|FG001|COMPLETED|Overall Study||11
8941580|NCT02372396|10003226|FG000|NOT COMPLETED|Overall Study||7
8941581|NCT02372396|10003227|FG001|NOT COMPLETED|Overall Study||9
8941582|NCT02372682|10003235|FG000|STARTED|Overall Study||78
8941583|NCT02372682|10003236|FG001|STARTED|Overall Study||93
8941584|NCT02372682|10003235|FG000|COMPLETED|Overall Study||70
8941585|NCT02372682|10003236|FG001|COMPLETED|Overall Study||79
8941586|NCT02372682|10003235|FG000|NOT COMPLETED|Overall Study||8
8941587|NCT02372682|10003236|FG001|NOT COMPLETED|Overall Study||14
8941588|NCT02372799|10003252|FG000|STARTED|Treatment Period||186
8941589|NCT02372799|10003253|FG001|STARTED|Treatment Period||187
8941590|NCT02372799|10003254|FG002|STARTED|Treatment Period||97
8941591|NCT02372799|10003252|FG000|COMPLETED|Treatment Period||152
8941592|NCT02372799|10003253|FG001|COMPLETED|Treatment Period||155
8941593|NCT02372799|10003254|FG002|COMPLETED|Treatment Period||82
8941594|NCT02372799|10003252|FG000|NOT COMPLETED|Treatment Period||34
8941595|NCT02372799|10003253|FG001|NOT COMPLETED|Treatment Period||32
8941596|NCT02372799|10003254|FG002|NOT COMPLETED|Treatment Period||15
8941597|NCT02372799|10003252|FG000|STARTED|Down-taper Period||152
8941598|NCT02372799|10003253|FG001|STARTED|Down-taper Period||159
8941599|NCT02372799|10003254|FG002|STARTED|Down-taper Period||82
8941600|NCT02372799|10003252|FG000|COMPLETED|Down-taper Period||151
8941601|NCT02372799|10003253|FG001|COMPLETED|Down-taper Period||157
8941602|NCT02372799|10003254|FG002|COMPLETED|Down-taper Period||80
8941603|NCT02372799|10003252|FG000|NOT COMPLETED|Down-taper Period||1
8941604|NCT02372799|10003253|FG001|NOT COMPLETED|Down-taper Period||2
8941605|NCT02372799|10003254|FG002|NOT COMPLETED|Down-taper Period||2
8941606|NCT02373098|10003264|FG000|STARTED|Overall Study||66
8941607|NCT02373098|10003265|FG001|STARTED|Overall Study||60
8941608|NCT02373098|10003264|FG000|COMPLETED|Overall Study||54
8941609|NCT02373098|10003265|FG001|COMPLETED|Overall Study||60
8941610|NCT02373098|10003264|FG000|NOT COMPLETED|Overall Study||12
8941611|NCT02373098|10003265|FG001|NOT COMPLETED|Overall Study||0
8941612|NCT02373124|10003277|FG000|STARTED|Overall Study||4
8941613|NCT02373124|10003277|FG000|COMPLETED|Overall Study||3
8941614|NCT02373124|10003277|FG000|NOT COMPLETED|Overall Study||1
8941615|NCT02373137|10003283|FG000|STARTED|Overall Study||19
8941616|NCT02373137|10003284|FG001|STARTED|Overall Study||19
8941617|NCT02373137|10003283|FG000|3-Month Follow-Up|Overall Study||19
8941618|NCT02373137|10003284|FG001|3-Month Follow-Up|Overall Study||19
8941619|NCT02373137|10003283|FG000|6-Month Follow-Up|Overall Study||19
8941620|NCT02373137|10003284|FG001|6-Month Follow-Up|Overall Study||18
8941621|NCT02373137|10003283|FG000|12-Month Follow-Up|Overall Study||19
8941622|NCT02373137|10003284|FG001|12-Month Follow-Up|Overall Study||19
8941623|NCT02373137|10003283|FG000|COMPLETED|Overall Study||18
8941624|NCT02373137|10003284|FG001|COMPLETED|Overall Study||18
9065545|NCT04160975|10125937|FG002|NOT COMPLETED|Overall Study||61
8941625|NCT02373137|10003283|FG000|NOT COMPLETED|Overall Study||1
8941626|NCT02373137|10003284|FG001|NOT COMPLETED|Overall Study||1
8941627|NCT02373202|10003295|FG000|STARTED|Overall Study||15
8941628|NCT02373202|10003296|FG001|STARTED|Overall Study||15
8941629|NCT02373202|10003297|FG002|STARTED|Overall Study||30
8941630|NCT02373202|10003298|FG003|STARTED|Overall Study||31
8941631|NCT02373202|10003295|FG000|COMPLETED|Overall Study||13
8941632|NCT02373202|10003296|FG001|COMPLETED|Overall Study||9
8941633|NCT02373202|10003297|FG002|COMPLETED|Overall Study||27
8941634|NCT02373202|10003298|FG003|COMPLETED|Overall Study||30
8941635|NCT02373202|10003295|FG000|NOT COMPLETED|Overall Study||2
8941636|NCT02373202|10003296|FG001|NOT COMPLETED|Overall Study||6
8941637|NCT02373202|10003297|FG002|NOT COMPLETED|Overall Study||3
8941638|NCT02373202|10003298|FG003|NOT COMPLETED|Overall Study||1
8941639|NCT02373371|10003310|FG000|STARTED|Overall Study||13
8941640|NCT02373371|10003311|FG001|STARTED|Overall Study||13
8941641|NCT02373371|10003310|FG000|COMPLETED|Overall Study||13
8941642|NCT02373371|10003311|FG001|COMPLETED|Overall Study||13
8941643|NCT02373371|10003310|FG000|NOT COMPLETED|Overall Study||0
8941644|NCT02373371|10003311|FG001|NOT COMPLETED|Overall Study||0
8941645|NCT02373813|10003320|FG000|STARTED|Run-In Period||371
8941646|NCT02373813|10003321|FG001|STARTED|Run-In Period||0
8941647|NCT02373813|10003322|FG002|STARTED|Run-In Period||0
8941648|NCT02373813|10003323|FG003|STARTED|Run-In Period||0
8941649|NCT02373813|10003320|FG000|Treated|Run-In Period||368
8941650|NCT02373813|10003321|FG001|Treated|Run-In Period||0
8941651|NCT02373813|10003322|FG002|Treated|Run-In Period||0
8941652|NCT02373813|10003323|FG003|Treated|Run-In Period||0
8941653|NCT02373813|10003320|FG000|COMPLETED|Run-In Period|1 participant who completed the run-in period had no end of study case report form.|255
8941654|NCT02373813|10003321|FG001|COMPLETED|Run-In Period||0
8941655|NCT02373813|10003322|FG002|COMPLETED|Run-In Period||0
8941656|NCT02373813|10003323|FG003|COMPLETED|Run-In Period||0
8941657|NCT02373813|10003320|FG000|NOT COMPLETED|Run-In Period||116
8941658|NCT02373813|10003321|FG001|NOT COMPLETED|Run-In Period||0
8941659|NCT02373813|10003322|FG002|NOT COMPLETED|Run-In Period||0
8941660|NCT02373813|10003323|FG003|NOT COMPLETED|Run-In Period||0
8941661|NCT02373813|10003320|FG000|STARTED|Double-Blind Treatment Period||0
8941662|NCT02373813|10003321|FG001|STARTED|Double-Blind Treatment Period||101
8941663|NCT02373813|10003322|FG002|STARTED|Double-Blind Treatment Period||101
8941664|NCT02373813|10003323|FG003|STARTED|Double-Blind Treatment Period||51
8941665|NCT02373813|10003320|FG000|Received Investigational Product (IP)|Double-Blind Treatment Period||0
8941666|NCT02373813|10003321|FG001|Received Investigational Product (IP)|Double-Blind Treatment Period||101
8941667|NCT02373813|10003322|FG002|Received Investigational Product (IP)|Double-Blind Treatment Period||100
8941668|NCT02373813|10003323|FG003|Received Investigational Product (IP)|Double-Blind Treatment Period||51
8941669|NCT02373813|10003320|FG000|Received Rescue Treatment|Double-Blind Treatment Period||0
8941670|NCT02373813|10003321|FG001|Received Rescue Treatment|Double-Blind Treatment Period||52
8941671|NCT02373813|10003322|FG002|Received Rescue Treatment|Double-Blind Treatment Period||36
8941672|NCT02373813|10003323|FG003|Received Rescue Treatment|Double-Blind Treatment Period||15
8941673|NCT02373813|10003320|FG000|COMPLETED|Double-Blind Treatment Period||0
8941674|NCT02373813|10003321|FG001|COMPLETED|Double-Blind Treatment Period||88
8941675|NCT02373813|10003322|FG002|COMPLETED|Double-Blind Treatment Period||92
8941676|NCT02373813|10003323|FG003|COMPLETED|Double-Blind Treatment Period||47
8941677|NCT02373813|10003320|FG000|NOT COMPLETED|Double-Blind Treatment Period||0
8941678|NCT02373813|10003321|FG001|NOT COMPLETED|Double-Blind Treatment Period||13
8941679|NCT02373813|10003322|FG002|NOT COMPLETED|Double-Blind Treatment Period||9
8941680|NCT02373813|10003323|FG003|NOT COMPLETED|Double-Blind Treatment Period||4
8941681|NCT02373852|10003334|FG000|STARTED|Overall Study|Includes patients from a previous retrospective study NCT01042444|12
8941682|NCT02373852|10003334|FG000|COMPLETED|Overall Study||11
8941683|NCT02373852|10003334|FG000|NOT COMPLETED|Overall Study||1
8941684|NCT02374060|10003341|FG000|STARTED|Overall Study||65
8941685|NCT02374060|10003342|FG001|STARTED|Overall Study||63
8941686|NCT02374060|10003343|FG002|STARTED|Overall Study||64
8941687|NCT02374060|10003341|FG000|COMPLETED|Overall Study||63
8941688|NCT02374060|10003342|FG001|COMPLETED|Overall Study||62
8941689|NCT02374060|10003343|FG002|COMPLETED|Overall Study||61
8941690|NCT02374060|10003341|FG000|NOT COMPLETED|Overall Study||2
8941691|NCT02374060|10003342|FG001|NOT COMPLETED|Overall Study||1
8941692|NCT02374060|10003343|FG002|NOT COMPLETED|Overall Study||3
8941693|NCT02374099|10003353|FG000|STARTED|Overall Study||48
8941694|NCT02374099|10003354|FG001|STARTED|Overall Study||49
8941695|NCT02374099|10003353|FG000|Participants Treated|Overall Study|2 participants randomized, but not treated|46
8941696|NCT02374099|10003354|FG001|Participants Treated|Overall Study|1 participant randomized, but not treated|48
8719375|NCT01004042|9766872|FG001|NOT COMPLETED|Overall Study||0
8719376|NCT01004107|9766880|FG000|STARTED|Overall Study||76
8719377|NCT01004107|9766881|FG001|STARTED|Overall Study||25
8719378|NCT01004107|9766880|FG000|COMPLETED|Overall Study||75
8941697|NCT02374099|10003353|FG000|COMPLETED|Overall Study||0
8941698|NCT02374099|10003354|FG001|COMPLETED|Overall Study||0
8941699|NCT02374099|10003353|FG000|NOT COMPLETED|Overall Study||48
8941700|NCT02374099|10003354|FG001|NOT COMPLETED|Overall Study||49
8941701|NCT02374138|10003362|FG000|STARTED|Six Month Follow Up||110
8941702|NCT02374138|10003363|FG001|STARTED|Six Month Follow Up||107
8941703|NCT02374138|10003362|FG000|COMPLETED|Six Month Follow Up|6 Month Follow Up|102
8941704|NCT02374138|10003363|FG001|COMPLETED|Six Month Follow Up|6 Month Follow Up|93
8941705|NCT02374138|10003362|FG000|NOT COMPLETED|Six Month Follow Up||8
8941706|NCT02374138|10003363|FG001|NOT COMPLETED|Six Month Follow Up||14
8941707|NCT02374138|10003362|FG000|STARTED|Twelve Month FollowUp||110
8941708|NCT02374138|10003363|FG001|STARTED|Twelve Month FollowUp||107
8941709|NCT02374138|10003362|FG000|COMPLETED|Twelve Month FollowUp||101
8941710|NCT02374138|10003363|FG001|COMPLETED|Twelve Month FollowUp||95
8941711|NCT02374138|10003362|FG000|NOT COMPLETED|Twelve Month FollowUp||9
8941712|NCT02374138|10003363|FG001|NOT COMPLETED|Twelve Month FollowUp||12
8941713|NCT02374164|10003373|FG000|STARTED|Treatment Period 1||12
8941714|NCT02374164|10003374|FG001|STARTED|Treatment Period 1||12
8941715|NCT02374164|10003375|FG002|STARTED|Treatment Period 1||12
8941716|NCT02374164|10003373|FG000|COMPLETED|Treatment Period 1||12
8941717|NCT02374164|10003374|FG001|COMPLETED|Treatment Period 1||12
8941718|NCT02374164|10003375|FG002|COMPLETED|Treatment Period 1||12
8941719|NCT02374164|10003373|FG000|NOT COMPLETED|Treatment Period 1||0
8941720|NCT02374164|10003374|FG001|NOT COMPLETED|Treatment Period 1||0
8941721|NCT02374164|10003375|FG002|NOT COMPLETED|Treatment Period 1||0
8941722|NCT02374164|10003373|FG000|STARTED|Treatment Period 2||12
8941723|NCT02374164|10003374|FG001|STARTED|Treatment Period 2||12
8941724|NCT02374164|10003375|FG002|STARTED|Treatment Period 2||12
8941725|NCT02374164|10003373|FG000|COMPLETED|Treatment Period 2||12
8941726|NCT02374164|10003374|FG001|COMPLETED|Treatment Period 2||12
8941727|NCT02374164|10003375|FG002|COMPLETED|Treatment Period 2||12
8941728|NCT02374164|10003373|FG000|NOT COMPLETED|Treatment Period 2||0
8941729|NCT02374164|10003374|FG001|NOT COMPLETED|Treatment Period 2||0
8941730|NCT02374164|10003375|FG002|NOT COMPLETED|Treatment Period 2||0
8941731|NCT02374164|10003373|FG000|STARTED|Treatment Period 3||12
8941732|NCT02374164|10003374|FG001|STARTED|Treatment Period 3|One participant was Lost-to-Follow-Up prior to treatment A.|11
8941733|NCT02374164|10003375|FG002|STARTED|Treatment Period 3||12
8941734|NCT02374164|10003373|FG000|COMPLETED|Treatment Period 3||12
8941735|NCT02374164|10003374|FG001|COMPLETED|Treatment Period 3||11
8941736|NCT02374164|10003375|FG002|COMPLETED|Treatment Period 3||12
8941737|NCT02374164|10003373|FG000|NOT COMPLETED|Treatment Period 3||0
8941738|NCT02374164|10003374|FG001|NOT COMPLETED|Treatment Period 3||0
8941739|NCT02374164|10003375|FG002|NOT COMPLETED|Treatment Period 3||0
8941740|NCT02374255|10003387|FG000|STARTED|Overall Study||155
8941741|NCT02374255|10003388|FG001|STARTED|Overall Study||110
8941742|NCT02374255|10003389|FG002|STARTED|Overall Study||11
8941743|NCT02374255|10003390|FG003|STARTED|Overall Study||11
8941744|NCT02374255|10003387|FG000|COMPLETED|Overall Study||153
8941745|NCT02374255|10003388|FG001|COMPLETED|Overall Study||110
8941746|NCT02374255|10003389|FG002|COMPLETED|Overall Study||11
8941747|NCT02374255|10003390|FG003|COMPLETED|Overall Study||11
8941748|NCT02374255|10003387|FG000|NOT COMPLETED|Overall Study||2
8941749|NCT02374255|10003388|FG001|NOT COMPLETED|Overall Study||0
8941750|NCT02374255|10003389|FG002|NOT COMPLETED|Overall Study||0
8941751|NCT02374255|10003390|FG003|NOT COMPLETED|Overall Study||0
8941752|NCT02374307|10003408|FG000|STARTED|3-months Follow-up||77
8941753|NCT02374307|10003409|FG001|STARTED|3-months Follow-up||78
8941754|NCT02374307|10003408|FG000|COMPLETED|3-months Follow-up||69
8941755|NCT02374307|10003409|FG001|COMPLETED|3-months Follow-up||69
8941756|NCT02374307|10003408|FG000|NOT COMPLETED|3-months Follow-up||8
8941757|NCT02374307|10003409|FG001|NOT COMPLETED|3-months Follow-up||9
8941758|NCT02374307|10003408|FG000|STARTED|6-months Follow-up|5 subjects missed the first follow-up, but continued the study and were assessed at 6 months.|74
8941759|NCT02374307|10003409|FG001|STARTED|6-months Follow-up|1 subject missed the first follow-up, but continued the study and was assessed at 6 months.|70
8941760|NCT02374307|10003408|FG000|COMPLETED|6-months Follow-up||71
8941761|NCT02374307|10003409|FG001|COMPLETED|6-months Follow-up||64
8941762|NCT02374307|10003408|FG000|NOT COMPLETED|6-months Follow-up||3
8941763|NCT02374307|10003409|FG001|NOT COMPLETED|6-months Follow-up||6
8941764|NCT02374346|10003415|FG000|STARTED|Overall Study||494
8941765|NCT02374346|10003415|FG000|COMPLETED|Overall Study||446
8941766|NCT02374346|10003415|FG000|NOT COMPLETED|Overall Study||48
8941767|NCT02374398|10003425|FG000|STARTED|Overall Study||31
8941768|NCT02374398|10003426|FG001|STARTED|Overall Study||32
8941769|NCT02374398|10003427|FG002|STARTED|Overall Study||32
8941770|NCT02374398|10003428|FG003|STARTED|Overall Study||32
8941771|NCT02374398|10003425|FG000|COMPLETED|Overall Study||29
8941772|NCT02374398|10003426|FG001|COMPLETED|Overall Study||31
8941773|NCT02374398|10003427|FG002|COMPLETED|Overall Study||29
8941774|NCT02374398|10003428|FG003|COMPLETED|Overall Study||32
8941775|NCT02374398|10003425|FG000|NOT COMPLETED|Overall Study||2
8941776|NCT02374398|10003426|FG001|NOT COMPLETED|Overall Study||1
8941777|NCT02374398|10003427|FG002|NOT COMPLETED|Overall Study||3
8941778|NCT02374398|10003428|FG003|NOT COMPLETED|Overall Study||0
8941779|NCT02374463|10003441|FG000|STARTED|Overall Study||15
8941780|NCT02374463|10003442|FG001|STARTED|Overall Study||12
8941781|NCT02374463|10003441|FG000|COMPLETED|Overall Study||12
8941782|NCT02374463|10003442|FG001|COMPLETED|Overall Study||9
8941783|NCT02374463|10003441|FG000|NOT COMPLETED|Overall Study||3
8941784|NCT02374463|10003442|FG001|NOT COMPLETED|Overall Study||3
8941785|NCT02374593|10003451|FG000|STARTED|Overall Study||24
8941786|NCT02374593|10003452|FG001|STARTED|Overall Study||44
8941787|NCT02374593|10003451|FG000|COMPLETED|Overall Study||22
8941788|NCT02374593|10003452|FG001|COMPLETED|Overall Study||44
8941789|NCT02374593|10003451|FG000|NOT COMPLETED|Overall Study||2
8941790|NCT02374593|10003452|FG001|NOT COMPLETED|Overall Study||0
8941791|NCT02374671|10003465|FG000|STARTED|Observation (Deferred Implantation)||0
8941792|NCT02374671|10003466|FG001|STARTED|Observation (Deferred Implantation)||0
8941793|NCT02374671|10003467|FG002|STARTED|Observation (Deferred Implantation)||31
8941794|NCT02374671|10003465|FG000|COMPLETED|Observation (Deferred Implantation)||0
8941795|NCT02374671|10003466|FG001|COMPLETED|Observation (Deferred Implantation)||0
8941796|NCT02374671|10003467|FG002|COMPLETED|Observation (Deferred Implantation)||26
8941797|NCT02374671|10003465|FG000|NOT COMPLETED|Observation (Deferred Implantation)||0
8941798|NCT02374671|10003466|FG001|NOT COMPLETED|Observation (Deferred Implantation)||0
8941799|NCT02374671|10003467|FG002|NOT COMPLETED|Observation (Deferred Implantation)||5
8941800|NCT02374671|10003465|FG000|STARTED|Implantation- Nonrandomized & Randomized|(8) subjects were unilaterally implanted|306
8941801|NCT02374671|10003466|FG001|STARTED|Implantation- Nonrandomized & Randomized|(1) subject was unilaterally implanted|28
8941802|NCT02374671|10003467|FG002|STARTED|Implantation- Nonrandomized & Randomized|(3) subjects were unilaterally implanted|26
8941803|NCT02374671|10003465|FG000|COMPLETED|Implantation- Nonrandomized & Randomized||281
8941804|NCT02374671|10003466|FG001|COMPLETED|Implantation- Nonrandomized & Randomized||27
8941805|NCT02374671|10003467|FG002|COMPLETED|Implantation- Nonrandomized & Randomized|(1) unilaterally implanted subject discontinued (1 eye)|23
8941806|NCT02374671|10003465|FG000|NOT COMPLETED|Implantation- Nonrandomized & Randomized||25
8941807|NCT02374671|10003466|FG001|NOT COMPLETED|Implantation- Nonrandomized & Randomized||1
8941808|NCT02374671|10003467|FG002|NOT COMPLETED|Implantation- Nonrandomized & Randomized||3
8941809|NCT02374918|10003477|FG000|STARTED|Overall Study||17
8941810|NCT02374918|10003478|FG001|STARTED|Overall Study||18
8941811|NCT02374918|10003479|FG002|STARTED|Overall Study||22
8941812|NCT02374918|10003480|FG003|STARTED|Overall Study||20
8941813|NCT02374918|10003477|FG000|COMPLETED|Overall Study||14
8941814|NCT02374918|10003478|FG001|COMPLETED|Overall Study||17
8941815|NCT02374918|10003479|FG002|COMPLETED|Overall Study||18
8941816|NCT02374918|10003480|FG003|COMPLETED|Overall Study||18
8941817|NCT02374918|10003477|FG000|NOT COMPLETED|Overall Study||3
8941818|NCT02374918|10003478|FG001|NOT COMPLETED|Overall Study||1
8941819|NCT02374918|10003479|FG002|NOT COMPLETED|Overall Study||4
8941820|NCT02374918|10003480|FG003|NOT COMPLETED|Overall Study||2
8941821|NCT02374957|10003490|FG000|STARTED|Overall Study||11
8941822|NCT02374957|10003491|FG001|STARTED|Overall Study||9
8941823|NCT02374957|10003490|FG000|COMPLETED|Overall Study||10
8941824|NCT02374957|10003491|FG001|COMPLETED|Overall Study||9
8941825|NCT02374957|10003490|FG000|NOT COMPLETED|Overall Study||1
8941826|NCT02374957|10003491|FG001|NOT COMPLETED|Overall Study||0
8941827|NCT02375347|10003497|FG000|STARTED|Overall Study||13
8941828|NCT02375347|10003497|FG000|COMPLETED|Overall Study||12
8941829|NCT02375347|10003497|FG000|NOT COMPLETED|Overall Study||1
8941830|NCT02375373|10003501|FG000|STARTED|Overall Study||12
8941831|NCT02375373|10003501|FG000|COMPLETED|Overall Study||1
8941832|NCT02375373|10003501|FG000|NOT COMPLETED|Overall Study||11
8941833|NCT02375698|10003507|FG000|STARTED|Overall Study||16
8941834|NCT02375698|10003508|FG001|STARTED|Overall Study||6
8941835|NCT02375698|10003507|FG000|COMPLETED|Overall Study||14
8941836|NCT02375698|10003508|FG001|COMPLETED|Overall Study||4
8941837|NCT02375698|10003507|FG000|NOT COMPLETED|Overall Study||2
8941838|NCT02375698|10003508|FG001|NOT COMPLETED|Overall Study||2
8941839|NCT02375724|10003516|FG000|STARTED|Overall Study||135
8941840|NCT02375724|10003517|FG001|STARTED|Overall Study||134
8941841|NCT02375724|10003516|FG000|COMPLETED|Overall Study||129
9065546|NCT04160975|10125938|FG003|NOT COMPLETED|Overall Study||75
9065547|NCT04160975|10125939|FG004|NOT COMPLETED|Overall Study||35
9065548|NCT04160975|10125940|FG005|NOT COMPLETED|Overall Study||51
9065549|NCT04153409|10125955|FG000|STARTED|Overall Study||10
9065550|NCT04153409|10125956|FG001|STARTED|Overall Study||11
9065551|NCT04153409|10125955|FG000|COMPLETED|Overall Study||8
9065552|NCT04153409|10125956|FG001|COMPLETED|Overall Study||9
9065553|NCT04153409|10125955|FG000|NOT COMPLETED|Overall Study||2
9065554|NCT04153409|10125956|FG001|NOT COMPLETED|Overall Study||2
9065555|NCT04167189|10125962|FG000|STARTED|Overall Study||28
9065556|NCT04167189|10125962|FG000|COMPLETED|Overall Study||28
9065557|NCT04167189|10125962|FG000|NOT COMPLETED|Overall Study||0
9065558|NCT04162795|10125966|FG000|STARTED|Overall Study||468
9065559|NCT04162795|10125966|FG000|COMPLETED|Overall Study||442
8617643|NCT00457977|9655811|FG000|1-Month|Overall Study||88
8617644|NCT00457977|9655812|FG001|1-Month|Overall Study||87
8617645|NCT00457977|9655811|FG000|1-Year|Overall Study||69
9065560|NCT04162795|10125966|FG000|NOT COMPLETED|Overall Study||26
9065561|NCT04161807|10125970|FG000|STARTED|Overall Study||42
9065562|NCT04161807|10125970|FG000|COMPLETED|Overall Study||38
9065563|NCT04161807|10125970|FG000|NOT COMPLETED|Overall Study||4
9065564|NCT04161144|10125976|FG000|STARTED|Overall Study||12
9065565|NCT04161144|10125977|FG001|STARTED|Overall Study||10
9065566|NCT04161144|10125976|FG000|COMPLETED|Overall Study||11
9065567|NCT04161144|10125977|FG001|COMPLETED|Overall Study||9
9065568|NCT04161144|10125976|FG000|NOT COMPLETED|Overall Study||1
9065569|NCT04161144|10125977|FG001|NOT COMPLETED|Overall Study||1
9065570|NCT04161079|10125983|FG000|STARTED|Clinical Investigation 2010-040||12
9065571|NCT04161079|10125983|FG000|COMPLETED|Clinical Investigation 2010-040||11
9065572|NCT04161079|10125983|FG000|NOT COMPLETED|Clinical Investigation 2010-040||1
9065573|NCT04161079|10125983|FG000|STARTED|2010-040FU5 >5 Years Follow-up|Of 11 subjects 3 refused to participate and 1 died.|7
9065574|NCT04161079|10125983|FG000|COMPLETED|2010-040FU5 >5 Years Follow-up|Timepoint distribution for individual patients ranged approximately 6-8 yrs after MAR implantation.|7
9065575|NCT04161079|10125983|FG000|NOT COMPLETED|2010-040FU5 >5 Years Follow-up||0
9065576|NCT04158466|10125993|FG000|STARTED|Overall Study||124
9065577|NCT04158466|10125994|FG001|STARTED|Overall Study||127
8941842|NCT02375724|10003517|FG001|COMPLETED|Overall Study||128
8941843|NCT02375724|10003516|FG000|NOT COMPLETED|Overall Study||6
8941844|NCT02375724|10003517|FG001|NOT COMPLETED|Overall Study||6
8941845|NCT02375971|10003526|FG000|STARTED|Treatment (Day 1 - Baseline)||74
8941846|NCT02375971|10003527|FG001|STARTED|Treatment (Day 1 - Baseline)||77
8941847|NCT02375971|10003528|FG002|STARTED|Treatment (Day 1 - Baseline)||74
8941848|NCT02375971|10003526|FG000|Safety Set|Treatment (Day 1 - Baseline)||73
8941849|NCT02375971|10003527|FG001|Safety Set|Treatment (Day 1 - Baseline)||76
8941850|NCT02375971|10003528|FG002|Safety Set|Treatment (Day 1 - Baseline)||69
8941851|NCT02375971|10003526|FG000|VEGF Set|Treatment (Day 1 - Baseline)||19
8941852|NCT02375971|10003527|FG001|VEGF Set|Treatment (Day 1 - Baseline)||26
8941853|NCT02375971|10003528|FG002|VEGF Set|Treatment (Day 1 - Baseline)||51
8941854|NCT02375971|10003526|FG000|PK Set|Treatment (Day 1 - Baseline)||49
8941855|NCT02375971|10003527|FG001|PK Set|Treatment (Day 1 - Baseline)||46
8941856|NCT02375971|10003528|FG002|PK Set|Treatment (Day 1 - Baseline)||0
8941857|NCT02375971|10003526|FG000|COMPLETED|Treatment (Day 1 - Baseline)||73
8941858|NCT02375971|10003527|FG001|COMPLETED|Treatment (Day 1 - Baseline)||76
8941859|NCT02375971|10003528|FG002|COMPLETED|Treatment (Day 1 - Baseline)||69
8941860|NCT02375971|10003526|FG000|NOT COMPLETED|Treatment (Day 1 - Baseline)||1
8941861|NCT02375971|10003527|FG001|NOT COMPLETED|Treatment (Day 1 - Baseline)||1
8941862|NCT02375971|10003528|FG002|NOT COMPLETED|Treatment (Day 1 - Baseline)||5
8941863|NCT02375971|10003526|FG000|STARTED|Follow-Up Phase (up to Day 169)||73
8941864|NCT02375971|10003527|FG001|STARTED|Follow-Up Phase (up to Day 169)||76
8941865|NCT02375971|10003528|FG002|STARTED|Follow-Up Phase (up to Day 169)||69
8941866|NCT02375971|10003526|FG000|COMPLETED|Follow-Up Phase (up to Day 169)||66
8941867|NCT02375971|10003527|FG001|COMPLETED|Follow-Up Phase (up to Day 169)||71
8941868|NCT02375971|10003528|FG002|COMPLETED|Follow-Up Phase (up to Day 169)||64
8941869|NCT02375971|10003526|FG000|NOT COMPLETED|Follow-Up Phase (up to Day 169)||7
8941870|NCT02375971|10003527|FG001|NOT COMPLETED|Follow-Up Phase (up to Day 169)||5
8941871|NCT02375971|10003528|FG002|NOT COMPLETED|Follow-Up Phase (up to Day 169)||5
8941872|NCT02375984|10003536|FG000|STARTED|Overall Study||1
8941873|NCT02375984|10003536|FG000|COMPLETED|Overall Study||1
8941874|NCT02375984|10003536|FG000|NOT COMPLETED|Overall Study||0
8941875|NCT02376010|10003542|FG000|STARTED|Overall Study||55
8941876|NCT02376010|10003543|FG001|STARTED|Overall Study||55
8941877|NCT02376010|10003542|FG000|COMPLETED|Overall Study||46
8941878|NCT02376010|10003543|FG001|COMPLETED|Overall Study||51
8941879|NCT02376010|10003542|FG000|NOT COMPLETED|Overall Study||9
8941880|NCT02376010|10003543|FG001|NOT COMPLETED|Overall Study||4
8941881|NCT02376166|10003549|FG000|STARTED|Overall Study||15
8941882|NCT02376166|10003549|FG000|COMPLETED|Overall Study||12
8941883|NCT02376166|10003549|FG000|NOT COMPLETED|Overall Study||3
8941884|NCT02376179|10003553|FG000|STARTED|Overall Study||84
8941885|NCT02376179|10003553|FG000|COMPLETED|Overall Study||84
8941886|NCT02376179|10003553|FG000|NOT COMPLETED|Overall Study||0
8941887|NCT02376257|10003560|FG000|STARTED|Overall Study||13
8941888|NCT02376257|10003561|FG001|STARTED|Overall Study||12
8941889|NCT02376257|10003562|FG002|STARTED|Overall Study||11
8941890|NCT02376257|10003560|FG000|COMPLETED|Overall Study||13
8941891|NCT02376257|10003561|FG001|COMPLETED|Overall Study||12
8941892|NCT02376257|10003562|FG002|COMPLETED|Overall Study||11
8941893|NCT02376257|10003560|FG000|NOT COMPLETED|Overall Study||0
8941894|NCT02376257|10003561|FG001|NOT COMPLETED|Overall Study||0
8941895|NCT02376257|10003562|FG002|NOT COMPLETED|Overall Study||0
8941896|NCT02376283|10003573|FG000|STARTED|Overall Study||27
8941897|NCT02376283|10003574|FG001|STARTED|Overall Study||30
8941898|NCT02376283|10003575|FG002|STARTED|Overall Study||30
8941899|NCT02376283|10003573|FG000|COMPLETED|Overall Study||27
8941900|NCT02376283|10003574|FG001|COMPLETED|Overall Study||30
8941901|NCT02376283|10003575|FG002|COMPLETED|Overall Study||30
8941902|NCT02376283|10003573|FG000|NOT COMPLETED|Overall Study||0
8941903|NCT02376283|10003574|FG001|NOT COMPLETED|Overall Study||0
8941904|NCT02376283|10003575|FG002|NOT COMPLETED|Overall Study||0
8941905|NCT02376361|10003586|FG000|STARTED|Overall Study||229
8941906|NCT02376361|10003587|FG001|STARTED|Overall Study||207
8941907|NCT02376361|10003586|FG000|COMPLETED|Overall Study||58
8941908|NCT02376361|10003587|FG001|COMPLETED|Overall Study||90
8941909|NCT02376361|10003586|FG000|NOT COMPLETED|Overall Study||171
8941910|NCT02376361|10003587|FG001|NOT COMPLETED|Overall Study||117
8941911|NCT02376530|10003597|FG000|STARTED|Overall Study||196
8941912|NCT02376530|10003598|FG001|STARTED|Overall Study||198
8941913|NCT02376530|10003599|FG002|STARTED|Overall Study||197
8941914|NCT02376530|10003600|FG003|STARTED|Overall Study||197
8941915|NCT02376530|10003597|FG000|COMPLETED|Overall Study||196
8941916|NCT02376530|10003598|FG001|COMPLETED|Overall Study||198
8941917|NCT02376530|10003599|FG002|COMPLETED|Overall Study||197
8941918|NCT02376530|10003600|FG003|COMPLETED|Overall Study||197
8941919|NCT02376530|10003597|FG000|NOT COMPLETED|Overall Study||0
8941920|NCT02376530|10003598|FG001|NOT COMPLETED|Overall Study||0
8941921|NCT02376530|10003599|FG002|NOT COMPLETED|Overall Study||0
8941922|NCT02376530|10003600|FG003|NOT COMPLETED|Overall Study||0
8941923|NCT02376790|10003613|FG000|STARTED|Overall Study||284
8941924|NCT02376790|10003614|FG001|STARTED|Overall Study||284
8941925|NCT02376790|10003615|FG002|STARTED|Overall Study||283
8941926|NCT02376790|10003613|FG000|Received Treatment|Overall Study||282
8941927|NCT02376790|10003614|FG001|Received Treatment|Overall Study||284
8941928|NCT02376790|10003615|FG002|Received Treatment|Overall Study||282
8941929|NCT02376790|10003613|FG000|COMPLETED|Overall Study||224
8941930|NCT02376790|10003614|FG001|COMPLETED|Overall Study||237
8941931|NCT02376790|10003615|FG002|COMPLETED|Overall Study||230
8941932|NCT02376790|10003613|FG000|NOT COMPLETED|Overall Study||60
8941933|NCT02376790|10003614|FG001|NOT COMPLETED|Overall Study||47
8941934|NCT02376790|10003615|FG002|NOT COMPLETED|Overall Study||53
8941935|NCT02376998|10003623|FG000|STARTED|Overall Study||20
8941936|NCT02376998|10003623|FG000|COMPLETED|Overall Study||11
8941937|NCT02376998|10003623|FG000|NOT COMPLETED|Overall Study||9
8941938|NCT02377063|10003627|FG000|STARTED|Overall Study||25
8941939|NCT02377063|10003627|FG000|COMPLETED|Overall Study||20
8941940|NCT02377063|10003627|FG000|NOT COMPLETED|Overall Study||5
8941941|NCT02377349|10003633|FG000|STARTED|Overall Study||341
8941942|NCT02377349|10003634|FG001|STARTED|Overall Study||346
8941943|NCT02377349|10003633|FG000|COMPLETED|Overall Study||325
8941944|NCT02377349|10003634|FG001|COMPLETED|Overall Study||335
8941945|NCT02377349|10003633|FG000|NOT COMPLETED|Overall Study||16
8941946|NCT02377349|10003634|FG001|NOT COMPLETED|Overall Study||11
8941947|NCT02377362|10003662|FG000|STARTED|Part A First Treatment||4
8941948|NCT02377362|10003663|FG001|STARTED|Part A First Treatment||4
8941949|NCT02377362|10003664|FG002|STARTED|Part A First Treatment||4
8941950|NCT02377362|10003665|FG003|STARTED|Part A First Treatment||4
8941951|NCT02377362|10003666|FG004|STARTED|Part A First Treatment||4
8941952|NCT02377362|10003667|FG005|STARTED|Part A First Treatment||4
8941953|NCT02377362|10003668|FG006|STARTED|Part A First Treatment||0
8941954|NCT02377362|10003669|FG007|STARTED|Part A First Treatment||0
8941955|NCT02377362|10003670|FG008|STARTED|Part A First Treatment||0
8941956|NCT02377362|10003671|FG009|STARTED|Part A First Treatment||0
8941957|NCT02377362|10003672|FG010|STARTED|Part A First Treatment||0
8941958|NCT02377362|10003673|FG011|STARTED|Part A First Treatment||0
8941959|NCT02377362|10003674|FG012|STARTED|Part A First Treatment||0
8941960|NCT02377362|10003662|FG000|COMPLETED|Part A First Treatment||4
8941961|NCT02377362|10003663|FG001|COMPLETED|Part A First Treatment||4
8941962|NCT02377362|10003664|FG002|COMPLETED|Part A First Treatment||4
8941963|NCT02377362|10003665|FG003|COMPLETED|Part A First Treatment||4
8941964|NCT02377362|10003666|FG004|COMPLETED|Part A First Treatment||4
8941965|NCT02377362|10003667|FG005|COMPLETED|Part A First Treatment||4
8941966|NCT02377362|10003668|FG006|COMPLETED|Part A First Treatment||0
8941967|NCT02377362|10003669|FG007|COMPLETED|Part A First Treatment||0
8941968|NCT02377362|10003670|FG008|COMPLETED|Part A First Treatment||0
8941969|NCT02377362|10003671|FG009|COMPLETED|Part A First Treatment||0
8941970|NCT02377362|10003672|FG010|COMPLETED|Part A First Treatment||0
8941971|NCT02377362|10003673|FG011|COMPLETED|Part A First Treatment||0
8941972|NCT02377362|10003674|FG012|COMPLETED|Part A First Treatment||0
8941973|NCT02377362|10003662|FG000|NOT COMPLETED|Part A First Treatment||0
8941974|NCT02377362|10003663|FG001|NOT COMPLETED|Part A First Treatment||0
8941975|NCT02377362|10003664|FG002|NOT COMPLETED|Part A First Treatment||0
8813693|NCT01527045|9866891|FG001|COMPLETED|Overall Study||5
8813694|NCT01527045|9866892|FG002|COMPLETED|Overall Study||12
8813695|NCT01527045|9866890|FG000|NOT COMPLETED|Overall Study||1
8941976|NCT02377362|10003665|FG003|NOT COMPLETED|Part A First Treatment||0
8941977|NCT02377362|10003666|FG004|NOT COMPLETED|Part A First Treatment||0
8941978|NCT02377362|10003667|FG005|NOT COMPLETED|Part A First Treatment||0
8941979|NCT02377362|10003668|FG006|NOT COMPLETED|Part A First Treatment||0
8941980|NCT02377362|10003669|FG007|NOT COMPLETED|Part A First Treatment||0
8941981|NCT02377362|10003670|FG008|NOT COMPLETED|Part A First Treatment||0
8941982|NCT02377362|10003671|FG009|NOT COMPLETED|Part A First Treatment||0
8941983|NCT02377362|10003672|FG010|NOT COMPLETED|Part A First Treatment||0
8941984|NCT02377362|10003673|FG011|NOT COMPLETED|Part A First Treatment||0
8941985|NCT02377362|10003674|FG012|NOT COMPLETED|Part A First Treatment||0
8941986|NCT02377362|10003662|FG000|STARTED|Part A Second Treatment||4
8941987|NCT02377362|10003663|FG001|STARTED|Part A Second Treatment||4
8941988|NCT02377362|10003664|FG002|STARTED|Part A Second Treatment||4
8941989|NCT02377362|10003665|FG003|STARTED|Part A Second Treatment||4
8941990|NCT02377362|10003666|FG004|STARTED|Part A Second Treatment||4
8941991|NCT02377362|10003667|FG005|STARTED|Part A Second Treatment||4
8941992|NCT02377362|10003668|FG006|STARTED|Part A Second Treatment||0
8941993|NCT02377362|10003669|FG007|STARTED|Part A Second Treatment||0
8941994|NCT02377362|10003670|FG008|STARTED|Part A Second Treatment||0
8941995|NCT02377362|10003671|FG009|STARTED|Part A Second Treatment||0
8941996|NCT02377362|10003672|FG010|STARTED|Part A Second Treatment||0
8941997|NCT02377362|10003673|FG011|STARTED|Part A Second Treatment||0
8941998|NCT02377362|10003674|FG012|STARTED|Part A Second Treatment||0
8941999|NCT02377362|10003662|FG000|COMPLETED|Part A Second Treatment||4
8942000|NCT02377362|10003663|FG001|COMPLETED|Part A Second Treatment||4
8942001|NCT02377362|10003664|FG002|COMPLETED|Part A Second Treatment||4
8942002|NCT02377362|10003665|FG003|COMPLETED|Part A Second Treatment||4
8942003|NCT02377362|10003666|FG004|COMPLETED|Part A Second Treatment||3
8942004|NCT02377362|10003667|FG005|COMPLETED|Part A Second Treatment||4
8942005|NCT02377362|10003668|FG006|COMPLETED|Part A Second Treatment||0
8942006|NCT02377362|10003669|FG007|COMPLETED|Part A Second Treatment||0
8942007|NCT02377362|10003670|FG008|COMPLETED|Part A Second Treatment||0
8942008|NCT02377362|10003671|FG009|COMPLETED|Part A Second Treatment||0
8942009|NCT02377362|10003672|FG010|COMPLETED|Part A Second Treatment||0
8942010|NCT02377362|10003673|FG011|COMPLETED|Part A Second Treatment||0
8942011|NCT02377362|10003674|FG012|COMPLETED|Part A Second Treatment||0
8942012|NCT02377362|10003662|FG000|NOT COMPLETED|Part A Second Treatment||0
8942013|NCT02377362|10003663|FG001|NOT COMPLETED|Part A Second Treatment||0
8942014|NCT02377362|10003664|FG002|NOT COMPLETED|Part A Second Treatment||0
8942015|NCT02377362|10003665|FG003|NOT COMPLETED|Part A Second Treatment||0
8942016|NCT02377362|10003666|FG004|NOT COMPLETED|Part A Second Treatment||1
8942017|NCT02377362|10003667|FG005|NOT COMPLETED|Part A Second Treatment||0
8942018|NCT02377362|10003668|FG006|NOT COMPLETED|Part A Second Treatment||0
8942019|NCT02377362|10003669|FG007|NOT COMPLETED|Part A Second Treatment||0
8942020|NCT02377362|10003670|FG008|NOT COMPLETED|Part A Second Treatment||0
8942021|NCT02377362|10003671|FG009|NOT COMPLETED|Part A Second Treatment||0
8942022|NCT02377362|10003672|FG010|NOT COMPLETED|Part A Second Treatment||0
8942023|NCT02377362|10003673|FG011|NOT COMPLETED|Part A Second Treatment||0
8942024|NCT02377362|10003674|FG012|NOT COMPLETED|Part A Second Treatment||0
8942025|NCT02377362|10003662|FG000|STARTED|Part A Third Treatment||4
8942026|NCT02377362|10003663|FG001|STARTED|Part A Third Treatment||4
8942027|NCT02377362|10003664|FG002|STARTED|Part A Third Treatment||4
8942028|NCT02377362|10003665|FG003|STARTED|Part A Third Treatment||4
8942029|NCT02377362|10003666|FG004|STARTED|Part A Third Treatment||3
8942030|NCT02377362|10003667|FG005|STARTED|Part A Third Treatment||4
8942031|NCT02377362|10003668|FG006|STARTED|Part A Third Treatment||0
8942032|NCT02377362|10003669|FG007|STARTED|Part A Third Treatment||0
8942033|NCT02377362|10003670|FG008|STARTED|Part A Third Treatment||0
8942034|NCT02377362|10003671|FG009|STARTED|Part A Third Treatment||0
8942035|NCT02377362|10003672|FG010|STARTED|Part A Third Treatment||0
8942036|NCT02377362|10003673|FG011|STARTED|Part A Third Treatment||0
8942037|NCT02377362|10003674|FG012|STARTED|Part A Third Treatment||0
8942038|NCT02377362|10003662|FG000|COMPLETED|Part A Third Treatment||4
8942039|NCT02377362|10003663|FG001|COMPLETED|Part A Third Treatment||4
8942040|NCT02377362|10003664|FG002|COMPLETED|Part A Third Treatment||4
8942041|NCT02377362|10003665|FG003|COMPLETED|Part A Third Treatment||0
8942042|NCT02377362|10003666|FG004|COMPLETED|Part A Third Treatment||0
8942043|NCT02377362|10003667|FG005|COMPLETED|Part A Third Treatment||0
8942044|NCT02377362|10003668|FG006|COMPLETED|Part A Third Treatment||0
8942045|NCT02377362|10003669|FG007|COMPLETED|Part A Third Treatment||0
8942046|NCT02377362|10003670|FG008|COMPLETED|Part A Third Treatment||0
8942047|NCT02377362|10003671|FG009|COMPLETED|Part A Third Treatment||0
8942048|NCT02377362|10003672|FG010|COMPLETED|Part A Third Treatment||0
8942049|NCT02377362|10003673|FG011|COMPLETED|Part A Third Treatment||0
8942050|NCT02377362|10003674|FG012|COMPLETED|Part A Third Treatment||0
8942051|NCT02377362|10003662|FG000|NOT COMPLETED|Part A Third Treatment||0
8942052|NCT02377362|10003663|FG001|NOT COMPLETED|Part A Third Treatment||0
8942053|NCT02377362|10003664|FG002|NOT COMPLETED|Part A Third Treatment||0
8942054|NCT02377362|10003665|FG003|NOT COMPLETED|Part A Third Treatment||4
8942055|NCT02377362|10003666|FG004|NOT COMPLETED|Part A Third Treatment||3
8942056|NCT02377362|10003667|FG005|NOT COMPLETED|Part A Third Treatment||4
8942057|NCT02377362|10003668|FG006|NOT COMPLETED|Part A Third Treatment||0
8942058|NCT02377362|10003669|FG007|NOT COMPLETED|Part A Third Treatment||0
8942059|NCT02377362|10003670|FG008|NOT COMPLETED|Part A Third Treatment||0
8942060|NCT02377362|10003671|FG009|NOT COMPLETED|Part A Third Treatment||0
8942061|NCT02377362|10003672|FG010|NOT COMPLETED|Part A Third Treatment||0
8942062|NCT02377362|10003673|FG011|NOT COMPLETED|Part A Third Treatment||0
8942063|NCT02377362|10003674|FG012|NOT COMPLETED|Part A Third Treatment||0
8942064|NCT02377362|10003662|FG000|STARTED|Part B Overall||0
8942065|NCT02377362|10003663|FG001|STARTED|Part B Overall||0
8942066|NCT02377362|10003664|FG002|STARTED|Part B Overall||0
8942067|NCT02377362|10003665|FG003|STARTED|Part B Overall||0
8942068|NCT02377362|10003666|FG004|STARTED|Part B Overall||0
8942069|NCT02377362|10003667|FG005|STARTED|Part B Overall||0
8942070|NCT02377362|10003668|FG006|STARTED|Part B Overall||6
8942071|NCT02377362|10003669|FG007|STARTED|Part B Overall||6
8942072|NCT02377362|10003670|FG008|STARTED|Part B Overall||6
8942073|NCT02377362|10003671|FG009|STARTED|Part B Overall||7
8942074|NCT02377362|10003672|FG010|STARTED|Part B Overall||6
8942075|NCT02377362|10003673|FG011|STARTED|Part B Overall||7
8942076|NCT02377362|10003674|FG012|STARTED|Part B Overall||12
8942077|NCT02377362|10003662|FG000|COMPLETED|Part B Overall||0
8942078|NCT02377362|10003663|FG001|COMPLETED|Part B Overall||0
8942079|NCT02377362|10003664|FG002|COMPLETED|Part B Overall||0
8942080|NCT02377362|10003665|FG003|COMPLETED|Part B Overall||0
8942081|NCT02377362|10003666|FG004|COMPLETED|Part B Overall||0
8942082|NCT02377362|10003667|FG005|COMPLETED|Part B Overall||0
8942083|NCT02377362|10003668|FG006|COMPLETED|Part B Overall||4
8942084|NCT02377362|10003669|FG007|COMPLETED|Part B Overall||5
8942085|NCT02377362|10003670|FG008|COMPLETED|Part B Overall||6
8942086|NCT02377362|10003671|FG009|COMPLETED|Part B Overall||6
8942087|NCT02377362|10003672|FG010|COMPLETED|Part B Overall||6
8942088|NCT02377362|10003673|FG011|COMPLETED|Part B Overall||6
8942089|NCT02377362|10003674|FG012|COMPLETED|Part B Overall||12
8942090|NCT02377362|10003662|FG000|NOT COMPLETED|Part B Overall||0
8942091|NCT02377362|10003663|FG001|NOT COMPLETED|Part B Overall||0
8942092|NCT02377362|10003664|FG002|NOT COMPLETED|Part B Overall||0
8942093|NCT02377362|10003665|FG003|NOT COMPLETED|Part B Overall||0
8942094|NCT02377362|10003666|FG004|NOT COMPLETED|Part B Overall||0
8942095|NCT02377362|10003667|FG005|NOT COMPLETED|Part B Overall||0
8942096|NCT02377362|10003668|FG006|NOT COMPLETED|Part B Overall||2
8942097|NCT02377362|10003669|FG007|NOT COMPLETED|Part B Overall||1
8942098|NCT02377362|10003670|FG008|NOT COMPLETED|Part B Overall||0
8942099|NCT02377362|10003671|FG009|NOT COMPLETED|Part B Overall||1
8942100|NCT02377362|10003672|FG010|NOT COMPLETED|Part B Overall||0
8942101|NCT02377362|10003673|FG011|NOT COMPLETED|Part B Overall||1
8942102|NCT02377362|10003674|FG012|NOT COMPLETED|Part B Overall||0
8942103|NCT02377427|10003714|FG000|STARTED|Part A (Up to Week 20)||26
8942104|NCT02377427|10003715|FG001|STARTED|Part A (Up to Week 20)||10
8942105|NCT02377427|10003716|FG002|STARTED|Part A (Up to Week 20)||0
8942106|NCT02377427|10003717|FG003|STARTED|Part A (Up to Week 20)||0
8942107|NCT02377427|10003718|FG004|STARTED|Part A (Up to Week 20)||0
8942108|NCT02377427|10003714|FG000|COMPLETED|Part A (Up to Week 20)||22
8942109|NCT02377427|10003715|FG001|COMPLETED|Part A (Up to Week 20)||10
8942110|NCT02377427|10003716|FG002|COMPLETED|Part A (Up to Week 20)||0
8942111|NCT02377427|10003717|FG003|COMPLETED|Part A (Up to Week 20)||0
8942112|NCT02377427|10003718|FG004|COMPLETED|Part A (Up to Week 20)||0
8942113|NCT02377427|10003714|FG000|NOT COMPLETED|Part A (Up to Week 20)||4
8942114|NCT02377427|10003715|FG001|NOT COMPLETED|Part A (Up to Week 20)||0
8942115|NCT02377427|10003716|FG002|NOT COMPLETED|Part A (Up to Week 20)||0
8942116|NCT02377427|10003717|FG003|NOT COMPLETED|Part A (Up to Week 20)||0
8942117|NCT02377427|10003718|FG004|NOT COMPLETED|Part A (Up to Week 20)||0
8942118|NCT02377427|10003714|FG000|STARTED|Part B (From Week 20 and up to Week 80)||0
8942119|NCT02377427|10003715|FG001|STARTED|Part B (From Week 20 and up to Week 80)||0
8942120|NCT02377427|10003716|FG002|STARTED|Part B (From Week 20 and up to Week 80)|Two participants of PartA chose not to continue in PartB;4 shifted to PartB Mepolizumab 40/100mg arm|16
8942121|NCT02377427|10003717|FG003|STARTED|Part B (From Week 20 and up to Week 80)||10
8942122|NCT02377427|10003718|FG004|STARTED|Part B (From Week 20 and up to Week 80)||4
8942123|NCT02377427|10003714|FG000|COMPLETED|Part B (From Week 20 and up to Week 80)||0
8942124|NCT02377427|10003715|FG001|COMPLETED|Part B (From Week 20 and up to Week 80)||0
8942125|NCT02377427|10003716|FG002|COMPLETED|Part B (From Week 20 and up to Week 80)||15
8942126|NCT02377427|10003717|FG003|COMPLETED|Part B (From Week 20 and up to Week 80)||10
8942127|NCT02377427|10003718|FG004|COMPLETED|Part B (From Week 20 and up to Week 80)||4
8942128|NCT02377427|10003714|FG000|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||0
8942129|NCT02377427|10003715|FG001|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||0
8942130|NCT02377427|10003716|FG002|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||1
8942131|NCT02377427|10003717|FG003|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||0
8942132|NCT02377427|10003718|FG004|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||0
8942133|NCT02377466|10003733|FG000|STARTED|Overall Study||13
8942134|NCT02377466|10003734|FG001|STARTED|Overall Study||12
8942135|NCT02377466|10003733|FG000|Treated|Overall Study||13
8942136|NCT02377466|10003734|FG001|Treated|Overall Study||10
8942137|NCT02377466|10003733|FG000|COMPLETED|Overall Study||13
8942138|NCT02377466|10003734|FG001|COMPLETED|Overall Study||10
8942139|NCT02377466|10003733|FG000|NOT COMPLETED|Overall Study||0
8942140|NCT02377466|10003734|FG001|NOT COMPLETED|Overall Study||2
8942141|NCT02377674|10003747|FG000|STARTED|Overall Study||5
8942142|NCT02377674|10003747|FG000|COMPLETED|Overall Study||5
8942143|NCT02377674|10003747|FG000|NOT COMPLETED|Overall Study||0
8942144|NCT02377700|10003751|FG000|STARTED|Overall Study||5
8942145|NCT02377700|10003751|FG000|COMPLETED|Overall Study||5
8942146|NCT02377700|10003751|FG000|NOT COMPLETED|Overall Study||0
8942147|NCT02377752|10003759|FG000|STARTED|Overall Study||7
8942148|NCT02377752|10003760|FG001|STARTED|Overall Study||6
8942149|NCT02377752|10003761|FG002|STARTED|Overall Study||6
8942150|NCT02377752|10003762|FG003|STARTED|Overall Study||6
8942151|NCT02377752|10003759|FG000|Received at Least 1 Dose of Study Drug|Overall Study||7
8942152|NCT02377752|10003760|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
8942153|NCT02377752|10003761|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
8942154|NCT02377752|10003762|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
8942155|NCT02377752|10003759|FG000|COMPLETED|Overall Study||7
9065578|NCT04158466|10125993|FG000|COMPLETED|Overall Study||121
9065579|NCT04158466|10125994|FG001|COMPLETED|Overall Study||126
9065580|NCT04158466|10125993|FG000|NOT COMPLETED|Overall Study||3
9065581|NCT04158466|10125994|FG001|NOT COMPLETED|Overall Study||1
9065582|NCT04152083|10126002|FG000|STARTED|Overall Study||241
9065583|NCT04152083|10126003|FG001|STARTED|Overall Study||244
9065584|NCT04152083|10126002|FG000|Received at Least 1 Dose of Study Drug|Overall Study||238
9065585|NCT04152083|10126003|FG001|Received at Least 1 Dose of Study Drug|Overall Study||242
9065586|NCT04152083|10126002|FG000|COMPLETED|Overall Study||235
9065587|NCT04152083|10126003|FG001|COMPLETED|Overall Study||241
9065588|NCT04152083|10126002|FG000|NOT COMPLETED|Overall Study||6
9065589|NCT04152083|10126003|FG001|NOT COMPLETED|Overall Study||3
9065590|NCT04155567|10126009|FG000|STARTED|Overall Study||10
9065591|NCT04155567|10126009|FG000|COMPLETED|Overall Study||10
9065592|NCT04155567|10126009|FG000|NOT COMPLETED|Overall Study||0
9065593|NCT04155047|10126015|FG000|STARTED|Overall Study||11
9065594|NCT04155047|10126016|FG001|STARTED|Overall Study||11
9065595|NCT04155047|10126015|FG000|COMPLETED|Overall Study||9
9065596|NCT04155047|10126016|FG001|COMPLETED|Overall Study||11
9065597|NCT04155047|10126015|FG000|NOT COMPLETED|Overall Study||2
9065598|NCT04155047|10126016|FG001|NOT COMPLETED|Overall Study||0
9065599|NCT04152642|10126022|FG000|STARTED|Overall Study||22
9065600|NCT04152642|10126022|FG000|C (Water/Negative) Control|Overall Study||20
9065601|NCT04152642|10126022|FG000|A (Marketed Rinse)|Overall Study||19
9065602|NCT04152642|10126022|FG000|B (Experimental Rinse)|Overall Study||19
9065603|NCT04152642|10126022|FG000|COMPLETED|Overall Study||15
9065604|NCT04152642|10126022|FG000|NOT COMPLETED|Overall Study||7
9065605|NCT04150861|10126033|FG000|STARTED|Overall Study||8
9065606|NCT04150861|10126034|FG001|STARTED|Overall Study||8
9065607|NCT04150861|10126035|FG002|STARTED|Overall Study||8
9065608|NCT04150861|10126033|FG000|COMPLETED|Overall Study||8
9065609|NCT04150861|10126034|FG001|COMPLETED|Overall Study||8
8617646|NCT00457977|9655812|FG001|1-Year|Overall Study||76
9065610|NCT04150861|10126035|FG002|COMPLETED|Overall Study||8
9065611|NCT04150861|10126033|FG000|NOT COMPLETED|Overall Study||0
9065612|NCT04150861|10126034|FG001|NOT COMPLETED|Overall Study||0
8617647|NCT00457977|9655811|FG000|2-Year|Overall Study||62
8617648|NCT00457977|9655812|FG001|2-Year|Overall Study||66
9065613|NCT04150861|10126035|FG002|NOT COMPLETED|Overall Study||0
8617649|NCT00457977|9655811|FG000|COMPLETED|Overall Study||62
8942156|NCT02377752|10003760|FG001|COMPLETED|Overall Study||6
8942157|NCT02377752|10003761|FG002|COMPLETED|Overall Study||6
8942158|NCT02377752|10003762|FG003|COMPLETED|Overall Study||6
8942159|NCT02377752|10003759|FG000|NOT COMPLETED|Overall Study||0
8942160|NCT02377752|10003760|FG001|NOT COMPLETED|Overall Study||0
8942161|NCT02377752|10003761|FG002|NOT COMPLETED|Overall Study||0
8942162|NCT02377752|10003762|FG003|NOT COMPLETED|Overall Study||0
8942163|NCT02377817|10003777|FG000|STARTED|Overall Study||13
8942164|NCT02377817|10003778|FG001|STARTED|Overall Study||10
8942165|NCT02377817|10003777|FG000|COMPLETED|Overall Study||10
8942166|NCT02377817|10003778|FG001|COMPLETED|Overall Study||10
8942167|NCT02377817|10003777|FG000|NOT COMPLETED|Overall Study||3
8942168|NCT02377817|10003778|FG001|NOT COMPLETED|Overall Study||0
8942169|NCT02377921|10003788|FG000|STARTED|Overall Study||45
8617650|NCT00457977|9655812|FG001|COMPLETED|Overall Study||66
8617651|NCT00457977|9655811|FG000|NOT COMPLETED|Overall Study||28
8617652|NCT00457977|9655812|FG001|NOT COMPLETED|Overall Study||25
8617653|NCT00458211|9655818|FG000|STARTED|Overall Study||40
8617654|NCT00458211|9655818|FG000|COMPLETED|Overall Study|12 early termination 2 protocol violation 2 ( from Rochester) withdrawn from further analysis|24
8617655|NCT00458211|9655818|FG000|NOT COMPLETED|Overall Study||16
8617656|NCT00458237|9655829|FG000|STARTED|Overall Study||3
8617657|NCT00458237|9655830|FG001|STARTED|Overall Study||3
8617658|NCT00458237|9655831|FG002|STARTED|Overall Study||5
8617659|NCT00458237|9655829|FG000|COMPLETED|Overall Study||3
8942170|NCT02377921|10003789|FG001|STARTED|Overall Study||44
8942171|NCT02377921|10003788|FG000|COMPLETED|Overall Study||44
8942172|NCT02377921|10003789|FG001|COMPLETED|Overall Study||43
8942173|NCT02377921|10003788|FG000|NOT COMPLETED|Overall Study||1
8942174|NCT02377921|10003789|FG001|NOT COMPLETED|Overall Study||1
8942175|NCT02377947|10003795|FG000|STARTED|Overall Study||50
8942176|NCT02377947|10003795|FG000|COMPLETED|Overall Study||50
8942177|NCT02377947|10003795|FG000|NOT COMPLETED|Overall Study||0
8942178|NCT02377986|10003799|FG000|STARTED|Overall Study||5
8942179|NCT02377986|10003799|FG000|COMPLETED|Overall Study||5
8942180|NCT02377986|10003799|FG000|NOT COMPLETED|Overall Study||0
8942181|NCT02378025|10003805|FG000|STARTED|Overall Study||39
8942182|NCT02378025|10003806|FG001|STARTED|Overall Study||36
8942183|NCT02378025|10003805|FG000|COMPLETED|Overall Study||26
8942184|NCT02378025|10003806|FG001|COMPLETED|Overall Study||15
8942185|NCT02378025|10003805|FG000|NOT COMPLETED|Overall Study||13
8942186|NCT02378025|10003806|FG001|NOT COMPLETED|Overall Study||21
8942187|NCT02378038|10003812|FG000|STARTED|Overall Study||5
8942188|NCT02378038|10003812|FG000|COMPLETED|Overall Study||0
8942189|NCT02378038|10003812|FG000|NOT COMPLETED|Overall Study||5
8942190|NCT02378207|10003820|FG000|STARTED|Overall Study||24
8942191|NCT02378207|10003821|FG001|STARTED|Overall Study||24
8942192|NCT02378207|10003822|FG002|STARTED|Overall Study||24
8942193|NCT02378207|10003823|FG003|STARTED|Overall Study||12
8942194|NCT02378207|10003820|FG000|COMPLETED|Overall Study||24
8942195|NCT02378207|10003821|FG001|COMPLETED|Overall Study||21
8942196|NCT02378207|10003822|FG002|COMPLETED|Overall Study||22
8942197|NCT02378207|10003823|FG003|COMPLETED|Overall Study||11
8942198|NCT02378207|10003820|FG000|NOT COMPLETED|Overall Study||0
8942199|NCT02378207|10003821|FG001|NOT COMPLETED|Overall Study||3
8942200|NCT02378207|10003822|FG002|NOT COMPLETED|Overall Study||2
8942201|NCT02378207|10003823|FG003|NOT COMPLETED|Overall Study||1
8942202|NCT02378220|10003835|FG000|STARTED|Overall Study||53
8942203|NCT02378220|10003836|FG001|STARTED|Overall Study||57
8942204|NCT02378220|10003835|FG000|COMPLETED|Overall Study||47
8942205|NCT02378220|10003836|FG001|COMPLETED|Overall Study||56
8942206|NCT02378220|10003835|FG000|NOT COMPLETED|Overall Study||6
8942207|NCT02378220|10003836|FG001|NOT COMPLETED|Overall Study||1
8942208|NCT02378402|10003846|FG000|STARTED|Overall Study||25
8942209|NCT02378402|10003847|FG001|STARTED|Overall Study||25
8942210|NCT02378402|10003848|FG002|STARTED|Overall Study||21
8942211|NCT02378402|10003846|FG000|COMPLETED|Overall Study||25
8942212|NCT02378402|10003847|FG001|COMPLETED|Overall Study||23
8942213|NCT02378402|10003848|FG002|COMPLETED|Overall Study||21
8617660|NCT00458237|9655830|FG001|COMPLETED|Overall Study||3
8617661|NCT00458237|9655831|FG002|COMPLETED|Overall Study||5
8617662|NCT00458237|9655829|FG000|NOT COMPLETED|Overall Study||0
8617663|NCT00458237|9655830|FG001|NOT COMPLETED|Overall Study||0
8617664|NCT00458237|9655831|FG002|NOT COMPLETED|Overall Study||0
8617665|NCT00458302|9655842|FG000|STARTED|Overall Study||129
8617666|NCT00458302|9655843|FG001|STARTED|Overall Study||127
8617667|NCT00458302|9655842|FG000|COMPLETED|Overall Study||109
8942214|NCT02378402|10003846|FG000|NOT COMPLETED|Overall Study||0
8942215|NCT02378402|10003847|FG001|NOT COMPLETED|Overall Study||2
8942216|NCT02378402|10003848|FG002|NOT COMPLETED|Overall Study||0
8942217|NCT02378480|10003858|FG000|STARTED|Overall Study||329
8942218|NCT02378480|10003859|FG001|STARTED|Overall Study||326
8942219|NCT02378480|10003858|FG000|COMPLETED|Overall Study||301
8942220|NCT02378480|10003859|FG001|COMPLETED|Overall Study||294
8942221|NCT02378480|10003858|FG000|NOT COMPLETED|Overall Study||28
8942222|NCT02378480|10003859|FG001|NOT COMPLETED|Overall Study||32
8942223|NCT02378506|10003865|FG000|STARTED|Overall Study||188
8942224|NCT02378506|10003865|FG000|Treated|Overall Study||187
8942225|NCT02378506|10003865|FG000|COMPLETED|Overall Study||163
8942226|NCT02378506|10003865|FG000|NOT COMPLETED|Overall Study||25
8617668|NCT00458302|9655843|FG001|COMPLETED|Overall Study||103
8617669|NCT00458302|9655842|FG000|NOT COMPLETED|Overall Study||20
8617670|NCT00458302|9655843|FG001|NOT COMPLETED|Overall Study||24
8942227|NCT02378662|10003871|FG000|STARTED|Overall Study||2
8942228|NCT02378662|10003872|FG001|STARTED|Overall Study||0
8942229|NCT02378662|10003871|FG000|Harvesting|Overall Study||2
8942230|NCT02378662|10003872|FG001|Harvesting|Overall Study||0
8942231|NCT02378662|10003871|FG000|Implantation|Overall Study||2
8942232|NCT02378662|10003872|FG001|Implantation|Overall Study||0
8942233|NCT02378662|10003871|FG000|COMPLETED|Overall Study||0
8942234|NCT02378662|10003872|FG001|COMPLETED|Overall Study||0
8942235|NCT02378662|10003871|FG000|NOT COMPLETED|Overall Study||2
8942236|NCT02378662|10003872|FG001|NOT COMPLETED|Overall Study||0
8942237|NCT02378714|10003882|FG000|STARTED|Overall Study||68
8942238|NCT02378714|10003883|FG001|STARTED|Overall Study||68
8942239|NCT02378714|10003884|FG002|STARTED|Overall Study||81
8942240|NCT02378714|10003885|FG003|STARTED|Overall Study||83
8942241|NCT02378714|10003882|FG000|COMPLETED|Overall Study||39
8942242|NCT02378714|10003883|FG001|COMPLETED|Overall Study||29
8942243|NCT02378714|10003884|FG002|COMPLETED|Overall Study||51
8942244|NCT02378714|10003885|FG003|COMPLETED|Overall Study||51
8942245|NCT02378714|10003882|FG000|NOT COMPLETED|Overall Study||29
8942246|NCT02378714|10003883|FG001|NOT COMPLETED|Overall Study||39
8942247|NCT02378714|10003884|FG002|NOT COMPLETED|Overall Study||30
8942248|NCT02378714|10003885|FG003|NOT COMPLETED|Overall Study||32
8942249|NCT02378753|10003919|FG000|STARTED|Overall Study||4319
8942250|NCT02378753|10003920|FG001|STARTED|Overall Study||4332
8942251|NCT02378753|10003919|FG000|COMPLETED|Overall Study||4101
8942252|NCT02378753|10003920|FG001|COMPLETED|Overall Study||3637
8942253|NCT02378753|10003919|FG000|NOT COMPLETED|Overall Study||218
8942254|NCT02378753|10003920|FG001|NOT COMPLETED|Overall Study||695
8942255|NCT02378844|10003928|FG000|STARTED|Run-in Period||169
8942256|NCT02378844|10003929|FG001|STARTED|Run-in Period||172
8942257|NCT02378844|10003930|FG002|STARTED|Run-in Period||136
8942258|NCT02378844|10003928|FG000|COMPLETED|Run-in Period||165
8942259|NCT02378844|10003929|FG001|COMPLETED|Run-in Period||167
8942260|NCT02378844|10003930|FG002|COMPLETED|Run-in Period||0
8942261|NCT02378844|10003928|FG000|NOT COMPLETED|Run-in Period||4
8942262|NCT02378844|10003929|FG001|NOT COMPLETED|Run-in Period||5
8942263|NCT02378844|10003930|FG002|NOT COMPLETED|Run-in Period||136
8942264|NCT02378844|10003928|FG000|STARTED|Randomized Period (Double Blind)||165
8942265|NCT02378844|10003929|FG001|STARTED|Randomized Period (Double Blind)||167
8942266|NCT02378844|10003930|FG002|STARTED|Randomized Period (Double Blind)||0
8942267|NCT02378844|10003928|FG000|COMPLETED|Randomized Period (Double Blind)||142
8942268|NCT02378844|10003929|FG001|COMPLETED|Randomized Period (Double Blind)||135
8942269|NCT02378844|10003930|FG002|COMPLETED|Randomized Period (Double Blind)||0
8942270|NCT02378844|10003928|FG000|NOT COMPLETED|Randomized Period (Double Blind)||23
8942271|NCT02378844|10003929|FG001|NOT COMPLETED|Randomized Period (Double Blind)||32
8942272|NCT02378844|10003930|FG002|NOT COMPLETED|Randomized Period (Double Blind)||0
8942273|NCT02378844|10003928|FG000|STARTED|Open Label Period||142
8942274|NCT02378844|10003929|FG001|STARTED|Open Label Period||135
8942275|NCT02378844|10003930|FG002|STARTED|Open Label Period||0
8942276|NCT02378844|10003928|FG000|COMPLETED|Open Label Period||99
8942277|NCT02378844|10003929|FG001|COMPLETED|Open Label Period||87
8942278|NCT02378844|10003930|FG002|COMPLETED|Open Label Period||0
8942279|NCT02378844|10003928|FG000|NOT COMPLETED|Open Label Period||43
8942280|NCT02378844|10003929|FG001|NOT COMPLETED|Open Label Period||48
8942281|NCT02378844|10003930|FG002|NOT COMPLETED|Open Label Period||0
8942282|NCT02378883|10003940|FG000|STARTED|Enrollment|Participants consented and assessed for eligibility|121
8942283|NCT02378883|10003940|FG000|COMPLETED|Enrollment|Attempted with study device - intent to treat population|112
8942284|NCT02378883|10003940|FG000|NOT COMPLETED|Enrollment||9
8617671|NCT00458341|9655852|FG000|STARTED|Cycle 1||15
8617672|NCT00458341|9655853|FG001|STARTED|Cycle 1||15
8942285|NCT02378883|10003940|FG000|STARTED|Discharge||112
8942286|NCT02378883|10003940|FG000|COMPLETED|Discharge||112
8942287|NCT02378883|10003940|FG000|NOT COMPLETED|Discharge||0
8942288|NCT02378883|10003940|FG000|STARTED|30 Day Follow-Up||112
8942289|NCT02378883|10003940|FG000|COMPLETED|30 Day Follow-Up||106
8942290|NCT02378883|10003940|FG000|NOT COMPLETED|30 Day Follow-Up||6
8942291|NCT02378883|10003940|FG000|STARTED|12 Months Follow-Up|Two deaths occurred between 30 day FU and prior to 12 month FU.|46
8942292|NCT02378883|10003940|FG000|COMPLETED|12 Months Follow-Up||41
8942293|NCT02378883|10003940|FG000|NOT COMPLETED|12 Months Follow-Up||5
8942294|NCT02378935|10003952|FG000|STARTED|Overall Study||34
8942295|NCT02378935|10003953|FG001|STARTED|Overall Study||36
8942296|NCT02378935|10003954|FG002|STARTED|Overall Study||33
8942297|NCT02378935|10003955|FG003|STARTED|Overall Study||31
8942298|NCT02378935|10003956|FG004|STARTED|Overall Study||31
8942299|NCT02378935|10003957|FG005|STARTED|Overall Study||32
8942300|NCT02378935|10003958|FG006|STARTED|Overall Study||8
8942301|NCT02378935|10003952|FG000|COMPLETED|Overall Study||24
8942302|NCT02378935|10003953|FG001|COMPLETED|Overall Study||36
8942303|NCT02378935|10003954|FG002|COMPLETED|Overall Study||30
8942304|NCT02378935|10003955|FG003|COMPLETED|Overall Study||25
8942305|NCT02378935|10003956|FG004|COMPLETED|Overall Study||31
8942306|NCT02378935|10003957|FG005|COMPLETED|Overall Study||32
8942307|NCT02378935|10003958|FG006|COMPLETED|Overall Study||8
8942308|NCT02378935|10003952|FG000|NOT COMPLETED|Overall Study||10
8942309|NCT02378935|10003953|FG001|NOT COMPLETED|Overall Study||0
8942310|NCT02378935|10003954|FG002|NOT COMPLETED|Overall Study||3
8942311|NCT02378935|10003955|FG003|NOT COMPLETED|Overall Study||6
8942312|NCT02378935|10003956|FG004|NOT COMPLETED|Overall Study||0
8942313|NCT02378935|10003957|FG005|NOT COMPLETED|Overall Study||0
8942314|NCT02378935|10003958|FG006|NOT COMPLETED|Overall Study||0
8942315|NCT02378961|10003978|FG000|STARTED|Overall Study||33
8942316|NCT02378961|10003979|FG001|STARTED|Overall Study||30
8942317|NCT02378961|10003980|FG002|STARTED|Overall Study||36
8942318|NCT02378961|10003981|FG003|STARTED|Overall Study||29
8942319|NCT02378961|10003978|FG000|COMPLETED|Overall Study||29
8942320|NCT02378961|10003979|FG001|COMPLETED|Overall Study||28
8942321|NCT02378961|10003980|FG002|COMPLETED|Overall Study||35
8942322|NCT02378961|10003981|FG003|COMPLETED|Overall Study||28
8942323|NCT02378961|10003978|FG000|NOT COMPLETED|Overall Study||4
8942324|NCT02378961|10003979|FG001|NOT COMPLETED|Overall Study||2
8942325|NCT02378961|10003980|FG002|NOT COMPLETED|Overall Study||1
8942326|NCT02378961|10003981|FG003|NOT COMPLETED|Overall Study||1
8942327|NCT02379052|10003993|FG000|STARTED|Overall Study||24
8942328|NCT02379052|10003994|FG001|STARTED|Overall Study||23
8942329|NCT02379052|10003993|FG000|COMPLETED|Overall Study||18
8942330|NCT02379052|10003994|FG001|COMPLETED|Overall Study||18
8942331|NCT02379052|10003993|FG000|NOT COMPLETED|Overall Study||6
8942332|NCT02379052|10003994|FG001|NOT COMPLETED|Overall Study||5
8942333|NCT02379078|10004002|FG000|STARTED|Overall Study||111
8942334|NCT02379078|10004003|FG001|STARTED|Overall Study||114
8942335|NCT02379078|10004002|FG000|COMPLETED|Overall Study||72
8942336|NCT02379078|10004003|FG001|COMPLETED|Overall Study||79
8942337|NCT02379078|10004002|FG000|NOT COMPLETED|Overall Study||39
8942338|NCT02379078|10004003|FG001|NOT COMPLETED|Overall Study||35
8942339|NCT02379091|10004013|FG000|STARTED|Overall Study||27
8942340|NCT02379091|10004014|FG001|STARTED|Overall Study||28
8942341|NCT02379091|10004015|FG002|STARTED|Overall Study||25
8942342|NCT02379091|10004016|FG003|STARTED|Overall Study||28
8942343|NCT02379091|10004013|FG000|Full Analysis Set|Overall Study|One participant was excluded because of data collection issues.|26
8942344|NCT02379091|10004014|FG001|Full Analysis Set|Overall Study||28
8942345|NCT02379091|10004015|FG002|Full Analysis Set|Overall Study|One participant was excluded because of data collection issues.|24
8942346|NCT02379091|10004016|FG003|Full Analysis Set|Overall Study||28
8942347|NCT02379091|10004013|FG000|COMPLETED|Overall Study||15
8942348|NCT02379091|10004014|FG001|COMPLETED|Overall Study||18
8942349|NCT02379091|10004015|FG002|COMPLETED|Overall Study||18
8942350|NCT02379091|10004016|FG003|COMPLETED|Overall Study||14
8942351|NCT02379091|10004013|FG000|NOT COMPLETED|Overall Study||12
8942352|NCT02379091|10004014|FG001|NOT COMPLETED|Overall Study||10
8942353|NCT02379091|10004015|FG002|NOT COMPLETED|Overall Study||7
8942354|NCT02379091|10004016|FG003|NOT COMPLETED|Overall Study||14
8942355|NCT02379117|10004030|FG000|STARTED|Overall Study||30
8942356|NCT02379117|10004031|FG001|STARTED|Overall Study||31
8719379|NCT01004107|9766881|FG001|COMPLETED|Overall Study||23
8942357|NCT02379117|10004030|FG000|COMPLETED|Overall Study||30
8942358|NCT02379117|10004031|FG001|COMPLETED|Overall Study||31
8942359|NCT02379117|10004030|FG000|NOT COMPLETED|Overall Study||0
8942360|NCT02379117|10004031|FG001|NOT COMPLETED|Overall Study||0
8942361|NCT02379195|10004037|FG000|STARTED|Overall Study||12
8942362|NCT02379195|10004037|FG000|COMPLETED|Overall Study||12
8942363|NCT02379195|10004037|FG000|NOT COMPLETED|Overall Study||0
8942364|NCT02379221|10004041|FG000|STARTED|Overall Study||49
8942365|NCT02379221|10004041|FG000|COMPLETED|Overall Study||48
8942366|NCT02379221|10004041|FG000|NOT COMPLETED|Overall Study||1
8942367|NCT02379247|10004054|FG000|STARTED|Overall Study||3
8942368|NCT02379247|10004055|FG001|STARTED|Overall Study||3
8942369|NCT02379247|10004056|FG002|STARTED|Overall Study||7
8942370|NCT02379247|10004057|FG003|STARTED|Overall Study||30
8942371|NCT02379247|10004054|FG000|COMPLETED|Overall Study||3
8942372|NCT02379247|10004055|FG001|COMPLETED|Overall Study||3
8942373|NCT02379247|10004056|FG002|COMPLETED|Overall Study||7
8942374|NCT02379247|10004057|FG003|COMPLETED|Overall Study||30
8942375|NCT02379247|10004054|FG000|NOT COMPLETED|Overall Study||0
8942376|NCT02379247|10004055|FG001|NOT COMPLETED|Overall Study||0
8942377|NCT02379247|10004056|FG002|NOT COMPLETED|Overall Study||0
8942378|NCT02379247|10004057|FG003|NOT COMPLETED|Overall Study||0
8942379|NCT02379273|10004070|FG000|STARTED|Overall Study||35
8942380|NCT02379273|10004070|FG000|COMPLETED|Overall Study|Completed 5 years postactivation.|35
8942381|NCT02379273|10004070|FG000|NOT COMPLETED|Overall Study||0
8942382|NCT02379442|10004074|FG000|STARTED|Overall Study||1
8942383|NCT02379442|10004074|FG000|COMPLETED|Overall Study||1
8942384|NCT02379442|10004074|FG000|NOT COMPLETED|Overall Study||0
8942385|NCT02379637|10004080|FG000|STARTED|Overall Study||35
8942386|NCT02379637|10004081|FG001|STARTED|Overall Study||35
8942387|NCT02379637|10004080|FG000|COMPLETED|Overall Study||33
8942388|NCT02379637|10004081|FG001|COMPLETED|Overall Study||34
8942389|NCT02379637|10004080|FG000|NOT COMPLETED|Overall Study||2
8942390|NCT02379637|10004081|FG001|NOT COMPLETED|Overall Study||1
8942391|NCT02379728|10004089|FG000|STARTED|Overall Study||84
8942392|NCT02379728|10004090|FG001|STARTED|Overall Study||16
8942393|NCT02379728|10004091|FG002|STARTED|Overall Study||84
8942394|NCT02379728|10004092|FG003|STARTED|Overall Study||16
8942395|NCT02379728|10004089|FG000|COMPLETED|Overall Study||78
8942396|NCT02379728|10004090|FG001|COMPLETED|Overall Study||16
8942397|NCT02379728|10004091|FG002|COMPLETED|Overall Study||74
8942398|NCT02379728|10004092|FG003|COMPLETED|Overall Study||13
8942399|NCT02379728|10004089|FG000|NOT COMPLETED|Overall Study||6
8942400|NCT02379728|10004090|FG001|NOT COMPLETED|Overall Study||0
8942401|NCT02379728|10004091|FG002|NOT COMPLETED|Overall Study||10
8942402|NCT02379728|10004092|FG003|NOT COMPLETED|Overall Study||3
8942403|NCT02379858|10004103|FG000|STARTED|Overall Study||6
8719380|NCT01004107|9766880|FG000|NOT COMPLETED|Overall Study||1
8942404|NCT02379858|10004104|FG001|STARTED|Overall Study||4
8942405|NCT02379858|10004103|FG000|COMPLETED|Overall Study||6
8942406|NCT02379858|10004104|FG001|COMPLETED|Overall Study||4
8942407|NCT02379858|10004103|FG000|NOT COMPLETED|Overall Study||0
8942408|NCT02379858|10004104|FG001|NOT COMPLETED|Overall Study||0
8942409|NCT02379923|10004110|FG000|STARTED|Overall Study||163
8942410|NCT02379923|10004110|FG000|COMPLETED|Overall Study||158
8942411|NCT02379923|10004110|FG000|NOT COMPLETED|Overall Study||5
8942412|NCT02380183|10004119|FG000|STARTED|Overall Study||36
8617673|NCT00458341|9655852|FG000|Received at Least 1 Dose of Study Drug|Cycle 1||15
8617674|NCT00458341|9655853|FG001|Received at Least 1 Dose of Study Drug|Cycle 1||15
8617675|NCT00458341|9655852|FG000|COMPLETED|Cycle 1|1 participant did not complete Cycle 1 since all procedures were not performed due to adverse event.|14
8617676|NCT00458341|9655853|FG001|COMPLETED|Cycle 1||15
8617677|NCT00458341|9655852|FG000|NOT COMPLETED|Cycle 1||1
8942413|NCT02380183|10004120|FG001|STARTED|Overall Study||34
8942414|NCT02380183|10004119|FG000|COMPLETED|Overall Study||36
8942415|NCT02380183|10004120|FG001|COMPLETED|Overall Study||34
8942416|NCT02380183|10004119|FG000|NOT COMPLETED|Overall Study||0
8942417|NCT02380183|10004120|FG001|NOT COMPLETED|Overall Study||0
8942418|NCT02380248|10004126|FG000|STARTED|Overall Study||200
8942419|NCT02380248|10004126|FG000|COMPLETED|Overall Study||186
8942420|NCT02380248|10004126|FG000|NOT COMPLETED|Overall Study||14
8942421|NCT02380261|10004131|FG000|STARTED|Overall Study||35
8942422|NCT02380261|10004131|FG000|COMPLETED|Overall Study||35
8942423|NCT02380261|10004131|FG000|NOT COMPLETED|Overall Study||0
8942424|NCT02380287|10004143|FG000|STARTED|Overall Study||1
8942425|NCT02380287|10004144|FG001|STARTED|Overall Study||3
8942426|NCT02380287|10004145|FG002|STARTED|Overall Study||3
8942427|NCT02380287|10004146|FG003|STARTED|Overall Study||3
8942428|NCT02380287|10004147|FG004|STARTED|Overall Study||3
8942429|NCT02380287|10004148|FG005|STARTED|Overall Study||3
8942430|NCT02380287|10004149|FG006|STARTED|Overall Study||3
8942431|NCT02380287|10004150|FG007|STARTED|Overall Study||3
8942432|NCT02380287|10004143|FG000|COMPLETED|Overall Study||1
8942433|NCT02380287|10004144|FG001|COMPLETED|Overall Study||3
8942434|NCT02380287|10004145|FG002|COMPLETED|Overall Study||2
8942435|NCT02380287|10004146|FG003|COMPLETED|Overall Study||3
8942436|NCT02380287|10004147|FG004|COMPLETED|Overall Study||3
8942437|NCT02380287|10004148|FG005|COMPLETED|Overall Study||3
8942438|NCT02380287|10004149|FG006|COMPLETED|Overall Study||3
8942439|NCT02380287|10004150|FG007|COMPLETED|Overall Study||3
8942440|NCT02380287|10004143|FG000|NOT COMPLETED|Overall Study||0
8942441|NCT02380287|10004144|FG001|NOT COMPLETED|Overall Study||0
8942442|NCT02380287|10004145|FG002|NOT COMPLETED|Overall Study||1
8942443|NCT02380287|10004146|FG003|NOT COMPLETED|Overall Study||0
8942444|NCT02380287|10004147|FG004|NOT COMPLETED|Overall Study||0
8942445|NCT02380287|10004148|FG005|NOT COMPLETED|Overall Study||0
8942446|NCT02380287|10004149|FG006|NOT COMPLETED|Overall Study||0
8942447|NCT02380287|10004150|FG007|NOT COMPLETED|Overall Study||0
8942448|NCT02380612|10004175|FG000|STARTED|Overall Study||30
8942449|NCT02380612|10004175|FG000|COMPLETED|Overall Study||27
8942450|NCT02380612|10004175|FG000|NOT COMPLETED|Overall Study||3
8942451|NCT02380677|10004194|FG000|STARTED|Overall Study||1
8942452|NCT02380677|10004195|FG001|STARTED|Overall Study||1
8942453|NCT02380677|10004196|FG002|STARTED|Overall Study||3
8942454|NCT02380677|10004197|FG003|STARTED|Overall Study||3
8942455|NCT02380677|10004198|FG004|STARTED|Overall Study||6
8942456|NCT02380677|10004199|FG005|STARTED|Overall Study||6
8942457|NCT02380677|10004200|FG006|STARTED|Overall Study||3
8942458|NCT02380677|10004201|FG007|STARTED|Overall Study||4
8942459|NCT02380677|10004202|FG008|STARTED|Overall Study||4
8942460|NCT02380677|10004203|FG009|STARTED|Overall Study||2
8942461|NCT02380677|10004204|FG010|STARTED|Overall Study||4
8942462|NCT02380677|10004205|FG011|STARTED|Overall Study||5
8942463|NCT02380677|10004194|FG000|COMPLETED|Overall Study||0
8942464|NCT02380677|10004195|FG001|COMPLETED|Overall Study||0
8942465|NCT02380677|10004196|FG002|COMPLETED|Overall Study||0
8942466|NCT02380677|10004197|FG003|COMPLETED|Overall Study||0
8942467|NCT02380677|10004198|FG004|COMPLETED|Overall Study||0
8942468|NCT02380677|10004199|FG005|COMPLETED|Overall Study||0
8942469|NCT02380677|10004200|FG006|COMPLETED|Overall Study||0
8942470|NCT02380677|10004201|FG007|COMPLETED|Overall Study||0
8942471|NCT02380677|10004202|FG008|COMPLETED|Overall Study||0
8942472|NCT02380677|10004203|FG009|COMPLETED|Overall Study||0
8942473|NCT02380677|10004204|FG010|COMPLETED|Overall Study||0
8942474|NCT02380677|10004205|FG011|COMPLETED|Overall Study||0
8617678|NCT00458341|9655853|FG001|NOT COMPLETED|Cycle 1||0
8617679|NCT00458341|9655852|FG000|STARTED|Cycle 2|The participant who did not complete Cycle 1 was eligible for Cycle 2 and completed Cycle 2.|15
8617680|NCT00458341|9655853|FG001|STARTED|Cycle 2||15
8942475|NCT02380677|10004194|FG000|NOT COMPLETED|Overall Study||1
8942476|NCT02380677|10004195|FG001|NOT COMPLETED|Overall Study||1
8942477|NCT02380677|10004196|FG002|NOT COMPLETED|Overall Study||3
8942478|NCT02380677|10004197|FG003|NOT COMPLETED|Overall Study||3
8942479|NCT02380677|10004198|FG004|NOT COMPLETED|Overall Study||6
8942480|NCT02380677|10004199|FG005|NOT COMPLETED|Overall Study||6
8942481|NCT02380677|10004200|FG006|NOT COMPLETED|Overall Study||3
8942482|NCT02380677|10004201|FG007|NOT COMPLETED|Overall Study||4
8942483|NCT02380677|10004202|FG008|NOT COMPLETED|Overall Study||4
8942484|NCT02380677|10004203|FG009|NOT COMPLETED|Overall Study||2
8942485|NCT02380677|10004204|FG010|NOT COMPLETED|Overall Study||4
8942486|NCT02380677|10004205|FG011|NOT COMPLETED|Overall Study||5
8617681|NCT00458341|9655852|FG000|Received at Least 1 Dose of Study Drug|Cycle 2||15
8617682|NCT00458341|9655853|FG001|Received at Least 1 Dose of Study Drug|Cycle 2||15
8942487|NCT02380690|10004235|FG000|STARTED|Overall Study||119
8942488|NCT02380690|10004236|FG001|STARTED|Overall Study||94
8942489|NCT02380690|10004235|FG000|COMPLETED|Overall Study||85
8942490|NCT02380690|10004236|FG001|COMPLETED|Overall Study||82
8942491|NCT02380690|10004235|FG000|NOT COMPLETED|Overall Study||34
8942492|NCT02380690|10004236|FG001|NOT COMPLETED|Overall Study||12
8942493|NCT02380703|10004244|FG000|STARTED|Overall Study||114
8942494|NCT02380703|10004245|FG001|STARTED|Overall Study||114
8942495|NCT02380703|10004244|FG000|Month 3|Overall Study||104
8942496|NCT02380703|10004245|FG001|Month 3|Overall Study||109
8942497|NCT02380703|10004244|FG000|Month 6|Overall Study||102
8942498|NCT02380703|10004245|FG001|Month 6|Overall Study||107
8942499|NCT02380703|10004244|FG000|Month 12|Overall Study||99
8942500|NCT02380703|10004245|FG001|Month 12|Overall Study||100
8942501|NCT02380703|10004244|FG000|COMPLETED|Overall Study||78
8942502|NCT02380703|10004245|FG001|COMPLETED|Overall Study||78
8942503|NCT02380703|10004244|FG000|NOT COMPLETED|Overall Study||36
8942504|NCT02380703|10004245|FG001|NOT COMPLETED|Overall Study||36
8942505|NCT02380742|10004253|FG000|STARTED|Overall Study||28
8942506|NCT02380742|10004254|FG001|STARTED|Overall Study||26
8942507|NCT02380742|10004253|FG000|COMPLETED|Overall Study||27
8942508|NCT02380742|10004254|FG001|COMPLETED|Overall Study||26
8942509|NCT02380742|10004253|FG000|NOT COMPLETED|Overall Study||1
8942510|NCT02380742|10004254|FG001|NOT COMPLETED|Overall Study||0
8942511|NCT02380859|10004262|FG000|STARTED|Overall Study||19
8942512|NCT02380859|10004263|FG001|STARTED|Overall Study||13
8942513|NCT02380859|10004262|FG000|COMPLETED|Overall Study||17
8942514|NCT02380859|10004263|FG001|COMPLETED|Overall Study||13
8942515|NCT02380859|10004262|FG000|NOT COMPLETED|Overall Study||2
8942516|NCT02380859|10004263|FG001|NOT COMPLETED|Overall Study||0
8942517|NCT02381015|10004273|FG000|STARTED|Visit 1 - Enrollment||175
8942518|NCT02381015|10004274|FG001|STARTED|Visit 1 - Enrollment||175
8942519|NCT02381015|10004275|FG002|STARTED|Visit 1 - Enrollment||175
8942520|NCT02381015|10004276|FG003|STARTED|Visit 1 - Enrollment||175
8942521|NCT02381015|10004273|FG000|COMPLETED|Visit 1 - Enrollment||175
8942522|NCT02381015|10004274|FG001|COMPLETED|Visit 1 - Enrollment||173
8942523|NCT02381015|10004275|FG002|COMPLETED|Visit 1 - Enrollment||175
8942524|NCT02381015|10004276|FG003|COMPLETED|Visit 1 - Enrollment||172
8942525|NCT02381015|10004273|FG000|NOT COMPLETED|Visit 1 - Enrollment||0
8942526|NCT02381015|10004274|FG001|NOT COMPLETED|Visit 1 - Enrollment||2
8942527|NCT02381015|10004275|FG002|NOT COMPLETED|Visit 1 - Enrollment||0
8942528|NCT02381015|10004276|FG003|NOT COMPLETED|Visit 1 - Enrollment||3
8942529|NCT02381015|10004273|FG000|STARTED|Visit 2 - Results DIsclosure||175
8942530|NCT02381015|10004274|FG001|STARTED|Visit 2 - Results DIsclosure||173
8942531|NCT02381015|10004275|FG002|STARTED|Visit 2 - Results DIsclosure||175
8942532|NCT02381015|10004276|FG003|STARTED|Visit 2 - Results DIsclosure||172
8942533|NCT02381015|10004273|FG000|COMPLETED|Visit 2 - Results DIsclosure||172
8942534|NCT02381015|10004274|FG001|COMPLETED|Visit 2 - Results DIsclosure||168
8942535|NCT02381015|10004275|FG002|COMPLETED|Visit 2 - Results DIsclosure||173
8942536|NCT02381015|10004276|FG003|COMPLETED|Visit 2 - Results DIsclosure||169
8942537|NCT02381015|10004273|FG000|NOT COMPLETED|Visit 2 - Results DIsclosure||3
8942538|NCT02381015|10004274|FG001|NOT COMPLETED|Visit 2 - Results DIsclosure||5
8942539|NCT02381015|10004275|FG002|NOT COMPLETED|Visit 2 - Results DIsclosure||2
8942540|NCT02381015|10004276|FG003|NOT COMPLETED|Visit 2 - Results DIsclosure||3
8942541|NCT02381015|10004273|FG000|STARTED|Visit 3 - 3 Months Followup||172
8942542|NCT02381015|10004274|FG001|STARTED|Visit 3 - 3 Months Followup||168
8942543|NCT02381015|10004275|FG002|STARTED|Visit 3 - 3 Months Followup||173
8942544|NCT02381015|10004276|FG003|STARTED|Visit 3 - 3 Months Followup||169
8942545|NCT02381015|10004273|FG000|COMPLETED|Visit 3 - 3 Months Followup||172
8942546|NCT02381015|10004274|FG001|COMPLETED|Visit 3 - 3 Months Followup||168
8942547|NCT02381015|10004275|FG002|COMPLETED|Visit 3 - 3 Months Followup||173
8942548|NCT02381015|10004276|FG003|COMPLETED|Visit 3 - 3 Months Followup||169
8942549|NCT02381015|10004273|FG000|NOT COMPLETED|Visit 3 - 3 Months Followup||0
8942550|NCT02381015|10004274|FG001|NOT COMPLETED|Visit 3 - 3 Months Followup||0
8942551|NCT02381015|10004275|FG002|NOT COMPLETED|Visit 3 - 3 Months Followup||0
8942552|NCT02381015|10004276|FG003|NOT COMPLETED|Visit 3 - 3 Months Followup||0
8942553|NCT02381015|10004273|FG000|STARTED|Year 3 Chart Review||172
8942554|NCT02381015|10004274|FG001|STARTED|Year 3 Chart Review||168
8942555|NCT02381015|10004275|FG002|STARTED|Year 3 Chart Review||173
8942556|NCT02381015|10004276|FG003|STARTED|Year 3 Chart Review||169
8942557|NCT02381015|10004273|FG000|COMPLETED|Year 3 Chart Review||125
8942558|NCT02381015|10004274|FG001|COMPLETED|Year 3 Chart Review||134
8942559|NCT02381015|10004275|FG002|COMPLETED|Year 3 Chart Review||115
8942560|NCT02381015|10004276|FG003|COMPLETED|Year 3 Chart Review||118
8942561|NCT02381015|10004273|FG000|NOT COMPLETED|Year 3 Chart Review||47
8942562|NCT02381015|10004274|FG001|NOT COMPLETED|Year 3 Chart Review||34
8942563|NCT02381015|10004275|FG002|NOT COMPLETED|Year 3 Chart Review||58
8942564|NCT02381015|10004276|FG003|NOT COMPLETED|Year 3 Chart Review||51
8942565|NCT02381288|10004295|FG000|STARTED|Overall Study||5
8942566|NCT02381288|10004296|FG001|STARTED|Overall Study||2
8942567|NCT02381288|10004297|FG002|STARTED|Overall Study||5
8942568|NCT02381288|10004298|FG003|STARTED|Overall Study||5
8942569|NCT02381288|10004295|FG000|COMPLETED|Overall Study||5
8942570|NCT02381288|10004296|FG001|COMPLETED|Overall Study||2
8942571|NCT02381288|10004297|FG002|COMPLETED|Overall Study||5
8942572|NCT02381288|10004298|FG003|COMPLETED|Overall Study||5
8942573|NCT02381288|10004295|FG000|NOT COMPLETED|Overall Study||0
8942574|NCT02381288|10004296|FG001|NOT COMPLETED|Overall Study||0
8942575|NCT02381288|10004297|FG002|NOT COMPLETED|Overall Study||0
8942576|NCT02381288|10004298|FG003|NOT COMPLETED|Overall Study||0
8942577|NCT02381392|10004313|FG000|STARTED|Overall Study||11
8942578|NCT02381392|10004314|FG001|STARTED|Overall Study||12
8942579|NCT02381392|10004313|FG000|COMPLETED|Overall Study||11
8942580|NCT02381392|10004314|FG001|COMPLETED|Overall Study||12
8942581|NCT02381392|10004313|FG000|NOT COMPLETED|Overall Study||0
8942582|NCT02381392|10004314|FG001|NOT COMPLETED|Overall Study||0
8942583|NCT02381418|10004320|FG000|STARTED|Overall Study||120
8942584|NCT02381418|10004320|FG000|COMPLETED|Overall Study||120
8942585|NCT02381418|10004320|FG000|NOT COMPLETED|Overall Study||0
8942586|NCT02381678|10004325|FG000|STARTED|Overall Study||54
8942587|NCT02381678|10004326|FG001|STARTED|Overall Study||139
8942588|NCT02381678|10004327|FG002|STARTED|Overall Study||32
8942589|NCT02381678|10004325|FG000|COMPLETED|Overall Study||54
8942590|NCT02381678|10004326|FG001|COMPLETED|Overall Study||139
8942591|NCT02381678|10004327|FG002|COMPLETED|Overall Study||32
8942592|NCT02381678|10004325|FG000|NOT COMPLETED|Overall Study||0
8942593|NCT02381678|10004326|FG001|NOT COMPLETED|Overall Study||0
8942594|NCT02381678|10004327|FG002|NOT COMPLETED|Overall Study||0
8942595|NCT02381795|10004333|FG000|STARTED|Overall Study||10
8942596|NCT02381795|10004333|FG000|COMPLETED|Overall Study||7
8942597|NCT02381795|10004333|FG000|NOT COMPLETED|Overall Study||3
8942598|NCT02382016|10004339|FG000|STARTED|Double-blind (DB) Treatment Period||43
8942599|NCT02382016|10004340|FG001|STARTED|Double-blind (DB) Treatment Period||42
8942600|NCT02382016|10004339|FG000|COMPLETED|Double-blind (DB) Treatment Period||39
8942601|NCT02382016|10004340|FG001|COMPLETED|Double-blind (DB) Treatment Period||41
8942602|NCT02382016|10004339|FG000|NOT COMPLETED|Double-blind (DB) Treatment Period||4
8942603|NCT02382016|10004340|FG001|NOT COMPLETED|Double-blind (DB) Treatment Period||1
8942604|NCT02382016|10004339|FG000|STARTED|Open-label (OL) Treatment Period||80
8942605|NCT02382016|10004340|FG001|STARTED|Open-label (OL) Treatment Period||0
8942606|NCT02382016|10004339|FG000|COMPLETED|Open-label (OL) Treatment Period||71
8942607|NCT02382016|10004340|FG001|COMPLETED|Open-label (OL) Treatment Period||0
8942608|NCT02382016|10004339|FG000|NOT COMPLETED|Open-label (OL) Treatment Period||9
8942609|NCT02382016|10004340|FG001|NOT COMPLETED|Open-label (OL) Treatment Period||0
8942610|NCT02382016|10004339|FG000|STARTED|OL Extension Period|Participants(French site) who completed DB,OL periods, consented receiving macitentan in OLE period.|33
8942611|NCT02382016|10004340|FG001|STARTED|OL Extension Period||0
8942612|NCT02382016|10004339|FG000|COMPLETED|OL Extension Period||27
8942613|NCT02382016|10004340|FG001|COMPLETED|OL Extension Period||0
8942614|NCT02382016|10004339|FG000|NOT COMPLETED|OL Extension Period||6
8942615|NCT02382016|10004340|FG001|NOT COMPLETED|OL Extension Period||0
8942616|NCT02382133|10004348|FG000|STARTED|Overall Study||43
8942617|NCT02382133|10004348|FG000|COMPLETED|Overall Study||10
8942618|NCT02382133|10004348|FG000|NOT COMPLETED|Overall Study||33
8942619|NCT02382276|10004355|FG000|STARTED|Overall Study||137
8942620|NCT02382276|10004356|FG001|STARTED|Overall Study||94
8942621|NCT02382276|10004357|FG002|STARTED|Overall Study||172
8942622|NCT02382276|10004355|FG000|COMPLETED|Overall Study||126
8942623|NCT02382276|10004356|FG001|COMPLETED|Overall Study||84
8942624|NCT02382276|10004357|FG002|COMPLETED|Overall Study||133
8942625|NCT02382276|10004355|FG000|NOT COMPLETED|Overall Study||11
8942626|NCT02382276|10004356|FG001|NOT COMPLETED|Overall Study||10
8942627|NCT02382276|10004357|FG002|NOT COMPLETED|Overall Study||39
8942628|NCT02382640|10004367|FG000|STARTED|Intervention Period 1 (3 Days)||9
8942629|NCT02382640|10004368|FG001|STARTED|Intervention Period 1 (3 Days)||9
8942630|NCT02382640|10004369|FG002|STARTED|Intervention Period 1 (3 Days)||9
8942631|NCT02382640|10004370|FG003|STARTED|Intervention Period 1 (3 Days)||9
8942632|NCT02382640|10004367|FG000|COMPLETED|Intervention Period 1 (3 Days)||9
8942633|NCT02382640|10004368|FG001|COMPLETED|Intervention Period 1 (3 Days)||9
8942634|NCT02382640|10004369|FG002|COMPLETED|Intervention Period 1 (3 Days)||9
8942635|NCT02382640|10004370|FG003|COMPLETED|Intervention Period 1 (3 Days)||9
8942636|NCT02382640|10004367|FG000|NOT COMPLETED|Intervention Period 1 (3 Days)||0
8942637|NCT02382640|10004368|FG001|NOT COMPLETED|Intervention Period 1 (3 Days)||0
8942638|NCT02382640|10004369|FG002|NOT COMPLETED|Intervention Period 1 (3 Days)||0
8942639|NCT02382640|10004370|FG003|NOT COMPLETED|Intervention Period 1 (3 Days)||0
8942640|NCT02382640|10004367|FG000|STARTED|Washout Period 1 (7 Days)||9
8942641|NCT02382640|10004368|FG001|STARTED|Washout Period 1 (7 Days)||9
8942642|NCT02382640|10004369|FG002|STARTED|Washout Period 1 (7 Days)||9
8942643|NCT02382640|10004370|FG003|STARTED|Washout Period 1 (7 Days)||9
8942644|NCT02382640|10004367|FG000|COMPLETED|Washout Period 1 (7 Days)||9
8942645|NCT02382640|10004368|FG001|COMPLETED|Washout Period 1 (7 Days)||9
8942646|NCT02382640|10004369|FG002|COMPLETED|Washout Period 1 (7 Days)||9
8942647|NCT02382640|10004370|FG003|COMPLETED|Washout Period 1 (7 Days)||9
8942648|NCT02382640|10004367|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
8942649|NCT02382640|10004368|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
8942650|NCT02382640|10004369|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
8942651|NCT02382640|10004370|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
8942652|NCT02382640|10004367|FG000|STARTED|Intervention Period 2 (3 Days)||9
8942653|NCT02382640|10004368|FG001|STARTED|Intervention Period 2 (3 Days)||9
8942654|NCT02382640|10004369|FG002|STARTED|Intervention Period 2 (3 Days)||9
8942655|NCT02382640|10004370|FG003|STARTED|Intervention Period 2 (3 Days)||9
8942656|NCT02382640|10004367|FG000|COMPLETED|Intervention Period 2 (3 Days)||9
8942657|NCT02382640|10004368|FG001|COMPLETED|Intervention Period 2 (3 Days)||9
8942658|NCT02382640|10004369|FG002|COMPLETED|Intervention Period 2 (3 Days)||9
8942659|NCT02382640|10004370|FG003|COMPLETED|Intervention Period 2 (3 Days)||9
8942660|NCT02382640|10004367|FG000|NOT COMPLETED|Intervention Period 2 (3 Days)||0
8942661|NCT02382640|10004368|FG001|NOT COMPLETED|Intervention Period 2 (3 Days)||0
8942662|NCT02382640|10004369|FG002|NOT COMPLETED|Intervention Period 2 (3 Days)||0
8942663|NCT02382640|10004370|FG003|NOT COMPLETED|Intervention Period 2 (3 Days)||0
8942664|NCT02382640|10004367|FG000|STARTED|Washout Period 2 (7 Days)||9
8942665|NCT02382640|10004368|FG001|STARTED|Washout Period 2 (7 Days)||9
8942666|NCT02382640|10004369|FG002|STARTED|Washout Period 2 (7 Days)||9
8942667|NCT02382640|10004370|FG003|STARTED|Washout Period 2 (7 Days)||9
8942668|NCT02382640|10004367|FG000|COMPLETED|Washout Period 2 (7 Days)||9
8942669|NCT02382640|10004368|FG001|COMPLETED|Washout Period 2 (7 Days)||9
8942670|NCT02382640|10004369|FG002|COMPLETED|Washout Period 2 (7 Days)||9
8942671|NCT02382640|10004370|FG003|COMPLETED|Washout Period 2 (7 Days)||9
8942672|NCT02382640|10004367|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
8942673|NCT02382640|10004368|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
8942674|NCT02382640|10004369|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
8942675|NCT02382640|10004370|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
8942676|NCT02382640|10004367|FG000|STARTED|Intervention Period 3 (3 Days)||9
8942677|NCT02382640|10004368|FG001|STARTED|Intervention Period 3 (3 Days)||9
8942678|NCT02382640|10004369|FG002|STARTED|Intervention Period 3 (3 Days)||9
8942679|NCT02382640|10004370|FG003|STARTED|Intervention Period 3 (3 Days)||9
8942680|NCT02382640|10004367|FG000|COMPLETED|Intervention Period 3 (3 Days)||9
8942681|NCT02382640|10004368|FG001|COMPLETED|Intervention Period 3 (3 Days)||9
8942682|NCT02382640|10004369|FG002|COMPLETED|Intervention Period 3 (3 Days)||9
8942683|NCT02382640|10004370|FG003|COMPLETED|Intervention Period 3 (3 Days)||9
8942684|NCT02382640|10004367|FG000|NOT COMPLETED|Intervention Period 3 (3 Days)||0
8942685|NCT02382640|10004368|FG001|NOT COMPLETED|Intervention Period 3 (3 Days)||0
8942686|NCT02382640|10004369|FG002|NOT COMPLETED|Intervention Period 3 (3 Days)||0
8942687|NCT02382640|10004370|FG003|NOT COMPLETED|Intervention Period 3 (3 Days)||0
8942688|NCT02382640|10004367|FG000|STARTED|Washout Period 3 (7 Days)||9
8942689|NCT02382640|10004368|FG001|STARTED|Washout Period 3 (7 Days)||9
8942690|NCT02382640|10004369|FG002|STARTED|Washout Period 3 (7 Days)||9
8942691|NCT02382640|10004370|FG003|STARTED|Washout Period 3 (7 Days)||9
8942692|NCT02382640|10004367|FG000|COMPLETED|Washout Period 3 (7 Days)||9
8942693|NCT02382640|10004368|FG001|COMPLETED|Washout Period 3 (7 Days)||9
8942694|NCT02382640|10004369|FG002|COMPLETED|Washout Period 3 (7 Days)||9
8942695|NCT02382640|10004370|FG003|COMPLETED|Washout Period 3 (7 Days)||9
8942696|NCT02382640|10004367|FG000|NOT COMPLETED|Washout Period 3 (7 Days)||0
8942697|NCT02382640|10004368|FG001|NOT COMPLETED|Washout Period 3 (7 Days)||0
8942698|NCT02382640|10004369|FG002|NOT COMPLETED|Washout Period 3 (7 Days)||0
8942699|NCT02382640|10004370|FG003|NOT COMPLETED|Washout Period 3 (7 Days)||0
8942700|NCT02382640|10004367|FG000|STARTED|Intervention Period 4 (3 Days)||9
8942701|NCT02382640|10004368|FG001|STARTED|Intervention Period 4 (3 Days)||9
8942702|NCT02382640|10004369|FG002|STARTED|Intervention Period 4 (3 Days)||9
8942703|NCT02382640|10004370|FG003|STARTED|Intervention Period 4 (3 Days)||9
8942704|NCT02382640|10004367|FG000|COMPLETED|Intervention Period 4 (3 Days)||8
8942705|NCT02382640|10004368|FG001|COMPLETED|Intervention Period 4 (3 Days)||9
8942706|NCT02382640|10004369|FG002|COMPLETED|Intervention Period 4 (3 Days)||9
8942707|NCT02382640|10004370|FG003|COMPLETED|Intervention Period 4 (3 Days)||9
8942708|NCT02382640|10004367|FG000|NOT COMPLETED|Intervention Period 4 (3 Days)||1
8942709|NCT02382640|10004368|FG001|NOT COMPLETED|Intervention Period 4 (3 Days)||0
8942710|NCT02382640|10004369|FG002|NOT COMPLETED|Intervention Period 4 (3 Days)||0
8942711|NCT02382640|10004370|FG003|NOT COMPLETED|Intervention Period 4 (3 Days)||0
8942712|NCT02382705|10004380|FG000|STARTED|Overall Study||57
8942713|NCT02382705|10004380|FG000|COMPLETED|Overall Study||33
8942714|NCT02382705|10004380|FG000|NOT COMPLETED|Overall Study||24
8942715|NCT02382744|10004386|FG000|STARTED|Overall Study||40
8942716|NCT02382744|10004387|FG001|STARTED|Overall Study||40
8942717|NCT02382744|10004386|FG000|Allocated|Overall Study||40
8942718|NCT02382744|10004387|FG001|Allocated|Overall Study||40
8942719|NCT02382744|10004386|FG000|Analyzed|Overall Study||40
8942720|NCT02382744|10004387|FG001|Analyzed|Overall Study||40
8942721|NCT02382744|10004386|FG000|COMPLETED|Overall Study||40
8942722|NCT02382744|10004387|FG001|COMPLETED|Overall Study||40
8942723|NCT02382744|10004386|FG000|NOT COMPLETED|Overall Study||0
8942724|NCT02382744|10004387|FG001|NOT COMPLETED|Overall Study||0
8948700|NCT02432235|10011172|FG002|STARTED|Overall Study||2
8948701|NCT02432235|10011173|FG003|STARTED|Overall Study||3
8948702|NCT02432235|10011174|FG004|STARTED|Overall Study||2
8948703|NCT02432235|10011175|FG005|STARTED|Overall Study||20
8948704|NCT02432235|10011176|FG006|STARTED|Overall Study||41
8948705|NCT02432235|10011177|FG007|STARTED|Overall Study||29
8948706|NCT02432235|10011178|FG008|STARTED|Overall Study||26
8948707|NCT02432235|10011179|FG009|STARTED|Overall Study||3
8948708|NCT02432235|10011180|FG010|STARTED|Overall Study||2
8948709|NCT02432235|10011181|FG011|STARTED|Overall Study||1
8948710|NCT02432235|10011170|FG000|COMPLETED|Overall Study||1
8948711|NCT02432235|10011171|FG001|COMPLETED|Overall Study||0
8948712|NCT02432235|10011172|FG002|COMPLETED|Overall Study||0
8948713|NCT02432235|10011173|FG003|COMPLETED|Overall Study||1
8948714|NCT02432235|10011174|FG004|COMPLETED|Overall Study||0
8948715|NCT02432235|10011175|FG005|COMPLETED|Overall Study||8
8942725|NCT02382796|10004397|FG000|STARTED|Overall Study||7
8942726|NCT02382796|10004397|FG000|COMPLETED|Overall Study||0
8942727|NCT02382796|10004397|FG000|NOT COMPLETED|Overall Study||7
8942728|NCT02382848|10004401|FG000|STARTED|First Intervention (3 Weeks)||3
8942729|NCT02382848|10004402|FG001|STARTED|First Intervention (3 Weeks)||5
8942730|NCT02382848|10004401|FG000|COMPLETED|First Intervention (3 Weeks)||3
8942731|NCT02382848|10004402|FG001|COMPLETED|First Intervention (3 Weeks)||5
8942732|NCT02382848|10004401|FG000|NOT COMPLETED|First Intervention (3 Weeks)||0
8942733|NCT02382848|10004402|FG001|NOT COMPLETED|First Intervention (3 Weeks)||0
8942734|NCT02382848|10004401|FG000|STARTED|Washout (1 Week)||3
8942735|NCT02382848|10004402|FG001|STARTED|Washout (1 Week)||5
8942736|NCT02382848|10004401|FG000|COMPLETED|Washout (1 Week)||3
8942737|NCT02382848|10004402|FG001|COMPLETED|Washout (1 Week)||5
8942738|NCT02382848|10004401|FG000|NOT COMPLETED|Washout (1 Week)||0
8942739|NCT02382848|10004402|FG001|NOT COMPLETED|Washout (1 Week)||0
8942740|NCT02382848|10004401|FG000|STARTED|Second Intervention (3 Weeks)||3
8942741|NCT02382848|10004402|FG001|STARTED|Second Intervention (3 Weeks)||5
8942742|NCT02382848|10004401|FG000|COMPLETED|Second Intervention (3 Weeks)||3
8942743|NCT02382848|10004402|FG001|COMPLETED|Second Intervention (3 Weeks)||5
8942744|NCT02382848|10004401|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0
8942745|NCT02382848|10004402|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
8942746|NCT02382913|10004418|FG000|STARTED|Overall Study||27
8942747|NCT02382913|10004419|FG001|STARTED|Overall Study||36
8942748|NCT02382913|10004420|FG002|STARTED|Overall Study||32
8942749|NCT02382913|10004421|FG003|STARTED|Overall Study||27
8942750|NCT02382913|10004422|FG004|STARTED|Overall Study||33
8942751|NCT02382913|10004423|FG005|STARTED|Overall Study||30
8942752|NCT02382913|10004424|FG006|STARTED|Overall Study||37
8942753|NCT02382913|10004425|FG007|STARTED|Overall Study||30
8942754|NCT02382913|10004426|FG008|STARTED|Overall Study||30
8942755|NCT02382913|10004427|FG009|STARTED|Overall Study||33
8942756|NCT02382913|10004418|FG000|COMPLETED|Overall Study||27
8942757|NCT02382913|10004419|FG001|COMPLETED|Overall Study||36
8942758|NCT02382913|10004420|FG002|COMPLETED|Overall Study||32
8942759|NCT02382913|10004421|FG003|COMPLETED|Overall Study||27
8942760|NCT02382913|10004422|FG004|COMPLETED|Overall Study||33
8942761|NCT02382913|10004423|FG005|COMPLETED|Overall Study||30
8942762|NCT02382913|10004424|FG006|COMPLETED|Overall Study||37
8942763|NCT02382913|10004425|FG007|COMPLETED|Overall Study||30
8942764|NCT02382913|10004426|FG008|COMPLETED|Overall Study||30
8942765|NCT02382913|10004427|FG009|COMPLETED|Overall Study||33
8942766|NCT02382913|10004418|FG000|NOT COMPLETED|Overall Study||0
8942767|NCT02382913|10004419|FG001|NOT COMPLETED|Overall Study||0
8942768|NCT02382913|10004420|FG002|NOT COMPLETED|Overall Study||0
8942769|NCT02382913|10004421|FG003|NOT COMPLETED|Overall Study||0
8942770|NCT02382913|10004422|FG004|NOT COMPLETED|Overall Study||0
8942771|NCT02382913|10004423|FG005|NOT COMPLETED|Overall Study||0
8942772|NCT02382913|10004424|FG006|NOT COMPLETED|Overall Study||0
8942773|NCT02382913|10004425|FG007|NOT COMPLETED|Overall Study||0
8942774|NCT02382913|10004426|FG008|NOT COMPLETED|Overall Study||0
8942775|NCT02382913|10004427|FG009|NOT COMPLETED|Overall Study||0
8942776|NCT02382939|10004451|FG000|STARTED|Overall Study||31
8942777|NCT02382939|10004452|FG001|STARTED|Overall Study||61
8942778|NCT02382939|10004451|FG000|Exposed|Overall Study||31
8942779|NCT02382939|10004452|FG001|Exposed|Overall Study||61
8942780|NCT02382939|10004451|FG000|COMPLETED|Overall Study||28
8942781|NCT02382939|10004452|FG001|COMPLETED|Overall Study||58
8942782|NCT02382939|10004451|FG000|NOT COMPLETED|Overall Study||3
8942783|NCT02382939|10004452|FG001|NOT COMPLETED|Overall Study||3
8942784|NCT02382991|10004461|FG000|STARTED|Overall Study||17
8942785|NCT02382991|10004462|FG001|STARTED|Overall Study||18
8942786|NCT02382991|10004461|FG000|COMPLETED|Overall Study||15
8942787|NCT02382991|10004462|FG001|COMPLETED|Overall Study||15
8942788|NCT02382991|10004461|FG000|NOT COMPLETED|Overall Study||2
8942789|NCT02382991|10004462|FG001|NOT COMPLETED|Overall Study||3
8942790|NCT02383017|10004469|FG000|STARTED|Overall Study||15
8942791|NCT02383017|10004470|FG001|STARTED|Overall Study||13
8942792|NCT02383017|10004469|FG000|COMPLETED|Overall Study||10
8942793|NCT02383017|10004470|FG001|COMPLETED|Overall Study||11
8942794|NCT02383017|10004469|FG000|NOT COMPLETED|Overall Study||5
8942795|NCT02383017|10004470|FG001|NOT COMPLETED|Overall Study||2
8942796|NCT02383043|10004479|FG000|STARTED|Overall Study||9
8942797|NCT02383043|10004480|FG001|STARTED|Overall Study||5
8942798|NCT02383043|10004481|FG002|STARTED|Overall Study||4
8942799|NCT02383043|10004479|FG000|COMPLETED|Overall Study||7
8942800|NCT02383043|10004480|FG001|COMPLETED|Overall Study||5
8942801|NCT02383043|10004481|FG002|COMPLETED|Overall Study||4
8942802|NCT02383043|10004479|FG000|NOT COMPLETED|Overall Study||2
8942803|NCT02383043|10004480|FG001|NOT COMPLETED|Overall Study||0
8942804|NCT02383043|10004481|FG002|NOT COMPLETED|Overall Study||0
8942805|NCT02383056|10004492|FG000|STARTED|Overall Study||7
8942806|NCT02383056|10004493|FG001|STARTED|Overall Study||7
8942807|NCT02383056|10004492|FG000|COMPLETED|Overall Study||6
8942808|NCT02383056|10004493|FG001|COMPLETED|Overall Study||5
8942809|NCT02383056|10004492|FG000|NOT COMPLETED|Overall Study||1
8942810|NCT02383056|10004493|FG001|NOT COMPLETED|Overall Study||2
8942811|NCT02383173|10004501|FG000|STARTED|Overall Study||88
8942812|NCT02383173|10004502|FG001|STARTED|Overall Study||46
8942813|NCT02383173|10004501|FG000|COMPLETED|Overall Study||88
8942814|NCT02383173|10004502|FG001|COMPLETED|Overall Study||44
8942815|NCT02383173|10004501|FG000|NOT COMPLETED|Overall Study||0
8942816|NCT02383173|10004502|FG001|NOT COMPLETED|Overall Study||2
8942817|NCT02383355|10004510|FG000|STARTED|Overall Study||19
8942818|NCT02383355|10004511|FG001|STARTED|Overall Study||21
8942819|NCT02383355|10004510|FG000|COMPLETED|Overall Study||17
8942820|NCT02383355|10004511|FG001|COMPLETED|Overall Study||21
8942821|NCT02383355|10004510|FG000|NOT COMPLETED|Overall Study||2
8942822|NCT02383355|10004511|FG001|NOT COMPLETED|Overall Study||0
8942823|NCT02383420|10004520|FG000|STARTED|Overall Study||10
8942824|NCT02383420|10004521|FG001|STARTED|Overall Study||10
8942825|NCT02383420|10004522|FG002|STARTED|Overall Study||3
8942826|NCT02383420|10004520|FG000|COMPLETED|Overall Study||8
8942827|NCT02383420|10004521|FG001|COMPLETED|Overall Study||10
8942828|NCT02383420|10004522|FG002|COMPLETED|Overall Study||3
8942829|NCT02383420|10004520|FG000|NOT COMPLETED|Overall Study||2
8942830|NCT02383420|10004521|FG001|NOT COMPLETED|Overall Study||0
8942831|NCT02383420|10004522|FG002|NOT COMPLETED|Overall Study||0
8942832|NCT02383472|10004532|FG000|STARTED|Overall Study||23
8942833|NCT02383472|10004533|FG001|STARTED|Overall Study||30
8942834|NCT02383472|10004532|FG000|COMPLETED|Overall Study||22
8942835|NCT02383472|10004533|FG001|COMPLETED|Overall Study||29
8942836|NCT02383472|10004532|FG000|NOT COMPLETED|Overall Study||1
8942837|NCT02383472|10004533|FG001|NOT COMPLETED|Overall Study||1
8942838|NCT02383576|10004543|FG000|STARTED|Overall Study||94
8942839|NCT02383576|10004544|FG001|STARTED|Overall Study||91
8942840|NCT02383576|10004543|FG000|COMPLETED|Overall Study||31
8942841|NCT02383576|10004544|FG001|COMPLETED|Overall Study||46
8942842|NCT02383576|10004543|FG000|NOT COMPLETED|Overall Study||63
8942843|NCT02383576|10004544|FG001|NOT COMPLETED|Overall Study||45
8942844|NCT02383589|10004552|FG000|STARTED|Treatment Period||67
8942845|NCT02383589|10004553|FG001|STARTED|Treatment Period||68
8942846|NCT02383589|10004552|FG000|COMPLETED|Treatment Period||66
8617683|NCT00458341|9655852|FG000|COMPLETED|Cycle 2||15
8617684|NCT00458341|9655853|FG001|COMPLETED|Cycle 2||15
8942847|NCT02383589|10004553|FG001|COMPLETED|Treatment Period||58
8942848|NCT02383589|10004552|FG000|NOT COMPLETED|Treatment Period||1
8942849|NCT02383589|10004553|FG001|NOT COMPLETED|Treatment Period||10
8617685|NCT00458341|9655852|FG000|NOT COMPLETED|Cycle 2||0
8942850|NCT02383589|10004552|FG000|STARTED|Safety Follow-up (SFU)||66
8942851|NCT02383589|10004553|FG001|STARTED|Safety Follow-up (SFU)||58
8942852|NCT02383589|10004552|FG000|COMPLETED|Safety Follow-up (SFU)||59
8942853|NCT02383589|10004553|FG001|COMPLETED|Safety Follow-up (SFU)||53
8942854|NCT02383589|10004552|FG000|NOT COMPLETED|Safety Follow-up (SFU)||7
8942855|NCT02383589|10004553|FG001|NOT COMPLETED|Safety Follow-up (SFU)||5
8942856|NCT02383667|10004561|FG000|STARTED|Overall Study||20
8942857|NCT02383667|10004561|FG000|COMPLETED|Overall Study||20
8942858|NCT02383667|10004561|FG000|NOT COMPLETED|Overall Study||0
8942859|NCT02383706|10004565|FG000|STARTED|Overall Study||108
8942860|NCT02383706|10004565|FG000|COMPLETED|Overall Study||80
8942861|NCT02383706|10004565|FG000|NOT COMPLETED|Overall Study||28
8942862|NCT02383719|10004570|FG000|STARTED|Overall Study||18
8942863|NCT02383719|10004570|FG000|COMPLETED|Overall Study||18
8942864|NCT02383719|10004570|FG000|NOT COMPLETED|Overall Study||0
8942865|NCT02383758|10004576|FG000|STARTED|Overall Study||10
8942866|NCT02383758|10004577|FG001|STARTED|Overall Study||10
8942867|NCT02383758|10004576|FG000|COMPLETED|Overall Study||10
8942868|NCT02383758|10004577|FG001|COMPLETED|Overall Study||8
8719381|NCT01004107|9766881|FG001|NOT COMPLETED|Overall Study||2
8942869|NCT02383758|10004576|FG000|NOT COMPLETED|Overall Study||0
8942870|NCT02383758|10004577|FG001|NOT COMPLETED|Overall Study||2
8942871|NCT02383862|10004585|FG000|STARTED|Baseline||151
8942872|NCT02383862|10004586|FG001|STARTED|Baseline||149
8942873|NCT02383862|10004585|FG000|COMPLETED|Baseline||151
8942874|NCT02383862|10004586|FG001|COMPLETED|Baseline||149
8942875|NCT02383862|10004585|FG000|NOT COMPLETED|Baseline||0
8942876|NCT02383862|10004586|FG001|NOT COMPLETED|Baseline||0
8942877|NCT02383862|10004585|FG000|STARTED|3 Month Follow up||151
8942878|NCT02383862|10004586|FG001|STARTED|3 Month Follow up||149
8942879|NCT02383862|10004585|FG000|COMPLETED|3 Month Follow up||128
8942880|NCT02383862|10004586|FG001|COMPLETED|3 Month Follow up||128
8942881|NCT02383862|10004585|FG000|NOT COMPLETED|3 Month Follow up||23
8942882|NCT02383862|10004586|FG001|NOT COMPLETED|3 Month Follow up||21
8942883|NCT02383940|10004601|FG000|STARTED|Overall Study||44
8617686|NCT00458341|9655853|FG001|NOT COMPLETED|Cycle 2||0
8942884|NCT02383940|10004602|FG001|STARTED|Overall Study||43
8942885|NCT02383940|10004601|FG000|Treated|Overall Study||42
8942886|NCT02383940|10004602|FG001|Treated|Overall Study||43
8942887|NCT02383940|10004601|FG000|COMPLETED|Overall Study||35
8942888|NCT02383940|10004602|FG001|COMPLETED|Overall Study||40
8942889|NCT02383940|10004601|FG000|NOT COMPLETED|Overall Study||9
8942890|NCT02383940|10004602|FG001|NOT COMPLETED|Overall Study||3
8942891|NCT02384044|10004610|FG000|STARTED|Overall Study||15
8942892|NCT02384044|10004611|FG001|STARTED|Overall Study||15
8617687|NCT00458393|9655861|FG000|STARTED|Overall Study||1251
8617688|NCT00458393|9655862|FG001|STARTED|Overall Study||1248
8617689|NCT00458393|9655861|FG000|COMPLETED|Overall Study||942
8617690|NCT00458393|9655862|FG001|COMPLETED|Overall Study||953
8617691|NCT00458393|9655861|FG000|NOT COMPLETED|Overall Study||309
8617692|NCT00458393|9655862|FG001|NOT COMPLETED|Overall Study||295
8942893|NCT02384044|10004610|FG000|COMPLETED|Overall Study||15
8942894|NCT02384044|10004611|FG001|COMPLETED|Overall Study||15
8942895|NCT02384044|10004610|FG000|NOT COMPLETED|Overall Study||0
8617693|NCT00458406|9655872|FG000|STARTED|Month 1||43
8719382|NCT01004146|9766908|FG000|STARTED|Overall Study||25
8942896|NCT02384044|10004611|FG001|NOT COMPLETED|Overall Study||0
8942897|NCT02384070|10004620|FG000|STARTED|Overall Study||100
8942898|NCT02384070|10004621|FG001|STARTED|Overall Study||100
8942899|NCT02384070|10004622|FG002|STARTED|Overall Study||100
8942900|NCT02384070|10004620|FG000|COMPLETED|Overall Study||100
8942901|NCT02384070|10004621|FG001|COMPLETED|Overall Study||100
8942902|NCT02384070|10004622|FG002|COMPLETED|Overall Study||100
8942903|NCT02384070|10004620|FG000|NOT COMPLETED|Overall Study||0
8942904|NCT02384070|10004621|FG001|NOT COMPLETED|Overall Study||0
8942905|NCT02384070|10004622|FG002|NOT COMPLETED|Overall Study||0
8942906|NCT02384096|10004632|FG000|STARTED|First Intervention (7 Days)||5
8942907|NCT02384096|10004633|FG001|STARTED|First Intervention (7 Days)||7
8942908|NCT02384096|10004632|FG000|COMPLETED|First Intervention (7 Days)||4
8942909|NCT02384096|10004633|FG001|COMPLETED|First Intervention (7 Days)||7
8942910|NCT02384096|10004632|FG000|NOT COMPLETED|First Intervention (7 Days)||1
8942911|NCT02384096|10004633|FG001|NOT COMPLETED|First Intervention (7 Days)||0
9065614|NCT04150250|10126045|FG000|STARTED|Overall Study||23
9065615|NCT04150250|10126046|FG001|STARTED|Overall Study||24
9065616|NCT04150250|10126045|FG000|COMPLETED|Overall Study||23
9065617|NCT04150250|10126046|FG001|COMPLETED|Overall Study||22
9065618|NCT04150250|10126045|FG000|NOT COMPLETED|Overall Study||0
9065619|NCT04150250|10126046|FG001|NOT COMPLETED|Overall Study||2
9065620|NCT04149925|10126054|FG000|STARTED|Overall Study||30
9065621|NCT04149925|10126055|FG001|STARTED|Overall Study||30
9065622|NCT04149925|10126054|FG000|COMPLETED|Overall Study||30
9065623|NCT04149925|10126055|FG001|COMPLETED|Overall Study||30
9065624|NCT04149925|10126054|FG000|NOT COMPLETED|Overall Study||0
9065625|NCT04149925|10126055|FG001|NOT COMPLETED|Overall Study||0
9065626|NCT04150224|10126067|FG000|STARTED|Overall Study|10 healthy volunteers receiving PBTZ169 + 1 backup volunteer|10
9065627|NCT04150224|10126068|FG001|STARTED|Overall Study|10 healthy volunteers receiving PBTZ169 + 1 backup volunteer|10
9065628|NCT04150224|10126069|FG002|STARTED|Overall Study|10 healthy volunteers receiving PBTZ169 + 1 backup volunteer|10
9065629|NCT04150224|10126070|FG003|STARTED|Overall Study|10 healthy volunteers receiving PBTZ169 + 1 backup volunteer|10
9065630|NCT04150224|10126071|FG004|STARTED|Overall Study|10 healthy volunteers receiving PBTZ169 + 1 backup volunteer|10
9065631|NCT04150224|10126072|FG005|STARTED|Overall Study|Period 2: Multple Dosing|10
9065632|NCT04150224|10126067|FG000|COMPLETED|Overall Study||10
9065633|NCT04150224|10126068|FG001|COMPLETED|Overall Study||10
9065634|NCT04150224|10126069|FG002|COMPLETED|Overall Study||10
9065635|NCT04150224|10126070|FG003|COMPLETED|Overall Study||10
9065636|NCT04150224|10126071|FG004|COMPLETED|Overall Study||10
9065637|NCT04150224|10126072|FG005|COMPLETED|Overall Study|Period 2: Multple Dosing|10
9065638|NCT04150224|10126067|FG000|NOT COMPLETED|Overall Study||0
9065639|NCT04150224|10126068|FG001|NOT COMPLETED|Overall Study||0
8617694|NCT00458406|9655873|FG001|STARTED|Month 1||13
8617695|NCT00458406|9655872|FG000|COMPLETED|Month 1||43
8617696|NCT00458406|9655873|FG001|COMPLETED|Month 1||13
8617697|NCT00458406|9655872|FG000|NOT COMPLETED|Month 1||0
8617698|NCT00458406|9655873|FG001|NOT COMPLETED|Month 1||0
8617699|NCT00458406|9655872|FG000|STARTED|Month 3||43
8617700|NCT00458406|9655873|FG001|STARTED|Month 3||13
8617701|NCT00458406|9655872|FG000|COMPLETED|Month 3||43
8617702|NCT00458406|9655873|FG001|COMPLETED|Month 3||13
8617703|NCT00458406|9655872|FG000|NOT COMPLETED|Month 3||0
9065640|NCT04150224|10126069|FG002|NOT COMPLETED|Overall Study||0
9065641|NCT04150224|10126070|FG003|NOT COMPLETED|Overall Study||0
9065642|NCT04150224|10126071|FG004|NOT COMPLETED|Overall Study||0
9065643|NCT04150224|10126072|FG005|NOT COMPLETED|Overall Study||0
9065644|NCT04149405|10126099|FG000|STARTED|Overall Study||12
9065645|NCT04149405|10126100|FG001|STARTED|Overall Study||10
9065646|NCT04149405|10126101|FG002|STARTED|Overall Study||11
9065647|NCT04149405|10126102|FG003|STARTED|Overall Study||10
9065648|NCT04149405|10126099|FG000|COMPLETED|Overall Study||12
9065649|NCT04149405|10126100|FG001|COMPLETED|Overall Study||10
9065650|NCT04149405|10126101|FG002|COMPLETED|Overall Study||11
9065651|NCT04149405|10126102|FG003|COMPLETED|Overall Study||10
9065652|NCT04149405|10126099|FG000|NOT COMPLETED|Overall Study||0
9065653|NCT04149405|10126100|FG001|NOT COMPLETED|Overall Study||0
9065654|NCT04149405|10126101|FG002|NOT COMPLETED|Overall Study||0
9065655|NCT04149405|10126102|FG003|NOT COMPLETED|Overall Study||0
9065656|NCT04144088|10126121|FG000|STARTED|Overall Study||20
9065657|NCT04144088|10126122|FG001|STARTED|Overall Study||20
9065658|NCT04144088|10126123|FG002|STARTED|Overall Study||20
9065659|NCT04144088|10126121|FG000|COMPLETED|Overall Study||14
9065660|NCT04144088|10126122|FG001|COMPLETED|Overall Study||15
9065661|NCT04144088|10126123|FG002|COMPLETED|Overall Study||13
9065662|NCT04144088|10126121|FG000|NOT COMPLETED|Overall Study||6
9065663|NCT04144088|10126122|FG001|NOT COMPLETED|Overall Study||5
9065664|NCT04144088|10126123|FG002|NOT COMPLETED|Overall Study||7
9065665|NCT04149353|10126131|FG000|STARTED|Overall Study|The study was terminated for low recruitment before this subject's second imaging scan was due.|1
9065666|NCT04149353|10126131|FG000|COMPLETED|Overall Study||0
9065667|NCT04149353|10126131|FG000|NOT COMPLETED|Overall Study||1
9065668|NCT04137783|10126139|FG000|STARTED|Overall Study||7
8942912|NCT02384096|10004632|FG000|STARTED|Second Intervention (7 Days)||4
9065669|NCT04137783|10126140|FG001|STARTED|Overall Study||10
8617704|NCT00458406|9655873|FG001|NOT COMPLETED|Month 3||0
8617705|NCT00458484|9655893|FG000|STARTED|Overall Study||4
8617706|NCT00458484|9655894|FG001|STARTED|Overall Study||6
8617707|NCT00458484|9655895|FG002|STARTED|Overall Study||3
8942913|NCT02384096|10004633|FG001|STARTED|Second Intervention (7 Days)||7
8942914|NCT02384096|10004632|FG000|COMPLETED|Second Intervention (7 Days)||4
8942915|NCT02384096|10004633|FG001|COMPLETED|Second Intervention (7 Days)||6
8942916|NCT02384096|10004632|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
8942917|NCT02384096|10004633|FG001|NOT COMPLETED|Second Intervention (7 Days)||1
8942918|NCT02384200|10004640|FG000|STARTED|Overall Study||43
8942919|NCT02384200|10004641|FG001|STARTED|Overall Study||43
8942920|NCT02384200|10004640|FG000|COMPLETED|Overall Study||43
8942921|NCT02384200|10004641|FG001|COMPLETED|Overall Study||43
8942922|NCT02384200|10004640|FG000|NOT COMPLETED|Overall Study||0
8942923|NCT02384200|10004641|FG001|NOT COMPLETED|Overall Study||0
8942924|NCT02384382|10004647|FG000|STARTED|Overall Study||23
8942925|NCT02384382|10004647|FG000|COMPLETED|Overall Study||0
8942926|NCT02384382|10004647|FG000|NOT COMPLETED|Overall Study||23
8942927|NCT02384395|10004651|FG000|STARTED|Overall Study||40
8942928|NCT02384395|10004651|FG000|Enrolled|Overall Study||40
8942929|NCT02384395|10004651|FG000|Initiated Treatment|Overall Study||37
8942930|NCT02384395|10004651|FG000|Completed Week 24|Overall Study||34
8942931|NCT02384395|10004651|FG000|Completed Week 48|Overall Study||33
8942932|NCT02384395|10004651|FG000|Completed Week 96|Overall Study||30
8942933|NCT02384395|10004651|FG000|COMPLETED|Overall Study||30
8942934|NCT02384395|10004651|FG000|NOT COMPLETED|Overall Study||10
8942935|NCT02384460|10004657|FG000|STARTED|Overall Study||82
8942936|NCT02384460|10004658|FG001|STARTED|Overall Study||87
8942937|NCT02384460|10004657|FG000|Received at Least 1 Dose of Study Drug|Overall Study||82
8942938|NCT02384460|10004658|FG001|Received at Least 1 Dose of Study Drug|Overall Study||87
8942939|NCT02384460|10004657|FG000|COMPLETED|Overall Study||75
8942940|NCT02384460|10004658|FG001|COMPLETED|Overall Study||80
8942941|NCT02384460|10004657|FG000|NOT COMPLETED|Overall Study||7
8942942|NCT02384460|10004658|FG001|NOT COMPLETED|Overall Study||7
8942943|NCT02384538|10004666|FG000|STARTED|Overall Study||67
8942944|NCT02384538|10004667|FG001|STARTED|Overall Study||64
8942945|NCT02384538|10004666|FG000|COMPLETED|Overall Study||61
8942946|NCT02384538|10004667|FG001|COMPLETED|Overall Study||49
8942947|NCT02384538|10004666|FG000|NOT COMPLETED|Overall Study||6
8942948|NCT02384538|10004667|FG001|NOT COMPLETED|Overall Study||15
8942949|NCT02384941|10004676|FG000|STARTED|Overall Study||268
8942950|NCT02384941|10004677|FG001|STARTED|Overall Study||263
8942951|NCT02384941|10004678|FG002|STARTED|Overall Study||262
8942952|NCT02384941|10004676|FG000|COMPLETED|Overall Study||218
8942953|NCT02384941|10004677|FG001|COMPLETED|Overall Study||228
8942954|NCT02384941|10004678|FG002|COMPLETED|Overall Study||221
8942955|NCT02384941|10004676|FG000|NOT COMPLETED|Overall Study||50
8942956|NCT02384941|10004677|FG001|NOT COMPLETED|Overall Study||35
8942957|NCT02384941|10004678|FG002|NOT COMPLETED|Overall Study||41
8942958|NCT02385084|10004687|FG000|STARTED|Period 1||3
8942959|NCT02385084|10004688|FG001|STARTED|Period 1||3
8942960|NCT02385084|10004689|FG002|STARTED|Period 1||3
8942961|NCT02385084|10004690|FG003|STARTED|Period 1||3
8942962|NCT02385084|10004691|FG004|STARTED|Period 1||3
8942963|NCT02385084|10004692|FG005|STARTED|Period 1||3
8942964|NCT02385084|10004687|FG000|Received LY2409021|Period 1||3
8942965|NCT02385084|10004688|FG001|Received LY2409021|Period 1||3
8942966|NCT02385084|10004689|FG002|Received LY2409021|Period 1||3
8942967|NCT02385084|10004690|FG003|Received LY2409021|Period 1||3
8942968|NCT02385084|10004691|FG004|Received LY2409021|Period 1||3
8942969|NCT02385084|10004692|FG005|Received LY2409021|Period 1||3
8942970|NCT02385084|10004687|FG000|Washout|Period 1||3
8942971|NCT02385084|10004688|FG001|Washout|Period 1||3
8942972|NCT02385084|10004689|FG002|Washout|Period 1||3
8942973|NCT02385084|10004690|FG003|Washout|Period 1||3
8942974|NCT02385084|10004691|FG004|Washout|Period 1||3
8942975|NCT02385084|10004692|FG005|Washout|Period 1||3
8942976|NCT02385084|10004687|FG000|COMPLETED|Period 1||3
8942977|NCT02385084|10004688|FG001|COMPLETED|Period 1||3
8942978|NCT02385084|10004689|FG002|COMPLETED|Period 1||3
8942979|NCT02385084|10004690|FG003|COMPLETED|Period 1||3
8942980|NCT02385084|10004691|FG004|COMPLETED|Period 1||3
8942981|NCT02385084|10004692|FG005|COMPLETED|Period 1||3
8942982|NCT02385084|10004687|FG000|NOT COMPLETED|Period 1||0
8942983|NCT02385084|10004688|FG001|NOT COMPLETED|Period 1||0
8942984|NCT02385084|10004689|FG002|NOT COMPLETED|Period 1||0
8942985|NCT02385084|10004690|FG003|NOT COMPLETED|Period 1||0
8942986|NCT02385084|10004691|FG004|NOT COMPLETED|Period 1||0
8942987|NCT02385084|10004692|FG005|NOT COMPLETED|Period 1||0
8942988|NCT02385084|10004687|FG000|STARTED|Period 2|1 participant discontinued after Period 1 - physician decision. Did not enter Period 2.|2
8942989|NCT02385084|10004688|FG001|STARTED|Period 2||3
8942990|NCT02385084|10004689|FG002|STARTED|Period 2||3
8942991|NCT02385084|10004690|FG003|STARTED|Period 2||3
8942992|NCT02385084|10004691|FG004|STARTED|Period 2||3
8942993|NCT02385084|10004692|FG005|STARTED|Period 2||3
8942994|NCT02385084|10004687|FG000|Received LY2409021|Period 2||2
8942995|NCT02385084|10004688|FG001|Received LY2409021|Period 2||3
8942996|NCT02385084|10004689|FG002|Received LY2409021|Period 2||3
8942997|NCT02385084|10004690|FG003|Received LY2409021|Period 2||3
8942998|NCT02385084|10004691|FG004|Received LY2409021|Period 2||3
8942999|NCT02385084|10004692|FG005|Received LY2409021|Period 2||3
8943000|NCT02385084|10004687|FG000|Washout|Period 2||2
8943001|NCT02385084|10004688|FG001|Washout|Period 2||3
8943002|NCT02385084|10004689|FG002|Washout|Period 2||3
8943003|NCT02385084|10004690|FG003|Washout|Period 2||3
8943004|NCT02385084|10004691|FG004|Washout|Period 2||3
8943005|NCT02385084|10004692|FG005|Washout|Period 2||3
8943006|NCT02385084|10004687|FG000|COMPLETED|Period 2||2
8943007|NCT02385084|10004688|FG001|COMPLETED|Period 2||3
8943008|NCT02385084|10004689|FG002|COMPLETED|Period 2||2
8943009|NCT02385084|10004690|FG003|COMPLETED|Period 2||3
8943010|NCT02385084|10004691|FG004|COMPLETED|Period 2||3
8943011|NCT02385084|10004692|FG005|COMPLETED|Period 2||3
8943012|NCT02385084|10004687|FG000|NOT COMPLETED|Period 2||0
8943013|NCT02385084|10004688|FG001|NOT COMPLETED|Period 2||0
8943014|NCT02385084|10004689|FG002|NOT COMPLETED|Period 2||1
8943015|NCT02385084|10004690|FG003|NOT COMPLETED|Period 2||0
8943016|NCT02385084|10004691|FG004|NOT COMPLETED|Period 2||0
8943017|NCT02385084|10004692|FG005|NOT COMPLETED|Period 2||0
8943018|NCT02385084|10004687|FG000|STARTED|Period 3||2
8943019|NCT02385084|10004688|FG001|STARTED|Period 3||3
8943020|NCT02385084|10004689|FG002|STARTED|Period 3|1 participant discontinued after Period 2 - adverse event. Did not enter Period 3.|1
8943021|NCT02385084|10004690|FG003|STARTED|Period 3||3
8943022|NCT02385084|10004691|FG004|STARTED|Period 3|1 participant discontinued after Period 2 - adverse event. Did not enter Period 3.|2
8943023|NCT02385084|10004692|FG005|STARTED|Period 3||3
8943024|NCT02385084|10004687|FG000|Received LY2409021|Period 3||2
8943025|NCT02385084|10004688|FG001|Received LY2409021|Period 3||3
8943026|NCT02385084|10004689|FG002|Received LY2409021|Period 3||1
8943027|NCT02385084|10004690|FG003|Received LY2409021|Period 3||3
8943028|NCT02385084|10004691|FG004|Received LY2409021|Period 3||2
8943029|NCT02385084|10004692|FG005|Received LY2409021|Period 3||3
8943030|NCT02385084|10004687|FG000|Washout|Period 3||2
8943031|NCT02385084|10004688|FG001|Washout|Period 3||3
8943032|NCT02385084|10004689|FG002|Washout|Period 3||1
8943033|NCT02385084|10004690|FG003|Washout|Period 3||3
8943034|NCT02385084|10004691|FG004|Washout|Period 3||2
8943035|NCT02385084|10004692|FG005|Washout|Period 3||3
8943036|NCT02385084|10004687|FG000|COMPLETED|Period 3||2
8943037|NCT02385084|10004688|FG001|COMPLETED|Period 3||3
8943038|NCT02385084|10004689|FG002|COMPLETED|Period 3||1
8943039|NCT02385084|10004690|FG003|COMPLETED|Period 3||3
8943040|NCT02385084|10004691|FG004|COMPLETED|Period 3||2
8943041|NCT02385084|10004692|FG005|COMPLETED|Period 3||3
8943042|NCT02385084|10004687|FG000|NOT COMPLETED|Period 3||0
8943043|NCT02385084|10004688|FG001|NOT COMPLETED|Period 3||0
8943044|NCT02385084|10004689|FG002|NOT COMPLETED|Period 3||0
8943045|NCT02385084|10004690|FG003|NOT COMPLETED|Period 3||0
8943046|NCT02385084|10004691|FG004|NOT COMPLETED|Period 3||0
8943047|NCT02385084|10004692|FG005|NOT COMPLETED|Period 3||0
8943048|NCT02385097|10004703|FG000|STARTED|Overall Study||106
8943049|NCT02385097|10004704|FG001|STARTED|Overall Study||105
8943050|NCT02385097|10004703|FG000|COMPLETED|Overall Study||106
8943051|NCT02385097|10004704|FG001|COMPLETED|Overall Study||105
8943052|NCT02385097|10004703|FG000|NOT COMPLETED|Overall Study||0
8943053|NCT02385097|10004704|FG001|NOT COMPLETED|Overall Study||0
8943054|NCT02385240|10004713|FG000|STARTED|Overall Study||183
8943055|NCT02385240|10004714|FG001|STARTED|Overall Study||184
8943056|NCT02385240|10004715|FG002|STARTED|Overall Study||185
8943057|NCT02385240|10004713|FG000|COMPLETED|Overall Study||182
8943058|NCT02385240|10004714|FG001|COMPLETED|Overall Study||178
8943059|NCT02385240|10004715|FG002|COMPLETED|Overall Study||184
8943060|NCT02385240|10004713|FG000|NOT COMPLETED|Overall Study||1
8943061|NCT02385240|10004714|FG001|NOT COMPLETED|Overall Study||6
8943062|NCT02385240|10004715|FG002|NOT COMPLETED|Overall Study||1
8943063|NCT02385318|10004726|FG000|STARTED|Overall Study||204
8943064|NCT02385318|10004727|FG001|STARTED|Overall Study||210
8943065|NCT02385318|10004728|FG002|STARTED|Overall Study||105
8943066|NCT02385318|10004726|FG000|COMPLETED|Overall Study||200
8943067|NCT02385318|10004727|FG001|COMPLETED|Overall Study||203
8943068|NCT02385318|10004728|FG002|COMPLETED|Overall Study||99
8943069|NCT02385318|10004726|FG000|NOT COMPLETED|Overall Study||4
8943070|NCT02385318|10004727|FG001|NOT COMPLETED|Overall Study||7
8943071|NCT02385318|10004728|FG002|NOT COMPLETED|Overall Study||6
8943072|NCT02385526|10004739|FG000|STARTED|Overall Study||22
8943073|NCT02385526|10004740|FG001|STARTED|Overall Study||20
8943074|NCT02385526|10004741|FG002|STARTED|Overall Study||20
8943075|NCT02385526|10004739|FG000|COMPLETED|Overall Study||20
8943076|NCT02385526|10004740|FG001|COMPLETED|Overall Study||17
8943077|NCT02385526|10004741|FG002|COMPLETED|Overall Study||20
8943078|NCT02385526|10004739|FG000|NOT COMPLETED|Overall Study||2
8943079|NCT02385526|10004740|FG001|NOT COMPLETED|Overall Study||3
8943080|NCT02385526|10004741|FG002|NOT COMPLETED|Overall Study||0
8943081|NCT02385669|10004749|FG000|STARTED|Overall Study||3
8943082|NCT02385669|10004749|FG000|COMPLETED|Overall Study||1
8943083|NCT02385669|10004749|FG000|NOT COMPLETED|Overall Study||2
8943084|NCT02385708|10004755|FG000|STARTED|Overall Study||81
8943085|NCT02385708|10004756|FG001|STARTED|Overall Study||82
8943086|NCT02385708|10004755|FG000|Intervention Started|Overall Study||81
8943087|NCT02385708|10004756|FG001|Intervention Started|Overall Study||82
8943088|NCT02385708|10004755|FG000|COMPLETED|Overall Study||73
8943089|NCT02385708|10004756|FG001|COMPLETED|Overall Study||67
8943090|NCT02385708|10004755|FG000|NOT COMPLETED|Overall Study||8
8943091|NCT02385708|10004756|FG001|NOT COMPLETED|Overall Study||15
8943092|NCT02385721|10004762|FG000|STARTED|Overall Study||601
8943093|NCT02385721|10004762|FG000|COMPLETED|Overall Study||371
8943094|NCT02385721|10004762|FG000|NOT COMPLETED|Overall Study||230
8943095|NCT02385799|10004768|FG000|STARTED|Overall Study||26
8943096|NCT02385799|10004769|FG001|STARTED|Overall Study||32
8943097|NCT02385799|10004768|FG000|Completed End-of-Treatment Visit|Overall Study||21
8943098|NCT02385799|10004769|FG001|Completed End-of-Treatment Visit|Overall Study||26
8943099|NCT02385799|10004768|FG000|COMPLETED|Overall Study||21
8943100|NCT02385799|10004769|FG001|COMPLETED|Overall Study||24
8943101|NCT02385799|10004768|FG000|NOT COMPLETED|Overall Study||5
8943102|NCT02385799|10004769|FG001|NOT COMPLETED|Overall Study||8
8943103|NCT02386098|10004780|FG000|STARTED|Stage 1 (96 Weeks)||43
8943104|NCT02386098|10004781|FG001|STARTED|Stage 1 (96 Weeks)||43
8943105|NCT02386098|10004782|FG002|STARTED|Stage 1 (96 Weeks)||0
8943106|NCT02386098|10004783|FG003|STARTED|Stage 1 (96 Weeks)||0
8943107|NCT02386098|10004784|FG004|STARTED|Stage 1 (96 Weeks)||0
8943108|NCT02386098|10004780|FG000|COMPLETED|Stage 1 (96 Weeks)||0
8943109|NCT02386098|10004781|FG001|COMPLETED|Stage 1 (96 Weeks)||0
8943110|NCT02386098|10004782|FG002|COMPLETED|Stage 1 (96 Weeks)||0
8943111|NCT02386098|10004783|FG003|COMPLETED|Stage 1 (96 Weeks)||0
8943112|NCT02386098|10004784|FG004|COMPLETED|Stage 1 (96 Weeks)||0
8943113|NCT02386098|10004780|FG000|NOT COMPLETED|Stage 1 (96 Weeks)||43
8943114|NCT02386098|10004781|FG001|NOT COMPLETED|Stage 1 (96 Weeks)||43
8943115|NCT02386098|10004782|FG002|NOT COMPLETED|Stage 1 (96 Weeks)||0
8943116|NCT02386098|10004783|FG003|NOT COMPLETED|Stage 1 (96 Weeks)||0
8943117|NCT02386098|10004784|FG004|NOT COMPLETED|Stage 1 (96 Weeks)||0
8943118|NCT02386098|10004780|FG000|STARTED|Stage 2 (96 Weeks)||0
8943119|NCT02386098|10004781|FG001|STARTED|Stage 2 (96 Weeks)||0
8943120|NCT02386098|10004782|FG002|STARTED|Stage 2 (96 Weeks)||0
8943121|NCT02386098|10004783|FG003|STARTED|Stage 2 (96 Weeks)||0
8943122|NCT02386098|10004784|FG004|STARTED|Stage 2 (96 Weeks)||0
8943123|NCT02386098|10004780|FG000|COMPLETED|Stage 2 (96 Weeks)||0
8943124|NCT02386098|10004781|FG001|COMPLETED|Stage 2 (96 Weeks)||0
8943125|NCT02386098|10004782|FG002|COMPLETED|Stage 2 (96 Weeks)||0
8943126|NCT02386098|10004783|FG003|COMPLETED|Stage 2 (96 Weeks)||0
8943127|NCT02386098|10004784|FG004|COMPLETED|Stage 2 (96 Weeks)||0
8943128|NCT02386098|10004780|FG000|NOT COMPLETED|Stage 2 (96 Weeks)||0
8943129|NCT02386098|10004781|FG001|NOT COMPLETED|Stage 2 (96 Weeks)||0
8943130|NCT02386098|10004782|FG002|NOT COMPLETED|Stage 2 (96 Weeks)||0
8943131|NCT02386098|10004783|FG003|NOT COMPLETED|Stage 2 (96 Weeks)||0
8943132|NCT02386098|10004784|FG004|NOT COMPLETED|Stage 2 (96 Weeks)||0
8943133|NCT02386189|10004798|FG000|STARTED|Overall Study||30
8943134|NCT02386189|10004799|FG001|STARTED|Overall Study||33
8943135|NCT02386189|10004798|FG000|COMPLETED|Overall Study||26
8943136|NCT02386189|10004799|FG001|COMPLETED|Overall Study||30
8943137|NCT02386189|10004798|FG000|NOT COMPLETED|Overall Study||4
8943138|NCT02386189|10004799|FG001|NOT COMPLETED|Overall Study||3
8943139|NCT02386319|10004807|FG000|STARTED|Overall Study||18
8943140|NCT02386319|10004808|FG001|STARTED|Overall Study||18
8943141|NCT02386319|10004807|FG000|COMPLETED|Overall Study||16
8943142|NCT02386319|10004808|FG001|COMPLETED|Overall Study||17
8943143|NCT02386319|10004807|FG000|NOT COMPLETED|Overall Study||2
8943144|NCT02386319|10004808|FG001|NOT COMPLETED|Overall Study||1
8943145|NCT02386345|10004814|FG000|STARTED|Overall Study||299
8943146|NCT02386345|10004814|FG000|COMPLETED|Overall Study||197
8943147|NCT02386345|10004814|FG000|NOT COMPLETED|Overall Study||102
8943148|NCT02386605|10004820|FG000|STARTED|Overall Study||41
8943149|NCT02386605|10004821|FG001|STARTED|Overall Study||38
8943150|NCT02386605|10004820|FG000|COMPLETED|Overall Study||34
8943151|NCT02386605|10004821|FG001|COMPLETED|Overall Study||28
8943152|NCT02386605|10004820|FG000|NOT COMPLETED|Overall Study||7
8943153|NCT02386605|10004821|FG001|NOT COMPLETED|Overall Study||10
8943154|NCT02386995|10004827|FG000|STARTED|Overall Study||30
8943155|NCT02386995|10004827|FG000|COMPLETED|Overall Study||30
8943156|NCT02386995|10004827|FG000|NOT COMPLETED|Overall Study||0
8943157|NCT02387008|10004835|FG000|STARTED|Overall Study||2
8943158|NCT02387008|10004836|FG001|STARTED|Overall Study||0
8943159|NCT02387008|10004837|FG002|STARTED|Overall Study||4
8943160|NCT02387008|10004835|FG000|COMPLETED|Overall Study||2
8943161|NCT02387008|10004836|FG001|COMPLETED|Overall Study||0
8943162|NCT02387008|10004837|FG002|COMPLETED|Overall Study||4
8943163|NCT02387008|10004835|FG000|NOT COMPLETED|Overall Study||0
8943164|NCT02387008|10004836|FG001|NOT COMPLETED|Overall Study||0
8943165|NCT02387008|10004837|FG002|NOT COMPLETED|Overall Study||0
8943166|NCT02387164|10004847|FG000|STARTED|Overall Study||13
8943167|NCT02387164|10004848|FG001|STARTED|Overall Study||13
8943168|NCT02387164|10004847|FG000|COMPLETED|Overall Study||10
8943169|NCT02387164|10004848|FG001|COMPLETED|Overall Study||11
8943170|NCT02387164|10004847|FG000|NOT COMPLETED|Overall Study||3
8943171|NCT02387164|10004848|FG001|NOT COMPLETED|Overall Study||2
8943172|NCT02387216|10004856|FG000|STARTED|Overall Study||103
9065670|NCT04137783|10126141|FG002|STARTED|Overall Study||22
9065671|NCT04137783|10126139|FG000|COMPLETED|Overall Study||7
8943173|NCT02387216|10004857|FG001|STARTED|Overall Study||49
8943174|NCT02387216|10004856|FG000|COMPLETED|Overall Study||3
8943175|NCT02387216|10004857|FG001|COMPLETED|Overall Study||2
8943176|NCT02387216|10004856|FG000|NOT COMPLETED|Overall Study||100
8943177|NCT02387216|10004857|FG001|NOT COMPLETED|Overall Study||47
8943178|NCT02387268|10004863|FG000|STARTED|Overall Study||10
8943179|NCT02387268|10004863|FG000|COMPLETED|Overall Study||9
8943180|NCT02387268|10004863|FG000|NOT COMPLETED|Overall Study||1
8943181|NCT02387294|10004869|FG000|STARTED|Overall Study||60
8943182|NCT02387294|10004870|FG001|STARTED|Overall Study||60
8943183|NCT02387294|10004869|FG000|COMPLETED|Overall Study||60
8943184|NCT02387294|10004870|FG001|COMPLETED|Overall Study||60
8943185|NCT02387294|10004869|FG000|NOT COMPLETED|Overall Study||0
8943186|NCT02387294|10004870|FG001|NOT COMPLETED|Overall Study||0
8943187|NCT02387359|10004880|FG000|STARTED|Overall Study||354
8943188|NCT02387359|10004881|FG001|STARTED|Overall Study||351
8943189|NCT02387359|10004882|FG002|STARTED|Overall Study||349
8943190|NCT02387359|10004880|FG000|COMPLETED|Overall Study||295
8943191|NCT02387359|10004881|FG001|COMPLETED|Overall Study||309
8943192|NCT02387359|10004882|FG002|COMPLETED|Overall Study||293
8943193|NCT02387359|10004880|FG000|NOT COMPLETED|Overall Study||59
8943194|NCT02387359|10004881|FG001|NOT COMPLETED|Overall Study||42
8943195|NCT02387359|10004882|FG002|NOT COMPLETED|Overall Study||56
8943196|NCT02387372|10004892|FG000|STARTED|Overall Study||27
8943197|NCT02387372|10004893|FG001|STARTED|Overall Study||10
8943198|NCT02387372|10004892|FG000|Treated|Overall Study||26
8943199|NCT02387372|10004893|FG001|Treated|Overall Study||10
8943200|NCT02387372|10004892|FG000|COMPLETED|Overall Study||26
8943201|NCT02387372|10004893|FG001|COMPLETED|Overall Study||10
8943202|NCT02387372|10004892|FG000|NOT COMPLETED|Overall Study||1
8943203|NCT02387372|10004893|FG001|NOT COMPLETED|Overall Study||0
8943204|NCT02387476|10004909|FG000|STARTED|Overall Study||25
8943205|NCT02387476|10004910|FG001|STARTED|Overall Study||22
8943206|NCT02387476|10004909|FG000|COMPLETED|Overall Study||19
8943207|NCT02387476|10004910|FG001|COMPLETED|Overall Study||17
8943208|NCT02387476|10004909|FG000|NOT COMPLETED|Overall Study||6
8943209|NCT02387476|10004910|FG001|NOT COMPLETED|Overall Study||5
8943210|NCT02387502|10004921|FG000|STARTED|Overall Study||40
8943211|NCT02387502|10004922|FG001|STARTED|Overall Study||40
8943212|NCT02387502|10004923|FG002|STARTED|Overall Study||40
8943213|NCT02387502|10004921|FG000|COMPLETED|Overall Study||40
8943214|NCT02387502|10004922|FG001|COMPLETED|Overall Study||40
8943215|NCT02387502|10004923|FG002|COMPLETED|Overall Study||40
8943216|NCT02387502|10004921|FG000|NOT COMPLETED|Overall Study||0
8943217|NCT02387502|10004922|FG001|NOT COMPLETED|Overall Study||0
8943218|NCT02387502|10004923|FG002|NOT COMPLETED|Overall Study||0
8943219|NCT02387554|10004935|FG000|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|10
8943220|NCT02387554|10004936|FG001|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|7
8943221|NCT02387554|10004937|FG002|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|8
8943222|NCT02387554|10004938|FG003|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|8
8943223|NCT02387554|10004935|FG000|COMPLETED|Overall Study||7
8943224|NCT02387554|10004936|FG001|COMPLETED|Overall Study||7
8943225|NCT02387554|10004937|FG002|COMPLETED|Overall Study||6
8943226|NCT02387554|10004938|FG003|COMPLETED|Overall Study||6
8943227|NCT02387554|10004935|FG000|NOT COMPLETED|Overall Study||3
8943228|NCT02387554|10004936|FG001|NOT COMPLETED|Overall Study||0
8943229|NCT02387554|10004937|FG002|NOT COMPLETED|Overall Study||2
8943230|NCT02387554|10004938|FG003|NOT COMPLETED|Overall Study||2
8943231|NCT02387580|10004954|FG000|STARTED|Overall Study||8
8943232|NCT02387580|10004955|FG001|STARTED|Overall Study||8
8943233|NCT02387580|10004956|FG002|STARTED|Overall Study||8
8943234|NCT02387580|10004957|FG003|STARTED|Overall Study||8
8943235|NCT02387580|10004958|FG004|STARTED|Overall Study||8
8943236|NCT02387580|10004959|FG005|STARTED|Overall Study||8
8943237|NCT02387580|10004954|FG000|COMPLETED|Overall Study||8
8943238|NCT02387580|10004955|FG001|COMPLETED|Overall Study||8
8943239|NCT02387580|10004956|FG002|COMPLETED|Overall Study||8
8943240|NCT02387580|10004957|FG003|COMPLETED|Overall Study||7
8943241|NCT02387580|10004958|FG004|COMPLETED|Overall Study||8
8943242|NCT02387580|10004959|FG005|COMPLETED|Overall Study||8
8943243|NCT02387580|10004954|FG000|NOT COMPLETED|Overall Study||0
8943244|NCT02387580|10004955|FG001|NOT COMPLETED|Overall Study||0
8943245|NCT02387580|10004956|FG002|NOT COMPLETED|Overall Study||0
8943246|NCT02387580|10004957|FG003|NOT COMPLETED|Overall Study||1
8943247|NCT02387580|10004958|FG004|NOT COMPLETED|Overall Study||0
8943248|NCT02387580|10004959|FG005|NOT COMPLETED|Overall Study||0
8943249|NCT02387710|10004975|FG000|STARTED|First Study Night||9
8943250|NCT02387710|10004976|FG001|STARTED|First Study Night||9
8943251|NCT02387710|10004975|FG000|COMPLETED|First Study Night||9
8943252|NCT02387710|10004976|FG001|COMPLETED|First Study Night||9
8943253|NCT02387710|10004975|FG000|NOT COMPLETED|First Study Night||0
8943254|NCT02387710|10004976|FG001|NOT COMPLETED|First Study Night||0
8943255|NCT02387710|10004975|FG000|STARTED|Second Study Night||9
8943256|NCT02387710|10004976|FG001|STARTED|Second Study Night|2 patients did not come back for excessive sleep disruption due to the equipment|7
8943257|NCT02387710|10004975|FG000|COMPLETED|Second Study Night||9
8943258|NCT02387710|10004976|FG001|COMPLETED|Second Study Night||7
8943259|NCT02387710|10004975|FG000|NOT COMPLETED|Second Study Night||0
8943260|NCT02387710|10004976|FG001|NOT COMPLETED|Second Study Night||0
8943261|NCT02387749|10004984|FG000|STARTED|Overall Study||10
8943262|NCT02387749|10004984|FG000|COMPLETED|Overall Study||10
8943263|NCT02387749|10004984|FG000|NOT COMPLETED|Overall Study||0
8943264|NCT02387762|10004995|FG000|STARTED|Overall Study||16
8943265|NCT02387762|10004996|FG001|STARTED|Overall Study||15
8943266|NCT02387762|10004995|FG000|COMPLETED|Overall Study||15
8943267|NCT02387762|10004996|FG001|COMPLETED|Overall Study||15
8943268|NCT02387762|10004995|FG000|NOT COMPLETED|Overall Study||1
8943269|NCT02387762|10004996|FG001|NOT COMPLETED|Overall Study||0
8943270|NCT02387801|10005004|FG000|STARTED|Induction Dosing Period||6
8943271|NCT02387801|10005005|FG001|STARTED|Induction Dosing Period||6
8943272|NCT02387801|10005004|FG000|COMPLETED|Induction Dosing Period||6
8943273|NCT02387801|10005005|FG001|COMPLETED|Induction Dosing Period||6
8943274|NCT02387801|10005004|FG000|NOT COMPLETED|Induction Dosing Period||0
8943275|NCT02387801|10005005|FG001|NOT COMPLETED|Induction Dosing Period||0
8943276|NCT02387801|10005004|FG000|STARTED|Maintenance Dosing Period|All participants from Induction Dosing Period went to ixe Q4W arm during Maintenance Dosing Period.|0
8943277|NCT02387801|10005005|FG001|STARTED|Maintenance Dosing Period||12
8943278|NCT02387801|10005004|FG000|COMPLETED|Maintenance Dosing Period||0
8943279|NCT02387801|10005005|FG001|COMPLETED|Maintenance Dosing Period||12
8943280|NCT02387801|10005004|FG000|NOT COMPLETED|Maintenance Dosing Period||0
8943281|NCT02387801|10005005|FG001|NOT COMPLETED|Maintenance Dosing Period||0
8943282|NCT02387801|10005004|FG000|STARTED|Post-Treatment Follow-up||0
8943283|NCT02387801|10005005|FG001|STARTED|Post-Treatment Follow-up||12
8943284|NCT02387801|10005004|FG000|COMPLETED|Post-Treatment Follow-up||0
8943285|NCT02387801|10005005|FG001|COMPLETED|Post-Treatment Follow-up||12
8943286|NCT02387801|10005004|FG000|NOT COMPLETED|Post-Treatment Follow-up||0
8943287|NCT02387801|10005005|FG001|NOT COMPLETED|Post-Treatment Follow-up||0
8943288|NCT02387814|10005017|FG000|STARTED|Overall Study||10
8943289|NCT02387814|10005018|FG001|STARTED|Overall Study||9
8943290|NCT02387814|10005019|FG002|STARTED|Overall Study||10
8943291|NCT02387814|10005020|FG003|STARTED|Overall Study||6
8943292|NCT02387814|10005017|FG000|Received Abemaciclib|Overall Study||10
8943293|NCT02387814|10005018|FG001|Received Abemaciclib|Overall Study||9
8943294|NCT02387814|10005019|FG002|Received Abemaciclib|Overall Study||10
8943295|NCT02387814|10005020|FG003|Received Abemaciclib|Overall Study||6
8943296|NCT02387814|10005017|FG000|COMPLETED|Overall Study||10
8943297|NCT02387814|10005018|FG001|COMPLETED|Overall Study||9
8943298|NCT02387814|10005019|FG002|COMPLETED|Overall Study||10
8943299|NCT02387814|10005020|FG003|COMPLETED|Overall Study||6
8943300|NCT02387814|10005017|FG000|NOT COMPLETED|Overall Study||0
8943301|NCT02387814|10005018|FG001|NOT COMPLETED|Overall Study||0
8943302|NCT02387814|10005019|FG002|NOT COMPLETED|Overall Study||0
8943303|NCT02387814|10005020|FG003|NOT COMPLETED|Overall Study||0
8943304|NCT02387840|10005036|FG000|STARTED|Overall Study||4
8943305|NCT02387840|10005037|FG001|STARTED|Overall Study||6
8943306|NCT02387840|10005038|FG002|STARTED|Overall Study||6
8943307|NCT02387840|10005039|FG003|STARTED|Overall Study||8
8943308|NCT02387840|10005040|FG004|STARTED|Overall Study||4
8943309|NCT02387840|10005041|FG005|STARTED|Overall Study||6
8943310|NCT02387840|10005036|FG000|COMPLETED|Overall Study||4
8943311|NCT02387840|10005037|FG001|COMPLETED|Overall Study||6
8943312|NCT02387840|10005038|FG002|COMPLETED|Overall Study||6
8943313|NCT02387840|10005039|FG003|COMPLETED|Overall Study||8
8943314|NCT02387840|10005040|FG004|COMPLETED|Overall Study||4
8943315|NCT02387840|10005041|FG005|COMPLETED|Overall Study||5
8943316|NCT02387840|10005036|FG000|NOT COMPLETED|Overall Study||0
8943317|NCT02387840|10005037|FG001|NOT COMPLETED|Overall Study||0
8943318|NCT02387840|10005038|FG002|NOT COMPLETED|Overall Study||0
8943319|NCT02387840|10005039|FG003|NOT COMPLETED|Overall Study||0
8943320|NCT02387840|10005040|FG004|NOT COMPLETED|Overall Study||0
8943321|NCT02387840|10005041|FG005|NOT COMPLETED|Overall Study||1
8943322|NCT02387853|10005061|FG000|STARTED|Overall Study||106
8943323|NCT02387853|10005061|FG000|COMPLETED|Overall Study||103
8943324|NCT02387853|10005061|FG000|NOT COMPLETED|Overall Study||3
8943325|NCT02387957|10005068|FG000|STARTED|Overall Study||21
8943326|NCT02387957|10005069|FG001|STARTED|Overall Study||21
8943327|NCT02387957|10005070|FG002|STARTED|Overall Study||21
8943328|NCT02387957|10005068|FG000|COMPLETED|Overall Study|The study was discontinued|0
8943329|NCT02387957|10005069|FG001|COMPLETED|Overall Study|The study was discontinued|0
8943330|NCT02387957|10005070|FG002|COMPLETED|Overall Study|The study was discontinued|1
8943331|NCT02387957|10005068|FG000|NOT COMPLETED|Overall Study||21
8943332|NCT02387957|10005069|FG001|NOT COMPLETED|Overall Study||21
8943333|NCT02387957|10005070|FG002|NOT COMPLETED|Overall Study||20
8943334|NCT02387970|10005080|FG000|STARTED|Overall Study||27
8943335|NCT02387970|10005081|FG001|STARTED|Overall Study||25
8943336|NCT02387970|10005080|FG000|COMPLETED|Overall Study||26
8943337|NCT02387970|10005081|FG001|COMPLETED|Overall Study||23
8943338|NCT02387970|10005080|FG000|NOT COMPLETED|Overall Study||1
8943339|NCT02387970|10005081|FG001|NOT COMPLETED|Overall Study||2
8943340|NCT02387983|10005087|FG000|STARTED|Overall Study||65
8943341|NCT02387983|10005087|FG000|COMPLETED|Overall Study||58
8943342|NCT02387983|10005087|FG000|NOT COMPLETED|Overall Study||7
8943343|NCT02388074|10005091|FG000|STARTED|Overall Study||25
8943344|NCT02388074|10005091|FG000|COMPLETED|Overall Study||22
8943345|NCT02388074|10005091|FG000|NOT COMPLETED|Overall Study||3
8943346|NCT02388165|10005097|FG000|STARTED|Overall Study||1726
8943347|NCT02388165|10005098|FG001|STARTED|Overall Study||1724
8943348|NCT02388165|10005097|FG000|Vaccinated (Safety Population)|Overall Study||1708
8943349|NCT02388165|10005098|FG001|Vaccinated (Safety Population)|Overall Study||1709
8943350|NCT02388165|10005097|FG000|COMPLETED|Overall Study||1599
8943351|NCT02388165|10005098|FG001|COMPLETED|Overall Study||1594
8943352|NCT02388165|10005097|FG000|NOT COMPLETED|Overall Study||127
8943353|NCT02388165|10005098|FG001|NOT COMPLETED|Overall Study||130
8943354|NCT02388191|10005106|FG000|STARTED|Overall Study||59
8943355|NCT02388191|10005107|FG001|STARTED|Overall Study||60
8943356|NCT02388191|10005106|FG000|COMPLETED|Overall Study||58
8943357|NCT02388191|10005107|FG001|COMPLETED|Overall Study||60
8943358|NCT02388191|10005106|FG000|NOT COMPLETED|Overall Study||1
8943359|NCT02388191|10005107|FG001|NOT COMPLETED|Overall Study||0
8943360|NCT02388269|10005117|FG000|STARTED|Overall Study||41
8943361|NCT02388269|10005118|FG001|STARTED|Overall Study||40
8943362|NCT02388269|10005119|FG002|STARTED|Overall Study||10
8943363|NCT02388269|10005117|FG000|Randomised Period|Overall Study||41
8943364|NCT02388269|10005118|FG001|Randomised Period|Overall Study||40
8943365|NCT02388269|10005119|FG002|Randomised Period|Overall Study||0
8943366|NCT02388269|10005117|FG000|Open Label|Overall Study||37
8943367|NCT02388269|10005118|FG001|Open Label|Overall Study||38
8943368|NCT02388269|10005119|FG002|Open Label|Overall Study||0
8943369|NCT02388269|10005117|FG000|COMPLETED|Overall Study||32
8943370|NCT02388269|10005118|FG001|COMPLETED|Overall Study||38
8943371|NCT02388269|10005119|FG002|COMPLETED|Overall Study||0
8943372|NCT02388269|10005117|FG000|NOT COMPLETED|Overall Study||9
8943373|NCT02388269|10005118|FG001|NOT COMPLETED|Overall Study||2
8943374|NCT02388269|10005119|FG002|NOT COMPLETED|Overall Study||10
8943375|NCT02388295|10005146|FG000|STARTED|Dose Escalation Week 1|Number randomized to treatment|19
8943376|NCT02388295|10005147|FG001|STARTED|Dose Escalation Week 1|Number randomized to treatment|19
8943377|NCT02388295|10005148|FG002|STARTED|Dose Escalation Week 1|Number randomized to treatment|20
8719383|NCT01004146|9766909|FG001|STARTED|Overall Study||25
8719384|NCT01004146|9766908|FG000|Have Incentive Spirometry Data|Overall Study||21
8719385|NCT01004146|9766909|FG001|Have Incentive Spirometry Data|Overall Study||20
8719386|NCT01004146|9766908|FG000|COMPLETED|Overall Study||21
8719387|NCT01004146|9766909|FG001|COMPLETED|Overall Study||20
8943378|NCT02388295|10005146|FG000|COMPLETED|Dose Escalation Week 1||17
8943379|NCT02388295|10005147|FG001|COMPLETED|Dose Escalation Week 1||16
8943380|NCT02388295|10005148|FG002|COMPLETED|Dose Escalation Week 1||18
8943381|NCT02388295|10005146|FG000|NOT COMPLETED|Dose Escalation Week 1||2
8943382|NCT02388295|10005147|FG001|NOT COMPLETED|Dose Escalation Week 1||3
8943383|NCT02388295|10005148|FG002|NOT COMPLETED|Dose Escalation Week 1||2
8943384|NCT02388295|10005146|FG000|STARTED|Dose Escalation Week 2||17
8943385|NCT02388295|10005147|FG001|STARTED|Dose Escalation Week 2||16
8943386|NCT02388295|10005148|FG002|STARTED|Dose Escalation Week 2||18
8943387|NCT02388295|10005146|FG000|COMPLETED|Dose Escalation Week 2||16
8943388|NCT02388295|10005147|FG001|COMPLETED|Dose Escalation Week 2||14
8943389|NCT02388295|10005148|FG002|COMPLETED|Dose Escalation Week 2||17
8943390|NCT02388295|10005146|FG000|NOT COMPLETED|Dose Escalation Week 2||1
8943391|NCT02388295|10005147|FG001|NOT COMPLETED|Dose Escalation Week 2||2
8943392|NCT02388295|10005148|FG002|NOT COMPLETED|Dose Escalation Week 2||1
8617708|NCT00458484|9655896|FG003|STARTED|Overall Study||6
8617709|NCT00458484|9655897|FG004|STARTED|Overall Study||4
8617710|NCT00458484|9655898|FG005|STARTED|Overall Study||5
8943393|NCT02388295|10005146|FG000|STARTED|Treatment Weeks 3 to 12||16
8943394|NCT02388295|10005147|FG001|STARTED|Treatment Weeks 3 to 12||14
8943395|NCT02388295|10005148|FG002|STARTED|Treatment Weeks 3 to 12||17
8943396|NCT02388295|10005146|FG000|COMPLETED|Treatment Weeks 3 to 12||15
8943397|NCT02388295|10005147|FG001|COMPLETED|Treatment Weeks 3 to 12||13
8943398|NCT02388295|10005148|FG002|COMPLETED|Treatment Weeks 3 to 12||17
8943399|NCT02388295|10005146|FG000|NOT COMPLETED|Treatment Weeks 3 to 12||1
8943400|NCT02388295|10005147|FG001|NOT COMPLETED|Treatment Weeks 3 to 12||1
8943401|NCT02388295|10005148|FG002|NOT COMPLETED|Treatment Weeks 3 to 12||0
8943402|NCT02388321|10005158|FG000|STARTED|Overall Study||11
8943403|NCT02388321|10005159|FG001|STARTED|Overall Study||11
8943404|NCT02388321|10005158|FG000|COMPLETED|Overall Study||11
8943405|NCT02388321|10005159|FG001|COMPLETED|Overall Study||11
8943406|NCT02388321|10005158|FG000|NOT COMPLETED|Overall Study||0
8943407|NCT02388321|10005159|FG001|NOT COMPLETED|Overall Study||0
8943408|NCT02388347|10005170|FG000|STARTED|Overall Study||8
8943409|NCT02388347|10005171|FG001|STARTED|Overall Study||6
8943410|NCT02388347|10005172|FG002|STARTED|Overall Study||6
8943411|NCT02388347|10005173|FG003|STARTED|Overall Study||6
8943412|NCT02388347|10005174|FG004|STARTED|Overall Study||6
8943413|NCT02388347|10005170|FG000|COMPLETED|Overall Study||8
8943414|NCT02388347|10005171|FG001|COMPLETED|Overall Study||6
8943415|NCT02388347|10005172|FG002|COMPLETED|Overall Study||5
8943416|NCT02388347|10005173|FG003|COMPLETED|Overall Study||6
8943417|NCT02388347|10005174|FG004|COMPLETED|Overall Study||6
8943418|NCT02388347|10005170|FG000|NOT COMPLETED|Overall Study||0
8943419|NCT02388347|10005171|FG001|NOT COMPLETED|Overall Study||0
8943420|NCT02388347|10005172|FG002|NOT COMPLETED|Overall Study||1
8943421|NCT02388347|10005173|FG003|NOT COMPLETED|Overall Study||0
8943422|NCT02388347|10005174|FG004|NOT COMPLETED|Overall Study||0
8943423|NCT02388386|10005190|FG000|STARTED|Overall Study||10
8943424|NCT02388386|10005190|FG000|COMPLETED|Overall Study||10
8617711|NCT00458484|9655899|FG006|STARTED|Overall Study||3
8617712|NCT00458484|9655893|FG000|COMPLETED|Overall Study||4
8617713|NCT00458484|9655894|FG001|COMPLETED|Overall Study||6
8617714|NCT00458484|9655895|FG002|COMPLETED|Overall Study||3
8617715|NCT00458484|9655896|FG003|COMPLETED|Overall Study||6
8617716|NCT00458484|9655897|FG004|COMPLETED|Overall Study||4
8617717|NCT00458484|9655898|FG005|COMPLETED|Overall Study||4
8617718|NCT00458484|9655899|FG006|COMPLETED|Overall Study||3
8617719|NCT00458484|9655893|FG000|NOT COMPLETED|Overall Study||0
8617720|NCT00458484|9655894|FG001|NOT COMPLETED|Overall Study||0
8719388|NCT01004146|9766908|FG000|NOT COMPLETED|Overall Study||4
8719389|NCT01004146|9766909|FG001|NOT COMPLETED|Overall Study||5
8943425|NCT02388386|10005190|FG000|NOT COMPLETED|Overall Study||0
8943426|NCT02388568|10005200|FG000|STARTED|Overall Study||69
8943427|NCT02388568|10005201|FG001|STARTED|Overall Study||68
8943428|NCT02388568|10005200|FG000|COMPLETED|Overall Study||59
8943429|NCT02388568|10005201|FG001|COMPLETED|Overall Study||53
8617721|NCT00458484|9655895|FG002|NOT COMPLETED|Overall Study||0
8617722|NCT00458484|9655896|FG003|NOT COMPLETED|Overall Study||0
8617723|NCT00458484|9655897|FG004|NOT COMPLETED|Overall Study||0
8617724|NCT00458484|9655898|FG005|NOT COMPLETED|Overall Study||1
8617725|NCT00458484|9655899|FG006|NOT COMPLETED|Overall Study||0
8943430|NCT02388568|10005200|FG000|NOT COMPLETED|Overall Study||10
8943431|NCT02388568|10005201|FG001|NOT COMPLETED|Overall Study||15
8943432|NCT02388633|10005207|FG000|STARTED|Overall Study||8
8943433|NCT02388633|10005207|FG000|COMPLETED|Overall Study||8
8943434|NCT02388633|10005207|FG000|NOT COMPLETED|Overall Study||0
8943435|NCT02388646|10005214|FG000|STARTED|Overall Study||20
8943436|NCT02388646|10005215|FG001|STARTED|Overall Study||20
8943437|NCT02388646|10005216|FG002|STARTED|Overall Study||20
8943438|NCT02388646|10005214|FG000|COMPLETED|Overall Study||16
8943439|NCT02388646|10005215|FG001|COMPLETED|Overall Study||19
8943440|NCT02388646|10005216|FG002|COMPLETED|Overall Study||14
8943441|NCT02388646|10005214|FG000|NOT COMPLETED|Overall Study||4
8943442|NCT02388646|10005215|FG001|NOT COMPLETED|Overall Study||1
8943443|NCT02388646|10005216|FG002|NOT COMPLETED|Overall Study||6
8943444|NCT02388724|10005226|FG000|STARTED|Overall Study||244
8943445|NCT02388724|10005227|FG001|STARTED|Overall Study||237
8943446|NCT02388724|10005226|FG000|Safety Set: Randomized But Not Treated|Overall Study||0
8943447|NCT02388724|10005227|FG001|Safety Set: Randomized But Not Treated|Overall Study||2
8943448|NCT02388724|10005226|FG000|COMPLETED|Overall Study||232
8617726|NCT00458705|9655924|FG000|STARTED|Overall Study||45
8617727|NCT00458705|9655924|FG000|COMPLETED|Overall Study||40
8617728|NCT00458705|9655924|FG000|NOT COMPLETED|Overall Study||5
8617729|NCT00458783|9655930|FG000|STARTED|Overall Study||1914
8617730|NCT00458783|9655931|FG001|STARTED|Overall Study||1921
8617731|NCT00458783|9655930|FG000|COMPLETED|Overall Study||686
8617732|NCT00458783|9655931|FG001|COMPLETED|Overall Study||701
8617733|NCT00458783|9655930|FG000|NOT COMPLETED|Overall Study||1228
8943449|NCT02388724|10005227|FG001|COMPLETED|Overall Study||224
8943450|NCT02388724|10005226|FG000|NOT COMPLETED|Overall Study||12
8943451|NCT02388724|10005227|FG001|NOT COMPLETED|Overall Study||13
8943452|NCT02388737|10005236|FG000|STARTED|Overall Study||235
8943453|NCT02388737|10005237|FG001|STARTED|Overall Study||226
8943454|NCT02388737|10005238|FG002|STARTED|Overall Study||242
8943455|NCT02388737|10005236|FG000|COMPLETED|Overall Study||181
8943456|NCT02388737|10005237|FG001|COMPLETED|Overall Study||166
8943457|NCT02388737|10005238|FG002|COMPLETED|Overall Study||180
8943458|NCT02388737|10005236|FG000|NOT COMPLETED|Overall Study||54
8943459|NCT02388737|10005237|FG001|NOT COMPLETED|Overall Study||60
8943460|NCT02388737|10005238|FG002|NOT COMPLETED|Overall Study||62
8943461|NCT02388763|10005246|FG000|STARTED|Habitual, 10 Days of Wear||32
8943462|NCT02388763|10005247|FG001|STARTED|Habitual, 10 Days of Wear||32
8943463|NCT02388763|10005246|FG000|COMPLETED|Habitual, 10 Days of Wear||31
8943464|NCT02388763|10005247|FG001|COMPLETED|Habitual, 10 Days of Wear||31
8943465|NCT02388763|10005246|FG000|NOT COMPLETED|Habitual, 10 Days of Wear||1
8943466|NCT02388763|10005247|FG001|NOT COMPLETED|Habitual, 10 Days of Wear||1
8943467|NCT02388763|10005246|FG000|STARTED|Period 1, 10 Days of Wear||31
8943468|NCT02388763|10005247|FG001|STARTED|Period 1, 10 Days of Wear||31
8943469|NCT02388763|10005246|FG000|COMPLETED|Period 1, 10 Days of Wear||30
8943470|NCT02388763|10005247|FG001|COMPLETED|Period 1, 10 Days of Wear||30
8943471|NCT02388763|10005246|FG000|NOT COMPLETED|Period 1, 10 Days of Wear||1
8943472|NCT02388763|10005247|FG001|NOT COMPLETED|Period 1, 10 Days of Wear||1
8943473|NCT02388763|10005246|FG000|STARTED|Period 2, 10 Days of Wear||30
8943474|NCT02388763|10005247|FG001|STARTED|Period 2, 10 Days of Wear||30
8943475|NCT02388763|10005246|FG000|COMPLETED|Period 2, 10 Days of Wear||30
8943476|NCT02388763|10005247|FG001|COMPLETED|Period 2, 10 Days of Wear||30
8943477|NCT02388763|10005246|FG000|NOT COMPLETED|Period 2, 10 Days of Wear||0
8943478|NCT02388763|10005247|FG001|NOT COMPLETED|Period 2, 10 Days of Wear||0
8943479|NCT02388815|10005256|FG000|STARTED|Overall Study||89
8943480|NCT02388815|10005256|FG000|COMPLETED|Overall Study||85
8943481|NCT02388815|10005256|FG000|NOT COMPLETED|Overall Study||4
8943482|NCT02388880|10005260|FG000|STARTED|Overall Study||3
8943483|NCT02388880|10005260|FG000|COMPLETED|Overall Study||3
8943484|NCT02388880|10005260|FG000|NOT COMPLETED|Overall Study||0
8943485|NCT02388932|10005264|FG000|STARTED|Overall Study||3
8943486|NCT02388932|10005264|FG000|COMPLETED|Overall Study||2
8943487|NCT02388932|10005264|FG000|NOT COMPLETED|Overall Study||1
8943488|NCT02388997|10005271|FG000|STARTED|Overall Study||15
8943489|NCT02388997|10005272|FG001|STARTED|Overall Study||16
8943490|NCT02388997|10005271|FG000|COMPLETED|Overall Study||12
8943491|NCT02388997|10005272|FG001|COMPLETED|Overall Study||10
8943492|NCT02388997|10005271|FG000|NOT COMPLETED|Overall Study||3
8943493|NCT02388997|10005272|FG001|NOT COMPLETED|Overall Study||6
8943494|NCT02389088|10005278|FG000|STARTED|Overall Study - Phase I||9
8943495|NCT02389088|10005278|FG000|COMPLETED|Overall Study - Phase I||9
8943496|NCT02389088|10005278|FG000|NOT COMPLETED|Overall Study - Phase I||0
8943497|NCT02389088|10005278|FG000|STARTED|Phase II - All Study Participants||9
8943498|NCT02389088|10005278|FG000|COMPLETED|Phase II - All Study Participants||9
8943499|NCT02389088|10005278|FG000|NOT COMPLETED|Phase II - All Study Participants||0
8943500|NCT02389101|10005292|FG000|STARTED|Overall Study||21
8943501|NCT02389101|10005292|FG000|COMPLETED|Overall Study||21
8943502|NCT02389101|10005292|FG000|NOT COMPLETED|Overall Study||0
8943503|NCT02389361|10005298|FG000|STARTED|Overall Study||24
8943504|NCT02389361|10005299|FG001|STARTED|Overall Study||27
8943505|NCT02389361|10005298|FG000|COMPLETED|Overall Study||24
8943506|NCT02389361|10005299|FG001|COMPLETED|Overall Study||27
8943507|NCT02389361|10005298|FG000|NOT COMPLETED|Overall Study||0
8943508|NCT02389361|10005299|FG001|NOT COMPLETED|Overall Study||0
8943509|NCT02389452|10005305|FG000|STARTED|Overall Study||394
8948716|NCT02432235|10011176|FG006|COMPLETED|Overall Study||23
8617734|NCT00458783|9655931|FG001|NOT COMPLETED|Overall Study||1220
8943510|NCT02389452|10005305|FG000|Participants Received Repeat Injection|Overall Study|Repeat injection based on physician's assessment of efficacy and safety at Week 26, 39 or 52.|11
8943511|NCT02389452|10005305|FG000|COMPLETED|Overall Study||369
8943512|NCT02389452|10005305|FG000|NOT COMPLETED|Overall Study||25
8943513|NCT02389621|10005312|FG000|STARTED|Treatment Period||108
8943514|NCT02389621|10005313|FG001|STARTED|Treatment Period||107
8943515|NCT02389621|10005312|FG000|Received Study Drug|Treatment Period||107
8943516|NCT02389621|10005313|FG001|Received Study Drug|Treatment Period||107
8943517|NCT02389621|10005312|FG000|COMPLETED|Treatment Period||107
8943518|NCT02389621|10005313|FG001|COMPLETED|Treatment Period||106
8943519|NCT02389621|10005312|FG000|NOT COMPLETED|Treatment Period||1
8943520|NCT02389621|10005313|FG001|NOT COMPLETED|Treatment Period||1
8943521|NCT02389621|10005312|FG000|STARTED|Posttreatment Period||107
8943522|NCT02389621|10005313|FG001|STARTED|Posttreatment Period||106
8943523|NCT02389621|10005312|FG000|COMPLETED|Posttreatment Period||98
8943524|NCT02389621|10005313|FG001|COMPLETED|Posttreatment Period||102
8943525|NCT02389621|10005312|FG000|NOT COMPLETED|Posttreatment Period||9
8943526|NCT02389621|10005313|FG001|NOT COMPLETED|Posttreatment Period||4
8943527|NCT02389725|10005325|FG000|STARTED|Overall Study||59
8943528|NCT02389725|10005326|FG001|STARTED|Overall Study||60
8943529|NCT02389725|10005325|FG000|COMPLETED|Overall Study||59
8943530|NCT02389725|10005326|FG001|COMPLETED|Overall Study||60
8943531|NCT02389725|10005325|FG000|NOT COMPLETED|Overall Study||0
8943532|NCT02389725|10005326|FG001|NOT COMPLETED|Overall Study||0
8943533|NCT02389738|10005334|FG000|STARTED|Overall Study||6
8943534|NCT02389738|10005334|FG000|COMPLETED|Overall Study||5
8943535|NCT02389738|10005334|FG000|NOT COMPLETED|Overall Study||1
8943536|NCT02389764|10005338|FG000|STARTED|Overall Study||9
8943537|NCT02389764|10005338|FG000|COMPLETED|Overall Study||0
8943538|NCT02389764|10005338|FG000|NOT COMPLETED|Overall Study||9
8943539|NCT02389816|10005345|FG000|STARTED|Overall Study||164
8943540|NCT02389816|10005346|FG001|STARTED|Overall Study||165
8943541|NCT02389816|10005347|FG002|STARTED|Overall Study||164
8943542|NCT02389816|10005345|FG000|COMPLETED|Overall Study||149
8943543|NCT02389816|10005346|FG001|COMPLETED|Overall Study||152
8943544|NCT02389816|10005347|FG002|COMPLETED|Overall Study||152
8943545|NCT02389816|10005345|FG000|NOT COMPLETED|Overall Study||15
8943546|NCT02389816|10005346|FG001|NOT COMPLETED|Overall Study||13
8943547|NCT02389816|10005347|FG002|NOT COMPLETED|Overall Study||12
8943548|NCT02389829|10005357|FG000|STARTED|Overall Study||64
8943549|NCT02389829|10005358|FG001|STARTED|Overall Study||63
8943550|NCT02389829|10005357|FG000|COMPLETED|Overall Study||64
8943551|NCT02389829|10005358|FG001|COMPLETED|Overall Study||62
8943552|NCT02389829|10005357|FG000|NOT COMPLETED|Overall Study||0
8943553|NCT02389829|10005358|FG001|NOT COMPLETED|Overall Study||1
8943554|NCT02389881|10005371|FG000|STARTED|Overall Study||6
8943555|NCT02389881|10005372|FG001|STARTED|Overall Study||6
8943556|NCT02389881|10005373|FG002|STARTED|Overall Study||6
8943557|NCT02389881|10005374|FG003|STARTED|Overall Study||6
8943558|NCT02389881|10005375|FG004|STARTED|Overall Study||6
8943559|NCT02389881|10005376|FG005|STARTED|Overall Study||8
8943560|NCT02389881|10005377|FG006|STARTED|Overall Study||2
8943561|NCT02389881|10005371|FG000|COMPLETED|Overall Study||6
8943562|NCT02389881|10005372|FG001|COMPLETED|Overall Study||6
8943563|NCT02389881|10005373|FG002|COMPLETED|Overall Study||6
8943564|NCT02389881|10005374|FG003|COMPLETED|Overall Study||6
8943565|NCT02389881|10005375|FG004|COMPLETED|Overall Study||6
8943566|NCT02389881|10005376|FG005|COMPLETED|Overall Study||8
8943567|NCT02389881|10005377|FG006|COMPLETED|Overall Study||2
8943568|NCT02389881|10005371|FG000|NOT COMPLETED|Overall Study||0
8943569|NCT02389881|10005372|FG001|NOT COMPLETED|Overall Study||0
8943570|NCT02389881|10005373|FG002|NOT COMPLETED|Overall Study||0
8943571|NCT02389881|10005374|FG003|NOT COMPLETED|Overall Study||0
8943572|NCT02389881|10005375|FG004|NOT COMPLETED|Overall Study||0
8943573|NCT02389881|10005376|FG005|NOT COMPLETED|Overall Study||0
8943574|NCT02389881|10005377|FG006|NOT COMPLETED|Overall Study||0
8943575|NCT02389894|10005396|FG000|STARTED|Overall Study||133
8617735|NCT00458822|9655937|FG000|STARTED|Overall Study||40
8617736|NCT00458822|9655937|FG000|COMPLETED|Overall Study||40
8617737|NCT00458822|9655937|FG000|NOT COMPLETED|Overall Study||0
8943576|NCT02389894|10005397|FG001|STARTED|Overall Study||118
8943577|NCT02389894|10005398|FG002|STARTED|Overall Study||132
8943578|NCT02389894|10005396|FG000|COMPLETED|Overall Study||125
8943579|NCT02389894|10005397|FG001|COMPLETED|Overall Study||108
8943580|NCT02389894|10005398|FG002|COMPLETED|Overall Study||123
8943581|NCT02389894|10005396|FG000|NOT COMPLETED|Overall Study||8
8943582|NCT02389894|10005397|FG001|NOT COMPLETED|Overall Study||10
8617738|NCT00458848|9655941|FG000|STARTED|Overall Study||51
8943583|NCT02389894|10005398|FG002|NOT COMPLETED|Overall Study||9
8943584|NCT02389959|10005408|FG000|STARTED|Overall Study||20
8943585|NCT02389959|10005409|FG001|STARTED|Overall Study||20
8943586|NCT02389959|10005408|FG000|COMPLETED|Overall Study||18
8943587|NCT02389959|10005409|FG001|COMPLETED|Overall Study||19
8617739|NCT00458848|9655941|FG000|COMPLETED|Overall Study||51
8943588|NCT02389959|10005408|FG000|NOT COMPLETED|Overall Study||2
8943589|NCT02389959|10005409|FG001|NOT COMPLETED|Overall Study||1
8943590|NCT02389998|10005417|FG000|STARTED|Overall Study||16
8943591|NCT02389998|10005418|FG001|STARTED|Overall Study||15
8943592|NCT02389998|10005417|FG000|COMPLETED|Overall Study||15
8943593|NCT02389998|10005418|FG001|COMPLETED|Overall Study||15
8943594|NCT02389998|10005417|FG000|NOT COMPLETED|Overall Study||1
8943595|NCT02389998|10005418|FG001|NOT COMPLETED|Overall Study||0
8943596|NCT02390050|10005430|FG000|STARTED|Overall Study||72
8943597|NCT02390050|10005431|FG001|STARTED|Overall Study||72
8943598|NCT02390050|10005432|FG002|STARTED|Overall Study||72
8943599|NCT02390050|10005433|FG003|STARTED|Overall Study||76
8943600|NCT02390050|10005430|FG000|COMPLETED|Overall Study||65
8943601|NCT02390050|10005431|FG001|COMPLETED|Overall Study||67
8943602|NCT02390050|10005432|FG002|COMPLETED|Overall Study||68
8943603|NCT02390050|10005433|FG003|COMPLETED|Overall Study||69
8943604|NCT02390050|10005430|FG000|NOT COMPLETED|Overall Study||7
8943605|NCT02390050|10005431|FG001|NOT COMPLETED|Overall Study||5
8943606|NCT02390050|10005432|FG002|NOT COMPLETED|Overall Study||4
8943607|NCT02390050|10005433|FG003|NOT COMPLETED|Overall Study||7
8943608|NCT02390076|10005446|FG000|STARTED|Overall Study||18
8943609|NCT02390076|10005447|FG001|STARTED|Overall Study||18
8943610|NCT02390076|10005448|FG002|STARTED|Overall Study||15
8943611|NCT02390076|10005446|FG000|COMPLETED|Overall Study||16
8943612|NCT02390076|10005447|FG001|COMPLETED|Overall Study||17
8943613|NCT02390076|10005448|FG002|COMPLETED|Overall Study||11
8943614|NCT02390076|10005446|FG000|NOT COMPLETED|Overall Study||2
8943615|NCT02390076|10005447|FG001|NOT COMPLETED|Overall Study||1
8943616|NCT02390076|10005448|FG002|NOT COMPLETED|Overall Study||4
8943617|NCT02390167|10005456|FG000|STARTED|Overall Study||376
8943618|NCT02390167|10005456|FG000|With Diabetes|Overall Study||333
8943619|NCT02390167|10005456|FG000|Without Diabetes|Overall Study||43
8943620|NCT02390167|10005456|FG000|COMPLETED|Overall Study||375
8943621|NCT02390167|10005456|FG000|NOT COMPLETED|Overall Study||1
8948717|NCT02432235|10011177|FG007|COMPLETED|Overall Study||9
8948718|NCT02432235|10011178|FG008|COMPLETED|Overall Study||5
8948719|NCT02432235|10011179|FG009|COMPLETED|Overall Study||0
8948720|NCT02432235|10011180|FG010|COMPLETED|Overall Study||1
8948721|NCT02432235|10011181|FG011|COMPLETED|Overall Study||0
8948722|NCT02432235|10011170|FG000|NOT COMPLETED|Overall Study||1
8948723|NCT02432235|10011171|FG001|NOT COMPLETED|Overall Study||2
8948724|NCT02432235|10011172|FG002|NOT COMPLETED|Overall Study||2
8948725|NCT02432235|10011173|FG003|NOT COMPLETED|Overall Study||2
8948726|NCT02432235|10011174|FG004|NOT COMPLETED|Overall Study||2
8948727|NCT02432235|10011175|FG005|NOT COMPLETED|Overall Study||12
8948728|NCT02432235|10011176|FG006|NOT COMPLETED|Overall Study||18
8948729|NCT02432235|10011177|FG007|NOT COMPLETED|Overall Study||20
8948730|NCT02432235|10011178|FG008|NOT COMPLETED|Overall Study||21
8948731|NCT02432235|10011179|FG009|NOT COMPLETED|Overall Study||3
8948732|NCT02432235|10011180|FG010|NOT COMPLETED|Overall Study||1
8948733|NCT02432235|10011181|FG011|NOT COMPLETED|Overall Study||1
8948734|NCT02432274|10011217|FG000|STARTED|Overall Study||3
9065672|NCT04137783|10126140|FG001|COMPLETED|Overall Study||10
9065673|NCT04137783|10126141|FG002|COMPLETED|Overall Study||22
9065674|NCT04137783|10126139|FG000|NOT COMPLETED|Overall Study||0
9065675|NCT04137783|10126140|FG001|NOT COMPLETED|Overall Study||0
9065676|NCT04137783|10126141|FG002|NOT COMPLETED|Overall Study||0
9065677|NCT04136444|10126151|FG000|STARTED|Overall Study||3
9065678|NCT04136444|10126152|FG001|STARTED|Overall Study||9
9065679|NCT04136444|10126151|FG000|COMPLETED|Overall Study|The cohort was not completely recruited, as the study was stopped/terminated due to COVID-19.|3
9065680|NCT04136444|10126152|FG001|COMPLETED|Overall Study||8
9065681|NCT04136444|10126151|FG000|NOT COMPLETED|Overall Study||0
9065682|NCT04136444|10126152|FG001|NOT COMPLETED|Overall Study||1
9065683|NCT04124536|10126169|FG000|STARTED|Overall Study||58
9065684|NCT04124536|10126170|FG001|STARTED|Overall Study||58
9065685|NCT04124536|10126171|FG002|STARTED|Overall Study||105
9065686|NCT04124536|10126172|FG003|STARTED|Overall Study||105
9065687|NCT04124536|10126173|FG004|STARTED|Overall Study||15
9065688|NCT04124536|10126169|FG000|COMPLETED|Overall Study||47
9065689|NCT04124536|10126170|FG001|COMPLETED|Overall Study||53
9065690|NCT04124536|10126171|FG002|COMPLETED|Overall Study||102
9065691|NCT04124536|10126172|FG003|COMPLETED|Overall Study||98
9065692|NCT04124536|10126173|FG004|COMPLETED|Overall Study||15
9065693|NCT04124536|10126169|FG000|NOT COMPLETED|Overall Study||11
9065694|NCT04124536|10126170|FG001|NOT COMPLETED|Overall Study||5
9065695|NCT04124536|10126171|FG002|NOT COMPLETED|Overall Study||3
9065696|NCT04124536|10126172|FG003|NOT COMPLETED|Overall Study||7
9065697|NCT04124536|10126173|FG004|NOT COMPLETED|Overall Study||0
9065698|NCT04147611|10126186|FG000|STARTED|Overall Study||9
9065699|NCT04147611|10126187|FG001|STARTED|Overall Study||13
9065700|NCT04147611|10126186|FG000|COMPLETED|Overall Study||9
9065701|NCT04147611|10126187|FG001|COMPLETED|Overall Study||12
9065702|NCT04147611|10126186|FG000|NOT COMPLETED|Overall Study||0
9065703|NCT04147611|10126187|FG001|NOT COMPLETED|Overall Study||1
9065704|NCT04147442|10126193|FG000|STARTED|Overall Study||20
9065705|NCT04147442|10126193|FG000|COMPLETED|Overall Study||20
9065706|NCT04147442|10126193|FG000|NOT COMPLETED|Overall Study||0
9065707|NCT04147455|10126207|FG000|STARTED|Overall Study||397
8948735|NCT02432274|10011218|FG001|STARTED|Overall Study||9
8948736|NCT02432274|10011219|FG002|STARTED|Overall Study||11
8948737|NCT02432274|10011220|FG003|STARTED|Overall Study||1
8948738|NCT02432274|10011221|FG004|STARTED|Overall Study||31
9065708|NCT04147455|10126208|FG001|STARTED|Overall Study||396
9065709|NCT04147455|10126207|FG000|COMPLETED|Overall Study||375
9065710|NCT04147455|10126208|FG001|COMPLETED|Overall Study||364
9065711|NCT04147455|10126207|FG000|NOT COMPLETED|Overall Study||22
9065712|NCT04147455|10126208|FG001|NOT COMPLETED|Overall Study||32
8948739|NCT02432274|10011222|FG005|STARTED|Overall Study||7
8948740|NCT02432274|10011223|FG006|STARTED|Overall Study||15
8948741|NCT02432274|10011224|FG007|STARTED|Overall Study||20
9065713|NCT04146272|10126218|FG000|STARTED|First Intervention||11
9065714|NCT04146272|10126219|FG001|STARTED|First Intervention||11
9065715|NCT04146272|10126220|FG002|STARTED|First Intervention||6
9065716|NCT04146272|10126221|FG003|STARTED|First Intervention||5
9065717|NCT04146272|10126218|FG000|COMPLETED|First Intervention||11
9065718|NCT04146272|10126219|FG001|COMPLETED|First Intervention||11
9065719|NCT04146272|10126220|FG002|COMPLETED|First Intervention||6
9065720|NCT04146272|10126221|FG003|COMPLETED|First Intervention||5
9065721|NCT04146272|10126218|FG000|NOT COMPLETED|First Intervention||0
9065722|NCT04146272|10126219|FG001|NOT COMPLETED|First Intervention||0
9065723|NCT04146272|10126220|FG002|NOT COMPLETED|First Intervention||0
9065724|NCT04146272|10126221|FG003|NOT COMPLETED|First Intervention||0
9065725|NCT04146272|10126218|FG000|STARTED|Second Intervention||11
9065726|NCT04146272|10126219|FG001|STARTED|Second Intervention||11
9065727|NCT04146272|10126220|FG002|STARTED|Second Intervention||6
9065728|NCT04146272|10126221|FG003|STARTED|Second Intervention||5
9065729|NCT04146272|10126218|FG000|COMPLETED|Second Intervention||11
9065730|NCT04146272|10126219|FG001|COMPLETED|Second Intervention||11
9065731|NCT04146272|10126220|FG002|COMPLETED|Second Intervention||6
9065732|NCT04146272|10126221|FG003|COMPLETED|Second Intervention||5
9065733|NCT04146272|10126218|FG000|NOT COMPLETED|Second Intervention||0
9065734|NCT04146272|10126219|FG001|NOT COMPLETED|Second Intervention||0
9065735|NCT04146272|10126220|FG002|NOT COMPLETED|Second Intervention||0
9065736|NCT04146272|10126221|FG003|NOT COMPLETED|Second Intervention||0
9065737|NCT04143945|10126240|FG000|STARTED|Treatment Period 1 (Day 1)||26
9065738|NCT04143945|10126241|FG001|STARTED|Treatment Period 1 (Day 1)||26
9065739|NCT04143945|10126242|FG002|STARTED|Treatment Period 1 (Day 1)||26
9065740|NCT04143945|10126243|FG003|STARTED|Treatment Period 1 (Day 1)||26
9065741|NCT04143945|10126240|FG000|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26
9065742|NCT04143945|10126241|FG001|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26
9065743|NCT04143945|10126242|FG002|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26
9065744|NCT04143945|10126243|FG003|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26
9065745|NCT04143945|10126240|FG000|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26
9065746|NCT04143945|10126241|FG001|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26
9065747|NCT04143945|10126242|FG002|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26
9065748|NCT04143945|10126243|FG003|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26
9065749|NCT04143945|10126240|FG000|Per Protocol Set|Treatment Period 1 (Day 1)||26
9065750|NCT04143945|10126241|FG001|Per Protocol Set|Treatment Period 1 (Day 1)||26
9065751|NCT04143945|10126242|FG002|Per Protocol Set|Treatment Period 1 (Day 1)||26
9065752|NCT04143945|10126243|FG003|Per Protocol Set|Treatment Period 1 (Day 1)||26
9065753|NCT04143945|10126240|FG000|COMPLETED|Treatment Period 1 (Day 1)||26
9065754|NCT04143945|10126241|FG001|COMPLETED|Treatment Period 1 (Day 1)||26
9065755|NCT04143945|10126242|FG002|COMPLETED|Treatment Period 1 (Day 1)||26
9065756|NCT04143945|10126243|FG003|COMPLETED|Treatment Period 1 (Day 1)||26
9065757|NCT04143945|10126240|FG000|NOT COMPLETED|Treatment Period 1 (Day 1)||0
8617740|NCT00458848|9655941|FG000|NOT COMPLETED|Overall Study||0
8617741|NCT00458952|9655947|FG000|STARTED|Overall Study||7
8617742|NCT00458952|9655948|FG001|STARTED|Overall Study||14
8617743|NCT00458952|9655947|FG000|COMPLETED|Overall Study||5
8719390|NCT01004159|9766915|FG000|STARTED|Overall Study||20
8617744|NCT00458952|9655948|FG001|COMPLETED|Overall Study||9
8617745|NCT00458952|9655947|FG000|NOT COMPLETED|Overall Study||2
8719391|NCT01004159|9766915|FG000|COMPLETED|Overall Study||0
8719392|NCT01004159|9766915|FG000|NOT COMPLETED|Overall Study||20
8719393|NCT01004172|9766919|FG000|STARTED|Overall Study||38
8719394|NCT01004172|9766919|FG000|COMPLETED|Overall Study||0
8719395|NCT01004172|9766919|FG000|NOT COMPLETED|Overall Study||38
8557780|NCT00003222|9589704|FG001|NOT COMPLETED|Overall Study||1
8557781|NCT00003224|9589716|FG000|STARTED|Overall Study||4
8557782|NCT00003224|9589717|FG001|STARTED|Overall Study||5
8557783|NCT00003224|9589718|FG002|STARTED|Overall Study||4
8557784|NCT00003224|9589719|FG003|STARTED|Overall Study||2
8557785|NCT00003224|9589720|FG004|STARTED|Overall Study||4
8557786|NCT00003224|9589721|FG005|STARTED|Overall Study||3
8557787|NCT00003224|9589716|FG000|COMPLETED|Overall Study||4
8557788|NCT00003224|9589717|FG001|COMPLETED|Overall Study||5
8557789|NCT00003224|9589718|FG002|COMPLETED|Overall Study||4
8557790|NCT00003224|9589719|FG003|COMPLETED|Overall Study||2
8617746|NCT00458952|9655948|FG001|NOT COMPLETED|Overall Study||5
8617747|NCT00459043|9655954|FG000|STARTED|Overall Study||15
8617748|NCT00459043|9655955|FG001|STARTED|Overall Study||15
8617749|NCT00459043|9655954|FG000|COMPLETED|Overall Study||14
8617750|NCT00459043|9655955|FG001|COMPLETED|Overall Study||15
8617751|NCT00459043|9655954|FG000|NOT COMPLETED|Overall Study||1
8617752|NCT00459043|9655955|FG001|NOT COMPLETED|Overall Study||0
8617753|NCT00459056|9655963|FG000|STARTED|First Intervention (First Three Months)||10
8617754|NCT00459056|9655964|FG001|STARTED|First Intervention (First Three Months)||15
8617755|NCT00459056|9655963|FG000|COMPLETED|First Intervention (First Three Months)||9
8617756|NCT00459056|9655964|FG001|COMPLETED|First Intervention (First Three Months)||14
8617757|NCT00459056|9655963|FG000|NOT COMPLETED|First Intervention (First Three Months)||1
8617758|NCT00459056|9655964|FG001|NOT COMPLETED|First Intervention (First Three Months)||1
8617759|NCT00459056|9655963|FG000|STARTED|Washout (1 Month)||9
8617760|NCT00459056|9655964|FG001|STARTED|Washout (1 Month)||14
8617761|NCT00459056|9655963|FG000|COMPLETED|Washout (1 Month)||9
8617762|NCT00459056|9655964|FG001|COMPLETED|Washout (1 Month)||14
8617763|NCT00459056|9655963|FG000|NOT COMPLETED|Washout (1 Month)||0
8813696|NCT01527045|9866891|FG001|NOT COMPLETED|Overall Study||0
8813697|NCT01527045|9866892|FG002|NOT COMPLETED|Overall Study||0
8813698|NCT01527110|9866900|FG000|STARTED|Overall Study||21
8813699|NCT01527110|9866900|FG000|COMPLETED|Overall Study||20
8813700|NCT01527110|9866900|FG000|NOT COMPLETED|Overall Study||1
8813701|NCT01527162|9866904|FG000|STARTED|Overall Study||6
8813702|NCT01527162|9866905|FG001|STARTED|Overall Study||5
8813703|NCT01527162|9866904|FG000|COMPLETED|Overall Study||6
8813704|NCT01527162|9866905|FG001|COMPLETED|Overall Study||5
8813705|NCT01527162|9866904|FG000|NOT COMPLETED|Overall Study||0
8813706|NCT01527162|9866905|FG001|NOT COMPLETED|Overall Study||0
8813707|NCT01527357|9866915|FG000|STARTED|Overall Study||482
8813708|NCT01527357|9866916|FG001|STARTED|Overall Study||239
8813709|NCT01527357|9866915|FG000|Efficacy Population|Overall Study|Two participants did not receive study treatment.|480
8617764|NCT00459056|9655964|FG001|NOT COMPLETED|Washout (1 Month)||0
8813710|NCT01527357|9866916|FG001|Efficacy Population|Overall Study||239
8813711|NCT01527357|9866915|FG000|COMPLETED|Overall Study||465
8813712|NCT01527357|9866916|FG001|COMPLETED|Overall Study||230
8813713|NCT01527357|9866915|FG000|NOT COMPLETED|Overall Study||17
8813714|NCT01527357|9866916|FG001|NOT COMPLETED|Overall Study||9
8813715|NCT01527370|9866922|FG000|STARTED|Overall Study||250
8813716|NCT01527370|9866922|FG000|COMPLETED|Overall Study||244
8813717|NCT01527370|9866922|FG000|NOT COMPLETED|Overall Study||6
8813718|NCT01527383|9866928|FG000|STARTED|Overall Study||292
8813719|NCT01527383|9866929|FG001|STARTED|Overall Study||62
8813720|NCT01527383|9866928|FG000|Vaccination 1 (Day 1)|Overall Study||291
8813721|NCT01527383|9866929|FG001|Vaccination 1 (Day 1)|Overall Study||62
8813722|NCT01527383|9866928|FG000|Vaccination 2 (~Day 30)|Overall Study||283
8813723|NCT01527383|9866929|FG001|Vaccination 2 (~Day 30)|Overall Study||61
8813724|NCT01527383|9866928|FG000|Vaccination 3 (~Day 60)|Overall Study||278
8813725|NCT01527383|9866929|FG001|Vaccination 3 (~Day 60)|Overall Study||58
8719396|NCT01004185|9766926|FG000|STARTED|Overall Study||19
8813726|NCT01527383|9866928|FG000|Vaccination 4 (~Day 90)|Overall Study||277
8719397|NCT01004185|9766927|FG001|STARTED|Overall Study||20
8719398|NCT01004185|9766926|FG000|COMPLETED|Overall Study||10
8719399|NCT01004185|9766927|FG001|COMPLETED|Overall Study||11
8617765|NCT00459056|9655963|FG000|STARTED|Second Intervention (Final Three Months)||9
8719400|NCT01004185|9766926|FG000|NOT COMPLETED|Overall Study||9
8719401|NCT01004185|9766927|FG001|NOT COMPLETED|Overall Study||9
8719402|NCT01004250|9766933|FG000|STARTED|Induction Therapy Period||109
8719403|NCT01004250|9766933|FG000|Received at Least One Dose of Study Drug|Induction Therapy Period||109
8813727|NCT01527383|9866929|FG001|Vaccination 4 (~Day 90)|Overall Study||58
8813728|NCT01527383|9866928|FG000|COMPLETED|Overall Study||277
8813729|NCT01527383|9866929|FG001|COMPLETED|Overall Study||58
8813730|NCT01527383|9866928|FG000|NOT COMPLETED|Overall Study||15
8557791|NCT00003224|9589720|FG004|COMPLETED|Overall Study||4
8557792|NCT00003224|9589721|FG005|COMPLETED|Overall Study||3
8557793|NCT00003224|9589716|FG000|NOT COMPLETED|Overall Study||0
8557794|NCT00003224|9589717|FG001|NOT COMPLETED|Overall Study||0
8557795|NCT00003224|9589718|FG002|NOT COMPLETED|Overall Study||0
8557796|NCT00003224|9589719|FG003|NOT COMPLETED|Overall Study||0
8557797|NCT00003224|9589720|FG004|NOT COMPLETED|Overall Study||0
8617766|NCT00459056|9655964|FG001|STARTED|Second Intervention (Final Three Months)||14
8617767|NCT00459056|9655963|FG000|COMPLETED|Second Intervention (Final Three Months)||9
8557798|NCT00003224|9589721|FG005|NOT COMPLETED|Overall Study||0
8557799|NCT00003270|9589733|FG000|STARTED|Overall Study||20
8557800|NCT00003270|9589733|FG000|COMPLETED|Overall Study||20
8557801|NCT00003270|9589733|FG000|NOT COMPLETED|Overall Study||0
8568837|NCT00094302|9601079|FG000|NOT COMPLETED|Overall Study||417
8568838|NCT00094302|9601080|FG001|NOT COMPLETED|Overall Study||406
8568839|NCT00094328|9601086|FG000|STARTED|Overall Study|Received treatment|14
8568840|NCT00094328|9601086|FG000|COMPLETED|Overall Study|Completed 12 months on treatment|13
8568841|NCT00094328|9601086|FG000|NOT COMPLETED|Overall Study||1
8568842|NCT00094445|9601090|FG000|STARTED|Overall Study||50
8568843|NCT00094445|9601090|FG000|COMPLETED|Overall Study||44
8568844|NCT00094445|9601090|FG000|NOT COMPLETED|Overall Study||6
8568845|NCT00094458|9601097|FG000|STARTED|Main Study: Through Week 30||170
8568846|NCT00094458|9601098|FG001|STARTED|Main Study: Through Week 30||169
8568847|NCT00094458|9601099|FG002|STARTED|Main Study: Through Week 30||169
8568848|NCT00094458|9601100|FG003|STARTED|Main Study: Through Week 30||0
8568849|NCT00094458|9601101|FG004|STARTED|Main Study: Through Week 30||0
8568850|NCT00094458|9601102|FG005|STARTED|Main Study: Through Week 30||0
8568851|NCT00094458|9601097|FG000|COMPLETED|Main Study: Through Week 30||86
8568852|NCT00094458|9601098|FG001|COMPLETED|Main Study: Through Week 30||111
8568853|NCT00094458|9601099|FG002|COMPLETED|Main Study: Through Week 30||121
8568854|NCT00094458|9601100|FG003|COMPLETED|Main Study: Through Week 30||0
8568855|NCT00094458|9601101|FG004|COMPLETED|Main Study: Through Week 30||0
8568856|NCT00094458|9601102|FG005|COMPLETED|Main Study: Through Week 30||0
8568857|NCT00094458|9601097|FG000|NOT COMPLETED|Main Study: Through Week 30||84
8568858|NCT00094458|9601098|FG001|NOT COMPLETED|Main Study: Through Week 30||58
8568859|NCT00094458|9601099|FG002|NOT COMPLETED|Main Study: Through Week 30||48
8568860|NCT00094458|9601100|FG003|NOT COMPLETED|Main Study: Through Week 30||0
8568861|NCT00094458|9601101|FG004|NOT COMPLETED|Main Study: Through Week 30||0
8568862|NCT00094458|9601102|FG005|NOT COMPLETED|Main Study: Through Week 30||0
8568863|NCT00094458|9601097|FG000|STARTED|Study Extension: Week 30 Through Week 50||75
8568864|NCT00094458|9601098|FG001|STARTED|Study Extension: Week 30 Through Week 50||97
8568865|NCT00094458|9601099|FG002|STARTED|Study Extension: Week 30 Through Week 50||108
8568866|NCT00094458|9601100|FG003|STARTED|Study Extension: Week 30 Through Week 50||0
8568867|NCT00094458|9601101|FG004|STARTED|Study Extension: Week 30 Through Week 50||0
8568868|NCT00094458|9601102|FG005|STARTED|Study Extension: Week 30 Through Week 50||0
8617768|NCT00459056|9655964|FG001|COMPLETED|Second Intervention (Final Three Months)||14
8719404|NCT01004250|9766933|FG000|Death (Any Cause) or Disease Progression|Induction Therapy Period|Participants (pts) with death or disease progression considered to have completed phase.|21
8719405|NCT01004250|9766933|FG000|COMPLETED|Induction Therapy Period||94
8719406|NCT01004250|9766933|FG000|NOT COMPLETED|Induction Therapy Period||15
8617769|NCT00459056|9655963|FG000|NOT COMPLETED|Second Intervention (Final Three Months)||0
8617770|NCT00459056|9655964|FG001|NOT COMPLETED|Second Intervention (Final Three Months)||0
8617771|NCT00459108|9655970|FG000|STARTED|Overall Study||25
8719407|NCT01004250|9766933|FG000|STARTED|Maintenance Therapy Period|Did not enter Maint: 21 pts due to death or disease progression; 1 pts had performance status 2.|72
8719408|NCT01004250|9766933|FG000|Death (Any Cause) or Disease Progression|Maintenance Therapy Period|Pts with death or disease progression considered to have completed phase.|46
8719409|NCT01004250|9766933|FG000|COMPLETED|Maintenance Therapy Period||46
8719410|NCT01004250|9766933|FG000|NOT COMPLETED|Maintenance Therapy Period||26
8719411|NCT01004250|9766933|FG000|STARTED|Follow-Up (FU) Period|Did not enter FU:Death-4pts Ind,1pts Maint; Pt Withdrew-1 pts Ind,1pts Maint; Lost to FU-1 pts Maint|101
8719412|NCT01004250|9766933|FG000|COMPLETED|Follow-Up (FU) Period||100
8719413|NCT01004250|9766933|FG000|NOT COMPLETED|Follow-Up (FU) Period||1
8719414|NCT01004354|9766941|FG000|STARTED|Overall Study||12
8617772|NCT00459108|9655970|FG000|COMPLETED|Overall Study||14
8617773|NCT00459108|9655970|FG000|NOT COMPLETED|Overall Study||11
8617774|NCT00459134|9655977|FG000|STARTED|Overall Study||94
8617775|NCT00459134|9655978|FG001|STARTED|Overall Study||92
8617776|NCT00459134|9655977|FG000|COMPLETED|Overall Study||71
8617777|NCT00459134|9655978|FG001|COMPLETED|Overall Study||67
8617778|NCT00459134|9655977|FG000|NOT COMPLETED|Overall Study||23
8617779|NCT00459134|9655978|FG001|NOT COMPLETED|Overall Study||25
8617780|NCT00459186|9655984|FG000|STARTED|Single Agent RAD001||19
8617781|NCT00459186|9655984|FG000|COMPLETED|Single Agent RAD001||18
8617782|NCT00459186|9655984|FG000|NOT COMPLETED|Single Agent RAD001||1
8617783|NCT00459186|9655984|FG000|STARTED|PET Imaging and Assessment||18
8617784|NCT00459186|9655984|FG000|COMPLETED|PET Imaging and Assessment||15
8617785|NCT00459186|9655984|FG000|NOT COMPLETED|PET Imaging and Assessment||3
8617786|NCT00459186|9655984|FG000|STARTED|Combination RAD001 + Docetaxel||15
8617787|NCT00459186|9655984|FG000|COMPLETED|Combination RAD001 + Docetaxel||15
8617788|NCT00459186|9655984|FG000|NOT COMPLETED|Combination RAD001 + Docetaxel||0
8617789|NCT00459290|9655988|FG000|STARTED|Overall Study||24
8617790|NCT00459290|9655988|FG000|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|19
8617791|NCT00459290|9655988|FG000|NOT COMPLETED|Overall Study||5
8617792|NCT00459303|9655999|FG000|STARTED|Overall Study||20
8617793|NCT00459303|9655999|FG000|COMPLETED|Overall Study||20
8617794|NCT00459303|9655999|FG000|NOT COMPLETED|Overall Study||0
8617795|NCT00459316|9656011|FG000|STARTED|Steps 1 & 2||280
8617796|NCT00459316|9656012|FG001|STARTED|Steps 1 & 2||39
8617797|NCT00459316|9656013|FG002|STARTED|Steps 1 & 2||59
8617798|NCT00459316|9656011|FG000|COMPLETED|Steps 1 & 2||259
8617799|NCT00459316|9656012|FG001|COMPLETED|Steps 1 & 2||32
8617800|NCT00459316|9656013|FG002|COMPLETED|Steps 1 & 2||57
8617801|NCT00459316|9656011|FG000|NOT COMPLETED|Steps 1 & 2||21
8617802|NCT00459316|9656012|FG001|NOT COMPLETED|Steps 1 & 2||7
8617803|NCT00459316|9656013|FG002|NOT COMPLETED|Steps 1 & 2||2
8617804|NCT00459316|9656011|FG000|STARTED|Step 3|Not all participants from Steps 1/2 were eligible for Step 3|152
8617805|NCT00459316|9656012|FG001|STARTED|Step 3|Group 2 participants were not eligible for Step 3|0
8719415|NCT01004354|9766941|FG000|COMPLETED|Overall Study||12
8719416|NCT01004354|9766941|FG000|NOT COMPLETED|Overall Study||0
8719417|NCT01004393|9766945|FG000|STARTED|Overall Study||12
8719418|NCT01004393|9766945|FG000|COMPLETED|Overall Study||12
8719419|NCT01004393|9766945|FG000|NOT COMPLETED|Overall Study||0
8719420|NCT01004406|9766951|FG000|STARTED|Overall Study||21
8719421|NCT01004406|9766952|FG001|STARTED|Overall Study||10
8719422|NCT01004406|9766951|FG000|COMPLETED|Overall Study||18
8719423|NCT01004406|9766952|FG001|COMPLETED|Overall Study||10
8719424|NCT01004406|9766951|FG000|NOT COMPLETED|Overall Study||3
8719425|NCT01004406|9766952|FG001|NOT COMPLETED|Overall Study||0
8719426|NCT01004432|9766958|FG000|STARTED|Open-label (OL) Period (Week 0 - 16)||433
8719427|NCT01004432|9766959|FG001|STARTED|Open-label (OL) Period (Week 0 - 16)||0
8719428|NCT01004432|9766960|FG002|STARTED|Open-label (OL) Period (Week 0 - 16)||0
8719429|NCT01004432|9766961|FG003|STARTED|Open-label (OL) Period (Week 0 - 16)||0
8719430|NCT01004432|9766962|FG004|STARTED|Open-label (OL) Period (Week 0 - 16)||0
8719431|NCT01004432|9766958|FG000|COMPLETED|Open-label (OL) Period (Week 0 - 16)|1 Participant died after completing open-label period. Discontinuation was noted as adverse event.|350
8719432|NCT01004432|9766959|FG001|COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
8719433|NCT01004432|9766960|FG002|COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
8813731|NCT01527383|9866929|FG001|NOT COMPLETED|Overall Study||4
8813732|NCT01527487|9866937|FG000|STARTED|Overall Study|Includes 10 patients from safety lead-in.|54
8813733|NCT01527487|9866938|FG001|STARTED|Overall Study||22
8813734|NCT01527487|9866937|FG000|COMPLETED|Overall Study|Patients who completed 6 cycles plus surgery.|46
8719434|NCT01004432|9766961|FG003|COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
8719435|NCT01004432|9766962|FG004|COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
8719436|NCT01004432|9766958|FG000|NOT COMPLETED|Open-label (OL) Period (Week 0 - 16)||83
8719437|NCT01004432|9766959|FG001|NOT COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
8813735|NCT01527487|9866938|FG001|COMPLETED|Overall Study||15
8719438|NCT01004432|9766960|FG002|NOT COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
8719439|NCT01004432|9766961|FG003|NOT COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
8719440|NCT01004432|9766962|FG004|NOT COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
8719441|NCT01004432|9766958|FG000|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||0
8719442|NCT01004432|9766959|FG001|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||75
8719443|NCT01004432|9766960|FG002|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||91
8719444|NCT01004432|9766961|FG003|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||184
8719445|NCT01004432|9766962|FG004|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||0
8719446|NCT01004432|9766958|FG000|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
8719447|NCT01004432|9766959|FG001|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||65
8719448|NCT01004432|9766960|FG002|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||54
8719449|NCT01004432|9766961|FG003|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||126
8719450|NCT01004432|9766962|FG004|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
8719451|NCT01004432|9766958|FG000|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
8719452|NCT01004432|9766959|FG001|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||10
8719453|NCT01004432|9766960|FG002|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||37
8719454|NCT01004432|9766961|FG003|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||58
8719455|NCT01004432|9766962|FG004|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
8719456|NCT01004432|9766958|FG000|STARTED|OL Study Extension (Week 52 - 76)||0
8719457|NCT01004432|9766959|FG001|STARTED|OL Study Extension (Week 52 - 76)||0
8719458|NCT01004432|9766960|FG002|STARTED|OL Study Extension (Week 52 - 76)||0
8719459|NCT01004432|9766961|FG003|STARTED|OL Study Extension (Week 52 - 76)||0
8719460|NCT01004432|9766962|FG004|STARTED|OL Study Extension (Week 52 - 76)||212
8719461|NCT01004432|9766958|FG000|COMPLETED|OL Study Extension (Week 52 - 76)||0
8719462|NCT01004432|9766959|FG001|COMPLETED|OL Study Extension (Week 52 - 76)||0
8719463|NCT01004432|9766960|FG002|COMPLETED|OL Study Extension (Week 52 - 76)||0
8719464|NCT01004432|9766961|FG003|COMPLETED|OL Study Extension (Week 52 - 76)||0
8719465|NCT01004432|9766962|FG004|COMPLETED|OL Study Extension (Week 52 - 76)||194
8719466|NCT01004432|9766958|FG000|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
8719467|NCT01004432|9766959|FG001|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
8719468|NCT01004432|9766960|FG002|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
8719469|NCT01004432|9766961|FG003|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
8719470|NCT01004432|9766962|FG004|NOT COMPLETED|OL Study Extension (Week 52 - 76)||18
8724982|NCT01029340|9772249|FG003|STARTED|Part B Treatment Period|Enrolled 7 participants from Arm 1 and 4 participants from Arm 2|32
8724983|NCT01029340|9772250|FG004|STARTED|Part B Treatment Period||0
8724984|NCT01029340|9772251|FG005|STARTED|Part B Treatment Period||0
8725198|NCT01029704|9772381|FG003|NOT COMPLETED|Overall Study||0
8617806|NCT00459316|9656013|FG002|STARTED|Step 3|Not all participants from Steps 1/2 were eligible for Step 3|40
8617807|NCT00459316|9656011|FG000|COMPLETED|Step 3||149
8617808|NCT00459316|9656012|FG001|COMPLETED|Step 3||0
8617809|NCT00459316|9656013|FG002|COMPLETED|Step 3||39
8557802|NCT04848662|9589739|FG000|STARTED|Period 1 (First Treatment Intervention)||6
8557803|NCT04848662|9589740|FG001|STARTED|Period 1 (First Treatment Intervention)||6
8557804|NCT04848662|9589739|FG000|COMPLETED|Period 1 (First Treatment Intervention)||6
8557805|NCT04848662|9589740|FG001|COMPLETED|Period 1 (First Treatment Intervention)||6
8557806|NCT04848662|9589739|FG000|NOT COMPLETED|Period 1 (First Treatment Intervention)||0
8557807|NCT04848662|9589740|FG001|NOT COMPLETED|Period 1 (First Treatment Intervention)||0
8557808|NCT04848662|9589739|FG000|STARTED|Period 2 (Second Treatment Intervention)||6
8557809|NCT04848662|9589740|FG001|STARTED|Period 2 (Second Treatment Intervention)||6
8557810|NCT04848662|9589739|FG000|COMPLETED|Period 2 (Second Treatment Intervention)||5
8557811|NCT04848662|9589740|FG001|COMPLETED|Period 2 (Second Treatment Intervention)||6
8557812|NCT04848662|9589739|FG000|NOT COMPLETED|Period 2 (Second Treatment Intervention)||1
8557813|NCT04848662|9589740|FG001|NOT COMPLETED|Period 2 (Second Treatment Intervention)||0
8557817|NCT03969719|9589753|FG000|STARTED|Overall Study||54
8557818|NCT03969719|9589754|FG001|STARTED|Overall Study||55
8557819|NCT03969719|9589755|FG002|STARTED|Overall Study||55
8557820|NCT03969719|9589753|FG000|COMPLETED|Overall Study||50
8557821|NCT03969719|9589754|FG001|COMPLETED|Overall Study||46
8557822|NCT03969719|9589755|FG002|COMPLETED|Overall Study||50
8557823|NCT03969719|9589753|FG000|NOT COMPLETED|Overall Study||4
8557824|NCT03969719|9589754|FG001|NOT COMPLETED|Overall Study||9
8557825|NCT03969719|9589755|FG002|NOT COMPLETED|Overall Study||5
8557826|NCT03883477|9589765|FG000|STARTED|Overall Study||13
8557827|NCT03883477|9589766|FG001|STARTED|Overall Study||13
8557828|NCT03883477|9589765|FG000|COMPLETED|Overall Study||12
8557829|NCT03883477|9589766|FG001|COMPLETED|Overall Study||12
8557830|NCT03883477|9589765|FG000|NOT COMPLETED|Overall Study||1
8557831|NCT03883477|9589766|FG001|NOT COMPLETED|Overall Study||1
8557832|NCT03813108|9589778|FG000|STARTED|Overall Study||10
8557833|NCT03813108|9589779|FG001|STARTED|Overall Study||10
8557834|NCT03813108|9589780|FG002|STARTED|Overall Study||20
8557835|NCT03813108|9589781|FG003|STARTED|Overall Study||3
8557836|NCT03813108|9589782|FG004|STARTED|Overall Study||0
8617810|NCT00459316|9656011|FG000|NOT COMPLETED|Step 3||3
8617811|NCT00459316|9656012|FG001|NOT COMPLETED|Step 3||0
8617812|NCT00459316|9656013|FG002|NOT COMPLETED|Step 3||1
8617813|NCT00459342|9656036|FG000|STARTED|Overall Study||35
8557837|NCT03813108|9589783|FG005|STARTED|Overall Study||0
8557838|NCT03813108|9589778|FG000|COMPLETED|Overall Study||8
8557839|NCT03813108|9589779|FG001|COMPLETED|Overall Study||9
8557840|NCT03813108|9589780|FG002|COMPLETED|Overall Study||0
8557841|NCT03813108|9589781|FG003|COMPLETED|Overall Study||3
8617814|NCT00459342|9656036|FG000|COMPLETED|Overall Study||34
8617815|NCT00459342|9656036|FG000|NOT COMPLETED|Overall Study||1
8617816|NCT00459355|9656042|FG000|STARTED|Overall Study|Includes 70 dyads, caregiver/care-recipient|140
8617817|NCT00459355|9656043|FG001|STARTED|Overall Study|Includes 57 dyads, caregiver + care-recipient|114
8617818|NCT00459355|9656042|FG000|COMPLETED|Overall Study|Includes 60 dyads, caregiver + care-recipient|120
8617819|NCT00459355|9656043|FG001|COMPLETED|Overall Study|Includes 48 dyads, caregiver + care-recipient|96
8617820|NCT00459355|9656042|FG000|NOT COMPLETED|Overall Study||20
8617821|NCT00459355|9656043|FG001|NOT COMPLETED|Overall Study||18
8617822|NCT00459368|9656055|FG000|STARTED|Overall Study||1335
8617823|NCT00459368|9656056|FG001|STARTED|Overall Study||1363
8617824|NCT00459368|9656055|FG000|COMPLETED|Overall Study||1040
8617825|NCT00459368|9656056|FG001|COMPLETED|Overall Study||1034
8617826|NCT00459368|9656055|FG000|NOT COMPLETED|Overall Study||295
8617827|NCT00459368|9656056|FG001|NOT COMPLETED|Overall Study||329
8617828|NCT00459381|9656062|FG000|STARTED|Overall Study||35
8617829|NCT00459381|9656062|FG000|COMPLETED|Overall Study||35
8617830|NCT00459381|9656062|FG000|NOT COMPLETED|Overall Study||0
8617831|NCT00459537|9656068|FG000|STARTED|Overall Study||507
8719471|NCT01004614|9766980|FG000|STARTED|First Intervention||12
8719472|NCT01004614|9766981|FG001|STARTED|First Intervention||12
8719473|NCT01004614|9766982|FG002|STARTED|First Intervention||12
8719474|NCT01004614|9766983|FG003|STARTED|First Intervention||12
8719475|NCT01004614|9766980|FG000|COMPLETED|First Intervention||12
8719476|NCT01004614|9766981|FG001|COMPLETED|First Intervention||12
8719477|NCT01004614|9766982|FG002|COMPLETED|First Intervention||12
8719478|NCT01004614|9766983|FG003|COMPLETED|First Intervention||12
8719479|NCT01004614|9766980|FG000|NOT COMPLETED|First Intervention||0
8617832|NCT00459537|9656069|FG001|STARTED|Overall Study||522
8629401|NCT00529789|9669129|FG000|STARTED|Study Period IV||48
8617833|NCT00459537|9656068|FG000|Safety Population|Overall Study|Participants who had at least one dose of study drug and one post-baseline safety assessment.|493
8617834|NCT00459537|9656069|FG001|Safety Population|Overall Study||512
8617835|NCT00459537|9656068|FG000|COMPLETED|Overall Study||441
8719480|NCT01004614|9766981|FG001|NOT COMPLETED|First Intervention||0
8719481|NCT01004614|9766982|FG002|NOT COMPLETED|First Intervention||0
8719482|NCT01004614|9766983|FG003|NOT COMPLETED|First Intervention||0
8719483|NCT01004614|9766980|FG000|STARTED|Washout||12
8719484|NCT01004614|9766981|FG001|STARTED|Washout||12
8719485|NCT01004614|9766982|FG002|STARTED|Washout||12
8719486|NCT01004614|9766983|FG003|STARTED|Washout||12
8719487|NCT01004614|9766980|FG000|COMPLETED|Washout||12
8617836|NCT00459537|9656069|FG001|COMPLETED|Overall Study||446
8617837|NCT00459537|9656068|FG000|NOT COMPLETED|Overall Study||66
8719488|NCT01004614|9766981|FG001|COMPLETED|Washout||11
8617838|NCT00459537|9656069|FG001|NOT COMPLETED|Overall Study||76
8719489|NCT01004614|9766982|FG002|COMPLETED|Washout||12
8719490|NCT01004614|9766983|FG003|COMPLETED|Washout||12
8719491|NCT01004614|9766980|FG000|NOT COMPLETED|Washout||0
8719492|NCT01004614|9766981|FG001|NOT COMPLETED|Washout||1
8719493|NCT01004614|9766982|FG002|NOT COMPLETED|Washout||0
8719494|NCT01004614|9766983|FG003|NOT COMPLETED|Washout||0
8719495|NCT01004614|9766980|FG000|STARTED|Second Intervention||12
8719496|NCT01004614|9766981|FG001|STARTED|Second Intervention||11
8719497|NCT01004614|9766982|FG002|STARTED|Second Intervention||12
8719498|NCT01004614|9766983|FG003|STARTED|Second Intervention||12
8719499|NCT01004614|9766980|FG000|COMPLETED|Second Intervention||12
8719500|NCT01004614|9766981|FG001|COMPLETED|Second Intervention||11
8719501|NCT01004614|9766982|FG002|COMPLETED|Second Intervention||12
8719502|NCT01004614|9766983|FG003|COMPLETED|Second Intervention||12
8617839|NCT00459667|9656078|FG000|STARTED|Overall Study||592
8617840|NCT00459667|9656079|FG001|STARTED|Overall Study||647
8617841|NCT00459667|9656080|FG002|STARTED|Overall Study||181
8719503|NCT01004614|9766980|FG000|NOT COMPLETED|Second Intervention||0
8719504|NCT01004614|9766981|FG001|NOT COMPLETED|Second Intervention||0
8617842|NCT00459667|9656078|FG000|Study Medication Dispensed|Overall Study||586
8719505|NCT01004614|9766982|FG002|NOT COMPLETED|Second Intervention||0
8719506|NCT01004614|9766983|FG003|NOT COMPLETED|Second Intervention||0
8719507|NCT01004705|9766993|FG000|STARTED|Run-In||44
8719508|NCT01004705|9766994|FG001|STARTED|Run-In||0
8719509|NCT01004705|9766995|FG002|STARTED|Run-In||0
8719510|NCT01004705|9766993|FG000|COMPLETED|Run-In||36
8719511|NCT01004705|9766994|FG001|COMPLETED|Run-In||0
8719512|NCT01004705|9766995|FG002|COMPLETED|Run-In||0
8719513|NCT01004705|9766993|FG000|NOT COMPLETED|Run-In||8
8719514|NCT01004705|9766994|FG001|NOT COMPLETED|Run-In||0
8719515|NCT01004705|9766995|FG002|NOT COMPLETED|Run-In||0
8719516|NCT01004705|9766993|FG000|STARTED|Period 1 (12 Weeks)||0
8719517|NCT01004705|9766994|FG001|STARTED|Period 1 (12 Weeks)||18
8719518|NCT01004705|9766995|FG002|STARTED|Period 1 (12 Weeks)||18
8719519|NCT01004705|9766993|FG000|COMPLETED|Period 1 (12 Weeks)||0
8719520|NCT01004705|9766994|FG001|COMPLETED|Period 1 (12 Weeks)||13
8719521|NCT01004705|9766995|FG002|COMPLETED|Period 1 (12 Weeks)||13
8719522|NCT01004705|9766993|FG000|NOT COMPLETED|Period 1 (12 Weeks)||0
8719523|NCT01004705|9766994|FG001|NOT COMPLETED|Period 1 (12 Weeks)||5
8719524|NCT01004705|9766995|FG002|NOT COMPLETED|Period 1 (12 Weeks)||5
8719525|NCT01004705|9766993|FG000|STARTED|Washout Period (6 Weeks)||0
8719526|NCT01004705|9766994|FG001|STARTED|Washout Period (6 Weeks)||13
8719527|NCT01004705|9766995|FG002|STARTED|Washout Period (6 Weeks)||13
8719528|NCT01004705|9766993|FG000|COMPLETED|Washout Period (6 Weeks)||0
8719529|NCT01004705|9766994|FG001|COMPLETED|Washout Period (6 Weeks)||13
8719530|NCT01004705|9766995|FG002|COMPLETED|Washout Period (6 Weeks)||13
8719531|NCT01004705|9766993|FG000|NOT COMPLETED|Washout Period (6 Weeks)||0
8719532|NCT01004705|9766994|FG001|NOT COMPLETED|Washout Period (6 Weeks)||0
8719533|NCT01004705|9766995|FG002|NOT COMPLETED|Washout Period (6 Weeks)||0
8719534|NCT01004705|9766993|FG000|STARTED|Period 2 (12 Weeks)||0
8719535|NCT01004705|9766994|FG001|STARTED|Period 2 (12 Weeks)||13
8719536|NCT01004705|9766995|FG002|STARTED|Period 2 (12 Weeks)||13
8719537|NCT01004705|9766993|FG000|COMPLETED|Period 2 (12 Weeks)||0
8719538|NCT01004705|9766994|FG001|COMPLETED|Period 2 (12 Weeks)||13
8719539|NCT01004705|9766995|FG002|COMPLETED|Period 2 (12 Weeks)||9
8719540|NCT01004705|9766993|FG000|NOT COMPLETED|Period 2 (12 Weeks)||0
8719541|NCT01004705|9766994|FG001|NOT COMPLETED|Period 2 (12 Weeks)||0
8719542|NCT01004705|9766995|FG002|NOT COMPLETED|Period 2 (12 Weeks)||4
8719543|NCT01004718|9767002|FG000|STARTED|Overall Study||10
8719544|NCT01004718|9767002|FG000|COMPLETED|Overall Study||10
8719545|NCT01004718|9767002|FG000|NOT COMPLETED|Overall Study||0
8719546|NCT01004744|9767007|FG000|STARTED|Overall Study||10
8719547|NCT01004744|9767007|FG000|COMPLETED|Overall Study||10
8719548|NCT01004744|9767007|FG000|NOT COMPLETED|Overall Study||0
8719549|NCT01004770|9767016|FG000|STARTED|Overall Study||10
8719550|NCT01004770|9767017|FG001|STARTED|Overall Study||10
8719551|NCT01004770|9767018|FG002|STARTED|Overall Study||10
8719552|NCT01004770|9767019|FG003|STARTED|Overall Study||10
8719553|NCT01004770|9767020|FG004|STARTED|Overall Study||10
8719554|NCT01004770|9767016|FG000|COMPLETED|Overall Study||10
8719555|NCT01004770|9767017|FG001|COMPLETED|Overall Study||10
8719556|NCT01004770|9767018|FG002|COMPLETED|Overall Study||10
8719557|NCT01004770|9767019|FG003|COMPLETED|Overall Study||10
8719558|NCT01004770|9767020|FG004|COMPLETED|Overall Study||10
8719559|NCT01004770|9767016|FG000|NOT COMPLETED|Overall Study||0
8719560|NCT01004770|9767017|FG001|NOT COMPLETED|Overall Study||0
8719561|NCT01004770|9767018|FG002|NOT COMPLETED|Overall Study||0
8719562|NCT01004770|9767019|FG003|NOT COMPLETED|Overall Study||0
8719563|NCT01004770|9767020|FG004|NOT COMPLETED|Overall Study||0
8719564|NCT01004822|9767040|FG000|STARTED|Overall Study||3
8617843|NCT00459667|9656079|FG001|Study Medication Dispensed|Overall Study||645
8617844|NCT00459667|9656080|FG002|Study Medication Dispensed|Overall Study||180
8617845|NCT00459667|9656078|FG000|Started Treatment|Overall Study||586
8719565|NCT01004822|9767041|FG001|STARTED|Overall Study||3
8719566|NCT01004822|9767042|FG002|STARTED|Overall Study||4
8719567|NCT01004822|9767043|FG003|STARTED|Overall Study||4
8719568|NCT01004822|9767044|FG004|STARTED|Overall Study||4
8719569|NCT01004822|9767045|FG005|STARTED|Overall Study||4
8719570|NCT01004822|9767046|FG006|STARTED|Overall Study||4
8719571|NCT01004822|9767047|FG007|STARTED|Overall Study||5
8719572|NCT01004822|9767040|FG000|Treated|Overall Study||3
8719573|NCT01004822|9767041|FG001|Treated|Overall Study||3
8719574|NCT01004822|9767042|FG002|Treated|Overall Study||3
8617846|NCT00459667|9656079|FG001|Started Treatment|Overall Study||644
8617847|NCT00459667|9656080|FG002|Started Treatment|Overall Study||180
8617848|NCT00459667|9656078|FG000|COMPLETED|Overall Study||554
8617849|NCT00459667|9656079|FG001|COMPLETED|Overall Study||600
8617850|NCT00459667|9656080|FG002|COMPLETED|Overall Study||161
8617851|NCT00459667|9656078|FG000|NOT COMPLETED|Overall Study||38
8943622|NCT02390219|10005464|FG000|STARTED|Overall Study||46
8943623|NCT02390219|10005464|FG000|COMPLETED|Overall Study||33
8943624|NCT02390219|10005464|FG000|NOT COMPLETED|Overall Study||13
8943625|NCT02390557|10005471|FG000|STARTED|Wave 1||160
8943626|NCT02390557|10005472|FG001|STARTED|Wave 1||156
8719575|NCT01004822|9767043|FG003|Treated|Overall Study||4
8719576|NCT01004822|9767044|FG004|Treated|Overall Study||4
8719577|NCT01004822|9767045|FG005|Treated|Overall Study||4
8719578|NCT01004822|9767046|FG006|Treated|Overall Study||4
8719579|NCT01004822|9767047|FG007|Treated|Overall Study||5
8617852|NCT00459667|9656079|FG001|NOT COMPLETED|Overall Study||47
8617853|NCT00459667|9656080|FG002|NOT COMPLETED|Overall Study||20
8617854|NCT00459706|9656090|FG000|STARTED|Overall Study||325
8617855|NCT00459706|9656091|FG001|STARTED|Overall Study||315
8719580|NCT01004822|9767040|FG000|COMPLETED|Overall Study||0
8943627|NCT02390557|10005473|FG002|STARTED|Wave 1||135
8719581|NCT01004822|9767041|FG001|COMPLETED|Overall Study||0
8719582|NCT01004822|9767042|FG002|COMPLETED|Overall Study||0
8719583|NCT01004822|9767043|FG003|COMPLETED|Overall Study||0
8719584|NCT01004822|9767044|FG004|COMPLETED|Overall Study||0
8719585|NCT01004822|9767045|FG005|COMPLETED|Overall Study||0
8719586|NCT01004822|9767046|FG006|COMPLETED|Overall Study||0
8719587|NCT01004822|9767047|FG007|COMPLETED|Overall Study||0
8719588|NCT01004822|9767040|FG000|NOT COMPLETED|Overall Study||3
8719589|NCT01004822|9767041|FG001|NOT COMPLETED|Overall Study||3
8719590|NCT01004822|9767042|FG002|NOT COMPLETED|Overall Study||4
8719591|NCT01004822|9767043|FG003|NOT COMPLETED|Overall Study||4
8719592|NCT01004822|9767044|FG004|NOT COMPLETED|Overall Study||4
8719593|NCT01004822|9767045|FG005|NOT COMPLETED|Overall Study||4
8719594|NCT01004822|9767046|FG006|NOT COMPLETED|Overall Study||4
8719595|NCT01004822|9767047|FG007|NOT COMPLETED|Overall Study||5
8719596|NCT01004848|9767069|FG000|STARTED|Overall Study||210
8719597|NCT01004848|9767070|FG001|STARTED|Overall Study||192
8719598|NCT01004848|9767069|FG000|COMPLETED|Overall Study||155
8719599|NCT01004848|9767070|FG001|COMPLETED|Overall Study||147
8719600|NCT01004848|9767069|FG000|NOT COMPLETED|Overall Study||55
8719601|NCT01004848|9767070|FG001|NOT COMPLETED|Overall Study||45
8719602|NCT01004939|9767078|FG000|STARTED|Overall Study||120
8719603|NCT01004939|9767078|FG000|COMPLETED|Overall Study||120
8719604|NCT01004939|9767078|FG000|NOT COMPLETED|Overall Study||0
8719605|NCT01004991|9767084|FG000|STARTED|Overall Study||12
8719606|NCT01004991|9767084|FG000|COMPLETED|Overall Study||12
8719607|NCT01004991|9767084|FG000|NOT COMPLETED|Overall Study||0
8719608|NCT01005251|9767093|FG000|STARTED|Overall Study||134
8719609|NCT01005251|9767094|FG001|STARTED|Overall Study||125
8719610|NCT01005251|9767095|FG002|STARTED|Overall Study||136
8719611|NCT01005251|9767096|FG003|STARTED|Overall Study||126
8719612|NCT01005251|9767097|FG004|STARTED|Overall Study||140
8719613|NCT01005251|9767093|FG000|COMPLETED|Overall Study||121
8719614|NCT01005251|9767094|FG001|COMPLETED|Overall Study||109
8719615|NCT01005251|9767095|FG002|COMPLETED|Overall Study||114
8719616|NCT01005251|9767096|FG003|COMPLETED|Overall Study||114
8719617|NCT01005251|9767097|FG004|COMPLETED|Overall Study||122
8719618|NCT01005251|9767093|FG000|NOT COMPLETED|Overall Study||13
8617856|NCT00459706|9656090|FG000|MODIFIED INTENT-TO-TREAT POPULATION|Overall Study|1 participant had no evaluation after the first injection|324
8617857|NCT00459706|9656091|FG001|MODIFIED INTENT-TO-TREAT POPULATION|Overall Study|2 participants withdrew consent before the first injection|313
8617858|NCT00459706|9656090|FG000|COMPLETED|Overall Study||299
8617859|NCT00459706|9656091|FG001|COMPLETED|Overall Study||294
8617860|NCT00459706|9656090|FG000|NOT COMPLETED|Overall Study||26
8617861|NCT00459706|9656091|FG001|NOT COMPLETED|Overall Study||21
8719619|NCT01005251|9767094|FG001|NOT COMPLETED|Overall Study||16
8719620|NCT01005251|9767095|FG002|NOT COMPLETED|Overall Study||22
8719621|NCT01005251|9767096|FG003|NOT COMPLETED|Overall Study||12
8719622|NCT01005251|9767097|FG004|NOT COMPLETED|Overall Study||18
8719623|NCT01005290|9767109|FG000|STARTED|Run-In||52
8719624|NCT01005290|9767110|FG001|STARTED|Run-In||0
8719625|NCT01005290|9767111|FG002|STARTED|Run-In||0
8719626|NCT01005290|9767109|FG000|COMPLETED|Run-In||38
8719627|NCT01005290|9767110|FG001|COMPLETED|Run-In||0
8719628|NCT01005290|9767111|FG002|COMPLETED|Run-In||0
8719629|NCT01005290|9767109|FG000|NOT COMPLETED|Run-In||14
8719630|NCT01005290|9767110|FG001|NOT COMPLETED|Run-In||0
8719631|NCT01005290|9767111|FG002|NOT COMPLETED|Run-In||0
8719632|NCT01005290|9767109|FG000|STARTED|Period 1 (5 Weeks)||0
8719633|NCT01005290|9767110|FG001|STARTED|Period 1 (5 Weeks)||20
8719634|NCT01005290|9767111|FG002|STARTED|Period 1 (5 Weeks)||18
8719635|NCT01005290|9767109|FG000|COMPLETED|Period 1 (5 Weeks)||0
8719636|NCT01005290|9767110|FG001|COMPLETED|Period 1 (5 Weeks)||13
8719637|NCT01005290|9767111|FG002|COMPLETED|Period 1 (5 Weeks)||9
8719638|NCT01005290|9767109|FG000|NOT COMPLETED|Period 1 (5 Weeks)||0
8719639|NCT01005290|9767110|FG001|NOT COMPLETED|Period 1 (5 Weeks)||7
8719640|NCT01005290|9767111|FG002|NOT COMPLETED|Period 1 (5 Weeks)||9
8719641|NCT01005290|9767109|FG000|STARTED|Washout Period (2 Weeks)||0
8719642|NCT01005290|9767110|FG001|STARTED|Washout Period (2 Weeks)||13
8719643|NCT01005290|9767111|FG002|STARTED|Washout Period (2 Weeks)||9
8719644|NCT01005290|9767109|FG000|COMPLETED|Washout Period (2 Weeks)||0
8719645|NCT01005290|9767110|FG001|COMPLETED|Washout Period (2 Weeks)||13
8719646|NCT01005290|9767111|FG002|COMPLETED|Washout Period (2 Weeks)||9
8719647|NCT01005290|9767109|FG000|NOT COMPLETED|Washout Period (2 Weeks)||0
8719648|NCT01005290|9767110|FG001|NOT COMPLETED|Washout Period (2 Weeks)||0
8719649|NCT01005290|9767111|FG002|NOT COMPLETED|Washout Period (2 Weeks)||0
8719650|NCT01005290|9767109|FG000|STARTED|Period 2 (5 Weeks)||0
8719651|NCT01005290|9767110|FG001|STARTED|Period 2 (5 Weeks)||13
8719652|NCT01005290|9767111|FG002|STARTED|Period 2 (5 Weeks)||9
8719653|NCT01005290|9767109|FG000|COMPLETED|Period 2 (5 Weeks)||0
8617862|NCT00459732|9656099|FG000|STARTED|Overall Study||23
8719654|NCT01005290|9767110|FG001|COMPLETED|Period 2 (5 Weeks)||13
8719655|NCT01005290|9767111|FG002|COMPLETED|Period 2 (5 Weeks)||7
8719656|NCT01005290|9767109|FG000|NOT COMPLETED|Period 2 (5 Weeks)||0
8719657|NCT01005290|9767110|FG001|NOT COMPLETED|Period 2 (5 Weeks)||0
8719658|NCT01005290|9767111|FG002|NOT COMPLETED|Period 2 (5 Weeks)||2
8719659|NCT01005316|9767121|FG000|STARTED|Overall Study||50
8617863|NCT00459732|9656100|FG001|STARTED|Overall Study||17
8617864|NCT00459732|9656099|FG000|COMPLETED|Overall Study|4 on zn dropped: 1 pregnant and 1 nausea after baseline, 1 lost to followup, 1 exited after 12 month|19
8617865|NCT00459732|9656100|FG001|COMPLETED|Overall Study|3 on placebo dropped: 1 pregnant after 12 mo, 1 lost to followup, one died after 12 month timepoint|14
8617866|NCT00459732|9656099|FG000|NOT COMPLETED|Overall Study||4
8617867|NCT00459732|9656100|FG001|NOT COMPLETED|Overall Study||3
8617868|NCT00459810|9656106|FG000|STARTED|Overall Study||21
8617869|NCT00459810|9656106|FG000|COMPLETED|Overall Study||21
8617870|NCT00459810|9656106|FG000|NOT COMPLETED|Overall Study||0
8617871|NCT00459862|9656110|FG000|STARTED|Overall Study||34
8617872|NCT00459862|9656110|FG000|COMPLETED|Overall Study||34
8617873|NCT00459862|9656110|FG000|NOT COMPLETED|Overall Study||0
8617874|NCT00459875|9656114|FG000|STARTED|Overall Study||24
8617875|NCT00459875|9656114|FG000|COMPLETED|Overall Study||21
8617876|NCT00459875|9656114|FG000|NOT COMPLETED|Overall Study||3
8617877|NCT00459953|9656120|FG000|STARTED|Overall Study||72
8617878|NCT00459953|9656121|FG001|STARTED|Overall Study||71
8617879|NCT00459953|9656120|FG000|COMPLETED|Overall Study||71
8617880|NCT00459953|9656121|FG001|COMPLETED|Overall Study||70
8617881|NCT00459953|9656120|FG000|NOT COMPLETED|Overall Study||1
8617882|NCT00459953|9656121|FG001|NOT COMPLETED|Overall Study||1
8617883|NCT00459979|9656127|FG000|STARTED|Overall Study||30
8617884|NCT00459979|9656127|FG000|COMPLETED|Overall Study||28
8617885|NCT00459979|9656127|FG000|NOT COMPLETED|Overall Study||2
8617886|NCT00460031|9656131|FG000|STARTED|Overall Study||34
8617887|NCT00460031|9656131|FG000|COMPLETED|Overall Study||23
8617888|NCT00460031|9656131|FG000|NOT COMPLETED|Overall Study||11
8617889|NCT00460109|9656135|FG000|STARTED|Overall Study||24
8719660|NCT01005316|9767122|FG001|STARTED|Overall Study||97
8719661|NCT01005316|9767123|FG002|STARTED|Overall Study||16
8719662|NCT01005316|9767124|FG003|STARTED|Overall Study||127
8719663|NCT01005316|9767121|FG000|COMPLETED|Overall Study||0
8719664|NCT01005316|9767122|FG001|COMPLETED|Overall Study||21
8719665|NCT01005316|9767123|FG002|COMPLETED|Overall Study||5
8617890|NCT00460109|9656135|FG000|COMPLETED|Overall Study||23
8617891|NCT00460109|9656135|FG000|NOT COMPLETED|Overall Study||1
8719666|NCT01005316|9767124|FG003|COMPLETED|Overall Study||19
8719667|NCT01005316|9767121|FG000|NOT COMPLETED|Overall Study||50
8719668|NCT01005316|9767122|FG001|NOT COMPLETED|Overall Study||76
8719669|NCT01005316|9767123|FG002|NOT COMPLETED|Overall Study||11
8719670|NCT01005316|9767124|FG003|NOT COMPLETED|Overall Study||108
8719671|NCT01005329|9767135|FG000|STARTED|Overall Study||34
8719672|NCT01005329|9767135|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|30
8719673|NCT01005329|9767135|FG000|NOT COMPLETED|Overall Study||4
8719674|NCT01005355|9767143|FG000|STARTED|Overall Study||3
8719675|NCT01005355|9767144|FG001|STARTED|Overall Study||6
8719676|NCT01005355|9767145|FG002|STARTED|Overall Study||6
8719677|NCT01005355|9767143|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
8719678|NCT01005355|9767144|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
8719679|NCT01005355|9767145|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
8719680|NCT01005355|9767143|FG000|COMPLETED|Overall Study||3
8719681|NCT01005355|9767144|FG001|COMPLETED|Overall Study||6
8719682|NCT01005355|9767145|FG002|COMPLETED|Overall Study||6
8719683|NCT01005355|9767143|FG000|NOT COMPLETED|Overall Study||0
8719684|NCT01005355|9767144|FG001|NOT COMPLETED|Overall Study||0
8719685|NCT01005355|9767145|FG002|NOT COMPLETED|Overall Study||0
8719686|NCT01005407|9767158|FG000|STARTED|Overall Study||1969
8719687|NCT01005407|9767159|FG001|STARTED|Overall Study||483
8719688|NCT01005407|9767158|FG000|COMPLETED|Overall Study||1818
8719689|NCT01005407|9767159|FG001|COMPLETED|Overall Study||451
8719690|NCT01005407|9767158|FG000|NOT COMPLETED|Overall Study||151
8719691|NCT01005407|9767159|FG001|NOT COMPLETED|Overall Study||32
8719692|NCT01005459|9767167|FG000|STARTED|Overall Study||23
8719693|NCT01005459|9767168|FG001|STARTED|Overall Study||23
8719694|NCT01005459|9767167|FG000|COMPLETED|Overall Study||23
8719695|NCT01005459|9767168|FG001|COMPLETED|Overall Study||23
8719696|NCT01005459|9767167|FG000|NOT COMPLETED|Overall Study||0
8719697|NCT01005459|9767168|FG001|NOT COMPLETED|Overall Study||0
8719698|NCT01005576|9767174|FG000|STARTED|Overall Study||21
8719699|NCT01005576|9767174|FG000|COMPLETED|Overall Study|All participants completed the conditioning regimen and received their stem cell transplant|21
8719700|NCT01005576|9767174|FG000|NOT COMPLETED|Overall Study||0
8719701|NCT01005602|9767180|FG000|STARTED|Overall Study||66
8719702|NCT01005602|9767181|FG001|STARTED|Overall Study||66
8617892|NCT00460239|9656139|FG000|STARTED|Overall Study||0
8617893|NCT00460239|9656140|FG001|STARTED|Overall Study||3
8617894|NCT00460239|9656141|FG002|STARTED|Overall Study||1
8617895|NCT00460239|9656142|FG003|STARTED|Overall Study||0
8617896|NCT00460239|9656143|FG004|STARTED|Overall Study||1
8617897|NCT00460239|9656144|FG005|STARTED|Overall Study||4
8617898|NCT00460239|9656145|FG006|STARTED|Overall Study||1
8617899|NCT00460239|9656146|FG007|STARTED|Overall Study||1
8617900|NCT00460239|9656147|FG008|STARTED|Overall Study||1
8719703|NCT01005602|9767180|FG000|COMPLETED|Overall Study|One patient completed the trial but was excluded from data analyses due to unreliable clinical data.|65
8719704|NCT01005602|9767181|FG001|COMPLETED|Overall Study||66
8719705|NCT01005602|9767180|FG000|NOT COMPLETED|Overall Study||1
8719706|NCT01005602|9767181|FG001|NOT COMPLETED|Overall Study||0
8719707|NCT01005680|9767196|FG000|STARTED|Overall Study||126
8719708|NCT01005680|9767197|FG001|STARTED|Overall Study||130
8719709|NCT01005680|9767196|FG000|Received at Least 1 Dose of Study Drug|Overall Study||125
8719710|NCT01005680|9767197|FG001|Received at Least 1 Dose of Study Drug|Overall Study||127
8719711|NCT01005680|9767196|FG000|COMPLETED|Overall Study||120
8719712|NCT01005680|9767197|FG001|COMPLETED|Overall Study||119
8617901|NCT00460239|9656139|FG000|COMPLETED|Overall Study||0
8617902|NCT00460239|9656140|FG001|COMPLETED|Overall Study||2
8617903|NCT00460239|9656141|FG002|COMPLETED|Overall Study||1
8617904|NCT00460239|9656142|FG003|COMPLETED|Overall Study||0
8617905|NCT00460239|9656143|FG004|COMPLETED|Overall Study||1
8617906|NCT00460239|9656144|FG005|COMPLETED|Overall Study||1
8617907|NCT00460239|9656145|FG006|COMPLETED|Overall Study||1
8617908|NCT00460239|9656146|FG007|COMPLETED|Overall Study||1
8617909|NCT00460239|9656147|FG008|COMPLETED|Overall Study||1
8617910|NCT00460239|9656139|FG000|NOT COMPLETED|Overall Study||0
8617911|NCT00460239|9656140|FG001|NOT COMPLETED|Overall Study||1
8617912|NCT00460239|9656141|FG002|NOT COMPLETED|Overall Study||0
8617913|NCT00460239|9656142|FG003|NOT COMPLETED|Overall Study||0
8617914|NCT00460239|9656143|FG004|NOT COMPLETED|Overall Study||0
8617915|NCT00460239|9656144|FG005|NOT COMPLETED|Overall Study||3
8617916|NCT00460239|9656145|FG006|NOT COMPLETED|Overall Study||0
8617917|NCT00460239|9656146|FG007|NOT COMPLETED|Overall Study||0
8617918|NCT00460239|9656147|FG008|NOT COMPLETED|Overall Study||0
8617919|NCT00460265|9656162|FG000|STARTED|Overall Study||328
8617920|NCT00460265|9656163|FG001|STARTED|Overall Study||330
8617921|NCT00460265|9656162|FG000|Randomized While Alive|Overall Study|1 subject was randomized by error after death|327
8617922|NCT00460265|9656163|FG001|Randomized While Alive|Overall Study||330
8617923|NCT00460265|9656162|FG000|Received Study Medication|Overall Study||325
8617924|NCT00460265|9656163|FG001|Received Study Medication|Overall Study||325
8617925|NCT00460265|9656162|FG000|COMPLETED|Overall Study|Completed study=death|243
8617926|NCT00460265|9656163|FG001|COMPLETED|Overall Study|Completed study=death|241
8617927|NCT00460265|9656162|FG000|NOT COMPLETED|Overall Study||85
8617928|NCT00460265|9656163|FG001|NOT COMPLETED|Overall Study||89
8719713|NCT01005680|9767196|FG000|NOT COMPLETED|Overall Study||6
8617929|NCT00460408|9656173|FG000|STARTED|Overall Study||403
8617930|NCT00460408|9656174|FG001|STARTED|Overall Study||16
8617931|NCT00460408|9656175|FG002|STARTED|Overall Study||75
8617932|NCT00460408|9656176|FG003|STARTED|Overall Study||7
8617933|NCT00460408|9656173|FG000|COMPLETED|Overall Study||336
8617934|NCT00460408|9656174|FG001|COMPLETED|Overall Study||13
8617935|NCT00460408|9656175|FG002|COMPLETED|Overall Study||69
8617936|NCT00460408|9656176|FG003|COMPLETED|Overall Study||7
8719714|NCT01005680|9767197|FG001|NOT COMPLETED|Overall Study||11
8719715|NCT01005706|9767206|FG000|STARTED|Overall Study||23
8719716|NCT01005706|9767207|FG001|STARTED|Overall Study||17
8617937|NCT00460408|9656173|FG000|NOT COMPLETED|Overall Study||67
8617938|NCT00460408|9656174|FG001|NOT COMPLETED|Overall Study||3
8617939|NCT00460408|9656175|FG002|NOT COMPLETED|Overall Study||6
8617940|NCT00460408|9656176|FG003|NOT COMPLETED|Overall Study||0
8617941|NCT00460421|9656189|FG000|STARTED|Overall Study||9
8617942|NCT00460421|9656190|FG001|STARTED|Overall Study||9
8617943|NCT00460421|9656191|FG002|STARTED|Overall Study||9
8617944|NCT00460421|9656189|FG000|COMPLETED|Overall Study||9
8617945|NCT00460421|9656190|FG001|COMPLETED|Overall Study||9
8617946|NCT00460421|9656191|FG002|COMPLETED|Overall Study||9
8617947|NCT00460421|9656189|FG000|NOT COMPLETED|Overall Study||0
8617948|NCT00460421|9656190|FG001|NOT COMPLETED|Overall Study||0
8617949|NCT00460421|9656191|FG002|NOT COMPLETED|Overall Study||0
8617950|NCT00460434|9656200|FG000|STARTED|Overall Study||165
8617951|NCT00460434|9656201|FG001|STARTED|Overall Study||172
8617952|NCT00460434|9656200|FG000|3 Months|Overall Study||163
8719717|NCT01005706|9767206|FG000|COMPLETED|Overall Study||23
8719718|NCT01005706|9767207|FG001|COMPLETED|Overall Study||17
8719719|NCT01005706|9767206|FG000|NOT COMPLETED|Overall Study||0
8719720|NCT01005706|9767207|FG001|NOT COMPLETED|Overall Study||0
8719721|NCT01005719|9767213|FG000|STARTED|Period 1||10
8719722|NCT01005719|9767214|FG001|STARTED|Period 1||10
8719723|NCT01005719|9767215|FG002|STARTED|Period 1||10
8557814|NCT04697693|9589746|FG000|STARTED|Overall Study||1
8719724|NCT01005719|9767216|FG003|STARTED|Period 1||11
8719725|NCT01005719|9767217|FG004|STARTED|Period 1||11
8719726|NCT01005719|9767218|FG005|STARTED|Period 1||11
8719727|NCT01005719|9767213|FG000|COMPLETED|Period 1||10
8719728|NCT01005719|9767214|FG001|COMPLETED|Period 1||10
8719729|NCT01005719|9767215|FG002|COMPLETED|Period 1||10
8719730|NCT01005719|9767216|FG003|COMPLETED|Period 1||10
8719731|NCT01005719|9767217|FG004|COMPLETED|Period 1||11
8719732|NCT01005719|9767218|FG005|COMPLETED|Period 1||10
8719733|NCT01005719|9767213|FG000|NOT COMPLETED|Period 1||0
8719734|NCT01005719|9767214|FG001|NOT COMPLETED|Period 1||0
8719735|NCT01005719|9767215|FG002|NOT COMPLETED|Period 1||0
8719736|NCT01005719|9767216|FG003|NOT COMPLETED|Period 1||1
8719737|NCT01005719|9767217|FG004|NOT COMPLETED|Period 1||0
8719738|NCT01005719|9767218|FG005|NOT COMPLETED|Period 1||1
8719739|NCT01005719|9767213|FG000|STARTED|Period 2||10
8719740|NCT01005719|9767214|FG001|STARTED|Period 2||10
8719741|NCT01005719|9767215|FG002|STARTED|Period 2||10
8719742|NCT01005719|9767216|FG003|STARTED|Period 2||10
8719743|NCT01005719|9767217|FG004|STARTED|Period 2||11
8719744|NCT01005719|9767218|FG005|STARTED|Period 2||10
8719745|NCT01005719|9767213|FG000|COMPLETED|Period 2||10
8719746|NCT01005719|9767214|FG001|COMPLETED|Period 2||10
8719747|NCT01005719|9767215|FG002|COMPLETED|Period 2||10
8719748|NCT01005719|9767216|FG003|COMPLETED|Period 2||10
8719749|NCT01005719|9767217|FG004|COMPLETED|Period 2||10
8719750|NCT01005719|9767218|FG005|COMPLETED|Period 2||9
8719751|NCT01005719|9767213|FG000|NOT COMPLETED|Period 2||0
8719752|NCT01005719|9767214|FG001|NOT COMPLETED|Period 2||0
8719753|NCT01005719|9767215|FG002|NOT COMPLETED|Period 2||0
8719754|NCT01005719|9767216|FG003|NOT COMPLETED|Period 2||0
8719755|NCT01005719|9767217|FG004|NOT COMPLETED|Period 2||1
8719756|NCT01005719|9767218|FG005|NOT COMPLETED|Period 2||1
8719757|NCT01005719|9767213|FG000|STARTED|Period 3||10
8719758|NCT01005719|9767214|FG001|STARTED|Period 3||10
8719759|NCT01005719|9767215|FG002|STARTED|Period 3||10
8719760|NCT01005719|9767216|FG003|STARTED|Period 3||10
8719761|NCT01005719|9767217|FG004|STARTED|Period 3||10
8719762|NCT01005719|9767218|FG005|STARTED|Period 3||9
8719763|NCT01005719|9767213|FG000|COMPLETED|Period 3||10
8719764|NCT01005719|9767214|FG001|COMPLETED|Period 3||10
8557815|NCT04697693|9589746|FG000|COMPLETED|Overall Study||1
8719765|NCT01005719|9767215|FG002|COMPLETED|Period 3||10
8719766|NCT01005719|9767216|FG003|COMPLETED|Period 3||10
8719767|NCT01005719|9767217|FG004|COMPLETED|Period 3||10
8719768|NCT01005719|9767218|FG005|COMPLETED|Period 3||9
8557816|NCT04697693|9589746|FG000|NOT COMPLETED|Overall Study||0
8557842|NCT03813108|9589782|FG004|COMPLETED|Overall Study||0
8557843|NCT03813108|9589783|FG005|COMPLETED|Overall Study||0
8557844|NCT03813108|9589778|FG000|NOT COMPLETED|Overall Study||2
8557845|NCT03813108|9589779|FG001|NOT COMPLETED|Overall Study||1
8557846|NCT03813108|9589780|FG002|NOT COMPLETED|Overall Study||20
8557847|NCT03813108|9589781|FG003|NOT COMPLETED|Overall Study||0
8557848|NCT03813108|9589782|FG004|NOT COMPLETED|Overall Study||0
8557849|NCT03813108|9589783|FG005|NOT COMPLETED|Overall Study||0
8557850|NCT03809611|9589795|FG000|STARTED|Overall Study||62
8719769|NCT01005719|9767213|FG000|NOT COMPLETED|Period 3||0
8719770|NCT01005719|9767214|FG001|NOT COMPLETED|Period 3||0
8719771|NCT01005719|9767215|FG002|NOT COMPLETED|Period 3||0
8719772|NCT01005719|9767216|FG003|NOT COMPLETED|Period 3||0
8719773|NCT01005719|9767217|FG004|NOT COMPLETED|Period 3||0
8719774|NCT01005719|9767218|FG005|NOT COMPLETED|Period 3||0
8719775|NCT01005732|9767227|FG000|STARTED|Overall Study||54
8719776|NCT01005732|9767227|FG000|COMPLETED|Overall Study||43
8719777|NCT01005732|9767227|FG000|NOT COMPLETED|Overall Study||11
8719778|NCT01005810|9767237|FG000|STARTED|Overall Study||58
8719779|NCT01005810|9767238|FG001|STARTED|Overall Study||58
8719780|NCT01005810|9767237|FG000|COMPLETED|Overall Study||37
8719781|NCT01005810|9767238|FG001|COMPLETED|Overall Study||33
8719782|NCT01005810|9767237|FG000|NOT COMPLETED|Overall Study||21
8719783|NCT01005810|9767238|FG001|NOT COMPLETED|Overall Study||25
8719784|NCT01005875|9767244|FG000|STARTED|Overall Study||5
8719785|NCT01005875|9767244|FG000|COMPLETED|Overall Study||2
8719786|NCT01005875|9767244|FG000|NOT COMPLETED|Overall Study||3
8719787|NCT01005888|9767252|FG000|STARTED|First Intervention||12
8719788|NCT01005888|9767253|FG001|STARTED|First Intervention||12
8719789|NCT01005888|9767252|FG000|COMPLETED|First Intervention||11
8719790|NCT01005888|9767253|FG001|COMPLETED|First Intervention||11
8719791|NCT01005888|9767252|FG000|NOT COMPLETED|First Intervention||1
8719792|NCT01005888|9767253|FG001|NOT COMPLETED|First Intervention||1
8719793|NCT01005888|9767252|FG000|STARTED|Second Intervention||11
8719794|NCT01005888|9767253|FG001|STARTED|Second Intervention||11
8719795|NCT01005888|9767252|FG000|COMPLETED|Second Intervention||10
8719796|NCT01005888|9767253|FG001|COMPLETED|Second Intervention||10
8719797|NCT01005888|9767252|FG000|NOT COMPLETED|Second Intervention||1
8719798|NCT01005888|9767253|FG001|NOT COMPLETED|Second Intervention||1
8719799|NCT01005901|9767261|FG000|STARTED|Overall Study||552
8719800|NCT01005901|9767262|FG001|STARTED|Overall Study||270
8719801|NCT01005901|9767261|FG000|Safety Population|Overall Study||550
8719802|NCT01005901|9767262|FG001|Safety Population|Overall Study||267
8719803|NCT01005901|9767261|FG000|Full Analysis Set|Overall Study||534
8719804|NCT01005901|9767262|FG001|Full Analysis Set|Overall Study||260
8719805|NCT01005901|9767261|FG000|COMPLETED|Overall Study||450
8719806|NCT01005901|9767262|FG001|COMPLETED|Overall Study||212
8719807|NCT01005901|9767261|FG000|NOT COMPLETED|Overall Study||102
8719808|NCT01005901|9767262|FG001|NOT COMPLETED|Overall Study||58
8719809|NCT01005966|9767268|FG000|STARTED|Treatment Period 1 (14 Days)||13
8719810|NCT01005966|9767269|FG001|STARTED|Treatment Period 1 (14 Days)||13
8719811|NCT01005966|9767270|FG002|STARTED|Treatment Period 1 (14 Days)||13
8719812|NCT01005966|9767271|FG003|STARTED|Treatment Period 1 (14 Days)||13
8719813|NCT01005966|9767272|FG004|STARTED|Treatment Period 1 (14 Days)||13
8719814|NCT01005966|9767268|FG000|COMPLETED|Treatment Period 1 (14 Days)||11
8719815|NCT01005966|9767269|FG001|COMPLETED|Treatment Period 1 (14 Days)||13
8719816|NCT01005966|9767270|FG002|COMPLETED|Treatment Period 1 (14 Days)||12
8719817|NCT01005966|9767271|FG003|COMPLETED|Treatment Period 1 (14 Days)||13
8617953|NCT00460434|9656201|FG001|3 Months|Overall Study||171
8617954|NCT00460434|9656200|FG000|12 Months|Overall Study||162
8617955|NCT00460434|9656201|FG001|12 Months|Overall Study||165
8719818|NCT01005966|9767272|FG004|COMPLETED|Treatment Period 1 (14 Days)||13
8719819|NCT01005966|9767268|FG000|NOT COMPLETED|Treatment Period 1 (14 Days)||2
8719820|NCT01005966|9767269|FG001|NOT COMPLETED|Treatment Period 1 (14 Days)||0
8719821|NCT01005966|9767270|FG002|NOT COMPLETED|Treatment Period 1 (14 Days)||1
8719822|NCT01005966|9767271|FG003|NOT COMPLETED|Treatment Period 1 (14 Days)||0
8719823|NCT01005966|9767272|FG004|NOT COMPLETED|Treatment Period 1 (14 Days)||0
8719824|NCT01005966|9767268|FG000|STARTED|Washout Period 1 (4 Days)||11
8719825|NCT01005966|9767269|FG001|STARTED|Washout Period 1 (4 Days)||13
8719826|NCT01005966|9767270|FG002|STARTED|Washout Period 1 (4 Days)||12
8719827|NCT01005966|9767271|FG003|STARTED|Washout Period 1 (4 Days)||13
8719828|NCT01005966|9767272|FG004|STARTED|Washout Period 1 (4 Days)||13
8719829|NCT01005966|9767268|FG000|COMPLETED|Washout Period 1 (4 Days)||11
8719830|NCT01005966|9767269|FG001|COMPLETED|Washout Period 1 (4 Days)||13
8719831|NCT01005966|9767270|FG002|COMPLETED|Washout Period 1 (4 Days)||12
8617956|NCT00460434|9656200|FG000|COMPLETED|Overall Study||162
8617957|NCT00460434|9656201|FG001|COMPLETED|Overall Study||165
8617958|NCT00460434|9656200|FG000|NOT COMPLETED|Overall Study||3
8617959|NCT00460434|9656201|FG001|NOT COMPLETED|Overall Study||7
8617960|NCT00460525|9656209|FG000|STARTED|Overall Study||201
8617961|NCT00460525|9656210|FG001|STARTED|Overall Study||199
8617962|NCT00460525|9656209|FG000|COMPLETED|Overall Study||190
8617963|NCT00460525|9656210|FG001|COMPLETED|Overall Study||194
8617964|NCT00460525|9656209|FG000|NOT COMPLETED|Overall Study||11
8617965|NCT00460525|9656210|FG001|NOT COMPLETED|Overall Study||5
8617966|NCT00460551|9656216|FG000|STARTED|Overall Study||13
8617967|NCT00460551|9656216|FG000|COMPLETED|Overall Study|The trial was terminated after Period 1A. Only safety was measured.|13
8617968|NCT00460551|9656216|FG000|NOT COMPLETED|Overall Study||0
8617969|NCT00460564|9656224|FG000|STARTED|Double-Blind Phase (12 Weeks)||51
8617970|NCT00460564|9656225|FG001|STARTED|Double-Blind Phase (12 Weeks)||26
8617971|NCT00460564|9656226|FG002|STARTED|Double-Blind Phase (12 Weeks)||21
8617972|NCT00460564|9656227|FG003|STARTED|Double-Blind Phase (12 Weeks)||11
8943628|NCT02390557|10005471|FG000|COMPLETED|Wave 1||160
8943629|NCT02390557|10005472|FG001|COMPLETED|Wave 1||156
8617973|NCT00460564|9656228|FG004|STARTED|Double-Blind Phase (12 Weeks)||0
8617974|NCT00460564|9656229|FG005|STARTED|Double-Blind Phase (12 Weeks)||0
8617975|NCT00460564|9656230|FG006|STARTED|Double-Blind Phase (12 Weeks)||0
8617976|NCT00460564|9656231|FG007|STARTED|Double-Blind Phase (12 Weeks)||0
8617977|NCT00460564|9656224|FG000|COMPLETED|Double-Blind Phase (12 Weeks)||47
8617978|NCT00460564|9656225|FG001|COMPLETED|Double-Blind Phase (12 Weeks)||25
8617979|NCT00460564|9656226|FG002|COMPLETED|Double-Blind Phase (12 Weeks)||21
8617980|NCT00460564|9656227|FG003|COMPLETED|Double-Blind Phase (12 Weeks)||11
8617981|NCT00460564|9656228|FG004|COMPLETED|Double-Blind Phase (12 Weeks)||0
8617982|NCT00460564|9656229|FG005|COMPLETED|Double-Blind Phase (12 Weeks)||0
8943630|NCT02390557|10005473|FG002|COMPLETED|Wave 1||135
8943631|NCT02390557|10005471|FG000|NOT COMPLETED|Wave 1||0
8617983|NCT00460564|9656230|FG006|COMPLETED|Double-Blind Phase (12 Weeks)||0
8617984|NCT00460564|9656231|FG007|COMPLETED|Double-Blind Phase (12 Weeks)||0
8617985|NCT00460564|9656224|FG000|NOT COMPLETED|Double-Blind Phase (12 Weeks)||4
8719832|NCT01005966|9767271|FG003|COMPLETED|Washout Period 1 (4 Days)||12
8719833|NCT01005966|9767272|FG004|COMPLETED|Washout Period 1 (4 Days)||13
8719834|NCT01005966|9767268|FG000|NOT COMPLETED|Washout Period 1 (4 Days)||0
8719835|NCT01005966|9767269|FG001|NOT COMPLETED|Washout Period 1 (4 Days)||0
8719836|NCT01005966|9767270|FG002|NOT COMPLETED|Washout Period 1 (4 Days)||0
8719837|NCT01005966|9767271|FG003|NOT COMPLETED|Washout Period 1 (4 Days)||1
8719838|NCT01005966|9767272|FG004|NOT COMPLETED|Washout Period 1 (4 Days)||0
8719839|NCT01005966|9767268|FG000|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
8719840|NCT01005966|9767269|FG001|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
8719841|NCT01005966|9767270|FG002|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|12
8719842|NCT01005966|9767271|FG003|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|12
8719843|NCT01005966|9767272|FG004|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|11
8719844|NCT01005966|9767268|FG000|COMPLETED|Treatment Period 2 (14 Days)||13
8719845|NCT01005966|9767269|FG001|COMPLETED|Treatment Period 2 (14 Days)||12
8719846|NCT01005966|9767270|FG002|COMPLETED|Treatment Period 2 (14 Days)||10
8719847|NCT01005966|9767271|FG003|COMPLETED|Treatment Period 2 (14 Days)||11
8719848|NCT01005966|9767272|FG004|COMPLETED|Treatment Period 2 (14 Days)||11
8719849|NCT01005966|9767268|FG000|NOT COMPLETED|Treatment Period 2 (14 Days)||0
8719850|NCT01005966|9767269|FG001|NOT COMPLETED|Treatment Period 2 (14 Days)||1
8719851|NCT01005966|9767270|FG002|NOT COMPLETED|Treatment Period 2 (14 Days)||2
8719852|NCT01005966|9767271|FG003|NOT COMPLETED|Treatment Period 2 (14 Days)||1
8719853|NCT01005966|9767272|FG004|NOT COMPLETED|Treatment Period 2 (14 Days)||0
8719854|NCT01005966|9767268|FG000|STARTED|Washout Period 2 (4 Days)||13
8719855|NCT01005966|9767269|FG001|STARTED|Washout Period 2 (4 Days)||12
8719856|NCT01005966|9767270|FG002|STARTED|Washout Period 2 (4 Days)||10
8719857|NCT01005966|9767271|FG003|STARTED|Washout Period 2 (4 Days)||11
8719858|NCT01005966|9767272|FG004|STARTED|Washout Period 2 (4 Days)||11
8719859|NCT01005966|9767268|FG000|COMPLETED|Washout Period 2 (4 Days)||13
8719860|NCT01005966|9767269|FG001|COMPLETED|Washout Period 2 (4 Days)||12
8719861|NCT01005966|9767270|FG002|COMPLETED|Washout Period 2 (4 Days)||10
8719862|NCT01005966|9767271|FG003|COMPLETED|Washout Period 2 (4 Days)||11
8719863|NCT01005966|9767272|FG004|COMPLETED|Washout Period 2 (4 Days)||11
8719864|NCT01005966|9767268|FG000|NOT COMPLETED|Washout Period 2 (4 Days)||0
8719865|NCT01005966|9767269|FG001|NOT COMPLETED|Washout Period 2 (4 Days)||0
8719866|NCT01005966|9767270|FG002|NOT COMPLETED|Washout Period 2 (4 Days)||0
8719867|NCT01005966|9767271|FG003|NOT COMPLETED|Washout Period 2 (4 Days)||0
8719868|NCT01005966|9767272|FG004|NOT COMPLETED|Washout Period 2 (4 Days)||0
8719869|NCT01005966|9767268|FG000|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
8719870|NCT01005966|9767269|FG001|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|8
8719871|NCT01005966|9767270|FG002|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
8719872|NCT01005966|9767271|FG003|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|13
8719873|NCT01005966|9767272|FG004|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
8719874|NCT01005966|9767268|FG000|COMPLETED|Treatment Period 3 (14 Days)||12
8719875|NCT01005966|9767269|FG001|COMPLETED|Treatment Period 3 (14 Days)||7
8719876|NCT01005966|9767270|FG002|COMPLETED|Treatment Period 3 (14 Days)||12
8719877|NCT01005966|9767271|FG003|COMPLETED|Treatment Period 3 (14 Days)||13
8719878|NCT01005966|9767272|FG004|COMPLETED|Treatment Period 3 (14 Days)||11
8719879|NCT01005966|9767268|FG000|NOT COMPLETED|Treatment Period 3 (14 Days)||0
8719880|NCT01005966|9767269|FG001|NOT COMPLETED|Treatment Period 3 (14 Days)||1
8719881|NCT01005966|9767270|FG002|NOT COMPLETED|Treatment Period 3 (14 Days)||0
8719882|NCT01005966|9767271|FG003|NOT COMPLETED|Treatment Period 3 (14 Days)||0
8617986|NCT00460564|9656225|FG001|NOT COMPLETED|Double-Blind Phase (12 Weeks)||1
8617987|NCT00460564|9656226|FG002|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
8617988|NCT00460564|9656227|FG003|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
8617989|NCT00460564|9656228|FG004|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
8617990|NCT00460564|9656229|FG005|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
8719883|NCT01005966|9767272|FG004|NOT COMPLETED|Treatment Period 3 (14 Days)||1
8617991|NCT00460564|9656230|FG006|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
8719884|NCT01005966|9767268|FG000|STARTED|Washout Period 3 ( 4 Days)||12
8719885|NCT01005966|9767269|FG001|STARTED|Washout Period 3 ( 4 Days)||7
8719886|NCT01005966|9767270|FG002|STARTED|Washout Period 3 ( 4 Days)||12
8719887|NCT01005966|9767271|FG003|STARTED|Washout Period 3 ( 4 Days)||13
8719888|NCT01005966|9767272|FG004|STARTED|Washout Period 3 ( 4 Days)||11
8719889|NCT01005966|9767268|FG000|COMPLETED|Washout Period 3 ( 4 Days)||12
8719890|NCT01005966|9767269|FG001|COMPLETED|Washout Period 3 ( 4 Days)||7
8719891|NCT01005966|9767270|FG002|COMPLETED|Washout Period 3 ( 4 Days)||12
8719892|NCT01005966|9767271|FG003|COMPLETED|Washout Period 3 ( 4 Days)||13
8719893|NCT01005966|9767272|FG004|COMPLETED|Washout Period 3 ( 4 Days)||11
8719894|NCT01005966|9767268|FG000|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
8719895|NCT01005966|9767269|FG001|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
8719896|NCT01005966|9767270|FG002|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
8719897|NCT01005966|9767271|FG003|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
8719898|NCT01005966|9767272|FG004|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
8719899|NCT01005966|9767268|FG000|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
8719900|NCT01005966|9767269|FG001|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|11
8719901|NCT01005966|9767270|FG002|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|11
8719902|NCT01005966|9767271|FG003|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
8719903|NCT01005966|9767272|FG004|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|13
8719904|NCT01005966|9767268|FG000|COMPLETED|Treatment Period 4 (14 Days)||10
8719905|NCT01005966|9767269|FG001|COMPLETED|Treatment Period 4 (14 Days)||10
8719906|NCT01005966|9767270|FG002|COMPLETED|Treatment Period 4 (14 Days)||11
8719907|NCT01005966|9767271|FG003|COMPLETED|Treatment Period 4 (14 Days)||10
8719908|NCT01005966|9767272|FG004|COMPLETED|Treatment Period 4 (14 Days)||12
8719909|NCT01005966|9767268|FG000|NOT COMPLETED|Treatment Period 4 (14 Days)||0
8719910|NCT01005966|9767269|FG001|NOT COMPLETED|Treatment Period 4 (14 Days)||1
8719911|NCT01005966|9767270|FG002|NOT COMPLETED|Treatment Period 4 (14 Days)||0
8719912|NCT01005966|9767271|FG003|NOT COMPLETED|Treatment Period 4 (14 Days)||0
8719913|NCT01005966|9767272|FG004|NOT COMPLETED|Treatment Period 4 (14 Days)||1
8719914|NCT01005966|9767268|FG000|STARTED|Washout Period 4 (4 Days)||10
8719915|NCT01005966|9767269|FG001|STARTED|Washout Period 4 (4 Days)||10
8719916|NCT01005966|9767270|FG002|STARTED|Washout Period 4 (4 Days)||11
8719917|NCT01005966|9767271|FG003|STARTED|Washout Period 4 (4 Days)||10
8719918|NCT01005966|9767272|FG004|STARTED|Washout Period 4 (4 Days)||12
8719919|NCT01005966|9767268|FG000|COMPLETED|Washout Period 4 (4 Days)||10
8719920|NCT01005966|9767269|FG001|COMPLETED|Washout Period 4 (4 Days)||10
8719921|NCT01005966|9767270|FG002|COMPLETED|Washout Period 4 (4 Days)||11
8719922|NCT01005966|9767271|FG003|COMPLETED|Washout Period 4 (4 Days)||10
8719923|NCT01005966|9767272|FG004|COMPLETED|Washout Period 4 (4 Days)||12
8719924|NCT01005966|9767268|FG000|NOT COMPLETED|Washout Period 4 (4 Days)||0
8617992|NCT00460564|9656231|FG007|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
8617993|NCT00460564|9656224|FG000|STARTED|Open-Label Phase (36 Weeks)||0
8617994|NCT00460564|9656225|FG001|STARTED|Open-Label Phase (36 Weeks)||0
8617995|NCT00460564|9656226|FG002|STARTED|Open-Label Phase (36 Weeks)||0
8557851|NCT03809611|9589796|FG001|STARTED|Overall Study||62
8557852|NCT03809611|9589795|FG000|COMPLETED|Overall Study||61
8557853|NCT03809611|9589796|FG001|COMPLETED|Overall Study||61
8557854|NCT03809611|9589795|FG000|NOT COMPLETED|Overall Study||1
8557855|NCT03809611|9589796|FG001|NOT COMPLETED|Overall Study||1
8557856|NCT03721705|9589805|FG000|STARTED|Overall Study||95
8557857|NCT03721705|9589806|FG001|STARTED|Overall Study||95
8557858|NCT03721705|9589805|FG000|COMPLETED|Overall Study||85
8557859|NCT03721705|9589806|FG001|COMPLETED|Overall Study||77
8557860|NCT03721705|9589805|FG000|NOT COMPLETED|Overall Study||10
8557861|NCT03721705|9589806|FG001|NOT COMPLETED|Overall Study||18
8568869|NCT00094458|9601097|FG000|COMPLETED|Study Extension: Week 30 Through Week 50||67
8568870|NCT00094458|9601098|FG001|COMPLETED|Study Extension: Week 30 Through Week 50||85
8719925|NCT01005966|9767269|FG001|NOT COMPLETED|Washout Period 4 (4 Days)||0
8719926|NCT01005966|9767270|FG002|NOT COMPLETED|Washout Period 4 (4 Days)||0
8719927|NCT01005966|9767271|FG003|NOT COMPLETED|Washout Period 4 (4 Days)||0
8719928|NCT01005966|9767272|FG004|NOT COMPLETED|Washout Period 4 (4 Days)||0
8719929|NCT01005966|9767268|FG000|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|9
8719930|NCT01005966|9767269|FG001|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|12
8719931|NCT01005966|9767270|FG002|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|11
8719932|NCT01005966|9767271|FG003|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|11
8719933|NCT01005966|9767272|FG004|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|10
8719934|NCT01005966|9767268|FG000|COMPLETED|Treatment Period 5 (14 Days)||9
8719935|NCT01005966|9767269|FG001|COMPLETED|Treatment Period 5 (14 Days)||12
8719936|NCT01005966|9767270|FG002|COMPLETED|Treatment Period 5 (14 Days)||11
8719937|NCT01005966|9767271|FG003|COMPLETED|Treatment Period 5 (14 Days)||11
8719938|NCT01005966|9767272|FG004|COMPLETED|Treatment Period 5 (14 Days)||10
8719939|NCT01005966|9767268|FG000|NOT COMPLETED|Treatment Period 5 (14 Days)||0
8719940|NCT01005966|9767269|FG001|NOT COMPLETED|Treatment Period 5 (14 Days)||0
8719941|NCT01005966|9767270|FG002|NOT COMPLETED|Treatment Period 5 (14 Days)||0
8719942|NCT01005966|9767271|FG003|NOT COMPLETED|Treatment Period 5 (14 Days)||0
8719943|NCT01005966|9767272|FG004|NOT COMPLETED|Treatment Period 5 (14 Days)||0
8719944|NCT01006122|9767289|FG000|STARTED|First Double-blind Intervention Period||47
8719945|NCT01006122|9767290|FG001|STARTED|First Double-blind Intervention Period||48
8719946|NCT01006122|9767289|FG000|COMPLETED|First Double-blind Intervention Period||31
8719947|NCT01006122|9767290|FG001|COMPLETED|First Double-blind Intervention Period||31
8719948|NCT01006122|9767289|FG000|NOT COMPLETED|First Double-blind Intervention Period||16
8719949|NCT01006122|9767290|FG001|NOT COMPLETED|First Double-blind Intervention Period||17
8719950|NCT01006122|9767289|FG000|STARTED|Wash-out Period (at Least 7 Days)||31
8719951|NCT01006122|9767290|FG001|STARTED|Wash-out Period (at Least 7 Days)||31
8719952|NCT01006122|9767289|FG000|COMPLETED|Wash-out Period (at Least 7 Days)||31
8719953|NCT01006122|9767290|FG001|COMPLETED|Wash-out Period (at Least 7 Days)||31
8719954|NCT01006122|9767289|FG000|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
8719955|NCT01006122|9767290|FG001|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
8719956|NCT01006122|9767289|FG000|STARTED|Second Double-blind Intervention Period||31
8719957|NCT01006122|9767290|FG001|STARTED|Second Double-blind Intervention Period||31
8719958|NCT01006122|9767289|FG000|COMPLETED|Second Double-blind Intervention Period||29
8719959|NCT01006122|9767290|FG001|COMPLETED|Second Double-blind Intervention Period||24
8719960|NCT01006122|9767289|FG000|NOT COMPLETED|Second Double-blind Intervention Period||2
8719961|NCT01006122|9767290|FG001|NOT COMPLETED|Second Double-blind Intervention Period||7
8719962|NCT01006135|9767296|FG000|STARTED|Overall Study||4852
8719963|NCT01006135|9767296|FG000|COMPLETED|Overall Study||4712
8719964|NCT01006135|9767296|FG000|NOT COMPLETED|Overall Study||140
8719965|NCT01006252|9767302|FG000|STARTED|Overall Study||168
8719966|NCT01006252|9767303|FG001|STARTED|Overall Study||168
8719967|NCT01006252|9767302|FG000|Received Treatment|Overall Study||164
8719968|NCT01006252|9767303|FG001|Received Treatment|Overall Study||161
8719969|NCT01006252|9767302|FG000|COMPLETED|Overall Study||168
8719970|NCT01006252|9767303|FG001|COMPLETED|Overall Study||168
8719971|NCT01006252|9767302|FG000|NOT COMPLETED|Overall Study||0
8719972|NCT01006252|9767303|FG001|NOT COMPLETED|Overall Study||0
8719973|NCT01006291|9767316|FG000|STARTED|Overall Study||229
8719974|NCT01006291|9767317|FG001|STARTED|Overall Study||228
8719975|NCT01006291|9767318|FG002|STARTED|Overall Study||230
8719976|NCT01006291|9767316|FG000|Exposed|Overall Study|1 subject withdrew before exposure to drug. 2 subjects randomised to IDeg OD received IDeg OD FF|230
8719977|NCT01006291|9767317|FG001|Exposed|Overall Study|2 subjects received IDeg OD FF|226
8719978|NCT01006291|9767318|FG002|Exposed|Overall Study|1 subject withdrew prior to exposure to trial drug|229
8719979|NCT01006291|9767316|FG000|COMPLETED|Overall Study||203
8719980|NCT01006291|9767317|FG001|COMPLETED|Overall Study||204
8568871|NCT00094458|9601099|FG002|COMPLETED|Study Extension: Week 30 Through Week 50||90
8568872|NCT00094458|9601100|FG003|COMPLETED|Study Extension: Week 30 Through Week 50||0
8719981|NCT01006291|9767318|FG002|COMPLETED|Overall Study||203
8719982|NCT01006291|9767316|FG000|NOT COMPLETED|Overall Study||26
8719983|NCT01006291|9767317|FG001|NOT COMPLETED|Overall Study||24
8719984|NCT01006291|9767318|FG002|NOT COMPLETED|Overall Study||27
8719985|NCT01006356|9767326|FG000|STARTED|Overall Study||141
8719986|NCT01006356|9767326|FG000|COMPLETED|Overall Study||99
8719987|NCT01006356|9767326|FG000|NOT COMPLETED|Overall Study||42
8719988|NCT01006369|9767332|FG000|STARTED|Overall Study||13
8719989|NCT01006369|9767333|FG001|STARTED|Overall Study||25
8719990|NCT01006369|9767332|FG000|COMPLETED|Overall Study||1
8719991|NCT01006369|9767333|FG001|COMPLETED|Overall Study||0
8719992|NCT01006369|9767332|FG000|NOT COMPLETED|Overall Study||12
8719993|NCT01006369|9767333|FG001|NOT COMPLETED|Overall Study||25
8719994|NCT01006538|9767340|FG000|STARTED|Overall Study||244
8719995|NCT01006538|9767341|FG001|STARTED|Overall Study||119
8719996|NCT01006538|9767340|FG000|COMPLETED|Overall Study||233
8719997|NCT01006538|9767341|FG001|COMPLETED|Overall Study||115
8719998|NCT01006538|9767340|FG000|NOT COMPLETED|Overall Study||11
8719999|NCT01006538|9767341|FG001|NOT COMPLETED|Overall Study||4
8720000|NCT01006590|9767349|FG000|STARTED|Overall Study|Randomised and treated|147
8720001|NCT01006590|9767350|FG001|STARTED|Overall Study|Randomised and treated|139
8720002|NCT01006590|9767349|FG000|COMPLETED|Overall Study|Completed 24 weeks of treatment|119
8720003|NCT01006590|9767350|FG001|COMPLETED|Overall Study|Completed 24 weeks of treatment|107
8720004|NCT01006590|9767349|FG000|NOT COMPLETED|Overall Study||28
8720005|NCT01006590|9767350|FG001|NOT COMPLETED|Overall Study||32
8720006|NCT01006603|9767358|FG000|STARTED|Overall Study|Completed lead-in period and were randomised|360
8720007|NCT01006603|9767359|FG001|STARTED|Overall Study|Completed lead-in period and were randomised|360
8720008|NCT01006603|9767358|FG000|COMPLETED|Overall Study||289
8720009|NCT01006603|9767359|FG001|COMPLETED|Overall Study||285
8720010|NCT01006603|9767358|FG000|NOT COMPLETED|Overall Study||71
8720011|NCT01006603|9767359|FG001|NOT COMPLETED|Overall Study||75
8720012|NCT01006616|9767369|FG000|STARTED|Period 1 (6 Months)||152
8720013|NCT01006616|9767370|FG001|STARTED|Period 1 (6 Months)||156
8720014|NCT01006616|9767371|FG002|STARTED|Period 1 (6 Months)||153
8720015|NCT01006616|9767372|FG003|STARTED|Period 1 (6 Months)||155
8720016|NCT01006616|9767369|FG000|Treated|Period 1 (6 Months)||152
8720017|NCT01006616|9767370|FG001|Treated|Period 1 (6 Months)||156
8720018|NCT01006616|9767371|FG002|Treated|Period 1 (6 Months)||152
8720019|NCT01006616|9767372|FG003|Treated|Period 1 (6 Months)||154
8720020|NCT01006616|9767369|FG000|COMPLETED|Period 1 (6 Months)||126
8720021|NCT01006616|9767370|FG001|COMPLETED|Period 1 (6 Months)||102
8720022|NCT01006616|9767371|FG002|COMPLETED|Period 1 (6 Months)||102
8720023|NCT01006616|9767372|FG003|COMPLETED|Period 1 (6 Months)||128
8720024|NCT01006616|9767369|FG000|NOT COMPLETED|Period 1 (6 Months)||26
8720025|NCT01006616|9767370|FG001|NOT COMPLETED|Period 1 (6 Months)||54
8720026|NCT01006616|9767371|FG002|NOT COMPLETED|Period 1 (6 Months)||51
8720027|NCT01006616|9767372|FG003|NOT COMPLETED|Period 1 (6 Months)||27
8720028|NCT01006616|9767369|FG000|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|75
8720029|NCT01006616|9767370|FG001|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|63
8720030|NCT01006616|9767371|FG002|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|55
8720031|NCT01006616|9767372|FG003|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|82
8720032|NCT01006616|9767369|FG000|Treated|Period 2 (18 Months)||75
8720033|NCT01006616|9767370|FG001|Treated|Period 2 (18 Months)||63
8720034|NCT01006616|9767371|FG002|Treated|Period 2 (18 Months)||55
8720035|NCT01006616|9767372|FG003|Treated|Period 2 (18 Months)||82
8720036|NCT01006616|9767369|FG000|COMPLETED|Period 2 (18 Months)||0
8720037|NCT01006616|9767370|FG001|COMPLETED|Period 2 (18 Months)||0
8720038|NCT01006616|9767371|FG002|COMPLETED|Period 2 (18 Months)||0
8720039|NCT01006616|9767372|FG003|COMPLETED|Period 2 (18 Months)||0
8720040|NCT01006616|9767369|FG000|NOT COMPLETED|Period 2 (18 Months)||75
8720041|NCT01006616|9767370|FG001|NOT COMPLETED|Period 2 (18 Months)||63
8720042|NCT01006616|9767371|FG002|NOT COMPLETED|Period 2 (18 Months)||55
8720043|NCT01006616|9767372|FG003|NOT COMPLETED|Period 2 (18 Months)||82
8720044|NCT01006629|9767382|FG000|STARTED|Overall Study||100
8720045|NCT01006629|9767382|FG000|COMPLETED|Overall Study||94
8720046|NCT01006629|9767382|FG000|NOT COMPLETED|Overall Study||6
8720047|NCT01006655|9767388|FG000|STARTED|First Intervention||11
8720048|NCT01006655|9767389|FG001|STARTED|First Intervention||10
8720049|NCT01006655|9767388|FG000|COMPLETED|First Intervention||11
8720050|NCT01006655|9767389|FG001|COMPLETED|First Intervention||10
8720051|NCT01006655|9767388|FG000|NOT COMPLETED|First Intervention||0
8720052|NCT01006655|9767389|FG001|NOT COMPLETED|First Intervention||0
8720053|NCT01006655|9767388|FG000|STARTED|Washout Period of 2 Weeks||11
8720054|NCT01006655|9767389|FG001|STARTED|Washout Period of 2 Weeks||10
8720055|NCT01006655|9767388|FG000|COMPLETED|Washout Period of 2 Weeks||11
8720056|NCT01006655|9767389|FG001|COMPLETED|Washout Period of 2 Weeks||10
8720057|NCT01006655|9767388|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
8720058|NCT01006655|9767389|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
8720059|NCT01006655|9767388|FG000|STARTED|Second Intervention||11
8720060|NCT01006655|9767389|FG001|STARTED|Second Intervention||10
8720061|NCT01006655|9767388|FG000|COMPLETED|Second Intervention||11
8720062|NCT01006655|9767389|FG001|COMPLETED|Second Intervention||10
8720063|NCT01006655|9767388|FG000|NOT COMPLETED|Second Intervention||0
8720064|NCT01006655|9767389|FG001|NOT COMPLETED|Second Intervention||0
8720065|NCT01006707|9767395|FG000|STARTED|Study Session 1||15
8720066|NCT01006707|9767396|FG001|STARTED|Study Session 1||0
8720067|NCT01006707|9767397|FG002|STARTED|Study Session 1||0
8720068|NCT01006707|9767395|FG000|COMPLETED|Study Session 1||10
8720069|NCT01006707|9767396|FG001|COMPLETED|Study Session 1||0
8720070|NCT01006707|9767397|FG002|COMPLETED|Study Session 1||0
8720071|NCT01006707|9767395|FG000|NOT COMPLETED|Study Session 1||5
8720072|NCT01006707|9767396|FG001|NOT COMPLETED|Study Session 1||0
8720073|NCT01006707|9767397|FG002|NOT COMPLETED|Study Session 1||0
8720074|NCT01006707|9767395|FG000|STARTED|Study Session 2||0
8720075|NCT01006707|9767396|FG001|STARTED|Study Session 2||4
8720076|NCT01006707|9767397|FG002|STARTED|Study Session 2||6
8720077|NCT01006707|9767395|FG000|COMPLETED|Study Session 2||0
8720078|NCT01006707|9767396|FG001|COMPLETED|Study Session 2||4
8720079|NCT01006707|9767397|FG002|COMPLETED|Study Session 2||6
8720080|NCT01006707|9767395|FG000|NOT COMPLETED|Study Session 2||0
8720081|NCT01006707|9767396|FG001|NOT COMPLETED|Study Session 2||0
8720082|NCT01006707|9767397|FG002|NOT COMPLETED|Study Session 2||0
8720083|NCT01006707|9767395|FG000|STARTED|Study Session 3||0
8720084|NCT01006707|9767396|FG001|STARTED|Study Session 3||4
8720085|NCT01006707|9767397|FG002|STARTED|Study Session 3||6
8720086|NCT01006707|9767395|FG000|COMPLETED|Study Session 3||0
8720087|NCT01006707|9767396|FG001|COMPLETED|Study Session 3||4
8720088|NCT01006707|9767397|FG002|COMPLETED|Study Session 3||6
8720089|NCT01006707|9767395|FG000|NOT COMPLETED|Study Session 3||0
8720090|NCT01006707|9767396|FG001|NOT COMPLETED|Study Session 3||0
8720091|NCT01006707|9767397|FG002|NOT COMPLETED|Study Session 3||0
8720092|NCT01006889|9767405|FG000|STARTED|Overall Study||20
8720093|NCT01006889|9767405|FG000|COMPLETED|Overall Study||17
8720094|NCT01006889|9767405|FG000|NOT COMPLETED|Overall Study||3
8720095|NCT01006967|9767412|FG000|STARTED|Overall Study||253
8720096|NCT01006967|9767413|FG001|STARTED|Overall Study||253
8720097|NCT01006967|9767412|FG000|Received Treatment|Overall Study||245
8720098|NCT01006967|9767413|FG001|Received Treatment|Overall Study||245
8720099|NCT01006967|9767412|FG000|3 Month Follow-up|Overall Study||212
8720100|NCT01006967|9767413|FG001|3 Month Follow-up|Overall Study||210
8720101|NCT01006967|9767412|FG000|COMPLETED|Overall Study||187
8720102|NCT01006967|9767413|FG001|COMPLETED|Overall Study||190
8720103|NCT01006967|9767412|FG000|NOT COMPLETED|Overall Study||66
8720104|NCT01006967|9767413|FG001|NOT COMPLETED|Overall Study||63
8720105|NCT01006980|9767423|FG000|STARTED|Vemurafenib and Dacarbazine||337
8720106|NCT01006980|9767424|FG001|STARTED|Vemurafenib and Dacarbazine||338
8720107|NCT01006980|9767423|FG000|Treated|Vemurafenib and Dacarbazine||336
8720108|NCT01006980|9767424|FG001|Treated|Vemurafenib and Dacarbazine||293
8720109|NCT01006980|9767423|FG000|COMPLETED|Vemurafenib and Dacarbazine||0
8720110|NCT01006980|9767424|FG001|COMPLETED|Vemurafenib and Dacarbazine||0
8720111|NCT01006980|9767423|FG000|NOT COMPLETED|Vemurafenib and Dacarbazine||337
8720112|NCT01006980|9767424|FG001|NOT COMPLETED|Vemurafenib and Dacarbazine||338
8720113|NCT01006980|9767423|FG000|STARTED|Crossover: Dacarbazine to Vemurafenib||0
8720114|NCT01006980|9767424|FG001|STARTED|Crossover: Dacarbazine to Vemurafenib|Participants who crossed over from dacarbazine to vemurafenib treatment.|84
8617996|NCT00460564|9656227|FG003|STARTED|Open-Label Phase (36 Weeks)||0
8617997|NCT00460564|9656228|FG004|STARTED|Open-Label Phase (36 Weeks)||47
8617998|NCT00460564|9656229|FG005|STARTED|Open-Label Phase (36 Weeks)||25
8617999|NCT00460564|9656230|FG006|STARTED|Open-Label Phase (36 Weeks)||21
8618000|NCT00460564|9656231|FG007|STARTED|Open-Label Phase (36 Weeks)||11
8618001|NCT00460564|9656224|FG000|COMPLETED|Open-Label Phase (36 Weeks)||0
8618002|NCT00460564|9656225|FG001|COMPLETED|Open-Label Phase (36 Weeks)||0
8618003|NCT00460564|9656226|FG002|COMPLETED|Open-Label Phase (36 Weeks)||0
8618004|NCT00460564|9656227|FG003|COMPLETED|Open-Label Phase (36 Weeks)||0
8618005|NCT00460564|9656228|FG004|COMPLETED|Open-Label Phase (36 Weeks)||38
8720115|NCT01006980|9767423|FG000|COMPLETED|Crossover: Dacarbazine to Vemurafenib||0
8720116|NCT01006980|9767424|FG001|COMPLETED|Crossover: Dacarbazine to Vemurafenib||0
8720117|NCT01006980|9767423|FG000|NOT COMPLETED|Crossover: Dacarbazine to Vemurafenib||0
8720118|NCT01006980|9767424|FG001|NOT COMPLETED|Crossover: Dacarbazine to Vemurafenib||84
8720119|NCT01007032|9767435|FG000|STARTED|Overall Study||4
8720120|NCT01007032|9767436|FG001|STARTED|Overall Study||7
8720121|NCT01007032|9767437|FG002|STARTED|Overall Study||3
8720122|NCT01007032|9767438|FG003|STARTED|Overall Study||7
8720123|NCT01007032|9767435|FG000|Received at Least 1 Dose of Study Drug|Overall Study||4
8720124|NCT01007032|9767436|FG001|Received at Least 1 Dose of Study Drug|Overall Study||7
8720125|NCT01007032|9767437|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
8720126|NCT01007032|9767438|FG003|Received at Least 1 Dose of Study Drug|Overall Study||7
8720127|NCT01007032|9767435|FG000|COMPLETED|Overall Study||4
8720128|NCT01007032|9767436|FG001|COMPLETED|Overall Study||6
8720129|NCT01007032|9767437|FG002|COMPLETED|Overall Study||2
8720130|NCT01007032|9767438|FG003|COMPLETED|Overall Study||6
8720131|NCT01007032|9767435|FG000|NOT COMPLETED|Overall Study||0
8720132|NCT01007032|9767436|FG001|NOT COMPLETED|Overall Study||1
8720133|NCT01007032|9767437|FG002|NOT COMPLETED|Overall Study||1
8720134|NCT01007032|9767438|FG003|NOT COMPLETED|Overall Study||1
8720135|NCT01007071|9767455|FG000|STARTED|Overall Study||6
8720136|NCT01007071|9767456|FG001|STARTED|Overall Study||5
8720137|NCT01007071|9767455|FG000|COMPLETED|Overall Study||6
8720138|NCT01007071|9767456|FG001|COMPLETED|Overall Study||5
8720139|NCT01007071|9767455|FG000|NOT COMPLETED|Overall Study||0
8720140|NCT01007071|9767456|FG001|NOT COMPLETED|Overall Study||0
8720141|NCT01007110|9767465|FG000|STARTED|Allocation||32
8720142|NCT01007110|9767466|FG001|STARTED|Allocation||35
8720143|NCT01007110|9767465|FG000|COMPLETED|Allocation||25
8720144|NCT01007110|9767466|FG001|COMPLETED|Allocation||27
8720145|NCT01007110|9767465|FG000|NOT COMPLETED|Allocation||7
8720146|NCT01007110|9767466|FG001|NOT COMPLETED|Allocation||8
8720147|NCT01007110|9767465|FG000|STARTED|Follow-Up at 24 Weeks||25
8720148|NCT01007110|9767466|FG001|STARTED|Follow-Up at 24 Weeks||27
8618006|NCT00460564|9656229|FG005|COMPLETED|Open-Label Phase (36 Weeks)||19
8720149|NCT01007110|9767465|FG000|COMPLETED|Follow-Up at 24 Weeks||25
8720150|NCT01007110|9767466|FG001|COMPLETED|Follow-Up at 24 Weeks||23
8618007|NCT00460564|9656230|FG006|COMPLETED|Open-Label Phase (36 Weeks)||19
8618008|NCT00460564|9656231|FG007|COMPLETED|Open-Label Phase (36 Weeks)||11
8618009|NCT00460564|9656224|FG000|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
8618010|NCT00460564|9656225|FG001|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
8618011|NCT00460564|9656226|FG002|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
8618012|NCT00460564|9656227|FG003|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
8618013|NCT00460564|9656228|FG004|NOT COMPLETED|Open-Label Phase (36 Weeks)||9
8618014|NCT00460564|9656229|FG005|NOT COMPLETED|Open-Label Phase (36 Weeks)||6
8618015|NCT00460564|9656230|FG006|NOT COMPLETED|Open-Label Phase (36 Weeks)||2
8618016|NCT00460564|9656231|FG007|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
8618017|NCT00460577|9656253|FG000|STARTED|Overall Study|148 patients were screened; however, 22 did not consent and 66 did not meet inclusion/exclusion.|30
8618018|NCT00460577|9656254|FG001|STARTED|Overall Study||30
8618019|NCT00460577|9656253|FG000|COMPLETED|Overall Study||28
8618020|NCT00460577|9656254|FG001|COMPLETED|Overall Study||24
8618021|NCT00460577|9656253|FG000|NOT COMPLETED|Overall Study||2
8618022|NCT00460577|9656254|FG001|NOT COMPLETED|Overall Study||6
8618023|NCT00460603|9656272|FG000|STARTED|Phase 1||6
8618024|NCT00460603|9656273|FG001|STARTED|Phase 1||6
8618025|NCT00460603|9656274|FG002|STARTED|Phase 1||4
8618026|NCT00460603|9656275|FG003|STARTED|Phase 1||8
8720151|NCT01007110|9767465|FG000|NOT COMPLETED|Follow-Up at 24 Weeks||0
8720152|NCT01007110|9767466|FG001|NOT COMPLETED|Follow-Up at 24 Weeks||4
8720153|NCT01007110|9767465|FG000|STARTED|Follow-Up at 32 Weeks||25
8720154|NCT01007110|9767466|FG001|STARTED|Follow-Up at 32 Weeks||23
8720155|NCT01007110|9767465|FG000|COMPLETED|Follow-Up at 32 Weeks||24
8720156|NCT01007110|9767466|FG001|COMPLETED|Follow-Up at 32 Weeks||22
8720157|NCT01007110|9767465|FG000|NOT COMPLETED|Follow-Up at 32 Weeks||1
8720158|NCT01007110|9767466|FG001|NOT COMPLETED|Follow-Up at 32 Weeks||1
8720159|NCT01007110|9767465|FG000|STARTED|Follow-Up at 36 Weeks||24
8720160|NCT01007110|9767466|FG001|STARTED|Follow-Up at 36 Weeks||22
8720161|NCT01007110|9767465|FG000|COMPLETED|Follow-Up at 36 Weeks||24
8720162|NCT01007110|9767466|FG001|COMPLETED|Follow-Up at 36 Weeks||20
8720163|NCT01007110|9767465|FG000|NOT COMPLETED|Follow-Up at 36 Weeks||0
8720164|NCT01007110|9767466|FG001|NOT COMPLETED|Follow-Up at 36 Weeks||2
8720165|NCT01007110|9767465|FG000|STARTED|Neonatal Behavioral Assessment Scale (NB||24
8720166|NCT01007110|9767466|FG001|STARTED|Neonatal Behavioral Assessment Scale (NB||20
8720167|NCT01007110|9767465|FG000|COMPLETED|Neonatal Behavioral Assessment Scale (NB||12
8720168|NCT01007110|9767466|FG001|COMPLETED|Neonatal Behavioral Assessment Scale (NB||15
8720169|NCT01007110|9767465|FG000|NOT COMPLETED|Neonatal Behavioral Assessment Scale (NB||12
8720170|NCT01007110|9767466|FG001|NOT COMPLETED|Neonatal Behavioral Assessment Scale (NB||5
8720171|NCT01007123|9767477|FG000|STARTED|Overall Study||48
8720172|NCT01007123|9767478|FG001|STARTED|Overall Study||47
8720173|NCT01007123|9767479|FG002|STARTED|Overall Study||48
8720174|NCT01007123|9767480|FG003|STARTED|Overall Study||47
8720175|NCT01007123|9767477|FG000|COMPLETED|Overall Study||42
8720176|NCT01007123|9767478|FG001|COMPLETED|Overall Study||41
8720177|NCT01007123|9767479|FG002|COMPLETED|Overall Study||37
8720178|NCT01007123|9767480|FG003|COMPLETED|Overall Study||41
8720179|NCT01007123|9767477|FG000|NOT COMPLETED|Overall Study||6
8720180|NCT01007123|9767478|FG001|NOT COMPLETED|Overall Study||6
8720181|NCT01007123|9767479|FG002|NOT COMPLETED|Overall Study||11
8720182|NCT01007123|9767480|FG003|NOT COMPLETED|Overall Study||6
8720183|NCT01007136|9767496|FG000|STARTED|Overall Study||19
8720184|NCT01007136|9767497|FG001|STARTED|Overall Study|One additional subject was excluded prior to randomization due to illicit drug use.|17
8720185|NCT01007136|9767498|FG002|STARTED|Overall Study||15
8720186|NCT01007136|9767499|FG003|STARTED|Overall Study||6
8720187|NCT01007136|9767500|FG004|STARTED|Overall Study||4
8720188|NCT01007136|9767496|FG000|COMPLETED|Overall Study||15
8720189|NCT01007136|9767497|FG001|COMPLETED|Overall Study||13
8720190|NCT01007136|9767498|FG002|COMPLETED|Overall Study||15
8720191|NCT01007136|9767499|FG003|COMPLETED|Overall Study||6
8720192|NCT01007136|9767500|FG004|COMPLETED|Overall Study||4
8720193|NCT01007136|9767496|FG000|NOT COMPLETED|Overall Study||4
8720194|NCT01007136|9767497|FG001|NOT COMPLETED|Overall Study||4
8720195|NCT01007136|9767498|FG002|NOT COMPLETED|Overall Study||0
8720196|NCT01007136|9767499|FG003|NOT COMPLETED|Overall Study||0
8720197|NCT01007136|9767500|FG004|NOT COMPLETED|Overall Study||0
8720198|NCT01007149|9767513|FG000|STARTED|Overall Study||20
8618027|NCT00460603|9656276|FG004|STARTED|Phase 1||6
8618028|NCT00460603|9656277|FG005|STARTED|Phase 1||4
8618029|NCT00460603|9656278|FG006|STARTED|Phase 1||6
8618030|NCT00460603|9656279|FG007|STARTED|Phase 1||3
8618031|NCT00460603|9656280|FG008|STARTED|Phase 1||18
8618032|NCT00460603|9656281|FG009|STARTED|Phase 1||0
8720199|NCT01007149|9767514|FG001|STARTED|Overall Study||21
8720200|NCT01007149|9767513|FG000|COMPLETED|Overall Study||20
8720201|NCT01007149|9767514|FG001|COMPLETED|Overall Study||20
8720202|NCT01007149|9767513|FG000|NOT COMPLETED|Overall Study||0
8720203|NCT01007149|9767514|FG001|NOT COMPLETED|Overall Study||1
8720204|NCT01007253|9767520|FG000|STARTED|First Intervention||6
8720205|NCT01007253|9767521|FG001|STARTED|First Intervention||5
8720206|NCT01007253|9767522|FG002|STARTED|First Intervention||5
8720207|NCT01007253|9767523|FG003|STARTED|First Intervention||5
8720208|NCT01007253|9767520|FG000|COMPLETED|First Intervention||6
8618033|NCT00460603|9656282|FG010|STARTED|Phase 1||0
8618034|NCT00460603|9656283|FG011|STARTED|Phase 1||0
8720209|NCT01007253|9767521|FG001|COMPLETED|First Intervention||5
8720210|NCT01007253|9767522|FG002|COMPLETED|First Intervention||5
8720211|NCT01007253|9767523|FG003|COMPLETED|First Intervention||5
8720212|NCT01007253|9767520|FG000|NOT COMPLETED|First Intervention||0
8720213|NCT01007253|9767521|FG001|NOT COMPLETED|First Intervention||0
8720214|NCT01007253|9767522|FG002|NOT COMPLETED|First Intervention||0
8720215|NCT01007253|9767523|FG003|NOT COMPLETED|First Intervention||0
8720216|NCT01007253|9767520|FG000|STARTED|Washout Period (2 Weeks) # 1||6
8720217|NCT01007253|9767521|FG001|STARTED|Washout Period (2 Weeks) # 1||5
8720218|NCT01007253|9767522|FG002|STARTED|Washout Period (2 Weeks) # 1||5
8720219|NCT01007253|9767523|FG003|STARTED|Washout Period (2 Weeks) # 1||5
8720220|NCT01007253|9767520|FG000|COMPLETED|Washout Period (2 Weeks) # 1||6
8720221|NCT01007253|9767521|FG001|COMPLETED|Washout Period (2 Weeks) # 1||5
8720222|NCT01007253|9767522|FG002|COMPLETED|Washout Period (2 Weeks) # 1||5
8720223|NCT01007253|9767523|FG003|COMPLETED|Washout Period (2 Weeks) # 1||5
8720224|NCT01007253|9767520|FG000|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
8720225|NCT01007253|9767521|FG001|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
8720226|NCT01007253|9767522|FG002|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
8720227|NCT01007253|9767523|FG003|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
8720228|NCT01007253|9767520|FG000|STARTED|Second Intervention||6
8720229|NCT01007253|9767521|FG001|STARTED|Second Intervention||5
8720230|NCT01007253|9767522|FG002|STARTED|Second Intervention||5
8720231|NCT01007253|9767523|FG003|STARTED|Second Intervention||5
8720232|NCT01007253|9767520|FG000|COMPLETED|Second Intervention||6
8720233|NCT01007253|9767521|FG001|COMPLETED|Second Intervention||5
8720234|NCT01007253|9767522|FG002|COMPLETED|Second Intervention||5
8720235|NCT01007253|9767523|FG003|COMPLETED|Second Intervention||5
8720236|NCT01007253|9767520|FG000|NOT COMPLETED|Second Intervention||0
8720237|NCT01007253|9767521|FG001|NOT COMPLETED|Second Intervention||0
8720238|NCT01007253|9767522|FG002|NOT COMPLETED|Second Intervention||0
8720239|NCT01007253|9767523|FG003|NOT COMPLETED|Second Intervention||0
8720240|NCT01007253|9767520|FG000|STARTED|Washout Period (2 Weeks) # 2||6
8720241|NCT01007253|9767521|FG001|STARTED|Washout Period (2 Weeks) # 2||5
8720242|NCT01007253|9767522|FG002|STARTED|Washout Period (2 Weeks) # 2||5
8720243|NCT01007253|9767523|FG003|STARTED|Washout Period (2 Weeks) # 2||5
8720244|NCT01007253|9767520|FG000|COMPLETED|Washout Period (2 Weeks) # 2||6
8720245|NCT01007253|9767521|FG001|COMPLETED|Washout Period (2 Weeks) # 2||5
8720246|NCT01007253|9767522|FG002|COMPLETED|Washout Period (2 Weeks) # 2||5
8720247|NCT01007253|9767523|FG003|COMPLETED|Washout Period (2 Weeks) # 2||5
8720248|NCT01007253|9767520|FG000|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
8720249|NCT01007253|9767521|FG001|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
8720250|NCT01007253|9767522|FG002|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
8720251|NCT01007253|9767523|FG003|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
8720252|NCT01007253|9767520|FG000|STARTED|Third Intervention||6
8720253|NCT01007253|9767521|FG001|STARTED|Third Intervention||5
8813736|NCT01527487|9866937|FG000|NOT COMPLETED|Overall Study||8
8813737|NCT01527487|9866938|FG001|NOT COMPLETED|Overall Study||7
8813738|NCT01527500|9866953|FG000|STARTED|Part A||99
8813739|NCT01527500|9866954|FG001|STARTED|Part A||51
8720254|NCT01007253|9767522|FG002|STARTED|Third Intervention||5
8720255|NCT01007253|9767523|FG003|STARTED|Third Intervention||5
8720256|NCT01007253|9767520|FG000|COMPLETED|Third Intervention||6
8720257|NCT01007253|9767521|FG001|COMPLETED|Third Intervention||5
8813740|NCT01527500|9866953|FG000|COMPLETED|Part A||69
8813741|NCT01527500|9866954|FG001|COMPLETED|Part A||38
8720258|NCT01007253|9767522|FG002|COMPLETED|Third Intervention||5
8720259|NCT01007253|9767523|FG003|COMPLETED|Third Intervention||5
8813742|NCT01527500|9866953|FG000|NOT COMPLETED|Part A||30
8813743|NCT01527500|9866954|FG001|NOT COMPLETED|Part A||13
8618035|NCT00460603|9656272|FG000|COMPLETED|Phase 1||0
8618036|NCT00460603|9656273|FG001|COMPLETED|Phase 1||0
8618037|NCT00460603|9656274|FG002|COMPLETED|Phase 1||0
8720260|NCT01007253|9767520|FG000|NOT COMPLETED|Third Intervention||0
8720261|NCT01007253|9767521|FG001|NOT COMPLETED|Third Intervention||0
8720262|NCT01007253|9767522|FG002|NOT COMPLETED|Third Intervention||0
8720263|NCT01007253|9767523|FG003|NOT COMPLETED|Third Intervention||0
8720264|NCT01007253|9767520|FG000|STARTED|Washout Period (2 Weeks) # 3||6
8720265|NCT01007253|9767521|FG001|STARTED|Washout Period (2 Weeks) # 3||5
8720266|NCT01007253|9767522|FG002|STARTED|Washout Period (2 Weeks) # 3||5
8720267|NCT01007253|9767523|FG003|STARTED|Washout Period (2 Weeks) # 3||5
8720268|NCT01007253|9767520|FG000|COMPLETED|Washout Period (2 Weeks) # 3||5
8720269|NCT01007253|9767521|FG001|COMPLETED|Washout Period (2 Weeks) # 3||5
8720270|NCT01007253|9767522|FG002|COMPLETED|Washout Period (2 Weeks) # 3||5
8720271|NCT01007253|9767523|FG003|COMPLETED|Washout Period (2 Weeks) # 3||5
8720272|NCT01007253|9767520|FG000|NOT COMPLETED|Washout Period (2 Weeks) # 3||1
8720273|NCT01007253|9767521|FG001|NOT COMPLETED|Washout Period (2 Weeks) # 3||0
8720274|NCT01007253|9767522|FG002|NOT COMPLETED|Washout Period (2 Weeks) # 3||0
8720275|NCT01007253|9767523|FG003|NOT COMPLETED|Washout Period (2 Weeks) # 3||0
8720276|NCT01007253|9767520|FG000|STARTED|Fourth Intervention||5
8720277|NCT01007253|9767521|FG001|STARTED|Fourth Intervention||5
8720278|NCT01007253|9767522|FG002|STARTED|Fourth Intervention||5
8720279|NCT01007253|9767523|FG003|STARTED|Fourth Intervention||5
8720280|NCT01007253|9767520|FG000|COMPLETED|Fourth Intervention||5
8720281|NCT01007253|9767521|FG001|COMPLETED|Fourth Intervention||5
8720282|NCT01007253|9767522|FG002|COMPLETED|Fourth Intervention||5
8720283|NCT01007253|9767523|FG003|COMPLETED|Fourth Intervention||5
8720284|NCT01007253|9767520|FG000|NOT COMPLETED|Fourth Intervention||0
8720285|NCT01007253|9767521|FG001|NOT COMPLETED|Fourth Intervention||0
8720286|NCT01007253|9767522|FG002|NOT COMPLETED|Fourth Intervention||0
8720287|NCT01007253|9767523|FG003|NOT COMPLETED|Fourth Intervention||0
8720288|NCT01007396|9767533|FG000|STARTED|Overall Study||322
8720289|NCT01007396|9767533|FG000|COMPLETED|Overall Study||275
8720290|NCT01007396|9767533|FG000|NOT COMPLETED|Overall Study||47
8720291|NCT01007435|9767541|FG000|STARTED|Overall Study||289
8720292|NCT01007435|9767542|FG001|STARTED|Overall Study||290
8720293|NCT01007435|9767543|FG002|STARTED|Overall Study||291
8720294|NCT01007435|9767544|FG003|STARTED|Overall Study||292
8720295|NCT01007435|9767541|FG000|COMPLETED|Overall Study||226
8720296|NCT01007435|9767542|FG001|COMPLETED|Overall Study||231
8720297|NCT01007435|9767543|FG002|COMPLETED|Overall Study||227
8618038|NCT00460603|9656275|FG003|COMPLETED|Phase 1||0
8618039|NCT00460603|9656276|FG004|COMPLETED|Phase 1||0
8618040|NCT00460603|9656277|FG005|COMPLETED|Phase 1||0
8618041|NCT00460603|9656278|FG006|COMPLETED|Phase 1||0
8618042|NCT00460603|9656279|FG007|COMPLETED|Phase 1||0
8618043|NCT00460603|9656280|FG008|COMPLETED|Phase 1||0
8720298|NCT01007435|9767544|FG003|COMPLETED|Overall Study||236
8720299|NCT01007435|9767541|FG000|NOT COMPLETED|Overall Study||63
8720300|NCT01007435|9767542|FG001|NOT COMPLETED|Overall Study||59
8720301|NCT01007435|9767543|FG002|NOT COMPLETED|Overall Study||64
8720302|NCT01007435|9767544|FG003|NOT COMPLETED|Overall Study||56
8720303|NCT01007448|9767556|FG000|STARTED|Overall Study||30
8720304|NCT01007448|9767557|FG001|STARTED|Overall Study||29
8720305|NCT01007448|9767556|FG000|Full Analysis Population|Overall Study||30
8720306|NCT01007448|9767557|FG001|Full Analysis Population|Overall Study||29
8720307|NCT01007448|9767556|FG000|Safety Population|Overall Study||30
8720308|NCT01007448|9767557|FG001|Safety Population|Overall Study||29
8720309|NCT01007448|9767556|FG000|COMPLETED|Overall Study||20
8720310|NCT01007448|9767557|FG001|COMPLETED|Overall Study||20
8720311|NCT01007448|9767556|FG000|NOT COMPLETED|Overall Study||10
8618044|NCT00460603|9656281|FG009|COMPLETED|Phase 1||0
8618045|NCT00460603|9656282|FG010|COMPLETED|Phase 1||0
8720312|NCT01007448|9767557|FG001|NOT COMPLETED|Overall Study||9
8720313|NCT01007526|9767563|FG000|STARTED|Overall Study||31
8720314|NCT01007526|9767563|FG000|COMPLETED|Overall Study||31
8720315|NCT01007526|9767563|FG000|NOT COMPLETED|Overall Study||0
8720316|NCT01007552|9767567|FG000|STARTED|Overall Study||50
8720317|NCT01007552|9767567|FG000|COMPLETED|Overall Study||49
8618046|NCT00460603|9656283|FG011|COMPLETED|Phase 1||0
8618047|NCT00460603|9656272|FG000|NOT COMPLETED|Phase 1||6
8618048|NCT00460603|9656273|FG001|NOT COMPLETED|Phase 1||6
8618049|NCT00460603|9656274|FG002|NOT COMPLETED|Phase 1||4
8618050|NCT00460603|9656275|FG003|NOT COMPLETED|Phase 1||8
8618051|NCT00460603|9656276|FG004|NOT COMPLETED|Phase 1||6
8618052|NCT00460603|9656277|FG005|NOT COMPLETED|Phase 1||4
8618053|NCT00460603|9656278|FG006|NOT COMPLETED|Phase 1||6
8618054|NCT00460603|9656279|FG007|NOT COMPLETED|Phase 1||3
8618055|NCT00460603|9656280|FG008|NOT COMPLETED|Phase 1||18
8618056|NCT00460603|9656281|FG009|NOT COMPLETED|Phase 1||0
8618057|NCT00460603|9656282|FG010|NOT COMPLETED|Phase 1||0
8618058|NCT00460603|9656283|FG011|NOT COMPLETED|Phase 1||0
8618059|NCT00460603|9656272|FG000|STARTED|Phase 2||0
8618060|NCT00460603|9656273|FG001|STARTED|Phase 2||0
8618061|NCT00460603|9656274|FG002|STARTED|Phase 2||0
8618062|NCT00460603|9656275|FG003|STARTED|Phase 2||0
8618063|NCT00460603|9656276|FG004|STARTED|Phase 2||0
8618064|NCT00460603|9656277|FG005|STARTED|Phase 2||0
8618065|NCT00460603|9656278|FG006|STARTED|Phase 2||0
8618066|NCT00460603|9656279|FG007|STARTED|Phase 2||0
8618067|NCT00460603|9656280|FG008|STARTED|Phase 2||0
8618068|NCT00460603|9656281|FG009|STARTED|Phase 2||42
8618069|NCT00460603|9656282|FG010|STARTED|Phase 2||43
8557862|NCT03505671|9589814|FG000|STARTED|Overall Study||11
8557863|NCT03505671|9589815|FG001|STARTED|Overall Study||12
8557864|NCT03505671|9589814|FG000|COMPLETED|Overall Study||8
8557865|NCT03505671|9589815|FG001|COMPLETED|Overall Study||11
8557866|NCT03505671|9589814|FG000|NOT COMPLETED|Overall Study||3
8557867|NCT03505671|9589815|FG001|NOT COMPLETED|Overall Study||1
8557868|NCT03505021|9589823|FG000|STARTED|Overall Study||329
8557869|NCT03505021|9589824|FG001|STARTED|Overall Study||167
8557870|NCT03505021|9589823|FG000|COMPLETED|Overall Study||217
8557871|NCT03505021|9589824|FG001|COMPLETED|Overall Study||112
8557872|NCT03505021|9589823|FG000|NOT COMPLETED|Overall Study||112
8618070|NCT00460603|9656283|FG011|STARTED|Phase 2||41
8618071|NCT00460603|9656272|FG000|Treated|Phase 2||0
8618072|NCT00460603|9656273|FG001|Treated|Phase 2||0
8618073|NCT00460603|9656274|FG002|Treated|Phase 2||0
8618074|NCT00460603|9656275|FG003|Treated|Phase 2||0
8618075|NCT00460603|9656276|FG004|Treated|Phase 2||0
8618076|NCT00460603|9656277|FG005|Treated|Phase 2||0
8720318|NCT01007552|9767567|FG000|NOT COMPLETED|Overall Study||1
8720319|NCT01007591|9767573|FG000|STARTED|Overall Study||27
8720320|NCT01007591|9767574|FG001|STARTED|Overall Study||13
8720321|NCT01007591|9767573|FG000|COMPLETED|Overall Study||26
8720322|NCT01007591|9767574|FG001|COMPLETED|Overall Study||12
8720323|NCT01007591|9767573|FG000|NOT COMPLETED|Overall Study||1
8720324|NCT01007591|9767574|FG001|NOT COMPLETED|Overall Study||1
8720325|NCT01007643|9767582|FG000|STARTED|Overall Study||8
8720326|NCT01007643|9767583|FG001|STARTED|Overall Study||14
8720327|NCT01007643|9767582|FG000|COMPLETED|Overall Study||8
8720328|NCT01007643|9767583|FG001|COMPLETED|Overall Study||14
8720329|NCT01007643|9767582|FG000|NOT COMPLETED|Overall Study||0
8720330|NCT01007643|9767583|FG001|NOT COMPLETED|Overall Study||0
8720331|NCT01007656|9767589|FG000|STARTED|Overall Study||31
8720332|NCT01007656|9767589|FG000|COMPLETED|Overall Study||31
8720333|NCT01007656|9767589|FG000|NOT COMPLETED|Overall Study||0
8720334|NCT01007812|9767593|FG000|STARTED|Period 1, One Week||25
8720335|NCT01007812|9767594|FG001|STARTED|Period 1, One Week||25
8720336|NCT01007812|9767593|FG000|COMPLETED|Period 1, One Week||24
8720337|NCT01007812|9767594|FG001|COMPLETED|Period 1, One Week||24
8720338|NCT01007812|9767593|FG000|NOT COMPLETED|Period 1, One Week||1
8720339|NCT01007812|9767594|FG001|NOT COMPLETED|Period 1, One Week||1
8720340|NCT01007812|9767593|FG000|STARTED|Period 2, One Week||24
8720341|NCT01007812|9767594|FG001|STARTED|Period 2, One Week||24
8720342|NCT01007812|9767593|FG000|COMPLETED|Period 2, One Week||24
8720343|NCT01007812|9767594|FG001|COMPLETED|Period 2, One Week||24
8720344|NCT01007812|9767593|FG000|NOT COMPLETED|Period 2, One Week||0
8720345|NCT01007812|9767594|FG001|NOT COMPLETED|Period 2, One Week||0
8720346|NCT01007838|9767604|FG000|STARTED|Overall Study||12
8720347|NCT01007838|9767605|FG001|STARTED|Overall Study||11
8720348|NCT01007838|9767606|FG002|STARTED|Overall Study||5
8720349|NCT01007838|9767607|FG003|STARTED|Overall Study||4
8720350|NCT01007838|9767604|FG000|COMPLETED|Overall Study||9
8720351|NCT01007838|9767605|FG001|COMPLETED|Overall Study||11
8813744|NCT01527500|9866953|FG000|STARTED|Part B||7
8813745|NCT01527500|9866954|FG001|STARTED|Part B||1
8813746|NCT01527500|9866953|FG000|COMPLETED|Part B||6
8813747|NCT01527500|9866954|FG001|COMPLETED|Part B||1
8813748|NCT01527500|9866953|FG000|NOT COMPLETED|Part B||1
8813749|NCT01527500|9866954|FG001|NOT COMPLETED|Part B||0
8813750|NCT01527513|9866972|FG000|STARTED|Double Blind Period (DB) - Part I||40
8813751|NCT01527513|9866973|FG001|STARTED|Double Blind Period (DB) - Part I||83
8813752|NCT01527513|9866972|FG000|Randomized|Double Blind Period (DB) - Part I||40
8813753|NCT01527513|9866973|FG001|Randomized|Double Blind Period (DB) - Part I||83
8813754|NCT01527513|9866972|FG000|Safety Population|Double Blind Period (DB) - Part I||40
8813755|NCT01527513|9866973|FG001|Safety Population|Double Blind Period (DB) - Part I||83
8813756|NCT01527513|9866972|FG000|Entered Maintenance Period|Double Blind Period (DB) - Part I||40
8813757|NCT01527513|9866973|FG001|Entered Maintenance Period|Double Blind Period (DB) - Part I||76
8813758|NCT01527513|9866972|FG000|Completed the Double Blind (DB)- Part I|Double Blind Period (DB) - Part I||37
8813759|NCT01527513|9866973|FG001|Completed the Double Blind (DB)- Part I|Double Blind Period (DB) - Part I||75
8813760|NCT01527513|9866972|FG000|Eligible for Open Label Period (OL)|Double Blind Period (DB) - Part I||37
8813761|NCT01527513|9866973|FG001|Eligible for Open Label Period (OL)|Double Blind Period (DB) - Part I||75
8813762|NCT01527513|9866972|FG000|Efficacy PP Population|Double Blind Period (DB) - Part I||37
8813763|NCT01527513|9866973|FG001|Efficacy PP Population|Double Blind Period (DB) - Part I||67
8813764|NCT01527513|9866972|FG000|Per-protocol (PP) Population|Double Blind Period (DB) - Part I||36
8618077|NCT00460603|9656278|FG006|Treated|Phase 2||0
8618078|NCT00460603|9656279|FG007|Treated|Phase 2||0
8618079|NCT00460603|9656280|FG008|Treated|Phase 2||0
8618080|NCT00460603|9656281|FG009|Treated|Phase 2||39
8813765|NCT01527513|9866973|FG001|Per-protocol (PP) Population|Double Blind Period (DB) - Part I||66
8813766|NCT01527513|9866972|FG000|COMPLETED|Double Blind Period (DB) - Part I||37
8813767|NCT01527513|9866973|FG001|COMPLETED|Double Blind Period (DB) - Part I||75
8813768|NCT01527513|9866972|FG000|NOT COMPLETED|Double Blind Period (DB) - Part I||3
8618081|NCT00460603|9656282|FG010|Treated|Phase 2||43
8618082|NCT00460603|9656283|FG011|Treated|Phase 2||41
8618083|NCT00460603|9656272|FG000|COMPLETED|Phase 2||0
8720352|NCT01007838|9767606|FG002|COMPLETED|Overall Study||5
8720353|NCT01007838|9767607|FG003|COMPLETED|Overall Study||4
8618084|NCT00460603|9656273|FG001|COMPLETED|Phase 2||0
8618085|NCT00460603|9656274|FG002|COMPLETED|Phase 2||0
8720354|NCT01007838|9767604|FG000|NOT COMPLETED|Overall Study||3
8720355|NCT01007838|9767605|FG001|NOT COMPLETED|Overall Study||0
8720356|NCT01007838|9767606|FG002|NOT COMPLETED|Overall Study||0
8720357|NCT01007838|9767607|FG003|NOT COMPLETED|Overall Study||0
8720358|NCT01007916|9767617|FG000|STARTED|Period 1, 4 Weeks of Wear||23
8720359|NCT01007916|9767618|FG001|STARTED|Period 1, 4 Weeks of Wear||26
8720360|NCT01007916|9767617|FG000|COMPLETED|Period 1, 4 Weeks of Wear||22
8720361|NCT01007916|9767618|FG001|COMPLETED|Period 1, 4 Weeks of Wear||26
8720362|NCT01007916|9767617|FG000|NOT COMPLETED|Period 1, 4 Weeks of Wear||1
8720363|NCT01007916|9767618|FG001|NOT COMPLETED|Period 1, 4 Weeks of Wear||0
8720364|NCT01007916|9767617|FG000|STARTED|Period 2, 4 Weeks of Wear||22
8720365|NCT01007916|9767618|FG001|STARTED|Period 2, 4 Weeks of Wear|One participant completed Period 1 but did not start Period 2 due to failing inclusion criteria.|25
8720366|NCT01007916|9767617|FG000|COMPLETED|Period 2, 4 Weeks of Wear||21
8720367|NCT01007916|9767618|FG001|COMPLETED|Period 2, 4 Weeks of Wear||25
8720368|NCT01007916|9767617|FG000|NOT COMPLETED|Period 2, 4 Weeks of Wear||1
8720369|NCT01007916|9767618|FG001|NOT COMPLETED|Period 2, 4 Weeks of Wear||0
8720370|NCT01007942|9767626|FG000|STARTED|Overall Study||284
8720371|NCT01007942|9767627|FG001|STARTED|Overall Study||285
8720372|NCT01007942|9767626|FG000|COMPLETED|Overall Study|Pts completed= on treatment at time of DCO. Not Completed = ended treatment as per protocol.|3
8720373|NCT01007942|9767627|FG001|COMPLETED|Overall Study|Pts completed= on treatment at time of DCO. Not Completed = ended treatment as per protocol.|7
8720374|NCT01007942|9767626|FG000|NOT COMPLETED|Overall Study||281
8720375|NCT01007942|9767627|FG001|NOT COMPLETED|Overall Study||278
8720376|NCT01007994|9767639|FG000|STARTED|Overall Study||17
8720377|NCT01007994|9767640|FG001|STARTED|Overall Study||16
8720378|NCT01007994|9767639|FG000|COMPLETED|Overall Study||15
8720379|NCT01007994|9767640|FG001|COMPLETED|Overall Study||14
8720380|NCT01007994|9767639|FG000|NOT COMPLETED|Overall Study||2
8720381|NCT01007994|9767640|FG001|NOT COMPLETED|Overall Study||2
8720382|NCT01008059|9767646|FG000|STARTED|Control Sequential Alfentanil||6
8720383|NCT01008059|9767647|FG001|STARTED|Control Sequential Alfentanil||0
8720384|NCT01008059|9767648|FG002|STARTED|Control Sequential Alfentanil||0
8720385|NCT01008059|9767649|FG003|STARTED|Control Sequential Alfentanil||0
8720386|NCT01008059|9767650|FG004|STARTED|Control Sequential Alfentanil||0
8720387|NCT01008059|9767651|FG005|STARTED|Control Sequential Alfentanil||0
8720388|NCT01008059|9767652|FG006|STARTED|Control Sequential Alfentanil||0
8720389|NCT01008059|9767653|FG007|STARTED|Control Sequential Alfentanil||0
8720390|NCT01008059|9767646|FG000|COMPLETED|Control Sequential Alfentanil||6
8720391|NCT01008059|9767647|FG001|COMPLETED|Control Sequential Alfentanil||0
8720392|NCT01008059|9767648|FG002|COMPLETED|Control Sequential Alfentanil||0
8720393|NCT01008059|9767649|FG003|COMPLETED|Control Sequential Alfentanil||0
8720394|NCT01008059|9767650|FG004|COMPLETED|Control Sequential Alfentanil||0
8720395|NCT01008059|9767651|FG005|COMPLETED|Control Sequential Alfentanil||0
8720396|NCT01008059|9767652|FG006|COMPLETED|Control Sequential Alfentanil||0
8720397|NCT01008059|9767653|FG007|COMPLETED|Control Sequential Alfentanil||0
8720398|NCT01008059|9767646|FG000|NOT COMPLETED|Control Sequential Alfentanil||0
8720399|NCT01008059|9767647|FG001|NOT COMPLETED|Control Sequential Alfentanil||0
8720400|NCT01008059|9767648|FG002|NOT COMPLETED|Control Sequential Alfentanil||0
8720401|NCT01008059|9767649|FG003|NOT COMPLETED|Control Sequential Alfentanil||0
8720402|NCT01008059|9767650|FG004|NOT COMPLETED|Control Sequential Alfentanil||0
8720403|NCT01008059|9767651|FG005|NOT COMPLETED|Control Sequential Alfentanil||0
8720404|NCT01008059|9767652|FG006|NOT COMPLETED|Control Sequential Alfentanil||0
8720405|NCT01008059|9767653|FG007|NOT COMPLETED|Control Sequential Alfentanil||0
8720406|NCT01008059|9767646|FG000|STARTED|Rifampin Sequential Alfentanil||0
8720407|NCT01008059|9767647|FG001|STARTED|Rifampin Sequential Alfentanil||6
8720408|NCT01008059|9767648|FG002|STARTED|Rifampin Sequential Alfentanil||0
8720409|NCT01008059|9767649|FG003|STARTED|Rifampin Sequential Alfentanil||0
8720410|NCT01008059|9767650|FG004|STARTED|Rifampin Sequential Alfentanil||0
8720411|NCT01008059|9767651|FG005|STARTED|Rifampin Sequential Alfentanil||0
8720412|NCT01008059|9767652|FG006|STARTED|Rifampin Sequential Alfentanil||0
8720413|NCT01008059|9767653|FG007|STARTED|Rifampin Sequential Alfentanil||0
8720414|NCT01008059|9767646|FG000|COMPLETED|Rifampin Sequential Alfentanil||0
8720415|NCT01008059|9767647|FG001|COMPLETED|Rifampin Sequential Alfentanil||6
8720416|NCT01008059|9767648|FG002|COMPLETED|Rifampin Sequential Alfentanil||0
8720417|NCT01008059|9767649|FG003|COMPLETED|Rifampin Sequential Alfentanil||0
8720418|NCT01008059|9767650|FG004|COMPLETED|Rifampin Sequential Alfentanil||0
8720419|NCT01008059|9767651|FG005|COMPLETED|Rifampin Sequential Alfentanil||0
8720420|NCT01008059|9767652|FG006|COMPLETED|Rifampin Sequential Alfentanil||0
8720421|NCT01008059|9767653|FG007|COMPLETED|Rifampin Sequential Alfentanil||0
8720422|NCT01008059|9767646|FG000|NOT COMPLETED|Rifampin Sequential Alfentanil||0
8720423|NCT01008059|9767647|FG001|NOT COMPLETED|Rifampin Sequential Alfentanil||0
8720424|NCT01008059|9767648|FG002|NOT COMPLETED|Rifampin Sequential Alfentanil||0
8720425|NCT01008059|9767649|FG003|NOT COMPLETED|Rifampin Sequential Alfentanil||0
8720426|NCT01008059|9767650|FG004|NOT COMPLETED|Rifampin Sequential Alfentanil||0
8720427|NCT01008059|9767651|FG005|NOT COMPLETED|Rifampin Sequential Alfentanil||0
8720428|NCT01008059|9767652|FG006|NOT COMPLETED|Rifampin Sequential Alfentanil||0
8720429|NCT01008059|9767653|FG007|NOT COMPLETED|Rifampin Sequential Alfentanil||0
8720430|NCT01008059|9767646|FG000|STARTED|Grapefruit Juice Sequential Alfentanil||0
8720431|NCT01008059|9767647|FG001|STARTED|Grapefruit Juice Sequential Alfentanil||0
8720432|NCT01008059|9767648|FG002|STARTED|Grapefruit Juice Sequential Alfentanil||6
8720433|NCT01008059|9767649|FG003|STARTED|Grapefruit Juice Sequential Alfentanil||0
8720434|NCT01008059|9767650|FG004|STARTED|Grapefruit Juice Sequential Alfentanil||0
8720435|NCT01008059|9767651|FG005|STARTED|Grapefruit Juice Sequential Alfentanil||0
8720436|NCT01008059|9767652|FG006|STARTED|Grapefruit Juice Sequential Alfentanil||0
8720437|NCT01008059|9767653|FG007|STARTED|Grapefruit Juice Sequential Alfentanil||0
8720438|NCT01008059|9767646|FG000|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
8720439|NCT01008059|9767647|FG001|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
8720440|NCT01008059|9767648|FG002|COMPLETED|Grapefruit Juice Sequential Alfentanil||6
8720441|NCT01008059|9767649|FG003|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
8720442|NCT01008059|9767650|FG004|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
8720443|NCT01008059|9767651|FG005|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
8720444|NCT01008059|9767652|FG006|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
8720445|NCT01008059|9767653|FG007|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
8720446|NCT01008059|9767646|FG000|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
8720447|NCT01008059|9767647|FG001|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
8720448|NCT01008059|9767648|FG002|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
8720449|NCT01008059|9767649|FG003|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
8720450|NCT01008059|9767650|FG004|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
8720451|NCT01008059|9767651|FG005|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
8720452|NCT01008059|9767652|FG006|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
8720453|NCT01008059|9767653|FG007|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
8720454|NCT01008059|9767646|FG000|STARTED|Ketoconazole Sequential Alfentanil||0
8720455|NCT01008059|9767647|FG001|STARTED|Ketoconazole Sequential Alfentanil||0
8720456|NCT01008059|9767648|FG002|STARTED|Ketoconazole Sequential Alfentanil||0
8720457|NCT01008059|9767649|FG003|STARTED|Ketoconazole Sequential Alfentanil||6
8720458|NCT01008059|9767650|FG004|STARTED|Ketoconazole Sequential Alfentanil||0
8720459|NCT01008059|9767651|FG005|STARTED|Ketoconazole Sequential Alfentanil||0
8720460|NCT01008059|9767652|FG006|STARTED|Ketoconazole Sequential Alfentanil||0
8720461|NCT01008059|9767653|FG007|STARTED|Ketoconazole Sequential Alfentanil||0
8720462|NCT01008059|9767646|FG000|COMPLETED|Ketoconazole Sequential Alfentanil||0
8720463|NCT01008059|9767647|FG001|COMPLETED|Ketoconazole Sequential Alfentanil||0
8720464|NCT01008059|9767648|FG002|COMPLETED|Ketoconazole Sequential Alfentanil||0
8720465|NCT01008059|9767649|FG003|COMPLETED|Ketoconazole Sequential Alfentanil||6
8720466|NCT01008059|9767650|FG004|COMPLETED|Ketoconazole Sequential Alfentanil||0
8720467|NCT01008059|9767651|FG005|COMPLETED|Ketoconazole Sequential Alfentanil||0
8720468|NCT01008059|9767652|FG006|COMPLETED|Ketoconazole Sequential Alfentanil||0
8720469|NCT01008059|9767653|FG007|COMPLETED|Ketoconazole Sequential Alfentanil||0
8720470|NCT01008059|9767646|FG000|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
8720471|NCT01008059|9767647|FG001|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
8720472|NCT01008059|9767648|FG002|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
8720473|NCT01008059|9767649|FG003|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
8720474|NCT01008059|9767650|FG004|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
8720475|NCT01008059|9767651|FG005|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
8720476|NCT01008059|9767652|FG006|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
8720477|NCT01008059|9767653|FG007|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
8720478|NCT01008059|9767646|FG000|STARTED|Control Simultaneous Alfentanil||0
8720479|NCT01008059|9767647|FG001|STARTED|Control Simultaneous Alfentanil||0
8720480|NCT01008059|9767648|FG002|STARTED|Control Simultaneous Alfentanil||0
8720481|NCT01008059|9767649|FG003|STARTED|Control Simultaneous Alfentanil||0
8720482|NCT01008059|9767650|FG004|STARTED|Control Simultaneous Alfentanil||6
8720483|NCT01008059|9767651|FG005|STARTED|Control Simultaneous Alfentanil||0
8720484|NCT01008059|9767652|FG006|STARTED|Control Simultaneous Alfentanil||0
8720485|NCT01008059|9767653|FG007|STARTED|Control Simultaneous Alfentanil||0
8720486|NCT01008059|9767646|FG000|COMPLETED|Control Simultaneous Alfentanil||0
8720487|NCT01008059|9767647|FG001|COMPLETED|Control Simultaneous Alfentanil||0
8720488|NCT01008059|9767648|FG002|COMPLETED|Control Simultaneous Alfentanil||0
8720489|NCT01008059|9767649|FG003|COMPLETED|Control Simultaneous Alfentanil||0
8720490|NCT01008059|9767650|FG004|COMPLETED|Control Simultaneous Alfentanil||6
8720491|NCT01008059|9767651|FG005|COMPLETED|Control Simultaneous Alfentanil||0
8720492|NCT01008059|9767652|FG006|COMPLETED|Control Simultaneous Alfentanil||0
8720493|NCT01008059|9767653|FG007|COMPLETED|Control Simultaneous Alfentanil||0
8720494|NCT01008059|9767646|FG000|NOT COMPLETED|Control Simultaneous Alfentanil||0
8720495|NCT01008059|9767647|FG001|NOT COMPLETED|Control Simultaneous Alfentanil||0
8720496|NCT01008059|9767648|FG002|NOT COMPLETED|Control Simultaneous Alfentanil||0
8720497|NCT01008059|9767649|FG003|NOT COMPLETED|Control Simultaneous Alfentanil||0
8720498|NCT01008059|9767650|FG004|NOT COMPLETED|Control Simultaneous Alfentanil||0
8720499|NCT01008059|9767651|FG005|NOT COMPLETED|Control Simultaneous Alfentanil||0
8720500|NCT01008059|9767652|FG006|NOT COMPLETED|Control Simultaneous Alfentanil||0
8720501|NCT01008059|9767653|FG007|NOT COMPLETED|Control Simultaneous Alfentanil||0
8720502|NCT01008059|9767646|FG000|STARTED|Rifampin Simultaneous Alfentanil||0
8618086|NCT00460603|9656275|FG003|COMPLETED|Phase 2||0
8618087|NCT00460603|9656276|FG004|COMPLETED|Phase 2||0
8618088|NCT00460603|9656277|FG005|COMPLETED|Phase 2||0
8618089|NCT00460603|9656278|FG006|COMPLETED|Phase 2||0
8618090|NCT00460603|9656279|FG007|COMPLETED|Phase 2||0
8618091|NCT00460603|9656280|FG008|COMPLETED|Phase 2||0
8618092|NCT00460603|9656281|FG009|COMPLETED|Phase 2||0
8618093|NCT00460603|9656282|FG010|COMPLETED|Phase 2||0
8618094|NCT00460603|9656283|FG011|COMPLETED|Phase 2||0
8618095|NCT00460603|9656272|FG000|NOT COMPLETED|Phase 2||0
8618096|NCT00460603|9656273|FG001|NOT COMPLETED|Phase 2||0
8618097|NCT00460603|9656274|FG002|NOT COMPLETED|Phase 2||0
8618098|NCT00460603|9656275|FG003|NOT COMPLETED|Phase 2||0
8618099|NCT00460603|9656276|FG004|NOT COMPLETED|Phase 2||0
8618100|NCT00460603|9656277|FG005|NOT COMPLETED|Phase 2||0
8618101|NCT00460603|9656278|FG006|NOT COMPLETED|Phase 2||0
8618102|NCT00460603|9656279|FG007|NOT COMPLETED|Phase 2||0
8618103|NCT00460603|9656280|FG008|NOT COMPLETED|Phase 2||0
8720503|NCT01008059|9767647|FG001|STARTED|Rifampin Simultaneous Alfentanil||0
8720504|NCT01008059|9767648|FG002|STARTED|Rifampin Simultaneous Alfentanil||0
8720505|NCT01008059|9767649|FG003|STARTED|Rifampin Simultaneous Alfentanil||0
8618104|NCT00460603|9656281|FG009|NOT COMPLETED|Phase 2||42
8618105|NCT00460603|9656282|FG010|NOT COMPLETED|Phase 2||43
8618106|NCT00460603|9656283|FG011|NOT COMPLETED|Phase 2||41
8618107|NCT00460655|9656311|FG000|STARTED|Double-Blind Phase (12 Weeks)||58
8618108|NCT00460655|9656312|FG001|STARTED|Double-Blind Phase (12 Weeks)||62
8618109|NCT00460655|9656313|FG002|STARTED|Double-Blind Phase (12 Weeks)||0
8618110|NCT00460655|9656314|FG003|STARTED|Double-Blind Phase (12 Weeks)||0
8618111|NCT00460655|9656311|FG000|COMPLETED|Double-Blind Phase (12 Weeks)||52
8618112|NCT00460655|9656312|FG001|COMPLETED|Double-Blind Phase (12 Weeks)||61
8618113|NCT00460655|9656313|FG002|COMPLETED|Double-Blind Phase (12 Weeks)||0
8618114|NCT00460655|9656314|FG003|COMPLETED|Double-Blind Phase (12 Weeks)||0
8618115|NCT00460655|9656311|FG000|NOT COMPLETED|Double-Blind Phase (12 Weeks)||6
8618116|NCT00460655|9656312|FG001|NOT COMPLETED|Double-Blind Phase (12 Weeks)||1
8618117|NCT00460655|9656313|FG002|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
8618118|NCT00460655|9656314|FG003|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
8618119|NCT00460655|9656311|FG000|STARTED|Open-Label Phase (36 Weeks)||0
8618120|NCT00460655|9656312|FG001|STARTED|Open-Label Phase (36 Weeks)||0
8618121|NCT00460655|9656313|FG002|STARTED|Open-Label Phase (36 Weeks)||52
8618122|NCT00460655|9656314|FG003|STARTED|Open-Label Phase (36 Weeks)||61
8618123|NCT00460655|9656311|FG000|COMPLETED|Open-Label Phase (36 Weeks)||0
8720506|NCT01008059|9767650|FG004|STARTED|Rifampin Simultaneous Alfentanil||0
8618124|NCT00460655|9656312|FG001|COMPLETED|Open-Label Phase (36 Weeks)||0
8618125|NCT00460655|9656313|FG002|COMPLETED|Open-Label Phase (36 Weeks)||45
8618126|NCT00460655|9656314|FG003|COMPLETED|Open-Label Phase (36 Weeks)||52
8618127|NCT00460655|9656311|FG000|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
8618128|NCT00460655|9656312|FG001|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
8618129|NCT00460655|9656313|FG002|NOT COMPLETED|Open-Label Phase (36 Weeks)||7
8618130|NCT00460655|9656314|FG003|NOT COMPLETED|Open-Label Phase (36 Weeks)||9
8618131|NCT00460746|9656324|FG000|STARTED|Overall Study||10
8618132|NCT00460746|9656324|FG000|COMPLETED|Overall Study||8
8618133|NCT00460746|9656324|FG000|NOT COMPLETED|Overall Study||2
8618134|NCT00460798|9656328|FG000|STARTED|Overall Study||448
8618135|NCT00460798|9656328|FG000|Treated|Overall Study|Subjects with complete dosing information were recorded as 'Treated'|421
8618136|NCT00460798|9656328|FG000|COMPLETED|Overall Study||108
8618137|NCT00460798|9656328|FG000|NOT COMPLETED|Overall Study||340
8618138|NCT00460811|9656337|FG000|STARTED|Overall Study||79
8618139|NCT00460811|9656338|FG001|STARTED|Overall Study||82
8618140|NCT00460811|9656339|FG002|STARTED|Overall Study||85
8618141|NCT00460811|9656340|FG003|STARTED|Overall Study||89
8618142|NCT00460811|9656341|FG004|STARTED|Overall Study||85
8618143|NCT00460811|9656337|FG000|COMPLETED|Overall Study||63
8618144|NCT00460811|9656338|FG001|COMPLETED|Overall Study||67
8618145|NCT00460811|9656339|FG002|COMPLETED|Overall Study||71
8618146|NCT00460811|9656340|FG003|COMPLETED|Overall Study||71
8618147|NCT00460811|9656341|FG004|COMPLETED|Overall Study||65
8618148|NCT00460811|9656337|FG000|NOT COMPLETED|Overall Study||16
8618149|NCT00460811|9656338|FG001|NOT COMPLETED|Overall Study||15
8618150|NCT00460811|9656339|FG002|NOT COMPLETED|Overall Study||14
8720507|NCT01008059|9767651|FG005|STARTED|Rifampin Simultaneous Alfentanil||6
8618151|NCT00460811|9656340|FG003|NOT COMPLETED|Overall Study||18
8720508|NCT01008059|9767652|FG006|STARTED|Rifampin Simultaneous Alfentanil||0
8720509|NCT01008059|9767653|FG007|STARTED|Rifampin Simultaneous Alfentanil||0
8720510|NCT01008059|9767646|FG000|COMPLETED|Rifampin Simultaneous Alfentanil||0
8720511|NCT01008059|9767647|FG001|COMPLETED|Rifampin Simultaneous Alfentanil||0
8618152|NCT00460811|9656341|FG004|NOT COMPLETED|Overall Study||20
8720512|NCT01008059|9767648|FG002|COMPLETED|Rifampin Simultaneous Alfentanil||0
8618153|NCT00460993|9656360|FG000|STARTED|Phase 1 (6 Days)||14
8720513|NCT01008059|9767649|FG003|COMPLETED|Rifampin Simultaneous Alfentanil||0
8720514|NCT01008059|9767650|FG004|COMPLETED|Rifampin Simultaneous Alfentanil||0
8720515|NCT01008059|9767651|FG005|COMPLETED|Rifampin Simultaneous Alfentanil||6
8720516|NCT01008059|9767652|FG006|COMPLETED|Rifampin Simultaneous Alfentanil||0
8720517|NCT01008059|9767653|FG007|COMPLETED|Rifampin Simultaneous Alfentanil||0
8720518|NCT01008059|9767646|FG000|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
8720519|NCT01008059|9767647|FG001|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
8618154|NCT00460993|9656361|FG001|STARTED|Phase 1 (6 Days)||17
8618155|NCT00460993|9656360|FG000|COMPLETED|Phase 1 (6 Days)||14
8618156|NCT00460993|9656361|FG001|COMPLETED|Phase 1 (6 Days)||17
8618157|NCT00460993|9656360|FG000|NOT COMPLETED|Phase 1 (6 Days)||0
8618158|NCT00460993|9656361|FG001|NOT COMPLETED|Phase 1 (6 Days)||0
8618159|NCT00460993|9656360|FG000|STARTED|Phase 2 (6 Days)||14
8618160|NCT00460993|9656361|FG001|STARTED|Phase 2 (6 Days)||17
8618161|NCT00460993|9656360|FG000|COMPLETED|Phase 2 (6 Days)||14
8618162|NCT00460993|9656361|FG001|COMPLETED|Phase 2 (6 Days)||17
8618163|NCT00460993|9656360|FG000|NOT COMPLETED|Phase 2 (6 Days)||0
8720520|NCT01008059|9767648|FG002|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
8720521|NCT01008059|9767649|FG003|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
8618164|NCT00460993|9656361|FG001|NOT COMPLETED|Phase 2 (6 Days)||0
8618165|NCT00461045|9656367|FG000|STARTED|Overall Study||15
8618166|NCT00461045|9656367|FG000|COMPLETED|Overall Study||15
8618167|NCT00461045|9656367|FG000|NOT COMPLETED|Overall Study||0
8618168|NCT00461097|9656373|FG000|STARTED|Overall Study||40
8618169|NCT00461097|9656374|FG001|STARTED|Overall Study||15
8618170|NCT00461097|9656373|FG000|Had Month 10 (Wk 44) Oral Food Challenge|Overall Study||35
8618171|NCT00461097|9656374|FG001|Had Month 10 (Wk 44) Oral Food Challenge|Overall Study||13
8618172|NCT00461097|9656373|FG000|Had Month 22 (Wk 96) Oral Food Challenge|Overall Study||34
8618173|NCT00461097|9656374|FG001|Had Month 22 (Wk 96) Oral Food Challenge|Overall Study||1
8618174|NCT00461097|9656373|FG000|Had Year 3 (Mnth 36) Oral Food Challenge|Overall Study||16
8618175|NCT00461097|9656374|FG001|Had Year 3 (Mnth 36) Oral Food Challenge|Overall Study||0
8618176|NCT00461097|9656373|FG000|Had Year 4 (Mnth 48) Oral Food Challenge|Overall Study||7
8629657|NCT00531050|9669381|FG000|NOT COMPLETED|Part 2: Period 1||0
8720522|NCT01008059|9767650|FG004|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
8557873|NCT03505021|9589824|FG001|NOT COMPLETED|Overall Study||55
8557874|NCT03405714|9589834|FG000|STARTED|Overall Study||12
8557875|NCT03405714|9589835|FG001|STARTED|Overall Study||12
8557876|NCT03405714|9589836|FG002|STARTED|Overall Study||13
8557877|NCT03405714|9589837|FG003|STARTED|Overall Study||13
8618177|NCT00461097|9656374|FG001|Had Year 4 (Mnth 48) Oral Food Challenge|Overall Study||0
8618178|NCT00461097|9656373|FG000|COMPLETED|Overall Study|Completed: Participants who were assessed for the primary outcome measure and outcome measure #6.|40
8618179|NCT00461097|9656374|FG001|COMPLETED|Overall Study|Completed: Participants who were assessed for the primary outcome measure.|15
8618180|NCT00461097|9656373|FG000|NOT COMPLETED|Overall Study||0
8618181|NCT00461097|9656374|FG001|NOT COMPLETED|Overall Study||0
8618182|NCT00461123|9656383|FG000|STARTED|Overall Study||25
8618183|NCT00461123|9656384|FG001|STARTED|Overall Study||25
8618184|NCT00461123|9656383|FG000|COMPLETED|Overall Study||19
8618185|NCT00461123|9656384|FG001|COMPLETED|Overall Study||19
8618186|NCT00461123|9656383|FG000|NOT COMPLETED|Overall Study||6
8618187|NCT00461123|9656384|FG001|NOT COMPLETED|Overall Study||6
8618188|NCT00461175|9656392|FG000|STARTED|Overall Study|859 patients could not be assigned to a cohort and are therefore missing in the participant flow.|43600
8618189|NCT00461175|9656393|FG001|STARTED|Overall Study|859 patients could not be assigned to a cohort and are therefore missing in the participant flow.|18735
8618190|NCT00461175|9656392|FG000|COMPLETED|Overall Study||43078
8725199|NCT01029704|9772382|FG004|NOT COMPLETED|Overall Study||5
8618191|NCT00461175|9656393|FG001|COMPLETED|Overall Study||18370
8618192|NCT00461175|9656392|FG000|NOT COMPLETED|Overall Study||522
8618193|NCT00461175|9656393|FG001|NOT COMPLETED|Overall Study||365
8943632|NCT02390557|10005472|FG001|NOT COMPLETED|Wave 1||0
8943633|NCT02390557|10005473|FG002|NOT COMPLETED|Wave 1||0
8618194|NCT00461253|9656401|FG000|STARTED|Overall Study|Identified cases|10093
8943634|NCT02390557|10005471|FG000|STARTED|Wave 2||160
8618195|NCT00461253|9656402|FG001|STARTED|Overall Study|Identified controls|40250
8618196|NCT00461253|9656401|FG000|COMPLETED|Overall Study|Analyzed cases|5113
8618197|NCT00461253|9656402|FG001|COMPLETED|Overall Study|Analyzed controls|20452
8618198|NCT00461253|9656401|FG000|NOT COMPLETED|Overall Study||4980
8618199|NCT00461253|9656402|FG001|NOT COMPLETED|Overall Study||19798
8618200|NCT00461292|9656411|FG000|STARTED|Treatment Cycle 1||91
8618201|NCT00461292|9656412|FG001|STARTED|Treatment Cycle 1||92
8618202|NCT00461292|9656413|FG002|STARTED|Treatment Cycle 1||92
8618203|NCT00461292|9656411|FG000|COMPLETED|Treatment Cycle 1||76
8618204|NCT00461292|9656412|FG001|COMPLETED|Treatment Cycle 1||80
8618205|NCT00461292|9656413|FG002|COMPLETED|Treatment Cycle 1||81
8720523|NCT01008059|9767651|FG005|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
8720524|NCT01008059|9767652|FG006|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
8720525|NCT01008059|9767653|FG007|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
8720526|NCT01008059|9767646|FG000|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
8720527|NCT01008059|9767647|FG001|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
8720528|NCT01008059|9767648|FG002|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
8720529|NCT01008059|9767649|FG003|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
8720530|NCT01008059|9767650|FG004|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
8720531|NCT01008059|9767651|FG005|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
8720532|NCT01008059|9767652|FG006|STARTED|Grapefruit Juice Simultaneous Alfentanil||6
8720533|NCT01008059|9767653|FG007|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
8720534|NCT01008059|9767646|FG000|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
8720535|NCT01008059|9767647|FG001|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
8720536|NCT01008059|9767648|FG002|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
8720537|NCT01008059|9767649|FG003|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
8720538|NCT01008059|9767650|FG004|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
8720539|NCT01008059|9767651|FG005|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
8720540|NCT01008059|9767652|FG006|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||6
8720541|NCT01008059|9767653|FG007|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
8720542|NCT01008059|9767646|FG000|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
8720543|NCT01008059|9767647|FG001|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
8720544|NCT01008059|9767648|FG002|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
8720545|NCT01008059|9767649|FG003|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
8720546|NCT01008059|9767650|FG004|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
8720547|NCT01008059|9767651|FG005|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
8720548|NCT01008059|9767652|FG006|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
8720549|NCT01008059|9767653|FG007|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
8720550|NCT01008059|9767646|FG000|STARTED|Ketoconazole Simultaneous Alfentanil||0
8720551|NCT01008059|9767647|FG001|STARTED|Ketoconazole Simultaneous Alfentanil||0
8720552|NCT01008059|9767648|FG002|STARTED|Ketoconazole Simultaneous Alfentanil||0
8720553|NCT01008059|9767649|FG003|STARTED|Ketoconazole Simultaneous Alfentanil||0
8720554|NCT01008059|9767650|FG004|STARTED|Ketoconazole Simultaneous Alfentanil||0
8720555|NCT01008059|9767651|FG005|STARTED|Ketoconazole Simultaneous Alfentanil||0
8720556|NCT01008059|9767652|FG006|STARTED|Ketoconazole Simultaneous Alfentanil||0
8720557|NCT01008059|9767653|FG007|STARTED|Ketoconazole Simultaneous Alfentanil||6
8720558|NCT01008059|9767646|FG000|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
8720559|NCT01008059|9767647|FG001|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
8720560|NCT01008059|9767648|FG002|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
8720561|NCT01008059|9767649|FG003|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
8720562|NCT01008059|9767650|FG004|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
8720563|NCT01008059|9767651|FG005|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
8720564|NCT01008059|9767652|FG006|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
8813769|NCT01527513|9866973|FG001|NOT COMPLETED|Double Blind Period (DB) - Part I||8
8813770|NCT01527513|9866972|FG000|STARTED|Eligible for 1-Year Open Label Period||0
8813771|NCT01527513|9866973|FG001|STARTED|Eligible for 1-Year Open Label Period|Participants that were eligible to participate in for 1-Year Open Label Period - Part II|112
8813772|NCT01527513|9866972|FG000|COMPLETED|Eligible for 1-Year Open Label Period||0
8813773|NCT01527513|9866973|FG001|COMPLETED|Eligible for 1-Year Open Label Period||95
8813774|NCT01527513|9866972|FG000|NOT COMPLETED|Eligible for 1-Year Open Label Period||0
8813775|NCT01527513|9866973|FG001|NOT COMPLETED|Eligible for 1-Year Open Label Period||17
8813776|NCT01527682|9866981|FG000|STARTED|Overall Study||37
8618206|NCT00461292|9656411|FG000|NOT COMPLETED|Treatment Cycle 1||15
8618207|NCT00461292|9656412|FG001|NOT COMPLETED|Treatment Cycle 1||12
8618208|NCT00461292|9656413|FG002|NOT COMPLETED|Treatment Cycle 1||11
8618209|NCT00461292|9656411|FG000|STARTED|Treatment Cycle 2|32 from the 300U group + 31 from the Placebo group entered Cycle 2|63
8618210|NCT00461292|9656412|FG001|STARTED|Treatment Cycle 2|42 from the 200U group + 32 from the Placebo group entered Cycle 2|74
8618211|NCT00461292|9656413|FG002|STARTED|Treatment Cycle 2|Cycle 1 Placebo pts were randomized to receive 300U or 200 U in Cycle 2|0
8618212|NCT00461292|9656411|FG000|COMPLETED|Treatment Cycle 2||58
8618213|NCT00461292|9656412|FG001|COMPLETED|Treatment Cycle 2||72
8618214|NCT00461292|9656413|FG002|COMPLETED|Treatment Cycle 2||0
8618215|NCT00461292|9656411|FG000|NOT COMPLETED|Treatment Cycle 2||5
8618216|NCT00461292|9656412|FG001|NOT COMPLETED|Treatment Cycle 2||2
8618217|NCT00461292|9656413|FG002|NOT COMPLETED|Treatment Cycle 2||0
8618218|NCT00461305|9656423|FG000|STARTED|Treatment|Enrolled|355
8618219|NCT00461305|9656424|FG001|STARTED|Treatment|Enrolled|65
8618220|NCT00461305|9656423|FG000|Subjects Dispensed Drugs|Treatment||350
8618221|NCT00461305|9656424|FG001|Subjects Dispensed Drugs|Treatment||65
8618222|NCT00461305|9656423|FG000|Subjects Received Treatment|Treatment|FAS, safety population|349
8618223|NCT00461305|9656424|FG001|Subjects Received Treatment|Treatment|FAS, safety population|65
8618224|NCT00461305|9656423|FG000|COMPLETED|Treatment||254
8618225|NCT00461305|9656424|FG001|COMPLETED|Treatment||56
8618226|NCT00461305|9656423|FG000|NOT COMPLETED|Treatment||101
8618227|NCT00461305|9656424|FG001|NOT COMPLETED|Treatment||9
8618228|NCT00461305|9656423|FG000|STARTED|Continued Treatment|FAS, participants from previous treatment who were available to continue treatment|349
8618229|NCT00461305|9656424|FG001|STARTED|Continued Treatment|no participants were treated with the DRSP 3 mg/EE 30 μg combination beyond 6 cycles|0
8618230|NCT00461305|9656423|FG000|COMPLETED|Continued Treatment||254
8618231|NCT00461305|9656424|FG001|COMPLETED|Continued Treatment||0
8618232|NCT00461305|9656423|FG000|NOT COMPLETED|Continued Treatment||95
8618233|NCT00461305|9656424|FG001|NOT COMPLETED|Continued Treatment||0
8618234|NCT00461331|9656431|FG000|STARTED|Intervention 1||10
8557878|NCT03405714|9589834|FG000|COMPLETED|Overall Study||12
8557879|NCT03405714|9589835|FG001|COMPLETED|Overall Study||12
8557880|NCT03405714|9589836|FG002|COMPLETED|Overall Study||13
8557881|NCT03405714|9589837|FG003|COMPLETED|Overall Study||13
8557882|NCT03405714|9589834|FG000|NOT COMPLETED|Overall Study||0
8557883|NCT03405714|9589835|FG001|NOT COMPLETED|Overall Study||0
8557884|NCT03405714|9589836|FG002|NOT COMPLETED|Overall Study||0
8557885|NCT03405714|9589837|FG003|NOT COMPLETED|Overall Study||0
8557886|NCT03366194|9589853|FG000|STARTED|Overall Study||36
8557887|NCT03366194|9589853|FG000|COMPLETED|Overall Study||34
8557888|NCT03366194|9589853|FG000|NOT COMPLETED|Overall Study||2
8557889|NCT03272139|9589860|FG000|STARTED|Overall Study||63
8557890|NCT03272139|9589861|FG001|STARTED|Overall Study||63
8557891|NCT03272139|9589860|FG000|COMPLETED|Overall Study||63
8557892|NCT03272139|9589861|FG001|COMPLETED|Overall Study||63
8618235|NCT00461331|9656432|FG001|STARTED|Intervention 1||10
8618236|NCT00461331|9656431|FG000|COMPLETED|Intervention 1||10
8557893|NCT03272139|9589860|FG000|NOT COMPLETED|Overall Study||0
8557894|NCT03272139|9589861|FG001|NOT COMPLETED|Overall Study||0
8557895|NCT03213158|9589867|FG000|STARTED|Overall Study||10
8557896|NCT03213158|9589867|FG000|COMPLETED|Overall Study||7
8557897|NCT03213158|9589867|FG000|NOT COMPLETED|Overall Study||3
8557898|NCT03203473|9589871|FG000|STARTED|Induction Phase||85
8557899|NCT03203473|9589872|FG001|STARTED|Induction Phase||0
8557900|NCT03203473|9589873|FG002|STARTED|Induction Phase||0
8557901|NCT03203473|9589871|FG000|COMPLETED|Induction Phase||69
8557902|NCT03203473|9589872|FG001|COMPLETED|Induction Phase||0
8557903|NCT03203473|9589873|FG002|COMPLETED|Induction Phase||0
8720565|NCT01008059|9767653|FG007|COMPLETED|Ketoconazole Simultaneous Alfentanil||6
8725200|NCT01029704|9772383|FG005|NOT COMPLETED|Overall Study||4
8618237|NCT00461331|9656432|FG001|COMPLETED|Intervention 1||10
8618238|NCT00461331|9656431|FG000|NOT COMPLETED|Intervention 1||0
8618239|NCT00461331|9656432|FG001|NOT COMPLETED|Intervention 1||0
8618240|NCT00461331|9656431|FG000|STARTED|Washout||10
8618241|NCT00461331|9656432|FG001|STARTED|Washout||10
8618242|NCT00461331|9656431|FG000|COMPLETED|Washout||10
8618243|NCT00461331|9656432|FG001|COMPLETED|Washout||10
8618244|NCT00461331|9656431|FG000|NOT COMPLETED|Washout||0
8618245|NCT00461331|9656432|FG001|NOT COMPLETED|Washout||0
8618246|NCT00461331|9656431|FG000|STARTED|Intervention 2||10
8618247|NCT00461331|9656432|FG001|STARTED|Intervention 2||10
8618248|NCT00461331|9656431|FG000|COMPLETED|Intervention 2||10
8618249|NCT00461331|9656432|FG001|COMPLETED|Intervention 2||10
8618250|NCT00461331|9656431|FG000|NOT COMPLETED|Intervention 2||0
8618251|NCT00461331|9656432|FG001|NOT COMPLETED|Intervention 2||0
8618252|NCT00461500|9656441|FG000|STARTED|Overall Study||37
8618253|NCT00461500|9656442|FG001|STARTED|Overall Study||44
8618254|NCT00461500|9656441|FG000|COMPLETED|Overall Study||30
8618255|NCT00461500|9656442|FG001|COMPLETED|Overall Study||38
8618256|NCT00461500|9656441|FG000|NOT COMPLETED|Overall Study||7
8618257|NCT00461500|9656442|FG001|NOT COMPLETED|Overall Study||6
8720566|NCT01008059|9767646|FG000|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
8720567|NCT01008059|9767647|FG001|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
8720568|NCT01008059|9767648|FG002|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
8618258|NCT00461513|9656450|FG000|STARTED|Overall Study|6 patients dropped at time of randomization|187
8618259|NCT00461513|9656451|FG001|STARTED|Overall Study|2 patients dropped at time of randomization|197
8618260|NCT00461513|9656450|FG000|COMPLETED|Overall Study||165
8720569|NCT01008059|9767649|FG003|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
8720570|NCT01008059|9767650|FG004|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
8720571|NCT01008059|9767651|FG005|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
8720572|NCT01008059|9767652|FG006|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
8618261|NCT00461513|9656451|FG001|COMPLETED|Overall Study||172
8618262|NCT00461513|9656450|FG000|NOT COMPLETED|Overall Study||22
8618263|NCT00461513|9656451|FG001|NOT COMPLETED|Overall Study||25
8618264|NCT00461552|9656463|FG000|STARTED|Overall Study||7
8618265|NCT00461552|9656464|FG001|STARTED|Overall Study||7
8618266|NCT00461552|9656463|FG000|COMPLETED|Overall Study||7
8618267|NCT00461552|9656464|FG001|COMPLETED|Overall Study||5
8618268|NCT00461552|9656463|FG000|NOT COMPLETED|Overall Study||0
8618269|NCT00461552|9656464|FG001|NOT COMPLETED|Overall Study||2
8618270|NCT00461591|9656472|FG000|STARTED|Overall Study||406
8618271|NCT00461591|9656473|FG001|STARTED|Overall Study||396
8618272|NCT00461591|9656472|FG000|COMPLETED|Overall Study||317
8618273|NCT00461591|9656473|FG001|COMPLETED|Overall Study||311
8618274|NCT00461591|9656472|FG000|NOT COMPLETED|Overall Study||89
8725201|NCT01029704|9772384|FG006|NOT COMPLETED|Overall Study||4
8618275|NCT00461591|9656473|FG001|NOT COMPLETED|Overall Study||85
8618276|NCT00461630|9656481|FG000|STARTED|Overall Study||12838
8618277|NCT00461630|9656482|FG001|STARTED|Overall Study||12835
8618278|NCT00461630|9656481|FG000|COMPLETED|Overall Study||11932
8618279|NCT00461630|9656482|FG001|COMPLETED|Overall Study||12008
8618280|NCT00461630|9656481|FG000|NOT COMPLETED|Overall Study||906
8618281|NCT00461630|9656482|FG001|NOT COMPLETED|Overall Study||827
8618282|NCT00461708|9656490|FG000|STARTED|Overall Study||115
8618283|NCT00461708|9656491|FG001|STARTED|Overall Study||38
8618284|NCT00461708|9656490|FG000|COMPLETED|Overall Study||0
8618285|NCT00461708|9656491|FG001|COMPLETED|Overall Study||0
8618286|NCT00461708|9656490|FG000|NOT COMPLETED|Overall Study||115
8618287|NCT00461708|9656491|FG001|NOT COMPLETED|Overall Study||38
8720573|NCT01008059|9767653|FG007|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
8720574|NCT01008150|9767668|FG000|STARTED|Overall Study||43
8720575|NCT01008150|9767669|FG001|STARTED|Overall Study||43
8720576|NCT01008150|9767670|FG002|STARTED|Overall Study||43
8720577|NCT01008150|9767671|FG003|STARTED|Overall Study||12
8720578|NCT01008150|9767668|FG000|COMPLETED|Overall Study||42
8720579|NCT01008150|9767669|FG001|COMPLETED|Overall Study||42
8720580|NCT01008150|9767670|FG002|COMPLETED|Overall Study||42
8720581|NCT01008150|9767671|FG003|COMPLETED|Overall Study||12
8720582|NCT01008150|9767668|FG000|NOT COMPLETED|Overall Study||1
8720583|NCT01008150|9767669|FG001|NOT COMPLETED|Overall Study||1
8720584|NCT01008150|9767670|FG002|NOT COMPLETED|Overall Study||1
8720585|NCT01008150|9767671|FG003|NOT COMPLETED|Overall Study||0
8720586|NCT01008280|9767684|FG000|STARTED|Overall Study||88
8720587|NCT01008280|9767685|FG001|STARTED|Overall Study||92
8720588|NCT01008280|9767684|FG000|COMPLETED|Overall Study||67
8618288|NCT00461734|9656502|FG000|STARTED|Overall Study||120
8618289|NCT00461734|9656503|FG001|STARTED|Overall Study||120
8618290|NCT00461734|9656502|FG000|COMPLETED|Overall Study||62
8618291|NCT00461734|9656503|FG001|COMPLETED|Overall Study||60
8618292|NCT00461734|9656502|FG000|NOT COMPLETED|Overall Study||58
8618293|NCT00461734|9656503|FG001|NOT COMPLETED|Overall Study||60
8618294|NCT00461773|9656516|FG000|STARTED|Overall Study||3
8618295|NCT00461773|9656517|FG001|STARTED|Overall Study||2
8618296|NCT00461773|9656516|FG000|COMPLETED|Overall Study||3
8618297|NCT00461773|9656517|FG001|COMPLETED|Overall Study||2
8720589|NCT01008280|9767685|FG001|COMPLETED|Overall Study||73
8720590|NCT01008280|9767684|FG000|NOT COMPLETED|Overall Study||21
8720591|NCT01008280|9767685|FG001|NOT COMPLETED|Overall Study||19
8720592|NCT01008319|9767693|FG000|STARTED|Overall Study||60
8720593|NCT01008319|9767694|FG001|STARTED|Overall Study||60
8720594|NCT01008319|9767693|FG000|COMPLETED|Overall Study||60
8720595|NCT01008319|9767694|FG001|COMPLETED|Overall Study||60
8720596|NCT01008319|9767693|FG000|NOT COMPLETED|Overall Study||0
8720597|NCT01008319|9767694|FG001|NOT COMPLETED|Overall Study||0
8720598|NCT01008410|9767706|FG000|STARTED|Overall Study||133
8720599|NCT01008410|9767707|FG001|STARTED|Overall Study||132
8618298|NCT00461773|9656516|FG000|NOT COMPLETED|Overall Study||0
8618299|NCT00461773|9656517|FG001|NOT COMPLETED|Overall Study||0
8557904|NCT03203473|9589871|FG000|NOT COMPLETED|Induction Phase||16
8557905|NCT03203473|9589872|FG001|NOT COMPLETED|Induction Phase||0
8557906|NCT03203473|9589873|FG002|NOT COMPLETED|Induction Phase||0
8557907|NCT03203473|9589871|FG000|STARTED|Arm Allocation Phase||0
8557908|NCT03203473|9589872|FG001|STARTED|Arm Allocation Phase||12
8557909|NCT03203473|9589873|FG002|STARTED|Arm Allocation Phase||57
8557910|NCT03203473|9589871|FG000|COMPLETED|Arm Allocation Phase||0
8557911|NCT03203473|9589872|FG001|COMPLETED|Arm Allocation Phase||0
8557912|NCT03203473|9589873|FG002|COMPLETED|Arm Allocation Phase||0
8557913|NCT03203473|9589871|FG000|NOT COMPLETED|Arm Allocation Phase||0
8618300|NCT00461786|9656523|FG000|STARTED|Overall Study||51
8618301|NCT00461786|9656523|FG000|COMPLETED|Overall Study|Completed means the patient was evaluable for response.|48
8618302|NCT00461786|9656523|FG000|NOT COMPLETED|Overall Study||3
8618303|NCT00461851|9656527|FG000|STARTED|Overall Study||17
8618304|NCT00461851|9656527|FG000|COMPLETED|Overall Study||17
8618305|NCT00461851|9656527|FG000|NOT COMPLETED|Overall Study||0
8618306|NCT00461981|9656533|FG000|STARTED|Overall Study||50
8618307|NCT00461981|9656534|FG001|STARTED|Overall Study||51
8557914|NCT03203473|9589872|FG001|NOT COMPLETED|Arm Allocation Phase||12
8557915|NCT03203473|9589873|FG002|NOT COMPLETED|Arm Allocation Phase||57
8557916|NCT03180736|9589886|FG000|STARTED|Overall Study||151
8557917|NCT03180736|9589887|FG001|STARTED|Overall Study||153
8557918|NCT03180736|9589886|FG000|Treated|Overall Study||149
8557919|NCT03180736|9589887|FG001|Treated|Overall Study||150
8557920|NCT03180736|9589886|FG000|COMPLETED|Overall Study||60
8557921|NCT03180736|9589887|FG001|COMPLETED|Overall Study||33
8557922|NCT03180736|9589886|FG000|NOT COMPLETED|Overall Study||91
8557923|NCT03180736|9589887|FG001|NOT COMPLETED|Overall Study||120
8557924|NCT03051659|9589900|FG000|STARTED|Treatment Period||44
8557925|NCT03051659|9589901|FG001|STARTED|Treatment Period||46
8557926|NCT03051659|9589900|FG000|COMPLETED|Treatment Period||44
8557927|NCT03051659|9589901|FG001|COMPLETED|Treatment Period||44
8557928|NCT03051659|9589900|FG000|NOT COMPLETED|Treatment Period||0
8557929|NCT03051659|9589901|FG001|NOT COMPLETED|Treatment Period||2
8557930|NCT03051659|9589900|FG000|STARTED|Survival Follow-up||44
8557931|NCT03051659|9589901|FG001|STARTED|Survival Follow-up||44
8557932|NCT03051659|9589900|FG000|COMPLETED|Survival Follow-up||21
8557933|NCT03051659|9589901|FG001|COMPLETED|Survival Follow-up||22
8557934|NCT03051659|9589900|FG000|NOT COMPLETED|Survival Follow-up||23
8557935|NCT03051659|9589901|FG001|NOT COMPLETED|Survival Follow-up||22
8557936|NCT03048552|9589911|FG000|STARTED|Overall Study||4
8557937|NCT03048552|9589912|FG001|STARTED|Overall Study||18
8557938|NCT03048552|9589913|FG002|STARTED|Overall Study||4
8557939|NCT03048552|9589914|FG003|STARTED|Overall Study|Fewer caregivers were enrolled in Family CONNECT arm than youth as 2 caregivers had multiple children in the Family CONNECT arm: one caregiver had n=2 children and 1 caregiver had n=3 children.|15
8557940|NCT03048552|9589911|FG000|COMPLETED|Overall Study||4
8618308|NCT00461981|9656533|FG000|COMPLETED|Overall Study||39
8557941|NCT03048552|9589912|FG001|COMPLETED|Overall Study||18
8557942|NCT03048552|9589913|FG002|COMPLETED|Overall Study||4
8557943|NCT03048552|9589914|FG003|COMPLETED|Overall Study||15
8557944|NCT03048552|9589911|FG000|NOT COMPLETED|Overall Study||0
8557945|NCT03048552|9589912|FG001|NOT COMPLETED|Overall Study||0
8557946|NCT03048552|9589913|FG002|NOT COMPLETED|Overall Study||0
8720600|NCT01008410|9767706|FG000|Received at Least 1 Dose of Study Drug|Overall Study||133
8720601|NCT01008410|9767707|FG001|Received at Least 1 Dose of Study Drug|Overall Study||132
8720602|NCT01008410|9767706|FG000|COMPLETED|Overall Study||108
8720603|NCT01008410|9767707|FG001|COMPLETED|Overall Study||116
8720604|NCT01008410|9767706|FG000|NOT COMPLETED|Overall Study||25
8720605|NCT01008410|9767707|FG001|NOT COMPLETED|Overall Study||16
8720606|NCT01008423|9767715|FG000|STARTED|Overall Study||134
8720607|NCT01008423|9767716|FG001|STARTED|Overall Study||147
8720608|NCT01008423|9767715|FG000|Received at Least 1 Dose of Study Drug|Overall Study||134
8618309|NCT00461981|9656534|FG001|COMPLETED|Overall Study||42
8618310|NCT00461981|9656533|FG000|NOT COMPLETED|Overall Study||11
8618311|NCT00461981|9656534|FG001|NOT COMPLETED|Overall Study||9
8618312|NCT00462020|9656542|FG000|STARTED|Overall Study||52
8618313|NCT00462020|9656543|FG001|STARTED|Overall Study||50
8618314|NCT00462020|9656542|FG000|COMPLETED|Overall Study||52
8618315|NCT00462020|9656543|FG001|COMPLETED|Overall Study||50
8618316|NCT00462020|9656542|FG000|NOT COMPLETED|Overall Study||0
8720609|NCT01008423|9767716|FG001|Received at Least 1 Dose of Study Drug|Overall Study||147
8720610|NCT01008423|9767715|FG000|COMPLETED|Overall Study||115
8720611|NCT01008423|9767716|FG001|COMPLETED|Overall Study||125
8720612|NCT01008423|9767715|FG000|NOT COMPLETED|Overall Study||19
8720613|NCT01008423|9767716|FG001|NOT COMPLETED|Overall Study||22
8720614|NCT01008449|9767724|FG000|STARTED|Overall Study||200
8720615|NCT01008449|9767725|FG001|STARTED|Overall Study||198
8720616|NCT01008449|9767724|FG000|COMPLETED|Overall Study||171
8720617|NCT01008449|9767725|FG001|COMPLETED|Overall Study||179
8720618|NCT01008449|9767724|FG000|NOT COMPLETED|Overall Study||29
8720619|NCT01008449|9767725|FG001|NOT COMPLETED|Overall Study||19
8720620|NCT01008462|9767731|FG000|STARTED|Overall Study||16
8720621|NCT01008462|9767731|FG000|COMPLETED|Overall Study||16
8720622|NCT01008462|9767731|FG000|NOT COMPLETED|Overall Study||0
8720623|NCT01008475|9767742|FG000|STARTED|Overall Study||3
8720624|NCT01008475|9767743|FG001|STARTED|Overall Study||3
8720625|NCT01008475|9767744|FG002|STARTED|Overall Study||7
8720626|NCT01008475|9767745|FG003|STARTED|Overall Study||3
8720627|NCT01008475|9767746|FG004|STARTED|Overall Study||72
8720628|NCT01008475|9767747|FG005|STARTED|Overall Study||73
8720629|NCT01008475|9767748|FG006|STARTED|Overall Study||71
8720630|NCT01008475|9767742|FG000|Safety Analysis Set|Overall Study||3
8720631|NCT01008475|9767743|FG001|Safety Analysis Set|Overall Study||3
8720632|NCT01008475|9767744|FG002|Safety Analysis Set|Overall Study||7
8720633|NCT01008475|9767745|FG003|Safety Analysis Set|Overall Study||3
8724985|NCT01029340|9772246|FG000|Participants Received Treatment|Part B Treatment Period||0
8557947|NCT03048552|9589914|FG003|NOT COMPLETED|Overall Study||0
8720634|NCT01008475|9767746|FG004|Safety Analysis Set|Overall Study|1 subject randomized to EMD525797 1000 mg group received only SoC. Hence, reported under SOC group.|73
8720635|NCT01008475|9767747|FG005|Safety Analysis Set|Overall Study||72
8720636|NCT01008475|9767748|FG006|Safety Analysis Set|Overall Study||69
8720637|NCT01008475|9767742|FG000|COMPLETED|Overall Study||3
8720638|NCT01008475|9767743|FG001|COMPLETED|Overall Study||3
8720639|NCT01008475|9767744|FG002|COMPLETED|Overall Study||7
8720640|NCT01008475|9767745|FG003|COMPLETED|Overall Study||3
8720641|NCT01008475|9767746|FG004|COMPLETED|Overall Study||67
8720642|NCT01008475|9767747|FG005|COMPLETED|Overall Study||67
8720643|NCT01008475|9767748|FG006|COMPLETED|Overall Study||67
8720644|NCT01008475|9767742|FG000|NOT COMPLETED|Overall Study||0
8720645|NCT01008475|9767743|FG001|NOT COMPLETED|Overall Study||0
8720646|NCT01008475|9767744|FG002|NOT COMPLETED|Overall Study||0
8720647|NCT01008475|9767745|FG003|NOT COMPLETED|Overall Study||0
8720648|NCT01008475|9767746|FG004|NOT COMPLETED|Overall Study||5
8618317|NCT00462020|9656543|FG001|NOT COMPLETED|Overall Study||0
8618318|NCT00462072|9656552|FG000|STARTED|Baseline (Week 0)||10
8618319|NCT00462072|9656553|FG001|STARTED|Baseline (Week 0)||12
8618320|NCT00462072|9656554|FG002|STARTED|Baseline (Week 0)||9
8618321|NCT00462072|9656552|FG000|COMPLETED|Baseline (Week 0)||10
8618322|NCT00462072|9656553|FG001|COMPLETED|Baseline (Week 0)||12
8618323|NCT00462072|9656554|FG002|COMPLETED|Baseline (Week 0)||9
8618324|NCT00462072|9656552|FG000|NOT COMPLETED|Baseline (Week 0)||0
8618325|NCT00462072|9656553|FG001|NOT COMPLETED|Baseline (Week 0)||0
8618326|NCT00462072|9656554|FG002|NOT COMPLETED|Baseline (Week 0)||0
8618327|NCT00462072|9656552|FG000|STARTED|Week 10||10
8618328|NCT00462072|9656553|FG001|STARTED|Week 10||12
8618329|NCT00462072|9656554|FG002|STARTED|Week 10||9
8618330|NCT00462072|9656552|FG000|COMPLETED|Week 10||10
8618331|NCT00462072|9656553|FG001|COMPLETED|Week 10||12
8618332|NCT00462072|9656554|FG002|COMPLETED|Week 10||9
8618333|NCT00462072|9656552|FG000|NOT COMPLETED|Week 10||0
8618334|NCT00462072|9656553|FG001|NOT COMPLETED|Week 10||0
8618335|NCT00462072|9656554|FG002|NOT COMPLETED|Week 10||0
8618336|NCT00462124|9656566|FG000|STARTED|Overall Study||7
8618337|NCT00462124|9656566|FG000|COMPLETED|Overall Study|One implant was misplaced and was disacitivated by puncture.|6
8618338|NCT00462124|9656566|FG000|NOT COMPLETED|Overall Study||1
8618339|NCT00462228|9656571|FG000|STARTED|Memantine or Placebo 12 Weeks||11
8618340|NCT00462228|9656571|FG000|COMPLETED|Memantine or Placebo 12 Weeks||11
8618341|NCT00462228|9656571|FG000|NOT COMPLETED|Memantine or Placebo 12 Weeks||0
8618342|NCT00462228|9656571|FG000|STARTED|No Treatment (Washout) 4 Weeks||11
8618343|NCT00462228|9656571|FG000|COMPLETED|No Treatment (Washout) 4 Weeks||11
8943635|NCT02390557|10005472|FG001|STARTED|Wave 2||156
8943636|NCT02390557|10005473|FG002|STARTED|Wave 2||135
8943637|NCT02390557|10005471|FG000|COMPLETED|Wave 2||88
8943638|NCT02390557|10005472|FG001|COMPLETED|Wave 2||115
8943639|NCT02390557|10005473|FG002|COMPLETED|Wave 2||112
8943640|NCT02390557|10005471|FG000|NOT COMPLETED|Wave 2||72
8943641|NCT02390557|10005472|FG001|NOT COMPLETED|Wave 2||41
8943642|NCT02390557|10005473|FG002|NOT COMPLETED|Wave 2||23
8943643|NCT02390791|10005483|FG000|STARTED|Overall Study||40
8943644|NCT02390791|10005484|FG001|STARTED|Overall Study||45
8943645|NCT02390791|10005483|FG000|COMPLETED|Overall Study||40
8943646|NCT02390791|10005484|FG001|COMPLETED|Overall Study||45
8943647|NCT02390791|10005483|FG000|NOT COMPLETED|Overall Study||0
8943648|NCT02390791|10005484|FG001|NOT COMPLETED|Overall Study||0
8943649|NCT02390908|10005495|FG000|STARTED|Overall Study||40
8943650|NCT02390908|10005496|FG001|STARTED|Overall Study||22
8943651|NCT02390908|10005497|FG002|STARTED|Overall Study||22
8943652|NCT02390908|10005498|FG003|STARTED|Overall Study||90
8943653|NCT02390908|10005499|FG004|STARTED|Overall Study||120
8943654|NCT02390908|10005495|FG000|COMPLETED|Overall Study||40
8943655|NCT02390908|10005496|FG001|COMPLETED|Overall Study||22
8943656|NCT02390908|10005497|FG002|COMPLETED|Overall Study||22
8943657|NCT02390908|10005498|FG003|COMPLETED|Overall Study||90
8943658|NCT02390908|10005499|FG004|COMPLETED|Overall Study||120
8943659|NCT02390908|10005495|FG000|NOT COMPLETED|Overall Study||0
8943660|NCT02390908|10005496|FG001|NOT COMPLETED|Overall Study||0
8943661|NCT02390908|10005497|FG002|NOT COMPLETED|Overall Study||0
8943662|NCT02390908|10005498|FG003|NOT COMPLETED|Overall Study||0
8943663|NCT02390908|10005499|FG004|NOT COMPLETED|Overall Study||0
8618344|NCT00462228|9656571|FG000|NOT COMPLETED|No Treatment (Washout) 4 Weeks||0
8618345|NCT00462228|9656571|FG000|STARTED|Placebo or Memantine 12 Weeks||11
8618346|NCT00462228|9656571|FG000|COMPLETED|Placebo or Memantine 12 Weeks||11
8618347|NCT00462228|9656571|FG000|NOT COMPLETED|Placebo or Memantine 12 Weeks||0
8618348|NCT00462228|9656571|FG000|STARTED|No Treatment (Washout) 4 Weeks||11
8618349|NCT00462228|9656571|FG000|COMPLETED|No Treatment (Washout) 4 Weeks||11
8618350|NCT00462228|9656571|FG000|NOT COMPLETED|No Treatment (Washout) 4 Weeks||0
8618351|NCT00462280|9656582|FG000|STARTED|Overall Study||34
8618352|NCT00462280|9656583|FG001|STARTED|Overall Study||32
8618353|NCT00462280|9656584|FG002|STARTED|Overall Study||7
8618354|NCT00462280|9656585|FG003|STARTED|Overall Study||7
8618355|NCT00462280|9656582|FG000|COMPLETED|Overall Study||24
8618356|NCT00462280|9656583|FG001|COMPLETED|Overall Study||25
8618357|NCT00462280|9656584|FG002|COMPLETED|Overall Study||7
8618358|NCT00462280|9656585|FG003|COMPLETED|Overall Study||4
8618359|NCT00462280|9656582|FG000|NOT COMPLETED|Overall Study||10
8618360|NCT00462280|9656583|FG001|NOT COMPLETED|Overall Study||7
8618361|NCT00462280|9656584|FG002|NOT COMPLETED|Overall Study||0
8618362|NCT00462280|9656585|FG003|NOT COMPLETED|Overall Study||3
8618363|NCT00462306|9656599|FG000|STARTED|Overall Study||4074
8618364|NCT00462306|9656600|FG001|STARTED|Overall Study||503
8618365|NCT00462306|9656599|FG000|COMPLETED|Overall Study||4074
8618366|NCT00462306|9656600|FG001|COMPLETED|Overall Study||490
8618367|NCT00462306|9656599|FG000|NOT COMPLETED|Overall Study||0
8557948|NCT02949219|9589924|FG000|STARTED|Overall Study||41
8557949|NCT02949219|9589924|FG000|COMPLETED|Overall Study||40
8557950|NCT02949219|9589924|FG000|NOT COMPLETED|Overall Study||1
8557951|NCT02886884|9589932|FG000|STARTED|Treatment||3
8557952|NCT02886884|9589933|FG001|STARTED|Treatment||3
8557953|NCT02886884|9589934|FG002|STARTED|Treatment||5
8557954|NCT02886884|9589935|FG003|STARTED|Treatment||5
8557955|NCT02886884|9589932|FG000|COMPLETED|Treatment||3
8557956|NCT02886884|9589933|FG001|COMPLETED|Treatment||3
8557957|NCT02886884|9589934|FG002|COMPLETED|Treatment||5
8557958|NCT02886884|9589935|FG003|COMPLETED|Treatment||5
8557959|NCT02886884|9589932|FG000|NOT COMPLETED|Treatment||0
8557960|NCT02886884|9589933|FG001|NOT COMPLETED|Treatment||0
8557961|NCT02886884|9589934|FG002|NOT COMPLETED|Treatment||0
8557962|NCT02886884|9589935|FG003|NOT COMPLETED|Treatment||0
8557963|NCT02886884|9589932|FG000|STARTED|Follow-up||3
8557964|NCT02886884|9589933|FG001|STARTED|Follow-up||3
8618368|NCT00462306|9656600|FG001|NOT COMPLETED|Overall Study||13
8618369|NCT00462332|9656610|FG000|STARTED|Overall Study||45
8618370|NCT00462332|9656611|FG001|STARTED|Overall Study||41
8618371|NCT00462332|9656610|FG000|COMPLETED|Overall Study||45
8618372|NCT00462332|9656611|FG001|COMPLETED|Overall Study||41
8618373|NCT00462332|9656610|FG000|NOT COMPLETED|Overall Study||0
8618374|NCT00462332|9656611|FG001|NOT COMPLETED|Overall Study||0
8618375|NCT00462345|9656619|FG000|STARTED|Overall Study||40
8618376|NCT00462345|9656619|FG000|Completed First Course|Overall Study||38
8618377|NCT00462345|9656619|FG000|COMPLETED|Overall Study||37
8618378|NCT00462345|9656619|FG000|NOT COMPLETED|Overall Study||3
8618379|NCT00462384|9656623|FG000|STARTED|Overall Study||39
8618380|NCT00462384|9656623|FG000|COMPLETED|Overall Study||30
8618381|NCT00462384|9656623|FG000|NOT COMPLETED|Overall Study||9
8618382|NCT00462423|9656627|FG000|STARTED|Overall Study||50
8618383|NCT00462423|9656627|FG000|COMPLETED|Overall Study||50
8618384|NCT00462423|9656627|FG000|NOT COMPLETED|Overall Study||0
8618385|NCT00462449|9656634|FG000|STARTED|Overall Study||13
8618386|NCT00462449|9656635|FG001|STARTED|Overall Study||10
8618387|NCT00462449|9656634|FG000|COMPLETED|Overall Study||13
8618388|NCT00462449|9656635|FG001|COMPLETED|Overall Study||10
8618389|NCT00462449|9656634|FG000|NOT COMPLETED|Overall Study||0
8618390|NCT00462449|9656635|FG001|NOT COMPLETED|Overall Study||0
8618391|NCT00462462|9656643|FG000|STARTED|Overall Study||17
8618392|NCT00462462|9656644|FG001|STARTED|Overall Study||14
8618393|NCT00462462|9656643|FG000|COMPLETED|Overall Study||17
8618394|NCT00462462|9656644|FG001|COMPLETED|Overall Study||13
8618395|NCT00462462|9656643|FG000|NOT COMPLETED|Overall Study||0
8618396|NCT00462462|9656644|FG001|NOT COMPLETED|Overall Study||1
8618397|NCT00462488|9656654|FG000|STARTED|Overall Study||23
8618398|NCT00462488|9656655|FG001|STARTED|Overall Study||23
8618399|NCT00462488|9656654|FG000|Completed Induction Phase|Overall Study||22
8618400|NCT00462488|9656655|FG001|Completed Induction Phase|Overall Study||23
8618401|NCT00462488|9656654|FG000|Completed Induction 2/Maintenance 1|Overall Study||18
8618402|NCT00462488|9656655|FG001|Completed Induction 2/Maintenance 1|Overall Study||9
8618403|NCT00462488|9656654|FG000|Completed Maintenance 2|Overall Study||7
8720649|NCT01008475|9767747|FG005|NOT COMPLETED|Overall Study||6
8720650|NCT01008475|9767748|FG006|NOT COMPLETED|Overall Study||4
8720651|NCT01008553|9767764|FG000|STARTED|Period 1 (Titration Period)||258
8720652|NCT01008553|9767765|FG001|STARTED|Period 1 (Titration Period)||0
8720653|NCT01008553|9767766|FG002|STARTED|Period 1 (Titration Period)||0
8720654|NCT01008553|9767764|FG000|COMPLETED|Period 1 (Titration Period)||163
8618404|NCT00462488|9656655|FG001|Completed Maintenance 2|Overall Study||6
8618405|NCT00462488|9656654|FG000|COMPLETED|Overall Study||3
8720655|NCT01008553|9767765|FG001|COMPLETED|Period 1 (Titration Period)||0
8720656|NCT01008553|9767766|FG002|COMPLETED|Period 1 (Titration Period)||0
8720657|NCT01008553|9767764|FG000|NOT COMPLETED|Period 1 (Titration Period)||95
8720658|NCT01008553|9767765|FG001|NOT COMPLETED|Period 1 (Titration Period)||0
8720659|NCT01008553|9767766|FG002|NOT COMPLETED|Period 1 (Titration Period)||0
8720660|NCT01008553|9767764|FG000|STARTED|Period 2 (Double-Blind Period)||0
8720661|NCT01008553|9767765|FG001|STARTED|Period 2 (Double-Blind Period)||84
8720662|NCT01008553|9767766|FG002|STARTED|Period 2 (Double-Blind Period)||79
8720663|NCT01008553|9767764|FG000|COMPLETED|Period 2 (Double-Blind Period)||0
8720664|NCT01008553|9767765|FG001|COMPLETED|Period 2 (Double-Blind Period)||47
8720665|NCT01008553|9767766|FG002|COMPLETED|Period 2 (Double-Blind Period)||28
8720666|NCT01008553|9767764|FG000|NOT COMPLETED|Period 2 (Double-Blind Period)||0
8720667|NCT01008553|9767765|FG001|NOT COMPLETED|Period 2 (Double-Blind Period)||37
8720668|NCT01008553|9767766|FG002|NOT COMPLETED|Period 2 (Double-Blind Period)||51
8720669|NCT01008605|9767775|FG000|STARTED|Overall Study||48
8720670|NCT01008605|9767775|FG000|COMPLETED|Overall Study||48
8720671|NCT01008605|9767775|FG000|NOT COMPLETED|Overall Study||0
8720672|NCT01008618|9767787|FG000|STARTED|Period 1 (Titration Period)||218
8720673|NCT01008618|9767788|FG001|STARTED|Period 1 (Titration Period)||0
8720674|NCT01008618|9767789|FG002|STARTED|Period 1 (Titration Period)||0
8720675|NCT01008618|9767787|FG000|COMPLETED|Period 1 (Titration Period)||150
8720676|NCT01008618|9767788|FG001|COMPLETED|Period 1 (Titration Period)||0
8720677|NCT01008618|9767789|FG002|COMPLETED|Period 1 (Titration Period)||0
8720678|NCT01008618|9767787|FG000|NOT COMPLETED|Period 1 (Titration Period)||68
8720679|NCT01008618|9767788|FG001|NOT COMPLETED|Period 1 (Titration Period)||0
8720680|NCT01008618|9767789|FG002|NOT COMPLETED|Period 1 (Titration Period)||0
8720681|NCT01008618|9767787|FG000|STARTED|Period 2 (Double-Blind Period)||0
8720682|NCT01008618|9767788|FG001|STARTED|Period 2 (Double-Blind Period)||73
8720683|NCT01008618|9767789|FG002|STARTED|Period 2 (Double-Blind Period)||77
8720684|NCT01008618|9767787|FG000|COMPLETED|Period 2 (Double-Blind Period)||0
8720685|NCT01008618|9767788|FG001|COMPLETED|Period 2 (Double-Blind Period)||37
8720686|NCT01008618|9767789|FG002|COMPLETED|Period 2 (Double-Blind Period)||39
8720687|NCT01008618|9767787|FG000|NOT COMPLETED|Period 2 (Double-Blind Period)||0
8720688|NCT01008618|9767788|FG001|NOT COMPLETED|Period 2 (Double-Blind Period)||36
8720689|NCT01008618|9767789|FG002|NOT COMPLETED|Period 2 (Double-Blind Period)||38
8720690|NCT01008696|9767800|FG000|STARTED|Overall Study||108
8720691|NCT01008696|9767801|FG001|STARTED|Overall Study||109
8720692|NCT01008696|9767800|FG000|COMPLETED|Overall Study||91
8720693|NCT01008696|9767801|FG001|COMPLETED|Overall Study||92
8720694|NCT01008696|9767800|FG000|NOT COMPLETED|Overall Study||17
8720695|NCT01008696|9767801|FG001|NOT COMPLETED|Overall Study||17
8720696|NCT01008722|9767810|FG000|STARTED|Overall Study|Based on Power Calculations to see 20% outcome improvement by adding FIRM-guided ablation to PVI|36
8720697|NCT01008722|9767811|FG001|STARTED|Overall Study|Based on Power Calculations to see 20% outcome improvement by adding FIRM-guided ablation to PVI|71
8720698|NCT01008722|9767810|FG000|COMPLETED|Overall Study||36
8720699|NCT01008722|9767811|FG001|COMPLETED|Overall Study||71
8720700|NCT01008722|9767810|FG000|NOT COMPLETED|Overall Study||0
8720701|NCT01008722|9767811|FG001|NOT COMPLETED|Overall Study||0
8720702|NCT01008748|9767817|FG000|STARTED|Overall Study||200
8720703|NCT01008748|9767817|FG000|Baseline|Overall Study||188
8720704|NCT01008748|9767817|FG000|Week 0|Overall Study||182
8720705|NCT01008748|9767817|FG000|Week 3|Overall Study||168
8720706|NCT01008748|9767817|FG000|Week 26|Overall Study||119
8720707|NCT01008748|9767817|FG000|COMPLETED|Overall Study||119
8720708|NCT01008748|9767817|FG000|NOT COMPLETED|Overall Study||81
8720709|NCT01008904|9767821|FG000|STARTED|Overall Study||29
8720710|NCT01008904|9767821|FG000|COMPLETED|Overall Study||25
8720711|NCT01008904|9767821|FG000|NOT COMPLETED|Overall Study||4
8720712|NCT01008943|9767825|FG000|STARTED|Overall Study||16
8720713|NCT01008943|9767825|FG000|COMPLETED|Overall Study||15
8720714|NCT01008943|9767825|FG000|NOT COMPLETED|Overall Study||1
8943664|NCT02391038|10005516|FG000|STARTED|Overall Study||3
8943665|NCT02391038|10005517|FG001|STARTED|Overall Study||3
8943666|NCT02391038|10005518|FG002|STARTED|Overall Study||6
8943667|NCT02391038|10005516|FG000|COMPLETED|Overall Study||0
8943668|NCT02391038|10005517|FG001|COMPLETED|Overall Study||0
8720715|NCT01008969|9767829|FG000|STARTED|Overall Study||10
8720716|NCT01008969|9767829|FG000|COMPLETED|Overall Study||10
8720717|NCT01008969|9767829|FG000|NOT COMPLETED|Overall Study||0
8720718|NCT01008995|9767835|FG000|STARTED|Controlled Period||162
8720719|NCT01008995|9767836|FG001|STARTED|Controlled Period||160
8720720|NCT01008995|9767837|FG002|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
8720721|NCT01008995|9767838|FG003|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
8720722|NCT01008995|9767835|FG000|COMPLETED|Controlled Period||159
8720723|NCT01008995|9767836|FG001|COMPLETED|Controlled Period||157
8720724|NCT01008995|9767837|FG002|COMPLETED|Controlled Period||0
8720725|NCT01008995|9767838|FG003|COMPLETED|Controlled Period||0
8943669|NCT02391038|10005518|FG002|COMPLETED|Overall Study||0
8943670|NCT02391038|10005516|FG000|NOT COMPLETED|Overall Study||3
8943671|NCT02391038|10005517|FG001|NOT COMPLETED|Overall Study||3
8943672|NCT02391038|10005518|FG002|NOT COMPLETED|Overall Study||6
8943673|NCT02391116|10005527|FG000|STARTED|Treatment||67
8943674|NCT02391116|10005527|FG000|Included in Per Protocol Set|Treatment||40
8943675|NCT02391116|10005527|FG000|COMPLETED|Treatment|Reasons for completion in this period included death (2), PD (50) and lack of efficacy (1)|53
8720726|NCT01008995|9767835|FG000|NOT COMPLETED|Controlled Period||3
8720727|NCT01008995|9767836|FG001|NOT COMPLETED|Controlled Period||3
8720728|NCT01008995|9767837|FG002|NOT COMPLETED|Controlled Period||0
8720729|NCT01008995|9767838|FG003|NOT COMPLETED|Controlled Period||0
8720730|NCT01008995|9767835|FG000|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
8720731|NCT01008995|9767836|FG001|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
8720732|NCT01008995|9767837|FG002|STARTED|After Controlled Period|1 placebo participant discontinued after completing the CP and did not receive ustekinumab 45 mg.|158
8720733|NCT01008995|9767838|FG003|STARTED|After Controlled Period|2 participants discontinued in CP, had follow-up, and are among frequent and serious adverse events.|157
8720734|NCT01008995|9767835|FG000|COMPLETED|After Controlled Period||0
8720735|NCT01008995|9767836|FG001|COMPLETED|After Controlled Period||0
8720736|NCT01008995|9767837|FG002|COMPLETED|After Controlled Period||156
8720737|NCT01008995|9767838|FG003|COMPLETED|After Controlled Period||156
8720738|NCT01008995|9767835|FG000|NOT COMPLETED|After Controlled Period||0
8720739|NCT01008995|9767836|FG001|NOT COMPLETED|After Controlled Period||0
8720740|NCT01008995|9767837|FG002|NOT COMPLETED|After Controlled Period||2
8720741|NCT01008995|9767838|FG003|NOT COMPLETED|After Controlled Period||1
8720742|NCT01009034|9767846|FG000|STARTED|Overall Study||14
8720743|NCT01009034|9767846|FG000|COMPLETED|Overall Study||10
8720744|NCT01009034|9767846|FG000|NOT COMPLETED|Overall Study||4
8720745|NCT01009047|9767852|FG000|STARTED|Overall Study||113
8720746|NCT01009047|9767853|FG001|STARTED|Overall Study||115
8720747|NCT01009047|9767852|FG000|COMPLETED|Overall Study||85
8720748|NCT01009047|9767853|FG001|COMPLETED|Overall Study||89
8720749|NCT01009047|9767852|FG000|NOT COMPLETED|Overall Study||28
8720750|NCT01009047|9767853|FG001|NOT COMPLETED|Overall Study||26
8720751|NCT01009060|9767861|FG000|STARTED|Overall Study||25
8720752|NCT01009060|9767862|FG001|STARTED|Overall Study||25
8720753|NCT01009060|9767861|FG000|COMPLETED|Overall Study||21
8720754|NCT01009060|9767862|FG001|COMPLETED|Overall Study||20
8720755|NCT01009060|9767861|FG000|NOT COMPLETED|Overall Study||4
8720756|NCT01009060|9767862|FG001|NOT COMPLETED|Overall Study||5
8720757|NCT01009086|9767875|FG000|STARTED|Overall Study||206
8720758|NCT01009086|9767876|FG001|STARTED|Overall Study||205
8720759|NCT01009086|9767877|FG002|STARTED|Overall Study||204
8720760|NCT01009086|9767875|FG000|COMPLETED|Overall Study||162
8720761|NCT01009086|9767876|FG001|COMPLETED|Overall Study||158
8720762|NCT01009086|9767877|FG002|COMPLETED|Overall Study||170
8720763|NCT01009086|9767875|FG000|NOT COMPLETED|Overall Study||44
8720764|NCT01009086|9767876|FG001|NOT COMPLETED|Overall Study||47
8720765|NCT01009086|9767877|FG002|NOT COMPLETED|Overall Study||34
8720766|NCT01009099|9767892|FG000|STARTED|Overall Study||58
8720767|NCT01009099|9767893|FG001|STARTED|Overall Study||61
8720768|NCT01009099|9767892|FG000|COMPLETED|Overall Study||53
8720769|NCT01009099|9767893|FG001|COMPLETED|Overall Study||57
8720770|NCT01009099|9767892|FG000|NOT COMPLETED|Overall Study||5
8720771|NCT01009099|9767893|FG001|NOT COMPLETED|Overall Study||4
8720772|NCT01009138|9767901|FG000|STARTED|Overall Study||106
8618406|NCT00462488|9656655|FG001|COMPLETED|Overall Study||6
8618407|NCT00462488|9656654|FG000|NOT COMPLETED|Overall Study||20
8618408|NCT00462488|9656655|FG001|NOT COMPLETED|Overall Study||17
8618409|NCT00462501|9656661|FG000|STARTED|Overall Study||35
8618410|NCT00462501|9656661|FG000|COMPLETED|Overall Study||30
8618411|NCT00462501|9656661|FG000|NOT COMPLETED|Overall Study||5
8618412|NCT00462605|9656665|FG000|STARTED|Overall Study||24
8618413|NCT00462605|9656665|FG000|COMPLETED|Overall Study||10
8618414|NCT00462605|9656665|FG000|NOT COMPLETED|Overall Study||14
8618415|NCT00462644|9656671|FG000|STARTED|Overall Study||18
8618416|NCT00462644|9656672|FG001|STARTED|Overall Study||12
8618417|NCT00462644|9656671|FG000|COMPLETED|Overall Study||18
8618418|NCT00462644|9656672|FG001|COMPLETED|Overall Study||12
8618419|NCT00462644|9656671|FG000|NOT COMPLETED|Overall Study||0
8618420|NCT00462644|9656672|FG001|NOT COMPLETED|Overall Study||0
8618421|NCT00462670|9656680|FG000|STARTED|Overall Study||57
8618422|NCT00462670|9656681|FG001|STARTED|Overall Study||53
8813777|NCT01527682|9866981|FG000|COMPLETED|Overall Study||29
8813778|NCT01527682|9866981|FG000|NOT COMPLETED|Overall Study||8
8813779|NCT01528033|9866987|FG000|STARTED|Primary Endpoint Assessment ITT||273
8813780|NCT01528033|9866988|FG001|STARTED|Primary Endpoint Assessment ITT||266
8813781|NCT01528033|9866987|FG000|COMPLETED|Primary Endpoint Assessment ITT||256
8813782|NCT01528033|9866988|FG001|COMPLETED|Primary Endpoint Assessment ITT||251
8813783|NCT01528033|9866987|FG000|NOT COMPLETED|Primary Endpoint Assessment ITT||17
8813784|NCT01528033|9866988|FG001|NOT COMPLETED|Primary Endpoint Assessment ITT||15
8813785|NCT01528033|9866987|FG000|STARTED|Follow Up||256
8813786|NCT01528033|9866988|FG001|STARTED|Follow Up||251
8557965|NCT02886884|9589934|FG002|STARTED|Follow-up||5
8557966|NCT02886884|9589935|FG003|STARTED|Follow-up||5
8557967|NCT02886884|9589932|FG000|COMPLETED|Follow-up||3
8557968|NCT02886884|9589933|FG001|COMPLETED|Follow-up||3
8557969|NCT02886884|9589934|FG002|COMPLETED|Follow-up||5
8557970|NCT02886884|9589935|FG003|COMPLETED|Follow-up||4
8557971|NCT02886884|9589932|FG000|NOT COMPLETED|Follow-up||0
8557972|NCT02886884|9589933|FG001|NOT COMPLETED|Follow-up||0
8557973|NCT02886884|9589934|FG002|NOT COMPLETED|Follow-up||0
8557974|NCT02886884|9589935|FG003|NOT COMPLETED|Follow-up||1
8557975|NCT02845453|9589947|FG000|STARTED|Overall Study||13
8557976|NCT02845453|9589948|FG001|STARTED|Overall Study||11
8557977|NCT02845453|9589947|FG000|Took One Dose of Study Medication|Overall Study||11
8557978|NCT02845453|9589948|FG001|Took One Dose of Study Medication|Overall Study||10
8557979|NCT02845453|9589947|FG000|Took One Week of Study Medication|Overall Study||10
8557980|NCT02845453|9589948|FG001|Took One Week of Study Medication|Overall Study||9
8557981|NCT02845453|9589947|FG000|COMPLETED|Overall Study||7
8557982|NCT02845453|9589948|FG001|COMPLETED|Overall Study||6
8557983|NCT02845453|9589947|FG000|NOT COMPLETED|Overall Study||6
8557984|NCT02845453|9589948|FG001|NOT COMPLETED|Overall Study||5
8557985|NCT02739542|9589956|FG000|STARTED|Overall Study||44
8557986|NCT02739542|9589957|FG001|STARTED|Overall Study||43
8557987|NCT02739542|9589956|FG000|COMPLETED|Overall Study||30
8557988|NCT02739542|9589957|FG001|COMPLETED|Overall Study||29
8557989|NCT02739542|9589956|FG000|NOT COMPLETED|Overall Study||14
8557990|NCT02739542|9589957|FG001|NOT COMPLETED|Overall Study||14
8557991|NCT02717832|9589963|FG000|STARTED|Overall Study||20
8557992|NCT02717832|9589963|FG000|COMPLETED|Overall Study||17
8557993|NCT02717832|9589963|FG000|NOT COMPLETED|Overall Study||3
8557994|NCT02677324|9589968|FG000|STARTED|Overall Study||33
8557995|NCT02677324|9589968|FG000|COMPLETED|Overall Study||21
8557996|NCT02677324|9589968|FG000|NOT COMPLETED|Overall Study||12
8557997|NCT02563028|9589974|FG000|STARTED|Overall Study||20
8557998|NCT02563028|9589974|FG000|COMPLETED|Overall Study||18
8557999|NCT02563028|9589974|FG000|NOT COMPLETED|Overall Study||2
8558000|NCT02552212|9589980|FG000|STARTED|Double-Blind Period (Week 0 - 52)||158
8558001|NCT02552212|9589981|FG001|STARTED|Double-Blind Period (Week 0 - 52)||159
8558002|NCT02552212|9589982|FG002|STARTED|Double-Blind Period (Week 0 - 52)||0
8558003|NCT02552212|9589980|FG000|Received OL CZP|Double-Blind Period (Week 0 - 52)||96
8558004|NCT02552212|9589981|FG001|Received OL CZP|Double-Blind Period (Week 0 - 52)||20
8558005|NCT02552212|9589982|FG002|Received OL CZP|Double-Blind Period (Week 0 - 52)||0
8558006|NCT02552212|9589980|FG000|Completed Week 52 Without Starting SFE|Double-Blind Period (Week 0 - 52)||20
8558007|NCT02552212|9589981|FG001|Completed Week 52 Without Starting SFE|Double-Blind Period (Week 0 - 52)||22
8558008|NCT02552212|9589982|FG002|Completed Week 52 Without Starting SFE|Double-Blind Period (Week 0 - 52)||0
8558009|NCT02552212|9589980|FG000|COMPLETED|Double-Blind Period (Week 0 - 52)||143
8720773|NCT01009138|9767902|FG001|STARTED|Overall Study||108
8720774|NCT01009138|9767901|FG000|COMPLETED|Overall Study||93
8720775|NCT01009138|9767902|FG001|COMPLETED|Overall Study||88
8720776|NCT01009138|9767901|FG000|NOT COMPLETED|Overall Study||13
8720777|NCT01009138|9767902|FG001|NOT COMPLETED|Overall Study||20
8720778|NCT01009203|9767908|FG000|STARTED|Overall Study||13
8720779|NCT01009203|9767908|FG000|Received Treatment|Overall Study|One patient withdrew consent before treatment started.|12
8720780|NCT01009203|9767908|FG000|COMPLETED|Overall Study||6
8618423|NCT00462670|9656680|FG000|COMPLETED|Overall Study||52
8618424|NCT00462670|9656681|FG001|COMPLETED|Overall Study||46
8618425|NCT00462670|9656680|FG000|NOT COMPLETED|Overall Study||5
8618426|NCT00462670|9656681|FG001|NOT COMPLETED|Overall Study||7
8618427|NCT00462709|9656687|FG000|STARTED|Overall Study||146
8618428|NCT00462709|9656687|FG000|COMPLETED|Overall Study||79
8618429|NCT00462709|9656687|FG000|NOT COMPLETED|Overall Study||67
8618430|NCT00462722|9656694|FG000|STARTED|Overall Study||50
8618431|NCT00462722|9656695|FG001|STARTED|Overall Study||55
8618432|NCT00462722|9656696|FG002|STARTED|Overall Study||54
8618433|NCT00462722|9656694|FG000|COMPLETED|Overall Study||37
8618434|NCT00462722|9656695|FG001|COMPLETED|Overall Study||51
8618435|NCT00462722|9656696|FG002|COMPLETED|Overall Study||42
8618436|NCT00462722|9656694|FG000|NOT COMPLETED|Overall Study||13
8618437|NCT00462722|9656695|FG001|NOT COMPLETED|Overall Study||4
8618438|NCT00462722|9656696|FG002|NOT COMPLETED|Overall Study||12
8618439|NCT00462735|9656704|FG000|STARTED|Overall Study||33
8618440|NCT00462735|9656704|FG000|COMPLETED|Overall Study||33
8618441|NCT00462735|9656704|FG000|NOT COMPLETED|Overall Study||0
8618442|NCT00462761|9656709|FG000|STARTED|Overall Study||76
8618443|NCT00462761|9656709|FG000|COMPLETED|Overall Study||0
8618444|NCT00462761|9656709|FG000|NOT COMPLETED|Overall Study||76
8618445|NCT00462826|9656741|FG000|STARTED|Overall Study||49
8618446|NCT00462826|9656741|FG000|COMPLETED|Overall Study||44
8618447|NCT00462826|9656741|FG000|NOT COMPLETED|Overall Study||5
8618448|NCT00462839|9656753|FG000|STARTED|Viewed First||53
8618449|NCT00462839|9656754|FG001|STARTED|Viewed First||53
8720781|NCT01009203|9767908|FG000|NOT COMPLETED|Overall Study||7
8720782|NCT01009281|9767912|FG000|STARTED|Overall Study||7
8618450|NCT00462839|9656753|FG000|COMPLETED|Viewed First||53
8720783|NCT01009281|9767912|FG000|COMPLETED|Overall Study||0
8618451|NCT00462839|9656754|FG001|COMPLETED|Viewed First||53
8618452|NCT00462839|9656753|FG000|NOT COMPLETED|Viewed First||0
8618453|NCT00462839|9656754|FG001|NOT COMPLETED|Viewed First||0
8618454|NCT00462839|9656753|FG000|STARTED|Viewed Second||53
8618455|NCT00462839|9656754|FG001|STARTED|Viewed Second||53
8618456|NCT00462839|9656753|FG000|COMPLETED|Viewed Second||53
8618457|NCT00462839|9656754|FG001|COMPLETED|Viewed Second||53
8618458|NCT00462839|9656753|FG000|NOT COMPLETED|Viewed Second||0
8618459|NCT00462839|9656754|FG001|NOT COMPLETED|Viewed Second||0
8618460|NCT00462865|9656760|FG000|STARTED|Overall Study|18 pts enrolled,1 pt experienced a SAE infection normal ANC (gr 3) and did not begin study,see SAE|18
8618461|NCT00462865|9656760|FG000|COMPLETED|Overall Study||17
8618462|NCT00462865|9656760|FG000|NOT COMPLETED|Overall Study||1
8618463|NCT00462917|9656768|FG000|STARTED|Overall Study||72
8618464|NCT00462917|9656769|FG001|STARTED|Overall Study||75
8618465|NCT00462917|9656770|FG002|STARTED|Overall Study||66
8618466|NCT00462917|9656771|FG003|STARTED|Overall Study||77
8618467|NCT00462917|9656768|FG000|Met With Genetic Counselor|Overall Study||66
8618468|NCT00462917|9656769|FG001|Met With Genetic Counselor|Overall Study||71
8618469|NCT00462917|9656770|FG002|Met With Genetic Counselor|Overall Study||56
8618470|NCT00462917|9656771|FG003|Met With Genetic Counselor|Overall Study||71
8618471|NCT00462917|9656768|FG000|Received Risk Information|Overall Study||64
8618472|NCT00462917|9656769|FG001|Received Risk Information|Overall Study||70
8618473|NCT00462917|9656770|FG002|Received Risk Information|Overall Study||55
8618474|NCT00462917|9656771|FG003|Received Risk Information|Overall Study||68
8618475|NCT00462917|9656768|FG000|Completed 6 Week Follow-up|Overall Study||63
8618476|NCT00462917|9656769|FG001|Completed 6 Week Follow-up|Overall Study||70
8618477|NCT00462917|9656770|FG002|Completed 6 Week Follow-up|Overall Study||55
8618478|NCT00462917|9656771|FG003|Completed 6 Week Follow-up|Overall Study||68
8618479|NCT00462917|9656768|FG000|Completed 6 Month Follow-up|Overall Study||63
8618480|NCT00462917|9656769|FG001|Completed 6 Month Follow-up|Overall Study||68
8618481|NCT00462917|9656770|FG002|Completed 6 Month Follow-up|Overall Study||55
8618482|NCT00462917|9656771|FG003|Completed 6 Month Follow-up|Overall Study||66
8618483|NCT00462917|9656768|FG000|COMPLETED|Overall Study||62
8618484|NCT00462917|9656769|FG001|COMPLETED|Overall Study||65
8618485|NCT00462917|9656770|FG002|COMPLETED|Overall Study||54
8618486|NCT00462917|9656771|FG003|COMPLETED|Overall Study||66
8618487|NCT00462917|9656768|FG000|NOT COMPLETED|Overall Study||10
8618488|NCT00462917|9656769|FG001|NOT COMPLETED|Overall Study||10
8618489|NCT00462917|9656770|FG002|NOT COMPLETED|Overall Study||12
8618490|NCT00462917|9656771|FG003|NOT COMPLETED|Overall Study||11
8618491|NCT00462982|9656781|FG000|STARTED|Overall Study||8
8618492|NCT00462982|9656781|FG000|COMPLETED|Overall Study||5
8720784|NCT01009281|9767912|FG000|NOT COMPLETED|Overall Study||7
8720785|NCT01009333|9767916|FG000|STARTED|Week 1||2
8618493|NCT00462982|9656781|FG000|NOT COMPLETED|Overall Study||3
8558010|NCT02552212|9589981|FG001|COMPLETED|Double-Blind Period (Week 0 - 52)||142
8558011|NCT02552212|9589982|FG002|COMPLETED|Double-Blind Period (Week 0 - 52)||0
8558012|NCT02552212|9589980|FG000|NOT COMPLETED|Double-Blind Period (Week 0 - 52)||15
8558013|NCT02552212|9589981|FG001|NOT COMPLETED|Double-Blind Period (Week 0 - 52)||17
8618494|NCT00463047|9656785|FG000|STARTED|Titration Period 1|323 subjects entered study period but 3 discontinued before being randomized to treatment|160
8618495|NCT00463047|9656786|FG001|STARTED|Titration Period 1||160
8618496|NCT00463047|9656785|FG000|COMPLETED|Titration Period 1||123
8618497|NCT00463047|9656786|FG001|COMPLETED|Titration Period 1||121
8618498|NCT00463047|9656785|FG000|NOT COMPLETED|Titration Period 1||37
8618499|NCT00463047|9656786|FG001|NOT COMPLETED|Titration Period 1||39
8618500|NCT00463047|9656785|FG000|STARTED|Titration Period 2||123
8618501|NCT00463047|9656786|FG001|STARTED|Titration Period 2||121
8618502|NCT00463047|9656785|FG000|COMPLETED|Titration Period 2||93
8618503|NCT00463047|9656786|FG001|COMPLETED|Titration Period 2||98
8618504|NCT00463047|9656785|FG000|NOT COMPLETED|Titration Period 2||30
8618505|NCT00463047|9656786|FG001|NOT COMPLETED|Titration Period 2||23
8618506|NCT00463047|9656785|FG000|STARTED|Double-Blind Treatment Period 1|After completion of titration period subjects were re-randomized to these two treatment arms|96
8618507|NCT00463047|9656786|FG001|STARTED|Double-Blind Treatment Period 1|After completion of titration period subjects were re-randomized to these two treatment arms|94
8618508|NCT00463047|9656785|FG000|COMPLETED|Double-Blind Treatment Period 1||93
8618509|NCT00463047|9656786|FG001|COMPLETED|Double-Blind Treatment Period 1||90
8558014|NCT02552212|9589982|FG002|NOT COMPLETED|Double-Blind Period (Week 0 - 52)||0
8558015|NCT02552212|9589980|FG000|STARTED|SFE Period (Week 52 - 156)||0
8558016|NCT02552212|9589981|FG001|STARTED|SFE Period (Week 52 - 156)||0
8558017|NCT02552212|9589982|FG002|STARTED|SFE Period (Week 52 - 156)|123 subjects from Placebo arm and 120 subjects from CZP 200 mg Q2W arm|243
8558018|NCT02552212|9589980|FG000|COMPLETED|SFE Period (Week 52 - 156)||0
8558019|NCT02552212|9589981|FG001|COMPLETED|SFE Period (Week 52 - 156)||0
8558020|NCT02552212|9589982|FG002|COMPLETED|SFE Period (Week 52 - 156)||206
8558021|NCT02552212|9589980|FG000|NOT COMPLETED|SFE Period (Week 52 - 156)||0
8558022|NCT02552212|9589981|FG001|NOT COMPLETED|SFE Period (Week 52 - 156)||0
8558023|NCT02552212|9589982|FG002|NOT COMPLETED|SFE Period (Week 52 - 156)||37
8568873|NCT00094458|9601101|FG004|COMPLETED|Study Extension: Week 30 Through Week 50||0
8568874|NCT00094458|9601102|FG005|COMPLETED|Study Extension: Week 30 Through Week 50||0
8568875|NCT00094458|9601097|FG000|NOT COMPLETED|Study Extension: Week 30 Through Week 50||8
8568876|NCT00094458|9601098|FG001|NOT COMPLETED|Study Extension: Week 30 Through Week 50||12
8568877|NCT00094458|9601099|FG002|NOT COMPLETED|Study Extension: Week 30 Through Week 50||18
8568878|NCT00094458|9601100|FG003|NOT COMPLETED|Study Extension: Week 30 Through Week 50||0
8568879|NCT00094458|9601101|FG004|NOT COMPLETED|Study Extension: Week 30 Through Week 50||0
8568880|NCT00094458|9601102|FG005|NOT COMPLETED|Study Extension: Week 30 Through Week 50||0
8568881|NCT00094458|9601097|FG000|STARTED|OLE: Open-Label Extension||0
8568882|NCT00094458|9601098|FG001|STARTED|OLE: Open-Label Extension||0
8568883|NCT00094458|9601099|FG002|STARTED|OLE: Open-Label Extension||0
8568884|NCT00094458|9601100|FG003|STARTED|OLE: Open-Label Extension||8
8568885|NCT00094458|9601101|FG004|STARTED|OLE: Open-Label Extension||18
8568886|NCT00094458|9601102|FG005|STARTED|OLE: Open-Label Extension||17
8568887|NCT00094458|9601097|FG000|COMPLETED|OLE: Open-Label Extension||0
8568888|NCT00094458|9601098|FG001|COMPLETED|OLE: Open-Label Extension||0
8568889|NCT00094458|9601099|FG002|COMPLETED|OLE: Open-Label Extension||0
8568890|NCT00094458|9601100|FG003|COMPLETED|OLE: Open-Label Extension||7
8568891|NCT00094458|9601101|FG004|COMPLETED|OLE: Open-Label Extension||13
8568892|NCT00094458|9601102|FG005|COMPLETED|OLE: Open-Label Extension||13
8618510|NCT00463047|9656785|FG000|NOT COMPLETED|Double-Blind Treatment Period 1||3
8618511|NCT00463047|9656786|FG001|NOT COMPLETED|Double-Blind Treatment Period 1||4
8618512|NCT00463047|9656785|FG000|STARTED|Double-Blind Treatment Period 2||93
8618513|NCT00463047|9656786|FG001|STARTED|Double-Blind Treatment Period 2||90
8618514|NCT00463047|9656785|FG000|COMPLETED|Double-Blind Treatment Period 2||92
8618515|NCT00463047|9656786|FG001|COMPLETED|Double-Blind Treatment Period 2||88
8618516|NCT00463047|9656785|FG000|NOT COMPLETED|Double-Blind Treatment Period 2||1
8618517|NCT00463047|9656786|FG001|NOT COMPLETED|Double-Blind Treatment Period 2||2
8618518|NCT00463060|9656795|FG000|STARTED|Phase 1-Radiation 40 Gy + Sunitinib 25mg||3
8618519|NCT00463060|9656795|FG000|COMPLETED|Phase 1-Radiation 40 Gy + Sunitinib 25mg||3
8618520|NCT00463060|9656795|FG000|NOT COMPLETED|Phase 1-Radiation 40 Gy + Sunitinib 25mg||0
8618521|NCT00463060|9656795|FG000|STARTED|Phase 1-Radiation 40 Gy+Sunitinib 37.5mg||3
8618522|NCT00463060|9656795|FG000|COMPLETED|Phase 1-Radiation 40 Gy+Sunitinib 37.5mg||3
8618523|NCT00463060|9656795|FG000|NOT COMPLETED|Phase 1-Radiation 40 Gy+Sunitinib 37.5mg||0
8618524|NCT00463060|9656795|FG000|STARTED|Phase 1-Radiation 50 Gy+Sunitinib 37.5mg||10
8618525|NCT00463060|9656795|FG000|COMPLETED|Phase 1-Radiation 50 Gy+Sunitinib 37.5mg||10
8720786|NCT01009333|9767917|FG001|STARTED|Week 1||3
8720787|NCT01009333|9767918|FG002|STARTED|Week 1||2
8720788|NCT01009333|9767919|FG003|STARTED|Week 1||2
8720789|NCT01009333|9767920|FG004|STARTED|Week 1||2
8720790|NCT01009333|9767921|FG005|STARTED|Week 1||2
8720791|NCT01009333|9767916|FG000|COMPLETED|Week 1||2
8720792|NCT01009333|9767917|FG001|COMPLETED|Week 1|1 participant did not progress to the second period due to a protocol violation.|3
8720793|NCT01009333|9767918|FG002|COMPLETED|Week 1||2
8720794|NCT01009333|9767919|FG003|COMPLETED|Week 1||2
8618526|NCT00463060|9656795|FG000|NOT COMPLETED|Phase 1-Radiation 50 Gy+Sunitinib 37.5mg||0
8618527|NCT00463060|9656795|FG000|STARTED|Phase 1-Radiation 50Gy +Sunitinib 50mg||5
8618528|NCT00463060|9656795|FG000|COMPLETED|Phase 1-Radiation 50Gy +Sunitinib 50mg||0
8618529|NCT00463060|9656795|FG000|NOT COMPLETED|Phase 1-Radiation 50Gy +Sunitinib 50mg||5
8629658|NCT00531050|9669382|FG001|NOT COMPLETED|Part 2: Period 1||0
8720795|NCT01009333|9767920|FG004|COMPLETED|Week 1||2
8720796|NCT01009333|9767921|FG005|COMPLETED|Week 1||2
8618530|NCT00463060|9656795|FG000|STARTED|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Not all patients participated in both Phase 1 and Phase II|26
8618531|NCT00463060|9656795|FG000|COMPLETED|Phase 2-Radiation 50Gy +Sunitinib 37.5mg||25
8720797|NCT01009333|9767916|FG000|NOT COMPLETED|Week 1||0
8618532|NCT00463060|9656795|FG000|NOT COMPLETED|Phase 2-Radiation 50Gy +Sunitinib 37.5mg||1
8618533|NCT00463151|9656808|FG000|STARTED|Overall Study||35
8618534|NCT00463151|9656809|FG001|STARTED|Overall Study||29
8618535|NCT00463151|9656810|FG002|STARTED|Overall Study||29
8618536|NCT00463151|9656811|FG003|STARTED|Overall Study||31
8618537|NCT00463151|9656808|FG000|COMPLETED|Overall Study||33
8618538|NCT00463151|9656809|FG001|COMPLETED|Overall Study||24
8618539|NCT00463151|9656810|FG002|COMPLETED|Overall Study||26
8618540|NCT00463151|9656811|FG003|COMPLETED|Overall Study||24
8618541|NCT00463151|9656808|FG000|NOT COMPLETED|Overall Study||2
8618542|NCT00463151|9656809|FG001|NOT COMPLETED|Overall Study||5
8618543|NCT00463151|9656810|FG002|NOT COMPLETED|Overall Study||3
8618544|NCT00463151|9656811|FG003|NOT COMPLETED|Overall Study||7
8618545|NCT00463229|9656823|FG000|STARTED|Overall Study||52
8618546|NCT00463229|9656824|FG001|STARTED|Overall Study||49
8618547|NCT00463229|9656823|FG000|COMPLETED|Overall Study||43
8618548|NCT00463229|9656824|FG001|COMPLETED|Overall Study||39
8618549|NCT00463229|9656823|FG000|NOT COMPLETED|Overall Study||9
8618550|NCT00463229|9656824|FG001|NOT COMPLETED|Overall Study||10
8618551|NCT00463346|9656833|FG000|STARTED|Overall Study||12
8618552|NCT00463346|9656834|FG001|STARTED|Overall Study||11
8618553|NCT00463346|9656833|FG000|COMPLETED|Overall Study||9
8618554|NCT00463346|9656834|FG001|COMPLETED|Overall Study||8
8618555|NCT00463346|9656833|FG000|NOT COMPLETED|Overall Study||3
8618556|NCT00463346|9656834|FG001|NOT COMPLETED|Overall Study||3
8618557|NCT00463385|9656846|FG000|STARTED|Overall Study||22
8618558|NCT00463385|9656847|FG001|STARTED|Overall Study||22
8618559|NCT00463385|9656848|FG002|STARTED|Overall Study||22
8618560|NCT00463385|9656849|FG003|STARTED|Overall Study||22
8618561|NCT00463385|9656846|FG000|Treated|Overall Study||22
8618562|NCT00463385|9656847|FG001|Treated|Overall Study||22
8618563|NCT00463385|9656848|FG002|Treated|Overall Study||19
8618564|NCT00463385|9656849|FG003|Treated|Overall Study||22
8618565|NCT00463385|9656846|FG000|COMPLETED|Overall Study||0
8618566|NCT00463385|9656847|FG001|COMPLETED|Overall Study||0
8618567|NCT00463385|9656848|FG002|COMPLETED|Overall Study||0
8618568|NCT00463385|9656849|FG003|COMPLETED|Overall Study||0
8618569|NCT00463385|9656846|FG000|NOT COMPLETED|Overall Study||22
8618570|NCT00463385|9656847|FG001|NOT COMPLETED|Overall Study||22
8618571|NCT00463385|9656848|FG002|NOT COMPLETED|Overall Study||22
8618572|NCT00463385|9656849|FG003|NOT COMPLETED|Overall Study||22
8618573|NCT00463437|9656871|FG000|STARTED|Overall Study||359
8618574|NCT00463437|9656872|FG001|STARTED|Overall Study||363
8618575|NCT00463437|9656873|FG002|STARTED|Overall Study||358
8618576|NCT00463437|9656874|FG003|STARTED|Overall Study||357
8618577|NCT00463437|9656871|FG000|COMPLETED|Overall Study||355
8618578|NCT00463437|9656872|FG001|COMPLETED|Overall Study||352
8618579|NCT00463437|9656873|FG002|COMPLETED|Overall Study||352
8618580|NCT00463437|9656874|FG003|COMPLETED|Overall Study||350
8618581|NCT00463437|9656871|FG000|NOT COMPLETED|Overall Study||4
8618582|NCT00463437|9656872|FG001|NOT COMPLETED|Overall Study||11
8618583|NCT00463437|9656873|FG002|NOT COMPLETED|Overall Study||6
8618584|NCT00463437|9656874|FG003|NOT COMPLETED|Overall Study||7
8618585|NCT00463476|9656886|FG000|STARTED|Overall Study||151
8618586|NCT00463476|9656887|FG001|STARTED|Overall Study||154
8618587|NCT00463476|9656886|FG000|COMPLETED|Overall Study||149
8618588|NCT00463476|9656887|FG001|COMPLETED|Overall Study||151
8618589|NCT00463476|9656886|FG000|NOT COMPLETED|Overall Study||2
8618590|NCT00463476|9656887|FG001|NOT COMPLETED|Overall Study||3
8618591|NCT00463567|9656900|FG000|STARTED|Overall Study|Randomized Participants|420
8618592|NCT00463567|9656901|FG001|STARTED|Overall Study||418
8618593|NCT00463567|9656902|FG002|STARTED|Overall Study||420
8618594|NCT00463567|9656903|FG003|STARTED|Overall Study||425
8618595|NCT00463567|9656904|FG004|STARTED|Overall Study||130
8618596|NCT00463567|9656905|FG005|STARTED|Overall Study||123
8618597|NCT00463567|9656906|FG006|STARTED|Overall Study||123
8618598|NCT00463567|9656900|FG000|Safety Population: Received Study Drug|Overall Study||416
8618599|NCT00463567|9656901|FG001|Safety Population: Received Study Drug|Overall Study||416
8618600|NCT00463567|9656902|FG002|Safety Population: Received Study Drug|Overall Study||415
8618601|NCT00463567|9656903|FG003|Safety Population: Received Study Drug|Overall Study||418
8618602|NCT00463567|9656904|FG004|Safety Population: Received Study Drug|Overall Study|'Completed' indicates the number of patients in the interim analysis.|127
8618603|NCT00463567|9656905|FG005|Safety Population: Received Study Drug|Overall Study|'Completed' indicates the number of patients in the interim analysis.|122
8618604|NCT00463567|9656906|FG006|Safety Population: Received Study Drug|Overall Study|'Completed' indicates the number of patients in the interim analysis.|122
8618605|NCT00463567|9656900|FG000|COMPLETED|Overall Study||325
8618606|NCT00463567|9656901|FG001|COMPLETED|Overall Study||341
8618607|NCT00463567|9656902|FG002|COMPLETED|Overall Study||331
8618608|NCT00463567|9656903|FG003|COMPLETED|Overall Study||294
8618609|NCT00463567|9656904|FG004|COMPLETED|Overall Study||107
8618610|NCT00463567|9656905|FG005|COMPLETED|Overall Study||102
8618611|NCT00463567|9656906|FG006|COMPLETED|Overall Study||112
8618612|NCT00463567|9656900|FG000|NOT COMPLETED|Overall Study||95
8618613|NCT00463567|9656901|FG001|NOT COMPLETED|Overall Study||77
8618614|NCT00463567|9656902|FG002|NOT COMPLETED|Overall Study||89
8618615|NCT00463567|9656903|FG003|NOT COMPLETED|Overall Study||131
8618616|NCT00463567|9656904|FG004|NOT COMPLETED|Overall Study||23
8618617|NCT00463567|9656905|FG005|NOT COMPLETED|Overall Study||21
8618618|NCT00463567|9656906|FG006|NOT COMPLETED|Overall Study||11
8618619|NCT00463580|9656930|FG000|STARTED|Overall Study||30
8618620|NCT00463580|9656931|FG001|STARTED|Overall Study||30
8618621|NCT00463580|9656930|FG000|COMPLETED|Overall Study||27
8618622|NCT00463580|9656931|FG001|COMPLETED|Overall Study||28
8618623|NCT00463580|9656930|FG000|NOT COMPLETED|Overall Study||3
8558024|NCT02439749|9590000|FG000|STARTED|Overall Study||182
8558025|NCT02439749|9590001|FG001|STARTED|Overall Study||184
8558026|NCT02439749|9590000|FG000|COMPLETED|Overall Study||153
8558027|NCT02439749|9590001|FG001|COMPLETED|Overall Study||147
8558028|NCT02439749|9590000|FG000|NOT COMPLETED|Overall Study||29
8558029|NCT02439749|9590001|FG001|NOT COMPLETED|Overall Study||37
8558030|NCT02435511|9590009|FG000|STARTED|Overall Study|Defined as enrolled and completed baseline|202
8558031|NCT02435511|9590010|FG001|STARTED|Overall Study|Defined as enrolled and completed baseline|209
8558032|NCT02435511|9590009|FG000|COMPLETED|Overall Study|Defined as completing the 3 month follow-up, not necessarily all time points|158
8558033|NCT02435511|9590010|FG001|COMPLETED|Overall Study|Defined as completing the 3 month follow-up; not necessarily all time points|174
8558034|NCT02435511|9590009|FG000|NOT COMPLETED|Overall Study||44
8558035|NCT02435511|9590010|FG001|NOT COMPLETED|Overall Study||35
8558036|NCT02411448|9590019|FG000|STARTED|Overall Study||14
8558037|NCT02411448|9590020|FG001|STARTED|Overall Study||224
8558038|NCT02411448|9590021|FG002|STARTED|Overall Study||225
8558039|NCT02411448|9590019|FG000|Received at Least One Dose of Study Drug|Overall Study||14
8558040|NCT02411448|9590020|FG001|Received at Least One Dose of Study Drug|Overall Study||221
8558041|NCT02411448|9590021|FG002|Received at Least One Dose of Study Drug|Overall Study||225
8558042|NCT02411448|9590019|FG000|COMPLETED|Overall Study||10
8558043|NCT02411448|9590020|FG001|COMPLETED|Overall Study||141
8558044|NCT02411448|9590021|FG002|COMPLETED|Overall Study||173
8558045|NCT02411448|9590019|FG000|NOT COMPLETED|Overall Study||4
8558046|NCT02411448|9590020|FG001|NOT COMPLETED|Overall Study||83
8558047|NCT02411448|9590021|FG002|NOT COMPLETED|Overall Study||52
8558048|NCT02371369|9590035|FG000|STARTED|Part 1||61
8558049|NCT02371369|9590036|FG001|STARTED|Part 1||59
8558050|NCT02371369|9590035|FG000|COMPLETED|Part 1||52
8558051|NCT02371369|9590036|FG001|COMPLETED|Part 1||48
8558052|NCT02371369|9590035|FG000|NOT COMPLETED|Part 1||9
8558053|NCT02371369|9590036|FG001|NOT COMPLETED|Part 1||11
8558054|NCT02371369|9590035|FG000|STARTED|Part 2|N=48; Only participants who were eligible to receive treatment in Part 2.|48
8558055|NCT02371369|9590036|FG001|STARTED|Part 2|N=30; Only participants who were eligible to receive treatment in Part 2.|30
8558056|NCT02371369|9590035|FG000|COMPLETED|Part 2||0
8558057|NCT02371369|9590036|FG001|COMPLETED|Part 2||0
8558058|NCT02371369|9590035|FG000|NOT COMPLETED|Part 2||48
8558059|NCT02371369|9590036|FG001|NOT COMPLETED|Part 2||30
8558060|NCT02282917|9590058|FG000|STARTED|Overall Study||7
8558061|NCT02282917|9590058|FG000|COMPLETED|Overall Study||5
8558062|NCT02282917|9590058|FG000|NOT COMPLETED|Overall Study||2
8558063|NCT01849783|9590062|FG000|STARTED|Overall Study||41
8558064|NCT01849783|9590062|FG000|COMPLETED|Overall Study||19
8558065|NCT01849783|9590062|FG000|NOT COMPLETED|Overall Study||22
8558066|NCT01741480|9590074|FG000|STARTED|Overall Study||285
8558067|NCT01741480|9590075|FG001|STARTED|Overall Study||286
8558068|NCT01741480|9590074|FG000|COMPLETED|Overall Study||285
8558069|NCT01741480|9590075|FG001|COMPLETED|Overall Study||286
8558070|NCT01741480|9590074|FG000|NOT COMPLETED|Overall Study||0
8558071|NCT01741480|9590075|FG001|NOT COMPLETED|Overall Study||0
8558072|NCT01737021|9590083|FG000|STARTED|Overall Study||22
8558073|NCT01737021|9590084|FG001|STARTED|Overall Study||9
8558074|NCT01737021|9590083|FG000|COMPLETED|Overall Study||17
8558075|NCT01737021|9590084|FG001|COMPLETED|Overall Study||6
8720798|NCT01009333|9767917|FG001|NOT COMPLETED|Week 1||0
8720799|NCT01009333|9767918|FG002|NOT COMPLETED|Week 1||0
8720800|NCT01009333|9767919|FG003|NOT COMPLETED|Week 1||0
8720801|NCT01009333|9767920|FG004|NOT COMPLETED|Week 1||0
8720802|NCT01009333|9767921|FG005|NOT COMPLETED|Week 1||0
8720803|NCT01009333|9767916|FG000|STARTED|Week 2||2
8720804|NCT01009333|9767917|FG001|STARTED|Week 2||2
8720805|NCT01009333|9767918|FG002|STARTED|Week 2||2
8558076|NCT01737021|9590083|FG000|NOT COMPLETED|Overall Study||5
8558077|NCT01737021|9590084|FG001|NOT COMPLETED|Overall Study||3
8558078|NCT01505465|9590092|FG000|STARTED|Overall Study||25
8558079|NCT01505465|9590093|FG001|STARTED|Overall Study||25
8558080|NCT01505465|9590092|FG000|COMPLETED|Overall Study||19
8558081|NCT01505465|9590093|FG001|COMPLETED|Overall Study||18
8558082|NCT01505465|9590092|FG000|NOT COMPLETED|Overall Study||6
8558083|NCT01505465|9590093|FG001|NOT COMPLETED|Overall Study||7
8558084|NCT01333943|9590101|FG000|STARTED|Overall Study||47
8558085|NCT01333943|9590102|FG001|STARTED|Overall Study||47
8558086|NCT01333943|9590101|FG000|COMPLETED|Overall Study||46
8558087|NCT01333943|9590102|FG001|COMPLETED|Overall Study||47
8558088|NCT01333943|9590101|FG000|NOT COMPLETED|Overall Study||1
8558089|NCT01333943|9590102|FG001|NOT COMPLETED|Overall Study||0
8558090|NCT01322646|9590110|FG000|STARTED|Overall Study||86
8558091|NCT01322646|9590111|FG001|STARTED|Overall Study||86
8558092|NCT01322646|9590110|FG000|COMPLETED|Overall Study||83
8558093|NCT01322646|9590111|FG001|COMPLETED|Overall Study||84
8558094|NCT01322646|9590110|FG000|NOT COMPLETED|Overall Study||3
8558095|NCT01322646|9590111|FG001|NOT COMPLETED|Overall Study||2
8558096|NCT01090024|9590117|FG000|STARTED|Period 1||6
8558097|NCT01090024|9590118|FG001|STARTED|Period 1||6
8558098|NCT01090024|9590119|FG002|STARTED|Period 1||6
8720806|NCT01009333|9767919|FG003|STARTED|Week 2||2
8558099|NCT01090024|9590120|FG003|STARTED|Period 1||6
8720807|NCT01009333|9767920|FG004|STARTED|Week 2||2
8720808|NCT01009333|9767921|FG005|STARTED|Week 2||2
8720809|NCT01009333|9767916|FG000|COMPLETED|Week 2||2
8618624|NCT00463580|9656931|FG001|NOT COMPLETED|Overall Study||2
8618625|NCT00463606|9656946|FG000|STARTED|Overall Study||253
8618626|NCT00463606|9656947|FG001|STARTED|Overall Study||254
8618627|NCT00463606|9656948|FG002|STARTED|Overall Study||251
8618628|NCT00463606|9656946|FG000|COMPLETED|Overall Study||212
8618629|NCT00463606|9656947|FG001|COMPLETED|Overall Study||220
8618630|NCT00463606|9656948|FG002|COMPLETED|Overall Study||231
8618631|NCT00463606|9656946|FG000|NOT COMPLETED|Overall Study||41
8618632|NCT00463606|9656947|FG001|NOT COMPLETED|Overall Study||34
8618633|NCT00463606|9656948|FG002|NOT COMPLETED|Overall Study||20
8618634|NCT00463684|9656956|FG000|STARTED|Overall Study||278
8618635|NCT00463684|9656956|FG000|COMPLETED|Overall Study||274
8618636|NCT00463684|9656956|FG000|NOT COMPLETED|Overall Study||4
8618637|NCT00463788|9656962|FG000|STARTED|Overall Study||115
8618638|NCT00463788|9656963|FG001|STARTED|Overall Study||58
8618639|NCT00463788|9656962|FG000|Treated|Overall Study||114
8618640|NCT00463788|9656963|FG001|Treated|Overall Study||57
8618641|NCT00463788|9656962|FG000|COMPLETED|Overall Study||6
8618642|NCT00463788|9656963|FG001|COMPLETED|Overall Study||4
8618643|NCT00463788|9656962|FG000|NOT COMPLETED|Overall Study||109
8618644|NCT00463788|9656963|FG001|NOT COMPLETED|Overall Study||54
8618645|NCT00463801|9656970|FG000|STARTED|Overall Study||52
8618646|NCT00463801|9656970|FG000|COMPLETED|Overall Study||39
8618647|NCT00463801|9656970|FG000|NOT COMPLETED|Overall Study||13
8558100|NCT01090024|9590121|FG004|STARTED|Period 1||6
8558101|NCT01090024|9590122|FG005|STARTED|Period 1||6
8558102|NCT01090024|9590123|FG006|STARTED|Period 1||6
8558103|NCT01090024|9590124|FG007|STARTED|Period 1||6
8558104|NCT01090024|9590125|FG008|STARTED|Period 1||6
8558105|NCT01090024|9590126|FG009|STARTED|Period 1||6
8558106|NCT01090024|9590127|FG010|STARTED|Period 1||6
8558107|NCT01090024|9590128|FG011|STARTED|Period 1||6
8558108|NCT01090024|9590129|FG012|STARTED|Period 1||6
8558109|NCT01090024|9590130|FG013|STARTED|Period 1||6
8558110|NCT01090024|9590131|FG014|STARTED|Period 1||6
8558111|NCT01090024|9590132|FG015|STARTED|Period 1||6
8558112|NCT01090024|9590133|FG016|STARTED|Period 1||6
8618648|NCT00463840|9656974|FG000|STARTED|Overall Study||24
8558113|NCT01090024|9590134|FG017|STARTED|Period 1||6
8558114|NCT01090024|9590117|FG000|COMPLETED|Period 1||6
8558115|NCT01090024|9590118|FG001|COMPLETED|Period 1||5
8558116|NCT01090024|9590119|FG002|COMPLETED|Period 1||6
8558117|NCT01090024|9590120|FG003|COMPLETED|Period 1||5
8558118|NCT01090024|9590121|FG004|COMPLETED|Period 1||6
8558119|NCT01090024|9590122|FG005|COMPLETED|Period 1||6
8618649|NCT00463840|9656974|FG000|COMPLETED|Overall Study||12
8618650|NCT00463840|9656974|FG000|NOT COMPLETED|Overall Study||12
8720810|NCT01009333|9767917|FG001|COMPLETED|Week 2||2
8720811|NCT01009333|9767918|FG002|COMPLETED|Week 2||2
8720812|NCT01009333|9767919|FG003|COMPLETED|Week 2||2
8720813|NCT01009333|9767920|FG004|COMPLETED|Week 2||2
8720814|NCT01009333|9767921|FG005|COMPLETED|Week 2||2
8720815|NCT01009333|9767916|FG000|NOT COMPLETED|Week 2||0
8720816|NCT01009333|9767917|FG001|NOT COMPLETED|Week 2||0
8618651|NCT00463866|9656980|FG000|STARTED|Overall Study|4203 participants randomised. Out of these, 195 had no efficacy data after randomisation.|4008
8618652|NCT00463866|9656981|FG001|STARTED|Overall Study|4221 participants randomised. Out of these, 176 had no efficacy data after randomisation.|4045
8618653|NCT00463866|9656980|FG000|COMPLETED|Overall Study||3699
8618654|NCT00463866|9656981|FG001|COMPLETED|Overall Study||3705
8618655|NCT00463866|9656980|FG000|NOT COMPLETED|Overall Study||309
8618656|NCT00463866|9656981|FG001|NOT COMPLETED|Overall Study||340
8618657|NCT00464087|9656990|FG000|STARTED|Overall Study||49
8618658|NCT00464087|9656991|FG001|STARTED|Overall Study||51
8618659|NCT00464087|9656992|FG002|STARTED|Overall Study||29
8618660|NCT00464087|9656990|FG000|COMPLETED|Overall Study||49
8618661|NCT00464087|9656991|FG001|COMPLETED|Overall Study||51
8618662|NCT00464087|9656992|FG002|COMPLETED|Overall Study||0
8618663|NCT00464087|9656990|FG000|NOT COMPLETED|Overall Study||0
8618664|NCT00464087|9656991|FG001|NOT COMPLETED|Overall Study||0
8618665|NCT00464087|9656992|FG002|NOT COMPLETED|Overall Study||29
8618666|NCT00464204|9657002|FG000|STARTED|Overall Study||100
8558120|NCT01090024|9590123|FG006|COMPLETED|Period 1||6
8558121|NCT01090024|9590124|FG007|COMPLETED|Period 1||6
8558122|NCT01090024|9590125|FG008|COMPLETED|Period 1||6
8558123|NCT01090024|9590126|FG009|COMPLETED|Period 1||5
8558124|NCT01090024|9590127|FG010|COMPLETED|Period 1||6
8558125|NCT01090024|9590128|FG011|COMPLETED|Period 1||5
8558126|NCT01090024|9590129|FG012|COMPLETED|Period 1||6
8558127|NCT01090024|9590130|FG013|COMPLETED|Period 1||6
8558128|NCT01090024|9590131|FG014|COMPLETED|Period 1||5
8558129|NCT01090024|9590132|FG015|COMPLETED|Period 1||6
8558130|NCT01090024|9590133|FG016|COMPLETED|Period 1||6
8558131|NCT01090024|9590134|FG017|COMPLETED|Period 1||5
8558132|NCT01090024|9590117|FG000|NOT COMPLETED|Period 1||0
8558133|NCT01090024|9590118|FG001|NOT COMPLETED|Period 1||1
8558134|NCT01090024|9590119|FG002|NOT COMPLETED|Period 1||0
8558135|NCT01090024|9590120|FG003|NOT COMPLETED|Period 1||1
8558136|NCT01090024|9590121|FG004|NOT COMPLETED|Period 1||0
8558137|NCT01090024|9590122|FG005|NOT COMPLETED|Period 1||0
8558138|NCT01090024|9590123|FG006|NOT COMPLETED|Period 1||0
8558139|NCT01090024|9590124|FG007|NOT COMPLETED|Period 1||0
8558140|NCT01090024|9590125|FG008|NOT COMPLETED|Period 1||0
8558141|NCT01090024|9590126|FG009|NOT COMPLETED|Period 1||1
8558142|NCT01090024|9590127|FG010|NOT COMPLETED|Period 1||0
8558143|NCT01090024|9590128|FG011|NOT COMPLETED|Period 1||1
8558144|NCT01090024|9590129|FG012|NOT COMPLETED|Period 1||0
8558145|NCT01090024|9590130|FG013|NOT COMPLETED|Period 1||0
8558146|NCT01090024|9590131|FG014|NOT COMPLETED|Period 1||1
8558147|NCT01090024|9590132|FG015|NOT COMPLETED|Period 1||0
8558148|NCT01090024|9590133|FG016|NOT COMPLETED|Period 1||0
8558149|NCT01090024|9590134|FG017|NOT COMPLETED|Period 1||1
8558150|NCT01090024|9590117|FG000|STARTED|Period 2||6
8558151|NCT01090024|9590118|FG001|STARTED|Period 2||5
8558152|NCT01090024|9590119|FG002|STARTED|Period 2||6
8558153|NCT01090024|9590120|FG003|STARTED|Period 2||5
8558154|NCT01090024|9590121|FG004|STARTED|Period 2||6
8558155|NCT01090024|9590122|FG005|STARTED|Period 2||6
8558156|NCT01090024|9590123|FG006|STARTED|Period 2||6
8558157|NCT01090024|9590124|FG007|STARTED|Period 2||6
8558158|NCT01090024|9590125|FG008|STARTED|Period 2||6
8558159|NCT01090024|9590126|FG009|STARTED|Period 2||5
8558160|NCT01090024|9590127|FG010|STARTED|Period 2||6
8558161|NCT01090024|9590128|FG011|STARTED|Period 2||5
8558162|NCT01090024|9590129|FG012|STARTED|Period 2||6
8558163|NCT01090024|9590130|FG013|STARTED|Period 2||6
8558164|NCT01090024|9590131|FG014|STARTED|Period 2||5
8558165|NCT01090024|9590132|FG015|STARTED|Period 2||6
8558166|NCT01090024|9590133|FG016|STARTED|Period 2||6
8558167|NCT01090024|9590134|FG017|STARTED|Period 2||5
8558168|NCT01090024|9590117|FG000|COMPLETED|Period 2||5
8558169|NCT01090024|9590118|FG001|COMPLETED|Period 2||5
8558170|NCT01090024|9590119|FG002|COMPLETED|Period 2||6
8558171|NCT01090024|9590120|FG003|COMPLETED|Period 2||4
8558172|NCT01090024|9590121|FG004|COMPLETED|Period 2||6
8558173|NCT01090024|9590122|FG005|COMPLETED|Period 2||6
8558174|NCT01090024|9590123|FG006|COMPLETED|Period 2||6
8558175|NCT01090024|9590124|FG007|COMPLETED|Period 2||6
8558176|NCT01090024|9590125|FG008|COMPLETED|Period 2||6
8558177|NCT01090024|9590126|FG009|COMPLETED|Period 2||5
8558178|NCT01090024|9590127|FG010|COMPLETED|Period 2||6
8558179|NCT01090024|9590128|FG011|COMPLETED|Period 2||5
8558180|NCT01090024|9590129|FG012|COMPLETED|Period 2||6
8558181|NCT01090024|9590130|FG013|COMPLETED|Period 2||6
8558182|NCT01090024|9590131|FG014|COMPLETED|Period 2||5
8558183|NCT01090024|9590132|FG015|COMPLETED|Period 2||6
8558184|NCT01090024|9590133|FG016|COMPLETED|Period 2||6
8558185|NCT01090024|9590134|FG017|COMPLETED|Period 2||5
8558186|NCT01090024|9590117|FG000|NOT COMPLETED|Period 2||1
8558187|NCT01090024|9590118|FG001|NOT COMPLETED|Period 2||0
8558188|NCT01090024|9590119|FG002|NOT COMPLETED|Period 2||0
8558189|NCT01090024|9590120|FG003|NOT COMPLETED|Period 2||1
8558190|NCT01090024|9590121|FG004|NOT COMPLETED|Period 2||0
8558191|NCT01090024|9590122|FG005|NOT COMPLETED|Period 2||0
8558192|NCT01090024|9590123|FG006|NOT COMPLETED|Period 2||0
8558193|NCT01090024|9590124|FG007|NOT COMPLETED|Period 2||0
8558194|NCT01090024|9590125|FG008|NOT COMPLETED|Period 2||0
8558195|NCT01090024|9590126|FG009|NOT COMPLETED|Period 2||0
8558196|NCT01090024|9590127|FG010|NOT COMPLETED|Period 2||0
8558197|NCT01090024|9590128|FG011|NOT COMPLETED|Period 2||0
8558198|NCT01090024|9590129|FG012|NOT COMPLETED|Period 2||0
8558199|NCT01090024|9590130|FG013|NOT COMPLETED|Period 2||0
8558200|NCT01090024|9590131|FG014|NOT COMPLETED|Period 2||0
8558201|NCT01090024|9590132|FG015|NOT COMPLETED|Period 2||0
8558202|NCT01090024|9590133|FG016|NOT COMPLETED|Period 2||0
8558203|NCT01090024|9590134|FG017|NOT COMPLETED|Period 2||0
8558204|NCT01090024|9590117|FG000|STARTED|Period 3||5
8558205|NCT01090024|9590118|FG001|STARTED|Period 3||5
8558206|NCT01090024|9590119|FG002|STARTED|Period 3||6
8558207|NCT01090024|9590120|FG003|STARTED|Period 3||4
8558208|NCT01090024|9590121|FG004|STARTED|Period 3||6
8558209|NCT01090024|9590122|FG005|STARTED|Period 3||6
8558210|NCT01090024|9590123|FG006|STARTED|Period 3||6
8558211|NCT01090024|9590124|FG007|STARTED|Period 3||6
8558212|NCT01090024|9590125|FG008|STARTED|Period 3||6
8558213|NCT01090024|9590126|FG009|STARTED|Period 3||5
8558214|NCT01090024|9590127|FG010|STARTED|Period 3||6
8558215|NCT01090024|9590128|FG011|STARTED|Period 3||5
8558216|NCT01090024|9590129|FG012|STARTED|Period 3||6
8558217|NCT01090024|9590130|FG013|STARTED|Period 3||6
8558218|NCT01090024|9590131|FG014|STARTED|Period 3||5
8720817|NCT01009333|9767918|FG002|NOT COMPLETED|Week 2||0
8720818|NCT01009333|9767919|FG003|NOT COMPLETED|Week 2||0
8720819|NCT01009333|9767920|FG004|NOT COMPLETED|Week 2||0
8720820|NCT01009333|9767921|FG005|NOT COMPLETED|Week 2||0
8720821|NCT01009333|9767916|FG000|STARTED|Week 3||2
8720822|NCT01009333|9767917|FG001|STARTED|Week 3||2
8720823|NCT01009333|9767918|FG002|STARTED|Week 3||2
8720824|NCT01009333|9767919|FG003|STARTED|Week 3||2
8720825|NCT01009333|9767920|FG004|STARTED|Week 3||2
8720826|NCT01009333|9767921|FG005|STARTED|Week 3||2
8720827|NCT01009333|9767916|FG000|COMPLETED|Week 3||2
8720828|NCT01009333|9767917|FG001|COMPLETED|Week 3||2
8720829|NCT01009333|9767918|FG002|COMPLETED|Week 3||2
8720830|NCT01009333|9767919|FG003|COMPLETED|Week 3||2
8720831|NCT01009333|9767920|FG004|COMPLETED|Week 3||2
8720832|NCT01009333|9767921|FG005|COMPLETED|Week 3||2
8720833|NCT01009333|9767916|FG000|NOT COMPLETED|Week 3||0
8720834|NCT01009333|9767917|FG001|NOT COMPLETED|Week 3||0
8720835|NCT01009333|9767918|FG002|NOT COMPLETED|Week 3||0
8720836|NCT01009333|9767919|FG003|NOT COMPLETED|Week 3||0
8720837|NCT01009333|9767920|FG004|NOT COMPLETED|Week 3||0
8720838|NCT01009333|9767921|FG005|NOT COMPLETED|Week 3||0
8720839|NCT01009346|9767929|FG000|STARTED|Overall Study||9
8720840|NCT01009346|9767929|FG000|COMPLETED|Overall Study||5
8720841|NCT01009346|9767929|FG000|NOT COMPLETED|Overall Study||4
8720842|NCT01009463|9767938|FG000|STARTED|4-week, Open-label Run-In Period||2071
8720843|NCT01009463|9767939|FG001|STARTED|4-week, Open-label Run-In Period||0
8720844|NCT01009463|9767940|FG002|STARTED|4-week, Open-label Run-In Period||0
8720845|NCT01009463|9767941|FG003|STARTED|4-week, Open-label Run-In Period||0
8720846|NCT01009463|9767942|FG004|STARTED|4-week, Open-label Run-In Period||0
8720847|NCT01009463|9767938|FG000|COMPLETED|4-week, Open-label Run-In Period||1622
8720848|NCT01009463|9767939|FG001|COMPLETED|4-week, Open-label Run-In Period||0
8720849|NCT01009463|9767940|FG002|COMPLETED|4-week, Open-label Run-In Period||0
8720850|NCT01009463|9767941|FG003|COMPLETED|4-week, Open-label Run-In Period||0
8720851|NCT01009463|9767942|FG004|COMPLETED|4-week, Open-label Run-In Period||0
8720852|NCT01009463|9767938|FG000|NOT COMPLETED|4-week, Open-label Run-In Period||449
8720853|NCT01009463|9767939|FG001|NOT COMPLETED|4-week, Open-label Run-In Period||0
8618667|NCT00464204|9657003|FG001|STARTED|Overall Study||96
8618668|NCT00464204|9657002|FG000|Completed Treatment|Overall Study||81
8618669|NCT00464204|9657003|FG001|Completed Treatment|Overall Study||83
8618670|NCT00464204|9657002|FG000|Day 30 Follow-up Performed|Overall Study||89
8618671|NCT00464204|9657003|FG001|Day 30 Follow-up Performed|Overall Study||83
8618672|NCT00464204|9657002|FG000|Day 90 Follow-up Performed|Overall Study||69
8618673|NCT00464204|9657003|FG001|Day 90 Follow-up Performed|Overall Study||74
8618674|NCT00464204|9657002|FG000|Withdrawal Due to Discharge From ICU|Overall Study||18
8720854|NCT01009463|9767940|FG002|NOT COMPLETED|4-week, Open-label Run-In Period||0
8720855|NCT01009463|9767941|FG003|NOT COMPLETED|4-week, Open-label Run-In Period||0
8720856|NCT01009463|9767942|FG004|NOT COMPLETED|4-week, Open-label Run-In Period||0
8720857|NCT01009463|9767938|FG000|STARTED|52-week, Double-blind Treatment Period||0
8720858|NCT01009463|9767939|FG001|STARTED|52-week, Double-blind Treatment Period||409
8720859|NCT01009463|9767940|FG002|STARTED|52-week, Double-blind Treatment Period||408
8720860|NCT01009463|9767941|FG003|STARTED|52-week, Double-blind Treatment Period||403
8720861|NCT01009463|9767942|FG004|STARTED|52-week, Double-blind Treatment Period||402
8725202|NCT01029704|9772385|FG007|NOT COMPLETED|Overall Study||6
8618675|NCT00464204|9657003|FG001|Withdrawal Due to Discharge From ICU|Overall Study||11
8618676|NCT00464204|9657002|FG000|COMPLETED|Overall Study|Completed=no withdrawal until day 8.|51
8618677|NCT00464204|9657003|FG001|COMPLETED|Overall Study|Completed=no withdrawal until day 8.|64
8618678|NCT00464204|9657002|FG000|NOT COMPLETED|Overall Study||49
8618679|NCT00464204|9657003|FG001|NOT COMPLETED|Overall Study||32
8618680|NCT00464269|9657015|FG000|STARTED|Overall Study||99
8618681|NCT00464269|9657016|FG001|STARTED|Overall Study||99
8618682|NCT00464269|9657017|FG002|STARTED|Overall Study||100
8618683|NCT00464269|9657018|FG003|STARTED|Overall Study||102
8618684|NCT00464269|9657015|FG000|COMPLETED|Overall Study||93
8618685|NCT00464269|9657016|FG001|COMPLETED|Overall Study||82
8618686|NCT00464269|9657017|FG002|COMPLETED|Overall Study||93
8618687|NCT00464269|9657018|FG003|COMPLETED|Overall Study||93
8618688|NCT00464269|9657015|FG000|NOT COMPLETED|Overall Study||6
8618689|NCT00464269|9657016|FG001|NOT COMPLETED|Overall Study||17
8618690|NCT00464269|9657017|FG002|NOT COMPLETED|Overall Study||7
8618691|NCT00464269|9657018|FG003|NOT COMPLETED|Overall Study||9
8618692|NCT00464308|9657033|FG000|STARTED|Overall Study||464
8720862|NCT01009463|9767938|FG000|Completed the Treatment Period|52-week, Double-blind Treatment Period||0
8720863|NCT01009463|9767939|FG001|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|295
8720864|NCT01009463|9767940|FG002|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|318
8720865|NCT01009463|9767941|FG003|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|314
8720866|NCT01009463|9767942|FG004|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|303
8720867|NCT01009463|9767938|FG000|COMPLETED|52-week, Double-blind Treatment Period||0
8558219|NCT01090024|9590132|FG015|STARTED|Period 3||6
8558220|NCT01090024|9590133|FG016|STARTED|Period 3||6
8558221|NCT01090024|9590134|FG017|STARTED|Period 3||5
8558222|NCT01090024|9590117|FG000|Treated|Period 3||5
8558223|NCT01090024|9590118|FG001|Treated|Period 3||5
8558224|NCT01090024|9590119|FG002|Treated|Period 3||6
8558225|NCT01090024|9590120|FG003|Treated|Period 3||4
8558226|NCT01090024|9590121|FG004|Treated|Period 3||6
8558227|NCT01090024|9590122|FG005|Treated|Period 3||6
8558228|NCT01090024|9590123|FG006|Treated|Period 3||6
8558229|NCT01090024|9590124|FG007|Treated|Period 3||6
8558230|NCT01090024|9590125|FG008|Treated|Period 3||6
8558231|NCT01090024|9590126|FG009|Treated|Period 3||5
8558232|NCT01090024|9590127|FG010|Treated|Period 3||6
8558233|NCT01090024|9590128|FG011|Treated|Period 3||5
8558234|NCT01090024|9590129|FG012|Treated|Period 3||6
8558235|NCT01090024|9590130|FG013|Treated|Period 3||6
8558236|NCT01090024|9590131|FG014|Treated|Period 3||5
8558237|NCT01090024|9590132|FG015|Treated|Period 3||5
8558238|NCT01090024|9590133|FG016|Treated|Period 3||6
8558239|NCT01090024|9590134|FG017|Treated|Period 3||5
8558240|NCT01090024|9590117|FG000|COMPLETED|Period 3||5
8558241|NCT01090024|9590118|FG001|COMPLETED|Period 3||5
8558242|NCT01090024|9590119|FG002|COMPLETED|Period 3||6
8558243|NCT01090024|9590120|FG003|COMPLETED|Period 3||4
8558244|NCT01090024|9590121|FG004|COMPLETED|Period 3||6
8558245|NCT01090024|9590122|FG005|COMPLETED|Period 3||5
8558246|NCT01090024|9590123|FG006|COMPLETED|Period 3||6
8558247|NCT01090024|9590124|FG007|COMPLETED|Period 3||6
8558248|NCT01090024|9590125|FG008|COMPLETED|Period 3||5
8558249|NCT01090024|9590126|FG009|COMPLETED|Period 3||5
8558250|NCT01090024|9590127|FG010|COMPLETED|Period 3||6
8558251|NCT01090024|9590128|FG011|COMPLETED|Period 3||5
8558252|NCT01090024|9590129|FG012|COMPLETED|Period 3||6
8558253|NCT01090024|9590130|FG013|COMPLETED|Period 3||6
8558254|NCT01090024|9590131|FG014|COMPLETED|Period 3||5
8558255|NCT01090024|9590132|FG015|COMPLETED|Period 3||5
8558256|NCT01090024|9590133|FG016|COMPLETED|Period 3||6
8558257|NCT01090024|9590134|FG017|COMPLETED|Period 3||5
8558258|NCT01090024|9590117|FG000|NOT COMPLETED|Period 3||0
8558259|NCT01090024|9590118|FG001|NOT COMPLETED|Period 3||0
8558260|NCT01090024|9590119|FG002|NOT COMPLETED|Period 3||0
8558261|NCT01090024|9590120|FG003|NOT COMPLETED|Period 3||0
8558262|NCT01090024|9590121|FG004|NOT COMPLETED|Period 3||0
8558263|NCT01090024|9590122|FG005|NOT COMPLETED|Period 3||1
8558264|NCT01090024|9590123|FG006|NOT COMPLETED|Period 3||0
8558265|NCT01090024|9590124|FG007|NOT COMPLETED|Period 3||0
8558266|NCT01090024|9590125|FG008|NOT COMPLETED|Period 3||1
8558267|NCT01090024|9590126|FG009|NOT COMPLETED|Period 3||0
8558268|NCT01090024|9590127|FG010|NOT COMPLETED|Period 3||0
8558269|NCT01090024|9590128|FG011|NOT COMPLETED|Period 3||0
8558270|NCT01090024|9590129|FG012|NOT COMPLETED|Period 3||0
8558271|NCT01090024|9590130|FG013|NOT COMPLETED|Period 3||0
8558272|NCT01090024|9590131|FG014|NOT COMPLETED|Period 3||0
8558273|NCT01090024|9590132|FG015|NOT COMPLETED|Period 3||1
8558274|NCT01090024|9590133|FG016|NOT COMPLETED|Period 3||0
8618693|NCT00464308|9657034|FG001|STARTED|Overall Study||469
8618694|NCT00464308|9657035|FG002|STARTED|Overall Study||459
8618695|NCT00464308|9657033|FG000|COMPLETED|Overall Study||395
8618696|NCT00464308|9657034|FG001|COMPLETED|Overall Study||406
8618697|NCT00464308|9657035|FG002|COMPLETED|Overall Study||400
8618698|NCT00464308|9657033|FG000|NOT COMPLETED|Overall Study||69
8618699|NCT00464308|9657034|FG001|NOT COMPLETED|Overall Study||63
8618700|NCT00464308|9657035|FG002|NOT COMPLETED|Overall Study||59
8618701|NCT00464334|9657054|FG000|STARTED|Overall Study||5
8618702|NCT00464334|9657055|FG001|STARTED|Overall Study||13
8618703|NCT00464334|9657056|FG002|STARTED|Overall Study||8
8618704|NCT00464334|9657057|FG003|STARTED|Overall Study||8
8618705|NCT00464334|9657058|FG004|STARTED|Overall Study||7
8618706|NCT00464334|9657059|FG005|STARTED|Overall Study||7
8618707|NCT00464334|9657060|FG006|STARTED|Overall Study||9
8618708|NCT00464334|9657061|FG007|STARTED|Overall Study||8
8618709|NCT00464334|9657062|FG008|STARTED|Overall Study||8
8618710|NCT00464334|9657063|FG009|STARTED|Overall Study||5
8618711|NCT00464334|9657064|FG010|STARTED|Overall Study||8
8618712|NCT00464334|9657054|FG000|COMPLETED|Overall Study||4
8618713|NCT00464334|9657055|FG001|COMPLETED|Overall Study||5
8618714|NCT00464334|9657056|FG002|COMPLETED|Overall Study||3
8618715|NCT00464334|9657057|FG003|COMPLETED|Overall Study||4
8618716|NCT00464334|9657058|FG004|COMPLETED|Overall Study||3
8618717|NCT00464334|9657059|FG005|COMPLETED|Overall Study||3
8618718|NCT00464334|9657060|FG006|COMPLETED|Overall Study||6
8943676|NCT02391116|10005527|FG000|NOT COMPLETED|Treatment||14
8943677|NCT02391116|10005527|FG000|STARTED|Safety Follow-up|This period excludes 2 deaths on treatment and 9 participants entering active follow-up|56
8943678|NCT02391116|10005527|FG000|COMPLETED|Safety Follow-up|14 participants were considered completed due to death|43
8943679|NCT02391116|10005527|FG000|NOT COMPLETED|Safety Follow-up||13
8943680|NCT02391116|10005527|FG000|STARTED|Active Follow-up|This period incorporates safety follow-up with radiological|9
8943681|NCT02391116|10005527|FG000|COMPLETED|Active Follow-up|Reasons for completion in this period included death (2) and PD (4)|6
8943682|NCT02391116|10005527|FG000|NOT COMPLETED|Active Follow-up||3
8943683|NCT02391116|10005527|FG000|STARTED|Survival Follow-up|21 participants discontinued from treatment didn't enter due to withdrawal by subject (3) and death|46
8948742|NCT02432274|10011217|FG000|Underwent Run-in Period|Overall Study||1
8720868|NCT01009463|9767939|FG001|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|294
8720869|NCT01009463|9767940|FG002|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|315
8720870|NCT01009463|9767941|FG003|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|312
8558275|NCT01090024|9590134|FG017|NOT COMPLETED|Period 3||0
8558276|NCT00980538|9590144|FG000|STARTED|Overall Study||180
8558277|NCT00980538|9590144|FG000|COMPLETED|Overall Study||0
8558278|NCT00980538|9590144|FG000|NOT COMPLETED|Overall Study||180
8558279|NCT00943722|9590153|FG000|STARTED|Base Study||648
8720871|NCT01009463|9767942|FG004|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|301
8720872|NCT01009463|9767938|FG000|NOT COMPLETED|52-week, Double-blind Treatment Period||0
8720873|NCT01009463|9767939|FG001|NOT COMPLETED|52-week, Double-blind Treatment Period||115
8558280|NCT00943722|9590154|FG001|STARTED|Base Study||643
8558281|NCT00943722|9590155|FG002|STARTED|Base Study||644
8558282|NCT00943722|9590156|FG003|STARTED|Base Study||669
8558283|NCT00943722|9590157|FG004|STARTED|Base Study||470
8558284|NCT00943722|9590158|FG005|STARTED|Base Study||0
8558285|NCT00943722|9590159|FG006|STARTED|Base Study||0
8558286|NCT00943722|9590153|FG000|Vaccination 1|Base Study||646
8558287|NCT00943722|9590154|FG001|Vaccination 1|Base Study||642
8558288|NCT00943722|9590155|FG002|Vaccination 1|Base Study||644
8558289|NCT00943722|9590156|FG003|Vaccination 1|Base Study||666
8558290|NCT00943722|9590157|FG004|Vaccination 1|Base Study||468
8558291|NCT00943722|9590158|FG005|Vaccination 1|Base Study||0
8558292|NCT00943722|9590159|FG006|Vaccination 1|Base Study||0
8558293|NCT00943722|9590153|FG000|Vaccination 2|Base Study||637
8558294|NCT00943722|9590154|FG001|Vaccination 2|Base Study||633
8558295|NCT00943722|9590155|FG002|Vaccination 2|Base Study||638
8558296|NCT00943722|9590156|FG003|Vaccination 2|Base Study||658
8720874|NCT01009463|9767940|FG002|NOT COMPLETED|52-week, Double-blind Treatment Period||93
8720875|NCT01009463|9767941|FG003|NOT COMPLETED|52-week, Double-blind Treatment Period||91
8720876|NCT01009463|9767942|FG004|NOT COMPLETED|52-week, Double-blind Treatment Period||101
8720877|NCT01009515|9767953|FG000|STARTED|Overall Study||19
8720878|NCT01009515|9767953|FG000|COMPLETED|Overall Study||16
8720879|NCT01009515|9767953|FG000|NOT COMPLETED|Overall Study||3
8720880|NCT01009554|9767959|FG000|STARTED|Overall Study||48
8720881|NCT01009554|9767960|FG001|STARTED|Overall Study||48
8720882|NCT01009554|9767959|FG000|COMPLETED|Overall Study||46
8720883|NCT01009554|9767960|FG001|COMPLETED|Overall Study||41
8720884|NCT01009554|9767959|FG000|NOT COMPLETED|Overall Study||2
8720885|NCT01009554|9767960|FG001|NOT COMPLETED|Overall Study||7
8720886|NCT01009580|9767968|FG000|STARTED|Overall Study||224
8720887|NCT01009580|9767969|FG001|STARTED|Overall Study||223
8720888|NCT01009580|9767968|FG000|Exposed|Overall Study||224
8720889|NCT01009580|9767969|FG001|Exposed|Overall Study|One subject was randomised in error and withdrew prior to exposure to drug|222
8720890|NCT01009580|9767968|FG000|COMPLETED|Overall Study||197
8720891|NCT01009580|9767969|FG001|COMPLETED|Overall Study||188
8720892|NCT01009580|9767968|FG000|NOT COMPLETED|Overall Study||27
8720893|NCT01009580|9767969|FG001|NOT COMPLETED|Overall Study||35
8720894|NCT01009619|9767977|FG000|STARTED|Overall Study||40
8720895|NCT01009619|9767978|FG001|STARTED|Overall Study||43
8720896|NCT01009619|9767977|FG000|COMPLETED|Overall Study||40
8720897|NCT01009619|9767978|FG001|COMPLETED|Overall Study||43
8720898|NCT01009619|9767977|FG000|NOT COMPLETED|Overall Study||0
8720899|NCT01009619|9767978|FG001|NOT COMPLETED|Overall Study||0
8720900|NCT01009645|9767988|FG000|STARTED|Overall Study||31
8720901|NCT01009645|9767989|FG001|STARTED|Overall Study||31
8558297|NCT00943722|9590157|FG004|Vaccination 2|Base Study||462
8558298|NCT00943722|9590158|FG005|Vaccination 2|Base Study||0
8558299|NCT00943722|9590159|FG006|Vaccination 2|Base Study||0
8558300|NCT00943722|9590153|FG000|Vaccination 3|Base Study||635
8558301|NCT00943722|9590154|FG001|Vaccination 3|Base Study||627
8558302|NCT00943722|9590155|FG002|Vaccination 3|Base Study||637
8558303|NCT00943722|9590156|FG003|Vaccination 3|Base Study||653
8558304|NCT00943722|9590157|FG004|Vaccination 3|Base Study||455
8558305|NCT00943722|9590158|FG005|Vaccination 3|Base Study||0
8558306|NCT00943722|9590159|FG006|Vaccination 3|Base Study||0
8558307|NCT00943722|9590153|FG000|At Least One Dose With Protocol-specified Safety Follow-up|Base Study||643
8558308|NCT00943722|9590154|FG001|At Least One Dose With Protocol-specified Safety Follow-up|Base Study||639
8558309|NCT00943722|9590155|FG002|At Least One Dose With Protocol-specified Safety Follow-up|Base Study||641
8558310|NCT00943722|9590156|FG003|At Least One Dose With Protocol-specified Safety Follow-up|Base Study||662
8558311|NCT00943722|9590157|FG004|At Least One Dose With Protocol-specified Safety Follow-up|Base Study||466
8558312|NCT00943722|9590158|FG005|At Least One Dose With Protocol-specified Safety Follow-up|Base Study||0
8618719|NCT00464334|9657061|FG007|COMPLETED|Overall Study||7
8618720|NCT00464334|9657062|FG008|COMPLETED|Overall Study||2
8618721|NCT00464334|9657063|FG009|COMPLETED|Overall Study||4
8618722|NCT00464334|9657064|FG010|COMPLETED|Overall Study||4
8618723|NCT00464334|9657054|FG000|NOT COMPLETED|Overall Study||1
8720902|NCT01009645|9767990|FG002|STARTED|Overall Study||32
8720903|NCT01009645|9767991|FG003|STARTED|Overall Study||31
8720904|NCT01009645|9767988|FG000|COMPLETED|Overall Study||29
8720905|NCT01009645|9767989|FG001|COMPLETED|Overall Study||23
8618724|NCT00464334|9657055|FG001|NOT COMPLETED|Overall Study||8
8618725|NCT00464334|9657056|FG002|NOT COMPLETED|Overall Study||5
8618726|NCT00464334|9657057|FG003|NOT COMPLETED|Overall Study||4
8618727|NCT00464334|9657058|FG004|NOT COMPLETED|Overall Study||4
8618728|NCT00464334|9657059|FG005|NOT COMPLETED|Overall Study||4
8618729|NCT00464334|9657060|FG006|NOT COMPLETED|Overall Study||3
8618730|NCT00464334|9657061|FG007|NOT COMPLETED|Overall Study||1
8618731|NCT00464334|9657062|FG008|NOT COMPLETED|Overall Study||6
8618732|NCT00464334|9657063|FG009|NOT COMPLETED|Overall Study||1
8618733|NCT00464334|9657064|FG010|NOT COMPLETED|Overall Study||4
9065758|NCT04143945|10126241|FG001|NOT COMPLETED|Treatment Period 1 (Day 1)||0
9065759|NCT04143945|10126242|FG002|NOT COMPLETED|Treatment Period 1 (Day 1)||0
9065760|NCT04143945|10126243|FG003|NOT COMPLETED|Treatment Period 1 (Day 1)||0
9065761|NCT04143945|10126240|FG000|STARTED|Treatment Period 2 (Day 1)||26
9065762|NCT04143945|10126241|FG001|STARTED|Treatment Period 2 (Day 1)||26
9065763|NCT04143945|10126242|FG002|STARTED|Treatment Period 2 (Day 1)||26
9065764|NCT04143945|10126243|FG003|STARTED|Treatment Period 2 (Day 1)||26
9065765|NCT04143945|10126240|FG000|COMPLETED|Treatment Period 2 (Day 1)||26
9065766|NCT04143945|10126241|FG001|COMPLETED|Treatment Period 2 (Day 1)||26
9065767|NCT04143945|10126242|FG002|COMPLETED|Treatment Period 2 (Day 1)||26
9065768|NCT04143945|10126243|FG003|COMPLETED|Treatment Period 2 (Day 1)||26
9065769|NCT04143945|10126240|FG000|NOT COMPLETED|Treatment Period 2 (Day 1)||0
8720906|NCT01009645|9767990|FG002|COMPLETED|Overall Study||28
8720907|NCT01009645|9767991|FG003|COMPLETED|Overall Study||26
8720908|NCT01009645|9767988|FG000|NOT COMPLETED|Overall Study||2
8720909|NCT01009645|9767989|FG001|NOT COMPLETED|Overall Study||8
8720910|NCT01009645|9767990|FG002|NOT COMPLETED|Overall Study||4
8720911|NCT01009645|9767991|FG003|NOT COMPLETED|Overall Study||5
8720912|NCT01009762|9768003|FG000|STARTED|Overall Study||1
8720913|NCT01009762|9768004|FG001|STARTED|Overall Study||10
8720914|NCT01009762|9768003|FG000|Primary Outcome|Overall Study|no Serious Adverse Events (SAE), no treatment related side effects DLT grade 3 or more|0
8720915|NCT01009762|9768004|FG001|Primary Outcome|Overall Study|no SAE, no treatment related side effects DLT grade 3 or more|0
8720916|NCT01009762|9768003|FG000|COMPLETED|Overall Study|according to randomization this one participant received placebo|1
8720917|NCT01009762|9768004|FG001|COMPLETED|Overall Study|10 participants received vaccine|10
8720918|NCT01009762|9768003|FG000|NOT COMPLETED|Overall Study||0
8720919|NCT01009762|9768004|FG001|NOT COMPLETED|Overall Study||0
8720920|NCT01009814|9768017|FG000|STARTED|Overall Study||10
8720921|NCT01009814|9768018|FG001|STARTED|Overall Study||10
8720922|NCT01009814|9768019|FG002|STARTED|Overall Study||10
8720923|NCT01009814|9768020|FG003|STARTED|Overall Study||10
8720924|NCT01009814|9768021|FG004|STARTED|Overall Study||10
8720925|NCT01009814|9768017|FG000|COMPLETED|Overall Study||9
8720926|NCT01009814|9768018|FG001|COMPLETED|Overall Study||9
8720927|NCT01009814|9768019|FG002|COMPLETED|Overall Study||10
8720928|NCT01009814|9768020|FG003|COMPLETED|Overall Study||10
8720929|NCT01009814|9768021|FG004|COMPLETED|Overall Study||10
8720930|NCT01009814|9768017|FG000|NOT COMPLETED|Overall Study||1
8720931|NCT01009814|9768018|FG001|NOT COMPLETED|Overall Study||1
8720932|NCT01009814|9768019|FG002|NOT COMPLETED|Overall Study||0
8720933|NCT01009814|9768020|FG003|NOT COMPLETED|Overall Study||0
8720934|NCT01009814|9768021|FG004|NOT COMPLETED|Overall Study||0
8724986|NCT01029340|9772247|FG001|Participants Received Treatment|Part B Treatment Period||0
8724987|NCT01029340|9772248|FG002|Participants Received Treatment|Part B Treatment Period||30
8724988|NCT01029340|9772249|FG003|Participants Received Treatment|Part B Treatment Period||32
8724989|NCT01029340|9772250|FG004|Participants Received Treatment|Part B Treatment Period||0
8724990|NCT01029340|9772251|FG005|Participants Received Treatment|Part B Treatment Period||0
8724991|NCT01029340|9772246|FG000|COMPLETED|Part B Treatment Period||0
8724992|NCT01029340|9772247|FG001|COMPLETED|Part B Treatment Period||0
8724993|NCT01029340|9772248|FG002|COMPLETED|Part B Treatment Period||29
8724994|NCT01029340|9772249|FG003|COMPLETED|Part B Treatment Period||32
8618734|NCT00464438|9657101|FG000|STARTED|Overall Study||85
8720935|NCT01009840|9768037|FG000|STARTED|Overall Study||30
8720936|NCT01009840|9768037|FG000|COMPLETED|Overall Study||16
8720937|NCT01009840|9768037|FG000|NOT COMPLETED|Overall Study||14
8720938|NCT01009918|9768044|FG000|STARTED|Overall Study||158
8720939|NCT01009918|9768045|FG001|STARTED|Overall Study||156
8720940|NCT01009918|9768046|FG002|STARTED|Overall Study||154
8720941|NCT01009918|9768044|FG000|COMPLETED|Overall Study||134
8720942|NCT01009918|9768045|FG001|COMPLETED|Overall Study||132
8720943|NCT01009918|9768046|FG002|COMPLETED|Overall Study||124
8720944|NCT01009918|9768044|FG000|NOT COMPLETED|Overall Study||24
8720945|NCT01009918|9768045|FG001|NOT COMPLETED|Overall Study||24
8720946|NCT01009918|9768046|FG002|NOT COMPLETED|Overall Study||30
8720947|NCT01009983|9768054|FG000|STARTED|Overall Study||14
8720948|NCT01009983|9768054|FG000|COMPLETED|Overall Study||13
8720949|NCT01009983|9768054|FG000|NOT COMPLETED|Overall Study||1
8618735|NCT00464438|9657102|FG001|STARTED|Overall Study||86
8618736|NCT00464438|9657101|FG000|COMPLETED|Overall Study||83
8618737|NCT00464438|9657102|FG001|COMPLETED|Overall Study||80
8618738|NCT00464438|9657101|FG000|NOT COMPLETED|Overall Study||2
8618739|NCT00464438|9657102|FG001|NOT COMPLETED|Overall Study||6
8618740|NCT00464464|9657110|FG000|STARTED|Overall Study||41
8618741|NCT00464464|9657111|FG001|STARTED|Overall Study||39
8618742|NCT00464464|9657110|FG000|COMPLETED|Overall Study||36
8618743|NCT00464464|9657111|FG001|COMPLETED|Overall Study||36
8618744|NCT00464464|9657110|FG000|NOT COMPLETED|Overall Study||5
8618745|NCT00464464|9657111|FG001|NOT COMPLETED|Overall Study||3
8618746|NCT00464490|9657119|FG000|STARTED|Overall Study||21
8618747|NCT00464490|9657120|FG001|STARTED|Overall Study||21
8618748|NCT00464490|9657119|FG000|COMPLETED|Overall Study||10
8618749|NCT00464490|9657120|FG001|COMPLETED|Overall Study||10
8618750|NCT00464490|9657119|FG000|NOT COMPLETED|Overall Study||11
8618751|NCT00464490|9657120|FG001|NOT COMPLETED|Overall Study||11
8618752|NCT00464542|9657126|FG000|STARTED|Pre-treatment||12
8618753|NCT00464542|9657126|FG000|COMPLETED|Pre-treatment||10
8618754|NCT00464542|9657126|FG000|NOT COMPLETED|Pre-treatment||2
8618755|NCT00464542|9657126|FG000|STARTED|Post-treatment||10
8618756|NCT00464542|9657126|FG000|COMPLETED|Post-treatment||10
8618757|NCT00464542|9657126|FG000|NOT COMPLETED|Post-treatment||0
8618758|NCT00464568|9657130|FG000|STARTED|Overall Study||32
8618759|NCT00464568|9657130|FG000|COMPLETED|Overall Study||30
8720950|NCT01010009|9768061|FG000|STARTED|Overall Study||8
8558313|NCT00943722|9590159|FG006|At Least One Dose With Protocol-specified Safety Follow-up|Base Study||0
8558314|NCT00943722|9590153|FG000|COMPLETED|Base Study||623
8558315|NCT00943722|9590154|FG001|COMPLETED|Base Study||621
8558316|NCT00943722|9590155|FG002|COMPLETED|Base Study||631
8558317|NCT00943722|9590156|FG003|COMPLETED|Base Study||647
8558318|NCT00943722|9590157|FG004|COMPLETED|Base Study||444
8558319|NCT00943722|9590158|FG005|COMPLETED|Base Study||0
8558320|NCT00943722|9590159|FG006|COMPLETED|Base Study||0
8558321|NCT00943722|9590153|FG000|NOT COMPLETED|Base Study||25
8558322|NCT00943722|9590154|FG001|NOT COMPLETED|Base Study||22
8558323|NCT00943722|9590155|FG002|NOT COMPLETED|Base Study||13
8558324|NCT00943722|9590156|FG003|NOT COMPLETED|Base Study||22
8558325|NCT00943722|9590157|FG004|NOT COMPLETED|Base Study||26
8558326|NCT00943722|9590158|FG005|NOT COMPLETED|Base Study||0
8558327|NCT00943722|9590159|FG006|NOT COMPLETED|Base Study||0
8558328|NCT00943722|9590153|FG000|STARTED|First Extension Study: EXT 1||0
8558329|NCT00943722|9590154|FG001|STARTED|First Extension Study: EXT 1||0
8558330|NCT00943722|9590155|FG002|STARTED|First Extension Study: EXT 1||0
8558331|NCT00943722|9590156|FG003|STARTED|First Extension Study: EXT 1||0
8558332|NCT00943722|9590157|FG004|STARTED|First Extension Study: EXT 1||0
8720951|NCT01010009|9768062|FG001|STARTED|Overall Study||8
8720952|NCT01010009|9768063|FG002|STARTED|Overall Study||8
8720953|NCT01010009|9768061|FG000|COMPLETED|Overall Study||8
8720954|NCT01010009|9768062|FG001|COMPLETED|Overall Study||8
8720955|NCT01010009|9768063|FG002|COMPLETED|Overall Study||8
8720956|NCT01010009|9768061|FG000|NOT COMPLETED|Overall Study||0
8720957|NCT01010009|9768062|FG001|NOT COMPLETED|Overall Study||0
8720958|NCT01010009|9768063|FG002|NOT COMPLETED|Overall Study||0
8720959|NCT01010061|9768073|FG000|STARTED|Overall Study||238
8720960|NCT01010061|9768074|FG001|STARTED|Overall Study||118
8720961|NCT01010061|9768073|FG000|Received Study Drug|Overall Study||236
8720962|NCT01010061|9768074|FG001|Received Study Drug|Overall Study||116
8720963|NCT01010061|9768073|FG000|COMPLETED|Overall Study|Completed=Completed treatment.|190
8720964|NCT01010061|9768074|FG001|COMPLETED|Overall Study||78
8813787|NCT01528033|9866987|FG000|COMPLETED|Follow Up||210
8813788|NCT01528033|9866988|FG001|COMPLETED|Follow Up||207
8813789|NCT01528033|9866987|FG000|NOT COMPLETED|Follow Up||46
8813790|NCT01528033|9866988|FG001|NOT COMPLETED|Follow Up||44
8813791|NCT01528072|9866994|FG000|STARTED|Overall Study||140
8813792|NCT01528072|9866994|FG000|COMPLETED|Overall Study||66
8813793|NCT01528072|9866994|FG000|NOT COMPLETED|Overall Study||74
8813794|NCT01528124|9867005|FG000|STARTED|Overall Study||6
8813795|NCT01528124|9867006|FG001|STARTED|Overall Study||6
8813796|NCT01528124|9867007|FG002|STARTED|Overall Study||6
8813797|NCT01528124|9867008|FG003|STARTED|Overall Study||6
8813798|NCT01528124|9867009|FG004|STARTED|Overall Study||5
8813799|NCT01528124|9867010|FG005|STARTED|Overall Study||6
8813800|NCT01528124|9867011|FG006|STARTED|Overall Study||6
8813801|NCT01528124|9867005|FG000|Received Study Drug|Overall Study||6
8813802|NCT01528124|9867006|FG001|Received Study Drug|Overall Study||6
8813803|NCT01528124|9867007|FG002|Received Study Drug|Overall Study||6
8813804|NCT01528124|9867008|FG003|Received Study Drug|Overall Study||6
8813805|NCT01528124|9867009|FG004|Received Study Drug|Overall Study||5
8813806|NCT01528124|9867010|FG005|Received Study Drug|Overall Study||6
8813807|NCT01528124|9867011|FG006|Received Study Drug|Overall Study||6
8813808|NCT01528124|9867005|FG000|COMPLETED|Overall Study||6
8813809|NCT01528124|9867006|FG001|COMPLETED|Overall Study||6
8813810|NCT01528124|9867007|FG002|COMPLETED|Overall Study||6
8813811|NCT01528124|9867008|FG003|COMPLETED|Overall Study||6
8813812|NCT01528124|9867009|FG004|COMPLETED|Overall Study||5
8813813|NCT01528124|9867010|FG005|COMPLETED|Overall Study||6
8813814|NCT01528124|9867011|FG006|COMPLETED|Overall Study||6
8813815|NCT01528124|9867005|FG000|NOT COMPLETED|Overall Study||0
8813816|NCT01528124|9867006|FG001|NOT COMPLETED|Overall Study||0
8813817|NCT01528124|9867007|FG002|NOT COMPLETED|Overall Study||0
8813818|NCT01528124|9867008|FG003|NOT COMPLETED|Overall Study||0
8813819|NCT01528124|9867009|FG004|NOT COMPLETED|Overall Study||0
8813820|NCT01528124|9867010|FG005|NOT COMPLETED|Overall Study||0
8813821|NCT01528124|9867011|FG006|NOT COMPLETED|Overall Study||0
8813822|NCT01528150|9867033|FG000|STARTED|Overall Study||466
8813823|NCT01528150|9867033|FG000|COMPLETED|Overall Study||422
8720965|NCT01010061|9768073|FG000|NOT COMPLETED|Overall Study||48
8720966|NCT01010061|9768074|FG001|NOT COMPLETED|Overall Study||40
8720967|NCT01010126|9768088|FG000|STARTED|Overall Study||27
8813824|NCT01528150|9867033|FG000|NOT COMPLETED|Overall Study||44
8813825|NCT01528215|9867039|FG000|STARTED|Enrollment to 1 Year Follow-up||59
8813826|NCT01528215|9867040|FG001|STARTED|Enrollment to 1 Year Follow-up||61
8813827|NCT01528215|9867039|FG000|COMPLETED|Enrollment to 1 Year Follow-up||55
8813828|NCT01528215|9867040|FG001|COMPLETED|Enrollment to 1 Year Follow-up||60
8558333|NCT00943722|9590158|FG005|STARTED|First Extension Study: EXT 1||1604
8558334|NCT00943722|9590159|FG006|STARTED|First Extension Study: EXT 1||568
8720968|NCT01010126|9768089|FG001|STARTED|Overall Study||58
8720969|NCT01010126|9768090|FG002|STARTED|Overall Study||28
8720970|NCT01010126|9768091|FG003|STARTED|Overall Study||57
8720971|NCT01010126|9768092|FG004|STARTED|Overall Study||58
8720972|NCT01010126|9768093|FG005|STARTED|Overall Study||24
8720973|NCT01010126|9768088|FG000|COMPLETED|Overall Study||26
8720974|NCT01010126|9768089|FG001|COMPLETED|Overall Study||58
8720975|NCT01010126|9768090|FG002|COMPLETED|Overall Study||27
8720976|NCT01010126|9768091|FG003|COMPLETED|Overall Study||57
8720977|NCT01010126|9768092|FG004|COMPLETED|Overall Study||55
8720978|NCT01010126|9768093|FG005|COMPLETED|Overall Study||24
8720979|NCT01010126|9768088|FG000|NOT COMPLETED|Overall Study||1
8720980|NCT01010126|9768089|FG001|NOT COMPLETED|Overall Study||0
8720981|NCT01010126|9768090|FG002|NOT COMPLETED|Overall Study||1
8720982|NCT01010126|9768091|FG003|NOT COMPLETED|Overall Study||0
8720983|NCT01010126|9768092|FG004|NOT COMPLETED|Overall Study||3
8720984|NCT01010126|9768093|FG005|NOT COMPLETED|Overall Study||0
8720985|NCT01010204|9768109|FG000|STARTED|Overall Study||31
8720986|NCT01010204|9768110|FG001|STARTED|Overall Study||29
8720987|NCT01010204|9768109|FG000|COMPLETED|Overall Study||24
8720988|NCT01010204|9768110|FG001|COMPLETED|Overall Study||20
8720989|NCT01010204|9768109|FG000|NOT COMPLETED|Overall Study||7
8720990|NCT01010204|9768110|FG001|NOT COMPLETED|Overall Study||9
8720991|NCT01010217|9768121|FG000|STARTED|Overall Study||89
8720992|NCT01010217|9768122|FG001|STARTED|Overall Study||56
8720993|NCT01010217|9768123|FG002|STARTED|Overall Study||22
8720994|NCT01010217|9768124|FG003|STARTED|Overall Study||6
8720995|NCT01010217|9768125|FG004|STARTED|Overall Study||3
8720996|NCT01010217|9768121|FG000|COMPLETED|Overall Study||84
8720997|NCT01010217|9768122|FG001|COMPLETED|Overall Study||51
8720998|NCT01010217|9768123|FG002|COMPLETED|Overall Study||21
8720999|NCT01010217|9768124|FG003|COMPLETED|Overall Study||0
8721000|NCT01010217|9768125|FG004|COMPLETED|Overall Study||0
8721001|NCT01010217|9768121|FG000|NOT COMPLETED|Overall Study||5
8721002|NCT01010217|9768122|FG001|NOT COMPLETED|Overall Study||5
8721003|NCT01010217|9768123|FG002|NOT COMPLETED|Overall Study||1
8721004|NCT01010217|9768124|FG003|NOT COMPLETED|Overall Study||6
8721005|NCT01010217|9768125|FG004|NOT COMPLETED|Overall Study||3
8721006|NCT01010230|9768139|FG000|STARTED|Overall Study||32
8721007|NCT01010230|9768140|FG001|STARTED|Overall Study||33
8721008|NCT01010230|9768139|FG000|COMPLETED|Overall Study||22
8721009|NCT01010230|9768140|FG001|COMPLETED|Overall Study||26
8721010|NCT01010230|9768139|FG000|NOT COMPLETED|Overall Study||10
8721011|NCT01010230|9768140|FG001|NOT COMPLETED|Overall Study||7
8721012|NCT01010282|9768149|FG000|STARTED|Overall Study||97
8721013|NCT01010282|9768150|FG001|STARTED|Overall Study||95
8721014|NCT01010282|9768151|FG002|STARTED|Overall Study||96
8721015|NCT01010282|9768149|FG000|COMPLETED|Overall Study||91
8721016|NCT01010282|9768150|FG001|COMPLETED|Overall Study||88
8721017|NCT01010282|9768151|FG002|COMPLETED|Overall Study||77
8721018|NCT01010282|9768149|FG000|NOT COMPLETED|Overall Study||6
8721019|NCT01010282|9768150|FG001|NOT COMPLETED|Overall Study||7
8721020|NCT01010282|9768151|FG002|NOT COMPLETED|Overall Study||19
8721021|NCT01010399|9768159|FG000|STARTED|Overall Study||36
8721022|NCT01010399|9768159|FG000|COMPLETED|Overall Study||31
8618760|NCT00464568|9657130|FG000|NOT COMPLETED|Overall Study||2
8618761|NCT00464620|9657147|FG000|STARTED|Overall Study||50
8618762|NCT00464620|9657148|FG001|STARTED|Overall Study||200
8618763|NCT00464620|9657149|FG002|STARTED|Overall Study||116
8618764|NCT00464620|9657147|FG000|COMPLETED|Overall Study|48 patients were evaluable.|48
8618765|NCT00464620|9657148|FG001|COMPLETED|Overall Study||198
8618766|NCT00464620|9657149|FG002|COMPLETED|Overall Study||109
8721023|NCT01010399|9768159|FG000|NOT COMPLETED|Overall Study||5
8721024|NCT01010477|9768165|FG000|STARTED|Overall Study||27
8618767|NCT00464620|9657147|FG000|NOT COMPLETED|Overall Study||2
8618768|NCT00464620|9657148|FG001|NOT COMPLETED|Overall Study||2
8618769|NCT00464620|9657149|FG002|NOT COMPLETED|Overall Study||7
8618770|NCT00464646|9657164|FG000|STARTED|Overall Study||76
8721025|NCT01010477|9768166|FG001|STARTED|Overall Study||25
8721026|NCT01010477|9768165|FG000|COMPLETED|Overall Study||21
8721027|NCT01010477|9768166|FG001|COMPLETED|Overall Study||22
8721028|NCT01010477|9768165|FG000|NOT COMPLETED|Overall Study||6
8721029|NCT01010477|9768166|FG001|NOT COMPLETED|Overall Study||3
8721030|NCT01010503|9768172|FG000|STARTED|Overall Study||32
8721031|NCT01010503|9768172|FG000|COMPLETED|Overall Study||30
8721032|NCT01010503|9768172|FG000|NOT COMPLETED|Overall Study||2
8721033|NCT01010555|9768176|FG000|STARTED|First Four Weeks of Wear||11
8721034|NCT01010555|9768177|FG001|STARTED|First Four Weeks of Wear||10
8721035|NCT01010555|9768176|FG000|COMPLETED|First Four Weeks of Wear|One participant who completed Period 1 did not start Period 2. Relocation.|11
8721036|NCT01010555|9768177|FG001|COMPLETED|First Four Weeks of Wear|One participant who completed Period 1 did not start Period 2. Non-compliance with visit schedule.|10
8721037|NCT01010555|9768176|FG000|NOT COMPLETED|First Four Weeks of Wear||0
8721038|NCT01010555|9768177|FG001|NOT COMPLETED|First Four Weeks of Wear||0
8721039|NCT01010555|9768176|FG000|STARTED|Second Four Weeks of Wear||10
8721040|NCT01010555|9768177|FG001|STARTED|Second Four Weeks of Wear||9
8721041|NCT01010555|9768176|FG000|COMPLETED|Second Four Weeks of Wear||10
8721042|NCT01010555|9768177|FG001|COMPLETED|Second Four Weeks of Wear||9
8721043|NCT01010555|9768176|FG000|NOT COMPLETED|Second Four Weeks of Wear||0
8721044|NCT01010555|9768177|FG001|NOT COMPLETED|Second Four Weeks of Wear||0
8721045|NCT01010568|9768187|FG000|STARTED|Overall Study||10
8721046|NCT01010568|9768187|FG000|COMPLETED|Overall Study||5
8721047|NCT01010568|9768187|FG000|NOT COMPLETED|Overall Study||5
8721048|NCT01010633|9768194|FG000|STARTED|Overall Study||203
8721049|NCT01010633|9768195|FG001|STARTED|Overall Study||203
8721050|NCT01010633|9768194|FG000|COMPLETED|Overall Study||199
8721051|NCT01010633|9768195|FG001|COMPLETED|Overall Study||198
8721052|NCT01010633|9768194|FG000|NOT COMPLETED|Overall Study||4
8721053|NCT01010633|9768195|FG001|NOT COMPLETED|Overall Study||5
8721054|NCT01010750|9768207|FG000|STARTED|First Intervention||3
8721055|NCT01010750|9768208|FG001|STARTED|First Intervention||4
8721056|NCT01010750|9768209|FG002|STARTED|First Intervention||3
8721057|NCT01010750|9768210|FG003|STARTED|First Intervention||3
8721058|NCT01010750|9768211|FG004|STARTED|First Intervention||2
8721059|NCT01010750|9768212|FG005|STARTED|First Intervention||3
8721060|NCT01010750|9768207|FG000|COMPLETED|First Intervention||3
8721061|NCT01010750|9768208|FG001|COMPLETED|First Intervention||4
8721062|NCT01010750|9768209|FG002|COMPLETED|First Intervention||3
8721063|NCT01010750|9768210|FG003|COMPLETED|First Intervention||3
8721064|NCT01010750|9768211|FG004|COMPLETED|First Intervention||2
8721065|NCT01010750|9768212|FG005|COMPLETED|First Intervention||3
8721066|NCT01010750|9768207|FG000|NOT COMPLETED|First Intervention||0
8721067|NCT01010750|9768208|FG001|NOT COMPLETED|First Intervention||0
8721068|NCT01010750|9768209|FG002|NOT COMPLETED|First Intervention||0
8618771|NCT00464646|9657165|FG001|STARTED|Overall Study||29
8618772|NCT00464646|9657164|FG000|COMPLETED|Overall Study||76
8618773|NCT00464646|9657165|FG001|COMPLETED|Overall Study||29
8618774|NCT00464646|9657164|FG000|NOT COMPLETED|Overall Study||0
8618775|NCT00464646|9657165|FG001|NOT COMPLETED|Overall Study||0
8618776|NCT00464672|9657174|FG000|STARTED|Overall Study||460
8618777|NCT00464672|9657175|FG001|STARTED|Overall Study||232
8618778|NCT00464672|9657176|FG002|STARTED|Overall Study||400
8618779|NCT00464672|9657177|FG003|STARTED|Overall Study||200
8618780|NCT00464672|9657178|FG004|STARTED|Overall Study||402
8618781|NCT00464672|9657179|FG005|STARTED|Overall Study||199
8618782|NCT00464672|9657174|FG000|COMPLETED|Overall Study||435
8618783|NCT00464672|9657175|FG001|COMPLETED|Overall Study||222
8618784|NCT00464672|9657176|FG002|COMPLETED|Overall Study||400
8618785|NCT00464672|9657177|FG003|COMPLETED|Overall Study||199
8618786|NCT00464672|9657178|FG004|COMPLETED|Overall Study||392
8618787|NCT00464672|9657179|FG005|COMPLETED|Overall Study||195
8618788|NCT00464672|9657174|FG000|NOT COMPLETED|Overall Study||25
8618789|NCT00464672|9657175|FG001|NOT COMPLETED|Overall Study||10
8618790|NCT00464672|9657176|FG002|NOT COMPLETED|Overall Study||0
8618791|NCT00464672|9657177|FG003|NOT COMPLETED|Overall Study||1
8618792|NCT00464672|9657178|FG004|NOT COMPLETED|Overall Study||10
8618793|NCT00464672|9657179|FG005|NOT COMPLETED|Overall Study||4
8618794|NCT00464685|9657209|FG000|STARTED|Overall Study||126
8618795|NCT00464685|9657210|FG001|STARTED|Overall Study||127
8721069|NCT01010750|9768210|FG003|NOT COMPLETED|First Intervention||0
8721070|NCT01010750|9768211|FG004|NOT COMPLETED|First Intervention||0
8618796|NCT00464685|9657209|FG000|COMPLETED|Overall Study||103
8618797|NCT00464685|9657210|FG001|COMPLETED|Overall Study||94
8618798|NCT00464685|9657209|FG000|NOT COMPLETED|Overall Study||23
8618799|NCT00464685|9657210|FG001|NOT COMPLETED|Overall Study||33
8618800|NCT00464698|9657216|FG000|STARTED|Period 1: 30 mg||20
8618801|NCT00464698|9657216|FG000|COMPLETED|Period 1: 30 mg||17
8618802|NCT00464698|9657216|FG000|NOT COMPLETED|Period 1: 30 mg||3
8618803|NCT00464698|9657216|FG000|STARTED|Period 2: 60 mg||17
8618804|NCT00464698|9657216|FG000|COMPLETED|Period 2: 60 mg||17
8721071|NCT01010750|9768212|FG005|NOT COMPLETED|First Intervention||0
8721072|NCT01010750|9768207|FG000|STARTED|Second Intervention||3
8721073|NCT01010750|9768208|FG001|STARTED|Second Intervention||4
8618805|NCT00464698|9657216|FG000|NOT COMPLETED|Period 2: 60 mg||0
8618806|NCT00464698|9657216|FG000|STARTED|Period 3: 120mg||14
8618807|NCT00464698|9657216|FG000|COMPLETED|Period 3: 120mg||12
8618808|NCT00464698|9657216|FG000|NOT COMPLETED|Period 3: 120mg||2
8618809|NCT00464711|9657222|FG000|STARTED|Overall Study||40
8618810|NCT00464711|9657222|FG000|COMPLETED|Overall Study||25
8618811|NCT00464711|9657222|FG000|NOT COMPLETED|Overall Study||15
8618812|NCT00464737|9657229|FG000|STARTED|Overall Study||82
8618813|NCT00464737|9657230|FG001|STARTED|Overall Study||74
8618814|NCT00464737|9657231|FG002|STARTED|Overall Study||74
8618815|NCT00464737|9657229|FG000|COMPLETED|Overall Study||50
8618816|NCT00464737|9657230|FG001|COMPLETED|Overall Study||42
8618817|NCT00464737|9657231|FG002|COMPLETED|Overall Study||19
8618818|NCT00464737|9657229|FG000|NOT COMPLETED|Overall Study||32
8618819|NCT00464737|9657230|FG001|NOT COMPLETED|Overall Study||32
8618820|NCT00464737|9657231|FG002|NOT COMPLETED|Overall Study||55
8618821|NCT00464815|9657241|FG000|STARTED|Overall Study||768
8618822|NCT00464815|9657242|FG001|STARTED|Overall Study||257
8618823|NCT00464815|9657241|FG000|COMPLETED|Overall Study||762
8618824|NCT00464815|9657242|FG001|COMPLETED|Overall Study||254
8618825|NCT00464815|9657241|FG000|NOT COMPLETED|Overall Study||6
8618826|NCT00464815|9657242|FG001|NOT COMPLETED|Overall Study||3
8618827|NCT00464945|9657250|FG000|STARTED|Infant Series||135
8618828|NCT00464945|9657251|FG001|STARTED|Infant Series||134
8618829|NCT00464945|9657250|FG000|Vaccinated Dose 1|Infant Series||134
8618830|NCT00464945|9657251|FG001|Vaccinated Dose 1|Infant Series||134
8618831|NCT00464945|9657250|FG000|Vaccinated Dose 2|Infant Series||132
8618832|NCT00464945|9657251|FG001|Vaccinated Dose 2|Infant Series||133
8618833|NCT00464945|9657250|FG000|Vaccinated Dose 3|Infant Series||132
8618834|NCT00464945|9657251|FG001|Vaccinated Dose 3|Infant Series||133
8618835|NCT00464945|9657250|FG000|COMPLETED|Infant Series||131
8618836|NCT00464945|9657251|FG001|COMPLETED|Infant Series||133
8618837|NCT00464945|9657250|FG000|NOT COMPLETED|Infant Series||4
8618838|NCT00464945|9657251|FG001|NOT COMPLETED|Infant Series||1
8618839|NCT00464945|9657250|FG000|STARTED|After Infant Series||131
8618840|NCT00464945|9657251|FG001|STARTED|After Infant Series||133
8618841|NCT00464945|9657250|FG000|COMPLETED|After Infant Series||131
8618842|NCT00464945|9657251|FG001|COMPLETED|After Infant Series||131
8618843|NCT00464945|9657250|FG000|NOT COMPLETED|After Infant Series||0
8618844|NCT00464945|9657251|FG001|NOT COMPLETED|After Infant Series||2
8618845|NCT00464945|9657250|FG000|STARTED|Toddler Dose||131
8618846|NCT00464945|9657251|FG001|STARTED|Toddler Dose||131
8618847|NCT00464945|9657250|FG000|COMPLETED|Toddler Dose||131
8618848|NCT00464945|9657251|FG001|COMPLETED|Toddler Dose||130
8618849|NCT00464945|9657250|FG000|NOT COMPLETED|Toddler Dose||0
8618850|NCT00464945|9657251|FG001|NOT COMPLETED|Toddler Dose||1
8618851|NCT00465088|9657275|FG000|STARTED|Overall Study|For both arms, started means treated.|114
8618852|NCT00465088|9657276|FG001|STARTED|Overall Study||79
8721074|NCT01010750|9768209|FG002|STARTED|Second Intervention||3
8618853|NCT00465088|9657275|FG000|COMPLETED|Overall Study||82
8618854|NCT00465088|9657276|FG001|COMPLETED|Overall Study||70
8618855|NCT00465088|9657275|FG000|NOT COMPLETED|Overall Study||32
8618856|NCT00465088|9657276|FG001|NOT COMPLETED|Overall Study||9
8618857|NCT00465101|9657282|FG000|STARTED|Overall Study||150
8618858|NCT00465101|9657282|FG000|COMPLETED|Overall Study||91
8618859|NCT00465101|9657282|FG000|NOT COMPLETED|Overall Study||59
8618860|NCT00465179|9657308|FG000|STARTED|Overall Study||57
8618861|NCT00465179|9657308|FG000|COMPLETED|Overall Study||4
8618862|NCT00465179|9657308|FG000|NOT COMPLETED|Overall Study||53
8618863|NCT00465270|9657314|FG000|STARTED|Overall Study||499
8618864|NCT00465270|9657315|FG001|STARTED|Overall Study||481
8618865|NCT00465270|9657314|FG000|COMPLETED|Overall Study||395
8618866|NCT00465270|9657315|FG001|COMPLETED|Overall Study||321
8618867|NCT00465270|9657314|FG000|NOT COMPLETED|Overall Study||104
8618868|NCT00465270|9657315|FG001|NOT COMPLETED|Overall Study||160
8618869|NCT00465361|9657321|FG000|STARTED|Baseline Assessment||7
8618870|NCT00465361|9657321|FG000|COMPLETED|Baseline Assessment||3
8618871|NCT00465361|9657321|FG000|NOT COMPLETED|Baseline Assessment||4
8618872|NCT00465361|9657321|FG000|STARTED|Post-Intervention Assessment||3
8618873|NCT00465361|9657321|FG000|COMPLETED|Post-Intervention Assessment||3
8618874|NCT00465361|9657321|FG000|NOT COMPLETED|Post-Intervention Assessment||0
8629402|NCT00529789|9669129|FG000|COMPLETED|Study Period IV|Includes 1 patient who withdrew at last visit; didn't enter Taper; however received 30 weeks of drug|42
8629403|NCT00529789|9669129|FG000|NOT COMPLETED|Study Period IV||6
8629404|NCT00529802|9669139|FG000|STARTED|Evaluable for Primary Endpoint|60 patients started trial|60
8629405|NCT00529802|9669139|FG000|COMPLETED|Evaluable for Primary Endpoint|Evaluable for primary endpoint|50
8629406|NCT00529802|9669139|FG000|NOT COMPLETED|Evaluable for Primary Endpoint||10
8721075|NCT01010750|9768210|FG003|STARTED|Second Intervention||3
8721076|NCT01010750|9768211|FG004|STARTED|Second Intervention||2
8629407|NCT00529802|9669139|FG000|STARTED|Evaluable for Secondary Endpoint||50
8629408|NCT00529802|9669139|FG000|COMPLETED|Evaluable for Secondary Endpoint||48
8721077|NCT01010750|9768212|FG005|STARTED|Second Intervention||3
8721078|NCT01010750|9768207|FG000|COMPLETED|Second Intervention||3
8721079|NCT01010750|9768208|FG001|COMPLETED|Second Intervention||3
8721080|NCT01010750|9768209|FG002|COMPLETED|Second Intervention||3
8721081|NCT01010750|9768210|FG003|COMPLETED|Second Intervention||3
8813829|NCT01528215|9867039|FG000|NOT COMPLETED|Enrollment to 1 Year Follow-up||4
8813830|NCT01528215|9867040|FG001|NOT COMPLETED|Enrollment to 1 Year Follow-up||1
8813831|NCT01528215|9867039|FG000|STARTED|1 Year Follow-up to 5 Year Follow-up||55
8813832|NCT01528215|9867040|FG001|STARTED|1 Year Follow-up to 5 Year Follow-up||60
8813833|NCT01528215|9867039|FG000|COMPLETED|1 Year Follow-up to 5 Year Follow-up||40
8813834|NCT01528215|9867040|FG001|COMPLETED|1 Year Follow-up to 5 Year Follow-up||45
8813835|NCT01528215|9867039|FG000|NOT COMPLETED|1 Year Follow-up to 5 Year Follow-up||15
8813836|NCT01528215|9867040|FG001|NOT COMPLETED|1 Year Follow-up to 5 Year Follow-up||15
8813837|NCT01528228|9867048|FG000|STARTED|Overall Study||10
8813838|NCT01528228|9867049|FG001|STARTED|Overall Study||10
8813839|NCT01528228|9867048|FG000|COMPLETED|Overall Study||9
8813840|NCT01528228|9867049|FG001|COMPLETED|Overall Study||9
8558335|NCT00943722|9590153|FG000|COMPLETED|First Extension Study: EXT 1||0
8558336|NCT00943722|9590154|FG001|COMPLETED|First Extension Study: EXT 1||0
8558337|NCT00943722|9590155|FG002|COMPLETED|First Extension Study: EXT 1||0
8558338|NCT00943722|9590156|FG003|COMPLETED|First Extension Study: EXT 1||0
8558339|NCT00943722|9590157|FG004|COMPLETED|First Extension Study: EXT 1||0
8558340|NCT00943722|9590158|FG005|COMPLETED|First Extension Study: EXT 1||1489
8558341|NCT00943722|9590159|FG006|COMPLETED|First Extension Study: EXT 1||527
8558342|NCT00943722|9590153|FG000|NOT COMPLETED|First Extension Study: EXT 1||0
8558343|NCT00943722|9590154|FG001|NOT COMPLETED|First Extension Study: EXT 1||0
8558344|NCT00943722|9590155|FG002|NOT COMPLETED|First Extension Study: EXT 1||0
8558345|NCT00943722|9590156|FG003|NOT COMPLETED|First Extension Study: EXT 1||0
8558346|NCT00943722|9590157|FG004|NOT COMPLETED|First Extension Study: EXT 1||0
8558347|NCT00943722|9590158|FG005|NOT COMPLETED|First Extension Study: EXT 1||115
8558348|NCT00943722|9590159|FG006|NOT COMPLETED|First Extension Study: EXT 1||41
8558349|NCT00943722|9590153|FG000|STARTED|Second Extension Study: EXT 2||0
8813841|NCT01528228|9867048|FG000|NOT COMPLETED|Overall Study||1
8813842|NCT01528228|9867049|FG001|NOT COMPLETED|Overall Study||1
8813843|NCT01528254|9867057|FG000|STARTED|Overall Study||998
8558350|NCT00943722|9590154|FG001|STARTED|Second Extension Study: EXT 2||0
8558351|NCT00943722|9590155|FG002|STARTED|Second Extension Study: EXT 2||0
8558352|NCT00943722|9590156|FG003|STARTED|Second Extension Study: EXT 2||0
8558353|NCT00943722|9590157|FG004|STARTED|Second Extension Study: EXT 2||0
8558354|NCT00943722|9590158|FG005|STARTED|Second Extension Study: EXT 2||971
8558355|NCT00943722|9590159|FG006|STARTED|Second Extension Study: EXT 2||301
8558356|NCT00943722|9590153|FG000|COMPLETED|Second Extension Study: EXT 2||0
8558357|NCT00943722|9590154|FG001|COMPLETED|Second Extension Study: EXT 2||0
8558358|NCT00943722|9590155|FG002|COMPLETED|Second Extension Study: EXT 2||0
8558359|NCT00943722|9590156|FG003|COMPLETED|Second Extension Study: EXT 2||0
8618875|NCT00465530|9657327|FG000|STARTED|Overall Study||21
8618876|NCT00465530|9657328|FG001|STARTED|Overall Study||19
8618877|NCT00465530|9657327|FG000|COMPLETED|Overall Study||19
8618878|NCT00465530|9657328|FG001|COMPLETED|Overall Study||15
8618879|NCT00465530|9657327|FG000|NOT COMPLETED|Overall Study||2
8618880|NCT00465530|9657328|FG001|NOT COMPLETED|Overall Study||4
8721082|NCT01010750|9768211|FG004|COMPLETED|Second Intervention||2
8721083|NCT01010750|9768212|FG005|COMPLETED|Second Intervention||3
8721084|NCT01010750|9768207|FG000|NOT COMPLETED|Second Intervention||0
8721085|NCT01010750|9768208|FG001|NOT COMPLETED|Second Intervention||1
8721086|NCT01010750|9768209|FG002|NOT COMPLETED|Second Intervention||0
8721087|NCT01010750|9768210|FG003|NOT COMPLETED|Second Intervention||0
8721088|NCT01010750|9768211|FG004|NOT COMPLETED|Second Intervention||0
8721089|NCT01010750|9768212|FG005|NOT COMPLETED|Second Intervention||0
8721090|NCT01010750|9768207|FG000|STARTED|Third Intervention||3
8721091|NCT01010750|9768208|FG001|STARTED|Third Intervention||3
8721092|NCT01010750|9768209|FG002|STARTED|Third Intervention||3
8721093|NCT01010750|9768210|FG003|STARTED|Third Intervention||3
8721094|NCT01010750|9768211|FG004|STARTED|Third Intervention||2
8721095|NCT01010750|9768212|FG005|STARTED|Third Intervention||3
8721096|NCT01010750|9768207|FG000|COMPLETED|Third Intervention||3
8721097|NCT01010750|9768208|FG001|COMPLETED|Third Intervention||3
8721098|NCT01010750|9768209|FG002|COMPLETED|Third Intervention||3
8721099|NCT01010750|9768210|FG003|COMPLETED|Third Intervention||3
8721100|NCT01010750|9768211|FG004|COMPLETED|Third Intervention||2
8721101|NCT01010750|9768212|FG005|COMPLETED|Third Intervention||3
8721102|NCT01010750|9768207|FG000|NOT COMPLETED|Third Intervention||0
8721103|NCT01010750|9768208|FG001|NOT COMPLETED|Third Intervention||0
8721104|NCT01010750|9768209|FG002|NOT COMPLETED|Third Intervention||0
8721105|NCT01010750|9768210|FG003|NOT COMPLETED|Third Intervention||0
8721106|NCT01010750|9768211|FG004|NOT COMPLETED|Third Intervention||0
8721107|NCT01010750|9768212|FG005|NOT COMPLETED|Third Intervention||0
8721108|NCT01010763|9768222|FG000|STARTED|Overall Study||96
8721109|NCT01010763|9768223|FG001|STARTED|Overall Study||84
8721110|NCT01010763|9768222|FG000|COMPLETED|Overall Study||61
8721111|NCT01010763|9768223|FG001|COMPLETED|Overall Study||54
8721112|NCT01010763|9768222|FG000|NOT COMPLETED|Overall Study||35
8721113|NCT01010763|9768223|FG001|NOT COMPLETED|Overall Study||30
8721114|NCT01010776|9768229|FG000|STARTED|Main Phase||223
8721115|NCT01010776|9768229|FG000|Treated|Main Phase||218
8721116|NCT01010776|9768229|FG000|COMPLETED|Main Phase||174
8721117|NCT01010776|9768229|FG000|NOT COMPLETED|Main Phase||49
8721118|NCT01010776|9768229|FG000|STARTED|In-Between Main Phase & Extension Phase||174
8721119|NCT01010776|9768229|FG000|COMPLETED|In-Between Main Phase & Extension Phase||159
8721120|NCT01010776|9768229|FG000|NOT COMPLETED|In-Between Main Phase & Extension Phase||15
8721121|NCT01010776|9768229|FG000|STARTED|Extension Phase||159
8721122|NCT01010776|9768229|FG000|COMPLETED|Extension Phase||156
8721123|NCT01010776|9768229|FG000|NOT COMPLETED|Extension Phase||3
8721124|NCT01010854|9768244|FG000|STARTED|Overall Study||6
8721125|NCT01010854|9768244|FG000|COMPLETED|Overall Study||6
8721126|NCT01010854|9768244|FG000|NOT COMPLETED|Overall Study||0
8721127|NCT01010867|9768248|FG000|STARTED|Overall Study||31
8721128|NCT01010867|9768248|FG000|COMPLETED|Overall Study||30
8721129|NCT01010867|9768248|FG000|NOT COMPLETED|Overall Study||1
8721130|NCT01010906|9768258|FG000|STARTED|Overall Study||10
8721131|NCT01010906|9768259|FG001|STARTED|Overall Study||10
8721132|NCT01010906|9768260|FG002|STARTED|Overall Study||10
8721133|NCT01010906|9768261|FG003|STARTED|Overall Study||10
8721134|NCT01010906|9768262|FG004|STARTED|Overall Study||10
8721135|NCT01010906|9768263|FG005|STARTED|Overall Study||10
8721136|NCT01010906|9768258|FG000|COMPLETED|Overall Study||10
8721137|NCT01010906|9768259|FG001|COMPLETED|Overall Study||10
8721138|NCT01010906|9768260|FG002|COMPLETED|Overall Study||10
8721139|NCT01010906|9768261|FG003|COMPLETED|Overall Study||10
8721140|NCT01010906|9768262|FG004|COMPLETED|Overall Study||10
8721141|NCT01010906|9768263|FG005|COMPLETED|Overall Study||10
8721142|NCT01010906|9768258|FG000|NOT COMPLETED|Overall Study||0
8721143|NCT01010906|9768259|FG001|NOT COMPLETED|Overall Study||0
8721144|NCT01010906|9768260|FG002|NOT COMPLETED|Overall Study||0
8721145|NCT01010906|9768261|FG003|NOT COMPLETED|Overall Study||0
8721146|NCT01010906|9768262|FG004|NOT COMPLETED|Overall Study||0
8721147|NCT01010906|9768263|FG005|NOT COMPLETED|Overall Study||0
8721148|NCT01010932|9768277|FG000|STARTED|Overall Study||222
8721149|NCT01010932|9768277|FG000|COMPLETED|Overall Study||200
8721150|NCT01010932|9768277|FG000|NOT COMPLETED|Overall Study||22
8721151|NCT01010971|9768288|FG000|STARTED|Overall Study||225
8721152|NCT01010971|9768289|FG001|STARTED|Overall Study||226
8721153|NCT01010971|9768290|FG002|STARTED|Overall Study||220
8721154|NCT01010971|9768288|FG000|COMPLETED|Overall Study||222
8721155|NCT01010971|9768289|FG001|COMPLETED|Overall Study||218
8721156|NCT01010971|9768290|FG002|COMPLETED|Overall Study||207
8721157|NCT01010971|9768288|FG000|NOT COMPLETED|Overall Study||3
8721158|NCT01010971|9768289|FG001|NOT COMPLETED|Overall Study||8
8721159|NCT01010971|9768290|FG002|NOT COMPLETED|Overall Study||13
8721160|NCT01010984|9768298|FG000|STARTED|Overall Study||20
8721161|NCT01010984|9768298|FG000|COMPLETED|Overall Study||20
8721162|NCT01010984|9768298|FG000|NOT COMPLETED|Overall Study||0
8721163|NCT01011049|9768307|FG000|STARTED|Overall Study||507
8721164|NCT01011049|9768308|FG001|STARTED|Overall Study||252
8721165|NCT01011049|9768309|FG002|STARTED|Overall Study||243
8721166|NCT01011049|9768310|FG003|STARTED|Overall Study||246
8721167|NCT01011049|9768307|FG000|COMPLETED|Overall Study||506
8721168|NCT01011049|9768308|FG001|COMPLETED|Overall Study||250
8721169|NCT01011049|9768309|FG002|COMPLETED|Overall Study||239
8721170|NCT01011049|9768310|FG003|COMPLETED|Overall Study||246
8721171|NCT01011049|9768307|FG000|NOT COMPLETED|Overall Study||1
8721172|NCT01011049|9768308|FG001|NOT COMPLETED|Overall Study||2
8721173|NCT01011049|9768309|FG002|NOT COMPLETED|Overall Study||4
8721174|NCT01011049|9768310|FG003|NOT COMPLETED|Overall Study||0
8721175|NCT01011075|9768320|FG000|STARTED|Overall Study||34
8721176|NCT01011075|9768320|FG000|COMPLETED|Overall Study||34
8721177|NCT01011075|9768320|FG000|NOT COMPLETED|Overall Study||0
8721178|NCT01011153|9768327|FG000|STARTED|Overall Study||54
8721179|NCT01011153|9768328|FG001|STARTED|Overall Study||75
8721180|NCT01011153|9768329|FG002|STARTED|Overall Study||54
8721181|NCT01011153|9768327|FG000|COMPLETED|Overall Study||46
8721182|NCT01011153|9768328|FG001|COMPLETED|Overall Study||64
8721183|NCT01011153|9768329|FG002|COMPLETED|Overall Study||45
8721184|NCT01011153|9768327|FG000|NOT COMPLETED|Overall Study||8
8721185|NCT01011153|9768328|FG001|NOT COMPLETED|Overall Study||11
8721186|NCT01011153|9768329|FG002|NOT COMPLETED|Overall Study||9
8721187|NCT01011179|9768347|FG000|STARTED|Overall Study||24
8721188|NCT01011179|9768348|FG001|STARTED|Overall Study||22
8721189|NCT01011179|9768347|FG000|COMPLETED|Overall Study||20
8721190|NCT01011179|9768348|FG001|COMPLETED|Overall Study||20
8721191|NCT01011179|9768347|FG000|NOT COMPLETED|Overall Study||4
8618881|NCT00465569|9657336|FG000|STARTED|Overall Study||13
8618882|NCT00465569|9657337|FG001|STARTED|Overall Study||7
8721192|NCT01011179|9768348|FG001|NOT COMPLETED|Overall Study||2
8618883|NCT00465569|9657336|FG000|COMPLETED|Overall Study||12
8721193|NCT01011218|9768360|FG000|STARTED|Overall Study||9
8721194|NCT01011218|9768361|FG001|STARTED|Overall Study||9
8721195|NCT01011218|9768362|FG002|STARTED|Overall Study||26
8618884|NCT00465569|9657337|FG001|COMPLETED|Overall Study||7
8618885|NCT00465569|9657336|FG000|NOT COMPLETED|Overall Study||1
8618886|NCT00465569|9657337|FG001|NOT COMPLETED|Overall Study||0
8618887|NCT00465595|9657345|FG000|STARTED|Overall Study||27
8618888|NCT00465595|9657346|FG001|STARTED|Overall Study||29
8618889|NCT00465595|9657345|FG000|COMPLETED|Overall Study||22
8618890|NCT00465595|9657346|FG001|COMPLETED|Overall Study||24
8618891|NCT00465595|9657345|FG000|NOT COMPLETED|Overall Study||5
8618892|NCT00465595|9657346|FG001|NOT COMPLETED|Overall Study||5
8618893|NCT00465647|9657362|FG000|STARTED|Overall Study||39
8618894|NCT00465647|9657363|FG001|STARTED|Overall Study||23
8618895|NCT00465647|9657364|FG002|STARTED|Overall Study||29
8618896|NCT00465647|9657365|FG003|STARTED|Overall Study||25
8618897|NCT00465647|9657362|FG000|COMPLETED|Overall Study||26
8618898|NCT00465647|9657363|FG001|COMPLETED|Overall Study||15
8618899|NCT00465647|9657364|FG002|COMPLETED|Overall Study||18
8618900|NCT00465647|9657365|FG003|COMPLETED|Overall Study||12
8618901|NCT00465647|9657362|FG000|NOT COMPLETED|Overall Study||13
8618902|NCT00465647|9657363|FG001|NOT COMPLETED|Overall Study||8
8618903|NCT00465647|9657364|FG002|NOT COMPLETED|Overall Study||11
8721196|NCT01011218|9768363|FG003|STARTED|Overall Study||26
8721197|NCT01011218|9768360|FG000|COMPLETED|Overall Study||9
8721198|NCT01011218|9768361|FG001|COMPLETED|Overall Study||9
8721199|NCT01011218|9768362|FG002|COMPLETED|Overall Study||26
8721200|NCT01011218|9768363|FG003|COMPLETED|Overall Study||26
8721201|NCT01011218|9768360|FG000|NOT COMPLETED|Overall Study||0
8721202|NCT01011218|9768361|FG001|NOT COMPLETED|Overall Study||0
8721203|NCT01011218|9768362|FG002|NOT COMPLETED|Overall Study||0
8721204|NCT01011218|9768363|FG003|NOT COMPLETED|Overall Study||0
8721205|NCT01011283|9768375|FG000|STARTED|Overall Study||13
8721206|NCT01011283|9768376|FG001|STARTED|Overall Study||13
8721207|NCT01011283|9768375|FG000|COMPLETED|Overall Study||2
8721208|NCT01011283|9768376|FG001|COMPLETED|Overall Study||2
8721209|NCT01011283|9768375|FG000|NOT COMPLETED|Overall Study||11
8721210|NCT01011283|9768376|FG001|NOT COMPLETED|Overall Study||11
8721211|NCT01011309|9768385|FG000|STARTED|Overall Study||14
8721212|NCT01011309|9768386|FG001|STARTED|Overall Study||10
8721213|NCT01011309|9768387|FG002|STARTED|Overall Study||21
8721214|NCT01011309|9768385|FG000|COMPLETED|Overall Study||12
8721215|NCT01011309|9768386|FG001|COMPLETED|Overall Study||7
8721216|NCT01011309|9768387|FG002|COMPLETED|Overall Study||16
8721217|NCT01011309|9768385|FG000|NOT COMPLETED|Overall Study||2
8721218|NCT01011309|9768386|FG001|NOT COMPLETED|Overall Study||3
8721219|NCT01011309|9768387|FG002|NOT COMPLETED|Overall Study||5
8721220|NCT01011335|9768399|FG000|STARTED|Overall Study||11
8721221|NCT01011335|9768400|FG001|STARTED|Overall Study||12
8721222|NCT01011335|9768401|FG002|STARTED|Overall Study||12
8721223|NCT01011335|9768402|FG003|STARTED|Overall Study||12
8721224|NCT01011335|9768403|FG004|STARTED|Overall Study||13
8721225|NCT01011335|9768404|FG005|STARTED|Overall Study||12
8721226|NCT01011335|9768405|FG006|STARTED|Overall Study||12
8721227|NCT01011335|9768406|FG007|STARTED|Overall Study||12
8721228|NCT01011335|9768407|FG008|STARTED|Overall Study||12
8721229|NCT01011335|9768408|FG009|STARTED|Overall Study||12
8721230|NCT01011335|9768409|FG010|STARTED|Overall Study||12
8721231|NCT01011335|9768410|FG011|STARTED|Overall Study||22
8721232|NCT01011335|9768411|FG012|STARTED|Overall Study||22
8721233|NCT01011335|9768399|FG000|COMPLETED|Overall Study||10
8721234|NCT01011335|9768400|FG001|COMPLETED|Overall Study||11
8721235|NCT01011335|9768401|FG002|COMPLETED|Overall Study||11
8721236|NCT01011335|9768402|FG003|COMPLETED|Overall Study||10
8721237|NCT01011335|9768403|FG004|COMPLETED|Overall Study||12
8721238|NCT01011335|9768404|FG005|COMPLETED|Overall Study||11
8721239|NCT01011335|9768405|FG006|COMPLETED|Overall Study||9
8721240|NCT01011335|9768406|FG007|COMPLETED|Overall Study||10
8721241|NCT01011335|9768407|FG008|COMPLETED|Overall Study||10
8721242|NCT01011335|9768408|FG009|COMPLETED|Overall Study||12
8721243|NCT01011335|9768409|FG010|COMPLETED|Overall Study||6
8721244|NCT01011335|9768410|FG011|COMPLETED|Overall Study||21
8721245|NCT01011335|9768411|FG012|COMPLETED|Overall Study||19
8721246|NCT01011335|9768399|FG000|NOT COMPLETED|Overall Study||1
8721247|NCT01011335|9768400|FG001|NOT COMPLETED|Overall Study||1
8721248|NCT01011335|9768401|FG002|NOT COMPLETED|Overall Study||1
8721249|NCT01011335|9768402|FG003|NOT COMPLETED|Overall Study||2
8721250|NCT01011335|9768403|FG004|NOT COMPLETED|Overall Study||1
8721251|NCT01011335|9768404|FG005|NOT COMPLETED|Overall Study||1
8721252|NCT01011335|9768405|FG006|NOT COMPLETED|Overall Study||3
8721253|NCT01011335|9768406|FG007|NOT COMPLETED|Overall Study||2
8721254|NCT01011335|9768407|FG008|NOT COMPLETED|Overall Study||2
8721255|NCT01011335|9768408|FG009|NOT COMPLETED|Overall Study||0
8618904|NCT00465647|9657365|FG003|NOT COMPLETED|Overall Study||13
8618905|NCT00465738|9657387|FG000|STARTED|Overall Study||97
8618906|NCT00465738|9657388|FG001|STARTED|Overall Study||95
8618907|NCT00465738|9657387|FG000|COMPLETED|Overall Study||91
8618908|NCT00465738|9657388|FG001|COMPLETED|Overall Study||89
8618909|NCT00465738|9657387|FG000|NOT COMPLETED|Overall Study||6
8618910|NCT00465738|9657388|FG001|NOT COMPLETED|Overall Study||6
8618911|NCT00465816|9657397|FG000|STARTED|Overall Study||367
8618912|NCT00465816|9657398|FG001|STARTED|Overall Study||122
8618913|NCT00465816|9657399|FG002|STARTED|Overall Study||122
8721256|NCT01011335|9768409|FG010|NOT COMPLETED|Overall Study||6
8721257|NCT01011335|9768410|FG011|NOT COMPLETED|Overall Study||1
8721258|NCT01011335|9768411|FG012|NOT COMPLETED|Overall Study||3
8721259|NCT01011387|9768448|FG000|STARTED|Overall Study||16
8721260|NCT01011387|9768448|FG000|COMPLETED|Overall Study||10
8721261|NCT01011387|9768448|FG000|NOT COMPLETED|Overall Study||6
8721262|NCT01011413|9768454|FG000|STARTED|Overall Study|312 randomised|312
8721263|NCT01011413|9768455|FG001|STARTED|Overall Study|324 randomised|324
8721264|NCT01011413|9768454|FG000|Did Not Start Study Drug|Overall Study||3
8721265|NCT01011413|9768455|FG001|Did Not Start Study Drug|Overall Study||3
8721266|NCT01011413|9768454|FG000|In Modified ITT|Overall Study||309
8721267|NCT01011413|9768455|FG001|In Modified ITT|Overall Study||321
8721268|NCT01011413|9768454|FG000|Died Before Week 48|Overall Study||3
8721269|NCT01011413|9768455|FG001|Died Before Week 48|Overall Study||2
8721270|NCT01011413|9768454|FG000|Lost to Follow up Before w48|Overall Study||3
8721271|NCT01011413|9768455|FG001|Lost to Follow up Before w48|Overall Study||4
8721272|NCT01011413|9768454|FG000|Withdrew Consent Before w48|Overall Study||3
8721273|NCT01011413|9768455|FG001|Withdrew Consent Before w48|Overall Study||3
8721274|NCT01011413|9768454|FG000|Attended w48 Visit|Overall Study||295
8721275|NCT01011413|9768455|FG001|Attended w48 Visit|Overall Study||311
8721276|NCT01011413|9768454|FG000|Died Between Week 48 and 96|Overall Study||2
8721277|NCT01011413|9768455|FG001|Died Between Week 48 and 96|Overall Study||3
8721278|NCT01011413|9768454|FG000|Withdrew Consent Between Week 48 and 96|Overall Study||2
8721279|NCT01011413|9768455|FG001|Withdrew Consent Between Week 48 and 96|Overall Study||6
8721280|NCT01011413|9768454|FG000|Lost to Follow-up Between Week 48 and 96|Overall Study||10
8721281|NCT01011413|9768455|FG001|Lost to Follow-up Between Week 48 and 96|Overall Study||4
8721282|NCT01011413|9768454|FG000|COMPLETED|Overall Study||286
8721283|NCT01011413|9768455|FG001|COMPLETED|Overall Study||299
8721284|NCT01011413|9768454|FG000|NOT COMPLETED|Overall Study||26
8721285|NCT01011413|9768455|FG001|NOT COMPLETED|Overall Study||25
8721286|NCT01011439|9768468|FG000|STARTED|Overall Study||72
8721287|NCT01011439|9768468|FG000|COMPLETED|Overall Study||15
8721288|NCT01011439|9768468|FG000|NOT COMPLETED|Overall Study||57
8721289|NCT01011465|9768481|FG000|STARTED|Overall Study||36
8721290|NCT01011465|9768482|FG001|STARTED|Overall Study||20
8721291|NCT01011465|9768483|FG002|STARTED|Overall Study||36
8721292|NCT01011465|9768484|FG003|STARTED|Overall Study||18
8721293|NCT01011465|9768485|FG004|STARTED|Overall Study||47
8721294|NCT01011465|9768486|FG005|STARTED|Overall Study||29
8721295|NCT01011465|9768487|FG006|STARTED|Overall Study||52
8721296|NCT01011465|9768488|FG007|STARTED|Overall Study||32
8721297|NCT01011465|9768481|FG000|COMPLETED|Overall Study||34
8721298|NCT01011465|9768482|FG001|COMPLETED|Overall Study||19
8721299|NCT01011465|9768483|FG002|COMPLETED|Overall Study||36
8721300|NCT01011465|9768484|FG003|COMPLETED|Overall Study||18
8721301|NCT01011465|9768485|FG004|COMPLETED|Overall Study||46
8721302|NCT01011465|9768486|FG005|COMPLETED|Overall Study||29
8721303|NCT01011465|9768487|FG006|COMPLETED|Overall Study||51
8618914|NCT00465816|9657397|FG000|COMPLETED|Overall Study||367
8721304|NCT01011465|9768488|FG007|COMPLETED|Overall Study||32
8721305|NCT01011465|9768481|FG000|NOT COMPLETED|Overall Study||2
8721306|NCT01011465|9768482|FG001|NOT COMPLETED|Overall Study||1
8721307|NCT01011465|9768483|FG002|NOT COMPLETED|Overall Study||0
8721308|NCT01011465|9768484|FG003|NOT COMPLETED|Overall Study||0
8721309|NCT01011465|9768485|FG004|NOT COMPLETED|Overall Study||1
8721310|NCT01011465|9768486|FG005|NOT COMPLETED|Overall Study||0
8721311|NCT01011465|9768487|FG006|NOT COMPLETED|Overall Study||1
8721312|NCT01011465|9768488|FG007|NOT COMPLETED|Overall Study||0
8721313|NCT01011556|9768508|FG000|STARTED|Overall Study||58
8721314|NCT01011556|9768509|FG001|STARTED|Overall Study||56
8721315|NCT01011556|9768510|FG002|STARTED|Overall Study||55
8721316|NCT01011556|9768511|FG003|STARTED|Overall Study||64
8721317|NCT01011556|9768508|FG000|Received at Least 1 Dose of Study Drug|Overall Study||57
8618915|NCT00465816|9657398|FG001|COMPLETED|Overall Study||122
8618916|NCT00465816|9657399|FG002|COMPLETED|Overall Study||120
8618917|NCT00465816|9657397|FG000|NOT COMPLETED|Overall Study||0
8618918|NCT00465816|9657398|FG001|NOT COMPLETED|Overall Study||0
8558360|NCT00943722|9590157|FG004|COMPLETED|Second Extension Study: EXT 2||0
8558361|NCT00943722|9590158|FG005|COMPLETED|Second Extension Study: EXT 2||720
8558362|NCT00943722|9590159|FG006|COMPLETED|Second Extension Study: EXT 2||202
8558363|NCT00943722|9590153|FG000|NOT COMPLETED|Second Extension Study: EXT 2||0
8558364|NCT00943722|9590154|FG001|NOT COMPLETED|Second Extension Study: EXT 2||0
8558365|NCT00943722|9590155|FG002|NOT COMPLETED|Second Extension Study: EXT 2||0
8558366|NCT00943722|9590156|FG003|NOT COMPLETED|Second Extension Study: EXT 2||0
8558367|NCT00943722|9590157|FG004|NOT COMPLETED|Second Extension Study: EXT 2||0
8558368|NCT00943722|9590158|FG005|NOT COMPLETED|Second Extension Study: EXT 2||251
8558369|NCT00943722|9590159|FG006|NOT COMPLETED|Second Extension Study: EXT 2||99
8558370|NCT00676663|9590184|FG000|STARTED|Overall Study||66
8558371|NCT00676663|9590185|FG001|STARTED|Overall Study||64
8558372|NCT00676663|9590184|FG000|COMPLETED|Overall Study||21
8558373|NCT00676663|9590185|FG001|COMPLETED|Overall Study||26
8558374|NCT00676663|9590184|FG000|NOT COMPLETED|Overall Study||45
8558375|NCT00676663|9590185|FG001|NOT COMPLETED|Overall Study||38
8558376|NCT00573131|9590195|FG000|STARTED|Overall Study||72
8558377|NCT00573131|9590196|FG001|STARTED|Overall Study||65
8558378|NCT00573131|9590195|FG000|COMPLETED|Overall Study||62
8558379|NCT00573131|9590196|FG001|COMPLETED|Overall Study||57
8558380|NCT00573131|9590195|FG000|NOT COMPLETED|Overall Study||10
8558381|NCT00573131|9590196|FG001|NOT COMPLETED|Overall Study||8
8558382|NCT00479765|9590202|FG000|STARTED|Overall Study||4
8558383|NCT00479765|9590202|FG000|COMPLETED|Overall Study||0
8558384|NCT00479765|9590202|FG000|NOT COMPLETED|Overall Study||4
8558385|NCT00391365|9590208|FG000|STARTED|Overall Study||103
8558386|NCT00391365|9590209|FG001|STARTED|Overall Study||170
8558387|NCT00391365|9590208|FG000|COMPLETED|Overall Study||78
8558388|NCT00391365|9590209|FG001|COMPLETED|Overall Study||151
8558389|NCT00391365|9590208|FG000|NOT COMPLETED|Overall Study||25
8558390|NCT00391365|9590209|FG001|NOT COMPLETED|Overall Study||19
8568893|NCT00094458|9601097|FG000|NOT COMPLETED|OLE: Open-Label Extension||0
8568894|NCT00094458|9601098|FG001|NOT COMPLETED|OLE: Open-Label Extension||0
8568895|NCT00094458|9601099|FG002|NOT COMPLETED|OLE: Open-Label Extension||0
8568896|NCT00094458|9601100|FG003|NOT COMPLETED|OLE: Open-Label Extension||1
8568897|NCT00094458|9601101|FG004|NOT COMPLETED|OLE: Open-Label Extension||5
8568898|NCT00094458|9601102|FG005|NOT COMPLETED|OLE: Open-Label Extension||4
8568899|NCT00094497|9601118|FG000|STARTED|Overall Study||151
8568900|NCT00094497|9601119|FG001|STARTED|Overall Study||153
8568901|NCT00094497|9601118|FG000|Treated|Overall Study||148
8568902|NCT00094497|9601119|FG001|Treated|Overall Study||149
8568903|NCT00094497|9601118|FG000|Received Second Line Therapy|Overall Study||84
8568904|NCT00094497|9601119|FG001|Received Second Line Therapy|Overall Study||101
8568905|NCT00094497|9601118|FG000|COMPLETED|Overall Study||151
8568906|NCT00094497|9601119|FG001|COMPLETED|Overall Study||153
8568907|NCT00094497|9601118|FG000|NOT COMPLETED|Overall Study||0
8568908|NCT00094497|9601119|FG001|NOT COMPLETED|Overall Study||0
8568909|NCT00094536|9601125|FG000|STARTED|Inclusion Exclusion Evaluation||106
8568910|NCT00094536|9601125|FG000|COMPLETED|Inclusion Exclusion Evaluation||82
8568911|NCT00094536|9601125|FG000|NOT COMPLETED|Inclusion Exclusion Evaluation||24
8568912|NCT00094536|9601125|FG000|STARTED|Treatment and Follow-up|82 subjects qualified for and underwent the study treatment.|82
8568913|NCT00094536|9601125|FG000|12 Month Follow-up|Treatment and Follow-up|69 subjects were evaluated at 1-year post-treatment for the primary endpoint of success.|69
8721318|NCT01011556|9768509|FG001|Received at Least 1 Dose of Study Drug|Overall Study||56
8721319|NCT01011556|9768510|FG002|Received at Least 1 Dose of Study Drug|Overall Study||54
8618919|NCT00465816|9657399|FG002|NOT COMPLETED|Overall Study||2
8618920|NCT00465894|9657410|FG000|STARTED|Treatment For 12 Weeks||30
8618921|NCT00465894|9657411|FG001|STARTED|Treatment For 12 Weeks||28
8618922|NCT00465894|9657410|FG000|COMPLETED|Treatment For 12 Weeks||25
8618923|NCT00465894|9657411|FG001|COMPLETED|Treatment For 12 Weeks||25
8618924|NCT00465894|9657410|FG000|NOT COMPLETED|Treatment For 12 Weeks||5
8618925|NCT00465894|9657411|FG001|NOT COMPLETED|Treatment For 12 Weeks||3
8618926|NCT00465894|9657410|FG000|STARTED|Treatment From 12 Weeks To 24 Weeks|We included data only from participants that had complete data sets.|14
8618927|NCT00465894|9657411|FG001|STARTED|Treatment From 12 Weeks To 24 Weeks|We included data only from participants that had complete data sets.|14
8721320|NCT01011556|9768511|FG003|Received at Least 1 Dose of Study Drug|Overall Study||64
8721321|NCT01011556|9768508|FG000|COMPLETED|Overall Study||52
8721322|NCT01011556|9768509|FG001|COMPLETED|Overall Study||48
8721323|NCT01011556|9768510|FG002|COMPLETED|Overall Study||45
8721324|NCT01011556|9768511|FG003|COMPLETED|Overall Study||51
8721325|NCT01011556|9768508|FG000|NOT COMPLETED|Overall Study||6
8721326|NCT01011556|9768509|FG001|NOT COMPLETED|Overall Study||8
8721327|NCT01011556|9768510|FG002|NOT COMPLETED|Overall Study||10
8721328|NCT01011556|9768511|FG003|NOT COMPLETED|Overall Study||13
8721329|NCT01011673|9768526|FG000|STARTED|Randomized||62
8721330|NCT01011673|9768527|FG001|STARTED|Randomized||61
8721331|NCT01011673|9768526|FG000|COMPLETED|Randomized|2 patients were randomized but not included in analyses bc they did not truly meet study criteria.|60
8721332|NCT01011673|9768527|FG001|COMPLETED|Randomized|1 patient was randomized but not included in analyses bc they did not truly meet study criteria.|60
8721333|NCT01011673|9768526|FG000|NOT COMPLETED|Randomized||2
8721334|NCT01011673|9768527|FG001|NOT COMPLETED|Randomized||1
8721335|NCT01011673|9768526|FG000|STARTED|Emergency Department Portion||60
8721336|NCT01011673|9768527|FG001|STARTED|Emergency Department Portion||60
8721337|NCT01011673|9768526|FG000|COMPLETED|Emergency Department Portion||60
8721338|NCT01011673|9768527|FG001|COMPLETED|Emergency Department Portion||60
8721339|NCT01011673|9768526|FG000|NOT COMPLETED|Emergency Department Portion||0
8721340|NCT01011673|9768527|FG001|NOT COMPLETED|Emergency Department Portion||0
8721341|NCT01011673|9768526|FG000|STARTED|24 Hour Follow-up||60
8721342|NCT01011673|9768527|FG001|STARTED|24 Hour Follow-up||60
8721343|NCT01011673|9768526|FG000|COMPLETED|24 Hour Follow-up||57
8721344|NCT01011673|9768527|FG001|COMPLETED|24 Hour Follow-up||57
8721345|NCT01011673|9768526|FG000|NOT COMPLETED|24 Hour Follow-up||3
8721346|NCT01011673|9768527|FG001|NOT COMPLETED|24 Hour Follow-up||3
8721347|NCT01011738|9768536|FG000|STARTED|Overall Study||877
8721348|NCT01011738|9768537|FG001|STARTED|Overall Study||912
8721349|NCT01011738|9768538|FG002|STARTED|Overall Study||53
8721350|NCT01011738|9768536|FG000|COMPLETED|Overall Study||553
8721351|NCT01011738|9768537|FG001|COMPLETED|Overall Study||618
8721352|NCT01011738|9768538|FG002|COMPLETED|Overall Study||36
8721353|NCT01011738|9768536|FG000|NOT COMPLETED|Overall Study||324
8618928|NCT00465894|9657410|FG000|COMPLETED|Treatment From 12 Weeks To 24 Weeks||14
8618929|NCT00465894|9657411|FG001|COMPLETED|Treatment From 12 Weeks To 24 Weeks||14
8618930|NCT00465894|9657410|FG000|NOT COMPLETED|Treatment From 12 Weeks To 24 Weeks||0
8721354|NCT01011738|9768537|FG001|NOT COMPLETED|Overall Study||294
8721355|NCT01011738|9768538|FG002|NOT COMPLETED|Overall Study||17
8721356|NCT01011816|9768549|FG000|STARTED|26-Week Primary Endpoint||164
8721357|NCT01011816|9768550|FG001|STARTED|26-Week Primary Endpoint||56
8721358|NCT01011816|9768549|FG000|COMPLETED|26-Week Primary Endpoint||157
8721359|NCT01011816|9768550|FG001|COMPLETED|26-Week Primary Endpoint||54
8721360|NCT01011816|9768549|FG000|NOT COMPLETED|26-Week Primary Endpoint||7
8721361|NCT01011816|9768550|FG001|NOT COMPLETED|26-Week Primary Endpoint||2
8721362|NCT01011816|9768549|FG000|STARTED|78-Week Extended Follow-up||157
8721363|NCT01011816|9768550|FG001|STARTED|78-Week Extended Follow-up||54
8721364|NCT01011816|9768549|FG000|COMPLETED|78-Week Extended Follow-up||85
8721365|NCT01011816|9768550|FG001|COMPLETED|78-Week Extended Follow-up||26
8721366|NCT01011816|9768549|FG000|NOT COMPLETED|78-Week Extended Follow-up||72
8721367|NCT01011816|9768550|FG001|NOT COMPLETED|78-Week Extended Follow-up||28
8721368|NCT01011829|9768560|FG000|STARTED|Overall Study||10
8721369|NCT01011829|9768561|FG001|STARTED|Overall Study||10
8721370|NCT01011829|9768560|FG000|COMPLETED|Overall Study||6
8721371|NCT01011829|9768561|FG001|COMPLETED|Overall Study||1
8721372|NCT01011829|9768560|FG000|NOT COMPLETED|Overall Study||4
8721373|NCT01011829|9768561|FG001|NOT COMPLETED|Overall Study||9
8721374|NCT01011868|9768570|FG000|STARTED|After Week 18 Follow-up||170
8721375|NCT01011868|9768571|FG001|STARTED|After Week 18 Follow-up||169
8721376|NCT01011868|9768572|FG002|STARTED|After Week 18 Follow-up||155
8721377|NCT01011868|9768570|FG000|COMPLETED|After Week 18 Follow-up||147
8721378|NCT01011868|9768571|FG001|COMPLETED|After Week 18 Follow-up||153
8721379|NCT01011868|9768572|FG002|COMPLETED|After Week 18 Follow-up||129
8721380|NCT01011868|9768570|FG000|NOT COMPLETED|After Week 18 Follow-up||23
8721381|NCT01011868|9768571|FG001|NOT COMPLETED|After Week 18 Follow-up||16
8721382|NCT01011868|9768572|FG002|NOT COMPLETED|After Week 18 Follow-up||26
8721383|NCT01011868|9768570|FG000|STARTED|After Week 78 Follow-up||170
8721384|NCT01011868|9768571|FG001|STARTED|After Week 78 Follow-up||169
8721385|NCT01011868|9768572|FG002|STARTED|After Week 78 Follow-up||155
8721386|NCT01011868|9768570|FG000|COMPLETED|After Week 78 Follow-up||118
8721387|NCT01011868|9768571|FG001|COMPLETED|After Week 78 Follow-up||131
8721388|NCT01011868|9768572|FG002|COMPLETED|After Week 78 Follow-up||111
8721389|NCT01011868|9768570|FG000|NOT COMPLETED|After Week 78 Follow-up||52
8721390|NCT01011868|9768571|FG001|NOT COMPLETED|After Week 78 Follow-up||38
8721391|NCT01011868|9768572|FG002|NOT COMPLETED|After Week 78 Follow-up||44
8618931|NCT00465894|9657411|FG001|NOT COMPLETED|Treatment From 12 Weeks To 24 Weeks||0
8618932|NCT00465894|9657410|FG000|STARTED|Treatment From 24 Weeks to 52 Weeks|We included data only from participants that had complete data sets.|11
8618933|NCT00465894|9657411|FG001|STARTED|Treatment From 24 Weeks to 52 Weeks||14
8618934|NCT00465894|9657410|FG000|COMPLETED|Treatment From 24 Weeks to 52 Weeks||11
8618935|NCT00465894|9657411|FG001|COMPLETED|Treatment From 24 Weeks to 52 Weeks||14
8618936|NCT00465894|9657410|FG000|NOT COMPLETED|Treatment From 24 Weeks to 52 Weeks||0
8618937|NCT00465894|9657411|FG001|NOT COMPLETED|Treatment From 24 Weeks to 52 Weeks||0
8618938|NCT00465972|9657435|FG000|STARTED|Overall Study||20
8618939|NCT00465972|9657436|FG001|STARTED|Overall Study||24
8618940|NCT00465972|9657435|FG000|COMPLETED|Overall Study||18
8618941|NCT00465972|9657436|FG001|COMPLETED|Overall Study||23
8618942|NCT00465972|9657435|FG000|NOT COMPLETED|Overall Study||2
8618943|NCT00465972|9657436|FG001|NOT COMPLETED|Overall Study||1
8618944|NCT00465985|9657444|FG000|STARTED|Part I - Open-label Treatment Period|All patients received treatment with ACZ885 in Part I of the study.|35
8618945|NCT00465985|9657445|FG001|STARTED|Part I - Open-label Treatment Period||0
8721392|NCT01011894|9768580|FG000|STARTED|Overall Study||26
8721393|NCT01011894|9768580|FG000|COMPLETED|Overall Study||26
8721394|NCT01011894|9768580|FG000|NOT COMPLETED|Overall Study||0
8721395|NCT01011907|9768586|FG000|STARTED|Overall Study||31
8721396|NCT01011907|9768587|FG001|STARTED|Overall Study||33
8721397|NCT01011907|9768586|FG000|COMPLETED|Overall Study||17
8721398|NCT01011907|9768587|FG001|COMPLETED|Overall Study||18
8721399|NCT01011907|9768586|FG000|NOT COMPLETED|Overall Study||14
8721400|NCT01011907|9768587|FG001|NOT COMPLETED|Overall Study||15
8618946|NCT00465985|9657444|FG000|COMPLETED|Part I - Open-label Treatment Period|Only patients with a complete response completed Part I and entered Part II of the study.|31
8618947|NCT00465985|9657445|FG001|COMPLETED|Part I - Open-label Treatment Period||0
8721401|NCT01011933|9768593|FG000|STARTED|Overall Study|total enrolled|54
8721402|NCT01011933|9768593|FG000|COMPLETED|Overall Study|total eligible and evaluable|50
8813844|NCT01528254|9867058|FG001|STARTED|Overall Study||1003
8813845|NCT01528254|9867057|FG000|Safety Set|Overall Study||998
8813846|NCT01528254|9867058|FG001|Safety Set|Overall Study||1001
8813847|NCT01528254|9867057|FG000|Full Analysis Set (FAS)|Overall Study||983
8813848|NCT01528254|9867058|FG001|Full Analysis Set (FAS)|Overall Study||989
8618948|NCT00465985|9657444|FG000|NOT COMPLETED|Part I - Open-label Treatment Period||4
8721403|NCT01011933|9768593|FG000|NOT COMPLETED|Overall Study||4
8721404|NCT01011946|9768603|FG000|STARTED|Overall Study||36
8721405|NCT01011946|9768603|FG000|COMPLETED|Overall Study||33
8721406|NCT01011946|9768603|FG000|NOT COMPLETED|Overall Study||3
8721407|NCT01012037|9768610|FG000|STARTED|Overall Study||44
8721408|NCT01012037|9768611|FG001|STARTED|Overall Study||223
8721409|NCT01012037|9768612|FG002|STARTED|Overall Study||224
8721410|NCT01012037|9768610|FG000|COMPLETED|Overall Study||43
8721411|NCT01012037|9768611|FG001|COMPLETED|Overall Study||207
8721412|NCT01012037|9768612|FG002|COMPLETED|Overall Study||214
8721413|NCT01012037|9768610|FG000|NOT COMPLETED|Overall Study||1
8721414|NCT01012037|9768611|FG001|NOT COMPLETED|Overall Study||16
8721415|NCT01012037|9768612|FG002|NOT COMPLETED|Overall Study||10
8721416|NCT01012089|9768622|FG000|STARTED|Overall Study||6
8721417|NCT01012089|9768622|FG000|COMPLETED|Overall Study||6
8721418|NCT01012089|9768622|FG000|NOT COMPLETED|Overall Study||0
8721419|NCT01012219|9768628|FG000|STARTED|Period 1|Number randomized|36
8721420|NCT01012219|9768628|FG000|COMPLETED|Period 1||35
8618949|NCT00465985|9657445|FG001|NOT COMPLETED|Part I - Open-label Treatment Period||0
8618950|NCT00465985|9657444|FG000|STARTED|Part II - 1:1 ACZ885:Placebo|Patients with complete response to treatment entered Part II and were randomized to ACZ885 ,placebo.|15
8618951|NCT00465985|9657445|FG001|STARTED|Part II - 1:1 ACZ885:Placebo||16
8618952|NCT00465985|9657444|FG000|COMPLETED|Part II - 1:1 ACZ885:Placebo||15
8618953|NCT00465985|9657445|FG001|COMPLETED|Part II - 1:1 ACZ885:Placebo||4
8618954|NCT00465985|9657444|FG000|NOT COMPLETED|Part II - 1:1 ACZ885:Placebo||0
8618955|NCT00465985|9657445|FG001|NOT COMPLETED|Part II - 1:1 ACZ885:Placebo||12
8618956|NCT00465985|9657444|FG000|STARTED|Part III - Open-label Treatment Period|All patients received treatment with ACZ885 in Part III of the study.|31
8618957|NCT00465985|9657445|FG001|STARTED|Part III - Open-label Treatment Period||0
8618958|NCT00465985|9657444|FG000|COMPLETED|Part III - Open-label Treatment Period||29
8618959|NCT00465985|9657445|FG001|COMPLETED|Part III - Open-label Treatment Period||0
8618960|NCT00465985|9657444|FG000|NOT COMPLETED|Part III - Open-label Treatment Period||2
8618961|NCT00465985|9657445|FG001|NOT COMPLETED|Part III - Open-label Treatment Period||0
8618962|NCT00465998|9657454|FG000|STARTED|Overall Study||275
8618963|NCT00465998|9657454|FG000|COMPLETED|Overall Study||275
8618964|NCT00465998|9657454|FG000|NOT COMPLETED|Overall Study||0
8618965|NCT00466167|9657462|FG000|STARTED|Overall Study||165
8618966|NCT00466167|9657463|FG001|STARTED|Overall Study||175
8618967|NCT00466167|9657464|FG002|STARTED|Overall Study||178
8618968|NCT00466167|9657462|FG000|COMPLETED|Overall Study||145
8618969|NCT00466167|9657463|FG001|COMPLETED|Overall Study||163
8618970|NCT00466167|9657464|FG002|COMPLETED|Overall Study||157
8618971|NCT00466167|9657462|FG000|NOT COMPLETED|Overall Study||20
8618972|NCT00466167|9657463|FG001|NOT COMPLETED|Overall Study||12
8618973|NCT00466167|9657464|FG002|NOT COMPLETED|Overall Study||21
8618974|NCT00466193|9657474|FG000|STARTED|Overall Study||150
8618975|NCT00466193|9657475|FG001|STARTED|Overall Study||145
8618976|NCT00466193|9657474|FG000|COMPLETED|Overall Study||138
8618977|NCT00466193|9657475|FG001|COMPLETED|Overall Study|One patient did not report at least one Latency Sleep Onset following middle-of-the-night awakening.|137
8618978|NCT00466193|9657474|FG000|NOT COMPLETED|Overall Study||12
8618979|NCT00466193|9657475|FG001|NOT COMPLETED|Overall Study||8
8618980|NCT00466206|9657481|FG000|STARTED|Overall Study||10
8618981|NCT00466206|9657481|FG000|COMPLETED|Overall Study|One of 10 patients withdrawn from study but completed treatment under Compassionate Use Designation|10
8618982|NCT00466206|9657481|FG000|NOT COMPLETED|Overall Study||0
8618983|NCT00466310|9657491|FG000|STARTED|Overall Study||20
8618984|NCT00466310|9657492|FG001|STARTED|Overall Study||20
8618985|NCT00466310|9657493|FG002|STARTED|Overall Study||31
8618986|NCT00466310|9657491|FG000|COMPLETED|Overall Study||20
8618987|NCT00466310|9657492|FG001|COMPLETED|Overall Study||20
8618988|NCT00466310|9657493|FG002|COMPLETED|Overall Study||31
8721421|NCT01012219|9768628|FG000|NOT COMPLETED|Period 1||1
8721422|NCT01012219|9768628|FG000|STARTED|Period 2|Number who completed Period 1|35
8813849|NCT01528254|9867057|FG000|Completed Treatment Period 1|Overall Study||458
8721423|NCT01012219|9768628|FG000|COMPLETED|Period 2||34
8721424|NCT01012219|9768628|FG000|NOT COMPLETED|Period 2||1
8721425|NCT01012219|9768628|FG000|STARTED|Period 3|of the 36 who started Period 1|20
8721426|NCT01012219|9768628|FG000|COMPLETED|Period 3||20
8721427|NCT01012219|9768628|FG000|NOT COMPLETED|Period 3||0
8721428|NCT01012245|9768639|FG000|STARTED|Overall Study||28812
8721429|NCT01012245|9768639|FG000|COMPLETED|Overall Study|More than 1 discontinuation (DC) reason possible per subject. See outcome measure Reasons for DC.|26385
8721430|NCT01012245|9768639|FG000|NOT COMPLETED|Overall Study||2427
8721431|NCT01012258|9768650|FG000|STARTED|Overall Study||66
8721432|NCT01012258|9768650|FG000|COMPLETED|Overall Study||0
8721433|NCT01012258|9768650|FG000|NOT COMPLETED|Overall Study||66
8721434|NCT01012297|9768657|FG000|STARTED|Overall Study||54
8721435|NCT01012297|9768658|FG001|STARTED|Overall Study||53
8721436|NCT01012297|9768657|FG000|COMPLETED|Overall Study||54
8721437|NCT01012297|9768658|FG001|COMPLETED|Overall Study||53
8721438|NCT01012297|9768657|FG000|NOT COMPLETED|Overall Study||0
8721439|NCT01012297|9768658|FG001|NOT COMPLETED|Overall Study||0
8721440|NCT01012323|9768664|FG000|STARTED|Overall Study||51
8721441|NCT01012323|9768664|FG000|COMPLETED|Overall Study||50
8721442|NCT01012323|9768664|FG000|NOT COMPLETED|Overall Study||1
8721443|NCT01012336|9768668|FG000|STARTED|Overall Study||85
8721444|NCT01012336|9768668|FG000|COMPLETED|Overall Study||85
8721445|NCT01012336|9768668|FG000|NOT COMPLETED|Overall Study||0
8724995|NCT01029340|9772250|FG004|COMPLETED|Part B Treatment Period||0
8724996|NCT01029340|9772251|FG005|COMPLETED|Part B Treatment Period||0
8724997|NCT01029340|9772246|FG000|NOT COMPLETED|Part B Treatment Period||0
8724998|NCT01029340|9772247|FG001|NOT COMPLETED|Part B Treatment Period||0
8724999|NCT01029340|9772248|FG002|NOT COMPLETED|Part B Treatment Period||2
8725000|NCT01029340|9772249|FG003|NOT COMPLETED|Part B Treatment Period||0
8725001|NCT01029340|9772250|FG004|NOT COMPLETED|Part B Treatment Period||0
8725002|NCT01029340|9772251|FG005|NOT COMPLETED|Part B Treatment Period||0
8725003|NCT01029340|9772246|FG000|STARTED|Part B Follow up Period||0
8725004|NCT01029340|9772247|FG001|STARTED|Part B Follow up Period||0
8725005|NCT01029340|9772248|FG002|STARTED|Part B Follow up Period||29
8725006|NCT01029340|9772249|FG003|STARTED|Part B Follow up Period||32
8725007|NCT01029340|9772250|FG004|STARTED|Part B Follow up Period||0
8725008|NCT01029340|9772251|FG005|STARTED|Part B Follow up Period||0
8725009|NCT01029340|9772246|FG000|COMPLETED|Part B Follow up Period||0
8725010|NCT01029340|9772247|FG001|COMPLETED|Part B Follow up Period||0
8725011|NCT01029340|9772248|FG002|COMPLETED|Part B Follow up Period||29
8725012|NCT01029340|9772249|FG003|COMPLETED|Part B Follow up Period||32
8725013|NCT01029340|9772250|FG004|COMPLETED|Part B Follow up Period||0
8725014|NCT01029340|9772251|FG005|COMPLETED|Part B Follow up Period||0
8725015|NCT01029340|9772246|FG000|NOT COMPLETED|Part B Follow up Period||0
8725016|NCT01029340|9772247|FG001|NOT COMPLETED|Part B Follow up Period||0
8725017|NCT01029340|9772248|FG002|NOT COMPLETED|Part B Follow up Period||0
8725018|NCT01029340|9772249|FG003|NOT COMPLETED|Part B Follow up Period||0
8725019|NCT01029340|9772250|FG004|NOT COMPLETED|Part B Follow up Period||0
8725020|NCT01029340|9772251|FG005|NOT COMPLETED|Part B Follow up Period||0
8725021|NCT01029340|9772246|FG000|STARTED|Extension Period||0
8725022|NCT01029340|9772247|FG001|STARTED|Extension Period||0
8725023|NCT01029340|9772248|FG002|STARTED|Extension Period||0
8725024|NCT01029340|9772249|FG003|STARTED|Extension Period||0
8725025|NCT01029340|9772250|FG004|STARTED|Extension Period||0
8725026|NCT01029340|9772251|FG005|STARTED|Extension Period||55
8725027|NCT01029340|9772246|FG000|COMPLETED|Extension Period||0
8725028|NCT01029340|9772247|FG001|COMPLETED|Extension Period||0
8725029|NCT01029340|9772248|FG002|COMPLETED|Extension Period||0
8725030|NCT01029340|9772249|FG003|COMPLETED|Extension Period||0
8725031|NCT01029340|9772250|FG004|COMPLETED|Extension Period||0
8725032|NCT01029340|9772251|FG005|COMPLETED|Extension Period||43
8725033|NCT01029340|9772246|FG000|NOT COMPLETED|Extension Period||0
8725034|NCT01029340|9772247|FG001|NOT COMPLETED|Extension Period||0
8725035|NCT01029340|9772248|FG002|NOT COMPLETED|Extension Period||0
8725036|NCT01029340|9772249|FG003|NOT COMPLETED|Extension Period||0
8725037|NCT01029340|9772250|FG004|NOT COMPLETED|Extension Period||0
8725038|NCT01029340|9772251|FG005|NOT COMPLETED|Extension Period||12
8725039|NCT01029340|9772246|FG000|STARTED|Part C Treatment Period||0
8725040|NCT01029340|9772247|FG001|STARTED|Part C Treatment Period||0
8725041|NCT01029340|9772248|FG002|STARTED|Part C Treatment Period||0
8725042|NCT01029340|9772249|FG003|STARTED|Part C Treatment Period||0
8725043|NCT01029340|9772250|FG004|STARTED|Part C Treatment Period||5
8725044|NCT01029340|9772251|FG005|STARTED|Part C Treatment Period||0
8725045|NCT01029340|9772246|FG000|Participants Received Treatment|Part C Treatment Period||0
8725046|NCT01029340|9772247|FG001|Participants Received Treatment|Part C Treatment Period||0
8725047|NCT01029340|9772248|FG002|Participants Received Treatment|Part C Treatment Period||0
8618989|NCT00466310|9657491|FG000|NOT COMPLETED|Overall Study||0
8618990|NCT00466310|9657492|FG001|NOT COMPLETED|Overall Study||0
8618991|NCT00466310|9657493|FG002|NOT COMPLETED|Overall Study||0
8618992|NCT00466323|9657503|FG000|STARTED|Overall Study||117
8618993|NCT00466323|9657504|FG001|STARTED|Overall Study||115
8721446|NCT01012362|9768677|FG000|STARTED|Overall Study||9
8721447|NCT01012362|9768678|FG001|STARTED|Overall Study||6
8721448|NCT01012362|9768679|FG002|STARTED|Overall Study||3
8721449|NCT01012362|9768680|FG003|STARTED|Overall Study||4
8721450|NCT01012362|9768681|FG004|STARTED|Overall Study||9
8721451|NCT01012362|9768677|FG000|COMPLETED|Overall Study||9
8721452|NCT01012362|9768678|FG001|COMPLETED|Overall Study||6
8721453|NCT01012362|9768679|FG002|COMPLETED|Overall Study||3
8721454|NCT01012362|9768680|FG003|COMPLETED|Overall Study||4
8721455|NCT01012362|9768681|FG004|COMPLETED|Overall Study||9
8721456|NCT01012362|9768677|FG000|NOT COMPLETED|Overall Study||0
8721457|NCT01012362|9768678|FG001|NOT COMPLETED|Overall Study||0
8721458|NCT01012362|9768679|FG002|NOT COMPLETED|Overall Study||0
8721459|NCT01012362|9768680|FG003|NOT COMPLETED|Overall Study||0
8721460|NCT01012362|9768681|FG004|NOT COMPLETED|Overall Study||0
8721461|NCT01012388|9768697|FG000|STARTED|Overall Study||100
8721462|NCT01012388|9768697|FG000|COMPLETED|Overall Study||100
8721463|NCT01012388|9768697|FG000|NOT COMPLETED|Overall Study||0
8721464|NCT01012440|9768701|FG000|STARTED|Overall Study||5
8721465|NCT01012440|9768701|FG000|COMPLETED|Overall Study||3
8721466|NCT01012440|9768701|FG000|NOT COMPLETED|Overall Study||2
8721467|NCT01012492|9768705|FG000|STARTED|Overall Study||10
8721468|NCT01012492|9768705|FG000|COMPLETED|Overall Study||10
8721469|NCT01012492|9768705|FG000|NOT COMPLETED|Overall Study||0
8721470|NCT01012622|9768709|FG000|STARTED|Overall Study||142
8721471|NCT01012622|9768709|FG000|COMPLETED|Overall Study||111
8721472|NCT01012622|9768709|FG000|NOT COMPLETED|Overall Study||31
8721473|NCT01012661|9768713|FG000|STARTED|Overall Study||50
8721474|NCT01012661|9768713|FG000|COMPLETED|Overall Study||50
8721475|NCT01012661|9768713|FG000|NOT COMPLETED|Overall Study||0
8721476|NCT01012674|9768719|FG000|STARTED|Overall Study||211
8721477|NCT01012674|9768719|FG000|COMPLETED|Overall Study||187
8721478|NCT01012674|9768719|FG000|NOT COMPLETED|Overall Study||24
8721479|NCT01012713|9768727|FG000|STARTED|Overall Study||30
8721480|NCT01012713|9768727|FG000|COMPLETED|Overall Study||27
8721481|NCT01012713|9768727|FG000|NOT COMPLETED|Overall Study||3
8721482|NCT01012739|9768732|FG000|STARTED|Treatment Period 1||9
8721483|NCT01012739|9768733|FG001|STARTED|Treatment Period 1||8
8721484|NCT01012739|9768734|FG002|STARTED|Treatment Period 1||9
8721485|NCT01012739|9768735|FG003|STARTED|Treatment Period 1||9
8721486|NCT01012739|9768732|FG000|COMPLETED|Treatment Period 1||9
8721487|NCT01012739|9768733|FG001|COMPLETED|Treatment Period 1||8
8721488|NCT01012739|9768734|FG002|COMPLETED|Treatment Period 1||9
8721489|NCT01012739|9768735|FG003|COMPLETED|Treatment Period 1||8
8721490|NCT01012739|9768732|FG000|NOT COMPLETED|Treatment Period 1||0
8721491|NCT01012739|9768733|FG001|NOT COMPLETED|Treatment Period 1||0
8721492|NCT01012739|9768734|FG002|NOT COMPLETED|Treatment Period 1||0
8721493|NCT01012739|9768735|FG003|NOT COMPLETED|Treatment Period 1||1
8721494|NCT01012739|9768732|FG000|STARTED|Treatment Period 2||9
8721495|NCT01012739|9768733|FG001|STARTED|Treatment Period 2||8
8721496|NCT01012739|9768734|FG002|STARTED|Treatment Period 2||9
8721497|NCT01012739|9768735|FG003|STARTED|Treatment Period 2||8
8721498|NCT01012739|9768732|FG000|COMPLETED|Treatment Period 2||9
8721499|NCT01012739|9768733|FG001|COMPLETED|Treatment Period 2||8
8721500|NCT01012739|9768734|FG002|COMPLETED|Treatment Period 2||9
8721501|NCT01012739|9768735|FG003|COMPLETED|Treatment Period 2||7
8721502|NCT01012739|9768732|FG000|NOT COMPLETED|Treatment Period 2||0
8721503|NCT01012739|9768733|FG001|NOT COMPLETED|Treatment Period 2||0
8721504|NCT01012739|9768734|FG002|NOT COMPLETED|Treatment Period 2||0
8721505|NCT01012739|9768735|FG003|NOT COMPLETED|Treatment Period 2||1
8618994|NCT00466323|9657503|FG000|COMPLETED|Overall Study||89
8618995|NCT00466323|9657504|FG001|COMPLETED|Overall Study||92
8618996|NCT00466323|9657503|FG000|NOT COMPLETED|Overall Study||28
8618997|NCT00466323|9657504|FG001|NOT COMPLETED|Overall Study||23
8721506|NCT01012739|9768732|FG000|STARTED|Treatment Period 3||9
8721507|NCT01012739|9768733|FG001|STARTED|Treatment Period 3||8
8721508|NCT01012739|9768734|FG002|STARTED|Treatment Period 3||9
8721509|NCT01012739|9768735|FG003|STARTED|Treatment Period 3||7
8618998|NCT00466440|9657513|FG000|STARTED|Overall Study||14
8618999|NCT00466440|9657514|FG001|STARTED|Overall Study||48
8619000|NCT00466440|9657515|FG002|STARTED|Overall Study||46
8721510|NCT01012739|9768732|FG000|COMPLETED|Treatment Period 3||9
8721511|NCT01012739|9768733|FG001|COMPLETED|Treatment Period 3||8
8721512|NCT01012739|9768734|FG002|COMPLETED|Treatment Period 3||9
8721513|NCT01012739|9768735|FG003|COMPLETED|Treatment Period 3||7
8721514|NCT01012739|9768732|FG000|NOT COMPLETED|Treatment Period 3||0
8721515|NCT01012739|9768733|FG001|NOT COMPLETED|Treatment Period 3||0
8721516|NCT01012739|9768734|FG002|NOT COMPLETED|Treatment Period 3||0
8721517|NCT01012739|9768735|FG003|NOT COMPLETED|Treatment Period 3||0
8721518|NCT01012739|9768732|FG000|STARTED|Treatment Period 4||9
8721519|NCT01012739|9768733|FG001|STARTED|Treatment Period 4||8
8721520|NCT01012739|9768734|FG002|STARTED|Treatment Period 4||9
8721521|NCT01012739|9768735|FG003|STARTED|Treatment Period 4||7
8721522|NCT01012739|9768732|FG000|COMPLETED|Treatment Period 4||9
8721523|NCT01012739|9768733|FG001|COMPLETED|Treatment Period 4||8
8721524|NCT01012739|9768734|FG002|COMPLETED|Treatment Period 4||9
8721525|NCT01012739|9768735|FG003|COMPLETED|Treatment Period 4||7
8721526|NCT01012739|9768732|FG000|NOT COMPLETED|Treatment Period 4||0
8721527|NCT01012739|9768733|FG001|NOT COMPLETED|Treatment Period 4||0
8721528|NCT01012739|9768734|FG002|NOT COMPLETED|Treatment Period 4||0
8721529|NCT01012739|9768735|FG003|NOT COMPLETED|Treatment Period 4||0
8721530|NCT01012765|9768746|FG000|STARTED|Treatment Period 1||20
8721531|NCT01012765|9768747|FG001|STARTED|Treatment Period 1||21
8721532|NCT01012765|9768748|FG002|STARTED|Treatment Period 1||23
8721533|NCT01012765|9768749|FG003|STARTED|Treatment Period 1||18
8721534|NCT01012765|9768750|FG004|STARTED|Treatment Period 1||22
8721535|NCT01012765|9768751|FG005|STARTED|Treatment Period 1||25
8721536|NCT01012765|9768746|FG000|COMPLETED|Treatment Period 1||17
8721537|NCT01012765|9768747|FG001|COMPLETED|Treatment Period 1||21
8721538|NCT01012765|9768748|FG002|COMPLETED|Treatment Period 1||21
8721539|NCT01012765|9768749|FG003|COMPLETED|Treatment Period 1||15
8721540|NCT01012765|9768750|FG004|COMPLETED|Treatment Period 1||19
8721541|NCT01012765|9768751|FG005|COMPLETED|Treatment Period 1||25
8721542|NCT01012765|9768746|FG000|NOT COMPLETED|Treatment Period 1||3
8721543|NCT01012765|9768747|FG001|NOT COMPLETED|Treatment Period 1||0
8721544|NCT01012765|9768748|FG002|NOT COMPLETED|Treatment Period 1||2
8721545|NCT01012765|9768749|FG003|NOT COMPLETED|Treatment Period 1||3
8721546|NCT01012765|9768750|FG004|NOT COMPLETED|Treatment Period 1||3
8721547|NCT01012765|9768751|FG005|NOT COMPLETED|Treatment Period 1||0
8721548|NCT01012765|9768746|FG000|STARTED|Treatment Period 2||17
8721549|NCT01012765|9768747|FG001|STARTED|Treatment Period 2||21
8721550|NCT01012765|9768748|FG002|STARTED|Treatment Period 2||21
8721551|NCT01012765|9768749|FG003|STARTED|Treatment Period 2||15
8721552|NCT01012765|9768750|FG004|STARTED|Treatment Period 2||19
8721553|NCT01012765|9768751|FG005|STARTED|Treatment Period 2||25
8721554|NCT01012765|9768746|FG000|COMPLETED|Treatment Period 2||16
8721555|NCT01012765|9768747|FG001|COMPLETED|Treatment Period 2||19
8721556|NCT01012765|9768748|FG002|COMPLETED|Treatment Period 2||18
8721557|NCT01012765|9768749|FG003|COMPLETED|Treatment Period 2||15
8721558|NCT01012765|9768750|FG004|COMPLETED|Treatment Period 2||18
8721559|NCT01012765|9768751|FG005|COMPLETED|Treatment Period 2||24
8721560|NCT01012765|9768746|FG000|NOT COMPLETED|Treatment Period 2||1
8721561|NCT01012765|9768747|FG001|NOT COMPLETED|Treatment Period 2||2
8721562|NCT01012765|9768748|FG002|NOT COMPLETED|Treatment Period 2||3
8721563|NCT01012765|9768749|FG003|NOT COMPLETED|Treatment Period 2||0
8721564|NCT01012765|9768750|FG004|NOT COMPLETED|Treatment Period 2||1
8721565|NCT01012765|9768751|FG005|NOT COMPLETED|Treatment Period 2||1
8721566|NCT01012765|9768746|FG000|STARTED|Treatment Period 3||16
8721567|NCT01012765|9768747|FG001|STARTED|Treatment Period 3||19
8721568|NCT01012765|9768748|FG002|STARTED|Treatment Period 3||18
8721569|NCT01012765|9768749|FG003|STARTED|Treatment Period 3||15
8721570|NCT01012765|9768750|FG004|STARTED|Treatment Period 3||18
8721571|NCT01012765|9768751|FG005|STARTED|Treatment Period 3||24
8721572|NCT01012765|9768746|FG000|COMPLETED|Treatment Period 3||16
8721573|NCT01012765|9768747|FG001|COMPLETED|Treatment Period 3||19
8721574|NCT01012765|9768748|FG002|COMPLETED|Treatment Period 3||18
8721575|NCT01012765|9768749|FG003|COMPLETED|Treatment Period 3||15
8721576|NCT01012765|9768750|FG004|COMPLETED|Treatment Period 3||18
8721577|NCT01012765|9768751|FG005|COMPLETED|Treatment Period 3||24
8721578|NCT01012765|9768746|FG000|NOT COMPLETED|Treatment Period 3||0
8721579|NCT01012765|9768747|FG001|NOT COMPLETED|Treatment Period 3||0
8721580|NCT01012765|9768748|FG002|NOT COMPLETED|Treatment Period 3||0
8721581|NCT01012765|9768749|FG003|NOT COMPLETED|Treatment Period 3||0
8721582|NCT01012765|9768750|FG004|NOT COMPLETED|Treatment Period 3||0
8721583|NCT01012765|9768751|FG005|NOT COMPLETED|Treatment Period 3||0
8721584|NCT01012921|9768761|FG000|STARTED|Overall Study||57
8721585|NCT01012921|9768762|FG001|STARTED|Overall Study||60
8721586|NCT01012921|9768761|FG000|COMPLETED|Overall Study||47
8721587|NCT01012921|9768762|FG001|COMPLETED|Overall Study||47
8721588|NCT01012921|9768761|FG000|NOT COMPLETED|Overall Study||10
8721589|NCT01012921|9768762|FG001|NOT COMPLETED|Overall Study||13
8721590|NCT01012947|9768773|FG000|STARTED|Overall Study||212
8721591|NCT01012947|9768774|FG001|STARTED|Overall Study||215
8721592|NCT01012947|9768775|FG002|STARTED|Overall Study||241
8721593|NCT01012947|9768776|FG003|STARTED|Overall Study||211
8721594|NCT01012947|9768777|FG004|STARTED|Overall Study||236
8619001|NCT00466440|9657513|FG000|Received at Least One Dose of Study Drug|Overall Study||14
8619002|NCT00466440|9657514|FG001|Received at Least One Dose of Study Drug|Overall Study||47
8721595|NCT01012947|9768773|FG000|COMPLETED|Overall Study||81
8721596|NCT01012947|9768774|FG001|COMPLETED|Overall Study||80
8721597|NCT01012947|9768775|FG002|COMPLETED|Overall Study||111
8721598|NCT01012947|9768776|FG003|COMPLETED|Overall Study||93
8721599|NCT01012947|9768777|FG004|COMPLETED|Overall Study||94
8721600|NCT01012947|9768773|FG000|NOT COMPLETED|Overall Study||131
8721601|NCT01012947|9768774|FG001|NOT COMPLETED|Overall Study||135
8721602|NCT01012947|9768775|FG002|NOT COMPLETED|Overall Study||130
8721603|NCT01012947|9768776|FG003|NOT COMPLETED|Overall Study||118
8721604|NCT01012947|9768777|FG004|NOT COMPLETED|Overall Study||142
8721605|NCT01012973|9768791|FG000|STARTED|Overall Study||106
8721606|NCT01012973|9768792|FG001|STARTED|Overall Study||71
8721607|NCT01012973|9768791|FG000|Participants Received Treatment|Overall Study|Safety Population: Participants received treatment|104
8721608|NCT01012973|9768792|FG001|Participants Received Treatment|Overall Study|Safety Population: Participants received treatment|68
8725048|NCT01029340|9772249|FG003|Participants Received Treatment|Part C Treatment Period||0
8725049|NCT01029340|9772250|FG004|Participants Received Treatment|Part C Treatment Period||5
8725050|NCT01029340|9772251|FG005|Participants Received Treatment|Part C Treatment Period||0
8725051|NCT01029340|9772246|FG000|COMPLETED|Part C Treatment Period||0
8725052|NCT01029340|9772247|FG001|COMPLETED|Part C Treatment Period||0
8725053|NCT01029340|9772248|FG002|COMPLETED|Part C Treatment Period||0
8725054|NCT01029340|9772249|FG003|COMPLETED|Part C Treatment Period||0
8725055|NCT01029340|9772250|FG004|COMPLETED|Part C Treatment Period||5
8725056|NCT01029340|9772251|FG005|COMPLETED|Part C Treatment Period||0
8725057|NCT01029340|9772246|FG000|NOT COMPLETED|Part C Treatment Period||0
8725058|NCT01029340|9772247|FG001|NOT COMPLETED|Part C Treatment Period||0
8725059|NCT01029340|9772248|FG002|NOT COMPLETED|Part C Treatment Period||0
8725060|NCT01029340|9772249|FG003|NOT COMPLETED|Part C Treatment Period||0
8725061|NCT01029340|9772250|FG004|NOT COMPLETED|Part C Treatment Period||0
8725062|NCT01029340|9772251|FG005|NOT COMPLETED|Part C Treatment Period||0
8725063|NCT01029340|9772246|FG000|STARTED|Part C Follow up Period||0
8725064|NCT01029340|9772247|FG001|STARTED|Part C Follow up Period||0
8725065|NCT01029340|9772248|FG002|STARTED|Part C Follow up Period||0
8725066|NCT01029340|9772249|FG003|STARTED|Part C Follow up Period||0
8725067|NCT01029340|9772250|FG004|STARTED|Part C Follow up Period||5
8725068|NCT01029340|9772251|FG005|STARTED|Part C Follow up Period||0
8725069|NCT01029340|9772246|FG000|COMPLETED|Part C Follow up Period||0
8725070|NCT01029340|9772247|FG001|COMPLETED|Part C Follow up Period||0
8725071|NCT01029340|9772248|FG002|COMPLETED|Part C Follow up Period||0
8725072|NCT01029340|9772249|FG003|COMPLETED|Part C Follow up Period||0
8725073|NCT01029340|9772250|FG004|COMPLETED|Part C Follow up Period||5
8725074|NCT01029340|9772251|FG005|COMPLETED|Part C Follow up Period||0
8725075|NCT01029340|9772246|FG000|NOT COMPLETED|Part C Follow up Period||0
8725076|NCT01029340|9772247|FG001|NOT COMPLETED|Part C Follow up Period||0
8725077|NCT01029340|9772248|FG002|NOT COMPLETED|Part C Follow up Period||0
8725078|NCT01029340|9772249|FG003|NOT COMPLETED|Part C Follow up Period||0
8725079|NCT01029340|9772250|FG004|NOT COMPLETED|Part C Follow up Period||0
8725080|NCT01029340|9772251|FG005|NOT COMPLETED|Part C Follow up Period||0
8725081|NCT01029353|9772268|FG000|STARTED|Overall Study||148
8725082|NCT01029353|9772269|FG001|STARTED|Overall Study||162
8725083|NCT01029353|9772270|FG002|STARTED|Overall Study||100
8725084|NCT01029353|9772271|FG003|STARTED|Overall Study||119
8725085|NCT01029353|9772268|FG000|Included in ITT Analysis|Overall Study||146
8725086|NCT01029353|9772269|FG001|Included in ITT Analysis|Overall Study||162
8725087|NCT01029353|9772270|FG002|Included in ITT Analysis|Overall Study||100
8725088|NCT01029353|9772271|FG003|Included in ITT Analysis|Overall Study||119
8725089|NCT01029353|9772268|FG000|Reached Network Status|Overall Study||146
8725090|NCT01029353|9772269|FG001|Reached Network Status|Overall Study||162
8725091|NCT01029353|9772270|FG002|Reached Network Status|Overall Study||100
8725092|NCT01029353|9772271|FG003|Reached Network Status|Overall Study||119
8725093|NCT01029353|9772268|FG000|COMPLETED|Overall Study||141
8725094|NCT01029353|9772269|FG001|COMPLETED|Overall Study||154
8725095|NCT01029353|9772270|FG002|COMPLETED|Overall Study||93
8725096|NCT01029353|9772271|FG003|COMPLETED|Overall Study||115
8725097|NCT01029353|9772268|FG000|NOT COMPLETED|Overall Study||7
8725098|NCT01029353|9772269|FG001|NOT COMPLETED|Overall Study||8
8725099|NCT01029353|9772270|FG002|NOT COMPLETED|Overall Study||7
8725100|NCT01029353|9772271|FG003|NOT COMPLETED|Overall Study||4
8725101|NCT01029366|9772283|FG000|STARTED|Overall Study||18
8725102|NCT01029366|9772284|FG001|STARTED|Overall Study||8
8725103|NCT01029366|9772283|FG000|COMPLETED|Overall Study||14
8725104|NCT01029366|9772284|FG001|COMPLETED|Overall Study||6
8725105|NCT01029366|9772283|FG000|NOT COMPLETED|Overall Study||4
8725106|NCT01029366|9772284|FG001|NOT COMPLETED|Overall Study||2
8725107|NCT01029392|9772293|FG000|STARTED|Overall Study||37
8725108|NCT01029392|9772294|FG001|STARTED|Overall Study||38
8721609|NCT01012973|9768791|FG000|Fulfilled Requirements of FAS Population|Overall Study|Full Analysis Set (FAS) Population: Participants received treatment with post baseline measurements|103
8721610|NCT01012973|9768792|FG001|Fulfilled Requirements of FAS Population|Overall Study|Full Analysis Set (FAS) Population: Participants received treatment with post baseline measurements|68
8721611|NCT01012973|9768791|FG000|Completed Week 24, From FAS|Overall Study||97
8721612|NCT01012973|9768792|FG001|Completed Week 24, From FAS|Overall Study||57
8721613|NCT01012973|9768791|FG000|Completed Week 52, From FAS|Overall Study||91
8721614|NCT01012973|9768792|FG001|Completed Week 52, From FAS|Overall Study||52
8721615|NCT01012973|9768791|FG000|COMPLETED|Overall Study||90
8721616|NCT01012973|9768792|FG001|COMPLETED|Overall Study||52
8721617|NCT01012973|9768791|FG000|NOT COMPLETED|Overall Study||16
8721618|NCT01012973|9768792|FG001|NOT COMPLETED|Overall Study||19
8721619|NCT01012999|9768802|FG000|STARTED|Overall Study||16
8721620|NCT01012999|9768802|FG000|COMPLETED|Overall Study||15
8721621|NCT01012999|9768802|FG000|NOT COMPLETED|Overall Study||1
8558391|NCT04617860|9590219|FG000|STARTED|Overall Study||8
8558392|NCT04617860|9590220|FG001|STARTED|Overall Study||10
8558393|NCT04617860|9590221|FG002|STARTED|Overall Study||18
8558394|NCT04617860|9590219|FG000|Dose Modified to 8 mg|Overall Study||8
8558395|NCT04617860|9590220|FG001|Dose Modified to 8 mg|Overall Study||1
8558396|NCT04617860|9590221|FG002|Dose Modified to 8 mg|Overall Study||0
8558397|NCT04617860|9590219|FG000|Dose Modified to 16 mg|Overall Study||8
8558398|NCT04617860|9590220|FG001|Dose Modified to 16 mg|Overall Study||9
8629659|NCT00531050|9669383|FG002|NOT COMPLETED|Part 2: Period 1||0
8619003|NCT00466440|9657515|FG002|Received at Least One Dose of Study Drug|Overall Study||41
8619004|NCT00466440|9657513|FG000|COMPLETED|Overall Study||0
8619005|NCT00466440|9657514|FG001|COMPLETED|Overall Study|Completed = completed 4 cycles of treatment|36
8619006|NCT00466440|9657515|FG002|COMPLETED|Overall Study|Completed = completed 4 cycles of treatment|34
8619007|NCT00466440|9657513|FG000|NOT COMPLETED|Overall Study||14
8619008|NCT00466440|9657514|FG001|NOT COMPLETED|Overall Study||12
8619009|NCT00466440|9657515|FG002|NOT COMPLETED|Overall Study||12
8619010|NCT00466505|9657532|FG000|STARTED|Overall Study||17
8619011|NCT00466505|9657532|FG000|COMPLETED|Overall Study||0
8619012|NCT00466505|9657532|FG000|NOT COMPLETED|Overall Study||17
8619013|NCT00466661|9657538|FG000|STARTED|Overall Study||16
8619014|NCT00466661|9657539|FG001|STARTED|Overall Study||17
8619015|NCT00466661|9657538|FG000|At Least 1 Postrandomization Visit|Overall Study||14
8619016|NCT00466661|9657539|FG001|At Least 1 Postrandomization Visit|Overall Study||16
8619017|NCT00466661|9657538|FG000|COMPLETED|Overall Study||12
8619018|NCT00466661|9657539|FG001|COMPLETED|Overall Study||11
8619019|NCT00466661|9657538|FG000|NOT COMPLETED|Overall Study||4
8619020|NCT00466661|9657539|FG001|NOT COMPLETED|Overall Study||6
8619021|NCT00466687|9657545|FG000|STARTED|Overall Study||34
8721622|NCT01013194|9768808|FG000|STARTED|Overall Study||9
8721623|NCT01013194|9768809|FG001|STARTED|Overall Study||16
8721624|NCT01013194|9768808|FG000|COMPLETED|Overall Study|Consecutive patients|9
8721625|NCT01013194|9768809|FG001|COMPLETED|Overall Study|Retrospectively contemporary matched-pair group|16
8721626|NCT01013194|9768808|FG000|NOT COMPLETED|Overall Study||0
8721627|NCT01013194|9768809|FG001|NOT COMPLETED|Overall Study||0
8721628|NCT01013207|9768819|FG000|STARTED|CPAP Pre Nexus (S9)||50
8721629|NCT01013207|9768819|FG000|COMPLETED|CPAP Pre Nexus (S9)||50
8721630|NCT01013207|9768819|FG000|NOT COMPLETED|CPAP Pre Nexus (S9)||0
8721631|NCT01013207|9768819|FG000|STARTED|Nexus (S9)||50
8721632|NCT01013207|9768819|FG000|COMPLETED|Nexus (S9)||50
8721633|NCT01013207|9768819|FG000|NOT COMPLETED|Nexus (S9)||0
8721634|NCT01013207|9768819|FG000|STARTED|CPAP Post Nexus (S9)||50
8721635|NCT01013207|9768819|FG000|COMPLETED|CPAP Post Nexus (S9)||44
8721636|NCT01013207|9768819|FG000|NOT COMPLETED|CPAP Post Nexus (S9)||6
8721637|NCT01013285|9768825|FG000|STARTED|Overall Study||70
8721638|NCT01013285|9768826|FG001|STARTED|Overall Study||110
8813850|NCT01528254|9867058|FG001|Completed Treatment Period 1|Overall Study||273
8813851|NCT01528254|9867057|FG000|Completed Treatment Period 2|Overall Study||244
8813852|NCT01528254|9867058|FG001|Completed Treatment Period 2|Overall Study||399
8813853|NCT01528254|9867057|FG000|Completed Treatment Period 3|Overall Study||109
8721639|NCT01013285|9768825|FG000|COMPLETED|Overall Study||22
8721640|NCT01013285|9768826|FG001|COMPLETED|Overall Study||21
8721641|NCT01013285|9768825|FG000|NOT COMPLETED|Overall Study||48
8721642|NCT01013285|9768826|FG001|NOT COMPLETED|Overall Study||89
8721643|NCT01013350|9768833|FG000|STARTED|Overall Study||198
8721644|NCT01013350|9768834|FG001|STARTED|Overall Study||963
8619022|NCT00466687|9657545|FG000|COMPLETED|Overall Study||0
8619023|NCT00466687|9657545|FG000|NOT COMPLETED|Overall Study||34
8619024|NCT00466726|9657551|FG000|STARTED|Overall Study||57
8619025|NCT00466726|9657551|FG000|COMPLETED|Overall Study||43
8813854|NCT01528254|9867058|FG001|Completed Treatment Period 3|Overall Study||115
8813855|NCT01528254|9867057|FG000|COMPLETED|Overall Study||811
8813856|NCT01528254|9867058|FG001|COMPLETED|Overall Study||787
8558399|NCT04617860|9590221|FG002|Dose Modified to 16 mg|Overall Study||8
8558400|NCT04617860|9590219|FG000|Dose Modified to 32 mg|Overall Study||2
8558401|NCT04617860|9590220|FG001|Dose Modified to 32 mg|Overall Study||4
8558402|NCT04617860|9590221|FG002|Dose Modified to 32 mg|Overall Study||11
8558403|NCT04617860|9590219|FG000|COMPLETED|Overall Study||0
8558404|NCT04617860|9590220|FG001|COMPLETED|Overall Study||0
8558405|NCT04617860|9590221|FG002|COMPLETED|Overall Study||0
8558406|NCT04617860|9590219|FG000|NOT COMPLETED|Overall Study||8
8558407|NCT04617860|9590220|FG001|NOT COMPLETED|Overall Study||10
8558408|NCT04617860|9590221|FG002|NOT COMPLETED|Overall Study||18
8558409|NCT04617847|9590233|FG000|STARTED|Overall Study||3
8558410|NCT04617847|9590234|FG001|STARTED|Overall Study||24
8558411|NCT04617847|9590233|FG000|Dose Modified to 16 mg WVE-120101|Overall Study||3
8558412|NCT04617847|9590234|FG001|Dose Modified to 16 mg WVE-120101|Overall Study||1
8558413|NCT04617847|9590233|FG000|Dose Modified to 32 mg WVE-120101|Overall Study||0
8558414|NCT04617847|9590234|FG001|Dose Modified to 32 mg WVE-120101|Overall Study||5
8558415|NCT04617847|9590233|FG000|COMPLETED|Overall Study||0
8558416|NCT04617847|9590234|FG001|COMPLETED|Overall Study||0
8558417|NCT04617847|9590233|FG000|NOT COMPLETED|Overall Study||3
8558418|NCT04617847|9590234|FG001|NOT COMPLETED|Overall Study||24
8568914|NCT00094536|9601125|FG000|24 Month Follow-up|Treatment and Follow-up||53
8568915|NCT00094536|9601125|FG000|36 Month Follow-up|Treatment and Follow-up||51
8568916|NCT00094536|9601125|FG000|COMPLETED|Treatment and Follow-up|51 subjects successfully completed the study.|51
8568917|NCT00094536|9601125|FG000|NOT COMPLETED|Treatment and Follow-up||31
8568918|NCT00094575|9601131|FG000|STARTED|Overall Study||444
8568919|NCT00094575|9601132|FG001|STARTED|Overall Study||437
8568920|NCT00094575|9601131|FG000|COMPLETED|Overall Study||298
8568921|NCT00094575|9601132|FG001|COMPLETED|Overall Study||291
8568922|NCT00094575|9601131|FG000|NOT COMPLETED|Overall Study||146
8568923|NCT00094575|9601132|FG001|NOT COMPLETED|Overall Study||146
8568924|NCT00094653|9601143|FG000|STARTED|Overall Study||403
8813857|NCT01528254|9867057|FG000|NOT COMPLETED|Overall Study||187
8568925|NCT00094653|9601144|FG001|STARTED|Overall Study||137
8619026|NCT00466726|9657551|FG000|NOT COMPLETED|Overall Study||14
8619027|NCT00466752|9657557|FG000|STARTED|Overall Study||5
8619028|NCT00466752|9657558|FG001|STARTED|Overall Study||0
8619029|NCT00466752|9657557|FG000|COMPLETED|Overall Study||5
8721645|NCT01013350|9768833|FG000|Safety Analysis Set|Overall Study||198
8721646|NCT01013350|9768834|FG001|Safety Analysis Set|Overall Study||950
8721647|NCT01013350|9768833|FG000|COMPLETED|Overall Study||160
8721648|NCT01013350|9768834|FG001|COMPLETED|Overall Study||771
8721649|NCT01013350|9768833|FG000|NOT COMPLETED|Overall Study||38
8721650|NCT01013350|9768834|FG001|NOT COMPLETED|Overall Study||192
8619030|NCT00466752|9657558|FG001|COMPLETED|Overall Study||0
8619031|NCT00466752|9657557|FG000|NOT COMPLETED|Overall Study||0
8619032|NCT00466752|9657558|FG001|NOT COMPLETED|Overall Study||0
8619033|NCT00466817|9657566|FG000|STARTED|Overall Study||49
8619034|NCT00466817|9657567|FG001|STARTED|Overall Study||47
8619035|NCT00466817|9657566|FG000|COMPLETED|Overall Study||44
8721651|NCT01013597|9768841|FG000|STARTED|Overall Study||13
8721652|NCT01013597|9768841|FG000|COMPLETED|Overall Study||12
8721653|NCT01013597|9768841|FG000|NOT COMPLETED|Overall Study||1
8721654|NCT01013740|9768847|FG000|STARTED|Overall Study|13 participants (par.) experiencing PD in the RP elected to enroll in the optional CP.|37
8558419|NCT04426318|9590244|FG000|STARTED|Overall Study||346
8558420|NCT04426318|9590245|FG001|STARTED|Overall Study||320
8558421|NCT04426318|9590244|FG000|Failed Attention Checks|Overall Study||4
8558422|NCT04426318|9590245|FG001|Failed Attention Checks|Overall Study||6
8558423|NCT04426318|9590244|FG000|Downloaded HMP App|Overall Study||329
8558424|NCT04426318|9590245|FG001|Downloaded HMP App|Overall Study||0
8558425|NCT04426318|9590244|FG000|Completed T2 Assessment|Overall Study||281
8558426|NCT04426318|9590245|FG001|Completed T2 Assessment|Overall Study||280
8558427|NCT04426318|9590244|FG000|Completed T3 Assessment|Overall Study||261
8558428|NCT04426318|9590245|FG001|Completed T3 Assessment|Overall Study||274
8558429|NCT04426318|9590244|FG000|Completed T4 Assessment|Overall Study||261
8558430|NCT04426318|9590245|FG001|Completed T4 Assessment|Overall Study||275
8558431|NCT04426318|9590244|FG000|Completed T5 Assessment|Overall Study||284
8558432|NCT04426318|9590245|FG001|Completed T5 Assessment|Overall Study||293
8558433|NCT04426318|9590244|FG000|Completed T6 Assessment|Overall Study||286
8558434|NCT04426318|9590245|FG001|Completed T6 Assessment|Overall Study||293
8558435|NCT04426318|9590244|FG000|Final Intent to Treat Sample|Overall Study||344
8558436|NCT04426318|9590245|FG001|Final Intent to Treat Sample|Overall Study||318
8558437|NCT04426318|9590244|FG000|COMPLETED|Overall Study||344
8558438|NCT04426318|9590245|FG001|COMPLETED|Overall Study||318
8558439|NCT04426318|9590244|FG000|NOT COMPLETED|Overall Study||2
8558440|NCT04426318|9590245|FG001|NOT COMPLETED|Overall Study||2
8558441|NCT04255381|9590251|FG000|STARTED|Overall Study||20
8558442|NCT04255381|9590251|FG000|COMPLETED|Overall Study||20
8558443|NCT04255381|9590251|FG000|NOT COMPLETED|Overall Study||0
8558444|NCT04063657|9590257|FG000|STARTED|Overall Study||1
8558445|NCT04063657|9590258|FG001|STARTED|Overall Study||0
8558446|NCT04063657|9590257|FG000|COMPLETED|Overall Study||0
8558447|NCT04063657|9590258|FG001|COMPLETED|Overall Study||0
8558448|NCT04063657|9590257|FG000|NOT COMPLETED|Overall Study||1
8558449|NCT04063657|9590258|FG001|NOT COMPLETED|Overall Study||0
8558450|NCT04042623|9590264|FG000|STARTED|Overall Study||1
8558451|NCT04042623|9590264|FG000|COMPLETED|Overall Study||0
8558452|NCT04042623|9590264|FG000|NOT COMPLETED|Overall Study||1
8558453|NCT03882047|9590271|FG000|STARTED|Overall Study||104
8558454|NCT03882047|9590272|FG001|STARTED|Overall Study||105
8558455|NCT03882047|9590273|FG002|STARTED|Overall Study||104
8558456|NCT03882047|9590271|FG000|Treated|Overall Study||104
8558457|NCT03882047|9590272|FG001|Treated|Overall Study||104
8558458|NCT03882047|9590273|FG002|Treated|Overall Study||103
8558459|NCT03882047|9590271|FG000|COMPLETED|Overall Study||98
8558460|NCT03882047|9590272|FG001|COMPLETED|Overall Study||95
8558461|NCT03882047|9590273|FG002|COMPLETED|Overall Study||88
8558462|NCT03882047|9590271|FG000|NOT COMPLETED|Overall Study||6
8558463|NCT03882047|9590272|FG001|NOT COMPLETED|Overall Study||10
8558464|NCT03882047|9590273|FG002|NOT COMPLETED|Overall Study||16
8558465|NCT03879772|9590286|FG000|STARTED|Overall Study||137
8558466|NCT03879772|9590287|FG001|STARTED|Overall Study||135
8558467|NCT03879772|9590288|FG002|STARTED|Overall Study||133
8558468|NCT03879772|9590289|FG003|STARTED|Overall Study||138
8558469|NCT03879772|9590290|FG004|STARTED|Overall Study||136
8558470|NCT03879772|9590286|FG000|COMPLETED|Overall Study||133
8558471|NCT03879772|9590287|FG001|COMPLETED|Overall Study||132
8558472|NCT03879772|9590288|FG002|COMPLETED|Overall Study||123
8558473|NCT03879772|9590289|FG003|COMPLETED|Overall Study||130
8558474|NCT03879772|9590290|FG004|COMPLETED|Overall Study||128
8558475|NCT03879772|9590286|FG000|NOT COMPLETED|Overall Study||4
8558476|NCT03879772|9590287|FG001|NOT COMPLETED|Overall Study||3
8558477|NCT03879772|9590288|FG002|NOT COMPLETED|Overall Study||10
8558478|NCT03879772|9590289|FG003|NOT COMPLETED|Overall Study||8
8558479|NCT03879772|9590290|FG004|NOT COMPLETED|Overall Study||8
8558480|NCT03861559|9590304|FG000|STARTED|Overall Study||101
8558481|NCT03861559|9590305|FG001|STARTED|Overall Study||100
8558482|NCT03861559|9590304|FG000|COMPLETED|Overall Study||99
8558483|NCT03861559|9590305|FG001|COMPLETED|Overall Study||95
8558484|NCT03861559|9590304|FG000|NOT COMPLETED|Overall Study||2
8558485|NCT03861559|9590305|FG001|NOT COMPLETED|Overall Study||5
8558486|NCT03855228|9590315|FG000|STARTED|Overall Study||169
8558487|NCT03855228|9590316|FG001|STARTED|Overall Study||176
8558488|NCT03855228|9590317|FG002|STARTED|Overall Study||182
8619036|NCT00466817|9657567|FG001|COMPLETED|Overall Study||43
8619037|NCT00466817|9657566|FG000|NOT COMPLETED|Overall Study||5
8619038|NCT00466817|9657567|FG001|NOT COMPLETED|Overall Study||4
8619039|NCT00466921|9657582|FG000|STARTED|First 3 Cycles of Treatment|One patient completed only a few days of treatment|33
8619040|NCT00466921|9657582|FG000|Completed 1 Cycle|First 3 Cycles of Treatment||32
8619041|NCT00466921|9657582|FG000|Started Cycle 2|First 3 Cycles of Treatment||31
8721655|NCT01013740|9768848|FG001|STARTED|Overall Study|29 participants experiencing PD in the RP elected to enroll in the optional CP.|75
8721656|NCT01013740|9768847|FG000|Ongoing|Overall Study||0
8721657|NCT01013740|9768848|FG001|Ongoing|Overall Study||0
8725109|NCT01029392|9772293|FG000|COMPLETED|Overall Study||17
8725110|NCT01029392|9772294|FG001|COMPLETED|Overall Study||27
8619042|NCT00466921|9657582|FG000|Completed 3 Cycles|First 3 Cycles of Treatment||26
8619043|NCT00466921|9657582|FG000|COMPLETED|First 3 Cycles of Treatment||26
8619044|NCT00466921|9657582|FG000|NOT COMPLETED|First 3 Cycles of Treatment||7
8619045|NCT00466921|9657582|FG000|STARTED|Completed 4 Cycles/Reached 1st Response||26
8619046|NCT00466921|9657582|FG000|Completed 4 Cycles/1st Response|Completed 4 Cycles/Reached 1st Response||21
8619047|NCT00466921|9657582|FG000|COMPLETED|Completed 4 Cycles/Reached 1st Response||21
8619048|NCT00466921|9657582|FG000|NOT COMPLETED|Completed 4 Cycles/Reached 1st Response||5
8619049|NCT00466921|9657582|FG000|STARTED|Continued Treatment||21
8619050|NCT00466921|9657582|FG000|COMPLETED|Continued Treatment||21
8619051|NCT00466921|9657582|FG000|NOT COMPLETED|Continued Treatment||0
8619052|NCT00466921|9657582|FG000|STARTED|Follow up for a Minimum of 1 Year||33
8619053|NCT00466921|9657582|FG000|COMPLETED|Follow up for a Minimum of 1 Year||27
8619054|NCT00466921|9657582|FG000|NOT COMPLETED|Follow up for a Minimum of 1 Year||6
8619055|NCT00466947|9657588|FG000|STARTED|Primary Outcome Analysis Period||11875
8619056|NCT00466947|9657589|FG001|STARTED|Primary Outcome Analysis Period||11863
8619057|NCT00466947|9657588|FG000|Ongoing|Primary Outcome Analysis Period||11875
8619058|NCT00466947|9657589|FG001|Ongoing|Primary Outcome Analysis Period||11863
8619059|NCT00466947|9657588|FG000|COMPLETED|Primary Outcome Analysis Period|No data on study completion and withdrawal were available at first analysis as the study was ongoing|0
8619060|NCT00466947|9657589|FG001|COMPLETED|Primary Outcome Analysis Period|No data on study completion and withdrawal were available at first analysis as the study was ongoing|0
8619061|NCT00466947|9657588|FG000|NOT COMPLETED|Primary Outcome Analysis Period||11875
8619062|NCT00466947|9657589|FG001|NOT COMPLETED|Primary Outcome Analysis Period||11863
8619063|NCT00466947|9657588|FG000|STARTED|Study End Analysis Period||11798
8619064|NCT00466947|9657589|FG001|STARTED|Study End Analysis Period||11799
8558489|NCT03855228|9590318|FG003|STARTED|Overall Study||177
8558490|NCT03855228|9590315|FG000|Treated|Overall Study||169
8558491|NCT03855228|9590316|FG001|Treated|Overall Study||176
8558492|NCT03855228|9590317|FG002|Treated|Overall Study|1 participant immediately dropped out prior to starting study intervention.|181
8558493|NCT03855228|9590318|FG003|Treated|Overall Study|1 participant immediately dropped out prior to starting study intervention.|176
8558494|NCT03855228|9590315|FG000|COMPLETED|Overall Study||166
8558495|NCT03855228|9590316|FG001|COMPLETED|Overall Study||167
8558496|NCT03855228|9590317|FG002|COMPLETED|Overall Study||174
8558497|NCT03855228|9590318|FG003|COMPLETED|Overall Study||158
8558498|NCT03855228|9590315|FG000|NOT COMPLETED|Overall Study||3
8558499|NCT03855228|9590316|FG001|NOT COMPLETED|Overall Study||9
8558500|NCT03855228|9590317|FG002|NOT COMPLETED|Overall Study||8
8558501|NCT03855228|9590318|FG003|NOT COMPLETED|Overall Study||19
8558502|NCT03855189|9590331|FG000|STARTED|Overall Study||113
8558503|NCT03855189|9590332|FG001|STARTED|Overall Study||116
8558504|NCT03855189|9590333|FG002|STARTED|Overall Study||116
8558505|NCT03855189|9590331|FG000|Treated|Overall Study|Does not include 1 participant who received first dose but was excluded from safety analysis.|112
8558506|NCT03855189|9590332|FG001|Treated|Overall Study||116
8558507|NCT03855189|9590333|FG002|Treated|Overall Study||116
8558508|NCT03855189|9590331|FG000|COMPLETED|Overall Study||103
8558509|NCT03855189|9590332|FG001|COMPLETED|Overall Study||109
8558510|NCT03855189|9590333|FG002|COMPLETED|Overall Study||110
8558511|NCT03855189|9590331|FG000|NOT COMPLETED|Overall Study||10
8558512|NCT03855189|9590332|FG001|NOT COMPLETED|Overall Study||7
8558513|NCT03855189|9590333|FG002|NOT COMPLETED|Overall Study||6
8568926|NCT00094653|9601145|FG002|STARTED|Overall Study||136
8568927|NCT00094653|9601143|FG000|Treated|Overall Study||381
8568928|NCT00094653|9601144|FG001|Treated|Overall Study||131
8568929|NCT00094653|9601145|FG002|Treated|Overall Study||131
8568930|NCT00094653|9601143|FG000|COMPLETED|Overall Study||82
8568931|NCT00094653|9601144|FG001|COMPLETED|Overall Study||31
8568932|NCT00094653|9601145|FG002|COMPLETED|Overall Study||10
8568933|NCT00094653|9601143|FG000|NOT COMPLETED|Overall Study||321
8568934|NCT00094653|9601144|FG001|NOT COMPLETED|Overall Study||106
8568935|NCT00094653|9601145|FG002|NOT COMPLETED|Overall Study||126
8568936|NCT00094757|9601157|FG000|STARTED|Overall Study||205
8568937|NCT00094757|9601158|FG001|STARTED|Overall Study||206
8568938|NCT00094757|9601159|FG002|STARTED|Overall Study||110
8568939|NCT00094757|9601157|FG000|COMPLETED|Overall Study||152
8568940|NCT00094757|9601158|FG001|COMPLETED|Overall Study||144
8568941|NCT00094757|9601159|FG002|COMPLETED|Overall Study||80
8568942|NCT00094757|9601157|FG000|NOT COMPLETED|Overall Study||53
8568943|NCT00094757|9601158|FG001|NOT COMPLETED|Overall Study||62
8619065|NCT00466947|9657588|FG000|COMPLETED|Study End Analysis Period||9302
8619066|NCT00466947|9657589|FG001|COMPLETED|Study End Analysis Period||9265
8619067|NCT00466947|9657588|FG000|NOT COMPLETED|Study End Analysis Period||2496
8619068|NCT00466947|9657589|FG001|NOT COMPLETED|Study End Analysis Period||2534
8619069|NCT00466960|9657596|FG000|STARTED|Overall Study||21
8568944|NCT00094757|9601159|FG002|NOT COMPLETED|Overall Study||30
8568945|NCT00094770|9601169|FG000|STARTED|Year 1 ( Week 0 to Week 52)||588
8568946|NCT00094770|9601170|FG001|STARTED|Year 1 ( Week 0 to Week 52)||584
8568947|NCT00094770|9601169|FG000|COMPLETED|Year 1 ( Week 0 to Week 52)|4 Participants who Completed Week 52, Did NOT Enter second year|386
8568948|NCT00094770|9601170|FG001|COMPLETED|Year 1 ( Week 0 to Week 52)|11 Participants who Completed Week 52, Did NOT Enter second year|412
8568949|NCT00094770|9601169|FG000|NOT COMPLETED|Year 1 ( Week 0 to Week 52)||202
8568950|NCT00094770|9601170|FG001|NOT COMPLETED|Year 1 ( Week 0 to Week 52)||172
8568951|NCT00094770|9601169|FG000|STARTED|Year 2 (Week 0 to Week 104)||588
8568952|NCT00094770|9601170|FG001|STARTED|Year 2 (Week 0 to Week 104)||584
8568953|NCT00094770|9601169|FG000|COMPLETED|Year 2 (Week 0 to Week 104)||255
8568954|NCT00094770|9601170|FG001|COMPLETED|Year 2 (Week 0 to Week 104)||264
8568955|NCT00094770|9601169|FG000|NOT COMPLETED|Year 2 (Week 0 to Week 104)||333
8721658|NCT01013740|9768847|FG000|COMPLETED|Overall Study|Completion also = 18 mos.of a new anti-cancer therapy initiation +/or progression of disease|26
8725111|NCT01029392|9772293|FG000|NOT COMPLETED|Overall Study||20
8725112|NCT01029392|9772294|FG001|NOT COMPLETED|Overall Study||11
8619070|NCT00466960|9657596|FG000|COMPLETED|Overall Study||21
8619071|NCT00466960|9657596|FG000|NOT COMPLETED|Overall Study||0
8813858|NCT01528254|9867058|FG001|NOT COMPLETED|Overall Study||216
8849204|NCT01738971|9904352|FG001|COMPLETED|Overall Study|28 participants successfully contacted to complete telephone follow-up at 6-8 weeks.|28
8619072|NCT00467038|9657602|FG000|STARTED|Overall Study||11
8619073|NCT00467038|9657603|FG001|STARTED|Overall Study||11
8619074|NCT00467038|9657602|FG000|COMPLETED|Overall Study||11
8619075|NCT00467038|9657603|FG001|COMPLETED|Overall Study||11
8619076|NCT00467038|9657602|FG000|NOT COMPLETED|Overall Study||0
8619077|NCT00467038|9657603|FG001|NOT COMPLETED|Overall Study||0
8619078|NCT00467051|9657610|FG000|STARTED|Overall Study||20
8619079|NCT00467051|9657610|FG000|COMPLETED|Overall Study||18
8619080|NCT00467051|9657610|FG000|NOT COMPLETED|Overall Study||2
8619081|NCT00467077|9657615|FG000|STARTED|Overall Study||21
8619082|NCT00467077|9657615|FG000|COMPLETED|Overall Study||21
8619083|NCT00467077|9657615|FG000|NOT COMPLETED|Overall Study||0
8558514|NCT03764631|9590343|FG000|STARTED|Overall Study||751
8558515|NCT03764631|9590344|FG001|STARTED|Overall Study||751
8558516|NCT03764631|9590343|FG000|COMPLETED|Overall Study||710
8558517|NCT03764631|9590344|FG001|COMPLETED|Overall Study||698
8558518|NCT03764631|9590343|FG000|NOT COMPLETED|Overall Study||41
8558519|NCT03764631|9590344|FG001|NOT COMPLETED|Overall Study||53
8558520|NCT03764072|9590356|FG000|STARTED|Overall Study||46
8558521|NCT03764072|9590357|FG001|STARTED|Overall Study||42
8558522|NCT03764072|9590358|FG002|STARTED|Overall Study||44
8558523|NCT03764072|9590359|FG003|STARTED|Overall Study||45
8558524|NCT03764072|9590360|FG004|STARTED|Overall Study||46
8558525|NCT03764072|9590361|FG005|STARTED|Overall Study||27
8558526|NCT03764072|9590356|FG000|COMPLETED|Overall Study||46
8558527|NCT03764072|9590357|FG001|COMPLETED|Overall Study||42
8558528|NCT03764072|9590358|FG002|COMPLETED|Overall Study||43
8558529|NCT03764072|9590359|FG003|COMPLETED|Overall Study||45
8558530|NCT03764072|9590360|FG004|COMPLETED|Overall Study||45
8558531|NCT03764072|9590361|FG005|COMPLETED|Overall Study||26
8558532|NCT03764072|9590356|FG000|NOT COMPLETED|Overall Study||0
8558533|NCT03764072|9590357|FG001|NOT COMPLETED|Overall Study||0
8558534|NCT03764072|9590358|FG002|NOT COMPLETED|Overall Study||1
8558535|NCT03764072|9590359|FG003|NOT COMPLETED|Overall Study||0
8558536|NCT03764072|9590360|FG004|NOT COMPLETED|Overall Study||1
8558537|NCT03764072|9590361|FG005|NOT COMPLETED|Overall Study||1
8558538|NCT03645408|9590382|FG000|STARTED|Overall Study||1
8558539|NCT03645408|9590383|FG001|STARTED|Overall Study||2
8558540|NCT03645408|9590382|FG000|COMPLETED|Overall Study||1
8558541|NCT03645408|9590383|FG001|COMPLETED|Overall Study||2
8558542|NCT03645408|9590382|FG000|NOT COMPLETED|Overall Study||0
8558543|NCT03645408|9590383|FG001|NOT COMPLETED|Overall Study||0
8558544|NCT03578809|9590393|FG000|STARTED|Overall Study||94
8558545|NCT03578809|9590394|FG001|STARTED|Overall Study||185
8558546|NCT03578809|9590395|FG002|STARTED|Overall Study||112
8558547|NCT03578809|9590396|FG003|STARTED|Overall Study||202
8558548|NCT03578809|9590393|FG000|Treated|Overall Study||90
8558549|NCT03578809|9590394|FG001|Treated|Overall Study||179
8558550|NCT03578809|9590395|FG002|Treated|Overall Study||111
8558551|NCT03578809|9590396|FG003|Treated|Overall Study||195
8558552|NCT03578809|9590393|FG000|COMPLETED|Overall Study||88
8558553|NCT03578809|9590394|FG001|COMPLETED|Overall Study||171
8558554|NCT03578809|9590395|FG002|COMPLETED|Overall Study||108
8558555|NCT03578809|9590396|FG003|COMPLETED|Overall Study||193
8558556|NCT03578809|9590393|FG000|NOT COMPLETED|Overall Study||6
8558557|NCT03578809|9590394|FG001|NOT COMPLETED|Overall Study||14
8558558|NCT03578809|9590395|FG002|NOT COMPLETED|Overall Study||4
8619084|NCT00467259|9657621|FG000|STARTED|Overall Study||251
8619085|NCT00467259|9657622|FG001|STARTED|Overall Study||1020
8558559|NCT03578809|9590396|FG003|NOT COMPLETED|Overall Study||9
8558560|NCT03571204|9590412|FG000|STARTED|Overall Study||8
8558561|NCT03571204|9590413|FG001|STARTED|Overall Study||8
8558562|NCT03571204|9590414|FG002|STARTED|Overall Study||5
8558563|NCT03571204|9590412|FG000|COMPLETED|Overall Study||7
8558564|NCT03571204|9590413|FG001|COMPLETED|Overall Study||6
8558565|NCT03571204|9590414|FG002|COMPLETED|Overall Study||5
8558566|NCT03571204|9590412|FG000|NOT COMPLETED|Overall Study||1
8558567|NCT03571204|9590413|FG001|NOT COMPLETED|Overall Study||2
8558568|NCT03571204|9590414|FG002|NOT COMPLETED|Overall Study||0
8558569|NCT03523091|9590425|FG000|STARTED|Overall Study||1
8558570|NCT03523091|9590426|FG001|STARTED|Overall Study||5
8558571|NCT03523091|9590425|FG000|COMPLETED|Overall Study||0
8558572|NCT03523091|9590426|FG001|COMPLETED|Overall Study||1
8558573|NCT03523091|9590425|FG000|NOT COMPLETED|Overall Study||1
8558574|NCT03523091|9590426|FG001|NOT COMPLETED|Overall Study||4
8568956|NCT00094770|9601170|FG001|NOT COMPLETED|Year 2 (Week 0 to Week 104)||320
8619086|NCT00467259|9657621|FG000|ITT Population|Overall Study||251
8619087|NCT00467259|9657622|FG001|ITT Population|Overall Study|One subject did not take any study medication and was excluded from ITT population.|1019
8619088|NCT00467259|9657621|FG000|COMPLETED|Overall Study||176
8619089|NCT00467259|9657622|FG001|COMPLETED|Overall Study||778
8619090|NCT00467259|9657621|FG000|NOT COMPLETED|Overall Study||75
8619091|NCT00467259|9657622|FG001|NOT COMPLETED|Overall Study||242
8619092|NCT00467272|9657628|FG000|STARTED|Overall Study||41
8619093|NCT00467272|9657628|FG000|COMPLETED|Overall Study||38
8619094|NCT00467272|9657628|FG000|NOT COMPLETED|Overall Study||3
8619095|NCT00467285|9657634|FG000|STARTED|Overall Study||32
8619096|NCT00467285|9657635|FG001|STARTED|Overall Study||64
8619097|NCT00467285|9657634|FG000|COMPLETED|Overall Study||28
8619098|NCT00467285|9657635|FG001|COMPLETED|Overall Study||60
8619099|NCT00467285|9657634|FG000|NOT COMPLETED|Overall Study||4
8619100|NCT00467285|9657635|FG001|NOT COMPLETED|Overall Study||4
8619101|NCT00467298|9657645|FG000|STARTED|Overall Study||46
8619102|NCT00467298|9657646|FG001|STARTED|Overall Study||44
8619103|NCT00467298|9657645|FG000|COMPLETED|Overall Study||42
8619104|NCT00467298|9657646|FG001|COMPLETED|Overall Study||38
8619105|NCT00467298|9657645|FG000|NOT COMPLETED|Overall Study||4
8619106|NCT00467298|9657646|FG001|NOT COMPLETED|Overall Study||6
8619107|NCT00467350|9657654|FG000|STARTED|Overall Study||41
8619108|NCT00467350|9657655|FG001|STARTED|Overall Study||39
8619109|NCT00467350|9657654|FG000|COMPLETED|Overall Study||40
8619110|NCT00467350|9657655|FG001|COMPLETED|Overall Study||39
8619111|NCT00467350|9657654|FG000|NOT COMPLETED|Overall Study||1
8619112|NCT00467350|9657655|FG001|NOT COMPLETED|Overall Study||0
8619113|NCT00467363|9657663|FG000|STARTED|Overall Study||615
8619114|NCT00467363|9657664|FG001|STARTED|Overall Study||613
8619115|NCT00467363|9657663|FG000|COMPLETED|Overall Study||535
8619116|NCT00467363|9657664|FG001|COMPLETED|Overall Study||543
8619117|NCT00467363|9657663|FG000|NOT COMPLETED|Overall Study||80
8619118|NCT00467363|9657664|FG001|NOT COMPLETED|Overall Study||70
8619119|NCT00467389|9657670|FG000|STARTED|Overall Study||6
8619120|NCT00467389|9657671|FG001|STARTED|Overall Study||6
8619121|NCT00467389|9657670|FG000|COMPLETED|Overall Study||6
8619122|NCT00467389|9657671|FG001|COMPLETED|Overall Study||6
8619123|NCT00467389|9657670|FG000|NOT COMPLETED|Overall Study||0
8619124|NCT00467389|9657671|FG001|NOT COMPLETED|Overall Study||0
8721659|NCT01013740|9768848|FG001|COMPLETED|Overall Study|Completion also = 18 mos.of a new anti-cancer therapy initiation +/or progression of disease|56
8721660|NCT01013740|9768847|FG000|NOT COMPLETED|Overall Study||11
8721661|NCT01013740|9768848|FG001|NOT COMPLETED|Overall Study||19
8721662|NCT01013753|9768856|FG000|STARTED|Overall Study|Entered and treated|198
8721663|NCT01013753|9768856|FG000|Received Placebo|Overall Study||125
8721664|NCT01013753|9768856|FG000|Received Olo 2 mcg qd|Overall Study||121
8721665|NCT01013753|9768856|FG000|Received Olo 5 mcg qd|Overall Study||130
8721666|NCT01013753|9768856|FG000|Received Olo 10 mcg qd|Overall Study||127
8721667|NCT01013753|9768856|FG000|Received Olo 20 mcg qd|Overall Study||124
8721668|NCT01013753|9768856|FG000|Received Form 12 mcg Bid|Overall Study||125
8721669|NCT01013753|9768856|FG000|COMPLETED|Overall Study||182
8721670|NCT01013753|9768856|FG000|NOT COMPLETED|Overall Study||16
8721671|NCT01013792|9768872|FG000|STARTED|Overall Study||14
8721672|NCT01013792|9768873|FG001|STARTED|Overall Study||16
8721673|NCT01013792|9768872|FG000|COMPLETED|Overall Study||12
8721674|NCT01013792|9768873|FG001|COMPLETED|Overall Study||11
8721675|NCT01013792|9768872|FG000|NOT COMPLETED|Overall Study||2
8721676|NCT01013792|9768873|FG001|NOT COMPLETED|Overall Study||5
8619125|NCT00467519|9657679|FG000|STARTED|Overall Study||531
8619126|NCT00467519|9657680|FG001|STARTED|Overall Study||511
8619127|NCT00467519|9657679|FG000|COMPLETED|Overall Study||517
8619128|NCT00467519|9657680|FG001|COMPLETED|Overall Study||488
8721677|NCT01013844|9768881|FG000|STARTED|Overall Study||65
8721678|NCT01013844|9768882|FG001|STARTED|Overall Study||65
8721679|NCT01013844|9768881|FG000|COMPLETED|Overall Study||65
8721680|NCT01013844|9768882|FG001|COMPLETED|Overall Study||65
8721681|NCT01013844|9768881|FG000|NOT COMPLETED|Overall Study||0
8721682|NCT01013844|9768882|FG001|NOT COMPLETED|Overall Study||0
8721683|NCT01013870|9768894|FG000|STARTED|Overall Study||28
8721684|NCT01013870|9768895|FG001|STARTED|Overall Study||24
8721685|NCT01013870|9768894|FG000|COMPLETED|Overall Study||27
8619129|NCT00467519|9657679|FG000|NOT COMPLETED|Overall Study||14
8619130|NCT00467519|9657680|FG001|NOT COMPLETED|Overall Study||23
8619131|NCT00467558|9657688|FG000|STARTED|Overall Study||4
8619132|NCT00467558|9657689|FG001|STARTED|Overall Study||3
8619133|NCT00467558|9657688|FG000|COMPLETED|Overall Study||2
8619134|NCT00467558|9657689|FG001|COMPLETED|Overall Study||3
8619135|NCT00467558|9657688|FG000|NOT COMPLETED|Overall Study||2
8619136|NCT00467558|9657689|FG001|NOT COMPLETED|Overall Study||0
8721686|NCT01013870|9768895|FG001|COMPLETED|Overall Study||21
8619137|NCT00467584|9657698|FG000|STARTED|Overall Study||21
8619138|NCT00467584|9657699|FG001|STARTED|Overall Study||20
8619139|NCT00467584|9657700|FG002|STARTED|Overall Study||21
8619140|NCT00467584|9657698|FG000|COMPLETED|Overall Study||17
8721687|NCT01013870|9768894|FG000|NOT COMPLETED|Overall Study||1
8619141|NCT00467584|9657699|FG001|COMPLETED|Overall Study||15
8619142|NCT00467584|9657700|FG002|COMPLETED|Overall Study||20
8619143|NCT00467584|9657698|FG000|NOT COMPLETED|Overall Study||4
8619144|NCT00467584|9657699|FG001|NOT COMPLETED|Overall Study||5
8619145|NCT00467584|9657700|FG002|NOT COMPLETED|Overall Study||1
8619146|NCT00467597|9657712|FG000|STARTED|Overall Study||26
8619147|NCT00467597|9657713|FG001|STARTED|Overall Study||6
8619148|NCT00467597|9657712|FG000|COMPLETED|Overall Study||24
8619149|NCT00467597|9657713|FG001|COMPLETED|Overall Study||6
8619150|NCT00467597|9657712|FG000|NOT COMPLETED|Overall Study||2
8619151|NCT00467597|9657713|FG001|NOT COMPLETED|Overall Study||0
8619152|NCT00467610|9657723|FG000|STARTED|Overall Study||6
8619153|NCT00467610|9657723|FG000|COMPLETED|Overall Study||5
8568957|NCT00094809|9601178|FG000|STARTED|Overall Study||126
8568958|NCT00094809|9601179|FG001|STARTED|Overall Study||126
8568959|NCT00094809|9601178|FG000|Received Study Drug|Overall Study||124
8568960|NCT00094809|9601179|FG001|Received Study Drug|Overall Study||118
8568961|NCT00094809|9601178|FG000|Properly Consented; Received Study Drug|Overall Study||123
8568962|NCT00094809|9601179|FG001|Properly Consented; Received Study Drug|Overall Study||118
8568963|NCT00094809|9601178|FG000|Completed All 4 Cycles of Treatment|Overall Study||98
8568964|NCT00094809|9601179|FG001|Completed All 4 Cycles of Treatment|Overall Study||90
8558575|NCT03503474|9590434|FG000|STARTED|Overall Study|The number of participant with a diarrhoeal sample that returned a positive test result at the coordinating laboratory. There is no intervention as this is an observational study only.|103
8558576|NCT03503474|9590435|FG001|STARTED|Overall Study|The number of participant with a diarrhoeal sample that returned a negative test result at the coordinating laboratory. There is no intervention as this is an observational study only.|3050
8558577|NCT03503474|9590434|FG000|COMPLETED|Overall Study||103
8558578|NCT03503474|9590435|FG001|COMPLETED|Overall Study||3050
8558579|NCT03503474|9590434|FG000|NOT COMPLETED|Overall Study||0
8558580|NCT03503474|9590435|FG001|NOT COMPLETED|Overall Study||0
8558581|NCT03476317|9590444|FG000|STARTED|Overall Study|Group 1 study was not completed|0
8558582|NCT03476317|9590445|FG001|STARTED|Overall Study|Group 1 study was not completed|0
8558583|NCT03476317|9590446|FG002|STARTED|Overall Study||10
8558584|NCT03476317|9590444|FG000|COMPLETED|Overall Study|Group 1 study was not completed|0
8558585|NCT03476317|9590445|FG001|COMPLETED|Overall Study|Group 1 study was not completed|0
8558586|NCT03476317|9590446|FG002|COMPLETED|Overall Study||10
8558587|NCT03476317|9590444|FG000|NOT COMPLETED|Overall Study||0
8558588|NCT03476317|9590445|FG001|NOT COMPLETED|Overall Study||0
8558589|NCT03476317|9590446|FG002|NOT COMPLETED|Overall Study||0
8558590|NCT03391960|9590454|FG000|STARTED|Overall Study|Units were not assessed for this Arm/Group. Data was collected from the health care worker surveys for the retrospective study to monitor compliance with the scrub-the-hub protocol (signed informed consent and were enrolled)|165
8558591|NCT03391960|9590455|FG001|STARTED|Overall Study|No individual patient was recruited into the study. Data was collected from the compliance audits to monitor compliance with the disinfecting barrier cap protocol.|
8558592|NCT03391960|9590454|FG000|COMPLETED|Overall Study||165
8558593|NCT03391960|9590455|FG001|COMPLETED|Overall Study|No individual patient was recruited into the study. Data was collected from the compliance audits to monitor compliance with the disinfecting barrier cap protocol.|
8558594|NCT03391960|9590454|FG000|NOT COMPLETED|Overall Study||0
8558595|NCT03391960|9590455|FG001|NOT COMPLETED|Overall Study||
8558596|NCT03362190|9590474|FG000|STARTED|Overall Study||10
8558597|NCT03362190|9590475|FG001|STARTED|Overall Study||10
8558598|NCT03362190|9590476|FG002|STARTED|Overall Study||22
8619154|NCT00467610|9657723|FG000|NOT COMPLETED|Overall Study||1
8619155|NCT00467649|9657729|FG000|STARTED|Phase 1 (Randomized Population)|One patient randomized to the SYMLIN group withdrew consent prior to receiving the first dose|57
8619156|NCT00467649|9657730|FG001|STARTED|Phase 1 (Randomized Population)||56
8619157|NCT00467649|9657731|FG002|STARTED|Phase 1 (Randomized Population)||0
8619158|NCT00467649|9657732|FG003|STARTED|Phase 1 (Randomized Population)||0
8619159|NCT00467649|9657733|FG004|STARTED|Phase 1 (Randomized Population)||0
8558599|NCT03362190|9590477|FG003|STARTED|Overall Study||22
8558600|NCT03362190|9590474|FG000|COMPLETED|Overall Study||10
8558601|NCT03362190|9590475|FG001|COMPLETED|Overall Study||10
8558602|NCT03362190|9590476|FG002|COMPLETED|Overall Study||22
8558603|NCT03362190|9590477|FG003|COMPLETED|Overall Study||20
8558604|NCT03362190|9590474|FG000|NOT COMPLETED|Overall Study||0
8558605|NCT03362190|9590475|FG001|NOT COMPLETED|Overall Study||0
8558606|NCT03362190|9590476|FG002|NOT COMPLETED|Overall Study||0
8558607|NCT03362190|9590477|FG003|NOT COMPLETED|Overall Study||2
8568965|NCT00094809|9601178|FG000|COMPLETED|Overall Study|Subjects who completed treatment and Long term follow up (LTFU)|74
8568966|NCT00094809|9601179|FG001|COMPLETED|Overall Study|Subjects who completed treatment and LTFU|61
8568967|NCT00094809|9601178|FG000|NOT COMPLETED|Overall Study||52
8568968|NCT00094809|9601179|FG001|NOT COMPLETED|Overall Study||65
8568969|NCT00094835|9601192|FG000|STARTED|Overall Study||9
8568970|NCT00094835|9601193|FG001|STARTED|Overall Study||11
8568971|NCT00094835|9601194|FG002|STARTED|Overall Study||7
8568972|NCT00094835|9601195|FG003|STARTED|Overall Study||5
8568973|NCT00094835|9601196|FG004|STARTED|Overall Study||7
8568974|NCT00094835|9601197|FG005|STARTED|Overall Study||6
8568975|NCT00094835|9601198|FG006|STARTED|Overall Study||6
8619160|NCT00467649|9657734|FG005|STARTED|Phase 1 (Randomized Population)||0
8943684|NCT02391116|10005527|FG000|COMPLETED|Survival Follow-up|Reason for completed in this period included death (35) and clinical endpoint reached (7)|42
8943685|NCT02391116|10005527|FG000|NOT COMPLETED|Survival Follow-up||4
8943686|NCT02391311|10005540|FG000|STARTED|Overall Study||21
8943687|NCT02391311|10005541|FG001|STARTED|Overall Study||21
8943688|NCT02391311|10005540|FG000|COMPLETED|Overall Study||18
8943689|NCT02391311|10005541|FG001|COMPLETED|Overall Study||19
8943690|NCT02391311|10005540|FG000|NOT COMPLETED|Overall Study||3
8943691|NCT02391311|10005541|FG001|NOT COMPLETED|Overall Study||2
8943692|NCT02391337|10005549|FG000|STARTED|Baseline||80
8943693|NCT02391337|10005550|FG001|STARTED|Baseline||81
8943694|NCT02391337|10005549|FG000|COMPLETED|Baseline||80
8943695|NCT02391337|10005550|FG001|COMPLETED|Baseline||81
8943696|NCT02391337|10005549|FG000|NOT COMPLETED|Baseline||0
8943697|NCT02391337|10005550|FG001|NOT COMPLETED|Baseline||0
8943698|NCT02391337|10005549|FG000|STARTED|6 Months Follow-up||80
8943699|NCT02391337|10005550|FG001|STARTED|6 Months Follow-up||81
8943700|NCT02391337|10005549|FG000|COMPLETED|6 Months Follow-up||74
8943701|NCT02391337|10005550|FG001|COMPLETED|6 Months Follow-up||76
8943702|NCT02391337|10005549|FG000|NOT COMPLETED|6 Months Follow-up||6
8943703|NCT02391337|10005550|FG001|NOT COMPLETED|6 Months Follow-up||5
8943704|NCT02391337|10005549|FG000|STARTED|12 Months Follow-up||74
8943705|NCT02391337|10005550|FG001|STARTED|12 Months Follow-up||76
8943706|NCT02391337|10005549|FG000|COMPLETED|12 Months Follow-up||72
8558608|NCT03252522|9590492|FG000|STARTED|Overall Study||78
8619161|NCT00467649|9657729|FG000|Intent to Treat|Phase 1 (Randomized Population)||56
8619162|NCT00467649|9657730|FG001|Intent to Treat|Phase 1 (Randomized Population)||56
8619163|NCT00467649|9657731|FG002|Intent to Treat|Phase 1 (Randomized Population)||0
8619164|NCT00467649|9657732|FG003|Intent to Treat|Phase 1 (Randomized Population)||0
8619165|NCT00467649|9657733|FG004|Intent to Treat|Phase 1 (Randomized Population)||0
8619166|NCT00467649|9657734|FG005|Intent to Treat|Phase 1 (Randomized Population)||0
8619167|NCT00467649|9657729|FG000|COMPLETED|Phase 1 (Randomized Population)||48
8619168|NCT00467649|9657730|FG001|COMPLETED|Phase 1 (Randomized Population)||50
8619169|NCT00467649|9657731|FG002|COMPLETED|Phase 1 (Randomized Population)||0
8619170|NCT00467649|9657732|FG003|COMPLETED|Phase 1 (Randomized Population)||0
8619171|NCT00467649|9657733|FG004|COMPLETED|Phase 1 (Randomized Population)||0
8619172|NCT00467649|9657734|FG005|COMPLETED|Phase 1 (Randomized Population)||0
8558609|NCT03252522|9590493|FG001|STARTED|Overall Study||57
8558610|NCT03252522|9590494|FG002|STARTED|Overall Study||0
8558611|NCT03252522|9590492|FG000|COMPLETED|Overall Study||69
8558612|NCT03252522|9590493|FG001|COMPLETED|Overall Study||54
8558613|NCT03252522|9590494|FG002|COMPLETED|Overall Study||0
8558614|NCT03252522|9590492|FG000|NOT COMPLETED|Overall Study||9
8558615|NCT03252522|9590493|FG001|NOT COMPLETED|Overall Study||3
8558616|NCT03252522|9590494|FG002|NOT COMPLETED|Overall Study||0
8558617|NCT03235544|9590509|FG000|STARTED|Overall Study||12
8558618|NCT03235544|9590510|FG001|STARTED|Overall Study||41
8558619|NCT03235544|9590511|FG002|STARTED|Overall Study||31
8558620|NCT03235544|9590512|FG003|STARTED|Overall Study||77
8558621|NCT03235544|9590509|FG000|COMPLETED|Overall Study||0
8558622|NCT03235544|9590510|FG001|COMPLETED|Overall Study||0
8558623|NCT03235544|9590511|FG002|COMPLETED|Overall Study||0
8558624|NCT03235544|9590512|FG003|COMPLETED|Overall Study||0
8558625|NCT03235544|9590509|FG000|NOT COMPLETED|Overall Study||12
8558626|NCT03235544|9590510|FG001|NOT COMPLETED|Overall Study||41
8558627|NCT03235544|9590511|FG002|NOT COMPLETED|Overall Study||31
8558628|NCT03235544|9590512|FG003|NOT COMPLETED|Overall Study||77
8558629|NCT03225833|9590529|FG000|STARTED|Overall Study||16
8558630|NCT03225833|9590530|FG001|STARTED|Overall Study||9
8558631|NCT03225833|9590531|FG002|STARTED|Overall Study||9
8558632|NCT03225833|9590532|FG003|STARTED|Overall Study||9
8558633|NCT03225833|9590533|FG004|STARTED|Overall Study||8
8558634|NCT03225833|9590534|FG005|STARTED|Overall Study||10
8558635|NCT03225833|9590529|FG000|Single Dose Period Only|Overall Study||1
8558636|NCT03225833|9590530|FG001|Single Dose Period Only|Overall Study||1
8558637|NCT03225833|9590531|FG002|Single Dose Period Only|Overall Study||2
8558638|NCT03225833|9590532|FG003|Single Dose Period Only|Overall Study||0
8558639|NCT03225833|9590533|FG004|Single Dose Period Only|Overall Study||0
8558640|NCT03225833|9590534|FG005|Single Dose Period Only|Overall Study||4
8558641|NCT03225833|9590529|FG000|Multiple Dose Period Only|Overall Study||0
8558642|NCT03225833|9590530|FG001|Multiple Dose Period Only|Overall Study||0
8558643|NCT03225833|9590531|FG002|Multiple Dose Period Only|Overall Study||0
8558644|NCT03225833|9590532|FG003|Multiple Dose Period Only|Overall Study||0
8558645|NCT03225833|9590533|FG004|Multiple Dose Period Only|Overall Study||0
8558646|NCT03225833|9590534|FG005|Multiple Dose Period Only|Overall Study||1
8558647|NCT03225833|9590529|FG000|Single Dose and Multiple Dose Periods|Overall Study||15
8558648|NCT03225833|9590530|FG001|Single Dose and Multiple Dose Periods|Overall Study||8
8558649|NCT03225833|9590531|FG002|Single Dose and Multiple Dose Periods|Overall Study||7
8558650|NCT03225833|9590532|FG003|Single Dose and Multiple Dose Periods|Overall Study||9
8558651|NCT03225833|9590533|FG004|Single Dose and Multiple Dose Periods|Overall Study||8
8558652|NCT03225833|9590534|FG005|Single Dose and Multiple Dose Periods|Overall Study||5
8558653|NCT03225833|9590529|FG000|COMPLETED|Overall Study||11
8558654|NCT03225833|9590530|FG001|COMPLETED|Overall Study||8
8558655|NCT03225833|9590531|FG002|COMPLETED|Overall Study||7
8558656|NCT03225833|9590532|FG003|COMPLETED|Overall Study||9
8558657|NCT03225833|9590533|FG004|COMPLETED|Overall Study||7
8558658|NCT03225833|9590534|FG005|COMPLETED|Overall Study||0
8558659|NCT03225833|9590529|FG000|NOT COMPLETED|Overall Study||5
8558660|NCT03225833|9590530|FG001|NOT COMPLETED|Overall Study||1
8558661|NCT03225833|9590531|FG002|NOT COMPLETED|Overall Study||2
8558662|NCT03225833|9590532|FG003|NOT COMPLETED|Overall Study||0
8558663|NCT03225833|9590533|FG004|NOT COMPLETED|Overall Study||1
8558664|NCT03225833|9590534|FG005|NOT COMPLETED|Overall Study||10
8558665|NCT03167242|9590565|FG000|STARTED|Overall Study||12
8558666|NCT03167242|9590566|FG001|STARTED|Overall Study||51
8558667|NCT03167242|9590567|FG002|STARTED|Overall Study||51
8558668|NCT03167242|9590568|FG003|STARTED|Overall Study||51
8558669|NCT03167242|9590569|FG004|STARTED|Overall Study||54
8558670|NCT03167242|9590570|FG005|STARTED|Overall Study||51
8558671|NCT03167242|9590571|FG006|STARTED|Overall Study||52
8558672|NCT03167242|9590572|FG007|STARTED|Overall Study||27
8558673|NCT03167242|9590573|FG008|STARTED|Overall Study||53
8558674|NCT03167242|9590574|FG009|STARTED|Overall Study||53
8558675|NCT03167242|9590575|FG010|STARTED|Overall Study||45
8558676|NCT03167242|9590576|FG011|STARTED|Overall Study||24
8558677|NCT03167242|9590565|FG000|Full Analysis Set (FAS)|Overall Study||12
8558678|NCT03167242|9590566|FG001|Full Analysis Set (FAS)|Overall Study||51
8558679|NCT03167242|9590567|FG002|Full Analysis Set (FAS)|Overall Study||51
8558680|NCT03167242|9590568|FG003|Full Analysis Set (FAS)|Overall Study||51
8558681|NCT03167242|9590569|FG004|Full Analysis Set (FAS)|Overall Study||54
8558682|NCT03167242|9590570|FG005|Full Analysis Set (FAS)|Overall Study||51
8558683|NCT03167242|9590571|FG006|Full Analysis Set (FAS)|Overall Study||52
8558684|NCT03167242|9590572|FG007|Full Analysis Set (FAS)|Overall Study||27
8558685|NCT03167242|9590573|FG008|Full Analysis Set (FAS)|Overall Study||52
8721688|NCT01013870|9768895|FG001|NOT COMPLETED|Overall Study||3
8721689|NCT01013883|9768903|FG000|STARTED|Overall Study||270
8721690|NCT01013883|9768904|FG001|STARTED|Overall Study||243
8721691|NCT01013883|9768903|FG000|COMPLETED|Overall Study||268
8721692|NCT01013883|9768904|FG001|COMPLETED|Overall Study||241
8721693|NCT01013883|9768903|FG000|NOT COMPLETED|Overall Study||2
8721694|NCT01013883|9768904|FG001|NOT COMPLETED|Overall Study||2
8721695|NCT01013961|9768912|FG000|STARTED|Overall Study||16
8721696|NCT01013961|9768913|FG001|STARTED|Overall Study||15
8721697|NCT01013961|9768912|FG000|COMPLETED|Overall Study||13
8721698|NCT01013961|9768913|FG001|COMPLETED|Overall Study||12
8721699|NCT01013961|9768912|FG000|NOT COMPLETED|Overall Study||3
8721700|NCT01013961|9768913|FG001|NOT COMPLETED|Overall Study||3
8721701|NCT01014013|9768921|FG000|STARTED|Overall Study||135
8721702|NCT01014013|9768922|FG001|STARTED|Overall Study||136
8721703|NCT01014013|9768921|FG000|Adverse Event Reporting|Overall Study|Patients who received at least 1 dose of MK0826 parenteral therapy|132
8619173|NCT00467649|9657729|FG000|NOT COMPLETED|Phase 1 (Randomized Population)||9
8619174|NCT00467649|9657730|FG001|NOT COMPLETED|Phase 1 (Randomized Population)||6
8721704|NCT01014013|9768922|FG001|Adverse Event Reporting|Overall Study|Patients who received at least 1 dose of Ceftriaxone parenteral therapy|135
8721705|NCT01014013|9768921|FG000|Completed Parenteral Therapy|Overall Study|"Patients completing MK0826 as a single daily dose of 1.0g intravenous~infusion at least 3 days"|87
8721706|NCT01014013|9768922|FG001|Completed Parenteral Therapy|Overall Study|Patients completing Ceftriaxone as a single daily dose of 2.0g intravenous infusion at least 3 days|88
8721707|NCT01014013|9768921|FG000|COMPLETED|Overall Study|Patients who completed 7 days therapy including minimum 3 days of MK0826 parentheral therapy|84
8721708|NCT01014013|9768922|FG001|COMPLETED|Overall Study|Patients who completed 7 days therapy including minimum 3 days of Ceftriaxone parentheral therapy|80
8721709|NCT01014013|9768921|FG000|NOT COMPLETED|Overall Study||51
8721710|NCT01014013|9768922|FG001|NOT COMPLETED|Overall Study||56
8721711|NCT01014091|9768936|FG000|STARTED|Overall Study||7
8721712|NCT01014091|9768937|FG001|STARTED|Overall Study||13
8721713|NCT01014091|9768938|FG002|STARTED|Overall Study||5
8558686|NCT03167242|9590574|FG009|Full Analysis Set (FAS)|Overall Study||53
8558687|NCT03167242|9590575|FG010|Full Analysis Set (FAS)|Overall Study||45
8558688|NCT03167242|9590576|FG011|Full Analysis Set (FAS)|Overall Study||24
8558689|NCT03167242|9590565|FG000|Pharmacokinetics (PK) Analysis Set|Overall Study||12
8558690|NCT03167242|9590566|FG001|Pharmacokinetics (PK) Analysis Set|Overall Study||47
8558691|NCT03167242|9590567|FG002|Pharmacokinetics (PK) Analysis Set|Overall Study||51
8558692|NCT03167242|9590568|FG003|Pharmacokinetics (PK) Analysis Set|Overall Study||46
8721714|NCT01014091|9768939|FG003|STARTED|Overall Study||15
8721715|NCT01014091|9768940|FG004|STARTED|Overall Study||6
8721716|NCT01014091|9768941|FG005|STARTED|Overall Study||12
8721717|NCT01014091|9768936|FG000|COMPLETED|Overall Study||7
8721718|NCT01014091|9768937|FG001|COMPLETED|Overall Study||13
8721719|NCT01014091|9768938|FG002|COMPLETED|Overall Study||5
8721720|NCT01014091|9768939|FG003|COMPLETED|Overall Study||15
8721721|NCT01014091|9768940|FG004|COMPLETED|Overall Study||6
8721722|NCT01014091|9768941|FG005|COMPLETED|Overall Study||12
8721723|NCT01014091|9768936|FG000|NOT COMPLETED|Overall Study||0
8721724|NCT01014091|9768937|FG001|NOT COMPLETED|Overall Study||0
8721725|NCT01014091|9768938|FG002|NOT COMPLETED|Overall Study||0
8721726|NCT01014091|9768939|FG003|NOT COMPLETED|Overall Study||0
8721727|NCT01014091|9768940|FG004|NOT COMPLETED|Overall Study||0
8721728|NCT01014091|9768941|FG005|NOT COMPLETED|Overall Study||0
8721729|NCT01014143|9768967|FG000|STARTED|First Intervention||10
8721730|NCT01014143|9768968|FG001|STARTED|First Intervention||9
8721731|NCT01014143|9768969|FG002|STARTED|First Intervention||9
8721732|NCT01014143|9768967|FG000|COMPLETED|First Intervention||10
8721733|NCT01014143|9768968|FG001|COMPLETED|First Intervention||9
8721734|NCT01014143|9768969|FG002|COMPLETED|First Intervention||9
8721735|NCT01014143|9768967|FG000|NOT COMPLETED|First Intervention||0
8721736|NCT01014143|9768968|FG001|NOT COMPLETED|First Intervention||0
8721737|NCT01014143|9768969|FG002|NOT COMPLETED|First Intervention||0
8721738|NCT01014143|9768967|FG000|STARTED|Washout Period After 1st Intervention||10
8721739|NCT01014143|9768968|FG001|STARTED|Washout Period After 1st Intervention||9
8721740|NCT01014143|9768969|FG002|STARTED|Washout Period After 1st Intervention||9
8721741|NCT01014143|9768967|FG000|COMPLETED|Washout Period After 1st Intervention||10
8721742|NCT01014143|9768968|FG001|COMPLETED|Washout Period After 1st Intervention||9
8619175|NCT00467649|9657731|FG002|NOT COMPLETED|Phase 1 (Randomized Population)||0
8619176|NCT00467649|9657732|FG003|NOT COMPLETED|Phase 1 (Randomized Population)||0
8619177|NCT00467649|9657733|FG004|NOT COMPLETED|Phase 1 (Randomized Population)||0
8619178|NCT00467649|9657734|FG005|NOT COMPLETED|Phase 1 (Randomized Population)||0
8619179|NCT00467649|9657729|FG000|STARTED|Phase 2 (Intent-to-Treat Population)||0
8619180|NCT00467649|9657730|FG001|STARTED|Phase 2 (Intent-to-Treat Population)||0
8619181|NCT00467649|9657731|FG002|STARTED|Phase 2 (Intent-to-Treat Population)||17
8619182|NCT00467649|9657732|FG003|STARTED|Phase 2 (Intent-to-Treat Population)||31
8619183|NCT00467649|9657733|FG004|STARTED|Phase 2 (Intent-to-Treat Population)||14
8619184|NCT00467649|9657734|FG005|STARTED|Phase 2 (Intent-to-Treat Population)||36
8619185|NCT00467649|9657729|FG000|COMPLETED|Phase 2 (Intent-to-Treat Population)||0
8619186|NCT00467649|9657730|FG001|COMPLETED|Phase 2 (Intent-to-Treat Population)||0
8619187|NCT00467649|9657731|FG002|COMPLETED|Phase 2 (Intent-to-Treat Population)||17
8619188|NCT00467649|9657732|FG003|COMPLETED|Phase 2 (Intent-to-Treat Population)||29
8619189|NCT00467649|9657733|FG004|COMPLETED|Phase 2 (Intent-to-Treat Population)||14
8558693|NCT03167242|9590569|FG004|Pharmacokinetics (PK) Analysis Set|Overall Study||48
8558694|NCT03167242|9590570|FG005|Pharmacokinetics (PK) Analysis Set|Overall Study||46
8558695|NCT03167242|9590571|FG006|Pharmacokinetics (PK) Analysis Set|Overall Study||45
8558696|NCT03167242|9590572|FG007|Pharmacokinetics (PK) Analysis Set|Overall Study||24
8558697|NCT03167242|9590573|FG008|Pharmacokinetics (PK) Analysis Set|Overall Study||48
8558698|NCT03167242|9590574|FG009|Pharmacokinetics (PK) Analysis Set|Overall Study||46
8558699|NCT03167242|9590575|FG010|Pharmacokinetics (PK) Analysis Set|Overall Study||41
8558700|NCT03167242|9590576|FG011|Pharmacokinetics (PK) Analysis Set|Overall Study||24
8558701|NCT03167242|9590565|FG000|Per-Protocol Set (PPS)|Overall Study||12
8558702|NCT03167242|9590566|FG001|Per-Protocol Set (PPS)|Overall Study||50
8558703|NCT03167242|9590567|FG002|Per-Protocol Set (PPS)|Overall Study||48
8558704|NCT03167242|9590568|FG003|Per-Protocol Set (PPS)|Overall Study||48
8558705|NCT03167242|9590569|FG004|Per-Protocol Set (PPS)|Overall Study||47
8558706|NCT03167242|9590570|FG005|Per-Protocol Set (PPS)|Overall Study||44
8558707|NCT03167242|9590571|FG006|Per-Protocol Set (PPS)|Overall Study||43
8558708|NCT03167242|9590572|FG007|Per-Protocol Set (PPS)|Overall Study||25
8558709|NCT03167242|9590573|FG008|Per-Protocol Set (PPS)|Overall Study||48
8558710|NCT03167242|9590574|FG009|Per-Protocol Set (PPS)|Overall Study||46
8558711|NCT03167242|9590575|FG010|Per-Protocol Set (PPS)|Overall Study||40
8558712|NCT03167242|9590576|FG011|Per-Protocol Set (PPS)|Overall Study||22
8558713|NCT03167242|9590565|FG000|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||12
8558714|NCT03167242|9590566|FG001|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||5
8558715|NCT03167242|9590567|FG002|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||6
8558716|NCT03167242|9590568|FG003|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||6
8558717|NCT03167242|9590569|FG004|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||6
8558718|NCT03167242|9590570|FG005|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||12
8558719|NCT03167242|9590571|FG006|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||5
8558720|NCT03167242|9590572|FG007|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||0
8558721|NCT03167242|9590573|FG008|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||0
8558722|NCT03167242|9590574|FG009|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||0
8558723|NCT03167242|9590575|FG010|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||0
8558724|NCT03167242|9590576|FG011|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||0
8558725|NCT03167242|9590565|FG000|COMPLETED|Overall Study||12
8558726|NCT03167242|9590566|FG001|COMPLETED|Overall Study||50
8558727|NCT03167242|9590567|FG002|COMPLETED|Overall Study||48
8558728|NCT03167242|9590568|FG003|COMPLETED|Overall Study||50
8558729|NCT03167242|9590569|FG004|COMPLETED|Overall Study||53
8558730|NCT03167242|9590570|FG005|COMPLETED|Overall Study||49
8558731|NCT03167242|9590571|FG006|COMPLETED|Overall Study||50
8558732|NCT03167242|9590572|FG007|COMPLETED|Overall Study||26
8558733|NCT03167242|9590573|FG008|COMPLETED|Overall Study||52
8558734|NCT03167242|9590574|FG009|COMPLETED|Overall Study||53
8558735|NCT03167242|9590575|FG010|COMPLETED|Overall Study||43
8558736|NCT03167242|9590576|FG011|COMPLETED|Overall Study||23
8558737|NCT03167242|9590565|FG000|NOT COMPLETED|Overall Study||0
8558738|NCT03167242|9590566|FG001|NOT COMPLETED|Overall Study||1
8558739|NCT03167242|9590567|FG002|NOT COMPLETED|Overall Study||3
8558740|NCT03167242|9590568|FG003|NOT COMPLETED|Overall Study||1
8558741|NCT03167242|9590569|FG004|NOT COMPLETED|Overall Study||1
8558742|NCT03167242|9590570|FG005|NOT COMPLETED|Overall Study||2
8558743|NCT03167242|9590571|FG006|NOT COMPLETED|Overall Study||2
8619190|NCT00467649|9657734|FG005|COMPLETED|Phase 2 (Intent-to-Treat Population)||35
8619191|NCT00467649|9657729|FG000|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
8619192|NCT00467649|9657730|FG001|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
8619193|NCT00467649|9657731|FG002|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
8619194|NCT00467649|9657732|FG003|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||2
8619195|NCT00467649|9657733|FG004|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
8619196|NCT00467649|9657734|FG005|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||1
8619197|NCT00467740|9657757|FG000|STARTED|Overall Study||54
8619198|NCT00467740|9657758|FG001|STARTED|Overall Study||61
8619199|NCT00467740|9657759|FG002|STARTED|Overall Study||60
8619200|NCT00467740|9657760|FG003|STARTED|Overall Study||60
8619201|NCT00467740|9657761|FG004|STARTED|Overall Study||61
8619202|NCT00467740|9657757|FG000|COMPLETED|Overall Study||53
8619203|NCT00467740|9657758|FG001|COMPLETED|Overall Study||58
8619204|NCT00467740|9657759|FG002|COMPLETED|Overall Study||58
8619205|NCT00467740|9657760|FG003|COMPLETED|Overall Study||59
8619206|NCT00467740|9657761|FG004|COMPLETED|Overall Study||61
8619207|NCT00467740|9657757|FG000|NOT COMPLETED|Overall Study||1
8619208|NCT00467740|9657758|FG001|NOT COMPLETED|Overall Study||3
8619209|NCT00467740|9657759|FG002|NOT COMPLETED|Overall Study||2
8619210|NCT00467740|9657760|FG003|NOT COMPLETED|Overall Study||1
8721743|NCT01014143|9768969|FG002|COMPLETED|Washout Period After 1st Intervention||9
8721744|NCT01014143|9768967|FG000|NOT COMPLETED|Washout Period After 1st Intervention||0
8721745|NCT01014143|9768968|FG001|NOT COMPLETED|Washout Period After 1st Intervention||0
8721746|NCT01014143|9768969|FG002|NOT COMPLETED|Washout Period After 1st Intervention||0
8721747|NCT01014143|9768967|FG000|STARTED|Second Intervention||10
8721748|NCT01014143|9768968|FG001|STARTED|Second Intervention||9
8721749|NCT01014143|9768969|FG002|STARTED|Second Intervention||9
8721750|NCT01014143|9768967|FG000|COMPLETED|Second Intervention||8
8721751|NCT01014143|9768968|FG001|COMPLETED|Second Intervention||9
8721752|NCT01014143|9768969|FG002|COMPLETED|Second Intervention||9
8721753|NCT01014143|9768967|FG000|NOT COMPLETED|Second Intervention||2
8721754|NCT01014143|9768968|FG001|NOT COMPLETED|Second Intervention||0
8721755|NCT01014143|9768969|FG002|NOT COMPLETED|Second Intervention||0
8721756|NCT01014143|9768967|FG000|STARTED|Washout After 2nd Intervention||8
8721757|NCT01014143|9768968|FG001|STARTED|Washout After 2nd Intervention||9
8721758|NCT01014143|9768969|FG002|STARTED|Washout After 2nd Intervention||9
8721759|NCT01014143|9768967|FG000|COMPLETED|Washout After 2nd Intervention||8
8721760|NCT01014143|9768968|FG001|COMPLETED|Washout After 2nd Intervention||9
8558744|NCT03167242|9590572|FG007|NOT COMPLETED|Overall Study||1
8558745|NCT03167242|9590573|FG008|NOT COMPLETED|Overall Study||1
8558746|NCT03167242|9590574|FG009|NOT COMPLETED|Overall Study||0
8558747|NCT03167242|9590575|FG010|NOT COMPLETED|Overall Study||2
8558748|NCT03167242|9590576|FG011|NOT COMPLETED|Overall Study||1
8558749|NCT03137537|9590614|FG000|STARTED|Overall Study||12
8558750|NCT03137537|9590615|FG001|STARTED|Overall Study||11
8558751|NCT03137537|9590614|FG000|COMPLETED|Overall Study||12
8558752|NCT03137537|9590615|FG001|COMPLETED|Overall Study||10
8558753|NCT03137537|9590614|FG000|NOT COMPLETED|Overall Study||0
8558754|NCT03137537|9590615|FG001|NOT COMPLETED|Overall Study||1
8558755|NCT03126019|9590623|FG000|STARTED|Overall Study||23
8558756|NCT03126019|9590624|FG001|STARTED|Overall Study||103
8558757|NCT03126019|9590623|FG000|COMPLETED|Overall Study||0
8558758|NCT03126019|9590624|FG001|COMPLETED|Overall Study||0
8558759|NCT03126019|9590623|FG000|NOT COMPLETED|Overall Study||23
8558760|NCT03126019|9590624|FG001|NOT COMPLETED|Overall Study||103
8558761|NCT03113383|9590631|FG000|STARTED|Overall Study||4
8558762|NCT03113383|9590632|FG001|STARTED|Overall Study||0
8558763|NCT03113383|9590631|FG000|COMPLETED|Overall Study||0
8558764|NCT03113383|9590632|FG001|COMPLETED|Overall Study||0
8558765|NCT03113383|9590631|FG000|NOT COMPLETED|Overall Study||4
8558766|NCT03113383|9590632|FG001|NOT COMPLETED|Overall Study||0
8558767|NCT03057106|9590640|FG000|STARTED|Overall Study|1 patient refused the treatment|149
8558768|NCT03057106|9590641|FG001|STARTED|Overall Study|3 patients refused the treatment|148
8558769|NCT03057106|9590640|FG000|COMPLETED|Overall Study||149
8558770|NCT03057106|9590641|FG001|COMPLETED|Overall Study||148
8558771|NCT03057106|9590640|FG000|NOT COMPLETED|Overall Study||0
8558772|NCT03057106|9590641|FG001|NOT COMPLETED|Overall Study||0
8558773|NCT03028896|9590649|FG000|STARTED|Overall Study||66
8558774|NCT03028896|9590650|FG001|STARTED|Overall Study||66
8558775|NCT03028896|9590649|FG000|COMPLETED|Overall Study||63
8558776|NCT03028896|9590650|FG001|COMPLETED|Overall Study||66
8558777|NCT03028896|9590649|FG000|NOT COMPLETED|Overall Study||3
8558778|NCT03028896|9590650|FG001|NOT COMPLETED|Overall Study||0
8558779|NCT03008369|9590656|FG000|STARTED|Overall Study||3
8558780|NCT03008369|9590656|FG000|COMPLETED|Overall Study||3
8558781|NCT03008369|9590656|FG000|NOT COMPLETED|Overall Study||0
8558782|NCT02978326|9590663|FG000|STARTED|Part A (Up to 75 Days)||1
8558783|NCT02978326|9590664|FG001|STARTED|Part A (Up to 75 Days)||0
8558784|NCT02978326|9590665|FG002|STARTED|Part A (Up to 75 Days)||0
8558785|NCT02978326|9590663|FG000|COMPLETED|Part A (Up to 75 Days)||1
8558786|NCT02978326|9590664|FG001|COMPLETED|Part A (Up to 75 Days)||0
8558787|NCT02978326|9590665|FG002|COMPLETED|Part A (Up to 75 Days)||0
8558788|NCT02978326|9590663|FG000|NOT COMPLETED|Part A (Up to 75 Days)||0
8558789|NCT02978326|9590664|FG001|NOT COMPLETED|Part A (Up to 75 Days)||0
8558790|NCT02978326|9590665|FG002|NOT COMPLETED|Part A (Up to 75 Days)||0
8558791|NCT02978326|9590663|FG000|STARTED|Part B (Up to 45 Days)||0
8558792|NCT02978326|9590664|FG001|STARTED|Part B (Up to 45 Days)||76
8558793|NCT02978326|9590665|FG002|STARTED|Part B (Up to 45 Days)||77
8558794|NCT02978326|9590663|FG000|Received Study Drug|Part B (Up to 45 Days)||0
8558795|NCT02978326|9590664|FG001|Received Study Drug|Part B (Up to 45 Days)||73
8558796|NCT02978326|9590665|FG002|Received Study Drug|Part B (Up to 45 Days)|Two participants were randomized to placebo but received at least 1 dose of SAGE-217 in error and were included in the SAGE-217 group for 'Received Study Drug' and for 'Safety Analysis'.|78
8558797|NCT02978326|9590663|FG000|Safety Set (Part B)|Part B (Up to 45 Days)||0
8558798|NCT02978326|9590664|FG001|Safety Set (Part B)|Part B (Up to 45 Days)||73
8558799|NCT02978326|9590665|FG002|Safety Set (Part B)|Part B (Up to 45 Days)||78
8558800|NCT02978326|9590663|FG000|Efficacy Set (Part B)|Part B (Up to 45 Days)||0
8558801|NCT02978326|9590664|FG001|Efficacy Set (Part B)|Part B (Up to 45 Days)||74
8558802|NCT02978326|9590665|FG002|Efficacy Set (Part B)|Part B (Up to 45 Days)||76
8558803|NCT02978326|9590663|FG000|COMPLETED|Part B (Up to 45 Days)||0
8558804|NCT02978326|9590664|FG001|COMPLETED|Part B (Up to 45 Days)||69
8558805|NCT02978326|9590665|FG002|COMPLETED|Part B (Up to 45 Days)||73
8558806|NCT02978326|9590663|FG000|NOT COMPLETED|Part B (Up to 45 Days)||0
8558807|NCT02978326|9590664|FG001|NOT COMPLETED|Part B (Up to 45 Days)||7
8558808|NCT02978326|9590665|FG002|NOT COMPLETED|Part B (Up to 45 Days)||4
8558809|NCT02970929|9590675|FG000|STARTED|Overall Study||157
8558810|NCT02970929|9590675|FG000|Subjects Who Received Study Medication|Overall Study||156
8558811|NCT02970929|9590675|FG000|COMPLETED|Overall Study||105
8558812|NCT02970929|9590675|FG000|NOT COMPLETED|Overall Study||52
8558813|NCT02963493|9590681|FG000|STARTED|Overall Study||157
8558814|NCT02963493|9590681|FG000|COMPLETED|Overall Study||157
8558815|NCT02963493|9590681|FG000|NOT COMPLETED|Overall Study||0
8558816|NCT02899078|9590692|FG000|STARTED|Overall Study||31
8558817|NCT02899078|9590692|FG000|COMPLETED|Overall Study||28
8558818|NCT02899078|9590692|FG000|NOT COMPLETED|Overall Study||3
8558819|NCT02873975|9590699|FG000|STARTED|Overall Study||8
8558820|NCT02873975|9590700|FG001|STARTED|Overall Study||10
8558821|NCT02873975|9590701|FG002|STARTED|Overall Study||9
8558822|NCT02873975|9590699|FG000|COMPLETED|Overall Study||8
8558823|NCT02873975|9590700|FG001|COMPLETED|Overall Study||10
8558824|NCT02873975|9590701|FG002|COMPLETED|Overall Study||9
8558825|NCT02873975|9590699|FG000|NOT COMPLETED|Overall Study||0
8558826|NCT02873975|9590700|FG001|NOT COMPLETED|Overall Study||0
8558827|NCT02873975|9590701|FG002|NOT COMPLETED|Overall Study||0
8619211|NCT00467740|9657761|FG004|NOT COMPLETED|Overall Study||0
8619212|NCT00467779|9657788|FG000|STARTED|Stage 1||4
8619213|NCT00467779|9657789|FG001|STARTED|Stage 1||3
8619214|NCT00467779|9657790|FG002|STARTED|Stage 1||3
8619215|NCT00467779|9657791|FG003|STARTED|Stage 1||3
8619216|NCT00467779|9657792|FG004|STARTED|Stage 1||3
8619217|NCT00467779|9657793|FG005|STARTED|Stage 1||6
8558828|NCT02797951|9590709|FG000|STARTED|Overall Study||165
8558829|NCT02797951|9590709|FG000|Received at Least One Dose of Study Drug|Overall Study||164
8558830|NCT02797951|9590709|FG000|COMPLETED|Overall Study||116
8558831|NCT02797951|9590709|FG000|NOT COMPLETED|Overall Study||49
8558832|NCT02753751|9590715|FG000|STARTED|Overall Study||2971
8558833|NCT02753751|9590716|FG001|STARTED|Overall Study||3059
8558834|NCT02753751|9590715|FG000|COMPLETED|Overall Study||2971
8558835|NCT02753751|9590716|FG001|COMPLETED|Overall Study||3059
8558836|NCT02753751|9590715|FG000|NOT COMPLETED|Overall Study||0
8558837|NCT02753751|9590716|FG001|NOT COMPLETED|Overall Study||0
8558838|NCT02748057|9590724|FG000|STARTED|Overall Study||114
8558839|NCT02748057|9590725|FG001|STARTED|Overall Study||21
8558840|NCT02748057|9590724|FG000|COMPLETED|Overall Study||109
8558841|NCT02748057|9590725|FG001|COMPLETED|Overall Study||19
8558842|NCT02748057|9590724|FG000|NOT COMPLETED|Overall Study||5
8558843|NCT02748057|9590725|FG001|NOT COMPLETED|Overall Study||2
8558844|NCT02741271|9590733|FG000|STARTED|Overall Study||91
8558845|NCT02741271|9590734|FG001|STARTED|Overall Study||90
8558846|NCT02741271|9590733|FG000|COMPLETED|Overall Study||89
8558847|NCT02741271|9590734|FG001|COMPLETED|Overall Study||88
8558848|NCT02741271|9590733|FG000|NOT COMPLETED|Overall Study||2
8558849|NCT02741271|9590734|FG001|NOT COMPLETED|Overall Study||2
8558850|NCT02741245|9590747|FG000|STARTED|Overall Study||35
8558851|NCT02741245|9590748|FG001|STARTED|Overall Study||72
8558852|NCT02741245|9590749|FG002|STARTED|Overall Study||71
8558853|NCT02741245|9590750|FG003|STARTED|Overall Study||71
8558854|NCT02741245|9590751|FG004|STARTED|Overall Study||72
8558855|NCT02741245|9590747|FG000|COMPLETED|Overall Study||35
8558856|NCT02741245|9590748|FG001|COMPLETED|Overall Study||71
8558857|NCT02741245|9590749|FG002|COMPLETED|Overall Study||71
8558858|NCT02741245|9590750|FG003|COMPLETED|Overall Study||67
8558859|NCT02741245|9590751|FG004|COMPLETED|Overall Study||70
8558860|NCT02741245|9590747|FG000|NOT COMPLETED|Overall Study||0
8558861|NCT02741245|9590748|FG001|NOT COMPLETED|Overall Study||1
8558862|NCT02741245|9590749|FG002|NOT COMPLETED|Overall Study||0
8558863|NCT02741245|9590750|FG003|NOT COMPLETED|Overall Study||4
8558864|NCT02741245|9590751|FG004|NOT COMPLETED|Overall Study||2
8558865|NCT02688608|9590763|FG000|STARTED|Overall Study||6
8558866|NCT02688608|9590763|FG000|COMPLETED|Overall Study||5
8558867|NCT02688608|9590763|FG000|NOT COMPLETED|Overall Study||1
8558868|NCT02675231|9590770|FG000|STARTED|Overall Study||79
8558869|NCT02675231|9590771|FG001|STARTED|Overall Study||79
8558870|NCT02675231|9590772|FG002|STARTED|Overall Study||79
8558871|NCT02675231|9590770|FG000|Received at Least One Dose of Drug|Overall Study||78
8558872|NCT02675231|9590771|FG001|Received at Least One Dose of Drug|Overall Study||77
8558873|NCT02675231|9590772|FG002|Received at Least One Dose of Drug|Overall Study||72
8558874|NCT02675231|9590770|FG000|COMPLETED|Overall Study||53
8558875|NCT02675231|9590771|FG001|COMPLETED|Overall Study||43
8558876|NCT02675231|9590772|FG002|COMPLETED|Overall Study||53
8558877|NCT02675231|9590770|FG000|NOT COMPLETED|Overall Study||26
8558878|NCT02675231|9590771|FG001|NOT COMPLETED|Overall Study||36
8558879|NCT02675231|9590772|FG002|NOT COMPLETED|Overall Study||26
8558880|NCT02634268|9590783|FG000|STARTED|Overall Study||346
8558881|NCT02634268|9590784|FG001|STARTED|Overall Study||338
8558882|NCT02634268|9590783|FG000|COMPLETED|Overall Study|In-person visit completion = 267 for both groups. Some participants completed only surveys because of Covid-19 restrictions.|287
8558883|NCT02634268|9590784|FG001|COMPLETED|Overall Study|In-person visit completion = 267 for both groups. Some participants completed only surveys because of Covid-19 restrictions.|291
8558884|NCT02634268|9590783|FG000|NOT COMPLETED|Overall Study||59
8558885|NCT02634268|9590784|FG001|NOT COMPLETED|Overall Study||47
8558886|NCT02605967|9590792|FG000|STARTED|Overall Study||82
8558887|NCT02605967|9590793|FG001|STARTED|Overall Study||40
8558888|NCT02605967|9590792|FG000|Safety Set|Overall Study||82
8558889|NCT02605967|9590793|FG001|Safety Set|Overall Study||39
8558890|NCT02605967|9590792|FG000|Crossover to Spartalizumab|Overall Study||0
8558891|NCT02605967|9590793|FG001|Crossover to Spartalizumab|Overall Study||27
8558892|NCT02605967|9590792|FG000|COMPLETED|Overall Study||0
8619218|NCT00467779|9657794|FG006|STARTED|Stage 1||7
8619219|NCT00467779|9657795|FG007|STARTED|Stage 1||7
8619220|NCT00467779|9657796|FG008|STARTED|Stage 1||0
8619221|NCT00467779|9657797|FG009|STARTED|Stage 1||0
8619222|NCT00467779|9657798|FG010|STARTED|Stage 1||0
8619223|NCT00467779|9657799|FG011|STARTED|Stage 1||0
8619224|NCT00467779|9657800|FG012|STARTED|Stage 1||0
8721761|NCT01014143|9768969|FG002|COMPLETED|Washout After 2nd Intervention||9
8619225|NCT00467779|9657801|FG013|STARTED|Stage 1||0
8619226|NCT00467779|9657802|FG014|STARTED|Stage 1||0
8558893|NCT02605967|9590793|FG001|COMPLETED|Overall Study||0
8558894|NCT02605967|9590792|FG000|NOT COMPLETED|Overall Study||82
8558895|NCT02605967|9590793|FG001|NOT COMPLETED|Overall Study||40
8558896|NCT02584634|9590805|FG000|STARTED|Overall Study||12
8558897|NCT02584634|9590806|FG001|STARTED|Overall Study||31
8558898|NCT02584634|9590805|FG000|COMPLETED|Overall Study||0
8558899|NCT02584634|9590806|FG001|COMPLETED|Overall Study||0
8558900|NCT02584634|9590805|FG000|NOT COMPLETED|Overall Study||12
8558901|NCT02584634|9590806|FG001|NOT COMPLETED|Overall Study||31
8558902|NCT02581137|9590815|FG000|STARTED|Overall Study||26
8558903|NCT02581137|9590815|FG000|COMPLETED|Overall Study||22
8558904|NCT02581137|9590815|FG000|NOT COMPLETED|Overall Study||4
8568976|NCT00094835|9601192|FG000|Treated With Motesanib|Overall Study||6
8568977|NCT00094835|9601193|FG001|Treated With Motesanib|Overall Study||11
8568978|NCT00094835|9601194|FG002|Treated With Motesanib|Overall Study||6
8568979|NCT00094835|9601195|FG003|Treated With Motesanib|Overall Study||4
8619227|NCT00467779|9657788|FG000|COMPLETED|Stage 1||0
8619228|NCT00467779|9657789|FG001|COMPLETED|Stage 1||0
8619229|NCT00467779|9657790|FG002|COMPLETED|Stage 1||0
8619230|NCT00467779|9657791|FG003|COMPLETED|Stage 1||0
8619231|NCT00467779|9657792|FG004|COMPLETED|Stage 1||0
8619232|NCT00467779|9657793|FG005|COMPLETED|Stage 1||1
8619233|NCT00467779|9657794|FG006|COMPLETED|Stage 1||0
8619234|NCT00467779|9657795|FG007|COMPLETED|Stage 1||0
8721762|NCT01014143|9768967|FG000|NOT COMPLETED|Washout After 2nd Intervention||0
8721763|NCT01014143|9768968|FG001|NOT COMPLETED|Washout After 2nd Intervention||0
8721764|NCT01014143|9768969|FG002|NOT COMPLETED|Washout After 2nd Intervention||0
8721765|NCT01014143|9768967|FG000|STARTED|Third Intervention||8
8721766|NCT01014143|9768968|FG001|STARTED|Third Intervention||9
8721767|NCT01014143|9768969|FG002|STARTED|Third Intervention||9
8721768|NCT01014143|9768967|FG000|COMPLETED|Third Intervention||8
8721769|NCT01014143|9768968|FG001|COMPLETED|Third Intervention||9
8721770|NCT01014143|9768969|FG002|COMPLETED|Third Intervention||9
8721771|NCT01014143|9768967|FG000|NOT COMPLETED|Third Intervention||0
8721772|NCT01014143|9768968|FG001|NOT COMPLETED|Third Intervention||0
8721773|NCT01014143|9768969|FG002|NOT COMPLETED|Third Intervention||0
8721774|NCT01014169|9768979|FG000|STARTED|Overall Study||65
8721775|NCT01014169|9768980|FG001|STARTED|Overall Study||61
8721776|NCT01014169|9768979|FG000|COMPLETED|Overall Study||58
8721777|NCT01014169|9768980|FG001|COMPLETED|Overall Study||48
8721778|NCT01014169|9768979|FG000|NOT COMPLETED|Overall Study||7
8721779|NCT01014169|9768980|FG001|NOT COMPLETED|Overall Study||13
8721780|NCT01014208|9768988|FG000|STARTED|Overall Study||225
8721781|NCT01014208|9768989|FG001|STARTED|Overall Study||222
8721782|NCT01014208|9768988|FG000|Intent-to-Treat Population|Overall Study||223
8721783|NCT01014208|9768989|FG001|Intent-to-Treat Population|Overall Study||222
8721784|NCT01014208|9768988|FG000|COMPLETED|Overall Study||131
8568980|NCT00094835|9601196|FG004|Treated With Motesanib|Overall Study||7
8568981|NCT00094835|9601197|FG005|Treated With Motesanib|Overall Study||5
8568982|NCT00094835|9601198|FG006|Treated With Motesanib|Overall Study||6
8568983|NCT00094835|9601192|FG000|COMPLETED|Overall Study||5
8568984|NCT00094835|9601193|FG001|COMPLETED|Overall Study||8
8568985|NCT00094835|9601194|FG002|COMPLETED|Overall Study||4
8568986|NCT00094835|9601195|FG003|COMPLETED|Overall Study||4
8568987|NCT00094835|9601196|FG004|COMPLETED|Overall Study||3
8568988|NCT00094835|9601197|FG005|COMPLETED|Overall Study||3
8568989|NCT00094835|9601198|FG006|COMPLETED|Overall Study||4
8568990|NCT00094835|9601192|FG000|NOT COMPLETED|Overall Study||4
8568991|NCT00094835|9601193|FG001|NOT COMPLETED|Overall Study||3
8568992|NCT00094835|9601194|FG002|NOT COMPLETED|Overall Study||3
8568993|NCT00094835|9601195|FG003|NOT COMPLETED|Overall Study||1
8568994|NCT00094835|9601196|FG004|NOT COMPLETED|Overall Study||4
8568995|NCT00094835|9601197|FG005|NOT COMPLETED|Overall Study||3
8568996|NCT00094835|9601198|FG006|NOT COMPLETED|Overall Study||2
8568997|NCT00094861|9601221|FG000|STARTED|Overall Study||46
8568998|NCT00094861|9601222|FG001|STARTED|Overall Study||49
8568999|NCT00094861|9601221|FG000|Participants Treated|Overall Study||46
8619235|NCT00467779|9657796|FG008|COMPLETED|Stage 1||0
8619236|NCT00467779|9657797|FG009|COMPLETED|Stage 1||0
8721785|NCT01014208|9768989|FG001|COMPLETED|Overall Study||122
8721786|NCT01014208|9768988|FG000|NOT COMPLETED|Overall Study||94
8721787|NCT01014208|9768989|FG001|NOT COMPLETED|Overall Study||100
8721788|NCT01014351|9768995|FG000|STARTED|Overall Study||70
8569000|NCT00094861|9601222|FG001|Participants Treated|Overall Study||48
8569001|NCT00094861|9601221|FG000|COMPLETED|Overall Study|Participants who completed the acute dysphagia evaluation phase|28
8569002|NCT00094861|9601222|FG001|COMPLETED|Overall Study|Participants who completed the acute dysphagia evaluation phase|40
8569003|NCT00094861|9601221|FG000|NOT COMPLETED|Overall Study||18
8569004|NCT00094861|9601222|FG001|NOT COMPLETED|Overall Study||9
8569005|NCT00094887|9601230|FG000|STARTED|Overall Study||75
8569006|NCT00094887|9601231|FG001|STARTED|Overall Study||75
8569007|NCT00094887|9601230|FG000|Safety Population|Overall Study||75
8619237|NCT00467779|9657798|FG010|COMPLETED|Stage 1||0
8619238|NCT00467779|9657799|FG011|COMPLETED|Stage 1||0
8619239|NCT00467779|9657800|FG012|COMPLETED|Stage 1||0
8558905|NCT02570503|9590821|FG000|STARTED|Overall Study||34
8558906|NCT02570503|9590822|FG001|STARTED|Overall Study||30
8558907|NCT02570503|9590821|FG000|COMPLETED|Overall Study||34
8558908|NCT02570503|9590822|FG001|COMPLETED|Overall Study||30
8558909|NCT02570503|9590821|FG000|NOT COMPLETED|Overall Study||0
8558910|NCT02570503|9590822|FG001|NOT COMPLETED|Overall Study||0
8558911|NCT02553265|9590828|FG000|STARTED|Enrollment||9
8558912|NCT02553265|9590829|FG001|STARTED|Enrollment||7
8558913|NCT02553265|9590830|FG002|STARTED|Enrollment||6
8558914|NCT02553265|9590828|FG000|COMPLETED|Enrollment||9
8558915|NCT02553265|9590829|FG001|COMPLETED|Enrollment||7
8558916|NCT02553265|9590830|FG002|COMPLETED|Enrollment||5
8558917|NCT02553265|9590828|FG000|NOT COMPLETED|Enrollment||0
8558918|NCT02553265|9590829|FG001|NOT COMPLETED|Enrollment||0
8558919|NCT02553265|9590830|FG002|NOT COMPLETED|Enrollment||1
8558920|NCT02553265|9590828|FG000|STARTED|First Intervention (28 Days)||9
8619240|NCT00467779|9657801|FG013|COMPLETED|Stage 1||0
8619241|NCT00467779|9657802|FG014|COMPLETED|Stage 1||0
8619242|NCT00467779|9657788|FG000|NOT COMPLETED|Stage 1||4
8619243|NCT00467779|9657789|FG001|NOT COMPLETED|Stage 1||3
8619244|NCT00467779|9657790|FG002|NOT COMPLETED|Stage 1||3
8558921|NCT02553265|9590829|FG001|STARTED|First Intervention (28 Days)||7
8558922|NCT02553265|9590830|FG002|STARTED|First Intervention (28 Days)||5
8558923|NCT02553265|9590828|FG000|COMPLETED|First Intervention (28 Days)||8
8558924|NCT02553265|9590829|FG001|COMPLETED|First Intervention (28 Days)||7
8558925|NCT02553265|9590830|FG002|COMPLETED|First Intervention (28 Days)||4
8619245|NCT00467779|9657791|FG003|NOT COMPLETED|Stage 1||3
8619246|NCT00467779|9657792|FG004|NOT COMPLETED|Stage 1||3
8619247|NCT00467779|9657793|FG005|NOT COMPLETED|Stage 1||5
8619248|NCT00467779|9657794|FG006|NOT COMPLETED|Stage 1||7
8619249|NCT00467779|9657795|FG007|NOT COMPLETED|Stage 1||7
8619250|NCT00467779|9657796|FG008|NOT COMPLETED|Stage 1||0
8619251|NCT00467779|9657797|FG009|NOT COMPLETED|Stage 1||0
8619252|NCT00467779|9657798|FG010|NOT COMPLETED|Stage 1||0
8619253|NCT00467779|9657799|FG011|NOT COMPLETED|Stage 1||0
8619254|NCT00467779|9657800|FG012|NOT COMPLETED|Stage 1||0
8619255|NCT00467779|9657801|FG013|NOT COMPLETED|Stage 1||0
8558926|NCT02553265|9590828|FG000|NOT COMPLETED|First Intervention (28 Days)||1
8558927|NCT02553265|9590829|FG001|NOT COMPLETED|First Intervention (28 Days)||0
8558928|NCT02553265|9590830|FG002|NOT COMPLETED|First Intervention (28 Days)||1
8558929|NCT02553265|9590828|FG000|STARTED|Second Intervention (28 Days)||8
8558930|NCT02553265|9590829|FG001|STARTED|Second Intervention (28 Days)||7
8558931|NCT02553265|9590830|FG002|STARTED|Second Intervention (28 Days)||4
8558932|NCT02553265|9590828|FG000|COMPLETED|Second Intervention (28 Days)||7
8558933|NCT02553265|9590829|FG001|COMPLETED|Second Intervention (28 Days)||7
8558934|NCT02553265|9590830|FG002|COMPLETED|Second Intervention (28 Days)||4
8558935|NCT02553265|9590828|FG000|NOT COMPLETED|Second Intervention (28 Days)||1
8558936|NCT02553265|9590829|FG001|NOT COMPLETED|Second Intervention (28 Days)||0
8558937|NCT02553265|9590830|FG002|NOT COMPLETED|Second Intervention (28 Days)||0
8558938|NCT02553265|9590828|FG000|STARTED|Third Intervention (28 Days)||7
8558939|NCT02553265|9590829|FG001|STARTED|Third Intervention (28 Days)||7
8558940|NCT02553265|9590830|FG002|STARTED|Third Intervention (28 Days)||4
8558941|NCT02553265|9590828|FG000|COMPLETED|Third Intervention (28 Days)||6
8558942|NCT02553265|9590829|FG001|COMPLETED|Third Intervention (28 Days)||7
8558943|NCT02553265|9590830|FG002|COMPLETED|Third Intervention (28 Days)||3
8558944|NCT02553265|9590828|FG000|NOT COMPLETED|Third Intervention (28 Days)||1
8558945|NCT02553265|9590829|FG001|NOT COMPLETED|Third Intervention (28 Days)||0
8558946|NCT02553265|9590830|FG002|NOT COMPLETED|Third Intervention (28 Days)||1
8558947|NCT02550288|9590846|FG000|STARTED|Overall Study||35
8558948|NCT02550288|9590847|FG001|STARTED|Overall Study||68
8558949|NCT02550288|9590848|FG002|STARTED|Overall Study||69
8558950|NCT02550288|9590849|FG003|STARTED|Overall Study||68
8558951|NCT02550288|9590850|FG004|STARTED|Overall Study||69
8558952|NCT02550288|9590846|FG000|COMPLETED|Overall Study||33
8558953|NCT02550288|9590847|FG001|COMPLETED|Overall Study||65
8558954|NCT02550288|9590848|FG002|COMPLETED|Overall Study||68
8558955|NCT02550288|9590849|FG003|COMPLETED|Overall Study||65
8558956|NCT02550288|9590850|FG004|COMPLETED|Overall Study||66
8558957|NCT02550288|9590846|FG000|NOT COMPLETED|Overall Study||2
8558958|NCT02550288|9590847|FG001|NOT COMPLETED|Overall Study||3
8558959|NCT02550288|9590848|FG002|NOT COMPLETED|Overall Study||1
8558960|NCT02550288|9590849|FG003|NOT COMPLETED|Overall Study||3
8558961|NCT02550288|9590850|FG004|NOT COMPLETED|Overall Study||3
8558962|NCT02510040|9590865|FG000|STARTED|Overall Study||81
8558963|NCT02510040|9590866|FG001|STARTED|Overall Study||114
8558964|NCT02510040|9590867|FG002|STARTED|Overall Study||22
8558965|NCT02510040|9590865|FG000|COMPLETED|Overall Study||63
8558966|NCT02510040|9590866|FG001|COMPLETED|Overall Study||111
8558967|NCT02510040|9590867|FG002|COMPLETED|Overall Study||21
8558968|NCT02510040|9590865|FG000|NOT COMPLETED|Overall Study||18
8558969|NCT02510040|9590866|FG001|NOT COMPLETED|Overall Study||3
8558970|NCT02510040|9590867|FG002|NOT COMPLETED|Overall Study||1
8558971|NCT02499328|9590895|FG000|STARTED|Overall Study||4
8558972|NCT02499328|9590896|FG001|STARTED|Overall Study||7
8558973|NCT02499328|9590897|FG002|STARTED|Overall Study||10
8558974|NCT02499328|9590898|FG003|STARTED|Overall Study||11
8558975|NCT02499328|9590899|FG004|STARTED|Overall Study||15
8558976|NCT02499328|9590900|FG005|STARTED|Overall Study||9
8558977|NCT02499328|9590901|FG006|STARTED|Overall Study||7
8558978|NCT02499328|9590902|FG007|STARTED|Overall Study||6
8558979|NCT02499328|9590903|FG008|STARTED|Overall Study||14
8558980|NCT02499328|9590904|FG009|STARTED|Overall Study||24
8558981|NCT02499328|9590905|FG010|STARTED|Overall Study||20
8558982|NCT02499328|9590906|FG011|STARTED|Overall Study||54
8558983|NCT02499328|9590907|FG012|STARTED|Overall Study||25
8558984|NCT02499328|9590908|FG013|STARTED|Overall Study||17
8558985|NCT02499328|9590909|FG014|STARTED|Overall Study||10
8558986|NCT02499328|9590910|FG015|STARTED|Overall Study||1
8558987|NCT02499328|9590911|FG016|STARTED|Overall Study||1
8558988|NCT02499328|9590912|FG017|STARTED|Overall Study||55
8558989|NCT02499328|9590913|FG018|STARTED|Overall Study||50
8558990|NCT02499328|9590895|FG000|COMPLETED|Overall Study||0
8558991|NCT02499328|9590896|FG001|COMPLETED|Overall Study||0
8558992|NCT02499328|9590897|FG002|COMPLETED|Overall Study||0
8558993|NCT02499328|9590898|FG003|COMPLETED|Overall Study||0
8558994|NCT02499328|9590899|FG004|COMPLETED|Overall Study||0
8558995|NCT02499328|9590900|FG005|COMPLETED|Overall Study||0
8721789|NCT01014351|9768995|FG000|COMPLETED|Overall Study||33
8721790|NCT01014351|9768995|FG000|NOT COMPLETED|Overall Study||37
8721791|NCT01014390|9768999|FG000|STARTED|Overall Study||187
8558996|NCT02499328|9590901|FG006|COMPLETED|Overall Study||0
8558997|NCT02499328|9590902|FG007|COMPLETED|Overall Study||0
8721792|NCT01014390|9768999|FG000|COMPLETED|Overall Study||177
8558998|NCT02499328|9590903|FG008|COMPLETED|Overall Study||0
8558999|NCT02499328|9590904|FG009|COMPLETED|Overall Study||0
8559000|NCT02499328|9590905|FG010|COMPLETED|Overall Study||0
8559001|NCT02499328|9590906|FG011|COMPLETED|Overall Study||0
8559002|NCT02499328|9590907|FG012|COMPLETED|Overall Study||0
8721793|NCT01014390|9768999|FG000|NOT COMPLETED|Overall Study||10
8619256|NCT00467779|9657802|FG014|NOT COMPLETED|Stage 1||0
8721794|NCT01014403|9769005|FG000|STARTED|Overall Study||34
8619257|NCT00467779|9657788|FG000|STARTED|Stage 1A||0
8619258|NCT00467779|9657789|FG001|STARTED|Stage 1A||0
8619259|NCT00467779|9657790|FG002|STARTED|Stage 1A||0
8619260|NCT00467779|9657791|FG003|STARTED|Stage 1A||0
8619261|NCT00467779|9657792|FG004|STARTED|Stage 1A||0
8619262|NCT00467779|9657793|FG005|STARTED|Stage 1A||0
8559003|NCT02499328|9590908|FG013|COMPLETED|Overall Study||0
8559004|NCT02499328|9590909|FG014|COMPLETED|Overall Study||0
8559005|NCT02499328|9590910|FG015|COMPLETED|Overall Study||0
8559006|NCT02499328|9590911|FG016|COMPLETED|Overall Study||0
8559007|NCT02499328|9590912|FG017|COMPLETED|Overall Study||0
8559008|NCT02499328|9590913|FG018|COMPLETED|Overall Study||1
8559009|NCT02499328|9590895|FG000|NOT COMPLETED|Overall Study||4
8559010|NCT02499328|9590896|FG001|NOT COMPLETED|Overall Study||7
8559011|NCT02499328|9590897|FG002|NOT COMPLETED|Overall Study||10
8559012|NCT02499328|9590898|FG003|NOT COMPLETED|Overall Study||11
8559013|NCT02499328|9590899|FG004|NOT COMPLETED|Overall Study||15
8559014|NCT02499328|9590900|FG005|NOT COMPLETED|Overall Study||9
8559015|NCT02499328|9590901|FG006|NOT COMPLETED|Overall Study||7
8559016|NCT02499328|9590902|FG007|NOT COMPLETED|Overall Study||6
8559017|NCT02499328|9590903|FG008|NOT COMPLETED|Overall Study||14
8559018|NCT02499328|9590904|FG009|NOT COMPLETED|Overall Study||24
8559019|NCT02499328|9590905|FG010|NOT COMPLETED|Overall Study||20
8559020|NCT02499328|9590906|FG011|NOT COMPLETED|Overall Study||54
8559021|NCT02499328|9590907|FG012|NOT COMPLETED|Overall Study||25
8559022|NCT02499328|9590908|FG013|NOT COMPLETED|Overall Study||17
8559023|NCT02499328|9590909|FG014|NOT COMPLETED|Overall Study||10
8559024|NCT02499328|9590910|FG015|NOT COMPLETED|Overall Study||1
8559025|NCT02499328|9590911|FG016|NOT COMPLETED|Overall Study||1
8559026|NCT02499328|9590912|FG017|NOT COMPLETED|Overall Study||55
8559027|NCT02499328|9590913|FG018|NOT COMPLETED|Overall Study||49
8559028|NCT02463981|9590998|FG000|STARTED|Overall Study||21
8559029|NCT02463981|9590999|FG001|STARTED|Overall Study||16
8559030|NCT02463981|9590998|FG000|COMPLETED|Overall Study||18
8559031|NCT02463981|9590999|FG001|COMPLETED|Overall Study||14
8559032|NCT02463981|9590998|FG000|NOT COMPLETED|Overall Study||3
8559033|NCT02463981|9590999|FG001|NOT COMPLETED|Overall Study||2
8559034|NCT02460224|9591034|FG000|STARTED|Overall Study||17
8559035|NCT02460224|9591035|FG001|STARTED|Overall Study||12
8559036|NCT02460224|9591036|FG002|STARTED|Overall Study||6
8559037|NCT02460224|9591037|FG003|STARTED|Overall Study||6
8559038|NCT02460224|9591038|FG004|STARTED|Overall Study||6
8619263|NCT00467779|9657794|FG006|STARTED|Stage 1A||0
8619264|NCT00467779|9657795|FG007|STARTED|Stage 1A||0
8619265|NCT00467779|9657796|FG008|STARTED|Stage 1A||0
8619266|NCT00467779|9657797|FG009|STARTED|Stage 1A||3
8559039|NCT02460224|9591039|FG005|STARTED|Overall Study||30
8559040|NCT02460224|9591040|FG006|STARTED|Overall Study||30
8619267|NCT00467779|9657798|FG010|STARTED|Stage 1A||3
8619268|NCT00467779|9657799|FG011|STARTED|Stage 1A||8
8619269|NCT00467779|9657800|FG012|STARTED|Stage 1A||6
8559041|NCT02460224|9591041|FG007|STARTED|Overall Study||5
8559042|NCT02460224|9591042|FG008|STARTED|Overall Study||6
8619270|NCT00467779|9657801|FG013|STARTED|Stage 1A||0
8619271|NCT00467779|9657802|FG014|STARTED|Stage 1A||0
8721795|NCT01014403|9769006|FG001|STARTED|Overall Study||28
8721796|NCT01014403|9769005|FG000|COMPLETED|Overall Study||34
8721797|NCT01014403|9769006|FG001|COMPLETED|Overall Study||28
8721798|NCT01014403|9769005|FG000|NOT COMPLETED|Overall Study||0
8721799|NCT01014403|9769006|FG001|NOT COMPLETED|Overall Study||0
8721800|NCT01014442|9769014|FG000|STARTED|Overall Study||33
8721801|NCT01014442|9769015|FG001|STARTED|Overall Study||35
8721802|NCT01014442|9769014|FG000|COMPLETED|Overall Study||26
8721803|NCT01014442|9769015|FG001|COMPLETED|Overall Study||16
8619272|NCT00467779|9657788|FG000|COMPLETED|Stage 1A||0
8619273|NCT00467779|9657789|FG001|COMPLETED|Stage 1A||0
8619274|NCT00467779|9657790|FG002|COMPLETED|Stage 1A||0
8619275|NCT00467779|9657791|FG003|COMPLETED|Stage 1A||0
8619276|NCT00467779|9657792|FG004|COMPLETED|Stage 1A||0
8619277|NCT00467779|9657793|FG005|COMPLETED|Stage 1A||0
8619278|NCT00467779|9657794|FG006|COMPLETED|Stage 1A||0
8619279|NCT00467779|9657795|FG007|COMPLETED|Stage 1A||0
8619280|NCT00467779|9657796|FG008|COMPLETED|Stage 1A||0
8619281|NCT00467779|9657797|FG009|COMPLETED|Stage 1A||0
8619282|NCT00467779|9657798|FG010|COMPLETED|Stage 1A||0
8619283|NCT00467779|9657799|FG011|COMPLETED|Stage 1A||0
8619284|NCT00467779|9657800|FG012|COMPLETED|Stage 1A||0
8619285|NCT00467779|9657801|FG013|COMPLETED|Stage 1A||0
8619286|NCT00467779|9657802|FG014|COMPLETED|Stage 1A||0
8619287|NCT00467779|9657788|FG000|NOT COMPLETED|Stage 1A||0
8619288|NCT00467779|9657789|FG001|NOT COMPLETED|Stage 1A||0
8619289|NCT00467779|9657790|FG002|NOT COMPLETED|Stage 1A||0
8619290|NCT00467779|9657791|FG003|NOT COMPLETED|Stage 1A||0
8619291|NCT00467779|9657792|FG004|NOT COMPLETED|Stage 1A||0
8721804|NCT01014442|9769014|FG000|NOT COMPLETED|Overall Study||7
8619292|NCT00467779|9657793|FG005|NOT COMPLETED|Stage 1A||0
8619293|NCT00467779|9657794|FG006|NOT COMPLETED|Stage 1A||0
8721805|NCT01014442|9769015|FG001|NOT COMPLETED|Overall Study||19
8721806|NCT01014455|9769027|FG000|STARTED|Overall Study||82
8721807|NCT01014455|9769028|FG001|STARTED|Overall Study||87
8721808|NCT01014455|9769027|FG000|COMPLETED|Overall Study||82
8721809|NCT01014455|9769028|FG001|COMPLETED|Overall Study||87
8619294|NCT00467779|9657795|FG007|NOT COMPLETED|Stage 1A||0
8619295|NCT00467779|9657796|FG008|NOT COMPLETED|Stage 1A||0
8619296|NCT00467779|9657797|FG009|NOT COMPLETED|Stage 1A||3
8619297|NCT00467779|9657798|FG010|NOT COMPLETED|Stage 1A||3
8619298|NCT00467779|9657799|FG011|NOT COMPLETED|Stage 1A||8
8619299|NCT00467779|9657800|FG012|NOT COMPLETED|Stage 1A||6
8619300|NCT00467779|9657801|FG013|NOT COMPLETED|Stage 1A||0
8619301|NCT00467779|9657802|FG014|NOT COMPLETED|Stage 1A||0
8721810|NCT01014455|9769027|FG000|NOT COMPLETED|Overall Study||0
8619302|NCT00467779|9657788|FG000|STARTED|Stage 2||0
8619303|NCT00467779|9657789|FG001|STARTED|Stage 2||0
8619304|NCT00467779|9657790|FG002|STARTED|Stage 2||0
8559043|NCT02460224|9591043|FG009|STARTED|Overall Study||11
8559044|NCT02460224|9591044|FG010|STARTED|Overall Study||5
8559045|NCT02460224|9591045|FG011|STARTED|Overall Study||6
8559046|NCT02460224|9591046|FG012|STARTED|Overall Study||6
8559047|NCT02460224|9591047|FG013|STARTED|Overall Study||6
8559048|NCT02460224|9591048|FG014|STARTED|Overall Study||5
8559049|NCT02460224|9591049|FG015|STARTED|Overall Study||6
8559050|NCT02460224|9591050|FG016|STARTED|Overall Study||20
8559051|NCT02460224|9591051|FG017|STARTED|Overall Study||6
8721811|NCT01014455|9769028|FG001|NOT COMPLETED|Overall Study||0
8721812|NCT01014533|9769036|FG000|STARTED|Overall Study||29
8721813|NCT01014533|9769037|FG001|STARTED|Overall Study||30
8721814|NCT01014533|9769036|FG000|COMPLETED|Overall Study||24
8721815|NCT01014533|9769037|FG001|COMPLETED|Overall Study||25
8721816|NCT01014533|9769036|FG000|NOT COMPLETED|Overall Study||5
8721817|NCT01014533|9769037|FG001|NOT COMPLETED|Overall Study||5
8721818|NCT01014585|9769048|FG000|STARTED|Overall Study||51
8721819|NCT01014585|9769049|FG001|STARTED|Overall Study||100
8721820|NCT01014585|9769050|FG002|STARTED|Overall Study||60
8721821|NCT01014585|9769051|FG003|STARTED|Overall Study||129
8721822|NCT01014585|9769048|FG000|COMPLETED|Overall Study||31
8721823|NCT01014585|9769049|FG001|COMPLETED|Overall Study||75
8721824|NCT01014585|9769050|FG002|COMPLETED|Overall Study||37
8721825|NCT01014585|9769051|FG003|COMPLETED|Overall Study||99
8559052|NCT02460224|9591052|FG018|STARTED|Overall Study||12
8559053|NCT02460224|9591053|FG019|STARTED|Overall Study||7
8559054|NCT02460224|9591054|FG020|STARTED|Overall Study||6
8559055|NCT02460224|9591055|FG021|STARTED|Overall Study||12
8559056|NCT02460224|9591056|FG022|STARTED|Overall Study||6
8559057|NCT02460224|9591057|FG023|STARTED|Overall Study||11
8559058|NCT02460224|9591058|FG024|STARTED|Overall Study||6
8559059|NCT02460224|9591059|FG025|STARTED|Overall Study||6
8559060|NCT02460224|9591060|FG026|STARTED|Overall Study||121
8721826|NCT01014585|9769048|FG000|NOT COMPLETED|Overall Study||20
8559061|NCT02460224|9591061|FG027|STARTED|Overall Study||21
8721827|NCT01014585|9769049|FG001|NOT COMPLETED|Overall Study||25
8559062|NCT02460224|9591062|FG028|STARTED|Overall Study||93
8559063|NCT02460224|9591034|FG000|Rest of the World Patients in the Dose Escalation Part|Overall Study||13
8559064|NCT02460224|9591035|FG001|Rest of the World Patients in the Dose Escalation Part|Overall Study||12
8559065|NCT02460224|9591036|FG002|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
8559066|NCT02460224|9591037|FG003|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
8559067|NCT02460224|9591038|FG004|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
8721828|NCT01014585|9769050|FG002|NOT COMPLETED|Overall Study||23
8721829|NCT01014585|9769051|FG003|NOT COMPLETED|Overall Study||30
8721830|NCT01014624|9769063|FG000|STARTED|Overall Study||29
8721831|NCT01014624|9769064|FG001|STARTED|Overall Study||27
8721832|NCT01014624|9769063|FG000|COMPLETED|Overall Study||27
8559068|NCT02460224|9591039|FG005|Rest of the World Patients in the Dose Escalation Part|Overall Study||25
8569008|NCT00094887|9601231|FG001|Safety Population|Overall Study||75
8619305|NCT00467779|9657791|FG003|STARTED|Stage 2||0
8619306|NCT00467779|9657792|FG004|STARTED|Stage 2||0
8619307|NCT00467779|9657793|FG005|STARTED|Stage 2||0
8619308|NCT00467779|9657794|FG006|STARTED|Stage 2||0
8619309|NCT00467779|9657795|FG007|STARTED|Stage 2||0
8619310|NCT00467779|9657796|FG008|STARTED|Stage 2||21
8619311|NCT00467779|9657797|FG009|STARTED|Stage 2||0
8619312|NCT00467779|9657798|FG010|STARTED|Stage 2||0
8619313|NCT00467779|9657799|FG011|STARTED|Stage 2||0
8619314|NCT00467779|9657800|FG012|STARTED|Stage 2||0
8619315|NCT00467779|9657801|FG013|STARTED|Stage 2||0
8619316|NCT00467779|9657802|FG014|STARTED|Stage 2||0
8619317|NCT00467779|9657788|FG000|COMPLETED|Stage 2||0
8559069|NCT02460224|9591040|FG006|Rest of the World Patients in the Dose Escalation Part|Overall Study||24
8559070|NCT02460224|9591041|FG007|Rest of the World Patients in the Dose Escalation Part|Overall Study||5
8559071|NCT02460224|9591042|FG008|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
8559072|NCT02460224|9591043|FG009|Rest of the World Patients in the Dose Escalation Part|Overall Study||11
8559073|NCT02460224|9591044|FG010|Rest of the World Patients in the Dose Escalation Part|Overall Study||5
8559074|NCT02460224|9591045|FG011|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
8559075|NCT02460224|9591046|FG012|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
8559076|NCT02460224|9591047|FG013|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
8559077|NCT02460224|9591048|FG014|Rest of the World Patients in the Dose Escalation Part|Overall Study||5
8559078|NCT02460224|9591049|FG015|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
8559079|NCT02460224|9591050|FG016|Rest of the World Patients in the Dose Escalation Part|Overall Study||20
8559080|NCT02460224|9591051|FG017|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
8559081|NCT02460224|9591052|FG018|Rest of the World Patients in the Dose Escalation Part|Overall Study||12
8559082|NCT02460224|9591053|FG019|Rest of the World Patients in the Dose Escalation Part|Overall Study||7
8559083|NCT02460224|9591054|FG020|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
8559084|NCT02460224|9591055|FG021|Rest of the World Patients in the Dose Escalation Part|Overall Study||12
8559085|NCT02460224|9591056|FG022|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
8559086|NCT02460224|9591057|FG023|Rest of the World Patients in the Dose Escalation Part|Overall Study||11
8559087|NCT02460224|9591058|FG024|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
8559088|NCT02460224|9591059|FG025|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
8559089|NCT02460224|9591060|FG026|Rest of the World Patients in the Dose Escalation Part|Overall Study||0
8559090|NCT02460224|9591061|FG027|Rest of the World Patients in the Dose Escalation Part|Overall Study||0
8559091|NCT02460224|9591062|FG028|Rest of the World Patients in the Dose Escalation Part|Overall Study||0
8559092|NCT02460224|9591034|FG000|Japanese Patients in the Dose Escalation Part|Overall Study||4
8559093|NCT02460224|9591035|FG001|Japanese Patients in the Dose Escalation Part|Overall Study||0
8559094|NCT02460224|9591036|FG002|Japanese Patients in the Dose Escalation Part|Overall Study||0
8559095|NCT02460224|9591037|FG003|Japanese Patients in the Dose Escalation Part|Overall Study||0
8559096|NCT02460224|9591038|FG004|Japanese Patients in the Dose Escalation Part|Overall Study||0
8559097|NCT02460224|9591039|FG005|Japanese Patients in the Dose Escalation Part|Overall Study||5
8559098|NCT02460224|9591040|FG006|Japanese Patients in the Dose Escalation Part|Overall Study||6
8559099|NCT02460224|9591041|FG007|Japanese Patients in the Dose Escalation Part|Overall Study||0
8559100|NCT02460224|9591042|FG008|Japanese Patients in the Dose Escalation Part|Overall Study||0
8559101|NCT02460224|9591043|FG009|Japanese Patients in the Dose Escalation Part|Overall Study||0
8559102|NCT02460224|9591044|FG010|Japanese Patients in the Dose Escalation Part|Overall Study||0
8559103|NCT02460224|9591045|FG011|Japanese Patients in the Dose Escalation Part|Overall Study||0
8559104|NCT02460224|9591046|FG012|Japanese Patients in the Dose Escalation Part|Overall Study||0
8559105|NCT02460224|9591047|FG013|Japanese Patients in the Dose Escalation Part|Overall Study||0
8559106|NCT02460224|9591048|FG014|Japanese Patients in the Dose Escalation Part|Overall Study||0
8559107|NCT02460224|9591049|FG015|Japanese Patients in the Dose Escalation Part|Overall Study||0
8559108|NCT02460224|9591050|FG016|Japanese Patients in the Dose Escalation Part|Overall Study||0
8559109|NCT02460224|9591051|FG017|Japanese Patients in the Dose Escalation Part|Overall Study||0
8559110|NCT02460224|9591052|FG018|Japanese Patients in the Dose Escalation Part|Overall Study||0
8559111|NCT02460224|9591053|FG019|Japanese Patients in the Dose Escalation Part|Overall Study||0
8559112|NCT02460224|9591054|FG020|Japanese Patients in the Dose Escalation Part|Overall Study||0
8559113|NCT02460224|9591055|FG021|Japanese Patients in the Dose Escalation Part|Overall Study||0
8619318|NCT00467779|9657789|FG001|COMPLETED|Stage 2||0
8619319|NCT00467779|9657790|FG002|COMPLETED|Stage 2||0
8619320|NCT00467779|9657791|FG003|COMPLETED|Stage 2||0
8619321|NCT00467779|9657792|FG004|COMPLETED|Stage 2||0
8619322|NCT00467779|9657793|FG005|COMPLETED|Stage 2||0
8619323|NCT00467779|9657794|FG006|COMPLETED|Stage 2||0
8721833|NCT01014624|9769064|FG001|COMPLETED|Overall Study||26
8721834|NCT01014624|9769063|FG000|NOT COMPLETED|Overall Study||2
8721835|NCT01014624|9769064|FG001|NOT COMPLETED|Overall Study||1
8721836|NCT01014689|9769074|FG000|STARTED|Overall Study||191
8721837|NCT01014689|9769075|FG001|STARTED|Overall Study||187
8721838|NCT01014689|9769074|FG000|COMPLETED|Overall Study||178
8721839|NCT01014689|9769075|FG001|COMPLETED|Overall Study||174
8721840|NCT01014689|9769074|FG000|NOT COMPLETED|Overall Study||13
8721841|NCT01014689|9769075|FG001|NOT COMPLETED|Overall Study||13
8721842|NCT01014728|9769083|FG000|STARTED|Overall Study||18
8721843|NCT01014728|9769084|FG001|STARTED|Overall Study||15
8721844|NCT01014728|9769083|FG000|COMPLETED|Overall Study||18
8619324|NCT00467779|9657795|FG007|COMPLETED|Stage 2||0
8619325|NCT00467779|9657796|FG008|COMPLETED|Stage 2||0
8619326|NCT00467779|9657797|FG009|COMPLETED|Stage 2||0
8619327|NCT00467779|9657798|FG010|COMPLETED|Stage 2||0
8721845|NCT01014728|9769084|FG001|COMPLETED|Overall Study||15
8619328|NCT00467779|9657799|FG011|COMPLETED|Stage 2||0
8619329|NCT00467779|9657800|FG012|COMPLETED|Stage 2||0
8721846|NCT01014728|9769083|FG000|NOT COMPLETED|Overall Study||0
8619330|NCT00467779|9657801|FG013|COMPLETED|Stage 2||0
8619331|NCT00467779|9657802|FG014|COMPLETED|Stage 2||0
8619332|NCT00467779|9657788|FG000|NOT COMPLETED|Stage 2||0
8619333|NCT00467779|9657789|FG001|NOT COMPLETED|Stage 2||0
8721847|NCT01014728|9769084|FG001|NOT COMPLETED|Overall Study||0
8559114|NCT02460224|9591056|FG022|Japanese Patients in the Dose Escalation Part|Overall Study||0
8559115|NCT02460224|9591057|FG023|Japanese Patients in the Dose Escalation Part|Overall Study||0
8559116|NCT02460224|9591058|FG024|Japanese Patients in the Dose Escalation Part|Overall Study||0
8559117|NCT02460224|9591059|FG025|Japanese Patients in the Dose Escalation Part|Overall Study||0
8559118|NCT02460224|9591060|FG026|Japanese Patients in the Dose Escalation Part|Overall Study||0
8559119|NCT02460224|9591061|FG027|Japanese Patients in the Dose Escalation Part|Overall Study||0
8559120|NCT02460224|9591062|FG028|Japanese Patients in the Dose Escalation Part|Overall Study||0
8559121|NCT02460224|9591034|FG000|COMPLETED|Overall Study||0
8559122|NCT02460224|9591035|FG001|COMPLETED|Overall Study||0
8559123|NCT02460224|9591036|FG002|COMPLETED|Overall Study||0
8559124|NCT02460224|9591037|FG003|COMPLETED|Overall Study||0
8559125|NCT02460224|9591038|FG004|COMPLETED|Overall Study||0
8559126|NCT02460224|9591039|FG005|COMPLETED|Overall Study||0
8559127|NCT02460224|9591040|FG006|COMPLETED|Overall Study||0
8559128|NCT02460224|9591041|FG007|COMPLETED|Overall Study||0
8559129|NCT02460224|9591042|FG008|COMPLETED|Overall Study||0
8559130|NCT02460224|9591043|FG009|COMPLETED|Overall Study||0
8559131|NCT02460224|9591044|FG010|COMPLETED|Overall Study||0
8559132|NCT02460224|9591045|FG011|COMPLETED|Overall Study||0
8559133|NCT02460224|9591046|FG012|COMPLETED|Overall Study||0
8559134|NCT02460224|9591047|FG013|COMPLETED|Overall Study||0
8559135|NCT02460224|9591048|FG014|COMPLETED|Overall Study||0
8559136|NCT02460224|9591049|FG015|COMPLETED|Overall Study||0
8559137|NCT02460224|9591050|FG016|COMPLETED|Overall Study||0
8559138|NCT02460224|9591051|FG017|COMPLETED|Overall Study||0
8559139|NCT02460224|9591052|FG018|COMPLETED|Overall Study||0
8559140|NCT02460224|9591053|FG019|COMPLETED|Overall Study||0
8559141|NCT02460224|9591054|FG020|COMPLETED|Overall Study||0
8559142|NCT02460224|9591055|FG021|COMPLETED|Overall Study||0
8559143|NCT02460224|9591056|FG022|COMPLETED|Overall Study||0
8559144|NCT02460224|9591057|FG023|COMPLETED|Overall Study||0
8559145|NCT02460224|9591058|FG024|COMPLETED|Overall Study||0
8559146|NCT02460224|9591059|FG025|COMPLETED|Overall Study||0
8559147|NCT02460224|9591060|FG026|COMPLETED|Overall Study||0
8559148|NCT02460224|9591061|FG027|COMPLETED|Overall Study||0
8559149|NCT02460224|9591062|FG028|COMPLETED|Overall Study||0
8559150|NCT02460224|9591034|FG000|NOT COMPLETED|Overall Study||17
8559151|NCT02460224|9591035|FG001|NOT COMPLETED|Overall Study||12
8559152|NCT02460224|9591036|FG002|NOT COMPLETED|Overall Study||6
8559153|NCT02460224|9591037|FG003|NOT COMPLETED|Overall Study||6
8559154|NCT02460224|9591038|FG004|NOT COMPLETED|Overall Study||6
8559155|NCT02460224|9591039|FG005|NOT COMPLETED|Overall Study||30
8559156|NCT02460224|9591040|FG006|NOT COMPLETED|Overall Study||30
8559157|NCT02460224|9591041|FG007|NOT COMPLETED|Overall Study||5
8559158|NCT02460224|9591042|FG008|NOT COMPLETED|Overall Study||6
8559159|NCT02460224|9591043|FG009|NOT COMPLETED|Overall Study||11
8559160|NCT02460224|9591044|FG010|NOT COMPLETED|Overall Study||5
8559161|NCT02460224|9591045|FG011|NOT COMPLETED|Overall Study||6
8559162|NCT02460224|9591046|FG012|NOT COMPLETED|Overall Study||6
8559163|NCT02460224|9591047|FG013|NOT COMPLETED|Overall Study||6
8559164|NCT02460224|9591048|FG014|NOT COMPLETED|Overall Study||5
8559165|NCT02460224|9591049|FG015|NOT COMPLETED|Overall Study||6
8559166|NCT02460224|9591050|FG016|NOT COMPLETED|Overall Study||20
8559167|NCT02460224|9591051|FG017|NOT COMPLETED|Overall Study||6
8559168|NCT02460224|9591052|FG018|NOT COMPLETED|Overall Study||12
8559169|NCT02460224|9591053|FG019|NOT COMPLETED|Overall Study||7
8559170|NCT02460224|9591054|FG020|NOT COMPLETED|Overall Study||6
8559171|NCT02460224|9591055|FG021|NOT COMPLETED|Overall Study||12
8559172|NCT02460224|9591056|FG022|NOT COMPLETED|Overall Study||6
8559173|NCT02460224|9591057|FG023|NOT COMPLETED|Overall Study||11
8559174|NCT02460224|9591058|FG024|NOT COMPLETED|Overall Study||6
8559175|NCT02460224|9591059|FG025|NOT COMPLETED|Overall Study||6
8559176|NCT02460224|9591060|FG026|NOT COMPLETED|Overall Study||121
8559177|NCT02460224|9591061|FG027|NOT COMPLETED|Overall Study||21
8619334|NCT00467779|9657790|FG002|NOT COMPLETED|Stage 2||0
8619335|NCT00467779|9657791|FG003|NOT COMPLETED|Stage 2||0
8619336|NCT00467779|9657792|FG004|NOT COMPLETED|Stage 2||0
8619337|NCT00467779|9657793|FG005|NOT COMPLETED|Stage 2||0
8619338|NCT00467779|9657794|FG006|NOT COMPLETED|Stage 2||0
8619339|NCT00467779|9657795|FG007|NOT COMPLETED|Stage 2||0
8619340|NCT00467779|9657796|FG008|NOT COMPLETED|Stage 2||21
8619341|NCT00467779|9657797|FG009|NOT COMPLETED|Stage 2||0
8619342|NCT00467779|9657798|FG010|NOT COMPLETED|Stage 2||0
8619343|NCT00467779|9657799|FG011|NOT COMPLETED|Stage 2||0
8619344|NCT00467779|9657800|FG012|NOT COMPLETED|Stage 2||0
8619345|NCT00467779|9657801|FG013|NOT COMPLETED|Stage 2||0
8619346|NCT00467779|9657802|FG014|NOT COMPLETED|Stage 2||0
8619347|NCT00467779|9657788|FG000|STARTED|Stage 2A||0
8619348|NCT00467779|9657789|FG001|STARTED|Stage 2A||0
8619349|NCT00467779|9657790|FG002|STARTED|Stage 2A||0
8619350|NCT00467779|9657791|FG003|STARTED|Stage 2A||0
8619351|NCT00467779|9657792|FG004|STARTED|Stage 2A||0
8619352|NCT00467779|9657793|FG005|STARTED|Stage 2A||0
8619353|NCT00467779|9657794|FG006|STARTED|Stage 2A||0
9065770|NCT04143945|10126241|FG001|NOT COMPLETED|Treatment Period 2 (Day 1)||0
9065771|NCT04143945|10126242|FG002|NOT COMPLETED|Treatment Period 2 (Day 1)||0
9065772|NCT04143945|10126243|FG003|NOT COMPLETED|Treatment Period 2 (Day 1)||0
8619354|NCT00467779|9657795|FG007|STARTED|Stage 2A||0
8619355|NCT00467779|9657796|FG008|STARTED|Stage 2A||0
8619356|NCT00467779|9657797|FG009|STARTED|Stage 2A||0
8619357|NCT00467779|9657798|FG010|STARTED|Stage 2A||0
8619358|NCT00467779|9657799|FG011|STARTED|Stage 2A||0
8619359|NCT00467779|9657800|FG012|STARTED|Stage 2A||0
8619360|NCT00467779|9657801|FG013|STARTED|Stage 2A||22
8619361|NCT00467779|9657802|FG014|STARTED|Stage 2A||0
8619362|NCT00467779|9657788|FG000|COMPLETED|Stage 2A||0
8619363|NCT00467779|9657789|FG001|COMPLETED|Stage 2A||0
8619364|NCT00467779|9657790|FG002|COMPLETED|Stage 2A||0
8619365|NCT00467779|9657791|FG003|COMPLETED|Stage 2A||0
8619366|NCT00467779|9657792|FG004|COMPLETED|Stage 2A||0
8619367|NCT00467779|9657793|FG005|COMPLETED|Stage 2A||0
8619368|NCT00467779|9657794|FG006|COMPLETED|Stage 2A||0
8619369|NCT00467779|9657795|FG007|COMPLETED|Stage 2A||0
8619370|NCT00467779|9657796|FG008|COMPLETED|Stage 2A||0
8619371|NCT00467779|9657797|FG009|COMPLETED|Stage 2A||0
8619372|NCT00467779|9657798|FG010|COMPLETED|Stage 2A||0
8559178|NCT02460224|9591062|FG028|NOT COMPLETED|Overall Study||93
8559179|NCT02460159|9591136|FG000|STARTED|Overall Study||117
8559180|NCT02460159|9591137|FG001|STARTED|Overall Study||18
8559181|NCT02460159|9591136|FG000|COMPLETED|Overall Study||111
8559182|NCT02460159|9591137|FG001|COMPLETED|Overall Study||17
8559183|NCT02460159|9591136|FG000|NOT COMPLETED|Overall Study||6
8559184|NCT02460159|9591137|FG001|NOT COMPLETED|Overall Study||1
8559185|NCT02457910|9591149|FG000|STARTED|Overall Study||3
8559186|NCT02457910|9591150|FG001|STARTED|Overall Study|In dose escalation, two patients receiving the 4 mg dose of taselisib were removed for toxicities|5
8559187|NCT02457910|9591151|FG002|STARTED|Overall Study||3
8559188|NCT02457910|9591152|FG003|STARTED|Overall Study||2
8559189|NCT02457910|9591153|FG004|STARTED|Overall Study|3 participants crossed over to enzalutamide and taselisib|5
8559190|NCT02457910|9591154|FG005|STARTED|Overall Study||12
8559191|NCT02457910|9591149|FG000|COMPLETED|Overall Study||0
8559192|NCT02457910|9591150|FG001|COMPLETED|Overall Study||0
8559193|NCT02457910|9591151|FG002|COMPLETED|Overall Study||0
8559194|NCT02457910|9591152|FG003|COMPLETED|Overall Study||0
8559195|NCT02457910|9591153|FG004|COMPLETED|Overall Study||0
8559196|NCT02457910|9591154|FG005|COMPLETED|Overall Study||1
8559197|NCT02457910|9591149|FG000|NOT COMPLETED|Overall Study||3
8559198|NCT02457910|9591150|FG001|NOT COMPLETED|Overall Study||5
8559199|NCT02457910|9591151|FG002|NOT COMPLETED|Overall Study||3
8559200|NCT02457910|9591152|FG003|NOT COMPLETED|Overall Study||2
8559201|NCT02457910|9591153|FG004|NOT COMPLETED|Overall Study||5
8559202|NCT02457910|9591154|FG005|NOT COMPLETED|Overall Study||11
8559203|NCT02407236|9591179|FG000|STARTED|Induction Study (8 Weeks)||319
8559204|NCT02407236|9591180|FG001|STARTED|Induction Study (8 Weeks)||320
8559205|NCT02407236|9591181|FG002|STARTED|Induction Study (8 Weeks)||322
8619373|NCT00467779|9657799|FG011|COMPLETED|Stage 2A||0
8559206|NCT02407236|9591182|FG003|STARTED|Induction Study (8 Weeks)||0
8559207|NCT02407236|9591183|FG004|STARTED|Induction Study (8 Weeks)||0
8559208|NCT02407236|9591184|FG005|STARTED|Induction Study (8 Weeks)||0
8559209|NCT02407236|9591185|FG006|STARTED|Induction Study (8 Weeks)||0
8559210|NCT02407236|9591186|FG007|STARTED|Induction Study (8 Weeks)||0
8559211|NCT02407236|9591179|FG000|Clinical Response at IS Week 8|Induction Study (8 Weeks)||103
8559212|NCT02407236|9591180|FG001|Clinical Response at IS Week 8|Induction Study (8 Weeks)||172
8559213|NCT02407236|9591181|FG002|Clinical Response at IS Week 8|Induction Study (8 Weeks)||208
8559214|NCT02407236|9591182|FG003|Clinical Response at IS Week 8|Induction Study (8 Weeks)||0
8559215|NCT02407236|9591183|FG004|Clinical Response at IS Week 8|Induction Study (8 Weeks)||0
8559216|NCT02407236|9591184|FG005|Clinical Response at IS Week 8|Induction Study (8 Weeks)||0
8559217|NCT02407236|9591185|FG006|Clinical Response at IS Week 8|Induction Study (8 Weeks)||0
8559218|NCT02407236|9591186|FG007|Clinical Response at IS Week 8|Induction Study (8 Weeks)||0
8559219|NCT02407236|9591179|FG000|Clinical Response at IS Week 16|Induction Study (8 Weeks)||143
8559220|NCT02407236|9591180|FG001|Clinical Response at IS Week 16|Induction Study (8 Weeks)||90
8559221|NCT02407236|9591181|FG002|Clinical Response at IS Week 16|Induction Study (8 Weeks)||67
8559222|NCT02407236|9591182|FG003|Clinical Response at IS Week 16|Induction Study (8 Weeks)||0
8559223|NCT02407236|9591183|FG004|Clinical Response at IS Week 16|Induction Study (8 Weeks)||0
8559224|NCT02407236|9591184|FG005|Clinical Response at IS Week 16|Induction Study (8 Weeks)||0
8559225|NCT02407236|9591185|FG006|Clinical Response at IS Week 16|Induction Study (8 Weeks)||0
8559226|NCT02407236|9591186|FG007|Clinical Response at IS Week 16|Induction Study (8 Weeks)||0
8559227|NCT02407236|9591179|FG000|Completed Safety Follow-up|Induction Study (8 Weeks)|17 participants from Induction Week (IW)- 8 and 33 participants from IW- 16.|50
8559228|NCT02407236|9591180|FG001|Completed Safety Follow-up|Induction Study (8 Weeks)|10 participants from IW- 8 and 37 from IW- 16.|47
8559229|NCT02407236|9591181|FG002|Completed Safety Follow-up|Induction Study (8 Weeks)|10 participants from IW- 8 and 22 from IW- 16.|32
8559230|NCT02407236|9591182|FG003|Completed Safety Follow-up|Induction Study (8 Weeks)||0
8559231|NCT02407236|9591183|FG004|Completed Safety Follow-up|Induction Study (8 Weeks)||0
8559232|NCT02407236|9591184|FG005|Completed Safety Follow-up|Induction Study (8 Weeks)||0
8559233|NCT02407236|9591185|FG006|Completed Safety Follow-up|Induction Study (8 Weeks)||0
8559234|NCT02407236|9591186|FG007|Completed Safety Follow-up|Induction Study (8 Weeks)||0
8559235|NCT02407236|9591179|FG000|Safety Analysis Set|Induction Study (8 Weeks)||319
8559236|NCT02407236|9591180|FG001|Safety Analysis Set|Induction Study (8 Weeks)|1 participant of ustekinumab 130mg never had drug, 2 participants planned to 6 mg/kg but had 130mg.|321
8559237|NCT02407236|9591181|FG002|Safety Analysis Set|Induction Study (8 Weeks)||320
8559238|NCT02407236|9591182|FG003|Safety Analysis Set|Induction Study (8 Weeks)||0
8559239|NCT02407236|9591183|FG004|Safety Analysis Set|Induction Study (8 Weeks)||0
8559240|NCT02407236|9591184|FG005|Safety Analysis Set|Induction Study (8 Weeks)||0
8559241|NCT02407236|9591185|FG006|Safety Analysis Set|Induction Study (8 Weeks)||0
8559242|NCT02407236|9591186|FG007|Safety Analysis Set|Induction Study (8 Weeks)||0
8559243|NCT02407236|9591179|FG000|Non-responders at Week 8|Induction Study (8 Weeks)||184
8559244|NCT02407236|9591180|FG001|Non-responders at Week 8|Induction Study (8 Weeks)||132
8559245|NCT02407236|9591181|FG002|Non-responders at Week 8|Induction Study (8 Weeks)||101
8559246|NCT02407236|9591182|FG003|Non-responders at Week 8|Induction Study (8 Weeks)||0
8559247|NCT02407236|9591183|FG004|Non-responders at Week 8|Induction Study (8 Weeks)||0
8559248|NCT02407236|9591184|FG005|Non-responders at Week 8|Induction Study (8 Weeks)||0
8559249|NCT02407236|9591185|FG006|Non-responders at Week 8|Induction Study (8 Weeks)||0
8559250|NCT02407236|9591186|FG007|Non-responders at Week 8|Induction Study (8 Weeks)||0
8559251|NCT02407236|9591179|FG000|COMPLETED|Induction Study (8 Weeks)||296
8559252|NCT02407236|9591180|FG001|COMPLETED|Induction Study (8 Weeks)||309
8559253|NCT02407236|9591181|FG002|COMPLETED|Induction Study (8 Weeks)||307
8559254|NCT02407236|9591182|FG003|COMPLETED|Induction Study (8 Weeks)||0
8559255|NCT02407236|9591183|FG004|COMPLETED|Induction Study (8 Weeks)||0
8559256|NCT02407236|9591184|FG005|COMPLETED|Induction Study (8 Weeks)||0
8559257|NCT02407236|9591185|FG006|COMPLETED|Induction Study (8 Weeks)||0
8559258|NCT02407236|9591186|FG007|COMPLETED|Induction Study (8 Weeks)||0
8559259|NCT02407236|9591179|FG000|NOT COMPLETED|Induction Study (8 Weeks)||23
8559260|NCT02407236|9591180|FG001|NOT COMPLETED|Induction Study (8 Weeks)||11
8559261|NCT02407236|9591181|FG002|NOT COMPLETED|Induction Study (8 Weeks)||15
8559262|NCT02407236|9591182|FG003|NOT COMPLETED|Induction Study (8 Weeks)||0
8559263|NCT02407236|9591183|FG004|NOT COMPLETED|Induction Study (8 Weeks)||0
8559264|NCT02407236|9591184|FG005|NOT COMPLETED|Induction Study (8 Weeks)||0
8559265|NCT02407236|9591185|FG006|NOT COMPLETED|Induction Study (8 Weeks)||0
8559266|NCT02407236|9591186|FG007|NOT COMPLETED|Induction Study (8 Weeks)||0
8559267|NCT02407236|9591179|FG000|STARTED|Maintenance Study (44 Weeks)||0
8559268|NCT02407236|9591180|FG001|STARTED|Maintenance Study (44 Weeks)||0
8559269|NCT02407236|9591181|FG002|STARTED|Maintenance Study (44 Weeks)||0
8559270|NCT02407236|9591182|FG003|STARTED|Maintenance Study (44 Weeks)||175
8559271|NCT02407236|9591183|FG004|STARTED|Maintenance Study (44 Weeks)||172
8559272|NCT02407236|9591184|FG005|STARTED|Maintenance Study (44 Weeks)||176
8559273|NCT02407236|9591185|FG006|STARTED|Maintenance Study (44 Weeks)||103
8559274|NCT02407236|9591186|FG007|STARTED|Maintenance Study (44 Weeks)||157
8619374|NCT00467779|9657800|FG012|COMPLETED|Stage 2A||0
8619375|NCT00467779|9657801|FG013|COMPLETED|Stage 2A||1
8619376|NCT00467779|9657802|FG014|COMPLETED|Stage 2A||0
8619377|NCT00467779|9657788|FG000|NOT COMPLETED|Stage 2A||0
8559275|NCT02407236|9591179|FG000|COMPLETED|Maintenance Study (44 Weeks)||0
8559276|NCT02407236|9591180|FG001|COMPLETED|Maintenance Study (44 Weeks)||0
8559277|NCT02407236|9591181|FG002|COMPLETED|Maintenance Study (44 Weeks)||0
8559278|NCT02407236|9591182|FG003|COMPLETED|Maintenance Study (44 Weeks)||165
8559279|NCT02407236|9591183|FG004|COMPLETED|Maintenance Study (44 Weeks)||161
8559280|NCT02407236|9591184|FG005|COMPLETED|Maintenance Study (44 Weeks)||168
8559281|NCT02407236|9591185|FG006|COMPLETED|Maintenance Study (44 Weeks)||94
8559282|NCT02407236|9591186|FG007|COMPLETED|Maintenance Study (44 Weeks)||149
8619378|NCT00467779|9657789|FG001|NOT COMPLETED|Stage 2A||0
8559283|NCT02407236|9591179|FG000|NOT COMPLETED|Maintenance Study (44 Weeks)||0
8559284|NCT02407236|9591180|FG001|NOT COMPLETED|Maintenance Study (44 Weeks)||0
8559285|NCT02407236|9591181|FG002|NOT COMPLETED|Maintenance Study (44 Weeks)||0
8569009|NCT00094887|9601230|FG000|Intent to Treat Population|Overall Study||75
8619379|NCT00467779|9657790|FG002|NOT COMPLETED|Stage 2A||0
8619380|NCT00467779|9657791|FG003|NOT COMPLETED|Stage 2A||0
8619381|NCT00467779|9657792|FG004|NOT COMPLETED|Stage 2A||0
8619382|NCT00467779|9657793|FG005|NOT COMPLETED|Stage 2A||0
8619383|NCT00467779|9657794|FG006|NOT COMPLETED|Stage 2A||0
8619384|NCT00467779|9657795|FG007|NOT COMPLETED|Stage 2A||0
8619385|NCT00467779|9657796|FG008|NOT COMPLETED|Stage 2A||0
8619386|NCT00467779|9657797|FG009|NOT COMPLETED|Stage 2A||0
8619387|NCT00467779|9657798|FG010|NOT COMPLETED|Stage 2A||0
8619388|NCT00467779|9657799|FG011|NOT COMPLETED|Stage 2A||0
8619389|NCT00467779|9657800|FG012|NOT COMPLETED|Stage 2A||0
8619390|NCT00467779|9657801|FG013|NOT COMPLETED|Stage 2A||21
8619391|NCT00467779|9657802|FG014|NOT COMPLETED|Stage 2A||0
8619392|NCT00467779|9657788|FG000|STARTED|Stage 3||0
8619393|NCT00467779|9657789|FG001|STARTED|Stage 3||0
8559286|NCT02407236|9591182|FG003|NOT COMPLETED|Maintenance Study (44 Weeks)||10
8559287|NCT02407236|9591183|FG004|NOT COMPLETED|Maintenance Study (44 Weeks)||11
8559288|NCT02407236|9591184|FG005|NOT COMPLETED|Maintenance Study (44 Weeks)||8
8559289|NCT02407236|9591185|FG006|NOT COMPLETED|Maintenance Study (44 Weeks)||9
8559290|NCT02407236|9591186|FG007|NOT COMPLETED|Maintenance Study (44 Weeks)||8
8559291|NCT02320396|9591206|FG000|STARTED|Overall Study||224
8559292|NCT02320396|9591207|FG001|STARTED|Overall Study||225
8559293|NCT02320396|9591206|FG000|Treated (Full Analysis Set)|Overall Study||223
8559294|NCT02320396|9591207|FG001|Treated (Full Analysis Set)|Overall Study||225
8559295|NCT02320396|9591206|FG000|COMPLETED|Overall Study||220
8559296|NCT02320396|9591207|FG001|COMPLETED|Overall Study||221
8559297|NCT02320396|9591206|FG000|NOT COMPLETED|Overall Study||4
8559298|NCT02320396|9591207|FG001|NOT COMPLETED|Overall Study||4
8559299|NCT02282345|9591215|FG000|STARTED|Overall Study||13
8559300|NCT02282345|9591216|FG001|STARTED|Overall Study||20
8559301|NCT02282345|9591215|FG000|COMPLETED|Overall Study||13
8559302|NCT02282345|9591216|FG001|COMPLETED|Overall Study||19
8559303|NCT02282345|9591215|FG000|NOT COMPLETED|Overall Study||0
8559304|NCT02282345|9591216|FG001|NOT COMPLETED|Overall Study||1
8559305|NCT02230410|9591225|FG000|STARTED|Overall Study||18
8559306|NCT02230410|9591225|FG000|COMPLETED|Overall Study||15
8559307|NCT02230410|9591225|FG000|NOT COMPLETED|Overall Study||3
8559308|NCT02053246|9591229|FG000|STARTED|Overall Study||11
8559309|NCT02053246|9591229|FG000|COMPLETED|Overall Study||7
8559310|NCT02053246|9591229|FG000|NOT COMPLETED|Overall Study||4
8559311|NCT01980940|9591241|FG000|STARTED|Overall Study||5
8559312|NCT01980940|9591242|FG001|STARTED|Overall Study||5
8559313|NCT01980940|9591243|FG002|STARTED|Overall Study||5
8559314|NCT01980940|9591244|FG003|STARTED|Overall Study||3
8559315|NCT01980940|9591245|FG004|STARTED|Overall Study||2
8559316|NCT01980940|9591246|FG005|STARTED|Overall Study||2
8559317|NCT01980940|9591247|FG006|STARTED|Overall Study||24
8559318|NCT01980940|9591248|FG007|STARTED|Overall Study||24
8559319|NCT01980940|9591241|FG000|Treated|Overall Study||5
8559320|NCT01980940|9591242|FG001|Treated|Overall Study||5
8559321|NCT01980940|9591243|FG002|Treated|Overall Study||5
8559322|NCT01980940|9591244|FG003|Treated|Overall Study||3
8559323|NCT01980940|9591245|FG004|Treated|Overall Study||2
8559324|NCT01980940|9591246|FG005|Treated|Overall Study||2
8559325|NCT01980940|9591247|FG006|Treated|Overall Study||24
8559326|NCT01980940|9591248|FG007|Treated|Overall Study||24
8619394|NCT00467779|9657790|FG002|STARTED|Stage 3||0
8559327|NCT01980940|9591241|FG000|COMPLETED|Overall Study||5
8559328|NCT01980940|9591242|FG001|COMPLETED|Overall Study||5
8559329|NCT01980940|9591243|FG002|COMPLETED|Overall Study||5
8559330|NCT01980940|9591244|FG003|COMPLETED|Overall Study||3
8559331|NCT01980940|9591245|FG004|COMPLETED|Overall Study||2
8559332|NCT01980940|9591246|FG005|COMPLETED|Overall Study||0
8559333|NCT01980940|9591247|FG006|COMPLETED|Overall Study||24
8559334|NCT01980940|9591248|FG007|COMPLETED|Overall Study||24
8559335|NCT01980940|9591241|FG000|NOT COMPLETED|Overall Study||0
8559336|NCT01980940|9591242|FG001|NOT COMPLETED|Overall Study||0
8559337|NCT01980940|9591243|FG002|NOT COMPLETED|Overall Study||0
8559338|NCT01980940|9591244|FG003|NOT COMPLETED|Overall Study||0
8559339|NCT01980940|9591245|FG004|NOT COMPLETED|Overall Study||0
8559340|NCT01980940|9591246|FG005|NOT COMPLETED|Overall Study||2
8559341|NCT01980940|9591247|FG006|NOT COMPLETED|Overall Study||0
8559342|NCT01980940|9591248|FG007|NOT COMPLETED|Overall Study||0
8559343|NCT01923298|9591272|FG000|STARTED|Overall Study||14
8559344|NCT01923298|9591272|FG000|COMPLETED|Overall Study||14
8559345|NCT01923298|9591272|FG000|NOT COMPLETED|Overall Study||0
8559346|NCT01918033|9591279|FG000|STARTED|Overall Study||203
8559347|NCT01918033|9591280|FG001|STARTED|Overall Study||203
8559348|NCT01918033|9591281|FG002|STARTED|Overall Study||202
8559349|NCT01918033|9591279|FG000|Treated|Overall Study|One randomized participant did not receive study drug.|202
8559350|NCT01918033|9591280|FG001|Treated|Overall Study||203
8559351|NCT01918033|9591281|FG002|Treated|Overall Study|One randomized participant did not receive study drug.|201
8559352|NCT01918033|9591279|FG000|COMPLETED|Overall Study||198
8559353|NCT01918033|9591280|FG001|COMPLETED|Overall Study||201
8559354|NCT01918033|9591281|FG002|COMPLETED|Overall Study||199
8559355|NCT01918033|9591279|FG000|NOT COMPLETED|Overall Study||5
8559356|NCT01918033|9591280|FG001|NOT COMPLETED|Overall Study||2
8559357|NCT01918033|9591281|FG002|NOT COMPLETED|Overall Study||3
8559358|NCT01916980|9591291|FG000|STARTED|Overall Study||65
8559359|NCT01916980|9591292|FG001|STARTED|Overall Study||29
8559360|NCT01916980|9591291|FG000|COMPLETED|Overall Study||58
8559361|NCT01916980|9591292|FG001|COMPLETED|Overall Study||25
8559362|NCT01916980|9591291|FG000|NOT COMPLETED|Overall Study||7
8559363|NCT01916980|9591292|FG001|NOT COMPLETED|Overall Study||4
8559364|NCT01916967|9591301|FG000|STARTED|Overall Study||80
8559365|NCT01916967|9591302|FG001|STARTED|Overall Study||79
8559366|NCT01916967|9591303|FG002|STARTED|Overall Study||80
8559367|NCT01916967|9591301|FG000|COMPLETED|Overall Study||80
8559368|NCT01916967|9591302|FG001|COMPLETED|Overall Study||78
8559369|NCT01916967|9591303|FG002|COMPLETED|Overall Study||71
8559370|NCT01916967|9591301|FG000|NOT COMPLETED|Overall Study||0
8559371|NCT01916967|9591302|FG001|NOT COMPLETED|Overall Study||1
8559372|NCT01916967|9591303|FG002|NOT COMPLETED|Overall Study||9
8559373|NCT01910402|9591315|FG000|STARTED|Randomized Phase||248
8559374|NCT01910402|9591316|FG001|STARTED|Randomized Phase||247
8559375|NCT01910402|9591315|FG000|COMPLETED|Randomized Phase||206
8559376|NCT01910402|9591316|FG001|COMPLETED|Randomized Phase||192
8559377|NCT01910402|9591315|FG000|NOT COMPLETED|Randomized Phase||42
8559378|NCT01910402|9591316|FG001|NOT COMPLETED|Randomized Phase||55
8559379|NCT01910402|9591315|FG000|STARTED|Continuation Phase||120
8559380|NCT01910402|9591316|FG001|STARTED|Continuation Phase||0
8559381|NCT01910402|9591315|FG000|COMPLETED|Continuation Phase||30
8559382|NCT01910402|9591316|FG001|COMPLETED|Continuation Phase||0
8559383|NCT01910402|9591315|FG000|NOT COMPLETED|Continuation Phase||90
8559384|NCT01910402|9591316|FG001|NOT COMPLETED|Continuation Phase||0
8559385|NCT01893320|9591326|FG000|STARTED|Overall Study||7
8619395|NCT00467779|9657791|FG003|STARTED|Stage 3||0
8619396|NCT00467779|9657792|FG004|STARTED|Stage 3||0
8619397|NCT00467779|9657793|FG005|STARTED|Stage 3||0
8619398|NCT00467779|9657794|FG006|STARTED|Stage 3||0
8619399|NCT00467779|9657795|FG007|STARTED|Stage 3||0
8619400|NCT00467779|9657796|FG008|STARTED|Stage 3||0
8619401|NCT00467779|9657797|FG009|STARTED|Stage 3||0
8721848|NCT01014741|9769092|FG000|STARTED|Overall Study||105
8721849|NCT01014741|9769093|FG001|STARTED|Overall Study||95
8721850|NCT01014741|9769092|FG000|COMPLETED|Overall Study||94
8721851|NCT01014741|9769093|FG001|COMPLETED|Overall Study||90
8721852|NCT01014741|9769092|FG000|NOT COMPLETED|Overall Study||11
8721853|NCT01014741|9769093|FG001|NOT COMPLETED|Overall Study||5
8619402|NCT00467779|9657798|FG010|STARTED|Stage 3||0
8619403|NCT00467779|9657799|FG011|STARTED|Stage 3||0
8619404|NCT00467779|9657800|FG012|STARTED|Stage 3||0
8619405|NCT00467779|9657801|FG013|STARTED|Stage 3||0
8619406|NCT00467779|9657802|FG014|STARTED|Stage 3||20
8619407|NCT00467779|9657788|FG000|COMPLETED|Stage 3||0
8619408|NCT00467779|9657789|FG001|COMPLETED|Stage 3||0
8721854|NCT01014871|9769099|FG000|STARTED|Overall Study||30
8721855|NCT01014871|9769099|FG000|COMPLETED|Overall Study||30
8559386|NCT01893320|9591327|FG001|STARTED|Overall Study||59
8559387|NCT01893320|9591326|FG000|COMPLETED|Overall Study||7
8559388|NCT01893320|9591327|FG001|COMPLETED|Overall Study||59
8559389|NCT01893320|9591326|FG000|NOT COMPLETED|Overall Study||0
8559390|NCT01893320|9591327|FG001|NOT COMPLETED|Overall Study||0
8559391|NCT01870401|9591335|FG000|STARTED|Overall Study||287
8559392|NCT01870401|9591336|FG001|STARTED|Overall Study||155
8559393|NCT01870401|9591335|FG000|COMPLETED|Overall Study||137
8559394|NCT01870401|9591336|FG001|COMPLETED|Overall Study||59
8559395|NCT01870401|9591335|FG000|NOT COMPLETED|Overall Study||150
8559396|NCT01870401|9591336|FG001|NOT COMPLETED|Overall Study||96
8559397|NCT01867606|9591346|FG000|STARTED|Overall Study||26
8559398|NCT01867606|9591347|FG001|STARTED|Overall Study||32
8559399|NCT01867606|9591346|FG000|COMPLETED|Overall Study||16
8559400|NCT01867606|9591347|FG001|COMPLETED|Overall Study||17
8559401|NCT01867606|9591346|FG000|NOT COMPLETED|Overall Study||10
8559402|NCT01867606|9591347|FG001|NOT COMPLETED|Overall Study||15
8559403|NCT01857063|9591361|FG000|STARTED|Period 1 (7 Days)||110
8559404|NCT01857063|9591362|FG001|STARTED|Period 1 (7 Days)||110
8559405|NCT01857063|9591361|FG000|COMPLETED|Period 1 (7 Days)||108
8559406|NCT01857063|9591362|FG001|COMPLETED|Period 1 (7 Days)||106
8559407|NCT01857063|9591361|FG000|NOT COMPLETED|Period 1 (7 Days)||2
8559408|NCT01857063|9591362|FG001|NOT COMPLETED|Period 1 (7 Days)||4
8559409|NCT01857063|9591361|FG000|STARTED|Period 2 (7 Days)||108
8559410|NCT01857063|9591362|FG001|STARTED|Period 2 (7 Days)||106
8559411|NCT01857063|9591361|FG000|COMPLETED|Period 2 (7 Days)||104
8559412|NCT01857063|9591362|FG001|COMPLETED|Period 2 (7 Days)||104
8559413|NCT01857063|9591361|FG000|NOT COMPLETED|Period 2 (7 Days)||4
8559414|NCT01857063|9591362|FG001|NOT COMPLETED|Period 2 (7 Days)||2
8559415|NCT01854268|9591368|FG000|STARTED|Overall Study||25
8559416|NCT01854268|9591368|FG000|COMPLETED|Overall Study||25
8559417|NCT01854268|9591368|FG000|NOT COMPLETED|Overall Study||0
8559418|NCT01852812|9591375|FG000|STARTED|Overall Study||51
8559419|NCT01852812|9591376|FG001|STARTED|Overall Study||18
8559420|NCT01852812|9591377|FG002|STARTED|Overall Study||18
8559421|NCT01852812|9591375|FG000|COMPLETED|Overall Study||51
8559422|NCT01852812|9591376|FG001|COMPLETED|Overall Study||17
8559423|NCT01852812|9591377|FG002|COMPLETED|Overall Study||17
8559424|NCT01852812|9591375|FG000|NOT COMPLETED|Overall Study||0
8559425|NCT01852812|9591376|FG001|NOT COMPLETED|Overall Study||1
8559426|NCT01852812|9591377|FG002|NOT COMPLETED|Overall Study||1
8559427|NCT01828021|9591385|FG000|STARTED|Overall Study||25
8559428|NCT01828021|9591385|FG000|COMPLETED|Overall Study||0
8559429|NCT01828021|9591385|FG000|NOT COMPLETED|Overall Study||25
8559430|NCT01709318|9591396|FG000|STARTED|Overall Study||82
8559431|NCT01709318|9591397|FG001|STARTED|Overall Study||85
8559432|NCT01709318|9591398|FG002|STARTED|Overall Study||77
8559433|NCT01709318|9591399|FG003|STARTED|Overall Study||78
8559434|NCT01709318|9591400|FG004|STARTED|Overall Study||78
8559435|NCT01709318|9591401|FG005|STARTED|Overall Study||84
8559436|NCT01709318|9591402|FG006|STARTED|Overall Study||182
8559437|NCT01709318|9591396|FG000|Treated|Overall Study||79
8559438|NCT01709318|9591397|FG001|Treated|Overall Study||85
8559439|NCT01709318|9591398|FG002|Treated|Overall Study||78
8559440|NCT01709318|9591399|FG003|Treated|Overall Study||77
8559441|NCT01709318|9591400|FG004|Treated|Overall Study||77
8559442|NCT01709318|9591401|FG005|Treated|Overall Study||86
8559443|NCT01709318|9591402|FG006|Treated|Overall Study||178
8559444|NCT01709318|9591396|FG000|COMPLETED|Overall Study||73
8559445|NCT01709318|9591397|FG001|COMPLETED|Overall Study||78
8559446|NCT01709318|9591398|FG002|COMPLETED|Overall Study||71
8559447|NCT01709318|9591399|FG003|COMPLETED|Overall Study||72
8559448|NCT01709318|9591400|FG004|COMPLETED|Overall Study||74
8559449|NCT01709318|9591401|FG005|COMPLETED|Overall Study||80
8559450|NCT01709318|9591402|FG006|COMPLETED|Overall Study||171
8559451|NCT01709318|9591396|FG000|NOT COMPLETED|Overall Study||9
8559452|NCT01709318|9591397|FG001|NOT COMPLETED|Overall Study||7
8559453|NCT01709318|9591398|FG002|NOT COMPLETED|Overall Study||6
8619409|NCT00467779|9657790|FG002|COMPLETED|Stage 3||0
8619410|NCT00467779|9657791|FG003|COMPLETED|Stage 3||0
8619411|NCT00467779|9657792|FG004|COMPLETED|Stage 3||0
8619412|NCT00467779|9657793|FG005|COMPLETED|Stage 3||0
8619413|NCT00467779|9657794|FG006|COMPLETED|Stage 3||0
8619414|NCT00467779|9657795|FG007|COMPLETED|Stage 3||0
8619415|NCT00467779|9657796|FG008|COMPLETED|Stage 3||0
8619416|NCT00467779|9657797|FG009|COMPLETED|Stage 3||0
8619417|NCT00467779|9657798|FG010|COMPLETED|Stage 3||0
8619418|NCT00467779|9657799|FG011|COMPLETED|Stage 3||0
8619419|NCT00467779|9657800|FG012|COMPLETED|Stage 3||0
8619420|NCT00467779|9657801|FG013|COMPLETED|Stage 3||0
8619421|NCT00467779|9657802|FG014|COMPLETED|Stage 3||3
8619422|NCT00467779|9657788|FG000|NOT COMPLETED|Stage 3||0
8619423|NCT00467779|9657789|FG001|NOT COMPLETED|Stage 3||0
8619424|NCT00467779|9657790|FG002|NOT COMPLETED|Stage 3||0
8619425|NCT00467779|9657791|FG003|NOT COMPLETED|Stage 3||0
8559454|NCT01709318|9591399|FG003|NOT COMPLETED|Overall Study||6
8559455|NCT01709318|9591400|FG004|NOT COMPLETED|Overall Study||4
8559456|NCT01709318|9591401|FG005|NOT COMPLETED|Overall Study||4
8559457|NCT01709318|9591402|FG006|NOT COMPLETED|Overall Study||11
8559458|NCT01698918|9591418|FG000|STARTED|First Line Treatment (Core+Extension)||202
8559459|NCT01698918|9591418|FG000|Dexamethasone Randomized Set (Stomatitis Sub-study)|First Line Treatment (Core+Extension)||11
8559460|NCT01698918|9591418|FG000|Standard of Care Randomized Set (Stomatitis Sub-study)|First Line Treatment (Core+Extension)||13
8559461|NCT01698918|9591418|FG000|COMPLETED|First Line Treatment (Core+Extension)||29
8559462|NCT01698918|9591418|FG000|NOT COMPLETED|First Line Treatment (Core+Extension)||173
8559463|NCT01698918|9591418|FG000|STARTED|Second Line Treatment (Core+Extension)||53
8559464|NCT01698918|9591418|FG000|COMPLETED|Second Line Treatment (Core+Extension)||7
8559465|NCT01698918|9591418|FG000|NOT COMPLETED|Second Line Treatment (Core+Extension)||46
8559466|NCT01673620|9591432|FG000|STARTED|Overall Study||47
8559467|NCT01673620|9591433|FG001|STARTED|Overall Study||22
8559468|NCT01673620|9591432|FG000|COMPLETED|Overall Study||46
8559469|NCT01673620|9591433|FG001|COMPLETED|Overall Study||22
8559470|NCT01673620|9591432|FG000|NOT COMPLETED|Overall Study||1
8559471|NCT01673620|9591433|FG001|NOT COMPLETED|Overall Study||0
8559472|NCT01660243|9591443|FG000|STARTED|Overall Study||10
8559473|NCT01660243|9591444|FG001|STARTED|Overall Study||13
8559474|NCT01660243|9591445|FG002|STARTED|Overall Study||11
8559475|NCT01660243|9591446|FG003|STARTED|Overall Study||11
8559476|NCT01660243|9591443|FG000|COMPLETED|Overall Study||8
8559477|NCT01660243|9591444|FG001|COMPLETED|Overall Study||13
8559478|NCT01660243|9591445|FG002|COMPLETED|Overall Study||9
8559479|NCT01660243|9591446|FG003|COMPLETED|Overall Study||10
8559480|NCT01660243|9591443|FG000|NOT COMPLETED|Overall Study||2
8559481|NCT01660243|9591444|FG001|NOT COMPLETED|Overall Study||0
8559482|NCT01660243|9591445|FG002|NOT COMPLETED|Overall Study||2
8559483|NCT01660243|9591446|FG003|NOT COMPLETED|Overall Study||1
8559484|NCT01617187|9591460|FG000|STARTED|Randomization Through Start Treatment|Randomized|98
8559485|NCT01617187|9591461|FG001|STARTED|Randomization Through Start Treatment|Randomized|113
8559486|NCT01617187|9591462|FG002|STARTED|Randomization Through Start Treatment|Randomized|46
8559487|NCT01617187|9591463|FG003|STARTED|Randomization Through Start Treatment|Randomized|103
8559488|NCT01617187|9591460|FG000|COMPLETED|Randomization Through Start Treatment||97
8559489|NCT01617187|9591461|FG001|COMPLETED|Randomization Through Start Treatment||113
8559490|NCT01617187|9591462|FG002|COMPLETED|Randomization Through Start Treatment||46
8559491|NCT01617187|9591463|FG003|COMPLETED|Randomization Through Start Treatment||101
8559492|NCT01617187|9591460|FG000|NOT COMPLETED|Randomization Through Start Treatment||1
8559493|NCT01617187|9591461|FG001|NOT COMPLETED|Randomization Through Start Treatment||0
8559494|NCT01617187|9591462|FG002|NOT COMPLETED|Randomization Through Start Treatment||0
8559495|NCT01617187|9591463|FG003|NOT COMPLETED|Randomization Through Start Treatment||2
8559496|NCT01617187|9591460|FG000|STARTED|Treatment Through Study Completion|Treated|97
8559497|NCT01617187|9591461|FG001|STARTED|Treatment Through Study Completion|Treated|113
8559498|NCT01617187|9591462|FG002|STARTED|Treatment Through Study Completion|Treated|46
8559499|NCT01617187|9591463|FG003|STARTED|Treatment Through Study Completion|Treated|101
8559500|NCT01617187|9591460|FG000|COMPLETED|Treatment Through Study Completion|Excludes the participant who did not receive study drug but completed study in database|86
8559501|NCT01617187|9591461|FG001|COMPLETED|Treatment Through Study Completion||102
8559502|NCT01617187|9591462|FG002|COMPLETED|Treatment Through Study Completion||41
8559503|NCT01617187|9591463|FG003|COMPLETED|Treatment Through Study Completion||91
8559504|NCT01617187|9591460|FG000|NOT COMPLETED|Treatment Through Study Completion||11
8559505|NCT01617187|9591461|FG001|NOT COMPLETED|Treatment Through Study Completion||11
8559506|NCT01617187|9591462|FG002|NOT COMPLETED|Treatment Through Study Completion||5
8559507|NCT01617187|9591463|FG003|NOT COMPLETED|Treatment Through Study Completion||10
8559508|NCT01611883|9591475|FG000|STARTED|Overall Study||75
8559509|NCT01611883|9591476|FG001|STARTED|Overall Study||77
8559510|NCT01611883|9591475|FG000|COMPLETED|Overall Study||74
8559511|NCT01611883|9591476|FG001|COMPLETED|Overall Study||76
8559512|NCT01611883|9591475|FG000|NOT COMPLETED|Overall Study||1
8559513|NCT01611883|9591476|FG001|NOT COMPLETED|Overall Study||1
8559514|NCT01572675|9591484|FG000|STARTED|Overall Study||268
8559515|NCT01572675|9591485|FG001|STARTED|Overall Study||279
8559516|NCT01572675|9591484|FG000|COMPLETED|Overall Study||31
8559517|NCT01572675|9591485|FG001|COMPLETED|Overall Study||56
8559518|NCT01572675|9591484|FG000|NOT COMPLETED|Overall Study||237
8559519|NCT01572675|9591485|FG001|NOT COMPLETED|Overall Study||223
8559520|NCT01554163|9591506|FG000|STARTED|Overall Study||120
8619426|NCT00467779|9657792|FG004|NOT COMPLETED|Stage 3||0
8619427|NCT00467779|9657793|FG005|NOT COMPLETED|Stage 3||0
8619428|NCT00467779|9657794|FG006|NOT COMPLETED|Stage 3||0
8619429|NCT00467779|9657795|FG007|NOT COMPLETED|Stage 3||0
8619430|NCT00467779|9657796|FG008|NOT COMPLETED|Stage 3||0
8619431|NCT00467779|9657797|FG009|NOT COMPLETED|Stage 3||0
8619432|NCT00467779|9657798|FG010|NOT COMPLETED|Stage 3||0
8721856|NCT01014871|9769099|FG000|NOT COMPLETED|Overall Study||0
8721857|NCT01014910|9769107|FG000|STARTED|Overall Study||80
8721858|NCT01014910|9769108|FG001|STARTED|Overall Study||81
8619433|NCT00467779|9657799|FG011|NOT COMPLETED|Stage 3||0
8619434|NCT00467779|9657800|FG012|NOT COMPLETED|Stage 3||0
8619435|NCT00467779|9657801|FG013|NOT COMPLETED|Stage 3||0
8619436|NCT00467779|9657802|FG014|NOT COMPLETED|Stage 3||17
8559521|NCT01554163|9591507|FG001|STARTED|Overall Study||119
8559522|NCT01554163|9591506|FG000|Number Treated|Overall Study||119
8559523|NCT01554163|9591507|FG001|Number Treated|Overall Study||119
8559524|NCT01554163|9591506|FG000|COMPLETED|Overall Study||112
8559525|NCT01554163|9591507|FG001|COMPLETED|Overall Study||109
8559526|NCT01554163|9591506|FG000|NOT COMPLETED|Overall Study||8
8559527|NCT01554163|9591507|FG001|NOT COMPLETED|Overall Study||10
8559528|NCT01502371|9591518|FG000|STARTED|Overall Study||120
8559529|NCT01502371|9591519|FG001|STARTED|Overall Study||113
8559530|NCT01502371|9591520|FG002|STARTED|Overall Study||108
8559531|NCT01502371|9591521|FG003|STARTED|Overall Study||125
8559532|NCT01502371|9591522|FG004|STARTED|Overall Study||112
8559533|NCT01502371|9591518|FG000|COMPLETED|Overall Study||79
8559534|NCT01502371|9591519|FG001|COMPLETED|Overall Study||81
8559535|NCT01502371|9591520|FG002|COMPLETED|Overall Study||83
8559536|NCT01502371|9591521|FG003|COMPLETED|Overall Study||88
8559537|NCT01502371|9591522|FG004|COMPLETED|Overall Study||60
8559538|NCT01502371|9591518|FG000|NOT COMPLETED|Overall Study||41
8559539|NCT01502371|9591519|FG001|NOT COMPLETED|Overall Study||32
8559540|NCT01502371|9591520|FG002|NOT COMPLETED|Overall Study||25
8559541|NCT01502371|9591521|FG003|NOT COMPLETED|Overall Study||37
8559542|NCT01502371|9591522|FG004|NOT COMPLETED|Overall Study||52
8619437|NCT00467818|9657842|FG000|STARTED|Overall Study||9
8619438|NCT00467818|9657843|FG001|STARTED|Overall Study||8
8559543|NCT01490190|9591535|FG000|STARTED|Overall Study||252
8559544|NCT01490190|9591535|FG000|COMPLETED|Overall Study||204
8559545|NCT01490190|9591535|FG000|NOT COMPLETED|Overall Study||48
8559546|NCT01471340|9591541|FG000|STARTED|Overall Study|This value corresponds to randomized participants who received at least of dose of study medication|5868
8559547|NCT01471340|9591542|FG001|STARTED|Overall Study|This value corresponds to randomized participants who received at least of dose of study medication|5861
8559548|NCT01471340|9591541|FG000|COMPLETED|Overall Study||5862
8721859|NCT01014910|9769107|FG000|COMPLETED|Overall Study||80
8721860|NCT01014910|9769108|FG001|COMPLETED|Overall Study||79
8721861|NCT01014910|9769107|FG000|NOT COMPLETED|Overall Study||0
8721862|NCT01014910|9769108|FG001|NOT COMPLETED|Overall Study||2
8721863|NCT01014936|9769117|FG000|STARTED|Overall Study||42
8721864|NCT01014936|9769118|FG001|STARTED|Overall Study||45
8721865|NCT01014936|9769119|FG002|STARTED|Overall Study||62
8721866|NCT01014936|9769117|FG000|COMPLETED|Overall Study||42
8721867|NCT01014936|9769118|FG001|COMPLETED|Overall Study||45
8721868|NCT01014936|9769119|FG002|COMPLETED|Overall Study||62
8721869|NCT01014936|9769117|FG000|NOT COMPLETED|Overall Study||0
8721870|NCT01014936|9769118|FG001|NOT COMPLETED|Overall Study||0
8721871|NCT01014936|9769119|FG002|NOT COMPLETED|Overall Study||0
8725113|NCT01029405|9772306|FG000|STARTED|Overall Study||36
8725114|NCT01029405|9772307|FG001|STARTED|Overall Study||37
8721872|NCT01014975|9769185|FG000|STARTED|Overall Study||8
8721873|NCT01014975|9769186|FG001|STARTED|Overall Study||16
8721874|NCT01014975|9769187|FG002|STARTED|Overall Study||16
8721875|NCT01014975|9769185|FG000|COMPLETED|Overall Study||4
8721876|NCT01014975|9769186|FG001|COMPLETED|Overall Study||13
8721877|NCT01014975|9769187|FG002|COMPLETED|Overall Study||10
8721878|NCT01014975|9769185|FG000|NOT COMPLETED|Overall Study||4
8721879|NCT01014975|9769186|FG001|NOT COMPLETED|Overall Study||3
8721880|NCT01014975|9769187|FG002|NOT COMPLETED|Overall Study||6
8721881|NCT01014988|9769201|FG000|STARTED|Overall Study||130
8721882|NCT01014988|9769202|FG001|STARTED|Overall Study||7
8619439|NCT00467818|9657842|FG000|COMPLETED|Overall Study||6
8619440|NCT00467818|9657843|FG001|COMPLETED|Overall Study||6
8619441|NCT00467818|9657842|FG000|NOT COMPLETED|Overall Study||3
8619442|NCT00467818|9657843|FG001|NOT COMPLETED|Overall Study||2
8619443|NCT00467831|9657851|FG000|STARTED|Overall Study||3
8619444|NCT00467831|9657851|FG000|COMPLETED|Overall Study||0
8619445|NCT00467831|9657851|FG000|NOT COMPLETED|Overall Study||3
8619446|NCT00467844|9657858|FG000|STARTED|Overall Study||53
8619447|NCT00467844|9657859|FG001|STARTED|Overall Study||54
8619448|NCT00467844|9657860|FG002|STARTED|Overall Study||52
8619449|NCT00467844|9657858|FG000|COMPLETED|Overall Study||34
8559549|NCT01471340|9591542|FG001|COMPLETED|Overall Study||5855
8559550|NCT01471340|9591541|FG000|NOT COMPLETED|Overall Study||6
8559551|NCT01471340|9591542|FG001|NOT COMPLETED|Overall Study||6
8559552|NCT01462370|9591548|FG000|STARTED|Overall Study||69
8559553|NCT01462370|9591549|FG001|STARTED|Overall Study||70
8559554|NCT01462370|9591548|FG000|COMPLETED|Overall Study||68
8559555|NCT01462370|9591549|FG001|COMPLETED|Overall Study||65
8559556|NCT01462370|9591548|FG000|NOT COMPLETED|Overall Study||1
8559557|NCT01462370|9591549|FG001|NOT COMPLETED|Overall Study||5
8559558|NCT01436253|9591555|FG000|STARTED|Overall Study||2196
8559559|NCT01436253|9591555|FG000|COMPLETED|Overall Study||1897
8559560|NCT01436253|9591555|FG000|NOT COMPLETED|Overall Study||299
8559561|NCT01414192|9591563|FG000|STARTED|Overall Study||490
8559562|NCT01414192|9591564|FG001|STARTED|Overall Study||575
8559563|NCT01414192|9591565|FG002|STARTED|Overall Study||424
8559564|NCT01414192|9591566|FG003|STARTED|Overall Study||1726
8559565|NCT01414192|9591563|FG000|COMPLETED|Overall Study||490
8559566|NCT01414192|9591564|FG001|COMPLETED|Overall Study||575
8559567|NCT01414192|9591565|FG002|COMPLETED|Overall Study||424
8559568|NCT01414192|9591566|FG003|COMPLETED|Overall Study||1726
8559569|NCT01414192|9591563|FG000|NOT COMPLETED|Overall Study||0
8559570|NCT01414192|9591564|FG001|NOT COMPLETED|Overall Study||0
8559571|NCT01414192|9591565|FG002|NOT COMPLETED|Overall Study||0
8559572|NCT01414192|9591566|FG003|NOT COMPLETED|Overall Study||0
8559573|NCT01390415|9591582|FG000|STARTED|Overall Study||99
8559574|NCT01390415|9591583|FG001|STARTED|Overall Study||37
8559575|NCT01390415|9591582|FG000|COMPLETED|Overall Study||99
8559576|NCT01390415|9591583|FG001|COMPLETED|Overall Study||37
8559577|NCT01390415|9591582|FG000|NOT COMPLETED|Overall Study||0
8559578|NCT01390415|9591583|FG001|NOT COMPLETED|Overall Study||0
8559579|NCT01381679|9591589|FG000|STARTED|Overall Study||1682
8559580|NCT01381679|9591589|FG000|COMPLETED|Overall Study||794
8559581|NCT01381679|9591589|FG000|NOT COMPLETED|Overall Study||888
8559582|NCT01370603|9591595|FG000|STARTED|Period 1||164
8559583|NCT01370603|9591596|FG001|STARTED|Period 1||164
8559584|NCT01370603|9591595|FG000|COMPLETED|Period 1||150
8559585|NCT01370603|9591596|FG001|COMPLETED|Period 1||154
8559586|NCT01370603|9591595|FG000|NOT COMPLETED|Period 1||14
8559587|NCT01370603|9591596|FG001|NOT COMPLETED|Period 1||10
8559588|NCT01370603|9591595|FG000|STARTED|Crossover Washout||150
8559589|NCT01370603|9591596|FG001|STARTED|Crossover Washout||154
8559590|NCT01370603|9591595|FG000|COMPLETED|Crossover Washout||141
8559591|NCT01370603|9591596|FG001|COMPLETED|Crossover Washout||150
8559592|NCT01370603|9591595|FG000|NOT COMPLETED|Crossover Washout||9
8559593|NCT01370603|9591596|FG001|NOT COMPLETED|Crossover Washout||4
8559594|NCT01370603|9591595|FG000|STARTED|Period 2||141
8559595|NCT01370603|9591596|FG001|STARTED|Period 2||150
8559596|NCT01370603|9591595|FG000|COMPLETED|Period 2||138
8559597|NCT01370603|9591596|FG001|COMPLETED|Period 2||146
8559598|NCT01370603|9591595|FG000|NOT COMPLETED|Period 2||3
8559599|NCT01370603|9591596|FG001|NOT COMPLETED|Period 2||4
8559600|NCT01370590|9591604|FG000|STARTED|Period 1||203
8559601|NCT01370590|9591605|FG001|STARTED|Period 1||203
8559602|NCT01370590|9591604|FG000|COMPLETED|Period 1||187
8559603|NCT01370590|9591605|FG001|COMPLETED|Period 1||192
8559604|NCT01370590|9591604|FG000|NOT COMPLETED|Period 1||16
8559605|NCT01370590|9591605|FG001|NOT COMPLETED|Period 1||11
8559606|NCT01370590|9591604|FG000|STARTED|Crossover Washout Period||187
8559607|NCT01370590|9591605|FG001|STARTED|Crossover Washout Period||192
8559608|NCT01370590|9591604|FG000|COMPLETED|Crossover Washout Period||181
8559609|NCT01370590|9591605|FG001|COMPLETED|Crossover Washout Period||186
8559610|NCT01370590|9591604|FG000|NOT COMPLETED|Crossover Washout Period||6
8559611|NCT01370590|9591605|FG001|NOT COMPLETED|Crossover Washout Period||6
8559612|NCT01370590|9591604|FG000|STARTED|Period 2||181
8559613|NCT01370590|9591605|FG001|STARTED|Period 2||186
8559614|NCT01370590|9591604|FG000|COMPLETED|Period 2||180
8559615|NCT01370590|9591605|FG001|COMPLETED|Period 2||184
8559616|NCT01370590|9591604|FG000|NOT COMPLETED|Period 2||1
8559617|NCT01370590|9591605|FG001|NOT COMPLETED|Period 2||2
8559618|NCT01368185|9591611|FG000|STARTED|Overall Study||1705
8559619|NCT01368185|9591611|FG000|COMPLETED|Overall Study||1705
8559620|NCT01368185|9591611|FG000|NOT COMPLETED|Overall Study||0
8559621|NCT01349907|9591617|FG000|STARTED|Overall Study|Enrolled and Treated|241
8559622|NCT01349907|9591618|FG001|STARTED|Overall Study|Enrolled and Treated|81
8559623|NCT01349907|9591617|FG000|COMPLETED|Overall Study||102
8559624|NCT01349907|9591618|FG001|COMPLETED|Overall Study||38
8559625|NCT01349907|9591617|FG000|NOT COMPLETED|Overall Study||139
8559626|NCT01349907|9591618|FG001|NOT COMPLETED|Overall Study||43
8559627|NCT01345786|9591628|FG000|STARTED|Overall Study|Number randomized|41
8559628|NCT01345786|9591629|FG001|STARTED|Overall Study|Number randomized|41
8559629|NCT01345786|9591630|FG002|STARTED|Overall Study|Number randomized|38
8559630|NCT01345786|9591631|FG003|STARTED|Overall Study|Number randomized|38
8559631|NCT01345786|9591628|FG000|Treated|Overall Study||41
8559632|NCT01345786|9591629|FG001|Treated|Overall Study||41
8721883|NCT01014988|9769203|FG002|STARTED|Overall Study||11
8559633|NCT01345786|9591630|FG002|Treated|Overall Study||37
8559634|NCT01345786|9591631|FG003|Treated|Overall Study||37
8559635|NCT01345786|9591628|FG000|COMPLETED|Overall Study||35
8559636|NCT01345786|9591629|FG001|COMPLETED|Overall Study||33
8559637|NCT01345786|9591630|FG002|COMPLETED|Overall Study||33
8559638|NCT01345786|9591631|FG003|COMPLETED|Overall Study||35
8559639|NCT01345786|9591628|FG000|NOT COMPLETED|Overall Study||6
8559640|NCT01345786|9591629|FG001|NOT COMPLETED|Overall Study||8
8559641|NCT01345786|9591630|FG002|NOT COMPLETED|Overall Study||5
8559642|NCT01345786|9591631|FG003|NOT COMPLETED|Overall Study||3
8559643|NCT01306929|9591641|FG000|STARTED|Overall Study||134
8559644|NCT01306929|9591641|FG000|COMPLETED|Overall Study||40
8559645|NCT01306929|9591641|FG000|NOT COMPLETED|Overall Study||94
8559646|NCT01294696|9591647|FG000|STARTED|Overall Study||1261
8559647|NCT01294696|9591647|FG000|COMPLETED|Overall Study||1187
8559648|NCT01294696|9591647|FG000|NOT COMPLETED|Overall Study||74
8559649|NCT01277822|9591654|FG000|STARTED|Overall Study||168
8559650|NCT01277822|9591655|FG001|STARTED|Overall Study||166
8559651|NCT01277822|9591654|FG000|COMPLETED|Overall Study||153
8559652|NCT01277822|9591655|FG001|COMPLETED|Overall Study||155
8559653|NCT01277822|9591654|FG000|NOT COMPLETED|Overall Study||15
8559654|NCT01277822|9591655|FG001|NOT COMPLETED|Overall Study||11
8559655|NCT01244763|9591667|FG000|STARTED|Overall Study||24
8559656|NCT01244763|9591668|FG001|STARTED|Overall Study||24
8559657|NCT01244763|9591669|FG002|STARTED|Overall Study||24
8559658|NCT01244763|9591670|FG003|STARTED|Overall Study||24
8721884|NCT01014988|9769204|FG003|STARTED|Overall Study||12
8559659|NCT01244763|9591671|FG004|STARTED|Overall Study||24
8559660|NCT01244763|9591672|FG005|STARTED|Overall Study||25
8559661|NCT01244763|9591667|FG000|Safety Population|Overall Study||24
8559662|NCT01244763|9591668|FG001|Safety Population|Overall Study||24
8559663|NCT01244763|9591669|FG002|Safety Population|Overall Study||24
8559664|NCT01244763|9591670|FG003|Safety Population|Overall Study||24
8559665|NCT01244763|9591671|FG004|Safety Population|Overall Study||24
8559666|NCT01244763|9591672|FG005|Safety Population|Overall Study||25
8559667|NCT01244763|9591667|FG000|Efficacy Evaluable (EE) Population|Overall Study||23
8559668|NCT01244763|9591668|FG001|Efficacy Evaluable (EE) Population|Overall Study||24
8559669|NCT01244763|9591669|FG002|Efficacy Evaluable (EE) Population|Overall Study||23
8559670|NCT01244763|9591670|FG003|Efficacy Evaluable (EE) Population|Overall Study||24
8619450|NCT00467844|9657859|FG001|COMPLETED|Overall Study||34
8619451|NCT00467844|9657860|FG002|COMPLETED|Overall Study||38
8619452|NCT00467844|9657858|FG000|NOT COMPLETED|Overall Study||19
8619453|NCT00467844|9657859|FG001|NOT COMPLETED|Overall Study||20
8619454|NCT00467844|9657860|FG002|NOT COMPLETED|Overall Study||14
8619455|NCT00467857|9657873|FG000|STARTED|Overall Study||146
8619456|NCT00467857|9657874|FG001|STARTED|Overall Study||147
8619457|NCT00467857|9657873|FG000|COMPLETED|Overall Study||143
8721885|NCT01014988|9769205|FG004|STARTED|Overall Study||27
8721886|NCT01014988|9769206|FG005|STARTED|Overall Study||14
8721887|NCT01014988|9769201|FG000|COMPLETED|Overall Study||107
8721888|NCT01014988|9769202|FG001|COMPLETED|Overall Study||7
8619458|NCT00467857|9657874|FG001|COMPLETED|Overall Study||139
8721889|NCT01014988|9769203|FG002|COMPLETED|Overall Study||9
8721890|NCT01014988|9769204|FG003|COMPLETED|Overall Study||12
8721891|NCT01014988|9769205|FG004|COMPLETED|Overall Study||26
8721892|NCT01014988|9769206|FG005|COMPLETED|Overall Study||11
8721893|NCT01014988|9769201|FG000|NOT COMPLETED|Overall Study||23
8721894|NCT01014988|9769202|FG001|NOT COMPLETED|Overall Study||0
8721895|NCT01014988|9769203|FG002|NOT COMPLETED|Overall Study||2
8721896|NCT01014988|9769204|FG003|NOT COMPLETED|Overall Study||0
8619459|NCT00467857|9657873|FG000|NOT COMPLETED|Overall Study||3
8619460|NCT00467857|9657874|FG001|NOT COMPLETED|Overall Study||8
8619461|NCT00467870|9657886|FG000|STARTED|Overall Study||120
8721897|NCT01014988|9769205|FG004|NOT COMPLETED|Overall Study||1
8721898|NCT01014988|9769206|FG005|NOT COMPLETED|Overall Study||3
8721899|NCT01015118|9769230|FG000|STARTED|Overall Study||911
8559671|NCT01244763|9591671|FG004|Efficacy Evaluable (EE) Population|Overall Study||24
8559672|NCT01244763|9591672|FG005|Efficacy Evaluable (EE) Population|Overall Study||25
8559673|NCT01244763|9591667|FG000|COMPLETED|Overall Study||21
8559674|NCT01244763|9591668|FG001|COMPLETED|Overall Study||21
8559675|NCT01244763|9591669|FG002|COMPLETED|Overall Study||22
8559676|NCT01244763|9591670|FG003|COMPLETED|Overall Study||23
8559677|NCT01244763|9591671|FG004|COMPLETED|Overall Study||21
8559678|NCT01244763|9591672|FG005|COMPLETED|Overall Study||21
8559679|NCT01244763|9591667|FG000|NOT COMPLETED|Overall Study||3
8559680|NCT01244763|9591668|FG001|NOT COMPLETED|Overall Study||3
8559681|NCT01244763|9591669|FG002|NOT COMPLETED|Overall Study||2
8559682|NCT01244763|9591670|FG003|NOT COMPLETED|Overall Study||1
8559683|NCT01244763|9591671|FG004|NOT COMPLETED|Overall Study||3
8559684|NCT01244763|9591672|FG005|NOT COMPLETED|Overall Study||4
8569010|NCT00094887|9601231|FG001|Intent to Treat Population|Overall Study||75
8569011|NCT00094887|9601230|FG000|Per Protocol Analysis Set|Overall Study||71
8569012|NCT00094887|9601231|FG001|Per Protocol Analysis Set|Overall Study||71
8569013|NCT00094887|9601230|FG000|Primary Efficacy Population|Overall Study||65
8569014|NCT00094887|9601231|FG001|Primary Efficacy Population|Overall Study||64
8569015|NCT00094887|9601230|FG000|COMPLETED|Overall Study||71
8569016|NCT00094887|9601231|FG001|COMPLETED|Overall Study||71
8569017|NCT00094887|9601230|FG000|NOT COMPLETED|Overall Study||4
8569018|NCT00094887|9601231|FG001|NOT COMPLETED|Overall Study||4
8569019|NCT00094900|9601237|FG000|STARTED|Overall Study||11
8569020|NCT00094900|9601237|FG000|COMPLETED|Overall Study||10
8569021|NCT00094900|9601237|FG000|NOT COMPLETED|Overall Study||1
8569022|NCT00095056|9601243|FG000|STARTED|Phase A (Weeks 0-12)||65
8569023|NCT00095056|9601244|FG001|STARTED|Phase A (Weeks 0-12)||26
8569024|NCT00095056|9601243|FG000|COMPLETED|Phase A (Weeks 0-12)||58
8569025|NCT00095056|9601244|FG001|COMPLETED|Phase A (Weeks 0-12)||25
8569026|NCT00095056|9601243|FG000|NOT COMPLETED|Phase A (Weeks 0-12)||7
8569027|NCT00095056|9601244|FG001|NOT COMPLETED|Phase A (Weeks 0-12)||1
8569028|NCT00095056|9601243|FG000|STARTED|Phase B (Weeks 12-54)|2 randomized patients completed Period 1 but did not enter Period 2.|56
8569029|NCT00095056|9601244|FG001|STARTED|Phase B (Weeks 12-54)||25
8569030|NCT00095056|9601243|FG000|COMPLETED|Phase B (Weeks 12-54)||46
8569031|NCT00095056|9601244|FG001|COMPLETED|Phase B (Weeks 12-54)||20
8569032|NCT00095056|9601243|FG000|NOT COMPLETED|Phase B (Weeks 12-54)||10
8569033|NCT00095056|9601244|FG001|NOT COMPLETED|Phase B (Weeks 12-54)||5
8569034|NCT00095121|9601252|FG000|STARTED|Double-Blind (Study Weeks 0 Through 48)||115
8569035|NCT00095121|9601253|FG001|STARTED|Double-Blind (Study Weeks 0 Through 48)||58
8569036|NCT00095121|9601252|FG000|COMPLETED|Double-Blind (Study Weeks 0 Through 48)||112
8569037|NCT00095121|9601253|FG001|COMPLETED|Double-Blind (Study Weeks 0 Through 48)||58
8569038|NCT00095121|9601252|FG000|NOT COMPLETED|Double-Blind (Study Weeks 0 Through 48)||3
8569039|NCT00095121|9601253|FG001|NOT COMPLETED|Double-Blind (Study Weeks 0 Through 48)||0
8569040|NCT00095121|9601252|FG000|STARTED|Open-Label (Study Weeks 49 Through 240)||108
8569041|NCT00095121|9601253|FG001|STARTED|Open-Label (Study Weeks 49 Through 240)||54
8569042|NCT00095121|9601252|FG000|Received Lamivudine (LAM) After Week 96|Open-Label (Study Weeks 49 Through 240)||21
8569043|NCT00095121|9601253|FG001|Received Lamivudine (LAM) After Week 96|Open-Label (Study Weeks 49 Through 240)||11
8569044|NCT00095121|9601252|FG000|COMPLETED|Open-Label (Study Weeks 49 Through 240)|Completed the 240-week study period either on or off treatment at Week 240.|46
8569045|NCT00095121|9601253|FG001|COMPLETED|Open-Label (Study Weeks 49 Through 240)|Completed the 240-week study period either on or off treatment at Week 240.|35
8569046|NCT00095121|9601252|FG000|NOT COMPLETED|Open-Label (Study Weeks 49 Through 240)||62
8569047|NCT00095121|9601253|FG001|NOT COMPLETED|Open-Label (Study Weeks 49 Through 240)||19
8569048|NCT00095147|9601272|FG000|STARTED|Double-blind Period 1 (Days 1-197)||156
8569049|NCT00095147|9601273|FG001|STARTED|Double-blind Period 1 (Days 1-197)||165
8569050|NCT00095147|9601274|FG002|STARTED|Double-blind Period 1 (Days 1-197)||110
8569051|NCT00095147|9601275|FG003|STARTED|Double-blind Period 1 (Days 1-197)||0
8569052|NCT00095147|9601276|FG004|STARTED|Double-blind Period 1 (Days 1-197)||0
8569053|NCT00095147|9601272|FG000|COMPLETED|Double-blind Period 1 (Days 1-197)||147
8569054|NCT00095147|9601273|FG001|COMPLETED|Double-blind Period 1 (Days 1-197)||152
8569055|NCT00095147|9601274|FG002|COMPLETED|Double-blind Period 1 (Days 1-197)||107
8569056|NCT00095147|9601275|FG003|COMPLETED|Double-blind Period 1 (Days 1-197)||0
8569057|NCT00095147|9601276|FG004|COMPLETED|Double-blind Period 1 (Days 1-197)||0
8569058|NCT00095147|9601272|FG000|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||9
8569059|NCT00095147|9601273|FG001|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||13
8569060|NCT00095147|9601274|FG002|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||3
8619462|NCT00467870|9657887|FG001|STARTED|Overall Study||117
8619463|NCT00467870|9657888|FG002|STARTED|Overall Study||22
8619464|NCT00467870|9657889|FG003|STARTED|Overall Study||112
8569061|NCT00095147|9601275|FG003|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||0
8569062|NCT00095147|9601276|FG004|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||0
8569063|NCT00095147|9601272|FG000|STARTED|Double-blind Period 2 (Days 198-365)||147
8569064|NCT00095147|9601273|FG001|STARTED|Double-blind Period 2 (Days 198-365)||152
8569065|NCT00095147|9601274|FG002|STARTED|Double-blind Period 2 (Days 198-365)||0
8569066|NCT00095147|9601275|FG003|STARTED|Double-blind Period 2 (Days 198-365)||107
8569067|NCT00095147|9601276|FG004|STARTED|Double-blind Period 2 (Days 198-365)||0
8559685|NCT01208207|9591689|FG000|STARTED|Part I||702
8559686|NCT01208207|9591690|FG001|STARTED|Part I||156
8559687|NCT01208207|9591691|FG002|STARTED|Part I||157
8559688|NCT01208207|9591692|FG003|STARTED|Part I||0
8559689|NCT01208207|9591693|FG004|STARTED|Part I||0
8559690|NCT01208207|9591694|FG005|STARTED|Part I||0
8559691|NCT01208207|9591695|FG006|STARTED|Part I||0
8559692|NCT01208207|9591689|FG000|COMPLETED|Part I||632
8559693|NCT01208207|9591690|FG001|COMPLETED|Part I||145
8559694|NCT01208207|9591691|FG002|COMPLETED|Part I||142
8559695|NCT01208207|9591692|FG003|COMPLETED|Part I||0
8559696|NCT01208207|9591693|FG004|COMPLETED|Part I||0
8559697|NCT01208207|9591694|FG005|COMPLETED|Part I||0
8559698|NCT01208207|9591695|FG006|COMPLETED|Part I||0
8559699|NCT01208207|9591689|FG000|NOT COMPLETED|Part I||70
8559700|NCT01208207|9591690|FG001|NOT COMPLETED|Part I||11
8559701|NCT01208207|9591691|FG002|NOT COMPLETED|Part I||15
8559702|NCT01208207|9591692|FG003|NOT COMPLETED|Part I||0
8559703|NCT01208207|9591693|FG004|NOT COMPLETED|Part I||0
8559704|NCT01208207|9591694|FG005|NOT COMPLETED|Part I||0
8559705|NCT01208207|9591695|FG006|NOT COMPLETED|Part I||0
8559706|NCT01208207|9591689|FG000|STARTED|Part II||0
8559707|NCT01208207|9591690|FG001|STARTED|Part II||0
8559708|NCT01208207|9591691|FG002|STARTED|Part II||0
8559709|NCT01208207|9591692|FG003|STARTED|Part II||314
8559710|NCT01208207|9591693|FG004|STARTED|Part II||318
8559711|NCT01208207|9591694|FG005|STARTED|Part II||145
8559712|NCT01208207|9591695|FG006|STARTED|Part II||142
8559713|NCT01208207|9591689|FG000|COMPLETED|Part II||0
8559714|NCT01208207|9591690|FG001|COMPLETED|Part II||0
8559715|NCT01208207|9591691|FG002|COMPLETED|Part II||0
8559716|NCT01208207|9591692|FG003|COMPLETED|Part II||282
8559717|NCT01208207|9591693|FG004|COMPLETED|Part II||295
8559718|NCT01208207|9591694|FG005|COMPLETED|Part II||129
8559719|NCT01208207|9591695|FG006|COMPLETED|Part II||131
8559720|NCT01208207|9591689|FG000|NOT COMPLETED|Part II||0
8559721|NCT01208207|9591690|FG001|NOT COMPLETED|Part II||0
8559722|NCT01208207|9591691|FG002|NOT COMPLETED|Part II||0
8559723|NCT01208207|9591692|FG003|NOT COMPLETED|Part II||32
8559724|NCT01208207|9591693|FG004|NOT COMPLETED|Part II||23
8559725|NCT01208207|9591694|FG005|NOT COMPLETED|Part II||16
8559726|NCT01208207|9591695|FG006|NOT COMPLETED|Part II||11
8559727|NCT01208181|9591720|FG000|STARTED|Part 1||818
8559728|NCT01208181|9591721|FG001|STARTED|Part 1||468
8559729|NCT01208181|9591722|FG002|STARTED|Part 1||0
8559730|NCT01208181|9591723|FG003|STARTED|Part 1||0
8559731|NCT01208181|9591724|FG004|STARTED|Part 1||118
8559732|NCT01208181|9591720|FG000|COMPLETED|Part 1|Six participants from this arm did not continue into Part II of the study|719
8559733|NCT01208181|9591721|FG001|COMPLETED|Part 1|Per protocol, participants in this arm did not continue into Part II of the study|413
8559734|NCT01208181|9591722|FG002|COMPLETED|Part 1||0
8559735|NCT01208181|9591723|FG003|COMPLETED|Part 1||0
8559736|NCT01208181|9591724|FG004|COMPLETED|Part 1|Per protocol, participants in this arm did not continue into Part II of the study|96
8559737|NCT01208181|9591720|FG000|NOT COMPLETED|Part 1||99
8559738|NCT01208181|9591721|FG001|NOT COMPLETED|Part 1||55
8559739|NCT01208181|9591722|FG002|NOT COMPLETED|Part 1||0
8559740|NCT01208181|9591723|FG003|NOT COMPLETED|Part 1||0
8559741|NCT01208181|9591724|FG004|NOT COMPLETED|Part 1||22
8559742|NCT01208181|9591720|FG000|STARTED|Part 2|Per protocol, there were no participants in this arm during Part II of the study|0
8559743|NCT01208181|9591721|FG001|STARTED|Part 2|Per protocol, there were no participants in this arm during Part II of the study|0
8559744|NCT01208181|9591722|FG002|STARTED|Part 2|Participants receiving etoricoxib 60 mg in Part I received etoricoxib 60 mg in Part II of the study|350
8559745|NCT01208181|9591723|FG003|STARTED|Part 2|Participants receiving etoricoxib 60 mg in Part I received etoricoxib 90 mg in Part II of the study|363
8559746|NCT01208181|9591724|FG004|STARTED|Part 2|Per protocol, participants did not receive placebo during Part II of the study|0
8559747|NCT01208181|9591720|FG000|COMPLETED|Part 2||0
8559748|NCT01208181|9591721|FG001|COMPLETED|Part 2||0
8559749|NCT01208181|9591722|FG002|COMPLETED|Part 2||334
8559750|NCT01208181|9591723|FG003|COMPLETED|Part 2||343
8559751|NCT01208181|9591724|FG004|COMPLETED|Part 2||0
8559752|NCT01208181|9591720|FG000|NOT COMPLETED|Part 2||0
8559753|NCT01208181|9591721|FG001|NOT COMPLETED|Part 2||0
8559754|NCT01208181|9591722|FG002|NOT COMPLETED|Part 2||16
8559755|NCT01208181|9591723|FG003|NOT COMPLETED|Part 2||20
8559756|NCT01208181|9591724|FG004|NOT COMPLETED|Part 2||0
8559757|NCT01206517|9591747|FG000|STARTED|Overall Study||6
8559758|NCT01206517|9591748|FG001|STARTED|Overall Study||6
8559759|NCT01206517|9591749|FG002|STARTED|Overall Study||6
8559760|NCT01206517|9591750|FG003|STARTED|Overall Study||4
8559761|NCT01206517|9591751|FG004|STARTED|Overall Study||4
8559762|NCT01206517|9591752|FG005|STARTED|Overall Study||4
8559763|NCT01206517|9591747|FG000|COMPLETED|Overall Study||6
8559764|NCT01206517|9591748|FG001|COMPLETED|Overall Study||6
8559765|NCT01206517|9591749|FG002|COMPLETED|Overall Study||4
8559766|NCT01206517|9591750|FG003|COMPLETED|Overall Study||4
8559767|NCT01206517|9591751|FG004|COMPLETED|Overall Study||3
8559768|NCT01206517|9591752|FG005|COMPLETED|Overall Study||4
8559769|NCT01206517|9591747|FG000|NOT COMPLETED|Overall Study||0
8559770|NCT01206517|9591748|FG001|NOT COMPLETED|Overall Study||0
8721900|NCT01015118|9769231|FG001|STARTED|Overall Study||455
8721901|NCT01015118|9769230|FG000|COMPLETED|Overall Study|Patients who completed max trial therapy duration.|242
8721902|NCT01015118|9769231|FG001|COMPLETED|Overall Study|Patients who completed max trial therapy duration.|128
8721903|NCT01015118|9769230|FG000|NOT COMPLETED|Overall Study||669
8721904|NCT01015118|9769231|FG001|NOT COMPLETED|Overall Study||327
8721905|NCT01015131|9769237|FG000|STARTED|Overall Study||44
8559771|NCT01206517|9591749|FG002|NOT COMPLETED|Overall Study||2
8559772|NCT01206517|9591750|FG003|NOT COMPLETED|Overall Study||0
8559773|NCT01206517|9591751|FG004|NOT COMPLETED|Overall Study||1
8559774|NCT01206517|9591752|FG005|NOT COMPLETED|Overall Study||0
8559775|NCT01190267|9591765|FG000|STARTED|Overall Study||196
8559776|NCT01190267|9591766|FG001|STARTED|Overall Study||8
8559777|NCT01190267|9591765|FG000|COMPLETED|Overall Study||155
8559778|NCT01190267|9591766|FG001|COMPLETED|Overall Study||4
8559779|NCT01190267|9591765|FG000|NOT COMPLETED|Overall Study||41
8559780|NCT01190267|9591766|FG001|NOT COMPLETED|Overall Study||4
8559781|NCT01190254|9591775|FG000|STARTED|Overall Study||102
8559782|NCT01190254|9591776|FG001|STARTED|Overall Study||98
8559783|NCT01190254|9591777|FG002|STARTED|Overall Study||106
8559784|NCT01190254|9591775|FG000|Treated|Overall Study||102
8559785|NCT01190254|9591776|FG001|Treated|Overall Study||98
8559786|NCT01190254|9591777|FG002|Treated|Overall Study||106
8559787|NCT01190254|9591775|FG000|COMPLETED|Overall Study||81
8559788|NCT01190254|9591776|FG001|COMPLETED|Overall Study||81
8559789|NCT01190254|9591777|FG002|COMPLETED|Overall Study||84
8559790|NCT01190254|9591775|FG000|NOT COMPLETED|Overall Study||21
8559791|NCT01190254|9591776|FG001|NOT COMPLETED|Overall Study||17
8559792|NCT01190254|9591777|FG002|NOT COMPLETED|Overall Study||22
8559793|NCT01154036|9591788|FG000|STARTED|Phase I||120
8559794|NCT01154036|9591789|FG001|STARTED|Phase I||483
8559795|NCT01154036|9591790|FG002|STARTED|Phase I||944
8559796|NCT01154036|9591791|FG003|STARTED|Phase I||0
8559797|NCT01154036|9591792|FG004|STARTED|Phase I||0
8559798|NCT01154036|9591793|FG005|STARTED|Phase I||0
8559799|NCT01154036|9591794|FG006|STARTED|Phase I||0
8559800|NCT01154036|9591795|FG007|STARTED|Phase I||0
8559801|NCT01154036|9591788|FG000|COMPLETED|Phase I|Not all completers were eligible for Phase II|117
8559802|NCT01154036|9591789|FG001|COMPLETED|Phase I|Not all completers were eligible for Phase II|455
8559803|NCT01154036|9591790|FG002|COMPLETED|Phase I|Not all completers were eligible for Phase II|888
8559804|NCT01154036|9591791|FG003|COMPLETED|Phase I||0
8559805|NCT01154036|9591792|FG004|COMPLETED|Phase I||0
8559806|NCT01154036|9591793|FG005|COMPLETED|Phase I||0
8559807|NCT01154036|9591794|FG006|COMPLETED|Phase I||0
8559808|NCT01154036|9591795|FG007|COMPLETED|Phase I||0
8559809|NCT01154036|9591788|FG000|NOT COMPLETED|Phase I||3
8559810|NCT01154036|9591789|FG001|NOT COMPLETED|Phase I||28
8559811|NCT01154036|9591790|FG002|NOT COMPLETED|Phase I||56
8559812|NCT01154036|9591791|FG003|NOT COMPLETED|Phase I||0
8559813|NCT01154036|9591792|FG004|NOT COMPLETED|Phase I||0
8559814|NCT01154036|9591793|FG005|NOT COMPLETED|Phase I||0
8559815|NCT01154036|9591794|FG006|NOT COMPLETED|Phase I||0
8559816|NCT01154036|9591795|FG007|NOT COMPLETED|Phase I||0
8559817|NCT01154036|9591788|FG000|STARTED|Phase II||0
8559818|NCT01154036|9591789|FG001|STARTED|Phase II||0
8559819|NCT01154036|9591790|FG002|STARTED|Phase II||0
8559820|NCT01154036|9591791|FG003|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|28
8559821|NCT01154036|9591792|FG004|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|124
8559822|NCT01154036|9591793|FG005|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|126
8559823|NCT01154036|9591794|FG006|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|234
8559824|NCT01154036|9591795|FG007|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|206
8559825|NCT01154036|9591788|FG000|COMPLETED|Phase II||0
8559826|NCT01154036|9591789|FG001|COMPLETED|Phase II||0
8559827|NCT01154036|9591790|FG002|COMPLETED|Phase II||0
8813859|NCT01528319|9867065|FG000|STARTED|Overall Study||24
8813860|NCT01528319|9867065|FG000|12 Weeks After Surgery|Overall Study||24
8813861|NCT01528319|9867065|FG000|COMPLETED|Overall Study||23
8813862|NCT01528319|9867065|FG000|NOT COMPLETED|Overall Study||1
8813863|NCT01528332|9867071|FG000|STARTED|Overall Study||85
8559828|NCT01154036|9591791|FG003|COMPLETED|Phase II||27
8559829|NCT01154036|9591792|FG004|COMPLETED|Phase II||116
8559830|NCT01154036|9591793|FG005|COMPLETED|Phase II||121
8559831|NCT01154036|9591794|FG006|COMPLETED|Phase II||225
8559832|NCT01154036|9591795|FG007|COMPLETED|Phase II||200
8559833|NCT01154036|9591788|FG000|NOT COMPLETED|Phase II||0
8721906|NCT01015131|9769237|FG000|COMPLETED|Overall Study||36
8559834|NCT01154036|9591789|FG001|NOT COMPLETED|Phase II||0
8559835|NCT01154036|9591790|FG002|NOT COMPLETED|Phase II||0
8559836|NCT01154036|9591791|FG003|NOT COMPLETED|Phase II||1
8559837|NCT01154036|9591792|FG004|NOT COMPLETED|Phase II||8
8559838|NCT01154036|9591793|FG005|NOT COMPLETED|Phase II||5
8559839|NCT01154036|9591794|FG006|NOT COMPLETED|Phase II||9
8559840|NCT01154036|9591795|FG007|NOT COMPLETED|Phase II||6
8559841|NCT01101464|9591817|FG000|STARTED|Day 1 Through AM Dose of Day 5||4
8559842|NCT01101464|9591818|FG001|STARTED|Day 1 Through AM Dose of Day 5||4
8559843|NCT01101464|9591817|FG000|COMPLETED|Day 1 Through AM Dose of Day 5||4
8721907|NCT01015131|9769237|FG000|NOT COMPLETED|Overall Study||8
8721908|NCT01015170|9769241|FG000|STARTED|Overall Study||454
8721909|NCT01015170|9769241|FG000|COMPLETED|Overall Study||215
8721910|NCT01015170|9769241|FG000|NOT COMPLETED|Overall Study||239
8721911|NCT01015287|9769249|FG000|STARTED|Overall Study||1996
8721912|NCT01015287|9769250|FG001|STARTED|Overall Study||2037
8721913|NCT01015287|9769249|FG000|Received at Least 1 Dose of Study Drug|Overall Study||1996
8721914|NCT01015287|9769250|FG001|Received at Least 1 Dose of Study Drug|Overall Study||2037
8721915|NCT01015287|9769249|FG000|COMPLETED|Overall Study||1924
8721916|NCT01015287|9769250|FG001|COMPLETED|Overall Study||1958
8721917|NCT01015287|9769249|FG000|NOT COMPLETED|Overall Study||72
8721918|NCT01015287|9769250|FG001|NOT COMPLETED|Overall Study||79
8721919|NCT01015326|9769260|FG000|STARTED|Overall Study||12
8721920|NCT01015326|9769261|FG001|STARTED|Overall Study||20
8721921|NCT01015326|9769260|FG000|COMPLETED|Overall Study||11
8721922|NCT01015326|9769261|FG001|COMPLETED|Overall Study||18
8721923|NCT01015326|9769260|FG000|NOT COMPLETED|Overall Study||1
8721924|NCT01015326|9769261|FG001|NOT COMPLETED|Overall Study||2
8721925|NCT01015443|9769269|FG000|STARTED|Overall Study||191
8721926|NCT01015443|9769270|FG001|STARTED|Overall Study||94
8721927|NCT01015443|9769269|FG000|Treated|Overall Study||191
8721928|NCT01015443|9769270|FG001|Treated|Overall Study||93
8721929|NCT01015443|9769269|FG000|COMPLETED|Overall Study||191
8721930|NCT01015443|9769270|FG001|COMPLETED|Overall Study||94
8721931|NCT01015443|9769269|FG000|NOT COMPLETED|Overall Study||0
8721932|NCT01015443|9769270|FG001|NOT COMPLETED|Overall Study||0
8721933|NCT01015534|9769278|FG000|STARTED|Overall Study||28
8721934|NCT01015534|9769279|FG001|STARTED|Overall Study||27
8721935|NCT01015534|9769278|FG000|COMPLETED|Overall Study||27
8721936|NCT01015534|9769279|FG001|COMPLETED|Overall Study||27
8721937|NCT01015534|9769278|FG000|NOT COMPLETED|Overall Study||1
8721938|NCT01015534|9769279|FG001|NOT COMPLETED|Overall Study||0
8721939|NCT01015560|9769288|FG000|STARTED|Overall Study||44
8721940|NCT01015560|9769288|FG000|Eligible and Analyzable|Overall Study||43
8721941|NCT01015560|9769288|FG000|COMPLETED|Overall Study||41
8721942|NCT01015560|9769288|FG000|NOT COMPLETED|Overall Study||3
8721943|NCT01015586|9769294|FG000|STARTED|Overall Study||21
8721944|NCT01015586|9769295|FG001|STARTED|Overall Study||22
8721945|NCT01015586|9769294|FG000|COMPLETED|Overall Study||14
8721946|NCT01015586|9769295|FG001|COMPLETED|Overall Study||11
8721947|NCT01015586|9769294|FG000|NOT COMPLETED|Overall Study||7
8721948|NCT01015586|9769295|FG001|NOT COMPLETED|Overall Study||11
8721949|NCT01015612|9769301|FG000|STARTED|Overall Study||634
8721950|NCT01015612|9769301|FG000|COMPLETED|Overall Study||481
8721951|NCT01015612|9769301|FG000|NOT COMPLETED|Overall Study||153
8721952|NCT01015638|9769307|FG000|STARTED|Overall Study||17
8721953|NCT01015638|9769308|FG001|STARTED|Overall Study||19
8721954|NCT01015638|9769307|FG000|COMPLETED|Overall Study||16
8721955|NCT01015638|9769308|FG001|COMPLETED|Overall Study||19
8721956|NCT01015638|9769307|FG000|NOT COMPLETED|Overall Study||1
8721957|NCT01015638|9769308|FG001|NOT COMPLETED|Overall Study||0
8721958|NCT01015677|9769317|FG000|STARTED|Overall Study||34
8721959|NCT01015677|9769318|FG001|STARTED|Overall Study||32
8721960|NCT01015677|9769319|FG002|STARTED|Overall Study||33
8721961|NCT01015677|9769317|FG000|COMPLETED|Overall Study||33
8721962|NCT01015677|9769318|FG001|COMPLETED|Overall Study||28
8721963|NCT01015677|9769319|FG002|COMPLETED|Overall Study||33
8721964|NCT01015677|9769317|FG000|NOT COMPLETED|Overall Study||1
8721965|NCT01015677|9769318|FG001|NOT COMPLETED|Overall Study||4
8721966|NCT01015677|9769319|FG002|NOT COMPLETED|Overall Study||0
8721967|NCT01015703|9769332|FG000|STARTED|Overall Study||10
8721968|NCT01015703|9769333|FG001|STARTED|Overall Study||10
8721969|NCT01015703|9769334|FG002|STARTED|Overall Study||10
8721970|NCT01015703|9769335|FG003|STARTED|Overall Study||10
8721971|NCT01015703|9769336|FG004|STARTED|Overall Study||10
8721972|NCT01015703|9769332|FG000|COMPLETED|Overall Study||8
8721973|NCT01015703|9769333|FG001|COMPLETED|Overall Study||9
8721974|NCT01015703|9769334|FG002|COMPLETED|Overall Study||10
8721975|NCT01015703|9769335|FG003|COMPLETED|Overall Study||10
8721976|NCT01015703|9769336|FG004|COMPLETED|Overall Study||10
8721977|NCT01015703|9769332|FG000|NOT COMPLETED|Overall Study||2
8721978|NCT01015703|9769333|FG001|NOT COMPLETED|Overall Study||1
8721979|NCT01015703|9769334|FG002|NOT COMPLETED|Overall Study||0
8721980|NCT01015703|9769335|FG003|NOT COMPLETED|Overall Study||0
8721981|NCT01015703|9769336|FG004|NOT COMPLETED|Overall Study||0
8721982|NCT01015768|9769348|FG000|STARTED|Overall Study||30
8721983|NCT01015768|9769349|FG001|STARTED|Overall Study||30
8721984|NCT01015768|9769348|FG000|COMPLETED|Overall Study||26
8721985|NCT01015768|9769349|FG001|COMPLETED|Overall Study||26
8721986|NCT01015768|9769348|FG000|NOT COMPLETED|Overall Study||4
8721987|NCT01015768|9769349|FG001|NOT COMPLETED|Overall Study||4
8721988|NCT01015781|9769359|FG000|STARTED|Overall Study||150
8721989|NCT01015781|9769360|FG001|STARTED|Overall Study||150
8721990|NCT01015781|9769359|FG000|COMPLETED|Overall Study||113
8721991|NCT01015781|9769360|FG001|COMPLETED|Overall Study||121
8721992|NCT01015781|9769359|FG000|NOT COMPLETED|Overall Study||37
8721993|NCT01015781|9769360|FG001|NOT COMPLETED|Overall Study||29
8721994|NCT01015807|9769369|FG000|STARTED|Overall Study||30
8721995|NCT01015807|9769370|FG001|STARTED|Overall Study||30
8721996|NCT01015807|9769371|FG002|STARTED|Overall Study||30
8721997|NCT01015807|9769369|FG000|COMPLETED|Overall Study||30
8559844|NCT01101464|9591818|FG001|COMPLETED|Day 1 Through AM Dose of Day 5||4
8559845|NCT01101464|9591817|FG000|NOT COMPLETED|Day 1 Through AM Dose of Day 5||0
8559846|NCT01101464|9591818|FG001|NOT COMPLETED|Day 1 Through AM Dose of Day 5||0
8559847|NCT01101464|9591817|FG000|STARTED|PM Dose of Day 5 Through AM Dose of Day7||4
8559848|NCT01101464|9591818|FG001|STARTED|PM Dose of Day 5 Through AM Dose of Day7||4
8559849|NCT01101464|9591817|FG000|COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||4
8559850|NCT01101464|9591818|FG001|COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||4
8559851|NCT01101464|9591817|FG000|NOT COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||0
8559852|NCT01101464|9591818|FG001|NOT COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||0
8559853|NCT01098071|9591826|FG000|STARTED|Overall Study||34
8559854|NCT01098071|9591826|FG000|COMPLETED|Overall Study||19
8559855|NCT01098071|9591826|FG000|NOT COMPLETED|Overall Study||15
8559856|NCT01077830|9591832|FG000|STARTED|Overall Study||677
8559857|NCT01077830|9591833|FG001|STARTED|Overall Study||682
8559858|NCT01077830|9591832|FG000|COMPLETED|Overall Study||677
8559859|NCT01077830|9591833|FG001|COMPLETED|Overall Study||682
8559860|NCT01077830|9591832|FG000|NOT COMPLETED|Overall Study||0
8559861|NCT01077830|9591833|FG001|NOT COMPLETED|Overall Study||0
8559862|NCT01070966|9591839|FG000|STARTED|Participants for Safety Evaluation||2089
8559863|NCT01070966|9591839|FG000|COMPLETED|Participants for Safety Evaluation||2011
8559864|NCT01070966|9591839|FG000|NOT COMPLETED|Participants for Safety Evaluation||78
8559865|NCT01070966|9591839|FG000|STARTED|Participants for Efficacy Evaluation||2011
8559866|NCT01070966|9591839|FG000|COMPLETED|Participants for Efficacy Evaluation||1929
8559867|NCT01070966|9591839|FG000|NOT COMPLETED|Participants for Efficacy Evaluation||82
8559868|NCT01070953|9591850|FG000|STARTED|Participants for Safety Evaluation||4467
8559869|NCT01070953|9591850|FG000|COMPLETED|Participants for Safety Evaluation||3536
8559870|NCT01070953|9591850|FG000|NOT COMPLETED|Participants for Safety Evaluation||931
8559871|NCT01070953|9591850|FG000|STARTED|Participants for Efficacy Evaluation||3536
8559872|NCT01070953|9591850|FG000|COMPLETED|Participants for Efficacy Evaluation||3309
8559873|NCT01070953|9591850|FG000|NOT COMPLETED|Participants for Efficacy Evaluation||227
8559874|NCT01030341|9591860|FG000|STARTED|Overall Study|45 participants met all enrollment criteria by completing the screening and run-in phases|45
8559875|NCT01030341|9591860|FG000|COMPLETED|Overall Study|42 participants completed the study|42
8559876|NCT01030341|9591860|FG000|NOT COMPLETED|Overall Study||3
8559877|NCT00979901|9591868|FG000|STARTED|Overall Study||352
8559878|NCT00979901|9591869|FG001|STARTED|Overall Study||348
8559879|NCT00979901|9591870|FG002|STARTED|Overall Study||602
8559880|NCT00979901|9591871|FG003|STARTED|Overall Study||275
8559881|NCT00979901|9591868|FG000|COMPLETED|Overall Study||334
8559882|NCT00979901|9591869|FG001|COMPLETED|Overall Study||336
8559883|NCT00979901|9591870|FG002|COMPLETED|Overall Study||573
8559884|NCT00979901|9591871|FG003|COMPLETED|Overall Study||159
8559885|NCT00979901|9591868|FG000|NOT COMPLETED|Overall Study||18
8559886|NCT00979901|9591869|FG001|NOT COMPLETED|Overall Study||12
8559887|NCT00979901|9591870|FG002|NOT COMPLETED|Overall Study||29
8559888|NCT00979901|9591871|FG003|NOT COMPLETED|Overall Study||116
8559889|NCT00963599|9591884|FG000|STARTED|Overall Study||149
8559890|NCT00963599|9591885|FG001|STARTED|Overall Study||155
8559891|NCT00963599|9591886|FG002|STARTED|Overall Study||301
8559892|NCT00963599|9591887|FG003|STARTED|Overall Study||302
8559893|NCT00963599|9591884|FG000|COMPLETED|Overall Study||143
8559894|NCT00963599|9591885|FG001|COMPLETED|Overall Study||149
8559895|NCT00963599|9591886|FG002|COMPLETED|Overall Study||292
8559896|NCT00963599|9591887|FG003|COMPLETED|Overall Study||288
8559897|NCT00963599|9591884|FG000|NOT COMPLETED|Overall Study||6
8559898|NCT00963599|9591885|FG001|NOT COMPLETED|Overall Study||6
8559899|NCT00963599|9591886|FG002|NOT COMPLETED|Overall Study||9
8559900|NCT00963599|9591887|FG003|NOT COMPLETED|Overall Study||14
8559901|NCT00954915|9591897|FG000|STARTED|Overall Study||1
8559902|NCT00954915|9591897|FG000|COMPLETED|Overall Study||1
8559903|NCT00954915|9591897|FG000|NOT COMPLETED|Overall Study||0
8559904|NCT00953680|9591902|FG000|STARTED|Period 1||38
8559905|NCT00953680|9591903|FG001|STARTED|Period 1||39
8559906|NCT00953680|9591902|FG000|COMPLETED|Period 1||38
8559907|NCT00953680|9591903|FG001|COMPLETED|Period 1||38
8559908|NCT00953680|9591902|FG000|NOT COMPLETED|Period 1||0
8559909|NCT00953680|9591903|FG001|NOT COMPLETED|Period 1||1
8559910|NCT00953680|9591902|FG000|STARTED|Period 2||38
8559911|NCT00953680|9591903|FG001|STARTED|Period 2||38
8559912|NCT00953680|9591902|FG000|COMPLETED|Period 2||38
8559913|NCT00953680|9591903|FG001|COMPLETED|Period 2||38
8559914|NCT00953680|9591902|FG000|NOT COMPLETED|Period 2||0
8559915|NCT00953680|9591903|FG001|NOT COMPLETED|Period 2||0
8619465|NCT00467870|9657890|FG004|STARTED|Overall Study||130
8619466|NCT00467870|9657891|FG005|STARTED|Overall Study||23
8619467|NCT00467870|9657886|FG000|COMPLETED|Overall Study||75
8619468|NCT00467870|9657887|FG001|COMPLETED|Overall Study||74
8619469|NCT00467870|9657888|FG002|COMPLETED|Overall Study||18
8619470|NCT00467870|9657889|FG003|COMPLETED|Overall Study||79
8619471|NCT00467870|9657890|FG004|COMPLETED|Overall Study||93
8721998|NCT01015807|9769370|FG001|COMPLETED|Overall Study||30
8721999|NCT01015807|9769371|FG002|COMPLETED|Overall Study||30
8722000|NCT01015807|9769369|FG000|NOT COMPLETED|Overall Study||0
8722001|NCT01015807|9769370|FG001|NOT COMPLETED|Overall Study||0
8722002|NCT01015807|9769371|FG002|NOT COMPLETED|Overall Study||0
8619472|NCT00467870|9657891|FG005|COMPLETED|Overall Study||21
8619473|NCT00467870|9657886|FG000|NOT COMPLETED|Overall Study||45
8619474|NCT00467870|9657887|FG001|NOT COMPLETED|Overall Study||43
8619475|NCT00467870|9657888|FG002|NOT COMPLETED|Overall Study||4
8619476|NCT00467870|9657889|FG003|NOT COMPLETED|Overall Study||33
8619477|NCT00467870|9657890|FG004|NOT COMPLETED|Overall Study||37
8619478|NCT00467870|9657891|FG005|NOT COMPLETED|Overall Study||2
8619479|NCT00467896|9657901|FG000|STARTED|Overall Study||62
8619480|NCT00467896|9657901|FG000|COMPLETED|Overall Study||11
8619481|NCT00467896|9657901|FG000|NOT COMPLETED|Overall Study||51
8619482|NCT00467961|9657907|FG000|STARTED|Overall Study||31
8619483|NCT00467961|9657907|FG000|COMPLETED|Overall Study||24
8619484|NCT00467961|9657907|FG000|NOT COMPLETED|Overall Study||7
8619485|NCT00468052|9657913|FG000|STARTED|Overall Study|1 subject withdrew consent.Surgery was cancelled for 2. 4 subjects eliminated for break in protocol|68
8619486|NCT00468052|9657914|FG001|STARTED|Overall Study|One had an intraoperative complication and was withdrawn. 7 eliminated for a break in protocol.|69
8619487|NCT00468052|9657913|FG000|Target Enrollment|Overall Study||70
8722003|NCT01015820|9769381|FG000|STARTED|Overall Study||15
8722004|NCT01015820|9769382|FG001|STARTED|Overall Study||15
8813864|NCT01528332|9867072|FG001|STARTED|Overall Study||86
8813865|NCT01528332|9867071|FG000|COMPLETED|Overall Study||81
8559916|NCT00945035|9591909|FG000|STARTED|Period 1||18
8559917|NCT00945035|9591910|FG001|STARTED|Period 1||18
8559918|NCT00945035|9591909|FG000|COMPLETED|Period 1||18
8559919|NCT00945035|9591910|FG001|COMPLETED|Period 1||18
8559920|NCT00945035|9591909|FG000|NOT COMPLETED|Period 1||0
8559921|NCT00945035|9591910|FG001|NOT COMPLETED|Period 1||0
8559922|NCT00945035|9591909|FG000|STARTED|Period 2||18
8559923|NCT00945035|9591910|FG001|STARTED|Period 2||18
8559924|NCT00945035|9591909|FG000|COMPLETED|Period 2||18
8559925|NCT00945035|9591910|FG001|COMPLETED|Period 2||18
8559926|NCT00945035|9591909|FG000|NOT COMPLETED|Period 2||0
8619488|NCT00468052|9657914|FG001|Target Enrollment|Overall Study||70
8619489|NCT00468052|9657913|FG000|COMPLETED|Overall Study||61
8619490|NCT00468052|9657914|FG001|COMPLETED|Overall Study||61
8619491|NCT00468052|9657913|FG000|NOT COMPLETED|Overall Study||7
8619492|NCT00468052|9657914|FG001|NOT COMPLETED|Overall Study||8
8619493|NCT00468104|9657922|FG000|STARTED|First Intervention||54
8619494|NCT00468104|9657923|FG001|STARTED|First Intervention||46
8619495|NCT00468104|9657922|FG000|COMPLETED|First Intervention||45
8619496|NCT00468104|9657923|FG001|COMPLETED|First Intervention||45
8619497|NCT00468104|9657922|FG000|NOT COMPLETED|First Intervention||9
8619498|NCT00468104|9657923|FG001|NOT COMPLETED|First Intervention||1
8619499|NCT00468104|9657922|FG000|STARTED|Second Intervention|37 responded to Alteplase and did not go to the second intervention|8
8722005|NCT01015820|9769381|FG000|COMPLETED|Overall Study||14
8559927|NCT00945035|9591910|FG001|NOT COMPLETED|Period 2||0
8559928|NCT00943852|9591916|FG000|STARTED|First Period of Treatment Intervention||2
8559929|NCT00943852|9591917|FG001|STARTED|First Period of Treatment Intervention||1
8559930|NCT00943852|9591918|FG002|STARTED|First Period of Treatment Intervention||1
8722006|NCT01015820|9769382|FG001|COMPLETED|Overall Study||15
8722007|NCT01015820|9769381|FG000|NOT COMPLETED|Overall Study||1
8722008|NCT01015820|9769382|FG001|NOT COMPLETED|Overall Study||0
8722009|NCT01015976|9769388|FG000|STARTED|Overall Study||5
8722010|NCT01015976|9769389|FG001|STARTED|Overall Study||5
8722011|NCT01015976|9769388|FG000|COMPLETED|Overall Study||5
8722012|NCT01015976|9769389|FG001|COMPLETED|Overall Study||5
8722013|NCT01015976|9769388|FG000|NOT COMPLETED|Overall Study||0
8722014|NCT01015976|9769389|FG001|NOT COMPLETED|Overall Study||0
8559931|NCT00943852|9591919|FG003|STARTED|First Period of Treatment Intervention||2
8559932|NCT00943852|9591920|FG004|STARTED|First Period of Treatment Intervention||1
8559933|NCT00943852|9591921|FG005|STARTED|First Period of Treatment Intervention||1
8559934|NCT00943852|9591922|FG006|STARTED|First Period of Treatment Intervention||2
8559935|NCT00943852|9591923|FG007|STARTED|First Period of Treatment Intervention||1
8559936|NCT00943852|9591924|FG008|STARTED|First Period of Treatment Intervention||1
8559937|NCT00943852|9591925|FG009|STARTED|First Period of Treatment Intervention||1
8559938|NCT00943852|9591916|FG000|COMPLETED|First Period of Treatment Intervention||2
8559939|NCT00943852|9591917|FG001|COMPLETED|First Period of Treatment Intervention||1
8559940|NCT00943852|9591918|FG002|COMPLETED|First Period of Treatment Intervention||1
8559941|NCT00943852|9591919|FG003|COMPLETED|First Period of Treatment Intervention||2
8559942|NCT00943852|9591920|FG004|COMPLETED|First Period of Treatment Intervention||1
8559943|NCT00943852|9591921|FG005|COMPLETED|First Period of Treatment Intervention||1
8559944|NCT00943852|9591922|FG006|COMPLETED|First Period of Treatment Intervention||2
8559945|NCT00943852|9591923|FG007|COMPLETED|First Period of Treatment Intervention||1
8559946|NCT00943852|9591924|FG008|COMPLETED|First Period of Treatment Intervention||1
8559947|NCT00943852|9591925|FG009|COMPLETED|First Period of Treatment Intervention||1
8559948|NCT00943852|9591916|FG000|NOT COMPLETED|First Period of Treatment Intervention||0
8559949|NCT00943852|9591917|FG001|NOT COMPLETED|First Period of Treatment Intervention||0
8559950|NCT00943852|9591918|FG002|NOT COMPLETED|First Period of Treatment Intervention||0
8559951|NCT00943852|9591919|FG003|NOT COMPLETED|First Period of Treatment Intervention||0
8559952|NCT00943852|9591920|FG004|NOT COMPLETED|First Period of Treatment Intervention||0
8559953|NCT00943852|9591921|FG005|NOT COMPLETED|First Period of Treatment Intervention||0
8559954|NCT00943852|9591922|FG006|NOT COMPLETED|First Period of Treatment Intervention||0
8559955|NCT00943852|9591923|FG007|NOT COMPLETED|First Period of Treatment Intervention||0
8559956|NCT00943852|9591924|FG008|NOT COMPLETED|First Period of Treatment Intervention||0
8559957|NCT00943852|9591925|FG009|NOT COMPLETED|First Period of Treatment Intervention||0
8559958|NCT00943852|9591916|FG000|STARTED|Washout Period After Period 1 Treatment||2
8559959|NCT00943852|9591917|FG001|STARTED|Washout Period After Period 1 Treatment||1
8559960|NCT00943852|9591918|FG002|STARTED|Washout Period After Period 1 Treatment||1
8559961|NCT00943852|9591919|FG003|STARTED|Washout Period After Period 1 Treatment||2
8559962|NCT00943852|9591920|FG004|STARTED|Washout Period After Period 1 Treatment||1
8559963|NCT00943852|9591921|FG005|STARTED|Washout Period After Period 1 Treatment||1
8722015|NCT01016015|9769393|FG000|STARTED|Overall Study||178
8722016|NCT01016015|9769393|FG000|COMPLETED|Overall Study||159
8722017|NCT01016015|9769393|FG000|NOT COMPLETED|Overall Study||19
8722018|NCT01016067|9769399|FG000|STARTED|Overall Study||11
8722019|NCT01016067|9769400|FG001|STARTED|Overall Study||12
8722020|NCT01016067|9769399|FG000|COMPLETED|Overall Study||9
8722021|NCT01016067|9769400|FG001|COMPLETED|Overall Study||8
8722022|NCT01016067|9769399|FG000|NOT COMPLETED|Overall Study||2
8722023|NCT01016067|9769400|FG001|NOT COMPLETED|Overall Study||4
8722024|NCT01016106|9769408|FG000|STARTED|Overall Study||17
8722025|NCT01016106|9769409|FG001|STARTED|Overall Study||18
8722026|NCT01016106|9769408|FG000|COMPLETED|Overall Study||17
8722027|NCT01016106|9769409|FG001|COMPLETED|Overall Study||18
8722028|NCT01016106|9769408|FG000|NOT COMPLETED|Overall Study||0
8722029|NCT01016106|9769409|FG001|NOT COMPLETED|Overall Study||0
8722030|NCT01016132|9769415|FG000|STARTED|Overall Study||152
8559964|NCT00943852|9591922|FG006|STARTED|Washout Period After Period 1 Treatment||2
8559965|NCT00943852|9591923|FG007|STARTED|Washout Period After Period 1 Treatment||1
8559966|NCT00943852|9591924|FG008|STARTED|Washout Period After Period 1 Treatment||1
8619500|NCT00468104|9657923|FG001|STARTED|Second Intervention|4 patients responded to Placebo and did not go to the second intervention|41
8619501|NCT00468104|9657922|FG000|COMPLETED|Second Intervention||3
8619502|NCT00468104|9657923|FG001|COMPLETED|Second Intervention||37
8619503|NCT00468104|9657922|FG000|NOT COMPLETED|Second Intervention||5
8619504|NCT00468104|9657923|FG001|NOT COMPLETED|Second Intervention||4
8619505|NCT00468143|9657932|FG000|STARTED|First Intervention (3 Weeks)||31
8722031|NCT01016132|9769415|FG000|COMPLETED|Overall Study||151
8722032|NCT01016132|9769415|FG000|NOT COMPLETED|Overall Study||1
8722033|NCT01016262|9769422|FG000|STARTED|Double-blind Phase||41
8722034|NCT01016262|9769423|FG001|STARTED|Double-blind Phase||39
8619506|NCT00468143|9657933|FG001|STARTED|First Intervention (3 Weeks)||31
8619507|NCT00468143|9657932|FG000|COMPLETED|First Intervention (3 Weeks)||28
8619508|NCT00468143|9657933|FG001|COMPLETED|First Intervention (3 Weeks)||27
8619509|NCT00468143|9657932|FG000|NOT COMPLETED|First Intervention (3 Weeks)||3
8619510|NCT00468143|9657933|FG001|NOT COMPLETED|First Intervention (3 Weeks)||4
8619511|NCT00468143|9657932|FG000|STARTED|Second Intervention (3 Weeks)||28
8619512|NCT00468143|9657933|FG001|STARTED|Second Intervention (3 Weeks)||27
8619513|NCT00468143|9657932|FG000|COMPLETED|Second Intervention (3 Weeks)||25
8619514|NCT00468143|9657933|FG001|COMPLETED|Second Intervention (3 Weeks)||24
8619515|NCT00468143|9657932|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||3
8722035|NCT01016262|9769424|FG002|STARTED|Double-blind Phase||39
8722036|NCT01016262|9769425|FG003|STARTED|Double-blind Phase||0
8722037|NCT01016262|9769426|FG004|STARTED|Double-blind Phase||0
8722038|NCT01016262|9769427|FG005|STARTED|Double-blind Phase||0
8722039|NCT01016262|9769422|FG000|COMPLETED|Double-blind Phase||40
8722040|NCT01016262|9769423|FG001|COMPLETED|Double-blind Phase||38
8722041|NCT01016262|9769424|FG002|COMPLETED|Double-blind Phase||30
8559967|NCT00943852|9591925|FG009|STARTED|Washout Period After Period 1 Treatment||1
8559968|NCT00943852|9591916|FG000|COMPLETED|Washout Period After Period 1 Treatment||2
8559969|NCT00943852|9591917|FG001|COMPLETED|Washout Period After Period 1 Treatment||1
8559970|NCT00943852|9591918|FG002|COMPLETED|Washout Period After Period 1 Treatment||1
8559971|NCT00943852|9591919|FG003|COMPLETED|Washout Period After Period 1 Treatment||1
8559972|NCT00943852|9591920|FG004|COMPLETED|Washout Period After Period 1 Treatment||1
8559973|NCT00943852|9591921|FG005|COMPLETED|Washout Period After Period 1 Treatment||1
8559974|NCT00943852|9591922|FG006|COMPLETED|Washout Period After Period 1 Treatment||2
8559975|NCT00943852|9591923|FG007|COMPLETED|Washout Period After Period 1 Treatment||1
8559976|NCT00943852|9591924|FG008|COMPLETED|Washout Period After Period 1 Treatment||1
8559977|NCT00943852|9591925|FG009|COMPLETED|Washout Period After Period 1 Treatment||1
8559978|NCT00943852|9591916|FG000|NOT COMPLETED|Washout Period After Period 1 Treatment||0
8559979|NCT00943852|9591917|FG001|NOT COMPLETED|Washout Period After Period 1 Treatment||0
8559980|NCT00943852|9591918|FG002|NOT COMPLETED|Washout Period After Period 1 Treatment||0
8559981|NCT00943852|9591919|FG003|NOT COMPLETED|Washout Period After Period 1 Treatment||1
8559982|NCT00943852|9591920|FG004|NOT COMPLETED|Washout Period After Period 1 Treatment||0
8559983|NCT00943852|9591921|FG005|NOT COMPLETED|Washout Period After Period 1 Treatment||0
8559984|NCT00943852|9591922|FG006|NOT COMPLETED|Washout Period After Period 1 Treatment||0
8559985|NCT00943852|9591923|FG007|NOT COMPLETED|Washout Period After Period 1 Treatment||0
8559986|NCT00943852|9591924|FG008|NOT COMPLETED|Washout Period After Period 1 Treatment||0
8559987|NCT00943852|9591925|FG009|NOT COMPLETED|Washout Period After Period 1 Treatment||0
8559988|NCT00943852|9591916|FG000|STARTED|Second Period of Treatment Intervention||2
8559989|NCT00943852|9591917|FG001|STARTED|Second Period of Treatment Intervention||1
8559990|NCT00943852|9591918|FG002|STARTED|Second Period of Treatment Intervention||1
8559991|NCT00943852|9591919|FG003|STARTED|Second Period of Treatment Intervention||1
8559992|NCT00943852|9591920|FG004|STARTED|Second Period of Treatment Intervention||1
8559993|NCT00943852|9591921|FG005|STARTED|Second Period of Treatment Intervention||1
8559994|NCT00943852|9591922|FG006|STARTED|Second Period of Treatment Intervention||2
8559995|NCT00943852|9591923|FG007|STARTED|Second Period of Treatment Intervention||1
8559996|NCT00943852|9591924|FG008|STARTED|Second Period of Treatment Intervention||1
8559997|NCT00943852|9591925|FG009|STARTED|Second Period of Treatment Intervention||1
8559998|NCT00943852|9591916|FG000|COMPLETED|Second Period of Treatment Intervention||2
8559999|NCT00943852|9591917|FG001|COMPLETED|Second Period of Treatment Intervention||1
8560000|NCT00943852|9591918|FG002|COMPLETED|Second Period of Treatment Intervention||1
8560001|NCT00943852|9591919|FG003|COMPLETED|Second Period of Treatment Intervention||1
8560002|NCT00943852|9591920|FG004|COMPLETED|Second Period of Treatment Intervention||1
8560003|NCT00943852|9591921|FG005|COMPLETED|Second Period of Treatment Intervention||1
8560004|NCT00943852|9591922|FG006|COMPLETED|Second Period of Treatment Intervention||2
8560005|NCT00943852|9591923|FG007|COMPLETED|Second Period of Treatment Intervention||1
8560006|NCT00943852|9591924|FG008|COMPLETED|Second Period of Treatment Intervention||1
8560007|NCT00943852|9591925|FG009|COMPLETED|Second Period of Treatment Intervention||1
8560008|NCT00943852|9591916|FG000|NOT COMPLETED|Second Period of Treatment Intervention||0
8560009|NCT00943852|9591917|FG001|NOT COMPLETED|Second Period of Treatment Intervention||0
8560010|NCT00943852|9591918|FG002|NOT COMPLETED|Second Period of Treatment Intervention||0
8560011|NCT00943852|9591919|FG003|NOT COMPLETED|Second Period of Treatment Intervention||0
8560012|NCT00943852|9591920|FG004|NOT COMPLETED|Second Period of Treatment Intervention||0
8560013|NCT00943852|9591921|FG005|NOT COMPLETED|Second Period of Treatment Intervention||0
8560014|NCT00943852|9591922|FG006|NOT COMPLETED|Second Period of Treatment Intervention||0
8560015|NCT00943852|9591923|FG007|NOT COMPLETED|Second Period of Treatment Intervention||0
8560016|NCT00943852|9591924|FG008|NOT COMPLETED|Second Period of Treatment Intervention||0
8560017|NCT00943852|9591925|FG009|NOT COMPLETED|Second Period of Treatment Intervention||0
8560018|NCT00943852|9591916|FG000|STARTED|Washout Period After Period 2 Treatment||2
8560019|NCT00943852|9591917|FG001|STARTED|Washout Period After Period 2 Treatment||1
8560020|NCT00943852|9591918|FG002|STARTED|Washout Period After Period 2 Treatment||1
8560021|NCT00943852|9591919|FG003|STARTED|Washout Period After Period 2 Treatment||1
8560022|NCT00943852|9591920|FG004|STARTED|Washout Period After Period 2 Treatment||1
8560023|NCT00943852|9591921|FG005|STARTED|Washout Period After Period 2 Treatment||1
8560024|NCT00943852|9591922|FG006|STARTED|Washout Period After Period 2 Treatment||2
8560025|NCT00943852|9591923|FG007|STARTED|Washout Period After Period 2 Treatment||1
8722042|NCT01016262|9769425|FG003|COMPLETED|Double-blind Phase||0
8722043|NCT01016262|9769426|FG004|COMPLETED|Double-blind Phase||0
8722044|NCT01016262|9769427|FG005|COMPLETED|Double-blind Phase||0
8722045|NCT01016262|9769422|FG000|NOT COMPLETED|Double-blind Phase||1
8722046|NCT01016262|9769423|FG001|NOT COMPLETED|Double-blind Phase||1
8722047|NCT01016262|9769424|FG002|NOT COMPLETED|Double-blind Phase||9
8722048|NCT01016262|9769425|FG003|NOT COMPLETED|Double-blind Phase||0
8722049|NCT01016262|9769426|FG004|NOT COMPLETED|Double-blind Phase||0
8722050|NCT01016262|9769427|FG005|NOT COMPLETED|Double-blind Phase||0
8722051|NCT01016262|9769422|FG000|STARTED|Open-Label Phase||0
8722052|NCT01016262|9769423|FG001|STARTED|Open-Label Phase||0
8722053|NCT01016262|9769424|FG002|STARTED|Open-Label Phase||0
8722054|NCT01016262|9769425|FG003|STARTED|Open-Label Phase||44
8722055|NCT01016262|9769426|FG004|STARTED|Open-Label Phase||52
8722056|NCT01016262|9769427|FG005|STARTED|Open-Label Phase||20
8722057|NCT01016262|9769422|FG000|COMPLETED|Open-Label Phase||0
8722058|NCT01016262|9769423|FG001|COMPLETED|Open-Label Phase||0
8722059|NCT01016262|9769424|FG002|COMPLETED|Open-Label Phase||0
8722060|NCT01016262|9769425|FG003|COMPLETED|Open-Label Phase||42
8722061|NCT01016262|9769426|FG004|COMPLETED|Open-Label Phase||50
8722062|NCT01016262|9769427|FG005|COMPLETED|Open-Label Phase||20
8722063|NCT01016262|9769422|FG000|NOT COMPLETED|Open-Label Phase||0
8722064|NCT01016262|9769423|FG001|NOT COMPLETED|Open-Label Phase||0
8722065|NCT01016262|9769424|FG002|NOT COMPLETED|Open-Label Phase||0
8722066|NCT01016262|9769425|FG003|NOT COMPLETED|Open-Label Phase||2
8722067|NCT01016262|9769426|FG004|NOT COMPLETED|Open-Label Phase||2
8722068|NCT01016262|9769427|FG005|NOT COMPLETED|Open-Label Phase||0
8722069|NCT01016353|9769440|FG000|STARTED|Overall Study||180
8722070|NCT01016353|9769441|FG001|STARTED|Overall Study||103
8560026|NCT00943852|9591924|FG008|STARTED|Washout Period After Period 2 Treatment||1
8560027|NCT00943852|9591925|FG009|STARTED|Washout Period After Period 2 Treatment||1
8560028|NCT00943852|9591916|FG000|COMPLETED|Washout Period After Period 2 Treatment||2
8560029|NCT00943852|9591917|FG001|COMPLETED|Washout Period After Period 2 Treatment||1
8560030|NCT00943852|9591918|FG002|COMPLETED|Washout Period After Period 2 Treatment||1
8560031|NCT00943852|9591919|FG003|COMPLETED|Washout Period After Period 2 Treatment||1
8560032|NCT00943852|9591920|FG004|COMPLETED|Washout Period After Period 2 Treatment||1
8560033|NCT00943852|9591921|FG005|COMPLETED|Washout Period After Period 2 Treatment||0
8560034|NCT00943852|9591922|FG006|COMPLETED|Washout Period After Period 2 Treatment||2
8560035|NCT00943852|9591923|FG007|COMPLETED|Washout Period After Period 2 Treatment||1
8560036|NCT00943852|9591924|FG008|COMPLETED|Washout Period After Period 2 Treatment||1
8560037|NCT00943852|9591925|FG009|COMPLETED|Washout Period After Period 2 Treatment||1
8560038|NCT00943852|9591916|FG000|NOT COMPLETED|Washout Period After Period 2 Treatment||0
8560039|NCT00943852|9591917|FG001|NOT COMPLETED|Washout Period After Period 2 Treatment||0
8560040|NCT00943852|9591918|FG002|NOT COMPLETED|Washout Period After Period 2 Treatment||0
8560041|NCT00943852|9591919|FG003|NOT COMPLETED|Washout Period After Period 2 Treatment||0
8560042|NCT00943852|9591920|FG004|NOT COMPLETED|Washout Period After Period 2 Treatment||0
8560043|NCT00943852|9591921|FG005|NOT COMPLETED|Washout Period After Period 2 Treatment||1
8560044|NCT00943852|9591922|FG006|NOT COMPLETED|Washout Period After Period 2 Treatment||0
8560045|NCT00943852|9591923|FG007|NOT COMPLETED|Washout Period After Period 2 Treatment||0
8560046|NCT00943852|9591924|FG008|NOT COMPLETED|Washout Period After Period 2 Treatment||0
8560047|NCT00943852|9591925|FG009|NOT COMPLETED|Washout Period After Period 2 Treatment||0
8560048|NCT00943852|9591916|FG000|STARTED|Third Period of Treatment Intervention||2
8560049|NCT00943852|9591917|FG001|STARTED|Third Period of Treatment Intervention||1
8560050|NCT00943852|9591918|FG002|STARTED|Third Period of Treatment Intervention||1
8560051|NCT00943852|9591919|FG003|STARTED|Third Period of Treatment Intervention||1
8560052|NCT00943852|9591920|FG004|STARTED|Third Period of Treatment Intervention||1
8560053|NCT00943852|9591921|FG005|STARTED|Third Period of Treatment Intervention||0
8560054|NCT00943852|9591922|FG006|STARTED|Third Period of Treatment Intervention||2
8560055|NCT00943852|9591923|FG007|STARTED|Third Period of Treatment Intervention||1
8560056|NCT00943852|9591924|FG008|STARTED|Third Period of Treatment Intervention||1
8560057|NCT00943852|9591925|FG009|STARTED|Third Period of Treatment Intervention||1
8560058|NCT00943852|9591916|FG000|COMPLETED|Third Period of Treatment Intervention||2
8560059|NCT00943852|9591917|FG001|COMPLETED|Third Period of Treatment Intervention||1
8619516|NCT00468143|9657933|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||3
8619517|NCT00468169|9657941|FG000|STARTED|Overall Study||57
8619518|NCT00468169|9657942|FG001|STARTED|Overall Study||53
8619519|NCT00468169|9657941|FG000|COMPLETED|Overall Study||56
8619520|NCT00468169|9657942|FG001|COMPLETED|Overall Study||53
8619521|NCT00468169|9657941|FG000|NOT COMPLETED|Overall Study||1
8722071|NCT01016353|9769440|FG000|COMPLETED|Overall Study||178
8722072|NCT01016353|9769441|FG001|COMPLETED|Overall Study||102
8722073|NCT01016353|9769440|FG000|NOT COMPLETED|Overall Study||2
8722074|NCT01016353|9769441|FG001|NOT COMPLETED|Overall Study||1
8722075|NCT01016483|9769451|FG000|STARTED|Safety Run-in Part||27
8722076|NCT01016483|9769452|FG001|STARTED|Safety Run-in Part||26
8722077|NCT01016483|9769453|FG002|STARTED|Safety Run-in Part||0
8722078|NCT01016483|9769454|FG003|STARTED|Safety Run-in Part||0
8722079|NCT01016483|9769451|FG000|COMPLETED|Safety Run-in Part||27
8722080|NCT01016483|9769452|FG001|COMPLETED|Safety Run-in Part||26
8722081|NCT01016483|9769453|FG002|COMPLETED|Safety Run-in Part||0
8722082|NCT01016483|9769454|FG003|COMPLETED|Safety Run-in Part||0
8722083|NCT01016483|9769451|FG000|NOT COMPLETED|Safety Run-in Part||0
8722084|NCT01016483|9769452|FG001|NOT COMPLETED|Safety Run-in Part||0
8722085|NCT01016483|9769453|FG002|NOT COMPLETED|Safety Run-in Part||0
8722086|NCT01016483|9769454|FG003|NOT COMPLETED|Safety Run-in Part||0
8722087|NCT01016483|9769451|FG000|STARTED|Phase II||0
8722088|NCT01016483|9769452|FG001|STARTED|Phase II||0
8722089|NCT01016483|9769453|FG002|STARTED|Phase II|Subjects presented as randomized (Intention-to-Treat [ITT] Analysis Set).|44
8722090|NCT01016483|9769454|FG003|STARTED|Phase II|Subjects presented as randomized (ITT Analysis Set).|44
8722091|NCT01016483|9769451|FG000|Treated (Safety Analysis Set [SAF])|Phase II||0
8722092|NCT01016483|9769452|FG001|Treated (Safety Analysis Set [SAF])|Phase II||0
8722093|NCT01016483|9769453|FG002|Treated (Safety Analysis Set [SAF])|Phase II|Subjects presented as treated (SAF).|42
8722094|NCT01016483|9769454|FG003|Treated (Safety Analysis Set [SAF])|Phase II|Subjects presented as treated (SAF).|45
8722095|NCT01016483|9769451|FG000|COMPLETED|Phase II||0
8722096|NCT01016483|9769452|FG001|COMPLETED|Phase II||0
8722097|NCT01016483|9769453|FG002|COMPLETED|Phase II||44
8619522|NCT00468169|9657942|FG001|NOT COMPLETED|Overall Study||0
8619523|NCT00468208|9657950|FG000|STARTED|Overall Study||20
8619524|NCT00468208|9657950|FG000|COMPLETED|Overall Study|All patients reached common closing or early termination|20
8722098|NCT01016483|9769454|FG003|COMPLETED|Phase II||44
8722099|NCT01016483|9769451|FG000|NOT COMPLETED|Phase II||0
8722100|NCT01016483|9769452|FG001|NOT COMPLETED|Phase II||0
8722101|NCT01016483|9769453|FG002|NOT COMPLETED|Phase II||0
8813866|NCT01528332|9867072|FG001|COMPLETED|Overall Study||84
8813867|NCT01528332|9867071|FG000|NOT COMPLETED|Overall Study||4
8722102|NCT01016483|9769454|FG003|NOT COMPLETED|Phase II||0
8722103|NCT01016600|9769496|FG000|STARTED|Overall Study||9
8722104|NCT01016600|9769497|FG001|STARTED|Overall Study||4
8722105|NCT01016600|9769498|FG002|STARTED|Overall Study||6
8722106|NCT01016600|9769499|FG003|STARTED|Overall Study||12
8722107|NCT01016600|9769496|FG000|COMPLETED|Overall Study||8
8722108|NCT01016600|9769497|FG001|COMPLETED|Overall Study||4
8722109|NCT01016600|9769498|FG002|COMPLETED|Overall Study||6
8813868|NCT01528332|9867072|FG001|NOT COMPLETED|Overall Study||2
8813869|NCT01528345|9867080|FG000|STARTED|Overall Study||47
8813870|NCT01528345|9867081|FG001|STARTED|Overall Study||50
8619525|NCT00468208|9657950|FG000|NOT COMPLETED|Overall Study||0
8619526|NCT00468286|9657956|FG000|STARTED|Overall Study|Started=Intention to treat (ITT) population.|67
8722110|NCT01016600|9769499|FG003|COMPLETED|Overall Study||12
8722111|NCT01016600|9769496|FG000|NOT COMPLETED|Overall Study||1
8722112|NCT01016600|9769497|FG001|NOT COMPLETED|Overall Study||0
8722113|NCT01016600|9769498|FG002|NOT COMPLETED|Overall Study||0
8722114|NCT01016600|9769499|FG003|NOT COMPLETED|Overall Study||0
8722115|NCT01016652|9769512|FG000|STARTED|Period 1||25
8722116|NCT01016652|9769513|FG001|STARTED|Period 1||24
8619527|NCT00468286|9657957|FG001|STARTED|Overall Study||66
8619528|NCT00468286|9657956|FG000|COMPLETED|Overall Study||60
8619529|NCT00468286|9657957|FG001|COMPLETED|Overall Study||54
8619530|NCT00468286|9657956|FG000|NOT COMPLETED|Overall Study||7
8619531|NCT00468286|9657957|FG001|NOT COMPLETED|Overall Study||12
8619532|NCT00468299|9657965|FG000|STARTED|Overall Study||9
8619533|NCT00468299|9657966|FG001|STARTED|Overall Study||8
8619534|NCT00468299|9657965|FG000|COMPLETED|Overall Study||9
8619535|NCT00468299|9657966|FG001|COMPLETED|Overall Study||7
8619536|NCT00468299|9657965|FG000|NOT COMPLETED|Overall Study||0
8722117|NCT01016652|9769512|FG000|COMPLETED|Period 1||25
8722118|NCT01016652|9769513|FG001|COMPLETED|Period 1||24
8560060|NCT00943852|9591918|FG002|COMPLETED|Third Period of Treatment Intervention||1
8560061|NCT00943852|9591919|FG003|COMPLETED|Third Period of Treatment Intervention||1
8560062|NCT00943852|9591920|FG004|COMPLETED|Third Period of Treatment Intervention||1
8560063|NCT00943852|9591921|FG005|COMPLETED|Third Period of Treatment Intervention||0
8560064|NCT00943852|9591922|FG006|COMPLETED|Third Period of Treatment Intervention||2
8560065|NCT00943852|9591923|FG007|COMPLETED|Third Period of Treatment Intervention||1
8560066|NCT00943852|9591924|FG008|COMPLETED|Third Period of Treatment Intervention||1
8560067|NCT00943852|9591925|FG009|COMPLETED|Third Period of Treatment Intervention||1
8560068|NCT00943852|9591916|FG000|NOT COMPLETED|Third Period of Treatment Intervention||0
8722119|NCT01016652|9769512|FG000|NOT COMPLETED|Period 1||0
8722120|NCT01016652|9769513|FG001|NOT COMPLETED|Period 1||0
8722121|NCT01016652|9769512|FG000|STARTED|Period 2|Crossover study: the completed from period 1 will crossover in period 2 to the opposite arm.|25
8722122|NCT01016652|9769513|FG001|STARTED|Period 2|Crossover study: the completed from period 1 will crossover in period 2 to the opposite arm.|24
8722123|NCT01016652|9769512|FG000|COMPLETED|Period 2||25
8722124|NCT01016652|9769513|FG001|COMPLETED|Period 2||24
8722125|NCT01016652|9769512|FG000|NOT COMPLETED|Period 2||0
8722126|NCT01016652|9769513|FG001|NOT COMPLETED|Period 2||0
8722127|NCT01016678|9769521|FG000|STARTED|Overall Study||20
8722128|NCT01016678|9769522|FG001|STARTED|Overall Study||17
8722129|NCT01016678|9769523|FG002|STARTED|Overall Study||19
8722130|NCT01016678|9769524|FG003|STARTED|Overall Study||19
8722131|NCT01016678|9769525|FG004|STARTED|Overall Study||19
8722132|NCT01016678|9769521|FG000|COMPLETED|Overall Study||18
8722133|NCT01016678|9769522|FG001|COMPLETED|Overall Study||14
8722134|NCT01016678|9769523|FG002|COMPLETED|Overall Study||15
8722135|NCT01016678|9769524|FG003|COMPLETED|Overall Study||19
8722136|NCT01016678|9769525|FG004|COMPLETED|Overall Study||13
8722137|NCT01016678|9769521|FG000|NOT COMPLETED|Overall Study||2
8722138|NCT01016678|9769522|FG001|NOT COMPLETED|Overall Study||3
8722139|NCT01016678|9769523|FG002|NOT COMPLETED|Overall Study||4
8722140|NCT01016678|9769524|FG003|NOT COMPLETED|Overall Study||0
8722141|NCT01016678|9769525|FG004|NOT COMPLETED|Overall Study||6
8722142|NCT01016691|9769546|FG000|STARTED|Overall Study||17
8722143|NCT01016691|9769547|FG001|STARTED|Overall Study||12
8722144|NCT01016691|9769548|FG002|STARTED|Overall Study||18
8722145|NCT01016691|9769546|FG000|COMPLETED|Overall Study||17
8722146|NCT01016691|9769547|FG001|COMPLETED|Overall Study||12
8722147|NCT01016691|9769548|FG002|COMPLETED|Overall Study||18
8722148|NCT01016691|9769546|FG000|NOT COMPLETED|Overall Study||0
8722149|NCT01016691|9769547|FG001|NOT COMPLETED|Overall Study||0
8722150|NCT01016691|9769548|FG002|NOT COMPLETED|Overall Study||0
8722151|NCT01016769|9769560|FG000|STARTED|Overall Study||4
8722152|NCT01016769|9769561|FG001|STARTED|Overall Study||7
8722153|NCT01016769|9769562|FG002|STARTED|Overall Study||7
8722154|NCT01016769|9769563|FG003|STARTED|Overall Study||30
8722155|NCT01016769|9769560|FG000|COMPLETED|Overall Study||3
8722156|NCT01016769|9769561|FG001|COMPLETED|Overall Study||6
8722157|NCT01016769|9769562|FG002|COMPLETED|Overall Study||6
8722158|NCT01016769|9769563|FG003|COMPLETED|Overall Study||30
8722159|NCT01016769|9769560|FG000|NOT COMPLETED|Overall Study||1
8722160|NCT01016769|9769561|FG001|NOT COMPLETED|Overall Study||1
8722161|NCT01016769|9769562|FG002|NOT COMPLETED|Overall Study||1
8722162|NCT01016769|9769563|FG003|NOT COMPLETED|Overall Study||0
8722163|NCT01016834|9769572|FG000|STARTED|Overall Study||242
8722164|NCT01016834|9769572|FG000|COMPLETED|Overall Study||220
8722165|NCT01016834|9769572|FG000|NOT COMPLETED|Overall Study||22
8560069|NCT00943852|9591917|FG001|NOT COMPLETED|Third Period of Treatment Intervention||0
8560070|NCT00943852|9591918|FG002|NOT COMPLETED|Third Period of Treatment Intervention||0
8722166|NCT01016873|9769579|FG000|STARTED|12 Months||75
8722167|NCT01016873|9769580|FG001|STARTED|12 Months||75
8722168|NCT01016873|9769581|FG002|STARTED|12 Months||80
8722169|NCT01016873|9769579|FG000|COMPLETED|12 Months||74
8560071|NCT00943852|9591919|FG003|NOT COMPLETED|Third Period of Treatment Intervention||0
8569414|NCT00097253|9601656|FG000|NOT COMPLETED|Lavender||0
8722170|NCT01016873|9769580|FG001|COMPLETED|12 Months||72
8722171|NCT01016873|9769581|FG002|COMPLETED|12 Months||79
8722172|NCT01016873|9769579|FG000|NOT COMPLETED|12 Months||1
8560072|NCT00943852|9591920|FG004|NOT COMPLETED|Third Period of Treatment Intervention||0
8560073|NCT00943852|9591921|FG005|NOT COMPLETED|Third Period of Treatment Intervention||0
8560074|NCT00943852|9591922|FG006|NOT COMPLETED|Third Period of Treatment Intervention||0
8560075|NCT00943852|9591923|FG007|NOT COMPLETED|Third Period of Treatment Intervention||0
8560076|NCT00943852|9591924|FG008|NOT COMPLETED|Third Period of Treatment Intervention||0
8560077|NCT00943852|9591925|FG009|NOT COMPLETED|Third Period of Treatment Intervention||0
8560078|NCT00943852|9591916|FG000|STARTED|Washout Period After Period 3 Treatment||2
8560079|NCT00943852|9591917|FG001|STARTED|Washout Period After Period 3 Treatment||1
8560080|NCT00943852|9591918|FG002|STARTED|Washout Period After Period 3 Treatment||1
8560081|NCT00943852|9591919|FG003|STARTED|Washout Period After Period 3 Treatment||1
8560082|NCT00943852|9591920|FG004|STARTED|Washout Period After Period 3 Treatment||1
8560083|NCT00943852|9591921|FG005|STARTED|Washout Period After Period 3 Treatment||0
8560084|NCT00943852|9591922|FG006|STARTED|Washout Period After Period 3 Treatment||2
8560085|NCT00943852|9591923|FG007|STARTED|Washout Period After Period 3 Treatment||1
8560086|NCT00943852|9591924|FG008|STARTED|Washout Period After Period 3 Treatment||1
8560087|NCT00943852|9591925|FG009|STARTED|Washout Period After Period 3 Treatment||1
8560088|NCT00943852|9591916|FG000|COMPLETED|Washout Period After Period 3 Treatment||2
8560089|NCT00943852|9591917|FG001|COMPLETED|Washout Period After Period 3 Treatment||1
8560090|NCT00943852|9591918|FG002|COMPLETED|Washout Period After Period 3 Treatment||1
8560091|NCT00943852|9591919|FG003|COMPLETED|Washout Period After Period 3 Treatment||1
8560092|NCT00943852|9591920|FG004|COMPLETED|Washout Period After Period 3 Treatment||1
8560093|NCT00943852|9591921|FG005|COMPLETED|Washout Period After Period 3 Treatment||0
8560094|NCT00943852|9591922|FG006|COMPLETED|Washout Period After Period 3 Treatment||1
8560095|NCT00943852|9591923|FG007|COMPLETED|Washout Period After Period 3 Treatment||1
8560096|NCT00943852|9591924|FG008|COMPLETED|Washout Period After Period 3 Treatment||1
8560097|NCT00943852|9591925|FG009|COMPLETED|Washout Period After Period 3 Treatment||1
8560098|NCT00943852|9591916|FG000|NOT COMPLETED|Washout Period After Period 3 Treatment||0
8560099|NCT00943852|9591917|FG001|NOT COMPLETED|Washout Period After Period 3 Treatment||0
8560100|NCT00943852|9591918|FG002|NOT COMPLETED|Washout Period After Period 3 Treatment||0
8560101|NCT00943852|9591919|FG003|NOT COMPLETED|Washout Period After Period 3 Treatment||0
8560102|NCT00943852|9591920|FG004|NOT COMPLETED|Washout Period After Period 3 Treatment||0
8560103|NCT00943852|9591921|FG005|NOT COMPLETED|Washout Period After Period 3 Treatment||0
8560104|NCT00943852|9591922|FG006|NOT COMPLETED|Washout Period After Period 3 Treatment||1
8560105|NCT00943852|9591923|FG007|NOT COMPLETED|Washout Period After Period 3 Treatment||0
8560106|NCT00943852|9591924|FG008|NOT COMPLETED|Washout Period After Period 3 Treatment||0
8560107|NCT00943852|9591925|FG009|NOT COMPLETED|Washout Period After Period 3 Treatment||0
8560108|NCT00943852|9591916|FG000|STARTED|Fourth Period of Treatment Intervention||2
8560109|NCT00943852|9591917|FG001|STARTED|Fourth Period of Treatment Intervention||1
8560110|NCT00943852|9591918|FG002|STARTED|Fourth Period of Treatment Intervention||1
8560111|NCT00943852|9591919|FG003|STARTED|Fourth Period of Treatment Intervention||1
8619537|NCT00468299|9657966|FG001|NOT COMPLETED|Overall Study||1
8619538|NCT00468481|9657976|FG000|STARTED|Overall Study|6 of these randomized subjects did not take any study medication|291
8619539|NCT00468481|9657977|FG001|STARTED|Overall Study||94
8619540|NCT00468481|9657976|FG000|Subjects Treated|Overall Study||285
8722173|NCT01016873|9769580|FG001|NOT COMPLETED|12 Months||3
8722174|NCT01016873|9769581|FG002|NOT COMPLETED|12 Months||1
8722175|NCT01016873|9769579|FG000|STARTED|24 Months||74
8722176|NCT01016873|9769580|FG001|STARTED|24 Months||72
8722177|NCT01016873|9769581|FG002|STARTED|24 Months||79
8813871|NCT01528345|9867080|FG000|COMPLETED|Overall Study||0
8813872|NCT01528345|9867081|FG001|COMPLETED|Overall Study||0
8560112|NCT00943852|9591920|FG004|STARTED|Fourth Period of Treatment Intervention||1
8619541|NCT00468481|9657977|FG001|Subjects Treated|Overall Study||94
8619542|NCT00468481|9657976|FG000|COMPLETED|Overall Study||203
8619543|NCT00468481|9657977|FG001|COMPLETED|Overall Study||70
8619544|NCT00468481|9657976|FG000|NOT COMPLETED|Overall Study||88
8619545|NCT00468481|9657977|FG001|NOT COMPLETED|Overall Study||24
8619546|NCT00468546|9657985|FG000|STARTED|Week 24 Analysis||208
8619547|NCT00468546|9657986|FG001|STARTED|Week 24 Analysis||308
8619548|NCT00468546|9657985|FG000|COMPLETED|Week 24 Analysis||111
8619549|NCT00468546|9657986|FG001|COMPLETED|Week 24 Analysis||253
8619550|NCT00468546|9657985|FG000|NOT COMPLETED|Week 24 Analysis||97
8619551|NCT00468546|9657986|FG001|NOT COMPLETED|Week 24 Analysis||55
8619552|NCT00468546|9657985|FG000|STARTED|Week 24 to Week 104 Analysis|Participants who completed/not completed Week (W) 24 analysis were entered in W24 to W104 analysis.|208
8619553|NCT00468546|9657986|FG001|STARTED|Week 24 to Week 104 Analysis|Participants who completed/not completed W24 analysis were entered in W24 to W104 analysis.|308
8619554|NCT00468546|9657985|FG000|COMPLETED|Week 24 to Week 104 Analysis||103
8619555|NCT00468546|9657986|FG001|COMPLETED|Week 24 to Week 104 Analysis||83
8619556|NCT00468546|9657985|FG000|NOT COMPLETED|Week 24 to Week 104 Analysis||105
8619557|NCT00468546|9657986|FG001|NOT COMPLETED|Week 24 to Week 104 Analysis||225
8629660|NCT00531050|9669384|FG003|NOT COMPLETED|Part 2: Period 1||0
8943707|NCT02391337|10005550|FG001|COMPLETED|12 Months Follow-up||73
8943708|NCT02391337|10005549|FG000|NOT COMPLETED|12 Months Follow-up||2
8943709|NCT02391337|10005550|FG001|NOT COMPLETED|12 Months Follow-up||3
8943710|NCT02391350|10005558|FG000|STARTED|Overall Study||110
8943711|NCT02391350|10005559|FG001|STARTED|Overall Study||110
8943712|NCT02391350|10005558|FG000|4-week Follow-up|Overall Study||106
8943713|NCT02391350|10005559|FG001|4-week Follow-up|Overall Study||105
8943714|NCT02391350|10005558|FG000|6-month Follow-up|Overall Study||100
8943715|NCT02391350|10005559|FG001|6-month Follow-up|Overall Study||96
8943716|NCT02391350|10005558|FG000|COMPLETED|Overall Study||98
8943717|NCT02391350|10005559|FG001|COMPLETED|Overall Study||93
8943718|NCT02391350|10005558|FG000|NOT COMPLETED|Overall Study||12
8722178|NCT01016873|9769579|FG000|COMPLETED|24 Months||69
8722179|NCT01016873|9769580|FG001|COMPLETED|24 Months||68
8722180|NCT01016873|9769581|FG002|COMPLETED|24 Months||73
8722181|NCT01016873|9769579|FG000|NOT COMPLETED|24 Months||5
8722182|NCT01016873|9769580|FG001|NOT COMPLETED|24 Months||4
8722183|NCT01016873|9769581|FG002|NOT COMPLETED|24 Months||6
8722184|NCT01016873|9769579|FG000|STARTED|36 Months||69
8722185|NCT01016873|9769580|FG001|STARTED|36 Months||68
8722186|NCT01016873|9769581|FG002|STARTED|36 Months||73
8722187|NCT01016873|9769579|FG000|COMPLETED|36 Months||58
8722188|NCT01016873|9769580|FG001|COMPLETED|36 Months||64
8722189|NCT01016873|9769581|FG002|COMPLETED|36 Months||67
8722190|NCT01016873|9769579|FG000|NOT COMPLETED|36 Months||11
8722191|NCT01016873|9769580|FG001|NOT COMPLETED|36 Months||4
8722192|NCT01016873|9769581|FG002|NOT COMPLETED|36 Months||6
8722193|NCT01016912|9769594|FG000|STARTED|End of Treatment Period||8
8722194|NCT01016912|9769595|FG001|STARTED|End of Treatment Period||9
8722195|NCT01016912|9769596|FG002|STARTED|End of Treatment Period||10
8722196|NCT01016912|9769597|FG003|STARTED|End of Treatment Period||9
8722197|NCT01016912|9769598|FG004|STARTED|End of Treatment Period||9
8722198|NCT01016912|9769594|FG000|Received Treatment|End of Treatment Period||8
8722199|NCT01016912|9769595|FG001|Received Treatment|End of Treatment Period||9
8722200|NCT01016912|9769596|FG002|Received Treatment|End of Treatment Period||10
8722201|NCT01016912|9769597|FG003|Received Treatment|End of Treatment Period||9
8722202|NCT01016912|9769598|FG004|Received Treatment|End of Treatment Period||9
8722203|NCT01016912|9769594|FG000|COMPLETED|End of Treatment Period||8
8722204|NCT01016912|9769595|FG001|COMPLETED|End of Treatment Period||6
8722205|NCT01016912|9769596|FG002|COMPLETED|End of Treatment Period||9
8722206|NCT01016912|9769597|FG003|COMPLETED|End of Treatment Period||5
8722207|NCT01016912|9769598|FG004|COMPLETED|End of Treatment Period||5
8722208|NCT01016912|9769594|FG000|NOT COMPLETED|End of Treatment Period||0
8722209|NCT01016912|9769595|FG001|NOT COMPLETED|End of Treatment Period||3
8722210|NCT01016912|9769596|FG002|NOT COMPLETED|End of Treatment Period||1
8722211|NCT01016912|9769597|FG003|NOT COMPLETED|End of Treatment Period||4
8722212|NCT01016912|9769598|FG004|NOT COMPLETED|End of Treatment Period||4
8722213|NCT01016912|9769594|FG000|STARTED|Follow-up Period||8
8722214|NCT01016912|9769595|FG001|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|9
8722215|NCT01016912|9769596|FG002|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|10
8722216|NCT01016912|9769597|FG003|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|9
8722217|NCT01016912|9769598|FG004|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|9
8722218|NCT01016912|9769594|FG000|COMPLETED|Follow-up Period||8
8722219|NCT01016912|9769595|FG001|COMPLETED|Follow-up Period||9
8722220|NCT01016912|9769596|FG002|COMPLETED|Follow-up Period||9
8722221|NCT01016912|9769597|FG003|COMPLETED|Follow-up Period||8
8722222|NCT01016912|9769598|FG004|COMPLETED|Follow-up Period||9
8722223|NCT01016912|9769594|FG000|NOT COMPLETED|Follow-up Period||0
8722224|NCT01016912|9769595|FG001|NOT COMPLETED|Follow-up Period||0
8722225|NCT01016912|9769596|FG002|NOT COMPLETED|Follow-up Period||1
8722226|NCT01016912|9769597|FG003|NOT COMPLETED|Follow-up Period||1
8722227|NCT01016912|9769598|FG004|NOT COMPLETED|Follow-up Period||0
8722228|NCT01016938|9769630|FG000|STARTED|Overall Study||16
8722229|NCT01016938|9769630|FG000|COMPLETED|Overall Study||7
8722230|NCT01016938|9769630|FG000|NOT COMPLETED|Overall Study||9
8722231|NCT01016964|9769637|FG000|STARTED|Overall Study||21
8722232|NCT01016964|9769638|FG001|STARTED|Overall Study||42
8722233|NCT01016964|9769637|FG000|COMPLETED|Overall Study||18
8722234|NCT01016964|9769638|FG001|COMPLETED|Overall Study||39
8722235|NCT01016964|9769637|FG000|NOT COMPLETED|Overall Study||3
8722236|NCT01016964|9769638|FG001|NOT COMPLETED|Overall Study||3
8722237|NCT01016977|9769646|FG000|STARTED|Overall Study||20
8722238|NCT01016977|9769647|FG001|STARTED|Overall Study||20
8722239|NCT01016977|9769646|FG000|COMPLETED|Overall Study||17
8722240|NCT01016977|9769647|FG001|COMPLETED|Overall Study||18
8722241|NCT01016977|9769646|FG000|NOT COMPLETED|Overall Study||3
8722242|NCT01016977|9769647|FG001|NOT COMPLETED|Overall Study||2
8722243|NCT01017003|9769656|FG000|STARTED|Single Dose Colchicine 0.6 mg, Day 1||13
8722244|NCT01017003|9769656|FG000|COMPLETED|Single Dose Colchicine 0.6 mg, Day 1||13
8722245|NCT01017003|9769656|FG000|NOT COMPLETED|Single Dose Colchicine 0.6 mg, Day 1||0
8722246|NCT01017003|9769656|FG000|STARTED|14 Day Washout Period||13
8722247|NCT01017003|9769656|FG000|COMPLETED|14 Day Washout Period||13
8722248|NCT01017003|9769656|FG000|NOT COMPLETED|14 Day Washout Period||0
8722249|NCT01017003|9769656|FG000|STARTED|Colchicine 0.6 mg Twice Daily x 10 Days||13
8722250|NCT01017003|9769656|FG000|COMPLETED|Colchicine 0.6 mg Twice Daily x 10 Days||13
8722251|NCT01017003|9769656|FG000|NOT COMPLETED|Colchicine 0.6 mg Twice Daily x 10 Days||0
8722252|NCT01017003|9769656|FG000|STARTED|Colchicine 0.6 mg Final Dose||13
8722253|NCT01017003|9769656|FG000|COMPLETED|Colchicine 0.6 mg Final Dose||13
8722254|NCT01017003|9769656|FG000|NOT COMPLETED|Colchicine 0.6 mg Final Dose||0
8722255|NCT01017029|9769664|FG000|STARTED|Overall Study||89
8722256|NCT01017029|9769665|FG001|STARTED|Overall Study||92
8722257|NCT01017029|9769664|FG000|COMPLETED|Overall Study||85
8722258|NCT01017029|9769665|FG001|COMPLETED|Overall Study||90
8722259|NCT01017029|9769664|FG000|NOT COMPLETED|Overall Study||4
8722260|NCT01017029|9769665|FG001|NOT COMPLETED|Overall Study||2
8722261|NCT01017042|9769671|FG000|STARTED|Overall Study||13
8722262|NCT01017042|9769671|FG000|COMPLETED|Overall Study||13
8722263|NCT01017042|9769671|FG000|NOT COMPLETED|Overall Study||0
8722264|NCT01017120|9769682|FG000|STARTED|Overall Study||373
8722265|NCT01017120|9769683|FG001|STARTED|Overall Study||369
8722266|NCT01017120|9769682|FG000|COMPLETED|Overall Study||307
8722267|NCT01017120|9769683|FG001|COMPLETED|Overall Study||334
8722268|NCT01017120|9769682|FG000|NOT COMPLETED|Overall Study||66
8722269|NCT01017120|9769683|FG001|NOT COMPLETED|Overall Study||35
8722270|NCT01017146|9769691|FG000|STARTED|Overall Study||372
8722271|NCT01017146|9769692|FG001|STARTED|Overall Study||372
8722272|NCT01017146|9769691|FG000|COMPLETED|Overall Study||306
8722273|NCT01017146|9769692|FG001|COMPLETED|Overall Study||333
8722274|NCT01017146|9769691|FG000|NOT COMPLETED|Overall Study||66
8722275|NCT01017146|9769692|FG001|NOT COMPLETED|Overall Study||39
8722276|NCT01017237|9769700|FG000|STARTED|Overall Study||10
8722277|NCT01017237|9769701|FG001|STARTED|Overall Study||8
8722278|NCT01017237|9769700|FG000|COMPLETED|Overall Study||5
8722279|NCT01017237|9769701|FG001|COMPLETED|Overall Study||6
8722280|NCT01017237|9769700|FG000|NOT COMPLETED|Overall Study||5
8722281|NCT01017237|9769701|FG001|NOT COMPLETED|Overall Study||2
8722282|NCT01017250|9769710|FG000|STARTED|Overall Study||15
8722283|NCT01017250|9769710|FG000|2-month MRI|Overall Study|1 participant did not return for the 2 month MRI at treating facility. Resides out of state.|14
8722284|NCT01017250|9769710|FG000|COMPLETED|Overall Study||15
8722285|NCT01017250|9769710|FG000|NOT COMPLETED|Overall Study||0
8722286|NCT01017497|9769715|FG000|STARTED|Overall Study||49
8722287|NCT01017497|9769715|FG000|COMPLETED|Overall Study||49
8722288|NCT01017497|9769715|FG000|NOT COMPLETED|Overall Study||0
8722289|NCT01017536|9769723|FG000|STARTED|Overall Study||13
8722290|NCT01017536|9769724|FG001|STARTED|Overall Study||13
8722291|NCT01017536|9769723|FG000|COMPLETED|Overall Study||13
8722292|NCT01017536|9769724|FG001|COMPLETED|Overall Study||13
8722293|NCT01017536|9769723|FG000|NOT COMPLETED|Overall Study||0
8722294|NCT01017536|9769724|FG001|NOT COMPLETED|Overall Study||0
8722295|NCT01017549|9769730|FG000|STARTED|Eligibility Through 6 Month Follow-up||44
8722296|NCT01017549|9769730|FG000|COMPLETED|Eligibility Through 6 Month Follow-up|6 month follow-up complete Oct 2008; data through 6 months and 1 year are published.|43
8722297|NCT01017549|9769730|FG000|NOT COMPLETED|Eligibility Through 6 Month Follow-up||1
8722298|NCT01017549|9769730|FG000|STARTED|One-year Follow-up||43
8722299|NCT01017549|9769730|FG000|COMPLETED|One-year Follow-up||36
8722300|NCT01017549|9769730|FG000|NOT COMPLETED|One-year Follow-up||7
8619558|NCT00468559|9657994|FG000|STARTED|Open-label Treatment Phase|All participants received open-label esomeprazole during this phase of the study|98
8619559|NCT00468559|9657995|FG001|STARTED|Open-label Treatment Phase||0
8722301|NCT01017549|9769730|FG000|STARTED|5 Year Follow-up||36
8722302|NCT01017549|9769730|FG000|COMPLETED|5 Year Follow-up||24
8722303|NCT01017549|9769730|FG000|NOT COMPLETED|5 Year Follow-up||12
8722304|NCT01017575|9769739|FG000|STARTED|Overall Study||8
8722305|NCT01017575|9769740|FG001|STARTED|Overall Study||9
8722306|NCT01017575|9769741|FG002|STARTED|Overall Study||8
8722307|NCT01017575|9769742|FG003|STARTED|Overall Study||8
8722308|NCT01017575|9769743|FG004|STARTED|Overall Study||9
8722309|NCT01017575|9769739|FG000|COMPLETED|Overall Study||7
8722310|NCT01017575|9769740|FG001|COMPLETED|Overall Study||7
8722311|NCT01017575|9769741|FG002|COMPLETED|Overall Study||8
8722312|NCT01017575|9769742|FG003|COMPLETED|Overall Study||7
8722313|NCT01017575|9769743|FG004|COMPLETED|Overall Study||6
8722314|NCT01017575|9769739|FG000|NOT COMPLETED|Overall Study||1
8722315|NCT01017575|9769740|FG001|NOT COMPLETED|Overall Study||2
8722316|NCT01017575|9769741|FG002|NOT COMPLETED|Overall Study||0
8722317|NCT01017575|9769742|FG003|NOT COMPLETED|Overall Study||1
8722318|NCT01017575|9769743|FG004|NOT COMPLETED|Overall Study||3
8722319|NCT01017601|9769757|FG000|STARTED|Overall Study||26
8619560|NCT00468559|9657996|FG002|STARTED|Open-label Treatment Phase||0
8619561|NCT00468559|9657994|FG000|COMPLETED|Open-label Treatment Phase|18 patients discontinued (were not randomized into the double-blind treatment withdrawal phase)|80
8619562|NCT00468559|9657995|FG001|COMPLETED|Open-label Treatment Phase||0
8619563|NCT00468559|9657996|FG002|COMPLETED|Open-label Treatment Phase||0
8619564|NCT00468559|9657994|FG000|NOT COMPLETED|Open-label Treatment Phase||18
8722320|NCT01017601|9769758|FG001|STARTED|Overall Study||24
8722321|NCT01017601|9769757|FG000|COMPLETED|Overall Study||14
8722322|NCT01017601|9769758|FG001|COMPLETED|Overall Study||11
8722323|NCT01017601|9769757|FG000|NOT COMPLETED|Overall Study||12
8722324|NCT01017601|9769758|FG001|NOT COMPLETED|Overall Study||13
8722325|NCT01017653|9769764|FG000|STARTED|Overall Study||16
8722326|NCT01017653|9769764|FG000|COMPLETED|Overall Study||16
8722327|NCT01017653|9769764|FG000|NOT COMPLETED|Overall Study||0
8722328|NCT01017731|9769768|FG000|STARTED|Overall Study||68
8569415|NCT00097253|9601656|FG000|STARTED|Lemon||56
8569416|NCT00097253|9601656|FG000|COMPLETED|Lemon||56
8569417|NCT00097253|9601656|FG000|NOT COMPLETED|Lemon||0
8569418|NCT00097253|9601656|FG000|STARTED|Water (Control)||56
8569419|NCT00097253|9601656|FG000|COMPLETED|Water (Control)||56
8569420|NCT00097253|9601656|FG000|NOT COMPLETED|Water (Control)||0
8569421|NCT00097370|9601664|FG000|STARTED|Stage 1|Participants entered from study MHE100185.|37
8569422|NCT00097370|9601664|FG000|COMPLETED|Stage 1||31
8569423|NCT00097370|9601664|FG000|NOT COMPLETED|Stage 1||6
8569424|NCT00097370|9601664|FG000|STARTED|Stage 2|41 participants entered from study MHE100185 and 31 participants continued from Stage 1.|72
8569425|NCT00097370|9601664|FG000|COMPLETED|Stage 2||59
8569426|NCT00097370|9601664|FG000|NOT COMPLETED|Stage 2||13
8569427|NCT00097370|9601664|FG000|STARTED|Stage 3|Participants continued from Stage 2.|59
8569428|NCT00097370|9601664|FG000|COMPLETED|Stage 3||0
8569429|NCT00097370|9601664|FG000|NOT COMPLETED|Stage 3||59
8569430|NCT00097448|9601670|FG000|STARTED|Overall Study||125
8569431|NCT00097448|9601671|FG001|STARTED|Overall Study||130
8569432|NCT00097448|9601670|FG000|COMPLETED|Overall Study||121
8569433|NCT00097448|9601671|FG001|COMPLETED|Overall Study||129
8569434|NCT00097448|9601670|FG000|NOT COMPLETED|Overall Study||4
8569435|NCT00097448|9601671|FG001|NOT COMPLETED|Overall Study||1
8569436|NCT00097500|9601679|FG000|STARTED|On-drug Period (Week 0 to Week 52)||36
8569437|NCT00097500|9601680|FG001|STARTED|On-drug Period (Week 0 to Week 52)||33
8569438|NCT00097500|9601679|FG000|COMPLETED|On-drug Period (Week 0 to Week 52)|Subjects experiencing loss of glucose control after Week 52 are considered to have completed study.|30
8569439|NCT00097500|9601680|FG001|COMPLETED|On-drug Period (Week 0 to Week 52)|Subjects experiencing loss of glucose control after Week 52 are considered to have completed study.|30
8569440|NCT00097500|9601679|FG000|NOT COMPLETED|On-drug Period (Week 0 to Week 52)||6
8569441|NCT00097500|9601680|FG001|NOT COMPLETED|On-drug Period (Week 0 to Week 52)||3
8569442|NCT00097500|9601679|FG000|STARTED|Off-drug Period (Week 52 to Week 64)|Exenatide is discontinued, metformin is continued|30
8569443|NCT00097500|9601680|FG001|STARTED|Off-drug Period (Week 52 to Week 64)|Insulin Glargine is discontinued, metformin is continued|30
8569444|NCT00097500|9601679|FG000|COMPLETED|Off-drug Period (Week 52 to Week 64)||25
8569445|NCT00097500|9601680|FG001|COMPLETED|Off-drug Period (Week 52 to Week 64)||26
8569446|NCT00097500|9601679|FG000|NOT COMPLETED|Off-drug Period (Week 52 to Week 64)||5
8569447|NCT00097500|9601680|FG001|NOT COMPLETED|Off-drug Period (Week 52 to Week 64)||4
8569448|NCT00097539|9601693|FG000|STARTED|Overall Study||27286
8569449|NCT00097539|9601694|FG001|STARTED|Overall Study||9356
8569450|NCT00097539|9601695|FG002|STARTED|Overall Study||12519
8560113|NCT00943852|9591921|FG005|STARTED|Fourth Period of Treatment Intervention||0
8560114|NCT00943852|9591922|FG006|STARTED|Fourth Period of Treatment Intervention||1
8560115|NCT00943852|9591923|FG007|STARTED|Fourth Period of Treatment Intervention||1
8560116|NCT00943852|9591924|FG008|STARTED|Fourth Period of Treatment Intervention||1
8560117|NCT00943852|9591925|FG009|STARTED|Fourth Period of Treatment Intervention||1
8560118|NCT00943852|9591916|FG000|COMPLETED|Fourth Period of Treatment Intervention||2
8560119|NCT00943852|9591917|FG001|COMPLETED|Fourth Period of Treatment Intervention||1
8560120|NCT00943852|9591918|FG002|COMPLETED|Fourth Period of Treatment Intervention||1
8560121|NCT00943852|9591919|FG003|COMPLETED|Fourth Period of Treatment Intervention||1
8560122|NCT00943852|9591920|FG004|COMPLETED|Fourth Period of Treatment Intervention||1
8560123|NCT00943852|9591921|FG005|COMPLETED|Fourth Period of Treatment Intervention||0
8560124|NCT00943852|9591922|FG006|COMPLETED|Fourth Period of Treatment Intervention||1
8560125|NCT00943852|9591923|FG007|COMPLETED|Fourth Period of Treatment Intervention||1
8560126|NCT00943852|9591924|FG008|COMPLETED|Fourth Period of Treatment Intervention||1
8560127|NCT00943852|9591925|FG009|COMPLETED|Fourth Period of Treatment Intervention||1
8560128|NCT00943852|9591916|FG000|NOT COMPLETED|Fourth Period of Treatment Intervention||0
8560129|NCT00943852|9591917|FG001|NOT COMPLETED|Fourth Period of Treatment Intervention||0
8560130|NCT00943852|9591918|FG002|NOT COMPLETED|Fourth Period of Treatment Intervention||0
8560131|NCT00943852|9591919|FG003|NOT COMPLETED|Fourth Period of Treatment Intervention||0
8560132|NCT00943852|9591920|FG004|NOT COMPLETED|Fourth Period of Treatment Intervention||0
8560133|NCT00943852|9591921|FG005|NOT COMPLETED|Fourth Period of Treatment Intervention||0
8560134|NCT00943852|9591922|FG006|NOT COMPLETED|Fourth Period of Treatment Intervention||0
8560135|NCT00943852|9591923|FG007|NOT COMPLETED|Fourth Period of Treatment Intervention||0
8560136|NCT00943852|9591924|FG008|NOT COMPLETED|Fourth Period of Treatment Intervention||0
8560137|NCT00943852|9591925|FG009|NOT COMPLETED|Fourth Period of Treatment Intervention||0
8560138|NCT00943852|9591916|FG000|STARTED|Washout Period After Period 4 Treatment||2
8560139|NCT00943852|9591917|FG001|STARTED|Washout Period After Period 4 Treatment||1
8560140|NCT00943852|9591918|FG002|STARTED|Washout Period After Period 4 Treatment||1
8560141|NCT00943852|9591919|FG003|STARTED|Washout Period After Period 4 Treatment||1
8560142|NCT00943852|9591920|FG004|STARTED|Washout Period After Period 4 Treatment||1
8560143|NCT00943852|9591921|FG005|STARTED|Washout Period After Period 4 Treatment||0
8560144|NCT00943852|9591922|FG006|STARTED|Washout Period After Period 4 Treatment||1
8560145|NCT00943852|9591923|FG007|STARTED|Washout Period After Period 4 Treatment||1
8560146|NCT00943852|9591924|FG008|STARTED|Washout Period After Period 4 Treatment||1
8560147|NCT00943852|9591925|FG009|STARTED|Washout Period After Period 4 Treatment||1
8560148|NCT00943852|9591916|FG000|COMPLETED|Washout Period After Period 4 Treatment||1
8560149|NCT00943852|9591917|FG001|COMPLETED|Washout Period After Period 4 Treatment||1
8560150|NCT00943852|9591918|FG002|COMPLETED|Washout Period After Period 4 Treatment||0
8560151|NCT00943852|9591919|FG003|COMPLETED|Washout Period After Period 4 Treatment||0
8722329|NCT01017731|9769768|FG000|Received at Least 1 Dose of Study Drug|Overall Study||66
8722330|NCT01017731|9769768|FG000|COMPLETED|Overall Study||60
8722331|NCT01017731|9769768|FG000|NOT COMPLETED|Overall Study||8
8722332|NCT01017874|9769775|FG000|STARTED|Overall Study||118
8722333|NCT01017874|9769776|FG001|STARTED|Overall Study||118
8722334|NCT01017874|9769775|FG000|Received at Least 1 Dose of Study Drug|Overall Study||114
8722335|NCT01017874|9769776|FG001|Received at Least 1 Dose of Study Drug|Overall Study||118
8722336|NCT01017874|9769775|FG000|COMPLETED|Overall Study||88
8722337|NCT01017874|9769776|FG001|COMPLETED|Overall Study||92
8722338|NCT01017874|9769775|FG000|NOT COMPLETED|Overall Study||30
8722339|NCT01017874|9769776|FG001|NOT COMPLETED|Overall Study||26
8722340|NCT01017952|9769786|FG000|STARTED|4-week, Open-label Run-In Period||2092
8722341|NCT01017952|9769787|FG001|STARTED|4-week, Open-label Run-In Period||0
8722342|NCT01017952|9769788|FG002|STARTED|4-week, Open-label Run-In Period||0
8722343|NCT01017952|9769789|FG003|STARTED|4-week, Open-label Run-In Period||0
8722344|NCT01017952|9769790|FG004|STARTED|4-week, Open-label Run-In Period||0
8722345|NCT01017952|9769786|FG000|COMPLETED|4-week, Open-label Run-In Period||1633
8722346|NCT01017952|9769787|FG001|COMPLETED|4-week, Open-label Run-In Period||0
8722347|NCT01017952|9769788|FG002|COMPLETED|4-week, Open-label Run-In Period||0
8722348|NCT01017952|9769789|FG003|COMPLETED|4-week, Open-label Run-In Period||0
8722349|NCT01017952|9769790|FG004|COMPLETED|4-week, Open-label Run-In Period||0
8722350|NCT01017952|9769786|FG000|NOT COMPLETED|4-week, Open-label Run-In Period||459
8722351|NCT01017952|9769787|FG001|NOT COMPLETED|4-week, Open-label Run-In Period||0
8722352|NCT01017952|9769788|FG002|NOT COMPLETED|4-week, Open-label Run-In Period||0
8722353|NCT01017952|9769789|FG003|NOT COMPLETED|4-week, Open-label Run-In Period||0
8722354|NCT01017952|9769790|FG004|NOT COMPLETED|4-week, Open-label Run-In Period||0
8722355|NCT01017952|9769786|FG000|STARTED|52-week, Double-blind Treatment Period||0
8722356|NCT01017952|9769787|FG001|STARTED|52-week, Double-blind Treatment Period||409
8722357|NCT01017952|9769788|FG002|STARTED|52-week, Double-blind Treatment Period||412
8722358|NCT01017952|9769789|FG003|STARTED|52-week, Double-blind Treatment Period||403
8722359|NCT01017952|9769790|FG004|STARTED|52-week, Double-blind Treatment Period||409
8722360|NCT01017952|9769786|FG000|Completed the Treatment Period|52-week, Double-blind Treatment Period||0
8722361|NCT01017952|9769787|FG001|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|285
8722362|NCT01017952|9769788|FG002|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|305
8722363|NCT01017952|9769789|FG003|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|293
8722364|NCT01017952|9769790|FG004|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|307
8722365|NCT01017952|9769786|FG000|COMPLETED|52-week, Double-blind Treatment Period||0
8722366|NCT01017952|9769787|FG001|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|284
8722367|NCT01017952|9769788|FG002|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|303
8722368|NCT01017952|9769789|FG003|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|291
8722369|NCT01017952|9769790|FG004|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|306
8722370|NCT01017952|9769786|FG000|NOT COMPLETED|52-week, Double-blind Treatment Period||0
8722371|NCT01017952|9769787|FG001|NOT COMPLETED|52-week, Double-blind Treatment Period||125
8722372|NCT01017952|9769788|FG002|NOT COMPLETED|52-week, Double-blind Treatment Period||109
8722373|NCT01017952|9769789|FG003|NOT COMPLETED|52-week, Double-blind Treatment Period||112
8722374|NCT01017952|9769790|FG004|NOT COMPLETED|52-week, Double-blind Treatment Period||103
8722375|NCT01018030|9769803|FG000|STARTED|Overall Study||246
8722376|NCT01018030|9769804|FG001|STARTED|Overall Study||243
8560152|NCT00943852|9591920|FG004|COMPLETED|Washout Period After Period 4 Treatment||1
8560153|NCT00943852|9591921|FG005|COMPLETED|Washout Period After Period 4 Treatment||0
8560154|NCT00943852|9591922|FG006|COMPLETED|Washout Period After Period 4 Treatment||0
8560155|NCT00943852|9591923|FG007|COMPLETED|Washout Period After Period 4 Treatment||0
8560156|NCT00943852|9591924|FG008|COMPLETED|Washout Period After Period 4 Treatment||1
8560157|NCT00943852|9591925|FG009|COMPLETED|Washout Period After Period 4 Treatment||1
8560158|NCT00943852|9591916|FG000|NOT COMPLETED|Washout Period After Period 4 Treatment||1
8560159|NCT00943852|9591917|FG001|NOT COMPLETED|Washout Period After Period 4 Treatment||0
8560160|NCT00943852|9591918|FG002|NOT COMPLETED|Washout Period After Period 4 Treatment||1
8560161|NCT00943852|9591919|FG003|NOT COMPLETED|Washout Period After Period 4 Treatment||1
8560162|NCT00943852|9591920|FG004|NOT COMPLETED|Washout Period After Period 4 Treatment||0
8560163|NCT00943852|9591921|FG005|NOT COMPLETED|Washout Period After Period 4 Treatment||0
8560164|NCT00943852|9591922|FG006|NOT COMPLETED|Washout Period After Period 4 Treatment||1
8560165|NCT00943852|9591923|FG007|NOT COMPLETED|Washout Period After Period 4 Treatment||1
8560166|NCT00943852|9591924|FG008|NOT COMPLETED|Washout Period After Period 4 Treatment||0
8560167|NCT00943852|9591925|FG009|NOT COMPLETED|Washout Period After Period 4 Treatment||0
8560168|NCT00943852|9591916|FG000|STARTED|Fifth Period of Treatment Intervention||1
8560169|NCT00943852|9591917|FG001|STARTED|Fifth Period of Treatment Intervention||1
8560170|NCT00943852|9591918|FG002|STARTED|Fifth Period of Treatment Intervention||0
8560171|NCT00943852|9591919|FG003|STARTED|Fifth Period of Treatment Intervention||0
8560172|NCT00943852|9591920|FG004|STARTED|Fifth Period of Treatment Intervention||1
8560173|NCT00943852|9591921|FG005|STARTED|Fifth Period of Treatment Intervention||0
8560174|NCT00943852|9591922|FG006|STARTED|Fifth Period of Treatment Intervention||0
8560175|NCT00943852|9591923|FG007|STARTED|Fifth Period of Treatment Intervention||0
8560176|NCT00943852|9591924|FG008|STARTED|Fifth Period of Treatment Intervention||1
8560177|NCT00943852|9591925|FG009|STARTED|Fifth Period of Treatment Intervention||1
8560178|NCT00943852|9591916|FG000|COMPLETED|Fifth Period of Treatment Intervention||1
8560179|NCT00943852|9591917|FG001|COMPLETED|Fifth Period of Treatment Intervention||1
8560180|NCT00943852|9591918|FG002|COMPLETED|Fifth Period of Treatment Intervention||0
8560181|NCT00943852|9591919|FG003|COMPLETED|Fifth Period of Treatment Intervention||0
8560182|NCT00943852|9591920|FG004|COMPLETED|Fifth Period of Treatment Intervention||1
8560183|NCT00943852|9591921|FG005|COMPLETED|Fifth Period of Treatment Intervention||0
8560184|NCT00943852|9591922|FG006|COMPLETED|Fifth Period of Treatment Intervention||0
8560185|NCT00943852|9591923|FG007|COMPLETED|Fifth Period of Treatment Intervention||0
8560186|NCT00943852|9591924|FG008|COMPLETED|Fifth Period of Treatment Intervention||1
8560187|NCT00943852|9591925|FG009|COMPLETED|Fifth Period of Treatment Intervention||1
8560188|NCT00943852|9591916|FG000|NOT COMPLETED|Fifth Period of Treatment Intervention||0
8560189|NCT00943852|9591917|FG001|NOT COMPLETED|Fifth Period of Treatment Intervention||0
8560190|NCT00943852|9591918|FG002|NOT COMPLETED|Fifth Period of Treatment Intervention||0
8560191|NCT00943852|9591919|FG003|NOT COMPLETED|Fifth Period of Treatment Intervention||0
8560192|NCT00943852|9591920|FG004|NOT COMPLETED|Fifth Period of Treatment Intervention||0
8560193|NCT00943852|9591921|FG005|NOT COMPLETED|Fifth Period of Treatment Intervention||0
8560194|NCT00943852|9591922|FG006|NOT COMPLETED|Fifth Period of Treatment Intervention||0
8560195|NCT00943852|9591923|FG007|NOT COMPLETED|Fifth Period of Treatment Intervention||0
8560196|NCT00943852|9591924|FG008|NOT COMPLETED|Fifth Period of Treatment Intervention||0
8560197|NCT00943852|9591925|FG009|NOT COMPLETED|Fifth Period of Treatment Intervention||0
8560198|NCT00927953|9591937|FG000|STARTED|Overall Study||6
8560199|NCT00927953|9591938|FG001|STARTED|Overall Study||7
8560200|NCT00927953|9591937|FG000|COMPLETED|Overall Study||4
8560201|NCT00927953|9591938|FG001|COMPLETED|Overall Study||6
8560202|NCT00927953|9591937|FG000|NOT COMPLETED|Overall Study||2
8560203|NCT00927953|9591938|FG001|NOT COMPLETED|Overall Study||1
8560204|NCT00909389|9591945|FG000|STARTED|Overall Study||4748
8560205|NCT00909389|9591945|FG000|COMPLETED|Overall Study||4615
8560206|NCT00909389|9591945|FG000|NOT COMPLETED|Overall Study||133
8560207|NCT00820027|9591953|FG000|STARTED|Overall Study||224
8560208|NCT00820027|9591954|FG001|STARTED|Overall Study||230
8560209|NCT00820027|9591955|FG002|STARTED|Overall Study||224
8560210|NCT00820027|9591956|FG003|STARTED|Overall Study||98
8560211|NCT00820027|9591953|FG000|COMPLETED|Overall Study||198
8560212|NCT00820027|9591954|FG001|COMPLETED|Overall Study||216
8560213|NCT00820027|9591955|FG002|COMPLETED|Overall Study||203
8560214|NCT00820027|9591956|FG003|COMPLETED|Overall Study||85
8560215|NCT00820027|9591953|FG000|NOT COMPLETED|Overall Study||26
8560216|NCT00820027|9591954|FG001|NOT COMPLETED|Overall Study||14
8560217|NCT00820027|9591955|FG002|NOT COMPLETED|Overall Study||21
8560218|NCT00820027|9591956|FG003|NOT COMPLETED|Overall Study||13
8560219|NCT00788710|9591970|FG000|STARTED|Overall Study||144
8560220|NCT00788710|9591971|FG001|STARTED|Overall Study||142
8560221|NCT00788710|9591972|FG002|STARTED|Overall Study||144
8560222|NCT00788710|9591970|FG000|COMPLETED|Overall Study||139
8560223|NCT00788710|9591971|FG001|COMPLETED|Overall Study||134
8722377|NCT01018030|9769805|FG002|STARTED|Overall Study||252
8722378|NCT01018030|9769803|FG000|COMPLETED|Overall Study||227
8722379|NCT01018030|9769804|FG001|COMPLETED|Overall Study||232
8722380|NCT01018030|9769805|FG002|COMPLETED|Overall Study||239
8722381|NCT01018030|9769803|FG000|NOT COMPLETED|Overall Study||19
8722382|NCT01018030|9769804|FG001|NOT COMPLETED|Overall Study||11
8722383|NCT01018030|9769805|FG002|NOT COMPLETED|Overall Study||13
8722384|NCT01018056|9769818|FG000|STARTED|Overall Study||12
8722385|NCT01018056|9769819|FG001|STARTED|Overall Study||12
8722386|NCT01018056|9769820|FG002|STARTED|Overall Study||6
8722387|NCT01018056|9769818|FG000|COMPLETED|Overall Study||9
8722388|NCT01018056|9769819|FG001|COMPLETED|Overall Study||10
8722389|NCT01018056|9769820|FG002|COMPLETED|Overall Study||5
8722390|NCT01018056|9769818|FG000|NOT COMPLETED|Overall Study||3
8722391|NCT01018056|9769819|FG001|NOT COMPLETED|Overall Study||2
8722392|NCT01018056|9769820|FG002|NOT COMPLETED|Overall Study||1
8722393|NCT01018095|9769833|FG000|STARTED|Overall Study||135
8722394|NCT01018095|9769834|FG001|STARTED|Overall Study||135
8722395|NCT01018095|9769833|FG000|COMPLETED|Overall Study||79
8722396|NCT01018095|9769834|FG001|COMPLETED|Overall Study||73
8722397|NCT01018095|9769833|FG000|NOT COMPLETED|Overall Study||56
8722398|NCT01018095|9769834|FG001|NOT COMPLETED|Overall Study||62
8722399|NCT01018134|9769846|FG000|STARTED|Overall Study||30
8722400|NCT01018134|9769847|FG001|STARTED|Overall Study||31
8722401|NCT01018134|9769848|FG002|STARTED|Overall Study||30
8722402|NCT01018134|9769849|FG003|STARTED|Overall Study|30 enrolled patients, one who did not use the study medication was excluded from all analyses|29
8722403|NCT01018134|9769850|FG004|STARTED|Overall Study||15
8722404|NCT01018134|9769851|FG005|STARTED|Overall Study||15
8722405|NCT01018134|9769846|FG000|COMPLETED|Overall Study||30
8722406|NCT01018134|9769847|FG001|COMPLETED|Overall Study||30
8722407|NCT01018134|9769848|FG002|COMPLETED|Overall Study||29
8722408|NCT01018134|9769849|FG003|COMPLETED|Overall Study||29
8722409|NCT01018134|9769850|FG004|COMPLETED|Overall Study||15
8722410|NCT01018134|9769851|FG005|COMPLETED|Overall Study||15
8722411|NCT01018134|9769846|FG000|NOT COMPLETED|Overall Study||0
8722412|NCT01018134|9769847|FG001|NOT COMPLETED|Overall Study||1
8722413|NCT01018134|9769848|FG002|NOT COMPLETED|Overall Study||1
8722414|NCT01018134|9769849|FG003|NOT COMPLETED|Overall Study||0
8722415|NCT01018134|9769850|FG004|NOT COMPLETED|Overall Study||0
8722416|NCT01018134|9769851|FG005|NOT COMPLETED|Overall Study||0
8722417|NCT01018186|9769868|FG000|STARTED|2-week Run-in Period||617
8722418|NCT01018186|9769869|FG001|STARTED|2-week Run-in Period||0
8722419|NCT01018186|9769870|FG002|STARTED|2-week Run-in Period||0
8722420|NCT01018186|9769871|FG003|STARTED|2-week Run-in Period||0
8722421|NCT01018186|9769868|FG000|COMPLETED|2-week Run-in Period||503
8722422|NCT01018186|9769869|FG001|COMPLETED|2-week Run-in Period||0
8722423|NCT01018186|9769870|FG002|COMPLETED|2-week Run-in Period||0
8722424|NCT01018186|9769871|FG003|COMPLETED|2-week Run-in Period||0
8722425|NCT01018186|9769868|FG000|NOT COMPLETED|2-week Run-in Period||114
8722426|NCT01018186|9769869|FG001|NOT COMPLETED|2-week Run-in Period||0
8722427|NCT01018186|9769870|FG002|NOT COMPLETED|2-week Run-in Period||0
8722428|NCT01018186|9769871|FG003|NOT COMPLETED|2-week Run-in Period||0
8722429|NCT01018186|9769868|FG000|STARTED|52-week Double-blind Treatment Period||0
8722430|NCT01018186|9769869|FG001|STARTED|52-week Double-blind Treatment Period||201
8722431|NCT01018186|9769870|FG002|STARTED|52-week Double-blind Treatment Period||202
8722432|NCT01018186|9769871|FG003|STARTED|52-week Double-blind Treatment Period||100
8722433|NCT01018186|9769868|FG000|COMPLETED|52-week Double-blind Treatment Period||0
8722434|NCT01018186|9769869|FG001|COMPLETED|52-week Double-blind Treatment Period||161
8722435|NCT01018186|9769870|FG002|COMPLETED|52-week Double-blind Treatment Period||161
8722436|NCT01018186|9769871|FG003|COMPLETED|52-week Double-blind Treatment Period||71
8722437|NCT01018186|9769868|FG000|NOT COMPLETED|52-week Double-blind Treatment Period||0
8722438|NCT01018186|9769869|FG001|NOT COMPLETED|52-week Double-blind Treatment Period||40
8722439|NCT01018186|9769870|FG002|NOT COMPLETED|52-week Double-blind Treatment Period||41
8722440|NCT01018186|9769871|FG003|NOT COMPLETED|52-week Double-blind Treatment Period||29
8722441|NCT01018264|9769885|FG000|STARTED|Overall Study||10
8722442|NCT01018264|9769886|FG001|STARTED|Overall Study||13
8722443|NCT01018264|9769885|FG000|COMPLETED|Overall Study||9
8722444|NCT01018264|9769886|FG001|COMPLETED|Overall Study||12
8722445|NCT01018264|9769885|FG000|NOT COMPLETED|Overall Study||1
8722446|NCT01018264|9769886|FG001|NOT COMPLETED|Overall Study||1
8722447|NCT01018394|9769894|FG000|STARTED|Overall Study||40
8722448|NCT01018394|9769895|FG001|STARTED|Overall Study||41
8722449|NCT01018394|9769894|FG000|COMPLETED|Overall Study||31
8722450|NCT01018394|9769895|FG001|COMPLETED|Overall Study||33
8722451|NCT01018394|9769894|FG000|NOT COMPLETED|Overall Study||9
8722452|NCT01018394|9769895|FG001|NOT COMPLETED|Overall Study||8
8722453|NCT01018420|9769903|FG000|STARTED|Overall Study||15
8722454|NCT01018420|9769904|FG001|STARTED|Overall Study||3
8722455|NCT01018420|9769903|FG000|COMPLETED|Overall Study||15
8722456|NCT01018420|9769904|FG001|COMPLETED|Overall Study||3
8619565|NCT00468559|9657995|FG001|NOT COMPLETED|Open-label Treatment Phase||0
8619566|NCT00468559|9657996|FG002|NOT COMPLETED|Open-label Treatment Phase||0
8619567|NCT00468559|9657994|FG000|STARTED|Double-blind, Treatment-withdrawal Phase||0
8619568|NCT00468559|9657995|FG001|STARTED|Double-blind, Treatment-withdrawal Phase||39
8722457|NCT01018420|9769903|FG000|NOT COMPLETED|Overall Study||0
8722458|NCT01018420|9769904|FG001|NOT COMPLETED|Overall Study||0
8619569|NCT00468559|9657996|FG002|STARTED|Double-blind, Treatment-withdrawal Phase||41
8619570|NCT00468559|9657994|FG000|COMPLETED|Double-blind, Treatment-withdrawal Phase||0
8619571|NCT00468559|9657995|FG001|COMPLETED|Double-blind, Treatment-withdrawal Phase||29
8722459|NCT01018511|9769931|FG000|STARTED|Overall Study||341
8722460|NCT01018511|9769932|FG001|STARTED|Overall Study||327
8722461|NCT01018511|9769933|FG002|STARTED|Overall Study||339
8722462|NCT01018511|9769934|FG003|STARTED|Overall Study||327
8722463|NCT01018511|9769931|FG000|Randomized and Treated|Overall Study||341
8722464|NCT01018511|9769932|FG001|Randomized and Treated|Overall Study||326
8722465|NCT01018511|9769933|FG002|Randomized and Treated|Overall Study||338
8722466|NCT01018511|9769934|FG003|Randomized and Treated|Overall Study||324
8722467|NCT01018511|9769931|FG000|COMPLETED|Overall Study||315
8722468|NCT01018511|9769932|FG001|COMPLETED|Overall Study||295
8722469|NCT01018511|9769933|FG002|COMPLETED|Overall Study||299
8722470|NCT01018511|9769934|FG003|COMPLETED|Overall Study||294
8722471|NCT01018511|9769931|FG000|NOT COMPLETED|Overall Study||26
8722472|NCT01018511|9769932|FG001|NOT COMPLETED|Overall Study||32
8722473|NCT01018511|9769933|FG002|NOT COMPLETED|Overall Study||40
8722474|NCT01018511|9769934|FG003|NOT COMPLETED|Overall Study||33
8722475|NCT01018680|9769952|FG000|STARTED|Overall Study||260
8722476|NCT01018680|9769953|FG001|STARTED|Overall Study||264
8722477|NCT01018680|9769952|FG000|COMPLETED|Overall Study||199
8722478|NCT01018680|9769953|FG001|COMPLETED|Overall Study||189
8722479|NCT01018680|9769952|FG000|NOT COMPLETED|Overall Study||61
8722480|NCT01018680|9769953|FG001|NOT COMPLETED|Overall Study||75
8722481|NCT01018732|9769962|FG000|STARTED|Overall Study||50
8722482|NCT01018732|9769963|FG001|STARTED|Overall Study||51
8722483|NCT01018732|9769964|FG002|STARTED|Overall Study||54
8722484|NCT01018732|9769962|FG000|COMPLETED|Overall Study||49
8722485|NCT01018732|9769963|FG001|COMPLETED|Overall Study||49
8722486|NCT01018732|9769964|FG002|COMPLETED|Overall Study||50
8813873|NCT01528345|9867080|FG000|NOT COMPLETED|Overall Study||47
8813874|NCT01528345|9867081|FG001|NOT COMPLETED|Overall Study||50
8813875|NCT01528592|9867087|FG000|STARTED|Overall Study||18
8813876|NCT01528592|9867087|FG000|COMPLETED|Overall Study||18
8813877|NCT01528592|9867087|FG000|NOT COMPLETED|Overall Study||0
8813878|NCT01528605|9867097|FG000|STARTED|Overall Study||28
8813879|NCT01528605|9867098|FG001|STARTED|Overall Study||28
8813880|NCT01528605|9867099|FG002|STARTED|Overall Study||28
8813881|NCT01528605|9867100|FG003|STARTED|Overall Study||28
8813882|NCT01528605|9867101|FG004|STARTED|Overall Study||28
8813883|NCT01528605|9867102|FG005|STARTED|Overall Study||28
8813884|NCT01528605|9867097|FG000|COMPLETED|Overall Study||26
8619572|NCT00468559|9657996|FG002|COMPLETED|Double-blind, Treatment-withdrawal Phase||24
8619573|NCT00468559|9657994|FG000|NOT COMPLETED|Double-blind, Treatment-withdrawal Phase||0
8619574|NCT00468559|9657995|FG001|NOT COMPLETED|Double-blind, Treatment-withdrawal Phase||10
8619575|NCT00468559|9657996|FG002|NOT COMPLETED|Double-blind, Treatment-withdrawal Phase||17
8619576|NCT00468585|9658008|FG000|STARTED|Overall Study||4
8722487|NCT01018732|9769962|FG000|NOT COMPLETED|Overall Study||1
8722488|NCT01018732|9769963|FG001|NOT COMPLETED|Overall Study||2
8722489|NCT01018732|9769964|FG002|NOT COMPLETED|Overall Study||4
8722490|NCT01018862|9769975|FG000|STARTED|Overall Study||161
8722491|NCT01018862|9769976|FG001|STARTED|Overall Study||166
8813885|NCT01528605|9867098|FG001|COMPLETED|Overall Study||28
8813886|NCT01528605|9867099|FG002|COMPLETED|Overall Study||27
8813887|NCT01528605|9867100|FG003|COMPLETED|Overall Study||27
8560224|NCT00788710|9591972|FG002|COMPLETED|Overall Study||138
8560225|NCT00788710|9591970|FG000|NOT COMPLETED|Overall Study||5
8560226|NCT00788710|9591971|FG001|NOT COMPLETED|Overall Study||8
8560227|NCT00788710|9591972|FG002|NOT COMPLETED|Overall Study||6
8560228|NCT00783224|9591984|FG000|STARTED|Overall Study||32
8560229|NCT00783224|9591985|FG001|STARTED|Overall Study||34
8560230|NCT00783224|9591986|FG002|STARTED|Overall Study||143
8560231|NCT00783224|9591987|FG003|STARTED|Overall Study||142
8560232|NCT00783224|9591984|FG000|COMPLETED|Overall Study||32
8560233|NCT00783224|9591985|FG001|COMPLETED|Overall Study||34
8560234|NCT00783224|9591986|FG002|COMPLETED|Overall Study||142
8560235|NCT00783224|9591987|FG003|COMPLETED|Overall Study||140
8560236|NCT00783224|9591984|FG000|NOT COMPLETED|Overall Study||0
8560237|NCT00783224|9591985|FG001|NOT COMPLETED|Overall Study||0
8560238|NCT00783224|9591986|FG002|NOT COMPLETED|Overall Study||1
8943719|NCT02391350|10005559|FG001|NOT COMPLETED|Overall Study||17
8943720|NCT02391363|10005567|FG000|STARTED|Overall Study||70
8560239|NCT00783224|9591987|FG003|NOT COMPLETED|Overall Study||2
8560240|NCT00780403|9591996|FG000|STARTED|First Intervention||109
8560241|NCT00780403|9591997|FG001|STARTED|First Intervention||111
8560242|NCT00780403|9591996|FG000|COMPLETED|First Intervention||109
8560243|NCT00780403|9591997|FG001|COMPLETED|First Intervention||111
8560244|NCT00780403|9591996|FG000|NOT COMPLETED|First Intervention||0
8560245|NCT00780403|9591997|FG001|NOT COMPLETED|First Intervention||0
8560246|NCT00780403|9591996|FG000|STARTED|Interval Between Doses (8-10 Minutes)||109
8560247|NCT00780403|9591997|FG001|STARTED|Interval Between Doses (8-10 Minutes)||111
8560248|NCT00780403|9591996|FG000|COMPLETED|Interval Between Doses (8-10 Minutes)||109
8560249|NCT00780403|9591997|FG001|COMPLETED|Interval Between Doses (8-10 Minutes)||111
8722492|NCT01018862|9769977|FG002|STARTED|Overall Study||162
8722493|NCT01018862|9769975|FG000|COMPLETED|Overall Study||148
8722494|NCT01018862|9769976|FG001|COMPLETED|Overall Study||156
8722495|NCT01018862|9769977|FG002|COMPLETED|Overall Study||146
8722496|NCT01018862|9769975|FG000|NOT COMPLETED|Overall Study||13
8722497|NCT01018862|9769976|FG001|NOT COMPLETED|Overall Study||10
8722498|NCT01018862|9769977|FG002|NOT COMPLETED|Overall Study||16
8722499|NCT01018953|9769985|FG000|STARTED|Overall Study||8
8722500|NCT01018953|9769985|FG000|BIM 23A760 1 mg|Overall Study||3
8722501|NCT01018953|9769985|FG000|BIM 23A760 2 mg|Overall Study||2
8722502|NCT01018953|9769985|FG000|BIM 23A760 4 mg|Overall Study||3
8722503|NCT01018953|9769985|FG000|COMPLETED|Overall Study||0
8722504|NCT01018953|9769985|FG000|NOT COMPLETED|Overall Study||8
8722505|NCT01018979|9769992|FG000|STARTED|Overall Study||7
8722506|NCT01018979|9769993|FG001|STARTED|Overall Study|A total of 20 subjects were randomized.|13
8722507|NCT01018979|9769992|FG000|Received at Least One Dose|Overall Study||7
8722508|NCT01018979|9769993|FG001|Received at Least One Dose|Overall Study||12
8722509|NCT01018979|9769992|FG000|COMPLETED|Overall Study||4
8722510|NCT01018979|9769993|FG001|COMPLETED|Overall Study||3
8722511|NCT01018979|9769992|FG000|NOT COMPLETED|Overall Study||3
8722512|NCT01018979|9769993|FG001|NOT COMPLETED|Overall Study||10
8722513|NCT01018992|9770004|FG000|STARTED|Overall Study||63
8722514|NCT01018992|9770005|FG001|STARTED|Overall Study||65
8722515|NCT01018992|9770004|FG000|COMPLETED|Overall Study||47
8722516|NCT01018992|9770005|FG001|COMPLETED|Overall Study||49
8722517|NCT01018992|9770004|FG000|NOT COMPLETED|Overall Study||16
8722518|NCT01018992|9770005|FG001|NOT COMPLETED|Overall Study||16
8722519|NCT01019135|9770014|FG000|STARTED|Overall Study||55
8722520|NCT01019135|9770015|FG001|STARTED|Overall Study||59
8722521|NCT01019135|9770016|FG002|STARTED|Overall Study||55
8722522|NCT01019135|9770014|FG000|COMPLETED|Overall Study||35
8722523|NCT01019135|9770015|FG001|COMPLETED|Overall Study||40
8722524|NCT01019135|9770016|FG002|COMPLETED|Overall Study||24
8722525|NCT01019135|9770014|FG000|NOT COMPLETED|Overall Study||20
8722526|NCT01019135|9770015|FG001|NOT COMPLETED|Overall Study||19
8722527|NCT01019135|9770016|FG002|NOT COMPLETED|Overall Study||31
8722528|NCT01019252|9770026|FG000|STARTED|Initial CBT for ADHD vs. Wait List|Stratified based on biological sex and clinician-rated severity (CGI score)|24
8722529|NCT01019252|9770027|FG001|STARTED|Initial CBT for ADHD vs. Wait List|Stratified based on biological sex and clinician-rated severity (CGI score)|22
8722530|NCT01019252|9770026|FG000|COMPLETED|Initial CBT for ADHD vs. Wait List||21
8722531|NCT01019252|9770027|FG001|COMPLETED|Initial CBT for ADHD vs. Wait List||22
8722532|NCT01019252|9770026|FG000|NOT COMPLETED|Initial CBT for ADHD vs. Wait List||3
8722533|NCT01019252|9770027|FG001|NOT COMPLETED|Initial CBT for ADHD vs. Wait List||0
8560250|NCT00780403|9591996|FG000|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
8560251|NCT00780403|9591997|FG001|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
8560252|NCT00780403|9591996|FG000|STARTED|Second Intervention||109
8722534|NCT01019252|9770026|FG000|STARTED|Wait List Cross-over to CBT for ADHD|Lost to follow up, did not start treatment following wait list completion (n=3)|21
8722535|NCT01019252|9770027|FG001|STARTED|Wait List Cross-over to CBT for ADHD||22
8722536|NCT01019252|9770026|FG000|COMPLETED|Wait List Cross-over to CBT for ADHD||21
8722537|NCT01019252|9770027|FG001|COMPLETED|Wait List Cross-over to CBT for ADHD||15
8722538|NCT01019252|9770026|FG000|NOT COMPLETED|Wait List Cross-over to CBT for ADHD||0
8722539|NCT01019252|9770027|FG001|NOT COMPLETED|Wait List Cross-over to CBT for ADHD||7
8722540|NCT01019317|9770033|FG000|STARTED|Overall Study||151
8722541|NCT01019317|9770033|FG000|COMPLETED|Overall Study||147
8722542|NCT01019317|9770033|FG000|NOT COMPLETED|Overall Study||4
8722543|NCT01019369|9770039|FG000|STARTED|Overall Study||86
8722544|NCT01019369|9770040|FG001|STARTED|Overall Study||46
8722545|NCT01019369|9770039|FG000|COMPLETED|Overall Study||76
8722546|NCT01019369|9770040|FG001|COMPLETED|Overall Study||39
8722547|NCT01019369|9770039|FG000|NOT COMPLETED|Overall Study||10
8722548|NCT01019369|9770040|FG001|NOT COMPLETED|Overall Study||7
8722549|NCT01019486|9770050|FG000|STARTED|Overall Study||5
8722550|NCT01019486|9770051|FG001|STARTED|Overall Study||5
8722551|NCT01019486|9770052|FG002|STARTED|Overall Study||16
8722552|NCT01019486|9770050|FG000|COMPLETED|Overall Study||4
8722553|NCT01019486|9770051|FG001|COMPLETED|Overall Study||4
8722554|NCT01019486|9770052|FG002|COMPLETED|Overall Study||15
8722555|NCT01019486|9770050|FG000|NOT COMPLETED|Overall Study||1
8722556|NCT01019486|9770051|FG001|NOT COMPLETED|Overall Study||1
8722557|NCT01019486|9770052|FG002|NOT COMPLETED|Overall Study||1
8722558|NCT01019694|9770064|FG000|STARTED|Overall Study|2 pats. in Comb. Inh. Aero. and 3 pats. in Atro+Alb not treated and excluded from the Treated Set|157
8722559|NCT01019694|9770065|FG001|STARTED|Overall Study|2 pats. in Comb. Inh. Aero. and 3 pats. in Atro+Alb not treated and excluded from the Treated Set|156
8722560|NCT01019694|9770066|FG002|STARTED|Overall Study|2 pats. in Comb. Inh. Aero. and 3 pats. in Atro+Alb not treated and excluded from the Treated Set|157
8722561|NCT01019694|9770064|FG000|COMPLETED|Overall Study||133
8722562|NCT01019694|9770065|FG001|COMPLETED|Overall Study||118
8722563|NCT01019694|9770066|FG002|COMPLETED|Overall Study||110
8722564|NCT01019694|9770064|FG000|NOT COMPLETED|Overall Study||24
8722565|NCT01019694|9770065|FG001|NOT COMPLETED|Overall Study||38
8722566|NCT01019694|9770066|FG002|NOT COMPLETED|Overall Study||47
8722567|NCT01019707|9770074|FG000|STARTED|First Phase||3
8722568|NCT01019707|9770075|FG001|STARTED|First Phase||3
8722569|NCT01019707|9770074|FG000|COMPLETED|First Phase||3
8722570|NCT01019707|9770075|FG001|COMPLETED|First Phase||3
8722571|NCT01019707|9770074|FG000|NOT COMPLETED|First Phase||0
8722572|NCT01019707|9770075|FG001|NOT COMPLETED|First Phase||0
8722573|NCT01019707|9770074|FG000|STARTED|Washout||3
8722574|NCT01019707|9770075|FG001|STARTED|Washout||3
8722575|NCT01019707|9770074|FG000|COMPLETED|Washout||3
8722576|NCT01019707|9770075|FG001|COMPLETED|Washout||1
8722577|NCT01019707|9770074|FG000|NOT COMPLETED|Washout||0
8560253|NCT00780403|9591997|FG001|STARTED|Second Intervention||111
8560254|NCT00780403|9591996|FG000|COMPLETED|Second Intervention||109
8560255|NCT00780403|9591997|FG001|COMPLETED|Second Intervention||111
8560256|NCT00780403|9591996|FG000|NOT COMPLETED|Second Intervention||0
8560257|NCT00780403|9591997|FG001|NOT COMPLETED|Second Intervention||0
8560258|NCT00779116|9592004|FG000|STARTED|First Intervention||109
8560259|NCT00779116|9592005|FG001|STARTED|First Intervention||108
8560260|NCT00779116|9592004|FG000|COMPLETED|First Intervention||109
8560261|NCT00779116|9592005|FG001|COMPLETED|First Intervention||108
8560262|NCT00779116|9592004|FG000|NOT COMPLETED|First Intervention||0
8560263|NCT00779116|9592005|FG001|NOT COMPLETED|First Intervention||0
8560264|NCT00779116|9592004|FG000|STARTED|Interval Between Doses (8-10 Minutes)||109
8560265|NCT00779116|9592005|FG001|STARTED|Interval Between Doses (8-10 Minutes)||108
8560266|NCT00779116|9592004|FG000|COMPLETED|Interval Between Doses (8-10 Minutes)||109
8560267|NCT00779116|9592005|FG001|COMPLETED|Interval Between Doses (8-10 Minutes)||108
8560268|NCT00779116|9592004|FG000|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
8560269|NCT00779116|9592005|FG001|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
8560270|NCT00779116|9592004|FG000|STARTED|Second Intervention||109
8560271|NCT00779116|9592005|FG001|STARTED|Second Intervention||108
8560272|NCT00779116|9592004|FG000|COMPLETED|Second Intervention||109
8560273|NCT00779116|9592005|FG001|COMPLETED|Second Intervention||108
8560274|NCT00779116|9592004|FG000|NOT COMPLETED|Second Intervention||0
8560275|NCT00779116|9592005|FG001|NOT COMPLETED|Second Intervention||0
8560276|NCT00778700|9592016|FG000|STARTED|Overall Study||50
8560277|NCT00778700|9592017|FG001|STARTED|Overall Study||51
8560278|NCT00778700|9592018|FG002|STARTED|Overall Study||49
8560279|NCT00778700|9592019|FG003|STARTED|Overall Study||49
8560280|NCT00778700|9592016|FG000|COMPLETED|Overall Study||32
8560281|NCT00778700|9592017|FG001|COMPLETED|Overall Study||44
8560282|NCT00778700|9592018|FG002|COMPLETED|Overall Study||43
8560283|NCT00778700|9592019|FG003|COMPLETED|Overall Study||36
8560284|NCT00778700|9592016|FG000|NOT COMPLETED|Overall Study||18
8560285|NCT00778700|9592017|FG001|NOT COMPLETED|Overall Study||7
8560286|NCT00778700|9592018|FG002|NOT COMPLETED|Overall Study||6
8560287|NCT00778700|9592019|FG003|NOT COMPLETED|Overall Study||13
8560288|NCT00764478|9592036|FG000|STARTED|Overall Study||122
8560289|NCT00764478|9592037|FG001|STARTED|Overall Study||119
8560290|NCT00764478|9592038|FG002|STARTED|Overall Study||126
8560291|NCT00764478|9592036|FG000|COMPLETED|Overall Study||107
8560292|NCT00764478|9592037|FG001|COMPLETED|Overall Study||97
8560293|NCT00764478|9592038|FG002|COMPLETED|Overall Study||118
8560294|NCT00764478|9592036|FG000|NOT COMPLETED|Overall Study||15
8560295|NCT00764478|9592037|FG001|NOT COMPLETED|Overall Study||22
8560296|NCT00764478|9592038|FG002|NOT COMPLETED|Overall Study||8
8560297|NCT00761527|9592046|FG000|STARTED|Overall Study||2980
8560298|NCT00761527|9592046|FG000|Received One Dose of Study Medication|Overall Study||2978
8560299|NCT00761527|9592046|FG000|COMPLETED|Overall Study||2958
8560300|NCT00761527|9592046|FG000|NOT COMPLETED|Overall Study||22
8560301|NCT00757627|9592050|FG000|STARTED|Overall Study||500
8560302|NCT00757627|9592050|FG000|COMPLETED|Overall Study||419
8560303|NCT00757627|9592050|FG000|NOT COMPLETED|Overall Study||81
8560304|NCT00756938|9592062|FG000|STARTED|12-week Base Study||33
8560305|NCT00756938|9592063|FG001|STARTED|12-week Base Study||34
8560306|NCT00756938|9592064|FG002|STARTED|12-week Base Study||34
8560307|NCT00756938|9592065|FG003|STARTED|12-week Base Study||0
8560308|NCT00756938|9592062|FG000|COMPLETED|12-week Base Study||31
8560309|NCT00756938|9592063|FG001|COMPLETED|12-week Base Study||34
8560310|NCT00756938|9592064|FG002|COMPLETED|12-week Base Study||32
8560311|NCT00756938|9592065|FG003|COMPLETED|12-week Base Study||0
8560312|NCT00756938|9592062|FG000|NOT COMPLETED|12-week Base Study||2
8560313|NCT00756938|9592063|FG001|NOT COMPLETED|12-week Base Study||0
8560314|NCT00756938|9592064|FG002|NOT COMPLETED|12-week Base Study||2
8560315|NCT00756938|9592065|FG003|NOT COMPLETED|12-week Base Study||0
8560316|NCT00756938|9592062|FG000|STARTED|Optional Extension||0
8560317|NCT00756938|9592063|FG001|STARTED|Optional Extension||0
8560318|NCT00756938|9592064|FG002|STARTED|Optional Extension||0
8560319|NCT00756938|9592065|FG003|STARTED|Optional Extension|7 participants who completed base study opted not to enter extension|90
8560320|NCT00756938|9592062|FG000|COMPLETED|Optional Extension||0
8560321|NCT00756938|9592063|FG001|COMPLETED|Optional Extension||0
8722578|NCT01019707|9770075|FG001|NOT COMPLETED|Washout||2
8722579|NCT01019707|9770074|FG000|STARTED|Second Phase||3
8722580|NCT01019707|9770075|FG001|STARTED|Second Phase||1
8722581|NCT01019707|9770074|FG000|COMPLETED|Second Phase||3
8560322|NCT00756938|9592064|FG002|COMPLETED|Optional Extension||0
8560323|NCT00756938|9592065|FG003|COMPLETED|Optional Extension||53
8560324|NCT00756938|9592062|FG000|NOT COMPLETED|Optional Extension||0
8560325|NCT00756938|9592063|FG001|NOT COMPLETED|Optional Extension||0
8722582|NCT01019707|9770075|FG001|COMPLETED|Second Phase||1
8722583|NCT01019707|9770074|FG000|NOT COMPLETED|Second Phase||0
8722584|NCT01019707|9770075|FG001|NOT COMPLETED|Second Phase||0
8722585|NCT01019928|9770083|FG000|STARTED|Period 1||7
8722586|NCT01019928|9770084|FG001|STARTED|Period 1||7
8722587|NCT01019928|9770083|FG000|COMPLETED|Period 1||7
8722588|NCT01019928|9770084|FG001|COMPLETED|Period 1||7
8722589|NCT01019928|9770083|FG000|NOT COMPLETED|Period 1||0
8722590|NCT01019928|9770084|FG001|NOT COMPLETED|Period 1||0
8722591|NCT01019928|9770083|FG000|STARTED|Period 2||7
8722592|NCT01019928|9770084|FG001|STARTED|Period 2||7
8722593|NCT01019928|9770083|FG000|COMPLETED|Period 2||7
8722594|NCT01019928|9770084|FG001|COMPLETED|Period 2|One patient had an SAE, and was withdrawn, prior to receiving AZD1386|6
8722595|NCT01019928|9770083|FG000|NOT COMPLETED|Period 2||0
8722596|NCT01019928|9770084|FG001|NOT COMPLETED|Period 2||1
8722597|NCT01019928|9770083|FG000|STARTED|Period 3||7
8722598|NCT01019928|9770084|FG001|STARTED|Period 3|One patient had an SAE, and was withdrawn, prior to receiving AZD1386|6
8722599|NCT01019928|9770083|FG000|COMPLETED|Period 3||7
8722600|NCT01019928|9770084|FG001|COMPLETED|Period 3|One patient had an SAE, and was withdrawn, prior to receiving AZD1386|6
8722601|NCT01019928|9770083|FG000|NOT COMPLETED|Period 3||0
8722602|NCT01019928|9770084|FG001|NOT COMPLETED|Period 3||0
8722603|NCT01020006|9770093|FG000|STARTED|Overall Study||8
8722604|NCT01020006|9770094|FG001|STARTED|Overall Study||18
8722605|NCT01020006|9770095|FG002|STARTED|Overall Study||16
8722606|NCT01020006|9770093|FG000|COMPLETED|Overall Study|No subjects reached study completion as defined by protocol.|0
8722607|NCT01020006|9770094|FG001|COMPLETED|Overall Study|No subjects reached study completion as defined by protocol.|0
8722608|NCT01020006|9770095|FG002|COMPLETED|Overall Study|No subjects reached study completion as defined by protocol.|0
8722609|NCT01020006|9770093|FG000|NOT COMPLETED|Overall Study||8
8722610|NCT01020006|9770094|FG001|NOT COMPLETED|Overall Study||18
8722611|NCT01020006|9770095|FG002|NOT COMPLETED|Overall Study||16
8722612|NCT01020019|9770105|FG000|STARTED|Overall Study||61
8722613|NCT01020019|9770106|FG001|STARTED|Overall Study||61
8722614|NCT01020019|9770105|FG000|COMPLETED|Overall Study||35
8722615|NCT01020019|9770106|FG001|COMPLETED|Overall Study||32
8722616|NCT01020019|9770105|FG000|NOT COMPLETED|Overall Study||26
8722617|NCT01020019|9770106|FG001|NOT COMPLETED|Overall Study||29
8722618|NCT01020123|9770119|FG000|STARTED|Main Period||93
8722619|NCT01020123|9770120|FG001|STARTED|Main Period||91
8722620|NCT01020123|9770121|FG002|STARTED|Main Period||52
8722621|NCT01020123|9770122|FG003|STARTED|Main Period||40
8722622|NCT01020123|9770123|FG004|STARTED|Main Period||88
8722623|NCT01020123|9770124|FG005|STARTED|Main Period||94
8722624|NCT01020123|9770125|FG006|STARTED|Main Period||72
8722625|NCT01020123|9770119|FG000|COMPLETED|Main Period||76
8722626|NCT01020123|9770120|FG001|COMPLETED|Main Period||77
8722627|NCT01020123|9770121|FG002|COMPLETED|Main Period||44
8722628|NCT01020123|9770122|FG003|COMPLETED|Main Period||33
8722629|NCT01020123|9770123|FG004|COMPLETED|Main Period||77
8722630|NCT01020123|9770124|FG005|COMPLETED|Main Period||83
8722631|NCT01020123|9770125|FG006|COMPLETED|Main Period||61
8722632|NCT01020123|9770119|FG000|NOT COMPLETED|Main Period||17
8722633|NCT01020123|9770120|FG001|NOT COMPLETED|Main Period||14
8722634|NCT01020123|9770121|FG002|NOT COMPLETED|Main Period||8
8722635|NCT01020123|9770122|FG003|NOT COMPLETED|Main Period||7
8722636|NCT01020123|9770123|FG004|NOT COMPLETED|Main Period||11
8722637|NCT01020123|9770124|FG005|NOT COMPLETED|Main Period||11
8722638|NCT01020123|9770125|FG006|NOT COMPLETED|Main Period||11
8722639|NCT01020123|9770119|FG000|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|40
8722640|NCT01020123|9770120|FG001|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|35
8722641|NCT01020123|9770121|FG002|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|19
8722642|NCT01020123|9770122|FG003|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|13
8722643|NCT01020123|9770123|FG004|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|31
8722644|NCT01020123|9770124|FG005|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|38
8722645|NCT01020123|9770125|FG006|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|19
8722646|NCT01020123|9770119|FG000|COMPLETED|Extention Period||37
8722647|NCT01020123|9770120|FG001|COMPLETED|Extention Period||33
8722648|NCT01020123|9770121|FG002|COMPLETED|Extention Period||17
8722649|NCT01020123|9770122|FG003|COMPLETED|Extention Period||12
8722650|NCT01020123|9770123|FG004|COMPLETED|Extention Period||31
8722651|NCT01020123|9770124|FG005|COMPLETED|Extention Period||36
8722652|NCT01020123|9770125|FG006|COMPLETED|Extention Period||18
8722653|NCT01020123|9770119|FG000|NOT COMPLETED|Extention Period||3
8722654|NCT01020123|9770120|FG001|NOT COMPLETED|Extention Period||2
8722655|NCT01020123|9770121|FG002|NOT COMPLETED|Extention Period||2
8722656|NCT01020123|9770122|FG003|NOT COMPLETED|Extention Period||1
8722657|NCT01020123|9770123|FG004|NOT COMPLETED|Extention Period||0
8722658|NCT01020123|9770124|FG005|NOT COMPLETED|Extention Period||2
8722659|NCT01020123|9770125|FG006|NOT COMPLETED|Extention Period||1
8722660|NCT01020305|9770142|FG000|STARTED|Overall Study||5
8722661|NCT01020305|9770142|FG000|COMPLETED|Overall Study||3
8722662|NCT01020305|9770142|FG000|NOT COMPLETED|Overall Study||2
8722663|NCT01020435|9770148|FG000|STARTED|Overall Study||24
8722664|NCT01020435|9770149|FG001|STARTED|Overall Study||27
8722665|NCT01020435|9770148|FG000|COMPLETED|Overall Study||24
8722666|NCT01020435|9770149|FG001|COMPLETED|Overall Study||26
8722667|NCT01020435|9770148|FG000|NOT COMPLETED|Overall Study||0
8722668|NCT01020435|9770149|FG001|NOT COMPLETED|Overall Study||1
8813888|NCT01528605|9867101|FG004|COMPLETED|Overall Study||28
8813889|NCT01528605|9867102|FG005|COMPLETED|Overall Study||28
8813890|NCT01528605|9867097|FG000|NOT COMPLETED|Overall Study||2
8813891|NCT01528605|9867098|FG001|NOT COMPLETED|Overall Study||0
8813892|NCT01528605|9867099|FG002|NOT COMPLETED|Overall Study||1
8813893|NCT01528605|9867100|FG003|NOT COMPLETED|Overall Study||1
8813894|NCT01528605|9867101|FG004|NOT COMPLETED|Overall Study||0
8813895|NCT01528605|9867102|FG005|NOT COMPLETED|Overall Study||0
8813896|NCT01528709|9867118|FG000|STARTED|Overall Study||86
8813897|NCT01528709|9867119|FG001|STARTED|Overall Study||87
8813898|NCT01528709|9867118|FG000|COMPLETED|Overall Study||73
8813899|NCT01528709|9867119|FG001|COMPLETED|Overall Study||72
8813900|NCT01528709|9867118|FG000|NOT COMPLETED|Overall Study||13
8813901|NCT01528709|9867119|FG001|NOT COMPLETED|Overall Study||15
8813902|NCT01528735|9867127|FG000|STARTED|Treatment Period 1: Faldap/Del/RBV||12
8813903|NCT01528735|9867128|FG001|STARTED|Treatment Period 1: Faldap/Del/RBV||13
8813904|NCT01528735|9867127|FG000|COMPLETED|Treatment Period 1: Faldap/Del/RBV||11
8813905|NCT01528735|9867128|FG001|COMPLETED|Treatment Period 1: Faldap/Del/RBV||12
8813906|NCT01528735|9867127|FG000|NOT COMPLETED|Treatment Period 1: Faldap/Del/RBV||1
8813907|NCT01528735|9867128|FG001|NOT COMPLETED|Treatment Period 1: Faldap/Del/RBV||1
8813908|NCT01528735|9867127|FG000|STARTED|Treatment Period 2: Faldap/PegIFN/RBV||11
8813909|NCT01528735|9867128|FG001|STARTED|Treatment Period 2: Faldap/PegIFN/RBV|One patient was treated with only PegIFN/RBV, as faldaprevir was discontinued due to adverse events|12
8813910|NCT01528735|9867127|FG000|COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||10
8813911|NCT01528735|9867128|FG001|COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||12
8813912|NCT01528735|9867127|FG000|NOT COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||1
8813913|NCT01528735|9867128|FG001|NOT COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||0
8813914|NCT01528787|9867140|FG000|STARTED|Overall Study||22
8813915|NCT01528787|9867141|FG001|STARTED|Overall Study||21
8813916|NCT01528787|9867142|FG002|STARTED|Overall Study||19
8813917|NCT01528787|9867143|FG003|STARTED|Overall Study||23
8813918|NCT01528787|9867140|FG000|COMPLETED|Overall Study||22
8813919|NCT01528787|9867141|FG001|COMPLETED|Overall Study||21
8813920|NCT01528787|9867142|FG002|COMPLETED|Overall Study||18
8813921|NCT01528787|9867143|FG003|COMPLETED|Overall Study||22
8813922|NCT01528787|9867140|FG000|NOT COMPLETED|Overall Study||0
8813923|NCT01528787|9867141|FG001|NOT COMPLETED|Overall Study||0
8813924|NCT01528787|9867142|FG002|NOT COMPLETED|Overall Study||1
8813925|NCT01528787|9867143|FG003|NOT COMPLETED|Overall Study||1
8813926|NCT01528878|9867153|FG000|STARTED|Overall Study||30
8813927|NCT01528878|9867153|FG000|COMPLETED|Overall Study||30
8813928|NCT01528878|9867153|FG000|NOT COMPLETED|Overall Study||0
8813929|NCT01528891|9867161|FG000|STARTED|Overall Study||200
8813930|NCT01528891|9867162|FG001|STARTED|Overall Study||200
8813931|NCT01528891|9867161|FG000|COMPLETED|Overall Study||200
8813932|NCT01528891|9867162|FG001|COMPLETED|Overall Study||200
8813933|NCT01528891|9867161|FG000|NOT COMPLETED|Overall Study||0
8813934|NCT01528891|9867162|FG001|NOT COMPLETED|Overall Study||0
8722669|NCT01020448|9770156|FG000|STARTED|Pre-assignment||339
8722670|NCT01020448|9770156|FG000|COMPLETED|Pre-assignment||326
8813935|NCT01528969|9867172|FG000|STARTED|Overall Study||37
8813936|NCT01528969|9867173|FG001|STARTED|Overall Study||38
8813937|NCT01528969|9867172|FG000|COMPLETED|Overall Study||35
8813938|NCT01528969|9867173|FG001|COMPLETED|Overall Study||38
8813939|NCT01528969|9867172|FG000|NOT COMPLETED|Overall Study||2
8813940|NCT01528969|9867173|FG001|NOT COMPLETED|Overall Study||0
8813941|NCT01529034|9867179|FG000|STARTED|Overall Study|Completed Study P261-401 and rolled over to Study P261-402|175
8813942|NCT01529034|9867179|FG000|Exposed|Overall Study|Treated at least 1 seizure cluster with USL261|161
8813943|NCT01529034|9867179|FG000|COMPLETED|Overall Study|Completed under initial protocol duration of 2 years; amended protocol open-ended duration|1
8813944|NCT01529034|9867179|FG000|NOT COMPLETED|Overall Study||174
8813945|NCT01529060|9867186|FG000|STARTED|Overall Study||10
8813946|NCT01529060|9867187|FG001|STARTED|Overall Study||10
8813947|NCT01529060|9867186|FG000|COMPLETED|Overall Study||10
8813948|NCT01529060|9867187|FG001|COMPLETED|Overall Study||10
8813949|NCT01529060|9867186|FG000|NOT COMPLETED|Overall Study||0
8813950|NCT01529060|9867187|FG001|NOT COMPLETED|Overall Study||0
8813951|NCT01529112|9867196|FG000|STARTED|Overall Study||89
8813952|NCT01529112|9867197|FG001|STARTED|Overall Study||46
8813953|NCT01529112|9867196|FG000|COMPLETED|Overall Study|On treatment=2, Discontinued treatment-continued follow-up=18 (data cut-off date 21 January 2014)|20
8813954|NCT01529112|9867197|FG001|COMPLETED|Overall Study|Discontinued treatment-continued follow-up=5 (data cut-off date 21 January 2014)|5
8813955|NCT01529112|9867196|FG000|NOT COMPLETED|Overall Study||69
8813956|NCT01529112|9867197|FG001|NOT COMPLETED|Overall Study||41
8813957|NCT01529203|9867203|FG000|STARTED|Overall Study||60
8813958|NCT01529203|9867203|FG000|COMPLETED|Overall Study||57
8813959|NCT01529203|9867203|FG000|NOT COMPLETED|Overall Study||3
8813960|NCT01529268|9867209|FG000|STARTED|Overall Study||88
8813961|NCT01529268|9867210|FG001|STARTED|Overall Study||81
8813962|NCT01529268|9867209|FG000|Completed 52-week Biopsy|Overall Study||71
8813963|NCT01529268|9867210|FG001|Completed 52-week Biopsy|Overall Study||75
8813964|NCT01529268|9867209|FG000|COMPLETED|Overall Study||76
8813965|NCT01529268|9867210|FG001|COMPLETED|Overall Study||78
8813966|NCT01529268|9867209|FG000|NOT COMPLETED|Overall Study||12
8813967|NCT01529268|9867210|FG001|NOT COMPLETED|Overall Study||3
8813968|NCT01529346|9867221|FG000|STARTED|Overall Study||55
8813969|NCT01529346|9867222|FG001|STARTED|Overall Study||54
8813970|NCT01529346|9867223|FG002|STARTED|Overall Study||54
8813971|NCT01529346|9867224|FG003|STARTED|Overall Study||36
8813972|NCT01529346|9867225|FG004|STARTED|Overall Study||36
8813973|NCT01529346|9867221|FG000|COMPLETED|Overall Study||53
8813974|NCT01529346|9867222|FG001|COMPLETED|Overall Study||53
8813975|NCT01529346|9867223|FG002|COMPLETED|Overall Study||52
8813976|NCT01529346|9867224|FG003|COMPLETED|Overall Study||36
8813977|NCT01529346|9867225|FG004|COMPLETED|Overall Study||36
8813978|NCT01529346|9867221|FG000|NOT COMPLETED|Overall Study||2
8813979|NCT01529346|9867222|FG001|NOT COMPLETED|Overall Study||1
8813980|NCT01529346|9867223|FG002|NOT COMPLETED|Overall Study||2
8813981|NCT01529346|9867224|FG003|NOT COMPLETED|Overall Study||0
8813982|NCT01529346|9867225|FG004|NOT COMPLETED|Overall Study||0
8813983|NCT01529385|9867240|FG000|STARTED|Overall Study||40
8813984|NCT01529385|9867241|FG001|STARTED|Overall Study||40
8813985|NCT01529385|9867240|FG000|Received Intervention|Overall Study|1 participant failed to show up to treatment allocation visit and was subsequently lost to follow up|39
8813986|NCT01529385|9867241|FG001|Received Intervention|Overall Study||40
8813987|NCT01529385|9867240|FG000|COMPLETED|Overall Study||38
8813988|NCT01529385|9867241|FG001|COMPLETED|Overall Study||39
8813989|NCT01529385|9867240|FG000|NOT COMPLETED|Overall Study||2
8813990|NCT01529385|9867241|FG001|NOT COMPLETED|Overall Study||1
8813991|NCT01529450|9867249|FG000|STARTED|Overall Study||3
8813992|NCT01529450|9867250|FG001|STARTED|Overall Study||8
8813993|NCT01529450|9867249|FG000|COMPLETED|Overall Study||3
8813994|NCT01529450|9867250|FG001|COMPLETED|Overall Study||6
8813995|NCT01529450|9867249|FG000|NOT COMPLETED|Overall Study||0
8813996|NCT01529450|9867250|FG001|NOT COMPLETED|Overall Study||2
8813997|NCT01529502|9867263|FG000|STARTED|Overall Study||2
8813998|NCT01529502|9867264|FG001|STARTED|Overall Study||3
8813999|NCT01529502|9867265|FG002|STARTED|Overall Study||2
8814000|NCT01529502|9867266|FG003|STARTED|Overall Study||3
8814001|NCT01529502|9867267|FG004|STARTED|Overall Study||2
8814002|NCT01529502|9867268|FG005|STARTED|Overall Study||2
8814003|NCT01529502|9867263|FG000|COMPLETED|Overall Study||2
8814004|NCT01529502|9867264|FG001|COMPLETED|Overall Study||3
8814005|NCT01529502|9867265|FG002|COMPLETED|Overall Study||2
8814006|NCT01529502|9867266|FG003|COMPLETED|Overall Study||1
8814007|NCT01529502|9867267|FG004|COMPLETED|Overall Study||2
8814008|NCT01529502|9867268|FG005|COMPLETED|Overall Study||2
8814009|NCT01529502|9867263|FG000|NOT COMPLETED|Overall Study||0
8814010|NCT01529502|9867264|FG001|NOT COMPLETED|Overall Study||0
8814011|NCT01529502|9867265|FG002|NOT COMPLETED|Overall Study||0
8814012|NCT01529502|9867266|FG003|NOT COMPLETED|Overall Study||2
8814013|NCT01529502|9867267|FG004|NOT COMPLETED|Overall Study||0
8814014|NCT01529502|9867268|FG005|NOT COMPLETED|Overall Study||0
8814015|NCT01529515|9867278|FG000|STARTED|TRANSITION PHASE||506
8814016|NCT01529515|9867279|FG001|STARTED|TRANSITION PHASE||0
8814017|NCT01529515|9867280|FG002|STARTED|TRANSITION PHASE||0
8814018|NCT01529515|9867281|FG003|STARTED|TRANSITION PHASE||0
8814019|NCT01529515|9867278|FG000|COMPLETED|TRANSITION PHASE||379
8814020|NCT01529515|9867279|FG001|COMPLETED|TRANSITION PHASE||0
8814021|NCT01529515|9867280|FG002|COMPLETED|TRANSITION PHASE||0
8814022|NCT01529515|9867281|FG003|COMPLETED|TRANSITION PHASE||0
8814023|NCT01529515|9867278|FG000|NOT COMPLETED|TRANSITION PHASE||127
8814024|NCT01529515|9867279|FG001|NOT COMPLETED|TRANSITION PHASE||0
8814025|NCT01529515|9867280|FG002|NOT COMPLETED|TRANSITION PHASE||0
8814026|NCT01529515|9867281|FG003|NOT COMPLETED|TRANSITION PHASE||0
8814027|NCT01529515|9867278|FG000|STARTED|MAINTENANCE PHASE||0
8814028|NCT01529515|9867279|FG001|STARTED|MAINTENANCE PHASE||379
8814029|NCT01529515|9867280|FG002|STARTED|MAINTENANCE PHASE||0
8814030|NCT01529515|9867281|FG003|STARTED|MAINTENANCE PHASE||0
8814031|NCT01529515|9867278|FG000|COMPLETED|MAINTENANCE PHASE||0
8814032|NCT01529515|9867279|FG001|COMPLETED|MAINTENANCE PHASE||305
8814033|NCT01529515|9867280|FG002|COMPLETED|MAINTENANCE PHASE||0
8814034|NCT01529515|9867281|FG003|COMPLETED|MAINTENANCE PHASE||0
8814035|NCT01529515|9867278|FG000|NOT COMPLETED|MAINTENANCE PHASE||0
8814036|NCT01529515|9867279|FG001|NOT COMPLETED|MAINTENANCE PHASE||74
8814037|NCT01529515|9867280|FG002|NOT COMPLETED|MAINTENANCE PHASE||0
8814038|NCT01529515|9867281|FG003|NOT COMPLETED|MAINTENANCE PHASE||0
8814039|NCT01529515|9867278|FG000|STARTED|DOUBLE BLIND PHASE||0
8814040|NCT01529515|9867279|FG001|STARTED|DOUBLE BLIND PHASE||0
8814041|NCT01529515|9867280|FG002|STARTED|DOUBLE BLIND PHASE||145
8814042|NCT01529515|9867281|FG003|STARTED|DOUBLE BLIND PHASE||160
8814043|NCT01529515|9867278|FG000|COMPLETED|DOUBLE BLIND PHASE||0
8814044|NCT01529515|9867279|FG001|COMPLETED|DOUBLE BLIND PHASE||0
8814045|NCT01529515|9867280|FG002|COMPLETED|DOUBLE BLIND PHASE||122
8814046|NCT01529515|9867281|FG003|COMPLETED|DOUBLE BLIND PHASE||148
8814047|NCT01529515|9867278|FG000|NOT COMPLETED|DOUBLE BLIND PHASE||0
8814048|NCT01529515|9867279|FG001|NOT COMPLETED|DOUBLE BLIND PHASE||0
8814049|NCT01529515|9867280|FG002|NOT COMPLETED|DOUBLE BLIND PHASE||23
8814050|NCT01529515|9867281|FG003|NOT COMPLETED|DOUBLE BLIND PHASE||12
8814051|NCT01529606|9867290|FG000|STARTED|Overall Study||55
8814052|NCT01529606|9867291|FG001|STARTED|Overall Study||47
8814053|NCT01529606|9867290|FG000|COMPLETED|Overall Study||34
8814054|NCT01529606|9867291|FG001|COMPLETED|Overall Study||29
8814055|NCT01529606|9867290|FG000|NOT COMPLETED|Overall Study||21
8814056|NCT01529606|9867291|FG001|NOT COMPLETED|Overall Study||18
8814057|NCT01529632|9867299|FG000|STARTED|Overall Study||90
8814058|NCT01529632|9867300|FG001|STARTED|Overall Study||103
8814059|NCT01529632|9867299|FG000|COMPLETED|Overall Study||87
8814060|NCT01529632|9867300|FG001|COMPLETED|Overall Study||100
8814061|NCT01529632|9867299|FG000|NOT COMPLETED|Overall Study||3
8814062|NCT01529632|9867300|FG001|NOT COMPLETED|Overall Study||3
8814063|NCT01529645|9867316|FG000|STARTED|Overall Study||42
8814064|NCT01529645|9867317|FG001|STARTED|Overall Study||42
8814065|NCT01529645|9867318|FG002|STARTED|Overall Study||42
8814066|NCT01529645|9867319|FG003|STARTED|Overall Study||42
8814067|NCT01529645|9867320|FG004|STARTED|Overall Study||42
8814068|NCT01529645|9867321|FG005|STARTED|Overall Study||42
8814069|NCT01529645|9867322|FG006|STARTED|Overall Study||42
8814070|NCT01529645|9867323|FG007|STARTED|Overall Study||42
8814071|NCT01529645|9867324|FG008|STARTED|Overall Study||42
8814072|NCT01529645|9867325|FG009|STARTED|Overall Study||42
8814073|NCT01529645|9867316|FG000|COMPLETED|Overall Study||40
8814074|NCT01529645|9867317|FG001|COMPLETED|Overall Study||41
8814075|NCT01529645|9867318|FG002|COMPLETED|Overall Study||40
8814076|NCT01529645|9867319|FG003|COMPLETED|Overall Study||40
8814077|NCT01529645|9867320|FG004|COMPLETED|Overall Study||40
8814078|NCT01529645|9867321|FG005|COMPLETED|Overall Study||41
8814079|NCT01529645|9867322|FG006|COMPLETED|Overall Study||40
8814080|NCT01529645|9867323|FG007|COMPLETED|Overall Study||42
8814081|NCT01529645|9867324|FG008|COMPLETED|Overall Study||41
8814082|NCT01529645|9867325|FG009|COMPLETED|Overall Study||42
8814083|NCT01529645|9867316|FG000|NOT COMPLETED|Overall Study||2
8814084|NCT01529645|9867317|FG001|NOT COMPLETED|Overall Study||1
8814085|NCT01529645|9867318|FG002|NOT COMPLETED|Overall Study||2
8814086|NCT01529645|9867319|FG003|NOT COMPLETED|Overall Study||2
8814087|NCT01529645|9867320|FG004|NOT COMPLETED|Overall Study||2
8814088|NCT01529645|9867321|FG005|NOT COMPLETED|Overall Study||1
8814089|NCT01529645|9867322|FG006|NOT COMPLETED|Overall Study||2
8814090|NCT01529645|9867323|FG007|NOT COMPLETED|Overall Study||0
8814091|NCT01529645|9867324|FG008|NOT COMPLETED|Overall Study||1
8814092|NCT01529645|9867325|FG009|NOT COMPLETED|Overall Study||0
8814093|NCT01529749|9867359|FG000|STARTED|Overall Study||12
8814094|NCT01529749|9867360|FG001|STARTED|Overall Study||12
8814095|NCT01529749|9867361|FG002|STARTED|Overall Study||12
8814096|NCT01529749|9867362|FG003|STARTED|Overall Study||12
8814097|NCT01529749|9867359|FG000|COMPLETED|Overall Study||12
8814098|NCT01529749|9867360|FG001|COMPLETED|Overall Study||10
8814099|NCT01529749|9867361|FG002|COMPLETED|Overall Study||10
8814100|NCT01529749|9867362|FG003|COMPLETED|Overall Study||10
8814101|NCT01529749|9867359|FG000|NOT COMPLETED|Overall Study||0
8814102|NCT01529749|9867360|FG001|NOT COMPLETED|Overall Study||2
8814103|NCT01529749|9867361|FG002|NOT COMPLETED|Overall Study||2
8814104|NCT01529749|9867362|FG003|NOT COMPLETED|Overall Study||2
8814105|NCT01529827|9867372|FG000|STARTED|Overall Study||94
8814106|NCT01529827|9867372|FG000|COMPLETED|Overall Study||94
8814107|NCT01529827|9867372|FG000|NOT COMPLETED|Overall Study||0
8619577|NCT00468585|9658009|FG001|STARTED|Overall Study||3
8619578|NCT00468585|9658010|FG002|STARTED|Overall Study||50
8619579|NCT00468585|9658011|FG003|STARTED|Overall Study||6
8619580|NCT00468585|9658008|FG000|COMPLETED|Overall Study||3
8619581|NCT00468585|9658009|FG001|COMPLETED|Overall Study||3
8619582|NCT00468585|9658010|FG002|COMPLETED|Overall Study||45
8619583|NCT00468585|9658011|FG003|COMPLETED|Overall Study||5
8619584|NCT00468585|9658008|FG000|NOT COMPLETED|Overall Study||1
8619585|NCT00468585|9658009|FG001|NOT COMPLETED|Overall Study||0
8619586|NCT00468585|9658010|FG002|NOT COMPLETED|Overall Study||5
8619587|NCT00468585|9658011|FG003|NOT COMPLETED|Overall Study||1
8619588|NCT00468650|9658021|FG000|STARTED|Overall Study||117
8619589|NCT00468650|9658021|FG000|COMPLETED|Overall Study||110
8619590|NCT00468650|9658021|FG000|NOT COMPLETED|Overall Study||7
8619591|NCT00468676|9658028|FG000|STARTED|Overall Study||108
8619592|NCT00468676|9658029|FG001|STARTED|Overall Study||106
8619593|NCT00468676|9658028|FG000|COMPLETED|Overall Study||92
8619594|NCT00468676|9658029|FG001|COMPLETED|Overall Study||94
8619595|NCT00468676|9658028|FG000|NOT COMPLETED|Overall Study||16
8619596|NCT00468676|9658029|FG001|NOT COMPLETED|Overall Study||12
8619597|NCT00468728|9658039|FG000|STARTED|Enrollment||264
8619598|NCT00468728|9658040|FG001|STARTED|Enrollment||271
8619599|NCT00468728|9658039|FG000|COMPLETED|Enrollment|1 fidaxomicin subject received vancomycin, 11 subjects didn't take drug|260
8619600|NCT00468728|9658040|FG001|COMPLETED|Enrollment|1 fidaxomicin subject received vancomycin, 11 subjects didn't take drug|264
8814108|NCT01530178|9867378|FG000|STARTED|Overall Study||2
8814109|NCT01530178|9867379|FG001|STARTED|Overall Study||6
8814110|NCT01530178|9867378|FG000|COMPLETED|Overall Study||2
8814111|NCT01530178|9867379|FG001|COMPLETED|Overall Study||6
8814112|NCT01530178|9867378|FG000|NOT COMPLETED|Overall Study||0
8814113|NCT01530178|9867379|FG001|NOT COMPLETED|Overall Study||0
8814114|NCT01530243|9867393|FG000|STARTED|Overall Study||26
8814115|NCT01530243|9867394|FG001|STARTED|Overall Study||26
8814116|NCT01530243|9867395|FG002|STARTED|Overall Study||26
8814117|NCT01530243|9867396|FG003|STARTED|Overall Study||26
8814118|NCT01530243|9867393|FG000|COMPLETED|Overall Study||24
8814119|NCT01530243|9867394|FG001|COMPLETED|Overall Study||23
8814120|NCT01530243|9867395|FG002|COMPLETED|Overall Study||23
8814121|NCT01530243|9867396|FG003|COMPLETED|Overall Study||24
8814122|NCT01530243|9867393|FG000|NOT COMPLETED|Overall Study||2
8814123|NCT01530243|9867394|FG001|NOT COMPLETED|Overall Study||3
8814124|NCT01530243|9867395|FG002|NOT COMPLETED|Overall Study||3
8814125|NCT01530243|9867396|FG003|NOT COMPLETED|Overall Study||2
8814126|NCT01530256|9867407|FG000|STARTED|Overall Study||3
8814127|NCT01530256|9867407|FG000|COMPLETED|Overall Study||1
8814128|NCT01530256|9867407|FG000|NOT COMPLETED|Overall Study||2
8814129|NCT01530334|9867411|FG000|STARTED|Overall Study||61
8814130|NCT01530334|9867411|FG000|COMPLETED|Overall Study||10
8814131|NCT01530334|9867411|FG000|NOT COMPLETED|Overall Study||51
8814132|NCT01530399|9867421|FG000|STARTED|Overall Study||8
8814133|NCT01530399|9867422|FG001|STARTED|Overall Study||10
8814134|NCT01530399|9867423|FG002|STARTED|Overall Study||8
8814135|NCT01530399|9867424|FG003|STARTED|Overall Study||10
8814136|NCT01530399|9867425|FG004|STARTED|Overall Study||6
8814137|NCT01530399|9867426|FG005|STARTED|Overall Study||7
8814138|NCT01530399|9867421|FG000|COMPLETED|Overall Study||7
8814139|NCT01530399|9867422|FG001|COMPLETED|Overall Study||8
8814140|NCT01530399|9867423|FG002|COMPLETED|Overall Study||7
8814141|NCT01530399|9867424|FG003|COMPLETED|Overall Study||10
8814142|NCT01530399|9867425|FG004|COMPLETED|Overall Study||6
8814143|NCT01530399|9867426|FG005|COMPLETED|Overall Study||6
8814144|NCT01530399|9867421|FG000|NOT COMPLETED|Overall Study||1
8814145|NCT01530399|9867422|FG001|NOT COMPLETED|Overall Study||2
8814146|NCT01530399|9867423|FG002|NOT COMPLETED|Overall Study||1
8814147|NCT01530399|9867424|FG003|NOT COMPLETED|Overall Study||0
8814148|NCT01530399|9867425|FG004|NOT COMPLETED|Overall Study||0
8814149|NCT01530399|9867426|FG005|NOT COMPLETED|Overall Study||1
8814150|NCT01530464|9867442|FG000|STARTED|First Intervention (24h)||10
8814151|NCT01530464|9867443|FG001|STARTED|First Intervention (24h)||8
8814152|NCT01530464|9867442|FG000|COMPLETED|First Intervention (24h)||10
8814153|NCT01530464|9867443|FG001|COMPLETED|First Intervention (24h)||8
8814154|NCT01530464|9867442|FG000|NOT COMPLETED|First Intervention (24h)||0
8814155|NCT01530464|9867443|FG001|NOT COMPLETED|First Intervention (24h)||0
8814156|NCT01530464|9867442|FG000|STARTED|Washout (24h)||10
8814157|NCT01530464|9867443|FG001|STARTED|Washout (24h)||8
8814158|NCT01530464|9867442|FG000|COMPLETED|Washout (24h)||10
8814159|NCT01530464|9867443|FG001|COMPLETED|Washout (24h)||8
8814160|NCT01530464|9867442|FG000|NOT COMPLETED|Washout (24h)||0
8814161|NCT01530464|9867443|FG001|NOT COMPLETED|Washout (24h)||0
8814162|NCT01530464|9867442|FG000|STARTED|Second Intervention (24h)||10
8814163|NCT01530464|9867443|FG001|STARTED|Second Intervention (24h)||8
8814164|NCT01530464|9867442|FG000|COMPLETED|Second Intervention (24h)||10
8814165|NCT01530464|9867443|FG001|COMPLETED|Second Intervention (24h)||8
8814166|NCT01530464|9867442|FG000|NOT COMPLETED|Second Intervention (24h)||0
8814167|NCT01530464|9867443|FG001|NOT COMPLETED|Second Intervention (24h)||0
8814168|NCT01530464|9867442|FG000|STARTED|Washout (24h)||10
8814169|NCT01530464|9867443|FG001|STARTED|Washout (24h)||8
8814170|NCT01530464|9867442|FG000|COMPLETED|Washout (24h)|1 subject withdrew consent and left due to family emergencies|9
8814171|NCT01530464|9867443|FG001|COMPLETED|Washout (24h)||8
8814172|NCT01530464|9867442|FG000|NOT COMPLETED|Washout (24h)||1
8814173|NCT01530464|9867443|FG001|NOT COMPLETED|Washout (24h)||0
8814174|NCT01530464|9867442|FG000|STARTED|Third Intervention (24h)||9
8814175|NCT01530464|9867443|FG001|STARTED|Third Intervention (24h)||8
8814176|NCT01530464|9867442|FG000|COMPLETED|Third Intervention (24h)||9
8814177|NCT01530464|9867443|FG001|COMPLETED|Third Intervention (24h)||8
8814178|NCT01530464|9867442|FG000|NOT COMPLETED|Third Intervention (24h)||0
8814179|NCT01530464|9867443|FG001|NOT COMPLETED|Third Intervention (24h)||0
8814180|NCT01530464|9867442|FG000|STARTED|Washout (24h)||9
8814181|NCT01530464|9867443|FG001|STARTED|Washout (24h)||8
8814182|NCT01530464|9867442|FG000|COMPLETED|Washout (24h)||9
8814183|NCT01530464|9867443|FG001|COMPLETED|Washout (24h)|1 subject withdrew consent and left due to family emergencies|7
8814184|NCT01530464|9867442|FG000|NOT COMPLETED|Washout (24h)||0
8814185|NCT01530464|9867443|FG001|NOT COMPLETED|Washout (24h)||1
8850426|NCT01746420|9905638|FG002|STARTED|Overall Study||20
8814186|NCT01530477|9867457|FG000|STARTED|Overall Study|17 subjects consented to the Skeletal cohort only.|17
8814187|NCT01530477|9867458|FG001|STARTED|Overall Study|12 subjects consented to the Body Composition cohort only.|12
8814188|NCT01530477|9867459|FG002|STARTED|Overall Study|53 subjects consented to both the Skeletal and body Composition cohorts.|53
8814189|NCT01530477|9867457|FG000|COMPLETED|Overall Study|17 subjects completed imaging in the Skeletal cohort only.|17
8814190|NCT01530477|9867458|FG001|COMPLETED|Overall Study|12 subjects completed imaging in the Body Composition cohort only.|12
8814191|NCT01530477|9867459|FG002|COMPLETED|Overall Study|53 subjects completed the imaging in both the Skeletal and Body Composition cohorts.|53
8814192|NCT01530477|9867457|FG000|NOT COMPLETED|Overall Study||0
8814193|NCT01530477|9867458|FG001|NOT COMPLETED|Overall Study||0
8814194|NCT01530477|9867459|FG002|NOT COMPLETED|Overall Study||0
8814195|NCT01531153|9867468|FG000|STARTED|Overall Study||32
8814196|NCT01531153|9867469|FG001|STARTED|Overall Study||31
8814197|NCT01531153|9867470|FG002|STARTED|Overall Study||30
8814198|NCT01531153|9867468|FG000|COMPLETED|Overall Study||22
8814199|NCT01531153|9867469|FG001|COMPLETED|Overall Study||22
8814200|NCT01531153|9867470|FG002|COMPLETED|Overall Study||15
8814201|NCT01531153|9867468|FG000|NOT COMPLETED|Overall Study||10
8814202|NCT01531153|9867469|FG001|NOT COMPLETED|Overall Study||9
8814203|NCT01531153|9867470|FG002|NOT COMPLETED|Overall Study||15
8814204|NCT01531205|9867481|FG000|STARTED|Overall Study||2
8814205|NCT01531205|9867481|FG000|COMPLETED|Overall Study||1
8814206|NCT01531205|9867481|FG000|NOT COMPLETED|Overall Study||1
8814207|NCT01531335|9867489|FG000|STARTED|Overall Study||40
8814208|NCT01531335|9867490|FG001|STARTED|Overall Study||40
8814209|NCT01531335|9867489|FG000|COMPLETED|Overall Study||40
8814210|NCT01531335|9867490|FG001|COMPLETED|Overall Study||40
8814211|NCT01531335|9867489|FG000|NOT COMPLETED|Overall Study||0
8814212|NCT01531335|9867490|FG001|NOT COMPLETED|Overall Study||0
8814213|NCT01531439|9867498|FG000|STARTED|Overall Study||41
8814214|NCT01531439|9867499|FG001|STARTED|Overall Study||43
8814215|NCT01531439|9867498|FG000|COMPLETED|Overall Study||37
8814216|NCT01531439|9867499|FG001|COMPLETED|Overall Study||42
8814217|NCT01531439|9867498|FG000|NOT COMPLETED|Overall Study||4
8814218|NCT01531439|9867499|FG001|NOT COMPLETED|Overall Study||1
8814219|NCT01531673|9867518|FG000|STARTED|Overall Study||33
8814220|NCT01531673|9867519|FG001|STARTED|Overall Study||8
8814221|NCT01531673|9867520|FG002|STARTED|Overall Study||8
8814222|NCT01531673|9867521|FG003|STARTED|Overall Study||18
8814223|NCT01531673|9867522|FG004|STARTED|Overall Study||8
8814224|NCT01531673|9867523|FG005|STARTED|Overall Study||19
8814225|NCT01531673|9867524|FG006|STARTED|Overall Study||17
8814226|NCT01531673|9867525|FG007|STARTED|Overall Study||9
8814227|NCT01531673|9867526|FG008|STARTED|Overall Study||17
8814228|NCT01531673|9867527|FG009|STARTED|Overall Study||19
8814229|NCT01531673|9867528|FG010|STARTED|Overall Study||16
8814230|NCT01531673|9867529|FG011|STARTED|Overall Study||4
8814231|NCT01531673|9867530|FG012|STARTED|Overall Study||14
8814232|NCT01531673|9867518|FG000|COMPLETED|Overall Study||33
8814233|NCT01531673|9867519|FG001|COMPLETED|Overall Study||7
8814234|NCT01531673|9867520|FG002|COMPLETED|Overall Study||8
8814235|NCT01531673|9867521|FG003|COMPLETED|Overall Study||17
8814236|NCT01531673|9867522|FG004|COMPLETED|Overall Study||7
8814237|NCT01531673|9867523|FG005|COMPLETED|Overall Study||18
8814238|NCT01531673|9867524|FG006|COMPLETED|Overall Study||17
8814239|NCT01531673|9867525|FG007|COMPLETED|Overall Study||9
8814240|NCT01531673|9867526|FG008|COMPLETED|Overall Study||17
8814241|NCT01531673|9867527|FG009|COMPLETED|Overall Study||18
8814242|NCT01531673|9867528|FG010|COMPLETED|Overall Study||16
8814243|NCT01531673|9867529|FG011|COMPLETED|Overall Study||4
8814244|NCT01531673|9867530|FG012|COMPLETED|Overall Study||14
8814245|NCT01531673|9867518|FG000|NOT COMPLETED|Overall Study||0
8814246|NCT01531673|9867519|FG001|NOT COMPLETED|Overall Study||1
8814247|NCT01531673|9867520|FG002|NOT COMPLETED|Overall Study||0
8814248|NCT01531673|9867521|FG003|NOT COMPLETED|Overall Study||1
8814249|NCT01531673|9867522|FG004|NOT COMPLETED|Overall Study||1
8814250|NCT01531673|9867523|FG005|NOT COMPLETED|Overall Study||1
8814251|NCT01531673|9867524|FG006|NOT COMPLETED|Overall Study||0
8814252|NCT01531673|9867525|FG007|NOT COMPLETED|Overall Study||0
8814253|NCT01531673|9867526|FG008|NOT COMPLETED|Overall Study||0
8814254|NCT01531673|9867527|FG009|NOT COMPLETED|Overall Study||1
8814255|NCT01531673|9867528|FG010|NOT COMPLETED|Overall Study||0
8814256|NCT01531673|9867529|FG011|NOT COMPLETED|Overall Study||0
8814257|NCT01531673|9867530|FG012|NOT COMPLETED|Overall Study||0
8814258|NCT01531725|9867582|FG000|STARTED|Overall Study|5 patients with protocol violation were excluded.|202
8560326|NCT00756938|9592064|FG002|NOT COMPLETED|Optional Extension||0
8619601|NCT00468728|9658039|FG000|NOT COMPLETED|Enrollment||4
8619602|NCT00468728|9658040|FG001|NOT COMPLETED|Enrollment||7
8619603|NCT00468728|9658039|FG000|STARTED|Treatment||260
8619604|NCT00468728|9658040|FG001|STARTED|Treatment||264
8619605|NCT00468728|9658039|FG000|COMPLETED|Treatment||256
8619606|NCT00468728|9658040|FG001|COMPLETED|Treatment||253
8814259|NCT01531725|9867582|FG000|COMPLETED|Overall Study||197
8814260|NCT01531725|9867582|FG000|NOT COMPLETED|Overall Study||5
8814261|NCT01531738|9867588|FG000|STARTED|Overall Study||11
8814262|NCT01531738|9867589|FG001|STARTED|Overall Study||11
8814263|NCT01531738|9867588|FG000|COMPLETED|Overall Study||11
8814264|NCT01531738|9867589|FG001|COMPLETED|Overall Study||11
8814265|NCT01531738|9867588|FG000|NOT COMPLETED|Overall Study||0
8814266|NCT01531738|9867589|FG001|NOT COMPLETED|Overall Study||0
8814267|NCT01531803|9867597|FG000|STARTED|Overall Study||1
8814268|NCT01531803|9867598|FG001|STARTED|Overall Study||2
8814269|NCT01531803|9867597|FG000|COMPLETED|Overall Study||1
8814270|NCT01531803|9867598|FG001|COMPLETED|Overall Study||2
8814271|NCT01531803|9867597|FG000|NOT COMPLETED|Overall Study||0
8814272|NCT01531803|9867598|FG001|NOT COMPLETED|Overall Study||0
8814273|NCT01531894|9867604|FG000|STARTED|Overall Study||11
8619607|NCT00468728|9658039|FG000|NOT COMPLETED|Treatment||4
8619608|NCT00468728|9658040|FG001|NOT COMPLETED|Treatment||11
8619609|NCT00468728|9658039|FG000|STARTED|Follow-up||256
8619610|NCT00468728|9658040|FG001|STARTED|Follow-up||253
8619611|NCT00468728|9658039|FG000|COMPLETED|Follow-up||222
8814274|NCT01531894|9867604|FG000|COMPLETED|Overall Study||2
8814275|NCT01531894|9867604|FG000|NOT COMPLETED|Overall Study||9
8814276|NCT01531959|9867610|FG000|STARTED|Overall Study||68
8814277|NCT01531959|9867611|FG001|STARTED|Overall Study||68
8814278|NCT01531959|9867610|FG000|COMPLETED|Overall Study||66
8814279|NCT01531959|9867611|FG001|COMPLETED|Overall Study||66
8814280|NCT01531959|9867610|FG000|NOT COMPLETED|Overall Study||2
8814281|NCT01531959|9867611|FG001|NOT COMPLETED|Overall Study||2
8814282|NCT01531998|9867617|FG000|STARTED|Overall Study||11
8814283|NCT01531998|9867617|FG000|COMPLETED|Overall Study||8
8814284|NCT01531998|9867617|FG000|NOT COMPLETED|Overall Study||3
8814285|NCT01532089|9867623|FG000|STARTED|Overall Study||45
8814286|NCT01532089|9867624|FG001|STARTED|Overall Study||43
8814287|NCT01532089|9867623|FG000|COMPLETED|Overall Study||45
8814288|NCT01532089|9867624|FG001|COMPLETED|Overall Study||43
8814289|NCT01532089|9867623|FG000|NOT COMPLETED|Overall Study||0
8814290|NCT01532089|9867624|FG001|NOT COMPLETED|Overall Study||0
8814291|NCT01532128|9867635|FG000|STARTED|Overall Study||8
8814292|NCT01532128|9867636|FG001|STARTED|Overall Study||8
8814293|NCT01532128|9867637|FG002|STARTED|Overall Study||8
8814294|NCT01532128|9867635|FG000|COMPLETED|Overall Study||8
8814295|NCT01532128|9867636|FG001|COMPLETED|Overall Study||8
8814296|NCT01532128|9867637|FG002|COMPLETED|Overall Study||8
8814297|NCT01532128|9867635|FG000|NOT COMPLETED|Overall Study||0
8814298|NCT01532128|9867636|FG001|NOT COMPLETED|Overall Study||0
8814299|NCT01532128|9867637|FG002|NOT COMPLETED|Overall Study||0
8814300|NCT01532141|9867649|FG000|STARTED|Overall Study||9
8814301|NCT01532141|9867650|FG001|STARTED|Overall Study||8
8814302|NCT01532141|9867651|FG002|STARTED|Overall Study||8
8814303|NCT01532141|9867649|FG000|Period 1|Overall Study||9
8814304|NCT01532141|9867650|FG001|Period 1|Overall Study||8
8814305|NCT01532141|9867651|FG002|Period 1|Overall Study||8
8814306|NCT01532141|9867649|FG000|Period 2|Overall Study||8
8814307|NCT01532141|9867650|FG001|Period 2|Overall Study||8
8814308|NCT01532141|9867651|FG002|Period 2|Overall Study||8
8814309|NCT01532141|9867649|FG000|Period 3|Overall Study||8
8814310|NCT01532141|9867650|FG001|Period 3|Overall Study||8
8814311|NCT01532141|9867651|FG002|Period 3|Overall Study||8
8814312|NCT01532141|9867649|FG000|COMPLETED|Overall Study||8
8814313|NCT01532141|9867650|FG001|COMPLETED|Overall Study||8
8814314|NCT01532141|9867651|FG002|COMPLETED|Overall Study||8
8814315|NCT01532141|9867649|FG000|NOT COMPLETED|Overall Study||1
8814316|NCT01532141|9867650|FG001|NOT COMPLETED|Overall Study||0
8814317|NCT01532141|9867651|FG002|NOT COMPLETED|Overall Study||0
8814318|NCT01532349|9867662|FG000|STARTED|Overall Study||17
8814319|NCT01532349|9867663|FG001|STARTED|Overall Study||17
8814320|NCT01532349|9867662|FG000|COMPLETED|Overall Study||15
8619612|NCT00468728|9658040|FG001|COMPLETED|Follow-up||222
8814321|NCT01532349|9867663|FG001|COMPLETED|Overall Study||12
8814322|NCT01532349|9867662|FG000|NOT COMPLETED|Overall Study||2
8619613|NCT00468728|9658039|FG000|NOT COMPLETED|Follow-up||34
8619614|NCT00468728|9658040|FG001|NOT COMPLETED|Follow-up||31
8814323|NCT01532349|9867663|FG001|NOT COMPLETED|Overall Study||5
8814324|NCT01532388|9867671|FG000|STARTED|3-month Follow-up||101
8814325|NCT01532388|9867672|FG001|STARTED|3-month Follow-up||101
8814326|NCT01532388|9867671|FG000|COMPLETED|3-month Follow-up||33
8814327|NCT01532388|9867672|FG001|COMPLETED|3-month Follow-up||33
8814328|NCT01532388|9867671|FG000|NOT COMPLETED|3-month Follow-up||68
8814329|NCT01532388|9867672|FG001|NOT COMPLETED|3-month Follow-up||68
8814330|NCT01532388|9867671|FG000|STARTED|6-month Follow-up|All participants registered in the trial were contacted for follow-ups at 3, 6 and 12 months.|101
8814331|NCT01532388|9867672|FG001|STARTED|6-month Follow-up|All participants registered in the trial were contacted for follow-ups at 3, 6 and 12 months.|101
8814332|NCT01532388|9867671|FG000|COMPLETED|6-month Follow-up||27
8814333|NCT01532388|9867672|FG001|COMPLETED|6-month Follow-up||35
8814334|NCT01532388|9867671|FG000|NOT COMPLETED|6-month Follow-up||74
8814335|NCT01532388|9867672|FG001|NOT COMPLETED|6-month Follow-up||66
8814336|NCT01532388|9867671|FG000|STARTED|12-month Follow-up|All participants registered in the trial were contacted for follow-ups at 3, 6 and 12 months.|101
8814337|NCT01532388|9867672|FG001|STARTED|12-month Follow-up|All participants registered in the trial were contacted for follow-ups at 3, 6 and 12 months.|101
8814338|NCT01532388|9867671|FG000|COMPLETED|12-month Follow-up||32
8814339|NCT01532388|9867672|FG001|COMPLETED|12-month Follow-up||34
8814340|NCT01532388|9867671|FG000|NOT COMPLETED|12-month Follow-up||69
8814341|NCT01532388|9867672|FG001|NOT COMPLETED|12-month Follow-up||67
8814342|NCT01532414|9867681|FG000|STARTED|Overall Study||92
8814343|NCT01532414|9867682|FG001|STARTED|Overall Study|Up-titrated at 6 weeks from a starting dose of 12.5 mg due to morning testosterone <300 ng/dL|21
8814344|NCT01532414|9867683|FG002|STARTED|Overall Study||38
8814345|NCT01532414|9867681|FG000|COMPLETED|Overall Study||85
8814346|NCT01532414|9867682|FG001|COMPLETED|Overall Study||19
8814347|NCT01532414|9867683|FG002|COMPLETED|Overall Study||35
8814348|NCT01532414|9867681|FG000|NOT COMPLETED|Overall Study||7
8814349|NCT01532414|9867682|FG001|NOT COMPLETED|Overall Study||2
8814350|NCT01532414|9867683|FG002|NOT COMPLETED|Overall Study||3
8814351|NCT01532453|9867693|FG000|STARTED|Overall Study||81
8814352|NCT01532453|9867694|FG001|STARTED|Overall Study||160
8814353|NCT01532453|9867693|FG000|COMPLETED|Overall Study||54
8814354|NCT01532453|9867694|FG001|COMPLETED|Overall Study||90
8814355|NCT01532453|9867693|FG000|NOT COMPLETED|Overall Study||27
8814356|NCT01532453|9867694|FG001|NOT COMPLETED|Overall Study||70
8814357|NCT01532570|9867704|FG000|STARTED|Overall Study||11
8814358|NCT01532570|9867705|FG001|STARTED|Overall Study||2
8814359|NCT01532570|9867706|FG002|STARTED|Overall Study||1
8814360|NCT01532570|9867707|FG003|STARTED|Overall Study||4
8814361|NCT01532570|9867704|FG000|COMPLETED|Overall Study||10
8814362|NCT01532570|9867705|FG001|COMPLETED|Overall Study||1
8814363|NCT01532570|9867706|FG002|COMPLETED|Overall Study||1
8814364|NCT01532570|9867707|FG003|COMPLETED|Overall Study||4
8814365|NCT01532570|9867704|FG000|NOT COMPLETED|Overall Study||1
8814366|NCT01532570|9867705|FG001|NOT COMPLETED|Overall Study||1
8814367|NCT01532570|9867706|FG002|NOT COMPLETED|Overall Study||0
8814368|NCT01532570|9867707|FG003|NOT COMPLETED|Overall Study||0
8814369|NCT01532648|9867726|FG000|STARTED|Overall Study||255
8814370|NCT01532648|9867727|FG001|STARTED|Overall Study||255
8814371|NCT01532648|9867726|FG000|Safety Population|Overall Study||255
8814372|NCT01532648|9867727|FG001|Safety Population|Overall Study||255
8814373|NCT01532648|9867726|FG000|Intent-To-Treat Population|Overall Study||230
8814374|NCT01532648|9867727|FG001|Intent-To-Treat Population|Overall Study||228
8814375|NCT01532648|9867726|FG000|COMPLETED|Overall Study||219
8814376|NCT01532648|9867727|FG001|COMPLETED|Overall Study||238
8814377|NCT01532648|9867726|FG000|NOT COMPLETED|Overall Study||36
8814378|NCT01532648|9867727|FG001|NOT COMPLETED|Overall Study||17
8814379|NCT01532687|9867735|FG000|STARTED|Overall Study||29
8814380|NCT01532687|9867736|FG001|STARTED|Overall Study||25
8814381|NCT01532687|9867735|FG000|Crossover to Open-label Pazopanib|Overall Study||0
8814382|NCT01532687|9867736|FG001|Crossover to Open-label Pazopanib|Overall Study||14
8814383|NCT01532687|9867735|FG000|COMPLETED|Overall Study|Participants remain on treatment until time of progression and through the AE assessment period|15
8814384|NCT01532687|9867736|FG001|COMPLETED|Overall Study|Participants remain on treatment until time of progression|23
8814385|NCT01532687|9867735|FG000|NOT COMPLETED|Overall Study||14
8814386|NCT01532687|9867736|FG001|NOT COMPLETED|Overall Study||2
8814387|NCT01532700|9867744|FG000|STARTED|Overall Study||28
8814388|NCT01532700|9867744|FG000|COMPLETED|Overall Study||28
8814389|NCT01532700|9867744|FG000|NOT COMPLETED|Overall Study||0
8814390|NCT01532817|9867748|FG000|STARTED|Overall Study||30
8814391|NCT01532817|9867748|FG000|COMPLETED|Overall Study||30
8814392|NCT01532817|9867748|FG000|NOT COMPLETED|Overall Study||0
8814393|NCT01532830|9867752|FG000|STARTED|Overall Study||30
8814394|NCT01532830|9867752|FG000|COMPLETED|Overall Study||26
8814395|NCT01532830|9867752|FG000|NOT COMPLETED|Overall Study||4
8814396|NCT01532869|9867758|FG000|STARTED|Blinded-Treatment Period (Up to Week 24)||44
8814397|NCT01532869|9867759|FG001|STARTED|Blinded-Treatment Period (Up to Week 24)||43
8814398|NCT01532869|9867758|FG000|COMPLETED|Blinded-Treatment Period (Up to Week 24)|Number of participants who completed the first 24 weeks of full 48 weeks blinded-treatment period.|36
8814399|NCT01532869|9867759|FG001|COMPLETED|Blinded-Treatment Period (Up to Week 24)|Number of participants who completed the first 24 weeks of full 48 weeks blinded-treatment period.|35
8814400|NCT01532869|9867758|FG000|NOT COMPLETED|Blinded-Treatment Period (Up to Week 24)||8
8814401|NCT01532869|9867759|FG001|NOT COMPLETED|Blinded-Treatment Period (Up to Week 24)||8
8814402|NCT01532869|9867758|FG000|STARTED|Blinded-Treatment Period (Up to Week 48)||44
8814403|NCT01532869|9867759|FG001|STARTED|Blinded-Treatment Period (Up to Week 48)||43
8814404|NCT01532869|9867758|FG000|COMPLETED|Blinded-Treatment Period (Up to Week 48)|Number of participants who completed 48 weeks of blinded-treatment period.|33
8814405|NCT01532869|9867759|FG001|COMPLETED|Blinded-Treatment Period (Up to Week 48)|Number of participants who completed 48 weeks of blinded-treatment period.|30
8814406|NCT01532869|9867758|FG000|NOT COMPLETED|Blinded-Treatment Period (Up to Week 48)||11
8814407|NCT01532869|9867759|FG001|NOT COMPLETED|Blinded-Treatment Period (Up to Week 48)||13
8814408|NCT01532869|9867758|FG000|STARTED|Open-label Period (Week 48 to Week 96)|Two participants did not start the open label extension period.|31
8814409|NCT01532869|9867759|FG001|STARTED|Open-label Period (Week 48 to Week 96)||30
8814410|NCT01532869|9867758|FG000|COMPLETED|Open-label Period (Week 48 to Week 96)|Number of participants who completed study to Week 96.|24
8814411|NCT01532869|9867759|FG001|COMPLETED|Open-label Period (Week 48 to Week 96)|Number of participants who completed study to Week 96.|27
8814412|NCT01532869|9867758|FG000|NOT COMPLETED|Open-label Period (Week 48 to Week 96)||7
8814413|NCT01532869|9867759|FG001|NOT COMPLETED|Open-label Period (Week 48 to Week 96)||3
8814414|NCT01532908|9867772|FG000|STARTED|Overall Study||9
8814415|NCT01532908|9867773|FG001|STARTED|Overall Study||2
8814416|NCT01532908|9867772|FG000|Infused|Overall Study||9
8814417|NCT01532908|9867773|FG001|Infused|Overall Study||2
8814418|NCT01532908|9867772|FG000|Transplanted|Overall Study||8
8814419|NCT01532908|9867773|FG001|Transplanted|Overall Study||2
8814420|NCT01532908|9867772|FG000|COMPLETED|Overall Study||8
8814421|NCT01532908|9867773|FG001|COMPLETED|Overall Study||2
8814422|NCT01532908|9867772|FG000|NOT COMPLETED|Overall Study||1
8814423|NCT01532908|9867773|FG001|NOT COMPLETED|Overall Study||0
8814424|NCT01532921|9867779|FG000|STARTED|Overall Study||85
8814425|NCT01532921|9867779|FG000|Implantation Procedure|Overall Study||76
8814426|NCT01532921|9867779|FG000|Discharge|Overall Study||75
8814427|NCT01532921|9867779|FG000|6 Months Follow Up|Overall Study||68
8814428|NCT01532921|9867779|FG000|COMPLETED|Overall Study||69
8814429|NCT01532921|9867779|FG000|NOT COMPLETED|Overall Study||16
8814430|NCT01532934|9867789|FG000|STARTED|Overall Study||53
8814431|NCT01532934|9867790|FG001|STARTED|Overall Study||52
8814432|NCT01532934|9867789|FG000|COMPLETED|Overall Study||39
8814433|NCT01532934|9867790|FG001|COMPLETED|Overall Study||39
8814434|NCT01532934|9867789|FG000|NOT COMPLETED|Overall Study||14
8814435|NCT01532934|9867790|FG001|NOT COMPLETED|Overall Study||13
8814436|NCT01532973|9867807|FG000|STARTED|Part 1||6
8814437|NCT01532973|9867808|FG001|STARTED|Part 1||6
8814438|NCT01532973|9867809|FG002|STARTED|Part 1||6
8814439|NCT01532973|9867810|FG003|STARTED|Part 1|Planned panel not performed. No participants were enrolled.|0
8814440|NCT01532973|9867811|FG004|STARTED|Part 1||0
8814441|NCT01532973|9867812|FG005|STARTED|Part 1||0
8814442|NCT01532973|9867813|FG006|STARTED|Part 1||0
8814443|NCT01532973|9867814|FG007|STARTED|Part 1||0
8814444|NCT01532973|9867815|FG008|STARTED|Part 1||0
8814445|NCT01532973|9867816|FG009|STARTED|Part 1||0
8814446|NCT01532973|9867807|FG000|COMPLETED|Part 1||6
8814447|NCT01532973|9867808|FG001|COMPLETED|Part 1||6
8814448|NCT01532973|9867809|FG002|COMPLETED|Part 1||6
8814449|NCT01532973|9867810|FG003|COMPLETED|Part 1||0
8814450|NCT01532973|9867811|FG004|COMPLETED|Part 1||0
8814451|NCT01532973|9867812|FG005|COMPLETED|Part 1||0
8814452|NCT01532973|9867813|FG006|COMPLETED|Part 1||0
8814453|NCT01532973|9867814|FG007|COMPLETED|Part 1||0
8814454|NCT01532973|9867815|FG008|COMPLETED|Part 1||0
8814455|NCT01532973|9867816|FG009|COMPLETED|Part 1||0
8814456|NCT01532973|9867807|FG000|NOT COMPLETED|Part 1||0
8814457|NCT01532973|9867808|FG001|NOT COMPLETED|Part 1||0
8814458|NCT01532973|9867809|FG002|NOT COMPLETED|Part 1||0
8814459|NCT01532973|9867810|FG003|NOT COMPLETED|Part 1||0
8814460|NCT01532973|9867811|FG004|NOT COMPLETED|Part 1||0
8814461|NCT01532973|9867812|FG005|NOT COMPLETED|Part 1||0
8814462|NCT01532973|9867813|FG006|NOT COMPLETED|Part 1||0
8814463|NCT01532973|9867814|FG007|NOT COMPLETED|Part 1||0
8814464|NCT01532973|9867815|FG008|NOT COMPLETED|Part 1||0
8814465|NCT01532973|9867816|FG009|NOT COMPLETED|Part 1||0
8814466|NCT01532973|9867807|FG000|STARTED|Part 2||0
8814467|NCT01532973|9867808|FG001|STARTED|Part 2||0
8814468|NCT01532973|9867809|FG002|STARTED|Part 2||0
8814469|NCT01532973|9867810|FG003|STARTED|Part 2||0
8814470|NCT01532973|9867811|FG004|STARTED|Part 2||6
8814471|NCT01532973|9867812|FG005|STARTED|Part 2||6
8814472|NCT01532973|9867813|FG006|STARTED|Part 2||6
8814473|NCT01532973|9867814|FG007|STARTED|Part 2|Planned panel not performed. No participants were enrolled.|0
8814474|NCT01532973|9867815|FG008|STARTED|Part 2||0
8814475|NCT01532973|9867816|FG009|STARTED|Part 2||0
8814476|NCT01532973|9867807|FG000|COMPLETED|Part 2||0
8814477|NCT01532973|9867808|FG001|COMPLETED|Part 2||0
8814478|NCT01532973|9867809|FG002|COMPLETED|Part 2||0
8814479|NCT01532973|9867810|FG003|COMPLETED|Part 2||0
8814480|NCT01532973|9867811|FG004|COMPLETED|Part 2||6
8560327|NCT00756938|9592065|FG003|NOT COMPLETED|Optional Extension||37
8560328|NCT00746590|9592083|FG000|STARTED|Overall Study||1
8560329|NCT00746590|9592083|FG000|COMPLETED|Overall Study||0
8560330|NCT00746590|9592083|FG000|NOT COMPLETED|Overall Study||1
8560331|NCT00730132|9592087|FG000|STARTED|Overall Study||712
8560332|NCT00730132|9592087|FG000|COMPLETED|Overall Study||557
8560333|NCT00730132|9592087|FG000|NOT COMPLETED|Overall Study||155
8560334|NCT00728416|9592096|FG000|STARTED|Overall Study||168
8560335|NCT00728416|9592097|FG001|STARTED|Overall Study||165
8560336|NCT00728416|9592096|FG000|COMPLETED|Overall Study||166
8560337|NCT00728416|9592097|FG001|COMPLETED|Overall Study||163
8560338|NCT00728416|9592096|FG000|NOT COMPLETED|Overall Study||2
8560339|NCT00728416|9592097|FG001|NOT COMPLETED|Overall Study||2
8560340|NCT00724477|9592103|FG000|STARTED|Overall Study|This safety population (SAF)analysed consisted of all patients who took at least one tablet of INEGY|1663
8560341|NCT00724477|9592103|FG000|COMPLETED|Overall Study||1663
8560342|NCT00724477|9592103|FG000|NOT COMPLETED|Overall Study||0
8560343|NCT00723736|9592107|FG000|STARTED|Overall Study||100
8560344|NCT00723736|9592107|FG000|COMPLETED|Overall Study|Subject's caregiver did not wish to continue, reasons unrelated.|99
8560345|NCT00723736|9592107|FG000|NOT COMPLETED|Overall Study||1
8619615|NCT00468819|9658051|FG000|STARTED|Overall Study|Enrolled participants|48
8619616|NCT00468819|9658052|FG001|STARTED|Overall Study|Enrolled participants|44
8560346|NCT00705081|9592113|FG000|STARTED|Overall Study||255
8560347|NCT00705081|9592114|FG001|STARTED|Overall Study||198
8560348|NCT00705081|9592113|FG000|COMPLETED|Overall Study||255
8560349|NCT00705081|9592114|FG001|COMPLETED|Overall Study||198
8560350|NCT00705081|9592113|FG000|NOT COMPLETED|Overall Study||0
8560351|NCT00705081|9592114|FG001|NOT COMPLETED|Overall Study||0
8560352|NCT00704769|9592120|FG000|STARTED|Overall Study||591
8560353|NCT00704769|9592120|FG000|COMPLETED|Overall Study||591
8560354|NCT00704769|9592120|FG000|NOT COMPLETED|Overall Study||0
8560355|NCT00704535|9592124|FG000|STARTED|Overall Study||4105
8560356|NCT00704535|9592124|FG000|COMPLETED|Overall Study||3959
8560357|NCT00704535|9592124|FG000|NOT COMPLETED|Overall Study||146
8560358|NCT00694369|9592133|FG000|STARTED|Overall Study||46
8560359|NCT00694369|9592134|FG001|STARTED|Overall Study||191
8560360|NCT00694369|9592135|FG002|STARTED|Overall Study||97
8560361|NCT00694369|9592136|FG003|STARTED|Overall Study||192
8560362|NCT00694369|9592137|FG004|STARTED|Overall Study||62
8560363|NCT00694369|9592133|FG000|COMPLETED|Overall Study||45
8560364|NCT00694369|9592134|FG001|COMPLETED|Overall Study||188
8560365|NCT00694369|9592135|FG002|COMPLETED|Overall Study||95
8560366|NCT00694369|9592136|FG003|COMPLETED|Overall Study||189
8560367|NCT00694369|9592137|FG004|COMPLETED|Overall Study||56
8560368|NCT00694369|9592133|FG000|NOT COMPLETED|Overall Study||1
8560369|NCT00694369|9592134|FG001|NOT COMPLETED|Overall Study||3
8560370|NCT00694369|9592135|FG002|NOT COMPLETED|Overall Study||2
8560371|NCT00694369|9592136|FG003|NOT COMPLETED|Overall Study||3
8560372|NCT00694369|9592137|FG004|NOT COMPLETED|Overall Study||6
8560373|NCT00671528|9592152|FG000|STARTED|Overall Study||1
8560374|NCT00671528|9592153|FG001|STARTED|Overall Study||1
8560375|NCT00671528|9592154|FG002|STARTED|Overall Study||1
8560376|NCT00671528|9592152|FG000|COMPLETED|Overall Study||1
8560377|NCT00671528|9592153|FG001|COMPLETED|Overall Study||1
8560378|NCT00671528|9592154|FG002|COMPLETED|Overall Study||1
8560379|NCT00671528|9592152|FG000|NOT COMPLETED|Overall Study||0
8560380|NCT00671528|9592153|FG001|NOT COMPLETED|Overall Study||0
8560381|NCT00671528|9592154|FG002|NOT COMPLETED|Overall Study||0
8560382|NCT00667823|9592162|FG000|STARTED|Overall Study||550
8560383|NCT00667823|9592162|FG000|COMPLETED|Overall Study||334
8560384|NCT00667823|9592162|FG000|NOT COMPLETED|Overall Study||216
8560385|NCT00652327|9592168|FG000|STARTED|Overall Study|Participants who recieved randomized treatment assignment to ezetimibe and ongoing statin|42
8560386|NCT00652327|9592169|FG001|STARTED|Overall Study|Participants who recieved randomized treatment assignment to double the dose of ongoing statin|41
8560387|NCT00652327|9592168|FG000|COMPLETED|Overall Study||42
8560388|NCT00652327|9592169|FG001|COMPLETED|Overall Study||36
8560389|NCT00652327|9592168|FG000|NOT COMPLETED|Overall Study||0
8560390|NCT00652327|9592169|FG001|NOT COMPLETED|Overall Study||5
8560391|NCT00604500|9592175|FG000|STARTED|Overall Study||272
8560392|NCT00604500|9592175|FG000|COMPLETED|Overall Study|There were 233 participants who took at least 90% of the labeled actuations (Completer Population).|261
8560393|NCT00604500|9592175|FG000|NOT COMPLETED|Overall Study||11
8560394|NCT00568178|9592181|FG000|STARTED|Double Blind Base Study||122
8560395|NCT00568178|9592182|FG001|STARTED|Double Blind Base Study||124
8560396|NCT00568178|9592183|FG002|STARTED|Double Blind Base Study||30
8560397|NCT00568178|9592184|FG003|STARTED|Double Blind Base Study||30
8560398|NCT00568178|9592185|FG004|STARTED|Double Blind Base Study||0
8560399|NCT00568178|9592186|FG005|STARTED|Double Blind Base Study||0
8560400|NCT00568178|9592181|FG000|COMPLETED|Double Blind Base Study||116
8619617|NCT00468819|9658053|FG002|STARTED|Overall Study|Enrolled participants|48
8560401|NCT00568178|9592182|FG001|COMPLETED|Double Blind Base Study||118
8560402|NCT00568178|9592183|FG002|COMPLETED|Double Blind Base Study||29
8560403|NCT00568178|9592184|FG003|COMPLETED|Double Blind Base Study||25
8560404|NCT00568178|9592185|FG004|COMPLETED|Double Blind Base Study||0
8560405|NCT00568178|9592186|FG005|COMPLETED|Double Blind Base Study||0
8560406|NCT00568178|9592181|FG000|NOT COMPLETED|Double Blind Base Study||6
8560407|NCT00568178|9592182|FG001|NOT COMPLETED|Double Blind Base Study||6
8560408|NCT00568178|9592183|FG002|NOT COMPLETED|Double Blind Base Study||1
8560409|NCT00568178|9592184|FG003|NOT COMPLETED|Double Blind Base Study||5
8560410|NCT00568178|9592185|FG004|NOT COMPLETED|Double Blind Base Study||0
8560411|NCT00568178|9592186|FG005|NOT COMPLETED|Double Blind Base Study||0
8560412|NCT00568178|9592181|FG000|STARTED|Open Label Extension||0
8560413|NCT00568178|9592182|FG001|STARTED|Open Label Extension||0
8560414|NCT00568178|9592183|FG002|STARTED|Open Label Extension||0
8560415|NCT00568178|9592184|FG003|STARTED|Open Label Extension||0
8560416|NCT00568178|9592185|FG004|STARTED|Open Label Extension||134
8560417|NCT00568178|9592186|FG005|STARTED|Open Label Extension||134
8560418|NCT00568178|9592181|FG000|COMPLETED|Open Label Extension||0
8560419|NCT00568178|9592182|FG001|COMPLETED|Open Label Extension||0
8560420|NCT00568178|9592183|FG002|COMPLETED|Open Label Extension||0
8560421|NCT00568178|9592184|FG003|COMPLETED|Open Label Extension||0
8560422|NCT00568178|9592185|FG004|COMPLETED|Open Label Extension||55
8560423|NCT00568178|9592186|FG005|COMPLETED|Open Label Extension||54
8560424|NCT00568178|9592181|FG000|NOT COMPLETED|Open Label Extension||0
8560425|NCT00568178|9592182|FG001|NOT COMPLETED|Open Label Extension||0
8560426|NCT00568178|9592183|FG002|NOT COMPLETED|Open Label Extension||0
8560427|NCT00568178|9592184|FG003|NOT COMPLETED|Open Label Extension||0
8560428|NCT00568178|9592185|FG004|NOT COMPLETED|Open Label Extension||79
8560429|NCT00568178|9592186|FG005|NOT COMPLETED|Open Label Extension||80
8560430|NCT00545844|9592200|FG000|STARTED|Overall Study||313
8560431|NCT00545844|9592200|FG000|COMPLETED|Overall Study||301
8560432|NCT00545844|9592200|FG000|NOT COMPLETED|Overall Study||12
8560433|NCT00511433|9592208|FG000|STARTED|Overall Study||32
8560434|NCT00511433|9592209|FG001|STARTED|Overall Study||16
8560435|NCT00511433|9592208|FG000|COMPLETED|Overall Study||26
8619618|NCT00468819|9658051|FG000|Treatment Received/ Safety Follow-up|Overall Study|FAS (Full Analysis Set)|46
8619619|NCT00468819|9658052|FG001|Treatment Received/ Safety Follow-up|Overall Study|FAS|44
8619620|NCT00468819|9658053|FG002|Treatment Received/ Safety Follow-up|Overall Study|FAS|48
8619621|NCT00468819|9658051|FG000|COMPLETED|Overall Study||42
8619622|NCT00468819|9658052|FG001|COMPLETED|Overall Study||44
8619623|NCT00468819|9658053|FG002|COMPLETED|Overall Study||46
8619624|NCT00468819|9658051|FG000|NOT COMPLETED|Overall Study||6
8619625|NCT00468819|9658052|FG001|NOT COMPLETED|Overall Study||0
8560436|NCT00511433|9592209|FG001|COMPLETED|Overall Study||15
8560437|NCT00511433|9592208|FG000|NOT COMPLETED|Overall Study||6
8560438|NCT00511433|9592209|FG001|NOT COMPLETED|Overall Study||1
8560439|NCT00511355|9592219|FG000|STARTED|Overall Study||60
8560440|NCT00511355|9592220|FG001|STARTED|Overall Study||61
8560441|NCT00511355|9592219|FG000|COMPLETED|Overall Study||53
8560442|NCT00511355|9592220|FG001|COMPLETED|Overall Study||52
8560443|NCT00511355|9592219|FG000|NOT COMPLETED|Overall Study||7
8560444|NCT00511355|9592220|FG001|NOT COMPLETED|Overall Study||9
8560445|NCT00511342|9592230|FG000|STARTED|Overall Study||56
8560446|NCT00511342|9592231|FG001|STARTED|Overall Study||54
8560447|NCT00511342|9592230|FG000|COMPLETED|Overall Study||43
8560448|NCT00511342|9592231|FG001|COMPLETED|Overall Study||32
8560449|NCT00511342|9592230|FG000|NOT COMPLETED|Overall Study||13
8560450|NCT00511342|9592231|FG001|NOT COMPLETED|Overall Study||22
8619626|NCT00468819|9658053|FG002|NOT COMPLETED|Overall Study||2
8619627|NCT00468845|9658066|FG000|STARTED|Overall Study||162
8560451|NCT00511199|9592239|FG000|STARTED|Overall Study||1591
8560452|NCT00511199|9592240|FG001|STARTED|Overall Study||535
8560453|NCT00511199|9592239|FG000|COMPLETED|Overall Study||1142
8560454|NCT00511199|9592240|FG001|COMPLETED|Overall Study||410
8560455|NCT00511199|9592239|FG000|NOT COMPLETED|Overall Study||449
8560456|NCT00511199|9592240|FG001|NOT COMPLETED|Overall Study||125
8560457|NCT00491504|9592252|FG000|STARTED|Overall Study|All subjects who received MFNS only on Day 1|77
8560458|NCT00491504|9592253|FG001|STARTED|Overall Study|All subjects who received placebo only on Day 1|78
8569068|NCT00095147|9601272|FG000|COMPLETED|Double-blind Period 2 (Days 198-365)||139
8814481|NCT01532973|9867812|FG005|COMPLETED|Part 2||6
8814482|NCT01532973|9867813|FG006|COMPLETED|Part 2||6
8814483|NCT01532973|9867814|FG007|COMPLETED|Part 2||0
8814484|NCT01532973|9867815|FG008|COMPLETED|Part 2||0
8814485|NCT01532973|9867816|FG009|COMPLETED|Part 2||0
8814486|NCT01532973|9867807|FG000|NOT COMPLETED|Part 2||0
8814487|NCT01532973|9867808|FG001|NOT COMPLETED|Part 2||0
8619628|NCT00468845|9658067|FG001|STARTED|Overall Study||170
8619629|NCT00468845|9658068|FG002|STARTED|Overall Study||169
8619630|NCT00468845|9658066|FG000|Received Treatment|Overall Study||161
8560459|NCT00491504|9592254|FG002|STARTED|Overall Study|All subjects who received MFNS on Day 1 through Day 7|78
8560460|NCT00491504|9592255|FG003|STARTED|Overall Study|All subjects who received placebo on Day 1 through Day 7|77
8560461|NCT00491504|9592252|FG000|COMPLETED|Overall Study||77
8560462|NCT00491504|9592253|FG001|COMPLETED|Overall Study||77
8560463|NCT00491504|9592254|FG002|COMPLETED|Overall Study||74
8560464|NCT00491504|9592255|FG003|COMPLETED|Overall Study||73
8560465|NCT00491504|9592252|FG000|NOT COMPLETED|Overall Study||0
8560466|NCT00491504|9592253|FG001|NOT COMPLETED|Overall Study||1
8560467|NCT00491504|9592254|FG002|NOT COMPLETED|Overall Study||4
8560468|NCT00491504|9592255|FG003|NOT COMPLETED|Overall Study||4
8560469|NCT00468312|9592265|FG000|STARTED|Overall Study||220
8560470|NCT00468312|9592266|FG001|STARTED|Overall Study||209
8814488|NCT01532973|9867809|FG002|NOT COMPLETED|Part 2||0
8814489|NCT01532973|9867810|FG003|NOT COMPLETED|Part 2||0
8814490|NCT01532973|9867811|FG004|NOT COMPLETED|Part 2||0
8814491|NCT01532973|9867812|FG005|NOT COMPLETED|Part 2||0
8814492|NCT01532973|9867813|FG006|NOT COMPLETED|Part 2||0
8814493|NCT01532973|9867814|FG007|NOT COMPLETED|Part 2||0
8814494|NCT01532973|9867815|FG008|NOT COMPLETED|Part 2||0
8560471|NCT00468312|9592265|FG000|COMPLETED|Overall Study||216
8560472|NCT00468312|9592266|FG001|COMPLETED|Overall Study||204
8619631|NCT00468845|9658067|FG001|Received Treatment|Overall Study||166
8814495|NCT01532973|9867816|FG009|NOT COMPLETED|Part 2||0
8560473|NCT00468312|9592265|FG000|NOT COMPLETED|Overall Study||4
8560474|NCT00468312|9592266|FG001|NOT COMPLETED|Overall Study||5
8560475|NCT00453063|9592274|FG000|STARTED|Overall Study||211
8560476|NCT00453063|9592275|FG001|STARTED|Overall Study||215
8560477|NCT00453063|9592274|FG000|COMPLETED|Overall Study||208
8560478|NCT00453063|9592275|FG001|COMPLETED|Overall Study||212
8560479|NCT00453063|9592274|FG000|NOT COMPLETED|Overall Study||3
8814496|NCT01532973|9867807|FG000|STARTED|Part 3||0
8619632|NCT00468845|9658068|FG002|Received Treatment|Overall Study||167
8619633|NCT00468845|9658066|FG000|COMPLETED|Overall Study||141
8619634|NCT00468845|9658067|FG001|COMPLETED|Overall Study||136
8619635|NCT00468845|9658068|FG002|COMPLETED|Overall Study||139
8619636|NCT00468845|9658066|FG000|NOT COMPLETED|Overall Study||21
8619637|NCT00468845|9658067|FG001|NOT COMPLETED|Overall Study||34
8619638|NCT00468845|9658068|FG002|NOT COMPLETED|Overall Study||30
8619639|NCT00468858|9658079|FG000|STARTED|Overall Study||211
8619640|NCT00468858|9658080|FG001|STARTED|Overall Study||212
8619641|NCT00468858|9658081|FG002|STARTED|Overall Study||213
8619642|NCT00468858|9658079|FG000|COMPLETED|Overall Study||202
8619643|NCT00468858|9658080|FG001|COMPLETED|Overall Study||202
8560480|NCT00453063|9592275|FG001|NOT COMPLETED|Overall Study||3
8560481|NCT00447603|9592281|FG000|STARTED|Screening||40
8560482|NCT00447603|9592282|FG001|STARTED|Screening||0
8560483|NCT00447603|9592283|FG002|STARTED|Screening||0
8560484|NCT00447603|9592281|FG000|COMPLETED|Screening||19
8560485|NCT00447603|9592282|FG001|COMPLETED|Screening||0
8560486|NCT00447603|9592283|FG002|COMPLETED|Screening||0
8560487|NCT00447603|9592281|FG000|NOT COMPLETED|Screening||21
8560488|NCT00447603|9592282|FG001|NOT COMPLETED|Screening||0
8560489|NCT00447603|9592283|FG002|NOT COMPLETED|Screening||0
8560490|NCT00447603|9592281|FG000|STARTED|Filter Period||0
8560491|NCT00447603|9592282|FG001|STARTED|Filter Period|The study was discontinued early; no participant entered treatment period|4
8560492|NCT00447603|9592283|FG002|STARTED|Filter Period|The study was discontinued early; no participant entered treatment period|15
8560493|NCT00447603|9592281|FG000|COMPLETED|Filter Period||0
8560494|NCT00447603|9592282|FG001|COMPLETED|Filter Period||0
8560495|NCT00447603|9592283|FG002|COMPLETED|Filter Period||0
8560496|NCT00447603|9592281|FG000|NOT COMPLETED|Filter Period||0
8560497|NCT00447603|9592282|FG001|NOT COMPLETED|Filter Period||4
8560498|NCT00447603|9592283|FG002|NOT COMPLETED|Filter Period||15
8560499|NCT00442351|9592293|FG000|STARTED|Overall Study|Due to poor enrollment and a high screening failure rate, this study was terminated early.|17
8560500|NCT00442351|9592294|FG001|STARTED|Overall Study||9
8560501|NCT00442351|9592293|FG000|COMPLETED|Overall Study||10
8560502|NCT00442351|9592294|FG001|COMPLETED|Overall Study||3
8560503|NCT00442351|9592293|FG000|NOT COMPLETED|Overall Study||7
8560504|NCT00442351|9592294|FG001|NOT COMPLETED|Overall Study||6
8560505|NCT00423488|9592302|FG000|STARTED|Overall Study||42
8560506|NCT00423488|9592303|FG001|STARTED|Overall Study||51
8560507|NCT00423488|9592302|FG000|COMPLETED|Overall Study||37
8560508|NCT00423488|9592303|FG001|COMPLETED|Overall Study||50
8560509|NCT00423488|9592302|FG000|NOT COMPLETED|Overall Study||5
8560510|NCT00423488|9592303|FG001|NOT COMPLETED|Overall Study||1
8560511|NCT00413972|9592313|FG000|STARTED|Overall Study|1 of the 98 randomized subjects was not treated and was excluded from the ITT data set.|98
8560512|NCT00413972|9592314|FG001|STARTED|Overall Study|1 of the 98 randomized subjects was not treated and was excluded from the ITT data set.|98
8560513|NCT00413972|9592315|FG002|STARTED|Overall Study||98
8619644|NCT00468858|9658081|FG002|COMPLETED|Overall Study||199
8814497|NCT01532973|9867808|FG001|STARTED|Part 3||0
8814498|NCT01532973|9867809|FG002|STARTED|Part 3||0
8814499|NCT01532973|9867810|FG003|STARTED|Part 3||0
8560514|NCT00413972|9592316|FG003|STARTED|Overall Study|1 of the 98 randomized subjects was not treated and was excluded from the ITT data set.|98
8560515|NCT00413972|9592313|FG000|COMPLETED|Overall Study||91
8560516|NCT00413972|9592314|FG001|COMPLETED|Overall Study||90
8560517|NCT00413972|9592315|FG002|COMPLETED|Overall Study||88
8560518|NCT00413972|9592316|FG003|COMPLETED|Overall Study||95
8560519|NCT00413972|9592313|FG000|NOT COMPLETED|Overall Study||7
8560520|NCT00413972|9592314|FG001|NOT COMPLETED|Overall Study||8
8560521|NCT00413972|9592315|FG002|NOT COMPLETED|Overall Study||10
8560522|NCT00413972|9592316|FG003|NOT COMPLETED|Overall Study||3
8560523|NCT00413062|9592328|FG000|STARTED|Overall Study||1666
8560524|NCT00413062|9592329|FG001|STARTED|Overall Study||554
8560525|NCT00413062|9592328|FG000|COMPLETED|Overall Study||988
8560526|NCT00413062|9592329|FG001|COMPLETED|Overall Study||344
8560527|NCT00413062|9592328|FG000|NOT COMPLETED|Overall Study||678
8560528|NCT00413062|9592329|FG001|NOT COMPLETED|Overall Study||210
8560529|NCT00391170|9592339|FG000|STARTED|Overall Study||27
8560530|NCT00391170|9592340|FG001|STARTED|Overall Study||27
8560531|NCT00391170|9592339|FG000|COMPLETED|Overall Study||21
8560532|NCT00391170|9592340|FG001|COMPLETED|Overall Study||23
8560533|NCT00391170|9592339|FG000|NOT COMPLETED|Overall Study||6
8560534|NCT00391170|9592340|FG001|NOT COMPLETED|Overall Study||4
8560535|NCT00359138|9592349|FG000|STARTED|Overall Study||12
8560536|NCT00359138|9592350|FG001|STARTED|Overall Study||12
8560537|NCT00359138|9592351|FG002|STARTED|Overall Study||12
8560538|NCT00359138|9592349|FG000|COMPLETED|Overall Study||12
8560539|NCT00359138|9592350|FG001|COMPLETED|Overall Study||12
8560540|NCT00359138|9592351|FG002|COMPLETED|Overall Study||12
8560541|NCT00359138|9592349|FG000|NOT COMPLETED|Overall Study||0
8560542|NCT00359138|9592350|FG001|NOT COMPLETED|Overall Study||0
8560543|NCT00359138|9592351|FG002|NOT COMPLETED|Overall Study||0
8560544|NCT00350701|9592362|FG000|STARTED|Overall Study||17
8560545|NCT00350701|9592363|FG001|STARTED|Overall Study||17
8619645|NCT00468858|9658079|FG000|NOT COMPLETED|Overall Study||9
8619646|NCT00468858|9658080|FG001|NOT COMPLETED|Overall Study||10
8814500|NCT01532973|9867811|FG004|STARTED|Part 3||0
8814501|NCT01532973|9867812|FG005|STARTED|Part 3||0
8814502|NCT01532973|9867813|FG006|STARTED|Part 3||0
8814503|NCT01532973|9867814|FG007|STARTED|Part 3||0
8814504|NCT01532973|9867815|FG008|STARTED|Part 3||6
8814505|NCT01532973|9867816|FG009|STARTED|Part 3||6
8814506|NCT01532973|9867807|FG000|COMPLETED|Part 3||0
8814507|NCT01532973|9867808|FG001|COMPLETED|Part 3||0
8814508|NCT01532973|9867809|FG002|COMPLETED|Part 3||0
8814509|NCT01532973|9867810|FG003|COMPLETED|Part 3||0
8619647|NCT00468858|9658081|FG002|NOT COMPLETED|Overall Study||14
8814510|NCT01532973|9867811|FG004|COMPLETED|Part 3||0
8814511|NCT01532973|9867812|FG005|COMPLETED|Part 3||0
8814512|NCT01532973|9867813|FG006|COMPLETED|Part 3||0
8814513|NCT01532973|9867814|FG007|COMPLETED|Part 3||0
8814514|NCT01532973|9867815|FG008|COMPLETED|Part 3||6
8619648|NCT00468910|9658145|FG000|STARTED|Overall Study||40
8619649|NCT00468910|9658146|FG001|STARTED|Overall Study||39
8619650|NCT00468910|9658145|FG000|Randomization|Overall Study||40
8619651|NCT00468910|9658146|FG001|Randomization|Overall Study||39
8619652|NCT00468910|9658145|FG000|Treatment|Overall Study||36
8619653|NCT00468910|9658146|FG001|Treatment|Overall Study||36
8619654|NCT00468910|9658145|FG000|Post-Treatment Biopsy|Overall Study||36
8619655|NCT00468910|9658146|FG001|Post-Treatment Biopsy|Overall Study||36
9065773|NCT04143373|10126248|FG000|STARTED|Overall Study||20
9065774|NCT04143373|10126249|FG001|STARTED|Overall Study||20
9065775|NCT04143373|10126248|FG000|COMPLETED|Overall Study||20
9065776|NCT04143373|10126249|FG001|COMPLETED|Overall Study||20
9065777|NCT04143373|10126248|FG000|NOT COMPLETED|Overall Study||0
8560546|NCT00350701|9592364|FG002|STARTED|Overall Study||15
8560547|NCT00350701|9592362|FG000|COMPLETED|Overall Study||17
8560548|NCT00350701|9592363|FG001|COMPLETED|Overall Study||17
8560549|NCT00350701|9592364|FG002|COMPLETED|Overall Study||15
8560550|NCT00350701|9592362|FG000|NOT COMPLETED|Overall Study||0
8560551|NCT00350701|9592363|FG001|NOT COMPLETED|Overall Study||0
8560552|NCT00350701|9592364|FG002|NOT COMPLETED|Overall Study||0
8560553|NCT00319449|9592374|FG000|STARTED|Overall Study||10
8560554|NCT00319449|9592375|FG001|STARTED|Overall Study||12
8560555|NCT00319449|9592374|FG000|COMPLETED|Overall Study||8
8560556|NCT00319449|9592375|FG001|COMPLETED|Overall Study||12
8560557|NCT00319449|9592374|FG000|NOT COMPLETED|Overall Study||2
8560558|NCT00319449|9592375|FG001|NOT COMPLETED|Overall Study||0
8560559|NCT00305344|9592381|FG000|STARTED|Overall Study||23
8560560|NCT00305344|9592381|FG000|COMPLETED|Overall Study||23
8560561|NCT00305344|9592381|FG000|NOT COMPLETED|Overall Study||0
8560562|NCT00289887|9592387|FG000|STARTED|Overall Study||127
8560563|NCT00289887|9592388|FG001|STARTED|Overall Study||134
8560564|NCT00289887|9592387|FG000|COMPLETED|Overall Study||105
8560565|NCT00289887|9592388|FG001|COMPLETED|Overall Study||105
8560566|NCT00289887|9592387|FG000|NOT COMPLETED|Overall Study||22
8560567|NCT00289887|9592388|FG001|NOT COMPLETED|Overall Study||29
8560568|NCT00281320|9592396|FG000|STARTED|Overall Study||61
8560569|NCT00281320|9592397|FG001|STARTED|Overall Study||61
8560570|NCT00281320|9592396|FG000|COMPLETED|Overall Study||36
8560571|NCT00281320|9592397|FG001|COMPLETED|Overall Study||40
8560572|NCT00281320|9592396|FG000|NOT COMPLETED|Overall Study||25
8560573|NCT00281320|9592397|FG001|NOT COMPLETED|Overall Study||21
8560574|NCT00276016|9592415|FG000|STARTED|Intervention 1||7
8560575|NCT00276016|9592416|FG001|STARTED|Intervention 1||7
8560576|NCT00276016|9592417|FG002|STARTED|Intervention 1||7
8560577|NCT00276016|9592418|FG003|STARTED|Intervention 1||6
8560578|NCT00276016|9592419|FG004|STARTED|Intervention 1||6
8560579|NCT00276016|9592420|FG005|STARTED|Intervention 1||6
8560580|NCT00276016|9592415|FG000|COMPLETED|Intervention 1||7
8560581|NCT00276016|9592416|FG001|COMPLETED|Intervention 1||6
8560582|NCT00276016|9592417|FG002|COMPLETED|Intervention 1||7
8560583|NCT00276016|9592418|FG003|COMPLETED|Intervention 1||6
8560584|NCT00276016|9592419|FG004|COMPLETED|Intervention 1||6
8560585|NCT00276016|9592420|FG005|COMPLETED|Intervention 1||6
8560586|NCT00276016|9592415|FG000|NOT COMPLETED|Intervention 1||0
8560587|NCT00276016|9592416|FG001|NOT COMPLETED|Intervention 1||1
8560588|NCT00276016|9592417|FG002|NOT COMPLETED|Intervention 1||0
8560589|NCT00276016|9592418|FG003|NOT COMPLETED|Intervention 1||0
8560590|NCT00276016|9592419|FG004|NOT COMPLETED|Intervention 1||0
8560591|NCT00276016|9592420|FG005|NOT COMPLETED|Intervention 1||0
8560592|NCT00276016|9592415|FG000|STARTED|Wash Out 1||7
8560593|NCT00276016|9592416|FG001|STARTED|Wash Out 1||6
8560594|NCT00276016|9592417|FG002|STARTED|Wash Out 1||7
8560595|NCT00276016|9592418|FG003|STARTED|Wash Out 1||6
8560596|NCT00276016|9592419|FG004|STARTED|Wash Out 1||6
8560597|NCT00276016|9592420|FG005|STARTED|Wash Out 1||6
8560598|NCT00276016|9592415|FG000|COMPLETED|Wash Out 1||7
8560599|NCT00276016|9592416|FG001|COMPLETED|Wash Out 1||6
8560600|NCT00276016|9592417|FG002|COMPLETED|Wash Out 1||7
8560601|NCT00276016|9592418|FG003|COMPLETED|Wash Out 1||6
8560602|NCT00276016|9592419|FG004|COMPLETED|Wash Out 1||6
8560603|NCT00276016|9592420|FG005|COMPLETED|Wash Out 1||6
8560604|NCT00276016|9592415|FG000|NOT COMPLETED|Wash Out 1||0
8560605|NCT00276016|9592416|FG001|NOT COMPLETED|Wash Out 1||0
8560606|NCT00276016|9592417|FG002|NOT COMPLETED|Wash Out 1||0
8560607|NCT00276016|9592418|FG003|NOT COMPLETED|Wash Out 1||0
8560608|NCT00276016|9592419|FG004|NOT COMPLETED|Wash Out 1||0
8560609|NCT00276016|9592420|FG005|NOT COMPLETED|Wash Out 1||0
8560610|NCT00276016|9592415|FG000|STARTED|Intervention 2||7
8560611|NCT00276016|9592416|FG001|STARTED|Intervention 2||6
8560612|NCT00276016|9592417|FG002|STARTED|Intervention 2||7
8560613|NCT00276016|9592418|FG003|STARTED|Intervention 2||6
8560614|NCT00276016|9592419|FG004|STARTED|Intervention 2||6
8560615|NCT00276016|9592420|FG005|STARTED|Intervention 2||6
8560616|NCT00276016|9592415|FG000|COMPLETED|Intervention 2||7
8560617|NCT00276016|9592416|FG001|COMPLETED|Intervention 2||6
8560618|NCT00276016|9592417|FG002|COMPLETED|Intervention 2||7
8560619|NCT00276016|9592418|FG003|COMPLETED|Intervention 2||6
8560620|NCT00276016|9592419|FG004|COMPLETED|Intervention 2||6
8560621|NCT00276016|9592420|FG005|COMPLETED|Intervention 2||6
8560622|NCT00276016|9592415|FG000|NOT COMPLETED|Intervention 2||0
8560623|NCT00276016|9592416|FG001|NOT COMPLETED|Intervention 2||0
8560624|NCT00276016|9592417|FG002|NOT COMPLETED|Intervention 2||0
8560625|NCT00276016|9592418|FG003|NOT COMPLETED|Intervention 2||0
8560626|NCT00276016|9592419|FG004|NOT COMPLETED|Intervention 2||0
8560627|NCT00276016|9592420|FG005|NOT COMPLETED|Intervention 2||0
8560628|NCT00276016|9592415|FG000|STARTED|Wash Out 2||7
8560629|NCT00276016|9592416|FG001|STARTED|Wash Out 2||6
8560630|NCT00276016|9592417|FG002|STARTED|Wash Out 2||7
8560631|NCT00276016|9592418|FG003|STARTED|Wash Out 2||6
8560632|NCT00276016|9592419|FG004|STARTED|Wash Out 2||6
8560633|NCT00276016|9592420|FG005|STARTED|Wash Out 2||6
8560634|NCT00276016|9592415|FG000|COMPLETED|Wash Out 2||7
8560635|NCT00276016|9592416|FG001|COMPLETED|Wash Out 2||6
8814515|NCT01532973|9867816|FG009|COMPLETED|Part 3||6
8814516|NCT01532973|9867807|FG000|NOT COMPLETED|Part 3||0
8814517|NCT01532973|9867808|FG001|NOT COMPLETED|Part 3||0
8619656|NCT00468910|9658145|FG000|Follow-up|Overall Study||36
8619657|NCT00468910|9658146|FG001|Follow-up|Overall Study||36
8619658|NCT00468910|9658145|FG000|COMPLETED|Overall Study||36
8619659|NCT00468910|9658146|FG001|COMPLETED|Overall Study||36
8619660|NCT00468910|9658145|FG000|NOT COMPLETED|Overall Study||4
8619661|NCT00468910|9658146|FG001|NOT COMPLETED|Overall Study||3
8619662|NCT00469014|9658157|FG000|STARTED|Initial Phase Randomization||5
8619663|NCT00469014|9658158|FG001|STARTED|Initial Phase Randomization||4
8619664|NCT00469014|9658159|FG002|STARTED|Initial Phase Randomization||5
8619665|NCT00469014|9658160|FG003|STARTED|Initial Phase Randomization||6
8619666|NCT00469014|9658157|FG000|COMPLETED|Initial Phase Randomization||4
8619667|NCT00469014|9658158|FG001|COMPLETED|Initial Phase Randomization||3
8619668|NCT00469014|9658159|FG002|COMPLETED|Initial Phase Randomization||4
8619669|NCT00469014|9658160|FG003|COMPLETED|Initial Phase Randomization||5
8619670|NCT00469014|9658157|FG000|NOT COMPLETED|Initial Phase Randomization||1
8619671|NCT00469014|9658158|FG001|NOT COMPLETED|Initial Phase Randomization||1
8619672|NCT00469014|9658159|FG002|NOT COMPLETED|Initial Phase Randomization||1
8619673|NCT00469014|9658160|FG003|NOT COMPLETED|Initial Phase Randomization||1
8619674|NCT00469014|9658157|FG000|STARTED|Adaptive Randomization||13
8619675|NCT00469014|9658158|FG001|STARTED|Adaptive Randomization||3
8619676|NCT00469014|9658159|FG002|STARTED|Adaptive Randomization||24
8619677|NCT00469014|9658160|FG003|STARTED|Adaptive Randomization||11
8619678|NCT00469014|9658157|FG000|COMPLETED|Adaptive Randomization||12
8619679|NCT00469014|9658158|FG001|COMPLETED|Adaptive Randomization||2
8619680|NCT00469014|9658159|FG002|COMPLETED|Adaptive Randomization||23
8619681|NCT00469014|9658160|FG003|COMPLETED|Adaptive Randomization||10
8619682|NCT00469014|9658157|FG000|NOT COMPLETED|Adaptive Randomization||1
8619683|NCT00469014|9658158|FG001|NOT COMPLETED|Adaptive Randomization||1
8619684|NCT00469014|9658159|FG002|NOT COMPLETED|Adaptive Randomization||1
8619685|NCT00469014|9658160|FG003|NOT COMPLETED|Adaptive Randomization||1
8619686|NCT00469079|9658173|FG000|STARTED|Overall Study||27
8619687|NCT00469079|9658174|FG001|STARTED|Overall Study||52
8619688|NCT00469079|9658175|FG002|STARTED|Overall Study||51
8619689|NCT00469079|9658173|FG000|COMPLETED|Overall Study||18
8619690|NCT00469079|9658174|FG001|COMPLETED|Overall Study||30
8619691|NCT00469079|9658175|FG002|COMPLETED|Overall Study||32
8619692|NCT00469079|9658173|FG000|NOT COMPLETED|Overall Study||9
8619693|NCT00469079|9658174|FG001|NOT COMPLETED|Overall Study||22
8619694|NCT00469079|9658175|FG002|NOT COMPLETED|Overall Study||19
8619695|NCT00469092|9658191|FG000|STARTED|Overall Study||239
8619696|NCT00469092|9658192|FG001|STARTED|Overall Study||241
8619697|NCT00469092|9658191|FG000|Exposed to Study Drug|Overall Study||231
8619698|NCT00469092|9658192|FG001|Exposed to Study Drug|Overall Study||238
8619699|NCT00469092|9658191|FG000|COMPLETED|Overall Study||213
8619700|NCT00469092|9658192|FG001|COMPLETED|Overall Study||220
8619701|NCT00469092|9658191|FG000|NOT COMPLETED|Overall Study||26
8619702|NCT00469092|9658192|FG001|NOT COMPLETED|Overall Study||21
8814518|NCT01532973|9867809|FG002|NOT COMPLETED|Part 3||0
8814519|NCT01532973|9867810|FG003|NOT COMPLETED|Part 3||0
8619703|NCT00469144|9658200|FG000|STARTED|Overall Study|Eight assigned to Fixed Dose without randomization.|114
8619704|NCT00469144|9658201|FG001|STARTED|Overall Study||111
8619705|NCT00469144|9658200|FG000|COMPLETED|Overall Study||108
8619706|NCT00469144|9658201|FG001|COMPLETED|Overall Study||105
8619707|NCT00469144|9658200|FG000|NOT COMPLETED|Overall Study||6
8619708|NCT00469144|9658201|FG001|NOT COMPLETED|Overall Study||6
8619709|NCT00469209|9658214|FG000|STARTED|Overall Study||20
8814520|NCT01532973|9867811|FG004|NOT COMPLETED|Part 3||0
8814521|NCT01532973|9867812|FG005|NOT COMPLETED|Part 3||0
8814522|NCT01532973|9867813|FG006|NOT COMPLETED|Part 3||0
8814523|NCT01532973|9867814|FG007|NOT COMPLETED|Part 3||0
8814524|NCT01532973|9867815|FG008|NOT COMPLETED|Part 3||0
8814525|NCT01532973|9867816|FG009|NOT COMPLETED|Part 3||0
8814526|NCT01532986|9867842|FG000|STARTED|Overall Study||166
8814527|NCT01532986|9867843|FG001|STARTED|Overall Study||162
8814528|NCT01532986|9867842|FG000|COMPLETED|Overall Study||143
8814529|NCT01532986|9867843|FG001|COMPLETED|Overall Study||138
8814530|NCT01532986|9867842|FG000|NOT COMPLETED|Overall Study||23
8814531|NCT01532986|9867843|FG001|NOT COMPLETED|Overall Study||24
8814532|NCT01532999|9867852|FG000|STARTED|Overall Study||96
8814533|NCT01532999|9867853|FG001|STARTED|Overall Study||95
8814534|NCT01532999|9867852|FG000|COMPLETED|Overall Study||65
8814535|NCT01532999|9867853|FG001|COMPLETED|Overall Study||77
8814536|NCT01532999|9867852|FG000|NOT COMPLETED|Overall Study||31
8814537|NCT01532999|9867853|FG001|NOT COMPLETED|Overall Study||18
8814538|NCT01533038|9867861|FG000|STARTED|Overall Study||45
8814539|NCT01533038|9867862|FG001|STARTED|Overall Study||35
8814540|NCT01533038|9867861|FG000|COMPLETED|Overall Study||45
8814541|NCT01533038|9867862|FG001|COMPLETED|Overall Study||34
8814542|NCT01533038|9867861|FG000|NOT COMPLETED|Overall Study||0
8814543|NCT01533038|9867862|FG001|NOT COMPLETED|Overall Study||1
8814544|NCT01533077|9867872|FG000|STARTED|Overall Study||5
8814545|NCT01533077|9867873|FG001|STARTED|Overall Study||5
8814546|NCT01533077|9867874|FG002|STARTED|Overall Study||4
8814547|NCT01533077|9867875|FG003|STARTED|Overall Study||4
8814548|NCT01533077|9867872|FG000|BIA 9-1067 50 mg|Overall Study||5
8814549|NCT01533077|9867873|FG001|BIA 9-1067 50 mg|Overall Study||5
8814550|NCT01533077|9867874|FG002|BIA 9-1067 50 mg|Overall Study||4
8814551|NCT01533077|9867875|FG003|BIA 9-1067 50 mg|Overall Study||4
8814552|NCT01533077|9867872|FG000|Sinemet® 100/25|Overall Study||4
8814553|NCT01533077|9867873|FG001|Sinemet® 100/25|Overall Study||5
8814554|NCT01533077|9867874|FG002|Sinemet® 100/25|Overall Study||4
8814555|NCT01533077|9867875|FG003|Sinemet® 100/25|Overall Study||4
8814556|NCT01533077|9867872|FG000|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
8814557|NCT01533077|9867873|FG001|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
8560636|NCT00276016|9592417|FG002|COMPLETED|Wash Out 2||7
8560637|NCT00276016|9592418|FG003|COMPLETED|Wash Out 2||6
8560638|NCT00276016|9592419|FG004|COMPLETED|Wash Out 2||6
8560639|NCT00276016|9592420|FG005|COMPLETED|Wash Out 2||6
8560640|NCT00276016|9592415|FG000|NOT COMPLETED|Wash Out 2||0
8560641|NCT00276016|9592416|FG001|NOT COMPLETED|Wash Out 2||0
8560642|NCT00276016|9592417|FG002|NOT COMPLETED|Wash Out 2||0
8560643|NCT00276016|9592418|FG003|NOT COMPLETED|Wash Out 2||0
8560644|NCT00276016|9592419|FG004|NOT COMPLETED|Wash Out 2||0
8560645|NCT00276016|9592420|FG005|NOT COMPLETED|Wash Out 2||0
8560646|NCT00276016|9592415|FG000|STARTED|Intervention 3||7
8560647|NCT00276016|9592416|FG001|STARTED|Intervention 3||6
8560648|NCT00276016|9592417|FG002|STARTED|Intervention 3||7
8560649|NCT00276016|9592418|FG003|STARTED|Intervention 3||6
8560650|NCT00276016|9592419|FG004|STARTED|Intervention 3||6
8560651|NCT00276016|9592420|FG005|STARTED|Intervention 3||6
8560652|NCT00276016|9592415|FG000|COMPLETED|Intervention 3||7
8560653|NCT00276016|9592416|FG001|COMPLETED|Intervention 3||6
8560654|NCT00276016|9592417|FG002|COMPLETED|Intervention 3||7
8560655|NCT00276016|9592418|FG003|COMPLETED|Intervention 3||6
8560656|NCT00276016|9592419|FG004|COMPLETED|Intervention 3||6
8560657|NCT00276016|9592420|FG005|COMPLETED|Intervention 3||6
8560658|NCT00276016|9592415|FG000|NOT COMPLETED|Intervention 3||0
8560659|NCT00276016|9592416|FG001|NOT COMPLETED|Intervention 3||0
8560660|NCT00276016|9592417|FG002|NOT COMPLETED|Intervention 3||0
8560661|NCT00276016|9592418|FG003|NOT COMPLETED|Intervention 3||0
8560662|NCT00276016|9592419|FG004|NOT COMPLETED|Intervention 3||0
8560663|NCT00276016|9592420|FG005|NOT COMPLETED|Intervention 3||0
8560664|NCT00265343|9592431|FG000|STARTED|Overall Study||134
8560665|NCT00265343|9592432|FG001|STARTED|Overall Study||172
8560666|NCT00265343|9592431|FG000|COMPLETED|Overall Study||113
8560667|NCT00265343|9592432|FG001|COMPLETED|Overall Study||153
8560668|NCT00265343|9592431|FG000|NOT COMPLETED|Overall Study||21
8560669|NCT00265343|9592432|FG001|NOT COMPLETED|Overall Study||19
8560670|NCT00264147|9592443|FG000|STARTED|Treatment I Period||161
8560671|NCT00264147|9592444|FG001|STARTED|Treatment I Period||154
8560672|NCT00264147|9592445|FG002|STARTED|Treatment I Period||151
8560673|NCT00264147|9592446|FG003|STARTED|Treatment I Period||140
8560674|NCT00264147|9592447|FG004|STARTED|Treatment I Period||155
8560675|NCT00264147|9592448|FG005|STARTED|Treatment I Period||0
8560676|NCT00264147|9592443|FG000|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|63
8560677|NCT00264147|9592444|FG001|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|71
8560678|NCT00264147|9592445|FG002|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|74
8560679|NCT00264147|9592446|FG003|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|68
8560680|NCT00264147|9592447|FG004|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|99
8560681|NCT00264147|9592448|FG005|COMPLETED|Treatment I Period||0
8560682|NCT00264147|9592443|FG000|NOT COMPLETED|Treatment I Period||98
8560683|NCT00264147|9592444|FG001|NOT COMPLETED|Treatment I Period||83
8560684|NCT00264147|9592445|FG002|NOT COMPLETED|Treatment I Period||77
8560685|NCT00264147|9592446|FG003|NOT COMPLETED|Treatment I Period||72
8560686|NCT00264147|9592447|FG004|NOT COMPLETED|Treatment I Period||56
8560687|NCT00264147|9592448|FG005|NOT COMPLETED|Treatment I Period||0
8560688|NCT00264147|9592443|FG000|STARTED|Treatment II Period||0
8560689|NCT00264147|9592444|FG001|STARTED|Treatment II Period||0
8560690|NCT00264147|9592445|FG002|STARTED|Treatment II Period||0
8560691|NCT00264147|9592446|FG003|STARTED|Treatment II Period||0
8560692|NCT00264147|9592447|FG004|STARTED|Treatment II Period|Etoricoxib 10 mg (38), 30 mg (28), 60 mg (33), 90 mg (45) and placebo (36) reassigned to 90 mg (180)|180
8560693|NCT00264147|9592448|FG005|STARTED|Treatment II Period|Etoricoxib 10 mg (34), 30 mg (37), 60 mg (29), and placebo (49) reassigned to diclofenac (149)|149
8560694|NCT00264147|9592443|FG000|COMPLETED|Treatment II Period||0
8560695|NCT00264147|9592444|FG001|COMPLETED|Treatment II Period||0
8560696|NCT00264147|9592445|FG002|COMPLETED|Treatment II Period||0
8560697|NCT00264147|9592446|FG003|COMPLETED|Treatment II Period||0
8619710|NCT00469209|9658215|FG001|STARTED|Overall Study||20
8619711|NCT00469209|9658216|FG002|STARTED|Overall Study||20
8619712|NCT00469209|9658214|FG000|COMPLETED|Overall Study||19
8619713|NCT00469209|9658215|FG001|COMPLETED|Overall Study||20
8619714|NCT00469209|9658216|FG002|COMPLETED|Overall Study||19
8619715|NCT00469209|9658214|FG000|NOT COMPLETED|Overall Study||1
8619716|NCT00469209|9658215|FG001|NOT COMPLETED|Overall Study||0
8619717|NCT00469209|9658216|FG002|NOT COMPLETED|Overall Study||1
8619718|NCT00469274|9658226|FG000|STARTED|Overall Study||44
8619719|NCT00469274|9658227|FG001|STARTED|Overall Study||42
8619720|NCT00469274|9658226|FG000|COMPLETED|Overall Study||44
8619721|NCT00469274|9658227|FG001|COMPLETED|Overall Study||42
8619722|NCT00469274|9658226|FG000|NOT COMPLETED|Overall Study||0
8619723|NCT00469274|9658227|FG001|NOT COMPLETED|Overall Study||0
8619724|NCT00469391|9658235|FG000|STARTED|Overall Study||27
8619725|NCT00469391|9658236|FG001|STARTED|Overall Study||29
8619726|NCT00469391|9658235|FG000|Discontinued Prior to Procedure|Overall Study||2
8619727|NCT00469391|9658236|FG001|Discontinued Prior to Procedure|Overall Study||3
8619728|NCT00469391|9658235|FG000|Unsuccessful Implant Procedure|Overall Study||4
8619729|NCT00469391|9658236|FG001|Unsuccessful Implant Procedure|Overall Study||0
8619730|NCT00469391|9658235|FG000|Adverse Event|Overall Study||8
8619731|NCT00469391|9658236|FG001|Adverse Event|Overall Study||0
8619732|NCT00469391|9658235|FG000|Lost to Follow up|Overall Study||0
8619733|NCT00469391|9658236|FG001|Lost to Follow up|Overall Study||1
8619734|NCT00469391|9658235|FG000|Patient Preference|Overall Study||0
8619735|NCT00469391|9658236|FG001|Patient Preference|Overall Study||1
8619736|NCT00469391|9658235|FG000|COMPLETED|Overall Study||13
8619737|NCT00469391|9658236|FG001|COMPLETED|Overall Study||24
8619738|NCT00469391|9658235|FG000|NOT COMPLETED|Overall Study||14
8619739|NCT00469391|9658236|FG001|NOT COMPLETED|Overall Study||5
8619740|NCT00469456|9658244|FG000|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug|129
8619741|NCT00469456|9658245|FG001|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug.|135
8619742|NCT00469456|9658244|FG000|COMPLETED|Overall Study||120
8619743|NCT00469456|9658245|FG001|COMPLETED|Overall Study||131
8619744|NCT00469456|9658244|FG000|NOT COMPLETED|Overall Study||9
8619745|NCT00469456|9658245|FG001|NOT COMPLETED|Overall Study||4
8619746|NCT00469508|9658253|FG000|STARTED|Overall Study||34
8619747|NCT00469508|9658254|FG001|STARTED|Overall Study||37
8619748|NCT00469508|9658253|FG000|COMPLETED|Overall Study||14
8619749|NCT00469508|9658254|FG001|COMPLETED|Overall Study||13
8619750|NCT00469508|9658253|FG000|NOT COMPLETED|Overall Study||20
8814558|NCT01533077|9867874|FG002|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
8814559|NCT01533077|9867875|FG003|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
8814560|NCT01533077|9867872|FG000|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||5
8814561|NCT01533077|9867873|FG001|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||5
8814562|NCT01533077|9867874|FG002|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||4
8814563|NCT01533077|9867875|FG003|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||4
8619751|NCT00469508|9658254|FG001|NOT COMPLETED|Overall Study||24
8560698|NCT00264147|9592447|FG004|COMPLETED|Treatment II Period||147
8560699|NCT00264147|9592448|FG005|COMPLETED|Treatment II Period||116
8560700|NCT00264147|9592443|FG000|NOT COMPLETED|Treatment II Period||0
8560701|NCT00264147|9592444|FG001|NOT COMPLETED|Treatment II Period||0
8560702|NCT00264147|9592445|FG002|NOT COMPLETED|Treatment II Period||0
8560703|NCT00264147|9592446|FG003|NOT COMPLETED|Treatment II Period||0
8560704|NCT00264147|9592447|FG004|NOT COMPLETED|Treatment II Period||33
8560705|NCT00264147|9592448|FG005|NOT COMPLETED|Treatment II Period||33
8560706|NCT00202878|9592464|FG000|STARTED|Overall Study||9067
8560707|NCT00202878|9592465|FG001|STARTED|Overall Study||9077
8560708|NCT00202878|9592464|FG000|COMPLETED|Overall Study||6868
8560709|NCT00202878|9592465|FG001|COMPLETED|Overall Study||6860
8560710|NCT00202878|9592464|FG000|NOT COMPLETED|Overall Study||2199
8560711|NCT00202878|9592465|FG001|NOT COMPLETED|Overall Study||2217
8560712|NCT00174265|9592473|FG000|STARTED|Overall Study|85 participants received randomized treatment assignment and at least one dose of study medication.|86
8560713|NCT00174265|9592474|FG001|STARTED|Overall Study||110
8560714|NCT00174265|9592473|FG000|COMPLETED|Overall Study||57
8560715|NCT00174265|9592474|FG001|COMPLETED|Overall Study||89
8560716|NCT00174265|9592473|FG000|NOT COMPLETED|Overall Study||29
8560717|NCT00174265|9592474|FG001|NOT COMPLETED|Overall Study||21
8560718|NCT00159783|9592483|FG000|STARTED|Overall Study||32
8560719|NCT00159783|9592484|FG001|STARTED|Overall Study||79
8560720|NCT00159783|9592485|FG002|STARTED|Overall Study||107
8560721|NCT00159783|9592483|FG000|COMPLETED|Overall Study||13
8560722|NCT00159783|9592484|FG001|COMPLETED|Overall Study||52
8560723|NCT00159783|9592485|FG002|COMPLETED|Overall Study||68
8560724|NCT00159783|9592483|FG000|NOT COMPLETED|Overall Study||19
8560725|NCT00159783|9592484|FG001|NOT COMPLETED|Overall Study||27
8560726|NCT00159783|9592485|FG002|NOT COMPLETED|Overall Study||39
8560727|NCT00114101|9592496|FG000|STARTED|Overall Study||231
8560728|NCT00114101|9592497|FG001|STARTED|Overall Study||229
8560729|NCT00114101|9592496|FG000|COMPLETED|Overall Study||231
8560730|NCT00114101|9592497|FG001|COMPLETED|Overall Study||229
8560731|NCT00114101|9592496|FG000|NOT COMPLETED|Overall Study||0
8560732|NCT00114101|9592497|FG001|NOT COMPLETED|Overall Study||0
8560733|NCT00092677|9592507|FG000|STARTED|Overall Study||944
8560734|NCT00092677|9592508|FG001|STARTED|Overall Study||929
8560735|NCT00092677|9592507|FG000|COMPLETED|Overall Study|EZ/Simva: 694 (on drug), 140 (after drug discon), 105 (at death)|939
8560736|NCT00092677|9592508|FG001|COMPLETED|Overall Study|Placebo: 698 (on drug), 120 (after drug discon), 100 (at death)|918
8560737|NCT00092677|9592507|FG000|NOT COMPLETED|Overall Study||5
8560738|NCT00092677|9592508|FG001|NOT COMPLETED|Overall Study||11
8560739|NCT00090259|9592516|FG000|STARTED|Overall Study||1913
8560740|NCT00090259|9592517|FG001|STARTED|Overall Study||1921
8560741|NCT00090259|9592516|FG000|COMPLETED|Overall Study|Completed follow-up: 963 on drug, 223 off drug, & 665 at death (death was considered an endpoint)|1851
8560742|NCT00090259|9592517|FG001|COMPLETED|Overall Study|Completed follow-up: 1005 on drug, 233 off drug,& 635 at death (death was considered an endpoint)|1873
8560743|NCT00090259|9592516|FG000|NOT COMPLETED|Overall Study||62
8560744|NCT00090259|9592517|FG001|NOT COMPLETED|Overall Study||48
8560745|NCT00003298|9592523|FG000|STARTED|Step 1 (Neoadjuvant Therapy)||39
8560746|NCT00003298|9592523|FG000|Eligible and Treated|Step 1 (Neoadjuvant Therapy)||38
8560747|NCT00003298|9592523|FG000|Complete 3 Cycles of Neoadjuvant Therapy|Step 1 (Neoadjuvant Therapy)||35
8560748|NCT00003298|9592523|FG000|COMPLETED|Step 1 (Neoadjuvant Therapy)||35
8560749|NCT00003298|9592523|FG000|NOT COMPLETED|Step 1 (Neoadjuvant Therapy)||4
8560750|NCT00003298|9592523|FG000|STARTED|Surgery||35
8560751|NCT00003298|9592523|FG000|COMPLETED|Surgery|1 patient did not complete neoadjuvant therapy but went to surgery anyway, not included here.|28
8560752|NCT00003298|9592523|FG000|NOT COMPLETED|Surgery||7
8560753|NCT00003298|9592523|FG000|STARTED|Re-register to Step 2 After Surgery||28
8560754|NCT00003298|9592523|FG000|COMPLETED|Re-register to Step 2 After Surgery||10
8560755|NCT00003298|9592523|FG000|NOT COMPLETED|Re-register to Step 2 After Surgery||18
8560756|NCT00003298|9592523|FG000|STARTED|Step 2 (Adjuvant Therapy)||10
8560757|NCT00003298|9592523|FG000|Eligible and Treated on Step 2|Step 2 (Adjuvant Therapy)||7
8560758|NCT00003298|9592523|FG000|COMPLETED|Step 2 (Adjuvant Therapy)||4
8560759|NCT00003298|9592523|FG000|NOT COMPLETED|Step 2 (Adjuvant Therapy)||6
8560760|NCT00003377|9592533|FG000|STARTED|Period I||3
8560761|NCT00003377|9592534|FG001|STARTED|Period I||3
8560762|NCT00003377|9592535|FG002|STARTED|Period I||3
8560763|NCT00003377|9592536|FG003|STARTED|Period I||3
8560764|NCT00003377|9592537|FG004|STARTED|Period I||0
8560765|NCT00003377|9592533|FG000|COMPLETED|Period I||3
8560766|NCT00003377|9592534|FG001|COMPLETED|Period I||3
8560767|NCT00003377|9592535|FG002|COMPLETED|Period I||2
8560768|NCT00003377|9592536|FG003|COMPLETED|Period I||2
8560769|NCT00003377|9592537|FG004|COMPLETED|Period I||0
8560770|NCT00003377|9592533|FG000|NOT COMPLETED|Period I||0
8560771|NCT00003377|9592534|FG001|NOT COMPLETED|Period I||0
8560772|NCT00003377|9592535|FG002|NOT COMPLETED|Period I||1
8560773|NCT00003377|9592536|FG003|NOT COMPLETED|Period I||1
8560774|NCT00003377|9592537|FG004|NOT COMPLETED|Period I||0
8560775|NCT00003377|9592533|FG000|STARTED|Period II|Patients participated at this dose level only in Period I.|0
8560776|NCT00003377|9592534|FG001|STARTED|Period II|Patients participated at this dose level only in Period I.|0
8560777|NCT00003377|9592535|FG002|STARTED|Period II|Patients participated at this dose level only in Period I.|0
8560778|NCT00003377|9592536|FG003|STARTED|Period II|Patients participated at this dose level only in Period I.|0
8560779|NCT00003377|9592537|FG004|STARTED|Period II|All pts enrolled on Per II received cisplatin 40 mg/m2 & paclitaxel 40 mg/m2 concurrent w/ radiation|17
8560780|NCT00003377|9592533|FG000|COMPLETED|Period II||0
8560781|NCT00003377|9592534|FG001|COMPLETED|Period II||0
8619752|NCT00469833|9658260|FG000|STARTED|Overall Study|17 subjects met inclusion criteria and consented for the study|17
8619753|NCT00469833|9658260|FG000|COMPLETED|Overall Study||15
8560782|NCT00003377|9592535|FG002|COMPLETED|Period II||0
8560783|NCT00003377|9592536|FG003|COMPLETED|Period II||0
8560784|NCT00003377|9592537|FG004|COMPLETED|Period II||16
8560785|NCT00003377|9592533|FG000|NOT COMPLETED|Period II||0
8560786|NCT00003377|9592534|FG001|NOT COMPLETED|Period II||0
8619754|NCT00469833|9658260|FG000|NOT COMPLETED|Overall Study||2
8619755|NCT00469859|9658272|FG000|STARTED|Overall Study||6
8619756|NCT00469859|9658273|FG001|STARTED|Overall Study||8
8619757|NCT00469859|9658272|FG000|COMPLETED|Overall Study||6
8619758|NCT00469859|9658273|FG001|COMPLETED|Overall Study||6
8619759|NCT00469859|9658272|FG000|NOT COMPLETED|Overall Study||0
8560787|NCT00003377|9592535|FG002|NOT COMPLETED|Period II||0
8560788|NCT00003377|9592536|FG003|NOT COMPLETED|Period II||0
8560789|NCT00003377|9592537|FG004|NOT COMPLETED|Period II||1
8560790|NCT00003389|9592552|FG000|STARTED|Overall Study||428
8560791|NCT00003389|9592553|FG001|STARTED|Overall Study||426
8560792|NCT00003389|9592552|FG000|Treated Pts w/ Toxicity Data Available|Overall Study||414
8560793|NCT00003389|9592553|FG001|Treated Pts w/ Toxicity Data Available|Overall Study||422
8560794|NCT00003389|9592552|FG000|Eligible Patients|Overall Study||395
8560795|NCT00003389|9592553|FG001|Eligible Patients|Overall Study||399
8560796|NCT00003389|9592552|FG000|COMPLETED|Overall Study||330
8560797|NCT00003389|9592553|FG001|COMPLETED|Overall Study||366
8560798|NCT00003389|9592552|FG000|NOT COMPLETED|Overall Study||98
8560799|NCT00003389|9592553|FG001|NOT COMPLETED|Overall Study||60
8560800|NCT00003404|9592559|FG000|STARTED|Overall Study||46
8560801|NCT00003404|9592559|FG000|COMPLETED|Overall Study||46
8560802|NCT00003404|9592559|FG000|NOT COMPLETED|Overall Study||0
8560803|NCT00003453|9592564|FG000|STARTED|Overall Study||6
8560804|NCT00003453|9592564|FG000|COMPLETED|Overall Study|One patient was not evaluable|5
8560805|NCT00003453|9592564|FG000|NOT COMPLETED|Overall Study||1
8560806|NCT00003456|9592568|FG000|STARTED|Overall Study||40
8560807|NCT00003456|9592568|FG000|COMPLETED|Overall Study||32
8560808|NCT00003456|9592568|FG000|NOT COMPLETED|Overall Study||8
8560809|NCT00003457|9592572|FG000|STARTED|Overall Study||40
8560810|NCT00003457|9592572|FG000|COMPLETED|Overall Study||31
8560811|NCT00003457|9592572|FG000|NOT COMPLETED|Overall Study||9
8560812|NCT00003459|9592576|FG000|STARTED|Overall Study||40
8560813|NCT00003459|9592576|FG000|COMPLETED|Overall Study|Nine patients were not evaluable.|31
8619760|NCT00469859|9658273|FG001|NOT COMPLETED|Overall Study||2
8560814|NCT00003459|9592576|FG000|NOT COMPLETED|Overall Study||9
8560815|NCT00003460|9592580|FG000|STARTED|Overall Study||13
8560816|NCT00003460|9592580|FG000|COMPLETED|Overall Study|One patient was not evaluable.|12
8560817|NCT00003460|9592580|FG000|NOT COMPLETED|Overall Study||1
8560818|NCT00003468|9592584|FG000|STARTED|Overall Study||11
8560819|NCT00003468|9592584|FG000|COMPLETED|Overall Study|Two patients were not evaluable.|9
8560820|NCT00003468|9592584|FG000|NOT COMPLETED|Overall Study||2
8560821|NCT00003469|9592588|FG000|STARTED|Overall Study||4
8560822|NCT00003469|9592588|FG000|COMPLETED|Overall Study||4
8560823|NCT00003469|9592588|FG000|NOT COMPLETED|Overall Study||0
8560824|NCT00003470|9592592|FG000|STARTED|Overall Study||27
8560825|NCT00003470|9592592|FG000|COMPLETED|Overall Study||21
8560826|NCT00003470|9592592|FG000|NOT COMPLETED|Overall Study||6
8560827|NCT00003471|9592596|FG000|STARTED|Overall Study||7
8560828|NCT00003471|9592596|FG000|COMPLETED|Overall Study||3
8560829|NCT00003471|9592596|FG000|NOT COMPLETED|Overall Study||4
8560830|NCT00003472|9592600|FG000|STARTED|Overall Study||13
8560831|NCT00003472|9592600|FG000|COMPLETED|Overall Study||10
8560832|NCT00003472|9592600|FG000|NOT COMPLETED|Overall Study||3
8560833|NCT00003473|9592604|FG000|STARTED|Overall Study||20
8560834|NCT00003473|9592604|FG000|COMPLETED|Overall Study||17
8560835|NCT00003473|9592604|FG000|NOT COMPLETED|Overall Study||3
8560836|NCT00003474|9592608|FG000|STARTED|Overall Study||40
8560837|NCT00003474|9592608|FG000|COMPLETED|Overall Study||26
8560838|NCT00003474|9592608|FG000|NOT COMPLETED|Overall Study||14
8560839|NCT00003475|9592612|FG000|STARTED|Overall Study||40
8560840|NCT00003475|9592612|FG000|COMPLETED|Overall Study||27
8560841|NCT00003475|9592612|FG000|NOT COMPLETED|Overall Study||13
8569069|NCT00095147|9601273|FG001|COMPLETED|Double-blind Period 2 (Days 198-365)||141
8569070|NCT00095147|9601274|FG002|COMPLETED|Double-blind Period 2 (Days 198-365)||0
8569071|NCT00095147|9601275|FG003|COMPLETED|Double-blind Period 2 (Days 198-365)||104
8569072|NCT00095147|9601276|FG004|COMPLETED|Double-blind Period 2 (Days 198-365)||0
8569073|NCT00095147|9601272|FG000|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||8
8569074|NCT00095147|9601273|FG001|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||11
8569075|NCT00095147|9601274|FG002|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||0
8569076|NCT00095147|9601275|FG003|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||3
8569077|NCT00095147|9601276|FG004|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||0
8569078|NCT00095147|9601272|FG000|STARTED|Long-term Extension Period||0
8569079|NCT00095147|9601273|FG001|STARTED|Long-term Extension Period||0
8569080|NCT00095147|9601274|FG002|STARTED|Long-term Extension Period||0
8569081|NCT00095147|9601275|FG003|STARTED|Long-term Extension Period||0
8569082|NCT00095147|9601276|FG004|STARTED|Long-term Extension Period||372
8569083|NCT00095147|9601272|FG000|COMPLETED|Long-term Extension Period||0
8569084|NCT00095147|9601273|FG001|COMPLETED|Long-term Extension Period||0
8814564|NCT01533077|9867872|FG000|COMPLETED|Overall Study||4
8814565|NCT01533077|9867873|FG001|COMPLETED|Overall Study||4
8814566|NCT01533077|9867874|FG002|COMPLETED|Overall Study||4
8814567|NCT01533077|9867875|FG003|COMPLETED|Overall Study||4
8814568|NCT01533077|9867872|FG000|NOT COMPLETED|Overall Study||1
8814569|NCT01533077|9867873|FG001|NOT COMPLETED|Overall Study||1
8814570|NCT01533077|9867874|FG002|NOT COMPLETED|Overall Study||0
8814571|NCT01533077|9867875|FG003|NOT COMPLETED|Overall Study||0
8814572|NCT01533116|9867889|FG000|STARTED|Overall Study||14
8814573|NCT01533116|9867890|FG001|STARTED|Overall Study||13
8560842|NCT00003476|9592617|FG000|STARTED|Overall Study||8
8560843|NCT00003476|9592617|FG000|COMPLETED|Overall Study||7
8560844|NCT00003476|9592617|FG000|NOT COMPLETED|Overall Study||1
8560845|NCT00003477|9592621|FG000|STARTED|Overall Study||12
8560846|NCT00003477|9592621|FG000|COMPLETED|Overall Study||8
8560847|NCT00003477|9592621|FG000|NOT COMPLETED|Overall Study||4
8560848|NCT00003483|9592625|FG000|STARTED|Overall Study||3
8560849|NCT00003483|9592625|FG000|COMPLETED|Overall Study||2
8560850|NCT00003483|9592625|FG000|NOT COMPLETED|Overall Study||1
8560851|NCT00003487|9592629|FG000|STARTED|Overall Study||8
8560852|NCT00003487|9592629|FG000|COMPLETED|Overall Study||6
8560853|NCT00003487|9592629|FG000|NOT COMPLETED|Overall Study||2
8560854|NCT00003492|9592633|FG000|STARTED|Overall Study||9
8560855|NCT00003492|9592633|FG000|COMPLETED|Overall Study||3
8560856|NCT00003492|9592633|FG000|NOT COMPLETED|Overall Study||6
8560857|NCT00003498|9592637|FG000|STARTED|Overall Study||5
8560858|NCT00003498|9592637|FG000|COMPLETED|Overall Study||1
8560859|NCT00003498|9592637|FG000|NOT COMPLETED|Overall Study||4
8560860|NCT00003499|9592641|FG000|STARTED|Overall Study||31
8560861|NCT00003499|9592641|FG000|COMPLETED|Overall Study||23
8560862|NCT00003499|9592641|FG000|NOT COMPLETED|Overall Study||8
8560863|NCT00003508|9592645|FG000|STARTED|Overall Study||8
8560864|NCT00003508|9592645|FG000|COMPLETED|Overall Study||3
8560865|NCT00003508|9592645|FG000|NOT COMPLETED|Overall Study||5
8560866|NCT00003509|9592649|FG000|STARTED|Overall Study||13
8560867|NCT00003509|9592649|FG000|COMPLETED|Overall Study||8
8560868|NCT00003509|9592649|FG000|NOT COMPLETED|Overall Study||5
8560869|NCT00003511|9592653|FG000|STARTED|Overall Study||5
8560870|NCT00003511|9592653|FG000|COMPLETED|Overall Study||1
8560871|NCT00003511|9592653|FG000|NOT COMPLETED|Overall Study||4
8560872|NCT00003526|9592657|FG000|STARTED|Overall Study||8
8560873|NCT00003526|9592657|FG000|COMPLETED|Overall Study||2
8560874|NCT00003526|9592657|FG000|NOT COMPLETED|Overall Study||6
8560875|NCT00003531|9592661|FG000|STARTED|Overall Study||15
8560876|NCT00003531|9592661|FG000|COMPLETED|Overall Study||5
8560877|NCT00003531|9592661|FG000|NOT COMPLETED|Overall Study||10
8560878|NCT00003535|9592665|FG000|STARTED|Overall Study||9
8560879|NCT00003535|9592665|FG000|COMPLETED|Overall Study||4
8560880|NCT00003535|9592665|FG000|NOT COMPLETED|Overall Study||5
8560881|NCT00003537|9592669|FG000|STARTED|Overall Study||19
8560882|NCT00003537|9592669|FG000|COMPLETED|Overall Study||18
8560883|NCT00003537|9592669|FG000|NOT COMPLETED|Overall Study||1
8560884|NCT00003590|9592673|FG000|STARTED|Overall Study||29
8560885|NCT00003590|9592673|FG000|Eligible|Overall Study||28
8560886|NCT00003590|9592673|FG000|Eligible and Began Protocol Therapy|Overall Study||28
8560887|NCT00003590|9592673|FG000|COMPLETED|Overall Study|Patients were to receive Hydroxyurea up to 2 years in absence of progressive disease.|7
8560888|NCT00003590|9592673|FG000|NOT COMPLETED|Overall Study||22
8560889|NCT00003631|9592680|FG000|STARTED|Overall Study||50
8560890|NCT00003631|9592681|FG001|STARTED|Overall Study||44
8560891|NCT00003631|9592682|FG002|STARTED|Overall Study||24
8560892|NCT00003631|9592680|FG000|COMPLETED|Overall Study||47
8560893|NCT00003631|9592681|FG001|COMPLETED|Overall Study||43
8560894|NCT00003631|9592682|FG002|COMPLETED|Overall Study||15
8560895|NCT00003631|9592680|FG000|NOT COMPLETED|Overall Study||3
8560896|NCT00003631|9592681|FG001|NOT COMPLETED|Overall Study||1
8560897|NCT00003631|9592682|FG002|NOT COMPLETED|Overall Study||9
8560898|NCT00003641|9592692|FG000|STARTED|Overall Study||569
8560899|NCT00003641|9592693|FG001|STARTED|Overall Study||581
8560900|NCT00003641|9592692|FG000|Treated|Overall Study|Patients on arm I should undergo observation, but 2 patients received interferon therapy|2
8560901|NCT00003641|9592693|FG001|Treated|Overall Study||569
8560902|NCT00003641|9592692|FG000|Toxicity Assessed|Overall Study|439 patients on arm I had their toxicity assessed even though they did not receive any treatment|439
8560903|NCT00003641|9592693|FG001|Toxicity Assessed|Overall Study||568
8560904|NCT00003641|9592692|FG000|COMPLETED|Overall Study||0
8560905|NCT00003641|9592693|FG001|COMPLETED|Overall Study||407
8560906|NCT00003641|9592692|FG000|NOT COMPLETED|Overall Study||569
8560907|NCT00003641|9592693|FG001|NOT COMPLETED|Overall Study||174
8560908|NCT00003644|9592701|FG000|STARTED|Overall Study||289
8560909|NCT00003644|9592702|FG001|STARTED|Overall Study||282
8560910|NCT00003644|9592701|FG000|COMPLETED|Overall Study||274
8560911|NCT00003644|9592702|FG001|COMPLETED|Overall Study||268
8560912|NCT00003644|9592701|FG000|NOT COMPLETED|Overall Study||15
8560913|NCT00003644|9592702|FG001|NOT COMPLETED|Overall Study||14
8560914|NCT00003645|9592712|FG000|STARTED|Overall Study||30
8560915|NCT00003645|9592713|FG001|STARTED|Overall Study||34
8560916|NCT00003645|9592712|FG000|COMPLETED|Overall Study||18
8560917|NCT00003645|9592713|FG001|COMPLETED|Overall Study||22
8560918|NCT00003645|9592712|FG000|NOT COMPLETED|Overall Study||12
8560919|NCT00003645|9592713|FG001|NOT COMPLETED|Overall Study||12
8560920|NCT00003659|9592721|FG000|STARTED|Overall Study||39
8560921|NCT00003659|9592721|FG000|COMPLETED|Overall Study||36
8560922|NCT00003659|9592721|FG000|NOT COMPLETED|Overall Study||3
8560923|NCT00003702|9592727|FG000|STARTED|Overall Study||120
8560924|NCT00003702|9592728|FG001|STARTED|Overall Study||120
8560925|NCT00003702|9592727|FG000|COMPLETED|Overall Study||107
8560926|NCT00003702|9592728|FG001|COMPLETED|Overall Study||109
8560927|NCT00003702|9592727|FG000|NOT COMPLETED|Overall Study||13
8943721|NCT02391363|10005568|FG001|STARTED|Overall Study||64
8943722|NCT02391363|10005567|FG000|COMPLETED|Overall Study||59
8943723|NCT02391363|10005568|FG001|COMPLETED|Overall Study||56
8943724|NCT02391363|10005567|FG000|NOT COMPLETED|Overall Study||11
8943725|NCT02391363|10005568|FG001|NOT COMPLETED|Overall Study||8
8943726|NCT02391545|10005576|FG000|STARTED|Overall Study||27
8943727|NCT02391545|10005577|FG001|STARTED|Overall Study||28
8943728|NCT02391545|10005576|FG000|COMPLETED|Overall Study||1
8943729|NCT02391545|10005577|FG001|COMPLETED|Overall Study||0
8722671|NCT01020448|9770156|FG000|NOT COMPLETED|Pre-assignment||13
8722672|NCT01020448|9770156|FG000|STARTED|Treatment|One patient was excluded from the safety population as no post-baseline assessment was available|325
8722673|NCT01020448|9770156|FG000|COMPLETED|Treatment||299
8722674|NCT01020448|9770156|FG000|NOT COMPLETED|Treatment||26
8560928|NCT00003702|9592728|FG001|NOT COMPLETED|Overall Study||11
8560929|NCT00003782|9592738|FG000|STARTED|Overall Study||1783
8560930|NCT00003782|9592739|FG001|STARTED|Overall Study||1784
8560931|NCT00003782|9592740|FG002|STARTED|Overall Study||1784
8560932|NCT00003782|9592738|FG000|COMPLETED|Overall Study||1753
8560933|NCT00003782|9592739|FG001|COMPLETED|Overall Study||1753
8560934|NCT00003782|9592740|FG002|COMPLETED|Overall Study||1758
8560935|NCT00003782|9592738|FG000|NOT COMPLETED|Overall Study||30
8560936|NCT00003782|9592739|FG001|NOT COMPLETED|Overall Study||31
8560937|NCT00003782|9592740|FG002|NOT COMPLETED|Overall Study||26
8560938|NCT00003816|9592753|FG000|STARTED|Overall Study||55
8560939|NCT00003816|9592754|FG001|STARTED|Overall Study||69
8560940|NCT00003816|9592755|FG002|STARTED|Overall Study||199
8560941|NCT00003816|9592756|FG003|STARTED|Overall Study||23
8560942|NCT00003816|9592757|FG004|STARTED|Overall Study||15
8560943|NCT00003816|9592753|FG000|COMPLETED|Overall Study||55
8560944|NCT00003816|9592754|FG001|COMPLETED|Overall Study||69
8560945|NCT00003816|9592755|FG002|COMPLETED|Overall Study||199
8560946|NCT00003816|9592756|FG003|COMPLETED|Overall Study||23
8560947|NCT00003816|9592757|FG004|COMPLETED|Overall Study||15
8560948|NCT00003816|9592753|FG000|NOT COMPLETED|Overall Study||0
8560949|NCT00003816|9592754|FG001|NOT COMPLETED|Overall Study||0
8560950|NCT00003816|9592755|FG002|NOT COMPLETED|Overall Study||0
8722675|NCT01020474|9770163|FG000|STARTED|Overall Study||54
8722676|NCT01020474|9770164|FG001|STARTED|Overall Study||53
8943730|NCT02391545|10005576|FG000|NOT COMPLETED|Overall Study||26
8943731|NCT02391545|10005577|FG001|NOT COMPLETED|Overall Study||28
8943732|NCT02391584|10005586|FG000|STARTED|Primary Endpoint (6-weeks)||31
8560951|NCT00003816|9592756|FG003|NOT COMPLETED|Overall Study||0
8560952|NCT00003816|9592757|FG004|NOT COMPLETED|Overall Study||0
8560953|NCT00003820|9592769|FG000|STARTED|Cycle 1 (Initial Treatment)||23
8560954|NCT00003820|9592770|FG001|STARTED|Cycle 1 (Initial Treatment)||16
8560955|NCT00003820|9592769|FG000|COMPLETED|Cycle 1 (Initial Treatment)||23
8560956|NCT00003820|9592770|FG001|COMPLETED|Cycle 1 (Initial Treatment)||16
8560957|NCT00003820|9592769|FG000|NOT COMPLETED|Cycle 1 (Initial Treatment)||0
8560958|NCT00003820|9592770|FG001|NOT COMPLETED|Cycle 1 (Initial Treatment)||0
8560959|NCT00003820|9592769|FG000|STARTED|Cycle 2 (Maintenance Treatment)|Initial Group of participants only received 1 cycle of treatment|0
8814574|NCT01533116|9867891|FG002|STARTED|Overall Study||13
8814575|NCT01533116|9867892|FG003|STARTED|Overall Study||12
8814576|NCT01533116|9867889|FG000|COMPLETED|Overall Study||12
8814577|NCT01533116|9867890|FG001|COMPLETED|Overall Study||12
8814578|NCT01533116|9867891|FG002|COMPLETED|Overall Study||12
8814579|NCT01533116|9867892|FG003|COMPLETED|Overall Study||12
8814580|NCT01533116|9867889|FG000|NOT COMPLETED|Overall Study||2
8814581|NCT01533116|9867890|FG001|NOT COMPLETED|Overall Study||1
8814582|NCT01533116|9867891|FG002|NOT COMPLETED|Overall Study||1
8560960|NCT00003820|9592770|FG001|STARTED|Cycle 2 (Maintenance Treatment)|Pts with treatment response/stable disease at 6 mos, & eligible to continue.|16
8560961|NCT00003820|9592769|FG000|COMPLETED|Cycle 2 (Maintenance Treatment)||0
8560962|NCT00003820|9592770|FG001|COMPLETED|Cycle 2 (Maintenance Treatment)|Patients with treatment assessment at 12 months|16
8560963|NCT00003820|9592769|FG000|NOT COMPLETED|Cycle 2 (Maintenance Treatment)||0
8560964|NCT00003820|9592770|FG001|NOT COMPLETED|Cycle 2 (Maintenance Treatment)||0
8560965|NCT00003820|9592769|FG000|STARTED|Cycle 3 (Maintenance Treatment)|Initial Group of participants only received 1 cycle of treatment|0
8560966|NCT00003820|9592770|FG001|STARTED|Cycle 3 (Maintenance Treatment)|Patients with treatment response/stable disease at 12 months|16
8560967|NCT00003820|9592769|FG000|COMPLETED|Cycle 3 (Maintenance Treatment)||0
8560968|NCT00003820|9592770|FG001|COMPLETED|Cycle 3 (Maintenance Treatment)|Patients with treatment assessment at 18 months|16
8560969|NCT00003820|9592769|FG000|NOT COMPLETED|Cycle 3 (Maintenance Treatment)||0
8560970|NCT00003820|9592770|FG001|NOT COMPLETED|Cycle 3 (Maintenance Treatment)||0
8560971|NCT00003820|9592769|FG000|STARTED|Cycle 4 (Maintenance Treatment)|Initial Group of participants only received 1 cycle of treatment|0
8560972|NCT00003820|9592770|FG001|STARTED|Cycle 4 (Maintenance Treatment)|Patients with treatment response/stable disease at 18 months|16
8560973|NCT00003820|9592769|FG000|COMPLETED|Cycle 4 (Maintenance Treatment)||0
8560974|NCT00003820|9592770|FG001|COMPLETED|Cycle 4 (Maintenance Treatment)|Patients with treatment assessment at 24 months|16
8560975|NCT00003820|9592769|FG000|NOT COMPLETED|Cycle 4 (Maintenance Treatment)||0
8560976|NCT00003820|9592770|FG001|NOT COMPLETED|Cycle 4 (Maintenance Treatment)||0
8560977|NCT00003830|9592778|FG000|STARTED|Overall Study||2807
8560978|NCT00003830|9592779|FG001|STARTED|Overall Study||2804
8560979|NCT00003830|9592778|FG000|COMPLETED|Overall Study||1975
8560980|NCT00003830|9592779|FG001|COMPLETED|Overall Study||2011
8560981|NCT00003830|9592778|FG000|NOT COMPLETED|Overall Study||832
8560982|NCT00003830|9592779|FG001|NOT COMPLETED|Overall Study||793
8560983|NCT00003869|9592789|FG000|STARTED|Overall Study||94
8560984|NCT00003869|9592790|FG001|STARTED|Overall Study||92
8560985|NCT00003869|9592789|FG000|COMPLETED|Overall Study||53
8560986|NCT00003869|9592790|FG001|COMPLETED|Overall Study||80
8560987|NCT00003869|9592789|FG000|NOT COMPLETED|Overall Study||41
8560988|NCT00003869|9592790|FG001|NOT COMPLETED|Overall Study||12
8560989|NCT00003875|9592796|FG000|STARTED|Overall Study||30
8560990|NCT00003875|9592796|FG000|COMPLETED|Overall Study||29
8560991|NCT00003875|9592796|FG000|NOT COMPLETED|Overall Study||1
8560992|NCT00003895|9592802|FG000|STARTED|Overall Study||18
8560993|NCT00003895|9592803|FG001|STARTED|Overall Study||18
8560994|NCT00003895|9592802|FG000|COMPLETED|Overall Study||11
8560995|NCT00003895|9592803|FG001|COMPLETED|Overall Study||14
8560996|NCT00003895|9592802|FG000|NOT COMPLETED|Overall Study||7
8814583|NCT01533116|9867892|FG003|NOT COMPLETED|Overall Study||0
8814584|NCT01533181|9867904|FG000|STARTED|Overall Study||15
8814585|NCT01533181|9867905|FG001|STARTED|Overall Study||29
8560997|NCT00003895|9592803|FG001|NOT COMPLETED|Overall Study||4
8560998|NCT00003896|9592809|FG000|STARTED|Overall Study||68
8814586|NCT01533181|9867904|FG000|COMPLETED|Overall Study||14
8814587|NCT01533181|9867905|FG001|COMPLETED|Overall Study||28
8814588|NCT01533181|9867904|FG000|NOT COMPLETED|Overall Study||1
8814589|NCT01533181|9867905|FG001|NOT COMPLETED|Overall Study||1
8814590|NCT01533207|9867913|FG000|STARTED|Overall Study||20
8560999|NCT00003896|9592809|FG000|Eligible|Overall Study|2 eligible patients did not have any toxicity assessments reported.|63
8561000|NCT00003896|9592809|FG000|COMPLETED|Overall Study||39
8561001|NCT00003896|9592809|FG000|NOT COMPLETED|Overall Study||29
8561002|NCT00003901|9592814|FG000|STARTED|Overall Study||1047
8561003|NCT00003901|9592814|FG000|COMPLETED|Overall Study||1030
8561004|NCT00003901|9592814|FG000|NOT COMPLETED|Overall Study||17
8561005|NCT00003907|9592823|FG000|STARTED|Overall Study||19
8561006|NCT00003907|9592824|FG001|STARTED|Overall Study||31
8561007|NCT00003907|9592823|FG000|Eligible|Overall Study||18
8561008|NCT00003907|9592824|FG001|Eligible|Overall Study||29
8561009|NCT00003907|9592823|FG000|Received Protocol Therapy (Treated)|Overall Study||18
8561010|NCT00003907|9592824|FG001|Received Protocol Therapy (Treated)|Overall Study||31
8561011|NCT00003907|9592823|FG000|Eligible and Treated|Overall Study||17
8561012|NCT00003907|9592824|FG001|Eligible and Treated|Overall Study||29
8561013|NCT00003907|9592823|FG000|COMPLETED|Overall Study||6
8561014|NCT00003907|9592824|FG001|COMPLETED|Overall Study||8
8561015|NCT00003907|9592823|FG000|NOT COMPLETED|Overall Study||13
8561016|NCT00003907|9592824|FG001|NOT COMPLETED|Overall Study||23
8561017|NCT00003910|9592830|FG000|STARTED|Step 1|Of 59 (step 1), 4 pts were ineligible.|55
8561018|NCT00003910|9592831|FG001|STARTED|Step 1||0
8561019|NCT00003910|9592830|FG000|COMPLETED|Step 1||55
8561020|NCT00003910|9592831|FG001|COMPLETED|Step 1||0
8561021|NCT00003910|9592830|FG000|NOT COMPLETED|Step 1||0
8561022|NCT00003910|9592831|FG001|NOT COMPLETED|Step 1||0
8561023|NCT00003910|9592830|FG000|STARTED|Step 2||0
8561024|NCT00003910|9592831|FG001|STARTED|Step 2|The 16 includes 2 ineligible pts.|16
8561025|NCT00003910|9592830|FG000|COMPLETED|Step 2||0
8561026|NCT00003910|9592831|FG001|COMPLETED|Step 2||16
8561027|NCT00003910|9592830|FG000|NOT COMPLETED|Step 2||0
8561028|NCT00003910|9592831|FG001|NOT COMPLETED|Step 2||0
8561029|NCT00004031|9592839|FG000|STARTED|Overall Study||128
8561030|NCT00004031|9592840|FG001|STARTED|Overall Study||125
8561031|NCT00004031|9592839|FG000|Assessed for Adverse Events|Overall Study||123
8561032|NCT00004031|9592840|FG001|Assessed for Adverse Events|Overall Study||113
8561033|NCT00004031|9592839|FG000|COMPLETED|Overall Study||103
8561034|NCT00004031|9592840|FG001|COMPLETED|Overall Study||104
8561035|NCT00004031|9592839|FG000|NOT COMPLETED|Overall Study||25
8561036|NCT00004031|9592840|FG001|NOT COMPLETED|Overall Study||21
8561037|NCT00004054|9592850|FG000|STARTED|Overall Study||197
8561038|NCT00004054|9592851|FG001|STARTED|Overall Study||200
8561039|NCT00004054|9592850|FG000|COMPLETED|Overall Study||197
8561040|NCT00004054|9592851|FG001|COMPLETED|Overall Study||200
8561041|NCT00004054|9592850|FG000|NOT COMPLETED|Overall Study||0
8561042|NCT00004054|9592851|FG001|NOT COMPLETED|Overall Study||0
8561043|NCT00004088|9592857|FG000|STARTED|Overall Study||77
8561044|NCT00004088|9592857|FG000|COMPLETED|Overall Study||68
8561045|NCT00004088|9592857|FG000|NOT COMPLETED|Overall Study||9
8561046|NCT00004092|9592863|FG000|STARTED|Overall Study||21
8561047|NCT00004092|9592864|FG001|STARTED|Overall Study||51
8561048|NCT00004092|9592863|FG000|COMPLETED|Overall Study||21
8561049|NCT00004092|9592864|FG001|COMPLETED|Overall Study||51
8561050|NCT00004092|9592863|FG000|NOT COMPLETED|Overall Study||0
8561051|NCT00004092|9592864|FG001|NOT COMPLETED|Overall Study||0
8561052|NCT00004124|9592872|FG000|STARTED|Overall Study||481
8561053|NCT00004124|9592873|FG001|STARTED|Overall Study||480
8561054|NCT00004124|9592872|FG000|COMPLETED|Overall Study||469
8561055|NCT00004124|9592873|FG001|COMPLETED|Overall Study||460
8561056|NCT00004124|9592872|FG000|NOT COMPLETED|Overall Study||12
8561057|NCT00004124|9592873|FG001|NOT COMPLETED|Overall Study||20
8561058|NCT00004143|9592879|FG000|STARTED|Overall Study||2
8561059|NCT00004143|9592879|FG000|COMPLETED|Overall Study||2
8561060|NCT00004143|9592879|FG000|NOT COMPLETED|Overall Study||0
8561061|NCT00004146|9592883|FG000|STARTED|Overall Study||55
8561062|NCT00004146|9592883|FG000|COMPLETED|Overall Study||55
8561063|NCT00004146|9592883|FG000|NOT COMPLETED|Overall Study||0
8561064|NCT00004228|9592896|FG000|STARTED|Overall Study||60
8561065|NCT00004228|9592897|FG001|STARTED|Overall Study||66
8561066|NCT00004228|9592898|FG002|STARTED|Overall Study||65
8561067|NCT00004228|9592899|FG003|STARTED|Overall Study||13
8561068|NCT00004228|9592900|FG004|STARTED|Overall Study||67
8561069|NCT00004228|9592901|FG005|STARTED|Overall Study||65
8561070|NCT00004228|9592902|FG006|STARTED|Overall Study||57
8561071|NCT00004228|9592896|FG000|COMPLETED|Overall Study||51
8561072|NCT00004228|9592897|FG001|COMPLETED|Overall Study||51
8561073|NCT00004228|9592898|FG002|COMPLETED|Overall Study||46
8561074|NCT00004228|9592899|FG003|COMPLETED|Overall Study||6
8561075|NCT00004228|9592900|FG004|COMPLETED|Overall Study||51
8561076|NCT00004228|9592901|FG005|COMPLETED|Overall Study||51
8561077|NCT00004228|9592902|FG006|COMPLETED|Overall Study||45
8561078|NCT00004228|9592896|FG000|NOT COMPLETED|Overall Study||9
8561079|NCT00004228|9592897|FG001|NOT COMPLETED|Overall Study||15
8561080|NCT00004228|9592898|FG002|NOT COMPLETED|Overall Study||19
8561081|NCT00004228|9592899|FG003|NOT COMPLETED|Overall Study||7
8561082|NCT00004228|9592900|FG004|NOT COMPLETED|Overall Study||16
8561083|NCT00004228|9592901|FG005|NOT COMPLETED|Overall Study||14
8561084|NCT00004228|9592902|FG006|NOT COMPLETED|Overall Study||12
8561085|NCT00004259|9592923|FG000|STARTED|Overall Study||98
8561086|NCT00004259|9592924|FG001|STARTED|Overall Study||103
8814591|NCT01533207|9867914|FG001|STARTED|Overall Study||18
8561087|NCT00004259|9592925|FG002|STARTED|Overall Study||15
8561088|NCT00004259|9592926|FG003|STARTED|Overall Study||14
8561089|NCT00004259|9592923|FG000|COMPLETED|Overall Study||97
8561090|NCT00004259|9592924|FG001|COMPLETED|Overall Study||99
8561091|NCT00004259|9592925|FG002|COMPLETED|Overall Study||15
8561092|NCT00004259|9592926|FG003|COMPLETED|Overall Study||14
8561093|NCT00004259|9592923|FG000|NOT COMPLETED|Overall Study||1
8561094|NCT00004259|9592924|FG001|NOT COMPLETED|Overall Study||4
8561095|NCT00004259|9592925|FG002|NOT COMPLETED|Overall Study||0
8561096|NCT00004259|9592926|FG003|NOT COMPLETED|Overall Study||0
8561097|NCT00004412|9592942|FG000|STARTED|Randomized Period||11
8561098|NCT00004412|9592943|FG001|STARTED|Randomized Period||12
8561099|NCT00004412|9592944|FG002|STARTED|Randomized Period||0
8561100|NCT00004412|9592942|FG000|COMPLETED|Randomized Period||8
8561101|NCT00004412|9592943|FG001|COMPLETED|Randomized Period||12
8561102|NCT00004412|9592944|FG002|COMPLETED|Randomized Period||0
8561103|NCT00004412|9592942|FG000|NOT COMPLETED|Randomized Period||3
8561104|NCT00004412|9592943|FG001|NOT COMPLETED|Randomized Period||0
8561105|NCT00004412|9592944|FG002|NOT COMPLETED|Randomized Period||0
8561106|NCT00004412|9592942|FG000|STARTED|Crossover Period|Eight subjects were randomized to Standard of Care dressing Arm|8
8561107|NCT00004412|9592943|FG001|STARTED|Crossover Period|Twelve patients were randomized to the Arginine Butyrate plus Standard local care dressing Arm|12
8561108|NCT00004412|9592944|FG002|STARTED|Crossover Period|Three of Randomized Period's Arm I elected to move to Crossover Period's Crossover Arm.|3
8561109|NCT00004412|9592942|FG000|COMPLETED|Crossover Period|Eight subjects in this arm completed study without crossing over.|8
8561110|NCT00004412|9592943|FG001|COMPLETED|Crossover Period|Twelve subjects in this arm completed the study.|12
8561111|NCT00004412|9592944|FG002|COMPLETED|Crossover Period|Three subjects, from Arm I, who crossed- over to Arm II completed the study.|3
8561112|NCT00004412|9592942|FG000|NOT COMPLETED|Crossover Period||0
8561113|NCT00004412|9592943|FG001|NOT COMPLETED|Crossover Period||0
8561114|NCT00004412|9592944|FG002|NOT COMPLETED|Crossover Period||0
8561115|NCT00004418|9592950|FG000|STARTED|Overall Study||126
8561116|NCT00004418|9592950|FG000|COMPLETED|Overall Study|The definition of completed is until the subject wished to stop taking the oil.|126
8561117|NCT00004418|9592950|FG000|NOT COMPLETED|Overall Study||0
8561118|NCT00004445|9592954|FG000|STARTED|Overall Study||18
8561119|NCT00004445|9592954|FG000|COMPLETED|Overall Study||15
8561120|NCT00004445|9592954|FG000|NOT COMPLETED|Overall Study||3
8561121|NCT00004500|9592960|FG000|STARTED|Overall Study||38
8561122|NCT00004500|9592961|FG001|STARTED|Overall Study||31
8561123|NCT00004500|9592960|FG000|1 Year Follow-Up|Overall Study||24
8561124|NCT00004500|9592961|FG001|1 Year Follow-Up|Overall Study||24
8561125|NCT00004500|9592960|FG000|COMPLETED|Overall Study||38
8814592|NCT01533207|9867913|FG000|COMPLETED|Overall Study||20
8814593|NCT01533207|9867914|FG001|COMPLETED|Overall Study||18
8814594|NCT01533207|9867913|FG000|NOT COMPLETED|Overall Study||0
8814595|NCT01533207|9867914|FG001|NOT COMPLETED|Overall Study||0
8561126|NCT00004500|9592961|FG001|COMPLETED|Overall Study||31
8561127|NCT00004500|9592960|FG000|NOT COMPLETED|Overall Study||0
8561128|NCT00004500|9592961|FG001|NOT COMPLETED|Overall Study||0
8561129|NCT00004547|9592970|FG000|STARTED|Overall Study||83
8561130|NCT00004547|9592971|FG001|STARTED|Overall Study||48
8561131|NCT00004547|9592972|FG002|STARTED|Overall Study||57
8561132|NCT00004547|9592970|FG000|Not Evaluable|Overall Study||21
8561133|NCT00004547|9592971|FG001|Not Evaluable|Overall Study||9
8561134|NCT00004547|9592972|FG002|Not Evaluable|Overall Study||23
8561135|NCT00004547|9592970|FG000|COMPLETED|Overall Study||61
8561136|NCT00004547|9592971|FG001|COMPLETED|Overall Study||39
8561137|NCT00004547|9592972|FG002|COMPLETED|Overall Study||35
8561138|NCT00004547|9592970|FG000|NOT COMPLETED|Overall Study||22
8561139|NCT00004547|9592971|FG001|NOT COMPLETED|Overall Study||9
8561140|NCT00004547|9592972|FG002|NOT COMPLETED|Overall Study||22
8561141|NCT00004562|9592983|FG000|STARTED|Overall Study||1101
8561142|NCT00004562|9592984|FG001|STARTED|Overall Study||1100
8561143|NCT00004562|9592983|FG000|COMPLETED|Overall Study||999
8561144|NCT00004562|9592984|FG001|COMPLETED|Overall Study||1009
8561145|NCT00004562|9592983|FG000|NOT COMPLETED|Overall Study||102
8561146|NCT00004562|9592984|FG001|NOT COMPLETED|Overall Study||91
8561147|NCT00004563|9592992|FG000|STARTED|Overall Study||79
8561148|NCT00004563|9592993|FG001|STARTED|Overall Study||79
8561149|NCT00004563|9592992|FG000|COMPLETED|Overall Study||54
8561150|NCT00004563|9592993|FG001|COMPLETED|Overall Study||55
8561151|NCT00004563|9592992|FG000|NOT COMPLETED|Overall Study||25
8561152|NCT00004563|9592993|FG001|NOT COMPLETED|Overall Study||24
8561153|NCT00004635|9593001|FG000|STARTED|Period One||79
8561154|NCT00004635|9593002|FG001|STARTED|Period One||80
8561155|NCT00004635|9593001|FG000|Received Treatment|Period One||73
8561156|NCT00004635|9593002|FG001|Received Treatment|Period One||75
8561157|NCT00004635|9593001|FG000|COMPLETED|Period One||73
8561158|NCT00004635|9593002|FG001|COMPLETED|Period One||74
8561159|NCT00004635|9593001|FG000|NOT COMPLETED|Period One||6
8561160|NCT00004635|9593002|FG001|NOT COMPLETED|Period One||6
8561161|NCT00004635|9593001|FG000|STARTED|Period Two||44
8561162|NCT00004635|9593002|FG001|STARTED|Period Two||59
8561163|NCT00004635|9593001|FG000|COMPLETED|Period Two||38
8561164|NCT00004635|9593002|FG001|COMPLETED|Period Two||50
8561165|NCT00004635|9593001|FG000|NOT COMPLETED|Period Two||6
8561166|NCT00004635|9593002|FG001|NOT COMPLETED|Period Two||9
8561167|NCT00004732|9593013|FG000|STARTED|Overall Study||1262
8561168|NCT00004732|9593014|FG001|STARTED|Overall Study||1240
8561169|NCT00004732|9593013|FG000|COMPLETED|Overall Study||1193
8561170|NCT00004732|9593014|FG001|COMPLETED|Overall Study||1129
8561171|NCT00004732|9593013|FG000|NOT COMPLETED|Overall Study||69
8561172|NCT00004732|9593014|FG001|NOT COMPLETED|Overall Study||111
8561173|NCT00004859|9593024|FG000|STARTED|Overall Study||295
8561174|NCT00004859|9593025|FG001|STARTED|Overall Study||294
8561175|NCT00004859|9593024|FG000|Eligible|Overall Study||275
8561176|NCT00004859|9593025|FG001|Eligible|Overall Study||271
8814596|NCT01533246|9867920|FG000|STARTED|Overall Study||17
8814597|NCT01533246|9867920|FG000|COMPLETED|Overall Study||15
8561177|NCT00004859|9593024|FG000|Treated|Overall Study||289
8561178|NCT00004859|9593025|FG001|Treated|Overall Study||289
8561179|NCT00004859|9593024|FG000|Treated and Having Toxicity Data|Overall Study||289
8561180|NCT00004859|9593025|FG001|Treated and Having Toxicity Data|Overall Study|1 patient had missing record for toxicity|288
8561181|NCT00004859|9593024|FG000|COMPLETED|Overall Study||177
8561182|NCT00004859|9593025|FG001|COMPLETED|Overall Study||12
8619761|NCT00469898|9658279|FG000|STARTED|Overall Study||50
8619762|NCT00469898|9658279|FG000|COMPLETED|Overall Study||25
8619763|NCT00469898|9658279|FG000|NOT COMPLETED|Overall Study||25
8619764|NCT00469911|9658285|FG000|STARTED|Overall Study||8
8619765|NCT00469911|9658286|FG001|STARTED|Overall Study||10
8619766|NCT00469911|9658285|FG000|COMPLETED|Overall Study||8
8619767|NCT00469911|9658286|FG001|COMPLETED|Overall Study||10
8619768|NCT00469911|9658285|FG000|NOT COMPLETED|Overall Study||0
8619769|NCT00469911|9658286|FG001|NOT COMPLETED|Overall Study||0
8619770|NCT00470054|9658291|FG000|STARTED|Overall Study||44
8619771|NCT00470054|9658291|FG000|COMPLETED|Overall Study||43
8619772|NCT00470054|9658291|FG000|NOT COMPLETED|Overall Study||1
8619773|NCT00470093|9658295|FG000|STARTED|Overall Study||2
8619774|NCT00470093|9658295|FG000|COMPLETED|Overall Study||0
8619775|NCT00470093|9658295|FG000|NOT COMPLETED|Overall Study||2
8619776|NCT00470106|9658303|FG000|STARTED|Overall Study||19
8619777|NCT00470106|9658304|FG001|STARTED|Overall Study||24
8619778|NCT00470106|9658305|FG002|STARTED|Overall Study||21
8619779|NCT00470106|9658306|FG003|STARTED|Overall Study||21
8619780|NCT00470106|9658303|FG000|COMPLETED|Overall Study||16
8619781|NCT00470106|9658304|FG001|COMPLETED|Overall Study||19
8619782|NCT00470106|9658305|FG002|COMPLETED|Overall Study||14
8619783|NCT00470106|9658306|FG003|COMPLETED|Overall Study||19
8619784|NCT00470106|9658303|FG000|NOT COMPLETED|Overall Study||3
8619785|NCT00470106|9658304|FG001|NOT COMPLETED|Overall Study||5
8619786|NCT00470106|9658305|FG002|NOT COMPLETED|Overall Study||7
8619787|NCT00470106|9658306|FG003|NOT COMPLETED|Overall Study||2
8619788|NCT00470158|9658325|FG000|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|201
8619789|NCT00470158|9658326|FG001|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|199
8619790|NCT00470158|9658327|FG002|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|201
8619791|NCT00470158|9658328|FG003|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|198
8619792|NCT00470158|9658329|FG004|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|201
8619793|NCT00470158|9658325|FG000|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|193
8619794|NCT00470158|9658326|FG001|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|191
8619795|NCT00470158|9658327|FG002|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|193
8619796|NCT00470158|9658328|FG003|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|193
8619797|NCT00470158|9658329|FG004|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|195
8619798|NCT00470158|9658325|FG000|NOT COMPLETED|Overall Study||8
8619799|NCT00470158|9658326|FG001|NOT COMPLETED|Overall Study||8
8814598|NCT01533246|9867920|FG000|NOT COMPLETED|Overall Study||2
8814599|NCT01533259|9867924|FG000|STARTED|Overall Study||48
8814600|NCT01533259|9867924|FG000|COMPLETED|Overall Study||48
8814601|NCT01533259|9867924|FG000|NOT COMPLETED|Overall Study||0
8814602|NCT01533428|9867930|FG000|STARTED|Overall Study||186
8814603|NCT01533428|9867931|FG001|STARTED|Overall Study||183
8814604|NCT01533428|9867930|FG000|COMPLETED|Overall Study||177
8814605|NCT01533428|9867931|FG001|COMPLETED|Overall Study||175
8814606|NCT01533428|9867930|FG000|NOT COMPLETED|Overall Study||9
8814607|NCT01533428|9867931|FG001|NOT COMPLETED|Overall Study||8
8561183|NCT00004859|9593024|FG000|NOT COMPLETED|Overall Study||118
8561184|NCT00004859|9593025|FG001|NOT COMPLETED|Overall Study||282
8561185|NCT00004888|9593035|FG000|STARTED|Overall Study|Of the 41 pts, 3 were ineligible.|38
8561186|NCT00004888|9593036|FG001|STARTED|Overall Study|Of the 48 pts, 2 were ineligible.|46
8561187|NCT00004888|9593035|FG000|COMPLETED|Overall Study||27
8561188|NCT00004888|9593036|FG001|COMPLETED|Overall Study||22
8561189|NCT00004888|9593035|FG000|NOT COMPLETED|Overall Study||11
8561190|NCT00004888|9593036|FG001|NOT COMPLETED|Overall Study||24
8561191|NCT00004978|9593044|FG000|STARTED|Overall Study|includes patients participating in Vanguard studies from the sites which participated in ESPRIT|2090
8561192|NCT00004978|9593045|FG001|STARTED|Overall Study|includes patients participating in Vanguard studies from the sites which participated in ESPRIT|2060
8561193|NCT00004978|9593044|FG000|COMPLETED|Overall Study||1846
8561194|NCT00004978|9593045|FG001|COMPLETED|Overall Study||1790
8561195|NCT00004978|9593044|FG000|NOT COMPLETED|Overall Study||244
8561196|NCT00004978|9593045|FG001|NOT COMPLETED|Overall Study||270
8561197|NCT00004980|9593053|FG000|STARTED|Overall Study||27
8561198|NCT00004980|9593054|FG001|STARTED|Overall Study||23
8561199|NCT00004980|9593053|FG000|COMPLETED|Overall Study||25
8561200|NCT00004980|9593054|FG001|COMPLETED|Overall Study||21
8561201|NCT00004980|9593053|FG000|NOT COMPLETED|Overall Study||2
8561202|NCT00004980|9593054|FG001|NOT COMPLETED|Overall Study||2
8561203|NCT00005044|9593062|FG000|STARTED|Overall Study||790
8561204|NCT00005044|9593063|FG001|STARTED|Overall Study||789
8561205|NCT00005044|9593062|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|752
8561206|NCT00005044|9593063|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|737
8561207|NCT00005044|9593062|FG000|NOT COMPLETED|Overall Study||38
8561208|NCT00005044|9593063|FG001|NOT COMPLETED|Overall Study||52
8561209|NCT00005047|9593073|FG000|STARTED|Overall Study||58
8561210|NCT00005047|9593074|FG001|STARTED|Overall Study||56
8561211|NCT00005047|9593075|FG002|STARTED|Overall Study||227
8561212|NCT00005047|9593076|FG003|STARTED|Overall Study||158
8561213|NCT00005047|9593073|FG000|COMPLETED|Overall Study||39
8561214|NCT00005047|9593074|FG001|COMPLETED|Overall Study||56
8561215|NCT00005047|9593075|FG002|COMPLETED|Overall Study||227
8561216|NCT00005047|9593076|FG003|COMPLETED|Overall Study||158
8561217|NCT00005047|9593073|FG000|NOT COMPLETED|Overall Study||19
8561218|NCT00005047|9593074|FG001|NOT COMPLETED|Overall Study||0
8561219|NCT00005047|9593075|FG002|NOT COMPLETED|Overall Study||0
8561220|NCT00005047|9593076|FG003|NOT COMPLETED|Overall Study||0
8814608|NCT01533493|9867939|FG000|STARTED|Overall Study||12
8814609|NCT01533493|9867940|FG001|STARTED|Overall Study||14
8814610|NCT01533493|9867939|FG000|COMPLETED|Overall Study||7
8561221|NCT00005669|9593088|FG000|STARTED|Overall Study||53
8561222|NCT00005669|9593089|FG001|STARTED|Overall Study||47
8561223|NCT00005669|9593088|FG000|COMPLETED|Overall Study||45
8814611|NCT01533493|9867940|FG001|COMPLETED|Overall Study||11
8814612|NCT01533493|9867939|FG000|NOT COMPLETED|Overall Study||5
8814613|NCT01533493|9867940|FG001|NOT COMPLETED|Overall Study||3
8814614|NCT01533597|9867948|FG000|STARTED|Overall Study||35
8814615|NCT01533597|9867949|FG001|STARTED|Overall Study||35
8814616|NCT01533597|9867948|FG000|COMPLETED|Overall Study||29
8814617|NCT01533597|9867949|FG001|COMPLETED|Overall Study||25
8814618|NCT01533597|9867948|FG000|NOT COMPLETED|Overall Study||6
8814619|NCT01533597|9867949|FG001|NOT COMPLETED|Overall Study||10
8814620|NCT01533688|9867958|FG000|STARTED|Overall Study||71
8814621|NCT01533688|9867959|FG001|STARTED|Overall Study||70
8814622|NCT01533688|9867960|FG002|STARTED|Overall Study||71
8814623|NCT01533688|9867958|FG000|COMPLETED|Overall Study||63
8814624|NCT01533688|9867959|FG001|COMPLETED|Overall Study||60
8814625|NCT01533688|9867960|FG002|COMPLETED|Overall Study||63
8814626|NCT01533688|9867958|FG000|NOT COMPLETED|Overall Study||8
8814627|NCT01533688|9867959|FG001|NOT COMPLETED|Overall Study||10
8814628|NCT01533688|9867960|FG002|NOT COMPLETED|Overall Study||8
8814629|NCT01533922|9867970|FG000|STARTED|Overall Study||59
8619800|NCT00470158|9658327|FG002|NOT COMPLETED|Overall Study||8
8619801|NCT00470158|9658328|FG003|NOT COMPLETED|Overall Study||5
8619802|NCT00470158|9658329|FG004|NOT COMPLETED|Overall Study||6
8619803|NCT00470184|9658341|FG000|STARTED|Overall Study||41
8619804|NCT00470184|9658341|FG000|Treated With Study Therapy|Overall Study||36
8619805|NCT00470184|9658341|FG000|COMPLETED|Overall Study||19
8619806|NCT00470184|9658341|FG000|NOT COMPLETED|Overall Study||22
8619807|NCT00470262|9658348|FG000|STARTED|Overall Study||15
8619808|NCT00470262|9658349|FG001|STARTED|Overall Study||12
8619809|NCT00470262|9658348|FG000|COMPLETED|Overall Study||13
8619810|NCT00470262|9658349|FG001|COMPLETED|Overall Study||12
8619811|NCT00470262|9658348|FG000|NOT COMPLETED|Overall Study||2
8619812|NCT00470262|9658349|FG001|NOT COMPLETED|Overall Study||0
8619813|NCT00470275|9658356|FG000|STARTED|Overall Study||10
8619814|NCT00470275|9658356|FG000|COMPLETED|Overall Study||0
8619815|NCT00470275|9658356|FG000|NOT COMPLETED|Overall Study||10
8619816|NCT00470301|9658360|FG000|STARTED|Overall Study||60
8619817|NCT00470301|9658360|FG000|COMPLETED|Overall Study||55
8619818|NCT00470301|9658360|FG000|NOT COMPLETED|Overall Study||5
8619819|NCT00470366|9658365|FG000|STARTED|Overall Study||60
8619820|NCT00470366|9658365|FG000|COMPLETED|Overall Study||56
8561224|NCT00005669|9593089|FG001|COMPLETED|Overall Study||40
8561225|NCT00005669|9593088|FG000|NOT COMPLETED|Overall Study||8
8561226|NCT00005669|9593089|FG001|NOT COMPLETED|Overall Study||7
8561227|NCT00005803|9593095|FG000|STARTED|Overall Study||76
8561228|NCT00005803|9593095|FG000|COMPLETED|Overall Study||54
8561229|NCT00005803|9593095|FG000|NOT COMPLETED|Overall Study||22
8561230|NCT00005879|9593104|FG000|STARTED|Overall Study||101
8561231|NCT00005879|9593105|FG001|STARTED|Overall Study||98
8561232|NCT00005879|9593104|FG000|COMPLETED|Overall Study||93
8561233|NCT00005879|9593105|FG001|COMPLETED|Overall Study||88
8561234|NCT00005879|9593104|FG000|NOT COMPLETED|Overall Study||8
8722677|NCT01020474|9770163|FG000|COMPLETED|Overall Study||44
8722678|NCT01020474|9770164|FG001|COMPLETED|Overall Study||36
8722679|NCT01020474|9770163|FG000|NOT COMPLETED|Overall Study||10
8722680|NCT01020474|9770164|FG001|NOT COMPLETED|Overall Study||17
8722681|NCT01020487|9770173|FG000|STARTED|Part 1||12
8619821|NCT00470366|9658365|FG000|NOT COMPLETED|Overall Study||4
8619822|NCT00470392|9658371|FG000|STARTED|Overall Study|Number of subjects enrolled, passed screening and assigned to this arm.|7
8619823|NCT00470392|9658372|FG001|STARTED|Overall Study|Number of subjects enrolled, passed screening and assigned to this arm.|2
8561235|NCT00005879|9593105|FG001|NOT COMPLETED|Overall Study||10
8561236|NCT00005901|9593113|FG000|STARTED|Overall Study||19
8561237|NCT00005901|9593114|FG001|STARTED|Overall Study||15
8619824|NCT00470392|9658371|FG000|COMPLETED|Overall Study||7
8619825|NCT00470392|9658372|FG001|COMPLETED|Overall Study||2
8619826|NCT00470392|9658371|FG000|NOT COMPLETED|Overall Study||0
8619827|NCT00470392|9658372|FG001|NOT COMPLETED|Overall Study||0
8561238|NCT00005901|9593113|FG000|COMPLETED|Overall Study||19
8561239|NCT00005901|9593114|FG001|COMPLETED|Overall Study||15
8561240|NCT00005901|9593113|FG000|NOT COMPLETED|Overall Study||0
8561241|NCT00005901|9593114|FG001|NOT COMPLETED|Overall Study||0
8561242|NCT00005906|9593120|FG000|STARTED|Overall Study||4
8561243|NCT00005906|9593120|FG000|COMPLETED|Overall Study||1
8619828|NCT00470418|9658381|FG000|STARTED|Overall Study||7
8561244|NCT00005906|9593120|FG000|NOT COMPLETED|Overall Study||3
8561245|NCT00005908|9593124|FG000|STARTED|Overall Study||10
8561246|NCT00005908|9593125|FG001|STARTED|Overall Study||20
8561247|NCT00005908|9593124|FG000|COMPLETED|Overall Study||9
8722682|NCT01020487|9770174|FG001|STARTED|Part 1||0
8722683|NCT01020487|9770175|FG002|STARTED|Part 1||0
8814630|NCT01533922|9867971|FG001|STARTED|Overall Study||59
8814631|NCT01533922|9867972|FG002|STARTED|Overall Study||60
8814632|NCT01533922|9867973|FG003|STARTED|Overall Study||58
8814633|NCT01533922|9867974|FG004|STARTED|Overall Study||59
8814634|NCT01533922|9867970|FG000|Received Placebo|Overall Study||0
8814635|NCT01533922|9867971|FG001|Received Placebo|Overall Study||49
8814636|NCT01533922|9867972|FG002|Received Placebo|Overall Study||57
8814637|NCT01533922|9867973|FG003|Received Placebo|Overall Study||57
8561248|NCT00005908|9593125|FG001|COMPLETED|Overall Study||20
8561249|NCT00005908|9593124|FG000|NOT COMPLETED|Overall Study||1
8561250|NCT00005908|9593125|FG001|NOT COMPLETED|Overall Study||0
8561251|NCT00005937|9593134|FG000|STARTED|Overall Study||42
8561252|NCT00005937|9593134|FG000|COMPLETED|Overall Study||37
8561253|NCT00005937|9593134|FG000|NOT COMPLETED|Overall Study||5
8561254|NCT00005947|9593140|FG000|STARTED|Overall Study||82
8561255|NCT00005947|9593141|FG001|STARTED|Overall Study||45
8561256|NCT00005947|9593140|FG000|COMPLETED|Overall Study||25
8561257|NCT00005947|9593141|FG001|COMPLETED|Overall Study||4
8561258|NCT00005947|9593140|FG000|NOT COMPLETED|Overall Study||57
8561259|NCT00005947|9593141|FG001|NOT COMPLETED|Overall Study||41
8561260|NCT00005957|9593151|FG000|STARTED|Overall Study||916
8561261|NCT00005957|9593152|FG001|STARTED|Overall Study||916
8561262|NCT00005957|9593151|FG000|COMPLETED|Overall Study||908
8561263|NCT00005957|9593152|FG001|COMPLETED|Overall Study||888
8561264|NCT00005957|9593151|FG000|NOT COMPLETED|Overall Study||8
8561265|NCT00005957|9593152|FG001|NOT COMPLETED|Overall Study||28
8561266|NCT00006011|9593161|FG000|STARTED|Overall Study|total number of participants enrolled, that received random treatment assignment to Arm 1 of study.|288
8561267|NCT00006011|9593162|FG001|STARTED|Overall Study|total number of participants enrolled, that received random treatment assignment to Arm 2 of study.|298
8561268|NCT00006011|9593163|FG002|STARTED|Overall Study|total number of participants enrolled, that only received radiation treatment.|73
8561269|NCT00006011|9593161|FG000|COMPLETED|Overall Study|total number of partipants that completed 6 cycles of chemotherapy.|223
8561270|NCT00006011|9593162|FG001|COMPLETED|Overall Study|total number of partipants that completed 6 cycles of chemotherapy.|221
8561271|NCT00006011|9593163|FG002|COMPLETED|Overall Study|total number of partipants that completed 6 cycles of chemotherapy.|0
8561272|NCT00006011|9593161|FG000|NOT COMPLETED|Overall Study||65
8561273|NCT00006011|9593162|FG001|NOT COMPLETED|Overall Study||77
8561274|NCT00006011|9593163|FG002|NOT COMPLETED|Overall Study||73
8561275|NCT00006046|9593174|FG000|STARTED|Overall Study||7
8814638|NCT01533922|9867974|FG004|Received Placebo|Overall Study||59
8814639|NCT01533922|9867970|FG000|Received Olo 5|Overall Study||51
8814640|NCT01533922|9867971|FG001|Received Olo 5|Overall Study||52
8814641|NCT01533922|9867972|FG002|Received Olo 5|Overall Study||57
8814642|NCT01533922|9867973|FG003|Received Olo 5|Overall Study||57
8814643|NCT01533922|9867974|FG004|Received Olo 5|Overall Study||0
8814644|NCT01533922|9867970|FG000|Received Tio 5|Overall Study||54
8619829|NCT00470418|9658382|FG001|STARTED|Overall Study||3
8619830|NCT00470418|9658381|FG000|COMPLETED|Overall Study||6
8619831|NCT00470418|9658382|FG001|COMPLETED|Overall Study||3
8619832|NCT00470418|9658381|FG000|NOT COMPLETED|Overall Study||1
8619833|NCT00470418|9658382|FG001|NOT COMPLETED|Overall Study||0
8619834|NCT00470470|9658388|FG000|STARTED|Overall Study||30
8619835|NCT00470470|9658388|FG000|COMPLETED|Overall Study||25
8619836|NCT00470470|9658388|FG000|NOT COMPLETED|Overall Study||5
8619837|NCT00470535|9658392|FG000|STARTED|Overall Study||18
8619838|NCT00470535|9658392|FG000|COMPLETED|Overall Study||0
8619839|NCT00470535|9658392|FG000|NOT COMPLETED|Overall Study||18
8619840|NCT00470548|9658398|FG000|STARTED|Overall Study||3
8619841|NCT00470548|9658399|FG001|STARTED|Overall Study||3
8619842|NCT00470548|9658400|FG002|STARTED|Overall Study||6
8619843|NCT00470548|9658401|FG003|STARTED|Overall Study||37
8619844|NCT00470548|9658398|FG000|COMPLETED|Overall Study||3
8619845|NCT00470548|9658399|FG001|COMPLETED|Overall Study||3
8943733|NCT02391584|10005587|FG001|STARTED|Primary Endpoint (6-weeks)||29
8943734|NCT02391584|10005586|FG000|COMPLETED|Primary Endpoint (6-weeks)||29
8943735|NCT02391584|10005587|FG001|COMPLETED|Primary Endpoint (6-weeks)||27
8943736|NCT02391584|10005586|FG000|NOT COMPLETED|Primary Endpoint (6-weeks)||2
8943737|NCT02391584|10005587|FG001|NOT COMPLETED|Primary Endpoint (6-weeks)||2
8943738|NCT02391584|10005586|FG000|STARTED|3 Month|Includes 30 balloon dilation and 23 crossover participants|53
8943739|NCT02391584|10005587|FG001|STARTED|3 Month|23 Crossover participants are included in balloon dilation arm for remainder of study visits.|0
8943740|NCT02391584|10005586|FG000|COMPLETED|3 Month||52
8943741|NCT02391584|10005587|FG001|COMPLETED|3 Month||0
8561276|NCT00006046|9593175|FG001|STARTED|Overall Study||0
8561277|NCT00006046|9593176|FG002|STARTED|Overall Study||0
8561278|NCT00006046|9593177|FG003|STARTED|Overall Study||0
8561279|NCT00006046|9593178|FG004|STARTED|Overall Study||0
8561280|NCT00006046|9593174|FG000|COMPLETED|Overall Study||2
8561281|NCT00006046|9593175|FG001|COMPLETED|Overall Study||0
8561282|NCT00006046|9593176|FG002|COMPLETED|Overall Study||0
8561283|NCT00006046|9593177|FG003|COMPLETED|Overall Study||0
8561284|NCT00006046|9593178|FG004|COMPLETED|Overall Study||0
8561285|NCT00006046|9593174|FG000|NOT COMPLETED|Overall Study||5
8561286|NCT00006046|9593175|FG001|NOT COMPLETED|Overall Study||0
8561287|NCT00006046|9593176|FG002|NOT COMPLETED|Overall Study||0
8561288|NCT00006046|9593177|FG003|NOT COMPLETED|Overall Study||0
8561289|NCT00006046|9593178|FG004|NOT COMPLETED|Overall Study||0
8561290|NCT00006099|9593192|FG000|STARTED|Overall Study||1
8561291|NCT00006099|9593193|FG001|STARTED|Overall Study||0
8561292|NCT00006099|9593192|FG000|COMPLETED|Overall Study||1
8561293|NCT00006099|9593193|FG001|COMPLETED|Overall Study||0
8561294|NCT00006099|9593192|FG000|NOT COMPLETED|Overall Study||0
8561295|NCT00006099|9593193|FG001|NOT COMPLETED|Overall Study||0
8561296|NCT00006101|9593201|FG000|STARTED|Overall Study||38
8561297|NCT00006101|9593202|FG001|STARTED|Overall Study||38
8561298|NCT00006101|9593201|FG000|COMPLETED|Overall Study||33
8561299|NCT00006101|9593202|FG001|COMPLETED|Overall Study||33
8561300|NCT00006101|9593201|FG000|NOT COMPLETED|Overall Study||5
8561301|NCT00006101|9593202|FG001|NOT COMPLETED|Overall Study||5
8561302|NCT00006110|9593210|FG000|STARTED|Overall Study||52
8561303|NCT00006110|9593211|FG001|STARTED|Overall Study||30
8561304|NCT00006110|9593210|FG000|COMPLETED|Overall Study||52
8561305|NCT00006110|9593211|FG001|COMPLETED|Overall Study||30
8561306|NCT00006110|9593210|FG000|NOT COMPLETED|Overall Study||0
8561307|NCT00006110|9593211|FG001|NOT COMPLETED|Overall Study||0
8561308|NCT00006151|9593225|FG000|STARTED|Overall Study||30
8561309|NCT00006151|9593226|FG001|STARTED|Overall Study||30
8561310|NCT00006151|9593225|FG000|COMPLETED|Overall Study||17
8561311|NCT00006151|9593226|FG001|COMPLETED|Overall Study||16
8561312|NCT00006151|9593225|FG000|NOT COMPLETED|Overall Study||13
8561313|NCT00006151|9593226|FG001|NOT COMPLETED|Overall Study||14
8561314|NCT00006156|9593234|FG000|STARTED|Overall Study||42
8561315|NCT00006156|9593235|FG001|STARTED|Overall Study||7
8561316|NCT00006156|9593234|FG000|COMPLETED|Overall Study||42
8814645|NCT01533922|9867971|FG001|Received Tio 5|Overall Study||58
8814646|NCT01533922|9867972|FG002|Received Tio 5|Overall Study||59
8814647|NCT01533922|9867973|FG003|Received Tio 5|Overall Study|One patient received Tio 5 instead of Olo 5 by mistake.|1
8561317|NCT00006156|9593235|FG001|COMPLETED|Overall Study||7
8561318|NCT00006156|9593234|FG000|NOT COMPLETED|Overall Study||0
8561319|NCT00006156|9593235|FG001|NOT COMPLETED|Overall Study||0
8561320|NCT00006164|9593242|FG000|STARTED|Overall Study||517
8561321|NCT00006164|9593243|FG001|STARTED|Overall Study||533
8561322|NCT00006164|9593242|FG000|COMPLETED|Overall Study|70 Withdrew or were lost to followup; 158 Discontinued peginterferon but were followed|447
8561323|NCT00006164|9593243|FG001|COMPLETED|Overall Study|81 Withdrew or were lost to followup; 9 took peginterferon outside of protocol|452
8561324|NCT00006164|9593242|FG000|NOT COMPLETED|Overall Study||70
8561325|NCT00006164|9593243|FG001|NOT COMPLETED|Overall Study||81
8561326|NCT00006170|9593253|FG000|STARTED|Overall Study||106
8561327|NCT00006170|9593254|FG001|STARTED|Overall Study||87
8814648|NCT01533922|9867974|FG004|Received Tio 5|Overall Study||54
8561328|NCT00006170|9593255|FG002|STARTED|Overall Study||89
8561329|NCT00006170|9593256|FG003|STARTED|Overall Study||67
8561330|NCT00006170|9593253|FG000|COMPLETED|Overall Study||57
8561331|NCT00006170|9593254|FG001|COMPLETED|Overall Study||37
8561332|NCT00006170|9593255|FG002|COMPLETED|Overall Study||46
8561333|NCT00006170|9593256|FG003|COMPLETED|Overall Study||28
8561334|NCT00006170|9593253|FG000|NOT COMPLETED|Overall Study||49
8561335|NCT00006170|9593254|FG001|NOT COMPLETED|Overall Study||50
8561336|NCT00006170|9593255|FG002|NOT COMPLETED|Overall Study||43
8561337|NCT00006170|9593256|FG003|NOT COMPLETED|Overall Study||39
8569085|NCT00095147|9601274|FG002|COMPLETED|Long-term Extension Period||0
8569086|NCT00095147|9601275|FG003|COMPLETED|Long-term Extension Period||0
8569087|NCT00095147|9601276|FG004|COMPLETED|Long-term Extension Period||327
8569088|NCT00095147|9601272|FG000|NOT COMPLETED|Long-term Extension Period||0
8569089|NCT00095147|9601273|FG001|NOT COMPLETED|Long-term Extension Period||0
8569090|NCT00095147|9601274|FG002|NOT COMPLETED|Long-term Extension Period||0
8569091|NCT00095147|9601275|FG003|NOT COMPLETED|Long-term Extension Period||0
8569092|NCT00095147|9601276|FG004|NOT COMPLETED|Long-term Extension Period||45
8569093|NCT00095173|9601294|FG000|STARTED|Open-Label Lead-In Phase (Period A)||190
8569094|NCT00095173|9601295|FG001|STARTED|Open-Label Lead-In Phase (Period A)||0
8569095|NCT00095173|9601296|FG002|STARTED|Open-Label Lead-In Phase (Period A)||0
8569096|NCT00095173|9601297|FG003|STARTED|Open-Label Lead-In Phase (Period A)||0
8569097|NCT00095173|9601298|FG004|STARTED|Open-Label Lead-In Phase (Period A)||0
8569098|NCT00095173|9601299|FG005|STARTED|Open-Label Lead-In Phase (Period A)||0
8569099|NCT00095173|9601294|FG000|COMPLETED|Open-Label Lead-In Phase (Period A)||170
8569100|NCT00095173|9601295|FG001|COMPLETED|Open-Label Lead-In Phase (Period A)||0
8569101|NCT00095173|9601296|FG002|COMPLETED|Open-Label Lead-In Phase (Period A)||0
8569102|NCT00095173|9601297|FG003|COMPLETED|Open-Label Lead-In Phase (Period A)||0
8569103|NCT00095173|9601298|FG004|COMPLETED|Open-Label Lead-In Phase (Period A)||0
8569104|NCT00095173|9601299|FG005|COMPLETED|Open-Label Lead-In Phase (Period A)||0
8569105|NCT00095173|9601294|FG000|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||20
8569106|NCT00095173|9601295|FG001|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
8569107|NCT00095173|9601296|FG002|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
8569108|NCT00095173|9601297|FG003|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
8569109|NCT00095173|9601298|FG004|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
8569110|NCT00095173|9601299|FG005|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
8569111|NCT00095173|9601294|FG000|STARTED|Double-Blind Phase (Period B)|All participants did not continue; responders entered Period B; non-responders re-entered Period C.|0
8569112|NCT00095173|9601295|FG001|STARTED|Double-Blind Phase (Period B)|123 responders from Period A qualified;122 entered and were randomized to abatacept and placebo.|60
8569113|NCT00095173|9601296|FG002|STARTED|Double-Blind Phase (Period B)|123 responders from Period A qualified;122 entered and were randomized to abatacept and placebo.|62
8569114|NCT00095173|9601297|FG003|STARTED|Double-Blind Phase (Period B)||0
8569115|NCT00095173|9601298|FG004|STARTED|Double-Blind Phase (Period B)||0
8569116|NCT00095173|9601299|FG005|STARTED|Double-Blind Phase (Period B)||0
8569117|NCT00095173|9601294|FG000|COMPLETED|Double-Blind Phase (Period B)||0
8569118|NCT00095173|9601295|FG001|COMPLETED|Double-Blind Phase (Period B)||49
8569119|NCT00095173|9601296|FG002|COMPLETED|Double-Blind Phase (Period B)||31
8569120|NCT00095173|9601297|FG003|COMPLETED|Double-Blind Phase (Period B)||0
8569121|NCT00095173|9601298|FG004|COMPLETED|Double-Blind Phase (Period B)||0
8569122|NCT00095173|9601299|FG005|COMPLETED|Double-Blind Phase (Period B)||0
8569123|NCT00095173|9601294|FG000|NOT COMPLETED|Double-Blind Phase (Period B)||0
8569124|NCT00095173|9601295|FG001|NOT COMPLETED|Double-Blind Phase (Period B)||11
8569125|NCT00095173|9601296|FG002|NOT COMPLETED|Double-Blind Phase (Period B)||31
8569126|NCT00095173|9601297|FG003|NOT COMPLETED|Double-Blind Phase (Period B)||0
8569127|NCT00095173|9601298|FG004|NOT COMPLETED|Double-Blind Phase (Period B)||0
8569128|NCT00095173|9601299|FG005|NOT COMPLETED|Double-Blind Phase (Period B)||0
8569129|NCT00095173|9601294|FG000|STARTED|Open-Label Extension Phase (Period C)||0
8569130|NCT00095173|9601295|FG001|STARTED|Open-Label Extension Phase (Period C)||0
8569131|NCT00095173|9601296|FG002|STARTED|Open-Label Extension Phase (Period C)||0
8569451|NCT00097539|9601696|FG003|STARTED|Overall Study||5651
8619846|NCT00470548|9658400|FG002|COMPLETED|Overall Study||6
8619847|NCT00470548|9658401|FG003|COMPLETED|Overall Study||37
8619848|NCT00470548|9658398|FG000|NOT COMPLETED|Overall Study||0
8619849|NCT00470548|9658399|FG001|NOT COMPLETED|Overall Study||0
8619850|NCT00470548|9658400|FG002|NOT COMPLETED|Overall Study||0
8619851|NCT00470548|9658401|FG003|NOT COMPLETED|Overall Study||0
8619852|NCT00470600|9658413|FG000|STARTED|Overall Study||86
8619853|NCT00470600|9658414|FG001|STARTED|Overall Study||99
8619854|NCT00470600|9658413|FG000|COMPLETED|Overall Study|Two subjects were randomized to incorrect stratification categories (weight).|86
8619855|NCT00470600|9658414|FG001|COMPLETED|Overall Study|One subject was randomized to incorrect stratification categories (weight).|99
8619856|NCT00470600|9658413|FG000|NOT COMPLETED|Overall Study||0
8619857|NCT00470600|9658414|FG001|NOT COMPLETED|Overall Study||0
8619858|NCT00470626|9658420|FG000|STARTED|Overall Study||129
8619859|NCT00470626|9658420|FG000|COMPLETED|Overall Study||112
8619860|NCT00470626|9658420|FG000|NOT COMPLETED|Overall Study||17
8619861|NCT00470717|9658424|FG000|STARTED|Overall Study|Each participant could be called up to 4 times weekly for 13 weeks (38x4x13)|38
8619862|NCT00470717|9658424|FG000|COMPLETED|Overall Study||38
8619863|NCT00470717|9658424|FG000|NOT COMPLETED|Overall Study||0
8619864|NCT00470834|9658430|FG000|STARTED|Treatment Period (18 Months)||65
8619865|NCT00470834|9658431|FG001|STARTED|Treatment Period (18 Months)||62
8619866|NCT00470834|9658430|FG000|COMPLETED|Treatment Period (18 Months)||27
8619867|NCT00470834|9658431|FG001|COMPLETED|Treatment Period (18 Months)||31
8619868|NCT00470834|9658430|FG000|NOT COMPLETED|Treatment Period (18 Months)||38
8619869|NCT00470834|9658431|FG001|NOT COMPLETED|Treatment Period (18 Months)||31
8619870|NCT00470834|9658430|FG000|STARTED|Extension Period (24 Months)|One participant who completed the Treatment Period did not participate in the Extension Period.|26
8619871|NCT00470834|9658431|FG001|STARTED|Extension Period (24 Months)|One participant who completed the Treatment Period did not participate in the Extension Period.|30
8619872|NCT00470834|9658430|FG000|COMPLETED|Extension Period (24 Months)||11
8619873|NCT00470834|9658431|FG001|COMPLETED|Extension Period (24 Months)||7
8619874|NCT00470834|9658430|FG000|NOT COMPLETED|Extension Period (24 Months)||15
8619875|NCT00470834|9658431|FG001|NOT COMPLETED|Extension Period (24 Months)||23
8619876|NCT00470847|9658437|FG000|STARTED|Overall Study||35
8619877|NCT00470847|9658437|FG000|COMPLETED|Overall Study||34
8619878|NCT00470847|9658437|FG000|NOT COMPLETED|Overall Study||1
8629409|NCT00529802|9669139|FG000|NOT COMPLETED|Evaluable for Secondary Endpoint||2
8629410|NCT00529958|9669148|FG000|STARTED|2-Year Follow-up||110
8629411|NCT00529958|9669149|FG001|STARTED|2-Year Follow-up|110 randomized to HT, but there was (n=1) cross-over from the DB group|110
8629412|NCT00529958|9669150|FG002|STARTED|2-Year Follow-up|110 randomized to DB, but there was (n=1) cross-over to the HT group|110
8629413|NCT00529958|9669148|FG000|COMPLETED|2-Year Follow-up||106
8629414|NCT00529958|9669149|FG001|COMPLETED|2-Year Follow-up|108 HT patients analyzed excludes n=1 cross-over patient (analyzed on intention-to-treat basis).|108
8629415|NCT00529958|9669150|FG002|COMPLETED|2-Year Follow-up|108 DB patients analyzed include 1 cross-over with HT graft (analyzed on intention-to-treat basis).|108
8629416|NCT00529958|9669148|FG000|NOT COMPLETED|2-Year Follow-up||4
8629417|NCT00529958|9669149|FG001|NOT COMPLETED|2-Year Follow-up||2
8629418|NCT00529958|9669150|FG002|NOT COMPLETED|2-Year Follow-up||2
8629419|NCT00529958|9669148|FG000|STARTED|5-Year Follow-up||106
8629661|NCT00531050|9669385|FG004|NOT COMPLETED|Part 2: Period 1||0
8619879|NCT00471068|9658445|FG000|STARTED|Overall Study||21
8619880|NCT00471068|9658446|FG001|STARTED|Overall Study||25
8619881|NCT00471068|9658445|FG000|COMPLETED|Overall Study||20
8619882|NCT00471068|9658446|FG001|COMPLETED|Overall Study||24
8619883|NCT00471068|9658445|FG000|NOT COMPLETED|Overall Study||1
8619884|NCT00471068|9658446|FG001|NOT COMPLETED|Overall Study||1
8619885|NCT00471081|9658454|FG000|STARTED|Active Phase||160
8619886|NCT00471081|9658455|FG001|STARTED|Active Phase||189
8619887|NCT00471081|9658454|FG000|COMPLETED|Active Phase||158
8619888|NCT00471081|9658455|FG001|COMPLETED|Active Phase||176
8619889|NCT00471081|9658454|FG000|NOT COMPLETED|Active Phase||2
8619890|NCT00471081|9658455|FG001|NOT COMPLETED|Active Phase||13
8619891|NCT00471081|9658454|FG000|STARTED|Extended Safety Follow-Up||160
8619892|NCT00471081|9658455|FG001|STARTED|Extended Safety Follow-Up||189
8619893|NCT00471081|9658454|FG000|COMPLETED|Extended Safety Follow-Up||158
8619894|NCT00471081|9658455|FG001|COMPLETED|Extended Safety Follow-Up||176
8619895|NCT00471081|9658454|FG000|NOT COMPLETED|Extended Safety Follow-Up||2
8619896|NCT00471081|9658455|FG001|NOT COMPLETED|Extended Safety Follow-Up||13
8619897|NCT00471107|9658465|FG000|STARTED|Overall Study||15
8619898|NCT00471107|9658466|FG001|STARTED|Overall Study||15
8619899|NCT00471107|9658467|FG002|STARTED|Overall Study||15
8619900|NCT00471107|9658465|FG000|COMPLETED|Overall Study||12
8619901|NCT00471107|9658466|FG001|COMPLETED|Overall Study||14
8619902|NCT00471107|9658467|FG002|COMPLETED|Overall Study||12
8619903|NCT00471107|9658465|FG000|NOT COMPLETED|Overall Study||3
8619904|NCT00471107|9658466|FG001|NOT COMPLETED|Overall Study||1
8619905|NCT00471107|9658467|FG002|NOT COMPLETED|Overall Study||3
8619906|NCT00471146|9658477|FG000|STARTED|Overall Study||314
8619907|NCT00471146|9658478|FG001|STARTED|Overall Study||316
8619908|NCT00471146|9658477|FG000|Treated|Overall Study||305
8619909|NCT00471146|9658478|FG001|Treated|Overall Study||308
8619910|NCT00471146|9658477|FG000|COMPLETED|Overall Study||142
8619911|NCT00471146|9658478|FG001|COMPLETED|Overall Study||142
8619912|NCT00471146|9658477|FG000|NOT COMPLETED|Overall Study||172
8619913|NCT00471146|9658478|FG001|NOT COMPLETED|Overall Study||174
8619914|NCT00471237|9658491|FG000|STARTED|Overall Study||90
8619915|NCT00471237|9658492|FG001|STARTED|Overall Study||87
8619916|NCT00471237|9658493|FG002|STARTED|Overall Study||82
8619917|NCT00471237|9658494|FG003|STARTED|Overall Study||88
8619918|NCT00471237|9658495|FG004|STARTED|Overall Study||87
8619919|NCT00471237|9658496|FG005|STARTED|Overall Study||89
8619920|NCT00471237|9658497|FG006|STARTED|Overall Study||41
8619921|NCT00471237|9658491|FG000|COMPLETED|Overall Study||49
8619922|NCT00471237|9658492|FG001|COMPLETED|Overall Study||45
8619923|NCT00471237|9658493|FG002|COMPLETED|Overall Study||48
8619924|NCT00471237|9658494|FG003|COMPLETED|Overall Study||43
8619925|NCT00471237|9658495|FG004|COMPLETED|Overall Study||46
8814649|NCT01533922|9867970|FG000|Received Tio+Olo 2.5/5|Overall Study||59
8814650|NCT01533922|9867971|FG001|Received Tio+Olo 2.5/5|Overall Study||0
8814651|NCT01533922|9867972|FG002|Received Tio+Olo 2.5/5|Overall Study||52
8619926|NCT00471237|9658496|FG005|COMPLETED|Overall Study||50
8619927|NCT00471237|9658497|FG006|COMPLETED|Overall Study||38
8619928|NCT00471237|9658491|FG000|NOT COMPLETED|Overall Study||41
8619929|NCT00471237|9658492|FG001|NOT COMPLETED|Overall Study||42
8619930|NCT00471237|9658493|FG002|NOT COMPLETED|Overall Study||34
8619931|NCT00471237|9658494|FG003|NOT COMPLETED|Overall Study||45
8619932|NCT00471237|9658495|FG004|NOT COMPLETED|Overall Study||41
8619933|NCT00471237|9658496|FG005|NOT COMPLETED|Overall Study||39
8814652|NCT01533922|9867973|FG003|Received Tio+Olo 2.5/5|Overall Study||55
8814653|NCT01533922|9867974|FG004|Received Tio+Olo 2.5/5|Overall Study||56
8814654|NCT01533922|9867970|FG000|Received Tio+Olo 5/5|Overall Study||58
8619934|NCT00471237|9658497|FG006|NOT COMPLETED|Overall Study||3
8619935|NCT00471276|9658517|FG000|STARTED|Overall Study||83
8619936|NCT00471276|9658517|FG000|COMPLETED|Overall Study||0
8619937|NCT00471276|9658517|FG000|NOT COMPLETED|Overall Study||83
8619938|NCT00471315|9658521|FG000|STARTED|Overall Study||18
8619939|NCT00471315|9658521|FG000|COMPLETED|Overall Study||10
8619940|NCT00471315|9658521|FG000|NOT COMPLETED|Overall Study||8
8619941|NCT00471328|9658527|FG000|STARTED|Core Phase||165
8619942|NCT00471328|9658528|FG001|STARTED|Core Phase||83
8619943|NCT00471328|9658527|FG000|Crossover to Nilotinib:Started Extension|Core Phase||0
8619944|NCT00471328|9658528|FG001|Crossover to Nilotinib:Started Extension|Core Phase||53
8619945|NCT00471328|9658527|FG000|COMPLETED|Core Phase|Ongoing on treatment during completion of core.|58
8619946|NCT00471328|9658528|FG001|COMPLETED|Core Phase|Ongoing on treatment during completion of core|16
8619947|NCT00471328|9658527|FG000|NOT COMPLETED|Core Phase||107
8619948|NCT00471328|9658528|FG001|NOT COMPLETED|Core Phase||67
8619949|NCT00471328|9658527|FG000|STARTED|Extension Phase|Out of 58 ongoing patients, 17 patients had progression or died before they could enter extension|41
8619950|NCT00471328|9658528|FG001|STARTED|Extension Phase||67
8619951|NCT00471328|9658527|FG000|Started:CrossOver Before PrimaryAnalysis|Extension Phase||0
8619952|NCT00471328|9658528|FG001|Started:CrossOver Before PrimaryAnalysis|Extension Phase||53
8619953|NCT00471328|9658527|FG000|Started:CrossOver After PrimaryAnalysis|Extension Phase||0
8619954|NCT00471328|9658528|FG001|Started:CrossOver After PrimaryAnalysis|Extension Phase||4
8619955|NCT00471328|9658527|FG000|Started:CrossOver During Extension|Extension Phase||0
8619956|NCT00471328|9658528|FG001|Started:CrossOver During Extension|Extension Phase||10
8619957|NCT00471328|9658527|FG000|COMPLETED|Extension Phase||0
8619958|NCT00471328|9658528|FG001|COMPLETED|Extension Phase||0
8619959|NCT00471328|9658527|FG000|NOT COMPLETED|Extension Phase||41
8619960|NCT00471328|9658528|FG001|NOT COMPLETED|Extension Phase||67
8619961|NCT00471354|9658536|FG000|STARTED|Overall Study||228
8619962|NCT00471354|9658536|FG000|COMPLETED|Overall Study||176
8619963|NCT00471354|9658536|FG000|NOT COMPLETED|Overall Study||52
8619964|NCT00471380|9658540|FG000|STARTED|First Intervention||22
8619965|NCT00471380|9658541|FG001|STARTED|First Intervention||24
8619966|NCT00471380|9658540|FG000|COMPLETED|First Intervention||18
8619967|NCT00471380|9658541|FG001|COMPLETED|First Intervention||20
8619968|NCT00471380|9658540|FG000|NOT COMPLETED|First Intervention||4
8619969|NCT00471380|9658541|FG001|NOT COMPLETED|First Intervention||4
8619970|NCT00471380|9658540|FG000|STARTED|Second Intervention||18
8561338|NCT04323800|9593268|FG000|STARTED|Overall Study||87
8561339|NCT04323800|9593269|FG001|STARTED|Overall Study||93
8561340|NCT04323800|9593268|FG000|COMPLETED|Overall Study||81
8561341|NCT04323800|9593269|FG001|COMPLETED|Overall Study||87
8561342|NCT04323800|9593268|FG000|NOT COMPLETED|Overall Study||6
8561343|NCT04323800|9593269|FG001|NOT COMPLETED|Overall Study||6
8561409|NCT03527264|9593332|FG001|COMPLETED|Overall Study||1
8561410|NCT03527264|9593333|FG002|COMPLETED|Overall Study||0
8561411|NCT03527264|9593334|FG003|COMPLETED|Overall Study||0
8561412|NCT03527264|9593331|FG000|NOT COMPLETED|Overall Study||0
8561413|NCT03527264|9593332|FG001|NOT COMPLETED|Overall Study||0
8561414|NCT03527264|9593333|FG002|NOT COMPLETED|Overall Study||0
8561415|NCT03527264|9593334|FG003|NOT COMPLETED|Overall Study||0
8569132|NCT00095173|9601297|FG003|STARTED|Open-Label Extension Phase (Period C)|Participants were non-responders from Period A who re-entered in Period C.|36
8569133|NCT00095173|9601298|FG004|STARTED|Open-Label Extension Phase (Period C)|Includes 47 who completed Period B with no flare and 11 who discontinued Period B due to a flare|58
8569134|NCT00095173|9601299|FG005|STARTED|Open-Label Extension Phase (Period C)|Includes 33 who discontinued Period B due to a flare and 26 who completed Period B with no flare|59
8814655|NCT01533922|9867971|FG001|Received Tio+Olo 5/5|Overall Study||59
8814656|NCT01533922|9867972|FG002|Received Tio+Olo 5/5|Overall Study||0
8814657|NCT01533922|9867973|FG003|Received Tio+Olo 5/5|Overall Study||53
8814658|NCT01533922|9867974|FG004|Received Tio+Olo 5/5|Overall Study||56
8814659|NCT01533922|9867970|FG000|COMPLETED|Overall Study|Completed all treatment arms|49
8814660|NCT01533922|9867971|FG001|COMPLETED|Overall Study|Completed all treatment arms|47
8814661|NCT01533922|9867972|FG002|COMPLETED|Overall Study|Completed all treatment arms|50
8814662|NCT01533922|9867973|FG003|COMPLETED|Overall Study|Completed all treatment arms|53
8814663|NCT01533922|9867974|FG004|COMPLETED|Overall Study|Completed all treatment arms|53
8814664|NCT01533922|9867970|FG000|NOT COMPLETED|Overall Study||10
8814665|NCT01533922|9867971|FG001|NOT COMPLETED|Overall Study||12
8814666|NCT01533922|9867972|FG002|NOT COMPLETED|Overall Study||10
8814667|NCT01533922|9867973|FG003|NOT COMPLETED|Overall Study||5
8814668|NCT01533922|9867974|FG004|NOT COMPLETED|Overall Study||6
8814669|NCT01533935|9867986|FG000|STARTED|Overall Study||58
8814670|NCT01533935|9867987|FG001|STARTED|Overall Study||58
8569135|NCT00095173|9601294|FG000|COMPLETED|Open-Label Extension Phase (Period C)||0
8569136|NCT00095173|9601295|FG001|COMPLETED|Open-Label Extension Phase (Period C)||0
8569137|NCT00095173|9601296|FG002|COMPLETED|Open-Label Extension Phase (Period C)||0
8569138|NCT00095173|9601297|FG003|COMPLETED|Open-Label Extension Phase (Period C)||13
8569139|NCT00095173|9601298|FG004|COMPLETED|Open-Label Extension Phase (Period C)||29
8569140|NCT00095173|9601299|FG005|COMPLETED|Open-Label Extension Phase (Period C)||27
8814671|NCT01533935|9867988|FG002|STARTED|Overall Study||58
8814672|NCT01533935|9867989|FG003|STARTED|Overall Study||59
8814673|NCT01533935|9867990|FG004|STARTED|Overall Study||58
8814674|NCT01533935|9867986|FG000|Received Placebo|Overall Study||0
8569141|NCT00095173|9601294|FG000|NOT COMPLETED|Open-Label Extension Phase (Period C)||0
8619971|NCT00471380|9658541|FG001|STARTED|Second Intervention||20
8619972|NCT00471380|9658540|FG000|COMPLETED|Second Intervention||18
8619973|NCT00471380|9658541|FG001|COMPLETED|Second Intervention||16
8619974|NCT00471380|9658540|FG000|NOT COMPLETED|Second Intervention||0
8814675|NCT01533935|9867987|FG001|Received Placebo|Overall Study||47
8814676|NCT01533935|9867988|FG002|Received Placebo|Overall Study||52
8814677|NCT01533935|9867989|FG003|Received Placebo|Overall Study||57
8814678|NCT01533935|9867990|FG004|Received Placebo|Overall Study||58
8814679|NCT01533935|9867986|FG000|Received Olo 5|Overall Study||52
8561344|NCT04279925|9593277|FG000|STARTED|Overall Study||4
8561345|NCT04279925|9593278|FG001|STARTED|Overall Study||5
8561346|NCT04279925|9593277|FG000|COMPLETED|Overall Study||4
8561347|NCT04279925|9593278|FG001|COMPLETED|Overall Study||5
8561348|NCT04279925|9593277|FG000|NOT COMPLETED|Overall Study||0
8561349|NCT04279925|9593278|FG001|NOT COMPLETED|Overall Study||0
8561350|NCT04110145|9593289|FG000|STARTED|Double-Blind Treatment Period (4 Weeks)||7
8561351|NCT04110145|9593290|FG001|STARTED|Double-Blind Treatment Period (4 Weeks)||7
8561352|NCT04110145|9593291|FG002|STARTED|Double-Blind Treatment Period (4 Weeks)||6
8561353|NCT04110145|9593292|FG003|STARTED|Double-Blind Treatment Period (4 Weeks)||7
8561354|NCT04110145|9593293|FG004|STARTED|Double-Blind Treatment Period (4 Weeks)||8
8561355|NCT04110145|9593289|FG000|COMPLETED|Double-Blind Treatment Period (4 Weeks)||7
8561356|NCT04110145|9593290|FG001|COMPLETED|Double-Blind Treatment Period (4 Weeks)||7
8561357|NCT04110145|9593291|FG002|COMPLETED|Double-Blind Treatment Period (4 Weeks)||6
8561358|NCT04110145|9593292|FG003|COMPLETED|Double-Blind Treatment Period (4 Weeks)||6
8561359|NCT04110145|9593293|FG004|COMPLETED|Double-Blind Treatment Period (4 Weeks)||8
8561360|NCT04110145|9593289|FG000|NOT COMPLETED|Double-Blind Treatment Period (4 Weeks)||0
8561361|NCT04110145|9593290|FG001|NOT COMPLETED|Double-Blind Treatment Period (4 Weeks)||0
8561362|NCT04110145|9593291|FG002|NOT COMPLETED|Double-Blind Treatment Period (4 Weeks)||0
8561363|NCT04110145|9593292|FG003|NOT COMPLETED|Double-Blind Treatment Period (4 Weeks)||1
8561364|NCT04110145|9593293|FG004|NOT COMPLETED|Double-Blind Treatment Period (4 Weeks)||0
8561365|NCT04110145|9593289|FG000|STARTED|Post-Treatment Period (1 Week)||7
8561366|NCT04110145|9593290|FG001|STARTED|Post-Treatment Period (1 Week)||7
8561367|NCT04110145|9593291|FG002|STARTED|Post-Treatment Period (1 Week)||5
8561368|NCT04110145|9593292|FG003|STARTED|Post-Treatment Period (1 Week)||6
8561369|NCT04110145|9593293|FG004|STARTED|Post-Treatment Period (1 Week)||8
8561370|NCT04110145|9593289|FG000|COMPLETED|Post-Treatment Period (1 Week)||7
8561371|NCT04110145|9593290|FG001|COMPLETED|Post-Treatment Period (1 Week)||7
8561372|NCT04110145|9593291|FG002|COMPLETED|Post-Treatment Period (1 Week)||5
8561373|NCT04110145|9593292|FG003|COMPLETED|Post-Treatment Period (1 Week)||6
8561374|NCT04110145|9593293|FG004|COMPLETED|Post-Treatment Period (1 Week)||8
8561375|NCT04110145|9593289|FG000|NOT COMPLETED|Post-Treatment Period (1 Week)||0
8561376|NCT04110145|9593290|FG001|NOT COMPLETED|Post-Treatment Period (1 Week)||0
8561377|NCT04110145|9593291|FG002|NOT COMPLETED|Post-Treatment Period (1 Week)||0
8561378|NCT04110145|9593292|FG003|NOT COMPLETED|Post-Treatment Period (1 Week)||0
8561379|NCT04110145|9593293|FG004|NOT COMPLETED|Post-Treatment Period (1 Week)||0
8561380|NCT03986866|9593307|FG000|STARTED|Overall Study||55
8561381|NCT03986866|9593308|FG001|STARTED|Overall Study||55
8561382|NCT03986866|9593307|FG000|COMPLETED|Overall Study||53
8561383|NCT03986866|9593308|FG001|COMPLETED|Overall Study||50
8561384|NCT03986866|9593307|FG000|NOT COMPLETED|Overall Study||2
8561385|NCT03986866|9593308|FG001|NOT COMPLETED|Overall Study||5
8561386|NCT03636269|9593316|FG000|STARTED|Period 1: Double-blind Phase||235
8561387|NCT03636269|9593317|FG001|STARTED|Period 1: Double-blind Phase||236
8561388|NCT03636269|9593318|FG002|STARTED|Period 1: Double-blind Phase||0
8561389|NCT03636269|9593316|FG000|COMPLETED|Period 1: Double-blind Phase||206
8561390|NCT03636269|9593317|FG001|COMPLETED|Period 1: Double-blind Phase||223
8561391|NCT03636269|9593318|FG002|COMPLETED|Period 1: Double-blind Phase||0
8561392|NCT03636269|9593316|FG000|NOT COMPLETED|Period 1: Double-blind Phase||29
8561393|NCT03636269|9593317|FG001|NOT COMPLETED|Period 1: Double-blind Phase||13
8561394|NCT03636269|9593318|FG002|NOT COMPLETED|Period 1: Double-blind Phase||0
8561395|NCT03636269|9593316|FG000|STARTED|Period 2: Open-label Phase||0
8561396|NCT03636269|9593317|FG001|STARTED|Period 2: Open-label Phase||0
8561397|NCT03636269|9593318|FG002|STARTED|Period 2: Open-label Phase||399
8561398|NCT03636269|9593316|FG000|COMPLETED|Period 2: Open-label Phase||0
8561399|NCT03636269|9593317|FG001|COMPLETED|Period 2: Open-label Phase||0
8561400|NCT03636269|9593318|FG002|COMPLETED|Period 2: Open-label Phase||5
8561401|NCT03636269|9593316|FG000|NOT COMPLETED|Period 2: Open-label Phase||0
8561402|NCT03636269|9593317|FG001|NOT COMPLETED|Period 2: Open-label Phase||0
8561403|NCT03636269|9593318|FG002|NOT COMPLETED|Period 2: Open-label Phase||394
8561404|NCT03527264|9593331|FG000|STARTED|Overall Study||3
8561405|NCT03527264|9593332|FG001|STARTED|Overall Study||1
8561406|NCT03527264|9593333|FG002|STARTED|Overall Study||0
8561407|NCT03527264|9593334|FG003|STARTED|Overall Study||0
8561408|NCT03527264|9593331|FG000|COMPLETED|Overall Study||3
8814680|NCT01533935|9867987|FG001|Received Olo 5|Overall Study||52
8619975|NCT00471380|9658541|FG001|NOT COMPLETED|Second Intervention||4
8619976|NCT00471380|9658540|FG000|STARTED|Third Intervention||18
8619977|NCT00471380|9658541|FG001|STARTED|Third Intervention||16
8619978|NCT00471380|9658540|FG000|COMPLETED|Third Intervention||17
8619979|NCT00471380|9658541|FG001|COMPLETED|Third Intervention||14
8561416|NCT03447314|9593358|FG000|STARTED|Part 1 (Up to 27 Months)||9
8561417|NCT03447314|9593359|FG001|STARTED|Part 1 (Up to 27 Months)||6
8561418|NCT03447314|9593360|FG002|STARTED|Part 1 (Up to 27 Months)||9
8561419|NCT03447314|9593361|FG003|STARTED|Part 1 (Up to 27 Months)||4
8561420|NCT03447314|9593362|FG004|STARTED|Part 1 (Up to 27 Months)||2
8561421|NCT03447314|9593363|FG005|STARTED|Part 1 (Up to 27 Months)||6
8561422|NCT03447314|9593364|FG006|STARTED|Part 1 (Up to 27 Months)||5
8561423|NCT03447314|9593365|FG007|STARTED|Part 1 (Up to 27 Months)||0
8561424|NCT03447314|9593366|FG008|STARTED|Part 1 (Up to 27 Months)||0
8561425|NCT03447314|9593367|FG009|STARTED|Part 1 (Up to 27 Months)||0
8561426|NCT03447314|9593368|FG010|STARTED|Part 1 (Up to 27 Months)||7
8561427|NCT03447314|9593369|FG011|STARTED|Part 1 (Up to 27 Months)||6
8561428|NCT03447314|9593370|FG012|STARTED|Part 1 (Up to 27 Months)||0
8561429|NCT03447314|9593371|FG013|STARTED|Part 1 (Up to 27 Months)||0
8561430|NCT03447314|9593372|FG014|STARTED|Part 1 (Up to 27 Months)||0
8561431|NCT03447314|9593373|FG015|STARTED|Part 1 (Up to 27 Months)||0
8561432|NCT03447314|9593374|FG016|STARTED|Part 1 (Up to 27 Months)||0
8561433|NCT03447314|9593375|FG017|STARTED|Part 1 (Up to 27 Months)||0
8561434|NCT03447314|9593358|FG000|COMPLETED|Part 1 (Up to 27 Months)||0
8561435|NCT03447314|9593359|FG001|COMPLETED|Part 1 (Up to 27 Months)||0
8561436|NCT03447314|9593360|FG002|COMPLETED|Part 1 (Up to 27 Months)||0
8561437|NCT03447314|9593361|FG003|COMPLETED|Part 1 (Up to 27 Months)||0
8561438|NCT03447314|9593362|FG004|COMPLETED|Part 1 (Up to 27 Months)||0
8561439|NCT03447314|9593363|FG005|COMPLETED|Part 1 (Up to 27 Months)||0
8561440|NCT03447314|9593364|FG006|COMPLETED|Part 1 (Up to 27 Months)||0
8561441|NCT03447314|9593365|FG007|COMPLETED|Part 1 (Up to 27 Months)||0
8561442|NCT03447314|9593366|FG008|COMPLETED|Part 1 (Up to 27 Months)||0
8561443|NCT03447314|9593367|FG009|COMPLETED|Part 1 (Up to 27 Months)||0
8561444|NCT03447314|9593368|FG010|COMPLETED|Part 1 (Up to 27 Months)||0
8561445|NCT03447314|9593369|FG011|COMPLETED|Part 1 (Up to 27 Months)||0
8561446|NCT03447314|9593370|FG012|COMPLETED|Part 1 (Up to 27 Months)||0
8561447|NCT03447314|9593371|FG013|COMPLETED|Part 1 (Up to 27 Months)||0
8561448|NCT03447314|9593372|FG014|COMPLETED|Part 1 (Up to 27 Months)||0
8561449|NCT03447314|9593373|FG015|COMPLETED|Part 1 (Up to 27 Months)||0
8561450|NCT03447314|9593374|FG016|COMPLETED|Part 1 (Up to 27 Months)||0
8561451|NCT03447314|9593375|FG017|COMPLETED|Part 1 (Up to 27 Months)||0
8561452|NCT03447314|9593358|FG000|NOT COMPLETED|Part 1 (Up to 27 Months)||9
8561453|NCT03447314|9593359|FG001|NOT COMPLETED|Part 1 (Up to 27 Months)||6
8561454|NCT03447314|9593360|FG002|NOT COMPLETED|Part 1 (Up to 27 Months)||9
8561455|NCT03447314|9593361|FG003|NOT COMPLETED|Part 1 (Up to 27 Months)||4
8561456|NCT03447314|9593362|FG004|NOT COMPLETED|Part 1 (Up to 27 Months)||2
8561457|NCT03447314|9593363|FG005|NOT COMPLETED|Part 1 (Up to 27 Months)||6
8561458|NCT03447314|9593364|FG006|NOT COMPLETED|Part 1 (Up to 27 Months)||5
8561459|NCT03447314|9593365|FG007|NOT COMPLETED|Part 1 (Up to 27 Months)||0
8561460|NCT03447314|9593366|FG008|NOT COMPLETED|Part 1 (Up to 27 Months)||0
8561461|NCT03447314|9593367|FG009|NOT COMPLETED|Part 1 (Up to 27 Months)||0
8561462|NCT03447314|9593368|FG010|NOT COMPLETED|Part 1 (Up to 27 Months)||7
8561463|NCT03447314|9593369|FG011|NOT COMPLETED|Part 1 (Up to 27 Months)||6
8561464|NCT03447314|9593370|FG012|NOT COMPLETED|Part 1 (Up to 27 Months)||0
8561465|NCT03447314|9593371|FG013|NOT COMPLETED|Part 1 (Up to 27 Months)||0
8561466|NCT03447314|9593372|FG014|NOT COMPLETED|Part 1 (Up to 27 Months)||0
8561467|NCT03447314|9593373|FG015|NOT COMPLETED|Part 1 (Up to 27 Months)||0
8561468|NCT03447314|9593374|FG016|NOT COMPLETED|Part 1 (Up to 27 Months)||0
8561469|NCT03447314|9593375|FG017|NOT COMPLETED|Part 1 (Up to 27 Months)||0
8561470|NCT03447314|9593358|FG000|STARTED|Part 2 (Up to 27 Months)||0
8561471|NCT03447314|9593359|FG001|STARTED|Part 2 (Up to 27 Months)||0
8561472|NCT03447314|9593360|FG002|STARTED|Part 2 (Up to 27 Months)||0
8561473|NCT03447314|9593361|FG003|STARTED|Part 2 (Up to 27 Months)||0
8561474|NCT03447314|9593362|FG004|STARTED|Part 2 (Up to 27 Months)||0
8814681|NCT01533935|9867988|FG002|Received Olo 5|Overall Study||55
8814682|NCT01533935|9867989|FG003|Received Olo 5|Overall Study||59
8814683|NCT01533935|9867990|FG004|Received Olo 5|Overall Study||0
8814684|NCT01533935|9867986|FG000|Received Tio 5|Overall Study||54
8814685|NCT01533935|9867987|FG001|Received Tio 5|Overall Study||54
8814686|NCT01533935|9867988|FG002|Received Tio 5|Overall Study||58
8814687|NCT01533935|9867989|FG003|Received Tio 5|Overall Study||0
8814688|NCT01533935|9867990|FG004|Received Tio 5|Overall Study||52
8814689|NCT01533935|9867986|FG000|Received Tio+Olo 2.5/5|Overall Study||58
8814690|NCT01533935|9867987|FG001|Received Tio+Olo 2.5/5|Overall Study||0
8814691|NCT01533935|9867988|FG002|Received Tio+Olo 2.5/5|Overall Study||49
8814692|NCT01533935|9867989|FG003|Received Tio+Olo 2.5/5|Overall Study||56
8561475|NCT03447314|9593363|FG005|STARTED|Part 2 (Up to 27 Months)||0
8561476|NCT03447314|9593364|FG006|STARTED|Part 2 (Up to 27 Months)||0
8561477|NCT03447314|9593365|FG007|STARTED|Part 2 (Up to 27 Months)||0
8561478|NCT03447314|9593366|FG008|STARTED|Part 2 (Up to 27 Months)||0
8561479|NCT03447314|9593367|FG009|STARTED|Part 2 (Up to 27 Months)||0
8561480|NCT03447314|9593368|FG010|STARTED|Part 2 (Up to 27 Months)||0
8561481|NCT03447314|9593369|FG011|STARTED|Part 2 (Up to 27 Months)||0
8561482|NCT03447314|9593370|FG012|STARTED|Part 2 (Up to 27 Months)||0
8561483|NCT03447314|9593371|FG013|STARTED|Part 2 (Up to 27 Months)||0
8561484|NCT03447314|9593372|FG014|STARTED|Part 2 (Up to 27 Months)||0
8561485|NCT03447314|9593373|FG015|STARTED|Part 2 (Up to 27 Months)||0
8561486|NCT03447314|9593374|FG016|STARTED|Part 2 (Up to 27 Months)||0
8561487|NCT03447314|9593375|FG017|STARTED|Part 2 (Up to 27 Months)||0
8561488|NCT03447314|9593358|FG000|COMPLETED|Part 2 (Up to 27 Months)||0
8814693|NCT01533935|9867990|FG004|Received Tio+Olo 2.5/5|Overall Study||56
8814694|NCT01533935|9867986|FG000|Received Tio+Olo 5/5|Overall Study||56
8814695|NCT01533935|9867987|FG001|Received Tio+Olo 5/5|Overall Study||58
8814696|NCT01533935|9867988|FG002|Received Tio+Olo 5/5|Overall Study|One patient received Tio+Olo 5/5 instead of Tio+Olo 2.5/5 by mistake.|1
8814697|NCT01533935|9867989|FG003|Received Tio+Olo 5/5|Overall Study||54
8814698|NCT01533935|9867990|FG004|Received Tio+Olo 5/5|Overall Study||55
8814699|NCT01533935|9867986|FG000|COMPLETED|Overall Study|All treatment periods|52
8814700|NCT01533935|9867987|FG001|COMPLETED|Overall Study|All treatment periods|45
8814701|NCT01533935|9867988|FG002|COMPLETED|Overall Study|All treatment periods|50
8814702|NCT01533935|9867989|FG003|COMPLETED|Overall Study|All treatment periods|52
8814703|NCT01533935|9867990|FG004|COMPLETED|Overall Study|All treatment periods|50
8814704|NCT01533935|9867986|FG000|NOT COMPLETED|Overall Study||6
8814705|NCT01533935|9867987|FG001|NOT COMPLETED|Overall Study||13
8814706|NCT01533935|9867988|FG002|NOT COMPLETED|Overall Study||8
8814707|NCT01533935|9867989|FG003|NOT COMPLETED|Overall Study||7
8814708|NCT01533935|9867990|FG004|NOT COMPLETED|Overall Study||8
8814709|NCT01533948|9868002|FG000|STARTED|Overall Study||25
8561489|NCT03447314|9593359|FG001|COMPLETED|Part 2 (Up to 27 Months)||0
8561490|NCT03447314|9593360|FG002|COMPLETED|Part 2 (Up to 27 Months)||0
8561491|NCT03447314|9593361|FG003|COMPLETED|Part 2 (Up to 27 Months)||0
8561492|NCT03447314|9593362|FG004|COMPLETED|Part 2 (Up to 27 Months)||0
8561493|NCT03447314|9593363|FG005|COMPLETED|Part 2 (Up to 27 Months)||0
8814710|NCT01533948|9868002|FG000|COMPLETED|Overall Study||25
8814711|NCT01533948|9868002|FG000|NOT COMPLETED|Overall Study||0
8814712|NCT01533974|9868008|FG000|STARTED|Overall Study||224
8814713|NCT01533974|9868009|FG001|STARTED|Overall Study||226
8814714|NCT01533974|9868008|FG000|COMPLETED|Overall Study||173
8814715|NCT01533974|9868009|FG001|COMPLETED|Overall Study||176
8561494|NCT03447314|9593364|FG006|COMPLETED|Part 2 (Up to 27 Months)||0
8561495|NCT03447314|9593365|FG007|COMPLETED|Part 2 (Up to 27 Months)||0
8561496|NCT03447314|9593366|FG008|COMPLETED|Part 2 (Up to 27 Months)||0
8561497|NCT03447314|9593367|FG009|COMPLETED|Part 2 (Up to 27 Months)||0
8561498|NCT03447314|9593368|FG010|COMPLETED|Part 2 (Up to 27 Months)||0
8561499|NCT03447314|9593369|FG011|COMPLETED|Part 2 (Up to 27 Months)||0
8561500|NCT03447314|9593370|FG012|COMPLETED|Part 2 (Up to 27 Months)||0
8561501|NCT03447314|9593371|FG013|COMPLETED|Part 2 (Up to 27 Months)||0
8561502|NCT03447314|9593372|FG014|COMPLETED|Part 2 (Up to 27 Months)||0
8561503|NCT03447314|9593373|FG015|COMPLETED|Part 2 (Up to 27 Months)||0
8619980|NCT00471380|9658540|FG000|NOT COMPLETED|Third Intervention||1
8619981|NCT00471380|9658541|FG001|NOT COMPLETED|Third Intervention||2
8619982|NCT00471445|9658549|FG000|STARTED|Overall Study||229
8619983|NCT00471445|9658550|FG001|STARTED|Overall Study||233
8561504|NCT03447314|9593374|FG016|COMPLETED|Part 2 (Up to 27 Months)||0
8561505|NCT03447314|9593375|FG017|COMPLETED|Part 2 (Up to 27 Months)||0
8561506|NCT03447314|9593358|FG000|NOT COMPLETED|Part 2 (Up to 27 Months)||0
8561507|NCT03447314|9593359|FG001|NOT COMPLETED|Part 2 (Up to 27 Months)||0
8561508|NCT03447314|9593360|FG002|NOT COMPLETED|Part 2 (Up to 27 Months)||0
8561509|NCT03447314|9593361|FG003|NOT COMPLETED|Part 2 (Up to 27 Months)||0
8561510|NCT03447314|9593362|FG004|NOT COMPLETED|Part 2 (Up to 27 Months)||0
8561511|NCT03447314|9593363|FG005|NOT COMPLETED|Part 2 (Up to 27 Months)||0
8561512|NCT03447314|9593364|FG006|NOT COMPLETED|Part 2 (Up to 27 Months)||0
8561513|NCT03447314|9593365|FG007|NOT COMPLETED|Part 2 (Up to 27 Months)||0
8561514|NCT03447314|9593366|FG008|NOT COMPLETED|Part 2 (Up to 27 Months)||0
8561515|NCT03447314|9593367|FG009|NOT COMPLETED|Part 2 (Up to 27 Months)||0
8561516|NCT03447314|9593368|FG010|NOT COMPLETED|Part 2 (Up to 27 Months)||0
8561517|NCT03447314|9593369|FG011|NOT COMPLETED|Part 2 (Up to 27 Months)||0
8561518|NCT03447314|9593370|FG012|NOT COMPLETED|Part 2 (Up to 27 Months)||0
8561519|NCT03447314|9593371|FG013|NOT COMPLETED|Part 2 (Up to 27 Months)||0
8561520|NCT03447314|9593372|FG014|NOT COMPLETED|Part 2 (Up to 27 Months)||0
8561521|NCT03447314|9593373|FG015|NOT COMPLETED|Part 2 (Up to 27 Months)||0
8561522|NCT03447314|9593374|FG016|NOT COMPLETED|Part 2 (Up to 27 Months)||0
8619984|NCT00471445|9658549|FG000|COMPLETED|Overall Study||227
8722684|NCT01020487|9770173|FG000|COMPLETED|Part 1||12
8722685|NCT01020487|9770174|FG001|COMPLETED|Part 1||0
8722686|NCT01020487|9770175|FG002|COMPLETED|Part 1||0
8722687|NCT01020487|9770173|FG000|NOT COMPLETED|Part 1||0
8722688|NCT01020487|9770174|FG001|NOT COMPLETED|Part 1||0
8722689|NCT01020487|9770175|FG002|NOT COMPLETED|Part 1||0
8722690|NCT01020487|9770173|FG000|STARTED|Part 2 Double-blind Treatment Period||0
8725115|NCT01029405|9772308|FG002|STARTED|Overall Study||35
8722691|NCT01020487|9770174|FG001|STARTED|Part 2 Double-blind Treatment Period|Includes one participant who enrolled in Part 2 after completing Part 1|18
8814716|NCT01533974|9868008|FG000|NOT COMPLETED|Overall Study||51
8814717|NCT01533974|9868009|FG001|NOT COMPLETED|Overall Study||50
8814718|NCT01534013|9868017|FG000|STARTED|Overall Study||8
8814719|NCT01534013|9868018|FG001|STARTED|Overall Study||6
8814720|NCT01534013|9868017|FG000|COMPLETED|Overall Study||6
8814721|NCT01534013|9868018|FG001|COMPLETED|Overall Study||6
8814722|NCT01534013|9868017|FG000|NOT COMPLETED|Overall Study||2
8814723|NCT01534013|9868018|FG001|NOT COMPLETED|Overall Study||0
8814724|NCT01534052|9868024|FG000|STARTED|Overall Study||52
8814725|NCT01534052|9868024|FG000|Treatment Received|Overall Study||52
8814726|NCT01534052|9868024|FG000|COMPLETED|Overall Study||52
8722692|NCT01020487|9770175|FG002|STARTED|Part 2 Double-blind Treatment Period|Includes one participant who enrolled in Part 2 after completing Part 1|19
8722693|NCT01020487|9770173|FG000|Received Treatment|Part 2 Double-blind Treatment Period||0
8722694|NCT01020487|9770174|FG001|Received Treatment|Part 2 Double-blind Treatment Period||18
8722695|NCT01020487|9770175|FG002|Received Treatment|Part 2 Double-blind Treatment Period||18
8722696|NCT01020487|9770173|FG000|COMPLETED|Part 2 Double-blind Treatment Period||0
8722697|NCT01020487|9770174|FG001|COMPLETED|Part 2 Double-blind Treatment Period||16
8722698|NCT01020487|9770175|FG002|COMPLETED|Part 2 Double-blind Treatment Period||13
8722699|NCT01020487|9770173|FG000|NOT COMPLETED|Part 2 Double-blind Treatment Period||0
8722700|NCT01020487|9770174|FG001|NOT COMPLETED|Part 2 Double-blind Treatment Period||2
8722701|NCT01020487|9770175|FG002|NOT COMPLETED|Part 2 Double-blind Treatment Period||6
8722702|NCT01020487|9770173|FG000|STARTED|Part 2 Open-label Period||0
8814727|NCT01534052|9868024|FG000|NOT COMPLETED|Overall Study||0
8814728|NCT01534078|9868028|FG000|STARTED|Overall Study||34
8814729|NCT01534078|9868028|FG000|COMPLETED|Overall Study||32
8561523|NCT03447314|9593375|FG017|NOT COMPLETED|Part 2 (Up to 27 Months)||0
8561524|NCT03422653|9593418|FG000|STARTED|Period 1: Double-blind Phase||189
8561525|NCT03422653|9593419|FG001|STARTED|Period 1: Double-blind Phase||189
8561526|NCT03422653|9593420|FG002|STARTED|Period 1: Double-blind Phase||0
8561527|NCT03422653|9593418|FG000|COMPLETED|Period 1: Double-blind Phase||162
8561528|NCT03422653|9593419|FG001|COMPLETED|Period 1: Double-blind Phase||170
8561529|NCT03422653|9593420|FG002|COMPLETED|Period 1: Double-blind Phase||0
8561530|NCT03422653|9593418|FG000|NOT COMPLETED|Period 1: Double-blind Phase||27
8561531|NCT03422653|9593419|FG001|NOT COMPLETED|Period 1: Double-blind Phase||19
8561532|NCT03422653|9593420|FG002|NOT COMPLETED|Period 1: Double-blind Phase||0
8619985|NCT00471445|9658550|FG001|COMPLETED|Overall Study||231
8619986|NCT00471445|9658549|FG000|NOT COMPLETED|Overall Study||2
8619987|NCT00471445|9658550|FG001|NOT COMPLETED|Overall Study||2
8561533|NCT03422653|9593418|FG000|STARTED|Period 2: Open-label Phase||0
8561534|NCT03422653|9593419|FG001|STARTED|Period 2: Open-label Phase||0
8561535|NCT03422653|9593420|FG002|STARTED|Period 2: Open-label Phase||313
8561536|NCT03422653|9593418|FG000|COMPLETED|Period 2: Open-label Phase||0
8561537|NCT03422653|9593419|FG001|COMPLETED|Period 2: Open-label Phase||0
8561538|NCT03422653|9593420|FG002|COMPLETED|Period 2: Open-label Phase||189
8561539|NCT03422653|9593418|FG000|NOT COMPLETED|Period 2: Open-label Phase||0
8561540|NCT03422653|9593419|FG001|NOT COMPLETED|Period 2: Open-label Phase||0
8561541|NCT03422653|9593420|FG002|NOT COMPLETED|Period 2: Open-label Phase||124
8619988|NCT00471497|9658559|FG000|STARTED|Core Treatment Phase||283
8619989|NCT00471497|9658560|FG001|STARTED|Core Treatment Phase||282
8619990|NCT00471497|9658561|FG002|STARTED|Core Treatment Phase||281
8619991|NCT00471497|9658559|FG000|Safety Analysis Set|Core Treatment Phase|Safety set contained patients who received at least one dose of study medication.|280
8619992|NCT00471497|9658560|FG001|Safety Analysis Set|Core Treatment Phase|Safety set contained patients who received at least one dose of study medication.|279
8619993|NCT00471497|9658561|FG002|Safety Analysis Set|Core Treatment Phase|Safety set contained patients who received at least one dose of study medication.|277
8561542|NCT03320330|9593432|FG000|STARTED|Overall Study||6
8561543|NCT03320330|9593433|FG001|STARTED|Overall Study||6
8561544|NCT03320330|9593434|FG002|STARTED|Overall Study||14
8561545|NCT03320330|9593432|FG000|COMPLETED|Overall Study||0
8561546|NCT03320330|9593433|FG001|COMPLETED|Overall Study||1
8619994|NCT00471497|9658559|FG000|Discon. Core/Did Not Enter Ext.|Core Treatment Phase||235
8619995|NCT00471497|9658560|FG001|Discon. Core/Did Not Enter Ext.|Core Treatment Phase||256
8619996|NCT00471497|9658561|FG002|Discon. Core/Did Not Enter Ext.|Core Treatment Phase||278
8619997|NCT00471497|9658559|FG000|Discontinued Core/Entered Ext.|Core Treatment Phase||48
8619998|NCT00471497|9658560|FG001|Discontinued Core/Entered Ext.|Core Treatment Phase||26
8619999|NCT00471497|9658561|FG002|Discontinued Core/Entered Ext.|Core Treatment Phase||3
8620000|NCT00471497|9658559|FG000|COMPLETED|Core Treatment Phase||99
8620001|NCT00471497|9658560|FG001|COMPLETED|Core Treatment Phase||107
8620002|NCT00471497|9658561|FG002|COMPLETED|Core Treatment Phase||99
8620003|NCT00471497|9658559|FG000|NOT COMPLETED|Core Treatment Phase||184
8620004|NCT00471497|9658560|FG001|NOT COMPLETED|Core Treatment Phase||175
8620005|NCT00471497|9658561|FG002|NOT COMPLETED|Core Treatment Phase||182
8620006|NCT00471497|9658559|FG000|STARTED|Extension Phase||48
8620007|NCT00471497|9658560|FG001|STARTED|Extension Phase||26
8620008|NCT00471497|9658561|FG002|STARTED|Extension Phase||3
8620009|NCT00471497|9658559|FG000|COMPLETED|Extension Phase||21
8620010|NCT00471497|9658560|FG001|COMPLETED|Extension Phase||12
8620011|NCT00471497|9658561|FG002|COMPLETED|Extension Phase||2
8620012|NCT00471497|9658559|FG000|NOT COMPLETED|Extension Phase||27
8620013|NCT00471497|9658560|FG001|NOT COMPLETED|Extension Phase||14
8620014|NCT00471497|9658561|FG002|NOT COMPLETED|Extension Phase||1
8620015|NCT00471536|9658572|FG000|STARTED|Overall Study||19
8620016|NCT00471536|9658572|FG000|COMPLETED|Overall Study||18
8620017|NCT00471536|9658572|FG000|NOT COMPLETED|Overall Study||1
8561547|NCT03320330|9593434|FG002|COMPLETED|Overall Study||0
8620018|NCT00471705|9658579|FG000|STARTED|Overall Study||145
8620019|NCT00471705|9658580|FG001|STARTED|Overall Study||143
8620020|NCT00471705|9658581|FG002|STARTED|Overall Study||149
8620021|NCT00471705|9658579|FG000|COMPLETED|Overall Study||121
8620022|NCT00471705|9658580|FG001|COMPLETED|Overall Study||121
8620023|NCT00471705|9658581|FG002|COMPLETED|Overall Study||134
8620024|NCT00471705|9658579|FG000|NOT COMPLETED|Overall Study||24
8620025|NCT00471705|9658580|FG001|NOT COMPLETED|Overall Study||22
8620026|NCT00471705|9658581|FG002|NOT COMPLETED|Overall Study||15
8620027|NCT00471718|9658589|FG000|STARTED|Overall Study||27
8561548|NCT03320330|9593432|FG000|NOT COMPLETED|Overall Study||6
8561549|NCT03320330|9593433|FG001|NOT COMPLETED|Overall Study||5
8620028|NCT00471718|9658589|FG000|COMPLETED|Overall Study||0
8620029|NCT00471718|9658589|FG000|NOT COMPLETED|Overall Study||27
8620030|NCT00471822|9658597|FG000|STARTED|Overall Study||9707
8620031|NCT00471822|9658597|FG000|Treated|Overall Study||9705
8561550|NCT03320330|9593434|FG002|NOT COMPLETED|Overall Study||14
8561551|NCT03271151|9593445|FG000|STARTED|Overall Study||80
8561552|NCT03271151|9593446|FG001|STARTED|Overall Study||80
8561553|NCT03271151|9593445|FG000|COMPLETED|Overall Study||78
8561554|NCT03271151|9593446|FG001|COMPLETED|Overall Study||77
8561555|NCT03271151|9593445|FG000|NOT COMPLETED|Overall Study||2
8620032|NCT00471822|9658597|FG000|COMPLETED|Overall Study||9705
8620033|NCT00471822|9658597|FG000|NOT COMPLETED|Overall Study||2
8620034|NCT00471848|9658601|FG000|STARTED|Overall Study||35
8620035|NCT00471848|9658601|FG000|COMPLETED|Overall Study|35 registered patients received the full 5-day Rabbit Antithymocyte Globuline (RATG) treatment|35
8620036|NCT00471848|9658601|FG000|NOT COMPLETED|Overall Study||0
8620037|NCT00471887|9658605|FG000|STARTED|Overall Study||32
8620038|NCT00471887|9658605|FG000|COMPLETED|Overall Study||23
8620039|NCT00471887|9658605|FG000|NOT COMPLETED|Overall Study||9
8561556|NCT03271151|9593446|FG001|NOT COMPLETED|Overall Study||3
8561557|NCT03141177|9593455|FG000|STARTED|Overall Study||323
8561558|NCT03141177|9593456|FG001|STARTED|Overall Study||50
8561559|NCT03141177|9593457|FG002|STARTED|Overall Study||328
8561560|NCT03141177|9593455|FG000|Treated|Overall Study||320
8561561|NCT03141177|9593456|FG001|Treated|Overall Study||50
8561562|NCT03141177|9593457|FG002|Treated|Overall Study||320
8561563|NCT03141177|9593455|FG000|COMPLETED|Overall Study||242
8561564|NCT03141177|9593456|FG001|COMPLETED|Overall Study||34
8561565|NCT03141177|9593457|FG002|COMPLETED|Overall Study||210
8561566|NCT03141177|9593455|FG000|NOT COMPLETED|Overall Study||81
8561567|NCT03141177|9593456|FG001|NOT COMPLETED|Overall Study||16
8561568|NCT03141177|9593457|FG002|NOT COMPLETED|Overall Study||118
8561569|NCT03117049|9593468|FG000|STARTED|Overall Study||275
8561570|NCT03117049|9593469|FG001|STARTED|Overall Study||275
8561571|NCT03117049|9593468|FG000|COMPLETED|Overall Study||74
8561572|NCT03117049|9593469|FG001|COMPLETED|Overall Study||44
8561573|NCT03117049|9593468|FG000|NOT COMPLETED|Overall Study||201
8561574|NCT03117049|9593469|FG001|NOT COMPLETED|Overall Study||231
8561575|NCT03023813|9593478|FG000|STARTED|Overall Study||39
8561576|NCT03023813|9593479|FG001|STARTED|Overall Study||34
8561577|NCT03023813|9593480|FG002|STARTED|Overall Study||31
8561578|NCT03023813|9593478|FG000|COMPLETED|Overall Study||38
8561579|NCT03023813|9593479|FG001|COMPLETED|Overall Study||32
8561580|NCT03023813|9593480|FG002|COMPLETED|Overall Study||31
8561581|NCT03023813|9593478|FG000|NOT COMPLETED|Overall Study||1
8561582|NCT03023813|9593479|FG001|NOT COMPLETED|Overall Study||2
8561583|NCT03023813|9593480|FG002|NOT COMPLETED|Overall Study||0
8561584|NCT02993822|9593493|FG000|STARTED|Overall Study||79
8561585|NCT02993822|9593494|FG001|STARTED|Overall Study||78
8561586|NCT02993822|9593495|FG002|STARTED|Overall Study||79
8561587|NCT02993822|9593496|FG003|STARTED|Overall Study||79
8561588|NCT02993822|9593493|FG000|COMPLETED|Overall Study||69
8561589|NCT02993822|9593494|FG001|COMPLETED|Overall Study||74
8561590|NCT02993822|9593495|FG002|COMPLETED|Overall Study||69
8561591|NCT02993822|9593496|FG003|COMPLETED|Overall Study||75
8561592|NCT02993822|9593493|FG000|NOT COMPLETED|Overall Study||10
8561593|NCT02993822|9593494|FG001|NOT COMPLETED|Overall Study||4
8561594|NCT02993822|9593495|FG002|NOT COMPLETED|Overall Study||10
8561595|NCT02993822|9593496|FG003|NOT COMPLETED|Overall Study||4
8561596|NCT02924324|9593508|FG000|STARTED|Overall Study||28
8561597|NCT02924324|9593509|FG001|STARTED|Overall Study||28
8561598|NCT02924324|9593508|FG000|COMPLETED|Overall Study||28
8561599|NCT02924324|9593509|FG001|COMPLETED|Overall Study||28
8561600|NCT02924324|9593508|FG000|NOT COMPLETED|Overall Study||0
8561601|NCT02924324|9593509|FG001|NOT COMPLETED|Overall Study||0
8561602|NCT02828917|9593515|FG000|STARTED|Overall Study||104
8561603|NCT02828917|9593515|FG000|COMPLETED|Overall Study||104
8561604|NCT02828917|9593515|FG000|NOT COMPLETED|Overall Study||0
8561605|NCT02753127|9593521|FG000|STARTED|Overall Study||624
8561606|NCT02753127|9593522|FG001|STARTED|Overall Study||629
8561607|NCT02753127|9593521|FG000|Discontinued Due to Death|Overall Study||507
8561608|NCT02753127|9593522|FG001|Discontinued Due to Death|Overall Study||499
8561609|NCT02753127|9593521|FG000|Completion of Survival Follow-Up Due to Study Completion|Overall Study||64
8561610|NCT02753127|9593522|FG001|Completion of Survival Follow-Up Due to Study Completion|Overall Study||62
8561611|NCT02753127|9593521|FG000|COMPLETED|Overall Study||571
8561612|NCT02753127|9593522|FG001|COMPLETED|Overall Study||561
8561613|NCT02753127|9593521|FG000|NOT COMPLETED|Overall Study||53
8561614|NCT02753127|9593522|FG001|NOT COMPLETED|Overall Study||68
8561615|NCT02744430|9593538|FG000|STARTED|Overall Study||17
8561616|NCT02744430|9593539|FG001|STARTED|Overall Study||16
8561617|NCT02744430|9593538|FG000|COMPLETED|Overall Study||17
8561618|NCT02744430|9593539|FG001|COMPLETED|Overall Study||16
8561619|NCT02744430|9593538|FG000|NOT COMPLETED|Overall Study||0
8561620|NCT02744430|9593539|FG001|NOT COMPLETED|Overall Study||0
8561621|NCT02460198|9593547|FG000|STARTED|Overall Study||61
8561622|NCT02460198|9593548|FG001|STARTED|Overall Study||63
8561623|NCT02460198|9593547|FG000|COMPLETED|Overall Study||0
8561624|NCT02460198|9593548|FG001|COMPLETED|Overall Study||0
8561625|NCT02460198|9593547|FG000|NOT COMPLETED|Overall Study||61
8561626|NCT02460198|9593548|FG001|NOT COMPLETED|Overall Study||63
8561627|NCT02260869|9593558|FG000|STARTED|Overall Study||38
8561628|NCT02260869|9593559|FG001|STARTED|Overall Study||37
8561629|NCT02260869|9593558|FG000|COMPLETED|Overall Study||31
8561630|NCT02260869|9593559|FG001|COMPLETED|Overall Study||29
8561631|NCT02260869|9593558|FG000|NOT COMPLETED|Overall Study||7
8561632|NCT02260869|9593559|FG001|NOT COMPLETED|Overall Study||8
8561633|NCT02255838|9593565|FG000|STARTED|Overall Study||6
8561634|NCT02255838|9593566|FG001|STARTED|Overall Study||6
8561635|NCT02255838|9593565|FG000|COMPLETED|Overall Study||6
8561636|NCT02255838|9593566|FG001|COMPLETED|Overall Study||6
8561637|NCT02255838|9593565|FG000|NOT COMPLETED|Overall Study||0
8561638|NCT02255838|9593566|FG001|NOT COMPLETED|Overall Study||0
8561639|NCT02151526|9593576|FG000|STARTED|Overall Study||3
8561640|NCT02151526|9593577|FG001|STARTED|Overall Study||4
8561641|NCT02151526|9593576|FG000|COMPLETED|Overall Study||3
8561642|NCT02151526|9593577|FG001|COMPLETED|Overall Study||4
8561643|NCT02151526|9593576|FG000|NOT COMPLETED|Overall Study||0
8561644|NCT02151526|9593577|FG001|NOT COMPLETED|Overall Study||0
8561645|NCT02119468|9593587|FG000|STARTED|Overall Study||7
8561646|NCT02119468|9593588|FG001|STARTED|Overall Study||25
8561647|NCT02119468|9593587|FG000|COMPLETED|Overall Study||7
8561648|NCT02119468|9593588|FG001|COMPLETED|Overall Study||25
8561649|NCT02119468|9593587|FG000|NOT COMPLETED|Overall Study||0
8561650|NCT02119468|9593588|FG001|NOT COMPLETED|Overall Study||0
8561651|NCT01960530|9593595|FG000|STARTED|Overall Study||14
8561652|NCT01960530|9593595|FG000|COMPLETED|Overall Study||14
8561653|NCT01960530|9593595|FG000|NOT COMPLETED|Overall Study||0
8561654|NCT01892722|9593612|FG000|STARTED|Overall Study||107
8561655|NCT01892722|9593613|FG001|STARTED|Overall Study||108
8561656|NCT01892722|9593612|FG000|Full Analysis Set|Overall Study||107
8561657|NCT01892722|9593613|FG001|Full Analysis Set|Overall Study||107
8561658|NCT01892722|9593612|FG000|COMPLETED|Overall Study||100
8561659|NCT01892722|9593613|FG001|COMPLETED|Overall Study||88
8561660|NCT01892722|9593612|FG000|NOT COMPLETED|Overall Study||7
8561661|NCT01892722|9593613|FG001|NOT COMPLETED|Overall Study||20
8569142|NCT00095173|9601295|FG001|NOT COMPLETED|Open-Label Extension Phase (Period C)||0
8569143|NCT00095173|9601296|FG002|NOT COMPLETED|Open-Label Extension Phase (Period C)||0
8569144|NCT00095173|9601297|FG003|NOT COMPLETED|Open-Label Extension Phase (Period C)||23
8569145|NCT00095173|9601298|FG004|NOT COMPLETED|Open-Label Extension Phase (Period C)||29
8569146|NCT00095173|9601299|FG005|NOT COMPLETED|Open-Label Extension Phase (Period C)||32
8569147|NCT00095199|9601317|FG000|STARTED|Overall Study|1 participant has no data in database; not included in analyses. Data was lost/destroyed at site.|302
8569148|NCT00095199|9601318|FG001|STARTED|Overall Study||304
8569149|NCT00095199|9601319|FG002|STARTED|Overall Study||167
8569150|NCT00095199|9601320|FG003|STARTED|Overall Study||166
8569151|NCT00095199|9601317|FG000|COMPLETED|Overall Study||6
8569152|NCT00095199|9601318|FG001|COMPLETED|Overall Study||62
8569153|NCT00095199|9601319|FG002|COMPLETED|Overall Study||7
8569154|NCT00095199|9601320|FG003|COMPLETED|Overall Study||23
8569155|NCT00095199|9601317|FG000|NOT COMPLETED|Overall Study||296
8569156|NCT00095199|9601318|FG001|NOT COMPLETED|Overall Study||242
8569157|NCT00095199|9601319|FG002|NOT COMPLETED|Overall Study||160
8569158|NCT00095199|9601320|FG003|NOT COMPLETED|Overall Study||143
8569159|NCT00095212|9601337|FG000|STARTED|Overall Study||13
8569160|NCT00095212|9601338|FG001|STARTED|Overall Study||12
8569161|NCT00095212|9601337|FG000|COMPLETED|Overall Study||12
8569162|NCT00095212|9601338|FG001|COMPLETED|Overall Study||9
8569163|NCT00095212|9601337|FG000|NOT COMPLETED|Overall Study||1
8569164|NCT00095212|9601338|FG001|NOT COMPLETED|Overall Study||3
8569165|NCT00095238|9601346|FG000|STARTED|Overall Study|number randomized|2067
8569166|NCT00095238|9601347|FG001|STARTED|Overall Study|number randomized|2061
8569167|NCT00095238|9601346|FG000|Safety (Treated) Population|Overall Study|Two participants were randomized but not treated; 1 randomized to irbesartan received placebo|2064
8569168|NCT00095238|9601347|FG001|Safety (Treated) Population|Overall Study|One participant randomized to irbesartan received placebo.|2062
8569169|NCT00095238|9601346|FG000|COMPLETED|Overall Study|completed double-blind therapy|1210
8569170|NCT00095238|9601347|FG001|COMPLETED|Overall Study|completed double-blind therapy|1209
8569171|NCT00095238|9601346|FG000|NOT COMPLETED|Overall Study||857
8569172|NCT00095238|9601347|FG001|NOT COMPLETED|Overall Study||852
8569173|NCT00095303|9601387|FG000|STARTED|Main Study||245
8569174|NCT00095303|9601388|FG001|STARTED|Main Study||235
8569175|NCT00095303|9601387|FG000|COMPLETED|Main Study||154
8569176|NCT00095303|9601388|FG001|COMPLETED|Main Study||148
8569177|NCT00095303|9601387|FG000|NOT COMPLETED|Main Study||91
8569178|NCT00095303|9601388|FG001|NOT COMPLETED|Main Study||87
8569179|NCT00095303|9601387|FG000|STARTED|Follow Up Study|199 (BSFT) gave permission for future contact; not a requirement to finish Main to start Follow up|199
8569180|NCT00095303|9601388|FG001|STARTED|Follow Up Study|179 (TAU) gave permission for future contact; not a requirement to finish Main to start Follow up|179
8569181|NCT00095303|9601387|FG000|COMPLETED|Follow Up Study||140
8569182|NCT00095303|9601388|FG001|COMPLETED|Follow Up Study||121
8569183|NCT00095303|9601387|FG000|NOT COMPLETED|Follow Up Study||59
8814730|NCT01534078|9868028|FG000|NOT COMPLETED|Overall Study||2
8814731|NCT01534182|9868034|FG000|STARTED|Overall Study||230
8814732|NCT01534182|9868035|FG001|STARTED|Overall Study||68
8814733|NCT01534182|9868034|FG000|Safety Set|Overall Study||230
8814734|NCT01534182|9868035|FG001|Safety Set|Overall Study||64
8814735|NCT01534182|9868034|FG000|Full Analysis Set|Overall Study||229
8814736|NCT01534182|9868035|FG001|Full Analysis Set|Overall Study||62
8814737|NCT01534182|9868034|FG000|COMPLETED|Overall Study||218
8561662|NCT01516216|9593621|FG000|STARTED|Overall Study||70
8561663|NCT01516216|9593622|FG001|STARTED|Overall Study||69
8561664|NCT01516216|9593621|FG000|AE Evaluable|Overall Study||67
8561665|NCT01516216|9593622|FG001|AE Evaluable|Overall Study||68
8561666|NCT01516216|9593621|FG000|Response Evaluable|Overall Study||62
8561667|NCT01516216|9593622|FG001|Response Evaluable|Overall Study||66
8561668|NCT01516216|9593621|FG000|COMPLETED|Overall Study||0
8561669|NCT01516216|9593622|FG001|COMPLETED|Overall Study||0
8561670|NCT01516216|9593621|FG000|NOT COMPLETED|Overall Study||70
8561671|NCT01516216|9593622|FG001|NOT COMPLETED|Overall Study||69
8561672|NCT00519818|9593630|FG000|STARTED|Overall Study||14
8561673|NCT00519818|9593630|FG000|COMPLETED|Overall Study||14
8620040|NCT00472030|9658611|FG000|STARTED|Overall Study||2
8620041|NCT00472030|9658612|FG001|STARTED|Overall Study||0
8620042|NCT00472030|9658611|FG000|COMPLETED|Overall Study||1
8620043|NCT00472030|9658612|FG001|COMPLETED|Overall Study||0
8620044|NCT00472030|9658611|FG000|NOT COMPLETED|Overall Study||1
8620045|NCT00472030|9658612|FG001|NOT COMPLETED|Overall Study||0
8620046|NCT00472056|9658626|FG000|STARTED|Overall Study||25
8620047|NCT00472056|9658627|FG001|STARTED|Overall Study||19
8620048|NCT00472056|9658628|FG002|STARTED|Overall Study||32
8620049|NCT00472056|9658629|FG003|STARTED|Overall Study||17
8620050|NCT00472056|9658626|FG000|COMPLETED|Overall Study||25
8620051|NCT00472056|9658627|FG001|COMPLETED|Overall Study||19
8620052|NCT00472056|9658628|FG002|COMPLETED|Overall Study||32
8620053|NCT00472056|9658629|FG003|COMPLETED|Overall Study||17
8620054|NCT00472056|9658626|FG000|NOT COMPLETED|Overall Study||0
8561674|NCT00519818|9593630|FG000|NOT COMPLETED|Overall Study||0
8561675|NCT00381641|9593638|FG000|STARTED|Overall Study||38
8561676|NCT00381641|9593639|FG001|STARTED|Overall Study||25
8620055|NCT00472056|9658627|FG001|NOT COMPLETED|Overall Study||0
8561677|NCT00381641|9593638|FG000|COMPLETED|Overall Study||38
8561678|NCT00381641|9593639|FG001|COMPLETED|Overall Study||23
8561679|NCT00381641|9593638|FG000|NOT COMPLETED|Overall Study||0
8561680|NCT00381641|9593639|FG001|NOT COMPLETED|Overall Study||2
8561681|NCT00006178|9593645|FG000|STARTED|Overall Study||12
8561682|NCT00006178|9593645|FG000|COMPLETED|Overall Study||12
8561683|NCT00006178|9593645|FG000|NOT COMPLETED|Overall Study||0
8561684|NCT00006184|9593651|FG000|STARTED|Overall Study||10
8561685|NCT00006184|9593652|FG001|STARTED|Overall Study||10
8561686|NCT00006184|9593651|FG000|COMPLETED|Overall Study||9
8620056|NCT00472056|9658628|FG002|NOT COMPLETED|Overall Study||0
8620057|NCT00472056|9658629|FG003|NOT COMPLETED|Overall Study||0
8620058|NCT00472199|9658639|FG000|STARTED|Overall Study||166
8814738|NCT01534182|9868035|FG001|COMPLETED|Overall Study||58
8722703|NCT01020487|9770174|FG001|STARTED|Part 2 Open-label Period||16
8722704|NCT01020487|9770175|FG002|STARTED|Part 2 Open-label Period||13
8722705|NCT01020487|9770173|FG000|COMPLETED|Part 2 Open-label Period||0
8722706|NCT01020487|9770174|FG001|COMPLETED|Part 2 Open-label Period||12
8722707|NCT01020487|9770175|FG002|COMPLETED|Part 2 Open-label Period||12
8722708|NCT01020487|9770173|FG000|NOT COMPLETED|Part 2 Open-label Period||0
8722709|NCT01020487|9770174|FG001|NOT COMPLETED|Part 2 Open-label Period||4
8722710|NCT01020487|9770175|FG002|NOT COMPLETED|Part 2 Open-label Period||1
8722711|NCT01020526|9770185|FG000|STARTED|Overall Study||63
8722712|NCT01020526|9770185|FG000|COMPLETED|Overall Study||49
8722713|NCT01020526|9770185|FG000|NOT COMPLETED|Overall Study||14
8722714|NCT01020591|9770191|FG000|STARTED|Overall Study||15
8722715|NCT01020591|9770192|FG001|STARTED|Overall Study||15
8722716|NCT01020591|9770191|FG000|COMPLETED|Overall Study||15
8561687|NCT00006184|9593652|FG001|COMPLETED|Overall Study||10
8561688|NCT00006184|9593651|FG000|NOT COMPLETED|Overall Study||1
8561689|NCT00006184|9593652|FG001|NOT COMPLETED|Overall Study||0
8561690|NCT00006227|9593658|FG000|STARTED|Overall Study||31
8561691|NCT00006227|9593658|FG000|COMPLETED|Overall Study||31
8620059|NCT00472199|9658640|FG001|STARTED|Overall Study||163
8620060|NCT00472199|9658639|FG000|COMPLETED|Overall Study||131
8620061|NCT00472199|9658640|FG001|COMPLETED|Overall Study||103
8620062|NCT00472199|9658639|FG000|NOT COMPLETED|Overall Study||35
8620063|NCT00472199|9658640|FG001|NOT COMPLETED|Overall Study||60
8620064|NCT00472290|9658646|FG000|STARTED|Overall Study||72
8814739|NCT01534182|9868034|FG000|NOT COMPLETED|Overall Study||12
8814740|NCT01534182|9868035|FG001|NOT COMPLETED|Overall Study||10
8814741|NCT01534195|9868044|FG000|STARTED|Overall Study||5
8814742|NCT01534195|9868045|FG001|STARTED|Overall Study||6
8814743|NCT01534195|9868044|FG000|COMPLETED|Overall Study||4
8814744|NCT01534195|9868045|FG001|COMPLETED|Overall Study||5
8814745|NCT01534195|9868044|FG000|NOT COMPLETED|Overall Study||1
8814746|NCT01534195|9868045|FG001|NOT COMPLETED|Overall Study||1
8814747|NCT01534208|9868053|FG000|STARTED|Overall Study||216
8814748|NCT01534208|9868054|FG001|STARTED|Overall Study||283
8814749|NCT01534208|9868053|FG000|COMPLETED|Overall Study||159
8814750|NCT01534208|9868054|FG001|COMPLETED|Overall Study||234
8814751|NCT01534208|9868053|FG000|NOT COMPLETED|Overall Study||57
8620065|NCT00472290|9658646|FG000|COMPLETED|Overall Study||0
8620066|NCT00472290|9658646|FG000|NOT COMPLETED|Overall Study||72
8620067|NCT00472303|9658652|FG000|STARTED|Titration Phase||338
8620068|NCT00472303|9658653|FG001|STARTED|Titration Phase||158
8620069|NCT00472303|9658654|FG002|STARTED|Titration Phase|All participants in the titration phase were in the tapentadol arm during the titration phase.|0
8620070|NCT00472303|9658652|FG000|COMPLETED|Titration Phase||279
8620071|NCT00472303|9658653|FG001|COMPLETED|Titration Phase||129
8620072|NCT00472303|9658654|FG002|COMPLETED|Titration Phase||0
8620073|NCT00472303|9658652|FG000|NOT COMPLETED|Titration Phase||59
8620074|NCT00472303|9658653|FG001|NOT COMPLETED|Titration Phase||29
8620075|NCT00472303|9658654|FG002|NOT COMPLETED|Titration Phase||0
8620076|NCT00472303|9658652|FG000|STARTED|Discontinuations After Titration Phase||279
8620077|NCT00472303|9658653|FG001|STARTED|Discontinuations After Titration Phase||129
8629662|NCT00531050|9669386|FG005|NOT COMPLETED|Part 2: Period 1||1
8814752|NCT01534208|9868054|FG001|NOT COMPLETED|Overall Study||49
8814753|NCT01534260|9868062|FG000|STARTED|Overall Study||17
8814754|NCT01534260|9868063|FG001|STARTED|Overall Study||20
8814755|NCT01534260|9868062|FG000|COMPLETED|Overall Study||1
8814756|NCT01534260|9868063|FG001|COMPLETED|Overall Study||0
8814757|NCT01534260|9868062|FG000|NOT COMPLETED|Overall Study||16
8814758|NCT01534260|9868063|FG001|NOT COMPLETED|Overall Study||20
8814759|NCT01534273|9868073|FG000|STARTED|Period 1||3
8814760|NCT01534273|9868074|FG001|STARTED|Period 1||6
8814761|NCT01534273|9868075|FG002|STARTED|Period 1||2
8814762|NCT01534273|9868076|FG003|STARTED|Period 1||7
8814763|NCT01534273|9868077|FG004|STARTED|Period 1||3
8814764|NCT01534273|9868078|FG005|STARTED|Period 1||3
8814765|NCT01534273|9868079|FG006|STARTED|Period 1||6
8814766|NCT01534273|9868073|FG000|Received at Least 1 Dose of Study Drug|Period 1||3
8814767|NCT01534273|9868074|FG001|Received at Least 1 Dose of Study Drug|Period 1||6
8814768|NCT01534273|9868075|FG002|Received at Least 1 Dose of Study Drug|Period 1||2
8814769|NCT01534273|9868076|FG003|Received at Least 1 Dose of Study Drug|Period 1||7
8814770|NCT01534273|9868077|FG004|Received at Least 1 Dose of Study Drug|Period 1||3
8814771|NCT01534273|9868078|FG005|Received at Least 1 Dose of Study Drug|Period 1||3
8814772|NCT01534273|9868079|FG006|Received at Least 1 Dose of Study Drug|Period 1||6
8814773|NCT01534273|9868073|FG000|COMPLETED|Period 1||3
8814774|NCT01534273|9868074|FG001|COMPLETED|Period 1||6
8814775|NCT01534273|9868075|FG002|COMPLETED|Period 1||2
8814776|NCT01534273|9868076|FG003|COMPLETED|Period 1||6
8814777|NCT01534273|9868077|FG004|COMPLETED|Period 1||3
8814778|NCT01534273|9868078|FG005|COMPLETED|Period 1||3
8814779|NCT01534273|9868079|FG006|COMPLETED|Period 1||6
8814780|NCT01534273|9868073|FG000|NOT COMPLETED|Period 1||0
8814781|NCT01534273|9868074|FG001|NOT COMPLETED|Period 1||0
8814782|NCT01534273|9868075|FG002|NOT COMPLETED|Period 1||0
8814783|NCT01534273|9868076|FG003|NOT COMPLETED|Period 1||1
8814784|NCT01534273|9868077|FG004|NOT COMPLETED|Period 1||0
8814785|NCT01534273|9868078|FG005|NOT COMPLETED|Period 1||0
8814786|NCT01534273|9868079|FG006|NOT COMPLETED|Period 1||0
8814787|NCT01534273|9868073|FG000|STARTED|Period 2|Participants in Cohort A participated in only 1 treatment period.|0
8814788|NCT01534273|9868074|FG001|STARTED|Period 2|Participants in Cohort A participated in only 1 treatment period.|0
8814789|NCT01534273|9868075|FG002|STARTED|Period 2||2
8814790|NCT01534273|9868076|FG003|STARTED|Period 2||6
8814791|NCT01534273|9868077|FG004|STARTED|Period 2|Participants in Cohort C participated in only 1 treatment period.|0
8814792|NCT01534273|9868078|FG005|STARTED|Period 2|Participants in Cohort C participated in only 1 treatment period.|0
8814793|NCT01534273|9868079|FG006|STARTED|Period 2|Participants in Cohort C participated in only 1 treatment period.|0
8814794|NCT01534273|9868073|FG000|COMPLETED|Period 2||0
8814795|NCT01534273|9868074|FG001|COMPLETED|Period 2||0
8814796|NCT01534273|9868075|FG002|COMPLETED|Period 2||2
8561692|NCT00006227|9593658|FG000|NOT COMPLETED|Overall Study||0
8561693|NCT00006237|9593664|FG000|STARTED|Overall Study||212
8561694|NCT00006237|9593665|FG001|STARTED|Overall Study||220
8561695|NCT00006237|9593664|FG000|Eligible|Overall Study||203
8561696|NCT00006237|9593665|FG001|Eligible|Overall Study||200
8561697|NCT00006237|9593664|FG000|Eligible and Treated|Overall Study||203
8561698|NCT00006237|9593665|FG001|Eligible and Treated|Overall Study||199
8561699|NCT00006237|9593664|FG000|COMPLETED|Overall Study||87
8561700|NCT00006237|9593665|FG001|COMPLETED|Overall Study||159
8561701|NCT00006237|9593664|FG000|NOT COMPLETED|Overall Study||125
8561702|NCT00006237|9593665|FG001|NOT COMPLETED|Overall Study||61
8561703|NCT00006244|9593674|FG000|STARTED|Overall Study||36
8561704|NCT00006244|9593674|FG000|COMPLETED|Overall Study||36
8561705|NCT00006244|9593674|FG000|NOT COMPLETED|Overall Study||0
8561706|NCT00006289|9593680|FG000|STARTED|First Intervention (5 Weeks)||11
8561707|NCT00006289|9593681|FG001|STARTED|First Intervention (5 Weeks)||10
8561708|NCT00006289|9593680|FG000|COMPLETED|First Intervention (5 Weeks)||10
8561709|NCT00006289|9593681|FG001|COMPLETED|First Intervention (5 Weeks)||10
8814797|NCT01534273|9868076|FG003|COMPLETED|Period 2||6
8814798|NCT01534273|9868077|FG004|COMPLETED|Period 2||0
8814799|NCT01534273|9868078|FG005|COMPLETED|Period 2||0
8814800|NCT01534273|9868079|FG006|COMPLETED|Period 2||0
8561710|NCT00006289|9593680|FG000|NOT COMPLETED|First Intervention (5 Weeks)||1
8561711|NCT00006289|9593681|FG001|NOT COMPLETED|First Intervention (5 Weeks)||0
8561712|NCT00006289|9593680|FG000|STARTED|Washout (>= 1 Week)||10
8561713|NCT00006289|9593681|FG001|STARTED|Washout (>= 1 Week)||10
8814801|NCT01534273|9868073|FG000|NOT COMPLETED|Period 2||0
8814802|NCT01534273|9868074|FG001|NOT COMPLETED|Period 2||0
8814803|NCT01534273|9868075|FG002|NOT COMPLETED|Period 2||0
8814804|NCT01534273|9868076|FG003|NOT COMPLETED|Period 2||0
8814805|NCT01534273|9868077|FG004|NOT COMPLETED|Period 2||0
8814806|NCT01534273|9868078|FG005|NOT COMPLETED|Period 2||0
8814807|NCT01534273|9868079|FG006|NOT COMPLETED|Period 2||0
8814808|NCT01534351|9868103|FG000|STARTED|Overall Study||1
8620078|NCT00472303|9658654|FG002|STARTED|Discontinuations After Titration Phase||0
8620079|NCT00472303|9658652|FG000|COMPLETED|Discontinuations After Titration Phase|Participants meeting stabilization criteria on days 13-15 in the titration phase were re-randomized.|218
8620080|NCT00472303|9658653|FG001|COMPLETED|Discontinuations After Titration Phase|Participants meeting stabilization criteria on days 13-15 in the titration phase were re-randomized.|109
8620081|NCT00472303|9658654|FG002|COMPLETED|Discontinuations After Titration Phase||0
8620082|NCT00472303|9658652|FG000|NOT COMPLETED|Discontinuations After Titration Phase||61
8620083|NCT00472303|9658653|FG001|NOT COMPLETED|Discontinuations After Titration Phase||20
8620084|NCT00472303|9658654|FG002|NOT COMPLETED|Discontinuations After Titration Phase||0
8620085|NCT00472303|9658652|FG000|STARTED|Maintenance Phase|106 of 218 participants in the tapentadol titration arm were re-randomized and treated.|106
8620086|NCT00472303|9658653|FG001|STARTED|Maintenance Phase||109
8620087|NCT00472303|9658654|FG002|STARTED|Maintenance Phase|112 of 218 participants in the tapentadol titration arm were re-randomized and treated.|112
8620088|NCT00472303|9658652|FG000|COMPLETED|Maintenance Phase||89
8620089|NCT00472303|9658653|FG001|COMPLETED|Maintenance Phase||93
8620090|NCT00472303|9658654|FG002|COMPLETED|Maintenance Phase||95
8620091|NCT00472303|9658652|FG000|NOT COMPLETED|Maintenance Phase||17
8620092|NCT00472303|9658653|FG001|NOT COMPLETED|Maintenance Phase||16
8620093|NCT00472303|9658654|FG002|NOT COMPLETED|Maintenance Phase||17
8620094|NCT00472420|9658682|FG000|STARTED|Induction Treatment Period||48
8620095|NCT00472420|9658682|FG000|COMPLETED|Induction Treatment Period||32
8620096|NCT00472420|9658682|FG000|NOT COMPLETED|Induction Treatment Period||16
8620097|NCT00472420|9658682|FG000|STARTED|Follow-up Period||32
8620098|NCT00472420|9658682|FG000|COMPLETED|Follow-up Period||15
8620099|NCT00472420|9658682|FG000|NOT COMPLETED|Follow-up Period||17
8620100|NCT00472446|9658690|FG000|STARTED|Overall Study||46
8561714|NCT00006289|9593680|FG000|COMPLETED|Washout (>= 1 Week)||10
8561715|NCT00006289|9593681|FG001|COMPLETED|Washout (>= 1 Week)||10
8561716|NCT00006289|9593680|FG000|NOT COMPLETED|Washout (>= 1 Week)||0
8561717|NCT00006289|9593681|FG001|NOT COMPLETED|Washout (>= 1 Week)||0
8561718|NCT00006289|9593680|FG000|STARTED|Second Intervention (5 Weeks)||10
8561719|NCT00006289|9593681|FG001|STARTED|Second Intervention (5 Weeks)||10
8561720|NCT00006289|9593680|FG000|COMPLETED|Second Intervention (5 Weeks)||9
8561721|NCT00006289|9593681|FG001|COMPLETED|Second Intervention (5 Weeks)||9
8561722|NCT00006289|9593680|FG000|NOT COMPLETED|Second Intervention (5 Weeks)||1
8561723|NCT00006289|9593681|FG001|NOT COMPLETED|Second Intervention (5 Weeks)||1
8561724|NCT00006305|9593701|FG000|STARTED|Overall Study||592
8561725|NCT00006305|9593702|FG001|STARTED|Overall Study||584
8561726|NCT00006305|9593703|FG002|STARTED|Overall Study||593
8561727|NCT00006305|9593704|FG003|STARTED|Overall Study||599
8561728|NCT00006305|9593701|FG000|COMPLETED|Overall Study||575
8561729|NCT00006305|9593702|FG001|COMPLETED|Overall Study||574
8561730|NCT00006305|9593703|FG002|COMPLETED|Overall Study||578
8561731|NCT00006305|9593704|FG003|COMPLETED|Overall Study||585
8561732|NCT00006305|9593701|FG000|NOT COMPLETED|Overall Study||17
8561733|NCT00006305|9593702|FG001|NOT COMPLETED|Overall Study||10
8561734|NCT00006305|9593703|FG002|NOT COMPLETED|Overall Study||15
8561735|NCT00006305|9593704|FG003|NOT COMPLETED|Overall Study||14
8561736|NCT00006389|9593714|FG000|STARTED|Overall Study||12
8561737|NCT00006389|9593714|FG000|COMPLETED|Overall Study||11
8561738|NCT00006389|9593714|FG000|NOT COMPLETED|Overall Study||1
8561739|NCT00006392|9593723|FG000|STARTED|Overall Study||8904
8561740|NCT00006392|9593724|FG001|STARTED|Overall Study||8910
8561741|NCT00006392|9593725|FG002|STARTED|Overall Study||8863
8561742|NCT00006392|9593726|FG003|STARTED|Overall Study||8856
8561743|NCT00006392|9593723|FG000|COMPLETED|Overall Study||8737
8561744|NCT00006392|9593724|FG001|COMPLETED|Overall Study||8752
8561745|NCT00006392|9593725|FG002|COMPLETED|Overall Study||8703
8561746|NCT00006392|9593726|FG003|COMPLETED|Overall Study||8696
8561747|NCT00006392|9593723|FG000|NOT COMPLETED|Overall Study||167
8561748|NCT00006392|9593724|FG001|NOT COMPLETED|Overall Study||158
8561749|NCT00006392|9593725|FG002|NOT COMPLETED|Overall Study||160
8561750|NCT00006392|9593726|FG003|NOT COMPLETED|Overall Study||160
8561751|NCT00006400|9593738|FG000|STARTED|Overall Study||96
8561752|NCT00006400|9593739|FG001|STARTED|Overall Study||97
8561753|NCT00006400|9593738|FG000|COMPLETED|Overall Study||83
8561754|NCT00006400|9593739|FG001|COMPLETED|Overall Study||84
8561755|NCT00006400|9593738|FG000|NOT COMPLETED|Overall Study||13
8561756|NCT00006400|9593739|FG001|NOT COMPLETED|Overall Study||13
8561757|NCT00006409|9593751|FG000|STARTED|Baseline||865
8561758|NCT00006409|9593752|FG001|STARTED|Baseline||856
8561759|NCT00006409|9593753|FG002|STARTED|Baseline||0
8561760|NCT00006409|9593754|FG003|STARTED|Baseline||0
8561761|NCT00006409|9593755|FG004|STARTED|Baseline||0
8561762|NCT00006409|9593756|FG005|STARTED|Baseline||0
8561763|NCT00006409|9593751|FG000|COMPLETED|Baseline||817
8561764|NCT00006409|9593752|FG001|COMPLETED|Baseline||786
8561765|NCT00006409|9593753|FG002|COMPLETED|Baseline||0
8561766|NCT00006409|9593754|FG003|COMPLETED|Baseline||0
8561767|NCT00006409|9593755|FG004|COMPLETED|Baseline||0
8561768|NCT00006409|9593756|FG005|COMPLETED|Baseline||0
8561769|NCT00006409|9593751|FG000|NOT COMPLETED|Baseline||48
8561770|NCT00006409|9593752|FG001|NOT COMPLETED|Baseline||70
8561771|NCT00006409|9593753|FG002|NOT COMPLETED|Baseline||0
8561772|NCT00006409|9593754|FG003|NOT COMPLETED|Baseline||0
8561773|NCT00006409|9593755|FG004|NOT COMPLETED|Baseline||0
8561774|NCT00006409|9593756|FG005|NOT COMPLETED|Baseline||0
8561775|NCT00006409|9593751|FG000|STARTED|Post-2 Year Intervention|6th grade/2003 sample was not followed over time|0
8561776|NCT00006409|9593752|FG001|STARTED|Post-2 Year Intervention|6th grade/2003 sample was not followed over time|0
8561777|NCT00006409|9593753|FG002|STARTED|Post-2 Year Intervention|Sample is independent of 6th-grade/2003 sample that was measured at baseline|1791
8561778|NCT00006409|9593754|FG003|STARTED|Post-2 Year Intervention|Sample is independent of 6th-grade/2003 sample that was measured at baseline|1713
8561779|NCT00006409|9593755|FG004|STARTED|Post-2 Year Intervention||0
8561780|NCT00006409|9593756|FG005|STARTED|Post-2 Year Intervention||0
8561781|NCT00006409|9593751|FG000|COMPLETED|Post-2 Year Intervention||0
8561782|NCT00006409|9593752|FG001|COMPLETED|Post-2 Year Intervention||0
8561783|NCT00006409|9593753|FG002|COMPLETED|Post-2 Year Intervention||1540
8561784|NCT00006409|9593754|FG003|COMPLETED|Post-2 Year Intervention||1545
8561785|NCT00006409|9593755|FG004|COMPLETED|Post-2 Year Intervention||0
8561786|NCT00006409|9593756|FG005|COMPLETED|Post-2 Year Intervention||0
8561787|NCT00006409|9593751|FG000|NOT COMPLETED|Post-2 Year Intervention||0
8561788|NCT00006409|9593752|FG001|NOT COMPLETED|Post-2 Year Intervention||0
8620101|NCT00472446|9658691|FG001|STARTED|Overall Study||47
8620102|NCT00472446|9658692|FG002|STARTED|Overall Study||45
8620103|NCT00472446|9658693|FG003|STARTED|Overall Study||45
8620104|NCT00472446|9658690|FG000|COMPLETED|Overall Study||41
8620105|NCT00472446|9658691|FG001|COMPLETED|Overall Study||41
8620106|NCT00472446|9658692|FG002|COMPLETED|Overall Study||38
8620107|NCT00472446|9658693|FG003|COMPLETED|Overall Study||39
8620108|NCT00472446|9658690|FG000|NOT COMPLETED|Overall Study||5
8620109|NCT00472446|9658691|FG001|NOT COMPLETED|Overall Study||6
8620110|NCT00472446|9658692|FG002|NOT COMPLETED|Overall Study||7
8620111|NCT00472446|9658693|FG003|NOT COMPLETED|Overall Study||6
8620112|NCT00472576|9658705|FG000|STARTED|First Intervention||2
8620113|NCT00472576|9658706|FG001|STARTED|First Intervention||3
8620114|NCT00472576|9658705|FG000|COMPLETED|First Intervention||2
8620115|NCT00472576|9658706|FG001|COMPLETED|First Intervention||3
8620116|NCT00472576|9658705|FG000|NOT COMPLETED|First Intervention||0
8722717|NCT01020591|9770192|FG001|COMPLETED|Overall Study||15
8722718|NCT01020591|9770191|FG000|NOT COMPLETED|Overall Study||0
8722719|NCT01020591|9770192|FG001|NOT COMPLETED|Overall Study||0
8561789|NCT00006409|9593753|FG002|NOT COMPLETED|Post-2 Year Intervention||251
8722720|NCT01020747|9770200|FG000|STARTED|Overall Study||20
8561790|NCT00006409|9593754|FG003|NOT COMPLETED|Post-2 Year Intervention||168
8561791|NCT00006409|9593755|FG004|NOT COMPLETED|Post-2 Year Intervention||0
8561792|NCT00006409|9593756|FG005|NOT COMPLETED|Post-2 Year Intervention||0
8561793|NCT00006409|9593751|FG000|STARTED|Post-3 Year Intervention||0
8814809|NCT01534351|9868104|FG001|STARTED|Overall Study||0
8814810|NCT01534351|9868105|FG002|STARTED|Overall Study||0
8814811|NCT01534351|9868103|FG000|COMPLETED|Overall Study||0
8814812|NCT01534351|9868104|FG001|COMPLETED|Overall Study||0
8814813|NCT01534351|9868105|FG002|COMPLETED|Overall Study||0
8814814|NCT01534351|9868103|FG000|NOT COMPLETED|Overall Study||1
8814815|NCT01534351|9868104|FG001|NOT COMPLETED|Overall Study||0
8814816|NCT01534351|9868105|FG002|NOT COMPLETED|Overall Study||0
8814817|NCT01534416|9868115|FG000|STARTED|Overall Study||68
8814818|NCT01534416|9868116|FG001|STARTED|Overall Study||64
8814819|NCT01534416|9868115|FG000|COMPLETED|Overall Study||68
8814820|NCT01534416|9868116|FG001|COMPLETED|Overall Study||64
8814821|NCT01534416|9868115|FG000|NOT COMPLETED|Overall Study||0
8814822|NCT01534416|9868116|FG001|NOT COMPLETED|Overall Study||0
8814823|NCT01534520|9868134|FG000|STARTED|Overall Study||30
8561794|NCT00006409|9593752|FG001|STARTED|Post-3 Year Intervention||0
8561795|NCT00006409|9593753|FG002|STARTED|Post-3 Year Intervention|8th-grade/2005 sample was not followed over time|0
8561796|NCT00006409|9593754|FG003|STARTED|Post-3 Year Intervention|8th-grade/2005 sample was not followed over time|0
8561797|NCT00006409|9593755|FG004|STARTED|Post-3 Year Intervention|Sample is independent of 8th-grade/2005 sample that was measured post-2 year intervention|1726
8561798|NCT00006409|9593756|FG005|STARTED|Post-3 Year Intervention|Sample is independent of 8th-grade/2005 sample that was measured post-2 year intervention|1776
8561799|NCT00006409|9593751|FG000|COMPLETED|Post-3 Year Intervention||0
8561800|NCT00006409|9593752|FG001|COMPLETED|Post-3 Year Intervention||0
8561801|NCT00006409|9593753|FG002|COMPLETED|Post-3 Year Intervention||0
8561802|NCT00006409|9593754|FG003|COMPLETED|Post-3 Year Intervention||0
8561803|NCT00006409|9593755|FG004|COMPLETED|Post-3 Year Intervention||1664
8561804|NCT00006409|9593756|FG005|COMPLETED|Post-3 Year Intervention||1714
8561805|NCT00006409|9593751|FG000|NOT COMPLETED|Post-3 Year Intervention||0
8561806|NCT00006409|9593752|FG001|NOT COMPLETED|Post-3 Year Intervention||0
8561807|NCT00006409|9593753|FG002|NOT COMPLETED|Post-3 Year Intervention||0
8561808|NCT00006409|9593754|FG003|NOT COMPLETED|Post-3 Year Intervention||0
8561809|NCT00006409|9593755|FG004|NOT COMPLETED|Post-3 Year Intervention||62
8561810|NCT00006409|9593756|FG005|NOT COMPLETED|Post-3 Year Intervention||62
8561811|NCT00006411|9593772|FG000|STARTED|Overall Study||707
8561812|NCT00006411|9593773|FG001|STARTED|Overall Study||383
8561813|NCT00006411|9593772|FG000|COMPLETED|Overall Study||707
8561814|NCT00006411|9593773|FG001|COMPLETED|Overall Study||383
8561815|NCT00006411|9593772|FG000|NOT COMPLETED|Overall Study||0
8561816|NCT00006411|9593773|FG001|NOT COMPLETED|Overall Study||0
8561817|NCT00006489|9593783|FG000|STARTED|Overall Study||42
8561818|NCT00006489|9593784|FG001|STARTED|Overall Study||40
8561819|NCT00006489|9593785|FG002|STARTED|Overall Study||40
8561820|NCT00006489|9593786|FG003|STARTED|Overall Study||43
8561821|NCT00006489|9593783|FG000|COMPLETED|Overall Study||29
8561822|NCT00006489|9593784|FG001|COMPLETED|Overall Study||26
8561823|NCT00006489|9593785|FG002|COMPLETED|Overall Study||25
8561824|NCT00006489|9593786|FG003|COMPLETED|Overall Study||32
8561825|NCT00006489|9593783|FG000|NOT COMPLETED|Overall Study||13
8561826|NCT00006489|9593784|FG001|NOT COMPLETED|Overall Study||14
8561827|NCT00006489|9593785|FG002|NOT COMPLETED|Overall Study||15
8561828|NCT00006489|9593786|FG003|NOT COMPLETED|Overall Study||11
8561829|NCT00006604|9593803|FG000|STARTED|Overall Study||6
8561830|NCT00006604|9593804|FG001|STARTED|Overall Study||2
8561831|NCT00006604|9593805|FG002|STARTED|Overall Study||5
8561832|NCT00006604|9593806|FG003|STARTED|Overall Study||6
8561833|NCT00006604|9593807|FG004|STARTED|Overall Study||5
8561834|NCT00006604|9593808|FG005|STARTED|Overall Study||5
8561835|NCT00006604|9593809|FG006|STARTED|Overall Study||21
8561836|NCT00006604|9593810|FG007|STARTED|Overall Study||5
8561837|NCT00006604|9593811|FG008|STARTED|Overall Study||5
8561838|NCT00006604|9593812|FG009|STARTED|Overall Study||25
8561839|NCT00006604|9593813|FG010|STARTED|Overall Study||21
8561840|NCT00006604|9593814|FG011|STARTED|Overall Study||12
8561841|NCT00006604|9593815|FG012|STARTED|Overall Study||26
8561842|NCT00006604|9593816|FG013|STARTED|Overall Study||6
8561843|NCT00006604|9593817|FG014|STARTED|Overall Study||24
8561844|NCT00006604|9593818|FG015|STARTED|Overall Study||6
8561845|NCT00006604|9593819|FG016|STARTED|Overall Study||15
8561846|NCT00006604|9593803|FG000|COMPLETED|Overall Study||4
8561847|NCT00006604|9593804|FG001|COMPLETED|Overall Study||2
8561848|NCT00006604|9593805|FG002|COMPLETED|Overall Study||1
8561849|NCT00006604|9593806|FG003|COMPLETED|Overall Study||1
8561850|NCT00006604|9593807|FG004|COMPLETED|Overall Study||3
8561851|NCT00006604|9593808|FG005|COMPLETED|Overall Study||2
8561852|NCT00006604|9593809|FG006|COMPLETED|Overall Study||12
8561853|NCT00006604|9593810|FG007|COMPLETED|Overall Study||2
8561854|NCT00006604|9593811|FG008|COMPLETED|Overall Study||4
8561855|NCT00006604|9593812|FG009|COMPLETED|Overall Study||6
8561856|NCT00006604|9593813|FG010|COMPLETED|Overall Study||13
8561857|NCT00006604|9593814|FG011|COMPLETED|Overall Study||6
8561858|NCT00006604|9593815|FG012|COMPLETED|Overall Study||22
8561859|NCT00006604|9593816|FG013|COMPLETED|Overall Study||0
8561860|NCT00006604|9593817|FG014|COMPLETED|Overall Study||14
8561861|NCT00006604|9593818|FG015|COMPLETED|Overall Study||1
8561862|NCT00006604|9593819|FG016|COMPLETED|Overall Study||6
8561863|NCT00006604|9593803|FG000|NOT COMPLETED|Overall Study||2
8561864|NCT00006604|9593804|FG001|NOT COMPLETED|Overall Study||0
8561865|NCT00006604|9593805|FG002|NOT COMPLETED|Overall Study||4
8561866|NCT00006604|9593806|FG003|NOT COMPLETED|Overall Study||5
8561867|NCT00006604|9593807|FG004|NOT COMPLETED|Overall Study||2
8620117|NCT00472576|9658706|FG001|NOT COMPLETED|First Intervention||0
8620118|NCT00472576|9658705|FG000|STARTED|Second Intervention||2
8620119|NCT00472576|9658706|FG001|STARTED|Second Intervention||3
8620120|NCT00472576|9658705|FG000|COMPLETED|Second Intervention||2
8620121|NCT00472576|9658706|FG001|COMPLETED|Second Intervention||3
8620122|NCT00472576|9658705|FG000|NOT COMPLETED|Second Intervention||0
8620123|NCT00472576|9658706|FG001|NOT COMPLETED|Second Intervention||0
8814824|NCT01534520|9868135|FG001|STARTED|Overall Study||29
8561868|NCT00006604|9593808|FG005|NOT COMPLETED|Overall Study||3
8561869|NCT00006604|9593809|FG006|NOT COMPLETED|Overall Study||9
8561870|NCT00006604|9593810|FG007|NOT COMPLETED|Overall Study||3
8561871|NCT00006604|9593811|FG008|NOT COMPLETED|Overall Study||1
8561872|NCT00006604|9593812|FG009|NOT COMPLETED|Overall Study||19
8561873|NCT00006604|9593813|FG010|NOT COMPLETED|Overall Study||8
8561874|NCT00006604|9593814|FG011|NOT COMPLETED|Overall Study||6
8561875|NCT00006604|9593815|FG012|NOT COMPLETED|Overall Study||4
8561876|NCT00006604|9593816|FG013|NOT COMPLETED|Overall Study||6
8561877|NCT00006604|9593817|FG014|NOT COMPLETED|Overall Study||10
8561878|NCT00006604|9593818|FG015|NOT COMPLETED|Overall Study||5
8561879|NCT00006604|9593819|FG016|NOT COMPLETED|Overall Study||9
8561880|NCT00006721|9593845|FG000|STARTED|Overall Study||17
8561881|NCT00006721|9593846|FG001|STARTED|Overall Study||279
8561882|NCT00006721|9593847|FG002|STARTED|Overall Study||275
8561883|NCT00006721|9593845|FG000|Eligible|Overall Study||15
8561884|NCT00006721|9593846|FG001|Eligible|Overall Study||267
8561885|NCT00006721|9593847|FG002|Eligible|Overall Study||265
8561886|NCT00006721|9593845|FG000|Eligible and Began Protocol Therapy|Overall Study||14
8561887|NCT00006721|9593846|FG001|Eligible and Began Protocol Therapy|Overall Study||267
8620124|NCT00472641|9658712|FG000|STARTED|Overall Study||25
8620125|NCT00472641|9658712|FG000|COMPLETED|Overall Study||18
8620126|NCT00472641|9658712|FG000|NOT COMPLETED|Overall Study||7
8620127|NCT00472732|9658718|FG000|STARTED|Overall Study||24
8620128|NCT00472732|9658719|FG001|STARTED|Overall Study||22
8620129|NCT00472732|9658718|FG000|COMPLETED|Overall Study||24
8620130|NCT00472732|9658719|FG001|COMPLETED|Overall Study||22
8620131|NCT00472732|9658718|FG000|NOT COMPLETED|Overall Study||0
8620132|NCT00472732|9658719|FG001|NOT COMPLETED|Overall Study||0
8620133|NCT00472797|9658727|FG000|STARTED|Overall Study||119
8620134|NCT00472797|9658728|FG001|STARTED|Overall Study||113
8620135|NCT00472797|9658727|FG000|COMPLETED|Overall Study||115
8620136|NCT00472797|9658728|FG001|COMPLETED|Overall Study||112
8620137|NCT00472797|9658727|FG000|NOT COMPLETED|Overall Study||4
8620138|NCT00472797|9658728|FG001|NOT COMPLETED|Overall Study||1
8620139|NCT00472849|9658739|FG000|STARTED|Overall Study||12
8620140|NCT00472849|9658740|FG001|STARTED|Overall Study||78
8620141|NCT00472849|9658739|FG000|COMPLETED|Overall Study||12
8620142|NCT00472849|9658740|FG001|COMPLETED|Overall Study||78
8620143|NCT00472849|9658739|FG000|NOT COMPLETED|Overall Study||0
8620144|NCT00472849|9658740|FG001|NOT COMPLETED|Overall Study||0
8561888|NCT00006721|9593847|FG002|Eligible and Began Protocol Therapy|Overall Study||265
8561889|NCT00006721|9593845|FG000|COMPLETED|Overall Study||13
8561890|NCT00006721|9593846|FG001|COMPLETED|Overall Study||254
8561891|NCT00006721|9593847|FG002|COMPLETED|Overall Study||242
8561892|NCT00006721|9593845|FG000|NOT COMPLETED|Overall Study||4
8561893|NCT00006721|9593846|FG001|NOT COMPLETED|Overall Study||25
8561894|NCT00006721|9593847|FG002|NOT COMPLETED|Overall Study||33
8561895|NCT00006903|9593859|FG000|STARTED|Overall Study||10
8561896|NCT00006903|9593860|FG001|STARTED|Overall Study||24
8561897|NCT00006903|9593861|FG002|STARTED|Overall Study||33
8561898|NCT00006903|9593859|FG000|COMPLETED|Overall Study||0
8561899|NCT00006903|9593860|FG001|COMPLETED|Overall Study||20
8561900|NCT00006903|9593861|FG002|COMPLETED|Overall Study||27
8561901|NCT00006903|9593859|FG000|NOT COMPLETED|Overall Study||10
8561902|NCT00006903|9593860|FG001|NOT COMPLETED|Overall Study||4
8561903|NCT00006903|9593861|FG002|NOT COMPLETED|Overall Study||6
8561904|NCT00007020|9593869|FG000|STARTED|Overall Study||85
8561905|NCT00007020|9593869|FG000|COMPLETED|Overall Study||41
8561906|NCT00007020|9593869|FG000|NOT COMPLETED|Overall Study||44
8561907|NCT00007345|9593877|FG000|STARTED|Overall Study||47
8561908|NCT00007345|9593878|FG001|STARTED|Overall Study||84
8561909|NCT00007345|9593877|FG000|COMPLETED|Overall Study||45
8561910|NCT00007345|9593878|FG001|COMPLETED|Overall Study||73
8561911|NCT00007345|9593877|FG000|NOT COMPLETED|Overall Study||2
8561912|NCT00007345|9593878|FG001|NOT COMPLETED|Overall Study||11
8561913|NCT00007475|9593887|FG000|STARTED|Overall Study|[ arm reflects un-assayed participants' disposition ]|12
8561914|NCT00007475|9593888|FG001|STARTED|Overall Study|[ arm reflects eventual participant disposition ]|1
8561915|NCT00007475|9593889|FG002|STARTED|Overall Study|[ arm reflects eventual participant disposition ]|2
8561916|NCT00007475|9593890|FG003|STARTED|Overall Study||0
8561917|NCT00007475|9593887|FG000|FSGS Permeability Factor (FPF) Assayed|Overall Study|FSGS Permeability Factor's provisional assay only applied to minority of early enrollees, by design.|0
8561918|NCT00007475|9593888|FG001|FSGS Permeability Factor (FPF) Assayed|Overall Study||1
8561919|NCT00007475|9593889|FG002|FSGS Permeability Factor (FPF) Assayed|Overall Study||2
8561920|NCT00007475|9593890|FG003|FSGS Permeability Factor (FPF) Assayed|Overall Study||0
8561921|NCT00007475|9593887|FG000|Initial Transplant|Overall Study||12
8561922|NCT00007475|9593888|FG001|Initial Transplant|Overall Study||1
8561923|NCT00007475|9593889|FG002|Initial Transplant|Overall Study||2
8561924|NCT00007475|9593890|FG003|Initial Transplant|Overall Study||0
8620145|NCT00473083|9658749|FG000|STARTED|Overall Study||50
8620146|NCT00473083|9658750|FG001|STARTED|Overall Study||50
8620147|NCT00473083|9658751|FG002|STARTED|Overall Study||50
8620148|NCT00473083|9658749|FG000|COMPLETED|Overall Study|One patient (2%) from treatment arm 1 discontinued the study drug as a result of a TEAE (dizziness)|49
8620149|NCT00473083|9658750|FG001|COMPLETED|Overall Study||50
8620150|NCT00473083|9658751|FG002|COMPLETED|Overall Study||50
8620151|NCT00473083|9658749|FG000|NOT COMPLETED|Overall Study||1
8620152|NCT00473083|9658750|FG001|NOT COMPLETED|Overall Study||0
8620153|NCT00473083|9658751|FG002|NOT COMPLETED|Overall Study||0
8620154|NCT00473265|9658762|FG000|STARTED|Overall Study||68
8620155|NCT00473265|9658762|FG000|COMPLETED|Overall Study||48
8620156|NCT00473265|9658762|FG000|NOT COMPLETED|Overall Study||20
8620157|NCT00473330|9658769|FG000|STARTED|Core Study||125
8620158|NCT00473330|9658770|FG001|STARTED|Core Study||125
8620159|NCT00473330|9658771|FG002|STARTED|Core Study||127
8620160|NCT00473330|9658769|FG000|COMPLETED|Core Study||98
8620161|NCT00473330|9658770|FG001|COMPLETED|Core Study||100
8620162|NCT00473330|9658771|FG002|COMPLETED|Core Study||86
8620163|NCT00473330|9658769|FG000|NOT COMPLETED|Core Study||27
8620164|NCT00473330|9658770|FG001|NOT COMPLETED|Core Study||25
8620165|NCT00473330|9658771|FG002|NOT COMPLETED|Core Study||41
8629663|NCT00531050|9669381|FG000|STARTED|Part 2: Period 2||3
8814825|NCT01534520|9868134|FG000|COMPLETED|Overall Study||30
8814826|NCT01534520|9868135|FG001|COMPLETED|Overall Study|1 subject withdrew consent at time of uterine sound attempt due to intolerable pain|28
8814827|NCT01534520|9868134|FG000|NOT COMPLETED|Overall Study||0
8814828|NCT01534520|9868135|FG001|NOT COMPLETED|Overall Study||1
8814829|NCT01534533|9868149|FG000|STARTED|Overall Study||48
8814830|NCT01534533|9868150|FG001|STARTED|Overall Study||48
8814831|NCT01534533|9868151|FG002|STARTED|Overall Study||48
8814832|NCT01534533|9868152|FG003|STARTED|Overall Study||48
8814833|NCT01534533|9868149|FG000|COMPLETED|Overall Study||40
8561925|NCT00007475|9593887|FG000|Post-initial Transplant Proteinuria|Overall Study||12
8561926|NCT00007475|9593888|FG001|Post-initial Transplant Proteinuria|Overall Study||1
8561927|NCT00007475|9593889|FG002|Post-initial Transplant Proteinuria|Overall Study||2
8561928|NCT00007475|9593890|FG003|Post-initial Transplant Proteinuria|Overall Study||0
8561929|NCT00007475|9593887|FG000|Initial Plasma Exchange|Overall Study||12
8561930|NCT00007475|9593888|FG001|Initial Plasma Exchange|Overall Study||1
8561931|NCT00007475|9593889|FG002|Initial Plasma Exchange|Overall Study||2
8561932|NCT00007475|9593890|FG003|Initial Plasma Exchange|Overall Study||0
8561933|NCT00007475|9593887|FG000|Initiate Cyclophosphamide|Overall Study||12
8561934|NCT00007475|9593888|FG001|Initiate Cyclophosphamide|Overall Study||1
8561935|NCT00007475|9593889|FG002|Initiate Cyclophosphamide|Overall Study||2
8561936|NCT00007475|9593890|FG003|Initiate Cyclophosphamide|Overall Study||0
8561937|NCT00007475|9593887|FG000|COMPLETED|Overall Study||8
8620166|NCT00473330|9658769|FG000|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|89
8620167|NCT00473330|9658770|FG001|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|79
8620168|NCT00473330|9658771|FG002|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|77
8620169|NCT00473330|9658769|FG000|COMPLETED|Open-label Extension Through Month 48||63
8620170|NCT00473330|9658770|FG001|COMPLETED|Open-label Extension Through Month 48||59
8620171|NCT00473330|9658771|FG002|COMPLETED|Open-label Extension Through Month 48||50
8722721|NCT01020747|9770200|FG000|COMPLETED|Overall Study||19
8722722|NCT01020747|9770200|FG000|NOT COMPLETED|Overall Study||1
8722723|NCT01020773|9770207|FG000|STARTED|Overall Study||35
8722724|NCT01020773|9770208|FG001|STARTED|Overall Study||32
8722725|NCT01020773|9770207|FG000|COMPLETED|Overall Study||31
8561938|NCT00007475|9593888|FG001|COMPLETED|Overall Study||1
8561939|NCT00007475|9593889|FG002|COMPLETED|Overall Study||2
8561940|NCT00007475|9593890|FG003|COMPLETED|Overall Study||0
8561941|NCT00007475|9593887|FG000|NOT COMPLETED|Overall Study||4
8561942|NCT00007475|9593888|FG001|NOT COMPLETED|Overall Study||0
8561943|NCT00007475|9593889|FG002|NOT COMPLETED|Overall Study||0
8561944|NCT00007475|9593890|FG003|NOT COMPLETED|Overall Study||0
8561945|NCT00007644|9593902|FG000|STARTED|Overall Study||364
8561946|NCT00007644|9593903|FG001|STARTED|Overall Study||367
8561947|NCT00007644|9593902|FG000|COMPLETED|Overall Study||364
8561948|NCT00007644|9593903|FG001|COMPLETED|Overall Study||367
8561949|NCT00007644|9593902|FG000|NOT COMPLETED|Overall Study||0
8561950|NCT00007644|9593903|FG001|NOT COMPLETED|Overall Study||0
8561951|NCT00008138|9593909|FG000|STARTED|Neoadjuvant Chemotherapy||58
8561952|NCT00008138|9593909|FG000|Eligible|Neoadjuvant Chemotherapy||58
8561953|NCT00008138|9593909|FG000|COMPLETED|Neoadjuvant Chemotherapy||38
8561954|NCT00008138|9593909|FG000|NOT COMPLETED|Neoadjuvant Chemotherapy||20
8561955|NCT00008138|9593909|FG000|STARTED|Interval Debulking||38
8561956|NCT00008138|9593909|FG000|Received Protocol Surgery|Interval Debulking||36
8561957|NCT00008138|9593909|FG000|COMPLETED|Interval Debulking||36
8561958|NCT00008138|9593909|FG000|NOT COMPLETED|Interval Debulking||2
8561959|NCT00008138|9593909|FG000|STARTED|Post-Cytoreduction Chemotherapy|Among 36 patients from previous period, 5 patients rejected and 5 patients are ineligible.|26
8561960|NCT00008138|9593909|FG000|COMPLETED|Post-Cytoreduction Chemotherapy||18
8561961|NCT00008138|9593909|FG000|NOT COMPLETED|Post-Cytoreduction Chemotherapy||8
8561962|NCT00008385|9593916|FG000|STARTED|Overall Study||521
8722726|NCT01020773|9770208|FG001|COMPLETED|Overall Study||29
8722727|NCT01020773|9770207|FG000|NOT COMPLETED|Overall Study||4
8722728|NCT01020773|9770208|FG001|NOT COMPLETED|Overall Study||3
8722729|NCT01020786|9770214|FG000|STARTED|Induction Period||109
8722730|NCT01020786|9770214|FG000|COMPLETED|Induction Period|Completed induction therapy. Completed=starting the maintenance therapy.|60
8722731|NCT01020786|9770214|FG000|NOT COMPLETED|Induction Period||49
8814834|NCT01534533|9868150|FG001|COMPLETED|Overall Study||45
8814835|NCT01534533|9868151|FG002|COMPLETED|Overall Study||40
8561963|NCT00008385|9593917|FG001|STARTED|Overall Study||1040
8561964|NCT00008385|9593916|FG000|Treated|Overall Study||477
8561965|NCT00008385|9593917|FG001|Treated|Overall Study||865
8561966|NCT00008385|9593916|FG000|Off Treatment Reasons Reported|Overall Study||398
8561967|NCT00008385|9593917|FG001|Off Treatment Reasons Reported|Overall Study||795
8561968|NCT00008385|9593916|FG000|COMPLETED|Overall Study||134
8561969|NCT00008385|9593917|FG001|COMPLETED|Overall Study||238
8561970|NCT00008385|9593916|FG000|NOT COMPLETED|Overall Study||387
8561971|NCT00008385|9593917|FG001|NOT COMPLETED|Overall Study||802
8561972|NCT00009737|9593925|FG000|STARTED|Overall Study||1004
8561973|NCT00009737|9593926|FG001|STARTED|Overall Study||983
8561974|NCT00009737|9593925|FG000|COMPLETED|Overall Study||834
8561975|NCT00009737|9593926|FG001|COMPLETED|Overall Study||860
8814836|NCT01534533|9868152|FG003|COMPLETED|Overall Study||44
8814837|NCT01534533|9868149|FG000|NOT COMPLETED|Overall Study||8
8814838|NCT01534533|9868150|FG001|NOT COMPLETED|Overall Study||3
8814839|NCT01534533|9868151|FG002|NOT COMPLETED|Overall Study||8
8814840|NCT01534533|9868152|FG003|NOT COMPLETED|Overall Study||4
8814841|NCT01534637|9868164|FG000|STARTED|Overall Study||22
8814842|NCT01534637|9868164|FG000|COMPLETED|Overall Study||13
8814843|NCT01534637|9868164|FG000|NOT COMPLETED|Overall Study||9
8620172|NCT00473330|9658769|FG000|NOT COMPLETED|Open-label Extension Through Month 48||26
8620173|NCT00473330|9658770|FG001|NOT COMPLETED|Open-label Extension Through Month 48||20
8620174|NCT00473330|9658771|FG002|NOT COMPLETED|Open-label Extension Through Month 48||27
8620175|NCT00473330|9658769|FG000|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|89
8629664|NCT00531050|9669382|FG001|STARTED|Part 2: Period 2||4
8814844|NCT01534663|9868170|FG000|STARTED|Overall Study||14
8814845|NCT01534663|9868171|FG001|STARTED|Overall Study||17
8814846|NCT01534663|9868170|FG000|COMPLETED|Overall Study||12
8814847|NCT01534663|9868171|FG001|COMPLETED|Overall Study||14
8814848|NCT01534663|9868170|FG000|NOT COMPLETED|Overall Study||2
8814849|NCT01534663|9868171|FG001|NOT COMPLETED|Overall Study||3
8814850|NCT01534689|9868177|FG000|STARTED|Overall Study||105
8814851|NCT01534689|9868177|FG000|COMPLETED|Overall Study||105
8814852|NCT01534689|9868177|FG000|NOT COMPLETED|Overall Study||0
8814853|NCT01534897|9868181|FG000|STARTED|Overall Study||10
8814854|NCT01534897|9868181|FG000|Day 25 Iodine-131 Scan|Overall Study||10
8814855|NCT01534897|9868181|FG000|Day 37 Iodine-131 Treatment|Overall Study||6
8814856|NCT01534897|9868181|FG000|COMPLETED|Overall Study||10
8814857|NCT01534897|9868181|FG000|NOT COMPLETED|Overall Study||0
8814858|NCT01534910|9868188|FG000|STARTED|Overall Study||33
8814859|NCT01534910|9868189|FG001|STARTED|Overall Study||32
8814860|NCT01534910|9868188|FG000|COMPLETED|Overall Study||29
8814861|NCT01534910|9868189|FG001|COMPLETED|Overall Study||28
8814862|NCT01534910|9868188|FG000|NOT COMPLETED|Overall Study||4
8814863|NCT01534910|9868189|FG001|NOT COMPLETED|Overall Study||4
8814864|NCT01534962|9868201|FG000|STARTED|Overall Study||67
8814865|NCT01534962|9868202|FG001|STARTED|Overall Study||60
8814866|NCT01534962|9868203|FG002|STARTED|Overall Study||58
8814867|NCT01534962|9868204|FG003|STARTED|Overall Study||56
8814868|NCT01534962|9868201|FG000|COMPLETED|Overall Study||30
8814869|NCT01534962|9868202|FG001|COMPLETED|Overall Study||34
8814870|NCT01534962|9868203|FG002|COMPLETED|Overall Study||34
8814871|NCT01534962|9868204|FG003|COMPLETED|Overall Study||24
8814872|NCT01534962|9868201|FG000|NOT COMPLETED|Overall Study||37
8814873|NCT01534962|9868202|FG001|NOT COMPLETED|Overall Study||26
8814874|NCT01534962|9868203|FG002|NOT COMPLETED|Overall Study||24
8561976|NCT00009737|9593925|FG000|NOT COMPLETED|Overall Study||170
8814875|NCT01534962|9868204|FG003|NOT COMPLETED|Overall Study||32
8814876|NCT01534975|9868218|FG000|STARTED|Overall Study||136
8814877|NCT01534975|9868219|FG001|STARTED|Overall Study||133
8814878|NCT01534975|9868220|FG002|STARTED|Overall Study||160
8814879|NCT01534975|9868221|FG003|STARTED|Overall Study||84
8561977|NCT00009737|9593926|FG001|NOT COMPLETED|Overall Study||123
8561978|NCT00009945|9593934|FG000|STARTED|Overall Study||1662
8561979|NCT00009945|9593935|FG001|STARTED|Overall Study||1661
8561980|NCT00009945|9593934|FG000|COMPLETED|Overall Study||1655
8561981|NCT00009945|9593935|FG001|COMPLETED|Overall Study||1656
8561982|NCT00009945|9593934|FG000|NOT COMPLETED|Overall Study||7
8620176|NCT00473330|9658770|FG001|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|79
8620177|NCT00473330|9658771|FG002|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|77
8620178|NCT00473330|9658769|FG000|COMPLETED|Open-label Extension Through Month 60||1
8620179|NCT00473330|9658770|FG001|COMPLETED|Open-label Extension Through Month 60||1
8561983|NCT00009945|9593935|FG001|NOT COMPLETED|Overall Study||5
8620180|NCT00473330|9658771|FG002|COMPLETED|Open-label Extension Through Month 60||0
8561984|NCT00010257|9593943|FG000|STARTED|Overall Study||25
8561985|NCT00010257|9593944|FG001|STARTED|Overall Study||21
8561986|NCT00010257|9593943|FG000|COMPLETED|Overall Study||24
8561987|NCT00010257|9593944|FG001|COMPLETED|Overall Study||21
8561988|NCT00010257|9593943|FG000|NOT COMPLETED|Overall Study||1
8561989|NCT00010257|9593944|FG001|NOT COMPLETED|Overall Study||0
8561990|NCT00010374|9593950|FG000|STARTED|Overall Study||54
8561991|NCT00010374|9593950|FG000|COMPLETED|Overall Study|One compassionate use participant was withheld from analysis per FDA instructions|53
8561992|NCT00010374|9593950|FG000|NOT COMPLETED|Overall Study||1
8561993|NCT00010439|9593955|FG000|STARTED|Overall Study||10
8561994|NCT00010439|9593955|FG000|6 Months|Overall Study||10
8561995|NCT00010439|9593955|FG000|COMPLETED|Overall Study||10
8561996|NCT00010439|9593955|FG000|NOT COMPLETED|Overall Study||0
8561997|NCT00010803|9593961|FG000|STARTED|Overall Study|Randomized|1545
8561998|NCT00010803|9593962|FG001|STARTED|Overall Study|Randomized|1524
8561999|NCT00010803|9593961|FG000|COMPLETED|Overall Study|Reached endpoint of dementia, death or completion|1448
8562000|NCT00010803|9593962|FG001|COMPLETED|Overall Study|Reached endpoint of dementia, death or completion|1426
8562001|NCT00010803|9593961|FG000|NOT COMPLETED|Overall Study||97
8562002|NCT00010803|9593962|FG001|NOT COMPLETED|Overall Study||98
8562003|NCT00011986|9593973|FG000|STARTED|Overall Study||864
8562004|NCT00011986|9593974|FG001|STARTED|Overall Study||864
8562005|NCT00011986|9593975|FG002|STARTED|Overall Study||862
8562006|NCT00011986|9593976|FG003|STARTED|Overall Study||861
8562007|NCT00011986|9593977|FG004|STARTED|Overall Study||861
8562008|NCT00011986|9593973|FG000|Initiated Treatment|Overall Study||862
8562009|NCT00011986|9593974|FG001|Initiated Treatment|Overall Study||860
8562010|NCT00011986|9593975|FG002|Initiated Treatment|Overall Study||854
8562011|NCT00011986|9593976|FG003|Initiated Treatment|Overall Study||846
8562012|NCT00011986|9593977|FG004|Initiated Treatment|Overall Study||851
8562013|NCT00011986|9593973|FG000|COMPLETED|Overall Study||864
8562014|NCT00011986|9593974|FG001|COMPLETED|Overall Study||864
8562015|NCT00011986|9593975|FG002|COMPLETED|Overall Study||862
8562016|NCT00011986|9593976|FG003|COMPLETED|Overall Study||861
8562017|NCT00011986|9593977|FG004|COMPLETED|Overall Study||861
8562018|NCT00011986|9593973|FG000|NOT COMPLETED|Overall Study||0
8562019|NCT00011986|9593974|FG001|NOT COMPLETED|Overall Study||0
8562020|NCT00011986|9593975|FG002|NOT COMPLETED|Overall Study||0
8562021|NCT00011986|9593976|FG003|NOT COMPLETED|Overall Study||0
8562022|NCT00011986|9593977|FG004|NOT COMPLETED|Overall Study||0
8562023|NCT00012012|9593996|FG000|STARTED|Overall Study||27
8562024|NCT00012012|9593997|FG001|STARTED|Overall Study||18
8562025|NCT00012012|9593996|FG000|COMPLETED|Overall Study||26
8562026|NCT00012012|9593997|FG001|COMPLETED|Overall Study||15
8562027|NCT00012012|9593996|FG000|NOT COMPLETED|Overall Study||1
8562028|NCT00012012|9593997|FG001|NOT COMPLETED|Overall Study||3
8562029|NCT00012298|9594010|FG000|STARTED|Overall Study||11
8562030|NCT00012298|9594011|FG001|STARTED|Overall Study||7
8562031|NCT00012298|9594012|FG002|STARTED|Overall Study||9
8562032|NCT00012298|9594013|FG003|STARTED|Overall Study||4
8562033|NCT00012298|9594014|FG004|STARTED|Overall Study||5
8562034|NCT00012298|9594015|FG005|STARTED|Overall Study||6
8562035|NCT00012298|9594016|FG006|STARTED|Overall Study||39
8562036|NCT00012298|9594010|FG000|COMPLETED|Overall Study||11
8562037|NCT00012298|9594011|FG001|COMPLETED|Overall Study||7
8562038|NCT00012298|9594012|FG002|COMPLETED|Overall Study||9
8562039|NCT00012298|9594013|FG003|COMPLETED|Overall Study||4
8562040|NCT00012298|9594014|FG004|COMPLETED|Overall Study||5
8562041|NCT00012298|9594015|FG005|COMPLETED|Overall Study||6
8562042|NCT00012298|9594016|FG006|COMPLETED|Overall Study||39
8562043|NCT00012298|9594010|FG000|NOT COMPLETED|Overall Study||0
8562044|NCT00012298|9594011|FG001|NOT COMPLETED|Overall Study||0
8562045|NCT00012298|9594012|FG002|NOT COMPLETED|Overall Study||0
8562046|NCT00012298|9594013|FG003|NOT COMPLETED|Overall Study||0
8562047|NCT00012298|9594014|FG004|NOT COMPLETED|Overall Study||0
8562048|NCT00012298|9594015|FG005|NOT COMPLETED|Overall Study||0
8562049|NCT00012298|9594016|FG006|NOT COMPLETED|Overall Study||0
8562050|NCT00013611|9594036|FG000|STARTED|Overall Study|138 were excluded from sites that did not re-consent 2/3 of patients to the amended protocol in 2003|849
8562051|NCT00013611|9594037|FG001|STARTED|Overall Study|138 were excluded from sites that did not re-consent 2/3 of patients to the amended protocol in 2003|846
8562052|NCT00013611|9594036|FG000|COMPLETED|Overall Study||758
8562053|NCT00013611|9594037|FG001|COMPLETED|Overall Study||746
8562054|NCT00013611|9594036|FG000|NOT COMPLETED|Overall Study||91
8562055|NCT00013611|9594037|FG001|NOT COMPLETED|Overall Study||100
8562056|NCT00014222|9594046|FG000|STARTED|Overall Study||701
8562057|NCT00014222|9594047|FG001|STARTED|Overall Study||701
8562058|NCT00014222|9594048|FG002|STARTED|Overall Study||702
8562059|NCT00014222|9594046|FG000|COMPLETED|Overall Study||680
8620181|NCT00473330|9658769|FG000|NOT COMPLETED|Open-label Extension Through Month 60||88
8562060|NCT00014222|9594047|FG001|COMPLETED|Overall Study||688
8562061|NCT00014222|9594048|FG002|COMPLETED|Overall Study||675
8562062|NCT00014222|9594046|FG000|NOT COMPLETED|Overall Study||21
8562063|NCT00014222|9594047|FG001|NOT COMPLETED|Overall Study||13
8562064|NCT00014222|9594048|FG002|NOT COMPLETED|Overall Study||27
8562065|NCT00014495|9594060|FG000|STARTED|Overall Study||3
8562066|NCT00014495|9594061|FG001|STARTED|Overall Study||3
8562067|NCT00014495|9594062|FG002|STARTED|Overall Study||20
8562068|NCT00014495|9594063|FG003|STARTED|Overall Study||6
8562069|NCT00014495|9594060|FG000|COMPLETED|Overall Study||3
8562070|NCT00014495|9594061|FG001|COMPLETED|Overall Study||3
8562071|NCT00014495|9594062|FG002|COMPLETED|Overall Study||19
8562072|NCT00014495|9594063|FG003|COMPLETED|Overall Study||5
8562073|NCT00014495|9594060|FG000|NOT COMPLETED|Overall Study||0
8562074|NCT00014495|9594061|FG001|NOT COMPLETED|Overall Study||0
8562075|NCT00014495|9594062|FG002|NOT COMPLETED|Overall Study||1
8562076|NCT00014495|9594063|FG003|NOT COMPLETED|Overall Study||1
8562077|NCT00014911|9594070|FG000|STARTED|Overall Study||36
8562078|NCT00014911|9594070|FG000|COMPLETED|Overall Study|One subject experienced pneumonia, myocardial infarction, and acute renal failure|25
8562079|NCT00014911|9594070|FG000|NOT COMPLETED|Overall Study||11
8562080|NCT00015457|9594074|FG000|STARTED|First Intervention||8
8562081|NCT00015457|9594075|FG001|STARTED|First Intervention||8
8562082|NCT00015457|9594074|FG000|COMPLETED|First Intervention||8
8562083|NCT00015457|9594075|FG001|COMPLETED|First Intervention||5
8562084|NCT00015457|9594074|FG000|NOT COMPLETED|First Intervention||0
8562085|NCT00015457|9594075|FG001|NOT COMPLETED|First Intervention||3
8562086|NCT00015457|9594074|FG000|STARTED|Second Intervention||8
8562087|NCT00015457|9594075|FG001|STARTED|Second Intervention||5
8562088|NCT00015457|9594074|FG000|COMPLETED|Second Intervention||7
8562089|NCT00015457|9594075|FG001|COMPLETED|Second Intervention||5
8562090|NCT00015457|9594074|FG000|NOT COMPLETED|Second Intervention||1
8562091|NCT00015457|9594075|FG001|NOT COMPLETED|Second Intervention||0
8562092|NCT00015847|9594081|FG000|STARTED|Overall Study||25
8562093|NCT00015847|9594081|FG000|COMPLETED|Overall Study||25
8562094|NCT00015847|9594081|FG000|NOT COMPLETED|Overall Study||0
8562095|NCT00016354|9594085|FG000|STARTED|Overall Study||1
8562096|NCT00016354|9594086|FG001|STARTED|Overall Study||1
8562097|NCT00016354|9594087|FG002|STARTED|Overall Study||1
8562098|NCT00016354|9594088|FG003|STARTED|Overall Study||1
8562099|NCT00016354|9594089|FG004|STARTED|Overall Study||1
8562100|NCT00016354|9594090|FG005|STARTED|Overall Study||1
8562101|NCT00016354|9594091|FG006|STARTED|Overall Study||6
8562102|NCT00016354|9594092|FG007|STARTED|Overall Study||7
8562103|NCT00016354|9594085|FG000|COMPLETED|Overall Study||1
8562104|NCT00016354|9594086|FG001|COMPLETED|Overall Study||1
8562105|NCT00016354|9594087|FG002|COMPLETED|Overall Study||1
8562106|NCT00016354|9594088|FG003|COMPLETED|Overall Study||1
8562107|NCT00016354|9594089|FG004|COMPLETED|Overall Study||1
8562108|NCT00016354|9594090|FG005|COMPLETED|Overall Study||1
8562109|NCT00016354|9594091|FG006|COMPLETED|Overall Study||6
8562110|NCT00016354|9594092|FG007|COMPLETED|Overall Study||6
8562111|NCT00016354|9594085|FG000|NOT COMPLETED|Overall Study||0
8562112|NCT00016354|9594086|FG001|NOT COMPLETED|Overall Study||0
8562113|NCT00016354|9594087|FG002|NOT COMPLETED|Overall Study||0
8562114|NCT00016354|9594088|FG003|NOT COMPLETED|Overall Study||0
8562115|NCT00016354|9594089|FG004|NOT COMPLETED|Overall Study||0
8562116|NCT00016354|9594090|FG005|NOT COMPLETED|Overall Study||0
8562117|NCT00016354|9594091|FG006|NOT COMPLETED|Overall Study||0
8562118|NCT00016354|9594092|FG007|NOT COMPLETED|Overall Study||1
8562119|NCT00016718|9594099|FG000|STARTED|Overall Study||6
8562120|NCT00016718|9594100|FG001|STARTED|Overall Study||21
8562121|NCT00016718|9594101|FG002|STARTED|Overall Study||16
8814880|NCT01534975|9868218|FG000|COMPLETED|Overall Study||136
8814881|NCT01534975|9868219|FG001|COMPLETED|Overall Study||133
8814882|NCT01534975|9868220|FG002|COMPLETED|Overall Study||160
8562122|NCT00016718|9594099|FG000|COMPLETED|Overall Study||6
8562123|NCT00016718|9594100|FG001|COMPLETED|Overall Study||21
8562124|NCT00016718|9594101|FG002|COMPLETED|Overall Study||16
8562125|NCT00016718|9594099|FG000|NOT COMPLETED|Overall Study||0
8562126|NCT00016718|9594100|FG001|NOT COMPLETED|Overall Study||0
8562127|NCT00016718|9594101|FG002|NOT COMPLETED|Overall Study||0
8562128|NCT00016913|9594109|FG000|STARTED|Overall Study||27
8562129|NCT00016913|9594109|FG000|COMPLETED|Overall Study||27
8562130|NCT00016913|9594109|FG000|NOT COMPLETED|Overall Study||0
8562131|NCT00017563|9594113|FG000|STARTED|Overall Study||57
8562132|NCT00017563|9594113|FG000|COMPLETED|Overall Study||56
8562133|NCT00017563|9594113|FG000|NOT COMPLETED|Overall Study||1
8562134|NCT00018031|9594117|FG000|STARTED|Overall Study||36
8562135|NCT00018031|9594117|FG000|COMPLETED|Overall Study||36
8562136|NCT00018031|9594117|FG000|NOT COMPLETED|Overall Study||0
8562137|NCT00019604|9594121|FG000|STARTED|Overall Study||44
8562138|NCT00019604|9594121|FG000|COMPLETED|Overall Study||5
8562139|NCT00019604|9594121|FG000|NOT COMPLETED|Overall Study||39
8562140|NCT00019682|9594127|FG000|STARTED|Overall Study||94
8562141|NCT00019682|9594128|FG001|STARTED|Overall Study||91
8562142|NCT00019682|9594127|FG000|COMPLETED|Overall Study||93
8562143|NCT00019682|9594128|FG001|COMPLETED|Overall Study||85
8562144|NCT00019682|9594127|FG000|NOT COMPLETED|Overall Study||1
8562145|NCT00019682|9594128|FG001|NOT COMPLETED|Overall Study||6
8562146|NCT00021229|9594137|FG000|STARTED|Overall Study||36
8562147|NCT00021229|9594138|FG001|STARTED|Overall Study||33
8562148|NCT00021229|9594139|FG002|STARTED|Overall Study||16
8562149|NCT00021229|9594137|FG000|Enrolled in Phase I|Overall Study||35
8562150|NCT00021229|9594138|FG001|Enrolled in Phase I|Overall Study||33
8562151|NCT00021229|9594139|FG002|Enrolled in Phase I|Overall Study||16
8562152|NCT00021229|9594137|FG000|Maximum Tolerated Dose (MTD) Estimation|Overall Study|12 participants enrolled in the Phase I part did not complete the 8 week MTD estimation period.|23
8562153|NCT00021229|9594138|FG001|Maximum Tolerated Dose (MTD) Estimation|Overall Study|13 participants enrolled in the Phase I part did not complete the 8 week MTD estimation period.|20
8562154|NCT00021229|9594139|FG002|Maximum Tolerated Dose (MTD) Estimation|Overall Study|4 participants enrolled in the Phase I part did not complete the 8 week MTD estimation period.|12
8562155|NCT00021229|9594137|FG000|Enrolled in Phase II|Overall Study|Thirteen participants treated at the MTD in the phase I were also part of the phase II.|14
8562156|NCT00021229|9594138|FG001|Enrolled in Phase II|Overall Study|Participants from stratum IIA did not participate in the phase II part of the study.|0
8814883|NCT01534975|9868221|FG003|COMPLETED|Overall Study||84
8814884|NCT01534975|9868218|FG000|NOT COMPLETED|Overall Study||0
8562157|NCT00021229|9594139|FG002|Enrolled in Phase II|Overall Study|Participants from stratum IIB did not participate in the phase II part of the study.|0
8562158|NCT00021229|9594137|FG000|COMPLETED|Overall Study|1 participant completed 13 courses of therapy|1
8814885|NCT01534975|9868219|FG001|NOT COMPLETED|Overall Study||0
8620182|NCT00473330|9658770|FG001|NOT COMPLETED|Open-label Extension Through Month 60||78
8620183|NCT00473330|9658771|FG002|NOT COMPLETED|Open-label Extension Through Month 60||77
8620184|NCT00473382|9658802|FG000|STARTED|Core Study||130
8722732|NCT01020786|9770214|FG000|STARTED|Maintenance Period||60
8722733|NCT01020786|9770214|FG000|COMPLETED|Maintenance Period||0
8722734|NCT01020786|9770214|FG000|NOT COMPLETED|Maintenance Period||60
8722735|NCT01020799|9770222|FG000|STARTED|Overall Study||98
8722736|NCT01020799|9770223|FG001|STARTED|Overall Study||99
8722737|NCT01020799|9770224|FG002|STARTED|Overall Study||50
8722738|NCT01020799|9770222|FG000|Patients Received Treatment|Overall Study||96
8722739|NCT01020799|9770223|FG001|Patients Received Treatment|Overall Study||99
8722740|NCT01020799|9770224|FG002|Patients Received Treatment|Overall Study||50
8722741|NCT01020799|9770222|FG000|Full Analysis Set|Overall Study||91
8722742|NCT01020799|9770223|FG001|Full Analysis Set|Overall Study||94
8722743|NCT01020799|9770224|FG002|Full Analysis Set|Overall Study||49
8722744|NCT01020799|9770222|FG000|COMPLETED|Overall Study||79
8722745|NCT01020799|9770223|FG001|COMPLETED|Overall Study||85
8722746|NCT01020799|9770224|FG002|COMPLETED|Overall Study||43
8722747|NCT01020799|9770222|FG000|NOT COMPLETED|Overall Study||19
8722748|NCT01020799|9770223|FG001|NOT COMPLETED|Overall Study||14
8722749|NCT01020799|9770224|FG002|NOT COMPLETED|Overall Study||7
8722750|NCT01020812|9770232|FG000|STARTED|Overall Study||11
8722751|NCT01020812|9770232|FG000|COMPLETED|Overall Study||8
8722752|NCT01020812|9770232|FG000|NOT COMPLETED|Overall Study||3
8722753|NCT01020838|9770236|FG000|STARTED|Overall Study||218
8722754|NCT01020838|9770236|FG000|Safety Analysis Set|Overall Study|Two patients were excluded from this population because injection of florbetaben was not done.|216
8722755|NCT01020838|9770236|FG000|Interim Analysis Set (Primary Efficacy)|Overall Study|Primary efficacy analysis of initial study period (tissue-scan matched regional analysis)|41
8722756|NCT01020838|9770236|FG000|Final Analysis Set (Whole Brain)|Overall Study|Final analysis set comparing PET scans with different histopathological evaluations.|97
8620185|NCT00473382|9658803|FG001|STARTED|Core Study||125
8620186|NCT00473382|9658804|FG002|STARTED|Core Study||127
8620187|NCT00473382|9658802|FG000|COMPLETED|Core Study||102
8620188|NCT00473382|9658803|FG001|COMPLETED|Core Study||98
8620189|NCT00473382|9658804|FG002|COMPLETED|Core Study||98
8620190|NCT00473382|9658802|FG000|NOT COMPLETED|Core Study||28
8620191|NCT00473382|9658803|FG001|NOT COMPLETED|Core Study||27
8620192|NCT00473382|9658804|FG002|NOT COMPLETED|Core Study||29
8629665|NCT00531050|9669383|FG002|STARTED|Part 2: Period 2||4
8620193|NCT00473382|9658802|FG000|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|88
8620194|NCT00473382|9658803|FG001|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|83
8620195|NCT00473382|9658804|FG002|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|84
8620196|NCT00473382|9658802|FG000|COMPLETED|Open-label Extension Through Month 48||38
8620197|NCT00473382|9658803|FG001|COMPLETED|Open-label Extension Through Month 48||42
8620198|NCT00473382|9658804|FG002|COMPLETED|Open-label Extension Through Month 48||37
8620199|NCT00473382|9658802|FG000|NOT COMPLETED|Open-label Extension Through Month 48||50
8620200|NCT00473382|9658803|FG001|NOT COMPLETED|Open-label Extension Through Month 48||41
8620201|NCT00473382|9658804|FG002|NOT COMPLETED|Open-label Extension Through Month 48||47
8620202|NCT00473382|9658802|FG000|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|88
8620203|NCT00473382|9658803|FG001|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|83
8629666|NCT00531050|9669384|FG003|STARTED|Part 2: Period 2||4
8629667|NCT00531050|9669385|FG004|STARTED|Part 2: Period 2||4
8814886|NCT01534975|9868220|FG002|NOT COMPLETED|Overall Study||0
8814887|NCT01534975|9868221|FG003|NOT COMPLETED|Overall Study||0
8814888|NCT01535001|9868233|FG000|STARTED|Overall Study||50
8814889|NCT01535001|9868234|FG001|STARTED|Overall Study||50
8814890|NCT01535001|9868233|FG000|COMPLETED|Overall Study||47
8814891|NCT01535001|9868234|FG001|COMPLETED|Overall Study||44
8814892|NCT01535001|9868233|FG000|NOT COMPLETED|Overall Study||3
8814893|NCT01535001|9868234|FG001|NOT COMPLETED|Overall Study||6
8814894|NCT01535014|9868244|FG000|STARTED|Overall Study||210
8814895|NCT01535014|9868245|FG001|STARTED|Overall Study||200
8814896|NCT01535014|9868246|FG002|STARTED|Overall Study||50
8814897|NCT01535014|9868247|FG003|STARTED|Overall Study||33
8814898|NCT01535014|9868244|FG000|COMPLETED|Overall Study||208
8814899|NCT01535014|9868245|FG001|COMPLETED|Overall Study||194
8814900|NCT01535014|9868246|FG002|COMPLETED|Overall Study||49
8814901|NCT01535014|9868247|FG003|COMPLETED|Overall Study||33
8814902|NCT01535014|9868244|FG000|NOT COMPLETED|Overall Study||2
8814903|NCT01535014|9868245|FG001|NOT COMPLETED|Overall Study||6
8814904|NCT01535014|9868246|FG002|NOT COMPLETED|Overall Study||1
8562159|NCT00021229|9594138|FG001|COMPLETED|Overall Study||0
8562160|NCT00021229|9594139|FG002|COMPLETED|Overall Study||0
8562161|NCT00021229|9594137|FG000|NOT COMPLETED|Overall Study||35
8562162|NCT00021229|9594138|FG001|NOT COMPLETED|Overall Study||33
8562163|NCT00021229|9594139|FG002|NOT COMPLETED|Overall Study||16
8562164|NCT00021255|9594152|FG000|STARTED|Overall Study|Randomized|1073
8562165|NCT00021255|9594153|FG001|STARTED|Overall Study|Randomized|1074
8620204|NCT00473382|9658804|FG002|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|84
8620205|NCT00473382|9658802|FG000|COMPLETED|Open-label Extension Through Month 60||2
8620206|NCT00473382|9658803|FG001|COMPLETED|Open-label Extension Through Month 60||1
8620207|NCT00473382|9658804|FG002|COMPLETED|Open-label Extension Through Month 60||2
8620208|NCT00473382|9658802|FG000|NOT COMPLETED|Open-label Extension Through Month 60||86
8620209|NCT00473382|9658803|FG001|NOT COMPLETED|Open-label Extension Through Month 60||82
8620210|NCT00473382|9658804|FG002|NOT COMPLETED|Open-label Extension Through Month 60||82
8620211|NCT00473434|9658830|FG000|STARTED|Overall Study||64
8620212|NCT00473434|9658830|FG000|COMPLETED|Overall Study||32
8620213|NCT00473434|9658830|FG000|NOT COMPLETED|Overall Study||32
8620214|NCT00473512|9658852|FG000|STARTED|Period 1 (Phase 1)||3
8620215|NCT00473512|9658853|FG001|STARTED|Period 1 (Phase 1)||3
8620216|NCT00473512|9658854|FG002|STARTED|Period 1 (Phase 1)||3
8620217|NCT00473512|9658855|FG003|STARTED|Period 1 (Phase 1)||42
8814905|NCT01535014|9868247|FG003|NOT COMPLETED|Overall Study||0
8849205|NCT01738971|9904353|FG002|COMPLETED|Overall Study|39 participants successfully contacted to complete telephone follow-up at 6-8 weeks.|39
8814906|NCT01535040|9868257|FG000|STARTED|Overall Study||65
8562166|NCT00021255|9594154|FG002|STARTED|Overall Study|Randomized|1075
8562167|NCT00021255|9594152|FG000|Treated|Overall Study||1045
8562168|NCT00021255|9594153|FG001|Treated|Overall Study||1072
8814907|NCT01535040|9868258|FG001|STARTED|Overall Study||65
8620218|NCT00473512|9658856|FG004|STARTED|Period 1 (Phase 1)||3
8620219|NCT00473512|9658852|FG000|COMPLETED|Period 1 (Phase 1)||2
8620220|NCT00473512|9658853|FG001|COMPLETED|Period 1 (Phase 1)||2
8620221|NCT00473512|9658854|FG002|COMPLETED|Period 1 (Phase 1)||3
8620222|NCT00473512|9658855|FG003|COMPLETED|Period 1 (Phase 1)||25
8562169|NCT00021255|9594154|FG002|Treated|Overall Study||1057
8562170|NCT00021255|9594152|FG000|Safety Population|Overall Study|1018 participants received AC-T (1012 from AC-T arm, 6 from AC-TH arm).|1018
8562171|NCT00021255|9594153|FG001|Safety Population|Overall Study|1100 participants received AC-TH (1066 from AC-TH arm, 33 from AC-T arm and 1 from TCH arm).|1100
8562172|NCT00021255|9594154|FG002|Safety Population|Overall Study|1056 participants received TCH.|1056
8562173|NCT00021255|9594152|FG000|COMPLETED|Overall Study||952
8562174|NCT00021255|9594153|FG001|COMPLETED|Overall Study||804
8562175|NCT00021255|9594154|FG002|COMPLETED|Overall Study||926
8562176|NCT00021255|9594152|FG000|NOT COMPLETED|Overall Study||121
8562177|NCT00021255|9594153|FG001|NOT COMPLETED|Overall Study||270
8562178|NCT00021255|9594154|FG002|NOT COMPLETED|Overall Study||149
8562179|NCT00021541|9594164|FG000|STARTED|Period 1-First Treatment||31
8562180|NCT00021541|9594165|FG001|STARTED|Period 1-First Treatment|These are the patients randomized to receive placebo. Two of these patients were deemed ineligible.|31
8562181|NCT00021541|9594164|FG000|Pts Who Progressed to Second Treatment|Period 1-First Treatment||20
8562182|NCT00021541|9594165|FG001|Pts Who Progressed to Second Treatment|Period 1-First Treatment||23
8562183|NCT00021541|9594164|FG000|Ineligible Patients|Period 1-First Treatment||0
8562184|NCT00021541|9594165|FG001|Ineligible Patients|Period 1-First Treatment||2
8562185|NCT00021541|9594164|FG000|COMPLETED|Period 1-First Treatment||20
8562186|NCT00021541|9594165|FG001|COMPLETED|Period 1-First Treatment||23
8562187|NCT00021541|9594164|FG000|NOT COMPLETED|Period 1-First Treatment||11
8562188|NCT00021541|9594165|FG001|NOT COMPLETED|Period 1-First Treatment||8
8562189|NCT00021541|9594164|FG000|STARTED|Period 2-crossover||20
8562190|NCT00021541|9594165|FG001|STARTED|Period 2-crossover||23
8562191|NCT00021541|9594164|FG000|COMPLETED|Period 2-crossover||10
8562192|NCT00021541|9594165|FG001|COMPLETED|Period 2-crossover||12
8562193|NCT00021541|9594164|FG000|NOT COMPLETED|Period 2-crossover||10
8620223|NCT00473512|9658856|FG004|COMPLETED|Period 1 (Phase 1)||2
8620224|NCT00473512|9658852|FG000|NOT COMPLETED|Period 1 (Phase 1)||1
8620225|NCT00473512|9658853|FG001|NOT COMPLETED|Period 1 (Phase 1)||1
8620226|NCT00473512|9658854|FG002|NOT COMPLETED|Period 1 (Phase 1)||0
8620227|NCT00473512|9658855|FG003|NOT COMPLETED|Period 1 (Phase 1)||17
8620228|NCT00473512|9658856|FG004|NOT COMPLETED|Period 1 (Phase 1)||1
8620229|NCT00473512|9658852|FG000|STARTED|Period 2 (Phase 2)|1 participant did not continue to Phase 2 of the study.|1
8620230|NCT00473512|9658853|FG001|STARTED|Period 2 (Phase 2)||2
8620231|NCT00473512|9658854|FG002|STARTED|Period 2 (Phase 2)|1 participant did not continue to Phase 2 of the study.|2
8562194|NCT00021541|9594165|FG001|NOT COMPLETED|Period 2-crossover||11
8562195|NCT00022490|9594173|FG000|STARTED|Overall Study||24
8562196|NCT00022490|9594173|FG000|COMPLETED|Overall Study||24
8562197|NCT00022490|9594173|FG000|NOT COMPLETED|Overall Study||0
8562198|NCT00022516|9594179|FG000|STARTED|Overall Study||542
8562199|NCT00022516|9594180|FG001|STARTED|Overall Study||544
8562200|NCT00022516|9594179|FG000|COMPLETED|Overall Study||539
8620232|NCT00473512|9658855|FG003|STARTED|Period 2 (Phase 2)|2 participants did not continue to Phase 2 of the study.|23
8620233|NCT00473512|9658856|FG004|STARTED|Period 2 (Phase 2)||2
8620234|NCT00473512|9658852|FG000|COMPLETED|Period 2 (Phase 2)||0
8620235|NCT00473512|9658853|FG001|COMPLETED|Period 2 (Phase 2)||0
8620236|NCT00473512|9658854|FG002|COMPLETED|Period 2 (Phase 2)||0
8620237|NCT00473512|9658855|FG003|COMPLETED|Period 2 (Phase 2)||0
8620238|NCT00473512|9658856|FG004|COMPLETED|Period 2 (Phase 2)||0
8620239|NCT00473512|9658852|FG000|NOT COMPLETED|Period 2 (Phase 2)||1
8620240|NCT00473512|9658853|FG001|NOT COMPLETED|Period 2 (Phase 2)||2
8620241|NCT00473512|9658854|FG002|NOT COMPLETED|Period 2 (Phase 2)||2
8620242|NCT00473512|9658855|FG003|NOT COMPLETED|Period 2 (Phase 2)||23
8620243|NCT00473512|9658856|FG004|NOT COMPLETED|Period 2 (Phase 2)||2
8620244|NCT00473564|9658876|FG000|STARTED|Overall Study||170
8620245|NCT00473564|9658876|FG000|COMPLETED|Overall Study||147
8620246|NCT00473564|9658876|FG000|NOT COMPLETED|Overall Study||23
8620247|NCT00473590|9658882|FG000|STARTED|Overall Study||53
8620248|NCT00473590|9658883|FG001|STARTED|Overall Study||49
8562201|NCT00022516|9594180|FG001|COMPLETED|Overall Study||314
8562202|NCT00022516|9594179|FG000|NOT COMPLETED|Overall Study||3
8562203|NCT00022516|9594180|FG001|NOT COMPLETED|Overall Study||230
8562204|NCT00022633|9594188|FG000|STARTED|Overall Study||55
8562205|NCT00022633|9594189|FG001|STARTED|Overall Study||10
8562206|NCT00022633|9594188|FG000|Eligible|Overall Study||51
8562207|NCT00022633|9594189|FG001|Eligible|Overall Study||10
8562208|NCT00022633|9594188|FG000|COMPLETED|Overall Study||23
8562209|NCT00022633|9594189|FG001|COMPLETED|Overall Study||5
8562210|NCT00022633|9594188|FG000|NOT COMPLETED|Overall Study||32
8562211|NCT00022633|9594189|FG001|NOT COMPLETED|Overall Study||5
8562212|NCT00022659|9594194|FG000|STARTED|Overall Study||64
8562213|NCT00022659|9594194|FG000|COMPLETED|Overall Study|Eligible and treated patients.|62
8562214|NCT00022659|9594194|FG000|NOT COMPLETED|Overall Study||2
8562215|NCT00022672|9594204|FG000|STARTED|Main Phase: 24 Months||103
8562216|NCT00022672|9594205|FG001|STARTED|Main Phase: 24 Months||104
8620249|NCT00473590|9658882|FG000|Treated|Overall Study||52
8620250|NCT00473590|9658883|FG001|Treated|Overall Study||48
8562217|NCT00022672|9594204|FG000|Safety Set: Received Study Drug|Main Phase: 24 Months||103
8562218|NCT00022672|9594205|FG001|Safety Set: Received Study Drug|Main Phase: 24 Months||104
8562219|NCT00022672|9594204|FG000|COMPLETED|Main Phase: 24 Months||16
8562220|NCT00022672|9594205|FG001|COMPLETED|Main Phase: 24 Months||4
8562221|NCT00022672|9594204|FG000|NOT COMPLETED|Main Phase: 24 Months||87
8562222|NCT00022672|9594205|FG001|NOT COMPLETED|Main Phase: 24 Months||100
8562223|NCT00022672|9594204|FG000|STARTED|Extension Phase|2 patients completed Main Phase; but did not enter Extension (1-did not cooperate and 1-withdrew).|14
8562224|NCT00022672|9594205|FG001|STARTED|Extension Phase||58
8562225|NCT00022672|9594204|FG000|Safety Set: Received Study Drug|Extension Phase||14
8562226|NCT00022672|9594205|FG001|Safety Set: Received Study Drug|Extension Phase||58
8562227|NCT00022672|9594204|FG000|COMPLETED|Extension Phase||11
8562228|NCT00022672|9594205|FG001|COMPLETED|Extension Phase||7
8562229|NCT00022672|9594204|FG000|NOT COMPLETED|Extension Phase||3
8562230|NCT00022672|9594205|FG001|NOT COMPLETED|Extension Phase||51
8562231|NCT00022698|9594214|FG000|STARTED|Overall Study||15
8814908|NCT01535040|9868257|FG000|COMPLETED|Overall Study||35
8814909|NCT01535040|9868258|FG001|COMPLETED|Overall Study||44
8814910|NCT01535040|9868257|FG000|NOT COMPLETED|Overall Study||30
8814911|NCT01535040|9868258|FG001|NOT COMPLETED|Overall Study||21
8814912|NCT01535053|9868266|FG000|STARTED|Overall Study||29
8814913|NCT01535053|9868267|FG001|STARTED|Overall Study||28
8814914|NCT01535053|9868266|FG000|COMPLETED|Overall Study|treated for 3 cycles after hCG <5mIU/ml or until biologic,disease progression, unacceptable toxicity|28
8814915|NCT01535053|9868267|FG001|COMPLETED|Overall Study|treated for 3 cycles after hCG <5mIU/ml or until biologic,disease progression, unacceptable toxicity|26
8814916|NCT01535053|9868266|FG000|NOT COMPLETED|Overall Study||1
8814917|NCT01535053|9868267|FG001|NOT COMPLETED|Overall Study||2
8814918|NCT01535118|9868273|FG000|STARTED|Overall Study||2765
8814919|NCT01535118|9868273|FG000|COMPLETED|Overall Study||2765
8814920|NCT01535118|9868273|FG000|NOT COMPLETED|Overall Study||0
8814921|NCT01535222|9868283|FG000|STARTED|Overall Study||3
8814922|NCT01535222|9868284|FG001|STARTED|Overall Study||3
8814923|NCT01535222|9868285|FG002|STARTED|Overall Study|Patient randomized but did not meet inclusion/exclusion criteria and did not receive study drug|7
8814924|NCT01535222|9868286|FG003|STARTED|Overall Study||6
8814925|NCT01535222|9868287|FG004|STARTED|Overall Study||6
8814926|NCT01535222|9868288|FG005|STARTED|Overall Study||8
8814927|NCT01535222|9868283|FG000|COMPLETED|Overall Study||3
8814928|NCT01535222|9868284|FG001|COMPLETED|Overall Study||3
8814929|NCT01535222|9868285|FG002|COMPLETED|Overall Study||6
8814930|NCT01535222|9868286|FG003|COMPLETED|Overall Study||6
8814931|NCT01535222|9868287|FG004|COMPLETED|Overall Study||6
8814932|NCT01535222|9868288|FG005|COMPLETED|Overall Study||8
8814933|NCT01535222|9868283|FG000|NOT COMPLETED|Overall Study||0
8814934|NCT01535222|9868284|FG001|NOT COMPLETED|Overall Study||0
8814935|NCT01535222|9868285|FG002|NOT COMPLETED|Overall Study||1
8814936|NCT01535222|9868286|FG003|NOT COMPLETED|Overall Study||0
8814937|NCT01535222|9868287|FG004|NOT COMPLETED|Overall Study||0
8814938|NCT01535222|9868288|FG005|NOT COMPLETED|Overall Study||0
8814939|NCT01535235|9868304|FG000|STARTED|Overall Study||16
8814940|NCT01535235|9868305|FG001|STARTED|Overall Study||15
8814941|NCT01535235|9868304|FG000|COMPLETED|Overall Study||15
8814942|NCT01535235|9868305|FG001|COMPLETED|Overall Study||15
8814943|NCT01535235|9868304|FG000|NOT COMPLETED|Overall Study||1
8620251|NCT00473590|9658882|FG000|Safety Population|Overall Study|2 patients received at least 1 bevacizumab dose & were analyzed as bevacizumab-treated patients|50
8620252|NCT00473590|9658883|FG001|Safety Population|Overall Study||50
8620253|NCT00473590|9658882|FG000|COMPLETED|Overall Study|Continuing on study as of the data cutoff date of 9 November 2009.|8
8620254|NCT00473590|9658883|FG001|COMPLETED|Overall Study|Continuing on study as of the data cutoff date of 9 November 2009.|11
8620255|NCT00473590|9658882|FG000|NOT COMPLETED|Overall Study||45
8620256|NCT00473590|9658883|FG001|NOT COMPLETED|Overall Study||38
8620257|NCT00473642|9658892|FG000|STARTED|Overall Study||10
8620258|NCT00473642|9658893|FG001|STARTED|Overall Study||11
8620259|NCT00473642|9658894|FG002|STARTED|Overall Study||10
8620260|NCT00473642|9658892|FG000|COMPLETED|Overall Study||8
8620261|NCT00473642|9658893|FG001|COMPLETED|Overall Study||10
8620262|NCT00473642|9658894|FG002|COMPLETED|Overall Study||8
8620263|NCT00473642|9658892|FG000|NOT COMPLETED|Overall Study||2
8620264|NCT00473642|9658893|FG001|NOT COMPLETED|Overall Study||1
8620265|NCT00473642|9658894|FG002|NOT COMPLETED|Overall Study||2
8620266|NCT00473655|9658908|FG000|STARTED|Overall Study|Just participants with TG above 200 mg/dl entered this period|111
8620267|NCT00473655|9658909|FG001|STARTED|Overall Study|Just participants with TG above 200 mg/dl entered this period|112
8620268|NCT00473655|9658910|FG002|STARTED|Overall Study|Just participants with TG above 200 mg/dl entered this period|111
8620269|NCT00473655|9658908|FG000|COMPLETED|Overall Study|9 participants were lost of follow up|102
8620270|NCT00473655|9658909|FG001|COMPLETED|Overall Study|5 participants were lost of follow up|107
8620271|NCT00473655|9658910|FG002|COMPLETED|Overall Study|8 participants were lost of follow up|103
8620272|NCT00473655|9658908|FG000|NOT COMPLETED|Overall Study||9
8620273|NCT00473655|9658909|FG001|NOT COMPLETED|Overall Study||5
8620274|NCT00473655|9658910|FG002|NOT COMPLETED|Overall Study||8
8620275|NCT00473668|9658921|FG000|STARTED|Overall Study||100
8620276|NCT00473668|9658922|FG001|STARTED|Overall Study||100
8620277|NCT00473668|9658923|FG002|STARTED|Overall Study||99
8620278|NCT00473668|9658921|FG000|COMPLETED|Overall Study||95
8620279|NCT00473668|9658922|FG001|COMPLETED|Overall Study||89
8620280|NCT00473668|9658923|FG002|COMPLETED|Overall Study||89
8620281|NCT00473668|9658921|FG000|NOT COMPLETED|Overall Study||5
8620282|NCT00473668|9658922|FG001|NOT COMPLETED|Overall Study||11
8620283|NCT00473668|9658923|FG002|NOT COMPLETED|Overall Study||10
8620284|NCT00473694|9658935|FG000|STARTED|Overall Study||48
8620285|NCT00473694|9658936|FG001|STARTED|Overall Study|Includes 1 participant randomized to vecuronium+sugammadex but treated with rocuronium+neostigmine|41
8620286|NCT00473694|9658937|FG002|STARTED|Overall Study||51
8620287|NCT00473694|9658938|FG003|STARTED|Overall Study||42
8620288|NCT00473694|9658935|FG000|Treated|Overall Study|Number of participants treated was based on actual treatment received.|37
8620289|NCT00473694|9658936|FG001|Treated|Overall Study|Number of participants treated was based on actual treatment received.|38
8620290|NCT00473694|9658937|FG002|Treated|Overall Study|Number of participants treated was based on actual treatment received.|46
8620291|NCT00473694|9658938|FG003|Treated|Overall Study|Number of participants treated was based on actual treatment received.|36
8620292|NCT00473694|9658935|FG000|COMPLETED|Overall Study|Number of participants completed was based on actual treatment received.|37
8620293|NCT00473694|9658936|FG001|COMPLETED|Overall Study|Number of participants completed was based on actual treatment received.|37
8620294|NCT00473694|9658937|FG002|COMPLETED|Overall Study|Number of participants completed was based on actual treatment received.|46
8620295|NCT00473694|9658938|FG003|COMPLETED|Overall Study|Number of participants completed was based on actual treatment received.|35
8620296|NCT00473694|9658935|FG000|NOT COMPLETED|Overall Study||11
8620297|NCT00473694|9658936|FG001|NOT COMPLETED|Overall Study||4
8620298|NCT00473694|9658937|FG002|NOT COMPLETED|Overall Study||5
8620299|NCT00473694|9658938|FG003|NOT COMPLETED|Overall Study||7
8620300|NCT00473746|9658956|FG000|STARTED|Period 1 (Phase 1)||6
8620301|NCT00473746|9658957|FG001|STARTED|Period 1 (Phase 1)||9
8620302|NCT00473746|9658958|FG002|STARTED|Period 1 (Phase 1)||6
8562232|NCT00022698|9594215|FG001|STARTED|Overall Study||52
8562233|NCT00022698|9594214|FG000|COMPLETED|Overall Study||7
8562234|NCT00022698|9594215|FG001|COMPLETED|Overall Study||17
8562235|NCT00022698|9594214|FG000|NOT COMPLETED|Overall Study||8
8562236|NCT00022698|9594215|FG001|NOT COMPLETED|Overall Study||35
8562237|NCT00022763|9594225|FG000|STARTED|Overall Study||24
8562238|NCT00022763|9594226|FG001|STARTED|Overall Study||28
8562239|NCT00022763|9594225|FG000|COMPLETED|Overall Study||15
8562240|NCT00022763|9594226|FG001|COMPLETED|Overall Study||11
8562241|NCT00022763|9594225|FG000|NOT COMPLETED|Overall Study||9
8562242|NCT00022763|9594226|FG001|NOT COMPLETED|Overall Study||17
8562243|NCT00023309|9594233|FG000|STARTED|Overall Study||22
8562244|NCT00023309|9594234|FG001|STARTED|Overall Study||19
8562245|NCT00023309|9594233|FG000|COMPLETED|Overall Study||22
8562246|NCT00023309|9594234|FG001|COMPLETED|Overall Study||19
8562247|NCT00023309|9594233|FG000|NOT COMPLETED|Overall Study||0
8562248|NCT00023309|9594234|FG001|NOT COMPLETED|Overall Study||0
8562249|NCT00023322|9594240|FG000|STARTED|Overall Study||13
8562250|NCT00023322|9594240|FG000|COMPLETED|Overall Study||12
8562251|NCT00023322|9594240|FG000|NOT COMPLETED|Overall Study||1
8562252|NCT00023452|9594246|FG000|STARTED|Overall Study||3908
8562253|NCT00023452|9594247|FG001|STARTED|Overall Study||4145
8562254|NCT00023452|9594246|FG000|Randomized|Overall Study||3190
8562255|NCT00023452|9594247|FG001|Randomized|Overall Study||3174
8562256|NCT00023452|9594246|FG000|Enrolled as Part of a Cluster|Overall Study||718
8562257|NCT00023452|9594247|FG001|Enrolled as Part of a Cluster|Overall Study||971
8562258|NCT00023452|9594246|FG000|Completed Treatment|Overall Study||2585
8562259|NCT00023452|9594247|FG001|Completed Treatment|Overall Study||3273
8562260|NCT00023452|9594246|FG000|Not Treated|Overall Study||149
8562261|NCT00023452|9594247|FG001|Not Treated|Overall Study||105
8562262|NCT00023452|9594246|FG000|Completed Study|Overall Study||3174
8562263|NCT00023452|9594247|FG001|Completed Study|Overall Study||3475
8562264|NCT00023452|9594246|FG000|COMPLETED|Overall Study||2585
8562265|NCT00023452|9594247|FG001|COMPLETED|Overall Study||3273
8562266|NCT00023452|9594246|FG000|NOT COMPLETED|Overall Study||1323
8562267|NCT00023452|9594247|FG001|NOT COMPLETED|Overall Study||872
8562268|NCT00023595|9594262|FG000|STARTED|5 Year Follow up||602
8562269|NCT00023595|9594263|FG001|STARTED|5 Year Follow up||534
8562270|NCT00023595|9594264|FG002|STARTED|5 Year Follow up||76
8562271|NCT00023595|9594265|FG003|STARTED|5 Year Follow up|76 of stratum B pts who were randomized to med therapy + CABG group belong to both H01 and H02.|423
8562272|NCT00023595|9594266|FG004|STARTED|5 Year Follow up||501
8562273|NCT00023595|9594262|FG000|COMPLETED|5 Year Follow up||600
8562274|NCT00023595|9594263|FG001|COMPLETED|5 Year Follow up||532
8562275|NCT00023595|9594264|FG002|COMPLETED|5 Year Follow up||75
8562276|NCT00023595|9594265|FG003|COMPLETED|5 Year Follow up||416
8562277|NCT00023595|9594266|FG004|COMPLETED|5 Year Follow up||498
8562278|NCT00023595|9594262|FG000|NOT COMPLETED|5 Year Follow up||2
8562279|NCT00023595|9594263|FG001|NOT COMPLETED|5 Year Follow up||2
8562280|NCT00023595|9594264|FG002|NOT COMPLETED|5 Year Follow up||1
8562281|NCT00023595|9594265|FG003|NOT COMPLETED|5 Year Follow up||7
8562282|NCT00023595|9594266|FG004|NOT COMPLETED|5 Year Follow up||3
8562283|NCT00023595|9594262|FG000|STARTED|10 Year Follow up|all participants who started H01 were counted as starting the 10 year follow up.|602
8562284|NCT00023595|9594263|FG001|STARTED|10 Year Follow up|all participants who started H01 were counted as starting the 10 year follow up.|534
8562285|NCT00023595|9594264|FG002|STARTED|10 Year Follow up|all participants who started H01 were counted as starting the 10 year follow up.|76
8562286|NCT00023595|9594265|FG003|STARTED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
8562287|NCT00023595|9594266|FG004|STARTED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
8562288|NCT00023595|9594262|FG000|COMPLETED|10 Year Follow up||590
8562289|NCT00023595|9594263|FG001|COMPLETED|10 Year Follow up||524
8562290|NCT00023595|9594264|FG002|COMPLETED|10 Year Follow up||73
8562291|NCT00023595|9594265|FG003|COMPLETED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
8562292|NCT00023595|9594266|FG004|COMPLETED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
8562293|NCT00023595|9594262|FG000|NOT COMPLETED|10 Year Follow up||12
8562294|NCT00023595|9594263|FG001|NOT COMPLETED|10 Year Follow up||10
8562295|NCT00023595|9594264|FG002|NOT COMPLETED|10 Year Follow up||3
8562296|NCT00023595|9594265|FG003|NOT COMPLETED|10 Year Follow up||0
8562297|NCT00023595|9594266|FG004|NOT COMPLETED|10 Year Follow up||0
8562298|NCT00023673|9594292|FG000|STARTED|Overall Study||8
8562299|NCT00023673|9594293|FG001|STARTED|Overall Study||9
8562300|NCT00023673|9594294|FG002|STARTED|Overall Study||0
8562301|NCT00023673|9594295|FG003|STARTED|Overall Study||46
8562302|NCT00023673|9594292|FG000|COMPLETED|Overall Study|Phase I eligible patients starting protocol treatment are considered to have completed the study.|8
8562303|NCT00023673|9594293|FG001|COMPLETED|Overall Study|Phase I eligible patients starting protocol treatment are considered to have completed the study.|9
8562304|NCT00023673|9594294|FG002|COMPLETED|Overall Study|This arm was not used since further de-escalation was not required.|0
8562305|NCT00023673|9594295|FG003|COMPLETED|Overall Study|Phase II subjects contributing data to primary analysis are considered to have completed the study.|44
8620303|NCT00473746|9658959|FG003|STARTED|Period 1 (Phase 1)||12
8620304|NCT00473746|9658960|FG004|STARTED|Period 1 (Phase 1)||0
8814944|NCT01535235|9868305|FG001|NOT COMPLETED|Overall Study||0
8620305|NCT00473746|9658956|FG000|COMPLETED|Period 1 (Phase 1)||0
8814945|NCT01535261|9868311|FG000|STARTED|Overall Study||357
8814946|NCT01535261|9868311|FG000|COMPLETED|Overall Study||307
8814947|NCT01535261|9868311|FG000|NOT COMPLETED|Overall Study||50
8814948|NCT01535287|9868317|FG000|STARTED|Overall Study||70
8814949|NCT01535287|9868318|FG001|STARTED|Overall Study||70
8814950|NCT01535287|9868317|FG000|COMPLETED|Overall Study||65
8814951|NCT01535287|9868318|FG001|COMPLETED|Overall Study||64
8562306|NCT00023673|9594292|FG000|NOT COMPLETED|Overall Study||0
8562307|NCT00023673|9594293|FG001|NOT COMPLETED|Overall Study||0
8562308|NCT00023673|9594294|FG002|NOT COMPLETED|Overall Study||0
8562309|NCT00023673|9594295|FG003|NOT COMPLETED|Overall Study||2
8562310|NCT00023712|9594307|FG000|STARTED|Overall Study|total number of participants enrolled on study|28
8562311|NCT00023712|9594308|FG001|STARTED|Overall Study|total number of participants enrolled on study|30
8562312|NCT00023712|9594307|FG000|COMPLETED|Overall Study|total number of participants eligible and evaluable|26
8562313|NCT00023712|9594308|FG001|COMPLETED|Overall Study|total number of participants eligible and evaluable|29
8562314|NCT00023712|9594307|FG000|NOT COMPLETED|Overall Study||2
8562315|NCT00023712|9594308|FG001|NOT COMPLETED|Overall Study||1
8562316|NCT00023764|9594324|FG000|STARTED|Overall Study||103
8562317|NCT00023764|9594324|FG000|COMPLETED|Overall Study||89
8562318|NCT00023764|9594324|FG000|NOT COMPLETED|Overall Study||14
8562319|NCT00024102|9594331|FG000|STARTED|Overall Study||326
8562320|NCT00024102|9594332|FG001|STARTED|Overall Study||307
8562321|NCT00024102|9594331|FG000|COMPLETED|Overall Study||326
8562322|NCT00024102|9594332|FG001|COMPLETED|Overall Study||307
8562323|NCT00024102|9594331|FG000|NOT COMPLETED|Overall Study||0
8562324|NCT00024102|9594332|FG001|NOT COMPLETED|Overall Study||0
8562325|NCT00024167|9594345|FG000|STARTED|Overall Study||65
8562326|NCT00024167|9594346|FG001|STARTED|Overall Study||62
8620306|NCT00473746|9658957|FG001|COMPLETED|Period 1 (Phase 1)||0
8814952|NCT01535287|9868317|FG000|NOT COMPLETED|Overall Study||5
8814953|NCT01535287|9868318|FG001|NOT COMPLETED|Overall Study||6
8814954|NCT01535326|9868327|FG000|STARTED|Overall Study||90
8814955|NCT01535326|9868328|FG001|STARTED|Overall Study||90
8814956|NCT01535326|9868329|FG002|STARTED|Overall Study||90
8814957|NCT01535326|9868327|FG000|COMPLETED|Overall Study||90
8814958|NCT01535326|9868328|FG001|COMPLETED|Overall Study||90
8814959|NCT01535326|9868329|FG002|COMPLETED|Overall Study||90
8620307|NCT00473746|9658958|FG002|COMPLETED|Period 1 (Phase 1)||0
8620308|NCT00473746|9658959|FG003|COMPLETED|Period 1 (Phase 1)|Treatment ongoing|2
8620309|NCT00473746|9658960|FG004|COMPLETED|Period 1 (Phase 1)||0
8620310|NCT00473746|9658956|FG000|NOT COMPLETED|Period 1 (Phase 1)||6
9065778|NCT04143373|10126249|FG001|NOT COMPLETED|Overall Study||0
9065779|NCT04142216|10126256|FG000|STARTED|Overall Study||28
8562327|NCT00024167|9594345|FG000|Induction Treatment Option 1 Completed|Overall Study||22
8562328|NCT00024167|9594346|FG001|Induction Treatment Option 1 Completed|Overall Study||21
8562329|NCT00024167|9594345|FG000|Induction Treatment Option 2 Completed|Overall Study||43
8562330|NCT00024167|9594346|FG001|Induction Treatment Option 2 Completed|Overall Study||41
8562331|NCT00024167|9594345|FG000|COMPLETED|Overall Study||12
8562332|NCT00024167|9594346|FG001|COMPLETED|Overall Study||15
8562333|NCT00024167|9594345|FG000|NOT COMPLETED|Overall Study||53
8562334|NCT00024167|9594346|FG001|NOT COMPLETED|Overall Study||47
8562335|NCT00024258|9594353|FG000|STARTED|Overall Study||22
8562336|NCT00024258|9594353|FG000|COMPLETED|Overall Study||13
8562337|NCT00024258|9594353|FG000|NOT COMPLETED|Overall Study||9
8562338|NCT00025155|9594357|FG000|STARTED|Overall Study||51
8562339|NCT00025155|9594357|FG000|COMPLETED|Overall Study|Patients who were eligible and received any study treatment.|49
8562340|NCT00025155|9594357|FG000|NOT COMPLETED|Overall Study||2
8562341|NCT00025233|9594366|FG000|STARTED|Overall Study||50
8562342|NCT00025233|9594366|FG000|COMPLETED|Overall Study||46
8562343|NCT00025233|9594366|FG000|NOT COMPLETED|Overall Study||4
8814960|NCT01535326|9868327|FG000|NOT COMPLETED|Overall Study||0
8814961|NCT01535326|9868328|FG001|NOT COMPLETED|Overall Study||0
8814962|NCT01535326|9868329|FG002|NOT COMPLETED|Overall Study||0
8814963|NCT01535365|9868342|FG000|STARTED|Overall Study||31
8814964|NCT01535365|9868343|FG001|STARTED|Overall Study||29
8814965|NCT01535365|9868342|FG000|COMPLETED|Overall Study||31
8814966|NCT01535365|9868343|FG001|COMPLETED|Overall Study||29
8562344|NCT00025259|9594383|FG000|STARTED|Overall Study||52
8562345|NCT00025259|9594384|FG001|STARTED|Overall Study||381
8562346|NCT00025259|9594385|FG002|STARTED|Overall Study||382
8562347|NCT00025259|9594386|FG003|STARTED|Overall Study||571
8562348|NCT00025259|9594387|FG004|STARTED|Overall Study||42
8562349|NCT00025259|9594388|FG005|STARTED|Overall Study||153
8562350|NCT00025259|9594389|FG006|STARTED|Overall Study||153
8562351|NCT00025259|9594383|FG000|COMPLETED|Overall Study||7
8562352|NCT00025259|9594384|FG001|COMPLETED|Overall Study||292
8562353|NCT00025259|9594385|FG002|COMPLETED|Overall Study||301
8562354|NCT00025259|9594386|FG003|COMPLETED|Overall Study||457
8562355|NCT00025259|9594387|FG004|COMPLETED|Overall Study||6
8562356|NCT00025259|9594388|FG005|COMPLETED|Overall Study||101
8562357|NCT00025259|9594389|FG006|COMPLETED|Overall Study||102
8562358|NCT00025259|9594383|FG000|NOT COMPLETED|Overall Study||45
8562359|NCT00025259|9594384|FG001|NOT COMPLETED|Overall Study||89
8562360|NCT00025259|9594385|FG002|NOT COMPLETED|Overall Study||81
8814967|NCT01535365|9868342|FG000|NOT COMPLETED|Overall Study||0
8814968|NCT01535365|9868343|FG001|NOT COMPLETED|Overall Study||0
8814969|NCT01535443|9868351|FG000|STARTED|Overall Study||35
8562361|NCT00025259|9594386|FG003|NOT COMPLETED|Overall Study||114
8562362|NCT00025259|9594387|FG004|NOT COMPLETED|Overall Study||36
8562363|NCT00025259|9594388|FG005|NOT COMPLETED|Overall Study||52
8562364|NCT00025259|9594389|FG006|NOT COMPLETED|Overall Study||51
8562365|NCT00025506|9594408|FG000|STARTED|Overall Study||55
8562366|NCT00025506|9594408|FG000|COMPLETED|Overall Study|Eligible and treated patients.|45
8562367|NCT00025506|9594408|FG000|NOT COMPLETED|Overall Study||10
8562368|NCT00025662|9594417|FG000|STARTED|Overall Study||25
8562369|NCT00025662|9594417|FG000|COMPLETED|Overall Study|One patient who received a transplant did not meet eligibility and was a special exemption.|22
8562370|NCT00025662|9594417|FG000|NOT COMPLETED|Overall Study||3
8562371|NCT00025883|9594423|FG000|STARTED|Overall Study||103
8562372|NCT00025883|9594423|FG000|Generalized Lipodystrophy|Overall Study||63
8562373|NCT00025883|9594423|FG000|Partial Lipodystrophy|Overall Study||40
8562374|NCT00025883|9594423|FG000|COMPLETED|Overall Study||86
8562375|NCT00025883|9594423|FG000|NOT COMPLETED|Overall Study||17
8562376|NCT00026208|9594430|FG000|STARTED|Overall Study||72
8562377|NCT00026208|9594431|FG001|STARTED|Overall Study||4
8562378|NCT00026208|9594430|FG000|COMPLETED|Overall Study||71
8562379|NCT00026208|9594431|FG001|COMPLETED|Overall Study||4
8562380|NCT00026208|9594430|FG000|NOT COMPLETED|Overall Study||1
8562381|NCT00026208|9594431|FG001|NOT COMPLETED|Overall Study||0
8620311|NCT00473746|9658957|FG001|NOT COMPLETED|Period 1 (Phase 1)||9
8620312|NCT00473746|9658958|FG002|NOT COMPLETED|Period 1 (Phase 1)||6
8620313|NCT00473746|9658959|FG003|NOT COMPLETED|Period 1 (Phase 1)||10
8814970|NCT01535443|9868351|FG000|COMPLETED|Overall Study||32
8814971|NCT01535443|9868351|FG000|NOT COMPLETED|Overall Study||3
8814972|NCT01535560|9868358|FG000|STARTED|Overall Study||274
8814973|NCT01535560|9868359|FG001|STARTED|Overall Study||275
8814974|NCT01535560|9868358|FG000|COMPLETED|Overall Study||237
8814975|NCT01535560|9868359|FG001|COMPLETED|Overall Study||179
8814976|NCT01535560|9868358|FG000|NOT COMPLETED|Overall Study||37
8814977|NCT01535560|9868359|FG001|NOT COMPLETED|Overall Study||96
8814978|NCT01535573|9868368|FG000|STARTED|Overall Study||21
8814979|NCT01535573|9868369|FG001|STARTED|Overall Study||44
8814980|NCT01535573|9868370|FG002|STARTED|Overall Study||43
8814981|NCT01535573|9868368|FG000|COMPLETED|Overall Study||13
8814982|NCT01535573|9868369|FG001|COMPLETED|Overall Study||23
8814983|NCT01535573|9868370|FG002|COMPLETED|Overall Study||24
8814984|NCT01535573|9868368|FG000|NOT COMPLETED|Overall Study||8
8814985|NCT01535573|9868369|FG001|NOT COMPLETED|Overall Study||21
8814986|NCT01535573|9868370|FG002|NOT COMPLETED|Overall Study||19
8814987|NCT01535599|9868380|FG000|STARTED|Overall Study||347
8814988|NCT01535599|9868381|FG001|STARTED|Overall Study||346
8814989|NCT01535599|9868380|FG000|COMPLETED|Overall Study||297
8814990|NCT01535599|9868381|FG001|COMPLETED|Overall Study||250
8814991|NCT01535599|9868380|FG000|NOT COMPLETED|Overall Study||50
8814992|NCT01535599|9868381|FG001|NOT COMPLETED|Overall Study||96
8814993|NCT01535638|9868387|FG000|STARTED|Treatment 1 (Single Dose)||3
8814994|NCT01535638|9868388|FG001|STARTED|Treatment 1 (Single Dose)||3
8814995|NCT01535638|9868389|FG002|STARTED|Treatment 1 (Single Dose)||3
8814996|NCT01535638|9868390|FG003|STARTED|Treatment 1 (Single Dose)||3
8814997|NCT01535638|9868391|FG004|STARTED|Treatment 1 (Single Dose)||3
8814998|NCT01535638|9868392|FG005|STARTED|Treatment 1 (Single Dose)||3
8814999|NCT01535638|9868387|FG000|COMPLETED|Treatment 1 (Single Dose)||3
8815000|NCT01535638|9868388|FG001|COMPLETED|Treatment 1 (Single Dose)||3
8815001|NCT01535638|9868389|FG002|COMPLETED|Treatment 1 (Single Dose)||3
8815002|NCT01535638|9868390|FG003|COMPLETED|Treatment 1 (Single Dose)||3
8815003|NCT01535638|9868391|FG004|COMPLETED|Treatment 1 (Single Dose)||3
8815004|NCT01535638|9868392|FG005|COMPLETED|Treatment 1 (Single Dose)||2
8815005|NCT01535638|9868387|FG000|NOT COMPLETED|Treatment 1 (Single Dose)||0
8815006|NCT01535638|9868388|FG001|NOT COMPLETED|Treatment 1 (Single Dose)||0
8815007|NCT01535638|9868389|FG002|NOT COMPLETED|Treatment 1 (Single Dose)||0
8815008|NCT01535638|9868390|FG003|NOT COMPLETED|Treatment 1 (Single Dose)||0
8815009|NCT01535638|9868391|FG004|NOT COMPLETED|Treatment 1 (Single Dose)||0
8815010|NCT01535638|9868392|FG005|NOT COMPLETED|Treatment 1 (Single Dose)||1
8815011|NCT01535638|9868387|FG000|STARTED|Treatment 2 (Single Dose)||3
8815012|NCT01535638|9868388|FG001|STARTED|Treatment 2 (Single Dose)||3
8815013|NCT01535638|9868389|FG002|STARTED|Treatment 2 (Single Dose)||3
8815014|NCT01535638|9868390|FG003|STARTED|Treatment 2 (Single Dose)||3
8815015|NCT01535638|9868391|FG004|STARTED|Treatment 2 (Single Dose)||3
8815016|NCT01535638|9868392|FG005|STARTED|Treatment 2 (Single Dose)||2
8815017|NCT01535638|9868387|FG000|COMPLETED|Treatment 2 (Single Dose)||3
8815018|NCT01535638|9868388|FG001|COMPLETED|Treatment 2 (Single Dose)||3
8815019|NCT01535638|9868389|FG002|COMPLETED|Treatment 2 (Single Dose)||3
8815020|NCT01535638|9868390|FG003|COMPLETED|Treatment 2 (Single Dose)||3
8815021|NCT01535638|9868391|FG004|COMPLETED|Treatment 2 (Single Dose)||3
8815022|NCT01535638|9868392|FG005|COMPLETED|Treatment 2 (Single Dose)||2
8815023|NCT01535638|9868387|FG000|NOT COMPLETED|Treatment 2 (Single Dose)||0
8815024|NCT01535638|9868388|FG001|NOT COMPLETED|Treatment 2 (Single Dose)||0
8815025|NCT01535638|9868389|FG002|NOT COMPLETED|Treatment 2 (Single Dose)||0
8815026|NCT01535638|9868390|FG003|NOT COMPLETED|Treatment 2 (Single Dose)||0
8815027|NCT01535638|9868391|FG004|NOT COMPLETED|Treatment 2 (Single Dose)||0
8815028|NCT01535638|9868392|FG005|NOT COMPLETED|Treatment 2 (Single Dose)||0
8815029|NCT01535638|9868387|FG000|STARTED|Treatment 3 (Single Dose)||3
8815030|NCT01535638|9868388|FG001|STARTED|Treatment 3 (Single Dose)||3
8815031|NCT01535638|9868389|FG002|STARTED|Treatment 3 (Single Dose)||3
8815032|NCT01535638|9868390|FG003|STARTED|Treatment 3 (Single Dose)||3
8815033|NCT01535638|9868391|FG004|STARTED|Treatment 3 (Single Dose)||3
8815034|NCT01535638|9868392|FG005|STARTED|Treatment 3 (Single Dose)||2
8815035|NCT01535638|9868387|FG000|COMPLETED|Treatment 3 (Single Dose)||3
8815036|NCT01535638|9868388|FG001|COMPLETED|Treatment 3 (Single Dose)||3
8815037|NCT01535638|9868389|FG002|COMPLETED|Treatment 3 (Single Dose)||3
8815038|NCT01535638|9868390|FG003|COMPLETED|Treatment 3 (Single Dose)||2
8815039|NCT01535638|9868391|FG004|COMPLETED|Treatment 3 (Single Dose)||3
8815040|NCT01535638|9868392|FG005|COMPLETED|Treatment 3 (Single Dose)||2
8815041|NCT01535638|9868387|FG000|NOT COMPLETED|Treatment 3 (Single Dose)||0
8815042|NCT01535638|9868388|FG001|NOT COMPLETED|Treatment 3 (Single Dose)||0
8815043|NCT01535638|9868389|FG002|NOT COMPLETED|Treatment 3 (Single Dose)||0
8815044|NCT01535638|9868390|FG003|NOT COMPLETED|Treatment 3 (Single Dose)||1
8815045|NCT01535638|9868391|FG004|NOT COMPLETED|Treatment 3 (Single Dose)||0
8815046|NCT01535638|9868392|FG005|NOT COMPLETED|Treatment 3 (Single Dose)||0
8815047|NCT01535664|9868401|FG000|STARTED|Overall Study||20
8815048|NCT01535664|9868401|FG000|COMPLETED|Overall Study||20
8815049|NCT01535664|9868401|FG000|NOT COMPLETED|Overall Study||0
8815050|NCT01535729|9868409|FG000|STARTED|Overall Study||465
8815051|NCT01535729|9868409|FG000|Treated|Overall Study||385
8815052|NCT01535729|9868409|FG000|COMPLETED|Overall Study||49
8815053|NCT01535729|9868409|FG000|NOT COMPLETED|Overall Study||416
8815054|NCT01535924|9868419|FG000|STARTED|Overall Study||3
8815055|NCT01535924|9868420|FG001|STARTED|Overall Study||3
8815056|NCT01535924|9868421|FG002|STARTED|Overall Study||3
8815057|NCT01535924|9868422|FG003|STARTED|Overall Study||4
8815058|NCT01535924|9868423|FG004|STARTED|Overall Study||6
8815059|NCT01535924|9868424|FG005|STARTED|Overall Study||7
8815060|NCT01535924|9868419|FG000|COMPLETED|Overall Study||3
8815061|NCT01535924|9868420|FG001|COMPLETED|Overall Study||3
8815062|NCT01535924|9868421|FG002|COMPLETED|Overall Study||3
8815063|NCT01535924|9868422|FG003|COMPLETED|Overall Study||4
8815064|NCT01535924|9868423|FG004|COMPLETED|Overall Study||6
8815065|NCT01535924|9868424|FG005|COMPLETED|Overall Study||7
8815066|NCT01535924|9868419|FG000|NOT COMPLETED|Overall Study||0
8815067|NCT01535924|9868420|FG001|NOT COMPLETED|Overall Study||0
8815068|NCT01535924|9868421|FG002|NOT COMPLETED|Overall Study||0
8815069|NCT01535924|9868422|FG003|NOT COMPLETED|Overall Study||0
8815070|NCT01535924|9868423|FG004|NOT COMPLETED|Overall Study||0
8815071|NCT01535924|9868424|FG005|NOT COMPLETED|Overall Study||0
8815072|NCT01535937|9868441|FG000|STARTED|Overall Study||27
8815073|NCT01535937|9868442|FG001|STARTED|Overall Study||28
8815074|NCT01535937|9868441|FG000|COMPLETED|Overall Study||27
8815075|NCT01535937|9868442|FG001|COMPLETED|Overall Study||28
8815076|NCT01535937|9868441|FG000|NOT COMPLETED|Overall Study||0
8815077|NCT01535937|9868442|FG001|NOT COMPLETED|Overall Study||0
8815078|NCT01535976|9868450|FG000|STARTED|Overall Study||27
8815079|NCT01535976|9868451|FG001|STARTED|Overall Study||27
8815080|NCT01535976|9868450|FG000|COMPLETED|Overall Study||26
8815081|NCT01535976|9868451|FG001|COMPLETED|Overall Study||26
8815082|NCT01535976|9868450|FG000|NOT COMPLETED|Overall Study||1
8815083|NCT01535976|9868451|FG001|NOT COMPLETED|Overall Study||1
8815084|NCT01536067|9868457|FG000|STARTED|Overall Study||3
8815085|NCT01536067|9868457|FG000|COMPLETED|Overall Study||2
8815086|NCT01536067|9868457|FG000|NOT COMPLETED|Overall Study||1
8815087|NCT01536093|9868463|FG000|STARTED|Overall Study||24
8815088|NCT01536093|9868464|FG001|STARTED|Overall Study||24
8815089|NCT01536093|9868463|FG000|COMPLETED|Overall Study||21
8815090|NCT01536093|9868464|FG001|COMPLETED|Overall Study||21
8815091|NCT01536093|9868463|FG000|NOT COMPLETED|Overall Study||3
8815092|NCT01536093|9868464|FG001|NOT COMPLETED|Overall Study||3
8815093|NCT01536119|9868472|FG000|STARTED|Overall Study|(107*2= 214) (107 mothers and 107 fathers)|214
8815094|NCT01536119|9868473|FG001|STARTED|Overall Study|(107*2=214) (107 mothers and 107 fathers)|214
8815095|NCT01536119|9868472|FG000|COMPLETED|Overall Study|104 Mothers + 93 fathers = 197 participants 3 mothers + 14 fathers = 17 did not complete the study|197
8815096|NCT01536119|9868473|FG001|COMPLETED|Overall Study|105 mothers + 95 fathers = 200 participants 2 mothers + 12 fathers = 14 did not complete the study|200
8815097|NCT01536119|9868472|FG000|NOT COMPLETED|Overall Study||17
8815098|NCT01536119|9868473|FG001|NOT COMPLETED|Overall Study||14
8815099|NCT01536145|9868479|FG000|STARTED|Overall Study||3
8815100|NCT01536145|9868480|FG001|STARTED|Overall Study||4
8815101|NCT01536145|9868481|FG002|STARTED|Overall Study||3
8815102|NCT01536145|9868482|FG003|STARTED|Overall Study||3
8815103|NCT01536145|9868483|FG004|STARTED|Overall Study||4
8815104|NCT01536145|9868484|FG005|STARTED|Overall Study||3
8815105|NCT01536145|9868485|FG006|STARTED|Overall Study||3
8815106|NCT01536145|9868486|FG007|STARTED|Overall Study||4
8815107|NCT01536145|9868487|FG008|STARTED|Overall Study||3
8815108|NCT01536145|9868488|FG009|STARTED|Overall Study||7
8815109|NCT01536145|9868489|FG010|STARTED|Overall Study||10
8815110|NCT01536145|9868479|FG000|COMPLETED|Overall Study||0
8815111|NCT01536145|9868480|FG001|COMPLETED|Overall Study||0
8815112|NCT01536145|9868481|FG002|COMPLETED|Overall Study||1
8815113|NCT01536145|9868482|FG003|COMPLETED|Overall Study||1
8815114|NCT01536145|9868483|FG004|COMPLETED|Overall Study||2
8815115|NCT01536145|9868484|FG005|COMPLETED|Overall Study||0
8815116|NCT01536145|9868485|FG006|COMPLETED|Overall Study||1
8815117|NCT01536145|9868486|FG007|COMPLETED|Overall Study||0
8815118|NCT01536145|9868487|FG008|COMPLETED|Overall Study||0
8815119|NCT01536145|9868488|FG009|COMPLETED|Overall Study||1
8562382|NCT00026221|9594440|FG000|STARTED|Overall Study||16
8562383|NCT00026221|9594441|FG001|STARTED|Overall Study||16
8562384|NCT00026221|9594442|FG002|STARTED|Overall Study||25
8562385|NCT00026221|9594440|FG000|COMPLETED|Overall Study||16
8562386|NCT00026221|9594441|FG001|COMPLETED|Overall Study||16
8562387|NCT00026221|9594442|FG002|COMPLETED|Overall Study||25
8562388|NCT00026221|9594440|FG000|NOT COMPLETED|Overall Study||0
8562389|NCT00026221|9594441|FG001|NOT COMPLETED|Overall Study||0
8562390|NCT00026221|9594442|FG002|NOT COMPLETED|Overall Study||0
8562391|NCT00026494|9594454|FG000|STARTED|Overall Study||7
8562392|NCT00026494|9594455|FG001|STARTED|Overall Study||4
8562393|NCT00026494|9594456|FG002|STARTED|Overall Study||22
8562394|NCT00026494|9594457|FG003|STARTED|Overall Study||16
8562395|NCT00026494|9594454|FG000|COMPLETED|Overall Study||5
8562396|NCT00026494|9594455|FG001|COMPLETED|Overall Study||4
8562397|NCT00026494|9594456|FG002|COMPLETED|Overall Study||16
8562398|NCT00026494|9594457|FG003|COMPLETED|Overall Study||16
8562399|NCT00026494|9594454|FG000|NOT COMPLETED|Overall Study||2
8562400|NCT00026494|9594455|FG001|NOT COMPLETED|Overall Study||0
8562401|NCT00026494|9594456|FG002|NOT COMPLETED|Overall Study||6
8562402|NCT00026494|9594457|FG003|NOT COMPLETED|Overall Study||0
8562403|NCT00026793|9594467|FG000|STARTED|Overall Study||29
8562404|NCT00026793|9594467|FG000|COMPLETED|Overall Study||21
8562405|NCT00026793|9594467|FG000|NOT COMPLETED|Overall Study||8
8562406|NCT00027027|9594476|FG000|STARTED|Overall Study||3
8562407|NCT00027027|9594477|FG001|STARTED|Overall Study||3
8562408|NCT00027027|9594478|FG002|STARTED|Overall Study||4
8562409|NCT00027027|9594479|FG003|STARTED|Overall Study||3
8562410|NCT00027027|9594480|FG004|STARTED|Overall Study||8
8562411|NCT00027027|9594476|FG000|Discontinued Before 2 Treatment Cycles|Overall Study||0
8815120|NCT01536145|9868489|FG010|COMPLETED|Overall Study||0
8815121|NCT01536145|9868479|FG000|NOT COMPLETED|Overall Study||3
8815122|NCT01536145|9868480|FG001|NOT COMPLETED|Overall Study||4
8815123|NCT01536145|9868481|FG002|NOT COMPLETED|Overall Study||2
8815124|NCT01536145|9868482|FG003|NOT COMPLETED|Overall Study||2
8815125|NCT01536145|9868483|FG004|NOT COMPLETED|Overall Study||2
8815126|NCT01536145|9868484|FG005|NOT COMPLETED|Overall Study||3
8815127|NCT01536145|9868485|FG006|NOT COMPLETED|Overall Study||2
8815128|NCT01536145|9868486|FG007|NOT COMPLETED|Overall Study||4
8815129|NCT01536145|9868487|FG008|NOT COMPLETED|Overall Study||3
8815130|NCT01536145|9868488|FG009|NOT COMPLETED|Overall Study||6
8815131|NCT01536145|9868489|FG010|NOT COMPLETED|Overall Study||10
8815132|NCT01536171|9868520|FG000|STARTED|Overall Study||22
8815133|NCT01536171|9868520|FG000|COMPLETED|Overall Study||21
8815134|NCT01536171|9868520|FG000|NOT COMPLETED|Overall Study||1
8815135|NCT01536184|9868527|FG000|STARTED|Overall Study||8
8815136|NCT01536184|9868528|FG001|STARTED|Overall Study||4
8815137|NCT01536184|9868527|FG000|COMPLETED|Overall Study||8
8815138|NCT01536184|9868528|FG001|COMPLETED|Overall Study||4
8815139|NCT01536184|9868527|FG000|NOT COMPLETED|Overall Study||0
8815140|NCT01536184|9868528|FG001|NOT COMPLETED|Overall Study||0
8815141|NCT01536197|9868536|FG000|STARTED|Overall Study||23
8815142|NCT01536197|9868537|FG001|STARTED|Overall Study||10
8815143|NCT01536197|9868536|FG000|COMPLETED|Overall Study||23
8815144|NCT01536197|9868537|FG001|COMPLETED|Overall Study||10
8562412|NCT00027027|9594477|FG001|Discontinued Before 2 Treatment Cycles|Overall Study||0
8562413|NCT00027027|9594478|FG002|Discontinued Before 2 Treatment Cycles|Overall Study||1
8562414|NCT00027027|9594479|FG003|Discontinued Before 2 Treatment Cycles|Overall Study||0
8562415|NCT00027027|9594480|FG004|Discontinued Before 2 Treatment Cycles|Overall Study||1
8562416|NCT00027027|9594476|FG000|Completed 2 Cycles of Treatment|Overall Study||3
8562417|NCT00027027|9594477|FG001|Completed 2 Cycles of Treatment|Overall Study||3
8815145|NCT01536197|9868536|FG000|NOT COMPLETED|Overall Study||0
8815146|NCT01536197|9868537|FG001|NOT COMPLETED|Overall Study||0
8815147|NCT01536262|9868546|FG000|STARTED|Overall Study||41
8815148|NCT01536262|9868547|FG001|STARTED|Overall Study||40
8815149|NCT01536262|9868548|FG002|STARTED|Overall Study||41
8815150|NCT01536262|9868546|FG000|COMPLETED|Overall Study||33
8815151|NCT01536262|9868547|FG001|COMPLETED|Overall Study||38
8815152|NCT01536262|9868548|FG002|COMPLETED|Overall Study||39
8620314|NCT00473746|9658960|FG004|NOT COMPLETED|Period 1 (Phase 1)||0
8620315|NCT00473746|9658956|FG000|STARTED|Period 2 (Phase 2)||0
8815153|NCT01536262|9868546|FG000|NOT COMPLETED|Overall Study||8
8943742|NCT02391584|10005586|FG000|NOT COMPLETED|3 Month||1
8943743|NCT02391584|10005587|FG001|NOT COMPLETED|3 Month||0
8943744|NCT02391584|10005586|FG000|STARTED|6 Month||52
8943745|NCT02391584|10005587|FG001|STARTED|6 Month||0
8620316|NCT00473746|9658957|FG001|STARTED|Period 2 (Phase 2)||0
8815154|NCT01536262|9868547|FG001|NOT COMPLETED|Overall Study||2
8815155|NCT01536262|9868548|FG002|NOT COMPLETED|Overall Study||2
8815156|NCT01536366|9868559|FG000|STARTED|Overall Study||14
8815157|NCT01536366|9868560|FG001|STARTED|Overall Study||13
8815158|NCT01536366|9868559|FG000|BIA 9-1067 + Repaglinide|Overall Study||14
8943746|NCT02391584|10005586|FG000|COMPLETED|6 Month||51
8620317|NCT00473746|9658958|FG002|STARTED|Period 2 (Phase 2)||0
8815159|NCT01536366|9868560|FG001|BIA 9-1067 + Repaglinide|Overall Study||10
8815160|NCT01536366|9868559|FG000|Repaglinide|Overall Study||14
8943747|NCT02391584|10005587|FG001|COMPLETED|6 Month||0
8943748|NCT02391584|10005586|FG000|NOT COMPLETED|6 Month||1
8943749|NCT02391584|10005587|FG001|NOT COMPLETED|6 Month||0
8943750|NCT02391584|10005586|FG000|STARTED|12 Month (End of Study)||51
8815161|NCT01536366|9868560|FG001|Repaglinide|Overall Study||13
8815162|NCT01536366|9868559|FG000|Follow-up|Overall Study||13
8815163|NCT01536366|9868560|FG001|Follow-up|Overall Study||9
8815164|NCT01536366|9868559|FG000|COMPLETED|Overall Study||1
8815165|NCT01536366|9868560|FG001|COMPLETED|Overall Study||9
8815166|NCT01536366|9868559|FG000|NOT COMPLETED|Overall Study||13
8815167|NCT01536366|9868560|FG001|NOT COMPLETED|Overall Study||4
8815168|NCT01536379|9868568|FG000|STARTED|Overall Study||13
8815169|NCT01536379|9868569|FG001|STARTED|Overall Study||12
8815170|NCT01536379|9868568|FG000|COMPLETED|Overall Study||11
8815171|NCT01536379|9868569|FG001|COMPLETED|Overall Study||9
8815172|NCT01536379|9868568|FG000|NOT COMPLETED|Overall Study||2
8815173|NCT01536379|9868569|FG001|NOT COMPLETED|Overall Study||3
8815174|NCT01536392|9868577|FG000|STARTED|Overall Study||41
8815175|NCT01536392|9868578|FG001|STARTED|Overall Study||34
8815176|NCT01536392|9868577|FG000|COMPLETED|Overall Study||28
8815177|NCT01536392|9868578|FG001|COMPLETED|Overall Study||19
8815178|NCT01536392|9868577|FG000|NOT COMPLETED|Overall Study||13
8815179|NCT01536392|9868578|FG001|NOT COMPLETED|Overall Study||15
8620318|NCT00473746|9658959|FG003|STARTED|Period 2 (Phase 2)||0
8620319|NCT00473746|9658960|FG004|STARTED|Period 2 (Phase 2)||33
8620320|NCT00473746|9658956|FG000|COMPLETED|Period 2 (Phase 2)||0
8620321|NCT00473746|9658957|FG001|COMPLETED|Period 2 (Phase 2)||0
8620322|NCT00473746|9658958|FG002|COMPLETED|Period 2 (Phase 2)||0
8815180|NCT01536405|9868586|FG000|STARTED|Randomization to Visit 1 (Vaccination 1)||706
8815181|NCT01536405|9868587|FG001|STARTED|Randomization to Visit 1 (Vaccination 1)||706
8815182|NCT01536405|9868586|FG000|COMPLETED|Randomization to Visit 1 (Vaccination 1)||698
8815183|NCT01536405|9868587|FG001|COMPLETED|Randomization to Visit 1 (Vaccination 1)||702
8815184|NCT01536405|9868586|FG000|NOT COMPLETED|Randomization to Visit 1 (Vaccination 1)||8
8815185|NCT01536405|9868587|FG001|NOT COMPLETED|Randomization to Visit 1 (Vaccination 1)||4
8815186|NCT01536405|9868586|FG000|STARTED|Visit 1 (Vaccination 1) to Visit 2||698
8815187|NCT01536405|9868587|FG001|STARTED|Visit 1 (Vaccination 1) to Visit 2||702
8815188|NCT01536405|9868586|FG000|Received Vaccination 1|Visit 1 (Vaccination 1) to Visit 2||698
8815189|NCT01536405|9868587|FG001|Received Vaccination 1|Visit 1 (Vaccination 1) to Visit 2||702
8815190|NCT01536405|9868586|FG000|COMPLETED|Visit 1 (Vaccination 1) to Visit 2||666
8620323|NCT00473746|9658959|FG003|COMPLETED|Period 2 (Phase 2)||0
8620324|NCT00473746|9658960|FG004|COMPLETED|Period 2 (Phase 2)||6
8620325|NCT00473746|9658956|FG000|NOT COMPLETED|Period 2 (Phase 2)||0
8815191|NCT01536405|9868587|FG001|COMPLETED|Visit 1 (Vaccination 1) to Visit 2||662
8815192|NCT01536405|9868586|FG000|NOT COMPLETED|Visit 1 (Vaccination 1) to Visit 2||32
8620326|NCT00473746|9658957|FG001|NOT COMPLETED|Period 2 (Phase 2)||0
8815193|NCT01536405|9868587|FG001|NOT COMPLETED|Visit 1 (Vaccination 1) to Visit 2||40
8815194|NCT01536405|9868586|FG000|STARTED|Visit 2 to Visit 3 (Vaccination 2)||666
8815195|NCT01536405|9868587|FG001|STARTED|Visit 2 to Visit 3 (Vaccination 2)||662
8815196|NCT01536405|9868586|FG000|COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||635
8815197|NCT01536405|9868587|FG001|COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||634
8815198|NCT01536405|9868586|FG000|NOT COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||31
8815199|NCT01536405|9868587|FG001|NOT COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||28
8562418|NCT00027027|9594478|FG002|Completed 2 Cycles of Treatment|Overall Study||3
8562419|NCT00027027|9594479|FG003|Completed 2 Cycles of Treatment|Overall Study||3
8562420|NCT00027027|9594480|FG004|Completed 2 Cycles of Treatment|Overall Study||7
8562421|NCT00027027|9594476|FG000|Discontinued at Cycle 2|Overall Study||2
8562422|NCT00027027|9594477|FG001|Discontinued at Cycle 2|Overall Study||2
8562423|NCT00027027|9594478|FG002|Discontinued at Cycle 2|Overall Study||1
8562424|NCT00027027|9594479|FG003|Discontinued at Cycle 2|Overall Study||1
8562425|NCT00027027|9594480|FG004|Discontinued at Cycle 2|Overall Study||3
8562426|NCT00027027|9594476|FG000|Treated Beyond Cycle 2|Overall Study||1
8562427|NCT00027027|9594477|FG001|Treated Beyond Cycle 2|Overall Study||1
8562428|NCT00027027|9594478|FG002|Treated Beyond Cycle 2|Overall Study||2
8562429|NCT00027027|9594479|FG003|Treated Beyond Cycle 2|Overall Study||2
8562430|NCT00027027|9594480|FG004|Treated Beyond Cycle 2|Overall Study||4
8562431|NCT00027027|9594476|FG000|COMPLETED|Overall Study||0
8562432|NCT00027027|9594477|FG001|COMPLETED|Overall Study||0
8562433|NCT00027027|9594478|FG002|COMPLETED|Overall Study||0
8562434|NCT00027027|9594479|FG003|COMPLETED|Overall Study||0
8562435|NCT00027027|9594480|FG004|COMPLETED|Overall Study||0
8562436|NCT00027027|9594476|FG000|NOT COMPLETED|Overall Study||3
8562437|NCT00027027|9594477|FG001|NOT COMPLETED|Overall Study||3
8562438|NCT00027027|9594478|FG002|NOT COMPLETED|Overall Study||4
8562439|NCT00027027|9594479|FG003|NOT COMPLETED|Overall Study||3
8562440|NCT00027027|9594480|FG004|NOT COMPLETED|Overall Study||8
8562441|NCT00027378|9594498|FG000|STARTED|Overall Study||24
8562442|NCT00027378|9594499|FG001|STARTED|Overall Study||26
8562443|NCT00027378|9594498|FG000|COMPLETED|Overall Study||24
8562444|NCT00027378|9594499|FG001|COMPLETED|Overall Study||23
8562445|NCT00027378|9594498|FG000|NOT COMPLETED|Overall Study||0
8562446|NCT00027378|9594499|FG001|NOT COMPLETED|Overall Study||3
8562447|NCT00027560|9594505|FG000|STARTED|Overall Study||51
8562448|NCT00027560|9594505|FG000|COMPLETED|Overall Study||50
8562449|NCT00027560|9594505|FG000|NOT COMPLETED|Overall Study||1
8562450|NCT00027846|9594514|FG000|STARTED|Overall Study||13
8562451|NCT00027846|9594515|FG001|STARTED|Overall Study||287
8562452|NCT00027846|9594516|FG002|STARTED|Overall Study||78
8562453|NCT00027846|9594514|FG000|COMPLETED|Overall Study||11
8562454|NCT00027846|9594515|FG001|COMPLETED|Overall Study||219
8562455|NCT00027846|9594516|FG002|COMPLETED|Overall Study||41
8562456|NCT00027846|9594514|FG000|NOT COMPLETED|Overall Study||2
8562457|NCT00027846|9594515|FG001|NOT COMPLETED|Overall Study||68
8562458|NCT00027846|9594516|FG002|NOT COMPLETED|Overall Study||37
8562459|NCT00028002|9594526|FG000|STARTED|Overall Study||63
8562460|NCT00028002|9594526|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|52
8562461|NCT00028002|9594526|FG000|NOT COMPLETED|Overall Study||11
8562462|NCT00028093|9594533|FG000|STARTED|Overall Study||25
8562463|NCT00028093|9594534|FG001|STARTED|Overall Study||25
8562464|NCT00028093|9594533|FG000|COMPLETED|Overall Study||25
8562465|NCT00028093|9594534|FG001|COMPLETED|Overall Study||25
8562466|NCT00028093|9594533|FG000|NOT COMPLETED|Overall Study||0
8562467|NCT00028093|9594534|FG001|NOT COMPLETED|Overall Study||0
8562468|NCT00028262|9594540|FG000|STARTED|Overall Study||10
8562469|NCT00028262|9594540|FG000|COMPLETED|Overall Study||9
8562470|NCT00028262|9594540|FG000|NOT COMPLETED|Overall Study||1
8562471|NCT00028769|9594544|FG000|STARTED|Overall Study||41
8562472|NCT00028769|9594544|FG000|Eligible|Overall Study||36
8562473|NCT00028769|9594544|FG000|Eligible and Began Protocol Therapy|Overall Study|One patient refused all protocol treatment and was not evaluable for the present analysis|35
8562474|NCT00028769|9594544|FG000|COMPLETED|Overall Study|Patients receive protocol treatments until evidence of disease progression|0
8562475|NCT00028769|9594544|FG000|NOT COMPLETED|Overall Study||41
8562476|NCT00029107|9594550|FG000|STARTED|Overall Study||12
8562477|NCT00029107|9594551|FG001|STARTED|Overall Study||12
8562478|NCT00029107|9594550|FG000|COMPLETED|Overall Study||12
8562479|NCT00029107|9594551|FG001|COMPLETED|Overall Study||12
8562480|NCT00029107|9594550|FG000|NOT COMPLETED|Overall Study||0
8562481|NCT00029107|9594551|FG001|NOT COMPLETED|Overall Study||0
8569184|NCT00095303|9601388|FG001|NOT COMPLETED|Follow Up Study||58
8569185|NCT00095498|9601397|FG000|STARTED|Overall Study||76
8569186|NCT00095498|9601398|FG001|STARTED|Overall Study||73
8569187|NCT00095498|9601399|FG002|STARTED|Overall Study||78
8569188|NCT00095498|9601397|FG000|Received Investigational Product|Overall Study||72
8569189|NCT00095498|9601398|FG001|Received Investigational Product|Overall Study||71
8569190|NCT00095498|9601399|FG002|Received Investigational Product|Overall Study||75
8569191|NCT00095498|9601397|FG000|COMPLETED|Overall Study||39
8569192|NCT00095498|9601398|FG001|COMPLETED|Overall Study||38
8620327|NCT00473746|9658958|FG002|NOT COMPLETED|Period 2 (Phase 2)||0
8620328|NCT00473746|9658959|FG003|NOT COMPLETED|Period 2 (Phase 2)||0
8620329|NCT00473746|9658960|FG004|NOT COMPLETED|Period 2 (Phase 2)||27
8620330|NCT00473824|9658976|FG000|STARTED|Overall Study||5
8815200|NCT01536405|9868586|FG000|STARTED|Visit 3 (Vaccination 2) to Visit 4||635
8815201|NCT01536405|9868587|FG001|STARTED|Visit 3 (Vaccination 2) to Visit 4||634
8620331|NCT00473824|9658977|FG001|STARTED|Overall Study||2
8815202|NCT01536405|9868586|FG000|Received Vaccination 2|Visit 3 (Vaccination 2) to Visit 4||634
8815203|NCT01536405|9868587|FG001|Received Vaccination 2|Visit 3 (Vaccination 2) to Visit 4||632
8815204|NCT01536405|9868586|FG000|COMPLETED|Visit 3 (Vaccination 2) to Visit 4||615
8815205|NCT01536405|9868587|FG001|COMPLETED|Visit 3 (Vaccination 2) to Visit 4||618
8815206|NCT01536405|9868586|FG000|NOT COMPLETED|Visit 3 (Vaccination 2) to Visit 4||20
8815207|NCT01536405|9868587|FG001|NOT COMPLETED|Visit 3 (Vaccination 2) to Visit 4||16
8815208|NCT01536405|9868586|FG000|STARTED|Visit 4 to Extended Study Follow-up||615
8815209|NCT01536405|9868587|FG001|STARTED|Visit 4 to Extended Study Follow-up||618
8815210|NCT01536405|9868586|FG000|COMPLETED|Visit 4 to Extended Study Follow-up||595
8815211|NCT01536405|9868587|FG001|COMPLETED|Visit 4 to Extended Study Follow-up||595
8815212|NCT01536405|9868586|FG000|NOT COMPLETED|Visit 4 to Extended Study Follow-up||20
8815213|NCT01536405|9868587|FG001|NOT COMPLETED|Visit 4 to Extended Study Follow-up||23
8815214|NCT01536418|9868595|FG000|STARTED|Overall Study||127
8815215|NCT01536418|9868596|FG001|STARTED|Overall Study||126
8815216|NCT01536418|9868595|FG000|COMPLETED|Overall Study||58
8815217|NCT01536418|9868596|FG001|COMPLETED|Overall Study||60
8815218|NCT01536418|9868595|FG000|NOT COMPLETED|Overall Study||69
8815219|NCT01536418|9868596|FG001|NOT COMPLETED|Overall Study||66
8815220|NCT01536496|9868605|FG000|STARTED|Overall Study||57
8815221|NCT01536496|9868606|FG001|STARTED|Overall Study||57
8815222|NCT01536496|9868605|FG000|COMPLETED|Overall Study||55
8815223|NCT01536496|9868606|FG001|COMPLETED|Overall Study||56
8815224|NCT01536496|9868605|FG000|NOT COMPLETED|Overall Study||2
8815225|NCT01536496|9868606|FG001|NOT COMPLETED|Overall Study||1
8815226|NCT01536535|9868616|FG000|STARTED|Overall Study||178
8815227|NCT01536535|9868617|FG001|STARTED|Overall Study||250
8562482|NCT00029146|9594559|FG000|STARTED|Overall Study||97
8562483|NCT00029146|9594560|FG001|STARTED|Overall Study||98
8562484|NCT00029146|9594559|FG000|COMPLETED|Overall Study||95
8562485|NCT00029146|9594560|FG001|COMPLETED|Overall Study||97
8562486|NCT00029146|9594559|FG000|NOT COMPLETED|Overall Study||2
8562487|NCT00029146|9594560|FG001|NOT COMPLETED|Overall Study||1
8562488|NCT00029172|9594566|FG000|STARTED|Overall Study||188
8562489|NCT00029172|9594566|FG000|COMPLETED|Overall Study||182
8562490|NCT00029172|9594566|FG000|NOT COMPLETED|Overall Study||6
8562491|NCT00029536|9594574|FG000|STARTED|Overall Study||85
8562492|NCT00029536|9594575|FG001|STARTED|Overall Study||45
8562493|NCT00029536|9594576|FG002|STARTED|Overall Study||105
8562494|NCT00029536|9594577|FG003|STARTED|Overall Study||59
8562495|NCT00029536|9594574|FG000|COMPLETED|Overall Study||85
8562496|NCT00029536|9594575|FG001|COMPLETED|Overall Study||45
8562497|NCT00029536|9594576|FG002|COMPLETED|Overall Study||105
8562498|NCT00029536|9594577|FG003|COMPLETED|Overall Study||59
8562499|NCT00029536|9594574|FG000|NOT COMPLETED|Overall Study||0
8562500|NCT00029536|9594575|FG001|NOT COMPLETED|Overall Study||0
8562501|NCT00029536|9594576|FG002|NOT COMPLETED|Overall Study||0
8562502|NCT00029536|9594577|FG003|NOT COMPLETED|Overall Study||0
8562503|NCT00030147|9594593|FG000|STARTED|Overall Study||17
8562504|NCT00030147|9594594|FG001|STARTED|Overall Study||19
8562505|NCT00030147|9594595|FG002|STARTED|Overall Study||16
8562506|NCT00030147|9594596|FG003|STARTED|Overall Study||11
8562507|NCT00030147|9594593|FG000|COMPLETED|Overall Study||17
8562508|NCT00030147|9594594|FG001|COMPLETED|Overall Study||18
8562509|NCT00030147|9594595|FG002|COMPLETED|Overall Study||16
8562510|NCT00030147|9594596|FG003|COMPLETED|Overall Study||11
8562511|NCT00030147|9594593|FG000|NOT COMPLETED|Overall Study||0
8562512|NCT00030147|9594594|FG001|NOT COMPLETED|Overall Study||1
8562513|NCT00030147|9594595|FG002|NOT COMPLETED|Overall Study||0
8562514|NCT00030147|9594596|FG003|NOT COMPLETED|Overall Study||0
8562515|NCT00030264|9594606|FG000|STARTED|Overall Study||23
8562516|NCT00030264|9594606|FG000|COMPLETED|Overall Study||23
8562517|NCT00030264|9594606|FG000|NOT COMPLETED|Overall Study||0
8562518|NCT00030823|9594610|FG000|STARTED|Overall Study||14
8562519|NCT00030823|9594610|FG000|COMPLETED|Overall Study||13
8562520|NCT00030823|9594610|FG000|NOT COMPLETED|Overall Study||1
8562521|NCT00030901|9594616|FG000|STARTED|Initial Registration||619
8562522|NCT00030901|9594617|FG001|STARTED|Initial Registration||0
8562523|NCT00030901|9594618|FG002|STARTED|Initial Registration||0
8562524|NCT00030901|9594616|FG000|COMPLETED|Initial Registration||452
8562525|NCT00030901|9594617|FG001|COMPLETED|Initial Registration||0
8562526|NCT00030901|9594618|FG002|COMPLETED|Initial Registration||0
8562527|NCT00030901|9594616|FG000|NOT COMPLETED|Initial Registration||167
8562528|NCT00030901|9594617|FG001|NOT COMPLETED|Initial Registration||0
8562529|NCT00030901|9594618|FG002|NOT COMPLETED|Initial Registration||0
8562530|NCT00030901|9594616|FG000|STARTED|Randomization||0
8562531|NCT00030901|9594617|FG001|STARTED|Randomization||227
8562532|NCT00030901|9594618|FG002|STARTED|Randomization||225
8562533|NCT00030901|9594616|FG000|Eligible|Randomization||0
8562534|NCT00030901|9594617|FG001|Eligible|Randomization||212
8562535|NCT00030901|9594618|FG002|Eligible|Randomization||211
8562536|NCT00030901|9594616|FG000|COMPLETED|Randomization||0
8562537|NCT00030901|9594617|FG001|COMPLETED|Randomization||126
8562538|NCT00030901|9594618|FG002|COMPLETED|Randomization||137
8562539|NCT00030901|9594616|FG000|NOT COMPLETED|Randomization||0
8562540|NCT00030901|9594617|FG001|NOT COMPLETED|Randomization||101
8562541|NCT00030901|9594618|FG002|NOT COMPLETED|Randomization||88
8562542|NCT00030992|9594624|FG000|STARTED|Overall Study||102
8562543|NCT00030992|9594624|FG000|COMPLETED|Overall Study||102
8562544|NCT00030992|9594624|FG000|NOT COMPLETED|Overall Study||0
8562545|NCT00031447|9594630|FG000|STARTED|Overall Study||14
8562546|NCT00031447|9594631|FG001|STARTED|Overall Study||15
8562547|NCT00031447|9594630|FG000|COMPLETED|Overall Study||4
8562548|NCT00031447|9594631|FG001|COMPLETED|Overall Study||8
8562549|NCT00031447|9594630|FG000|NOT COMPLETED|Overall Study||10
8562550|NCT00031447|9594631|FG001|NOT COMPLETED|Overall Study||7
8562551|NCT00031460|9594639|FG000|STARTED|Overall Study||24
8562552|NCT00031460|9594640|FG001|STARTED|Overall Study||22
8562553|NCT00031460|9594639|FG000|COMPLETED|Overall Study||15
8562554|NCT00031460|9594640|FG001|COMPLETED|Overall Study||8
8562555|NCT00031460|9594639|FG000|NOT COMPLETED|Overall Study||9
8562556|NCT00031460|9594640|FG001|NOT COMPLETED|Overall Study||14
8562557|NCT00031486|9594648|FG000|STARTED|Overall Study||40
8562558|NCT00031486|9594649|FG001|STARTED|Overall Study||47
8562559|NCT00031486|9594648|FG000|COMPLETED|Overall Study||33
8562560|NCT00031486|9594649|FG001|COMPLETED|Overall Study||35
8562561|NCT00031486|9594648|FG000|NOT COMPLETED|Overall Study||7
8815228|NCT01536535|9868616|FG000|COMPLETED|Overall Study|Patients either completed week 52 visit or had early colectomy or had additional therapy.|163
8815229|NCT01536535|9868617|FG001|COMPLETED|Overall Study|Patients either completed week 52 visit or had early colectomy or had additional therapy.|237
8815230|NCT01536535|9868616|FG000|NOT COMPLETED|Overall Study||15
8815231|NCT01536535|9868617|FG001|NOT COMPLETED|Overall Study||13
8815232|NCT01536561|9868624|FG000|STARTED|Dosimetric and Therapeutic Treatment||59
8815233|NCT01536561|9868624|FG000|COMPLETED|Dosimetric and Therapeutic Treatment||0
8815234|NCT01536561|9868624|FG000|NOT COMPLETED|Dosimetric and Therapeutic Treatment||59
8815235|NCT01536561|9868624|FG000|STARTED|Long-Term Follow-Up||13
8815236|NCT01536561|9868624|FG000|COMPLETED|Long-Term Follow-Up||13
8815237|NCT01536561|9868624|FG000|NOT COMPLETED|Long-Term Follow-Up||0
8815238|NCT01536574|9868633|FG000|STARTED|Overall Study||162
8815239|NCT01536574|9868634|FG001|STARTED|Overall Study||133
8815240|NCT01536574|9868633|FG000|COMPLETED|Overall Study||156
8815241|NCT01536574|9868634|FG001|COMPLETED|Overall Study||126
8815242|NCT01536574|9868633|FG000|NOT COMPLETED|Overall Study||6
8815243|NCT01536574|9868634|FG001|NOT COMPLETED|Overall Study||7
8815244|NCT01536587|9868640|FG000|STARTED|Overall Study||32
8815245|NCT01536587|9868640|FG000|COMPLETED|Overall Study||30
8815246|NCT01536587|9868640|FG000|NOT COMPLETED|Overall Study||2
8815247|NCT01536704|9868644|FG000|STARTED|Period 1||12
8815248|NCT01536704|9868645|FG001|STARTED|Period 1||12
8815249|NCT01536704|9868646|FG002|STARTED|Period 1||13
8815250|NCT01536704|9868647|FG003|STARTED|Period 1||13
8815251|NCT01536704|9868644|FG000|COMPLETED|Period 1||12
8815252|NCT01536704|9868645|FG001|COMPLETED|Period 1||12
8815253|NCT01536704|9868646|FG002|COMPLETED|Period 1||13
8815254|NCT01536704|9868647|FG003|COMPLETED|Period 1||13
8815255|NCT01536704|9868644|FG000|NOT COMPLETED|Period 1||0
8815256|NCT01536704|9868645|FG001|NOT COMPLETED|Period 1||0
8815257|NCT01536704|9868646|FG002|NOT COMPLETED|Period 1||0
8815258|NCT01536704|9868647|FG003|NOT COMPLETED|Period 1||0
8815259|NCT01536704|9868644|FG000|STARTED|Washout Period 1||12
8815260|NCT01536704|9868645|FG001|STARTED|Washout Period 1||12
8815261|NCT01536704|9868646|FG002|STARTED|Washout Period 1||13
8815262|NCT01536704|9868647|FG003|STARTED|Washout Period 1||13
8815263|NCT01536704|9868644|FG000|COMPLETED|Washout Period 1||11
8815264|NCT01536704|9868645|FG001|COMPLETED|Washout Period 1||10
8815265|NCT01536704|9868646|FG002|COMPLETED|Washout Period 1||13
8815266|NCT01536704|9868647|FG003|COMPLETED|Washout Period 1||13
8815267|NCT01536704|9868644|FG000|NOT COMPLETED|Washout Period 1||1
8815268|NCT01536704|9868645|FG001|NOT COMPLETED|Washout Period 1||2
8815269|NCT01536704|9868646|FG002|NOT COMPLETED|Washout Period 1||0
8815270|NCT01536704|9868647|FG003|NOT COMPLETED|Washout Period 1||0
8815271|NCT01536704|9868644|FG000|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
8815272|NCT01536704|9868645|FG001|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|11
8815273|NCT01536704|9868646|FG002|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|10
8815274|NCT01536704|9868647|FG003|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
8815275|NCT01536704|9868644|FG000|COMPLETED|Period 2||13
8815276|NCT01536704|9868645|FG001|COMPLETED|Period 2||11
8815277|NCT01536704|9868646|FG002|COMPLETED|Period 2||10
8815278|NCT01536704|9868647|FG003|COMPLETED|Period 2||13
8815279|NCT01536704|9868644|FG000|NOT COMPLETED|Period 2||0
8815280|NCT01536704|9868645|FG001|NOT COMPLETED|Period 2||0
8815281|NCT01536704|9868646|FG002|NOT COMPLETED|Period 2||0
8815282|NCT01536704|9868647|FG003|NOT COMPLETED|Period 2||0
8815283|NCT01536704|9868644|FG000|STARTED|Washout Period 2||13
8815284|NCT01536704|9868645|FG001|STARTED|Washout Period 2||11
8562562|NCT00031486|9594649|FG001|NOT COMPLETED|Overall Study||12
8562563|NCT00031551|9594659|FG000|STARTED|Overall Study||2
8562564|NCT00031551|9594660|FG001|STARTED|Overall Study||25
8562565|NCT00031551|9594659|FG000|COMPLETED|Overall Study||0
8562566|NCT00031551|9594660|FG001|COMPLETED|Overall Study||25
8562567|NCT00031551|9594659|FG000|NOT COMPLETED|Overall Study||2
8562568|NCT00031551|9594660|FG001|NOT COMPLETED|Overall Study||0
8562569|NCT00031590|9594670|FG000|STARTED|Overall Study||28
8562570|NCT00031590|9594670|FG000|COMPLETED|Overall Study||25
8562571|NCT00031590|9594670|FG000|NOT COMPLETED|Overall Study||3
8562572|NCT00031694|9594675|FG000|STARTED|Overall Study||19
8562573|NCT00031694|9594675|FG000|COMPLETED|Overall Study||0
8562574|NCT00031694|9594675|FG000|NOT COMPLETED|Overall Study||19
8562575|NCT00032487|9594682|FG000|STARTED|Overall Study||899
8562576|NCT00032487|9594683|FG001|STARTED|Overall Study||892
8562577|NCT00032487|9594682|FG000|COMPLETED|Overall Study||760
8562578|NCT00032487|9594683|FG001|COMPLETED|Overall Study||772
8562579|NCT00032487|9594682|FG000|NOT COMPLETED|Overall Study||139
8562580|NCT00032487|9594683|FG001|NOT COMPLETED|Overall Study||120
8562581|NCT00032591|9594691|FG000|STARTED|Screening|3745 patients provided informed consent and were screened for participation.|1873
8562582|NCT00032591|9594692|FG001|STARTED|Screening|Treatment assigned at randomization; screening counts by arm represent half of the total screened.|1872
8562583|NCT00032591|9594691|FG000|COMPLETED|Screening|823 were excluded from the study|1465
8562584|NCT00032591|9594692|FG001|COMPLETED|Screening||1457
8562585|NCT00032591|9594691|FG000|NOT COMPLETED|Screening||408
8562586|NCT00032591|9594692|FG001|NOT COMPLETED|Screening||415
8562587|NCT00032591|9594691|FG000|STARTED|Randomization|2922 underwent randomization|1465
8562588|NCT00032591|9594692|FG001|STARTED|Randomization||1457
8562589|NCT00032591|9594691|FG000|COMPLETED|Randomization|1465 were assigned to self-testing|1465
8562590|NCT00032591|9594692|FG001|COMPLETED|Randomization|1457 were assigned to clinic testing|1457
8562591|NCT00032591|9594691|FG000|NOT COMPLETED|Randomization||0
8562592|NCT00032591|9594692|FG001|NOT COMPLETED|Randomization||0
8562593|NCT00032591|9594691|FG000|STARTED|Follow-up|2 were lost to follow-up, both with Atrial Fibrillation, no Mechanical Heart Valves|1465
8562594|NCT00032591|9594692|FG001|STARTED|Follow-up|5 were lost to follow-up, all with Atrial Fibrillation, no Mechanical Heart Valves|1457
8562595|NCT00032591|9594691|FG000|COMPLETED|Follow-up|1463 were included in analysis with greater than 1 day of follow-up|1463
8562596|NCT00032591|9594692|FG001|COMPLETED|Follow-up|1452 were included in analysis with greater than 1 day of follow-up|1452
8562597|NCT00032591|9594691|FG000|NOT COMPLETED|Follow-up||2
8562598|NCT00032591|9594692|FG001|NOT COMPLETED|Follow-up||5
8620332|NCT00473824|9658976|FG000|COMPLETED|Overall Study|Study Completion/Early Termination Date|0
8620333|NCT00473824|9658977|FG001|COMPLETED|Overall Study|Study Completion/Early Termination Date|2
8620334|NCT00473824|9658976|FG000|NOT COMPLETED|Overall Study||5
8620335|NCT00473824|9658977|FG001|NOT COMPLETED|Overall Study||0
8620336|NCT00473837|9658985|FG000|STARTED|Overall Study||50
8620337|NCT00473837|9658986|FG001|STARTED|Overall Study||46
8620338|NCT00473837|9658985|FG000|COMPLETED|Overall Study||49
8620339|NCT00473837|9658986|FG001|COMPLETED|Overall Study||43
8620340|NCT00473837|9658985|FG000|NOT COMPLETED|Overall Study||1
8620341|NCT00473837|9658986|FG001|NOT COMPLETED|Overall Study||3
8620342|NCT00473876|9658994|FG000|STARTED|Overall Study||39
8620343|NCT00473876|9658995|FG001|STARTED|Overall Study||23
8620344|NCT00473876|9658994|FG000|COMPLETED|Overall Study||36
8620345|NCT00473876|9658995|FG001|COMPLETED|Overall Study||22
8620346|NCT00473876|9658994|FG000|NOT COMPLETED|Overall Study||3
8620347|NCT00473876|9658995|FG001|NOT COMPLETED|Overall Study||1
8620348|NCT00473889|9659005|FG000|STARTED|Overall Study||126
8620349|NCT00473889|9659006|FG001|STARTED|Overall Study||127
8620350|NCT00473889|9659005|FG000|COMPLETED|Overall Study||43
8620351|NCT00473889|9659006|FG001|COMPLETED|Overall Study||63
8620352|NCT00473889|9659005|FG000|NOT COMPLETED|Overall Study||83
8620353|NCT00473889|9659006|FG001|NOT COMPLETED|Overall Study||64
8620354|NCT00474045|9659014|FG000|STARTED|Overall Study||233
8620355|NCT00474045|9659015|FG001|STARTED|Overall Study||237
8620356|NCT00474045|9659014|FG000|Exposed-All Subjects|Overall Study||233
8620357|NCT00474045|9659015|FG001|Exposed-All Subjects|Overall Study|5 withdrawn before treatment initiation|232
8620358|NCT00474045|9659014|FG000|Exposed-Pregnant Subjects|Overall Study||152
8620359|NCT00474045|9659015|FG001|Exposed-Pregnant Subjects|Overall Study|3 withdrawn before treatment initiation|158
8620360|NCT00474045|9659014|FG000|Pregnancies (for Exposed-pregnant)|Overall Study||152
8620361|NCT00474045|9659015|FG001|Pregnancies (for Exposed-pregnant)|Overall Study|2 subjects had spontaneous abortion and became pregnant again|160
8620362|NCT00474045|9659014|FG000|COMPLETED|Overall Study||127
8620363|NCT00474045|9659015|FG001|COMPLETED|Overall Study||136
8620364|NCT00474045|9659014|FG000|NOT COMPLETED|Overall Study||106
8620365|NCT00474045|9659015|FG001|NOT COMPLETED|Overall Study||101
8620366|NCT00474058|9659023|FG000|STARTED|Overall Study||190
8620367|NCT00474058|9659024|FG001|STARTED|Overall Study||97
8620368|NCT00474058|9659023|FG000|COMPLETED|Overall Study||166
8620369|NCT00474058|9659024|FG001|COMPLETED|Overall Study||80
8620370|NCT00474058|9659023|FG000|NOT COMPLETED|Overall Study||24
8620371|NCT00474058|9659024|FG001|NOT COMPLETED|Overall Study||17
8620372|NCT00474123|9659032|FG000|STARTED|Overall Study||38
8620373|NCT00474123|9659033|FG001|STARTED|Overall Study||40
8620374|NCT00474123|9659032|FG000|COMPLETED|Overall Study||38
8620375|NCT00474123|9659033|FG001|COMPLETED|Overall Study||40
8815285|NCT01536704|9868646|FG002|STARTED|Washout Period 2||10
8815286|NCT01536704|9868647|FG003|STARTED|Washout Period 2||13
8815287|NCT01536704|9868644|FG000|COMPLETED|Washout Period 2||12
8815288|NCT01536704|9868645|FG001|COMPLETED|Washout Period 2||11
8815289|NCT01536704|9868646|FG002|COMPLETED|Washout Period 2||10
8815290|NCT01536704|9868647|FG003|COMPLETED|Washout Period 2||12
8815291|NCT01536704|9868644|FG000|NOT COMPLETED|Washout Period 2||1
8815292|NCT01536704|9868645|FG001|NOT COMPLETED|Washout Period 2||0
8815293|NCT01536704|9868646|FG002|NOT COMPLETED|Washout Period 2||0
8815294|NCT01536704|9868647|FG003|NOT COMPLETED|Washout Period 2||1
8815295|NCT01536704|9868644|FG000|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|10
8815296|NCT01536704|9868645|FG001|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
8815297|NCT01536704|9868646|FG002|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
8815298|NCT01536704|9868647|FG003|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|11
8815299|NCT01536704|9868644|FG000|COMPLETED|Period 3||10
8815300|NCT01536704|9868645|FG001|COMPLETED|Period 3||12
8815301|NCT01536704|9868646|FG002|COMPLETED|Period 3||12
8815302|NCT01536704|9868647|FG003|COMPLETED|Period 3||10
8815303|NCT01536704|9868644|FG000|NOT COMPLETED|Period 3||0
8815304|NCT01536704|9868645|FG001|NOT COMPLETED|Period 3||0
8815305|NCT01536704|9868646|FG002|NOT COMPLETED|Period 3||0
8815306|NCT01536704|9868647|FG003|NOT COMPLETED|Period 3||1
8815307|NCT01536704|9868644|FG000|STARTED|Washout Period 3||10
8815308|NCT01536704|9868645|FG001|STARTED|Washout Period 3||12
8815309|NCT01536704|9868646|FG002|STARTED|Washout Period 3||12
8815310|NCT01536704|9868647|FG003|STARTED|Washout Period 3||10
8815311|NCT01536704|9868644|FG000|COMPLETED|Washout Period 3||10
8815312|NCT01536704|9868645|FG001|COMPLETED|Washout Period 3||12
8815313|NCT01536704|9868646|FG002|COMPLETED|Washout Period 3||11
8815314|NCT01536704|9868647|FG003|COMPLETED|Washout Period 3||10
8815315|NCT01536704|9868644|FG000|NOT COMPLETED|Washout Period 3||0
8815316|NCT01536704|9868645|FG001|NOT COMPLETED|Washout Period 3||0
8815317|NCT01536704|9868646|FG002|NOT COMPLETED|Washout Period 3||1
8815318|NCT01536704|9868647|FG003|NOT COMPLETED|Washout Period 3||0
8815319|NCT01536704|9868644|FG000|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|12
8815320|NCT01536704|9868645|FG001|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|11
8815321|NCT01536704|9868646|FG002|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
8815322|NCT01536704|9868647|FG003|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
8815323|NCT01536704|9868644|FG000|COMPLETED|Period 4||12
8815324|NCT01536704|9868645|FG001|COMPLETED|Period 4||11
8815325|NCT01536704|9868646|FG002|COMPLETED|Period 4||10
8815326|NCT01536704|9868647|FG003|COMPLETED|Period 4||10
8815327|NCT01536704|9868644|FG000|NOT COMPLETED|Period 4||0
8815328|NCT01536704|9868645|FG001|NOT COMPLETED|Period 4||0
8815329|NCT01536704|9868646|FG002|NOT COMPLETED|Period 4||0
8815330|NCT01536704|9868647|FG003|NOT COMPLETED|Period 4||0
8815331|NCT01536795|9868663|FG000|STARTED|Overall Study||24
8815332|NCT01536795|9868664|FG001|STARTED|Overall Study||24
8815333|NCT01536795|9868663|FG000|COMPLETED|Overall Study||23
8815334|NCT01536795|9868664|FG001|COMPLETED|Overall Study||22
8815335|NCT01536795|9868663|FG000|NOT COMPLETED|Overall Study||1
8815336|NCT01536795|9868664|FG001|NOT COMPLETED|Overall Study||2
8815337|NCT01536860|9868670|FG000|STARTED|First Intervention (1 Day)||4
8815338|NCT01536860|9868671|FG001|STARTED|First Intervention (1 Day)||4
8815339|NCT01536860|9868672|FG002|STARTED|First Intervention (1 Day)||4
8815340|NCT01536860|9868670|FG000|COMPLETED|First Intervention (1 Day)||4
8815341|NCT01536860|9868671|FG001|COMPLETED|First Intervention (1 Day)||4
8815342|NCT01536860|9868672|FG002|COMPLETED|First Intervention (1 Day)||4
8815343|NCT01536860|9868670|FG000|NOT COMPLETED|First Intervention (1 Day)||0
8620376|NCT00474123|9659032|FG000|NOT COMPLETED|Overall Study||0
8620377|NCT00474123|9659033|FG001|NOT COMPLETED|Overall Study||0
8620378|NCT00474175|9659042|FG000|STARTED|Overall Study||115
8620379|NCT00474175|9659043|FG001|STARTED|Overall Study||233
8620380|NCT00474175|9659044|FG002|STARTED|Overall Study||229
8620381|NCT00474175|9659042|FG000|Treated|Overall Study||115
8815344|NCT01536860|9868671|FG001|NOT COMPLETED|First Intervention (1 Day)||0
8815345|NCT01536860|9868672|FG002|NOT COMPLETED|First Intervention (1 Day)||0
8620382|NCT00474175|9659043|FG001|Treated|Overall Study||233
8620383|NCT00474175|9659044|FG002|Treated|Overall Study||228
8815346|NCT01536860|9868670|FG000|STARTED|Washout Period (3 Days)||4
8815347|NCT01536860|9868671|FG001|STARTED|Washout Period (3 Days)||4
8815348|NCT01536860|9868672|FG002|STARTED|Washout Period (3 Days)||4
8815349|NCT01536860|9868670|FG000|COMPLETED|Washout Period (3 Days)||4
8815350|NCT01536860|9868671|FG001|COMPLETED|Washout Period (3 Days)||4
8815351|NCT01536860|9868672|FG002|COMPLETED|Washout Period (3 Days)||4
8815352|NCT01536860|9868670|FG000|NOT COMPLETED|Washout Period (3 Days)||0
8815353|NCT01536860|9868671|FG001|NOT COMPLETED|Washout Period (3 Days)||0
8815354|NCT01536860|9868672|FG002|NOT COMPLETED|Washout Period (3 Days)||0
8815355|NCT01536860|9868670|FG000|STARTED|Second Intervention (1 Day)||4
8815356|NCT01536860|9868671|FG001|STARTED|Second Intervention (1 Day)||4
8815357|NCT01536860|9868672|FG002|STARTED|Second Intervention (1 Day)||4
8815358|NCT01536860|9868670|FG000|COMPLETED|Second Intervention (1 Day)||4
8815359|NCT01536860|9868671|FG001|COMPLETED|Second Intervention (1 Day)||4
8815360|NCT01536860|9868672|FG002|COMPLETED|Second Intervention (1 Day)||4
8815361|NCT01536860|9868670|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
8815362|NCT01536860|9868671|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
8815363|NCT01536860|9868672|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
8815364|NCT01536860|9868670|FG000|STARTED|Washout Period (3 Days)||4
8815365|NCT01536860|9868671|FG001|STARTED|Washout Period (3 Days)||4
8620384|NCT00474175|9659042|FG000|COMPLETED|Overall Study||114
8620385|NCT00474175|9659043|FG001|COMPLETED|Overall Study||226
8620386|NCT00474175|9659044|FG002|COMPLETED|Overall Study||225
8620387|NCT00474175|9659042|FG000|NOT COMPLETED|Overall Study||1
8815366|NCT01536860|9868672|FG002|STARTED|Washout Period (3 Days)||4
8815367|NCT01536860|9868670|FG000|COMPLETED|Washout Period (3 Days)||3
8815368|NCT01536860|9868671|FG001|COMPLETED|Washout Period (3 Days)||4
8620388|NCT00474175|9659043|FG001|NOT COMPLETED|Overall Study||7
8620389|NCT00474175|9659044|FG002|NOT COMPLETED|Overall Study||4
8815369|NCT01536860|9868672|FG002|COMPLETED|Washout Period (3 Days)||4
8815370|NCT01536860|9868670|FG000|NOT COMPLETED|Washout Period (3 Days)||1
8815371|NCT01536860|9868671|FG001|NOT COMPLETED|Washout Period (3 Days)||0
8815372|NCT01536860|9868672|FG002|NOT COMPLETED|Washout Period (3 Days)||0
8815373|NCT01536860|9868670|FG000|STARTED|Third Intervention (1 Day)||3
8815374|NCT01536860|9868671|FG001|STARTED|Third Intervention (1 Day)||4
8815375|NCT01536860|9868672|FG002|STARTED|Third Intervention (1 Day)||4
8815376|NCT01536860|9868670|FG000|COMPLETED|Third Intervention (1 Day)||3
8815377|NCT01536860|9868671|FG001|COMPLETED|Third Intervention (1 Day)||4
8815378|NCT01536860|9868672|FG002|COMPLETED|Third Intervention (1 Day)||4
8815379|NCT01536860|9868670|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
8815380|NCT01536860|9868671|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
8815381|NCT01536860|9868672|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
8815382|NCT01536886|9868684|FG000|STARTED|Overall Study||141
8815383|NCT01536886|9868685|FG001|STARTED|Overall Study||135
8815384|NCT01536886|9868686|FG002|STARTED|Overall Study||49
8815385|NCT01536886|9868687|FG003|STARTED|Overall Study||51
8815386|NCT01536886|9868684|FG000|COMPLETED|Overall Study||136
8815387|NCT01536886|9868685|FG001|COMPLETED|Overall Study||127
8815388|NCT01536886|9868686|FG002|COMPLETED|Overall Study||47
8815389|NCT01536886|9868687|FG003|COMPLETED|Overall Study||48
8815390|NCT01536886|9868684|FG000|NOT COMPLETED|Overall Study||5
8815391|NCT01536886|9868685|FG001|NOT COMPLETED|Overall Study||8
8815392|NCT01536886|9868686|FG002|NOT COMPLETED|Overall Study||2
8815393|NCT01536886|9868687|FG003|NOT COMPLETED|Overall Study||3
8815394|NCT01536938|9868700|FG000|STARTED|Overall Study||100
8815395|NCT01536938|9868701|FG001|STARTED|Overall Study||101
8815396|NCT01536938|9868702|FG002|STARTED|Overall Study||101
8815397|NCT01536938|9868700|FG000|COMPLETED|Overall Study||94
8815398|NCT01536938|9868701|FG001|COMPLETED|Overall Study||94
8815399|NCT01536938|9868702|FG002|COMPLETED|Overall Study||93
8815400|NCT01536938|9868700|FG000|NOT COMPLETED|Overall Study||6
8815401|NCT01536938|9868701|FG001|NOT COMPLETED|Overall Study||7
8815402|NCT01536938|9868702|FG002|NOT COMPLETED|Overall Study||8
8815403|NCT01536951|9868712|FG000|STARTED|First Intervention and Washout Period 1||3
8815404|NCT01536951|9868713|FG001|STARTED|First Intervention and Washout Period 1||3
8815405|NCT01536951|9868714|FG002|STARTED|First Intervention and Washout Period 1||3
8815406|NCT01536951|9868715|FG003|STARTED|First Intervention and Washout Period 1||8
8815407|NCT01536951|9868716|FG004|STARTED|First Intervention and Washout Period 1||9
8815408|NCT01536951|9868717|FG005|STARTED|First Intervention and Washout Period 1||9
8815409|NCT01536951|9868718|FG006|STARTED|First Intervention and Washout Period 1||9
8815410|NCT01536951|9868719|FG007|STARTED|First Intervention and Washout Period 1||9
8815411|NCT01536951|9868720|FG008|STARTED|First Intervention and Washout Period 1||9
8815412|NCT01536951|9868712|FG000|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1|Across all reporting groups, study drug is LY3009104, moxifloxacin, or placebo.|3
8815413|NCT01536951|9868713|FG001|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||3
8815414|NCT01536951|9868714|FG002|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||3
8815415|NCT01536951|9868715|FG003|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||8
8815416|NCT01536951|9868716|FG004|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
8620390|NCT00474201|9659052|FG000|STARTED|Overall Study||15
8620391|NCT00474201|9659052|FG000|COMPLETED|Overall Study||15
8620392|NCT00474201|9659052|FG000|NOT COMPLETED|Overall Study||0
8620393|NCT00474240|9659063|FG000|STARTED|Overall Study||27
8620394|NCT00474240|9659064|FG001|STARTED|Overall Study||26
8620395|NCT00474240|9659065|FG002|STARTED|Overall Study||26
8620396|NCT00474240|9659066|FG003|STARTED|Overall Study||26
8620397|NCT00474240|9659067|FG004|STARTED|Overall Study||26
8620398|NCT00474240|9659068|FG005|STARTED|Overall Study||26
8620399|NCT00474240|9659063|FG000|COMPLETED|Overall Study||26
8620400|NCT00474240|9659064|FG001|COMPLETED|Overall Study||25
8620401|NCT00474240|9659065|FG002|COMPLETED|Overall Study||17
8620402|NCT00474240|9659066|FG003|COMPLETED|Overall Study||10
8722757|NCT01020838|9770236|FG000|First Annual Repeat Injection|Overall Study|Patients returning for first follow-up administration and PET-scan.|91
8722758|NCT01020838|9770236|FG000|Second Annual Repeat Injection|Overall Study|Patients returning for second follow-up administration and PET-scan.|34
8620403|NCT00474240|9659067|FG004|COMPLETED|Overall Study||18
8620404|NCT00474240|9659068|FG005|COMPLETED|Overall Study||8
8620405|NCT00474240|9659063|FG000|NOT COMPLETED|Overall Study||1
8815417|NCT01536951|9868717|FG005|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
8815418|NCT01536951|9868718|FG006|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
8815419|NCT01536951|9868719|FG007|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
8815420|NCT01536951|9868720|FG008|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
8815421|NCT01536951|9868712|FG000|COMPLETED|First Intervention and Washout Period 1||3
8815422|NCT01536951|9868713|FG001|COMPLETED|First Intervention and Washout Period 1||3
8815423|NCT01536951|9868714|FG002|COMPLETED|First Intervention and Washout Period 1||2
8815424|NCT01536951|9868715|FG003|COMPLETED|First Intervention and Washout Period 1||8
8815425|NCT01536951|9868716|FG004|COMPLETED|First Intervention and Washout Period 1||9
8815426|NCT01536951|9868717|FG005|COMPLETED|First Intervention and Washout Period 1||9
8815427|NCT01536951|9868718|FG006|COMPLETED|First Intervention and Washout Period 1||9
8815428|NCT01536951|9868719|FG007|COMPLETED|First Intervention and Washout Period 1||9
8815429|NCT01536951|9868720|FG008|COMPLETED|First Intervention and Washout Period 1||9
8815430|NCT01536951|9868712|FG000|NOT COMPLETED|First Intervention and Washout Period 1||0
8815431|NCT01536951|9868713|FG001|NOT COMPLETED|First Intervention and Washout Period 1||0
8815432|NCT01536951|9868714|FG002|NOT COMPLETED|First Intervention and Washout Period 1||1
8815433|NCT01536951|9868715|FG003|NOT COMPLETED|First Intervention and Washout Period 1||0
8815434|NCT01536951|9868716|FG004|NOT COMPLETED|First Intervention and Washout Period 1||0
8815435|NCT01536951|9868717|FG005|NOT COMPLETED|First Intervention and Washout Period 1||0
8815436|NCT01536951|9868718|FG006|NOT COMPLETED|First Intervention and Washout Period 1||0
8815437|NCT01536951|9868719|FG007|NOT COMPLETED|First Intervention and Washout Period 1||0
8815438|NCT01536951|9868720|FG008|NOT COMPLETED|First Intervention and Washout Period 1||0
8815439|NCT01536951|9868712|FG000|STARTED|Second Intervention and Washout Period 2||3
8815440|NCT01536951|9868713|FG001|STARTED|Second Intervention and Washout Period 2||3
8815441|NCT01536951|9868714|FG002|STARTED|Second Intervention and Washout Period 2||2
8815442|NCT01536951|9868715|FG003|STARTED|Second Intervention and Washout Period 2||8
8815443|NCT01536951|9868716|FG004|STARTED|Second Intervention and Washout Period 2||9
8815444|NCT01536951|9868717|FG005|STARTED|Second Intervention and Washout Period 2||9
8562599|NCT00032630|9594700|FG000|STARTED|Overall Study||1099
8562600|NCT00032630|9594701|FG001|STARTED|Overall Study||1104
8562601|NCT00032630|9594700|FG000|COMPLETED|Overall Study||1050
8562602|NCT00032630|9594701|FG001|COMPLETED|Overall Study||1061
8562603|NCT00032630|9594700|FG000|NOT COMPLETED|Overall Study||49
8562604|NCT00032630|9594701|FG001|NOT COMPLETED|Overall Study||43
8562605|NCT00033371|9594709|FG000|STARTED|Overall Study||55
8562606|NCT00033371|9594710|FG001|STARTED|Overall Study||57
8562607|NCT00033371|9594709|FG000|COMPLETED|Overall Study||49
8562608|NCT00033371|9594710|FG001|COMPLETED|Overall Study||47
8562609|NCT00033371|9594709|FG000|NOT COMPLETED|Overall Study||6
8562610|NCT00033371|9594710|FG001|NOT COMPLETED|Overall Study||10
8562611|NCT00033514|9594722|FG000|STARTED|Overall Study||16
8562612|NCT00033514|9594723|FG001|STARTED|Overall Study||11
8562613|NCT00033514|9594722|FG000|COMPLETED|Overall Study||15
8562614|NCT00033514|9594723|FG001|COMPLETED|Overall Study||7
8562615|NCT00033514|9594722|FG000|NOT COMPLETED|Overall Study||1
8562616|NCT00033514|9594723|FG001|NOT COMPLETED|Overall Study||4
8562617|NCT00033540|9594730|FG000|STARTED|Overall Study||57
8562618|NCT00033540|9594730|FG000|Eligible|Overall Study||54
8562619|NCT00033540|9594730|FG000|Eligible and Began Protocol Therapy|Overall Study|One patient went off study prior to any toxicity assessments and is not evaluable for toxicities.|52
8562620|NCT00033540|9594730|FG000|COMPLETED|Overall Study||0
8562621|NCT00033540|9594730|FG000|NOT COMPLETED|Overall Study||57
8562622|NCT00033631|9594737|FG000|STARTED|Overall Study||769
8562623|NCT00033631|9594738|FG001|STARTED|Overall Study||763
8562624|NCT00033631|9594737|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|751
8562625|NCT00033631|9594738|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|748
8562626|NCT00033631|9594737|FG000|NOT COMPLETED|Overall Study||18
8562627|NCT00033631|9594738|FG001|NOT COMPLETED|Overall Study||15
8562628|NCT00033657|9594747|FG000|STARTED|Neoadjuvant Chemotherapy||50
8562629|NCT00033657|9594748|FG001|STARTED|Neoadjuvant Chemotherapy||47
8562630|NCT00033657|9594747|FG000|Eligible|Neoadjuvant Chemotherapy||42
8562631|NCT00033657|9594748|FG001|Eligible|Neoadjuvant Chemotherapy||43
8562632|NCT00033657|9594747|FG000|Eligible and Treated|Neoadjuvant Chemotherapy||39
8562633|NCT00033657|9594748|FG001|Eligible and Treated|Neoadjuvant Chemotherapy||42
8562634|NCT00033657|9594747|FG000|COMPLETED|Neoadjuvant Chemotherapy||36
8562635|NCT00033657|9594748|FG001|COMPLETED|Neoadjuvant Chemotherapy||36
8562636|NCT00033657|9594747|FG000|NOT COMPLETED|Neoadjuvant Chemotherapy||14
8562637|NCT00033657|9594748|FG001|NOT COMPLETED|Neoadjuvant Chemotherapy||11
8562638|NCT00033657|9594747|FG000|STARTED|Surgical Resection||36
8562639|NCT00033657|9594748|FG001|STARTED|Surgical Resection||36
8562640|NCT00033657|9594747|FG000|COMPLETED|Surgical Resection||36
8562641|NCT00033657|9594748|FG001|COMPLETED|Surgical Resection||33
8562642|NCT00033657|9594747|FG000|NOT COMPLETED|Surgical Resection||0
8562643|NCT00033657|9594748|FG001|NOT COMPLETED|Surgical Resection||3
8562644|NCT00033657|9594747|FG000|STARTED|Adjuvant Chemotherapy||36
8562645|NCT00033657|9594748|FG001|STARTED|Adjuvant Chemotherapy||33
8562646|NCT00033657|9594747|FG000|COMPLETED|Adjuvant Chemotherapy||18
8562647|NCT00033657|9594748|FG001|COMPLETED|Adjuvant Chemotherapy||16
8562648|NCT00033657|9594747|FG000|NOT COMPLETED|Adjuvant Chemotherapy||18
8562649|NCT00033657|9594748|FG001|NOT COMPLETED|Adjuvant Chemotherapy||17
8562650|NCT00033917|9594758|FG000|STARTED|Overall Study||209
8562651|NCT00033917|9594759|FG001|STARTED|Overall Study||222
8562652|NCT00033917|9594758|FG000|COMPLETED|Overall Study||209
8562653|NCT00033917|9594759|FG001|COMPLETED|Overall Study||222
8562654|NCT00033917|9594758|FG000|NOT COMPLETED|Overall Study||0
8562655|NCT00033917|9594759|FG001|NOT COMPLETED|Overall Study||0
8562656|NCT00035555|9594772|FG000|STARTED|Overall Study|Randomized patients|74
8562657|NCT00035555|9594773|FG001|STARTED|Overall Study|Randomized patients|71
8562658|NCT00035555|9594774|FG002|STARTED|Overall Study|Randomized patients|73
8562659|NCT00035555|9594772|FG000|Number Who Had Undergone Transplantation|Overall Study||74
8562660|NCT00035555|9594773|FG001|Number Who Had Undergone Transplantation|Overall Study||71
8562661|NCT00035555|9594774|FG002|Number Who Had Undergone Transplantation|Overall Study||73
8562662|NCT00035555|9594772|FG000|Number Who Received Study Drug|Overall Study||74
8562663|NCT00035555|9594773|FG001|Number Who Received Study Drug|Overall Study||71
8562664|NCT00035555|9594774|FG002|Number Who Received Study Drug|Overall Study||71
8562665|NCT00035555|9594772|FG000|COMPLETED|Overall Study||58
8562666|NCT00035555|9594773|FG001|COMPLETED|Overall Study||55
8562667|NCT00035555|9594774|FG002|COMPLETED|Overall Study||51
8562668|NCT00035555|9594772|FG000|NOT COMPLETED|Overall Study||16
8562669|NCT00035555|9594773|FG001|NOT COMPLETED|Overall Study||16
8562670|NCT00035555|9594774|FG002|NOT COMPLETED|Overall Study||22
8562671|NCT00035815|9594785|FG000|STARTED|Overall Study|Enrollment began June 2003, accrual was for 2 years, follow-up period was 2 years.|167
8562672|NCT00035815|9594786|FG001|STARTED|Overall Study|Enrollment began June 2003, accrual was for 2 years, follow-up period was 2 years.|163
8562673|NCT00035815|9594785|FG000|COMPLETED|Overall Study||150
8815445|NCT01536951|9868718|FG006|STARTED|Second Intervention and Washout Period 2||9
8815446|NCT01536951|9868719|FG007|STARTED|Second Intervention and Washout Period 2||9
8815447|NCT01536951|9868720|FG008|STARTED|Second Intervention and Washout Period 2||9
8815448|NCT01536951|9868712|FG000|COMPLETED|Second Intervention and Washout Period 2||3
8815449|NCT01536951|9868713|FG001|COMPLETED|Second Intervention and Washout Period 2||3
8815450|NCT01536951|9868714|FG002|COMPLETED|Second Intervention and Washout Period 2||2
8815451|NCT01536951|9868715|FG003|COMPLETED|Second Intervention and Washout Period 2||8
8815452|NCT01536951|9868716|FG004|COMPLETED|Second Intervention and Washout Period 2||9
8815453|NCT01536951|9868717|FG005|COMPLETED|Second Intervention and Washout Period 2||9
8815454|NCT01536951|9868718|FG006|COMPLETED|Second Intervention and Washout Period 2||9
8815455|NCT01536951|9868719|FG007|COMPLETED|Second Intervention and Washout Period 2||8
8815456|NCT01536951|9868720|FG008|COMPLETED|Second Intervention and Washout Period 2||9
8815457|NCT01536951|9868712|FG000|NOT COMPLETED|Second Intervention and Washout Period 2||0
8815458|NCT01536951|9868713|FG001|NOT COMPLETED|Second Intervention and Washout Period 2||0
8815459|NCT01536951|9868714|FG002|NOT COMPLETED|Second Intervention and Washout Period 2||0
8815460|NCT01536951|9868715|FG003|NOT COMPLETED|Second Intervention and Washout Period 2||0
8815461|NCT01536951|9868716|FG004|NOT COMPLETED|Second Intervention and Washout Period 2||0
8815462|NCT01536951|9868717|FG005|NOT COMPLETED|Second Intervention and Washout Period 2||0
8815463|NCT01536951|9868718|FG006|NOT COMPLETED|Second Intervention and Washout Period 2||0
8815464|NCT01536951|9868719|FG007|NOT COMPLETED|Second Intervention and Washout Period 2||1
8815465|NCT01536951|9868720|FG008|NOT COMPLETED|Second Intervention and Washout Period 2||0
8815466|NCT01536951|9868712|FG000|STARTED|Third Intervention||3
8815467|NCT01536951|9868713|FG001|STARTED|Third Intervention||3
8815468|NCT01536951|9868714|FG002|STARTED|Third Intervention||2
8815469|NCT01536951|9868715|FG003|STARTED|Third Intervention||8
8815470|NCT01536951|9868716|FG004|STARTED|Third Intervention||9
8815471|NCT01536951|9868717|FG005|STARTED|Third Intervention||9
8815472|NCT01536951|9868718|FG006|STARTED|Third Intervention||9
8815473|NCT01536951|9868719|FG007|STARTED|Third Intervention||8
8815474|NCT01536951|9868720|FG008|STARTED|Third Intervention||9
8815475|NCT01536951|9868712|FG000|COMPLETED|Third Intervention||3
8815476|NCT01536951|9868713|FG001|COMPLETED|Third Intervention||3
8562674|NCT00035815|9594786|FG001|COMPLETED|Overall Study||152
8562675|NCT00035815|9594785|FG000|NOT COMPLETED|Overall Study||17
8562676|NCT00035815|9594786|FG001|NOT COMPLETED|Overall Study||11
8562677|NCT00035932|9594795|FG000|STARTED|Overall Study|120 randomized, 119 treated|119
8562678|NCT00035932|9594796|FG001|STARTED|Overall Study|115 randomized, 110 treated|110
8562679|NCT00035932|9594797|FG002|STARTED|Overall Study|123 randomized, 118 treated|118
8562680|NCT00035932|9594795|FG000|Discontinued Prior to Week 48 Visit|Overall Study||26
8562681|NCT00035932|9594796|FG001|Discontinued Prior to Week 48 Visit|Overall Study||29
8562682|NCT00035932|9594797|FG002|Discontinued Prior to Week 48 Visit|Overall Study||13
8562683|NCT00035932|9594795|FG000|Discontinued Between Weeks 48 and 96|Overall Study||26
8562684|NCT00035932|9594796|FG001|Discontinued Between Weeks 48 and 96|Overall Study||27
8562685|NCT00035932|9594797|FG002|Discontinued Between Weeks 48 and 96|Overall Study||30
8562686|NCT00035932|9594795|FG000|Discontinued on or After Week 96|Overall Study||4
8562687|NCT00035932|9594796|FG001|Discontinued on or After Week 96|Overall Study||4
8562688|NCT00035932|9594797|FG002|Discontinued on or After Week 96|Overall Study||6
8562689|NCT00035932|9594795|FG000|COMPLETED|Overall Study|63 remained on treatment, 0 completed at Week 96|63
8562690|NCT00035932|9594796|FG001|COMPLETED|Overall Study|50 remained on treatment, 0 completed at Week 96|50
8562691|NCT00035932|9594797|FG002|COMPLETED|Overall Study|59 remained on treatment, 10 completed at Week 96|69
8562692|NCT00035932|9594795|FG000|NOT COMPLETED|Overall Study||56
8562693|NCT00035932|9594796|FG001|NOT COMPLETED|Overall Study||60
8562694|NCT00035932|9594797|FG002|NOT COMPLETED|Overall Study||49
8562695|NCT00036270|9594812|FG000|STARTED|Randomized to Study Treatment||4904
8562696|NCT00036270|9594813|FG001|STARTED|Randomized to Study Treatment||4875
8562697|NCT00036270|9594812|FG000|COMPLETED|Randomized to Study Treatment||4898
8562698|NCT00036270|9594813|FG001|COMPLETED|Randomized to Study Treatment||4868
8562699|NCT00036270|9594812|FG000|NOT COMPLETED|Randomized to Study Treatment||6
8562700|NCT00036270|9594813|FG001|NOT COMPLETED|Randomized to Study Treatment||7
8562701|NCT00036270|9594812|FG000|STARTED|Study Treatment to 5 Year Report||4898
8562702|NCT00036270|9594813|FG001|STARTED|Study Treatment to 5 Year Report||4868
8562703|NCT00036270|9594812|FG000|Treated|Study Treatment to 5 Year Report||4852
8562704|NCT00036270|9594813|FG001|Treated|Study Treatment to 5 Year Report||4814
8562705|NCT00036270|9594812|FG000|COMPLETED|Study Treatment to 5 Year Report||2333
8562706|NCT00036270|9594813|FG001|COMPLETED|Study Treatment to 5 Year Report||1380
8562707|NCT00036270|9594812|FG000|NOT COMPLETED|Study Treatment to 5 Year Report||2565
8562708|NCT00036270|9594813|FG001|NOT COMPLETED|Study Treatment to 5 Year Report||3488
8562709|NCT00036569|9594819|FG000|STARTED|Overall Study||32
8562710|NCT00036569|9594819|FG000|COMPLETED|Overall Study||32
8562711|NCT00036569|9594819|FG000|NOT COMPLETED|Overall Study||0
8562712|NCT00036738|9594825|FG000|STARTED|Overall Study||28
8562713|NCT00036738|9594825|FG000|COMPLETED|Overall Study||28
8562714|NCT00036738|9594825|FG000|NOT COMPLETED|Overall Study||0
8562715|NCT00037830|9594832|FG000|STARTED|Overall Study||39
8562716|NCT00037830|9594833|FG001|STARTED|Overall Study||38
8562717|NCT00037830|9594834|FG002|STARTED|Overall Study||17
8562718|NCT00037830|9594832|FG000|COMPLETED|Overall Study||29
8562719|NCT00037830|9594833|FG001|COMPLETED|Overall Study||31
8562720|NCT00037830|9594834|FG002|COMPLETED|Overall Study||16
8562721|NCT00037830|9594832|FG000|NOT COMPLETED|Overall Study||10
8562722|NCT00037830|9594833|FG001|NOT COMPLETED|Overall Study||7
8562723|NCT00037830|9594834|FG002|NOT COMPLETED|Overall Study||1
8562724|NCT00038103|9594844|FG000|STARTED|Overall Study||55
8562725|NCT00038103|9594845|FG001|STARTED|Overall Study||56
8562726|NCT00038103|9594844|FG000|End of Treatment|Overall Study|patients remained on treatment until discontinued|53
8562727|NCT00038103|9594845|FG001|End of Treatment|Overall Study|patients remained on treatment until discontinued|56
8562728|NCT00038103|9594844|FG000|COMPLETED|Overall Study||0
8562729|NCT00038103|9594845|FG001|COMPLETED|Overall Study||0
8562730|NCT00038103|9594844|FG000|NOT COMPLETED|Overall Study||55
8562731|NCT00038103|9594845|FG001|NOT COMPLETED|Overall Study||56
8562732|NCT00038467|9594853|FG000|STARTED|Overall Study||2352
8562733|NCT00038467|9594854|FG001|STARTED|Overall Study||2372
8562734|NCT00038467|9594853|FG000|Treated|Overall Study|8 participants randomized to receive exemestane, received tamoxifen. Reported as per randomization.|2321
8562735|NCT00038467|9594854|FG001|Treated|Overall Study|7 participants randomized to receive tamoxifen, received exemestane. Reported as per randomization.|2337
8562736|NCT00038467|9594853|FG000|COMPLETED|Overall Study||1810
8562737|NCT00038467|9594854|FG001|COMPLETED|Overall Study||1830
8562738|NCT00038467|9594853|FG000|NOT COMPLETED|Overall Study||542
8562739|NCT00038467|9594854|FG001|NOT COMPLETED|Overall Study||542
8562740|NCT00038610|9594860|FG000|STARTED|Overall Study||54
8525974|NCT02983617|9557518|FG000|STARTED|Overall Study||6
8525975|NCT02983617|9557519|FG001|STARTED|Overall Study||30
8525976|NCT02983617|9557518|FG000|COMPLETED|Overall Study||6
8525977|NCT02983617|9557519|FG001|COMPLETED|Overall Study||21
8525978|NCT02983617|9557518|FG000|NOT COMPLETED|Overall Study||0
8525979|NCT02983617|9557519|FG001|NOT COMPLETED|Overall Study||9
8525980|NCT02964377|9557528|FG000|STARTED|Overall Study||5
8525981|NCT02964377|9557529|FG001|STARTED|Overall Study||5
8525982|NCT02964377|9557530|FG002|STARTED|Overall Study||5
8525983|NCT02964377|9557528|FG000|COMPLETED|Overall Study||5
8525984|NCT02964377|9557529|FG001|COMPLETED|Overall Study||5
8525985|NCT02964377|9557530|FG002|COMPLETED|Overall Study||5
8525986|NCT02964377|9557528|FG000|NOT COMPLETED|Overall Study||0
8525987|NCT02964377|9557529|FG001|NOT COMPLETED|Overall Study||0
8525988|NCT02964377|9557530|FG002|NOT COMPLETED|Overall Study||0
8525989|NCT02790034|9557541|FG000|STARTED|Overall Study||33
8525990|NCT02790034|9557542|FG001|STARTED|Overall Study||56
8525991|NCT02790034|9557543|FG002|STARTED|Overall Study||40
8525992|NCT02790034|9557541|FG000|COMPLETED|Overall Study||27
8525993|NCT02790034|9557542|FG001|COMPLETED|Overall Study||46
8525994|NCT02790034|9557543|FG002|COMPLETED|Overall Study||36
8525995|NCT02790034|9557541|FG000|NOT COMPLETED|Overall Study||6
8525996|NCT02790034|9557542|FG001|NOT COMPLETED|Overall Study||10
8525997|NCT02790034|9557543|FG002|NOT COMPLETED|Overall Study||4
8525998|NCT02649946|9557553|FG000|STARTED|Overall Study||142
8525999|NCT02649946|9557554|FG001|STARTED|Overall Study||138
8526000|NCT02649946|9557553|FG000|COMPLETED|Overall Study||130
8526001|NCT02649946|9557554|FG001|COMPLETED|Overall Study||123
8526002|NCT02649946|9557553|FG000|NOT COMPLETED|Overall Study||12
8526003|NCT02649946|9557554|FG001|NOT COMPLETED|Overall Study||15
8526004|NCT02431247|9557562|FG000|STARTED|BL to EOE-Test and BL to Switch- Control||362
8526005|NCT02431247|9557563|FG001|STARTED|BL to EOE-Test and BL to Switch- Control||363
8526006|NCT02431247|9557564|FG002|STARTED|BL to EOE-Test and BL to Switch- Control||0
8526007|NCT02431247|9557562|FG000|COMPLETED|BL to EOE-Test and BL to Switch- Control||296
8526008|NCT02431247|9557563|FG001|COMPLETED|BL to EOE-Test and BL to Switch- Control||322
8526009|NCT02431247|9557564|FG002|COMPLETED|BL to EOE-Test and BL to Switch- Control||0
8526010|NCT02431247|9557562|FG000|NOT COMPLETED|BL to EOE-Test and BL to Switch- Control||66
8526011|NCT02431247|9557563|FG001|NOT COMPLETED|BL to EOE-Test and BL to Switch- Control||41
8526012|NCT02431247|9557564|FG002|NOT COMPLETED|BL to EOE-Test and BL to Switch- Control||0
8526013|NCT02431247|9557562|FG000|STARTED|Switch to D/C/F/TAF (Until EOE)||0
8562741|NCT00038610|9594860|FG000|COMPLETED|Overall Study||54
8562742|NCT00038610|9594860|FG000|NOT COMPLETED|Overall Study||0
8526014|NCT02431247|9557563|FG001|STARTED|Switch to D/C/F/TAF (Until EOE)|322 participants from DRV/COBI+ FTC/TDF (Control) group switched to D/C/F/TAF (Test) Group|0
8526015|NCT02431247|9557564|FG002|STARTED|Switch to D/C/F/TAF (Until EOE)|322 participants from DRV/COBI+ FTC/TDF (Control) group switched to D/C/F/TAF (Test) Group|322
8526016|NCT02431247|9557562|FG000|COMPLETED|Switch to D/C/F/TAF (Until EOE)||0
8526017|NCT02431247|9557563|FG001|COMPLETED|Switch to D/C/F/TAF (Until EOE)||0
8526018|NCT02431247|9557564|FG002|COMPLETED|Switch to D/C/F/TAF (Until EOE)||289
8526019|NCT02431247|9557562|FG000|NOT COMPLETED|Switch to D/C/F/TAF (Until EOE)||0
8526020|NCT02431247|9557563|FG001|NOT COMPLETED|Switch to D/C/F/TAF (Until EOE)||0
8526021|NCT02431247|9557564|FG002|NOT COMPLETED|Switch to D/C/F/TAF (Until EOE)||33
8526022|NCT02345850|9557579|FG000|STARTED|Overall Study||114
8526023|NCT02345850|9557580|FG001|STARTED|Overall Study||114
8526024|NCT02345850|9557581|FG002|STARTED|Overall Study||118
8526025|NCT02345850|9557579|FG000|COMPLETED|Overall Study||101
8526026|NCT02345850|9557580|FG001|COMPLETED|Overall Study||106
8526027|NCT02345850|9557581|FG002|COMPLETED|Overall Study||112
8526028|NCT02345850|9557579|FG000|NOT COMPLETED|Overall Study||13
8526029|NCT02345850|9557580|FG001|NOT COMPLETED|Overall Study||8
8526030|NCT02345850|9557581|FG002|NOT COMPLETED|Overall Study||6
8526031|NCT02343302|9557591|FG000|STARTED|Overall Study||1
8526032|NCT02343302|9557592|FG001|STARTED|Overall Study||1
8526033|NCT02343302|9557591|FG000|COMPLETED|Overall Study||0
8526034|NCT02343302|9557592|FG001|COMPLETED|Overall Study||0
8815477|NCT01536951|9868714|FG002|COMPLETED|Third Intervention||2
8815478|NCT01536951|9868715|FG003|COMPLETED|Third Intervention||8
8815479|NCT01536951|9868716|FG004|COMPLETED|Third Intervention||9
8815480|NCT01536951|9868717|FG005|COMPLETED|Third Intervention||9
8815481|NCT01536951|9868718|FG006|COMPLETED|Third Intervention||9
8815482|NCT01536951|9868719|FG007|COMPLETED|Third Intervention||8
8815483|NCT01536951|9868720|FG008|COMPLETED|Third Intervention||9
8815484|NCT01536951|9868712|FG000|NOT COMPLETED|Third Intervention||0
8815485|NCT01536951|9868713|FG001|NOT COMPLETED|Third Intervention||0
8815486|NCT01536951|9868714|FG002|NOT COMPLETED|Third Intervention||0
8815487|NCT01536951|9868715|FG003|NOT COMPLETED|Third Intervention||0
8815488|NCT01536951|9868716|FG004|NOT COMPLETED|Third Intervention||0
8815489|NCT01536951|9868717|FG005|NOT COMPLETED|Third Intervention||0
8815490|NCT01536951|9868718|FG006|NOT COMPLETED|Third Intervention||0
8815491|NCT01536951|9868719|FG007|NOT COMPLETED|Third Intervention||0
8815492|NCT01536951|9868720|FG008|NOT COMPLETED|Third Intervention||0
8815493|NCT01537029|9868743|FG000|STARTED|Overall Study||15
8815494|NCT01537029|9868743|FG000|COMPLETED|Overall Study||15
8815495|NCT01537029|9868743|FG000|NOT COMPLETED|Overall Study||0
8815496|NCT01537042|9868749|FG000|STARTED|Overall Study||10
8815497|NCT01537042|9868750|FG001|STARTED|Overall Study||20
8815498|NCT01537042|9868749|FG000|COMPLETED|Overall Study||10
8815499|NCT01537042|9868750|FG001|COMPLETED|Overall Study||15
8815500|NCT01537042|9868749|FG000|NOT COMPLETED|Overall Study||0
8815501|NCT01537042|9868750|FG001|NOT COMPLETED|Overall Study||5
8815502|NCT01537068|9868762|FG000|STARTED|Overall Study||30
8815503|NCT01537068|9868763|FG001|STARTED|Overall Study||29
8815504|NCT01537068|9868762|FG000|COMPLETED|Overall Study||26
8815505|NCT01537068|9868763|FG001|COMPLETED|Overall Study||26
8815506|NCT01537068|9868762|FG000|NOT COMPLETED|Overall Study||4
8815507|NCT01537068|9868763|FG001|NOT COMPLETED|Overall Study||3
8815508|NCT01537081|9868772|FG000|STARTED|Overall Study||1123
8815509|NCT01537081|9868773|FG001|STARTED|Overall Study||1124
8815510|NCT01537081|9868774|FG002|STARTED|Overall Study||563
8815511|NCT01537081|9868772|FG000|Safety Population|Overall Study||1122
8815512|NCT01537081|9868773|FG001|Safety Population|Overall Study||1122
8815513|NCT01537081|9868774|FG002|Safety Population|Overall Study||561
8815514|NCT01537081|9868772|FG000|Modified Intent to Treat Population|Overall Study||1106
8815515|NCT01537081|9868773|FG001|Modified Intent to Treat Population|Overall Study||1109
8815516|NCT01537081|9868774|FG002|Modified Intent to Treat Population|Overall Study||556
8815517|NCT01537081|9868772|FG000|COMPLETED|Overall Study||1084
8815518|NCT01537081|9868773|FG001|COMPLETED|Overall Study||1086
8815519|NCT01537081|9868774|FG002|COMPLETED|Overall Study||547
8815520|NCT01537081|9868772|FG000|NOT COMPLETED|Overall Study||39
8815521|NCT01537081|9868773|FG001|NOT COMPLETED|Overall Study||38
8815522|NCT01537081|9868774|FG002|NOT COMPLETED|Overall Study||16
8815523|NCT01537120|9868783|FG000|STARTED|Enrolled||25
8815524|NCT01537120|9868783|FG000|COMPLETED|Enrolled||25
8815525|NCT01537120|9868783|FG000|NOT COMPLETED|Enrolled||0
8815526|NCT01537120|9868783|FG000|STARTED|8 Weeks Washout||25
8526035|NCT02343302|9557591|FG000|NOT COMPLETED|Overall Study||1
8526036|NCT02343302|9557592|FG001|NOT COMPLETED|Overall Study||1
8526037|NCT02281084|9557602|FG000|STARTED|Overall Study||32
8526038|NCT02281084|9557603|FG001|STARTED|Overall Study||22
8526039|NCT02281084|9557604|FG002|STARTED|Overall Study||6
8526040|NCT02281084|9557605|FG003|STARTED|Overall Study||5
8815527|NCT01537120|9868783|FG000|COMPLETED|8 Weeks Washout||24
8815528|NCT01537120|9868783|FG000|NOT COMPLETED|8 Weeks Washout||1
8815529|NCT01537120|9868783|FG000|STARTED|3 Weeks Placebo||24
8815530|NCT01537120|9868783|FG000|COMPLETED|3 Weeks Placebo||23
8815531|NCT01537120|9868783|FG000|NOT COMPLETED|3 Weeks Placebo||1
8815532|NCT01537120|9868783|FG000|STARTED|12 Weeks Vildagliptin||23
8815533|NCT01537120|9868783|FG000|COMPLETED|12 Weeks Vildagliptin||23
8815534|NCT01537120|9868783|FG000|NOT COMPLETED|12 Weeks Vildagliptin||0
8815535|NCT01537133|9868793|FG000|STARTED|Overall Study||28
8815536|NCT01537133|9868794|FG001|STARTED|Overall Study||14
8815537|NCT01537133|9868795|FG002|STARTED|Overall Study||21
8526041|NCT02281084|9557602|FG000|COMPLETED|Overall Study||10
8526042|NCT02281084|9557603|FG001|COMPLETED|Overall Study||4
8526043|NCT02281084|9557604|FG002|COMPLETED|Overall Study||2
8526044|NCT02281084|9557605|FG003|COMPLETED|Overall Study||0
8526045|NCT02281084|9557602|FG000|NOT COMPLETED|Overall Study||22
8526046|NCT02281084|9557603|FG001|NOT COMPLETED|Overall Study||18
8526047|NCT02281084|9557604|FG002|NOT COMPLETED|Overall Study||4
8526048|NCT02281084|9557605|FG003|NOT COMPLETED|Overall Study||5
8526049|NCT02053584|9557615|FG000|STARTED|Overall Study||230
8526050|NCT02053584|9557615|FG000|COMPLETED|Overall Study|68 subjects (day one participants) were excluded from the final analysis.|230
8815538|NCT01537133|9868796|FG003|STARTED|Overall Study||21
8815539|NCT01537133|9868793|FG000|COMPLETED|Overall Study||25
8815540|NCT01537133|9868794|FG001|COMPLETED|Overall Study||14
8815541|NCT01537133|9868795|FG002|COMPLETED|Overall Study||21
8815542|NCT01537133|9868796|FG003|COMPLETED|Overall Study||21
8815543|NCT01537133|9868793|FG000|NOT COMPLETED|Overall Study||3
8815544|NCT01537133|9868794|FG001|NOT COMPLETED|Overall Study||0
8815545|NCT01537133|9868795|FG002|NOT COMPLETED|Overall Study||0
8815546|NCT01537133|9868796|FG003|NOT COMPLETED|Overall Study||0
8815547|NCT01537185|9868808|FG000|STARTED|Overall Study||10
8815548|NCT01537185|9868809|FG001|STARTED|Overall Study||12
8815549|NCT01537185|9868810|FG002|STARTED|Overall Study||10
8815550|NCT01537185|9868811|FG003|STARTED|Overall Study||10
8815551|NCT01537185|9868808|FG000|COMPLETED|Overall Study||7
8815552|NCT01537185|9868809|FG001|COMPLETED|Overall Study||6
8815553|NCT01537185|9868810|FG002|COMPLETED|Overall Study||4
8815554|NCT01537185|9868811|FG003|COMPLETED|Overall Study||8
8815555|NCT01537185|9868808|FG000|NOT COMPLETED|Overall Study||3
8815556|NCT01537185|9868809|FG001|NOT COMPLETED|Overall Study||6
8815557|NCT01537185|9868810|FG002|NOT COMPLETED|Overall Study||6
8815558|NCT01537185|9868811|FG003|NOT COMPLETED|Overall Study||2
8815559|NCT01537198|9868823|FG000|STARTED|Overall Study||617
8815560|NCT01537198|9868823|FG000|COMPLETED|Overall Study||463
8815561|NCT01537198|9868823|FG000|NOT COMPLETED|Overall Study||154
8815562|NCT01537211|9868829|FG000|STARTED|Overall Study||4
8815563|NCT01537211|9868830|FG001|STARTED|Overall Study||6
8815564|NCT01537211|9868829|FG000|COMPLETED|Overall Study||4
8815565|NCT01537211|9868830|FG001|COMPLETED|Overall Study||5
8815566|NCT01537211|9868829|FG000|NOT COMPLETED|Overall Study||0
8815567|NCT01537211|9868830|FG001|NOT COMPLETED|Overall Study||1
8815568|NCT01537302|9868840|FG000|STARTED|Overall Study||100
8815569|NCT01537302|9868840|FG000|COMPLETED|Overall Study||100
8815570|NCT01537302|9868840|FG000|NOT COMPLETED|Overall Study||0
8815571|NCT01537315|9868846|FG000|STARTED|Overall Study||1
8815572|NCT01537315|9868847|FG001|STARTED|Overall Study||7
8815573|NCT01537315|9868846|FG000|COMPLETED|Overall Study||1
8815574|NCT01537315|9868847|FG001|COMPLETED|Overall Study||7
8815575|NCT01537315|9868846|FG000|NOT COMPLETED|Overall Study||0
8815576|NCT01537315|9868847|FG001|NOT COMPLETED|Overall Study||0
8815577|NCT01537367|9868856|FG000|STARTED|Overall Study||615
8815578|NCT01537367|9868857|FG001|STARTED|Overall Study||610
8815579|NCT01537367|9868858|FG002|STARTED|Overall Study||613
8815580|NCT01537367|9868856|FG000|COMPLETED|Overall Study|All participants who were enrolled were followed for routine HIV clinic attendance via clinic EMR.|615
8815581|NCT01537367|9868857|FG001|COMPLETED|Overall Study|All participants who were enrolled were followed for routine HIV clinic attendance via clinic EMR.|610
8815582|NCT01537367|9868858|FG002|COMPLETED|Overall Study|All participants who were enrolled were followed for routine HIV clinic attendance via clinic EMR.|613
8815583|NCT01537367|9868856|FG000|NOT COMPLETED|Overall Study||0
8815584|NCT01537367|9868857|FG001|NOT COMPLETED|Overall Study||0
8815585|NCT01537367|9868858|FG002|NOT COMPLETED|Overall Study||0
8815586|NCT01537393|9868868|FG000|STARTED|Overall Study||707
8815587|NCT01537393|9868869|FG001|STARTED|Overall Study||698
8815588|NCT01537393|9868868|FG000|COMPLETED|Overall Study||553
8815589|NCT01537393|9868869|FG001|COMPLETED|Overall Study||507
8815590|NCT01537393|9868868|FG000|NOT COMPLETED|Overall Study||154
8815591|NCT01537393|9868869|FG001|NOT COMPLETED|Overall Study||191
8815592|NCT01537419|9868877|FG000|STARTED|Overall Study||63
8815593|NCT01537419|9868878|FG001|STARTED|Overall Study||66
8815594|NCT01537419|9868877|FG000|COMPLETED|Overall Study||52
8526051|NCT02053584|9557615|FG000|NOT COMPLETED|Overall Study||0
8562743|NCT00038649|9594864|FG000|STARTED|Overall Study||114
8562744|NCT00038649|9594864|FG000|COMPLETED|Overall Study||105
8562745|NCT00038649|9594864|FG000|NOT COMPLETED|Overall Study||9
8562746|NCT00038857|9594868|FG000|STARTED|Overall Study||29
8562747|NCT00038857|9594868|FG000|COMPLETED|Overall Study||28
8562748|NCT00038857|9594868|FG000|NOT COMPLETED|Overall Study||1
8815595|NCT01537419|9868878|FG001|COMPLETED|Overall Study||54
8815596|NCT01537419|9868877|FG000|NOT COMPLETED|Overall Study||11
8815597|NCT01537419|9868878|FG001|NOT COMPLETED|Overall Study||12
8815598|NCT01537432|9868886|FG000|STARTED|Overall Study||24
8815599|NCT01537432|9868887|FG001|STARTED|Overall Study||12
8815600|NCT01537432|9868886|FG000|COMPLETED|Overall Study||18
8815601|NCT01537432|9868887|FG001|COMPLETED|Overall Study||10
8815602|NCT01537432|9868886|FG000|NOT COMPLETED|Overall Study||6
8815603|NCT01537432|9868887|FG001|NOT COMPLETED|Overall Study||2
8815604|NCT01537549|9868893|FG000|STARTED|Overall Study||11
8815605|NCT01537549|9868893|FG000|COMPLETED|Overall Study||8
8815606|NCT01537549|9868893|FG000|NOT COMPLETED|Overall Study||3
8815607|NCT01537666|9868903|FG000|STARTED|Overall Study|2 of these 6 also received a single 250 mg IV dose of vancomycin at least 72 hours after AeroVanc.|6
8849206|NCT01738971|9904351|FG000|NOT COMPLETED|Overall Study||19
8526052|NCT01962792|9557626|FG000|STARTED|Overall Study||3
8526053|NCT01962792|9557627|FG001|STARTED|Overall Study||5
8526054|NCT01962792|9557628|FG002|STARTED|Overall Study||17
8526055|NCT01962792|9557629|FG003|STARTED|Overall Study||59
8526056|NCT01962792|9557626|FG000|COMPLETED|Overall Study||3
8526057|NCT01962792|9557627|FG001|COMPLETED|Overall Study||5
8526058|NCT01962792|9557628|FG002|COMPLETED|Overall Study||17
8526059|NCT01962792|9557629|FG003|COMPLETED|Overall Study||59
8526060|NCT01962792|9557626|FG000|NOT COMPLETED|Overall Study||0
8526061|NCT01962792|9557627|FG001|NOT COMPLETED|Overall Study||0
8526062|NCT01962792|9557628|FG002|NOT COMPLETED|Overall Study||0
8526063|NCT01962792|9557629|FG003|NOT COMPLETED|Overall Study||0
8526064|NCT01878500|9557640|FG000|STARTED|Overall Study||47
8526065|NCT01878500|9557640|FG000|COMPLETED|Overall Study||47
8526066|NCT01878500|9557640|FG000|NOT COMPLETED|Overall Study||0
8526067|NCT01464164|9557651|FG000|STARTED|Overall Study||3
8526068|NCT01464164|9557652|FG001|STARTED|Overall Study||4
8526069|NCT01464164|9557653|FG002|STARTED|Overall Study||4
8526070|NCT01464164|9557654|FG003|STARTED|Overall Study||2
8526071|NCT01464164|9557655|FG004|STARTED|Overall Study||3
8526072|NCT01464164|9557656|FG005|STARTED|Overall Study||0
8526073|NCT01464164|9557657|FG006|STARTED|Overall Study||3
8526074|NCT01464164|9557651|FG000|COMPLETED|Overall Study||3
8526075|NCT01464164|9557652|FG001|COMPLETED|Overall Study||3
8526076|NCT01464164|9557653|FG002|COMPLETED|Overall Study||2
8526077|NCT01464164|9557654|FG003|COMPLETED|Overall Study||2
8526078|NCT01464164|9557655|FG004|COMPLETED|Overall Study||3
8526079|NCT01464164|9557656|FG005|COMPLETED|Overall Study||0
8526080|NCT01464164|9557657|FG006|COMPLETED|Overall Study||1
8526081|NCT01464164|9557651|FG000|NOT COMPLETED|Overall Study||0
8526082|NCT01464164|9557652|FG001|NOT COMPLETED|Overall Study||1
8526083|NCT01464164|9557653|FG002|NOT COMPLETED|Overall Study||2
8526084|NCT01464164|9557654|FG003|NOT COMPLETED|Overall Study||0
8526085|NCT01464164|9557655|FG004|NOT COMPLETED|Overall Study||0
8526086|NCT01464164|9557656|FG005|NOT COMPLETED|Overall Study||0
8526087|NCT01464164|9557657|FG006|NOT COMPLETED|Overall Study||2
8526088|NCT01318317|9557676|FG000|STARTED|Overall Study||1
8526089|NCT01318317|9557677|FG001|STARTED|Overall Study||4
8526090|NCT01318317|9557678|FG002|STARTED|Overall Study||3
8526091|NCT01318317|9557676|FG000|COMPLETED|Overall Study||1
8526092|NCT01318317|9557677|FG001|COMPLETED|Overall Study||4
8526093|NCT01318317|9557678|FG002|COMPLETED|Overall Study||3
8526094|NCT01318317|9557676|FG000|NOT COMPLETED|Overall Study||0
8526095|NCT01318317|9557677|FG001|NOT COMPLETED|Overall Study||0
8526096|NCT01318317|9557678|FG002|NOT COMPLETED|Overall Study||0
8526097|NCT01111565|9557687|FG000|STARTED|Phase B (Weeks 0 to 8)||137
8526098|NCT01111565|9557688|FG001|STARTED|Phase B (Weeks 0 to 8)||0
8526099|NCT01111565|9557689|FG002|STARTED|Phase B (Weeks 0 to 8)||0
8526100|NCT01111565|9557690|FG003|STARTED|Phase B (Weeks 0 to 8)||0
8526101|NCT01111565|9557691|FG004|STARTED|Phase B (Weeks 0 to 8)||0
8526102|NCT01111565|9557687|FG000|COMPLETED|Phase B (Weeks 0 to 8)||71
8526103|NCT01111565|9557688|FG001|COMPLETED|Phase B (Weeks 0 to 8)||0
8526104|NCT01111565|9557689|FG002|COMPLETED|Phase B (Weeks 0 to 8)||0
8526105|NCT01111565|9557690|FG003|COMPLETED|Phase B (Weeks 0 to 8)||0
8526106|NCT01111565|9557691|FG004|COMPLETED|Phase B (Weeks 0 to 8)||0
8526107|NCT01111565|9557687|FG000|NOT COMPLETED|Phase B (Weeks 0 to 8)||66
8526108|NCT01111565|9557688|FG001|NOT COMPLETED|Phase B (Weeks 0 to 8)||0
8526109|NCT01111565|9557689|FG002|NOT COMPLETED|Phase B (Weeks 0 to 8)||0
8526110|NCT01111565|9557690|FG003|NOT COMPLETED|Phase B (Weeks 0 to 8)||0
8526111|NCT01111565|9557691|FG004|NOT COMPLETED|Phase B (Weeks 0 to 8)||0
8526112|NCT01111565|9557687|FG000|STARTED|Phase B + and Phase C (Weeks 9 to 14)||0
8526113|NCT01111565|9557688|FG001|STARTED|Phase B + and Phase C (Weeks 9 to 14)||26
8526114|NCT01111565|9557689|FG002|STARTED|Phase B + and Phase C (Weeks 9 to 14)||16
8526115|NCT01111565|9557690|FG003|STARTED|Phase B + and Phase C (Weeks 9 to 14)||14
8526116|NCT01111565|9557691|FG004|STARTED|Phase B + and Phase C (Weeks 9 to 14)||15
8526117|NCT01111565|9557687|FG000|COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||0
8526118|NCT01111565|9557688|FG001|COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||19
8526119|NCT01111565|9557689|FG002|COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||11
8526120|NCT01111565|9557690|FG003|COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||10
8526121|NCT01111565|9557691|FG004|COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||11
8526122|NCT01111565|9557687|FG000|NOT COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||0
8526123|NCT01111565|9557688|FG001|NOT COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||7
8526124|NCT01111565|9557689|FG002|NOT COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||5
8526125|NCT01111565|9557690|FG003|NOT COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||4
8526126|NCT01111565|9557691|FG004|NOT COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||4
8526127|NCT01092117|9557701|FG000|STARTED|Index Procedure to 1 Month||161
8526128|NCT01092117|9557701|FG000|COMPLETED|Index Procedure to 1 Month||160
8526129|NCT01092117|9557701|FG000|NOT COMPLETED|Index Procedure to 1 Month||1
8526130|NCT01092117|9557701|FG000|STARTED|1 Month||160
8526131|NCT01092117|9557701|FG000|COMPLETED|1 Month||157
8526132|NCT01092117|9557701|FG000|NOT COMPLETED|1 Month||3
8526133|NCT01092117|9557701|FG000|STARTED|6 Months||157
8526134|NCT01092117|9557701|FG000|COMPLETED|6 Months||152
8526135|NCT01092117|9557701|FG000|NOT COMPLETED|6 Months||5
8526136|NCT01092117|9557701|FG000|STARTED|12 Month||152
8526137|NCT01092117|9557701|FG000|COMPLETED|12 Month||138
8526138|NCT01092117|9557701|FG000|NOT COMPLETED|12 Month||14
8526139|NCT01092117|9557701|FG000|STARTED|Year 2||138
8526140|NCT01092117|9557701|FG000|COMPLETED|Year 2||128
8526141|NCT01092117|9557701|FG000|NOT COMPLETED|Year 2||10
8526142|NCT01092117|9557701|FG000|STARTED|Year 3||128
8526143|NCT01092117|9557701|FG000|COMPLETED|Year 3||109
8526144|NCT01092117|9557701|FG000|NOT COMPLETED|Year 3||19
8526145|NCT01092117|9557701|FG000|STARTED|Year 4||109
8526146|NCT01092117|9557701|FG000|COMPLETED|Year 4||93
8526147|NCT01092117|9557701|FG000|NOT COMPLETED|Year 4||16
8526148|NCT00950989|9557709|FG000|STARTED|Overall Study||63
8815608|NCT01537666|9868904|FG001|STARTED|Overall Study|2 of these 6 also received a single 250 mg IV dose of vancomycin at least 72 hours after AeroVanc.|6
8815609|NCT01537666|9868905|FG002|STARTED|Overall Study|2 of these 6 also received a single 250 mg IV dose of vancomycin at least 72 hours after AeroVanc.|6
8815610|NCT01537666|9868906|FG003|STARTED|Overall Study|5 of 7 patients received a 32 mg dose of AeroVanc followed by a dose of 80 mg at least 1 week later.|7
8815611|NCT01537666|9868903|FG000|COMPLETED|Overall Study||6
8815612|NCT01537666|9868904|FG001|COMPLETED|Overall Study||6
8815613|NCT01537666|9868905|FG002|COMPLETED|Overall Study||6
8815614|NCT01537666|9868906|FG003|COMPLETED|Overall Study|1 patient withdrew after a 32 mg dose and was replaced by a patient who only received an 80 mg dose.|7
8815615|NCT01537666|9868903|FG000|NOT COMPLETED|Overall Study||0
8815616|NCT01537666|9868904|FG001|NOT COMPLETED|Overall Study||0
8815617|NCT01537666|9868905|FG002|NOT COMPLETED|Overall Study||0
8815618|NCT01537666|9868906|FG003|NOT COMPLETED|Overall Study||0
8815619|NCT01537783|9868928|FG000|STARTED|Overall Study||25
8815620|NCT01537783|9868929|FG001|STARTED|Overall Study||25
8815621|NCT01537783|9868928|FG000|COMPLETED|Overall Study||14
8815622|NCT01537783|9868929|FG001|COMPLETED|Overall Study||23
8815623|NCT01537783|9868928|FG000|NOT COMPLETED|Overall Study||11
8815624|NCT01537783|9868929|FG001|NOT COMPLETED|Overall Study||2
8815625|NCT01537835|9868938|FG000|STARTED|Overall Study||37
8815626|NCT01537835|9868939|FG001|STARTED|Overall Study||37
8815627|NCT01537835|9868940|FG002|STARTED|Overall Study||35
8815628|NCT01537835|9868938|FG000|COMPLETED|Overall Study||37
8815629|NCT01537835|9868939|FG001|COMPLETED|Overall Study||37
8815630|NCT01537835|9868940|FG002|COMPLETED|Overall Study||35
8815631|NCT01537835|9868938|FG000|NOT COMPLETED|Overall Study||0
8815632|NCT01537835|9868939|FG001|NOT COMPLETED|Overall Study||0
8815633|NCT01537835|9868940|FG002|NOT COMPLETED|Overall Study||0
8815634|NCT01537887|9868948|FG000|STARTED|Period 1||12
8815635|NCT01537887|9868949|FG001|STARTED|Period 1||12
8815636|NCT01537887|9868950|FG002|STARTED|Period 1||12
8815637|NCT01537887|9868951|FG003|STARTED|Period 1||12
8815638|NCT01537887|9868952|FG004|STARTED|Period 1||12
8815639|NCT01537887|9868953|FG005|STARTED|Period 1||12
8815640|NCT01537887|9868948|FG000|Received at Least 1 Dose of Study Drug|Period 1||12
8815641|NCT01537887|9868949|FG001|Received at Least 1 Dose of Study Drug|Period 1||12
8815642|NCT01537887|9868950|FG002|Received at Least 1 Dose of Study Drug|Period 1||11
8815643|NCT01537887|9868951|FG003|Received at Least 1 Dose of Study Drug|Period 1||12
8815644|NCT01537887|9868952|FG004|Received at Least 1 Dose of Study Drug|Period 1||12
8815645|NCT01537887|9868953|FG005|Received at Least 1 Dose of Study Drug|Period 1||12
8815646|NCT01537887|9868948|FG000|COMPLETED|Period 1||12
8815647|NCT01537887|9868949|FG001|COMPLETED|Period 1||12
8815648|NCT01537887|9868950|FG002|COMPLETED|Period 1||11
8815649|NCT01537887|9868951|FG003|COMPLETED|Period 1||12
8815650|NCT01537887|9868952|FG004|COMPLETED|Period 1||11
8815651|NCT01537887|9868953|FG005|COMPLETED|Period 1||11
8815652|NCT01537887|9868948|FG000|NOT COMPLETED|Period 1||0
8815653|NCT01537887|9868949|FG001|NOT COMPLETED|Period 1||0
8815654|NCT01537887|9868950|FG002|NOT COMPLETED|Period 1||1
8815655|NCT01537887|9868951|FG003|NOT COMPLETED|Period 1||0
8815656|NCT01537887|9868952|FG004|NOT COMPLETED|Period 1||1
8815657|NCT01537887|9868953|FG005|NOT COMPLETED|Period 1||1
8815658|NCT01537887|9868948|FG000|STARTED|Period 2||12
8815659|NCT01537887|9868949|FG001|STARTED|Period 2||12
8815660|NCT01537887|9868950|FG002|STARTED|Period 2||11
8526149|NCT00950989|9557710|FG001|STARTED|Overall Study||63
8526150|NCT00950989|9557711|FG002|STARTED|Overall Study||63
8526151|NCT00950989|9557712|FG003|STARTED|Overall Study||63
8526152|NCT00950989|9557709|FG000|COMPLETED|Overall Study||59
8526153|NCT00950989|9557710|FG001|COMPLETED|Overall Study||60
8526154|NCT00950989|9557711|FG002|COMPLETED|Overall Study||60
8526155|NCT00950989|9557712|FG003|COMPLETED|Overall Study||63
8526156|NCT00950989|9557709|FG000|NOT COMPLETED|Overall Study||4
8526157|NCT00950989|9557710|FG001|NOT COMPLETED|Overall Study||3
8526158|NCT00950989|9557711|FG002|NOT COMPLETED|Overall Study||3
8526159|NCT00950989|9557712|FG003|NOT COMPLETED|Overall Study||0
8526160|NCT00489307|9557727|FG000|STARTED|Overall Study||67
8815661|NCT01537887|9868951|FG003|STARTED|Period 2||12
8815662|NCT01537887|9868952|FG004|STARTED|Period 2||11
8815663|NCT01537887|9868953|FG005|STARTED|Period 2||11
8815664|NCT01537887|9868948|FG000|COMPLETED|Period 2||12
8815665|NCT01537887|9868949|FG001|COMPLETED|Period 2||11
8815666|NCT01537887|9868950|FG002|COMPLETED|Period 2||11
8815667|NCT01537887|9868951|FG003|COMPLETED|Period 2||12
8815668|NCT01537887|9868952|FG004|COMPLETED|Period 2||11
8815669|NCT01537887|9868953|FG005|COMPLETED|Period 2||11
8815670|NCT01537887|9868948|FG000|NOT COMPLETED|Period 2||0
8815671|NCT01537887|9868949|FG001|NOT COMPLETED|Period 2||1
8815672|NCT01537887|9868950|FG002|NOT COMPLETED|Period 2||0
8526161|NCT00489307|9557728|FG001|STARTED|Overall Study||65
8526162|NCT00489307|9557727|FG000|COMPLETED|Overall Study||43
8526163|NCT00489307|9557728|FG001|COMPLETED|Overall Study||41
8526164|NCT00489307|9557727|FG000|NOT COMPLETED|Overall Study||24
8526165|NCT00489307|9557728|FG001|NOT COMPLETED|Overall Study||24
8526166|NCT00072410|9557736|FG000|STARTED|Overall Study||3
8815673|NCT01537887|9868951|FG003|NOT COMPLETED|Period 2||0
8815674|NCT01537887|9868952|FG004|NOT COMPLETED|Period 2||0
8815675|NCT01537887|9868953|FG005|NOT COMPLETED|Period 2||0
8815676|NCT01537887|9868948|FG000|STARTED|Period 3||12
8815677|NCT01537887|9868949|FG001|STARTED|Period 3||11
8815678|NCT01537887|9868950|FG002|STARTED|Period 3||11
8815679|NCT01537887|9868951|FG003|STARTED|Period 3||12
8815680|NCT01537887|9868952|FG004|STARTED|Period 3||11
8815681|NCT01537887|9868953|FG005|STARTED|Period 3||11
8815682|NCT01537887|9868948|FG000|COMPLETED|Period 3||12
8815683|NCT01537887|9868949|FG001|COMPLETED|Period 3||10
8815684|NCT01537887|9868950|FG002|COMPLETED|Period 3||10
8815685|NCT01537887|9868951|FG003|COMPLETED|Period 3||12
8815686|NCT01537887|9868952|FG004|COMPLETED|Period 3||11
8815687|NCT01537887|9868953|FG005|COMPLETED|Period 3||11
8815688|NCT01537887|9868948|FG000|NOT COMPLETED|Period 3||0
8815689|NCT01537887|9868949|FG001|NOT COMPLETED|Period 3||1
8815690|NCT01537887|9868950|FG002|NOT COMPLETED|Period 3||1
8815691|NCT01537887|9868951|FG003|NOT COMPLETED|Period 3||0
8815692|NCT01537887|9868952|FG004|NOT COMPLETED|Period 3||0
8815693|NCT01537887|9868953|FG005|NOT COMPLETED|Period 3||0
8815694|NCT01537900|9868961|FG000|STARTED|Overall Study||4
8815695|NCT01537900|9868961|FG000|COMPLETED|Overall Study||4
8815696|NCT01537900|9868961|FG000|NOT COMPLETED|Overall Study||0
8815697|NCT01537926|9868967|FG000|STARTED|Overall Study||29
8815698|NCT01537926|9868968|FG001|STARTED|Overall Study||13
8815699|NCT01537926|9868967|FG000|COMPLETED|Overall Study||24
8815700|NCT01537926|9868968|FG001|COMPLETED|Overall Study||11
8815701|NCT01537926|9868967|FG000|NOT COMPLETED|Overall Study||5
8815702|NCT01537926|9868968|FG001|NOT COMPLETED|Overall Study||2
8815703|NCT01538199|9868981|FG000|STARTED|Overall Study||10
8815704|NCT01538199|9868982|FG001|STARTED|Overall Study||11
8815705|NCT01538199|9868983|FG002|STARTED|Overall Study||4
8815706|NCT01538199|9868984|FG003|STARTED|Overall Study||3
8815707|NCT01538199|9868981|FG000|COMPLETED|Overall Study|"1 completed study but was excluded as a completer from analyses because started a new treatment"|8
8815708|NCT01538199|9868982|FG001|COMPLETED|Overall Study|"1 completed study but was excluded as a completer from analyses because started a new treatment"|8
8815709|NCT01538199|9868983|FG002|COMPLETED|Overall Study|1 non-completer included in analyses because only missed follow up, completed all treatment visits.|3
8815710|NCT01538199|9868984|FG003|COMPLETED|Overall Study|Completer excluded from analyses because determined to be not eligible at end of study.|1
8815711|NCT01538199|9868981|FG000|NOT COMPLETED|Overall Study||2
8815712|NCT01538199|9868982|FG001|NOT COMPLETED|Overall Study||3
8815713|NCT01538199|9868983|FG002|NOT COMPLETED|Overall Study||1
8815714|NCT01538199|9868984|FG003|NOT COMPLETED|Overall Study||2
8815715|NCT01538472|9869001|FG000|STARTED|Overall Study||40
8815716|NCT01538472|9869001|FG000|COMPLETED|Overall Study||36
8815717|NCT01538472|9869001|FG000|NOT COMPLETED|Overall Study||4
8815718|NCT01538615|9869007|FG000|STARTED|Overall Study||162
8815719|NCT01538615|9869008|FG001|STARTED|Overall Study||158
8815720|NCT01538615|9869007|FG000|COMPLETED|Overall Study||140
8815721|NCT01538615|9869008|FG001|COMPLETED|Overall Study||146
8815722|NCT01538615|9869007|FG000|NOT COMPLETED|Overall Study||22
8815723|NCT01538615|9869008|FG001|NOT COMPLETED|Overall Study||12
8815724|NCT01538628|9869016|FG000|STARTED|Overall Study||149
8815725|NCT01538628|9869017|FG001|STARTED|Overall Study||73
8815726|NCT01538628|9869016|FG000|COMPLETED|Overall Study||148
8815727|NCT01538628|9869017|FG001|COMPLETED|Overall Study||71
8815728|NCT01538628|9869016|FG000|NOT COMPLETED|Overall Study||1
8815729|NCT01538628|9869017|FG001|NOT COMPLETED|Overall Study||2
8815730|NCT01538719|9869026|FG000|STARTED|Overall Study||7
8815731|NCT01538719|9869027|FG001|STARTED|Overall Study||12
8815732|NCT01538719|9869026|FG000|COMPLETED|Overall Study||5
8815733|NCT01538719|9869027|FG001|COMPLETED|Overall Study||12
8815734|NCT01538719|9869026|FG000|NOT COMPLETED|Overall Study||2
8815735|NCT01538719|9869027|FG001|NOT COMPLETED|Overall Study||0
8815736|NCT01538745|9869035|FG000|STARTED|Overall Study||24
8815737|NCT01538745|9869036|FG001|STARTED|Overall Study||21
8815738|NCT01538745|9869035|FG000|COMPLETED|Overall Study||24
8815739|NCT01538745|9869036|FG001|COMPLETED|Overall Study||21
8815740|NCT01538745|9869035|FG000|NOT COMPLETED|Overall Study||0
8815741|NCT01538745|9869036|FG001|NOT COMPLETED|Overall Study||0
8526167|NCT00072410|9557737|FG001|STARTED|Overall Study||4
8526168|NCT00072410|9557736|FG000|COMPLETED|Overall Study||3
8526169|NCT00072410|9557737|FG001|COMPLETED|Overall Study||1
8526170|NCT00072410|9557736|FG000|NOT COMPLETED|Overall Study||0
8526171|NCT00072410|9557737|FG001|NOT COMPLETED|Overall Study||3
8562749|NCT00038948|9594874|FG000|STARTED|Overall Study||555
8562750|NCT00038948|9594875|FG001|STARTED|Overall Study||275
8562751|NCT00038948|9594874|FG000|COMPLETED|Overall Study||386
8562752|NCT00038948|9594875|FG001|COMPLETED|Overall Study||198
8815742|NCT01538862|9869042|FG000|STARTED|Overall Study||7
8815743|NCT01538862|9869042|FG000|COMPLETED|Overall Study||7
8562753|NCT00038948|9594874|FG000|NOT COMPLETED|Overall Study||169
8562754|NCT00038948|9594875|FG001|NOT COMPLETED|Overall Study||77
8815744|NCT01538862|9869042|FG000|NOT COMPLETED|Overall Study||0
8815745|NCT01539070|9869049|FG000|STARTED|Overall Study||168
8815746|NCT01539070|9869050|FG001|STARTED|Overall Study||138
8815747|NCT01539070|9869049|FG000|COMPLETED|Overall Study||109
8815748|NCT01539070|9869050|FG001|COMPLETED|Overall Study||99
8815749|NCT01539070|9869049|FG000|NOT COMPLETED|Overall Study||59
8526172|NCT05057923|9557743|FG000|STARTED|Overall Study||6
8526173|NCT05057923|9557743|FG000|COMPLETED|Overall Study||6
8526174|NCT05057923|9557743|FG000|NOT COMPLETED|Overall Study||0
8526175|NCT04632706|9557751|FG000|STARTED|Overall Study||6
8526176|NCT04632706|9557752|FG001|STARTED|Overall Study||6
8526177|NCT04632706|9557753|FG002|STARTED|Overall Study||6
8526178|NCT04632706|9557754|FG003|STARTED|Overall Study||6
8526179|NCT04632706|9557751|FG000|COMPLETED|Overall Study||6
8526180|NCT04632706|9557752|FG001|COMPLETED|Overall Study||6
8526181|NCT04632706|9557753|FG002|COMPLETED|Overall Study||5
8526182|NCT04632706|9557754|FG003|COMPLETED|Overall Study||6
8526183|NCT04632706|9557751|FG000|NOT COMPLETED|Overall Study||0
8526184|NCT04632706|9557752|FG001|NOT COMPLETED|Overall Study||0
8526185|NCT04632706|9557753|FG002|NOT COMPLETED|Overall Study||1
8526186|NCT04632706|9557754|FG003|NOT COMPLETED|Overall Study||0
8526187|NCT04544358|9557768|FG000|STARTED|Overall Study||12
8526188|NCT04544358|9557769|FG001|STARTED|Overall Study||10
8526189|NCT04544358|9557768|FG000|COMPLETED|Overall Study||12
8526190|NCT04544358|9557769|FG001|COMPLETED|Overall Study||10
8526191|NCT04544358|9557768|FG000|NOT COMPLETED|Overall Study||0
8526192|NCT04544358|9557769|FG001|NOT COMPLETED|Overall Study||0
8526193|NCT04498247|9557784|FG000|STARTED|Overall Study||21
8526194|NCT04498247|9557785|FG001|STARTED|Overall Study||80
8815750|NCT01539070|9869050|FG001|NOT COMPLETED|Overall Study||39
8815751|NCT01539083|9869056|FG000|STARTED|Before Randomization (VCD Induction)||256
8815752|NCT01539083|9869057|FG001|STARTED|Before Randomization (VCD Induction)||0
8815753|NCT01539083|9869058|FG002|STARTED|Before Randomization (VCD Induction)||0
8815754|NCT01539083|9869056|FG000|Treated|Before Randomization (VCD Induction)||254
8815755|NCT01539083|9869057|FG001|Treated|Before Randomization (VCD Induction)||0
8815756|NCT01539083|9869058|FG002|Treated|Before Randomization (VCD Induction)||0
8815757|NCT01539083|9869056|FG000|COMPLETED|Before Randomization (VCD Induction)||203
8815758|NCT01539083|9869057|FG001|COMPLETED|Before Randomization (VCD Induction)||0
8815759|NCT01539083|9869058|FG002|COMPLETED|Before Randomization (VCD Induction)||0
8815760|NCT01539083|9869056|FG000|NOT COMPLETED|Before Randomization (VCD Induction)||53
8815761|NCT01539083|9869057|FG001|NOT COMPLETED|Before Randomization (VCD Induction)||0
8815762|NCT01539083|9869058|FG002|NOT COMPLETED|Before Randomization (VCD Induction)||0
8815763|NCT01539083|9869056|FG000|STARTED|After Randomization (TP and VTP)||0
8815764|NCT01539083|9869057|FG001|STARTED|After Randomization (TP and VTP)|Participants who completed induction phase were randomized for the consolidated treatment.|100
8815765|NCT01539083|9869058|FG002|STARTED|After Randomization (TP and VTP)|Participants who completed induction phase were randomized for the consolidation treatment phase.|103
8815766|NCT01539083|9869056|FG000|Safety Population|After Randomization (TP and VTP)||0
8815767|NCT01539083|9869057|FG001|Safety Population|After Randomization (TP and VTP)|One participant was randomized but not treated. Hence, was not included in safety population.|99
8815768|NCT01539083|9869058|FG002|Safety Population|After Randomization (TP and VTP)||103
8815769|NCT01539083|9869056|FG000|COMPLETED|After Randomization (TP and VTP)||0
8815770|NCT01539083|9869057|FG001|COMPLETED|After Randomization (TP and VTP)||79
8815771|NCT01539083|9869058|FG002|COMPLETED|After Randomization (TP and VTP)||80
8815772|NCT01539083|9869056|FG000|NOT COMPLETED|After Randomization (TP and VTP)||0
8815773|NCT01539083|9869057|FG001|NOT COMPLETED|After Randomization (TP and VTP)||21
8815774|NCT01539083|9869058|FG002|NOT COMPLETED|After Randomization (TP and VTP)||23
8815775|NCT01539135|9869067|FG000|STARTED|Overall Study||43
8815776|NCT01539135|9869068|FG001|STARTED|Overall Study||37
8815777|NCT01539135|9869067|FG000|COMPLETED|Overall Study||43
8815778|NCT01539135|9869068|FG001|COMPLETED|Overall Study||37
8815779|NCT01539135|9869067|FG000|NOT COMPLETED|Overall Study||0
8815780|NCT01539135|9869068|FG001|NOT COMPLETED|Overall Study||0
8815781|NCT01539239|9869076|FG000|STARTED|Overall Study||369
8815782|NCT01539239|9869077|FG001|STARTED|Overall Study||187
8815783|NCT01539239|9869076|FG000|COMPLETED|Overall Study||357
8815784|NCT01539239|9869077|FG001|COMPLETED|Overall Study||170
8815785|NCT01539239|9869076|FG000|NOT COMPLETED|Overall Study||12
8815786|NCT01539239|9869077|FG001|NOT COMPLETED|Overall Study||17
8815787|NCT01539291|9869086|FG000|STARTED|Study GS-US-312-0116|Started = Randomized in Study GS-US-312-0116.|106
8815788|NCT01539291|9869087|FG001|STARTED|Study GS-US-312-0116|Started = Randomized in Study GS-US-312-0116.|4
8815789|NCT01539291|9869088|FG002|STARTED|Study GS-US-312-0116|Started = Randomized in Study GS-US-312-0116.|42
8815790|NCT01539291|9869089|FG003|STARTED|Study GS-US-312-0116|Started = Randomized in Study GS-US-312-0116.|44
8815791|NCT01539291|9869086|FG000|COMPLETED|Study GS-US-312-0116|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|81
8815792|NCT01539291|9869087|FG001|COMPLETED|Study GS-US-312-0116|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|4
8815793|NCT01539291|9869088|FG002|COMPLETED|Study GS-US-312-0116|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|42
8815794|NCT01539291|9869089|FG003|COMPLETED|Study GS-US-312-0116|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|44
8526195|NCT04498247|9557786|FG002|STARTED|Overall Study||4
8526196|NCT04498247|9557787|FG003|STARTED|Overall Study||81
8526197|NCT04498247|9557788|FG004|STARTED|Overall Study||4
8526198|NCT04498247|9557789|FG005|STARTED|Overall Study||20
8526199|NCT04498247|9557790|FG006|STARTED|Overall Study||51
8526200|NCT04498247|9557791|FG007|STARTED|Overall Study||2
8526201|NCT04498247|9557784|FG000|Vaccination 1|Overall Study||20
8526202|NCT04498247|9557785|FG001|Vaccination 1|Overall Study||80
8526203|NCT04498247|9557786|FG002|Vaccination 1|Overall Study||4
8526204|NCT04498247|9557787|FG003|Vaccination 1|Overall Study||81
8526205|NCT04498247|9557788|FG004|Vaccination 1|Overall Study||4
8526206|NCT04498247|9557789|FG005|Vaccination 1|Overall Study||20
8526207|NCT04498247|9557790|FG006|Vaccination 1|Overall Study||51
8526208|NCT04498247|9557791|FG007|Vaccination 1|Overall Study||2
8526209|NCT04498247|9557784|FG000|Vaccination 2|Overall Study||0
8526210|NCT04498247|9557785|FG001|Vaccination 2|Overall Study||0
8526211|NCT04498247|9557786|FG002|Vaccination 2|Overall Study||4
8526212|NCT04498247|9557787|FG003|Vaccination 2|Overall Study||0
8526213|NCT04498247|9557788|FG004|Vaccination 2|Overall Study||4
8526214|NCT04498247|9557789|FG005|Vaccination 2|Overall Study||0
8526215|NCT04498247|9557790|FG006|Vaccination 2|Overall Study||0
8526216|NCT04498247|9557791|FG007|Vaccination 2|Overall Study||2
8526217|NCT04498247|9557784|FG000|COMPLETED|Overall Study||20
8526218|NCT04498247|9557785|FG001|COMPLETED|Overall Study||68
8526219|NCT04498247|9557786|FG002|COMPLETED|Overall Study||4
8526220|NCT04498247|9557787|FG003|COMPLETED|Overall Study||70
8526221|NCT04498247|9557788|FG004|COMPLETED|Overall Study||4
8526222|NCT04498247|9557789|FG005|COMPLETED|Overall Study||20
8526223|NCT04498247|9557790|FG006|COMPLETED|Overall Study||43
8526224|NCT04498247|9557791|FG007|COMPLETED|Overall Study||2
8526225|NCT04498247|9557784|FG000|NOT COMPLETED|Overall Study||1
8526226|NCT04498247|9557785|FG001|NOT COMPLETED|Overall Study||12
8526227|NCT04498247|9557786|FG002|NOT COMPLETED|Overall Study||0
8526228|NCT04498247|9557787|FG003|NOT COMPLETED|Overall Study||11
8526229|NCT04498247|9557788|FG004|NOT COMPLETED|Overall Study||0
8526230|NCT04498247|9557789|FG005|NOT COMPLETED|Overall Study||0
8815795|NCT01539291|9869086|FG000|NOT COMPLETED|Study GS-US-312-0116||25
8815796|NCT01539291|9869087|FG001|NOT COMPLETED|Study GS-US-312-0116||0
8815797|NCT01539291|9869088|FG002|NOT COMPLETED|Study GS-US-312-0116||0
8815798|NCT01539291|9869089|FG003|NOT COMPLETED|Study GS-US-312-0116||0
8815799|NCT01539291|9869086|FG000|STARTED|Study GS-US-312-0117|Started = Completed GS-US-312-0116 and Enrolled in GS-US-312-0117.|71
8815800|NCT01539291|9869087|FG001|STARTED|Study GS-US-312-0117|Started = Completed GS-US-312-0116 and Enrolled in GS-US-312-0117.|4
8815801|NCT01539291|9869088|FG002|STARTED|Study GS-US-312-0117|Started = Completed GS-US-312-0116 and Enrolled in GS-US-312-0117.|42
8815802|NCT01539291|9869089|FG003|STARTED|Study GS-US-312-0117|Started = Completed GS-US-312-0116 and Enrolled in GS-US-312-0117.|44
8815803|NCT01539291|9869086|FG000|COMPLETED|Study GS-US-312-0117|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|30
8815804|NCT01539291|9869087|FG001|COMPLETED|Study GS-US-312-0117|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|2
8815805|NCT01539291|9869088|FG002|COMPLETED|Study GS-US-312-0117|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|20
8815806|NCT01539291|9869089|FG003|COMPLETED|Study GS-US-312-0117|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|18
8815807|NCT01539291|9869086|FG000|NOT COMPLETED|Study GS-US-312-0117||41
8815808|NCT01539291|9869087|FG001|NOT COMPLETED|Study GS-US-312-0117||2
8815809|NCT01539291|9869088|FG002|NOT COMPLETED|Study GS-US-312-0117||22
8815810|NCT01539291|9869089|FG003|NOT COMPLETED|Study GS-US-312-0117||26
8815811|NCT01539317|9869108|FG000|STARTED|Overall Study||25
8815812|NCT01539317|9869109|FG001|STARTED|Overall Study||25
8815813|NCT01539317|9869108|FG000|COMPLETED|Overall Study||24
8815814|NCT01539317|9869109|FG001|COMPLETED|Overall Study||25
8815815|NCT01539317|9869108|FG000|NOT COMPLETED|Overall Study||1
8815816|NCT01539317|9869109|FG001|NOT COMPLETED|Overall Study||0
8815817|NCT01539512|9869120|FG000|STARTED|Overall Study||110
8815818|NCT01539512|9869121|FG001|STARTED|Overall Study||110
8815819|NCT01539512|9869120|FG000|COMPLETED|Overall Study|Completed=reached primary efficacy endpoint (progressive disease or death) or finished study period.|87
8815820|NCT01539512|9869121|FG001|COMPLETED|Overall Study|Completed=reached primary efficacy endpoint (progressive disease or death) or finished study period.|97
8815821|NCT01539512|9869120|FG000|NOT COMPLETED|Overall Study||23
8815822|NCT01539512|9869121|FG001|NOT COMPLETED|Overall Study||13
8815823|NCT01539525|9869130|FG000|STARTED|Overall Study||145
8815824|NCT01539525|9869131|FG001|STARTED|Overall Study||143
8815825|NCT01539525|9869132|FG002|STARTED|Overall Study||151
8815826|NCT01539525|9869130|FG000|COMPLETED|Overall Study||125
8815827|NCT01539525|9869131|FG001|COMPLETED|Overall Study||127
8815828|NCT01539525|9869132|FG002|COMPLETED|Overall Study||134
8815829|NCT01539525|9869130|FG000|NOT COMPLETED|Overall Study||20
8815830|NCT01539525|9869131|FG001|NOT COMPLETED|Overall Study||16
8815831|NCT01539525|9869132|FG002|NOT COMPLETED|Overall Study||17
8815832|NCT01539538|9869145|FG000|STARTED|Overall Study||177
8815833|NCT01539538|9869146|FG001|STARTED|Overall Study||180
8815834|NCT01539538|9869145|FG000|COMPLETED|Overall Study||146
8815835|NCT01539538|9869146|FG001|COMPLETED|Overall Study||136
8815836|NCT01539538|9869145|FG000|NOT COMPLETED|Overall Study||31
8526231|NCT04498247|9557790|FG006|NOT COMPLETED|Overall Study||8
8526232|NCT04498247|9557791|FG007|NOT COMPLETED|Overall Study||0
8526233|NCT04472650|9557808|FG000|STARTED|Period 1 (Up to 15 Days)||13
8526234|NCT04472650|9557809|FG001|STARTED|Period 1 (Up to 15 Days)||13
8526235|NCT04472650|9557808|FG000|COMPLETED|Period 1 (Up to 15 Days)||13
8526236|NCT04472650|9557809|FG001|COMPLETED|Period 1 (Up to 15 Days)||13
8526237|NCT04472650|9557808|FG000|NOT COMPLETED|Period 1 (Up to 15 Days)||0
8526238|NCT04472650|9557809|FG001|NOT COMPLETED|Period 1 (Up to 15 Days)||0
8526239|NCT04472650|9557808|FG000|STARTED|Washout Period (Minimum 14 Days)||13
8526240|NCT04472650|9557809|FG001|STARTED|Washout Period (Minimum 14 Days)||13
8526241|NCT04472650|9557808|FG000|COMPLETED|Washout Period (Minimum 14 Days)||12
8526242|NCT04472650|9557809|FG001|COMPLETED|Washout Period (Minimum 14 Days)||13
8526243|NCT04472650|9557808|FG000|NOT COMPLETED|Washout Period (Minimum 14 Days)||1
8526244|NCT04472650|9557809|FG001|NOT COMPLETED|Washout Period (Minimum 14 Days)||0
8526245|NCT04472650|9557808|FG000|STARTED|Period 2 (Up to 15 Days)||12
8526246|NCT04472650|9557809|FG001|STARTED|Period 2 (Up to 15 Days)||13
8526247|NCT04472650|9557808|FG000|COMPLETED|Period 2 (Up to 15 Days)||12
8526248|NCT04472650|9557809|FG001|COMPLETED|Period 2 (Up to 15 Days)||13
8526249|NCT04472650|9557808|FG000|NOT COMPLETED|Period 2 (Up to 15 Days)||0
8526250|NCT04472650|9557809|FG001|NOT COMPLETED|Period 2 (Up to 15 Days)||0
8562755|NCT00039130|9594887|FG000|STARTED|Overall Study||105
8562756|NCT00039130|9594887|FG000|COMPLETED|Overall Study||75
8562757|NCT00039130|9594887|FG000|NOT COMPLETED|Overall Study||30
8562758|NCT00039195|9594891|FG000|STARTED|Overall Study||98
8562759|NCT00039195|9594891|FG000|COMPLETED|Overall Study||98
8562760|NCT00039195|9594891|FG000|NOT COMPLETED|Overall Study||0
8562761|NCT00039377|9594895|FG000|STARTED|Initial Registration||57
8562762|NCT00039377|9594896|FG001|STARTED|Initial Registration||0
8562763|NCT00039377|9594897|FG002|STARTED|Initial Registration||0
8815837|NCT01539538|9869146|FG001|NOT COMPLETED|Overall Study||44
8815838|NCT01539642|9869154|FG000|STARTED|Overall Study||114
8815839|NCT01539642|9869155|FG001|STARTED|Overall Study||58
8815840|NCT01539642|9869154|FG000|COMPLETED|Overall Study||78
8815841|NCT01539642|9869155|FG001|COMPLETED|Overall Study||27
8815842|NCT01539642|9869154|FG000|NOT COMPLETED|Overall Study||36
8815843|NCT01539642|9869155|FG001|NOT COMPLETED|Overall Study||31
8815844|NCT01539694|9869161|FG000|STARTED|Overall Study||63
8815845|NCT01539694|9869162|FG001|STARTED|Overall Study||63
8815846|NCT01539694|9869161|FG000|COMPLETED|Overall Study||62
8815847|NCT01539694|9869162|FG001|COMPLETED|Overall Study||62
8815848|NCT01539694|9869161|FG000|NOT COMPLETED|Overall Study||1
8815849|NCT01539694|9869162|FG001|NOT COMPLETED|Overall Study||1
8815850|NCT01539759|9869170|FG000|STARTED|Overall Study||56
8815851|NCT01539759|9869171|FG001|STARTED|Overall Study||56
8815852|NCT01539759|9869170|FG000|Had Successful IUD Placement|Overall Study||34
8815853|NCT01539759|9869171|FG001|Had Successful IUD Placement|Overall Study||53
8815854|NCT01539759|9869170|FG000|IUD Expulsion|Overall Study||1
8815855|NCT01539759|9869171|FG001|IUD Expulsion|Overall Study||4
8815856|NCT01539759|9869170|FG000|IUD Removal|Overall Study||2
8815857|NCT01539759|9869171|FG001|IUD Removal|Overall Study||7
8815858|NCT01539759|9869170|FG000|IUD in Place at 6 Months Posptartum|Overall Study||32
8815859|NCT01539759|9869171|FG001|IUD in Place at 6 Months Posptartum|Overall Study||40
8815860|NCT01539759|9869170|FG000|COMPLETED|Overall Study||50
8815861|NCT01539759|9869171|FG001|COMPLETED|Overall Study||48
8815862|NCT01539759|9869170|FG000|NOT COMPLETED|Overall Study||6
8815863|NCT01539759|9869171|FG001|NOT COMPLETED|Overall Study||8
8815864|NCT01539837|9869180|FG000|STARTED|Overall Study||8
8815865|NCT01539837|9869181|FG001|STARTED|Overall Study||7
8815866|NCT01539837|9869182|FG002|STARTED|Overall Study||7
8815867|NCT01539837|9869180|FG000|COMPLETED|Overall Study||8
8815868|NCT01539837|9869181|FG001|COMPLETED|Overall Study||6
8815869|NCT01539837|9869182|FG002|COMPLETED|Overall Study||5
8815870|NCT01539837|9869180|FG000|NOT COMPLETED|Overall Study||0
8815871|NCT01539837|9869181|FG001|NOT COMPLETED|Overall Study||1
8815872|NCT01539837|9869182|FG002|NOT COMPLETED|Overall Study||2
8815873|NCT01539980|9869190|FG000|STARTED|Overall Study||30
8815874|NCT01539980|9869190|FG000|COMPLETED|Overall Study||30
8815875|NCT01539980|9869190|FG000|NOT COMPLETED|Overall Study||0
8815876|NCT01540045|9869194|FG000|STARTED|Overall Study||40
8815877|NCT01540045|9869194|FG000|COMPLETED|Overall Study||40
8815878|NCT01540045|9869194|FG000|NOT COMPLETED|Overall Study||0
8815879|NCT01540071|9869219|FG000|STARTED|Overall Study||38
8815880|NCT01540071|9869219|FG000|COMPLETED|Overall Study||38
8815881|NCT01540071|9869219|FG000|NOT COMPLETED|Overall Study||0
8815882|NCT01540162|9869226|FG000|STARTED|Overall Study||30
8815883|NCT01540162|9869227|FG001|STARTED|Overall Study||32
8815884|NCT01540162|9869226|FG000|COMPLETED|Overall Study||30
8815885|NCT01540162|9869227|FG001|COMPLETED|Overall Study||32
8815886|NCT01540162|9869226|FG000|NOT COMPLETED|Overall Study||0
8815887|NCT01540162|9869227|FG001|NOT COMPLETED|Overall Study||0
8815888|NCT01540266|9869239|FG000|STARTED|Overall Study||63
8815889|NCT01540266|9869240|FG001|STARTED|Overall Study||42
8815890|NCT01540266|9869241|FG002|STARTED|Overall Study||60
8562764|NCT00039377|9594898|FG003|STARTED|Initial Registration||0
8562765|NCT00039377|9594895|FG000|COMPLETED|Initial Registration||35
8562766|NCT00039377|9594896|FG001|COMPLETED|Initial Registration||0
8562767|NCT00039377|9594897|FG002|COMPLETED|Initial Registration||0
8562768|NCT00039377|9594898|FG003|COMPLETED|Initial Registration||0
8562769|NCT00039377|9594895|FG000|NOT COMPLETED|Initial Registration||22
8815891|NCT01540266|9869242|FG003|STARTED|Overall Study||38
8815892|NCT01540266|9869243|FG004|STARTED|Overall Study||20
8815893|NCT01540266|9869244|FG005|STARTED|Overall Study||19
8815894|NCT01540266|9869239|FG000|COMPLETED|Overall Study||57
8815895|NCT01540266|9869240|FG001|COMPLETED|Overall Study||41
8815896|NCT01540266|9869241|FG002|COMPLETED|Overall Study||59
8815897|NCT01540266|9869242|FG003|COMPLETED|Overall Study||38
8815898|NCT01540266|9869243|FG004|COMPLETED|Overall Study||20
8815899|NCT01540266|9869244|FG005|COMPLETED|Overall Study||19
8815900|NCT01540266|9869239|FG000|NOT COMPLETED|Overall Study||6
8526251|NCT04359797|9557819|FG000|STARTED|Overall Study||243
8526252|NCT04359797|9557820|FG001|STARTED|Overall Study||258
8526253|NCT04359797|9557819|FG000|COMPLETED|Overall Study||243
8526254|NCT04359797|9557820|FG001|COMPLETED|Overall Study||258
8526255|NCT04359797|9557819|FG000|NOT COMPLETED|Overall Study||0
8526256|NCT04359797|9557820|FG001|NOT COMPLETED|Overall Study||0
8526257|NCT04151290|9557826|FG000|STARTED|Overall Study||711
8526258|NCT04151290|9557826|FG000|COMPLETED|Overall Study||425
8526259|NCT04151290|9557826|FG000|NOT COMPLETED|Overall Study||286
8526260|NCT04038385|9557832|FG000|STARTED|Overall Study||160
8526261|NCT04038385|9557833|FG001|STARTED|Overall Study||137
8526262|NCT04038385|9557832|FG000|COMPLETED|Overall Study||143
8526263|NCT04038385|9557833|FG001|COMPLETED|Overall Study||130
8526264|NCT04038385|9557832|FG000|NOT COMPLETED|Overall Study||17
8526265|NCT04038385|9557833|FG001|NOT COMPLETED|Overall Study||7
8526266|NCT03978091|9557845|FG000|STARTED|Overall Study||8
8526267|NCT03978091|9557846|FG001|STARTED|Overall Study||8
8526268|NCT03978091|9557847|FG002|STARTED|Overall Study||8
8526269|NCT03978091|9557848|FG003|STARTED|Overall Study||8
8526270|NCT03978091|9557849|FG004|STARTED|Overall Study||8
8526271|NCT03978091|9557850|FG005|STARTED|Overall Study||8
8526272|NCT03978091|9557845|FG000|COMPLETED|Overall Study||8
8526273|NCT03978091|9557846|FG001|COMPLETED|Overall Study||8
8526274|NCT03978091|9557847|FG002|COMPLETED|Overall Study||7
8526275|NCT03978091|9557848|FG003|COMPLETED|Overall Study||7
8815901|NCT01540266|9869240|FG001|NOT COMPLETED|Overall Study||1
8815902|NCT01540266|9869241|FG002|NOT COMPLETED|Overall Study||1
8815903|NCT01540266|9869242|FG003|NOT COMPLETED|Overall Study||0
8815904|NCT01540266|9869243|FG004|NOT COMPLETED|Overall Study||0
8815905|NCT01540266|9869244|FG005|NOT COMPLETED|Overall Study||0
8815906|NCT01540370|9869258|FG000|STARTED|Overall Study||102
8815907|NCT01540370|9869258|FG000|COMPLETED|Overall Study||100
8815908|NCT01540370|9869258|FG000|NOT COMPLETED|Overall Study||2
8815909|NCT01540409|9869264|FG000|STARTED|Overall Study||6
8815910|NCT01540409|9869265|FG001|STARTED|Overall Study||6
8815911|NCT01540409|9869264|FG000|COMPLETED|Overall Study||6
8815912|NCT01540409|9869265|FG001|COMPLETED|Overall Study||6
8815913|NCT01540409|9869264|FG000|NOT COMPLETED|Overall Study||0
8815914|NCT01540409|9869265|FG001|NOT COMPLETED|Overall Study||0
8815915|NCT01540474|9869278|FG000|STARTED|Vaccination Period||10
8815916|NCT01540474|9869279|FG001|STARTED|Vaccination Period||10
8815917|NCT01540474|9869280|FG002|STARTED|Vaccination Period||10
8815918|NCT01540474|9869281|FG003|STARTED|Vaccination Period||0
8815919|NCT01540474|9869278|FG000|COMPLETED|Vaccination Period||10
8815920|NCT01540474|9869279|FG001|COMPLETED|Vaccination Period||9
8815921|NCT01540474|9869280|FG002|COMPLETED|Vaccination Period||10
8815922|NCT01540474|9869281|FG003|COMPLETED|Vaccination Period||0
8815923|NCT01540474|9869278|FG000|NOT COMPLETED|Vaccination Period||0
8815924|NCT01540474|9869279|FG001|NOT COMPLETED|Vaccination Period||1
8815925|NCT01540474|9869280|FG002|NOT COMPLETED|Vaccination Period||0
8815926|NCT01540474|9869281|FG003|NOT COMPLETED|Vaccination Period||0
8815927|NCT01540474|9869278|FG000|STARTED|Malaria Challenge||10
8815928|NCT01540474|9869279|FG001|STARTED|Malaria Challenge||9
8815929|NCT01540474|9869280|FG002|STARTED|Malaria Challenge||10
8815930|NCT01540474|9869281|FG003|STARTED|Malaria Challenge||6
8815931|NCT01540474|9869278|FG000|COMPLETED|Malaria Challenge||10
8815932|NCT01540474|9869279|FG001|COMPLETED|Malaria Challenge||9
8815933|NCT01540474|9869280|FG002|COMPLETED|Malaria Challenge||10
8815934|NCT01540474|9869281|FG003|COMPLETED|Malaria Challenge||5
8815935|NCT01540474|9869278|FG000|NOT COMPLETED|Malaria Challenge||0
8815936|NCT01540474|9869279|FG001|NOT COMPLETED|Malaria Challenge||0
8815937|NCT01540474|9869280|FG002|NOT COMPLETED|Malaria Challenge||0
8815938|NCT01540474|9869281|FG003|NOT COMPLETED|Malaria Challenge||1
8815939|NCT01540487|9869294|FG000|STARTED|Overall Study||24
8815940|NCT01540487|9869295|FG001|STARTED|Overall Study||24
8815941|NCT01540487|9869294|FG000|COMPLETED|Overall Study||23
8815942|NCT01540487|9869295|FG001|COMPLETED|Overall Study||24
8815943|NCT01540487|9869294|FG000|NOT COMPLETED|Overall Study||1
8815944|NCT01540487|9869295|FG001|NOT COMPLETED|Overall Study||0
8815945|NCT01540513|9869305|FG000|STARTED|Overall Study||12
8815946|NCT01540513|9869305|FG000|COMPLETED|Overall Study||12
8815947|NCT01540513|9869305|FG000|NOT COMPLETED|Overall Study||0
8815948|NCT01540565|9869309|FG000|STARTED|Overall Study||52
8815949|NCT01540565|9869309|FG000|COMPLETED|Overall Study||50
8815950|NCT01540565|9869309|FG000|NOT COMPLETED|Overall Study||2
8815951|NCT01540773|9869313|FG000|STARTED|First Intervention||8
8815952|NCT01540773|9869314|FG001|STARTED|First Intervention||8
8815953|NCT01540773|9869313|FG000|COMPLETED|First Intervention||8
8815954|NCT01540773|9869314|FG001|COMPLETED|First Intervention||8
8526276|NCT03978091|9557849|FG004|COMPLETED|Overall Study||7
8526277|NCT03978091|9557850|FG005|COMPLETED|Overall Study||8
8526278|NCT03978091|9557845|FG000|NOT COMPLETED|Overall Study||0
8526279|NCT03978091|9557846|FG001|NOT COMPLETED|Overall Study||0
8526280|NCT03978091|9557847|FG002|NOT COMPLETED|Overall Study||1
8526281|NCT03978091|9557848|FG003|NOT COMPLETED|Overall Study||1
8526282|NCT03978091|9557849|FG004|NOT COMPLETED|Overall Study||1
8526283|NCT03978091|9557850|FG005|NOT COMPLETED|Overall Study||0
8815955|NCT01540773|9869313|FG000|NOT COMPLETED|First Intervention||0
8815956|NCT01540773|9869314|FG001|NOT COMPLETED|First Intervention||0
8562770|NCT00039377|9594896|FG001|NOT COMPLETED|Initial Registration||0
8562771|NCT00039377|9594897|FG002|NOT COMPLETED|Initial Registration||0
8815957|NCT01540773|9869313|FG000|STARTED|Wash Out Period of 1 Week||8
8815958|NCT01540773|9869314|FG001|STARTED|Wash Out Period of 1 Week||8
8815959|NCT01540773|9869313|FG000|COMPLETED|Wash Out Period of 1 Week||8
8815960|NCT01540773|9869314|FG001|COMPLETED|Wash Out Period of 1 Week||8
8815961|NCT01540773|9869313|FG000|NOT COMPLETED|Wash Out Period of 1 Week||0
8815962|NCT01540773|9869314|FG001|NOT COMPLETED|Wash Out Period of 1 Week||0
8815963|NCT01540773|9869313|FG000|STARTED|Second Intervention||8
8815964|NCT01540773|9869314|FG001|STARTED|Second Intervention||8
8815965|NCT01540773|9869313|FG000|COMPLETED|Second Intervention||8
8815966|NCT01540773|9869314|FG001|COMPLETED|Second Intervention||8
8815967|NCT01540773|9869313|FG000|NOT COMPLETED|Second Intervention||0
8815968|NCT01540773|9869314|FG001|NOT COMPLETED|Second Intervention||0
8815969|NCT01540825|9869333|FG000|STARTED|Overall Study||20
8815970|NCT01540825|9869334|FG001|STARTED|Overall Study||6
8815971|NCT01540825|9869335|FG002|STARTED|Overall Study||6
8815972|NCT01540825|9869336|FG003|STARTED|Overall Study||6
8815973|NCT01540825|9869337|FG004|STARTED|Overall Study||6
8815974|NCT01540825|9869338|FG005|STARTED|Overall Study||6
8815975|NCT01540825|9869339|FG006|STARTED|Overall Study||6
8815976|NCT01540825|9869340|FG007|STARTED|Overall Study||6
8815977|NCT01540825|9869341|FG008|STARTED|Overall Study||6
8815978|NCT01540825|9869342|FG009|STARTED|Overall Study||6
8815979|NCT01540825|9869343|FG010|STARTED|Overall Study||6
8815980|NCT01540825|9869333|FG000|COMPLETED|Overall Study||20
8815981|NCT01540825|9869334|FG001|COMPLETED|Overall Study||6
8815982|NCT01540825|9869335|FG002|COMPLETED|Overall Study||6
8815983|NCT01540825|9869336|FG003|COMPLETED|Overall Study||6
8815984|NCT01540825|9869337|FG004|COMPLETED|Overall Study||6
8815985|NCT01540825|9869338|FG005|COMPLETED|Overall Study||6
8815986|NCT01540825|9869339|FG006|COMPLETED|Overall Study||6
8815987|NCT01540825|9869340|FG007|COMPLETED|Overall Study||6
8815988|NCT01540825|9869341|FG008|COMPLETED|Overall Study||6
8815989|NCT01540825|9869342|FG009|COMPLETED|Overall Study||6
8815990|NCT01540825|9869343|FG010|COMPLETED|Overall Study||6
8815991|NCT01540825|9869333|FG000|NOT COMPLETED|Overall Study||0
8815992|NCT01540825|9869334|FG001|NOT COMPLETED|Overall Study||0
8815993|NCT01540825|9869335|FG002|NOT COMPLETED|Overall Study||0
8815994|NCT01540825|9869336|FG003|NOT COMPLETED|Overall Study||0
8815995|NCT01540825|9869337|FG004|NOT COMPLETED|Overall Study||0
8815996|NCT01540825|9869338|FG005|NOT COMPLETED|Overall Study||0
8815997|NCT01540825|9869339|FG006|NOT COMPLETED|Overall Study||0
8815998|NCT01540825|9869340|FG007|NOT COMPLETED|Overall Study||0
8815999|NCT01540825|9869341|FG008|NOT COMPLETED|Overall Study||0
8816000|NCT01540825|9869342|FG009|NOT COMPLETED|Overall Study||0
8816001|NCT01540825|9869343|FG010|NOT COMPLETED|Overall Study||0
8816002|NCT01540838|9869379|FG000|STARTED|Overall Study||188
8816003|NCT01540838|9869380|FG001|STARTED|Overall Study||187
8816004|NCT01540838|9869379|FG000|COMPLETED|Overall Study||166
8816005|NCT01540838|9869380|FG001|COMPLETED|Overall Study||164
8816006|NCT01540838|9869379|FG000|NOT COMPLETED|Overall Study||22
8816007|NCT01540838|9869380|FG001|NOT COMPLETED|Overall Study||23
8816008|NCT01540851|9869388|FG000|STARTED|Overall Study||154
8816009|NCT01540851|9869389|FG001|STARTED|Overall Study||154
8816010|NCT01540851|9869388|FG000|COMPLETED|Overall Study||133
8816011|NCT01540851|9869389|FG001|COMPLETED|Overall Study||136
8816012|NCT01540851|9869388|FG000|NOT COMPLETED|Overall Study||21
8816013|NCT01540851|9869389|FG001|NOT COMPLETED|Overall Study||18
8849207|NCT01738971|9904352|FG001|NOT COMPLETED|Overall Study||30
8849208|NCT01738971|9904353|FG002|NOT COMPLETED|Overall Study||17
8849209|NCT01738984|9904363|FG000|STARTED|Overall Study||250
8849210|NCT01738984|9904364|FG001|STARTED|Overall Study||249
8849211|NCT01738984|9904363|FG000|COMPLETED|Overall Study||186
8849212|NCT01738984|9904364|FG001|COMPLETED|Overall Study||210
8849213|NCT01738984|9904363|FG000|NOT COMPLETED|Overall Study||64
8849214|NCT01738984|9904364|FG001|NOT COMPLETED|Overall Study||39
8849215|NCT01739231|9904376|FG000|STARTED|Part A||24
8849216|NCT01739231|9904377|FG001|STARTED|Part A||24
8849217|NCT01739231|9904378|FG002|STARTED|Part A||12
8849218|NCT01739231|9904379|FG003|STARTED|Part A||0
8849219|NCT01739231|9904376|FG000|Received All 3 Vaccinations|Part A||21
8849220|NCT01739231|9904377|FG001|Received All 3 Vaccinations|Part A||20
8849221|NCT01739231|9904378|FG002|Received All 3 Vaccinations|Part A||12
8849222|NCT01739231|9904379|FG003|Received All 3 Vaccinations|Part A||0
8849223|NCT01739231|9904376|FG000|COMPLETED|Part A||20
8849224|NCT01739231|9904377|FG001|COMPLETED|Part A||17
8849225|NCT01739231|9904378|FG002|COMPLETED|Part A||12
8849226|NCT01739231|9904379|FG003|COMPLETED|Part A||0
8849227|NCT01739231|9904376|FG000|NOT COMPLETED|Part A||4
8849228|NCT01739231|9904377|FG001|NOT COMPLETED|Part A||7
8849229|NCT01739231|9904378|FG002|NOT COMPLETED|Part A||0
8849230|NCT01739231|9904379|FG003|NOT COMPLETED|Part A||0
8849231|NCT01739231|9904376|FG000|STARTED|Part B||20
8849232|NCT01739231|9904377|FG001|STARTED|Part B||17
8849233|NCT01739231|9904378|FG002|STARTED|Part B||12
8849234|NCT01739231|9904379|FG003|STARTED|Part B||21
8849235|NCT01739231|9904376|FG000|Challenged|Part B||13
8849236|NCT01739231|9904377|FG001|Challenged|Part B||13
8849237|NCT01739231|9904378|FG002|Challenged|Part B||10
8849238|NCT01739231|9904379|FG003|Challenged|Part B||21
8849239|NCT01739231|9904376|FG000|COMPLETED|Part B||13
8849240|NCT01739231|9904377|FG001|COMPLETED|Part B||12
8849241|NCT01739231|9904378|FG002|COMPLETED|Part B||10
8849242|NCT01739231|9904379|FG003|COMPLETED|Part B||19
8849243|NCT01739231|9904376|FG000|NOT COMPLETED|Part B||7
8849244|NCT01739231|9904377|FG001|NOT COMPLETED|Part B||5
8526284|NCT03923738|9557864|FG000|STARTED|Period 1||24
8526285|NCT03923738|9557864|FG000|COMPLETED|Period 1||22
8526286|NCT03923738|9557864|FG000|NOT COMPLETED|Period 1||2
8526287|NCT03923738|9557864|FG000|STARTED|Period 2||22
8526288|NCT03923738|9557864|FG000|COMPLETED|Period 2||22
8526289|NCT03923738|9557864|FG000|NOT COMPLETED|Period 2||0
8526290|NCT03887117|9557874|FG000|STARTED|Overall Study||25
8526291|NCT03887117|9557875|FG001|STARTED|Overall Study||15
8526292|NCT03887117|9557876|FG002|STARTED|Overall Study||26
8526293|NCT03887117|9557877|FG003|STARTED|Overall Study||27
8816014|NCT01540981|9869399|FG000|STARTED|Overall Study||6
8816015|NCT01540981|9869400|FG001|STARTED|Overall Study||6
8816016|NCT01540981|9869399|FG000|COMPLETED|Overall Study||5
8816017|NCT01540981|9869400|FG001|COMPLETED|Overall Study||6
8816018|NCT01540981|9869399|FG000|NOT COMPLETED|Overall Study||1
8816019|NCT01540981|9869400|FG001|NOT COMPLETED|Overall Study||0
8816020|NCT01541215|9869408|FG000|STARTED|Treatment Period (52 Weeks)||66
8816021|NCT01541215|9869409|FG001|STARTED|Treatment Period (52 Weeks)||69
8816022|NCT01541215|9869408|FG000|Exposed|Treatment Period (52 Weeks)||66
8816023|NCT01541215|9869409|FG001|Exposed|Treatment Period (52 Weeks)||68
8816024|NCT01541215|9869408|FG000|COMPLETED|Treatment Period (52 Weeks)||56
8816025|NCT01541215|9869409|FG001|COMPLETED|Treatment Period (52 Weeks)||53
8816026|NCT01541215|9869408|FG000|NOT COMPLETED|Treatment Period (52 Weeks)||10
8816027|NCT01541215|9869409|FG001|NOT COMPLETED|Treatment Period (52 Weeks)||16
8816028|NCT01541215|9869408|FG000|STARTED|Follow up 1 (Weeks 53-104)|Subjects who attended safety follow up visit at week 104 were included.|52
8816029|NCT01541215|9869409|FG001|STARTED|Follow up 1 (Weeks 53-104)|Follow up was not planned for the subjects who received placebo.|0
8816030|NCT01541215|9869408|FG000|COMPLETED|Follow up 1 (Weeks 53-104)||50
8816031|NCT01541215|9869409|FG001|COMPLETED|Follow up 1 (Weeks 53-104)||0
8816032|NCT01541215|9869408|FG000|NOT COMPLETED|Follow up 1 (Weeks 53-104)||2
8816033|NCT01541215|9869409|FG001|NOT COMPLETED|Follow up 1 (Weeks 53-104)||0
8816034|NCT01541215|9869408|FG000|STARTED|Follow up 2 (Weeks 105-156)|Subjects who attended safety follow up visit at week 156 were included.|48
8816035|NCT01541215|9869409|FG001|STARTED|Follow up 2 (Weeks 105-156)||0
8816036|NCT01541215|9869408|FG000|COMPLETED|Follow up 2 (Weeks 105-156)||48
8816037|NCT01541215|9869409|FG001|COMPLETED|Follow up 2 (Weeks 105-156)||0
8816038|NCT01541215|9869408|FG000|NOT COMPLETED|Follow up 2 (Weeks 105-156)||0
8816039|NCT01541215|9869409|FG001|NOT COMPLETED|Follow up 2 (Weeks 105-156)||0
8816040|NCT01541254|9869419|FG000|STARTED|Overall Study||36
8816041|NCT01541254|9869419|FG000|COMPLETED|Overall Study||30
8816042|NCT01541254|9869419|FG000|NOT COMPLETED|Overall Study||6
8816043|NCT01541358|9869423|FG000|STARTED|Overall Study||2
8816044|NCT01541358|9869423|FG000|COMPLETED|Overall Study||2
8816045|NCT01541358|9869423|FG000|NOT COMPLETED|Overall Study||0
8816046|NCT01541371|9869428|FG000|STARTED|Overall Study||403
8816047|NCT01541371|9869428|FG000|Full Analysis Set|Overall Study||394
8816048|NCT01541371|9869428|FG000|COMPLETED|Overall Study||326
8816049|NCT01541371|9869428|FG000|NOT COMPLETED|Overall Study||77
8816050|NCT01541384|9869439|FG000|STARTED|Overall Study||40
8816051|NCT01541384|9869440|FG001|STARTED|Overall Study||40
8816052|NCT01541384|9869441|FG002|STARTED|Overall Study||40
8816053|NCT01541384|9869439|FG000|COMPLETED|Overall Study||40
8816054|NCT01541384|9869440|FG001|COMPLETED|Overall Study||39
8816055|NCT01541384|9869441|FG002|COMPLETED|Overall Study||38
8816056|NCT01541384|9869439|FG000|NOT COMPLETED|Overall Study||0
8816057|NCT01541384|9869440|FG001|NOT COMPLETED|Overall Study||1
8816058|NCT01541384|9869441|FG002|NOT COMPLETED|Overall Study||2
8816059|NCT01541553|9869451|FG000|STARTED|Overall Study||167
8816060|NCT01541553|9869452|FG001|STARTED|Overall Study||162
8816061|NCT01541553|9869451|FG000|COMPLETED|Overall Study||155
8816062|NCT01541553|9869452|FG001|COMPLETED|Overall Study||148
8816063|NCT01541553|9869451|FG000|NOT COMPLETED|Overall Study||12
8816064|NCT01541553|9869452|FG001|NOT COMPLETED|Overall Study||14
8816065|NCT01541644|9869458|FG000|STARTED|Overall Study||27
8816066|NCT01541644|9869458|FG000|COMPLETED|Overall Study||24
8816067|NCT01541644|9869458|FG000|NOT COMPLETED|Overall Study||3
8816068|NCT01541735|9869464|FG000|STARTED|Overall Study||7
8816069|NCT01541735|9869465|FG001|STARTED|Overall Study||7
8816070|NCT01541735|9869464|FG000|COMPLETED|Overall Study||7
8816071|NCT01541735|9869465|FG001|COMPLETED|Overall Study||7
8816072|NCT01541735|9869464|FG000|NOT COMPLETED|Overall Study||0
8816073|NCT01541735|9869465|FG001|NOT COMPLETED|Overall Study||0
8816074|NCT01541748|9869471|FG000|STARTED|Overall Study|74 subjects were consented; however, 5 were screen failures and 1 did not receive the study device.|74
8526294|NCT03887117|9557874|FG000|COMPLETED|Overall Study||25
8526295|NCT03887117|9557875|FG001|COMPLETED|Overall Study||14
8526296|NCT03887117|9557876|FG002|COMPLETED|Overall Study||25
8526297|NCT03887117|9557877|FG003|COMPLETED|Overall Study||25
8526298|NCT03887117|9557874|FG000|NOT COMPLETED|Overall Study||0
8816075|NCT01541748|9869471|FG000|COMPLETED|Overall Study||43
8816076|NCT01541748|9869471|FG000|NOT COMPLETED|Overall Study||31
8816077|NCT01541826|9869487|FG000|STARTED|Overall Study||28
8816078|NCT01541826|9869488|FG001|STARTED|Overall Study||28
8816079|NCT01541826|9869489|FG002|STARTED|Overall Study||6
8816080|NCT01541826|9869487|FG000|COMPLETED|Overall Study||24
8816081|NCT01541826|9869488|FG001|COMPLETED|Overall Study||25
8816082|NCT01541826|9869489|FG002|COMPLETED|Overall Study||6
8816083|NCT01541826|9869487|FG000|NOT COMPLETED|Overall Study||4
8816084|NCT01541826|9869488|FG001|NOT COMPLETED|Overall Study||3
8816085|NCT01541826|9869489|FG002|NOT COMPLETED|Overall Study||0
8816086|NCT01541865|9869497|FG000|STARTED|Overall Study||146
8526299|NCT03887117|9557875|FG001|NOT COMPLETED|Overall Study||1
8526300|NCT03887117|9557876|FG002|NOT COMPLETED|Overall Study||1
8526301|NCT03887117|9557877|FG003|NOT COMPLETED|Overall Study||2
8526302|NCT03858634|9557898|FG000|STARTED|Overall Study||39
8526303|NCT03858634|9557899|FG001|STARTED|Overall Study||19
8526304|NCT03858634|9557898|FG000|Participants With Chronic Idiopathic Urticaria (CIU)|Overall Study||4
8526305|NCT03858634|9557899|FG001|Participants With Chronic Idiopathic Urticaria (CIU)|Overall Study||2
8526306|NCT03858634|9557898|FG000|Participants With Chronic Idiopathic Pruritus (CIP)|Overall Study||14
8526307|NCT03858634|9557899|FG001|Participants With Chronic Idiopathic Pruritus (CIP)|Overall Study||9
8816087|NCT01541865|9869497|FG000|COMPLETED|Overall Study||124
8816088|NCT01541865|9869497|FG000|NOT COMPLETED|Overall Study||22
8816089|NCT01541891|9869503|FG000|STARTED|Overall Study||15
8816090|NCT01541891|9869504|FG001|STARTED|Overall Study||15
8816091|NCT01541891|9869503|FG000|COMPLETED|Overall Study||14
8816092|NCT01541891|9869504|FG001|COMPLETED|Overall Study||14
8816093|NCT01541891|9869503|FG000|NOT COMPLETED|Overall Study||1
8816094|NCT01541891|9869504|FG001|NOT COMPLETED|Overall Study||1
8816095|NCT01541917|9869515|FG000|STARTED|Overall Study||144
8816096|NCT01541917|9869516|FG001|STARTED|Overall Study||145
8816097|NCT01541917|9869515|FG000|COMPLETED|Overall Study||129
8816098|NCT01541917|9869516|FG001|COMPLETED|Overall Study||136
8816099|NCT01541917|9869515|FG000|NOT COMPLETED|Overall Study||15
8816100|NCT01541917|9869516|FG001|NOT COMPLETED|Overall Study||9
8816101|NCT01541930|9869525|FG000|STARTED|Overall Study||21
8816102|NCT01541930|9869525|FG000|COMPLETED|Overall Study||20
8816103|NCT01541930|9869525|FG000|NOT COMPLETED|Overall Study||1
8816104|NCT01541969|9869542|FG000|STARTED|Double-blind (0-12 Weeks)||50
8816105|NCT01541969|9869543|FG001|STARTED|Double-blind (0-12 Weeks)||50
8816106|NCT01541969|9869542|FG000|COMPLETED|Double-blind (0-12 Weeks)||44
8816107|NCT01541969|9869543|FG001|COMPLETED|Double-blind (0-12 Weeks)||48
8816108|NCT01541969|9869542|FG000|NOT COMPLETED|Double-blind (0-12 Weeks)||6
8816109|NCT01541969|9869543|FG001|NOT COMPLETED|Double-blind (0-12 Weeks)||2
8816110|NCT01541969|9869542|FG000|STARTED|Open Label Extension (12-36 Weeks)||44
8816111|NCT01541969|9869543|FG001|STARTED|Open Label Extension (12-36 Weeks)||48
8816112|NCT01541969|9869542|FG000|COMPLETED|Open Label Extension (12-36 Weeks)||33
8816113|NCT01541969|9869543|FG001|COMPLETED|Open Label Extension (12-36 Weeks)||35
8816114|NCT01541969|9869542|FG000|NOT COMPLETED|Open Label Extension (12-36 Weeks)||11
8816115|NCT01541969|9869543|FG001|NOT COMPLETED|Open Label Extension (12-36 Weeks)||13
8816116|NCT01542034|9869554|FG000|STARTED|Overall Study||256
8816117|NCT01542034|9869555|FG001|STARTED|Overall Study||250
8816118|NCT01542034|9869554|FG000|Received Treatment|Overall Study||256
8816119|NCT01542034|9869555|FG001|Received Treatment|Overall Study||249
8816120|NCT01542034|9869554|FG000|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|226
8816121|NCT01542034|9869555|FG001|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|227
8816122|NCT01542034|9869554|FG000|NOT COMPLETED|Overall Study||30
8816123|NCT01542034|9869555|FG001|NOT COMPLETED|Overall Study||23
8816124|NCT01542125|9869563|FG000|STARTED|Overall Study||140
8816125|NCT01542125|9869564|FG001|STARTED|Overall Study||141
8816126|NCT01542125|9869563|FG000|COMPLETED|Overall Study||140
8816127|NCT01542125|9869564|FG001|COMPLETED|Overall Study||141
8816128|NCT01542125|9869563|FG000|NOT COMPLETED|Overall Study||0
8816129|NCT01542125|9869564|FG001|NOT COMPLETED|Overall Study||0
8816130|NCT01542229|9869572|FG000|STARTED|Overall Study||68
8816131|NCT01542229|9869573|FG001|STARTED|Overall Study||66
8816132|NCT01542229|9869572|FG000|COMPLETED|Overall Study||45
8816133|NCT01542229|9869573|FG001|COMPLETED|Overall Study||30
8816134|NCT01542229|9869572|FG000|NOT COMPLETED|Overall Study||23
8816135|NCT01542229|9869573|FG001|NOT COMPLETED|Overall Study||36
8816136|NCT01542255|9869580|FG000|STARTED|Overall Study||7
8816137|NCT01542255|9869580|FG000|Analyzed for Time to Progression|Overall Study||7
8816138|NCT01542255|9869580|FG000|COMPLETED|Overall Study||7
8816139|NCT01542255|9869580|FG000|NOT COMPLETED|Overall Study||0
8816140|NCT01542307|9869585|FG000|STARTED|Overall Study|Each subject inhaled Oxygen for 30 minutes in blinded fashion for 2 of the 4 migraine attacks|22
8816141|NCT01542307|9869586|FG001|STARTED|Overall Study|Each subject inhaled Medical Air for 30 minutes in blinded fashion for 2 of the 4 migraine attacks|22
8816142|NCT01542307|9869585|FG000|COMPLETED|Overall Study||22
8816143|NCT01542307|9869586|FG001|COMPLETED|Overall Study||22
8816144|NCT01542307|9869585|FG000|NOT COMPLETED|Overall Study||0
8816145|NCT01542307|9869586|FG001|NOT COMPLETED|Overall Study||0
8816146|NCT01542372|9869592|FG000|STARTED|Overall Study||11
8816147|NCT01542372|9869593|FG001|STARTED|Overall Study||11
8816148|NCT01542372|9869592|FG000|COMPLETED|Overall Study||11
8816149|NCT01542372|9869593|FG001|COMPLETED|Overall Study||11
8816150|NCT01542372|9869592|FG000|NOT COMPLETED|Overall Study||0
8816151|NCT01542372|9869593|FG001|NOT COMPLETED|Overall Study||0
8816152|NCT01542398|9869600|FG000|STARTED|Overall Study||79
8526308|NCT03858634|9557898|FG000|Participants With Lichen Planus (LP)|Overall Study||3
8526309|NCT03858634|9557899|FG001|Participants With Lichen Planus (LP)|Overall Study||0
8816153|NCT01542398|9869601|FG001|STARTED|Overall Study||80
8816154|NCT01542398|9869600|FG000|Post-Intervention Assessment|Overall Study||78
8816155|NCT01542398|9869601|FG001|Post-Intervention Assessment|Overall Study||80
8816156|NCT01542398|9869600|FG000|COMPLETED|Overall Study||71
8816157|NCT01542398|9869601|FG001|COMPLETED|Overall Study||67
8816158|NCT01542398|9869600|FG000|NOT COMPLETED|Overall Study||8
8526310|NCT03858634|9557898|FG000|Participants With Lichen Simplex Chronicus (LSC)|Overall Study||4
8526311|NCT03858634|9557899|FG001|Participants With Lichen Simplex Chronicus (LSC)|Overall Study||1
8526312|NCT03858634|9557898|FG000|Participants With Plaque Psoriasis (PPs)|Overall Study||14
8526313|NCT03858634|9557899|FG001|Participants With Plaque Psoriasis (PPs)|Overall Study||7
8526314|NCT03858634|9557898|FG000|COMPLETED|Overall Study||36
8526315|NCT03858634|9557899|FG001|COMPLETED|Overall Study||17
8526316|NCT03858634|9557898|FG000|NOT COMPLETED|Overall Study||3
8526317|NCT03858634|9557899|FG001|NOT COMPLETED|Overall Study||2
8816159|NCT01542398|9869601|FG001|NOT COMPLETED|Overall Study||13
8816160|NCT01542502|9869609|FG000|STARTED|Overall Study||6
8816161|NCT01542502|9869610|FG001|STARTED|Overall Study||6
8816162|NCT01542502|9869609|FG000|COMPLETED|Overall Study||6
8816163|NCT01542502|9869610|FG001|COMPLETED|Overall Study||6
8816164|NCT01542502|9869609|FG000|NOT COMPLETED|Overall Study||0
8816165|NCT01542502|9869610|FG001|NOT COMPLETED|Overall Study||0
8816166|NCT01542528|9869619|FG000|STARTED|Overall Study||61
8816167|NCT01542528|9869620|FG001|STARTED|Overall Study||56
8816168|NCT01542528|9869619|FG000|COMPLETED|Overall Study||49
8816169|NCT01542528|9869620|FG001|COMPLETED|Overall Study||49
8816170|NCT01542528|9869619|FG000|NOT COMPLETED|Overall Study||12
8816171|NCT01542528|9869620|FG001|NOT COMPLETED|Overall Study||7
8816172|NCT01542541|9869628|FG000|STARTED|Overall Study||38
8816173|NCT01542541|9869629|FG001|STARTED|Overall Study||30
8816174|NCT01542541|9869628|FG000|COMPLETED|Overall Study||30
8816175|NCT01542541|9869629|FG001|COMPLETED|Overall Study||30
8816176|NCT01542541|9869628|FG000|NOT COMPLETED|Overall Study||8
8816177|NCT01542541|9869629|FG001|NOT COMPLETED|Overall Study||0
8816178|NCT01542632|9869641|FG000|STARTED|Overall Study||25
8816179|NCT01542632|9869642|FG001|STARTED|Overall Study||25
8816180|NCT01542632|9869643|FG002|STARTED|Overall Study||24
8816181|NCT01542632|9869644|FG003|STARTED|Overall Study||21
8816182|NCT01542632|9869645|FG004|STARTED|Overall Study||21
8816183|NCT01542632|9869646|FG005|STARTED|Overall Study||24
8816184|NCT01542632|9869641|FG000|COMPLETED|Overall Study||25
8816185|NCT01542632|9869642|FG001|COMPLETED|Overall Study||24
8816186|NCT01542632|9869643|FG002|COMPLETED|Overall Study||23
8816187|NCT01542632|9869644|FG003|COMPLETED|Overall Study||19
8816188|NCT01542632|9869645|FG004|COMPLETED|Overall Study||17
8816189|NCT01542632|9869646|FG005|COMPLETED|Overall Study||24
8816190|NCT01542632|9869641|FG000|NOT COMPLETED|Overall Study||0
8816191|NCT01542632|9869642|FG001|NOT COMPLETED|Overall Study||1
8816192|NCT01542632|9869643|FG002|NOT COMPLETED|Overall Study||1
8816193|NCT01542632|9869644|FG003|NOT COMPLETED|Overall Study||2
8816194|NCT01542632|9869645|FG004|NOT COMPLETED|Overall Study||4
8816195|NCT01542632|9869646|FG005|NOT COMPLETED|Overall Study||0
8816196|NCT01542645|9869667|FG000|STARTED|Overall Study||82
8816197|NCT01542645|9869668|FG001|STARTED|Overall Study||82
8816198|NCT01542645|9869667|FG000|COMPLETED|Overall Study||77
8816199|NCT01542645|9869668|FG001|COMPLETED|Overall Study||79
8816200|NCT01542645|9869667|FG000|NOT COMPLETED|Overall Study||5
8816201|NCT01542645|9869668|FG001|NOT COMPLETED|Overall Study||3
8816202|NCT01542684|9869678|FG000|STARTED|Overall Study||8
8816203|NCT01542684|9869678|FG000|COMPLETED|Overall Study||8
8816204|NCT01542684|9869678|FG000|NOT COMPLETED|Overall Study||0
8816205|NCT01542788|9869684|FG000|STARTED|Overall Study||209
8816206|NCT01542788|9869685|FG001|STARTED|Overall Study||71
8816207|NCT01542788|9869684|FG000|Randomized and Treated|Overall Study||207
8816208|NCT01542788|9869685|FG001|Randomized and Treated|Overall Study||71
8816209|NCT01542788|9869684|FG000|COMPLETED|Overall Study||154
8816210|NCT01542788|9869685|FG001|COMPLETED|Overall Study||0
8816211|NCT01542788|9869684|FG000|NOT COMPLETED|Overall Study||55
8816212|NCT01542788|9869685|FG001|NOT COMPLETED|Overall Study||71
8816213|NCT01542957|9869693|FG000|STARTED|End of Therapy||65
8816214|NCT01542957|9869694|FG001|STARTED|End of Therapy||63
8816215|NCT01542957|9869693|FG000|COMPLETED|End of Therapy||53
8816216|NCT01542957|9869694|FG001|COMPLETED|End of Therapy||53
8816217|NCT01542957|9869693|FG000|NOT COMPLETED|End of Therapy||12
8816218|NCT01542957|9869694|FG001|NOT COMPLETED|End of Therapy||10
8816219|NCT01542957|9869693|FG000|STARTED|3-month Follow-up||53
8816220|NCT01542957|9869694|FG001|STARTED|3-month Follow-up||53
8816221|NCT01542957|9869693|FG000|COMPLETED|3-month Follow-up||50
8816222|NCT01542957|9869694|FG001|COMPLETED|3-month Follow-up||45
8816223|NCT01542957|9869693|FG000|NOT COMPLETED|3-month Follow-up||3
8816224|NCT01542957|9869694|FG001|NOT COMPLETED|3-month Follow-up||8
8816225|NCT01542957|9869693|FG000|STARTED|12-month Follow-up||53
8816226|NCT01542957|9869694|FG001|STARTED|12-month Follow-up||53
8816227|NCT01542957|9869693|FG000|COMPLETED|12-month Follow-up||37
8816228|NCT01542957|9869694|FG001|COMPLETED|12-month Follow-up||40
8816229|NCT01542957|9869693|FG000|NOT COMPLETED|12-month Follow-up||16
8816230|NCT01542957|9869694|FG001|NOT COMPLETED|12-month Follow-up||13
8816231|NCT01543074|9869704|FG000|STARTED|Overall Study||5
8816232|NCT01543074|9869705|FG001|STARTED|Overall Study||7
8816233|NCT01543074|9869706|FG002|STARTED|Overall Study||5
8816234|NCT01543074|9869707|FG003|STARTED|Overall Study||6
8816235|NCT01543074|9869704|FG000|COMPLETED|Overall Study||5
8526318|NCT03819114|9557917|FG000|STARTED|Overall Study||17
8816236|NCT01543074|9869705|FG001|COMPLETED|Overall Study||7
8816237|NCT01543074|9869706|FG002|COMPLETED|Overall Study||5
8816238|NCT01543074|9869707|FG003|COMPLETED|Overall Study||6
8816239|NCT01543074|9869704|FG000|NOT COMPLETED|Overall Study||0
8816240|NCT01543074|9869705|FG001|NOT COMPLETED|Overall Study||0
8526319|NCT03819114|9557918|FG001|STARTED|Overall Study||36
8526320|NCT03819114|9557919|FG002|STARTED|Overall Study||35
8526321|NCT03819114|9557920|FG003|STARTED|Overall Study||34
8526322|NCT03819114|9557917|FG000|Received LNG Treatment|Overall Study||17
8526323|NCT03819114|9557918|FG001|Received LNG Treatment|Overall Study||36
8526324|NCT03819114|9557919|FG002|Received LNG Treatment|Overall Study||35
8816241|NCT01543074|9869706|FG002|NOT COMPLETED|Overall Study||0
8816242|NCT01543074|9869707|FG003|NOT COMPLETED|Overall Study||0
8816243|NCT01543087|9869727|FG000|STARTED|Stage 1 (48 Months)||70
8816244|NCT01543087|9869728|FG001|STARTED|Stage 1 (48 Months)||103
8816245|NCT01543087|9869729|FG002|STARTED|Stage 1 (48 Months)||277
8816246|NCT01543087|9869730|FG003|STARTED|Stage 1 (48 Months)||116
8816247|NCT01543087|9869731|FG004|STARTED|Stage 1 (48 Months)||86
8816248|NCT01543087|9869732|FG005|STARTED|Stage 1 (48 Months)||46
8816249|NCT01543087|9869727|FG000|Safety Population|Stage 1 (48 Months)||70
8816250|NCT01543087|9869728|FG001|Safety Population|Stage 1 (48 Months)||101
8816251|NCT01543087|9869729|FG002|Safety Population|Stage 1 (48 Months)||277
8816252|NCT01543087|9869730|FG003|Safety Population|Stage 1 (48 Months)||116
8816253|NCT01543087|9869731|FG004|Safety Population|Stage 1 (48 Months)||86
8816254|NCT01543087|9869732|FG005|Safety Population|Stage 1 (48 Months)||46
8816255|NCT01543087|9869727|FG000|COMPLETED|Stage 1 (48 Months)||56
8816256|NCT01543087|9869728|FG001|COMPLETED|Stage 1 (48 Months)||93
8816257|NCT01543087|9869729|FG002|COMPLETED|Stage 1 (48 Months)||237
8816258|NCT01543087|9869730|FG003|COMPLETED|Stage 1 (48 Months)||108
8816259|NCT01543087|9869731|FG004|COMPLETED|Stage 1 (48 Months)||83
8816260|NCT01543087|9869732|FG005|COMPLETED|Stage 1 (48 Months)||46
8816261|NCT01543087|9869727|FG000|NOT COMPLETED|Stage 1 (48 Months)||14
8816262|NCT01543087|9869728|FG001|NOT COMPLETED|Stage 1 (48 Months)||10
8816263|NCT01543087|9869729|FG002|NOT COMPLETED|Stage 1 (48 Months)||40
8816264|NCT01543087|9869730|FG003|NOT COMPLETED|Stage 1 (48 Months)||8
8816265|NCT01543087|9869731|FG004|NOT COMPLETED|Stage 1 (48 Months)||3
8816266|NCT01543087|9869732|FG005|NOT COMPLETED|Stage 1 (48 Months)||0
8816267|NCT01543087|9869727|FG000|STARTED|Booster Stage (26 Months)|Group1 participants (primary study B1971015)were not invited to participate in Booster stage (BS).|0
8816268|NCT01543087|9869728|FG001|STARTED|Booster Stage (26 Months)|BS was optional for eligible participants. Not all participants completing stage 1 continued to BS.|60
8816269|NCT01543087|9869729|FG002|STARTED|Booster Stage (26 Months)|BS was optional for eligible participants. Not all participants completing stage 1 continued to BS.|92
8816270|NCT01543087|9869730|FG003|STARTED|Booster Stage (26 Months)|BS was optional for eligible participants. Not all participants completing stage 1 continued to BS.|64
8816271|NCT01543087|9869731|FG004|STARTED|Booster Stage (26 Months)|BS was optional for eligible participants. Not all participants completing stage 1 continued to BS.|56
8816272|NCT01543087|9869732|FG005|STARTED|Booster Stage (26 Months)|BS was optional for eligible participants. Not all participants completing stage 1 continued to BS.|32
8816273|NCT01543087|9869727|FG000|Vaccinated|Booster Stage (26 Months)||0
8816274|NCT01543087|9869728|FG001|Vaccinated|Booster Stage (26 Months)||59
8816275|NCT01543087|9869729|FG002|Vaccinated|Booster Stage (26 Months)||92
8816276|NCT01543087|9869730|FG003|Vaccinated|Booster Stage (26 Months)||64
8816277|NCT01543087|9869731|FG004|Vaccinated|Booster Stage (26 Months)||54
8816278|NCT01543087|9869732|FG005|Vaccinated|Booster Stage (26 Months)||32
8816279|NCT01543087|9869727|FG000|COMPLETED|Booster Stage (26 Months)||0
8816280|NCT01543087|9869728|FG001|COMPLETED|Booster Stage (26 Months)||59
8816281|NCT01543087|9869729|FG002|COMPLETED|Booster Stage (26 Months)||91
8816282|NCT01543087|9869730|FG003|COMPLETED|Booster Stage (26 Months)||64
8816283|NCT01543087|9869731|FG004|COMPLETED|Booster Stage (26 Months)||54
8816284|NCT01543087|9869732|FG005|COMPLETED|Booster Stage (26 Months)||32
8816285|NCT01543087|9869727|FG000|NOT COMPLETED|Booster Stage (26 Months)||0
8816286|NCT01543087|9869728|FG001|NOT COMPLETED|Booster Stage (26 Months)||1
8816287|NCT01543087|9869729|FG002|NOT COMPLETED|Booster Stage (26 Months)||1
8816288|NCT01543087|9869730|FG003|NOT COMPLETED|Booster Stage (26 Months)||0
8816289|NCT01543087|9869731|FG004|NOT COMPLETED|Booster Stage (26 Months)||2
8816290|NCT01543087|9869732|FG005|NOT COMPLETED|Booster Stage (26 Months)||0
8816291|NCT01543152|9869773|FG000|STARTED|Overall Study||3
8816292|NCT01543152|9869774|FG001|STARTED|Overall Study||6
8816293|NCT01543152|9869775|FG002|STARTED|Overall Study||11
8816294|NCT01543152|9869776|FG003|STARTED|Overall Study||3
8816295|NCT01543152|9869777|FG004|STARTED|Overall Study||3
8816296|NCT01543152|9869773|FG000|COMPLETED|Overall Study||3
8816297|NCT01543152|9869774|FG001|COMPLETED|Overall Study||4
8816298|NCT01543152|9869775|FG002|COMPLETED|Overall Study||11
8816299|NCT01543152|9869776|FG003|COMPLETED|Overall Study||3
8816300|NCT01543152|9869777|FG004|COMPLETED|Overall Study||3
8816301|NCT01543152|9869773|FG000|NOT COMPLETED|Overall Study||0
8816302|NCT01543152|9869774|FG001|NOT COMPLETED|Overall Study||2
8816303|NCT01543152|9869775|FG002|NOT COMPLETED|Overall Study||0
8816304|NCT01543152|9869776|FG003|NOT COMPLETED|Overall Study||0
8816305|NCT01543152|9869777|FG004|NOT COMPLETED|Overall Study||0
8816306|NCT01543178|9869792|FG000|STARTED|Open-label Period|2583 subjects entered the open-label period, but 4 received no rifaximin; 2579 received rifaximin.|2583
8526325|NCT03819114|9557920|FG003|Received LNG Treatment|Overall Study||34
8526326|NCT03819114|9557917|FG000|COMPLETED|Overall Study||17
8816307|NCT01543178|9869793|FG001|STARTED|Open-label Period|The double-blind rifaximin arm/group is not applicable to the open-label period.|0
8816308|NCT01543178|9869794|FG002|STARTED|Open-label Period|The double-blind placebo arm/group is not applicable to the open-label period.|0
8526327|NCT03819114|9557918|FG001|COMPLETED|Overall Study||35
8526328|NCT03819114|9557919|FG002|COMPLETED|Overall Study||33
8526329|NCT03819114|9557920|FG003|COMPLETED|Overall Study||34
8526330|NCT03819114|9557917|FG000|NOT COMPLETED|Overall Study||0
8526331|NCT03819114|9557918|FG001|NOT COMPLETED|Overall Study||1
8526332|NCT03819114|9557919|FG002|NOT COMPLETED|Overall Study||2
8526333|NCT03819114|9557920|FG003|NOT COMPLETED|Overall Study||0
8526334|NCT03804268|9557934|FG000|STARTED|Overall Study||160
8526335|NCT03804268|9557935|FG001|STARTED|Overall Study||163
8526336|NCT03804268|9557934|FG000|COMPLETED|Overall Study||153
8526337|NCT03804268|9557935|FG001|COMPLETED|Overall Study||161
8526338|NCT03804268|9557934|FG000|NOT COMPLETED|Overall Study||7
8526339|NCT03804268|9557935|FG001|NOT COMPLETED|Overall Study||2
8562772|NCT00039377|9594898|FG003|NOT COMPLETED|Initial Registration||0
8562773|NCT00039377|9594895|FG000|STARTED|Course 5 (Transplant Assignments)|After Course I-IV, participants were grouped into autologous, allogeneic or no transplant arms.|0
8562774|NCT00039377|9594896|FG001|STARTED|Course 5 (Transplant Assignments)||15
8562775|NCT00039377|9594897|FG002|STARTED|Course 5 (Transplant Assignments)||19
8562776|NCT00039377|9594898|FG003|STARTED|Course 5 (Transplant Assignments)||1
8562777|NCT00039377|9594895|FG000|COMPLETED|Course 5 (Transplant Assignments)||0
8562778|NCT00039377|9594896|FG001|COMPLETED|Course 5 (Transplant Assignments)||15
8562779|NCT00039377|9594897|FG002|COMPLETED|Course 5 (Transplant Assignments)||19
8562780|NCT00039377|9594898|FG003|COMPLETED|Course 5 (Transplant Assignments)||1
8562781|NCT00039377|9594895|FG000|NOT COMPLETED|Course 5 (Transplant Assignments)||0
8562782|NCT00039377|9594896|FG001|NOT COMPLETED|Course 5 (Transplant Assignments)||0
8562783|NCT00039377|9594897|FG002|NOT COMPLETED|Course 5 (Transplant Assignments)||0
8562784|NCT00039377|9594898|FG003|NOT COMPLETED|Course 5 (Transplant Assignments)||0
8562785|NCT00039741|9594910|FG000|STARTED|Overall Study||66
8562786|NCT00039741|9594911|FG001|STARTED|Overall Study||68
8562787|NCT00039741|9594912|FG002|STARTED|Overall Study||65
8562788|NCT00039741|9594913|FG003|STARTED|Overall Study||64
8562789|NCT00039741|9594910|FG000|Death|Overall Study||0
8562790|NCT00039741|9594911|FG001|Death|Overall Study||1
8562791|NCT00039741|9594912|FG002|Death|Overall Study||0
8562792|NCT00039741|9594913|FG003|Death|Overall Study||0
8562793|NCT00039741|9594910|FG000|COMPLETED|Overall Study||51
8562794|NCT00039741|9594911|FG001|COMPLETED|Overall Study||56
8562795|NCT00039741|9594912|FG002|COMPLETED|Overall Study||54
8562796|NCT00039741|9594913|FG003|COMPLETED|Overall Study||50
8562797|NCT00039741|9594910|FG000|NOT COMPLETED|Overall Study||15
8562798|NCT00039741|9594911|FG001|NOT COMPLETED|Overall Study||12
8562799|NCT00039741|9594912|FG002|NOT COMPLETED|Overall Study||11
8562800|NCT00039741|9594913|FG003|NOT COMPLETED|Overall Study||14
8562801|NCT00039871|9594923|FG000|STARTED|Overall Study|Enrolled 2333; 21 subjects excluded due to GCP non-compliance|2312
8562802|NCT00039871|9594923|FG000|COMPLETED|Overall Study||928
8562803|NCT00039871|9594923|FG000|NOT COMPLETED|Overall Study||1384
8562804|NCT00040365|9594927|FG000|STARTED|Overall Study||30
8562805|NCT00040365|9594927|FG000|Completed Follow Up Phase|Overall Study||19
8562806|NCT00040365|9594927|FG000|COMPLETED|Overall Study||19
8562807|NCT00040365|9594927|FG000|NOT COMPLETED|Overall Study||11
8562808|NCT00040443|9594933|FG000|STARTED|Overall Study||84
8562809|NCT00040443|9594934|FG001|STARTED|Overall Study||91
8562810|NCT00040443|9594933|FG000|COMPLETED|Overall Study||84
8562811|NCT00040443|9594934|FG001|COMPLETED|Overall Study||91
8562812|NCT00040443|9594933|FG000|NOT COMPLETED|Overall Study||0
8562813|NCT00040443|9594934|FG001|NOT COMPLETED|Overall Study||0
8562814|NCT00040664|9594940|FG000|STARTED|Overall Study|All (69) enrolled on QD; 10 switched to twice daily. Participant flow not collected for this group.|69
8562815|NCT00040664|9594941|FG001|STARTED|Overall Study||17
8562816|NCT00040664|9594942|FG002|STARTED|Overall Study||17
8562817|NCT00040664|9594943|FG003|STARTED|Overall Study||35
8562818|NCT00040664|9594940|FG000|COMPLETED|Overall Study||16
8562819|NCT00040664|9594941|FG001|COMPLETED|Overall Study||4
8562820|NCT00040664|9594942|FG002|COMPLETED|Overall Study||4
8562821|NCT00040664|9594943|FG003|COMPLETED|Overall Study||8
8562822|NCT00040664|9594940|FG000|NOT COMPLETED|Overall Study||53
8562823|NCT00040664|9594941|FG001|NOT COMPLETED|Overall Study||13
8562824|NCT00040664|9594942|FG002|NOT COMPLETED|Overall Study||13
8562825|NCT00040664|9594943|FG003|NOT COMPLETED|Overall Study||27
8562826|NCT00040742|9594965|FG000|STARTED|Overall Study||188
8562827|NCT00040742|9594966|FG001|STARTED|Overall Study||183
8562828|NCT00040742|9594967|FG002|STARTED|Overall Study||187
8562829|NCT00040742|9594968|FG003|STARTED|Overall Study|One subject found to be ineligible after randomization. No baseline data collected.|186
8562830|NCT00040742|9594965|FG000|COMPLETED|Overall Study||149
8562831|NCT00040742|9594966|FG001|COMPLETED|Overall Study||134
8562832|NCT00040742|9594967|FG002|COMPLETED|Overall Study||141
8562833|NCT00040742|9594968|FG003|COMPLETED|Overall Study||152
8562834|NCT00040742|9594965|FG000|NOT COMPLETED|Overall Study||39
8562835|NCT00040742|9594966|FG001|NOT COMPLETED|Overall Study||49
8562836|NCT00040742|9594967|FG002|NOT COMPLETED|Overall Study||46
8562837|NCT00040742|9594968|FG003|NOT COMPLETED|Overall Study||34
8562838|NCT00040846|9594984|FG000|STARTED|Overall Study||60
8562839|NCT00040846|9594985|FG001|STARTED|Overall Study||0
8562840|NCT00040846|9594986|FG002|STARTED|Overall Study||0
8562841|NCT00040846|9594987|FG003|STARTED|Overall Study||0
8562842|NCT00040846|9594988|FG004|STARTED|Overall Study||0
8562843|NCT00040846|9594989|FG005|STARTED|Overall Study||0
8562844|NCT00040846|9594984|FG000|COMPLETED|Overall Study||60
8562845|NCT00040846|9594985|FG001|COMPLETED|Overall Study||0
8562846|NCT00040846|9594986|FG002|COMPLETED|Overall Study||0
8526340|NCT04435808|9557944|FG000|STARTED|Overall Study||0
8526341|NCT04435808|9557945|FG001|STARTED|Overall Study||1
8526342|NCT04435808|9557944|FG000|COMPLETED|Overall Study||0
8526343|NCT04435808|9557945|FG001|COMPLETED|Overall Study|Study stopped prior to any data collection for this lone participant|0
8526344|NCT04435808|9557944|FG000|NOT COMPLETED|Overall Study||0
8526345|NCT04435808|9557945|FG001|NOT COMPLETED|Overall Study||1
8526346|NCT04409262|9557953|FG000|STARTED|Overall Study||215
8526347|NCT04409262|9557954|FG001|STARTED|Overall Study||434
8526348|NCT04409262|9557953|FG000|COMPLETED|Overall Study||140
8526349|NCT04409262|9557954|FG001|COMPLETED|Overall Study||300
8526350|NCT04409262|9557953|FG000|NOT COMPLETED|Overall Study||75
8526351|NCT04409262|9557954|FG001|NOT COMPLETED|Overall Study||134
8526352|NCT04305912|9557963|FG000|STARTED|First Intervention||26
8526353|NCT04305912|9557964|FG001|STARTED|First Intervention||25
8526354|NCT04305912|9557963|FG000|COMPLETED|First Intervention||24
8526355|NCT04305912|9557964|FG001|COMPLETED|First Intervention||24
8526356|NCT04305912|9557963|FG000|NOT COMPLETED|First Intervention||2
8526357|NCT04305912|9557964|FG001|NOT COMPLETED|First Intervention||1
8526358|NCT04305912|9557963|FG000|STARTED|Second Intervention||24
8526359|NCT04305912|9557964|FG001|STARTED|Second Intervention||24
8526360|NCT04305912|9557963|FG000|COMPLETED|Second Intervention||24
8620406|NCT00474240|9659064|FG001|NOT COMPLETED|Overall Study||1
8620407|NCT00474240|9659065|FG002|NOT COMPLETED|Overall Study||9
8620408|NCT00474240|9659066|FG003|NOT COMPLETED|Overall Study||16
8620409|NCT00474240|9659067|FG004|NOT COMPLETED|Overall Study||8
8620410|NCT00474240|9659068|FG005|NOT COMPLETED|Overall Study||18
8620411|NCT00474253|9659084|FG000|STARTED|Overall Study|Includes 2 participants randomized to succinylcholine group who received rocuronium + sugammadex.|58
8620412|NCT00474253|9659085|FG001|STARTED|Overall Study|Includes 1 participant randomized to rocuronium + sugammadex group who received succinylcholine.|57
8620413|NCT00474253|9659084|FG000|Treated|Overall Study|Based on actual treatment received.|56
8620414|NCT00474253|9659085|FG001|Treated|Overall Study|Based on actual treatment received.|54
8526361|NCT04305912|9557964|FG001|COMPLETED|Second Intervention||23
8526362|NCT04305912|9557963|FG000|NOT COMPLETED|Second Intervention||0
8526363|NCT04305912|9557964|FG001|NOT COMPLETED|Second Intervention||1
8526444|NCT03410693|9558064|FG001|Started Treatment|Overall Study||82
8526445|NCT03410693|9558063|FG000|Active Follow-up Performed|Overall Study||61
8526446|NCT03410693|9558064|FG001|Active Follow-up Performed|Overall Study||56
8526447|NCT03410693|9558063|FG000|Entered Long Term Follow-up|Overall Study||56
8526448|NCT03410693|9558064|FG001|Entered Long Term Follow-up|Overall Study||69
8526449|NCT03410693|9558063|FG000|COMPLETED|Overall Study|Completed treatment|0
8526450|NCT03410693|9558064|FG001|COMPLETED|Overall Study|Completed treatment|0
8526451|NCT03410693|9558063|FG000|NOT COMPLETED|Overall Study||87
8526452|NCT03410693|9558064|FG001|NOT COMPLETED|Overall Study||88
8526453|NCT03359356|9558078|FG000|STARTED|Overall Study||20
8526454|NCT03359356|9558079|FG001|STARTED|Overall Study||40
8526455|NCT03359356|9558078|FG000|COMPLETED|Overall Study||20
8526456|NCT03359356|9558079|FG001|COMPLETED|Overall Study||40
8526457|NCT03359356|9558078|FG000|NOT COMPLETED|Overall Study||0
8526458|NCT03359356|9558079|FG001|NOT COMPLETED|Overall Study||0
8526459|NCT03252925|9558091|FG000|STARTED|Overall Study||80
8526460|NCT03252925|9558092|FG001|STARTED|Overall Study||80
8526461|NCT03252925|9558091|FG000|COMPLETED|Overall Study||66
8526462|NCT03252925|9558092|FG001|COMPLETED|Overall Study||74
8526463|NCT03252925|9558091|FG000|NOT COMPLETED|Overall Study||14
8526464|NCT03252925|9558092|FG001|NOT COMPLETED|Overall Study||6
8526465|NCT03185832|9558102|FG000|STARTED|Overall Study||69
8526466|NCT03185832|9558103|FG001|STARTED|Overall Study||102
8526467|NCT03185832|9558104|FG002|STARTED|Overall Study||68
8526468|NCT03185832|9558105|FG003|STARTED|Overall Study||115
8526469|NCT03185832|9558102|FG000|COMPLETED|Overall Study||60
8526470|NCT03185832|9558103|FG001|COMPLETED|Overall Study||87
8526471|NCT03185832|9558104|FG002|COMPLETED|Overall Study||58
8526472|NCT03185832|9558105|FG003|COMPLETED|Overall Study||104
8526473|NCT03185832|9558102|FG000|NOT COMPLETED|Overall Study||9
8526474|NCT03185832|9558103|FG001|NOT COMPLETED|Overall Study||15
8526475|NCT03185832|9558104|FG002|NOT COMPLETED|Overall Study||10
8526476|NCT03185832|9558105|FG003|NOT COMPLETED|Overall Study||11
8526477|NCT02963714|9558115|FG000|STARTED|Overall Study||176
8526478|NCT02963714|9558116|FG001|STARTED|Overall Study||176
8526479|NCT02963714|9558115|FG000|COMPLETED|Overall Study||126
8526480|NCT02963714|9558116|FG001|COMPLETED|Overall Study||126
8526481|NCT02963714|9558115|FG000|NOT COMPLETED|Overall Study||50
8526482|NCT02963714|9558116|FG001|NOT COMPLETED|Overall Study||50
8526483|NCT02959918|9558136|FG000|STARTED|Overall Study||3
8526484|NCT02959918|9558137|FG001|STARTED|Overall Study||3
8526485|NCT02959918|9558138|FG002|STARTED|Overall Study||9
8526486|NCT02959918|9558139|FG003|STARTED|Overall Study||10
8526487|NCT02959918|9558140|FG004|STARTED|Overall Study||6
8526488|NCT02959918|9558141|FG005|STARTED|Overall Study||11
8526489|NCT02959918|9558142|FG006|STARTED|Overall Study||11
8526490|NCT02959918|9558143|FG007|STARTED|Overall Study||12
8526491|NCT02959918|9558144|FG008|STARTED|Overall Study||14
8526492|NCT02959918|9558145|FG009|STARTED|Overall Study||13
8526493|NCT02959918|9558146|FG010|STARTED|Overall Study||14
8526494|NCT02959918|9558147|FG011|STARTED|Overall Study||23
8526495|NCT02959918|9558148|FG012|STARTED|Overall Study||11
8526496|NCT02959918|9558149|FG013|STARTED|Overall Study||12
8526497|NCT02959918|9558136|FG000|COMPLETED|Overall Study||0
8526498|NCT02959918|9558137|FG001|COMPLETED|Overall Study||0
8526364|NCT04030416|9557970|FG000|STARTED|Overall Study||120
8526365|NCT04030416|9557970|FG000|COMPLETED|Overall Study||119
8526366|NCT04030416|9557970|FG000|NOT COMPLETED|Overall Study||1
8526367|NCT04028648|9557974|FG000|STARTED|Overall Study||150
8526368|NCT04028648|9557974|FG000|COMPLETED|Overall Study||150
8526369|NCT04028648|9557974|FG000|NOT COMPLETED|Overall Study||0
8526370|NCT03987919|9557983|FG000|STARTED|Overall Study||471
8526371|NCT03987919|9557984|FG001|STARTED|Overall Study||469
8526372|NCT03987919|9557985|FG002|STARTED|Overall Study||470
8526373|NCT03987919|9557986|FG003|STARTED|Overall Study||469
8526374|NCT03987919|9557983|FG000|Received at Least One Dose of Study Drug|Overall Study||470
8526375|NCT03987919|9557984|FG001|Received at Least One Dose of Study Drug|Overall Study||469
8526376|NCT03987919|9557985|FG002|Received at Least One Dose of Study Drug|Overall Study||470
8526377|NCT03987919|9557986|FG003|Received at Least One Dose of Study Drug|Overall Study||469
8526378|NCT03987919|9557983|FG000|COMPLETED|Overall Study||452
8526379|NCT03987919|9557984|FG001|COMPLETED|Overall Study||442
8526380|NCT03987919|9557985|FG002|COMPLETED|Overall Study||446
8526381|NCT03987919|9557986|FG003|COMPLETED|Overall Study||443
8526382|NCT03987919|9557983|FG000|NOT COMPLETED|Overall Study||19
8526383|NCT03987919|9557984|FG001|NOT COMPLETED|Overall Study||27
8526384|NCT03987919|9557985|FG002|NOT COMPLETED|Overall Study||24
8526385|NCT03987919|9557986|FG003|NOT COMPLETED|Overall Study||26
8526386|NCT03980145|9558003|FG000|STARTED|Overall Study||7
8526387|NCT03980145|9558004|FG001|STARTED|Overall Study||8
8526388|NCT03980145|9558003|FG000|COMPLETED|Overall Study||7
8526389|NCT03980145|9558004|FG001|COMPLETED|Overall Study||8
8526390|NCT03980145|9558003|FG000|NOT COMPLETED|Overall Study||0
8526391|NCT03980145|9558004|FG001|NOT COMPLETED|Overall Study||0
8526392|NCT03861039|9558015|FG000|STARTED|Overall Study||148
8526393|NCT03861039|9558016|FG001|STARTED|Overall Study||147
8526394|NCT03861039|9558017|FG002|STARTED|Overall Study||148
8526395|NCT03861039|9558015|FG000|Received at Least One Dose of Study Drug|Overall Study||148
8526396|NCT03861039|9558016|FG001|Received at Least One Dose of Study Drug|Overall Study||147
8526397|NCT03861039|9558017|FG002|Received at Least One Dose of Study Drug|Overall Study||148
8526398|NCT03861039|9558015|FG000|COMPLETED|Overall Study||145
8526399|NCT03861039|9558016|FG001|COMPLETED|Overall Study||139
8526400|NCT03861039|9558017|FG002|COMPLETED|Overall Study||133
8526401|NCT03861039|9558015|FG000|NOT COMPLETED|Overall Study||3
8526402|NCT03861039|9558016|FG001|NOT COMPLETED|Overall Study||8
8526403|NCT03861039|9558017|FG002|NOT COMPLETED|Overall Study||15
8526404|NCT03759587|9558027|FG000|STARTED|Overall Study||19
8526405|NCT03759587|9558027|FG000|COMPLETED|Overall Study||0
8526406|NCT03759587|9558027|FG000|NOT COMPLETED|Overall Study||19
8526407|NCT03730662|9558035|FG000|STARTED|Treatment Period (52 Weeks)||329
8526408|NCT03730662|9558036|FG001|STARTED|Treatment Period (52 Weeks)||330
8526409|NCT03730662|9558037|FG002|STARTED|Treatment Period (52 Weeks)||338
8526410|NCT03730662|9558038|FG003|STARTED|Treatment Period (52 Weeks)||1005
8526411|NCT03730662|9558035|FG000|Received at Least One Dose of Study Drug|Treatment Period (52 Weeks)||329
8526412|NCT03730662|9558036|FG001|Received at Least One Dose of Study Drug|Treatment Period (52 Weeks)||328
8526413|NCT03730662|9558037|FG002|Received at Least One Dose of Study Drug|Treatment Period (52 Weeks)||338
8526414|NCT03730662|9558038|FG003|Received at Least One Dose of Study Drug|Treatment Period (52 Weeks)||1000
8526415|NCT03730662|9558035|FG000|COMPLETED|Treatment Period (52 Weeks)||308
8526416|NCT03730662|9558036|FG001|COMPLETED|Treatment Period (52 Weeks)||319
8526417|NCT03730662|9558037|FG002|COMPLETED|Treatment Period (52 Weeks)||329
8526418|NCT03730662|9558038|FG003|COMPLETED|Treatment Period (52 Weeks)||953
8526419|NCT03730662|9558035|FG000|NOT COMPLETED|Treatment Period (52 Weeks)||21
8526420|NCT03730662|9558036|FG001|NOT COMPLETED|Treatment Period (52 Weeks)||11
8526421|NCT03730662|9558037|FG002|NOT COMPLETED|Treatment Period (52 Weeks)||9
8526422|NCT03730662|9558038|FG003|NOT COMPLETED|Treatment Period (52 Weeks)||52
8526423|NCT03730662|9558035|FG000|STARTED|Variable Treatment Period||308
8526424|NCT03730662|9558036|FG001|STARTED|Variable Treatment Period||319
8526425|NCT03730662|9558037|FG002|STARTED|Variable Treatment Period||329
8526426|NCT03730662|9558038|FG003|STARTED|Variable Treatment Period||953
8526427|NCT03730662|9558035|FG000|COMPLETED|Variable Treatment Period||294
8526428|NCT03730662|9558036|FG001|COMPLETED|Variable Treatment Period||312
8526429|NCT03730662|9558037|FG002|COMPLETED|Variable Treatment Period||313
8526430|NCT03730662|9558038|FG003|COMPLETED|Variable Treatment Period||882
8526431|NCT03730662|9558035|FG000|NOT COMPLETED|Variable Treatment Period||14
8526432|NCT03730662|9558036|FG001|NOT COMPLETED|Variable Treatment Period||7
8526433|NCT03730662|9558037|FG002|NOT COMPLETED|Variable Treatment Period||16
8526434|NCT03730662|9558038|FG003|NOT COMPLETED|Variable Treatment Period||71
8816309|NCT01543178|9869792|FG000|COMPLETED|Open-label Period||636
8816310|NCT01543178|9869793|FG001|COMPLETED|Open-label Period||0
8816311|NCT01543178|9869794|FG002|COMPLETED|Open-label Period||0
8816312|NCT01543178|9869792|FG000|NOT COMPLETED|Open-label Period||1947
8526435|NCT03538444|9558054|FG000|STARTED|Overall Study||4
8816313|NCT01543178|9869793|FG001|NOT COMPLETED|Open-label Period||0
8526436|NCT03538444|9558055|FG001|STARTED|Overall Study||3
8526437|NCT03538444|9558054|FG000|COMPLETED|Overall Study||3
8526438|NCT03538444|9558055|FG001|COMPLETED|Overall Study||3
8526439|NCT03538444|9558054|FG000|NOT COMPLETED|Overall Study||1
8526440|NCT03538444|9558055|FG001|NOT COMPLETED|Overall Study||0
8526441|NCT03410693|9558063|FG000|STARTED|Overall Study||87
8526442|NCT03410693|9558064|FG001|STARTED|Overall Study||88
8526443|NCT03410693|9558063|FG000|Started Treatment|Overall Study||86
8620415|NCT00474253|9659084|FG000|COMPLETED|Overall Study|Based on actual treatment received.|55
8620416|NCT00474253|9659085|FG001|COMPLETED|Overall Study|Based on actual treatment received.|53
8620417|NCT00474253|9659084|FG000|NOT COMPLETED|Overall Study||3
8526499|NCT02959918|9558138|FG002|COMPLETED|Overall Study||1
8526500|NCT02959918|9558139|FG003|COMPLETED|Overall Study||1
8526501|NCT02959918|9558140|FG004|COMPLETED|Overall Study||1
8526502|NCT02959918|9558141|FG005|COMPLETED|Overall Study||5
8526503|NCT02959918|9558142|FG006|COMPLETED|Overall Study||6
8526504|NCT02959918|9558143|FG007|COMPLETED|Overall Study||6
8526505|NCT02959918|9558144|FG008|COMPLETED|Overall Study||7
8526506|NCT02959918|9558145|FG009|COMPLETED|Overall Study||7
8526507|NCT02959918|9558146|FG010|COMPLETED|Overall Study||8
8526508|NCT02959918|9558147|FG011|COMPLETED|Overall Study||11
8526509|NCT02959918|9558148|FG012|COMPLETED|Overall Study||4
8526510|NCT02959918|9558149|FG013|COMPLETED|Overall Study||6
8526511|NCT02959918|9558136|FG000|NOT COMPLETED|Overall Study||3
8526512|NCT02959918|9558137|FG001|NOT COMPLETED|Overall Study||3
8526513|NCT02959918|9558138|FG002|NOT COMPLETED|Overall Study||8
8526514|NCT02959918|9558139|FG003|NOT COMPLETED|Overall Study||9
8526515|NCT02959918|9558140|FG004|NOT COMPLETED|Overall Study||5
8526516|NCT02959918|9558141|FG005|NOT COMPLETED|Overall Study||6
8526517|NCT02959918|9558142|FG006|NOT COMPLETED|Overall Study||5
8526518|NCT02959918|9558143|FG007|NOT COMPLETED|Overall Study||6
8526519|NCT02959918|9558144|FG008|NOT COMPLETED|Overall Study||7
8620418|NCT00474253|9659085|FG001|NOT COMPLETED|Overall Study||4
8620419|NCT00474266|9659095|FG000|STARTED|Overall Study||375
8620420|NCT00474266|9659096|FG001|STARTED|Overall Study||374
8620421|NCT00474266|9659097|FG002|STARTED|Overall Study||126
8620422|NCT00474266|9659098|FG003|STARTED|Overall Study||125
8620423|NCT00474266|9659095|FG000|COMPLETED|Overall Study||368
8620424|NCT00474266|9659096|FG001|COMPLETED|Overall Study||354
8620425|NCT00474266|9659097|FG002|COMPLETED|Overall Study||122
8620426|NCT00474266|9659098|FG003|COMPLETED|Overall Study||118
8620427|NCT00474266|9659095|FG000|NOT COMPLETED|Overall Study||7
8620428|NCT00474266|9659096|FG001|NOT COMPLETED|Overall Study||20
8620429|NCT00474266|9659097|FG002|NOT COMPLETED|Overall Study||4
8620430|NCT00474266|9659098|FG003|NOT COMPLETED|Overall Study||7
8620431|NCT00474383|9659111|FG000|STARTED|Main Study||47
8620432|NCT00474383|9659112|FG001|STARTED|Main Study||0
8620433|NCT00474383|9659111|FG000|COMPLETED|Main Study||11
8620434|NCT00474383|9659112|FG001|COMPLETED|Main Study||0
8620435|NCT00474383|9659111|FG000|NOT COMPLETED|Main Study||36
8620436|NCT00474383|9659112|FG001|NOT COMPLETED|Main Study||0
8620437|NCT00474383|9659111|FG000|STARTED|Between Main Study and Extension||11
8620438|NCT00474383|9659112|FG001|STARTED|Between Main Study and Extension||0
8620439|NCT00474383|9659111|FG000|COMPLETED|Between Main Study and Extension||5
8620440|NCT00474383|9659112|FG001|COMPLETED|Between Main Study and Extension||0
8620441|NCT00474383|9659111|FG000|NOT COMPLETED|Between Main Study and Extension||6
8620442|NCT00474383|9659112|FG001|NOT COMPLETED|Between Main Study and Extension||0
8620443|NCT00474383|9659111|FG000|STARTED|Extension||0
8620444|NCT00474383|9659112|FG001|STARTED|Extension||5
8620445|NCT00474383|9659111|FG000|COMPLETED|Extension||0
8620446|NCT00474383|9659112|FG001|COMPLETED|Extension||0
8816314|NCT01543178|9869794|FG002|NOT COMPLETED|Open-label Period||0
8526520|NCT02959918|9558145|FG009|NOT COMPLETED|Overall Study||6
8526521|NCT02959918|9558146|FG010|NOT COMPLETED|Overall Study||6
8526522|NCT02959918|9558147|FG011|NOT COMPLETED|Overall Study||12
8526523|NCT02959918|9558148|FG012|NOT COMPLETED|Overall Study||7
8526524|NCT02959918|9558149|FG013|NOT COMPLETED|Overall Study||6
8562847|NCT00040846|9594987|FG003|COMPLETED|Overall Study||0
8562848|NCT00040846|9594988|FG004|COMPLETED|Overall Study||0
8562849|NCT00040846|9594989|FG005|COMPLETED|Overall Study||0
8816315|NCT01543178|9869792|FG000|STARTED|Double-blind Period|The open-label rifaximin arm/group is not applicable to the double-blind period.|0
8562850|NCT00040846|9594984|FG000|NOT COMPLETED|Overall Study||0
8562851|NCT00040846|9594985|FG001|NOT COMPLETED|Overall Study||0
8562852|NCT00040846|9594986|FG002|NOT COMPLETED|Overall Study||0
8562853|NCT00040846|9594987|FG003|NOT COMPLETED|Overall Study||0
8562854|NCT00040846|9594988|FG004|NOT COMPLETED|Overall Study||0
8562855|NCT00040846|9594989|FG005|NOT COMPLETED|Overall Study||0
8562856|NCT00040937|9595003|FG000|STARTED|Induction/PBSC Mobilization|147 registered to this period; 142 were eligible and analyzable; 140 were assessable for toxicity.|147
8562857|NCT00040937|9595003|FG000|COMPLETED|Induction/PBSC Mobilization||110
8562858|NCT00040937|9595003|FG000|NOT COMPLETED|Induction/PBSC Mobilization||37
8562859|NCT00040937|9595003|FG000|STARTED|Autologous PBSCT|108 registered to this period; 105 were eligible and analyzable; 105 were assessable for toxicity.|108
8562860|NCT00040937|9595003|FG000|COMPLETED|Autologous PBSCT||77
8562861|NCT00040937|9595003|FG000|NOT COMPLETED|Autologous PBSCT||31
8562862|NCT00040937|9595003|FG000|STARTED|Maintenance||76
8562863|NCT00040937|9595003|FG000|COMPLETED|Maintenance|Patients remained on protocol therapy until progression.|76
8562864|NCT00040937|9595003|FG000|NOT COMPLETED|Maintenance||0
8562865|NCT00041067|9595010|FG000|STARTED|Overall Study||76
8562866|NCT00041067|9595010|FG000|Eligible|Overall Study||74
8620447|NCT00474383|9659111|FG000|NOT COMPLETED|Extension||0
8562867|NCT00041067|9595010|FG000|COMPLETED|Overall Study||0
8562868|NCT00041067|9595010|FG000|NOT COMPLETED|Overall Study||76
8569193|NCT00095498|9601399|FG002|COMPLETED|Overall Study||39
8620448|NCT00474383|9659112|FG001|NOT COMPLETED|Extension||5
8620449|NCT00474487|9659120|FG000|STARTED|Overall Study||1606
8620450|NCT00474487|9659121|FG001|STARTED|Overall Study||217
8816316|NCT01543178|9869793|FG001|STARTED|Double-blind Period|636 subjects had recurrence in open-label period; 328 randomized to rifaximin.|328
8816317|NCT01543178|9869794|FG002|STARTED|Double-blind Period|636 subjects had recurrence in open-label period; 308 randomized to placebo.|308
8816318|NCT01543178|9869792|FG000|COMPLETED|Double-blind Period||0
8816319|NCT01543178|9869793|FG001|COMPLETED|Double-blind Period|295 completed 1st double-blind retreatment and 284 completed 2nd double-blind retreatment.|284
8849245|NCT01739231|9904378|FG002|NOT COMPLETED|Part B||2
8526533|NCT02472964|9558194|FG000|STARTED|Part 1 (up to Week 24)||246
8526534|NCT02472964|9558195|FG001|STARTED|Part 1 (up to Week 24)||247
8526535|NCT02472964|9558194|FG000|COMPLETED|Part 1 (up to Week 24)||171
8526536|NCT02472964|9558195|FG001|COMPLETED|Part 1 (up to Week 24)||185
8526537|NCT02472964|9558194|FG000|NOT COMPLETED|Part 1 (up to Week 24)||75
8526538|NCT02472964|9558195|FG001|NOT COMPLETED|Part 1 (up to Week 24)||62
8526539|NCT02472964|9558194|FG000|STARTED|Part 2 (Week 24-week 48)||163
8526540|NCT02472964|9558195|FG001|STARTED|Part 2 (Week 24-week 48)||179
8526541|NCT02472964|9558194|FG000|COMPLETED|Part 2 (Week 24-week 48)||98
8526542|NCT02472964|9558195|FG001|COMPLETED|Part 2 (Week 24-week 48)||116
8526543|NCT02472964|9558194|FG000|NOT COMPLETED|Part 2 (Week 24-week 48)||65
8526544|NCT02472964|9558195|FG001|NOT COMPLETED|Part 2 (Week 24-week 48)||63
8526545|NCT02178722|9558206|FG000|STARTED|Overall Study||4
8526546|NCT02178722|9558207|FG001|STARTED|Overall Study||20
8526547|NCT02178722|9558208|FG002|STARTED|Overall Study||18
8526548|NCT02178722|9558209|FG003|STARTED|Overall Study||20
8526549|NCT02178722|9558210|FG004|STARTED|Overall Study||382
8526550|NCT02178722|9558206|FG000|COMPLETED|Overall Study||0
8526551|NCT02178722|9558207|FG001|COMPLETED|Overall Study||0
8526552|NCT02178722|9558208|FG002|COMPLETED|Overall Study||0
8526553|NCT02178722|9558209|FG003|COMPLETED|Overall Study||0
8526554|NCT02178722|9558210|FG004|COMPLETED|Overall Study||0
8526555|NCT02178722|9558206|FG000|NOT COMPLETED|Overall Study||4
8526556|NCT02178722|9558207|FG001|NOT COMPLETED|Overall Study||20
8526557|NCT02178722|9558208|FG002|NOT COMPLETED|Overall Study||18
8526558|NCT02178722|9558209|FG003|NOT COMPLETED|Overall Study||20
8526559|NCT02178722|9558210|FG004|NOT COMPLETED|Overall Study||382
8526560|NCT01258803|9558225|FG000|STARTED|Treatment Period 1 (1 Dose)||15
8526561|NCT01258803|9558226|FG001|STARTED|Treatment Period 1 (1 Dose)||16
8526562|NCT01258803|9558227|FG002|STARTED|Treatment Period 1 (1 Dose)||15
8526563|NCT01258803|9558228|FG003|STARTED|Treatment Period 1 (1 Dose)||15
8526564|NCT01258803|9558229|FG004|STARTED|Treatment Period 1 (1 Dose)||15
8526565|NCT01258803|9558230|FG005|STARTED|Treatment Period 1 (1 Dose)||16
8526566|NCT01258803|9558225|FG000|COMPLETED|Treatment Period 1 (1 Dose)||15
8526567|NCT01258803|9558226|FG001|COMPLETED|Treatment Period 1 (1 Dose)||16
8526568|NCT01258803|9558227|FG002|COMPLETED|Treatment Period 1 (1 Dose)||15
8526569|NCT01258803|9558228|FG003|COMPLETED|Treatment Period 1 (1 Dose)||15
8526570|NCT01258803|9558229|FG004|COMPLETED|Treatment Period 1 (1 Dose)||15
8526571|NCT01258803|9558230|FG005|COMPLETED|Treatment Period 1 (1 Dose)||16
8526572|NCT01258803|9558225|FG000|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
8526573|NCT01258803|9558226|FG001|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
8526574|NCT01258803|9558227|FG002|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
8526575|NCT01258803|9558228|FG003|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
8526576|NCT01258803|9558229|FG004|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
8526577|NCT01258803|9558230|FG005|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
8526578|NCT01258803|9558225|FG000|STARTED|Treatment Period 2 (1 Dose)||15
8526579|NCT01258803|9558226|FG001|STARTED|Treatment Period 2 (1 Dose)||16
8526580|NCT01258803|9558227|FG002|STARTED|Treatment Period 2 (1 Dose)||15
8526581|NCT01258803|9558228|FG003|STARTED|Treatment Period 2 (1 Dose)||15
8526582|NCT01258803|9558229|FG004|STARTED|Treatment Period 2 (1 Dose)||15
8526583|NCT01258803|9558230|FG005|STARTED|Treatment Period 2 (1 Dose)||16
8526584|NCT01258803|9558225|FG000|COMPLETED|Treatment Period 2 (1 Dose)||14
8526585|NCT01258803|9558226|FG001|COMPLETED|Treatment Period 2 (1 Dose)||14
8526586|NCT01258803|9558227|FG002|COMPLETED|Treatment Period 2 (1 Dose)||15
8526587|NCT01258803|9558228|FG003|COMPLETED|Treatment Period 2 (1 Dose)||15
8526588|NCT01258803|9558229|FG004|COMPLETED|Treatment Period 2 (1 Dose)||15
8526589|NCT01258803|9558230|FG005|COMPLETED|Treatment Period 2 (1 Dose)||15
8526590|NCT01258803|9558225|FG000|NOT COMPLETED|Treatment Period 2 (1 Dose)||1
8526591|NCT01258803|9558226|FG001|NOT COMPLETED|Treatment Period 2 (1 Dose)||2
8526592|NCT01258803|9558227|FG002|NOT COMPLETED|Treatment Period 2 (1 Dose)||0
8526593|NCT01258803|9558228|FG003|NOT COMPLETED|Treatment Period 2 (1 Dose)||0
8526594|NCT01258803|9558229|FG004|NOT COMPLETED|Treatment Period 2 (1 Dose)||0
8526595|NCT01258803|9558230|FG005|NOT COMPLETED|Treatment Period 2 (1 Dose)||1
8526596|NCT01258803|9558225|FG000|STARTED|Treatment Period 3 (1 Dose)||14
8526597|NCT01258803|9558226|FG001|STARTED|Treatment Period 3 (1 Dose)||14
8526598|NCT01258803|9558227|FG002|STARTED|Treatment Period 3 (1 Dose)||15
8526599|NCT01258803|9558228|FG003|STARTED|Treatment Period 3 (1 Dose)||15
8526600|NCT01258803|9558229|FG004|STARTED|Treatment Period 3 (1 Dose)||15
8526601|NCT01258803|9558230|FG005|STARTED|Treatment Period 3 (1 Dose)||15
8526602|NCT01258803|9558225|FG000|COMPLETED|Treatment Period 3 (1 Dose)||14
8526603|NCT01258803|9558226|FG001|COMPLETED|Treatment Period 3 (1 Dose)||14
8526604|NCT01258803|9558227|FG002|COMPLETED|Treatment Period 3 (1 Dose)||14
8526605|NCT01258803|9558228|FG003|COMPLETED|Treatment Period 3 (1 Dose)||15
8526606|NCT01258803|9558229|FG004|COMPLETED|Treatment Period 3 (1 Dose)||15
8526607|NCT01258803|9558230|FG005|COMPLETED|Treatment Period 3 (1 Dose)||15
8526608|NCT01258803|9558225|FG000|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
8526609|NCT01258803|9558226|FG001|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
8526610|NCT01258803|9558227|FG002|NOT COMPLETED|Treatment Period 3 (1 Dose)||1
8526611|NCT01258803|9558228|FG003|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
8526612|NCT01258803|9558229|FG004|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
8526613|NCT01258803|9558230|FG005|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
8526614|NCT01258803|9558225|FG000|STARTED|Treatment Period 4 (1 Dose)||14
8526615|NCT01258803|9558226|FG001|STARTED|Treatment Period 4 (1 Dose)||14
8526616|NCT01258803|9558227|FG002|STARTED|Treatment Period 4 (1 Dose)||14
8526617|NCT01258803|9558228|FG003|STARTED|Treatment Period 4 (1 Dose)||15
8526618|NCT01258803|9558229|FG004|STARTED|Treatment Period 4 (1 Dose)||15
8526619|NCT01258803|9558230|FG005|STARTED|Treatment Period 4 (1 Dose)||15
8526620|NCT01258803|9558225|FG000|COMPLETED|Treatment Period 4 (1 Dose)||14
8526621|NCT01258803|9558226|FG001|COMPLETED|Treatment Period 4 (1 Dose)||14
8526622|NCT01258803|9558227|FG002|COMPLETED|Treatment Period 4 (1 Dose)||14
8526623|NCT01258803|9558228|FG003|COMPLETED|Treatment Period 4 (1 Dose)||15
8526624|NCT01258803|9558229|FG004|COMPLETED|Treatment Period 4 (1 Dose)||15
8526625|NCT01258803|9558230|FG005|COMPLETED|Treatment Period 4 (1 Dose)||15
8526626|NCT01258803|9558225|FG000|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
8526627|NCT01258803|9558226|FG001|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
8526628|NCT01258803|9558227|FG002|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
8526629|NCT01258803|9558228|FG003|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
8526630|NCT01258803|9558229|FG004|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
8526631|NCT01258803|9558230|FG005|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
8526632|NCT01104922|9558244|FG000|STARTED|Overall Study||48
8526633|NCT01104922|9558244|FG000|COMPLETED|Overall Study||48
8526634|NCT01104922|9558244|FG000|NOT COMPLETED|Overall Study||0
8526635|NCT00862251|9558251|FG000|STARTED|Overall Study||322
8526636|NCT00862251|9558252|FG001|STARTED|Overall Study||162
8526637|NCT00862251|9558253|FG002|STARTED|Overall Study||324
8526638|NCT00862251|9558251|FG000|COMPLETED|Overall Study||303
8526639|NCT00862251|9558252|FG001|COMPLETED|Overall Study||157
8526640|NCT00862251|9558253|FG002|COMPLETED|Overall Study||315
8526641|NCT00862251|9558251|FG000|NOT COMPLETED|Overall Study||19
8526642|NCT00862251|9558252|FG001|NOT COMPLETED|Overall Study||5
8526643|NCT00862251|9558253|FG002|NOT COMPLETED|Overall Study||9
8526644|NCT00783263|9558268|FG000|STARTED|Overall Study||99
8526645|NCT00783263|9558269|FG001|STARTED|Overall Study||98
8526646|NCT00783263|9558270|FG002|STARTED|Overall Study||122
8526647|NCT00783263|9558271|FG003|STARTED|Overall Study||121
8526648|NCT00783263|9558268|FG000|COMPLETED|Overall Study||95
8526649|NCT00783263|9558269|FG001|COMPLETED|Overall Study||96
8526650|NCT00783263|9558270|FG002|COMPLETED|Overall Study||119
8526651|NCT00783263|9558271|FG003|COMPLETED|Overall Study||118
8526652|NCT00783263|9558268|FG000|NOT COMPLETED|Overall Study||4
8526653|NCT00783263|9558269|FG001|NOT COMPLETED|Overall Study||2
8526654|NCT00783263|9558270|FG002|NOT COMPLETED|Overall Study||3
8526655|NCT00783263|9558271|FG003|NOT COMPLETED|Overall Study||3
8526656|NCT00782184|9558296|FG000|STARTED|Overall Study||120
8526657|NCT00782184|9558297|FG001|STARTED|Overall Study||130
8526658|NCT00782184|9558296|FG000|COMPLETED|Overall Study||116
8526659|NCT00782184|9558297|FG001|COMPLETED|Overall Study||125
8526660|NCT00782184|9558296|FG000|NOT COMPLETED|Overall Study||4
8526661|NCT00782184|9558297|FG001|NOT COMPLETED|Overall Study||5
8526662|NCT00635882|9558310|FG000|STARTED|Overall Study||20
8526663|NCT00635882|9558311|FG001|STARTED|Overall Study||17
8526664|NCT00635882|9558312|FG002|STARTED|Overall Study||12
8526665|NCT00635882|9558313|FG003|STARTED|Overall Study||15
8526666|NCT00635882|9558314|FG004|STARTED|Overall Study||16
8526667|NCT00635882|9558315|FG005|STARTED|Overall Study||13
8526668|NCT00635882|9558310|FG000|COMPLETED|Overall Study||19
8526669|NCT00635882|9558311|FG001|COMPLETED|Overall Study||17
8526670|NCT00635882|9558312|FG002|COMPLETED|Overall Study||12
8526671|NCT00635882|9558313|FG003|COMPLETED|Overall Study||15
8526672|NCT00635882|9558314|FG004|COMPLETED|Overall Study||16
8526673|NCT00635882|9558315|FG005|COMPLETED|Overall Study||13
8526674|NCT00635882|9558310|FG000|NOT COMPLETED|Overall Study||1
8526675|NCT00635882|9558311|FG001|NOT COMPLETED|Overall Study||0
8526676|NCT00635882|9558312|FG002|NOT COMPLETED|Overall Study||0
8526677|NCT00635882|9558313|FG003|NOT COMPLETED|Overall Study||0
8526678|NCT00635882|9558314|FG004|NOT COMPLETED|Overall Study||0
8526679|NCT00635882|9558315|FG005|NOT COMPLETED|Overall Study||0
8526680|NCT00594620|9558331|FG000|STARTED|Overall Study|Study was terminated early due to low accrual. Study was blinded and no data was collected|0
8526681|NCT00594620|9558332|FG001|STARTED|Overall Study|Study was terminated early due to low accrual. Study was blinded and no data was collected|0
8526682|NCT00594620|9558331|FG000|COMPLETED|Overall Study||0
8526683|NCT00594620|9558332|FG001|COMPLETED|Overall Study||0
8526684|NCT00594620|9558331|FG000|NOT COMPLETED|Overall Study||0
8526685|NCT00594620|9558332|FG001|NOT COMPLETED|Overall Study||0
8526686|NCT00535405|9558343|FG000|STARTED|Overall Study||257
8526687|NCT00535405|9558344|FG001|STARTED|Overall Study||259
8526688|NCT00535405|9558345|FG002|STARTED|Overall Study||259
8526689|NCT00535405|9558346|FG003|STARTED|Overall Study||257
8526690|NCT00535405|9558347|FG004|STARTED|Overall Study||257
8526691|NCT00535405|9558343|FG000|COMPLETED|Overall Study||240
8526692|NCT00535405|9558344|FG001|COMPLETED|Overall Study||233
8526693|NCT00535405|9558345|FG002|COMPLETED|Overall Study||241
8526694|NCT00535405|9558346|FG003|COMPLETED|Overall Study||235
8526695|NCT00535405|9558347|FG004|COMPLETED|Overall Study||241
8526696|NCT00535405|9558343|FG000|NOT COMPLETED|Overall Study||17
8526697|NCT00535405|9558344|FG001|NOT COMPLETED|Overall Study||26
8526698|NCT00535405|9558345|FG002|NOT COMPLETED|Overall Study||18
8526699|NCT00535405|9558346|FG003|NOT COMPLETED|Overall Study||22
8526700|NCT00535405|9558347|FG004|NOT COMPLETED|Overall Study||16
8526701|NCT00496730|9558361|FG000|STARTED|Overall Study||130
8526702|NCT00496730|9558362|FG001|STARTED|Overall Study||126
8526703|NCT00496730|9558361|FG000|COMPLETED|Overall Study||124
8526704|NCT00496730|9558362|FG001|COMPLETED|Overall Study||121
8526705|NCT00496730|9558361|FG000|NOT COMPLETED|Overall Study||6
8526706|NCT00496730|9558362|FG001|NOT COMPLETED|Overall Study||5
8526707|NCT00462748|9558371|FG000|STARTED|Overall Study||261
8526708|NCT00462748|9558372|FG001|STARTED|Overall Study||263
8526709|NCT00462748|9558373|FG002|STARTED|Overall Study||262
8526710|NCT00462748|9558371|FG000|COMPLETED|Overall Study||249
8526711|NCT00462748|9558372|FG001|COMPLETED|Overall Study||252
8526712|NCT00462748|9558373|FG002|COMPLETED|Overall Study||251
8526713|NCT00462748|9558371|FG000|NOT COMPLETED|Overall Study||12
8526714|NCT00462748|9558372|FG001|NOT COMPLETED|Overall Study||11
8526715|NCT00462748|9558373|FG002|NOT COMPLETED|Overall Study||11
8526716|NCT00418834|9558383|FG000|STARTED|Overall Study||526
8526717|NCT00418834|9558384|FG001|STARTED|Overall Study||527
8526718|NCT00418834|9558383|FG000|COMPLETED|Overall Study||503
8526719|NCT00418834|9558384|FG001|COMPLETED|Overall Study||507
8526720|NCT00418834|9558383|FG000|NOT COMPLETED|Overall Study||23
8526721|NCT00418834|9558384|FG001|NOT COMPLETED|Overall Study||20
8526722|NCT00409773|9558395|FG000|STARTED|Overall Study||229
8526723|NCT00409773|9558396|FG001|STARTED|Overall Study||229
8526724|NCT00409773|9558397|FG002|STARTED|Overall Study||229
8526725|NCT00409773|9558398|FG003|STARTED|Overall Study||228
8526726|NCT00409773|9558399|FG004|STARTED|Overall Study||228
8526727|NCT00409773|9558395|FG000|COMPLETED|Overall Study||220
8526728|NCT00409773|9558396|FG001|COMPLETED|Overall Study||222
8526729|NCT00409773|9558397|FG002|COMPLETED|Overall Study||220
8526730|NCT00409773|9558398|FG003|COMPLETED|Overall Study||216
8526731|NCT00409773|9558399|FG004|COMPLETED|Overall Study||218
8526732|NCT00409773|9558395|FG000|NOT COMPLETED|Overall Study||9
8526733|NCT00409773|9558396|FG001|NOT COMPLETED|Overall Study||7
8526734|NCT00409773|9558397|FG002|NOT COMPLETED|Overall Study||9
8526735|NCT00409773|9558398|FG003|NOT COMPLETED|Overall Study||12
8526736|NCT00409773|9558399|FG004|NOT COMPLETED|Overall Study||10
8526737|NCT00276484|9558413|FG000|STARTED|Overall Study||288
8526738|NCT00276484|9558414|FG001|STARTED|Overall Study||291
8526739|NCT00276484|9558413|FG000|COMPLETED|Overall Study||279
8526740|NCT00276484|9558414|FG001|COMPLETED|Overall Study||278
8526741|NCT00276484|9558413|FG000|NOT COMPLETED|Overall Study||9
8526742|NCT00276484|9558414|FG001|NOT COMPLETED|Overall Study||13
8526743|NCT00276458|9558422|FG000|STARTED|Overall Study||98
8526744|NCT00276458|9558423|FG001|STARTED|Overall Study||98
8526745|NCT00276458|9558422|FG000|COMPLETED|Overall Study||92
8816320|NCT01543178|9869794|FG002|COMPLETED|Double-blind Period|283 completed 1st double-blind retreatment and 271 completed 2nd double-blind retreatment.|271
8816321|NCT01543178|9869792|FG000|NOT COMPLETED|Double-blind Period||0
8816322|NCT01543178|9869793|FG001|NOT COMPLETED|Double-blind Period||44
8526746|NCT00276458|9558423|FG001|COMPLETED|Overall Study||91
8526747|NCT00276458|9558422|FG000|NOT COMPLETED|Overall Study||6
8526748|NCT00276458|9558423|FG001|NOT COMPLETED|Overall Study||7
8526749|NCT00271817|9558432|FG000|STARTED|Part 1||272
8526750|NCT00271817|9558433|FG001|STARTED|Part 1||272
8526751|NCT00271817|9558434|FG002|STARTED|Part 1||676
8526752|NCT00271817|9558432|FG000|COMPLETED|Part 1|6 patients who completed Part 1 did not continue to Part 2; 1 patient never received drug in Part 2|166
8526753|NCT00271817|9558433|FG001|COMPLETED|Part 1|1 patient who completed Part 1 did not continue to Part 2|213
8526754|NCT00271817|9558434|FG002|COMPLETED|Part 1|11 patients who completed Part 1 did not continue to Part 2|391
8526755|NCT00271817|9558432|FG000|NOT COMPLETED|Part 1||106
8526756|NCT00271817|9558433|FG001|NOT COMPLETED|Part 1||59
8526757|NCT00271817|9558434|FG002|NOT COMPLETED|Part 1||285
8526758|NCT00271817|9558432|FG000|STARTED|Part 2|Patients completing the niacin group in Part 1, were re-allocated to one of the two arms in Part 2|0
8526759|NCT00271817|9558433|FG001|STARTED|Part 2|Includes 54 patients re-allocated from the niacin group in Part 1|266
8526760|NCT00271817|9558434|FG002|STARTED|Part 2|Includes 105 patients re-allocated from the niacin group in Part 1|485
8526761|NCT00271817|9558432|FG000|COMPLETED|Part 2||0
8526762|NCT00271817|9558433|FG001|COMPLETED|Part 2||234
8526763|NCT00271817|9558434|FG002|COMPLETED|Part 2||401
8526764|NCT00271817|9558432|FG000|NOT COMPLETED|Part 2||0
8526765|NCT00271817|9558433|FG001|NOT COMPLETED|Part 2||32
8526766|NCT00271817|9558434|FG002|NOT COMPLETED|Part 2||84
8526767|NCT03660865|9558448|FG000|STARTED|Overall Study||105
8526768|NCT03660865|9558449|FG001|STARTED|Overall Study||105
8526769|NCT03660865|9558448|FG000|COMPLETED|Overall Study||105
8526770|NCT03660865|9558449|FG001|COMPLETED|Overall Study||105
8526771|NCT03660865|9558448|FG000|NOT COMPLETED|Overall Study||0
8526772|NCT03660865|9558449|FG001|NOT COMPLETED|Overall Study||0
8562869|NCT00041080|9595017|FG000|STARTED|Overall Study|number patients enrolled on study|69
8562870|NCT00041080|9595018|FG001|STARTED|Overall Study|number patients enrolled on study|70
8562871|NCT00041080|9595017|FG000|COMPLETED|Overall Study||39
8562872|NCT00041080|9595018|FG001|COMPLETED|Overall Study||60
8562873|NCT00041080|9595017|FG000|NOT COMPLETED|Overall Study||30
8562874|NCT00041080|9595018|FG001|NOT COMPLETED|Overall Study||10
8562875|NCT00041119|9595028|FG000|STARTED|Overall Study||1142
8562876|NCT00041119|9595029|FG001|STARTED|Overall Study||789
8562877|NCT00041119|9595030|FG002|STARTED|Overall Study||1151
8526773|NCT03493126|9558457|FG000|STARTED|Overall Study||31
8526774|NCT03493126|9558458|FG001|STARTED|Overall Study||28
8526775|NCT03493126|9558457|FG000|COMPLETED|Overall Study||28
8526776|NCT03493126|9558458|FG001|COMPLETED|Overall Study||28
8526777|NCT03493126|9558457|FG000|NOT COMPLETED|Overall Study||3
8526778|NCT03493126|9558458|FG001|NOT COMPLETED|Overall Study||0
8526779|NCT03420781|9558466|FG000|STARTED|Treatment Period (40 Weeks)||236
8526780|NCT03420781|9558467|FG001|STARTED|Treatment Period (40 Weeks)||231
8526781|NCT03420781|9558468|FG002|STARTED|Treatment Period (40 Weeks)||0
8526782|NCT03420781|9558469|FG003|STARTED|Treatment Period (40 Weeks)||0
8526783|NCT03420781|9558470|FG004|STARTED|Treatment Period (40 Weeks)||0
8526784|NCT03420781|9558466|FG000|Safety Population|Treatment Period (40 Weeks)||235
8526785|NCT03420781|9558467|FG001|Safety Population|Treatment Period (40 Weeks)||231
8526786|NCT03420781|9558468|FG002|Safety Population|Treatment Period (40 Weeks)||0
8526787|NCT03420781|9558469|FG003|Safety Population|Treatment Period (40 Weeks)||0
8526788|NCT03420781|9558470|FG004|Safety Population|Treatment Period (40 Weeks)||0
8526789|NCT03420781|9558466|FG000|COMPLETED|Treatment Period (40 Weeks)||92
8526790|NCT03420781|9558467|FG001|COMPLETED|Treatment Period (40 Weeks)||105
8526791|NCT03420781|9558468|FG002|COMPLETED|Treatment Period (40 Weeks)||0
8526792|NCT03420781|9558469|FG003|COMPLETED|Treatment Period (40 Weeks)||0
8526793|NCT03420781|9558470|FG004|COMPLETED|Treatment Period (40 Weeks)||0
8526794|NCT03420781|9558466|FG000|NOT COMPLETED|Treatment Period (40 Weeks)||144
8526795|NCT03420781|9558467|FG001|NOT COMPLETED|Treatment Period (40 Weeks)||126
8526796|NCT03420781|9558468|FG002|NOT COMPLETED|Treatment Period (40 Weeks)||0
8526797|NCT03420781|9558469|FG003|NOT COMPLETED|Treatment Period (40 Weeks)||0
8526798|NCT03420781|9558470|FG004|NOT COMPLETED|Treatment Period (40 Weeks)||0
8526799|NCT03420781|9558466|FG000|STARTED|RW Period: 6 Weeks (Week 41 to Week 46)||0
8526800|NCT03420781|9558467|FG001|STARTED|RW Period: 6 Weeks (Week 41 to Week 46)||0
8526801|NCT03420781|9558468|FG002|STARTED|RW Period: 6 Weeks (Week 41 to Week 46)||91
8620451|NCT00474487|9659122|FG002|STARTED|Overall Study||899
8620452|NCT00474487|9659123|FG003|STARTED|Overall Study||109
8620453|NCT00474487|9659120|FG000|COMPLETED|Overall Study||1576
8620454|NCT00474487|9659121|FG001|COMPLETED|Overall Study||215
8620455|NCT00474487|9659122|FG002|COMPLETED|Overall Study||885
8620456|NCT00474487|9659123|FG003|COMPLETED|Overall Study||109
8526802|NCT03420781|9558469|FG003|STARTED|RW Period: 6 Weeks (Week 41 to Week 46)||59
8526803|NCT03420781|9558470|FG004|STARTED|RW Period: 6 Weeks (Week 41 to Week 46)||43
8526804|NCT03420781|9558466|FG000|COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||0
8526805|NCT03420781|9558467|FG001|COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||0
8526806|NCT03420781|9558468|FG002|COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||85
8526807|NCT03420781|9558469|FG003|COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||54
8526808|NCT03420781|9558470|FG004|COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||38
8526809|NCT03420781|9558466|FG000|NOT COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||0
8620457|NCT00474487|9659120|FG000|NOT COMPLETED|Overall Study||30
8620458|NCT00474487|9659121|FG001|NOT COMPLETED|Overall Study||2
8620459|NCT00474487|9659122|FG002|NOT COMPLETED|Overall Study||14
8620460|NCT00474487|9659123|FG003|NOT COMPLETED|Overall Study||0
8620461|NCT00474526|9659150|FG000|STARTED|Overall Study||154
8620462|NCT00474526|9659151|FG001|STARTED|Overall Study||166
8526810|NCT03420781|9558467|FG001|NOT COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||0
8526811|NCT03420781|9558468|FG002|NOT COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||6
8526812|NCT03420781|9558469|FG003|NOT COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||5
8526813|NCT03420781|9558470|FG004|NOT COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||5
8526814|NCT03316586|9558486|FG000|STARTED|Overall Study||18
8526815|NCT03316586|9558486|FG000|COMPLETED|Overall Study||0
8526816|NCT03316586|9558486|FG000|NOT COMPLETED|Overall Study||18
8526817|NCT03277066|9558493|FG000|STARTED|Overall Study||71
8526818|NCT03277066|9558494|FG001|STARTED|Overall Study||72
8526819|NCT03277066|9558495|FG002|STARTED|Overall Study||146
8526820|NCT03277066|9558493|FG000|COMPLETED|Overall Study||69
8526821|NCT03277066|9558494|FG001|COMPLETED|Overall Study||71
8526822|NCT03277066|9558495|FG002|COMPLETED|Overall Study||143
8526823|NCT03277066|9558493|FG000|NOT COMPLETED|Overall Study||2
8526824|NCT03277066|9558494|FG001|NOT COMPLETED|Overall Study||1
8526825|NCT03277066|9558495|FG002|NOT COMPLETED|Overall Study||3
8526826|NCT03269695|9558505|FG000|STARTED|Overall Study||10
8526827|NCT03269695|9558506|FG001|STARTED|Overall Study||10
8526828|NCT03269695|9558505|FG000|Treated|Overall Study||10
8526829|NCT03269695|9558506|FG001|Treated|Overall Study||10
8526830|NCT03269695|9558505|FG000|COMPLETED|Overall Study||8
8526831|NCT03269695|9558506|FG001|COMPLETED|Overall Study||7
8526832|NCT03269695|9558505|FG000|NOT COMPLETED|Overall Study||2
8526833|NCT03269695|9558506|FG001|NOT COMPLETED|Overall Study||3
8526834|NCT03268811|9558515|FG000|STARTED|Overall Study||7
8526835|NCT03268811|9558516|FG001|STARTED|Overall Study||2
8526836|NCT03268811|9558515|FG000|COMPLETED|Overall Study||7
8526837|NCT03268811|9558516|FG001|COMPLETED|Overall Study||1
8526838|NCT03268811|9558515|FG000|NOT COMPLETED|Overall Study||0
8620463|NCT00474526|9659152|FG002|STARTED|Overall Study||159
8620464|NCT00474526|9659153|FG003|STARTED|Overall Study||680
8620465|NCT00474526|9659154|FG004|STARTED|Overall Study||76
8526839|NCT03268811|9558516|FG001|NOT COMPLETED|Overall Study||1
8526840|NCT03227757|9558523|FG000|STARTED|Overall Study||85
8526841|NCT03227757|9558523|FG000|COMPLETED|Overall Study||69
8526842|NCT03227757|9558523|FG000|NOT COMPLETED|Overall Study||16
8620466|NCT00474526|9659155|FG005|STARTED|Overall Study||70
8526843|NCT03222128|9558527|FG000|STARTED|Overall Study||1074
8526844|NCT03222128|9558527|FG000|Valve-Implanted|Overall Study||1069
8526845|NCT03222128|9558527|FG000|COMPLETED|Overall Study||968
8526846|NCT03222128|9558527|FG000|NOT COMPLETED|Overall Study||106
8526847|NCT03142334|9558533|FG000|STARTED|Overall Study||496
8526848|NCT03142334|9558534|FG001|STARTED|Overall Study||498
8526849|NCT03142334|9558533|FG000|Treated|Overall Study||488
8526850|NCT03142334|9558534|FG001|Treated|Overall Study||496
8526851|NCT03142334|9558533|FG000|Continuing Study Treatment|Overall Study||0
8526852|NCT03142334|9558534|FG001|Continuing Study Treatment|Overall Study||1
8526853|NCT03142334|9558533|FG000|Completed Study Treatment|Overall Study||298
8526854|NCT03142334|9558534|FG001|Completed Study Treatment|Overall Study||365
8526855|NCT03142334|9558533|FG000|Discontinued Study Treatment|Overall Study||190
8526856|NCT03142334|9558534|FG001|Discontinued Study Treatment|Overall Study||130
8526857|NCT03142334|9558533|FG000|COMPLETED|Overall Study||0
8526858|NCT03142334|9558534|FG001|COMPLETED|Overall Study||0
8526859|NCT03142334|9558533|FG000|NOT COMPLETED|Overall Study||496
8526860|NCT03142334|9558534|FG001|NOT COMPLETED|Overall Study||498
8526861|NCT03093701|9558543|FG000|STARTED|Overall Study||10
8526862|NCT03093701|9558544|FG001|STARTED|Overall Study||10
8526863|NCT03093701|9558545|FG002|STARTED|Overall Study||11
8526864|NCT03093701|9558546|FG003|STARTED|Overall Study||0
8526865|NCT03093701|9558543|FG000|COMPLETED|Overall Study||10
8526866|NCT03093701|9558544|FG001|COMPLETED|Overall Study||7
8526867|NCT03093701|9558545|FG002|COMPLETED|Overall Study||11
8526868|NCT03093701|9558546|FG003|COMPLETED|Overall Study||0
8526869|NCT03093701|9558543|FG000|NOT COMPLETED|Overall Study||0
8526870|NCT03093701|9558544|FG001|NOT COMPLETED|Overall Study||3
8526871|NCT03093701|9558545|FG002|NOT COMPLETED|Overall Study||0
8526872|NCT03093701|9558546|FG003|NOT COMPLETED|Overall Study||0
8526873|NCT03093246|9558556|FG000|STARTED|Overall Study||19
8526874|NCT03093246|9558557|FG001|STARTED|Overall Study||19
8526875|NCT03093246|9558556|FG000|COMPLETED|Overall Study||19
8526876|NCT03093246|9558557|FG001|COMPLETED|Overall Study||19
8526877|NCT03093246|9558556|FG000|NOT COMPLETED|Overall Study||0
8526878|NCT03093246|9558557|FG001|NOT COMPLETED|Overall Study||0
8562878|NCT00041119|9595031|FG003|STARTED|Overall Study||789
8562879|NCT00041119|9595028|FG000|COMPLETED|Overall Study||1142
8562880|NCT00041119|9595029|FG001|COMPLETED|Overall Study||789
8562881|NCT00041119|9595030|FG002|COMPLETED|Overall Study||1151
8562882|NCT00041119|9595031|FG003|COMPLETED|Overall Study||789
8562883|NCT00041119|9595028|FG000|NOT COMPLETED|Overall Study||0
8562884|NCT00041119|9595029|FG001|NOT COMPLETED|Overall Study||0
8562885|NCT00041119|9595030|FG002|NOT COMPLETED|Overall Study||0
8562886|NCT00041119|9595031|FG003|NOT COMPLETED|Overall Study||0
8562887|NCT00041132|9595045|FG000|STARTED|Overall Study||56
8562888|NCT00041132|9595045|FG000|Eligible|Overall Study||49
8562889|NCT00041132|9595045|FG000|Eligible and Began Protocol Therapy|Overall Study||49
8562890|NCT00041132|9595045|FG000|COMPLETED|Overall Study||26
8562891|NCT00041132|9595045|FG000|NOT COMPLETED|Overall Study||30
8562892|NCT00041470|9595049|FG000|STARTED|Overall Study||38
8562893|NCT00041470|9595049|FG000|COMPLETED|Overall Study||0
8562894|NCT00041470|9595049|FG000|NOT COMPLETED|Overall Study||38
8562895|NCT00041717|9595055|FG000|STARTED|Overall Study||114
8562896|NCT00041717|9595056|FG001|STARTED|Overall Study||98
8562897|NCT00041717|9595055|FG000|COMPLETED|Overall Study||81
8562898|NCT00041717|9595056|FG001|COMPLETED|Overall Study||86
8562899|NCT00041717|9595055|FG000|NOT COMPLETED|Overall Study||33
8562900|NCT00041717|9595056|FG001|NOT COMPLETED|Overall Study||12
8562901|NCT00041756|9595067|FG000|STARTED|Overall Study||77
8562902|NCT00041756|9595068|FG001|STARTED|Overall Study||80
8562903|NCT00041756|9595069|FG002|STARTED|Overall Study||79
8562904|NCT00041756|9595070|FG003|STARTED|Overall Study||80
8562905|NCT00041756|9595071|FG004|STARTED|Overall Study||79
8562906|NCT00041756|9595067|FG000|COMPLETED|Overall Study||69
8562907|NCT00041756|9595068|FG001|COMPLETED|Overall Study||65
8562908|NCT00041756|9595069|FG002|COMPLETED|Overall Study||66
8562909|NCT00041756|9595070|FG003|COMPLETED|Overall Study||64
8562910|NCT00041756|9595071|FG004|COMPLETED|Overall Study||19
8562911|NCT00041756|9595067|FG000|NOT COMPLETED|Overall Study||8
8562912|NCT00041756|9595068|FG001|NOT COMPLETED|Overall Study||15
8562913|NCT00041756|9595069|FG002|NOT COMPLETED|Overall Study||13
8562914|NCT00041756|9595070|FG003|NOT COMPLETED|Overall Study||16
8562915|NCT00041756|9595071|FG004|NOT COMPLETED|Overall Study||60
8562916|NCT00041938|9595085|FG000|STARTED|Overall Study||1163
8562917|NCT00041938|9595086|FG001|STARTED|Overall Study||1142
8562918|NCT00041938|9595085|FG000|Completed Follow-up|Overall Study||761
8562919|NCT00041938|9595086|FG001|Completed Follow-up|Overall Study||745
8562920|NCT00041938|9595085|FG000|Primary Endpoint|Overall Study||320
8562921|NCT00041938|9595086|FG001|Primary Endpoint|Overall Study||302
8562922|NCT00041938|9595085|FG000|Only Vital Status Known|Overall Study||44
8562923|NCT00041938|9595086|FG001|Only Vital Status Known|Overall Study||46
8562924|NCT00041938|9595085|FG000|Lost to Follow-up|Overall Study||18
8562925|NCT00041938|9595086|FG001|Lost to Follow-up|Overall Study||17
8562926|NCT00041938|9595085|FG000|Withdrew Consent|Overall Study||20
8562927|NCT00041938|9595086|FG001|Withdrew Consent|Overall Study||14
8562928|NCT00041938|9595085|FG000|COMPLETED|Overall Study||1125
8562929|NCT00041938|9595086|FG001|COMPLETED|Overall Study||1111
8562930|NCT00041938|9595085|FG000|NOT COMPLETED|Overall Study||38
8562931|NCT00041938|9595086|FG001|NOT COMPLETED|Overall Study||31
8562932|NCT00042224|9595094|FG000|STARTED|Overall Study||20
8526879|NCT02991599|9558565|FG000|STARTED|Overall Study||98
8526880|NCT02991599|9558566|FG001|STARTED|Overall Study||98
8526881|NCT02991599|9558565|FG000|COMPLETED|Overall Study||60
8526882|NCT02991599|9558566|FG001|COMPLETED|Overall Study||61
8526883|NCT02991599|9558565|FG000|NOT COMPLETED|Overall Study||38
8526884|NCT02991599|9558566|FG001|NOT COMPLETED|Overall Study||37
8526885|NCT02976129|9558574|FG000|STARTED|Overall Study||82
8526886|NCT02976129|9558575|FG001|STARTED|Overall Study||43
8526887|NCT02976129|9558574|FG000|COMPLETED|Overall Study||77
8526888|NCT02976129|9558575|FG001|COMPLETED|Overall Study||41
8526889|NCT02976129|9558574|FG000|NOT COMPLETED|Overall Study||5
8526890|NCT02976129|9558575|FG001|NOT COMPLETED|Overall Study||2
8526891|NCT02970136|9558583|FG000|STARTED|Overall Study||377
8526892|NCT02970136|9558584|FG001|STARTED|Overall Study||377
8526893|NCT02970136|9558583|FG000|COMPLETED|Overall Study||297
8526894|NCT02970136|9558584|FG001|COMPLETED|Overall Study||282
8526895|NCT02970136|9558583|FG000|NOT COMPLETED|Overall Study||80
8526896|NCT02970136|9558584|FG001|NOT COMPLETED|Overall Study||95
8526897|NCT02969928|9558592|FG000|STARTED|Overall Study||23
8526898|NCT02969928|9558593|FG001|STARTED|Overall Study||23
8526899|NCT02969928|9558592|FG000|COMPLETED|Overall Study||23
8526900|NCT02969928|9558593|FG001|COMPLETED|Overall Study||23
8526901|NCT02969928|9558592|FG000|NOT COMPLETED|Overall Study||0
8526902|NCT02969928|9558593|FG001|NOT COMPLETED|Overall Study||0
8526903|NCT02949297|9558599|FG000|STARTED|1 Month||75
8526904|NCT02949297|9558599|FG000|COMPLETED|1 Month||75
8526905|NCT02949297|9558599|FG000|NOT COMPLETED|1 Month||0
8526906|NCT02949297|9558599|FG000|STARTED|6 Months||75
8526907|NCT02949297|9558599|FG000|COMPLETED|6 Months||72
8526908|NCT02949297|9558599|FG000|NOT COMPLETED|6 Months||3
8526909|NCT02949297|9558599|FG000|STARTED|12 Months||72
8526910|NCT02949297|9558599|FG000|COMPLETED|12 Months||67
8526911|NCT02949297|9558599|FG000|NOT COMPLETED|12 Months||5
8526912|NCT02945787|9558605|FG000|STARTED|Overall Study||714
8526913|NCT02945787|9558606|FG001|STARTED|Overall Study||703
8526914|NCT02945787|9558605|FG000|COMPLETED|Overall Study||714
8526915|NCT02945787|9558606|FG001|COMPLETED|Overall Study||703
8620467|NCT00474526|9659156|FG006|STARTED|Overall Study||203
8620468|NCT00474526|9659157|FG007|STARTED|Overall Study||151
8526916|NCT02945787|9558605|FG000|NOT COMPLETED|Overall Study||0
8526917|NCT02945787|9558606|FG001|NOT COMPLETED|Overall Study||0
8526918|NCT02857426|9558614|FG000|STARTED|Overall Study||47
8526919|NCT02857426|9558615|FG001|STARTED|Overall Study||19
8526920|NCT02857426|9558614|FG000|COMPLETED|Overall Study||0
8526921|NCT02857426|9558615|FG001|COMPLETED|Overall Study||0
8526922|NCT02857426|9558614|FG000|NOT COMPLETED|Overall Study||47
8526923|NCT02857426|9558615|FG001|NOT COMPLETED|Overall Study||19
8526924|NCT02855125|9558623|FG000|STARTED|Overall Study||64
8526925|NCT02855125|9558624|FG001|STARTED|Overall Study||64
8526926|NCT02855125|9558623|FG000|Treated|Overall Study||64
8526927|NCT02855125|9558624|FG001|Treated|Overall Study||63
8526928|NCT02855125|9558623|FG000|COMPLETED|Overall Study||0
8526929|NCT02855125|9558624|FG001|COMPLETED|Overall Study||0
8526930|NCT02855125|9558623|FG000|NOT COMPLETED|Overall Study||64
8526931|NCT02855125|9558624|FG001|NOT COMPLETED|Overall Study||64
8526932|NCT02836236|9558632|FG000|STARTED|Overall Study||105
8526933|NCT02836236|9558633|FG001|STARTED|Overall Study||50
8526934|NCT02836236|9558632|FG000|COMPLETED|Overall Study||0
8526935|NCT02836236|9558633|FG001|COMPLETED|Overall Study||0
8526936|NCT02836236|9558632|FG000|NOT COMPLETED|Overall Study||105
8526937|NCT02836236|9558633|FG001|NOT COMPLETED|Overall Study||50
8526938|NCT02728752|9558641|FG000|STARTED|First Period||48
8526939|NCT02728752|9558642|FG001|STARTED|First Period||47
8526940|NCT02728752|9558641|FG000|COMPLETED|First Period||46
8526941|NCT02728752|9558642|FG001|COMPLETED|First Period||45
8526942|NCT02728752|9558641|FG000|NOT COMPLETED|First Period||2
8526943|NCT02728752|9558642|FG001|NOT COMPLETED|First Period||2
8526944|NCT02728752|9558641|FG000|STARTED|Extension Period||46
8526945|NCT02728752|9558642|FG001|STARTED|Extension Period||45
8526946|NCT02728752|9558641|FG000|COMPLETED|Extension Period||35
8526947|NCT02728752|9558642|FG001|COMPLETED|Extension Period||34
8526948|NCT02728752|9558641|FG000|NOT COMPLETED|Extension Period||11
8526949|NCT02728752|9558642|FG001|NOT COMPLETED|Extension Period||11
8526950|NCT02680587|9558651|FG000|STARTED|Overall Study||18
8526951|NCT02680587|9558652|FG001|STARTED|Overall Study||36
8526952|NCT02680587|9558651|FG000|COMPLETED|Overall Study||17
8526953|NCT02680587|9558652|FG001|COMPLETED|Overall Study||36
8526954|NCT02680587|9558651|FG000|NOT COMPLETED|Overall Study||1
8526955|NCT02680587|9558652|FG001|NOT COMPLETED|Overall Study||0
8620469|NCT00474526|9659158|FG008|STARTED|Overall Study||150
8526956|NCT02667639|9558664|FG000|STARTED|Overall Study||25
8526957|NCT02667639|9558665|FG001|STARTED|Overall Study||10
8526958|NCT02667639|9558664|FG000|COMPLETED|Overall Study||25
8526959|NCT02667639|9558665|FG001|COMPLETED|Overall Study||10
8526960|NCT02667639|9558664|FG000|NOT COMPLETED|Overall Study||0
8526961|NCT02667639|9558665|FG001|NOT COMPLETED|Overall Study||0
8620470|NCT00474526|9659159|FG009|STARTED|Overall Study||148
8620471|NCT00474526|9659160|FG010|STARTED|Overall Study||151
8620472|NCT00474526|9659161|FG011|STARTED|Overall Study||150
8620473|NCT00474526|9659162|FG012|STARTED|Overall Study||150
8620474|NCT00474526|9659163|FG013|STARTED|Overall Study||1426
8620475|NCT00474526|9659164|FG014|STARTED|Overall Study||358
8620476|NCT00474526|9659165|FG015|STARTED|Overall Study||170
8620477|NCT00474526|9659166|FG016|STARTED|Overall Study||183
8620478|NCT00474526|9659150|FG000|COMPLETED|Overall Study||121
8620479|NCT00474526|9659151|FG001|COMPLETED|Overall Study||120
8620480|NCT00474526|9659152|FG002|COMPLETED|Overall Study||110
8620481|NCT00474526|9659153|FG003|COMPLETED|Overall Study||561
8620482|NCT00474526|9659154|FG004|COMPLETED|Overall Study||8
8620483|NCT00474526|9659155|FG005|COMPLETED|Overall Study||54
8620484|NCT00474526|9659156|FG006|COMPLETED|Overall Study||178
8620485|NCT00474526|9659157|FG007|COMPLETED|Overall Study||145
8620486|NCT00474526|9659158|FG008|COMPLETED|Overall Study||144
8620487|NCT00474526|9659159|FG009|COMPLETED|Overall Study||121
8526977|NCT02574455|9558685|FG000|STARTED|Overall Study||267
8526978|NCT02574455|9558686|FG001|STARTED|Overall Study||262
8526979|NCT02574455|9558685|FG000|Enrolled and Treated|Overall Study||258
8526980|NCT02574455|9558686|FG001|Enrolled and Treated|Overall Study||224
8526981|NCT02574455|9558685|FG000|COMPLETED|Overall Study||0
8526982|NCT02574455|9558686|FG001|COMPLETED|Overall Study||0
8526983|NCT02574455|9558685|FG000|NOT COMPLETED|Overall Study||267
8526984|NCT02574455|9558686|FG001|NOT COMPLETED|Overall Study||262
8526985|NCT02527798|9558698|FG000|STARTED|Overall Study||32
8526986|NCT02527798|9558699|FG001|STARTED|Overall Study||10
8526987|NCT02527798|9558700|FG002|STARTED|Overall Study||30
8526988|NCT02527798|9558701|FG003|STARTED|Overall Study||10
8526989|NCT02527798|9558702|FG004|STARTED|Overall Study||0
8526990|NCT02527798|9558703|FG005|STARTED|Overall Study||0
8526991|NCT02527798|9558698|FG000|Randomized, Not Dosed|Overall Study||31
8526992|NCT02527798|9558699|FG001|Randomized, Not Dosed|Overall Study||9
8526993|NCT02527798|9558700|FG002|Randomized, Not Dosed|Overall Study||30
8526994|NCT02527798|9558701|FG003|Randomized, Not Dosed|Overall Study||10
8526995|NCT02527798|9558702|FG004|Randomized, Not Dosed|Overall Study||0
8526996|NCT02527798|9558703|FG005|Randomized, Not Dosed|Overall Study||0
8526997|NCT02527798|9558698|FG000|Pharmacokinetic (PK) Population|Overall Study||20
8526998|NCT02527798|9558699|FG001|Pharmacokinetic (PK) Population|Overall Study||0
8526999|NCT02527798|9558700|FG002|Pharmacokinetic (PK) Population|Overall Study||19
8527000|NCT02527798|9558701|FG003|Pharmacokinetic (PK) Population|Overall Study||0
8527001|NCT02527798|9558702|FG004|Pharmacokinetic (PK) Population|Overall Study||0
8527002|NCT02527798|9558703|FG005|Pharmacokinetic (PK) Population|Overall Study||0
8527003|NCT02527798|9558698|FG000|COMPLETED|Overall Study||29
8527004|NCT02527798|9558699|FG001|COMPLETED|Overall Study||8
8527005|NCT02527798|9558700|FG002|COMPLETED|Overall Study||25
8527006|NCT02527798|9558701|FG003|COMPLETED|Overall Study||9
8527007|NCT02527798|9558702|FG004|COMPLETED|Overall Study||0
8527008|NCT02527798|9558703|FG005|COMPLETED|Overall Study||0
8527009|NCT02527798|9558698|FG000|NOT COMPLETED|Overall Study||3
8527010|NCT02527798|9558699|FG001|NOT COMPLETED|Overall Study||2
8527011|NCT02527798|9558700|FG002|NOT COMPLETED|Overall Study||5
8527012|NCT02527798|9558701|FG003|NOT COMPLETED|Overall Study||1
8527013|NCT02527798|9558702|FG004|NOT COMPLETED|Overall Study||0
8527014|NCT02527798|9558703|FG005|NOT COMPLETED|Overall Study||0
8527015|NCT02416492|9558734|FG000|STARTED|Overall Study||15
8527016|NCT02416492|9558735|FG001|STARTED|Overall Study||15
8527017|NCT02416492|9558736|FG002|STARTED|Overall Study||16
8527018|NCT02416492|9558737|FG003|STARTED|Overall Study||15
8527019|NCT02416492|9558734|FG000|COMPLETED|Overall Study||15
8527020|NCT02416492|9558735|FG001|COMPLETED|Overall Study||15
8527021|NCT02416492|9558736|FG002|COMPLETED|Overall Study||16
8527022|NCT02416492|9558737|FG003|COMPLETED|Overall Study||15
8527023|NCT02416492|9558734|FG000|NOT COMPLETED|Overall Study||0
8527024|NCT02416492|9558735|FG001|NOT COMPLETED|Overall Study||0
8527025|NCT02416492|9558736|FG002|NOT COMPLETED|Overall Study||0
8527026|NCT02416492|9558737|FG003|NOT COMPLETED|Overall Study||0
8527027|NCT02324816|9558750|FG000|STARTED|Overall Study||19
8527028|NCT02324816|9558750|FG000|COMPLETED|Overall Study||19
8527029|NCT02324816|9558750|FG000|NOT COMPLETED|Overall Study||0
8527030|NCT02279745|9558754|FG000|STARTED|Overall Study||45
8527031|NCT02279745|9558754|FG000|COMPLETED|Overall Study||25
8527032|NCT02279745|9558754|FG000|NOT COMPLETED|Overall Study||20
8527033|NCT02067975|9558760|FG000|STARTED|Overall Study||20
8527034|NCT02067975|9558761|FG001|STARTED|Overall Study||18
8527035|NCT02067975|9558762|FG002|STARTED|Overall Study||21
8527036|NCT02067975|9558763|FG003|STARTED|Overall Study||18
8527037|NCT02067975|9558764|FG004|STARTED|Overall Study||8
8527038|NCT02067975|9558765|FG005|STARTED|Overall Study||8
8527039|NCT02067975|9558760|FG000|COMPLETED|Overall Study||16
8527040|NCT02067975|9558761|FG001|COMPLETED|Overall Study||16
8527041|NCT02067975|9558762|FG002|COMPLETED|Overall Study||19
8527042|NCT02067975|9558763|FG003|COMPLETED|Overall Study||14
8527043|NCT02067975|9558764|FG004|COMPLETED|Overall Study||0
8527044|NCT02067975|9558765|FG005|COMPLETED|Overall Study||0
8527045|NCT02067975|9558760|FG000|NOT COMPLETED|Overall Study||4
8527046|NCT02067975|9558761|FG001|NOT COMPLETED|Overall Study||2
8527047|NCT02067975|9558762|FG002|NOT COMPLETED|Overall Study||2
8527048|NCT02067975|9558763|FG003|NOT COMPLETED|Overall Study||4
8527049|NCT02067975|9558764|FG004|NOT COMPLETED|Overall Study||8
8527050|NCT02067975|9558765|FG005|NOT COMPLETED|Overall Study||8
8527051|NCT02030938|9558777|FG000|STARTED|Overall Study||34
8527052|NCT02030938|9558777|FG000|COMPLETED|Overall Study||29
8527053|NCT02030938|9558777|FG000|NOT COMPLETED|Overall Study||5
8620488|NCT00474526|9659160|FG010|COMPLETED|Overall Study||141
8620489|NCT00474526|9659161|FG011|COMPLETED|Overall Study||139
8620490|NCT00474526|9659162|FG012|COMPLETED|Overall Study||135
8620491|NCT00474526|9659163|FG013|COMPLETED|Overall Study||1270
8527054|NCT02006147|9558789|FG000|STARTED|Overall Study||5
8527055|NCT02006147|9558790|FG001|STARTED|Overall Study||9
8527056|NCT02006147|9558791|FG002|STARTED|Overall Study||0
8527057|NCT02006147|9558792|FG003|STARTED|Overall Study||0
8527058|NCT02006147|9558789|FG000|COMPLETED|Overall Study||3
8527059|NCT02006147|9558790|FG001|COMPLETED|Overall Study||7
8527060|NCT02006147|9558791|FG002|COMPLETED|Overall Study||0
8527061|NCT02006147|9558792|FG003|COMPLETED|Overall Study||0
8527062|NCT02006147|9558789|FG000|NOT COMPLETED|Overall Study||2
8527063|NCT02006147|9558790|FG001|NOT COMPLETED|Overall Study||2
8527064|NCT02006147|9558791|FG002|NOT COMPLETED|Overall Study||0
8527065|NCT02006147|9558792|FG003|NOT COMPLETED|Overall Study||0
8562933|NCT00042224|9595095|FG001|STARTED|Overall Study||19
8562934|NCT00042224|9595094|FG000|COMPLETED|Overall Study||17
8562935|NCT00042224|9595095|FG001|COMPLETED|Overall Study||16
8562936|NCT00042224|9595094|FG000|NOT COMPLETED|Overall Study||3
8562937|NCT00042224|9595095|FG001|NOT COMPLETED|Overall Study||3
8562938|NCT00042432|9595103|FG000|STARTED|Overall Study||27
8562939|NCT00042432|9595104|FG001|STARTED|Overall Study||27
8562940|NCT00042432|9595103|FG000|COMPLETED|Overall Study||18
8562941|NCT00042432|9595104|FG001|COMPLETED|Overall Study||20
8562942|NCT00042432|9595103|FG000|NOT COMPLETED|Overall Study||9
8562943|NCT00042432|9595104|FG001|NOT COMPLETED|Overall Study||7
8562944|NCT00042666|9595110|FG000|STARTED|Overall Study||55
8620492|NCT00474526|9659164|FG014|COMPLETED|Overall Study||281
8620493|NCT00474526|9659165|FG015|COMPLETED|Overall Study||152
8620494|NCT00474526|9659166|FG016|COMPLETED|Overall Study||174
8620495|NCT00474526|9659150|FG000|NOT COMPLETED|Overall Study||33
8620496|NCT00474526|9659151|FG001|NOT COMPLETED|Overall Study||46
8620497|NCT00474526|9659152|FG002|NOT COMPLETED|Overall Study||49
8562945|NCT00042666|9595110|FG000|Received at Least 1 Dose of Study Drug|Overall Study||55
8562946|NCT00042666|9595110|FG000|Completed at Least 1 Cycle of Study Drug|Overall Study||42
8562947|NCT00042666|9595110|FG000|COMPLETED|Overall Study||1
8562948|NCT00042666|9595110|FG000|NOT COMPLETED|Overall Study||54
8562949|NCT00042939|9595117|FG000|STARTED|Overall Study||48
8562950|NCT00042939|9595118|FG001|STARTED|Overall Study||46
8562951|NCT00042939|9595117|FG000|Treated|Overall Study||46
8562952|NCT00042939|9595118|FG001|Treated|Overall Study||45
8562953|NCT00042939|9595117|FG000|Eligible and Began Protocol Therapy|Overall Study||44
8562954|NCT00042939|9595118|FG001|Eligible and Began Protocol Therapy|Overall Study||43
8562955|NCT00042939|9595117|FG000|Patients With EGFR Results Available|Overall Study||30
8562956|NCT00042939|9595118|FG001|Patients With EGFR Results Available|Overall Study||31
8562957|NCT00042939|9595117|FG000|COMPLETED|Overall Study||24
8562958|NCT00042939|9595118|FG001|COMPLETED|Overall Study||25
8562959|NCT00042939|9595117|FG000|NOT COMPLETED|Overall Study||24
8562960|NCT00042939|9595118|FG001|NOT COMPLETED|Overall Study||21
8562961|NCT00042991|9595131|FG000|STARTED|Overall Study||6
8562962|NCT00042991|9595132|FG001|STARTED|Overall Study|These 43 patients form the Phase-II cohort, seven contributing from the Phase-I trial.|43
8562963|NCT00042991|9595133|FG002|STARTED|Overall Study||7
8562964|NCT00042991|9595134|FG003|STARTED|Overall Study||2
8562965|NCT00042991|9595135|FG004|STARTED|Overall Study||3
8562966|NCT00042991|9595136|FG005|STARTED|Overall Study||5
8562967|NCT00042991|9595137|FG006|STARTED|Overall Study||3
8562968|NCT00042991|9595131|FG000|Phase-I Trial|Overall Study||6
8562969|NCT00042991|9595132|FG001|Phase-I Trial|Overall Study|These seven patients contributed to both Phase-I and Phase-II objectives.|7
8562970|NCT00042991|9595133|FG002|Phase-I Trial|Overall Study||7
8562971|NCT00042991|9595134|FG003|Phase-I Trial|Overall Study||2
8562972|NCT00042991|9595135|FG004|Phase-I Trial|Overall Study||3
8562973|NCT00042991|9595136|FG005|Phase-I Trial|Overall Study||5
8562974|NCT00042991|9595137|FG006|Phase-I Trial|Overall Study||3
8562975|NCT00042991|9595131|FG000|Phase-II Trial|Overall Study||0
8562976|NCT00042991|9595132|FG001|Phase-II Trial|Overall Study||36
8562977|NCT00042991|9595133|FG002|Phase-II Trial|Overall Study||0
8562978|NCT00042991|9595134|FG003|Phase-II Trial|Overall Study||0
8562979|NCT00042991|9595135|FG004|Phase-II Trial|Overall Study||0
8562980|NCT00042991|9595136|FG005|Phase-II Trial|Overall Study||0
8562981|NCT00042991|9595137|FG006|Phase-II Trial|Overall Study||0
8562982|NCT00042991|9595131|FG000|COMPLETED|Overall Study||0
8562983|NCT00042991|9595132|FG001|COMPLETED|Overall Study||3
8562984|NCT00042991|9595133|FG002|COMPLETED|Overall Study||1
8562985|NCT00042991|9595134|FG003|COMPLETED|Overall Study||0
8562986|NCT00042991|9595135|FG004|COMPLETED|Overall Study||0
8562987|NCT00042991|9595136|FG005|COMPLETED|Overall Study||0
8562988|NCT00042991|9595137|FG006|COMPLETED|Overall Study||1
8562989|NCT00042991|9595131|FG000|NOT COMPLETED|Overall Study||6
8562990|NCT00042991|9595132|FG001|NOT COMPLETED|Overall Study||40
8562991|NCT00042991|9595133|FG002|NOT COMPLETED|Overall Study||6
8562992|NCT00042991|9595134|FG003|NOT COMPLETED|Overall Study||2
8562993|NCT00042991|9595135|FG004|NOT COMPLETED|Overall Study||3
8562994|NCT00042991|9595136|FG005|NOT COMPLETED|Overall Study||5
8562995|NCT00042991|9595137|FG006|NOT COMPLETED|Overall Study||2
8562996|NCT00043186|9595164|FG000|STARTED|Overall Study||46
8562997|NCT00043186|9595165|FG001|STARTED|Overall Study||44
8562998|NCT00043186|9595166|FG002|STARTED|Overall Study||44
8562999|NCT00043186|9595167|FG003|STARTED|Overall Study||41
8620498|NCT00474526|9659153|FG003|NOT COMPLETED|Overall Study||119
8563000|NCT00043186|9595168|FG004|STARTED|Overall Study||54
8563001|NCT00043186|9595169|FG005|STARTED|Overall Study||47
8563002|NCT00043186|9595170|FG006|STARTED|Overall Study||42
8527066|NCT01940341|9558800|FG000|STARTED|Double-Blind Phase||285
8527067|NCT01940341|9558801|FG001|STARTED|Double-Blind Phase||141
8527068|NCT01940341|9558800|FG000|COMPLETED|Double-Blind Phase||4
8527069|NCT01940341|9558801|FG001|COMPLETED|Double-Blind Phase||1
8527070|NCT01940341|9558800|FG000|NOT COMPLETED|Double-Blind Phase||281
8527071|NCT01940341|9558801|FG001|NOT COMPLETED|Double-Blind Phase||140
8527072|NCT01940341|9558800|FG000|STARTED|Open-label Extension Phase||4
8527073|NCT01940341|9558801|FG001|STARTED|Open-label Extension Phase||1
8527074|NCT01940341|9558800|FG000|COMPLETED|Open-label Extension Phase||0
8527075|NCT01940341|9558801|FG001|COMPLETED|Open-label Extension Phase||0
8527076|NCT01940341|9558800|FG000|NOT COMPLETED|Open-label Extension Phase||4
8527077|NCT01940341|9558801|FG001|NOT COMPLETED|Open-label Extension Phase||1
8527078|NCT01925794|9558809|FG000|STARTED|30 Days||296
8527079|NCT01925794|9558809|FG000|COMPLETED|30 Days||296
8527080|NCT01925794|9558809|FG000|NOT COMPLETED|30 Days||0
8527081|NCT01925794|9558809|FG000|STARTED|180 Days||296
8527082|NCT01925794|9558809|FG000|COMPLETED|180 Days||292
8527083|NCT01925794|9558809|FG000|NOT COMPLETED|180 Days||4
8527084|NCT01925794|9558809|FG000|STARTED|270 Days||292
8527085|NCT01925794|9558809|FG000|COMPLETED|270 Days||287
8527086|NCT01925794|9558809|FG000|NOT COMPLETED|270 Days||5
8527087|NCT01907360|9558819|FG000|STARTED|Overall Study||18
8527088|NCT01907360|9558820|FG001|STARTED|Overall Study||11
8527089|NCT01907360|9558819|FG000|COMPLETED|Overall Study||18
8527090|NCT01907360|9558820|FG001|COMPLETED|Overall Study||11
8527091|NCT01907360|9558819|FG000|NOT COMPLETED|Overall Study||0
8527092|NCT01907360|9558820|FG001|NOT COMPLETED|Overall Study||0
8527093|NCT01856868|9558826|FG000|STARTED|Overall Study||7
8527094|NCT01856868|9558826|FG000|COMPLETED|Overall Study||7
8527095|NCT01856868|9558826|FG000|NOT COMPLETED|Overall Study||0
8527096|NCT01849250|9558832|FG000|STARTED|Overall Study||32
8527097|NCT01849250|9558833|FG001|STARTED|Overall Study||32
8527098|NCT01849250|9558832|FG000|COMPLETED|Overall Study||25
8527099|NCT01849250|9558833|FG001|COMPLETED|Overall Study||29
8527100|NCT01849250|9558832|FG000|NOT COMPLETED|Overall Study||7
8527101|NCT01849250|9558833|FG001|NOT COMPLETED|Overall Study||3
8527102|NCT01592643|9558840|FG000|STARTED|Overall Study||30
8527103|NCT01592643|9558840|FG000|COMPLETED|Overall Study||30
8527104|NCT01592643|9558840|FG000|NOT COMPLETED|Overall Study||0
8527105|NCT01441115|9558844|FG000|STARTED|Overall Study||2
8527106|NCT01441115|9558844|FG000|COMPLETED|Overall Study||1
8527107|NCT01441115|9558844|FG000|NOT COMPLETED|Overall Study||1
8527108|NCT01199302|9558855|FG000|STARTED|Overall Study||20
8527109|NCT01199302|9558856|FG001|STARTED|Overall Study||16
8527110|NCT01199302|9558857|FG002|STARTED|Overall Study||20
8527111|NCT01199302|9558858|FG003|STARTED|Overall Study||11
8527112|NCT01199302|9558855|FG000|COMPLETED|Overall Study||0
8527113|NCT01199302|9558856|FG001|COMPLETED|Overall Study||0
8527114|NCT01199302|9558857|FG002|COMPLETED|Overall Study||0
8527115|NCT01199302|9558858|FG003|COMPLETED|Overall Study||0
8527116|NCT01199302|9558855|FG000|NOT COMPLETED|Overall Study||20
8527117|NCT01199302|9558856|FG001|NOT COMPLETED|Overall Study||16
8527118|NCT01199302|9558857|FG002|NOT COMPLETED|Overall Study||20
8527119|NCT01199302|9558858|FG003|NOT COMPLETED|Overall Study||11
8527120|NCT01123707|9558869|FG000|STARTED|Overall Study||44
8527121|NCT01123707|9558870|FG001|STARTED|Overall Study||41
8527122|NCT01123707|9558871|FG002|STARTED|Overall Study||38
8527123|NCT01123707|9558872|FG003|STARTED|Overall Study||50
8527124|NCT01123707|9558869|FG000|Safety Sample|Overall Study||44
8527125|NCT01123707|9558870|FG001|Safety Sample|Overall Study||41
8527126|NCT01123707|9558871|FG002|Safety Sample|Overall Study||36
8527127|NCT01123707|9558872|FG003|Safety Sample|Overall Study||49
8527128|NCT01123707|9558869|FG000|COMPLETED|Overall Study||0
8527129|NCT01123707|9558870|FG001|COMPLETED|Overall Study||0
8527130|NCT01123707|9558871|FG002|COMPLETED|Overall Study||0
8527131|NCT01123707|9558872|FG003|COMPLETED|Overall Study||0
8527132|NCT01123707|9558869|FG000|NOT COMPLETED|Overall Study||44
8527133|NCT01123707|9558870|FG001|NOT COMPLETED|Overall Study||41
8527134|NCT01123707|9558871|FG002|NOT COMPLETED|Overall Study||38
8527135|NCT01123707|9558872|FG003|NOT COMPLETED|Overall Study||50
8527136|NCT00894244|9558882|FG000|STARTED|Overall Study||25
8527137|NCT00894244|9558882|FG000|COMPLETED|Overall Study||24
8527138|NCT00894244|9558882|FG000|NOT COMPLETED|Overall Study||1
8527139|NCT00462943|9558889|FG000|STARTED|Overall Study||46
8527140|NCT00462943|9558890|FG001|STARTED|Overall Study||31
8527141|NCT00462943|9558891|FG002|STARTED|Overall Study||23
8527142|NCT00462943|9558889|FG000|COMPLETED|Overall Study||1
8527143|NCT00462943|9558890|FG001|COMPLETED|Overall Study||1
8527144|NCT00462943|9558891|FG002|COMPLETED|Overall Study||0
8527145|NCT00462943|9558889|FG000|NOT COMPLETED|Overall Study||45
8527146|NCT00462943|9558890|FG001|NOT COMPLETED|Overall Study||30
8527147|NCT00462943|9558891|FG002|NOT COMPLETED|Overall Study||23
8527148|NCT00248287|9558901|FG000|STARTED|Overall Study||75
8527149|NCT00248287|9558902|FG001|STARTED|Overall Study||79
8527150|NCT00248287|9558901|FG000|COMPLETED|Overall Study||51
8527151|NCT00248287|9558902|FG001|COMPLETED|Overall Study||60
8527152|NCT00248287|9558901|FG000|NOT COMPLETED|Overall Study||24
8527153|NCT00248287|9558902|FG001|NOT COMPLETED|Overall Study||19
8527154|NCT00182728|9558908|FG000|STARTED|Overall Study||71
8527155|NCT00182728|9558908|FG000|COMPLETED|Overall Study||71
8527156|NCT00182728|9558908|FG000|NOT COMPLETED|Overall Study||0
8527157|NCT00105560|9558912|FG000|STARTED|Overall Study||59
8527158|NCT00105560|9558912|FG000|COMPLETED|Overall Study||58
8527159|NCT00105560|9558912|FG000|NOT COMPLETED|Overall Study||1
8527160|NCT00038727|9558928|FG000|STARTED|Overall Study|Includes all enrollees from DPPOS 1-3|916
8527161|NCT00038727|9558929|FG001|STARTED|Overall Study|Includes all enrollees from DPPOS 1-3|927
8527162|NCT00038727|9558930|FG002|STARTED|Overall Study|Includes all enrollees from DPPOS 1-3|936
8527163|NCT00038727|9558928|FG000|DPPOS Phase 1 Primary|Overall Study|As reported in the Lancet 2009|910
8527164|NCT00038727|9558929|FG001|DPPOS Phase 1 Primary|Overall Study|As reported in the Lancet 2009|924
8527165|NCT00038727|9558930|FG002|DPPOS Phase 1 Primary|Overall Study|As reported in the Lancet 2009|932
8527166|NCT00038727|9558928|FG000|DPPOS Phase 2 Enrolled|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|915
8527167|NCT00038727|9558929|FG001|DPPOS Phase 2 Enrolled|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|926
8527168|NCT00038727|9558930|FG002|DPPOS Phase 2 Enrolled|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|935
8527169|NCT00038727|9558928|FG000|DPPOS Phase 2 Primary|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|751
8527170|NCT00038727|9558929|FG001|DPPOS Phase 2 Primary|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|772
8527171|NCT00038727|9558930|FG002|DPPOS Phase 2 Primary|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|780
8527172|NCT00038727|9558928|FG000|DPPOS Phase 3 Enrolled|Overall Study||916
8527173|NCT00038727|9558929|FG001|DPPOS Phase 3 Enrolled|Overall Study||927
8527174|NCT00038727|9558930|FG002|DPPOS Phase 3 Enrolled|Overall Study||936
8527175|NCT00038727|9558928|FG000|COMPLETED|Overall Study||916
8527176|NCT00038727|9558929|FG001|COMPLETED|Overall Study||927
8527177|NCT00038727|9558930|FG002|COMPLETED|Overall Study||936
8527178|NCT00038727|9558928|FG000|NOT COMPLETED|Overall Study||0
8527179|NCT00038727|9558929|FG001|NOT COMPLETED|Overall Study||0
8527180|NCT00038727|9558930|FG002|NOT COMPLETED|Overall Study||0
8563003|NCT00043186|9595171|FG007|STARTED|Overall Study||47
8563004|NCT00043186|9595172|FG008|STARTED|Overall Study||47
8563005|NCT00043186|9595164|FG000|COMPLETED|Overall Study||29
8563006|NCT00043186|9595165|FG001|COMPLETED|Overall Study||29
8563007|NCT00043186|9595166|FG002|COMPLETED|Overall Study||24
8563008|NCT00043186|9595167|FG003|COMPLETED|Overall Study||19
8563009|NCT00043186|9595168|FG004|COMPLETED|Overall Study||36
8563010|NCT00043186|9595169|FG005|COMPLETED|Overall Study||39
8563011|NCT00043186|9595170|FG006|COMPLETED|Overall Study||25
8563012|NCT00043186|9595171|FG007|COMPLETED|Overall Study||31
8563013|NCT00043186|9595172|FG008|COMPLETED|Overall Study||30
8563014|NCT00043186|9595164|FG000|NOT COMPLETED|Overall Study||17
8563015|NCT00043186|9595165|FG001|NOT COMPLETED|Overall Study||15
8563016|NCT00043186|9595166|FG002|NOT COMPLETED|Overall Study||20
8563017|NCT00043186|9595167|FG003|NOT COMPLETED|Overall Study||22
8563018|NCT00043186|9595168|FG004|NOT COMPLETED|Overall Study||18
8563019|NCT00043186|9595169|FG005|NOT COMPLETED|Overall Study||8
8563020|NCT00043186|9595170|FG006|NOT COMPLETED|Overall Study||17
8563021|NCT00043186|9595171|FG007|NOT COMPLETED|Overall Study||16
8563022|NCT00043186|9595172|FG008|NOT COMPLETED|Overall Study||17
8563023|NCT00043550|9595196|FG000|STARTED|Overall Study||55
8563024|NCT00043550|9595197|FG001|STARTED|Overall Study||51
8563025|NCT00043550|9595198|FG002|STARTED|Overall Study||50
8563026|NCT00043550|9595196|FG000|Week 8 Completed|Overall Study||35
8563027|NCT00043550|9595197|FG001|Week 8 Completed|Overall Study||40
8563028|NCT00043550|9595198|FG002|Week 8 Completed|Overall Study||35
8563029|NCT00043550|9595196|FG000|COMPLETED|Overall Study||33
8563030|NCT00043550|9595197|FG001|COMPLETED|Overall Study||39
8563031|NCT00043550|9595198|FG002|COMPLETED|Overall Study||30
8563032|NCT00043550|9595196|FG000|NOT COMPLETED|Overall Study||22
8563033|NCT00043550|9595197|FG001|NOT COMPLETED|Overall Study||12
8563034|NCT00043550|9595198|FG002|NOT COMPLETED|Overall Study||20
8563035|NCT00043979|9595208|FG000|STARTED|Period 1||30
8563036|NCT00043979|9595209|FG001|STARTED|Period 1||17
8563037|NCT00043979|9595210|FG002|STARTED|Period 1||13
8563038|NCT00043979|9595208|FG000|COMPLETED|Period 1||23
8563039|NCT00043979|9595209|FG001|COMPLETED|Period 1||13
8563040|NCT00043979|9595210|FG002|COMPLETED|Period 1||10
8563041|NCT00043979|9595208|FG000|NOT COMPLETED|Period 1||7
8563042|NCT00043979|9595209|FG001|NOT COMPLETED|Period 1||4
8563043|NCT00043979|9595210|FG002|NOT COMPLETED|Period 1||3
8563044|NCT00043979|9595208|FG000|STARTED|Period 2||0
8563045|NCT00043979|9595209|FG001|STARTED|Period 2||13
8563046|NCT00043979|9595210|FG002|STARTED|Period 2||10
8563047|NCT00043979|9595208|FG000|COMPLETED|Period 2||0
8563048|NCT00043979|9595209|FG001|COMPLETED|Period 2||13
8563049|NCT00043979|9595210|FG002|COMPLETED|Period 2||10
8563050|NCT00043979|9595208|FG000|NOT COMPLETED|Period 2||0
8563051|NCT00043979|9595209|FG001|NOT COMPLETED|Period 2||0
8563052|NCT00043979|9595210|FG002|NOT COMPLETED|Period 2||0
8563053|NCT00044005|9595219|FG000|STARTED|Overall Study||32
8563054|NCT00044005|9595220|FG001|STARTED|Overall Study||33
8563055|NCT00044005|9595221|FG002|STARTED|Overall Study||33
8563056|NCT00044005|9595219|FG000|COMPLETED|Overall Study||13
8563057|NCT00044005|9595220|FG001|COMPLETED|Overall Study||19
8563058|NCT00044005|9595221|FG002|COMPLETED|Overall Study||11
8563059|NCT00044005|9595219|FG000|NOT COMPLETED|Overall Study||19
8563060|NCT00044005|9595220|FG001|NOT COMPLETED|Overall Study||14
8563061|NCT00044005|9595221|FG002|NOT COMPLETED|Overall Study||22
8563062|NCT00044044|9595234|FG000|STARTED|Overall Study||71
8563063|NCT00044044|9595235|FG001|STARTED|Overall Study||69
8563064|NCT00044044|9595236|FG002|STARTED|Overall Study||71
8563065|NCT00044044|9595237|FG003|STARTED|Overall Study||73
8563066|NCT00044044|9595238|FG004|STARTED|Overall Study||72
8527181|NCT04569786|9558946|FG000|STARTED|Overall Study||39
8527182|NCT04569786|9558947|FG001|STARTED|Overall Study||39
8527183|NCT04569786|9558948|FG002|STARTED|Overall Study||42
8527184|NCT04569786|9558949|FG003|STARTED|Overall Study||56
8527185|NCT04569786|9558950|FG004|STARTED|Overall Study||56
8527186|NCT04569786|9558946|FG000|COMPLETED|Overall Study||38
8527187|NCT04569786|9558947|FG001|COMPLETED|Overall Study||39
8527188|NCT04569786|9558948|FG002|COMPLETED|Overall Study||38
8527189|NCT04569786|9558949|FG003|COMPLETED|Overall Study||49
8527190|NCT04569786|9558950|FG004|COMPLETED|Overall Study||55
8527191|NCT04569786|9558946|FG000|NOT COMPLETED|Overall Study||1
8527192|NCT04569786|9558947|FG001|NOT COMPLETED|Overall Study||0
8527193|NCT04569786|9558948|FG002|NOT COMPLETED|Overall Study||4
8527194|NCT04569786|9558949|FG003|NOT COMPLETED|Overall Study||7
8527195|NCT04569786|9558950|FG004|NOT COMPLETED|Overall Study||1
8527196|NCT04409041|9558962|FG000|STARTED|Overall Study||43
8527197|NCT04409041|9558962|FG000|COMPLETED|Overall Study||26
8527198|NCT04409041|9558962|FG000|NOT COMPLETED|Overall Study||17
8527199|NCT04129944|9558971|FG000|STARTED|Overall Study||46
8527200|NCT04129944|9558972|FG001|STARTED|Overall Study||45
8527201|NCT04129944|9558973|FG002|STARTED|Overall Study||46
8527202|NCT04129944|9558974|FG003|STARTED|Overall Study||46
8527203|NCT04129944|9558971|FG000|COMPLETED|Overall Study||44
8527204|NCT04129944|9558972|FG001|COMPLETED|Overall Study||45
8527205|NCT04129944|9558973|FG002|COMPLETED|Overall Study||45
8527206|NCT04129944|9558974|FG003|COMPLETED|Overall Study||43
8527207|NCT04129944|9558971|FG000|NOT COMPLETED|Overall Study||2
8527208|NCT04129944|9558972|FG001|NOT COMPLETED|Overall Study||0
8527209|NCT04129944|9558973|FG002|NOT COMPLETED|Overall Study||1
8527210|NCT04129944|9558974|FG003|NOT COMPLETED|Overall Study||3
8527211|NCT03861728|9558986|FG000|STARTED|Overall Study||6
8527212|NCT03861728|9558987|FG001|STARTED|Overall Study||5
8527213|NCT03861728|9558986|FG000|COMPLETED|Overall Study||6
8527214|NCT03861728|9558987|FG001|COMPLETED|Overall Study||5
8527215|NCT03861728|9558986|FG000|NOT COMPLETED|Overall Study||0
8527216|NCT03861728|9558987|FG001|NOT COMPLETED|Overall Study||0
8527217|NCT03857542|9558995|FG000|STARTED|Overall Study||215
8527218|NCT03857542|9558996|FG001|STARTED|Overall Study||212
8527219|NCT03857542|9558995|FG000|COMPLETED|Overall Study||209
8527220|NCT03857542|9558996|FG001|COMPLETED|Overall Study||207
8527221|NCT03857542|9558995|FG000|NOT COMPLETED|Overall Study||6
8527222|NCT03857542|9558996|FG001|NOT COMPLETED|Overall Study||5
8527223|NCT03848832|9559006|FG000|STARTED|Overall Study||10
8527224|NCT03848832|9559007|FG001|STARTED|Overall Study||9
8527225|NCT03848832|9559008|FG002|STARTED|Overall Study||10
8527226|NCT03848832|9559006|FG000|COMPLETED|Overall Study||7
8527227|NCT03848832|9559007|FG001|COMPLETED|Overall Study||6
8527228|NCT03848832|9559008|FG002|COMPLETED|Overall Study||4
8527229|NCT03848832|9559006|FG000|NOT COMPLETED|Overall Study||3
8527230|NCT03848832|9559007|FG001|NOT COMPLETED|Overall Study||3
8527231|NCT03848832|9559008|FG002|NOT COMPLETED|Overall Study||6
8527232|NCT03688802|9559020|FG000|STARTED|Overall Study||12
8527233|NCT03688802|9559021|FG001|STARTED|Overall Study||6
8527234|NCT03688802|9559020|FG000|COMPLETED|Overall Study||11
8527235|NCT03688802|9559021|FG001|COMPLETED|Overall Study||6
8527236|NCT03688802|9559020|FG000|NOT COMPLETED|Overall Study||1
8527237|NCT03688802|9559021|FG001|NOT COMPLETED|Overall Study||0
8527238|NCT03656744|9559030|FG000|STARTED|Overall Study||34
8527239|NCT03656744|9559031|FG001|STARTED|Overall Study||34
8527240|NCT03656744|9559032|FG002|STARTED|Overall Study||33
8527241|NCT03656744|9559030|FG000|COMPLETED|Overall Study||29
8527242|NCT03656744|9559031|FG001|COMPLETED|Overall Study||27
8527243|NCT03656744|9559032|FG002|COMPLETED|Overall Study||32
8527244|NCT03656744|9559030|FG000|NOT COMPLETED|Overall Study||5
8527245|NCT03656744|9559031|FG001|NOT COMPLETED|Overall Study||7
8527246|NCT03656744|9559032|FG002|NOT COMPLETED|Overall Study||1
8527247|NCT03510598|9559040|FG000|STARTED|Overall Study||16
8527248|NCT03510598|9559040|FG000|COMPLETED|Overall Study||15
8527249|NCT03510598|9559040|FG000|NOT COMPLETED|Overall Study||1
8527250|NCT03487796|9559048|FG000|STARTED|Overall Study||41
8527251|NCT03487796|9559049|FG001|STARTED|Overall Study||31
8527252|NCT03487796|9559048|FG000|2 Month Follow-up|Overall Study||24
8527253|NCT03487796|9559049|FG001|2 Month Follow-up|Overall Study||26
8527254|NCT03487796|9559048|FG000|COMPLETED|Overall Study||23
8527255|NCT03487796|9559049|FG001|COMPLETED|Overall Study||25
8527256|NCT03487796|9559048|FG000|NOT COMPLETED|Overall Study||18
8527257|NCT03487796|9559049|FG001|NOT COMPLETED|Overall Study||6
8527258|NCT03446612|9559063|FG000|STARTED|Overall Study||2
8527259|NCT03446612|9559064|FG001|STARTED|Overall Study||3
8527260|NCT03446612|9559063|FG000|COMPLETED|Overall Study||2
8527261|NCT03446612|9559064|FG001|COMPLETED|Overall Study||2
8527262|NCT03446612|9559063|FG000|NOT COMPLETED|Overall Study||0
8527263|NCT03446612|9559064|FG001|NOT COMPLETED|Overall Study||1
8527264|NCT03436433|9559075|FG000|STARTED|Overall Study||1
8527265|NCT03436433|9559076|FG001|STARTED|Overall Study||2
8527266|NCT03436433|9559077|FG002|STARTED|Overall Study||1
8527267|NCT03436433|9559075|FG000|COMPLETED|Overall Study||1
8527268|NCT03436433|9559076|FG001|COMPLETED|Overall Study||2
8527269|NCT03436433|9559077|FG002|COMPLETED|Overall Study||1
8527270|NCT03436433|9559075|FG000|NOT COMPLETED|Overall Study||0
8527271|NCT03436433|9559076|FG001|NOT COMPLETED|Overall Study||0
8527272|NCT03436433|9559077|FG002|NOT COMPLETED|Overall Study||0
8527273|NCT03370120|9559085|FG000|STARTED|Overall Study||406
8527274|NCT03370120|9559085|FG000|COMPLETED|Overall Study||0
8527275|NCT03370120|9559085|FG000|NOT COMPLETED|Overall Study||406
8527276|NCT03367429|9559094|FG000|STARTED|Overall Study||0
8527277|NCT03367429|9559095|FG001|STARTED|Overall Study||1
8527278|NCT03367429|9559096|FG002|STARTED|Overall Study||2
8527279|NCT03367429|9559094|FG000|COMPLETED|Overall Study||0
8527280|NCT03367429|9559095|FG001|COMPLETED|Overall Study||1
8620499|NCT00474526|9659154|FG004|NOT COMPLETED|Overall Study||68
8620500|NCT00474526|9659155|FG005|NOT COMPLETED|Overall Study||16
8620501|NCT00474526|9659156|FG006|NOT COMPLETED|Overall Study||25
8620502|NCT00474526|9659157|FG007|NOT COMPLETED|Overall Study||6
8620503|NCT00474526|9659158|FG008|NOT COMPLETED|Overall Study||6
8527281|NCT03367429|9559096|FG002|COMPLETED|Overall Study||2
8527282|NCT03367429|9559094|FG000|NOT COMPLETED|Overall Study||0
8527283|NCT03367429|9559095|FG001|NOT COMPLETED|Overall Study||0
8527284|NCT03367429|9559096|FG002|NOT COMPLETED|Overall Study||0
8527285|NCT03143829|9559108|FG000|STARTED|Overall Study||38
8527286|NCT03143829|9559109|FG001|STARTED|Overall Study||42
8527287|NCT03143829|9559108|FG000|COMPLETED|Overall Study||33
8527288|NCT03143829|9559109|FG001|COMPLETED|Overall Study||32
8527289|NCT03143829|9559108|FG000|NOT COMPLETED|Overall Study||5
8527290|NCT03143829|9559109|FG001|NOT COMPLETED|Overall Study||10
8563067|NCT00044044|9595234|FG000|COMPLETED|Overall Study||27
8563068|NCT00044044|9595235|FG001|COMPLETED|Overall Study||28
8563069|NCT00044044|9595236|FG002|COMPLETED|Overall Study||31
8563070|NCT00044044|9595237|FG003|COMPLETED|Overall Study||29
8563071|NCT00044044|9595238|FG004|COMPLETED|Overall Study||36
8563072|NCT00044044|9595234|FG000|NOT COMPLETED|Overall Study||44
8563073|NCT00044044|9595235|FG001|NOT COMPLETED|Overall Study||41
8563074|NCT00044044|9595236|FG002|NOT COMPLETED|Overall Study||40
8563075|NCT00044044|9595237|FG003|NOT COMPLETED|Overall Study||44
8563076|NCT00044044|9595238|FG004|NOT COMPLETED|Overall Study||36
8563077|NCT00044083|9595252|FG000|STARTED|First Intervention (One Week)- HV's||74
8563078|NCT00044083|9595253|FG001|STARTED|First Intervention (One Week)- HV's||73
8563079|NCT00044083|9595252|FG000|COMPLETED|First Intervention (One Week)- HV's||64
8563080|NCT00044083|9595253|FG001|COMPLETED|First Intervention (One Week)- HV's||66
8563081|NCT00044083|9595252|FG000|NOT COMPLETED|First Intervention (One Week)- HV's||10
8563082|NCT00044083|9595253|FG001|NOT COMPLETED|First Intervention (One Week)- HV's||7
8563083|NCT00044083|9595252|FG000|STARTED|Second Intervention (One Week) HV's||64
8563084|NCT00044083|9595253|FG001|STARTED|Second Intervention (One Week) HV's||66
8563085|NCT00044083|9595252|FG000|COMPLETED|Second Intervention (One Week) HV's||64
8563086|NCT00044083|9595253|FG001|COMPLETED|Second Intervention (One Week) HV's||66
8563087|NCT00044083|9595252|FG000|NOT COMPLETED|Second Intervention (One Week) HV's||0
8563088|NCT00044083|9595253|FG001|NOT COMPLETED|Second Intervention (One Week) HV's||0
8563089|NCT00044083|9595252|FG000|STARTED|First Intervention (One Week) Patients||31
8563090|NCT00044083|9595253|FG001|STARTED|First Intervention (One Week) Patients||32
8563091|NCT00044083|9595252|FG000|COMPLETED|First Intervention (One Week) Patients||30
8563092|NCT00044083|9595253|FG001|COMPLETED|First Intervention (One Week) Patients||30
8563093|NCT00044083|9595252|FG000|NOT COMPLETED|First Intervention (One Week) Patients||1
8563094|NCT00044083|9595253|FG001|NOT COMPLETED|First Intervention (One Week) Patients||2
8563095|NCT00044083|9595252|FG000|STARTED|Second Intervention (One Week) Patients||30
8563096|NCT00044083|9595253|FG001|STARTED|Second Intervention (One Week) Patients||30
8563097|NCT00044083|9595252|FG000|COMPLETED|Second Intervention (One Week) Patients||30
8563098|NCT00044083|9595253|FG001|COMPLETED|Second Intervention (One Week) Patients||29
8563099|NCT00044083|9595252|FG000|NOT COMPLETED|Second Intervention (One Week) Patients||0
8563100|NCT00044083|9595253|FG001|NOT COMPLETED|Second Intervention (One Week) Patients||1
8563101|NCT00044213|9595290|FG000|STARTED|Overall Study||421
8563102|NCT00044213|9595291|FG001|STARTED|Overall Study||418
8563103|NCT00044213|9595292|FG002|STARTED|Overall Study||432
8563104|NCT00044213|9595293|FG003|STARTED|Overall Study||437
8563105|NCT00044213|9595290|FG000|COMPLETED|Overall Study||321
8563106|NCT00044213|9595291|FG001|COMPLETED|Overall Study||306
8563107|NCT00044213|9595292|FG002|COMPLETED|Overall Study||294
8563108|NCT00044213|9595293|FG003|COMPLETED|Overall Study||301
8563109|NCT00044213|9595290|FG000|NOT COMPLETED|Overall Study||100
8563110|NCT00044213|9595291|FG001|NOT COMPLETED|Overall Study||112
8563111|NCT00044213|9595292|FG002|NOT COMPLETED|Overall Study||138
8563112|NCT00044213|9595293|FG003|NOT COMPLETED|Overall Study||136
8563113|NCT00044512|9595303|FG000|STARTED|Treatment||137
8563114|NCT00044512|9595303|FG000|COMPLETED|Treatment||137
8563115|NCT00044512|9595303|FG000|NOT COMPLETED|Treatment||0
8563116|NCT00044512|9595303|FG000|STARTED|Follow Up||137
8563117|NCT00044512|9595303|FG000|COMPLETED|Follow Up||135
8563118|NCT00044512|9595303|FG000|NOT COMPLETED|Follow Up||2
8563119|NCT00044655|9595309|FG000|STARTED|Overall Study||102
8563120|NCT00044655|9595310|FG001|STARTED|Overall Study||117
8563121|NCT00044655|9595309|FG000|COMPLETED|Overall Study||82
8563122|NCT00044655|9595310|FG001|COMPLETED|Overall Study||79
8563123|NCT00044655|9595309|FG000|NOT COMPLETED|Overall Study||20
8563124|NCT00044655|9595310|FG001|NOT COMPLETED|Overall Study||38
8563125|NCT00045032|9595319|FG000|STARTED|Overall Study|Included all participants with available signed Informed Consent Form.|1697
8563126|NCT00045032|9595320|FG001|STARTED|Overall Study|Included all participants with available signed Informed Consent Form.|1702
8563127|NCT00045032|9595321|FG002|STARTED|Overall Study|Included all participants with available signed Informed Consent Form.|1700
8563128|NCT00045032|9595319|FG000|Crossover to Adjuvant Herceptin|Overall Study||888
8569194|NCT00095498|9601397|FG000|NOT COMPLETED|Overall Study||37
8527291|NCT03099863|9559117|FG000|STARTED|Overall Study||121
8527292|NCT03099863|9559118|FG001|STARTED|Overall Study||121
8527293|NCT03099863|9559117|FG000|COMPLETED|Overall Study||111
8527294|NCT03099863|9559118|FG001|COMPLETED|Overall Study||105
8527295|NCT03099863|9559117|FG000|NOT COMPLETED|Overall Study||10
8527296|NCT03099863|9559118|FG001|NOT COMPLETED|Overall Study||16
8527297|NCT02963610|9559124|FG000|STARTED|Overall Study||3
8527298|NCT02963610|9559124|FG000|COMPLETED|Overall Study||0
8527299|NCT02963610|9559124|FG000|NOT COMPLETED|Overall Study||3
8527300|NCT02766335|9559131|FG000|STARTED|Initial Registration||68
8527301|NCT02766335|9559132|FG001|STARTED|Initial Registration||30
8527302|NCT02766335|9559133|FG002|STARTED|Initial Registration||0
8527303|NCT02766335|9559131|FG000|Eligible Participants Enrolled Before Docetaxel Arm Closed|Initial Registration||32
8527304|NCT02766335|9559132|FG001|Eligible Participants Enrolled Before Docetaxel Arm Closed|Initial Registration||30
8527305|NCT02766335|9559133|FG002|Eligible Participants Enrolled Before Docetaxel Arm Closed|Initial Registration||0
8527306|NCT02766335|9559131|FG000|COMPLETED|Initial Registration||10
8527307|NCT02766335|9559132|FG001|COMPLETED|Initial Registration||0
8527308|NCT02766335|9559133|FG002|COMPLETED|Initial Registration||0
8527309|NCT02766335|9559131|FG000|NOT COMPLETED|Initial Registration||58
8527310|NCT02766335|9559132|FG001|NOT COMPLETED|Initial Registration||30
8527311|NCT02766335|9559133|FG002|NOT COMPLETED|Initial Registration||0
8527312|NCT02766335|9559131|FG000|STARTED|Re-registration of Arm I to MEDI4738||0
8527313|NCT02766335|9559132|FG001|STARTED|Re-registration of Arm I to MEDI4738||0
8527314|NCT02766335|9559133|FG002|STARTED|Re-registration of Arm I to MEDI4738||4
8527315|NCT02766335|9559131|FG000|COMPLETED|Re-registration of Arm I to MEDI4738||0
8527316|NCT02766335|9559132|FG001|COMPLETED|Re-registration of Arm I to MEDI4738||0
8527317|NCT02766335|9559133|FG002|COMPLETED|Re-registration of Arm I to MEDI4738||2
8527318|NCT02766335|9559131|FG000|NOT COMPLETED|Re-registration of Arm I to MEDI4738||0
8527319|NCT02766335|9559132|FG001|NOT COMPLETED|Re-registration of Arm I to MEDI4738||0
8527320|NCT02766335|9559133|FG002|NOT COMPLETED|Re-registration of Arm I to MEDI4738||2
8527321|NCT02606136|9559139|FG000|STARTED|Overall Study||21
8527322|NCT02606136|9559139|FG000|Received at Least 1 Dose of Study Drug|Overall Study||21
8527323|NCT02606136|9559139|FG000|COMPLETED|Overall Study||15
8527324|NCT02606136|9559139|FG000|NOT COMPLETED|Overall Study||6
8527325|NCT02228382|9559148|FG000|STARTED|Overall Study||46
8527326|NCT02228382|9559149|FG001|STARTED|Overall Study||61
8527327|NCT02228382|9559150|FG002|STARTED|Overall Study||49
8527328|NCT02228382|9559151|FG003|STARTED|Overall Study||4
8527329|NCT02228382|9559152|FG004|STARTED|Overall Study||3
8527330|NCT02228382|9559148|FG000|COMPLETED|Overall Study||36
8527331|NCT02228382|9559149|FG001|COMPLETED|Overall Study||43
8527332|NCT02228382|9559150|FG002|COMPLETED|Overall Study||28
8527333|NCT02228382|9559151|FG003|COMPLETED|Overall Study||2
8527334|NCT02228382|9559152|FG004|COMPLETED|Overall Study||1
8527335|NCT02228382|9559148|FG000|NOT COMPLETED|Overall Study||10
8527336|NCT02228382|9559149|FG001|NOT COMPLETED|Overall Study||18
8527337|NCT02228382|9559150|FG002|NOT COMPLETED|Overall Study||21
8527338|NCT02228382|9559151|FG003|NOT COMPLETED|Overall Study||2
8527339|NCT02228382|9559152|FG004|NOT COMPLETED|Overall Study||2
8527340|NCT02090998|9559171|FG000|STARTED|Overall Study||2
8527341|NCT02090998|9559172|FG001|STARTED|Overall Study||8
8527342|NCT02090998|9559171|FG000|COMPLETED|Overall Study||2
8527343|NCT02090998|9559172|FG001|COMPLETED|Overall Study||8
8527344|NCT02090998|9559171|FG000|NOT COMPLETED|Overall Study||0
8527345|NCT02090998|9559172|FG001|NOT COMPLETED|Overall Study||0
8527346|NCT02051309|9559180|FG000|STARTED|Overall Study||58
8527347|NCT02051309|9559181|FG001|STARTED|Overall Study||63
8527348|NCT02051309|9559180|FG000|COMPLETED|Overall Study||26
8527349|NCT02051309|9559181|FG001|COMPLETED|Overall Study||35
8527350|NCT02051309|9559180|FG000|NOT COMPLETED|Overall Study||32
8527351|NCT02051309|9559181|FG001|NOT COMPLETED|Overall Study||28
8527352|NCT02001623|9559202|FG000|STARTED|Overall Study||3
8527353|NCT02001623|9559203|FG001|STARTED|Overall Study||3
8527354|NCT02001623|9559204|FG002|STARTED|Overall Study||3
8527355|NCT02001623|9559205|FG003|STARTED|Overall Study||3
8527356|NCT02001623|9559206|FG004|STARTED|Overall Study||3
8527357|NCT02001623|9559207|FG005|STARTED|Overall Study||3
8527358|NCT02001623|9559208|FG006|STARTED|Overall Study||3
8527359|NCT02001623|9559209|FG007|STARTED|Overall Study||6
8527360|NCT02001623|9559210|FG008|STARTED|Overall Study||15
8527361|NCT02001623|9559211|FG009|STARTED|Overall Study||55
8527362|NCT02001623|9559212|FG010|STARTED|Overall Study||14
8527363|NCT02001623|9559213|FG011|STARTED|Overall Study||15
8527364|NCT02001623|9559214|FG012|STARTED|Overall Study||15
8527365|NCT02001623|9559215|FG013|STARTED|Overall Study||36
8527366|NCT02001623|9559216|FG014|STARTED|Overall Study||18
8527367|NCT02001623|9559202|FG000|Completed 4 Cycles of Treatment|Overall Study||0
8527368|NCT02001623|9559203|FG001|Completed 4 Cycles of Treatment|Overall Study||1
8527369|NCT02001623|9559204|FG002|Completed 4 Cycles of Treatment|Overall Study||1
8527370|NCT02001623|9559205|FG003|Completed 4 Cycles of Treatment|Overall Study||2
8527371|NCT02001623|9559206|FG004|Completed 4 Cycles of Treatment|Overall Study||0
8527372|NCT02001623|9559207|FG005|Completed 4 Cycles of Treatment|Overall Study||2
8527373|NCT02001623|9559208|FG006|Completed 4 Cycles of Treatment|Overall Study||2
8527374|NCT02001623|9559209|FG007|Completed 4 Cycles of Treatment|Overall Study||1
8527375|NCT02001623|9559210|FG008|Completed 4 Cycles of Treatment|Overall Study||5
8527376|NCT02001623|9559211|FG009|Completed 4 Cycles of Treatment|Overall Study||31
8527377|NCT02001623|9559212|FG010|Completed 4 Cycles of Treatment|Overall Study||6
8527378|NCT02001623|9559213|FG011|Completed 4 Cycles of Treatment|Overall Study||4
8527379|NCT02001623|9559214|FG012|Completed 4 Cycles of Treatment|Overall Study||6
8527380|NCT02001623|9559215|FG013|Completed 4 Cycles of Treatment|Overall Study||22
8527381|NCT02001623|9559216|FG014|Completed 4 Cycles of Treatment|Overall Study||7
8527382|NCT02001623|9559202|FG000|Completed 12 Cycles of Treatment|Overall Study||0
8527383|NCT02001623|9559203|FG001|Completed 12 Cycles of Treatment|Overall Study||1
8527384|NCT02001623|9559204|FG002|Completed 12 Cycles of Treatment|Overall Study||0
8527385|NCT02001623|9559205|FG003|Completed 12 Cycles of Treatment|Overall Study||1
8527386|NCT02001623|9559206|FG004|Completed 12 Cycles of Treatment|Overall Study||0
8527387|NCT02001623|9559207|FG005|Completed 12 Cycles of Treatment|Overall Study||0
8527388|NCT02001623|9559208|FG006|Completed 12 Cycles of Treatment|Overall Study||0
8527389|NCT02001623|9559209|FG007|Completed 12 Cycles of Treatment|Overall Study||0
8527390|NCT02001623|9559210|FG008|Completed 12 Cycles of Treatment|Overall Study||0
8527391|NCT02001623|9559211|FG009|Completed 12 Cycles of Treatment|Overall Study||3
8527392|NCT02001623|9559212|FG010|Completed 12 Cycles of Treatment|Overall Study||0
8527393|NCT02001623|9559213|FG011|Completed 12 Cycles of Treatment|Overall Study||0
8527394|NCT02001623|9559214|FG012|Completed 12 Cycles of Treatment|Overall Study||1
8527395|NCT02001623|9559215|FG013|Completed 12 Cycles of Treatment|Overall Study||1
8527396|NCT02001623|9559216|FG014|Completed 12 Cycles of Treatment|Overall Study||0
8527397|NCT02001623|9559202|FG000|COMPLETED|Overall Study||0
8527398|NCT02001623|9559203|FG001|COMPLETED|Overall Study||0
8527399|NCT02001623|9559204|FG002|COMPLETED|Overall Study||0
8527400|NCT02001623|9559205|FG003|COMPLETED|Overall Study||1
8527401|NCT02001623|9559206|FG004|COMPLETED|Overall Study||0
8527402|NCT02001623|9559207|FG005|COMPLETED|Overall Study||0
8527403|NCT02001623|9559208|FG006|COMPLETED|Overall Study||0
8527404|NCT02001623|9559209|FG007|COMPLETED|Overall Study||0
8527405|NCT02001623|9559210|FG008|COMPLETED|Overall Study||0
8527406|NCT02001623|9559211|FG009|COMPLETED|Overall Study||2
8527407|NCT02001623|9559212|FG010|COMPLETED|Overall Study||0
8527408|NCT02001623|9559213|FG011|COMPLETED|Overall Study||0
8527409|NCT02001623|9559214|FG012|COMPLETED|Overall Study||1
8527410|NCT02001623|9559215|FG013|COMPLETED|Overall Study||1
8527411|NCT02001623|9559216|FG014|COMPLETED|Overall Study||0
8527412|NCT02001623|9559202|FG000|NOT COMPLETED|Overall Study||3
8527413|NCT02001623|9559203|FG001|NOT COMPLETED|Overall Study||3
8527414|NCT02001623|9559204|FG002|NOT COMPLETED|Overall Study||3
8527415|NCT02001623|9559205|FG003|NOT COMPLETED|Overall Study||2
8527416|NCT02001623|9559206|FG004|NOT COMPLETED|Overall Study||3
8527417|NCT02001623|9559207|FG005|NOT COMPLETED|Overall Study||3
8527418|NCT02001623|9559208|FG006|NOT COMPLETED|Overall Study||3
8527419|NCT02001623|9559209|FG007|NOT COMPLETED|Overall Study||6
8527420|NCT02001623|9559210|FG008|NOT COMPLETED|Overall Study||15
8527421|NCT02001623|9559211|FG009|NOT COMPLETED|Overall Study||53
8527422|NCT02001623|9559212|FG010|NOT COMPLETED|Overall Study||14
8527423|NCT02001623|9559213|FG011|NOT COMPLETED|Overall Study||15
8527424|NCT02001623|9559214|FG012|NOT COMPLETED|Overall Study||14
8527425|NCT02001623|9559215|FG013|NOT COMPLETED|Overall Study||35
8527426|NCT02001623|9559216|FG014|NOT COMPLETED|Overall Study||18
8527427|NCT01900002|9559265|FG000|STARTED|Overall Study||40
8527428|NCT01900002|9559265|FG000|COMPLETED|Overall Study||34
8527429|NCT01900002|9559265|FG000|NOT COMPLETED|Overall Study||6
8527430|NCT01595061|9559269|FG000|STARTED|Overall Study||57
8527431|NCT01595061|9559269|FG000|COMPLETED|Overall Study||53
8527432|NCT01595061|9559269|FG000|NOT COMPLETED|Overall Study||4
8563129|NCT00045032|9595320|FG001|Crossover to Adjuvant Herceptin|Overall Study|This milestone is not applicable to participants who were already randomized to Herceptin.|0
8563130|NCT00045032|9595321|FG002|Crossover to Adjuvant Herceptin|Overall Study|This milestone is not applicable to participants who were already randomized to Herceptin.|0
8563131|NCT00045032|9595319|FG000|COMPLETED|Overall Study||834
8563132|NCT00045032|9595320|FG001|COMPLETED|Overall Study||994
8563133|NCT00045032|9595321|FG002|COMPLETED|Overall Study||974
8563134|NCT00045032|9595319|FG000|NOT COMPLETED|Overall Study||863
8563135|NCT00045032|9595320|FG001|NOT COMPLETED|Overall Study||708
8563136|NCT00045032|9595321|FG002|NOT COMPLETED|Overall Study||726
8563137|NCT00045110|9595334|FG000|STARTED|100mg Phase 1 Dose Escalalation||6
8563138|NCT00045110|9595335|FG001|STARTED|100mg Phase 1 Dose Escalalation||59
8563139|NCT00045110|9595336|FG002|STARTED|100mg Phase 1 Dose Escalalation||45
8563140|NCT00045110|9595334|FG000|COMPLETED|100mg Phase 1 Dose Escalalation||6
8563141|NCT00045110|9595335|FG001|COMPLETED|100mg Phase 1 Dose Escalalation||53
8563142|NCT00045110|9595336|FG002|COMPLETED|100mg Phase 1 Dose Escalalation||43
8563143|NCT00045110|9595334|FG000|NOT COMPLETED|100mg Phase 1 Dose Escalalation||0
8563144|NCT00045110|9595335|FG001|NOT COMPLETED|100mg Phase 1 Dose Escalalation||6
8563145|NCT00045110|9595336|FG002|NOT COMPLETED|100mg Phase 1 Dose Escalalation||2
8563146|NCT00045110|9595334|FG000|STARTED|200mg Phase 1 Dose Escalation||4
8563147|NCT00045110|9595335|FG001|STARTED|200mg Phase 1 Dose Escalation||0
8563148|NCT00045110|9595336|FG002|STARTED|200mg Phase 1 Dose Escalation||0
8563149|NCT00045110|9595334|FG000|COMPLETED|200mg Phase 1 Dose Escalation||4
8563150|NCT00045110|9595335|FG001|COMPLETED|200mg Phase 1 Dose Escalation||0
8563151|NCT00045110|9595336|FG002|COMPLETED|200mg Phase 1 Dose Escalation||0
8563152|NCT00045110|9595334|FG000|NOT COMPLETED|200mg Phase 1 Dose Escalation||0
8563153|NCT00045110|9595335|FG001|NOT COMPLETED|200mg Phase 1 Dose Escalation||0
8563154|NCT00045110|9595336|FG002|NOT COMPLETED|200mg Phase 1 Dose Escalation||0
8527433|NCT04442230|9559275|FG000|STARTED|Overall Study||23
8527434|NCT04442230|9559276|FG001|STARTED|Overall Study||25
8527435|NCT04442230|9559275|FG000|COMPLETED|Overall Study||23
8527436|NCT04442230|9559276|FG001|COMPLETED|Overall Study||24
8527437|NCT04442230|9559275|FG000|NOT COMPLETED|Overall Study||0
8527438|NCT04442230|9559276|FG001|NOT COMPLETED|Overall Study||1
8527439|NCT04794803|9559284|FG000|STARTED|Overall Study||37
8527440|NCT04794803|9559285|FG001|STARTED|Overall Study||19
8527441|NCT04794803|9559284|FG000|FAS Population|Overall Study||36
8527442|NCT04794803|9559285|FG001|FAS Population|Overall Study||19
8527443|NCT04794803|9559284|FG000|Safety Set|Overall Study||36
8527444|NCT04794803|9559285|FG001|Safety Set|Overall Study||19
8527445|NCT04794803|9559284|FG000|Per Protocol Set|Overall Study||17
8527446|NCT04794803|9559285|FG001|Per Protocol Set|Overall Study||11
8527447|NCT04794803|9559284|FG000|COMPLETED|Overall Study||27
8527448|NCT04794803|9559285|FG001|COMPLETED|Overall Study||11
8527449|NCT04794803|9559284|FG000|NOT COMPLETED|Overall Study||10
8527450|NCT04794803|9559285|FG001|NOT COMPLETED|Overall Study||8
8527451|NCT04706403|9559296|FG000|STARTED|Overall Study||172
8527452|NCT04706403|9559297|FG001|STARTED|Overall Study||121
8527453|NCT04706403|9559298|FG002|STARTED|Overall Study||165
8527454|NCT04706403|9559299|FG003|STARTED|Overall Study||146
8527455|NCT04706403|9559300|FG004|STARTED|Overall Study||152
8816323|NCT01543178|9869794|FG002|NOT COMPLETED|Double-blind Period||37
8816324|NCT01543204|9869801|FG000|STARTED|Overall Study||64
8816325|NCT01543204|9869801|FG000|COMPLETED|Overall Study||56
8816326|NCT01543204|9869801|FG000|NOT COMPLETED|Overall Study||8
8816327|NCT01543490|9869811|FG000|STARTED|Overall Study||368
8527456|NCT04706403|9559296|FG000|COMPLETED|Overall Study||172
8527457|NCT04706403|9559297|FG001|COMPLETED|Overall Study||121
8527458|NCT04706403|9559298|FG002|COMPLETED|Overall Study||164
8527459|NCT04706403|9559299|FG003|COMPLETED|Overall Study||145
8527460|NCT04706403|9559300|FG004|COMPLETED|Overall Study||150
8527461|NCT04706403|9559296|FG000|NOT COMPLETED|Overall Study||0
8527462|NCT04706403|9559297|FG001|NOT COMPLETED|Overall Study||0
8527463|NCT04706403|9559298|FG002|NOT COMPLETED|Overall Study||1
8527464|NCT04706403|9559299|FG003|NOT COMPLETED|Overall Study||1
8527465|NCT04706403|9559300|FG004|NOT COMPLETED|Overall Study||2
8527466|NCT04440449|9559314|FG000|STARTED|Overall Study||20
8527467|NCT04440449|9559315|FG001|STARTED|Overall Study||0
8527468|NCT04440449|9559314|FG000|COMPLETED|Overall Study||18
8527469|NCT04440449|9559315|FG001|COMPLETED|Overall Study||0
8527470|NCT04440449|9559314|FG000|NOT COMPLETED|Overall Study||2
8527471|NCT04440449|9559315|FG001|NOT COMPLETED|Overall Study||0
8527472|NCT04369469|9559324|FG000|STARTED|Overall Study||135
8527473|NCT04369469|9559325|FG001|STARTED|Overall Study||67
8527474|NCT04369469|9559324|FG000|Intent to Treat (ITT) Population|Overall Study||135
8527475|NCT04369469|9559325|FG001|Intent to Treat (ITT) Population|Overall Study||66
8527476|NCT04369469|9559324|FG000|Pharmacokinetic (PK)|Overall Study||127
8527477|NCT04369469|9559325|FG001|Pharmacokinetic (PK)|Overall Study||52
8527478|NCT04369469|9559324|FG000|Safety Population|Overall Study||127
8527479|NCT04369469|9559325|FG001|Safety Population|Overall Study||67
8527480|NCT04369469|9559324|FG000|COMPLETED|Overall Study||125
8527481|NCT04369469|9559325|FG001|COMPLETED|Overall Study||58
8527482|NCT04369469|9559324|FG000|NOT COMPLETED|Overall Study||10
8527483|NCT04369469|9559325|FG001|NOT COMPLETED|Overall Study||9
8527484|NCT04128696|9559333|FG000|STARTED|Overall Study||158
8527485|NCT04128696|9559334|FG001|STARTED|Overall Study||157
8527486|NCT04128696|9559333|FG000|Modified Intent to Treat (mITT) Population|Overall Study||157
8527487|NCT04128696|9559334|FG001|Modified Intent to Treat (mITT) Population|Overall Study||156
8527488|NCT04128696|9559333|FG000|Safety Population|Overall Study||159
8527489|NCT04128696|9559334|FG001|Safety Population|Overall Study||156
8527490|NCT04128696|9559333|FG000|COMPLETED|Overall Study||51
8527491|NCT04128696|9559334|FG001|COMPLETED|Overall Study||38
8527492|NCT04128696|9559333|FG000|NOT COMPLETED|Overall Study||107
8527493|NCT04128696|9559334|FG001|NOT COMPLETED|Overall Study||119
8527494|NCT04036799|9559340|FG000|STARTED|Overall Study||572
8527495|NCT04036799|9559340|FG000|COMPLETED|Overall Study||572
8527496|NCT04036799|9559340|FG000|NOT COMPLETED|Overall Study||0
8527497|NCT03965962|9559348|FG000|STARTED|Overall Study||320
8527498|NCT03965962|9559349|FG001|STARTED|Overall Study||107
8527499|NCT03965962|9559350|FG002|STARTED|Overall Study||107
8527500|NCT03965962|9559351|FG003|STARTED|Overall Study||106
8527501|NCT03965962|9559348|FG000|Vaccination 1 (Day 0)|Overall Study||318
8527502|NCT03965962|9559349|FG001|Vaccination 1 (Day 0)|Overall Study||107
8527503|NCT03965962|9559350|FG002|Vaccination 1 (Day 0)|Overall Study||107
8527504|NCT03965962|9559351|FG003|Vaccination 1 (Day 0)|Overall Study||106
8527505|NCT03965962|9559348|FG000|Vaccination 2 (Day 3)|Overall Study||317
8527506|NCT03965962|9559349|FG001|Vaccination 2 (Day 3)|Overall Study||104
8527507|NCT03965962|9559350|FG002|Vaccination 2 (Day 3)|Overall Study||107
8527508|NCT03965962|9559351|FG003|Vaccination 2 (Day 3)|Overall Study||106
8527509|NCT03965962|9559348|FG000|Vaccination 3 (Day 7)|Overall Study||311
8527510|NCT03965962|9559349|FG001|Vaccination 3 (Day 7)|Overall Study||103
8527511|NCT03965962|9559350|FG002|Vaccination 3 (Day 7)|Overall Study||105
8527512|NCT03965962|9559351|FG003|Vaccination 3 (Day 7)|Overall Study||105
8527513|NCT03965962|9559348|FG000|Vaccination 4 (Day 14)|Overall Study||301
8527514|NCT03965962|9559349|FG001|Vaccination 4 (Day 14)|Overall Study||101
8527515|NCT03965962|9559350|FG002|Vaccination 4 (Day 14)|Overall Study||101
8816328|NCT01543490|9869812|FG001|STARTED|Overall Study||190
8527516|NCT03965962|9559351|FG003|Vaccination 4 (Day 14)|Overall Study||103
8527517|NCT03965962|9559348|FG000|Vaccination 5 (Day 28)|Overall Study||294
8527518|NCT03965962|9559349|FG001|Vaccination 5 (Day 28)|Overall Study||98
8527519|NCT03965962|9559350|FG002|Vaccination 5 (Day 28)|Overall Study||97
8527520|NCT03965962|9559351|FG003|Vaccination 5 (Day 28)|Overall Study||98
8527521|NCT03965962|9559348|FG000|Safety Analysis Set (SafAS)|Overall Study|2 participants randomized to Group 4: VRVg-2 received vaccination in Group 1: VRVg-2+HRIG and were considered in Group 1 for safety analysis purpose.|320
8527522|NCT03965962|9559349|FG001|Safety Analysis Set (SafAS)|Overall Study||107
8527523|NCT03965962|9559350|FG002|Safety Analysis Set (SafAS)|Overall Study||107
8527524|NCT03965962|9559351|FG003|Safety Analysis Set (SafAS)|Overall Study|2 participants randomized to Group 4: VRVg-2 received vaccination in Group 1: VRVg-2+HRIG and were considered in Group 1 for safety analysis purpose.|104
8527525|NCT03965962|9559348|FG000|COMPLETED|Overall Study||295
8527526|NCT03965962|9559349|FG001|COMPLETED|Overall Study||102
8527527|NCT03965962|9559350|FG002|COMPLETED|Overall Study||97
8527528|NCT03965962|9559351|FG003|COMPLETED|Overall Study||100
8527529|NCT03965962|9559348|FG000|NOT COMPLETED|Overall Study||25
8527530|NCT03965962|9559349|FG001|NOT COMPLETED|Overall Study||5
8527531|NCT03965962|9559350|FG002|NOT COMPLETED|Overall Study||10
8527532|NCT03965962|9559351|FG003|NOT COMPLETED|Overall Study||6
8527533|NCT03772574|9559364|FG000|STARTED|Overall Study||42
8527534|NCT03772574|9559365|FG001|STARTED|Overall Study||25
8527535|NCT03772574|9559366|FG002|STARTED|Overall Study||24
8527536|NCT03772574|9559364|FG000|COMPLETED|Overall Study||40
8527537|NCT03772574|9559365|FG001|COMPLETED|Overall Study||20
8527538|NCT03772574|9559366|FG002|COMPLETED|Overall Study||20
8527539|NCT03772574|9559364|FG000|NOT COMPLETED|Overall Study||2
8527540|NCT03772574|9559365|FG001|NOT COMPLETED|Overall Study||5
8527541|NCT03772574|9559366|FG002|NOT COMPLETED|Overall Study||4
8527542|NCT03694522|9559376|FG000|STARTED|Overall Study||77
8527543|NCT03694522|9559377|FG001|STARTED|Overall Study||78
8527544|NCT03694522|9559376|FG000|Received Any Study Treatment|Overall Study||76
8527545|NCT03694522|9559377|FG001|Received Any Study Treatment|Overall Study||77
8527546|NCT03694522|9559376|FG000|COMPLETED|Overall Study||0
8527547|NCT03694522|9559377|FG001|COMPLETED|Overall Study||0
8527548|NCT03694522|9559376|FG000|NOT COMPLETED|Overall Study||77
8527549|NCT03694522|9559377|FG001|NOT COMPLETED|Overall Study||78
8527550|NCT03615040|9559385|FG000|STARTED|Overall Study||42
8527551|NCT03615040|9559386|FG001|STARTED|Overall Study||39
8527552|NCT03615040|9559385|FG000|COMPLETED|Overall Study||36
8527553|NCT03615040|9559386|FG001|COMPLETED|Overall Study||34
8527554|NCT03615040|9559385|FG000|NOT COMPLETED|Overall Study||6
8527555|NCT03615040|9559386|FG001|NOT COMPLETED|Overall Study||5
8527556|NCT03594955|9559392|FG000|STARTED|Overall Study||7
8527557|NCT03594955|9559392|FG000|COMPLETED|Overall Study||0
8527558|NCT03594955|9559392|FG000|NOT COMPLETED|Overall Study||7
8527559|NCT03548220|9559400|FG000|STARTED|Overall Study||40
8527560|NCT03548220|9559401|FG001|STARTED|Overall Study||2
8527561|NCT03548220|9559402|FG002|STARTED|Overall Study||3
8527562|NCT03548220|9559403|FG003|STARTED|Overall Study||35
8527563|NCT03548220|9559400|FG000|COMPLETED|Overall Study||39
8527564|NCT03548220|9559401|FG001|COMPLETED|Overall Study||2
8527565|NCT03548220|9559402|FG002|COMPLETED|Overall Study||3
8527566|NCT03548220|9559403|FG003|COMPLETED|Overall Study||35
8527567|NCT03548220|9559400|FG000|NOT COMPLETED|Overall Study||1
8527568|NCT03548220|9559401|FG001|NOT COMPLETED|Overall Study||0
8527569|NCT03548220|9559402|FG002|NOT COMPLETED|Overall Study||0
8527570|NCT03548220|9559403|FG003|NOT COMPLETED|Overall Study||0
8527571|NCT03474107|9559425|FG000|STARTED|Overall Study||301
8527572|NCT03474107|9559426|FG001|STARTED|Overall Study||307
8527573|NCT03474107|9559425|FG000|Treated|Overall Study||296
8527574|NCT03474107|9559426|FG001|Treated|Overall Study||291
8527575|NCT03474107|9559425|FG000|COMPLETED|Overall Study|Participants still on treatment as of data cut-off date 15-Jul-2020|56
8527576|NCT03474107|9559426|FG001|COMPLETED|Overall Study|Participants still on treatment as of data cut-off date 15-Jul-2020|22
8527577|NCT03474107|9559425|FG000|NOT COMPLETED|Overall Study||245
8527578|NCT03474107|9559426|FG001|NOT COMPLETED|Overall Study||285
8527579|NCT03453684|9559432|FG000|STARTED|Overall Study||60
8527580|NCT03453684|9559432|FG000|COMPLETED|Overall Study||60
8527581|NCT03453684|9559432|FG000|NOT COMPLETED|Overall Study||0
8527582|NCT03434041|9559438|FG000|STARTED|Double Blind Treatment Phase (4 Weeks)||126
8527583|NCT03434041|9559439|FG001|STARTED|Double Blind Treatment Phase (4 Weeks)||126
8527584|NCT03434041|9559438|FG000|Full Analysis Set|Double Blind Treatment Phase (4 Weeks)||124
8527585|NCT03434041|9559439|FG001|Full Analysis Set|Double Blind Treatment Phase (4 Weeks)||126
8527586|NCT03434041|9559438|FG000|COMPLETED|Double Blind Treatment Phase (4 Weeks)||108
8527587|NCT03434041|9559439|FG001|COMPLETED|Double Blind Treatment Phase (4 Weeks)||106
8527588|NCT03434041|9559438|FG000|NOT COMPLETED|Double Blind Treatment Phase (4 Weeks)||18
8527589|NCT03434041|9559439|FG001|NOT COMPLETED|Double Blind Treatment Phase (4 Weeks)||20
8527590|NCT03434041|9559438|FG000|STARTED|Follow-up Phase (Up to 8 Weeks)||106
8527591|NCT03434041|9559439|FG001|STARTED|Follow-up Phase (Up to 8 Weeks)||103
8527592|NCT03434041|9559438|FG000|COMPLETED|Follow-up Phase (Up to 8 Weeks)||99
8527593|NCT03434041|9559439|FG001|COMPLETED|Follow-up Phase (Up to 8 Weeks)||100
8527594|NCT03434041|9559438|FG000|NOT COMPLETED|Follow-up Phase (Up to 8 Weeks)||7
8527595|NCT03434041|9559439|FG001|NOT COMPLETED|Follow-up Phase (Up to 8 Weeks)||3
8527596|NCT03420222|9559449|FG000|STARTED|Overall Study||8
8527597|NCT03420222|9559450|FG001|STARTED|Overall Study||2
8527598|NCT03420222|9559449|FG000|COMPLETED|Overall Study||3
8527599|NCT03420222|9559450|FG001|COMPLETED|Overall Study||1
8527600|NCT03420222|9559449|FG000|NOT COMPLETED|Overall Study||5
8527601|NCT03420222|9559450|FG001|NOT COMPLETED|Overall Study||1
8527602|NCT03409796|9559458|FG000|STARTED|Overall Study||9
8527603|NCT03409796|9559459|FG001|STARTED|Overall Study||7
8527604|NCT03409796|9559458|FG000|COMPLETED|Overall Study||7
8527605|NCT03409796|9559459|FG001|COMPLETED|Overall Study||6
8527606|NCT03409796|9559458|FG000|NOT COMPLETED|Overall Study||2
8527607|NCT03409796|9559459|FG001|NOT COMPLETED|Overall Study||1
8527608|NCT03215706|9559467|FG000|STARTED|Randomization||361
8527609|NCT03215706|9559468|FG001|STARTED|Randomization||358
8527610|NCT03215706|9559467|FG000|COMPLETED|Randomization||358
8527611|NCT03215706|9559468|FG001|COMPLETED|Randomization||349
8527612|NCT03215706|9559467|FG000|NOT COMPLETED|Randomization||3
8527613|NCT03215706|9559468|FG001|NOT COMPLETED|Randomization||9
8527614|NCT03215706|9559467|FG000|STARTED|Treatment Period||358
8527615|NCT03215706|9559468|FG001|STARTED|Treatment Period||349
8527616|NCT03215706|9559467|FG000|COMPLETED|Treatment Period||16
8527617|NCT03215706|9559468|FG001|COMPLETED|Treatment Period||103
8527618|NCT03215706|9559467|FG000|NOT COMPLETED|Treatment Period||342
8527619|NCT03215706|9559468|FG001|NOT COMPLETED|Treatment Period||246
8527620|NCT03189563|9559477|FG000|STARTED|Overall Study||20
8527621|NCT03189563|9559478|FG001|STARTED|Overall Study||21
8527622|NCT03189563|9559479|FG002|STARTED|Overall Study||20
8527623|NCT03189563|9559477|FG000|ITT Population|Overall Study||20
8527624|NCT03189563|9559478|FG001|ITT Population|Overall Study||21
8527625|NCT03189563|9559479|FG002|ITT Population|Overall Study||19
8527626|NCT03189563|9559477|FG000|Safety Population|Overall Study||20
8527627|NCT03189563|9559478|FG001|Safety Population|Overall Study||21
8527628|NCT03189563|9559479|FG002|Safety Population|Overall Study||19
8527629|NCT03189563|9559477|FG000|COMPLETED|Overall Study||19
8527630|NCT03189563|9559478|FG001|COMPLETED|Overall Study||20
8527631|NCT03189563|9559479|FG002|COMPLETED|Overall Study||18
8527632|NCT03189563|9559477|FG000|NOT COMPLETED|Overall Study||1
8527633|NCT03189563|9559478|FG001|NOT COMPLETED|Overall Study||1
8527634|NCT03189563|9559479|FG002|NOT COMPLETED|Overall Study||2
8527635|NCT03144674|9559491|FG000|STARTED|Overall Study||4
8527636|NCT03144674|9559492|FG001|STARTED|Overall Study||6
8527637|NCT03144674|9559493|FG002|STARTED|Overall Study||28
8527638|NCT03144674|9559494|FG003|STARTED|Overall Study||72
8527639|NCT03144674|9559491|FG000|COMPLETED|Overall Study||0
8527640|NCT03144674|9559492|FG001|COMPLETED|Overall Study||0
8527641|NCT03144674|9559493|FG002|COMPLETED|Overall Study||0
8527642|NCT03144674|9559494|FG003|COMPLETED|Overall Study||0
8527643|NCT03144674|9559491|FG000|NOT COMPLETED|Overall Study||4
8527644|NCT03144674|9559492|FG001|NOT COMPLETED|Overall Study||6
8527645|NCT03144674|9559493|FG002|NOT COMPLETED|Overall Study||28
8527646|NCT03144674|9559494|FG003|NOT COMPLETED|Overall Study||72
8527647|NCT03143153|9559512|FG000|STARTED|Pre-Treatment||325
8527648|NCT03143153|9559513|FG001|STARTED|Pre-Treatment||321
8527649|NCT03143153|9559514|FG002|STARTED|Pre-Treatment||324
8527650|NCT03143153|9559512|FG000|COMPLETED|Pre-Treatment||322
8527651|NCT03143153|9559513|FG001|COMPLETED|Pre-Treatment||310
8527652|NCT03143153|9559514|FG002|COMPLETED|Pre-Treatment||304
8527653|NCT03143153|9559512|FG000|NOT COMPLETED|Pre-Treatment||3
8527654|NCT03143153|9559513|FG001|NOT COMPLETED|Pre-Treatment||11
8527655|NCT03143153|9559514|FG002|NOT COMPLETED|Pre-Treatment||20
8527656|NCT03143153|9559512|FG000|STARTED|Treatment||322
8527657|NCT03143153|9559513|FG001|STARTED|Treatment||310
8527658|NCT03143153|9559514|FG002|STARTED|Treatment||304
8527659|NCT03143153|9559512|FG000|COMPLETED|Treatment||21
8527660|NCT03143153|9559513|FG001|COMPLETED|Treatment||25
8527661|NCT03143153|9559514|FG002|COMPLETED|Treatment||4
8527662|NCT03143153|9559512|FG000|NOT COMPLETED|Treatment||301
8527663|NCT03143153|9559513|FG001|NOT COMPLETED|Treatment||285
8527664|NCT03143153|9559514|FG002|NOT COMPLETED|Treatment||300
8527665|NCT03093350|9559522|FG000|STARTED|Overall Study||12
8527666|NCT03093350|9559522|FG000|Started Treatment|Overall Study||10
8527667|NCT03093350|9559522|FG000|COMPLETED|Overall Study||10
8527668|NCT03093350|9559522|FG000|NOT COMPLETED|Overall Study||2
8527669|NCT03070236|9559528|FG000|STARTED|Overall Study||912
8527670|NCT03070236|9559528|FG000|Guideline Concordant Care (GCC) Arm|Overall Study||538
8527671|NCT03070236|9559528|FG000|Active Surveillance (AS) Arm|Overall Study||374
8527672|NCT03070236|9559528|FG000|COMPLETED|Overall Study||912
8527673|NCT03070236|9559528|FG000|NOT COMPLETED|Overall Study||0
8527674|NCT02999854|9559535|FG000|STARTED|Active Study Phase (up to 18 Months)||32
8527675|NCT02999854|9559536|FG001|STARTED|Active Study Phase (up to 18 Months)||31
8527676|NCT02999854|9559535|FG000|COMPLETED|Active Study Phase (up to 18 Months)||8
8527677|NCT02999854|9559536|FG001|COMPLETED|Active Study Phase (up to 18 Months)||22
8527678|NCT02999854|9559535|FG000|NOT COMPLETED|Active Study Phase (up to 18 Months)||24
8527679|NCT02999854|9559536|FG001|NOT COMPLETED|Active Study Phase (up to 18 Months)||9
8527680|NCT02999854|9559535|FG000|STARTED|Long Term Safety FU (up to 24 Months)||8
8527681|NCT02999854|9559536|FG001|STARTED|Long Term Safety FU (up to 24 Months)||22
8527682|NCT02999854|9559535|FG000|COMPLETED|Long Term Safety FU (up to 24 Months)||5
8527683|NCT02999854|9559536|FG001|COMPLETED|Long Term Safety FU (up to 24 Months)||19
8527684|NCT02999854|9559535|FG000|NOT COMPLETED|Long Term Safety FU (up to 24 Months)||3
8527685|NCT02999854|9559536|FG001|NOT COMPLETED|Long Term Safety FU (up to 24 Months)||3
8527686|NCT02960763|9559547|FG000|STARTED|Step 1||211
8527687|NCT02960763|9559548|FG001|STARTED|Step 1||206
8527688|NCT02960763|9559549|FG002|STARTED|Step 1||202
8527689|NCT02960763|9559550|FG003|STARTED|Step 1||0
8527690|NCT02960763|9559551|FG004|STARTED|Step 1||0
8527691|NCT02960763|9559547|FG000|COMPLETED|Step 1||192
8527692|NCT02960763|9559548|FG001|COMPLETED|Step 1||188
8527693|NCT02960763|9559549|FG002|COMPLETED|Step 1||174
8527694|NCT02960763|9559550|FG003|COMPLETED|Step 1||0
8527695|NCT02960763|9559551|FG004|COMPLETED|Step 1||0
8527696|NCT02960763|9559547|FG000|NOT COMPLETED|Step 1||19
8527697|NCT02960763|9559548|FG001|NOT COMPLETED|Step 1||18
8527698|NCT02960763|9559549|FG002|NOT COMPLETED|Step 1||28
8527699|NCT02960763|9559550|FG003|NOT COMPLETED|Step 1||0
8527700|NCT02960763|9559551|FG004|NOT COMPLETED|Step 1||0
8527701|NCT02960763|9559547|FG000|STARTED|Step 2||0
8527702|NCT02960763|9559548|FG001|STARTED|Step 2||0
8527703|NCT02960763|9559549|FG002|STARTED|Step 2||0
8527704|NCT02960763|9559550|FG003|STARTED|Step 2||127
8527705|NCT02960763|9559551|FG004|STARTED|Step 2||121
8527706|NCT02960763|9559547|FG000|People Who Participated in Step 1 and Continued to Participate in Step 2|Step 2||43
8527707|NCT02960763|9559548|FG001|People Who Participated in Step 1 and Continued to Participate in Step 2|Step 2||44
8527708|NCT02960763|9559549|FG002|People Who Participated in Step 1 and Continued to Participate in Step 2|Step 2||38
8527709|NCT02960763|9559550|FG003|People Who Participated in Step 1 and Continued to Participate in Step 2|Step 2||0
8527710|NCT02960763|9559551|FG004|People Who Participated in Step 1 and Continued to Participate in Step 2|Step 2||0
8527711|NCT02960763|9559547|FG000|People Who Began Step 2 Without Having Participated in Step 1|Step 2||0
8527712|NCT02960763|9559548|FG001|People Who Began Step 2 Without Having Participated in Step 1|Step 2||0
8527713|NCT02960763|9559549|FG002|People Who Began Step 2 Without Having Participated in Step 1|Step 2||0
8527714|NCT02960763|9559550|FG003|People Who Began Step 2 Without Having Participated in Step 1|Step 2||63
8527715|NCT02960763|9559551|FG004|People Who Began Step 2 Without Having Participated in Step 1|Step 2||60
8527716|NCT02960763|9559547|FG000|COMPLETED|Step 2||0
8527717|NCT02960763|9559548|FG001|COMPLETED|Step 2||0
8527718|NCT02960763|9559549|FG002|COMPLETED|Step 2||0
8527719|NCT02960763|9559550|FG003|COMPLETED|Step 2||116
8527720|NCT02960763|9559551|FG004|COMPLETED|Step 2||116
8527721|NCT02960763|9559547|FG000|NOT COMPLETED|Step 2||0
8527722|NCT02960763|9559548|FG001|NOT COMPLETED|Step 2||0
8527723|NCT02960763|9559549|FG002|NOT COMPLETED|Step 2||0
8527724|NCT02960763|9559550|FG003|NOT COMPLETED|Step 2||11
8527725|NCT02960763|9559551|FG004|NOT COMPLETED|Step 2||5
8527726|NCT02839343|9559565|FG000|STARTED|Overall Study||70
8527727|NCT02839343|9559566|FG001|STARTED|Overall Study||56
8527728|NCT02839343|9559565|FG000|COMPLETED|Overall Study||65
8527729|NCT02839343|9559566|FG001|COMPLETED|Overall Study||55
8527730|NCT02839343|9559565|FG000|NOT COMPLETED|Overall Study||5
8527731|NCT02839343|9559566|FG001|NOT COMPLETED|Overall Study||1
8527732|NCT02819479|9559572|FG000|STARTED|Overall Study||10
8527733|NCT02819479|9559572|FG000|COMPLETED|Overall Study|2 subjects experienced recurrence of radiation necrosis requiring intervention at approx. month 11.|8
8527734|NCT02819479|9559572|FG000|NOT COMPLETED|Overall Study||2
8527735|NCT02601313|9559580|FG000|STARTED|Overall Study||14
8527736|NCT02601313|9559581|FG001|STARTED|Overall Study||74
8527737|NCT02601313|9559582|FG002|STARTED|Overall Study||17
8527738|NCT02601313|9559580|FG000|COMPLETED|Overall Study||8
8527739|NCT02601313|9559581|FG001|COMPLETED|Overall Study||0
8527740|NCT02601313|9559582|FG002|COMPLETED|Overall Study||0
8527741|NCT02601313|9559580|FG000|NOT COMPLETED|Overall Study||6
8527742|NCT02601313|9559581|FG001|NOT COMPLETED|Overall Study||74
8527743|NCT02601313|9559582|FG002|NOT COMPLETED|Overall Study||17
8527744|NCT02581930|9559590|FG000|STARTED|Overall Study||18
8527745|NCT02581930|9559590|FG000|COMPLETED|Overall Study||16
8527746|NCT02581930|9559590|FG000|NOT COMPLETED|Overall Study||2
8527747|NCT02542293|9559596|FG000|STARTED|Overall Study||474
8527748|NCT02542293|9559597|FG001|STARTED|Overall Study||479
8527749|NCT02542293|9559596|FG000|Randomized in Global Cohort|Overall Study||410
8527750|NCT02542293|9559597|FG001|Randomized in Global Cohort|Overall Study||413
8527751|NCT02542293|9559596|FG000|Received Treatment in Global Cohort|Overall Study||410
8527752|NCT02542293|9559597|FG001|Received Treatment in Global Cohort|Overall Study||399
8527753|NCT02542293|9559596|FG000|Randomized in China Cohort|Overall Study||78
8527754|NCT02542293|9559597|FG001|Randomized in China Cohort|Overall Study||82
8527755|NCT02542293|9559596|FG000|Received Treatment in China Cohort|Overall Study||77
8527756|NCT02542293|9559597|FG001|Received Treatment in China Cohort|Overall Study||78
8527757|NCT02542293|9559596|FG000|Included in Both Cohorts (Global and China)|Overall Study||14
8527758|NCT02542293|9559597|FG001|Included in Both Cohorts (Global and China)|Overall Study||16
8527759|NCT02542293|9559596|FG000|Ongoing in Study at DCO for Final Analysis in Global Cohort|Overall Study||75
8527760|NCT02542293|9559597|FG001|Ongoing in Study at DCO for Final Analysis in Global Cohort|Overall Study||67
8527761|NCT02542293|9559596|FG000|Ongoing in Study at DCO for Final Analysis in China Cohort|Overall Study||27
8527762|NCT02542293|9559597|FG001|Ongoing in Study at DCO for Final Analysis in China Cohort|Overall Study||18
8527763|NCT02542293|9559596|FG000|COMPLETED|Overall Study||99
8527764|NCT02542293|9559597|FG001|COMPLETED|Overall Study||83
8527765|NCT02542293|9559596|FG000|NOT COMPLETED|Overall Study||375
8527766|NCT02542293|9559597|FG001|NOT COMPLETED|Overall Study||396
8527767|NCT02484430|9559610|FG000|STARTED|Overall Study||16
8527768|NCT02484430|9559610|FG000|COMPLETED|Overall Study||16
8527769|NCT02484430|9559610|FG000|NOT COMPLETED|Overall Study||0
8527770|NCT02438722|9559616|FG000|STARTED|Overall Study||83
8527771|NCT02438722|9559617|FG001|STARTED|Overall Study||85
8527772|NCT02438722|9559616|FG000|Participants Evaluable for Adverse Events|Overall Study||78
8527773|NCT02438722|9559617|FG001|Participants Evaluable for Adverse Events|Overall Study||85
8527774|NCT02438722|9559616|FG000|COMPLETED|Overall Study||0
8527775|NCT02438722|9559617|FG001|COMPLETED|Overall Study||0
8527776|NCT02438722|9559616|FG000|NOT COMPLETED|Overall Study||83
8527777|NCT02438722|9559617|FG001|NOT COMPLETED|Overall Study||85
8527778|NCT02425306|9559627|FG000|STARTED|Overall Study||3
8527779|NCT02425306|9559628|FG001|STARTED|Overall Study||7
8527780|NCT02425306|9559629|FG002|STARTED|Overall Study||6
8527781|NCT02425306|9559630|FG003|STARTED|Overall Study||32
8527782|NCT02425306|9559627|FG000|COMPLETED|Overall Study||3
8527783|NCT02425306|9559628|FG001|COMPLETED|Overall Study||6
8620504|NCT00474526|9659159|FG009|NOT COMPLETED|Overall Study||27
8620505|NCT00474526|9659160|FG010|NOT COMPLETED|Overall Study||10
8620506|NCT00474526|9659161|FG011|NOT COMPLETED|Overall Study||11
8620507|NCT00474526|9659162|FG012|NOT COMPLETED|Overall Study||15
8620508|NCT00474526|9659163|FG013|NOT COMPLETED|Overall Study||156
8620509|NCT00474526|9659164|FG014|NOT COMPLETED|Overall Study||77
8620510|NCT00474526|9659165|FG015|NOT COMPLETED|Overall Study||18
8620511|NCT00474526|9659166|FG016|NOT COMPLETED|Overall Study||9
8620512|NCT00474539|9659254|FG000|STARTED|Infant Series|One participant was randomized to 7vPnC, but received 13vPnC.|223
8620513|NCT00474539|9659255|FG001|STARTED|Infant Series|One participant was randomized to 7vPnC, but received 13vPnC.|226
8620514|NCT00474539|9659254|FG000|Vaccinated Dose 1|Infant Series||218
8620515|NCT00474539|9659255|FG001|Vaccinated Dose 1|Infant Series||226
8527784|NCT02425306|9559629|FG002|COMPLETED|Overall Study||5
8527785|NCT02425306|9559630|FG003|COMPLETED|Overall Study||18
8527786|NCT02425306|9559627|FG000|NOT COMPLETED|Overall Study||0
8527787|NCT02425306|9559628|FG001|NOT COMPLETED|Overall Study||1
8527788|NCT02425306|9559629|FG002|NOT COMPLETED|Overall Study||1
8527789|NCT02425306|9559630|FG003|NOT COMPLETED|Overall Study||14
8527790|NCT02278120|9559642|FG000|STARTED|Overall Study||335
8527791|NCT02278120|9559643|FG001|STARTED|Overall Study||337
8527792|NCT02278120|9559642|FG000|COMPLETED|Overall Study||174
8527793|NCT02278120|9559643|FG001|COMPLETED|Overall Study||121
8527794|NCT02278120|9559642|FG000|NOT COMPLETED|Overall Study||161
8527795|NCT02278120|9559643|FG001|NOT COMPLETED|Overall Study||216
8527796|NCT02258451|9559651|FG000|STARTED|Overall Study||142
8527797|NCT02258451|9559652|FG001|STARTED|Overall Study||141
8527798|NCT02258451|9559651|FG000|COMPLETED|Overall Study||0
8527799|NCT02258451|9559652|FG001|COMPLETED|Overall Study||0
8527800|NCT02258451|9559651|FG000|NOT COMPLETED|Overall Study||142
8527801|NCT02258451|9559652|FG001|NOT COMPLETED|Overall Study||141
8527802|NCT02120352|9559660|FG000|STARTED|Induction Period (20 Weeks)||309
8527803|NCT02120352|9559661|FG001|STARTED|Induction Period (20 Weeks)||0
8620516|NCT00474539|9659254|FG000|Vaccinated Dose 2|Infant Series||217
8620517|NCT00474539|9659255|FG001|Vaccinated Dose 2|Infant Series||222
8527804|NCT02120352|9559662|FG002|STARTED|Induction Period (20 Weeks)||0
8527805|NCT02120352|9559663|FG003|STARTED|Induction Period (20 Weeks)||0
8527806|NCT02120352|9559660|FG000|COMPLETED|Induction Period (20 Weeks)||288
8527807|NCT02120352|9559661|FG001|COMPLETED|Induction Period (20 Weeks)||0
8527808|NCT02120352|9559662|FG002|COMPLETED|Induction Period (20 Weeks)||0
8527809|NCT02120352|9559663|FG003|COMPLETED|Induction Period (20 Weeks)||0
8527810|NCT02120352|9559660|FG000|NOT COMPLETED|Induction Period (20 Weeks)||21
8527811|NCT02120352|9559661|FG001|NOT COMPLETED|Induction Period (20 Weeks)||0
8527812|NCT02120352|9559662|FG002|NOT COMPLETED|Induction Period (20 Weeks)||0
8527813|NCT02120352|9559663|FG003|NOT COMPLETED|Induction Period (20 Weeks)||0
8527814|NCT02120352|9559660|FG000|STARTED|Maintenance Period (32 Weeks)||0
8527815|NCT02120352|9559661|FG001|STARTED|Maintenance Period (32 Weeks)||115
8527816|NCT02120352|9559662|FG002|STARTED|Maintenance Period (32 Weeks)||115
8527817|NCT02120352|9559663|FG003|STARTED|Maintenance Period (32 Weeks)||56
8527818|NCT02120352|9559660|FG000|COMPLETED|Maintenance Period (32 Weeks)||0
8527819|NCT02120352|9559661|FG001|COMPLETED|Maintenance Period (32 Weeks)||0
8527820|NCT02120352|9559662|FG002|COMPLETED|Maintenance Period (32 Weeks)||0
8527821|NCT02120352|9559663|FG003|COMPLETED|Maintenance Period (32 Weeks)||0
8527822|NCT02120352|9559660|FG000|NOT COMPLETED|Maintenance Period (32 Weeks)||0
8527823|NCT02120352|9559661|FG001|NOT COMPLETED|Maintenance Period (32 Weeks)||115
8527824|NCT02120352|9559662|FG002|NOT COMPLETED|Maintenance Period (32 Weeks)||115
8527825|NCT02120352|9559663|FG003|NOT COMPLETED|Maintenance Period (32 Weeks)||56
8527826|NCT02114814|9559679|FG000|STARTED|Overall Study||103
8527827|NCT02114814|9559680|FG001|STARTED|Overall Study||83
8527828|NCT02114814|9559679|FG000|COMPLETED|Overall Study||88
8527829|NCT02114814|9559680|FG001|COMPLETED|Overall Study||74
8527830|NCT02114814|9559679|FG000|NOT COMPLETED|Overall Study||15
8527831|NCT02114814|9559680|FG001|NOT COMPLETED|Overall Study||9
8527832|NCT02067819|9559692|FG000|STARTED|Overall Study||11
8527833|NCT02067819|9559693|FG001|STARTED|Overall Study||10
8527834|NCT02067819|9559692|FG000|COMPLETED|Overall Study||6
8527835|NCT02067819|9559693|FG001|COMPLETED|Overall Study||7
9065780|NCT04142216|10126257|FG001|STARTED|Overall Study||28
9065781|NCT04142216|10126256|FG000|COMPLETED|Overall Study||22
9065782|NCT04142216|10126257|FG001|COMPLETED|Overall Study||22
9065783|NCT04142216|10126256|FG000|NOT COMPLETED|Overall Study||6
9065784|NCT04142216|10126257|FG001|NOT COMPLETED|Overall Study||6
8527836|NCT02067819|9559692|FG000|NOT COMPLETED|Overall Study||5
8527837|NCT02067819|9559693|FG001|NOT COMPLETED|Overall Study||3
8527838|NCT02004691|9559701|FG000|STARTED|PAP: Up to 52 Weeks||18
9065785|NCT04141930|10126263|FG000|STARTED|Overall Study||302
8527839|NCT02004691|9559702|FG001|STARTED|PAP: Up to 52 Weeks||18
8527840|NCT02004691|9559701|FG000|COMPLETED|PAP: Up to 52 Weeks||17
8527841|NCT02004691|9559702|FG001|COMPLETED|PAP: Up to 52 Weeks||18
8527842|NCT02004691|9559701|FG000|NOT COMPLETED|PAP: Up to 52 Weeks||1
8527843|NCT02004691|9559702|FG001|NOT COMPLETED|PAP: Up to 52 Weeks||0
8527844|NCT02004691|9559701|FG000|STARTED|ETP: Ongoing From Week 52||17
8527845|NCT02004691|9559702|FG001|STARTED|ETP: Ongoing From Week 52||18
8527846|NCT02004691|9559701|FG000|COMPLETED|ETP: Ongoing From Week 52||0
8527847|NCT02004691|9559702|FG001|COMPLETED|ETP: Ongoing From Week 52||0
8527848|NCT02004691|9559701|FG000|NOT COMPLETED|ETP: Ongoing From Week 52||17
8527849|NCT02004691|9559702|FG001|NOT COMPLETED|ETP: Ongoing From Week 52||18
8527850|NCT01886872|9559711|FG000|STARTED|Overall Study||183
8527851|NCT01886872|9559712|FG001|STARTED|Overall Study||182
8620518|NCT00474539|9659254|FG000|Vaccinated Dose 3|Infant Series||214
8620519|NCT00474539|9659255|FG001|Vaccinated Dose 3|Infant Series||221
8620520|NCT00474539|9659254|FG000|COMPLETED|Infant Series||213
8527852|NCT01886872|9559713|FG002|STARTED|Overall Study||182
8527853|NCT01886872|9559711|FG000|Evaluable for Secondary Endpoints|Overall Study||183
8527854|NCT01886872|9559712|FG001|Evaluable for Secondary Endpoints|Overall Study||182
8527855|NCT01886872|9559713|FG002|Evaluable for Secondary Endpoints|Overall Study||182
8527856|NCT01886872|9559711|FG000|Evaluable for Adverse Events|Overall Study||176
8527857|NCT01886872|9559712|FG001|Evaluable for Adverse Events|Overall Study||180
8527858|NCT01886872|9559713|FG002|Evaluable for Adverse Events|Overall Study||181
8527859|NCT01886872|9559711|FG000|Crossover Cohort|Overall Study||30
8527860|NCT01886872|9559712|FG001|Crossover Cohort|Overall Study||0
8527861|NCT01886872|9559713|FG002|Crossover Cohort|Overall Study||0
8527862|NCT01886872|9559711|FG000|COMPLETED|Overall Study||176
8527863|NCT01886872|9559712|FG001|COMPLETED|Overall Study||178
8527864|NCT01886872|9559713|FG002|COMPLETED|Overall Study||170
8527865|NCT01886872|9559711|FG000|NOT COMPLETED|Overall Study||7
8527866|NCT01886872|9559712|FG001|NOT COMPLETED|Overall Study||4
8527867|NCT01886872|9559713|FG002|NOT COMPLETED|Overall Study||12
8527868|NCT01835145|9559724|FG000|STARTED|Overall Study||32
8527869|NCT01835145|9559725|FG001|STARTED|Overall Study||15
8527870|NCT01835145|9559724|FG000|COMPLETED|Overall Study||31
8527871|NCT01835145|9559725|FG001|COMPLETED|Overall Study||15
8527872|NCT01835145|9559724|FG000|NOT COMPLETED|Overall Study||1
8527873|NCT01835145|9559725|FG001|NOT COMPLETED|Overall Study||0
8527874|NCT01802632|9559739|FG000|STARTED|Overall Study||201
8527875|NCT01802632|9559740|FG001|STARTED|Overall Study||31
8527876|NCT01802632|9559741|FG002|STARTED|Overall Study||271
8527877|NCT01802632|9559742|FG003|STARTED|Overall Study||60
8527878|NCT01802632|9559743|FG004|STARTED|Overall Study||12
8527879|NCT01802632|9559744|FG005|STARTED|Overall Study||28
8527880|NCT01802632|9559739|FG000|COMPLETED|Overall Study||0
8527881|NCT01802632|9559740|FG001|COMPLETED|Overall Study||0
8527882|NCT01802632|9559741|FG002|COMPLETED|Overall Study||0
8527883|NCT01802632|9559742|FG003|COMPLETED|Overall Study||0
8527884|NCT01802632|9559743|FG004|COMPLETED|Overall Study||0
8527885|NCT01802632|9559744|FG005|COMPLETED|Overall Study||0
8527886|NCT01802632|9559739|FG000|NOT COMPLETED|Overall Study||201
8527887|NCT01802632|9559740|FG001|NOT COMPLETED|Overall Study||31
8527888|NCT01802632|9559741|FG002|NOT COMPLETED|Overall Study||271
8527889|NCT01802632|9559742|FG003|NOT COMPLETED|Overall Study||60
8527890|NCT01802632|9559743|FG004|NOT COMPLETED|Overall Study||12
8527891|NCT01802632|9559744|FG005|NOT COMPLETED|Overall Study||28
8527892|NCT01668719|9559759|FG000|STARTED|Phase I||6
8527893|NCT01668719|9559760|FG001|STARTED|Phase I||0
8527894|NCT01668719|9559761|FG002|STARTED|Phase I||0
8527895|NCT01668719|9559759|FG000|COMPLETED|Phase I||0
8527896|NCT01668719|9559760|FG001|COMPLETED|Phase I||0
8527897|NCT01668719|9559761|FG002|COMPLETED|Phase I||0
8527898|NCT01668719|9559759|FG000|NOT COMPLETED|Phase I||6
8527899|NCT01668719|9559760|FG001|NOT COMPLETED|Phase I||0
8527900|NCT01668719|9559761|FG002|NOT COMPLETED|Phase I||0
8527901|NCT01668719|9559759|FG000|STARTED|Phase II||0
8527902|NCT01668719|9559760|FG001|STARTED|Phase II||52
8527903|NCT01668719|9559761|FG002|STARTED|Phase II||48
8527904|NCT01668719|9559759|FG000|COMPLETED|Phase II||0
8527905|NCT01668719|9559760|FG001|COMPLETED|Phase II||0
8527906|NCT01668719|9559761|FG002|COMPLETED|Phase II||0
8527907|NCT01668719|9559759|FG000|NOT COMPLETED|Phase II||0
8527908|NCT01668719|9559760|FG001|NOT COMPLETED|Phase II||52
8527909|NCT01668719|9559761|FG002|NOT COMPLETED|Phase II||48
8527910|NCT01625286|9559778|FG000|STARTED|Overall Study||12
8527911|NCT01625286|9559779|FG001|STARTED|Overall Study||8
8527912|NCT01625286|9559780|FG002|STARTED|Overall Study||5
8527913|NCT01625286|9559781|FG003|STARTED|Overall Study||7
8527914|NCT01625286|9559782|FG004|STARTED|Overall Study||6
8527915|NCT01625286|9559783|FG005|STARTED|Overall Study||54
8527916|NCT01625286|9559784|FG006|STARTED|Overall Study||56
8527917|NCT01625286|9559778|FG000|Received AZD5363/Placebo Treatment|Overall Study||12
8527918|NCT01625286|9559779|FG001|Received AZD5363/Placebo Treatment|Overall Study||8
8527919|NCT01625286|9559780|FG002|Received AZD5363/Placebo Treatment|Overall Study||5
8527920|NCT01625286|9559781|FG003|Received AZD5363/Placebo Treatment|Overall Study||7
8527921|NCT01625286|9559782|FG004|Received AZD5363/Placebo Treatment|Overall Study||6
8527922|NCT01625286|9559783|FG005|Received AZD5363/Placebo Treatment|Overall Study||54
8527923|NCT01625286|9559784|FG006|Received AZD5363/Placebo Treatment|Overall Study||55
8527924|NCT01625286|9559778|FG000|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
8527925|NCT01625286|9559779|FG001|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
8527926|NCT01625286|9559780|FG002|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
8527927|NCT01625286|9559781|FG003|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
8527928|NCT01625286|9559782|FG004|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
8527929|NCT01625286|9559783|FG005|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
8527930|NCT01625286|9559784|FG006|Did Not Receive AZD5363/Placebo Trt|Overall Study||1
8527931|NCT01625286|9559778|FG000|COMPLETED|Overall Study||0
8527932|NCT01625286|9559779|FG001|COMPLETED|Overall Study||0
8527933|NCT01625286|9559780|FG002|COMPLETED|Overall Study||0
8527934|NCT01625286|9559781|FG003|COMPLETED|Overall Study||0
8527935|NCT01625286|9559782|FG004|COMPLETED|Overall Study||0
8527936|NCT01625286|9559783|FG005|COMPLETED|Overall Study||0
8527937|NCT01625286|9559784|FG006|COMPLETED|Overall Study||0
8527938|NCT01625286|9559778|FG000|NOT COMPLETED|Overall Study||12
8527939|NCT01625286|9559779|FG001|NOT COMPLETED|Overall Study||8
8527940|NCT01625286|9559780|FG002|NOT COMPLETED|Overall Study||5
8527941|NCT01625286|9559781|FG003|NOT COMPLETED|Overall Study||7
8527942|NCT01625286|9559782|FG004|NOT COMPLETED|Overall Study||6
8527943|NCT01625286|9559783|FG005|NOT COMPLETED|Overall Study||54
8527944|NCT01625286|9559784|FG006|NOT COMPLETED|Overall Study||56
8527945|NCT01515748|9559802|FG000|STARTED|Overall Study||264
8527946|NCT01515748|9559803|FG001|STARTED|Overall Study||266
8527947|NCT01515748|9559802|FG000|Treated|Overall Study||195
8527948|NCT01515748|9559803|FG001|Treated|Overall Study||241
8527949|NCT01515748|9559802|FG000|COMPLETED|Overall Study||144
8527950|NCT01515748|9559803|FG001|COMPLETED|Overall Study||131
8527951|NCT01515748|9559802|FG000|NOT COMPLETED|Overall Study||120
8527952|NCT01515748|9559803|FG001|NOT COMPLETED|Overall Study||135
8527953|NCT01261247|9559810|FG000|STARTED|Overall Study||41
8527954|NCT01261247|9559810|FG000|COMPLETED|Overall Study||39
8527955|NCT01261247|9559810|FG000|NOT COMPLETED|Overall Study||2
8527956|NCT01169259|9559818|FG000|STARTED|Overall Study||6463
8527957|NCT01169259|9559819|FG001|STARTED|Overall Study||6464
8527958|NCT01169259|9559820|FG002|STARTED|Overall Study||6470
8527959|NCT01169259|9559821|FG003|STARTED|Overall Study||6474
8527960|NCT01169259|9559818|FG000|COMPLETED|Overall Study||6463
8527961|NCT01169259|9559819|FG001|COMPLETED|Overall Study||6464
8527962|NCT01169259|9559820|FG002|COMPLETED|Overall Study||6470
8527963|NCT01169259|9559821|FG003|COMPLETED|Overall Study||6474
8527964|NCT01169259|9559818|FG000|NOT COMPLETED|Overall Study||0
8527965|NCT01169259|9559819|FG001|NOT COMPLETED|Overall Study||0
8527966|NCT01169259|9559820|FG002|NOT COMPLETED|Overall Study||0
8527967|NCT01169259|9559821|FG003|NOT COMPLETED|Overall Study||0
8527968|NCT00790933|9559842|FG000|STARTED|Overall Study||675
8527969|NCT00790933|9559843|FG001|STARTED|Overall Study||726
8527970|NCT00790933|9559844|FG002|STARTED|Overall Study||384
8527971|NCT00790933|9559845|FG003|STARTED|Overall Study||37
8527972|NCT00790933|9559846|FG004|STARTED|Overall Study||421
8527973|NCT00790933|9559842|FG000|COMPLETED|Overall Study||237
8527974|NCT00790933|9559843|FG001|COMPLETED|Overall Study||246
8527975|NCT00790933|9559844|FG002|COMPLETED|Overall Study||115
8527976|NCT00790933|9559845|FG003|COMPLETED|Overall Study||23
8527977|NCT00790933|9559846|FG004|COMPLETED|Overall Study||145
8527978|NCT00790933|9559842|FG000|NOT COMPLETED|Overall Study||438
8527979|NCT00790933|9559843|FG001|NOT COMPLETED|Overall Study||480
8527980|NCT00790933|9559844|FG002|NOT COMPLETED|Overall Study||269
8527981|NCT00790933|9559845|FG003|NOT COMPLETED|Overall Study||14
8527982|NCT00790933|9559846|FG004|NOT COMPLETED|Overall Study||276
8527983|NCT00624234|9559868|FG000|STARTED|Overall Study||8
8527984|NCT00624234|9559869|FG001|STARTED|Overall Study||9
8527985|NCT00624234|9559870|FG002|STARTED|Overall Study||26
8527986|NCT00624234|9559871|FG003|STARTED|Overall Study||14
8527987|NCT00624234|9559872|FG004|STARTED|Overall Study||18
8527988|NCT00624234|9559873|FG005|STARTED|Overall Study||14
8527989|NCT00624234|9559868|FG000|COMPLETED|Overall Study||8
8527990|NCT00624234|9559869|FG001|COMPLETED|Overall Study||9
8527991|NCT00624234|9559870|FG002|COMPLETED|Overall Study||26
8527992|NCT00624234|9559871|FG003|COMPLETED|Overall Study||14
8527993|NCT00624234|9559872|FG004|COMPLETED|Overall Study||18
8527994|NCT00624234|9559873|FG005|COMPLETED|Overall Study||14
8527995|NCT00624234|9559868|FG000|NOT COMPLETED|Overall Study||0
8527996|NCT00624234|9559869|FG001|NOT COMPLETED|Overall Study||0
8527997|NCT00624234|9559870|FG002|NOT COMPLETED|Overall Study||0
8527998|NCT00624234|9559871|FG003|NOT COMPLETED|Overall Study||0
8527999|NCT00624234|9559872|FG004|NOT COMPLETED|Overall Study||0
8528000|NCT00624234|9559873|FG005|NOT COMPLETED|Overall Study||0
8528001|NCT00602459|9559891|FG000|STARTED|Initial Registration/Randomization||138
8528002|NCT00602459|9559892|FG001|STARTED|Initial Registration/Randomization||140
8528003|NCT00602459|9559893|FG002|STARTED|Initial Registration/Randomization||140
8528004|NCT00602459|9559894|FG003|STARTED|Initial Registration/Randomization||0
8528005|NCT00602459|9559891|FG000|COMPLETED|Initial Registration/Randomization||133
8528006|NCT00602459|9559892|FG001|COMPLETED|Initial Registration/Randomization||130
8528007|NCT00602459|9559893|FG002|COMPLETED|Initial Registration/Randomization||137
8528008|NCT00602459|9559894|FG003|COMPLETED|Initial Registration/Randomization||0
8528009|NCT00602459|9559891|FG000|NOT COMPLETED|Initial Registration/Randomization||5
8528010|NCT00602459|9559892|FG001|NOT COMPLETED|Initial Registration/Randomization||10
8528011|NCT00602459|9559893|FG002|NOT COMPLETED|Initial Registration/Randomization||3
8528012|NCT00602459|9559894|FG003|NOT COMPLETED|Initial Registration/Randomization||0
8528013|NCT00602459|9559891|FG000|STARTED|Re-assignment After Del(11q22.3) Testing||123
8528014|NCT00602459|9559892|FG001|STARTED|Re-assignment After Del(11q22.3) Testing||109
8528015|NCT00602459|9559893|FG002|STARTED|Re-assignment After Del(11q22.3) Testing||137
8528016|NCT00602459|9559894|FG003|STARTED|Re-assignment After Del(11q22.3) Testing||31
8528017|NCT00602459|9559891|FG000|COMPLETED|Re-assignment After Del(11q22.3) Testing||123
8528018|NCT00602459|9559892|FG001|COMPLETED|Re-assignment After Del(11q22.3) Testing||109
8528019|NCT00602459|9559893|FG002|COMPLETED|Re-assignment After Del(11q22.3) Testing||137
8528020|NCT00602459|9559894|FG003|COMPLETED|Re-assignment After Del(11q22.3) Testing||31
8528021|NCT00602459|9559891|FG000|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
8528022|NCT00602459|9559892|FG001|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
8528023|NCT00602459|9559893|FG002|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
8528024|NCT00602459|9559894|FG003|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
8528025|NCT00127673|9559914|FG000|STARTED|Overall Study||48
8528026|NCT00127673|9559915|FG001|STARTED|Overall Study||61
8528027|NCT00127673|9559916|FG002|STARTED|Overall Study||55
8528028|NCT00127673|9559917|FG003|STARTED|Overall Study||36
8528029|NCT00127673|9559914|FG000|COMPLETED|Overall Study||23
8528030|NCT00127673|9559915|FG001|COMPLETED|Overall Study||44
8528031|NCT00127673|9559916|FG002|COMPLETED|Overall Study||35
8528032|NCT00127673|9559917|FG003|COMPLETED|Overall Study||25
8528033|NCT00127673|9559914|FG000|NOT COMPLETED|Overall Study||25
8528034|NCT00127673|9559915|FG001|NOT COMPLETED|Overall Study||17
8528035|NCT00127673|9559916|FG002|NOT COMPLETED|Overall Study||20
8528036|NCT00127673|9559917|FG003|NOT COMPLETED|Overall Study||11
8563155|NCT00045110|9595334|FG000|STARTED|275mg Phase 1 Dose Escalation||3
8563156|NCT00045110|9595335|FG001|STARTED|275mg Phase 1 Dose Escalation||0
8563157|NCT00045110|9595336|FG002|STARTED|275mg Phase 1 Dose Escalation||0
8563158|NCT00045110|9595334|FG000|COMPLETED|275mg Phase 1 Dose Escalation||3
8563159|NCT00045110|9595335|FG001|COMPLETED|275mg Phase 1 Dose Escalation||0
8563160|NCT00045110|9595336|FG002|COMPLETED|275mg Phase 1 Dose Escalation||0
8563161|NCT00045110|9595334|FG000|NOT COMPLETED|275mg Phase 1 Dose Escalation||0
8563162|NCT00045110|9595335|FG001|NOT COMPLETED|275mg Phase 1 Dose Escalation||0
8563163|NCT00045110|9595336|FG002|NOT COMPLETED|275mg Phase 1 Dose Escalation||0
8563164|NCT00045110|9595334|FG000|STARTED|400mg Phase 1 Dose Escalation||3
8563165|NCT00045110|9595335|FG001|STARTED|400mg Phase 1 Dose Escalation||0
8563166|NCT00045110|9595336|FG002|STARTED|400mg Phase 1 Dose Escalation||0
8563167|NCT00045110|9595334|FG000|COMPLETED|400mg Phase 1 Dose Escalation||3
8563168|NCT00045110|9595335|FG001|COMPLETED|400mg Phase 1 Dose Escalation||0
8563169|NCT00045110|9595336|FG002|COMPLETED|400mg Phase 1 Dose Escalation||0
8563170|NCT00045110|9595334|FG000|NOT COMPLETED|400mg Phase 1 Dose Escalation||0
8563171|NCT00045110|9595335|FG001|NOT COMPLETED|400mg Phase 1 Dose Escalation||0
8563172|NCT00045110|9595336|FG002|NOT COMPLETED|400mg Phase 1 Dose Escalation||0
8563173|NCT00045110|9595334|FG000|STARTED|525mg Phase 1 Dose Escalation||3
8563174|NCT00045110|9595335|FG001|STARTED|525mg Phase 1 Dose Escalation||0
8563175|NCT00045110|9595336|FG002|STARTED|525mg Phase 1 Dose Escalation||0
8563176|NCT00045110|9595334|FG000|COMPLETED|525mg Phase 1 Dose Escalation||3
8563177|NCT00045110|9595335|FG001|COMPLETED|525mg Phase 1 Dose Escalation||0
8563178|NCT00045110|9595336|FG002|COMPLETED|525mg Phase 1 Dose Escalation||0
8563179|NCT00045110|9595334|FG000|NOT COMPLETED|525mg Phase 1 Dose Escalation||0
8563180|NCT00045110|9595335|FG001|NOT COMPLETED|525mg Phase 1 Dose Escalation||0
8563181|NCT00045110|9595336|FG002|NOT COMPLETED|525mg Phase 1 Dose Escalation||0
8563182|NCT00045110|9595334|FG000|STARTED|650mg Phase 1 Dose Escalation||6
8563183|NCT00045110|9595335|FG001|STARTED|650mg Phase 1 Dose Escalation||0
8563184|NCT00045110|9595336|FG002|STARTED|650mg Phase 1 Dose Escalation||0
8563185|NCT00045110|9595334|FG000|COMPLETED|650mg Phase 1 Dose Escalation||6
8563186|NCT00045110|9595335|FG001|COMPLETED|650mg Phase 1 Dose Escalation||0
8563187|NCT00045110|9595336|FG002|COMPLETED|650mg Phase 1 Dose Escalation||0
8563188|NCT00045110|9595334|FG000|NOT COMPLETED|650mg Phase 1 Dose Escalation||0
8563189|NCT00045110|9595335|FG001|NOT COMPLETED|650mg Phase 1 Dose Escalation||0
8563190|NCT00045110|9595336|FG002|NOT COMPLETED|650mg Phase 1 Dose Escalation||0
8563191|NCT00045110|9595334|FG000|STARTED|775mg Dose Escalation||7
8563192|NCT00045110|9595335|FG001|STARTED|775mg Dose Escalation||0
8620521|NCT00474539|9659255|FG001|COMPLETED|Infant Series||220
8620522|NCT00474539|9659254|FG000|NOT COMPLETED|Infant Series||10
8563193|NCT00045110|9595336|FG002|STARTED|775mg Dose Escalation||0
8563194|NCT00045110|9595334|FG000|COMPLETED|775mg Dose Escalation||7
8563195|NCT00045110|9595335|FG001|COMPLETED|775mg Dose Escalation||0
8563196|NCT00045110|9595336|FG002|COMPLETED|775mg Dose Escalation||0
8563197|NCT00045110|9595334|FG000|NOT COMPLETED|775mg Dose Escalation||0
8563198|NCT00045110|9595335|FG001|NOT COMPLETED|775mg Dose Escalation||0
8563199|NCT00045110|9595336|FG002|NOT COMPLETED|775mg Dose Escalation||0
8563200|NCT00045162|9595355|FG000|STARTED|Overall Study||336
8563201|NCT00045162|9595356|FG001|STARTED|Overall Study||335
8563202|NCT00045162|9595355|FG000|COMPLETED|Overall Study||194
8563203|NCT00045162|9595356|FG001|COMPLETED|Overall Study||217
8563204|NCT00045162|9595355|FG000|NOT COMPLETED|Overall Study||142
8563205|NCT00045162|9595356|FG001|NOT COMPLETED|Overall Study||118
8563206|NCT00045305|9595362|FG000|STARTED|Overall Study||17
8563207|NCT00045305|9595362|FG000|Eligible and Treated|Overall Study||17
8563208|NCT00045305|9595362|FG000|COMPLETED|Overall Study||3
8563209|NCT00045305|9595362|FG000|NOT COMPLETED|Overall Study||14
8563210|NCT00045435|9595366|FG000|STARTED|Overall Study||17
8563211|NCT00045435|9595366|FG000|COMPLETED|Overall Study||17
8620523|NCT00474539|9659255|FG001|NOT COMPLETED|Infant Series||6
8528037|NCT04388527|9559931|FG000|STARTED|Overall Study||32
8528038|NCT04388527|9559931|FG000|COMPLETED|Overall Study||15
8528039|NCT04388527|9559931|FG000|NOT COMPLETED|Overall Study||17
8528040|NCT04369833|9559935|FG000|STARTED|Overall Study||130
8528041|NCT04369833|9559935|FG000|COMPLETED|Overall Study||129
8528042|NCT04369833|9559935|FG000|NOT COMPLETED|Overall Study||1
8528043|NCT04238429|9559941|FG000|STARTED|Overall Study||43
8528044|NCT04238429|9559942|FG001|STARTED|Overall Study||43
8528045|NCT04238429|9559941|FG000|COMPLETED|Overall Study||40
8528046|NCT04238429|9559942|FG001|COMPLETED|Overall Study||41
8528047|NCT04238429|9559941|FG000|NOT COMPLETED|Overall Study||3
8528048|NCT04238429|9559942|FG001|NOT COMPLETED|Overall Study||2
8528049|NCT04126083|9559948|FG000|STARTED|Overall Study||6
8528050|NCT04126083|9559948|FG000|COMPLETED|Overall Study||5
8528051|NCT04126083|9559948|FG000|NOT COMPLETED|Overall Study||1
8528052|NCT03901300|9559954|FG000|STARTED|Overall Study|Children were enrolled study participants. Parents were not study participants.|35
8528053|NCT03901300|9559955|FG001|STARTED|Overall Study||37
8528054|NCT03901300|9559954|FG000|COMPLETED|Overall Study||32
8528055|NCT03901300|9559955|FG001|COMPLETED|Overall Study||37
8528056|NCT03901300|9559954|FG000|NOT COMPLETED|Overall Study||3
8528057|NCT03901300|9559955|FG001|NOT COMPLETED|Overall Study||0
8528058|NCT03744637|9559971|FG000|STARTED|Overall Study||2
8528059|NCT03744637|9559972|FG001|STARTED|Overall Study||2
8528060|NCT03744637|9559973|FG002|STARTED|Overall Study||2
8528061|NCT03744637|9559974|FG003|STARTED|Overall Study||1
8528062|NCT03744637|9559975|FG004|STARTED|Overall Study||1
8528063|NCT03744637|9559976|FG005|STARTED|Overall Study||1
8528064|NCT03744637|9559977|FG006|STARTED|Overall Study||8
8528065|NCT03744637|9559978|FG007|STARTED|Overall Study||4
8528066|NCT03744637|9559979|FG008|STARTED|Overall Study||3
8528067|NCT03744637|9559980|FG009|STARTED|Overall Study||1
8528068|NCT03744637|9559971|FG000|COMPLETED|Overall Study||2
8528069|NCT03744637|9559972|FG001|COMPLETED|Overall Study||2
8528070|NCT03744637|9559973|FG002|COMPLETED|Overall Study||2
8528071|NCT03744637|9559974|FG003|COMPLETED|Overall Study||1
8528072|NCT03744637|9559975|FG004|COMPLETED|Overall Study|Participant did not receive MK-5475 240 ug in Part 2 as planned.|1
8528073|NCT03744637|9559976|FG005|COMPLETED|Overall Study|Participant received 165 ug in Part 2 Periods 2 and 3, instead of planned 360 ug.|1
8528074|NCT03744637|9559977|FG006|COMPLETED|Overall Study||8
8528075|NCT03744637|9559978|FG007|COMPLETED|Overall Study|Participants received 120 ug in Part 2 Periods 2 and 3, instead of planned 360 ug.|4
8528076|NCT03744637|9559979|FG008|COMPLETED|Overall Study||3
8528077|NCT03744637|9559980|FG009|COMPLETED|Overall Study|Participant did not receive 120 ug in Part 2 Period 3 as planned.|1
8528078|NCT03744637|9559971|FG000|NOT COMPLETED|Overall Study||0
8528079|NCT03744637|9559972|FG001|NOT COMPLETED|Overall Study||0
8528080|NCT03744637|9559973|FG002|NOT COMPLETED|Overall Study||0
8528081|NCT03744637|9559974|FG003|NOT COMPLETED|Overall Study||0
8528082|NCT03744637|9559975|FG004|NOT COMPLETED|Overall Study||0
8528083|NCT03744637|9559976|FG005|NOT COMPLETED|Overall Study||0
8528084|NCT03744637|9559977|FG006|NOT COMPLETED|Overall Study||0
8528085|NCT03744637|9559978|FG007|NOT COMPLETED|Overall Study||0
8528086|NCT03744637|9559979|FG008|NOT COMPLETED|Overall Study||0
8528087|NCT03744637|9559980|FG009|NOT COMPLETED|Overall Study||0
8528088|NCT03576144|9560047|FG000|STARTED|Overall Study||10
8528089|NCT03576144|9560048|FG001|STARTED|Overall Study||8
8528090|NCT03576144|9560049|FG002|STARTED|Overall Study||8
8528091|NCT03576144|9560050|FG003|STARTED|Overall Study||8
8528092|NCT03576144|9560051|FG004|STARTED|Overall Study||8
8528093|NCT03576144|9560052|FG005|STARTED|Overall Study||8
8528094|NCT03576144|9560047|FG000|COMPLETED|Overall Study||10
8528095|NCT03576144|9560048|FG001|COMPLETED|Overall Study||8
8528096|NCT03576144|9560049|FG002|COMPLETED|Overall Study||8
8528097|NCT03576144|9560050|FG003|COMPLETED|Overall Study||8
8528098|NCT03576144|9560051|FG004|COMPLETED|Overall Study||8
8528099|NCT03576144|9560052|FG005|COMPLETED|Overall Study||8
8528100|NCT03576144|9560047|FG000|NOT COMPLETED|Overall Study||0
8528101|NCT03576144|9560048|FG001|NOT COMPLETED|Overall Study||0
8528102|NCT03576144|9560049|FG002|NOT COMPLETED|Overall Study||0
8528103|NCT03576144|9560050|FG003|NOT COMPLETED|Overall Study||0
8528104|NCT03576144|9560051|FG004|NOT COMPLETED|Overall Study||0
8528105|NCT03576144|9560052|FG005|NOT COMPLETED|Overall Study||0
8528106|NCT03444038|9560071|FG000|STARTED|Overall Study||85
8528107|NCT03444038|9560071|FG000|COMPLETED|Overall Study||56
8528108|NCT03444038|9560071|FG000|NOT COMPLETED|Overall Study||29
8528109|NCT03432897|9560075|FG000|STARTED|Overall Study||1
8528110|NCT03432897|9560075|FG000|COMPLETED|Overall Study||1
8528111|NCT03432897|9560075|FG000|NOT COMPLETED|Overall Study||0
8528112|NCT03265665|9560081|FG000|STARTED|24-week Data Collection||25
8528113|NCT03265665|9560082|FG001|STARTED|24-week Data Collection||28
8528114|NCT03265665|9560081|FG000|COMPLETED|24-week Data Collection||19
8528115|NCT03265665|9560082|FG001|COMPLETED|24-week Data Collection||21
8528116|NCT03265665|9560081|FG000|NOT COMPLETED|24-week Data Collection||6
8528117|NCT03265665|9560082|FG001|NOT COMPLETED|24-week Data Collection||7
8528118|NCT03265665|9560081|FG000|STARTED|36-week Data Collection|Used the number of participants that did not withdraw from the study. If a participant did not complete the 24 week week data collection, they were still allowed to complete the 36-week data collection. Thus the number we started with for this period was the total number of participants in each group that did not withdraw from the study.|23
8563212|NCT00045435|9595366|FG000|NOT COMPLETED|Overall Study||0
8563213|NCT00045487|9595370|FG000|STARTED|Overall Study||41
8528119|NCT03265665|9560082|FG001|STARTED|36-week Data Collection|Used the number of participants that did not withdraw from the study. If a participant did not complete the 24 week week data collection, they were still allowed to complete the 36-week data collection. Thus the number we started with for this period was the total number of participants in each group that did not withdraw from the study.|26
8528120|NCT03265665|9560081|FG000|COMPLETED|36-week Data Collection||17
8528121|NCT03265665|9560082|FG001|COMPLETED|36-week Data Collection||18
8528122|NCT03265665|9560081|FG000|NOT COMPLETED|36-week Data Collection||6
8528123|NCT03265665|9560082|FG001|NOT COMPLETED|36-week Data Collection||8
8563214|NCT00045487|9595370|FG000|COMPLETED|Overall Study||30
8620524|NCT00474539|9659254|FG000|STARTED|After Infant Series||213
8620525|NCT00474539|9659255|FG001|STARTED|After Infant Series||220
8620526|NCT00474539|9659254|FG000|COMPLETED|After Infant Series||209
8620527|NCT00474539|9659255|FG001|COMPLETED|After Infant Series||220
8620528|NCT00474539|9659254|FG000|NOT COMPLETED|After Infant Series||4
8620529|NCT00474539|9659255|FG001|NOT COMPLETED|After Infant Series||0
8620530|NCT00474539|9659254|FG000|STARTED|Toddler Dose||209
8563215|NCT00045487|9595370|FG000|NOT COMPLETED|Overall Study||11
8563216|NCT00045630|9595374|FG000|STARTED|Overall Study||77
8563217|NCT00045630|9595374|FG000|Eligible|Overall Study||75
8563218|NCT00045630|9595374|FG000|Eligible and Began Protocol Therapy|Overall Study||74
8563219|NCT00045630|9595374|FG000|COMPLETED|Overall Study||71
8563220|NCT00045630|9595374|FG000|NOT COMPLETED|Overall Study||6
8563221|NCT00045708|9595381|FG000|STARTED|Phase 1||21
8563222|NCT00045708|9595382|FG001|STARTED|Phase 1||17
8563223|NCT00045708|9595383|FG002|STARTED|Phase 1||0
8563224|NCT00045708|9595381|FG000|COMPLETED|Phase 1||21
8563225|NCT00045708|9595382|FG001|COMPLETED|Phase 1||16
8563226|NCT00045708|9595383|FG002|COMPLETED|Phase 1||0
8563227|NCT00045708|9595381|FG000|NOT COMPLETED|Phase 1||0
8563228|NCT00045708|9595382|FG001|NOT COMPLETED|Phase 1||1
8563229|NCT00045708|9595383|FG002|NOT COMPLETED|Phase 1||0
8563230|NCT00045708|9595381|FG000|STARTED|Phase 2||0
8563231|NCT00045708|9595382|FG001|STARTED|Phase 2||0
8563232|NCT00045708|9595383|FG002|STARTED|Phase 2||19
8563233|NCT00045708|9595381|FG000|COMPLETED|Phase 2||0
8563234|NCT00045708|9595382|FG001|COMPLETED|Phase 2||0
8563235|NCT00045708|9595383|FG002|COMPLETED|Phase 2||19
8563236|NCT00045708|9595381|FG000|NOT COMPLETED|Phase 2||0
8563237|NCT00045708|9595382|FG001|NOT COMPLETED|Phase 2||0
8563238|NCT00045708|9595383|FG002|NOT COMPLETED|Phase 2||0
8563239|NCT00045734|9595400|FG000|STARTED|Overall Study||23
8563240|NCT00045734|9595400|FG000|COMPLETED|Overall Study||22
8563241|NCT00045734|9595400|FG000|NOT COMPLETED|Overall Study||1
8563242|NCT00045942|9595413|FG000|STARTED|PKC412A2104 (Core)||20
8563243|NCT00045942|9595414|FG001|STARTED|PKC412A2104 (Core)||0
8563244|NCT00045942|9595415|FG002|STARTED|PKC412A2104 (Core)||0
8563245|NCT00045942|9595416|FG003|STARTED|PKC412A2104 (Core)||0
8563246|NCT00045942|9595417|FG004|STARTED|PKC412A2104 (Core)||0
8563247|NCT00045942|9595418|FG005|STARTED|PKC412A2104 (Core)||0
8563248|NCT00045942|9595419|FG006|STARTED|PKC412A2104 (Core)||0
8563249|NCT00045942|9595420|FG007|STARTED|PKC412A2104 (Core)||0
8563250|NCT00045942|9595421|FG008|STARTED|PKC412A2104 (Core)||0
8563251|NCT00045942|9595413|FG000|Core Primary Efficacy|PKC412A2104 (Core)||20
8563252|NCT00045942|9595414|FG001|Core Primary Efficacy|PKC412A2104 (Core)||0
8563253|NCT00045942|9595415|FG002|Core Primary Efficacy|PKC412A2104 (Core)||0
8563254|NCT00045942|9595416|FG003|Core Primary Efficacy|PKC412A2104 (Core)||0
8563255|NCT00045942|9595417|FG004|Core Primary Efficacy|PKC412A2104 (Core)||0
8563256|NCT00045942|9595418|FG005|Core Primary Efficacy|PKC412A2104 (Core)||0
8563257|NCT00045942|9595419|FG006|Core Primary Efficacy|PKC412A2104 (Core)||0
8563258|NCT00045942|9595420|FG007|Core Primary Efficacy|PKC412A2104 (Core)||0
8563259|NCT00045942|9595421|FG008|Core Primary Efficacy|PKC412A2104 (Core)||0
8563260|NCT00045942|9595413|FG000|COMPLETED|PKC412A2104 (Core)||0
8563261|NCT00045942|9595414|FG001|COMPLETED|PKC412A2104 (Core)||0
8620531|NCT00474539|9659255|FG001|STARTED|Toddler Dose||220
8620532|NCT00474539|9659254|FG000|COMPLETED|Toddler Dose||208
8620533|NCT00474539|9659255|FG001|COMPLETED|Toddler Dose||220
8620534|NCT00474539|9659254|FG000|NOT COMPLETED|Toddler Dose||1
8620535|NCT00474539|9659255|FG001|NOT COMPLETED|Toddler Dose||0
8620536|NCT00474617|9659289|FG000|STARTED|Overall Study||56
8620537|NCT00474617|9659290|FG001|STARTED|Overall Study||64
8620538|NCT00474617|9659291|FG002|STARTED|Overall Study||42
8620539|NCT00474617|9659289|FG000|Treated|Overall Study||48
8620540|NCT00474617|9659290|FG001|Treated|Overall Study||62
8620541|NCT00474617|9659291|FG002|Treated|Overall Study||40
8620542|NCT00474617|9659289|FG000|COMPLETED|Overall Study||48
8620543|NCT00474617|9659290|FG001|COMPLETED|Overall Study||61
8620544|NCT00474617|9659291|FG002|COMPLETED|Overall Study||40
8620545|NCT00474617|9659289|FG000|NOT COMPLETED|Overall Study||8
8620546|NCT00474617|9659290|FG001|NOT COMPLETED|Overall Study||3
8563262|NCT00045942|9595415|FG002|COMPLETED|PKC412A2104 (Core)||0
8563263|NCT00045942|9595416|FG003|COMPLETED|PKC412A2104 (Core)||0
8563264|NCT00045942|9595417|FG004|COMPLETED|PKC412A2104 (Core)||0
8563265|NCT00045942|9595418|FG005|COMPLETED|PKC412A2104 (Core)||0
8563266|NCT00045942|9595419|FG006|COMPLETED|PKC412A2104 (Core)||0
8563267|NCT00045942|9595420|FG007|COMPLETED|PKC412A2104 (Core)||0
8620547|NCT00474617|9659291|FG002|NOT COMPLETED|Overall Study||2
8620548|NCT00474630|9659301|FG000|STARTED|Overall Study||335
8620549|NCT00474630|9659302|FG001|STARTED|Overall Study||170
8620550|NCT00474630|9659301|FG000|COMPLETED|Overall Study||175
8620551|NCT00474630|9659302|FG001|COMPLETED|Overall Study||100
8620552|NCT00474630|9659301|FG000|NOT COMPLETED|Overall Study||160
8528124|NCT03196180|9560090|FG000|STARTED|Overall Study||13
8528125|NCT03196180|9560090|FG000|COMPLETED|Overall Study||11
8528126|NCT03196180|9560090|FG000|NOT COMPLETED|Overall Study||2
8528127|NCT02725593|9560096|FG000|STARTED|Blinded Treatment Period||39
8528128|NCT02725593|9560097|FG001|STARTED|Blinded Treatment Period||33
8528129|NCT02725593|9560096|FG000|Received Treatment|Blinded Treatment Period||39
8528130|NCT02725593|9560097|FG001|Received Treatment|Blinded Treatment Period||33
8528131|NCT02725593|9560096|FG000|COMPLETED|Blinded Treatment Period||34
8528132|NCT02725593|9560097|FG001|COMPLETED|Blinded Treatment Period||27
8528133|NCT02725593|9560096|FG000|NOT COMPLETED|Blinded Treatment Period||5
8528134|NCT02725593|9560097|FG001|NOT COMPLETED|Blinded Treatment Period||6
8528135|NCT02725593|9560096|FG000|STARTED|Long Term Extension|1 participant who completed Period 1 did not enter the long-term extension period.|33
8528136|NCT02725593|9560097|FG001|STARTED|Long Term Extension||27
8528137|NCT02725593|9560096|FG000|COMPLETED|Long Term Extension||32
8528138|NCT02725593|9560097|FG001|COMPLETED|Long Term Extension||24
8528139|NCT02725593|9560096|FG000|NOT COMPLETED|Long Term Extension||1
8528140|NCT02725593|9560097|FG001|NOT COMPLETED|Long Term Extension||3
8528141|NCT02716675|9560106|FG000|STARTED|Overall Study||903
8528142|NCT02716675|9560107|FG001|STARTED|Overall Study||899
8528143|NCT02716675|9560108|FG002|STARTED|Overall Study||897
8528144|NCT02716675|9560106|FG000|Modified Intent-to-treat Population|Overall Study||898
8528145|NCT02716675|9560107|FG001|Modified Intent-to-treat Population|Overall Study||895
8528146|NCT02716675|9560108|FG002|Modified Intent-to-treat Population|Overall Study||894
8528147|NCT02716675|9560106|FG000|COMPLETED|Overall Study||703
8528148|NCT02716675|9560107|FG001|COMPLETED|Overall Study||702
8528149|NCT02716675|9560108|FG002|COMPLETED|Overall Study||686
8528150|NCT02716675|9560106|FG000|NOT COMPLETED|Overall Study||200
8528151|NCT02716675|9560107|FG001|NOT COMPLETED|Overall Study||197
8528152|NCT02716675|9560108|FG002|NOT COMPLETED|Overall Study||211
8528153|NCT02636946|9560123|FG000|STARTED|Cycle 1 (Day 1 to Week 15)||72
8528154|NCT02636946|9560124|FG001|STARTED|Cycle 1 (Day 1 to Week 15)||72
8528155|NCT02636946|9560123|FG000|Received Treatment in Either Eye|Cycle 1 (Day 1 to Week 15)||72
8528156|NCT02636946|9560124|FG001|Received Treatment in Either Eye|Cycle 1 (Day 1 to Week 15)||70
8528157|NCT02636946|9560123|FG000|COMPLETED|Cycle 1 (Day 1 to Week 15)||71
8528158|NCT02636946|9560124|FG001|COMPLETED|Cycle 1 (Day 1 to Week 15)||67
8528159|NCT02636946|9560123|FG000|NOT COMPLETED|Cycle 1 (Day 1 to Week 15)||1
8528160|NCT02636946|9560124|FG001|NOT COMPLETED|Cycle 1 (Day 1 to Week 15)||5
8528161|NCT02636946|9560123|FG000|STARTED|Cycle 2 (Week 16 to Week 31)||65
8528162|NCT02636946|9560124|FG001|STARTED|Cycle 2 (Week 16 to Week 31)||62
8528163|NCT02636946|9560123|FG000|COMPLETED|Cycle 2 (Week 16 to Week 31)||63
8528164|NCT02636946|9560124|FG001|COMPLETED|Cycle 2 (Week 16 to Week 31)||61
8528165|NCT02636946|9560123|FG000|NOT COMPLETED|Cycle 2 (Week 16 to Week 31)||2
8528166|NCT02636946|9560124|FG001|NOT COMPLETED|Cycle 2 (Week 16 to Week 31)||1
8528167|NCT02636946|9560123|FG000|STARTED|Cycle 3 (Week 32 to Week 52)||17
8528168|NCT02636946|9560124|FG001|STARTED|Cycle 3 (Week 32 to Week 52)||16
8528169|NCT02636946|9560123|FG000|COMPLETED|Cycle 3 (Week 32 to Week 52)||17
8528170|NCT02636946|9560124|FG001|COMPLETED|Cycle 3 (Week 32 to Week 52)||16
8528171|NCT02636946|9560123|FG000|NOT COMPLETED|Cycle 3 (Week 32 to Week 52)||0
8528172|NCT02636946|9560124|FG001|NOT COMPLETED|Cycle 3 (Week 32 to Week 52)||0
8528173|NCT02631941|9560140|FG000|STARTED|Overall Study||9
8528174|NCT02631941|9560141|FG001|STARTED|Overall Study||10
8528175|NCT02631941|9560142|FG002|STARTED|Overall Study||9
8528176|NCT02631941|9560143|FG003|STARTED|Overall Study||9
8528177|NCT02631941|9560144|FG004|STARTED|Overall Study||9
8528178|NCT02631941|9560145|FG005|STARTED|Overall Study||8
8528179|NCT02631941|9560146|FG006|STARTED|Overall Study||9
8528180|NCT02631941|9560147|FG007|STARTED|Overall Study||9
8528181|NCT02631941|9560148|FG008|STARTED|Overall Study||10
8528182|NCT02631941|9560149|FG009|STARTED|Overall Study||9
8528183|NCT02631941|9560140|FG000|A|Overall Study||9
8528184|NCT02631941|9560141|FG001|A|Overall Study||8
8528185|NCT02631941|9560142|FG002|A|Overall Study||9
8528186|NCT02631941|9560143|FG003|A|Overall Study||9
8528187|NCT02631941|9560144|FG004|A|Overall Study||9
8528188|NCT02631941|9560145|FG005|A|Overall Study||8
8528189|NCT02631941|9560146|FG006|A|Overall Study||9
8528190|NCT02631941|9560147|FG007|A|Overall Study||9
8528191|NCT02631941|9560148|FG008|A|Overall Study||9
8528192|NCT02631941|9560149|FG009|A|Overall Study||9
8528193|NCT02631941|9560140|FG000|B1|Overall Study||9
8528194|NCT02631941|9560141|FG001|B1|Overall Study||10
8528195|NCT02631941|9560142|FG002|B1|Overall Study||9
8528196|NCT02631941|9560143|FG003|B1|Overall Study||9
8528197|NCT02631941|9560144|FG004|B1|Overall Study||8
8528198|NCT02631941|9560145|FG005|B1|Overall Study||8
8528199|NCT02631941|9560146|FG006|B1|Overall Study||9
8528200|NCT02631941|9560147|FG007|B1|Overall Study||9
8528201|NCT02631941|9560148|FG008|B1|Overall Study||10
8528202|NCT02631941|9560149|FG009|B1|Overall Study||9
8528203|NCT02631941|9560140|FG000|B2|Overall Study||9
8528204|NCT02631941|9560141|FG001|B2|Overall Study||8
8528205|NCT02631941|9560142|FG002|B2|Overall Study||9
8528206|NCT02631941|9560143|FG003|B2|Overall Study||9
8528207|NCT02631941|9560144|FG004|B2|Overall Study||9
8528208|NCT02631941|9560145|FG005|B2|Overall Study||8
8528209|NCT02631941|9560146|FG006|B2|Overall Study||9
8528210|NCT02631941|9560147|FG007|B2|Overall Study||9
8528211|NCT02631941|9560148|FG008|B2|Overall Study||9
8528212|NCT02631941|9560149|FG009|B2|Overall Study||9
8528213|NCT02631941|9560140|FG000|C|Overall Study||9
8528214|NCT02631941|9560141|FG001|C|Overall Study||8
8528215|NCT02631941|9560142|FG002|C|Overall Study||9
8528216|NCT02631941|9560143|FG003|C|Overall Study||9
8528217|NCT02631941|9560144|FG004|C|Overall Study||8
8528218|NCT02631941|9560145|FG005|C|Overall Study||8
8528219|NCT02631941|9560146|FG006|C|Overall Study||9
8528220|NCT02631941|9560147|FG007|C|Overall Study||8
8528221|NCT02631941|9560148|FG008|C|Overall Study||9
8528222|NCT02631941|9560149|FG009|C|Overall Study||9
8528223|NCT02631941|9560140|FG000|D|Overall Study||9
8528224|NCT02631941|9560141|FG001|D|Overall Study||8
8528225|NCT02631941|9560142|FG002|D|Overall Study||9
8528226|NCT02631941|9560143|FG003|D|Overall Study||9
8528227|NCT02631941|9560144|FG004|D|Overall Study||8
8528228|NCT02631941|9560145|FG005|D|Overall Study||8
8528229|NCT02631941|9560146|FG006|D|Overall Study||9
8528230|NCT02631941|9560147|FG007|D|Overall Study||9
8528231|NCT02631941|9560148|FG008|D|Overall Study||9
8528232|NCT02631941|9560149|FG009|D|Overall Study||9
8528233|NCT02631941|9560140|FG000|COMPLETED|Overall Study||9
8528234|NCT02631941|9560141|FG001|COMPLETED|Overall Study||8
8528235|NCT02631941|9560142|FG002|COMPLETED|Overall Study||9
8528236|NCT02631941|9560143|FG003|COMPLETED|Overall Study||9
8528237|NCT02631941|9560144|FG004|COMPLETED|Overall Study||8
8528238|NCT02631941|9560145|FG005|COMPLETED|Overall Study||8
8528239|NCT02631941|9560146|FG006|COMPLETED|Overall Study||9
8528240|NCT02631941|9560147|FG007|COMPLETED|Overall Study||8
8528241|NCT02631941|9560148|FG008|COMPLETED|Overall Study||9
8528242|NCT02631941|9560149|FG009|COMPLETED|Overall Study||9
8528243|NCT02631941|9560140|FG000|NOT COMPLETED|Overall Study||0
8528244|NCT02631941|9560141|FG001|NOT COMPLETED|Overall Study||2
8528245|NCT02631941|9560142|FG002|NOT COMPLETED|Overall Study||0
8528246|NCT02631941|9560143|FG003|NOT COMPLETED|Overall Study||0
8528247|NCT02631941|9560144|FG004|NOT COMPLETED|Overall Study||1
8528248|NCT02631941|9560145|FG005|NOT COMPLETED|Overall Study||0
8528249|NCT02631941|9560146|FG006|NOT COMPLETED|Overall Study||0
8528250|NCT02631941|9560147|FG007|NOT COMPLETED|Overall Study||1
8528251|NCT02631941|9560148|FG008|NOT COMPLETED|Overall Study||1
8528252|NCT02631941|9560149|FG009|NOT COMPLETED|Overall Study||0
8528253|NCT02568215|9560162|FG000|STARTED|Overall Study||637
8528254|NCT02568215|9560163|FG001|STARTED|Overall Study||642
8528255|NCT02568215|9560164|FG002|STARTED|Overall Study||645
8528256|NCT02568215|9560162|FG000|Modified Intent-to-treat Population|Overall Study||637
8528257|NCT02568215|9560163|FG001|Modified Intent-to-treat Population|Overall Study||642
8528258|NCT02568215|9560164|FG002|Modified Intent-to-treat Population|Overall Study||645
8528259|NCT02568215|9560162|FG000|COMPLETED|Overall Study||558
8528260|NCT02568215|9560163|FG001|COMPLETED|Overall Study||562
8528261|NCT02568215|9560164|FG002|COMPLETED|Overall Study||555
8528262|NCT02568215|9560162|FG000|NOT COMPLETED|Overall Study||79
8528263|NCT02568215|9560163|FG001|NOT COMPLETED|Overall Study||80
8528264|NCT02568215|9560164|FG002|NOT COMPLETED|Overall Study||90
8528265|NCT02562378|9560180|FG000|STARTED|Overall Study||3
8528266|NCT02562378|9560181|FG001|STARTED|Overall Study||3
8528267|NCT02562378|9560182|FG002|STARTED|Overall Study||9
8528268|NCT02562378|9560180|FG000|COMPLETED|Overall Study||3
8528269|NCT02562378|9560181|FG001|COMPLETED|Overall Study||3
8528270|NCT02562378|9560182|FG002|COMPLETED|Overall Study||9
8528271|NCT02562378|9560180|FG000|NOT COMPLETED|Overall Study||0
8528272|NCT02562378|9560181|FG001|NOT COMPLETED|Overall Study||0
8528273|NCT02562378|9560182|FG002|NOT COMPLETED|Overall Study||0
8528274|NCT02528643|9560192|FG000|STARTED|DB (Median Duration up to 14.65 Months)||55
8528275|NCT02528643|9560193|FG001|STARTED|DB (Median Duration up to 14.65 Months)||110
8528276|NCT02528643|9560192|FG000|Treated|DB (Median Duration up to 14.65 Months)||55
8528277|NCT02528643|9560193|FG001|Treated|DB (Median Duration up to 14.65 Months)||107
8528278|NCT02528643|9560192|FG000|COMPLETED|DB (Median Duration up to 14.65 Months)||0
8528279|NCT02528643|9560193|FG001|COMPLETED|DB (Median Duration up to 14.65 Months)||0
8528280|NCT02528643|9560192|FG000|NOT COMPLETED|DB (Median Duration up to 14.65 Months)||55
8528281|NCT02528643|9560193|FG001|NOT COMPLETED|DB (Median Duration up to 14.65 Months)||110
8528282|NCT02528643|9560192|FG000|STARTED|OL (Median Duration up to 27.56 Months)||0
8528283|NCT02528643|9560193|FG001|STARTED|OL (Median Duration up to 27.56 Months)||1
8528284|NCT02528643|9560192|FG000|COMPLETED|OL (Median Duration up to 27.56 Months)||0
8528285|NCT02528643|9560193|FG001|COMPLETED|OL (Median Duration up to 27.56 Months)||0
8528286|NCT02528643|9560192|FG000|NOT COMPLETED|OL (Median Duration up to 27.56 Months)||0
8528287|NCT02528643|9560193|FG001|NOT COMPLETED|OL (Median Duration up to 27.56 Months)||1
8528288|NCT02416011|9560204|FG000|STARTED|Overall Study||575
8528289|NCT02416011|9560205|FG001|STARTED|Overall Study||1154
8528290|NCT02416011|9560206|FG002|STARTED|Overall Study||1167
8722759|NCT01020838|9770236|FG000|COMPLETED|Overall Study||35
8722760|NCT01020838|9770236|FG000|NOT COMPLETED|Overall Study||183
8722761|NCT01020877|9770251|FG000|STARTED|First Intervention||19
8722762|NCT01020877|9770252|FG001|STARTED|First Intervention||19
8528291|NCT02416011|9560204|FG000|COMPLETED|Overall Study||561
8528292|NCT02416011|9560205|FG001|COMPLETED|Overall Study||1101
8528293|NCT02416011|9560206|FG002|COMPLETED|Overall Study||1114
8528294|NCT02416011|9560204|FG000|NOT COMPLETED|Overall Study||14
8528295|NCT02416011|9560205|FG001|NOT COMPLETED|Overall Study||53
8528296|NCT02416011|9560206|FG002|NOT COMPLETED|Overall Study||53
8528297|NCT02237508|9560237|FG000|STARTED|Overall Study||9
8528298|NCT02237508|9560238|FG001|STARTED|Overall Study||9
8528299|NCT02237508|9560239|FG002|STARTED|Overall Study||9
8528300|NCT02237508|9560240|FG003|STARTED|Overall Study||9
8528301|NCT02237508|9560241|FG004|STARTED|Overall Study||9
8528302|NCT02237508|9560242|FG005|STARTED|Overall Study||9
8528303|NCT02237508|9560243|FG006|STARTED|Overall Study||9
8528304|NCT02237508|9560244|FG007|STARTED|Overall Study||9
8528305|NCT02237508|9560245|FG008|STARTED|Overall Study||9
8528306|NCT02237508|9560246|FG009|STARTED|Overall Study||9
8528307|NCT02237508|9560237|FG000|A|Overall Study||9
8528308|NCT02237508|9560238|FG001|A|Overall Study||6
8528309|NCT02237508|9560239|FG002|A|Overall Study||8
8528310|NCT02237508|9560240|FG003|A|Overall Study||8
8528311|NCT02237508|9560241|FG004|A|Overall Study||9
8528312|NCT02237508|9560242|FG005|A|Overall Study||8
8528313|NCT02237508|9560243|FG006|A|Overall Study||8
8528314|NCT02237508|9560244|FG007|A|Overall Study||9
8528315|NCT02237508|9560245|FG008|A|Overall Study||9
8528316|NCT02237508|9560246|FG009|A|Overall Study||9
8528317|NCT02237508|9560237|FG000|B1|Overall Study||9
8528318|NCT02237508|9560238|FG001|B1|Overall Study||9
8528319|NCT02237508|9560239|FG002|B1|Overall Study||9
8528320|NCT02237508|9560240|FG003|B1|Overall Study||8
8528321|NCT02237508|9560241|FG004|B1|Overall Study||9
8528322|NCT02237508|9560242|FG005|B1|Overall Study||9
8528323|NCT02237508|9560243|FG006|B1|Overall Study||9
8528324|NCT02237508|9560244|FG007|B1|Overall Study||9
8528325|NCT02237508|9560245|FG008|B1|Overall Study||9
8528326|NCT02237508|9560246|FG009|B1|Overall Study||9
8528327|NCT02237508|9560237|FG000|B2|Overall Study||9
8528328|NCT02237508|9560238|FG001|B2|Overall Study||6
8528329|NCT02237508|9560239|FG002|B2|Overall Study||9
8528330|NCT02237508|9560240|FG003|B2|Overall Study||9
8528331|NCT02237508|9560241|FG004|B2|Overall Study||9
8528332|NCT02237508|9560242|FG005|B2|Overall Study||9
8528333|NCT02237508|9560243|FG006|B2|Overall Study||9
8528334|NCT02237508|9560244|FG007|B2|Overall Study||9
8528335|NCT02237508|9560245|FG008|B2|Overall Study||8
8528336|NCT02237508|9560246|FG009|B2|Overall Study||9
8528337|NCT02237508|9560237|FG000|C|Overall Study||9
8528338|NCT02237508|9560238|FG001|C|Overall Study||8
8528339|NCT02237508|9560239|FG002|C|Overall Study||9
8528340|NCT02237508|9560240|FG003|C|Overall Study||8
8528341|NCT02237508|9560241|FG004|C|Overall Study||9
8528342|NCT02237508|9560242|FG005|C|Overall Study||9
8528343|NCT02237508|9560243|FG006|C|Overall Study||9
8528344|NCT02237508|9560244|FG007|C|Overall Study||9
8528345|NCT02237508|9560245|FG008|C|Overall Study||9
8528346|NCT02237508|9560246|FG009|C|Overall Study||9
8528347|NCT02237508|9560237|FG000|D|Overall Study||9
8528348|NCT02237508|9560238|FG001|D|Overall Study||6
8528349|NCT02237508|9560239|FG002|D|Overall Study||9
8528350|NCT02237508|9560240|FG003|D|Overall Study||9
8528351|NCT02237508|9560241|FG004|D|Overall Study||9
8528352|NCT02237508|9560242|FG005|D|Overall Study||9
8528353|NCT02237508|9560243|FG006|D|Overall Study||9
8528354|NCT02237508|9560244|FG007|D|Overall Study||9
8528355|NCT02237508|9560245|FG008|D|Overall Study||8
8528356|NCT02237508|9560246|FG009|D|Overall Study||9
8528357|NCT02237508|9560237|FG000|COMPLETED|Overall Study||9
8528358|NCT02237508|9560238|FG001|COMPLETED|Overall Study||6
8528359|NCT02237508|9560239|FG002|COMPLETED|Overall Study||8
8528360|NCT02237508|9560240|FG003|COMPLETED|Overall Study||8
8528361|NCT02237508|9560241|FG004|COMPLETED|Overall Study||9
8528362|NCT02237508|9560242|FG005|COMPLETED|Overall Study||8
8528363|NCT02237508|9560243|FG006|COMPLETED|Overall Study||8
8528364|NCT02237508|9560244|FG007|COMPLETED|Overall Study||9
8528365|NCT02237508|9560245|FG008|COMPLETED|Overall Study||8
8528366|NCT02237508|9560246|FG009|COMPLETED|Overall Study||9
8528367|NCT02237508|9560237|FG000|NOT COMPLETED|Overall Study||0
8528368|NCT02237508|9560238|FG001|NOT COMPLETED|Overall Study||3
8528369|NCT02237508|9560239|FG002|NOT COMPLETED|Overall Study||1
8528370|NCT02237508|9560240|FG003|NOT COMPLETED|Overall Study||1
8528371|NCT02237508|9560241|FG004|NOT COMPLETED|Overall Study||0
8528372|NCT02237508|9560242|FG005|NOT COMPLETED|Overall Study||1
8528373|NCT02237508|9560243|FG006|NOT COMPLETED|Overall Study||1
8528374|NCT02237508|9560244|FG007|NOT COMPLETED|Overall Study||0
8528375|NCT02237508|9560245|FG008|NOT COMPLETED|Overall Study||1
8528376|NCT02237508|9560246|FG009|NOT COMPLETED|Overall Study||0
8528377|NCT02197234|9560264|FG000|STARTED|Part A: Day 1-2 (Simvastatin Alone)||52
8528378|NCT02197234|9560264|FG000|COMPLETED|Part A: Day 1-2 (Simvastatin Alone)||52
8528379|NCT02197234|9560264|FG000|NOT COMPLETED|Part A: Day 1-2 (Simvastatin Alone)||0
8528380|NCT02197234|9560264|FG000|STARTED|Part A: Day 3-30 (AZD9291 Alone)||52
8528381|NCT02197234|9560264|FG000|COMPLETED|Part A: Day 3-30 (AZD9291 Alone)||49
8528382|NCT02197234|9560264|FG000|NOT COMPLETED|Part A: Day 3-30 (AZD9291 Alone)||3
8528383|NCT02197234|9560264|FG000|STARTED|Part A: Day 31-32 (Simvastatin+AZD9291)||49
8528384|NCT02197234|9560264|FG000|COMPLETED|Part A: Day 31-32 (Simvastatin+AZD9291)||49
8528385|NCT02197234|9560264|FG000|NOT COMPLETED|Part A: Day 31-32 (Simvastatin+AZD9291)||0
8528386|NCT02197234|9560264|FG000|STARTED|Part B: Day 33 to End Part B (AZD9291)|49 completed Part A + 1 entered Part B without completing Part A (due to AE) = 50 started Part B|50
8528387|NCT02197234|9560264|FG000|COMPLETED|Part B: Day 33 to End Part B (AZD9291)||20
8528388|NCT02197234|9560264|FG000|NOT COMPLETED|Part B: Day 33 to End Part B (AZD9291)||30
8528389|NCT02163733|9560273|FG000|STARTED|Part A: Day 1-9 (1st Intervention)||18
8528390|NCT02163733|9560274|FG001|STARTED|Part A: Day 1-9 (1st Intervention)||20
8528391|NCT02163733|9560275|FG002|STARTED|Part A: Day 1-9 (1st Intervention)||0
8528392|NCT02163733|9560273|FG000|COMPLETED|Part A: Day 1-9 (1st Intervention)||18
8528393|NCT02163733|9560274|FG001|COMPLETED|Part A: Day 1-9 (1st Intervention)||20
8528394|NCT02163733|9560275|FG002|COMPLETED|Part A: Day 1-9 (1st Intervention)||0
8528395|NCT02163733|9560273|FG000|NOT COMPLETED|Part A: Day 1-9 (1st Intervention)||0
8528396|NCT02163733|9560274|FG001|NOT COMPLETED|Part A: Day 1-9 (1st Intervention)||0
8528397|NCT02163733|9560275|FG002|NOT COMPLETED|Part A: Day 1-9 (1st Intervention)||0
8528398|NCT02163733|9560273|FG000|STARTED|Part A: Day 10-15 (2nd Intervention)||18
8528399|NCT02163733|9560274|FG001|STARTED|Part A: Day 10-15 (2nd Intervention)||20
8528400|NCT02163733|9560275|FG002|STARTED|Part A: Day 10-15 (2nd Intervention)||0
8528401|NCT02163733|9560273|FG000|COMPLETED|Part A: Day 10-15 (2nd Intervention)||18
8528402|NCT02163733|9560274|FG001|COMPLETED|Part A: Day 10-15 (2nd Intervention)||20
8528403|NCT02163733|9560275|FG002|COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
8528404|NCT02163733|9560273|FG000|NOT COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
8528405|NCT02163733|9560274|FG001|NOT COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
8528406|NCT02163733|9560275|FG002|NOT COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
8528407|NCT02163733|9560273|FG000|STARTED|Part B: Day 15 to End Part B (AZD9291)|Only the AZD9291 once daily (Part B) arm is applicable for this period.|0
8528408|NCT02163733|9560274|FG001|STARTED|Part B: Day 15 to End Part B (AZD9291)|Only the AZD9291 once daily (Part B) arm is applicable for this period.|0
8528409|NCT02163733|9560275|FG002|STARTED|Part B: Day 15 to End Part B (AZD9291)|No patients completed previous period as relates to Part A and arm is applicable only for Part B.|38
8620553|NCT00474630|9659302|FG001|NOT COMPLETED|Overall Study||70
8620554|NCT00474708|9659311|FG000|STARTED|Overall Study||791
8620555|NCT00474708|9659312|FG001|STARTED|Overall Study||367
8620556|NCT00474708|9659311|FG000|COMPLETED|Overall Study||734
8620557|NCT00474708|9659312|FG001|COMPLETED|Overall Study||342
8528410|NCT02163733|9560273|FG000|COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
8528411|NCT02163733|9560274|FG001|COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
8528412|NCT02163733|9560275|FG002|COMPLETED|Part B: Day 15 to End Part B (AZD9291)||14
8528413|NCT02163733|9560273|FG000|NOT COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
8528414|NCT02163733|9560274|FG001|NOT COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
8528415|NCT02163733|9560275|FG002|NOT COMPLETED|Part B: Day 15 to End Part B (AZD9291)||24
8528416|NCT02157883|9560282|FG000|STARTED|Part A: Day 1-5 (AZD9291 Alone)||39
8528417|NCT02157883|9560282|FG000|COMPLETED|Part A: Day 1-5 (AZD9291 Alone)||39
8528418|NCT02157883|9560282|FG000|NOT COMPLETED|Part A: Day 1-5 (AZD9291 Alone)||0
8528419|NCT02157883|9560282|FG000|STARTED|Part A: Day 6-18 (AZD9291+Itraconozole)||39
8528420|NCT02157883|9560282|FG000|COMPLETED|Part A: Day 6-18 (AZD9291+Itraconozole)||38
8528421|NCT02157883|9560282|FG000|NOT COMPLETED|Part A: Day 6-18 (AZD9291+Itraconozole)||1
8528422|NCT02157883|9560282|FG000|STARTED|Part B: Day 19 to End Part B (AZD9291)||38
8528423|NCT02157883|9560282|FG000|COMPLETED|Part B: Day 19 to End Part B (AZD9291)||16
8528424|NCT02157883|9560282|FG000|NOT COMPLETED|Part B: Day 19 to End Part B (AZD9291)||22
8528425|NCT01706705|9560289|FG000|STARTED|Overall Study||57
8528426|NCT01706705|9560289|FG000|COMPLETED|Overall Study||37
8528427|NCT01706705|9560289|FG000|NOT COMPLETED|Overall Study||20
8528428|NCT01609842|9560298|FG000|STARTED|Pre-Intervention Control||0
8528429|NCT01609842|9560299|FG001|STARTED|Pre-Intervention Control|Intervention sites patients prior to enrollment period who did not receive the intervention|6081
8528430|NCT01609842|9560298|FG000|COMPLETED|Pre-Intervention Control||0
8528431|NCT01609842|9560299|FG001|COMPLETED|Pre-Intervention Control||6081
8528432|NCT01609842|9560298|FG000|NOT COMPLETED|Pre-Intervention Control||0
8528433|NCT01609842|9560299|FG001|NOT COMPLETED|Pre-Intervention Control||0
8528434|NCT01609842|9560298|FG000|STARTED|Post-Intervention Control||0
8528435|NCT01609842|9560299|FG001|STARTED|Post-Intervention Control|Intervention sites patients after enrollment period ended who did not receive the intervention.|2917
8528436|NCT01609842|9560298|FG000|COMPLETED|Post-Intervention Control||0
8528437|NCT01609842|9560299|FG001|COMPLETED|Post-Intervention Control||2917
8528438|NCT01609842|9560298|FG000|NOT COMPLETED|Post-Intervention Control||0
8528439|NCT01609842|9560299|FG001|NOT COMPLETED|Post-Intervention Control||0
8528440|NCT01609842|9560298|FG000|STARTED|Concurrent Intervention Control||708
8528441|NCT01609842|9560299|FG001|STARTED|Concurrent Intervention Control|Nonintervention sites patients during the period prior and post enrollment at the intervention sites|4869
8528442|NCT01609842|9560298|FG000|COMPLETED|Concurrent Intervention Control||706
8528443|NCT01609842|9560299|FG001|COMPLETED|Concurrent Intervention Control||4869
8528444|NCT01609842|9560298|FG000|NOT COMPLETED|Concurrent Intervention Control||2
8528445|NCT01609842|9560299|FG001|NOT COMPLETED|Concurrent Intervention Control||0
8528446|NCT01341600|9560312|FG000|STARTED|Clopidogrel 75 mg||6
8528447|NCT01341600|9560313|FG001|STARTED|Clopidogrel 75 mg||6
8528448|NCT01341600|9560314|FG002|STARTED|Clopidogrel 75 mg||6
8528449|NCT01341600|9560312|FG000|COMPLETED|Clopidogrel 75 mg||6
8528450|NCT01341600|9560313|FG001|COMPLETED|Clopidogrel 75 mg||6
8528451|NCT01341600|9560314|FG002|COMPLETED|Clopidogrel 75 mg||6
8528452|NCT01341600|9560312|FG000|NOT COMPLETED|Clopidogrel 75 mg||0
8528453|NCT01341600|9560313|FG001|NOT COMPLETED|Clopidogrel 75 mg||0
8528454|NCT01341600|9560314|FG002|NOT COMPLETED|Clopidogrel 75 mg||0
8528455|NCT01341600|9560312|FG000|STARTED|Clopidogrel 150 mg||6
8528456|NCT01341600|9560313|FG001|STARTED|Clopidogrel 150 mg||6
8528457|NCT01341600|9560314|FG002|STARTED|Clopidogrel 150 mg||6
8528458|NCT01341600|9560312|FG000|COMPLETED|Clopidogrel 150 mg||6
8528459|NCT01341600|9560313|FG001|COMPLETED|Clopidogrel 150 mg||6
8528460|NCT01341600|9560314|FG002|COMPLETED|Clopidogrel 150 mg||6
8528461|NCT01341600|9560312|FG000|NOT COMPLETED|Clopidogrel 150 mg||0
8528462|NCT01341600|9560313|FG001|NOT COMPLETED|Clopidogrel 150 mg||0
8620558|NCT00474708|9659311|FG000|NOT COMPLETED|Overall Study||57
8620559|NCT00474708|9659312|FG001|NOT COMPLETED|Overall Study||25
8528463|NCT01341600|9560314|FG002|NOT COMPLETED|Clopidogrel 150 mg||0
8528464|NCT01341600|9560312|FG000|STARTED|Clopidogrel 225 mg||6
8528465|NCT01341600|9560313|FG001|STARTED|Clopidogrel 225 mg||6
8528466|NCT01341600|9560314|FG002|STARTED|Clopidogrel 225 mg||6
8528467|NCT01341600|9560312|FG000|COMPLETED|Clopidogrel 225 mg||6
8528468|NCT01341600|9560313|FG001|COMPLETED|Clopidogrel 225 mg||6
8620560|NCT00474760|9659325|FG000|STARTED|Overall Study||3
8620561|NCT00474760|9659326|FG001|STARTED|Overall Study||3
8620562|NCT00474760|9659327|FG002|STARTED|Overall Study||3
8620563|NCT00474760|9659328|FG003|STARTED|Overall Study||3
8620564|NCT00474760|9659329|FG004|STARTED|Overall Study||13
8528469|NCT01341600|9560314|FG002|COMPLETED|Clopidogrel 225 mg||6
8528470|NCT01341600|9560312|FG000|NOT COMPLETED|Clopidogrel 225 mg||0
8528471|NCT01341600|9560313|FG001|NOT COMPLETED|Clopidogrel 225 mg||0
8528472|NCT01341600|9560314|FG002|NOT COMPLETED|Clopidogrel 225 mg||0
8528473|NCT01341600|9560312|FG000|STARTED|Clopidogrel Plus Omeprazole||5
8528474|NCT01341600|9560313|FG001|STARTED|Clopidogrel Plus Omeprazole||5
8528475|NCT01341600|9560314|FG002|STARTED|Clopidogrel Plus Omeprazole||4
8528476|NCT01341600|9560312|FG000|COMPLETED|Clopidogrel Plus Omeprazole||5
8528477|NCT01341600|9560313|FG001|COMPLETED|Clopidogrel Plus Omeprazole||5
8528478|NCT01341600|9560314|FG002|COMPLETED|Clopidogrel Plus Omeprazole||4
8528479|NCT01341600|9560312|FG000|NOT COMPLETED|Clopidogrel Plus Omeprazole||0
8528480|NCT01341600|9560313|FG001|NOT COMPLETED|Clopidogrel Plus Omeprazole||0
8528481|NCT01341600|9560314|FG002|NOT COMPLETED|Clopidogrel Plus Omeprazole||0
8528482|NCT01044901|9560324|FG000|STARTED|Overall Study||38
8528483|NCT01044901|9560325|FG001|STARTED|Overall Study||13
8528484|NCT01044901|9560324|FG000|COMPLETED|Overall Study||38
8528485|NCT01044901|9560325|FG001|COMPLETED|Overall Study||13
8528486|NCT01044901|9560324|FG000|NOT COMPLETED|Overall Study||0
8528487|NCT01044901|9560325|FG001|NOT COMPLETED|Overall Study||0
8528488|NCT00288080|9560333|FG000|STARTED|Overall Study||307
8528489|NCT00288080|9560334|FG001|STARTED|Overall Study||305
8528490|NCT00288080|9560333|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|281
8528491|NCT00288080|9560334|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|282
8528492|NCT00288080|9560333|FG000|NOT COMPLETED|Overall Study||26
8528493|NCT00288080|9560334|FG001|NOT COMPLETED|Overall Study||23
8528494|NCT00099437|9560342|FG000|STARTED|Overall Study|randomised patients|374
8528495|NCT00099437|9560343|FG001|STARTED|Overall Study|randomised patients|362
8528496|NCT00099437|9560342|FG000|COMPLETED|Overall Study|ongoing study treatment at survival follow-up data cut-off|8
8528497|NCT00099437|9560343|FG001|COMPLETED|Overall Study|ongoing study treatment at survival follow-up data cut-off|13
8528498|NCT00099437|9560342|FG000|NOT COMPLETED|Overall Study||366
8528499|NCT00099437|9560343|FG001|NOT COMPLETED|Overall Study||349
8528500|NCT00003479|9560349|FG000|STARTED|Overall Study||9
8528501|NCT00003479|9560349|FG000|COMPLETED|Overall Study||6
8528502|NCT00003479|9560349|FG000|NOT COMPLETED|Overall Study||3
8563268|NCT00045942|9595421|FG008|COMPLETED|PKC412A2104 (Core)||0
8563269|NCT00045942|9595413|FG000|NOT COMPLETED|PKC412A2104 (Core)||20
8563270|NCT00045942|9595414|FG001|NOT COMPLETED|PKC412A2104 (Core)||0
8563271|NCT00045942|9595415|FG002|NOT COMPLETED|PKC412A2104 (Core)||0
8563272|NCT00045942|9595416|FG003|NOT COMPLETED|PKC412A2104 (Core)||0
8563273|NCT00045942|9595417|FG004|NOT COMPLETED|PKC412A2104 (Core)||0
8563274|NCT00045942|9595418|FG005|NOT COMPLETED|PKC412A2104 (Core)||0
8563275|NCT00045942|9595419|FG006|NOT COMPLETED|PKC412A2104 (Core)||0
8563276|NCT00045942|9595420|FG007|NOT COMPLETED|PKC412A2104 (Core)||0
8563277|NCT00045942|9595421|FG008|NOT COMPLETED|PKC412A2104 (Core)||0
8563278|NCT00045942|9595413|FG000|STARTED|PKC412A2104E1||0
8563279|NCT00045942|9595414|FG001|STARTED|PKC412A2104E1||18
8563280|NCT00045942|9595415|FG002|STARTED|PKC412A2104E1||17
8563281|NCT00045942|9595416|FG003|STARTED|PKC412A2104E1||33
8563282|NCT00045942|9595417|FG004|STARTED|PKC412A2104E1||27
8563283|NCT00045942|9595418|FG005|STARTED|PKC412A2104E1||0
8563284|NCT00045942|9595419|FG006|STARTED|PKC412A2104E1||0
8563285|NCT00045942|9595420|FG007|STARTED|PKC412A2104E1||0
8563286|NCT00045942|9595421|FG008|STARTED|PKC412A2104E1||0
8563287|NCT00045942|9595413|FG000|Primary Efficacy|PKC412A2104E1||0
8563288|NCT00045942|9595414|FG001|Primary Efficacy|PKC412A2104E1||18
8563289|NCT00045942|9595415|FG002|Primary Efficacy|PKC412A2104E1||17
8563290|NCT00045942|9595416|FG003|Primary Efficacy|PKC412A2104E1||32
8563291|NCT00045942|9595417|FG004|Primary Efficacy|PKC412A2104E1||25
8563292|NCT00045942|9595418|FG005|Primary Efficacy|PKC412A2104E1||0
8563293|NCT00045942|9595419|FG006|Primary Efficacy|PKC412A2104E1||0
8563294|NCT00045942|9595420|FG007|Primary Efficacy|PKC412A2104E1||0
8563295|NCT00045942|9595421|FG008|Primary Efficacy|PKC412A2104E1||0
8563296|NCT00045942|9595413|FG000|COMPLETED|PKC412A2104E1||0
8563297|NCT00045942|9595414|FG001|COMPLETED|PKC412A2104E1||0
8563298|NCT00045942|9595415|FG002|COMPLETED|PKC412A2104E1||0
8563299|NCT00045942|9595416|FG003|COMPLETED|PKC412A2104E1||0
8563300|NCT00045942|9595417|FG004|COMPLETED|PKC412A2104E1||0
8563301|NCT00045942|9595418|FG005|COMPLETED|PKC412A2104E1||0
8563302|NCT00045942|9595419|FG006|COMPLETED|PKC412A2104E1||0
8563303|NCT00045942|9595420|FG007|COMPLETED|PKC412A2104E1||0
8563304|NCT00045942|9595421|FG008|COMPLETED|PKC412A2104E1||0
8620565|NCT00474760|9659330|FG005|STARTED|Overall Study||29
8563305|NCT00045942|9595413|FG000|NOT COMPLETED|PKC412A2104E1||0
8563306|NCT00045942|9595414|FG001|NOT COMPLETED|PKC412A2104E1||18
8563307|NCT00045942|9595415|FG002|NOT COMPLETED|PKC412A2104E1||17
8563308|NCT00045942|9595416|FG003|NOT COMPLETED|PKC412A2104E1||33
8528503|NCT04160195|9560355|FG000|STARTED|Overall Study||2
8528504|NCT04160195|9560356|FG001|STARTED|Overall Study||0
8528505|NCT04160195|9560355|FG000|COMPLETED|Overall Study||1
8528506|NCT04160195|9560356|FG001|COMPLETED|Overall Study||0
8528507|NCT04160195|9560355|FG000|NOT COMPLETED|Overall Study||1
8528508|NCT04160195|9560356|FG001|NOT COMPLETED|Overall Study||0
8528509|NCT04159701|9560366|FG000|STARTED|Period 1: Treatment Period||39
8528510|NCT04159701|9560367|FG001|STARTED|Period 1: Treatment Period||13
8528511|NCT04159701|9560366|FG000|Received at Least One Dose of Study Drug|Period 1: Treatment Period||39
8528512|NCT04159701|9560367|FG001|Received at Least One Dose of Study Drug|Period 1: Treatment Period||13
8528513|NCT04159701|9560366|FG000|COMPLETED|Period 1: Treatment Period||31
8528514|NCT04159701|9560367|FG001|COMPLETED|Period 1: Treatment Period||12
8528515|NCT04159701|9560366|FG000|NOT COMPLETED|Period 1: Treatment Period||8
8528516|NCT04159701|9560367|FG001|NOT COMPLETED|Period 1: Treatment Period||1
8528517|NCT04159701|9560366|FG000|STARTED|Washout Period||31
8528518|NCT04159701|9560367|FG001|STARTED|Washout Period||12
8528519|NCT04159701|9560366|FG000|COMPLETED|Washout Period||18
8528520|NCT04159701|9560367|FG001|COMPLETED|Washout Period||8
8528521|NCT04159701|9560366|FG000|NOT COMPLETED|Washout Period||13
8528522|NCT04159701|9560367|FG001|NOT COMPLETED|Washout Period||4
8528523|NCT04159701|9560366|FG000|STARTED|Period 2: Treatment Period (Crossover)||18
8528524|NCT04159701|9560367|FG001|STARTED|Period 2: Treatment Period (Crossover)||8
8528525|NCT04159701|9560366|FG000|COMPLETED|Period 2: Treatment Period (Crossover)||18
8528526|NCT04159701|9560367|FG001|COMPLETED|Period 2: Treatment Period (Crossover)||5
8528527|NCT04159701|9560366|FG000|NOT COMPLETED|Period 2: Treatment Period (Crossover)||0
8528528|NCT04159701|9560367|FG001|NOT COMPLETED|Period 2: Treatment Period (Crossover)||3
8528529|NCT04159701|9560366|FG000|STARTED|Post-treatment Follow-up|All participants who received study drug could move to post-treatment follow-up.|29
8528530|NCT04159701|9560367|FG001|STARTED|Post-treatment Follow-up|All participants who received study drug could move to post-treatment follow-up.|9
8528531|NCT04159701|9560366|FG000|COMPLETED|Post-treatment Follow-up||19
8528532|NCT04159701|9560367|FG001|COMPLETED|Post-treatment Follow-up||6
8528533|NCT04159701|9560366|FG000|NOT COMPLETED|Post-treatment Follow-up||10
8528534|NCT04159701|9560367|FG001|NOT COMPLETED|Post-treatment Follow-up||3
8528535|NCT04152447|9560379|FG000|STARTED|Overall Study||16
8528536|NCT04152447|9560380|FG001|STARTED|Overall Study||19
8528537|NCT04152447|9560379|FG000|COMPLETED|Overall Study||13
8528538|NCT04152447|9560380|FG001|COMPLETED|Overall Study||14
8528539|NCT04152447|9560379|FG000|NOT COMPLETED|Overall Study||3
8528540|NCT04152447|9560380|FG001|NOT COMPLETED|Overall Study||5
8528541|NCT04097925|9560386|FG000|STARTED|Overall Study||30
8528542|NCT04097925|9560386|FG000|COMPLETED|Overall Study||29
8528543|NCT04097925|9560386|FG000|NOT COMPLETED|Overall Study||1
8528544|NCT04011475|9560393|FG000|STARTED|Overall Study||239
8528545|NCT04011475|9560394|FG001|STARTED|Overall Study||937
8528546|NCT04011475|9560395|FG002|STARTED|Overall Study||441
8528547|NCT04011475|9560393|FG000|Propensity Score Matched Cohort|Overall Study||114
8528548|NCT04011475|9560394|FG001|Propensity Score Matched Cohort|Overall Study||114
8528549|NCT04011475|9560395|FG002|Propensity Score Matched Cohort|Overall Study||114
8528550|NCT04011475|9560393|FG000|COMPLETED|Overall Study||239
8528551|NCT04011475|9560394|FG001|COMPLETED|Overall Study||937
8528552|NCT04011475|9560395|FG002|COMPLETED|Overall Study||441
8528553|NCT04011475|9560393|FG000|NOT COMPLETED|Overall Study||0
8528554|NCT04011475|9560394|FG001|NOT COMPLETED|Overall Study||0
8528555|NCT04011475|9560395|FG002|NOT COMPLETED|Overall Study||0
8620566|NCT00474760|9659331|FG006|STARTED|Overall Study||11
8620567|NCT00474760|9659325|FG000|COMPLETED|Overall Study||0
8620568|NCT00474760|9659326|FG001|COMPLETED|Overall Study||0
8620569|NCT00474760|9659327|FG002|COMPLETED|Overall Study||0
8620570|NCT00474760|9659328|FG003|COMPLETED|Overall Study||0
8620571|NCT00474760|9659329|FG004|COMPLETED|Overall Study||1
8620572|NCT00474760|9659330|FG005|COMPLETED|Overall Study||0
8620573|NCT00474760|9659331|FG006|COMPLETED|Overall Study||1
8620574|NCT00474760|9659325|FG000|NOT COMPLETED|Overall Study||3
8528565|NCT03882788|9560419|FG000|STARTED|Overall Study||44
8528566|NCT03882788|9560420|FG001|STARTED|Overall Study||45
8528567|NCT03882788|9560419|FG000|COMPLETED|Overall Study||44
8528568|NCT03882788|9560420|FG001|COMPLETED|Overall Study||45
8528569|NCT03882788|9560419|FG000|NOT COMPLETED|Overall Study||0
8528570|NCT03882788|9560420|FG001|NOT COMPLETED|Overall Study||0
8528571|NCT03834974|9560428|FG000|STARTED|Overall Study||34
8528572|NCT03834974|9560429|FG001|STARTED|Overall Study||32
8528573|NCT03834974|9560428|FG000|COMPLETED|Overall Study||34
8528574|NCT03834974|9560429|FG001|COMPLETED|Overall Study||32
8528575|NCT03834974|9560428|FG000|NOT COMPLETED|Overall Study||0
8528576|NCT03834974|9560429|FG001|NOT COMPLETED|Overall Study||0
8528577|NCT03821675|9560438|FG000|STARTED|Overall Study||19
8528578|NCT03821675|9560439|FG001|STARTED|Overall Study||19
8528579|NCT03821675|9560438|FG000|COMPLETED|Overall Study||16
8528580|NCT03821675|9560439|FG001|COMPLETED|Overall Study||17
8528581|NCT03821675|9560438|FG000|NOT COMPLETED|Overall Study||3
8528582|NCT03821675|9560439|FG001|NOT COMPLETED|Overall Study||2
8528583|NCT03794544|9560451|FG000|STARTED|Overall Study||27
8528584|NCT03794544|9560452|FG001|STARTED|Overall Study||21
8528585|NCT03794544|9560453|FG002|STARTED|Overall Study||20
8528586|NCT03794544|9560454|FG003|STARTED|Overall Study||16
8528587|NCT03794544|9560451|FG000|Treated|Overall Study||26
8528588|NCT03794544|9560452|FG001|Treated|Overall Study||21
8528589|NCT03794544|9560453|FG002|Treated|Overall Study||20
8528590|NCT03794544|9560454|FG003|Treated|Overall Study||16
8528591|NCT03794544|9560451|FG000|COMPLETED|Overall Study||26
8528592|NCT03794544|9560452|FG001|COMPLETED|Overall Study||18
8528593|NCT03794544|9560453|FG002|COMPLETED|Overall Study||19
8528594|NCT03794544|9560454|FG003|COMPLETED|Overall Study||15
8528595|NCT03794544|9560451|FG000|NOT COMPLETED|Overall Study||1
8528596|NCT03794544|9560452|FG001|NOT COMPLETED|Overall Study||3
8528597|NCT03794544|9560453|FG002|NOT COMPLETED|Overall Study||1
8528598|NCT03794544|9560454|FG003|NOT COMPLETED|Overall Study||1
8563309|NCT00045942|9595417|FG004|NOT COMPLETED|PKC412A2104E1||27
8563310|NCT00045942|9595418|FG005|NOT COMPLETED|PKC412A2104E1||0
8563311|NCT00045942|9595419|FG006|NOT COMPLETED|PKC412A2104E1||0
8563312|NCT00045942|9595420|FG007|NOT COMPLETED|PKC412A2104E1||0
8563313|NCT00045942|9595421|FG008|NOT COMPLETED|PKC412A2104E1||0
8563314|NCT00045942|9595413|FG000|STARTED|PKC412A2104E2||0
8563315|NCT00045942|9595414|FG001|STARTED|PKC412A2104E2||0
8563316|NCT00045942|9595415|FG002|STARTED|PKC412A2104E2||0
8563317|NCT00045942|9595416|FG003|STARTED|PKC412A2104E2||0
8563318|NCT00045942|9595417|FG004|STARTED|PKC412A2104E2||0
8563319|NCT00045942|9595418|FG005|STARTED|PKC412A2104E2||9
8563320|NCT00045942|9595419|FG006|STARTED|PKC412A2104E2||7
8563321|NCT00045942|9595420|FG007|STARTED|PKC412A2104E2||7
8563322|NCT00045942|9595421|FG008|STARTED|PKC412A2104E2||6
8563323|NCT00045942|9595413|FG000|Primary Efficacy|PKC412A2104E2||0
8563324|NCT00045942|9595414|FG001|Primary Efficacy|PKC412A2104E2||0
8563325|NCT00045942|9595415|FG002|Primary Efficacy|PKC412A2104E2||0
8563326|NCT00045942|9595416|FG003|Primary Efficacy|PKC412A2104E2||0
8563327|NCT00045942|9595417|FG004|Primary Efficacy|PKC412A2104E2||0
8563328|NCT00045942|9595418|FG005|Primary Efficacy|PKC412A2104E2||9
8563329|NCT00045942|9595419|FG006|Primary Efficacy|PKC412A2104E2||7
8563330|NCT00045942|9595420|FG007|Primary Efficacy|PKC412A2104E2||7
8563331|NCT00045942|9595421|FG008|Primary Efficacy|PKC412A2104E2||6
8563332|NCT00045942|9595413|FG000|COMPLETED|PKC412A2104E2||0
8563333|NCT00045942|9595414|FG001|COMPLETED|PKC412A2104E2||0
8563334|NCT00045942|9595415|FG002|COMPLETED|PKC412A2104E2||0
8563335|NCT00045942|9595416|FG003|COMPLETED|PKC412A2104E2||0
8563336|NCT00045942|9595417|FG004|COMPLETED|PKC412A2104E2||0
8563337|NCT00045942|9595418|FG005|COMPLETED|PKC412A2104E2||0
8563338|NCT00045942|9595419|FG006|COMPLETED|PKC412A2104E2||0
8563339|NCT00045942|9595420|FG007|COMPLETED|PKC412A2104E2||0
8563340|NCT00045942|9595421|FG008|COMPLETED|PKC412A2104E2||0
8563341|NCT00045942|9595413|FG000|NOT COMPLETED|PKC412A2104E2||0
8563342|NCT00045942|9595414|FG001|NOT COMPLETED|PKC412A2104E2||0
8563343|NCT00045942|9595415|FG002|NOT COMPLETED|PKC412A2104E2||0
8563344|NCT00045942|9595416|FG003|NOT COMPLETED|PKC412A2104E2||0
8563345|NCT00045942|9595417|FG004|NOT COMPLETED|PKC412A2104E2||0
8563346|NCT00045942|9595418|FG005|NOT COMPLETED|PKC412A2104E2||9
8563347|NCT00045942|9595419|FG006|NOT COMPLETED|PKC412A2104E2||7
8563348|NCT00045942|9595420|FG007|NOT COMPLETED|PKC412A2104E2||7
8563349|NCT00045942|9595421|FG008|NOT COMPLETED|PKC412A2104E2||6
8563350|NCT00046228|9595448|FG000|STARTED|90 Days||806
8563351|NCT00046228|9595449|FG001|STARTED|90 Days||818
8563352|NCT00046228|9595450|FG002|STARTED|90 Days||828
8563353|NCT00046228|9595448|FG000|COMPLETED|90 Days|The number completed includes subjects who died or were seen for a visit within specified window.|793
8563354|NCT00046228|9595449|FG001|COMPLETED|90 Days|The number completed includes subjects who died or were seen for a visit within specified window.|810
8563355|NCT00046228|9595450|FG002|COMPLETED|90 Days|The number completed includes subjects who died or were seen for a visit within specified window.|813
8563356|NCT00046228|9595448|FG000|NOT COMPLETED|90 Days||13
8563357|NCT00046228|9595449|FG001|NOT COMPLETED|90 Days||8
8563358|NCT00046228|9595450|FG002|NOT COMPLETED|90 Days||15
8563359|NCT00046228|9595448|FG000|STARTED|1 Year|This is the number of participants that were originally randomized to the trial.|806
8563360|NCT00046228|9595449|FG001|STARTED|1 Year|This is the number of participants that were originally randomized to the trial.|818
8563361|NCT00046228|9595450|FG002|STARTED|1 Year|This is the number of participants that were originally randomized to the trial.|828
8563362|NCT00046228|9595448|FG000|COMPLETED|1 Year|The number completed includes subjects who died or were seen for a visit within specified window.|787
8563363|NCT00046228|9595449|FG001|COMPLETED|1 Year|The number completed includes subjects who died or were seen for a visit within specified window.|804
8563364|NCT00046228|9595450|FG002|COMPLETED|1 Year|The number completed includes subjects who died or were seen for a visit within specified window|816
8563365|NCT00046228|9595448|FG000|NOT COMPLETED|1 Year||19
8563366|NCT00046228|9595449|FG001|NOT COMPLETED|1 Year||14
8563367|NCT00046228|9595450|FG002|NOT COMPLETED|1 Year||12
8563368|NCT00046475|9595460|FG000|STARTED|Screening/Washout Period (Up to 2 Weeks)||140
8563369|NCT00046475|9595461|FG001|STARTED|Screening/Washout Period (Up to 2 Weeks)||0
8563370|NCT00046475|9595462|FG002|STARTED|Screening/Washout Period (Up to 2 Weeks)||0
8563371|NCT00046475|9595460|FG000|COMPLETED|Screening/Washout Period (Up to 2 Weeks)||136
8563372|NCT00046475|9595461|FG001|COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
8563373|NCT00046475|9595462|FG002|COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
8563374|NCT00046475|9595460|FG000|NOT COMPLETED|Screening/Washout Period (Up to 2 Weeks)||4
8563375|NCT00046475|9595461|FG001|NOT COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
8563376|NCT00046475|9595462|FG002|NOT COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
8563377|NCT00046475|9595460|FG000|STARTED|Titration (1 Week)||136
8563378|NCT00046475|9595461|FG001|STARTED|Titration (1 Week)||0
8563379|NCT00046475|9595462|FG002|STARTED|Titration (1 Week)||0
8563380|NCT00046475|9595460|FG000|COMPLETED|Titration (1 Week)||136
8528599|NCT03732807|9560471|FG000|STARTED|Treatment Period (up to Week 24)||132
8528600|NCT03732807|9560472|FG001|STARTED|Treatment Period (up to Week 24)||130
8528601|NCT03732807|9560473|FG002|STARTED|Treatment Period (up to Week 24)||130
8528602|NCT03732807|9560474|FG003|STARTED|Treatment Period (up to Week 24)||132
8528603|NCT03732807|9560475|FG004|STARTED|Treatment Period (up to Week 24)||63
8528604|NCT03732807|9560476|FG005|STARTED|Treatment Period (up to Week 24)||65
8528605|NCT03732807|9560477|FG006|STARTED|Treatment Period (up to Week 24)||66
8528606|NCT03732807|9560471|FG000|COMPLETED|Treatment Period (up to Week 24)||122
8528607|NCT03732807|9560472|FG001|COMPLETED|Treatment Period (up to Week 24)||124
8528608|NCT03732807|9560473|FG002|COMPLETED|Treatment Period (up to Week 24)||121
8528609|NCT03732807|9560474|FG003|COMPLETED|Treatment Period (up to Week 24)||117
8528610|NCT03732807|9560475|FG004|COMPLETED|Treatment Period (up to Week 24)||58
8528611|NCT03732807|9560476|FG005|COMPLETED|Treatment Period (up to Week 24)||63
8528612|NCT03732807|9560477|FG006|COMPLETED|Treatment Period (up to Week 24)||61
8528613|NCT03732807|9560471|FG000|NOT COMPLETED|Treatment Period (up to Week 24)||10
8528614|NCT03732807|9560472|FG001|NOT COMPLETED|Treatment Period (up to Week 24)||6
8528615|NCT03732807|9560473|FG002|NOT COMPLETED|Treatment Period (up to Week 24)||9
8528616|NCT03732807|9560474|FG003|NOT COMPLETED|Treatment Period (up to Week 24)||15
8528617|NCT03732807|9560475|FG004|NOT COMPLETED|Treatment Period (up to Week 24)||5
8528618|NCT03732807|9560476|FG005|NOT COMPLETED|Treatment Period (up to Week 24)||2
8528619|NCT03732807|9560477|FG006|NOT COMPLETED|Treatment Period (up to Week 24)||5
8528620|NCT03732807|9560471|FG000|STARTED|Treatment Extension (Week 25 up to 48)|Participants continued dosing according to their assigned sequence in the preceding period.|113
8528621|NCT03732807|9560472|FG001|STARTED|Treatment Extension (Week 25 up to 48)|Participants continued dosing according to their assigned sequence in the preceding period.|111
8528622|NCT03732807|9560473|FG002|STARTED|Treatment Extension (Week 25 up to 48)|Participants continued dosing according to their assigned sequence in the preceding period.|108
8528623|NCT03732807|9560474|FG003|STARTED|Treatment Extension (Week 25 up to 48)|Participants continued dosing according to their assigned sequence in the preceding period.|106
8528624|NCT03732807|9560475|FG004|STARTED|Treatment Extension (Week 25 up to 48)|Participants continued dosing according to their assigned sequence in the preceding period.|49
8528625|NCT03732807|9560476|FG005|STARTED|Treatment Extension (Week 25 up to 48)|Participants continued dosing according to their assigned sequence in the preceding period.|59
8528626|NCT03732807|9560477|FG006|STARTED|Treatment Extension (Week 25 up to 48)|Participants continued dosing according to their assigned sequence in the preceding period.|57
8528627|NCT03732807|9560471|FG000|COMPLETED|Treatment Extension (Week 25 up to 48)||107
8528628|NCT03732807|9560472|FG001|COMPLETED|Treatment Extension (Week 25 up to 48)||100
8528629|NCT03732807|9560473|FG002|COMPLETED|Treatment Extension (Week 25 up to 48)||103
8528630|NCT03732807|9560474|FG003|COMPLETED|Treatment Extension (Week 25 up to 48)||97
8528631|NCT03732807|9560475|FG004|COMPLETED|Treatment Extension (Week 25 up to 48)||44
8528632|NCT03732807|9560476|FG005|COMPLETED|Treatment Extension (Week 25 up to 48)||56
8528633|NCT03732807|9560477|FG006|COMPLETED|Treatment Extension (Week 25 up to 48)||53
8528634|NCT03732807|9560471|FG000|NOT COMPLETED|Treatment Extension (Week 25 up to 48)||6
8528635|NCT03732807|9560472|FG001|NOT COMPLETED|Treatment Extension (Week 25 up to 48)||11
8528636|NCT03732807|9560473|FG002|NOT COMPLETED|Treatment Extension (Week 25 up to 48)||5
8528637|NCT03732807|9560474|FG003|NOT COMPLETED|Treatment Extension (Week 25 up to 48)||9
8528638|NCT03732807|9560475|FG004|NOT COMPLETED|Treatment Extension (Week 25 up to 48)||5
8528639|NCT03732807|9560476|FG005|NOT COMPLETED|Treatment Extension (Week 25 up to 48)||3
8528640|NCT03732807|9560477|FG006|NOT COMPLETED|Treatment Extension (Week 25 up to 48)||4
8528656|NCT03728153|9560515|FG000|STARTED|Overall Study||34
8528657|NCT03728153|9560515|FG000|COMPLETED|Overall Study||32
8528658|NCT03728153|9560515|FG000|NOT COMPLETED|Overall Study||2
8528659|NCT03724422|9560521|FG000|STARTED|Overall Study||1
8528660|NCT03724422|9560522|FG001|STARTED|Overall Study||2
8528661|NCT03724422|9560521|FG000|COMPLETED|Overall Study||1
8528662|NCT03724422|9560522|FG001|COMPLETED|Overall Study|Patients had interval healing then lost follow up|0
8528663|NCT03724422|9560521|FG000|NOT COMPLETED|Overall Study||0
8528664|NCT03724422|9560522|FG001|NOT COMPLETED|Overall Study||2
8528665|NCT03720899|9560530|FG000|STARTED|Overall Study||21
8528666|NCT03720899|9560531|FG001|STARTED|Overall Study||24
8528667|NCT03720899|9560530|FG000|COMPLETED|Overall Study||13
8528668|NCT03720899|9560531|FG001|COMPLETED|Overall Study||13
8528669|NCT03720899|9560530|FG000|NOT COMPLETED|Overall Study||8
8528670|NCT03720899|9560531|FG001|NOT COMPLETED|Overall Study||11
8528671|NCT03716869|9560539|FG000|STARTED|Overall Study||6436
8528672|NCT03716869|9560540|FG001|STARTED|Overall Study||6473
8528673|NCT03716869|9560539|FG000|COMPLETED|Overall Study||6436
8528674|NCT03716869|9560540|FG001|COMPLETED|Overall Study||6473
8528675|NCT03716869|9560539|FG000|NOT COMPLETED|Overall Study||0
8528676|NCT03716869|9560540|FG001|NOT COMPLETED|Overall Study||0
8528683|NCT04598152|9560555|FG000|STARTED|Overall Study||3
8528684|NCT04598152|9560556|FG001|STARTED|Overall Study||1
8528685|NCT04598152|9560555|FG000|COMPLETED|Overall Study||3
8528686|NCT04598152|9560556|FG001|COMPLETED|Overall Study||0
8528687|NCT04598152|9560555|FG000|NOT COMPLETED|Overall Study||0
8528688|NCT04598152|9560556|FG001|NOT COMPLETED|Overall Study||1
8528695|NCT05166824|9560575|FG000|STARTED|Overall Study||1
8528696|NCT05166824|9560576|FG001|STARTED|Overall Study||10
8528697|NCT05166824|9560577|FG002|STARTED|Overall Study||68
8528698|NCT05166824|9560578|FG003|STARTED|Overall Study||10
8528699|NCT05166824|9560575|FG000|COMPLETED|Overall Study||1
8816329|NCT01543490|9869811|FG000|COMPLETED|Overall Study||352
8816330|NCT01543490|9869812|FG001|COMPLETED|Overall Study||185
8816331|NCT01543490|9869811|FG000|NOT COMPLETED|Overall Study||16
8528641|NCT03731364|9560499|FG000|STARTED|Overall Study||9
8528642|NCT03731364|9560500|FG001|STARTED|Overall Study||9
8528643|NCT03731364|9560501|FG002|STARTED|Overall Study||13
8528644|NCT03731364|9560502|FG003|STARTED|Overall Study||13
8528645|NCT03731364|9560503|FG004|STARTED|Overall Study||11
8528646|NCT03731364|9560499|FG000|COMPLETED|Overall Study||9
8528647|NCT03731364|9560500|FG001|COMPLETED|Overall Study||9
8528648|NCT03731364|9560501|FG002|COMPLETED|Overall Study||12
8528649|NCT03731364|9560502|FG003|COMPLETED|Overall Study||11
8528650|NCT03731364|9560503|FG004|COMPLETED|Overall Study||10
8528651|NCT03731364|9560499|FG000|NOT COMPLETED|Overall Study||0
8528652|NCT03731364|9560500|FG001|NOT COMPLETED|Overall Study||0
8528653|NCT03731364|9560501|FG002|NOT COMPLETED|Overall Study||1
8528654|NCT03731364|9560502|FG003|NOT COMPLETED|Overall Study||2
8528655|NCT03731364|9560503|FG004|NOT COMPLETED|Overall Study||1
8528677|NCT03713957|9560548|FG000|STARTED|Overall Study||53
8528678|NCT03713957|9560549|FG001|STARTED|Overall Study||26
8528679|NCT03713957|9560548|FG000|COMPLETED|Overall Study||35
8528680|NCT03713957|9560549|FG001|COMPLETED|Overall Study||16
8528681|NCT03713957|9560548|FG000|NOT COMPLETED|Overall Study||18
8528682|NCT03713957|9560549|FG001|NOT COMPLETED|Overall Study||10
8528689|NCT04353271|9560564|FG000|STARTED|Overall Study||1
8528690|NCT04353271|9560565|FG001|STARTED|Overall Study||2
8528691|NCT04353271|9560564|FG000|COMPLETED|Overall Study||1
8528692|NCT04353271|9560565|FG001|COMPLETED|Overall Study||1
8528693|NCT04353271|9560564|FG000|NOT COMPLETED|Overall Study||0
8528694|NCT04353271|9560565|FG001|NOT COMPLETED|Overall Study||1
8528700|NCT05166824|9560576|FG001|COMPLETED|Overall Study||10
8528701|NCT05166824|9560577|FG002|COMPLETED|Overall Study||59
8528702|NCT05166824|9560578|FG003|COMPLETED|Overall Study||10
8528703|NCT05166824|9560575|FG000|NOT COMPLETED|Overall Study||0
8528704|NCT05166824|9560576|FG001|NOT COMPLETED|Overall Study||0
8528705|NCT05166824|9560577|FG002|NOT COMPLETED|Overall Study||9
8528706|NCT05166824|9560578|FG003|NOT COMPLETED|Overall Study||0
8563381|NCT00046475|9595461|FG001|COMPLETED|Titration (1 Week)||0
8563382|NCT00046475|9595462|FG002|COMPLETED|Titration (1 Week)||0
8563383|NCT00046475|9595460|FG000|NOT COMPLETED|Titration (1 Week)||0
8563384|NCT00046475|9595461|FG001|NOT COMPLETED|Titration (1 Week)||0
8563385|NCT00046475|9595462|FG002|NOT COMPLETED|Titration (1 Week)||0
8563386|NCT00046475|9595460|FG000|STARTED|Treatment Period 1 (Up to 2 Weeks)||0
8563387|NCT00046475|9595461|FG001|STARTED|Treatment Period 1 (Up to 2 Weeks)|Patients did not meet the criteria for randomization, had an AE, or withdrew from the study.|45
8563388|NCT00046475|9595462|FG002|STARTED|Treatment Period 1 (Up to 2 Weeks)|Patients did not meet the criteria for randomization, had an AE, or withdrew from the study.|60
8563389|NCT00046475|9595460|FG000|COMPLETED|Treatment Period 1 (Up to 2 Weeks)||0
8563390|NCT00046475|9595461|FG001|COMPLETED|Treatment Period 1 (Up to 2 Weeks)||45
8563391|NCT00046475|9595462|FG002|COMPLETED|Treatment Period 1 (Up to 2 Weeks)||59
8563392|NCT00046475|9595460|FG000|NOT COMPLETED|Treatment Period 1 (Up to 2 Weeks)||0
8563393|NCT00046475|9595461|FG001|NOT COMPLETED|Treatment Period 1 (Up to 2 Weeks)||0
8563394|NCT00046475|9595462|FG002|NOT COMPLETED|Treatment Period 1 (Up to 2 Weeks)||1
8563395|NCT00046475|9595460|FG000|STARTED|Treatment Period 2 (Up to 2 Weeks)||0
8563396|NCT00046475|9595461|FG001|STARTED|Treatment Period 2 (Up to 2 Weeks)||45
8563397|NCT00046475|9595462|FG002|STARTED|Treatment Period 2 (Up to 2 Weeks)||59
8563398|NCT00046475|9595460|FG000|COMPLETED|Treatment Period 2 (Up to 2 Weeks)||0
8563399|NCT00046475|9595461|FG001|COMPLETED|Treatment Period 2 (Up to 2 Weeks)||44
8563400|NCT00046475|9595462|FG002|COMPLETED|Treatment Period 2 (Up to 2 Weeks)||59
8563401|NCT00046475|9595460|FG000|NOT COMPLETED|Treatment Period 2 (Up to 2 Weeks)||0
8563402|NCT00046475|9595461|FG001|NOT COMPLETED|Treatment Period 2 (Up to 2 Weeks)||1
8563403|NCT00046475|9595462|FG002|NOT COMPLETED|Treatment Period 2 (Up to 2 Weeks)||0
8563404|NCT00046566|9595475|FG000|STARTED|Intervention 1 (8 Weeks)|Soy protein 8 weeks|117
8563405|NCT00046566|9595476|FG001|STARTED|Intervention 1 (8 Weeks)|Milk protein 8 weeks|117
8563406|NCT00046566|9595477|FG002|STARTED|Intervention 1 (8 Weeks)|Carbohydrate 8 weeks|118
8563407|NCT00046566|9595475|FG000|COMPLETED|Intervention 1 (8 Weeks)||101
8563408|NCT00046566|9595476|FG001|COMPLETED|Intervention 1 (8 Weeks)||104
8563409|NCT00046566|9595477|FG002|COMPLETED|Intervention 1 (8 Weeks)||101
8563410|NCT00046566|9595475|FG000|NOT COMPLETED|Intervention 1 (8 Weeks)||16
8563411|NCT00046566|9595476|FG001|NOT COMPLETED|Intervention 1 (8 Weeks)||13
8563412|NCT00046566|9595477|FG002|NOT COMPLETED|Intervention 1 (8 Weeks)||17
8563413|NCT00046566|9595475|FG000|STARTED|Intervention 2 (8 Weeks)|Milk protein 8 weeks|101
8563414|NCT00046566|9595476|FG001|STARTED|Intervention 2 (8 Weeks)|Carbohydrate 8 weeks|104
8563415|NCT00046566|9595477|FG002|STARTED|Intervention 2 (8 Weeks)|Soy protein 8 weeks|101
8563416|NCT00046566|9595475|FG000|COMPLETED|Intervention 2 (8 Weeks)||93
8563417|NCT00046566|9595476|FG001|COMPLETED|Intervention 2 (8 Weeks)||92
8620575|NCT00474760|9659326|FG001|NOT COMPLETED|Overall Study||3
8620576|NCT00474760|9659327|FG002|NOT COMPLETED|Overall Study||3
8620577|NCT00474760|9659328|FG003|NOT COMPLETED|Overall Study||3
8620578|NCT00474760|9659329|FG004|NOT COMPLETED|Overall Study||12
8620579|NCT00474760|9659330|FG005|NOT COMPLETED|Overall Study||29
8816332|NCT01543490|9869812|FG001|NOT COMPLETED|Overall Study||5
8816333|NCT01543503|9869820|FG000|STARTED|Overall Study||426
8816334|NCT01543503|9869821|FG001|STARTED|Overall Study||798
8816335|NCT01543503|9869820|FG000|COMPLETED|Overall Study||350
8528707|NCT04570670|9560590|FG000|STARTED|Overall Study||25
8528708|NCT04570670|9560591|FG001|STARTED|Overall Study||25
8528709|NCT04570670|9560590|FG000|COMPLETED|Overall Study||24
8528710|NCT04570670|9560591|FG001|COMPLETED|Overall Study||25
8528711|NCT04570670|9560590|FG000|NOT COMPLETED|Overall Study||1
8528712|NCT04570670|9560591|FG001|NOT COMPLETED|Overall Study||0
8528713|NCT04552704|9560600|FG000|STARTED|Overall Study||3
8528714|NCT04552704|9560600|FG000|COMPLETED|Overall Study||3
8528715|NCT04552704|9560600|FG000|NOT COMPLETED|Overall Study||0
8528716|NCT04546581|9560607|FG000|STARTED|Overall Study||301
8528717|NCT04546581|9560608|FG001|STARTED|Overall Study||292
8528718|NCT04546581|9560607|FG000|COMPLETED|Overall Study||288
8528719|NCT04546581|9560608|FG001|COMPLETED|Overall Study||279
8528720|NCT04546581|9560607|FG000|NOT COMPLETED|Overall Study||13
8528721|NCT04546581|9560608|FG001|NOT COMPLETED|Overall Study||13
8528784|NCT03283670|9560706|FG000|STARTED|Placebo Gas||24
8528785|NCT03283670|9560706|FG000|COMPLETED|Placebo Gas||22
8528786|NCT03283670|9560706|FG000|NOT COMPLETED|Placebo Gas||2
8528787|NCT03283670|9560706|FG000|STARTED|25% Nitrous Oxide||24
8528788|NCT03283670|9560706|FG000|COMPLETED|25% Nitrous Oxide||20
8528789|NCT03283670|9560706|FG000|NOT COMPLETED|25% Nitrous Oxide||4
8528790|NCT03283670|9560706|FG000|STARTED|50% Nitrous Oxide||24
8528791|NCT03283670|9560706|FG000|COMPLETED|50% Nitrous Oxide||23
8528792|NCT03283670|9560706|FG000|NOT COMPLETED|50% Nitrous Oxide||1
8528793|NCT03233217|9560719|FG000|STARTED|Overall Study||5
8528794|NCT03233217|9560720|FG001|STARTED|Overall Study||5
8528795|NCT03233217|9560721|FG002|STARTED|Overall Study||55
8528796|NCT03233217|9560722|FG003|STARTED|Overall Study||55
8528797|NCT03233217|9560723|FG004|STARTED|Overall Study||55
8528798|NCT03233217|9560719|FG000|Safety Analysis Set (SafAS)|Overall Study||5
8528799|NCT03233217|9560720|FG001|Safety Analysis Set (SafAS)|Overall Study||5
8528800|NCT03233217|9560721|FG002|Safety Analysis Set (SafAS)|Overall Study||55
8528801|NCT03233217|9560722|FG003|Safety Analysis Set (SafAS)|Overall Study||55
8528802|NCT03233217|9560723|FG004|Safety Analysis Set (SafAS)|Overall Study||55
8528803|NCT03233217|9560719|FG000|Per-protocol Analysis Set (PPAS)|Overall Study||5
8528804|NCT03233217|9560720|FG001|Per-protocol Analysis Set (PPAS)|Overall Study||5
8528805|NCT03233217|9560721|FG002|Per-protocol Analysis Set (PPAS)|Overall Study||55
8528806|NCT03233217|9560722|FG003|Per-protocol Analysis Set (PPAS)|Overall Study||55
8528807|NCT03233217|9560723|FG004|Per-protocol Analysis Set (PPAS)|Overall Study||54
8528808|NCT03233217|9560719|FG000|COMPLETED|Overall Study||5
8528809|NCT03233217|9560720|FG001|COMPLETED|Overall Study||5
8528810|NCT03233217|9560721|FG002|COMPLETED|Overall Study||55
8528811|NCT03233217|9560722|FG003|COMPLETED|Overall Study||55
8528812|NCT03233217|9560723|FG004|COMPLETED|Overall Study||55
8528813|NCT03233217|9560719|FG000|NOT COMPLETED|Overall Study||0
8528814|NCT03233217|9560720|FG001|NOT COMPLETED|Overall Study||0
8528815|NCT03233217|9560721|FG002|NOT COMPLETED|Overall Study||0
8528816|NCT03233217|9560722|FG003|NOT COMPLETED|Overall Study||0
8528817|NCT03233217|9560723|FG004|NOT COMPLETED|Overall Study||0
8528818|NCT03219567|9560737|FG000|STARTED|Overall Study||18
8528819|NCT03219567|9560738|FG001|STARTED|Overall Study||64
8528820|NCT03219567|9560737|FG000|COMPLETED|Overall Study||18
8528821|NCT03219567|9560738|FG001|COMPLETED|Overall Study||63
8528822|NCT03219567|9560737|FG000|NOT COMPLETED|Overall Study||0
8528823|NCT03219567|9560738|FG001|NOT COMPLETED|Overall Study||1
8528824|NCT03205358|9560747|FG000|STARTED|Overall Study||94
8528825|NCT03205358|9560748|FG001|STARTED|Overall Study||94
8528826|NCT03205358|9560747|FG000|COMPLETED|Overall Study||94
8528827|NCT03205358|9560748|FG001|COMPLETED|Overall Study||94
8528828|NCT03205358|9560747|FG000|NOT COMPLETED|Overall Study||0
8528829|NCT03205358|9560748|FG001|NOT COMPLETED|Overall Study||0
8528830|NCT03153111|9560756|FG000|STARTED|Overall Study||71
8528831|NCT03153111|9560757|FG001|STARTED|Overall Study||71
8528832|NCT03153111|9560756|FG000|COMPLETED|Overall Study||60
8528833|NCT03153111|9560757|FG001|COMPLETED|Overall Study||62
8528834|NCT03153111|9560756|FG000|NOT COMPLETED|Overall Study||11
8528835|NCT03153111|9560757|FG001|NOT COMPLETED|Overall Study||9
8528836|NCT03073733|9560766|FG000|STARTED|Overall Study||29
8528837|NCT03073733|9560767|FG001|STARTED|Overall Study||27
8528838|NCT03073733|9560768|FG002|STARTED|Overall Study||27
8528839|NCT03073733|9560766|FG000|COMPLETED|Overall Study||28
8528840|NCT03073733|9560767|FG001|COMPLETED|Overall Study||26
8528841|NCT03073733|9560768|FG002|COMPLETED|Overall Study||26
8528842|NCT03073733|9560766|FG000|NOT COMPLETED|Overall Study||1
8528843|NCT03073733|9560767|FG001|NOT COMPLETED|Overall Study||1
8528844|NCT03073733|9560768|FG002|NOT COMPLETED|Overall Study||1
8528845|NCT02821000|9560778|FG000|STARTED|Overall Study||103
8528846|NCT02821000|9560778|FG000|Treated|Overall Study||103
8528847|NCT02821000|9560778|FG000|COMPLETED|Overall Study||0
8528848|NCT02821000|9560778|FG000|NOT COMPLETED|Overall Study||103
8528849|NCT02749968|9560784|FG000|STARTED|Overall Study||50
8528850|NCT02749968|9560785|FG001|STARTED|Overall Study||50
8528851|NCT02749968|9560784|FG000|Interim Analysis|Overall Study||25
8528852|NCT02749968|9560785|FG001|Interim Analysis|Overall Study||25
8528853|NCT02749968|9560784|FG000|COMPLETED|Overall Study||50
8528854|NCT02749968|9560785|FG001|COMPLETED|Overall Study||50
8528855|NCT02749968|9560784|FG000|NOT COMPLETED|Overall Study||0
8528856|NCT02749968|9560785|FG001|NOT COMPLETED|Overall Study||0
8528857|NCT02738255|9560793|FG000|STARTED|Overall Study||11
8528858|NCT02738255|9560794|FG001|STARTED|Overall Study||15
8528859|NCT02738255|9560793|FG000|COMPLETED|Overall Study||11
8528722|NCT04236245|9560614|FG000|STARTED|Overall Study||25
8528723|NCT04236245|9560614|FG000|COMPLETED|Overall Study||25
8528724|NCT04236245|9560614|FG000|NOT COMPLETED|Overall Study||0
8528725|NCT03915626|9560618|FG000|STARTED|Overall Study||7
8528726|NCT03915626|9560618|FG000|COMPLETED|Overall Study||6
8528727|NCT03915626|9560618|FG000|NOT COMPLETED|Overall Study||1
8528728|NCT03698279|9560634|FG000|STARTED|Overall Study||124
8528729|NCT03698279|9560635|FG001|STARTED|Overall Study||122
8528730|NCT03698279|9560636|FG002|STARTED|Overall Study||159
8528731|NCT03698279|9560637|FG003|STARTED|Overall Study||234
8528732|NCT03698279|9560638|FG004|STARTED|Overall Study||13
8528733|NCT03698279|9560639|FG005|STARTED|Overall Study||13
8528734|NCT03698279|9560634|FG000|Safety Analysis Set Population (SafAS)|Overall Study||122
8528735|NCT03698279|9560635|FG001|Safety Analysis Set Population (SafAS)|Overall Study||121
8528736|NCT03698279|9560636|FG002|Safety Analysis Set Population (SafAS)|Overall Study||158
8528737|NCT03698279|9560637|FG003|Safety Analysis Set Population (SafAS)|Overall Study||234
8528738|NCT03698279|9560638|FG004|Safety Analysis Set Population (SafAS)|Overall Study||13
8528739|NCT03698279|9560639|FG005|Safety Analysis Set Population (SafAS)|Overall Study||13
8528740|NCT03698279|9560634|FG000|COMPLETED|Overall Study||119
8528741|NCT03698279|9560635|FG001|COMPLETED|Overall Study||120
8528742|NCT03698279|9560636|FG002|COMPLETED|Overall Study||152
8528743|NCT03698279|9560637|FG003|COMPLETED|Overall Study||228
8528744|NCT03698279|9560638|FG004|COMPLETED|Overall Study||13
8528745|NCT03698279|9560639|FG005|COMPLETED|Overall Study||13
8528746|NCT03698279|9560634|FG000|NOT COMPLETED|Overall Study||5
8528747|NCT03698279|9560635|FG001|NOT COMPLETED|Overall Study||2
8528748|NCT03698279|9560636|FG002|NOT COMPLETED|Overall Study||7
8528749|NCT03698279|9560637|FG003|NOT COMPLETED|Overall Study||6
8528750|NCT03698279|9560638|FG004|NOT COMPLETED|Overall Study||0
8528751|NCT03698279|9560639|FG005|NOT COMPLETED|Overall Study||0
8528752|NCT03559010|9560658|FG000|STARTED|Overall Study|The number of participants to start a period is not equal to the number who completed previous period|189
8528753|NCT03559010|9560658|FG000|Purchaser Population|Overall Study||113
8528754|NCT03559010|9560658|FG000|Use Phase Norgestrel 0.075 mg|Overall Study||109
8528755|NCT03559010|9560658|FG000|COMPLETED|Overall Study||189
8528756|NCT03559010|9560658|FG000|NOT COMPLETED|Overall Study||0
8528757|NCT03478930|9560669|FG000|STARTED|Overall Study||126
8528758|NCT03478930|9560670|FG001|STARTED|Overall Study||123
8528759|NCT03478930|9560669|FG000|COMPLETED|Overall Study||117
8528760|NCT03478930|9560670|FG001|COMPLETED|Overall Study||114
8528761|NCT03478930|9560669|FG000|NOT COMPLETED|Overall Study||9
8528762|NCT03478930|9560670|FG001|NOT COMPLETED|Overall Study||9
8528763|NCT03434353|9560681|FG000|STARTED|Overall Study||30
8528764|NCT03434353|9560682|FG001|STARTED|Overall Study||12
8528765|NCT03434353|9560683|FG002|STARTED|Overall Study||30
8528766|NCT03434353|9560684|FG003|STARTED|Overall Study||21
8528767|NCT03434353|9560685|FG004|STARTED|Overall Study||30
8528768|NCT03434353|9560681|FG000|COMPLETED|Overall Study||16
8528769|NCT03434353|9560682|FG001|COMPLETED|Overall Study||9
8528770|NCT03434353|9560683|FG002|COMPLETED|Overall Study||16
8528771|NCT03434353|9560684|FG003|COMPLETED|Overall Study||18
8528772|NCT03434353|9560685|FG004|COMPLETED|Overall Study||12
8528773|NCT03434353|9560681|FG000|NOT COMPLETED|Overall Study||14
8528774|NCT03434353|9560682|FG001|NOT COMPLETED|Overall Study||3
8528775|NCT03434353|9560683|FG002|NOT COMPLETED|Overall Study||14
8528776|NCT03434353|9560684|FG003|NOT COMPLETED|Overall Study||3
8528777|NCT03434353|9560685|FG004|NOT COMPLETED|Overall Study||18
8528778|NCT03415022|9560699|FG000|STARTED|Overall Study||21
8528779|NCT03415022|9560700|FG001|STARTED|Overall Study||20
8528780|NCT03415022|9560699|FG000|COMPLETED|Overall Study||16
8528781|NCT03415022|9560700|FG001|COMPLETED|Overall Study||15
8528782|NCT03415022|9560699|FG000|NOT COMPLETED|Overall Study||5
8528783|NCT03415022|9560700|FG001|NOT COMPLETED|Overall Study||5
8528860|NCT02738255|9560794|FG001|COMPLETED|Overall Study||14
8528861|NCT02738255|9560793|FG000|NOT COMPLETED|Overall Study||0
8528862|NCT02738255|9560794|FG001|NOT COMPLETED|Overall Study||1
8528863|NCT02702414|9560806|FG000|STARTED|Overall Study||105
8528864|NCT02702414|9560807|FG001|STARTED|Overall Study||51
8528865|NCT02702414|9560806|FG000|Treated|Overall Study||104
8528866|NCT02702414|9560807|FG001|Treated|Overall Study||51
8528867|NCT02702414|9560806|FG000|COMPLETED|Overall Study||0
8620580|NCT00474760|9659331|FG006|NOT COMPLETED|Overall Study||10
8528868|NCT02702414|9560807|FG001|COMPLETED|Overall Study||0
8528869|NCT02702414|9560806|FG000|NOT COMPLETED|Overall Study||105
8528870|NCT02702414|9560807|FG001|NOT COMPLETED|Overall Study||51
8528871|NCT02605616|9560817|FG000|STARTED|Overall Study||46
8528872|NCT02605616|9560818|FG001|STARTED|Overall Study||47
8528873|NCT02605616|9560817|FG000|COMPLETED|Overall Study||42
8620581|NCT00474786|9659356|FG000|STARTED|Overall Study||259
8528874|NCT02605616|9560818|FG001|COMPLETED|Overall Study||43
8528875|NCT02605616|9560817|FG000|NOT COMPLETED|Overall Study||4
8528876|NCT02605616|9560818|FG001|NOT COMPLETED|Overall Study||4
8528877|NCT02573233|9560826|FG000|STARTED|Overall Study||22
8528878|NCT02573233|9560827|FG001|STARTED|Overall Study||20
8528879|NCT02573233|9560826|FG000|COMPLETED|Overall Study||22
8528880|NCT02573233|9560827|FG001|COMPLETED|Overall Study||20
8528881|NCT02573233|9560826|FG000|NOT COMPLETED|Overall Study||0
8528882|NCT02573233|9560827|FG001|NOT COMPLETED|Overall Study||0
8528883|NCT02425904|9560836|FG000|STARTED|Overall Study||20
8528884|NCT02425904|9560837|FG001|STARTED|Overall Study||5
8528885|NCT02425904|9560836|FG000|Efficacy Analysis|Overall Study||20
8528886|NCT02425904|9560837|FG001|Efficacy Analysis|Overall Study|1 patient was incorrectly assigned to LCH-related disorders cohort but it is actually LCH patients, so excluded from efficacy analysis.|4
8528887|NCT02425904|9560836|FG000|COMPLETED|Overall Study||17
8528888|NCT02425904|9560837|FG001|COMPLETED|Overall Study||2
8528889|NCT02425904|9560836|FG000|NOT COMPLETED|Overall Study||3
8528890|NCT02425904|9560837|FG001|NOT COMPLETED|Overall Study||3
8528891|NCT02420795|9560847|FG000|STARTED|Overall Study||4
8528892|NCT02420795|9560848|FG001|STARTED|Overall Study||2
8528893|NCT02420795|9560849|FG002|STARTED|Overall Study||5
8528894|NCT02420795|9560847|FG000|COMPLETED|Overall Study||0
8528895|NCT02420795|9560848|FG001|COMPLETED|Overall Study||0
8528896|NCT02420795|9560849|FG002|COMPLETED|Overall Study||0
8528897|NCT02420795|9560847|FG000|NOT COMPLETED|Overall Study||4
8528898|NCT02420795|9560848|FG001|NOT COMPLETED|Overall Study||2
8528899|NCT02420795|9560849|FG002|NOT COMPLETED|Overall Study||5
8528900|NCT02240485|9560861|FG000|STARTED|3 Months Post-admission||44
8528901|NCT02240485|9560862|FG001|STARTED|3 Months Post-admission||36
8528902|NCT02240485|9560861|FG000|COMPLETED|3 Months Post-admission|Couple modality: 1 couple refused and one gambler refused but his partner continued|41
8528903|NCT02240485|9560862|FG001|COMPLETED|3 Months Post-admission||30
8528904|NCT02240485|9560861|FG000|NOT COMPLETED|3 Months Post-admission||3
8528905|NCT02240485|9560862|FG001|NOT COMPLETED|3 Months Post-admission||6
8528906|NCT02240485|9560861|FG000|STARTED|9 Months Post-admission||41
8528907|NCT02240485|9560862|FG001|STARTED|9 Months Post-admission||30
8528908|NCT02240485|9560861|FG000|COMPLETED|9 Months Post-admission||38
8528909|NCT02240485|9560862|FG001|COMPLETED|9 Months Post-admission|26 couples completed + 1 individual (partner lost)|26
8528910|NCT02240485|9560861|FG000|NOT COMPLETED|9 Months Post-admission||3
8528911|NCT02240485|9560862|FG001|NOT COMPLETED|9 Months Post-admission||4
8528912|NCT02240485|9560861|FG000|STARTED|18 Months Post-admission||38
8528913|NCT02240485|9560862|FG001|STARTED|18 Months Post-admission||26
8528914|NCT02240485|9560861|FG000|COMPLETED|18 Months Post-admission||35
8528915|NCT02240485|9560862|FG001|COMPLETED|18 Months Post-admission||21
8528916|NCT02240485|9560861|FG000|NOT COMPLETED|18 Months Post-admission||3
8528917|NCT02240485|9560862|FG001|NOT COMPLETED|18 Months Post-admission||5
8528918|NCT02227147|9560874|FG000|STARTED|Controlled Treatment Period||24
8528919|NCT02227147|9560875|FG001|STARTED|Controlled Treatment Period||24
8528920|NCT02227147|9560874|FG000|COMPLETED|Controlled Treatment Period||18
8528921|NCT02227147|9560875|FG001|COMPLETED|Controlled Treatment Period||21
8528922|NCT02227147|9560874|FG000|NOT COMPLETED|Controlled Treatment Period||6
8528923|NCT02227147|9560875|FG001|NOT COMPLETED|Controlled Treatment Period||3
8528924|NCT02227147|9560874|FG000|STARTED|Follow-up Period||18
8528925|NCT02227147|9560875|FG001|STARTED|Follow-up Period||21
8528926|NCT02227147|9560874|FG000|COMPLETED|Follow-up Period||15
8528927|NCT02227147|9560875|FG001|COMPLETED|Follow-up Period||16
8528928|NCT02227147|9560874|FG000|NOT COMPLETED|Follow-up Period||3
8528929|NCT02227147|9560875|FG001|NOT COMPLETED|Follow-up Period||5
8528930|NCT02199691|9560889|FG000|STARTED|Overall Study||505
8528931|NCT02199691|9560890|FG001|STARTED|Overall Study||507
8528932|NCT02199691|9560891|FG002|STARTED|Overall Study||403
8528933|NCT02199691|9560892|FG003|STARTED|Overall Study||300
8528934|NCT02199691|9560889|FG000|Safety Analysis Set (SafAS)|Overall Study||503
8528935|NCT02199691|9560890|FG001|Safety Analysis Set (SafAS)|Overall Study||501
8528936|NCT02199691|9560891|FG002|Safety Analysis Set (SafAS)|Overall Study||392
8528937|NCT02199691|9560892|FG003|Safety Analysis Set (SafAS)|Overall Study||296
8528938|NCT02199691|9560889|FG000|COMPLETED|Overall Study||495
8528939|NCT02199691|9560890|FG001|COMPLETED|Overall Study||500
8528940|NCT02199691|9560891|FG002|COMPLETED|Overall Study||376
8528941|NCT02199691|9560892|FG003|COMPLETED|Overall Study||270
8528942|NCT02199691|9560889|FG000|NOT COMPLETED|Overall Study||10
8528943|NCT02199691|9560890|FG001|NOT COMPLETED|Overall Study||7
8528944|NCT02199691|9560891|FG002|NOT COMPLETED|Overall Study||27
8528945|NCT02199691|9560892|FG003|NOT COMPLETED|Overall Study||30
8528946|NCT02163694|9560906|FG000|STARTED|Overall Study||172
8528947|NCT02163694|9560907|FG001|STARTED|Overall Study||337
8528948|NCT02163694|9560906|FG000|COMPLETED|Overall Study||18
8528949|NCT02163694|9560907|FG001|COMPLETED|Overall Study||70
8528950|NCT02163694|9560906|FG000|NOT COMPLETED|Overall Study||154
8528951|NCT02163694|9560907|FG001|NOT COMPLETED|Overall Study||267
8528952|NCT02143726|9560915|FG000|STARTED|Overall Study||18
8528953|NCT02143726|9560916|FG001|STARTED|Overall Study||17
8528954|NCT02143726|9560915|FG000|Received Everolimus After Disease Progression|Overall Study||11
8528955|NCT02143726|9560916|FG001|Received Everolimus After Disease Progression|Overall Study||0
8528956|NCT02143726|9560915|FG000|COMPLETED|Overall Study||16
8528957|NCT02143726|9560916|FG001|COMPLETED|Overall Study||17
8528958|NCT02143726|9560915|FG000|NOT COMPLETED|Overall Study||2
8528959|NCT02143726|9560916|FG001|NOT COMPLETED|Overall Study||0
8528960|NCT02046512|9560924|FG000|STARTED|Overall Study||45
8528961|NCT02046512|9560925|FG001|STARTED|Overall Study||44
8528962|NCT02046512|9560924|FG000|COMPLETED|Overall Study||44
8528963|NCT02046512|9560925|FG001|COMPLETED|Overall Study||44
8528964|NCT02046512|9560924|FG000|NOT COMPLETED|Overall Study||1
8528965|NCT02046512|9560925|FG001|NOT COMPLETED|Overall Study||0
8528966|NCT01958593|9560933|FG000|STARTED|Overall Study||2
8528967|NCT01958593|9560934|FG001|STARTED|Overall Study||4
8528968|NCT01958593|9560933|FG000|COMPLETED|Overall Study||2
8528969|NCT01958593|9560934|FG001|COMPLETED|Overall Study||4
8528970|NCT01958593|9560933|FG000|NOT COMPLETED|Overall Study||0
8528971|NCT01958593|9560934|FG001|NOT COMPLETED|Overall Study||0
8528972|NCT01842035|9560941|FG000|STARTED|Overall Study||90
8528973|NCT01842035|9560941|FG000|COMPLETED|Overall Study||90
8528974|NCT01842035|9560941|FG000|NOT COMPLETED|Overall Study||0
8528975|NCT01751984|9560948|FG000|STARTED|Overall Study||37
8528976|NCT01751984|9560949|FG001|STARTED|Overall Study||19
8528977|NCT01751984|9560948|FG000|COMPLETED|Overall Study||31
8528978|NCT01751984|9560949|FG001|COMPLETED|Overall Study||15
8528979|NCT01751984|9560948|FG000|NOT COMPLETED|Overall Study||6
8528980|NCT01751984|9560949|FG001|NOT COMPLETED|Overall Study||4
8528981|NCT01732627|9560957|FG000|STARTED|Overall Study||201
8528982|NCT01732627|9560958|FG001|STARTED|Overall Study||100
8528983|NCT01732627|9560957|FG000|Safety Analysis Set (SafAS)|Overall Study||199
8528984|NCT01732627|9560958|FG001|Safety Analysis Set (SafAS)|Overall Study||100
8528985|NCT01732627|9560957|FG000|COMPLETED|Overall Study||200
8528986|NCT01732627|9560958|FG001|COMPLETED|Overall Study||100
8528987|NCT01732627|9560957|FG000|NOT COMPLETED|Overall Study||1
8528988|NCT01732627|9560958|FG001|NOT COMPLETED|Overall Study||0
8528989|NCT01702571|9560966|FG000|STARTED|Overall Study||2003
8528990|NCT01702571|9560967|FG001|STARTED|Overall Study||182
8528991|NCT01702571|9560966|FG000|COMPLETED|Overall Study|For one participant, the site incorrectly answered the question 'Did the participant complete follow-up as per protocol?' It was answered No, however the participant was in survival follow-up and the site should have answered Yes. This participant is wrongly counted in the 'discontinued from study' number.|494
8528992|NCT01702571|9560967|FG001|COMPLETED|Overall Study||65
8528993|NCT01702571|9560966|FG000|NOT COMPLETED|Overall Study||1509
8528994|NCT01702571|9560967|FG001|NOT COMPLETED|Overall Study||117
8563418|NCT00046566|9595477|FG002|COMPLETED|Intervention 2 (8 Weeks)||88
8563419|NCT00046566|9595475|FG000|NOT COMPLETED|Intervention 2 (8 Weeks)||8
8563420|NCT00046566|9595476|FG001|NOT COMPLETED|Intervention 2 (8 Weeks)||12
8563421|NCT00046566|9595477|FG002|NOT COMPLETED|Intervention 2 (8 Weeks)||13
8563422|NCT00046566|9595475|FG000|STARTED|Intervention 3 (8 Weeks)||93
8563423|NCT00046566|9595476|FG001|STARTED|Intervention 3 (8 Weeks)||92
8563424|NCT00046566|9595477|FG002|STARTED|Intervention 3 (8 Weeks)||88
8563425|NCT00046566|9595475|FG000|COMPLETED|Intervention 3 (8 Weeks)||93
8563426|NCT00046566|9595476|FG001|COMPLETED|Intervention 3 (8 Weeks)||92
8563427|NCT00046566|9595477|FG002|COMPLETED|Intervention 3 (8 Weeks)||88
8563428|NCT00046566|9595475|FG000|NOT COMPLETED|Intervention 3 (8 Weeks)||0
8563429|NCT00046566|9595476|FG001|NOT COMPLETED|Intervention 3 (8 Weeks)||0
8563430|NCT00046566|9595477|FG002|NOT COMPLETED|Intervention 3 (8 Weeks)||0
8563431|NCT00046839|9595488|FG000|STARTED|Overall Study||8
8563432|NCT00046839|9595489|FG001|STARTED|Overall Study||13
8563433|NCT00046839|9595488|FG000|COMPLETED|Overall Study|Subjects contributing data to either primary analysis are considered to have completed the study.|7
8563434|NCT00046839|9595489|FG001|COMPLETED|Overall Study|Subjects contributing data to either primary analysis are considered to have completed the study.|11
8563435|NCT00046839|9595488|FG000|NOT COMPLETED|Overall Study||1
8563436|NCT00046839|9595489|FG001|NOT COMPLETED|Overall Study||2
8563437|NCT00046891|9595498|FG000|STARTED|Overall Study||113
8563438|NCT00046891|9595499|FG001|STARTED|Overall Study||113
8563439|NCT00046891|9595498|FG000|COMPLETED|Overall Study||84
8563440|NCT00046891|9595499|FG001|COMPLETED|Overall Study||83
8563441|NCT00046891|9595498|FG000|NOT COMPLETED|Overall Study||29
8563442|NCT00046891|9595499|FG001|NOT COMPLETED|Overall Study||30
8563443|NCT00046930|9595515|FG000|STARTED|Overall Study||224
8563444|NCT00046930|9595516|FG001|STARTED|Overall Study||225
8563445|NCT00046930|9595515|FG000|COMPLETED|Overall Study||212
8563446|NCT00046930|9595516|FG001|COMPLETED|Overall Study||221
8563447|NCT00046930|9595515|FG000|NOT COMPLETED|Overall Study||12
8563448|NCT00046930|9595516|FG001|NOT COMPLETED|Overall Study||4
8563449|NCT00047008|9595527|FG000|STARTED|Overall Study||372
8563450|NCT00047008|9595528|FG001|STARTED|Overall Study||371
8563451|NCT00047008|9595527|FG000|COMPLETED|Overall Study||361
8563452|NCT00047008|9595528|FG001|COMPLETED|Overall Study||360
8563453|NCT00047008|9595527|FG000|NOT COMPLETED|Overall Study||11
8563454|NCT00047008|9595528|FG001|NOT COMPLETED|Overall Study||11
8563455|NCT00047060|9595534|FG000|STARTED|Overall Study||5
8563456|NCT00047060|9595534|FG000|COMPLETED|Overall Study||3
8563457|NCT00047060|9595534|FG000|NOT COMPLETED|Overall Study||2
8563458|NCT00047320|9595538|FG000|STARTED|Overall Study||104
8563459|NCT00047320|9595538|FG000|COMPLETED|Overall Study||76
8563460|NCT00047320|9595538|FG000|NOT COMPLETED|Overall Study||28
8563461|NCT00047385|9595544|FG000|STARTED|Overall Study||26722
8563462|NCT00047385|9595545|FG001|STARTED|Overall Study||26732
8563463|NCT00047385|9595544|FG000|COMPLETED|Overall Study|Had at least one screening exam.|26455
8563464|NCT00047385|9595545|FG001|COMPLETED|Overall Study||26232
9065786|NCT04141930|10126264|FG001|STARTED|Overall Study|The 179 individuals that were not eligible to receive the study drug, participated in an observation portion of the study where all study procedures were the same excluding telehealth visit and an antiviral delivery.|179
9065787|NCT04141930|10126263|FG000|COMPLETED|Overall Study||302
8563465|NCT00047385|9595544|FG000|NOT COMPLETED|Overall Study||267
8563466|NCT00047385|9595545|FG001|NOT COMPLETED|Overall Study||500
8563467|NCT00047463|9595553|FG000|STARTED|Overall Study||13
8563468|NCT00047463|9595554|FG001|STARTED|Overall Study||22
8563469|NCT00047463|9595553|FG000|COMPLETED|Overall Study||13
8563470|NCT00047463|9595554|FG001|COMPLETED|Overall Study||19
8563471|NCT00047463|9595553|FG000|NOT COMPLETED|Overall Study||0
8563472|NCT00047463|9595554|FG001|NOT COMPLETED|Overall Study||3
8563473|NCT00047619|9595565|FG000|STARTED|Overall Study||14
8563474|NCT00047619|9595566|FG001|STARTED|Overall Study||14
8528995|NCT01578239|9560975|FG000|STARTED|Treatment Period||117
8528996|NCT01578239|9560976|FG001|STARTED|Treatment Period||114
8528997|NCT01578239|9560975|FG000|Full Analysis Set (FAS)|Treatment Period||117
8528998|NCT01578239|9560976|FG001|Full Analysis Set (FAS)|Treatment Period||114
8528999|NCT01578239|9560975|FG000|Safety Analysis Set (SAF)|Treatment Period||111
8529000|NCT01578239|9560976|FG001|Safety Analysis Set (SAF)|Treatment Period||112
8529001|NCT01578239|9560975|FG000|FAS-Entered Long-term Follow-up|Treatment Period||101
8529002|NCT01578239|9560976|FG001|FAS-Entered Long-term Follow-up|Treatment Period||99
8529003|NCT01578239|9560975|FG000|COMPLETED|Treatment Period||50
8529004|NCT01578239|9560976|FG001|COMPLETED|Treatment Period||13
8529005|NCT01578239|9560975|FG000|NOT COMPLETED|Treatment Period||67
8529006|NCT01578239|9560976|FG001|NOT COMPLETED|Treatment Period||101
8529007|NCT01578239|9560975|FG000|STARTED|Long-term Follow-Up Period|FAS-Entered long-term follow-up|101
8529008|NCT01578239|9560976|FG001|STARTED|Long-term Follow-Up Period|FAS-Entered long-term follow-up|99
8529009|NCT01578239|9560975|FG000|COMPLETED|Long-term Follow-Up Period||24
8529010|NCT01578239|9560976|FG001|COMPLETED|Long-term Follow-Up Period||19
8529011|NCT01578239|9560975|FG000|NOT COMPLETED|Long-term Follow-Up Period||77
8529012|NCT01578239|9560976|FG001|NOT COMPLETED|Long-term Follow-Up Period||80
8529013|NCT01458340|9560985|FG000|STARTED|Overall Study||97
8529014|NCT01458340|9560986|FG001|STARTED|Overall Study||99
8529015|NCT01458340|9560987|FG002|STARTED|Overall Study||99
8529016|NCT01458340|9560985|FG000|Received Study Treatment|Overall Study||97
8529017|NCT01458340|9560986|FG001|Received Study Treatment|Overall Study||98
8529018|NCT01458340|9560987|FG002|Received Study Treatment|Overall Study||98
8529019|NCT01458340|9560985|FG000|COMPLETED|Overall Study||70
8529020|NCT01458340|9560986|FG001|COMPLETED|Overall Study||78
8529021|NCT01458340|9560987|FG002|COMPLETED|Overall Study||76
8529022|NCT01458340|9560985|FG000|NOT COMPLETED|Overall Study||27
8529023|NCT01458340|9560986|FG001|NOT COMPLETED|Overall Study||21
8529024|NCT01458340|9560987|FG002|NOT COMPLETED|Overall Study||23
8529025|NCT01411267|9561005|FG000|STARTED|Overall Study||0
8529026|NCT01411267|9561006|FG001|STARTED|Overall Study||3
8529027|NCT01411267|9561007|FG002|STARTED|Overall Study||2
8529028|NCT01411267|9561008|FG003|STARTED|Overall Study||5
8529029|NCT01411267|9561009|FG004|STARTED|Overall Study||2
8529030|NCT01411267|9561010|FG005|STARTED|Overall Study||12
8529031|NCT01411267|9561011|FG006|STARTED|Overall Study||0
8529032|NCT01411267|9561012|FG007|STARTED|Overall Study||0
8529033|NCT01411267|9561013|FG008|STARTED|Overall Study||0
8529034|NCT01411267|9561014|FG009|STARTED|Overall Study||0
8529035|NCT01411267|9561005|FG000|COMPLETED|Overall Study||0
8529036|NCT01411267|9561006|FG001|COMPLETED|Overall Study||3
8529037|NCT01411267|9561007|FG002|COMPLETED|Overall Study||2
8529038|NCT01411267|9561008|FG003|COMPLETED|Overall Study||4
8529039|NCT01411267|9561009|FG004|COMPLETED|Overall Study||0
8529040|NCT01411267|9561010|FG005|COMPLETED|Overall Study||10
8529041|NCT01411267|9561011|FG006|COMPLETED|Overall Study||0
8529042|NCT01411267|9561012|FG007|COMPLETED|Overall Study||0
8529043|NCT01411267|9561013|FG008|COMPLETED|Overall Study||0
8529044|NCT01411267|9561014|FG009|COMPLETED|Overall Study||0
8529045|NCT01411267|9561005|FG000|NOT COMPLETED|Overall Study||0
8529046|NCT01411267|9561006|FG001|NOT COMPLETED|Overall Study||0
8529047|NCT01411267|9561007|FG002|NOT COMPLETED|Overall Study||0
8529048|NCT01411267|9561008|FG003|NOT COMPLETED|Overall Study||1
8529049|NCT01411267|9561009|FG004|NOT COMPLETED|Overall Study||2
8529050|NCT01411267|9561010|FG005|NOT COMPLETED|Overall Study||2
8529051|NCT01411267|9561011|FG006|NOT COMPLETED|Overall Study||0
8529052|NCT01411267|9561012|FG007|NOT COMPLETED|Overall Study||0
8529053|NCT01411267|9561013|FG008|NOT COMPLETED|Overall Study||0
8529054|NCT01411267|9561014|FG009|NOT COMPLETED|Overall Study||0
8529055|NCT01336634|9561035|FG000|STARTED|Overall Study||84
8529056|NCT01336634|9561036|FG001|STARTED|Overall Study||57
8529057|NCT01336634|9561037|FG002|STARTED|Overall Study|includes 34 subjects from Cohort C and 2 subjects enrolled as protocol deviations from Cohort B.|36
8529058|NCT01336634|9561035|FG000|2nd Line Plus All Treated|Overall Study||78
8529059|NCT01336634|9561036|FG001|2nd Line Plus All Treated|Overall Study||57
8529060|NCT01336634|9561037|FG002|2nd Line Plus All Treated|Overall Study||0
8529061|NCT01336634|9561035|FG000|1st Line All Treated|Overall Study||6
8529062|NCT01336634|9561036|FG001|1st Line All Treated|Overall Study||2
8529063|NCT01336634|9561037|FG002|1st Line All Treated|Overall Study||34
8529064|NCT01336634|9561035|FG000|Crossover|Overall Study||20
8529065|NCT01336634|9561036|FG001|Crossover|Overall Study||0
8529066|NCT01336634|9561037|FG002|Crossover|Overall Study||0
8529067|NCT01336634|9561035|FG000|COMPLETED|Overall Study||70
8529068|NCT01336634|9561036|FG001|COMPLETED|Overall Study||49
8529069|NCT01336634|9561037|FG002|COMPLETED|Overall Study||27
8529070|NCT01336634|9561035|FG000|NOT COMPLETED|Overall Study||14
8529071|NCT01336634|9561036|FG001|NOT COMPLETED|Overall Study||8
8529072|NCT01336634|9561037|FG002|NOT COMPLETED|Overall Study||9
8529073|NCT01155375|9561050|FG000|STARTED|Overall Study||8
8529074|NCT01155375|9561051|FG001|STARTED|Overall Study||6
8529075|NCT01155375|9561050|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
8529076|NCT01155375|9561051|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
8529077|NCT01155375|9561050|FG000|COMPLETED|Overall Study||7
8529078|NCT01155375|9561051|FG001|COMPLETED|Overall Study||6
8529079|NCT01155375|9561050|FG000|NOT COMPLETED|Overall Study||1
8529080|NCT01155375|9561051|FG001|NOT COMPLETED|Overall Study||0
8529081|NCT00785798|9561058|FG000|STARTED|Overall Study||17
8529082|NCT00785798|9561058|FG000|COMPLETED|Overall Study||16
8529083|NCT00785798|9561058|FG000|NOT COMPLETED|Overall Study||1
8529084|NCT00628095|9561064|FG000|STARTED|Overall Study||53
8529085|NCT00628095|9561065|FG001|STARTED|Overall Study||47
8529086|NCT00628095|9561064|FG000|COMPLETED|Overall Study||46
8529087|NCT00628095|9561065|FG001|COMPLETED|Overall Study||40
8529088|NCT00628095|9561064|FG000|NOT COMPLETED|Overall Study||7
8529089|NCT00628095|9561065|FG001|NOT COMPLETED|Overall Study||7
8529090|NCT04246021|9561073|FG000|STARTED|Overall Study||84
8529091|NCT04246021|9561073|FG000|COMPLETED|Overall Study||84
8529092|NCT04246021|9561073|FG000|NOT COMPLETED|Overall Study||0
8529093|NCT04098497|9561087|FG000|STARTED|Overall Study||30
8529094|NCT04098497|9561087|FG000|Initial Interview|Overall Study||30
8529095|NCT04098497|9561087|FG000|Set Up Study App|Overall Study||29
8529096|NCT04098497|9561087|FG000|Logged Symptoms Into Study App at Least Once|Overall Study||26
8529097|NCT04098497|9561087|FG000|Linked Fitbit to Study Database|Overall Study||27
8529098|NCT04098497|9561087|FG000|Used Fitbit|Overall Study||24
8529099|NCT04098497|9561087|FG000|Exit Interview|Overall Study||29
8529100|NCT04098497|9561087|FG000|COMPLETED|Overall Study||30
8529101|NCT04098497|9561087|FG000|NOT COMPLETED|Overall Study||0
8563475|NCT00047619|9595565|FG000|COMPLETED|Overall Study||14
8563476|NCT00047619|9595566|FG001|COMPLETED|Overall Study||14
8563477|NCT00047619|9595565|FG000|NOT COMPLETED|Overall Study||0
8563478|NCT00047619|9595566|FG001|NOT COMPLETED|Overall Study||0
8563479|NCT00047697|9595574|FG000|STARTED|Overall Study||18
8563480|NCT00047697|9595575|FG001|STARTED|Overall Study||16
8563481|NCT00047697|9595574|FG000|COMPLETED|Overall Study||18
8563482|NCT00047697|9595575|FG001|COMPLETED|Overall Study||14
8563483|NCT00047697|9595574|FG000|NOT COMPLETED|Overall Study||0
8563484|NCT00047697|9595575|FG001|NOT COMPLETED|Overall Study||2
8563485|NCT00047879|9595584|FG000|STARTED|Overall Study||4
8563486|NCT00047879|9595585|FG001|STARTED|Overall Study||3
8563487|NCT00047879|9595584|FG000|COMPLETED|Overall Study||0
8563488|NCT00047879|9595585|FG001|COMPLETED|Overall Study||0
8563489|NCT00047879|9595584|FG000|NOT COMPLETED|Overall Study||4
8563490|NCT00047879|9595585|FG001|NOT COMPLETED|Overall Study||3
8563491|NCT00048035|9595597|FG000|STARTED|Core Period||15
8563492|NCT00048035|9595598|FG001|STARTED|Core Period||15
8563493|NCT00048035|9595599|FG002|STARTED|Core Period||15
8563494|NCT00048035|9595600|FG003|STARTED|Core Period||15
8563495|NCT00048035|9595601|FG004|STARTED|Core Period||16
8563496|NCT00048035|9595602|FG005|STARTED|Core Period||15
8563497|NCT00048035|9595603|FG006|STARTED|Core Period||0
8563498|NCT00048035|9595604|FG007|STARTED|Core Period||0
8563499|NCT00048035|9595597|FG000|COMPLETED|Core Period||11
8563500|NCT00048035|9595598|FG001|COMPLETED|Core Period||13
8563501|NCT00048035|9595599|FG002|COMPLETED|Core Period||14
8563502|NCT00048035|9595600|FG003|COMPLETED|Core Period||14
8563503|NCT00048035|9595601|FG004|COMPLETED|Core Period||15
8563504|NCT00048035|9595602|FG005|COMPLETED|Core Period||14
8563505|NCT00048035|9595603|FG006|COMPLETED|Core Period||0
8563506|NCT00048035|9595604|FG007|COMPLETED|Core Period||0
8563507|NCT00048035|9595597|FG000|NOT COMPLETED|Core Period||4
8563508|NCT00048035|9595598|FG001|NOT COMPLETED|Core Period||2
8563509|NCT00048035|9595599|FG002|NOT COMPLETED|Core Period||1
8563510|NCT00048035|9595600|FG003|NOT COMPLETED|Core Period||1
8563511|NCT00048035|9595601|FG004|NOT COMPLETED|Core Period||1
8563512|NCT00048035|9595602|FG005|NOT COMPLETED|Core Period||1
8563513|NCT00048035|9595603|FG006|NOT COMPLETED|Core Period||0
8563514|NCT00048035|9595604|FG007|NOT COMPLETED|Core Period||0
8563515|NCT00048035|9595597|FG000|STARTED|Extension Year 1||0
8563516|NCT00048035|9595598|FG001|STARTED|Extension Year 1||0
8563517|NCT00048035|9595599|FG002|STARTED|Extension Year 1||0
8563518|NCT00048035|9595600|FG003|STARTED|Extension Year 1||0
8563519|NCT00048035|9595601|FG004|STARTED|Extension Year 1||0
8563520|NCT00048035|9595602|FG005|STARTED|Extension Year 1||0
8563521|NCT00048035|9595603|FG006|STARTED|Extension Year 1|Participants (Cohorts 1, 3, and 5) who completed core, entered extension period (entry optional).|27
8563522|NCT00048035|9595604|FG007|STARTED|Extension Year 1|Participants (Cohorts 2, 4 and 6) who completed core, entered extension period (entry optional).|26
8563523|NCT00048035|9595597|FG000|COMPLETED|Extension Year 1||0
8563524|NCT00048035|9595598|FG001|COMPLETED|Extension Year 1||0
8563525|NCT00048035|9595599|FG002|COMPLETED|Extension Year 1||0
8563526|NCT00048035|9595600|FG003|COMPLETED|Extension Year 1||0
8563527|NCT00048035|9595601|FG004|COMPLETED|Extension Year 1||0
8563528|NCT00048035|9595602|FG005|COMPLETED|Extension Year 1||0
8563529|NCT00048035|9595603|FG006|COMPLETED|Extension Year 1||16
8563530|NCT00048035|9595604|FG007|COMPLETED|Extension Year 1||15
8563531|NCT00048035|9595597|FG000|NOT COMPLETED|Extension Year 1||0
8563532|NCT00048035|9595598|FG001|NOT COMPLETED|Extension Year 1||0
8563533|NCT00048035|9595599|FG002|NOT COMPLETED|Extension Year 1||0
8563534|NCT00048035|9595600|FG003|NOT COMPLETED|Extension Year 1||0
8563535|NCT00048035|9595601|FG004|NOT COMPLETED|Extension Year 1||0
8563536|NCT00048035|9595602|FG005|NOT COMPLETED|Extension Year 1||0
8563537|NCT00048035|9595603|FG006|NOT COMPLETED|Extension Year 1||11
8563538|NCT00048035|9595604|FG007|NOT COMPLETED|Extension Year 1||11
8563539|NCT00048035|9595597|FG000|STARTED|Extension Year 2||0
8563540|NCT00048035|9595598|FG001|STARTED|Extension Year 2||0
8563541|NCT00048035|9595599|FG002|STARTED|Extension Year 2||0
8563542|NCT00048035|9595600|FG003|STARTED|Extension Year 2||0
8563543|NCT00048035|9595601|FG004|STARTED|Extension Year 2||0
8563544|NCT00048035|9595602|FG005|STARTED|Extension Year 2||0
8529102|NCT03945825|9561097|FG000|STARTED|Overall Study||41
8529103|NCT03945825|9561098|FG001|STARTED|Overall Study||37
8529104|NCT03945825|9561099|FG002|STARTED|Overall Study||40
8529105|NCT03945825|9561100|FG003|STARTED|Overall Study||41
8529106|NCT03945825|9561101|FG004|STARTED|Overall Study||39
8529107|NCT03945825|9561102|FG005|STARTED|Overall Study||43
8529108|NCT03945825|9561097|FG000|COMPLETED|Overall Study||39
8529109|NCT03945825|9561098|FG001|COMPLETED|Overall Study||32
8529110|NCT03945825|9561099|FG002|COMPLETED|Overall Study||39
8529111|NCT03945825|9561100|FG003|COMPLETED|Overall Study||39
8529112|NCT03945825|9561101|FG004|COMPLETED|Overall Study||36
8529113|NCT03945825|9561102|FG005|COMPLETED|Overall Study||40
8529114|NCT03945825|9561097|FG000|NOT COMPLETED|Overall Study||2
8529115|NCT03945825|9561098|FG001|NOT COMPLETED|Overall Study||5
8529116|NCT03945825|9561099|FG002|NOT COMPLETED|Overall Study||1
8529117|NCT03945825|9561100|FG003|NOT COMPLETED|Overall Study||2
8529118|NCT03945825|9561101|FG004|NOT COMPLETED|Overall Study||3
8529119|NCT03945825|9561102|FG005|NOT COMPLETED|Overall Study||3
8529120|NCT03937141|9561125|FG000|STARTED|Overall Study||16
8529121|NCT03937141|9561125|FG000|COMPLETED|Overall Study||16
8529122|NCT03937141|9561125|FG000|NOT COMPLETED|Overall Study||0
8529123|NCT03678402|9561129|FG000|STARTED|Overall Study||521
8529124|NCT03678402|9561129|FG000|COMPLETED|Overall Study||521
8529125|NCT03678402|9561129|FG000|NOT COMPLETED|Overall Study||0
8529126|NCT03641937|9561133|FG000|STARTED|Overall Study||10
8529127|NCT03641937|9561133|FG000|COMPLETED|Overall Study||10
8529128|NCT03641937|9561133|FG000|NOT COMPLETED|Overall Study||0
8529129|NCT03572244|9561139|FG000|STARTED|Overall Study||6
8529130|NCT03572244|9561140|FG001|STARTED|Overall Study||6
8529131|NCT03572244|9561139|FG000|COMPLETED|Overall Study||6
8529132|NCT03572244|9561140|FG001|COMPLETED|Overall Study||6
8529133|NCT03572244|9561139|FG000|NOT COMPLETED|Overall Study||0
8529134|NCT03572244|9561140|FG001|NOT COMPLETED|Overall Study||0
8529135|NCT03562767|9561149|FG000|STARTED|Overall Study||10
8529136|NCT03562767|9561150|FG001|STARTED|Overall Study||10
8529137|NCT03562767|9561151|FG002|STARTED|Overall Study||0
8529138|NCT03562767|9561149|FG000|COMPLETED|Overall Study||7
8529139|NCT03562767|9561150|FG001|COMPLETED|Overall Study||7
8529140|NCT03562767|9561151|FG002|COMPLETED|Overall Study||0
8529141|NCT03562767|9561149|FG000|NOT COMPLETED|Overall Study||3
8529142|NCT03562767|9561150|FG001|NOT COMPLETED|Overall Study||3
8529143|NCT03562767|9561151|FG002|NOT COMPLETED|Overall Study||0
8529144|NCT03559699|9561163|FG000|STARTED|Overall Study||27
8529145|NCT03559699|9561163|FG000|COMPLETED|Overall Study||20
8529146|NCT03559699|9561163|FG000|NOT COMPLETED|Overall Study||7
8529147|NCT03333057|9561170|FG000|STARTED|Overall Study||111
8529148|NCT03333057|9561171|FG001|STARTED|Overall Study||114
8529149|NCT03333057|9561172|FG002|STARTED|Overall Study||111
8529150|NCT03333057|9561170|FG000|COMPLETED|Overall Study||105
8529151|NCT03333057|9561171|FG001|COMPLETED|Overall Study||110
8529152|NCT03333057|9561172|FG002|COMPLETED|Overall Study||108
8529153|NCT03333057|9561170|FG000|NOT COMPLETED|Overall Study||6
8529154|NCT03333057|9561171|FG001|NOT COMPLETED|Overall Study||4
8529155|NCT03333057|9561172|FG002|NOT COMPLETED|Overall Study||3
8529156|NCT03305016|9561180|FG000|STARTED|Overall Study||146
8529157|NCT03305016|9561180|FG000|COMPLETED|Overall Study||144
8529158|NCT03305016|9561180|FG000|NOT COMPLETED|Overall Study||2
8529159|NCT03300336|9561186|FG000|STARTED|Overall Study||7267
8529160|NCT03300336|9561187|FG001|STARTED|Overall Study||6859
8529161|NCT03300336|9561186|FG000|COMPLETED|Overall Study||7267
8529162|NCT03300336|9561187|FG001|COMPLETED|Overall Study||6859
8529163|NCT03300336|9561186|FG000|NOT COMPLETED|Overall Study||0
8529164|NCT03300336|9561187|FG001|NOT COMPLETED|Overall Study||0
8529165|NCT03291067|9561197|FG000|STARTED|Overall Study||94
8529166|NCT03291067|9561198|FG001|STARTED|Overall Study||92
8529167|NCT03291067|9561199|FG002|STARTED|Overall Study||94
8529168|NCT03291067|9561200|FG003|STARTED|Overall Study||94
8529169|NCT03291067|9561197|FG000|Treated|Overall Study||95
8529170|NCT03291067|9561198|FG001|Treated|Overall Study||90
8529171|NCT03291067|9561199|FG002|Treated|Overall Study||93
8529172|NCT03291067|9561200|FG003|Treated|Overall Study||90
8529173|NCT03291067|9561197|FG000|COMPLETED|Overall Study||84
8529174|NCT03291067|9561198|FG001|COMPLETED|Overall Study||78
8529175|NCT03291067|9561199|FG002|COMPLETED|Overall Study||61
8529176|NCT03291067|9561200|FG003|COMPLETED|Overall Study||77
8529177|NCT03291067|9561197|FG000|NOT COMPLETED|Overall Study||10
8529178|NCT03291067|9561198|FG001|NOT COMPLETED|Overall Study||14
8529179|NCT03291067|9561199|FG002|NOT COMPLETED|Overall Study||33
8529180|NCT03291067|9561200|FG003|NOT COMPLETED|Overall Study||17
8529181|NCT03271047|9561214|FG000|STARTED|Phase 1b: Dose Finding Period||10
8529182|NCT03271047|9561215|FG001|STARTED|Phase 1b: Dose Finding Period||11
8529183|NCT03271047|9561216|FG002|STARTED|Phase 1b: Dose Finding Period||0
8529184|NCT03271047|9561217|FG003|STARTED|Phase 1b: Dose Finding Period||0
8529185|NCT03271047|9561214|FG000|COMPLETED|Phase 1b: Dose Finding Period||0
8529186|NCT03271047|9561215|FG001|COMPLETED|Phase 1b: Dose Finding Period||0
8529187|NCT03271047|9561216|FG002|COMPLETED|Phase 1b: Dose Finding Period||0
8529188|NCT03271047|9561217|FG003|COMPLETED|Phase 1b: Dose Finding Period||0
8529189|NCT03271047|9561214|FG000|NOT COMPLETED|Phase 1b: Dose Finding Period||10
8529190|NCT03271047|9561215|FG001|NOT COMPLETED|Phase 1b: Dose Finding Period||11
8529191|NCT03271047|9561216|FG002|NOT COMPLETED|Phase 1b: Dose Finding Period||0
8529192|NCT03271047|9561217|FG003|NOT COMPLETED|Phase 1b: Dose Finding Period||0
8529193|NCT03271047|9561214|FG000|STARTED|Randomized Phase 2 Period||0
8529194|NCT03271047|9561215|FG001|STARTED|Randomized Phase 2 Period||0
8529195|NCT03271047|9561216|FG002|STARTED|Randomized Phase 2 Period|Participants randomized to Phase 2 of the study.|27
8529196|NCT03271047|9561217|FG003|STARTED|Randomized Phase 2 Period|Participants randomized to Phase 2 of the study.|27
8529197|NCT03271047|9561214|FG000|COMPLETED|Randomized Phase 2 Period||0
8529198|NCT03271047|9561215|FG001|COMPLETED|Randomized Phase 2 Period||0
8529199|NCT03271047|9561216|FG002|COMPLETED|Randomized Phase 2 Period||0
8529200|NCT03271047|9561217|FG003|COMPLETED|Randomized Phase 2 Period||0
8529201|NCT03271047|9561214|FG000|NOT COMPLETED|Randomized Phase 2 Period||0
8529202|NCT03271047|9561215|FG001|NOT COMPLETED|Randomized Phase 2 Period||0
8529203|NCT03271047|9561216|FG002|NOT COMPLETED|Randomized Phase 2 Period||27
8529204|NCT03271047|9561217|FG003|NOT COMPLETED|Randomized Phase 2 Period||27
8529205|NCT03257436|9561229|FG000|STARTED|Overall Study||584
8529206|NCT03257436|9561229|FG000|COMPLETED|Overall Study||489
8529207|NCT03257436|9561229|FG000|NOT COMPLETED|Overall Study||95
8563545|NCT00048035|9595603|FG006|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|14
8563546|NCT00048035|9595604|FG007|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|13
8563547|NCT00048035|9595597|FG000|COMPLETED|Extension Year 2||0
8563548|NCT00048035|9595598|FG001|COMPLETED|Extension Year 2||0
8563549|NCT00048035|9595599|FG002|COMPLETED|Extension Year 2||0
8563550|NCT00048035|9595600|FG003|COMPLETED|Extension Year 2||0
8563551|NCT00048035|9595601|FG004|COMPLETED|Extension Year 2||0
8563552|NCT00048035|9595602|FG005|COMPLETED|Extension Year 2||0
8563553|NCT00048035|9595603|FG006|COMPLETED|Extension Year 2||11
8563554|NCT00048035|9595604|FG007|COMPLETED|Extension Year 2||10
8563555|NCT00048035|9595597|FG000|NOT COMPLETED|Extension Year 2||0
8563556|NCT00048035|9595598|FG001|NOT COMPLETED|Extension Year 2||0
8563557|NCT00048035|9595599|FG002|NOT COMPLETED|Extension Year 2||0
8563558|NCT00048035|9595600|FG003|NOT COMPLETED|Extension Year 2||0
8563559|NCT00048035|9595601|FG004|NOT COMPLETED|Extension Year 2||0
8563560|NCT00048035|9595602|FG005|NOT COMPLETED|Extension Year 2||0
8563561|NCT00048035|9595603|FG006|NOT COMPLETED|Extension Year 2||3
8563562|NCT00048035|9595604|FG007|NOT COMPLETED|Extension Year 2||3
8563563|NCT00048048|9595628|FG000|STARTED|Core Treatment||6
8563564|NCT00048048|9595629|FG001|STARTED|Core Treatment||6
8563565|NCT00048048|9595630|FG002|STARTED|Core Treatment||10
8563566|NCT00048048|9595631|FG003|STARTED|Core Treatment||6
8563567|NCT00048048|9595632|FG004|STARTED|Core Treatment||6
8563568|NCT00048048|9595633|FG005|STARTED|Core Treatment||9
8563569|NCT00048048|9595634|FG006|STARTED|Core Treatment||6
8563570|NCT00048048|9595635|FG007|STARTED|Core Treatment||6
8563571|NCT00048048|9595636|FG008|STARTED|Core Treatment||10
8563572|NCT00048048|9595637|FG009|STARTED|Core Treatment||0
8563573|NCT00048048|9595638|FG010|STARTED|Core Treatment||0
8563574|NCT00048048|9595639|FG011|STARTED|Core Treatment||0
8563575|NCT00048048|9595628|FG000|COMPLETED|Core Treatment||6
8563576|NCT00048048|9595629|FG001|COMPLETED|Core Treatment||6
8563577|NCT00048048|9595630|FG002|COMPLETED|Core Treatment||9
8563578|NCT00048048|9595631|FG003|COMPLETED|Core Treatment||6
8563579|NCT00048048|9595632|FG004|COMPLETED|Core Treatment||6
8563580|NCT00048048|9595633|FG005|COMPLETED|Core Treatment||9
8563581|NCT00048048|9595634|FG006|COMPLETED|Core Treatment||6
8563582|NCT00048048|9595635|FG007|COMPLETED|Core Treatment||5
8563583|NCT00048048|9595636|FG008|COMPLETED|Core Treatment||10
8563584|NCT00048048|9595637|FG009|COMPLETED|Core Treatment||0
8563585|NCT00048048|9595638|FG010|COMPLETED|Core Treatment||0
8563586|NCT00048048|9595639|FG011|COMPLETED|Core Treatment||0
8563587|NCT00048048|9595628|FG000|NOT COMPLETED|Core Treatment||0
8563588|NCT00048048|9595629|FG001|NOT COMPLETED|Core Treatment||0
8563589|NCT00048048|9595630|FG002|NOT COMPLETED|Core Treatment||1
8563590|NCT00048048|9595631|FG003|NOT COMPLETED|Core Treatment||0
8563591|NCT00048048|9595632|FG004|NOT COMPLETED|Core Treatment||0
8563592|NCT00048048|9595633|FG005|NOT COMPLETED|Core Treatment||0
8563593|NCT00048048|9595634|FG006|NOT COMPLETED|Core Treatment||0
8563594|NCT00048048|9595635|FG007|NOT COMPLETED|Core Treatment||1
8563595|NCT00048048|9595636|FG008|NOT COMPLETED|Core Treatment||0
8563596|NCT00048048|9595637|FG009|NOT COMPLETED|Core Treatment||0
8563597|NCT00048048|9595638|FG010|NOT COMPLETED|Core Treatment||0
8563598|NCT00048048|9595639|FG011|NOT COMPLETED|Core Treatment||0
8563599|NCT00048048|9595628|FG000|STARTED|Extension Year 1||0
8563600|NCT00048048|9595629|FG001|STARTED|Extension Year 1||0
8563601|NCT00048048|9595630|FG002|STARTED|Extension Year 1||0
8563602|NCT00048048|9595631|FG003|STARTED|Extension Year 1||0
8563603|NCT00048048|9595632|FG004|STARTED|Extension Year 1||0
8563604|NCT00048048|9595633|FG005|STARTED|Extension Year 1||0
8563605|NCT00048048|9595634|FG006|STARTED|Extension Year 1||0
8563606|NCT00048048|9595635|FG007|STARTED|Extension Year 1||0
8563607|NCT00048048|9595636|FG008|STARTED|Extension Year 1||0
8563608|NCT00048048|9595637|FG009|STARTED|Extension Year 1|Participants (Cohorts 1, 2, and 3) who completed core, entered extension period (entry optional).|16
8563609|NCT00048048|9595638|FG010|STARTED|Extension Year 1|Participants (Cohorts 4, 5, and 6) who completed core, entered extension period (entry optional).|16
8563610|NCT00048048|9595639|FG011|STARTED|Extension Year 1|Participants (Cohorts 7, 8, and 9) who completed core, entered extension period (entry optional).|19
8563611|NCT00048048|9595628|FG000|COMPLETED|Extension Year 1||0
8563612|NCT00048048|9595629|FG001|COMPLETED|Extension Year 1||0
8563613|NCT00048048|9595630|FG002|COMPLETED|Extension Year 1||0
8563614|NCT00048048|9595631|FG003|COMPLETED|Extension Year 1||0
8529208|NCT03171480|9561235|FG000|STARTED|Overall Study||89
8529209|NCT03171480|9561236|FG001|STARTED|Overall Study||87
8529210|NCT03171480|9561235|FG000|COMPLETED|Overall Study||89
8529211|NCT03171480|9561236|FG001|COMPLETED|Overall Study||87
8529212|NCT03171480|9561235|FG000|NOT COMPLETED|Overall Study||0
8529213|NCT03171480|9561236|FG001|NOT COMPLETED|Overall Study||0
8529214|NCT03158285|9561246|FG000|STARTED|Placebo-controlled Period: Week 0 - 24||246
8529215|NCT03158285|9561247|FG001|STARTED|Placebo-controlled Period: Week 0 - 24||248
8529216|NCT03158285|9561248|FG002|STARTED|Placebo-controlled Period: Week 0 - 24||245
8529217|NCT03158285|9561246|FG000|Pooled Population: Enthesitis Assessment|Placebo-controlled Period: Week 0 - 24|Pooled population (255) = 77 (CNTO1959PSA3001[NCT03162796]) + 178 (CNTO1959PSA3002)|255
8529218|NCT03158285|9561247|FG001|Pooled Population: Enthesitis Assessment|Placebo-controlled Period: Week 0 - 24|Pooled population (230)= 72 (CNTO1959PSA3001) + 158 (CNTO1959PSA3002)|230
8529219|NCT03158285|9561248|FG002|Pooled Population: Enthesitis Assessment|Placebo-controlled Period: Week 0 - 24|Pooled population (243)= 73 (CNTO1959PSA3001) + 170 (CNTO1959PSA3002)|243
8529220|NCT03158285|9561246|FG000|Pooled Population: Dactylitis Assessment|Placebo-controlled Period: Week 0 - 24|Pooled population (154) = 55 (CNTO1959PSA3001) + 99 (CNTO1959PSA3002)|154
8529221|NCT03158285|9561247|FG001|Pooled Population: Dactylitis Assessment|Placebo-controlled Period: Week 0 - 24|Pooled population (160) = 49 (CNTO1959PSA3001) + 111 (CNTO1959PSA3002)|160
8529222|NCT03158285|9561248|FG002|Pooled Population: Dactylitis Assessment|Placebo-controlled Period: Week 0 - 24|Pooled population (159) = 38 (CNTO1959PSA3001) + 121 (CNTO1959PSA3002)|159
8529223|NCT03158285|9561246|FG000|COMPLETED|Placebo-controlled Period: Week 0 - 24||240
8529224|NCT03158285|9561247|FG001|COMPLETED|Placebo-controlled Period: Week 0 - 24||240
8529225|NCT03158285|9561248|FG002|COMPLETED|Placebo-controlled Period: Week 0 - 24||236
8529226|NCT03158285|9561246|FG000|NOT COMPLETED|Placebo-controlled Period: Week 0 - 24||6
8620582|NCT00474786|9659357|FG001|STARTED|Overall Study||253
8620583|NCT00474786|9659356|FG000|COMPLETED|Overall Study||0
8620584|NCT00474786|9659357|FG001|COMPLETED|Overall Study||0
8529227|NCT03158285|9561247|FG001|NOT COMPLETED|Placebo-controlled Period: Week 0 - 24||8
8529228|NCT03158285|9561248|FG002|NOT COMPLETED|Placebo-controlled Period: Week 0 - 24||9
8529229|NCT03158285|9561246|FG000|STARTED|Active Treatment Period: Week 24 - 52|2 participants did not enter the active treatment.|238
8529230|NCT03158285|9561247|FG001|STARTED|Active Treatment Period: Week 24 - 52||240
8529231|NCT03158285|9561248|FG002|STARTED|Active Treatment Period: Week 24 - 52|2 participants did not enter the active treatment.|234
8529232|NCT03158285|9561246|FG000|COMPLETED|Active Treatment Period: Week 24 - 52||228
8529233|NCT03158285|9561247|FG001|COMPLETED|Active Treatment Period: Week 24 - 52||234
8529234|NCT03158285|9561248|FG002|COMPLETED|Active Treatment Period: Week 24 - 52||227
8529235|NCT03158285|9561246|FG000|NOT COMPLETED|Active Treatment Period: Week 24 - 52||10
8529236|NCT03158285|9561247|FG001|NOT COMPLETED|Active Treatment Period: Week 24 - 52||6
8529237|NCT03158285|9561248|FG002|NOT COMPLETED|Active Treatment Period: Week 24 - 52||7
8529238|NCT03158285|9561246|FG000|STARTED|Active Treatment Period: Week 52-100||228
8529239|NCT03158285|9561247|FG001|STARTED|Active Treatment Period: Week 52-100|2 participants did not enter the active treatment.|232
8529240|NCT03158285|9561248|FG002|STARTED|Active Treatment Period: Week 52-100||227
8529241|NCT03158285|9561246|FG000|COMPLETED|Active Treatment Period: Week 52-100||210
8529242|NCT03158285|9561247|FG001|COMPLETED|Active Treatment Period: Week 52-100||223
8529243|NCT03158285|9561248|FG002|COMPLETED|Active Treatment Period: Week 52-100||219
8529244|NCT03158285|9561246|FG000|NOT COMPLETED|Active Treatment Period: Week 52-100||18
8722763|NCT01020877|9770251|FG000|COMPLETED|First Intervention||19
8722764|NCT01020877|9770252|FG001|COMPLETED|First Intervention||19
8529245|NCT03158285|9561247|FG001|NOT COMPLETED|Active Treatment Period: Week 52-100||9
8529246|NCT03158285|9561248|FG002|NOT COMPLETED|Active Treatment Period: Week 52-100||8
8563615|NCT00048048|9595632|FG004|COMPLETED|Extension Year 1||0
8563616|NCT00048048|9595633|FG005|COMPLETED|Extension Year 1||0
8563617|NCT00048048|9595634|FG006|COMPLETED|Extension Year 1||0
8563618|NCT00048048|9595635|FG007|COMPLETED|Extension Year 1||0
8563619|NCT00048048|9595636|FG008|COMPLETED|Extension Year 1||0
8563620|NCT00048048|9595637|FG009|COMPLETED|Extension Year 1||14
8563621|NCT00048048|9595638|FG010|COMPLETED|Extension Year 1||14
8563622|NCT00048048|9595639|FG011|COMPLETED|Extension Year 1||15
8563623|NCT00048048|9595628|FG000|NOT COMPLETED|Extension Year 1||0
8563624|NCT00048048|9595629|FG001|NOT COMPLETED|Extension Year 1||0
8563625|NCT00048048|9595630|FG002|NOT COMPLETED|Extension Year 1||0
8563626|NCT00048048|9595631|FG003|NOT COMPLETED|Extension Year 1||0
8563627|NCT00048048|9595632|FG004|NOT COMPLETED|Extension Year 1||0
8563628|NCT00048048|9595633|FG005|NOT COMPLETED|Extension Year 1||0
8563629|NCT00048048|9595634|FG006|NOT COMPLETED|Extension Year 1||0
8563630|NCT00048048|9595635|FG007|NOT COMPLETED|Extension Year 1||0
8563631|NCT00048048|9595636|FG008|NOT COMPLETED|Extension Year 1||0
8563632|NCT00048048|9595637|FG009|NOT COMPLETED|Extension Year 1||2
8563633|NCT00048048|9595638|FG010|NOT COMPLETED|Extension Year 1||2
8563634|NCT00048048|9595639|FG011|NOT COMPLETED|Extension Year 1||4
8563635|NCT00048048|9595628|FG000|STARTED|Extension Year 2||0
8563636|NCT00048048|9595629|FG001|STARTED|Extension Year 2||0
8563637|NCT00048048|9595630|FG002|STARTED|Extension Year 2||0
8620585|NCT00474786|9659356|FG000|NOT COMPLETED|Overall Study||259
8620586|NCT00474786|9659357|FG001|NOT COMPLETED|Overall Study||253
8620587|NCT00474812|9659363|FG000|STARTED|Overall Study||51
8620588|NCT00474812|9659363|FG000|COMPLETED|Overall Study||44
8620589|NCT00474812|9659363|FG000|NOT COMPLETED|Overall Study||7
8620590|NCT00474851|9659369|FG000|STARTED|Overall Study||26
8620591|NCT00474851|9659370|FG001|STARTED|Overall Study||27
8529247|NCT04723173|9561261|FG000|STARTED|Measure of Detection Threshold (in dB)||10
8529248|NCT04723173|9561261|FG000|Feature for Soft Sounds On|Measure of Detection Threshold (in dB)||10
8529249|NCT04723173|9561261|FG000|Feature for Soft Sounds Off|Measure of Detection Threshold (in dB)||10
8529250|NCT04723173|9561261|FG000|COMPLETED|Measure of Detection Threshold (in dB)||10
8529251|NCT04723173|9561261|FG000|NOT COMPLETED|Measure of Detection Threshold (in dB)||0
8529252|NCT04723173|9561261|FG000|STARTED|Subjective Listening Effort Scaling|The test in this test period is independent (also temporally) from the previous test period. That is the reason, why the number of participants, who started this test period is lesser than the number of participants, who completed the previous period.|9
8529253|NCT04723173|9561261|FG000|DNC on|Subjective Listening Effort Scaling||9
8529254|NCT04723173|9561261|FG000|DNC Off|Subjective Listening Effort Scaling||9
8529255|NCT04723173|9561261|FG000|COMPLETED|Subjective Listening Effort Scaling||8
8529256|NCT04723173|9561261|FG000|NOT COMPLETED|Subjective Listening Effort Scaling||1
8529257|NCT04723173|9561261|FG000|STARTED|Subjective Ratings of Sound Samples|The test in this test period is independent (also temporal) from the previous test period. That is the reason, why the number of participants, who started this test period is greater than the number of participants, who completed the previous period.|9
8529258|NCT04723173|9561261|FG000|DNC on|Subjective Ratings of Sound Samples||9
8529259|NCT04723173|9561261|FG000|DNC Off|Subjective Ratings of Sound Samples||9
8529260|NCT04723173|9561261|FG000|COMPLETED|Subjective Ratings of Sound Samples|"All participants completed this study period, but just the results of 8 participants could be used.~This was because technical issues limited the reliability of the measures made for one participant.~N.B. this test was independent from the other tests in the study. Therefore the results are not influenced by other test periods. The number of people included in the analysis described here relates only to this test."|9
8529261|NCT04723173|9561261|FG000|NOT COMPLETED|Subjective Ratings of Sound Samples||0
8529262|NCT04552470|9561277|FG000|STARTED|Overall Study||9
8529263|NCT04552470|9561278|FG001|STARTED|Overall Study||10
8529264|NCT04552470|9561279|FG002|STARTED|Overall Study||9
8529265|NCT04552470|9561280|FG003|STARTED|Overall Study||9
8529266|NCT04552470|9561277|FG000|COMPLETED|Overall Study||9
8620592|NCT00474851|9659369|FG000|Completed Baseline|Overall Study||25
8620593|NCT00474851|9659370|FG001|Completed Baseline|Overall Study||26
8620594|NCT00474851|9659369|FG000|COMPLETED|Overall Study||18
8816336|NCT01543503|9869821|FG001|COMPLETED|Overall Study||711
8816337|NCT01543503|9869820|FG000|NOT COMPLETED|Overall Study||76
8816338|NCT01543503|9869821|FG001|NOT COMPLETED|Overall Study||87
8529267|NCT04552470|9561278|FG001|COMPLETED|Overall Study||10
8529268|NCT04552470|9561279|FG002|COMPLETED|Overall Study||9
8529269|NCT04552470|9561280|FG003|COMPLETED|Overall Study||9
8529270|NCT04552470|9561277|FG000|NOT COMPLETED|Overall Study||0
8529271|NCT04552470|9561278|FG001|NOT COMPLETED|Overall Study||0
8529272|NCT04552470|9561279|FG002|NOT COMPLETED|Overall Study||0
8816339|NCT01543568|9869827|FG000|STARTED|Overall Study||46
8816340|NCT01543568|9869827|FG000|COMPLETED|Overall Study||45
8816341|NCT01543568|9869827|FG000|NOT COMPLETED|Overall Study||1
8816342|NCT01543581|9869831|FG000|STARTED|Overall Study||1
8816343|NCT01543581|9869832|FG001|STARTED|Overall Study||0
8816344|NCT01543581|9869831|FG000|COMPLETED|Overall Study||1
8816345|NCT01543581|9869832|FG001|COMPLETED|Overall Study||0
8529273|NCT04552470|9561280|FG003|NOT COMPLETED|Overall Study||0
8529362|NCT02987543|9561421|FG000|COMPLETED|Overall Study||0
8529363|NCT02987543|9561422|FG001|COMPLETED|Overall Study||0
8529364|NCT02987543|9561423|FG002|COMPLETED|Overall Study||0
8529365|NCT02987543|9561424|FG003|COMPLETED|Overall Study||0
8529366|NCT02987543|9561421|FG000|NOT COMPLETED|Overall Study||162
8529367|NCT02987543|9561422|FG001|NOT COMPLETED|Overall Study||83
8529368|NCT02987543|9561423|FG002|NOT COMPLETED|Overall Study||94
8529369|NCT02987543|9561424|FG003|NOT COMPLETED|Overall Study||48
8563638|NCT00048048|9595631|FG003|STARTED|Extension Year 2||0
8563639|NCT00048048|9595632|FG004|STARTED|Extension Year 2||0
8563640|NCT00048048|9595633|FG005|STARTED|Extension Year 2||0
8563641|NCT00048048|9595634|FG006|STARTED|Extension Year 2||0
8563642|NCT00048048|9595635|FG007|STARTED|Extension Year 2||0
8563643|NCT00048048|9595636|FG008|STARTED|Extension Year 2||0
8563644|NCT00048048|9595637|FG009|STARTED|Extension Year 2|Twelve participants who completed Extension Year 1 were switched to RO0503821 (1x/2Week).|2
8563645|NCT00048048|9595638|FG010|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1 + 12 participants from RO0503821 (1X/Week).|23
8563646|NCT00048048|9595639|FG011|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|15
8563647|NCT00048048|9595628|FG000|COMPLETED|Extension Year 2||0
8563648|NCT00048048|9595629|FG001|COMPLETED|Extension Year 2||0
8563649|NCT00048048|9595630|FG002|COMPLETED|Extension Year 2||0
8563650|NCT00048048|9595631|FG003|COMPLETED|Extension Year 2||0
8563651|NCT00048048|9595632|FG004|COMPLETED|Extension Year 2||0
8563652|NCT00048048|9595633|FG005|COMPLETED|Extension Year 2||0
8563653|NCT00048048|9595634|FG006|COMPLETED|Extension Year 2||0
8563654|NCT00048048|9595635|FG007|COMPLETED|Extension Year 2||0
8563655|NCT00048048|9595636|FG008|COMPLETED|Extension Year 2||0
8563656|NCT00048048|9595637|FG009|COMPLETED|Extension Year 2||2
8563657|NCT00048048|9595638|FG010|COMPLETED|Extension Year 2||19
8620595|NCT00474851|9659370|FG001|COMPLETED|Overall Study||16
8816346|NCT01543581|9869831|FG000|NOT COMPLETED|Overall Study||0
8816347|NCT01543581|9869832|FG001|NOT COMPLETED|Overall Study||0
8816348|NCT01543607|9869838|FG000|STARTED|Overall Study||1
8816349|NCT01543607|9869838|FG000|COMPLETED|Overall Study||1
8529274|NCT04251884|9561295|FG000|STARTED|Overall Study||23
8529275|NCT04251884|9561296|FG001|STARTED|Overall Study||26
8529276|NCT04251884|9561295|FG000|COMPLETED|Overall Study||23
8529277|NCT04251884|9561296|FG001|COMPLETED|Overall Study||26
8529278|NCT04251884|9561295|FG000|NOT COMPLETED|Overall Study||0
8529279|NCT04251884|9561296|FG001|NOT COMPLETED|Overall Study||0
8529280|NCT03683823|9561305|FG000|STARTED|Post-treatment Assessment||11
8529281|NCT03683823|9561306|FG001|STARTED|Post-treatment Assessment||10
8529282|NCT03683823|9561305|FG000|COMPLETED|Post-treatment Assessment||10
8529283|NCT03683823|9561306|FG001|COMPLETED|Post-treatment Assessment||8
8529284|NCT03683823|9561305|FG000|NOT COMPLETED|Post-treatment Assessment||1
8529285|NCT03683823|9561306|FG001|NOT COMPLETED|Post-treatment Assessment||2
8529286|NCT03683823|9561305|FG000|STARTED|1-week Follow-up||10
8529287|NCT03683823|9561306|FG001|STARTED|1-week Follow-up||8
8529288|NCT03683823|9561305|FG000|COMPLETED|1-week Follow-up||9
8529289|NCT03683823|9561306|FG001|COMPLETED|1-week Follow-up||7
8529290|NCT03683823|9561305|FG000|NOT COMPLETED|1-week Follow-up||1
8529291|NCT03683823|9561306|FG001|NOT COMPLETED|1-week Follow-up||1
8529292|NCT03546439|9561315|FG000|STARTED|Overall Study||203
8529293|NCT03546439|9561316|FG001|STARTED|Overall Study||156
8529294|NCT03546439|9561317|FG002|STARTED|Overall Study||75
8529295|NCT03546439|9561315|FG000|COMPLETED|Overall Study||203
8529296|NCT03546439|9561316|FG001|COMPLETED|Overall Study||156
8529297|NCT03546439|9561317|FG002|COMPLETED|Overall Study||75
8529298|NCT03546439|9561315|FG000|NOT COMPLETED|Overall Study||0
8529299|NCT03546439|9561316|FG001|NOT COMPLETED|Overall Study||0
8529300|NCT03546439|9561317|FG002|NOT COMPLETED|Overall Study||0
8529301|NCT03515551|9561332|FG000|STARTED|Overall Study||4
8529302|NCT03515551|9561333|FG001|STARTED|Overall Study||3
8529303|NCT03515551|9561334|FG002|STARTED|Overall Study||5
8529304|NCT03515551|9561335|FG003|STARTED|Overall Study||3
8529305|NCT03515551|9561336|FG004|STARTED|Overall Study|1 participant from the 10 mcg cohort was sequentially enrolled in the 30-100 mcg cohort and is counted as starting in both columns; reason for study discontinuation recorded as part of 30-100 mcg cohort.|5
8529306|NCT03515551|9561337|FG005|STARTED|Overall Study||4
8529307|NCT03515551|9561338|FG006|STARTED|Overall Study||5
8529308|NCT03515551|9561332|FG000|COMPLETED|Overall Study||0
8529309|NCT03515551|9561333|FG001|COMPLETED|Overall Study||0
8529310|NCT03515551|9561334|FG002|COMPLETED|Overall Study||0
8529311|NCT03515551|9561335|FG003|COMPLETED|Overall Study||0
8529312|NCT03515551|9561336|FG004|COMPLETED|Overall Study||0
8529313|NCT03515551|9561337|FG005|COMPLETED|Overall Study||0
8529314|NCT03515551|9561338|FG006|COMPLETED|Overall Study||0
8529315|NCT03515551|9561332|FG000|NOT COMPLETED|Overall Study||4
8529316|NCT03515551|9561333|FG001|NOT COMPLETED|Overall Study||3
8529317|NCT03515551|9561334|FG002|NOT COMPLETED|Overall Study||5
8529318|NCT03515551|9561335|FG003|NOT COMPLETED|Overall Study||3
8529319|NCT03515551|9561336|FG004|NOT COMPLETED|Overall Study||5
8529320|NCT03515551|9561337|FG005|NOT COMPLETED|Overall Study||4
8529321|NCT03515551|9561338|FG006|NOT COMPLETED|Overall Study||5
8529322|NCT03385265|9561363|FG000|STARTED|Overall Study||20
8529323|NCT03385265|9561364|FG001|STARTED|Overall Study||11
8529324|NCT03385265|9561365|FG002|STARTED|Overall Study||20
8529325|NCT03385265|9561366|FG003|STARTED|Overall Study||11
8529326|NCT03385265|9561363|FG000|COMPLETED|Overall Study|this is Time 3 or 33 weeks post-baseline|15
8529327|NCT03385265|9561364|FG001|COMPLETED|Overall Study|this is Time 3 or 33 weeks post-baseline|9
8529328|NCT03385265|9561365|FG002|COMPLETED|Overall Study|this is Time 3 or 33 weeks post-baseline|15
8529329|NCT03385265|9561366|FG003|COMPLETED|Overall Study|this is Time 3 or 33 weeks post-baseline|9
8529330|NCT03385265|9561363|FG000|NOT COMPLETED|Overall Study||5
8529331|NCT03385265|9561364|FG001|NOT COMPLETED|Overall Study||2
8529332|NCT03385265|9561365|FG002|NOT COMPLETED|Overall Study||5
8529333|NCT03385265|9561366|FG003|NOT COMPLETED|Overall Study||2
8529334|NCT03316807|9561380|FG000|STARTED|Overall Study||91
8529335|NCT03316807|9561381|FG001|STARTED|Overall Study||91
8529336|NCT03316807|9561380|FG000|COMPLETED|Overall Study||60
8529337|NCT03316807|9561381|FG001|COMPLETED|Overall Study||65
8529338|NCT03316807|9561380|FG000|NOT COMPLETED|Overall Study||31
8529339|NCT03316807|9561381|FG001|NOT COMPLETED|Overall Study||26
8529340|NCT03138538|9561393|FG000|STARTED|Overall Study||3
8529341|NCT03138538|9561394|FG001|STARTED|Overall Study||3
8529342|NCT03138538|9561395|FG002|STARTED|Overall Study||3
8529343|NCT03138538|9561396|FG003|STARTED|Overall Study||8
8529344|NCT03138538|9561397|FG004|STARTED|Overall Study||7
8529345|NCT03138538|9561398|FG005|STARTED|Overall Study||3
8529346|NCT03138538|9561393|FG000|COMPLETED|Overall Study||3
8529347|NCT03138538|9561394|FG001|COMPLETED|Overall Study||3
8529348|NCT03138538|9561395|FG002|COMPLETED|Overall Study||3
8529349|NCT03138538|9561396|FG003|COMPLETED|Overall Study||8
8529350|NCT03138538|9561397|FG004|COMPLETED|Overall Study||7
8529351|NCT03138538|9561398|FG005|COMPLETED|Overall Study||3
8529352|NCT03138538|9561393|FG000|NOT COMPLETED|Overall Study||0
8529353|NCT03138538|9561394|FG001|NOT COMPLETED|Overall Study||0
8529354|NCT03138538|9561395|FG002|NOT COMPLETED|Overall Study||0
8529355|NCT03138538|9561396|FG003|NOT COMPLETED|Overall Study||0
8529356|NCT03138538|9561397|FG004|NOT COMPLETED|Overall Study||0
8529357|NCT03138538|9561398|FG005|NOT COMPLETED|Overall Study||0
8529358|NCT02987543|9561421|FG000|STARTED|Overall Study||162
8529359|NCT02987543|9561422|FG001|STARTED|Overall Study||83
8529360|NCT02987543|9561423|FG002|STARTED|Overall Study||94
8529361|NCT02987543|9561424|FG003|STARTED|Overall Study||48
8529370|NCT02919306|9561432|FG000|STARTED|Overall Study||18
8529371|NCT02919306|9561433|FG001|STARTED|Overall Study||9
8529372|NCT02919306|9561432|FG000|COMPLETED|Overall Study||16
8529373|NCT02919306|9561433|FG001|COMPLETED|Overall Study||9
8529374|NCT02919306|9561432|FG000|NOT COMPLETED|Overall Study||2
8529375|NCT02919306|9561433|FG001|NOT COMPLETED|Overall Study||0
8529376|NCT02763189|9561441|FG000|STARTED|Overall Study||4
8529377|NCT02763189|9561442|FG001|STARTED|Overall Study||4
8529378|NCT02763189|9561441|FG000|COMPLETED|Overall Study||4
8529379|NCT02763189|9561442|FG001|COMPLETED|Overall Study||2
8529380|NCT02763189|9561441|FG000|NOT COMPLETED|Overall Study||0
8529381|NCT02763189|9561442|FG001|NOT COMPLETED|Overall Study||2
8529382|NCT02700945|9561450|FG000|STARTED|Overall Study||242
8529383|NCT02700945|9561451|FG001|STARTED|Overall Study||250
8529384|NCT02700945|9561450|FG000|COMPLETED|Overall Study||210
8529385|NCT02700945|9561451|FG001|COMPLETED|Overall Study||207
8529386|NCT02700945|9561450|FG000|NOT COMPLETED|Overall Study||32
8529387|NCT02700945|9561451|FG001|NOT COMPLETED|Overall Study||43
8529388|NCT02659514|9561459|FG000|STARTED|Overall Study||33
8529389|NCT02659514|9561460|FG001|STARTED|Overall Study||34
8529390|NCT02659514|9561459|FG000|Safety Population|Overall Study||33
8529391|NCT02659514|9561460|FG001|Safety Population|Overall Study||34
8529392|NCT02659514|9561459|FG000|Evaluable Population|Overall Study||30
8529393|NCT02659514|9561460|FG001|Evaluable Population|Overall Study||27
8529394|NCT02659514|9561459|FG000|COMPLETED|Overall Study||1
8529395|NCT02659514|9561460|FG001|COMPLETED|Overall Study||0
8529396|NCT02659514|9561459|FG000|NOT COMPLETED|Overall Study||32
8529397|NCT02659514|9561460|FG001|NOT COMPLETED|Overall Study||34
8529398|NCT02435173|9561469|FG000|STARTED|Overall Study||6
8529399|NCT02435173|9561470|FG001|STARTED|Overall Study||21
8529400|NCT02435173|9561471|FG002|STARTED|Overall Study||10
8529401|NCT02435173|9561469|FG000|Pharmacokinetics (PK) Analysis Set|Overall Study||6
8529402|NCT02435173|9561470|FG001|Pharmacokinetics (PK) Analysis Set|Overall Study||19
8529403|NCT02435173|9561471|FG002|Pharmacokinetics (PK) Analysis Set|Overall Study||0
8529404|NCT02435173|9561469|FG000|Pharmacodynamic (PD) Analysis Set|Overall Study||6
8529405|NCT02435173|9561470|FG001|Pharmacodynamic (PD) Analysis Set|Overall Study||19
8529406|NCT02435173|9561471|FG002|Pharmacodynamic (PD) Analysis Set|Overall Study||8
8529407|NCT02435173|9561469|FG000|COMPLETED|Overall Study||6
8529408|NCT02435173|9561470|FG001|COMPLETED|Overall Study||21
8529409|NCT02435173|9561471|FG002|COMPLETED|Overall Study||10
8529410|NCT02435173|9561469|FG000|NOT COMPLETED|Overall Study||0
8529411|NCT02435173|9561470|FG001|NOT COMPLETED|Overall Study||0
8529412|NCT02435173|9561471|FG002|NOT COMPLETED|Overall Study||0
8529413|NCT02390245|9561485|FG000|STARTED|Phase I. Telemedicine Screening||906
8529414|NCT02390245|9561486|FG001|STARTED|Phase I. Telemedicine Screening||0
8529415|NCT02390245|9561487|FG002|STARTED|Phase I. Telemedicine Screening||0
8529416|NCT02390245|9561485|FG000|COMPLETED|Phase I. Telemedicine Screening||906
8529417|NCT02390245|9561486|FG001|COMPLETED|Phase I. Telemedicine Screening||0
8529418|NCT02390245|9561487|FG002|COMPLETED|Phase I. Telemedicine Screening||0
8529419|NCT02390245|9561485|FG000|NOT COMPLETED|Phase I. Telemedicine Screening||0
8529420|NCT02390245|9561486|FG001|NOT COMPLETED|Phase I. Telemedicine Screening||0
8529421|NCT02390245|9561487|FG002|NOT COMPLETED|Phase I. Telemedicine Screening||0
8529422|NCT02390245|9561485|FG000|STARTED|Phase 2. Randomization Into 2 Groups|Remaining 355 participants from Phase I Telemedicine Screening had normal eye examinations requiring no further follow-up.|0
8529423|NCT02390245|9561486|FG001|STARTED|Phase 2. Randomization Into 2 Groups||275
8529424|NCT02390245|9561487|FG002|STARTED|Phase 2. Randomization Into 2 Groups||276
8529425|NCT02390245|9561485|FG000|COMPLETED|Phase 2. Randomization Into 2 Groups||0
8529426|NCT02390245|9561486|FG001|COMPLETED|Phase 2. Randomization Into 2 Groups||171
8529427|NCT02390245|9561487|FG002|COMPLETED|Phase 2. Randomization Into 2 Groups||171
8529428|NCT02390245|9561485|FG000|NOT COMPLETED|Phase 2. Randomization Into 2 Groups||0
8529429|NCT02390245|9561486|FG001|NOT COMPLETED|Phase 2. Randomization Into 2 Groups||104
8529430|NCT02390245|9561487|FG002|NOT COMPLETED|Phase 2. Randomization Into 2 Groups||105
8529431|NCT02390245|9561485|FG000|STARTED|Phase 3. Ophthalmic Follow-up Adherence||0
8529432|NCT02390245|9561486|FG001|STARTED|Phase 3. Ophthalmic Follow-up Adherence||171
8529433|NCT02390245|9561487|FG002|STARTED|Phase 3. Ophthalmic Follow-up Adherence||171
8529434|NCT02390245|9561485|FG000|COMPLETED|Phase 3. Ophthalmic Follow-up Adherence||0
8529435|NCT02390245|9561486|FG001|COMPLETED|Phase 3. Ophthalmic Follow-up Adherence||77
8529436|NCT02390245|9561487|FG002|COMPLETED|Phase 3. Ophthalmic Follow-up Adherence||66
8529437|NCT02390245|9561485|FG000|NOT COMPLETED|Phase 3. Ophthalmic Follow-up Adherence||0
8529438|NCT02390245|9561486|FG001|NOT COMPLETED|Phase 3. Ophthalmic Follow-up Adherence||94
8529439|NCT02390245|9561487|FG002|NOT COMPLETED|Phase 3. Ophthalmic Follow-up Adherence||105
8529440|NCT02254278|9561496|FG000|STARTED|Overall Study||158
8529441|NCT02254278|9561497|FG001|STARTED|Overall Study||150
8529442|NCT02254278|9561496|FG000|Eligible|Overall Study||157
8529443|NCT02254278|9561497|FG001|Eligible|Overall Study||149
8529444|NCT02254278|9561496|FG000|Started Study Treatment|Overall Study||152
8529445|NCT02254278|9561497|FG001|Started Study Treatment|Overall Study||147
8529446|NCT02254278|9561496|FG000|Negative Post-treatment PET|Overall Study||58
8529447|NCT02254278|9561497|FG001|Negative Post-treatment PET|Overall Study||57
8529448|NCT02254278|9561496|FG000|COMPLETED|Overall Study||157
8529449|NCT02254278|9561497|FG001|COMPLETED|Overall Study||149
8529450|NCT02254278|9561496|FG000|NOT COMPLETED|Overall Study||1
8529451|NCT02254278|9561497|FG001|NOT COMPLETED|Overall Study||1
8529452|NCT01850524|9561508|FG000|STARTED|Overall Study||354
8529453|NCT01850524|9561509|FG001|STARTED|Overall Study||351
8529454|NCT01850524|9561508|FG000|Intent-to-Treat (ITT) Population|Overall Study||354
8529455|NCT01850524|9561509|FG001|Intent-to-Treat (ITT) Population|Overall Study||351
8529456|NCT01850524|9561508|FG000|Safety Population|Overall Study|1 participant in this arm who withdrew from the study was not included in the safety population.|349
8529457|NCT01850524|9561509|FG001|Safety Population|Overall Study|Included 4 participants from placebo who received ixazomib; 1 participant who withdrew was excluded.|354
8529458|NCT01850524|9561508|FG000|Participants Completed Study Treatment Per Protocol|Overall Study||270
8529459|NCT01850524|9561509|FG001|Participants Completed Study Treatment Per Protocol|Overall Study||264
8529460|NCT01850524|9561508|FG000|Per Protocol (PP) Population|Overall Study||295
8529461|NCT01850524|9561509|FG001|Per Protocol (PP) Population|Overall Study||298
8529462|NCT01850524|9561508|FG000|Participants With Exposure of ≥ 19 Cycles|Overall Study||189
8529463|NCT01850524|9561509|FG001|Participants With Exposure of ≥ 19 Cycles|Overall Study||191
8529464|NCT01850524|9561508|FG000|COMPLETED|Overall Study||0
8529465|NCT01850524|9561509|FG001|COMPLETED|Overall Study||0
8529466|NCT01850524|9561508|FG000|NOT COMPLETED|Overall Study||354
8529467|NCT01850524|9561509|FG001|NOT COMPLETED|Overall Study||351
8529468|NCT01673867|9561519|FG000|STARTED|Randomization||292
8529469|NCT01673867|9561520|FG001|STARTED|Randomization||290
8529470|NCT01673867|9561519|FG000|COMPLETED|Randomization||287
8529471|NCT01673867|9561520|FG001|COMPLETED|Randomization||268
8529472|NCT01673867|9561519|FG000|NOT COMPLETED|Randomization||5
8529473|NCT01673867|9561520|FG001|NOT COMPLETED|Randomization||22
8529474|NCT01673867|9561519|FG000|STARTED|Treatment||287
8529475|NCT01673867|9561520|FG001|STARTED|Treatment||268
8529476|NCT01673867|9561519|FG000|COMPLETED|Treatment||43
8529477|NCT01673867|9561520|FG001|COMPLETED|Treatment||0
8529478|NCT01673867|9561519|FG000|NOT COMPLETED|Treatment||244
8529479|NCT01673867|9561520|FG001|NOT COMPLETED|Treatment||268
8529480|NCT01182727|9561526|FG000|STARTED|Overall Study||10
8529481|NCT01182727|9561526|FG000|COMPLETED|Overall Study||10
8529482|NCT01182727|9561526|FG000|NOT COMPLETED|Overall Study||0
8529483|NCT00335777|9561530|FG000|STARTED|Enrolled and Dispensed Study Medication|64 subjects enrolled. 35 treated 2 headaches, but 22/35 at appropriate times, as per protocol.|64
8529484|NCT00335777|9561530|FG000|COMPLETED|Enrolled and Dispensed Study Medication||35
8529485|NCT00335777|9561530|FG000|NOT COMPLETED|Enrolled and Dispensed Study Medication||29
8529486|NCT00335777|9561530|FG000|STARTED|Treated 2 Headaches Per Protocol||35
8529487|NCT00335777|9561530|FG000|COMPLETED|Treated 2 Headaches Per Protocol||22
8529488|NCT00335777|9561530|FG000|NOT COMPLETED|Treated 2 Headaches Per Protocol||13
8529489|NCT00159588|9561538|FG000|STARTED|5 Month Follow-up||19
8529490|NCT00159588|9561539|FG001|STARTED|5 Month Follow-up||22
8529491|NCT00159588|9561540|FG002|STARTED|5 Month Follow-up||20
8529492|NCT00159588|9561538|FG000|COMPLETED|5 Month Follow-up||17
8529493|NCT00159588|9561539|FG001|COMPLETED|5 Month Follow-up||18
8816350|NCT01543607|9869838|FG000|NOT COMPLETED|Overall Study||0
8816351|NCT01543685|9869847|FG000|STARTED|Overall Study||93
8529494|NCT00159588|9561540|FG002|COMPLETED|5 Month Follow-up||18
8529495|NCT00159588|9561538|FG000|NOT COMPLETED|5 Month Follow-up||2
8529496|NCT00159588|9561539|FG001|NOT COMPLETED|5 Month Follow-up||4
8529497|NCT00159588|9561540|FG002|NOT COMPLETED|5 Month Follow-up||2
8529498|NCT00159588|9561538|FG000|STARTED|1-year Follow-up for Group 1 and 2||17
8529499|NCT00159588|9561539|FG001|STARTED|1-year Follow-up for Group 1 and 2||18
8529500|NCT00159588|9561540|FG002|STARTED|1-year Follow-up for Group 1 and 2||18
8529501|NCT00159588|9561538|FG000|COMPLETED|1-year Follow-up for Group 1 and 2||16
8529502|NCT00159588|9561539|FG001|COMPLETED|1-year Follow-up for Group 1 and 2||14
8529503|NCT00159588|9561540|FG002|COMPLETED|1-year Follow-up for Group 1 and 2||18
8529504|NCT00159588|9561538|FG000|NOT COMPLETED|1-year Follow-up for Group 1 and 2||1
8529505|NCT00159588|9561539|FG001|NOT COMPLETED|1-year Follow-up for Group 1 and 2||4
8529506|NCT00159588|9561540|FG002|NOT COMPLETED|1-year Follow-up for Group 1 and 2||0
8529507|NCT03051217|9561554|FG000|STARTED|Initial Period (Week 0 to Week 16)||26
8529508|NCT03051217|9561555|FG001|STARTED|Initial Period (Week 0 to Week 16)||48
8529509|NCT03051217|9561556|FG002|STARTED|Initial Period (Week 0 to Week 16)||53
8529510|NCT03051217|9561557|FG003|STARTED|Initial Period (Week 0 to Week 16)||0
8529511|NCT03051217|9561558|FG004|STARTED|Initial Period (Week 0 to Week 16)||0
8529512|NCT03051217|9561559|FG005|STARTED|Initial Period (Week 0 to Week 16)||0
8529513|NCT03051217|9561560|FG006|STARTED|Initial Period (Week 0 to Week 16)||0
8529514|NCT03051217|9561554|FG000|COMPLETED|Initial Period (Week 0 to Week 16)||23
8529515|NCT03051217|9561555|FG001|COMPLETED|Initial Period (Week 0 to Week 16)||46
8529516|NCT03051217|9561556|FG002|COMPLETED|Initial Period (Week 0 to Week 16)||51
8529517|NCT03051217|9561557|FG003|COMPLETED|Initial Period (Week 0 to Week 16)||0
8529518|NCT03051217|9561558|FG004|COMPLETED|Initial Period (Week 0 to Week 16)||0
8529519|NCT03051217|9561559|FG005|COMPLETED|Initial Period (Week 0 to Week 16)||0
8529520|NCT03051217|9561560|FG006|COMPLETED|Initial Period (Week 0 to Week 16)||0
8529521|NCT03051217|9561554|FG000|NOT COMPLETED|Initial Period (Week 0 to Week 16)||3
8529522|NCT03051217|9561555|FG001|NOT COMPLETED|Initial Period (Week 0 to Week 16)||2
8529523|NCT03051217|9561556|FG002|NOT COMPLETED|Initial Period (Week 0 to Week 16)||2
8529524|NCT03051217|9561557|FG003|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8529525|NCT03051217|9561558|FG004|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8816352|NCT01543685|9869848|FG001|STARTED|Overall Study||91
8816353|NCT01543685|9869849|FG002|STARTED|Overall Study||91
8816354|NCT01543685|9869850|FG003|STARTED|Overall Study||93
8816355|NCT01543685|9869851|FG004|STARTED|Overall Study||94
8529526|NCT03051217|9561559|FG005|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8529527|NCT03051217|9561560|FG006|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8529528|NCT03051217|9561554|FG000|STARTED|Maintenance Period (Week 16 to Week 52)||0
8529529|NCT03051217|9561555|FG001|STARTED|Maintenance Period (Week 16 to Week 52)||0
8529530|NCT03051217|9561556|FG002|STARTED|Maintenance Period (Week 16 to Week 52)||0
8529531|NCT03051217|9561557|FG003|STARTED|Maintenance Period (Week 16 to Week 52)||23
8529532|NCT03051217|9561558|FG004|STARTED|Maintenance Period (Week 16 to Week 52)||51
8529533|NCT03051217|9561559|FG005|STARTED|Maintenance Period (Week 16 to Week 52)||26
8529534|NCT03051217|9561560|FG006|STARTED|Maintenance Period (Week 16 to Week 52)||20
8529535|NCT03051217|9561554|FG000|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||0
8529536|NCT03051217|9561555|FG001|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||0
8529537|NCT03051217|9561556|FG002|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||0
8529538|NCT03051217|9561557|FG003|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||21
8529539|NCT03051217|9561558|FG004|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||3
8529540|NCT03051217|9561559|FG005|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||7
8529541|NCT03051217|9561560|FG006|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||3
8529542|NCT03051217|9561554|FG000|COMPLETED|Maintenance Period (Week 16 to Week 52)||0
8529543|NCT03051217|9561555|FG001|COMPLETED|Maintenance Period (Week 16 to Week 52)||0
8529544|NCT03051217|9561556|FG002|COMPLETED|Maintenance Period (Week 16 to Week 52)||0
8529545|NCT03051217|9561557|FG003|COMPLETED|Maintenance Period (Week 16 to Week 52)||20
8529546|NCT03051217|9561558|FG004|COMPLETED|Maintenance Period (Week 16 to Week 52)||48
8529547|NCT03051217|9561559|FG005|COMPLETED|Maintenance Period (Week 16 to Week 52)||24
8529548|NCT03051217|9561560|FG006|COMPLETED|Maintenance Period (Week 16 to Week 52)||19
8529549|NCT03051217|9561554|FG000|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||0
8529550|NCT03051217|9561555|FG001|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||0
8529551|NCT03051217|9561556|FG002|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||0
8529552|NCT03051217|9561557|FG003|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||3
8529553|NCT03051217|9561558|FG004|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||3
8529554|NCT03051217|9561559|FG005|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||2
8529555|NCT03051217|9561560|FG006|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||1
8529556|NCT03025542|9561576|FG000|STARTED|Overall Study||32
8529557|NCT03025542|9561577|FG001|STARTED|Overall Study||17
8529558|NCT03025542|9561576|FG000|COMPLETED|Overall Study||30
8529559|NCT03025542|9561577|FG001|COMPLETED|Overall Study||15
8529560|NCT03025542|9561576|FG000|NOT COMPLETED|Overall Study||2
8529561|NCT03025542|9561577|FG001|NOT COMPLETED|Overall Study||2
8529562|NCT02958319|9561589|FG000|STARTED|Overall Study||145
8529563|NCT02958319|9561590|FG001|STARTED|Overall Study||133
8529564|NCT02958319|9561589|FG000|COMPLETED|Overall Study||145
8529565|NCT02958319|9561590|FG001|COMPLETED|Overall Study||133
8529566|NCT02958319|9561589|FG000|NOT COMPLETED|Overall Study||0
8529567|NCT02958319|9561590|FG001|NOT COMPLETED|Overall Study||0
8529568|NCT02929069|9561599|FG000|STARTED|Overall Study||100
8529569|NCT02929069|9561600|FG001|STARTED|Overall Study||102
8529570|NCT02929069|9561601|FG002|STARTED|Overall Study||52
8529571|NCT02929069|9561599|FG000|Completed 4 Month Follow Up|Overall Study||83
8529572|NCT02929069|9561600|FG001|Completed 4 Month Follow Up|Overall Study||76
8529573|NCT02929069|9561601|FG002|Completed 4 Month Follow Up|Overall Study||43
8529574|NCT02929069|9561599|FG000|Completed 8 Month Follow Up|Overall Study||82
8529575|NCT02929069|9561600|FG001|Completed 8 Month Follow Up|Overall Study||77
8529576|NCT02929069|9561601|FG002|Completed 8 Month Follow Up|Overall Study||36
8529577|NCT02929069|9561599|FG000|Assessed STI 12 Month|Overall Study||74
8529578|NCT02929069|9561600|FG001|Assessed STI 12 Month|Overall Study||75
8529579|NCT02929069|9561601|FG002|Assessed STI 12 Month|Overall Study||38
8529580|NCT02929069|9561599|FG000|Assessed HIV 12 Month|Overall Study||76
8529581|NCT02929069|9561600|FG001|Assessed HIV 12 Month|Overall Study||76
8529582|NCT02929069|9561601|FG002|Assessed HIV 12 Month|Overall Study||39
8529583|NCT02929069|9561599|FG000|Complete 12 Month Follow Up|Overall Study||81
8529584|NCT02929069|9561600|FG001|Complete 12 Month Follow Up|Overall Study||81
8529585|NCT02929069|9561601|FG002|Complete 12 Month Follow Up|Overall Study||42
8529586|NCT02929069|9561599|FG000|COMPLETED|Overall Study||81
8529587|NCT02929069|9561600|FG001|COMPLETED|Overall Study||81
8529588|NCT02929069|9561601|FG002|COMPLETED|Overall Study||42
8529589|NCT02929069|9561599|FG000|NOT COMPLETED|Overall Study||19
8529590|NCT02929069|9561600|FG001|NOT COMPLETED|Overall Study||21
8529591|NCT02929069|9561601|FG002|NOT COMPLETED|Overall Study||10
8529592|NCT02889809|9561613|FG000|STARTED|Overall Study||239
8529593|NCT02889809|9561614|FG001|STARTED|Overall Study||238
8529594|NCT02889809|9561613|FG000|COMPLETED|Overall Study||196
8529595|NCT02889809|9561614|FG001|COMPLETED|Overall Study||205
8529596|NCT02889809|9561613|FG000|NOT COMPLETED|Overall Study||43
8529597|NCT02889809|9561614|FG001|NOT COMPLETED|Overall Study||33
8529598|NCT02849587|9561623|FG000|STARTED|Overall Study||65
8529599|NCT02849587|9561624|FG001|STARTED|Overall Study||70
8529600|NCT02849587|9561625|FG002|STARTED|Overall Study||64
8529601|NCT02849587|9561623|FG000|COMPLETED|Overall Study||63
8529602|NCT02849587|9561624|FG001|COMPLETED|Overall Study||66
8529603|NCT02849587|9561625|FG002|COMPLETED|Overall Study||62
8529604|NCT02849587|9561623|FG000|NOT COMPLETED|Overall Study||2
8529605|NCT02849587|9561624|FG001|NOT COMPLETED|Overall Study||4
8529606|NCT02849587|9561625|FG002|NOT COMPLETED|Overall Study||2
8529607|NCT02815540|9561637|FG000|STARTED|Overall Study||2
8529608|NCT02815540|9561637|FG000|COMPLETED|Overall Study||0
8529609|NCT02815540|9561637|FG000|NOT COMPLETED|Overall Study||2
8529610|NCT02814708|9561648|FG000|STARTED|Overall Study||20
8529611|NCT02814708|9561649|FG001|STARTED|Overall Study||20
8529612|NCT02814708|9561650|FG002|STARTED|Overall Study||20
8529613|NCT02814708|9561651|FG003|STARTED|Overall Study||20
8529614|NCT02814708|9561652|FG004|STARTED|Overall Study||20
8529615|NCT02814708|9561653|FG005|STARTED|Overall Study||20
8529616|NCT02814708|9561654|FG006|STARTED|Overall Study||20
8529617|NCT02814708|9561648|FG000|COMPLETED|Overall Study||18
8529618|NCT02814708|9561649|FG001|COMPLETED|Overall Study||17
8529619|NCT02814708|9561650|FG002|COMPLETED|Overall Study||19
8529620|NCT02814708|9561651|FG003|COMPLETED|Overall Study||20
8529621|NCT02814708|9561652|FG004|COMPLETED|Overall Study||17
8529622|NCT02814708|9561653|FG005|COMPLETED|Overall Study||16
8529623|NCT02814708|9561654|FG006|COMPLETED|Overall Study||19
8529624|NCT02814708|9561648|FG000|NOT COMPLETED|Overall Study||2
8529625|NCT02814708|9561649|FG001|NOT COMPLETED|Overall Study||3
8529626|NCT02814708|9561650|FG002|NOT COMPLETED|Overall Study||1
8529627|NCT02814708|9561651|FG003|NOT COMPLETED|Overall Study||0
8529628|NCT02814708|9561652|FG004|NOT COMPLETED|Overall Study||3
8529629|NCT02814708|9561653|FG005|NOT COMPLETED|Overall Study||4
8529630|NCT02814708|9561654|FG006|NOT COMPLETED|Overall Study||1
8529631|NCT02781727|9561672|FG000|STARTED|Pre-dosing Period|106 subjects were randomized to the lonapegsomatropin arm, but 1 subject withdrew consent before receiving the first dose of study drug.|106
8529632|NCT02781727|9561673|FG001|STARTED|Pre-dosing Period||56
8529633|NCT02781727|9561672|FG000|COMPLETED|Pre-dosing Period||105
8529634|NCT02781727|9561673|FG001|COMPLETED|Pre-dosing Period||56
8529635|NCT02781727|9561672|FG000|NOT COMPLETED|Pre-dosing Period||1
8529636|NCT02781727|9561673|FG001|NOT COMPLETED|Pre-dosing Period||0
8529637|NCT02781727|9561672|FG000|STARTED|Treatment Period||105
8529638|NCT02781727|9561673|FG001|STARTED|Treatment Period||56
8529639|NCT02781727|9561672|FG000|COMPLETED|Treatment Period||104
8529640|NCT02781727|9561673|FG001|COMPLETED|Treatment Period||55
8529641|NCT02781727|9561672|FG000|NOT COMPLETED|Treatment Period||1
8529642|NCT02781727|9561673|FG001|NOT COMPLETED|Treatment Period||1
8529643|NCT02778204|9561683|FG000|STARTED|Overall Study||8
8529644|NCT02778204|9561684|FG001|STARTED|Overall Study||7
8529645|NCT02778204|9561685|FG002|STARTED|Overall Study||16
8529646|NCT02778204|9561686|FG003|STARTED|Overall Study||16
8529647|NCT02778204|9561683|FG000|COMPLETED|Overall Study||6
8529648|NCT02778204|9561684|FG001|COMPLETED|Overall Study||7
8529649|NCT02778204|9561685|FG002|COMPLETED|Overall Study||12
8529650|NCT02778204|9561686|FG003|COMPLETED|Overall Study||12
8529651|NCT02778204|9561683|FG000|NOT COMPLETED|Overall Study||2
8529652|NCT02778204|9561684|FG001|NOT COMPLETED|Overall Study||0
8529653|NCT02778204|9561685|FG002|NOT COMPLETED|Overall Study||4
8529654|NCT02778204|9561686|FG003|NOT COMPLETED|Overall Study||4
8529655|NCT02743364|9561700|FG000|STARTED|Overall Study||6
8529656|NCT02743364|9561701|FG001|STARTED|Overall Study||2
8529657|NCT02743364|9561700|FG000|COMPLETED|Overall Study||6
8529658|NCT02743364|9561701|FG001|COMPLETED|Overall Study||2
8529659|NCT02743364|9561700|FG000|NOT COMPLETED|Overall Study||0
8529660|NCT02743364|9561701|FG001|NOT COMPLETED|Overall Study||0
8563658|NCT00048048|9595639|FG011|COMPLETED|Extension Year 2||13
8563659|NCT00048048|9595628|FG000|NOT COMPLETED|Extension Year 2||0
8563660|NCT00048048|9595629|FG001|NOT COMPLETED|Extension Year 2||0
8563661|NCT00048048|9595630|FG002|NOT COMPLETED|Extension Year 2||0
8563662|NCT00048048|9595631|FG003|NOT COMPLETED|Extension Year 2||0
8563663|NCT00048048|9595632|FG004|NOT COMPLETED|Extension Year 2||0
8563664|NCT00048048|9595633|FG005|NOT COMPLETED|Extension Year 2||0
8563665|NCT00048048|9595634|FG006|NOT COMPLETED|Extension Year 2||0
8563666|NCT00048048|9595635|FG007|NOT COMPLETED|Extension Year 2||0
8563667|NCT00048048|9595636|FG008|NOT COMPLETED|Extension Year 2||0
8563668|NCT00048048|9595637|FG009|NOT COMPLETED|Extension Year 2||0
8563669|NCT00048048|9595638|FG010|NOT COMPLETED|Extension Year 2||4
8563670|NCT00048048|9595639|FG011|NOT COMPLETED|Extension Year 2||2
8563671|NCT00048061|9595670|FG000|STARTED|Overall Study||400
8563672|NCT00048061|9595671|FG001|STARTED|Overall Study||401
8563673|NCT00048061|9595672|FG002|STARTED|Overall Study||400
8563674|NCT00048061|9595673|FG003|STARTED|Overall Study||401
8563675|NCT00048061|9595670|FG000|COMPLETED|Overall Study||325
8563676|NCT00048061|9595671|FG001|COMPLETED|Overall Study||328
8563677|NCT00048061|9595672|FG002|COMPLETED|Overall Study||316
8563678|NCT00048061|9595673|FG003|COMPLETED|Overall Study||322
8563679|NCT00048061|9595670|FG000|NOT COMPLETED|Overall Study||75
8563680|NCT00048061|9595671|FG001|NOT COMPLETED|Overall Study||73
8563681|NCT00048061|9595672|FG002|NOT COMPLETED|Overall Study||84
8563682|NCT00048061|9595673|FG003|NOT COMPLETED|Overall Study||79
8563683|NCT00048074|9595686|FG000|STARTED|Overall Study||465
8563684|NCT00048074|9595687|FG001|STARTED|Overall Study||448
8563685|NCT00048074|9595688|FG002|STARTED|Overall Study||469
8563686|NCT00048074|9595686|FG000|COMPLETED|Overall Study||384
8563687|NCT00048074|9595687|FG001|COMPLETED|Overall Study||361
8563688|NCT00048074|9595688|FG002|COMPLETED|Overall Study||372
8563689|NCT00048074|9595686|FG000|NOT COMPLETED|Overall Study||81
8563690|NCT00048074|9595687|FG001|NOT COMPLETED|Overall Study||87
8563691|NCT00048074|9595688|FG002|NOT COMPLETED|Overall Study||97
8563692|NCT00048165|9595698|FG000|STARTED|Completed 6 Months Study||216
8563693|NCT00048165|9595699|FG001|STARTED|Completed 6 Months Study||218
8563694|NCT00048165|9595698|FG000|COMPLETED|Completed 6 Months Study||165
8529661|NCT02496611|9561709|FG000|STARTED|Overall Study||33
8529662|NCT02496611|9561710|FG001|STARTED|Overall Study||33
8529663|NCT02496611|9561709|FG000|COMPLETED|Overall Study||26
8529664|NCT02496611|9561710|FG001|COMPLETED|Overall Study||30
8529665|NCT02496611|9561709|FG000|NOT COMPLETED|Overall Study||7
8529666|NCT02496611|9561710|FG001|NOT COMPLETED|Overall Study||3
8529667|NCT02245308|9561719|FG000|STARTED|Overall Study||63
8529668|NCT02245308|9561720|FG001|STARTED|Overall Study||64
8529669|NCT02245308|9561719|FG000|COMPLETED|Overall Study|Using intent-to-treat analyses, i.e., missing=smoking|63
8529670|NCT02245308|9561720|FG001|COMPLETED|Overall Study|Using intent-to-treat analyses, i.e., missing=smoking|64
8529671|NCT02245308|9561719|FG000|NOT COMPLETED|Overall Study||0
8529672|NCT02245308|9561720|FG001|NOT COMPLETED|Overall Study||0
8529673|NCT02227199|9561729|FG000|STARTED|Overall Study||3
8529674|NCT02227199|9561730|FG001|STARTED|Overall Study||3
8529675|NCT02227199|9561731|FG002|STARTED|Overall Study||39
8529676|NCT02227199|9561729|FG000|COMPLETED|Overall Study||3
8529677|NCT02227199|9561730|FG001|COMPLETED|Overall Study||3
8620596|NCT00474851|9659369|FG000|NOT COMPLETED|Overall Study||8
8620597|NCT00474851|9659370|FG001|NOT COMPLETED|Overall Study||11
8620598|NCT00474903|9659380|FG000|STARTED|Overall Study||30
8620599|NCT00474903|9659381|FG001|STARTED|Overall Study||47
8620600|NCT00474903|9659382|FG002|STARTED|Overall Study||45
8620601|NCT00474903|9659380|FG000|COMPLETED|Overall Study||29
8529678|NCT02227199|9561731|FG002|COMPLETED|Overall Study||35
8529679|NCT02227199|9561729|FG000|NOT COMPLETED|Overall Study||0
8529680|NCT02227199|9561730|FG001|NOT COMPLETED|Overall Study||0
8529681|NCT02227199|9561731|FG002|NOT COMPLETED|Overall Study||4
8529682|NCT02177695|9561745|FG000|STARTED|ITT Analysis||120
8529683|NCT02177695|9561746|FG001|STARTED|ITT Analysis||117
8529684|NCT02177695|9561745|FG000|COMPLETED|ITT Analysis||115
8529685|NCT02177695|9561746|FG001|COMPLETED|ITT Analysis||112
8529686|NCT02177695|9561745|FG000|NOT COMPLETED|ITT Analysis||5
8529687|NCT02177695|9561746|FG001|NOT COMPLETED|ITT Analysis||5
8529688|NCT02177695|9561745|FG000|STARTED|Primary COXEN Analysis||115
8529689|NCT02177695|9561746|FG001|STARTED|Primary COXEN Analysis||112
8529690|NCT02177695|9561745|FG000|Participants Excluded From Primary COXEN Analysis|Primary COXEN Analysis||33
8529691|NCT02177695|9561746|FG001|Participants Excluded From Primary COXEN Analysis|Primary COXEN Analysis||27
8529692|NCT02177695|9561745|FG000|COMPLETED|Primary COXEN Analysis||82
8529693|NCT02177695|9561746|FG001|COMPLETED|Primary COXEN Analysis||85
8529694|NCT02177695|9561745|FG000|NOT COMPLETED|Primary COXEN Analysis||33
8529695|NCT02177695|9561746|FG001|NOT COMPLETED|Primary COXEN Analysis||27
8529696|NCT02145403|9561758|FG000|STARTED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||3
8529697|NCT02145403|9561759|FG001|STARTED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
8529698|NCT02145403|9561760|FG002|STARTED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
8529699|NCT02145403|9561761|FG003|STARTED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
8529700|NCT02145403|9561758|FG000|COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||3
8529701|NCT02145403|9561759|FG001|COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
8529702|NCT02145403|9561760|FG002|COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
8529703|NCT02145403|9561761|FG003|COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
8529704|NCT02145403|9561758|FG000|NOT COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
8529705|NCT02145403|9561759|FG001|NOT COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
8529706|NCT02145403|9561760|FG002|NOT COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
8529707|NCT02145403|9561761|FG003|NOT COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
8529708|NCT02145403|9561758|FG000|STARTED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
8529709|NCT02145403|9561759|FG001|STARTED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||3
8529710|NCT02145403|9561760|FG002|STARTED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
8529711|NCT02145403|9561761|FG003|STARTED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
8529712|NCT02145403|9561758|FG000|COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
8620602|NCT00474903|9659381|FG001|COMPLETED|Overall Study||42
8620603|NCT00474903|9659382|FG002|COMPLETED|Overall Study||43
8620604|NCT00474903|9659380|FG000|NOT COMPLETED|Overall Study||1
8529713|NCT02145403|9561759|FG001|COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||3
8529714|NCT02145403|9561760|FG002|COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
8529715|NCT02145403|9561761|FG003|COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
8529716|NCT02145403|9561758|FG000|NOT COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
8529717|NCT02145403|9561759|FG001|NOT COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
8529718|NCT02145403|9561760|FG002|NOT COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
8529719|NCT02145403|9561761|FG003|NOT COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
8529720|NCT02145403|9561758|FG000|STARTED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
8529721|NCT02145403|9561759|FG001|STARTED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
8529722|NCT02145403|9561760|FG002|STARTED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||4
8529723|NCT02145403|9561761|FG003|STARTED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
8529724|NCT02145403|9561758|FG000|COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
8529725|NCT02145403|9561759|FG001|COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
8529726|NCT02145403|9561760|FG002|COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||3
8529727|NCT02145403|9561761|FG003|COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
8529728|NCT02145403|9561758|FG000|NOT COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
8529729|NCT02145403|9561759|FG001|NOT COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
8529730|NCT02145403|9561760|FG002|NOT COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||1
8620605|NCT00474903|9659381|FG001|NOT COMPLETED|Overall Study||5
8529731|NCT02145403|9561761|FG003|NOT COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
8529732|NCT02145403|9561758|FG000|STARTED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
8529733|NCT02145403|9561759|FG001|STARTED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
8529734|NCT02145403|9561760|FG002|STARTED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
8529735|NCT02145403|9561761|FG003|STARTED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||4
8529736|NCT02145403|9561758|FG000|COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
8529737|NCT02145403|9561759|FG001|COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
8529738|NCT02145403|9561760|FG002|COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
8529739|NCT02145403|9561761|FG003|COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||2
8529740|NCT02145403|9561758|FG000|NOT COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
8529741|NCT02145403|9561759|FG001|NOT COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
8529742|NCT02145403|9561760|FG002|NOT COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
8529743|NCT02145403|9561761|FG003|NOT COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||2
8529744|NCT02145403|9561758|FG000|STARTED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
8529745|NCT02145403|9561759|FG001|STARTED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
8529746|NCT02145403|9561760|FG002|STARTED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||37
8529747|NCT02145403|9561761|FG003|STARTED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
8529748|NCT02145403|9561758|FG000|COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
8529749|NCT02145403|9561759|FG001|COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
8529750|NCT02145403|9561760|FG002|COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||36
8529751|NCT02145403|9561761|FG003|COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
8529752|NCT02145403|9561758|FG000|NOT COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
8529753|NCT02145403|9561759|FG001|NOT COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
8529754|NCT02145403|9561760|FG002|NOT COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||1
8529755|NCT02145403|9561761|FG003|NOT COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
8529756|NCT02105636|9561776|FG000|STARTED|Overall Study||236
8529757|NCT02105636|9561777|FG001|STARTED|Overall Study||111
8529758|NCT02105636|9561776|FG000|COMPLETED|Overall Study|Completed=Still on Treatment|41
8529759|NCT02105636|9561777|FG001|COMPLETED|Overall Study|Completed=Still on Treatment|3
8529760|NCT02105636|9561776|FG000|NOT COMPLETED|Overall Study||195
8529761|NCT02105636|9561777|FG001|NOT COMPLETED|Overall Study||108
8529762|NCT02038946|9561784|FG000|STARTED|Overall Study||92
8529763|NCT02038946|9561784|FG000|COMPLETED|Overall Study||80
8529764|NCT02038946|9561784|FG000|NOT COMPLETED|Overall Study||12
8529765|NCT01988571|9561790|FG000|STARTED|Overall Study||139
8529766|NCT01988571|9561791|FG001|STARTED|Overall Study||140
8529767|NCT01988571|9561790|FG000|Completed Baseline|Overall Study||136
8529768|NCT01988571|9561791|FG001|Completed Baseline|Overall Study||139
8529769|NCT01988571|9561790|FG000|Completed 6 Month Visit|Overall Study||122
8529770|NCT01988571|9561791|FG001|Completed 6 Month Visit|Overall Study||126
8529771|NCT01988571|9561790|FG000|COMPLETED|Overall Study||100
8529772|NCT01988571|9561791|FG001|COMPLETED|Overall Study||105
8529773|NCT01988571|9561790|FG000|NOT COMPLETED|Overall Study||39
8529774|NCT01988571|9561791|FG001|NOT COMPLETED|Overall Study||35
8529775|NCT01398852|9561797|FG000|STARTED|Overall Study|Due to termination of the study the exact number of participants enrolled is unknown at this time.|372
8529776|NCT01398852|9561797|FG000|COMPLETED|Overall Study||0
8529777|NCT01398852|9561797|FG000|NOT COMPLETED|Overall Study||372
8529778|NCT01332266|9561806|FG000|STARTED|Phase 1b||4
8529779|NCT01332266|9561807|FG001|STARTED|Phase 1b||5
8529780|NCT01332266|9561808|FG002|STARTED|Phase 1b||3
8529781|NCT01332266|9561809|FG003|STARTED|Phase 1b||0
8529782|NCT01332266|9561810|FG004|STARTED|Phase 1b||0
8529783|NCT01332266|9561806|FG000|COMPLETED|Phase 1b||0
8529784|NCT01332266|9561807|FG001|COMPLETED|Phase 1b||0
8529785|NCT01332266|9561808|FG002|COMPLETED|Phase 1b||0
8529786|NCT01332266|9561809|FG003|COMPLETED|Phase 1b||0
8529787|NCT01332266|9561810|FG004|COMPLETED|Phase 1b||0
8529788|NCT01332266|9561806|FG000|NOT COMPLETED|Phase 1b||4
8529789|NCT01332266|9561807|FG001|NOT COMPLETED|Phase 1b||5
8529790|NCT01332266|9561808|FG002|NOT COMPLETED|Phase 1b||3
8529791|NCT01332266|9561809|FG003|NOT COMPLETED|Phase 1b||0
8529792|NCT01332266|9561810|FG004|NOT COMPLETED|Phase 1b||0
8529793|NCT01332266|9561806|FG000|STARTED|Phase 2||0
8529794|NCT01332266|9561807|FG001|STARTED|Phase 2||0
8529795|NCT01332266|9561808|FG002|STARTED|Phase 2||0
8529796|NCT01332266|9561809|FG003|STARTED|Phase 2||42
8529797|NCT01332266|9561810|FG004|STARTED|Phase 2||41
8529798|NCT01332266|9561806|FG000|COMPLETED|Phase 2||0
8816356|NCT01543685|9869847|FG000|COMPLETED|Overall Study||90
8529799|NCT01332266|9561807|FG001|COMPLETED|Phase 2||0
8529800|NCT01332266|9561808|FG002|COMPLETED|Phase 2||0
8529801|NCT01332266|9561809|FG003|COMPLETED|Phase 2||0
8529802|NCT01332266|9561810|FG004|COMPLETED|Phase 2||0
8529803|NCT01332266|9561806|FG000|NOT COMPLETED|Phase 2||0
8529804|NCT01332266|9561807|FG001|NOT COMPLETED|Phase 2||0
8529805|NCT01332266|9561808|FG002|NOT COMPLETED|Phase 2||0
8529806|NCT01332266|9561809|FG003|NOT COMPLETED|Phase 2||42
8529807|NCT01332266|9561810|FG004|NOT COMPLETED|Phase 2||41
8529808|NCT01150890|9561827|FG000|STARTED|Overall Study||32
8529809|NCT01150890|9561828|FG001|STARTED|Overall Study||32
8529810|NCT01150890|9561829|FG002|STARTED|Overall Study||33
8529811|NCT01150890|9561830|FG003|STARTED|Overall Study||33
8529812|NCT01150890|9561827|FG000|Received Study Drug|Overall Study||32
8529813|NCT01150890|9561828|FG001|Received Study Drug|Overall Study||31
8529814|NCT01150890|9561829|FG002|Received Study Drug|Overall Study||32
8816357|NCT01543685|9869848|FG001|COMPLETED|Overall Study||88
8529815|NCT01150890|9561830|FG003|Received Study Drug|Overall Study||33
8529816|NCT01150890|9561827|FG000|COMPLETED|Overall Study||28
8529817|NCT01150890|9561828|FG001|COMPLETED|Overall Study||19
8529818|NCT01150890|9561829|FG002|COMPLETED|Overall Study||21
8529819|NCT01150890|9561830|FG003|COMPLETED|Overall Study||16
8529820|NCT01150890|9561827|FG000|NOT COMPLETED|Overall Study||4
8529821|NCT01150890|9561828|FG001|NOT COMPLETED|Overall Study||13
8529822|NCT01150890|9561829|FG002|NOT COMPLETED|Overall Study||12
8529823|NCT01150890|9561830|FG003|NOT COMPLETED|Overall Study||17
8529824|NCT01140867|9561843|FG000|STARTED|Overall Study||121
8529825|NCT01140867|9561843|FG000|COMPLETED|Overall Study||88
8529826|NCT01140867|9561843|FG000|NOT COMPLETED|Overall Study||33
8529827|NCT01137773|9561849|FG000|STARTED|Overall Study||33
8529828|NCT01137773|9561850|FG001|STARTED|Overall Study||23
8529829|NCT01137773|9561849|FG000|COMPLETED|Overall Study||24
8529830|NCT01137773|9561850|FG001|COMPLETED|Overall Study||20
8529831|NCT01137773|9561849|FG000|NOT COMPLETED|Overall Study||9
8529832|NCT01137773|9561850|FG001|NOT COMPLETED|Overall Study||3
8529833|NCT01127256|9561860|FG000|STARTED|Overall Study||96
8529834|NCT01127256|9561861|FG001|STARTED|Overall Study||104
8529835|NCT01127256|9561860|FG000|COMPLETED|Overall Study||57
8529836|NCT01127256|9561861|FG001|COMPLETED|Overall Study||65
8529837|NCT01127256|9561860|FG000|NOT COMPLETED|Overall Study||39
8529838|NCT01127256|9561861|FG001|NOT COMPLETED|Overall Study||39
8529839|NCT01004861|9561880|FG000|STARTED|Overall Study||3
8529840|NCT01004861|9561881|FG001|STARTED|Overall Study||6
8529841|NCT01004861|9561882|FG002|STARTED|Overall Study||6
8529842|NCT01004861|9561883|FG003|STARTED|Overall Study||6
8529843|NCT01004861|9561884|FG004|STARTED|Overall Study||7
8529844|NCT01004861|9561885|FG005|STARTED|Overall Study||6
8529845|NCT01004861|9561886|FG006|STARTED|Overall Study||7
8529846|NCT01004861|9561887|FG007|STARTED|Overall Study||4
8529847|NCT01004861|9561888|FG008|STARTED|Overall Study||39
8529848|NCT01004861|9561889|FG009|STARTED|Overall Study||11
8529849|NCT01004861|9561890|FG010|STARTED|Overall Study||9
8529850|NCT01004861|9561891|FG011|STARTED|Overall Study||8
8529851|NCT01004861|9561892|FG012|STARTED|Overall Study||20
8529852|NCT01004861|9561880|FG000|COMPLETED|Overall Study||0
8529853|NCT01004861|9561881|FG001|COMPLETED|Overall Study||0
8529854|NCT01004861|9561882|FG002|COMPLETED|Overall Study||0
8529855|NCT01004861|9561883|FG003|COMPLETED|Overall Study||0
8529856|NCT01004861|9561884|FG004|COMPLETED|Overall Study||0
8529857|NCT01004861|9561885|FG005|COMPLETED|Overall Study||0
8529858|NCT01004861|9561886|FG006|COMPLETED|Overall Study||0
8529859|NCT01004861|9561887|FG007|COMPLETED|Overall Study||0
8529860|NCT01004861|9561888|FG008|COMPLETED|Overall Study||0
8529861|NCT01004861|9561889|FG009|COMPLETED|Overall Study||0
8529862|NCT01004861|9561890|FG010|COMPLETED|Overall Study||0
8529863|NCT01004861|9561891|FG011|COMPLETED|Overall Study||0
8529864|NCT01004861|9561892|FG012|COMPLETED|Overall Study||0
8529865|NCT01004861|9561880|FG000|NOT COMPLETED|Overall Study||3
8529866|NCT01004861|9561881|FG001|NOT COMPLETED|Overall Study||6
8529867|NCT01004861|9561882|FG002|NOT COMPLETED|Overall Study||6
8529868|NCT01004861|9561883|FG003|NOT COMPLETED|Overall Study||6
8529869|NCT01004861|9561884|FG004|NOT COMPLETED|Overall Study||7
8529870|NCT01004861|9561885|FG005|NOT COMPLETED|Overall Study||6
8529871|NCT01004861|9561886|FG006|NOT COMPLETED|Overall Study||7
8529872|NCT01004861|9561887|FG007|NOT COMPLETED|Overall Study||4
8529873|NCT01004861|9561888|FG008|NOT COMPLETED|Overall Study||39
8529874|NCT01004861|9561889|FG009|NOT COMPLETED|Overall Study||11
8529875|NCT01004861|9561890|FG010|NOT COMPLETED|Overall Study||9
8529876|NCT01004861|9561891|FG011|NOT COMPLETED|Overall Study||8
8529877|NCT01004861|9561892|FG012|NOT COMPLETED|Overall Study||20
8529878|NCT00912223|9561924|FG000|STARTED|Overall Study||65
8529879|NCT00912223|9561924|FG000|COMPLETED|Overall Study||62
8529880|NCT00912223|9561924|FG000|NOT COMPLETED|Overall Study||3
8529881|NCT00381381|9561928|FG000|STARTED|Overall Study||199
8529882|NCT00381381|9561928|FG000|COMPLETED|Overall Study||135
8529883|NCT00381381|9561928|FG000|NOT COMPLETED|Overall Study||64
8529884|NCT00038675|9561932|FG000|STARTED|Overall Study||125
8529885|NCT00038675|9561932|FG000|COMPLETED|Overall Study||125
8529886|NCT00038675|9561932|FG000|NOT COMPLETED|Overall Study||0
8563695|NCT00048165|9595699|FG001|COMPLETED|Completed 6 Months Study||170
8563696|NCT00048165|9595698|FG000|NOT COMPLETED|Completed 6 Months Study||51
8563697|NCT00048165|9595699|FG001|NOT COMPLETED|Completed 6 Months Study||48
8563698|NCT00048165|9595698|FG000|STARTED|Completed 12 Months Study||165
8563699|NCT00048165|9595699|FG001|STARTED|Completed 12 Months Study||170
8563700|NCT00048165|9595698|FG000|COMPLETED|Completed 12 Months Study||162
8563701|NCT00048165|9595699|FG001|COMPLETED|Completed 12 Months Study||167
8563702|NCT00048165|9595698|FG000|NOT COMPLETED|Completed 12 Months Study||3
8563703|NCT00048165|9595699|FG001|NOT COMPLETED|Completed 12 Months Study||3
8563704|NCT00048347|9595707|FG000|STARTED|Overall Study||18
8563705|NCT00048347|9595707|FG000|COMPLETED|Overall Study||16
8563706|NCT00048347|9595707|FG000|NOT COMPLETED|Overall Study||2
8563707|NCT00048542|9595715|FG000|STARTED|Double-Blind Phase|For all groups, started indicates when the subjects entered the double-blind treatment phase.|38
8563708|NCT00048542|9595716|FG001|STARTED|Double-Blind Phase||37
8563709|NCT00048542|9595717|FG002|STARTED|Double-Blind Phase||30
8563710|NCT00048542|9595718|FG003|STARTED|Double-Blind Phase||28
8563711|NCT00048542|9595719|FG004|STARTED|Double-Blind Phase||0
8563712|NCT00048542|9595720|FG005|STARTED|Double-Blind Phase||0
8529887|NCT04957498|9561938|FG000|STARTED|Overall Study||20
8529888|NCT04957498|9561939|FG001|STARTED|Overall Study||20
8529889|NCT04957498|9561938|FG000|COMPLETED|Overall Study||19
8816358|NCT01543685|9869849|FG002|COMPLETED|Overall Study||89
8529890|NCT04957498|9561939|FG001|COMPLETED|Overall Study||18
8529891|NCT04957498|9561938|FG000|NOT COMPLETED|Overall Study||1
8529892|NCT04957498|9561939|FG001|NOT COMPLETED|Overall Study||2
8529893|NCT04389333|9561949|FG000|STARTED|Overall Study|From March 26th to April 26th, 2020, 20 patients were enrolled and underwent non-contract MCE in Changhai hpospital and the first medical center of PLA general hospital.|20
8529894|NCT04389333|9561950|FG001|STARTED|Overall Study|From March 26th to April 26th, 2020, 20 patients were enrolled and accept MCE in Changhai hpospital and the first medical center of PLA general hospital.|20
8529895|NCT04389333|9561949|FG000|COMPLETED|Overall Study||20
8529896|NCT04389333|9561950|FG001|COMPLETED|Overall Study||20
8529897|NCT04389333|9561949|FG000|NOT COMPLETED|Overall Study||0
8529898|NCT04389333|9561950|FG001|NOT COMPLETED|Overall Study||0
8529899|NCT03712124|9561959|FG000|STARTED|Overall Study||10
8529900|NCT03712124|9561960|FG001|STARTED|Overall Study||11
8529901|NCT03712124|9561959|FG000|Received at Least 1 Dose of Study Drug|Overall Study||10
8529902|NCT03712124|9561960|FG001|Received at Least 1 Dose of Study Drug|Overall Study||11
8529903|NCT03712124|9561959|FG000|COMPLETED|Overall Study||9
8529904|NCT03712124|9561960|FG001|COMPLETED|Overall Study||11
8529905|NCT03712124|9561959|FG000|NOT COMPLETED|Overall Study||1
8529906|NCT03712124|9561960|FG001|NOT COMPLETED|Overall Study||0
8529907|NCT03689582|9561966|FG000|STARTED|Overall Study||11
8529908|NCT03689582|9561966|FG000|COMPLETED|Overall Study||11
8529909|NCT03689582|9561966|FG000|NOT COMPLETED|Overall Study||0
8529910|NCT03535740|9561972|FG000|STARTED|Overall Study||103
8529911|NCT03535740|9561972|FG000|Participants Who Received Escalated Dose of Brigatinib 240 mg|Overall Study||13
8529912|NCT03535740|9561972|FG000|COMPLETED|Overall Study||0
8529913|NCT03535740|9561972|FG000|NOT COMPLETED|Overall Study||103
8529914|NCT02986789|9561979|FG000|STARTED|Overall Study||43
8529915|NCT02986789|9561980|FG001|STARTED|Overall Study||0
8529916|NCT02986789|9561979|FG000|COMPLETED|Overall Study||43
8529917|NCT02986789|9561980|FG001|COMPLETED|Overall Study||0
8529918|NCT02986789|9561979|FG000|NOT COMPLETED|Overall Study||0
8529919|NCT02986789|9561980|FG001|NOT COMPLETED|Overall Study||0
8529920|NCT02974907|9561988|FG000|STARTED|Overall Study||299
8529921|NCT02974907|9561989|FG001|STARTED|Overall Study||302
8529922|NCT02974907|9561988|FG000|COMPLETED|Overall Study||286
8529923|NCT02974907|9561989|FG001|COMPLETED|Overall Study||292
8529924|NCT02974907|9561988|FG000|NOT COMPLETED|Overall Study||13
8529925|NCT02974907|9561989|FG001|NOT COMPLETED|Overall Study||10
8529926|NCT02921789|9561997|FG000|STARTED|Overall Study||34
8529927|NCT02921789|9561998|FG001|STARTED|Overall Study||29
8529928|NCT02921789|9561997|FG000|Randomized and Took Study Drug|Overall Study||34
8529929|NCT02921789|9561998|FG001|Randomized and Took Study Drug|Overall Study||29
8529930|NCT02921789|9561997|FG000|COMPLETED|Overall Study||26
8529931|NCT02921789|9561998|FG001|COMPLETED|Overall Study||25
8529932|NCT02921789|9561997|FG000|NOT COMPLETED|Overall Study||8
8529933|NCT02921789|9561998|FG001|NOT COMPLETED|Overall Study||4
8529934|NCT02918500|9562006|FG000|STARTED|Overall Study||2
8529935|NCT02918500|9562007|FG001|STARTED|Overall Study||2
8529936|NCT02918500|9562006|FG000|COMPLETED|Overall Study||2
8529937|NCT02918500|9562007|FG001|COMPLETED|Overall Study||2
8529938|NCT02918500|9562006|FG000|NOT COMPLETED|Overall Study||0
8529939|NCT02918500|9562007|FG001|NOT COMPLETED|Overall Study||0
8529940|NCT02896257|9562018|FG000|STARTED|Providers||88
8529941|NCT02896257|9562019|FG001|STARTED|Providers||93
8529942|NCT02896257|9562018|FG000|PCPs Assigned to 1 Primary Care Team|Providers||68
8529943|NCT02896257|9562019|FG001|PCPs Assigned to 1 Primary Care Team|Providers||79
8529944|NCT02896257|9562018|FG000|PCPs Assigned to Two Primary Care Teams|Providers||18
8529945|NCT02896257|9562019|FG001|PCPs Assigned to Two Primary Care Teams|Providers||12
8529946|NCT02896257|9562018|FG000|PCPs Assigned to 3 Primary Care Teams|Providers||1
8529947|NCT02896257|9562019|FG001|PCPs Assigned to 3 Primary Care Teams|Providers||2
8529948|NCT02896257|9562018|FG000|PCPs Assigned to Four Primary Care Teams|Providers||1
8529949|NCT02896257|9562019|FG001|PCPs Assigned to Four Primary Care Teams|Providers||0
8529950|NCT02896257|9562018|FG000|COMPLETED|Providers||67
8529951|NCT02896257|9562019|FG001|COMPLETED|Providers||65
8529952|NCT02896257|9562018|FG000|NOT COMPLETED|Providers||21
8529953|NCT02896257|9562019|FG001|NOT COMPLETED|Providers||28
8529954|NCT02896257|9562018|FG000|STARTED|Patients|Eligible patient participants assigned to a usual care PCP=344|344
8529955|NCT02896257|9562019|FG001|STARTED|Patients|Eligible patient participants assigned to an intervention PCP=342|342
8529956|NCT02896257|9562018|FG000|COMPLETED|Patients|Patients with an eligible primary care appointment with a usual care PCP who were assigned an index date=281|281
8529957|NCT02896257|9562019|FG001|COMPLETED|Patients|Patients with an eligible primary care appointment with an intervention PCP who were assigned an index date=269|269
8529958|NCT02896257|9562018|FG000|NOT COMPLETED|Patients||63
8529959|NCT02896257|9562019|FG001|NOT COMPLETED|Patients||73
8529960|NCT02774265|9562028|FG000|STARTED|Overall Study||164
8529961|NCT02774265|9562029|FG001|STARTED|Overall Study||165
8529962|NCT02774265|9562028|FG000|COMPLETED|Overall Study||151
8529963|NCT02774265|9562029|FG001|COMPLETED|Overall Study||159
8529964|NCT02774265|9562028|FG000|NOT COMPLETED|Overall Study||13
8529965|NCT02774265|9562029|FG001|NOT COMPLETED|Overall Study||6
8529966|NCT02736617|9562035|FG000|STARTED|Treatment||10
8529967|NCT02736617|9562035|FG000|COMPLETED|Treatment||7
8529968|NCT02736617|9562035|FG000|NOT COMPLETED|Treatment||3
8529969|NCT02736617|9562035|FG000|STARTED|Maintenance||7
8529970|NCT02736617|9562035|FG000|COMPLETED|Maintenance||2
8529971|NCT02736617|9562035|FG000|NOT COMPLETED|Maintenance||5
8529972|NCT02652468|9562040|FG000|STARTED|Overall Study||11
8529973|NCT02652468|9562040|FG000|COMPLETED|Overall Study||11
8529974|NCT02652468|9562040|FG000|NOT COMPLETED|Overall Study||0
8529975|NCT02579265|9562046|FG000|STARTED|Overall Study||83
8529976|NCT02579265|9562047|FG001|STARTED|Overall Study||78
8529977|NCT02579265|9562046|FG000|COMPLETED|Overall Study||33
8529978|NCT02579265|9562047|FG001|COMPLETED|Overall Study||33
8529979|NCT02579265|9562046|FG000|NOT COMPLETED|Overall Study||50
8529980|NCT02579265|9562047|FG001|NOT COMPLETED|Overall Study||45
8563713|NCT00048542|9595721|FG006|STARTED|Double-Blind Phase||0
8563714|NCT00048542|9595722|FG007|STARTED|Double-Blind Phase||0
8563715|NCT00048542|9595715|FG000|COMPLETED|Double-Blind Phase||35
8563716|NCT00048542|9595716|FG001|COMPLETED|Double-Blind Phase||36
8563717|NCT00048542|9595717|FG002|COMPLETED|Double-Blind Phase||29
8563718|NCT00048542|9595718|FG003|COMPLETED|Double-Blind Phase||28
8563719|NCT00048542|9595719|FG004|COMPLETED|Double-Blind Phase||0
8563720|NCT00048542|9595720|FG005|COMPLETED|Double-Blind Phase||0
8563721|NCT00048542|9595721|FG006|COMPLETED|Double-Blind Phase||0
8563722|NCT00048542|9595722|FG007|COMPLETED|Double-Blind Phase||0
8563723|NCT00048542|9595715|FG000|NOT COMPLETED|Double-Blind Phase||3
8563724|NCT00048542|9595716|FG001|NOT COMPLETED|Double-Blind Phase||1
8563725|NCT00048542|9595717|FG002|NOT COMPLETED|Double-Blind Phase||1
8563726|NCT00048542|9595718|FG003|NOT COMPLETED|Double-Blind Phase||0
8563727|NCT00048542|9595719|FG004|NOT COMPLETED|Double-Blind Phase||0
8563728|NCT00048542|9595720|FG005|NOT COMPLETED|Double-Blind Phase||0
8563729|NCT00048542|9595721|FG006|NOT COMPLETED|Double-Blind Phase||0
8563730|NCT00048542|9595722|FG007|NOT COMPLETED|Double-Blind Phase||0
8563731|NCT00048542|9595715|FG000|STARTED|Open-Label Extension BSA Phase||0
8563732|NCT00048542|9595716|FG001|STARTED|Open-Label Extension BSA Phase||0
8563733|NCT00048542|9595717|FG002|STARTED|Open-Label Extension BSA Phase||0
8563734|NCT00048542|9595718|FG003|STARTED|Open-Label Extension BSA Phase||0
8563735|NCT00048542|9595719|FG004|STARTED|Open-Label Extension BSA Phase||71
8563736|NCT00048542|9595720|FG005|STARTED|Open-Label Extension BSA Phase||57
8563737|NCT00048542|9595721|FG006|STARTED|Open-Label Extension BSA Phase||0
8563738|NCT00048542|9595722|FG007|STARTED|Open-Label Extension BSA Phase||0
8563739|NCT00048542|9595715|FG000|COMPLETED|Open-Label Extension BSA Phase||0
8563740|NCT00048542|9595716|FG001|COMPLETED|Open-Label Extension BSA Phase||0
8563741|NCT00048542|9595717|FG002|COMPLETED|Open-Label Extension BSA Phase||0
8563742|NCT00048542|9595718|FG003|COMPLETED|Open-Label Extension BSA Phase||0
8563743|NCT00048542|9595719|FG004|COMPLETED|Open-Label Extension BSA Phase||59
8563744|NCT00048542|9595720|FG005|COMPLETED|Open-Label Extension BSA Phase||47
8563745|NCT00048542|9595721|FG006|COMPLETED|Open-Label Extension BSA Phase||0
8563746|NCT00048542|9595722|FG007|COMPLETED|Open-Label Extension BSA Phase||0
8563747|NCT00048542|9595715|FG000|NOT COMPLETED|Open-Label Extension BSA Phase||0
8563748|NCT00048542|9595716|FG001|NOT COMPLETED|Open-Label Extension BSA Phase||0
8563749|NCT00048542|9595717|FG002|NOT COMPLETED|Open-Label Extension BSA Phase||0
8563750|NCT00048542|9595718|FG003|NOT COMPLETED|Open-Label Extension BSA Phase||0
8563751|NCT00048542|9595719|FG004|NOT COMPLETED|Open-Label Extension BSA Phase||12
8563752|NCT00048542|9595720|FG005|NOT COMPLETED|Open-Label Extension BSA Phase||10
8563753|NCT00048542|9595721|FG006|NOT COMPLETED|Open-Label Extension BSA Phase||0
8563754|NCT00048542|9595722|FG007|NOT COMPLETED|Open-Label Extension BSA Phase||0
8563755|NCT00048542|9595715|FG000|STARTED|Open-Label Extension Fixed Dose Phase||0
8563756|NCT00048542|9595716|FG001|STARTED|Open-Label Extension Fixed Dose Phase||0
8563757|NCT00048542|9595717|FG002|STARTED|Open-Label Extension Fixed Dose Phase||0
8563758|NCT00048542|9595718|FG003|STARTED|Open-Label Extension Fixed Dose Phase||0
8563759|NCT00048542|9595719|FG004|STARTED|Open-Label Extension Fixed Dose Phase||0
8563760|NCT00048542|9595720|FG005|STARTED|Open-Label Extension Fixed Dose Phase||0
8563761|NCT00048542|9595721|FG006|STARTED|Open-Label Extension Fixed Dose Phase||59
8563762|NCT00048542|9595722|FG007|STARTED|Open-Label Extension Fixed Dose Phase||47
8563763|NCT00048542|9595715|FG000|COMPLETED|Open-Label Extension Fixed Dose Phase||0
8563764|NCT00048542|9595716|FG001|COMPLETED|Open-Label Extension Fixed Dose Phase||0
8563765|NCT00048542|9595717|FG002|COMPLETED|Open-Label Extension Fixed Dose Phase||0
8563766|NCT00048542|9595718|FG003|COMPLETED|Open-Label Extension Fixed Dose Phase||0
8563767|NCT00048542|9595719|FG004|COMPLETED|Open-Label Extension Fixed Dose Phase||0
8563768|NCT00048542|9595720|FG005|COMPLETED|Open-Label Extension Fixed Dose Phase||0
8563769|NCT00048542|9595721|FG006|COMPLETED|Open-Label Extension Fixed Dose Phase||37
8563770|NCT00048542|9595722|FG007|COMPLETED|Open-Label Extension Fixed Dose Phase||25
8563771|NCT00048542|9595715|FG000|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
8563772|NCT00048542|9595716|FG001|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
8563773|NCT00048542|9595717|FG002|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
8563774|NCT00048542|9595718|FG003|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
8563775|NCT00048542|9595719|FG004|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
8563776|NCT00048542|9595720|FG005|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
8563777|NCT00048542|9595721|FG006|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||22
8563778|NCT00048542|9595722|FG007|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||22
8569195|NCT00095498|9601398|FG001|NOT COMPLETED|Overall Study||35
8569196|NCT00095498|9601399|FG002|NOT COMPLETED|Overall Study||39
8529981|NCT02013167|9562055|FG000|STARTED|Overall Study||134
8529982|NCT02013167|9562056|FG001|STARTED|Overall Study||271
8529983|NCT02013167|9562055|FG000|Received Treatment|Overall Study||109
8529984|NCT02013167|9562056|FG001|Received Treatment|Overall Study||267
8529985|NCT02013167|9562055|FG000|COMPLETED|Overall Study|Indicates participants continuing study at time of data cut-off|33
8529986|NCT02013167|9562056|FG001|COMPLETED|Overall Study|Indicates participants continuing study at time of data cut-off; 22 were receiving treatment|93
8529987|NCT02013167|9562055|FG000|NOT COMPLETED|Overall Study||101
8529988|NCT02013167|9562056|FG001|NOT COMPLETED|Overall Study||178
8529989|NCT02004522|9562065|FG000|STARTED|Overall Study||160
8529990|NCT02004522|9562066|FG001|STARTED|Overall Study||159
8529991|NCT02004522|9562065|FG000|Number of Subjects Treated|Overall Study||158
8529992|NCT02004522|9562066|FG001|Number of Subjects Treated|Overall Study||155
8529993|NCT02004522|9562065|FG000|COMPLETED|Overall Study|Completed defined here as still on treatment.|34
8529994|NCT02004522|9562066|FG001|COMPLETED|Overall Study|Completed defined here as still on treatment.|0
8529995|NCT02004522|9562065|FG000|NOT COMPLETED|Overall Study||126
8529996|NCT02004522|9562066|FG001|NOT COMPLETED|Overall Study||159
8529997|NCT02000427|9562072|FG000|STARTED|Overall Study||45
8529998|NCT02000427|9562072|FG000|COMPLETED|Overall Study|Indicates participants ongoing in study as of the data cut-off date of 20 May 2015.|23
8529999|NCT02000427|9562072|FG000|NOT COMPLETED|Overall Study||22
8530000|NCT01981850|9562083|FG000|STARTED|Main Phase Stage 1||8
8530001|NCT01981850|9562084|FG001|STARTED|Main Phase Stage 1||7
8530002|NCT01981850|9562085|FG002|STARTED|Main Phase Stage 1||6
8530003|NCT01981850|9562086|FG003|STARTED|Main Phase Stage 1||6
8530004|NCT01981850|9562087|FG004|STARTED|Main Phase Stage 1||0
8530005|NCT01981850|9562088|FG005|STARTED|Main Phase Stage 1||0
8530006|NCT01981850|9562089|FG006|STARTED|Main Phase Stage 1||0
8530007|NCT01981850|9562090|FG007|STARTED|Main Phase Stage 1||0
8530008|NCT01981850|9562091|FG008|STARTED|Main Phase Stage 1||0
8530009|NCT01981850|9562092|FG009|STARTED|Main Phase Stage 1||0
8530010|NCT01981850|9562083|FG000|COMPLETED|Main Phase Stage 1||5
8530011|NCT01981850|9562084|FG001|COMPLETED|Main Phase Stage 1||5
8530012|NCT01981850|9562085|FG002|COMPLETED|Main Phase Stage 1||4
8530013|NCT01981850|9562086|FG003|COMPLETED|Main Phase Stage 1||6
8530014|NCT01981850|9562087|FG004|COMPLETED|Main Phase Stage 1||0
8530015|NCT01981850|9562088|FG005|COMPLETED|Main Phase Stage 1||0
8530016|NCT01981850|9562089|FG006|COMPLETED|Main Phase Stage 1||0
8530017|NCT01981850|9562090|FG007|COMPLETED|Main Phase Stage 1||0
8530018|NCT01981850|9562091|FG008|COMPLETED|Main Phase Stage 1||0
8530019|NCT01981850|9562092|FG009|COMPLETED|Main Phase Stage 1||0
8530020|NCT01981850|9562083|FG000|NOT COMPLETED|Main Phase Stage 1||3
8530021|NCT01981850|9562084|FG001|NOT COMPLETED|Main Phase Stage 1||2
8530022|NCT01981850|9562085|FG002|NOT COMPLETED|Main Phase Stage 1||2
8530023|NCT01981850|9562086|FG003|NOT COMPLETED|Main Phase Stage 1||0
8530024|NCT01981850|9562087|FG004|NOT COMPLETED|Main Phase Stage 1||0
8530025|NCT01981850|9562088|FG005|NOT COMPLETED|Main Phase Stage 1||0
8530026|NCT01981850|9562089|FG006|NOT COMPLETED|Main Phase Stage 1||0
8530027|NCT01981850|9562090|FG007|NOT COMPLETED|Main Phase Stage 1||0
8530028|NCT01981850|9562091|FG008|NOT COMPLETED|Main Phase Stage 1||0
8530029|NCT01981850|9562092|FG009|NOT COMPLETED|Main Phase Stage 1||0
8530030|NCT01981850|9562083|FG000|STARTED|Main Phase Stage 2||0
8530031|NCT01981850|9562084|FG001|STARTED|Main Phase Stage 2||0
8530032|NCT01981850|9562085|FG002|STARTED|Main Phase Stage 2||0
8530033|NCT01981850|9562086|FG003|STARTED|Main Phase Stage 2||0
8530034|NCT01981850|9562087|FG004|STARTED|Main Phase Stage 2||33
8530035|NCT01981850|9562088|FG005|STARTED|Main Phase Stage 2||32
8530036|NCT01981850|9562089|FG006|STARTED|Main Phase Stage 2||32
8530037|NCT01981850|9562090|FG007|STARTED|Main Phase Stage 2||0
8530038|NCT01981850|9562091|FG008|STARTED|Main Phase Stage 2||0
8530039|NCT01981850|9562092|FG009|STARTED|Main Phase Stage 2||0
8530040|NCT01981850|9562083|FG000|COMPLETED|Main Phase Stage 2||0
8530041|NCT01981850|9562084|FG001|COMPLETED|Main Phase Stage 2||0
8530042|NCT01981850|9562085|FG002|COMPLETED|Main Phase Stage 2||0
8530043|NCT01981850|9562086|FG003|COMPLETED|Main Phase Stage 2||0
8530044|NCT01981850|9562087|FG004|COMPLETED|Main Phase Stage 2||20
8530045|NCT01981850|9562088|FG005|COMPLETED|Main Phase Stage 2||16
8530046|NCT01981850|9562089|FG006|COMPLETED|Main Phase Stage 2||15
8530047|NCT01981850|9562090|FG007|COMPLETED|Main Phase Stage 2||0
8530048|NCT01981850|9562091|FG008|COMPLETED|Main Phase Stage 2||0
8530049|NCT01981850|9562092|FG009|COMPLETED|Main Phase Stage 2||0
8530050|NCT01981850|9562083|FG000|NOT COMPLETED|Main Phase Stage 2||0
8530051|NCT01981850|9562084|FG001|NOT COMPLETED|Main Phase Stage 2||0
8530052|NCT01981850|9562085|FG002|NOT COMPLETED|Main Phase Stage 2||0
8530053|NCT01981850|9562086|FG003|NOT COMPLETED|Main Phase Stage 2||0
8530054|NCT01981850|9562087|FG004|NOT COMPLETED|Main Phase Stage 2||13
8530055|NCT01981850|9562088|FG005|NOT COMPLETED|Main Phase Stage 2||16
8530056|NCT01981850|9562089|FG006|NOT COMPLETED|Main Phase Stage 2||17
8530057|NCT01981850|9562090|FG007|NOT COMPLETED|Main Phase Stage 2||0
8530058|NCT01981850|9562091|FG008|NOT COMPLETED|Main Phase Stage 2||0
8530059|NCT01981850|9562092|FG009|NOT COMPLETED|Main Phase Stage 2||0
8530060|NCT01981850|9562083|FG000|STARTED|Open Label Extension (OLE)||0
8530061|NCT01981850|9562084|FG001|STARTED|Open Label Extension (OLE)||0
8530062|NCT01981850|9562085|FG002|STARTED|Open Label Extension (OLE)||0
8530063|NCT01981850|9562086|FG003|STARTED|Open Label Extension (OLE)||0
8530064|NCT01981850|9562087|FG004|STARTED|Open Label Extension (OLE)||0
8530065|NCT01981850|9562088|FG005|STARTED|Open Label Extension (OLE)||0
8530066|NCT01981850|9562089|FG006|STARTED|Open Label Extension (OLE)||0
8530067|NCT01981850|9562090|FG007|STARTED|Open Label Extension (OLE)||13
8530068|NCT01981850|9562091|FG008|STARTED|Open Label Extension (OLE)||5
8530069|NCT01981850|9562092|FG009|STARTED|Open Label Extension (OLE)||48
8530070|NCT01981850|9562083|FG000|COMPLETED|Open Label Extension (OLE)||0
8530071|NCT01981850|9562084|FG001|COMPLETED|Open Label Extension (OLE)||0
8530072|NCT01981850|9562085|FG002|COMPLETED|Open Label Extension (OLE)||0
8530073|NCT01981850|9562086|FG003|COMPLETED|Open Label Extension (OLE)||0
8530074|NCT01981850|9562087|FG004|COMPLETED|Open Label Extension (OLE)||0
8530075|NCT01981850|9562088|FG005|COMPLETED|Open Label Extension (OLE)||0
8530076|NCT01981850|9562089|FG006|COMPLETED|Open Label Extension (OLE)||0
8530077|NCT01981850|9562090|FG007|COMPLETED|Open Label Extension (OLE)||1
8530078|NCT01981850|9562091|FG008|COMPLETED|Open Label Extension (OLE)||0
8530079|NCT01981850|9562092|FG009|COMPLETED|Open Label Extension (OLE)||0
8530080|NCT01981850|9562083|FG000|NOT COMPLETED|Open Label Extension (OLE)||0
8530081|NCT01981850|9562084|FG001|NOT COMPLETED|Open Label Extension (OLE)||0
8530082|NCT01981850|9562085|FG002|NOT COMPLETED|Open Label Extension (OLE)||0
8530083|NCT01981850|9562086|FG003|NOT COMPLETED|Open Label Extension (OLE)||0
8530084|NCT01981850|9562087|FG004|NOT COMPLETED|Open Label Extension (OLE)||0
8530085|NCT01981850|9562088|FG005|NOT COMPLETED|Open Label Extension (OLE)||0
8530086|NCT01981850|9562089|FG006|NOT COMPLETED|Open Label Extension (OLE)||0
8530087|NCT01981850|9562090|FG007|NOT COMPLETED|Open Label Extension (OLE)||12
8530088|NCT01981850|9562091|FG008|NOT COMPLETED|Open Label Extension (OLE)||5
8530089|NCT01981850|9562092|FG009|NOT COMPLETED|Open Label Extension (OLE)||48
8530090|NCT01804816|9562124|FG000|STARTED|No Acupuncture (Initial 5 Weeks)||14
8530091|NCT01804816|9562124|FG000|COMPLETED|No Acupuncture (Initial 5 Weeks)||11
8530092|NCT01804816|9562124|FG000|NOT COMPLETED|No Acupuncture (Initial 5 Weeks)||3
8530093|NCT01804816|9562124|FG000|STARTED|Acupuncture (Second 5 Weeks)||11
8530094|NCT01804816|9562124|FG000|COMPLETED|Acupuncture (Second 5 Weeks)||10
8530095|NCT01804816|9562124|FG000|NOT COMPLETED|Acupuncture (Second 5 Weeks)||1
8530096|NCT01572207|9562133|FG000|STARTED|Overall Study||14
8530097|NCT01572207|9562134|FG001|STARTED|Overall Study||16
8530098|NCT01572207|9562133|FG000|COMPLETED|Overall Study||12
8530099|NCT01572207|9562134|FG001|COMPLETED|Overall Study||13
8530100|NCT01572207|9562133|FG000|NOT COMPLETED|Overall Study||2
8530101|NCT01572207|9562134|FG001|NOT COMPLETED|Overall Study||3
8530102|NCT01550315|9562142|FG000|STARTED|Overall Study||7
8530103|NCT01550315|9562143|FG001|STARTED|Overall Study||7
8530104|NCT01550315|9562144|FG002|STARTED|Overall Study||6
8530105|NCT01550315|9562145|FG003|STARTED|Overall Study||7
8530106|NCT01550315|9562142|FG000|COMPLETED|Overall Study||7
8530107|NCT01550315|9562143|FG001|COMPLETED|Overall Study||7
8530108|NCT01550315|9562144|FG002|COMPLETED|Overall Study||6
8530109|NCT01550315|9562145|FG003|COMPLETED|Overall Study||7
8530110|NCT01550315|9562142|FG000|NOT COMPLETED|Overall Study||0
8530111|NCT01550315|9562143|FG001|NOT COMPLETED|Overall Study||0
8530112|NCT01550315|9562144|FG002|NOT COMPLETED|Overall Study||0
8530113|NCT01550315|9562145|FG003|NOT COMPLETED|Overall Study||0
8530114|NCT01519960|9562158|FG000|STARTED|Overall Study||101
8530115|NCT01519960|9562159|FG001|STARTED|Overall Study||50
8530116|NCT01519960|9562160|FG002|STARTED|Overall Study||10
8530117|NCT01519960|9562158|FG000|Completed Week 48|Overall Study||99
8530118|NCT01519960|9562159|FG001|Completed Week 48|Overall Study||47
8530119|NCT01519960|9562160|FG002|Completed Week 48|Overall Study||10
8530120|NCT01519960|9562158|FG000|Completed Follow-Up (FU) Week 12|Overall Study||101
8530121|NCT01519960|9562159|FG001|Completed Follow-Up (FU) Week 12|Overall Study||26
8530122|NCT01519960|9562160|FG002|Completed Follow-Up (FU) Week 12|Overall Study||10
8530123|NCT01519960|9562158|FG000|Completed FU Week 24|Overall Study||101
8530124|NCT01519960|9562159|FG001|Completed FU Week 24|Overall Study||15
8530125|NCT01519960|9562160|FG002|Completed FU Week 24|Overall Study||10
8530126|NCT01519960|9562158|FG000|COMPLETED|Overall Study||0
8530127|NCT01519960|9562159|FG001|COMPLETED|Overall Study||0
8530128|NCT01519960|9562160|FG002|COMPLETED|Overall Study||0
8530129|NCT01519960|9562158|FG000|NOT COMPLETED|Overall Study||101
8530130|NCT01519960|9562159|FG001|NOT COMPLETED|Overall Study||50
8530131|NCT01519960|9562160|FG002|NOT COMPLETED|Overall Study||10
8530132|NCT00688376|9562173|FG000|STARTED|Double-Blind Phase||40
8530133|NCT00688376|9562174|FG001|STARTED|Double-Blind Phase||32
8530134|NCT00688376|9562173|FG000|Safety Population|Double-Blind Phase||40
8530135|NCT00688376|9562174|FG001|Safety Population|Double-Blind Phase||31
8530136|NCT00688376|9562173|FG000|COMPLETED|Double-Blind Phase||34
8530137|NCT00688376|9562174|FG001|COMPLETED|Double-Blind Phase||25
8530138|NCT00688376|9562173|FG000|NOT COMPLETED|Double-Blind Phase||6
8530139|NCT00688376|9562174|FG001|NOT COMPLETED|Double-Blind Phase||7
8530140|NCT00688376|9562173|FG000|STARTED|Blinded Extension Phase||34
8530141|NCT00688376|9562174|FG001|STARTED|Blinded Extension Phase||25
8530142|NCT00688376|9562173|FG000|COMPLETED|Blinded Extension Phase||29
8530143|NCT00688376|9562174|FG001|COMPLETED|Blinded Extension Phase||20
8530144|NCT00688376|9562173|FG000|NOT COMPLETED|Blinded Extension Phase||5
8530145|NCT00688376|9562174|FG001|NOT COMPLETED|Blinded Extension Phase||5
8530146|NCT00604201|9562182|FG000|STARTED|Overall Study||31
8530147|NCT00604201|9562182|FG000|COMPLETED|Overall Study||21
8530148|NCT00604201|9562182|FG000|NOT COMPLETED|Overall Study||10
8530149|NCT00492349|9562188|FG000|STARTED|Overall Study||35
8530150|NCT00492349|9562189|FG001|STARTED|Overall Study||34
8530151|NCT00492349|9562188|FG000|Week 2|Overall Study||32
8530152|NCT00492349|9562189|FG001|Week 2|Overall Study||33
8530153|NCT00492349|9562188|FG000|Week 8|Overall Study||32
8530154|NCT00492349|9562189|FG001|Week 8|Overall Study||27
8530155|NCT00492349|9562188|FG000|COMPLETED|Overall Study||32
8530156|NCT00492349|9562189|FG001|COMPLETED|Overall Study||27
8530157|NCT00492349|9562188|FG000|NOT COMPLETED|Overall Study||3
8530158|NCT00492349|9562189|FG001|NOT COMPLETED|Overall Study||7
8530159|NCT00121108|9562201|FG000|STARTED|Overall Study||710
8530160|NCT00121108|9562202|FG001|STARTED|Overall Study||1417
8530161|NCT00121108|9562201|FG000|COMPLETED|Overall Study||589
8530162|NCT00121108|9562202|FG001|COMPLETED|Overall Study||1192
8530163|NCT00121108|9562201|FG000|NOT COMPLETED|Overall Study||121
8530164|NCT00121108|9562202|FG001|NOT COMPLETED|Overall Study||225
8530165|NCT00003102|9562212|FG000|STARTED|Overall Study||3
8530166|NCT00003102|9562213|FG001|STARTED|Overall Study||9
8530167|NCT00003102|9562214|FG002|STARTED|Overall Study||3
8530168|NCT00003102|9562212|FG000|COMPLETED|Overall Study||2
8530169|NCT00003102|9562213|FG001|COMPLETED|Overall Study||6
8530170|NCT00003102|9562214|FG002|COMPLETED|Overall Study||1
8530171|NCT00003102|9562212|FG000|NOT COMPLETED|Overall Study||1
8530172|NCT00003102|9562213|FG001|NOT COMPLETED|Overall Study||3
8530173|NCT00003102|9562214|FG002|NOT COMPLETED|Overall Study||2
8563779|NCT00048568|9595753|FG000|STARTED|Double-Blind Period Days 1 to 169||433
8563780|NCT00048568|9595754|FG001|STARTED|Double-Blind Period Days 1 to 169||219
8563781|NCT00048568|9595755|FG002|STARTED|Double-Blind Period Days 1 to 169||0
8563782|NCT00048568|9595753|FG000|COMPLETED|Double-Blind Period Days 1 to 169||401
8563783|NCT00048568|9595754|FG001|COMPLETED|Double-Blind Period Days 1 to 169||174
8563784|NCT00048568|9595755|FG002|COMPLETED|Double-Blind Period Days 1 to 169||0
8563785|NCT00048568|9595753|FG000|NOT COMPLETED|Double-Blind Period Days 1 to 169||32
8563786|NCT00048568|9595754|FG001|NOT COMPLETED|Double-Blind Period Days 1 to 169||45
8563787|NCT00048568|9595755|FG002|NOT COMPLETED|Double-Blind Period Days 1 to 169||0
8563788|NCT00048568|9595753|FG000|STARTED|Double-Blind Period Days 170 to 365||401
8563789|NCT00048568|9595754|FG001|STARTED|Double-Blind Period Days 170 to 365||174
8563790|NCT00048568|9595755|FG002|STARTED|Double-Blind Period Days 170 to 365||0
8563791|NCT00048568|9595753|FG000|COMPLETED|Double-Blind Period Days 170 to 365||385
8563792|NCT00048568|9595754|FG001|COMPLETED|Double-Blind Period Days 170 to 365||162
8563793|NCT00048568|9595755|FG002|COMPLETED|Double-Blind Period Days 170 to 365||0
8563794|NCT00048568|9595753|FG000|NOT COMPLETED|Double-Blind Period Days 170 to 365||16
8563795|NCT00048568|9595754|FG001|NOT COMPLETED|Double-Blind Period Days 170 to 365||12
8563796|NCT00048568|9595755|FG002|NOT COMPLETED|Double-Blind Period Days 170 to 365||0
8563797|NCT00048568|9595753|FG000|STARTED|Open-Label Period||0
8563798|NCT00048568|9595754|FG001|STARTED|Open-Label Period||0
8563799|NCT00048568|9595755|FG002|STARTED|Open-Label Period||539
8563800|NCT00048568|9595753|FG000|COMPLETED|Open-Label Period||0
8563801|NCT00048568|9595754|FG001|COMPLETED|Open-Label Period||0
8563802|NCT00048568|9595755|FG002|COMPLETED|Open-Label Period||379
8563803|NCT00048568|9595753|FG000|NOT COMPLETED|Open-Label Period||0
8563804|NCT00048568|9595754|FG001|NOT COMPLETED|Open-Label Period||0
8563805|NCT00048568|9595755|FG002|NOT COMPLETED|Open-Label Period||160
8563806|NCT00048581|9595778|FG000|STARTED|Double-Blind Period||258
8563807|NCT00048581|9595779|FG001|STARTED|Double-Blind Period||133
8563808|NCT00048581|9595780|FG002|STARTED|Double-Blind Period||0
8563809|NCT00048581|9595778|FG000|COMPLETED|Double-Blind Period||223
8563810|NCT00048581|9595779|FG001|COMPLETED|Double-Blind Period||99
8563811|NCT00048581|9595780|FG002|COMPLETED|Double-Blind Period||0
8563812|NCT00048581|9595778|FG000|NOT COMPLETED|Double-Blind Period||35
8563813|NCT00048581|9595779|FG001|NOT COMPLETED|Double-Blind Period||34
8563814|NCT00048581|9595780|FG002|NOT COMPLETED|Double-Blind Period||0
8563815|NCT00048581|9595778|FG000|STARTED|Open-Label Period||0
8563816|NCT00048581|9595779|FG001|STARTED|Open-Label Period||0
8563817|NCT00048581|9595780|FG002|STARTED|Open-Label Period||317
8563818|NCT00048581|9595778|FG000|COMPLETED|Open-Label Period||0
8563819|NCT00048581|9595779|FG001|COMPLETED|Open-Label Period||0
8563820|NCT00048581|9595780|FG002|COMPLETED|Open-Label Period||150
8563821|NCT00048581|9595778|FG000|NOT COMPLETED|Open-Label Period||0
8563822|NCT00048581|9595779|FG001|NOT COMPLETED|Open-Label Period||0
8563823|NCT00048581|9595780|FG002|NOT COMPLETED|Open-Label Period||167
8563824|NCT00048724|9595795|FG000|STARTED|Overall Study||311
8563825|NCT00048724|9595796|FG001|STARTED|Overall Study||315
8563826|NCT00048724|9595795|FG000|COMPLETED|Overall Study||195
8563827|NCT00048724|9595796|FG001|COMPLETED|Overall Study||197
8563828|NCT00048724|9595795|FG000|NOT COMPLETED|Overall Study||116
8563829|NCT00048724|9595796|FG001|NOT COMPLETED|Overall Study||118
8563830|NCT00048737|9595802|FG000|STARTED|Overall Study||70
8563831|NCT00048737|9595802|FG000|COMPLETED|Overall Study||70
8563832|NCT00048737|9595802|FG000|NOT COMPLETED|Overall Study||0
8563833|NCT00048815|9595809|FG000|STARTED|Overall Study||24
8563834|NCT00048815|9595810|FG001|STARTED|Overall Study||26
8563835|NCT00048815|9595811|FG002|STARTED|Overall Study||23
8563836|NCT00048815|9595809|FG000|COMPLETED|Overall Study||18
8563837|NCT00048815|9595810|FG001|COMPLETED|Overall Study||22
8563838|NCT00048815|9595811|FG002|COMPLETED|Overall Study||19
8563839|NCT00048815|9595809|FG000|NOT COMPLETED|Overall Study||6
8563840|NCT00048815|9595810|FG001|NOT COMPLETED|Overall Study||4
8563841|NCT00048815|9595811|FG002|NOT COMPLETED|Overall Study||4
8563842|NCT00048893|9595819|FG000|STARTED|Overall Study||37
8563843|NCT00048893|9595819|FG000|COMPLETED|Overall Study||37
8530174|NCT04633837|9562224|FG000|STARTED|Overall Study||5
8530175|NCT04633837|9562225|FG001|STARTED|Overall Study||0
8530176|NCT04633837|9562224|FG000|COMPLETED|Overall Study||0
8530177|NCT04633837|9562225|FG001|COMPLETED|Overall Study||0
8530178|NCT04633837|9562224|FG000|NOT COMPLETED|Overall Study||5
8530179|NCT04633837|9562225|FG001|NOT COMPLETED|Overall Study||0
8530180|NCT04352127|9562234|FG000|STARTED|Overall Study||29
8530181|NCT04352127|9562235|FG001|STARTED|Overall Study||26
8530182|NCT04352127|9562236|FG002|STARTED|Overall Study||50
8530183|NCT04352127|9562234|FG000|COMPLETED|Overall Study||25
8530184|NCT04352127|9562235|FG001|COMPLETED|Overall Study||25
8530185|NCT04352127|9562236|FG002|COMPLETED|Overall Study||50
8530186|NCT04352127|9562234|FG000|NOT COMPLETED|Overall Study||4
8530187|NCT04352127|9562235|FG001|NOT COMPLETED|Overall Study||1
8530188|NCT04352127|9562236|FG002|NOT COMPLETED|Overall Study||0
8530189|NCT04057937|9562246|FG000|STARTED|Placebo-controlled Phase||44
8530190|NCT04057937|9562247|FG001|STARTED|Placebo-controlled Phase||46
8530191|NCT04057937|9562246|FG000|COMPLETED|Placebo-controlled Phase||41
8620606|NCT00474903|9659382|FG002|NOT COMPLETED|Overall Study||2
8620607|NCT00474929|9659395|FG000|STARTED|Overall Study||6
8620608|NCT00474929|9659396|FG001|STARTED|Overall Study||6
8620609|NCT00474929|9659397|FG002|STARTED|Overall Study||7
8620610|NCT00474929|9659398|FG003|STARTED|Overall Study||7
8620611|NCT00474929|9659399|FG004|STARTED|Overall Study||77
8620612|NCT00474929|9659395|FG000|COMPLETED|Overall Study||6
8620613|NCT00474929|9659396|FG001|COMPLETED|Overall Study||5
8620614|NCT00474929|9659397|FG002|COMPLETED|Overall Study||5
8530192|NCT04057937|9562247|FG001|COMPLETED|Placebo-controlled Phase||46
8530193|NCT04057937|9562246|FG000|NOT COMPLETED|Placebo-controlled Phase||3
8530194|NCT04057937|9562247|FG001|NOT COMPLETED|Placebo-controlled Phase||0
8530195|NCT04057937|9562246|FG000|STARTED|Active-treatment Phase||41
8530196|NCT04057937|9562247|FG001|STARTED|Active-treatment Phase||46
8530197|NCT04057937|9562246|FG000|COMPLETED|Active-treatment Phase||40
8530198|NCT04057937|9562247|FG001|COMPLETED|Active-treatment Phase||44
8530199|NCT04057937|9562246|FG000|NOT COMPLETED|Active-treatment Phase||1
8530200|NCT04057937|9562247|FG001|NOT COMPLETED|Active-treatment Phase||2
8530201|NCT03566732|9562254|FG000|STARTED|Overall Study|1683 eligible cases identified and screened, 914 participants enrolled.|914
8530202|NCT03566732|9562254|FG000|COMPLETED|Overall Study|914 completed questionnaires|914
8530203|NCT03566732|9562254|FG000|NOT COMPLETED|Overall Study||0
8530204|NCT03032510|9562260|FG000|STARTED|Overall Study||603
8530205|NCT03032510|9562261|FG001|STARTED|Overall Study||602
8530206|NCT03032510|9562260|FG000|COMPLETED|Overall Study||576
8530207|NCT03032510|9562261|FG001|COMPLETED|Overall Study||584
8530208|NCT03032510|9562260|FG000|NOT COMPLETED|Overall Study||27
8530209|NCT03032510|9562261|FG001|NOT COMPLETED|Overall Study||18
8530210|NCT03029000|9562271|FG000|STARTED|Overall Study||1
8530211|NCT03029000|9562271|FG000|COMPLETED|Overall Study||1
8530212|NCT03029000|9562271|FG000|NOT COMPLETED|Overall Study||0
8530213|NCT03022292|9562275|FG000|STARTED|Overall Study||26
8530214|NCT03022292|9562275|FG000|COMPLETED|Overall Study||24
8530215|NCT03022292|9562275|FG000|NOT COMPLETED|Overall Study||2
8530216|NCT02968602|9562281|FG000|STARTED|Overall Study||16
8530217|NCT02968602|9562282|FG001|STARTED|Overall Study||16
8530218|NCT02968602|9562281|FG000|COMPLETED|Overall Study||16
8530219|NCT02968602|9562282|FG001|COMPLETED|Overall Study||16
8530220|NCT02968602|9562281|FG000|NOT COMPLETED|Overall Study||0
8530221|NCT02968602|9562282|FG001|NOT COMPLETED|Overall Study||0
8530222|NCT02946047|9562292|FG000|STARTED|Overall Study||4
8530223|NCT02946047|9562293|FG001|STARTED|Overall Study||3
8530224|NCT02946047|9562294|FG002|STARTED|Overall Study||3
8530225|NCT02946047|9562295|FG003|STARTED|Overall Study||7
8530226|NCT02946047|9562292|FG000|COMPLETED|Overall Study||3
8530227|NCT02946047|9562293|FG001|COMPLETED|Overall Study||3
8530228|NCT02946047|9562294|FG002|COMPLETED|Overall Study||3
8530229|NCT02946047|9562295|FG003|COMPLETED|Overall Study||7
8530230|NCT02946047|9562292|FG000|NOT COMPLETED|Overall Study||1
8530231|NCT02946047|9562293|FG001|NOT COMPLETED|Overall Study||0
8530232|NCT02946047|9562294|FG002|NOT COMPLETED|Overall Study||0
8530233|NCT02946047|9562295|FG003|NOT COMPLETED|Overall Study||0
8530234|NCT02830165|9562305|FG000|STARTED|Overall Study||11
8530235|NCT02830165|9562305|FG000|COMPLETED|Overall Study||11
8530236|NCT02830165|9562305|FG000|NOT COMPLETED|Overall Study||0
8530237|NCT02784704|9562313|FG000|STARTED|Overall Study||250
8530238|NCT02784704|9562314|FG001|STARTED|Overall Study||250
8620615|NCT00474929|9659398|FG003|COMPLETED|Overall Study||5
8620616|NCT00474929|9659399|FG004|COMPLETED|Overall Study||77
8620617|NCT00474929|9659395|FG000|NOT COMPLETED|Overall Study||0
8530239|NCT02784704|9562313|FG000|Treated|Overall Study||250
8530240|NCT02784704|9562314|FG001|Treated|Overall Study||249
8530241|NCT02784704|9562313|FG000|COMPLETED|Overall Study||237
8530242|NCT02784704|9562314|FG001|COMPLETED|Overall Study||241
8530243|NCT02784704|9562313|FG000|NOT COMPLETED|Overall Study||13
8530244|NCT02784704|9562314|FG001|NOT COMPLETED|Overall Study||9
8530245|NCT04831515|9562322|FG000|STARTED|First Intervention||24
8530246|NCT04831515|9562323|FG001|STARTED|First Intervention||24
8530247|NCT04831515|9562322|FG000|COMPLETED|First Intervention||24
8530248|NCT04831515|9562323|FG001|COMPLETED|First Intervention||23
8530249|NCT04831515|9562322|FG000|NOT COMPLETED|First Intervention||0
8620618|NCT00474929|9659396|FG001|NOT COMPLETED|Overall Study||1
8620619|NCT00474929|9659397|FG002|NOT COMPLETED|Overall Study||2
8620620|NCT00474929|9659398|FG003|NOT COMPLETED|Overall Study||2
8530250|NCT04831515|9562323|FG001|NOT COMPLETED|First Intervention||1
8530251|NCT04831515|9562322|FG000|STARTED|Second Intervention||24
8530252|NCT04831515|9562323|FG001|STARTED|Second Intervention||23
8530253|NCT04831515|9562322|FG000|COMPLETED|Second Intervention||24
8530254|NCT04831515|9562323|FG001|COMPLETED|Second Intervention||23
8530255|NCT04831515|9562322|FG000|NOT COMPLETED|Second Intervention||0
8530256|NCT04831515|9562323|FG001|NOT COMPLETED|Second Intervention||0
8563844|NCT00048893|9595819|FG000|NOT COMPLETED|Overall Study||0
8563845|NCT00048932|9595825|FG000|STARTED|Double Blind Period (DB)|Number Treated|959
8563846|NCT00048932|9595826|FG001|STARTED|Double Blind Period (DB)|Number Treated|482
8563847|NCT00048932|9595827|FG002|STARTED|Double Blind Period (DB)||0
8563848|NCT00048932|9595825|FG000|COMPLETED|Double Blind Period (DB)||836
8563849|NCT00048932|9595826|FG001|COMPLETED|Double Blind Period (DB)||395
8563850|NCT00048932|9595827|FG002|COMPLETED|Double Blind Period (DB)||0
8563851|NCT00048932|9595825|FG000|NOT COMPLETED|Double Blind Period (DB)||123
8563852|NCT00048932|9595826|FG001|NOT COMPLETED|Double Blind Period (DB)||87
8563853|NCT00048932|9595827|FG002|NOT COMPLETED|Double Blind Period (DB)||0
8563854|NCT00048932|9595825|FG000|STARTED|Open Label Period (OL)||0
8563855|NCT00048932|9595826|FG001|STARTED|Open Label Period (OL)||0
8563856|NCT00048932|9595827|FG002|STARTED|Open Label Period (OL)|47 participants who completed the double-blind did not enter the open-label|1184
8563857|NCT00048932|9595825|FG000|COMPLETED|Open Label Period (OL)||0
8563858|NCT00048932|9595826|FG001|COMPLETED|Open Label Period (OL)||0
8563859|NCT00048932|9595827|FG002|COMPLETED|Open Label Period (OL)||743
8563860|NCT00048932|9595825|FG000|NOT COMPLETED|Open Label Period (OL)||0
8563861|NCT00048932|9595826|FG001|NOT COMPLETED|Open Label Period (OL)||0
8563862|NCT00048932|9595827|FG002|NOT COMPLETED|Open Label Period (OL)||441
8563863|NCT00048997|9595838|FG000|STARTED|Overall Study||176
8563864|NCT00048997|9595839|FG001|STARTED|Overall Study||180
8563865|NCT00048997|9595838|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|163
8563866|NCT00048997|9595839|FG001|COMPLETED|Overall Study||177
8563867|NCT00048997|9595838|FG000|NOT COMPLETED|Overall Study||13
8563868|NCT00048997|9595839|FG001|NOT COMPLETED|Overall Study||3
8563869|NCT00049036|9595846|FG000|STARTED|Overall Study||51
8563870|NCT00049036|9595847|FG001|STARTED|Overall Study||55
8563871|NCT00049036|9595846|FG000|COMPLETED|Overall Study||51
8563872|NCT00049036|9595847|FG001|COMPLETED|Overall Study||55
8563873|NCT00049036|9595846|FG000|NOT COMPLETED|Overall Study||0
8563874|NCT00049036|9595847|FG001|NOT COMPLETED|Overall Study||0
8563875|NCT00049127|9595858|FG000|STARTED|Overall Study||12
8563876|NCT00049127|9595859|FG001|STARTED|Overall Study||0
8563877|NCT00049127|9595860|FG002|STARTED|Overall Study||40
8563878|NCT00049127|9595861|FG003|STARTED|Overall Study||0
8563879|NCT00049127|9595862|FG004|STARTED|Overall Study||12
8563880|NCT00049127|9595858|FG000|COMPLETED|Overall Study||12
8563881|NCT00049127|9595859|FG001|COMPLETED|Overall Study||0
8563882|NCT00049127|9595860|FG002|COMPLETED|Overall Study||39
8563883|NCT00049127|9595861|FG003|COMPLETED|Overall Study||0
8563884|NCT00049127|9595862|FG004|COMPLETED|Overall Study||12
8563885|NCT00049127|9595858|FG000|NOT COMPLETED|Overall Study||0
8563886|NCT00049127|9595859|FG001|NOT COMPLETED|Overall Study||0
8563887|NCT00049127|9595860|FG002|NOT COMPLETED|Overall Study||1
8563888|NCT00049127|9595861|FG003|NOT COMPLETED|Overall Study||0
8563889|NCT00049127|9595862|FG004|NOT COMPLETED|Overall Study||0
8563890|NCT00049257|9595874|FG000|STARTED|Carboplatin, Paclitaxel||58
8563891|NCT00049257|9595874|FG000|COMPLETED|Carboplatin, Paclitaxel|13 participants did not complete treatment|45
8563892|NCT00049257|9595874|FG000|NOT COMPLETED|Carboplatin, Paclitaxel||13
8563893|NCT00049257|9595874|FG000|STARTED|Follow-up Period for Survival Status||45
8563894|NCT00049257|9595874|FG000|COMPLETED|Follow-up Period for Survival Status||41
8563895|NCT00049257|9595874|FG000|NOT COMPLETED|Follow-up Period for Survival Status||4
8563896|NCT00049322|9595880|FG000|STARTED|Overall Study||15
8563897|NCT00049322|9595881|FG001|STARTED|Overall Study||15
8563898|NCT00049322|9595880|FG000|COMPLETED|Overall Study||14
8563899|NCT00049322|9595881|FG001|COMPLETED|Overall Study||9
8563900|NCT00049322|9595880|FG000|NOT COMPLETED|Overall Study||1
8563901|NCT00049322|9595881|FG001|NOT COMPLETED|Overall Study||6
8563902|NCT00049504|9595889|FG000|STARTED|Overall Study||55
8563903|NCT00049504|9595889|FG000|COMPLETED|Overall Study||55
8563904|NCT00049504|9595889|FG000|NOT COMPLETED|Overall Study||0
8563905|NCT00049517|9595895|FG000|STARTED|Induction||79
8563906|NCT00049517|9595896|FG001|STARTED|Induction||90
8563907|NCT00049517|9595897|FG002|STARTED|Induction||63
8563908|NCT00049517|9595898|FG003|STARTED|Induction||75
8563909|NCT00049517|9595899|FG004|STARTED|Induction||188
8563910|NCT00049517|9595900|FG005|STARTED|Induction||162
8563911|NCT00049517|9595895|FG000|Treated|Induction||79
8563912|NCT00049517|9595896|FG001|Treated|Induction||90
8563913|NCT00049517|9595897|FG002|Treated|Induction||63
8563914|NCT00049517|9595898|FG003|Treated|Induction||75
8563915|NCT00049517|9595899|FG004|Treated|Induction||186
8563916|NCT00049517|9595900|FG005|Treated|Induction||160
8563917|NCT00049517|9595895|FG000|COMPLETED|Induction||79
8563918|NCT00049517|9595896|FG001|COMPLETED|Induction||90
8563919|NCT00049517|9595897|FG002|COMPLETED|Induction||63
8563920|NCT00049517|9595898|FG003|COMPLETED|Induction||75
8563921|NCT00049517|9595899|FG004|COMPLETED|Induction||128
8563922|NCT00049517|9595900|FG005|COMPLETED|Induction||108
8563923|NCT00049517|9595895|FG000|NOT COMPLETED|Induction||0
8563924|NCT00049517|9595896|FG001|NOT COMPLETED|Induction||0
8563925|NCT00049517|9595897|FG002|NOT COMPLETED|Induction||0
8530257|NCT04343989|9562332|FG000|STARTED|Overall Study||78
8530258|NCT04343989|9562333|FG001|STARTED|Overall Study||26
8530259|NCT04343989|9562334|FG002|STARTED|Overall Study||74
8530260|NCT04343989|9562332|FG000|COMPLETED|Overall Study||78
8530261|NCT04343989|9562333|FG001|COMPLETED|Overall Study||26
8530262|NCT04343989|9562334|FG002|COMPLETED|Overall Study||74
8530263|NCT04343989|9562332|FG000|NOT COMPLETED|Overall Study||0
8530264|NCT04343989|9562333|FG001|NOT COMPLETED|Overall Study||0
8530265|NCT04343989|9562334|FG002|NOT COMPLETED|Overall Study||0
8530266|NCT04253834|9562344|FG000|STARTED|Overall Study||10
8530267|NCT04253834|9562345|FG001|STARTED|Overall Study||10
8530268|NCT04253834|9562344|FG000|COMPLETED|Overall Study||10
8530269|NCT04253834|9562345|FG001|COMPLETED|Overall Study||10
8530270|NCT04253834|9562344|FG000|NOT COMPLETED|Overall Study||0
8530271|NCT04253834|9562345|FG001|NOT COMPLETED|Overall Study||0
8530272|NCT03881059|9562354|FG000|STARTED|Treatment Period - Part A||66
8530273|NCT03881059|9562355|FG001|STARTED|Treatment Period - Part A||70
8530274|NCT03881059|9562356|FG002|STARTED|Treatment Period - Part A||67
8530275|NCT03881059|9562354|FG000|COMPLETED|Treatment Period - Part A||58
8530276|NCT03881059|9562355|FG001|COMPLETED|Treatment Period - Part A||63
8530277|NCT03881059|9562356|FG002|COMPLETED|Treatment Period - Part A||59
8530278|NCT03881059|9562354|FG000|NOT COMPLETED|Treatment Period - Part A||8
8530279|NCT03881059|9562355|FG001|NOT COMPLETED|Treatment Period - Part A||7
8530280|NCT03881059|9562356|FG002|NOT COMPLETED|Treatment Period - Part A||8
8530281|NCT03881059|9562354|FG000|STARTED|Treatment Period - Part B||55
8530282|NCT03881059|9562355|FG001|STARTED|Treatment Period - Part B||60
8530283|NCT03881059|9562356|FG002|STARTED|Treatment Period - Part B||58
8530284|NCT03881059|9562354|FG000|Participants Maintaining Same Treatment as in Part A|Treatment Period - Part B||0
8530285|NCT03881059|9562355|FG001|Participants Maintaining Same Treatment as in Part A|Treatment Period - Part B||13
8530286|NCT03881059|9562356|FG002|Participants Maintaining Same Treatment as in Part A|Treatment Period - Part B||16
8530287|NCT03881059|9562354|FG000|Participants Treated With Ustekinumab in Part B|Treatment Period - Part B||55
8530288|NCT03881059|9562355|FG001|Participants Treated With Ustekinumab in Part B|Treatment Period - Part B||47
8530289|NCT03881059|9562356|FG002|Participants Treated With Ustekinumab in Part B|Treatment Period - Part B||42
8530290|NCT03881059|9562354|FG000|COMPLETED|Treatment Period - Part B||47
8530291|NCT03881059|9562355|FG001|COMPLETED|Treatment Period - Part B||54
8530292|NCT03881059|9562356|FG002|COMPLETED|Treatment Period - Part B||47
8530293|NCT03881059|9562354|FG000|NOT COMPLETED|Treatment Period - Part B||8
8530294|NCT03881059|9562355|FG001|NOT COMPLETED|Treatment Period - Part B||6
8530295|NCT03881059|9562356|FG002|NOT COMPLETED|Treatment Period - Part B||11
8530296|NCT03878277|9562369|FG000|STARTED|Overall Study||10
8530297|NCT03878277|9562369|FG000|COMPLETED|Overall Study||10
8530298|NCT03878277|9562369|FG000|NOT COMPLETED|Overall Study||0
8530299|NCT03450629|9562375|FG000|STARTED|Overall Study||341
8530300|NCT03450629|9562376|FG001|STARTED|Overall Study||341
8530301|NCT03450629|9562375|FG000|COMPLETED|Overall Study||293
8530302|NCT03450629|9562376|FG001|COMPLETED|Overall Study||307
8530303|NCT03450629|9562375|FG000|NOT COMPLETED|Overall Study||48
8530304|NCT03450629|9562376|FG001|NOT COMPLETED|Overall Study||34
8530305|NCT03367403|9562385|FG000|STARTED|Overall Study||131
8530306|NCT03367403|9562386|FG001|STARTED|Overall Study||126
8530307|NCT03367403|9562387|FG002|STARTED|Overall Study||15
8530308|NCT03367403|9562385|FG000|Received at Least One Dose of Study Drug|Overall Study||131
8530309|NCT03367403|9562386|FG001|Received at Least One Dose of Study Drug|Overall Study||125
8530310|NCT03367403|9562387|FG002|Received at Least One Dose of Study Drug|Overall Study||15
8530311|NCT03367403|9562385|FG000|COMPLETED|Overall Study||94
8530312|NCT03367403|9562386|FG001|COMPLETED|Overall Study||93
8530313|NCT03367403|9562387|FG002|COMPLETED|Overall Study||12
8530314|NCT03367403|9562385|FG000|NOT COMPLETED|Overall Study||37
8530315|NCT03367403|9562386|FG001|NOT COMPLETED|Overall Study||33
8530316|NCT03367403|9562387|FG002|NOT COMPLETED|Overall Study||3
8530317|NCT03286426|9562395|FG000|STARTED|Overall Study||3
8530318|NCT03286426|9562395|FG000|COMPLETED|Overall Study||0
8530319|NCT03286426|9562395|FG000|NOT COMPLETED|Overall Study||3
8530320|NCT03135249|9562399|FG000|STARTED|Overall Study|Nine patient entered the study|9
8530321|NCT03135249|9562399|FG000|COMPLETED|Overall Study|Eight patient completed the study.|7
8530322|NCT03135249|9562399|FG000|NOT COMPLETED|Overall Study||2
8530323|NCT02818582|9562405|FG000|STARTED|Overall Study||20
8530324|NCT02818582|9562406|FG001|STARTED|Overall Study||18
8530325|NCT02818582|9562405|FG000|COMPLETED|Overall Study||20
8530326|NCT02818582|9562406|FG001|COMPLETED|Overall Study||18
8530327|NCT02818582|9562405|FG000|NOT COMPLETED|Overall Study||0
8620621|NCT00474929|9659399|FG004|NOT COMPLETED|Overall Study||0
8620622|NCT00474955|9659412|FG000|STARTED|Overall Study||27
8530328|NCT02818582|9562406|FG001|NOT COMPLETED|Overall Study||0
8530329|NCT02809677|9562412|FG000|STARTED|Overall Study||205
8530330|NCT02809677|9562412|FG000|COMPLETED|Overall Study||197
8530331|NCT02809677|9562412|FG000|NOT COMPLETED|Overall Study||8
8530332|NCT02728258|9562417|FG000|STARTED|Overall Study||11
8530333|NCT02728258|9562417|FG000|COMPLETED|Overall Study||11
8530334|NCT02728258|9562417|FG000|NOT COMPLETED|Overall Study||0
8530335|NCT02554253|9562423|FG000|STARTED|Overall Study||26
8530336|NCT02554253|9562424|FG001|STARTED|Overall Study||26
8530337|NCT02554253|9562423|FG000|COMPLETED|Overall Study||25
8530338|NCT02554253|9562424|FG001|COMPLETED|Overall Study||24
8530339|NCT02554253|9562423|FG000|NOT COMPLETED|Overall Study||1
8530340|NCT02554253|9562424|FG001|NOT COMPLETED|Overall Study||2
8530341|NCT01524536|9562431|FG000|STARTED|Overall Study||23
8530342|NCT01524536|9562431|FG000|COMPLETED|Overall Study||23
8530343|NCT01524536|9562431|FG000|NOT COMPLETED|Overall Study||0
8530344|NCT01307046|9562443|FG000|STARTED|Overall Study||166
8530345|NCT01307046|9562444|FG001|STARTED|Overall Study||170
8530346|NCT01307046|9562443|FG000|COMPLETED|Overall Study||154
8530347|NCT01307046|9562444|FG001|COMPLETED|Overall Study||159
8530348|NCT01307046|9562443|FG000|NOT COMPLETED|Overall Study||12
8816359|NCT01543685|9869850|FG003|COMPLETED|Overall Study||93
8816360|NCT01543685|9869851|FG004|COMPLETED|Overall Study||90
8530349|NCT01307046|9562444|FG001|NOT COMPLETED|Overall Study||11
8530350|NCT01307033|9562452|FG000|STARTED|8-week Double-blind Period||144
8530351|NCT01307033|9562453|FG001|STARTED|8-week Double-blind Period||134
8530352|NCT01307033|9562454|FG002|STARTED|8-week Double-blind Period||0
8530353|NCT01307033|9562455|FG003|STARTED|8-week Double-blind Period||0
8530354|NCT01307033|9562452|FG000|COMPLETED|8-week Double-blind Period||131
8530355|NCT01307033|9562453|FG001|COMPLETED|8-week Double-blind Period||127
8530356|NCT01307033|9562454|FG002|COMPLETED|8-week Double-blind Period||0
8530357|NCT01307033|9562455|FG003|COMPLETED|8-week Double-blind Period||0
8530358|NCT01307033|9562452|FG000|NOT COMPLETED|8-week Double-blind Period||13
8530359|NCT01307033|9562453|FG001|NOT COMPLETED|8-week Double-blind Period||7
8530360|NCT01307033|9562454|FG002|NOT COMPLETED|8-week Double-blind Period||0
8530361|NCT01307033|9562455|FG003|NOT COMPLETED|8-week Double-blind Period||0
8530362|NCT01307033|9562452|FG000|STARTED|44-week Open-label Extension||0
8530363|NCT01307033|9562453|FG001|STARTED|44-week Open-label Extension||0
8530364|NCT01307033|9562454|FG002|STARTED|44-week Open-label Extension||131
8530365|NCT01307033|9562455|FG003|STARTED|44-week Open-label Extension||127
8530366|NCT01307033|9562452|FG000|COMPLETED|44-week Open-label Extension||0
8530367|NCT01307033|9562453|FG001|COMPLETED|44-week Open-label Extension||0
8530368|NCT01307033|9562454|FG002|COMPLETED|44-week Open-label Extension||120
8530369|NCT01307033|9562455|FG003|COMPLETED|44-week Open-label Extension||115
8530370|NCT01307033|9562452|FG000|NOT COMPLETED|44-week Open-label Extension||0
8530371|NCT01307033|9562453|FG001|NOT COMPLETED|44-week Open-label Extension||0
8530372|NCT01307033|9562454|FG002|NOT COMPLETED|44-week Open-label Extension||11
8530373|NCT01307033|9562455|FG003|NOT COMPLETED|44-week Open-label Extension||12
8563926|NCT00049517|9595898|FG003|NOT COMPLETED|Induction||0
8563927|NCT00049517|9595899|FG004|NOT COMPLETED|Induction||60
8563928|NCT00049517|9595900|FG005|NOT COMPLETED|Induction||54
8563929|NCT00049517|9595895|FG000|STARTED|Conditioning/Transplant||79
8563930|NCT00049517|9595896|FG001|STARTED|Conditioning/Transplant||90
8563931|NCT00049517|9595897|FG002|STARTED|Conditioning/Transplant||63
8563932|NCT00049517|9595898|FG003|STARTED|Conditioning/Transplant||75
8563933|NCT00049517|9595899|FG004|STARTED|Conditioning/Transplant||21
8563934|NCT00049517|9595900|FG005|STARTED|Conditioning/Transplant||24
8563935|NCT00049517|9595895|FG000|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|Additional 20 patients received Autologous HCT without randomization.|59
8563936|NCT00049517|9595896|FG001|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|Additional 17 patients received Autologous HCT without randomization.|73
8563937|NCT00049517|9595897|FG002|Randomized to Autologous HCT +/- GO|Conditioning/Transplant||63
8563938|NCT00049517|9595898|FG003|Randomized to Autologous HCT +/- GO|Conditioning/Transplant||75
8563939|NCT00049517|9595899|FG004|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|These 21 patients received Allogeneic HCT without randomization.|0
8563940|NCT00049517|9595900|FG005|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|These 24 patients received Allogeneic HCT without randomization.|0
8563941|NCT00049517|9595895|FG000|COMPLETED|Conditioning/Transplant||27
8563942|NCT00049517|9595896|FG001|COMPLETED|Conditioning/Transplant||40
8563943|NCT00049517|9595897|FG002|COMPLETED|Conditioning/Transplant||25
8563944|NCT00049517|9595898|FG003|COMPLETED|Conditioning/Transplant||32
8563945|NCT00049517|9595899|FG004|COMPLETED|Conditioning/Transplant||15
8563946|NCT00049517|9595900|FG005|COMPLETED|Conditioning/Transplant||18
8563947|NCT00049517|9595895|FG000|NOT COMPLETED|Conditioning/Transplant||52
8563948|NCT00049517|9595896|FG001|NOT COMPLETED|Conditioning/Transplant||50
8563949|NCT00049517|9595897|FG002|NOT COMPLETED|Conditioning/Transplant||38
8563950|NCT00049517|9595898|FG003|NOT COMPLETED|Conditioning/Transplant||43
8563951|NCT00049517|9595899|FG004|NOT COMPLETED|Conditioning/Transplant||6
8563952|NCT00049517|9595900|FG005|NOT COMPLETED|Conditioning/Transplant||6
8563953|NCT00049530|9595908|FG000|STARTED|Overall Study||32
8563954|NCT00049530|9595908|FG000|Eligible and Treated|Overall Study||29
8563955|NCT00049530|9595908|FG000|COMPLETED|Overall Study||0
8563956|NCT00049530|9595908|FG000|NOT COMPLETED|Overall Study||32
8563957|NCT00049543|9595914|FG000|STARTED|Overall Study||251
8563958|NCT00049543|9595915|FG001|STARTED|Overall Study||252
8563959|NCT00049543|9595914|FG000|COMPLETED|Overall Study||249
8563960|NCT00049543|9595915|FG001|COMPLETED|Overall Study||243
8563961|NCT00049543|9595914|FG000|NOT COMPLETED|Overall Study||2
8563962|NCT00049543|9595915|FG001|NOT COMPLETED|Overall Study||9
8563963|NCT00049673|9595923|FG000|STARTED|Overall Study||166
8563964|NCT00049673|9595924|FG001|STARTED|Overall Study||166
8563965|NCT00049673|9595923|FG000|COMPLETED|Overall Study||165
8563966|NCT00049673|9595924|FG001|COMPLETED|Overall Study||163
8563967|NCT00049673|9595923|FG000|NOT COMPLETED|Overall Study||1
8563968|NCT00049673|9595924|FG001|NOT COMPLETED|Overall Study||3
8563969|NCT00049842|9595932|FG000|STARTED|Treatment Phase||270
8563970|NCT00049842|9595933|FG001|STARTED|Treatment Phase||270
8563971|NCT00049842|9595932|FG000|COMPLETED|Treatment Phase||177
8816361|NCT01543685|9869847|FG000|NOT COMPLETED|Overall Study||3
8530374|NCT00739674|9562469|FG000|STARTED|Overall Study||535
8530375|NCT00739674|9562470|FG001|STARTED|Overall Study||457
8530376|NCT00739674|9562469|FG000|Screening Failures|Overall Study||19
8530377|NCT00739674|9562470|FG001|Screening Failures|Overall Study|ITT population took at least one dose of the study medication and had one follow-up visit.|17
8530378|NCT00739674|9562469|FG000|Site 212 Removal|Overall Study|lack of source documentation & frequent discrepancies between source notes and case report entries.|19
8530379|NCT00739674|9562470|FG001|Site 212 Removal|Overall Study|lack of source documentation & frequent discrepancies between source notes and case report entries.|13
8530380|NCT00739674|9562469|FG000|No Follow-up Data|Overall Study||33
8530381|NCT00739674|9562470|FG001|No Follow-up Data|Overall Study||18
8530382|NCT00739674|9562469|FG000|Dietician Consultation >30 Days|Overall Study|Patients with dietician consultations >30 days after visit 1 were not included in the data analysis.|1
8530383|NCT00739674|9562470|FG001|Dietician Consultation >30 Days|Overall Study|Patients with dietician consultations >30 days after visit 1 were not included in the data analysis.|9
8530384|NCT00739674|9562469|FG000|Intent-to-treat (ITT) Population|Overall Study|ITT population took at least one dose of the study medication and had one follow-up visit.|463
8530385|NCT00739674|9562470|FG001|Intent-to-treat (ITT) Population|Overall Study|ITT population took at least one dose of the study medication and had one follow-up visit.|400
8530386|NCT00739674|9562469|FG000|COMPLETED|Overall Study||354
8530387|NCT00739674|9562470|FG001|COMPLETED|Overall Study||335
8530388|NCT00739674|9562469|FG000|NOT COMPLETED|Overall Study||181
8530389|NCT00739674|9562470|FG001|NOT COMPLETED|Overall Study||122
8530390|NCT00546754|9562478|FG000|STARTED|Overall Study|Number of patients enrolled and randomized|425
8530391|NCT00546754|9562479|FG001|STARTED|Overall Study|Number of patients enrolled and randomized|383
8530392|NCT00546754|9562478|FG000|Treated|Overall Study|Patients that received at least one dose of study medication and had 1 follow-up visit|416
8530393|NCT00546754|9562479|FG001|Treated|Overall Study|Patients that received at least one dose of study medication and had 1 follow-up visit|373
8530394|NCT00546754|9562478|FG000|Week 6|Overall Study||396
8530395|NCT00546754|9562479|FG001|Week 6|Overall Study||347
8530396|NCT00546754|9562478|FG000|Week 12|Overall Study||375
8530397|NCT00546754|9562479|FG001|Week 12|Overall Study||334
8530398|NCT00546754|9562478|FG000|COMPLETED|Overall Study||375
8530399|NCT00546754|9562479|FG001|COMPLETED|Overall Study||334
8530400|NCT00546754|9562478|FG000|NOT COMPLETED|Overall Study||50
8530401|NCT00546754|9562479|FG001|NOT COMPLETED|Overall Study||49
8530402|NCT00479713|9562487|FG000|STARTED|Overall Study||314
8530403|NCT00479713|9562488|FG001|STARTED|Overall Study||304
8530404|NCT00479713|9562487|FG000|COMPLETED|Overall Study||301
8530405|NCT00479713|9562488|FG001|COMPLETED|Overall Study||295
8530406|NCT00479713|9562487|FG000|NOT COMPLETED|Overall Study||13
8530407|NCT00479713|9562488|FG001|NOT COMPLETED|Overall Study||9
8530408|NCT00406783|9562496|FG000|STARTED|Overall Study||276
8530409|NCT00406783|9562497|FG001|STARTED|Overall Study||271
8530410|NCT00406783|9562496|FG000|COMPLETED|Overall Study||262
8530411|NCT00406783|9562497|FG001|COMPLETED|Overall Study||256
8530412|NCT00406783|9562496|FG000|NOT COMPLETED|Overall Study||14
8530413|NCT00406783|9562497|FG001|NOT COMPLETED|Overall Study||15
8620623|NCT00474955|9659412|FG000|COMPLETED|Overall Study||19
8620624|NCT00474955|9659412|FG000|NOT COMPLETED|Overall Study||8
8620625|NCT00474968|9659418|FG000|STARTED|Overall Study||366
8620626|NCT00474968|9659419|FG001|STARTED|Overall Study||371
8620627|NCT00474968|9659418|FG000|COMPLETED|Overall Study||348
8620628|NCT00474968|9659419|FG001|COMPLETED|Overall Study||355
8620629|NCT00474968|9659418|FG000|NOT COMPLETED|Overall Study||18
8620630|NCT00474968|9659419|FG001|NOT COMPLETED|Overall Study||16
8620631|NCT00474994|9659425|FG000|STARTED|Overall Study||53
8620632|NCT00474994|9659425|FG000|COMPLETED|Overall Study||48
8620633|NCT00474994|9659425|FG000|NOT COMPLETED|Overall Study||5
8620634|NCT00475020|9659429|FG000|STARTED|Overall Study||63
8620635|NCT00475020|9659429|FG000|COMPLETED|Overall Study||58
8620636|NCT00475020|9659429|FG000|NOT COMPLETED|Overall Study||5
8620637|NCT00475033|9659435|FG000|STARTED|Infant Series||300
8620638|NCT00475033|9659436|FG001|STARTED|Infant Series||303
8620639|NCT00475033|9659435|FG000|Vaccinated Dose 1|Infant Series||300
8620640|NCT00475033|9659436|FG001|Vaccinated Dose 1|Infant Series||303
8530414|NCT00405964|9562505|FG000|STARTED|Overall Study||360
8530415|NCT00405964|9562506|FG001|STARTED|Overall Study||356
8530416|NCT00405964|9562505|FG000|COMPLETED|Overall Study||301
8530417|NCT00405964|9562506|FG001|COMPLETED|Overall Study||261
8620641|NCT00475033|9659435|FG000|Vaccinated Dose 2|Infant Series||297
8620642|NCT00475033|9659436|FG001|Vaccinated Dose 2|Infant Series||296
8620643|NCT00475033|9659435|FG000|Vaccinated Dose 3|Infant Series||293
8620644|NCT00475033|9659436|FG001|Vaccinated Dose 3|Infant Series||294
8620645|NCT00475033|9659435|FG000|COMPLETED|Infant Series||293
8530418|NCT00405964|9562505|FG000|NOT COMPLETED|Overall Study||59
8530419|NCT00405964|9562506|FG001|NOT COMPLETED|Overall Study||95
8530420|NCT00383721|9562517|FG000|STARTED|26-Week Double-Blind Treatment Period||225
8530421|NCT00383721|9562518|FG001|STARTED|26-Week Double-Blind Treatment Period||239
8530422|NCT00383721|9562519|FG002|STARTED|26-Week Double-Blind Treatment Period||253
8620646|NCT00475033|9659436|FG001|COMPLETED|Infant Series||290
8620647|NCT00475033|9659435|FG000|NOT COMPLETED|Infant Series||7
8620648|NCT00475033|9659436|FG001|NOT COMPLETED|Infant Series||13
8620649|NCT00475033|9659435|FG000|STARTED|After the Infant Series||293
8620650|NCT00475033|9659436|FG001|STARTED|After the Infant Series||290
8620651|NCT00475033|9659435|FG000|Withdrawn After Infant Series|After the Infant Series||6
8620652|NCT00475033|9659436|FG001|Withdrawn After Infant Series|After the Infant Series||8
8530423|NCT00383721|9562520|FG003|STARTED|26-Week Double-Blind Treatment Period||243
8530424|NCT00383721|9562521|FG004|STARTED|26-Week Double-Blind Treatment Period||236
8530425|NCT00383721|9562517|FG000|COMPLETED|26-Week Double-Blind Treatment Period|"1 participant listed as ongoing since the participant status could not be formally confirmed."|190
8530426|NCT00383721|9562518|FG001|COMPLETED|26-Week Double-Blind Treatment Period||202
8530427|NCT00383721|9562519|FG002|COMPLETED|26-Week Double-Blind Treatment Period||202
8530428|NCT00383721|9562520|FG003|COMPLETED|26-Week Double-Blind Treatment Period||193
8530429|NCT00383721|9562521|FG004|COMPLETED|26-Week Double-Blind Treatment Period||169
8530430|NCT00383721|9562517|FG000|NOT COMPLETED|26-Week Double-Blind Treatment Period||35
8530431|NCT00383721|9562518|FG001|NOT COMPLETED|26-Week Double-Blind Treatment Period||37
8530432|NCT00383721|9562519|FG002|NOT COMPLETED|26-Week Double-Blind Treatment Period||51
8530433|NCT00383721|9562520|FG003|NOT COMPLETED|26-Week Double-Blind Treatment Period||50
8530434|NCT00383721|9562521|FG004|NOT COMPLETED|26-Week Double-Blind Treatment Period||67
8530435|NCT00383721|9562517|FG000|STARTED|26-Week Treatment Safety Extension||145
8530436|NCT00383721|9562518|FG001|STARTED|26-Week Treatment Safety Extension||153
8530437|NCT00383721|9562519|FG002|STARTED|26-Week Treatment Safety Extension||149
8530438|NCT00383721|9562520|FG003|STARTED|26-Week Treatment Safety Extension||148
8530439|NCT00383721|9562521|FG004|STARTED|26-Week Treatment Safety Extension||8
8530440|NCT00383721|9562517|FG000|COMPLETED|26-Week Treatment Safety Extension||126
8530441|NCT00383721|9562518|FG001|COMPLETED|26-Week Treatment Safety Extension||136
8530442|NCT00383721|9562519|FG002|COMPLETED|26-Week Treatment Safety Extension||126
8530443|NCT00383721|9562520|FG003|COMPLETED|26-Week Treatment Safety Extension||131
8530444|NCT00383721|9562521|FG004|COMPLETED|26-Week Treatment Safety Extension||8
8530445|NCT00383721|9562517|FG000|NOT COMPLETED|26-Week Treatment Safety Extension||19
8530446|NCT00383721|9562518|FG001|NOT COMPLETED|26-Week Treatment Safety Extension||17
8530447|NCT00383721|9562519|FG002|NOT COMPLETED|26-Week Treatment Safety Extension||23
8530448|NCT00383721|9562520|FG003|NOT COMPLETED|26-Week Treatment Safety Extension||17
8530449|NCT00383721|9562521|FG004|NOT COMPLETED|26-Week Treatment Safety Extension||0
8530450|NCT00383552|9562537|FG000|STARTED|Overall Study||182
8816362|NCT01543685|9869848|FG001|NOT COMPLETED|Overall Study||3
8816363|NCT01543685|9869849|FG002|NOT COMPLETED|Overall Study||2
8816364|NCT01543685|9869850|FG003|NOT COMPLETED|Overall Study||0
8816365|NCT01543685|9869851|FG004|NOT COMPLETED|Overall Study||4
8816366|NCT01543776|9869865|FG000|STARTED|Overall Study||36
8530451|NCT00383552|9562538|FG001|STARTED|Overall Study||188
8530452|NCT00383552|9562539|FG002|STARTED|Overall Study||188
8530453|NCT00383552|9562540|FG003|STARTED|Overall Study||188
8530454|NCT00383552|9562537|FG000|COMPLETED|Overall Study||146
8530455|NCT00383552|9562538|FG001|COMPLETED|Overall Study||147
8620653|NCT00475033|9659435|FG000|COMPLETED|After the Infant Series||287
8620654|NCT00475033|9659436|FG001|COMPLETED|After the Infant Series||282
8620655|NCT00475033|9659435|FG000|NOT COMPLETED|After the Infant Series||6
8620656|NCT00475033|9659436|FG001|NOT COMPLETED|After the Infant Series||8
8620657|NCT00475033|9659435|FG000|STARTED|Toddler Dose|Vaccinated Toddler Dose|287
8620658|NCT00475033|9659436|FG001|STARTED|Toddler Dose|Vaccinated Toddler Dose|282
8620659|NCT00475033|9659435|FG000|COMPLETED|Toddler Dose||283
8620660|NCT00475033|9659436|FG001|COMPLETED|Toddler Dose||282
8620661|NCT00475033|9659435|FG000|NOT COMPLETED|Toddler Dose||4
8620662|NCT00475033|9659436|FG001|NOT COMPLETED|Toddler Dose||0
8620663|NCT00475085|9659453|FG000|STARTED|Overall Study||253
8530456|NCT00383552|9562539|FG002|COMPLETED|Overall Study||127
8530457|NCT00383552|9562540|FG003|COMPLETED|Overall Study||116
8530458|NCT00383552|9562537|FG000|NOT COMPLETED|Overall Study||36
8530459|NCT00383552|9562538|FG001|NOT COMPLETED|Overall Study||41
8530460|NCT00383552|9562539|FG002|NOT COMPLETED|Overall Study||61
8530461|NCT00383552|9562540|FG003|NOT COMPLETED|Overall Study||72
8530462|NCT00383435|9562560|FG000|STARTED|26-Week Double-Blind Treatment Period||217
8530463|NCT00383435|9562561|FG001|STARTED|26-Week Double-Blind Treatment Period||207
8530464|NCT00383435|9562562|FG002|STARTED|26-Week Double-Blind Treatment Period||210
8530465|NCT00383435|9562563|FG003|STARTED|26-Week Double-Blind Treatment Period||209
8530466|NCT00383435|9562564|FG004|STARTED|26-Week Double-Blind Treatment Period||212
8530467|NCT00383435|9562560|FG000|COMPLETED|26-Week Double-Blind Treatment Period||176
8530468|NCT00383435|9562561|FG001|COMPLETED|26-Week Double-Blind Treatment Period||169
8530469|NCT00383435|9562562|FG002|COMPLETED|26-Week Double-Blind Treatment Period||164
8530470|NCT00383435|9562563|FG003|COMPLETED|26-Week Double-Blind Treatment Period||172
8530471|NCT00383435|9562564|FG004|COMPLETED|26-Week Double-Blind Treatment Period||159
8530472|NCT00383435|9562560|FG000|NOT COMPLETED|26-Week Double-Blind Treatment Period||41
8530473|NCT00383435|9562561|FG001|NOT COMPLETED|26-Week Double-Blind Treatment Period||38
8530474|NCT00383435|9562562|FG002|NOT COMPLETED|26-Week Double-Blind Treatment Period||46
8530475|NCT00383435|9562563|FG003|NOT COMPLETED|26-Week Double-Blind Treatment Period||37
8530476|NCT00383435|9562564|FG004|NOT COMPLETED|26-Week Double-Blind Treatment Period||53
8530477|NCT00383435|9562560|FG000|STARTED|26-Week Treatment Safety Extension||131
8530478|NCT00383435|9562561|FG001|STARTED|26-Week Treatment Safety Extension||130
8530479|NCT00383435|9562562|FG002|STARTED|26-Week Treatment Safety Extension||124
8530480|NCT00383435|9562563|FG003|STARTED|26-Week Treatment Safety Extension||131
8530481|NCT00383435|9562564|FG004|STARTED|26-Week Treatment Safety Extension||13
8620664|NCT00475085|9659454|FG001|STARTED|Overall Study||254
8620665|NCT00475085|9659455|FG002|STARTED|Overall Study||260
8816367|NCT01543776|9869866|FG001|STARTED|Overall Study||36
8530482|NCT00383435|9562560|FG000|COMPLETED|26-Week Treatment Safety Extension||117
8530483|NCT00383435|9562561|FG001|COMPLETED|26-Week Treatment Safety Extension||121
8530484|NCT00383435|9562562|FG002|COMPLETED|26-Week Treatment Safety Extension||108
8530485|NCT00383435|9562563|FG003|COMPLETED|26-Week Treatment Safety Extension||116
8530486|NCT00383435|9562564|FG004|COMPLETED|26-Week Treatment Safety Extension||10
8530487|NCT00383435|9562560|FG000|NOT COMPLETED|26-Week Treatment Safety Extension||14
8530488|NCT00383435|9562561|FG001|NOT COMPLETED|26-Week Treatment Safety Extension||9
8530489|NCT00383435|9562562|FG002|NOT COMPLETED|26-Week Treatment Safety Extension||16
8530490|NCT00383435|9562563|FG003|NOT COMPLETED|26-Week Treatment Safety Extension||15
8530491|NCT00383435|9562564|FG004|NOT COMPLETED|26-Week Treatment Safety Extension||3
8530492|NCT00381485|9562579|FG000|STARTED|Open-Label Run-In Period||834
8530493|NCT00381485|9562580|FG001|STARTED|Open-Label Run-In Period||0
8530494|NCT00381485|9562581|FG002|STARTED|Open-Label Run-In Period||0
8530495|NCT00381485|9562582|FG003|STARTED|Open-Label Run-In Period||0
8530496|NCT00381485|9562579|FG000|COMPLETED|Open-Label Run-In Period||728
8530497|NCT00381485|9562580|FG001|COMPLETED|Open-Label Run-In Period||0
8530498|NCT00381485|9562581|FG002|COMPLETED|Open-Label Run-In Period||0
8530499|NCT00381485|9562582|FG003|COMPLETED|Open-Label Run-In Period||0
8530500|NCT00381485|9562579|FG000|NOT COMPLETED|Open-Label Run-In Period||106
8530501|NCT00381485|9562580|FG001|NOT COMPLETED|Open-Label Run-In Period||0
8530502|NCT00381485|9562581|FG002|NOT COMPLETED|Open-Label Run-In Period||0
8530503|NCT00381485|9562582|FG003|NOT COMPLETED|Open-Label Run-In Period||0
8530504|NCT00381485|9562579|FG000|STARTED|Double-Blind Treatment Period||0
8530505|NCT00381485|9562580|FG001|STARTED|Double-Blind Treatment Period||255
8530506|NCT00381485|9562581|FG002|STARTED|Double-Blind Treatment Period||233
8530507|NCT00381485|9562582|FG003|STARTED|Double-Blind Treatment Period||240
8530508|NCT00381485|9562579|FG000|COMPLETED|Double-Blind Treatment Period||0
8530509|NCT00381485|9562580|FG001|COMPLETED|Double-Blind Treatment Period||228
8530510|NCT00381485|9562581|FG002|COMPLETED|Double-Blind Treatment Period||208
8530511|NCT00381485|9562582|FG003|COMPLETED|Double-Blind Treatment Period||207
8530512|NCT00381485|9562579|FG000|NOT COMPLETED|Double-Blind Treatment Period||0
8530513|NCT00381485|9562580|FG001|NOT COMPLETED|Double-Blind Treatment Period||27
8530514|NCT00381485|9562581|FG002|NOT COMPLETED|Double-Blind Treatment Period||25
8530515|NCT00381485|9562582|FG003|NOT COMPLETED|Double-Blind Treatment Period||33
8530516|NCT00379288|9562595|FG000|STARTED|Overall Study||141
8530517|NCT00379288|9562596|FG001|STARTED|Overall Study||130
8530518|NCT00379288|9562597|FG002|STARTED|Overall Study||68
8530519|NCT00379288|9562598|FG003|STARTED|Overall Study||65
8530520|NCT00379288|9562595|FG000|COMPLETED|Overall Study||122
8530521|NCT00379288|9562596|FG001|COMPLETED|Overall Study||108
8530522|NCT00379288|9562597|FG002|COMPLETED|Overall Study||58
8530523|NCT00379288|9562598|FG003|COMPLETED|Overall Study||57
8530524|NCT00379288|9562595|FG000|NOT COMPLETED|Overall Study||19
8530525|NCT00379288|9562596|FG001|NOT COMPLETED|Overall Study||22
8530526|NCT00379288|9562597|FG002|NOT COMPLETED|Overall Study||10
8530527|NCT00379288|9562598|FG003|NOT COMPLETED|Overall Study||8
8530528|NCT00378378|9562611|FG000|STARTED|Overall Study||51
8530529|NCT00378378|9562612|FG001|STARTED|Overall Study||50
8530530|NCT00378378|9562613|FG002|STARTED|Overall Study||26
8530531|NCT00378378|9562611|FG000|COMPLETED|Overall Study||51
8530532|NCT00378378|9562612|FG001|COMPLETED|Overall Study||49
8530533|NCT00378378|9562613|FG002|COMPLETED|Overall Study||24
8530534|NCT00378378|9562611|FG000|NOT COMPLETED|Overall Study||0
8530535|NCT00378378|9562612|FG001|NOT COMPLETED|Overall Study||1
8530536|NCT00378378|9562613|FG002|NOT COMPLETED|Overall Study||2
8530537|NCT00089895|9562623|FG000|STARTED|Overall Study|Number of Subjects Randomized with Intent to Treat|4722
8530538|NCT00089895|9562624|FG001|STARTED|Overall Study|Number of Subjects Randomized with Intent to Treat|4684
8530539|NCT00089895|9562623|FG000|COMPLETED|Overall Study|Number of Subjects treated|4687
8530540|NCT00089895|9562624|FG001|COMPLETED|Overall Study|Number of Subjects treated|4642
8530541|NCT00089895|9562623|FG000|NOT COMPLETED|Overall Study||35
8530542|NCT00089895|9562624|FG001|NOT COMPLETED|Overall Study||42
8530543|NCT02577354|9562632|FG000|STARTED|Overall Study||102
8530544|NCT02577354|9562633|FG001|STARTED|Overall Study||102
8530545|NCT02577354|9562632|FG000|120 Day Primary Endpoint|Overall Study||100
8530546|NCT02577354|9562633|FG001|120 Day Primary Endpoint|Overall Study||101
8530547|NCT02577354|9562632|FG000|COMPLETED|Overall Study||87
8530548|NCT02577354|9562633|FG001|COMPLETED|Overall Study||89
8530549|NCT02577354|9562632|FG000|NOT COMPLETED|Overall Study||15
8530550|NCT02577354|9562633|FG001|NOT COMPLETED|Overall Study||13
8530551|NCT02551718|9562649|FG000|STARTED|Overall Study||34
8530552|NCT02551718|9562649|FG000|COMPLETED|Overall Study||34
8530553|NCT02551718|9562649|FG000|NOT COMPLETED|Overall Study||0
8530554|NCT02471807|9562653|FG000|STARTED|Overall Study||34
8530555|NCT02471807|9562653|FG000|COMPLETED|Overall Study||11
8530556|NCT02471807|9562653|FG000|NOT COMPLETED|Overall Study||23
8530557|NCT02321514|9562657|FG000|STARTED|Overall Study||191
8530558|NCT02321514|9562657|FG000|COMPLETED|Overall Study||166
8530559|NCT02321514|9562657|FG000|NOT COMPLETED|Overall Study||25
8530560|NCT02118610|9562663|FG000|STARTED|Overall Study||30
8530561|NCT02118610|9562664|FG001|STARTED|Overall Study||33
8530562|NCT02118610|9562663|FG000|COMPLETED|Overall Study||29
8530563|NCT02118610|9562664|FG001|COMPLETED|Overall Study||32
8530564|NCT02118610|9562663|FG000|NOT COMPLETED|Overall Study||1
8530565|NCT02118610|9562664|FG001|NOT COMPLETED|Overall Study||1
8530566|NCT01909570|9562672|FG000|STARTED|Overall Study||84
8530567|NCT01909570|9562673|FG001|STARTED|Overall Study||91
8530568|NCT01909570|9562672|FG000|COMPLETED|Overall Study||57
8530569|NCT01909570|9562673|FG001|COMPLETED|Overall Study||64
8530570|NCT01909570|9562672|FG000|NOT COMPLETED|Overall Study||27
8530571|NCT01909570|9562673|FG001|NOT COMPLETED|Overall Study||27
8530572|NCT01453946|9562679|FG000|STARTED|Overall Study||50
8530573|NCT01453946|9562679|FG000|COMPLETED|Overall Study||41
8530574|NCT01453946|9562679|FG000|NOT COMPLETED|Overall Study||9
8530575|NCT01444092|9562683|FG000|STARTED|Overall Study||108
8530576|NCT01444092|9562683|FG000|INFORMED CONSENT OBTAINED|Overall Study||108
8530577|NCT01444092|9562683|FG000|COMPLETED|Overall Study||91
8530578|NCT01444092|9562683|FG000|NOT COMPLETED|Overall Study||17
8530579|NCT01265784|9562690|FG000|STARTED|Overall Study||56
8530580|NCT01265784|9562691|FG001|STARTED|Overall Study||57
8530581|NCT01265784|9562692|FG002|STARTED|Overall Study||30
8530582|NCT01265784|9562690|FG000|Received at Least 1 Dose of Study Drug|Overall Study|1 participant randomized to TP-434 1.5 mg/kg took ertapenem. Results are included in ertapenem arm.|54
8530583|NCT01265784|9562691|FG001|Received at Least 1 Dose of Study Drug|Overall Study||56
8530584|NCT01265784|9562692|FG002|Received at Least 1 Dose of Study Drug|Overall Study||29
8530585|NCT01265784|9562690|FG000|COMPLETED|Overall Study||44
8530586|NCT01265784|9562691|FG001|COMPLETED|Overall Study||49
8530587|NCT01265784|9562692|FG002|COMPLETED|Overall Study||26
8530588|NCT01265784|9562690|FG000|NOT COMPLETED|Overall Study||12
8530589|NCT01265784|9562691|FG001|NOT COMPLETED|Overall Study||8
8530590|NCT01265784|9562692|FG002|NOT COMPLETED|Overall Study||4
8530591|NCT00577577|9562702|FG000|STARTED|Overall Study||34
8530592|NCT00577577|9562703|FG001|STARTED|Overall Study||35
8530593|NCT00577577|9562702|FG000|Received Treatment|Overall Study||34
8530594|NCT00577577|9562703|FG001|Received Treatment|Overall Study||35
8530595|NCT00577577|9562702|FG000|COMPLETED|Overall Study||29
8530596|NCT00577577|9562703|FG001|COMPLETED|Overall Study||30
8530597|NCT00577577|9562702|FG000|NOT COMPLETED|Overall Study||5
8530598|NCT00577577|9562703|FG001|NOT COMPLETED|Overall Study||5
8530599|NCT00392327|9562717|FG000|STARTED|Overall Study||87
8530600|NCT00392327|9562718|FG001|STARTED|Overall Study||93
8530601|NCT00392327|9562719|FG002|STARTED|Overall Study||56
8530602|NCT00392327|9562720|FG003|STARTED|Overall Study||58
8530603|NCT00392327|9562721|FG004|STARTED|Overall Study||23
8530604|NCT00392327|9562722|FG005|STARTED|Overall Study||19
8530605|NCT00392327|9562723|FG006|STARTED|Overall Study||21
8530606|NCT00392327|9562724|FG007|STARTED|Overall Study||22
8530607|NCT00392327|9562717|FG000|COMPLETED|Overall Study||72
8530608|NCT00392327|9562718|FG001|COMPLETED|Overall Study||74
8530609|NCT00392327|9562719|FG002|COMPLETED|Overall Study||36
8530610|NCT00392327|9562720|FG003|COMPLETED|Overall Study||42
8530611|NCT00392327|9562721|FG004|COMPLETED|Overall Study||20
8530612|NCT00392327|9562722|FG005|COMPLETED|Overall Study||14
8530613|NCT00392327|9562723|FG006|COMPLETED|Overall Study||12
8530614|NCT00392327|9562724|FG007|COMPLETED|Overall Study||11
8530615|NCT00392327|9562717|FG000|NOT COMPLETED|Overall Study||15
8530616|NCT00392327|9562718|FG001|NOT COMPLETED|Overall Study||19
8530617|NCT00392327|9562719|FG002|NOT COMPLETED|Overall Study||20
8530618|NCT00392327|9562720|FG003|NOT COMPLETED|Overall Study||16
8530619|NCT00392327|9562721|FG004|NOT COMPLETED|Overall Study||3
8530620|NCT00392327|9562722|FG005|NOT COMPLETED|Overall Study||5
8530621|NCT00392327|9562723|FG006|NOT COMPLETED|Overall Study||9
8530622|NCT00392327|9562724|FG007|NOT COMPLETED|Overall Study||11
8530623|NCT00085202|9562744|FG000|STARTED|Overall Study||269
8530624|NCT00085202|9562745|FG001|STARTED|Overall Study||144
8530625|NCT00085202|9562744|FG000|COMPLETED|Overall Study||251
8530626|NCT00085202|9562745|FG001|COMPLETED|Overall Study||120
8530627|NCT00085202|9562744|FG000|NOT COMPLETED|Overall Study||18
8530628|NCT00085202|9562745|FG001|NOT COMPLETED|Overall Study||24
8563972|NCT00049842|9595933|FG001|COMPLETED|Treatment Phase||192
8563973|NCT00049842|9595932|FG000|NOT COMPLETED|Treatment Phase||93
8563974|NCT00049842|9595933|FG001|NOT COMPLETED|Treatment Phase||78
8563975|NCT00049842|9595932|FG000|STARTED|Follow-up Phase|Population is all treatment phase completers plus some who discontinued the treatment phase.|218
8563976|NCT00049842|9595933|FG001|STARTED|Follow-up Phase|Population is all treatment phase completers plus some who discontinued the treatment phase.|194
8563977|NCT00049842|9595932|FG000|COMPLETED|Follow-up Phase||211
8563978|NCT00049842|9595933|FG001|COMPLETED|Follow-up Phase||189
8563979|NCT00049842|9595932|FG000|NOT COMPLETED|Follow-up Phase||7
8563980|NCT00049842|9595933|FG001|NOT COMPLETED|Follow-up Phase||5
8563981|NCT00050011|9595941|FG000|STARTED|Overall Study||301
8563982|NCT00050011|9595942|FG001|STARTED|Overall Study||301
8563983|NCT00050011|9595941|FG000|Intent-to-treat Population|Overall Study||300
8563984|NCT00050011|9595942|FG001|Intent-to-treat Population|Overall Study||300
8620666|NCT00475085|9659456|FG003|STARTED|Overall Study||254
8620667|NCT00475085|9659453|FG000|COMPLETED|Overall Study||235
8620668|NCT00475085|9659454|FG001|COMPLETED|Overall Study||234
8620669|NCT00475085|9659455|FG002|COMPLETED|Overall Study||241
8563985|NCT00050011|9595941|FG000|COMPLETED|Overall Study||180
8563986|NCT00050011|9595942|FG001|COMPLETED|Overall Study||175
8563987|NCT00050011|9595941|FG000|NOT COMPLETED|Overall Study||121
8563988|NCT00050011|9595942|FG001|NOT COMPLETED|Overall Study||126
8563989|NCT00050089|9595953|FG000|STARTED|Overall Study||106
8563990|NCT00050089|9595954|FG001|STARTED|Overall Study||98
8563991|NCT00050089|9595955|FG002|STARTED|Overall Study||86
8563992|NCT00050089|9595956|FG003|STARTED|Overall Study||78
8569197|NCT00095563|9601407|FG000|STARTED|Overall Study||39
8620670|NCT00475085|9659456|FG003|COMPLETED|Overall Study||234
8530629|NCT05007639|9562764|FG000|STARTED|Overall Study||274
8530630|NCT05007639|9562764|FG000|COMPLETED|Overall Study||274
8530631|NCT05007639|9562764|FG000|NOT COMPLETED|Overall Study||0
8530632|NCT04739735|9562770|FG000|STARTED|Overall Study||25
8530633|NCT04739735|9562771|FG001|STARTED|Overall Study||25
8530634|NCT04739735|9562770|FG000|COMPLETED|Overall Study||25
8530635|NCT04739735|9562771|FG001|COMPLETED|Overall Study||25
8530636|NCT04739735|9562770|FG000|NOT COMPLETED|Overall Study||0
8530637|NCT04739735|9562771|FG001|NOT COMPLETED|Overall Study||0
8530638|NCT04552535|9562779|FG000|STARTED|Overall Study||99
8530639|NCT04552535|9562780|FG001|STARTED|Overall Study||101
8530640|NCT04552535|9562779|FG000|COMPLETED|Overall Study||99
8530641|NCT04552535|9562780|FG001|COMPLETED|Overall Study||101
8530642|NCT04552535|9562779|FG000|NOT COMPLETED|Overall Study||0
8530643|NCT04552535|9562780|FG001|NOT COMPLETED|Overall Study||0
8563993|NCT00050089|9595953|FG000|Baseline|Overall Study|15 participants randomized in the UK Option scheme (not displayed in the 2X2 baseline data)|91
8563994|NCT00050089|9595954|FG001|Baseline|Overall Study|14 participants randomized in the UK Option scheme (not shown in 2X2 baseline data)|84
8563995|NCT00050089|9595955|FG002|Baseline|Overall Study||86
8563996|NCT00050089|9595956|FG003|Baseline|Overall Study||78
8563997|NCT00050089|9595953|FG000|COMPLETED|Overall Study|For primary outcome assessment|106
8563998|NCT00050089|9595954|FG001|COMPLETED|Overall Study|For primary outcome assessment|98
8563999|NCT00050089|9595955|FG002|COMPLETED|Overall Study|For primary outcome assessment|86
8564000|NCT00050089|9595956|FG003|COMPLETED|Overall Study|For primary outcome assessment|78
8564001|NCT00050089|9595953|FG000|NOT COMPLETED|Overall Study||0
8564002|NCT00050089|9595954|FG001|NOT COMPLETED|Overall Study||0
8564003|NCT00050089|9595955|FG002|NOT COMPLETED|Overall Study||0
8564004|NCT00050089|9595956|FG003|NOT COMPLETED|Overall Study||0
8564005|NCT00050167|9595972|FG000|STARTED|Overall Study||302
8564006|NCT00050167|9595973|FG001|STARTED|Overall Study||301
8564007|NCT00050167|9595972|FG000|COMPLETED|Overall Study||301
8564008|NCT00050167|9595973|FG001|COMPLETED|Overall Study||300
8564009|NCT00050167|9595972|FG000|NOT COMPLETED|Overall Study||1
8564010|NCT00050167|9595973|FG001|NOT COMPLETED|Overall Study||1
8564011|NCT00050622|9595979|FG000|STARTED|Overall Study||154
8564012|NCT00050622|9595979|FG000|COMPLETED|Overall Study||153
8564013|NCT00050622|9595979|FG000|NOT COMPLETED|Overall Study||1
8564014|NCT00050778|9596006|FG000|STARTED|Overall Study|Randomized.|111
8564015|NCT00050778|9596007|FG001|STARTED|Overall Study||113
8564016|NCT00050778|9596008|FG002|STARTED|Overall Study||110
8564017|NCT00050778|9596006|FG000|Treated|Overall Study||107
8564018|NCT00050778|9596007|FG001|Treated|Overall Study||108
8564019|NCT00050778|9596008|FG002|Treated|Overall Study||108
8564020|NCT00050778|9596006|FG000|COMPLETED|Overall Study||66
8564021|NCT00050778|9596007|FG001|COMPLETED|Overall Study||92
8564022|NCT00050778|9596008|FG002|COMPLETED|Overall Study||92
8564023|NCT00050778|9596006|FG000|NOT COMPLETED|Overall Study||45
8564024|NCT00050778|9596007|FG001|NOT COMPLETED|Overall Study||21
8564025|NCT00050778|9596008|FG002|NOT COMPLETED|Overall Study||18
8564026|NCT00050960|9596020|FG000|STARTED|Overall Study||306
8564027|NCT00050960|9596021|FG001|STARTED|Overall Study||306
8564028|NCT00050960|9596020|FG000|COMPLETED|Overall Study|Represents number of patients with no primary reason for termination|4
8564029|NCT00050960|9596021|FG001|COMPLETED|Overall Study|Represents number of patients with no primary reason for termination|2
8564030|NCT00050960|9596020|FG000|NOT COMPLETED|Overall Study||302
8564031|NCT00050960|9596021|FG001|NOT COMPLETED|Overall Study||304
8564032|NCT00050986|9596027|FG000|STARTED|Overall Study||55
8564033|NCT00050986|9596027|FG000|COMPLETED|Overall Study|Two participants had withdrawn consents before the study treatment was initiated.|53
8564034|NCT00050986|9596027|FG000|NOT COMPLETED|Overall Study||2
8816368|NCT01543776|9869865|FG000|COMPLETED|Overall Study||34
8816369|NCT01543776|9869866|FG001|COMPLETED|Overall Study||34
8816370|NCT01543776|9869865|FG000|NOT COMPLETED|Overall Study||2
8816371|NCT01543776|9869866|FG001|NOT COMPLETED|Overall Study||2
8564035|NCT00051025|9596033|FG000|STARTED|Overall Study||5
8564036|NCT00051025|9596034|FG001|STARTED|Overall Study||4
8564037|NCT00051025|9596033|FG000|COMPLETED|Overall Study||3
8943751|NCT02391584|10005587|FG001|STARTED|12 Month (End of Study)||0
8943752|NCT02391584|10005586|FG000|COMPLETED|12 Month (End of Study)||49
8943753|NCT02391584|10005587|FG001|COMPLETED|12 Month (End of Study)||0
8943754|NCT02391584|10005586|FG000|NOT COMPLETED|12 Month (End of Study)||2
8943755|NCT02391584|10005587|FG001|NOT COMPLETED|12 Month (End of Study)||0
8943756|NCT02391701|10005598|FG000|STARTED|Overall Study||367
8943757|NCT02391701|10005599|FG001|STARTED|Overall Study||353
8564038|NCT00051025|9596034|FG001|COMPLETED|Overall Study||0
8564039|NCT00051025|9596033|FG000|NOT COMPLETED|Overall Study||2
8564040|NCT00051025|9596034|FG001|NOT COMPLETED|Overall Study||4
8816372|NCT01543828|9869874|FG000|STARTED|Treatment 1||20
8816373|NCT01543828|9869875|FG001|STARTED|Treatment 1||20
8564041|NCT00051168|9596040|FG000|STARTED|Overall Study||502
8816374|NCT01543828|9869874|FG000|COMPLETED|Treatment 1||20
8816375|NCT01543828|9869875|FG001|COMPLETED|Treatment 1||20
8943758|NCT02391701|10005598|FG000|COMPLETED|Overall Study||346
8943759|NCT02391701|10005599|FG001|COMPLETED|Overall Study||315
8564042|NCT00051168|9596040|FG000|COMPLETED|Overall Study||367
8564043|NCT00051168|9596040|FG000|NOT COMPLETED|Overall Study||135
8564044|NCT00051311|9596046|FG000|STARTED|Overall Study||31
8564045|NCT00051311|9596047|FG001|STARTED|Overall Study||31
8943760|NCT02391701|10005598|FG000|NOT COMPLETED|Overall Study||21
8943761|NCT02391701|10005599|FG001|NOT COMPLETED|Overall Study||38
8530644|NCT04502472|9562791|FG000|STARTED|Overall Study||61
8530645|NCT04502472|9562792|FG001|STARTED|Overall Study||48
8530646|NCT04502472|9562791|FG000|COMPLETED|Overall Study||58
8530647|NCT04502472|9562792|FG001|COMPLETED|Overall Study||45
8530648|NCT04502472|9562791|FG000|NOT COMPLETED|Overall Study||3
8530649|NCT04502472|9562792|FG001|NOT COMPLETED|Overall Study||3
8530650|NCT04495166|9562801|FG000|STARTED|Overall Study||37
8530651|NCT04495166|9562802|FG001|STARTED|Overall Study||44
8530652|NCT04495166|9562801|FG000|COMPLETED|Overall Study||30
8530653|NCT04495166|9562802|FG001|COMPLETED|Overall Study||41
8530654|NCT04495166|9562801|FG000|NOT COMPLETED|Overall Study||7
8530655|NCT04495166|9562802|FG001|NOT COMPLETED|Overall Study||3
8530656|NCT04461483|9562814|FG000|STARTED|Part 1 (Day 1)||6
8530657|NCT04461483|9562815|FG001|STARTED|Part 1 (Day 1)||6
8530658|NCT04461483|9562816|FG002|STARTED|Part 1 (Day 1)||6
8530659|NCT04461483|9562817|FG003|STARTED|Part 1 (Day 1)||6
8530660|NCT04461483|9562818|FG004|STARTED|Part 1 (Day 1)||0
8530661|NCT04461483|9562819|FG005|STARTED|Part 1 (Day 1)||0
8530662|NCT04461483|9562814|FG000|COMPLETED|Part 1 (Day 1)||6
8530663|NCT04461483|9562815|FG001|COMPLETED|Part 1 (Day 1)||6
8530664|NCT04461483|9562816|FG002|COMPLETED|Part 1 (Day 1)||6
8530665|NCT04461483|9562817|FG003|COMPLETED|Part 1 (Day 1)||6
8530666|NCT04461483|9562818|FG004|COMPLETED|Part 1 (Day 1)||0
8530667|NCT04461483|9562819|FG005|COMPLETED|Part 1 (Day 1)||0
8530668|NCT04461483|9562814|FG000|NOT COMPLETED|Part 1 (Day 1)||0
8530669|NCT04461483|9562815|FG001|NOT COMPLETED|Part 1 (Day 1)||0
8530670|NCT04461483|9562816|FG002|NOT COMPLETED|Part 1 (Day 1)||0
8530671|NCT04461483|9562817|FG003|NOT COMPLETED|Part 1 (Day 1)||0
8530672|NCT04461483|9562818|FG004|NOT COMPLETED|Part 1 (Day 1)||0
8530673|NCT04461483|9562819|FG005|NOT COMPLETED|Part 1 (Day 1)||0
8530674|NCT04461483|9562814|FG000|STARTED|Part 2 (Day 1 to 21)||0
8530675|NCT04461483|9562815|FG001|STARTED|Part 2 (Day 1 to 21)||0
8530676|NCT04461483|9562816|FG002|STARTED|Part 2 (Day 1 to 21)||0
8530677|NCT04461483|9562817|FG003|STARTED|Part 2 (Day 1 to 21)||0
8530678|NCT04461483|9562818|FG004|STARTED|Part 2 (Day 1 to 21)||3
8530679|NCT04461483|9562819|FG005|STARTED|Part 2 (Day 1 to 21)||6
8530680|NCT04461483|9562814|FG000|COMPLETED|Part 2 (Day 1 to 21)||0
8530681|NCT04461483|9562815|FG001|COMPLETED|Part 2 (Day 1 to 21)||0
8530682|NCT04461483|9562816|FG002|COMPLETED|Part 2 (Day 1 to 21)||0
8530683|NCT04461483|9562817|FG003|COMPLETED|Part 2 (Day 1 to 21)||0
8530684|NCT04461483|9562818|FG004|COMPLETED|Part 2 (Day 1 to 21)||3
8530685|NCT04461483|9562819|FG005|COMPLETED|Part 2 (Day 1 to 21)||6
8530686|NCT04461483|9562814|FG000|NOT COMPLETED|Part 2 (Day 1 to 21)||0
8530687|NCT04461483|9562815|FG001|NOT COMPLETED|Part 2 (Day 1 to 21)||0
8530688|NCT04461483|9562816|FG002|NOT COMPLETED|Part 2 (Day 1 to 21)||0
8530689|NCT04461483|9562817|FG003|NOT COMPLETED|Part 2 (Day 1 to 21)||0
8722765|NCT01020877|9770251|FG000|NOT COMPLETED|First Intervention||0
8722766|NCT01020877|9770252|FG001|NOT COMPLETED|First Intervention||0
8722767|NCT01020877|9770251|FG000|STARTED|Washout of 7 Days||19
8722768|NCT01020877|9770252|FG001|STARTED|Washout of 7 Days||19
8722769|NCT01020877|9770251|FG000|COMPLETED|Washout of 7 Days||19
8722770|NCT01020877|9770252|FG001|COMPLETED|Washout of 7 Days||19
8722771|NCT01020877|9770251|FG000|NOT COMPLETED|Washout of 7 Days||0
8722772|NCT01020877|9770252|FG001|NOT COMPLETED|Washout of 7 Days||0
8722773|NCT01020877|9770251|FG000|STARTED|Second Intervention||19
8722774|NCT01020877|9770252|FG001|STARTED|Second Intervention||19
8722775|NCT01020877|9770251|FG000|COMPLETED|Second Intervention||18
8722776|NCT01020877|9770252|FG001|COMPLETED|Second Intervention||19
8722777|NCT01020877|9770251|FG000|NOT COMPLETED|Second Intervention||1
8722778|NCT01020877|9770252|FG001|NOT COMPLETED|Second Intervention||0
8722779|NCT01020981|9770260|FG000|STARTED|Overall Study||150
8722780|NCT01020981|9770261|FG001|STARTED|Overall Study||150
8722781|NCT01020981|9770260|FG000|COMPLETED|Overall Study||66
8722782|NCT01020981|9770261|FG001|COMPLETED|Overall Study||60
8722783|NCT01020981|9770260|FG000|NOT COMPLETED|Overall Study||84
8722784|NCT01020981|9770261|FG001|NOT COMPLETED|Overall Study||90
8722785|NCT01021007|9770271|FG000|STARTED|Overall Study||36
8722786|NCT01021007|9770272|FG001|STARTED|Overall Study||37
8722787|NCT01021007|9770271|FG000|COMPLETED|Overall Study||34
8722788|NCT01021007|9770272|FG001|COMPLETED|Overall Study||33
8722789|NCT01021007|9770271|FG000|NOT COMPLETED|Overall Study||2
8722790|NCT01021007|9770272|FG001|NOT COMPLETED|Overall Study||4
8722791|NCT01021020|9770278|FG000|STARTED|Period I||28
8722792|NCT01021020|9770278|FG000|COMPLETED|Period I|Colchicine(fasted)-subject took Claritin-D 12hour.Colchicine(fed)arm-subject had schedule conflict.|26
8722793|NCT01021020|9770278|FG000|NOT COMPLETED|Period I||2
8722794|NCT01021020|9770278|FG000|STARTED|14 Day Washout Period A||26
8722795|NCT01021020|9770278|FG000|COMPLETED|14 Day Washout Period A|Colchicine/Probenecid-medical investigator dropped due to abnormal check-in lab results.|25
8722796|NCT01021020|9770278|FG000|NOT COMPLETED|14 Day Washout Period A||1
8722797|NCT01021020|9770278|FG000|STARTED|Period II||25
8722798|NCT01021020|9770278|FG000|COMPLETED|Period II||25
8722799|NCT01021020|9770278|FG000|NOT COMPLETED|Period II||0
8722800|NCT01021020|9770278|FG000|STARTED|14 Day Washout Period B||25
8530690|NCT04461483|9562818|FG004|NOT COMPLETED|Part 2 (Day 1 to 21)||0
8530691|NCT04461483|9562819|FG005|NOT COMPLETED|Part 2 (Day 1 to 21)||0
8530692|NCT04386616|9562846|FG000|STARTED|Overall Study||134
8530693|NCT04386616|9562847|FG001|STARTED|Overall Study||130
8530694|NCT04386616|9562848|FG002|STARTED|Overall Study||132
8564046|NCT00051311|9596046|FG000|COMPLETED|Overall Study||19
8564047|NCT00051311|9596047|FG001|COMPLETED|Overall Study||17
8722801|NCT01021020|9770278|FG000|COMPLETED|14 Day Washout Period B||25
8722802|NCT01021020|9770278|FG000|NOT COMPLETED|14 Day Washout Period B||0
8722803|NCT01021020|9770278|FG000|STARTED|Period III||25
8722804|NCT01021020|9770278|FG000|COMPLETED|Period III||25
8722805|NCT01021020|9770278|FG000|NOT COMPLETED|Period III||0
8722806|NCT01021111|9770290|FG000|STARTED|Overall Study||17
8722807|NCT01021111|9770290|FG000|COMPLETED|Overall Study||17
8722808|NCT01021111|9770290|FG000|NOT COMPLETED|Overall Study||0
8722809|NCT01021137|9770298|FG000|STARTED|Overall Study||62
8722810|NCT01021137|9770299|FG001|STARTED|Overall Study||20
8722811|NCT01021137|9770300|FG002|STARTED|Overall Study||11
8722812|NCT01021137|9770301|FG003|STARTED|Overall Study||41
8722813|NCT01021137|9770298|FG000|COMPLETED|Overall Study||52
8722814|NCT01021137|9770299|FG001|COMPLETED|Overall Study||16
8722815|NCT01021137|9770300|FG002|COMPLETED|Overall Study||9
8722816|NCT01021137|9770301|FG003|COMPLETED|Overall Study||32
8722817|NCT01021137|9770298|FG000|NOT COMPLETED|Overall Study||10
8722818|NCT01021137|9770299|FG001|NOT COMPLETED|Overall Study||4
8722819|NCT01021137|9770300|FG002|NOT COMPLETED|Overall Study||2
8722820|NCT01021137|9770301|FG003|NOT COMPLETED|Overall Study||9
8722821|NCT01021215|9770314|FG000|STARTED|Overall Study||60
8722822|NCT01021215|9770315|FG001|STARTED|Overall Study||20
8722823|NCT01021215|9770314|FG000|Received Allocated Intervention|Overall Study||60
8722824|NCT01021215|9770315|FG001|Received Allocated Intervention|Overall Study||20
8722825|NCT01021215|9770314|FG000|COMPLETED|Overall Study||57
8722826|NCT01021215|9770315|FG001|COMPLETED|Overall Study||20
8722827|NCT01021215|9770314|FG000|NOT COMPLETED|Overall Study||3
8722828|NCT01021215|9770315|FG001|NOT COMPLETED|Overall Study||0
8725116|NCT01029405|9772309|FG003|STARTED|Overall Study||37
8725117|NCT01029405|9772306|FG000|COMPLETED|Overall Study||34
8725118|NCT01029405|9772307|FG001|COMPLETED|Overall Study||34
8725119|NCT01029405|9772308|FG002|COMPLETED|Overall Study||31
8725120|NCT01029405|9772309|FG003|COMPLETED|Overall Study||32
8725121|NCT01029405|9772306|FG000|NOT COMPLETED|Overall Study||2
8725122|NCT01029405|9772307|FG001|NOT COMPLETED|Overall Study||3
8725123|NCT01029405|9772308|FG002|NOT COMPLETED|Overall Study||4
8725124|NCT01029405|9772309|FG003|NOT COMPLETED|Overall Study||5
8816376|NCT01543828|9869874|FG000|NOT COMPLETED|Treatment 1||0
8816377|NCT01543828|9869875|FG001|NOT COMPLETED|Treatment 1||0
8816378|NCT01543828|9869874|FG000|STARTED|Treatment 2||20
8816379|NCT01543828|9869875|FG001|STARTED|Treatment 2|1 participant completed treatment 1, had an adverse event, and did not receive treatment 2.|19
8816380|NCT01543828|9869874|FG000|COMPLETED|Treatment 2||19
8816381|NCT01543828|9869875|FG001|COMPLETED|Treatment 2||19
8816382|NCT01543828|9869874|FG000|NOT COMPLETED|Treatment 2||1
8816383|NCT01543828|9869875|FG001|NOT COMPLETED|Treatment 2||0
8816384|NCT01543958|9869883|FG000|STARTED|Overall Study||40
8816385|NCT01543958|9869883|FG000|COMPLETED|Overall Study||36
8816386|NCT01543958|9869883|FG000|NOT COMPLETED|Overall Study||4
8816387|NCT01544023|9869887|FG000|STARTED|Overall Study|retrospective|207
8816388|NCT01544023|9869887|FG000|COMPLETED|Overall Study||207
8725125|NCT01029535|9772319|FG000|STARTED|Overall Study||103
8725126|NCT01029535|9772319|FG000|COMPLETED|Overall Study||72
8725127|NCT01029535|9772319|FG000|NOT COMPLETED|Overall Study||31
8725128|NCT01029587|9772324|FG000|STARTED|Overall Study||1
8725129|NCT01029587|9772324|FG000|COMPLETED|Overall Study||1
8725130|NCT01029587|9772324|FG000|NOT COMPLETED|Overall Study||0
8725131|NCT01029652|9772330|FG000|STARTED|Core Study (0-12 Weeks)||115
8725132|NCT01029652|9772331|FG001|STARTED|Core Study (0-12 Weeks)||115
8725133|NCT01029652|9772330|FG000|Full Analysis Set (FAS), Safety Set|Core Study (0-12 Weeks)||113
8725134|NCT01029652|9772331|FG001|Full Analysis Set (FAS), Safety Set|Core Study (0-12 Weeks)||115
8725135|NCT01029652|9772330|FG000|COMPLETED|Core Study (0-12 Weeks)||109
8725136|NCT01029652|9772331|FG001|COMPLETED|Core Study (0-12 Weeks)||105
8725137|NCT01029652|9772330|FG000|NOT COMPLETED|Core Study (0-12 Weeks)||6
8725138|NCT01029652|9772331|FG001|NOT COMPLETED|Core Study (0-12 Weeks)||10
8725139|NCT01029652|9772330|FG000|STARTED|Extension Study 1 (12-24 Weeks)||90
8725140|NCT01029652|9772331|FG001|STARTED|Extension Study 1 (12-24 Weeks)||85
8725141|NCT01029652|9772330|FG000|COMPLETED|Extension Study 1 (12-24 Weeks)||87
8530695|NCT04386616|9562846|FG000|Received at Least One Dose of Study Drug|Overall Study|In this arm, 68 and 66 participants received MSTT1041A-matched placebo and UTTR1147A-matched placebo, respectively.|134
8530696|NCT04386616|9562847|FG001|Received at Least One Dose of Study Drug|Overall Study||130
8530697|NCT04386616|9562848|FG002|Received at Least One Dose of Study Drug|Overall Study||132
8530698|NCT04386616|9562846|FG000|Completed Both Doses of Study Drug at Day 15|Overall Study||31
8530699|NCT04386616|9562847|FG001|Completed Both Doses of Study Drug at Day 15|Overall Study||27
8530700|NCT04386616|9562848|FG002|Completed Both Doses of Study Drug at Day 15|Overall Study||25
8530701|NCT04386616|9562846|FG000|COMPLETED|Overall Study||104
8530702|NCT04386616|9562847|FG001|COMPLETED|Overall Study||95
8530703|NCT04386616|9562848|FG002|COMPLETED|Overall Study||104
8530704|NCT04386616|9562846|FG000|NOT COMPLETED|Overall Study||30
8725142|NCT01029652|9772331|FG001|COMPLETED|Extension Study 1 (12-24 Weeks)||80
8816389|NCT01544023|9869887|FG000|NOT COMPLETED|Overall Study||0
8816390|NCT01544062|9869893|FG000|STARTED|Overall Study||33
8816391|NCT01544062|9869894|FG001|STARTED|Overall Study||35
8725143|NCT01029652|9772330|FG000|NOT COMPLETED|Extension Study 1 (12-24 Weeks)||3
8725144|NCT01029652|9772331|FG001|NOT COMPLETED|Extension Study 1 (12-24 Weeks)||5
8725145|NCT01029652|9772330|FG000|STARTED|Extension Study 2 (25-72 Weeks)||69
8816392|NCT01544062|9869893|FG000|COMPLETED|Overall Study||33
8816393|NCT01544062|9869894|FG001|COMPLETED|Overall Study||35
8530705|NCT04386616|9562847|FG001|NOT COMPLETED|Overall Study||35
8530706|NCT04386616|9562848|FG002|NOT COMPLETED|Overall Study||28
8530707|NCT04377711|9562867|FG000|STARTED|Overall Study||197
8530708|NCT04377711|9562868|FG001|STARTED|Overall Study||203
8530709|NCT04377711|9562867|FG000|COMPLETED|Overall Study||178
8530710|NCT04377711|9562868|FG001|COMPLETED|Overall Study||181
8530711|NCT04377711|9562867|FG000|NOT COMPLETED|Overall Study||19
8530712|NCT04377711|9562868|FG001|NOT COMPLETED|Overall Study||22
8530713|NCT04347408|9562874|FG000|STARTED|Overall Study||992
8530714|NCT04347408|9562874|FG000|COMPLETED|Overall Study||992
8530715|NCT04347408|9562874|FG000|NOT COMPLETED|Overall Study||0
8530716|NCT04296942|9562881|FG000|STARTED|Overall Study||1
8530717|NCT04296942|9562882|FG001|STARTED|Overall Study||0
8530718|NCT04296942|9562883|FG002|STARTED|Overall Study||0
8530719|NCT04296942|9562881|FG000|COMPLETED|Overall Study||0
8530720|NCT04296942|9562882|FG001|COMPLETED|Overall Study||0
8530721|NCT04296942|9562883|FG002|COMPLETED|Overall Study||0
8530722|NCT04296942|9562881|FG000|NOT COMPLETED|Overall Study||1
8530723|NCT04296942|9562882|FG001|NOT COMPLETED|Overall Study||0
8530724|NCT04296942|9562883|FG002|NOT COMPLETED|Overall Study||0
8564048|NCT00051311|9596046|FG000|NOT COMPLETED|Overall Study||12
8564049|NCT00051311|9596047|FG001|NOT COMPLETED|Overall Study||14
8564050|NCT00051363|9596053|FG000|STARTED|Overall Study||558
8816394|NCT01544062|9869893|FG000|NOT COMPLETED|Overall Study||0
8816395|NCT01544062|9869894|FG001|NOT COMPLETED|Overall Study||0
8816396|NCT01544088|9869903|FG000|STARTED|Overall Study||98
8816397|NCT01544088|9869904|FG001|STARTED|Overall Study||100
8816398|NCT01544088|9869903|FG000|COMPLETED|Overall Study||61
8816399|NCT01544088|9869904|FG001|COMPLETED|Overall Study||79
8816400|NCT01544088|9869903|FG000|NOT COMPLETED|Overall Study||37
8816401|NCT01544088|9869904|FG001|NOT COMPLETED|Overall Study||21
8816402|NCT01544114|9869913|FG000|STARTED|Overall Study||4
8816403|NCT01544114|9869914|FG001|STARTED|Overall Study||20
8816404|NCT01544114|9869915|FG002|STARTED|Overall Study||22
8564051|NCT00051363|9596054|FG001|STARTED|Overall Study||547
8564052|NCT00051363|9596053|FG000|Randomized & Analyzed|Overall Study||556
8564053|NCT00051363|9596054|FG001|Randomized & Analyzed|Overall Study||542
8564054|NCT00051363|9596053|FG000|Completed 2M Visit On-Treatment|Overall Study||456
8564055|NCT00051363|9596054|FG001|Completed 2M Visit On-Treatment|Overall Study||417
8564056|NCT00051363|9596053|FG000|Completed 2M Visit On-Study|Overall Study||468
8564057|NCT00051363|9596054|FG001|Completed 2M Visit On-Study|Overall Study||432
8564058|NCT00051363|9596053|FG000|Completed 6M Visit On-Treatment|Overall Study||427
8564059|NCT00051363|9596054|FG001|Completed 6M Visit On-Treatment|Overall Study||372
8564060|NCT00051363|9596053|FG000|Completed 6M Vist On-Study|Overall Study||443
8564061|NCT00051363|9596054|FG001|Completed 6M Vist On-Study|Overall Study||403
8564062|NCT00051363|9596053|FG000|COMPLETED|Overall Study||443
8564063|NCT00051363|9596054|FG001|COMPLETED|Overall Study||403
8564064|NCT00051363|9596053|FG000|NOT COMPLETED|Overall Study||115
8564065|NCT00051363|9596054|FG001|NOT COMPLETED|Overall Study||144
8564066|NCT00051558|9596062|FG000|STARTED|Overall Study||214
8564067|NCT00051558|9596063|FG001|STARTED|Overall Study||214
8564068|NCT00051558|9596062|FG000|COMPLETED|Overall Study||123
8564069|NCT00051558|9596063|FG001|COMPLETED|Overall Study||118
8564070|NCT00051558|9596062|FG000|NOT COMPLETED|Overall Study||91
8564071|NCT00051558|9596063|FG001|NOT COMPLETED|Overall Study||96
8564072|NCT00051636|9596071|FG000|STARTED|Period 1 - Core||90
8564073|NCT00051636|9596072|FG001|STARTED|Period 1 - Core||82
8564074|NCT00051636|9596071|FG000|COMPLETED|Period 1 - Core||86
8564075|NCT00051636|9596072|FG001|COMPLETED|Period 1 - Core||76
8564076|NCT00051636|9596071|FG000|NOT COMPLETED|Period 1 - Core||4
8564077|NCT00051636|9596072|FG001|NOT COMPLETED|Period 1 - Core||6
8564078|NCT00051636|9596071|FG000|STARTED|Period 2- Extended Observation Period||75
8564079|NCT00051636|9596072|FG001|STARTED|Period 2- Extended Observation Period||52
8564080|NCT00051636|9596071|FG000|COMPLETED|Period 2- Extended Observation Period|Includes patients retreated for Paget's disease and patients discontinued when sponsor ended study|5
8564081|NCT00051636|9596072|FG001|COMPLETED|Period 2- Extended Observation Period|Includes patients retreated for Paget's disease|22
8564082|NCT00051636|9596071|FG000|NOT COMPLETED|Period 2- Extended Observation Period||70
8564083|NCT00051636|9596072|FG001|NOT COMPLETED|Period 2- Extended Observation Period||30
8564084|NCT00052078|9596082|FG000|STARTED|Overall Study||133
8564085|NCT00052078|9596083|FG001|STARTED|Overall Study||139
8564086|NCT00052078|9596084|FG002|STARTED|Overall Study||140
8564087|NCT00052078|9596085|FG003|STARTED|Overall Study||76
8564088|NCT00052078|9596082|FG000|COMPLETED|Overall Study||110
8564089|NCT00052078|9596083|FG001|COMPLETED|Overall Study||133
8564090|NCT00052078|9596084|FG002|COMPLETED|Overall Study||127
8816405|NCT01544114|9869913|FG000|COMPLETED|Overall Study|completed study and received 6 months of study drug|3
8816406|NCT01544114|9869914|FG001|COMPLETED|Overall Study|completed study and received 6 months of study drug|16
8816407|NCT01544114|9869915|FG002|COMPLETED|Overall Study|completed study and received 6 months of study drug|17
8816408|NCT01544114|9869913|FG000|NOT COMPLETED|Overall Study||1
8816409|NCT01544114|9869914|FG001|NOT COMPLETED|Overall Study||4
8564091|NCT00052078|9596085|FG003|COMPLETED|Overall Study||61
8564092|NCT00052078|9596082|FG000|NOT COMPLETED|Overall Study||23
8564093|NCT00052078|9596083|FG001|NOT COMPLETED|Overall Study||6
8564094|NCT00052078|9596084|FG002|NOT COMPLETED|Overall Study||13
8564095|NCT00052078|9596085|FG003|NOT COMPLETED|Overall Study||15
8564096|NCT00052429|9596095|FG000|STARTED|Overall Study||25
8816410|NCT01544114|9869915|FG002|NOT COMPLETED|Overall Study||5
8530725|NCT04278872|9562895|FG000|STARTED|Overall Study||7
8530726|NCT04278872|9562896|FG001|STARTED|Overall Study||6
8530727|NCT04278872|9562895|FG000|COMPLETED|Overall Study||4
8530728|NCT04278872|9562896|FG001|COMPLETED|Overall Study||5
8530729|NCT04278872|9562895|FG000|NOT COMPLETED|Overall Study||3
8530730|NCT04278872|9562896|FG001|NOT COMPLETED|Overall Study||1
8530731|NCT04213807|9562905|FG000|STARTED|Overall Study||5
8530732|NCT04213807|9562906|FG001|STARTED|Overall Study||6
8530733|NCT04213807|9562907|FG002|STARTED|Overall Study||7
8530734|NCT04213807|9562905|FG000|COMPLETED|Overall Study||5
8530735|NCT04213807|9562906|FG001|COMPLETED|Overall Study||6
8530736|NCT04213807|9562907|FG002|COMPLETED|Overall Study||6
8530737|NCT04213807|9562905|FG000|NOT COMPLETED|Overall Study||0
8530738|NCT04213807|9562906|FG001|NOT COMPLETED|Overall Study||0
8530739|NCT04213807|9562907|FG002|NOT COMPLETED|Overall Study||1
8530740|NCT04172467|9562917|FG000|STARTED|Overall Study||1086
8530741|NCT04172467|9562917|FG000|COMPLETED|Overall Study||1086
8530742|NCT04172467|9562917|FG000|NOT COMPLETED|Overall Study||0
8530743|NCT04132804|9562924|FG000|STARTED|Overall Study||31
8530744|NCT04132804|9562924|FG000|COMPLETED|Overall Study||20
8530745|NCT04132804|9562924|FG000|NOT COMPLETED|Overall Study||11
8530746|NCT03963011|9562930|FG000|STARTED|Overall Study||8
8530747|NCT03963011|9562931|FG001|STARTED|Overall Study||6
8530748|NCT03963011|9562930|FG000|COMPLETED|Overall Study||8
8530749|NCT03963011|9562931|FG001|COMPLETED|Overall Study||6
8530750|NCT03963011|9562930|FG000|NOT COMPLETED|Overall Study||0
8530751|NCT03963011|9562931|FG001|NOT COMPLETED|Overall Study||0
8530752|NCT03894501|9562939|FG000|STARTED|Overall Study||15
8530753|NCT03894501|9562940|FG001|STARTED|Overall Study||15
8530754|NCT03894501|9562939|FG000|COMPLETED|Overall Study||15
8530755|NCT03894501|9562940|FG001|COMPLETED|Overall Study||15
8530756|NCT03894501|9562939|FG000|NOT COMPLETED|Overall Study||0
8530757|NCT03894501|9562940|FG001|NOT COMPLETED|Overall Study||0
8530764|NCT03837184|9562966|FG000|STARTED|Overall Study||2
8530765|NCT03837184|9562966|FG000|COMPLETED|Overall Study||2
8530766|NCT03837184|9562966|FG000|NOT COMPLETED|Overall Study||0
8530767|NCT03735420|9562972|FG000|STARTED|Overall Study||16
8530768|NCT03735420|9562973|FG001|STARTED|Overall Study||14
8530769|NCT03735420|9562972|FG000|COMPLETED|Overall Study||16
8530770|NCT03735420|9562973|FG001|COMPLETED|Overall Study||14
8530771|NCT03735420|9562972|FG000|NOT COMPLETED|Overall Study||0
8530772|NCT03735420|9562973|FG001|NOT COMPLETED|Overall Study||0
8530773|NCT03721328|9562981|FG000|STARTED|Overall Study||15
8530774|NCT03721328|9562981|FG000|COMPLETED|Overall Study||15
8530775|NCT03721328|9562981|FG000|NOT COMPLETED|Overall Study||0
8530776|NCT03721107|9562989|FG000|STARTED|Overall Study||80
8530777|NCT03721107|9562990|FG001|STARTED|Overall Study||84
8530778|NCT03721107|9562991|FG002|STARTED|Overall Study||98
8530779|NCT03721107|9562992|FG003|STARTED|Overall Study||104
8530780|NCT03721107|9562989|FG000|Treated|Overall Study||80
8530781|NCT03721107|9562990|FG001|Treated|Overall Study||84
8530782|NCT03721107|9562991|FG002|Treated|Overall Study||97
8530783|NCT03721107|9562992|FG003|Treated|Overall Study||104
8530784|NCT03721107|9562989|FG000|COMPLETED|Overall Study||75
8530785|NCT03721107|9562990|FG001|COMPLETED|Overall Study||81
8530786|NCT03721107|9562991|FG002|COMPLETED|Overall Study||83
8530787|NCT03721107|9562992|FG003|COMPLETED|Overall Study||92
8530788|NCT03721107|9562989|FG000|NOT COMPLETED|Overall Study||5
9065788|NCT04141930|10126264|FG001|COMPLETED|Overall Study||179
9065789|NCT04141930|10126263|FG000|NOT COMPLETED|Overall Study||0
9065790|NCT04141930|10126264|FG001|NOT COMPLETED|Overall Study||0
9065791|NCT04142450|10126268|FG000|STARTED|Overall Study||50
8530789|NCT03721107|9562990|FG001|NOT COMPLETED|Overall Study||3
8530790|NCT03721107|9562991|FG002|NOT COMPLETED|Overall Study||15
8530791|NCT03721107|9562992|FG003|NOT COMPLETED|Overall Study||12
8530792|NCT03691727|9563004|FG000|STARTED|Overall Study||18
8530793|NCT03691727|9563005|FG001|STARTED|Overall Study||12
8530794|NCT03691727|9563004|FG000|COMPLETED|Overall Study||16
8620671|NCT00475085|9659453|FG000|NOT COMPLETED|Overall Study||18
8620672|NCT00475085|9659454|FG001|NOT COMPLETED|Overall Study||20
8530795|NCT03691727|9563005|FG001|COMPLETED|Overall Study||11
8530796|NCT03691727|9563004|FG000|NOT COMPLETED|Overall Study||2
8530797|NCT03691727|9563005|FG001|NOT COMPLETED|Overall Study||1
8530798|NCT03689920|9563013|FG000|STARTED|Overall Study||47
8530799|NCT03689920|9563014|FG001|STARTED|Overall Study||52
8530800|NCT03689920|9563013|FG000|COMPLETED|Overall Study||41
8530801|NCT03689920|9563014|FG001|COMPLETED|Overall Study||48
8530802|NCT03689920|9563013|FG000|NOT COMPLETED|Overall Study||6
8620673|NCT00475085|9659455|FG002|NOT COMPLETED|Overall Study||19
8620674|NCT00475085|9659456|FG003|NOT COMPLETED|Overall Study||20
8620675|NCT00475150|9659468|FG000|STARTED|Overall Study||23
8530803|NCT03689920|9563014|FG001|NOT COMPLETED|Overall Study||4
8530804|NCT03672227|9563022|FG000|STARTED|Overall Study||112
8530805|NCT03672227|9563023|FG001|STARTED|Overall Study||52
8530806|NCT03672227|9563022|FG000|Teachers Started|Overall Study||8
8530807|NCT03672227|9563023|FG001|Teachers Started|Overall Study||6
8530808|NCT03672227|9563022|FG000|Children Started|Overall Study||52
8943762|NCT02391714|10005607|FG000|STARTED|Overall Study||40
8943763|NCT02391714|10005608|FG001|STARTED|Overall Study||40
8943764|NCT02391714|10005607|FG000|COMPLETED|Overall Study||40
8943765|NCT02391714|10005608|FG001|COMPLETED|Overall Study||40
8943766|NCT02391714|10005607|FG000|NOT COMPLETED|Overall Study||0
8943767|NCT02391714|10005608|FG001|NOT COMPLETED|Overall Study||0
8530809|NCT03672227|9563023|FG001|Children Started|Overall Study||23
8530810|NCT03672227|9563022|FG000|Parents Started|Overall Study||52
8530811|NCT03672227|9563023|FG001|Parents Started|Overall Study||23
8530812|NCT03672227|9563022|FG000|COMPLETED|Overall Study||105
8530813|NCT03672227|9563023|FG001|COMPLETED|Overall Study||52
8530814|NCT03672227|9563022|FG000|NOT COMPLETED|Overall Study||7
8530815|NCT03672227|9563023|FG001|NOT COMPLETED|Overall Study||0
8530816|NCT03644849|9563032|FG000|STARTED|Overall Study||24
8530817|NCT03644849|9563033|FG001|STARTED|Overall Study||24
8530818|NCT03644849|9563032|FG000|COMPLETED|Overall Study||23
8943768|NCT02391948|10005621|FG000|STARTED|Baseline||227
8943769|NCT02391948|10005622|FG001|STARTED|Baseline||161
8943770|NCT02391948|10005623|FG002|STARTED|Baseline||80
8943771|NCT02391948|10005624|FG003|STARTED|Baseline||129
8943772|NCT02391948|10005625|FG004|STARTED|Baseline||111
8943773|NCT02391948|10005621|FG000|COMPLETED|Baseline||227
8943774|NCT02391948|10005622|FG001|COMPLETED|Baseline||161
8943775|NCT02391948|10005623|FG002|COMPLETED|Baseline||80
8943776|NCT02391948|10005624|FG003|COMPLETED|Baseline||129
8530819|NCT03644849|9563033|FG001|COMPLETED|Overall Study||21
8530820|NCT03644849|9563032|FG000|NOT COMPLETED|Overall Study||1
8530821|NCT03644849|9563033|FG001|NOT COMPLETED|Overall Study||3
8530822|NCT03604159|9563041|FG000|STARTED|Overall Study||26
8530823|NCT03604159|9563042|FG001|STARTED|Overall Study||26
8530824|NCT03604159|9563041|FG000|COMPLETED|Overall Study||20
8530825|NCT03604159|9563042|FG001|COMPLETED|Overall Study||19
8530826|NCT03604159|9563041|FG000|NOT COMPLETED|Overall Study||6
8530827|NCT03604159|9563042|FG001|NOT COMPLETED|Overall Study||7
8530828|NCT03602885|9563050|FG000|STARTED|Overall Study||5
8530829|NCT03602885|9563051|FG001|STARTED|Overall Study||5
8530830|NCT03602885|9563050|FG000|COMPLETED|Overall Study||2
8530831|NCT03602885|9563051|FG001|COMPLETED|Overall Study||5
8530832|NCT03602885|9563050|FG000|NOT COMPLETED|Overall Study||3
8530833|NCT03602885|9563051|FG001|NOT COMPLETED|Overall Study||0
8530834|NCT03539601|9563061|FG000|STARTED|Overall Study||60
8530835|NCT03539601|9563062|FG001|STARTED|Overall Study||59
8530836|NCT03539601|9563063|FG002|STARTED|Overall Study||71
8530837|NCT03539601|9563064|FG003|STARTED|Overall Study||47
8530838|NCT03539601|9563061|FG000|Treated|Overall Study||59
8530839|NCT03539601|9563062|FG001|Treated|Overall Study||58
8530840|NCT03539601|9563063|FG002|Treated|Overall Study||71
8530841|NCT03539601|9563064|FG003|Treated|Overall Study||47
8530842|NCT03539601|9563061|FG000|COMPLETED|Overall Study||54
8530843|NCT03539601|9563062|FG001|COMPLETED|Overall Study||52
8530844|NCT03539601|9563063|FG002|COMPLETED|Overall Study||65
8530845|NCT03539601|9563064|FG003|COMPLETED|Overall Study||46
8530846|NCT03539601|9563061|FG000|NOT COMPLETED|Overall Study||6
8530847|NCT03539601|9563062|FG001|NOT COMPLETED|Overall Study||7
8530848|NCT03539601|9563063|FG002|NOT COMPLETED|Overall Study||6
8530849|NCT03539601|9563064|FG003|NOT COMPLETED|Overall Study||1
8530850|NCT03539458|9563082|FG000|STARTED|Overall Study||11
8530851|NCT03539458|9563082|FG000|COMPLETED|Overall Study||10
8530852|NCT03539458|9563082|FG000|NOT COMPLETED|Overall Study||1
8530853|NCT03532451|9563088|FG000|STARTED|Overall Study||13
8530854|NCT03532451|9563089|FG001|STARTED|Overall Study||30
8530855|NCT03532451|9563088|FG000|COMPLETED|Overall Study||12
8530856|NCT03532451|9563089|FG001|COMPLETED|Overall Study||29
8530857|NCT03532451|9563088|FG000|NOT COMPLETED|Overall Study||1
8530858|NCT03532451|9563089|FG001|NOT COMPLETED|Overall Study||1
8530859|NCT03505099|9563097|FG000|STARTED|Overall Study||14
8530860|NCT03505099|9563098|FG001|STARTED|Overall Study||15
8530861|NCT03505099|9563097|FG000|Received AVXS-101|Overall Study||14
8530862|NCT03505099|9563098|FG001|Received AVXS-101|Overall Study||15
8530863|NCT03505099|9563097|FG000|COMPLETED|Overall Study||14
8530864|NCT03505099|9563098|FG001|COMPLETED|Overall Study||15
8530865|NCT03505099|9563097|FG000|NOT COMPLETED|Overall Study||0
8530866|NCT03505099|9563098|FG001|NOT COMPLETED|Overall Study||0
8564097|NCT00052429|9596095|FG000|COMPLETED|Overall Study||25
8564098|NCT00052429|9596095|FG000|NOT COMPLETED|Overall Study||0
8564099|NCT00052442|9596104|FG000|STARTED|Overall Study||16
8564100|NCT00052442|9596105|FG001|STARTED|Overall Study||3
8564101|NCT00052442|9596106|FG002|STARTED|Overall Study||27
8564102|NCT00052442|9596107|FG003|STARTED|Overall Study||11
8943777|NCT02391948|10005625|FG004|COMPLETED|Baseline||111
8943778|NCT02391948|10005621|FG000|NOT COMPLETED|Baseline||0
8564103|NCT00052442|9596108|FG004|STARTED|Overall Study||15
8564104|NCT00052442|9596104|FG000|COMPLETED|Overall Study||16
8564105|NCT00052442|9596105|FG001|COMPLETED|Overall Study||3
8564106|NCT00052442|9596106|FG002|COMPLETED|Overall Study||27
8564107|NCT00052442|9596107|FG003|COMPLETED|Overall Study||11
8564108|NCT00052442|9596108|FG004|COMPLETED|Overall Study||15
8564109|NCT00052442|9596104|FG000|NOT COMPLETED|Overall Study||0
8564110|NCT00052442|9596105|FG001|NOT COMPLETED|Overall Study||0
8564111|NCT00052442|9596106|FG002|NOT COMPLETED|Overall Study||0
8564112|NCT00052442|9596107|FG003|NOT COMPLETED|Overall Study||0
8943779|NCT02391948|10005622|FG001|NOT COMPLETED|Baseline||0
8943780|NCT02391948|10005623|FG002|NOT COMPLETED|Baseline||0
8943781|NCT02391948|10005624|FG003|NOT COMPLETED|Baseline||0
8530867|NCT03494647|9563106|FG000|STARTED|Overall Study||21
8530868|NCT03494647|9563107|FG001|STARTED|Overall Study||22
8530869|NCT03494647|9563106|FG000|COMPLETED|Overall Study||16
8530870|NCT03494647|9563107|FG001|COMPLETED|Overall Study||16
8530871|NCT03494647|9563106|FG000|NOT COMPLETED|Overall Study||5
8530872|NCT03494647|9563107|FG001|NOT COMPLETED|Overall Study||6
8530873|NCT03464136|9563115|FG000|STARTED|Overall Study||195
8530874|NCT03464136|9563116|FG001|STARTED|Overall Study||191
8530875|NCT03464136|9563115|FG000|COMPLETED|Overall Study||165
8530876|NCT03464136|9563116|FG001|COMPLETED|Overall Study||166
8530877|NCT03464136|9563115|FG000|NOT COMPLETED|Overall Study||30
8530878|NCT03464136|9563116|FG001|NOT COMPLETED|Overall Study||25
8530879|NCT03439657|9563124|FG000|STARTED|Overall Study||449
8530880|NCT03439657|9563125|FG001|STARTED|Overall Study||463
8530881|NCT03439657|9563124|FG000|COMPLETED|Overall Study||442
8530882|NCT03439657|9563125|FG001|COMPLETED|Overall Study||459
8530883|NCT03439657|9563124|FG000|NOT COMPLETED|Overall Study||7
8530884|NCT03439657|9563125|FG001|NOT COMPLETED|Overall Study||4
8530885|NCT03377790|9563135|FG000|STARTED|Overall Study||160
8530886|NCT03377790|9563136|FG001|STARTED|Overall Study||106
8530887|NCT03377790|9563135|FG000|COMPLETED|Overall Study||150
8530888|NCT03377790|9563136|FG001|COMPLETED|Overall Study||100
8530889|NCT03377790|9563135|FG000|NOT COMPLETED|Overall Study||10
8530890|NCT03377790|9563136|FG001|NOT COMPLETED|Overall Study||6
8530891|NCT03353675|9563142|FG000|STARTED|Overall Study||44
8530892|NCT03353675|9563142|FG000|COMPLETED|Overall Study||40
8530893|NCT03353675|9563142|FG000|NOT COMPLETED|Overall Study||4
8530894|NCT03294109|9563148|FG000|STARTED|Overall Study||46
8530895|NCT03294109|9563149|FG001|STARTED|Overall Study||57
8530896|NCT03294109|9563148|FG000|Underwent Surgery|Overall Study||40
8530897|NCT03294109|9563149|FG001|Underwent Surgery|Overall Study||52
8530898|NCT03294109|9563148|FG000|COMPLETED|Overall Study||40
8530899|NCT03294109|9563149|FG001|COMPLETED|Overall Study||52
8530900|NCT03294109|9563148|FG000|NOT COMPLETED|Overall Study||6
8530901|NCT03294109|9563149|FG001|NOT COMPLETED|Overall Study||5
8530902|NCT03268005|9563158|FG000|STARTED|Overall Study||546
8530903|NCT03268005|9563159|FG001|STARTED|Overall Study||545
8530904|NCT03268005|9563158|FG000|Full Analysis Set|Overall Study||546
8530905|NCT03268005|9563159|FG001|Full Analysis Set|Overall Study||545
8530906|NCT03268005|9563158|FG000|Safety Analysis Set|Overall Study||544
8530907|NCT03268005|9563159|FG001|Safety Analysis Set|Overall Study||544
8530908|NCT03268005|9563158|FG000|COMPLETED|Overall Study||531
8530909|NCT03268005|9563159|FG001|COMPLETED|Overall Study||531
8530910|NCT03268005|9563158|FG000|NOT COMPLETED|Overall Study||15
8530911|NCT03268005|9563159|FG001|NOT COMPLETED|Overall Study||14
8530912|NCT03225170|9563168|FG000|STARTED|Overall Study||23
8530913|NCT03225170|9563169|FG001|STARTED|Overall Study||22
8530914|NCT03225170|9563170|FG002|STARTED|Overall Study||2
8530915|NCT03225170|9563168|FG000|COMPLETED|Overall Study||19
8530916|NCT03225170|9563169|FG001|COMPLETED|Overall Study||17
8530917|NCT03225170|9563170|FG002|COMPLETED|Overall Study||2
8530918|NCT03225170|9563168|FG000|NOT COMPLETED|Overall Study||4
8530919|NCT03225170|9563169|FG001|NOT COMPLETED|Overall Study||5
8530920|NCT03225170|9563170|FG002|NOT COMPLETED|Overall Study||0
8530921|NCT03220854|9563179|FG000|STARTED|Overall Study||4
8530922|NCT03220854|9563180|FG001|STARTED|Overall Study||0
8530923|NCT03220854|9563181|FG002|STARTED|Overall Study||1
8530924|NCT03220854|9563179|FG000|COMPLETED|Overall Study||4
8530925|NCT03220854|9563180|FG001|COMPLETED|Overall Study||0
8530926|NCT03220854|9563181|FG002|COMPLETED|Overall Study||1
8530927|NCT03220854|9563179|FG000|NOT COMPLETED|Overall Study||0
8530928|NCT03220854|9563180|FG001|NOT COMPLETED|Overall Study||0
8530929|NCT03220854|9563181|FG002|NOT COMPLETED|Overall Study||0
8530930|NCT03219034|9563194|FG000|STARTED|Overall Study||31
8530931|NCT03219034|9563195|FG001|STARTED|Overall Study||31
8530932|NCT03219034|9563194|FG000|COMPLETED|Overall Study||20
8530933|NCT03219034|9563195|FG001|COMPLETED|Overall Study||16
8530934|NCT03219034|9563194|FG000|NOT COMPLETED|Overall Study||11
8530935|NCT03219034|9563195|FG001|NOT COMPLETED|Overall Study||15
8530936|NCT03168438|9563205|FG000|STARTED|Overall Study||3
8530937|NCT03168438|9563206|FG001|STARTED|Overall Study||3
8530938|NCT03168438|9563205|FG000|COMPLETED|Overall Study||3
8530939|NCT03168438|9563206|FG001|COMPLETED|Overall Study||2
8530940|NCT03168438|9563205|FG000|NOT COMPLETED|Overall Study||0
8530941|NCT03168438|9563206|FG001|NOT COMPLETED|Overall Study||1
8530942|NCT03110380|9563215|FG000|STARTED|Double-Blind Treatment Phase||284
8530943|NCT03110380|9563216|FG001|STARTED|Double-Blind Treatment Phase||283
8530944|NCT03110380|9563217|FG002|STARTED|Double-Blind Treatment Phase||0
8530945|NCT03110380|9563218|FG003|STARTED|Double-Blind Treatment Phase||0
8530946|NCT03110380|9563215|FG000|Safety Analysis Set|Double-Blind Treatment Phase||284
8530947|NCT03110380|9563216|FG001|Safety Analysis Set|Double-Blind Treatment Phase||281
8530948|NCT03110380|9563217|FG002|Safety Analysis Set|Double-Blind Treatment Phase||0
8530949|NCT03110380|9563218|FG003|Safety Analysis Set|Double-Blind Treatment Phase||0
8530950|NCT03110380|9563215|FG000|COMPLETED|Double-Blind Treatment Phase||263
8530951|NCT03110380|9563216|FG001|COMPLETED|Double-Blind Treatment Phase||253
8530952|NCT03110380|9563217|FG002|COMPLETED|Double-Blind Treatment Phase||0
8530953|NCT03110380|9563218|FG003|COMPLETED|Double-Blind Treatment Phase||0
8530954|NCT03110380|9563215|FG000|NOT COMPLETED|Double-Blind Treatment Phase||21
8530955|NCT03110380|9563216|FG001|NOT COMPLETED|Double-Blind Treatment Phase||30
8530956|NCT03110380|9563217|FG002|NOT COMPLETED|Double-Blind Treatment Phase||0
8530957|NCT03110380|9563218|FG003|NOT COMPLETED|Double-Blind Treatment Phase||0
8530958|NCT03110380|9563215|FG000|STARTED|Open-label B/F/TAF Extension Phase|Following the end of Double-Blind treatment phase, participants in a country where B/F/TAF FDC was not available were given the option to receive open-label B/F/TAF.|0
8530959|NCT03110380|9563216|FG001|STARTED|Open-label B/F/TAF Extension Phase|Following the end of Double-Blind treatment phase, participants in a country where B/F/TAF FDC was not available were given the option to receive open-label B/F/TAF.|0
8530960|NCT03110380|9563217|FG002|STARTED|Open-label B/F/TAF Extension Phase|138 participants completed the Double-Blind treatment phase, but did not continue in the Open-label B/F/TAF extension phase.|125
8530961|NCT03110380|9563218|FG003|STARTED|Open-label B/F/TAF Extension Phase|137 participants completed the Double-Blind treatment phase, but did not continue in the Open-label B/F/TAF extension phase.|116
8530962|NCT03110380|9563215|FG000|COMPLETED|Open-label B/F/TAF Extension Phase||0
8530963|NCT03110380|9563216|FG001|COMPLETED|Open-label B/F/TAF Extension Phase||0
8530964|NCT03110380|9563217|FG002|COMPLETED|Open-label B/F/TAF Extension Phase||121
8530965|NCT03110380|9563218|FG003|COMPLETED|Open-label B/F/TAF Extension Phase||113
8530966|NCT03110380|9563215|FG000|NOT COMPLETED|Open-label B/F/TAF Extension Phase||0
8530967|NCT03110380|9563216|FG001|NOT COMPLETED|Open-label B/F/TAF Extension Phase||0
8530968|NCT03110380|9563217|FG002|NOT COMPLETED|Open-label B/F/TAF Extension Phase||4
8530969|NCT03110380|9563218|FG003|NOT COMPLETED|Open-label B/F/TAF Extension Phase||3
8530970|NCT03109262|9563226|FG000|STARTED|Overall Study||42
8530971|NCT03109262|9563226|FG000|COMPLETED|Overall Study||42
8530972|NCT03109262|9563226|FG000|NOT COMPLETED|Overall Study||0
8530973|NCT03078478|9563234|FG000|STARTED|Titration Period (16 Weeks)||805
8530974|NCT03078478|9563235|FG001|STARTED|Titration Period (16 Weeks)||804
8530975|NCT03078478|9563234|FG000|Full Analysis Set|Titration Period (16 Weeks)||805
8530976|NCT03078478|9563235|FG001|Full Analysis Set|Titration Period (16 Weeks)||804
8530977|NCT03078478|9563234|FG000|Safety Analysis Set|Titration Period (16 Weeks)||802
8530978|NCT03078478|9563235|FG001|Safety Analysis Set|Titration Period (16 Weeks)||798
8530979|NCT03078478|9563234|FG000|COMPLETED|Titration Period (16 Weeks)||805
8530980|NCT03078478|9563235|FG001|COMPLETED|Titration Period (16 Weeks)||804
8530981|NCT03078478|9563234|FG000|NOT COMPLETED|Titration Period (16 Weeks)||0
8530982|NCT03078478|9563235|FG001|NOT COMPLETED|Titration Period (16 Weeks)||0
8530983|NCT03078478|9563234|FG000|STARTED|Maintenance Period 1 (36 Weeks)||805
8530984|NCT03078478|9563235|FG001|STARTED|Maintenance Period 1 (36 Weeks)||804
8530985|NCT03078478|9563234|FG000|COMPLETED|Maintenance Period 1 (36 Weeks)||758
8530986|NCT03078478|9563235|FG001|COMPLETED|Maintenance Period 1 (36 Weeks)||761
8530987|NCT03078478|9563234|FG000|NOT COMPLETED|Maintenance Period 1 (36 Weeks)||47
8530988|NCT03078478|9563235|FG001|NOT COMPLETED|Maintenance Period 1 (36 Weeks)||43
8530989|NCT03078478|9563234|FG000|STARTED|Maintencance Period 2 (36 Weeks)||758
8530990|NCT03078478|9563235|FG001|STARTED|Maintencance Period 2 (36 Weeks)||761
8530991|NCT03078478|9563234|FG000|COMPLETED|Maintencance Period 2 (36 Weeks)||733
8530992|NCT03078478|9563235|FG001|COMPLETED|Maintencance Period 2 (36 Weeks)||734
8530993|NCT03078478|9563234|FG000|NOT COMPLETED|Maintencance Period 2 (36 Weeks)||25
8530994|NCT03078478|9563235|FG001|NOT COMPLETED|Maintencance Period 2 (36 Weeks)||27
8530995|NCT03040661|9563243|FG000|STARTED|Overall Study||35
8530996|NCT03040661|9563244|FG001|STARTED|Overall Study||35
8530997|NCT03040661|9563243|FG000|COMPLETED|Overall Study||35
8530998|NCT03040661|9563244|FG001|COMPLETED|Overall Study||35
8530999|NCT03040661|9563243|FG000|NOT COMPLETED|Overall Study||0
8531000|NCT03040661|9563244|FG001|NOT COMPLETED|Overall Study||0
8531001|NCT02993263|9563250|FG000|STARTED|Overall Study||323
8531002|NCT02993263|9563250|FG000|COMPLETED|Overall Study||0
8531003|NCT02993263|9563250|FG000|NOT COMPLETED|Overall Study||323
8531004|NCT02985684|9563254|FG000|STARTED|6-Month Clinical Success Evaluation||125
8531005|NCT02985684|9563254|FG000|COMPLETED|6-Month Clinical Success Evaluation||120
8531006|NCT02985684|9563254|FG000|NOT COMPLETED|6-Month Clinical Success Evaluation||5
8531007|NCT02985684|9563254|FG000|STARTED|6-Month Closure Success Evaluation||120
8531008|NCT02985684|9563254|FG000|COMPLETED|6-Month Closure Success Evaluation||112
8531009|NCT02985684|9563254|FG000|NOT COMPLETED|6-Month Closure Success Evaluation||8
8531010|NCT02964897|9563260|FG000|STARTED|Overall Study||43
8531011|NCT02964897|9563261|FG001|STARTED|Overall Study||36
8531012|NCT02964897|9563260|FG000|COMPLETED|Overall Study||43
8620676|NCT00475150|9659469|FG001|STARTED|Overall Study||16
8620677|NCT00475150|9659468|FG000|COMPLETED|Overall Study||23
8620678|NCT00475150|9659469|FG001|COMPLETED|Overall Study||16
8620679|NCT00475150|9659468|FG000|NOT COMPLETED|Overall Study||0
8620680|NCT00475150|9659469|FG001|NOT COMPLETED|Overall Study||0
8620681|NCT00475176|9659474|FG000|STARTED|Overall Study||24
8531013|NCT02964897|9563261|FG001|COMPLETED|Overall Study||36
8531014|NCT02964897|9563260|FG000|NOT COMPLETED|Overall Study||0
8531015|NCT02964897|9563261|FG001|NOT COMPLETED|Overall Study||0
8531016|NCT02873195|9563269|FG000|STARTED|Overall Study||87
8531017|NCT02873195|9563270|FG001|STARTED|Overall Study||46
8531018|NCT02873195|9563269|FG000|Never Began Treatment (Cancel)|Overall Study||1
8531019|NCT02873195|9563270|FG001|Never Began Treatment (Cancel)|Overall Study||0
8531020|NCT02873195|9563269|FG000|COMPLETED|Overall Study||82
8531021|NCT02873195|9563270|FG001|COMPLETED|Overall Study||46
8531022|NCT02873195|9563269|FG000|NOT COMPLETED|Overall Study||5
8531023|NCT02873195|9563270|FG001|NOT COMPLETED|Overall Study||0
8531024|NCT02809131|9563278|FG000|STARTED|Overall Study||505
8531025|NCT02809131|9563279|FG001|STARTED|Overall Study||505
8531026|NCT02809131|9563278|FG000|COMPLETED|Overall Study||445
8620682|NCT00475176|9659474|FG000|COMPLETED|Overall Study||20
8531027|NCT02809131|9563279|FG001|COMPLETED|Overall Study||445
8531028|NCT02809131|9563278|FG000|NOT COMPLETED|Overall Study||60
8531029|NCT02809131|9563279|FG001|NOT COMPLETED|Overall Study||60
8531030|NCT02785952|9563287|FG000|STARTED|Overall Study||125
8531031|NCT02785952|9563288|FG001|STARTED|Overall Study||127
8531032|NCT02785952|9563287|FG000|COMPLETED|Overall Study||0
8531033|NCT02785952|9563288|FG001|COMPLETED|Overall Study||0
8531034|NCT02785952|9563287|FG000|NOT COMPLETED|Overall Study||125
8531035|NCT02785952|9563288|FG001|NOT COMPLETED|Overall Study||127
8531036|NCT02758717|9563296|FG000|STARTED|Overall Study||46
8531037|NCT02758717|9563296|FG000|COMPLETED|Overall Study||46
8531038|NCT02758717|9563296|FG000|NOT COMPLETED|Overall Study||0
8531039|NCT02748616|9563300|FG000|STARTED|Overall Study||9
8531040|NCT02748616|9563300|FG000|COMPLETED|Overall Study||2
8531041|NCT02748616|9563300|FG000|NOT COMPLETED|Overall Study||7
8620683|NCT00475176|9659474|FG000|NOT COMPLETED|Overall Study||4
8620684|NCT00475215|9659480|FG000|STARTED|Overall Study||44
8620685|NCT00475215|9659481|FG001|STARTED|Overall Study||42
8620686|NCT00475215|9659480|FG000|Treated|Overall Study||39
8620687|NCT00475215|9659481|FG001|Treated|Overall Study||38
8620688|NCT00475215|9659480|FG000|COMPLETED|Overall Study||39
8620689|NCT00475215|9659481|FG001|COMPLETED|Overall Study||38
8620690|NCT00475215|9659480|FG000|NOT COMPLETED|Overall Study||5
8620691|NCT00475215|9659481|FG001|NOT COMPLETED|Overall Study||4
8620692|NCT00475228|9659489|FG000|STARTED|Overall Study||44
8620693|NCT00475228|9659490|FG001|STARTED|Overall Study||44
8620694|NCT00475228|9659489|FG000|COMPLETED|Overall Study||27
8620695|NCT00475228|9659490|FG001|COMPLETED|Overall Study||27
8620696|NCT00475228|9659489|FG000|NOT COMPLETED|Overall Study||17
8620697|NCT00475228|9659490|FG001|NOT COMPLETED|Overall Study||17
8620698|NCT00475241|9659502|FG000|STARTED|Overall Study||18
8620699|NCT00475241|9659503|FG001|STARTED|Overall Study||18
8620700|NCT00475241|9659502|FG000|COMPLETED|Overall Study||11
8620701|NCT00475241|9659503|FG001|COMPLETED|Overall Study||15
8620702|NCT00475241|9659502|FG000|NOT COMPLETED|Overall Study||7
8620703|NCT00475241|9659503|FG001|NOT COMPLETED|Overall Study||3
8620704|NCT00475306|9659514|FG000|STARTED|Overall Study||73
8620705|NCT00475306|9659515|FG001|STARTED|Overall Study||72
8620706|NCT00475306|9659516|FG002|STARTED|Overall Study||72
8620707|NCT00475306|9659517|FG003|STARTED|Overall Study||72
8620708|NCT00475306|9659514|FG000|COMPLETED|Overall Study|1 patient had resolution of nausea prior and did not receive the investigational medication|72
8531042|NCT02719522|9563304|FG000|STARTED|Overall Study|In 1 consented subject, device deployment was not attempted due to significant arterial stenosis.|204
8531043|NCT02719522|9563304|FG000|COMPLETED|Overall Study||193
8531044|NCT02719522|9563304|FG000|NOT COMPLETED|Overall Study||11
8531045|NCT02664181|9563310|FG000|STARTED|Overall Study||8
8531046|NCT02664181|9563311|FG001|STARTED|Overall Study||5
8531047|NCT02664181|9563310|FG000|COMPLETED|Overall Study||8
8531048|NCT02664181|9563311|FG001|COMPLETED|Overall Study||5
8531049|NCT02664181|9563310|FG000|NOT COMPLETED|Overall Study||0
8531050|NCT02664181|9563311|FG001|NOT COMPLETED|Overall Study||0
8531051|NCT02633241|9563317|FG000|STARTED|Overall Study||30
8531052|NCT02633241|9563317|FG000|COMPLETED|Overall Study||27
8531053|NCT02633241|9563317|FG000|NOT COMPLETED|Overall Study||3
8531054|NCT02585232|9563325|FG000|STARTED|Overall Study||40
8531055|NCT02585232|9563326|FG001|STARTED|Overall Study||42
8531056|NCT02585232|9563325|FG000|COMPLETED|Overall Study||28
8531057|NCT02585232|9563326|FG001|COMPLETED|Overall Study||26
8531058|NCT02585232|9563325|FG000|NOT COMPLETED|Overall Study||12
8531059|NCT02585232|9563326|FG001|NOT COMPLETED|Overall Study||16
8531060|NCT02583269|9563337|FG000|STARTED|Overall Study||3
8531061|NCT02583269|9563338|FG001|STARTED|Overall Study||7
8531062|NCT02583269|9563339|FG002|STARTED|Overall Study||3
8531063|NCT02583269|9563340|FG003|STARTED|Overall Study||5
8531064|NCT02583269|9563341|FG004|STARTED|Overall Study||6
8531065|NCT02583269|9563337|FG000|COMPLETED|Overall Study||2
8531066|NCT02583269|9563338|FG001|COMPLETED|Overall Study||7
8531067|NCT02583269|9563339|FG002|COMPLETED|Overall Study||3
8531068|NCT02583269|9563340|FG003|COMPLETED|Overall Study||5
8531069|NCT02583269|9563341|FG004|COMPLETED|Overall Study||6
8531070|NCT02583269|9563337|FG000|NOT COMPLETED|Overall Study||1
8531071|NCT02583269|9563338|FG001|NOT COMPLETED|Overall Study||0
8531072|NCT02583269|9563339|FG002|NOT COMPLETED|Overall Study||0
8531073|NCT02583269|9563340|FG003|NOT COMPLETED|Overall Study||0
8531074|NCT02583269|9563341|FG004|NOT COMPLETED|Overall Study||0
8564113|NCT00052442|9596108|FG004|NOT COMPLETED|Overall Study||0
8564114|NCT00052715|9596120|FG000|STARTED|Overall Study||31
8620709|NCT00475306|9659515|FG001|COMPLETED|Overall Study|For 1 patient, data collection was incomplete and results could not be analyzed|71
8620710|NCT00475306|9659516|FG002|COMPLETED|Overall Study||72
8620711|NCT00475306|9659517|FG003|COMPLETED|Overall Study|1 patient's intravenous line infiltrated.|71
8620712|NCT00475306|9659514|FG000|NOT COMPLETED|Overall Study||1
8620713|NCT00475306|9659515|FG001|NOT COMPLETED|Overall Study||1
8564115|NCT00052715|9596120|FG000|COMPLETED|Overall Study||30
8564116|NCT00052715|9596120|FG000|NOT COMPLETED|Overall Study||1
8564117|NCT00052910|9596126|FG000|STARTED|Overall Study||280
8564118|NCT00052910|9596127|FG001|STARTED|Overall Study||266
8564119|NCT00052910|9596126|FG000|COMPLETED|Overall Study||280
8564120|NCT00052910|9596127|FG001|COMPLETED|Overall Study||266
8564121|NCT00052910|9596126|FG000|NOT COMPLETED|Overall Study||0
8564122|NCT00052910|9596127|FG001|NOT COMPLETED|Overall Study||0
8564123|NCT00052962|9596135|FG000|STARTED|Overall Study||13
8531075|NCT02556606|9563358|FG000|STARTED|Overall Study||4
8531076|NCT02556606|9563359|FG001|STARTED|Overall Study||5
8531077|NCT02556606|9563360|FG002|STARTED|Overall Study||11
8531078|NCT02556606|9563361|FG003|STARTED|Overall Study||13
8531079|NCT02556606|9563358|FG000|COMPLETED|Overall Study||4
8531080|NCT02556606|9563359|FG001|COMPLETED|Overall Study||5
8531081|NCT02556606|9563360|FG002|COMPLETED|Overall Study||11
8531082|NCT02556606|9563361|FG003|COMPLETED|Overall Study||13
8531083|NCT02556606|9563358|FG000|NOT COMPLETED|Overall Study||0
8531084|NCT02556606|9563359|FG001|NOT COMPLETED|Overall Study||0
8531085|NCT02556606|9563360|FG002|NOT COMPLETED|Overall Study||0
8531086|NCT02556606|9563361|FG003|NOT COMPLETED|Overall Study||0
8531087|NCT02545283|9563377|FG000|STARTED|Overall Study||149
8531088|NCT02545283|9563378|FG001|STARTED|Overall Study||298
8531089|NCT02545283|9563377|FG000|Received Treatment|Overall Study||149
8531090|NCT02545283|9563378|FG001|Received Treatment|Overall Study||292
8531091|NCT02545283|9563377|FG000|Safety Follow Up|Overall Study|I participant was not treated and 1 participant entered from the Idasanutlin arm|149
8531092|NCT02545283|9563378|FG001|Safety Follow Up|Overall Study|5 participants were not treated, 1 participant did not receive Idasanutlin and was moved to the Placebo arm|292
8531093|NCT02545283|9563377|FG000|COMPLETED|Overall Study||0
8531094|NCT02545283|9563378|FG001|COMPLETED|Overall Study||0
8531095|NCT02545283|9563377|FG000|NOT COMPLETED|Overall Study||149
8531096|NCT02545283|9563378|FG001|NOT COMPLETED|Overall Study||298
8531097|NCT02524171|9563388|FG000|STARTED|6-month Follow-up||172
8531098|NCT02524171|9563389|FG001|STARTED|6-month Follow-up||169
8531099|NCT02524171|9563388|FG000|COMPLETED|6-month Follow-up||119
8531100|NCT02524171|9563389|FG001|COMPLETED|6-month Follow-up||124
8816411|NCT01544153|9869929|FG000|STARTED|Overall Study||1337
8531101|NCT02524171|9563388|FG000|NOT COMPLETED|6-month Follow-up||53
8531102|NCT02524171|9563389|FG001|NOT COMPLETED|6-month Follow-up||45
8531103|NCT02524171|9563388|FG000|STARTED|12-month Follow-up Interview||172
8531104|NCT02524171|9563389|FG001|STARTED|12-month Follow-up Interview||169
8531105|NCT02524171|9563388|FG000|COMPLETED|12-month Follow-up Interview||127
8531106|NCT02524171|9563389|FG001|COMPLETED|12-month Follow-up Interview||128
8531107|NCT02524171|9563388|FG000|NOT COMPLETED|12-month Follow-up Interview||45
8531108|NCT02524171|9563389|FG001|NOT COMPLETED|12-month Follow-up Interview||41
8531109|NCT02489422|9563397|FG000|STARTED|Overall Study||23
8531110|NCT02489422|9563398|FG001|STARTED|Overall Study||21
8531111|NCT02489422|9563397|FG000|COMPLETED|Overall Study||23
8531112|NCT02489422|9563398|FG001|COMPLETED|Overall Study||21
8531113|NCT02489422|9563397|FG000|NOT COMPLETED|Overall Study||0
8531114|NCT02489422|9563398|FG001|NOT COMPLETED|Overall Study||0
8531115|NCT02487251|9563409|FG000|STARTED|Overall Study||434
8531116|NCT02487251|9563410|FG001|STARTED|Overall Study||65
8531117|NCT02487251|9563411|FG002|STARTED|Overall Study||152
8531118|NCT02487251|9563412|FG003|STARTED|Overall Study||159
8531119|NCT02487251|9563409|FG000|COMPLETED|Overall Study||366
8531120|NCT02487251|9563410|FG001|COMPLETED|Overall Study||55
8531121|NCT02487251|9563411|FG002|COMPLETED|Overall Study||125
8531122|NCT02487251|9563412|FG003|COMPLETED|Overall Study||134
8531123|NCT02487251|9563409|FG000|NOT COMPLETED|Overall Study||68
8531124|NCT02487251|9563410|FG001|NOT COMPLETED|Overall Study||10
8531125|NCT02487251|9563411|FG002|NOT COMPLETED|Overall Study||27
8531126|NCT02487251|9563412|FG003|NOT COMPLETED|Overall Study||25
8531127|NCT02476968|9563425|FG000|STARTED|Overall Study||145
8531128|NCT02476968|9563426|FG001|STARTED|Overall Study||33
8531129|NCT02476968|9563427|FG002|STARTED|Overall Study||3
8531130|NCT02476968|9563425|FG000|Received Treatment|Overall Study||143
8531131|NCT02476968|9563426|FG001|Received Treatment|Overall Study||32
8531132|NCT02476968|9563427|FG002|Received Treatment|Overall Study||2
8531133|NCT02476968|9563425|FG000|COMPLETED|Overall Study||71
8531134|NCT02476968|9563426|FG001|COMPLETED|Overall Study||18
8531135|NCT02476968|9563427|FG002|COMPLETED|Overall Study||1
8531136|NCT02476968|9563425|FG000|NOT COMPLETED|Overall Study||74
8531137|NCT02476968|9563426|FG001|NOT COMPLETED|Overall Study||15
8531138|NCT02476968|9563427|FG002|NOT COMPLETED|Overall Study||2
8531139|NCT02306122|9563444|FG000|STARTED|Initial Physician Randomization||0
8531140|NCT02306122|9563445|FG001|STARTED|Initial Physician Randomization||0
8531141|NCT02306122|9563446|FG002|STARTED|Initial Physician Randomization||0
8531142|NCT02306122|9563447|FG003|STARTED|Initial Physician Randomization||0
8531143|NCT02306122|9563448|FG004|STARTED|Initial Physician Randomization||0
8531144|NCT02306122|9563449|FG005|STARTED|Initial Physician Randomization||0
8531145|NCT02306122|9563450|FG006|STARTED|Initial Physician Randomization||0
8531146|NCT02306122|9563451|FG007|STARTED|Initial Physician Randomization||0
8531147|NCT02306122|9563452|FG008|STARTED|Initial Physician Randomization||29
8531148|NCT02306122|9563453|FG009|STARTED|Initial Physician Randomization||31
8531149|NCT02306122|9563454|FG010|STARTED|Initial Physician Randomization||31
8816412|NCT01544153|9869930|FG001|STARTED|Overall Study||1324
8816413|NCT01544153|9869931|FG002|STARTED|Overall Study||1314
8531150|NCT02306122|9563444|FG000|COMPLETED|Initial Physician Randomization||0
8531151|NCT02306122|9563445|FG001|COMPLETED|Initial Physician Randomization||0
8531152|NCT02306122|9563446|FG002|COMPLETED|Initial Physician Randomization||0
8531153|NCT02306122|9563447|FG003|COMPLETED|Initial Physician Randomization||0
8531154|NCT02306122|9563448|FG004|COMPLETED|Initial Physician Randomization||0
8531155|NCT02306122|9563449|FG005|COMPLETED|Initial Physician Randomization||0
8531156|NCT02306122|9563450|FG006|COMPLETED|Initial Physician Randomization||0
8816414|NCT01544153|9869932|FG003|STARTED|Overall Study||1317
8816415|NCT01544153|9869929|FG000|COMPLETED|Overall Study||1337
8531157|NCT02306122|9563451|FG007|COMPLETED|Initial Physician Randomization||0
8531158|NCT02306122|9563452|FG008|COMPLETED|Initial Physician Randomization||28
8531159|NCT02306122|9563453|FG009|COMPLETED|Initial Physician Randomization||31
8531160|NCT02306122|9563454|FG010|COMPLETED|Initial Physician Randomization||31
8531161|NCT02306122|9563444|FG000|NOT COMPLETED|Initial Physician Randomization||0
8531162|NCT02306122|9563445|FG001|NOT COMPLETED|Initial Physician Randomization||0
8531163|NCT02306122|9563446|FG002|NOT COMPLETED|Initial Physician Randomization||0
8531164|NCT02306122|9563447|FG003|NOT COMPLETED|Initial Physician Randomization||0
8531165|NCT02306122|9563448|FG004|NOT COMPLETED|Initial Physician Randomization||0
8531166|NCT02306122|9563449|FG005|NOT COMPLETED|Initial Physician Randomization||0
8531167|NCT02306122|9563450|FG006|NOT COMPLETED|Initial Physician Randomization||0
8531168|NCT02306122|9563451|FG007|NOT COMPLETED|Initial Physician Randomization||0
8531169|NCT02306122|9563452|FG008|NOT COMPLETED|Initial Physician Randomization||1
8531170|NCT02306122|9563453|FG009|NOT COMPLETED|Initial Physician Randomization||0
8531171|NCT02306122|9563454|FG010|NOT COMPLETED|Initial Physician Randomization||0
8531172|NCT02306122|9563444|FG000|STARTED|Post Nonadherence Subgroup Randomization||244
8531173|NCT02306122|9563445|FG001|STARTED|Post Nonadherence Subgroup Randomization||123
8531174|NCT02306122|9563446|FG002|STARTED|Post Nonadherence Subgroup Randomization||121
8531175|NCT02306122|9563447|FG003|STARTED|Post Nonadherence Subgroup Randomization||274
8531176|NCT02306122|9563448|FG004|STARTED|Post Nonadherence Subgroup Randomization||134
8531177|NCT02306122|9563449|FG005|STARTED|Post Nonadherence Subgroup Randomization||137
8531178|NCT02306122|9563450|FG006|STARTED|Post Nonadherence Subgroup Randomization||220
8531179|NCT02306122|9563451|FG007|STARTED|Post Nonadherence Subgroup Randomization||221
8531180|NCT02306122|9563452|FG008|STARTED|Post Nonadherence Subgroup Randomization||28
8531181|NCT02306122|9563453|FG009|STARTED|Post Nonadherence Subgroup Randomization||31
8531182|NCT02306122|9563454|FG010|STARTED|Post Nonadherence Subgroup Randomization||31
8531183|NCT02306122|9563444|FG000|COMPLETED|Post Nonadherence Subgroup Randomization||244
8531184|NCT02306122|9563445|FG001|COMPLETED|Post Nonadherence Subgroup Randomization||123
8531185|NCT02306122|9563446|FG002|COMPLETED|Post Nonadherence Subgroup Randomization||121
8531186|NCT02306122|9563447|FG003|COMPLETED|Post Nonadherence Subgroup Randomization||274
8531187|NCT02306122|9563448|FG004|COMPLETED|Post Nonadherence Subgroup Randomization||134
8531188|NCT02306122|9563449|FG005|COMPLETED|Post Nonadherence Subgroup Randomization||137
8531189|NCT02306122|9563450|FG006|COMPLETED|Post Nonadherence Subgroup Randomization||220
8531190|NCT02306122|9563451|FG007|COMPLETED|Post Nonadherence Subgroup Randomization||221
8531191|NCT02306122|9563452|FG008|COMPLETED|Post Nonadherence Subgroup Randomization||28
8531192|NCT02306122|9563453|FG009|COMPLETED|Post Nonadherence Subgroup Randomization||31
8531193|NCT02306122|9563454|FG010|COMPLETED|Post Nonadherence Subgroup Randomization||31
8531194|NCT02306122|9563444|FG000|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0
8531195|NCT02306122|9563445|FG001|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0
8531196|NCT02306122|9563446|FG002|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0
8531197|NCT02306122|9563447|FG003|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0
8531198|NCT02306122|9563448|FG004|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0
8531199|NCT02306122|9563449|FG005|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0
8531200|NCT02306122|9563450|FG006|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0
8531201|NCT02306122|9563451|FG007|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0
8531202|NCT02306122|9563452|FG008|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0
8531203|NCT02306122|9563453|FG009|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0
8531204|NCT02306122|9563454|FG010|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0
8531205|NCT02304991|9563474|FG000|STARTED|Overall Study||25
8531206|NCT02304991|9563475|FG001|STARTED|Overall Study||25
8531207|NCT02304991|9563474|FG000|COMPLETED|Overall Study||18
8531208|NCT02304991|9563475|FG001|COMPLETED|Overall Study||15
8531209|NCT02304991|9563474|FG000|NOT COMPLETED|Overall Study||7
8531210|NCT02304991|9563475|FG001|NOT COMPLETED|Overall Study||10
8531211|NCT02223520|9563483|FG000|STARTED|Overall Study||147
8531212|NCT02223520|9563484|FG001|STARTED|Overall Study||160
8531213|NCT02223520|9563483|FG000|COMPLETED|Overall Study|101 neonates of these parents were enrolled. 12 were lost to follow-up.|147
8531214|NCT02223520|9563484|FG001|COMPLETED|Overall Study|107 neonates of these parents were enrolled. 6 were lost to follow-up.|160
8531215|NCT02223520|9563483|FG000|NOT COMPLETED|Overall Study||0
8531216|NCT02223520|9563484|FG001|NOT COMPLETED|Overall Study||0
8531217|NCT02147184|9563492|FG000|STARTED|Overall Study||127
8531218|NCT02147184|9563493|FG001|STARTED|Overall Study||137
8531219|NCT02147184|9563492|FG000|COMPLETED|Overall Study||78
8531220|NCT02147184|9563493|FG001|COMPLETED|Overall Study||110
8531221|NCT02147184|9563492|FG000|NOT COMPLETED|Overall Study||49
8531222|NCT02147184|9563493|FG001|NOT COMPLETED|Overall Study||27
8531223|NCT02122198|9563501|FG000|STARTED|Overall Study||5
8531224|NCT02122198|9563502|FG001|STARTED|Overall Study||12
8531225|NCT02122198|9563501|FG000|COMPLETED|Overall Study||3
8531226|NCT02122198|9563502|FG001|COMPLETED|Overall Study||10
8531227|NCT02122198|9563501|FG000|NOT COMPLETED|Overall Study||2
8531228|NCT02122198|9563502|FG001|NOT COMPLETED|Overall Study||2
8620714|NCT00475306|9659516|FG002|NOT COMPLETED|Overall Study||0
8620715|NCT00475306|9659517|FG003|NOT COMPLETED|Overall Study||1
8722829|NCT04525456|9770321|FG000|STARTED|Overall Study||20
8531229|NCT02055053|9563511|FG000|STARTED|Overall Study||35
8531230|NCT02055053|9563512|FG001|STARTED|Overall Study||35
8620716|NCT00475319|9659530|FG000|STARTED|Overall Study||103
8531231|NCT02055053|9563511|FG000|COMPLETED|Overall Study||35
8531232|NCT02055053|9563512|FG001|COMPLETED|Overall Study||35
8531233|NCT02055053|9563511|FG000|NOT COMPLETED|Overall Study||0
8531234|NCT02055053|9563512|FG001|NOT COMPLETED|Overall Study||0
8531235|NCT02000219|9563518|FG000|STARTED|14-Week Study Period||12
8531236|NCT02000219|9563518|FG000|COMPLETED|14-Week Study Period||9
8531237|NCT02000219|9563518|FG000|NOT COMPLETED|14-Week Study Period||3
8531238|NCT02000219|9563518|FG000|STARTED|Continuation Period||8
8531239|NCT02000219|9563518|FG000|COMPLETED|Continuation Period||3
8531240|NCT02000219|9563518|FG000|NOT COMPLETED|Continuation Period||5
8531241|NCT01978938|9563524|FG000|STARTED|Overall Study||455
8531242|NCT01978938|9563525|FG001|STARTED|Overall Study||453
8531243|NCT01978938|9563524|FG000|Received at Least 1 Dose of Study Drug|Overall Study||454
8531244|NCT01978938|9563525|FG001|Received at Least 1 Dose of Study Drug|Overall Study||451
8531245|NCT01978938|9563524|FG000|COMPLETED|Overall Study||432
8531246|NCT01978938|9563525|FG001|COMPLETED|Overall Study||439
8531247|NCT01978938|9563524|FG000|NOT COMPLETED|Overall Study||23
8531248|NCT01978938|9563525|FG001|NOT COMPLETED|Overall Study||14
8531249|NCT01854385|9563531|FG000|STARTED|Pre-Treatment||40
8531250|NCT01854385|9563531|FG000|COMPLETED|Pre-Treatment||17
8620717|NCT00475319|9659531|FG001|STARTED|Overall Study||102
8620718|NCT00475319|9659532|FG002|STARTED|Overall Study||103
8620719|NCT00475319|9659530|FG000|COMPLETED|Overall Study||101
8620720|NCT00475319|9659531|FG001|COMPLETED|Overall Study||101
8620721|NCT00475319|9659532|FG002|COMPLETED|Overall Study||99
8531251|NCT01854385|9563531|FG000|NOT COMPLETED|Pre-Treatment||23
8531252|NCT01854385|9563531|FG000|STARTED|Treatment||17
8531253|NCT01854385|9563531|FG000|COMPLETED|Treatment||16
8531254|NCT01854385|9563531|FG000|NOT COMPLETED|Treatment||1
8531255|NCT01844856|9563537|FG000|STARTED|Overall Study||270
8531256|NCT01844856|9563538|FG001|STARTED|Overall Study||271
8531257|NCT01844856|9563537|FG000|Received at Least 1 Dose of Study Drug|Overall Study||270
8531258|NCT01844856|9563538|FG001|Received at Least 1 Dose of Study Drug|Overall Study||268
8531259|NCT01844856|9563537|FG000|COMPLETED|Overall Study||246
8531260|NCT01844856|9563538|FG001|COMPLETED|Overall Study||255
8531261|NCT01844856|9563537|FG000|NOT COMPLETED|Overall Study||24
8531262|NCT01844856|9563538|FG001|NOT COMPLETED|Overall Study||16
8531263|NCT01788306|9563546|FG000|STARTED|Overall Study||125
8531264|NCT01788306|9563547|FG001|STARTED|Overall Study||131
8531265|NCT01788306|9563546|FG000|COMPLETED|Overall Study||115
8531266|NCT01788306|9563547|FG001|COMPLETED|Overall Study||126
8531267|NCT01788306|9563546|FG000|NOT COMPLETED|Overall Study||10
8531268|NCT01788306|9563547|FG001|NOT COMPLETED|Overall Study||5
8531269|NCT01776723|9563564|FG000|STARTED|Overall Study||6
8531270|NCT01776723|9563565|FG001|STARTED|Overall Study||4
8531271|NCT01776723|9563566|FG002|STARTED|Overall Study||5
8531272|NCT01776723|9563567|FG003|STARTED|Overall Study||5
8531273|NCT01776723|9563568|FG004|STARTED|Overall Study||30
8531274|NCT01776723|9563564|FG000|COMPLETED|Overall Study||6
8531275|NCT01776723|9563565|FG001|COMPLETED|Overall Study||4
8531276|NCT01776723|9563566|FG002|COMPLETED|Overall Study||5
8531277|NCT01776723|9563567|FG003|COMPLETED|Overall Study||5
8531278|NCT01776723|9563568|FG004|COMPLETED|Overall Study||30
8531279|NCT01776723|9563564|FG000|NOT COMPLETED|Overall Study||0
8531280|NCT01776723|9563565|FG001|NOT COMPLETED|Overall Study||0
8531281|NCT01776723|9563566|FG002|NOT COMPLETED|Overall Study||0
8531282|NCT01776723|9563567|FG003|NOT COMPLETED|Overall Study||0
8531283|NCT01776723|9563568|FG004|NOT COMPLETED|Overall Study||0
8531284|NCT01744041|9563586|FG000|STARTED|Overall Study||21
8531285|NCT01744041|9563587|FG001|STARTED|Overall Study||21
8531286|NCT01744041|9563586|FG000|COMPLETED|Overall Study||15
8531287|NCT01744041|9563587|FG001|COMPLETED|Overall Study||13
8531288|NCT01744041|9563586|FG000|NOT COMPLETED|Overall Study||6
8531289|NCT01744041|9563587|FG001|NOT COMPLETED|Overall Study||8
8531290|NCT01733147|9563595|FG000|STARTED|Overall Study||30
8531291|NCT01733147|9563596|FG001|STARTED|Overall Study||30
8531292|NCT01733147|9563595|FG000|COMPLETED|Overall Study||30
8531293|NCT01733147|9563596|FG001|COMPLETED|Overall Study||30
8531294|NCT01733147|9563595|FG000|NOT COMPLETED|Overall Study||0
8531295|NCT01733147|9563596|FG001|NOT COMPLETED|Overall Study||0
8564124|NCT00052962|9596136|FG001|STARTED|Overall Study||17
8564125|NCT00052962|9596135|FG000|COMPLETED|Overall Study||12
8564126|NCT00052962|9596136|FG001|COMPLETED|Overall Study||15
8564127|NCT00052962|9596135|FG000|NOT COMPLETED|Overall Study||1
8564128|NCT00052962|9596136|FG001|NOT COMPLETED|Overall Study||2
8564129|NCT00053014|9596142|FG000|STARTED|Overall Study||5
8564130|NCT00053014|9596142|FG000|COMPLETED|Overall Study||5
8564131|NCT00053014|9596142|FG000|NOT COMPLETED|Overall Study||0
8620722|NCT00475319|9659530|FG000|NOT COMPLETED|Overall Study||2
8564132|NCT00053352|9596148|FG000|STARTED|Overall Study||190
8564133|NCT00053352|9596149|FG001|STARTED|Overall Study||112
8564134|NCT00053352|9596148|FG000|COMPLETED|Overall Study||169
8564135|NCT00053352|9596149|FG001|COMPLETED|Overall Study||102
8564136|NCT00053352|9596148|FG000|NOT COMPLETED|Overall Study||21
8564137|NCT00053352|9596149|FG001|NOT COMPLETED|Overall Study||10
8564138|NCT00053365|9596156|FG000|STARTED|Overall Study||61
8564139|NCT00053365|9596156|FG000|COMPLETED|Overall Study||55
8564140|NCT00053365|9596156|FG000|NOT COMPLETED|Overall Study||6
8564141|NCT00053417|9596166|FG000|STARTED|Overall Study||47
8564142|NCT00053417|9596167|FG001|STARTED|Overall Study||52
8564143|NCT00053417|9596168|FG002|STARTED|Overall Study||50
8564144|NCT00053417|9596169|FG003|STARTED|Overall Study||57
8531296|NCT01712789|9563602|FG000|STARTED|Overall Study||682
8531297|NCT01712789|9563602|FG000|Received Study Treatment|Overall Study||676
8531298|NCT01712789|9563602|FG000|COMPLETED|Overall Study||0
8531299|NCT01712789|9563602|FG000|NOT COMPLETED|Overall Study||682
8531300|NCT01651403|9563608|FG000|STARTED|Double-Blind Period (Through Week 48/72)||60
8531301|NCT01651403|9563609|FG001|STARTED|Double-Blind Period (Through Week 48/72)||30
8531302|NCT01651403|9563608|FG000|COMPLETED|Double-Blind Period (Through Week 48/72)||56
8531303|NCT01651403|9563609|FG001|COMPLETED|Double-Blind Period (Through Week 48/72)||25
8531304|NCT01651403|9563608|FG000|NOT COMPLETED|Double-Blind Period (Through Week 48/72)||4
8531305|NCT01651403|9563609|FG001|NOT COMPLETED|Double-Blind Period (Through Week 48/72)||5
8531306|NCT01651403|9563608|FG000|STARTED|Open-Label Phase (Weeks 49/73-192)||56
8531307|NCT01651403|9563609|FG001|STARTED|Open-Label Phase (Weeks 49/73-192)||25
8531308|NCT01651403|9563608|FG000|COMPLETED|Open-Label Phase (Weeks 49/73-192)||35
8531309|NCT01651403|9563609|FG001|COMPLETED|Open-Label Phase (Weeks 49/73-192)||11
8531310|NCT01651403|9563608|FG000|NOT COMPLETED|Open-Label Phase (Weeks 49/73-192)||21
8531311|NCT01651403|9563609|FG001|NOT COMPLETED|Open-Label Phase (Weeks 49/73-192)||14
8531312|NCT01543633|9563620|FG000|STARTED|Overall Study||36
8531313|NCT01543633|9563620|FG000|COMPLETED|Overall Study||17
8531314|NCT01543633|9563620|FG000|NOT COMPLETED|Overall Study||19
8531315|NCT01542736|9563624|FG000|STARTED|Overall Study||8
8531316|NCT01542736|9563624|FG000|COMPLETED|Overall Study||7
8531317|NCT01542736|9563624|FG000|NOT COMPLETED|Overall Study||1
8531318|NCT01535807|9563630|FG000|STARTED|Overall Study||22
8531319|NCT01535807|9563631|FG001|STARTED|Overall Study||22
8531320|NCT01535807|9563630|FG000|COMPLETED|Overall Study||20
8531321|NCT01535807|9563631|FG001|COMPLETED|Overall Study||20
8531322|NCT01535807|9563630|FG000|NOT COMPLETED|Overall Study||2
8531323|NCT01535807|9563631|FG001|NOT COMPLETED|Overall Study||2
8531324|NCT01147666|9563652|FG000|STARTED|Dosing Period 1: 6-Week Treatment||12
8531325|NCT01147666|9563653|FG001|STARTED|Dosing Period 1: 6-Week Treatment||12
8531326|NCT01147666|9563654|FG002|STARTED|Dosing Period 1: 6-Week Treatment||12
8531327|NCT01147666|9563655|FG003|STARTED|Dosing Period 1: 6-Week Treatment||12
8531328|NCT01147666|9563656|FG004|STARTED|Dosing Period 1: 6-Week Treatment||12
8531329|NCT01147666|9563657|FG005|STARTED|Dosing Period 1: 6-Week Treatment||12
8531330|NCT01147666|9563658|FG006|STARTED|Dosing Period 1: 6-Week Treatment||12
8531331|NCT01147666|9563659|FG007|STARTED|Dosing Period 1: 6-Week Treatment||12
8531332|NCT01147666|9563660|FG008|STARTED|Dosing Period 1: 6-Week Treatment||2
8531333|NCT01147666|9563661|FG009|STARTED|Dosing Period 1: 6-Week Treatment||10
8531334|NCT01147666|9563662|FG010|STARTED|Dosing Period 1: 6-Week Treatment||36
8531335|NCT01147666|9563663|FG011|STARTED|Dosing Period 1: 6-Week Treatment||4
8531336|NCT01147666|9563664|FG012|STARTED|Dosing Period 1: 6-Week Treatment||5
8531337|NCT01147666|9563665|FG013|STARTED|Dosing Period 1: 6-Week Treatment||4
8531338|NCT01147666|9563666|FG014|STARTED|Dosing Period 1: 6-Week Treatment||4
8531339|NCT01147666|9563652|FG000|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||12
8531340|NCT01147666|9563653|FG001|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||12
8531341|NCT01147666|9563654|FG002|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||12
8531342|NCT01147666|9563655|FG003|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||12
8531343|NCT01147666|9563656|FG004|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||12
8531344|NCT01147666|9563657|FG005|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||12
8531345|NCT01147666|9563658|FG006|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||12
8531346|NCT01147666|9563659|FG007|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||12
8531347|NCT01147666|9563660|FG008|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||2
8531348|NCT01147666|9563661|FG009|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||10
8531349|NCT01147666|9563662|FG010|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||36
8531350|NCT01147666|9563663|FG011|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||4
8531351|NCT01147666|9563664|FG012|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||5
8531352|NCT01147666|9563665|FG013|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||4
8531353|NCT01147666|9563666|FG014|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||4
8531354|NCT01147666|9563652|FG000|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||9
8531355|NCT01147666|9563653|FG001|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||10
8531356|NCT01147666|9563654|FG002|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||9
8722830|NCT04525456|9770321|FG000|COMPLETED|Overall Study||20
8722831|NCT04525456|9770321|FG000|NOT COMPLETED|Overall Study||0
8722832|NCT04161131|9770326|FG000|STARTED|Overall Study||28
8722833|NCT04161131|9770326|FG000|Completed Baseline Surveys|Overall Study||27
8722834|NCT04161131|9770326|FG000|Received Intervention|Overall Study||22
8531357|NCT01147666|9563655|FG003|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||11
8531358|NCT01147666|9563656|FG004|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||11
8531359|NCT01147666|9563657|FG005|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||11
8531360|NCT01147666|9563658|FG006|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||11
8531361|NCT01147666|9563659|FG007|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||10
8531362|NCT01147666|9563660|FG008|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||2
8722835|NCT04161131|9770326|FG000|COMPLETED|Overall Study||22
8722836|NCT04161131|9770326|FG000|NOT COMPLETED|Overall Study||6
8531363|NCT01147666|9563661|FG009|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||10
8531364|NCT01147666|9563662|FG010|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||31
8531365|NCT01147666|9563663|FG011|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||1
8531366|NCT01147666|9563664|FG012|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||3
8531367|NCT01147666|9563665|FG013|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||4
8531368|NCT01147666|9563666|FG014|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||3
8531369|NCT01147666|9563652|FG000|COMPLETED|Dosing Period 1: 6-Week Treatment||10
8531370|NCT01147666|9563653|FG001|COMPLETED|Dosing Period 1: 6-Week Treatment||10
8531371|NCT01147666|9563654|FG002|COMPLETED|Dosing Period 1: 6-Week Treatment||11
8531372|NCT01147666|9563655|FG003|COMPLETED|Dosing Period 1: 6-Week Treatment||10
8531373|NCT01147666|9563656|FG004|COMPLETED|Dosing Period 1: 6-Week Treatment||7
8531374|NCT01147666|9563657|FG005|COMPLETED|Dosing Period 1: 6-Week Treatment||9
8531375|NCT01147666|9563658|FG006|COMPLETED|Dosing Period 1: 6-Week Treatment||9
8531376|NCT01147666|9563659|FG007|COMPLETED|Dosing Period 1: 6-Week Treatment||9
8531377|NCT01147666|9563660|FG008|COMPLETED|Dosing Period 1: 6-Week Treatment||2
8531378|NCT01147666|9563661|FG009|COMPLETED|Dosing Period 1: 6-Week Treatment||8
8531379|NCT01147666|9563662|FG010|COMPLETED|Dosing Period 1: 6-Week Treatment||33
8531380|NCT01147666|9563663|FG011|COMPLETED|Dosing Period 1: 6-Week Treatment||2
8531381|NCT01147666|9563664|FG012|COMPLETED|Dosing Period 1: 6-Week Treatment||1
8531382|NCT01147666|9563665|FG013|COMPLETED|Dosing Period 1: 6-Week Treatment||3
8531383|NCT01147666|9563666|FG014|COMPLETED|Dosing Period 1: 6-Week Treatment||0
8531384|NCT01147666|9563652|FG000|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||2
8531385|NCT01147666|9563653|FG001|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||2
8531386|NCT01147666|9563654|FG002|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||1
8531387|NCT01147666|9563655|FG003|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||2
8531388|NCT01147666|9563656|FG004|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||5
8531389|NCT01147666|9563657|FG005|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||3
8531390|NCT01147666|9563658|FG006|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||3
8531391|NCT01147666|9563659|FG007|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||3
8531392|NCT01147666|9563660|FG008|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||0
8531393|NCT01147666|9563661|FG009|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||2
8531394|NCT01147666|9563662|FG010|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||3
8531395|NCT01147666|9563663|FG011|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||2
8531396|NCT01147666|9563664|FG012|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||4
8531397|NCT01147666|9563665|FG013|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||1
8531398|NCT01147666|9563666|FG014|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||4
8531399|NCT01147666|9563652|FG000|STARTED|Dosing Period 2: 19-Week Treatment||0
8531400|NCT01147666|9563653|FG001|STARTED|Dosing Period 2: 19-Week Treatment||0
8531401|NCT01147666|9563654|FG002|STARTED|Dosing Period 2: 19-Week Treatment||0
8531402|NCT01147666|9563655|FG003|STARTED|Dosing Period 2: 19-Week Treatment||7
8531403|NCT01147666|9563656|FG004|STARTED|Dosing Period 2: 19-Week Treatment||12
8531404|NCT01147666|9563657|FG005|STARTED|Dosing Period 2: 19-Week Treatment||12
8531405|NCT01147666|9563658|FG006|STARTED|Dosing Period 2: 19-Week Treatment||12
8531406|NCT01147666|9563659|FG007|STARTED|Dosing Period 2: 19-Week Treatment||12
8531407|NCT01147666|9563660|FG008|STARTED|Dosing Period 2: 19-Week Treatment||2
8531408|NCT01147666|9563661|FG009|STARTED|Dosing Period 2: 19-Week Treatment||10
8531409|NCT01147666|9563662|FG010|STARTED|Dosing Period 2: 19-Week Treatment||23
8531410|NCT01147666|9563663|FG011|STARTED|Dosing Period 2: 19-Week Treatment||0
8531411|NCT01147666|9563664|FG012|STARTED|Dosing Period 2: 19-Week Treatment||5
8531412|NCT01147666|9563665|FG013|STARTED|Dosing Period 2: 19-Week Treatment||3
8531413|NCT01147666|9563666|FG014|STARTED|Dosing Period 2: 19-Week Treatment||3
8531414|NCT01147666|9563652|FG000|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||0
8531415|NCT01147666|9563653|FG001|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||0
8531416|NCT01147666|9563654|FG002|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||0
8531417|NCT01147666|9563655|FG003|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||7
8531418|NCT01147666|9563656|FG004|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||12
8531419|NCT01147666|9563657|FG005|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||12
8531420|NCT01147666|9563658|FG006|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||12
8531421|NCT01147666|9563659|FG007|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||12
8531422|NCT01147666|9563660|FG008|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||2
8722837|NCT04102501|9770332|FG000|STARTED|Overall Study||33
8722838|NCT04102501|9770333|FG001|STARTED|Overall Study||32
8722839|NCT04102501|9770332|FG000|11 Month Visit|Overall Study||25
8722840|NCT04102501|9770333|FG001|11 Month Visit|Overall Study||20
8722841|NCT04102501|9770332|FG000|COMPLETED|Overall Study||25
8722842|NCT04102501|9770333|FG001|COMPLETED|Overall Study||20
8722843|NCT04102501|9770332|FG000|NOT COMPLETED|Overall Study||8
8722844|NCT04102501|9770333|FG001|NOT COMPLETED|Overall Study||12
8722845|NCT04087343|9770343|FG000|STARTED|Overall Study||4
8722846|NCT04087343|9770344|FG001|STARTED|Overall Study||5
8722847|NCT04087343|9770343|FG000|COMPLETED|Overall Study||4
8722848|NCT04087343|9770344|FG001|COMPLETED|Overall Study||5
8722849|NCT04087343|9770343|FG000|NOT COMPLETED|Overall Study||0
8722850|NCT04087343|9770344|FG001|NOT COMPLETED|Overall Study||0
8531423|NCT01147666|9563661|FG009|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||10
8531424|NCT01147666|9563662|FG010|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||23
8531425|NCT01147666|9563663|FG011|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||0
8531426|NCT01147666|9563664|FG012|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||5
8531427|NCT01147666|9563665|FG013|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||3
8531428|NCT01147666|9563666|FG014|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||3
8531429|NCT01147666|9563652|FG000|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||0
8531430|NCT01147666|9563653|FG001|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||0
8531431|NCT01147666|9563654|FG002|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||0
8531432|NCT01147666|9563655|FG003|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||6
8531433|NCT01147666|9563656|FG004|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||11
8531434|NCT01147666|9563657|FG005|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||11
8531435|NCT01147666|9563658|FG006|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||11
8531436|NCT01147666|9563659|FG007|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||10
8531437|NCT01147666|9563660|FG008|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||2
8531438|NCT01147666|9563661|FG009|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||10
8531439|NCT01147666|9563662|FG010|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||22
8531440|NCT01147666|9563663|FG011|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||0
8531441|NCT01147666|9563664|FG012|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||3
8531442|NCT01147666|9563665|FG013|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||3
8531443|NCT01147666|9563666|FG014|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||2
8531444|NCT01147666|9563652|FG000|COMPLETED|Dosing Period 2: 19-Week Treatment||0
8531445|NCT01147666|9563653|FG001|COMPLETED|Dosing Period 2: 19-Week Treatment||0
8531446|NCT01147666|9563654|FG002|COMPLETED|Dosing Period 2: 19-Week Treatment||0
8531447|NCT01147666|9563655|FG003|COMPLETED|Dosing Period 2: 19-Week Treatment||5
8531448|NCT01147666|9563656|FG004|COMPLETED|Dosing Period 2: 19-Week Treatment||7
8531449|NCT01147666|9563657|FG005|COMPLETED|Dosing Period 2: 19-Week Treatment||9
8531450|NCT01147666|9563658|FG006|COMPLETED|Dosing Period 2: 19-Week Treatment||9
8531451|NCT01147666|9563659|FG007|COMPLETED|Dosing Period 2: 19-Week Treatment||9
8531452|NCT01147666|9563660|FG008|COMPLETED|Dosing Period 2: 19-Week Treatment||2
8531453|NCT01147666|9563661|FG009|COMPLETED|Dosing Period 2: 19-Week Treatment||8
8531454|NCT01147666|9563662|FG010|COMPLETED|Dosing Period 2: 19-Week Treatment||21
8531455|NCT01147666|9563663|FG011|COMPLETED|Dosing Period 2: 19-Week Treatment||0
8531456|NCT01147666|9563664|FG012|COMPLETED|Dosing Period 2: 19-Week Treatment||1
8531457|NCT01147666|9563665|FG013|COMPLETED|Dosing Period 2: 19-Week Treatment||2
8531458|NCT01147666|9563666|FG014|COMPLETED|Dosing Period 2: 19-Week Treatment||0
8531459|NCT01147666|9563652|FG000|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||0
8531460|NCT01147666|9563653|FG001|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||0
8531461|NCT01147666|9563654|FG002|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||0
8531462|NCT01147666|9563655|FG003|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||2
8531463|NCT01147666|9563656|FG004|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||5
8531464|NCT01147666|9563657|FG005|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||3
8531465|NCT01147666|9563658|FG006|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||3
8531466|NCT01147666|9563659|FG007|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||3
8531467|NCT01147666|9563660|FG008|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||0
8531468|NCT01147666|9563661|FG009|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||2
8531469|NCT01147666|9563662|FG010|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||2
8531470|NCT01147666|9563663|FG011|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||0
8531471|NCT01147666|9563664|FG012|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||4
8531472|NCT01147666|9563665|FG013|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||1
8531473|NCT01147666|9563666|FG014|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||3
8531474|NCT00982111|9563730|FG000|STARTED|Overall Study||315
8531475|NCT00982111|9563731|FG001|STARTED|Overall Study||318
8531476|NCT00982111|9563730|FG000|Received at Least 1 Dose of Study Drug|Overall Study||304
8531477|NCT00982111|9563731|FG001|Received at Least 1 Dose of Study Drug|Overall Study||312
8531478|NCT00982111|9563730|FG000|Death Due to Any Cause|Overall Study||236
8531479|NCT00982111|9563731|FG001|Death Due to Any Cause|Overall Study||246
8531480|NCT00982111|9563730|FG000|COMPLETED|Overall Study||236
8531481|NCT00982111|9563731|FG001|COMPLETED|Overall Study||246
8531482|NCT00982111|9563730|FG000|NOT COMPLETED|Overall Study||79
8531483|NCT00982111|9563731|FG001|NOT COMPLETED|Overall Study||72
8531484|NCT00193219|9563738|FG000|STARTED|Overall Study||36
8531485|NCT00193219|9563738|FG000|COMPLETED|Overall Study||6
8531486|NCT00193219|9563738|FG000|NOT COMPLETED|Overall Study||30
8531487|NCT00116142|9563745|FG000|STARTED|Overall Study||175
8531488|NCT00116142|9563746|FG001|STARTED|Overall Study||175
8531489|NCT00116142|9563745|FG000|Treated|Overall Study||174
8531490|NCT00116142|9563746|FG001|Treated|Overall Study||171
8531491|NCT00116142|9563745|FG000|COMPLETED|Overall Study||156
8531492|NCT00116142|9563746|FG001|COMPLETED|Overall Study||155
8531493|NCT00116142|9563745|FG000|NOT COMPLETED|Overall Study||19
8531494|NCT00116142|9563746|FG001|NOT COMPLETED|Overall Study||20
8531495|NCT00070018|9563755|FG000|STARTED|Overall Study||46
8531496|NCT00070018|9563755|FG000|Eligible|Overall Study||46
8531497|NCT00070018|9563755|FG000|Eligible and Began Protocol Therapy|Overall Study||46
8531498|NCT00070018|9563755|FG000|COMPLETED|Overall Study||42
8531499|NCT00070018|9563755|FG000|NOT COMPLETED|Overall Study||4
8564145|NCT00053417|9596166|FG000|COMPLETED|Overall Study||45
8564146|NCT00053417|9596167|FG001|COMPLETED|Overall Study||50
8564147|NCT00053417|9596168|FG002|COMPLETED|Overall Study||49
8564148|NCT00053417|9596169|FG003|COMPLETED|Overall Study||51
8564149|NCT00053417|9596166|FG000|NOT COMPLETED|Overall Study||2
8564150|NCT00053417|9596167|FG001|NOT COMPLETED|Overall Study||2
8564151|NCT00053417|9596168|FG002|NOT COMPLETED|Overall Study||1
8564152|NCT00053417|9596169|FG003|NOT COMPLETED|Overall Study||6
8564153|NCT00053482|9596184|FG000|STARTED|Overall Study||51
8564154|NCT00053482|9596185|FG001|STARTED|Overall Study||102
8564155|NCT00053482|9596186|FG002|STARTED|Overall Study||102
8564156|NCT00053482|9596187|FG003|STARTED|Overall Study||50
8564157|NCT00053482|9596188|FG004|STARTED|Overall Study||52
8564158|NCT00053482|9596184|FG000|COMPLETED|Overall Study||51
8564159|NCT00053482|9596185|FG001|COMPLETED|Overall Study||102
8564160|NCT00053482|9596186|FG002|COMPLETED|Overall Study||102
8564161|NCT00053482|9596187|FG003|COMPLETED|Overall Study||50
8564162|NCT00053482|9596188|FG004|COMPLETED|Overall Study||52
8564163|NCT00053482|9596184|FG000|NOT COMPLETED|Overall Study||0
8564164|NCT00053482|9596185|FG001|NOT COMPLETED|Overall Study||0
8564165|NCT00053482|9596186|FG002|NOT COMPLETED|Overall Study||0
8564166|NCT00053482|9596187|FG003|NOT COMPLETED|Overall Study||0
8564167|NCT00053482|9596188|FG004|NOT COMPLETED|Overall Study||0
8564168|NCT00041392|9596202|FG000|STARTED|Overall Study||198
8564169|NCT00041392|9596203|FG001|STARTED|Overall Study||191
8564170|NCT00041392|9596202|FG000|COMPLETED|Overall Study||198
8564171|NCT00041392|9596203|FG001|COMPLETED|Overall Study||191
8564172|NCT00041392|9596202|FG000|NOT COMPLETED|Overall Study||0
8564173|NCT00041392|9596203|FG001|NOT COMPLETED|Overall Study||0
8564174|NCT00053495|9596214|FG000|STARTED|Overall Study||51
8564175|NCT00053495|9596215|FG001|STARTED|Overall Study||101
8564176|NCT00053495|9596216|FG002|STARTED|Overall Study||101
8564177|NCT00053495|9596217|FG003|STARTED|Overall Study||51
8564178|NCT00053495|9596218|FG004|STARTED|Overall Study||49
8564179|NCT00053495|9596214|FG000|COMPLETED|Overall Study||51
8564180|NCT00053495|9596215|FG001|COMPLETED|Overall Study||101
8564181|NCT00053495|9596216|FG002|COMPLETED|Overall Study||101
8564182|NCT00053495|9596217|FG003|COMPLETED|Overall Study||51
8564183|NCT00053495|9596218|FG004|COMPLETED|Overall Study||49
8564184|NCT00053495|9596214|FG000|NOT COMPLETED|Overall Study||0
8564185|NCT00053495|9596215|FG001|NOT COMPLETED|Overall Study||0
8564186|NCT00053495|9596216|FG002|NOT COMPLETED|Overall Study||0
8564187|NCT00053495|9596217|FG003|NOT COMPLETED|Overall Study||0
8564188|NCT00053495|9596218|FG004|NOT COMPLETED|Overall Study||0
8564189|NCT00053677|9596232|FG000|STARTED|Overall Study||58
8564190|NCT00053677|9596233|FG001|STARTED|Overall Study||19
8564191|NCT00053677|9596232|FG000|COMPLETED|Overall Study||36
8564192|NCT00053677|9596233|FG001|COMPLETED|Overall Study||13
8564193|NCT00053677|9596232|FG000|NOT COMPLETED|Overall Study||22
8564194|NCT00053677|9596233|FG001|NOT COMPLETED|Overall Study||6
8564195|NCT00053703|9596242|FG000|STARTED|Overall Study||35
8564196|NCT00053703|9596243|FG001|STARTED|Overall Study||41
8564197|NCT00053703|9596244|FG002|STARTED|Overall Study||40
8564198|NCT00053703|9596242|FG000|COMPLETED|Overall Study||17
8564199|NCT00053703|9596243|FG001|COMPLETED|Overall Study||28
8564200|NCT00053703|9596244|FG002|COMPLETED|Overall Study||25
8564201|NCT00053703|9596242|FG000|NOT COMPLETED|Overall Study||18
8564202|NCT00053703|9596243|FG001|NOT COMPLETED|Overall Study||13
8564203|NCT00053703|9596244|FG002|NOT COMPLETED|Overall Study||15
8564204|NCT00053846|9596254|FG000|STARTED|Overall Study||213
8564205|NCT00053846|9596255|FG001|STARTED|Overall Study||219
8564206|NCT00053846|9596254|FG000|COMPLETED|Overall Study||187
8564207|NCT00053846|9596255|FG001|COMPLETED|Overall Study||192
8564208|NCT00053846|9596254|FG000|NOT COMPLETED|Overall Study||26
8564209|NCT00053846|9596255|FG001|NOT COMPLETED|Overall Study||27
8564210|NCT00053898|9596263|FG000|STARTED|Overall Study||1552
8564211|NCT00053898|9596264|FG001|STARTED|Overall Study||1552
8564212|NCT00053898|9596263|FG000|COMPLETED|Overall Study||1538
8564213|NCT00053898|9596264|FG001|COMPLETED|Overall Study||1539
8564214|NCT00053898|9596263|FG000|NOT COMPLETED|Overall Study||14
8564215|NCT00053898|9596264|FG001|NOT COMPLETED|Overall Study||13
8564216|NCT00053989|9596270|FG000|STARTED|Overall Study||41
8564217|NCT00053989|9596270|FG000|COMPLETED|Overall Study||41
8564218|NCT00053989|9596270|FG000|NOT COMPLETED|Overall Study||0
8564219|NCT00054028|9596276|FG000|STARTED|Overall Study||31
8564220|NCT00054028|9596276|FG000|Phase I|Overall Study||9
8564221|NCT00054028|9596276|FG000|Phase II|Overall Study||22
8564222|NCT00054028|9596276|FG000|COMPLETED|Overall Study||31
8564223|NCT00054028|9596276|FG000|NOT COMPLETED|Overall Study||0
8564224|NCT00054132|9596281|FG000|STARTED|Overall Study||38
8564225|NCT00054132|9596281|FG000|COMPLETED|Overall Study||37
8564226|NCT00054132|9596281|FG000|NOT COMPLETED|Overall Study||1
8564227|NCT00054275|9596286|FG000|STARTED|Overall Study||39
8564228|NCT00054275|9596286|FG000|COMPLETED|Overall Study||28
8564229|NCT00054275|9596286|FG000|NOT COMPLETED|Overall Study||11
8564230|NCT00054327|9596296|FG000|STARTED|Overall Study||11
8564231|NCT00054327|9596297|FG001|STARTED|Overall Study||4
8564232|NCT00054327|9596298|FG002|STARTED|Overall Study||3
8564233|NCT00054327|9596299|FG003|STARTED|Overall Study||4
8564234|NCT00054327|9596300|FG004|STARTED|Overall Study||10
8531500|NCT04631796|9563759|FG000|STARTED|Overall Study||35
8531501|NCT04631796|9563759|FG000|COMPLETED|Overall Study||35
8531502|NCT04631796|9563759|FG000|NOT COMPLETED|Overall Study||0
8531503|NCT04447287|9563768|FG000|STARTED|Period 1: Run-in Period||23
8531504|NCT04447287|9563769|FG001|STARTED|Period 1: Run-in Period||0
8531505|NCT04447287|9563770|FG002|STARTED|Period 1: Run-in Period||0
8531506|NCT04447287|9563768|FG000|COMPLETED|Period 1: Run-in Period||19
8531507|NCT04447287|9563769|FG001|COMPLETED|Period 1: Run-in Period||0
8531508|NCT04447287|9563770|FG002|COMPLETED|Period 1: Run-in Period||0
8531509|NCT04447287|9563768|FG000|NOT COMPLETED|Period 1: Run-in Period||4
8531510|NCT04447287|9563769|FG001|NOT COMPLETED|Period 1: Run-in Period||0
8531511|NCT04447287|9563770|FG002|NOT COMPLETED|Period 1: Run-in Period||0
8531512|NCT04447287|9563768|FG000|STARTED|Period 2: Investigational Period||1
8531513|NCT04447287|9563769|FG001|STARTED|Period 2: Investigational Period||12
8531514|NCT04447287|9563770|FG002|STARTED|Period 2: Investigational Period||6
8531515|NCT04447287|9563768|FG000|COMPLETED|Period 2: Investigational Period||0
8531516|NCT04447287|9563769|FG001|COMPLETED|Period 2: Investigational Period||12
8531517|NCT04447287|9563770|FG002|COMPLETED|Period 2: Investigational Period||6
8531518|NCT04447287|9563768|FG000|NOT COMPLETED|Period 2: Investigational Period||1
8531519|NCT04447287|9563769|FG001|NOT COMPLETED|Period 2: Investigational Period||0
8531520|NCT04447287|9563770|FG002|NOT COMPLETED|Period 2: Investigational Period||0
8531521|NCT04447287|9563768|FG000|STARTED|Period 3: Down-Titration Period||0
8531522|NCT04447287|9563769|FG001|STARTED|Period 3: Down-Titration Period||12
8531523|NCT04447287|9563770|FG002|STARTED|Period 3: Down-Titration Period||6
8531524|NCT04447287|9563768|FG000|COMPLETED|Period 3: Down-Titration Period||0
8531525|NCT04447287|9563769|FG001|COMPLETED|Period 3: Down-Titration Period||12
8531526|NCT04447287|9563770|FG002|COMPLETED|Period 3: Down-Titration Period||6
8531527|NCT04447287|9563768|FG000|NOT COMPLETED|Period 3: Down-Titration Period||0
8531528|NCT04447287|9563769|FG001|NOT COMPLETED|Period 3: Down-Titration Period||0
8531529|NCT04447287|9563770|FG002|NOT COMPLETED|Period 3: Down-Titration Period||0
8531530|NCT04203537|9563793|FG000|STARTED|Overall Study||6
8531531|NCT04203537|9563794|FG001|STARTED|Overall Study||6
8531532|NCT04203537|9563795|FG002|STARTED|Overall Study||6
8531533|NCT04203537|9563796|FG003|STARTED|Overall Study||6
8531534|NCT04203537|9563797|FG004|STARTED|Overall Study||54
8531535|NCT04203537|9563798|FG005|STARTED|Overall Study||55
8531536|NCT04203537|9563799|FG006|STARTED|Overall Study||60
8531537|NCT04203537|9563793|FG000|COMPLETED|Overall Study||6
8531538|NCT04203537|9563794|FG001|COMPLETED|Overall Study||6
8531539|NCT04203537|9563795|FG002|COMPLETED|Overall Study||6
8531540|NCT04203537|9563796|FG003|COMPLETED|Overall Study||6
8531541|NCT04203537|9563797|FG004|COMPLETED|Overall Study||54
8531542|NCT04203537|9563798|FG005|COMPLETED|Overall Study||55
8531543|NCT04203537|9563799|FG006|COMPLETED|Overall Study||60
8531544|NCT04203537|9563793|FG000|NOT COMPLETED|Overall Study||0
8531545|NCT04203537|9563794|FG001|NOT COMPLETED|Overall Study||0
8531546|NCT04203537|9563795|FG002|NOT COMPLETED|Overall Study||0
8531547|NCT04203537|9563796|FG003|NOT COMPLETED|Overall Study||0
8531548|NCT04203537|9563797|FG004|NOT COMPLETED|Overall Study||0
8531549|NCT04203537|9563798|FG005|NOT COMPLETED|Overall Study||0
8531550|NCT04203537|9563799|FG006|NOT COMPLETED|Overall Study||0
8531551|NCT04125745|9563809|FG000|STARTED|Overall Study||1
8531552|NCT04125745|9563809|FG000|COMPLETED|Overall Study||1
8531553|NCT04125745|9563809|FG000|NOT COMPLETED|Overall Study||0
8531554|NCT04074928|9563815|FG000|STARTED|Overall Study||1605
8531555|NCT04074928|9563816|FG001|STARTED|Overall Study||809
8531556|NCT04074928|9563815|FG000|Received Study Vaccine|Overall Study||1597
8531557|NCT04074928|9563816|FG001|Received Study Vaccine|Overall Study||805
8531558|NCT04074928|9563815|FG000|COMPLETED|Overall Study||1370
8531559|NCT04074928|9563816|FG001|COMPLETED|Overall Study||710
8531560|NCT04074928|9563815|FG000|NOT COMPLETED|Overall Study||235
8531561|NCT04074928|9563816|FG001|NOT COMPLETED|Overall Study||99
8531562|NCT04039503|9563826|FG000|STARTED|Overall Study||116
8531563|NCT04039503|9563827|FG001|STARTED|Overall Study||119
8531564|NCT04039503|9563828|FG002|STARTED|Overall Study||120
8531565|NCT04039503|9563829|FG003|STARTED|Overall Study||120
8531566|NCT04039503|9563826|FG000|Received at Least One Dose of Study Drug|Overall Study||116
8531567|NCT04039503|9563827|FG001|Received at Least One Dose of Study Drug|Overall Study||119
8531568|NCT04039503|9563828|FG002|Received at Least One Dose of Study Drug|Overall Study||120
8531569|NCT04039503|9563829|FG003|Received at Least One Dose of Study Drug|Overall Study||120
8531570|NCT04039503|9563826|FG000|COMPLETED|Overall Study||109
8531571|NCT04039503|9563827|FG001|COMPLETED|Overall Study||115
8531572|NCT04039503|9563828|FG002|COMPLETED|Overall Study||110
8531573|NCT04039503|9563829|FG003|COMPLETED|Overall Study||117
8531574|NCT04039503|9563826|FG000|NOT COMPLETED|Overall Study||7
8531575|NCT04039503|9563827|FG001|NOT COMPLETED|Overall Study||4
8531576|NCT04039503|9563828|FG002|NOT COMPLETED|Overall Study||10
8531577|NCT04039503|9563829|FG003|NOT COMPLETED|Overall Study||3
8531578|NCT03695172|9563847|FG000|STARTED|Overall Study||5
8531579|NCT03695172|9563848|FG001|STARTED|Overall Study||4
8531580|NCT03695172|9563849|FG002|STARTED|Overall Study||3
8531581|NCT03695172|9563847|FG000|COMPLETED|Overall Study||4
8531582|NCT03695172|9563848|FG001|COMPLETED|Overall Study||3
8531583|NCT03695172|9563849|FG002|COMPLETED|Overall Study||3
8531584|NCT03695172|9563847|FG000|NOT COMPLETED|Overall Study||1
8531585|NCT03695172|9563848|FG001|NOT COMPLETED|Overall Study||1
8531586|NCT03695172|9563849|FG002|NOT COMPLETED|Overall Study||0
8531587|NCT03485287|9563857|FG000|STARTED|Overall Study||4
8531588|NCT03485287|9563857|FG000|COMPLETED|Overall Study||3
8531589|NCT03485287|9563857|FG000|NOT COMPLETED|Overall Study||1
8531590|NCT03433040|9563864|FG000|STARTED|Overall Study||19
8531591|NCT03433040|9563865|FG001|STARTED|Overall Study||16
8531592|NCT03433040|9563866|FG002|STARTED|Overall Study||9
8531593|NCT03433040|9563864|FG000|COMPLETED|Overall Study||17
8531594|NCT03433040|9563865|FG001|COMPLETED|Overall Study||8
8531595|NCT03433040|9563866|FG002|COMPLETED|Overall Study||5
8531596|NCT03433040|9563864|FG000|NOT COMPLETED|Overall Study||2
8531597|NCT03433040|9563865|FG001|NOT COMPLETED|Overall Study||8
8531598|NCT03433040|9563866|FG002|NOT COMPLETED|Overall Study||4
8531599|NCT03394027|9563877|FG000|STARTED|Overall Study||10
8531600|NCT03394027|9563878|FG001|STARTED|Overall Study||6
8531601|NCT03394027|9563879|FG002|STARTED|Overall Study||14
8531602|NCT03394027|9563877|FG000|COMPLETED|Overall Study||7
8531603|NCT03394027|9563878|FG001|COMPLETED|Overall Study||5
8531604|NCT03394027|9563879|FG002|COMPLETED|Overall Study||10
8531605|NCT03394027|9563877|FG000|NOT COMPLETED|Overall Study||3
8531606|NCT03394027|9563878|FG001|NOT COMPLETED|Overall Study||1
8531607|NCT03394027|9563879|FG002|NOT COMPLETED|Overall Study||4
8531608|NCT03357952|9563907|FG000|STARTED|Overall Study||9
8531609|NCT03357952|9563908|FG001|STARTED|Overall Study||1
8531610|NCT03357952|9563907|FG000|COMPLETED|Overall Study||0
8531611|NCT03357952|9563908|FG001|COMPLETED|Overall Study||0
8531612|NCT03357952|9563907|FG000|NOT COMPLETED|Overall Study||9
8531613|NCT03357952|9563908|FG001|NOT COMPLETED|Overall Study||1
8531614|NCT03237234|9563916|FG000|STARTED|Overall Study||14
8531615|NCT03237234|9563917|FG001|STARTED|Overall Study||11
8531616|NCT03237234|9563916|FG000|COMPLETED|Overall Study||14
8531617|NCT03237234|9563917|FG001|COMPLETED|Overall Study||11
8531618|NCT03237234|9563916|FG000|NOT COMPLETED|Overall Study||0
8531619|NCT03237234|9563917|FG001|NOT COMPLETED|Overall Study||0
8531620|NCT03170869|9563923|FG000|STARTED|Overall Study||11
8531621|NCT03170869|9563923|FG000|COMPLETED|Overall Study||3
8531622|NCT03170869|9563923|FG000|NOT COMPLETED|Overall Study||8
8531623|NCT03066622|9563930|FG000|STARTED|Overall Study||61
8531624|NCT03066622|9563931|FG001|STARTED|Overall Study||61
8531625|NCT03066622|9563930|FG000|COMPLETED|Overall Study||35
8531626|NCT03066622|9563931|FG001|COMPLETED|Overall Study||35
8531627|NCT03066622|9563930|FG000|NOT COMPLETED|Overall Study||26
8531628|NCT03066622|9563931|FG001|NOT COMPLETED|Overall Study||26
8531629|NCT03052920|9563937|FG000|STARTED|Overall Study||40
8531630|NCT03052920|9563937|FG000|COMPLETED|Overall Study||39
8531631|NCT03052920|9563937|FG000|NOT COMPLETED|Overall Study||1
8531632|NCT03029104|9563944|FG000|STARTED|Overall Study||745
8531633|NCT03029104|9563945|FG001|STARTED|Overall Study||735
8531634|NCT03029104|9563946|FG002|STARTED|Overall Study||748
8531635|NCT03029104|9563944|FG000|COMPLETED|Overall Study||612
8531636|NCT03029104|9563945|FG001|COMPLETED|Overall Study||597
8531637|NCT03029104|9563946|FG002|COMPLETED|Overall Study||623
8531638|NCT03029104|9563944|FG000|NOT COMPLETED|Overall Study||133
8531639|NCT03029104|9563945|FG001|NOT COMPLETED|Overall Study||138
8531640|NCT03029104|9563946|FG002|NOT COMPLETED|Overall Study||125
8531641|NCT03016312|9563956|FG000|STARTED|Overall Study||391
8531642|NCT03016312|9563957|FG001|STARTED|Overall Study||380
8531643|NCT03016312|9563956|FG000|COMPLETED|Overall Study||150
8531644|NCT03016312|9563957|FG001|COMPLETED|Overall Study||162
8531645|NCT03016312|9563956|FG000|NOT COMPLETED|Overall Study||241
8531646|NCT03016312|9563957|FG001|NOT COMPLETED|Overall Study||218
8531647|NCT02876172|9563965|FG000|STARTED|Overall Study||6
8531648|NCT02876172|9563966|FG001|STARTED|Overall Study||6
8531649|NCT02876172|9563965|FG000|COMPLETED|Overall Study||6
8531650|NCT02876172|9563966|FG001|COMPLETED|Overall Study||6
8531651|NCT02876172|9563965|FG000|NOT COMPLETED|Overall Study||0
8531652|NCT02876172|9563966|FG001|NOT COMPLETED|Overall Study||0
8531653|NCT02722434|9563975|FG000|STARTED|Overall Study||25
8531654|NCT02722434|9563976|FG001|STARTED|Overall Study||25
8531655|NCT02722434|9563975|FG000|Started Treatment|Overall Study||24
8531656|NCT02722434|9563976|FG001|Started Treatment|Overall Study||25
8531657|NCT02722434|9563975|FG000|COMPLETED|Overall Study||24
8531658|NCT02722434|9563976|FG001|COMPLETED|Overall Study||22
8531659|NCT02722434|9563975|FG000|NOT COMPLETED|Overall Study||1
8531660|NCT02722434|9563976|FG001|NOT COMPLETED|Overall Study||3
8531661|NCT02721979|9563982|FG000|STARTED|Overall Study||23
8531662|NCT02721979|9563982|FG000|COMPLETED|Overall Study||22
8531663|NCT02721979|9563982|FG000|NOT COMPLETED|Overall Study||1
8564235|NCT00054327|9596301|FG005|STARTED|Overall Study||2
8564236|NCT00054327|9596296|FG000|COMPLETED|Overall Study||10
8564237|NCT00054327|9596297|FG001|COMPLETED|Overall Study||4
8564238|NCT00054327|9596298|FG002|COMPLETED|Overall Study||3
8564239|NCT00054327|9596299|FG003|COMPLETED|Overall Study||4
8564240|NCT00054327|9596300|FG004|COMPLETED|Overall Study||10
8564241|NCT00054327|9596301|FG005|COMPLETED|Overall Study||2
8564242|NCT00054327|9596296|FG000|NOT COMPLETED|Overall Study||1
8564243|NCT00054327|9596297|FG001|NOT COMPLETED|Overall Study||0
8564244|NCT00054327|9596298|FG002|NOT COMPLETED|Overall Study||0
8564245|NCT00054327|9596299|FG003|NOT COMPLETED|Overall Study||0
8564246|NCT00054327|9596300|FG004|NOT COMPLETED|Overall Study||0
8564247|NCT00054327|9596301|FG005|NOT COMPLETED|Overall Study||0
8564248|NCT00054353|9596317|FG000|STARTED|Overall Study||12
8564249|NCT00054353|9596318|FG001|STARTED|Overall Study||4
8564250|NCT00054353|9596317|FG000|COMPLETED|Overall Study||12
8564251|NCT00054353|9596318|FG001|COMPLETED|Overall Study||4
8531664|NCT02604511|9563986|FG000|STARTED|Overall Study||31
8531665|NCT02604511|9563986|FG000|COMPLETED|Overall Study||19
8531666|NCT02604511|9563986|FG000|NOT COMPLETED|Overall Study||12
8531667|NCT02369536|9563992|FG000|STARTED|Overall Study||62
8531668|NCT02369536|9563993|FG001|STARTED|Overall Study||64
8531669|NCT02369536|9563992|FG000|COMPLETED|Overall Study||55
8531670|NCT02369536|9563993|FG001|COMPLETED|Overall Study||58
8531671|NCT02369536|9563992|FG000|NOT COMPLETED|Overall Study||7
8531672|NCT02369536|9563993|FG001|NOT COMPLETED|Overall Study||6
8531673|NCT02358681|9564003|FG000|STARTED|Overall Study||29
8531674|NCT02358681|9564004|FG001|STARTED|Overall Study||30
8531675|NCT02358681|9564003|FG000|COMPLETED|Overall Study||27
8531676|NCT02358681|9564004|FG001|COMPLETED|Overall Study||29
8531677|NCT02358681|9564003|FG000|NOT COMPLETED|Overall Study||2
8531678|NCT02358681|9564004|FG001|NOT COMPLETED|Overall Study||1
8531679|NCT02101788|9564012|FG000|STARTED|Overall Study||130
8531680|NCT02101788|9564013|FG001|STARTED|Overall Study||130
8531681|NCT02101788|9564012|FG000|Crossover From Arm A to Arm B|Overall Study||88
8531682|NCT02101788|9564013|FG001|Crossover From Arm A to Arm B|Overall Study||0
8531683|NCT02101788|9564012|FG000|COMPLETED|Overall Study||120
8531684|NCT02101788|9564013|FG001|COMPLETED|Overall Study||116
8531685|NCT02101788|9564012|FG000|NOT COMPLETED|Overall Study||10
8531686|NCT02101788|9564013|FG001|NOT COMPLETED|Overall Study||14
8531687|NCT01963728|9564028|FG000|STARTED|Overall Study||0
8531688|NCT01963728|9564029|FG001|STARTED|Overall Study||1
8531689|NCT01963728|9564028|FG000|COMPLETED|Overall Study|study terminated early|0
8531690|NCT01963728|9564029|FG001|COMPLETED|Overall Study|study terminated early|0
8531691|NCT01963728|9564028|FG000|NOT COMPLETED|Overall Study||0
8531692|NCT01963728|9564029|FG001|NOT COMPLETED|Overall Study||1
8531693|NCT01248247|9564039|FG000|STARTED|Overall Study||22
8531694|NCT01248247|9564040|FG001|STARTED|Overall Study||42
8531695|NCT01248247|9564041|FG002|STARTED|Overall Study||75
8531696|NCT01248247|9564042|FG003|STARTED|Overall Study||61
8531697|NCT01248247|9564039|FG000|COMPLETED|Overall Study||0
8531698|NCT01248247|9564040|FG001|COMPLETED|Overall Study||0
8531699|NCT01248247|9564041|FG002|COMPLETED|Overall Study||0
8531700|NCT01248247|9564042|FG003|COMPLETED|Overall Study||0
8531701|NCT01248247|9564039|FG000|NOT COMPLETED|Overall Study||22
8531702|NCT01248247|9564040|FG001|NOT COMPLETED|Overall Study||42
8531703|NCT01248247|9564041|FG002|NOT COMPLETED|Overall Study||75
8531704|NCT01248247|9564042|FG003|NOT COMPLETED|Overall Study||61
8531705|NCT01164228|9564054|FG000|STARTED|Overall Study||47
8531706|NCT01164228|9564055|FG001|STARTED|Overall Study||40
8531707|NCT01164228|9564054|FG000|Receipt of Protocol Therapy|Overall Study||46
8531708|NCT01164228|9564055|FG001|Receipt of Protocol Therapy|Overall Study||37
8531709|NCT01164228|9564054|FG000|Treated and Eligible Patients|Overall Study||45
8531710|NCT01164228|9564055|FG001|Treated and Eligible Patients|Overall Study||37
8531711|NCT01164228|9564054|FG000|COMPLETED|Overall Study||3
8531712|NCT01164228|9564055|FG001|COMPLETED|Overall Study||2
8531713|NCT01164228|9564054|FG000|NOT COMPLETED|Overall Study||44
8531714|NCT01164228|9564055|FG001|NOT COMPLETED|Overall Study||38
8531715|NCT01012167|9564064|FG000|STARTED|Overall Study||17
8531716|NCT01012167|9564065|FG001|STARTED|Overall Study||20
8531717|NCT01012167|9564066|FG002|STARTED|Overall Study||21
8531718|NCT01012167|9564064|FG000|Withdrawn Prior to Study Drug Exposure|Overall Study||1
8531719|NCT01012167|9564065|FG001|Withdrawn Prior to Study Drug Exposure|Overall Study||0
8531720|NCT01012167|9564066|FG002|Withdrawn Prior to Study Drug Exposure|Overall Study||1
8531721|NCT01012167|9564064|FG000|Exposed to Study Drug|Overall Study||16
8531722|NCT01012167|9564065|FG001|Exposed to Study Drug|Overall Study||20
8531723|NCT01012167|9564066|FG002|Exposed to Study Drug|Overall Study||20
8531724|NCT01012167|9564064|FG000|COMPLETED|Overall Study||15
8531725|NCT01012167|9564065|FG001|COMPLETED|Overall Study||18
8531726|NCT01012167|9564066|FG002|COMPLETED|Overall Study||17
8531727|NCT01012167|9564064|FG000|NOT COMPLETED|Overall Study||2
8531728|NCT01012167|9564065|FG001|NOT COMPLETED|Overall Study||2
8531729|NCT01012167|9564066|FG002|NOT COMPLETED|Overall Study||4
8531730|NCT00924326|9564090|FG000|STARTED|Dose Administration||8
8531731|NCT00924326|9564091|FG001|STARTED|Dose Administration||2
8531732|NCT00924326|9564092|FG002|STARTED|Dose Administration||5
8531733|NCT00924326|9564093|FG003|STARTED|Dose Administration||6
8531734|NCT00924326|9564094|FG004|STARTED|Dose Administration||7
8531735|NCT00924326|9564095|FG005|STARTED|Dose Administration||10
8531736|NCT00924326|9564096|FG006|STARTED|Dose Administration||1
8531737|NCT00924326|9564097|FG007|STARTED|Dose Administration||2
8531738|NCT00924326|9564098|FG008|STARTED|Dose Administration||2
8531739|NCT00924326|9564090|FG000|COMPLETED|Dose Administration||8
8531740|NCT00924326|9564091|FG001|COMPLETED|Dose Administration||2
8531741|NCT00924326|9564092|FG002|COMPLETED|Dose Administration||5
8531742|NCT00924326|9564093|FG003|COMPLETED|Dose Administration||6
8531743|NCT00924326|9564094|FG004|COMPLETED|Dose Administration||7
8531744|NCT00924326|9564095|FG005|COMPLETED|Dose Administration||10
8531745|NCT00924326|9564096|FG006|COMPLETED|Dose Administration||1
8531746|NCT00924326|9564097|FG007|COMPLETED|Dose Administration||2
8531747|NCT00924326|9564098|FG008|COMPLETED|Dose Administration||2
8531748|NCT00924326|9564090|FG000|NOT COMPLETED|Dose Administration||0
8531749|NCT00924326|9564091|FG001|NOT COMPLETED|Dose Administration||0
8531750|NCT00924326|9564092|FG002|NOT COMPLETED|Dose Administration||0
8531751|NCT00924326|9564093|FG003|NOT COMPLETED|Dose Administration||0
8531752|NCT00924326|9564094|FG004|NOT COMPLETED|Dose Administration||0
8531753|NCT00924326|9564095|FG005|NOT COMPLETED|Dose Administration||0
8531754|NCT00924326|9564096|FG006|NOT COMPLETED|Dose Administration||0
8531755|NCT00924326|9564097|FG007|NOT COMPLETED|Dose Administration||0
8531756|NCT00924326|9564098|FG008|NOT COMPLETED|Dose Administration||0
8531757|NCT00924326|9564090|FG000|STARTED|1x10^9-1x10^10 + High Dose Retreat||3
8531758|NCT00924326|9564091|FG001|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
8531759|NCT00924326|9564092|FG002|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
8531760|NCT00924326|9564093|FG003|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
8531761|NCT00924326|9564094|FG004|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
8531762|NCT00924326|9564095|FG005|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
8531763|NCT00924326|9564096|FG006|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
8531764|NCT00924326|9564097|FG007|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
8531765|NCT00924326|9564098|FG008|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
8531766|NCT00924326|9564090|FG000|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||3
8531767|NCT00924326|9564091|FG001|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
8531768|NCT00924326|9564092|FG002|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
8531769|NCT00924326|9564093|FG003|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
8531770|NCT00924326|9564094|FG004|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
8531771|NCT00924326|9564095|FG005|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
8531772|NCT00924326|9564096|FG006|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
8531773|NCT00924326|9564097|FG007|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
8531774|NCT00924326|9564098|FG008|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
8531775|NCT00924326|9564090|FG000|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
8531776|NCT00924326|9564091|FG001|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
8531777|NCT00924326|9564092|FG002|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
8531778|NCT00924326|9564093|FG003|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
8531779|NCT00924326|9564094|FG004|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
8531780|NCT00924326|9564095|FG005|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
8531781|NCT00924326|9564096|FG006|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
8531782|NCT00924326|9564097|FG007|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
8531783|NCT00924326|9564098|FG008|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
8531784|NCT00591318|9564122|FG000|STARTED|Overall Study||5
8531785|NCT00591318|9564123|FG001|STARTED|Overall Study||5
8531786|NCT00591318|9564122|FG000|COMPLETED|Overall Study|For our protocol, participants in both treatment arms were considered completers if they completed at least 6 weeks. At the 6 week point, if response on PANS was not sufficient (15% or greater), they were considered unlikely to respond and therefore were not given the option of the 2 additional weeks of ceftriaxone or placebo. For the analysis, we used the last observed rating between baseline to week 8 for each participant, regardless of whether the participant completed the study treatments.|1
8531787|NCT00591318|9564123|FG001|COMPLETED|Overall Study|For our protocol, participants in both treatment arms were considered completers if they completed at least 6 weeks. At the 6 week point, if response on PANS was not sufficient (15% or greater), they were considered unlikely to respond and therefore were not given the option of the 2 additional weeks of ceftriaxone or placebo. For the analysis, we used the last observed rating between baseline to week 8 for each participant regardless of whether the participant completed the study treatments..|5
8531788|NCT00591318|9564122|FG000|NOT COMPLETED|Overall Study||4
8531789|NCT00591318|9564123|FG001|NOT COMPLETED|Overall Study||0
8531790|NCT00321100|9564135|FG000|STARTED|Overall Study||12
8531791|NCT00321100|9564136|FG001|STARTED|Overall Study||11
8531792|NCT00321100|9564135|FG000|COMPLETED|Overall Study||12
8531793|NCT00321100|9564136|FG001|COMPLETED|Overall Study||11
8531794|NCT00321100|9564135|FG000|NOT COMPLETED|Overall Study||0
8531795|NCT00321100|9564136|FG001|NOT COMPLETED|Overall Study||0
8564252|NCT00054353|9596317|FG000|NOT COMPLETED|Overall Study||0
8564253|NCT00054353|9596318|FG001|NOT COMPLETED|Overall Study||0
8564254|NCT00054639|9596328|FG000|STARTED|Overall Study||48
8564255|NCT00054639|9596328|FG000|COMPLETED|Overall Study||46
8564256|NCT00054639|9596328|FG000|NOT COMPLETED|Overall Study||2
8564257|NCT00054665|9596332|FG000|STARTED|Part A|5 participants only received Part A and 18 participants received Part B after Part A.|23
8564258|NCT00054665|9596333|FG001|STARTED|Part A||0
8564259|NCT00054665|9596332|FG000|COMPLETED|Part A||23
8564260|NCT00054665|9596333|FG001|COMPLETED|Part A||0
8564261|NCT00054665|9596332|FG000|NOT COMPLETED|Part A||0
8564262|NCT00054665|9596333|FG001|NOT COMPLETED|Part A||0
8564263|NCT00054665|9596332|FG000|STARTED|Part B||0
8564264|NCT00054665|9596333|FG001|STARTED|Part B|26 participants received only Part B|44
8564265|NCT00054665|9596332|FG000|COMPLETED|Part B||0
8564266|NCT00054665|9596333|FG001|COMPLETED|Part B||44
8564267|NCT00054665|9596332|FG000|NOT COMPLETED|Part B||0
8564268|NCT00054665|9596333|FG001|NOT COMPLETED|Part B||0
8564269|NCT00054691|9596341|FG000|STARTED|Overall Study||40
8564270|NCT00054691|9596341|FG000|COMPLETED|Overall Study||37
8564271|NCT00054691|9596341|FG000|NOT COMPLETED|Overall Study||3
8564272|NCT00054704|9596347|FG000|STARTED|Overall Study||8
8564273|NCT00054704|9596348|FG001|STARTED|Overall Study||11
8564274|NCT00054704|9596347|FG000|COMPLETED|Overall Study||3
8564275|NCT00054704|9596348|FG001|COMPLETED|Overall Study||6
8564276|NCT00054704|9596347|FG000|NOT COMPLETED|Overall Study||5
8564277|NCT00054704|9596348|FG001|NOT COMPLETED|Overall Study||5
8564278|NCT00054717|9596356|FG000|STARTED|Overall Study||313
8564279|NCT00054717|9596357|FG001|STARTED|Overall Study||317
8564280|NCT00054717|9596356|FG000|COMPLETED|Overall Study||51
8564281|NCT00054717|9596357|FG001|COMPLETED|Overall Study||18
8564282|NCT00054717|9596356|FG000|NOT COMPLETED|Overall Study||262
8531796|NCT04534517|9564144|FG000|STARTED|Overall Study||114
8531797|NCT04534517|9564144|FG000|COMPLETED|Overall Study||110
8531798|NCT04534517|9564144|FG000|NOT COMPLETED|Overall Study||4
8531799|NCT04494646|9564150|FG000|STARTED|Overall Study||21
8531800|NCT04494646|9564151|FG001|STARTED|Overall Study||19
8531801|NCT04494646|9564150|FG000|COMPLETED|Overall Study||21
8531802|NCT04494646|9564151|FG001|COMPLETED|Overall Study||17
8531803|NCT04494646|9564150|FG000|NOT COMPLETED|Overall Study||0
8531804|NCT04494646|9564151|FG001|NOT COMPLETED|Overall Study||2
8531805|NCT04258020|9564159|FG000|STARTED|Overall Study||4
8531806|NCT04258020|9564160|FG001|STARTED|Overall Study||0
8531807|NCT04258020|9564159|FG000|COMPLETED|Overall Study||3
8531808|NCT04258020|9564160|FG001|COMPLETED|Overall Study||0
8531809|NCT04258020|9564159|FG000|NOT COMPLETED|Overall Study||1
8531810|NCT04258020|9564160|FG001|NOT COMPLETED|Overall Study||0
8531811|NCT04234464|9564168|FG000|STARTED|Period 1 (First Treatment Intervention)||29
8531812|NCT04234464|9564169|FG001|STARTED|Period 1 (First Treatment Intervention)||31
8531813|NCT04234464|9564168|FG000|COMPLETED|Period 1 (First Treatment Intervention)||29
8531814|NCT04234464|9564169|FG001|COMPLETED|Period 1 (First Treatment Intervention)||31
8531815|NCT04234464|9564168|FG000|NOT COMPLETED|Period 1 (First Treatment Intervention)||0
8531816|NCT04234464|9564169|FG001|NOT COMPLETED|Period 1 (First Treatment Intervention)||0
8531817|NCT04234464|9564168|FG000|STARTED|Period 2 (Second Treatment Intervention)||29
8531818|NCT04234464|9564169|FG001|STARTED|Period 2 (Second Treatment Intervention)||31
8531819|NCT04234464|9564168|FG000|COMPLETED|Period 2 (Second Treatment Intervention)||28
8531820|NCT04234464|9564169|FG001|COMPLETED|Period 2 (Second Treatment Intervention)||31
8531821|NCT04234464|9564168|FG000|NOT COMPLETED|Period 2 (Second Treatment Intervention)||1
8531822|NCT04234464|9564169|FG001|NOT COMPLETED|Period 2 (Second Treatment Intervention)||0
8531823|NCT03852316|9564175|FG000|STARTED|Overall Study||1585
8531824|NCT03852316|9564175|FG000|COMPLETED|Overall Study||1581
8531825|NCT03852316|9564175|FG000|NOT COMPLETED|Overall Study||4
8531826|NCT03789318|9564184|FG000|STARTED|Overall Study||9
8531827|NCT03789318|9564185|FG001|STARTED|Overall Study||9
8531828|NCT03789318|9564186|FG002|STARTED|Overall Study||12
8531829|NCT03789318|9564187|FG003|STARTED|Overall Study||12
8531830|NCT03789318|9564188|FG004|STARTED|Overall Study||12
8531831|NCT03789318|9564184|FG000|COMPLETED|Overall Study||9
8531832|NCT03789318|9564185|FG001|COMPLETED|Overall Study||9
8531833|NCT03789318|9564186|FG002|COMPLETED|Overall Study||9
8531834|NCT03789318|9564187|FG003|COMPLETED|Overall Study||11
8531835|NCT03789318|9564188|FG004|COMPLETED|Overall Study||12
8531836|NCT03789318|9564184|FG000|NOT COMPLETED|Overall Study||0
8531837|NCT03789318|9564185|FG001|NOT COMPLETED|Overall Study||0
8531838|NCT03789318|9564186|FG002|NOT COMPLETED|Overall Study||3
8531839|NCT03789318|9564187|FG003|NOT COMPLETED|Overall Study||1
8531840|NCT03789318|9564188|FG004|NOT COMPLETED|Overall Study||0
8531841|NCT03774875|9564202|FG000|STARTED|Overall Study||92
8531842|NCT03774875|9564203|FG001|STARTED|Overall Study||185
8531843|NCT03774875|9564202|FG000|Received Study Drug|Overall Study||91
8531844|NCT03774875|9564203|FG001|Received Study Drug|Overall Study||185
8531845|NCT03774875|9564202|FG000|COMPLETED|Overall Study||69
8531846|NCT03774875|9564203|FG001|COMPLETED|Overall Study||152
8531847|NCT03774875|9564202|FG000|NOT COMPLETED|Overall Study||23
8531848|NCT03774875|9564203|FG001|NOT COMPLETED|Overall Study||33
8531849|NCT03613662|9564209|FG000|STARTED|Overall Study||19
8531850|NCT03613662|9564209|FG000|COMPLETED|Overall Study||19
8531851|NCT03613662|9564209|FG000|NOT COMPLETED|Overall Study||0
8531852|NCT03232736|9564215|FG000|STARTED|Overall Study||9
8531853|NCT03232736|9564216|FG001|STARTED|Overall Study||13
8531854|NCT03232736|9564215|FG000|COMPLETED|Overall Study||9
8531855|NCT03232736|9564216|FG001|COMPLETED|Overall Study||13
8531856|NCT03232736|9564215|FG000|NOT COMPLETED|Overall Study||0
8531857|NCT03232736|9564216|FG001|NOT COMPLETED|Overall Study||0
8531858|NCT03208530|9564226|FG000|STARTED|Overall Study||75
8531859|NCT03208530|9564226|FG000|COMPLETED|Overall Study||48
8531860|NCT03208530|9564226|FG000|NOT COMPLETED|Overall Study||27
8531861|NCT03158688|9564232|FG000|STARTED|Overall Study||154
8531862|NCT03158688|9564233|FG001|STARTED|Overall Study||312
8531863|NCT03158688|9564232|FG000|Treated|Overall Study||153
8531864|NCT03158688|9564233|FG001|Treated|Overall Study||308
8531865|NCT03158688|9564232|FG000|COMPLETED|Overall Study||0
8531866|NCT03158688|9564233|FG001|COMPLETED|Overall Study||0
8531867|NCT03158688|9564232|FG000|NOT COMPLETED|Overall Study||154
8531868|NCT03158688|9564233|FG001|NOT COMPLETED|Overall Study||312
8531869|NCT03103321|9564243|FG000|STARTED|Overall Study||25
8531870|NCT03103321|9564244|FG001|STARTED|Overall Study||39
8531871|NCT03103321|9564245|FG002|STARTED|Overall Study||44
8531872|NCT03103321|9564246|FG003|STARTED|Overall Study||50
8531873|NCT03103321|9564243|FG000|COMPLETED|Overall Study||24
8531874|NCT03103321|9564244|FG001|COMPLETED|Overall Study||38
8531875|NCT03103321|9564245|FG002|COMPLETED|Overall Study||43
8531876|NCT03103321|9564246|FG003|COMPLETED|Overall Study||50
8531877|NCT03103321|9564243|FG000|NOT COMPLETED|Overall Study||1
8531878|NCT03103321|9564244|FG001|NOT COMPLETED|Overall Study||1
8531879|NCT03103321|9564245|FG002|NOT COMPLETED|Overall Study||1
8531880|NCT03103321|9564246|FG003|NOT COMPLETED|Overall Study||0
8531881|NCT03079869|9564258|FG000|STARTED|Overall Study||28
8531882|NCT03079869|9564259|FG001|STARTED|Overall Study||27
8531883|NCT03079869|9564258|FG000|COMPLETED|Overall Study||15
8531884|NCT03079869|9564259|FG001|COMPLETED|Overall Study||16
8531885|NCT03079869|9564258|FG000|NOT COMPLETED|Overall Study||13
8531886|NCT03079869|9564259|FG001|NOT COMPLETED|Overall Study||11
8531887|NCT03033875|9564268|FG000|STARTED|Overall Study||96
8531888|NCT03033875|9564269|FG001|STARTED|Overall Study||111
8531889|NCT03033875|9564270|FG002|STARTED|Overall Study||54
8531890|NCT03033875|9564268|FG000|Completed Month 3 Assessment|Overall Study||71
8531891|NCT03033875|9564269|FG001|Completed Month 3 Assessment|Overall Study||83
8620723|NCT00475319|9659531|FG001|NOT COMPLETED|Overall Study||1
8620724|NCT00475319|9659532|FG002|NOT COMPLETED|Overall Study||4
8620725|NCT00475423|9659543|FG000|STARTED|Overall Study||122
8620726|NCT00475423|9659543|FG000|COMPLETED|Overall Study||90
8620727|NCT00475423|9659543|FG000|NOT COMPLETED|Overall Study||32
8531892|NCT03033875|9564270|FG002|Completed Month 3 Assessment|Overall Study||43
8531893|NCT03033875|9564268|FG000|Completed Month 6 Assessment|Overall Study||73
8531894|NCT03033875|9564269|FG001|Completed Month 6 Assessment|Overall Study||81
8531895|NCT03033875|9564270|FG002|Completed Month 6 Assessment|Overall Study||46
8531896|NCT03033875|9564268|FG000|COMPLETED|Overall Study||77
8531897|NCT03033875|9564269|FG001|COMPLETED|Overall Study||87
8531898|NCT03033875|9564270|FG002|COMPLETED|Overall Study||42
8531899|NCT03033875|9564268|FG000|NOT COMPLETED|Overall Study||19
8531900|NCT03033875|9564269|FG001|NOT COMPLETED|Overall Study||24
8531901|NCT03033875|9564270|FG002|NOT COMPLETED|Overall Study||12
8531902|NCT02935595|9564278|FG000|STARTED|Overall Study||5
8531903|NCT02935595|9564278|FG000|COMPLETED|Overall Study||4
8531904|NCT02935595|9564278|FG000|NOT COMPLETED|Overall Study||1
8531905|NCT02887248|9564282|FG000|STARTED|Overall Study||3
8531906|NCT02887248|9564282|FG000|COMPLETED|Overall Study||0
8531907|NCT02887248|9564282|FG000|NOT COMPLETED|Overall Study||3
8531908|NCT02849990|9564286|FG000|STARTED|Overall Study||22
8531909|NCT02849990|9564286|FG000|COMPLETED|Overall Study||20
8531910|NCT02849990|9564286|FG000|NOT COMPLETED|Overall Study||2
8531911|NCT02673151|9564290|FG000|STARTED|Overall Study||61
8531912|NCT02673151|9564290|FG000|COMPLETED|Overall Study||61
8531913|NCT02673151|9564290|FG000|NOT COMPLETED|Overall Study||0
8531914|NCT02523274|9564302|FG000|STARTED|Overall Study||20
8531915|NCT02523274|9564303|FG001|STARTED|Overall Study||20
8531916|NCT02523274|9564304|FG002|STARTED|Overall Study||20
8531917|NCT02523274|9564302|FG000|COMPLETED|Overall Study||19
8531918|NCT02523274|9564303|FG001|COMPLETED|Overall Study||18
8531919|NCT02523274|9564304|FG002|COMPLETED|Overall Study||18
8531920|NCT02523274|9564302|FG000|NOT COMPLETED|Overall Study||1
8531921|NCT02523274|9564303|FG001|NOT COMPLETED|Overall Study||2
8531922|NCT02523274|9564304|FG002|NOT COMPLETED|Overall Study||2
8564283|NCT00054717|9596357|FG001|NOT COMPLETED|Overall Study||299
8564284|NCT00054756|9596363|FG000|STARTED|Overall Study||96
8564285|NCT00054756|9596363|FG000|COMPLETED|Overall Study||94
8564286|NCT00054756|9596363|FG000|NOT COMPLETED|Overall Study||2
8564287|NCT00054847|9596369|FG000|STARTED|Overall Study||367
8564288|NCT00054847|9596370|FG001|STARTED|Overall Study||366
8564289|NCT00054847|9596369|FG000|COMPLETED|Overall Study||269
8564290|NCT00054847|9596370|FG001|COMPLETED|Overall Study||266
8564291|NCT00054847|9596369|FG000|NOT COMPLETED|Overall Study||98
8564292|NCT00054847|9596370|FG001|NOT COMPLETED|Overall Study||100
8564293|NCT00055237|9596382|FG000|STARTED|Overall Study||17
8564294|NCT00055237|9596383|FG001|STARTED|Overall Study||2
8564295|NCT00055237|9596382|FG000|COMPLETED|Overall Study||17
8564296|NCT00055237|9596383|FG001|COMPLETED|Overall Study||2
8564297|NCT00055237|9596382|FG000|NOT COMPLETED|Overall Study||0
8564298|NCT00055237|9596383|FG001|NOT COMPLETED|Overall Study||0
8564299|NCT00055471|9596391|FG000|STARTED|Period 1: Dose Escalation Period||3
8564300|NCT00055471|9596392|FG001|STARTED|Period 1: Dose Escalation Period|Dose level given only after lower dose was successfully administered.|10
8564301|NCT00055471|9596393|FG002|STARTED|Period 1: Dose Escalation Period|Dose level given only after lower dose was successfully administered.|3
8564302|NCT00055471|9596391|FG000|COMPLETED|Period 1: Dose Escalation Period||3
8564303|NCT00055471|9596392|FG001|COMPLETED|Period 1: Dose Escalation Period||8
8564304|NCT00055471|9596393|FG002|COMPLETED|Period 1: Dose Escalation Period||0
8564305|NCT00055471|9596391|FG000|NOT COMPLETED|Period 1: Dose Escalation Period||0
8564306|NCT00055471|9596392|FG001|NOT COMPLETED|Period 1: Dose Escalation Period||2
8564307|NCT00055471|9596393|FG002|NOT COMPLETED|Period 1: Dose Escalation Period||3
8564308|NCT00055471|9596391|FG000|STARTED|Period 2: Extension Period|Period 2 - attend Pts who,in the opinion of the Investigator,show benefit from treatment with ZD4054|3
8564309|NCT00055471|9596392|FG001|STARTED|Period 2: Extension Period|2 pts discontinued after completion of Period1,therefore 9 pts proceeded to participate in Period2|6
8564310|NCT00055471|9596393|FG002|STARTED|Period 2: Extension Period||0
8564311|NCT00055471|9596391|FG000|COMPLETED|Period 2: Extension Period||3
8564312|NCT00055471|9596392|FG001|COMPLETED|Period 2: Extension Period||6
8564313|NCT00055471|9596393|FG002|COMPLETED|Period 2: Extension Period||0
8564314|NCT00055471|9596391|FG000|NOT COMPLETED|Period 2: Extension Period||0
8564315|NCT00055471|9596392|FG001|NOT COMPLETED|Period 2: Extension Period||0
8564316|NCT00055471|9596393|FG002|NOT COMPLETED|Period 2: Extension Period||0
8564317|NCT00055497|9596405|FG000|STARTED|Overall Study||18
8564318|NCT00055497|9596406|FG001|STARTED|Overall Study||19
8564319|NCT00055497|9596407|FG002|STARTED|Overall Study||18
8564320|NCT00055497|9596408|FG003|STARTED|Overall Study|17 participants who discontinued at/before Week 4 are counted here because they were not randomized.|221
8564321|NCT00055497|9596405|FG000|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|13
8620728|NCT00475501|9659551|FG000|STARTED|Overall Study||14
8531923|NCT02467270|9564319|FG000|STARTED|Overall Study||94
8531924|NCT02467270|9564320|FG001|STARTED|Overall Study||95
8531925|NCT02467270|9564321|FG002|STARTED|Overall Study||94
8531926|NCT02467270|9564319|FG000|Treated (Safety Population)|Overall Study||94
8531927|NCT02467270|9564320|FG001|Treated (Safety Population)|Overall Study||94
8531928|NCT02467270|9564321|FG002|Treated (Safety Population)|Overall Study||94
8531929|NCT02467270|9564319|FG000|COMPLETED|Overall Study||0
8531930|NCT02467270|9564320|FG001|COMPLETED|Overall Study||0
8531931|NCT02467270|9564321|FG002|COMPLETED|Overall Study||0
8531932|NCT02467270|9564319|FG000|NOT COMPLETED|Overall Study||94
8531933|NCT02467270|9564320|FG001|NOT COMPLETED|Overall Study||95
8531934|NCT02467270|9564321|FG002|NOT COMPLETED|Overall Study||94
8816416|NCT01544153|9869930|FG001|COMPLETED|Overall Study||1323
8816417|NCT01544153|9869931|FG002|COMPLETED|Overall Study||1313
8816418|NCT01544153|9869932|FG003|COMPLETED|Overall Study||1317
8816419|NCT01544153|9869929|FG000|NOT COMPLETED|Overall Study||0
8816420|NCT01544153|9869930|FG001|NOT COMPLETED|Overall Study||1
8816421|NCT01544153|9869931|FG002|NOT COMPLETED|Overall Study||1
8816422|NCT01544153|9869932|FG003|NOT COMPLETED|Overall Study||0
8816423|NCT01544166|9869942|FG000|STARTED|Overall Study||44
8531935|NCT02452554|9564335|FG000|STARTED|Overall Study||17
8531936|NCT02452554|9564336|FG001|STARTED|Overall Study||17
8531937|NCT02452554|9564337|FG002|STARTED|Overall Study||12
8531938|NCT02452554|9564338|FG003|STARTED|Overall Study||1
8531939|NCT02452554|9564339|FG004|STARTED|Overall Study||5
8531940|NCT02452554|9564340|FG005|STARTED|Overall Study||10
8531941|NCT02452554|9564335|FG000|COMPLETED|Overall Study||0
8531942|NCT02452554|9564336|FG001|COMPLETED|Overall Study||0
8531943|NCT02452554|9564337|FG002|COMPLETED|Overall Study||1
8531944|NCT02452554|9564338|FG003|COMPLETED|Overall Study||0
8531945|NCT02452554|9564339|FG004|COMPLETED|Overall Study||0
8531946|NCT02452554|9564340|FG005|COMPLETED|Overall Study||1
8531947|NCT02452554|9564335|FG000|NOT COMPLETED|Overall Study||17
8531948|NCT02452554|9564336|FG001|NOT COMPLETED|Overall Study||17
8531949|NCT02452554|9564337|FG002|NOT COMPLETED|Overall Study||11
8531950|NCT02452554|9564338|FG003|NOT COMPLETED|Overall Study||1
8531951|NCT02452554|9564339|FG004|NOT COMPLETED|Overall Study||5
8531952|NCT02452554|9564340|FG005|NOT COMPLETED|Overall Study||9
8531953|NCT02427568|9564357|FG000|STARTED|Overall Study||5
8531954|NCT02427568|9564358|FG001|STARTED|Overall Study||13
8531955|NCT02427568|9564357|FG000|COMPLETED|Overall Study||5
8531956|NCT02427568|9564358|FG001|COMPLETED|Overall Study||13
8531957|NCT02427568|9564357|FG000|NOT COMPLETED|Overall Study||0
8531958|NCT02427568|9564358|FG001|NOT COMPLETED|Overall Study||0
8531959|NCT02318277|9564376|FG000|STARTED|Overall Study||6
8531960|NCT02318277|9564377|FG001|STARTED|Overall Study||3
8531961|NCT02318277|9564378|FG002|STARTED|Overall Study||4
8531962|NCT02318277|9564379|FG003|STARTED|Overall Study||4
8531963|NCT02318277|9564380|FG004|STARTED|Overall Study||8
8531964|NCT02318277|9564381|FG005|STARTED|Overall Study||9
8531965|NCT02318277|9564382|FG006|STARTED|Overall Study||49
8531966|NCT02318277|9564383|FG007|STARTED|Overall Study||93
8531967|NCT02318277|9564376|FG000|COMPLETED|Overall Study||0
8531968|NCT02318277|9564377|FG001|COMPLETED|Overall Study||0
8531969|NCT02318277|9564378|FG002|COMPLETED|Overall Study||0
8531970|NCT02318277|9564379|FG003|COMPLETED|Overall Study||0
8531971|NCT02318277|9564380|FG004|COMPLETED|Overall Study||0
8531972|NCT02318277|9564381|FG005|COMPLETED|Overall Study||0
8531973|NCT02318277|9564382|FG006|COMPLETED|Overall Study||0
8531974|NCT02318277|9564383|FG007|COMPLETED|Overall Study||0
8531975|NCT02318277|9564376|FG000|NOT COMPLETED|Overall Study||6
8531976|NCT02318277|9564377|FG001|NOT COMPLETED|Overall Study||3
8531977|NCT02318277|9564378|FG002|NOT COMPLETED|Overall Study||4
8531978|NCT02318277|9564379|FG003|NOT COMPLETED|Overall Study||4
8531979|NCT02318277|9564380|FG004|NOT COMPLETED|Overall Study||8
8531980|NCT02318277|9564381|FG005|NOT COMPLETED|Overall Study||9
8531981|NCT02318277|9564382|FG006|NOT COMPLETED|Overall Study||49
8531982|NCT02318277|9564383|FG007|NOT COMPLETED|Overall Study||93
8531983|NCT02296801|9564419|FG000|STARTED|Overall Study||103
8531984|NCT02296801|9564420|FG001|STARTED|Overall Study||68
8531985|NCT02296801|9564421|FG002|STARTED|Overall Study||69
8531986|NCT02296801|9564422|FG003|STARTED|Overall Study||67
8531987|NCT02296801|9564419|FG000|COMPLETED|Overall Study||83
8531988|NCT02296801|9564420|FG001|COMPLETED|Overall Study||53
8531989|NCT02296801|9564421|FG002|COMPLETED|Overall Study||50
8531990|NCT02296801|9564422|FG003|COMPLETED|Overall Study||58
8531991|NCT02296801|9564419|FG000|NOT COMPLETED|Overall Study||20
8531992|NCT02296801|9564420|FG001|NOT COMPLETED|Overall Study||15
8531993|NCT02296801|9564421|FG002|NOT COMPLETED|Overall Study||19
8531994|NCT02296801|9564422|FG003|NOT COMPLETED|Overall Study||9
8531995|NCT02143063|9564439|FG000|STARTED|Overall Study||61
8816424|NCT01544166|9869942|FG000|COMPLETED|Overall Study||44
8531996|NCT02143063|9564440|FG001|STARTED|Overall Study||105
8531997|NCT02143063|9564441|FG002|STARTED|Overall Study||108
8531998|NCT02143063|9564439|FG000|COMPLETED|Overall Study||45
8531999|NCT02143063|9564440|FG001|COMPLETED|Overall Study||75
8532000|NCT02143063|9564441|FG002|COMPLETED|Overall Study||78
8532001|NCT02143063|9564439|FG000|NOT COMPLETED|Overall Study||16
8532002|NCT02143063|9564440|FG001|NOT COMPLETED|Overall Study||30
8532003|NCT02143063|9564441|FG002|NOT COMPLETED|Overall Study||30
8532004|NCT02017964|9564449|FG000|STARTED|Overall Study||26
8532005|NCT02017964|9564449|FG000|COMPLETED|Overall Study||25
8532006|NCT02017964|9564449|FG000|NOT COMPLETED|Overall Study||1
8620729|NCT00475501|9659552|FG001|STARTED|Overall Study||13
8620730|NCT00475501|9659553|FG002|STARTED|Overall Study||17
8620731|NCT00475501|9659554|FG003|STARTED|Overall Study||16
8620732|NCT00475501|9659551|FG000|COMPLETED|Overall Study||7
8620733|NCT00475501|9659552|FG001|COMPLETED|Overall Study||8
8620734|NCT00475501|9659553|FG002|COMPLETED|Overall Study||13
8620735|NCT00475501|9659554|FG003|COMPLETED|Overall Study||12
8620736|NCT00475501|9659551|FG000|NOT COMPLETED|Overall Study||7
8532007|NCT01968785|9564455|FG000|STARTED|Overall Study||2
8532008|NCT01968785|9564456|FG001|STARTED|Overall Study||0
8532009|NCT01968785|9564455|FG000|COMPLETED|Overall Study||1
8532010|NCT01968785|9564456|FG001|COMPLETED|Overall Study||0
8532011|NCT01968785|9564455|FG000|NOT COMPLETED|Overall Study||1
8532012|NCT01968785|9564456|FG001|NOT COMPLETED|Overall Study||0
8532013|NCT01956110|9564464|FG000|STARTED|Overall Study||665
8532014|NCT01956110|9564465|FG001|STARTED|Overall Study||661
8532015|NCT01956110|9564464|FG000|COMPLETED|Overall Study||630
8532016|NCT01956110|9564465|FG001|COMPLETED|Overall Study||639
8532017|NCT01956110|9564464|FG000|NOT COMPLETED|Overall Study||35
8532018|NCT01956110|9564465|FG001|NOT COMPLETED|Overall Study||22
8532019|NCT01648023|9564474|FG000|STARTED|Overall Study||25
8532020|NCT01648023|9564475|FG001|STARTED|Overall Study||24
8532021|NCT01648023|9564474|FG000|COMPLETED|Overall Study||24
8532022|NCT01648023|9564475|FG001|COMPLETED|Overall Study||22
8532023|NCT01648023|9564474|FG000|NOT COMPLETED|Overall Study||1
8532024|NCT01648023|9564475|FG001|NOT COMPLETED|Overall Study||2
8532025|NCT01335581|9564483|FG000|STARTED|Overall Study||9
8532026|NCT01335581|9564484|FG001|STARTED|Overall Study||9
8532027|NCT01335581|9564483|FG000|COMPLETED|Overall Study||5
8532028|NCT01335581|9564484|FG001|COMPLETED|Overall Study||3
8532029|NCT01335581|9564483|FG000|NOT COMPLETED|Overall Study||4
8532030|NCT01335581|9564484|FG001|NOT COMPLETED|Overall Study||6
8532031|NCT01209923|9564490|FG000|STARTED|Overall Study||362
8532032|NCT01209923|9564490|FG000|COMPLETED|Overall Study||362
8532033|NCT01209923|9564490|FG000|NOT COMPLETED|Overall Study||0
8532034|NCT01083433|9564498|FG000|STARTED|Overall Study||22
8532035|NCT01083433|9564499|FG001|STARTED|Overall Study||23
8532036|NCT01083433|9564500|FG002|STARTED|Overall Study||23
8532037|NCT01083433|9564498|FG000|COMPLETED|Overall Study||20
8532038|NCT01083433|9564499|FG001|COMPLETED|Overall Study||17
8532039|NCT01083433|9564500|FG002|COMPLETED|Overall Study||18
8532040|NCT01083433|9564498|FG000|NOT COMPLETED|Overall Study||2
8532041|NCT01083433|9564499|FG001|NOT COMPLETED|Overall Study||6
8532042|NCT01083433|9564500|FG002|NOT COMPLETED|Overall Study||5
8532043|NCT00787176|9564516|FG000|STARTED|Overall Study||69
8532044|NCT00787176|9564517|FG001|STARTED|Overall Study||62
8532045|NCT00787176|9564518|FG002|STARTED|Overall Study||60
8532046|NCT00787176|9564519|FG003|STARTED|Overall Study||60
8532047|NCT00787176|9564516|FG000|COMPLETED|Overall Study||62
8532048|NCT00787176|9564517|FG001|COMPLETED|Overall Study||59
8532049|NCT00787176|9564518|FG002|COMPLETED|Overall Study||54
8532050|NCT00787176|9564519|FG003|COMPLETED|Overall Study||55
8532051|NCT00787176|9564516|FG000|NOT COMPLETED|Overall Study||7
8532052|NCT00787176|9564517|FG001|NOT COMPLETED|Overall Study||3
8532053|NCT00787176|9564518|FG002|NOT COMPLETED|Overall Study||6
8532054|NCT00787176|9564519|FG003|NOT COMPLETED|Overall Study||5
8532055|NCT00352534|9564532|FG000|STARTED|Initial Staging||211
8532056|NCT00352534|9564533|FG001|STARTED|Initial Staging||597
8532057|NCT00352534|9564534|FG002|STARTED|Initial Staging||0
8532058|NCT00352534|9564535|FG003|STARTED|Initial Staging||0
8532059|NCT00352534|9564536|FG004|STARTED|Initial Staging||0
8532060|NCT00352534|9564537|FG005|STARTED|Initial Staging||0
8532061|NCT00352534|9564538|FG006|STARTED|Initial Staging||0
8532062|NCT00352534|9564532|FG000|COMPLETED|Initial Staging||203
8532063|NCT00352534|9564533|FG001|COMPLETED|Initial Staging||588
8532064|NCT00352534|9564534|FG002|COMPLETED|Initial Staging||0
8532065|NCT00352534|9564535|FG003|COMPLETED|Initial Staging||0
8532066|NCT00352534|9564536|FG004|COMPLETED|Initial Staging||0
8532067|NCT00352534|9564537|FG005|COMPLETED|Initial Staging||0
8532068|NCT00352534|9564538|FG006|COMPLETED|Initial Staging||0
8532069|NCT00352534|9564532|FG000|NOT COMPLETED|Initial Staging||8
8532070|NCT00352534|9564533|FG001|NOT COMPLETED|Initial Staging||9
8532071|NCT00352534|9564534|FG002|NOT COMPLETED|Initial Staging||0
8532072|NCT00352534|9564535|FG003|NOT COMPLETED|Initial Staging||0
8532073|NCT00352534|9564536|FG004|NOT COMPLETED|Initial Staging||0
8532074|NCT00352534|9564537|FG005|NOT COMPLETED|Initial Staging||0
8532075|NCT00352534|9564538|FG006|NOT COMPLETED|Initial Staging||0
8532076|NCT00352534|9564532|FG000|STARTED|Final Risk Group Assignment||0
8532077|NCT00352534|9564533|FG001|STARTED|Final Risk Group Assignment||0
8620737|NCT00475501|9659552|FG001|NOT COMPLETED|Overall Study||5
8620738|NCT00475501|9659553|FG002|NOT COMPLETED|Overall Study||4
8620739|NCT00475501|9659554|FG003|NOT COMPLETED|Overall Study||4
8532078|NCT00352534|9564534|FG002|STARTED|Final Risk Group Assignment||119
8532079|NCT00352534|9564535|FG003|STARTED|Final Risk Group Assignment||52
8532080|NCT00352534|9564536|FG004|STARTED|Final Risk Group Assignment||32
8532081|NCT00352534|9564537|FG005|STARTED|Final Risk Group Assignment||548
8532082|NCT00352534|9564538|FG006|STARTED|Final Risk Group Assignment||40
8532083|NCT00352534|9564532|FG000|COMPLETED|Final Risk Group Assignment||0
8532084|NCT00352534|9564533|FG001|COMPLETED|Final Risk Group Assignment||0
8532085|NCT00352534|9564534|FG002|COMPLETED|Final Risk Group Assignment||116
8532086|NCT00352534|9564535|FG003|COMPLETED|Final Risk Group Assignment||49
8620740|NCT00475644|9659596|FG000|STARTED|Overall Study||66
8532087|NCT00352534|9564536|FG004|COMPLETED|Final Risk Group Assignment||31
8532088|NCT00352534|9564537|FG005|COMPLETED|Final Risk Group Assignment||503
8532089|NCT00352534|9564538|FG006|COMPLETED|Final Risk Group Assignment||1
8532090|NCT00352534|9564532|FG000|NOT COMPLETED|Final Risk Group Assignment||0
8532091|NCT00352534|9564533|FG001|NOT COMPLETED|Final Risk Group Assignment||0
8532092|NCT00352534|9564534|FG002|NOT COMPLETED|Final Risk Group Assignment||3
8532093|NCT00352534|9564535|FG003|NOT COMPLETED|Final Risk Group Assignment||3
8532094|NCT00352534|9564536|FG004|NOT COMPLETED|Final Risk Group Assignment||1
8532095|NCT00352534|9564537|FG005|NOT COMPLETED|Final Risk Group Assignment||45
8532096|NCT00352534|9564538|FG006|NOT COMPLETED|Final Risk Group Assignment||39
8532097|NCT00033293|9564550|FG000|STARTED|Overall Study||26
8532098|NCT00033293|9564551|FG001|STARTED|Overall Study||27
8532099|NCT00033293|9564550|FG000|COMPLETED|Overall Study||16
8532100|NCT00033293|9564551|FG001|COMPLETED|Overall Study||9
8532101|NCT00033293|9564550|FG000|NOT COMPLETED|Overall Study||10
8532102|NCT00033293|9564551|FG001|NOT COMPLETED|Overall Study||18
8564322|NCT00055497|9596406|FG001|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|16
8564323|NCT00055497|9596407|FG002|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|16
8564324|NCT00055497|9596408|FG003|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|131
8564325|NCT00055497|9596405|FG000|NOT COMPLETED|Overall Study||5
8564326|NCT00055497|9596406|FG001|NOT COMPLETED|Overall Study||3
8564327|NCT00055497|9596407|FG002|NOT COMPLETED|Overall Study||2
8564328|NCT00055497|9596408|FG003|NOT COMPLETED|Overall Study||90
8564329|NCT00055601|9596425|FG000|STARTED|Overall Study||48
8564330|NCT00055601|9596426|FG001|STARTED|Overall Study||49
8564331|NCT00055601|9596425|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|46
8564332|NCT00055601|9596426|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|47
8564333|NCT00055601|9596425|FG000|NOT COMPLETED|Overall Study||2
8564334|NCT00055601|9596426|FG001|NOT COMPLETED|Overall Study||2
8564335|NCT00055692|9596432|FG000|STARTED|Overall Study||46
8564336|NCT00055692|9596432|FG000|COMPLETED|Overall Study||46
8564337|NCT00055692|9596432|FG000|NOT COMPLETED|Overall Study||0
8564338|NCT00056160|9596440|FG000|STARTED|Up to Unblinding (07 Jun 2005)||177
8564339|NCT00056160|9596441|FG001|STARTED|Up to Unblinding (07 Jun 2005)||176
8564340|NCT00056160|9596440|FG000|COMPLETED|Up to Unblinding (07 Jun 2005)||64
8564341|NCT00056160|9596441|FG001|COMPLETED|Up to Unblinding (07 Jun 2005)||13
8564342|NCT00056160|9596440|FG000|NOT COMPLETED|Up to Unblinding (07 Jun 2005)||113
8564343|NCT00056160|9596441|FG001|NOT COMPLETED|Up to Unblinding (07 Jun 2005)||163
8564344|NCT00056160|9596440|FG000|STARTED|Extended Follow-up Cutoff (23 Jul 2008)||177
8564345|NCT00056160|9596441|FG001|STARTED|Extended Follow-up Cutoff (23 Jul 2008)||0
8564346|NCT00056160|9596440|FG000|COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||6
8564347|NCT00056160|9596441|FG001|COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||0
8564348|NCT00056160|9596440|FG000|NOT COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||171
8564349|NCT00056160|9596441|FG001|NOT COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||0
8564350|NCT00056160|9596440|FG000|STARTED|Final Follow-up||6
8564351|NCT00056160|9596441|FG001|STARTED|Final Follow-up||0
8564352|NCT00056160|9596440|FG000|COMPLETED|Final Follow-up||0
8564353|NCT00056160|9596441|FG001|COMPLETED|Final Follow-up||0
8564354|NCT00056160|9596440|FG000|NOT COMPLETED|Final Follow-up||6
8564355|NCT00056160|9596441|FG001|NOT COMPLETED|Final Follow-up||0
8564356|NCT00056316|9596449|FG000|STARTED|Overall Study||33
8564357|NCT00056316|9596450|FG001|STARTED|Overall Study|over-enrolled due to potential higher rates of drop-out.|41
8564358|NCT00056316|9596449|FG000|COMPLETED|Overall Study||30
8564359|NCT00056316|9596450|FG001|COMPLETED|Overall Study||38
8564360|NCT00056316|9596449|FG000|NOT COMPLETED|Overall Study||3
8564361|NCT00056316|9596450|FG001|NOT COMPLETED|Overall Study||3
8564362|NCT00056407|9596458|FG000|STARTED|Overall Study||4126
8564363|NCT00056407|9596459|FG001|STARTED|Overall Study||4105
8564364|NCT00056407|9596458|FG000|COMPLETED|Overall Study||2915
8564365|NCT00056407|9596459|FG001|COMPLETED|Overall Study||2912
8564366|NCT00056407|9596458|FG000|NOT COMPLETED|Overall Study||1211
8564367|NCT00056407|9596459|FG001|NOT COMPLETED|Overall Study||1193
8564368|NCT00056472|9596467|FG000|STARTED|Overall Study||129
8564369|NCT00056472|9596468|FG001|STARTED|Overall Study||130
8564370|NCT00056472|9596467|FG000|COMPLETED|Overall Study||81
8564371|NCT00056472|9596468|FG001|COMPLETED|Overall Study||61
8564372|NCT00056472|9596467|FG000|NOT COMPLETED|Overall Study||48
8564373|NCT00056472|9596468|FG001|NOT COMPLETED|Overall Study||69
8564374|NCT00056498|9596476|FG000|STARTED|Overall Study||30
8564375|NCT00056498|9596477|FG001|STARTED|Overall Study||35
8564376|NCT00056498|9596476|FG000|COMPLETED|Overall Study||25
8564377|NCT00056498|9596477|FG001|COMPLETED|Overall Study||28
8564378|NCT00056498|9596476|FG000|NOT COMPLETED|Overall Study||5
8620741|NCT00475644|9659596|FG000|Received at Least One Dose of Study Drug|Overall Study||66
8620742|NCT00475644|9659596|FG000|COMPLETED|Overall Study||53
8564379|NCT00056498|9596477|FG001|NOT COMPLETED|Overall Study||7
8564380|NCT00056550|9596483|FG000|STARTED|Overall Study||14
8564381|NCT00056550|9596483|FG000|COMPLETED|Overall Study||14
8564382|NCT00056550|9596483|FG000|NOT COMPLETED|Overall Study||0
8564383|NCT00056563|9596490|FG000|STARTED|Overall Study||121
8564384|NCT00056563|9596491|FG001|STARTED|Overall Study||134
8564385|NCT00056563|9596490|FG000|COMPLETED|Overall Study||121
8620743|NCT00475644|9659596|FG000|NOT COMPLETED|Overall Study||13
8532103|NCT04497415|9564561|FG000|STARTED|Overall Study||229
8532104|NCT04497415|9564562|FG001|STARTED|Overall Study||121
8532105|NCT04497415|9564561|FG000|Post-intervention Assessment (Day 1)|Overall Study||229
8532106|NCT04497415|9564562|FG001|Post-intervention Assessment (Day 1)|Overall Study||121
8532107|NCT04497415|9564561|FG000|First Follow-up Assessment (Day 14)|Overall Study||195
8532108|NCT04497415|9564562|FG001|First Follow-up Assessment (Day 14)|Overall Study||102
8620744|NCT00475670|9659602|FG000|STARTED|Overall Study||3
8620745|NCT00475670|9659603|FG001|STARTED|Overall Study||41
8620746|NCT00475670|9659602|FG000|COMPLETED|Overall Study|This cohort was closed prematurely (with only 3 participants) because of enrollment difficulties.|0
8620747|NCT00475670|9659603|FG001|COMPLETED|Overall Study||0
8620748|NCT00475670|9659602|FG000|NOT COMPLETED|Overall Study||3
8620749|NCT00475670|9659603|FG001|NOT COMPLETED|Overall Study||41
8620750|NCT00475709|9659609|FG000|STARTED|Overall Study||1022
8620751|NCT00475709|9659609|FG000|Eligible of Analysis|Overall Study|Excludes eight ineligible subjects|1014
8620752|NCT00475709|9659609|FG000|COMPLETED|Overall Study||946
8620753|NCT00475709|9659609|FG000|NOT COMPLETED|Overall Study||76
8620754|NCT00475722|9659615|FG000|STARTED|Overall Study||61
8620755|NCT00475722|9659616|FG001|STARTED|Overall Study||59
8620756|NCT00475722|9659615|FG000|COMPLETED|Overall Study||46
8620757|NCT00475722|9659616|FG001|COMPLETED|Overall Study||47
8620758|NCT00475722|9659615|FG000|NOT COMPLETED|Overall Study||15
8620759|NCT00475722|9659616|FG001|NOT COMPLETED|Overall Study||12
8620760|NCT00475735|9659628|FG000|STARTED|Treatment Period 1||14
8620761|NCT00475735|9659629|FG001|STARTED|Treatment Period 1||13
8532109|NCT04497415|9564561|FG000|COMPLETED|Overall Study||186
8532110|NCT04497415|9564562|FG001|COMPLETED|Overall Study||94
8532111|NCT04497415|9564561|FG000|NOT COMPLETED|Overall Study||43
8532112|NCT04497415|9564562|FG001|NOT COMPLETED|Overall Study||27
8532113|NCT04231396|9564568|FG000|STARTED|Overall Study||27
8532114|NCT04231396|9564568|FG000|COMPLETED|Overall Study||27
8532115|NCT04231396|9564568|FG000|NOT COMPLETED|Overall Study||0
8532116|NCT04118348|9564577|FG000|STARTED|Overall Study||3445
8532117|NCT04118348|9564578|FG001|STARTED|Overall Study||3312
8532118|NCT04118348|9564579|FG002|STARTED|Overall Study||3461
8532119|NCT04118348|9564580|FG003|STARTED|Overall Study||3262
8532120|NCT04118348|9564577|FG000|COMPLETED|Overall Study||3445
8532121|NCT04118348|9564578|FG001|COMPLETED|Overall Study||3312
8532122|NCT04118348|9564579|FG002|COMPLETED|Overall Study||3461
8532123|NCT04118348|9564580|FG003|COMPLETED|Overall Study||3262
8532124|NCT04118348|9564577|FG000|NOT COMPLETED|Overall Study||0
8532125|NCT04118348|9564578|FG001|NOT COMPLETED|Overall Study||0
8532126|NCT04118348|9564579|FG002|NOT COMPLETED|Overall Study||0
8532127|NCT04118348|9564580|FG003|NOT COMPLETED|Overall Study||0
8532128|NCT04975321|9564593|FG000|STARTED|Overall Study||25
8532129|NCT04975321|9564594|FG001|STARTED|Overall Study||26
8532130|NCT04975321|9564595|FG002|STARTED|Overall Study||25
8532131|NCT04975321|9564593|FG000|COMPLETED|Overall Study||15
8532132|NCT04975321|9564594|FG001|COMPLETED|Overall Study||15
8532133|NCT04975321|9564595|FG002|COMPLETED|Overall Study||17
8532134|NCT04975321|9564593|FG000|NOT COMPLETED|Overall Study||10
8532135|NCT04975321|9564594|FG001|NOT COMPLETED|Overall Study||11
8532136|NCT04975321|9564595|FG002|NOT COMPLETED|Overall Study||8
8532137|NCT04594759|9564603|FG000|STARTED|Overall Study||22
8532138|NCT04594759|9564603|FG000|COMPLETED|Overall Study||19
8532139|NCT04594759|9564603|FG000|NOT COMPLETED|Overall Study||3
8532140|NCT04463069|9564609|FG000|STARTED|Overall Study||41
8532141|NCT04463069|9564610|FG001|STARTED|Overall Study||45
8532142|NCT04463069|9564609|FG000|COMPLETED|Overall Study||39
8532143|NCT04463069|9564610|FG001|COMPLETED|Overall Study||22
8532144|NCT04463069|9564609|FG000|NOT COMPLETED|Overall Study||2
8532145|NCT04463069|9564610|FG001|NOT COMPLETED|Overall Study||23
8532146|NCT04250337|9564618|FG000|STARTED|Overall Study||75
8532147|NCT04250337|9564619|FG001|STARTED|Overall Study||153
8532148|NCT04250337|9564618|FG000|Received at Least One Dose of Study Drug|Overall Study||75
8532149|NCT04250337|9564619|FG001|Received at Least One Dose of Study Drug|Overall Study||153
8532150|NCT04250337|9564618|FG000|COMPLETED|Overall Study||67
8532151|NCT04250337|9564619|FG001|COMPLETED|Overall Study||142
8532152|NCT04250337|9564618|FG000|NOT COMPLETED|Overall Study||8
8532153|NCT04250337|9564619|FG001|NOT COMPLETED|Overall Study||11
8532154|NCT04126733|9564626|FG000|STARTED|Treatment Period||70
8532155|NCT04126733|9564626|FG000|COMPLETED|Treatment Period||0
8532156|NCT04126733|9564626|FG000|NOT COMPLETED|Treatment Period||70
8532157|NCT04126733|9564626|FG000|STARTED|Active Follow-up Period|Participants had the option to decline participation in active follow-up.|34
8532158|NCT04126733|9564626|FG000|COMPLETED|Active Follow-up Period||14
8532159|NCT04126733|9564626|FG000|NOT COMPLETED|Active Follow-up Period||20
8532160|NCT04126733|9564626|FG000|STARTED|Long-term Follow-up Period|All participants who accepted long-term follow-up.|6
8532161|NCT04126733|9564626|FG000|COMPLETED|Long-term Follow-up Period||0
8532162|NCT04126733|9564626|FG000|NOT COMPLETED|Long-term Follow-up Period||6
8620762|NCT00475735|9659630|FG002|STARTED|Treatment Period 1||7
8620763|NCT00475735|9659631|FG003|STARTED|Treatment Period 1||7
8620764|NCT00475735|9659632|FG004|STARTED|Treatment Period 1||16
8620765|NCT00475735|9659633|FG005|STARTED|Treatment Period 1||15
8620766|NCT00475735|9659628|FG000|COMPLETED|Treatment Period 1||10
8620767|NCT00475735|9659629|FG001|COMPLETED|Treatment Period 1||11
8620768|NCT00475735|9659630|FG002|COMPLETED|Treatment Period 1||7
8532163|NCT03909178|9564632|FG000|STARTED|Overall Study||46
8532164|NCT03909178|9564633|FG001|STARTED|Overall Study||44
8532165|NCT03909178|9564632|FG000|COMPLETED|Overall Study||42
8532166|NCT03909178|9564633|FG001|COMPLETED|Overall Study||39
8532167|NCT03909178|9564632|FG000|NOT COMPLETED|Overall Study||4
8532168|NCT03909178|9564633|FG001|NOT COMPLETED|Overall Study||5
8532169|NCT03662659|9564643|FG000|STARTED|Pre-treatment||138
8532170|NCT03662659|9564644|FG001|STARTED|Pre-treatment||136
8532171|NCT03662659|9564643|FG000|COMPLETED|Pre-treatment||136
8532172|NCT03662659|9564644|FG001|COMPLETED|Pre-treatment||135
8532173|NCT03662659|9564643|FG000|NOT COMPLETED|Pre-treatment||2
8532174|NCT03662659|9564644|FG001|NOT COMPLETED|Pre-treatment||1
8532175|NCT03662659|9564643|FG000|STARTED|Treatment||136
8532176|NCT03662659|9564644|FG001|STARTED|Treatment||135
8532177|NCT03662659|9564643|FG000|COMPLETED|Treatment||21
8532178|NCT03662659|9564644|FG001|COMPLETED|Treatment||29
8532179|NCT03662659|9564643|FG000|NOT COMPLETED|Treatment||115
8532180|NCT03662659|9564644|FG001|NOT COMPLETED|Treatment||106
8532181|NCT03631472|9564650|FG000|STARTED|Overall Study||21
8532182|NCT03631472|9564650|FG000|COMPLETED|Overall Study||21
8532183|NCT03631472|9564650|FG000|NOT COMPLETED|Overall Study||0
8532184|NCT03575572|9564656|FG000|STARTED|Overall Study||9
8532185|NCT03575572|9564656|FG000|COMPLETED|Overall Study||5
8532186|NCT03575572|9564656|FG000|NOT COMPLETED|Overall Study||4
8532187|NCT03521687|9564669|FG000|STARTED|Overall Study||20
8532188|NCT03521687|9564669|FG000|COMPLETED|Overall Study||15
8532189|NCT03521687|9564669|FG000|NOT COMPLETED|Overall Study||5
8532190|NCT03511664|9564675|FG000|STARTED|Overall Study||551
8532191|NCT03511664|9564676|FG001|STARTED|Overall Study||280
8532192|NCT03511664|9564675|FG000|FAS Safety Analysis Set|Overall Study||529
8532193|NCT03511664|9564676|FG001|FAS Safety Analysis Set|Overall Study||205
8532194|NCT03511664|9564675|FG000|Progression-Free Survival (PFS) Full Analysis Set (PFS-FAS)|Overall Study||385
8532195|NCT03511664|9564676|FG001|Progression-Free Survival (PFS) Full Analysis Set (PFS-FAS)|Overall Study||196
8532196|NCT03511664|9564675|FG000|Response Evaluable Analysis Set|Overall Study||319
8532197|NCT03511664|9564676|FG001|Response Evaluable Analysis Set|Overall Study||120
8532198|NCT03511664|9564675|FG000|COMPLETED|Overall Study||329
8532199|NCT03511664|9564676|FG001|COMPLETED|Overall Study||167
8532200|NCT03511664|9564675|FG000|NOT COMPLETED|Overall Study||222
8532201|NCT03511664|9564676|FG001|NOT COMPLETED|Overall Study||113
8564386|NCT00056563|9596491|FG001|COMPLETED|Overall Study||134
8564387|NCT00056563|9596490|FG000|NOT COMPLETED|Overall Study||0
8564388|NCT00056563|9596491|FG001|NOT COMPLETED|Overall Study||0
8564389|NCT00056862|9596499|FG000|STARTED|Overall Study||31
8564390|NCT00056862|9596500|FG001|STARTED|Overall Study||27
8564391|NCT00056862|9596499|FG000|COMPLETED|Overall Study||30
8564392|NCT00056862|9596500|FG001|COMPLETED|Overall Study||27
8564393|NCT00056862|9596499|FG000|NOT COMPLETED|Overall Study||1
8564394|NCT00056862|9596500|FG001|NOT COMPLETED|Overall Study||0
8564395|NCT00057330|9596508|FG000|STARTED|Overall Study||4577
8564396|NCT00057330|9596509|FG001|STARTED|Overall Study||3746
8564397|NCT00057330|9596508|FG000|COMPLETED|Overall Study||3445
8564398|NCT00057330|9596509|FG001|COMPLETED|Overall Study||2826
8564399|NCT00057330|9596508|FG000|NOT COMPLETED|Overall Study||1132
8564400|NCT00057330|9596509|FG001|NOT COMPLETED|Overall Study||920
8564401|NCT00057551|9596518|FG000|STARTED|Overall Study||200
8564402|NCT00057551|9596519|FG001|STARTED|Overall Study||195
8564403|NCT00057551|9596520|FG002|STARTED|Overall Study||96
8564404|NCT00057551|9596518|FG000|COMPLETED|Overall Study||175
8564405|NCT00057551|9596519|FG001|COMPLETED|Overall Study||168
8564406|NCT00057551|9596520|FG002|COMPLETED|Overall Study||80
8564407|NCT00057551|9596518|FG000|NOT COMPLETED|Overall Study||25
8564408|NCT00057551|9596519|FG001|NOT COMPLETED|Overall Study||27
8564409|NCT00057551|9596520|FG002|NOT COMPLETED|Overall Study||16
8564410|NCT00057577|9596530|FG000|STARTED|Overall Study||227
8564411|NCT00057577|9596531|FG001|STARTED|Overall Study||225
8564412|NCT00057577|9596530|FG000|COMPLETED|Overall Study||227
8564413|NCT00057577|9596531|FG001|COMPLETED|Overall Study||225
8564414|NCT00057577|9596530|FG000|NOT COMPLETED|Overall Study||0
8564415|NCT00057577|9596531|FG001|NOT COMPLETED|Overall Study||0
8564416|NCT00057681|9596545|FG000|STARTED|Overall Study||137
8564417|NCT00057681|9596546|FG001|STARTED|Overall Study||139
8564418|NCT00057681|9596547|FG002|STARTED|Overall Study||103
8564419|NCT00057681|9596545|FG000|COMPLETED|Overall Study||72
8564420|NCT00057681|9596546|FG001|COMPLETED|Overall Study||67
8564421|NCT00057681|9596547|FG002|COMPLETED|Overall Study||69
8564422|NCT00057681|9596545|FG000|NOT COMPLETED|Overall Study||65
8564423|NCT00057681|9596546|FG001|NOT COMPLETED|Overall Study||72
8564424|NCT00057681|9596547|FG002|NOT COMPLETED|Overall Study||34
8620769|NCT00475735|9659631|FG003|COMPLETED|Treatment Period 1||5
8620770|NCT00475735|9659632|FG004|COMPLETED|Treatment Period 1||14
8620771|NCT00475735|9659633|FG005|COMPLETED|Treatment Period 1||12
8564425|NCT00057746|9596558|FG000|STARTED|Overall Study||131
8564426|NCT00057746|9596559|FG001|STARTED|Overall Study||67
8564427|NCT00057746|9596560|FG002|STARTED|Overall Study||67
8564428|NCT00057746|9596558|FG000|COMPLETED|Overall Study||131
8564429|NCT00057746|9596559|FG001|COMPLETED|Overall Study||67
8564430|NCT00057746|9596560|FG002|COMPLETED|Overall Study||66
8564431|NCT00057746|9596558|FG000|NOT COMPLETED|Overall Study||0
8620772|NCT00475735|9659628|FG000|NOT COMPLETED|Treatment Period 1||4
8564432|NCT00057746|9596559|FG001|NOT COMPLETED|Overall Study||0
8564433|NCT00057746|9596560|FG002|NOT COMPLETED|Overall Study||1
8564434|NCT00057785|9596568|FG000|STARTED|Overall Study||68
8569198|NCT00095563|9601407|FG000|COMPLETED|Overall Study||39
8569199|NCT00095563|9601407|FG000|NOT COMPLETED|Overall Study||0
8532202|NCT03461289|9564682|FG000|STARTED|Overall Study||33
8532203|NCT03461289|9564682|FG000|COMPLETED|Overall Study||32
8532204|NCT03461289|9564682|FG000|NOT COMPLETED|Overall Study||1
8532205|NCT03406507|9564688|FG000|STARTED|Primary Evaluation Period||5
8532206|NCT03406507|9564689|FG001|STARTED|Primary Evaluation Period||8
8532207|NCT03406507|9564688|FG000|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||5
8532208|NCT03406507|9564689|FG001|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||8
8532209|NCT03406507|9564688|FG000|COMPLETED|Primary Evaluation Period||5
8532210|NCT03406507|9564689|FG001|COMPLETED|Primary Evaluation Period||8
8532211|NCT03406507|9564688|FG000|NOT COMPLETED|Primary Evaluation Period||0
8532212|NCT03406507|9564689|FG001|NOT COMPLETED|Primary Evaluation Period||0
8532213|NCT03406507|9564688|FG000|STARTED|Extension Period||5
8532214|NCT03406507|9564689|FG001|STARTED|Extension Period||8
8532215|NCT03406507|9564688|FG000|Received at Least 1 Dose of Study Drug|Extension Period||5
8532216|NCT03406507|9564689|FG001|Received at Least 1 Dose of Study Drug|Extension Period||8
8532217|NCT03406507|9564688|FG000|COMPLETED|Extension Period||0
8532218|NCT03406507|9564689|FG001|COMPLETED|Extension Period||2
8532219|NCT03406507|9564688|FG000|NOT COMPLETED|Extension Period||5
8532220|NCT03406507|9564689|FG001|NOT COMPLETED|Extension Period||6
8532221|NCT03256045|9564695|FG000|STARTED|Overall Study||9
8620773|NCT00475735|9659629|FG001|NOT COMPLETED|Treatment Period 1||2
8620774|NCT00475735|9659630|FG002|NOT COMPLETED|Treatment Period 1||0
8620775|NCT00475735|9659631|FG003|NOT COMPLETED|Treatment Period 1||2
8620776|NCT00475735|9659632|FG004|NOT COMPLETED|Treatment Period 1||2
8532222|NCT03256045|9564695|FG000|COMPLETED|Overall Study||9
8532223|NCT03256045|9564695|FG000|NOT COMPLETED|Overall Study||0
8532224|NCT03216499|9564699|FG000|STARTED|Overall Study||24
8532225|NCT03216499|9564699|FG000|COMPLETED|Overall Study||24
8532226|NCT03216499|9564699|FG000|NOT COMPLETED|Overall Study||0
8532227|NCT03046836|9564705|FG000|STARTED|Overall Study||100
8532228|NCT03046836|9564706|FG001|STARTED|Overall Study||100
8532229|NCT03046836|9564705|FG000|COMPLETED|Overall Study||100
8532230|NCT03046836|9564706|FG001|COMPLETED|Overall Study||100
8532231|NCT03046836|9564705|FG000|NOT COMPLETED|Overall Study||0
8532232|NCT03046836|9564706|FG001|NOT COMPLETED|Overall Study||0
8532233|NCT02966301|9564713|FG000|STARTED|Overall Study||21
8532234|NCT02966301|9564713|FG000|Full Analysis Set (FAS)|Overall Study|All patients who entered the study, completed their first cycle of ATO (11 infusions) and for whom the response at Week 6 after diagnosis of chronic GvHD has been evaluated.|20
8532235|NCT02966301|9564713|FG000|Safety Analysis (SA)|Overall Study|All patients included in the study for whom received at least one ATO infusion. One patient received 2 infusions and then exited the study due to SAE (reversible liver toxicity).|21
8532236|NCT02966301|9564713|FG000|COMPLETED|Overall Study||18
8532237|NCT02966301|9564713|FG000|NOT COMPLETED|Overall Study||3
8532238|NCT02941926|9564717|FG000|STARTED|Overall Study||3246
8532239|NCT02941926|9564717|FG000|Canadian Sub-study|Overall Study||88
8532240|NCT02941926|9564717|FG000|COMPLETED|Overall Study||1301
8532241|NCT02941926|9564717|FG000|NOT COMPLETED|Overall Study||1945
8532242|NCT02893514|9564725|FG000|STARTED|Overall Study||42
8532243|NCT02893514|9564726|FG001|STARTED|Overall Study||37
8532244|NCT02893514|9564725|FG000|COMPLETED|Overall Study||42
8532245|NCT02893514|9564726|FG001|COMPLETED|Overall Study||37
8532246|NCT02893514|9564725|FG000|NOT COMPLETED|Overall Study||0
8532247|NCT02893514|9564726|FG001|NOT COMPLETED|Overall Study||0
8532248|NCT02832167|9564732|FG000|STARTED|Treatment Period 1||239
8532249|NCT02832167|9564732|FG000|COMPLETED|Treatment Period 1||110
8532250|NCT02832167|9564732|FG000|NOT COMPLETED|Treatment Period 1||129
8532251|NCT02832167|9564732|FG000|STARTED|Transition From Period 1 to Period 2||110
8532252|NCT02832167|9564732|FG000|COMPLETED|Transition From Period 1 to Period 2||103
8532253|NCT02832167|9564732|FG000|NOT COMPLETED|Transition From Period 1 to Period 2||7
8532254|NCT02832167|9564732|FG000|STARTED|Treatment Period 2||103
8532255|NCT02832167|9564732|FG000|COMPLETED|Treatment Period 2||19
8532256|NCT02832167|9564732|FG000|NOT COMPLETED|Treatment Period 2||84
8532257|NCT02699554|9564736|FG000|STARTED|Overall Study||55
8532258|NCT02699554|9564736|FG000|COMPLETED|Overall Study||46
8532259|NCT02699554|9564736|FG000|NOT COMPLETED|Overall Study||9
8532260|NCT02659020|9564747|FG000|STARTED|Overall Study||21
8532261|NCT02659020|9564748|FG001|STARTED|Overall Study||18
8532262|NCT02659020|9564749|FG002|STARTED|Overall Study||15
8532263|NCT02659020|9564750|FG003|STARTED|Overall Study||81
8532264|NCT02659020|9564751|FG004|STARTED|Overall Study||46
8532265|NCT02659020|9564752|FG005|STARTED|Overall Study||86
8532266|NCT02659020|9564753|FG006|STARTED|Overall Study||43
8532267|NCT02659020|9564747|FG000|Received at Least 1 Dose of Study Drug|Overall Study||21
8532268|NCT02659020|9564748|FG001|Received at Least 1 Dose of Study Drug|Overall Study||18
8532269|NCT02659020|9564749|FG002|Received at Least 1 Dose of Study Drug|Overall Study||15
8532270|NCT02659020|9564750|FG003|Received at Least 1 Dose of Study Drug|Overall Study||81
8532271|NCT02659020|9564751|FG004|Received at Least 1 Dose of Study Drug|Overall Study||45
8532272|NCT02659020|9564752|FG005|Received at Least 1 Dose of Study Drug|Overall Study||86
8532273|NCT02659020|9564753|FG006|Received at Least 1 Dose of Study Drug|Overall Study||43
8532274|NCT02659020|9564747|FG000|COMPLETED|Overall Study||18
8532275|NCT02659020|9564748|FG001|COMPLETED|Overall Study||15
8532276|NCT02659020|9564749|FG002|COMPLETED|Overall Study||14
8532277|NCT02659020|9564750|FG003|COMPLETED|Overall Study||65
8532278|NCT02659020|9564751|FG004|COMPLETED|Overall Study||40
8620777|NCT00475735|9659633|FG005|NOT COMPLETED|Treatment Period 1||3
8620778|NCT00475735|9659628|FG000|STARTED|Treatment Washout||10
8532279|NCT02659020|9564752|FG005|COMPLETED|Overall Study||75
8532280|NCT02659020|9564753|FG006|COMPLETED|Overall Study||35
8532281|NCT02659020|9564747|FG000|NOT COMPLETED|Overall Study||3
8532282|NCT02659020|9564748|FG001|NOT COMPLETED|Overall Study||3
8532283|NCT02659020|9564749|FG002|NOT COMPLETED|Overall Study||1
8532284|NCT02659020|9564750|FG003|NOT COMPLETED|Overall Study||16
8532285|NCT02659020|9564751|FG004|NOT COMPLETED|Overall Study||6
8532286|NCT02659020|9564752|FG005|NOT COMPLETED|Overall Study||11
8532287|NCT02659020|9564753|FG006|NOT COMPLETED|Overall Study||8
8532288|NCT02626949|9564778|FG000|STARTED|Randomization, Pre-Enrollment||56
8532289|NCT02626949|9564779|FG001|STARTED|Randomization, Pre-Enrollment||58
8532290|NCT02626949|9564778|FG000|COMPLETED|Randomization, Pre-Enrollment||40
8532291|NCT02626949|9564779|FG001|COMPLETED|Randomization, Pre-Enrollment||44
8532292|NCT02626949|9564778|FG000|NOT COMPLETED|Randomization, Pre-Enrollment||16
8532293|NCT02626949|9564779|FG001|NOT COMPLETED|Randomization, Pre-Enrollment||14
8532294|NCT02626949|9564778|FG000|STARTED|Enrolled||40
8532295|NCT02626949|9564779|FG001|STARTED|Enrolled||44
8532296|NCT02626949|9564778|FG000|COMPLETED|Enrolled||30
8532297|NCT02626949|9564779|FG001|COMPLETED|Enrolled||36
8532298|NCT02626949|9564778|FG000|NOT COMPLETED|Enrolled||10
8532299|NCT02626949|9564779|FG001|NOT COMPLETED|Enrolled||8
8532300|NCT02625766|9564787|FG000|STARTED|Overall Study||47
8532301|NCT02625766|9564788|FG001|STARTED|Overall Study||48
8532302|NCT02625766|9564787|FG000|COMPLETED|Overall Study||47
8532303|NCT02625766|9564788|FG001|COMPLETED|Overall Study||48
8532304|NCT02625766|9564787|FG000|NOT COMPLETED|Overall Study||0
8532305|NCT02625766|9564788|FG001|NOT COMPLETED|Overall Study||0
8532306|NCT02565914|9564794|FG000|STARTED|Overall Study||1044
8532307|NCT02565914|9564794|FG000|Safety Set|Overall Study||1042
8532308|NCT02565914|9564794|FG000|COMPLETED|Overall Study||951
8532309|NCT02565914|9564794|FG000|NOT COMPLETED|Overall Study||93
8532310|NCT02550652|9564808|FG000|STARTED|Overall Study||63
8532311|NCT02550652|9564809|FG001|STARTED|Overall Study||62
8532312|NCT02550652|9564808|FG000|COMPLETED|Overall Study||42
8532313|NCT02550652|9564809|FG001|COMPLETED|Overall Study||41
8532314|NCT02550652|9564808|FG000|NOT COMPLETED|Overall Study||21
8532315|NCT02550652|9564809|FG001|NOT COMPLETED|Overall Study||21
8532316|NCT02385045|9564815|FG000|STARTED|Overall Study||157
8532317|NCT02385045|9564815|FG000|COMPLETED|Overall Study|4 patients could not complete endoscopy as planned|153
8532318|NCT02385045|9564815|FG000|NOT COMPLETED|Overall Study||4
8532319|NCT02373241|9564821|FG000|STARTED|Overall Study||0
8532320|NCT02373241|9564822|FG001|STARTED|Overall Study||1
8532321|NCT02373241|9564821|FG000|COMPLETED|Overall Study||0
8532322|NCT02373241|9564822|FG001|COMPLETED|Overall Study||1
8532323|NCT02373241|9564821|FG000|NOT COMPLETED|Overall Study||0
8532324|NCT02373241|9564822|FG001|NOT COMPLETED|Overall Study||0
8532325|NCT02005471|9564830|FG000|STARTED|Overall Study||195
8532326|NCT02005471|9564831|FG001|STARTED|Overall Study||194
8532327|NCT02005471|9564830|FG000|Treated|Overall Study||188
8532328|NCT02005471|9564831|FG001|Treated|Overall Study||194
8532329|NCT02005471|9564830|FG000|COMPLETED|Overall Study||0
8532330|NCT02005471|9564831|FG001|COMPLETED|Overall Study||0
8532331|NCT02005471|9564830|FG000|NOT COMPLETED|Overall Study||195
8532332|NCT02005471|9564831|FG001|NOT COMPLETED|Overall Study||194
8532333|NCT01845649|9564842|FG000|STARTED|Overall Study||273
8532334|NCT01845649|9564843|FG001|STARTED|Overall Study||277
8532335|NCT01845649|9564842|FG000|Safety Population|Overall Study||271
8532336|NCT01845649|9564843|FG001|Safety Population|Overall Study||277
8532337|NCT01845649|9564842|FG000|Modified Intent-to-treat (mITT) Population|Overall Study||233
8532338|NCT01845649|9564843|FG001|Modified Intent-to-treat (mITT) Population|Overall Study||239
8532339|NCT01845649|9564842|FG000|COMPLETED|Overall Study||242
8532340|NCT01845649|9564843|FG001|COMPLETED|Overall Study||255
8532341|NCT01845649|9564842|FG000|NOT COMPLETED|Overall Study||31
8532342|NCT01845649|9564843|FG001|NOT COMPLETED|Overall Study||22
8532343|NCT01844986|9564851|FG000|STARTED|Overall Study||260
8532344|NCT01844986|9564852|FG001|STARTED|Overall Study||131
8532345|NCT01844986|9564851|FG000|COMPLETED|Overall Study||183
8532346|NCT01844986|9564852|FG001|COMPLETED|Overall Study||91
8532347|NCT01844986|9564851|FG000|NOT COMPLETED|Overall Study||77
8532348|NCT01844986|9564852|FG001|NOT COMPLETED|Overall Study||40
8532349|NCT01816139|9564860|FG000|STARTED|Overall Study||289
8532350|NCT01816139|9564861|FG001|STARTED|Overall Study||287
8532351|NCT01816139|9564860|FG000|Safety Population|Overall Study||287
8532352|NCT01816139|9564861|FG001|Safety Population|Overall Study||286
8532353|NCT01816139|9564860|FG000|Modified Intent-to-treat (mITT) Population|Overall Study||240
8532354|NCT01816139|9564861|FG001|Modified Intent-to-treat (mITT) Population|Overall Study||248
8532355|NCT01816139|9564860|FG000|COMPLETED|Overall Study||261
8532356|NCT01816139|9564861|FG001|COMPLETED|Overall Study||265
8532357|NCT01816139|9564860|FG000|NOT COMPLETED|Overall Study||28
8532358|NCT01816139|9564861|FG001|NOT COMPLETED|Overall Study||22
8532359|NCT01455597|9564867|FG000|STARTED|Overall Study||101
8532360|NCT01455597|9564868|FG001|STARTED|Overall Study||56
8532361|NCT01455597|9564869|FG002|STARTED|Overall Study||100
8532362|NCT01455597|9564870|FG003|STARTED|Overall Study||52
8532363|NCT01455597|9564867|FG000|All-Participants-Treated Population|Overall Study||101
8532364|NCT01455597|9564868|FG001|All-Participants-Treated Population|Overall Study||56
8532365|NCT01455597|9564869|FG002|All-Participants-Treated Population|Overall Study||99
8532366|NCT01455597|9564870|FG003|All-Participants-Treated Population|Overall Study||52
8532367|NCT01455597|9564867|FG000|COMPLETED|Overall Study||84
8532368|NCT01455597|9564868|FG001|COMPLETED|Overall Study||48
8532369|NCT01455597|9564869|FG002|COMPLETED|Overall Study||80
8532370|NCT01455597|9564870|FG003|COMPLETED|Overall Study||42
8532371|NCT01455597|9564867|FG000|NOT COMPLETED|Overall Study||17
8532372|NCT01455597|9564868|FG001|NOT COMPLETED|Overall Study||8
8532373|NCT01455597|9564869|FG002|NOT COMPLETED|Overall Study||20
8532374|NCT01455597|9564870|FG003|NOT COMPLETED|Overall Study||10
8532375|NCT01400776|9564886|FG000|STARTED|Overall Study||238
8532376|NCT01400776|9564887|FG001|STARTED|Overall Study||124
8532377|NCT01400776|9564888|FG002|STARTED|Overall Study||237
8620779|NCT00475735|9659629|FG001|STARTED|Treatment Washout|Includes 1 patient that discontinued Treatment Period 1 but continued the Study.|12
8620780|NCT00475735|9659630|FG002|STARTED|Treatment Washout||7
8620781|NCT00475735|9659631|FG003|STARTED|Treatment Washout|Includes 1 patient that discontinued Treatment Period 1 but continued the Study.|6
8620782|NCT00475735|9659632|FG004|STARTED|Treatment Washout|Includes 2 patients that discontinued Treatment Period 1 but continued the Study.|16
8620783|NCT00475735|9659633|FG005|STARTED|Treatment Washout|Includes 2 patients that discontinued Treatment Period 1 but continued the Study.|14
8620784|NCT00475735|9659628|FG000|COMPLETED|Treatment Washout||10
8620785|NCT00475735|9659629|FG001|COMPLETED|Treatment Washout||10
8620786|NCT00475735|9659630|FG002|COMPLETED|Treatment Washout||7
8620787|NCT00475735|9659631|FG003|COMPLETED|Treatment Washout||6
8620788|NCT00475735|9659632|FG004|COMPLETED|Treatment Washout||16
8620789|NCT00475735|9659633|FG005|COMPLETED|Treatment Washout||14
8620790|NCT00475735|9659628|FG000|NOT COMPLETED|Treatment Washout||0
8620791|NCT00475735|9659629|FG001|NOT COMPLETED|Treatment Washout||2
8620792|NCT00475735|9659630|FG002|NOT COMPLETED|Treatment Washout||0
8532378|NCT01400776|9564889|FG003|STARTED|Overall Study||123
8532379|NCT01400776|9564886|FG000|COMPLETED|Overall Study||217
8532380|NCT01400776|9564887|FG001|COMPLETED|Overall Study||119
8532381|NCT01400776|9564888|FG002|COMPLETED|Overall Study||209
8532382|NCT01400776|9564889|FG003|COMPLETED|Overall Study||114
8532383|NCT01400776|9564886|FG000|NOT COMPLETED|Overall Study||21
8532384|NCT01400776|9564887|FG001|NOT COMPLETED|Overall Study||5
8532385|NCT01400776|9564888|FG002|NOT COMPLETED|Overall Study||28
8532386|NCT01400776|9564889|FG003|NOT COMPLETED|Overall Study||9
8532387|NCT01194570|9564901|FG000|STARTED|Overall Study||244
8532388|NCT01194570|9564902|FG001|STARTED|Overall Study||488
8532389|NCT01194570|9564901|FG000|COMPLETED|Overall Study|"Reason for discontinuation were provided for Core Treatment Completion."|0
8532390|NCT01194570|9564902|FG001|COMPLETED|Overall Study||0
8532391|NCT01194570|9564901|FG000|NOT COMPLETED|Overall Study||244
8532392|NCT01194570|9564902|FG001|NOT COMPLETED|Overall Study||488
8532393|NCT00511134|9564910|FG000|STARTED|Overall Study||1
8532394|NCT00511134|9564911|FG001|STARTED|Overall Study||3
8532395|NCT00511134|9564910|FG000|COMPLETED|Overall Study||1
8532396|NCT00511134|9564911|FG001|COMPLETED|Overall Study||1
8532397|NCT00511134|9564910|FG000|NOT COMPLETED|Overall Study||0
8532398|NCT00511134|9564911|FG001|NOT COMPLETED|Overall Study||2
8532399|NCT00349466|9564919|FG000|STARTED|Overall Study||42
8532400|NCT00349466|9564920|FG001|STARTED|Overall Study||38
8532401|NCT00349466|9564919|FG000|COMPLETED|Overall Study||33
8532402|NCT00349466|9564920|FG001|COMPLETED|Overall Study||35
8532403|NCT00349466|9564919|FG000|NOT COMPLETED|Overall Study||9
8532404|NCT00349466|9564920|FG001|NOT COMPLETED|Overall Study||3
8532405|NCT00180414|9564930|FG000|STARTED|Overall Study||4
8532406|NCT00180414|9564931|FG001|STARTED|Overall Study||4
8532407|NCT00180414|9564930|FG000|COMPLETED|Overall Study||0
8532408|NCT00180414|9564931|FG001|COMPLETED|Overall Study||0
8532409|NCT00180414|9564930|FG000|NOT COMPLETED|Overall Study||4
8532410|NCT00180414|9564931|FG001|NOT COMPLETED|Overall Study||4
8532411|NCT03894540|9564943|FG000|STARTED|Overall Study||1
8532412|NCT03894540|9564944|FG001|STARTED|Overall Study||1
8532413|NCT03894540|9564945|FG002|STARTED|Overall Study||1
8532414|NCT03894540|9564946|FG003|STARTED|Overall Study||4
8532415|NCT03894540|9564947|FG004|STARTED|Overall Study||11
8532416|NCT03894540|9564948|FG005|STARTED|Overall Study||4
8532417|NCT03894540|9564943|FG000|COMPLETED|Overall Study||0
8532418|NCT03894540|9564944|FG001|COMPLETED|Overall Study||0
8532419|NCT03894540|9564945|FG002|COMPLETED|Overall Study||0
8532420|NCT03894540|9564946|FG003|COMPLETED|Overall Study||0
8532421|NCT03894540|9564947|FG004|COMPLETED|Overall Study||0
8532422|NCT03894540|9564948|FG005|COMPLETED|Overall Study||0
8532423|NCT03894540|9564943|FG000|NOT COMPLETED|Overall Study||1
8532424|NCT03894540|9564944|FG001|NOT COMPLETED|Overall Study||1
8532425|NCT03894540|9564945|FG002|NOT COMPLETED|Overall Study||1
8532426|NCT03894540|9564946|FG003|NOT COMPLETED|Overall Study||4
8532427|NCT03894540|9564947|FG004|NOT COMPLETED|Overall Study||11
8532428|NCT03894540|9564948|FG005|NOT COMPLETED|Overall Study||4
8564435|NCT00057785|9596568|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|68
8564436|NCT00057785|9596568|FG000|NOT COMPLETED|Overall Study||0
8564437|NCT00057811|9596574|FG000|STARTED|Overall Study||51
8564438|NCT00057811|9596575|FG001|STARTED|Overall Study||46
8564439|NCT00057811|9596574|FG000|COMPLETED|Overall Study||41
8564440|NCT00057811|9596575|FG001|COMPLETED|Overall Study||34
8564441|NCT00057811|9596574|FG000|NOT COMPLETED|Overall Study||10
8564442|NCT00057811|9596575|FG001|NOT COMPLETED|Overall Study||12
8564443|NCT00057837|9596583|FG000|STARTED|Overall Study||70
8564444|NCT00057837|9596584|FG001|STARTED|Overall Study||70
8564445|NCT00057837|9596583|FG000|Treated|Overall Study||69
8532429|NCT03816202|9564966|FG000|STARTED|Overall Study||100
8532430|NCT03816202|9564966|FG000|COMPLETED|Overall Study||100
8532431|NCT03816202|9564966|FG000|NOT COMPLETED|Overall Study||0
8532432|NCT03725293|9564972|FG000|STARTED|Overall Study||106
8532433|NCT03725293|9564973|FG001|STARTED|Overall Study||106
8532434|NCT03725293|9564972|FG000|COMPLETED|Overall Study||94
8532435|NCT03725293|9564973|FG001|COMPLETED|Overall Study||97
8532436|NCT03725293|9564972|FG000|NOT COMPLETED|Overall Study||12
8532437|NCT03725293|9564973|FG001|NOT COMPLETED|Overall Study||9
8532438|NCT03702231|9564982|FG000|STARTED|Overall Study||59
8532439|NCT03702231|9564983|FG001|STARTED|Overall Study||29
8532440|NCT03702231|9564984|FG002|STARTED|Overall Study||28
8532441|NCT03702231|9564982|FG000|COMPLETED|Overall Study||55
8532442|NCT03702231|9564983|FG001|COMPLETED|Overall Study||25
8532443|NCT03702231|9564984|FG002|COMPLETED|Overall Study||26
8532444|NCT03702231|9564982|FG000|NOT COMPLETED|Overall Study||4
8532445|NCT03702231|9564983|FG001|NOT COMPLETED|Overall Study||4
8532446|NCT03702231|9564984|FG002|NOT COMPLETED|Overall Study||2
8532447|NCT03690284|9564994|FG000|STARTED|Overall Study||25
8532448|NCT03690284|9564995|FG001|STARTED|Overall Study||25
8532449|NCT03690284|9564994|FG000|COMPLETED|Overall Study||25
8532450|NCT03690284|9564995|FG001|COMPLETED|Overall Study||25
8532451|NCT03690284|9564994|FG000|NOT COMPLETED|Overall Study||0
8532452|NCT03690284|9564995|FG001|NOT COMPLETED|Overall Study||0
8532453|NCT03670277|9565003|FG000|STARTED|Overall Study||20
8532454|NCT03670277|9565004|FG001|STARTED|Overall Study||8
8532455|NCT03670277|9565003|FG000|COMPLETED|Overall Study||20
8532456|NCT03670277|9565004|FG001|COMPLETED|Overall Study||8
8532457|NCT03670277|9565003|FG000|NOT COMPLETED|Overall Study||0
8532458|NCT03670277|9565004|FG001|NOT COMPLETED|Overall Study||0
8532459|NCT03556358|9565015|FG000|STARTED|Overall Study||404
8532460|NCT03556358|9565016|FG001|STARTED|Overall Study||405
8532461|NCT03556358|9565015|FG000|Subjects Treated|Overall Study||401
8532462|NCT03556358|9565016|FG001|Subjects Treated|Overall Study||405
8532463|NCT03556358|9565015|FG000|Subjects Receiving TX05 or Herceptin|Overall Study||394
8532464|NCT03556358|9565016|FG001|Subjects Receiving TX05 or Herceptin|Overall Study||400
8532465|NCT03556358|9565015|FG000|COMPLETED|Overall Study||393
8532466|NCT03556358|9565016|FG001|COMPLETED|Overall Study||393
8532467|NCT03556358|9565015|FG000|NOT COMPLETED|Overall Study||11
8532468|NCT03556358|9565016|FG001|NOT COMPLETED|Overall Study||12
8532469|NCT03290781|9565029|FG000|STARTED|Overall Study||73
8532470|NCT03290781|9565030|FG001|STARTED|Overall Study||71
8532471|NCT03290781|9565031|FG002|STARTED|Overall Study||86
8532472|NCT03290781|9565032|FG003|STARTED|Overall Study||82
8532473|NCT03290781|9565033|FG004|STARTED|Overall Study||11
8532474|NCT03290781|9565034|FG005|STARTED|Overall Study||22
8532475|NCT03290781|9565035|FG006|STARTED|Overall Study||21
8532476|NCT03290781|9565029|FG000|COMPLETED|Overall Study||24
8532477|NCT03290781|9565030|FG001|COMPLETED|Overall Study||53
8532478|NCT03290781|9565031|FG002|COMPLETED|Overall Study||30
8532479|NCT03290781|9565032|FG003|COMPLETED|Overall Study||59
8532480|NCT03290781|9565033|FG004|COMPLETED|Overall Study||6
8532481|NCT03290781|9565034|FG005|COMPLETED|Overall Study||19
8532482|NCT03290781|9565035|FG006|COMPLETED|Overall Study||17
8532483|NCT03290781|9565029|FG000|NOT COMPLETED|Overall Study||49
8532484|NCT03290781|9565030|FG001|NOT COMPLETED|Overall Study||18
8532485|NCT03290781|9565031|FG002|NOT COMPLETED|Overall Study||56
8532486|NCT03290781|9565032|FG003|NOT COMPLETED|Overall Study||23
8532487|NCT03290781|9565033|FG004|NOT COMPLETED|Overall Study||5
8532488|NCT03290781|9565034|FG005|NOT COMPLETED|Overall Study||3
8532489|NCT03290781|9565035|FG006|NOT COMPLETED|Overall Study||4
8532490|NCT03263195|9565062|FG000|STARTED|Overall Study||174
8532491|NCT03263195|9565063|FG001|STARTED|Overall Study||0
8532492|NCT03263195|9565064|FG002|STARTED|Overall Study||0
8532493|NCT03263195|9565065|FG003|STARTED|Overall Study||26
8532494|NCT03263195|9565066|FG004|STARTED|Overall Study||170
8532495|NCT03263195|9565067|FG005|STARTED|Overall Study||0
8532496|NCT03263195|9565068|FG006|STARTED|Overall Study||0
8532497|NCT03263195|9565069|FG007|STARTED|Overall Study||25
8532498|NCT03263195|9565062|FG000|COMPLETED|Overall Study||168
8532499|NCT03263195|9565063|FG001|COMPLETED|Overall Study||0
8532500|NCT03263195|9565064|FG002|COMPLETED|Overall Study||0
8532501|NCT03263195|9565065|FG003|COMPLETED|Overall Study||23
8532502|NCT03263195|9565066|FG004|COMPLETED|Overall Study||155
8532503|NCT03263195|9565067|FG005|COMPLETED|Overall Study||0
8532504|NCT03263195|9565068|FG006|COMPLETED|Overall Study||0
8532505|NCT03263195|9565069|FG007|COMPLETED|Overall Study||19
8532506|NCT03263195|9565062|FG000|NOT COMPLETED|Overall Study||6
8620793|NCT00475735|9659631|FG003|NOT COMPLETED|Treatment Washout||0
8532507|NCT03263195|9565063|FG001|NOT COMPLETED|Overall Study||0
8532508|NCT03263195|9565064|FG002|NOT COMPLETED|Overall Study||0
8532509|NCT03263195|9565065|FG003|NOT COMPLETED|Overall Study||3
8532510|NCT03263195|9565066|FG004|NOT COMPLETED|Overall Study||15
8532511|NCT03263195|9565067|FG005|NOT COMPLETED|Overall Study||0
8532512|NCT03263195|9565068|FG006|NOT COMPLETED|Overall Study||0
8532513|NCT03263195|9565069|FG007|NOT COMPLETED|Overall Study||6
8532514|NCT03228680|9565094|FG000|STARTED|Overall Study||170
8532515|NCT03228680|9565095|FG001|STARTED|Overall Study||178
8532516|NCT03228680|9565094|FG000|COMPLETED|Overall Study||147
8532517|NCT03228680|9565095|FG001|COMPLETED|Overall Study||143
8532518|NCT03228680|9565094|FG000|NOT COMPLETED|Overall Study||23
8532519|NCT03228680|9565095|FG001|NOT COMPLETED|Overall Study||35
8532520|NCT03196167|9565104|FG000|STARTED|Overall Study||45
8620794|NCT00475735|9659632|FG004|NOT COMPLETED|Treatment Washout||0
8620795|NCT00475735|9659633|FG005|NOT COMPLETED|Treatment Washout||0
8620796|NCT00475735|9659628|FG000|STARTED|Treatment Period 2||10
8620797|NCT00475735|9659629|FG001|STARTED|Treatment Period 2||10
8532521|NCT03196167|9565105|FG001|STARTED|Overall Study||45
8532522|NCT03196167|9565104|FG000|COMPLETED|Overall Study||40
8532523|NCT03196167|9565105|FG001|COMPLETED|Overall Study||43
8532524|NCT03196167|9565104|FG000|NOT COMPLETED|Overall Study||5
8532525|NCT03196167|9565105|FG001|NOT COMPLETED|Overall Study||2
8532526|NCT03077204|9565115|FG000|STARTED|Overall Study||20
8532527|NCT03077204|9565115|FG000|COMPLETED|Overall Study||20
8532528|NCT03077204|9565115|FG000|NOT COMPLETED|Overall Study||0
8532529|NCT03029611|9565120|FG000|STARTED|Overall Study|We had 11 patients sign consent with 2 patients deciding not to continue to receive treatment.|9
8532530|NCT03029611|9565120|FG000|COMPLETED|Overall Study|Please note that we did not fully enroll this study due to lack of funding. The complete date here relates to the last treatment administration.|9
8532531|NCT03029611|9565120|FG000|NOT COMPLETED|Overall Study||0
8532532|NCT02891798|9565126|FG000|STARTED|Overall Study||62
8532533|NCT02891798|9565127|FG001|STARTED|Overall Study||16
8532534|NCT02891798|9565126|FG000|COMPLETED|Overall Study||62
8532535|NCT02891798|9565127|FG001|COMPLETED|Overall Study||16
8532536|NCT02891798|9565126|FG000|NOT COMPLETED|Overall Study||0
8532537|NCT02891798|9565127|FG001|NOT COMPLETED|Overall Study||0
8532538|NCT02679781|9565135|FG000|STARTED|Overall Study||37
8532539|NCT02679781|9565136|FG001|STARTED|Overall Study||33
8532540|NCT02679781|9565135|FG000|COMPLETED|Overall Study||30
8532541|NCT02679781|9565136|FG001|COMPLETED|Overall Study||30
8532542|NCT02679781|9565135|FG000|NOT COMPLETED|Overall Study||7
8532543|NCT02679781|9565136|FG001|NOT COMPLETED|Overall Study||3
8532544|NCT02624869|9565145|FG000|STARTED|Overall Study||49
8532545|NCT02624869|9565146|FG001|STARTED|Overall Study||101
8532546|NCT02624869|9565147|FG002|STARTED|Overall Study||13
8532547|NCT02624869|9565145|FG000|Received Study Drug|Overall Study||49
8532548|NCT02624869|9565146|FG001|Received Study Drug|Overall Study||101
8532549|NCT02624869|9565147|FG002|Received Study Drug|Overall Study||12
8532550|NCT02624869|9565145|FG000|COMPLETED|Overall Study||48
8532551|NCT02624869|9565146|FG001|COMPLETED|Overall Study||98
8620798|NCT00475735|9659630|FG002|STARTED|Treatment Period 2||7
8620799|NCT00475735|9659631|FG003|STARTED|Treatment Period 2||6
8620800|NCT00475735|9659632|FG004|STARTED|Treatment Period 2||16
8532552|NCT02624869|9565147|FG002|COMPLETED|Overall Study||11
8532553|NCT02624869|9565145|FG000|NOT COMPLETED|Overall Study||1
8532554|NCT02624869|9565146|FG001|NOT COMPLETED|Overall Study||3
8532555|NCT02624869|9565147|FG002|NOT COMPLETED|Overall Study||2
8532556|NCT02614690|9565159|FG000|STARTED|Overall Study||20
8532557|NCT02614690|9565160|FG001|STARTED|Overall Study||20
8532558|NCT02614690|9565161|FG002|STARTED|Overall Study||20
8532559|NCT02614690|9565159|FG000|COMPLETED|Overall Study||20
8532560|NCT02614690|9565160|FG001|COMPLETED|Overall Study||20
8532561|NCT02614690|9565161|FG002|COMPLETED|Overall Study||20
8532562|NCT02614690|9565159|FG000|NOT COMPLETED|Overall Study||0
8532563|NCT02614690|9565160|FG001|NOT COMPLETED|Overall Study||0
8532564|NCT02614690|9565161|FG002|NOT COMPLETED|Overall Study||0
8532565|NCT02569242|9565171|FG000|STARTED|Overall Study|Included in intention-to-treat analysis for overall survival and progression-free survival|210
8532566|NCT02569242|9565172|FG001|STARTED|Overall Study|Included in intention-to-treat analysis for overall survival and progression-free survival|209
8532567|NCT02569242|9565171|FG000|COMPLETED|Overall Study|Analysed for safety|209
8532568|NCT02569242|9565172|FG001|COMPLETED|Overall Study|Analysed for safety|208
8532569|NCT02569242|9565171|FG000|NOT COMPLETED|Overall Study||1
8532570|NCT02569242|9565172|FG001|NOT COMPLETED|Overall Study||1
8532571|NCT02516969|9565180|FG000|STARTED|Overall Study||3
8532572|NCT02516969|9565181|FG001|STARTED|Overall Study||4
8532573|NCT02516969|9565180|FG000|COMPLETED|Overall Study||3
8532574|NCT02516969|9565181|FG001|COMPLETED|Overall Study||4
8532575|NCT02516969|9565180|FG000|NOT COMPLETED|Overall Study||0
8532576|NCT02516969|9565181|FG001|NOT COMPLETED|Overall Study||0
8532577|NCT02507960|9565189|FG000|STARTED|Overall Study||17
8532578|NCT02507960|9565189|FG000|COMPLETED|Overall Study||17
8532579|NCT02507960|9565189|FG000|NOT COMPLETED|Overall Study||0
8532580|NCT02435433|9565195|FG000|STARTED|Overall Study||197
8532581|NCT02435433|9565196|FG001|STARTED|Overall Study||95
8532582|NCT02435433|9565197|FG002|STARTED|Overall Study||0
8532583|NCT02435433|9565198|FG003|STARTED|Overall Study||0
8532584|NCT02435433|9565199|FG004|STARTED|Overall Study||0
8532585|NCT02435433|9565195|FG000|Participants Who Received Study Drug|Overall Study||197
8532586|NCT02435433|9565196|FG001|Participants Who Received Study Drug|Overall Study||95
8532587|NCT02435433|9565197|FG002|Participants Who Received Study Drug|Overall Study||0
8532588|NCT02435433|9565198|FG003|Participants Who Received Study Drug|Overall Study||0
8532589|NCT02435433|9565199|FG004|Participants Who Received Study Drug|Overall Study||0
8532590|NCT02435433|9565195|FG000|COMPLETED|Overall Study||182
8532591|NCT02435433|9565196|FG001|COMPLETED|Overall Study||90
8532592|NCT02435433|9565197|FG002|COMPLETED|Overall Study||0
8532593|NCT02435433|9565198|FG003|COMPLETED|Overall Study||0
8620801|NCT00475735|9659633|FG005|STARTED|Treatment Period 2||14
8532594|NCT02435433|9565199|FG004|COMPLETED|Overall Study||0
8532595|NCT02435433|9565195|FG000|NOT COMPLETED|Overall Study||15
8532596|NCT02435433|9565196|FG001|NOT COMPLETED|Overall Study||5
8620802|NCT00475735|9659628|FG000|COMPLETED|Treatment Period 2||10
8532597|NCT02435433|9565197|FG002|NOT COMPLETED|Overall Study||0
8532598|NCT02435433|9565198|FG003|NOT COMPLETED|Overall Study||0
8532599|NCT02435433|9565199|FG004|NOT COMPLETED|Overall Study||0
8532600|NCT02426125|9565209|FG000|STARTED|Overall Study||263
8532601|NCT02426125|9565210|FG001|STARTED|Overall Study||267
8532602|NCT02426125|9565209|FG000|Received at Least One Dose of Study Drug|Overall Study||258
8532603|NCT02426125|9565210|FG001|Received at Least One Dose of Study Drug|Overall Study||265
8532604|NCT02426125|9565209|FG000|First Randomized Participants|Overall Study||216
8532605|NCT02426125|9565210|FG001|First Randomized Participants|Overall Study||221
8532606|NCT02426125|9565209|FG000|COMPLETED|Overall Study||234
8532607|NCT02426125|9565210|FG001|COMPLETED|Overall Study||241
8532608|NCT02426125|9565209|FG000|NOT COMPLETED|Overall Study||29
8532609|NCT02426125|9565210|FG001|NOT COMPLETED|Overall Study||26
8532610|NCT02417142|9565220|FG000|STARTED|Overall Study||35
8532611|NCT02417142|9565221|FG001|STARTED|Overall Study||35
8532612|NCT02417142|9565220|FG000|COMPLETED|Overall Study||19
8532613|NCT02417142|9565221|FG001|COMPLETED|Overall Study||22
8532614|NCT02417142|9565220|FG000|NOT COMPLETED|Overall Study||16
8532615|NCT02417142|9565221|FG001|NOT COMPLETED|Overall Study||13
8532616|NCT02368886|9565231|FG000|STARTED|Overall Study||29
8532617|NCT02368886|9565232|FG001|STARTED|Overall Study||27
8532618|NCT02368886|9565233|FG002|STARTED|Overall Study||34
8532619|NCT02368886|9565234|FG003|STARTED|Overall Study||33
8532620|NCT02368886|9565231|FG000|COMPLETED|Overall Study||28
8532621|NCT02368886|9565232|FG001|COMPLETED|Overall Study||26
8532622|NCT02368886|9565233|FG002|COMPLETED|Overall Study||33
8532623|NCT02368886|9565234|FG003|COMPLETED|Overall Study||29
8532624|NCT02368886|9565231|FG000|NOT COMPLETED|Overall Study||1
8532625|NCT02368886|9565232|FG001|NOT COMPLETED|Overall Study||1
8532626|NCT02368886|9565233|FG002|NOT COMPLETED|Overall Study||1
8532627|NCT02368886|9565234|FG003|NOT COMPLETED|Overall Study||4
8532628|NCT02354703|9565246|FG000|STARTED|Overall Study||12
8532629|NCT02354703|9565247|FG001|STARTED|Overall Study||34
8532630|NCT02354703|9565248|FG002|STARTED|Overall Study||39
8532631|NCT02354703|9565249|FG003|STARTED|Overall Study||10
8532632|NCT02354703|9565246|FG000|COMPLETED|Overall Study||9
8532633|NCT02354703|9565247|FG001|COMPLETED|Overall Study||26
8532634|NCT02354703|9565248|FG002|COMPLETED|Overall Study||28
8532635|NCT02354703|9565249|FG003|COMPLETED|Overall Study||7
8532636|NCT02354703|9565246|FG000|NOT COMPLETED|Overall Study||3
8532637|NCT02354703|9565247|FG001|NOT COMPLETED|Overall Study||8
8532638|NCT02354703|9565248|FG002|NOT COMPLETED|Overall Study||11
8532639|NCT02354703|9565249|FG003|NOT COMPLETED|Overall Study||3
8564446|NCT00057837|9596584|FG001|Treated|Overall Study||68
8564447|NCT00057837|9596583|FG000|Eligible and Treated|Overall Study||66
8564448|NCT00057837|9596584|FG001|Eligible and Treated|Overall Study||66
8564449|NCT00057837|9596583|FG000|Patients With Response|Overall Study||46
8564450|NCT00057837|9596584|FG001|Patients With Response|Overall Study||38
8564451|NCT00057837|9596583|FG000|COMPLETED|Overall Study||39
8564452|NCT00057837|9596584|FG001|COMPLETED|Overall Study||31
8564453|NCT00057837|9596583|FG000|NOT COMPLETED|Overall Study||31
8564454|NCT00057837|9596584|FG001|NOT COMPLETED|Overall Study||39
8564455|NCT00057863|9596590|FG000|STARTED|Overall Study||35
8564456|NCT00057863|9596590|FG000|COMPLETED|Overall Study||32
8564457|NCT00057863|9596590|FG000|NOT COMPLETED|Overall Study||3
8564458|NCT00057876|9596596|FG000|STARTED|Overall Study||38
8564459|NCT00057876|9596597|FG001|STARTED|Overall Study||36
8564460|NCT00057876|9596596|FG000|Eligible|Overall Study||37
8564461|NCT00057876|9596597|FG001|Eligible|Overall Study||34
8564462|NCT00057876|9596596|FG000|Began Protocol Therapy|Overall Study||35
8564463|NCT00057876|9596597|FG001|Began Protocol Therapy|Overall Study||34
8564464|NCT00057876|9596596|FG000|Eligible and Treated|Overall Study||34
8564465|NCT00057876|9596597|FG001|Eligible and Treated|Overall Study||34
8564466|NCT00057876|9596596|FG000|COMPLETED|Overall Study||9
8564467|NCT00057876|9596597|FG001|COMPLETED|Overall Study||9
8564468|NCT00057876|9596596|FG000|NOT COMPLETED|Overall Study||29
8564469|NCT00057876|9596597|FG001|NOT COMPLETED|Overall Study||27
8564470|NCT00057941|9596605|FG000|STARTED|Overall Study||74
8564471|NCT00057941|9596606|FG001|STARTED|Overall Study||74
8564472|NCT00057941|9596605|FG000|Treated|Overall Study||74
8564473|NCT00057941|9596606|FG001|Treated|Overall Study||74
8564474|NCT00057941|9596605|FG000|Eligible|Overall Study||72
8564475|NCT00057941|9596606|FG001|Eligible|Overall Study||69
8564476|NCT00057941|9596605|FG000|COMPLETED|Overall Study||0
8564477|NCT00057941|9596606|FG001|COMPLETED|Overall Study||0
8564478|NCT00057941|9596605|FG000|NOT COMPLETED|Overall Study||74
8564479|NCT00057941|9596606|FG001|NOT COMPLETED|Overall Study||74
8564480|NCT00057954|9596612|FG000|STARTED|Overall Study||6
8564481|NCT00057954|9596612|FG000|COMPLETED|Overall Study||4
8564482|NCT00057954|9596612|FG000|NOT COMPLETED|Overall Study||2
8564483|NCT00058019|9596618|FG000|STARTED|Overall Study||39
8564484|NCT00058019|9596619|FG001|STARTED|Overall Study||12
8564485|NCT00058019|9596618|FG000|COMPLETED|Overall Study||39
8564486|NCT00058019|9596619|FG001|COMPLETED|Overall Study||12
8564487|NCT00058019|9596618|FG000|NOT COMPLETED|Overall Study||0
8564488|NCT00058019|9596619|FG001|NOT COMPLETED|Overall Study||0
8564489|NCT00058058|9596624|FG000|STARTED|Overall Study||1007
8564490|NCT00058058|9596624|FG000|COMPLETED|Overall Study||969
8564491|NCT00058058|9596624|FG000|NOT COMPLETED|Overall Study||38
8564492|NCT00058123|9596629|FG000|STARTED|Overall Study||55
8564493|NCT00058123|9596629|FG000|COMPLETED|Overall Study||45
8532640|NCT01981551|9565261|FG000|STARTED|Overall Study||17
8532641|NCT01981551|9565261|FG000|COMPLETED|Overall Study||8
8532642|NCT01981551|9565261|FG000|NOT COMPLETED|Overall Study||9
8532643|NCT00740181|9565265|FG000|STARTED|Overall Study||9
8532644|NCT00740181|9565265|FG000|COMPLETED|Overall Study||9
8532645|NCT00740181|9565265|FG000|NOT COMPLETED|Overall Study||0
8532646|NCT00468130|9565271|FG000|STARTED|Overall Study||7
8532647|NCT00468130|9565272|FG001|STARTED|Overall Study||6
8532648|NCT00468130|9565271|FG000|COMPLETED|Overall Study||5
8532649|NCT00468130|9565272|FG001|COMPLETED|Overall Study||4
8532650|NCT00468130|9565271|FG000|NOT COMPLETED|Overall Study||2
8532651|NCT00468130|9565272|FG001|NOT COMPLETED|Overall Study||2
8532652|NCT00384111|9565280|FG000|STARTED|Overall Study||26
8532653|NCT00384111|9565280|FG000|COMPLETED|Overall Study||0
8532654|NCT00384111|9565280|FG000|NOT COMPLETED|Overall Study||26
8532655|NCT04854642|9565284|FG000|STARTED|Overall Study||18
8532656|NCT04854642|9565285|FG001|STARTED|Overall Study||18
8532657|NCT04854642|9565284|FG000|Safety Set|Overall Study||18
8532658|NCT04854642|9565285|FG001|Safety Set|Overall Study||18
8532659|NCT04854642|9565284|FG000|PK Set 1|Overall Study||18
8532660|NCT04854642|9565285|FG001|PK Set 1|Overall Study||18
8532661|NCT04854642|9565284|FG000|PK Set 2|Overall Study||18
8532662|NCT04854642|9565285|FG001|PK Set 2|Overall Study||18
8532663|NCT04854642|9565284|FG000|COMPLETED|Overall Study||17
8532664|NCT04854642|9565285|FG001|COMPLETED|Overall Study||15
8532665|NCT04854642|9565284|FG000|NOT COMPLETED|Overall Study||1
8532666|NCT04854642|9565285|FG001|NOT COMPLETED|Overall Study||3
8532667|NCT04608344|9565295|FG000|STARTED|Period 1 (AB: 3 Days, BA: 11 Days)||14
8532668|NCT04608344|9565296|FG001|STARTED|Period 1 (AB: 3 Days, BA: 11 Days)||13
8532669|NCT04608344|9565295|FG000|COMPLETED|Period 1 (AB: 3 Days, BA: 11 Days)||13
8532670|NCT04608344|9565296|FG001|COMPLETED|Period 1 (AB: 3 Days, BA: 11 Days)||12
8532671|NCT04608344|9565295|FG000|NOT COMPLETED|Period 1 (AB: 3 Days, BA: 11 Days)||1
8532672|NCT04608344|9565296|FG001|NOT COMPLETED|Period 1 (AB: 3 Days, BA: 11 Days)||1
8532673|NCT04608344|9565295|FG000|STARTED|Period 2 (AB: 11 Days, BA: 3 Days)||13
8532674|NCT04608344|9565296|FG001|STARTED|Period 2 (AB: 11 Days, BA: 3 Days)||12
8532675|NCT04608344|9565295|FG000|COMPLETED|Period 2 (AB: 11 Days, BA: 3 Days)||13
8532676|NCT04608344|9565296|FG001|COMPLETED|Period 2 (AB: 11 Days, BA: 3 Days)||12
8532677|NCT04608344|9565295|FG000|NOT COMPLETED|Period 2 (AB: 11 Days, BA: 3 Days)||0
8532678|NCT04608344|9565296|FG001|NOT COMPLETED|Period 2 (AB: 11 Days, BA: 3 Days)||0
8532679|NCT04583592|9565312|FG000|STARTED|Overall Study||194
8532680|NCT04583592|9565313|FG001|STARTED|Overall Study||101
8532681|NCT04583592|9565312|FG000|COMPLETED|Overall Study||194
8532682|NCT04583592|9565313|FG001|COMPLETED|Overall Study||100
8532683|NCT04583592|9565312|FG000|NOT COMPLETED|Overall Study||0
8532684|NCT04583592|9565313|FG001|NOT COMPLETED|Overall Study||1
8532685|NCT04572399|9565319|FG000|STARTED|Overall Study||5
8532686|NCT04572399|9565319|FG000|COMPLETED|Overall Study||5
8532687|NCT04572399|9565319|FG000|NOT COMPLETED|Overall Study||0
8532688|NCT04388787|9565323|FG000|STARTED|Blinded Period||16
8532689|NCT04388787|9565323|FG000|Completed First Assessment - Approximately 15 Minutes (Specific Treatment Unknown)|Blinded Period||15
8532690|NCT04388787|9565323|FG000|Completed Second Assessment - Approximately 15 Minutes (Specific Treatment Unknown)|Blinded Period||15
8532691|NCT04388787|9565323|FG000|COMPLETED|Blinded Period||15
8532692|NCT04388787|9565323|FG000|NOT COMPLETED|Blinded Period||1
8532693|NCT04388787|9565323|FG000|STARTED|Unblinded Period||15
8532694|NCT04388787|9565323|FG000|COMPLETED|Unblinded Period||6
8532695|NCT04388787|9565323|FG000|NOT COMPLETED|Unblinded Period||9
8532696|NCT04380090|9565333|FG000|STARTED|Overall Study||76
8532697|NCT04380090|9565334|FG001|STARTED|Overall Study||78
8532698|NCT04380090|9565333|FG000|COMPLETED|Overall Study||60
8532699|NCT04380090|9565334|FG001|COMPLETED|Overall Study||58
8532700|NCT04380090|9565333|FG000|NOT COMPLETED|Overall Study||16
8532701|NCT04380090|9565334|FG001|NOT COMPLETED|Overall Study||20
8532702|NCT04377620|9565347|FG000|STARTED|Overall Study||77
8532703|NCT04377620|9565348|FG001|STARTED|Overall Study||87
8532704|NCT04377620|9565349|FG002|STARTED|Overall Study||47
8532705|NCT04377620|9565347|FG000|COMPLETED|Overall Study||35
8532706|NCT04377620|9565348|FG001|COMPLETED|Overall Study||37
8532707|NCT04377620|9565349|FG002|COMPLETED|Overall Study||11
8532708|NCT04377620|9565347|FG000|NOT COMPLETED|Overall Study||42
8532709|NCT04377620|9565348|FG001|NOT COMPLETED|Overall Study||50
8532710|NCT04377620|9565349|FG002|NOT COMPLETED|Overall Study||36
8532711|NCT04355169|9565362|FG000|STARTED|Overall Study||0
8532712|NCT04355169|9565363|FG001|STARTED|Overall Study||0
8532713|NCT04355169|9565364|FG002|STARTED|Overall Study||0
8532714|NCT04355169|9565365|FG003|STARTED|Overall Study||0
8532715|NCT04355169|9565362|FG000|COMPLETED|Overall Study||0
8532716|NCT04355169|9565363|FG001|COMPLETED|Overall Study||0
8532717|NCT04355169|9565364|FG002|COMPLETED|Overall Study||0
8532718|NCT04355169|9565365|FG003|COMPLETED|Overall Study||0
8532719|NCT04355169|9565362|FG000|NOT COMPLETED|Overall Study||0
8532720|NCT04355169|9565363|FG001|NOT COMPLETED|Overall Study||0
8532721|NCT04355169|9565364|FG002|NOT COMPLETED|Overall Study||0
8532722|NCT04355169|9565365|FG003|NOT COMPLETED|Overall Study||0
8532723|NCT04338971|9565375|FG000|STARTED|Overall Study||24
8532724|NCT04338971|9565375|FG000|COMPLETED|Overall Study||17
8532725|NCT04338971|9565375|FG000|NOT COMPLETED|Overall Study||7
8532726|NCT04310566|9565380|FG000|STARTED|Period 1||31
8532727|NCT04310566|9565381|FG001|STARTED|Period 1||34
8532728|NCT04310566|9565380|FG000|COMPLETED|Period 1||15
8532729|NCT04310566|9565381|FG001|COMPLETED|Period 1||14
8532730|NCT04310566|9565380|FG000|NOT COMPLETED|Period 1||16
8532731|NCT04310566|9565381|FG001|NOT COMPLETED|Period 1||20
8532732|NCT04310566|9565380|FG000|STARTED|Period 2||15
8532733|NCT04310566|9565381|FG001|STARTED|Period 2||14
8532734|NCT04310566|9565380|FG000|COMPLETED|Period 2||8
8532735|NCT04310566|9565381|FG001|COMPLETED|Period 2||9
8532736|NCT04310566|9565380|FG000|NOT COMPLETED|Period 2||7
8532737|NCT04310566|9565381|FG001|NOT COMPLETED|Period 2||5
8532738|NCT04206020|9565389|FG000|STARTED|Overall Study||306
8532739|NCT04206020|9565390|FG001|STARTED|Overall Study||304
8532740|NCT04206020|9565389|FG000|COMPLETED|Overall Study||298
8532741|NCT04206020|9565390|FG001|COMPLETED|Overall Study||297
8532742|NCT04206020|9565389|FG000|NOT COMPLETED|Overall Study||8
8532743|NCT04206020|9565390|FG001|NOT COMPLETED|Overall Study||7
8564494|NCT00058123|9596629|FG000|NOT COMPLETED|Overall Study||10
8564495|NCT00058214|9596634|FG000|STARTED|Overall Study||25
8564496|NCT00058214|9596634|FG000|COMPLETED|Overall Study||24
8564497|NCT00058214|9596634|FG000|NOT COMPLETED|Overall Study||1
8564498|NCT00058240|9596642|FG000|STARTED|First Dose Level||20
8564499|NCT00058240|9596643|FG001|STARTED|First Dose Level||3
8564500|NCT00058240|9596644|FG002|STARTED|First Dose Level||17
8564501|NCT00058240|9596645|FG003|STARTED|First Dose Level||12
8564502|NCT00058240|9596642|FG000|Treated|First Dose Level||20
8564503|NCT00058240|9596643|FG001|Treated|First Dose Level||3
8564504|NCT00058240|9596644|FG002|Treated|First Dose Level||17
8564505|NCT00058240|9596645|FG003|Treated|First Dose Level||12
8564506|NCT00058240|9596642|FG000|COMPLETED|First Dose Level||20
8564507|NCT00058240|9596643|FG001|COMPLETED|First Dose Level||3
8564508|NCT00058240|9596644|FG002|COMPLETED|First Dose Level||17
8564509|NCT00058240|9596645|FG003|COMPLETED|First Dose Level||12
8564510|NCT00058240|9596642|FG000|NOT COMPLETED|First Dose Level||0
8564511|NCT00058240|9596643|FG001|NOT COMPLETED|First Dose Level||0
8564512|NCT00058240|9596644|FG002|NOT COMPLETED|First Dose Level||0
8564513|NCT00058240|9596645|FG003|NOT COMPLETED|First Dose Level||0
8564514|NCT00058240|9596642|FG000|STARTED|Second Dose Level||0
8564515|NCT00058240|9596643|FG001|STARTED|Second Dose Level||0
8564516|NCT00058240|9596644|FG002|STARTED|Second Dose Level|2 patients were previously treated at Dose level 1, relapsed, and retreated at Dose level 3.|2
8564517|NCT00058240|9596645|FG003|STARTED|Second Dose Level|4 patients previously relapsed on a different Dose level and were retreated at Dose level 4.|4
8564518|NCT00058240|9596642|FG000|COMPLETED|Second Dose Level||0
8564519|NCT00058240|9596643|FG001|COMPLETED|Second Dose Level||0
8564520|NCT00058240|9596644|FG002|COMPLETED|Second Dose Level||2
8564521|NCT00058240|9596645|FG003|COMPLETED|Second Dose Level||4
8564522|NCT00058240|9596642|FG000|NOT COMPLETED|Second Dose Level||0
8564523|NCT00058240|9596643|FG001|NOT COMPLETED|Second Dose Level||0
8564524|NCT00058240|9596644|FG002|NOT COMPLETED|Second Dose Level||0
8564525|NCT00058240|9596645|FG003|NOT COMPLETED|Second Dose Level||0
8564526|NCT00058370|9596655|FG000|STARTED|Overall Study||6
8564527|NCT00058370|9596655|FG000|COMPLETED|Overall Study||6
8564528|NCT00058370|9596655|FG000|NOT COMPLETED|Overall Study||0
8564529|NCT00058422|9596659|FG000|STARTED|Overall Study||65
8564530|NCT00058422|9596659|FG000|COMPLETED|Overall Study||63
8564531|NCT00058422|9596659|FG000|NOT COMPLETED|Overall Study||2
8564532|NCT00058539|9596663|FG000|STARTED|Overall Study||42
8564533|NCT00058539|9596663|FG000|COMPLETED|Overall Study||0
8564534|NCT00058539|9596663|FG000|NOT COMPLETED|Overall Study||42
8564535|NCT00058552|9596669|FG000|STARTED|Overall Study||65
8564536|NCT00058552|9596670|FG001|STARTED|Overall Study||64
8564537|NCT00058552|9596669|FG000|COMPLETED|Overall Study||0
8564538|NCT00058552|9596670|FG001|COMPLETED|Overall Study||2
8564539|NCT00058552|9596669|FG000|NOT COMPLETED|Overall Study||65
8564540|NCT00058552|9596670|FG001|NOT COMPLETED|Overall Study||62
8564541|NCT00058825|9596678|FG000|STARTED|Overall Study||27
8564542|NCT00058825|9596678|FG000|COMPLETED|Overall Study||5
8564543|NCT00058825|9596678|FG000|NOT COMPLETED|Overall Study||22
8564544|NCT00059202|9596686|FG000|STARTED|Overall Study||76
8564545|NCT00059202|9596687|FG001|STARTED|Overall Study||74
8564546|NCT00059202|9596686|FG000|COMPLETED|Overall Study||70
8564547|NCT00059202|9596687|FG001|COMPLETED|Overall Study||59
8564548|NCT00059202|9596686|FG000|NOT COMPLETED|Overall Study||6
8564549|NCT00059202|9596687|FG001|NOT COMPLETED|Overall Study||15
8564550|NCT00059215|9596700|FG000|STARTED|Overall Study||200
8564551|NCT00059215|9596701|FG001|STARTED|Overall Study||200
8564552|NCT00059215|9596702|FG002|STARTED|Overall Study||251
8564553|NCT00059215|9596703|FG003|STARTED|Overall Study||254
8564554|NCT00059215|9596700|FG000|COMPLETED|Overall Study|One subject discontinued before receiving treatment and is not included in the evaluable set.|187
8564555|NCT00059215|9596701|FG001|COMPLETED|Overall Study||186
8564556|NCT00059215|9596702|FG002|COMPLETED|Overall Study||236
8564557|NCT00059215|9596703|FG003|COMPLETED|Overall Study||239
8564558|NCT00059215|9596700|FG000|NOT COMPLETED|Overall Study||13
8564559|NCT00059215|9596701|FG001|NOT COMPLETED|Overall Study||14
8564560|NCT00059215|9596702|FG002|NOT COMPLETED|Overall Study||15
8564561|NCT00059215|9596703|FG003|NOT COMPLETED|Overall Study||15
8564562|NCT00059228|9596716|FG000|STARTED|Overall Study||6
8564563|NCT00059228|9596717|FG001|STARTED|Overall Study||6
8564564|NCT00059228|9596716|FG000|COMPLETED|Overall Study||6
8564565|NCT00059228|9596717|FG001|COMPLETED|Overall Study||5
8564566|NCT00059228|9596716|FG000|NOT COMPLETED|Overall Study||0
8564567|NCT00059228|9596717|FG001|NOT COMPLETED|Overall Study||1
8564568|NCT00059332|9596725|FG000|STARTED|Overall Study||843
8532744|NCT04097301|9565396|FG000|STARTED|Overall Study|Enrolled patients. Overall, 8 patients were enrolled in the study and underwent the screening phase to evaluate the compliance to the clinical inclusion / exclusion criteria as well as the CD44v6 expression by tumor cells.|8
8532745|NCT04097301|9565396|FG000|Treated Patients|Overall Study|Of the 8 enrolled patients, 2 were treated with MLM-CAR44.1 T-cell at the first dose level.|2
8532746|NCT04097301|9565396|FG000|COMPLETED|Overall Study||1
8532747|NCT04097301|9565396|FG000|NOT COMPLETED|Overall Study||7
8532748|NCT04054375|9565402|FG000|STARTED|Overall Study||20
8532749|NCT04054375|9565402|FG000|COMPLETED|Overall Study|Due to COVID-19, some participants were not able to come to our site to complete all outcome measurements. Our study team worked with individuals to make them feel safe and collect as much data as we possibly could. This is the reason why some outcome metrics have less than 20 data points. All 20 patients completed the study and took the medication for all 24 weeks.|20
8532750|NCT04054375|9565402|FG000|NOT COMPLETED|Overall Study||0
8532751|NCT03953079|9565409|FG000|STARTED|Core Study||21
8532752|NCT03953079|9565410|FG001|STARTED|Core Study||22
8532753|NCT03953079|9565411|FG002|STARTED|Core Study||13
8532754|NCT03953079|9565409|FG000|COMPLETED|Core Study||20
8532755|NCT03953079|9565410|FG001|COMPLETED|Core Study||18
8532756|NCT03953079|9565411|FG002|COMPLETED|Core Study||12
8532757|NCT03953079|9565409|FG000|NOT COMPLETED|Core Study||1
8532758|NCT03953079|9565410|FG001|NOT COMPLETED|Core Study||4
8532759|NCT03953079|9565411|FG002|NOT COMPLETED|Core Study||1
8532760|NCT03953079|9565409|FG000|STARTED|Extension Study||12
8532761|NCT03953079|9565410|FG001|STARTED|Extension Study||10
8532762|NCT03953079|9565411|FG002|STARTED|Extension Study||6
8532763|NCT03953079|9565409|FG000|COMPLETED|Extension Study||6
8532764|NCT03953079|9565410|FG001|COMPLETED|Extension Study||4
8532765|NCT03953079|9565411|FG002|COMPLETED|Extension Study||1
8532766|NCT03953079|9565409|FG000|NOT COMPLETED|Extension Study||6
8532767|NCT03953079|9565410|FG001|NOT COMPLETED|Extension Study||6
8532768|NCT03953079|9565411|FG002|NOT COMPLETED|Extension Study||5
8532769|NCT03922750|9565423|FG000|STARTED|Overall Study||50
8532770|NCT03922750|9565424|FG001|STARTED|Overall Study||54
8532771|NCT03922750|9565425|FG002|STARTED|Overall Study||50
8532772|NCT03922750|9565423|FG000|Full Analysis Set (FAS)|Overall Study||50
8532773|NCT03922750|9565424|FG001|Full Analysis Set (FAS)|Overall Study||54
8532774|NCT03922750|9565425|FG002|Full Analysis Set (FAS)|Overall Study||50
8532775|NCT03922750|9565423|FG000|Safety Analysis Set (SAS)|Overall Study||50
8532776|NCT03922750|9565424|FG001|Safety Analysis Set (SAS)|Overall Study||54
8532777|NCT03922750|9565425|FG002|Safety Analysis Set (SAS)|Overall Study||50
8532778|NCT03922750|9565423|FG000|COMPLETED|Overall Study||50
8532779|NCT03922750|9565424|FG001|COMPLETED|Overall Study||53
8532780|NCT03922750|9565425|FG002|COMPLETED|Overall Study||49
8532781|NCT03922750|9565423|FG000|NOT COMPLETED|Overall Study||0
8532782|NCT03922750|9565424|FG001|NOT COMPLETED|Overall Study||1
8532783|NCT03922750|9565425|FG002|NOT COMPLETED|Overall Study||1
8532784|NCT03910673|9565438|FG000|STARTED|Overall Study||7
8532785|NCT03910673|9565439|FG001|STARTED|Overall Study||6
8532786|NCT03910673|9565440|FG002|STARTED|Overall Study||7
8532787|NCT03910673|9565441|FG003|STARTED|Overall Study||13
8532788|NCT03910673|9565442|FG004|STARTED|Overall Study||6
8532789|NCT03910673|9565438|FG000|Enrolled and Randomized|Overall Study||6
8532790|NCT03910673|9565439|FG001|Enrolled and Randomized|Overall Study||6
8532791|NCT03910673|9565440|FG002|Enrolled and Randomized|Overall Study||6
8532792|NCT03910673|9565441|FG003|Enrolled and Randomized|Overall Study||6
8532793|NCT03910673|9565442|FG004|Enrolled and Randomized|Overall Study||6
8532794|NCT03910673|9565438|FG000|Enrolled as Replacement|Overall Study||1
8532795|NCT03910673|9565439|FG001|Enrolled as Replacement|Overall Study||0
8532796|NCT03910673|9565440|FG002|Enrolled as Replacement|Overall Study||1
8532797|NCT03910673|9565441|FG003|Enrolled as Replacement|Overall Study||7
8532798|NCT03910673|9565442|FG004|Enrolled as Replacement|Overall Study||0
8532799|NCT03910673|9565438|FG000|Began Infusion of Dose 1|Overall Study||7
8532800|NCT03910673|9565439|FG001|Began Infusion of Dose 1|Overall Study||6
8532801|NCT03910673|9565440|FG002|Began Infusion of Dose 1|Overall Study||7
8532802|NCT03910673|9565441|FG003|Began Infusion of Dose 1|Overall Study||13
8532803|NCT03910673|9565442|FG004|Began Infusion of Dose 1|Overall Study||6
8532804|NCT03910673|9565438|FG000|Completed Dose 1|Overall Study||7
8532805|NCT03910673|9565439|FG001|Completed Dose 1|Overall Study||6
8532806|NCT03910673|9565440|FG002|Completed Dose 1|Overall Study||7
8532807|NCT03910673|9565441|FG003|Completed Dose 1|Overall Study||13
8532808|NCT03910673|9565442|FG004|Completed Dose 1|Overall Study||6
8532809|NCT03910673|9565438|FG000|Completed Dose 2|Overall Study||7
8532810|NCT03910673|9565439|FG001|Completed Dose 2|Overall Study||6
8532811|NCT03910673|9565440|FG002|Completed Dose 2|Overall Study||7
8532812|NCT03910673|9565441|FG003|Completed Dose 2|Overall Study||13
8532813|NCT03910673|9565442|FG004|Completed Dose 2|Overall Study||6
8532814|NCT03910673|9565438|FG000|Completed Dose 3|Overall Study||6
8532815|NCT03910673|9565439|FG001|Completed Dose 3|Overall Study||6
8532816|NCT03910673|9565440|FG002|Completed Dose 3|Overall Study||7
8532817|NCT03910673|9565441|FG003|Completed Dose 3|Overall Study||12
8532818|NCT03910673|9565442|FG004|Completed Dose 3|Overall Study||6
8532819|NCT03910673|9565438|FG000|Completed All Scheduled Treatment|Overall Study||6
8532820|NCT03910673|9565439|FG001|Completed All Scheduled Treatment|Overall Study||6
8532821|NCT03910673|9565440|FG002|Completed All Scheduled Treatment|Overall Study||7
8532822|NCT03910673|9565441|FG003|Completed All Scheduled Treatment|Overall Study||12
8532823|NCT03910673|9565442|FG004|Completed All Scheduled Treatment|Overall Study||6
8532824|NCT03910673|9565438|FG000|Completed All PK Blood Draws|Overall Study||6
8532825|NCT03910673|9565439|FG001|Completed All PK Blood Draws|Overall Study||6
8532826|NCT03910673|9565440|FG002|Completed All PK Blood Draws|Overall Study||6
8532827|NCT03910673|9565441|FG003|Completed All PK Blood Draws|Overall Study||6
8532828|NCT03910673|9565442|FG004|Completed All PK Blood Draws|Overall Study||6
8532829|NCT03910673|9565438|FG000|Completed Bronchoscopy With BAL|Overall Study||6
8532830|NCT03910673|9565439|FG001|Completed Bronchoscopy With BAL|Overall Study||6
8532831|NCT03910673|9565440|FG002|Completed Bronchoscopy With BAL|Overall Study||6
8532832|NCT03910673|9565441|FG003|Completed Bronchoscopy With BAL|Overall Study||6
8532833|NCT03910673|9565442|FG004|Completed Bronchoscopy With BAL|Overall Study||6
8532834|NCT03910673|9565438|FG000|Completed All Plasma Urea Samples|Overall Study||6
8532835|NCT03910673|9565439|FG001|Completed All Plasma Urea Samples|Overall Study||6
8532836|NCT03910673|9565440|FG002|Completed All Plasma Urea Samples|Overall Study||6
8532837|NCT03910673|9565441|FG003|Completed All Plasma Urea Samples|Overall Study||6
8532838|NCT03910673|9565442|FG004|Completed All Plasma Urea Samples|Overall Study||6
8532839|NCT03910673|9565438|FG000|At Least One PK Blood Draw Concurrent With BAL Timepoint|Overall Study||6
8532840|NCT03910673|9565439|FG001|At Least One PK Blood Draw Concurrent With BAL Timepoint|Overall Study||6
8532841|NCT03910673|9565440|FG002|At Least One PK Blood Draw Concurrent With BAL Timepoint|Overall Study||6
8532842|NCT03910673|9565441|FG003|At Least One PK Blood Draw Concurrent With BAL Timepoint|Overall Study||6
8532843|NCT03910673|9565442|FG004|At Least One PK Blood Draw Concurrent With BAL Timepoint|Overall Study||6
8532844|NCT03910673|9565438|FG000|COMPLETED|Overall Study||7
8532845|NCT03910673|9565439|FG001|COMPLETED|Overall Study||6
8532846|NCT03910673|9565440|FG002|COMPLETED|Overall Study||7
8532847|NCT03910673|9565441|FG003|COMPLETED|Overall Study||11
8532848|NCT03910673|9565442|FG004|COMPLETED|Overall Study||6
8620803|NCT00475735|9659629|FG001|COMPLETED|Treatment Period 2||9
8620804|NCT00475735|9659630|FG002|COMPLETED|Treatment Period 2||7
8620805|NCT00475735|9659631|FG003|COMPLETED|Treatment Period 2||4
8620806|NCT00475735|9659632|FG004|COMPLETED|Treatment Period 2||15
8620807|NCT00475735|9659633|FG005|COMPLETED|Treatment Period 2||13
8620808|NCT00475735|9659628|FG000|NOT COMPLETED|Treatment Period 2||0
8532849|NCT03910673|9565438|FG000|NOT COMPLETED|Overall Study||0
8532850|NCT03910673|9565439|FG001|NOT COMPLETED|Overall Study||0
8532851|NCT03910673|9565440|FG002|NOT COMPLETED|Overall Study||0
8532852|NCT03910673|9565441|FG003|NOT COMPLETED|Overall Study||2
8532853|NCT03910673|9565442|FG004|NOT COMPLETED|Overall Study||0
8532854|NCT03885999|9565446|FG000|STARTED|Overall Study||12
8532855|NCT03885999|9565446|FG000|COMPLETED|Overall Study||11
8532856|NCT03885999|9565446|FG000|NOT COMPLETED|Overall Study||1
8532857|NCT03882970|9565454|FG000|STARTED|Overall Study||359
8532858|NCT03882970|9565455|FG001|STARTED|Overall Study||361
8532859|NCT03882970|9565456|FG002|STARTED|Overall Study||359
8620809|NCT00475735|9659629|FG001|NOT COMPLETED|Treatment Period 2||1
8620810|NCT00475735|9659630|FG002|NOT COMPLETED|Treatment Period 2||0
8620811|NCT00475735|9659631|FG003|NOT COMPLETED|Treatment Period 2||2
8620812|NCT00475735|9659632|FG004|NOT COMPLETED|Treatment Period 2||1
8620813|NCT00475735|9659633|FG005|NOT COMPLETED|Treatment Period 2||1
8620814|NCT00475787|9659643|FG000|STARTED|Overall Study||69
8620815|NCT00475787|9659644|FG001|STARTED|Overall Study||67
8620816|NCT00475787|9659643|FG000|COMPLETED|Overall Study||61
8620817|NCT00475787|9659644|FG001|COMPLETED|Overall Study||60
8532860|NCT03882970|9565457|FG003|STARTED|Overall Study||365
8532861|NCT03882970|9565454|FG000|Received at Least One Dose of Study Drug|Overall Study||358
8532862|NCT03882970|9565455|FG001|Received at Least One Dose of Study Drug|Overall Study||360
8532863|NCT03882970|9565456|FG002|Received at Least One Dose of Study Drug|Overall Study||359
8532864|NCT03882970|9565457|FG003|Received at Least One Dose of Study Drug|Overall Study||360
8532865|NCT03882970|9565454|FG000|COMPLETED|Overall Study||333
8532866|NCT03882970|9565455|FG001|COMPLETED|Overall Study||321
8532867|NCT03882970|9565456|FG002|COMPLETED|Overall Study||340
8532868|NCT03882970|9565457|FG003|COMPLETED|Overall Study||331
8532869|NCT03882970|9565454|FG000|NOT COMPLETED|Overall Study||26
8532870|NCT03882970|9565455|FG001|NOT COMPLETED|Overall Study||40
8532871|NCT03882970|9565456|FG002|NOT COMPLETED|Overall Study||19
8532872|NCT03882970|9565457|FG003|NOT COMPLETED|Overall Study||34
8532873|NCT03879525|9565473|FG000|STARTED|Overall Study||15
8532874|NCT03879525|9565474|FG001|STARTED|Overall Study||15
8532875|NCT03879525|9565473|FG000|COMPLETED|Overall Study||15
8532876|NCT03879525|9565474|FG001|COMPLETED|Overall Study||15
8532877|NCT03879525|9565473|FG000|NOT COMPLETED|Overall Study||0
8532878|NCT03879525|9565474|FG001|NOT COMPLETED|Overall Study||0
8620818|NCT00475787|9659643|FG000|NOT COMPLETED|Overall Study||8
8620819|NCT00475787|9659644|FG001|NOT COMPLETED|Overall Study||7
8620820|NCT00475852|9659654|FG000|STARTED|Overall Study||3564
8620821|NCT00475852|9659655|FG001|STARTED|Overall Study||3577
8620822|NCT00475852|9659654|FG000|COMPLETED|Overall Study||3047
8620823|NCT00475852|9659655|FG001|COMPLETED|Overall Study||3029
8620824|NCT00475852|9659654|FG000|NOT COMPLETED|Overall Study||517
8620825|NCT00475852|9659655|FG001|NOT COMPLETED|Overall Study||548
8620826|NCT00475865|9659664|FG000|STARTED|Overall Study|randomized|41
8620827|NCT00475865|9659665|FG001|STARTED|Overall Study|randomized|42
8620828|NCT00475865|9659666|FG002|STARTED|Overall Study|randomized|40
8532879|NCT03867734|9565481|FG000|STARTED|Overall Study||32
8532880|NCT03867734|9565481|FG000|COMPLETED|Overall Study||30
8532881|NCT03867734|9565481|FG000|NOT COMPLETED|Overall Study||2
8532882|NCT03781778|9565491|FG000|STARTED|Overall Study||4
8532883|NCT03781778|9565492|FG001|STARTED|Overall Study||6
8532884|NCT03781778|9565491|FG000|Started Intervention|Overall Study||3
8532885|NCT03781778|9565492|FG001|Started Intervention|Overall Study||4
8532886|NCT03781778|9565491|FG000|COMPLETED|Overall Study||2
8532887|NCT03781778|9565492|FG001|COMPLETED|Overall Study||4
8532888|NCT03781778|9565491|FG000|NOT COMPLETED|Overall Study||2
8532889|NCT03781778|9565492|FG001|NOT COMPLETED|Overall Study||2
8532890|NCT03764735|9565501|FG000|STARTED|Overall Study||151
8532891|NCT03764735|9565502|FG001|STARTED|Overall Study||150
8532892|NCT03764735|9565503|FG002|STARTED|Overall Study||151
8532893|NCT03764735|9565501|FG000|COMPLETED|Overall Study||147
8532894|NCT03764735|9565502|FG001|COMPLETED|Overall Study||144
8532895|NCT03764735|9565503|FG002|COMPLETED|Overall Study||147
8532896|NCT03764735|9565501|FG000|NOT COMPLETED|Overall Study||4
8532897|NCT03764735|9565502|FG001|NOT COMPLETED|Overall Study||6
8532898|NCT03764735|9565503|FG002|NOT COMPLETED|Overall Study||4
8564569|NCT00059332|9596726|FG001|STARTED|Overall Study||857
8564570|NCT00059332|9596725|FG000|COMPLETED|Overall Study||840
8564571|NCT00059332|9596726|FG001|COMPLETED|Overall Study||855
8564572|NCT00059332|9596725|FG000|NOT COMPLETED|Overall Study||3
8564573|NCT00059332|9596726|FG001|NOT COMPLETED|Overall Study||2
8569200|NCT00095576|9601413|FG000|STARTED|Overall Study||1484
8569201|NCT00095576|9601414|FG001|STARTED|Overall Study||1495
8569202|NCT00095576|9601413|FG000|VACCINATED AT VISIT 2 (Dose 1)|Overall Study||1484
8569203|NCT00095576|9601414|FG001|VACCINATED AT VISIT 2 (Dose 1)|Overall Study||1495
8569204|NCT00095576|9601413|FG000|VACCINATED AT VISIT 4 (Dose 2)|Overall Study||1426
8569205|NCT00095576|9601414|FG001|VACCINATED AT VISIT 4 (Dose 2)|Overall Study||1443
8569206|NCT00095576|9601413|FG000|VACCINATED AT VISIT 7 (Dose 3)|Overall Study||1328
8569207|NCT00095576|9601414|FG001|VACCINATED AT VISIT 7 (Dose 3)|Overall Study||1361
8569208|NCT00095576|9601413|FG000|COMPLETED|Overall Study|Subjects not completing entire study were eligible for observational long term follow up in V520-030|9
8569209|NCT00095576|9601414|FG001|COMPLETED|Overall Study|Subjects not completing entire study were eligible for observational long term follow up in V520-030|14
8569210|NCT00095576|9601413|FG000|NOT COMPLETED|Overall Study||1475
8569211|NCT00095576|9601414|FG001|NOT COMPLETED|Overall Study||1481
8569212|NCT00095628|9601420|FG000|STARTED|Overall Study||21
8569213|NCT00095628|9601420|FG000|COMPLETED|Overall Study||20
8569214|NCT00095628|9601420|FG000|NOT COMPLETED|Overall Study||1
8569215|NCT00095836|9601424|FG000|STARTED|Overall Study||27
8569216|NCT00095836|9601424|FG000|COMPLETED|Overall Study||23
8569217|NCT00095836|9601424|FG000|NOT COMPLETED|Overall Study||4
8569218|NCT00095875|9601430|FG000|STARTED|Overall Study||70
8569219|NCT00095875|9601431|FG001|STARTED|Overall Study||75
8569220|NCT00095875|9601430|FG000|COMPLETED|Overall Study||56
8569221|NCT00095875|9601431|FG001|COMPLETED|Overall Study||66
8569222|NCT00095875|9601430|FG000|NOT COMPLETED|Overall Study||14
8569223|NCT00095875|9601431|FG001|NOT COMPLETED|Overall Study||9
8569224|NCT00095940|9601444|FG000|STARTED|Molecular Biology Phase||2
8569225|NCT00095940|9601445|FG001|STARTED|Molecular Biology Phase||2
8569226|NCT00095940|9601446|FG002|STARTED|Molecular Biology Phase|No surgery prior to study enrollment; not eligible for the molecular biology phase|0
8569227|NCT00095940|9601447|FG003|STARTED|Molecular Biology Phase||0
8569228|NCT00095940|9601448|FG004|STARTED|Molecular Biology Phase||0
8569229|NCT00095940|9601449|FG005|STARTED|Molecular Biology Phase|No surgery prior to study enrollment; not eligible for the molecular biology phase|0
8569230|NCT00095940|9601450|FG006|STARTED|Molecular Biology Phase||2
8569231|NCT00095940|9601451|FG007|STARTED|Molecular Biology Phase||2
8569232|NCT00095940|9601452|FG008|STARTED|Molecular Biology Phase|No surgery prior to study enrollment; not eligible for the molecular biology phase|0
8569233|NCT00095940|9601444|FG000|COMPLETED|Molecular Biology Phase||2
8569234|NCT00095940|9601445|FG001|COMPLETED|Molecular Biology Phase||2
8569235|NCT00095940|9601446|FG002|COMPLETED|Molecular Biology Phase||0
8569236|NCT00095940|9601447|FG003|COMPLETED|Molecular Biology Phase||0
8569237|NCT00095940|9601448|FG004|COMPLETED|Molecular Biology Phase||0
8569238|NCT00095940|9601449|FG005|COMPLETED|Molecular Biology Phase||0
8569239|NCT00095940|9601450|FG006|COMPLETED|Molecular Biology Phase||2
8569240|NCT00095940|9601451|FG007|COMPLETED|Molecular Biology Phase||2
8569241|NCT00095940|9601452|FG008|COMPLETED|Molecular Biology Phase||0
8569242|NCT00095940|9601444|FG000|NOT COMPLETED|Molecular Biology Phase||0
8569243|NCT00095940|9601445|FG001|NOT COMPLETED|Molecular Biology Phase||0
8569244|NCT00095940|9601446|FG002|NOT COMPLETED|Molecular Biology Phase||0
8569245|NCT00095940|9601447|FG003|NOT COMPLETED|Molecular Biology Phase||0
8569246|NCT00095940|9601448|FG004|NOT COMPLETED|Molecular Biology Phase||0
8569247|NCT00095940|9601449|FG005|NOT COMPLETED|Molecular Biology Phase||0
8569248|NCT00095940|9601450|FG006|NOT COMPLETED|Molecular Biology Phase||0
8569249|NCT00095940|9601451|FG007|NOT COMPLETED|Molecular Biology Phase||0
8569250|NCT00095940|9601452|FG008|NOT COMPLETED|Molecular Biology Phase||0
8569251|NCT00095940|9601444|FG000|STARTED|Lapatinib Continuation/Phase II|Continued to receive lapatinib but were ineligible for the phase II.|2
8569252|NCT00095940|9601445|FG001|STARTED|Lapatinib Continuation/Phase II|No measurable disease post surgery - ineligible for the phase II. Continued to receive lapatinib.|2
8569253|NCT00095940|9601446|FG002|STARTED|Lapatinib Continuation/Phase II||17
8569254|NCT00095940|9601447|FG003|STARTED|Lapatinib Continuation/Phase II||0
8569255|NCT00095940|9601448|FG004|STARTED|Lapatinib Continuation/Phase II||0
8569256|NCT00095940|9601449|FG005|STARTED|Lapatinib Continuation/Phase II||13
8569452|NCT00097539|9601697|FG004|STARTED|Overall Study||2144
8532899|NCT03730480|9565511|FG000|STARTED|Overall Study||372
8532900|NCT03730480|9565511|FG000|COMPLETED|Overall Study||371
8532901|NCT03730480|9565511|FG000|NOT COMPLETED|Overall Study||1
8532902|NCT03713073|9565516|FG000|STARTED|Overall Study||19
8532903|NCT03713073|9565516|FG000|Allogenic Amnion Chorion Membrane|Overall Study||19
8532904|NCT03713073|9565516|FG000|Collagen Dressing|Overall Study||19
8532905|NCT03713073|9565516|FG000|COMPLETED|Overall Study||19
8532906|NCT03713073|9565516|FG000|NOT COMPLETED|Overall Study||0
8532907|NCT03713034|9565524|FG000|STARTED|Overall Study||150
8532908|NCT03713034|9565525|FG001|STARTED|Overall Study||146
8532909|NCT03713034|9565524|FG000|COMPLETED|Overall Study||145
8532910|NCT03713034|9565525|FG001|COMPLETED|Overall Study||142
8532911|NCT03713034|9565524|FG000|NOT COMPLETED|Overall Study||5
8532912|NCT03713034|9565525|FG001|NOT COMPLETED|Overall Study||4
8532913|NCT03654404|9565533|FG000|STARTED|Overall Study||20
8532914|NCT03654404|9565533|FG000|COMPLETED|Overall Study||12
8532915|NCT03654404|9565533|FG000|NOT COMPLETED|Overall Study||8
8532916|NCT03567057|9565540|FG000|STARTED|Overall Study||159
8532917|NCT03567057|9565541|FG001|STARTED|Overall Study||151
8532918|NCT03567057|9565542|FG002|STARTED|Overall Study||114
8532919|NCT03567057|9565540|FG000|COMPLETED|Overall Study||64
8532920|NCT03567057|9565541|FG001|COMPLETED|Overall Study||64
8532921|NCT03567057|9565542|FG002|COMPLETED|Overall Study||68
8532922|NCT03567057|9565540|FG000|NOT COMPLETED|Overall Study||95
8532923|NCT03567057|9565541|FG001|NOT COMPLETED|Overall Study||87
8532924|NCT03567057|9565542|FG002|NOT COMPLETED|Overall Study||46
8532925|NCT03548987|9565552|FG000|STARTED|Run-in Period (Week 0 to Week 20)||902
8532926|NCT03548987|9565553|FG001|STARTED|Run-in Period (Week 0 to Week 20)||0
8532927|NCT03548987|9565552|FG000|Safety Analysis Set (SAS)|Run-in Period (Week 0 to Week 20)||902
8532928|NCT03548987|9565553|FG001|Safety Analysis Set (SAS)|Run-in Period (Week 0 to Week 20)||0
8532929|NCT03548987|9565552|FG000|COMPLETED|Run-in Period (Week 0 to Week 20)||803
8532930|NCT03548987|9565553|FG001|COMPLETED|Run-in Period (Week 0 to Week 20)||0
8532931|NCT03548987|9565552|FG000|NOT COMPLETED|Run-in Period (Week 0 to Week 20)||99
8532932|NCT03548987|9565553|FG001|NOT COMPLETED|Run-in Period (Week 0 to Week 20)||0
8532933|NCT03548987|9565552|FG000|STARTED|Maintenance Period (Week 20 to Week 68)||535
8532934|NCT03548987|9565553|FG001|STARTED|Maintenance Period (Week 20 to Week 68)||268
8532935|NCT03548987|9565552|FG000|Full Analysis Set (FAS)|Maintenance Period (Week 20 to Week 68)||535
8532936|NCT03548987|9565553|FG001|Full Analysis Set (FAS)|Maintenance Period (Week 20 to Week 68)||268
8532937|NCT03548987|9565552|FG000|COMPLETED|Maintenance Period (Week 20 to Week 68)||504
8532938|NCT03548987|9565553|FG001|COMPLETED|Maintenance Period (Week 20 to Week 68)||237
8532939|NCT03548987|9565552|FG000|NOT COMPLETED|Maintenance Period (Week 20 to Week 68)||31
8532940|NCT03548987|9565553|FG001|NOT COMPLETED|Maintenance Period (Week 20 to Week 68)||31
8532941|NCT03548064|9565568|FG000|STARTED|Overall Study||12
8532942|NCT03548064|9565569|FG001|STARTED|Overall Study||12
8532943|NCT03548064|9565570|FG002|STARTED|Overall Study||6
8532944|NCT03548064|9565571|FG003|STARTED|Overall Study||12
8532945|NCT03548064|9565572|FG004|STARTED|Overall Study||12
8532946|NCT03548064|9565573|FG005|STARTED|Overall Study||6
8532947|NCT03548064|9565574|FG006|STARTED|Overall Study||12
8532948|NCT03548064|9565575|FG007|STARTED|Overall Study||3
8532949|NCT03548064|9565568|FG000|COMPLETED|Overall Study||12
8532950|NCT03548064|9565569|FG001|COMPLETED|Overall Study||12
8532951|NCT03548064|9565570|FG002|COMPLETED|Overall Study||6
8532952|NCT03548064|9565571|FG003|COMPLETED|Overall Study||11
8532953|NCT03548064|9565572|FG004|COMPLETED|Overall Study||0
8532954|NCT03548064|9565573|FG005|COMPLETED|Overall Study||3
8532955|NCT03548064|9565574|FG006|COMPLETED|Overall Study||12
8532956|NCT03548064|9565575|FG007|COMPLETED|Overall Study||3
8532957|NCT03548064|9565568|FG000|NOT COMPLETED|Overall Study||0
8532958|NCT03548064|9565569|FG001|NOT COMPLETED|Overall Study||0
8532959|NCT03548064|9565570|FG002|NOT COMPLETED|Overall Study||0
8532960|NCT03548064|9565571|FG003|NOT COMPLETED|Overall Study||1
8532961|NCT03548064|9565572|FG004|NOT COMPLETED|Overall Study||12
8620829|NCT00475865|9659664|FG000|Treated|Overall Study|completed treatment period|41
8620830|NCT00475865|9659665|FG001|Treated|Overall Study||42
8620831|NCT00475865|9659666|FG002|Treated|Overall Study||40
8532962|NCT03548064|9565573|FG005|NOT COMPLETED|Overall Study||3
8532963|NCT03548064|9565574|FG006|NOT COMPLETED|Overall Study||0
8532964|NCT03548064|9565575|FG007|NOT COMPLETED|Overall Study||0
8532965|NCT03446456|9565601|FG000|STARTED|Overall Study||20
8532966|NCT03446456|9565602|FG001|STARTED|Overall Study||20
8532967|NCT03446456|9565601|FG000|COMPLETED|Overall Study||16
8532968|NCT03446456|9565602|FG001|COMPLETED|Overall Study||16
8532969|NCT03446456|9565601|FG000|NOT COMPLETED|Overall Study||4
8532970|NCT03446456|9565602|FG001|NOT COMPLETED|Overall Study||4
8532971|NCT03382834|9565610|FG000|STARTED|Overall Study||21
8532972|NCT03382834|9565611|FG001|STARTED|Overall Study||10
8532973|NCT03382834|9565610|FG000|COMPLETED|Overall Study||20
8532974|NCT03382834|9565611|FG001|COMPLETED|Overall Study||9
8532975|NCT03382834|9565610|FG000|NOT COMPLETED|Overall Study||1
8532976|NCT03382834|9565611|FG001|NOT COMPLETED|Overall Study||1
8532977|NCT03371823|9565619|FG000|STARTED|Overall Study||8
8532978|NCT03371823|9565620|FG001|STARTED|Overall Study|We had trouble enrolling naive to therapy women with high blood pressure|0
8532979|NCT03371823|9565619|FG000|COMPLETED|Overall Study||7
8532980|NCT03371823|9565620|FG001|COMPLETED|Overall Study||0
8532981|NCT03371823|9565619|FG000|NOT COMPLETED|Overall Study||1
8620832|NCT00475865|9659664|FG000|COMPLETED|Overall Study||39
8532982|NCT03371823|9565620|FG001|NOT COMPLETED|Overall Study||0
8532983|NCT03353350|9565630|FG000|STARTED|30-week Core Treatment Period||102
8532984|NCT03353350|9565631|FG001|STARTED|30-week Core Treatment Period||100
8532985|NCT03353350|9565632|FG002|STARTED|30-week Core Treatment Period||101
8532986|NCT03353350|9565633|FG003|STARTED|30-week Core Treatment Period||103
8532987|NCT03353350|9565630|FG000|COMPLETED|30-week Core Treatment Period||80
8532988|NCT03353350|9565631|FG001|COMPLETED|30-week Core Treatment Period||81
8532989|NCT03353350|9565632|FG002|COMPLETED|30-week Core Treatment Period||77
8532990|NCT03353350|9565633|FG003|COMPLETED|30-week Core Treatment Period||81
8532991|NCT03353350|9565630|FG000|NOT COMPLETED|30-week Core Treatment Period||22
8532992|NCT03353350|9565631|FG001|NOT COMPLETED|30-week Core Treatment Period||19
8532993|NCT03353350|9565632|FG002|NOT COMPLETED|30-week Core Treatment Period||24
8532994|NCT03353350|9565633|FG003|NOT COMPLETED|30-week Core Treatment Period||22
8532995|NCT03353350|9565630|FG000|STARTED|26-week Treatment Extension Period||80
8532996|NCT03353350|9565631|FG001|STARTED|26-week Treatment Extension Period||81
8532997|NCT03353350|9565632|FG002|STARTED|26-week Treatment Extension Period||77
8532998|NCT03353350|9565633|FG003|STARTED|26-week Treatment Extension Period||81
8532999|NCT03353350|9565630|FG000|COMPLETED|26-week Treatment Extension Period||75
8533000|NCT03353350|9565631|FG001|COMPLETED|26-week Treatment Extension Period||78
8533001|NCT03353350|9565632|FG002|COMPLETED|26-week Treatment Extension Period||73
8533002|NCT03353350|9565633|FG003|COMPLETED|26-week Treatment Extension Period||67
8533003|NCT03353350|9565630|FG000|NOT COMPLETED|26-week Treatment Extension Period||5
8533004|NCT03353350|9565631|FG001|NOT COMPLETED|26-week Treatment Extension Period||3
8533005|NCT03353350|9565632|FG002|NOT COMPLETED|26-week Treatment Extension Period||4
8533006|NCT03353350|9565633|FG003|NOT COMPLETED|26-week Treatment Extension Period||14
8533007|NCT03350503|9565643|FG000|STARTED|Overall Study||121
8533008|NCT03350503|9565643|FG000|COMPLETED|Overall Study||116
8533009|NCT03350503|9565643|FG000|NOT COMPLETED|Overall Study||5
8533010|NCT03326193|9565647|FG000|STARTED|Overall Study||105
8533011|NCT03326193|9565647|FG000|COMPLETED|Overall Study||52
8533012|NCT03326193|9565647|FG000|NOT COMPLETED|Overall Study||53
8533013|NCT03287687|9565653|FG000|STARTED|Overall Study||88
8533014|NCT03287687|9565654|FG001|STARTED|Overall Study||90
8722851|NCT03656107|9770352|FG000|STARTED|Overall Study||28
8722852|NCT03656107|9770353|FG001|STARTED|Overall Study||28
8722853|NCT03656107|9770352|FG000|COMPLETED|Overall Study||25
8722854|NCT03656107|9770353|FG001|COMPLETED|Overall Study||27
8722855|NCT03656107|9770352|FG000|NOT COMPLETED|Overall Study||3
8722856|NCT03656107|9770353|FG001|NOT COMPLETED|Overall Study||1
8722857|NCT03554850|9770359|FG000|STARTED|Overall Study||201
8722858|NCT03554850|9770359|FG000|COMPLETED|Overall Study||190
8722859|NCT03554850|9770359|FG000|NOT COMPLETED|Overall Study||11
8722860|NCT03426566|9770367|FG000|STARTED|Overall Study||974
8722861|NCT03426566|9770367|FG000|COMPLETED|Overall Study||974
8722862|NCT03426566|9770367|FG000|NOT COMPLETED|Overall Study||0
8722863|NCT03398356|9770376|FG000|STARTED|Before Treatment||15
8722864|NCT03398356|9770377|FG001|STARTED|Before Treatment||21
8722865|NCT03398356|9770378|FG002|STARTED|Before Treatment||11
8722866|NCT03398356|9770376|FG000|COMPLETED|Before Treatment||12
8722867|NCT03398356|9770377|FG001|COMPLETED|Before Treatment||13
8722868|NCT03398356|9770378|FG002|COMPLETED|Before Treatment|only baseline parameters were taken, this group did not participate in the further part of the study|0
8722869|NCT03398356|9770376|FG000|NOT COMPLETED|Before Treatment||3
8722870|NCT03398356|9770377|FG001|NOT COMPLETED|Before Treatment||8
8722871|NCT03398356|9770378|FG002|NOT COMPLETED|Before Treatment||11
8722872|NCT03398356|9770376|FG000|STARTED|After 6 Weeks of Treatment||12
8722873|NCT03398356|9770377|FG001|STARTED|After 6 Weeks of Treatment||13
8722874|NCT03398356|9770378|FG002|STARTED|After 6 Weeks of Treatment|control group- only initial parameters were assessed to compare, no follow-up|0
8722875|NCT03398356|9770376|FG000|COMPLETED|After 6 Weeks of Treatment||12
8722876|NCT03398356|9770377|FG001|COMPLETED|After 6 Weeks of Treatment||11
8722877|NCT03398356|9770378|FG002|COMPLETED|After 6 Weeks of Treatment|control group- only initial parameters were assessed to compare, no follow-up|0
8722878|NCT03398356|9770376|FG000|NOT COMPLETED|After 6 Weeks of Treatment||0
8722879|NCT03398356|9770377|FG001|NOT COMPLETED|After 6 Weeks of Treatment||2
8722880|NCT03398356|9770378|FG002|NOT COMPLETED|After 6 Weeks of Treatment||0
8722881|NCT03398356|9770376|FG000|STARTED|Post 6 Week Period Initial Evaluation|two of the patients were moved from group B, because of intolerance of the higher dose of the drug|14
8722882|NCT03398356|9770377|FG001|STARTED|Post 6 Week Period Initial Evaluation||11
8722883|NCT03398356|9770378|FG002|STARTED|Post 6 Week Period Initial Evaluation||0
8722884|NCT03398356|9770376|FG000|COMPLETED|Post 6 Week Period Initial Evaluation||14
8722885|NCT03398356|9770377|FG001|COMPLETED|Post 6 Week Period Initial Evaluation||11
8722886|NCT03398356|9770378|FG002|COMPLETED|Post 6 Week Period Initial Evaluation||0
8722887|NCT03398356|9770376|FG000|NOT COMPLETED|Post 6 Week Period Initial Evaluation||0
8722888|NCT03398356|9770377|FG001|NOT COMPLETED|Post 6 Week Period Initial Evaluation||0
8722889|NCT03398356|9770378|FG002|NOT COMPLETED|Post 6 Week Period Initial Evaluation||0
8722890|NCT03398356|9770376|FG000|STARTED|After 12 Weeks of Treatment||14
8722891|NCT03398356|9770377|FG001|STARTED|After 12 Weeks of Treatment||11
8533015|NCT03287687|9565653|FG000|Procedures|Overall Study||88
8533016|NCT03287687|9565654|FG001|Procedures|Overall Study||90
8533017|NCT03287687|9565653|FG000|COMPLETED|Overall Study||88
8533018|NCT03287687|9565654|FG001|COMPLETED|Overall Study||90
8533019|NCT03287687|9565653|FG000|NOT COMPLETED|Overall Study||0
8722892|NCT03398356|9770378|FG002|STARTED|After 12 Weeks of Treatment|control group- only initial parameters were assessed to compare, no follow-up|0
8722893|NCT03398356|9770376|FG000|COMPLETED|After 12 Weeks of Treatment||14
8722894|NCT03398356|9770377|FG001|COMPLETED|After 12 Weeks of Treatment||11
8722895|NCT03398356|9770378|FG002|COMPLETED|After 12 Weeks of Treatment|control group- only initial parameters were assessed to compare, no follow-up|0
8722896|NCT03398356|9770376|FG000|NOT COMPLETED|After 12 Weeks of Treatment||0
8722897|NCT03398356|9770377|FG001|NOT COMPLETED|After 12 Weeks of Treatment||0
8722898|NCT03398356|9770378|FG002|NOT COMPLETED|After 12 Weeks of Treatment||0
8722899|NCT03398356|9770376|FG000|STARTED|After 15 Weeks of Treatment||14
8722900|NCT03398356|9770377|FG001|STARTED|After 15 Weeks of Treatment||11
8722901|NCT03398356|9770378|FG002|STARTED|After 15 Weeks of Treatment|control group- only initial parameters were assessed to compare, no follow-up|0
8722902|NCT03398356|9770376|FG000|COMPLETED|After 15 Weeks of Treatment||14
8722903|NCT03398356|9770377|FG001|COMPLETED|After 15 Weeks of Treatment||11
8722904|NCT03398356|9770378|FG002|COMPLETED|After 15 Weeks of Treatment|control group- only initial parameters were assessed to compare, no follow-up|0
8722905|NCT03398356|9770376|FG000|NOT COMPLETED|After 15 Weeks of Treatment||0
8722906|NCT03398356|9770377|FG001|NOT COMPLETED|After 15 Weeks of Treatment||0
8722907|NCT03398356|9770378|FG002|NOT COMPLETED|After 15 Weeks of Treatment||0
8722908|NCT03365791|9770386|FG000|STARTED|Overall Study||76
8722909|NCT03365791|9770386|FG000|Full Analysis Set (FAS)|Overall Study||75
8722910|NCT03365791|9770386|FG000|COMPLETED|Overall Study||4
8533020|NCT03287687|9565654|FG001|NOT COMPLETED|Overall Study||0
8533021|NCT03282565|9565663|FG000|STARTED|Overall Study||10
8533022|NCT03282565|9565664|FG001|STARTED|Overall Study||10
8533023|NCT03282565|9565665|FG002|STARTED|Overall Study||10
8533024|NCT03282565|9565663|FG000|COMPLETED|Overall Study||10
8533025|NCT03282565|9565664|FG001|COMPLETED|Overall Study||8
8533026|NCT03282565|9565665|FG002|COMPLETED|Overall Study||8
8533027|NCT03282565|9565663|FG000|NOT COMPLETED|Overall Study||0
8533028|NCT03282565|9565664|FG001|NOT COMPLETED|Overall Study||2
8533029|NCT03282565|9565665|FG002|NOT COMPLETED|Overall Study||2
8533030|NCT03276936|9565675|FG000|STARTED|Overall Study||332
8533031|NCT03276936|9565676|FG001|STARTED|Overall Study||172
8533032|NCT03276936|9565675|FG000|COMPLETED|Overall Study||276
8533033|NCT03276936|9565676|FG001|COMPLETED|Overall Study||134
8533034|NCT03276936|9565675|FG000|NOT COMPLETED|Overall Study||56
8533035|NCT03276936|9565676|FG001|NOT COMPLETED|Overall Study||38
8533036|NCT03271021|9565684|FG000|STARTED|Overall Study||738
8533037|NCT03271021|9565685|FG001|STARTED|Overall Study||750
8533038|NCT03271021|9565684|FG000|COMPLETED|Overall Study||649
8533039|NCT03271021|9565685|FG001|COMPLETED|Overall Study||644
8533040|NCT03271021|9565684|FG000|NOT COMPLETED|Overall Study||89
8533041|NCT03271021|9565685|FG001|NOT COMPLETED|Overall Study||106
8533042|NCT03255083|9565695|FG000|STARTED|Overall Study||6
8533043|NCT03255083|9565696|FG001|STARTED|Overall Study||3
8533044|NCT03255083|9565697|FG002|STARTED|Overall Study||3
8533045|NCT03255083|9565698|FG003|STARTED|Overall Study||1
8533046|NCT03255083|9565695|FG000|COMPLETED|Overall Study||0
8533047|NCT03255083|9565696|FG001|COMPLETED|Overall Study||0
8533048|NCT03255083|9565697|FG002|COMPLETED|Overall Study||0
8533049|NCT03255083|9565698|FG003|COMPLETED|Overall Study||0
8533050|NCT03255083|9565695|FG000|NOT COMPLETED|Overall Study||6
8533051|NCT03255083|9565696|FG001|NOT COMPLETED|Overall Study||3
8533052|NCT03255083|9565697|FG002|NOT COMPLETED|Overall Study||3
8533053|NCT03255083|9565698|FG003|NOT COMPLETED|Overall Study||1
8533054|NCT03227471|9565723|FG000|STARTED|Overall Study||9
8533055|NCT03227471|9565724|FG001|STARTED|Overall Study||30
8533056|NCT03227471|9565725|FG002|STARTED|Overall Study||8
8533057|NCT03227471|9565726|FG003|STARTED|Overall Study||7
8533058|NCT03227471|9565727|FG004|STARTED|Overall Study||25
8533059|NCT03227471|9565728|FG005|STARTED|Overall Study||6
8533060|NCT03227471|9565729|FG006|STARTED|Overall Study||17
8533061|NCT03227471|9565730|FG007|STARTED|Overall Study||12
8533062|NCT03227471|9565731|FG008|STARTED|Overall Study||10
8533063|NCT03227471|9565732|FG009|STARTED|Overall Study||22
8533064|NCT03227471|9565733|FG010|STARTED|Overall Study||21
8533065|NCT03227471|9565734|FG011|STARTED|Overall Study||7
8533066|NCT03227471|9565735|FG012|STARTED|Overall Study||21
8533067|NCT03227471|9565736|FG013|STARTED|Overall Study||8
8533068|NCT03227471|9565737|FG014|STARTED|Overall Study||22
8533069|NCT03227471|9565723|FG000|Safety Set|Overall Study||9
8533070|NCT03227471|9565724|FG001|Safety Set|Overall Study||30
8533071|NCT03227471|9565725|FG002|Safety Set|Overall Study||8
8533072|NCT03227471|9565726|FG003|Safety Set|Overall Study||7
8533073|NCT03227471|9565727|FG004|Safety Set|Overall Study||25
8533074|NCT03227471|9565728|FG005|Safety Set|Overall Study||6
8533075|NCT03227471|9565729|FG006|Safety Set|Overall Study||17
8533076|NCT03227471|9565730|FG007|Safety Set|Overall Study||12
8533077|NCT03227471|9565731|FG008|Safety Set|Overall Study||10
8533078|NCT03227471|9565732|FG009|Safety Set|Overall Study||22
8533079|NCT03227471|9565733|FG010|Safety Set|Overall Study||21
8533080|NCT03227471|9565734|FG011|Safety Set|Overall Study||7
8533081|NCT03227471|9565735|FG012|Safety Set|Overall Study||21
8533082|NCT03227471|9565736|FG013|Safety Set|Overall Study||8
8533083|NCT03227471|9565737|FG014|Safety Set|Overall Study||21
8533084|NCT03227471|9565723|FG000|COMPLETED|Overall Study||9
8533085|NCT03227471|9565724|FG001|COMPLETED|Overall Study||30
8533086|NCT03227471|9565725|FG002|COMPLETED|Overall Study||8
8533087|NCT03227471|9565726|FG003|COMPLETED|Overall Study||7
8533088|NCT03227471|9565727|FG004|COMPLETED|Overall Study||24
8533089|NCT03227471|9565728|FG005|COMPLETED|Overall Study||6
8533090|NCT03227471|9565729|FG006|COMPLETED|Overall Study||17
8533091|NCT03227471|9565730|FG007|COMPLETED|Overall Study||12
8533092|NCT03227471|9565731|FG008|COMPLETED|Overall Study||10
8533093|NCT03227471|9565732|FG009|COMPLETED|Overall Study||22
8533094|NCT03227471|9565733|FG010|COMPLETED|Overall Study||21
8533095|NCT03227471|9565734|FG011|COMPLETED|Overall Study||7
8533096|NCT03227471|9565735|FG012|COMPLETED|Overall Study||20
8533097|NCT03227471|9565736|FG013|COMPLETED|Overall Study||8
8533098|NCT03227471|9565737|FG014|COMPLETED|Overall Study||21
8533099|NCT03227471|9565723|FG000|NOT COMPLETED|Overall Study||0
8533100|NCT03227471|9565724|FG001|NOT COMPLETED|Overall Study||0
8533101|NCT03227471|9565725|FG002|NOT COMPLETED|Overall Study||0
8533102|NCT03227471|9565726|FG003|NOT COMPLETED|Overall Study||0
8533103|NCT03227471|9565727|FG004|NOT COMPLETED|Overall Study||1
8533104|NCT03227471|9565728|FG005|NOT COMPLETED|Overall Study||0
8533105|NCT03227471|9565729|FG006|NOT COMPLETED|Overall Study||0
8533106|NCT03227471|9565730|FG007|NOT COMPLETED|Overall Study||0
8533107|NCT03227471|9565731|FG008|NOT COMPLETED|Overall Study||0
8533108|NCT03227471|9565732|FG009|NOT COMPLETED|Overall Study||0
8533109|NCT03227471|9565733|FG010|NOT COMPLETED|Overall Study||0
8533110|NCT03227471|9565734|FG011|NOT COMPLETED|Overall Study||0
8533111|NCT03227471|9565735|FG012|NOT COMPLETED|Overall Study||1
8533112|NCT03227471|9565736|FG013|NOT COMPLETED|Overall Study||0
8533113|NCT03227471|9565737|FG014|NOT COMPLETED|Overall Study||1
8564574|NCT00059475|9596740|FG000|STARTED|Overall Study||33
8564575|NCT00059475|9596741|FG001|STARTED|Overall Study||2
8564576|NCT00059475|9596742|FG002|STARTED|Overall Study||24
8564577|NCT00059475|9596743|FG003|STARTED|Overall Study||3
8564578|NCT00059475|9596744|FG004|STARTED|Overall Study||33
8564579|NCT00059475|9596745|FG005|STARTED|Overall Study||2
8564580|NCT00059475|9596746|FG006|STARTED|Overall Study||34
8564581|NCT00059475|9596747|FG007|STARTED|Overall Study||7
8564582|NCT00059475|9596740|FG000|COMPLETED|Overall Study||33
8564583|NCT00059475|9596741|FG001|COMPLETED|Overall Study||2
8564584|NCT00059475|9596742|FG002|COMPLETED|Overall Study||24
8564585|NCT00059475|9596743|FG003|COMPLETED|Overall Study||3
8564586|NCT00059475|9596744|FG004|COMPLETED|Overall Study||33
8564587|NCT00059475|9596745|FG005|COMPLETED|Overall Study||2
8564588|NCT00059475|9596746|FG006|COMPLETED|Overall Study||34
8943782|NCT02391948|10005625|FG004|NOT COMPLETED|Baseline||0
8943783|NCT02391948|10005621|FG000|STARTED|6-month Assessment||227
8943784|NCT02391948|10005622|FG001|STARTED|6-month Assessment||161
8943785|NCT02391948|10005623|FG002|STARTED|6-month Assessment||80
8943786|NCT02391948|10005624|FG003|STARTED|6-month Assessment||129
8943787|NCT02391948|10005625|FG004|STARTED|6-month Assessment||111
8943788|NCT02391948|10005621|FG000|COMPLETED|6-month Assessment||148
8943789|NCT02391948|10005622|FG001|COMPLETED|6-month Assessment||105
8564589|NCT00059475|9596747|FG007|COMPLETED|Overall Study||7
8564590|NCT00059475|9596740|FG000|NOT COMPLETED|Overall Study||0
8564591|NCT00059475|9596741|FG001|NOT COMPLETED|Overall Study||0
8564592|NCT00059475|9596742|FG002|NOT COMPLETED|Overall Study||0
8564593|NCT00059475|9596743|FG003|NOT COMPLETED|Overall Study||0
8564594|NCT00059475|9596744|FG004|NOT COMPLETED|Overall Study||0
8564595|NCT00059475|9596745|FG005|NOT COMPLETED|Overall Study||0
8564596|NCT00059475|9596746|FG006|NOT COMPLETED|Overall Study||0
8564597|NCT00059475|9596747|FG007|NOT COMPLETED|Overall Study||0
8564598|NCT00059787|9596772|FG000|STARTED|Overall Study||56
8564599|NCT00059787|9596772|FG000|COMPLETED|Overall Study||36
8564600|NCT00059787|9596772|FG000|NOT COMPLETED|Overall Study||20
8564601|NCT00059839|9596779|FG000|STARTED|Overall Study||65
8564602|NCT00059839|9596780|FG001|STARTED|Overall Study||64
8564603|NCT00059839|9596779|FG000|COMPLETED|Overall Study||53
8564604|NCT00059839|9596780|FG001|COMPLETED|Overall Study||47
8564605|NCT00059839|9596779|FG000|NOT COMPLETED|Overall Study||12
8564606|NCT00059839|9596780|FG001|NOT COMPLETED|Overall Study||17
8564607|NCT00060008|9596786|FG000|STARTED|Overall Study||18
8564608|NCT00060008|9596786|FG000|COMPLETED|Overall Study||18
8564609|NCT00060008|9596786|FG000|NOT COMPLETED|Overall Study||0
8564610|NCT00060333|9596791|FG000|STARTED|Overall Study||20
8564611|NCT00060333|9596791|FG000|COMPLETED|Overall Study||20
8564612|NCT00060333|9596791|FG000|NOT COMPLETED|Overall Study||0
8564613|NCT00060346|9596798|FG000|STARTED|Overall Study||16
8564614|NCT00060346|9596798|FG000|Eligible and Treated|Overall Study||16
8564615|NCT00060346|9596798|FG000|COMPLETED|Overall Study||16
8564616|NCT00060346|9596798|FG000|NOT COMPLETED|Overall Study||0
8564617|NCT00060424|9596802|FG000|STARTED|Overall Study||21
8564618|NCT00060424|9596802|FG000|COMPLETED|Overall Study||21
8564619|NCT00060424|9596802|FG000|NOT COMPLETED|Overall Study||0
8564620|NCT00060528|9596806|FG000|STARTED|Overall Study|32 participants are reported for the phase II portion.|8
8564621|NCT00060528|9596807|FG001|STARTED|Overall Study||9
8564622|NCT00060528|9596808|FG002|STARTED|Overall Study||7
8564623|NCT00060528|9596809|FG003|STARTED|Overall Study||8
8564624|NCT00060528|9596806|FG000|COMPLETED|Overall Study||8
8564625|NCT00060528|9596807|FG001|COMPLETED|Overall Study||9
8564626|NCT00060528|9596808|FG002|COMPLETED|Overall Study||7
8564627|NCT00060528|9596809|FG003|COMPLETED|Overall Study||8
8564628|NCT00060528|9596806|FG000|NOT COMPLETED|Overall Study||0
8564629|NCT00060528|9596807|FG001|NOT COMPLETED|Overall Study||0
8564630|NCT00060528|9596808|FG002|NOT COMPLETED|Overall Study||0
8943790|NCT02391948|10005623|FG002|COMPLETED|6-month Assessment||49
8943791|NCT02391948|10005624|FG003|COMPLETED|6-month Assessment||84
8943792|NCT02391948|10005625|FG004|COMPLETED|6-month Assessment||85
8533114|NCT03221842|9565798|FG000|STARTED|Period 1 (Open-label)||63
8533115|NCT03221842|9565799|FG001|STARTED|Period 1 (Open-label)||0
8533116|NCT03221842|9565798|FG000|COMPLETED|Period 1 (Open-label)||53
8533117|NCT03221842|9565799|FG001|COMPLETED|Period 1 (Open-label)||0
8533118|NCT03221842|9565798|FG000|NOT COMPLETED|Period 1 (Open-label)||10
8533119|NCT03221842|9565799|FG001|NOT COMPLETED|Period 1 (Open-label)||0
8533120|NCT03221842|9565798|FG000|STARTED|Period 2 (Randomized, Blinded)||7
8533121|NCT03221842|9565799|FG001|STARTED|Period 2 (Randomized, Blinded)||6
8533122|NCT03221842|9565798|FG000|COMPLETED|Period 2 (Randomized, Blinded)||6
8533123|NCT03221842|9565799|FG001|COMPLETED|Period 2 (Randomized, Blinded)||5
8533124|NCT03221842|9565798|FG000|NOT COMPLETED|Period 2 (Randomized, Blinded)||1
8533125|NCT03221842|9565799|FG001|NOT COMPLETED|Period 2 (Randomized, Blinded)||1
8533126|NCT03194321|9565809|FG000|STARTED|Overall Study||20
8533127|NCT03194321|9565809|FG000|COMPLETED|Overall Study||17
8533128|NCT03194321|9565809|FG000|NOT COMPLETED|Overall Study||3
8533129|NCT03085095|9565815|FG000|STARTED|Overall Study||624
8533130|NCT03085095|9565816|FG001|STARTED|Overall Study||310
8533131|NCT03085095|9565815|FG000|Received at Least 1 Dose of Study Drug|Overall Study||622
8533132|NCT03085095|9565816|FG001|Received at Least 1 Dose of Study Drug|Overall Study||308
8533133|NCT03085095|9565815|FG000|COMPLETED|Overall Study||563
8533134|NCT03085095|9565816|FG001|COMPLETED|Overall Study||276
8533135|NCT03085095|9565815|FG000|NOT COMPLETED|Overall Study||61
8533136|NCT03085095|9565816|FG001|NOT COMPLETED|Overall Study||34
8533137|NCT03048422|9565828|FG000|STARTED|Overall Study||217
8533138|NCT03048422|9565829|FG001|STARTED|Overall Study||215
8533139|NCT03048422|9565830|FG002|STARTED|Overall Study||211
8533140|NCT03048422|9565828|FG000|COMPLETED|Overall Study||200
8533141|NCT03048422|9565829|FG001|COMPLETED|Overall Study||205
8533142|NCT03048422|9565830|FG002|COMPLETED|Overall Study||202
8533143|NCT03048422|9565828|FG000|NOT COMPLETED|Overall Study||17
8533144|NCT03048422|9565829|FG001|NOT COMPLETED|Overall Study||10
8533145|NCT03048422|9565830|FG002|NOT COMPLETED|Overall Study||9
8533146|NCT03032068|9565848|FG000|STARTED|Overall Study||10
8533147|NCT03032068|9565848|FG000|Preoperative Visit|Overall Study||10
8533148|NCT03032068|9565848|FG000|Postoperative Home Care Visit 1|Overall Study||10
8533149|NCT03032068|9565848|FG000|Postoperative Home Care Visit 2|Overall Study||10
8533150|NCT03032068|9565848|FG000|Postoperative Home Care Visit 3|Overall Study||10
8533151|NCT03032068|9565848|FG000|4 Weeks Postoperative Visit|Overall Study||9
8533152|NCT03032068|9565848|FG000|8 Weeks Postoperative Visit|Overall Study||9
8533153|NCT03032068|9565848|FG000|12 Weeks Postoperative Visit|Overall Study||9
8533154|NCT03032068|9565848|FG000|COMPLETED|Overall Study||9
8533155|NCT03032068|9565848|FG000|NOT COMPLETED|Overall Study||1
8533156|NCT02965729|9565855|FG000|STARTED|Overall Study||24
8533157|NCT02965729|9565856|FG001|STARTED|Overall Study||25
8533158|NCT02965729|9565857|FG002|STARTED|Overall Study||56
8533159|NCT02965729|9565855|FG000|COMPLETED|Overall Study||17
8533160|NCT02965729|9565856|FG001|COMPLETED|Overall Study||22
8533161|NCT02965729|9565857|FG002|COMPLETED|Overall Study||45
8533162|NCT02965729|9565855|FG000|NOT COMPLETED|Overall Study||7
8533163|NCT02965729|9565856|FG001|NOT COMPLETED|Overall Study||3
8533164|NCT02965729|9565857|FG002|NOT COMPLETED|Overall Study||11
8533165|NCT02835690|9565868|FG000|STARTED|Overall Study||14
8533166|NCT02835690|9565869|FG001|STARTED|Overall Study||15
8533167|NCT02835690|9565870|FG002|STARTED|Overall Study||15
8533168|NCT02835690|9565868|FG000|Treated|Overall Study||14
8533169|NCT02835690|9565869|FG001|Treated|Overall Study||13
8533170|NCT02835690|9565870|FG002|Treated|Overall Study||15
8533171|NCT02835690|9565868|FG000|COMPLETED|Overall Study||0
8533172|NCT02835690|9565869|FG001|COMPLETED|Overall Study||0
8533173|NCT02835690|9565870|FG002|COMPLETED|Overall Study||0
8533174|NCT02835690|9565868|FG000|NOT COMPLETED|Overall Study||14
8533175|NCT02835690|9565869|FG001|NOT COMPLETED|Overall Study||15
8533176|NCT02835690|9565870|FG002|NOT COMPLETED|Overall Study||15
8533177|NCT02828982|9565878|FG000|STARTED|First Intervention (3 Weeks)||5
8533178|NCT02828982|9565879|FG001|STARTED|First Intervention (3 Weeks)||7
8533179|NCT02828982|9565878|FG000|Received Intervention|First Intervention (3 Weeks)||5
8533180|NCT02828982|9565879|FG001|Received Intervention|First Intervention (3 Weeks)||7
8533181|NCT02828982|9565878|FG000|COMPLETED|First Intervention (3 Weeks)||4
8533182|NCT02828982|9565879|FG001|COMPLETED|First Intervention (3 Weeks)||6
8533183|NCT02828982|9565878|FG000|NOT COMPLETED|First Intervention (3 Weeks)||1
8533184|NCT02828982|9565879|FG001|NOT COMPLETED|First Intervention (3 Weeks)||1
8533185|NCT02828982|9565878|FG000|STARTED|Second Intervention (3 Weeks)||4
8533186|NCT02828982|9565879|FG001|STARTED|Second Intervention (3 Weeks)||6
8533187|NCT02828982|9565878|FG000|Received Intervention|Second Intervention (3 Weeks)||4
8533188|NCT02828982|9565879|FG001|Received Intervention|Second Intervention (3 Weeks)||6
8533189|NCT02828982|9565878|FG000|COMPLETED|Second Intervention (3 Weeks)||4
8533190|NCT02828982|9565879|FG001|COMPLETED|Second Intervention (3 Weeks)||6
8533191|NCT02828982|9565878|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0
8533192|NCT02828982|9565879|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
8533193|NCT02823457|9565887|FG000|STARTED|Overall Study||20
8533194|NCT02823457|9565887|FG000|COMPLETED|Overall Study||15
8533195|NCT02823457|9565887|FG000|NOT COMPLETED|Overall Study||5
8533196|NCT02815280|9565893|FG000|STARTED|Double-Blind Phase||333
8533197|NCT02815280|9565894|FG001|STARTED|Double-Blind Phase||162
8533198|NCT02815280|9565893|FG000|COMPLETED|Double-Blind Phase||297
8533199|NCT02815280|9565894|FG001|COMPLETED|Double-Blind Phase||137
8533200|NCT02815280|9565893|FG000|NOT COMPLETED|Double-Blind Phase||36
8533201|NCT02815280|9565894|FG001|NOT COMPLETED|Double-Blind Phase||25
8533202|NCT02815280|9565893|FG000|STARTED|Open-Label Phase||256
8533203|NCT02815280|9565894|FG001|STARTED|Open-Label Phase||117
8533204|NCT02815280|9565893|FG000|COMPLETED|Open-Label Phase||169
8533205|NCT02815280|9565894|FG001|COMPLETED|Open-Label Phase||73
8533206|NCT02815280|9565893|FG000|NOT COMPLETED|Open-Label Phase||87
8533207|NCT02815280|9565894|FG001|NOT COMPLETED|Open-Label Phase||44
8533208|NCT02815267|9565906|FG000|STARTED|Double-Blind Phase||307
8533209|NCT02815267|9565907|FG001|STARTED|Double-Blind Phase||159
8533210|NCT02815267|9565906|FG000|COMPLETED|Double-Blind Phase||274
8533211|NCT02815267|9565907|FG001|COMPLETED|Double-Blind Phase||128
8533212|NCT02815267|9565906|FG000|NOT COMPLETED|Double-Blind Phase||33
8533213|NCT02815267|9565907|FG001|NOT COMPLETED|Double-Blind Phase||31
8533214|NCT02815267|9565906|FG000|STARTED|Open-Label Phase||193
8533215|NCT02815267|9565907|FG001|STARTED|Open-Label Phase||91
8533216|NCT02815267|9565906|FG000|COMPLETED|Open-Label Phase||122
8533217|NCT02815267|9565907|FG001|COMPLETED|Open-Label Phase||50
8533218|NCT02815267|9565906|FG000|NOT COMPLETED|Open-Label Phase||71
8533219|NCT02815267|9565907|FG001|NOT COMPLETED|Open-Label Phase||41
8533220|NCT02802228|9565919|FG000|STARTED|Overall Study||20
8533221|NCT02802228|9565920|FG001|STARTED|Overall Study||10
8533222|NCT02802228|9565919|FG000|COMPLETED|Overall Study||15
8533223|NCT02802228|9565920|FG001|COMPLETED|Overall Study||10
8533224|NCT02802228|9565919|FG000|NOT COMPLETED|Overall Study||5
8533225|NCT02802228|9565920|FG001|NOT COMPLETED|Overall Study||0
8533226|NCT02719691|9565931|FG000|STARTED|Overall Study||3
8533227|NCT02719691|9565932|FG001|STARTED|Overall Study||4
8533228|NCT02719691|9565933|FG002|STARTED|Overall Study||6
8533229|NCT02719691|9565934|FG003|STARTED|Overall Study||2
8533230|NCT02719691|9565935|FG004|STARTED|Overall Study||31
8533231|NCT02719691|9565931|FG000|COMPLETED|Overall Study||3
8533232|NCT02719691|9565932|FG001|COMPLETED|Overall Study||4
8533233|NCT02719691|9565933|FG002|COMPLETED|Overall Study||6
8533234|NCT02719691|9565934|FG003|COMPLETED|Overall Study||2
8533235|NCT02719691|9565935|FG004|COMPLETED|Overall Study||31
8533236|NCT02719691|9565931|FG000|NOT COMPLETED|Overall Study||0
8533237|NCT02719691|9565932|FG001|NOT COMPLETED|Overall Study||0
8533238|NCT02719691|9565933|FG002|NOT COMPLETED|Overall Study||0
8533239|NCT02719691|9565934|FG003|NOT COMPLETED|Overall Study||0
8533240|NCT02719691|9565935|FG004|NOT COMPLETED|Overall Study||0
8533241|NCT02674516|9565951|FG000|STARTED|Overall Study||17
8533242|NCT02674516|9565952|FG001|STARTED|Overall Study||15
8533243|NCT02674516|9565951|FG000|COMPLETED|Overall Study||13
8533244|NCT02674516|9565952|FG001|COMPLETED|Overall Study||11
8533245|NCT02674516|9565951|FG000|NOT COMPLETED|Overall Study||4
8533246|NCT02674516|9565952|FG001|NOT COMPLETED|Overall Study||4
8533247|NCT02655016|9565960|FG000|STARTED|Overall Study||246
8533248|NCT02655016|9565961|FG001|STARTED|Overall Study||487
8533249|NCT02655016|9565960|FG000|Received Study Treatment|Overall Study|2 participants never received treatment due to screen failure after randomization.|244
8533250|NCT02655016|9565961|FG001|Received Study Treatment|Overall Study|3 participants never received treatment (2 failed screening & 1 withdrew consent before first dose).|484
8533251|NCT02655016|9565960|FG000|Ongoing With Treatment in the Study|Overall Study||69
8533252|NCT02655016|9565961|FG001|Ongoing With Treatment in the Study|Overall Study||177
8533253|NCT02655016|9565960|FG000|COMPLETED|Overall Study|69 participants are ongoing in the study.|191
8533254|NCT02655016|9565961|FG001|COMPLETED|Overall Study|177 participants are ongoing in the study.|397
8533255|NCT02655016|9565960|FG000|NOT COMPLETED|Overall Study||55
8533256|NCT02655016|9565961|FG001|NOT COMPLETED|Overall Study||90
8533257|NCT02607046|9565970|FG000|STARTED|Overall Study||22
8533258|NCT02607046|9565971|FG001|STARTED|Overall Study||13
8533259|NCT02607046|9565970|FG000|COMPLETED|Overall Study||14
8533260|NCT02607046|9565971|FG001|COMPLETED|Overall Study||10
8533261|NCT02607046|9565970|FG000|NOT COMPLETED|Overall Study||8
8533262|NCT02607046|9565971|FG001|NOT COMPLETED|Overall Study||3
8533263|NCT02505425|9565981|FG000|STARTED|Overall Study||208
8533264|NCT02505425|9565982|FG001|STARTED|Overall Study||207
8533265|NCT02505425|9565983|FG002|STARTED|Overall Study||82
8533266|NCT02505425|9565984|FG003|STARTED|Overall Study||76
8533267|NCT02505425|9565981|FG000|COMPLETED|Overall Study||120
8533268|NCT02505425|9565982|FG001|COMPLETED|Overall Study||125
8533269|NCT02505425|9565983|FG002|COMPLETED|Overall Study||32
8533270|NCT02505425|9565984|FG003|COMPLETED|Overall Study||50
8533271|NCT02505425|9565981|FG000|NOT COMPLETED|Overall Study||88
8533272|NCT02505425|9565982|FG001|NOT COMPLETED|Overall Study||82
8620833|NCT00475865|9659665|FG001|COMPLETED|Overall Study|completed treatment period|37
8533273|NCT02505425|9565983|FG002|NOT COMPLETED|Overall Study||50
8533274|NCT02505425|9565984|FG003|NOT COMPLETED|Overall Study||26
8533275|NCT02487979|9565994|FG000|STARTED|Overall Study||22
8533276|NCT02487979|9565994|FG000|COMPLETED|Overall Study||1
8533277|NCT02487979|9565994|FG000|NOT COMPLETED|Overall Study||21
8533278|NCT02463448|9565998|FG000|STARTED|Enrollment Through 6 Months||23
8533279|NCT02463448|9565998|FG000|COMPLETED|Enrollment Through 6 Months||20
8533280|NCT02463448|9565998|FG000|NOT COMPLETED|Enrollment Through 6 Months||3
8533281|NCT02463448|9565998|FG000|STARTED|6 Months Through 12 Months||20
8533282|NCT02463448|9565998|FG000|COMPLETED|6 Months Through 12 Months||18
8533283|NCT02463448|9565998|FG000|NOT COMPLETED|6 Months Through 12 Months||2
8533284|NCT02463448|9565998|FG000|STARTED|12 Months Through End of Study||18
8533285|NCT02463448|9565998|FG000|COMPLETED|12 Months Through End of Study||17
8533286|NCT02463448|9565998|FG000|NOT COMPLETED|12 Months Through End of Study||1
8533287|NCT02288897|9566004|FG000|STARTED|Overall Study||12
8533288|NCT02288897|9566005|FG001|STARTED|Overall Study||8
8533289|NCT02288897|9566004|FG000|COMPLETED|Overall Study||12
8533290|NCT02288897|9566005|FG001|COMPLETED|Overall Study||8
8533291|NCT02288897|9566004|FG000|NOT COMPLETED|Overall Study||0
8533292|NCT02288897|9566005|FG001|NOT COMPLETED|Overall Study||0
8533293|NCT02276547|9566011|FG000|STARTED|Overall Study||27
8533294|NCT02276547|9566011|FG000|COMPLETED|Overall Study||23
8533295|NCT02276547|9566011|FG000|NOT COMPLETED|Overall Study||4
8533296|NCT02263885|9566015|FG000|STARTED|Overall Study||20
8533297|NCT02263885|9566015|FG000|COMPLETED|Overall Study||10
8533298|NCT02263885|9566015|FG000|NOT COMPLETED|Overall Study||10
8533299|NCT02213926|9566020|FG000|STARTED|Overall Study||124
8533300|NCT02213926|9566020|FG000|COMPLETED|Overall Study||0
8533301|NCT02213926|9566020|FG000|NOT COMPLETED|Overall Study||124
8564631|NCT00060528|9596809|FG003|NOT COMPLETED|Overall Study||0
8564632|NCT00060606|9596824|FG000|STARTED|Overall Study||91
8564633|NCT00060606|9596825|FG001|STARTED|Overall Study||92
8564634|NCT00060606|9596824|FG000|First Primary Outcome - Shunt at 12 Mont|Overall Study||91
8564635|NCT00060606|9596825|FG001|First Primary Outcome - Shunt at 12 Mont|Overall Study||92
8564636|NCT00060606|9596824|FG000|COMPLETED|Overall Study||91
8564637|NCT00060606|9596825|FG001|COMPLETED|Overall Study||91
8564638|NCT00060606|9596824|FG000|NOT COMPLETED|Overall Study||0
8564639|NCT00060606|9596825|FG001|NOT COMPLETED|Overall Study||1
8564640|NCT00060840|9596833|FG000|STARTED|Overall Study||73
8564641|NCT00060840|9596834|FG001|STARTED|Overall Study||77
8564642|NCT00060840|9596833|FG000|COMPLETED|Overall Study||69
8564643|NCT00060840|9596834|FG001|COMPLETED|Overall Study||68
8564644|NCT00060840|9596833|FG000|NOT COMPLETED|Overall Study||4
8564645|NCT00060840|9596834|FG001|NOT COMPLETED|Overall Study||9
8564646|NCT00060944|9596842|FG000|STARTED|Overall Study||136
8564647|NCT00060944|9596843|FG001|STARTED|Overall Study||134
8564648|NCT00060944|9596842|FG000|Treated|Overall Study||130
8564649|NCT00060944|9596843|FG001|Treated|Overall Study||130
8564650|NCT00060944|9596842|FG000|COMPLETED|Overall Study||0
8564651|NCT00060944|9596843|FG001|COMPLETED|Overall Study||0
8564652|NCT00060944|9596842|FG000|NOT COMPLETED|Overall Study||136
8564653|NCT00060944|9596843|FG001|NOT COMPLETED|Overall Study||134
8564654|NCT00061048|9596849|FG000|STARTED|Overall Study||29
8564655|NCT00061048|9596849|FG000|COMPLETED|Overall Study|Began protocol specified follow-up period.|7
8564656|NCT00061048|9596849|FG000|NOT COMPLETED|Overall Study||22
8564657|NCT00061373|9596855|FG000|STARTED|Overall Study||15
8564658|NCT00061373|9596856|FG001|STARTED|Overall Study||3
8564659|NCT00061373|9596855|FG000|Aspirin and Tinzaparin|Overall Study||15
8564660|NCT00061373|9596856|FG001|Aspirin and Tinzaparin|Overall Study||3
8564661|NCT00061373|9596855|FG000|COMPLETED|Overall Study||15
8564662|NCT00061373|9596856|FG001|COMPLETED|Overall Study||3
8564663|NCT00061373|9596855|FG000|NOT COMPLETED|Overall Study||0
8564664|NCT00061373|9596856|FG001|NOT COMPLETED|Overall Study||0
8564665|NCT00061633|9596864|FG000|STARTED|Overall Study||84
8564666|NCT00061633|9596865|FG001|STARTED|Overall Study||85
8564667|NCT00061633|9596864|FG000|COMPLETED|Overall Study||79
8564668|NCT00061633|9596865|FG001|COMPLETED|Overall Study||74
8564669|NCT00061633|9596864|FG000|NOT COMPLETED|Overall Study||5
8564670|NCT00061633|9596865|FG001|NOT COMPLETED|Overall Study||11
8564671|NCT00061893|9596871|FG000|STARTED|Overall Study||38
8564672|NCT00061893|9596871|FG000|COMPLETED|Overall Study||20
8564673|NCT00061893|9596871|FG000|NOT COMPLETED|Overall Study||18
8564674|NCT00061932|9596877|FG000|STARTED|Overall Study||29
8564675|NCT00061932|9596878|FG001|STARTED|Overall Study||12
8564676|NCT00061932|9596877|FG000|COMPLETED|Overall Study||16
8564677|NCT00061932|9596878|FG001|COMPLETED|Overall Study||8
8564678|NCT00061932|9596877|FG000|NOT COMPLETED|Overall Study||13
8564679|NCT00061932|9596878|FG001|NOT COMPLETED|Overall Study||4
8564680|NCT00062010|9596885|FG000|STARTED|Overall Study||37
8564681|NCT00062010|9596885|FG000|Eligible and Treated|Overall Study||34
8564682|NCT00062010|9596885|FG000|COMPLETED|Overall Study||34
8564683|NCT00062010|9596885|FG000|NOT COMPLETED|Overall Study||3
8564684|NCT00062166|9596889|FG000|STARTED|Overall Study||340
8564685|NCT00062166|9596889|FG000|COMPLETED|Overall Study||334
8564686|NCT00062166|9596889|FG000|NOT COMPLETED|Overall Study||6
8564687|NCT00062374|9596894|FG000|STARTED|Overall Study||55
8564688|NCT00062374|9596894|FG000|COMPLETED|Overall Study||43
8564689|NCT00062374|9596894|FG000|NOT COMPLETED|Overall Study||12
8564690|NCT00062439|9596898|FG000|STARTED|Induction Chemotherapy + Radiotherapy||46
8564691|NCT00062439|9596898|FG000|COMPLETED|Induction Chemotherapy + Radiotherapy||38
8564692|NCT00062439|9596898|FG000|NOT COMPLETED|Induction Chemotherapy + Radiotherapy||8
8564693|NCT00062439|9596898|FG000|STARTED|Post Chemoradiation Assessment||38
8564694|NCT00062439|9596898|FG000|COMPLETED|Post Chemoradiation Assessment||29
8564695|NCT00062439|9596898|FG000|NOT COMPLETED|Post Chemoradiation Assessment||9
8564696|NCT00062439|9596898|FG000|STARTED|Surgery||29
8564697|NCT00062439|9596898|FG000|COMPLETED|Surgery||22
8564698|NCT00062439|9596898|FG000|NOT COMPLETED|Surgery||7
8564699|NCT00062439|9596898|FG000|STARTED|Consolidation Chemotherapy||22
8564700|NCT00062439|9596898|FG000|COMPLETED|Consolidation Chemotherapy||20
8564701|NCT00062439|9596898|FG000|NOT COMPLETED|Consolidation Chemotherapy||2
8564702|NCT00062647|9596909|FG000|STARTED|Overall Study||30
8564703|NCT00062647|9596910|FG001|STARTED|Overall Study||30
8564704|NCT00062647|9596909|FG000|COMPLETED|Overall Study||14
8533302|NCT02008396|9566026|FG000|STARTED|Overall Study||4
8533303|NCT02008396|9566027|FG001|STARTED|Overall Study||8
8533304|NCT02008396|9566026|FG000|COMPLETED|Overall Study||4
8533305|NCT02008396|9566027|FG001|COMPLETED|Overall Study||7
8533306|NCT02008396|9566026|FG000|NOT COMPLETED|Overall Study||0
8533307|NCT02008396|9566027|FG001|NOT COMPLETED|Overall Study||1
8533308|NCT01995175|9566034|FG000|STARTED|Overall Study||2401
8533309|NCT01995175|9566034|FG000|COMPLETED|Overall Study||2148
8533310|NCT01995175|9566034|FG000|NOT COMPLETED|Overall Study||253
8533311|NCT01883804|9566038|FG000|STARTED|Overall Study||25
8533312|NCT01883804|9566038|FG000|COMPLETED|Overall Study||20
8533313|NCT01883804|9566038|FG000|NOT COMPLETED|Overall Study||5
8533314|NCT01804296|9566042|FG000|STARTED|Overall Study||4
8533315|NCT01804296|9566042|FG000|COMPLETED|Overall Study||4
8533316|NCT01804296|9566042|FG000|NOT COMPLETED|Overall Study||0
8533317|NCT01804270|9566048|FG000|STARTED|Overall Study||2
8533318|NCT01804270|9566049|FG001|STARTED|Overall Study||4
8533319|NCT01804270|9566048|FG000|COMPLETED|Overall Study||1
8533320|NCT01804270|9566049|FG001|COMPLETED|Overall Study||3
8533321|NCT01804270|9566048|FG000|NOT COMPLETED|Overall Study||1
8533322|NCT01804270|9566049|FG001|NOT COMPLETED|Overall Study||1
8533323|NCT01781390|9566058|FG000|STARTED|Overall Study||35
8533324|NCT01781390|9566059|FG001|STARTED|Overall Study||35
8533325|NCT01781390|9566060|FG002|STARTED|Overall Study||36
8533326|NCT01781390|9566058|FG000|COMPLETED|Overall Study||32
8533327|NCT01781390|9566059|FG001|COMPLETED|Overall Study||28
8533328|NCT01781390|9566060|FG002|COMPLETED|Overall Study||32
8533329|NCT01781390|9566058|FG000|NOT COMPLETED|Overall Study||3
8533330|NCT01781390|9566059|FG001|NOT COMPLETED|Overall Study||7
8533331|NCT01781390|9566060|FG002|NOT COMPLETED|Overall Study||4
8533332|NCT01566695|9566070|FG000|STARTED|Overall Study||107
8533333|NCT01566695|9566071|FG001|STARTED|Overall Study||109
8533334|NCT01566695|9566070|FG000|COMPLETED|Overall Study||12
8533335|NCT01566695|9566071|FG001|COMPLETED|Overall Study||10
8533336|NCT01566695|9566070|FG000|NOT COMPLETED|Overall Study||95
8533337|NCT01566695|9566071|FG001|NOT COMPLETED|Overall Study||99
8533338|NCT01338636|9566077|FG000|STARTED|Overall Study||30
8533339|NCT01338636|9566077|FG000|COMPLETED|Overall Study||22
8533340|NCT01338636|9566077|FG000|NOT COMPLETED|Overall Study||8
8533341|NCT01208974|9566081|FG000|STARTED|NAC-Sparing Mastectomy||21
8533342|NCT01208974|9566082|FG001|STARTED|NAC-Sparing Mastectomy||0
8533343|NCT01208974|9566083|FG002|STARTED|NAC-Sparing Mastectomy||0
8533344|NCT01208974|9566084|FG003|STARTED|NAC-Sparing Mastectomy||0
8533345|NCT01208974|9566081|FG000|COMPLETED|NAC-Sparing Mastectomy||21
8533346|NCT01208974|9566082|FG001|COMPLETED|NAC-Sparing Mastectomy||0
8533347|NCT01208974|9566083|FG002|COMPLETED|NAC-Sparing Mastectomy||0
8533348|NCT01208974|9566084|FG003|COMPLETED|NAC-Sparing Mastectomy||0
8533349|NCT01208974|9566081|FG000|NOT COMPLETED|NAC-Sparing Mastectomy||0
8533350|NCT01208974|9566082|FG001|NOT COMPLETED|NAC-Sparing Mastectomy||0
8533351|NCT01208974|9566083|FG002|NOT COMPLETED|NAC-Sparing Mastectomy||0
8533352|NCT01208974|9566084|FG003|NOT COMPLETED|NAC-Sparing Mastectomy||0
8533353|NCT01208974|9566081|FG000|STARTED|Post-Mastectomy Period (Weeks 1 to 4)||21
8533354|NCT01208974|9566082|FG001|STARTED|Post-Mastectomy Period (Weeks 1 to 4)||0
8533355|NCT01208974|9566083|FG002|STARTED|Post-Mastectomy Period (Weeks 1 to 4)||0
8533356|NCT01208974|9566084|FG003|STARTED|Post-Mastectomy Period (Weeks 1 to 4)||0
8533357|NCT01208974|9566081|FG000|COMPLETED|Post-Mastectomy Period (Weeks 1 to 4)||18
8533358|NCT01208974|9566082|FG001|COMPLETED|Post-Mastectomy Period (Weeks 1 to 4)||0
8533359|NCT01208974|9566083|FG002|COMPLETED|Post-Mastectomy Period (Weeks 1 to 4)||0
8533360|NCT01208974|9566084|FG003|COMPLETED|Post-Mastectomy Period (Weeks 1 to 4)||0
8533361|NCT01208974|9566081|FG000|NOT COMPLETED|Post-Mastectomy Period (Weeks 1 to 4)||3
8533362|NCT01208974|9566082|FG001|NOT COMPLETED|Post-Mastectomy Period (Weeks 1 to 4)||0
8533363|NCT01208974|9566083|FG002|NOT COMPLETED|Post-Mastectomy Period (Weeks 1 to 4)||0
8533364|NCT01208974|9566084|FG003|NOT COMPLETED|Post-Mastectomy Period (Weeks 1 to 4)||0
8533365|NCT01208974|9566081|FG000|STARTED|Prophylactic NAC RT (Weeks 5 to 8)||0
8533366|NCT01208974|9566082|FG001|STARTED|Prophylactic NAC RT (Weeks 5 to 8)||6
8533367|NCT01208974|9566083|FG002|STARTED|Prophylactic NAC RT (Weeks 5 to 8)||6
8533368|NCT01208974|9566084|FG003|STARTED|Prophylactic NAC RT (Weeks 5 to 8)||6
8533369|NCT01208974|9566081|FG000|Cohort 1: Starting Dose|Prophylactic NAC RT (Weeks 5 to 8)||0
8533370|NCT01208974|9566082|FG001|Cohort 1: Starting Dose|Prophylactic NAC RT (Weeks 5 to 8)||6
8533371|NCT01208974|9566083|FG002|Cohort 1: Starting Dose|Prophylactic NAC RT (Weeks 5 to 8)||0
8533372|NCT01208974|9566084|FG003|Cohort 1: Starting Dose|Prophylactic NAC RT (Weeks 5 to 8)||0
8533373|NCT01208974|9566081|FG000|Cohort 2: 1st Dose Escalation|Prophylactic NAC RT (Weeks 5 to 8)||0
8533374|NCT01208974|9566082|FG001|Cohort 2: 1st Dose Escalation|Prophylactic NAC RT (Weeks 5 to 8)||0
8533375|NCT01208974|9566083|FG002|Cohort 2: 1st Dose Escalation|Prophylactic NAC RT (Weeks 5 to 8)||6
8533376|NCT01208974|9566084|FG003|Cohort 2: 1st Dose Escalation|Prophylactic NAC RT (Weeks 5 to 8)||0
8533377|NCT01208974|9566081|FG000|Cohort 3: 2nd Dose Escalation|Prophylactic NAC RT (Weeks 5 to 8)||0
8533378|NCT01208974|9566082|FG001|Cohort 3: 2nd Dose Escalation|Prophylactic NAC RT (Weeks 5 to 8)||0
8533379|NCT01208974|9566083|FG002|Cohort 3: 2nd Dose Escalation|Prophylactic NAC RT (Weeks 5 to 8)||0
8533380|NCT01208974|9566084|FG003|Cohort 3: 2nd Dose Escalation|Prophylactic NAC RT (Weeks 5 to 8)||6
8533381|NCT01208974|9566081|FG000|COMPLETED|Prophylactic NAC RT (Weeks 5 to 8)||0
8533382|NCT01208974|9566082|FG001|COMPLETED|Prophylactic NAC RT (Weeks 5 to 8)||6
8533383|NCT01208974|9566083|FG002|COMPLETED|Prophylactic NAC RT (Weeks 5 to 8)||6
8533384|NCT01208974|9566084|FG003|COMPLETED|Prophylactic NAC RT (Weeks 5 to 8)||6
8533385|NCT01208974|9566081|FG000|NOT COMPLETED|Prophylactic NAC RT (Weeks 5 to 8)||0
8533386|NCT01208974|9566082|FG001|NOT COMPLETED|Prophylactic NAC RT (Weeks 5 to 8)||0
8533387|NCT01208974|9566083|FG002|NOT COMPLETED|Prophylactic NAC RT (Weeks 5 to 8)||0
8533388|NCT01208974|9566084|FG003|NOT COMPLETED|Prophylactic NAC RT (Weeks 5 to 8)||0
8533389|NCT00938912|9566091|FG000|STARTED|Overall Study||365
8533390|NCT00938912|9566091|FG000|COMPLETED|Overall Study||254
8533391|NCT00938912|9566091|FG000|NOT COMPLETED|Overall Study||111
8533392|NCT00925652|9566102|FG000|STARTED|Overall Study||13
8533393|NCT00925652|9566103|FG001|STARTED|Overall Study||13
8533394|NCT00925652|9566104|FG002|STARTED|Overall Study||11
8533395|NCT00925652|9566105|FG003|STARTED|Overall Study||13
8533396|NCT00925652|9566102|FG000|Withdraw|Overall Study||6
8533397|NCT00925652|9566103|FG001|Withdraw|Overall Study||5
8533398|NCT00925652|9566104|FG002|Withdraw|Overall Study||3
8533399|NCT00925652|9566105|FG003|Withdraw|Overall Study||1
8533400|NCT00925652|9566102|FG000|Off Treatment Because of Other Complicating Disease|Overall Study||0
8533401|NCT00925652|9566103|FG001|Off Treatment Because of Other Complicating Disease|Overall Study||0
8533402|NCT00925652|9566104|FG002|Off Treatment Because of Other Complicating Disease|Overall Study||2
8533403|NCT00925652|9566105|FG003|Off Treatment Because of Other Complicating Disease|Overall Study||3
8533404|NCT00925652|9566102|FG000|Off Treatment Because of Disease Recurrence|Overall Study||1
8533405|NCT00925652|9566103|FG001|Off Treatment Because of Disease Recurrence|Overall Study||3
8533406|NCT00925652|9566104|FG002|Off Treatment Because of Disease Recurrence|Overall Study||0
8533407|NCT00925652|9566105|FG003|Off Treatment Because of Disease Recurrence|Overall Study||0
8533408|NCT00925652|9566102|FG000|Lost of Follow-up|Overall Study||0
8533409|NCT00925652|9566103|FG001|Lost of Follow-up|Overall Study||1
8533410|NCT00925652|9566104|FG002|Lost of Follow-up|Overall Study||0
8533411|NCT00925652|9566105|FG003|Lost of Follow-up|Overall Study||0
8533412|NCT00925652|9566102|FG000|Death|Overall Study||0
8533413|NCT00925652|9566103|FG001|Death|Overall Study||0
8533414|NCT00925652|9566104|FG002|Death|Overall Study||0
8533415|NCT00925652|9566105|FG003|Death|Overall Study||3
8533416|NCT00925652|9566102|FG000|COMPLETED|Overall Study||6
8533417|NCT00925652|9566103|FG001|COMPLETED|Overall Study||4
8533418|NCT00925652|9566104|FG002|COMPLETED|Overall Study||6
8533419|NCT00925652|9566105|FG003|COMPLETED|Overall Study||6
8533420|NCT00925652|9566102|FG000|NOT COMPLETED|Overall Study||7
8533421|NCT00925652|9566103|FG001|NOT COMPLETED|Overall Study||9
8533422|NCT00925652|9566104|FG002|NOT COMPLETED|Overall Study||5
8533423|NCT00925652|9566105|FG003|NOT COMPLETED|Overall Study||7
8533424|NCT00676715|9566127|FG000|STARTED|Overall Study||54
8533425|NCT00676715|9566128|FG001|STARTED|Overall Study||55
8533426|NCT00676715|9566129|FG002|STARTED|Overall Study||55
8533427|NCT00676715|9566130|FG003|STARTED|Overall Study||54
8533428|NCT00676715|9566127|FG000|COMPLETED|Overall Study||14
8533429|NCT00676715|9566128|FG001|COMPLETED|Overall Study||8
8533430|NCT00676715|9566129|FG002|COMPLETED|Overall Study||14
8533431|NCT00676715|9566130|FG003|COMPLETED|Overall Study||14
8533432|NCT00676715|9566127|FG000|NOT COMPLETED|Overall Study||40
8533433|NCT00676715|9566128|FG001|NOT COMPLETED|Overall Study||47
8533434|NCT00676715|9566129|FG002|NOT COMPLETED|Overall Study||41
8533435|NCT00676715|9566130|FG003|NOT COMPLETED|Overall Study||40
8533436|NCT00579826|9566142|FG000|STARTED|Overall Study||29
8533437|NCT00579826|9566143|FG001|STARTED|Overall Study||26
8533438|NCT00579826|9566142|FG000|6 Months|Overall Study|RPFNA for assessment for primary endpoint.|28
8533439|NCT00579826|9566143|FG001|6 Months|Overall Study|RPFNA for assessment for primary endpoint.|25
8533440|NCT00579826|9566142|FG000|COMPLETED|Overall Study|Optional open label letrozole months 6-12; followed by RPFNA,|24
8533441|NCT00579826|9566143|FG001|COMPLETED|Overall Study|Optional open label letrozole months 6-12; followed by RPFNA,|23
8533442|NCT00579826|9566142|FG000|NOT COMPLETED|Overall Study||5
8533443|NCT00579826|9566143|FG001|NOT COMPLETED|Overall Study||3
8533444|NCT00322218|9566151|FG000|STARTED|Overall Study||34
8533445|NCT00322218|9566152|FG001|STARTED|Overall Study||34
8533446|NCT00322218|9566151|FG000|Per-Protocol Set|Overall Study||33
8533447|NCT00322218|9566152|FG001|Per-Protocol Set|Overall Study||32
8533448|NCT00322218|9566151|FG000|COMPLETED|Overall Study||31
8533449|NCT00322218|9566152|FG001|COMPLETED|Overall Study||28
8533450|NCT00322218|9566151|FG000|NOT COMPLETED|Overall Study||3
8533451|NCT00322218|9566152|FG001|NOT COMPLETED|Overall Study||6
8533452|NCT00186888|9566161|FG000|STARTED|Overall Study||23
8533453|NCT00186888|9566162|FG001|STARTED|Overall Study||27
8533454|NCT00186888|9566163|FG002|STARTED|Overall Study||55
8533455|NCT00186888|9566161|FG000|Window Therapy|Overall Study||0
8533456|NCT00186888|9566162|FG001|Window Therapy|Overall Study||27
8533457|NCT00186888|9566163|FG002|Window Therapy|Overall Study||0
8533458|NCT00186888|9566161|FG000|COMPLETED|Overall Study||19
8533459|NCT00186888|9566162|FG001|COMPLETED|Overall Study||24
8533460|NCT00186888|9566163|FG002|COMPLETED|Overall Study||55
8533461|NCT00186888|9566161|FG000|NOT COMPLETED|Overall Study||4
8533462|NCT00186888|9566162|FG001|NOT COMPLETED|Overall Study||3
8533463|NCT00186888|9566163|FG002|NOT COMPLETED|Overall Study||0
8564705|NCT00062647|9596910|FG001|COMPLETED|Overall Study||17
8564706|NCT00062647|9596909|FG000|NOT COMPLETED|Overall Study||16
8564707|NCT00062647|9596910|FG001|NOT COMPLETED|Overall Study||13
8564708|NCT00062738|9596919|FG000|STARTED|Overall Study||17
8564709|NCT00062738|9596920|FG001|STARTED|Overall Study||18
8564710|NCT00062738|9596921|FG002|STARTED|Overall Study||17
8564711|NCT00062738|9596919|FG000|COMPLETED|Overall Study||17
8816425|NCT01544166|9869942|FG000|NOT COMPLETED|Overall Study||0
8533464|NCT04579549|9566198|FG000|STARTED|Overall Study||464
8533465|NCT04579549|9566198|FG000|Number of Individuals Trained In COVID-19 Assay|Overall Study||11
8533466|NCT04579549|9566198|FG000|COMPLETED|Overall Study||464
8533467|NCT04579549|9566198|FG000|NOT COMPLETED|Overall Study||0
8533534|NCT03740100|9566269|FG000|STARTED|Overall Study|Note: Ten patients were consented, but two died before starting therapy.|8
8533535|NCT03740100|9566269|FG000|Confirmed Partial Response|Overall Study|"Using a Simon's optimal two-stage design, we planned to enroll up to 10 evaluable patients in the first stage.~Two of eight treated patients were not evaluable for response based on toxicity.~We did not reach this milestone."|1
8533536|NCT03740100|9566269|FG000|COMPLETED|Overall Study||6
8533537|NCT03740100|9566269|FG000|NOT COMPLETED|Overall Study||2
8533538|NCT03597295|9566273|FG000|STARTED|Overall Study||94
8533539|NCT03597295|9566273|FG000|COMPLETED|Overall Study||0
8533540|NCT03597295|9566273|FG000|NOT COMPLETED|Overall Study||94
8533541|NCT03086369|9566283|FG000|STARTED|Overall Study||3
8533542|NCT03086369|9566284|FG001|STARTED|Overall Study||7
8533543|NCT03086369|9566285|FG002|STARTED|Overall Study||12
8533544|NCT03086369|9566286|FG003|STARTED|Overall Study||82
8533545|NCT03086369|9566287|FG004|STARTED|Overall Study||80
8533546|NCT03086369|9566283|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
8533547|NCT03086369|9566284|FG001|Received at Least 1 Dose of Study Drug|Overall Study||7
8533548|NCT03086369|9566285|FG002|Received at Least 1 Dose of Study Drug|Overall Study||12
8533549|NCT03086369|9566286|FG003|Received at Least 1 Dose of Study Drug|Overall Study||81
8533550|NCT03086369|9566287|FG004|Received at Least 1 Dose of Study Drug|Overall Study||78
8816426|NCT01544179|9869951|FG000|STARTED|Overall Study||133
8816427|NCT01544179|9869952|FG001|STARTED|Overall Study||132
8816428|NCT01544179|9869951|FG000|Received Treatment|Overall Study||132
8620834|NCT00475865|9659666|FG002|COMPLETED|Overall Study|completed treatment period|34
8816429|NCT01544179|9869952|FG001|Received Treatment|Overall Study||132
8533551|NCT03086369|9566283|FG000|COMPLETED|Overall Study||2
8533552|NCT03086369|9566284|FG001|COMPLETED|Overall Study||7
8533553|NCT03086369|9566285|FG002|COMPLETED|Overall Study||12
8533554|NCT03086369|9566286|FG003|COMPLETED|Overall Study||55
8533555|NCT03086369|9566287|FG004|COMPLETED|Overall Study||59
8533556|NCT03086369|9566283|FG000|NOT COMPLETED|Overall Study||1
8533557|NCT03086369|9566284|FG001|NOT COMPLETED|Overall Study||0
8533558|NCT03086369|9566285|FG002|NOT COMPLETED|Overall Study||0
8533559|NCT03086369|9566286|FG003|NOT COMPLETED|Overall Study||27
8533560|NCT03086369|9566287|FG004|NOT COMPLETED|Overall Study||21
8533561|NCT03053362|9566303|FG000|STARTED|Overall Study||100
8533562|NCT03053362|9566304|FG001|STARTED|Overall Study||58
8533563|NCT03053362|9566303|FG000|COMPLETED|Overall Study||83
8533564|NCT03053362|9566304|FG001|COMPLETED|Overall Study||50
8533565|NCT03053362|9566303|FG000|NOT COMPLETED|Overall Study||17
8533566|NCT03053362|9566304|FG001|NOT COMPLETED|Overall Study||8
8533567|NCT02849626|9566313|FG000|STARTED|Core Phase (up to 23 Weeks)||149
8533568|NCT02849626|9566314|FG001|STARTED|Core Phase (up to 23 Weeks)||31
8533569|NCT02849626|9566313|FG000|COMPLETED|Core Phase (up to 23 Weeks)||122
8533570|NCT02849626|9566314|FG001|COMPLETED|Core Phase (up to 23 Weeks)||24
8533571|NCT02849626|9566313|FG000|NOT COMPLETED|Core Phase (up to 23 Weeks)||27
8533572|NCT02849626|9566314|FG001|NOT COMPLETED|Core Phase (up to 23 Weeks)||7
8533573|NCT02849626|9566313|FG000|STARTED|Extension Phase A (up to 29 Weeks)||116
8533574|NCT02849626|9566314|FG001|STARTED|Extension Phase A (up to 29 Weeks)||20
8533575|NCT02849626|9566313|FG000|COMPLETED|Extension Phase A (up to 29 Weeks)||105
8533576|NCT02849626|9566314|FG001|COMPLETED|Extension Phase A (up to 29 Weeks)||17
8533577|NCT02849626|9566313|FG000|NOT COMPLETED|Extension Phase A (up to 29 Weeks)||11
8533578|NCT02849626|9566314|FG001|NOT COMPLETED|Extension Phase A (up to 29 Weeks)||3
8533579|NCT02779855|9566333|FG000|STARTED|Overall Study||4
8533580|NCT02779855|9566334|FG001|STARTED|Overall Study||6
8533581|NCT02779855|9566335|FG002|STARTED|Overall Study||40
8533582|NCT02779855|9566333|FG000|COMPLETED|Overall Study||3
8533583|NCT02779855|9566334|FG001|COMPLETED|Overall Study||6
8533584|NCT02779855|9566335|FG002|COMPLETED|Overall Study||40
8533585|NCT02779855|9566333|FG000|NOT COMPLETED|Overall Study||1
8533586|NCT02779855|9566334|FG001|NOT COMPLETED|Overall Study||0
8533587|NCT02779855|9566335|FG002|NOT COMPLETED|Overall Study||0
8533588|NCT02654132|9566346|FG000|STARTED|Overall Study||60
8533589|NCT02654132|9566347|FG001|STARTED|Overall Study||57
8533590|NCT02654132|9566346|FG000|COMPLETED|Overall Study||24
8533591|NCT02654132|9566347|FG001|COMPLETED|Overall Study||11
8533592|NCT02654132|9566346|FG000|NOT COMPLETED|Overall Study||36
8533593|NCT02654132|9566347|FG001|NOT COMPLETED|Overall Study||46
8533594|NCT02603432|9566356|FG000|STARTED|Overall Study||350
8533595|NCT02603432|9566357|FG001|STARTED|Overall Study||350
8533596|NCT02603432|9566356|FG000|COMPLETED|Overall Study||0
8533597|NCT02603432|9566357|FG001|COMPLETED|Overall Study||0
8533598|NCT02603432|9566356|FG000|NOT COMPLETED|Overall Study||350
8816430|NCT01544179|9869951|FG000|Did Not Receive Treatment|Overall Study||1
8533599|NCT02603432|9566357|FG001|NOT COMPLETED|Overall Study||350
8533600|NCT02600923|9566363|FG000|STARTED|Overall Study||131
8533601|NCT02600923|9566363|FG000|Treated|Overall Study||130
8533602|NCT02600923|9566363|FG000|COMPLETED|Overall Study||0
8533603|NCT02600923|9566363|FG000|NOT COMPLETED|Overall Study||131
8533604|NCT02597790|9566369|FG000|STARTED|Overall Study||45
8533605|NCT02597790|9566370|FG001|STARTED|Overall Study||41
8533606|NCT02597790|9566369|FG000|COMPLETED|Overall Study||36
8533607|NCT02597790|9566370|FG001|COMPLETED|Overall Study||29
8533468|NCT04460690|9566204|FG000|STARTED|Overall Study||93
8533469|NCT04460690|9566204|FG000|Community Participants|Overall Study||83
8533470|NCT04460690|9566204|FG000|Investigator Participants|Overall Study||10
8533471|NCT04460690|9566204|FG000|COMPLETED|Overall Study||93
8533472|NCT04460690|9566204|FG000|NOT COMPLETED|Overall Study||0
8620835|NCT00475865|9659664|FG000|NOT COMPLETED|Overall Study||2
8620836|NCT00475865|9659665|FG001|NOT COMPLETED|Overall Study||5
8620837|NCT00475865|9659666|FG002|NOT COMPLETED|Overall Study||6
8533473|NCT04374019|9566215|FG000|STARTED|Overall Study||1
8533474|NCT04374019|9566216|FG001|STARTED|Overall Study||1
8533475|NCT04374019|9566217|FG002|STARTED|Overall Study||6
8533476|NCT04374019|9566218|FG003|STARTED|Overall Study||5
8533477|NCT04374019|9566215|FG000|COMPLETED|Overall Study||1
8533478|NCT04374019|9566216|FG001|COMPLETED|Overall Study||1
8533479|NCT04374019|9566217|FG002|COMPLETED|Overall Study||5
8533480|NCT04374019|9566218|FG003|COMPLETED|Overall Study||5
8533481|NCT04374019|9566215|FG000|NOT COMPLETED|Overall Study||0
8533482|NCT04374019|9566216|FG001|NOT COMPLETED|Overall Study||0
8533483|NCT04374019|9566217|FG002|NOT COMPLETED|Overall Study||1
8533484|NCT04374019|9566218|FG003|NOT COMPLETED|Overall Study||0
8533485|NCT04357730|9566232|FG000|STARTED|Phase 1||17
8533486|NCT04357730|9566233|FG001|STARTED|Phase 1||19
8533487|NCT04357730|9566234|FG002|STARTED|Phase 1||0
8533488|NCT04357730|9566232|FG000|COMPLETED|Phase 1||17
8533489|NCT04357730|9566233|FG001|COMPLETED|Phase 1||19
8620838|NCT00475878|9659678|FG000|STARTED|Overall Study||75
8620839|NCT00475878|9659679|FG001|STARTED|Overall Study||72
8620840|NCT00475878|9659678|FG000|COMPLETED|Overall Study||75
8620841|NCT00475878|9659679|FG001|COMPLETED|Overall Study||72
8620842|NCT00475878|9659678|FG000|NOT COMPLETED|Overall Study||0
8620843|NCT00475878|9659679|FG001|NOT COMPLETED|Overall Study||0
8620844|NCT00475904|9659690|FG000|STARTED|Overall Study||140
8620845|NCT00475904|9659691|FG001|STARTED|Overall Study||144
8620846|NCT00475904|9659692|FG002|STARTED|Overall Study||76
8816431|NCT01544179|9869952|FG001|Did Not Receive Treatment|Overall Study||0
8816432|NCT01544179|9869951|FG000|COMPLETED|Overall Study|Patients are ongoing in the study|70
8533490|NCT04357730|9566234|FG002|COMPLETED|Phase 1||0
8533491|NCT04357730|9566232|FG000|NOT COMPLETED|Phase 1||0
8533492|NCT04357730|9566233|FG001|NOT COMPLETED|Phase 1||0
8533493|NCT04357730|9566234|FG002|NOT COMPLETED|Phase 1||0
8533494|NCT04357730|9566232|FG000|STARTED|Phase 2||8
8533495|NCT04357730|9566233|FG001|STARTED|Phase 2||0
8533496|NCT04357730|9566234|FG002|STARTED|Phase 2||6
8533497|NCT04357730|9566232|FG000|COMPLETED|Phase 2||8
8533498|NCT04357730|9566233|FG001|COMPLETED|Phase 2||0
8533499|NCT04357730|9566234|FG002|COMPLETED|Phase 2||6
8533500|NCT04357730|9566232|FG000|NOT COMPLETED|Phase 2||0
8533501|NCT04357730|9566233|FG001|NOT COMPLETED|Phase 2||0
8533502|NCT04357730|9566234|FG002|NOT COMPLETED|Phase 2||0
8533503|NCT04311463|9566248|FG000|STARTED|Period 1 (Up to Day 3)||19
8533504|NCT04311463|9566249|FG001|STARTED|Period 1 (Up to Day 3)||19
8533505|NCT04311463|9566248|FG000|COMPLETED|Period 1 (Up to Day 3)||18
8533506|NCT04311463|9566249|FG001|COMPLETED|Period 1 (Up to Day 3)||19
8533507|NCT04311463|9566248|FG000|NOT COMPLETED|Period 1 (Up to Day 3)||1
8533508|NCT04311463|9566249|FG001|NOT COMPLETED|Period 1 (Up to Day 3)||0
8533509|NCT04311463|9566248|FG000|STARTED|Washout Period (Up to Day 7)||18
8533510|NCT04311463|9566249|FG001|STARTED|Washout Period (Up to Day 7)||19
8533511|NCT04311463|9566248|FG000|COMPLETED|Washout Period (Up to Day 7)||17
8533512|NCT04311463|9566249|FG001|COMPLETED|Washout Period (Up to Day 7)||18
8533513|NCT04311463|9566248|FG000|NOT COMPLETED|Washout Period (Up to Day 7)||1
8533514|NCT04311463|9566249|FG001|NOT COMPLETED|Washout Period (Up to Day 7)||1
8533515|NCT04311463|9566248|FG000|STARTED|Period 2 (Up to Day 3)||17
8533516|NCT04311463|9566249|FG001|STARTED|Period 2 (Up to Day 3)||18
8533517|NCT04311463|9566248|FG000|COMPLETED|Period 2 (Up to Day 3)||15
8533518|NCT04311463|9566249|FG001|COMPLETED|Period 2 (Up to Day 3)||17
8533519|NCT04311463|9566248|FG000|NOT COMPLETED|Period 2 (Up to Day 3)||2
8533520|NCT04311463|9566249|FG001|NOT COMPLETED|Period 2 (Up to Day 3)||1
8533521|NCT04175509|9566258|FG000|STARTED|Overall Study||19
8533522|NCT04175509|9566259|FG001|STARTED|Overall Study||21
8533523|NCT04175509|9566258|FG000|COMPLETED|Overall Study||17
8533524|NCT04175509|9566259|FG001|COMPLETED|Overall Study||19
8533525|NCT04175509|9566258|FG000|NOT COMPLETED|Overall Study||2
8533526|NCT04175509|9566259|FG001|NOT COMPLETED|Overall Study||2
8533527|NCT03930186|9566265|FG000|STARTED|Weeks 0 to 16||152
8533528|NCT03930186|9566265|FG000|Received Study Drug|Weeks 0 to 16||152
8533529|NCT03930186|9566265|FG000|COMPLETED|Weeks 0 to 16||140
8533530|NCT03930186|9566265|FG000|NOT COMPLETED|Weeks 0 to 16||12
8533531|NCT03930186|9566265|FG000|STARTED|Weeks 16 to 32||140
8533532|NCT03930186|9566265|FG000|COMPLETED|Weeks 16 to 32||136
8533533|NCT03930186|9566265|FG000|NOT COMPLETED|Weeks 16 to 32||4
8533608|NCT02597790|9566369|FG000|NOT COMPLETED|Overall Study||9
8620847|NCT00475904|9659690|FG000|COMPLETED|Overall Study||125
8533609|NCT02597790|9566370|FG001|NOT COMPLETED|Overall Study||12
8533610|NCT02484664|9566381|FG000|STARTED|Overall Study||12
8533611|NCT02484664|9566381|FG000|COMPLETED|Overall Study||9
8533612|NCT02484664|9566381|FG000|NOT COMPLETED|Overall Study||3
8533613|NCT02412735|9566388|FG000|STARTED|Overall Study||143
8533614|NCT02412735|9566389|FG001|STARTED|Overall Study||129
8533615|NCT02412735|9566390|FG002|STARTED|Overall Study||132
8533616|NCT02412735|9566388|FG000|Received Treatment|Overall Study||140
8533617|NCT02412735|9566389|FG001|Received Treatment|Overall Study||128
8533618|NCT02412735|9566390|FG002|Received Treatment|Overall Study||130
8533619|NCT02412735|9566388|FG000|COMPLETED|Overall Study||97
8533620|NCT02412735|9566389|FG001|COMPLETED|Overall Study||85
8533621|NCT02412735|9566390|FG002|COMPLETED|Overall Study||86
8533622|NCT02412735|9566388|FG000|NOT COMPLETED|Overall Study||46
8533623|NCT02412735|9566389|FG001|NOT COMPLETED|Overall Study||44
8533624|NCT02412735|9566390|FG002|NOT COMPLETED|Overall Study||46
8533625|NCT02371889|9566400|FG000|STARTED|Overall Study||85
8533626|NCT02371889|9566401|FG001|STARTED|Overall Study||85
8533627|NCT02371889|9566400|FG000|COMPLETED|Overall Study||66
8533628|NCT02371889|9566401|FG001|COMPLETED|Overall Study||71
8533629|NCT02371889|9566400|FG000|NOT COMPLETED|Overall Study||19
8533630|NCT02371889|9566401|FG001|NOT COMPLETED|Overall Study||14
8533631|NCT02272803|9566413|FG000|STARTED|Overall Study||40
8533632|NCT02272803|9566414|FG001|STARTED|Overall Study||42
8533633|NCT02272803|9566413|FG000|COMPLETED|Overall Study|Completed = Still receiving treatment|31
8533634|NCT02272803|9566414|FG001|COMPLETED|Overall Study|Completed = Still receiving treatment|25
8533635|NCT02272803|9566413|FG000|NOT COMPLETED|Overall Study||9
8533636|NCT02272803|9566414|FG001|NOT COMPLETED|Overall Study||17
8564712|NCT00062738|9596920|FG001|COMPLETED|Overall Study||18
8564713|NCT00062738|9596921|FG002|COMPLETED|Overall Study||17
8564714|NCT00062738|9596919|FG000|NOT COMPLETED|Overall Study||0
8564715|NCT00062738|9596920|FG001|NOT COMPLETED|Overall Study||0
8564716|NCT00062738|9596921|FG002|NOT COMPLETED|Overall Study||0
8564717|NCT00062764|9596932|FG000|STARTED|Overall Study||18
8564718|NCT00062764|9596932|FG000|COMPLETED|Overall Study||18
8564719|NCT00062764|9596932|FG000|NOT COMPLETED|Overall Study||0
8564720|NCT00062868|9596957|FG000|STARTED|Dose Level 1||3
8564721|NCT00062868|9596958|FG001|STARTED|Dose Level 1||0
8564722|NCT00062868|9596959|FG002|STARTED|Dose Level 1||0
8564723|NCT00062868|9596960|FG003|STARTED|Dose Level 1||3
8564724|NCT00062868|9596961|FG004|STARTED|Dose Level 1||0
8564725|NCT00062868|9596962|FG005|STARTED|Dose Level 1||0
8564726|NCT00062868|9596963|FG006|STARTED|Dose Level 1||4
8564727|NCT00062868|9596964|FG007|STARTED|Dose Level 1||0
8564728|NCT00062868|9596965|FG008|STARTED|Dose Level 1||0
8564729|NCT00062868|9596966|FG009|STARTED|Dose Level 1||3
8564730|NCT00062868|9596967|FG010|STARTED|Dose Level 1||0
8564731|NCT00062868|9596968|FG011|STARTED|Dose Level 1||0
8564732|NCT00062868|9596969|FG012|STARTED|Dose Level 1||3
8564733|NCT00062868|9596970|FG013|STARTED|Dose Level 1||0
8564734|NCT00062868|9596971|FG014|STARTED|Dose Level 1||0
8564735|NCT00062868|9596972|FG015|STARTED|Dose Level 1||3
8564736|NCT00062868|9596973|FG016|STARTED|Dose Level 1||0
8564737|NCT00062868|9596974|FG017|STARTED|Dose Level 1||0
8564738|NCT00062868|9596975|FG018|STARTED|Dose Level 1||16
8564739|NCT00062868|9596976|FG019|STARTED|Dose Level 1||2
8564740|NCT00062868|9596977|FG020|STARTED|Dose Level 1||3
8564741|NCT00062868|9596957|FG000|COMPLETED|Dose Level 1||1
8564742|NCT00062868|9596958|FG001|COMPLETED|Dose Level 1||0
8564743|NCT00062868|9596959|FG002|COMPLETED|Dose Level 1||0
8564744|NCT00062868|9596960|FG003|COMPLETED|Dose Level 1||1
8564745|NCT00062868|9596961|FG004|COMPLETED|Dose Level 1||0
8564746|NCT00062868|9596962|FG005|COMPLETED|Dose Level 1||0
8564747|NCT00062868|9596963|FG006|COMPLETED|Dose Level 1||1
8564748|NCT00062868|9596964|FG007|COMPLETED|Dose Level 1||0
8564749|NCT00062868|9596965|FG008|COMPLETED|Dose Level 1||0
8564750|NCT00062868|9596966|FG009|COMPLETED|Dose Level 1||3
8564751|NCT00062868|9596967|FG010|COMPLETED|Dose Level 1||0
8564752|NCT00062868|9596968|FG011|COMPLETED|Dose Level 1||0
8564753|NCT00062868|9596969|FG012|COMPLETED|Dose Level 1||2
8564754|NCT00062868|9596970|FG013|COMPLETED|Dose Level 1||0
8564755|NCT00062868|9596971|FG014|COMPLETED|Dose Level 1||0
8564756|NCT00062868|9596972|FG015|COMPLETED|Dose Level 1||3
8564757|NCT00062868|9596973|FG016|COMPLETED|Dose Level 1||0
8564758|NCT00062868|9596974|FG017|COMPLETED|Dose Level 1||0
8564759|NCT00062868|9596975|FG018|COMPLETED|Dose Level 1||7
8564760|NCT00062868|9596976|FG019|COMPLETED|Dose Level 1||2
8564761|NCT00062868|9596977|FG020|COMPLETED|Dose Level 1||1
8564762|NCT00062868|9596957|FG000|NOT COMPLETED|Dose Level 1||2
8564763|NCT00062868|9596958|FG001|NOT COMPLETED|Dose Level 1||0
8564764|NCT00062868|9596959|FG002|NOT COMPLETED|Dose Level 1||0
8564765|NCT00062868|9596960|FG003|NOT COMPLETED|Dose Level 1||2
8564766|NCT00062868|9596961|FG004|NOT COMPLETED|Dose Level 1||0
8564767|NCT00062868|9596962|FG005|NOT COMPLETED|Dose Level 1||0
8564768|NCT00062868|9596963|FG006|NOT COMPLETED|Dose Level 1||3
8564769|NCT00062868|9596964|FG007|NOT COMPLETED|Dose Level 1||0
8564770|NCT00062868|9596965|FG008|NOT COMPLETED|Dose Level 1||0
8564771|NCT00062868|9596966|FG009|NOT COMPLETED|Dose Level 1||0
8564772|NCT00062868|9596967|FG010|NOT COMPLETED|Dose Level 1||0
8564773|NCT00062868|9596968|FG011|NOT COMPLETED|Dose Level 1||0
8564774|NCT00062868|9596969|FG012|NOT COMPLETED|Dose Level 1||1
8564775|NCT00062868|9596970|FG013|NOT COMPLETED|Dose Level 1||0
8564776|NCT00062868|9596971|FG014|NOT COMPLETED|Dose Level 1||0
8564777|NCT00062868|9596972|FG015|NOT COMPLETED|Dose Level 1||0
8564778|NCT00062868|9596973|FG016|NOT COMPLETED|Dose Level 1||0
8564779|NCT00062868|9596974|FG017|NOT COMPLETED|Dose Level 1||0
8564780|NCT00062868|9596975|FG018|NOT COMPLETED|Dose Level 1||9
8564781|NCT00062868|9596976|FG019|NOT COMPLETED|Dose Level 1||0
8564782|NCT00062868|9596977|FG020|NOT COMPLETED|Dose Level 1||2
8564783|NCT00062868|9596957|FG000|STARTED|Dose Level 2||0
8564784|NCT00062868|9596958|FG001|STARTED|Dose Level 2||6
8564785|NCT00062868|9596959|FG002|STARTED|Dose Level 2||0
8564786|NCT00062868|9596960|FG003|STARTED|Dose Level 2||0
8533637|NCT02186834|9566420|FG000|STARTED|Dose Escalation||6
8533638|NCT02186834|9566421|FG001|STARTED|Dose Escalation||3
8533639|NCT02186834|9566422|FG002|STARTED|Dose Escalation||0
8533640|NCT02186834|9566423|FG003|STARTED|Dose Escalation||7
8533641|NCT02186834|9566424|FG004|STARTED|Dose Escalation||4
8533642|NCT02186834|9566425|FG005|STARTED|Dose Escalation||0
8533643|NCT02186834|9566420|FG000|COMPLETED|Dose Escalation||6
8533644|NCT02186834|9566421|FG001|COMPLETED|Dose Escalation||3
8533645|NCT02186834|9566422|FG002|COMPLETED|Dose Escalation||0
8533646|NCT02186834|9566423|FG003|COMPLETED|Dose Escalation||6
8533647|NCT02186834|9566424|FG004|COMPLETED|Dose Escalation||4
8533648|NCT02186834|9566425|FG005|COMPLETED|Dose Escalation||0
8533649|NCT02186834|9566420|FG000|NOT COMPLETED|Dose Escalation||0
8533650|NCT02186834|9566421|FG001|NOT COMPLETED|Dose Escalation||0
8533651|NCT02186834|9566422|FG002|NOT COMPLETED|Dose Escalation||0
8533652|NCT02186834|9566423|FG003|NOT COMPLETED|Dose Escalation||1
8533653|NCT02186834|9566424|FG004|NOT COMPLETED|Dose Escalation||0
8533654|NCT02186834|9566425|FG005|NOT COMPLETED|Dose Escalation||0
8533655|NCT02186834|9566420|FG000|STARTED|Treatment at RP2D||0
8533656|NCT02186834|9566421|FG001|STARTED|Treatment at RP2D||0
8533657|NCT02186834|9566422|FG002|STARTED|Treatment at RP2D||0
8533658|NCT02186834|9566423|FG003|STARTED|Treatment at RP2D||0
8533659|NCT02186834|9566424|FG004|STARTED|Treatment at RP2D||0
8533660|NCT02186834|9566425|FG005|STARTED|Treatment at RP2D||14
8533661|NCT02186834|9566420|FG000|COMPLETED|Treatment at RP2D||0
8533662|NCT02186834|9566421|FG001|COMPLETED|Treatment at RP2D||0
8533663|NCT02186834|9566422|FG002|COMPLETED|Treatment at RP2D||0
8533664|NCT02186834|9566423|FG003|COMPLETED|Treatment at RP2D||0
8533665|NCT02186834|9566424|FG004|COMPLETED|Treatment at RP2D||0
8533666|NCT02186834|9566425|FG005|COMPLETED|Treatment at RP2D||13
8533667|NCT02186834|9566420|FG000|NOT COMPLETED|Treatment at RP2D||0
8533668|NCT02186834|9566421|FG001|NOT COMPLETED|Treatment at RP2D||0
8533669|NCT02186834|9566422|FG002|NOT COMPLETED|Treatment at RP2D||0
8533670|NCT02186834|9566423|FG003|NOT COMPLETED|Treatment at RP2D||0
8533671|NCT02186834|9566424|FG004|NOT COMPLETED|Treatment at RP2D||0
8533672|NCT02186834|9566425|FG005|NOT COMPLETED|Treatment at RP2D||1
8533673|NCT02121158|9566436|FG000|STARTED|Overall Study||85
8533674|NCT02121158|9566437|FG001|STARTED|Overall Study||82
8533675|NCT02121158|9566436|FG000|COMPLETED|Overall Study||85
8533676|NCT02121158|9566437|FG001|COMPLETED|Overall Study||82
8533677|NCT02121158|9566436|FG000|NOT COMPLETED|Overall Study||0
8533678|NCT02121158|9566437|FG001|NOT COMPLETED|Overall Study||0
8533679|NCT02100722|9566445|FG000|STARTED|Overall Study||757
8533680|NCT02100722|9566446|FG001|STARTED|Overall Study||743
8533681|NCT02100722|9566445|FG000|Underwent Alternate Procedure|Overall Study||11
8533682|NCT02100722|9566446|FG001|Underwent Alternate Procedure|Overall Study||37
8533683|NCT02100722|9566445|FG000|COMPLETED|Overall Study||0
8533684|NCT02100722|9566446|FG001|COMPLETED|Overall Study||0
8533685|NCT02100722|9566445|FG000|NOT COMPLETED|Overall Study||757
8533686|NCT02100722|9566446|FG001|NOT COMPLETED|Overall Study||743
8533687|NCT02046096|9566455|FG000|STARTED|Overall Study||149
8533688|NCT02046096|9566456|FG001|STARTED|Overall Study||324
8533689|NCT02046096|9566455|FG000|COMPLETED|Overall Study||105
8533690|NCT02046096|9566456|FG001|COMPLETED|Overall Study||223
8533691|NCT02046096|9566455|FG000|NOT COMPLETED|Overall Study||44
8533692|NCT02046096|9566456|FG001|NOT COMPLETED|Overall Study||101
8533693|NCT01945775|9566466|FG000|STARTED|Overall Study||287
8533694|NCT01945775|9566467|FG001|STARTED|Overall Study||144
8533695|NCT01945775|9566466|FG000|Treated|Overall Study||286
8620848|NCT00475904|9659691|FG001|COMPLETED|Overall Study||131
8620849|NCT00475904|9659692|FG002|COMPLETED|Overall Study||72
8620850|NCT00475904|9659690|FG000|NOT COMPLETED|Overall Study||15
8533696|NCT01945775|9566467|FG001|Treated|Overall Study||126
8533697|NCT01945775|9566466|FG000|COMPLETED|Overall Study||0
8533698|NCT01945775|9566467|FG001|COMPLETED|Overall Study||0
8533699|NCT01945775|9566466|FG000|NOT COMPLETED|Overall Study||287
8533700|NCT01945775|9566467|FG001|NOT COMPLETED|Overall Study||144
8533701|NCT01781637|9566475|FG000|STARTED|Overall Study||28
8620851|NCT00475904|9659691|FG001|NOT COMPLETED|Overall Study||13
8620852|NCT00475904|9659692|FG002|NOT COMPLETED|Overall Study||4
8620853|NCT00475982|9659702|FG000|STARTED|Overall Study||23
8620854|NCT00475982|9659703|FG001|STARTED|Overall Study||21
8620855|NCT00475982|9659702|FG000|COMPLETED|Overall Study||16
8533702|NCT01781637|9566476|FG001|STARTED|Overall Study||8
8533703|NCT01781637|9566475|FG000|COMPLETED|Overall Study||24
8533704|NCT01781637|9566476|FG001|COMPLETED|Overall Study||2
8533705|NCT01781637|9566475|FG000|NOT COMPLETED|Overall Study||4
8533706|NCT01781637|9566476|FG001|NOT COMPLETED|Overall Study||6
8533707|NCT01711541|9566487|FG000|STARTED|Overall Study||4
8533708|NCT01711541|9566488|FG001|STARTED|Overall Study||4
8533709|NCT01711541|9566489|FG002|STARTED|Overall Study||3
8533710|NCT01711541|9566490|FG003|STARTED|Overall Study||6
8533711|NCT01711541|9566491|FG004|STARTED|Overall Study||7
8533712|NCT01711541|9566487|FG000|COMPLETED|Overall Study||4
8533713|NCT01711541|9566488|FG001|COMPLETED|Overall Study||3
8533714|NCT01711541|9566489|FG002|COMPLETED|Overall Study||3
8620856|NCT00475982|9659703|FG001|COMPLETED|Overall Study||18
8620857|NCT00475982|9659702|FG000|NOT COMPLETED|Overall Study||7
8533715|NCT01711541|9566490|FG003|COMPLETED|Overall Study||5
8533716|NCT01711541|9566491|FG004|COMPLETED|Overall Study||7
8533717|NCT01711541|9566487|FG000|NOT COMPLETED|Overall Study||0
8533718|NCT01711541|9566488|FG001|NOT COMPLETED|Overall Study||1
8620858|NCT00475982|9659703|FG001|NOT COMPLETED|Overall Study||3
8620859|NCT00476008|9659711|FG000|STARTED|Overall Study||22
8620860|NCT00476008|9659712|FG001|STARTED|Overall Study||21
8620861|NCT00476008|9659711|FG000|6 Month Testing|Overall Study||15
8533719|NCT01711541|9566489|FG002|NOT COMPLETED|Overall Study||0
8533720|NCT01711541|9566490|FG003|NOT COMPLETED|Overall Study||1
8533721|NCT01711541|9566491|FG004|NOT COMPLETED|Overall Study||0
8533722|NCT01670539|9566508|FG000|STARTED|Overall Study||26
8533723|NCT01670539|9566509|FG001|STARTED|Overall Study||21
8533724|NCT01670539|9566508|FG000|COMPLETED|Overall Study||20
8533725|NCT01670539|9566509|FG001|COMPLETED|Overall Study||16
8533726|NCT01670539|9566508|FG000|NOT COMPLETED|Overall Study||6
8533727|NCT01670539|9566509|FG001|NOT COMPLETED|Overall Study||5
8533728|NCT00407602|9566516|FG000|STARTED|Overall Study||30
8533729|NCT00407602|9566516|FG000|COMPLETED|Overall Study||23
8533730|NCT00407602|9566516|FG000|NOT COMPLETED|Overall Study||7
8564787|NCT00062868|9596961|FG004|STARTED|Dose Level 2||3
8564788|NCT00062868|9596962|FG005|STARTED|Dose Level 2||0
8564789|NCT00062868|9596963|FG006|STARTED|Dose Level 2||0
8564790|NCT00062868|9596964|FG007|STARTED|Dose Level 2||0
8564791|NCT00062868|9596965|FG008|STARTED|Dose Level 2||0
8564792|NCT00062868|9596966|FG009|STARTED|Dose Level 2||0
8564793|NCT00062868|9596967|FG010|STARTED|Dose Level 2||4
8564794|NCT00062868|9596968|FG011|STARTED|Dose Level 2||0
8564795|NCT00062868|9596969|FG012|STARTED|Dose Level 2||0
8564796|NCT00062868|9596970|FG013|STARTED|Dose Level 2||3
8564797|NCT00062868|9596971|FG014|STARTED|Dose Level 2||0
8564798|NCT00062868|9596972|FG015|STARTED|Dose Level 2||0
8564799|NCT00062868|9596973|FG016|STARTED|Dose Level 2||3
8564800|NCT00062868|9596974|FG017|STARTED|Dose Level 2||0
8564801|NCT00062868|9596975|FG018|STARTED|Dose Level 2||0
8564802|NCT00062868|9596976|FG019|STARTED|Dose Level 2||0
8564803|NCT00062868|9596977|FG020|STARTED|Dose Level 2||0
8564804|NCT00062868|9596957|FG000|COMPLETED|Dose Level 2||0
8564805|NCT00062868|9596958|FG001|COMPLETED|Dose Level 2||3
8564806|NCT00062868|9596959|FG002|COMPLETED|Dose Level 2||0
8564807|NCT00062868|9596960|FG003|COMPLETED|Dose Level 2||0
8564808|NCT00062868|9596961|FG004|COMPLETED|Dose Level 2||1
8564809|NCT00062868|9596962|FG005|COMPLETED|Dose Level 2||0
8564810|NCT00062868|9596963|FG006|COMPLETED|Dose Level 2||0
8564811|NCT00062868|9596964|FG007|COMPLETED|Dose Level 2||0
8564812|NCT00062868|9596965|FG008|COMPLETED|Dose Level 2||0
8564813|NCT00062868|9596966|FG009|COMPLETED|Dose Level 2||0
8564814|NCT00062868|9596967|FG010|COMPLETED|Dose Level 2||3
8564815|NCT00062868|9596968|FG011|COMPLETED|Dose Level 2||0
8564816|NCT00062868|9596969|FG012|COMPLETED|Dose Level 2||0
8564817|NCT00062868|9596970|FG013|COMPLETED|Dose Level 2||2
8564818|NCT00062868|9596971|FG014|COMPLETED|Dose Level 2||0
8564819|NCT00062868|9596972|FG015|COMPLETED|Dose Level 2||0
8564820|NCT00062868|9596973|FG016|COMPLETED|Dose Level 2||0
8564821|NCT00062868|9596974|FG017|COMPLETED|Dose Level 2||0
8564822|NCT00062868|9596975|FG018|COMPLETED|Dose Level 2||0
8564823|NCT00062868|9596976|FG019|COMPLETED|Dose Level 2||0
8564824|NCT00062868|9596977|FG020|COMPLETED|Dose Level 2||0
8564825|NCT00062868|9596957|FG000|NOT COMPLETED|Dose Level 2||0
8564826|NCT00062868|9596958|FG001|NOT COMPLETED|Dose Level 2||3
8564827|NCT00062868|9596959|FG002|NOT COMPLETED|Dose Level 2||0
8564828|NCT00062868|9596960|FG003|NOT COMPLETED|Dose Level 2||0
8564829|NCT00062868|9596961|FG004|NOT COMPLETED|Dose Level 2||2
8564830|NCT00062868|9596962|FG005|NOT COMPLETED|Dose Level 2||0
8564831|NCT00062868|9596963|FG006|NOT COMPLETED|Dose Level 2||0
8564832|NCT00062868|9596964|FG007|NOT COMPLETED|Dose Level 2||0
8564833|NCT00062868|9596965|FG008|NOT COMPLETED|Dose Level 2||0
8564834|NCT00062868|9596966|FG009|NOT COMPLETED|Dose Level 2||0
8564835|NCT00062868|9596967|FG010|NOT COMPLETED|Dose Level 2||1
8564836|NCT00062868|9596968|FG011|NOT COMPLETED|Dose Level 2||0
8564837|NCT00062868|9596969|FG012|NOT COMPLETED|Dose Level 2||0
8564838|NCT00062868|9596970|FG013|NOT COMPLETED|Dose Level 2||1
8564839|NCT00062868|9596971|FG014|NOT COMPLETED|Dose Level 2||0
8564840|NCT00062868|9596972|FG015|NOT COMPLETED|Dose Level 2||0
8564841|NCT00062868|9596973|FG016|NOT COMPLETED|Dose Level 2||3
8564842|NCT00062868|9596974|FG017|NOT COMPLETED|Dose Level 2||0
8564843|NCT00062868|9596975|FG018|NOT COMPLETED|Dose Level 2||0
8564844|NCT00062868|9596976|FG019|NOT COMPLETED|Dose Level 2||0
8564845|NCT00062868|9596977|FG020|NOT COMPLETED|Dose Level 2||0
8564846|NCT00062868|9596957|FG000|STARTED|Dose Level 3||0
8564847|NCT00062868|9596958|FG001|STARTED|Dose Level 3||0
8564848|NCT00062868|9596959|FG002|STARTED|Dose Level 3||3
8564849|NCT00062868|9596960|FG003|STARTED|Dose Level 3||0
8564850|NCT00062868|9596961|FG004|STARTED|Dose Level 3||0
8564851|NCT00062868|9596962|FG005|STARTED|Dose Level 3||0
8564852|NCT00062868|9596963|FG006|STARTED|Dose Level 3||0
8564853|NCT00062868|9596964|FG007|STARTED|Dose Level 3||0
8564854|NCT00062868|9596965|FG008|STARTED|Dose Level 3||0
8564855|NCT00062868|9596966|FG009|STARTED|Dose Level 3||0
8564856|NCT00062868|9596967|FG010|STARTED|Dose Level 3||0
8564857|NCT00062868|9596968|FG011|STARTED|Dose Level 3||5
8564858|NCT00062868|9596969|FG012|STARTED|Dose Level 3||0
8564859|NCT00062868|9596970|FG013|STARTED|Dose Level 3||0
8620862|NCT00476008|9659712|FG001|6 Month Testing|Overall Study||14
8564860|NCT00062868|9596971|FG014|STARTED|Dose Level 3||3
8564861|NCT00062868|9596972|FG015|STARTED|Dose Level 3||0
8564862|NCT00062868|9596973|FG016|STARTED|Dose Level 3||0
8564863|NCT00062868|9596974|FG017|STARTED|Dose Level 3||4
8533731|NCT05143541|9566523|FG000|STARTED|Overall Study||80
8533732|NCT05143541|9566523|FG000|COMPLETED|Overall Study||80
8533733|NCT05143541|9566523|FG000|NOT COMPLETED|Overall Study||0
8533734|NCT04685213|9566529|FG000|STARTED|Overall Study||9
8533735|NCT04685213|9566530|FG001|STARTED|Overall Study||10
8533736|NCT04685213|9566529|FG000|COMPLETED|Overall Study||8
8533737|NCT04685213|9566530|FG001|COMPLETED|Overall Study||7
8533738|NCT04685213|9566529|FG000|NOT COMPLETED|Overall Study||1
8533739|NCT04685213|9566530|FG001|NOT COMPLETED|Overall Study||3
8533740|NCT04567186|9566536|FG000|STARTED|Period 1||38
8533741|NCT04567186|9566537|FG001|STARTED|Period 1||40
8533742|NCT04567186|9566536|FG000|COMPLETED|Period 1||37
8533743|NCT04567186|9566537|FG001|COMPLETED|Period 1||37
8533744|NCT04567186|9566536|FG000|NOT COMPLETED|Period 1||1
8533745|NCT04567186|9566537|FG001|NOT COMPLETED|Period 1||3
8533746|NCT04567186|9566536|FG000|STARTED|Period 2||37
8533747|NCT04567186|9566537|FG001|STARTED|Period 2||37
8533748|NCT04567186|9566536|FG000|COMPLETED|Period 2||37
8533749|NCT04567186|9566537|FG001|COMPLETED|Period 2||34
8533750|NCT04567186|9566536|FG000|NOT COMPLETED|Period 2||0
8533751|NCT04567186|9566537|FG001|NOT COMPLETED|Period 2||3
8533752|NCT04567186|9566536|FG000|STARTED|Period 3||37
8533753|NCT04567186|9566537|FG001|STARTED|Period 3||34
8533754|NCT04567186|9566536|FG000|COMPLETED|Period 3||36
8533755|NCT04567186|9566537|FG001|COMPLETED|Period 3||34
8533756|NCT04567186|9566536|FG000|NOT COMPLETED|Period 3||1
8533757|NCT04567186|9566537|FG001|NOT COMPLETED|Period 3||0
8533758|NCT04065074|9566543|FG000|STARTED|Overall Study||16
8533759|NCT04065074|9566543|FG000|COMPLETED|Overall Study||14
8533760|NCT04065074|9566543|FG000|NOT COMPLETED|Overall Study||2
8533761|NCT03980730|9566549|FG000|STARTED|Overall Study||21
8533762|NCT03980730|9566550|FG001|STARTED|Overall Study||22
8533763|NCT03980730|9566549|FG000|COMPLETED|Overall Study||19
8533764|NCT03980730|9566550|FG001|COMPLETED|Overall Study||18
8533765|NCT03980730|9566549|FG000|NOT COMPLETED|Overall Study||2
8533766|NCT03980730|9566550|FG001|NOT COMPLETED|Overall Study||4
8533767|NCT03793010|9566558|FG000|STARTED|Overall Study||35
8533768|NCT03793010|9566559|FG001|STARTED|Overall Study||35
8533769|NCT03793010|9566558|FG000|Randomized But Not Dosed|Overall Study||2
8533770|NCT03793010|9566559|FG001|Randomized But Not Dosed|Overall Study||0
8533771|NCT03793010|9566558|FG000|COMPLETED|Overall Study||7
8533772|NCT03793010|9566559|FG001|COMPLETED|Overall Study||8
8533773|NCT03793010|9566558|FG000|NOT COMPLETED|Overall Study||28
8533774|NCT03793010|9566559|FG001|NOT COMPLETED|Overall Study||27
8533775|NCT03644017|9566565|FG000|STARTED|Overall Study||46
8533776|NCT03644017|9566565|FG000|COMPLETED|Overall Study||39
8533777|NCT03644017|9566565|FG000|NOT COMPLETED|Overall Study||7
8533778|NCT03592186|9566571|FG000|STARTED|Overall Study||60
8533779|NCT03592186|9566572|FG001|STARTED|Overall Study||62
8533780|NCT03592186|9566571|FG000|6-week Follow-up|Overall Study||49
8533781|NCT03592186|9566572|FG001|6-week Follow-up|Overall Study||56
8533782|NCT03592186|9566571|FG000|12-week Follow-up|Overall Study||47
8533783|NCT03592186|9566572|FG001|12-week Follow-up|Overall Study||51
8533784|NCT03592186|9566571|FG000|COMPLETED|Overall Study||43
8533785|NCT03592186|9566572|FG001|COMPLETED|Overall Study||51
8533786|NCT03592186|9566571|FG000|NOT COMPLETED|Overall Study||17
8533787|NCT03592186|9566572|FG001|NOT COMPLETED|Overall Study||11
8533788|NCT03529942|9566578|FG000|STARTED|Overall Study||129
8533789|NCT03529942|9566578|FG000|Reached Week 6 With Paired MRI|Overall Study||108
8533790|NCT03529942|9566578|FG000|COMPLETED|Overall Study||106
8533791|NCT03529942|9566578|FG000|NOT COMPLETED|Overall Study||23
8533792|NCT03349775|9566587|FG000|STARTED|Overall Study||10
8533793|NCT03349775|9566588|FG001|STARTED|Overall Study||11
8533794|NCT03349775|9566587|FG000|COMPLETED|Overall Study||8
8533795|NCT03349775|9566588|FG001|COMPLETED|Overall Study||7
8533796|NCT03349775|9566587|FG000|NOT COMPLETED|Overall Study||2
8533797|NCT03349775|9566588|FG001|NOT COMPLETED|Overall Study||4
8533798|NCT03292471|9566596|FG000|STARTED|Overall Study||8
8533799|NCT03292471|9566597|FG001|STARTED|Overall Study||8
8533800|NCT03292471|9566596|FG000|COMPLETED|Overall Study||8
8533801|NCT03292471|9566597|FG001|COMPLETED|Overall Study||8
8533802|NCT03292471|9566596|FG000|NOT COMPLETED|Overall Study||0
8533803|NCT03292471|9566597|FG001|NOT COMPLETED|Overall Study||0
8533804|NCT03256344|9566605|FG000|STARTED|Overall Study||11
8533805|NCT03256344|9566606|FG001|STARTED|Overall Study||25
8533806|NCT03256344|9566605|FG000|Received Talimogene Laherparepvec|Overall Study||8
8533807|NCT03256344|9566606|FG001|Received Talimogene Laherparepvec|Overall Study||23
8533808|NCT03256344|9566605|FG000|Received Atezolizumab|Overall Study||10
8533809|NCT03256344|9566606|FG001|Received Atezolizumab|Overall Study||24
8533810|NCT03256344|9566605|FG000|COMPLETED|Overall Study||0
8533811|NCT03256344|9566606|FG001|COMPLETED|Overall Study||0
8533812|NCT03256344|9566605|FG000|NOT COMPLETED|Overall Study||11
8533813|NCT03256344|9566606|FG001|NOT COMPLETED|Overall Study||25
8533814|NCT03207815|9566614|FG000|STARTED|Overall Study||38
8533815|NCT03207815|9566615|FG001|STARTED|Overall Study||36
8533816|NCT03207815|9566614|FG000|COMPLETED|Overall Study||30
8533817|NCT03207815|9566615|FG001|COMPLETED|Overall Study||29
8533818|NCT03207815|9566614|FG000|NOT COMPLETED|Overall Study||8
8533819|NCT03207815|9566615|FG001|NOT COMPLETED|Overall Study||7
8533820|NCT03077737|9566623|FG000|STARTED|Week 6 (10 Weeks After Enrollment)||97
8533821|NCT03077737|9566624|FG001|STARTED|Week 6 (10 Weeks After Enrollment)||93
8533822|NCT03077737|9566623|FG000|COMPLETED|Week 6 (10 Weeks After Enrollment)||89
8533823|NCT03077737|9566624|FG001|COMPLETED|Week 6 (10 Weeks After Enrollment)||79
8533824|NCT03077737|9566623|FG000|NOT COMPLETED|Week 6 (10 Weeks After Enrollment)||8
8533825|NCT03077737|9566624|FG001|NOT COMPLETED|Week 6 (10 Weeks After Enrollment)||14
8533826|NCT03077737|9566623|FG000|STARTED|Week 14 (18 Weeks After Enrollment)||97
8533827|NCT03077737|9566624|FG001|STARTED|Week 14 (18 Weeks After Enrollment)||93
8533828|NCT03077737|9566623|FG000|COMPLETED|Week 14 (18 Weeks After Enrollment)||83
8533829|NCT03077737|9566624|FG001|COMPLETED|Week 14 (18 Weeks After Enrollment)||76
8533830|NCT03077737|9566623|FG000|NOT COMPLETED|Week 14 (18 Weeks After Enrollment)||14
8533831|NCT03077737|9566624|FG001|NOT COMPLETED|Week 14 (18 Weeks After Enrollment)||17
8533832|NCT03077737|9566623|FG000|STARTED|Week 28 (32 Weeks After Enrollment)||49
8533833|NCT03077737|9566624|FG001|STARTED|Week 28 (32 Weeks After Enrollment)||47
8533834|NCT03077737|9566623|FG000|COMPLETED|Week 28 (32 Weeks After Enrollment)||39
8533835|NCT03077737|9566624|FG001|COMPLETED|Week 28 (32 Weeks After Enrollment)||40
8533836|NCT03077737|9566623|FG000|NOT COMPLETED|Week 28 (32 Weeks After Enrollment)||10
8533837|NCT03077737|9566624|FG001|NOT COMPLETED|Week 28 (32 Weeks After Enrollment)||7
8533838|NCT02991937|9566632|FG000|STARTED|Overall Study||20
8533839|NCT02991937|9566633|FG001|STARTED|Overall Study||19
8533840|NCT02991937|9566632|FG000|COMPLETED|Overall Study||20
8533841|NCT02991937|9566633|FG001|COMPLETED|Overall Study||19
8533842|NCT02991937|9566632|FG000|NOT COMPLETED|Overall Study||0
8533843|NCT02991937|9566633|FG001|NOT COMPLETED|Overall Study||0
8533844|NCT02968563|9566641|FG000|STARTED|Overall Study||5
8533845|NCT02968563|9566642|FG001|STARTED|Overall Study||30
8533846|NCT02968563|9566641|FG000|COMPLETED|Overall Study||4
8533847|NCT02968563|9566642|FG001|COMPLETED|Overall Study||22
8533848|NCT02968563|9566641|FG000|NOT COMPLETED|Overall Study||1
8533849|NCT02968563|9566642|FG001|NOT COMPLETED|Overall Study||8
8533850|NCT02915783|9566648|FG000|STARTED|Overall Study||31
8533851|NCT02915783|9566648|FG000|COMPLETED|Overall Study||17
8533852|NCT02915783|9566648|FG000|NOT COMPLETED|Overall Study||14
8564864|NCT00062868|9596975|FG018|STARTED|Dose Level 3||0
8564865|NCT00062868|9596976|FG019|STARTED|Dose Level 3||0
8564866|NCT00062868|9596977|FG020|STARTED|Dose Level 3||0
8564867|NCT00062868|9596957|FG000|COMPLETED|Dose Level 3||0
8564868|NCT00062868|9596958|FG001|COMPLETED|Dose Level 3||0
8564869|NCT00062868|9596959|FG002|COMPLETED|Dose Level 3||1
8564870|NCT00062868|9596960|FG003|COMPLETED|Dose Level 3||0
8564871|NCT00062868|9596961|FG004|COMPLETED|Dose Level 3||0
8564872|NCT00062868|9596962|FG005|COMPLETED|Dose Level 3||0
8564873|NCT00062868|9596963|FG006|COMPLETED|Dose Level 3||0
8564874|NCT00062868|9596964|FG007|COMPLETED|Dose Level 3||0
8564875|NCT00062868|9596965|FG008|COMPLETED|Dose Level 3||0
8564876|NCT00062868|9596966|FG009|COMPLETED|Dose Level 3||0
8564877|NCT00062868|9596967|FG010|COMPLETED|Dose Level 3||0
8564878|NCT00062868|9596968|FG011|COMPLETED|Dose Level 3||4
8564879|NCT00062868|9596969|FG012|COMPLETED|Dose Level 3||0
8564880|NCT00062868|9596970|FG013|COMPLETED|Dose Level 3||0
8564881|NCT00062868|9596971|FG014|COMPLETED|Dose Level 3||2
8564882|NCT00062868|9596972|FG015|COMPLETED|Dose Level 3||0
8564883|NCT00062868|9596973|FG016|COMPLETED|Dose Level 3||0
8564884|NCT00062868|9596974|FG017|COMPLETED|Dose Level 3||3
8564885|NCT00062868|9596975|FG018|COMPLETED|Dose Level 3||0
8564886|NCT00062868|9596976|FG019|COMPLETED|Dose Level 3||0
8564887|NCT00062868|9596977|FG020|COMPLETED|Dose Level 3||0
8564888|NCT00062868|9596957|FG000|NOT COMPLETED|Dose Level 3||0
8564889|NCT00062868|9596958|FG001|NOT COMPLETED|Dose Level 3||0
8564890|NCT00062868|9596959|FG002|NOT COMPLETED|Dose Level 3||2
8564891|NCT00062868|9596960|FG003|NOT COMPLETED|Dose Level 3||0
8564892|NCT00062868|9596961|FG004|NOT COMPLETED|Dose Level 3||0
8564893|NCT00062868|9596962|FG005|NOT COMPLETED|Dose Level 3||0
8564894|NCT00062868|9596963|FG006|NOT COMPLETED|Dose Level 3||0
8564895|NCT00062868|9596964|FG007|NOT COMPLETED|Dose Level 3||0
8564896|NCT00062868|9596965|FG008|NOT COMPLETED|Dose Level 3||0
8564897|NCT00062868|9596966|FG009|NOT COMPLETED|Dose Level 3||0
8564898|NCT00062868|9596967|FG010|NOT COMPLETED|Dose Level 3||0
8564899|NCT00062868|9596968|FG011|NOT COMPLETED|Dose Level 3||1
8620863|NCT00476008|9659711|FG000|COMPLETED|Overall Study||13
8620864|NCT00476008|9659712|FG001|COMPLETED|Overall Study||13
8620865|NCT00476008|9659711|FG000|NOT COMPLETED|Overall Study||9
8620866|NCT00476008|9659712|FG001|NOT COMPLETED|Overall Study||8
8564900|NCT00062868|9596969|FG012|NOT COMPLETED|Dose Level 3||0
8620867|NCT00476021|9659724|FG000|STARTED|Overall Study||51
8564901|NCT00062868|9596970|FG013|NOT COMPLETED|Dose Level 3||0
8564902|NCT00062868|9596971|FG014|NOT COMPLETED|Dose Level 3||1
8564903|NCT00062868|9596972|FG015|NOT COMPLETED|Dose Level 3||0
8564904|NCT00062868|9596973|FG016|NOT COMPLETED|Dose Level 3||0
8564905|NCT00062868|9596974|FG017|NOT COMPLETED|Dose Level 3||1
8564906|NCT00062868|9596975|FG018|NOT COMPLETED|Dose Level 3||0
8564907|NCT00062868|9596976|FG019|NOT COMPLETED|Dose Level 3||0
8620868|NCT00476021|9659725|FG001|STARTED|Overall Study||51
8564908|NCT00062868|9596977|FG020|NOT COMPLETED|Dose Level 3||0
8564909|NCT00063154|9597021|FG000|STARTED|Overall Study||51
8564910|NCT00063154|9597021|FG000|COMPLETED|Overall Study||0
8564911|NCT00063154|9597021|FG000|NOT COMPLETED|Overall Study||51
8564912|NCT00063232|9597025|FG000|STARTED|Overall Study||26
8564913|NCT00063232|9597025|FG000|COMPLETED|Overall Study||26
8564914|NCT00063232|9597025|FG000|NOT COMPLETED|Overall Study||0
8564915|NCT00063258|9597031|FG000|STARTED|Overall Study||5
8564916|NCT00063258|9597032|FG001|STARTED|Overall Study||0
8533853|NCT02913482|9566655|FG000|STARTED|Overall Study||4
8533854|NCT02913482|9566656|FG001|STARTED|Overall Study||17
8533855|NCT02913482|9566657|FG002|STARTED|Overall Study||41
8533856|NCT02913482|9566655|FG000|COMPLETED|Overall Study|Participants remaining in the study at CCOD of 12 Nov 2020|3
8533857|NCT02913482|9566656|FG001|COMPLETED|Overall Study|Participants remaining in the study at CCOD of 12 Nov 2020|14
8533858|NCT02913482|9566657|FG002|COMPLETED|Overall Study|Participants remaining in the study at CCOD of 12 Nov 2020|38
8533859|NCT02913482|9566655|FG000|NOT COMPLETED|Overall Study||1
8533860|NCT02913482|9566656|FG001|NOT COMPLETED|Overall Study||3
8533861|NCT02913482|9566657|FG002|NOT COMPLETED|Overall Study||3
8533862|NCT02787044|9566669|FG000|STARTED|Overall Study||2630
8533863|NCT02787044|9566670|FG001|STARTED|Overall Study||2630
8533864|NCT02787044|9566669|FG000|COMPLETED|Overall Study||2615
8533865|NCT02787044|9566670|FG001|COMPLETED|Overall Study||2611
8533866|NCT02787044|9566669|FG000|NOT COMPLETED|Overall Study||15
8533867|NCT02787044|9566670|FG001|NOT COMPLETED|Overall Study||19
8533868|NCT02698163|9566682|FG000|STARTED|Overall Study||1
8533869|NCT02698163|9566683|FG001|STARTED|Overall Study||3
8533870|NCT02698163|9566682|FG000|COMPLETED|Overall Study||1
8533871|NCT02698163|9566683|FG001|COMPLETED|Overall Study||2
8533872|NCT02698163|9566682|FG000|NOT COMPLETED|Overall Study||0
8533873|NCT02698163|9566683|FG001|NOT COMPLETED|Overall Study||1
8533874|NCT02586675|9566689|FG000|STARTED|Overall Study||7
8533875|NCT02586675|9566689|FG000|COMPLETED|Overall Study||7
8533876|NCT02586675|9566689|FG000|NOT COMPLETED|Overall Study||0
8533877|NCT02367105|9566695|FG000|STARTED|Overall Study||41
8533878|NCT02367105|9566696|FG001|STARTED|Overall Study||42
8533879|NCT02367105|9566695|FG000|COMPLETED|Overall Study||36
8533880|NCT02367105|9566696|FG001|COMPLETED|Overall Study||34
8533881|NCT02367105|9566695|FG000|NOT COMPLETED|Overall Study||5
8533882|NCT02367105|9566696|FG001|NOT COMPLETED|Overall Study||8
8533883|NCT01816165|9566710|FG000|STARTED|Overall Study||5
8533884|NCT01816165|9566711|FG001|STARTED|Overall Study||4
8533885|NCT01816165|9566712|FG002|STARTED|Overall Study||5
8533886|NCT01816165|9566713|FG003|STARTED|Overall Study||4
8533887|NCT01816165|9566710|FG000|Completed Intervention 1|Overall Study||4
8533888|NCT01816165|9566711|FG001|Completed Intervention 1|Overall Study||4
8533889|NCT01816165|9566712|FG002|Completed Intervention 1|Overall Study||5
8533890|NCT01816165|9566713|FG003|Completed Intervention 1|Overall Study||4
8533891|NCT01816165|9566710|FG000|Completed ~2 Week Washout|Overall Study||4
8533892|NCT01816165|9566711|FG001|Completed ~2 Week Washout|Overall Study||4
8533893|NCT01816165|9566712|FG002|Completed ~2 Week Washout|Overall Study||5
8533894|NCT01816165|9566713|FG003|Completed ~2 Week Washout|Overall Study||4
8533895|NCT01816165|9566710|FG000|Started Second Intervention|Overall Study||4
8533896|NCT01816165|9566711|FG001|Started Second Intervention|Overall Study||4
8533897|NCT01816165|9566712|FG002|Started Second Intervention|Overall Study||5
8533898|NCT01816165|9566713|FG003|Started Second Intervention|Overall Study||4
8533899|NCT01816165|9566710|FG000|COMPLETED|Overall Study||4
8533900|NCT01816165|9566711|FG001|COMPLETED|Overall Study||4
8533901|NCT01816165|9566712|FG002|COMPLETED|Overall Study||5
8533902|NCT01816165|9566713|FG003|COMPLETED|Overall Study||4
8533903|NCT01816165|9566710|FG000|NOT COMPLETED|Overall Study||1
8533904|NCT01816165|9566711|FG001|NOT COMPLETED|Overall Study||0
8533905|NCT01816165|9566712|FG002|NOT COMPLETED|Overall Study||0
8533906|NCT01816165|9566713|FG003|NOT COMPLETED|Overall Study||0
8533907|NCT01813929|9566735|FG000|STARTED|Overall Study||5
8533908|NCT01813929|9566736|FG001|STARTED|Overall Study||12
8533909|NCT01813929|9566735|FG000|Completed Intervention 1|Overall Study||5
8533910|NCT01813929|9566736|FG001|Completed Intervention 1|Overall Study||12
8533911|NCT01813929|9566735|FG000|Completed Washout (2weeks up to 2 Months)|Overall Study||5
8533912|NCT01813929|9566736|FG001|Completed Washout (2weeks up to 2 Months)|Overall Study||11
8533913|NCT01813929|9566735|FG000|Started Intervention 2|Overall Study||5
8533914|NCT01813929|9566736|FG001|Started Intervention 2|Overall Study||11
8533915|NCT01813929|9566735|FG000|COMPLETED|Overall Study||5
8533916|NCT01813929|9566736|FG001|COMPLETED|Overall Study||11
8533917|NCT01813929|9566735|FG000|NOT COMPLETED|Overall Study||0
8533918|NCT01813929|9566736|FG001|NOT COMPLETED|Overall Study||1
8533919|NCT01502085|9566742|FG000|STARTED|Overall Study||25
8533920|NCT01502085|9566742|FG000|COMPLETED|Overall Study||25
8533921|NCT01502085|9566742|FG000|NOT COMPLETED|Overall Study||0
8533922|NCT01178814|9566746|FG000|STARTED|Overall Study||57
8533923|NCT01178814|9566746|FG000|COMPLETED|Overall Study||57
8533924|NCT01178814|9566746|FG000|NOT COMPLETED|Overall Study||0
8533925|NCT01125176|9566750|FG000|STARTED|Treatment Phase||14
8533926|NCT01125176|9566750|FG000|COMPLETED|Treatment Phase||13
8533927|NCT01125176|9566750|FG000|NOT COMPLETED|Treatment Phase||1
8533928|NCT01125176|9566750|FG000|STARTED|Post-treatment Follow-up Phase||13
8533929|NCT01125176|9566750|FG000|COMPLETED|Post-treatment Follow-up Phase||2
8533930|NCT01125176|9566750|FG000|NOT COMPLETED|Post-treatment Follow-up Phase||11
8533931|NCT00882050|9566757|FG000|STARTED|Overall Study||32
8533932|NCT00882050|9566758|FG001|STARTED|Overall Study||33
8533933|NCT00882050|9566759|FG002|STARTED|Overall Study||39
8533934|NCT00882050|9566757|FG000|COMPLETED|Overall Study||31
8533935|NCT00882050|9566758|FG001|COMPLETED|Overall Study||33
8533936|NCT00882050|9566759|FG002|COMPLETED|Overall Study||39
8533937|NCT00882050|9566757|FG000|NOT COMPLETED|Overall Study||1
8533938|NCT00882050|9566758|FG001|NOT COMPLETED|Overall Study||0
8533939|NCT00882050|9566759|FG002|NOT COMPLETED|Overall Study||0
8533940|NCT00070564|9566773|FG000|STARTED|Overall Study||678
8533941|NCT00070564|9566774|FG001|STARTED|Overall Study||693
8533942|NCT00070564|9566775|FG002|STARTED|Overall Study||697
8533943|NCT00070564|9566776|FG003|STARTED|Overall Study||648
8533944|NCT00070564|9566777|FG004|STARTED|Overall Study||282
8533945|NCT00070564|9566778|FG005|STARTED|Overall Study||296
8533946|NCT00070564|9566773|FG000|COMPLETED|Overall Study||478
8533947|NCT00070564|9566774|FG001|COMPLETED|Overall Study||490
8533948|NCT00070564|9566775|FG002|COMPLETED|Overall Study||526
8533949|NCT00070564|9566776|FG003|COMPLETED|Overall Study||481
8533950|NCT00070564|9566777|FG004|COMPLETED|Overall Study||203
8533951|NCT00070564|9566778|FG005|COMPLETED|Overall Study||244
8533952|NCT00070564|9566773|FG000|NOT COMPLETED|Overall Study||200
8533953|NCT00070564|9566774|FG001|NOT COMPLETED|Overall Study||203
8533954|NCT00070564|9566775|FG002|NOT COMPLETED|Overall Study||171
8533955|NCT00070564|9566776|FG003|NOT COMPLETED|Overall Study||167
8533956|NCT00070564|9566777|FG004|NOT COMPLETED|Overall Study||79
8533957|NCT00070564|9566778|FG005|NOT COMPLETED|Overall Study||52
8564917|NCT00063258|9597031|FG000|COMPLETED|Overall Study||1
8564918|NCT00063258|9597032|FG001|COMPLETED|Overall Study||0
8564919|NCT00063258|9597031|FG000|NOT COMPLETED|Overall Study||4
8564920|NCT00063258|9597032|FG001|NOT COMPLETED|Overall Study||0
8564921|NCT00063362|9597040|FG000|STARTED|Overall Study||23
8564922|NCT00063362|9597041|FG001|STARTED|Overall Study||26
8564923|NCT00063362|9597040|FG000|COMPLETED|Overall Study||19
8564924|NCT00063362|9597041|FG001|COMPLETED|Overall Study||22
8564925|NCT00063362|9597040|FG000|NOT COMPLETED|Overall Study||4
8564926|NCT00063362|9597041|FG001|NOT COMPLETED|Overall Study||4
8564927|NCT00063570|9597049|FG000|STARTED|Overall Study||52
8564928|NCT00063570|9597050|FG001|STARTED|Overall Study||21
8564929|NCT00063570|9597049|FG000|COMPLETED|Overall Study|Completed for this study means patient received study drug and was eligible for efficacy analysis.|52
8564930|NCT00063570|9597050|FG001|COMPLETED|Overall Study|Completed for this study means patient received study drug and was eligible for efficacy analysis.|21
8564931|NCT00063570|9597049|FG000|NOT COMPLETED|Overall Study||0
8564932|NCT00063570|9597050|FG001|NOT COMPLETED|Overall Study||0
8564933|NCT00063622|9597059|FG000|STARTED|Overall Study||80
8564934|NCT00063622|9597060|FG001|STARTED|Overall Study||84
8564935|NCT00063622|9597061|FG002|STARTED|Overall Study||83
8564936|NCT00063622|9597059|FG000|COMPLETED|Overall Study|All randomized patients were included in analysis of primary outcome|70
8564937|NCT00063622|9597060|FG001|COMPLETED|Overall Study|All randomized patients were included in analysis of primary outcome|80
8564938|NCT00063622|9597061|FG002|COMPLETED|Overall Study|All randomized patients were included in analysis of primary outcome|72
8564939|NCT00063622|9597059|FG000|NOT COMPLETED|Overall Study||10
8564940|NCT00063622|9597060|FG001|NOT COMPLETED|Overall Study||4
8564941|NCT00063622|9597061|FG002|NOT COMPLETED|Overall Study||11
8564942|NCT00063635|9597072|FG000|STARTED|Overall Study||57
8564943|NCT00063635|9597073|FG001|STARTED|Overall Study||58
8564944|NCT00063635|9597074|FG002|STARTED|Overall Study||58
8564945|NCT00063635|9597072|FG000|COMPLETED|Overall Study||51
8564946|NCT00063635|9597073|FG001|COMPLETED|Overall Study||50
8564947|NCT00063635|9597074|FG002|COMPLETED|Overall Study||49
8564948|NCT00063635|9597072|FG000|NOT COMPLETED|Overall Study||6
8564949|NCT00063635|9597073|FG001|NOT COMPLETED|Overall Study||8
8564950|NCT00063635|9597074|FG002|NOT COMPLETED|Overall Study||9
8564951|NCT00063882|9597084|FG000|STARTED|Overall Study||292
8564952|NCT00063882|9597085|FG001|STARTED|Overall Study||296
8564953|NCT00063882|9597084|FG000|Has Acute Adverse Event Data|Overall Study||282
8564954|NCT00063882|9597085|FG001|Has Acute Adverse Event Data|Overall Study||288
8564955|NCT00063882|9597084|FG000|Has Late Adverse Event Data|Overall Study||282
8564956|NCT00063882|9597085|FG001|Has Late Adverse Event Data|Overall Study||287
8564957|NCT00063882|9597084|FG000|Has Baseline/4-month EPIC Data|Overall Study||222
8564958|NCT00063882|9597085|FG001|Has Baseline/4-month EPIC Data|Overall Study||241
8564959|NCT00063882|9597084|FG000|Has Baseline/24-month EPIC Data|Overall Study||201
8564960|NCT00063882|9597085|FG001|Has Baseline/24-month EPIC Data|Overall Study||219
8564961|NCT00063882|9597084|FG000|Eligible Patients|Overall Study||287
8564962|NCT00063882|9597085|FG001|Eligible Patients|Overall Study||292
8564963|NCT00063882|9597084|FG000|COMPLETED|Overall Study||287
8564964|NCT00063882|9597085|FG001|COMPLETED|Overall Study||292
8564965|NCT00063882|9597084|FG000|NOT COMPLETED|Overall Study||5
8564966|NCT00063882|9597085|FG001|NOT COMPLETED|Overall Study||4
8564967|NCT00063934|9597091|FG000|STARTED|Overall Study||31
8564968|NCT00063934|9597091|FG000|COMPLETED|Overall Study||30
8564969|NCT00063934|9597091|FG000|NOT COMPLETED|Overall Study||1
8564970|NCT00063986|9597095|FG000|STARTED|Overall Study||110
8564971|NCT00063986|9597095|FG000|Treated|Overall Study||105
8564972|NCT00063986|9597095|FG000|Eligible and Treated|Overall Study||104
8564973|NCT00063986|9597095|FG000|COMPLETED|Overall Study||104
8564974|NCT00063986|9597095|FG000|NOT COMPLETED|Overall Study||6
8564975|NCT00063999|9597101|FG000|STARTED|Overall Study||692
8564976|NCT00063999|9597102|FG001|STARTED|Overall Study||689
8564977|NCT00063999|9597101|FG000|COMPLETED|Overall Study||647
8564978|NCT00063999|9597102|FG001|COMPLETED|Overall Study||665
8564979|NCT00063999|9597101|FG000|NOT COMPLETED|Overall Study||45
8564980|NCT00063999|9597102|FG001|NOT COMPLETED|Overall Study||24
8564981|NCT00064025|9597115|FG000|STARTED|Overall Study||75
8564982|NCT00064025|9597115|FG000|COMPLETED|Overall Study||68
8564983|NCT00064025|9597115|FG000|NOT COMPLETED|Overall Study||7
8564984|NCT00064038|9597123|FG000|STARTED|Initial Randomization||100
8564985|NCT00064038|9597124|FG001|STARTED|Initial Randomization||98
8533958|NCT05167370|9566798|FG000|STARTED|Overall Study||2
8533959|NCT05167370|9566798|FG000|COMPLETED|Overall Study||2
8533960|NCT05167370|9566798|FG000|NOT COMPLETED|Overall Study||0
8533961|NCT04500821|9566802|FG000|STARTED|Overall Study||44
8533962|NCT04500821|9566802|FG000|COMPLETED|Overall Study||44
8533963|NCT04500821|9566802|FG000|NOT COMPLETED|Overall Study||0
8533964|NCT04425720|9566809|FG000|STARTED|Overall Study||150
8533965|NCT04425720|9566810|FG001|STARTED|Overall Study||150
8533966|NCT04425720|9566809|FG000|COMPLETED|Overall Study||150
8533967|NCT04425720|9566810|FG001|COMPLETED|Overall Study||130
8533968|NCT04425720|9566809|FG000|NOT COMPLETED|Overall Study||0
8533969|NCT04425720|9566810|FG001|NOT COMPLETED|Overall Study||20
8533970|NCT04409509|9566819|FG000|STARTED|Overall Study||61
8533971|NCT04409509|9566820|FG001|STARTED|Overall Study||63
8533972|NCT04409509|9566819|FG000|COMPLETED|Overall Study||48
8533973|NCT04409509|9566820|FG001|COMPLETED|Overall Study||43
8533974|NCT04409509|9566819|FG000|NOT COMPLETED|Overall Study||13
8533975|NCT04409509|9566820|FG001|NOT COMPLETED|Overall Study||20
8533976|NCT04380519|9566830|FG000|STARTED|Overall Study||124
8533977|NCT04380519|9566831|FG001|STARTED|Overall Study||124
8533978|NCT04380519|9566832|FG002|STARTED|Overall Study||124
8533979|NCT04380519|9566830|FG000|Intent-to-Treat (ITT)|Overall Study||124
8533980|NCT04380519|9566831|FG001|Intent-to-Treat (ITT)|Overall Study||124
8533981|NCT04380519|9566832|FG002|Intent-to-Treat (ITT)|Overall Study||124
8533982|NCT04380519|9566830|FG000|Modified Intent-to-Treat (mITT)|Overall Study||115
8533983|NCT04380519|9566831|FG001|Modified Intent-to-Treat (mITT)|Overall Study||119
8533984|NCT04380519|9566832|FG002|Modified Intent-to-Treat (mITT)|Overall Study||118
8533985|NCT04380519|9566830|FG000|Safety Population|Overall Study||123
8533986|NCT04380519|9566831|FG001|Safety Population|Overall Study||124
8533987|NCT04380519|9566832|FG002|Safety Population|Overall Study||124
8533988|NCT04380519|9566830|FG000|COMPLETED|Overall Study||106
8533989|NCT04380519|9566831|FG001|COMPLETED|Overall Study||113
8533990|NCT04380519|9566832|FG002|COMPLETED|Overall Study||117
8533991|NCT04380519|9566830|FG000|NOT COMPLETED|Overall Study||18
8533992|NCT04380519|9566831|FG001|NOT COMPLETED|Overall Study||11
8533993|NCT04380519|9566832|FG002|NOT COMPLETED|Overall Study||7
8533994|NCT04362813|9566842|FG000|STARTED|Overall Study||227
8533995|NCT04362813|9566843|FG001|STARTED|Overall Study||227
8533996|NCT04362813|9566842|FG000|Safety Set|Overall Study||225
8533997|NCT04362813|9566843|FG001|Safety Set|Overall Study||223
8533998|NCT04362813|9566842|FG000|Completed Day 29|Overall Study||211
8533999|NCT04362813|9566843|FG001|Completed Day 29|Overall Study||206
8534000|NCT04362813|9566842|FG000|COMPLETED|Overall Study||209
8534001|NCT04362813|9566843|FG001|COMPLETED|Overall Study||202
8534002|NCT04362813|9566842|FG000|NOT COMPLETED|Overall Study||18
8534003|NCT04362813|9566843|FG001|NOT COMPLETED|Overall Study||25
8534004|NCT04231409|9566851|FG000|STARTED|Overall Study||5
8534005|NCT04231409|9566852|FG001|STARTED|Overall Study||4
8534006|NCT04231409|9566851|FG000|COMPLETED|Overall Study||0
8534007|NCT04231409|9566852|FG001|COMPLETED|Overall Study||0
8534008|NCT04231409|9566851|FG000|NOT COMPLETED|Overall Study||5
8534009|NCT04231409|9566852|FG001|NOT COMPLETED|Overall Study||4
8534010|NCT04136548|9566858|FG000|STARTED|Enrolled & Randomized||19
8534011|NCT04136548|9566859|FG001|STARTED|Enrolled & Randomized||19
8534012|NCT04136548|9566858|FG000|COMPLETED|Enrolled & Randomized||13
8534013|NCT04136548|9566859|FG001|COMPLETED|Enrolled & Randomized||15
8534014|NCT04136548|9566858|FG000|NOT COMPLETED|Enrolled & Randomized||6
8534015|NCT04136548|9566859|FG001|NOT COMPLETED|Enrolled & Randomized||4
8534016|NCT04136548|9566858|FG000|STARTED|First Visit||13
8534017|NCT04136548|9566859|FG001|STARTED|First Visit||15
8534018|NCT04136548|9566858|FG000|COMPLETED|First Visit||13
8534019|NCT04136548|9566859|FG001|COMPLETED|First Visit||15
8534020|NCT04136548|9566858|FG000|NOT COMPLETED|First Visit||0
8534021|NCT04136548|9566859|FG001|NOT COMPLETED|First Visit||0
8534022|NCT04136548|9566858|FG000|STARTED|Washout (at Least 48 Hours)||13
8534023|NCT04136548|9566859|FG001|STARTED|Washout (at Least 48 Hours)||15
8534024|NCT04136548|9566858|FG000|COMPLETED|Washout (at Least 48 Hours)||13
8534025|NCT04136548|9566859|FG001|COMPLETED|Washout (at Least 48 Hours)||15
8534026|NCT04136548|9566858|FG000|NOT COMPLETED|Washout (at Least 48 Hours)||0
8534027|NCT04136548|9566859|FG001|NOT COMPLETED|Washout (at Least 48 Hours)||0
8534028|NCT04136548|9566858|FG000|STARTED|Second Visit||13
8534029|NCT04136548|9566859|FG001|STARTED|Second Visit||15
8534030|NCT04136548|9566858|FG000|COMPLETED|Second Visit||13
8534031|NCT04136548|9566859|FG001|COMPLETED|Second Visit||15
8534032|NCT04136548|9566858|FG000|NOT COMPLETED|Second Visit||0
8534033|NCT04136548|9566859|FG001|NOT COMPLETED|Second Visit||0
8534034|NCT04126057|9566867|FG000|STARTED|Overall Study||50
8534035|NCT04126057|9566868|FG001|STARTED|Overall Study||50
8534036|NCT04126057|9566867|FG000|COMPLETED|Overall Study||47
8534037|NCT04126057|9566868|FG001|COMPLETED|Overall Study||46
8534038|NCT04126057|9566867|FG000|NOT COMPLETED|Overall Study||3
8534039|NCT04126057|9566868|FG001|NOT COMPLETED|Overall Study||4
8534040|NCT04087395|9566874|FG000|STARTED|Overall Study||30
8534041|NCT04087395|9566874|FG000|COMPLETED|Overall Study||30
8534042|NCT04087395|9566874|FG000|NOT COMPLETED|Overall Study||0
8534043|NCT04072432|9566885|FG000|STARTED|Overall Study||6
8534044|NCT04072432|9566886|FG001|STARTED|Overall Study||6
8534045|NCT04072432|9566887|FG002|STARTED|Overall Study||6
8534046|NCT04072432|9566885|FG000|COMPLETED|Overall Study||6
8534047|NCT04072432|9566886|FG001|COMPLETED|Overall Study||6
8534048|NCT04072432|9566887|FG002|COMPLETED|Overall Study||6
8534049|NCT04072432|9566885|FG000|NOT COMPLETED|Overall Study||0
8534050|NCT04072432|9566886|FG001|NOT COMPLETED|Overall Study||0
8534051|NCT04072432|9566887|FG002|NOT COMPLETED|Overall Study||0
8534052|NCT04069585|9566895|FG000|STARTED|Overall Study||30
8534053|NCT04069585|9566895|FG000|COMPLETED|Overall Study||30
8534054|NCT04069585|9566895|FG000|NOT COMPLETED|Overall Study||0
8564986|NCT00064038|9597125|FG002|STARTED|Initial Randomization||0
8564987|NCT00064038|9597123|FG000|Eligible and Analyzable|Initial Randomization||97
8564988|NCT00064038|9597124|FG001|Eligible and Analyzable|Initial Randomization||95
8564989|NCT00064038|9597125|FG002|Eligible and Analyzable|Initial Randomization||0
8564990|NCT00064038|9597123|FG000|Safety Population|Initial Randomization||96
8564991|NCT00064038|9597124|FG001|Safety Population|Initial Randomization||94
8564992|NCT00064038|9597125|FG002|Safety Population|Initial Randomization||0
8564993|NCT00064038|9597123|FG000|COMPLETED|Initial Randomization|The study was closed early per recommedation of the Data Safety Monitoring Committee.|0
8564994|NCT00064038|9597124|FG001|COMPLETED|Initial Randomization|The study was closed early per recommedation of the Data Safety Monitoring Committee.|0
8564995|NCT00064038|9597125|FG002|COMPLETED|Initial Randomization||0
8564996|NCT00064038|9597123|FG000|NOT COMPLETED|Initial Randomization||100
8564997|NCT00064038|9597124|FG001|NOT COMPLETED|Initial Randomization||98
8564998|NCT00064038|9597125|FG002|NOT COMPLETED|Initial Randomization||0
8564999|NCT00064038|9597123|FG000|STARTED|Crossover to Lenalidomide+Dexamethasone||0
8565000|NCT00064038|9597124|FG001|STARTED|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
8565001|NCT00064038|9597125|FG002|STARTED|Crossover to Lenalidomide+Dexamethasone||42
8565002|NCT00064038|9597123|FG000|Eligible and Analyzable|Crossover to Lenalidomide+Dexamethasone||0
8565003|NCT00064038|9597124|FG001|Eligible and Analyzable|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
8565004|NCT00064038|9597125|FG002|Eligible and Analyzable|Crossover to Lenalidomide+Dexamethasone||40
8565005|NCT00064038|9597123|FG000|Safety Population|Crossover to Lenalidomide+Dexamethasone||0
8565006|NCT00064038|9597124|FG001|Safety Population|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
8565007|NCT00064038|9597125|FG002|Safety Population|Crossover to Lenalidomide+Dexamethasone||40
8565008|NCT00064038|9597123|FG000|COMPLETED|Crossover to Lenalidomide+Dexamethasone||0
8565009|NCT00064038|9597124|FG001|COMPLETED|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
8565010|NCT00064038|9597125|FG002|COMPLETED|Crossover to Lenalidomide+Dexamethasone||40
8565011|NCT00064038|9597123|FG000|NOT COMPLETED|Crossover to Lenalidomide+Dexamethasone||0
8565012|NCT00064038|9597124|FG001|NOT COMPLETED|Crossover to Lenalidomide+Dexamethasone||0
8565013|NCT00064038|9597125|FG002|NOT COMPLETED|Crossover to Lenalidomide+Dexamethasone||2
8565014|NCT00064077|9597138|FG000|STARTED|Overall Study||118
8565015|NCT00064077|9597139|FG001|STARTED|Overall Study||117
8565016|NCT00064077|9597140|FG002|STARTED|Overall Study||119
8565017|NCT00064077|9597141|FG003|STARTED|Overall Study||118
8565018|NCT00064077|9597138|FG000|COMPLETED|Overall Study|Evaluable (treatment)|103
8565019|NCT00064077|9597139|FG001|COMPLETED|Overall Study|Evaluable (treatment)|108
8565020|NCT00064077|9597140|FG002|COMPLETED|Overall Study|Evaluable (treatment)|112
8565021|NCT00064077|9597141|FG003|COMPLETED|Overall Study|Evaluable (treatment)|111
8565022|NCT00064077|9597138|FG000|NOT COMPLETED|Overall Study||15
8565023|NCT00064077|9597139|FG001|NOT COMPLETED|Overall Study||9
8565024|NCT00064077|9597140|FG002|NOT COMPLETED|Overall Study||7
8565025|NCT00064077|9597141|FG003|NOT COMPLETED|Overall Study||7
8565026|NCT00064259|9597151|FG000|STARTED|Overall Study||4
8565027|NCT00064259|9597152|FG001|STARTED|Overall Study||4
8565028|NCT00064259|9597153|FG002|STARTED|Overall Study||6
8565029|NCT00064259|9597154|FG003|STARTED|Overall Study||1
8565030|NCT00064259|9597151|FG000|COMPLETED|Overall Study||3
8565031|NCT00064259|9597152|FG001|COMPLETED|Overall Study||4
8565032|NCT00064259|9597153|FG002|COMPLETED|Overall Study||6
8565033|NCT00064259|9597154|FG003|COMPLETED|Overall Study||0
8565034|NCT00064259|9597151|FG000|NOT COMPLETED|Overall Study||1
8565035|NCT00064259|9597152|FG001|NOT COMPLETED|Overall Study||0
8565036|NCT00064259|9597153|FG002|NOT COMPLETED|Overall Study||0
8565037|NCT00064259|9597154|FG003|NOT COMPLETED|Overall Study||1
8565038|NCT00064298|9597161|FG000|STARTED|Overall Study||72
8565039|NCT00064298|9597162|FG001|STARTED|Overall Study||62
8565040|NCT00064298|9597161|FG000|COMPLETED|Overall Study||66
8565041|NCT00064298|9597162|FG001|COMPLETED|Overall Study||57
8565042|NCT00064298|9597161|FG000|NOT COMPLETED|Overall Study||6
8565043|NCT00064298|9597162|FG001|NOT COMPLETED|Overall Study||5
8565044|NCT00064337|9597168|FG000|STARTED|PBSCC or Induction/PBSCC|104 patients were registered, 93 of whom were eligible and analyzable.|93
8565045|NCT00064337|9597168|FG000|COMPLETED|PBSCC or Induction/PBSCC||73
8565046|NCT00064337|9597168|FG000|NOT COMPLETED|PBSCC or Induction/PBSCC||20
8565047|NCT00064337|9597168|FG000|STARTED|Transplant|6 patients who completed PBSCC or Induction/PBSCC did not begin Transplant|67
8565048|NCT00064337|9597168|FG000|COMPLETED|Transplant||46
8565049|NCT00064337|9597168|FG000|NOT COMPLETED|Transplant||21
8565050|NCT00064337|9597168|FG000|STARTED|Maintenance|Only patients with High Risk MM or AL + MM were allowed to enroll to Maintenance treatment.|13
8565051|NCT00064337|9597168|FG000|COMPLETED|Maintenance||3
8565052|NCT00064337|9597168|FG000|NOT COMPLETED|Maintenance||10
8565053|NCT00064350|9597178|FG000|STARTED|Induction Treatment||59
8565054|NCT00064350|9597179|FG001|STARTED|Induction Treatment||46
8565055|NCT00064350|9597180|FG002|STARTED|Induction Treatment||237
8565056|NCT00064350|9597178|FG000|Treated|Induction Treatment||59
8534055|NCT03922321|9566901|FG000|STARTED|Overall Study||7
8534056|NCT03922321|9566901|FG000|COMPLETED|Overall Study||5
8534057|NCT03922321|9566901|FG000|NOT COMPLETED|Overall Study||2
8534058|NCT03911713|9566910|FG000|STARTED|Overall Study||12
8534059|NCT03911713|9566911|FG001|STARTED|Overall Study||6
8534060|NCT03911713|9566912|FG002|STARTED|Overall Study||11
8534061|NCT03911713|9566913|FG003|STARTED|Overall Study||24
8534062|NCT03911713|9566914|FG004|STARTED|Overall Study||24
8534063|NCT03911713|9566910|FG000|Full Analysis Set|Overall Study||11
8534064|NCT03911713|9566911|FG001|Full Analysis Set|Overall Study||6
8534065|NCT03911713|9566912|FG002|Full Analysis Set|Overall Study||11
8534066|NCT03911713|9566913|FG003|Full Analysis Set|Overall Study||23
8534067|NCT03911713|9566914|FG004|Full Analysis Set|Overall Study||24
8534068|NCT03911713|9566910|FG000|COMPLETED|Overall Study||11
8534069|NCT03911713|9566911|FG001|COMPLETED|Overall Study||4
8534070|NCT03911713|9566912|FG002|COMPLETED|Overall Study||11
8534071|NCT03911713|9566913|FG003|COMPLETED|Overall Study||22
8534072|NCT03911713|9566914|FG004|COMPLETED|Overall Study||24
8534073|NCT03911713|9566910|FG000|NOT COMPLETED|Overall Study||1
8534074|NCT03911713|9566911|FG001|NOT COMPLETED|Overall Study||2
8534075|NCT03911713|9566912|FG002|NOT COMPLETED|Overall Study||0
8534076|NCT03911713|9566913|FG003|NOT COMPLETED|Overall Study||2
8534077|NCT03911713|9566914|FG004|NOT COMPLETED|Overall Study||0
8534078|NCT03879642|9566930|FG000|STARTED|Overall Study||22
8534079|NCT03879642|9566931|FG001|STARTED|Overall Study||21
8534080|NCT03879642|9566930|FG000|COMPLETED|Overall Study||19
8534081|NCT03879642|9566931|FG001|COMPLETED|Overall Study||18
8534082|NCT03879642|9566930|FG000|NOT COMPLETED|Overall Study||3
8534083|NCT03879642|9566931|FG001|NOT COMPLETED|Overall Study||3
8534084|NCT03852459|9566939|FG000|STARTED|Overall Study||126
8534085|NCT03852459|9566940|FG001|STARTED|Overall Study||125
8534086|NCT03852459|9566939|FG000|COMPLETED|Overall Study||123
8534087|NCT03852459|9566940|FG001|COMPLETED|Overall Study||122
8534088|NCT03852459|9566939|FG000|NOT COMPLETED|Overall Study||3
8534089|NCT03852459|9566940|FG001|NOT COMPLETED|Overall Study||3
8534090|NCT03740919|9566949|FG000|STARTED|Lead-in Period||751
8534091|NCT03740919|9566950|FG001|STARTED|Lead-in Period||0
8534092|NCT03740919|9566951|FG002|STARTED|Lead-in Period||0
8534093|NCT03740919|9566952|FG003|STARTED|Lead-in Period||0
8534094|NCT03740919|9566949|FG000|Received at Least One Dose of Study Drug|Lead-in Period||751
8534095|NCT03740919|9566950|FG001|Received at Least One Dose of Study Drug|Lead-in Period||0
8534096|NCT03740919|9566951|FG002|Received at Least One Dose of Study Drug|Lead-in Period||0
8534097|NCT03740919|9566952|FG003|Received at Least One Dose of Study Drug|Lead-in Period||0
8534098|NCT03740919|9566949|FG000|COMPLETED|Lead-in Period||716
8534099|NCT03740919|9566950|FG001|COMPLETED|Lead-in Period||0
8534100|NCT03740919|9566951|FG002|COMPLETED|Lead-in Period||0
8534101|NCT03740919|9566952|FG003|COMPLETED|Lead-in Period||0
8534102|NCT03740919|9566949|FG000|NOT COMPLETED|Lead-in Period||35
8534103|NCT03740919|9566950|FG001|NOT COMPLETED|Lead-in Period||0
8534104|NCT03740919|9566951|FG002|NOT COMPLETED|Lead-in Period||0
8534105|NCT03740919|9566952|FG003|NOT COMPLETED|Lead-in Period||0
8534106|NCT03740919|9566949|FG000|STARTED|Treatment Period||0
8534107|NCT03740919|9566950|FG001|STARTED|Treatment Period|Participants were randomized from Lead-in Period to Insulin Lispro (Humalog).|298
8534108|NCT03740919|9566951|FG002|STARTED|Treatment Period|Participants were randomized from Lead-in Period to LY900014.|280
8534109|NCT03740919|9566952|FG003|STARTED|Treatment Period|Participants were randomized from Lead-in Period to open-label LY900014.|138
8534110|NCT03740919|9566949|FG000|Received at Least One Dose of Study Drug|Treatment Period||0
8534111|NCT03740919|9566950|FG001|Received at Least One Dose of Study Drug|Treatment Period||298
8534112|NCT03740919|9566951|FG002|Received at Least One Dose of Study Drug|Treatment Period||280
8534113|NCT03740919|9566952|FG003|Received at Least One Dose of Study Drug|Treatment Period||138
8534114|NCT03740919|9566949|FG000|COMPLETED|Treatment Period||0
8534115|NCT03740919|9566950|FG001|COMPLETED|Treatment Period||288
8534116|NCT03740919|9566951|FG002|COMPLETED|Treatment Period||266
8534117|NCT03740919|9566952|FG003|COMPLETED|Treatment Period||135
8534118|NCT03740919|9566949|FG000|NOT COMPLETED|Treatment Period||0
8534119|NCT03740919|9566950|FG001|NOT COMPLETED|Treatment Period||10
8534120|NCT03740919|9566951|FG002|NOT COMPLETED|Treatment Period||14
8534121|NCT03740919|9566952|FG003|NOT COMPLETED|Treatment Period||3
8534122|NCT03700970|9566965|FG000|STARTED|Overall Study||30
8534123|NCT03700970|9566966|FG001|STARTED|Overall Study||30
8534124|NCT03700970|9566965|FG000|COMPLETED|Overall Study||21
8534125|NCT03700970|9566966|FG001|COMPLETED|Overall Study||19
8534126|NCT03700970|9566965|FG000|NOT COMPLETED|Overall Study||9
8534127|NCT03700970|9566966|FG001|NOT COMPLETED|Overall Study||11
8534128|NCT03652454|9566976|FG000|STARTED|Overall Study||14
8534129|NCT03652454|9566977|FG001|STARTED|Overall Study||14
8534130|NCT03652454|9566976|FG000|COMPLETED|Overall Study||14
8534131|NCT03652454|9566977|FG001|COMPLETED|Overall Study||14
8534132|NCT03652454|9566976|FG000|NOT COMPLETED|Overall Study||0
8534133|NCT03652454|9566977|FG001|NOT COMPLETED|Overall Study||0
8534134|NCT03647488|9566986|FG000|STARTED|Overall Study||18
8534135|NCT03647488|9566987|FG001|STARTED|Overall Study|Randomized part was not opened|0
8534136|NCT03647488|9566988|FG002|STARTED|Overall Study|Randomized part was not opened|0
8534137|NCT03647488|9566986|FG000|COMPLETED|Overall Study||0
8534138|NCT03647488|9566987|FG001|COMPLETED|Overall Study||0
8534139|NCT03647488|9566988|FG002|COMPLETED|Overall Study||0
8534140|NCT03647488|9566986|FG000|NOT COMPLETED|Overall Study||18
8534141|NCT03647488|9566987|FG001|NOT COMPLETED|Overall Study||0
8534142|NCT03647488|9566988|FG002|NOT COMPLETED|Overall Study||0
8534143|NCT03614923|9566997|FG000|STARTED|Overall Study||35
8534144|NCT03614923|9566998|FG001|STARTED|Overall Study||35
8534145|NCT03614923|9566999|FG002|STARTED|Overall Study||35
8534146|NCT03614923|9566997|FG000|COMPLETED|Overall Study||30
8534147|NCT03614923|9566998|FG001|COMPLETED|Overall Study||30
8534148|NCT03614923|9566999|FG002|COMPLETED|Overall Study||30
8534149|NCT03614923|9566997|FG000|NOT COMPLETED|Overall Study||5
8534150|NCT03614923|9566998|FG001|NOT COMPLETED|Overall Study||5
8534151|NCT03614923|9566999|FG002|NOT COMPLETED|Overall Study||5
8534152|NCT03502187|9567010|FG000|STARTED|Overall Study||43
8534153|NCT03502187|9567011|FG001|STARTED|Overall Study||43
8534154|NCT03502187|9567012|FG002|STARTED|Overall Study||42
8534155|NCT03502187|9567010|FG000|COMPLETED|Overall Study||34
8534156|NCT03502187|9567011|FG001|COMPLETED|Overall Study||36
8534157|NCT03502187|9567012|FG002|COMPLETED|Overall Study||34
8534158|NCT03502187|9567010|FG000|NOT COMPLETED|Overall Study||9
8534159|NCT03502187|9567011|FG001|NOT COMPLETED|Overall Study||7
8534160|NCT03502187|9567012|FG002|NOT COMPLETED|Overall Study||8
8534161|NCT03447262|9567020|FG000|STARTED|Overall Study||481
8534162|NCT03447262|9567020|FG000|COMPLETED|Overall Study||2
8534163|NCT03447262|9567020|FG000|NOT COMPLETED|Overall Study||479
8534164|NCT03432819|9567029|FG000|STARTED|Overall Study||38
8534165|NCT03432819|9567030|FG001|STARTED|Overall Study||38
8534166|NCT03432819|9567029|FG000|COMPLETED|Overall Study||31
8534167|NCT03432819|9567030|FG001|COMPLETED|Overall Study||33
8534168|NCT03432819|9567029|FG000|NOT COMPLETED|Overall Study||7
8534169|NCT03432819|9567030|FG001|NOT COMPLETED|Overall Study||5
8565057|NCT00064350|9597179|FG001|Treated|Induction Treatment||46
8565058|NCT00064350|9597180|FG002|Treated|Induction Treatment||228
8565059|NCT00064350|9597178|FG000|Eligible and Treated|Induction Treatment||59
8816433|NCT01544179|9869952|FG001|COMPLETED|Overall Study|Patients are ongoing in the study|86
8816434|NCT01544179|9869951|FG000|NOT COMPLETED|Overall Study||63
8816435|NCT01544179|9869952|FG001|NOT COMPLETED|Overall Study||46
8816436|NCT01544309|9869960|FG000|STARTED|Overall Study||524
8816437|NCT01544309|9869961|FG001|STARTED|Overall Study||525
8816438|NCT01544309|9869960|FG000|COMPLETED|Overall Study||504
8816439|NCT01544309|9869961|FG001|COMPLETED|Overall Study||514
8816440|NCT01544309|9869960|FG000|NOT COMPLETED|Overall Study||20
8816441|NCT01544309|9869961|FG001|NOT COMPLETED|Overall Study||11
8565060|NCT00064350|9597179|FG001|Eligible and Treated|Induction Treatment||46
8565061|NCT00064350|9597180|FG002|Eligible and Treated|Induction Treatment||194
8565062|NCT00064350|9597178|FG000|COMPLETED|Induction Treatment||51
8565063|NCT00064350|9597179|FG001|COMPLETED|Induction Treatment||37
8565064|NCT00064350|9597180|FG002|COMPLETED|Induction Treatment||1
8565065|NCT00064350|9597178|FG000|NOT COMPLETED|Induction Treatment||8
8565066|NCT00064350|9597179|FG001|NOT COMPLETED|Induction Treatment||9
8565067|NCT00064350|9597180|FG002|NOT COMPLETED|Induction Treatment||236
8565068|NCT00064350|9597178|FG000|STARTED|Randomization||59
8565069|NCT00064350|9597179|FG001|STARTED|Randomization||46
8565070|NCT00064350|9597180|FG002|STARTED|Randomization||0
8565071|NCT00064350|9597178|FG000|Treated|Randomization||55
8565072|NCT00064350|9597179|FG001|Treated|Randomization||40
8565073|NCT00064350|9597180|FG002|Treated|Randomization||0
8565074|NCT00064350|9597178|FG000|Eligible and Treated|Randomization||50
8565075|NCT00064350|9597179|FG001|Eligible and Treated|Randomization||31
8565076|NCT00064350|9597180|FG002|Eligible and Treated|Randomization||0
8565077|NCT00064350|9597178|FG000|COMPLETED|Randomization||33
8565078|NCT00064350|9597179|FG001|COMPLETED|Randomization||28
8565079|NCT00064350|9597180|FG002|COMPLETED|Randomization||0
8565080|NCT00064350|9597178|FG000|NOT COMPLETED|Randomization||26
8565081|NCT00064350|9597179|FG001|NOT COMPLETED|Randomization||18
8565082|NCT00064350|9597180|FG002|NOT COMPLETED|Randomization||0
8565083|NCT00064350|9597178|FG000|STARTED|Cross-Over||10
8565084|NCT00064350|9597179|FG001|STARTED|Cross-Over||27
8565085|NCT00064350|9597180|FG002|STARTED|Cross-Over||0
8565086|NCT00064350|9597178|FG000|Treated|Cross-Over||9
8565087|NCT00064350|9597179|FG001|Treated|Cross-Over||26
8565088|NCT00064350|9597180|FG002|Treated|Cross-Over||0
8565089|NCT00064350|9597178|FG000|Eligible and Treated|Cross-Over||7
8565090|NCT00064350|9597179|FG001|Eligible and Treated|Cross-Over||21
8565091|NCT00064350|9597180|FG002|Eligible and Treated|Cross-Over||0
8565092|NCT00064350|9597178|FG000|COMPLETED|Cross-Over||4
8565093|NCT00064350|9597179|FG001|COMPLETED|Cross-Over||13
8565094|NCT00064350|9597180|FG002|COMPLETED|Cross-Over||0
8565095|NCT00064350|9597178|FG000|NOT COMPLETED|Cross-Over||6
8565096|NCT00064350|9597179|FG001|NOT COMPLETED|Cross-Over||14
8565097|NCT00064350|9597180|FG002|NOT COMPLETED|Cross-Over||0
8816442|NCT01544335|9869969|FG000|STARTED|Overall Study||191
8816443|NCT01544335|9869969|FG000|COMPLETED|Overall Study||138
8565098|NCT00064662|9597191|FG000|STARTED|Overall Study||329
8565099|NCT00064662|9597192|FG001|STARTED|Overall Study||326
8565100|NCT00064662|9597191|FG000|COMPLETED|Overall Study||255
8565101|NCT00064662|9597192|FG001|COMPLETED|Overall Study||265
8565102|NCT00064662|9597191|FG000|NOT COMPLETED|Overall Study||74
8565103|NCT00064662|9597192|FG001|NOT COMPLETED|Overall Study||61
8565104|NCT00064701|9597201|FG000|STARTED|One Year Post-transplant||219
8565105|NCT00064701|9597202|FG001|STARTED|One Year Post-transplant||226
8565106|NCT00064701|9597203|FG002|STARTED|One Year Post-transplant||223
8565107|NCT00064701|9597201|FG000|Received Study Drug|One Year Post-transplant||212
8569453|NCT00097539|9601698|FG005|STARTED|Overall Study||8010
8816444|NCT01544335|9869969|FG000|NOT COMPLETED|Overall Study||53
8816445|NCT01544348|9869981|FG000|STARTED|Overall Study||17
8816446|NCT01544348|9869982|FG001|STARTED|Overall Study||6
8816447|NCT01544348|9869983|FG002|STARTED|Overall Study||3
8534174|NCT03323749|9567043|FG000|STARTED|Double-blind Period||109
8534175|NCT03323749|9567044|FG001|STARTED|Double-blind Period||109
8534176|NCT03323749|9567043|FG000|COMPLETED|Double-blind Period||102
8534177|NCT03323749|9567044|FG001|COMPLETED|Double-blind Period||103
8534178|NCT03323749|9567043|FG000|NOT COMPLETED|Double-blind Period||7
8534179|NCT03323749|9567044|FG001|NOT COMPLETED|Double-blind Period||6
8534180|NCT03323749|9567043|FG000|STARTED|Open-Label Period||93
8534181|NCT03323749|9567044|FG001|STARTED|Open-Label Period||103
8534182|NCT03323749|9567043|FG000|COMPLETED|Open-Label Period||0
8534183|NCT03323749|9567044|FG001|COMPLETED|Open-Label Period||0
8534184|NCT03323749|9567043|FG000|NOT COMPLETED|Open-Label Period||93
8534185|NCT03323749|9567044|FG001|NOT COMPLETED|Open-Label Period||103
8534186|NCT03322566|9567057|FG000|STARTED|Overall Study||91
8534187|NCT03322566|9567058|FG001|STARTED|Overall Study||87
8534188|NCT03322566|9567059|FG002|STARTED|Overall Study||55
8534189|NCT03322566|9567057|FG000|COMPLETED|Overall Study||46
8534190|NCT03322566|9567058|FG001|COMPLETED|Overall Study||42
8534191|NCT03322566|9567059|FG002|COMPLETED|Overall Study||22
8534192|NCT03322566|9567057|FG000|NOT COMPLETED|Overall Study||45
8534193|NCT03322566|9567058|FG001|NOT COMPLETED|Overall Study||45
8534194|NCT03322566|9567059|FG002|NOT COMPLETED|Overall Study||33
8534195|NCT03322540|9567069|FG000|STARTED|Overall Study||77
8534196|NCT03322540|9567070|FG001|STARTED|Overall Study||77
8534197|NCT03322540|9567069|FG000|Number of Subjects Received Treatment (Actual Treatment) (ASaT)|Overall Study||75
8534198|NCT03322540|9567070|FG001|Number of Subjects Received Treatment (Actual Treatment) (ASaT)|Overall Study||77
8534199|NCT03322540|9567069|FG000|COMPLETED|Overall Study||46
8534200|NCT03322540|9567070|FG001|COMPLETED|Overall Study||40
8534201|NCT03322540|9567069|FG000|NOT COMPLETED|Overall Study||31
8534202|NCT03322540|9567070|FG001|NOT COMPLETED|Overall Study||37
8534203|NCT03240601|9567080|FG000|STARTED|Overall Study||9
8534204|NCT03240601|9567081|FG001|STARTED|Overall Study||9
8534205|NCT03240601|9567080|FG000|COMPLETED|Overall Study||8
8534206|NCT03240601|9567081|FG001|COMPLETED|Overall Study||8
8534207|NCT03240601|9567080|FG000|NOT COMPLETED|Overall Study||1
8534208|NCT03240601|9567081|FG001|NOT COMPLETED|Overall Study||1
8534209|NCT03189719|9567089|FG000|STARTED|Overall Study||373
8534210|NCT03189719|9567090|FG001|STARTED|Overall Study||376
8534211|NCT03189719|9567089|FG000|Treated|Overall Study||370
8534212|NCT03189719|9567090|FG001|Treated|Overall Study||370
8534213|NCT03189719|9567089|FG000|COMPLETED|Overall Study||0
8534214|NCT03189719|9567090|FG001|COMPLETED|Overall Study||0
8534215|NCT03189719|9567089|FG000|NOT COMPLETED|Overall Study||373
8534216|NCT03189719|9567090|FG001|NOT COMPLETED|Overall Study||376
8534217|NCT03155997|9567098|FG000|STARTED|Overall Study||2808
8534218|NCT03155997|9567099|FG001|STARTED|Overall Study||2829
8534219|NCT03155997|9567098|FG000|Received at Least One Dose of Study Drug|Overall Study||2791
8534220|NCT03155997|9567099|FG001|Received at Least One Dose of Study Drug|Overall Study||2800
8534221|NCT03155997|9567098|FG000|COMPLETED|Overall Study||650
8534222|NCT03155997|9567099|FG001|COMPLETED|Overall Study||607
8534223|NCT03155997|9567098|FG000|NOT COMPLETED|Overall Study||2158
8534224|NCT03155997|9567099|FG001|NOT COMPLETED|Overall Study||2222
8534225|NCT03104400|9567109|FG000|STARTED|Overall Study||211
8534226|NCT03104400|9567110|FG001|STARTED|Overall Study||212
8534227|NCT03104400|9567111|FG002|STARTED|Overall Study||429
8534228|NCT03104400|9567112|FG003|STARTED|Overall Study||430
8534229|NCT03104400|9567113|FG004|STARTED|Overall Study||423
8534230|NCT03104400|9567109|FG000|Received Study Drug|Overall Study||211
8534231|NCT03104400|9567110|FG001|Received Study Drug|Overall Study||212
8534232|NCT03104400|9567111|FG002|Received Study Drug|Overall Study||429
8534233|NCT03104400|9567112|FG003|Received Study Drug|Overall Study||429
8534234|NCT03104400|9567113|FG004|Received Study Drug|Overall Study||423
8534235|NCT03104400|9567109|FG000|Completed Week 24|Overall Study||190
8534236|NCT03104400|9567110|FG001|Completed Week 24|Overall Study||193
8534237|NCT03104400|9567111|FG002|Completed Week 24|Overall Study||404
8534238|NCT03104400|9567112|FG003|Completed Week 24|Overall Study||408
8534239|NCT03104400|9567113|FG004|Completed Week 24|Overall Study||394
8534240|NCT03104400|9567109|FG000|COMPLETED|Overall Study||177
8534241|NCT03104400|9567110|FG001|COMPLETED|Overall Study||178
8534242|NCT03104400|9567111|FG002|COMPLETED|Overall Study||370
8534243|NCT03104400|9567112|FG003|COMPLETED|Overall Study||379
8534244|NCT03104400|9567113|FG004|COMPLETED|Overall Study||366
8534245|NCT03104400|9567109|FG000|NOT COMPLETED|Overall Study||34
8534246|NCT03104400|9567110|FG001|NOT COMPLETED|Overall Study||34
8534247|NCT03104400|9567111|FG002|NOT COMPLETED|Overall Study||59
8534248|NCT03104400|9567112|FG003|NOT COMPLETED|Overall Study||51
8534249|NCT03104400|9567113|FG004|NOT COMPLETED|Overall Study||57
8534250|NCT03104374|9567130|FG000|STARTED|Overall Study||106
8534251|NCT03104374|9567131|FG001|STARTED|Overall Study||106
8534252|NCT03104374|9567132|FG002|STARTED|Overall Study||211
8534253|NCT03104374|9567133|FG003|STARTED|Overall Study||219
8534254|NCT03104374|9567130|FG000|Received Study Drug|Overall Study||106
8534255|NCT03104374|9567131|FG001|Received Study Drug|Overall Study||106
8534256|NCT03104374|9567132|FG002|Received Study Drug|Overall Study||211
8534257|NCT03104374|9567133|FG003|Received Study Drug|Overall Study||218
8534258|NCT03104374|9567130|FG000|Completed Week 24|Overall Study||81
8534259|NCT03104374|9567131|FG001|Completed Week 24|Overall Study||92
8534260|NCT03104374|9567132|FG002|Completed Week 24|Overall Study||192
8534261|NCT03104374|9567133|FG003|Completed Week 24|Overall Study||195
8534262|NCT03104374|9567130|FG000|COMPLETED|Overall Study||69
8534263|NCT03104374|9567131|FG001|COMPLETED|Overall Study||77
8534264|NCT03104374|9567132|FG002|COMPLETED|Overall Study||167
8534265|NCT03104374|9567133|FG003|COMPLETED|Overall Study||166
8534266|NCT03104374|9567130|FG000|NOT COMPLETED|Overall Study||37
8534267|NCT03104374|9567131|FG001|NOT COMPLETED|Overall Study||29
8534268|NCT03104374|9567132|FG002|NOT COMPLETED|Overall Study||44
8534269|NCT03104374|9567133|FG003|NOT COMPLETED|Overall Study||53
8534270|NCT03072043|9567146|FG000|STARTED|Overall Study||3
8534271|NCT03072043|9567147|FG001|STARTED|Overall Study||3
8534272|NCT03072043|9567148|FG002|STARTED|Overall Study||49
8534273|NCT03072043|9567146|FG000|COMPLETED|Overall Study||3
8534274|NCT03072043|9567147|FG001|COMPLETED|Overall Study||3
8816448|NCT01544348|9869984|FG003|STARTED|Overall Study||3
8816449|NCT01544348|9869985|FG004|STARTED|Overall Study||16
8816450|NCT01544348|9869986|FG005|STARTED|Overall Study||19
8816451|NCT01544348|9869987|FG006|STARTED|Overall Study||14
8816452|NCT01544348|9869988|FG007|STARTED|Overall Study||8
8816453|NCT01544348|9869981|FG000|Treated|Overall Study||17
8816454|NCT01544348|9869982|FG001|Treated|Overall Study||6
8816455|NCT01544348|9869983|FG002|Treated|Overall Study||3
8534275|NCT03072043|9567148|FG002|COMPLETED|Overall Study||40
8534276|NCT03072043|9567146|FG000|NOT COMPLETED|Overall Study||0
8534277|NCT03072043|9567147|FG001|NOT COMPLETED|Overall Study||0
8534278|NCT03072043|9567148|FG002|NOT COMPLETED|Overall Study||9
8534279|NCT02970981|9567160|FG000|STARTED|Overall Study||16
8534280|NCT02970981|9567160|FG000|COMPLETED|Overall Study||16
8534281|NCT02970981|9567160|FG000|NOT COMPLETED|Overall Study||0
8534282|NCT02946853|9567166|FG000|STARTED|Overall Study||13
8534283|NCT02946853|9567167|FG001|STARTED|Overall Study||13
8534284|NCT02946853|9567166|FG000|COMPLETED|Overall Study||12
8534285|NCT02946853|9567167|FG001|COMPLETED|Overall Study||13
8534286|NCT02946853|9567166|FG000|NOT COMPLETED|Overall Study||1
8534287|NCT02946853|9567167|FG001|NOT COMPLETED|Overall Study||0
8534288|NCT02905032|9567176|FG000|STARTED|Overall Study||467
8534289|NCT02905032|9567177|FG001|STARTED|Overall Study||475
8534290|NCT02905032|9567178|FG002|STARTED|Overall Study||244
8534291|NCT02905032|9567176|FG000|COMPLETED|Overall Study||459
8534292|NCT02905032|9567177|FG001|COMPLETED|Overall Study||463
8534293|NCT02905032|9567178|FG002|COMPLETED|Overall Study||244
8534294|NCT02905032|9567176|FG000|NOT COMPLETED|Overall Study||8
8534295|NCT02905032|9567177|FG001|NOT COMPLETED|Overall Study||12
8534296|NCT02905032|9567178|FG002|NOT COMPLETED|Overall Study||0
8534297|NCT02837029|9567188|FG000|STARTED|Screening||15
8534298|NCT02837029|9567189|FG001|STARTED|Screening||12
8534299|NCT02837029|9567190|FG002|STARTED|Screening||0
8534300|NCT02837029|9567188|FG000|COMPLETED|Screening||8
8534301|NCT02837029|9567189|FG001|COMPLETED|Screening||9
8534302|NCT02837029|9567190|FG002|COMPLETED|Screening||0
8534303|NCT02837029|9567188|FG000|NOT COMPLETED|Screening||7
8534304|NCT02837029|9567189|FG001|NOT COMPLETED|Screening||3
8534305|NCT02837029|9567190|FG002|NOT COMPLETED|Screening||0
8534306|NCT02837029|9567188|FG000|STARTED|Induction Treatment With Y90||8
8534307|NCT02837029|9567189|FG001|STARTED|Induction Treatment With Y90||9
8534308|NCT02837029|9567190|FG002|STARTED|Induction Treatment With Y90||0
8534309|NCT02837029|9567188|FG000|COMPLETED|Induction Treatment With Y90||8
8534310|NCT02837029|9567189|FG001|COMPLETED|Induction Treatment With Y90||9
8816456|NCT01544348|9869984|FG003|Treated|Overall Study||3
8816457|NCT01544348|9869985|FG004|Treated|Overall Study||15
8534311|NCT02837029|9567190|FG002|COMPLETED|Induction Treatment With Y90||0
8534312|NCT02837029|9567188|FG000|NOT COMPLETED|Induction Treatment With Y90||0
8534313|NCT02837029|9567189|FG001|NOT COMPLETED|Induction Treatment With Y90||0
8534314|NCT02837029|9567190|FG002|NOT COMPLETED|Induction Treatment With Y90||0
8534315|NCT02837029|9567188|FG000|STARTED|Cycle 1 (DLT Monitoring Period)||8
8534316|NCT02837029|9567189|FG001|STARTED|Cycle 1 (DLT Monitoring Period)||9
8534317|NCT02837029|9567190|FG002|STARTED|Cycle 1 (DLT Monitoring Period)||0
8534318|NCT02837029|9567188|FG000|Received Nivolumab Dose|Cycle 1 (DLT Monitoring Period)||6
8534319|NCT02837029|9567189|FG001|Received Nivolumab Dose|Cycle 1 (DLT Monitoring Period)||7
8534320|NCT02837029|9567190|FG002|Received Nivolumab Dose|Cycle 1 (DLT Monitoring Period)||0
8534321|NCT02837029|9567188|FG000|COMPLETED|Cycle 1 (DLT Monitoring Period)||6
8534322|NCT02837029|9567189|FG001|COMPLETED|Cycle 1 (DLT Monitoring Period)||6
8534323|NCT02837029|9567190|FG002|COMPLETED|Cycle 1 (DLT Monitoring Period)||0
8534324|NCT02837029|9567188|FG000|NOT COMPLETED|Cycle 1 (DLT Monitoring Period)||2
8534325|NCT02837029|9567189|FG001|NOT COMPLETED|Cycle 1 (DLT Monitoring Period)||3
8534326|NCT02837029|9567190|FG002|NOT COMPLETED|Cycle 1 (DLT Monitoring Period)||0
8534327|NCT02837029|9567188|FG000|STARTED|Cycle 2 and Beyond||6
8534328|NCT02837029|9567189|FG001|STARTED|Cycle 2 and Beyond||6
8534329|NCT02837029|9567190|FG002|STARTED|Cycle 2 and Beyond||0
8534330|NCT02837029|9567188|FG000|COMPLETED|Cycle 2 and Beyond||5
8534331|NCT02837029|9567189|FG001|COMPLETED|Cycle 2 and Beyond||6
8534332|NCT02837029|9567190|FG002|COMPLETED|Cycle 2 and Beyond||0
8534333|NCT02837029|9567188|FG000|NOT COMPLETED|Cycle 2 and Beyond||1
8816458|NCT01544348|9869986|FG005|Treated|Overall Study||18
8816459|NCT01544348|9869987|FG006|Treated|Overall Study||14
8534334|NCT02837029|9567189|FG001|NOT COMPLETED|Cycle 2 and Beyond||0
8816460|NCT01544348|9869988|FG007|Treated|Overall Study||8
8816461|NCT01544348|9869981|FG000|COMPLETED|Overall Study||15
8534335|NCT02837029|9567190|FG002|NOT COMPLETED|Cycle 2 and Beyond||0
8534336|NCT02837029|9567188|FG000|STARTED|2 Year Follow-up|All patients who receive at least one dose of nivolumab go into follow-up.|6
8534337|NCT02837029|9567189|FG001|STARTED|2 Year Follow-up|All patients who receive at least one dose of nivolumab go into follow-up.|7
8534338|NCT02837029|9567190|FG002|STARTED|2 Year Follow-up||0
8534339|NCT02837029|9567188|FG000|COMPLETED|2 Year Follow-up||0
8534340|NCT02837029|9567189|FG001|COMPLETED|2 Year Follow-up||0
8534341|NCT02837029|9567190|FG002|COMPLETED|2 Year Follow-up||0
8534342|NCT02837029|9567188|FG000|NOT COMPLETED|2 Year Follow-up||6
8534343|NCT02837029|9567189|FG001|NOT COMPLETED|2 Year Follow-up||7
8534344|NCT02837029|9567190|FG002|NOT COMPLETED|2 Year Follow-up||0
8534345|NCT02740127|9567201|FG000|STARTED|Overall Study||24
8534346|NCT02740127|9567202|FG001|STARTED|Overall Study||28
8534347|NCT02740127|9567201|FG000|COMPLETED|Overall Study||24
8534348|NCT02740127|9567202|FG001|COMPLETED|Overall Study||28
8534349|NCT02740127|9567201|FG000|NOT COMPLETED|Overall Study||0
8534350|NCT02740127|9567202|FG001|NOT COMPLETED|Overall Study||0
8534351|NCT02737553|9567210|FG000|STARTED|Overall Study||49
8534352|NCT02737553|9567211|FG001|STARTED|Overall Study||48
8534353|NCT02737553|9567210|FG000|COMPLETED|Overall Study||49
8534354|NCT02737553|9567211|FG001|COMPLETED|Overall Study||48
8534355|NCT02737553|9567210|FG000|NOT COMPLETED|Overall Study||0
8534356|NCT02737553|9567211|FG001|NOT COMPLETED|Overall Study||0
8534357|NCT02737475|9567245|FG000|STARTED|Overall Study||4
8534358|NCT02737475|9567246|FG001|STARTED|Overall Study||4
8534359|NCT02737475|9567247|FG002|STARTED|Overall Study||4
8534360|NCT02737475|9567248|FG003|STARTED|Overall Study||4
8534361|NCT02737475|9567249|FG004|STARTED|Overall Study||4
8534362|NCT02737475|9567250|FG005|STARTED|Overall Study||7
8534363|NCT02737475|9567251|FG006|STARTED|Overall Study||8
8534364|NCT02737475|9567252|FG007|STARTED|Overall Study||12
8534365|NCT02737475|9567253|FG008|STARTED|Overall Study||8
8534366|NCT02737475|9567254|FG009|STARTED|Overall Study||8
8534367|NCT02737475|9567255|FG010|STARTED|Overall Study||4
8534368|NCT02737475|9567256|FG011|STARTED|Overall Study||10
8534369|NCT02737475|9567257|FG012|STARTED|Overall Study||7
8534370|NCT02737475|9567258|FG013|STARTED|Overall Study||8
8534371|NCT02737475|9567259|FG014|STARTED|Overall Study||6
8534372|NCT02737475|9567260|FG015|STARTED|Overall Study||18
8534373|NCT02737475|9567261|FG016|STARTED|Overall Study||12
8534374|NCT02737475|9567262|FG017|STARTED|Overall Study||6
8534375|NCT02737475|9567263|FG018|STARTED|Overall Study||7
8534376|NCT02737475|9567264|FG019|STARTED|Overall Study||1
8534377|NCT02737475|9567265|FG020|STARTED|Overall Study||6
8534378|NCT02737475|9567266|FG021|STARTED|Overall Study||9
8534379|NCT02737475|9567267|FG022|STARTED|Overall Study||2
8534380|NCT02737475|9567268|FG023|STARTED|Overall Study||2
8620869|NCT00476021|9659724|FG000|COMPLETED|Overall Study||51
8620870|NCT00476021|9659725|FG001|COMPLETED|Overall Study||51
8534381|NCT02737475|9567269|FG024|STARTED|Overall Study||2
8534382|NCT02737475|9567270|FG025|STARTED|Overall Study||2
8534383|NCT02737475|9567271|FG026|STARTED|Overall Study||1
8534384|NCT02737475|9567245|FG000|COMPLETED|Overall Study||3
8534385|NCT02737475|9567246|FG001|COMPLETED|Overall Study||4
8534386|NCT02737475|9567247|FG002|COMPLETED|Overall Study||4
8534387|NCT02737475|9567248|FG003|COMPLETED|Overall Study||3
8534388|NCT02737475|9567249|FG004|COMPLETED|Overall Study||3
8534389|NCT02737475|9567250|FG005|COMPLETED|Overall Study||4
8534390|NCT02737475|9567251|FG006|COMPLETED|Overall Study||8
8534391|NCT02737475|9567252|FG007|COMPLETED|Overall Study||10
8534392|NCT02737475|9567253|FG008|COMPLETED|Overall Study||7
8534393|NCT02737475|9567254|FG009|COMPLETED|Overall Study||8
8534394|NCT02737475|9567255|FG010|COMPLETED|Overall Study||3
8534395|NCT02737475|9567256|FG011|COMPLETED|Overall Study||6
8534396|NCT02737475|9567257|FG012|COMPLETED|Overall Study||5
8534397|NCT02737475|9567258|FG013|COMPLETED|Overall Study||6
8534398|NCT02737475|9567259|FG014|COMPLETED|Overall Study||5
8534399|NCT02737475|9567260|FG015|COMPLETED|Overall Study||15
8534400|NCT02737475|9567261|FG016|COMPLETED|Overall Study||10
8534401|NCT02737475|9567262|FG017|COMPLETED|Overall Study||2
8534402|NCT02737475|9567263|FG018|COMPLETED|Overall Study||5
8534403|NCT02737475|9567264|FG019|COMPLETED|Overall Study||1
8534404|NCT02737475|9567265|FG020|COMPLETED|Overall Study||4
8534405|NCT02737475|9567266|FG021|COMPLETED|Overall Study||8
8534406|NCT02737475|9567267|FG022|COMPLETED|Overall Study||2
8534407|NCT02737475|9567268|FG023|COMPLETED|Overall Study||1
8534408|NCT02737475|9567269|FG024|COMPLETED|Overall Study||1
8534409|NCT02737475|9567270|FG025|COMPLETED|Overall Study||1
8534410|NCT02737475|9567271|FG026|COMPLETED|Overall Study||0
8620871|NCT00476021|9659724|FG000|NOT COMPLETED|Overall Study||0
8620872|NCT00476021|9659725|FG001|NOT COMPLETED|Overall Study||0
8534411|NCT02737475|9567245|FG000|NOT COMPLETED|Overall Study||1
8534412|NCT02737475|9567246|FG001|NOT COMPLETED|Overall Study||0
8534413|NCT02737475|9567247|FG002|NOT COMPLETED|Overall Study||0
8534414|NCT02737475|9567248|FG003|NOT COMPLETED|Overall Study||1
8534415|NCT02737475|9567249|FG004|NOT COMPLETED|Overall Study||1
8620873|NCT00476047|9659737|FG000|STARTED|Overall Study||16
8534416|NCT02737475|9567250|FG005|NOT COMPLETED|Overall Study||3
8534417|NCT02737475|9567251|FG006|NOT COMPLETED|Overall Study||0
8534418|NCT02737475|9567252|FG007|NOT COMPLETED|Overall Study||2
8534419|NCT02737475|9567253|FG008|NOT COMPLETED|Overall Study||1
8534420|NCT02737475|9567254|FG009|NOT COMPLETED|Overall Study||0
8534421|NCT02737475|9567255|FG010|NOT COMPLETED|Overall Study||1
8534422|NCT02737475|9567256|FG011|NOT COMPLETED|Overall Study||4
8534423|NCT02737475|9567257|FG012|NOT COMPLETED|Overall Study||2
8534424|NCT02737475|9567258|FG013|NOT COMPLETED|Overall Study||2
8534425|NCT02737475|9567259|FG014|NOT COMPLETED|Overall Study||1
8534426|NCT02737475|9567260|FG015|NOT COMPLETED|Overall Study||3
8534427|NCT02737475|9567261|FG016|NOT COMPLETED|Overall Study||2
8534428|NCT02737475|9567262|FG017|NOT COMPLETED|Overall Study||4
8534429|NCT02737475|9567263|FG018|NOT COMPLETED|Overall Study||2
8534430|NCT02737475|9567264|FG019|NOT COMPLETED|Overall Study||0
8534431|NCT02737475|9567265|FG020|NOT COMPLETED|Overall Study||2
8534432|NCT02737475|9567266|FG021|NOT COMPLETED|Overall Study||1
8534433|NCT02737475|9567267|FG022|NOT COMPLETED|Overall Study||0
8534434|NCT02737475|9567268|FG023|NOT COMPLETED|Overall Study||1
8534435|NCT02737475|9567269|FG024|NOT COMPLETED|Overall Study||1
8534436|NCT02737475|9567270|FG025|NOT COMPLETED|Overall Study||1
8534437|NCT02737475|9567271|FG026|NOT COMPLETED|Overall Study||1
8534438|NCT02703714|9567359|FG000|STARTED|Overall Study||42
8534439|NCT02703714|9567359|FG000|COMPLETED|Overall Study||42
8534440|NCT02703714|9567359|FG000|NOT COMPLETED|Overall Study||0
8534441|NCT02642965|9567363|FG000|STARTED|Overall Study||38
8534442|NCT02642965|9567363|FG000|COMPLETED|Overall Study||25
8534443|NCT02642965|9567363|FG000|NOT COMPLETED|Overall Study||13
8565108|NCT00064701|9597202|FG001|Received Study Drug|One Year Post-transplant||214
8565109|NCT00064701|9597203|FG002|Received Study Drug|One Year Post-transplant||212
8565110|NCT00064701|9597201|FG000|COMPLETED|One Year Post-transplant||179
8565111|NCT00064701|9597202|FG001|COMPLETED|One Year Post-transplant||183
8565112|NCT00064701|9597203|FG002|COMPLETED|One Year Post-transplant||151
8565113|NCT00064701|9597201|FG000|NOT COMPLETED|One Year Post-transplant||40
8565114|NCT00064701|9597202|FG001|NOT COMPLETED|One Year Post-transplant||43
8565115|NCT00064701|9597203|FG002|NOT COMPLETED|One Year Post-transplant||72
8565116|NCT00064701|9597201|FG000|STARTED|Clinical Continuation Phase||179
8565117|NCT00064701|9597202|FG001|STARTED|Clinical Continuation Phase|One participant did not enter the Clinical Continuation phase|182
8565118|NCT00064701|9597203|FG002|STARTED|Clinical Continuation Phase||151
8565119|NCT00064701|9597201|FG000|COMPLETED|Clinical Continuation Phase||9
8565120|NCT00064701|9597202|FG001|COMPLETED|Clinical Continuation Phase||4
8565121|NCT00064701|9597203|FG002|COMPLETED|Clinical Continuation Phase||11
8565122|NCT00064701|9597201|FG000|NOT COMPLETED|Clinical Continuation Phase||170
8565123|NCT00064701|9597202|FG001|NOT COMPLETED|Clinical Continuation Phase||178
8565124|NCT00064701|9597203|FG002|NOT COMPLETED|Clinical Continuation Phase||140
8565125|NCT00064753|9597213|FG000|STARTED|Overall Study||2056
8565126|NCT00064753|9597214|FG001|STARTED|Overall Study||2054
8565127|NCT00064753|9597213|FG000|COMPLETED|Overall Study||1382
8565128|NCT00064753|9597214|FG001|COMPLETED|Overall Study||1406
8565129|NCT00064753|9597213|FG000|NOT COMPLETED|Overall Study||674
8565130|NCT00064753|9597214|FG001|NOT COMPLETED|Overall Study||648
8565131|NCT00064792|9597222|FG000|STARTED|Overall Study||13
8565132|NCT00064792|9597223|FG001|STARTED|Overall Study||10
8565133|NCT00064792|9597222|FG000|COMPLETED|Overall Study||8
8565134|NCT00064792|9597223|FG001|COMPLETED|Overall Study||10
8565135|NCT00064792|9597222|FG000|NOT COMPLETED|Overall Study||5
8565136|NCT00064792|9597223|FG001|NOT COMPLETED|Overall Study||0
8565137|NCT00064844|9597231|FG000|STARTED|Overall Study||45
8565138|NCT00064844|9597232|FG001|STARTED|Overall Study||51
8565139|NCT00064844|9597231|FG000|2 Week Follow-up|Overall Study||45
8565140|NCT00064844|9597232|FG001|2 Week Follow-up|Overall Study||51
8565141|NCT00064844|9597231|FG000|3 Month Follow-up|Overall Study||40
8565142|NCT00064844|9597232|FG001|3 Month Follow-up|Overall Study||47
8565143|NCT00064844|9597231|FG000|6 Month Follow-up|Overall Study||39
8565144|NCT00064844|9597232|FG001|6 Month Follow-up|Overall Study||40
8565145|NCT00064844|9597231|FG000|12 Month Follow-up|Overall Study||37
8565146|NCT00064844|9597232|FG001|12 Month Follow-up|Overall Study||32
8565147|NCT00064844|9597231|FG000|COMPLETED|Overall Study||37
8565148|NCT00064844|9597232|FG001|COMPLETED|Overall Study||32
8565149|NCT00064844|9597231|FG000|NOT COMPLETED|Overall Study||8
8565150|NCT00064844|9597232|FG001|NOT COMPLETED|Overall Study||19
8565151|NCT00064987|9597240|FG000|STARTED|Overall Study||10
8565152|NCT00064987|9597241|FG001|STARTED|Overall Study||6
8565153|NCT00064987|9597240|FG000|COMPLETED|Overall Study||7
8565154|NCT00064987|9597241|FG001|COMPLETED|Overall Study||6
8565155|NCT00064987|9597240|FG000|NOT COMPLETED|Overall Study||3
8565156|NCT00064987|9597241|FG001|NOT COMPLETED|Overall Study||0
8565157|NCT00065065|9597249|FG000|STARTED|Overall Study||52
8565158|NCT00065065|9597250|FG001|STARTED|Overall Study||53
8565159|NCT00065065|9597249|FG000|COMPLETED|Overall Study||42
8565160|NCT00065065|9597250|FG001|COMPLETED|Overall Study||33
8565161|NCT00065065|9597249|FG000|NOT COMPLETED|Overall Study||10
8565162|NCT00065065|9597250|FG001|NOT COMPLETED|Overall Study||20
8565163|NCT00065156|9597258|FG000|STARTED|Overall Study||148
8565164|NCT00065156|9597258|FG000|Modified Intent to Treat Population|Overall Study||94
8565165|NCT00065156|9597258|FG000|COMPLETED|Overall Study|24 patients rolled over to free drug due to sponsor closure of study.|24
8565166|NCT00065156|9597258|FG000|NOT COMPLETED|Overall Study||124
8565167|NCT00065182|9597264|FG000|STARTED|Overall Study||202
8565168|NCT00065182|9597265|FG001|STARTED|Overall Study||197
8565169|NCT00065182|9597264|FG000|COMPLETED|Overall Study||154
8565170|NCT00065182|9597265|FG001|COMPLETED|Overall Study||160
8565171|NCT00065182|9597264|FG000|NOT COMPLETED|Overall Study||48
8565172|NCT00065182|9597265|FG001|NOT COMPLETED|Overall Study||37
8722911|NCT03365791|9770386|FG000|NOT COMPLETED|Overall Study||72
8620874|NCT00476047|9659737|FG000|Completed Treatment|Overall Study||16
8620875|NCT00476047|9659737|FG000|COMPLETED|Overall Study||15
8620876|NCT00476047|9659737|FG000|NOT COMPLETED|Overall Study||1
8722912|NCT03350750|9770393|FG000|STARTED|Overall Study||9
8722913|NCT03350750|9770394|FG001|STARTED|Overall Study||9
8722914|NCT03350750|9770393|FG000|4-month Follow-up (Randomized Evaluation)|Overall Study||8
8722915|NCT03350750|9770394|FG001|4-month Follow-up (Randomized Evaluation)|Overall Study||8
8534444|NCT02629159|9567370|FG000|STARTED|Overall Study||651
8534445|NCT02629159|9567371|FG001|STARTED|Overall Study||327
8816462|NCT01544348|9869982|FG001|COMPLETED|Overall Study||6
8816463|NCT01544348|9869983|FG002|COMPLETED|Overall Study||3
8816464|NCT01544348|9869984|FG003|COMPLETED|Overall Study||3
8816465|NCT01544348|9869985|FG004|COMPLETED|Overall Study||15
8816466|NCT01544348|9869986|FG005|COMPLETED|Overall Study||16
8534446|NCT02629159|9567372|FG002|STARTED|Overall Study||651
8534447|NCT02629159|9567370|FG000|Received Assigned Study Drug|Overall Study||651
8534448|NCT02629159|9567371|FG001|Received Assigned Study Drug|Overall Study||327
8534449|NCT02629159|9567372|FG002|Received Assigned Study Drug|Overall Study|One participant received a placebo injection but no oral study drug before discontinuing the study|650
8534450|NCT02629159|9567370|FG000|Completed Week 14 on Study Drug|Overall Study||620
8534451|NCT02629159|9567371|FG001|Completed Week 14 on Study Drug|Overall Study||300
8534452|NCT02629159|9567372|FG002|Completed Week 14 on Study Drug|Overall Study||620
8534453|NCT02629159|9567370|FG000|Rescued at Week 14|Overall Study||231
8534454|NCT02629159|9567371|FG001|Rescued at Week 14|Overall Study||56
8534455|NCT02629159|9567372|FG002|Rescued at Week 14|Overall Study||78
8534456|NCT02629159|9567370|FG000|Rescued at Week 18|Overall Study|One participant rescued at week 18 did not receive any dose of upadacitinib|48
8534457|NCT02629159|9567371|FG001|Rescued at Week 18|Overall Study||14
8620877|NCT00476086|9659743|FG000|STARTED|Overall Study||20
8620878|NCT00476086|9659743|FG000|Received Chemotherapy|Overall Study||19
8620879|NCT00476086|9659743|FG000|Received Radiation|Overall Study||15
8620880|NCT00476086|9659743|FG000|COMPLETED|Overall Study||15
8620881|NCT00476086|9659743|FG000|NOT COMPLETED|Overall Study||5
8620882|NCT00476151|9659751|FG000|STARTED|Overall Study||112
8620883|NCT00476151|9659752|FG001|STARTED|Overall Study||114
8620884|NCT00476151|9659751|FG000|COMPLETED|Overall Study||109
8620885|NCT00476151|9659752|FG001|COMPLETED|Overall Study||107
8620886|NCT00476151|9659751|FG000|NOT COMPLETED|Overall Study||3
8620887|NCT00476151|9659752|FG001|NOT COMPLETED|Overall Study||7
8620888|NCT00476229|9659758|FG000|STARTED|Overall Study||20
8620889|NCT00476229|9659758|FG000|COMPLETED|Overall Study||19
8620890|NCT00476229|9659758|FG000|NOT COMPLETED|Overall Study||1
8629420|NCT00529958|9669149|FG001|STARTED|5-Year Follow-up|108 HT patients available for 5-year follow-up excludes n=1 cross-over patient from the DB group|108
8629421|NCT00529958|9669150|FG002|STARTED|5-Year Follow-up|108 DB patients available for 5-year follow-up includes n=1 cross-over with a single-bundle HT graft|108
8629422|NCT00529958|9669148|FG000|COMPLETED|5-Year Follow-up||103
8629423|NCT00529958|9669149|FG001|COMPLETED|5-Year Follow-up||105
8629424|NCT00529958|9669150|FG002|COMPLETED|5-Year Follow-up||107
8629425|NCT00529958|9669148|FG000|NOT COMPLETED|5-Year Follow-up||3
8629426|NCT00529958|9669149|FG001|NOT COMPLETED|5-Year Follow-up||3
8629427|NCT00529958|9669150|FG002|NOT COMPLETED|5-Year Follow-up||1
8629428|NCT00530023|9669160|FG000|STARTED|Overall Study||14
8629429|NCT00530023|9669161|FG001|STARTED|Overall Study||15
8629430|NCT00530023|9669160|FG000|COMPLETED|Overall Study||14
8629431|NCT00530023|9669161|FG001|COMPLETED|Overall Study||14
8629432|NCT00530023|9669160|FG000|NOT COMPLETED|Overall Study||0
8629433|NCT00530023|9669161|FG001|NOT COMPLETED|Overall Study||1
8629434|NCT00530075|9669167|FG000|STARTED|Overall Study||45
8629435|NCT00530075|9669167|FG000|COMPLETED|Overall Study||38
8629436|NCT00530075|9669167|FG000|NOT COMPLETED|Overall Study||7
8629437|NCT00530088|9669171|FG000|STARTED|Overall Study||30
8629438|NCT00530088|9669171|FG000|COMPLETED|Overall Study||20
8629439|NCT00530088|9669171|FG000|NOT COMPLETED|Overall Study||10
8629440|NCT00530218|9669175|FG000|STARTED|Overall Study||61
8629441|NCT00530218|9669175|FG000|COMPLETED|Overall Study|CMV Reactivation Was Detected|36
8629442|NCT00530218|9669175|FG000|NOT COMPLETED|Overall Study||25
8629443|NCT00530257|9669182|FG000|STARTED|Overall Study||31
8629444|NCT00530257|9669182|FG000|COMPLETED|Overall Study||30
8629445|NCT00530257|9669182|FG000|NOT COMPLETED|Overall Study||1
8629446|NCT00530270|9669191|FG000|STARTED|Overall Study||6
8722916|NCT03350750|9770393|FG000|12-Month Follow-up (Entire Study)|Overall Study||8
8722917|NCT03350750|9770394|FG001|12-Month Follow-up (Entire Study)|Overall Study||8
8722918|NCT03350750|9770393|FG000|COMPLETED|Overall Study||8
8722919|NCT03350750|9770394|FG001|COMPLETED|Overall Study||8
8722920|NCT03350750|9770393|FG000|NOT COMPLETED|Overall Study||1
8722921|NCT03350750|9770394|FG001|NOT COMPLETED|Overall Study||1
8722922|NCT03125148|9770404|FG000|STARTED|Overall Study||9
8722923|NCT03125148|9770405|FG001|STARTED|Overall Study||8
8722924|NCT03125148|9770404|FG000|COMPLETED|Overall Study||9
8816467|NCT01544348|9869987|FG006|COMPLETED|Overall Study||12
8629447|NCT00530270|9669192|FG001|STARTED|Overall Study||6
8629448|NCT00530270|9669191|FG000|COMPLETED|Overall Study||5
8629449|NCT00530270|9669192|FG001|COMPLETED|Overall Study||6
8722925|NCT03125148|9770405|FG001|COMPLETED|Overall Study||8
8722926|NCT03125148|9770404|FG000|NOT COMPLETED|Overall Study||0
8722927|NCT03125148|9770405|FG001|NOT COMPLETED|Overall Study||0
8722928|NCT02819440|9770413|FG000|STARTED|Overall Study||61
8534458|NCT02629159|9567372|FG002|Rescued at Week 18|Overall Study||29
8534459|NCT02629159|9567370|FG000|Rescued at Week 22|Overall Study||26
8534460|NCT02629159|9567371|FG001|Rescued at Week 22|Overall Study||7
8534461|NCT02629159|9567372|FG002|Rescued at Week 22|Overall Study||18
8534462|NCT02629159|9567370|FG000|COMPLETED|Overall Study||595
8534463|NCT02629159|9567371|FG001|COMPLETED|Overall Study||288
8534464|NCT02629159|9567372|FG002|COMPLETED|Overall Study||600
8534465|NCT02629159|9567370|FG000|NOT COMPLETED|Overall Study||56
8534466|NCT02629159|9567371|FG001|NOT COMPLETED|Overall Study||39
8534467|NCT02629159|9567372|FG002|NOT COMPLETED|Overall Study||51
8534468|NCT02604433|9567385|FG000|STARTED|Overall Study||224
8534469|NCT02604433|9567386|FG001|STARTED|Overall Study||112
8534470|NCT02604433|9567385|FG000|Participants Treated|Overall Study||223
8534471|NCT02604433|9567386|FG001|Participants Treated|Overall Study||109
8534472|NCT02604433|9567385|FG000|Completed 24 Weeks of Treatment|Overall Study||211
8534473|NCT02604433|9567386|FG001|Completed 24 Weeks of Treatment|Overall Study||102
8534474|NCT02604433|9567385|FG000|Completed 48 Weeks of Treatment|Overall Study||202
8534475|NCT02604433|9567386|FG001|Completed 48 Weeks of Treatment|Overall Study||96
8534476|NCT02604433|9567385|FG000|Completed 96 Weeks of Treatment|Overall Study||155
8534477|NCT02604433|9567386|FG001|Completed 96 Weeks of Treatment|Overall Study||3
8534478|NCT02604433|9567385|FG000|Completed 144 Weeks of Treatment|Overall Study||125
8534479|NCT02604433|9567386|FG001|Completed 144 Weeks of Treatment|Overall Study||0
8534480|NCT02604433|9567385|FG000|Completed 192 Weeks of Treatment|Overall Study||6
8534481|NCT02604433|9567386|FG001|Completed 192 Weeks of Treatment|Overall Study||0
8816468|NCT01544348|9869988|FG007|COMPLETED|Overall Study||8
8816469|NCT01544348|9869981|FG000|NOT COMPLETED|Overall Study||2
8816470|NCT01544348|9869982|FG001|NOT COMPLETED|Overall Study||0
8816471|NCT01544348|9869983|FG002|NOT COMPLETED|Overall Study||0
8816472|NCT01544348|9869984|FG003|NOT COMPLETED|Overall Study||0
8816473|NCT01544348|9869985|FG004|NOT COMPLETED|Overall Study||1
8534482|NCT02604433|9567385|FG000|COMPLETED|Overall Study||6
8534483|NCT02604433|9567386|FG001|COMPLETED|Overall Study||6
8534484|NCT02604433|9567385|FG000|NOT COMPLETED|Overall Study||218
8534485|NCT02604433|9567386|FG001|NOT COMPLETED|Overall Study||106
8534486|NCT02519738|9567395|FG000|STARTED|Overall Study||20
8534487|NCT02519738|9567396|FG001|STARTED|Overall Study||17
8534488|NCT02519738|9567397|FG002|STARTED|Overall Study||15
8534489|NCT02519738|9567395|FG000|COMPLETED|Overall Study||6
8534490|NCT02519738|9567396|FG001|COMPLETED|Overall Study||4
8534491|NCT02519738|9567397|FG002|COMPLETED|Overall Study||3
8534492|NCT02519738|9567395|FG000|NOT COMPLETED|Overall Study||14
8534493|NCT02519738|9567396|FG001|NOT COMPLETED|Overall Study||13
8534494|NCT02519738|9567397|FG002|NOT COMPLETED|Overall Study||12
8534495|NCT02502071|9567405|FG000|STARTED|Overall Study||45
8534496|NCT02502071|9567405|FG000|COMPLETED|Overall Study||45
8534497|NCT02502071|9567405|FG000|NOT COMPLETED|Overall Study||0
8534498|NCT02420821|9567411|FG000|STARTED|Overall Study||461
8534499|NCT02420821|9567412|FG001|STARTED|Overall Study||454
8534500|NCT02420821|9567411|FG000|COMPLETED|Overall Study||293
8534501|NCT02420821|9567412|FG001|COMPLETED|Overall Study||317
8534502|NCT02420821|9567411|FG000|NOT COMPLETED|Overall Study||168
8534503|NCT02420821|9567412|FG001|NOT COMPLETED|Overall Study||137
8534504|NCT02412670|9567421|FG000|STARTED|Overall Study||30
8534505|NCT02412670|9567422|FG001|STARTED|Overall Study||6
8534506|NCT02412670|9567421|FG000|Eligible and Treated|Overall Study||29
8534507|NCT02412670|9567422|FG001|Eligible and Treated|Overall Study||6
8534508|NCT02412670|9567421|FG000|COMPLETED|Overall Study||23
8534509|NCT02412670|9567422|FG001|COMPLETED|Overall Study||5
8534510|NCT02412670|9567421|FG000|NOT COMPLETED|Overall Study||7
8534511|NCT02412670|9567422|FG001|NOT COMPLETED|Overall Study||1
8534512|NCT02410343|9567430|FG000|STARTED|Core Period (24 Weeks)||6
8534513|NCT02410343|9567431|FG001|STARTED|Core Period (24 Weeks)||8
8534514|NCT02410343|9567430|FG000|COMPLETED|Core Period (24 Weeks)||1
8534515|NCT02410343|9567431|FG001|COMPLETED|Core Period (24 Weeks)||1
8534516|NCT02410343|9567430|FG000|NOT COMPLETED|Core Period (24 Weeks)||5
8534517|NCT02410343|9567431|FG001|NOT COMPLETED|Core Period (24 Weeks)||7
8816474|NCT01544348|9869986|FG005|NOT COMPLETED|Overall Study||3
8534518|NCT02410343|9567430|FG000|STARTED|Extension Period (12 Months)||1
8534519|NCT02410343|9567431|FG001|STARTED|Extension Period (12 Months)||1
8534520|NCT02410343|9567430|FG000|COMPLETED|Extension Period (12 Months)||0
8534521|NCT02410343|9567431|FG001|COMPLETED|Extension Period (12 Months)||0
8534522|NCT02410343|9567430|FG000|NOT COMPLETED|Extension Period (12 Months)||1
8534523|NCT02410343|9567431|FG001|NOT COMPLETED|Extension Period (12 Months)||1
8534524|NCT02343224|9567438|FG000|STARTED|Overall Study||9
8534525|NCT02343224|9567438|FG000|COMPLETED|Overall Study||0
8534526|NCT02343224|9567438|FG000|NOT COMPLETED|Overall Study||9
8534527|NCT02339740|9567444|FG000|STARTED|Overall Study||101
8534528|NCT02339740|9567445|FG001|STARTED|Overall Study||57
8534529|NCT02339740|9567444|FG000|COMPLETED|Overall Study||92
8534530|NCT02339740|9567445|FG001|COMPLETED|Overall Study||53
8534531|NCT02339740|9567444|FG000|NOT COMPLETED|Overall Study||9
8534532|NCT02339740|9567445|FG001|NOT COMPLETED|Overall Study||4
8534533|NCT02291445|9567453|FG000|STARTED|Overall Study||4
8534534|NCT02291445|9567454|FG001|STARTED|Overall Study||4
8534535|NCT02291445|9567453|FG000|COMPLETED|Overall Study||4
8816475|NCT01544348|9869987|FG006|NOT COMPLETED|Overall Study||2
8816476|NCT01544348|9869988|FG007|NOT COMPLETED|Overall Study||0
8816477|NCT01544361|9870018|FG000|STARTED|Overall Study||8
8534536|NCT02291445|9567454|FG001|COMPLETED|Overall Study||4
8534537|NCT02291445|9567453|FG000|NOT COMPLETED|Overall Study||0
8534538|NCT02291445|9567454|FG001|NOT COMPLETED|Overall Study||0
8534539|NCT02248688|9567462|FG000|STARTED|Overall Study||5
8534540|NCT02248688|9567462|FG000|COMPLETED|Overall Study||5
8534541|NCT02248688|9567462|FG000|NOT COMPLETED|Overall Study||0
8534542|NCT02045303|9567468|FG000|STARTED|Overall Study||6
8534543|NCT02045303|9567469|FG001|STARTED|Overall Study||3
8534544|NCT02045303|9567470|FG002|STARTED|Overall Study||2
8534545|NCT02045303|9567468|FG000|COMPLETED|Overall Study||4
8534546|NCT02045303|9567469|FG001|COMPLETED|Overall Study||0
8534547|NCT02045303|9567470|FG002|COMPLETED|Overall Study||2
8534548|NCT02045303|9567468|FG000|NOT COMPLETED|Overall Study||2
8534549|NCT02045303|9567469|FG001|NOT COMPLETED|Overall Study||3
8534550|NCT02045303|9567470|FG002|NOT COMPLETED|Overall Study||0
8534551|NCT02025556|9567482|FG000|STARTED|Overall Study||104
8534552|NCT02025556|9567483|FG001|STARTED|Overall Study||96
8534553|NCT02025556|9567484|FG002|STARTED|Overall Study||97
8534554|NCT02025556|9567482|FG000|Safety Analysis Set|Overall Study||104
8534555|NCT02025556|9567483|FG001|Safety Analysis Set|Overall Study||96
8534556|NCT02025556|9567484|FG002|Safety Analysis Set|Overall Study||96
8534557|NCT02025556|9567482|FG000|Intent-to-treat (ITT) Set|Overall Study||104
8534558|NCT02025556|9567483|FG001|Intent-to-treat (ITT) Set|Overall Study||95
8534559|NCT02025556|9567484|FG002|Intent-to-treat (ITT) Set|Overall Study||96
8534560|NCT02025556|9567482|FG000|COMPLETED|Overall Study||98
8534561|NCT02025556|9567483|FG001|COMPLETED|Overall Study||83
8534562|NCT02025556|9567484|FG002|COMPLETED|Overall Study||88
8534563|NCT02025556|9567482|FG000|NOT COMPLETED|Overall Study||6
8534564|NCT02025556|9567483|FG001|NOT COMPLETED|Overall Study||13
8534565|NCT02025556|9567484|FG002|NOT COMPLETED|Overall Study||9
8534566|NCT01986933|9567497|FG000|STARTED|Placebo-controlled (Part A)||53
8534567|NCT01986933|9567498|FG001|STARTED|Placebo-controlled (Part A)||53
8534568|NCT01986933|9567499|FG002|STARTED|Placebo-controlled (Part A)||54
8534569|NCT01986933|9567500|FG003|STARTED|Placebo-controlled (Part A)||52
8534570|NCT01986933|9567501|FG004|STARTED|Placebo-controlled (Part A)||52
8534571|NCT01986933|9567497|FG000|COMPLETED|Placebo-controlled (Part A)||44
8534572|NCT01986933|9567498|FG001|COMPLETED|Placebo-controlled (Part A)||44
8534573|NCT01986933|9567499|FG002|COMPLETED|Placebo-controlled (Part A)||45
8534574|NCT01986933|9567500|FG003|COMPLETED|Placebo-controlled (Part A)||45
8534575|NCT01986933|9567501|FG004|COMPLETED|Placebo-controlled (Part A)||38
8534576|NCT01986933|9567497|FG000|NOT COMPLETED|Placebo-controlled (Part A)||9
8534577|NCT01986933|9567498|FG001|NOT COMPLETED|Placebo-controlled (Part A)||9
8534578|NCT01986933|9567499|FG002|NOT COMPLETED|Placebo-controlled (Part A)||9
8534579|NCT01986933|9567500|FG003|NOT COMPLETED|Placebo-controlled (Part A)||7
8534580|NCT01986933|9567501|FG004|NOT COMPLETED|Placebo-controlled (Part A)||14
8534581|NCT01986933|9567497|FG000|STARTED|Active-to-active (Part B)||0
8534582|NCT01986933|9567498|FG001|STARTED|Active-to-active (Part B)||41
8534583|NCT01986933|9567499|FG002|STARTED|Active-to-active (Part B)||38
8534584|NCT01986933|9567500|FG003|STARTED|Active-to-active (Part B)||39
8534585|NCT01986933|9567501|FG004|STARTED|Active-to-active (Part B)||35
8534586|NCT01986933|9567497|FG000|COMPLETED|Active-to-active (Part B)||0
8534587|NCT01986933|9567498|FG001|COMPLETED|Active-to-active (Part B)||31
8534588|NCT01986933|9567499|FG002|COMPLETED|Active-to-active (Part B)||28
8534589|NCT01986933|9567500|FG003|COMPLETED|Active-to-active (Part B)||30
8534590|NCT01986933|9567501|FG004|COMPLETED|Active-to-active (Part B)||19
8534591|NCT01986933|9567497|FG000|NOT COMPLETED|Active-to-active (Part B)||0
8534592|NCT01986933|9567498|FG001|NOT COMPLETED|Active-to-active (Part B)||10
8534593|NCT01986933|9567499|FG002|NOT COMPLETED|Active-to-active (Part B)||10
8534594|NCT01986933|9567500|FG003|NOT COMPLETED|Active-to-active (Part B)||9
8534595|NCT01986933|9567501|FG004|NOT COMPLETED|Active-to-active (Part B)||16
8534596|NCT01986933|9567497|FG000|STARTED|Placebo-to-active (Part B)||0
8534597|NCT01986933|9567498|FG001|STARTED|Placebo-to-active (Part B)|Patients in the initial placebo group were re-randomized into Nemoliozumab groups (0.1, 0.5 or 2.0 mg/kg Q4W) in Part B.|13
8534598|NCT01986933|9567499|FG002|STARTED|Placebo-to-active (Part B)|Patients in the initial placebo group were re-randomized into Nemoliozumab groups (0.1, 0.5 or 2.0 mg/kg Q4W) in Part B.|12
8534599|NCT01986933|9567500|FG003|STARTED|Placebo-to-active (Part B)|Patients in the initial placebo group were re-randomized into Nemoliozumab groups (0.1, 0.5 or 2.0 mg/kg Q4W) in Part B.|13
8534600|NCT01986933|9567501|FG004|STARTED|Placebo-to-active (Part B)|Patients in the initial placebo group were not re-randomized into Nemoliozumab (2.0 mg/kg) Q8W group in Part B.|0
8534601|NCT01986933|9567497|FG000|COMPLETED|Placebo-to-active (Part B)||0
8534602|NCT01986933|9567498|FG001|COMPLETED|Placebo-to-active (Part B)||8
8534603|NCT01986933|9567499|FG002|COMPLETED|Placebo-to-active (Part B)||7
8534604|NCT01986933|9567500|FG003|COMPLETED|Placebo-to-active (Part B)||8
8534605|NCT01986933|9567501|FG004|COMPLETED|Placebo-to-active (Part B)||0
8534606|NCT01986933|9567497|FG000|NOT COMPLETED|Placebo-to-active (Part B)||0
8534607|NCT01986933|9567498|FG001|NOT COMPLETED|Placebo-to-active (Part B)||5
8534608|NCT01986933|9567499|FG002|NOT COMPLETED|Placebo-to-active (Part B)||5
8534609|NCT01986933|9567500|FG003|NOT COMPLETED|Placebo-to-active (Part B)||5
8534610|NCT01986933|9567501|FG004|NOT COMPLETED|Placebo-to-active (Part B)||0
8534611|NCT01986075|9567523|FG000|STARTED|Initial CBT + CM (Pre-randomization)||0
8534612|NCT01986075|9567524|FG001|STARTED|Initial CBT + CM (Pre-randomization)||0
8534613|NCT01986075|9567525|FG002|STARTED|Initial CBT + CM (Pre-randomization)||145
8534614|NCT01986075|9567523|FG000|COMPLETED|Initial CBT + CM (Pre-randomization)||0
8534615|NCT01986075|9567524|FG001|COMPLETED|Initial CBT + CM (Pre-randomization)||0
8534616|NCT01986075|9567525|FG002|COMPLETED|Initial CBT + CM (Pre-randomization)||86
8534617|NCT01986075|9567523|FG000|NOT COMPLETED|Initial CBT + CM (Pre-randomization)||0
8534618|NCT01986075|9567524|FG001|NOT COMPLETED|Initial CBT + CM (Pre-randomization)||0
8534619|NCT01986075|9567525|FG002|NOT COMPLETED|Initial CBT + CM (Pre-randomization)||59
8534620|NCT01986075|9567523|FG000|STARTED|Randomized Intervention||45
8534621|NCT01986075|9567524|FG001|STARTED|Randomized Intervention||41
8534622|NCT01986075|9567525|FG002|STARTED|Randomized Intervention||0
8534623|NCT01986075|9567523|FG000|COMPLETED|Randomized Intervention||30
8534624|NCT01986075|9567524|FG001|COMPLETED|Randomized Intervention||27
8534625|NCT01986075|9567525|FG002|COMPLETED|Randomized Intervention||0
8534626|NCT01986075|9567523|FG000|NOT COMPLETED|Randomized Intervention||15
8534627|NCT01986075|9567524|FG001|NOT COMPLETED|Randomized Intervention||14
8534628|NCT01986075|9567525|FG002|NOT COMPLETED|Randomized Intervention||0
8534629|NCT01841333|9567532|FG000|STARTED|Overall Study||31
8534630|NCT01841333|9567532|FG000|COMPLETED|Overall Study||31
8534631|NCT01841333|9567532|FG000|NOT COMPLETED|Overall Study||0
8534632|NCT01802788|9567538|FG000|STARTED|Overall Study||941
8534633|NCT01802788|9567539|FG001|STARTED|Overall Study||59
8534634|NCT01802788|9567538|FG000|COMPLETED|Overall Study||755
8534635|NCT01802788|9567539|FG001|COMPLETED|Overall Study||59
8534636|NCT01802788|9567538|FG000|NOT COMPLETED|Overall Study||186
8534637|NCT01802788|9567539|FG001|NOT COMPLETED|Overall Study||0
8534638|NCT01701674|9567543|FG000|STARTED|Overall Study||13
8534639|NCT01701674|9567543|FG000|COMPLETED|Overall Study||12
8534640|NCT01701674|9567543|FG000|NOT COMPLETED|Overall Study||1
8534641|NCT01563107|9567551|FG000|STARTED|Overall Study|12 Healthy Controls were randomized to receive LS diet followed by HS diet|12
8534642|NCT01563107|9567552|FG001|STARTED|Overall Study|5 Healthy Controls were randomized to receive HS diet followed by LS diet|5
8534643|NCT01563107|9567553|FG002|STARTED|Overall Study|10 POTS patients were randomized to receive LS diet followed by HS diet|10
8534644|NCT01563107|9567554|FG003|STARTED|Overall Study|11 POTS patients were randomized to receive HS diet followed by LS diet|11
8534645|NCT01563107|9567551|FG000|Phase 1 Baseline Labs|Overall Study||12
8534646|NCT01563107|9567552|FG001|Phase 1 Baseline Labs|Overall Study|1 healthy control was unable to find time to schedule study|4
8534647|NCT01563107|9567553|FG002|Phase 1 Baseline Labs|Overall Study|2 patients with POTS did not discontinue medication that was prohibited by protocol.|8
8534648|NCT01563107|9567554|FG003|Phase 1 Baseline Labs|Overall Study|1 patient with POTS did not discontinue medication that was prohibited by protocol, 1 patient was unable to find time to schedule the study, 1 was noted to be too old to participate, and 1 became pregnant between enrollment and the start of phase 1.|7
8534649|NCT01563107|9567551|FG000|Phase 1-150 mEq Sodium/Day|Overall Study||12
8534650|NCT01563107|9567552|FG001|Phase 1-150 mEq Sodium/Day|Overall Study||4
8534651|NCT01563107|9567553|FG002|Phase 1-150 mEq Sodium/Day|Overall Study||8
8534652|NCT01563107|9567554|FG003|Phase 1-150 mEq Sodium/Day|Overall Study||7
8534653|NCT01563107|9567551|FG000|Phase 1-start Low Sodium or High Sodium Diet|Overall Study||12
8534654|NCT01563107|9567552|FG001|Phase 1-start Low Sodium or High Sodium Diet|Overall Study||4
8534655|NCT01563107|9567553|FG002|Phase 1-start Low Sodium or High Sodium Diet|Overall Study||8
8534656|NCT01563107|9567554|FG003|Phase 1-start Low Sodium or High Sodium Diet|Overall Study||7
8534657|NCT01563107|9567551|FG000|Phase 1-finish|Overall Study|1 healthy control withdrew with migraines during phase 1 (low Na+).|11
8534658|NCT01563107|9567552|FG001|Phase 1-finish|Overall Study|2 healthy controls withdrew during phase 1 (high Na+): 1 unable to tolerate study diet and another with difficulty cooperating with investigators.|2
8534659|NCT01563107|9567553|FG002|Phase 1-finish|Overall Study||8
8534660|NCT01563107|9567554|FG003|Phase 1-finish|Overall Study|1 patient with POTS withdrew during phase 1 due to a family illness.|6
8534661|NCT01563107|9567551|FG000|Phase 2-150 mEq Sodium/Day|Overall Study||11
8534662|NCT01563107|9567552|FG001|Phase 2-150 mEq Sodium/Day|Overall Study||2
8534663|NCT01563107|9567553|FG002|Phase 2-150 mEq Sodium/Day|Overall Study||8
8534664|NCT01563107|9567554|FG003|Phase 2-150 mEq Sodium/Day|Overall Study||6
8534665|NCT01563107|9567551|FG000|Phase 2-start Low Sodium or High Sodium Diet|Overall Study||11
8534666|NCT01563107|9567552|FG001|Phase 2-start Low Sodium or High Sodium Diet|Overall Study||2
8534667|NCT01563107|9567553|FG002|Phase 2-start Low Sodium or High Sodium Diet|Overall Study||8
8534668|NCT01563107|9567554|FG003|Phase 2-start Low Sodium or High Sodium Diet|Overall Study||6
8534669|NCT01563107|9567551|FG000|Phase 2-finish|Overall Study||11
8534670|NCT01563107|9567552|FG001|Phase 2-finish|Overall Study||2
8534671|NCT01563107|9567553|FG002|Phase 2-finish|Overall Study||8
8534672|NCT01563107|9567554|FG003|Phase 2-finish|Overall Study||6
8534673|NCT01563107|9567551|FG000|COMPLETED|Overall Study||11
8534674|NCT01563107|9567552|FG001|COMPLETED|Overall Study||2
8534675|NCT01563107|9567553|FG002|COMPLETED|Overall Study||8
8534676|NCT01563107|9567554|FG003|COMPLETED|Overall Study||6
8534677|NCT01563107|9567551|FG000|NOT COMPLETED|Overall Study||1
8534678|NCT01563107|9567552|FG001|NOT COMPLETED|Overall Study||3
8534679|NCT01563107|9567553|FG002|NOT COMPLETED|Overall Study||2
8534680|NCT01563107|9567554|FG003|NOT COMPLETED|Overall Study||5
8534681|NCT01320072|9567616|FG000|STARTED|Overall Study||16
8534682|NCT01320072|9567617|FG001|STARTED|Overall Study||13
8534683|NCT01320072|9567616|FG000|COMPLETED|Overall Study||16
8534684|NCT01320072|9567617|FG001|COMPLETED|Overall Study||13
8534685|NCT01320072|9567616|FG000|NOT COMPLETED|Overall Study||0
8534686|NCT01320072|9567617|FG001|NOT COMPLETED|Overall Study||0
8534687|NCT01064479|9567626|FG000|STARTED|Overall Study||60
8534688|NCT01064479|9567627|FG001|STARTED|Overall Study||59
8534689|NCT01064479|9567626|FG000|COMPLETED|Overall Study||45
8534690|NCT01064479|9567627|FG001|COMPLETED|Overall Study||42
8534691|NCT01064479|9567626|FG000|NOT COMPLETED|Overall Study||15
8534692|NCT01064479|9567627|FG001|NOT COMPLETED|Overall Study||17
8534693|NCT01042522|9567635|FG000|STARTED|Overall Study||31
8534694|NCT01042522|9567636|FG001|STARTED|Overall Study||32
8534695|NCT01042522|9567635|FG000|COMPLETED|Overall Study|Completed 6 cycles of protocol regimen|23
8534696|NCT01042522|9567636|FG001|COMPLETED|Overall Study|Completed 4 cycles of protocol regimen|26
8534697|NCT01042522|9567635|FG000|NOT COMPLETED|Overall Study||8
8534698|NCT01042522|9567636|FG001|NOT COMPLETED|Overall Study||6
8534699|NCT00944528|9567645|FG000|STARTED|Overall Study||9
8534700|NCT00944528|9567646|FG001|STARTED|Overall Study||10
8534701|NCT00944528|9567647|FG002|STARTED|Overall Study||16
8534702|NCT00944528|9567645|FG000|COMPLETED|Overall Study||8
8534703|NCT00944528|9567646|FG001|COMPLETED|Overall Study||8
8534704|NCT00944528|9567647|FG002|COMPLETED|Overall Study||16
8534705|NCT00944528|9567645|FG000|NOT COMPLETED|Overall Study||1
8534706|NCT00944528|9567646|FG001|NOT COMPLETED|Overall Study||2
8534707|NCT00944528|9567647|FG002|NOT COMPLETED|Overall Study||0
8534708|NCT00941915|9567656|FG000|STARTED|Overall Study||60
8534709|NCT00941915|9567656|FG000|COMPLETED|Overall Study||60
8534710|NCT00941915|9567656|FG000|NOT COMPLETED|Overall Study||0
8534711|NCT00826462|9567663|FG000|STARTED|Overall Study||59
8534712|NCT00826462|9567664|FG001|STARTED|Overall Study||58
8534713|NCT00826462|9567665|FG002|STARTED|Overall Study||60
8534714|NCT00826462|9567663|FG000|COMPLETED|Overall Study||52
8534715|NCT00826462|9567664|FG001|COMPLETED|Overall Study||53
8534716|NCT00826462|9567665|FG002|COMPLETED|Overall Study||52
8534717|NCT00826462|9567663|FG000|NOT COMPLETED|Overall Study||7
8534718|NCT00826462|9567664|FG001|NOT COMPLETED|Overall Study||5
8534719|NCT00826462|9567665|FG002|NOT COMPLETED|Overall Study||8
8534720|NCT00710970|9567675|FG000|STARTED|Overall Study||28
8534721|NCT00710970|9567675|FG000|COMPLETED|Overall Study||25
8534722|NCT00710970|9567675|FG000|NOT COMPLETED|Overall Study||3
8816478|NCT01544361|9870019|FG001|STARTED|Overall Study||6
8816479|NCT01544361|9870020|FG002|STARTED|Overall Study||6
8816480|NCT01544361|9870021|FG003|STARTED|Overall Study||6
8816481|NCT01544361|9870022|FG004|STARTED|Overall Study||6
8816482|NCT01544361|9870018|FG000|COMPLETED|Overall Study||8
8816483|NCT01544361|9870019|FG001|COMPLETED|Overall Study||6
8816484|NCT01544361|9870020|FG002|COMPLETED|Overall Study||6
8816485|NCT01544361|9870021|FG003|COMPLETED|Overall Study||6
8816486|NCT01544361|9870022|FG004|COMPLETED|Overall Study||6
8816487|NCT01544361|9870018|FG000|NOT COMPLETED|Overall Study||0
8816488|NCT01544361|9870019|FG001|NOT COMPLETED|Overall Study||0
8816489|NCT01544361|9870020|FG002|NOT COMPLETED|Overall Study||0
8816490|NCT01544361|9870021|FG003|NOT COMPLETED|Overall Study||0
8816491|NCT01544361|9870022|FG004|NOT COMPLETED|Overall Study||0
8816492|NCT01544478|9870034|FG000|STARTED|Overall Study||1030
8816493|NCT01544478|9870034|FG000|Vaccination 1|Overall Study||1030
8816494|NCT01544478|9870034|FG000|Vaccination 2|Overall Study||1026
8816495|NCT01544478|9870034|FG000|Vaccination 3|Overall Study||1019
8816496|NCT01544478|9870034|FG000|COMPLETED|Overall Study||912
8816497|NCT01544478|9870034|FG000|NOT COMPLETED|Overall Study||118
8816498|NCT01544491|9870040|FG000|STARTED|Overall Study||52
8816499|NCT01544491|9870041|FG001|STARTED|Overall Study||54
8816500|NCT01544491|9870040|FG000|COMPLETED|Overall Study||47
8816501|NCT01544491|9870041|FG001|COMPLETED|Overall Study||51
8816502|NCT01544491|9870040|FG000|NOT COMPLETED|Overall Study||5
8816503|NCT01544491|9870041|FG001|NOT COMPLETED|Overall Study||3
8816504|NCT01544582|9870050|FG000|STARTED|Screening/Eligibility||713
8816505|NCT01544582|9870051|FG001|STARTED|Screening/Eligibility||0
8816506|NCT01544582|9870052|FG002|STARTED|Screening/Eligibility||0
8816507|NCT01544582|9870053|FG003|STARTED|Screening/Eligibility||0
8816508|NCT01544582|9870050|FG000|Analysis Population|Screening/Eligibility||679
8816509|NCT01544582|9870051|FG001|Analysis Population|Screening/Eligibility||0
8816510|NCT01544582|9870052|FG002|Analysis Population|Screening/Eligibility||0
8816511|NCT01544582|9870053|FG003|Analysis Population|Screening/Eligibility||0
8816512|NCT01544582|9870050|FG000|COMPLETED|Screening/Eligibility|Completed means met criteria for Analysis Population|679
8816513|NCT01544582|9870051|FG001|COMPLETED|Screening/Eligibility||0
8816514|NCT01544582|9870052|FG002|COMPLETED|Screening/Eligibility||0
8816515|NCT01544582|9870053|FG003|COMPLETED|Screening/Eligibility||0
8816516|NCT01544582|9870050|FG000|NOT COMPLETED|Screening/Eligibility||34
8816517|NCT01544582|9870051|FG001|NOT COMPLETED|Screening/Eligibility||0
8816518|NCT01544582|9870052|FG002|NOT COMPLETED|Screening/Eligibility||0
8816519|NCT01544582|9870053|FG003|NOT COMPLETED|Screening/Eligibility||0
8816520|NCT01544582|9870050|FG000|STARTED|Analysis Population|Analysis Population was grouped into Boceprevir+PR, Telaprevir+PR, or PR Alone|0
8816521|NCT01544582|9870051|FG001|STARTED|Analysis Population||298
8816522|NCT01544582|9870052|FG002|STARTED|Analysis Population||307
8816523|NCT01544582|9870053|FG003|STARTED|Analysis Population||74
8816524|NCT01544582|9870050|FG000|COMPLETED|Analysis Population||0
8816525|NCT01544582|9870051|FG001|COMPLETED|Analysis Population||180
8534723|NCT00685919|9567683|FG000|STARTED|Overall Study|8 healthy controls were randomized to receive placebo followed by carbidopa. 1 received only 50 mg doses of carbidopa and her data were excluded.|8
8534724|NCT00685919|9567684|FG001|STARTED|Overall Study|9 healthy controls were randomized to receive carbidopa followed by placebo.|9
8565173|NCT00065260|9597273|FG000|STARTED|Overall Study||27
8816526|NCT01544582|9870052|FG002|COMPLETED|Analysis Population||205
8534725|NCT00685919|9567685|FG002|STARTED|Overall Study|8 patients with POTS were randomized to receive placebo followed by carbidopa. 1 of these received only 50 mg doses of carbidopa and her data are excluded.|8
8534726|NCT00685919|9567686|FG003|STARTED|Overall Study|3 patients with POTS were randomized to receive carbidopa followed by placebo.|3
8534727|NCT00685919|9567683|FG000|Baseline A|Overall Study|After achieving sodium balance on 200 mEq/day sodium diet, subjects collected baseline 24hr urine. They fasted from 7pm until the next morning. In the morning, while still supine, heart rate and blood pressure were recorded and blood was drawn. Participants then stood for 10 min. Heart rate and blood pressure were measured at intervals and an upright blood sample was collected. Urine was collected to end the 24hr collection.|8
8534728|NCT00685919|9567684|FG001|Baseline A|Overall Study|After achieving sodium balance on 200 mEq/day sodium diet, subjects collected baseline 24hr urine. They fasted from 7pm until the next morning. In the morning, while still supine, heart rate and blood pressure were recorded and blood was drawn. Participants then stood for 10 min. Heart rate and blood pressure were measured at intervals and an upright blood sample was collected. Urine was collected to end the 24hr collection. 1 patient withdrew after orthostatic symptoms during baseline.|9
8534729|NCT00685919|9567685|FG002|Baseline A|Overall Study|After achieving sodium balance on 200 mEq/day sodium diet, subjects collected baseline 24hr urine. They fasted from 7pm until the next morning. In the morning, while still supine, heart rate and blood pressure were recorded and blood was drawn. Participants then stood for 10 min. Heart rate and blood pressure were measured at intervals and an upright blood sample was collected. Urine was collected to end the 24hr collection. 1 patient withdrew after orthostatic symptoms during baseline.|8
8534730|NCT00685919|9567686|FG003|Baseline A|Overall Study|After achieving sodium balance on 200 mEq/day sodium diet, subjects collected baseline 24hr urine. They fasted from 7pm until the next morning. In the morning, while still supine, heart rate and blood pressure were recorded and blood was drawn. Participants then stood for 10 min. Heart rate and blood pressure were measured at intervals and an upright blood sample was collected. Urine was collected to end the 24hr collection.|3
8534731|NCT00685919|9567683|FG000|Treatment A|Overall Study|Following the urine collection to end the baseline urine and the baseline testing, placebo was given orally. Additional doses were given every 6 hours with the last dose at 7am the following morning. Urine was collected over 24hr and supine and upright heart rates, blood pressures and blood samples were collected.|7
8534732|NCT00685919|9567684|FG001|Treatment A|Overall Study|Following the urine collection to end the baseline urine and the baseline testing, carbidopa 200 mg was given orally. Additional doses were given every 6 hours with the last dose at 7am the following morning. Urine was collected over 24hr and supine and upright heart rates, blood pressures and blood samples were collected.|9
8534733|NCT00685919|9567685|FG002|Treatment A|Overall Study|Following the urine collection to end the baseline urine and the baseline testing, placebo was given orally. Additional doses were given every 6 hours with the last dose at 7am the following morning. Urine was collected over 24hr and supine and upright heart rates, blood pressures and blood samples were collected.|8
8534734|NCT00685919|9567686|FG003|Treatment A|Overall Study|Following the urine collection to end the baseline urine and the baseline testing, carbidopa 200 mg was given orally. Additional doses were given every 6 hours with the last dose at 7am the following morning. Urine was collected over 24hr and supine and upright heart rates, blood pressures and blood samples were collected.|3
8534735|NCT00685919|9567683|FG000|24 hr Post-treatment A|Overall Study|Urine was collected for 24 hr after the last dose of Treatment A.|7
8534736|NCT00685919|9567684|FG001|24 hr Post-treatment A|Overall Study|Urine was collected for 24 hr after the last dose of Treatment A.|9
8534737|NCT00685919|9567685|FG002|24 hr Post-treatment A|Overall Study|Urine was collected for 24 hr after the last dose of Treatment A.|7
8534738|NCT00685919|9567686|FG003|24 hr Post-treatment A|Overall Study|Urine was collected for 24 hr after the last dose of Treatment A.|3
8534739|NCT00685919|9567683|FG000|Baseline B|Overall Study|After at least a 1-day washout period, patients underwent baseline procedures as described previously.|7
8534740|NCT00685919|9567684|FG001|Baseline B|Overall Study|After at least a 1-day washout period, patients underwent baseline procedures as described previously.|9
8534741|NCT00685919|9567685|FG002|Baseline B|Overall Study|After at least a 1-day washout period, patients underwent baseline procedures as described previously.|7
8534742|NCT00685919|9567686|FG003|Baseline B|Overall Study|After at least a 1-day washout period, patients underwent baseline procedures as described previously.|3
8534743|NCT00685919|9567683|FG000|Treatment B|Overall Study|Following the urine collection to end the baseline urine and the baseline testing, carbidopa 200 mg was given orally. Additional doses were given every 6 hours with the last dose at 7am the following morning. Urine was collected over 24hr and supine and upright heart rates, blood pressures and blood samples were collected.|7
8534744|NCT00685919|9567684|FG001|Treatment B|Overall Study|Following the urine collection to end the baseline urine and the baseline testing, placebo was given orally. Additional doses were given every 6 hours with the last dose at 7am the following morning. Urine was collected over 24hr and supine and upright heart rates, blood pressures and blood samples were collected.|9
8534745|NCT00685919|9567685|FG002|Treatment B|Overall Study|Following the urine collection to end the baseline urine and the baseline testing, carbidopa 200 mg was given orally. Additional doses were given every 6 hours with the last dose at 7am the following morning. Urine was collected over 24hr and supine and upright heart rates, blood pressures and blood samples were collected.|7
8620891|NCT00476242|9659764|FG000|STARTED|Overall Study||27
8620892|NCT00476242|9659765|FG001|STARTED|Overall Study||28
8620893|NCT00476242|9659764|FG000|COMPLETED|Overall Study||19
8620894|NCT00476242|9659765|FG001|COMPLETED|Overall Study||12
8620895|NCT00476242|9659764|FG000|NOT COMPLETED|Overall Study||8
8620896|NCT00476242|9659765|FG001|NOT COMPLETED|Overall Study||16
8620897|NCT00476476|9659775|FG000|STARTED|Overall Study||17
8620898|NCT00476476|9659776|FG001|STARTED|Overall Study||24
8620899|NCT00476476|9659775|FG000|Response Evaluable|Overall Study||17
8620900|NCT00476476|9659776|FG001|Response Evaluable|Overall Study|One woman was unevaluable due to an allergic reaction that developed after the 2nd dose.|23
8620901|NCT00476476|9659775|FG000|COMPLETED|Overall Study||15
8534746|NCT00685919|9567686|FG003|Treatment B|Overall Study|Following the urine collection to end the baseline urine and the baseline testing, placebo was given orally. Additional doses were given every 6 hours with the last dose at 7am the following morning. Urine was collected over 24hr and supine and upright heart rates, blood pressures and blood samples were collected.|3
8534747|NCT00685919|9567683|FG000|24 hr Post Treatment B|Overall Study|Urine was collected for 24 hr after last dose of Treatment B.|7
8534748|NCT00685919|9567684|FG001|24 hr Post Treatment B|Overall Study|Urine was collected for 24 hr after last dose of Treatment B.|9
8534749|NCT00685919|9567685|FG002|24 hr Post Treatment B|Overall Study|Urine was collected for 24 hr after last dose of Treatment B.|7
8534750|NCT00685919|9567686|FG003|24 hr Post Treatment B|Overall Study|Urine was collected for 24 hr after last dose of Treatment B.|3
8534751|NCT00685919|9567683|FG000|COMPLETED|Overall Study||7
8534752|NCT00685919|9567684|FG001|COMPLETED|Overall Study||9
8534753|NCT00685919|9567685|FG002|COMPLETED|Overall Study||7
8534754|NCT00685919|9567686|FG003|COMPLETED|Overall Study||3
8534755|NCT00685919|9567683|FG000|NOT COMPLETED|Overall Study||1
8534756|NCT00685919|9567684|FG001|NOT COMPLETED|Overall Study||0
8534757|NCT00685919|9567685|FG002|NOT COMPLETED|Overall Study||1
8534758|NCT00685919|9567686|FG003|NOT COMPLETED|Overall Study||0
8534759|NCT00344487|9567696|FG000|STARTED|Overall Study||3
8534760|NCT00344487|9567696|FG000|COMPLETED|Overall Study|One subject was withdrawn at month 9 because he was considered an immunologic failure on study.|2
8534761|NCT00344487|9567696|FG000|NOT COMPLETED|Overall Study||1
8534762|NCT00281658|9567704|FG000|STARTED|Double-blind, Randomized Phase||222
8534763|NCT00281658|9567705|FG001|STARTED|Double-blind, Randomized Phase|Of these participants, 149 entered the open-label extension phase.|222
8534764|NCT00281658|9567706|FG002|STARTED|Double-blind, Randomized Phase||0
8534765|NCT00281658|9567704|FG000|COMPLETED|Double-blind, Randomized Phase|For the purposes of this report, completed pts are pts ongoing at the time of the analysis.|85
8534766|NCT00281658|9567705|FG001|COMPLETED|Double-blind, Randomized Phase|For the purposes of this report, completed pts are pts ongoing at the time of the analysis.|168
8534767|NCT00281658|9567706|FG002|COMPLETED|Double-blind, Randomized Phase||0
8534768|NCT00281658|9567704|FG000|NOT COMPLETED|Double-blind, Randomized Phase||137
8534769|NCT00281658|9567705|FG001|NOT COMPLETED|Double-blind, Randomized Phase||54
8534770|NCT00281658|9567706|FG002|NOT COMPLETED|Double-blind, Randomized Phase||0
8534771|NCT00281658|9567704|FG000|STARTED|Open-label Monotherapy Extension Phase||0
8534772|NCT00281658|9567705|FG001|STARTED|Open-label Monotherapy Extension Phase||0
8534773|NCT00281658|9567706|FG002|STARTED|Open-label Monotherapy Extension Phase||149
8534774|NCT00281658|9567704|FG000|COMPLETED|Open-label Monotherapy Extension Phase||0
8534775|NCT00281658|9567705|FG001|COMPLETED|Open-label Monotherapy Extension Phase||0
8534776|NCT00281658|9567706|FG002|COMPLETED|Open-label Monotherapy Extension Phase|For the purposes of this report, completed pts are pts ongoing at the time of the analysis.|48
8534777|NCT00281658|9567704|FG000|NOT COMPLETED|Open-label Monotherapy Extension Phase||0
8534778|NCT00281658|9567705|FG001|NOT COMPLETED|Open-label Monotherapy Extension Phase||0
8534779|NCT00281658|9567706|FG002|NOT COMPLETED|Open-label Monotherapy Extension Phase||101
8565174|NCT00065260|9597274|FG001|STARTED|Overall Study||27
8565175|NCT00065260|9597273|FG000|COMPLETED|Overall Study||27
8565176|NCT00065260|9597274|FG001|COMPLETED|Overall Study||26
8565177|NCT00065260|9597273|FG000|NOT COMPLETED|Overall Study||0
8565178|NCT00065260|9597274|FG001|NOT COMPLETED|Overall Study||1
8565179|NCT00065429|9597287|FG000|STARTED|Phase I - May 2001 - Oct 2002||4
8565180|NCT00065429|9597288|FG001|STARTED|Phase I - May 2001 - Oct 2002||3
8565181|NCT00065429|9597289|FG002|STARTED|Phase I - May 2001 - Oct 2002||4
8565182|NCT00065429|9597290|FG003|STARTED|Phase I - May 2001 - Oct 2002||4
8565183|NCT00065429|9597291|FG004|STARTED|Phase I - May 2001 - Oct 2002||9
8565184|NCT00065429|9597292|FG005|STARTED|Phase I - May 2001 - Oct 2002||4
8565185|NCT00065429|9597293|FG006|STARTED|Phase I - May 2001 - Oct 2002||4
8565186|NCT00065429|9597287|FG000|COMPLETED|Phase I - May 2001 - Oct 2002||3
8565187|NCT00065429|9597288|FG001|COMPLETED|Phase I - May 2001 - Oct 2002||3
8565188|NCT00065429|9597289|FG002|COMPLETED|Phase I - May 2001 - Oct 2002||3
8565189|NCT00065429|9597290|FG003|COMPLETED|Phase I - May 2001 - Oct 2002||3
8565190|NCT00065429|9597291|FG004|COMPLETED|Phase I - May 2001 - Oct 2002||8
8565191|NCT00065429|9597292|FG005|COMPLETED|Phase I - May 2001 - Oct 2002||2
8565192|NCT00065429|9597293|FG006|COMPLETED|Phase I - May 2001 - Oct 2002||2
8565193|NCT00065429|9597287|FG000|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
8565194|NCT00065429|9597288|FG001|NOT COMPLETED|Phase I - May 2001 - Oct 2002||0
8565195|NCT00065429|9597289|FG002|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
8565196|NCT00065429|9597290|FG003|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
8565197|NCT00065429|9597291|FG004|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
8565198|NCT00065429|9597292|FG005|NOT COMPLETED|Phase I - May 2001 - Oct 2002||2
8565199|NCT00065429|9597293|FG006|NOT COMPLETED|Phase I - May 2001 - Oct 2002||2
8565200|NCT00065429|9597287|FG000|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
8565201|NCT00065429|9597288|FG001|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
8569454|NCT00097539|9601699|FG006|STARTED|Overall Study||239
8620902|NCT00476476|9659776|FG001|COMPLETED|Overall Study|Treatment was not of fixed duration and thus pts are not considered to have 'Completed' treatment.|0
8620903|NCT00476476|9659775|FG000|NOT COMPLETED|Overall Study||2
8620904|NCT00476476|9659776|FG001|NOT COMPLETED|Overall Study||24
8620905|NCT00476593|9659785|FG000|STARTED|Overall Study||32
8722929|NCT02819440|9770414|FG001|STARTED|Overall Study||64
8620906|NCT00476593|9659786|FG001|STARTED|Overall Study||19
8534780|NCT04368910|9567715|FG000|STARTED|Overall Study||15
8534781|NCT04368910|9567716|FG001|STARTED|Overall Study||15
8534782|NCT04368910|9567715|FG000|COMPLETED|Overall Study||15
8534783|NCT04368910|9567716|FG001|COMPLETED|Overall Study||15
8534784|NCT04368910|9567715|FG000|NOT COMPLETED|Overall Study||0
8534785|NCT04368910|9567716|FG001|NOT COMPLETED|Overall Study||0
8534786|NCT04365985|9567725|FG000|STARTED|Overall Study||9
8534787|NCT04365985|9567726|FG001|STARTED|Overall Study||9
8534788|NCT04365985|9567727|FG002|STARTED|Overall Study||52
8534789|NCT04365985|9567725|FG000|COMPLETED|Overall Study||9
8534790|NCT04365985|9567726|FG001|COMPLETED|Overall Study||9
8534791|NCT04365985|9567727|FG002|COMPLETED|Overall Study||52
8534792|NCT04365985|9567725|FG000|NOT COMPLETED|Overall Study||0
8534793|NCT04365985|9567726|FG001|NOT COMPLETED|Overall Study||0
8534794|NCT04365985|9567727|FG002|NOT COMPLETED|Overall Study||0
8534795|NCT04034355|9567737|FG000|STARTED|Overall Study||151
8534796|NCT04034355|9567738|FG001|STARTED|Overall Study||150
8534797|NCT04034355|9567737|FG000|Treated|Overall Study||147
8534798|NCT04034355|9567738|FG001|Treated|Overall Study||150
8534799|NCT04034355|9567737|FG000|COMPLETED|Overall Study||117
8534800|NCT04034355|9567738|FG001|COMPLETED|Overall Study||115
8534801|NCT04034355|9567737|FG000|NOT COMPLETED|Overall Study||34
8534802|NCT04034355|9567738|FG001|NOT COMPLETED|Overall Study||35
8534803|NCT03781726|9567744|FG000|STARTED|Overall Study||30
8534804|NCT03781726|9567744|FG000|COMPLETED|Overall Study||28
8534805|NCT03781726|9567744|FG000|NOT COMPLETED|Overall Study||2
8534806|NCT03721276|9567750|FG000|STARTED|Overall Study||30
8534807|NCT03721276|9567751|FG001|STARTED|Overall Study||30
8534808|NCT03721276|9567750|FG000|Three-month Pre-intervention|Overall Study|Participants in this arm started therapy immediately after randomization, and therefore, did not have a three-month waiting period prior to receiving the intervention.|0
8534809|NCT03721276|9567751|FG001|Three-month Pre-intervention|Overall Study||30
8534810|NCT03721276|9567750|FG000|Immediate Pre-intervention|Overall Study||30
8534811|NCT03721276|9567751|FG001|Immediate Pre-intervention|Overall Study||29
8534812|NCT03721276|9567750|FG000|Post-intervention|Overall Study||25
8534813|NCT03721276|9567751|FG001|Post-intervention|Overall Study||26
8534814|NCT03721276|9567750|FG000|Three-month Follow-up (Post Intervention)|Overall Study||25
8534815|NCT03721276|9567751|FG001|Three-month Follow-up (Post Intervention)|Overall Study|Participants in this arm started therapy three months after randomization (waitlist) and therefore, were not assessed at the three-month follow-up time point due to completion of the study|0
8534816|NCT03721276|9567750|FG000|COMPLETED|Overall Study||25
8534817|NCT03721276|9567751|FG001|COMPLETED|Overall Study||26
8534818|NCT03721276|9567750|FG000|NOT COMPLETED|Overall Study||5
8534819|NCT03721276|9567751|FG001|NOT COMPLETED|Overall Study||4
8534820|NCT03700658|9567757|FG000|STARTED|Overall Study||27
8534821|NCT03700658|9567757|FG000|Received at Least 1 Dose of Study Drug|Overall Study||27
8534822|NCT03700658|9567757|FG000|COMPLETED|Overall Study||27
8534823|NCT03700658|9567757|FG000|NOT COMPLETED|Overall Study||0
8534824|NCT03637491|9567774|FG000|STARTED|Overall Study||10
8534825|NCT03637491|9567775|FG001|STARTED|Overall Study||12
8534826|NCT03637491|9567776|FG002|STARTED|Overall Study||7
8534827|NCT03637491|9567777|FG003|STARTED|Overall Study||6
8534828|NCT03637491|9567774|FG000|Received Treatment|Overall Study||10
8534829|NCT03637491|9567775|FG001|Received Treatment|Overall Study||12
8534830|NCT03637491|9567776|FG002|Received Treatment|Overall Study||7
8534831|NCT03637491|9567777|FG003|Received Treatment|Overall Study||6
8534832|NCT03637491|9567774|FG000|COMPLETED|Overall Study||0
8534833|NCT03637491|9567775|FG001|COMPLETED|Overall Study||0
8534834|NCT03637491|9567776|FG002|COMPLETED|Overall Study||0
8534835|NCT03637491|9567777|FG003|COMPLETED|Overall Study||0
8534836|NCT03637491|9567774|FG000|NOT COMPLETED|Overall Study||10
8534837|NCT03637491|9567775|FG001|NOT COMPLETED|Overall Study||12
8534838|NCT03637491|9567776|FG002|NOT COMPLETED|Overall Study||7
8534839|NCT03637491|9567777|FG003|NOT COMPLETED|Overall Study||6
8534840|NCT03610334|9567801|FG000|STARTED|Period 1: 2.5mg (1 Day)||6
8534841|NCT03610334|9567802|FG001|STARTED|Period 1: 2.5mg (1 Day)||2
8534842|NCT03610334|9567803|FG002|STARTED|Period 1: 2.5mg (1 Day)||0
8534843|NCT03610334|9567804|FG003|STARTED|Period 1: 2.5mg (1 Day)||0
8534844|NCT03610334|9567805|FG004|STARTED|Period 1: 2.5mg (1 Day)||0
8534845|NCT03610334|9567806|FG005|STARTED|Period 1: 2.5mg (1 Day)||0
8534846|NCT03610334|9567807|FG006|STARTED|Period 1: 2.5mg (1 Day)||0
8534847|NCT03610334|9567808|FG007|STARTED|Period 1: 2.5mg (1 Day)||0
8534848|NCT03610334|9567809|FG008|STARTED|Period 1: 2.5mg (1 Day)||0
8534849|NCT03610334|9567810|FG009|STARTED|Period 1: 2.5mg (1 Day)||0
8534850|NCT03610334|9567811|FG010|STARTED|Period 1: 2.5mg (1 Day)||0
8534851|NCT03610334|9567812|FG011|STARTED|Period 1: 2.5mg (1 Day)||0
8534852|NCT03610334|9567813|FG012|STARTED|Period 1: 2.5mg (1 Day)||0
8534853|NCT03610334|9567814|FG013|STARTED|Period 1: 2.5mg (1 Day)||0
8534854|NCT03610334|9567815|FG014|STARTED|Period 1: 2.5mg (1 Day)||0
8534855|NCT03610334|9567816|FG015|STARTED|Period 1: 2.5mg (1 Day)||0
8534856|NCT03610334|9567817|FG016|STARTED|Period 1: 2.5mg (1 Day)||0
8534857|NCT03610334|9567818|FG017|STARTED|Period 1: 2.5mg (1 Day)||0
8534858|NCT03610334|9567801|FG000|COMPLETED|Period 1: 2.5mg (1 Day)||6
8534859|NCT03610334|9567802|FG001|COMPLETED|Period 1: 2.5mg (1 Day)||2
8534860|NCT03610334|9567803|FG002|COMPLETED|Period 1: 2.5mg (1 Day)||0
8534861|NCT03610334|9567804|FG003|COMPLETED|Period 1: 2.5mg (1 Day)||0
8534862|NCT03610334|9567805|FG004|COMPLETED|Period 1: 2.5mg (1 Day)||0
8534863|NCT03610334|9567806|FG005|COMPLETED|Period 1: 2.5mg (1 Day)||0
8534864|NCT03610334|9567807|FG006|COMPLETED|Period 1: 2.5mg (1 Day)||0
8534865|NCT03610334|9567808|FG007|COMPLETED|Period 1: 2.5mg (1 Day)||0
8816527|NCT01544582|9870053|FG003|COMPLETED|Analysis Population||35
8816528|NCT01544582|9870050|FG000|NOT COMPLETED|Analysis Population||0
8816529|NCT01544582|9870051|FG001|NOT COMPLETED|Analysis Population||118
8816530|NCT01544582|9870052|FG002|NOT COMPLETED|Analysis Population||102
8816531|NCT01544582|9870053|FG003|NOT COMPLETED|Analysis Population||39
8620907|NCT00476593|9659787|FG002|STARTED|Overall Study||38
8620908|NCT00476593|9659788|FG003|STARTED|Overall Study||129
8620909|NCT00476593|9659785|FG000|COMPLETED|Overall Study|all subjects completed treatment in one eye. However, bilateral OCT scans included only in 22 cases|22
8816532|NCT01544595|9870072|FG000|STARTED|Status at Week 68||301
8816533|NCT01544595|9870073|FG001|STARTED|Status at Week 68||363
8534866|NCT03610334|9567809|FG008|COMPLETED|Period 1: 2.5mg (1 Day)||0
8534867|NCT03610334|9567810|FG009|COMPLETED|Period 1: 2.5mg (1 Day)||0
8534868|NCT03610334|9567811|FG010|COMPLETED|Period 1: 2.5mg (1 Day)||0
8534869|NCT03610334|9567812|FG011|COMPLETED|Period 1: 2.5mg (1 Day)||0
8534870|NCT03610334|9567813|FG012|COMPLETED|Period 1: 2.5mg (1 Day)||0
8534871|NCT03610334|9567814|FG013|COMPLETED|Period 1: 2.5mg (1 Day)||0
8534872|NCT03610334|9567815|FG014|COMPLETED|Period 1: 2.5mg (1 Day)||0
8534873|NCT03610334|9567816|FG015|COMPLETED|Period 1: 2.5mg (1 Day)||0
8534874|NCT03610334|9567817|FG016|COMPLETED|Period 1: 2.5mg (1 Day)||0
8534875|NCT03610334|9567818|FG017|COMPLETED|Period 1: 2.5mg (1 Day)||0
8534876|NCT03610334|9567801|FG000|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
8534877|NCT03610334|9567802|FG001|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
8534878|NCT03610334|9567803|FG002|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
8534879|NCT03610334|9567804|FG003|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
8534880|NCT03610334|9567805|FG004|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
8534881|NCT03610334|9567806|FG005|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
8534882|NCT03610334|9567807|FG006|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
8534883|NCT03610334|9567808|FG007|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
8534884|NCT03610334|9567809|FG008|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
8534885|NCT03610334|9567810|FG009|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
8534886|NCT03610334|9567811|FG010|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
8534887|NCT03610334|9567812|FG011|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
8534888|NCT03610334|9567813|FG012|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
8534889|NCT03610334|9567814|FG013|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
8534890|NCT03610334|9567815|FG014|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
8534891|NCT03610334|9567816|FG015|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
8534892|NCT03610334|9567817|FG016|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
8534893|NCT03610334|9567818|FG017|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
8534894|NCT03610334|9567801|FG000|STARTED|Period 2: 5.0mg (1 Day)||6
8534895|NCT03610334|9567802|FG001|STARTED|Period 2: 5.0mg (1 Day)||2
8534896|NCT03610334|9567803|FG002|STARTED|Period 2: 5.0mg (1 Day)||6
8534897|NCT03610334|9567804|FG003|STARTED|Period 2: 5.0mg (1 Day)||2
8620910|NCT00476593|9659786|FG001|COMPLETED|Overall Study|all subjects completed treatment in one eye. However, bilateral OCT scans included only in 17 cases|17
8620911|NCT00476593|9659787|FG002|COMPLETED|Overall Study||30
8620912|NCT00476593|9659788|FG003|COMPLETED|Overall Study||107
8620913|NCT00476593|9659785|FG000|NOT COMPLETED|Overall Study||10
8620914|NCT00476593|9659786|FG001|NOT COMPLETED|Overall Study||2
8620915|NCT00476593|9659787|FG002|NOT COMPLETED|Overall Study||8
8534898|NCT03610334|9567805|FG004|STARTED|Period 2: 5.0mg (1 Day)||0
8534899|NCT03610334|9567806|FG005|STARTED|Period 2: 5.0mg (1 Day)||0
8534900|NCT03610334|9567807|FG006|STARTED|Period 2: 5.0mg (1 Day)||0
8534901|NCT03610334|9567808|FG007|STARTED|Period 2: 5.0mg (1 Day)||0
8534902|NCT03610334|9567809|FG008|STARTED|Period 2: 5.0mg (1 Day)||0
8534903|NCT03610334|9567810|FG009|STARTED|Period 2: 5.0mg (1 Day)||0
8534904|NCT03610334|9567811|FG010|STARTED|Period 2: 5.0mg (1 Day)||0
8534905|NCT03610334|9567812|FG011|STARTED|Period 2: 5.0mg (1 Day)||0
8534906|NCT03610334|9567813|FG012|STARTED|Period 2: 5.0mg (1 Day)||0
8534907|NCT03610334|9567814|FG013|STARTED|Period 2: 5.0mg (1 Day)||0
8534908|NCT03610334|9567815|FG014|STARTED|Period 2: 5.0mg (1 Day)||0
8534909|NCT03610334|9567816|FG015|STARTED|Period 2: 5.0mg (1 Day)||0
8534910|NCT03610334|9567817|FG016|STARTED|Period 2: 5.0mg (1 Day)||0
8534911|NCT03610334|9567818|FG017|STARTED|Period 2: 5.0mg (1 Day)||0
8534912|NCT03610334|9567801|FG000|COMPLETED|Period 2: 5.0mg (1 Day)||6
8534913|NCT03610334|9567802|FG001|COMPLETED|Period 2: 5.0mg (1 Day)||2
8534914|NCT03610334|9567803|FG002|COMPLETED|Period 2: 5.0mg (1 Day)||6
8534915|NCT03610334|9567804|FG003|COMPLETED|Period 2: 5.0mg (1 Day)||2
8534916|NCT03610334|9567805|FG004|COMPLETED|Period 2: 5.0mg (1 Day)||0
8534917|NCT03610334|9567806|FG005|COMPLETED|Period 2: 5.0mg (1 Day)||0
8534918|NCT03610334|9567807|FG006|COMPLETED|Period 2: 5.0mg (1 Day)||0
8534919|NCT03610334|9567808|FG007|COMPLETED|Period 2: 5.0mg (1 Day)||0
8620916|NCT00476593|9659788|FG003|NOT COMPLETED|Overall Study||22
8620917|NCT00476645|9659798|FG000|STARTED|Overall Study||10
8620918|NCT00476645|9659798|FG000|COMPLETED|Overall Study||10
8620919|NCT00476645|9659798|FG000|NOT COMPLETED|Overall Study||0
8816534|NCT01544595|9870074|FG002|STARTED|Status at Week 68||150
8816535|NCT01544595|9870075|FG003|STARTED|Status at Week 68||181
8534920|NCT03610334|9567809|FG008|COMPLETED|Period 2: 5.0mg (1 Day)||0
8534921|NCT03610334|9567810|FG009|COMPLETED|Period 2: 5.0mg (1 Day)||0
8534922|NCT03610334|9567811|FG010|COMPLETED|Period 2: 5.0mg (1 Day)||0
8534923|NCT03610334|9567812|FG011|COMPLETED|Period 2: 5.0mg (1 Day)||0
8534924|NCT03610334|9567813|FG012|COMPLETED|Period 2: 5.0mg (1 Day)||0
8534925|NCT03610334|9567814|FG013|COMPLETED|Period 2: 5.0mg (1 Day)||0
8534926|NCT03610334|9567815|FG014|COMPLETED|Period 2: 5.0mg (1 Day)||0
8534927|NCT03610334|9567816|FG015|COMPLETED|Period 2: 5.0mg (1 Day)||0
8534928|NCT03610334|9567817|FG016|COMPLETED|Period 2: 5.0mg (1 Day)||0
8534929|NCT03610334|9567818|FG017|COMPLETED|Period 2: 5.0mg (1 Day)||0
8534930|NCT03610334|9567801|FG000|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
8534931|NCT03610334|9567802|FG001|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
8534932|NCT03610334|9567803|FG002|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
8534933|NCT03610334|9567804|FG003|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
8534934|NCT03610334|9567805|FG004|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
8534935|NCT03610334|9567806|FG005|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
8534936|NCT03610334|9567807|FG006|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
8534937|NCT03610334|9567808|FG007|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
8534938|NCT03610334|9567809|FG008|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
8534939|NCT03610334|9567810|FG009|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
8534940|NCT03610334|9567811|FG010|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
8534941|NCT03610334|9567812|FG011|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
8534942|NCT03610334|9567813|FG012|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
8534943|NCT03610334|9567814|FG013|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
8534944|NCT03610334|9567815|FG014|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
8534945|NCT03610334|9567816|FG015|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
8534946|NCT03610334|9567817|FG016|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
8534947|NCT03610334|9567818|FG017|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
8534948|NCT03610334|9567801|FG000|STARTED|Period 3: 10.0mg (1 Day)||6
8534949|NCT03610334|9567802|FG001|STARTED|Period 3: 10.0mg (1 Day)||2
8534950|NCT03610334|9567803|FG002|STARTED|Period 3: 10.0mg (1 Day)||6
8534951|NCT03610334|9567804|FG003|STARTED|Period 3: 10.0mg (1 Day)||2
8534952|NCT03610334|9567805|FG004|STARTED|Period 3: 10.0mg (1 Day)||6
8534953|NCT03610334|9567806|FG005|STARTED|Period 3: 10.0mg (1 Day)||2
8534954|NCT03610334|9567807|FG006|STARTED|Period 3: 10.0mg (1 Day)||0
8534955|NCT03610334|9567808|FG007|STARTED|Period 3: 10.0mg (1 Day)||0
8534956|NCT03610334|9567809|FG008|STARTED|Period 3: 10.0mg (1 Day)||0
8534957|NCT03610334|9567810|FG009|STARTED|Period 3: 10.0mg (1 Day)||0
8534958|NCT03610334|9567811|FG010|STARTED|Period 3: 10.0mg (1 Day)||0
8534959|NCT03610334|9567812|FG011|STARTED|Period 3: 10.0mg (1 Day)||0
8534960|NCT03610334|9567813|FG012|STARTED|Period 3: 10.0mg (1 Day)||0
8534961|NCT03610334|9567814|FG013|STARTED|Period 3: 10.0mg (1 Day)||0
8534962|NCT03610334|9567815|FG014|STARTED|Period 3: 10.0mg (1 Day)||0
8534963|NCT03610334|9567816|FG015|STARTED|Period 3: 10.0mg (1 Day)||0
8534964|NCT03610334|9567817|FG016|STARTED|Period 3: 10.0mg (1 Day)||0
8534965|NCT03610334|9567818|FG017|STARTED|Period 3: 10.0mg (1 Day)||0
8620920|NCT00476788|9659802|FG000|STARTED|Overall Study||14
8620921|NCT00476788|9659802|FG000|COMPLETED|Overall Study||11
8620922|NCT00476788|9659802|FG000|NOT COMPLETED|Overall Study||3
8620923|NCT00476957|9659808|FG000|STARTED|Overall Study||4357
8620924|NCT00476957|9659809|FG001|STARTED|Overall Study||4352
8620925|NCT00476957|9659808|FG000|COMPLETED|Overall Study||4181
8534966|NCT03610334|9567801|FG000|COMPLETED|Period 3: 10.0mg (1 Day)||6
8534967|NCT03610334|9567802|FG001|COMPLETED|Period 3: 10.0mg (1 Day)||2
8534968|NCT03610334|9567803|FG002|COMPLETED|Period 3: 10.0mg (1 Day)||6
8534969|NCT03610334|9567804|FG003|COMPLETED|Period 3: 10.0mg (1 Day)||2
8534970|NCT03610334|9567805|FG004|COMPLETED|Period 3: 10.0mg (1 Day)||6
8534971|NCT03610334|9567806|FG005|COMPLETED|Period 3: 10.0mg (1 Day)||2
8534972|NCT03610334|9567807|FG006|COMPLETED|Period 3: 10.0mg (1 Day)||0
8534973|NCT03610334|9567808|FG007|COMPLETED|Period 3: 10.0mg (1 Day)||0
8534974|NCT03610334|9567809|FG008|COMPLETED|Period 3: 10.0mg (1 Day)||0
8534975|NCT03610334|9567810|FG009|COMPLETED|Period 3: 10.0mg (1 Day)||0
8534976|NCT03610334|9567811|FG010|COMPLETED|Period 3: 10.0mg (1 Day)||0
8534977|NCT03610334|9567812|FG011|COMPLETED|Period 3: 10.0mg (1 Day)||0
8534978|NCT03610334|9567813|FG012|COMPLETED|Period 3: 10.0mg (1 Day)||0
8534979|NCT03610334|9567814|FG013|COMPLETED|Period 3: 10.0mg (1 Day)||0
8534980|NCT03610334|9567815|FG014|COMPLETED|Period 3: 10.0mg (1 Day)||0
8534981|NCT03610334|9567816|FG015|COMPLETED|Period 3: 10.0mg (1 Day)||0
8534982|NCT03610334|9567817|FG016|COMPLETED|Period 3: 10.0mg (1 Day)||0
8534983|NCT03610334|9567818|FG017|COMPLETED|Period 3: 10.0mg (1 Day)||0
8534984|NCT03610334|9567801|FG000|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
8534985|NCT03610334|9567802|FG001|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
8534986|NCT03610334|9567803|FG002|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
8620926|NCT00476957|9659809|FG001|COMPLETED|Overall Study||4159
8620927|NCT00476957|9659808|FG000|NOT COMPLETED|Overall Study||176
8620928|NCT00476957|9659809|FG001|NOT COMPLETED|Overall Study||193
8534987|NCT03610334|9567804|FG003|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
8534988|NCT03610334|9567805|FG004|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
8534989|NCT03610334|9567806|FG005|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
8534990|NCT03610334|9567807|FG006|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
8534991|NCT03610334|9567808|FG007|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
8534992|NCT03610334|9567809|FG008|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
8534993|NCT03610334|9567810|FG009|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
8534994|NCT03610334|9567811|FG010|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
8534995|NCT03610334|9567812|FG011|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
8534996|NCT03610334|9567813|FG012|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
8534997|NCT03610334|9567814|FG013|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
8534998|NCT03610334|9567815|FG014|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
8534999|NCT03610334|9567816|FG015|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
8535000|NCT03610334|9567817|FG016|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
8535001|NCT03610334|9567818|FG017|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
8620929|NCT00476996|9659818|FG000|STARTED|Blinded Treatment Phase (up to Week 48)||277
8620930|NCT00476996|9659819|FG001|STARTED|Blinded Treatment Phase (up to Week 48)||277
8620931|NCT00476996|9659820|FG002|STARTED|Blinded Treatment Phase (up to Week 48)||282
8620932|NCT00476996|9659821|FG003|STARTED|Blinded Treatment Phase (up to Week 48)||0
8620933|NCT00476996|9659818|FG000|COMPLETED|Blinded Treatment Phase (up to Week 48)||205
8620934|NCT00476996|9659819|FG001|COMPLETED|Blinded Treatment Phase (up to Week 48)||222
8620935|NCT00476996|9659820|FG002|COMPLETED|Blinded Treatment Phase (up to Week 48)||237
8620936|NCT00476996|9659821|FG003|COMPLETED|Blinded Treatment Phase (up to Week 48)||0
8535002|NCT03610334|9567801|FG000|STARTED|Period 4: 20.0mg (1 Day)||6
8535003|NCT03610334|9567802|FG001|STARTED|Period 4: 20.0mg (1 Day)||2
8535004|NCT03610334|9567803|FG002|STARTED|Period 4: 20.0mg (1 Day)||6
8535005|NCT03610334|9567804|FG003|STARTED|Period 4: 20.0mg (1 Day)||2
8535006|NCT03610334|9567805|FG004|STARTED|Period 4: 20.0mg (1 Day)||6
8535007|NCT03610334|9567806|FG005|STARTED|Period 4: 20.0mg (1 Day)||2
8535008|NCT03610334|9567807|FG006|STARTED|Period 4: 20.0mg (1 Day)||6
8535009|NCT03610334|9567808|FG007|STARTED|Period 4: 20.0mg (1 Day)||2
8535010|NCT03610334|9567809|FG008|STARTED|Period 4: 20.0mg (1 Day)||0
8535011|NCT03610334|9567810|FG009|STARTED|Period 4: 20.0mg (1 Day)||0
8535012|NCT03610334|9567811|FG010|STARTED|Period 4: 20.0mg (1 Day)||0
8535013|NCT03610334|9567812|FG011|STARTED|Period 4: 20.0mg (1 Day)||0
8535014|NCT03610334|9567813|FG012|STARTED|Period 4: 20.0mg (1 Day)||0
8535015|NCT03610334|9567814|FG013|STARTED|Period 4: 20.0mg (1 Day)||0
8535016|NCT03610334|9567815|FG014|STARTED|Period 4: 20.0mg (1 Day)||0
8535017|NCT03610334|9567816|FG015|STARTED|Period 4: 20.0mg (1 Day)||0
8535018|NCT03610334|9567817|FG016|STARTED|Period 4: 20.0mg (1 Day)||0
8535019|NCT03610334|9567818|FG017|STARTED|Period 4: 20.0mg (1 Day)||0
8535020|NCT03610334|9567801|FG000|COMPLETED|Period 4: 20.0mg (1 Day)||6
8535021|NCT03610334|9567802|FG001|COMPLETED|Period 4: 20.0mg (1 Day)||2
8535022|NCT03610334|9567803|FG002|COMPLETED|Period 4: 20.0mg (1 Day)||6
8535023|NCT03610334|9567804|FG003|COMPLETED|Period 4: 20.0mg (1 Day)||2
8535024|NCT03610334|9567805|FG004|COMPLETED|Period 4: 20.0mg (1 Day)||6
8535025|NCT03610334|9567806|FG005|COMPLETED|Period 4: 20.0mg (1 Day)||2
8535026|NCT03610334|9567807|FG006|COMPLETED|Period 4: 20.0mg (1 Day)||6
8535027|NCT03610334|9567808|FG007|COMPLETED|Period 4: 20.0mg (1 Day)||2
8535028|NCT03610334|9567809|FG008|COMPLETED|Period 4: 20.0mg (1 Day)||0
8535029|NCT03610334|9567810|FG009|COMPLETED|Period 4: 20.0mg (1 Day)||0
8535030|NCT03610334|9567811|FG010|COMPLETED|Period 4: 20.0mg (1 Day)||0
8535031|NCT03610334|9567812|FG011|COMPLETED|Period 4: 20.0mg (1 Day)||0
8535032|NCT03610334|9567813|FG012|COMPLETED|Period 4: 20.0mg (1 Day)||0
8535033|NCT03610334|9567814|FG013|COMPLETED|Period 4: 20.0mg (1 Day)||0
8535034|NCT03610334|9567815|FG014|COMPLETED|Period 4: 20.0mg (1 Day)||0
8535035|NCT03610334|9567816|FG015|COMPLETED|Period 4: 20.0mg (1 Day)||0
8535036|NCT03610334|9567817|FG016|COMPLETED|Period 4: 20.0mg (1 Day)||0
8535037|NCT03610334|9567818|FG017|COMPLETED|Period 4: 20.0mg (1 Day)||0
8535038|NCT03610334|9567801|FG000|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
8535039|NCT03610334|9567802|FG001|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
8535040|NCT03610334|9567803|FG002|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
8535041|NCT03610334|9567804|FG003|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
8535042|NCT03610334|9567805|FG004|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
8535043|NCT03610334|9567806|FG005|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
8535044|NCT03610334|9567807|FG006|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
8535045|NCT03610334|9567808|FG007|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
8535046|NCT03610334|9567809|FG008|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
8535047|NCT03610334|9567810|FG009|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
8535048|NCT03610334|9567811|FG010|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
8535049|NCT03610334|9567812|FG011|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
8535050|NCT03610334|9567813|FG012|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
8535051|NCT03610334|9567814|FG013|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
8535052|NCT03610334|9567815|FG014|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
8535053|NCT03610334|9567816|FG015|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
8535054|NCT03610334|9567817|FG016|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
8535055|NCT03610334|9567818|FG017|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
8535056|NCT03610334|9567801|FG000|STARTED|Period 5: 40.0mg (1 Day)||6
8535057|NCT03610334|9567802|FG001|STARTED|Period 5: 40.0mg (1 Day)||2
8535058|NCT03610334|9567803|FG002|STARTED|Period 5: 40.0mg (1 Day)||6
8535059|NCT03610334|9567804|FG003|STARTED|Period 5: 40.0mg (1 Day)||2
8535060|NCT03610334|9567805|FG004|STARTED|Period 5: 40.0mg (1 Day)||6
8535061|NCT03610334|9567806|FG005|STARTED|Period 5: 40.0mg (1 Day)||2
8535062|NCT03610334|9567807|FG006|STARTED|Period 5: 40.0mg (1 Day)||6
8535063|NCT03610334|9567808|FG007|STARTED|Period 5: 40.0mg (1 Day)||2
8535064|NCT03610334|9567809|FG008|STARTED|Period 5: 40.0mg (1 Day)||6
8535065|NCT03610334|9567810|FG009|STARTED|Period 5: 40.0mg (1 Day)||2
8535066|NCT03610334|9567811|FG010|STARTED|Period 5: 40.0mg (1 Day)||0
8535067|NCT03610334|9567812|FG011|STARTED|Period 5: 40.0mg (1 Day)||0
8535068|NCT03610334|9567813|FG012|STARTED|Period 5: 40.0mg (1 Day)||0
8535069|NCT03610334|9567814|FG013|STARTED|Period 5: 40.0mg (1 Day)||0
8535070|NCT03610334|9567815|FG014|STARTED|Period 5: 40.0mg (1 Day)||0
8535071|NCT03610334|9567816|FG015|STARTED|Period 5: 40.0mg (1 Day)||0
8535072|NCT03610334|9567817|FG016|STARTED|Period 5: 40.0mg (1 Day)||0
8535073|NCT03610334|9567818|FG017|STARTED|Period 5: 40.0mg (1 Day)||0
8535074|NCT03610334|9567801|FG000|COMPLETED|Period 5: 40.0mg (1 Day)||6
8535075|NCT03610334|9567802|FG001|COMPLETED|Period 5: 40.0mg (1 Day)||2
8535076|NCT03610334|9567803|FG002|COMPLETED|Period 5: 40.0mg (1 Day)||6
8535077|NCT03610334|9567804|FG003|COMPLETED|Period 5: 40.0mg (1 Day)||2
8535078|NCT03610334|9567805|FG004|COMPLETED|Period 5: 40.0mg (1 Day)||6
8535079|NCT03610334|9567806|FG005|COMPLETED|Period 5: 40.0mg (1 Day)||2
8535080|NCT03610334|9567807|FG006|COMPLETED|Period 5: 40.0mg (1 Day)||6
8535081|NCT03610334|9567808|FG007|COMPLETED|Period 5: 40.0mg (1 Day)||2
8535082|NCT03610334|9567809|FG008|COMPLETED|Period 5: 40.0mg (1 Day)||6
8535083|NCT03610334|9567810|FG009|COMPLETED|Period 5: 40.0mg (1 Day)||2
8535084|NCT03610334|9567811|FG010|COMPLETED|Period 5: 40.0mg (1 Day)||0
8535085|NCT03610334|9567812|FG011|COMPLETED|Period 5: 40.0mg (1 Day)||0
8535086|NCT03610334|9567813|FG012|COMPLETED|Period 5: 40.0mg (1 Day)||0
8535087|NCT03610334|9567814|FG013|COMPLETED|Period 5: 40.0mg (1 Day)||0
8535088|NCT03610334|9567815|FG014|COMPLETED|Period 5: 40.0mg (1 Day)||0
8535089|NCT03610334|9567816|FG015|COMPLETED|Period 5: 40.0mg (1 Day)||0
8535090|NCT03610334|9567817|FG016|COMPLETED|Period 5: 40.0mg (1 Day)||0
8535091|NCT03610334|9567818|FG017|COMPLETED|Period 5: 40.0mg (1 Day)||0
8535092|NCT03610334|9567801|FG000|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
8535093|NCT03610334|9567802|FG001|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
8535094|NCT03610334|9567803|FG002|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
8535095|NCT03610334|9567804|FG003|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
8535096|NCT03610334|9567805|FG004|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
8535097|NCT03610334|9567806|FG005|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
8535098|NCT03610334|9567807|FG006|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
8535099|NCT03610334|9567808|FG007|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
8535100|NCT03610334|9567809|FG008|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
8535101|NCT03610334|9567810|FG009|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
8535102|NCT03610334|9567811|FG010|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
8535103|NCT03610334|9567812|FG011|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
8535104|NCT03610334|9567813|FG012|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
8535105|NCT03610334|9567814|FG013|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
8535106|NCT03610334|9567815|FG014|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
8535107|NCT03610334|9567816|FG015|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
8535108|NCT03610334|9567817|FG016|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
8535109|NCT03610334|9567818|FG017|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
8535110|NCT03610334|9567801|FG000|STARTED|Period 6: 60.0mg (1 Day)||6
8535111|NCT03610334|9567802|FG001|STARTED|Period 6: 60.0mg (1 Day)||2
8535112|NCT03610334|9567803|FG002|STARTED|Period 6: 60.0mg (1 Day)||6
8535113|NCT03610334|9567804|FG003|STARTED|Period 6: 60.0mg (1 Day)||2
8535114|NCT03610334|9567805|FG004|STARTED|Period 6: 60.0mg (1 Day)||6
8535115|NCT03610334|9567806|FG005|STARTED|Period 6: 60.0mg (1 Day)||2
8535116|NCT03610334|9567807|FG006|STARTED|Period 6: 60.0mg (1 Day)||6
8535117|NCT03610334|9567808|FG007|STARTED|Period 6: 60.0mg (1 Day)||2
8535118|NCT03610334|9567809|FG008|STARTED|Period 6: 60.0mg (1 Day)||6
8535119|NCT03610334|9567810|FG009|STARTED|Period 6: 60.0mg (1 Day)||2
8535120|NCT03610334|9567811|FG010|STARTED|Period 6: 60.0mg (1 Day)||6
8535121|NCT03610334|9567812|FG011|STARTED|Period 6: 60.0mg (1 Day)||2
8535122|NCT03610334|9567813|FG012|STARTED|Period 6: 60.0mg (1 Day)||0
8535123|NCT03610334|9567814|FG013|STARTED|Period 6: 60.0mg (1 Day)||0
8535124|NCT03610334|9567815|FG014|STARTED|Period 6: 60.0mg (1 Day)||0
8535125|NCT03610334|9567816|FG015|STARTED|Period 6: 60.0mg (1 Day)||0
8535126|NCT03610334|9567817|FG016|STARTED|Period 6: 60.0mg (1 Day)||0
8535127|NCT03610334|9567818|FG017|STARTED|Period 6: 60.0mg (1 Day)||0
8535128|NCT03610334|9567801|FG000|COMPLETED|Period 6: 60.0mg (1 Day)||6
8535129|NCT03610334|9567802|FG001|COMPLETED|Period 6: 60.0mg (1 Day)||2
8535130|NCT03610334|9567803|FG002|COMPLETED|Period 6: 60.0mg (1 Day)||6
8535131|NCT03610334|9567804|FG003|COMPLETED|Period 6: 60.0mg (1 Day)||2
8535132|NCT03610334|9567805|FG004|COMPLETED|Period 6: 60.0mg (1 Day)||6
8535133|NCT03610334|9567806|FG005|COMPLETED|Period 6: 60.0mg (1 Day)||2
8535134|NCT03610334|9567807|FG006|COMPLETED|Period 6: 60.0mg (1 Day)||6
8535135|NCT03610334|9567808|FG007|COMPLETED|Period 6: 60.0mg (1 Day)||2
8535136|NCT03610334|9567809|FG008|COMPLETED|Period 6: 60.0mg (1 Day)||6
8535137|NCT03610334|9567810|FG009|COMPLETED|Period 6: 60.0mg (1 Day)||2
8535138|NCT03610334|9567811|FG010|COMPLETED|Period 6: 60.0mg (1 Day)||6
8535139|NCT03610334|9567812|FG011|COMPLETED|Period 6: 60.0mg (1 Day)||2
8535140|NCT03610334|9567813|FG012|COMPLETED|Period 6: 60.0mg (1 Day)||0
8535141|NCT03610334|9567814|FG013|COMPLETED|Period 6: 60.0mg (1 Day)||0
8535142|NCT03610334|9567815|FG014|COMPLETED|Period 6: 60.0mg (1 Day)||0
8535143|NCT03610334|9567816|FG015|COMPLETED|Period 6: 60.0mg (1 Day)||0
8535144|NCT03610334|9567817|FG016|COMPLETED|Period 6: 60.0mg (1 Day)||0
8535145|NCT03610334|9567818|FG017|COMPLETED|Period 6: 60.0mg (1 Day)||0
8535146|NCT03610334|9567801|FG000|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
8535147|NCT03610334|9567802|FG001|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
8535148|NCT03610334|9567803|FG002|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
8535149|NCT03610334|9567804|FG003|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
8535150|NCT03610334|9567805|FG004|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
8535151|NCT03610334|9567806|FG005|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
8535152|NCT03610334|9567807|FG006|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
8535153|NCT03610334|9567808|FG007|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
8535154|NCT03610334|9567809|FG008|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
8535155|NCT03610334|9567810|FG009|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
8535156|NCT03610334|9567811|FG010|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
8535157|NCT03610334|9567812|FG011|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
8535158|NCT03610334|9567813|FG012|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
8535159|NCT03610334|9567814|FG013|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
8535160|NCT03610334|9567815|FG014|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
8535161|NCT03610334|9567816|FG015|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
8535162|NCT03610334|9567817|FG016|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
8535163|NCT03610334|9567818|FG017|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
8535164|NCT03610334|9567801|FG000|STARTED|Period 7: 15.0mg (Day 1 to 14)||6
8535165|NCT03610334|9567802|FG001|STARTED|Period 7: 15.0mg (Day 1 to 14)||2
8535166|NCT03610334|9567803|FG002|STARTED|Period 7: 15.0mg (Day 1 to 14)||6
8535167|NCT03610334|9567804|FG003|STARTED|Period 7: 15.0mg (Day 1 to 14)||2
8535168|NCT03610334|9567805|FG004|STARTED|Period 7: 15.0mg (Day 1 to 14)||6
8535169|NCT03610334|9567806|FG005|STARTED|Period 7: 15.0mg (Day 1 to 14)||2
8535170|NCT03610334|9567807|FG006|STARTED|Period 7: 15.0mg (Day 1 to 14)||6
8535171|NCT03610334|9567808|FG007|STARTED|Period 7: 15.0mg (Day 1 to 14)||2
8535172|NCT03610334|9567809|FG008|STARTED|Period 7: 15.0mg (Day 1 to 14)||6
8535173|NCT03610334|9567810|FG009|STARTED|Period 7: 15.0mg (Day 1 to 14)||2
8535174|NCT03610334|9567811|FG010|STARTED|Period 7: 15.0mg (Day 1 to 14)||6
8535175|NCT03610334|9567812|FG011|STARTED|Period 7: 15.0mg (Day 1 to 14)||2
8535176|NCT03610334|9567813|FG012|STARTED|Period 7: 15.0mg (Day 1 to 14)||6
8535177|NCT03610334|9567814|FG013|STARTED|Period 7: 15.0mg (Day 1 to 14)||2
8535178|NCT03610334|9567815|FG014|STARTED|Period 7: 15.0mg (Day 1 to 14)||0
8535179|NCT03610334|9567816|FG015|STARTED|Period 7: 15.0mg (Day 1 to 14)||0
8535180|NCT03610334|9567817|FG016|STARTED|Period 7: 15.0mg (Day 1 to 14)||0
8535181|NCT03610334|9567818|FG017|STARTED|Period 7: 15.0mg (Day 1 to 14)||0
8535182|NCT03610334|9567801|FG000|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||6
8535183|NCT03610334|9567802|FG001|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||2
8535184|NCT03610334|9567803|FG002|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||6
8535185|NCT03610334|9567804|FG003|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||2
8535186|NCT03610334|9567805|FG004|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||6
8535187|NCT03610334|9567806|FG005|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||2
8535188|NCT03610334|9567807|FG006|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||6
8535189|NCT03610334|9567808|FG007|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||2
8535190|NCT03610334|9567809|FG008|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||6
8535191|NCT03610334|9567810|FG009|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||2
8535192|NCT03610334|9567811|FG010|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||6
8535193|NCT03610334|9567812|FG011|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||2
8535194|NCT03610334|9567813|FG012|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||6
8535195|NCT03610334|9567814|FG013|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||2
8535196|NCT03610334|9567815|FG014|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
8535197|NCT03610334|9567816|FG015|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
8535198|NCT03610334|9567817|FG016|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
8535199|NCT03610334|9567818|FG017|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
8535200|NCT03610334|9567801|FG000|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
8535201|NCT03610334|9567802|FG001|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
8535202|NCT03610334|9567803|FG002|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
8535203|NCT03610334|9567804|FG003|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
8535204|NCT03610334|9567805|FG004|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
8535205|NCT03610334|9567806|FG005|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
8535206|NCT03610334|9567807|FG006|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
8535207|NCT03610334|9567808|FG007|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
8535208|NCT03610334|9567809|FG008|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
8535209|NCT03610334|9567810|FG009|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
8535210|NCT03610334|9567811|FG010|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
8535211|NCT03610334|9567812|FG011|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
8535212|NCT03610334|9567813|FG012|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
8535213|NCT03610334|9567814|FG013|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
8535214|NCT03610334|9567815|FG014|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
8535215|NCT03610334|9567816|FG015|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
8535216|NCT03610334|9567817|FG016|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
8535217|NCT03610334|9567818|FG017|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
8535218|NCT03610334|9567801|FG000|STARTED|Period 8: 30.0mg (Day 1 to 14)||6
8535219|NCT03610334|9567802|FG001|STARTED|Period 8: 30.0mg (Day 1 to 14)||2
8535220|NCT03610334|9567803|FG002|STARTED|Period 8: 30.0mg (Day 1 to 14)||6
8535221|NCT03610334|9567804|FG003|STARTED|Period 8: 30.0mg (Day 1 to 14)||2
8535222|NCT03610334|9567805|FG004|STARTED|Period 8: 30.0mg (Day 1 to 14)||6
8535223|NCT03610334|9567806|FG005|STARTED|Period 8: 30.0mg (Day 1 to 14)||2
8535224|NCT03610334|9567807|FG006|STARTED|Period 8: 30.0mg (Day 1 to 14)||6
8535225|NCT03610334|9567808|FG007|STARTED|Period 8: 30.0mg (Day 1 to 14)||2
8535226|NCT03610334|9567809|FG008|STARTED|Period 8: 30.0mg (Day 1 to 14)||6
8535227|NCT03610334|9567810|FG009|STARTED|Period 8: 30.0mg (Day 1 to 14)||2
8535228|NCT03610334|9567811|FG010|STARTED|Period 8: 30.0mg (Day 1 to 14)||6
8535229|NCT03610334|9567812|FG011|STARTED|Period 8: 30.0mg (Day 1 to 14)||2
8535230|NCT03610334|9567813|FG012|STARTED|Period 8: 30.0mg (Day 1 to 14)||6
8535231|NCT03610334|9567814|FG013|STARTED|Period 8: 30.0mg (Day 1 to 14)||2
8535232|NCT03610334|9567815|FG014|STARTED|Period 8: 30.0mg (Day 1 to 14)||6
8535233|NCT03610334|9567816|FG015|STARTED|Period 8: 30.0mg (Day 1 to 14)||2
8535234|NCT03610334|9567817|FG016|STARTED|Period 8: 30.0mg (Day 1 to 14)||0
8535235|NCT03610334|9567818|FG017|STARTED|Period 8: 30.0mg (Day 1 to 14)||0
8535236|NCT03610334|9567801|FG000|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||6
8535237|NCT03610334|9567802|FG001|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||2
8535238|NCT03610334|9567803|FG002|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||6
8535239|NCT03610334|9567804|FG003|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||2
8535240|NCT03610334|9567805|FG004|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||6
8535241|NCT03610334|9567806|FG005|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||2
8535242|NCT03610334|9567807|FG006|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||6
8535243|NCT03610334|9567808|FG007|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||2
8535244|NCT03610334|9567809|FG008|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||6
8535245|NCT03610334|9567810|FG009|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||2
8535246|NCT03610334|9567811|FG010|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||6
8535247|NCT03610334|9567812|FG011|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||2
8535248|NCT03610334|9567813|FG012|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||6
8535249|NCT03610334|9567814|FG013|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||2
8535250|NCT03610334|9567815|FG014|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||6
8535251|NCT03610334|9567816|FG015|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||2
8535252|NCT03610334|9567817|FG016|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
8535253|NCT03610334|9567818|FG017|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
8535254|NCT03610334|9567801|FG000|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
8535255|NCT03610334|9567802|FG001|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
8535256|NCT03610334|9567803|FG002|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
8535257|NCT03610334|9567804|FG003|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
8535258|NCT03610334|9567805|FG004|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
8535259|NCT03610334|9567806|FG005|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
8535260|NCT03610334|9567807|FG006|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
8535261|NCT03610334|9567808|FG007|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
8535262|NCT03610334|9567809|FG008|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
8535263|NCT03610334|9567810|FG009|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
8535264|NCT03610334|9567811|FG010|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
8535265|NCT03610334|9567812|FG011|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
8535266|NCT03610334|9567813|FG012|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
8535267|NCT03610334|9567814|FG013|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
8535268|NCT03610334|9567815|FG014|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
8535269|NCT03610334|9567816|FG015|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
8535270|NCT03610334|9567817|FG016|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
8535271|NCT03610334|9567818|FG017|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
8535272|NCT03610334|9567801|FG000|STARTED|Period 9: 50.0mg (Day 1 to 14)||6
8535273|NCT03610334|9567802|FG001|STARTED|Period 9: 50.0mg (Day 1 to 14)||2
8535274|NCT03610334|9567803|FG002|STARTED|Period 9: 50.0mg (Day 1 to 14)||6
8535275|NCT03610334|9567804|FG003|STARTED|Period 9: 50.0mg (Day 1 to 14)||2
8535276|NCT03610334|9567805|FG004|STARTED|Period 9: 50.0mg (Day 1 to 14)||6
8535277|NCT03610334|9567806|FG005|STARTED|Period 9: 50.0mg (Day 1 to 14)||2
8535278|NCT03610334|9567807|FG006|STARTED|Period 9: 50.0mg (Day 1 to 14)||6
8535279|NCT03610334|9567808|FG007|STARTED|Period 9: 50.0mg (Day 1 to 14)||2
8535280|NCT03610334|9567809|FG008|STARTED|Period 9: 50.0mg (Day 1 to 14)||6
8535281|NCT03610334|9567810|FG009|STARTED|Period 9: 50.0mg (Day 1 to 14)||2
8535282|NCT03610334|9567811|FG010|STARTED|Period 9: 50.0mg (Day 1 to 14)||6
8535283|NCT03610334|9567812|FG011|STARTED|Period 9: 50.0mg (Day 1 to 14)||2
8535284|NCT03610334|9567813|FG012|STARTED|Period 9: 50.0mg (Day 1 to 14)||6
8535285|NCT03610334|9567814|FG013|STARTED|Period 9: 50.0mg (Day 1 to 14)||2
8535286|NCT03610334|9567815|FG014|STARTED|Period 9: 50.0mg (Day 1 to 14)||6
8535287|NCT03610334|9567816|FG015|STARTED|Period 9: 50.0mg (Day 1 to 14)||2
8535288|NCT03610334|9567817|FG016|STARTED|Period 9: 50.0mg (Day 1 to 14)||6
8535289|NCT03610334|9567818|FG017|STARTED|Period 9: 50.0mg (Day 1 to 14)||2
8535290|NCT03610334|9567801|FG000|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||6
8535291|NCT03610334|9567802|FG001|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||2
8535292|NCT03610334|9567803|FG002|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||6
8535293|NCT03610334|9567804|FG003|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||2
8535294|NCT03610334|9567805|FG004|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||6
8535295|NCT03610334|9567806|FG005|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||2
8535296|NCT03610334|9567807|FG006|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||6
8535297|NCT03610334|9567808|FG007|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||2
8535298|NCT03610334|9567809|FG008|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||6
8535299|NCT03610334|9567810|FG009|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||2
8535300|NCT03610334|9567811|FG010|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||6
8535301|NCT03610334|9567812|FG011|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||2
8535302|NCT03610334|9567813|FG012|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||6
8535303|NCT03610334|9567814|FG013|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||2
8535304|NCT03610334|9567815|FG014|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||6
8535305|NCT03610334|9567816|FG015|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||2
8535306|NCT03610334|9567817|FG016|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||6
8535307|NCT03610334|9567818|FG017|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||2
8535308|NCT03610334|9567801|FG000|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
8535309|NCT03610334|9567802|FG001|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
8535310|NCT03610334|9567803|FG002|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
8535311|NCT03610334|9567804|FG003|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
8535312|NCT03610334|9567805|FG004|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
8535313|NCT03610334|9567806|FG005|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
8535314|NCT03610334|9567807|FG006|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
8535315|NCT03610334|9567808|FG007|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
8535316|NCT03610334|9567809|FG008|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
8535317|NCT03610334|9567810|FG009|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
8535318|NCT03610334|9567811|FG010|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
8535319|NCT03610334|9567812|FG011|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
8535320|NCT03610334|9567813|FG012|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
8535321|NCT03610334|9567814|FG013|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
8535322|NCT03610334|9567815|FG014|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
8535323|NCT03610334|9567816|FG015|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
8535324|NCT03610334|9567817|FG016|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
8535325|NCT03610334|9567818|FG017|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
8535326|NCT03334539|9567868|FG000|STARTED|Overall Study||50
8535327|NCT03334539|9567869|FG001|STARTED|Overall Study||50
8535328|NCT03334539|9567870|FG002|STARTED|Overall Study||50
8535329|NCT03334539|9567868|FG000|COMPLETED|Overall Study||46
8535330|NCT03334539|9567869|FG001|COMPLETED|Overall Study||43
8535331|NCT03334539|9567870|FG002|COMPLETED|Overall Study||49
8535332|NCT03334539|9567868|FG000|NOT COMPLETED|Overall Study||4
8535333|NCT03334539|9567869|FG001|NOT COMPLETED|Overall Study||7
8535334|NCT03334539|9567870|FG002|NOT COMPLETED|Overall Study||1
8535335|NCT03311854|9567883|FG000|STARTED|Overall Study||14
8535336|NCT03311854|9567883|FG000|COMPLETED|Overall Study||14
8535337|NCT03311854|9567883|FG000|NOT COMPLETED|Overall Study||0
8535338|NCT03269344|9567892|FG000|STARTED|Overall Study||33
8535339|NCT03269344|9567893|FG001|STARTED|Overall Study||32
8535340|NCT03269344|9567892|FG000|COMPLETED|Overall Study||29
8535341|NCT03269344|9567893|FG001|COMPLETED|Overall Study||29
8535342|NCT03269344|9567892|FG000|NOT COMPLETED|Overall Study||4
8535343|NCT03269344|9567893|FG001|NOT COMPLETED|Overall Study||3
8535344|NCT03079284|9567899|FG000|STARTED|Overall Study||10
8535345|NCT03079284|9567899|FG000|COMPLETED|Overall Study||10
8535346|NCT03079284|9567899|FG000|NOT COMPLETED|Overall Study||0
8535347|NCT03076775|9567907|FG000|STARTED|Overall Study||44
8535348|NCT03076775|9567908|FG001|STARTED|Overall Study||42
8535349|NCT03076775|9567907|FG000|Neonates Born During Study|Overall Study||43
8535350|NCT03076775|9567908|FG001|Neonates Born During Study|Overall Study||42
8535351|NCT03076775|9567907|FG000|Umbilical Cord Blood Collected|Overall Study||33
8535352|NCT03076775|9567908|FG001|Umbilical Cord Blood Collected|Overall Study||38
8535353|NCT03076775|9567907|FG000|COMPLETED|Overall Study||43
8535354|NCT03076775|9567908|FG001|COMPLETED|Overall Study||42
8535355|NCT03076775|9567907|FG000|NOT COMPLETED|Overall Study||1
8535356|NCT03076775|9567908|FG001|NOT COMPLETED|Overall Study||0
8535357|NCT02933944|9567918|FG000|STARTED|Overall Study||6
8535358|NCT02933944|9567918|FG000|COMPLETED|Overall Study||6
8535359|NCT02933944|9567918|FG000|NOT COMPLETED|Overall Study||0
8535360|NCT02921997|9567927|FG000|STARTED|Overall Study||10
8535361|NCT02921997|9567928|FG001|STARTED|Overall Study||10
8535362|NCT02921997|9567929|FG002|STARTED|Overall Study||10
8535363|NCT02921997|9567927|FG000|COMPLETED|Overall Study||10
8535364|NCT02921997|9567928|FG001|COMPLETED|Overall Study||10
8535365|NCT02921997|9567929|FG002|COMPLETED|Overall Study||10
8535366|NCT02921997|9567927|FG000|NOT COMPLETED|Overall Study||0
8535367|NCT02921997|9567928|FG001|NOT COMPLETED|Overall Study||0
8535368|NCT02921997|9567929|FG002|NOT COMPLETED|Overall Study||0
8535369|NCT02833935|9567941|FG000|STARTED|Overall Study||12
8535370|NCT02833935|9567942|FG001|STARTED|Overall Study||12
8535371|NCT02833935|9567941|FG000|COMPLETED|Overall Study||10
8535372|NCT02833935|9567942|FG001|COMPLETED|Overall Study||12
8535373|NCT02833935|9567941|FG000|NOT COMPLETED|Overall Study||2
8535374|NCT02833935|9567942|FG001|NOT COMPLETED|Overall Study||0
8565202|NCT00065429|9597289|FG002|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
8565203|NCT00065429|9597290|FG003|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
8565204|NCT00065429|9597291|FG004|STARTED|Phase II - Apr 2003 - Aug 2008|All 32 patients enrolled in Phase 2 were at 60 mg/m2.|32
8565205|NCT00065429|9597292|FG005|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
8565206|NCT00065429|9597293|FG006|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
8565207|NCT00065429|9597287|FG000|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
8565208|NCT00065429|9597288|FG001|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
8565209|NCT00065429|9597289|FG002|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
8565210|NCT00065429|9597290|FG003|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
8565211|NCT00065429|9597291|FG004|COMPLETED|Phase II - Apr 2003 - Aug 2008||26
8565212|NCT00065429|9597292|FG005|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
8565213|NCT00065429|9597293|FG006|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
8565214|NCT00065429|9597287|FG000|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
8565215|NCT00065429|9597288|FG001|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
8565216|NCT00065429|9597289|FG002|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
8565217|NCT00065429|9597290|FG003|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
8565218|NCT00065429|9597291|FG004|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||6
8565219|NCT00065429|9597292|FG005|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
8565220|NCT00065429|9597293|FG006|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
8565221|NCT00065442|9597306|FG000|STARTED|Overall Study||171
8565222|NCT00065442|9597307|FG001|STARTED|Overall Study||341
8565223|NCT00065442|9597306|FG000|COMPLETED|Overall Study||46
8565224|NCT00065442|9597307|FG001|COMPLETED|Overall Study||121
8565225|NCT00065442|9597306|FG000|NOT COMPLETED|Overall Study||125
8565226|NCT00065442|9597307|FG001|NOT COMPLETED|Overall Study||220
8535375|NCT02660827|9567948|FG000|STARTED|From Study to End of Continued Access||151
8535376|NCT02660827|9567948|FG000|COMPLETED|From Study to End of Continued Access||120
8535377|NCT02660827|9567948|FG000|NOT COMPLETED|From Study to End of Continued Access||31
8535378|NCT02660827|9567948|FG000|STARTED|Period 1: Study Period||151
8535379|NCT02660827|9567948|FG000|COMPLETED|Period 1: Study Period||150
8535380|NCT02660827|9567948|FG000|NOT COMPLETED|Period 1: Study Period||1
8535381|NCT02660827|9567948|FG000|STARTED|Period 2: Continued Access Period||145
8535382|NCT02660827|9567948|FG000|COMPLETED|Period 2: Continued Access Period||120
8535383|NCT02660827|9567948|FG000|NOT COMPLETED|Period 2: Continued Access Period||25
8535384|NCT02627963|9567957|FG000|STARTED|Overall Study||175
8535385|NCT02627963|9567958|FG001|STARTED|Overall Study||175
8535386|NCT02627963|9567957|FG000|COMPLETED|Overall Study||139
8535387|NCT02627963|9567958|FG001|COMPLETED|Overall Study||161
8535388|NCT02627963|9567957|FG000|NOT COMPLETED|Overall Study||36
8535389|NCT02627963|9567958|FG001|NOT COMPLETED|Overall Study||14
8535390|NCT02425644|9567966|FG000|STARTED|Overall Study||567
8535391|NCT02425644|9567967|FG001|STARTED|Overall Study||566
8535392|NCT02425644|9567966|FG000|Treated|Overall Study||565
8535393|NCT02425644|9567967|FG001|Treated|Overall Study||566
8535394|NCT02425644|9567966|FG000|COMPLETED|Overall Study||490
8535395|NCT02425644|9567967|FG001|COMPLETED|Overall Study||495
8535396|NCT02425644|9567966|FG000|NOT COMPLETED|Overall Study||77
8535397|NCT02425644|9567967|FG001|NOT COMPLETED|Overall Study||71
8535398|NCT02395614|9567973|FG000|STARTED|Overall Study||88
8535399|NCT02395614|9567973|FG000|Chlorhexidine Irrigation|Overall Study||88
8535400|NCT02395614|9567973|FG000|Triple Antibiotic Irrigation|Overall Study||88
8535401|NCT02395614|9567973|FG000|COMPLETED|Overall Study||88
8535402|NCT02395614|9567973|FG000|NOT COMPLETED|Overall Study||0
8535403|NCT02340221|9567980|FG000|STARTED|Overall Study||214
8535404|NCT02340221|9567981|FG001|STARTED|Overall Study||417
8535405|NCT02340221|9567980|FG000|COMPLETED|Overall Study||0
8535406|NCT02340221|9567981|FG001|COMPLETED|Overall Study||0
8535407|NCT02340221|9567980|FG000|NOT COMPLETED|Overall Study||214
8535408|NCT02340221|9567981|FG001|NOT COMPLETED|Overall Study||417
8535409|NCT02270957|9567990|FG000|STARTED|Overall Study||31
8535410|NCT02270957|9567991|FG001|STARTED|Overall Study||35
8535411|NCT02270957|9567990|FG000|COMPLETED|Overall Study||27
8535412|NCT02270957|9567991|FG001|COMPLETED|Overall Study||31
8535413|NCT02270957|9567990|FG000|NOT COMPLETED|Overall Study||4
8535414|NCT02270957|9567991|FG001|NOT COMPLETED|Overall Study||4
8535415|NCT02134925|9568000|FG000|STARTED|Overall Study||54
8535416|NCT02134925|9568001|FG001|STARTED|Overall Study||56
8535417|NCT02134925|9568000|FG000|Received at Least One Dose of Treatment|Overall Study||53
8535418|NCT02134925|9568001|FG001|Received at Least One Dose of Treatment|Overall Study||50
8535419|NCT02134925|9568000|FG000|COMPLETED|Overall Study||52
8535420|NCT02134925|9568001|FG001|COMPLETED|Overall Study||50
8535421|NCT02134925|9568000|FG000|NOT COMPLETED|Overall Study||2
8535422|NCT02134925|9568001|FG001|NOT COMPLETED|Overall Study||6
8535423|NCT02054104|9568009|FG000|STARTED|Overall Study||10
8535424|NCT02054104|9568010|FG001|STARTED|Overall Study||11
8535425|NCT02054104|9568009|FG000|COMPLETED|Overall Study||2
8535426|NCT02054104|9568010|FG001|COMPLETED|Overall Study||2
8535427|NCT02054104|9568009|FG000|NOT COMPLETED|Overall Study||8
8535428|NCT02054104|9568010|FG001|NOT COMPLETED|Overall Study||9
8535429|NCT01899144|9568016|FG000|STARTED|Treatment Period 1||61
8535430|NCT01899144|9568016|FG000|COMPLETED|Treatment Period 1||61
8535431|NCT01899144|9568016|FG000|NOT COMPLETED|Treatment Period 1||0
8535432|NCT01899144|9568016|FG000|STARTED|Treatment Period 2||61
8535433|NCT01899144|9568016|FG000|COMPLETED|Treatment Period 2|Last treatment taken by the patient who discontinued was placebo.|60
8535434|NCT01899144|9568016|FG000|NOT COMPLETED|Treatment Period 2||1
8535435|NCT01899144|9568016|FG000|STARTED|Treatment Period 3||60
8535436|NCT01899144|9568016|FG000|COMPLETED|Treatment Period 3|Last treatment taken by patients who discontinued were ABS Spiromax 180 mcg and ABS Spiromax 90 mcg.|58
8535437|NCT01899144|9568016|FG000|NOT COMPLETED|Treatment Period 3||2
8535438|NCT01899144|9568016|FG000|STARTED|Treatment Period 4||58
8535439|NCT01899144|9568016|FG000|COMPLETED|Treatment Period 4||58
8535440|NCT01899144|9568016|FG000|NOT COMPLETED|Treatment Period 4||0
8535441|NCT01899144|9568016|FG000|STARTED|Treatment Period 5||58
8535442|NCT01899144|9568016|FG000|COMPLETED|Treatment Period 5|Last treatment taken by the patient who discontinued was ABS Spiromax 180 mcg.|57
8535443|NCT01899144|9568016|FG000|NOT COMPLETED|Treatment Period 5||1
8535444|NCT01793610|9568031|FG000|STARTED|Overall Study||6
8535445|NCT01793610|9568032|FG001|STARTED|Overall Study||9
8535446|NCT01793610|9568033|FG002|STARTED|Overall Study||13
8535447|NCT01793610|9568031|FG000|COMPLETED|Overall Study||5
8535448|NCT01793610|9568032|FG001|COMPLETED|Overall Study||9
8535449|NCT01793610|9568033|FG002|COMPLETED|Overall Study||12
8535450|NCT01793610|9568031|FG000|NOT COMPLETED|Overall Study||1
8535451|NCT01793610|9568032|FG001|NOT COMPLETED|Overall Study||0
8535452|NCT01793610|9568033|FG002|NOT COMPLETED|Overall Study||1
8535453|NCT01757665|9568047|FG000|STARTED|Overall Study||694
8535454|NCT01757665|9568048|FG001|STARTED|Overall Study||83
8535455|NCT01757665|9568047|FG000|Implanted With Device|Overall Study||689
8535456|NCT01757665|9568048|FG001|Implanted With Device|Overall Study||82
8535457|NCT01757665|9568047|FG000|COMPLETED|Overall Study||0
8535458|NCT01757665|9568048|FG001|COMPLETED|Overall Study||0
8535459|NCT01757665|9568047|FG000|NOT COMPLETED|Overall Study||694
8535460|NCT01757665|9568048|FG001|NOT COMPLETED|Overall Study||83
8535461|NCT01482195|9568069|FG000|STARTED|Overall Study||6
8535462|NCT01482195|9568069|FG000|One Year Results|Overall Study||6
8535463|NCT01482195|9568069|FG000|COMPLETED|Overall Study||6
8535464|NCT01482195|9568069|FG000|NOT COMPLETED|Overall Study||0
8535465|NCT01468831|9568076|FG000|STARTED|Overall Study||4
8535466|NCT01468831|9568077|FG001|STARTED|Overall Study||5
8535467|NCT01468831|9568076|FG000|Month 12 (Primary Outcome)|Overall Study||4
8535468|NCT01468831|9568077|FG001|Month 12 (Primary Outcome)|Overall Study||4
8535469|NCT01468831|9568076|FG000|COMPLETED|Overall Study||4
8535470|NCT01468831|9568077|FG001|COMPLETED|Overall Study||4
8535471|NCT01468831|9568076|FG000|NOT COMPLETED|Overall Study||0
8535472|NCT01468831|9568077|FG001|NOT COMPLETED|Overall Study||1
8535473|NCT01383109|9568083|FG000|STARTED|Overall Study||6
8535474|NCT01383109|9568083|FG000|COMPLETED|Overall Study||6
8535475|NCT01383109|9568083|FG000|NOT COMPLETED|Overall Study||0
8535476|NCT00822120|9568089|FG000|STARTED|Initial Registration||358
8535477|NCT00822120|9568090|FG001|STARTED|Initial Registration||13
8535478|NCT00822120|9568091|FG002|STARTED|Initial Registration||0
8535479|NCT00822120|9568092|FG003|STARTED|Initial Registration||0
8535480|NCT00822120|9568093|FG004|STARTED|Initial Registration||0
8535481|NCT00822120|9568094|FG005|STARTED|Initial Registration||0
8535482|NCT00822120|9568089|FG000|Eligible and Evaluable Patients|Initial Registration||336
8535483|NCT00822120|9568090|FG001|Eligible and Evaluable Patients|Initial Registration||12
8535484|NCT00822120|9568091|FG002|Eligible and Evaluable Patients|Initial Registration||0
8535485|NCT00822120|9568092|FG003|Eligible and Evaluable Patients|Initial Registration||0
8535486|NCT00822120|9568093|FG004|Eligible and Evaluable Patients|Initial Registration||0
8535487|NCT00822120|9568094|FG005|Eligible and Evaluable Patients|Initial Registration||0
8535488|NCT00822120|9568089|FG000|COMPLETED|Initial Registration||332
8535489|NCT00822120|9568090|FG001|COMPLETED|Initial Registration||12
8535490|NCT00822120|9568091|FG002|COMPLETED|Initial Registration||0
8535491|NCT00822120|9568092|FG003|COMPLETED|Initial Registration||0
8535492|NCT00822120|9568093|FG004|COMPLETED|Initial Registration||0
8535493|NCT00822120|9568094|FG005|COMPLETED|Initial Registration||0
8535494|NCT00822120|9568089|FG000|NOT COMPLETED|Initial Registration||26
8535495|NCT00822120|9568090|FG001|NOT COMPLETED|Initial Registration||1
8535496|NCT00822120|9568091|FG002|NOT COMPLETED|Initial Registration||0
8535497|NCT00822120|9568092|FG003|NOT COMPLETED|Initial Registration||0
8535498|NCT00822120|9568093|FG004|NOT COMPLETED|Initial Registration||0
8535499|NCT00822120|9568094|FG005|NOT COMPLETED|Initial Registration||0
8535500|NCT00822120|9568089|FG000|STARTED|PET-directed Therapy||0
8535501|NCT00822120|9568090|FG001|STARTED|PET-directed Therapy||0
8535502|NCT00822120|9568091|FG002|STARTED|PET-directed Therapy||270
8535503|NCT00822120|9568092|FG003|STARTED|PET-directed Therapy||55
8535504|NCT00822120|9568093|FG004|STARTED|PET-directed Therapy||10
8535505|NCT00822120|9568094|FG005|STARTED|PET-directed Therapy||1
8535506|NCT00822120|9568089|FG000|Eligibile and Evaluable Patients|PET-directed Therapy||0
8535507|NCT00822120|9568090|FG001|Eligibile and Evaluable Patients|PET-directed Therapy||0
8535508|NCT00822120|9568091|FG002|Eligibile and Evaluable Patients|PET-directed Therapy||270
8535509|NCT00822120|9568092|FG003|Eligibile and Evaluable Patients|PET-directed Therapy||55
8535510|NCT00822120|9568093|FG004|Eligibile and Evaluable Patients|PET-directed Therapy||10
8535511|NCT00822120|9568094|FG005|Eligibile and Evaluable Patients|PET-directed Therapy||1
8535512|NCT00822120|9568089|FG000|COMPLETED|PET-directed Therapy||0
8535513|NCT00822120|9568090|FG001|COMPLETED|PET-directed Therapy||0
8535514|NCT00822120|9568091|FG002|COMPLETED|PET-directed Therapy||270
8535515|NCT00822120|9568092|FG003|COMPLETED|PET-directed Therapy||45
8535516|NCT00822120|9568093|FG004|COMPLETED|PET-directed Therapy||10
8535517|NCT00822120|9568094|FG005|COMPLETED|PET-directed Therapy||1
8535518|NCT00822120|9568089|FG000|NOT COMPLETED|PET-directed Therapy||0
8535519|NCT00822120|9568090|FG001|NOT COMPLETED|PET-directed Therapy||0
8535520|NCT00822120|9568091|FG002|NOT COMPLETED|PET-directed Therapy||0
8535521|NCT00822120|9568092|FG003|NOT COMPLETED|PET-directed Therapy||10
8535522|NCT00822120|9568093|FG004|NOT COMPLETED|PET-directed Therapy||0
8535523|NCT00822120|9568094|FG005|NOT COMPLETED|PET-directed Therapy||0
8535524|NCT00603954|9568117|FG000|STARTED|Overall Study|5 patients in Screening failure between inclusion and transplantation|50
8535525|NCT00603954|9568118|FG001|STARTED|Overall Study|5 patients in Screening failure between inclusion and transplantation|47
8535526|NCT00603954|9568117|FG000|COMPLETED|Overall Study||49
8535527|NCT00603954|9568118|FG001|COMPLETED|Overall Study||45
8535528|NCT00603954|9568117|FG000|NOT COMPLETED|Overall Study||1
8535529|NCT00603954|9568118|FG001|NOT COMPLETED|Overall Study||2
8565227|NCT00065468|9597316|FG000|STARTED|Overall Study||207
8565228|NCT00065468|9597317|FG001|STARTED|Overall Study||209
8565229|NCT00065468|9597318|FG002|STARTED|Overall Study||210
8565230|NCT00065468|9597316|FG000|Received Treatment|Overall Study||200
8565231|NCT00065468|9597317|FG001|Received Treatment|Overall Study||208
8565232|NCT00065468|9597318|FG002|Received Treatment|Overall Study||208
8565233|NCT00065468|9597316|FG000|COMPLETED|Overall Study||0
8565234|NCT00065468|9597317|FG001|COMPLETED|Overall Study||0
8565235|NCT00065468|9597318|FG002|COMPLETED|Overall Study||0
8565236|NCT00065468|9597316|FG000|NOT COMPLETED|Overall Study||207
8565237|NCT00065468|9597317|FG001|NOT COMPLETED|Overall Study||209
8565238|NCT00065468|9597318|FG002|NOT COMPLETED|Overall Study||210
8565239|NCT00065507|9597328|FG000|STARTED|Overall Study|101 participants were randomized; 1 never treated.|100
8565240|NCT00065507|9597329|FG001|STARTED|Overall Study|94 participants were randomized; 3 never treated.|91
8535530|NCT05087524|9568125|FG000|STARTED|Overall Study||65
8535531|NCT05087524|9568125|FG000|COMPLETED|Overall Study||65
8535532|NCT05087524|9568125|FG000|NOT COMPLETED|Overall Study||0
8535533|NCT04532294|9568132|FG000|STARTED|Overall Study||4
8535534|NCT04532294|9568133|FG001|STARTED|Overall Study||6
8535535|NCT04532294|9568134|FG002|STARTED|Overall Study||8
8535536|NCT04532294|9568132|FG000|COMPLETED|Overall Study||4
8535537|NCT04532294|9568133|FG001|COMPLETED|Overall Study||6
8535538|NCT04532294|9568134|FG002|COMPLETED|Overall Study||5
8535539|NCT04532294|9568132|FG000|NOT COMPLETED|Overall Study||0
8535540|NCT04532294|9568133|FG001|NOT COMPLETED|Overall Study||0
8535541|NCT04532294|9568134|FG002|NOT COMPLETED|Overall Study||3
8535542|NCT04250077|9568147|FG000|STARTED|Overall Study||15
8535543|NCT04250077|9568148|FG001|STARTED|Overall Study||15
8535544|NCT04250077|9568149|FG002|STARTED|Overall Study||15
8535545|NCT04250077|9568147|FG000|COMPLETED|Overall Study||13
8535546|NCT04250077|9568148|FG001|COMPLETED|Overall Study||11
8535547|NCT04250077|9568149|FG002|COMPLETED|Overall Study||15
8535548|NCT04250077|9568147|FG000|NOT COMPLETED|Overall Study||2
8535549|NCT04250077|9568148|FG001|NOT COMPLETED|Overall Study||4
8535550|NCT04250077|9568149|FG002|NOT COMPLETED|Overall Study||0
8535551|NCT04068142|9568161|FG000|STARTED|Overall Study||17
8535552|NCT04068142|9568162|FG001|STARTED|Overall Study||20
8535553|NCT04068142|9568161|FG000|COMPLETED|Overall Study||15
8535554|NCT04068142|9568162|FG001|COMPLETED|Overall Study||16
8535555|NCT04068142|9568161|FG000|NOT COMPLETED|Overall Study||2
8535556|NCT04068142|9568162|FG001|NOT COMPLETED|Overall Study||4
8620937|NCT00476996|9659818|FG000|NOT COMPLETED|Blinded Treatment Phase (up to Week 48)||72
8816536|NCT01544595|9870076|FG004|STARTED|Status at Week 68|These patients were not in the study arms at this time point.|0
8816537|NCT01544595|9870077|FG005|STARTED|Status at Week 68|These patients were not in the study arms at this time point.|0
8816538|NCT01544595|9870072|FG000|COMPLETED|Status at Week 68||262
8535557|NCT03961009|9568168|FG000|STARTED|Overall Study||47
8535558|NCT03961009|9568168|FG000|COMPLETED|Overall Study||47
8535559|NCT03961009|9568168|FG000|NOT COMPLETED|Overall Study||0
8535560|NCT03875495|9568172|FG000|STARTED|Overall Study||3
8535561|NCT03875495|9568172|FG000|COMPLETED|Overall Study||0
8535562|NCT03875495|9568172|FG000|NOT COMPLETED|Overall Study||3
8535563|NCT03702439|9568176|FG000|STARTED|Overall Study||408
8535564|NCT03702439|9568176|FG000|COMPLETED|Overall Study||408
8535565|NCT03702439|9568176|FG000|NOT COMPLETED|Overall Study||0
8535566|NCT03687190|9568184|FG000|STARTED|Overall Study||12
8535567|NCT03687190|9568185|FG001|STARTED|Overall Study||9
8535568|NCT03687190|9568184|FG000|COMPLETED|Overall Study||12
8535569|NCT03687190|9568185|FG001|COMPLETED|Overall Study||9
8535570|NCT03687190|9568184|FG000|NOT COMPLETED|Overall Study||0
8535571|NCT03687190|9568185|FG001|NOT COMPLETED|Overall Study||0
8816539|NCT01544595|9870073|FG001|COMPLETED|Status at Week 68||346
8816540|NCT01544595|9870074|FG002|COMPLETED|Status at Week 68||87
8816541|NCT01544595|9870075|FG003|COMPLETED|Status at Week 68||130
8816542|NCT01544595|9870076|FG004|COMPLETED|Status at Week 68|These patients were not in the study arms at this time point.|0
8816543|NCT01544595|9870077|FG005|COMPLETED|Status at Week 68|These patients were not in the study arms at this time point.|0
8816544|NCT01544595|9870072|FG000|NOT COMPLETED|Status at Week 68||39
8816545|NCT01544595|9870073|FG001|NOT COMPLETED|Status at Week 68||17
8816546|NCT01544595|9870074|FG002|NOT COMPLETED|Status at Week 68||63
8816547|NCT01544595|9870075|FG003|NOT COMPLETED|Status at Week 68||51
8816548|NCT01544595|9870076|FG004|NOT COMPLETED|Status at Week 68||0
8816549|NCT01544595|9870077|FG005|NOT COMPLETED|Status at Week 68||0
8816550|NCT01544595|9870072|FG000|STARTED|Status at Week 156||301
8816551|NCT01544595|9870073|FG001|STARTED|Status at Week 156||363
8816552|NCT01544595|9870074|FG002|STARTED|Status at Week 156||150
8816553|NCT01544595|9870075|FG003|STARTED|Status at Week 156||181
8816554|NCT01544595|9870076|FG004|STARTED|Status at Week 156||98
8816555|NCT01544595|9870077|FG005|STARTED|Status at Week 156||53
8816556|NCT01544595|9870072|FG000|COMPLETED|Status at Week 156||184
8816557|NCT01544595|9870073|FG001|COMPLETED|Status at Week 156||285
8816558|NCT01544595|9870074|FG002|COMPLETED|Status at Week 156||10
8816559|NCT01544595|9870075|FG003|COMPLETED|Status at Week 156||15
8816560|NCT01544595|9870076|FG004|COMPLETED|Status at Week 156||60
8816561|NCT01544595|9870077|FG005|COMPLETED|Status at Week 156||38
8816562|NCT01544595|9870072|FG000|NOT COMPLETED|Status at Week 156||117
8816563|NCT01544595|9870073|FG001|NOT COMPLETED|Status at Week 156||78
8816564|NCT01544595|9870074|FG002|NOT COMPLETED|Status at Week 156||140
8535572|NCT03583931|9568193|FG000|STARTED|Overall Study||5
8535573|NCT03583931|9568194|FG001|STARTED|Overall Study||5
8535574|NCT03583931|9568193|FG000|COMPLETED|Overall Study||5
8535575|NCT03583931|9568194|FG001|COMPLETED|Overall Study||5
8535576|NCT03583931|9568193|FG000|NOT COMPLETED|Overall Study||0
8535577|NCT03583931|9568194|FG001|NOT COMPLETED|Overall Study||0
8535578|NCT03505710|9568203|FG000|STARTED|Overall Study||49
8535579|NCT03505710|9568204|FG001|STARTED|Overall Study||41
8535580|NCT03505710|9568205|FG002|STARTED|Overall Study||91
8535581|NCT03505710|9568203|FG000|COMPLETED|Overall Study||2
8535582|NCT03505710|9568204|FG001|COMPLETED|Overall Study||14
8535583|NCT03505710|9568205|FG002|COMPLETED|Overall Study||15
8535584|NCT03505710|9568203|FG000|NOT COMPLETED|Overall Study||47
8535585|NCT03505710|9568204|FG001|NOT COMPLETED|Overall Study||27
8535586|NCT03505710|9568205|FG002|NOT COMPLETED|Overall Study||76
8620938|NCT00476996|9659819|FG001|NOT COMPLETED|Blinded Treatment Phase (up to Week 48)||55
8535587|NCT03296553|9568215|FG000|STARTED|Overall Study||20
8535588|NCT03296553|9568216|FG001|STARTED|Overall Study||20
8535589|NCT03296553|9568215|FG000|COMPLETED|Overall Study||18
8535590|NCT03296553|9568216|FG001|COMPLETED|Overall Study||19
8535591|NCT03296553|9568215|FG000|NOT COMPLETED|Overall Study||2
8535592|NCT03296553|9568216|FG001|NOT COMPLETED|Overall Study||1
8535593|NCT03148795|9568222|FG000|STARTED|Overall Study||128
8535594|NCT03148795|9568222|FG000|Treated|Overall Study||127
8535595|NCT03148795|9568222|FG000|COMPLETED|Overall Study||0
8535596|NCT03148795|9568222|FG000|NOT COMPLETED|Overall Study||128
8535597|NCT03049449|9568234|FG000|STARTED|Overall Study||0
8535598|NCT03049449|9568235|FG001|STARTED|Overall Study||3
8535599|NCT03049449|9568236|FG002|STARTED|Overall Study|One participant was enrolled and removed from study with no treatment and was later re-enrolled and treated.|4
8535600|NCT03049449|9568237|FG003|STARTED|Overall Study|One participant was enrolled and removed from study with no treatment and was later re-enrolled and treated.|8
8535601|NCT03049449|9568238|FG004|STARTED|Overall Study||5
8535602|NCT03049449|9568239|FG005|STARTED|Overall Study||0
8535603|NCT03049449|9568240|FG006|STARTED|Overall Study||3
8535604|NCT03049449|9568241|FG007|STARTED|Overall Study||1
8535605|NCT03049449|9568242|FG008|STARTED|Overall Study||1
8535606|NCT03049449|9568243|FG009|STARTED|Overall Study||1
8535607|NCT03049449|9568234|FG000|COMPLETED|Overall Study||0
8535608|NCT03049449|9568235|FG001|COMPLETED|Overall Study||3
8535609|NCT03049449|9568236|FG002|COMPLETED|Overall Study||3
8535610|NCT03049449|9568237|FG003|COMPLETED|Overall Study||7
8535611|NCT03049449|9568238|FG004|COMPLETED|Overall Study||5
8535612|NCT03049449|9568239|FG005|COMPLETED|Overall Study||0
8535613|NCT03049449|9568240|FG006|COMPLETED|Overall Study||3
8535614|NCT03049449|9568241|FG007|COMPLETED|Overall Study||0
8535615|NCT03049449|9568242|FG008|COMPLETED|Overall Study||0
8535616|NCT03049449|9568243|FG009|COMPLETED|Overall Study||0
8535617|NCT03049449|9568234|FG000|NOT COMPLETED|Overall Study||0
8535618|NCT03049449|9568235|FG001|NOT COMPLETED|Overall Study||0
8535619|NCT03049449|9568236|FG002|NOT COMPLETED|Overall Study||1
8535620|NCT03049449|9568237|FG003|NOT COMPLETED|Overall Study||1
8535621|NCT03049449|9568238|FG004|NOT COMPLETED|Overall Study||0
8535622|NCT03049449|9568239|FG005|NOT COMPLETED|Overall Study||0
8535623|NCT03049449|9568240|FG006|NOT COMPLETED|Overall Study||0
8535624|NCT03049449|9568241|FG007|NOT COMPLETED|Overall Study||1
8535625|NCT03049449|9568242|FG008|NOT COMPLETED|Overall Study||1
8535626|NCT03049449|9568243|FG009|NOT COMPLETED|Overall Study||1
8535627|NCT03000569|9568263|FG000|STARTED|Overall Study||15
8535628|NCT03000569|9568264|FG001|STARTED|Overall Study||14
8535629|NCT03000569|9568263|FG000|COMPLETED|Overall Study||14
8535630|NCT03000569|9568264|FG001|COMPLETED|Overall Study||14
8535631|NCT03000569|9568263|FG000|NOT COMPLETED|Overall Study||1
8535632|NCT03000569|9568264|FG001|NOT COMPLETED|Overall Study||0
8535633|NCT03000530|9568281|FG000|STARTED|Overall Study||13
8535634|NCT03000530|9568282|FG001|STARTED|Overall Study||44
8535635|NCT03000530|9568283|FG002|STARTED|Overall Study||45
8535636|NCT03000530|9568281|FG000|COMPLETED|Overall Study||13
8535637|NCT03000530|9568282|FG001|COMPLETED|Overall Study||39
8535638|NCT03000530|9568283|FG002|COMPLETED|Overall Study||41
8535639|NCT03000530|9568281|FG000|NOT COMPLETED|Overall Study||0
8535640|NCT03000530|9568282|FG001|NOT COMPLETED|Overall Study||5
8535641|NCT03000530|9568283|FG002|NOT COMPLETED|Overall Study||4
8535642|NCT02978781|9568297|FG000|STARTED|Part A||2
8535643|NCT02978781|9568298|FG001|STARTED|Part A||14
8535644|NCT02978781|9568299|FG002|STARTED|Part A||0
8535645|NCT02978781|9568300|FG003|STARTED|Part A||0
8535646|NCT02978781|9568301|FG004|STARTED|Part A||0
8535647|NCT02978781|9568297|FG000|COMPLETED|Part A||1
8535648|NCT02978781|9568298|FG001|COMPLETED|Part A||12
8535649|NCT02978781|9568299|FG002|COMPLETED|Part A||0
8535650|NCT02978781|9568300|FG003|COMPLETED|Part A||0
8535651|NCT02978781|9568301|FG004|COMPLETED|Part A||0
8535652|NCT02978781|9568297|FG000|NOT COMPLETED|Part A||1
8535653|NCT02978781|9568298|FG001|NOT COMPLETED|Part A||2
8535654|NCT02978781|9568299|FG002|NOT COMPLETED|Part A||0
8535655|NCT02978781|9568300|FG003|NOT COMPLETED|Part A||0
8535656|NCT02978781|9568301|FG004|NOT COMPLETED|Part A||0
8535657|NCT02978781|9568297|FG000|STARTED|Part B||0
8535658|NCT02978781|9568298|FG001|STARTED|Part B||0
8535659|NCT02978781|9568299|FG002|STARTED|Part B|Include participants who tolerated a dose ≥10 mg in Part A and achieved response on Day 8.|4
8535660|NCT02978781|9568300|FG003|STARTED|Part B|Include participants who tolerated a dose ≥10 mg in Part A and achieved response on Day 8.|4
8535661|NCT02978781|9568301|FG004|STARTED|Part B||0
8535662|NCT02978781|9568297|FG000|COMPLETED|Part B||0
8535663|NCT02978781|9568298|FG001|COMPLETED|Part B||0
8535664|NCT02978781|9568299|FG002|COMPLETED|Part B||4
8535665|NCT02978781|9568300|FG003|COMPLETED|Part B||3
8535666|NCT02978781|9568301|FG004|COMPLETED|Part B||0
8535667|NCT02978781|9568297|FG000|NOT COMPLETED|Part B||0
8535668|NCT02978781|9568298|FG001|NOT COMPLETED|Part B||0
8535669|NCT02978781|9568299|FG002|NOT COMPLETED|Part B||0
8535670|NCT02978781|9568300|FG003|NOT COMPLETED|Part B||1
8535671|NCT02978781|9568301|FG004|NOT COMPLETED|Part B||0
8535672|NCT02978781|9568297|FG000|STARTED|Part C||0
8535673|NCT02978781|9568298|FG001|STARTED|Part C||0
8535674|NCT02978781|9568299|FG002|STARTED|Part C||0
8535675|NCT02978781|9568300|FG003|STARTED|Part C||0
8535676|NCT02978781|9568301|FG004|STARTED|Part C||18
8535677|NCT02978781|9568297|FG000|COMPLETED|Part C||0
8535678|NCT02978781|9568298|FG001|COMPLETED|Part C||0
8535679|NCT02978781|9568299|FG002|COMPLETED|Part C||0
8535680|NCT02978781|9568300|FG003|COMPLETED|Part C||0
8535681|NCT02978781|9568301|FG004|COMPLETED|Part C||14
8535682|NCT02978781|9568297|FG000|NOT COMPLETED|Part C||0
8535683|NCT02978781|9568298|FG001|NOT COMPLETED|Part C||0
8535684|NCT02978781|9568299|FG002|NOT COMPLETED|Part C||0
8535685|NCT02978781|9568300|FG003|NOT COMPLETED|Part C||0
8535686|NCT02978781|9568301|FG004|NOT COMPLETED|Part C||4
8535687|NCT02964507|9568335|FG000|STARTED|Overall Study||33
8535688|NCT02964507|9568336|FG001|STARTED|Overall Study||12
8535689|NCT02964507|9568337|FG002|STARTED|Overall Study||42
8535690|NCT02964507|9568338|FG003|STARTED|Overall Study||7
8535691|NCT02964507|9568339|FG004|STARTED|Overall Study||18
8535692|NCT02964507|9568340|FG005|STARTED|Overall Study||11
8535693|NCT02964507|9568341|FG006|STARTED|Overall Study||0
8535694|NCT02964507|9568342|FG007|STARTED|Overall Study||0
8535695|NCT02964507|9568335|FG000|COMPLETED|Overall Study||7
8535696|NCT02964507|9568336|FG001|COMPLETED|Overall Study||1
8535697|NCT02964507|9568337|FG002|COMPLETED|Overall Study||17
8535698|NCT02964507|9568338|FG003|COMPLETED|Overall Study||1
8535699|NCT02964507|9568339|FG004|COMPLETED|Overall Study||2
8535700|NCT02964507|9568340|FG005|COMPLETED|Overall Study||3
8535701|NCT02964507|9568341|FG006|COMPLETED|Overall Study||0
8535702|NCT02964507|9568342|FG007|COMPLETED|Overall Study||0
8535703|NCT02964507|9568335|FG000|NOT COMPLETED|Overall Study||26
8535704|NCT02964507|9568336|FG001|NOT COMPLETED|Overall Study||11
8535705|NCT02964507|9568337|FG002|NOT COMPLETED|Overall Study||25
8535706|NCT02964507|9568338|FG003|NOT COMPLETED|Overall Study||6
8535707|NCT02964507|9568339|FG004|NOT COMPLETED|Overall Study||16
8535708|NCT02964507|9568340|FG005|NOT COMPLETED|Overall Study||8
8535709|NCT02964507|9568341|FG006|NOT COMPLETED|Overall Study||0
8535710|NCT02964507|9568342|FG007|NOT COMPLETED|Overall Study||0
8535711|NCT02942277|9568372|FG000|STARTED|Year 1||5
8535712|NCT02942277|9568373|FG001|STARTED|Year 1||10
8535713|NCT02942277|9568374|FG002|STARTED|Year 1||5
8535714|NCT02942277|9568375|FG003|STARTED|Year 1||10
8535715|NCT02942277|9568376|FG004|STARTED|Year 1||56
8535716|NCT02942277|9568377|FG005|STARTED|Year 1||61
8535717|NCT02942277|9568378|FG006|STARTED|Year 1||5
8535718|NCT02942277|9568379|FG007|STARTED|Year 1||10
8535719|NCT02942277|9568380|FG008|STARTED|Year 1||10
8535720|NCT02942277|9568381|FG009|STARTED|Year 1||10
8535721|NCT02942277|9568382|FG010|STARTED|Year 1||119
8535722|NCT02942277|9568372|FG000|COMPLETED|Year 1||5
8722930|NCT02819440|9770413|FG000|COMPLETED|Overall Study||48
8722931|NCT02819440|9770414|FG001|COMPLETED|Overall Study||52
8722932|NCT02819440|9770413|FG000|NOT COMPLETED|Overall Study||13
8722933|NCT02819440|9770414|FG001|NOT COMPLETED|Overall Study||12
8722934|NCT02782741|9770422|FG000|STARTED|Blinded Treatment Period: up to Week 49||51
8722935|NCT02782741|9770423|FG001|STARTED|Blinded Treatment Period: up to Week 49||49
8722936|NCT02782741|9770422|FG000|Safety Population|Blinded Treatment Period: up to Week 49||51
8722937|NCT02782741|9770423|FG001|Safety Population|Blinded Treatment Period: up to Week 49||49
8722938|NCT02782741|9770422|FG000|COMPLETED|Blinded Treatment Period: up to Week 49||51
8722939|NCT02782741|9770423|FG001|COMPLETED|Blinded Treatment Period: up to Week 49||44
8535723|NCT02942277|9568373|FG001|COMPLETED|Year 1||8
8535724|NCT02942277|9568374|FG002|COMPLETED|Year 1||5
8535725|NCT02942277|9568375|FG003|COMPLETED|Year 1||9
8535726|NCT02942277|9568376|FG004|COMPLETED|Year 1||49
8535727|NCT02942277|9568377|FG005|COMPLETED|Year 1||51
8535728|NCT02942277|9568378|FG006|COMPLETED|Year 1||5
8535729|NCT02942277|9568379|FG007|COMPLETED|Year 1||9
8535730|NCT02942277|9568380|FG008|COMPLETED|Year 1||10
8535731|NCT02942277|9568381|FG009|COMPLETED|Year 1||10
8535732|NCT02942277|9568382|FG010|COMPLETED|Year 1||104
8535733|NCT02942277|9568372|FG000|NOT COMPLETED|Year 1||0
8535734|NCT02942277|9568373|FG001|NOT COMPLETED|Year 1||2
8535735|NCT02942277|9568374|FG002|NOT COMPLETED|Year 1||0
8535736|NCT02942277|9568375|FG003|NOT COMPLETED|Year 1||1
8535737|NCT02942277|9568376|FG004|NOT COMPLETED|Year 1||7
8535738|NCT02942277|9568377|FG005|NOT COMPLETED|Year 1||10
8535739|NCT02942277|9568378|FG006|NOT COMPLETED|Year 1||0
8535740|NCT02942277|9568379|FG007|NOT COMPLETED|Year 1||1
8535741|NCT02942277|9568380|FG008|NOT COMPLETED|Year 1||0
8535742|NCT02942277|9568381|FG009|NOT COMPLETED|Year 1||0
8535743|NCT02942277|9568382|FG010|NOT COMPLETED|Year 1||15
8535744|NCT02942277|9568372|FG000|STARTED|Year 2||5
8535745|NCT02942277|9568373|FG001|STARTED|Year 2||8
8535746|NCT02942277|9568374|FG002|STARTED|Year 2||5
8535747|NCT02942277|9568375|FG003|STARTED|Year 2||9
8535748|NCT02942277|9568376|FG004|STARTED|Year 2||49
8535749|NCT02942277|9568377|FG005|STARTED|Year 2||51
8535750|NCT02942277|9568378|FG006|STARTED|Year 2||5
8535751|NCT02942277|9568379|FG007|STARTED|Year 2||9
8535752|NCT02942277|9568380|FG008|STARTED|Year 2||10
8535753|NCT02942277|9568381|FG009|STARTED|Year 2||10
8535754|NCT02942277|9568382|FG010|STARTED|Year 2||104
8535755|NCT02942277|9568372|FG000|COMPLETED|Year 2||5
8535756|NCT02942277|9568373|FG001|COMPLETED|Year 2||7
8535757|NCT02942277|9568374|FG002|COMPLETED|Year 2||4
8535758|NCT02942277|9568375|FG003|COMPLETED|Year 2||8
8535759|NCT02942277|9568376|FG004|COMPLETED|Year 2||36
8535760|NCT02942277|9568377|FG005|COMPLETED|Year 2||40
8535761|NCT02942277|9568378|FG006|COMPLETED|Year 2||4
8535762|NCT02942277|9568379|FG007|COMPLETED|Year 2||8
8535763|NCT02942277|9568380|FG008|COMPLETED|Year 2||10
8535764|NCT02942277|9568381|FG009|COMPLETED|Year 2||9
8535765|NCT02942277|9568382|FG010|COMPLETED|Year 2||79
8535766|NCT02942277|9568372|FG000|NOT COMPLETED|Year 2||0
8535767|NCT02942277|9568373|FG001|NOT COMPLETED|Year 2||1
8535768|NCT02942277|9568374|FG002|NOT COMPLETED|Year 2||1
8535769|NCT02942277|9568375|FG003|NOT COMPLETED|Year 2||1
8535770|NCT02942277|9568376|FG004|NOT COMPLETED|Year 2||13
8535771|NCT02942277|9568377|FG005|NOT COMPLETED|Year 2||11
8535772|NCT02942277|9568378|FG006|NOT COMPLETED|Year 2||1
8535773|NCT02942277|9568379|FG007|NOT COMPLETED|Year 2||1
8535774|NCT02942277|9568380|FG008|NOT COMPLETED|Year 2||0
8535775|NCT02942277|9568381|FG009|NOT COMPLETED|Year 2||1
8535776|NCT02942277|9568382|FG010|NOT COMPLETED|Year 2||25
8535777|NCT02942017|9568411|FG000|STARTED|Overall Study||54
8535778|NCT02942017|9568412|FG001|STARTED|Overall Study||54
8535779|NCT02942017|9568411|FG000|Treated|Overall Study||53
8535780|NCT02942017|9568412|FG001|Treated|Overall Study||51
8535781|NCT02942017|9568411|FG000|COMPLETED|Overall Study||52
8535782|NCT02942017|9568412|FG001|COMPLETED|Overall Study||48
8535783|NCT02942017|9568411|FG000|NOT COMPLETED|Overall Study||2
8535784|NCT02942017|9568412|FG001|NOT COMPLETED|Overall Study||6
8535785|NCT02942004|9568421|FG000|STARTED|Overall Study||46
8535786|NCT02942004|9568422|FG001|STARTED|Overall Study||47
8535787|NCT02942004|9568423|FG002|STARTED|Overall Study||45
8535788|NCT02942004|9568421|FG000|Participants Who Received Study Drug|Overall Study||43
8535789|NCT02942004|9568422|FG001|Participants Who Received Study Drug|Overall Study||38
8535790|NCT02942004|9568423|FG002|Participants Who Received Study Drug|Overall Study||41
8535791|NCT02942004|9568421|FG000|COMPLETED|Overall Study||42
8535792|NCT02942004|9568422|FG001|COMPLETED|Overall Study||35
8535793|NCT02942004|9568423|FG002|COMPLETED|Overall Study||36
8535794|NCT02942004|9568421|FG000|NOT COMPLETED|Overall Study||4
8535795|NCT02942004|9568422|FG001|NOT COMPLETED|Overall Study||12
8535796|NCT02942004|9568423|FG002|NOT COMPLETED|Overall Study||9
8535797|NCT02861014|9568431|FG000|STARTED|Primary Analysis||680
8535798|NCT02861014|9568431|FG000|COMPLETED|Primary Analysis||641
8535799|NCT02861014|9568431|FG000|NOT COMPLETED|Primary Analysis||39
8535800|NCT02861014|9568431|FG000|STARTED|Safety Follow-up||64
8535801|NCT02861014|9568431|FG000|COMPLETED|Safety Follow-up||14
8535802|NCT02861014|9568431|FG000|NOT COMPLETED|Safety Follow-up||50
8535803|NCT02775435|9568439|FG000|STARTED|Overall Study||278
8535804|NCT02775435|9568440|FG001|STARTED|Overall Study||281
8535805|NCT02775435|9568439|FG000|Treated|Overall Study||278
8535806|NCT02775435|9568440|FG001|Treated|Overall Study||280
8535807|NCT02775435|9568439|FG000|Switched to Pembrolizumab+Chemotherapy|Overall Study||0
8535808|NCT02775435|9568440|FG001|Switched to Pembrolizumab+Chemotherapy|Overall Study||75
8535809|NCT02775435|9568439|FG000|COMPLETED|Overall Study||0
8535810|NCT02775435|9568440|FG001|COMPLETED|Overall Study||0
8535811|NCT02775435|9568439|FG000|NOT COMPLETED|Overall Study||278
8535812|NCT02775435|9568440|FG001|NOT COMPLETED|Overall Study||281
8535813|NCT02767531|9568446|FG000|STARTED|Period 1|Orlistat therapy|1
8535814|NCT02767531|9568447|FG001|STARTED|Period 1|Off Orlistat|1
8535815|NCT02767531|9568446|FG000|COMPLETED|Period 1||1
8535816|NCT02767531|9568447|FG001|COMPLETED|Period 1||1
8535817|NCT02767531|9568446|FG000|NOT COMPLETED|Period 1||0
8535818|NCT02767531|9568447|FG001|NOT COMPLETED|Period 1||0
8535819|NCT02767531|9568446|FG000|STARTED|Period 2|Off Orlistat|1
8535820|NCT02767531|9568447|FG001|STARTED|Period 2|Orlistat Therapy|1
8535821|NCT02767531|9568446|FG000|COMPLETED|Period 2||1
8535822|NCT02767531|9568447|FG001|COMPLETED|Period 2||1
8535823|NCT02767531|9568446|FG000|NOT COMPLETED|Period 2||0
8535824|NCT02767531|9568447|FG001|NOT COMPLETED|Period 2||0
8535825|NCT02767531|9568446|FG000|STARTED|Period 3|Orlistat Therapy|1
8535826|NCT02767531|9568447|FG001|STARTED|Period 3|Off Orlistat|1
8535827|NCT02767531|9568446|FG000|COMPLETED|Period 3||1
8535828|NCT02767531|9568447|FG001|COMPLETED|Period 3||1
8535829|NCT02767531|9568446|FG000|NOT COMPLETED|Period 3||0
8535830|NCT02767531|9568447|FG001|NOT COMPLETED|Period 3||0
8535831|NCT02767531|9568446|FG000|STARTED|Period 4|Off Orlistat|1
8535832|NCT02767531|9568447|FG001|STARTED|Period 4|Orlistat Therapy|1
8535833|NCT02767531|9568446|FG000|COMPLETED|Period 4||1
8535834|NCT02767531|9568447|FG001|COMPLETED|Period 4||1
8535835|NCT02767531|9568446|FG000|NOT COMPLETED|Period 4||0
8535836|NCT02767531|9568447|FG001|NOT COMPLETED|Period 4||0
8535837|NCT02726880|9568455|FG000|STARTED|Overall Study||17
8535838|NCT02726880|9568456|FG001|STARTED|Overall Study||19
8535839|NCT02726880|9568455|FG000|COMPLETED|Overall Study||14
8535840|NCT02726880|9568456|FG001|COMPLETED|Overall Study||16
8535841|NCT02726880|9568455|FG000|NOT COMPLETED|Overall Study||3
8535842|NCT02726880|9568456|FG001|NOT COMPLETED|Overall Study||3
8565241|NCT00065507|9597328|FG000|Treated (As-Randomized Population)|Overall Study|As-randomized population was used in efficacy analyses, unless otherwise noted.|100
8565242|NCT00065507|9597329|FG001|Treated (As-Randomized Population)|Overall Study|As-randomized population was used in efficacy analyses, unless otherwise noted.|91
8565243|NCT00065507|9597328|FG000|Treated (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|102
8565244|NCT00065507|9597329|FG001|Treated (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|89
8565245|NCT00065507|9597328|FG000|Treated, Wk 48 (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|102
8565246|NCT00065507|9597329|FG001|Treated, Wk 48 (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|89
8565247|NCT00065507|9597328|FG000|Treated, 24-Week Follow-Up Population|Overall Study||25
8565248|NCT00065507|9597329|FG001|Treated, 24-Week Follow-Up Population|Overall Study||28
8535843|NCT02614547|9568465|FG000|STARTED|Overall Study||11
8535844|NCT02614547|9568466|FG001|STARTED|Overall Study||10
8535845|NCT02614547|9568465|FG000|COMPLETED|Overall Study||11
8535846|NCT02614547|9568466|FG001|COMPLETED|Overall Study||10
8535847|NCT02614547|9568465|FG000|NOT COMPLETED|Overall Study||0
8535848|NCT02614547|9568466|FG001|NOT COMPLETED|Overall Study||0
8535849|NCT02592551|9568478|FG000|STARTED|Overall Study||9
8535850|NCT02592551|9568479|FG001|STARTED|Overall Study||11
8535851|NCT02592551|9568480|FG002|STARTED|Overall Study||4
8535852|NCT02592551|9568478|FG000|COMPLETED|Overall Study|One participant completed all study procedures and got the tumor sample for analysis. However, the sample was too small to analyze in the lab and so that it was not evaluable for primary and secondary analysis.|8
8535853|NCT02592551|9568479|FG001|COMPLETED|Overall Study||8
8620939|NCT00476996|9659820|FG002|NOT COMPLETED|Blinded Treatment Phase (up to Week 48)||45
8620940|NCT00476996|9659821|FG003|NOT COMPLETED|Blinded Treatment Phase (up to Week 48)||0
8620941|NCT00476996|9659818|FG000|STARTED|OLE Phase (From Week 48)||0
8535854|NCT02592551|9568480|FG002|COMPLETED|Overall Study||4
8535855|NCT02592551|9568478|FG000|NOT COMPLETED|Overall Study||1
8535856|NCT02592551|9568479|FG001|NOT COMPLETED|Overall Study||3
8535857|NCT02592551|9568480|FG002|NOT COMPLETED|Overall Study||0
8535858|NCT02583048|9568492|FG000|STARTED|Overall Study||28
8535859|NCT02583048|9568493|FG001|STARTED|Overall Study||28
8535860|NCT02583048|9568494|FG002|STARTED|Overall Study||28
8535861|NCT02583048|9568492|FG000|COMPLETED|Overall Study||28
8535862|NCT02583048|9568493|FG001|COMPLETED|Overall Study||27
8535863|NCT02583048|9568494|FG002|COMPLETED|Overall Study||27
8535864|NCT02583048|9568492|FG000|NOT COMPLETED|Overall Study||0
8535865|NCT02583048|9568493|FG001|NOT COMPLETED|Overall Study||1
8535866|NCT02583048|9568494|FG002|NOT COMPLETED|Overall Study||1
8535867|NCT02546986|9568507|FG000|STARTED|Treatment Period||51
8535868|NCT02546986|9568508|FG001|STARTED|Treatment Period||49
8535869|NCT02546986|9568507|FG000|COMPLETED|Treatment Period||0
8535870|NCT02546986|9568508|FG001|COMPLETED|Treatment Period||0
8535871|NCT02546986|9568507|FG000|NOT COMPLETED|Treatment Period||51
8535872|NCT02546986|9568508|FG001|NOT COMPLETED|Treatment Period||49
8535873|NCT02546986|9568507|FG000|STARTED|Survival Follow-Up Phase||36
8535874|NCT02546986|9568508|FG001|STARTED|Survival Follow-Up Phase||35
8535875|NCT02546986|9568507|FG000|COMPLETED|Survival Follow-Up Phase||0
8535876|NCT02546986|9568508|FG001|COMPLETED|Survival Follow-Up Phase||0
8535877|NCT02546986|9568507|FG000|NOT COMPLETED|Survival Follow-Up Phase||36
8535878|NCT02546986|9568508|FG001|NOT COMPLETED|Survival Follow-Up Phase||35
8535879|NCT02539160|9568516|FG000|STARTED|Phase 1 Pre-crossover||24
8535880|NCT02539160|9568517|FG001|STARTED|Phase 1 Pre-crossover||24
8535881|NCT02539160|9568518|FG002|STARTED|Phase 1 Pre-crossover||22
8535882|NCT02539160|9568519|FG003|STARTED|Phase 1 Pre-crossover||22
8535883|NCT02539160|9568516|FG000|COMPLETED|Phase 1 Pre-crossover||19
8535884|NCT02539160|9568517|FG001|COMPLETED|Phase 1 Pre-crossover||20
8535885|NCT02539160|9568518|FG002|COMPLETED|Phase 1 Pre-crossover||19
8535886|NCT02539160|9568519|FG003|COMPLETED|Phase 1 Pre-crossover||19
8535887|NCT02539160|9568516|FG000|NOT COMPLETED|Phase 1 Pre-crossover||5
8535888|NCT02539160|9568517|FG001|NOT COMPLETED|Phase 1 Pre-crossover||4
8535889|NCT02539160|9568518|FG002|NOT COMPLETED|Phase 1 Pre-crossover||3
8535890|NCT02539160|9568519|FG003|NOT COMPLETED|Phase 1 Pre-crossover||3
8535891|NCT02539160|9568516|FG000|STARTED|Phase 2 Post-crossover||19
8535892|NCT02539160|9568517|FG001|STARTED|Phase 2 Post-crossover||20
8535893|NCT02539160|9568518|FG002|STARTED|Phase 2 Post-crossover||19
8535894|NCT02539160|9568519|FG003|STARTED|Phase 2 Post-crossover||19
8535895|NCT02539160|9568516|FG000|COMPLETED|Phase 2 Post-crossover||19
8535896|NCT02539160|9568517|FG001|COMPLETED|Phase 2 Post-crossover||20
8535897|NCT02539160|9568518|FG002|COMPLETED|Phase 2 Post-crossover||19
8535898|NCT02539160|9568519|FG003|COMPLETED|Phase 2 Post-crossover||19
8535899|NCT02539160|9568516|FG000|NOT COMPLETED|Phase 2 Post-crossover||0
8535900|NCT02539160|9568517|FG001|NOT COMPLETED|Phase 2 Post-crossover||0
8535901|NCT02539160|9568518|FG002|NOT COMPLETED|Phase 2 Post-crossover||0
8535902|NCT02539160|9568519|FG003|NOT COMPLETED|Phase 2 Post-crossover||0
8535903|NCT02507973|9568529|FG000|STARTED|Overall Study||8
8535904|NCT02507973|9568529|FG000|COMPLETED|Overall Study||7
8535905|NCT02507973|9568529|FG000|NOT COMPLETED|Overall Study||1
8535906|NCT02477696|9568537|FG000|STARTED|Overall Study|3 patients withdrew after being randomized but prior to receiving Acalabrutinib treatment.|268
8535907|NCT02477696|9568538|FG001|STARTED|Overall Study|1 patient withdrew after being randomized but prior to receiving Ibrutinib treatment.|265
8535908|NCT02477696|9568537|FG000|COMPLETED|Overall Study||127
8535909|NCT02477696|9568538|FG001|COMPLETED|Overall Study||110
8535910|NCT02477696|9568537|FG000|NOT COMPLETED|Overall Study||141
8535911|NCT02477696|9568538|FG001|NOT COMPLETED|Overall Study||155
8535912|NCT02477618|9568546|FG000|STARTED|Overall Study||65
8535913|NCT02477618|9568547|FG001|STARTED|Overall Study||67
8535914|NCT02477618|9568546|FG000|Intent-to-Treat Analysis Set|Overall Study||66
8535915|NCT02477618|9568547|FG001|Intent-to-Treat Analysis Set|Overall Study||66
8535916|NCT02477618|9568546|FG000|COMPLETED|Overall Study||50
8535917|NCT02477618|9568547|FG001|COMPLETED|Overall Study||53
8535918|NCT02477618|9568546|FG000|NOT COMPLETED|Overall Study||15
8535919|NCT02477618|9568547|FG001|NOT COMPLETED|Overall Study||14
8535920|NCT02424851|9568555|FG000|STARTED|Overall Study||16
8535921|NCT02424851|9568556|FG001|STARTED|Overall Study||15
8535922|NCT02424851|9568555|FG000|COMPLETED|Overall Study||14
8535923|NCT02424851|9568556|FG001|COMPLETED|Overall Study||12
8535924|NCT02424851|9568555|FG000|NOT COMPLETED|Overall Study||2
8535925|NCT02424851|9568556|FG001|NOT COMPLETED|Overall Study||3
8535926|NCT02285504|9568562|FG000|STARTED|Overall Study||4
8535927|NCT02285504|9568562|FG000|COMPLETED|Overall Study||4
8535928|NCT02285504|9568562|FG000|NOT COMPLETED|Overall Study||0
8535929|NCT02227394|9568566|FG000|STARTED|Overall Study||10
8535930|NCT02227394|9568567|FG001|STARTED|Overall Study||10
8535931|NCT02227394|9568566|FG000|COMPLETED|Overall Study||10
8535932|NCT02227394|9568567|FG001|COMPLETED|Overall Study||10
8535933|NCT02227394|9568566|FG000|NOT COMPLETED|Overall Study||0
8535934|NCT02227394|9568567|FG001|NOT COMPLETED|Overall Study||0
8535935|NCT02073968|9568573|FG000|STARTED|Overall Study||35
8535936|NCT02073968|9568573|FG000|COMPLETED|Overall Study||35
8535937|NCT02073968|9568573|FG000|NOT COMPLETED|Overall Study||0
8535938|NCT02003924|9568579|FG000|STARTED|Double-blind Phase||933
8535939|NCT02003924|9568580|FG001|STARTED|Double-blind Phase||468
8535940|NCT02003924|9568581|FG002|STARTED|Double-blind Phase||0
8535941|NCT02003924|9568579|FG000|Treated|Double-blind Phase||930
8535942|NCT02003924|9568580|FG001|Treated|Double-blind Phase||465
8535943|NCT02003924|9568581|FG002|Treated|Double-blind Phase||0
8535944|NCT02003924|9568579|FG000|COMPLETED|Double-blind Phase||478
8535945|NCT02003924|9568580|FG001|COMPLETED|Double-blind Phase||87
8535946|NCT02003924|9568581|FG002|COMPLETED|Double-blind Phase||0
8535947|NCT02003924|9568579|FG000|NOT COMPLETED|Double-blind Phase||455
8535948|NCT02003924|9568580|FG001|NOT COMPLETED|Double-blind Phase||381
8535949|NCT02003924|9568581|FG002|NOT COMPLETED|Double-blind Phase||0
8535950|NCT02003924|9568579|FG000|STARTED|Open-label Phase||478
8535951|NCT02003924|9568580|FG001|STARTED|Open-label Phase|Participants were offered to switch from double blind placebo to open label Enzalutamide.|0
8535952|NCT02003924|9568581|FG002|STARTED|Open-label Phase|Participants previously treated with placebo, switched to receive open label Enzalutamide.|87
8535953|NCT02003924|9568579|FG000|Treated|Open-label Phase||478
8535954|NCT02003924|9568580|FG001|Treated|Open-label Phase||0
8535955|NCT02003924|9568581|FG002|Treated|Open-label Phase||87
8535956|NCT02003924|9568579|FG000|COMPLETED|Open-label Phase||378
8535957|NCT02003924|9568580|FG001|COMPLETED|Open-label Phase||0
8535958|NCT02003924|9568581|FG002|COMPLETED|Open-label Phase||70
8535959|NCT02003924|9568579|FG000|NOT COMPLETED|Open-label Phase||100
8535960|NCT02003924|9568580|FG001|NOT COMPLETED|Open-label Phase||0
8535961|NCT02003924|9568581|FG002|NOT COMPLETED|Open-label Phase||17
8535962|NCT02003924|9568579|FG000|STARTED|Long-term Follow-up Phase|Participants followed up after discontinuing study drug in either double blind or open label phase.|933
8535963|NCT02003924|9568580|FG001|STARTED|Long-term Follow-up Phase|Participants were followed up after study drug discontinuation in double blind phase.|381
8535964|NCT02003924|9568581|FG002|STARTED|Long-term Follow-up Phase|Participants were followed up after study drug discontinuation in open label phase.|87
8535965|NCT02003924|9568579|FG000|COMPLETED|Long-term Follow-up Phase||566
8535966|NCT02003924|9568580|FG001|COMPLETED|Long-term Follow-up Phase||144
8535967|NCT02003924|9568581|FG002|COMPLETED|Long-term Follow-up Phase||80
8535968|NCT02003924|9568579|FG000|NOT COMPLETED|Long-term Follow-up Phase||367
8535969|NCT02003924|9568580|FG001|NOT COMPLETED|Long-term Follow-up Phase||237
8535970|NCT02003924|9568581|FG002|NOT COMPLETED|Long-term Follow-up Phase||7
8535971|NCT01971970|9568590|FG000|STARTED|Baseline Until Week 6||24
8535972|NCT01971970|9568591|FG001|STARTED|Baseline Until Week 6||21
8535973|NCT01971970|9568590|FG000|Receiving Standard Therapy|Baseline Until Week 6||23
8535974|NCT01971970|9568591|FG001|Receiving Standard Therapy|Baseline Until Week 6||21
8535975|NCT01971970|9568590|FG000|Therapy Escalation|Baseline Until Week 6||1
8535976|NCT01971970|9568591|FG001|Therapy Escalation|Baseline Until Week 6||0
8535977|NCT01971970|9568590|FG000|COMPLETED|Baseline Until Week 6||23
8535978|NCT01971970|9568591|FG001|COMPLETED|Baseline Until Week 6||21
8535979|NCT01971970|9568590|FG000|NOT COMPLETED|Baseline Until Week 6||1
8535980|NCT01971970|9568591|FG001|NOT COMPLETED|Baseline Until Week 6||0
8535981|NCT01971970|9568590|FG000|STARTED|Week 6 Until Week 8||23
8535982|NCT01971970|9568591|FG001|STARTED|Week 6 Until Week 8||21
8535983|NCT01971970|9568590|FG000|Receiving Standard Therapy|Week 6 Until Week 8||23
8535984|NCT01971970|9568591|FG001|Receiving Standard Therapy|Week 6 Until Week 8||20
8535985|NCT01971970|9568590|FG000|COMPLETED|Week 6 Until Week 8||23
8535986|NCT01971970|9568591|FG001|COMPLETED|Week 6 Until Week 8||20
8535987|NCT01971970|9568590|FG000|NOT COMPLETED|Week 6 Until Week 8||0
8535988|NCT01971970|9568591|FG001|NOT COMPLETED|Week 6 Until Week 8||1
8535989|NCT01971970|9568590|FG000|STARTED|Week 8 Until Week 14||23
8535990|NCT01971970|9568591|FG001|STARTED|Week 8 Until Week 14||20
8535991|NCT01971970|9568590|FG000|Receiving Standard Therapy|Week 8 Until Week 14||16
8535992|NCT01971970|9568591|FG001|Receiving Standard Therapy|Week 8 Until Week 14||19
8535993|NCT01971970|9568590|FG000|Therapy Escalation|Week 8 Until Week 14||7
8535994|NCT01971970|9568591|FG001|Therapy Escalation|Week 8 Until Week 14||1
8535995|NCT01971970|9568590|FG000|COMPLETED|Week 8 Until Week 14||23
8535996|NCT01971970|9568591|FG001|COMPLETED|Week 8 Until Week 14||20
8535997|NCT01971970|9568590|FG000|NOT COMPLETED|Week 8 Until Week 14||0
8535998|NCT01971970|9568591|FG001|NOT COMPLETED|Week 8 Until Week 14||0
8535999|NCT01971970|9568590|FG000|STARTED|Week 14 Until Week 22||23
8536000|NCT01971970|9568591|FG001|STARTED|Week 14 Until Week 22||20
8536001|NCT01971970|9568590|FG000|Receiving Standard Therapy|Week 14 Until Week 22||12
8536002|NCT01971970|9568591|FG001|Receiving Standard Therapy|Week 14 Until Week 22||16
8536003|NCT01971970|9568590|FG000|Therapy Escalation|Week 14 Until Week 22||3
8536004|NCT01971970|9568591|FG001|Therapy Escalation|Week 14 Until Week 22||2
8536005|NCT01971970|9568590|FG000|COMPLETED|Week 14 Until Week 22||23
8536006|NCT01971970|9568591|FG001|COMPLETED|Week 14 Until Week 22||19
8536007|NCT01971970|9568590|FG000|NOT COMPLETED|Week 14 Until Week 22||0
8536008|NCT01971970|9568591|FG001|NOT COMPLETED|Week 14 Until Week 22||1
8536009|NCT01971970|9568590|FG000|STARTED|Week 22 Until Week 52||23
8536010|NCT01971970|9568591|FG001|STARTED|Week 22 Until Week 52||19
8536011|NCT01971970|9568590|FG000|Receiving Standard Therapy|Week 22 Until Week 52||5
8536012|NCT01971970|9568591|FG001|Receiving Standard Therapy|Week 22 Until Week 52||9
8536013|NCT01971970|9568590|FG000|Therapy Escalation|Week 22 Until Week 52||6
8536014|NCT01971970|9568591|FG001|Therapy Escalation|Week 22 Until Week 52||6
8536015|NCT01971970|9568590|FG000|COMPLETED|Week 22 Until Week 52||15
8536016|NCT01971970|9568591|FG001|COMPLETED|Week 22 Until Week 52||15
8536017|NCT01971970|9568590|FG000|NOT COMPLETED|Week 22 Until Week 52||8
8536018|NCT01971970|9568591|FG001|NOT COMPLETED|Week 22 Until Week 52||4
8536019|NCT01971970|9568590|FG000|STARTED|Week 52 Until Week 78||15
8536020|NCT01971970|9568591|FG001|STARTED|Week 52 Until Week 78||15
8536021|NCT01971970|9568590|FG000|COMPLETED|Week 52 Until Week 78||14
8536022|NCT01971970|9568591|FG001|COMPLETED|Week 52 Until Week 78||12
8536023|NCT01971970|9568590|FG000|NOT COMPLETED|Week 52 Until Week 78||1
8536024|NCT01971970|9568591|FG001|NOT COMPLETED|Week 52 Until Week 78||3
8536025|NCT01969409|9568604|FG000|STARTED|Overall Study||28
8536026|NCT01969409|9568605|FG001|STARTED|Overall Study||30
8536027|NCT01969409|9568604|FG000|COMPLETED|Overall Study||25
8536028|NCT01969409|9568605|FG001|COMPLETED|Overall Study||26
8536029|NCT01969409|9568604|FG000|NOT COMPLETED|Overall Study||3
8536030|NCT01969409|9568605|FG001|NOT COMPLETED|Overall Study||4
8536031|NCT01459497|9568613|FG000|STARTED|Overall Study||52
8536032|NCT01459497|9568614|FG001|STARTED|Overall Study||51
8536033|NCT01459497|9568613|FG000|COMPLETED|Overall Study||50
8536034|NCT01459497|9568614|FG001|COMPLETED|Overall Study||46
8536035|NCT01459497|9568613|FG000|NOT COMPLETED|Overall Study||2
8536036|NCT01459497|9568614|FG001|NOT COMPLETED|Overall Study||5
8536037|NCT01307787|9568622|FG000|STARTED|Overall Study||19
8536038|NCT01307787|9568623|FG001|STARTED|Overall Study||15
8536039|NCT01307787|9568622|FG000|T1= After 9 Weeks Post Intervention|Overall Study||18
8536040|NCT01307787|9568623|FG001|T1= After 9 Weeks Post Intervention|Overall Study||15
8536041|NCT01307787|9568622|FG000|T2= After 22 Weeks at Follow-up|Overall Study||17
8536042|NCT01307787|9568623|FG001|T2= After 22 Weeks at Follow-up|Overall Study||15
8536043|NCT01307787|9568622|FG000|COMPLETED|Overall Study||17
8536044|NCT01307787|9568623|FG001|COMPLETED|Overall Study||15
8536045|NCT01307787|9568622|FG000|NOT COMPLETED|Overall Study||2
8536046|NCT01307787|9568623|FG001|NOT COMPLETED|Overall Study||0
8536047|NCT01250912|9568634|FG000|STARTED|Overall Study||20
8536048|NCT01250912|9568634|FG000|COMPLETED|Overall Study||19
8536049|NCT01250912|9568634|FG000|NOT COMPLETED|Overall Study||1
8536050|NCT01218555|9568641|FG000|STARTED|Overall Study||3
8536051|NCT01218555|9568642|FG001|STARTED|Overall Study||3
8536052|NCT01218555|9568643|FG002|STARTED|Overall Study||5
8536053|NCT01218555|9568644|FG003|STARTED|Overall Study||3
8536054|NCT01218555|9568645|FG004|STARTED|Overall Study||8
8536055|NCT01218555|9568646|FG005|STARTED|Overall Study||22
8536056|NCT01218555|9568641|FG000|COMPLETED|Overall Study||3
8536057|NCT01218555|9568642|FG001|COMPLETED|Overall Study||3
8536058|NCT01218555|9568643|FG002|COMPLETED|Overall Study||5
8536059|NCT01218555|9568644|FG003|COMPLETED|Overall Study||3
8536060|NCT01218555|9568645|FG004|COMPLETED|Overall Study||8
8536061|NCT01218555|9568646|FG005|COMPLETED|Overall Study||22
8536062|NCT01218555|9568641|FG000|NOT COMPLETED|Overall Study||0
8536063|NCT01218555|9568642|FG001|NOT COMPLETED|Overall Study||0
8536064|NCT01218555|9568643|FG002|NOT COMPLETED|Overall Study||0
8536065|NCT01218555|9568644|FG003|NOT COMPLETED|Overall Study||0
8536066|NCT01218555|9568645|FG004|NOT COMPLETED|Overall Study||0
8536067|NCT01218555|9568646|FG005|NOT COMPLETED|Overall Study||0
8536068|NCT01141712|9568650|FG000|STARTED|Overall Study||43
8536069|NCT01141712|9568650|FG000|COMPLETED|Overall Study||40
8536070|NCT01141712|9568650|FG000|NOT COMPLETED|Overall Study||3
8536071|NCT01111305|9568656|FG000|STARTED|Overall Study||4
8536072|NCT01111305|9568657|FG001|STARTED|Overall Study||4
8536073|NCT01111305|9568656|FG000|COMPLETED|Overall Study||4
8536074|NCT01111305|9568657|FG001|COMPLETED|Overall Study||4
8536075|NCT01111305|9568656|FG000|NOT COMPLETED|Overall Study||0
8536076|NCT01111305|9568657|FG001|NOT COMPLETED|Overall Study||0
8536077|NCT00659646|9568667|FG000|STARTED|Overall Study||38
8536078|NCT00659646|9568668|FG001|STARTED|Overall Study||18
8536079|NCT00659646|9568667|FG000|COMPLETED|Overall Study||23
8536080|NCT00659646|9568668|FG001|COMPLETED|Overall Study||10
8536081|NCT00659646|9568667|FG000|NOT COMPLETED|Overall Study||15
8536082|NCT00659646|9568668|FG001|NOT COMPLETED|Overall Study||8
8536083|NCT00567580|9568679|FG000|STARTED|Overall Study||592
8536084|NCT00567580|9568680|FG001|STARTED|Overall Study||602
8536085|NCT00567580|9568681|FG002|STARTED|Overall Study||598
8536086|NCT00567580|9568679|FG000|Eligible|Overall Study||564
8536087|NCT00567580|9568680|FG001|Eligible|Overall Study||578
8536088|NCT00567580|9568681|FG002|Eligible|Overall Study||574
8536089|NCT00567580|9568679|FG000|Eligible, Started Study Treatment, and Have Adverse Event Data|Overall Study||547
8536090|NCT00567580|9568680|FG001|Eligible, Started Study Treatment, and Have Adverse Event Data|Overall Study||563
8536091|NCT00567580|9568681|FG002|Eligible, Started Study Treatment, and Have Adverse Event Data|Overall Study||563
8536092|NCT00567580|9568679|FG000|COMPLETED|Overall Study||564
8536093|NCT00567580|9568680|FG001|COMPLETED|Overall Study||578
8536094|NCT00567580|9568681|FG002|COMPLETED|Overall Study||574
8536095|NCT00567580|9568679|FG000|NOT COMPLETED|Overall Study||28
8536096|NCT00567580|9568680|FG001|NOT COMPLETED|Overall Study||24
8536097|NCT00567580|9568681|FG002|NOT COMPLETED|Overall Study||24
8565249|NCT00065507|9597328|FG000|COMPLETED|Overall Study|Completed first 48 weeks of treatment|71
8565250|NCT00065507|9597329|FG001|COMPLETED|Overall Study|Completed first 48 weeks of treatment|62
8565251|NCT00065507|9597328|FG000|NOT COMPLETED|Overall Study||29
8565252|NCT00065507|9597329|FG001|NOT COMPLETED|Overall Study||29
8565253|NCT00065611|9597341|FG000|STARTED|Overall Study||4
8565254|NCT00065611|9597342|FG001|STARTED|Overall Study||4
8565255|NCT00065611|9597341|FG000|COMPLETED|Overall Study||4
8565256|NCT00065611|9597342|FG001|COMPLETED|Overall Study||3
8565257|NCT00065611|9597341|FG000|NOT COMPLETED|Overall Study||0
8565258|NCT00065611|9597342|FG001|NOT COMPLETED|Overall Study||1
8565259|NCT00065806|9597350|FG000|STARTED|Overall Study||113
8565260|NCT00065806|9597351|FG001|STARTED|Overall Study||108
8565261|NCT00065806|9597350|FG000|COMPLETED|Overall Study||93
8565262|NCT00065806|9597351|FG001|COMPLETED|Overall Study||89
8565263|NCT00065806|9597350|FG000|NOT COMPLETED|Overall Study||20
8565264|NCT00065806|9597351|FG001|NOT COMPLETED|Overall Study||19
8565265|NCT00066066|9597360|FG000|STARTED|Overall Study||27
8565266|NCT00066066|9597361|FG001|STARTED|Overall Study||22
8565267|NCT00066066|9597362|FG002|STARTED|Overall Study||30
8565268|NCT00066066|9597363|FG003|STARTED|Overall Study||20
8565269|NCT00066066|9597364|FG004|STARTED|Overall Study||27
8565270|NCT00066066|9597365|FG005|STARTED|Overall Study||20
8565271|NCT00066066|9597360|FG000|Baseline|Overall Study||27
8565272|NCT00066066|9597361|FG001|Baseline|Overall Study||22
8565273|NCT00066066|9597362|FG002|Baseline|Overall Study||30
8565274|NCT00066066|9597363|FG003|Baseline|Overall Study||20
8565275|NCT00066066|9597364|FG004|Baseline|Overall Study||27
8565276|NCT00066066|9597365|FG005|Baseline|Overall Study||20
8565277|NCT00066066|9597360|FG000|3 Month|Overall Study||21
8565278|NCT00066066|9597361|FG001|3 Month|Overall Study||17
8565279|NCT00066066|9597362|FG002|3 Month|Overall Study||23
8565280|NCT00066066|9597363|FG003|3 Month|Overall Study||16
8565281|NCT00066066|9597364|FG004|3 Month|Overall Study||22
8565282|NCT00066066|9597365|FG005|3 Month|Overall Study||15
8565283|NCT00066066|9597360|FG000|6 Month|Overall Study||19
8565284|NCT00066066|9597361|FG001|6 Month|Overall Study||13
8565285|NCT00066066|9597362|FG002|6 Month|Overall Study||23
8565286|NCT00066066|9597363|FG003|6 Month|Overall Study||13
8565287|NCT00066066|9597364|FG004|6 Month|Overall Study||21
8565288|NCT00066066|9597365|FG005|6 Month|Overall Study||14
8565289|NCT00066066|9597360|FG000|12 Month|Overall Study||18
8565290|NCT00066066|9597361|FG001|12 Month|Overall Study||11
8565291|NCT00066066|9597362|FG002|12 Month|Overall Study||21
8565292|NCT00066066|9597363|FG003|12 Month|Overall Study||11
8565293|NCT00066066|9597364|FG004|12 Month|Overall Study||19
8565294|NCT00066066|9597365|FG005|12 Month|Overall Study||9
8565295|NCT00066066|9597360|FG000|COMPLETED|Overall Study|27 enrolled, 21 analyzed,18 subjects had complete data,3 subjects had data carried forward.|21
8565296|NCT00066066|9597361|FG001|COMPLETED|Overall Study|22 enrolled, 18 analyzed,11 subjects had complete data,7 subjects had data carried forward.|18
8565297|NCT00066066|9597362|FG002|COMPLETED|Overall Study|30 enrolled, 23 analyzed,21 subjects had complete data,2 subjects had data carried forward.|23
8565298|NCT00066066|9597363|FG003|COMPLETED|Overall Study|20 enrolled, 16 analyzed,11 subjects had complete data,5 subjects had data carried forward.|16
8565299|NCT00066066|9597364|FG004|COMPLETED|Overall Study|27 enrolled, 24 analyzed,19 subjects had complete data,5 subjects had data carried forward.|24
8565300|NCT00066066|9597365|FG005|COMPLETED|Overall Study|20 enrolled, 15 analyzed,9 subjects had complete data,6 subjects had data carried forward.|15
8565301|NCT00066066|9597360|FG000|NOT COMPLETED|Overall Study||6
8565302|NCT00066066|9597361|FG001|NOT COMPLETED|Overall Study||4
8565303|NCT00066066|9597362|FG002|NOT COMPLETED|Overall Study||7
8565304|NCT00066066|9597363|FG003|NOT COMPLETED|Overall Study||4
8565305|NCT00066066|9597364|FG004|NOT COMPLETED|Overall Study||3
8565306|NCT00066066|9597365|FG005|NOT COMPLETED|Overall Study||5
8565307|NCT00066170|9597383|FG000|STARTED|Overall Study||56
8565308|NCT00066170|9597384|FG001|STARTED|Overall Study||55
8565309|NCT00066170|9597385|FG002|STARTED|Overall Study||63
8565310|NCT00066170|9597386|FG003|STARTED|Overall Study||57
8565311|NCT00066170|9597383|FG000|Intent to Treat|Overall Study||55
8565312|NCT00066170|9597384|FG001|Intent to Treat|Overall Study||50
8565313|NCT00066170|9597385|FG002|Intent to Treat|Overall Study||63
8565314|NCT00066170|9597386|FG003|Intent to Treat|Overall Study||54
8565315|NCT00066170|9597383|FG000|COMPLETED|Overall Study||49
8565316|NCT00066170|9597384|FG001|COMPLETED|Overall Study||45
8565317|NCT00066170|9597385|FG002|COMPLETED|Overall Study||59
8620942|NCT00476996|9659819|FG001|STARTED|OLE Phase (From Week 48)||0
8565318|NCT00066170|9597386|FG003|COMPLETED|Overall Study||48
8565319|NCT00066170|9597383|FG000|NOT COMPLETED|Overall Study||7
8565320|NCT00066170|9597384|FG001|NOT COMPLETED|Overall Study||10
8565321|NCT00066170|9597385|FG002|NOT COMPLETED|Overall Study||4
8565322|NCT00066170|9597386|FG003|NOT COMPLETED|Overall Study||9
8565323|NCT00066222|9597396|FG000|STARTED|Overall Study||72
8565324|NCT00066222|9597396|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|71
8565325|NCT00066222|9597396|FG000|NOT COMPLETED|Overall Study||1
8565326|NCT00066365|9597402|FG000|STARTED|Overall Study||31
8565327|NCT00066365|9597403|FG001|STARTED|Overall Study||18
8565328|NCT00066365|9597402|FG000|COMPLETED|Overall Study||8
8536098|NCT00477412|9568696|FG000|STARTED|Overall Study||4
8536099|NCT00477412|9568697|FG001|STARTED|Overall Study||3
8536100|NCT00477412|9568698|FG002|STARTED|Overall Study||5
8536101|NCT00477412|9568699|FG003|STARTED|Overall Study||95
8536102|NCT00477412|9568696|FG000|COMPLETED|Overall Study||3
8536103|NCT00477412|9568697|FG001|COMPLETED|Overall Study||3
8536104|NCT00477412|9568698|FG002|COMPLETED|Overall Study||4
8536105|NCT00477412|9568699|FG003|COMPLETED|Overall Study||87
8536106|NCT00477412|9568696|FG000|NOT COMPLETED|Overall Study||1
8536107|NCT00477412|9568697|FG001|NOT COMPLETED|Overall Study||0
8536108|NCT00477412|9568698|FG002|NOT COMPLETED|Overall Study||1
8536109|NCT00477412|9568699|FG003|NOT COMPLETED|Overall Study||8
8536110|NCT00369317|9568707|FG000|STARTED|Overall Study||205
8536111|NCT00369317|9568707|FG000|COMPLETED|Overall Study||185
8536112|NCT00369317|9568707|FG000|NOT COMPLETED|Overall Study||20
8536113|NCT00261807|9568712|FG000|STARTED|Overall Study||25
8536114|NCT00261807|9568712|FG000|COMPLETED|Overall Study||18
8536115|NCT00261807|9568712|FG000|NOT COMPLETED|Overall Study||7
8536116|NCT04964193|9568717|FG000|STARTED|1st Intervention||12
8536117|NCT04964193|9568718|FG001|STARTED|1st Intervention||12
8536118|NCT04964193|9568717|FG000|COMPLETED|1st Intervention||12
8536119|NCT04964193|9568718|FG001|COMPLETED|1st Intervention||12
8536120|NCT04964193|9568717|FG000|NOT COMPLETED|1st Intervention||0
8536121|NCT04964193|9568718|FG001|NOT COMPLETED|1st Intervention||0
8536122|NCT04964193|9568717|FG000|STARTED|Washout = Three Weeks||12
8536123|NCT04964193|9568718|FG001|STARTED|Washout = Three Weeks||12
8536124|NCT04964193|9568717|FG000|COMPLETED|Washout = Three Weeks||12
8536125|NCT04964193|9568718|FG001|COMPLETED|Washout = Three Weeks||12
8536126|NCT04964193|9568717|FG000|NOT COMPLETED|Washout = Three Weeks||0
8536127|NCT04964193|9568718|FG001|NOT COMPLETED|Washout = Three Weeks||0
8536128|NCT04964193|9568717|FG000|STARTED|2nd Intervention||12
8536129|NCT04964193|9568718|FG001|STARTED|2nd Intervention||12
8536130|NCT04964193|9568717|FG000|COMPLETED|2nd Intervention||12
8536131|NCT04964193|9568718|FG001|COMPLETED|2nd Intervention||12
8536132|NCT04964193|9568717|FG000|NOT COMPLETED|2nd Intervention||0
8536133|NCT04964193|9568718|FG001|NOT COMPLETED|2nd Intervention||0
8536134|NCT04826731|9568726|FG000|STARTED|Overall Study||10
8536135|NCT04826731|9568727|FG001|STARTED|Overall Study||4
8536136|NCT04826731|9568726|FG000|COMPLETED|Overall Study|All patients were initially accepted as the study group per study design, with those unable to utilize respiratory exerciser (n=4) were later removed to standard care group.|10
8536137|NCT04826731|9568727|FG001|COMPLETED|Overall Study|Patients who could not use the respiratory exerciser (n=2) or refused to do so (n=2) were accepted as the control group.|4
8722940|NCT02782741|9770422|FG000|NOT COMPLETED|Blinded Treatment Period: up to Week 49||0
8722941|NCT02782741|9770423|FG001|NOT COMPLETED|Blinded Treatment Period: up to Week 49||5
8722942|NCT02782741|9770422|FG000|STARTED|Open-label Long-term: Week 50 to 145||51
8722943|NCT02782741|9770423|FG001|STARTED|Open-label Long-term: Week 50 to 145||44
8536138|NCT04826731|9568726|FG000|NOT COMPLETED|Overall Study||0
8536139|NCT04826731|9568727|FG001|NOT COMPLETED|Overall Study||0
8536140|NCT04620798|9568735|FG000|STARTED|Overall Study||536
8536141|NCT04620798|9568736|FG001|STARTED|Overall Study||540
8536142|NCT04620798|9568735|FG000|Completed Behavioral Survey|Overall Study||477
8536143|NCT04620798|9568736|FG001|Completed Behavioral Survey|Overall Study||508
8536144|NCT04620798|9568735|FG000|COMPLETED|Overall Study||410
8536145|NCT04620798|9568736|FG001|COMPLETED|Overall Study||402
8536146|NCT04620798|9568735|FG000|NOT COMPLETED|Overall Study||126
8536147|NCT04620798|9568736|FG001|NOT COMPLETED|Overall Study||138
8536148|NCT04507321|9568742|FG000|STARTED|Treatment Period 1 (8 Days)||5
8536149|NCT04507321|9568742|FG000|COMPLETED|Treatment Period 1 (8 Days)||5
8536150|NCT04507321|9568742|FG000|NOT COMPLETED|Treatment Period 1 (8 Days)||0
8536151|NCT04507321|9568742|FG000|STARTED|Treatment Period 2 (8 Days)||5
8536152|NCT04507321|9568742|FG000|COMPLETED|Treatment Period 2 (8 Days)||5
8536153|NCT04507321|9568742|FG000|NOT COMPLETED|Treatment Period 2 (8 Days)||0
8536154|NCT04256629|9568761|FG000|STARTED|Overall Study||4
8536155|NCT04256629|9568762|FG001|STARTED|Overall Study||4
8536156|NCT04256629|9568763|FG002|STARTED|Overall Study||4
8536157|NCT04256629|9568764|FG003|STARTED|Overall Study||4
8536158|NCT04256629|9568765|FG004|STARTED|Overall Study||4
8536159|NCT04256629|9568766|FG005|STARTED|Overall Study||4
8536160|NCT04256629|9568761|FG000|COMPLETED|Overall Study||4
8536161|NCT04256629|9568762|FG001|COMPLETED|Overall Study||3
8536162|NCT04256629|9568763|FG002|COMPLETED|Overall Study||4
8536163|NCT04256629|9568764|FG003|COMPLETED|Overall Study||4
8536164|NCT04256629|9568765|FG004|COMPLETED|Overall Study||4
8536165|NCT04256629|9568766|FG005|COMPLETED|Overall Study||3
8536166|NCT04256629|9568761|FG000|NOT COMPLETED|Overall Study||0
8536167|NCT04256629|9568762|FG001|NOT COMPLETED|Overall Study||1
8536168|NCT04256629|9568763|FG002|NOT COMPLETED|Overall Study||0
8536169|NCT04256629|9568764|FG003|NOT COMPLETED|Overall Study||0
8536170|NCT04256629|9568765|FG004|NOT COMPLETED|Overall Study||0
8536171|NCT04256629|9568766|FG005|NOT COMPLETED|Overall Study||1
8536172|NCT04174521|9568774|FG000|STARTED|Overall Study|A unit is defined as a mother-child pair; each unit was comprised of two participants: the mother and the child.|20670
8536173|NCT04174521|9568774|FG000|COMPLETED|Overall Study|This was a retrospective observational study so there really was no drop-out.|20670
8536174|NCT04174521|9568774|FG000|NOT COMPLETED|Overall Study||0
8536175|NCT04014075|9568778|FG000|STARTED|Overall Study||79
8536176|NCT04014075|9568778|FG000|COMPLETED|Overall Study||23
8536177|NCT04014075|9568778|FG000|NOT COMPLETED|Overall Study||56
8816565|NCT01544595|9870075|FG003|NOT COMPLETED|Status at Week 156||166
8816566|NCT01544595|9870076|FG004|NOT COMPLETED|Status at Week 156||38
8816567|NCT01544595|9870077|FG005|NOT COMPLETED|Status at Week 156||15
8565329|NCT00066365|9597403|FG001|COMPLETED|Overall Study||4
8565330|NCT00066365|9597402|FG000|NOT COMPLETED|Overall Study||23
8565331|NCT00066365|9597403|FG001|NOT COMPLETED|Overall Study||14
8565332|NCT00066469|9597411|FG000|STARTED|Overall Study||55
8565333|NCT00066469|9597411|FG000|COMPLETED|Overall Study||39
8565334|NCT00066469|9597411|FG000|NOT COMPLETED|Overall Study||16
8565335|NCT00066573|9597417|FG000|STARTED|Overall Study||3789
8565336|NCT00066573|9597418|FG001|STARTED|Overall Study||3787
8565337|NCT00066573|9597417|FG000|COMPLETED|Overall Study||3761
8565338|NCT00066573|9597418|FG001|COMPLETED|Overall Study||3759
8565339|NCT00066573|9597417|FG000|NOT COMPLETED|Overall Study||28
8565340|NCT00066573|9597418|FG001|NOT COMPLETED|Overall Study||28
8565341|NCT00066677|9597426|FG000|STARTED|Overall Study||16
8565342|NCT00066677|9597427|FG001|STARTED|Overall Study||16
8565343|NCT00066677|9597426|FG000|COMPLETED|Overall Study||16
8565344|NCT00066677|9597427|FG001|COMPLETED|Overall Study||16
8565345|NCT00066677|9597426|FG000|NOT COMPLETED|Overall Study||0
8565346|NCT00066677|9597427|FG001|NOT COMPLETED|Overall Study||0
8565347|NCT00066690|9597436|FG000|STARTED|Overall Study||1021
8565348|NCT00066690|9597437|FG001|STARTED|Overall Study||1024
8565349|NCT00066690|9597438|FG002|STARTED|Overall Study||1021
8565350|NCT00066690|9597436|FG000|COMPLETED|Overall Study||423
8565351|NCT00066690|9597437|FG001|COMPLETED|Overall Study||502
8565352|NCT00066690|9597438|FG002|COMPLETED|Overall Study||457
8565353|NCT00066690|9597436|FG000|NOT COMPLETED|Overall Study||598
8565354|NCT00066690|9597437|FG001|NOT COMPLETED|Overall Study||522
8565355|NCT00066690|9597438|FG002|NOT COMPLETED|Overall Study||564
8565356|NCT00066703|9597451|FG000|STARTED|Overall Study||1334
8565357|NCT00066703|9597452|FG001|STARTED|Overall Study||1338
8565358|NCT00066703|9597451|FG000|COMPLETED|Overall Study||722
8565359|NCT00066703|9597452|FG001|COMPLETED|Overall Study||756
8565360|NCT00066703|9597451|FG000|NOT COMPLETED|Overall Study||612
8565361|NCT00066703|9597452|FG001|NOT COMPLETED|Overall Study||582
8565362|NCT00066729|9597458|FG000|STARTED|Overall Study||9
8565363|NCT00066729|9597458|FG000|COMPLETED|Overall Study||7
8565364|NCT00066729|9597458|FG000|NOT COMPLETED|Overall Study||2
8565365|NCT00066742|9597462|FG000|STARTED|Induction Chemoradiotherapy||72
8565366|NCT00066742|9597462|FG000|Eligible|Induction Chemoradiotherapy||69
8565367|NCT00066742|9597462|FG000|Began Protocol Treatment|Induction Chemoradiotherapy||68
8565368|NCT00066742|9597462|FG000|COMPLETED|Induction Chemoradiotherapy||43
8565369|NCT00066742|9597462|FG000|NOT COMPLETED|Induction Chemoradiotherapy||29
8565370|NCT00066742|9597462|FG000|STARTED|Consolidation Chemotherapy||42
8565371|NCT00066742|9597462|FG000|Eligible|Consolidation Chemotherapy||40
8565372|NCT00066742|9597462|FG000|COMPLETED|Consolidation Chemotherapy||39
8565373|NCT00066742|9597462|FG000|NOT COMPLETED|Consolidation Chemotherapy||3
8565374|NCT00066781|9597470|FG000|STARTED|Overall Study||14
8565375|NCT00066781|9597471|FG001|STARTED|Overall Study||17
8565376|NCT00066781|9597470|FG000|COMPLETED|Overall Study||14
8565377|NCT00066781|9597471|FG001|COMPLETED|Overall Study||17
8565378|NCT00066781|9597470|FG000|NOT COMPLETED|Overall Study||0
8565379|NCT00066781|9597471|FG001|NOT COMPLETED|Overall Study||0
8620943|NCT00476996|9659820|FG002|STARTED|OLE Phase (From Week 48)||0
8620944|NCT00476996|9659821|FG003|STARTED|OLE Phase (From Week 48)||664
8620945|NCT00476996|9659818|FG000|COMPLETED|OLE Phase (From Week 48)||0
8565380|NCT00066937|9597481|FG000|STARTED|Treatment Phase||41
8565381|NCT00066937|9597482|FG001|STARTED|Treatment Phase||38
8565382|NCT00066937|9597483|FG002|STARTED|Treatment Phase||37
8565383|NCT00066937|9597484|FG003|STARTED|Treatment Phase||24
8943793|NCT02391948|10005621|FG000|NOT COMPLETED|6-month Assessment||79
8943794|NCT02391948|10005622|FG001|NOT COMPLETED|6-month Assessment||56
8943795|NCT02391948|10005623|FG002|NOT COMPLETED|6-month Assessment||31
8943796|NCT02391948|10005624|FG003|NOT COMPLETED|6-month Assessment||45
8943797|NCT02391948|10005625|FG004|NOT COMPLETED|6-month Assessment||26
8943798|NCT02391948|10005621|FG000|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 77 of the Not Completed remained active.|225
8943799|NCT02391948|10005622|FG001|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 51 of the Not Completed remained active.|156
8948743|NCT02432274|10011218|FG001|Underwent Run-in Period|Overall Study||1
8565384|NCT00066937|9597481|FG000|COMPLETED|Treatment Phase||38
8565385|NCT00066937|9597482|FG001|COMPLETED|Treatment Phase||33
8620946|NCT00476996|9659819|FG001|COMPLETED|OLE Phase (From Week 48)||0
8620947|NCT00476996|9659820|FG002|COMPLETED|OLE Phase (From Week 48)||0
8620948|NCT00476996|9659821|FG003|COMPLETED|OLE Phase (From Week 48)||0
8565386|NCT00066937|9597483|FG002|COMPLETED|Treatment Phase||26
8565387|NCT00066937|9597484|FG003|COMPLETED|Treatment Phase||19
8565388|NCT00066937|9597481|FG000|NOT COMPLETED|Treatment Phase||3
8565389|NCT00066937|9597482|FG001|NOT COMPLETED|Treatment Phase||5
8565390|NCT00066937|9597483|FG002|NOT COMPLETED|Treatment Phase||11
8565391|NCT00066937|9597484|FG003|NOT COMPLETED|Treatment Phase||5
8565392|NCT00066937|9597481|FG000|STARTED|3 Month Follow-up||38
8565393|NCT00066937|9597482|FG001|STARTED|3 Month Follow-up||33
8565394|NCT00066937|9597483|FG002|STARTED|3 Month Follow-up||26
8565395|NCT00066937|9597484|FG003|STARTED|3 Month Follow-up||19
8565396|NCT00066937|9597481|FG000|COMPLETED|3 Month Follow-up||33
8565397|NCT00066937|9597482|FG001|COMPLETED|3 Month Follow-up||32
8565398|NCT00066937|9597483|FG002|COMPLETED|3 Month Follow-up||25
8565399|NCT00066937|9597484|FG003|COMPLETED|3 Month Follow-up||15
8536181|NCT03284853|9568792|FG000|STARTED|Overall Study||218
8536182|NCT03284853|9568793|FG001|STARTED|Overall Study||212
8536183|NCT03284853|9568792|FG000|Intent-to-Treat Population|Overall Study||218
8536184|NCT03284853|9568793|FG001|Intent-to-Treat Population|Overall Study||212
8536185|NCT03284853|9568792|FG000|Per-Protocol Population|Overall Study||169
8536186|NCT03284853|9568793|FG001|Per-Protocol Population|Overall Study||170
8536187|NCT03284853|9568792|FG000|Safety Population|Overall Study||218
8536188|NCT03284853|9568793|FG001|Safety Population|Overall Study||212
8536189|NCT03284853|9568792|FG000|COMPLETED|Overall Study||163
8536190|NCT03284853|9568793|FG001|COMPLETED|Overall Study||199
8536191|NCT03284853|9568792|FG000|NOT COMPLETED|Overall Study||55
8536192|NCT03284853|9568793|FG001|NOT COMPLETED|Overall Study||13
8536193|NCT03032250|9568801|FG000|STARTED|Overall Study||17
8536194|NCT03032250|9568802|FG001|STARTED|Overall Study||18
8536195|NCT03032250|9568801|FG000|COMPLETED|Overall Study||17
8536196|NCT03032250|9568802|FG001|COMPLETED|Overall Study||18
8536197|NCT03032250|9568801|FG000|NOT COMPLETED|Overall Study||0
8536198|NCT03032250|9568802|FG001|NOT COMPLETED|Overall Study||0
8536199|NCT02942966|9568810|FG000|STARTED|Overall Study|Intent to Treat (ITT) population.|233
8536200|NCT02942966|9568810|FG000|COMPLETED|Overall Study|Completed 6-month follow-up|205
8536201|NCT02942966|9568810|FG000|NOT COMPLETED|Overall Study||28
8536202|NCT02774889|9568816|FG000|STARTED|Overall Study||23
8536203|NCT02774889|9568817|FG001|STARTED|Overall Study||22
8536204|NCT02774889|9568816|FG000|COMPLETED|Overall Study||21
8536205|NCT02774889|9568817|FG001|COMPLETED|Overall Study||21
8536206|NCT02774889|9568816|FG000|NOT COMPLETED|Overall Study||2
8536207|NCT02774889|9568817|FG001|NOT COMPLETED|Overall Study||1
8536208|NCT02721069|9568825|FG000|STARTED|Overall Study||175
8536209|NCT02721069|9568825|FG000|COMPLETED|Overall Study||117
8536210|NCT02721069|9568825|FG000|NOT COMPLETED|Overall Study||58
8536211|NCT02297438|9568837|FG000|STARTED|Overall Study||169
8536212|NCT02297438|9568838|FG001|STARTED|Overall Study||171
8536213|NCT02297438|9568837|FG000|Received Treatment|Overall Study||168
8536214|NCT02297438|9568838|FG001|Received Treatment|Overall Study||171
8536215|NCT02297438|9568837|FG000|COMPLETED|Overall Study||0
8536216|NCT02297438|9568838|FG001|COMPLETED|Overall Study||0
8536217|NCT02297438|9568837|FG000|NOT COMPLETED|Overall Study||169
8536218|NCT02297438|9568838|FG001|NOT COMPLETED|Overall Study||171
8536219|NCT02297412|9568846|FG000|STARTED|Overall Study||23
8536220|NCT02297412|9568847|FG001|STARTED|Overall Study||24
8536221|NCT02297412|9568846|FG000|COMPLETED|Overall Study||22
8536222|NCT02297412|9568847|FG001|COMPLETED|Overall Study||23
8536223|NCT02297412|9568846|FG000|NOT COMPLETED|Overall Study||1
8536224|NCT02297412|9568847|FG001|NOT COMPLETED|Overall Study||1
8536225|NCT02292758|9568855|FG000|STARTED|Overall Study||19
8536226|NCT02292758|9568856|FG001|STARTED|Overall Study||17
8536227|NCT02292758|9568855|FG000|COMPLETED|Overall Study||19
8536228|NCT02292758|9568856|FG001|COMPLETED|Overall Study||17
8536229|NCT02292758|9568855|FG000|NOT COMPLETED|Overall Study||0
8536230|NCT02292758|9568856|FG001|NOT COMPLETED|Overall Study||0
8536231|NCT02250326|9568865|FG000|STARTED|Treatment Period||81
8536232|NCT02250326|9568866|FG001|STARTED|Treatment Period||79
8536233|NCT02250326|9568867|FG002|STARTED|Treatment Period||80
8536234|NCT02250326|9568865|FG000|Treated Population|Treatment Period||79
8536235|NCT02250326|9568866|FG001|Treated Population|Treatment Period||78
8536236|NCT02250326|9568867|FG002|Treated Population|Treatment Period||79
8536237|NCT02250326|9568865|FG000|COMPLETED|Treatment Period|Data Cut-off Date = 30 August 2017|0
8536238|NCT02250326|9568866|FG001|COMPLETED|Treatment Period|Data Cut-off Date = 23 December 2017|15
8536239|NCT02250326|9568867|FG002|COMPLETED|Treatment Period|Data Cut-off Date = 30 August 2017|3
8536240|NCT02250326|9568865|FG000|NOT COMPLETED|Treatment Period||81
8536241|NCT02250326|9568866|FG001|NOT COMPLETED|Treatment Period||64
8536242|NCT02250326|9568867|FG002|NOT COMPLETED|Treatment Period||77
8536243|NCT02250326|9568865|FG000|STARTED|Follow-Up Period||67
8536244|NCT02250326|9568866|FG001|STARTED|Follow-Up Period||43
8536245|NCT02250326|9568867|FG002|STARTED|Follow-Up Period||64
8536246|NCT02250326|9568865|FG000|COMPLETED|Follow-Up Period||18
8536247|NCT02250326|9568866|FG001|COMPLETED|Follow-Up Period||13
8536248|NCT02250326|9568867|FG002|COMPLETED|Follow-Up Period||26
8536249|NCT02250326|9568865|FG000|NOT COMPLETED|Follow-Up Period||49
8536250|NCT02250326|9568866|FG001|NOT COMPLETED|Follow-Up Period||30
8536251|NCT02250326|9568867|FG002|NOT COMPLETED|Follow-Up Period||38
8536252|NCT01856270|9568878|FG000|STARTED|Overall Study||24
8536253|NCT01856270|9568879|FG001|STARTED|Overall Study||26
8536254|NCT01856270|9568878|FG000|COMPLETED|Overall Study||13
8536255|NCT01856270|9568879|FG001|COMPLETED|Overall Study||14
8536256|NCT01856270|9568878|FG000|NOT COMPLETED|Overall Study||11
8536257|NCT01856270|9568879|FG001|NOT COMPLETED|Overall Study||12
8536258|NCT01503515|9568889|FG000|STARTED|Overall Study||145
8536259|NCT01503515|9568890|FG001|STARTED|Overall Study||147
8536260|NCT01503515|9568889|FG000|COMPLETED|Overall Study||124
8536261|NCT01503515|9568890|FG001|COMPLETED|Overall Study||112
8536262|NCT01503515|9568889|FG000|NOT COMPLETED|Overall Study||21
8536263|NCT01503515|9568890|FG001|NOT COMPLETED|Overall Study||35
8536264|NCT01491893|9568896|FG000|STARTED|Overall Study||1
8536265|NCT01491893|9568897|FG001|STARTED|Overall Study||1
8536266|NCT01491893|9568898|FG002|STARTED|Overall Study||1
8536267|NCT01491893|9568899|FG003|STARTED|Overall Study||1
8536268|NCT01491893|9568900|FG004|STARTED|Overall Study||4
8536269|NCT01491893|9568901|FG005|STARTED|Overall Study||1
8536270|NCT01491893|9568902|FG006|STARTED|Overall Study||6
8536271|NCT01491893|9568903|FG007|STARTED|Overall Study||24
8536272|NCT01491893|9568904|FG008|STARTED|Overall Study||15
8536273|NCT01491893|9568905|FG009|STARTED|Overall Study||7
8536274|NCT01491893|9568896|FG000|COMPLETED|Overall Study||1
8536275|NCT01491893|9568897|FG001|COMPLETED|Overall Study||1
8536276|NCT01491893|9568898|FG002|COMPLETED|Overall Study||1
8536277|NCT01491893|9568899|FG003|COMPLETED|Overall Study||1
8536278|NCT01491893|9568900|FG004|COMPLETED|Overall Study||4
8536279|NCT01491893|9568901|FG005|COMPLETED|Overall Study||1
8536280|NCT01491893|9568902|FG006|COMPLETED|Overall Study||6
8536281|NCT01491893|9568903|FG007|COMPLETED|Overall Study||24
8536282|NCT01491893|9568904|FG008|COMPLETED|Overall Study||15
8536283|NCT01491893|9568905|FG009|COMPLETED|Overall Study||7
8536284|NCT01491893|9568896|FG000|NOT COMPLETED|Overall Study||0
8536285|NCT01491893|9568897|FG001|NOT COMPLETED|Overall Study||0
8536286|NCT01491893|9568898|FG002|NOT COMPLETED|Overall Study||0
8536287|NCT01491893|9568899|FG003|NOT COMPLETED|Overall Study||0
8536288|NCT01491893|9568900|FG004|NOT COMPLETED|Overall Study||0
8536289|NCT01491893|9568901|FG005|NOT COMPLETED|Overall Study||0
8536290|NCT01491893|9568902|FG006|NOT COMPLETED|Overall Study||0
8536291|NCT01491893|9568903|FG007|NOT COMPLETED|Overall Study||0
8536292|NCT01491893|9568904|FG008|NOT COMPLETED|Overall Study||0
8536293|NCT01491893|9568905|FG009|NOT COMPLETED|Overall Study||0
8536294|NCT00245960|9568923|FG000|STARTED|Period 1 (Double Blind): 1-12 Weeks||379
8536295|NCT00245960|9568924|FG001|STARTED|Period 1 (Double Blind): 1-12 Weeks||373
8536296|NCT00245960|9568923|FG000|COMPLETED|Period 1 (Double Blind): 1-12 Weeks||364
8536297|NCT00245960|9568924|FG001|COMPLETED|Period 1 (Double Blind): 1-12 Weeks||362
8536298|NCT00245960|9568923|FG000|NOT COMPLETED|Period 1 (Double Blind): 1-12 Weeks||15
8536299|NCT00245960|9568924|FG001|NOT COMPLETED|Period 1 (Double Blind): 1-12 Weeks||11
8536300|NCT00245960|9568923|FG000|STARTED|Period 2 (Open Label): 13-24 Weeks||364
8536301|NCT00245960|9568924|FG001|STARTED|Period 2 (Open Label): 13-24 Weeks||362
8536302|NCT00245960|9568923|FG000|COMPLETED|Period 2 (Open Label): 13-24 Weeks||350
8536303|NCT00245960|9568924|FG001|COMPLETED|Period 2 (Open Label): 13-24 Weeks||344
8536304|NCT00245960|9568923|FG000|NOT COMPLETED|Period 2 (Open Label): 13-24 Weeks||14
8536305|NCT00245960|9568924|FG001|NOT COMPLETED|Period 2 (Open Label): 13-24 Weeks||18
8565400|NCT00066937|9597481|FG000|NOT COMPLETED|3 Month Follow-up||5
8565401|NCT00066937|9597482|FG001|NOT COMPLETED|3 Month Follow-up||1
8565402|NCT00066937|9597483|FG002|NOT COMPLETED|3 Month Follow-up||1
8565403|NCT00066937|9597484|FG003|NOT COMPLETED|3 Month Follow-up||4
8565404|NCT00066937|9597481|FG000|STARTED|6 Month Follow-up||33
8565405|NCT00066937|9597482|FG001|STARTED|6 Month Follow-up||32
8565406|NCT00066937|9597483|FG002|STARTED|6 Month Follow-up||25
8565407|NCT00066937|9597484|FG003|STARTED|6 Month Follow-up||15
8565408|NCT00066937|9597481|FG000|COMPLETED|6 Month Follow-up||26
8565409|NCT00066937|9597482|FG001|COMPLETED|6 Month Follow-up||29
8565410|NCT00066937|9597483|FG002|COMPLETED|6 Month Follow-up||22
8565411|NCT00066937|9597484|FG003|COMPLETED|6 Month Follow-up||14
8565412|NCT00066937|9597481|FG000|NOT COMPLETED|6 Month Follow-up||7
8565413|NCT00066937|9597482|FG001|NOT COMPLETED|6 Month Follow-up||3
8565414|NCT00066937|9597483|FG002|NOT COMPLETED|6 Month Follow-up||3
8565415|NCT00066937|9597484|FG003|NOT COMPLETED|6 Month Follow-up||1
8565416|NCT00067002|9597496|FG000|STARTED|Overall Study||52
8565417|NCT00067002|9597497|FG001|STARTED|Overall Study||53
8565418|NCT00067002|9597496|FG000|COMPLETED|Overall Study||45
8565419|NCT00067002|9597497|FG001|COMPLETED|Overall Study||44
8565420|NCT00067002|9597496|FG000|NOT COMPLETED|Overall Study||7
8565421|NCT00067002|9597497|FG001|NOT COMPLETED|Overall Study||9
8565422|NCT00067028|9597506|FG000|STARTED|Overall Study||17
8565423|NCT00067028|9597507|FG001|STARTED|Overall Study||36
8565424|NCT00067028|9597508|FG002|STARTED|Overall Study||63
8565425|NCT00067028|9597506|FG000|COMPLETED|Overall Study||17
8565426|NCT00067028|9597507|FG001|COMPLETED|Overall Study||36
8565427|NCT00067028|9597508|FG002|COMPLETED|Overall Study||63
8565428|NCT00067028|9597506|FG000|NOT COMPLETED|Overall Study||0
8565429|NCT00067028|9597507|FG001|NOT COMPLETED|Overall Study||0
8565430|NCT00067028|9597508|FG002|NOT COMPLETED|Overall Study||0
8565431|NCT00067236|9597520|FG000|STARTED|Overall Study||128
8565432|NCT00067236|9597521|FG001|STARTED|Overall Study||125
8565433|NCT00067236|9597520|FG000|COMPLETED|Overall Study||108
8565434|NCT00067236|9597521|FG001|COMPLETED|Overall Study||99
8565435|NCT00067236|9597520|FG000|NOT COMPLETED|Overall Study||20
8565436|NCT00067236|9597521|FG001|NOT COMPLETED|Overall Study||26
8565437|NCT00067470|9597529|FG000|STARTED|Overall Study||19
8565438|NCT00067470|9597530|FG001|STARTED|Overall Study||20
8565439|NCT00067470|9597529|FG000|COMPLETED|Overall Study||19
8565440|NCT00067470|9597530|FG001|COMPLETED|Overall Study||19
8565441|NCT00067470|9597529|FG000|NOT COMPLETED|Overall Study||0
8565442|NCT00067470|9597530|FG001|NOT COMPLETED|Overall Study||1
8565443|NCT00067808|9597539|FG000|STARTED|Overall Study||17
8565444|NCT00067808|9597540|FG001|STARTED|Overall Study||93
8565445|NCT00067808|9597541|FG002|STARTED|Overall Study||14
8565446|NCT00067808|9597539|FG000|COMPLETED|Overall Study||17
8565447|NCT00067808|9597540|FG001|COMPLETED|Overall Study||93
8565448|NCT00067808|9597541|FG002|COMPLETED|Overall Study||14
8565449|NCT00067808|9597539|FG000|NOT COMPLETED|Overall Study||0
8565450|NCT00067808|9597540|FG001|NOT COMPLETED|Overall Study||0
8565451|NCT00067808|9597541|FG002|NOT COMPLETED|Overall Study||0
8565452|NCT00067990|9597551|FG000|STARTED|Overall Study||77
8565453|NCT00067990|9597552|FG001|STARTED|Overall Study||76
8565454|NCT00067990|9597551|FG000|COMPLETED|Overall Study||67
8816568|NCT01544920|9870097|FG000|STARTED|Overall Study||368
8816569|NCT01544920|9870098|FG001|STARTED|Overall Study||369
8816570|NCT01544920|9870097|FG000|COMPLETED|Overall Study||349
8816571|NCT01544920|9870098|FG001|COMPLETED|Overall Study||346
8536306|NCT04565353|9568950|FG000|STARTED|Overall Study||3742
8536307|NCT04565353|9568951|FG001|STARTED|Overall Study||3737
8536308|NCT04565353|9568952|FG002|STARTED|Overall Study||3709
8536309|NCT04565353|9568953|FG003|STARTED|Overall Study||3735
8536310|NCT04565353|9568954|FG004|STARTED|Overall Study||3758
8536311|NCT04565353|9568955|FG005|STARTED|Overall Study||3769
8536312|NCT04565353|9568956|FG006|STARTED|Overall Study||3719
8536313|NCT04565353|9568957|FG007|STARTED|Overall Study||3732
8536314|NCT04565353|9568958|FG008|STARTED|Overall Study||3728
8536315|NCT04565353|9568959|FG009|STARTED|Overall Study||3777
8536316|NCT04565353|9568960|FG010|STARTED|Overall Study||3672
8536317|NCT04565353|9568961|FG011|STARTED|Overall Study||3751
8536318|NCT04565353|9568962|FG012|STARTED|Overall Study||3737
8536319|NCT04565353|9568963|FG013|STARTED|Overall Study||3714
8536320|NCT04565353|9568964|FG014|STARTED|Overall Study||3773
8536321|NCT04565353|9568965|FG015|STARTED|Overall Study||3739
8536322|NCT04565353|9568966|FG016|STARTED|Overall Study||3776
8536323|NCT04565353|9568967|FG017|STARTED|Overall Study||3744
8536324|NCT04565353|9568968|FG018|STARTED|Overall Study||3741
8536325|NCT04565353|9568969|FG019|STARTED|Overall Study||3758
8536326|NCT04565353|9568950|FG000|COMPLETED|Overall Study||3742
8536327|NCT04565353|9568951|FG001|COMPLETED|Overall Study||3688
8536328|NCT04565353|9568952|FG002|COMPLETED|Overall Study||3670
8536329|NCT04565353|9568953|FG003|COMPLETED|Overall Study||3693
8536330|NCT04565353|9568954|FG004|COMPLETED|Overall Study||3717
8536331|NCT04565353|9568955|FG005|COMPLETED|Overall Study||3716
8536332|NCT04565353|9568956|FG006|COMPLETED|Overall Study||3665
8536333|NCT04565353|9568957|FG007|COMPLETED|Overall Study||3693
8536334|NCT04565353|9568958|FG008|COMPLETED|Overall Study||3662
8536335|NCT04565353|9568959|FG009|COMPLETED|Overall Study||3734
8536336|NCT04565353|9568960|FG010|COMPLETED|Overall Study||3623
8536337|NCT04565353|9568961|FG011|COMPLETED|Overall Study||3710
8536338|NCT04565353|9568962|FG012|COMPLETED|Overall Study||3685
8536339|NCT04565353|9568963|FG013|COMPLETED|Overall Study||3664
8536340|NCT04565353|9568964|FG014|COMPLETED|Overall Study||3736
8536341|NCT04565353|9568965|FG015|COMPLETED|Overall Study||3690
8536342|NCT04565353|9568966|FG016|COMPLETED|Overall Study||3734
8536343|NCT04565353|9568967|FG017|COMPLETED|Overall Study||3696
8536344|NCT04565353|9568968|FG018|COMPLETED|Overall Study||3698
8536345|NCT04565353|9568969|FG019|COMPLETED|Overall Study||3712
8536346|NCT04565353|9568950|FG000|NOT COMPLETED|Overall Study||0
8536347|NCT04565353|9568951|FG001|NOT COMPLETED|Overall Study||49
8536348|NCT04565353|9568952|FG002|NOT COMPLETED|Overall Study||39
8536349|NCT04565353|9568953|FG003|NOT COMPLETED|Overall Study||42
8536350|NCT04565353|9568954|FG004|NOT COMPLETED|Overall Study||41
8536351|NCT04565353|9568955|FG005|NOT COMPLETED|Overall Study||53
8536352|NCT04565353|9568956|FG006|NOT COMPLETED|Overall Study||54
8536353|NCT04565353|9568957|FG007|NOT COMPLETED|Overall Study||39
8536354|NCT04565353|9568958|FG008|NOT COMPLETED|Overall Study||66
8536355|NCT04565353|9568959|FG009|NOT COMPLETED|Overall Study||43
8536356|NCT04565353|9568960|FG010|NOT COMPLETED|Overall Study||49
8536357|NCT04565353|9568961|FG011|NOT COMPLETED|Overall Study||41
8536358|NCT04565353|9568962|FG012|NOT COMPLETED|Overall Study||52
8536359|NCT04565353|9568963|FG013|NOT COMPLETED|Overall Study||50
8536360|NCT04565353|9568964|FG014|NOT COMPLETED|Overall Study||37
8536361|NCT04565353|9568965|FG015|NOT COMPLETED|Overall Study||49
8536362|NCT04565353|9568966|FG016|NOT COMPLETED|Overall Study||42
8536363|NCT04565353|9568967|FG017|NOT COMPLETED|Overall Study||48
8536364|NCT04565353|9568968|FG018|NOT COMPLETED|Overall Study||43
8536365|NCT04565353|9568969|FG019|NOT COMPLETED|Overall Study||46
8536366|NCT04015336|9569011|FG000|STARTED|Overall Study||1
8536367|NCT04015336|9569011|FG000|COMPLETED|Overall Study||0
8536368|NCT04015336|9569011|FG000|NOT COMPLETED|Overall Study||1
8536369|NCT03972813|9569033|FG000|STARTED|Overall Study||85
8536370|NCT03972813|9569034|FG001|STARTED|Overall Study||49
8536371|NCT03972813|9569035|FG002|STARTED|Overall Study||58
8620949|NCT00476996|9659818|FG000|NOT COMPLETED|OLE Phase (From Week 48)||0
8620950|NCT00476996|9659819|FG001|NOT COMPLETED|OLE Phase (From Week 48)||0
8620951|NCT00476996|9659820|FG002|NOT COMPLETED|OLE Phase (From Week 48)||0
8620952|NCT00476996|9659821|FG003|NOT COMPLETED|OLE Phase (From Week 48)||664
8620953|NCT00477087|9659830|FG000|STARTED|Overall Study||10
8620954|NCT00477087|9659830|FG000|COMPLETED|Overall Study||10
8536372|NCT03972813|9569036|FG003|STARTED|Overall Study||55
8536373|NCT03972813|9569037|FG004|STARTED|Overall Study||52
8536374|NCT03972813|9569038|FG005|STARTED|Overall Study||51
8536375|NCT03972813|9569039|FG006|STARTED|Overall Study||53
8536376|NCT03972813|9569040|FG007|STARTED|Overall Study||55
8536377|NCT03972813|9569041|FG008|STARTED|Overall Study||58
8536378|NCT03972813|9569042|FG009|STARTED|Overall Study||60
8536379|NCT03972813|9569043|FG010|STARTED|Overall Study||62
8536380|NCT03972813|9569044|FG011|STARTED|Overall Study||55
8620955|NCT00477087|9659830|FG000|NOT COMPLETED|Overall Study||0
8620956|NCT00477152|9659834|FG000|STARTED|Overall Study|One patient withdrawn prior to treatment, so not included in analyses.|52
8816572|NCT01544920|9870097|FG000|NOT COMPLETED|Overall Study||19
8816573|NCT01544920|9870098|FG001|NOT COMPLETED|Overall Study||23
8536381|NCT03972813|9569045|FG012|STARTED|Overall Study||58
8536382|NCT03972813|9569046|FG013|STARTED|Overall Study||55
8536383|NCT03972813|9569047|FG014|STARTED|Overall Study||58
8536384|NCT03972813|9569048|FG015|STARTED|Overall Study||56
8536385|NCT03972813|9569049|FG016|STARTED|Overall Study||51
8536386|NCT03972813|9569050|FG017|STARTED|Overall Study||50
8536387|NCT03972813|9569033|FG000|COMPLETED|Overall Study||79
8536388|NCT03972813|9569034|FG001|COMPLETED|Overall Study||45
8536389|NCT03972813|9569035|FG002|COMPLETED|Overall Study||52
8536390|NCT03972813|9569036|FG003|COMPLETED|Overall Study||51
8536391|NCT03972813|9569037|FG004|COMPLETED|Overall Study||48
8536392|NCT03972813|9569038|FG005|COMPLETED|Overall Study||49
8536393|NCT03972813|9569039|FG006|COMPLETED|Overall Study||49
8536394|NCT03972813|9569040|FG007|COMPLETED|Overall Study||52
8536395|NCT03972813|9569041|FG008|COMPLETED|Overall Study||53
8536396|NCT03972813|9569042|FG009|COMPLETED|Overall Study||58
8536397|NCT03972813|9569043|FG010|COMPLETED|Overall Study||57
8536398|NCT03972813|9569044|FG011|COMPLETED|Overall Study||51
8536399|NCT03972813|9569045|FG012|COMPLETED|Overall Study||55
8536400|NCT03972813|9569046|FG013|COMPLETED|Overall Study||52
8536401|NCT03972813|9569047|FG014|COMPLETED|Overall Study||56
8536402|NCT03972813|9569048|FG015|COMPLETED|Overall Study||50
8536403|NCT03972813|9569049|FG016|COMPLETED|Overall Study||48
8536404|NCT03972813|9569050|FG017|COMPLETED|Overall Study||48
8536405|NCT03972813|9569033|FG000|NOT COMPLETED|Overall Study||6
8620957|NCT00477152|9659834|FG000|COMPLETED|Overall Study|Two patients treated, but assessments incomplete. All available data included in analyses for these.|49
8620958|NCT00477152|9659834|FG000|NOT COMPLETED|Overall Study||3
8620959|NCT00477165|9659840|FG000|STARTED|Overall Study||27
8620960|NCT00477165|9659841|FG001|STARTED|Overall Study||27
8816574|NCT01544998|9870106|FG000|STARTED|First Intervention (3 Hours)||26
8816575|NCT01544998|9870107|FG001|STARTED|First Intervention (3 Hours)||15
8816576|NCT01544998|9870106|FG000|COMPLETED|First Intervention (3 Hours)||26
8816577|NCT01544998|9870107|FG001|COMPLETED|First Intervention (3 Hours)||15
8816578|NCT01544998|9870106|FG000|NOT COMPLETED|First Intervention (3 Hours)||0
8816579|NCT01544998|9870107|FG001|NOT COMPLETED|First Intervention (3 Hours)||0
8816580|NCT01544998|9870106|FG000|STARTED|Washout (1 Week)||26
8816581|NCT01544998|9870107|FG001|STARTED|Washout (1 Week)||15
8816582|NCT01544998|9870106|FG000|COMPLETED|Washout (1 Week)||26
8816583|NCT01544998|9870107|FG001|COMPLETED|Washout (1 Week)||15
8816584|NCT01544998|9870106|FG000|NOT COMPLETED|Washout (1 Week)||0
8816585|NCT01544998|9870107|FG001|NOT COMPLETED|Washout (1 Week)||0
8816586|NCT01544998|9870106|FG000|STARTED|Second Intervention (3 Hours)||26
8816587|NCT01544998|9870107|FG001|STARTED|Second Intervention (3 Hours)||15
8816588|NCT01544998|9870106|FG000|COMPLETED|Second Intervention (3 Hours)||26
8816589|NCT01544998|9870107|FG001|COMPLETED|Second Intervention (3 Hours)||15
8816590|NCT01544998|9870106|FG000|NOT COMPLETED|Second Intervention (3 Hours)||0
8816591|NCT01544998|9870107|FG001|NOT COMPLETED|Second Intervention (3 Hours)||0
8816592|NCT01545076|9870115|FG000|STARTED|IgPro10 Restabilization Period||208
8816593|NCT01545076|9870116|FG001|STARTED|IgPro10 Restabilization Period||0
8816594|NCT01545076|9870117|FG002|STARTED|IgPro10 Restabilization Period||0
8816595|NCT01545076|9870118|FG003|STARTED|IgPro10 Restabilization Period||0
8816596|NCT01545076|9870119|FG004|STARTED|IgPro10 Restabilization Period||0
8816597|NCT01545076|9870115|FG000|COMPLETED|IgPro10 Restabilization Period||172
8816598|NCT01545076|9870116|FG001|COMPLETED|IgPro10 Restabilization Period||0
8816599|NCT01545076|9870117|FG002|COMPLETED|IgPro10 Restabilization Period||0
8816600|NCT01545076|9870118|FG003|COMPLETED|IgPro10 Restabilization Period||0
8816601|NCT01545076|9870119|FG004|COMPLETED|IgPro10 Restabilization Period||0
8816602|NCT01545076|9870115|FG000|NOT COMPLETED|IgPro10 Restabilization Period||36
8816603|NCT01545076|9870116|FG001|NOT COMPLETED|IgPro10 Restabilization Period||0
8816604|NCT01545076|9870117|FG002|NOT COMPLETED|IgPro10 Restabilization Period||0
8816605|NCT01545076|9870118|FG003|NOT COMPLETED|IgPro10 Restabilization Period||0
8816606|NCT01545076|9870119|FG004|NOT COMPLETED|IgPro10 Restabilization Period||0
8816607|NCT01545076|9870115|FG000|STARTED|IgPro20 Subcutaneous Treatment Period||0
8816608|NCT01545076|9870116|FG001|STARTED|IgPro20 Subcutaneous Treatment Period||58
8816609|NCT01545076|9870117|FG002|STARTED|IgPro20 Subcutaneous Treatment Period||57
8816610|NCT01545076|9870118|FG003|STARTED|IgPro20 Subcutaneous Treatment Period||57
8816611|NCT01545076|9870119|FG004|STARTED|IgPro20 Subcutaneous Treatment Period||0
8816612|NCT01545076|9870115|FG000|COMPLETED|IgPro20 Subcutaneous Treatment Period||0
8816613|NCT01545076|9870116|FG001|COMPLETED|IgPro20 Subcutaneous Treatment Period||39
8816614|NCT01545076|9870117|FG002|COMPLETED|IgPro20 Subcutaneous Treatment Period||36
8816615|NCT01545076|9870118|FG003|COMPLETED|IgPro20 Subcutaneous Treatment Period||21
8816616|NCT01545076|9870119|FG004|COMPLETED|IgPro20 Subcutaneous Treatment Period||0
8816617|NCT01545076|9870115|FG000|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||0
8816618|NCT01545076|9870116|FG001|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||19
8536406|NCT03972813|9569034|FG001|NOT COMPLETED|Overall Study||4
8536407|NCT03972813|9569035|FG002|NOT COMPLETED|Overall Study||6
8536408|NCT03972813|9569036|FG003|NOT COMPLETED|Overall Study||4
8536409|NCT03972813|9569037|FG004|NOT COMPLETED|Overall Study||4
8536410|NCT03972813|9569038|FG005|NOT COMPLETED|Overall Study||2
8536411|NCT03972813|9569039|FG006|NOT COMPLETED|Overall Study||4
8816619|NCT01545076|9870117|FG002|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||21
8816620|NCT01545076|9870118|FG003|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||36
8816621|NCT01545076|9870119|FG004|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||0
8816622|NCT01545076|9870115|FG000|STARTED|IgPro10 Rescue Period||0
8536412|NCT03972813|9569040|FG007|NOT COMPLETED|Overall Study||3
8536413|NCT03972813|9569041|FG008|NOT COMPLETED|Overall Study||5
8536414|NCT03972813|9569042|FG009|NOT COMPLETED|Overall Study||2
8536415|NCT03972813|9569043|FG010|NOT COMPLETED|Overall Study||5
8536416|NCT03972813|9569044|FG011|NOT COMPLETED|Overall Study||4
8536417|NCT03972813|9569045|FG012|NOT COMPLETED|Overall Study||3
8536418|NCT03972813|9569046|FG013|NOT COMPLETED|Overall Study||3
8536419|NCT03972813|9569047|FG014|NOT COMPLETED|Overall Study||2
8536420|NCT03972813|9569048|FG015|NOT COMPLETED|Overall Study||6
8536421|NCT03972813|9569049|FG016|NOT COMPLETED|Overall Study||3
8536422|NCT03972813|9569050|FG017|NOT COMPLETED|Overall Study||2
8536423|NCT03920280|9569090|FG000|STARTED|Overall Study||41
8536424|NCT03920280|9569091|FG001|STARTED|Overall Study||78
8536425|NCT03920280|9569090|FG000|COMPLETED|Overall Study||38
8536426|NCT03920280|9569091|FG001|COMPLETED|Overall Study||72
8536427|NCT03920280|9569090|FG000|NOT COMPLETED|Overall Study||3
8536428|NCT03920280|9569091|FG001|NOT COMPLETED|Overall Study||6
8536429|NCT03913091|9569102|FG000|STARTED|Overall Study||92
8536430|NCT03913091|9569103|FG001|STARTED|Overall Study||92
8536431|NCT03913091|9569102|FG000|COMPLETED|Overall Study||72
8536432|NCT03913091|9569103|FG001|COMPLETED|Overall Study||78
8536433|NCT03913091|9569102|FG000|NOT COMPLETED|Overall Study||20
8536434|NCT03913091|9569103|FG001|NOT COMPLETED|Overall Study||14
8536435|NCT03802565|9569114|FG000|STARTED|Overall Study||82
8536436|NCT03802565|9569115|FG001|STARTED|Overall Study||87
8536437|NCT03802565|9569116|FG002|STARTED|Overall Study||83
8536438|NCT03802565|9569117|FG003|STARTED|Overall Study||85
8536439|NCT03802565|9569118|FG004|STARTED|Overall Study||78
8536440|NCT03802565|9569114|FG000|COMPLETED|Overall Study||77
8536441|NCT03802565|9569115|FG001|COMPLETED|Overall Study||83
8536442|NCT03802565|9569116|FG002|COMPLETED|Overall Study||74
8536443|NCT03802565|9569117|FG003|COMPLETED|Overall Study||77
8536444|NCT03802565|9569118|FG004|COMPLETED|Overall Study||72
8536445|NCT03802565|9569114|FG000|NOT COMPLETED|Overall Study||5
8536446|NCT03802565|9569115|FG001|NOT COMPLETED|Overall Study||4
8536447|NCT03802565|9569116|FG002|NOT COMPLETED|Overall Study||9
8536448|NCT03802565|9569117|FG003|NOT COMPLETED|Overall Study||8
8536449|NCT03802565|9569118|FG004|NOT COMPLETED|Overall Study||6
8536450|NCT03769194|9569134|FG000|STARTED|Overall Study||29
8536451|NCT03769194|9569135|FG001|STARTED|Overall Study||214
8536452|NCT03769194|9569136|FG002|STARTED|Overall Study||205
8536453|NCT03769194|9569137|FG003|STARTED|Overall Study||124
8536454|NCT03769194|9569134|FG000|COMPLETED|Overall Study||25
8536455|NCT03769194|9569135|FG001|COMPLETED|Overall Study||196
8536456|NCT03769194|9569136|FG002|COMPLETED|Overall Study||197
8536457|NCT03769194|9569137|FG003|COMPLETED|Overall Study||115
8536458|NCT03769194|9569134|FG000|NOT COMPLETED|Overall Study||4
8536459|NCT03769194|9569135|FG001|NOT COMPLETED|Overall Study||18
8536460|NCT03769194|9569136|FG002|NOT COMPLETED|Overall Study||8
8536461|NCT03769194|9569137|FG003|NOT COMPLETED|Overall Study||9
8536462|NCT03738332|9569147|FG000|STARTED|Overall Study||12
8536463|NCT03738332|9569147|FG000|COMPLETED|Overall Study||11
8536464|NCT03738332|9569147|FG000|NOT COMPLETED|Overall Study||1
8565455|NCT00067990|9597552|FG001|COMPLETED|Overall Study||54
8565456|NCT00067990|9597551|FG000|NOT COMPLETED|Overall Study||10
8565457|NCT00067990|9597552|FG001|NOT COMPLETED|Overall Study||22
8565458|NCT00068107|9597558|FG000|STARTED|Overall Study||12
8565459|NCT00068107|9597558|FG000|COMPLETED|Overall Study||3
8565460|NCT00068107|9597558|FG000|NOT COMPLETED|Overall Study||9
8565461|NCT00068237|9597565|FG000|STARTED|Overall Study||49
8565462|NCT00068237|9597565|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|44
8620961|NCT00477165|9659840|FG000|COMPLETED|Overall Study||20
8620962|NCT00477165|9659841|FG001|COMPLETED|Overall Study||25
8620963|NCT00477165|9659840|FG000|NOT COMPLETED|Overall Study||7
8620964|NCT00477165|9659841|FG001|NOT COMPLETED|Overall Study||2
8620965|NCT00477191|9659847|FG000|STARTED|Overall Study||18
8565463|NCT00068237|9597565|FG000|NOT COMPLETED|Overall Study||5
8565464|NCT00068250|9597572|FG000|STARTED|Phase I: Dose Level 1||6
8565465|NCT00068250|9597573|FG001|STARTED|Phase I: Dose Level 1||0
8565466|NCT00068250|9597574|FG002|STARTED|Phase I: Dose Level 1||0
8565467|NCT00068250|9597575|FG003|STARTED|Phase I: Dose Level 1||0
8565468|NCT00068250|9597572|FG000|COMPLETED|Phase I: Dose Level 1|Subjects with data available for the primary analysis are considered to have completed the study.|6
8565469|NCT00068250|9597573|FG001|COMPLETED|Phase I: Dose Level 1||0
8565470|NCT00068250|9597574|FG002|COMPLETED|Phase I: Dose Level 1||0
8565471|NCT00068250|9597575|FG003|COMPLETED|Phase I: Dose Level 1||0
8565472|NCT00068250|9597572|FG000|NOT COMPLETED|Phase I: Dose Level 1||0
8565473|NCT00068250|9597573|FG001|NOT COMPLETED|Phase I: Dose Level 1||0
8565474|NCT00068250|9597574|FG002|NOT COMPLETED|Phase I: Dose Level 1||0
8565475|NCT00068250|9597575|FG003|NOT COMPLETED|Phase I: Dose Level 1||0
8565476|NCT00068250|9597572|FG000|STARTED|Phase I: Dose Level 2||0
8565477|NCT00068250|9597573|FG001|STARTED|Phase I: Dose Level 2||7
8565478|NCT00068250|9597574|FG002|STARTED|Phase I: Dose Level 2||0
8565479|NCT00068250|9597575|FG003|STARTED|Phase I: Dose Level 2||0
8565480|NCT00068250|9597572|FG000|COMPLETED|Phase I: Dose Level 2||0
8565481|NCT00068250|9597573|FG001|COMPLETED|Phase I: Dose Level 2|Subjects with data available for the primary analysis are considered to have completed the study.|6
8620966|NCT00477191|9659847|FG000|COMPLETED|Overall Study||13
8620967|NCT00477191|9659847|FG000|NOT COMPLETED|Overall Study||5
8565482|NCT00068250|9597574|FG002|COMPLETED|Phase I: Dose Level 2||0
8565483|NCT00068250|9597575|FG003|COMPLETED|Phase I: Dose Level 2||0
8565484|NCT00068250|9597572|FG000|NOT COMPLETED|Phase I: Dose Level 2||0
8565485|NCT00068250|9597573|FG001|NOT COMPLETED|Phase I: Dose Level 2||1
8536465|NCT03451786|9569152|FG000|STARTED|Overall Study||369
8536466|NCT03451786|9569152|FG000|COMPLETED|Overall Study||310
8536467|NCT03451786|9569152|FG000|NOT COMPLETED|Overall Study||59
8536468|NCT03416179|9569160|FG000|STARTED|Overall Study||201
8536469|NCT03416179|9569161|FG001|STARTED|Overall Study||203
8536470|NCT03416179|9569162|FG002|STARTED|Overall Study||163
8536471|NCT03416179|9569163|FG003|STARTED|Overall Study||162
8536472|NCT03416179|9569160|FG000|COMPLETED|Overall Study||0
8536473|NCT03416179|9569161|FG001|COMPLETED|Overall Study||0
8536474|NCT03416179|9569162|FG002|COMPLETED|Overall Study||0
8536475|NCT03416179|9569163|FG003|COMPLETED|Overall Study||0
8536476|NCT03416179|9569160|FG000|NOT COMPLETED|Overall Study||201
8536477|NCT03416179|9569161|FG001|NOT COMPLETED|Overall Study||203
8536478|NCT03416179|9569162|FG002|NOT COMPLETED|Overall Study||163
8536479|NCT03416179|9569163|FG003|NOT COMPLETED|Overall Study||162
8536480|NCT03353922|9569173|FG000|STARTED|Overall Study||6
8536481|NCT03353922|9569174|FG001|STARTED|Overall Study||6
8536482|NCT03353922|9569175|FG002|STARTED|Overall Study||6
8536483|NCT03353922|9569176|FG003|STARTED|Overall Study||6
8536484|NCT03353922|9569177|FG004|STARTED|Overall Study||5
8536485|NCT03353922|9569178|FG005|STARTED|Overall Study||6
8536486|NCT03353922|9569173|FG000|COMPLETED|Overall Study||5
8536487|NCT03353922|9569174|FG001|COMPLETED|Overall Study||5
8536488|NCT03353922|9569175|FG002|COMPLETED|Overall Study||5
8536489|NCT03353922|9569176|FG003|COMPLETED|Overall Study||5
8536490|NCT03353922|9569177|FG004|COMPLETED|Overall Study||5
8536491|NCT03353922|9569178|FG005|COMPLETED|Overall Study||6
8536492|NCT03353922|9569173|FG000|NOT COMPLETED|Overall Study||1
8536493|NCT03353922|9569174|FG001|NOT COMPLETED|Overall Study||1
8536494|NCT03353922|9569175|FG002|NOT COMPLETED|Overall Study||1
8536495|NCT03353922|9569176|FG003|NOT COMPLETED|Overall Study||1
8536496|NCT03353922|9569177|FG004|NOT COMPLETED|Overall Study||0
8536497|NCT03353922|9569178|FG005|NOT COMPLETED|Overall Study||0
8536498|NCT03322384|9569189|FG000|STARTED|Overall Study||20
8536499|NCT03322384|9569189|FG000|COMPLETED|Overall Study||14
8536500|NCT03322384|9569189|FG000|NOT COMPLETED|Overall Study||6
8536501|NCT03243071|9569195|FG000|STARTED|Overall Study||59
8536502|NCT03243071|9569196|FG001|STARTED|Overall Study||53
8536503|NCT03243071|9569195|FG000|COMPLETED|Overall Study||59
8536504|NCT03243071|9569196|FG001|COMPLETED|Overall Study||53
8536505|NCT03243071|9569195|FG000|NOT COMPLETED|Overall Study||0
8536506|NCT03243071|9569196|FG001|NOT COMPLETED|Overall Study||0
8536507|NCT03173456|9569213|FG000|STARTED|Baseline||120
8536508|NCT03173456|9569214|FG001|STARTED|Baseline||120
8536509|NCT03173456|9569215|FG002|STARTED|Baseline||120
8536510|NCT03173456|9569216|FG003|STARTED|Baseline||120
8536511|NCT03173456|9569217|FG004|STARTED|Baseline||120
8536512|NCT03173456|9569213|FG000|COMPLETED|Baseline||120
8536513|NCT03173456|9569214|FG001|COMPLETED|Baseline||119
8536514|NCT03173456|9569215|FG002|COMPLETED|Baseline||120
8536515|NCT03173456|9569216|FG003|COMPLETED|Baseline||120
8536516|NCT03173456|9569217|FG004|COMPLETED|Baseline||118
8536517|NCT03173456|9569213|FG000|NOT COMPLETED|Baseline||0
8536518|NCT03173456|9569214|FG001|NOT COMPLETED|Baseline||1
8536519|NCT03173456|9569215|FG002|NOT COMPLETED|Baseline||0
8536520|NCT03173456|9569216|FG003|NOT COMPLETED|Baseline||0
8536521|NCT03173456|9569217|FG004|NOT COMPLETED|Baseline||2
8536522|NCT03173456|9569213|FG000|STARTED|2 Hour Follow-up||120
8536523|NCT03173456|9569214|FG001|STARTED|2 Hour Follow-up||119
8536524|NCT03173456|9569215|FG002|STARTED|2 Hour Follow-up||120
8536525|NCT03173456|9569216|FG003|STARTED|2 Hour Follow-up||120
8722944|NCT02782741|9770422|FG000|Safety Population|Open-label Long-term: Week 50 to 145||51
8722945|NCT02782741|9770423|FG001|Safety Population|Open-label Long-term: Week 50 to 145||44
8722946|NCT02782741|9770422|FG000|COMPLETED|Open-label Long-term: Week 50 to 145||0
8722947|NCT02782741|9770423|FG001|COMPLETED|Open-label Long-term: Week 50 to 145||0
8722948|NCT02782741|9770422|FG000|NOT COMPLETED|Open-label Long-term: Week 50 to 145||51
8722949|NCT02782741|9770423|FG001|NOT COMPLETED|Open-label Long-term: Week 50 to 145||44
8722950|NCT02650284|9770435|FG000|STARTED|Overall Study||8
8722951|NCT02650284|9770436|FG001|STARTED|Overall Study||9
8722952|NCT02650284|9770435|FG000|COMPLETED|Overall Study||5
8722953|NCT02650284|9770436|FG001|COMPLETED|Overall Study||5
8722954|NCT02650284|9770435|FG000|NOT COMPLETED|Overall Study||3
8722955|NCT02650284|9770436|FG001|NOT COMPLETED|Overall Study||4
8722956|NCT02647359|9770444|FG000|STARTED|Stage 1: Double-Masked Period (48 Weeks)||26
8536526|NCT03173456|9569217|FG004|STARTED|2 Hour Follow-up||118
8536527|NCT03173456|9569213|FG000|COMPLETED|2 Hour Follow-up||120
8536528|NCT03173456|9569214|FG001|COMPLETED|2 Hour Follow-up||118
8536529|NCT03173456|9569215|FG002|COMPLETED|2 Hour Follow-up||119
8536530|NCT03173456|9569216|FG003|COMPLETED|2 Hour Follow-up||119
8536531|NCT03173456|9569217|FG004|COMPLETED|2 Hour Follow-up||116
8536532|NCT03173456|9569213|FG000|NOT COMPLETED|2 Hour Follow-up||0
8536533|NCT03173456|9569214|FG001|NOT COMPLETED|2 Hour Follow-up||1
8536534|NCT03173456|9569215|FG002|NOT COMPLETED|2 Hour Follow-up||1
8536535|NCT03173456|9569216|FG003|NOT COMPLETED|2 Hour Follow-up||1
8536536|NCT03173456|9569217|FG004|NOT COMPLETED|2 Hour Follow-up||2
8536537|NCT03101566|9569231|FG000|STARTED|Overall Study||37
8536538|NCT03101566|9569232|FG001|STARTED|Overall Study||38
8536539|NCT03101566|9569231|FG000|Received at Least One Dose of Protocol Therapy|Overall Study||35
8536540|NCT03101566|9569232|FG001|Received at Least One Dose of Protocol Therapy|Overall Study||33
8536541|NCT03101566|9569231|FG000|Assessed for Primary and Secondary Progression-free Survival|Overall Study||32
8816623|NCT01545076|9870116|FG001|STARTED|IgPro10 Rescue Period||0
8816624|NCT01545076|9870117|FG002|STARTED|IgPro10 Rescue Period||0
8816625|NCT01545076|9870118|FG003|STARTED|IgPro10 Rescue Period||0
8816626|NCT01545076|9870119|FG004|STARTED|IgPro10 Rescue Period||60
8816627|NCT01545076|9870115|FG000|COMPLETED|IgPro10 Rescue Period||0
8816628|NCT01545076|9870116|FG001|COMPLETED|IgPro10 Rescue Period||0
8816629|NCT01545076|9870117|FG002|COMPLETED|IgPro10 Rescue Period||0
8816630|NCT01545076|9870118|FG003|COMPLETED|IgPro10 Rescue Period||0
8816631|NCT01545076|9870119|FG004|COMPLETED|IgPro10 Rescue Period||60
8816632|NCT01545076|9870115|FG000|NOT COMPLETED|IgPro10 Rescue Period||0
8816633|NCT01545076|9870116|FG001|NOT COMPLETED|IgPro10 Rescue Period||0
8816634|NCT01545076|9870117|FG002|NOT COMPLETED|IgPro10 Rescue Period||0
8816635|NCT01545076|9870118|FG003|NOT COMPLETED|IgPro10 Rescue Period||0
8816636|NCT01545076|9870119|FG004|NOT COMPLETED|IgPro10 Rescue Period||0
8816637|NCT01545141|9870136|FG000|STARTED|Overall Study||2
8816638|NCT01545141|9870137|FG001|STARTED|Overall Study||3
8816639|NCT01545141|9870138|FG002|STARTED|Overall Study||3
8816640|NCT01545141|9870139|FG003|STARTED|Overall Study||7
8816641|NCT01545141|9870136|FG000|COMPLETED|Overall Study||2
8816642|NCT01545141|9870137|FG001|COMPLETED|Overall Study||3
8816643|NCT01545141|9870138|FG002|COMPLETED|Overall Study||3
8816644|NCT01545141|9870139|FG003|COMPLETED|Overall Study||7
8816645|NCT01545141|9870136|FG000|NOT COMPLETED|Overall Study||0
8816646|NCT01545141|9870137|FG001|NOT COMPLETED|Overall Study||0
8816647|NCT01545141|9870138|FG002|NOT COMPLETED|Overall Study||0
8816648|NCT01545141|9870139|FG003|NOT COMPLETED|Overall Study||0
8816649|NCT01545193|9870150|FG000|STARTED|Overall Study||150
8816650|NCT01545193|9870151|FG001|STARTED|Overall Study||150
8816651|NCT01545193|9870150|FG000|COMPLETED|Overall Study||150
8816652|NCT01545193|9870151|FG001|COMPLETED|Overall Study||149
8816653|NCT01545193|9870150|FG000|NOT COMPLETED|Overall Study||0
8816654|NCT01545193|9870151|FG001|NOT COMPLETED|Overall Study||1
8816655|NCT01545232|9870159|FG000|STARTED|Overall Study||338
8816656|NCT01545232|9870160|FG001|STARTED|Overall Study||342
8816657|NCT01545232|9870159|FG000|COMPLETED|Overall Study||338
8816658|NCT01545232|9870160|FG001|COMPLETED|Overall Study||342
8816659|NCT01545232|9870159|FG000|NOT COMPLETED|Overall Study||0
8816660|NCT01545232|9870160|FG001|NOT COMPLETED|Overall Study||0
8816661|NCT01545336|9870170|FG000|STARTED|Overall Study||12
8816662|NCT01545336|9870171|FG001|STARTED|Overall Study||6
8816663|NCT01545336|9870170|FG000|COMPLETED|Overall Study||12
8816664|NCT01545336|9870171|FG001|COMPLETED|Overall Study||6
8816665|NCT01545336|9870170|FG000|NOT COMPLETED|Overall Study||0
8816666|NCT01545336|9870171|FG001|NOT COMPLETED|Overall Study||0
8816667|NCT01545375|9870181|FG000|STARTED|Overall Study||900
8816668|NCT01545375|9870182|FG001|STARTED|Overall Study||903
8816669|NCT01545375|9870181|FG000|COMPLETED|Overall Study||803
8722957|NCT02647359|9770445|FG001|STARTED|Stage 1: Double-Masked Period (48 Weeks)||13
8722958|NCT02647359|9770444|FG000|Received at Least 1 Dose of Study Drug|Stage 1: Double-Masked Period (48 Weeks)||26
8722959|NCT02647359|9770445|FG001|Received at Least 1 Dose of Study Drug|Stage 1: Double-Masked Period (48 Weeks)||13
8722960|NCT02647359|9770444|FG000|COMPLETED|Stage 1: Double-Masked Period (48 Weeks)||22
8722961|NCT02647359|9770445|FG001|COMPLETED|Stage 1: Double-Masked Period (48 Weeks)||12
8722962|NCT02647359|9770444|FG000|NOT COMPLETED|Stage 1: Double-Masked Period (48 Weeks)||4
8722963|NCT02647359|9770445|FG001|NOT COMPLETED|Stage 1: Double-Masked Period (48 Weeks)||1
8722964|NCT02647359|9770444|FG000|STARTED|Stage 2: Open-Label Extension (96 Weeks)||22
8722965|NCT02647359|9770445|FG001|STARTED|Stage 2: Open-Label Extension (96 Weeks)|1 participant completed Stage 1 but did not enter open-label part|11
8722966|NCT02647359|9770444|FG000|COMPLETED|Stage 2: Open-Label Extension (96 Weeks)||12
8722967|NCT02647359|9770445|FG001|COMPLETED|Stage 2: Open-Label Extension (96 Weeks)||7
8722968|NCT02647359|9770444|FG000|NOT COMPLETED|Stage 2: Open-Label Extension (96 Weeks)||10
8722969|NCT02647359|9770445|FG001|NOT COMPLETED|Stage 2: Open-Label Extension (96 Weeks)||4
8722970|NCT02647359|9770444|FG000|STARTED|Open-Label Sub-Study (96 Weeks)|2 participants completed open-label 144-weeks but did not enter open-label sub-study|10
8722971|NCT02647359|9770445|FG001|STARTED|Open-Label Sub-Study (96 Weeks)||7
8722972|NCT02647359|9770444|FG000|COMPLETED|Open-Label Sub-Study (96 Weeks)||2
8722973|NCT02647359|9770445|FG001|COMPLETED|Open-Label Sub-Study (96 Weeks)||3
8722974|NCT02647359|9770444|FG000|NOT COMPLETED|Open-Label Sub-Study (96 Weeks)||8
8722975|NCT02647359|9770445|FG001|NOT COMPLETED|Open-Label Sub-Study (96 Weeks)||4
8722976|NCT02485691|9770457|FG000|STARTED|Overall Study||129
8722977|NCT02485691|9770458|FG001|STARTED|Overall Study||126
8722978|NCT02485691|9770457|FG000|Treated|Overall Study||126
8722979|NCT02485691|9770458|FG001|Treated|Overall Study||124
8722980|NCT02485691|9770457|FG000|COMPLETED|Overall Study||0
8722981|NCT02485691|9770458|FG001|COMPLETED|Overall Study||0
8722982|NCT02485691|9770457|FG000|NOT COMPLETED|Overall Study||129
8722983|NCT02485691|9770458|FG001|NOT COMPLETED|Overall Study||126
8816670|NCT01545375|9870182|FG001|COMPLETED|Overall Study||813
8816671|NCT01545375|9870181|FG000|NOT COMPLETED|Overall Study||97
8816672|NCT01545375|9870182|FG001|NOT COMPLETED|Overall Study||90
8816673|NCT01545388|9870191|FG000|STARTED|Overall Study||138
8816674|NCT01545388|9870192|FG001|STARTED|Overall Study||133
8816675|NCT01545388|9870193|FG002|STARTED|Overall Study||66
8816676|NCT01545388|9870191|FG000|COMPLETED|Overall Study||130
8816677|NCT01545388|9870192|FG001|COMPLETED|Overall Study||122
8816678|NCT01545388|9870193|FG002|COMPLETED|Overall Study||58
8816679|NCT01545388|9870191|FG000|NOT COMPLETED|Overall Study||8
8816680|NCT01545388|9870192|FG001|NOT COMPLETED|Overall Study||11
8722984|NCT02201251|9770467|FG000|STARTED|Overall Study||28
8722985|NCT02201251|9770468|FG001|STARTED|Overall Study||35
8722986|NCT02201251|9770467|FG000|COMPLETED|Overall Study||24
8722987|NCT02201251|9770468|FG001|COMPLETED|Overall Study||32
8722988|NCT02201251|9770467|FG000|NOT COMPLETED|Overall Study||4
8722989|NCT02201251|9770468|FG001|NOT COMPLETED|Overall Study||3
8722990|NCT02000596|9770477|FG000|STARTED|Cohort 1||2
8722991|NCT02000596|9770478|FG001|STARTED|Cohort 1||0
8722992|NCT02000596|9770479|FG002|STARTED|Cohort 1||0
8722993|NCT02000596|9770477|FG000|COMPLETED|Cohort 1||2
8722994|NCT02000596|9770478|FG001|COMPLETED|Cohort 1||0
8722995|NCT02000596|9770479|FG002|COMPLETED|Cohort 1||0
8722996|NCT02000596|9770477|FG000|NOT COMPLETED|Cohort 1||0
8722997|NCT02000596|9770478|FG001|NOT COMPLETED|Cohort 1||0
8722998|NCT02000596|9770479|FG002|NOT COMPLETED|Cohort 1||0
8722999|NCT02000596|9770477|FG000|STARTED|Cohort 2||0
8723000|NCT02000596|9770478|FG001|STARTED|Cohort 2||0
8723001|NCT02000596|9770479|FG002|STARTED|Cohort 2||2
8723002|NCT02000596|9770477|FG000|COMPLETED|Cohort 2||0
8723003|NCT02000596|9770478|FG001|COMPLETED|Cohort 2||0
8723004|NCT02000596|9770479|FG002|COMPLETED|Cohort 2||2
8723005|NCT02000596|9770477|FG000|NOT COMPLETED|Cohort 2||0
8723006|NCT02000596|9770478|FG001|NOT COMPLETED|Cohort 2||0
8723007|NCT02000596|9770479|FG002|NOT COMPLETED|Cohort 2||0
8723008|NCT00929253|9770489|FG000|STARTED|Overall Study||91
8723009|NCT00929253|9770490|FG001|STARTED|Overall Study||79
8723010|NCT00929253|9770489|FG000|COMPLETED|Overall Study||91
8723011|NCT00929253|9770490|FG001|COMPLETED|Overall Study||79
8723012|NCT00929253|9770489|FG000|NOT COMPLETED|Overall Study||0
8723013|NCT00929253|9770490|FG001|NOT COMPLETED|Overall Study||0
8723014|NCT00657241|9770498|FG000|STARTED|Overall Study||15
8723015|NCT00657241|9770499|FG001|STARTED|Overall Study||15
8723016|NCT00657241|9770498|FG000|COMPLETED|Overall Study||15
8723017|NCT00657241|9770499|FG001|COMPLETED|Overall Study||15
8723018|NCT00657241|9770498|FG000|NOT COMPLETED|Overall Study||0
8723019|NCT00657241|9770499|FG001|NOT COMPLETED|Overall Study||0
8723020|NCT00529763|9770512|FG000|STARTED|Overall Study||25
8723021|NCT00529763|9770513|FG001|STARTED|Overall Study|38 participants were enrolled; 37 were treated in this cohort|37
8816681|NCT01545388|9870193|FG002|NOT COMPLETED|Overall Study||8
8816682|NCT01545583|9870210|FG000|STARTED|Overall Study||12
8816683|NCT01545583|9870211|FG001|STARTED|Overall Study||2
8816684|NCT01545583|9870212|FG002|STARTED|Overall Study||6
8816685|NCT01545583|9870213|FG003|STARTED|Overall Study||6
8816686|NCT01545583|9870214|FG004|STARTED|Overall Study||6
8816687|NCT01545583|9870215|FG005|STARTED|Overall Study||6
8816688|NCT01545583|9870216|FG006|STARTED|Overall Study||6
8816689|NCT01545583|9870217|FG007|STARTED|Overall Study||6
8816690|NCT01545583|9870218|FG008|STARTED|Overall Study||6
8816691|NCT01545583|9870210|FG000|Received at Least 1 Dose of Study Drug|Overall Study||12
8816692|NCT01545583|9870211|FG001|Received at Least 1 Dose of Study Drug|Overall Study||2
8816693|NCT01545583|9870212|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
8816694|NCT01545583|9870213|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
8816695|NCT01545583|9870214|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6
8816696|NCT01545583|9870215|FG005|Received at Least 1 Dose of Study Drug|Overall Study||6
8536542|NCT03101566|9569232|FG001|Assessed for Primary and Secondary Progression-free Survival|Overall Study||33
8723022|NCT00529763|9770514|FG002|STARTED|Overall Study||59
8723023|NCT00529763|9770512|FG000|COMPLETED|Overall Study|15 participants still on treatment; not completed = off treatment (n=10)|15
8723024|NCT00529763|9770513|FG001|COMPLETED|Overall Study|4 participants still on treatment; not completed = off treatment (n=33)|4
8723025|NCT00529763|9770514|FG002|COMPLETED|Overall Study|52 participants still on treatment; not completed = off treatment (n=7)|52
8723026|NCT00529763|9770512|FG000|NOT COMPLETED|Overall Study||10
8723027|NCT00529763|9770513|FG001|NOT COMPLETED|Overall Study||33
8723028|NCT00529763|9770514|FG002|NOT COMPLETED|Overall Study||7
8725146|NCT01029652|9772331|FG001|STARTED|Extension Study 2 (25-72 Weeks)||66
8725147|NCT01029652|9772330|FG000|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients re-treated with canakinumab over 72 weeks study duration overall|69
8725148|NCT01029652|9772331|FG001|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients switched to canakinumab from Week 25 - Week 72|39
8725149|NCT01029652|9772330|FG000|COMPLETED|Extension Study 2 (25-72 Weeks)||68
8725150|NCT01029652|9772331|FG001|COMPLETED|Extension Study 2 (25-72 Weeks)||63
8725151|NCT01029652|9772330|FG000|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||1
8725152|NCT01029652|9772331|FG001|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||3
8725153|NCT01029691|9772358|FG000|STARTED|APAP Initiation to Week 1 or Delivery||20
8725154|NCT01029691|9772359|FG001|STARTED|APAP Initiation to Week 1 or Delivery|4 delivered before APAP initiation 7 elected not to have APAP following baseline study|27
8725155|NCT01029691|9772360|FG002|STARTED|APAP Initiation to Week 1 or Delivery||77
8725156|NCT01029691|9772358|FG000|Baseline Sleep Study|APAP Initiation to Week 1 or Delivery||20
8725157|NCT01029691|9772359|FG001|Baseline Sleep Study|APAP Initiation to Week 1 or Delivery||23
8725158|NCT01029691|9772360|FG002|Baseline Sleep Study|APAP Initiation to Week 1 or Delivery||77
8725159|NCT01029691|9772358|FG000|Began Actual APAP Use|APAP Initiation to Week 1 or Delivery||20
8725160|NCT01029691|9772359|FG001|Began Actual APAP Use|APAP Initiation to Week 1 or Delivery||16
8725161|NCT01029691|9772360|FG002|Began Actual APAP Use|APAP Initiation to Week 1 or Delivery||77
8725162|NCT01029691|9772358|FG000|COMPLETED|APAP Initiation to Week 1 or Delivery||20
8725163|NCT01029691|9772359|FG001|COMPLETED|APAP Initiation to Week 1 or Delivery||16
8723029|NCT01021293|9770531|FG000|STARTED|Overall Study||550
8723030|NCT01021293|9770532|FG001|STARTED|Overall Study||550
8723031|NCT01021293|9770531|FG000|COMPLETED|Overall Study||538
8723032|NCT01021293|9770532|FG001|COMPLETED|Overall Study||526
8723033|NCT01021293|9770531|FG000|NOT COMPLETED|Overall Study||12
8723034|NCT01021293|9770532|FG001|NOT COMPLETED|Overall Study||24
8723035|NCT01021306|9770543|FG000|STARTED|2 Month (Primary Outcome)||20
8723036|NCT01021306|9770544|FG001|STARTED|2 Month (Primary Outcome)||20
8723037|NCT01021306|9770545|FG002|STARTED|2 Month (Primary Outcome)||19
8536543|NCT03101566|9569231|FG000|COMPLETED|Overall Study||31
8536544|NCT03101566|9569232|FG001|COMPLETED|Overall Study||31
8536545|NCT03101566|9569231|FG000|NOT COMPLETED|Overall Study||6
8536546|NCT03101566|9569232|FG001|NOT COMPLETED|Overall Study||7
8536547|NCT03003520|9569240|FG000|STARTED|Induction||43
8536548|NCT03003520|9569241|FG001|STARTED|Induction||3
8536549|NCT03003520|9569240|FG000|Safety Population|Induction||43
8536550|NCT03003520|9569241|FG001|Safety Population|Induction||3
8536551|NCT03003520|9569240|FG000|Efficacy Evaluable Population|Induction||37
8536552|NCT03003520|9569241|FG001|Efficacy Evaluable Population|Induction||3
8536553|NCT03003520|9569240|FG000|COMPLETED|Induction||30
8536554|NCT03003520|9569241|FG001|COMPLETED|Induction||3
8536555|NCT03003520|9569240|FG000|NOT COMPLETED|Induction||13
8536556|NCT03003520|9569241|FG001|NOT COMPLETED|Induction||0
8536557|NCT03003520|9569240|FG000|STARTED|Consolidation||25
8536558|NCT03003520|9569241|FG001|STARTED|Consolidation||3
8536559|NCT03003520|9569240|FG000|COMPLETED|Consolidation||1
8536560|NCT03003520|9569241|FG001|COMPLETED|Consolidation||2
8536561|NCT03003520|9569240|FG000|NOT COMPLETED|Consolidation||24
8536562|NCT03003520|9569241|FG001|NOT COMPLETED|Consolidation||1
8536563|NCT03003520|9569240|FG000|STARTED|Follow-up||14
8536564|NCT03003520|9569241|FG001|STARTED|Follow-up||3
8536565|NCT03003520|9569240|FG000|COMPLETED|Follow-up||0
8536566|NCT03003520|9569241|FG001|COMPLETED|Follow-up||0
8536567|NCT03003520|9569240|FG000|NOT COMPLETED|Follow-up||14
8536568|NCT03003520|9569241|FG001|NOT COMPLETED|Follow-up||3
8536569|NCT02862457|9569262|FG000|STARTED|Overall Study||3
8536570|NCT02862457|9569263|FG001|STARTED|Overall Study||3
8536571|NCT02862457|9569264|FG002|STARTED|Overall Study||3
8536572|NCT02862457|9569265|FG003|STARTED|Overall Study||6
8536573|NCT02862457|9569266|FG004|STARTED|Overall Study||7
8536574|NCT02862457|9569267|FG005|STARTED|Overall Study||6
8536575|NCT02862457|9569268|FG006|STARTED|Overall Study||6
8536576|NCT02862457|9569262|FG000|COMPLETED|Overall Study||1
8536577|NCT02862457|9569263|FG001|COMPLETED|Overall Study||0
8536578|NCT02862457|9569264|FG002|COMPLETED|Overall Study||0
8536579|NCT02862457|9569265|FG003|COMPLETED|Overall Study||2
8536580|NCT02862457|9569266|FG004|COMPLETED|Overall Study||7
8536581|NCT02862457|9569267|FG005|COMPLETED|Overall Study||3
8536582|NCT02862457|9569268|FG006|COMPLETED|Overall Study||5
8536583|NCT02862457|9569262|FG000|NOT COMPLETED|Overall Study||2
8536584|NCT02862457|9569263|FG001|NOT COMPLETED|Overall Study||3
8536585|NCT02862457|9569264|FG002|NOT COMPLETED|Overall Study||3
8536586|NCT02862457|9569265|FG003|NOT COMPLETED|Overall Study||4
8536587|NCT02862457|9569266|FG004|NOT COMPLETED|Overall Study||0
8536588|NCT02862457|9569267|FG005|NOT COMPLETED|Overall Study||3
8536589|NCT02862457|9569268|FG006|NOT COMPLETED|Overall Study||1
8536590|NCT02820753|9569294|FG000|STARTED|Baseline||256
8536591|NCT02820753|9569295|FG001|STARTED|Baseline||421
8536592|NCT02820753|9569294|FG000|COMPLETED|Baseline||256
8536593|NCT02820753|9569295|FG001|COMPLETED|Baseline||421
8536594|NCT02820753|9569294|FG000|NOT COMPLETED|Baseline||0
8536595|NCT02820753|9569295|FG001|NOT COMPLETED|Baseline||0
8536596|NCT02820753|9569294|FG000|STARTED|2 Month||256
8536597|NCT02820753|9569295|FG001|STARTED|2 Month||421
8536598|NCT02820753|9569294|FG000|COMPLETED|2 Month||178
8536599|NCT02820753|9569295|FG001|COMPLETED|2 Month||379
8536600|NCT02820753|9569294|FG000|NOT COMPLETED|2 Month||78
8536601|NCT02820753|9569295|FG001|NOT COMPLETED|2 Month||42
8536602|NCT02820753|9569294|FG000|STARTED|6 Month||253
8536603|NCT02820753|9569295|FG001|STARTED|6 Month||418
8536604|NCT02820753|9569294|FG000|COMPLETED|6 Month||150
8536605|NCT02820753|9569295|FG001|COMPLETED|6 Month||307
8536606|NCT02820753|9569294|FG000|NOT COMPLETED|6 Month||103
8536607|NCT02820753|9569295|FG001|NOT COMPLETED|6 Month||111
8536608|NCT02733042|9569320|FG000|STARTED|Treatment Period||3
8536609|NCT02733042|9569321|FG001|STARTED|Treatment Period||3
8536610|NCT02733042|9569322|FG002|STARTED|Treatment Period||8
8536611|NCT02733042|9569323|FG003|STARTED|Treatment Period||3
8536612|NCT02733042|9569324|FG004|STARTED|Treatment Period||4
8723038|NCT01021306|9770546|FG003|STARTED|2 Month (Primary Outcome)||21
8723039|NCT01021306|9770543|FG000|COMPLETED|2 Month (Primary Outcome)||14
8536613|NCT02733042|9569325|FG005|STARTED|Treatment Period||3
8536614|NCT02733042|9569326|FG006|STARTED|Treatment Period||1
8536615|NCT02733042|9569327|FG007|STARTED|Treatment Period||4
8536616|NCT02733042|9569328|FG008|STARTED|Treatment Period||5
8536617|NCT02733042|9569329|FG009|STARTED|Treatment Period||10
8536618|NCT02733042|9569330|FG010|STARTED|Treatment Period||10
8536619|NCT02733042|9569331|FG011|STARTED|Treatment Period||10
8536620|NCT02733042|9569332|FG012|STARTED|Treatment Period||10
8536621|NCT02733042|9569333|FG013|STARTED|Treatment Period||5
8536622|NCT02733042|9569334|FG014|STARTED|Treatment Period||5
8536623|NCT02733042|9569335|FG015|STARTED|Treatment Period||10
8536624|NCT02733042|9569336|FG016|STARTED|Treatment Period||2
8536625|NCT02733042|9569337|FG017|STARTED|Treatment Period||5
8536626|NCT02733042|9569338|FG018|STARTED|Treatment Period||5
8536627|NCT02733042|9569320|FG000|COMPLETED|Treatment Period||0
8536628|NCT02733042|9569321|FG001|COMPLETED|Treatment Period||1
8536629|NCT02733042|9569322|FG002|COMPLETED|Treatment Period||1
8536630|NCT02733042|9569323|FG003|COMPLETED|Treatment Period||0
8536631|NCT02733042|9569324|FG004|COMPLETED|Treatment Period||0
8536632|NCT02733042|9569325|FG005|COMPLETED|Treatment Period||0
8536633|NCT02733042|9569326|FG006|COMPLETED|Treatment Period||0
8536634|NCT02733042|9569327|FG007|COMPLETED|Treatment Period||1
8536635|NCT02733042|9569328|FG008|COMPLETED|Treatment Period||0
8536636|NCT02733042|9569329|FG009|COMPLETED|Treatment Period||0
8536637|NCT02733042|9569330|FG010|COMPLETED|Treatment Period||0
8536638|NCT02733042|9569331|FG011|COMPLETED|Treatment Period||4
8536639|NCT02733042|9569332|FG012|COMPLETED|Treatment Period||1
8536640|NCT02733042|9569333|FG013|COMPLETED|Treatment Period||1
8536641|NCT02733042|9569334|FG014|COMPLETED|Treatment Period||0
8536642|NCT02733042|9569335|FG015|COMPLETED|Treatment Period||0
8536643|NCT02733042|9569336|FG016|COMPLETED|Treatment Period||0
8536644|NCT02733042|9569337|FG017|COMPLETED|Treatment Period||0
8536645|NCT02733042|9569338|FG018|COMPLETED|Treatment Period||0
8536646|NCT02733042|9569320|FG000|NOT COMPLETED|Treatment Period||3
8536647|NCT02733042|9569321|FG001|NOT COMPLETED|Treatment Period||2
8536648|NCT02733042|9569322|FG002|NOT COMPLETED|Treatment Period||7
8536649|NCT02733042|9569323|FG003|NOT COMPLETED|Treatment Period||3
8536650|NCT02733042|9569324|FG004|NOT COMPLETED|Treatment Period||4
8536651|NCT02733042|9569325|FG005|NOT COMPLETED|Treatment Period||3
8536652|NCT02733042|9569326|FG006|NOT COMPLETED|Treatment Period||1
8536653|NCT02733042|9569327|FG007|NOT COMPLETED|Treatment Period||3
8536654|NCT02733042|9569328|FG008|NOT COMPLETED|Treatment Period||5
8536655|NCT02733042|9569329|FG009|NOT COMPLETED|Treatment Period||10
8536656|NCT02733042|9569330|FG010|NOT COMPLETED|Treatment Period||10
8536657|NCT02733042|9569331|FG011|NOT COMPLETED|Treatment Period||6
8536658|NCT02733042|9569332|FG012|NOT COMPLETED|Treatment Period||9
8536659|NCT02733042|9569333|FG013|NOT COMPLETED|Treatment Period||4
8536660|NCT02733042|9569334|FG014|NOT COMPLETED|Treatment Period||5
8536661|NCT02733042|9569335|FG015|NOT COMPLETED|Treatment Period||10
8536662|NCT02733042|9569336|FG016|NOT COMPLETED|Treatment Period||2
8536663|NCT02733042|9569337|FG017|NOT COMPLETED|Treatment Period||5
8536664|NCT02733042|9569338|FG018|NOT COMPLETED|Treatment Period||5
8536665|NCT02733042|9569320|FG000|STARTED|Follow-up Period||3
8536666|NCT02733042|9569321|FG001|STARTED|Follow-up Period||3
8536667|NCT02733042|9569322|FG002|STARTED|Follow-up Period||6
8536668|NCT02733042|9569323|FG003|STARTED|Follow-up Period||3
8536669|NCT02733042|9569324|FG004|STARTED|Follow-up Period||1
8536670|NCT02733042|9569325|FG005|STARTED|Follow-up Period||2
8536671|NCT02733042|9569326|FG006|STARTED|Follow-up Period||0
8536672|NCT02733042|9569327|FG007|STARTED|Follow-up Period||4
8536673|NCT02733042|9569328|FG008|STARTED|Follow-up Period||4
8536674|NCT02733042|9569329|FG009|STARTED|Follow-up Period||2
8536675|NCT02733042|9569330|FG010|STARTED|Follow-up Period||5
8536676|NCT02733042|9569331|FG011|STARTED|Follow-up Period||9
8536677|NCT02733042|9569332|FG012|STARTED|Follow-up Period||9
8536678|NCT02733042|9569333|FG013|STARTED|Follow-up Period||4
8536679|NCT02733042|9569334|FG014|STARTED|Follow-up Period||1
8536680|NCT02733042|9569335|FG015|STARTED|Follow-up Period||5
8536681|NCT02733042|9569336|FG016|STARTED|Follow-up Period||0
8536682|NCT02733042|9569337|FG017|STARTED|Follow-up Period||3
8536683|NCT02733042|9569338|FG018|STARTED|Follow-up Period||2
8536684|NCT02733042|9569320|FG000|COMPLETED|Follow-up Period||0
8536685|NCT02733042|9569321|FG001|COMPLETED|Follow-up Period||0
8536686|NCT02733042|9569322|FG002|COMPLETED|Follow-up Period||0
8536687|NCT02733042|9569323|FG003|COMPLETED|Follow-up Period||0
8536688|NCT02733042|9569324|FG004|COMPLETED|Follow-up Period||0
8536689|NCT02733042|9569325|FG005|COMPLETED|Follow-up Period||0
8536690|NCT02733042|9569326|FG006|COMPLETED|Follow-up Period||0
8536691|NCT02733042|9569327|FG007|COMPLETED|Follow-up Period||0
8536692|NCT02733042|9569328|FG008|COMPLETED|Follow-up Period||0
8536693|NCT02733042|9569329|FG009|COMPLETED|Follow-up Period||0
8536694|NCT02733042|9569330|FG010|COMPLETED|Follow-up Period||0
8536695|NCT02733042|9569331|FG011|COMPLETED|Follow-up Period||0
8536696|NCT02733042|9569332|FG012|COMPLETED|Follow-up Period||0
8536697|NCT02733042|9569333|FG013|COMPLETED|Follow-up Period||0
8536698|NCT02733042|9569334|FG014|COMPLETED|Follow-up Period||0
8536699|NCT02733042|9569335|FG015|COMPLETED|Follow-up Period||0
8536700|NCT02733042|9569336|FG016|COMPLETED|Follow-up Period||0
8536701|NCT02733042|9569337|FG017|COMPLETED|Follow-up Period||1
8536702|NCT02733042|9569338|FG018|COMPLETED|Follow-up Period||0
8536703|NCT02733042|9569320|FG000|NOT COMPLETED|Follow-up Period||3
8536704|NCT02733042|9569321|FG001|NOT COMPLETED|Follow-up Period||3
8536705|NCT02733042|9569322|FG002|NOT COMPLETED|Follow-up Period||6
8536706|NCT02733042|9569323|FG003|NOT COMPLETED|Follow-up Period||3
8536707|NCT02733042|9569324|FG004|NOT COMPLETED|Follow-up Period||1
8536708|NCT02733042|9569325|FG005|NOT COMPLETED|Follow-up Period||2
8536709|NCT02733042|9569326|FG006|NOT COMPLETED|Follow-up Period||0
8536710|NCT02733042|9569327|FG007|NOT COMPLETED|Follow-up Period||4
8536711|NCT02733042|9569328|FG008|NOT COMPLETED|Follow-up Period||4
8536712|NCT02733042|9569329|FG009|NOT COMPLETED|Follow-up Period||2
8536713|NCT02733042|9569330|FG010|NOT COMPLETED|Follow-up Period||5
8536714|NCT02733042|9569331|FG011|NOT COMPLETED|Follow-up Period||9
8536715|NCT02733042|9569332|FG012|NOT COMPLETED|Follow-up Period||9
8536716|NCT02733042|9569333|FG013|NOT COMPLETED|Follow-up Period||4
8536717|NCT02733042|9569334|FG014|NOT COMPLETED|Follow-up Period||1
8536718|NCT02733042|9569335|FG015|NOT COMPLETED|Follow-up Period||5
8536719|NCT02733042|9569336|FG016|NOT COMPLETED|Follow-up Period||0
8536720|NCT02733042|9569337|FG017|NOT COMPLETED|Follow-up Period||2
8536721|NCT02733042|9569338|FG018|NOT COMPLETED|Follow-up Period||2
8536722|NCT02668874|9569388|FG000|STARTED|Overall Study||104
8536723|NCT02668874|9569389|FG001|STARTED|Overall Study||104
8536724|NCT02668874|9569388|FG000|6 Months After Placement|Overall Study||59
8536725|NCT02668874|9569389|FG001|6 Months After Placement|Overall Study||59
8536726|NCT02668874|9569388|FG000|COMPLETED|Overall Study||47
8536727|NCT02668874|9569389|FG001|COMPLETED|Overall Study||47
8536728|NCT02668874|9569388|FG000|NOT COMPLETED|Overall Study||57
8536729|NCT02668874|9569389|FG001|NOT COMPLETED|Overall Study||57
8536730|NCT02609737|9569395|FG000|STARTED|Overall Study||20
8536731|NCT02609737|9569395|FG000|COMPLETED|Overall Study||20
8536732|NCT02609737|9569395|FG000|NOT COMPLETED|Overall Study||0
8536733|NCT02574286|9569399|FG000|STARTED|Overall Study||21
8536734|NCT02574286|9569399|FG000|COMPLETED|Overall Study||16
8536735|NCT02574286|9569399|FG000|NOT COMPLETED|Overall Study||5
8536736|NCT02471144|9569407|FG000|STARTED|Induction Period (Up to Week 12)||40
8536737|NCT02471144|9569408|FG001|STARTED|Induction Period (Up to Week 12)||40
8536738|NCT02471144|9569409|FG002|STARTED|Induction Period (Up to Week 12)||41
8536739|NCT02471144|9569410|FG003|STARTED|Induction Period (Up to Week 12)||41
8536740|NCT02471144|9569411|FG004|STARTED|Induction Period (Up to Week 12)||0
8536741|NCT02471144|9569412|FG005|STARTED|Induction Period (Up to Week 12)||0
8536742|NCT02471144|9569413|FG006|STARTED|Induction Period (Up to Week 12)||0
8536743|NCT02471144|9569414|FG007|STARTED|Induction Period (Up to Week 12)||0
8536744|NCT02471144|9569415|FG008|STARTED|Induction Period (Up to Week 12)||0
8536745|NCT02471144|9569416|FG009|STARTED|Induction Period (Up to Week 12)||0
8536746|NCT02471144|9569417|FG010|STARTED|Induction Period (Up to Week 12)||0
8536747|NCT02471144|9569407|FG000|COMPLETED|Induction Period (Up to Week 12)||39
8536748|NCT02471144|9569408|FG001|COMPLETED|Induction Period (Up to Week 12)||38
8536749|NCT02471144|9569409|FG002|COMPLETED|Induction Period (Up to Week 12)||39
8536750|NCT02471144|9569410|FG003|COMPLETED|Induction Period (Up to Week 12)||40
8536751|NCT02471144|9569411|FG004|COMPLETED|Induction Period (Up to Week 12)||0
8536752|NCT02471144|9569412|FG005|COMPLETED|Induction Period (Up to Week 12)||0
8536753|NCT02471144|9569413|FG006|COMPLETED|Induction Period (Up to Week 12)||0
8536754|NCT02471144|9569414|FG007|COMPLETED|Induction Period (Up to Week 12)||0
8536755|NCT02471144|9569415|FG008|COMPLETED|Induction Period (Up to Week 12)||0
8536756|NCT02471144|9569416|FG009|COMPLETED|Induction Period (Up to Week 12)||0
8536757|NCT02471144|9569417|FG010|COMPLETED|Induction Period (Up to Week 12)||0
8536758|NCT02471144|9569407|FG000|NOT COMPLETED|Induction Period (Up to Week 12)||1
8536759|NCT02471144|9569408|FG001|NOT COMPLETED|Induction Period (Up to Week 12)||2
8536760|NCT02471144|9569409|FG002|NOT COMPLETED|Induction Period (Up to Week 12)||2
8536761|NCT02471144|9569410|FG003|NOT COMPLETED|Induction Period (Up to Week 12)||1
8536762|NCT02471144|9569411|FG004|NOT COMPLETED|Induction Period (Up to Week 12)||0
8536763|NCT02471144|9569412|FG005|NOT COMPLETED|Induction Period (Up to Week 12)||0
8536764|NCT02471144|9569413|FG006|NOT COMPLETED|Induction Period (Up to Week 12)||0
8536765|NCT02471144|9569414|FG007|NOT COMPLETED|Induction Period (Up to Week 12)||0
8536766|NCT02471144|9569415|FG008|NOT COMPLETED|Induction Period (Up to Week 12)||0
8536767|NCT02471144|9569416|FG009|NOT COMPLETED|Induction Period (Up to Week 12)||0
8536768|NCT02471144|9569417|FG010|NOT COMPLETED|Induction Period (Up to Week 12)||0
8536769|NCT02471144|9569407|FG000|STARTED|Maintenance Period (Week 12 to Week 52)||0
8536770|NCT02471144|9569408|FG001|STARTED|Maintenance Period (Week 12 to Week 52)||0
8536771|NCT02471144|9569409|FG002|STARTED|Maintenance Period (Week 12 to Week 52)||0
8536772|NCT02471144|9569410|FG003|STARTED|Maintenance Period (Week 12 to Week 52)||0
8536773|NCT02471144|9569411|FG004|STARTED|Maintenance Period (Week 12 to Week 52)||39
8536774|NCT02471144|9569412|FG005|STARTED|Maintenance Period (Week 12 to Week 52)||38
8536775|NCT02471144|9569413|FG006|STARTED|Maintenance Period (Week 12 to Week 52)||16
8536776|NCT02471144|9569414|FG007|STARTED|Maintenance Period (Week 12 to Week 52)||18
8536777|NCT02471144|9569415|FG008|STARTED|Maintenance Period (Week 12 to Week 52)||40
8536778|NCT02471144|9569416|FG009|STARTED|Maintenance Period (Week 12 to Week 52)||0
8536779|NCT02471144|9569417|FG010|STARTED|Maintenance Period (Week 12 to Week 52)||0
8536780|NCT02471144|9569407|FG000|COMPLETED|Maintenance Period (Week 12 to Week 52)||0
8536781|NCT02471144|9569408|FG001|COMPLETED|Maintenance Period (Week 12 to Week 52)||0
8536782|NCT02471144|9569409|FG002|COMPLETED|Maintenance Period (Week 12 to Week 52)||0
8536783|NCT02471144|9569410|FG003|COMPLETED|Maintenance Period (Week 12 to Week 52)||0
8536784|NCT02471144|9569411|FG004|COMPLETED|Maintenance Period (Week 12 to Week 52)||38
8536785|NCT02471144|9569412|FG005|COMPLETED|Maintenance Period (Week 12 to Week 52)||37
8536786|NCT02471144|9569413|FG006|COMPLETED|Maintenance Period (Week 12 to Week 52)||15
8536787|NCT02471144|9569414|FG007|COMPLETED|Maintenance Period (Week 12 to Week 52)||16
8536788|NCT02471144|9569415|FG008|COMPLETED|Maintenance Period (Week 12 to Week 52)||34
8536789|NCT02471144|9569416|FG009|COMPLETED|Maintenance Period (Week 12 to Week 52)||0
8536790|NCT02471144|9569417|FG010|COMPLETED|Maintenance Period (Week 12 to Week 52)||0
8536791|NCT02471144|9569407|FG000|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||0
8536792|NCT02471144|9569408|FG001|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||0
8536793|NCT02471144|9569409|FG002|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||0
8536794|NCT02471144|9569410|FG003|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||0
8536795|NCT02471144|9569411|FG004|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||1
8536796|NCT02471144|9569412|FG005|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||1
8536797|NCT02471144|9569413|FG006|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||1
8536798|NCT02471144|9569414|FG007|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||2
8536799|NCT02471144|9569415|FG008|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||6
8536800|NCT02471144|9569416|FG009|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||0
8536801|NCT02471144|9569417|FG010|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||0
8536802|NCT02471144|9569407|FG000|STARTED|Extension Period (Week 52 to Week 236)||0
8536803|NCT02471144|9569408|FG001|STARTED|Extension Period (Week 52 to Week 236)||0
8536804|NCT02471144|9569409|FG002|STARTED|Extension Period (Week 52 to Week 236)||0
8536805|NCT02471144|9569410|FG003|STARTED|Extension Period (Week 52 to Week 236)||0
8536806|NCT02471144|9569411|FG004|STARTED|Extension Period (Week 52 to Week 236)||0
8536807|NCT02471144|9569412|FG005|STARTED|Extension Period (Week 52 to Week 236)||0
8536808|NCT02471144|9569413|FG006|STARTED|Extension Period (Week 52 to Week 236)||0
8536809|NCT02471144|9569414|FG007|STARTED|Extension Period (Week 52 to Week 236)||0
8536810|NCT02471144|9569415|FG008|STARTED|Extension Period (Week 52 to Week 236)||0
8536811|NCT02471144|9569416|FG009|STARTED|Extension Period (Week 52 to Week 236)||53
8536812|NCT02471144|9569417|FG010|STARTED|Extension Period (Week 52 to Week 236)||53
8536813|NCT02471144|9569407|FG000|COMPLETED|Extension Period (Week 52 to Week 236)||0
8536814|NCT02471144|9569408|FG001|COMPLETED|Extension Period (Week 52 to Week 236)||0
8536815|NCT02471144|9569409|FG002|COMPLETED|Extension Period (Week 52 to Week 236)||0
8536816|NCT02471144|9569410|FG003|COMPLETED|Extension Period (Week 52 to Week 236)||0
8536817|NCT02471144|9569411|FG004|COMPLETED|Extension Period (Week 52 to Week 236)||0
8536818|NCT02471144|9569412|FG005|COMPLETED|Extension Period (Week 52 to Week 236)||0
8536819|NCT02471144|9569413|FG006|COMPLETED|Extension Period (Week 52 to Week 236)||0
8536820|NCT02471144|9569414|FG007|COMPLETED|Extension Period (Week 52 to Week 236)||0
8536821|NCT02471144|9569415|FG008|COMPLETED|Extension Period (Week 52 to Week 236)||0
8536822|NCT02471144|9569416|FG009|COMPLETED|Extension Period (Week 52 to Week 236)||46
8536823|NCT02471144|9569417|FG010|COMPLETED|Extension Period (Week 52 to Week 236)||49
8536824|NCT02471144|9569407|FG000|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0
8536825|NCT02471144|9569408|FG001|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0
8536826|NCT02471144|9569409|FG002|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0
8536827|NCT02471144|9569410|FG003|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0
8816697|NCT01545583|9870216|FG006|Received at Least 1 Dose of Study Drug|Overall Study||6
8816698|NCT01545583|9870217|FG007|Received at Least 1 Dose of Study Drug|Overall Study||6
8816699|NCT01545583|9870218|FG008|Received at Least 1 Dose of Study Drug|Overall Study||6
8816700|NCT01545583|9870210|FG000|COMPLETED|Overall Study||12
8816701|NCT01545583|9870211|FG001|COMPLETED|Overall Study||2
8816702|NCT01545583|9870212|FG002|COMPLETED|Overall Study||6
8816703|NCT01545583|9870213|FG003|COMPLETED|Overall Study||6
8816704|NCT01545583|9870214|FG004|COMPLETED|Overall Study||6
8816705|NCT01545583|9870215|FG005|COMPLETED|Overall Study||6
8816706|NCT01545583|9870216|FG006|COMPLETED|Overall Study||6
8816707|NCT01545583|9870217|FG007|COMPLETED|Overall Study||6
8816708|NCT01545583|9870218|FG008|COMPLETED|Overall Study||6
8816709|NCT01545583|9870210|FG000|NOT COMPLETED|Overall Study||0
8816710|NCT01545583|9870211|FG001|NOT COMPLETED|Overall Study||0
8816711|NCT01545583|9870212|FG002|NOT COMPLETED|Overall Study||0
8816712|NCT01545583|9870213|FG003|NOT COMPLETED|Overall Study||0
8816713|NCT01545583|9870214|FG004|NOT COMPLETED|Overall Study||0
8816714|NCT01545583|9870215|FG005|NOT COMPLETED|Overall Study||0
8816715|NCT01545583|9870216|FG006|NOT COMPLETED|Overall Study||0
8816716|NCT01545583|9870217|FG007|NOT COMPLETED|Overall Study||0
8816717|NCT01545583|9870218|FG008|NOT COMPLETED|Overall Study||0
8816718|NCT01545700|9870251|FG000|STARTED|Overall Study||34
8816719|NCT01545700|9870252|FG001|STARTED|Overall Study||33
8816720|NCT01545700|9870253|FG002|STARTED|Overall Study||33
8816721|NCT01545700|9870254|FG003|STARTED|Overall Study||34
8816722|NCT01545700|9870255|FG004|STARTED|Overall Study||33
8816723|NCT01545700|9870256|FG005|STARTED|Overall Study||33
8816724|NCT01545700|9870251|FG000|COMPLETED|Overall Study||33
8816725|NCT01545700|9870252|FG001|COMPLETED|Overall Study||32
8816726|NCT01545700|9870253|FG002|COMPLETED|Overall Study||31
8816727|NCT01545700|9870254|FG003|COMPLETED|Overall Study||34
8816728|NCT01545700|9870255|FG004|COMPLETED|Overall Study||32
8816729|NCT01545700|9870256|FG005|COMPLETED|Overall Study||33
8816730|NCT01545700|9870251|FG000|NOT COMPLETED|Overall Study||1
8816731|NCT01545700|9870252|FG001|NOT COMPLETED|Overall Study||1
8816732|NCT01545700|9870253|FG002|NOT COMPLETED|Overall Study||2
8816733|NCT01545700|9870254|FG003|NOT COMPLETED|Overall Study||0
8816734|NCT01545700|9870255|FG004|NOT COMPLETED|Overall Study||1
8816735|NCT01545700|9870256|FG005|NOT COMPLETED|Overall Study||0
8816736|NCT01545765|9870290|FG000|STARTED|Overall Study||31
8816737|NCT01545765|9870290|FG000|COMPLETED|Overall Study||31
8816738|NCT01545765|9870290|FG000|NOT COMPLETED|Overall Study||0
8816739|NCT01545817|9870297|FG000|STARTED|Pazopanib||74
8816740|NCT01545817|9870298|FG001|STARTED|Pazopanib||0
8816741|NCT01545817|9870297|FG000|COMPLETED|Pazopanib||0
8816742|NCT01545817|9870298|FG001|COMPLETED|Pazopanib||0
8536828|NCT02471144|9569411|FG004|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0
8816743|NCT01545817|9870297|FG000|NOT COMPLETED|Pazopanib||74
8816744|NCT01545817|9870298|FG001|NOT COMPLETED|Pazopanib||0
8816745|NCT01545817|9870297|FG000|STARTED|Everolimus||0
8536829|NCT02471144|9569412|FG005|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0
8536830|NCT02471144|9569413|FG006|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0
8536831|NCT02471144|9569414|FG007|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0
8536832|NCT02471144|9569415|FG008|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0
8536833|NCT02471144|9569416|FG009|NOT COMPLETED|Extension Period (Week 52 to Week 236)||7
8536834|NCT02471144|9569417|FG010|NOT COMPLETED|Extension Period (Week 52 to Week 236)||4
8536835|NCT02440464|9569435|FG000|STARTED|Overall Study||21
8536836|NCT02440464|9569436|FG001|STARTED|Overall Study||22
8536837|NCT02440464|9569435|FG000|COMPLETED|Overall Study||18
8536838|NCT02440464|9569436|FG001|COMPLETED|Overall Study||20
8536839|NCT02440464|9569435|FG000|NOT COMPLETED|Overall Study||3
8536840|NCT02440464|9569436|FG001|NOT COMPLETED|Overall Study||2
8536841|NCT02384421|9569443|FG000|STARTED|Overall Study||22
8536842|NCT02384421|9569443|FG000|COMPLETED|Overall Study||22
8536843|NCT02384421|9569443|FG000|NOT COMPLETED|Overall Study||0
8536844|NCT02366728|9569453|FG000|STARTED|Overall Study||27
8536845|NCT02366728|9569454|FG001|STARTED|Overall Study||28
8536846|NCT02366728|9569455|FG002|STARTED|Overall Study||9
8536847|NCT02366728|9569453|FG000|Received at Least One ppp65 Vaccine|Overall Study||25
8536848|NCT02366728|9569454|FG001|Received at Least One ppp65 Vaccine|Overall Study||27
8536849|NCT02366728|9569455|FG002|Received at Least One ppp65 Vaccine|Overall Study||8
8536850|NCT02366728|9569453|FG000|COMPLETED|Overall Study||23
8536851|NCT02366728|9569454|FG001|COMPLETED|Overall Study||27
8536852|NCT02366728|9569455|FG002|COMPLETED|Overall Study||8
8536853|NCT02366728|9569453|FG000|NOT COMPLETED|Overall Study||4
8536854|NCT02366728|9569454|FG001|NOT COMPLETED|Overall Study||1
8536855|NCT02366728|9569455|FG002|NOT COMPLETED|Overall Study||1
8536856|NCT02236572|9569463|FG000|STARTED|Overall Study||17
8536857|NCT02236572|9569463|FG000|COMPLETED|Overall Study||14
8536858|NCT02236572|9569463|FG000|NOT COMPLETED|Overall Study||3
8565486|NCT00068250|9597574|FG002|NOT COMPLETED|Phase I: Dose Level 2||0
8565487|NCT00068250|9597575|FG003|NOT COMPLETED|Phase I: Dose Level 2||0
8565488|NCT00068250|9597572|FG000|STARTED|Phase II: Dose Level 2||0
8565489|NCT00068250|9597573|FG001|STARTED|Phase II: Dose Level 2||0
8565490|NCT00068250|9597574|FG002|STARTED|Phase II: Dose Level 2||0
8565491|NCT00068250|9597575|FG003|STARTED|Phase II: Dose Level 2||47
8565492|NCT00068250|9597572|FG000|COMPLETED|Phase II: Dose Level 2||0
8565493|NCT00068250|9597573|FG001|COMPLETED|Phase II: Dose Level 2||0
8565494|NCT00068250|9597574|FG002|COMPLETED|Phase II: Dose Level 2||0
8565495|NCT00068250|9597575|FG003|COMPLETED|Phase II: Dose Level 2|Subjects with data available for the primary analysis are considered to have completed the study.|47
8565496|NCT00068250|9597572|FG000|NOT COMPLETED|Phase II: Dose Level 2||0
8620968|NCT00477204|9659853|FG000|STARTED|Overall Study||4
8620969|NCT00477204|9659854|FG001|STARTED|Overall Study||5
8620970|NCT00477204|9659853|FG000|COMPLETED|Overall Study||4
8620971|NCT00477204|9659854|FG001|COMPLETED|Overall Study||5
8565497|NCT00068250|9597573|FG001|NOT COMPLETED|Phase II: Dose Level 2||0
8565498|NCT00068250|9597574|FG002|NOT COMPLETED|Phase II: Dose Level 2||0
8565499|NCT00068250|9597575|FG003|NOT COMPLETED|Phase II: Dose Level 2||0
8565500|NCT00068341|9597586|FG000|STARTED|Overall Study||15
8565501|NCT00068341|9597587|FG001|STARTED|Overall Study||15
8565502|NCT00068341|9597588|FG002|STARTED|Overall Study||44
8565503|NCT00068341|9597586|FG000|COMPLETED|Overall Study||15
8565504|NCT00068341|9597587|FG001|COMPLETED|Overall Study||15
8565505|NCT00068341|9597588|FG002|COMPLETED|Overall Study||44
8565506|NCT00068341|9597586|FG000|NOT COMPLETED|Overall Study||0
8565507|NCT00068341|9597587|FG001|NOT COMPLETED|Overall Study||0
8565508|NCT00068341|9597588|FG002|NOT COMPLETED|Overall Study||0
8565509|NCT00068367|9597609|FG000|STARTED|Overall Study||20
8565510|NCT00068367|9597609|FG000|COMPLETED|Overall Study||20
8565511|NCT00068367|9597609|FG000|NOT COMPLETED|Overall Study||0
8565512|NCT00068380|9597613|FG000|STARTED|Overall Study||17
8565513|NCT00068380|9597613|FG000|COMPLETED|Overall Study||12
8565514|NCT00068380|9597613|FG000|NOT COMPLETED|Overall Study||5
8565515|NCT00068393|9597617|FG000|STARTED|Overall Study||39
8565516|NCT00068393|9597617|FG000|Eligible and Treated|Overall Study||38
8565517|NCT00068393|9597617|FG000|COMPLETED|Overall Study||29
8565518|NCT00068393|9597617|FG000|NOT COMPLETED|Overall Study||10
8565519|NCT00068406|9597621|FG000|STARTED|Overall Study||61
8565520|NCT00068406|9597621|FG000|COMPLETED|Overall Study||58
8565521|NCT00068406|9597621|FG000|NOT COMPLETED|Overall Study||3
8565522|NCT00068419|9597625|FG000|STARTED|Overall Study||70
8565523|NCT00068419|9597625|FG000|COMPLETED|Overall Study|Participant flow data reported here are for the period of protocol therapy.|10
8565524|NCT00068419|9597625|FG000|NOT COMPLETED|Overall Study||60
8565525|NCT00068445|9597631|FG000|STARTED|Randomization||65
8565526|NCT00068445|9597632|FG001|STARTED|Randomization||66
8565527|NCT00068445|9597631|FG000|COMPLETED|Randomization||63
8565528|NCT00068445|9597632|FG001|COMPLETED|Randomization||62
8565529|NCT00068445|9597631|FG000|NOT COMPLETED|Randomization||2
8565530|NCT00068445|9597632|FG001|NOT COMPLETED|Randomization||4
8565531|NCT00068445|9597631|FG000|STARTED|Treatment||63
8565532|NCT00068445|9597632|FG001|STARTED|Treatment||62
8565533|NCT00068445|9597631|FG000|COMPLETED|Treatment||34
8620972|NCT00477204|9659853|FG000|NOT COMPLETED|Overall Study||0
8565534|NCT00068445|9597632|FG001|COMPLETED|Treatment||46
8565535|NCT00068445|9597631|FG000|NOT COMPLETED|Treatment||29
8620973|NCT00477204|9659854|FG001|NOT COMPLETED|Overall Study||0
8620974|NCT00477269|9659862|FG000|STARTED|Core Study||28
8536859|NCT02083354|9569467|FG000|STARTED|Overall Study||77
8536860|NCT02083354|9569467|FG000|COMPLETED|Overall Study||13
8536861|NCT02083354|9569467|FG000|NOT COMPLETED|Overall Study||64
8536862|NCT01775813|9569475|FG000|STARTED|Overall Study||47
8536863|NCT01775813|9569476|FG001|STARTED|Overall Study||13
8536864|NCT01775813|9569477|FG002|STARTED|Overall Study||24
8536865|NCT01775813|9569478|FG003|STARTED|Overall Study||20
8536866|NCT01775813|9569475|FG000|Study Visit 2 (Tanner 4)|Overall Study||36
8536867|NCT01775813|9569476|FG001|Study Visit 2 (Tanner 4)|Overall Study||4
8536868|NCT01775813|9569477|FG002|Study Visit 2 (Tanner 4)|Overall Study||11
8536869|NCT01775813|9569478|FG003|Study Visit 2 (Tanner 4)|Overall Study||11
8536870|NCT01775813|9569475|FG000|Study Visit 3 (Tanner 5)|Overall Study||34
8536871|NCT01775813|9569476|FG001|Study Visit 3 (Tanner 5)|Overall Study||8
8536872|NCT01775813|9569477|FG002|Study Visit 3 (Tanner 5)|Overall Study||12
8536873|NCT01775813|9569478|FG003|Study Visit 3 (Tanner 5)|Overall Study||11
8536874|NCT01775813|9569475|FG000|Study Visit 4 (Post-Puberty)|Overall Study||10
8536875|NCT01775813|9569476|FG001|Study Visit 4 (Post-Puberty)|Overall Study||0
8536876|NCT01775813|9569477|FG002|Study Visit 4 (Post-Puberty)|Overall Study||13
8536877|NCT01775813|9569478|FG003|Study Visit 4 (Post-Puberty)|Overall Study||11
8536878|NCT01775813|9569475|FG000|COMPLETED|Overall Study||34
8536879|NCT01775813|9569476|FG001|COMPLETED|Overall Study||8
8536880|NCT01775813|9569477|FG002|COMPLETED|Overall Study||12
8536881|NCT01775813|9569478|FG003|COMPLETED|Overall Study||11
8536882|NCT01775813|9569475|FG000|NOT COMPLETED|Overall Study||13
8536883|NCT01775813|9569476|FG001|NOT COMPLETED|Overall Study||5
8536884|NCT01775813|9569477|FG002|NOT COMPLETED|Overall Study||12
8536885|NCT01775813|9569478|FG003|NOT COMPLETED|Overall Study||9
8536886|NCT01694069|9569495|FG000|STARTED|Overall Study||6
8536887|NCT01694069|9569495|FG000|COMPLETED|Overall Study||6
8536888|NCT01694069|9569495|FG000|NOT COMPLETED|Overall Study||0
8536889|NCT01446016|9569501|FG000|STARTED|Overall Study||38
8536890|NCT01446016|9569501|FG000|COMPLETED|Overall Study||31
8536891|NCT01446016|9569501|FG000|NOT COMPLETED|Overall Study||7
8536892|NCT01445327|9569508|FG000|STARTED|Overall Study||3
8536893|NCT01445327|9569509|FG001|STARTED|Overall Study||1
8536894|NCT01445327|9569510|FG002|STARTED|Overall Study||5
8536895|NCT01445327|9569508|FG000|COMPLETED|Overall Study||3
8536896|NCT01445327|9569509|FG001|COMPLETED|Overall Study||1
8536897|NCT01445327|9569510|FG002|COMPLETED|Overall Study||5
8536898|NCT01445327|9569508|FG000|NOT COMPLETED|Overall Study||0
8536899|NCT01445327|9569509|FG001|NOT COMPLETED|Overall Study||0
8536900|NCT01445327|9569510|FG002|NOT COMPLETED|Overall Study||0
8536901|NCT01434602|9569523|FG000|STARTED|Phase I Dose Escalation||6
8536902|NCT01434602|9569524|FG001|STARTED|Phase I Dose Escalation||7
8536903|NCT01434602|9569525|FG002|STARTED|Phase I Dose Escalation||0
8536904|NCT01434602|9569526|FG003|STARTED|Phase I Dose Escalation||0
8536905|NCT01434602|9569527|FG004|STARTED|Phase I Dose Escalation||0
8536906|NCT01434602|9569523|FG000|COMPLETED|Phase I Dose Escalation||6
8536907|NCT01434602|9569524|FG001|COMPLETED|Phase I Dose Escalation||6
8536908|NCT01434602|9569525|FG002|COMPLETED|Phase I Dose Escalation||0
8536909|NCT01434602|9569526|FG003|COMPLETED|Phase I Dose Escalation||0
8536910|NCT01434602|9569527|FG004|COMPLETED|Phase I Dose Escalation||0
8536911|NCT01434602|9569523|FG000|NOT COMPLETED|Phase I Dose Escalation||0
8536912|NCT01434602|9569524|FG001|NOT COMPLETED|Phase I Dose Escalation||1
8536913|NCT01434602|9569525|FG002|NOT COMPLETED|Phase I Dose Escalation||0
8536914|NCT01434602|9569526|FG003|NOT COMPLETED|Phase I Dose Escalation||0
8536915|NCT01434602|9569527|FG004|NOT COMPLETED|Phase I Dose Escalation||0
8536916|NCT01434602|9569523|FG000|STARTED|Phase II Recommended Phase 2 Dose||0
8536917|NCT01434602|9569524|FG001|STARTED|Phase II Recommended Phase 2 Dose||0
8536918|NCT01434602|9569525|FG002|STARTED|Phase II Recommended Phase 2 Dose||12
8536919|NCT01434602|9569526|FG003|STARTED|Phase II Recommended Phase 2 Dose||40
8536920|NCT01434602|9569527|FG004|STARTED|Phase II Recommended Phase 2 Dose||21
8536921|NCT01434602|9569523|FG000|COMPLETED|Phase II Recommended Phase 2 Dose||0
8536922|NCT01434602|9569524|FG001|COMPLETED|Phase II Recommended Phase 2 Dose||0
8536923|NCT01434602|9569525|FG002|COMPLETED|Phase II Recommended Phase 2 Dose||12
8536924|NCT01434602|9569526|FG003|COMPLETED|Phase II Recommended Phase 2 Dose||31
8536925|NCT01434602|9569527|FG004|COMPLETED|Phase II Recommended Phase 2 Dose||19
8536926|NCT01434602|9569523|FG000|NOT COMPLETED|Phase II Recommended Phase 2 Dose||0
8536927|NCT01434602|9569524|FG001|NOT COMPLETED|Phase II Recommended Phase 2 Dose||0
8536928|NCT01434602|9569525|FG002|NOT COMPLETED|Phase II Recommended Phase 2 Dose||0
8620975|NCT00477269|9659863|FG001|STARTED|Core Study||31
8536929|NCT01434602|9569526|FG003|NOT COMPLETED|Phase II Recommended Phase 2 Dose||9
8536930|NCT01434602|9569527|FG004|NOT COMPLETED|Phase II Recommended Phase 2 Dose||2
8536931|NCT01411332|9569548|FG000|STARTED|Overall Study||10
8536932|NCT01411332|9569549|FG001|STARTED|Overall Study||9
8536933|NCT01411332|9569548|FG000|COMPLETED|Overall Study||8
8536934|NCT01411332|9569549|FG001|COMPLETED|Overall Study||7
8536935|NCT01411332|9569548|FG000|NOT COMPLETED|Overall Study||2
8536936|NCT01411332|9569549|FG001|NOT COMPLETED|Overall Study||2
8536937|NCT01399918|9569555|FG000|STARTED|Overall Study||57
8536938|NCT01399918|9569555|FG000|COMPLETED|Overall Study||55
8536939|NCT01399918|9569555|FG000|NOT COMPLETED|Overall Study||2
8536940|NCT01377753|9569559|FG000|STARTED|Overall Study||15
8536941|NCT01377753|9569559|FG000|COMPLETED|Overall Study||15
8536942|NCT01377753|9569559|FG000|NOT COMPLETED|Overall Study||0
8536943|NCT01147653|9569565|FG000|STARTED|Year 1||32
8536944|NCT01147653|9569566|FG001|STARTED|Year 1||31
8620976|NCT00477269|9659864|FG002|STARTED|Core Study||0
8620977|NCT00477269|9659862|FG000|COMPLETED|Core Study||19
8620978|NCT00477269|9659863|FG001|COMPLETED|Core Study||23
8620979|NCT00477269|9659864|FG002|COMPLETED|Core Study||0
8620980|NCT00477269|9659862|FG000|NOT COMPLETED|Core Study||9
8620981|NCT00477269|9659863|FG001|NOT COMPLETED|Core Study||8
8620982|NCT00477269|9659864|FG002|NOT COMPLETED|Core Study||0
8620983|NCT00477269|9659862|FG000|STARTED|Open Label Extension|Arm in the Core study not extension|0
8620984|NCT00477269|9659863|FG001|STARTED|Open Label Extension|Arm in the Core study not extension|0
8620985|NCT00477269|9659864|FG002|STARTED|Open Label Extension||22
8620986|NCT00477269|9659862|FG000|COMPLETED|Open Label Extension|Arm in the Core study not extension|0
8620987|NCT00477269|9659863|FG001|COMPLETED|Open Label Extension|Arm in the Core study not extension|0
8620988|NCT00477269|9659864|FG002|COMPLETED|Open Label Extension||9
8620989|NCT00477269|9659862|FG000|NOT COMPLETED|Open Label Extension||0
8620990|NCT00477269|9659863|FG001|NOT COMPLETED|Open Label Extension||0
8620991|NCT00477269|9659864|FG002|NOT COMPLETED|Open Label Extension||13
8620992|NCT00477295|9659874|FG000|STARTED|Overall Study||282
8620993|NCT00477295|9659875|FG001|STARTED|Overall Study||301
8620994|NCT00477295|9659874|FG000|COMPLETED|Overall Study||161
8816746|NCT01545817|9870298|FG001|STARTED|Everolimus||38
8816747|NCT01545817|9870297|FG000|COMPLETED|Everolimus||0
8536945|NCT01147653|9569565|FG000|COMPLETED|Year 1||32
8536946|NCT01147653|9569566|FG001|COMPLETED|Year 1||31
8536947|NCT01147653|9569565|FG000|NOT COMPLETED|Year 1||0
8536948|NCT01147653|9569566|FG001|NOT COMPLETED|Year 1||0
8536949|NCT01147653|9569565|FG000|STARTED|Year 2||32
8536950|NCT01147653|9569566|FG001|STARTED|Year 2||31
8536951|NCT01147653|9569565|FG000|COMPLETED|Year 2||30
8536952|NCT01147653|9569566|FG001|COMPLETED|Year 2||28
8536953|NCT01147653|9569565|FG000|NOT COMPLETED|Year 2||2
8536954|NCT01147653|9569566|FG001|NOT COMPLETED|Year 2||3
8536955|NCT01078454|9569586|FG000|STARTED|Overall Study||6
8536956|NCT01078454|9569587|FG001|STARTED|Overall Study||5
8536957|NCT01078454|9569586|FG000|COMPLETED|Overall Study||5
8536958|NCT01078454|9569587|FG001|COMPLETED|Overall Study||3
8536959|NCT01078454|9569586|FG000|NOT COMPLETED|Overall Study||1
8536960|NCT01078454|9569587|FG001|NOT COMPLETED|Overall Study||2
8536961|NCT00687596|9569595|FG000|STARTED|Overall Study||26
8536962|NCT00687596|9569596|FG001|STARTED|Overall Study||26
8536963|NCT00687596|9569595|FG000|COMPLETED|Overall Study||0
8536964|NCT00687596|9569596|FG001|COMPLETED|Overall Study||0
8536965|NCT00687596|9569595|FG000|NOT COMPLETED|Overall Study||26
8536966|NCT00687596|9569596|FG001|NOT COMPLETED|Overall Study||26
8536967|NCT00458536|9569602|FG000|STARTED|Overall Study||38
8536968|NCT00458536|9569602|FG000|COMPLETED|Overall Study||19
8536969|NCT00458536|9569602|FG000|NOT COMPLETED|Overall Study||19
8536970|NCT00112840|9569609|FG000|STARTED|Overall Study||8
8536971|NCT00112840|9569610|FG001|STARTED|Overall Study||6
8536972|NCT00112840|9569611|FG002|STARTED|Overall Study||46
8536973|NCT00112840|9569609|FG000|COMPLETED|Overall Study||6
8536974|NCT00112840|9569610|FG001|COMPLETED|Overall Study||6
8536975|NCT00112840|9569611|FG002|COMPLETED|Overall Study||40
8536976|NCT00112840|9569609|FG000|NOT COMPLETED|Overall Study||2
8536977|NCT00112840|9569610|FG001|NOT COMPLETED|Overall Study||0
8536978|NCT00112840|9569611|FG002|NOT COMPLETED|Overall Study||6
8565536|NCT00068445|9597632|FG001|NOT COMPLETED|Treatment||16
8565537|NCT00068575|9597638|FG000|STARTED|Overall Study||28
8620995|NCT00477295|9659875|FG001|COMPLETED|Overall Study||192
8620996|NCT00477295|9659874|FG000|NOT COMPLETED|Overall Study||121
8816748|NCT01545817|9870298|FG001|COMPLETED|Everolimus||0
8816749|NCT01545817|9870297|FG000|NOT COMPLETED|Everolimus||0
8816750|NCT01545817|9870298|FG001|NOT COMPLETED|Everolimus||38
8816751|NCT01545843|9870309|FG000|STARTED|Overall Study||19
8816752|NCT01545843|9870310|FG001|STARTED|Overall Study||24
8816753|NCT01545843|9870311|FG002|STARTED|Overall Study||25
8816754|NCT01545843|9870309|FG000|COMPLETED|Overall Study||16
8816755|NCT01545843|9870310|FG001|COMPLETED|Overall Study||17
8816756|NCT01545843|9870311|FG002|COMPLETED|Overall Study||21
8816757|NCT01545843|9870309|FG000|NOT COMPLETED|Overall Study||3
8816758|NCT01545843|9870310|FG001|NOT COMPLETED|Overall Study||7
8816759|NCT01545843|9870311|FG002|NOT COMPLETED|Overall Study||4
8816760|NCT01545934|9870324|FG000|STARTED|Overall Study||132
8816761|NCT01545934|9870325|FG001|STARTED|Overall Study||132
8816762|NCT01545934|9870324|FG000|COMPLETED|Overall Study||127
8816763|NCT01545934|9870325|FG001|COMPLETED|Overall Study||129
8816764|NCT01545934|9870324|FG000|NOT COMPLETED|Overall Study||5
8816765|NCT01545934|9870325|FG001|NOT COMPLETED|Overall Study||3
8816766|NCT01546038|9870338|FG000|STARTED|Overall Study||17
8816767|NCT01546038|9870339|FG001|STARTED|Overall Study||6
8816768|NCT01546038|9870340|FG002|STARTED|Overall Study||4
8816769|NCT01546038|9870341|FG003|STARTED|Overall Study||3
8816770|NCT01546038|9870342|FG004|STARTED|Overall Study||16
8816771|NCT01546038|9870343|FG005|STARTED|Overall Study||6
8565538|NCT00068575|9597638|FG000|COMPLETED|Overall Study||28
8565539|NCT00068575|9597638|FG000|NOT COMPLETED|Overall Study||0
8565540|NCT00068588|9597645|FG000|STARTED|Overall Study||0
8565541|NCT00068588|9597646|FG001|STARTED|Overall Study||3
8565542|NCT00068588|9597647|FG002|STARTED|Overall Study||21
8565543|NCT00068588|9597645|FG000|COMPLETED|Overall Study||0
8565544|NCT00068588|9597646|FG001|COMPLETED|Overall Study||3
8565545|NCT00068588|9597647|FG002|COMPLETED|Overall Study||17
8565546|NCT00068588|9597645|FG000|NOT COMPLETED|Overall Study||0
8565547|NCT00068588|9597646|FG001|NOT COMPLETED|Overall Study||0
8536979|NCT04957732|9569626|FG000|STARTED|Overall Study||19
8536980|NCT04957732|9569627|FG001|STARTED|Overall Study||16
8536981|NCT04957732|9569626|FG000|COMPLETED|Overall Study||18
8536982|NCT04957732|9569627|FG001|COMPLETED|Overall Study||12
8536983|NCT04957732|9569626|FG000|NOT COMPLETED|Overall Study||1
8536984|NCT04957732|9569627|FG001|NOT COMPLETED|Overall Study||4
8536985|NCT04207749|9569640|FG000|STARTED|Overall Study||78
8536986|NCT04207749|9569641|FG001|STARTED|Overall Study||156
8536987|NCT04207749|9569640|FG000|COMPLETED|Overall Study||74
8536988|NCT04207749|9569641|FG001|COMPLETED|Overall Study||149
8536989|NCT04207749|9569640|FG000|NOT COMPLETED|Overall Study||4
8536990|NCT04207749|9569641|FG001|NOT COMPLETED|Overall Study||7
8537048|NCT03740009|9569726|FG000|STARTED|Overall Study||20
8537049|NCT03740009|9569726|FG000|Consented|Overall Study||20
8537050|NCT03740009|9569726|FG000|Received Intervention|Overall Study||10
8537051|NCT03740009|9569726|FG000|COMPLETED|Overall Study||10
8537052|NCT03740009|9569726|FG000|NOT COMPLETED|Overall Study||10
8537053|NCT03738397|9569732|FG000|STARTED|Overall Study||344
8537054|NCT03738397|9569733|FG001|STARTED|Overall Study||348
8537055|NCT03738397|9569732|FG000|COMPLETED|Overall Study||320
8537056|NCT03738397|9569733|FG001|COMPLETED|Overall Study||318
8537057|NCT03738397|9569732|FG000|NOT COMPLETED|Overall Study||24
8537058|NCT03738397|9569733|FG001|NOT COMPLETED|Overall Study||30
8537059|NCT03666624|9569741|FG000|STARTED|Overall Study||15
8537060|NCT03666624|9569742|FG001|STARTED|Overall Study||15
8537061|NCT03666624|9569741|FG000|COMPLETED|Overall Study||14
8537062|NCT03666624|9569742|FG001|COMPLETED|Overall Study||15
8537063|NCT03666624|9569741|FG000|NOT COMPLETED|Overall Study||1
8537064|NCT03666624|9569742|FG001|NOT COMPLETED|Overall Study||0
8537065|NCT03649217|9569748|FG000|STARTED|Overall Study||23
8537066|NCT03649217|9569748|FG000|COMPLETED|Overall Study||21
8537067|NCT03649217|9569748|FG000|NOT COMPLETED|Overall Study||2
8537068|NCT03576976|9569754|FG000|STARTED|Overall Study||27
8537069|NCT03576976|9569755|FG001|STARTED|Overall Study||28
8537070|NCT03576976|9569754|FG000|COMPLETED|Overall Study||18
8537071|NCT03576976|9569755|FG001|COMPLETED|Overall Study||17
8537072|NCT03576976|9569754|FG000|NOT COMPLETED|Overall Study||9
8816772|NCT01546038|9870344|FG006|STARTED|Overall Study||71
8816773|NCT01546038|9870345|FG007|STARTED|Overall Study||88
8816774|NCT01546038|9870346|FG008|STARTED|Overall Study||44
8816775|NCT01546038|9870338|FG000|Received Treatment|Overall Study||17
8816776|NCT01546038|9870339|FG001|Received Treatment|Overall Study||6
8816777|NCT01546038|9870340|FG002|Received Treatment|Overall Study||4
8816778|NCT01546038|9870341|FG003|Received Treatment|Overall Study||3
8816779|NCT01546038|9870342|FG004|Received Treatment|Overall Study||16
8816780|NCT01546038|9870343|FG005|Received Treatment|Overall Study||6
8816781|NCT01546038|9870344|FG006|Received Treatment|Overall Study||69
8816782|NCT01546038|9870345|FG007|Received Treatment|Overall Study||84
8816783|NCT01546038|9870346|FG008|Received Treatment|Overall Study||41
8816784|NCT01546038|9870338|FG000|COMPLETED|Overall Study||1
8816785|NCT01546038|9870339|FG001|COMPLETED|Overall Study||0
8816786|NCT01546038|9870340|FG002|COMPLETED|Overall Study||0
8816787|NCT01546038|9870341|FG003|COMPLETED|Overall Study||0
8816788|NCT01546038|9870342|FG004|COMPLETED|Overall Study||6
8816789|NCT01546038|9870343|FG005|COMPLETED|Overall Study||2
8816790|NCT01546038|9870344|FG006|COMPLETED|Overall Study||18
8816791|NCT01546038|9870345|FG007|COMPLETED|Overall Study||4
8816792|NCT01546038|9870346|FG008|COMPLETED|Overall Study||1
8816793|NCT01546038|9870338|FG000|NOT COMPLETED|Overall Study||16
8816794|NCT01546038|9870339|FG001|NOT COMPLETED|Overall Study||6
8816795|NCT01546038|9870340|FG002|NOT COMPLETED|Overall Study||4
8816796|NCT01546038|9870341|FG003|NOT COMPLETED|Overall Study||3
8816797|NCT01546038|9870342|FG004|NOT COMPLETED|Overall Study||10
8816798|NCT01546038|9870343|FG005|NOT COMPLETED|Overall Study||4
8816799|NCT01546038|9870344|FG006|NOT COMPLETED|Overall Study||53
8816800|NCT01546038|9870345|FG007|NOT COMPLETED|Overall Study||84
8816801|NCT01546038|9870346|FG008|NOT COMPLETED|Overall Study||43
8816802|NCT01546142|9870398|FG000|STARTED|Overall Study||258
8816803|NCT01546142|9870399|FG001|STARTED|Overall Study||258
8816804|NCT01546142|9870398|FG000|Received Treatment|Overall Study||257
8816805|NCT01546142|9870399|FG001|Received Treatment|Overall Study||257
8537073|NCT03576976|9569755|FG001|NOT COMPLETED|Overall Study||11
8537074|NCT03569293|9569767|FG000|STARTED|Overall Study||241
8537075|NCT03569293|9569768|FG001|STARTED|Overall Study||239
8816806|NCT01546142|9870398|FG000|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|214
8816807|NCT01546142|9870399|FG001|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|224
8816808|NCT01546142|9870398|FG000|NOT COMPLETED|Overall Study||44
8816809|NCT01546142|9870399|FG001|NOT COMPLETED|Overall Study||34
8816810|NCT01546155|9870405|FG000|STARTED|Overall Study||11
8816811|NCT01546155|9870405|FG000|COMPLETED|Overall Study||8
8816812|NCT01546155|9870405|FG000|NOT COMPLETED|Overall Study||3
8816813|NCT01546168|9870411|FG000|STARTED|Overall Study||55
8537076|NCT03569293|9569769|FG002|STARTED|Overall Study||243
8537077|NCT03569293|9569770|FG003|STARTED|Overall Study||61
8816814|NCT01546168|9870412|FG001|STARTED|Overall Study||33
8816815|NCT01546168|9870411|FG000|COMPLETED|Overall Study||51
8816816|NCT01546168|9870412|FG001|COMPLETED|Overall Study||33
8537078|NCT03569293|9569771|FG004|STARTED|Overall Study||64
8537079|NCT03569293|9569772|FG005|STARTED|Overall Study||64
8537080|NCT03569293|9569767|FG000|Received Study Drug|Overall Study||241
8537081|NCT03569293|9569768|FG001|Received Study Drug|Overall Study||239
8536991|NCT04167345|9569655|FG000|STARTED|Overall Study||10
8536992|NCT04167345|9569656|FG001|STARTED|Overall Study||4
8536993|NCT04167345|9569657|FG002|STARTED|Overall Study||3
8536994|NCT04167345|9569658|FG003|STARTED|Overall Study||13
8536995|NCT04167345|9569659|FG004|STARTED|Overall Study||18
8536996|NCT04167345|9569655|FG000|COMPLETED|Overall Study||9
8536997|NCT04167345|9569656|FG001|COMPLETED|Overall Study||3
8536998|NCT04167345|9569657|FG002|COMPLETED|Overall Study||3
8536999|NCT04167345|9569658|FG003|COMPLETED|Overall Study||13
8537000|NCT04167345|9569659|FG004|COMPLETED|Overall Study||18
8537001|NCT04167345|9569655|FG000|NOT COMPLETED|Overall Study||1
8537002|NCT04167345|9569656|FG001|NOT COMPLETED|Overall Study||1
8537003|NCT04167345|9569657|FG002|NOT COMPLETED|Overall Study||0
8537004|NCT04167345|9569658|FG003|NOT COMPLETED|Overall Study||0
8537005|NCT04167345|9569659|FG004|NOT COMPLETED|Overall Study||0
8537006|NCT04042077|9569677|FG000|STARTED|Overall Study||134
8537007|NCT04042077|9569678|FG001|STARTED|Overall Study||132
8537008|NCT04042077|9569677|FG000|Vancomycin IV|Overall Study||0
8537009|NCT04042077|9569678|FG001|Vancomycin IV|Overall Study||2
8537010|NCT04042077|9569677|FG000|Linezolid IV, With the Option to Switch to Linezolid Oral|Overall Study||0
8537011|NCT04042077|9569678|FG001|Linezolid IV, With the Option to Switch to Linezolid Oral|Overall Study||8
8537012|NCT04042077|9569677|FG000|Piperacillin/Tazobactam IV|Overall Study||0
8537013|NCT04042077|9569678|FG001|Piperacillin/Tazobactam IV|Overall Study||68
8537014|NCT04042077|9569677|FG000|Tigecycline IV|Overall Study||0
8537015|NCT04042077|9569678|FG001|Tigecycline IV|Overall Study||54
8537016|NCT04042077|9569677|FG000|COMPLETED|Overall Study||127
8537017|NCT04042077|9569678|FG001|COMPLETED|Overall Study||127
8537018|NCT04042077|9569677|FG000|NOT COMPLETED|Overall Study||7
8537019|NCT04042077|9569678|FG001|NOT COMPLETED|Overall Study||5
8537020|NCT04001803|9569690|FG000|STARTED|Overall Study||115
8537021|NCT04001803|9569690|FG000|COMPLETED|Overall Study||1
8537022|NCT04001803|9569690|FG000|NOT COMPLETED|Overall Study||114
8537023|NCT03936699|9569697|FG000|STARTED|Overall Study||83
8537024|NCT03936699|9569698|FG001|STARTED|Overall Study||78
8537025|NCT03936699|9569697|FG000|COMPLETED|Overall Study||61
8537026|NCT03936699|9569698|FG001|COMPLETED|Overall Study||55
8537027|NCT03936699|9569697|FG000|NOT COMPLETED|Overall Study||22
8537028|NCT03936699|9569698|FG001|NOT COMPLETED|Overall Study||23
8537029|NCT03925324|9569706|FG000|STARTED|Overall Study||2
8537030|NCT03925324|9569707|FG001|STARTED|Overall Study||2
8537031|NCT03925324|9569706|FG000|COMPLETED|Overall Study||1
8537032|NCT03925324|9569707|FG001|COMPLETED|Overall Study||1
8537033|NCT03925324|9569706|FG000|NOT COMPLETED|Overall Study||1
8537034|NCT03925324|9569707|FG001|NOT COMPLETED|Overall Study||1
8537035|NCT03875092|9569715|FG000|STARTED|Overall Study||65
8537036|NCT03875092|9569716|FG001|STARTED|Overall Study||60
8537037|NCT03875092|9569715|FG000|Treated|Overall Study||65
8537038|NCT03875092|9569716|FG001|Treated|Overall Study||60
8537039|NCT03875092|9569715|FG000|Switched to Pembrolizumab+Chemotherapy|Overall Study||0
8537040|NCT03875092|9569716|FG001|Switched to Pembrolizumab+Chemotherapy|Overall Study||38
8537041|NCT03875092|9569715|FG000|COMPLETED|Overall Study||0
8537042|NCT03875092|9569716|FG001|COMPLETED|Overall Study||0
8537043|NCT03875092|9569715|FG000|NOT COMPLETED|Overall Study||65
8537044|NCT03875092|9569716|FG001|NOT COMPLETED|Overall Study||60
8537045|NCT03814382|9569722|FG000|STARTED|Overall Study||10
8537046|NCT03814382|9569722|FG000|COMPLETED|Overall Study||10
8537047|NCT03814382|9569722|FG000|NOT COMPLETED|Overall Study||0
8537082|NCT03569293|9569769|FG002|Received Study Drug|Overall Study||243
8537083|NCT03569293|9569770|FG003|Received Study Drug|Overall Study||61
8537084|NCT03569293|9569771|FG004|Received Study Drug|Overall Study||64
8537085|NCT03569293|9569772|FG005|Received Study Drug|Overall Study||64
8537086|NCT03569293|9569767|FG000|COMPLETED|Overall Study||204
8537087|NCT03569293|9569768|FG001|COMPLETED|Overall Study||230
8537088|NCT03569293|9569769|FG002|COMPLETED|Overall Study||229
8537089|NCT03569293|9569770|FG003|COMPLETED|Overall Study||57
8537090|NCT03569293|9569771|FG004|COMPLETED|Overall Study||64
8537091|NCT03569293|9569772|FG005|COMPLETED|Overall Study||64
8537092|NCT03569293|9569767|FG000|NOT COMPLETED|Overall Study||37
8537093|NCT03569293|9569768|FG001|NOT COMPLETED|Overall Study||9
8537094|NCT03569293|9569769|FG002|NOT COMPLETED|Overall Study||14
8537095|NCT03569293|9569770|FG003|NOT COMPLETED|Overall Study||4
8537096|NCT03569293|9569771|FG004|NOT COMPLETED|Overall Study||0
8537097|NCT03569293|9569772|FG005|NOT COMPLETED|Overall Study||0
8537098|NCT03564353|9569790|FG000|STARTED|Overall Study||10
8537099|NCT03564353|9569791|FG001|STARTED|Overall Study||10
8537100|NCT03564353|9569792|FG002|STARTED|Overall Study||10
8537101|NCT03564353|9569793|FG003|STARTED|Overall Study||10
8537102|NCT03564353|9569790|FG000|COMPLETED|Overall Study||10
8537103|NCT03564353|9569791|FG001|COMPLETED|Overall Study||10
8537104|NCT03564353|9569792|FG002|COMPLETED|Overall Study||10
8537105|NCT03564353|9569793|FG003|COMPLETED|Overall Study||10
8537106|NCT03564353|9569790|FG000|NOT COMPLETED|Overall Study||0
8537107|NCT03564353|9569791|FG001|NOT COMPLETED|Overall Study||0
8537108|NCT03564353|9569792|FG002|NOT COMPLETED|Overall Study||0
8537109|NCT03564353|9569793|FG003|NOT COMPLETED|Overall Study||0
8537110|NCT03541499|9569807|FG000|STARTED|Overall Study||15
8537111|NCT03541499|9569808|FG001|STARTED|Overall Study||15
8537112|NCT03541499|9569809|FG002|STARTED|Overall Study||5
8537113|NCT03541499|9569810|FG003|STARTED|Overall Study||15
8537114|NCT03541499|9569807|FG000|COMPLETED|Overall Study||15
8537115|NCT03541499|9569808|FG001|COMPLETED|Overall Study||15
8537116|NCT03541499|9569809|FG002|COMPLETED|Overall Study||5
8537117|NCT03541499|9569810|FG003|COMPLETED|Overall Study||15
8537118|NCT03541499|9569807|FG000|NOT COMPLETED|Overall Study||0
8537119|NCT03541499|9569808|FG001|NOT COMPLETED|Overall Study||0
8537120|NCT03541499|9569809|FG002|NOT COMPLETED|Overall Study||0
8537121|NCT03541499|9569810|FG003|NOT COMPLETED|Overall Study||0
8537122|NCT03473977|9569822|FG000|STARTED|Overall Study||13
8537123|NCT03473977|9569823|FG001|STARTED|Overall Study||13
8816817|NCT01546168|9870411|FG000|NOT COMPLETED|Overall Study||4
8816818|NCT01546168|9870412|FG001|NOT COMPLETED|Overall Study||0
8816819|NCT01546194|9870420|FG000|STARTED|Overall Study||100
8537124|NCT03473977|9569822|FG000|COMPLETED|Overall Study||13
8537125|NCT03473977|9569823|FG001|COMPLETED|Overall Study||13
8537126|NCT03473977|9569822|FG000|NOT COMPLETED|Overall Study||0
8537127|NCT03473977|9569823|FG001|NOT COMPLETED|Overall Study||0
8537128|NCT03373110|9569832|FG000|STARTED|Overall Study||133
8537129|NCT03373110|9569833|FG001|STARTED|Overall Study||137
8537130|NCT03373110|9569834|FG002|STARTED|Overall Study||70
8537131|NCT03373110|9569832|FG000|Provided Fitbit Data|Overall Study||123
8537132|NCT03373110|9569833|FG001|Provided Fitbit Data|Overall Study||130
8620997|NCT00477295|9659875|FG001|NOT COMPLETED|Overall Study||109
8620998|NCT00477334|9659885|FG000|STARTED|Overall Study||312
8620999|NCT00477334|9659886|FG001|STARTED|Overall Study||151
8621000|NCT00477334|9659885|FG000|Randomized and Took Study Drug|Overall Study||206
8816820|NCT01546194|9870421|FG001|STARTED|Overall Study||100
8816821|NCT01546194|9870420|FG000|COMPLETED|Overall Study||64
8816822|NCT01546194|9870421|FG001|COMPLETED|Overall Study||65
8816823|NCT01546194|9870420|FG000|NOT COMPLETED|Overall Study||36
8816824|NCT01546194|9870421|FG001|NOT COMPLETED|Overall Study||35
8537133|NCT03373110|9569834|FG002|Provided Fitbit Data|Overall Study||63
8537134|NCT03373110|9569832|FG000|COMPLETED|Overall Study||55
8537135|NCT03373110|9569833|FG001|COMPLETED|Overall Study||58
8537136|NCT03373110|9569834|FG002|COMPLETED|Overall Study||26
8537137|NCT03373110|9569832|FG000|NOT COMPLETED|Overall Study||78
8537138|NCT03373110|9569833|FG001|NOT COMPLETED|Overall Study||79
8537139|NCT03373110|9569834|FG002|NOT COMPLETED|Overall Study||44
8537140|NCT03365102|9569845|FG000|STARTED|Overall Study||22
8537141|NCT03365102|9569846|FG001|STARTED|Overall Study||22
8537142|NCT03365102|9569847|FG002|STARTED|Overall Study||20
8537143|NCT03365102|9569845|FG000|COMPLETED|Overall Study||18
8537144|NCT03365102|9569846|FG001|COMPLETED|Overall Study||21
8537145|NCT03365102|9569847|FG002|COMPLETED|Overall Study||19
8537146|NCT03365102|9569845|FG000|NOT COMPLETED|Overall Study||4
8537147|NCT03365102|9569846|FG001|NOT COMPLETED|Overall Study||1
8537148|NCT03365102|9569847|FG002|NOT COMPLETED|Overall Study||1
8565548|NCT00068588|9597647|FG002|NOT COMPLETED|Overall Study||4
8565549|NCT00068601|9597656|FG000|STARTED|Overall Study||131
8565550|NCT00068601|9597657|FG001|STARTED|Overall Study||126
8565551|NCT00068601|9597656|FG000|COMPLETED|Overall Study||69
8565552|NCT00068601|9597657|FG001|COMPLETED|Overall Study||66
8565553|NCT00068601|9597656|FG000|NOT COMPLETED|Overall Study||62
8565554|NCT00068601|9597657|FG001|NOT COMPLETED|Overall Study||60
8565555|NCT00068692|9597666|FG000|STARTED|Step 1: Registration||128
8565556|NCT00068692|9597667|FG001|STARTED|Step 1: Registration|Group II patients were registered and randomized at the same time, and were reported in Step 2.|97
8565557|NCT00068692|9597668|FG002|STARTED|Step 1: Registration||0
8565558|NCT00068692|9597669|FG003|STARTED|Step 1: Registration||0
8565559|NCT00068692|9597670|FG004|STARTED|Step 1: Registration||0
8565560|NCT00068692|9597671|FG005|STARTED|Step 1: Registration|Group II patients was registered and randomized at the same time, and reported in step 2|0
8565561|NCT00068692|9597672|FG006|STARTED|Step 1: Registration|Group II patients was registered and randomized at the same time, and reported in step 2|0
8565562|NCT00068692|9597673|FG007|STARTED|Step 1: Registration|Group II patients was registered and randomized at the same time, and reported in step 2|0
8565563|NCT00068692|9597666|FG000|Started Concurrent Chemo/Radiation|Step 1: Registration||125
8621001|NCT00477334|9659886|FG001|Randomized and Took Study Drug|Overall Study||98
8621002|NCT00477334|9659885|FG000|Intent to Treat Population|Overall Study||201
8621003|NCT00477334|9659886|FG001|Intent to Treat Population|Overall Study||98
8816825|NCT01546285|9870427|FG000|STARTED|Overall Study||66
8816826|NCT01546285|9870427|FG000|COMPLETED|Overall Study||66
8816827|NCT01546285|9870427|FG000|NOT COMPLETED|Overall Study||0
8816828|NCT01546402|9870435|FG000|STARTED|Overall Study||10
8816829|NCT01546402|9870436|FG001|STARTED|Overall Study||10
8816830|NCT01546402|9870435|FG000|COMPLETED|Overall Study||10
8816831|NCT01546402|9870436|FG001|COMPLETED|Overall Study||10
8816832|NCT01546402|9870435|FG000|NOT COMPLETED|Overall Study||0
8816833|NCT01546402|9870436|FG001|NOT COMPLETED|Overall Study||0
8816834|NCT01546454|9870442|FG000|STARTED|Natural Menstrual Cycle||4
8816835|NCT01546454|9870442|FG000|COMPLETED|Natural Menstrual Cycle||4
8816836|NCT01546454|9870442|FG000|NOT COMPLETED|Natural Menstrual Cycle||0
8816837|NCT01546454|9870442|FG000|STARTED|Oral Contraceptive Cycle||4
8816838|NCT01546454|9870442|FG000|COMPLETED|Oral Contraceptive Cycle||4
8629450|NCT00530270|9669191|FG000|NOT COMPLETED|Overall Study||1
8816839|NCT01546454|9870442|FG000|NOT COMPLETED|Oral Contraceptive Cycle||0
8816840|NCT01546454|9870442|FG000|STARTED|Eligard Treatment||4
8816841|NCT01546454|9870442|FG000|COMPLETED|Eligard Treatment||4
8816842|NCT01546454|9870442|FG000|NOT COMPLETED|Eligard Treatment||0
8816843|NCT01546454|9870442|FG000|STARTED|Estrogen/Progesterone Replacement Cycle||4
8816844|NCT01546454|9870442|FG000|COMPLETED|Estrogen/Progesterone Replacement Cycle||4
8537149|NCT03318003|9569857|FG000|STARTED|Overall Study||21
8537150|NCT03318003|9569858|FG001|STARTED|Overall Study||22
8537151|NCT03318003|9569857|FG000|COMPLETED|Overall Study|completed means the presence of 3rd trimester ultrasound and delivery information.|20
8537152|NCT03318003|9569858|FG001|COMPLETED|Overall Study||20
8537153|NCT03318003|9569857|FG000|NOT COMPLETED|Overall Study||1
8537154|NCT03318003|9569858|FG001|NOT COMPLETED|Overall Study||2
8537155|NCT03309072|9569866|FG000|STARTED|Overall Study||15
8537156|NCT03309072|9569867|FG001|STARTED|Overall Study||15
8537157|NCT03309072|9569866|FG000|COMPLETED|Overall Study||15
8537158|NCT03309072|9569867|FG001|COMPLETED|Overall Study||15
8537159|NCT03309072|9569866|FG000|NOT COMPLETED|Overall Study||0
8537160|NCT03309072|9569867|FG001|NOT COMPLETED|Overall Study||0
8537161|NCT03138590|9569875|FG000|STARTED|Overall Study||10
8537162|NCT03138590|9569876|FG001|STARTED|Overall Study||10
8537163|NCT03138590|9569875|FG000|COMPLETED|Overall Study||10
8537164|NCT03138590|9569876|FG001|COMPLETED|Overall Study||10
8537165|NCT03138590|9569875|FG000|NOT COMPLETED|Overall Study||0
8537166|NCT03138590|9569876|FG001|NOT COMPLETED|Overall Study||0
8537167|NCT03132753|9569884|FG000|STARTED|Baseline - 6 Month Follow-Up||46
8537168|NCT03132753|9569885|FG001|STARTED|Baseline - 6 Month Follow-Up||54
8537169|NCT03132753|9569884|FG000|COMPLETED|Baseline - 6 Month Follow-Up||19
8537170|NCT03132753|9569885|FG001|COMPLETED|Baseline - 6 Month Follow-Up||22
8537171|NCT03132753|9569884|FG000|NOT COMPLETED|Baseline - 6 Month Follow-Up||27
8537172|NCT03132753|9569885|FG001|NOT COMPLETED|Baseline - 6 Month Follow-Up||32
8537173|NCT03132753|9569884|FG000|STARTED|6 Month Follow-Up - 12 Month Follow-Up||19
8537174|NCT03132753|9569885|FG001|STARTED|6 Month Follow-Up - 12 Month Follow-Up||22
8537175|NCT03132753|9569884|FG000|COMPLETED|6 Month Follow-Up - 12 Month Follow-Up||13
8537176|NCT03132753|9569885|FG001|COMPLETED|6 Month Follow-Up - 12 Month Follow-Up||20
8537177|NCT03132753|9569884|FG000|NOT COMPLETED|6 Month Follow-Up - 12 Month Follow-Up||6
8537178|NCT03132753|9569885|FG001|NOT COMPLETED|6 Month Follow-Up - 12 Month Follow-Up||2
8537179|NCT03085680|9569893|FG000|STARTED|Overall Study||9
8537180|NCT03085680|9569894|FG001|STARTED|Overall Study||8
8537181|NCT03085680|9569893|FG000|COMPLETED|Overall Study||9
8537182|NCT03085680|9569894|FG001|COMPLETED|Overall Study||8
8537183|NCT03085680|9569893|FG000|NOT COMPLETED|Overall Study||0
8537184|NCT03085680|9569894|FG001|NOT COMPLETED|Overall Study||0
8537185|NCT03067077|9569900|FG000|STARTED|Overall Study||44
8537186|NCT03067077|9569901|FG001|STARTED|Overall Study||44
8537187|NCT03067077|9569900|FG000|Received Surgery|Overall Study||40
8537188|NCT03067077|9569901|FG001|Received Surgery|Overall Study||39
8537189|NCT03067077|9569900|FG000|COMPLETED|Overall Study||37
8537190|NCT03067077|9569901|FG001|COMPLETED|Overall Study||37
8537191|NCT03067077|9569900|FG000|NOT COMPLETED|Overall Study||7
8537192|NCT03067077|9569901|FG001|NOT COMPLETED|Overall Study||7
8537193|NCT03059446|9569907|FG000|STARTED|Overall Study||167
8537194|NCT03059446|9569907|FG000|COMPLETED|Overall Study||0
8537195|NCT03059446|9569907|FG000|NOT COMPLETED|Overall Study||167
8537196|NCT03035409|9569911|FG000|STARTED|Overall Study||45
8537197|NCT03035409|9569911|FG000|Day 15|Overall Study||28
8537198|NCT03035409|9569911|FG000|Day 29|Overall Study||28
8537199|NCT03035409|9569911|FG000|Day 43|Overall Study||28
8537200|NCT03035409|9569911|FG000|COMPLETED|Overall Study||28
8537201|NCT03035409|9569911|FG000|NOT COMPLETED|Overall Study||17
8537202|NCT03019575|9569915|FG000|STARTED|Overall Study||17
8537203|NCT03019575|9569915|FG000|COMPLETED|Overall Study||17
8537204|NCT03019575|9569915|FG000|NOT COMPLETED|Overall Study||0
8537205|NCT03011034|9569921|FG000|STARTED|Overall Study||1
8537206|NCT03011034|9569922|FG001|STARTED|Overall Study||33
8537207|NCT03011034|9569921|FG000|COMPLETED|Overall Study||0
8537208|NCT03011034|9569922|FG001|COMPLETED|Overall Study||33
8537209|NCT03011034|9569921|FG000|NOT COMPLETED|Overall Study||1
8621004|NCT00477334|9659885|FG000|Participants Completing First Recurrence|Overall Study||187
8621005|NCT00477334|9659886|FG001|Participants Completing First Recurrence|Overall Study||92
8621006|NCT00477334|9659885|FG000|Modified Intent to Treat Population|Overall Study||152
8621007|NCT00477334|9659886|FG001|Modified Intent to Treat Population|Overall Study||78
8723040|NCT01021306|9770544|FG001|COMPLETED|2 Month (Primary Outcome)||14
8537210|NCT03011034|9569922|FG001|NOT COMPLETED|Overall Study||0
8537211|NCT02980666|9569930|FG000|STARTED|Overall Study||8
8537212|NCT02980666|9569931|FG001|STARTED|Overall Study||2
8537213|NCT02980666|9569930|FG000|COMPLETED|Overall Study||8
8537214|NCT02980666|9569931|FG001|COMPLETED|Overall Study||2
8537215|NCT02980666|9569930|FG000|NOT COMPLETED|Overall Study||0
8537216|NCT02980666|9569931|FG001|NOT COMPLETED|Overall Study||0
8537217|NCT02962102|9569940|FG000|STARTED|Overall Study||51
8537218|NCT02962102|9569941|FG001|STARTED|Overall Study||50
8537219|NCT02962102|9569942|FG002|STARTED|Overall Study||49
8537220|NCT02962102|9569940|FG000|COMPLETED|Overall Study||51
8537221|NCT02962102|9569941|FG001|COMPLETED|Overall Study||50
8537222|NCT02962102|9569942|FG002|COMPLETED|Overall Study||49
8537223|NCT02962102|9569940|FG000|NOT COMPLETED|Overall Study||0
8537224|NCT02962102|9569941|FG001|NOT COMPLETED|Overall Study||0
8621008|NCT00477334|9659885|FG000|COMPLETED|Overall Study|Participants completing the first recurrence and follow-up.|142
8537225|NCT02962102|9569942|FG002|NOT COMPLETED|Overall Study||0
8537226|NCT02853331|9569952|FG000|STARTED|Overall Study||432
8537227|NCT02853331|9569953|FG001|STARTED|Overall Study||429
8537228|NCT02853331|9569952|FG000|Treated|Overall Study||429
8537229|NCT02853331|9569953|FG001|Treated|Overall Study||425
8537230|NCT02853331|9569952|FG000|COMPLETED|Overall Study||0
8537231|NCT02853331|9569953|FG001|COMPLETED|Overall Study||0
8537232|NCT02853331|9569952|FG000|NOT COMPLETED|Overall Study||432
8537233|NCT02853331|9569953|FG001|NOT COMPLETED|Overall Study||429
8537234|NCT02841644|9569961|FG000|STARTED|Overall Study||60
8537235|NCT02841644|9569962|FG001|STARTED|Overall Study||120
8537236|NCT02841644|9569961|FG000|COMPLETED|Overall Study||60
8537237|NCT02841644|9569962|FG001|COMPLETED|Overall Study||120
8537238|NCT02841644|9569961|FG000|NOT COMPLETED|Overall Study||0
8537239|NCT02841644|9569962|FG001|NOT COMPLETED|Overall Study||0
8537240|NCT02749045|9569968|FG000|STARTED|Overall Study||27
8537241|NCT02749045|9569968|FG000|COMPLETED|Overall Study||27
8537242|NCT02749045|9569968|FG000|NOT COMPLETED|Overall Study||0
8537243|NCT02659605|9569974|FG000|STARTED|Overall Study||40
8537244|NCT02659605|9569975|FG001|STARTED|Overall Study||34
8537245|NCT02659605|9569974|FG000|COMPLETED|Overall Study||31
8537246|NCT02659605|9569975|FG001|COMPLETED|Overall Study||30
8537247|NCT02659605|9569974|FG000|NOT COMPLETED|Overall Study||9
8537248|NCT02659605|9569975|FG001|NOT COMPLETED|Overall Study||4
8537249|NCT02601014|9569983|FG000|STARTED|Overall Study||15
8537250|NCT02601014|9569984|FG001|STARTED|Overall Study||15
8537251|NCT02601014|9569983|FG000|COMPLETED|Overall Study||5
8537252|NCT02601014|9569984|FG001|COMPLETED|Overall Study||3
8537253|NCT02601014|9569983|FG000|NOT COMPLETED|Overall Study||10
8537254|NCT02601014|9569984|FG001|NOT COMPLETED|Overall Study||12
8537255|NCT02579096|9569992|FG000|STARTED|Phase 1, Weeks 0 - 24||468
8537256|NCT02579096|9569993|FG001|STARTED|Phase 1, Weeks 0 - 24||472
8537257|NCT02579096|9569992|FG000|COMPLETED|Phase 1, Weeks 0 - 24||411
8537258|NCT02579096|9569993|FG001|COMPLETED|Phase 1, Weeks 0 - 24||422
8537259|NCT02579096|9569992|FG000|NOT COMPLETED|Phase 1, Weeks 0 - 24||57
8537260|NCT02579096|9569993|FG001|NOT COMPLETED|Phase 1, Weeks 0 - 24||50
8537261|NCT02579096|9569992|FG000|STARTED|Phase 2, Weeks 25 - 48||411
8537262|NCT02579096|9569993|FG001|STARTED|Phase 2, Weeks 25 - 48||422
8537263|NCT02579096|9569992|FG000|COMPLETED|Phase 2, Weeks 25 - 48||389
8537264|NCT02579096|9569993|FG001|COMPLETED|Phase 2, Weeks 25 - 48||391
8537265|NCT02579096|9569992|FG000|NOT COMPLETED|Phase 2, Weeks 25 - 48||22
8537266|NCT02579096|9569993|FG001|NOT COMPLETED|Phase 2, Weeks 25 - 48||31
8537267|NCT02579096|9569992|FG000|STARTED|Phase 3, Weeks 49 - 72||389
8537268|NCT02579096|9569993|FG001|STARTED|Phase 3, Weeks 49 - 72||391
8537269|NCT02579096|9569992|FG000|COMPLETED|Phase 3, Weeks 49 - 72||367
8537270|NCT02579096|9569993|FG001|COMPLETED|Phase 3, Weeks 49 - 72||373
8537271|NCT02579096|9569992|FG000|NOT COMPLETED|Phase 3, Weeks 49 - 72||22
8537272|NCT02579096|9569993|FG001|NOT COMPLETED|Phase 3, Weeks 49 - 72||18
8537273|NCT02538666|9570002|FG000|STARTED|Overall Study||275
8537274|NCT02538666|9570003|FG001|STARTED|Overall Study||280
8537275|NCT02538666|9570004|FG002|STARTED|Overall Study||279
8537276|NCT02538666|9570002|FG000|COMPLETED|Overall Study||273
8537277|NCT02538666|9570003|FG001|COMPLETED|Overall Study||279
8537278|NCT02538666|9570004|FG002|COMPLETED|Overall Study||278
8816845|NCT01546454|9870442|FG000|NOT COMPLETED|Estrogen/Progesterone Replacement Cycle||0
8816846|NCT01546519|9870452|FG000|STARTED|Overall Study||9
8816847|NCT01546519|9870453|FG001|STARTED|Overall Study||8
8816848|NCT01546519|9870454|FG002|STARTED|Overall Study||8
8816849|NCT01546519|9870455|FG003|STARTED|Overall Study||6
8816850|NCT01546519|9870452|FG000|Safety-Evaluable Participants|Overall Study||9
8816851|NCT01546519|9870453|FG001|Safety-Evaluable Participants|Overall Study||8
8816852|NCT01546519|9870454|FG002|Safety-Evaluable Participants|Overall Study||8
8816853|NCT01546519|9870455|FG003|Safety-Evaluable Participants|Overall Study||6
8816854|NCT01546519|9870452|FG000|COMPLETED|Overall Study||0
8816855|NCT01546519|9870453|FG001|COMPLETED|Overall Study||0
8816856|NCT01546519|9870454|FG002|COMPLETED|Overall Study||0
8816857|NCT01546519|9870455|FG003|COMPLETED|Overall Study||0
8816858|NCT01546519|9870452|FG000|NOT COMPLETED|Overall Study||9
8816859|NCT01546519|9870453|FG001|NOT COMPLETED|Overall Study||8
8816860|NCT01546519|9870454|FG002|NOT COMPLETED|Overall Study||8
8816861|NCT01546519|9870455|FG003|NOT COMPLETED|Overall Study||6
8816862|NCT01546623|9870471|FG000|STARTED|Overall Study||82
8816863|NCT01546623|9870472|FG001|STARTED|Overall Study||80
8816864|NCT01546623|9870471|FG000|Received Study Drug|Overall Study||81
8816865|NCT01546623|9870472|FG001|Received Study Drug|Overall Study||79
8816866|NCT01546623|9870471|FG000|COMPLETED|Overall Study||76
8816867|NCT01546623|9870472|FG001|COMPLETED|Overall Study||74
8816868|NCT01546623|9870471|FG000|NOT COMPLETED|Overall Study||6
8816869|NCT01546623|9870472|FG001|NOT COMPLETED|Overall Study||6
8816870|NCT01546636|9870480|FG000|STARTED|Overall Study||36
8816871|NCT01546636|9870481|FG001|STARTED|Overall Study||34
8816872|NCT01546636|9870480|FG000|COMPLETED|Overall Study||36
8816873|NCT01546636|9870481|FG001|COMPLETED|Overall Study||34
8816874|NCT01546636|9870480|FG000|NOT COMPLETED|Overall Study||0
8816875|NCT01546636|9870481|FG001|NOT COMPLETED|Overall Study||0
8816876|NCT01546649|9870489|FG000|STARTED|Overall Study||83
8816877|NCT01546649|9870490|FG001|STARTED|Overall Study||84
8537279|NCT02538666|9570002|FG000|NOT COMPLETED|Overall Study||2
8537280|NCT02538666|9570003|FG001|NOT COMPLETED|Overall Study||1
8537281|NCT02538666|9570004|FG002|NOT COMPLETED|Overall Study||1
8537282|NCT02527200|9570017|FG000|STARTED|Overall Study||20
8537283|NCT02527200|9570018|FG001|STARTED|Overall Study||12
8816878|NCT01546649|9870489|FG000|COMPLETED|Overall Study||75
8816879|NCT01546649|9870490|FG001|COMPLETED|Overall Study||75
8537284|NCT02527200|9570019|FG002|STARTED|Overall Study||17
8537285|NCT02527200|9570020|FG003|STARTED|Overall Study||7
8537286|NCT02527200|9570017|FG000|Safety Analysis Set (SAS)|Overall Study||20
8537287|NCT02527200|9570018|FG001|Safety Analysis Set (SAS)|Overall Study||12
8537288|NCT02527200|9570019|FG002|Safety Analysis Set (SAS)|Overall Study||17
8537289|NCT02527200|9570020|FG003|Safety Analysis Set (SAS)|Overall Study||7
8537290|NCT02527200|9570017|FG000|Full Analysis Set (FAS)|Overall Study||19
8537291|NCT02527200|9570018|FG001|Full Analysis Set (FAS)|Overall Study||12
8537292|NCT02527200|9570019|FG002|Full Analysis Set (FAS)|Overall Study||17
8537293|NCT02527200|9570020|FG003|Full Analysis Set (FAS)|Overall Study||7
8537294|NCT02527200|9570017|FG000|COMPLETED|Overall Study||17
8537295|NCT02527200|9570018|FG001|COMPLETED|Overall Study||9
8537296|NCT02527200|9570019|FG002|COMPLETED|Overall Study||15
8537297|NCT02527200|9570020|FG003|COMPLETED|Overall Study||7
8537298|NCT02527200|9570017|FG000|NOT COMPLETED|Overall Study||3
8537299|NCT02527200|9570018|FG001|NOT COMPLETED|Overall Study||3
8537300|NCT02527200|9570019|FG002|NOT COMPLETED|Overall Study||2
8537301|NCT02527200|9570020|FG003|NOT COMPLETED|Overall Study||0
8565564|NCT00068692|9597667|FG001|Started Concurrent Chemo/Radiation|Step 1: Registration|Group II patients receive protocol therapy in Step 2 after randomization|0
8565565|NCT00068692|9597668|FG002|Started Concurrent Chemo/Radiation|Step 1: Registration||0
8565566|NCT00068692|9597669|FG003|Started Concurrent Chemo/Radiation|Step 1: Registration||0
8565567|NCT00068692|9597670|FG004|Started Concurrent Chemo/Radiation|Step 1: Registration||0
8565568|NCT00068692|9597671|FG005|Started Concurrent Chemo/Radiation|Step 1: Registration||0
8565569|NCT00068692|9597672|FG006|Started Concurrent Chemo/Radiation|Step 1: Registration||0
8565570|NCT00068692|9597673|FG007|Started Concurrent Chemo/Radiation|Step 1: Registration||0
8565571|NCT00068692|9597666|FG000|Reported AE Data|Step 1: Registration||123
8565572|NCT00068692|9597667|FG001|Reported AE Data|Step 1: Registration||0
8565573|NCT00068692|9597668|FG002|Reported AE Data|Step 1: Registration||0
8565574|NCT00068692|9597669|FG003|Reported AE Data|Step 1: Registration||0
8565575|NCT00068692|9597670|FG004|Reported AE Data|Step 1: Registration||0
8565576|NCT00068692|9597671|FG005|Reported AE Data|Step 1: Registration||0
8565577|NCT00068692|9597672|FG006|Reported AE Data|Step 1: Registration||0
8565578|NCT00068692|9597673|FG007|Reported AE Data|Step 1: Registration||0
8565579|NCT00068692|9597666|FG000|COMPLETED|Step 1: Registration||88
8565580|NCT00068692|9597667|FG001|COMPLETED|Step 1: Registration|Case 32191 entered the study as Group II patient but was never randomized.|96
8565581|NCT00068692|9597668|FG002|COMPLETED|Step 1: Registration||0
8565582|NCT00068692|9597669|FG003|COMPLETED|Step 1: Registration||0
8565583|NCT00068692|9597670|FG004|COMPLETED|Step 1: Registration||0
8565584|NCT00068692|9597671|FG005|COMPLETED|Step 1: Registration||0
8565585|NCT00068692|9597672|FG006|COMPLETED|Step 1: Registration||0
8816880|NCT01546649|9870489|FG000|NOT COMPLETED|Overall Study||8
8816881|NCT01546649|9870490|FG001|NOT COMPLETED|Overall Study||9
8816882|NCT01546675|9870498|FG000|STARTED|Overall Study||1
8816883|NCT01546675|9870499|FG001|STARTED|Overall Study||1
8816884|NCT01546675|9870498|FG000|COMPLETED|Overall Study||1
8816885|NCT01546675|9870499|FG001|COMPLETED|Overall Study||1
8816886|NCT01546675|9870498|FG000|NOT COMPLETED|Overall Study||0
8816887|NCT01546675|9870499|FG001|NOT COMPLETED|Overall Study||0
8816888|NCT01546688|9870507|FG000|STARTED|Overall Study||18
8816889|NCT01546688|9870508|FG001|STARTED|Overall Study||33
8816890|NCT01546688|9870507|FG000|COMPLETED|Overall Study||15
8816891|NCT01546688|9870508|FG001|COMPLETED|Overall Study||28
8816892|NCT01546688|9870507|FG000|NOT COMPLETED|Overall Study||3
8816893|NCT01546688|9870508|FG001|NOT COMPLETED|Overall Study||5
8816894|NCT01546857|9870516|FG000|STARTED|Overall Study||14
8816895|NCT01546857|9870517|FG001|STARTED|Overall Study||20
8816896|NCT01546857|9870516|FG000|COMPLETED|Overall Study||12
8816897|NCT01546857|9870517|FG001|COMPLETED|Overall Study||17
8816898|NCT01546857|9870516|FG000|NOT COMPLETED|Overall Study||2
8816899|NCT01546857|9870517|FG001|NOT COMPLETED|Overall Study||3
8816900|NCT01546922|9870524|FG000|STARTED|First Period of 10 Weeks||30
8816901|NCT01546922|9870525|FG001|STARTED|First Period of 10 Weeks||30
8816902|NCT01546922|9870524|FG000|COMPLETED|First Period of 10 Weeks||25
8816903|NCT01546922|9870525|FG001|COMPLETED|First Period of 10 Weeks||28
8816904|NCT01546922|9870524|FG000|NOT COMPLETED|First Period of 10 Weeks||5
8816905|NCT01546922|9870525|FG001|NOT COMPLETED|First Period of 10 Weeks||2
8816906|NCT01546922|9870524|FG000|STARTED|Second Period of 10 Weeks||25
8816907|NCT01546922|9870525|FG001|STARTED|Second Period of 10 Weeks||28
8816908|NCT01546922|9870524|FG000|COMPLETED|Second Period of 10 Weeks||22
8816909|NCT01546922|9870525|FG001|COMPLETED|Second Period of 10 Weeks||25
8816910|NCT01546922|9870524|FG000|NOT COMPLETED|Second Period of 10 Weeks||3
8816911|NCT01546922|9870525|FG001|NOT COMPLETED|Second Period of 10 Weeks||3
8816912|NCT01547000|9870533|FG000|STARTED|Overall Study||18
8816913|NCT01547000|9870534|FG001|STARTED|Overall Study||16
8816914|NCT01547000|9870533|FG000|COMPLETED|Overall Study||18
8816915|NCT01547000|9870534|FG001|COMPLETED|Overall Study||16
8816916|NCT01547000|9870533|FG000|NOT COMPLETED|Overall Study||0
8816917|NCT01547000|9870534|FG001|NOT COMPLETED|Overall Study||0
8816918|NCT01547130|9870542|FG000|STARTED|Overall Study||74
8816919|NCT01547130|9870543|FG001|STARTED|Overall Study||73
8565586|NCT00068692|9597673|FG007|COMPLETED|Step 1: Registration||0
8565587|NCT00068692|9597666|FG000|NOT COMPLETED|Step 1: Registration||40
8565588|NCT00068692|9597667|FG001|NOT COMPLETED|Step 1: Registration||1
8565589|NCT00068692|9597668|FG002|NOT COMPLETED|Step 1: Registration||0
8816920|NCT01547130|9870542|FG000|COMPLETED|Overall Study||65
8565590|NCT00068692|9597669|FG003|NOT COMPLETED|Step 1: Registration||0
8537302|NCT02511106|9570036|FG000|STARTED|Overall Study||339
8537303|NCT02511106|9570037|FG001|STARTED|Overall Study||343
8537304|NCT02511106|9570036|FG000|Received Treatment|Overall Study||337
8537305|NCT02511106|9570037|FG001|Received Treatment|Overall Study||343
8537306|NCT02511106|9570036|FG000|COMPLETED|Overall Study||8
8537307|NCT02511106|9570037|FG001|COMPLETED|Overall Study||20
8537308|NCT02511106|9570036|FG000|NOT COMPLETED|Overall Study||331
8537309|NCT02511106|9570037|FG001|NOT COMPLETED|Overall Study||323
8537310|NCT02477358|9570047|FG000|STARTED|Overall Study||18
8537311|NCT02477358|9570048|FG001|STARTED|Overall Study||18
8537312|NCT02477358|9570047|FG000|COMPLETED|Overall Study||18
8537313|NCT02477358|9570048|FG001|COMPLETED|Overall Study||18
8537314|NCT02477358|9570047|FG000|NOT COMPLETED|Overall Study||0
8537315|NCT02477358|9570048|FG001|NOT COMPLETED|Overall Study||0
8537316|NCT02432209|9570058|FG000|STARTED|Overall Study||188
8537317|NCT02432209|9570059|FG001|STARTED|Overall Study||191
8537318|NCT02432209|9570058|FG000|COMPLETED|Overall Study||157
8537319|NCT02432209|9570059|FG001|COMPLETED|Overall Study||151
8537320|NCT02432209|9570058|FG000|NOT COMPLETED|Overall Study||31
8537321|NCT02432209|9570059|FG001|NOT COMPLETED|Overall Study||40
8537322|NCT02392637|9570067|FG000|STARTED|Overall Study||32
8537323|NCT02392637|9570068|FG001|STARTED|Overall Study||28
8537324|NCT02392637|9570067|FG000|COMPLETED|Overall Study||32
8537325|NCT02392637|9570068|FG001|COMPLETED|Overall Study||28
8537326|NCT02392637|9570067|FG000|NOT COMPLETED|Overall Study||0
8537327|NCT02392637|9570068|FG001|NOT COMPLETED|Overall Study||0
8537328|NCT02253316|9570077|FG000|STARTED|Consolidation||236
8537329|NCT02253316|9570078|FG001|STARTED|Consolidation||0
8537330|NCT02253316|9570079|FG002|STARTED|Consolidation||0
8537331|NCT02253316|9570077|FG000|COMPLETED|Consolidation||220
8537332|NCT02253316|9570078|FG001|COMPLETED|Consolidation||0
8537333|NCT02253316|9570079|FG002|COMPLETED|Consolidation||0
8537334|NCT02253316|9570077|FG000|NOT COMPLETED|Consolidation||16
8537335|NCT02253316|9570078|FG001|NOT COMPLETED|Consolidation||0
8537336|NCT02253316|9570079|FG002|NOT COMPLETED|Consolidation||0
8537337|NCT02253316|9570077|FG000|STARTED|Maintenance||0
8537338|NCT02253316|9570078|FG001|STARTED|Maintenance||99
8537339|NCT02253316|9570079|FG002|STARTED|Maintenance||116
8537340|NCT02253316|9570077|FG000|COMPLETED|Maintenance||0
8537341|NCT02253316|9570078|FG001|COMPLETED|Maintenance||53
8537342|NCT02253316|9570079|FG002|COMPLETED|Maintenance||49
8537343|NCT02253316|9570077|FG000|NOT COMPLETED|Maintenance||0
8537344|NCT02253316|9570078|FG001|NOT COMPLETED|Maintenance||46
8537345|NCT02253316|9570079|FG002|NOT COMPLETED|Maintenance||67
8537346|NCT02224573|9570089|FG000|STARTED|Treatment Phase||315
8537347|NCT02224573|9570090|FG001|STARTED|Treatment Phase||366
8537348|NCT02224573|9570089|FG000|COMPLETED|Treatment Phase||170
8537349|NCT02224573|9570090|FG001|COMPLETED|Treatment Phase||243
8537350|NCT02224573|9570089|FG000|NOT COMPLETED|Treatment Phase||145
8537351|NCT02224573|9570090|FG001|NOT COMPLETED|Treatment Phase||123
8537352|NCT02224573|9570089|FG000|STARTED|Taper Phase|The number of participants to start the Taper Phase is not equal to the number who completed the Treatment Phase because not all participants tapered IMP.|79
8537353|NCT02224573|9570090|FG001|STARTED|Taper Phase|The number of participants to start the Taper Phase is not equal to the number who completed the Treatment Phase because not all participants tapered IMP.|71
8537354|NCT02224573|9570089|FG000|COMPLETED|Taper Phase||76
8537355|NCT02224573|9570090|FG001|COMPLETED|Taper Phase||67
8537356|NCT02224573|9570089|FG000|NOT COMPLETED|Taper Phase||3
8537357|NCT02224573|9570090|FG001|NOT COMPLETED|Taper Phase||4
8537358|NCT01991067|9570099|FG000|STARTED|Overall Study||19
8537359|NCT01991067|9570100|FG001|STARTED|Overall Study||15
8537360|NCT01991067|9570099|FG000|COMPLETED|Overall Study||13
8537361|NCT01991067|9570100|FG001|COMPLETED|Overall Study||10
8537362|NCT01991067|9570099|FG000|NOT COMPLETED|Overall Study||6
8537363|NCT01991067|9570100|FG001|NOT COMPLETED|Overall Study||5
8537364|NCT01966471|9570108|FG000|STARTED|Overall Study||918
8537365|NCT01966471|9570109|FG001|STARTED|Overall Study||928
8537366|NCT01966471|9570108|FG000|COMPLETED|Overall Study||815
8537367|NCT01966471|9570109|FG001|COMPLETED|Overall Study||815
8537368|NCT01966471|9570108|FG000|NOT COMPLETED|Overall Study||103
8537369|NCT01966471|9570109|FG001|NOT COMPLETED|Overall Study||113
8537370|NCT01928732|9570117|FG000|STARTED|Overall Study||455
8537371|NCT01928732|9570118|FG001|STARTED|Overall Study||461
8537372|NCT01928732|9570117|FG000|COMPLETED|Overall Study||326
8537373|NCT01928732|9570118|FG001|COMPLETED|Overall Study||334
8537374|NCT01928732|9570117|FG000|NOT COMPLETED|Overall Study||129
8537375|NCT01928732|9570118|FG001|NOT COMPLETED|Overall Study||127
8537376|NCT01925573|9570124|FG000|STARTED|Overall Study||7
8537377|NCT01925573|9570124|FG000|COMPLETED|Overall Study||0
8537378|NCT01925573|9570124|FG000|NOT COMPLETED|Overall Study||7
8537379|NCT01774721|9570130|FG000|STARTED|Overall Study||227
8537380|NCT01774721|9570131|FG001|STARTED|Overall Study||225
8537381|NCT01774721|9570130|FG000|Treated|Overall Study||227
8537382|NCT01774721|9570131|FG001|Treated|Overall Study||224
8537383|NCT01774721|9570130|FG000|COMPLETED|Overall Study||0
8537384|NCT01774721|9570131|FG001|COMPLETED|Overall Study||0
8537385|NCT01774721|9570130|FG000|NOT COMPLETED|Overall Study||227
8537386|NCT01774721|9570131|FG001|NOT COMPLETED|Overall Study||225
8537387|NCT01747447|9570141|FG000|STARTED|Overall Study||388
8537388|NCT01747447|9570142|FG001|STARTED|Overall Study||383
8537389|NCT01747447|9570141|FG000|COMPLETED|Overall Study||347
8537390|NCT01747447|9570142|FG001|COMPLETED|Overall Study||340
8537391|NCT01747447|9570141|FG000|NOT COMPLETED|Overall Study||41
8537392|NCT01747447|9570142|FG001|NOT COMPLETED|Overall Study||43
8537393|NCT01709331|9570148|FG000|STARTED|Overall Study||18
8537394|NCT01709331|9570148|FG000|COMPLETED|Overall Study||17
8537395|NCT01709331|9570148|FG000|NOT COMPLETED|Overall Study||1
8537396|NCT01689740|9570155|FG000|STARTED|Overall Study||2
8537397|NCT01689740|9570156|FG001|STARTED|Overall Study||3
8537398|NCT01689740|9570157|FG002|STARTED|Overall Study||5
8537399|NCT01689740|9570155|FG000|COMPLETED|Overall Study||2
8537400|NCT01689740|9570156|FG001|COMPLETED|Overall Study||3
8537401|NCT01689740|9570157|FG002|COMPLETED|Overall Study||5
8537402|NCT01689740|9570155|FG000|NOT COMPLETED|Overall Study||0
8537403|NCT01689740|9570156|FG001|NOT COMPLETED|Overall Study||0
8537404|NCT01689740|9570157|FG002|NOT COMPLETED|Overall Study||0
8537405|NCT01656434|9570169|FG000|STARTED|Overall Study||2553
8537406|NCT01656434|9570170|FG001|STARTED|Overall Study||620
8537407|NCT01656434|9570169|FG000|Treated|Overall Study|One treated participant had incomplete data and was not included in the Safety Analyses.|2466
8537408|NCT01656434|9570170|FG001|Treated|Overall Study||604
8537409|NCT01656434|9570169|FG000|COMPLETED|Overall Study||152
8537410|NCT01656434|9570170|FG001|COMPLETED|Overall Study||40
8537411|NCT01656434|9570169|FG000|NOT COMPLETED|Overall Study||2401
8537412|NCT01656434|9570170|FG001|NOT COMPLETED|Overall Study||580
8537413|NCT01518517|9570179|FG000|STARTED|Overall Study||29
8537414|NCT01518517|9570180|FG001|STARTED|Overall Study||30
8537415|NCT01518517|9570181|FG002|STARTED|Overall Study||26
8537416|NCT01518517|9570179|FG000|COMPLETED|Overall Study||1
8537417|NCT01518517|9570180|FG001|COMPLETED|Overall Study||3
8537418|NCT01518517|9570181|FG002|COMPLETED|Overall Study||0
8537419|NCT01518517|9570179|FG000|NOT COMPLETED|Overall Study||28
8537420|NCT01518517|9570180|FG001|NOT COMPLETED|Overall Study||27
8537421|NCT01518517|9570181|FG002|NOT COMPLETED|Overall Study||26
8537422|NCT01496118|9570199|FG000|STARTED|Overall Study||4
8537423|NCT01496118|9570200|FG001|STARTED|Overall Study||3
8537424|NCT01496118|9570201|FG002|STARTED|Overall Study||3
8537425|NCT01496118|9570202|FG003|STARTED|Overall Study||3
8537426|NCT01496118|9570203|FG004|STARTED|Overall Study||3
8537427|NCT01496118|9570204|FG005|STARTED|Overall Study||3
8537428|NCT01496118|9570205|FG006|STARTED|Overall Study||31
8537429|NCT01496118|9570206|FG007|STARTED|Overall Study||30
8537430|NCT01496118|9570199|FG000|COMPLETED|Overall Study||0
8537431|NCT01496118|9570200|FG001|COMPLETED|Overall Study||0
8537432|NCT01496118|9570201|FG002|COMPLETED|Overall Study||0
8537433|NCT01496118|9570202|FG003|COMPLETED|Overall Study||0
8537434|NCT01496118|9570203|FG004|COMPLETED|Overall Study||0
8537435|NCT01496118|9570204|FG005|COMPLETED|Overall Study||0
8537436|NCT01496118|9570205|FG006|COMPLETED|Overall Study||0
8537437|NCT01496118|9570206|FG007|COMPLETED|Overall Study||0
8537438|NCT01496118|9570199|FG000|NOT COMPLETED|Overall Study||4
8537439|NCT01496118|9570200|FG001|NOT COMPLETED|Overall Study||3
8537440|NCT01496118|9570201|FG002|NOT COMPLETED|Overall Study||3
8537441|NCT01496118|9570202|FG003|NOT COMPLETED|Overall Study||3
8537442|NCT01496118|9570203|FG004|NOT COMPLETED|Overall Study||3
8537443|NCT01496118|9570204|FG005|NOT COMPLETED|Overall Study||3
8537444|NCT01496118|9570205|FG006|NOT COMPLETED|Overall Study||31
8537445|NCT01496118|9570206|FG007|NOT COMPLETED|Overall Study||30
8537446|NCT01350934|9570226|FG000|STARTED|Base Study||111
8537447|NCT01350934|9570227|FG001|STARTED|Base Study||108
8537448|NCT01350934|9570226|FG000|COMPLETED|Base Study||100
8537449|NCT01350934|9570227|FG001|COMPLETED|Base Study||105
8537450|NCT01350934|9570226|FG000|NOT COMPLETED|Base Study||11
8537451|NCT01350934|9570227|FG001|NOT COMPLETED|Base Study||3
8537452|NCT01350934|9570226|FG000|STARTED|Extension Study||100
8537453|NCT01350934|9570227|FG001|STARTED|Extension Study||105
8537454|NCT01350934|9570226|FG000|COMPLETED|Extension Study||95
8537455|NCT01350934|9570227|FG001|COMPLETED|Extension Study||101
8537456|NCT01350934|9570226|FG000|NOT COMPLETED|Extension Study||5
8537457|NCT01350934|9570227|FG001|NOT COMPLETED|Extension Study||4
8537458|NCT01286207|9570236|FG000|STARTED|Overall Study||751
8537459|NCT01286207|9570237|FG001|STARTED|Overall Study||857
8537460|NCT01286207|9570238|FG002|STARTED|Overall Study||351
8537461|NCT01286207|9570236|FG000|COMPLETED|Overall Study||453
8537462|NCT01286207|9570237|FG001|COMPLETED|Overall Study||609
8537463|NCT01286207|9570238|FG002|COMPLETED|Overall Study||261
8537464|NCT01286207|9570236|FG000|NOT COMPLETED|Overall Study||298
8537465|NCT01286207|9570237|FG001|NOT COMPLETED|Overall Study||248
8537466|NCT01286207|9570238|FG002|NOT COMPLETED|Overall Study||90
8537467|NCT01263769|9570246|FG000|STARTED|Overall Study||25
8537468|NCT01263769|9570246|FG000|COMPLETED|Overall Study||24
8537469|NCT01263769|9570246|FG000|NOT COMPLETED|Overall Study||1
8537470|NCT01227187|9570254|FG000|STARTED|Overall Study||1
8537471|NCT01227187|9570255|FG001|STARTED|Overall Study||3
8537472|NCT01227187|9570256|FG002|STARTED|Overall Study||3
8537473|NCT01227187|9570257|FG003|STARTED|Overall Study||5
8537474|NCT01227187|9570254|FG000|COMPLETED|Overall Study||1
8537475|NCT01227187|9570255|FG001|COMPLETED|Overall Study||3
8537476|NCT01227187|9570256|FG002|COMPLETED|Overall Study||3
8537477|NCT01227187|9570257|FG003|COMPLETED|Overall Study||4
8537478|NCT01227187|9570254|FG000|NOT COMPLETED|Overall Study||0
8537479|NCT01227187|9570255|FG001|NOT COMPLETED|Overall Study||0
8537480|NCT01227187|9570256|FG002|NOT COMPLETED|Overall Study||0
8537481|NCT01227187|9570257|FG003|NOT COMPLETED|Overall Study||1
8537482|NCT01222247|9570269|FG000|STARTED|Overall Study||1429
8537483|NCT01222247|9570270|FG001|STARTED|Overall Study||1402
8537484|NCT01222247|9570269|FG000|Received 2 Doses|Overall Study||860
8537485|NCT01222247|9570270|FG001|Received 2 Doses|Overall Study||826
8537486|NCT01222247|9570269|FG000|Received 1 Dose|Overall Study||568
8537487|NCT01222247|9570270|FG001|Received 1 Dose|Overall Study||571
8537488|NCT01222247|9570269|FG000|Did Not Receive Assigned Medication|Overall Study||1
8537489|NCT01222247|9570270|FG001|Did Not Receive Assigned Medication|Overall Study||5
8537490|NCT01222247|9570269|FG000|COMPLETED|Overall Study||1427
8537491|NCT01222247|9570270|FG001|COMPLETED|Overall Study||1400
8537492|NCT01222247|9570269|FG000|NOT COMPLETED|Overall Study||2
8537493|NCT01222247|9570270|FG001|NOT COMPLETED|Overall Study||2
8537494|NCT01211405|9570279|FG000|STARTED|Overall Study||7
8537495|NCT01211405|9570280|FG001|STARTED|Overall Study||7
8537496|NCT01211405|9570281|FG002|STARTED|Overall Study||12
8537497|NCT01211405|9570279|FG000|Completed Primary Endpoint|Overall Study||7
8537498|NCT01211405|9570280|FG001|Completed Primary Endpoint|Overall Study||7
8537499|NCT01211405|9570281|FG002|Completed Primary Endpoint|Overall Study||12
8537500|NCT01211405|9570279|FG000|Completed Three Open-Label Sessions, Secondary, and End of Stage 2 Assessment|Overall Study||6
8537501|NCT01211405|9570280|FG001|Completed Three Open-Label Sessions, Secondary, and End of Stage 2 Assessment|Overall Study||6
8537502|NCT01211405|9570281|FG002|Completed Three Open-Label Sessions, Secondary, and End of Stage 2 Assessment|Overall Study||12
8537503|NCT01211405|9570279|FG000|COMPLETED|Overall Study||6
8537504|NCT01211405|9570280|FG001|COMPLETED|Overall Study||7
8537505|NCT01211405|9570281|FG002|COMPLETED|Overall Study||11
8537506|NCT01211405|9570279|FG000|NOT COMPLETED|Overall Study||1
8537507|NCT01211405|9570280|FG001|NOT COMPLETED|Overall Study||0
8537508|NCT01211405|9570281|FG002|NOT COMPLETED|Overall Study||1
8537509|NCT01146418|9570291|FG000|STARTED|Base Study P06029 (NCT01144416)||694
8537510|NCT01146418|9570292|FG001|STARTED|Base Study P06029 (NCT01144416)||696
8537511|NCT01146418|9570293|FG002|STARTED|Base Study P06029 (NCT01144416)||0
8537512|NCT01146418|9570294|FG003|STARTED|Base Study P06029 (NCT01144416)||0
8537513|NCT01146418|9570291|FG000|COMPLETED|Base Study P06029 (NCT01144416)|Participants who underwent ET in base study|632
8537514|NCT01146418|9570292|FG001|COMPLETED|Base Study P06029 (NCT01144416)|Participants who underwent ET in base study|647
8537515|NCT01146418|9570293|FG002|COMPLETED|Base Study P06029 (NCT01144416)||0
8537516|NCT01146418|9570294|FG003|COMPLETED|Base Study P06029 (NCT01144416)||0
8537517|NCT01146418|9570291|FG000|NOT COMPLETED|Base Study P06029 (NCT01144416)||62
8537518|NCT01146418|9570292|FG001|NOT COMPLETED|Base Study P06029 (NCT01144416)||49
8537519|NCT01146418|9570293|FG002|NOT COMPLETED|Base Study P06029 (NCT01144416)||0
8537520|NCT01146418|9570294|FG003|NOT COMPLETED|Base Study P06029 (NCT01144416)||0
8537521|NCT01146418|9570291|FG000|STARTED|Women/Expectant Mother Follow Up|Participants from Base Study P06029 with at least one embryo thawed for use in FTET cycle.|157
8537522|NCT01146418|9570292|FG001|STARTED|Women/Expectant Mother Follow Up|Participants from base study P06029 with at least one embryo thawed for use in FTET cycle.|150
8537523|NCT01146418|9570293|FG002|STARTED|Women/Expectant Mother Follow Up||0
8537524|NCT01146418|9570294|FG003|STARTED|Women/Expectant Mother Follow Up||0
8537525|NCT01146418|9570291|FG000|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||151
8537526|NCT01146418|9570292|FG001|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||147
8537527|NCT01146418|9570293|FG002|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||0
8537528|NCT01146418|9570294|FG003|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||0
8537529|NCT01146418|9570291|FG000|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up|Ongoing pregnancy defined as intra-uterine pregnancy with fetal heart beat on USS 10 weeks after ET|52
8537530|NCT01146418|9570292|FG001|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up|Ongoing pregnancy defined as intra-uterine pregnancy with fetal heart beat on USS 10 weeks after ET|50
8537531|NCT01146418|9570293|FG002|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up||0
8537532|NCT01146418|9570294|FG003|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up||0
8537533|NCT01146418|9570291|FG000|COMPLETED|Women/Expectant Mother Follow Up|Participants with ET transfer who completed follow-up study|113
8537534|NCT01146418|9570292|FG001|COMPLETED|Women/Expectant Mother Follow Up|Participants with ET transfer who completed follow-up study|110
8537535|NCT01146418|9570293|FG002|COMPLETED|Women/Expectant Mother Follow Up||0
8537536|NCT01146418|9570294|FG003|COMPLETED|Women/Expectant Mother Follow Up||0
8537537|NCT01146418|9570291|FG000|NOT COMPLETED|Women/Expectant Mother Follow Up||44
8537538|NCT01146418|9570292|FG001|NOT COMPLETED|Women/Expectant Mother Follow Up||40
8537539|NCT01146418|9570293|FG002|NOT COMPLETED|Women/Expectant Mother Follow Up||0
8537540|NCT01146418|9570294|FG003|NOT COMPLETED|Women/Expectant Mother Follow Up||0
8537541|NCT01146418|9570291|FG000|STARTED|Live-Born Infant Follow Up||0
8537542|NCT01146418|9570292|FG001|STARTED|Live-Born Infant Follow Up||0
8537543|NCT01146418|9570293|FG002|STARTED|Live-Born Infant Follow Up||61
8537544|NCT01146418|9570294|FG003|STARTED|Live-Born Infant Follow Up||56
8537545|NCT01146418|9570291|FG000|COMPLETED|Live-Born Infant Follow Up||0
8537546|NCT01146418|9570292|FG001|COMPLETED|Live-Born Infant Follow Up||0
8537547|NCT01146418|9570293|FG002|COMPLETED|Live-Born Infant Follow Up|Infants who completed follow up|55
8537548|NCT01146418|9570294|FG003|COMPLETED|Live-Born Infant Follow Up|Infants who completed follow up|51
8537549|NCT01146418|9570291|FG000|NOT COMPLETED|Live-Born Infant Follow Up||0
8537550|NCT01146418|9570292|FG001|NOT COMPLETED|Live-Born Infant Follow Up||0
8537551|NCT01146418|9570293|FG002|NOT COMPLETED|Live-Born Infant Follow Up||6
8537552|NCT01146418|9570294|FG003|NOT COMPLETED|Live-Born Infant Follow Up||5
8537553|NCT01144416|9570306|FG000|STARTED|Intervention Period||694
8537554|NCT01144416|9570307|FG001|STARTED|Intervention Period||696
8537555|NCT01144416|9570306|FG000|COMPLETED|Intervention Period||632
8537556|NCT01144416|9570307|FG001|COMPLETED|Intervention Period||647
8537557|NCT01144416|9570306|FG000|NOT COMPLETED|Intervention Period||62
8537558|NCT01144416|9570307|FG001|NOT COMPLETED|Intervention Period||49
8537559|NCT01144416|9570306|FG000|STARTED|Pregnancy Follow-up Period|Participants received 150 ug SCH 900962 in Intervention Period and became pregnant.|154
8537560|NCT01144416|9570307|FG001|STARTED|Pregnancy Follow-up Period|Participants received daily injections of 300 IU recFSH in Intervention Period and became pregnant.|167
8537561|NCT01144416|9570306|FG000|COMPLETED|Pregnancy Follow-up Period||146
8537562|NCT01144416|9570307|FG001|COMPLETED|Pregnancy Follow-up Period||157
8537563|NCT01144416|9570306|FG000|NOT COMPLETED|Pregnancy Follow-up Period||8
8537564|NCT01144416|9570307|FG001|NOT COMPLETED|Pregnancy Follow-up Period||10
8537565|NCT01140048|9570317|FG000|STARTED|Overall Study||343
8537566|NCT01140048|9570317|FG000|COMPLETED|Overall Study||298
8537567|NCT01140048|9570317|FG000|NOT COMPLETED|Overall Study||45
8537568|NCT01077817|9570321|FG000|STARTED|Overall Study|STARTED and COMPLETED is the number of participants meeting incl./excl. criteria in the GPRD.|684815
8537569|NCT01077817|9570321|FG000|COMPLETED|Overall Study||684815
8537570|NCT01077817|9570321|FG000|NOT COMPLETED|Overall Study||0
8537571|NCT01065779|9570332|FG000|STARTED|Overall Study||880
8537572|NCT01065779|9570332|FG000|COMPLETED|Overall Study||798
8537573|NCT01065779|9570332|FG000|NOT COMPLETED|Overall Study||82
8537574|NCT00974571|9570339|FG000|STARTED|Overall Study||630
8537575|NCT00974571|9570340|FG001|STARTED|Overall Study||122
8537576|NCT00974571|9570341|FG002|STARTED|Overall Study||613
8537577|NCT00974571|9570339|FG000|COMPLETED|Overall Study||562
8537578|NCT00974571|9570340|FG001|COMPLETED|Overall Study||106
8537579|NCT00974571|9570341|FG002|COMPLETED|Overall Study||530
8537580|NCT00974571|9570339|FG000|NOT COMPLETED|Overall Study||68
8537581|NCT00974571|9570340|FG001|NOT COMPLETED|Overall Study||16
8537582|NCT00974571|9570341|FG002|NOT COMPLETED|Overall Study||83
8537583|NCT00972738|9570352|FG000|STARTED|Overall Study||522
8537584|NCT00972738|9570353|FG001|STARTED|Overall Study||171
8537585|NCT00972738|9570354|FG002|STARTED|Overall Study||521
8537586|NCT00972738|9570352|FG000|COMPLETED|Overall Study||501
8537587|NCT00972738|9570353|FG001|COMPLETED|Overall Study||165
8537588|NCT00972738|9570354|FG002|COMPLETED|Overall Study||492
8537589|NCT00972738|9570352|FG000|NOT COMPLETED|Overall Study||21
8537590|NCT00972738|9570353|FG001|NOT COMPLETED|Overall Study||6
8537591|NCT00972738|9570354|FG002|NOT COMPLETED|Overall Study||29
8537592|NCT00968201|9570364|FG000|STARTED|Base Study - (Period II)|Includes patients who completed Period I (2-week placebo run-in) and were randomized to placebo.|228
8537593|NCT00968201|9570365|FG001|STARTED|Base Study - (Period II)||0
8537594|NCT00968201|9570366|FG002|STARTED|Base Study - (Period II)|Includes patients who completed Period I (2-week placebo run-in) and were randomized to montelukast.|461
8537595|NCT00968201|9570364|FG000|COMPLETED|Base Study - (Period II)|Patients completing Period II were eligible to enter the optional Period III|202
8537596|NCT00968201|9570365|FG001|COMPLETED|Base Study - (Period II)||0
8537597|NCT00968201|9570366|FG002|COMPLETED|Base Study - (Period II)|Patients completing Period II were eligible to enter the optional Period III|416
8537598|NCT00968201|9570364|FG000|NOT COMPLETED|Base Study - (Period II)||26
8537599|NCT00968201|9570365|FG001|NOT COMPLETED|Base Study - (Period II)||0
8537600|NCT00968201|9570366|FG002|NOT COMPLETED|Base Study - (Period II)||45
8537601|NCT00968201|9570364|FG000|STARTED|Extension Study - (Period III)||0
8537602|NCT00968201|9570365|FG001|STARTED|Extension Study - (Period III)|Eligible Patients who completed Period II and entered the optional Extension Study (Period III)|157
8537603|NCT00968201|9570366|FG002|STARTED|Extension Study - (Period III)|Eligible Patients who completed Period II and entered the optional Extension Study (Period III)|364
8537604|NCT00968201|9570364|FG000|COMPLETED|Extension Study - (Period III)||0
8537605|NCT00968201|9570365|FG001|COMPLETED|Extension Study - (Period III)||33
8537606|NCT00968201|9570366|FG002|COMPLETED|Extension Study - (Period III)||84
8537607|NCT00968201|9570364|FG000|NOT COMPLETED|Extension Study - (Period III)||0
8537608|NCT00968201|9570365|FG001|NOT COMPLETED|Extension Study - (Period III)||124
8537609|NCT00968201|9570366|FG002|NOT COMPLETED|Extension Study - (Period III)||280
8537610|NCT00968149|9570377|FG000|STARTED|Overall Study||280
8537611|NCT00968149|9570378|FG001|STARTED|Overall Study||133
8537612|NCT00968149|9570377|FG000|COMPLETED|Overall Study||269
8537613|NCT00968149|9570378|FG001|COMPLETED|Overall Study||127
8537614|NCT00968149|9570377|FG000|NOT COMPLETED|Overall Study||11
8537615|NCT00968149|9570378|FG001|NOT COMPLETED|Overall Study||6
8565591|NCT00068692|9597670|FG004|NOT COMPLETED|Step 1: Registration||0
8565592|NCT00068692|9597671|FG005|NOT COMPLETED|Step 1: Registration||0
8565593|NCT00068692|9597672|FG006|NOT COMPLETED|Step 1: Registration||0
8565594|NCT00068692|9597673|FG007|NOT COMPLETED|Step 1: Registration||0
8565595|NCT00068692|9597666|FG000|STARTED|Step 2: Randomization|Patients on arm S completing step 1 treatment were randomized to step 2 (Arms I-III).|0
8565596|NCT00068692|9597667|FG001|STARTED|Step 2: Randomization|Group II patients were registered and randomized at the same time, reported as arms I,II,III here.|0
8565597|NCT00068692|9597668|FG002|STARTED|Step 2: Randomization|Of the 128 patients registered to step 1in group 1, 83 were randomized to step 2(arms I-III).|28
8565598|NCT00068692|9597669|FG003|STARTED|Step 2: Randomization|Of the 128 patients registered to step 1in group 1, 83 were randomized to step 2(arms I-III).|25
8565599|NCT00068692|9597670|FG004|STARTED|Step 2: Randomization|Of the 128 patients registered to step 1in group 1, 83 were randomized to step 2(arms I-III).|30
8565600|NCT00068692|9597671|FG005|STARTED|Step 2: Randomization|Group 2 patients were registered and randomized at the same time.|31
8569455|NCT00097539|9601693|FG000|COMPLETED|Overall Study||8220
8537616|NCT00963469|9570387|FG000|STARTED|Overall Study||451
8537617|NCT00963469|9570388|FG001|STARTED|Overall Study||448
8537618|NCT00963469|9570389|FG002|STARTED|Overall Study||180
8537619|NCT00963469|9570387|FG000|COMPLETED|Overall Study||410
8537620|NCT00963469|9570388|FG001|COMPLETED|Overall Study||420
8537621|NCT00963469|9570389|FG002|COMPLETED|Overall Study||170
8537622|NCT00963469|9570387|FG000|NOT COMPLETED|Overall Study||41
8537623|NCT00963469|9570388|FG001|NOT COMPLETED|Overall Study||28
8537624|NCT00963469|9570389|FG002|NOT COMPLETED|Overall Study||10
8537625|NCT00960141|9570400|FG000|STARTED|Overall Study||333
8537626|NCT00960141|9570401|FG001|STARTED|Overall Study||326
8537627|NCT00960141|9570402|FG002|STARTED|Overall Study||170
8537628|NCT00960141|9570400|FG000|COMPLETED|Overall Study||323
8537629|NCT00960141|9570401|FG001|COMPLETED|Overall Study||309
8537630|NCT00960141|9570402|FG002|COMPLETED|Overall Study||163
8537631|NCT00960141|9570400|FG000|NOT COMPLETED|Overall Study||10
8537632|NCT00960141|9570401|FG001|NOT COMPLETED|Overall Study||17
8537633|NCT00960141|9570402|FG002|NOT COMPLETED|Overall Study||7
8537634|NCT00943683|9570412|FG000|STARTED|Overall Study||81
8537635|NCT00943683|9570413|FG001|STARTED|Overall Study||175
8537636|NCT00943683|9570412|FG000|COMPLETED|Overall Study||74
8537637|NCT00943683|9570413|FG001|COMPLETED|Overall Study||169
8537638|NCT00943683|9570412|FG000|NOT COMPLETED|Overall Study||7
8537639|NCT00943683|9570413|FG001|NOT COMPLETED|Overall Study||6
8537640|NCT00943397|9570421|FG000|STARTED|Overall Study||32
8537641|NCT00943397|9570422|FG001|STARTED|Overall Study||158
8537642|NCT00943397|9570421|FG000|COMPLETED|Overall Study|Site terminated - Merck administrative decision (11); Discontinued for other (1)|17
8537643|NCT00943397|9570422|FG001|COMPLETED|Overall Study|Site terminated - Merck administrative decision (52); Patient moved (1); Discontinued for other (3)|86
8537644|NCT00943397|9570421|FG000|NOT COMPLETED|Overall Study||15
8537645|NCT00943397|9570422|FG001|NOT COMPLETED|Overall Study||72
8537646|NCT00937937|9570428|FG000|STARTED|Overall Study||72
8537647|NCT00937937|9570428|FG000|COMPLETED|Overall Study||0
8537648|NCT00937937|9570428|FG000|NOT COMPLETED|Overall Study||72
8537649|NCT00911547|9570437|FG000|STARTED|Overall Study|Efficacy in last 10 wks to minimize confounding effect of beclo in 1st 4 wks & allow beclo washout.|48
8537650|NCT00911547|9570438|FG001|STARTED|Overall Study|Efficacy in last 10 wks to minimize confounding effect of beclo in 1st 4 wks & allow beclo washout.|201
8537651|NCT00911547|9570439|FG002|STARTED|Overall Study|Efficacy analyses were over the 16 weeks of treatment.|200
8537652|NCT00911547|9570440|FG003|STARTED|Overall Study|Efficacy analyses were over the 16 weeks of treatment.|193
8537653|NCT00911547|9570437|FG000|COMPLETED|Overall Study||37
8537654|NCT00911547|9570438|FG001|COMPLETED|Overall Study||159
8537655|NCT00911547|9570439|FG002|COMPLETED|Overall Study||178
8537656|NCT00911547|9570440|FG003|COMPLETED|Overall Study||177
8537657|NCT00911547|9570437|FG000|NOT COMPLETED|Overall Study||11
8537658|NCT00911547|9570438|FG001|NOT COMPLETED|Overall Study||42
8537659|NCT00911547|9570439|FG002|NOT COMPLETED|Overall Study||22
8537660|NCT00911547|9570440|FG003|NOT COMPLETED|Overall Study||16
8537661|NCT00899379|9570455|FG000|STARTED|Overall Study|Patients who were allocated study drug|95
8537662|NCT00899379|9570456|FG001|STARTED|Overall Study|Patients who were allocated study drug|95
8537663|NCT00899379|9570457|FG002|STARTED|Overall Study|Patients who were allocated study drug|95
8537664|NCT00899379|9570458|FG003|STARTED|Overall Study|Patients who were allocated study drug|94
8537665|NCT00899379|9570459|FG004|STARTED|Overall Study|Patients who were allocated study drug|94
8537666|NCT00899379|9570455|FG000|Patients Treated|Overall Study|Patients who took study drug|83
8537667|NCT00899379|9570456|FG001|Patients Treated|Overall Study|Patients who took study drug|82
8537668|NCT00899379|9570457|FG002|Patients Treated|Overall Study|Patients who took study drug|84
8537669|NCT00899379|9570458|FG003|Patients Treated|Overall Study|Patients who took study drug|77
8537670|NCT00899379|9570459|FG004|Patients Treated|Overall Study|Patients who took study drug|81
8537671|NCT00899379|9570455|FG000|Patients Not Treated|Overall Study|Patients who did not take study drug|12
8537672|NCT00899379|9570456|FG001|Patients Not Treated|Overall Study|Patients who did not take study drug|13
8537673|NCT00899379|9570457|FG002|Patients Not Treated|Overall Study|Patients who did not take study drug|11
8537674|NCT00899379|9570458|FG003|Patients Not Treated|Overall Study|Patients who did not take study drug|17
8537675|NCT00899379|9570459|FG004|Patients Not Treated|Overall Study|Patients who did not take study drug|13
8537676|NCT00899379|9570455|FG000|COMPLETED|Overall Study|Patients who took study drug and completed the study|61
8537677|NCT00899379|9570456|FG001|COMPLETED|Overall Study|Patients who took study drug and completed the study|66
8537678|NCT00899379|9570457|FG002|COMPLETED|Overall Study|Patients who took study drug and completed the study|66
8537679|NCT00899379|9570458|FG003|COMPLETED|Overall Study|Patients who took study drug and completed the study|57
8537680|NCT00899379|9570459|FG004|COMPLETED|Overall Study|Patients who took study drug and completed the study|63
8537681|NCT00899379|9570455|FG000|NOT COMPLETED|Overall Study||34
8537682|NCT00899379|9570456|FG001|NOT COMPLETED|Overall Study||29
8537683|NCT00899379|9570457|FG002|NOT COMPLETED|Overall Study||29
8537684|NCT00899379|9570458|FG003|NOT COMPLETED|Overall Study||37
8537685|NCT00899379|9570459|FG004|NOT COMPLETED|Overall Study||31
8537686|NCT00898677|9570469|FG000|STARTED|Overall Study||180
8537687|NCT00898677|9570470|FG001|STARTED|Overall Study||455
8537688|NCT00898677|9570471|FG002|STARTED|Overall Study||455
8537689|NCT00898677|9570472|FG003|STARTED|Overall Study||178
8537690|NCT00898677|9570469|FG000|Patients Treated|Overall Study|Patients Not Treated: 16|164
8537691|NCT00898677|9570470|FG001|Patients Treated|Overall Study|Patients Not Treated: 68|387
8537692|NCT00898677|9570471|FG002|Patients Treated|Overall Study|Patients Not Treated: 67|388
8537693|NCT00898677|9570472|FG003|Patients Treated|Overall Study|Patients Not Treated: 18|160
8537694|NCT00898677|9570469|FG000|COMPLETED|Overall Study||163
8537695|NCT00898677|9570470|FG001|COMPLETED|Overall Study||386
8537696|NCT00898677|9570471|FG002|COMPLETED|Overall Study||383
8537697|NCT00898677|9570472|FG003|COMPLETED|Overall Study||159
8537698|NCT00898677|9570469|FG000|NOT COMPLETED|Overall Study||17
8537699|NCT00898677|9570470|FG001|NOT COMPLETED|Overall Study||69
8537700|NCT00898677|9570471|FG002|NOT COMPLETED|Overall Study||72
8537701|NCT00898677|9570472|FG003|NOT COMPLETED|Overall Study||19
8537702|NCT00897949|9570485|FG000|STARTED|Overall Study|Patients who were allocated study drug|554
8537703|NCT00897949|9570486|FG001|STARTED|Overall Study|Patients who were allocated study drug|549
8537704|NCT00897949|9570487|FG002|STARTED|Overall Study|Patients who were allocated study drug|370
8537705|NCT00897949|9570485|FG000|Patients Treated|Overall Study|Patients who took study drug|458
8537706|NCT00897949|9570486|FG001|Patients Treated|Overall Study|Patients who took study drug|456
8537707|NCT00897949|9570487|FG002|Patients Treated|Overall Study|Patients who took study drug|304
8537708|NCT00897949|9570485|FG000|COMPLETED|Overall Study|Patients who took study drug and completed the study|450
8537709|NCT00897949|9570486|FG001|COMPLETED|Overall Study|Patients who took study drug and completed the study|446
8537710|NCT00897949|9570487|FG002|COMPLETED|Overall Study|Patients who took study drug and completed the study|301
8537711|NCT00897949|9570485|FG000|NOT COMPLETED|Overall Study||104
8537712|NCT00897949|9570486|FG001|NOT COMPLETED|Overall Study||103
8537713|NCT00897949|9570487|FG002|NOT COMPLETED|Overall Study||69
8537714|NCT00897104|9570504|FG000|STARTED|Overall Study|Participants who were allocated study drug|418
8537715|NCT00897104|9570505|FG001|STARTED|Overall Study|Participants who were allocated study drug|428
8537716|NCT00897104|9570506|FG002|STARTED|Overall Study|Participants who were allocated study drug|87
8537717|NCT00897104|9570504|FG000|Participants Treated|Overall Study|Participants who took study drug|355
8537718|NCT00897104|9570505|FG001|Participants Treated|Overall Study|Participants who took study drug|357
8537719|NCT00897104|9570506|FG002|Participants Treated|Overall Study|Participants who took study drug|80
8537720|NCT00897104|9570504|FG000|Participants Not Treated|Overall Study|Participants who did not take study drug|63
8537721|NCT00897104|9570505|FG001|Participants Not Treated|Overall Study|Participants who did not take study drug|71
8537722|NCT00897104|9570506|FG002|Participants Not Treated|Overall Study|Participants who did not take study drug|7
8537723|NCT00897104|9570504|FG000|COMPLETED|Overall Study|Participants who took study drug and completed the study|354
8537724|NCT00897104|9570505|FG001|COMPLETED|Overall Study|Participants who took study drug and completed the study|357
8537725|NCT00897104|9570506|FG002|COMPLETED|Overall Study|Participants who took study drug and completed the study|79
8537726|NCT00897104|9570504|FG000|NOT COMPLETED|Overall Study||64
8537727|NCT00897104|9570505|FG001|NOT COMPLETED|Overall Study||71
8537728|NCT00897104|9570506|FG002|NOT COMPLETED|Overall Study||8
8537729|NCT00803790|9570516|FG000|STARTED|Period 1||125
8537730|NCT00803790|9570517|FG001|STARTED|Period 1||126
8537731|NCT00803790|9570518|FG002|STARTED|Period 1||32
8537732|NCT00803790|9570519|FG003|STARTED|Period 1||35
8537733|NCT00803790|9570516|FG000|COMPLETED|Period 1||116
8537734|NCT00803790|9570517|FG001|COMPLETED|Period 1||114
8537735|NCT00803790|9570518|FG002|COMPLETED|Period 1||31
8537736|NCT00803790|9570519|FG003|COMPLETED|Period 1||31
8537737|NCT00803790|9570516|FG000|NOT COMPLETED|Period 1||9
8537738|NCT00803790|9570517|FG001|NOT COMPLETED|Period 1||12
8537739|NCT00803790|9570518|FG002|NOT COMPLETED|Period 1||1
8537740|NCT00803790|9570519|FG003|NOT COMPLETED|Period 1||4
8537741|NCT00803790|9570516|FG000|STARTED|Period 2||116
8537742|NCT00803790|9570517|FG001|STARTED|Period 2||114
8537743|NCT00803790|9570518|FG002|STARTED|Period 2||31
8537744|NCT00803790|9570519|FG003|STARTED|Period 2||31
8537745|NCT00803790|9570516|FG000|COMPLETED|Period 2||114
8537746|NCT00803790|9570517|FG001|COMPLETED|Period 2||114
8537747|NCT00803790|9570518|FG002|COMPLETED|Period 2||30
8537748|NCT00803790|9570519|FG003|COMPLETED|Period 2||30
8537749|NCT00803790|9570516|FG000|NOT COMPLETED|Period 2||2
8537750|NCT00803790|9570517|FG001|NOT COMPLETED|Period 2||0
8537751|NCT00803790|9570518|FG002|NOT COMPLETED|Period 2||1
8537752|NCT00803790|9570519|FG003|NOT COMPLETED|Period 2||1
8537753|NCT00725491|9570532|FG000|STARTED|Overall Study|Intent-to-Treat Group|113
8537754|NCT00725491|9570533|FG001|STARTED|Overall Study|Intent-to-Treat Group|120
8537755|NCT00725491|9570532|FG000|COMPLETED|Overall Study||104
8537756|NCT00725491|9570533|FG001|COMPLETED|Overall Study||102
8537757|NCT00725491|9570532|FG000|NOT COMPLETED|Overall Study||9
8537758|NCT00725491|9570533|FG001|NOT COMPLETED|Overall Study||18
8537759|NCT00703014|9570541|FG000|STARTED|Mothers Base Trial P05787 (NCT00696800)|Randomized in Base Trial P05787 (NCT00696800)|757
8537760|NCT00703014|9570542|FG001|STARTED|Mothers Base Trial P05787 (NCT00696800)|Randomized in Base Trial P05787 (NCT00696800)|752
8537761|NCT00703014|9570543|FG002|STARTED|Mothers Base Trial P05787 (NCT00696800)||0
8537762|NCT00703014|9570544|FG003|STARTED|Mothers Base Trial P05787 (NCT00696800)||0
8537763|NCT00703014|9570541|FG000|Treated|Mothers Base Trial P05787 (NCT00696800)|Intent-To-Treat (ITT) group in Base Trial P05787 (NCT00696800)|756
8537764|NCT00703014|9570542|FG001|Treated|Mothers Base Trial P05787 (NCT00696800)|ITT group in Base Trial P05787 (NCT006968000)|750
8537765|NCT00703014|9570543|FG002|Treated|Mothers Base Trial P05787 (NCT00696800)||0
8816921|NCT01547130|9870543|FG001|COMPLETED|Overall Study||68
8816922|NCT01547130|9870542|FG000|NOT COMPLETED|Overall Study||9
8816923|NCT01547130|9870543|FG001|NOT COMPLETED|Overall Study||5
8537766|NCT00703014|9570544|FG003|Treated|Mothers Base Trial P05787 (NCT00696800)||0
8537767|NCT00703014|9570541|FG000|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)|Embryo transfer (ET) in Base Trial P05787 (NCT006968000)|672
8537768|NCT00703014|9570542|FG001|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)|Embryo transfer (ET) in Base Trial P05787 (NCT006968000)|704
8537769|NCT00703014|9570543|FG002|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)||0
8537770|NCT00703014|9570544|FG003|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)||0
8537771|NCT00703014|9570541|FG000|COMPLETED|Mothers Base Trial P05787 (NCT00696800)|ITT group in P05712, ongoing pregnancy at 10 weeks after ET in Base Trial P05787 (NCT006968000)|295
8537772|NCT00703014|9570542|FG001|COMPLETED|Mothers Base Trial P05787 (NCT00696800)|ITT group in P05712, ongoing pregnancy at 10 weeks after ET in Base Trial P05787 (NCT006968000)|286
8537773|NCT00703014|9570543|FG002|COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
8537774|NCT00703014|9570544|FG003|COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
8537775|NCT00703014|9570541|FG000|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||462
8537776|NCT00703014|9570542|FG001|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||466
8537777|NCT00703014|9570543|FG002|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
8816924|NCT01547247|9870559|FG000|STARTED|Overall Study||104
8816925|NCT01547247|9870560|FG001|STARTED|Overall Study||104
8816926|NCT01547247|9870559|FG000|COMPLETED|Overall Study||98
8816927|NCT01547247|9870560|FG001|COMPLETED|Overall Study||98
8816928|NCT01547247|9870559|FG000|NOT COMPLETED|Overall Study||6
8816929|NCT01547247|9870560|FG001|NOT COMPLETED|Overall Study||6
8816930|NCT01547286|9870566|FG000|STARTED|Overall Study||7
8816931|NCT01547286|9870566|FG000|COMPLETED|Overall Study||5
8816932|NCT01547286|9870566|FG000|NOT COMPLETED|Overall Study||2
8816933|NCT01547299|9870573|FG000|STARTED|Overall Study||25
8816934|NCT01547299|9870574|FG001|STARTED|Overall Study||27
8816935|NCT01547299|9870573|FG000|COMPLETED|Overall Study||23
8816936|NCT01547299|9870574|FG001|COMPLETED|Overall Study||25
8816937|NCT01547299|9870573|FG000|NOT COMPLETED|Overall Study||2
8816938|NCT01547299|9870574|FG001|NOT COMPLETED|Overall Study||2
8816939|NCT01547390|9870582|FG000|STARTED|Overall Study||27
8816940|NCT01547390|9870583|FG001|STARTED|Overall Study||26
8816941|NCT01547390|9870582|FG000|COMPLETED|Overall Study||14
8816942|NCT01547390|9870583|FG001|COMPLETED|Overall Study||16
8816943|NCT01547390|9870582|FG000|NOT COMPLETED|Overall Study||13
8816944|NCT01547390|9870583|FG001|NOT COMPLETED|Overall Study||10
8816945|NCT01547598|9870591|FG000|STARTED|Overall Study||67
8816946|NCT01547598|9870592|FG001|STARTED|Overall Study||68
8816947|NCT01547598|9870591|FG000|COMPLETED|Overall Study||61
8816948|NCT01547598|9870592|FG001|COMPLETED|Overall Study||63
8816949|NCT01547598|9870591|FG000|NOT COMPLETED|Overall Study||6
8816950|NCT01547598|9870592|FG001|NOT COMPLETED|Overall Study||5
8816951|NCT01547715|9870602|FG000|STARTED|Overall Study||60
8816952|NCT01547715|9870603|FG001|STARTED|Overall Study||60
8816953|NCT01547715|9870604|FG002|STARTED|Overall Study||60
8816954|NCT01547715|9870602|FG000|COMPLETED|Overall Study||60
8816955|NCT01547715|9870603|FG001|COMPLETED|Overall Study||60
8816956|NCT01547715|9870604|FG002|COMPLETED|Overall Study||60
8816957|NCT01547715|9870602|FG000|NOT COMPLETED|Overall Study||0
8816958|NCT01547715|9870603|FG001|NOT COMPLETED|Overall Study||0
8816959|NCT01547715|9870604|FG002|NOT COMPLETED|Overall Study||0
8816960|NCT01547780|9870617|FG000|STARTED|Baseline PET Scan||12
8816961|NCT01547780|9870618|FG001|STARTED|Baseline PET Scan||0
8816962|NCT01547780|9870619|FG002|STARTED|Baseline PET Scan||19
8816963|NCT01547780|9870620|FG003|STARTED|Baseline PET Scan||19
8816964|NCT01547780|9870617|FG000|COMPLETED|Baseline PET Scan||9
8816965|NCT01547780|9870618|FG001|COMPLETED|Baseline PET Scan||0
8816966|NCT01547780|9870619|FG002|COMPLETED|Baseline PET Scan||17
8816967|NCT01547780|9870620|FG003|COMPLETED|Baseline PET Scan||19
8816968|NCT01547780|9870617|FG000|NOT COMPLETED|Baseline PET Scan||3
8816969|NCT01547780|9870618|FG001|NOT COMPLETED|Baseline PET Scan||0
8816970|NCT01547780|9870619|FG002|NOT COMPLETED|Baseline PET Scan||2
8816971|NCT01547780|9870620|FG003|NOT COMPLETED|Baseline PET Scan||0
8816972|NCT01547780|9870617|FG000|STARTED|Repeat PET Scan||0
8816973|NCT01547780|9870618|FG001|STARTED|Repeat PET Scan||4
8816974|NCT01547780|9870619|FG002|STARTED|Repeat PET Scan||0
8816975|NCT01547780|9870620|FG003|STARTED|Repeat PET Scan||0
8816976|NCT01547780|9870617|FG000|COMPLETED|Repeat PET Scan||0
8816977|NCT01547780|9870618|FG001|COMPLETED|Repeat PET Scan||4
8816978|NCT01547780|9870619|FG002|COMPLETED|Repeat PET Scan||0
8816979|NCT01547780|9870620|FG003|COMPLETED|Repeat PET Scan||0
8816980|NCT01547780|9870617|FG000|NOT COMPLETED|Repeat PET Scan||0
8816981|NCT01547780|9870618|FG001|NOT COMPLETED|Repeat PET Scan||0
8816982|NCT01547780|9870619|FG002|NOT COMPLETED|Repeat PET Scan||0
8816983|NCT01547780|9870620|FG003|NOT COMPLETED|Repeat PET Scan||0
8849246|NCT01739231|9904379|FG003|NOT COMPLETED|Part B||2
8849247|NCT01739309|9904397|FG000|STARTED|Overall Study||28
8849248|NCT01739309|9904397|FG000|Received at Least One Dose of Study Drug|Overall Study||28
8849249|NCT01739309|9904397|FG000|Death Due to Any Cause|Overall Study||17
8849250|NCT01739309|9904397|FG000|Alive and on Study, Off Treatment|Overall Study||8
8849251|NCT01739309|9904397|FG000|COMPLETED|Overall Study||25
8849252|NCT01739309|9904397|FG000|NOT COMPLETED|Overall Study||3
8849253|NCT01739335|9904405|FG000|STARTED|Overall Study||41
8849254|NCT01739335|9904406|FG001|STARTED|Overall Study||40
8849255|NCT01739335|9904405|FG000|COMPLETED|Overall Study||34
8849256|NCT01739335|9904406|FG001|COMPLETED|Overall Study||35
8849257|NCT01739335|9904405|FG000|NOT COMPLETED|Overall Study||7
8849258|NCT01739335|9904406|FG001|NOT COMPLETED|Overall Study||5
8537778|NCT00703014|9570544|FG003|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
8537779|NCT00703014|9570541|FG000|STARTED|Mothers Follow Up Trial P05712|Eligible participants who completed Base Trial P05787 and then enrolled in Follow Up Trial P05712|274
8537780|NCT00703014|9570542|FG001|STARTED|Mothers Follow Up Trial P05712|Eligible participants who completed Base Trial P05787 and then enrolled in Follow Up Trial P05712|267
8537781|NCT00703014|9570543|FG002|STARTED|Mothers Follow Up Trial P05712||0
8537782|NCT00703014|9570544|FG003|STARTED|Mothers Follow Up Trial P05712||0
8537783|NCT00703014|9570541|FG000|COMPLETED|Mothers Follow Up Trial P05712|Completed Follow Up in Trial P05712|241
8537784|NCT00703014|9570542|FG001|COMPLETED|Mothers Follow Up Trial P05712|Completed Follow Up in Trial P05712|235
8537785|NCT00703014|9570543|FG002|COMPLETED|Mothers Follow Up Trial P05712||0
8537786|NCT00703014|9570544|FG003|COMPLETED|Mothers Follow Up Trial P05712||0
8537787|NCT00703014|9570541|FG000|NOT COMPLETED|Mothers Follow Up Trial P05712||33
8537788|NCT00703014|9570542|FG001|NOT COMPLETED|Mothers Follow Up Trial P05712||32
8537789|NCT00703014|9570543|FG002|NOT COMPLETED|Mothers Follow Up Trial P05712||0
8537790|NCT00703014|9570544|FG003|NOT COMPLETED|Mothers Follow Up Trial P05712||0
8537791|NCT00703014|9570541|FG000|STARTED|Fetuses/Infants Follow Up Trial P05712||0
8816984|NCT01547806|9870630|FG000|STARTED|Overall Study||49
8816985|NCT01547806|9870630|FG000|COMPLETED|Overall Study||49
8816986|NCT01547806|9870630|FG000|NOT COMPLETED|Overall Study||0
8816987|NCT01548040|9870637|FG000|STARTED|Overall Study||56
8816988|NCT01548040|9870638|FG001|STARTED|Overall Study||55
8816989|NCT01548040|9870637|FG000|COMPLETED|Overall Study||43
8816990|NCT01548040|9870638|FG001|COMPLETED|Overall Study||45
8816991|NCT01548040|9870637|FG000|NOT COMPLETED|Overall Study||13
8537792|NCT00703014|9570542|FG001|STARTED|Fetuses/Infants Follow Up Trial P05712||0
8537793|NCT00703014|9570543|FG002|STARTED|Fetuses/Infants Follow Up Trial P05712|Fetuses in Follow Up Trial P05712|352
8537794|NCT00703014|9570544|FG003|STARTED|Fetuses/Infants Follow Up Trial P05712|Fetuses in Follow Up Trial P05712|326
8537795|NCT00703014|9570541|FG000|Live Born Infants|Fetuses/Infants Follow Up Trial P05712||0
8537796|NCT00703014|9570542|FG001|Live Born Infants|Fetuses/Infants Follow Up Trial P05712||0
8537797|NCT00703014|9570543|FG002|Live Born Infants|Fetuses/Infants Follow Up Trial P05712|Live born infants in Follow Up Trail P05712|344
8537798|NCT00703014|9570544|FG003|Live Born Infants|Fetuses/Infants Follow Up Trial P05712|Live born infants in Follow Up Trail P05712|315
8537799|NCT00703014|9570541|FG000|COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
8537800|NCT00703014|9570542|FG001|COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
8537801|NCT00703014|9570543|FG002|COMPLETED|Fetuses/Infants Follow Up Trial P05712|Infants in P05712 with Follow Up Completed|305
8537802|NCT00703014|9570544|FG003|COMPLETED|Fetuses/Infants Follow Up Trial P05712|Infants in P05712 with Follow Up Completed|284
8537803|NCT00703014|9570541|FG000|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
8537804|NCT00703014|9570542|FG001|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
8537805|NCT00703014|9570543|FG002|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||47
8537806|NCT00703014|9570544|FG003|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||42
8537807|NCT00702845|9570556|FG000|STARTED|Overall Study||268
8537808|NCT00702845|9570557|FG001|STARTED|Overall Study|Includes one treated participant who was not randomized|129
8537809|NCT00702845|9570556|FG000|Randomized|Overall Study||268
8537810|NCT00702845|9570557|FG001|Randomized|Overall Study||128
8537811|NCT00702845|9570556|FG000|COMPLETED|Overall Study||246
8537812|NCT00702845|9570557|FG001|COMPLETED|Overall Study||121
8537813|NCT00702845|9570556|FG000|NOT COMPLETED|Overall Study||22
8537814|NCT00702845|9570557|FG001|NOT COMPLETED|Overall Study||8
8537815|NCT00702624|9570565|FG000|STARTED|Base Study P05690 (NCT00702845)||268
8537816|NCT00702624|9570566|FG001|STARTED|Base Study P05690 (NCT00702845)||128
8537817|NCT00702624|9570567|FG002|STARTED|Base Study P05690 (NCT00702845)||0
8537818|NCT00702624|9570568|FG003|STARTED|Base Study P05690 (NCT00702845)||0
8537819|NCT00702624|9570565|FG000|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|246
8537820|NCT00702624|9570566|FG001|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|121
8537821|NCT00702624|9570567|FG002|COMPLETED|Base Study P05690 (NCT00702845)||0
8537822|NCT00702624|9570568|FG003|COMPLETED|Base Study P05690 (NCT00702845)||0
8537823|NCT00702624|9570565|FG000|NOT COMPLETED|Base Study P05690 (NCT00702845)||22
8537824|NCT00702624|9570566|FG001|NOT COMPLETED|Base Study P05690 (NCT00702845)||7
8537825|NCT00702624|9570567|FG002|NOT COMPLETED|Base Study P05690 (NCT00702845)||0
8537826|NCT00702624|9570568|FG003|NOT COMPLETED|Base Study P05690 (NCT00702845)||0
8537827|NCT00702624|9570565|FG000|STARTED|Expectant Mother Follow-up||68
8537828|NCT00702624|9570566|FG001|STARTED|Expectant Mother Follow-up||45
8537829|NCT00702624|9570567|FG002|STARTED|Expectant Mother Follow-up||0
8537830|NCT00702624|9570568|FG003|STARTED|Expectant Mother Follow-up||0
8537831|NCT00702624|9570565|FG000|COMPLETED|Expectant Mother Follow-up|To complete the study, participants must have completed a follow-up visit at 4-12 weeks postpartum.|61
8537832|NCT00702624|9570566|FG001|COMPLETED|Expectant Mother Follow-up|To complete the study, participants must have completed a follow-up visit at 4-12 weeks postpartum.|45
8537833|NCT00702624|9570567|FG002|COMPLETED|Expectant Mother Follow-up||0
8537834|NCT00702624|9570568|FG003|COMPLETED|Expectant Mother Follow-up||0
8537835|NCT00702624|9570565|FG000|NOT COMPLETED|Expectant Mother Follow-up||7
8537836|NCT00702624|9570566|FG001|NOT COMPLETED|Expectant Mother Follow-up||0
8816992|NCT01548040|9870638|FG001|NOT COMPLETED|Overall Study||10
8816993|NCT01548287|9870648|FG000|STARTED|Screening||19
8816994|NCT01548287|9870649|FG001|STARTED|Screening||22
8816995|NCT01548287|9870650|FG002|STARTED|Screening||20
8537837|NCT00702624|9570567|FG002|NOT COMPLETED|Expectant Mother Follow-up||0
8537838|NCT00702624|9570568|FG003|NOT COMPLETED|Expectant Mother Follow-up||0
8537839|NCT00702624|9570565|FG000|STARTED|Fetuses/Infant Follow-up||0
8537840|NCT00702624|9570566|FG001|STARTED|Fetuses/Infant Follow-up||0
8537841|NCT00702624|9570567|FG002|STARTED|Fetuses/Infant Follow-up||88
8537842|NCT00702624|9570568|FG003|STARTED|Fetuses/Infant Follow-up||55
8537843|NCT00702624|9570565|FG000|Live Born Infants|Fetuses/Infant Follow-up||0
8537844|NCT00702624|9570566|FG001|Live Born Infants|Fetuses/Infant Follow-up||0
8537845|NCT00702624|9570567|FG002|Live Born Infants|Fetuses/Infant Follow-up|Infants born to eligible mothers were followed for safety and efficacy|80
8537846|NCT00702624|9570568|FG003|Live Born Infants|Fetuses/Infant Follow-up|Infants born to eligible mothers were followed for safety and efficacy.|55
8537847|NCT00702624|9570565|FG000|COMPLETED|Fetuses/Infant Follow-up||0
8537848|NCT00702624|9570566|FG001|COMPLETED|Fetuses/Infant Follow-up||0
8537849|NCT00702624|9570567|FG002|COMPLETED|Fetuses/Infant Follow-up|To complete the study, infants must have completed a follow-up visit at 4-12 weeks postpartum.|78
8537850|NCT00702624|9570568|FG003|COMPLETED|Fetuses/Infant Follow-up|To complete the study, infants must have completed a follow-up visit at 4-12 weeks postpartum.|55
8537851|NCT00702624|9570565|FG000|NOT COMPLETED|Fetuses/Infant Follow-up||0
8537852|NCT00702624|9570566|FG001|NOT COMPLETED|Fetuses/Infant Follow-up||0
8537853|NCT00702624|9570567|FG002|NOT COMPLETED|Fetuses/Infant Follow-up||10
8537854|NCT00702624|9570568|FG003|NOT COMPLETED|Fetuses/Infant Follow-up||0
8537855|NCT00702546|9570583|FG000|STARTED|Base Study P05690 (NCT00702845)||268
8537856|NCT00702546|9570584|FG001|STARTED|Base Study P05690 (NCT00702845)||128
8537857|NCT00702546|9570583|FG000|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|246
8537858|NCT00702546|9570584|FG001|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|121
8537859|NCT00702546|9570583|FG000|NOT COMPLETED|Base Study P05690 (NCT00702845)||22
8537860|NCT00702546|9570584|FG001|NOT COMPLETED|Base Study P05690 (NCT00702845)||7
8537861|NCT00702546|9570583|FG000|STARTED|Follow Up Study P05711 (NCT00702546)|Participants from base study P05690 with at least one embryo thawed for use in FTET cycle.|77
8537862|NCT00702546|9570584|FG001|STARTED|Follow Up Study P05711 (NCT00702546)|Participants from base study P05690 with at least one embryo thawed for use in FTET cycle.|25
8537863|NCT00702546|9570583|FG000|COMPLETED|Follow Up Study P05711 (NCT00702546)|Participants with embryo transfer in any FTET cycle|72
8537864|NCT00702546|9570584|FG001|COMPLETED|Follow Up Study P05711 (NCT00702546)|Participants with embryo transfer in any FTET cycle|24
8537865|NCT00702546|9570583|FG000|NOT COMPLETED|Follow Up Study P05711 (NCT00702546)||5
8537866|NCT00702546|9570584|FG001|NOT COMPLETED|Follow Up Study P05711 (NCT00702546)||1
8537867|NCT00702520|9570592|FG000|STARTED|Base Study P05788 - Assigned Treatment||25
8537868|NCT00702520|9570593|FG001|STARTED|Base Study P05788 - Assigned Treatment||25
8537869|NCT00702520|9570594|FG002|STARTED|Base Study P05788 - Assigned Treatment||0
8537870|NCT00702520|9570595|FG003|STARTED|Base Study P05788 - Assigned Treatment||0
8537871|NCT00702520|9570592|FG000|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||25
8537872|NCT00702520|9570593|FG001|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||24
8537873|NCT00702520|9570594|FG002|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||0
8537874|NCT00702520|9570595|FG003|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||0
8537875|NCT00702520|9570592|FG000|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||25
8537876|NCT00702520|9570593|FG001|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||24
8537877|NCT00702520|9570594|FG002|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||0
8537878|NCT00702520|9570595|FG003|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||0
8537879|NCT00702520|9570592|FG000|COMPLETED|Base Study P05788 - Assigned Treatment||25
8537880|NCT00702520|9570593|FG001|COMPLETED|Base Study P05788 - Assigned Treatment||24
8537881|NCT00702520|9570594|FG002|COMPLETED|Base Study P05788 - Assigned Treatment||0
8537882|NCT00702520|9570595|FG003|COMPLETED|Base Study P05788 - Assigned Treatment||0
8537883|NCT00702520|9570592|FG000|NOT COMPLETED|Base Study P05788 - Assigned Treatment||0
8537884|NCT00702520|9570593|FG001|NOT COMPLETED|Base Study P05788 - Assigned Treatment||1
8537885|NCT00702520|9570594|FG002|NOT COMPLETED|Base Study P05788 - Assigned Treatment||0
8537886|NCT00702520|9570595|FG003|NOT COMPLETED|Base Study P05788 - Assigned Treatment||0
8537887|NCT00702520|9570592|FG000|STARTED|Base Study P05788 - Embryo Transfer||25
8537888|NCT00702520|9570593|FG001|STARTED|Base Study P05788 - Embryo Transfer||24
8537889|NCT00702520|9570594|FG002|STARTED|Base Study P05788 - Embryo Transfer||0
8537890|NCT00702520|9570595|FG003|STARTED|Base Study P05788 - Embryo Transfer||0
8537891|NCT00702520|9570592|FG000|Embryo Transfer|Base Study P05788 - Embryo Transfer||22
8537892|NCT00702520|9570593|FG001|Embryo Transfer|Base Study P05788 - Embryo Transfer||18
8537893|NCT00702520|9570594|FG002|Embryo Transfer|Base Study P05788 - Embryo Transfer||0
8537894|NCT00702520|9570595|FG003|Embryo Transfer|Base Study P05788 - Embryo Transfer||0
8537895|NCT00702520|9570592|FG000|COMPLETED|Base Study P05788 - Embryo Transfer||22
8537896|NCT00702520|9570593|FG001|COMPLETED|Base Study P05788 - Embryo Transfer||18
8537897|NCT00702520|9570594|FG002|COMPLETED|Base Study P05788 - Embryo Transfer||0
8537898|NCT00702520|9570595|FG003|COMPLETED|Base Study P05788 - Embryo Transfer||0
8537899|NCT00702520|9570592|FG000|NOT COMPLETED|Base Study P05788 - Embryo Transfer||3
8537900|NCT00702520|9570593|FG001|NOT COMPLETED|Base Study P05788 - Embryo Transfer||6
8537901|NCT00702520|9570594|FG002|NOT COMPLETED|Base Study P05788 - Embryo Transfer||0
8569456|NCT00097539|9601694|FG001|COMPLETED|Overall Study||2825
8537902|NCT00702520|9570595|FG003|NOT COMPLETED|Base Study P05788 - Embryo Transfer||0
8537903|NCT00702520|9570592|FG000|STARTED|Base Study P05788 - Follow-Up||22
8537904|NCT00702520|9570593|FG001|STARTED|Base Study P05788 - Follow-Up||18
8537905|NCT00702520|9570594|FG002|STARTED|Base Study P05788 - Follow-Up||0
8537906|NCT00702520|9570595|FG003|STARTED|Base Study P05788 - Follow-Up||0
8537907|NCT00702520|9570592|FG000|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||7
8537908|NCT00702520|9570593|FG001|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||8
8537909|NCT00702520|9570594|FG002|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||0
8621009|NCT00477334|9659886|FG001|COMPLETED|Overall Study|Participants completing the first recurrence and follow-up.|75
8621010|NCT00477334|9659885|FG000|NOT COMPLETED|Overall Study||170
8621011|NCT00477334|9659886|FG001|NOT COMPLETED|Overall Study||76
8621012|NCT00477386|9659898|FG000|STARTED|Overall Study||11
8621013|NCT00477386|9659899|FG001|STARTED|Overall Study||17
8621014|NCT00477386|9659898|FG000|COMPLETED|Overall Study||0
8621015|NCT00477386|9659899|FG001|COMPLETED|Overall Study||0
8621016|NCT00477386|9659898|FG000|NOT COMPLETED|Overall Study||11
8537910|NCT00702520|9570595|FG003|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||0
8537911|NCT00702520|9570592|FG000|COMPLETED|Base Study P05788 - Follow-Up||7
8537912|NCT00702520|9570593|FG001|COMPLETED|Base Study P05788 - Follow-Up||8
8537913|NCT00702520|9570594|FG002|COMPLETED|Base Study P05788 - Follow-Up||0
8537914|NCT00702520|9570595|FG003|COMPLETED|Base Study P05788 - Follow-Up||0
8537915|NCT00702520|9570592|FG000|NOT COMPLETED|Base Study P05788 - Follow-Up||15
8537916|NCT00702520|9570593|FG001|NOT COMPLETED|Base Study P05788 - Follow-Up||10
8537917|NCT00702520|9570594|FG002|NOT COMPLETED|Base Study P05788 - Follow-Up||0
8537918|NCT00702520|9570595|FG003|NOT COMPLETED|Base Study P05788 - Follow-Up||0
8537919|NCT00702520|9570592|FG000|STARTED|Follow-up Study P05783||7
8537920|NCT00702520|9570593|FG001|STARTED|Follow-up Study P05783||8
8537921|NCT00702520|9570594|FG002|STARTED|Follow-up Study P05783|This is the number of infants born from mothers administered Corifollitropin alpha 100 ug.|8
8537922|NCT00702520|9570595|FG003|STARTED|Follow-up Study P05783|This is the number of infants born from mothers administered Corifollitropin alpha 150 ug.|11
8537923|NCT00702520|9570592|FG000|COMPLETED|Follow-up Study P05783||7
8537924|NCT00702520|9570593|FG001|COMPLETED|Follow-up Study P05783||8
8537925|NCT00702520|9570594|FG002|COMPLETED|Follow-up Study P05783||8
8537926|NCT00702520|9570595|FG003|COMPLETED|Follow-up Study P05783||11
8537927|NCT00702520|9570592|FG000|NOT COMPLETED|Follow-up Study P05783||0
8537928|NCT00702520|9570593|FG001|NOT COMPLETED|Follow-up Study P05783||0
8537929|NCT00702520|9570594|FG002|NOT COMPLETED|Follow-up Study P05783||0
8537930|NCT00702520|9570595|FG003|NOT COMPLETED|Follow-up Study P05783||0
8537931|NCT00702338|9570605|FG000|STARTED|Base Study (NCT00697255)||5
8537932|NCT00702338|9570606|FG001|STARTED|Base Study (NCT00697255)||3
8537933|NCT00702338|9570607|FG002|STARTED|Base Study (NCT00697255)||0
8537934|NCT00702338|9570605|FG000|COMPLETED|Base Study (NCT00697255)|To complete the study, participants must have received hCG bolus injection.|2
8537935|NCT00702338|9570606|FG001|COMPLETED|Base Study (NCT00697255)|To complete the study, participants must have received hCG bolus injection.|1
8537936|NCT00702338|9570607|FG002|COMPLETED|Base Study (NCT00697255)||0
8537937|NCT00702338|9570605|FG000|NOT COMPLETED|Base Study (NCT00697255)||3
8537938|NCT00702338|9570606|FG001|NOT COMPLETED|Base Study (NCT00697255)||2
8537939|NCT00702338|9570607|FG002|NOT COMPLETED|Base Study (NCT00697255)||0
8537940|NCT00702338|9570605|FG000|STARTED|Follow-up Study: Expectant Mothers FU|To enroll in follow-up study, confirmed pregnancy at ≥10 wks after hCG bolus injection was required|0
8537941|NCT00702338|9570606|FG001|STARTED|Follow-up Study: Expectant Mothers FU|To enroll in follow-up study, confirmed pregnancy at ≥10 wks after hCG bolus injection was required|1
8537942|NCT00702338|9570607|FG002|STARTED|Follow-up Study: Expectant Mothers FU||0
8537943|NCT00702338|9570605|FG000|COMPLETED|Follow-up Study: Expectant Mothers FU||0
8537944|NCT00702338|9570606|FG001|COMPLETED|Follow-up Study: Expectant Mothers FU|To complete the study, participants must have completed a follow-up visit at 4-12 weeks postpartum.|0
8537945|NCT00702338|9570607|FG002|COMPLETED|Follow-up Study: Expectant Mothers FU||0
8537946|NCT00702338|9570605|FG000|NOT COMPLETED|Follow-up Study: Expectant Mothers FU||0
8537947|NCT00702338|9570606|FG001|NOT COMPLETED|Follow-up Study: Expectant Mothers FU||1
8537948|NCT00702338|9570607|FG002|NOT COMPLETED|Follow-up Study: Expectant Mothers FU||0
8537949|NCT00702338|9570605|FG000|STARTED|Follow-up Study: Infant FU||0
8537950|NCT00702338|9570606|FG001|STARTED|Follow-up Study: Infant FU||0
8537951|NCT00702338|9570607|FG002|STARTED|Follow-up Study: Infant FU|Participants died on day of delivery, did not complete follow-up visit at 4-12 weeks postpartum.|2
8537952|NCT00702338|9570605|FG000|COMPLETED|Follow-up Study: Infant FU||0
8537953|NCT00702338|9570606|FG001|COMPLETED|Follow-up Study: Infant FU||0
8537954|NCT00702338|9570607|FG002|COMPLETED|Follow-up Study: Infant FU||0
8537955|NCT00702338|9570605|FG000|NOT COMPLETED|Follow-up Study: Infant FU||0
8537956|NCT00702338|9570606|FG001|NOT COMPLETED|Follow-up Study: Infant FU||0
8537957|NCT00702338|9570607|FG002|NOT COMPLETED|Follow-up Study: Infant FU||2
8537958|NCT00702273|9570617|FG000|STARTED|Base Study P05787 (NCT00696800)|Participants randomized to the base study P05787 (NCT00696800)|757
8537959|NCT00702273|9570618|FG001|STARTED|Base Study P05787 (NCT00696800)|Participants randomized to the base study P05787 (NCT00696800)|752
8537960|NCT00702273|9570617|FG000|Treated|Base Study P05787 (NCT00696800)|Participants from the Intent to Treat group (ITT) from the base study P05787 (NCT00696800)|756
8621017|NCT00477386|9659899|FG001|NOT COMPLETED|Overall Study||17
8621018|NCT00477451|9659909|FG000|STARTED|Overall Study||20
8621019|NCT00477451|9659910|FG001|STARTED|Overall Study||20
8537961|NCT00702273|9570618|FG001|Treated|Base Study P05787 (NCT00696800)|Participants from the Intent to Treat group (ITT) from the base study P05787 (NCT00696800)|750
8537962|NCT00702273|9570617|FG000|COMPLETED|Base Study P05787 (NCT00696800)|To complete study, participants from the base study P05787 (NCT00696800) had embryos transferred|672
8537963|NCT00702273|9570618|FG001|COMPLETED|Base Study P05787 (NCT00696800)|To complete study, participants from the base study P05787 (NCT00696800) had embryos transferred|704
8537964|NCT00702273|9570617|FG000|NOT COMPLETED|Base Study P05787 (NCT00696800)||85
8537965|NCT00702273|9570618|FG001|NOT COMPLETED|Base Study P05787 (NCT00696800)||48
8537966|NCT00702273|9570617|FG000|STARTED|Follow Up Study P05716 (NCT00702273)|Participants from base study,who had at least one embryo thawed for a FTET cycle.|168
8537967|NCT00702273|9570618|FG001|STARTED|Follow Up Study P05716 (NCT00702273)|Participants from base study, who had at least one embryo thawed for a FTET cycle|176
8537968|NCT00702273|9570617|FG000|COMPLETED|Follow Up Study P05716 (NCT00702273)|Participants with embryo transfer in any FTET cycle|148
8537969|NCT00702273|9570618|FG001|COMPLETED|Follow Up Study P05716 (NCT00702273)|Participants with embryo transfer in any FTET cycle|147
8537970|NCT00702273|9570617|FG000|NOT COMPLETED|Follow Up Study P05716 (NCT00702273)||20
8537971|NCT00702273|9570618|FG001|NOT COMPLETED|Follow Up Study P05716 (NCT00702273)||29
8537972|NCT00702234|9570624|FG000|STARTED|Base Study (NCT00696878)||682
8537973|NCT00702234|9570625|FG001|STARTED|Base Study (NCT00696878)||0
8537974|NCT00702234|9570624|FG000|COMPLETED|Base Study (NCT00696878)||178
8537975|NCT00702234|9570625|FG001|COMPLETED|Base Study (NCT00696878)||0
8537976|NCT00702234|9570624|FG000|NOT COMPLETED|Base Study (NCT00696878)||504
8537977|NCT00702234|9570625|FG001|NOT COMPLETED|Base Study (NCT00696878)||0
8537978|NCT00702234|9570624|FG000|STARTED|Follow-up Study: Expectant Mothers|"A participant could enter follow-up study without meeting definition for Completion of base study"|268
8537979|NCT00702234|9570625|FG001|STARTED|Follow-up Study: Expectant Mothers||0
8537980|NCT00702234|9570624|FG000|COMPLETED|Follow-up Study: Expectant Mothers||246
8537981|NCT00702234|9570625|FG001|COMPLETED|Follow-up Study: Expectant Mothers||0
8537982|NCT00702234|9570624|FG000|NOT COMPLETED|Follow-up Study: Expectant Mothers||22
8537983|NCT00702234|9570625|FG001|NOT COMPLETED|Follow-up Study: Expectant Mothers||0
8537984|NCT00702234|9570624|FG000|STARTED|Follow-up Study: Fetuses/Infants||0
8537985|NCT00702234|9570625|FG001|STARTED|Follow-up Study: Fetuses/Infants|Fetuses present 10 weeks after fresh ET and/or at enrollment of expectant mother in follow-up study|315
8537986|NCT00702234|9570624|FG000|Live Born Infants|Follow-up Study: Fetuses/Infants||0
8537987|NCT00702234|9570625|FG001|Live Born Infants|Follow-up Study: Fetuses/Infants|Of the 11 that were not live born infants, outcome is known for 8 (fetus was lost) and unknown for 3|304
8537988|NCT00702234|9570624|FG000|COMPLETED|Follow-up Study: Fetuses/Infants||0
8816996|NCT01548287|9870651|FG003|STARTED|Screening||20
8816997|NCT01548287|9870652|FG004|STARTED|Screening||83
8816998|NCT01548287|9870648|FG000|COMPLETED|Screening||19
8816999|NCT01548287|9870649|FG001|COMPLETED|Screening||22
8817000|NCT01548287|9870650|FG002|COMPLETED|Screening||20
8817001|NCT01548287|9870651|FG003|COMPLETED|Screening||20
8817002|NCT01548287|9870652|FG004|COMPLETED|Screening||0
8817003|NCT01548287|9870648|FG000|NOT COMPLETED|Screening||0
8817004|NCT01548287|9870649|FG001|NOT COMPLETED|Screening||0
8817005|NCT01548287|9870650|FG002|NOT COMPLETED|Screening||0
8817006|NCT01548287|9870651|FG003|NOT COMPLETED|Screening||0
8817007|NCT01548287|9870652|FG004|NOT COMPLETED|Screening||83
8817008|NCT01548287|9870648|FG000|STARTED|Randomized Period||19
8817009|NCT01548287|9870649|FG001|STARTED|Randomized Period||22
8817010|NCT01548287|9870650|FG002|STARTED|Randomized Period||20
8817011|NCT01548287|9870651|FG003|STARTED|Randomized Period||20
8817012|NCT01548287|9870652|FG004|STARTED|Randomized Period||0
8817013|NCT01548287|9870648|FG000|COMPLETED|Randomized Period||19
8817014|NCT01548287|9870649|FG001|COMPLETED|Randomized Period||20
8817015|NCT01548287|9870650|FG002|COMPLETED|Randomized Period||13
8817016|NCT01548287|9870651|FG003|COMPLETED|Randomized Period||20
8817017|NCT01548287|9870652|FG004|COMPLETED|Randomized Period||0
8817018|NCT01548287|9870648|FG000|NOT COMPLETED|Randomized Period||0
8817019|NCT01548287|9870649|FG001|NOT COMPLETED|Randomized Period||2
8817020|NCT01548287|9870650|FG002|NOT COMPLETED|Randomized Period||7
8817021|NCT01548287|9870651|FG003|NOT COMPLETED|Randomized Period||0
8817022|NCT01548287|9870652|FG004|NOT COMPLETED|Randomized Period||0
8817023|NCT01548339|9870664|FG000|STARTED|Overall Study||44
8817024|NCT01548339|9870665|FG001|STARTED|Overall Study||42
8817025|NCT01548339|9870664|FG000|COMPLETED|Overall Study||38
8817026|NCT01548339|9870665|FG001|COMPLETED|Overall Study||41
8817027|NCT01548339|9870664|FG000|NOT COMPLETED|Overall Study||6
8817028|NCT01548339|9870665|FG001|NOT COMPLETED|Overall Study||1
8817029|NCT01548404|9870673|FG000|STARTED|Overall Study||54
8817030|NCT01548404|9870674|FG001|STARTED|Overall Study||55
8817031|NCT01548404|9870673|FG000|COMPLETED|Overall Study||24
8817032|NCT01548404|9870674|FG001|COMPLETED|Overall Study||41
8817033|NCT01548404|9870673|FG000|NOT COMPLETED|Overall Study||30
8817034|NCT01548404|9870674|FG001|NOT COMPLETED|Overall Study||14
8817035|NCT01548417|9870683|FG000|STARTED|Overall Study||28
8817036|NCT01548417|9870684|FG001|STARTED|Overall Study||28
8817037|NCT01548417|9870683|FG000|COMPLETED|Overall Study||28
8817038|NCT01548417|9870684|FG001|COMPLETED|Overall Study||26
8817039|NCT01548417|9870683|FG000|NOT COMPLETED|Overall Study||0
8817040|NCT01548417|9870684|FG001|NOT COMPLETED|Overall Study||2
8817041|NCT01548573|9870690|FG000|STARTED|Overall Study||19
8817042|NCT01548573|9870690|FG000|COMPLETED|Overall Study||14
8817043|NCT01548573|9870690|FG000|NOT COMPLETED|Overall Study||5
8817044|NCT01548599|9870697|FG000|STARTED|Overall Study||72
8537989|NCT00702234|9570625|FG001|COMPLETED|Follow-up Study: Fetuses/Infants|All 288 who completed were live born infants|288
8537990|NCT00702234|9570624|FG000|NOT COMPLETED|Follow-up Study: Fetuses/Infants||0
8537991|NCT00702234|9570625|FG001|NOT COMPLETED|Follow-up Study: Fetuses/Infants||27
8537992|NCT00697255|9570634|FG000|STARTED|Stage 1a||5
8537993|NCT00697255|9570635|FG001|STARTED|Stage 1a||0
8537994|NCT00697255|9570634|FG000|COMPLETED|Stage 1a|Participants who completed 1a received hCG bolus injection and did not proceed further in the trial|2
8537995|NCT00697255|9570635|FG001|COMPLETED|Stage 1a||0
8537996|NCT00697255|9570634|FG000|NOT COMPLETED|Stage 1a||3
8537997|NCT00697255|9570635|FG001|NOT COMPLETED|Stage 1a||0
8537998|NCT00697255|9570634|FG000|STARTED|Stage 1b||0
8537999|NCT00697255|9570635|FG001|STARTED|Stage 1b|After enrollment in Stage 1a completed, a new cohort of participants enrolled in Stage 1b.|3
8538000|NCT00697255|9570634|FG000|COMPLETED|Stage 1b||0
8538001|NCT00697255|9570635|FG001|COMPLETED|Stage 1b|Participants who completed 1b received hCG bolus injection and did not proceed further in the trial|1
8538002|NCT00697255|9570634|FG000|NOT COMPLETED|Stage 1b||0
8538003|NCT00697255|9570635|FG001|NOT COMPLETED|Stage 1b||2
8538004|NCT00696878|9570641|FG000|STARTED|Overall Study||682
8538005|NCT00696878|9570641|FG000|COMPLETED|Overall Study||178
8538006|NCT00696878|9570641|FG000|NOT COMPLETED|Overall Study||504
8538007|NCT00696800|9570647|FG000|STARTED|Overall Study||757
8538008|NCT00696800|9570648|FG001|STARTED|Overall Study||752
8538009|NCT00696800|9570647|FG000|Treated (ITT)|Overall Study|The ITT group|756
8538010|NCT00696800|9570648|FG001|Treated (ITT)|Overall Study|The ITT group|750
8538011|NCT00696800|9570647|FG000|COMPLETED|Overall Study|Participants who had embryos transferred|672
8538012|NCT00696800|9570648|FG001|COMPLETED|Overall Study|Participants who had embryos transferred|704
8538013|NCT00696800|9570647|FG000|NOT COMPLETED|Overall Study||85
8538014|NCT00696800|9570648|FG001|NOT COMPLETED|Overall Study||48
8538015|NCT00616967|9570656|FG000|STARTED|Overall Study||6
8538016|NCT00616967|9570657|FG001|STARTED|Overall Study||31
8538017|NCT00616967|9570658|FG002|STARTED|Overall Study||31
8538018|NCT00616967|9570656|FG000|COMPLETED|Overall Study||6
8538019|NCT00616967|9570657|FG001|COMPLETED|Overall Study||31
8538020|NCT00616967|9570658|FG002|COMPLETED|Overall Study||30
8538021|NCT00616967|9570656|FG000|NOT COMPLETED|Overall Study||0
8538022|NCT00616967|9570657|FG001|NOT COMPLETED|Overall Study||0
8538023|NCT00616967|9570658|FG002|NOT COMPLETED|Overall Study||1
8538024|NCT00461032|9570678|FG000|STARTED|Overall Study||582
8538025|NCT00461032|9570679|FG001|STARTED|Overall Study||580
8538026|NCT00461032|9570678|FG000|COMPLETED|Overall Study||545
8538027|NCT00461032|9570679|FG001|COMPLETED|Overall Study||536
8538028|NCT00461032|9570678|FG000|NOT COMPLETED|Overall Study||37
8538029|NCT00461032|9570679|FG001|NOT COMPLETED|Overall Study||44
8538030|NCT00442338|9570688|FG000|STARTED|Overall Study||30
8538031|NCT00442338|9570689|FG001|STARTED|Overall Study||30
8538032|NCT00442338|9570690|FG002|STARTED|Overall Study||31
8538033|NCT00442338|9570688|FG000|COMPLETED|Overall Study||30
8538034|NCT00442338|9570689|FG001|COMPLETED|Overall Study||30
8538035|NCT00442338|9570690|FG002|COMPLETED|Overall Study||31
8538036|NCT00442338|9570688|FG000|NOT COMPLETED|Overall Study||0
8538037|NCT00442338|9570689|FG001|NOT COMPLETED|Overall Study||0
8817045|NCT01548599|9870698|FG001|STARTED|Overall Study||68
8817046|NCT01548599|9870697|FG000|COMPLETED|Overall Study||66
8817047|NCT01548599|9870698|FG001|COMPLETED|Overall Study||66
8817048|NCT01548599|9870697|FG000|NOT COMPLETED|Overall Study||6
8817049|NCT01548599|9870698|FG001|NOT COMPLETED|Overall Study||2
8817050|NCT01548638|9870707|FG000|STARTED|Overall Study||13
8817051|NCT01548638|9870707|FG000|COMPLETED|Overall Study||9
8817052|NCT01548638|9870707|FG000|NOT COMPLETED|Overall Study||4
8817053|NCT01548690|9870716|FG000|STARTED|Overall Study||9
8817054|NCT01548690|9870717|FG001|STARTED|Overall Study||10
8817055|NCT01548690|9870718|FG002|STARTED|Overall Study||13
8817056|NCT01548690|9870719|FG003|STARTED|Overall Study||15
8817057|NCT01548690|9870716|FG000|Evaluable (72 Hours on Infusion)|Overall Study||6
8817058|NCT01548690|9870717|FG001|Evaluable (72 Hours on Infusion)|Overall Study||6
8817059|NCT01548690|9870718|FG002|Evaluable (72 Hours on Infusion)|Overall Study||12
8817060|NCT01548690|9870719|FG003|Evaluable (72 Hours on Infusion)|Overall Study||12
8817061|NCT01548690|9870716|FG000|COMPLETED|Overall Study||9
8817062|NCT01548690|9870717|FG001|COMPLETED|Overall Study||7
8817063|NCT01548690|9870718|FG002|COMPLETED|Overall Study||8
8817064|NCT01548690|9870719|FG003|COMPLETED|Overall Study||10
8817065|NCT01548690|9870716|FG000|NOT COMPLETED|Overall Study||0
8817066|NCT01548690|9870717|FG001|NOT COMPLETED|Overall Study||3
8538038|NCT00442338|9570690|FG002|NOT COMPLETED|Overall Study||0
8538039|NCT00289874|9570700|FG000|STARTED|Overall Study||203
8538040|NCT00289874|9570701|FG001|STARTED|Overall Study||218
8538041|NCT00289874|9570700|FG000|COMPLETED|Overall Study||197
8538042|NCT00289874|9570701|FG001|COMPLETED|Overall Study||210
8538043|NCT00289874|9570700|FG000|NOT COMPLETED|Overall Study||6
8538044|NCT00289874|9570701|FG001|NOT COMPLETED|Overall Study||8
8538045|NCT00250458|9570709|FG000|STARTED|Overall Study||232
8538046|NCT00250458|9570710|FG001|STARTED|Overall Study||114
8538047|NCT00250458|9570709|FG000|COMPLETED|Overall Study||200
8538048|NCT00250458|9570710|FG001|COMPLETED|Overall Study||97
8538049|NCT00250458|9570709|FG000|NOT COMPLETED|Overall Study||32
8538050|NCT00250458|9570710|FG001|NOT COMPLETED|Overall Study||17
8817067|NCT01548690|9870718|FG002|NOT COMPLETED|Overall Study||5
8817068|NCT01548690|9870719|FG003|NOT COMPLETED|Overall Study||5
8817069|NCT01548742|9870734|FG000|STARTED|Overall Study||58
8538051|NCT00245570|9570716|FG000|STARTED|Treatment Period II||7
8538052|NCT00245570|9570717|FG001|STARTED|Treatment Period II||8
8538053|NCT00245570|9570718|FG002|STARTED|Treatment Period II||8
8538054|NCT00245570|9570719|FG003|STARTED|Treatment Period II||8
8538055|NCT00245570|9570720|FG004|STARTED|Treatment Period II||8
8538056|NCT00245570|9570721|FG005|STARTED|Treatment Period II||8
8538057|NCT00245570|9570716|FG000|COMPLETED|Treatment Period II||7
8538058|NCT00245570|9570717|FG001|COMPLETED|Treatment Period II||8
8538059|NCT00245570|9570718|FG002|COMPLETED|Treatment Period II||8
8538060|NCT00245570|9570719|FG003|COMPLETED|Treatment Period II||8
8538061|NCT00245570|9570720|FG004|COMPLETED|Treatment Period II||8
8538062|NCT00245570|9570721|FG005|COMPLETED|Treatment Period II||8
8538063|NCT00245570|9570716|FG000|NOT COMPLETED|Treatment Period II||0
8538064|NCT00245570|9570717|FG001|NOT COMPLETED|Treatment Period II||0
8538065|NCT00245570|9570718|FG002|NOT COMPLETED|Treatment Period II||0
8538066|NCT00245570|9570719|FG003|NOT COMPLETED|Treatment Period II||0
8538067|NCT00245570|9570720|FG004|NOT COMPLETED|Treatment Period II||0
8538068|NCT00245570|9570721|FG005|NOT COMPLETED|Treatment Period II||0
8538069|NCT00245570|9570716|FG000|STARTED|Washout Between Periods II and III||7
8538070|NCT00245570|9570717|FG001|STARTED|Washout Between Periods II and III||8
8538071|NCT00245570|9570718|FG002|STARTED|Washout Between Periods II and III||8
8538072|NCT00245570|9570719|FG003|STARTED|Washout Between Periods II and III||8
8538073|NCT00245570|9570720|FG004|STARTED|Washout Between Periods II and III||8
8538074|NCT00245570|9570721|FG005|STARTED|Washout Between Periods II and III||8
8538075|NCT00245570|9570716|FG000|COMPLETED|Washout Between Periods II and III||7
8538076|NCT00245570|9570717|FG001|COMPLETED|Washout Between Periods II and III||8
8538077|NCT00245570|9570718|FG002|COMPLETED|Washout Between Periods II and III||8
8538078|NCT00245570|9570719|FG003|COMPLETED|Washout Between Periods II and III||8
8538079|NCT00245570|9570720|FG004|COMPLETED|Washout Between Periods II and III||8
8538080|NCT00245570|9570721|FG005|COMPLETED|Washout Between Periods II and III||8
8538081|NCT00245570|9570716|FG000|NOT COMPLETED|Washout Between Periods II and III||0
8538082|NCT00245570|9570717|FG001|NOT COMPLETED|Washout Between Periods II and III||0
8538083|NCT00245570|9570718|FG002|NOT COMPLETED|Washout Between Periods II and III||0
8538084|NCT00245570|9570719|FG003|NOT COMPLETED|Washout Between Periods II and III||0
8538085|NCT00245570|9570720|FG004|NOT COMPLETED|Washout Between Periods II and III||0
8538086|NCT00245570|9570721|FG005|NOT COMPLETED|Washout Between Periods II and III||0
8538087|NCT00245570|9570716|FG000|STARTED|Treatment Period III||7
8538088|NCT00245570|9570717|FG001|STARTED|Treatment Period III||8
8538089|NCT00245570|9570718|FG002|STARTED|Treatment Period III||8
8538090|NCT00245570|9570719|FG003|STARTED|Treatment Period III||8
8538091|NCT00245570|9570720|FG004|STARTED|Treatment Period III||8
8538092|NCT00245570|9570721|FG005|STARTED|Treatment Period III||8
8538093|NCT00245570|9570716|FG000|COMPLETED|Treatment Period III||7
8538094|NCT00245570|9570717|FG001|COMPLETED|Treatment Period III||8
8538095|NCT00245570|9570718|FG002|COMPLETED|Treatment Period III||8
8538096|NCT00245570|9570719|FG003|COMPLETED|Treatment Period III||8
8538097|NCT00245570|9570720|FG004|COMPLETED|Treatment Period III||8
8538098|NCT00245570|9570721|FG005|COMPLETED|Treatment Period III||8
8538099|NCT00245570|9570716|FG000|NOT COMPLETED|Treatment Period III||0
8817070|NCT01548742|9870735|FG001|STARTED|Overall Study||58
8817071|NCT01548742|9870734|FG000|COMPLETED|Overall Study||45
8817072|NCT01548742|9870735|FG001|COMPLETED|Overall Study||54
8817073|NCT01548742|9870734|FG000|NOT COMPLETED|Overall Study||13
8817074|NCT01548742|9870735|FG001|NOT COMPLETED|Overall Study||4
8817075|NCT01548768|9870747|FG000|STARTED|Overall Study||8
8817076|NCT01548768|9870748|FG001|STARTED|Overall Study||4
8817077|NCT01548768|9870749|FG002|STARTED|Overall Study||16
8817078|NCT01548768|9870750|FG003|STARTED|Overall Study||121
8817079|NCT01548768|9870747|FG000|COMPLETED|Overall Study||7
8817080|NCT01548768|9870748|FG001|COMPLETED|Overall Study||2
8817081|NCT01548768|9870749|FG002|COMPLETED|Overall Study||15
8817082|NCT01548768|9870750|FG003|COMPLETED|Overall Study||117
8817083|NCT01548768|9870747|FG000|NOT COMPLETED|Overall Study||1
8817084|NCT01548768|9870748|FG001|NOT COMPLETED|Overall Study||2
8817085|NCT01548768|9870749|FG002|NOT COMPLETED|Overall Study||1
8538100|NCT00245570|9570717|FG001|NOT COMPLETED|Treatment Period III||0
8538101|NCT00245570|9570718|FG002|NOT COMPLETED|Treatment Period III||0
8538102|NCT00245570|9570719|FG003|NOT COMPLETED|Treatment Period III||0
8538103|NCT00245570|9570720|FG004|NOT COMPLETED|Treatment Period III||0
8817086|NCT01548768|9870750|FG003|NOT COMPLETED|Overall Study||4
8817087|NCT01548833|9870762|FG000|STARTED|Overall Study||39
8817088|NCT01548833|9870762|FG000|COMPLETED|Overall Study||39
8538104|NCT00245570|9570721|FG005|NOT COMPLETED|Treatment Period III||0
8538105|NCT00245570|9570716|FG000|STARTED|Washout Between Periods III and IV||7
8538106|NCT00245570|9570717|FG001|STARTED|Washout Between Periods III and IV|1 pt in the montelukast/placebo/salmeterol group discontinued during washout period 2 after placebo|8
8538107|NCT00245570|9570718|FG002|STARTED|Washout Between Periods III and IV||8
8538108|NCT00245570|9570719|FG003|STARTED|Washout Between Periods III and IV||8
8538109|NCT00245570|9570720|FG004|STARTED|Washout Between Periods III and IV||8
8817089|NCT01548833|9870762|FG000|NOT COMPLETED|Overall Study||0
8817090|NCT01548885|9870770|FG000|STARTED|Overall Study||146
8817091|NCT01548885|9870770|FG000|COMPLETED|Overall Study||146
8817092|NCT01548885|9870770|FG000|NOT COMPLETED|Overall Study||0
8817093|NCT01549002|9870776|FG000|STARTED|Overall Study||10
8817094|NCT01549002|9870777|FG001|STARTED|Overall Study||10
8538110|NCT00245570|9570721|FG005|STARTED|Washout Between Periods III and IV||8
8538111|NCT00245570|9570716|FG000|COMPLETED|Washout Between Periods III and IV||7
8538112|NCT00245570|9570717|FG001|COMPLETED|Washout Between Periods III and IV||7
8538113|NCT00245570|9570718|FG002|COMPLETED|Washout Between Periods III and IV||8
8538114|NCT00245570|9570719|FG003|COMPLETED|Washout Between Periods III and IV||8
8538115|NCT00245570|9570720|FG004|COMPLETED|Washout Between Periods III and IV||8
8538116|NCT00245570|9570721|FG005|COMPLETED|Washout Between Periods III and IV||8
8538117|NCT00245570|9570716|FG000|NOT COMPLETED|Washout Between Periods III and IV||0
8538118|NCT00245570|9570717|FG001|NOT COMPLETED|Washout Between Periods III and IV||1
8538119|NCT00245570|9570718|FG002|NOT COMPLETED|Washout Between Periods III and IV||0
8538120|NCT00245570|9570719|FG003|NOT COMPLETED|Washout Between Periods III and IV||0
8538121|NCT00245570|9570720|FG004|NOT COMPLETED|Washout Between Periods III and IV||0
8538122|NCT00245570|9570721|FG005|NOT COMPLETED|Washout Between Periods III and IV||0
8538123|NCT00245570|9570716|FG000|STARTED|Treatment Period IV||7
8538124|NCT00245570|9570717|FG001|STARTED|Treatment Period IV||7
8538125|NCT00245570|9570718|FG002|STARTED|Treatment Period IV||8
8538126|NCT00245570|9570719|FG003|STARTED|Treatment Period IV||8
8538127|NCT00245570|9570720|FG004|STARTED|Treatment Period IV||8
8817095|NCT01549002|9870776|FG000|COMPLETED|Overall Study||10
8817096|NCT01549002|9870777|FG001|COMPLETED|Overall Study||6
8817097|NCT01549002|9870776|FG000|NOT COMPLETED|Overall Study||0
8817098|NCT01549002|9870777|FG001|NOT COMPLETED|Overall Study||4
8817099|NCT01549041|9870785|FG000|STARTED|Overall Study||12
8817100|NCT01549041|9870786|FG001|STARTED|Overall Study||18
8817101|NCT01549041|9870785|FG000|COMPLETED|Overall Study||10
8817102|NCT01549041|9870786|FG001|COMPLETED|Overall Study||10
8817103|NCT01549041|9870785|FG000|NOT COMPLETED|Overall Study||2
8817104|NCT01549041|9870786|FG001|NOT COMPLETED|Overall Study||8
8817105|NCT01549223|9870794|FG000|STARTED|Overall Study||30
8817106|NCT01549223|9870795|FG001|STARTED|Overall Study||30
8817107|NCT01549223|9870794|FG000|COMPLETED|Overall Study||30
8817108|NCT01549223|9870795|FG001|COMPLETED|Overall Study||30
8817109|NCT01549223|9870794|FG000|NOT COMPLETED|Overall Study||0
8817110|NCT01549223|9870795|FG001|NOT COMPLETED|Overall Study||0
8817111|NCT01549275|9870803|FG000|STARTED|Overall Study||76
8817112|NCT01549275|9870804|FG001|STARTED|Overall Study||29
8817113|NCT01549275|9870803|FG000|COMPLETED|Overall Study||75
8817114|NCT01549275|9870804|FG001|COMPLETED|Overall Study||29
8817115|NCT01549275|9870803|FG000|NOT COMPLETED|Overall Study||1
8817116|NCT01549275|9870804|FG001|NOT COMPLETED|Overall Study||0
8817117|NCT01549314|9870817|FG000|STARTED|Overall Study|1 subject signed the consent form but dropped out prior to any study procedures or data collection.|27
8817118|NCT01549314|9870818|FG001|STARTED|Overall Study||26
8538128|NCT00245570|9570721|FG005|STARTED|Treatment Period IV||8
8817119|NCT01549314|9870819|FG002|STARTED|Overall Study||26
8817120|NCT01549314|9870817|FG000|COMPLETED|Overall Study||23
8817121|NCT01549314|9870818|FG001|COMPLETED|Overall Study||21
8817122|NCT01549314|9870819|FG002|COMPLETED|Overall Study||24
8817123|NCT01549314|9870817|FG000|NOT COMPLETED|Overall Study||4
8817124|NCT01549314|9870818|FG001|NOT COMPLETED|Overall Study||5
8817125|NCT01549314|9870819|FG002|NOT COMPLETED|Overall Study||2
8817126|NCT01549340|9870827|FG000|STARTED|Overall Study|Advised to receive AIT|8790
8817127|NCT01549340|9870827|FG000|Started AIT|Overall Study||3182
8817128|NCT01549340|9870827|FG000|COMPLETED|Overall Study|Completed 5 years of AIT|385
8817129|NCT01549340|9870827|FG000|NOT COMPLETED|Overall Study||8405
8817130|NCT01549392|9870838|FG000|STARTED|Overall Study||3
8817131|NCT01549392|9870839|FG001|STARTED|Overall Study||0
8817132|NCT01549392|9870838|FG000|COMPLETED|Overall Study||2
8817133|NCT01549392|9870839|FG001|COMPLETED|Overall Study||0
8817134|NCT01549392|9870838|FG000|NOT COMPLETED|Overall Study||1
8817135|NCT01549392|9870839|FG001|NOT COMPLETED|Overall Study||0
8817136|NCT01549405|9870847|FG000|STARTED|Overall Study||20
8817137|NCT01549405|9870848|FG001|STARTED|Overall Study||20
8817138|NCT01549405|9870847|FG000|COMPLETED|Overall Study||20
8817139|NCT01549405|9870848|FG001|COMPLETED|Overall Study||20
8817140|NCT01549405|9870847|FG000|NOT COMPLETED|Overall Study||0
8817141|NCT01549405|9870848|FG001|NOT COMPLETED|Overall Study||0
8817142|NCT01549587|9870858|FG000|STARTED|Overall Study||373
8817143|NCT01549587|9870859|FG001|STARTED|Overall Study||373
8817144|NCT01549587|9870858|FG000|COMPLETED|Overall Study||334
8817145|NCT01549587|9870859|FG001|COMPLETED|Overall Study||336
8817146|NCT01549587|9870858|FG000|NOT COMPLETED|Overall Study||39
8817147|NCT01549587|9870859|FG001|NOT COMPLETED|Overall Study||37
8817148|NCT01549613|9870867|FG000|STARTED|Overall Study||50
8817149|NCT01549613|9870868|FG001|STARTED|Overall Study||50
8817150|NCT01549613|9870867|FG000|COMPLETED|Overall Study||39
8538129|NCT00245570|9570716|FG000|COMPLETED|Treatment Period IV||7
8817151|NCT01549613|9870868|FG001|COMPLETED|Overall Study||39
8817152|NCT01549613|9870867|FG000|NOT COMPLETED|Overall Study||11
8817153|NCT01549613|9870868|FG001|NOT COMPLETED|Overall Study||11
8817154|NCT01549652|9870877|FG000|STARTED|Overall Study||27
8817155|NCT01549652|9870878|FG001|STARTED|Overall Study||30
8817156|NCT01549652|9870879|FG002|STARTED|Overall Study||40
8817157|NCT01549652|9870880|FG003|STARTED|Overall Study||36
8817158|NCT01549652|9870877|FG000|COMPLETED|Overall Study||15
8817159|NCT01549652|9870878|FG001|COMPLETED|Overall Study||18
8817160|NCT01549652|9870879|FG002|COMPLETED|Overall Study||23
8817161|NCT01549652|9870880|FG003|COMPLETED|Overall Study||25
8817162|NCT01549652|9870877|FG000|NOT COMPLETED|Overall Study||12
8538130|NCT00245570|9570717|FG001|COMPLETED|Treatment Period IV||7
8538131|NCT00245570|9570718|FG002|COMPLETED|Treatment Period IV||8
8538132|NCT00245570|9570719|FG003|COMPLETED|Treatment Period IV||8
8538133|NCT00245570|9570720|FG004|COMPLETED|Treatment Period IV||8
8538134|NCT00245570|9570721|FG005|COMPLETED|Treatment Period IV||8
8538135|NCT00245570|9570716|FG000|NOT COMPLETED|Treatment Period IV||0
8538136|NCT00245570|9570717|FG001|NOT COMPLETED|Treatment Period IV||0
8538137|NCT00245570|9570718|FG002|NOT COMPLETED|Treatment Period IV||0
8538138|NCT00245570|9570719|FG003|NOT COMPLETED|Treatment Period IV||0
8538139|NCT00245570|9570720|FG004|NOT COMPLETED|Treatment Period IV||0
8538140|NCT00245570|9570721|FG005|NOT COMPLETED|Treatment Period IV||0
8538141|NCT00229970|9570735|FG000|STARTED|Overall Study||78
8538142|NCT00229970|9570736|FG001|STARTED|Overall Study||72
8538143|NCT00229970|9570737|FG002|STARTED|Overall Study||75
8538144|NCT00229970|9570735|FG000|COMPLETED|Overall Study||78
8538145|NCT00229970|9570736|FG001|COMPLETED|Overall Study||72
8538146|NCT00229970|9570737|FG002|COMPLETED|Overall Study||75
8538147|NCT00229970|9570735|FG000|NOT COMPLETED|Overall Study||0
8538148|NCT00229970|9570736|FG001|NOT COMPLETED|Overall Study||0
8538149|NCT00229970|9570737|FG002|NOT COMPLETED|Overall Study||0
8538150|NCT00092131|9570745|FG000|STARTED|Treatment Period I|1 patient discontinued due to influenza which started in washout (11 days after Period I medication)|25
8538151|NCT00092131|9570746|FG001|STARTED|Treatment Period I||26
8538152|NCT00092131|9570745|FG000|COMPLETED|Treatment Period I||24
8538153|NCT00092131|9570746|FG001|COMPLETED|Treatment Period I||26
8538154|NCT00092131|9570745|FG000|NOT COMPLETED|Treatment Period I||1
8538155|NCT00092131|9570746|FG001|NOT COMPLETED|Treatment Period I||0
8538156|NCT00092131|9570745|FG000|STARTED|Treatment Period II||24
8538157|NCT00092131|9570746|FG001|STARTED|Treatment Period II|1 patient discontinued after taking Period II study medication, due to asthma exacerbation|26
8538158|NCT00092131|9570745|FG000|COMPLETED|Treatment Period II||24
8538159|NCT00092131|9570746|FG001|COMPLETED|Treatment Period II||25
8538160|NCT00092131|9570745|FG000|NOT COMPLETED|Treatment Period II||0
8538161|NCT00092131|9570746|FG001|NOT COMPLETED|Treatment Period II||1
8538162|NCT00092118|9570754|FG000|STARTED|Overall Study|1 patient discontinued after randomization due to a adverse experience that began pre-randomization.|990
8538163|NCT00092118|9570755|FG001|STARTED|Overall Study|2 patients discontinued after randomization due to adverse experience that began pre-randomization.|1002
8538164|NCT00092118|9570754|FG000|COMPLETED|Overall Study||906
8538165|NCT00092118|9570755|FG001|COMPLETED|Overall Study||913
8538166|NCT00092118|9570754|FG000|NOT COMPLETED|Overall Study||84
8538167|NCT00092118|9570755|FG001|NOT COMPLETED|Overall Study||89
8538168|NCT00090142|9570761|FG000|STARTED|Treatment Period I|1 patient was lost to follow-up after randomization and did not receive any study drug.|31
8538169|NCT00090142|9570762|FG001|STARTED|Treatment Period I||31
8538170|NCT00090142|9570761|FG000|COMPLETED|Treatment Period I||26
8538171|NCT00090142|9570762|FG001|COMPLETED|Treatment Period I||28
8538172|NCT00090142|9570761|FG000|NOT COMPLETED|Treatment Period I||5
8538173|NCT00090142|9570762|FG001|NOT COMPLETED|Treatment Period I||3
8538174|NCT00090142|9570761|FG000|STARTED|Treatment Period II||26
8538175|NCT00090142|9570762|FG001|STARTED|Treatment Period II||28
8538176|NCT00090142|9570761|FG000|COMPLETED|Treatment Period II||25
8538177|NCT00090142|9570762|FG001|COMPLETED|Treatment Period II||28
8538178|NCT00090142|9570761|FG000|NOT COMPLETED|Treatment Period II||1
8538179|NCT00090142|9570762|FG001|NOT COMPLETED|Treatment Period II||0
8817163|NCT01549652|9870878|FG001|NOT COMPLETED|Overall Study||12
8817164|NCT01549652|9870879|FG002|NOT COMPLETED|Overall Study||17
8817165|NCT01549652|9870880|FG003|NOT COMPLETED|Overall Study||11
8817166|NCT01549860|9870888|FG000|STARTED|Overall Study||40
8817167|NCT01549860|9870889|FG001|STARTED|Overall Study||41
8817168|NCT01549860|9870888|FG000|COMPLETED|Overall Study||38
8817169|NCT01549860|9870889|FG001|COMPLETED|Overall Study||40
8817170|NCT01549860|9870888|FG000|NOT COMPLETED|Overall Study||2
8817171|NCT01549860|9870889|FG001|NOT COMPLETED|Overall Study||1
8817172|NCT01549873|9870897|FG000|STARTED|Overall Study||15
8817173|NCT01549873|9870898|FG001|STARTED|Overall Study||15
8817174|NCT01549873|9870897|FG000|COMPLETED|Overall Study||15
8817175|NCT01549873|9870898|FG001|COMPLETED|Overall Study||14
8817176|NCT01549873|9870897|FG000|NOT COMPLETED|Overall Study||0
8817177|NCT01549873|9870898|FG001|NOT COMPLETED|Overall Study||1
8817178|NCT01549886|9870906|FG000|STARTED|Overall Study||2
8817179|NCT01549886|9870907|FG001|STARTED|Overall Study||3
8817180|NCT01549886|9870906|FG000|COMPLETED|Overall Study||0
8817181|NCT01549886|9870907|FG001|COMPLETED|Overall Study||0
8817182|NCT01549886|9870906|FG000|NOT COMPLETED|Overall Study||2
8817183|NCT01549886|9870907|FG001|NOT COMPLETED|Overall Study||3
8817184|NCT01549925|9870917|FG000|STARTED|Overall Study||25
8817185|NCT01549925|9870918|FG001|STARTED|Overall Study||25
8817186|NCT01549925|9870917|FG000|COMPLETED|Overall Study||25
8948744|NCT02432274|10011219|FG002|Underwent Run-in Period|Overall Study||0
8538180|NCT00043108|9570768|FG000|STARTED|Overall Study||19
8538181|NCT00043108|9570768|FG000|COMPLETED|Overall Study||19
8538182|NCT00043108|9570768|FG000|NOT COMPLETED|Overall Study||0
8565601|NCT00068692|9597672|FG006|STARTED|Step 2: Randomization|Group 2 patients were registered and randomized at the same time.|33
8565602|NCT00068692|9597673|FG007|STARTED|Step 2: Randomization|Group 2 patients were registered and randomized at the same time.|32
8817187|NCT01549925|9870918|FG001|COMPLETED|Overall Study||25
8817188|NCT01549925|9870917|FG000|NOT COMPLETED|Overall Study||0
8817189|NCT01549925|9870918|FG001|NOT COMPLETED|Overall Study||0
8817190|NCT01549951|9870924|FG000|STARTED|Overall Study||50
8538183|NCT04771013|9570774|FG000|STARTED|Overall Study||22
8538184|NCT04771013|9570775|FG001|STARTED|Overall Study||22
8538185|NCT04771013|9570774|FG000|COMPLETED|Overall Study||20
8538186|NCT04771013|9570775|FG001|COMPLETED|Overall Study||16
8538187|NCT04771013|9570774|FG000|NOT COMPLETED|Overall Study||2
8538188|NCT04771013|9570775|FG001|NOT COMPLETED|Overall Study||6
8565603|NCT00068692|9597666|FG000|Treated|Step 2: Randomization||0
8565604|NCT00068692|9597667|FG001|Treated|Step 2: Randomization||0
8565605|NCT00068692|9597668|FG002|Treated|Step 2: Randomization||27
8565606|NCT00068692|9597669|FG003|Treated|Step 2: Randomization||25
8565607|NCT00068692|9597670|FG004|Treated|Step 2: Randomization||29
8565608|NCT00068692|9597671|FG005|Treated|Step 2: Randomization||31
8565609|NCT00068692|9597672|FG006|Treated|Step 2: Randomization||33
8565610|NCT00068692|9597673|FG007|Treated|Step 2: Randomization||32
8565611|NCT00068692|9597666|FG000|Had Sphincter Preservation|Step 2: Randomization||0
8565612|NCT00068692|9597667|FG001|Had Sphincter Preservation|Step 2: Randomization||0
8565613|NCT00068692|9597668|FG002|Had Sphincter Preservation|Step 2: Randomization||28
8565614|NCT00068692|9597669|FG003|Had Sphincter Preservation|Step 2: Randomization||25
8565615|NCT00068692|9597670|FG004|Had Sphincter Preservation|Step 2: Randomization||28
8565616|NCT00068692|9597671|FG005|Had Sphincter Preservation|Step 2: Randomization||31
8565617|NCT00068692|9597672|FG006|Had Sphincter Preservation|Step 2: Randomization||33
8565618|NCT00068692|9597673|FG007|Had Sphincter Preservation|Step 2: Randomization||30
8565619|NCT00068692|9597666|FG000|Reported AE Data|Step 2: Randomization||0
8565620|NCT00068692|9597667|FG001|Reported AE Data|Step 2: Randomization||0
8565621|NCT00068692|9597668|FG002|Reported AE Data|Step 2: Randomization||27
8565622|NCT00068692|9597669|FG003|Reported AE Data|Step 2: Randomization||22
8565623|NCT00068692|9597670|FG004|Reported AE Data|Step 2: Randomization||28
8565624|NCT00068692|9597671|FG005|Reported AE Data|Step 2: Randomization||31
8817191|NCT01549951|9870924|FG000|Primary Reason Off Study Treatment|Overall Study||50
8817192|NCT01549951|9870924|FG000|COMPLETED|Overall Study||0
8817193|NCT01549951|9870924|FG000|NOT COMPLETED|Overall Study||50
8817194|NCT01549964|9870932|FG000|STARTED|24-Week Treatment Period||132
8817195|NCT01549964|9870933|FG001|STARTED|24-Week Treatment Period||260
8817196|NCT01549964|9870934|FG002|STARTED|24-Week Treatment Period||263
8817197|NCT01549964|9870935|FG003|STARTED|24-Week Treatment Period||261
8817198|NCT01549964|9870932|FG000|Safety Analysis Set=Received Treatment|24-Week Treatment Period||132
8817199|NCT01549964|9870933|FG001|Safety Analysis Set=Received Treatment|24-Week Treatment Period||260
8817200|NCT01549964|9870934|FG002|Safety Analysis Set=Received Treatment|24-Week Treatment Period||263
8817201|NCT01549964|9870935|FG003|Safety Analysis Set=Received Treatment|24-Week Treatment Period||260
8817202|NCT01549964|9870932|FG000|COMPLETED|24-Week Treatment Period||71
8817203|NCT01549964|9870933|FG001|COMPLETED|24-Week Treatment Period||149
8817204|NCT01549964|9870934|FG002|COMPLETED|24-Week Treatment Period||147
8817205|NCT01549964|9870935|FG003|COMPLETED|24-Week Treatment Period||140
8817206|NCT01549964|9870932|FG000|NOT COMPLETED|24-Week Treatment Period||61
8817207|NCT01549964|9870933|FG001|NOT COMPLETED|24-Week Treatment Period||111
8817208|NCT01549964|9870934|FG002|NOT COMPLETED|24-Week Treatment Period||116
8817209|NCT01549964|9870935|FG003|NOT COMPLETED|24-Week Treatment Period||121
8817210|NCT01549964|9870932|FG000|STARTED|80-Week Extension Period||66
8817211|NCT01549964|9870933|FG001|STARTED|80-Week Extension Period||138
8817212|NCT01549964|9870934|FG002|STARTED|80-Week Extension Period||140
8817213|NCT01549964|9870935|FG003|STARTED|80-Week Extension Period||137
8817214|NCT01549964|9870932|FG000|COMPLETED|80-Week Extension Period||0
8817215|NCT01549964|9870933|FG001|COMPLETED|80-Week Extension Period||0
8817216|NCT01549964|9870934|FG002|COMPLETED|80-Week Extension Period||0
8817217|NCT01549964|9870935|FG003|COMPLETED|80-Week Extension Period||0
8817218|NCT01549964|9870932|FG000|NOT COMPLETED|80-Week Extension Period||66
8817219|NCT01549964|9870933|FG001|NOT COMPLETED|80-Week Extension Period||138
8817220|NCT01549964|9870934|FG002|NOT COMPLETED|80-Week Extension Period||140
8817221|NCT01549964|9870935|FG003|NOT COMPLETED|80-Week Extension Period||137
8817222|NCT01550224|9870947|FG000|STARTED|Overall Study||3
8817223|NCT01550224|9870948|FG001|STARTED|Overall Study||20
8817224|NCT01550224|9870947|FG000|COMPLETED|Overall Study||3
8817225|NCT01550224|9870948|FG001|COMPLETED|Overall Study||20
8817226|NCT01550224|9870947|FG000|NOT COMPLETED|Overall Study||0
8817227|NCT01550224|9870948|FG001|NOT COMPLETED|Overall Study||0
8817228|NCT01550341|9870956|FG000|STARTED|Overall Study||32
8817229|NCT01550341|9870957|FG001|STARTED|Overall Study||18
8817230|NCT01550341|9870956|FG000|COMPLETED|Overall Study||32
8817231|NCT01550341|9870957|FG001|COMPLETED|Overall Study||18
8817232|NCT01550341|9870956|FG000|NOT COMPLETED|Overall Study||0
8817233|NCT01550341|9870957|FG001|NOT COMPLETED|Overall Study||0
8817234|NCT01550367|9870963|FG000|STARTED|Overall Study||30
8817235|NCT01550367|9870963|FG000|1200 mg/d HCQ|Overall Study||13
8817236|NCT01550367|9870963|FG000|600 mg/d HCQ|Overall Study||17
8817237|NCT01550367|9870963|FG000|COMPLETED|Overall Study||30
8817238|NCT01550367|9870963|FG000|NOT COMPLETED|Overall Study||0
8817239|NCT01550471|9870972|FG000|STARTED|Run-In Period (3 Weeks)||3
8565625|NCT00068692|9597672|FG006|Reported AE Data|Step 2: Randomization||33
8565626|NCT00068692|9597673|FG007|Reported AE Data|Step 2: Randomization||32
8565627|NCT00068692|9597666|FG000|COMPLETED|Step 2: Randomization||0
8565628|NCT00068692|9597667|FG001|COMPLETED|Step 2: Randomization||0
8565629|NCT00068692|9597668|FG002|COMPLETED|Step 2: Randomization||18
8565630|NCT00068692|9597669|FG003|COMPLETED|Step 2: Randomization||13
8565631|NCT00068692|9597670|FG004|COMPLETED|Step 2: Randomization||21
8538189|NCT04497987|9570783|FG000|STARTED|Overall Study||592
8538190|NCT04497987|9570784|FG001|STARTED|Overall Study||588
8817240|NCT01550471|9870973|FG001|STARTED|Run-In Period (3 Weeks)||4
8817241|NCT01550471|9870974|FG002|STARTED|Run-In Period (3 Weeks)||3
8817242|NCT01550471|9870975|FG003|STARTED|Run-In Period (3 Weeks)||4
8817243|NCT01550471|9870976|FG004|STARTED|Run-In Period (3 Weeks)||4
8817244|NCT01550471|9870977|FG005|STARTED|Run-In Period (3 Weeks)||4
8817245|NCT01550471|9870972|FG000|COMPLETED|Run-In Period (3 Weeks)||3
8817246|NCT01550471|9870973|FG001|COMPLETED|Run-In Period (3 Weeks)||4
8817247|NCT01550471|9870974|FG002|COMPLETED|Run-In Period (3 Weeks)||3
8817248|NCT01550471|9870975|FG003|COMPLETED|Run-In Period (3 Weeks)||4
8817249|NCT01550471|9870976|FG004|COMPLETED|Run-In Period (3 Weeks)||4
8817250|NCT01550471|9870977|FG005|COMPLETED|Run-In Period (3 Weeks)||4
8817251|NCT01550471|9870972|FG000|NOT COMPLETED|Run-In Period (3 Weeks)||0
8817252|NCT01550471|9870973|FG001|NOT COMPLETED|Run-In Period (3 Weeks)||0
8817253|NCT01550471|9870974|FG002|NOT COMPLETED|Run-In Period (3 Weeks)||0
8817254|NCT01550471|9870975|FG003|NOT COMPLETED|Run-In Period (3 Weeks)||0
8817255|NCT01550471|9870976|FG004|NOT COMPLETED|Run-In Period (3 Weeks)||0
8817256|NCT01550471|9870977|FG005|NOT COMPLETED|Run-In Period (3 Weeks)||0
8817257|NCT01550471|9870972|FG000|STARTED|First Treatment Period (3 Weeks)||3
8817258|NCT01550471|9870973|FG001|STARTED|First Treatment Period (3 Weeks)||4
8817259|NCT01550471|9870974|FG002|STARTED|First Treatment Period (3 Weeks)||3
8817260|NCT01550471|9870975|FG003|STARTED|First Treatment Period (3 Weeks)||4
8817261|NCT01550471|9870976|FG004|STARTED|First Treatment Period (3 Weeks)||4
8817262|NCT01550471|9870977|FG005|STARTED|First Treatment Period (3 Weeks)||4
8817263|NCT01550471|9870972|FG000|COMPLETED|First Treatment Period (3 Weeks)||3
8817264|NCT01550471|9870973|FG001|COMPLETED|First Treatment Period (3 Weeks)||4
8817265|NCT01550471|9870974|FG002|COMPLETED|First Treatment Period (3 Weeks)||3
8817266|NCT01550471|9870975|FG003|COMPLETED|First Treatment Period (3 Weeks)||4
8817267|NCT01550471|9870976|FG004|COMPLETED|First Treatment Period (3 Weeks)||4
8817268|NCT01550471|9870977|FG005|COMPLETED|First Treatment Period (3 Weeks)||4
8817269|NCT01550471|9870972|FG000|NOT COMPLETED|First Treatment Period (3 Weeks)||0
8817270|NCT01550471|9870973|FG001|NOT COMPLETED|First Treatment Period (3 Weeks)||0
8817271|NCT01550471|9870974|FG002|NOT COMPLETED|First Treatment Period (3 Weeks)||0
8817272|NCT01550471|9870975|FG003|NOT COMPLETED|First Treatment Period (3 Weeks)||0
8817273|NCT01550471|9870976|FG004|NOT COMPLETED|First Treatment Period (3 Weeks)||0
8817274|NCT01550471|9870977|FG005|NOT COMPLETED|First Treatment Period (3 Weeks)||0
8817275|NCT01550471|9870972|FG000|STARTED|First Wash Out Period (3 Weeks)||3
8817276|NCT01550471|9870973|FG001|STARTED|First Wash Out Period (3 Weeks)||4
8817277|NCT01550471|9870974|FG002|STARTED|First Wash Out Period (3 Weeks)||3
8817278|NCT01550471|9870975|FG003|STARTED|First Wash Out Period (3 Weeks)||4
8817279|NCT01550471|9870976|FG004|STARTED|First Wash Out Period (3 Weeks)||4
8817280|NCT01550471|9870977|FG005|STARTED|First Wash Out Period (3 Weeks)||4
8817281|NCT01550471|9870972|FG000|COMPLETED|First Wash Out Period (3 Weeks)||3
8817282|NCT01550471|9870973|FG001|COMPLETED|First Wash Out Period (3 Weeks)||4
8817283|NCT01550471|9870974|FG002|COMPLETED|First Wash Out Period (3 Weeks)||3
8817284|NCT01550471|9870975|FG003|COMPLETED|First Wash Out Period (3 Weeks)||4
8817285|NCT01550471|9870976|FG004|COMPLETED|First Wash Out Period (3 Weeks)||4
8817286|NCT01550471|9870977|FG005|COMPLETED|First Wash Out Period (3 Weeks)||4
8817287|NCT01550471|9870972|FG000|NOT COMPLETED|First Wash Out Period (3 Weeks)||0
8817288|NCT01550471|9870973|FG001|NOT COMPLETED|First Wash Out Period (3 Weeks)||0
8817289|NCT01550471|9870974|FG002|NOT COMPLETED|First Wash Out Period (3 Weeks)||0
8817290|NCT01550471|9870975|FG003|NOT COMPLETED|First Wash Out Period (3 Weeks)||0
8817291|NCT01550471|9870976|FG004|NOT COMPLETED|First Wash Out Period (3 Weeks)||0
8817292|NCT01550471|9870977|FG005|NOT COMPLETED|First Wash Out Period (3 Weeks)||0
8817293|NCT01550471|9870972|FG000|STARTED|Second Treatment Period (3 Weeks)||3
8817294|NCT01550471|9870973|FG001|STARTED|Second Treatment Period (3 Weeks)||4
8817295|NCT01550471|9870974|FG002|STARTED|Second Treatment Period (3 Weeks)||3
8817296|NCT01550471|9870975|FG003|STARTED|Second Treatment Period (3 Weeks)||4
8817297|NCT01550471|9870976|FG004|STARTED|Second Treatment Period (3 Weeks)||4
8817298|NCT01550471|9870977|FG005|STARTED|Second Treatment Period (3 Weeks)||4
8817299|NCT01550471|9870972|FG000|COMPLETED|Second Treatment Period (3 Weeks)||3
8817300|NCT01550471|9870973|FG001|COMPLETED|Second Treatment Period (3 Weeks)||4
8817301|NCT01550471|9870974|FG002|COMPLETED|Second Treatment Period (3 Weeks)||3
8817302|NCT01550471|9870975|FG003|COMPLETED|Second Treatment Period (3 Weeks)||4
8817303|NCT01550471|9870976|FG004|COMPLETED|Second Treatment Period (3 Weeks)||4
8817304|NCT01550471|9870977|FG005|COMPLETED|Second Treatment Period (3 Weeks)||4
8817305|NCT01550471|9870972|FG000|NOT COMPLETED|Second Treatment Period (3 Weeks)||0
8817306|NCT01550471|9870973|FG001|NOT COMPLETED|Second Treatment Period (3 Weeks)||0
8817307|NCT01550471|9870974|FG002|NOT COMPLETED|Second Treatment Period (3 Weeks)||0
8817308|NCT01550471|9870975|FG003|NOT COMPLETED|Second Treatment Period (3 Weeks)||0
8538191|NCT04497987|9570783|FG000|Received at Least One Dose of Study Drug|Overall Study||587
8538192|NCT04497987|9570784|FG001|Received at Least One Dose of Study Drug|Overall Study||588
8538193|NCT04497987|9570783|FG000|Prevention Population|Overall Study||485
8538194|NCT04497987|9570784|FG001|Prevention Population|Overall Study||487
8538195|NCT04497987|9570783|FG000|Treatment Population|Overall Study||68
8538196|NCT04497987|9570784|FG001|Treatment Population|Overall Study||66
8538197|NCT04497987|9570783|FG000|Serology Positive|Overall Study||36
8538198|NCT04497987|9570784|FG001|Serology Positive|Overall Study||35
8538199|NCT04497987|9570783|FG000|COMPLETED|Overall Study||493
8538200|NCT04497987|9570784|FG001|COMPLETED|Overall Study||521
8538201|NCT04497987|9570783|FG000|NOT COMPLETED|Overall Study||99
8538202|NCT04497987|9570784|FG001|NOT COMPLETED|Overall Study||67
8538203|NCT04198584|9570793|FG000|STARTED|Overall Study||24
8538204|NCT04198584|9570794|FG001|STARTED|Overall Study||8
8538205|NCT04198584|9570793|FG000|Randomized to Wave 1|Overall Study||5
8538206|NCT04198584|9570794|FG001|Randomized to Wave 1|Overall Study||2
8538207|NCT04198584|9570793|FG000|Randomized to Wave 2|Overall Study||7
8538208|NCT04198584|9570794|FG001|Randomized to Wave 2|Overall Study||2
8538209|NCT04198584|9570793|FG000|Randomized to Wave 3|Overall Study||6
8538210|NCT04198584|9570794|FG001|Randomized to Wave 3|Overall Study||2
8538211|NCT04198584|9570793|FG000|Randomized to Wave 4|Overall Study||6
8538212|NCT04198584|9570794|FG001|Randomized to Wave 4|Overall Study||2
8538213|NCT04198584|9570793|FG000|Total Randomized|Overall Study||24
8538214|NCT04198584|9570794|FG001|Total Randomized|Overall Study||8
8538215|NCT04198584|9570793|FG000|Actually Received Treatment|Overall Study||21
8538216|NCT04198584|9570794|FG001|Actually Received Treatment|Overall Study||8
8538217|NCT04198584|9570793|FG000|COMPLETED|Overall Study||19
8538218|NCT04198584|9570794|FG001|COMPLETED|Overall Study||8
8538219|NCT04198584|9570793|FG000|NOT COMPLETED|Overall Study||5
8538220|NCT04198584|9570794|FG001|NOT COMPLETED|Overall Study||0
8538221|NCT04013932|9570807|FG000|STARTED|Overall Study||33
8538222|NCT04013932|9570808|FG001|STARTED|Overall Study||33
8538223|NCT04013932|9570807|FG000|COMPLETED|Overall Study||33
8538224|NCT04013932|9570808|FG001|COMPLETED|Overall Study||28
8538225|NCT04013932|9570807|FG000|NOT COMPLETED|Overall Study||0
8538226|NCT04013932|9570808|FG001|NOT COMPLETED|Overall Study||5
8538227|NCT03840616|9570818|FG000|STARTED|2-Week Induction Phase||147
8538228|NCT03840616|9570819|FG001|STARTED|2-Week Induction Phase||72
8538229|NCT03840616|9570818|FG000|COMPLETED|2-Week Induction Phase||123
8538230|NCT03840616|9570819|FG001|COMPLETED|2-Week Induction Phase||62
8538231|NCT03840616|9570818|FG000|NOT COMPLETED|2-Week Induction Phase||24
8538232|NCT03840616|9570819|FG001|NOT COMPLETED|2-Week Induction Phase||10
8538233|NCT03840616|9570818|FG000|STARTED|48-Week Maintenance Phase||123
8538234|NCT03840616|9570819|FG001|STARTED|48-Week Maintenance Phase||62
8538235|NCT03840616|9570818|FG000|COMPLETED|48-Week Maintenance Phase||112
8538236|NCT03840616|9570819|FG001|COMPLETED|48-Week Maintenance Phase||55
8538237|NCT03840616|9570818|FG000|NOT COMPLETED|48-Week Maintenance Phase||11
8538238|NCT03840616|9570819|FG001|NOT COMPLETED|48-Week Maintenance Phase||7
8538239|NCT03623373|9570827|FG000|STARTED|Overall Study||13
8538240|NCT03623373|9570827|FG000|COMPLETED|Overall Study||13
8538241|NCT03623373|9570827|FG000|NOT COMPLETED|Overall Study||0
8538242|NCT03581279|9570833|FG000|STARTED|Overall Study||18
8538243|NCT03581279|9570834|FG001|STARTED|Overall Study||0
8538244|NCT03581279|9570833|FG000|COMPLETED|Overall Study||16
8538245|NCT03581279|9570834|FG001|COMPLETED|Overall Study||0
8538246|NCT03581279|9570833|FG000|NOT COMPLETED|Overall Study||2
8538247|NCT03581279|9570834|FG001|NOT COMPLETED|Overall Study||0
8538248|NCT03512210|9570840|FG000|STARTED|Step 1: MINMON Intervention||400
8538249|NCT03512210|9570840|FG000|COMPLETED|Step 1: MINMON Intervention||396
8538250|NCT03512210|9570840|FG000|NOT COMPLETED|Step 1: MINMON Intervention||4
8538251|NCT03512210|9570840|FG000|STARTED|Step 2:Post-MINMON||396
8538252|NCT03512210|9570840|FG000|COMPLETED|Step 2:Post-MINMON||362
8538253|NCT03512210|9570840|FG000|NOT COMPLETED|Step 2:Post-MINMON||34
8538254|NCT03506412|9570846|FG000|STARTED|Overall Study||18
8538255|NCT03506412|9570847|FG001|STARTED|Overall Study||19
8538256|NCT03506412|9570846|FG000|COMPLETED|Overall Study||18
8538257|NCT03506412|9570847|FG001|COMPLETED|Overall Study||19
8538258|NCT03506412|9570846|FG000|NOT COMPLETED|Overall Study||0
8538259|NCT03506412|9570847|FG001|NOT COMPLETED|Overall Study||0
8565632|NCT00068692|9597671|FG005|COMPLETED|Step 2: Randomization||25
8565633|NCT00068692|9597672|FG006|COMPLETED|Step 2: Randomization||29
8565634|NCT00068692|9597673|FG007|COMPLETED|Step 2: Randomization||24
8565635|NCT00068692|9597666|FG000|NOT COMPLETED|Step 2: Randomization||0
8565636|NCT00068692|9597667|FG001|NOT COMPLETED|Step 2: Randomization||0
8565637|NCT00068692|9597668|FG002|NOT COMPLETED|Step 2: Randomization||10
8565638|NCT00068692|9597669|FG003|NOT COMPLETED|Step 2: Randomization||12
8565639|NCT00068692|9597670|FG004|NOT COMPLETED|Step 2: Randomization||9
8565640|NCT00068692|9597671|FG005|NOT COMPLETED|Step 2: Randomization||6
8565641|NCT00068692|9597672|FG006|NOT COMPLETED|Step 2: Randomization||4
8565642|NCT00068692|9597673|FG007|NOT COMPLETED|Step 2: Randomization||8
8565643|NCT00068718|9597686|FG000|STARTED|Overall Study||35
8565644|NCT00068718|9597686|FG000|COMPLETED|Overall Study||35
8565645|NCT00068718|9597686|FG000|NOT COMPLETED|Overall Study||0
8565646|NCT00068770|9597692|FG000|STARTED|Overall Study||13
8565647|NCT00068770|9597693|FG001|STARTED|Overall Study||22
8565648|NCT00068770|9597692|FG000|COMPLETED|Overall Study||13
8565649|NCT00068770|9597693|FG001|COMPLETED|Overall Study||22
8565650|NCT00068770|9597692|FG000|NOT COMPLETED|Overall Study||0
8565651|NCT00068770|9597693|FG001|NOT COMPLETED|Overall Study||0
8565652|NCT00068822|9597703|FG000|STARTED|First Randomized Intervention||68
8565653|NCT00068822|9597704|FG001|STARTED|First Randomized Intervention||63
8565654|NCT00068822|9597703|FG000|COMPLETED|First Randomized Intervention||67
8565655|NCT00068822|9597704|FG001|COMPLETED|First Randomized Intervention||61
8565656|NCT00068822|9597703|FG000|NOT COMPLETED|First Randomized Intervention||1
8565657|NCT00068822|9597704|FG001|NOT COMPLETED|First Randomized Intervention||2
8565658|NCT00068822|9597703|FG000|STARTED|Optional Crossover Intervention||9
8538260|NCT03420768|9570856|FG000|STARTED|Overall Study||18
8538261|NCT03420768|9570857|FG001|STARTED|Overall Study||28
8538262|NCT03420768|9570858|FG002|STARTED|Overall Study||15
8538263|NCT03420768|9570856|FG000|COMPLETED|Overall Study||18
8538264|NCT03420768|9570857|FG001|COMPLETED|Overall Study||28
8538265|NCT03420768|9570858|FG002|COMPLETED|Overall Study||15
8538266|NCT03420768|9570856|FG000|NOT COMPLETED|Overall Study||0
8538267|NCT03420768|9570857|FG001|NOT COMPLETED|Overall Study||0
8538268|NCT03420768|9570858|FG002|NOT COMPLETED|Overall Study||0
8538269|NCT03395288|9570869|FG000|STARTED|Overall Study||28
8538270|NCT03395288|9570870|FG001|STARTED|Overall Study||29
8538271|NCT03395288|9570871|FG002|STARTED|Overall Study||4
8538272|NCT03395288|9570869|FG000|COMPLETED|Overall Study||19
8538273|NCT03395288|9570870|FG001|COMPLETED|Overall Study||25
8538274|NCT03395288|9570871|FG002|COMPLETED|Overall Study||3
8538275|NCT03395288|9570869|FG000|NOT COMPLETED|Overall Study||9
8538276|NCT03395288|9570870|FG001|NOT COMPLETED|Overall Study||4
8538277|NCT03395288|9570871|FG002|NOT COMPLETED|Overall Study||1
8538278|NCT03180307|9570881|FG000|STARTED|Overall Study||134
8538279|NCT03180307|9570882|FG001|STARTED|Overall Study||6
8538280|NCT03180307|9570881|FG000|Safety Analysis Set|Overall Study||134
8538281|NCT03180307|9570882|FG001|Safety Analysis Set|Overall Study||16
8538282|NCT03180307|9570881|FG000|Full Analysis Set/ Intent to Image Set|Overall Study||134
8538283|NCT03180307|9570882|FG001|Full Analysis Set/ Intent to Image Set|Overall Study||0
8538284|NCT03180307|9570881|FG000|Per Protocol Analysis Set|Overall Study||106
8538285|NCT03180307|9570882|FG001|Per Protocol Analysis Set|Overall Study||0
8538286|NCT03180307|9570881|FG000|Pharmacokinetic Analysis Set|Overall Study||122
8538287|NCT03180307|9570882|FG001|Pharmacokinetic Analysis Set|Overall Study||6
8538288|NCT03180307|9570881|FG000|COMPLETED|Overall Study||128
8538289|NCT03180307|9570882|FG001|COMPLETED|Overall Study||6
8538290|NCT03180307|9570881|FG000|NOT COMPLETED|Overall Study||6
8538291|NCT03180307|9570882|FG001|NOT COMPLETED|Overall Study||0
8538292|NCT03151083|9570889|FG000|STARTED|Overall Study||27
8538293|NCT03151083|9570890|FG001|STARTED|Overall Study||20
8817309|NCT01550471|9870976|FG004|NOT COMPLETED|Second Treatment Period (3 Weeks)||0
8817310|NCT01550471|9870977|FG005|NOT COMPLETED|Second Treatment Period (3 Weeks)||0
8817311|NCT01550471|9870972|FG000|STARTED|Second Wash Out Period (3 Weeks)||3
8817312|NCT01550471|9870973|FG001|STARTED|Second Wash Out Period (3 Weeks)||4
8817313|NCT01550471|9870974|FG002|STARTED|Second Wash Out Period (3 Weeks)||3
8817314|NCT01550471|9870975|FG003|STARTED|Second Wash Out Period (3 Weeks)||4
8817315|NCT01550471|9870976|FG004|STARTED|Second Wash Out Period (3 Weeks)||4
8817316|NCT01550471|9870977|FG005|STARTED|Second Wash Out Period (3 Weeks)||4
8817317|NCT01550471|9870972|FG000|COMPLETED|Second Wash Out Period (3 Weeks)||3
8817318|NCT01550471|9870973|FG001|COMPLETED|Second Wash Out Period (3 Weeks)||4
8817319|NCT01550471|9870974|FG002|COMPLETED|Second Wash Out Period (3 Weeks)||3
8817320|NCT01550471|9870975|FG003|COMPLETED|Second Wash Out Period (3 Weeks)||4
8817321|NCT01550471|9870976|FG004|COMPLETED|Second Wash Out Period (3 Weeks)||4
8817322|NCT01550471|9870977|FG005|COMPLETED|Second Wash Out Period (3 Weeks)||3
8817323|NCT01550471|9870972|FG000|NOT COMPLETED|Second Wash Out Period (3 Weeks)||0
8817324|NCT01550471|9870973|FG001|NOT COMPLETED|Second Wash Out Period (3 Weeks)||0
8817325|NCT01550471|9870974|FG002|NOT COMPLETED|Second Wash Out Period (3 Weeks)||0
8817326|NCT01550471|9870975|FG003|NOT COMPLETED|Second Wash Out Period (3 Weeks)||0
8817327|NCT01550471|9870976|FG004|NOT COMPLETED|Second Wash Out Period (3 Weeks)||0
8817328|NCT01550471|9870977|FG005|NOT COMPLETED|Second Wash Out Period (3 Weeks)||1
8817329|NCT01550471|9870972|FG000|STARTED|Third Treatment Period (3 Weeks)||3
8817330|NCT01550471|9870973|FG001|STARTED|Third Treatment Period (3 Weeks)||4
8817331|NCT01550471|9870974|FG002|STARTED|Third Treatment Period (3 Weeks)||3
8817332|NCT01550471|9870975|FG003|STARTED|Third Treatment Period (3 Weeks)||4
8817333|NCT01550471|9870976|FG004|STARTED|Third Treatment Period (3 Weeks)||4
8817334|NCT01550471|9870977|FG005|STARTED|Third Treatment Period (3 Weeks)||3
8817335|NCT01550471|9870972|FG000|COMPLETED|Third Treatment Period (3 Weeks)||3
8817336|NCT01550471|9870973|FG001|COMPLETED|Third Treatment Period (3 Weeks)||4
8817337|NCT01550471|9870974|FG002|COMPLETED|Third Treatment Period (3 Weeks)||3
8817338|NCT01550471|9870975|FG003|COMPLETED|Third Treatment Period (3 Weeks)||4
8817339|NCT01550471|9870976|FG004|COMPLETED|Third Treatment Period (3 Weeks)||4
8817340|NCT01550471|9870977|FG005|COMPLETED|Third Treatment Period (3 Weeks)||3
8817341|NCT01550471|9870972|FG000|NOT COMPLETED|Third Treatment Period (3 Weeks)||0
8817342|NCT01550471|9870973|FG001|NOT COMPLETED|Third Treatment Period (3 Weeks)||0
8817343|NCT01550471|9870974|FG002|NOT COMPLETED|Third Treatment Period (3 Weeks)||0
8817344|NCT01550471|9870975|FG003|NOT COMPLETED|Third Treatment Period (3 Weeks)||0
8817345|NCT01550471|9870976|FG004|NOT COMPLETED|Third Treatment Period (3 Weeks)||0
8538294|NCT03151083|9570891|FG002|STARTED|Overall Study||30
8538295|NCT03151083|9570889|FG000|COMPLETED|Overall Study||25
8538296|NCT03151083|9570890|FG001|COMPLETED|Overall Study||19
8538297|NCT03151083|9570891|FG002|COMPLETED|Overall Study||26
8538298|NCT03151083|9570889|FG000|NOT COMPLETED|Overall Study||2
8538299|NCT03151083|9570890|FG001|NOT COMPLETED|Overall Study||1
8538300|NCT03151083|9570891|FG002|NOT COMPLETED|Overall Study||4
8538301|NCT02668822|9570901|FG000|STARTED|Overall Study||9
8538302|NCT02668822|9570902|FG001|STARTED|Overall Study||9
8538303|NCT02668822|9570901|FG000|COMPLETED|Overall Study||0
8538304|NCT02668822|9570902|FG001|COMPLETED|Overall Study||0
8538305|NCT02668822|9570901|FG000|NOT COMPLETED|Overall Study||9
8538306|NCT02668822|9570902|FG001|NOT COMPLETED|Overall Study||9
8538307|NCT02668783|9570910|FG000|STARTED|Overall Study||13
8538308|NCT02668783|9570911|FG001|STARTED|Overall Study||12
8538309|NCT02668783|9570910|FG000|Treated|Overall Study||13
8538310|NCT02668783|9570911|FG001|Treated|Overall Study||11
8538311|NCT02668783|9570910|FG000|COMPLETED|Overall Study||0
8538312|NCT02668783|9570911|FG001|COMPLETED|Overall Study||0
8538313|NCT02668783|9570910|FG000|NOT COMPLETED|Overall Study||13
8538314|NCT02668783|9570911|FG001|NOT COMPLETED|Overall Study||12
8538315|NCT02616146|9570919|FG000|STARTED|Overall Study||1512
8538316|NCT02616146|9570920|FG001|STARTED|Overall Study||504
8538317|NCT02616146|9570919|FG000|COMPLETED|Overall Study|Due to termination of study, ENG-E2 reporting group received only up to 10 cycles of treatment.|0
8538318|NCT02616146|9570920|FG001|COMPLETED|Overall Study|Due to termination of study, LNG-EE reporting group received only up to 9 cycles of treatment.|0
8538319|NCT02616146|9570919|FG000|NOT COMPLETED|Overall Study||1512
8538320|NCT02616146|9570920|FG001|NOT COMPLETED|Overall Study||504
8538321|NCT02538510|9570928|FG000|STARTED|Overall Study||25
8538322|NCT02538510|9570929|FG001|STARTED|Overall Study||25
8538323|NCT02538510|9570928|FG000|COMPLETED|Overall Study||25
8538324|NCT02538510|9570929|FG001|COMPLETED|Overall Study||25
8538325|NCT02538510|9570928|FG000|NOT COMPLETED|Overall Study||0
8538326|NCT02538510|9570929|FG001|NOT COMPLETED|Overall Study||0
8538327|NCT02524288|9570939|FG000|STARTED|Overall Study||1941
8538328|NCT02524288|9570939|FG000|Treated|Overall Study||1936
8538329|NCT02524288|9570939|FG000|COMPLETED|Overall Study||0
8538330|NCT02524288|9570939|FG000|NOT COMPLETED|Overall Study||1941
8538331|NCT02489942|9570943|FG000|STARTED|Overall Study||8145
8538332|NCT02489942|9570943|FG000|Case Report Form (CRF) Collected|Overall Study||8059
8538333|NCT02489942|9570943|FG000|Treated|Overall Study||8057
8538334|NCT02489942|9570943|FG000|COMPLETED|Overall Study||4729
8538335|NCT02489942|9570943|FG000|NOT COMPLETED|Overall Study||3416
8538336|NCT02409342|9570949|FG000|STARTED|Overall Study||287
8538337|NCT02409342|9570950|FG001|STARTED|Overall Study||285
8538338|NCT02409342|9570949|FG000|COMPLETED|Overall Study||0
8538339|NCT02409342|9570950|FG001|COMPLETED|Overall Study||0
8538340|NCT02409342|9570949|FG000|NOT COMPLETED|Overall Study||287
8538341|NCT02409342|9570950|FG001|NOT COMPLETED|Overall Study||285
8538342|NCT02293655|9570960|FG000|STARTED|Overall Study||92
8538343|NCT02293655|9570961|FG001|STARTED|Overall Study||17
8538344|NCT02293655|9570960|FG000|COMPLETED|Overall Study||85
8538345|NCT02293655|9570961|FG001|COMPLETED|Overall Study||15
8538346|NCT02293655|9570960|FG000|NOT COMPLETED|Overall Study||7
8538347|NCT02293655|9570961|FG001|NOT COMPLETED|Overall Study||2
8538348|NCT02275546|9570967|FG000|STARTED|Treatment Period 1||81
8538349|NCT02275546|9570968|FG001|STARTED|Treatment Period 1||83
8538350|NCT02275546|9570967|FG000|COMPLETED|Treatment Period 1||81
8538351|NCT02275546|9570968|FG001|COMPLETED|Treatment Period 1||83
8538352|NCT02275546|9570967|FG000|NOT COMPLETED|Treatment Period 1||0
8538353|NCT02275546|9570968|FG001|NOT COMPLETED|Treatment Period 1||0
8538354|NCT02275546|9570967|FG000|STARTED|Treatment Period 2||81
8538355|NCT02275546|9570968|FG001|STARTED|Treatment Period 2||83
8538356|NCT02275546|9570967|FG000|COMPLETED|Treatment Period 2||79
8538357|NCT02275546|9570968|FG001|COMPLETED|Treatment Period 2||81
8538358|NCT02275546|9570967|FG000|NOT COMPLETED|Treatment Period 2||2
8538359|NCT02275546|9570968|FG001|NOT COMPLETED|Treatment Period 2||2
8538360|NCT02077166|9570981|FG000|STARTED|Overall Study||12
8538361|NCT02077166|9570982|FG001|STARTED|Overall Study||7
8538362|NCT02077166|9570983|FG002|STARTED|Overall Study||9
8817346|NCT01550471|9870977|FG005|NOT COMPLETED|Third Treatment Period (3 Weeks)||0
8817347|NCT01550471|9870972|FG000|STARTED|Third Wash Out Period (3 Weeks)||3
8817348|NCT01550471|9870973|FG001|STARTED|Third Wash Out Period (3 Weeks)||4
8817349|NCT01550471|9870974|FG002|STARTED|Third Wash Out Period (3 Weeks)||3
8817350|NCT01550471|9870975|FG003|STARTED|Third Wash Out Period (3 Weeks)||4
8817351|NCT01550471|9870976|FG004|STARTED|Third Wash Out Period (3 Weeks)||4
8817352|NCT01550471|9870977|FG005|STARTED|Third Wash Out Period (3 Weeks)||3
8817353|NCT01550471|9870972|FG000|COMPLETED|Third Wash Out Period (3 Weeks)||3
8817354|NCT01550471|9870973|FG001|COMPLETED|Third Wash Out Period (3 Weeks)||4
8817355|NCT01550471|9870974|FG002|COMPLETED|Third Wash Out Period (3 Weeks)||3
8817356|NCT01550471|9870975|FG003|COMPLETED|Third Wash Out Period (3 Weeks)||4
8817357|NCT01550471|9870976|FG004|COMPLETED|Third Wash Out Period (3 Weeks)||4
8817358|NCT01550471|9870977|FG005|COMPLETED|Third Wash Out Period (3 Weeks)||3
8817359|NCT01550471|9870972|FG000|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0
8817360|NCT01550471|9870973|FG001|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0
8817361|NCT01550471|9870974|FG002|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0
8817362|NCT01550471|9870975|FG003|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0
8817363|NCT01550471|9870976|FG004|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0
8538363|NCT02077166|9570984|FG003|STARTED|Overall Study||9
8538364|NCT02077166|9570985|FG004|STARTED|Overall Study||8
8538365|NCT02077166|9570986|FG005|STARTED|Overall Study||55
8538366|NCT02077166|9570987|FG006|STARTED|Overall Study||34
8538367|NCT02077166|9570981|FG000|COMPLETED|Overall Study||0
8538368|NCT02077166|9570982|FG001|COMPLETED|Overall Study||0
8538369|NCT02077166|9570983|FG002|COMPLETED|Overall Study||0
8538370|NCT02077166|9570984|FG003|COMPLETED|Overall Study||0
8538371|NCT02077166|9570985|FG004|COMPLETED|Overall Study||0
8538372|NCT02077166|9570986|FG005|COMPLETED|Overall Study||0
8538373|NCT02077166|9570987|FG006|COMPLETED|Overall Study||0
8817364|NCT01550471|9870977|FG005|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0
8817365|NCT01550549|9870986|FG000|STARTED|Overall Study||151
8538374|NCT02077166|9570981|FG000|NOT COMPLETED|Overall Study||12
8538375|NCT02077166|9570982|FG001|NOT COMPLETED|Overall Study||7
8538376|NCT02077166|9570983|FG002|NOT COMPLETED|Overall Study||9
8538377|NCT02077166|9570984|FG003|NOT COMPLETED|Overall Study||9
8538378|NCT02077166|9570985|FG004|NOT COMPLETED|Overall Study||8
8538379|NCT02077166|9570986|FG005|NOT COMPLETED|Overall Study||55
8538380|NCT02077166|9570987|FG006|NOT COMPLETED|Overall Study||34
8538381|NCT01891344|9571012|FG000|STARTED|Overall Study||40
8538382|NCT01891344|9571013|FG001|STARTED|Overall Study||82
8538383|NCT01891344|9571014|FG002|STARTED|Overall Study||70
8538384|NCT01891344|9571015|FG003|STARTED|Overall Study||12
8817366|NCT01550549|9870986|FG000|COMPLETED|Overall Study||151
8817367|NCT01550549|9870986|FG000|NOT COMPLETED|Overall Study||0
8817368|NCT01550705|9870996|FG000|STARTED|Overall Study||11
8817369|NCT01550705|9870996|FG000|COMPLETED|Overall Study||10
8817370|NCT01550705|9870996|FG000|NOT COMPLETED|Overall Study||1
8817371|NCT01550731|9871002|FG000|STARTED|Overall Study||205
8817372|NCT01550731|9871003|FG001|STARTED|Overall Study||209
8817373|NCT01550731|9871002|FG000|COMPLETED|Overall Study||205
8817374|NCT01550731|9871003|FG001|COMPLETED|Overall Study||209
8817375|NCT01550731|9871002|FG000|NOT COMPLETED|Overall Study||0
8817376|NCT01550731|9871003|FG001|NOT COMPLETED|Overall Study||0
8817377|NCT01550744|9871009|FG000|STARTED|Open-Label||478
8817378|NCT01550744|9871010|FG001|STARTED|Open-Label||0
8817379|NCT01550744|9871011|FG002|STARTED|Open-Label||0
8817380|NCT01550744|9871009|FG000|COMPLETED|Open-Label||378
8817381|NCT01550744|9871010|FG001|COMPLETED|Open-Label||0
8817382|NCT01550744|9871011|FG002|COMPLETED|Open-Label||0
8817383|NCT01550744|9871009|FG000|NOT COMPLETED|Open-Label||100
8817384|NCT01550744|9871010|FG001|NOT COMPLETED|Open-Label||0
8817385|NCT01550744|9871011|FG002|NOT COMPLETED|Open-Label||0
8817386|NCT01550744|9871009|FG000|STARTED|Double-Blind||0
8817387|NCT01550744|9871010|FG001|STARTED|Double-Blind||76
8817388|NCT01550744|9871011|FG002|STARTED|Double-Blind||302
8817389|NCT01550744|9871009|FG000|COMPLETED|Double-Blind||0
8817390|NCT01550744|9871010|FG001|COMPLETED|Double-Blind||59
8817391|NCT01550744|9871011|FG002|COMPLETED|Double-Blind||235
8817392|NCT01550744|9871009|FG000|NOT COMPLETED|Double-Blind||0
8817393|NCT01550744|9871010|FG001|NOT COMPLETED|Double-Blind||17
8817394|NCT01550744|9871011|FG002|NOT COMPLETED|Double-Blind||67
8817395|NCT01550757|9871022|FG000|STARTED|Overall Study||56
8817396|NCT01550757|9871023|FG001|STARTED|Overall Study||52
8817397|NCT01550757|9871024|FG002|STARTED|Overall Study||130
8817398|NCT01550757|9871025|FG003|STARTED|Overall Study||144
8817399|NCT01550757|9871022|FG000|COMPLETED|Overall Study||33
8817400|NCT01550757|9871023|FG001|COMPLETED|Overall Study||38
8817401|NCT01550757|9871024|FG002|COMPLETED|Overall Study||85
8817402|NCT01550757|9871025|FG003|COMPLETED|Overall Study||90
8817403|NCT01550757|9871022|FG000|NOT COMPLETED|Overall Study||23
8817404|NCT01550757|9871023|FG001|NOT COMPLETED|Overall Study||14
8817405|NCT01550757|9871024|FG002|NOT COMPLETED|Overall Study||45
8817406|NCT01550757|9871025|FG003|NOT COMPLETED|Overall Study||54
8817407|NCT01550809|9871037|FG000|STARTED|Overall Study|Six patients started with the tBolus, the others with the iBolus, according to a crossover design.|6
8817408|NCT01550809|9871038|FG001|STARTED|Overall Study|Six patients started with the iBolus, the others with the tBolus, according to a crossover design.|6
8817409|NCT01550809|9871037|FG000|COMPLETED|Overall Study||6
8817410|NCT01550809|9871038|FG001|COMPLETED|Overall Study||6
8817411|NCT01550809|9871037|FG000|NOT COMPLETED|Overall Study||0
8817412|NCT01550809|9871038|FG001|NOT COMPLETED|Overall Study||0
8817413|NCT01550952|9871044|FG000|STARTED|Overall Study||10
8817414|NCT01550952|9871044|FG000|COMPLETED|Overall Study||10
8817415|NCT01550952|9871044|FG000|NOT COMPLETED|Overall Study||0
8817416|NCT01550965|9871048|FG000|STARTED|Overall Study||463
8817417|NCT01550965|9871048|FG000|COMPLETED|Overall Study||353
8817418|NCT01550965|9871048|FG000|NOT COMPLETED|Overall Study||110
8817419|NCT01551030|9871053|FG000|STARTED|Overall Study||19
8817420|NCT01551030|9871053|FG000|COMPLETED|Overall Study||19
8817421|NCT01551030|9871053|FG000|NOT COMPLETED|Overall Study||0
8817422|NCT01551056|9871059|FG000|STARTED|Overall Study||46
8817423|NCT01551056|9871060|FG001|STARTED|Overall Study||45
8817424|NCT01551056|9871059|FG000|COMPLETED|Overall Study||44
8538385|NCT01891344|9571016|FG004|STARTED|Overall Study||84
8817425|NCT01551056|9871060|FG001|COMPLETED|Overall Study||45
8817426|NCT01551056|9871059|FG000|NOT COMPLETED|Overall Study||2
8817427|NCT01551056|9871060|FG001|NOT COMPLETED|Overall Study||0
8817428|NCT01551095|9871066|FG000|STARTED|Overall Study||7
8817429|NCT01551095|9871066|FG000|COMPLETED|Overall Study||7
8817430|NCT01551095|9871066|FG000|NOT COMPLETED|Overall Study||0
8817431|NCT01551173|9871072|FG000|STARTED|Overall Study|"Started indicates randomized"|218
8538386|NCT01891344|9571017|FG005|STARTED|Overall Study||73
8538387|NCT01891344|9571018|FG006|STARTED|Overall Study||107
8538388|NCT01891344|9571019|FG007|STARTED|Overall Study||23
8538389|NCT01891344|9571012|FG000|COMPLETED|Overall Study||34
8817432|NCT01551173|9871073|FG001|STARTED|Overall Study||218
8817433|NCT01551173|9871072|FG000|Full Analysis Set (FAS)|Overall Study|Patients took at least 1 dose of study drug & had at least 1 post-randomization efficacy parameter|210
8817434|NCT01551173|9871073|FG001|Full Analysis Set (FAS)|Overall Study||214
8817435|NCT01551173|9871072|FG000|COMPLETED|Overall Study||190
8817436|NCT01551173|9871073|FG001|COMPLETED|Overall Study||186
8817437|NCT01551173|9871072|FG000|NOT COMPLETED|Overall Study||28
8817438|NCT01551173|9871073|FG001|NOT COMPLETED|Overall Study||32
8817439|NCT01551186|9871082|FG000|STARTED|Overall Study||50
8538390|NCT01891344|9571013|FG001|COMPLETED|Overall Study||80
8538391|NCT01891344|9571014|FG002|COMPLETED|Overall Study||70
8817440|NCT01551186|9871083|FG001|STARTED|Overall Study||53
8817441|NCT01551186|9871082|FG000|COMPLETED|Overall Study||30
8817442|NCT01551186|9871083|FG001|COMPLETED|Overall Study||40
8817443|NCT01551186|9871082|FG000|NOT COMPLETED|Overall Study||20
8817444|NCT01551186|9871083|FG001|NOT COMPLETED|Overall Study||13
8817445|NCT01551199|9871089|FG000|STARTED|Overall Study||7
8817446|NCT01551199|9871089|FG000|COMPLETED|Overall Study||2
8817447|NCT01551199|9871089|FG000|NOT COMPLETED|Overall Study||5
8817448|NCT01551212|9871095|FG000|STARTED|Overall Study||171
8817449|NCT01551212|9871096|FG001|STARTED|Overall Study||168
8817450|NCT01551212|9871095|FG000|Full Anylsis Set (FAS)|Overall Study||169
8817451|NCT01551212|9871096|FG001|Full Anylsis Set (FAS)|Overall Study||164
8817452|NCT01551212|9871095|FG000|Safety Set|Overall Study||169
8817453|NCT01551212|9871096|FG001|Safety Set|Overall Study||164
8817454|NCT01551212|9871095|FG000|Per Protocol Set (PP)|Overall Study||110
8817455|NCT01551212|9871096|FG001|Per Protocol Set (PP)|Overall Study||101
8817456|NCT01551212|9871095|FG000|COMPLETED|Overall Study||166
8817457|NCT01551212|9871096|FG001|COMPLETED|Overall Study||148
8817458|NCT01551212|9871095|FG000|NOT COMPLETED|Overall Study||5
8817459|NCT01551212|9871096|FG001|NOT COMPLETED|Overall Study||20
8817460|NCT01551264|9871104|FG000|STARTED|Overall Study||70
8817461|NCT01551264|9871105|FG001|STARTED|Overall Study||69
8817462|NCT01551264|9871104|FG000|Started Bracing|Overall Study||69
8817463|NCT01551264|9871105|FG001|Started Bracing|Overall Study||67
8817464|NCT01551264|9871104|FG000|Data for at Least One Follow-up After Brace Discontinuation Ascertained|Overall Study|Attended at least one visit within one year after discontinuing bracing|44
8817465|NCT01551264|9871105|FG001|Data for at Least One Follow-up After Brace Discontinuation Ascertained|Overall Study|Attended at least one visit within one year after discontinuing bracing|55
8817466|NCT01551264|9871104|FG000|COMPLETED|Overall Study|Attended 60 month follow-up visit|38
8817467|NCT01551264|9871105|FG001|COMPLETED|Overall Study|Attended 36 month follow-up visit|41
8817468|NCT01551264|9871104|FG000|NOT COMPLETED|Overall Study||32
8817469|NCT01551264|9871105|FG001|NOT COMPLETED|Overall Study||28
8817470|NCT01551303|9871113|FG000|STARTED|Overall Study||25
8817471|NCT01551303|9871114|FG001|STARTED|Overall Study||22
8817472|NCT01551303|9871113|FG000|COMPLETED|Overall Study||21
8817473|NCT01551303|9871114|FG001|COMPLETED|Overall Study||15
8817474|NCT01551303|9871113|FG000|NOT COMPLETED|Overall Study||4
8817475|NCT01551303|9871114|FG001|NOT COMPLETED|Overall Study||7
8817476|NCT01551355|9871126|FG000|STARTED|Overall Study||622
8817477|NCT01551355|9871127|FG001|STARTED|Overall Study||594
8817478|NCT01551355|9871128|FG002|STARTED|Overall Study||493
8817479|NCT01551355|9871129|FG003|STARTED|Overall Study||435
8817480|NCT01551355|9871130|FG004|STARTED|Overall Study||64
8817481|NCT01551355|9871131|FG005|STARTED|Overall Study||71
8817482|NCT01551355|9871126|FG000|COMPLETED|Overall Study||571
8817483|NCT01551355|9871127|FG001|COMPLETED|Overall Study||545
8817484|NCT01551355|9871128|FG002|COMPLETED|Overall Study||459
8817485|NCT01551355|9871129|FG003|COMPLETED|Overall Study||411
8817486|NCT01551355|9871130|FG004|COMPLETED|Overall Study||55
8817487|NCT01551355|9871131|FG005|COMPLETED|Overall Study||65
8817488|NCT01551355|9871126|FG000|NOT COMPLETED|Overall Study||51
8817489|NCT01551355|9871127|FG001|NOT COMPLETED|Overall Study||49
8817490|NCT01551355|9871128|FG002|NOT COMPLETED|Overall Study||34
8817491|NCT01551355|9871129|FG003|NOT COMPLETED|Overall Study||24
8817492|NCT01551355|9871130|FG004|NOT COMPLETED|Overall Study||9
8817493|NCT01551355|9871131|FG005|NOT COMPLETED|Overall Study||6
8817494|NCT01551420|9871141|FG000|STARTED|In-laboratory (Part A)||39
8817495|NCT01551420|9871142|FG001|STARTED|In-laboratory (Part A)||13
8817496|NCT01551420|9871141|FG000|COMPLETED|In-laboratory (Part A)||33
8817497|NCT01551420|9871142|FG001|COMPLETED|In-laboratory (Part A)||11
8817498|NCT01551420|9871141|FG000|NOT COMPLETED|In-laboratory (Part A)||6
8817499|NCT01551420|9871142|FG001|NOT COMPLETED|In-laboratory (Part A)||2
8817500|NCT01551420|9871141|FG000|STARTED|Screened for Part B Eligibility||33
8817501|NCT01551420|9871142|FG001|STARTED|Screened for Part B Eligibility||11
8817502|NCT01551420|9871141|FG000|COMPLETED|Screened for Part B Eligibility||24
8817503|NCT01551420|9871142|FG001|COMPLETED|Screened for Part B Eligibility||8
8817504|NCT01551420|9871141|FG000|NOT COMPLETED|Screened for Part B Eligibility||9
8817505|NCT01551420|9871142|FG001|NOT COMPLETED|Screened for Part B Eligibility||3
8817506|NCT01551420|9871141|FG000|STARTED|Home Use (Part B)||24
8817507|NCT01551420|9871142|FG001|STARTED|Home Use (Part B)||8
8817508|NCT01551420|9871141|FG000|COMPLETED|Home Use (Part B)||18
8817509|NCT01551420|9871142|FG001|COMPLETED|Home Use (Part B)||7
8817510|NCT01551420|9871141|FG000|NOT COMPLETED|Home Use (Part B)||6
8817511|NCT01551420|9871142|FG001|NOT COMPLETED|Home Use (Part B)||1
8817512|NCT01551693|9871150|FG000|STARTED|Overall Study||1
8817513|NCT01551693|9871151|FG001|STARTED|Overall Study||2
8817514|NCT01551693|9871150|FG000|COMPLETED|Overall Study||0
8817515|NCT01551693|9871151|FG001|COMPLETED|Overall Study||0
8817516|NCT01551693|9871150|FG000|NOT COMPLETED|Overall Study||1
8817517|NCT01551693|9871151|FG001|NOT COMPLETED|Overall Study||2
8817518|NCT01551745|9871157|FG000|STARTED|Overall Study||5
8817519|NCT01551745|9871157|FG000|COMPLETED|Overall Study|"Completed means subject had been given all manufactured doses"|2
8817520|NCT01551745|9871157|FG000|NOT COMPLETED|Overall Study||3
8817521|NCT01551758|9871163|FG000|STARTED|Overall Study||1403
8817522|NCT01551758|9871164|FG001|STARTED|Overall Study||1396
8817523|NCT01551758|9871163|FG000|COMPLETED|Overall Study||1309
8538392|NCT01891344|9571015|FG003|COMPLETED|Overall Study||11
8538393|NCT01891344|9571016|FG004|COMPLETED|Overall Study||80
8538394|NCT01891344|9571017|FG005|COMPLETED|Overall Study||72
8538395|NCT01891344|9571018|FG006|COMPLETED|Overall Study||107
8538396|NCT01891344|9571019|FG007|COMPLETED|Overall Study||23
8538397|NCT01891344|9571012|FG000|NOT COMPLETED|Overall Study||6
8538398|NCT01891344|9571013|FG001|NOT COMPLETED|Overall Study||2
8538399|NCT01891344|9571014|FG002|NOT COMPLETED|Overall Study||0
8538400|NCT01891344|9571015|FG003|NOT COMPLETED|Overall Study||1
8538401|NCT01891344|9571016|FG004|NOT COMPLETED|Overall Study||4
8538402|NCT01891344|9571017|FG005|NOT COMPLETED|Overall Study||1
8538403|NCT01891344|9571018|FG006|NOT COMPLETED|Overall Study||0
8538404|NCT01891344|9571019|FG007|NOT COMPLETED|Overall Study||0
8538405|NCT01847274|9571041|FG000|STARTED|Overall Study||138
8538406|NCT01847274|9571042|FG001|STARTED|Overall Study||65
8538407|NCT01847274|9571043|FG002|STARTED|Overall Study||234
8538408|NCT01847274|9571044|FG003|STARTED|Overall Study||116
8538409|NCT01847274|9571041|FG000|COMPLETED|Overall Study||47
8538410|NCT01847274|9571042|FG001|COMPLETED|Overall Study||4
8538411|NCT01847274|9571043|FG002|COMPLETED|Overall Study||46
8538412|NCT01847274|9571044|FG003|COMPLETED|Overall Study||12
8538413|NCT01847274|9571041|FG000|NOT COMPLETED|Overall Study||91
8538414|NCT01847274|9571042|FG001|NOT COMPLETED|Overall Study||61
8538415|NCT01847274|9571043|FG002|NOT COMPLETED|Overall Study||188
8538416|NCT01847274|9571044|FG003|NOT COMPLETED|Overall Study||104
8538417|NCT01670656|9571059|FG000|STARTED|Overall Study||86
8538418|NCT01670656|9571060|FG001|STARTED|Overall Study||91
8538419|NCT01670656|9571061|FG002|STARTED|Overall Study||87
8538420|NCT01670656|9571062|FG003|STARTED|Overall Study||85
8538421|NCT01670656|9571063|FG004|STARTED|Overall Study||90
8538422|NCT01670656|9571059|FG000|Treated|Overall Study||86
8817524|NCT01551758|9871164|FG001|COMPLETED|Overall Study||1291
8817525|NCT01551758|9871163|FG000|NOT COMPLETED|Overall Study||94
8817526|NCT01551758|9871164|FG001|NOT COMPLETED|Overall Study||105
8817527|NCT01551888|9871174|FG000|STARTED|Period 1||12
8817528|NCT01551888|9871175|FG001|STARTED|Period 1||12
8817529|NCT01551888|9871174|FG000|COMPLETED|Period 1||12
8817530|NCT01551888|9871175|FG001|COMPLETED|Period 1||12
8817531|NCT01551888|9871174|FG000|NOT COMPLETED|Period 1||0
8817532|NCT01551888|9871175|FG001|NOT COMPLETED|Period 1||0
8817533|NCT01551888|9871174|FG000|STARTED|Period 2||12
8817534|NCT01551888|9871175|FG001|STARTED|Period 2||12
8817535|NCT01551888|9871174|FG000|COMPLETED|Period 2||12
8817536|NCT01551888|9871175|FG001|COMPLETED|Period 2||12
8817537|NCT01551888|9871174|FG000|NOT COMPLETED|Period 2||0
8817538|NCT01551888|9871175|FG001|NOT COMPLETED|Period 2||0
8817539|NCT01551979|9871183|FG000|STARTED|Overall Study||10
8817540|NCT01551979|9871184|FG001|STARTED|Overall Study||7
8817541|NCT01551979|9871183|FG000|Last Day of Treatment (After 5 Days)|Overall Study||10
8817542|NCT01551979|9871184|FG001|Last Day of Treatment (After 5 Days)|Overall Study||7
8817543|NCT01551979|9871183|FG000|1 Week Post Treatment|Overall Study||10
8817544|NCT01551979|9871184|FG001|1 Week Post Treatment|Overall Study||6
8817545|NCT01551979|9871183|FG000|COMPLETED|Overall Study||8
8817546|NCT01551979|9871184|FG001|COMPLETED|Overall Study||5
8817547|NCT01551979|9871183|FG000|NOT COMPLETED|Overall Study||2
8817548|NCT01551979|9871184|FG001|NOT COMPLETED|Overall Study||2
8817549|NCT01552057|9871192|FG000|STARTED|Overall Study||196
8817550|NCT01552057|9871193|FG001|STARTED|Overall Study||197
8817551|NCT01552057|9871192|FG000|Received at Least 1 Dose of Study Drug|Overall Study||194
8817552|NCT01552057|9871193|FG001|Received at Least 1 Dose of Study Drug|Overall Study||196
8817553|NCT01552057|9871192|FG000|COMPLETED|Overall Study||166
8817554|NCT01552057|9871193|FG001|COMPLETED|Overall Study||149
8817555|NCT01552057|9871192|FG000|NOT COMPLETED|Overall Study||30
8817556|NCT01552057|9871193|FG001|NOT COMPLETED|Overall Study||48
8817557|NCT01552213|9871201|FG000|STARTED|Overall Study||50
8817558|NCT01552213|9871202|FG001|STARTED|Overall Study||45
8817559|NCT01552213|9871201|FG000|Analyzed|Overall Study||42
8817560|NCT01552213|9871202|FG001|Analyzed|Overall Study||41
8817561|NCT01552213|9871201|FG000|COMPLETED|Overall Study||37
8817562|NCT01552213|9871202|FG001|COMPLETED|Overall Study||37
8817563|NCT01552213|9871201|FG000|NOT COMPLETED|Overall Study||13
8817564|NCT01552213|9871202|FG001|NOT COMPLETED|Overall Study||8
8538423|NCT01670656|9571060|FG001|Treated|Overall Study||91
8538424|NCT01670656|9571061|FG002|Treated|Overall Study||86
8538425|NCT01670656|9571062|FG003|Treated|Overall Study||85
8538426|NCT01670656|9571063|FG004|Treated|Overall Study||90
8538427|NCT01670656|9571059|FG000|COMPLETED|Overall Study||83
8817565|NCT01552343|9871210|FG000|STARTED|Overall Study||29
8817566|NCT01552343|9871211|FG001|STARTED|Overall Study||27
8817567|NCT01552343|9871210|FG000|COMPLETED|Overall Study||29
8538428|NCT01670656|9571060|FG001|COMPLETED|Overall Study||84
8538429|NCT01670656|9571061|FG002|COMPLETED|Overall Study||79
8538430|NCT01670656|9571062|FG003|COMPLETED|Overall Study||79
8538431|NCT01670656|9571063|FG004|COMPLETED|Overall Study||79
8538432|NCT01670656|9571059|FG000|NOT COMPLETED|Overall Study||3
8817568|NCT01552343|9871211|FG001|COMPLETED|Overall Study||27
8817569|NCT01552343|9871210|FG000|NOT COMPLETED|Overall Study||0
8817570|NCT01552343|9871211|FG001|NOT COMPLETED|Overall Study||0
8817571|NCT01552369|9871228|FG000|STARTED|Overall Study||100
8817572|NCT01552369|9871229|FG001|STARTED|Overall Study||105
8817573|NCT01552369|9871228|FG000|One Year|Overall Study||100
8817574|NCT01552369|9871229|FG001|One Year|Overall Study||105
8817575|NCT01552369|9871228|FG000|Final Follow up|Overall Study||92
8817576|NCT01552369|9871229|FG001|Final Follow up|Overall Study||96
8817577|NCT01552369|9871228|FG000|COMPLETED|Overall Study||92
8817578|NCT01552369|9871229|FG001|COMPLETED|Overall Study||96
8817579|NCT01552369|9871228|FG000|NOT COMPLETED|Overall Study||8
8817580|NCT01552369|9871229|FG001|NOT COMPLETED|Overall Study||9
8817581|NCT01552408|9871239|FG000|STARTED|Overall Study||20
8817582|NCT01552408|9871240|FG001|STARTED|Overall Study||20
8817583|NCT01552408|9871239|FG000|COMPLETED|Overall Study||16
8817584|NCT01552408|9871240|FG001|COMPLETED|Overall Study||18
8817585|NCT01552408|9871239|FG000|NOT COMPLETED|Overall Study||4
8817586|NCT01552408|9871240|FG001|NOT COMPLETED|Overall Study||2
8817587|NCT01552603|9871247|FG000|STARTED|Overall Study||14
8817588|NCT01552603|9871247|FG000|COMPLETED|Overall Study||13
8817589|NCT01552603|9871247|FG000|NOT COMPLETED|Overall Study||1
8817590|NCT01552681|9871253|FG000|STARTED|Overall Study||33
8817591|NCT01552681|9871254|FG001|STARTED|Overall Study||19
8817592|NCT01552681|9871253|FG000|COMPLETED|Overall Study||28
8817593|NCT01552681|9871254|FG001|COMPLETED|Overall Study||18
8817594|NCT01552681|9871253|FG000|NOT COMPLETED|Overall Study||5
8817595|NCT01552681|9871254|FG001|NOT COMPLETED|Overall Study||1
8817596|NCT01552694|9871262|FG000|STARTED|Overall Study||18
8817597|NCT01552694|9871263|FG001|STARTED|Overall Study||20
8817598|NCT01552694|9871262|FG000|COMPLETED|Overall Study||18
8817599|NCT01552694|9871263|FG001|COMPLETED|Overall Study||18
8817600|NCT01552694|9871262|FG000|NOT COMPLETED|Overall Study||0
8817601|NCT01552694|9871263|FG001|NOT COMPLETED|Overall Study||2
8817602|NCT01552772|9871269|FG000|STARTED|Overall Study||60
8817603|NCT01552772|9871269|FG000|COMPLETED|Overall Study|Participants who completed the Day 28 visit were defined as completers for the trial.|56
8817604|NCT01552772|9871269|FG000|NOT COMPLETED|Overall Study||4
8817605|NCT01552876|9871274|FG000|STARTED|Overall Study||20
8817606|NCT01552876|9871275|FG001|STARTED|Overall Study||20
8817607|NCT01552876|9871274|FG000|COMPLETED|Overall Study||20
8817608|NCT01552876|9871275|FG001|COMPLETED|Overall Study||20
8817609|NCT01552876|9871274|FG000|NOT COMPLETED|Overall Study||0
8817610|NCT01552876|9871275|FG001|NOT COMPLETED|Overall Study||0
8817611|NCT01552889|9871289|FG000|STARTED|Overall Study||101
8817612|NCT01552889|9871290|FG001|STARTED|Overall Study||100
8817613|NCT01552889|9871289|FG000|COMPLETED|Overall Study||90
8817614|NCT01552889|9871290|FG001|COMPLETED|Overall Study||95
8817615|NCT01552889|9871289|FG000|NOT COMPLETED|Overall Study||11
8817616|NCT01552889|9871290|FG001|NOT COMPLETED|Overall Study||5
8817617|NCT01552902|9871301|FG000|STARTED|Overall Study||110
8817618|NCT01552902|9871302|FG001|STARTED|Overall Study||218
8817619|NCT01552902|9871303|FG002|STARTED|Overall Study||219
8817620|NCT01552902|9871301|FG000|COMPLETED|Overall Study||97
8817621|NCT01552902|9871302|FG001|COMPLETED|Overall Study||181
8817622|NCT01552902|9871303|FG002|COMPLETED|Overall Study||186
8817623|NCT01552902|9871301|FG000|NOT COMPLETED|Overall Study||13
8817624|NCT01552902|9871302|FG001|NOT COMPLETED|Overall Study||37
8817625|NCT01552902|9871303|FG002|NOT COMPLETED|Overall Study||33
8817626|NCT01552915|9871314|FG000|STARTED|Overall Study|This population is from the Safety Set. Two randomized subjects were not dosed and were excluded.|91
8817627|NCT01552915|9871315|FG001|STARTED|Overall Study|This population is from the Safety Set. Two randomized subjects were not dosed and were excluded.|184
8817628|NCT01552915|9871316|FG002|STARTED|Overall Study|This population is from the Safety Set. One randomized subject was not dosed and was excluded.|184
8817629|NCT01552915|9871314|FG000|COMPLETED|Overall Study||68
8817630|NCT01552915|9871315|FG001|COMPLETED|Overall Study||155
8817631|NCT01552915|9871316|FG002|COMPLETED|Overall Study||157
8817632|NCT01552915|9871314|FG000|NOT COMPLETED|Overall Study||23
8817633|NCT01552915|9871315|FG001|NOT COMPLETED|Overall Study||29
8817634|NCT01552915|9871316|FG002|NOT COMPLETED|Overall Study||27
8817635|NCT01552928|9871328|FG000|STARTED|Period 1||14
8817636|NCT01552928|9871329|FG001|STARTED|Period 1||15
8817637|NCT01552928|9871330|FG002|STARTED|Period 1||15
8817638|NCT01552928|9871331|FG003|STARTED|Period 1||16
8817639|NCT01552928|9871328|FG000|COMPLETED|Period 1||14
8817640|NCT01552928|9871329|FG001|COMPLETED|Period 1||15
8817641|NCT01552928|9871330|FG002|COMPLETED|Period 1||15
8817642|NCT01552928|9871331|FG003|COMPLETED|Period 1||16
8817643|NCT01552928|9871328|FG000|NOT COMPLETED|Period 1||0
8817644|NCT01552928|9871329|FG001|NOT COMPLETED|Period 1||0
8817645|NCT01552928|9871330|FG002|NOT COMPLETED|Period 1||0
8817646|NCT01552928|9871331|FG003|NOT COMPLETED|Period 1||0
8817647|NCT01552928|9871328|FG000|STARTED|Period 2||14
8817648|NCT01552928|9871329|FG001|STARTED|Period 2||15
8817649|NCT01552928|9871330|FG002|STARTED|Period 2||15
8817650|NCT01552928|9871331|FG003|STARTED|Period 2||16
8817651|NCT01552928|9871328|FG000|COMPLETED|Period 2||14
8817652|NCT01552928|9871329|FG001|COMPLETED|Period 2||15
8817653|NCT01552928|9871330|FG002|COMPLETED|Period 2||15
8817654|NCT01552928|9871331|FG003|COMPLETED|Period 2||16
8817655|NCT01552928|9871328|FG000|NOT COMPLETED|Period 2||0
8817656|NCT01552928|9871329|FG001|NOT COMPLETED|Period 2||0
8817657|NCT01552928|9871330|FG002|NOT COMPLETED|Period 2||0
8817658|NCT01552928|9871331|FG003|NOT COMPLETED|Period 2||0
8817659|NCT01552928|9871328|FG000|STARTED|Period 3||14
8817660|NCT01552928|9871329|FG001|STARTED|Period 3||15
8817661|NCT01552928|9871330|FG002|STARTED|Period 3||15
8817662|NCT01552928|9871331|FG003|STARTED|Period 3||16
8817663|NCT01552928|9871328|FG000|COMPLETED|Period 3||14
8817664|NCT01552928|9871329|FG001|COMPLETED|Period 3||15
8817665|NCT01552928|9871330|FG002|COMPLETED|Period 3||14
8817666|NCT01552928|9871331|FG003|COMPLETED|Period 3||16
8538433|NCT01670656|9571060|FG001|NOT COMPLETED|Overall Study||7
8538434|NCT01670656|9571061|FG002|NOT COMPLETED|Overall Study||8
8538435|NCT01670656|9571062|FG003|NOT COMPLETED|Overall Study||6
8538436|NCT01670656|9571063|FG004|NOT COMPLETED|Overall Study||11
8538437|NCT01501955|9571077|FG000|STARTED|Overall Study||11
8538438|NCT01501955|9571078|FG001|STARTED|Overall Study||9
8538439|NCT01501955|9571077|FG000|Surgery|Overall Study||11
8538440|NCT01501955|9571078|FG001|Surgery|Overall Study||9
8538441|NCT01501955|9571077|FG000|6 Weeks Postop|Overall Study|1 patient withdrew on own request|10
8538442|NCT01501955|9571078|FG001|6 Weeks Postop|Overall Study||9
8538443|NCT01501955|9571077|FG000|1 Year Postop|Overall Study|1 patient terminated due to stem revision|9
8538444|NCT01501955|9571078|FG001|1 Year Postop|Overall Study|2 patients terminated due to stem revision|7
8538445|NCT01501955|9571077|FG000|2 Years Postop|Overall Study||9
8538446|NCT01501955|9571078|FG001|2 Years Postop|Overall Study|1 patient terminated due to stem revision|6
8538447|NCT01501955|9571077|FG000|COMPLETED|Overall Study||9
8538448|NCT01501955|9571078|FG001|COMPLETED|Overall Study||6
8538449|NCT01501955|9571077|FG000|NOT COMPLETED|Overall Study||2
8538450|NCT01501955|9571078|FG001|NOT COMPLETED|Overall Study||3
8538451|NCT01335399|9571086|FG000|STARTED|Pre-treatment Period||374
8538452|NCT01335399|9571087|FG001|STARTED|Pre-treatment Period||374
8538453|NCT01335399|9571086|FG000|COMPLETED|Pre-treatment Period||371
8538454|NCT01335399|9571087|FG001|COMPLETED|Pre-treatment Period||371
8538455|NCT01335399|9571086|FG000|NOT COMPLETED|Pre-treatment Period||3
8538456|NCT01335399|9571087|FG001|NOT COMPLETED|Pre-treatment Period||3
8538457|NCT01335399|9571086|FG000|STARTED|Treatment Period||371
8538458|NCT01335399|9571087|FG001|STARTED|Treatment Period||371
8538459|NCT01335399|9571086|FG000|COMPLETED|Treatment Period||38
8538460|NCT01335399|9571087|FG001|COMPLETED|Treatment Period||32
8538461|NCT01335399|9571086|FG000|NOT COMPLETED|Treatment Period||333
8538462|NCT01335399|9571087|FG001|NOT COMPLETED|Treatment Period||339
8538463|NCT01277211|9571095|FG000|STARTED|Overall Study||738
8538464|NCT01277211|9571096|FG001|STARTED|Overall Study||245
8538465|NCT01277211|9571095|FG000|Treated|Overall Study||714
8538466|NCT01277211|9571096|FG001|Treated|Overall Study||232
8538467|NCT01277211|9571095|FG000|COMPLETED|Overall Study||588
8817667|NCT01552928|9871328|FG000|NOT COMPLETED|Period 3||0
8817668|NCT01552928|9871329|FG001|NOT COMPLETED|Period 3||0
8817669|NCT01552928|9871330|FG002|NOT COMPLETED|Period 3||1
8817670|NCT01552928|9871331|FG003|NOT COMPLETED|Period 3||0
8817671|NCT01552928|9871328|FG000|STARTED|Period 4||14
8817672|NCT01552928|9871329|FG001|STARTED|Period 4||15
8817673|NCT01552928|9871330|FG002|STARTED|Period 4||14
8817674|NCT01552928|9871331|FG003|STARTED|Period 4||16
8817675|NCT01552928|9871328|FG000|COMPLETED|Period 4||14
8817676|NCT01552928|9871329|FG001|COMPLETED|Period 4||15
8817677|NCT01552928|9871330|FG002|COMPLETED|Period 4||14
8817678|NCT01552928|9871331|FG003|COMPLETED|Period 4||16
8817679|NCT01552928|9871328|FG000|NOT COMPLETED|Period 4||0
8817680|NCT01552928|9871329|FG001|NOT COMPLETED|Period 4||0
8817681|NCT01552928|9871330|FG002|NOT COMPLETED|Period 4||0
8817682|NCT01552928|9871331|FG003|NOT COMPLETED|Period 4||0
8817683|NCT01552954|9871350|FG000|STARTED|Overall Study|A total of 13 patients were withdrawn from 269 patients. The remained 256 patients were randomized.|131
8817684|NCT01552954|9871351|FG001|STARTED|Overall Study||125
8817685|NCT01552954|9871350|FG000|COMPLETED|Overall Study||126
8817686|NCT01552954|9871351|FG001|COMPLETED|Overall Study||119
8817687|NCT01552954|9871350|FG000|NOT COMPLETED|Overall Study||5
8817688|NCT01552954|9871351|FG001|NOT COMPLETED|Overall Study||6
8817689|NCT01553058|9871360|FG000|STARTED|Overall Study||33
8817690|NCT01553058|9871361|FG001|STARTED|Overall Study||31
8817691|NCT01553058|9871362|FG002|STARTED|Overall Study||33
8817692|NCT01553058|9871360|FG000|COMPLETED|Overall Study||32
8817693|NCT01553058|9871361|FG001|COMPLETED|Overall Study||30
8817694|NCT01553058|9871362|FG002|COMPLETED|Overall Study||30
8817695|NCT01553058|9871360|FG000|NOT COMPLETED|Overall Study||1
8817696|NCT01553058|9871361|FG001|NOT COMPLETED|Overall Study||1
8817697|NCT01553058|9871362|FG002|NOT COMPLETED|Overall Study||3
8817698|NCT01553084|9871377|FG000|STARTED|Overall Study||241
8817699|NCT01553084|9871378|FG001|STARTED|Overall Study||421
8817700|NCT01553084|9871379|FG002|STARTED|Overall Study||424
8817701|NCT01553084|9871377|FG000|COMPLETED|Overall Study||226
8538468|NCT01277211|9571096|FG001|COMPLETED|Overall Study||182
8817702|NCT01553084|9871378|FG001|COMPLETED|Overall Study||408
8817703|NCT01553084|9871379|FG002|COMPLETED|Overall Study||389
8817704|NCT01553084|9871377|FG000|NOT COMPLETED|Overall Study||15
8817705|NCT01553084|9871378|FG001|NOT COMPLETED|Overall Study||13
8538469|NCT01277211|9571095|FG000|NOT COMPLETED|Overall Study||150
8538470|NCT01277211|9571096|FG001|NOT COMPLETED|Overall Study||63
8538471|NCT01267812|9571102|FG000|STARTED|Overall Study||23
8538472|NCT01267812|9571102|FG000|COMPLETED|Overall Study||23
8538473|NCT01267812|9571102|FG000|NOT COMPLETED|Overall Study||0
8538474|NCT01244828|9571106|FG000|STARTED|Overall Study|Received study drug|157
8538475|NCT01244828|9571106|FG000|COMPLETED|Overall Study||79
8817706|NCT01553084|9871379|FG002|NOT COMPLETED|Overall Study||35
8817707|NCT01553136|9871391|FG000|STARTED|Overall Study||64
8538476|NCT01244828|9571106|FG000|NOT COMPLETED|Overall Study||78
8538477|NCT01207492|9571110|FG000|STARTED|Overall Study||17
8817708|NCT01553136|9871392|FG001|STARTED|Overall Study||67
8817709|NCT01553136|9871391|FG000|Completed Treatment|Overall Study||55
8817710|NCT01553136|9871392|FG001|Completed Treatment|Overall Study||52
8817711|NCT01553136|9871391|FG000|COMPLETED|Overall Study||48
8538478|NCT01207492|9571110|FG000|COMPLETED|Overall Study||2
8538479|NCT01207492|9571110|FG000|NOT COMPLETED|Overall Study||15
8538480|NCT01181778|9571114|FG000|STARTED|Overall Study||1919
8538481|NCT01181778|9571114|FG000|COMPLETED|Overall Study||1871
8538482|NCT01181778|9571114|FG000|NOT COMPLETED|Overall Study||48
8538483|NCT01047540|9571125|FG000|STARTED|Overall Study||34
8538484|NCT01047540|9571126|FG001|STARTED|Overall Study||32
8538485|NCT01047540|9571127|FG002|STARTED|Overall Study||29
8538486|NCT01047540|9571128|FG003|STARTED|Overall Study||31
8817712|NCT01553136|9871392|FG001|COMPLETED|Overall Study||45
8817713|NCT01553136|9871391|FG000|NOT COMPLETED|Overall Study||16
8817714|NCT01553136|9871392|FG001|NOT COMPLETED|Overall Study||22
8817715|NCT01553188|9871402|FG000|STARTED|Overall Study||3
8817716|NCT01553188|9871403|FG001|STARTED|Overall Study||6
8817717|NCT01553188|9871404|FG002|STARTED|Overall Study||16
8817718|NCT01553188|9871405|FG003|STARTED|Overall Study||11
8817719|NCT01553188|9871402|FG000|COMPLETED|Overall Study||2
8817720|NCT01553188|9871403|FG001|COMPLETED|Overall Study||5
8817721|NCT01553188|9871404|FG002|COMPLETED|Overall Study||14
8817722|NCT01553188|9871405|FG003|COMPLETED|Overall Study||11
8817723|NCT01553188|9871402|FG000|NOT COMPLETED|Overall Study||1
8817724|NCT01553188|9871403|FG001|NOT COMPLETED|Overall Study||1
8817725|NCT01553188|9871404|FG002|NOT COMPLETED|Overall Study||2
8817726|NCT01553188|9871405|FG003|NOT COMPLETED|Overall Study||0
8817727|NCT01553201|9871420|FG000|STARTED|Overall Study||15
8817728|NCT01553201|9871421|FG001|STARTED|Overall Study||15
8817729|NCT01553201|9871420|FG000|COMPLETED|Overall Study||15
8817730|NCT01553201|9871421|FG001|COMPLETED|Overall Study||15
8817731|NCT01553201|9871420|FG000|NOT COMPLETED|Overall Study||0
8817732|NCT01553201|9871421|FG001|NOT COMPLETED|Overall Study||0
8817733|NCT01553279|9871429|FG000|STARTED|Part 1 (Infant Vaccinations)||142
8817734|NCT01553279|9871430|FG001|STARTED|Part 1 (Infant Vaccinations)||142
8817735|NCT01553279|9871429|FG000|COMPLETED|Part 1 (Infant Vaccinations)||140
8817736|NCT01553279|9871430|FG001|COMPLETED|Part 1 (Infant Vaccinations)||141
8817737|NCT01553279|9871429|FG000|NOT COMPLETED|Part 1 (Infant Vaccinations)||2
8817738|NCT01553279|9871430|FG001|NOT COMPLETED|Part 1 (Infant Vaccinations)||1
8817739|NCT01553279|9871429|FG000|STARTED|Interim Period||140
8817740|NCT01553279|9871430|FG001|STARTED|Interim Period||141
8817741|NCT01553279|9871429|FG000|COMPLETED|Interim Period||137
8817742|NCT01553279|9871430|FG001|COMPLETED|Interim Period||139
8817743|NCT01553279|9871429|FG000|NOT COMPLETED|Interim Period||3
8817744|NCT01553279|9871430|FG001|NOT COMPLETED|Interim Period||2
8817745|NCT01553279|9871429|FG000|STARTED|Period 2: Toddler Vaccinations||137
8817746|NCT01553279|9871430|FG001|STARTED|Period 2: Toddler Vaccinations||139
8817747|NCT01553279|9871429|FG000|COMPLETED|Period 2: Toddler Vaccinations||134
8817748|NCT01553279|9871430|FG001|COMPLETED|Period 2: Toddler Vaccinations||132
8817749|NCT01553279|9871429|FG000|NOT COMPLETED|Period 2: Toddler Vaccinations||3
8817750|NCT01553279|9871430|FG001|NOT COMPLETED|Period 2: Toddler Vaccinations||7
8817751|NCT01553292|9871437|FG000|STARTED|Overall Study||21
8817752|NCT01553292|9871437|FG000|COMPLETED|Overall Study||21
8817753|NCT01553292|9871437|FG000|NOT COMPLETED|Overall Study||0
8817754|NCT01553318|9871445|FG000|STARTED|Overall Study||24
8817755|NCT01553318|9871446|FG001|STARTED|Overall Study||27
8817756|NCT01553318|9871445|FG000|COMPLETED|Overall Study||21
8817757|NCT01553318|9871446|FG001|COMPLETED|Overall Study||25
8817758|NCT01553318|9871445|FG000|NOT COMPLETED|Overall Study||3
8817759|NCT01553318|9871446|FG001|NOT COMPLETED|Overall Study||2
8817760|NCT01553539|9871454|FG000|STARTED|Overall Study||20
8817761|NCT01553539|9871454|FG000|COMPLETED|Overall Study||20
8817762|NCT01553539|9871454|FG000|NOT COMPLETED|Overall Study||0
8817763|NCT01553591|9871461|FG000|STARTED|Overall Study||429
8817764|NCT01553591|9871462|FG001|STARTED|Overall Study||426
8817765|NCT01553591|9871463|FG002|STARTED|Overall Study||427
8817766|NCT01553591|9871461|FG000|Attended Week 12 Visit|Overall Study||341
8817767|NCT01553591|9871462|FG001|Attended Week 12 Visit|Overall Study||330
8817768|NCT01553591|9871463|FG002|Attended Week 12 Visit|Overall Study||342
8817769|NCT01553591|9871461|FG000|Attended Week 26 Visit|Overall Study||289
8817770|NCT01553591|9871462|FG001|Attended Week 26 Visit|Overall Study||291
8817771|NCT01553591|9871463|FG002|Attended Week 26 Visit|Overall Study||290
8817772|NCT01553591|9871461|FG000|COMPLETED|Overall Study||257
8817773|NCT01553591|9871462|FG001|COMPLETED|Overall Study||257
8538487|NCT01047540|9571129|FG004|STARTED|Overall Study||30
8817774|NCT01553591|9871463|FG002|COMPLETED|Overall Study||269
8817775|NCT01553591|9871461|FG000|NOT COMPLETED|Overall Study||172
8817776|NCT01553591|9871462|FG001|NOT COMPLETED|Overall Study||169
8817777|NCT01553591|9871463|FG002|NOT COMPLETED|Overall Study||158
8817778|NCT01553708|9871473|FG000|STARTED|Overall Study||17
8817779|NCT01553708|9871474|FG001|STARTED|Overall Study||17
8817780|NCT01553708|9871473|FG000|COMPLETED|Overall Study||17
8817781|NCT01553708|9871474|FG001|COMPLETED|Overall Study||17
8817782|NCT01553708|9871473|FG000|NOT COMPLETED|Overall Study||0
8817783|NCT01553708|9871474|FG001|NOT COMPLETED|Overall Study||0
8538488|NCT01047540|9571125|FG000|COMPLETED|Overall Study||29
8538489|NCT01047540|9571126|FG001|COMPLETED|Overall Study||32
8538490|NCT01047540|9571127|FG002|COMPLETED|Overall Study||26
8817784|NCT01553747|9871483|FG000|STARTED|Overall Study||381
8817785|NCT01553747|9871484|FG001|STARTED|Overall Study||383
8817786|NCT01553747|9871485|FG002|STARTED|Overall Study||382
8817787|NCT01553747|9871483|FG000|Attended Week 12 Visit|Overall Study||296
8817788|NCT01553747|9871484|FG001|Attended Week 12 Visit|Overall Study||301
8538491|NCT01047540|9571128|FG003|COMPLETED|Overall Study||31
8538492|NCT01047540|9571129|FG004|COMPLETED|Overall Study||29
8538493|NCT01047540|9571125|FG000|NOT COMPLETED|Overall Study||5
8538494|NCT01047540|9571126|FG001|NOT COMPLETED|Overall Study||0
8538495|NCT01047540|9571127|FG002|NOT COMPLETED|Overall Study||3
8538496|NCT01047540|9571128|FG003|NOT COMPLETED|Overall Study||0
8817789|NCT01553747|9871485|FG002|Attended Week 12 Visit|Overall Study||312
8817790|NCT01553747|9871483|FG000|Attended Week 26 Visit|Overall Study||259
8817791|NCT01553747|9871484|FG001|Attended Week 26 Visit|Overall Study||271
8817792|NCT01553747|9871485|FG002|Attended Week 26 Visit|Overall Study||278
8817793|NCT01553747|9871483|FG000|Participated in Blinded-Placebo Period|Overall Study||246
8817794|NCT01553747|9871484|FG001|Participated in Blinded-Placebo Period|Overall Study||253
8817795|NCT01553747|9871485|FG002|Participated in Blinded-Placebo Period|Overall Study||272
8817796|NCT01553747|9871483|FG000|COMPLETED|Overall Study||250
8817797|NCT01553747|9871484|FG001|COMPLETED|Overall Study||264
8817798|NCT01553747|9871485|FG002|COMPLETED|Overall Study||273
8817799|NCT01553747|9871483|FG000|NOT COMPLETED|Overall Study||131
8817800|NCT01553747|9871484|FG001|NOT COMPLETED|Overall Study||119
8817801|NCT01553747|9871485|FG002|NOT COMPLETED|Overall Study||109
8817802|NCT01553851|9871496|FG000|STARTED|Overall Study||20
8817803|NCT01553851|9871496|FG000|COMPLETED|Overall Study||17
8817804|NCT01553851|9871496|FG000|NOT COMPLETED|Overall Study||3
8817805|NCT01553916|9871500|FG000|STARTED|Overall Study||19
8817806|NCT01553916|9871500|FG000|COMPLETED|Overall Study||16
8817807|NCT01553916|9871500|FG000|NOT COMPLETED|Overall Study||3
8817808|NCT01554176|9871506|FG000|STARTED|Treatment Phase||65
8817809|NCT01554176|9871507|FG001|STARTED|Treatment Phase||64
8817810|NCT01554176|9871508|FG002|STARTED|Treatment Phase||0
8817811|NCT01554176|9871509|FG003|STARTED|Treatment Phase||0
8817812|NCT01554176|9871510|FG004|STARTED|Treatment Phase||0
8817813|NCT01554176|9871506|FG000|Treated|Treatment Phase||64
8817814|NCT01554176|9871507|FG001|Treated|Treatment Phase||64
8817815|NCT01554176|9871508|FG002|Treated|Treatment Phase||0
8817816|NCT01554176|9871509|FG003|Treated|Treatment Phase||0
8817817|NCT01554176|9871510|FG004|Treated|Treatment Phase||0
8817818|NCT01554176|9871506|FG000|COMPLETED|Treatment Phase||57
8817819|NCT01554176|9871507|FG001|COMPLETED|Treatment Phase||59
8817820|NCT01554176|9871508|FG002|COMPLETED|Treatment Phase||0
8817821|NCT01554176|9871509|FG003|COMPLETED|Treatment Phase||0
8817822|NCT01554176|9871510|FG004|COMPLETED|Treatment Phase||0
8817823|NCT01554176|9871506|FG000|NOT COMPLETED|Treatment Phase||8
8817824|NCT01554176|9871507|FG001|NOT COMPLETED|Treatment Phase||5
8817825|NCT01554176|9871508|FG002|NOT COMPLETED|Treatment Phase||0
8817826|NCT01554176|9871509|FG003|NOT COMPLETED|Treatment Phase||0
8817827|NCT01554176|9871510|FG004|NOT COMPLETED|Treatment Phase||0
8817828|NCT01554176|9871506|FG000|STARTED|Run-out Phase||0
8817829|NCT01554176|9871507|FG001|STARTED|Run-out Phase||0
8817830|NCT01554176|9871508|FG002|STARTED|Run-out Phase||29
8817831|NCT01554176|9871509|FG003|STARTED|Run-out Phase||28
8817832|NCT01554176|9871510|FG004|STARTED|Run-out Phase||59
8817833|NCT01554176|9871506|FG000|Treated|Run-out Phase||0
8817834|NCT01554176|9871507|FG001|Treated|Run-out Phase||0
8817835|NCT01554176|9871508|FG002|Treated|Run-out Phase||29
8817836|NCT01554176|9871509|FG003|Treated|Run-out Phase||28
8817837|NCT01554176|9871510|FG004|Treated|Run-out Phase||59
8817838|NCT01554176|9871506|FG000|COMPLETED|Run-out Phase||0
8817839|NCT01554176|9871507|FG001|COMPLETED|Run-out Phase||0
8817840|NCT01554176|9871508|FG002|COMPLETED|Run-out Phase||29
8817841|NCT01554176|9871509|FG003|COMPLETED|Run-out Phase||27
8817842|NCT01554176|9871510|FG004|COMPLETED|Run-out Phase||59
8817843|NCT01554176|9871506|FG000|NOT COMPLETED|Run-out Phase||0
8817844|NCT01554176|9871507|FG001|NOT COMPLETED|Run-out Phase||0
8817845|NCT01554176|9871508|FG002|NOT COMPLETED|Run-out Phase||0
8817846|NCT01554176|9871509|FG003|NOT COMPLETED|Run-out Phase||1
8817847|NCT01554176|9871510|FG004|NOT COMPLETED|Run-out Phase||0
8817848|NCT01554241|9871526|FG000|STARTED|Overall Study||23
8817849|NCT01554241|9871527|FG001|STARTED|Overall Study||20
8817850|NCT01554241|9871528|FG002|STARTED|Overall Study||24
8817851|NCT01554241|9871529|FG003|STARTED|Overall Study||14
8817852|NCT01554241|9871526|FG000|COMPLETED|Overall Study||20
8817853|NCT01554241|9871527|FG001|COMPLETED|Overall Study||19
8817854|NCT01554241|9871528|FG002|COMPLETED|Overall Study||20
8817855|NCT01554241|9871529|FG003|COMPLETED|Overall Study||13
8817856|NCT01554241|9871526|FG000|NOT COMPLETED|Overall Study||3
8817857|NCT01554241|9871527|FG001|NOT COMPLETED|Overall Study||1
8817858|NCT01554241|9871528|FG002|NOT COMPLETED|Overall Study||4
8817859|NCT01554241|9871529|FG003|NOT COMPLETED|Overall Study||1
8817860|NCT01554371|9871542|FG000|STARTED|Overall Study||3
8817861|NCT01554371|9871543|FG001|STARTED|Overall Study||3
8538497|NCT01047540|9571129|FG004|NOT COMPLETED|Overall Study||1
8538498|NCT01044056|9571144|FG000|STARTED|Overall Study||8
8538499|NCT01044056|9571145|FG001|STARTED|Overall Study||8
8817862|NCT01554371|9871544|FG002|STARTED|Overall Study||38
8817863|NCT01554371|9871542|FG000|COMPLETED|Overall Study||3
8817864|NCT01554371|9871543|FG001|COMPLETED|Overall Study||3
8817865|NCT01554371|9871544|FG002|COMPLETED|Overall Study||38
8817866|NCT01554371|9871542|FG000|NOT COMPLETED|Overall Study||0
8817867|NCT01554371|9871543|FG001|NOT COMPLETED|Overall Study||0
8817868|NCT01554371|9871544|FG002|NOT COMPLETED|Overall Study||0
8817869|NCT01554488|9871557|FG000|STARTED|Overall Study||13
8817870|NCT01554488|9871558|FG001|STARTED|Overall Study||12
8817871|NCT01554488|9871557|FG000|COMPLETED|Overall Study||12
8538500|NCT01044056|9571146|FG002|STARTED|Overall Study||8
8538501|NCT01044056|9571144|FG000|COMPLETED|Overall Study||8
8538502|NCT01044056|9571145|FG001|COMPLETED|Overall Study||8
8538503|NCT01044056|9571146|FG002|COMPLETED|Overall Study||8
8538504|NCT01044056|9571144|FG000|NOT COMPLETED|Overall Study||0
8538505|NCT01044056|9571145|FG001|NOT COMPLETED|Overall Study||0
8538506|NCT01044056|9571146|FG002|NOT COMPLETED|Overall Study||0
8538507|NCT00944216|9571154|FG000|STARTED|Overall Study||1
8538508|NCT00944216|9571154|FG000|COMPLETED|Overall Study||1
8538509|NCT00944216|9571154|FG000|NOT COMPLETED|Overall Study||0
8565659|NCT00068822|9597704|FG001|STARTED|Optional Crossover Intervention||29
8565660|NCT00068822|9597703|FG000|Crossover at Month 1|Optional Crossover Intervention||1
8565661|NCT00068822|9597704|FG001|Crossover at Month 1|Optional Crossover Intervention||2
8565662|NCT00068822|9597703|FG000|Crossover at Month 3|Optional Crossover Intervention||8
8565663|NCT00068822|9597704|FG001|Crossover at Month 3|Optional Crossover Intervention||27
8817872|NCT01554488|9871558|FG001|COMPLETED|Overall Study||9
8817873|NCT01554488|9871557|FG000|NOT COMPLETED|Overall Study||1
8817874|NCT01554488|9871558|FG001|NOT COMPLETED|Overall Study||3
8817875|NCT01554514|9871564|FG000|STARTED|Overall Study||19
8817876|NCT01554514|9871564|FG000|COMPLETED|Overall Study||17
8817877|NCT01554514|9871564|FG000|NOT COMPLETED|Overall Study||2
8817878|NCT01554527|9871571|FG000|STARTED|Overall Study||34
8817879|NCT01554527|9871572|FG001|STARTED|Overall Study||38
8817880|NCT01554527|9871573|FG002|STARTED|Overall Study||33
8817881|NCT01554527|9871571|FG000|Crossed Over to Control|Overall Study||0
8817882|NCT01554527|9871572|FG001|Crossed Over to Control|Overall Study||0
8817883|NCT01554527|9871573|FG002|Crossed Over to Control|Overall Study||2
8817884|NCT01554527|9871571|FG000|Had CPAP Titration|Overall Study|No control group members received CPAP (definitionally)|0
8817885|NCT01554527|9871572|FG001|Had CPAP Titration|Overall Study||38
8817886|NCT01554527|9871573|FG002|Had CPAP Titration|Overall Study||30
8817887|NCT01554527|9871571|FG000|Initiated CPAP Treatment at Home|Overall Study||0
8817888|NCT01554527|9871572|FG001|Initiated CPAP Treatment at Home|Overall Study||38
8817889|NCT01554527|9871573|FG002|Initiated CPAP Treatment at Home|Overall Study||28
8817890|NCT01554527|9871571|FG000|Completed as a Control|Overall Study||33
8817891|NCT01554527|9871572|FG001|Completed as a Control|Overall Study||0
8817892|NCT01554527|9871573|FG002|Completed as a Control|Overall Study||1
8817893|NCT01554527|9871571|FG000|COMPLETED|Overall Study||33
8817894|NCT01554527|9871572|FG001|COMPLETED|Overall Study||38
8817895|NCT01554527|9871573|FG002|COMPLETED|Overall Study||25
8817896|NCT01554527|9871571|FG000|NOT COMPLETED|Overall Study||1
8817897|NCT01554527|9871572|FG001|NOT COMPLETED|Overall Study||0
8817898|NCT01554527|9871573|FG002|NOT COMPLETED|Overall Study||8
8817899|NCT01554579|9871584|FG000|STARTED|Overall Study||86
8817900|NCT01554579|9871585|FG001|STARTED|Overall Study||85
8817901|NCT01554579|9871584|FG000|COMPLETED|Overall Study||76
8817902|NCT01554579|9871585|FG001|COMPLETED|Overall Study||58
8817903|NCT01554579|9871584|FG000|NOT COMPLETED|Overall Study||10
8817904|NCT01554579|9871585|FG001|NOT COMPLETED|Overall Study||27
8817905|NCT01554618|9871594|FG000|STARTED|Randomized Through Start of Treatment||59
8817906|NCT01554618|9871595|FG001|STARTED|Randomized Through Start of Treatment||24
8817907|NCT01554618|9871594|FG000|COMPLETED|Randomized Through Start of Treatment||58
8817908|NCT01554618|9871595|FG001|COMPLETED|Randomized Through Start of Treatment||24
8817909|NCT01554618|9871594|FG000|NOT COMPLETED|Randomized Through Start of Treatment||1
8817910|NCT01554618|9871595|FG001|NOT COMPLETED|Randomized Through Start of Treatment||0
8817911|NCT01554618|9871594|FG000|STARTED|Controlled Assessment Period||58
8817912|NCT01554618|9871595|FG001|STARTED|Controlled Assessment Period||24
8817913|NCT01554618|9871594|FG000|COMPLETED|Controlled Assessment Period||50
8817914|NCT01554618|9871595|FG001|COMPLETED|Controlled Assessment Period||23
8817915|NCT01554618|9871594|FG000|NOT COMPLETED|Controlled Assessment Period||8
8817916|NCT01554618|9871595|FG001|NOT COMPLETED|Controlled Assessment Period||1
8817917|NCT01554618|9871594|FG000|STARTED|Open-Label Extension Period|1 patient who was noncompliant with study medication did not enter the open-label extension period|49
8817918|NCT01554618|9871595|FG001|STARTED|Open-Label Extension Period||23
8817919|NCT01554618|9871594|FG000|COMPLETED|Open-Label Extension Period||46
8817920|NCT01554618|9871595|FG001|COMPLETED|Open-Label Extension Period||18
8817921|NCT01554618|9871594|FG000|NOT COMPLETED|Open-Label Extension Period||3
8817922|NCT01554618|9871595|FG001|NOT COMPLETED|Open-Label Extension Period||5
8817923|NCT01554683|9871605|FG000|STARTED|Overall Study||2
8817924|NCT01554683|9871606|FG001|STARTED|Overall Study||1
8817925|NCT01554683|9871607|FG002|STARTED|Overall Study||3
8817926|NCT01554683|9871608|FG003|STARTED|Overall Study||2
8817927|NCT01554683|9871609|FG004|STARTED|Overall Study||1
8817928|NCT01554683|9871610|FG005|STARTED|Overall Study||0
8817929|NCT01554683|9871605|FG000|COMPLETED|Overall Study||2
8817930|NCT01554683|9871606|FG001|COMPLETED|Overall Study||1
8817931|NCT01554683|9871607|FG002|COMPLETED|Overall Study||3
8817932|NCT01554683|9871608|FG003|COMPLETED|Overall Study||2
8817933|NCT01554683|9871609|FG004|COMPLETED|Overall Study||1
8565664|NCT00068822|9597703|FG000|COMPLETED|Optional Crossover Intervention||9
8565665|NCT00068822|9597704|FG001|COMPLETED|Optional Crossover Intervention||29
8565666|NCT00068822|9597703|FG000|NOT COMPLETED|Optional Crossover Intervention||0
8565667|NCT00068822|9597704|FG001|NOT COMPLETED|Optional Crossover Intervention||0
8817934|NCT01554683|9871610|FG005|COMPLETED|Overall Study||0
8817935|NCT01554683|9871605|FG000|NOT COMPLETED|Overall Study||0
8817936|NCT01554683|9871606|FG001|NOT COMPLETED|Overall Study||0
8538510|NCT00886691|9571161|FG000|STARTED|Overall Study||75
8817937|NCT01554683|9871607|FG002|NOT COMPLETED|Overall Study||0
8817938|NCT01554683|9871608|FG003|NOT COMPLETED|Overall Study||0
8817939|NCT01554683|9871609|FG004|NOT COMPLETED|Overall Study||0
8817940|NCT01554683|9871610|FG005|NOT COMPLETED|Overall Study||0
8817941|NCT01554891|9871621|FG000|STARTED|Overall Study||105
8817942|NCT01554891|9871622|FG001|STARTED|Overall Study||120
8817943|NCT01554891|9871623|FG002|STARTED|Overall Study||57
8817944|NCT01554891|9871621|FG000|COMPLETED|Overall Study||98
8817945|NCT01554891|9871622|FG001|COMPLETED|Overall Study||115
8817946|NCT01554891|9871623|FG002|COMPLETED|Overall Study||55
8817947|NCT01554891|9871621|FG000|NOT COMPLETED|Overall Study||7
8817948|NCT01554891|9871622|FG001|NOT COMPLETED|Overall Study||5
8817949|NCT01554891|9871623|FG002|NOT COMPLETED|Overall Study||2
8817950|NCT01554904|9871631|FG000|STARTED|Overall Study||18
8817951|NCT01554904|9871631|FG000|Home Sleep Study 1|Overall Study|After informed consent signed.|18
8817952|NCT01554904|9871631|FG000|Start 6 Weeks of Facial Training|Overall Study|1 participant was found to have obstructive sleep apnea on the home sleep study #1|17
8817953|NCT01554904|9871631|FG000|Complete 6 Weeks of Facial Training|Overall Study|3 subjects withdrew during training|14
8817954|NCT01554904|9871631|FG000|Home Sleep Study 2|Overall Study||14
8817955|NCT01554904|9871631|FG000|COMPLETED|Overall Study||14
8817956|NCT01554904|9871631|FG000|NOT COMPLETED|Overall Study||4
8817957|NCT01554982|9871635|FG000|STARTED|Overall Study||168
8817958|NCT01554982|9871635|FG000|Received Drug|Overall Study||166
8817959|NCT01554982|9871635|FG000|COMPLETED|Overall Study||125
8817960|NCT01554982|9871635|FG000|NOT COMPLETED|Overall Study||43
8849259|NCT01739348|9904420|FG000|STARTED|Part I (Base Study)||703
8849260|NCT01739348|9904421|FG001|STARTED|Part I (Base Study)||700
8849261|NCT01739348|9904422|FG002|STARTED|Part I (Base Study)||103
8849262|NCT01739348|9904423|FG003|STARTED|Part I (Base Study)||705
8849263|NCT01739348|9904420|FG000|Treated|Part I (Base Study)||702
8849264|NCT01739348|9904421|FG001|Treated|Part I (Base Study)||700
8849265|NCT01739348|9904422|FG002|Treated|Part I (Base Study)||103
8849266|NCT01739348|9904423|FG003|Treated|Part I (Base Study)||705
8849267|NCT01739348|9904420|FG000|COMPLETED|Part I (Base Study)||501
8849268|NCT01739348|9904421|FG001|COMPLETED|Part I (Base Study)||497
8849269|NCT01739348|9904422|FG002|COMPLETED|Part I (Base Study)||77
8849270|NCT01739348|9904423|FG003|COMPLETED|Part I (Base Study)||516
8849271|NCT01739348|9904420|FG000|NOT COMPLETED|Part I (Base Study)||202
8849272|NCT01739348|9904421|FG001|NOT COMPLETED|Part I (Base Study)||203
8849273|NCT01739348|9904422|FG002|NOT COMPLETED|Part I (Base Study)||26
8849274|NCT01739348|9904423|FG003|NOT COMPLETED|Part I (Base Study)||189
8849275|NCT01739348|9904420|FG000|STARTED|Part II (Extension Study)|Number started refers only to participants completing Part I, volunteering to continue to Part II.|379
8849276|NCT01739348|9904421|FG001|STARTED|Part II (Extension Study)|Number started refers only to participants completing Part I, volunteering to continue to Part II.|366
8849277|NCT01739348|9904422|FG002|STARTED|Part II (Extension Study)|Number started refers only to participants completing Part I, volunteering to continue to Part II.|61
8849278|NCT01739348|9904423|FG003|STARTED|Part II (Extension Study)|Number started refers only to participants completing Part I, volunteering to continue to Part II.|396
8849279|NCT01739348|9904420|FG000|Treated|Part II (Extension Study)||379
8849280|NCT01739348|9904421|FG001|Treated|Part II (Extension Study)||365
8849281|NCT01739348|9904422|FG002|Treated|Part II (Extension Study)||61
8849282|NCT01739348|9904423|FG003|Treated|Part II (Extension Study)||394
8849283|NCT01739348|9904420|FG000|COMPLETED|Part II (Extension Study)||0
8849284|NCT01739348|9904421|FG001|COMPLETED|Part II (Extension Study)||0
8849285|NCT01739348|9904422|FG002|COMPLETED|Part II (Extension Study)||0
8849286|NCT01739348|9904423|FG003|COMPLETED|Part II (Extension Study)||0
8849287|NCT01739348|9904420|FG000|NOT COMPLETED|Part II (Extension Study)||379
8849288|NCT01739348|9904421|FG001|NOT COMPLETED|Part II (Extension Study)||366
8849289|NCT01739348|9904422|FG002|NOT COMPLETED|Part II (Extension Study)||61
8849290|NCT01739348|9904423|FG003|NOT COMPLETED|Part II (Extension Study)||396
8849291|NCT01739361|9904439|FG000|STARTED|Overall Study||21
8849292|NCT01739361|9904440|FG001|STARTED|Overall Study||23
8849293|NCT01739361|9904439|FG000|COMPLETED|Overall Study||18
8849294|NCT01739361|9904440|FG001|COMPLETED|Overall Study||22
8849295|NCT01739361|9904439|FG000|NOT COMPLETED|Overall Study||3
8849296|NCT01739361|9904440|FG001|NOT COMPLETED|Overall Study||1
8849297|NCT01739400|9904448|FG000|STARTED|Overall Study||109
8849298|NCT01739400|9904449|FG001|STARTED|Overall Study||108
8849299|NCT01739400|9904448|FG000|Treated With 10 mg Macitentan|Overall Study||109
8849300|NCT01739400|9904449|FG001|Treated With 10 mg Macitentan|Overall Study||108
8849301|NCT01739400|9904448|FG000|COMPLETED|Overall Study||92
8849302|NCT01739400|9904449|FG001|COMPLETED|Overall Study||99
8849303|NCT01739400|9904448|FG000|NOT COMPLETED|Overall Study||17
8849304|NCT01739400|9904449|FG001|NOT COMPLETED|Overall Study||9
8849305|NCT01739595|9904457|FG000|STARTED|Overall Study||112
8849306|NCT01739595|9904458|FG001|STARTED|Overall Study||22
8849307|NCT01739595|9904459|FG002|STARTED|Overall Study||47
8849308|NCT01739595|9904457|FG000|COMPLETED|Overall Study||99
8849309|NCT01739595|9904458|FG001|COMPLETED|Overall Study||21
8849310|NCT01739595|9904459|FG002|COMPLETED|Overall Study||45
8849311|NCT01739595|9904457|FG000|NOT COMPLETED|Overall Study||13
8849312|NCT01739595|9904458|FG001|NOT COMPLETED|Overall Study||1
8849313|NCT01739595|9904459|FG002|NOT COMPLETED|Overall Study||2
8849314|NCT01739699|9904468|FG000|STARTED|Overall Study||70
8849315|NCT01739699|9904469|FG001|STARTED|Overall Study||70
8849316|NCT01739699|9904468|FG000|COMPLETED|Overall Study||66
8538511|NCT00886691|9571162|FG001|STARTED|Overall Study||75
8621020|NCT00477451|9659911|FG002|STARTED|Overall Study||7
8621021|NCT00477451|9659912|FG003|STARTED|Overall Study||2
8538512|NCT00886691|9571161|FG000|COMPLETED|Overall Study||75
8538513|NCT00886691|9571162|FG001|COMPLETED|Overall Study||75
8538514|NCT00886691|9571161|FG000|NOT COMPLETED|Overall Study||0
8538515|NCT00886691|9571162|FG001|NOT COMPLETED|Overall Study||0
8538516|NCT00778999|9571174|FG000|STARTED|Overall Study||223
8538517|NCT00778999|9571175|FG001|STARTED|Overall Study||219
8538518|NCT00778999|9571174|FG000|COMPLETED|Overall Study||195
8538519|NCT00778999|9571175|FG001|COMPLETED|Overall Study||185
8538520|NCT00778999|9571174|FG000|NOT COMPLETED|Overall Study||28
8538521|NCT00778999|9571175|FG001|NOT COMPLETED|Overall Study||34
8538522|NCT00620464|9571183|FG000|STARTED|Overall Study||52
8538523|NCT00620464|9571184|FG001|STARTED|Overall Study||56
8538524|NCT00620464|9571183|FG000|COMPLETED|Overall Study||32
8538525|NCT00620464|9571184|FG001|COMPLETED|Overall Study||32
8538526|NCT00620464|9571183|FG000|NOT COMPLETED|Overall Study||20
8538527|NCT00620464|9571184|FG001|NOT COMPLETED|Overall Study||24
8538528|NCT00620035|9571190|FG000|STARTED|Overall Study||301
8538529|NCT00620035|9571190|FG000|COMPLETED|Overall Study||156
8538530|NCT00620035|9571190|FG000|NOT COMPLETED|Overall Study||145
8538531|NCT00210249|9571194|FG000|STARTED|Overall Study||364
8538532|NCT00210249|9571194|FG000|COMPLETED|Overall Study||348
8538533|NCT00210249|9571194|FG000|NOT COMPLETED|Overall Study||16
8538534|NCT03704142|9571202|FG000|STARTED|Overall Study||10
8538535|NCT03704142|9571203|FG001|STARTED|Overall Study||10
8538536|NCT03704142|9571204|FG002|STARTED|Overall Study||10
8538537|NCT03704142|9571205|FG003|STARTED|Overall Study||10
8538538|NCT03704142|9571202|FG000|COMPLETED|Overall Study||10
8538539|NCT03704142|9571203|FG001|COMPLETED|Overall Study||10
8538540|NCT03704142|9571204|FG002|COMPLETED|Overall Study||10
8538541|NCT03704142|9571205|FG003|COMPLETED|Overall Study||10
8538542|NCT03704142|9571202|FG000|NOT COMPLETED|Overall Study||0
8538543|NCT03704142|9571203|FG001|NOT COMPLETED|Overall Study||0
8538544|NCT03704142|9571204|FG002|NOT COMPLETED|Overall Study||0
8538545|NCT03704142|9571205|FG003|NOT COMPLETED|Overall Study||0
8565668|NCT00069095|9597716|FG000|STARTED|Primary Treatment Phase||317
8565669|NCT00069095|9597717|FG001|STARTED|Primary Treatment Phase||317
8565670|NCT00069095|9597718|FG002|STARTED|Primary Treatment Phase||350
8565671|NCT00069095|9597719|FG003|STARTED|Primary Treatment Phase||351
8565672|NCT00069095|9597720|FG004|STARTED|Primary Treatment Phase||350
8565673|NCT00069095|9597721|FG005|STARTED|Primary Treatment Phase||349
8565674|NCT00069095|9597716|FG000|COMPLETED|Primary Treatment Phase||22
8565675|NCT00069095|9597717|FG001|COMPLETED|Primary Treatment Phase||15
8565676|NCT00069095|9597718|FG002|COMPLETED|Primary Treatment Phase||36
8565677|NCT00069095|9597719|FG003|COMPLETED|Primary Treatment Phase||31
8565678|NCT00069095|9597720|FG004|COMPLETED|Primary Treatment Phase||48
8565679|NCT00069095|9597721|FG005|COMPLETED|Primary Treatment Phase||48
8565680|NCT00069095|9597716|FG000|NOT COMPLETED|Primary Treatment Phase||295
8565681|NCT00069095|9597717|FG001|NOT COMPLETED|Primary Treatment Phase||302
8565682|NCT00069095|9597718|FG002|NOT COMPLETED|Primary Treatment Phase||314
8565683|NCT00069095|9597719|FG003|NOT COMPLETED|Primary Treatment Phase||320
8565684|NCT00069095|9597720|FG004|NOT COMPLETED|Primary Treatment Phase||302
8565685|NCT00069095|9597721|FG005|NOT COMPLETED|Primary Treatment Phase||301
8565686|NCT00069095|9597716|FG000|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|8
8565687|NCT00069095|9597717|FG001|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|13
8565688|NCT00069095|9597718|FG002|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|21
8565689|NCT00069095|9597719|FG003|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|17
8565690|NCT00069095|9597720|FG004|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|36
8565691|NCT00069095|9597721|FG005|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|29
8565692|NCT00069095|9597716|FG000|COMPLETED|Post-study Treatment Phase||0
8565693|NCT00069095|9597717|FG001|COMPLETED|Post-study Treatment Phase||0
8565694|NCT00069095|9597718|FG002|COMPLETED|Post-study Treatment Phase||0
8565695|NCT00069095|9597719|FG003|COMPLETED|Post-study Treatment Phase||0
8565696|NCT00069095|9597720|FG004|COMPLETED|Post-study Treatment Phase||0
8565697|NCT00069095|9597721|FG005|COMPLETED|Post-study Treatment Phase||0
8565698|NCT00069095|9597716|FG000|NOT COMPLETED|Post-study Treatment Phase||8
8565699|NCT00069095|9597717|FG001|NOT COMPLETED|Post-study Treatment Phase||13
8565700|NCT00069095|9597718|FG002|NOT COMPLETED|Post-study Treatment Phase||21
8565701|NCT00069095|9597719|FG003|NOT COMPLETED|Post-study Treatment Phase||17
8565702|NCT00069095|9597720|FG004|NOT COMPLETED|Post-study Treatment Phase||36
8565703|NCT00069095|9597721|FG005|NOT COMPLETED|Post-study Treatment Phase||29
8565704|NCT00069095|9597716|FG000|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|284
8565705|NCT00069095|9597717|FG001|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|299
8565706|NCT00069095|9597718|FG002|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|298
8621022|NCT00477451|9659909|FG000|COMPLETED|Overall Study||20
8621023|NCT00477451|9659910|FG001|COMPLETED|Overall Study||20
8621024|NCT00477451|9659911|FG002|COMPLETED|Overall Study||7
8538546|NCT03692871|9571217|FG000|STARTED|Overall Study||1972
8538547|NCT03692871|9571218|FG001|STARTED|Overall Study||437
8538548|NCT03692871|9571217|FG000|COMPLETED|Overall Study||1847
8538549|NCT03692871|9571218|FG001|COMPLETED|Overall Study||400
8538550|NCT03692871|9571217|FG000|NOT COMPLETED|Overall Study||125
8538551|NCT03692871|9571218|FG001|NOT COMPLETED|Overall Study||37
8538552|NCT03626168|9571226|FG000|STARTED|First Intervention (4 Weeks)||9
8538553|NCT03626168|9571227|FG001|STARTED|First Intervention (4 Weeks)||12
8538554|NCT03626168|9571226|FG000|COMPLETED|First Intervention (4 Weeks)||8
8538555|NCT03626168|9571227|FG001|COMPLETED|First Intervention (4 Weeks)||11
8538556|NCT03626168|9571226|FG000|NOT COMPLETED|First Intervention (4 Weeks)||1
8538557|NCT03626168|9571227|FG001|NOT COMPLETED|First Intervention (4 Weeks)||1
8538558|NCT03626168|9571226|FG000|STARTED|Washout (2 Weeks)||8
8538559|NCT03626168|9571227|FG001|STARTED|Washout (2 Weeks)||11
8538560|NCT03626168|9571226|FG000|COMPLETED|Washout (2 Weeks)||8
8538561|NCT03626168|9571227|FG001|COMPLETED|Washout (2 Weeks)||11
8538562|NCT03626168|9571226|FG000|NOT COMPLETED|Washout (2 Weeks)||0
8538563|NCT03626168|9571227|FG001|NOT COMPLETED|Washout (2 Weeks)||0
8538564|NCT03626168|9571226|FG000|STARTED|Second Intervention (4 Weeks)||8
8538565|NCT03626168|9571227|FG001|STARTED|Second Intervention (4 Weeks)||11
8538566|NCT03626168|9571226|FG000|COMPLETED|Second Intervention (4 Weeks)||8
8817961|NCT01555125|9871642|FG000|STARTED|Induction Period||59
8817962|NCT01555125|9871643|FG001|STARTED|Induction Period||59
8817963|NCT01555125|9871644|FG002|STARTED|Induction Period||0
8817964|NCT01555125|9871645|FG003|STARTED|Induction Period||0
8817965|NCT01555125|9871646|FG004|STARTED|Induction Period||59
8817966|NCT01555125|9871642|FG000|COMPLETED|Induction Period||58
8817967|NCT01555125|9871643|FG001|COMPLETED|Induction Period||56
8817968|NCT01555125|9871644|FG002|COMPLETED|Induction Period||0
8817969|NCT01555125|9871645|FG003|COMPLETED|Induction Period||0
8817970|NCT01555125|9871646|FG004|COMPLETED|Induction Period||56
8817971|NCT01555125|9871642|FG000|NOT COMPLETED|Induction Period||1
8817972|NCT01555125|9871643|FG001|NOT COMPLETED|Induction Period||3
8817973|NCT01555125|9871644|FG002|NOT COMPLETED|Induction Period||0
8817974|NCT01555125|9871645|FG003|NOT COMPLETED|Induction Period||0
8817975|NCT01555125|9871646|FG004|NOT COMPLETED|Induction Period||3
8817976|NCT01555125|9871642|FG000|STARTED|Maintenance Period||58
8817977|NCT01555125|9871643|FG001|STARTED|Maintenance Period||56
8817978|NCT01555125|9871644|FG002|STARTED|Maintenance Period||29
8817979|NCT01555125|9871645|FG003|STARTED|Maintenance Period||27
8817980|NCT01555125|9871646|FG004|STARTED|Maintenance Period||0
8817981|NCT01555125|9871642|FG000|COMPLETED|Maintenance Period||48
8817982|NCT01555125|9871643|FG001|COMPLETED|Maintenance Period||52
8817983|NCT01555125|9871644|FG002|COMPLETED|Maintenance Period||25
8817984|NCT01555125|9871645|FG003|COMPLETED|Maintenance Period||25
8817985|NCT01555125|9871646|FG004|COMPLETED|Maintenance Period||0
8817986|NCT01555125|9871642|FG000|NOT COMPLETED|Maintenance Period||10
8817987|NCT01555125|9871643|FG001|NOT COMPLETED|Maintenance Period||4
8538567|NCT03626168|9571227|FG001|COMPLETED|Second Intervention (4 Weeks)||9
8538568|NCT03626168|9571226|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0
8538569|NCT03626168|9571227|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||2
8538570|NCT03597035|9571233|FG000|STARTED|Overall Study||8
8538571|NCT03597035|9571233|FG000|COMPLETED|Overall Study||4
8538572|NCT03597035|9571233|FG000|NOT COMPLETED|Overall Study||4
8538573|NCT04823221|9571238|FG000|STARTED|Overall Study||22
8538574|NCT04823221|9571238|FG000|COMPLETED|Overall Study||22
8538575|NCT04823221|9571238|FG000|NOT COMPLETED|Overall Study||0
8538576|NCT04707573|9571244|FG000|STARTED|Overall Study||10
8538577|NCT04707573|9571245|FG001|STARTED|Overall Study||12
8538578|NCT04707573|9571244|FG000|COMPLETED|Overall Study||10
8538579|NCT04707573|9571245|FG001|COMPLETED|Overall Study||12
8538580|NCT04707573|9571244|FG000|NOT COMPLETED|Overall Study||0
8538581|NCT04707573|9571245|FG001|NOT COMPLETED|Overall Study||0
8538582|NCT04579393|9571253|FG000|STARTED|Overall Study||30
8538583|NCT04579393|9571254|FG001|STARTED|Overall Study||29
8538584|NCT04579393|9571253|FG000|COMPLETED|Overall Study||27
8538585|NCT04579393|9571254|FG001|COMPLETED|Overall Study||24
8538586|NCT04579393|9571253|FG000|NOT COMPLETED|Overall Study||3
8538587|NCT04579393|9571254|FG001|NOT COMPLETED|Overall Study||5
8538588|NCT04426656|9571263|FG000|STARTED|Overall Study||24
8538589|NCT04426656|9571264|FG001|STARTED|Overall Study||46
8538590|NCT04426656|9571263|FG000|COMPLETED|Overall Study||21
8538591|NCT04426656|9571264|FG001|COMPLETED|Overall Study||43
8538592|NCT04426656|9571263|FG000|NOT COMPLETED|Overall Study||3
8538593|NCT04426656|9571264|FG001|NOT COMPLETED|Overall Study||3
8538594|NCT04325906|9571272|FG000|STARTED|Overall Study||112
8817988|NCT01555125|9871644|FG002|NOT COMPLETED|Maintenance Period||4
8817989|NCT01555125|9871645|FG003|NOT COMPLETED|Maintenance Period||2
8817990|NCT01555125|9871646|FG004|NOT COMPLETED|Maintenance Period||0
8817991|NCT01555125|9871642|FG000|STARTED|Extension||46
8538595|NCT04325906|9571273|FG001|STARTED|Overall Study||112
8538596|NCT04325906|9571272|FG000|COMPLETED|Overall Study||110
8538597|NCT04325906|9571273|FG001|COMPLETED|Overall Study||112
8538598|NCT04325906|9571272|FG000|NOT COMPLETED|Overall Study||2
8538599|NCT04325906|9571273|FG001|NOT COMPLETED|Overall Study||0
8538600|NCT04319445|9571279|FG000|STARTED|Overall Study||144
8538601|NCT04319445|9571279|FG000|COMPLETED|Overall Study||144
8538602|NCT04319445|9571279|FG000|NOT COMPLETED|Overall Study||0
8538603|NCT04203667|9571283|FG000|STARTED|Overall Study||66
8817992|NCT01555125|9871643|FG001|STARTED|Extension||51
8621025|NCT00477451|9659912|FG003|COMPLETED|Overall Study||2
8621026|NCT00477451|9659909|FG000|NOT COMPLETED|Overall Study||0
8538604|NCT04203667|9571283|FG000|Per Protocol Population|Overall Study||45
8538605|NCT04203667|9571283|FG000|COMPLETED|Overall Study||62
8538606|NCT04203667|9571283|FG000|NOT COMPLETED|Overall Study||4
8565707|NCT00069095|9597719|FG003|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|299
8565708|NCT00069095|9597720|FG004|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|278
8565709|NCT00069095|9597721|FG005|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|272
8565710|NCT00069095|9597716|FG000|COMPLETED|Follow-up Phase||110
8565711|NCT00069095|9597717|FG001|COMPLETED|Follow-up Phase||93
8565712|NCT00069095|9597718|FG002|COMPLETED|Follow-up Phase||178
8565713|NCT00069095|9597719|FG003|COMPLETED|Follow-up Phase||187
8565714|NCT00069095|9597720|FG004|COMPLETED|Follow-up Phase||186
8565715|NCT00069095|9597721|FG005|COMPLETED|Follow-up Phase||171
8565716|NCT00069095|9597716|FG000|NOT COMPLETED|Follow-up Phase||174
8565717|NCT00069095|9597717|FG001|NOT COMPLETED|Follow-up Phase||206
8565718|NCT00069095|9597718|FG002|NOT COMPLETED|Follow-up Phase||120
8565719|NCT00069095|9597719|FG003|NOT COMPLETED|Follow-up Phase||112
8565720|NCT00069095|9597720|FG004|NOT COMPLETED|Follow-up Phase||92
8565721|NCT00069095|9597721|FG005|NOT COMPLETED|Follow-up Phase||101
8565722|NCT00069108|9597735|FG000|STARTED|Overall Study||313
8565723|NCT00069108|9597736|FG001|STARTED|Overall Study||314
8565724|NCT00069108|9597735|FG000|COMPLETED|Overall Study||100
8565725|NCT00069108|9597736|FG001|COMPLETED|Overall Study||95
8565726|NCT00069108|9597735|FG000|NOT COMPLETED|Overall Study||213
8565727|NCT00069108|9597736|FG001|NOT COMPLETED|Overall Study||219
8565728|NCT00069121|9597745|FG000|STARTED|Overall Study||942
8565729|NCT00069121|9597746|FG001|STARTED|Overall Study||944
8565730|NCT00069121|9597745|FG000|Received Treatment|Overall Study|Safety Population|926
8565731|NCT00069121|9597746|FG001|Received Treatment|Overall Study|Safety Population|938
8565732|NCT00069121|9597745|FG000|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|575
8565733|NCT00069121|9597746|FG001|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|619
8565734|NCT00069121|9597745|FG000|NOT COMPLETED|Overall Study||367
8565735|NCT00069121|9597746|FG001|NOT COMPLETED|Overall Study||325
8565736|NCT00069160|9597758|FG000|STARTED|Overall Study||23
8565737|NCT00069160|9597759|FG001|STARTED|Overall Study||25
8565738|NCT00069160|9597758|FG000|COMPLETED|Overall Study||23
8565739|NCT00069160|9597759|FG001|COMPLETED|Overall Study||25
8565740|NCT00069160|9597758|FG000|NOT COMPLETED|Overall Study||0
8565741|NCT00069160|9597759|FG001|NOT COMPLETED|Overall Study||0
8565742|NCT00069264|9597768|FG000|STARTED|Overall Study||32
8565743|NCT00069264|9597768|FG000|COMPLETED|Overall Study||0
8565744|NCT00069264|9597768|FG000|NOT COMPLETED|Overall Study||32
8565745|NCT00069277|9597772|FG000|STARTED|Overall Study||21
8565746|NCT00069277|9597772|FG000|COMPLETED|Overall Study||0
8565747|NCT00069277|9597772|FG000|NOT COMPLETED|Overall Study||21
8569257|NCT00095940|9601450|FG006|STARTED|Lapatinib Continuation/Phase II|Continued to receive lapatinib but were ineligible for the phase II.|2
8569258|NCT00095940|9601451|FG007|STARTED|Lapatinib Continuation/Phase II|No measurable disease post surgery - ineligible for the phase II. Continued to receive lapatinib.|2
8569259|NCT00095940|9601452|FG008|STARTED|Lapatinib Continuation/Phase II||14
8569260|NCT00095940|9601444|FG000|COMPLETED|Lapatinib Continuation/Phase II||0
8569261|NCT00095940|9601445|FG001|COMPLETED|Lapatinib Continuation/Phase II||0
8569262|NCT00095940|9601446|FG002|COMPLETED|Lapatinib Continuation/Phase II||1
8569263|NCT00095940|9601447|FG003|COMPLETED|Lapatinib Continuation/Phase II||0
8569264|NCT00095940|9601448|FG004|COMPLETED|Lapatinib Continuation/Phase II||0
8569265|NCT00095940|9601449|FG005|COMPLETED|Lapatinib Continuation/Phase II||0
8569266|NCT00095940|9601450|FG006|COMPLETED|Lapatinib Continuation/Phase II||0
8569267|NCT00095940|9601451|FG007|COMPLETED|Lapatinib Continuation/Phase II||0
8569268|NCT00095940|9601452|FG008|COMPLETED|Lapatinib Continuation/Phase II||1
8569269|NCT00095940|9601444|FG000|NOT COMPLETED|Lapatinib Continuation/Phase II||2
8569270|NCT00095940|9601445|FG001|NOT COMPLETED|Lapatinib Continuation/Phase II||2
8569271|NCT00095940|9601446|FG002|NOT COMPLETED|Lapatinib Continuation/Phase II||16
8569272|NCT00095940|9601447|FG003|NOT COMPLETED|Lapatinib Continuation/Phase II||0
8569273|NCT00095940|9601448|FG004|NOT COMPLETED|Lapatinib Continuation/Phase II||0
8569274|NCT00095940|9601449|FG005|NOT COMPLETED|Lapatinib Continuation/Phase II||13
8569275|NCT00095940|9601450|FG006|NOT COMPLETED|Lapatinib Continuation/Phase II||2
8569276|NCT00095940|9601451|FG007|NOT COMPLETED|Lapatinib Continuation/Phase II||2
8569277|NCT00095940|9601452|FG008|NOT COMPLETED|Lapatinib Continuation/Phase II||13
8569278|NCT00095979|9601470|FG000|STARTED|Overall Study||52
8569279|NCT00095979|9601470|FG000|COMPLETED|Overall Study||50
8569280|NCT00095979|9601470|FG000|NOT COMPLETED|Overall Study||2
8569281|NCT00096018|9601481|FG000|STARTED|Overall Study||13
8569282|NCT00096018|9601482|FG001|STARTED|Overall Study||30
8569283|NCT00096018|9601481|FG000|Treated With Study Therapy|Overall Study||13
8569284|NCT00096018|9601482|FG001|Treated With Study Therapy|Overall Study||25
8569285|NCT00096018|9601481|FG000|COMPLETED|Overall Study||11
8569286|NCT00096018|9601482|FG001|COMPLETED|Overall Study||16
8569287|NCT00096018|9601481|FG000|NOT COMPLETED|Overall Study||2
8569288|NCT00096018|9601482|FG001|NOT COMPLETED|Overall Study||14
8569289|NCT00096031|9601488|FG000|STARTED|Overall Study||63
8569290|NCT00096031|9601488|FG000|Eligible|Overall Study||57
8621027|NCT00477451|9659910|FG001|NOT COMPLETED|Overall Study||0
8538607|NCT03796637|9571288|FG000|STARTED|Overall Study||6
8538608|NCT03796637|9571288|FG000|COMPLETED|Overall Study||6
8538609|NCT03796637|9571288|FG000|NOT COMPLETED|Overall Study||0
8538610|NCT03679884|9571297|FG000|STARTED|Overall Study||142
8538611|NCT03679884|9571298|FG001|STARTED|Overall Study||268
8538612|NCT03679884|9571299|FG002|STARTED|Overall Study||137
8538613|NCT03679884|9571300|FG003|STARTED|Overall Study||128
8538614|NCT03679884|9571301|FG004|STARTED|Overall Study||126
8538615|NCT03679884|9571297|FG000|COMPLETED|Overall Study||99
8538616|NCT03679884|9571298|FG001|COMPLETED|Overall Study||190
8538617|NCT03679884|9571299|FG002|COMPLETED|Overall Study||93
8538618|NCT03679884|9571300|FG003|COMPLETED|Overall Study||78
8538619|NCT03679884|9571301|FG004|COMPLETED|Overall Study||90
8538620|NCT03679884|9571297|FG000|NOT COMPLETED|Overall Study||43
8538621|NCT03679884|9571298|FG001|NOT COMPLETED|Overall Study||78
8621028|NCT00477451|9659911|FG002|NOT COMPLETED|Overall Study||0
8621029|NCT00477451|9659912|FG003|NOT COMPLETED|Overall Study||0
8621030|NCT00477464|9659920|FG000|STARTED|Overall Study||51
8538622|NCT03679884|9571299|FG002|NOT COMPLETED|Overall Study||44
8538623|NCT03679884|9571300|FG003|NOT COMPLETED|Overall Study||50
8538624|NCT03679884|9571301|FG004|NOT COMPLETED|Overall Study||36
8538625|NCT03653026|9571315|FG000|STARTED|Part 1: Placebo-controlled Period||345
8538626|NCT03653026|9571316|FG001|STARTED|Part 1: Placebo-controlled Period||177
8538627|NCT03653026|9571317|FG002|STARTED|Part 1: Placebo-controlled Period||0
8538628|NCT03653026|9571318|FG003|STARTED|Part 1: Placebo-controlled Period||0
8538629|NCT03653026|9571315|FG000|Received Treatment|Part 1: Placebo-controlled Period||344
8538630|NCT03653026|9571316|FG001|Received Treatment|Part 1: Placebo-controlled Period||177
8538631|NCT03653026|9571317|FG002|Received Treatment|Part 1: Placebo-controlled Period||0
8538632|NCT03653026|9571318|FG003|Received Treatment|Part 1: Placebo-controlled Period||0
8538633|NCT03653026|9571315|FG000|COMPLETED|Part 1: Placebo-controlled Period||334
8538634|NCT03653026|9571316|FG001|COMPLETED|Part 1: Placebo-controlled Period||164
8538635|NCT03653026|9571317|FG002|COMPLETED|Part 1: Placebo-controlled Period||0
8538636|NCT03653026|9571318|FG003|COMPLETED|Part 1: Placebo-controlled Period||0
8538637|NCT03653026|9571315|FG000|NOT COMPLETED|Part 1: Placebo-controlled Period||11
8538638|NCT03653026|9571316|FG001|NOT COMPLETED|Part 1: Placebo-controlled Period||13
8538639|NCT03653026|9571317|FG002|NOT COMPLETED|Part 1: Placebo-controlled Period||0
8538640|NCT03653026|9571318|FG003|NOT COMPLETED|Part 1: Placebo-controlled Period||0
8538641|NCT03653026|9571315|FG000|STARTED|Part 2: Open-label Extension||0
8538642|NCT03653026|9571316|FG001|STARTED|Part 2: Open-label Extension||0
8538643|NCT03653026|9571317|FG002|STARTED|Part 2: Open-label Extension||68
8538644|NCT03653026|9571318|FG003|STARTED|Part 2: Open-label Extension||116
8538645|NCT03653026|9571315|FG000|COMPLETED|Part 2: Open-label Extension||0
8538646|NCT03653026|9571316|FG001|COMPLETED|Part 2: Open-label Extension||0
8538647|NCT03653026|9571317|FG002|COMPLETED|Part 2: Open-label Extension||65
8538648|NCT03653026|9571318|FG003|COMPLETED|Part 2: Open-label Extension||111
8538649|NCT03653026|9571315|FG000|NOT COMPLETED|Part 2: Open-label Extension||0
8538650|NCT03653026|9571316|FG001|NOT COMPLETED|Part 2: Open-label Extension||0
8538651|NCT03653026|9571317|FG002|NOT COMPLETED|Part 2: Open-label Extension||3
8538652|NCT03653026|9571318|FG003|NOT COMPLETED|Part 2: Open-label Extension||5
8538653|NCT03648827|9571326|FG000|STARTED|Overall Study||20
8538654|NCT03648827|9571326|FG000|Received at Least 1 Dose of Study Drug|Overall Study||20
8538655|NCT03648827|9571326|FG000|COMPLETED|Overall Study||20
8538656|NCT03648827|9571326|FG000|NOT COMPLETED|Overall Study||0
8621031|NCT00477464|9659920|FG000|COMPLETED|Overall Study||0
8621032|NCT00477464|9659920|FG000|NOT COMPLETED|Overall Study||51
8621033|NCT00477490|9659931|FG000|STARTED|Part I: 4 Week Efficacy||160
8621034|NCT00477490|9659932|FG001|STARTED|Part I: 4 Week Efficacy||163
8621035|NCT00477490|9659933|FG002|STARTED|Part I: 4 Week Efficacy||158
8817993|NCT01555125|9871644|FG002|STARTED|Extension||23
8817994|NCT01555125|9871645|FG003|STARTED|Extension||23
8817995|NCT01555125|9871646|FG004|STARTED|Extension||0
8817996|NCT01555125|9871642|FG000|COMPLETED|Extension||1
8817997|NCT01555125|9871643|FG001|COMPLETED|Extension||0
8817998|NCT01555125|9871644|FG002|COMPLETED|Extension||0
8817999|NCT01555125|9871645|FG003|COMPLETED|Extension||1
8818000|NCT01555125|9871646|FG004|COMPLETED|Extension||0
8818001|NCT01555125|9871642|FG000|NOT COMPLETED|Extension||45
8818002|NCT01555125|9871643|FG001|NOT COMPLETED|Extension||51
8818003|NCT01555125|9871644|FG002|NOT COMPLETED|Extension||23
8538657|NCT03553498|9571332|FG000|STARTED|Overall Study||81
8538658|NCT03553498|9571333|FG001|STARTED|Overall Study||81
8538659|NCT03553498|9571332|FG000|COMPLETED|Overall Study||80
8538660|NCT03553498|9571333|FG001|COMPLETED|Overall Study||79
8538661|NCT03553498|9571332|FG000|NOT COMPLETED|Overall Study||1
8538662|NCT03553498|9571333|FG001|NOT COMPLETED|Overall Study||2
8621036|NCT00477490|9659934|FG003|STARTED|Part I: 4 Week Efficacy||158
8621037|NCT00477490|9659935|FG004|STARTED|Part I: 4 Week Efficacy||160
8621038|NCT00477490|9659936|FG005|STARTED|Part I: 4 Week Efficacy||0
8621039|NCT00477490|9659937|FG006|STARTED|Part I: 4 Week Efficacy||0
8621040|NCT00477490|9659938|FG007|STARTED|Part I: 4 Week Efficacy||0
8621041|NCT00477490|9659939|FG008|STARTED|Part I: 4 Week Efficacy||0
8621042|NCT00477490|9659931|FG000|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|156
8818004|NCT01555125|9871645|FG003|NOT COMPLETED|Extension||22
8818005|NCT01555125|9871646|FG004|NOT COMPLETED|Extension||0
8538663|NCT03530293|9571341|FG000|STARTED|Pre-randomization||81
8818006|NCT01555125|9871642|FG000|STARTED|Follow-Up Period||36
8818007|NCT01555125|9871643|FG001|STARTED|Follow-Up Period||31
8818008|NCT01555125|9871644|FG002|STARTED|Follow-Up Period||19
8538664|NCT03530293|9571342|FG001|STARTED|Pre-randomization||0
8538665|NCT03530293|9571343|FG002|STARTED|Pre-randomization||0
8538666|NCT03530293|9571341|FG000|Safety Analysis Set|Pre-randomization||80
8538667|NCT03530293|9571342|FG001|Safety Analysis Set|Pre-randomization||0
8538668|NCT03530293|9571343|FG002|Safety Analysis Set|Pre-randomization||0
8538669|NCT03530293|9571341|FG000|COMPLETED|Pre-randomization||57
8538670|NCT03530293|9571342|FG001|COMPLETED|Pre-randomization||0
8538671|NCT03530293|9571343|FG002|COMPLETED|Pre-randomization||0
8538672|NCT03530293|9571341|FG000|NOT COMPLETED|Pre-randomization||24
8538673|NCT03530293|9571342|FG001|NOT COMPLETED|Pre-randomization||0
8538674|NCT03530293|9571343|FG002|NOT COMPLETED|Pre-randomization||0
8538675|NCT03530293|9571341|FG000|STARTED|Randomized Withdrawal Period / Follow-up||0
8538676|NCT03530293|9571342|FG001|STARTED|Randomized Withdrawal Period / Follow-up||26
8538677|NCT03530293|9571343|FG002|STARTED|Randomized Withdrawal Period / Follow-up||26
8538678|NCT03530293|9571341|FG000|COMPLETED|Randomized Withdrawal Period / Follow-up||0
8538679|NCT03530293|9571342|FG001|COMPLETED|Randomized Withdrawal Period / Follow-up||9
8538680|NCT03530293|9571343|FG002|COMPLETED|Randomized Withdrawal Period / Follow-up||9
8538681|NCT03530293|9571341|FG000|NOT COMPLETED|Randomized Withdrawal Period / Follow-up||0
8538682|NCT03530293|9571342|FG001|NOT COMPLETED|Randomized Withdrawal Period / Follow-up||17
8538683|NCT03530293|9571343|FG002|NOT COMPLETED|Randomized Withdrawal Period / Follow-up||17
8538684|NCT03505749|9571352|FG000|STARTED|Overall Study||38
8538685|NCT03505749|9571353|FG001|STARTED|Overall Study||45
8538686|NCT03505749|9571352|FG000|COMPLETED|Overall Study||22
8538687|NCT03505749|9571353|FG001|COMPLETED|Overall Study||28
8538688|NCT03505749|9571352|FG000|NOT COMPLETED|Overall Study||16
8538689|NCT03505749|9571353|FG001|NOT COMPLETED|Overall Study||17
8538690|NCT03472885|9571362|FG000|STARTED|Overall Study||12
8538691|NCT03472885|9571362|FG000|Safety Population: Received at Least 1 Dose of Study Drug|Overall Study||12
8538692|NCT03472885|9571362|FG000|Efficacy Population: Received Study Drug for at Least 4 Weeks|Overall Study||11
8538693|NCT03472885|9571362|FG000|COMPLETED|Overall Study||11
8538694|NCT03472885|9571362|FG000|NOT COMPLETED|Overall Study||1
8565748|NCT00069329|9597776|FG000|STARTED|Overall Study||43
8565749|NCT00069329|9597776|FG000|COMPLETED|Overall Study||41
8565750|NCT00069329|9597776|FG000|NOT COMPLETED|Overall Study||2
8565751|NCT00069576|9597782|FG000|STARTED|Original Trial||485
8565752|NCT00069576|9597783|FG001|STARTED|Original Trial||473
8565753|NCT00069576|9597782|FG000|COMPLETED|Original Trial||460
8565754|NCT00069576|9597783|FG001|COMPLETED|Original Trial||440
8565755|NCT00069576|9597782|FG000|NOT COMPLETED|Original Trial||25
8565756|NCT00069576|9597783|FG001|NOT COMPLETED|Original Trial||33
8565757|NCT00069576|9597782|FG000|STARTED|Follow-up Study at 5-10 Years||460
8565758|NCT00069576|9597783|FG001|STARTED|Follow-up Study at 5-10 Years||440
8565759|NCT00069576|9597782|FG000|COMPLETED|Follow-up Study at 5-10 Years||264
8565760|NCT00069576|9597783|FG001|COMPLETED|Follow-up Study at 5-10 Years||236
8565761|NCT00069576|9597782|FG000|NOT COMPLETED|Follow-up Study at 5-10 Years||196
8565762|NCT00069576|9597783|FG001|NOT COMPLETED|Follow-up Study at 5-10 Years||204
8565763|NCT00069641|9597792|FG000|STARTED|Overall Study||32
8565764|NCT00069641|9597793|FG001|STARTED|Overall Study||32
8565765|NCT00069641|9597794|FG002|STARTED|Overall Study||32
8565766|NCT00069641|9597792|FG000|COMPLETED|Overall Study||31
8565767|NCT00069641|9597793|FG001|COMPLETED|Overall Study||32
8565768|NCT00069641|9597794|FG002|COMPLETED|Overall Study||31
8565769|NCT00069641|9597792|FG000|NOT COMPLETED|Overall Study||1
8565770|NCT00069641|9597793|FG001|NOT COMPLETED|Overall Study||0
8565771|NCT00069641|9597794|FG002|NOT COMPLETED|Overall Study||1
8565772|NCT00069784|9597805|FG000|STARTED|Overall Study|randomized participants = intent-to-treat (ITT) population|6264
8565773|NCT00069784|9597806|FG001|STARTED|Overall Study|randomized participants = intent-to-treat (ITT) population|6273
8565774|NCT00069784|9597805|FG000|Safety Population (Treated)|Overall Study|randomized patients who received at least one dose of insulin glargine|6231
8565775|NCT00069784|9597806|FG001|Safety Population (Treated)|Overall Study|patients randomized to standard care arm|6273
8565776|NCT00069784|9597805|FG000|COMPLETED|Overall Study|completed study treatment|5052
8565777|NCT00069784|9597806|FG001|COMPLETED|Overall Study|not applicable (no treatment)|6273
8565778|NCT00069784|9597805|FG000|NOT COMPLETED|Overall Study||1212
8565779|NCT00069784|9597806|FG001|NOT COMPLETED|Overall Study||0
8565780|NCT00069823|9597814|FG000|STARTED|Overall Study|The design was for 200 participants per group, the study did not exactly meet the design.|199
8565781|NCT00069823|9597815|FG001|STARTED|Overall Study|The design was for 200 participants per group, the study did not exactly meet the design.|203
8565782|NCT00069823|9597814|FG000|COMPLETED|Overall Study||193
8565783|NCT00069823|9597815|FG001|COMPLETED|Overall Study||200
8565784|NCT00069823|9597814|FG000|NOT COMPLETED|Overall Study||6
8565785|NCT00069823|9597815|FG001|NOT COMPLETED|Overall Study||3
8565786|NCT00069953|9597821|FG000|STARTED|Overall Study||43
8565787|NCT00069953|9597821|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study|41
8565788|NCT00069953|9597821|FG000|NOT COMPLETED|Overall Study||2
8565789|NCT00070070|9597829|FG000|STARTED|Overall Study||1
8565790|NCT00070070|9597830|FG001|STARTED|Overall Study||0
8565791|NCT00070070|9597831|FG002|STARTED|Overall Study||0
8565792|NCT00070070|9597832|FG003|STARTED|Overall Study||5
8818009|NCT01555125|9871645|FG003|STARTED|Follow-Up Period||18
8565793|NCT00070070|9597829|FG000|COMPLETED|Overall Study||1
8565794|NCT00070070|9597830|FG001|COMPLETED|Overall Study||0
8538695|NCT03311269|9571368|FG000|STARTED|Overall Study||10
8538696|NCT03311269|9571369|FG001|STARTED|Overall Study||9
8538697|NCT03311269|9571368|FG000|COMPLETED|Overall Study||10
8538698|NCT03311269|9571369|FG001|COMPLETED|Overall Study||9
8538699|NCT03311269|9571368|FG000|NOT COMPLETED|Overall Study||0
8538700|NCT03311269|9571369|FG001|NOT COMPLETED|Overall Study||0
8538701|NCT03219164|9571377|FG000|STARTED|Overall Study||74
8538702|NCT03219164|9571378|FG001|STARTED|Overall Study||75
8538703|NCT03219164|9571377|FG000|COMPLETED|Overall Study||49
8538704|NCT03219164|9571378|FG001|COMPLETED|Overall Study||57
8538705|NCT03219164|9571377|FG000|NOT COMPLETED|Overall Study||25
8538706|NCT03219164|9571378|FG001|NOT COMPLETED|Overall Study||18
8538707|NCT03118570|9571389|FG000|STARTED|Overall Study||31
8538708|NCT03118570|9571390|FG001|STARTED|Overall Study||29
8538709|NCT03118570|9571391|FG002|STARTED|Overall Study||30
8538710|NCT03118570|9571392|FG003|STARTED|Overall Study||2
8538711|NCT03118570|9571393|FG004|STARTED|Overall Study||20
8538712|NCT03118570|9571389|FG000|Reassigned From Placebo to 20 mg/kg Open-Label Setrusumab|Overall Study||0
8538713|NCT03118570|9571390|FG001|Reassigned From Placebo to 20 mg/kg Open-Label Setrusumab|Overall Study||0
8538714|NCT03118570|9571391|FG002|Reassigned From Placebo to 20 mg/kg Open-Label Setrusumab|Overall Study||0
8538715|NCT03118570|9571392|FG003|Reassigned From Placebo to 20 mg/kg Open-Label Setrusumab|Overall Study||0
8538716|NCT03118570|9571393|FG004|Reassigned From Placebo to 20 mg/kg Open-Label Setrusumab|Overall Study||19
8538717|NCT03118570|9571389|FG000|COMPLETED|Overall Study||26
8538718|NCT03118570|9571390|FG001|COMPLETED|Overall Study||22
8538719|NCT03118570|9571391|FG002|COMPLETED|Overall Study||25
8538720|NCT03118570|9571392|FG003|COMPLETED|Overall Study||2
8538721|NCT03118570|9571393|FG004|COMPLETED|Overall Study||15
8538722|NCT03118570|9571389|FG000|NOT COMPLETED|Overall Study||5
8538723|NCT03118570|9571390|FG001|NOT COMPLETED|Overall Study||7
8538724|NCT03118570|9571391|FG002|NOT COMPLETED|Overall Study||5
8538725|NCT03118570|9571392|FG003|NOT COMPLETED|Overall Study||0
8538726|NCT03118570|9571393|FG004|NOT COMPLETED|Overall Study||5
8538727|NCT03094416|9571406|FG000|STARTED|Run-in||66
8538728|NCT03094416|9571406|FG000|COMPLETED|Run-in||47
8538729|NCT03094416|9571406|FG000|NOT COMPLETED|Run-in||19
8538730|NCT03094416|9571406|FG000|STARTED|Treatment Period||47
8538731|NCT03094416|9571406|FG000|COMPLETED|Treatment Period||45
8538732|NCT03094416|9571406|FG000|NOT COMPLETED|Treatment Period||2
8538733|NCT02811861|9571414|FG000|STARTED|Overall Study||357
8538734|NCT02811861|9571415|FG001|STARTED|Overall Study||355
8538735|NCT02811861|9571416|FG002|STARTED|Overall Study||357
8538736|NCT02811861|9571414|FG000|Treated|Overall Study||355
8538737|NCT02811861|9571415|FG001|Treated|Overall Study||352
8538738|NCT02811861|9571416|FG002|Treated|Overall Study||340
8538739|NCT02811861|9571414|FG000|COMPLETED|Overall Study||0
8538740|NCT02811861|9571415|FG001|COMPLETED|Overall Study||0
8538741|NCT02811861|9571416|FG002|COMPLETED|Overall Study||0
8538742|NCT02811861|9571414|FG000|NOT COMPLETED|Overall Study||357
8538743|NCT02811861|9571415|FG001|NOT COMPLETED|Overall Study||355
8538744|NCT02811861|9571416|FG002|NOT COMPLETED|Overall Study||357
8538745|NCT02734667|9571426|FG000|STARTED|Overall Study||84
8538746|NCT02734667|9571427|FG001|STARTED|Overall Study||36
8538747|NCT02734667|9571426|FG000|Youth|Overall Study||42
8538748|NCT02734667|9571427|FG001|Youth|Overall Study||18
8538749|NCT02734667|9571426|FG000|Parent|Overall Study||42
8538750|NCT02734667|9571427|FG001|Parent|Overall Study||18
8538751|NCT02734667|9571426|FG000|COMPLETED|Overall Study||82
8538752|NCT02734667|9571427|FG001|COMPLETED|Overall Study||30
8538753|NCT02734667|9571426|FG000|NOT COMPLETED|Overall Study||2
8538754|NCT02734667|9571427|FG001|NOT COMPLETED|Overall Study||6
8538755|NCT02709317|9571435|FG000|STARTED|Overall Study||50
8538756|NCT02709317|9571436|FG001|STARTED|Overall Study||58
8538757|NCT02709317|9571435|FG000|COMPLETED|Overall Study||18
8538758|NCT02709317|9571436|FG001|COMPLETED|Overall Study||31
8538759|NCT02709317|9571435|FG000|NOT COMPLETED|Overall Study||32
8538760|NCT02709317|9571436|FG001|NOT COMPLETED|Overall Study||27
8538761|NCT02607930|9571444|FG000|STARTED|Double-Blinded Treatment Phase||316
8538762|NCT02607930|9571445|FG001|STARTED|Double-Blinded Treatment Phase||315
8538763|NCT02607930|9571446|FG002|STARTED|Double-Blinded Treatment Phase||0
8538764|NCT02607930|9571447|FG003|STARTED|Double-Blinded Treatment Phase||0
8538765|NCT02607930|9571444|FG000|COMPLETED|Double-Blinded Treatment Phase||262
8538766|NCT02607930|9571445|FG001|COMPLETED|Double-Blinded Treatment Phase||262
8538767|NCT02607930|9571446|FG002|COMPLETED|Double-Blinded Treatment Phase||0
8538768|NCT02607930|9571447|FG003|COMPLETED|Double-Blinded Treatment Phase||0
8538769|NCT02607930|9571444|FG000|NOT COMPLETED|Double-Blinded Treatment Phase||54
8538770|NCT02607930|9571445|FG001|NOT COMPLETED|Double-Blinded Treatment Phase||53
8538771|NCT02607930|9571446|FG002|NOT COMPLETED|Double-Blinded Treatment Phase||0
8538772|NCT02607930|9571447|FG003|NOT COMPLETED|Double-Blinded Treatment Phase||0
8538773|NCT02607930|9571444|FG000|STARTED|Open-Label B/F/TAF Extension Phase|At the End of Blinded Treatment Visit, participants were given the option to receive B/F/TAF FDC in an OL extension phase for up to 96 weeks.|0
8538774|NCT02607930|9571445|FG001|STARTED|Open-Label B/F/TAF Extension Phase|At the End of Blinded Treatment Visit, participants were given the option to receive B/F/TAF FDC in an OL extension phase for up to 96 weeks.|0
8538775|NCT02607930|9571446|FG002|STARTED|Open-Label B/F/TAF Extension Phase|10 participants from B/F/TAF arm did not enter the Open-Label Extension Phase.|252
8538776|NCT02607930|9571447|FG003|STARTED|Open-Label B/F/TAF Extension Phase|8 participants from the ABC/DTG/3TC arm did not enter the Open-Label Extension Phase.|254
8538777|NCT02607930|9571444|FG000|COMPLETED|Open-Label B/F/TAF Extension Phase||0
8538778|NCT02607930|9571445|FG001|COMPLETED|Open-Label B/F/TAF Extension Phase||0
8538779|NCT02607930|9571446|FG002|COMPLETED|Open-Label B/F/TAF Extension Phase||218
8538780|NCT02607930|9571447|FG003|COMPLETED|Open-Label B/F/TAF Extension Phase||221
8538781|NCT02607930|9571444|FG000|NOT COMPLETED|Open-Label B/F/TAF Extension Phase||0
8538782|NCT02607930|9571445|FG001|NOT COMPLETED|Open-Label B/F/TAF Extension Phase||0
8538783|NCT02607930|9571446|FG002|NOT COMPLETED|Open-Label B/F/TAF Extension Phase||34
8538784|NCT02607930|9571447|FG003|NOT COMPLETED|Open-Label B/F/TAF Extension Phase||33
8538785|NCT02580058|9571460|FG000|STARTED|Overall Study||188
8538786|NCT02580058|9571461|FG001|STARTED|Overall Study||188
8538787|NCT02580058|9571462|FG002|STARTED|Overall Study||190
8538788|NCT02580058|9571460|FG000|Treated|Overall Study||187
8538789|NCT02580058|9571461|FG001|Treated|Overall Study||182
8538790|NCT02580058|9571462|FG002|Treated|Overall Study||177
8538791|NCT02580058|9571460|FG000|COMPLETED|Overall Study||109
8538792|NCT02580058|9571461|FG001|COMPLETED|Overall Study||102
8538793|NCT02580058|9571462|FG002|COMPLETED|Overall Study||104
8538794|NCT02580058|9571460|FG000|NOT COMPLETED|Overall Study||79
8538795|NCT02580058|9571461|FG001|NOT COMPLETED|Overall Study||86
8538796|NCT02580058|9571462|FG002|NOT COMPLETED|Overall Study||86
8538797|NCT02578680|9571472|FG000|STARTED|Overall Study||410
8538798|NCT02578680|9571473|FG001|STARTED|Overall Study||206
8538799|NCT02578680|9571472|FG000|Treated|Overall Study||405
8538800|NCT02578680|9571473|FG001|Treated|Overall Study||202
8538801|NCT02578680|9571472|FG000|Switched to Pembrolizumab|Overall Study||0
8538802|NCT02578680|9571473|FG001|Switched to Pembrolizumab|Overall Study||67
8538803|NCT02578680|9571472|FG000|COMPLETED|Overall Study||0
8538804|NCT02578680|9571473|FG001|COMPLETED|Overall Study||0
8538805|NCT02578680|9571472|FG000|NOT COMPLETED|Overall Study||410
8538806|NCT02578680|9571473|FG001|NOT COMPLETED|Overall Study||206
8565795|NCT00070070|9597831|FG002|COMPLETED|Overall Study||0
8565796|NCT00070070|9597832|FG003|COMPLETED|Overall Study||5
8565797|NCT00070070|9597829|FG000|NOT COMPLETED|Overall Study||0
8565798|NCT00070070|9597830|FG001|NOT COMPLETED|Overall Study||0
8565799|NCT00070070|9597831|FG002|NOT COMPLETED|Overall Study||0
8565800|NCT00070070|9597832|FG003|NOT COMPLETED|Overall Study||0
8565801|NCT00070109|9597847|FG000|STARTED|Overall Study||8
8565802|NCT00070109|9597848|FG001|STARTED|Overall Study||6
8565803|NCT00070109|9597849|FG002|STARTED|Overall Study||8
8565804|NCT00070109|9597850|FG003|STARTED|Overall Study||20
8565805|NCT00070109|9597851|FG004|STARTED|Overall Study||8
8565806|NCT00070109|9597847|FG000|COMPLETED|Overall Study||0
8565807|NCT00070109|9597848|FG001|COMPLETED|Overall Study||0
8565808|NCT00070109|9597849|FG002|COMPLETED|Overall Study||0
8565809|NCT00070109|9597850|FG003|COMPLETED|Overall Study||0
8565810|NCT00070109|9597851|FG004|COMPLETED|Overall Study||0
8565811|NCT00070109|9597847|FG000|NOT COMPLETED|Overall Study||8
8565812|NCT00070109|9597848|FG001|NOT COMPLETED|Overall Study||6
8565813|NCT00070109|9597849|FG002|NOT COMPLETED|Overall Study||8
8565814|NCT00070109|9597850|FG003|NOT COMPLETED|Overall Study||20
8565815|NCT00070109|9597851|FG004|NOT COMPLETED|Overall Study||8
8565816|NCT00070135|9597870|FG000|STARTED|Overall Study||114
8565817|NCT00070135|9597870|FG000|COMPLETED|Overall Study||114
8565818|NCT00070135|9597870|FG000|NOT COMPLETED|Overall Study||0
8565819|NCT00070291|9597874|FG000|STARTED|Step 1||4
8565820|NCT00070291|9597874|FG000|Treated|Step 1||3
8565821|NCT00070291|9597874|FG000|COMPLETED|Step 1||2
8565822|NCT00070291|9597874|FG000|NOT COMPLETED|Step 1||2
8565823|NCT00070291|9597874|FG000|STARTED|Step 2|One patient completed step 1, but opted to get alternative therapy. One patient entered step 2.|1
8565824|NCT00070291|9597874|FG000|COMPLETED|Step 2||0
8565825|NCT00070291|9597874|FG000|NOT COMPLETED|Step 2||1
8565826|NCT00070317|9597878|FG000|STARTED|Overall Study||102
8565827|NCT00070317|9597878|FG000|COMPLETED|Overall Study||89
8565828|NCT00070317|9597878|FG000|NOT COMPLETED|Overall Study||13
8565829|NCT00070941|9597885|FG000|STARTED|Overall Study||12
8565830|NCT00070941|9597886|FG001|STARTED|Overall Study||11
8565831|NCT00070941|9597887|FG002|STARTED|Overall Study||6
8565832|NCT00070941|9597885|FG000|COMPLETED|Overall Study||2
8565833|NCT00070941|9597886|FG001|COMPLETED|Overall Study||3
8565834|NCT00070941|9597887|FG002|COMPLETED|Overall Study||2
8565835|NCT00070941|9597885|FG000|NOT COMPLETED|Overall Study||10
8565836|NCT00070941|9597886|FG001|NOT COMPLETED|Overall Study||8
8629451|NCT00530270|9669192|FG001|NOT COMPLETED|Overall Study||0
8565837|NCT00070941|9597887|FG002|NOT COMPLETED|Overall Study||4
8565838|NCT00071006|9597895|FG000|STARTED|Overall Study||12
8565839|NCT00071006|9597895|FG000|COMPLETED|Overall Study||0
8565840|NCT00071006|9597895|FG000|NOT COMPLETED|Overall Study||12
8565841|NCT00071032|9597901|FG000|STARTED|Overall Study||1007
8565842|NCT00071032|9597902|FG001|STARTED|Overall Study||1009
8565843|NCT00071032|9597901|FG000|COMPLETED|Overall Study||998
8565844|NCT00071032|9597902|FG001|COMPLETED|Overall Study||1001
8565845|NCT00071032|9597901|FG000|NOT COMPLETED|Overall Study||9
8565846|NCT00071032|9597902|FG001|NOT COMPLETED|Overall Study||8
8565847|NCT00071058|9597909|FG000|STARTED|Overall Study||50
8565848|NCT00071058|9597909|FG000|COMPLETED|Overall Study||49
8565849|NCT00071058|9597909|FG000|NOT COMPLETED|Overall Study||1
8565850|NCT00071110|9597916|FG000|STARTED|Overall Study||28
8565851|NCT00071110|9597917|FG001|STARTED|Overall Study||29
8565852|NCT00071110|9597916|FG000|COMPLETED|Overall Study||28
8565853|NCT00071110|9597917|FG001|COMPLETED|Overall Study||25
8565854|NCT00071110|9597916|FG000|NOT COMPLETED|Overall Study||0
8565855|NCT00071110|9597917|FG001|NOT COMPLETED|Overall Study||4
8538807|NCT02513485|9571481|FG000|STARTED|Overall Study||28
8538808|NCT02513485|9571482|FG001|STARTED|Overall Study||29
8538809|NCT02513485|9571481|FG000|COMPLETED|Overall Study||27
8538810|NCT02513485|9571482|FG001|COMPLETED|Overall Study||29
8538811|NCT02513485|9571481|FG000|NOT COMPLETED|Overall Study||1
8538812|NCT02513485|9571482|FG001|NOT COMPLETED|Overall Study||0
8538813|NCT02476201|9571488|FG000|STARTED|Overall Study||105
8538814|NCT02476201|9571488|FG000|Implant Attempts|Overall Study||103
8538815|NCT02476201|9571488|FG000|Sucessful Implants|Overall Study||102
8538816|NCT02476201|9571488|FG000|6 Months Visit|Overall Study||82
8538817|NCT02476201|9571488|FG000|COMPLETED|Overall Study||79
8538818|NCT02476201|9571488|FG000|NOT COMPLETED|Overall Study||26
8538819|NCT02454933|9571495|FG000|STARTED|Overall Study||17
8538820|NCT02454933|9571496|FG001|STARTED|Overall Study|2 subjects switched to osimertinib monotherapy Cycle 1 Day 1|12
8538821|NCT02454933|9571495|FG000|Treatment Group Randomised to|Overall Study||15
8538822|NCT02454933|9571496|FG001|Treatment Group Randomised to|Overall Study||14
8538823|NCT02454933|9571495|FG000|COMPLETED|Overall Study||9
8538824|NCT02454933|9571496|FG001|COMPLETED|Overall Study||4
8538825|NCT02454933|9571495|FG000|NOT COMPLETED|Overall Study||8
8538826|NCT02454933|9571496|FG001|NOT COMPLETED|Overall Study||8
8538827|NCT02426684|9571501|FG000|STARTED|Overall Study||17
8538828|NCT02426684|9571501|FG000|COMPLETED|Overall Study||16
8538829|NCT02426684|9571501|FG000|NOT COMPLETED|Overall Study||1
8538830|NCT02337751|9571507|FG000|STARTED|Overall Study||95
8538831|NCT02337751|9571508|FG001|STARTED|Overall Study||103
8538832|NCT02337751|9571507|FG000|COMPLETED|Overall Study||84
8538833|NCT02337751|9571508|FG001|COMPLETED|Overall Study||87
8538834|NCT02337751|9571507|FG000|NOT COMPLETED|Overall Study||11
8538835|NCT02337751|9571508|FG001|NOT COMPLETED|Overall Study||16
8538836|NCT02337725|9571517|FG000|STARTED|Overall Study||126
8538837|NCT02337725|9571518|FG001|STARTED|Overall Study||118
8538838|NCT02337725|9571517|FG000|COMPLETED|Overall Study||100
8538839|NCT02337725|9571518|FG001|COMPLETED|Overall Study||110
8538840|NCT02337725|9571517|FG000|NOT COMPLETED|Overall Study||26
8538841|NCT02337725|9571518|FG001|NOT COMPLETED|Overall Study||8
8538842|NCT02332655|9571524|FG000|STARTED|Overall Study||5
8538843|NCT02332655|9571524|FG000|COMPLETED|Overall Study||4
8538844|NCT02332655|9571524|FG000|NOT COMPLETED|Overall Study||1
8538845|NCT02130687|9571531|FG000|STARTED|Washout||36
8538846|NCT02130687|9571532|FG001|STARTED|Washout||35
8538847|NCT02130687|9571533|FG002|STARTED|Washout||35
8538848|NCT02130687|9571531|FG000|COMPLETED|Washout||36
8538849|NCT02130687|9571532|FG001|COMPLETED|Washout||33
8538850|NCT02130687|9571533|FG002|COMPLETED|Washout||31
8538851|NCT02130687|9571531|FG000|NOT COMPLETED|Washout||0
8538852|NCT02130687|9571532|FG001|NOT COMPLETED|Washout||2
8538853|NCT02130687|9571533|FG002|NOT COMPLETED|Washout||4
8538854|NCT02130687|9571531|FG000|STARTED|Drug 1 Only||36
8538855|NCT02130687|9571532|FG001|STARTED|Drug 1 Only||33
8538856|NCT02130687|9571533|FG002|STARTED|Drug 1 Only||31
8538857|NCT02130687|9571531|FG000|COMPLETED|Drug 1 Only||33
8538858|NCT02130687|9571532|FG001|COMPLETED|Drug 1 Only||30
8538859|NCT02130687|9571533|FG002|COMPLETED|Drug 1 Only||30
8538860|NCT02130687|9571531|FG000|NOT COMPLETED|Drug 1 Only||3
8538861|NCT02130687|9571532|FG001|NOT COMPLETED|Drug 1 Only||3
8538862|NCT02130687|9571533|FG002|NOT COMPLETED|Drug 1 Only||1
8538863|NCT02130687|9571531|FG000|STARTED|Crossover Period 1||33
8538864|NCT02130687|9571532|FG001|STARTED|Crossover Period 1||30
8538865|NCT02130687|9571533|FG002|STARTED|Crossover Period 1||30
8818010|NCT01555125|9871646|FG004|STARTED|Follow-Up Period||0
8818011|NCT01555125|9871642|FG000|COMPLETED|Follow-Up Period||32
8818012|NCT01555125|9871643|FG001|COMPLETED|Follow-Up Period||30
8818013|NCT01555125|9871644|FG002|COMPLETED|Follow-Up Period||18
8818014|NCT01555125|9871645|FG003|COMPLETED|Follow-Up Period||17
8538866|NCT02130687|9571531|FG000|COMPLETED|Crossover Period 1||33
8538867|NCT02130687|9571532|FG001|COMPLETED|Crossover Period 1||30
8538868|NCT02130687|9571533|FG002|COMPLETED|Crossover Period 1||30
8538869|NCT02130687|9571531|FG000|NOT COMPLETED|Crossover Period 1||0
8538870|NCT02130687|9571532|FG001|NOT COMPLETED|Crossover Period 1||0
8538871|NCT02130687|9571533|FG002|NOT COMPLETED|Crossover Period 1||0
8538872|NCT02130687|9571531|FG000|STARTED|Drug 1 Only Between Periods 1 and 2||33
8538873|NCT02130687|9571532|FG001|STARTED|Drug 1 Only Between Periods 1 and 2||30
8538874|NCT02130687|9571533|FG002|STARTED|Drug 1 Only Between Periods 1 and 2||30
8538875|NCT02130687|9571531|FG000|COMPLETED|Drug 1 Only Between Periods 1 and 2||33
8538876|NCT02130687|9571532|FG001|COMPLETED|Drug 1 Only Between Periods 1 and 2||26
8538877|NCT02130687|9571533|FG002|COMPLETED|Drug 1 Only Between Periods 1 and 2||29
8538878|NCT02130687|9571531|FG000|NOT COMPLETED|Drug 1 Only Between Periods 1 and 2||0
8538879|NCT02130687|9571532|FG001|NOT COMPLETED|Drug 1 Only Between Periods 1 and 2||4
8538880|NCT02130687|9571533|FG002|NOT COMPLETED|Drug 1 Only Between Periods 1 and 2||1
8538881|NCT02130687|9571531|FG000|STARTED|Crossover Period 2||33
8538882|NCT02130687|9571532|FG001|STARTED|Crossover Period 2||26
8818015|NCT01555125|9871646|FG004|COMPLETED|Follow-Up Period||0
8818016|NCT01555125|9871642|FG000|NOT COMPLETED|Follow-Up Period||4
8818017|NCT01555125|9871643|FG001|NOT COMPLETED|Follow-Up Period||1
8538883|NCT02130687|9571533|FG002|STARTED|Crossover Period 2||29
8538884|NCT02130687|9571531|FG000|COMPLETED|Crossover Period 2||33
8538885|NCT02130687|9571532|FG001|COMPLETED|Crossover Period 2||26
8538886|NCT02130687|9571533|FG002|COMPLETED|Crossover Period 2||29
8538887|NCT02130687|9571531|FG000|NOT COMPLETED|Crossover Period 2||0
8538888|NCT02130687|9571532|FG001|NOT COMPLETED|Crossover Period 2||0
8538889|NCT02130687|9571533|FG002|NOT COMPLETED|Crossover Period 2||0
8538890|NCT02130687|9571531|FG000|STARTED|Drug 1 Only Between Periods 2 and 3||33
8538891|NCT02130687|9571532|FG001|STARTED|Drug 1 Only Between Periods 2 and 3||26
8538892|NCT02130687|9571533|FG002|STARTED|Drug 1 Only Between Periods 2 and 3||29
8538893|NCT02130687|9571531|FG000|COMPLETED|Drug 1 Only Between Periods 2 and 3||33
8538894|NCT02130687|9571532|FG001|COMPLETED|Drug 1 Only Between Periods 2 and 3||25
8538895|NCT02130687|9571533|FG002|COMPLETED|Drug 1 Only Between Periods 2 and 3||27
8538896|NCT02130687|9571531|FG000|NOT COMPLETED|Drug 1 Only Between Periods 2 and 3||0
8538897|NCT02130687|9571532|FG001|NOT COMPLETED|Drug 1 Only Between Periods 2 and 3||1
8538898|NCT02130687|9571533|FG002|NOT COMPLETED|Drug 1 Only Between Periods 2 and 3||2
8538899|NCT02130687|9571531|FG000|STARTED|Crossover Period 3||33
8538900|NCT02130687|9571532|FG001|STARTED|Crossover Period 3||25
8538901|NCT02130687|9571533|FG002|STARTED|Crossover Period 3||27
8538902|NCT02130687|9571531|FG000|COMPLETED|Crossover Period 3||33
8538903|NCT02130687|9571532|FG001|COMPLETED|Crossover Period 3||25
8538904|NCT02130687|9571533|FG002|COMPLETED|Crossover Period 3||27
8538905|NCT02130687|9571531|FG000|NOT COMPLETED|Crossover Period 3||0
8538906|NCT02130687|9571532|FG001|NOT COMPLETED|Crossover Period 3||0
8538907|NCT02130687|9571533|FG002|NOT COMPLETED|Crossover Period 3||0
8723041|NCT01021306|9770545|FG002|COMPLETED|2 Month (Primary Outcome)||14
8621043|NCT00477490|9659932|FG001|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|155
8621044|NCT00477490|9659933|FG002|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|152
8621045|NCT00477490|9659934|FG003|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|148
8621046|NCT00477490|9659935|FG004|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|146
8621047|NCT00477490|9659936|FG005|ITT Population|Part I: 4 Week Efficacy||0
8565856|NCT00071396|9597923|FG000|STARTED|Overall Study||44
8565857|NCT00071396|9597923|FG000|COMPLETED|Overall Study|Evaluable for response.|41
8565858|NCT00071396|9597923|FG000|NOT COMPLETED|Overall Study||3
8565859|NCT00071487|9597931|FG000|STARTED|52-Week Double-Blind Period||113
8565860|NCT00071487|9597932|FG001|STARTED|52-Week Double-Blind Period||114
8565861|NCT00071487|9597933|FG002|STARTED|52-Week Double-Blind Period||111
8565862|NCT00071487|9597934|FG003|STARTED|52-Week Double-Blind Period||111
8565863|NCT00071487|9597931|FG000|COMPLETED|52-Week Double-Blind Period||93
8565864|NCT00071487|9597932|FG001|COMPLETED|52-Week Double-Blind Period||87
8565865|NCT00071487|9597933|FG002|COMPLETED|52-Week Double-Blind Period||94
8565866|NCT00071487|9597934|FG003|COMPLETED|52-Week Double-Blind Period||90
8565867|NCT00071487|9597931|FG000|NOT COMPLETED|52-Week Double-Blind Period||20
8565868|NCT00071487|9597932|FG001|NOT COMPLETED|52-Week Double-Blind Period||27
8565869|NCT00071487|9597933|FG002|NOT COMPLETED|52-Week Double-Blind Period||17
8565870|NCT00071487|9597934|FG003|NOT COMPLETED|52-Week Double-Blind Period||21
8565871|NCT00071487|9597931|FG000|STARTED|24-Week Open-Label Extension Period|Of 93: 88 switched to 10 mg/kg; 5 elected not to continue in the open-label extension period.|0
8565872|NCT00071487|9597932|FG001|STARTED|24-Week Open-Label Extension Period|Of 87: 65 switched to 10 mg/kg; 3 elected not to continue in the open-label extension period.|19
8565873|NCT00071487|9597933|FG002|STARTED|24-Week Open-Label Extension Period|Of 94: 64 switched to 10 mg/kg; 6 elected not to continue in the open-label extension period.|24
8565874|NCT00071487|9597934|FG003|STARTED|24-Week Open-Label Extension Period|Of 90: 85 continued with 10 mg/kg; 5 elected not to continue in the open-label extension period.|302
8565875|NCT00071487|9597931|FG000|COMPLETED|24-Week Open-Label Extension Period||0
8565876|NCT00071487|9597932|FG001|COMPLETED|24-Week Open-Label Extension Period||19
8565877|NCT00071487|9597933|FG002|COMPLETED|24-Week Open-Label Extension Period||23
8565878|NCT00071487|9597934|FG003|COMPLETED|24-Week Open-Label Extension Period||279
8565879|NCT00071487|9597931|FG000|NOT COMPLETED|24-Week Open-Label Extension Period||0
8565880|NCT00071487|9597932|FG001|NOT COMPLETED|24-Week Open-Label Extension Period||0
8565881|NCT00071487|9597933|FG002|NOT COMPLETED|24-Week Open-Label Extension Period||1
8565882|NCT00071487|9597934|FG003|NOT COMPLETED|24-Week Open-Label Extension Period||23
8565883|NCT00071513|9597948|FG000|STARTED|Intervention Component||241
8565884|NCT00071513|9597949|FG001|STARTED|Intervention Component||256
8565885|NCT00071513|9597948|FG000|COMPLETED|Intervention Component||239
8565886|NCT00071513|9597949|FG001|COMPLETED|Intervention Component||253
8565887|NCT00071513|9597948|FG000|NOT COMPLETED|Intervention Component||2
8565888|NCT00071513|9597949|FG001|NOT COMPLETED|Intervention Component||3
8565889|NCT00071513|9597948|FG000|STARTED|Follow-up Assessment||239
8565890|NCT00071513|9597949|FG001|STARTED|Follow-up Assessment||253
8565891|NCT00071513|9597948|FG000|COMPLETED|Follow-up Assessment||233
8565892|NCT00071513|9597949|FG001|COMPLETED|Follow-up Assessment||247
8565893|NCT00071513|9597948|FG000|NOT COMPLETED|Follow-up Assessment||6
8565894|NCT00071513|9597949|FG001|NOT COMPLETED|Follow-up Assessment||6
8565895|NCT00071721|9597959|FG000|STARTED|Overall Study||153
8565896|NCT00071721|9597960|FG001|STARTED|Overall Study||160
8621048|NCT00477490|9659937|FG006|ITT Population|Part I: 4 Week Efficacy||0
8621049|NCT00477490|9659938|FG007|ITT Population|Part I: 4 Week Efficacy||0
8621050|NCT00477490|9659939|FG008|ITT Population|Part I: 4 Week Efficacy||0
8621051|NCT00477490|9659931|FG000|COMPLETED|Part I: 4 Week Efficacy||145
8621052|NCT00477490|9659932|FG001|COMPLETED|Part I: 4 Week Efficacy||144
8723042|NCT01021306|9770546|FG003|COMPLETED|2 Month (Primary Outcome)||17
8565897|NCT00071721|9597959|FG000|COMPLETED|Overall Study||81
8565898|NCT00071721|9597960|FG001|COMPLETED|Overall Study||69
8538908|NCT01994382|9571576|FG000|STARTED|Overall Study||3
8538909|NCT01994382|9571577|FG001|STARTED|Overall Study||6
8538910|NCT01994382|9571578|FG002|STARTED|Overall Study||7
8538911|NCT01994382|9571579|FG003|STARTED|Overall Study||3
8538912|NCT01994382|9571580|FG004|STARTED|Overall Study||3
8538913|NCT01994382|9571581|FG005|STARTED|Overall Study||3
8538914|NCT01994382|9571582|FG006|STARTED|Overall Study||4
8538915|NCT01994382|9571583|FG007|STARTED|Overall Study||6
8538916|NCT01994382|9571584|FG008|STARTED|Overall Study||3
8538917|NCT01994382|9571585|FG009|STARTED|Overall Study||5
8538918|NCT01994382|9571586|FG010|STARTED|Overall Study||42
8538919|NCT01994382|9571587|FG011|STARTED|Overall Study||12
8538920|NCT01994382|9571588|FG012|STARTED|Overall Study||26
8538921|NCT01994382|9571589|FG013|STARTED|Overall Study||6
8538922|NCT01994382|9571590|FG014|STARTED|Overall Study||28
8538923|NCT01994382|9571591|FG015|STARTED|Overall Study||65
8538924|NCT01994382|9571592|FG016|STARTED|Overall Study||41
8538925|NCT01994382|9571576|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
8538926|NCT01994382|9571577|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
8538927|NCT01994382|9571578|FG002|Received at Least 1 Dose of Study Drug|Overall Study||7
8538928|NCT01994382|9571579|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
8538929|NCT01994382|9571580|FG004|Received at Least 1 Dose of Study Drug|Overall Study||3
8538930|NCT01994382|9571581|FG005|Received at Least 1 Dose of Study Drug|Overall Study||3
8538931|NCT01994382|9571582|FG006|Received at Least 1 Dose of Study Drug|Overall Study||4
8538932|NCT01994382|9571583|FG007|Received at Least 1 Dose of Study Drug|Overall Study||6
8538933|NCT01994382|9571584|FG008|Received at Least 1 Dose of Study Drug|Overall Study||3
8538934|NCT01994382|9571585|FG009|Received at Least 1 Dose of Study Drug|Overall Study||5
8538935|NCT01994382|9571586|FG010|Received at Least 1 Dose of Study Drug|Overall Study||42
8538936|NCT01994382|9571587|FG011|Received at Least 1 Dose of Study Drug|Overall Study||12
8538937|NCT01994382|9571588|FG012|Received at Least 1 Dose of Study Drug|Overall Study||26
8538938|NCT01994382|9571589|FG013|Received at Least 1 Dose of Study Drug|Overall Study||6
8538939|NCT01994382|9571590|FG014|Received at Least 1 Dose of Study Drug|Overall Study||28
8538940|NCT01994382|9571591|FG015|Received at Least 1 Dose of Study Drug|Overall Study||65
8538941|NCT01994382|9571592|FG016|Received at Least 1 Dose of Study Drug|Overall Study||41
8538942|NCT01994382|9571576|FG000|COMPLETED|Overall Study||0
8538943|NCT01994382|9571577|FG001|COMPLETED|Overall Study||0
8538944|NCT01994382|9571578|FG002|COMPLETED|Overall Study||0
8538945|NCT01994382|9571579|FG003|COMPLETED|Overall Study||0
8538946|NCT01994382|9571580|FG004|COMPLETED|Overall Study||0
8538947|NCT01994382|9571581|FG005|COMPLETED|Overall Study||0
8538948|NCT01994382|9571582|FG006|COMPLETED|Overall Study||0
8538949|NCT01994382|9571583|FG007|COMPLETED|Overall Study||0
8538950|NCT01994382|9571584|FG008|COMPLETED|Overall Study||0
8538951|NCT01994382|9571585|FG009|COMPLETED|Overall Study||0
8538952|NCT01994382|9571586|FG010|COMPLETED|Overall Study||0
8538953|NCT01994382|9571587|FG011|COMPLETED|Overall Study||0
8538954|NCT01994382|9571588|FG012|COMPLETED|Overall Study||0
8538955|NCT01994382|9571589|FG013|COMPLETED|Overall Study||0
8538956|NCT01994382|9571590|FG014|COMPLETED|Overall Study||0
8538957|NCT01994382|9571591|FG015|COMPLETED|Overall Study||0
8538958|NCT01994382|9571592|FG016|COMPLETED|Overall Study||0
8538959|NCT01994382|9571576|FG000|NOT COMPLETED|Overall Study||3
8538960|NCT01994382|9571577|FG001|NOT COMPLETED|Overall Study||6
8538961|NCT01994382|9571578|FG002|NOT COMPLETED|Overall Study||7
8538962|NCT01994382|9571579|FG003|NOT COMPLETED|Overall Study||3
8538963|NCT01994382|9571580|FG004|NOT COMPLETED|Overall Study||3
8538964|NCT01994382|9571581|FG005|NOT COMPLETED|Overall Study||3
8538965|NCT01994382|9571582|FG006|NOT COMPLETED|Overall Study||4
8538966|NCT01994382|9571583|FG007|NOT COMPLETED|Overall Study||6
8538967|NCT01994382|9571584|FG008|NOT COMPLETED|Overall Study||3
8538968|NCT01994382|9571585|FG009|NOT COMPLETED|Overall Study||5
8538969|NCT01994382|9571586|FG010|NOT COMPLETED|Overall Study||42
8538970|NCT01994382|9571587|FG011|NOT COMPLETED|Overall Study||12
8538971|NCT01994382|9571588|FG012|NOT COMPLETED|Overall Study||26
8538972|NCT01994382|9571589|FG013|NOT COMPLETED|Overall Study||6
8538973|NCT01994382|9571590|FG014|NOT COMPLETED|Overall Study||28
8538974|NCT01994382|9571591|FG015|NOT COMPLETED|Overall Study||65
8538975|NCT01994382|9571592|FG016|NOT COMPLETED|Overall Study||41
8538976|NCT01896531|9571637|FG000|STARTED|Overall Study||71
8538977|NCT01896531|9571638|FG001|STARTED|Overall Study||82
8538978|NCT01896531|9571637|FG000|Treated|Overall Study||70
8538979|NCT01896531|9571638|FG001|Treated|Overall Study||82
8538980|NCT01896531|9571637|FG000|COMPLETED|Overall Study||0
8538981|NCT01896531|9571638|FG001|COMPLETED|Overall Study||0
8538982|NCT01896531|9571637|FG000|NOT COMPLETED|Overall Study||71
8538983|NCT01896531|9571638|FG001|NOT COMPLETED|Overall Study||82
8538984|NCT01864603|9571646|FG000|STARTED|Stage 1|Describes # of participants who were residents and aged 15+yrs at baseline|79818
8538985|NCT01864603|9571647|FG001|STARTED|Stage 1|Describes # of participants who were residents and aged 15+yrs at baseline|70577
8538986|NCT01864603|9571646|FG000|COMPLETED|Stage 1||71028
8538987|NCT01864603|9571647|FG001|COMPLETED|Stage 1||62912
8538988|NCT01864603|9571646|FG000|NOT COMPLETED|Stage 1||8790
8538989|NCT01864603|9571647|FG001|NOT COMPLETED|Stage 1||7665
8538990|NCT01864603|9571646|FG000|STARTED|Stage 2|Describes # of participants who were residents and aged 15+yrs at the start of Stage 2|91533
8538991|NCT01864603|9571647|FG001|STARTED|Stage 2|Describes # of participants who were residents and aged 15+yrs at the start of Stage 2|92558
8538992|NCT01864603|9571646|FG000|COMPLETED|Stage 2||5477
8538993|NCT01864603|9571647|FG001|COMPLETED|Stage 2||0
8538994|NCT01864603|9571646|FG000|NOT COMPLETED|Stage 2||86056
8538995|NCT01864603|9571647|FG001|NOT COMPLETED|Stage 2||92558
8565899|NCT00071721|9597959|FG000|NOT COMPLETED|Overall Study||72
8565900|NCT00071721|9597960|FG001|NOT COMPLETED|Overall Study||91
8565901|NCT00071760|9597966|FG000|STARTED|Overall Study||54
8565902|NCT00071760|9597966|FG000|Ongoing|Overall Study||25
8565903|NCT00071760|9597966|FG000|COMPLETED|Overall Study||0
8565904|NCT00071760|9597966|FG000|NOT COMPLETED|Overall Study||54
8565905|NCT00071799|9597978|FG000|STARTED|Overall Study||179
8565906|NCT00071799|9597979|FG001|STARTED|Overall Study|Best supportive care: 105, Low-dose cytarabine: 49, Standard chemotherapy: 25 patients|179
8565907|NCT00071799|9597978|FG000|COMPLETED|Overall Study|Includes those who died or transformed to AML, or receiving drug + eligible for extension period.|109
8565908|NCT00071799|9597979|FG001|COMPLETED|Overall Study|Includes patients who died or transformed to AML during treatment, or were still receiving drug.|81
8565909|NCT00071799|9597978|FG000|NOT COMPLETED|Overall Study||70
8565910|NCT00071799|9597979|FG001|NOT COMPLETED|Overall Study||98
8565911|NCT00071812|9597995|FG000|STARTED|24-Week Double-Blind Period||69
8565912|NCT00071812|9597996|FG001|STARTED|24-Week Double-Blind Period||72
8565913|NCT00071812|9597997|FG002|STARTED|24-Week Double-Blind Period||71
8565914|NCT00071812|9597998|FG003|STARTED|24-Week Double-Blind Period||71
8565915|NCT00071812|9597995|FG000|COMPLETED|24-Week Double-Blind Period||59
8565916|NCT00071812|9597996|FG001|COMPLETED|24-Week Double-Blind Period||66
8565917|NCT00071812|9597997|FG002|COMPLETED|24-Week Double-Blind Period||63
8565918|NCT00071812|9597998|FG003|COMPLETED|24-Week Double-Blind Period||60
8565919|NCT00071812|9597995|FG000|NOT COMPLETED|24-Week Double-Blind Period||10
8565920|NCT00071812|9597996|FG001|NOT COMPLETED|24-Week Double-Blind Period||6
8565921|NCT00071812|9597997|FG002|NOT COMPLETED|24-Week Double-Blind Period||8
8565922|NCT00071812|9597998|FG003|NOT COMPLETED|24-Week Double-Blind Period||11
8565923|NCT00071812|9597995|FG000|STARTED|24-Week Open-Label Extension Period|Of 59: 56 switched to 10 mg/kg; 3 elected not to continue in the open-label extension.|0
8565924|NCT00071812|9597996|FG001|STARTED|24-Week Open-Label Extension Period|Of 66: 53 switched to 10 mg/kg; 2 elected not continue in the open-label extension.|11
8565925|NCT00071812|9597997|FG002|STARTED|24-Week Open-Label Extension Period|Of 63: 53 switched to 10 mg/kg; 2 elected not continue in the open-label extension.|8
8565926|NCT00071812|9597998|FG003|STARTED|24-Week Open-Label Extension Period|Of 60: 56 continued with 10 mg/kg; 4 elected not to continue in the open-label extension.|218
8565927|NCT00071812|9597995|FG000|COMPLETED|24-Week Open-Label Extension Period||0
8565928|NCT00071812|9597996|FG001|COMPLETED|24-Week Open-Label Extension Period||11
8565929|NCT00071812|9597997|FG002|COMPLETED|24-Week Open-Label Extension Period||7
8565930|NCT00071812|9597998|FG003|COMPLETED|24-Week Open-Label Extension Period||178
8565931|NCT00071812|9597995|FG000|NOT COMPLETED|24-Week Open-Label Extension Period||0
8565932|NCT00071812|9597996|FG001|NOT COMPLETED|24-Week Open-Label Extension Period||0
8565933|NCT00071812|9597997|FG002|NOT COMPLETED|24-Week Open-Label Extension Period||1
8565934|NCT00071812|9597998|FG003|NOT COMPLETED|24-Week Open-Label Extension Period||40
8565935|NCT00071890|9598012|FG000|STARTED|Overall Study|3 patients did not received Interleukin-2|81
8565936|NCT00071890|9598013|FG001|STARTED|Overall Study|1 patients stopped HAART at week 0|67
8565937|NCT00071890|9598012|FG000|COMPLETED|Overall Study|"1 withdrawal~1 death 81 patients analysed"|81
8565938|NCT00071890|9598013|FG001|COMPLETED|Overall Study|"1 withdrawal~1 lost of follow-up~1 death 67 patients analysed"|67
8565939|NCT00071890|9598012|FG000|NOT COMPLETED|Overall Study||0
8565940|NCT00071890|9598013|FG001|NOT COMPLETED|Overall Study||0
8565941|NCT00071981|9598023|FG000|STARTED|Overall Study||47
8565942|NCT00071981|9598024|FG001|STARTED|Overall Study||43
8565943|NCT00071981|9598025|FG002|STARTED|Overall Study||37
8565944|NCT00071981|9598026|FG003|STARTED|Overall Study||48
8565945|NCT00071981|9598023|FG000|Eligible|Overall Study||43
8565946|NCT00071981|9598024|FG001|Eligible|Overall Study||36
8565947|NCT00071981|9598025|FG002|Eligible|Overall Study||33
8565948|NCT00071981|9598026|FG003|Eligible|Overall Study||42
8565949|NCT00071981|9598023|FG000|Treated|Overall Study||45
8565950|NCT00071981|9598024|FG001|Treated|Overall Study||38
8565951|NCT00071981|9598025|FG002|Treated|Overall Study||36
8565952|NCT00071981|9598026|FG003|Treated|Overall Study||48
8565953|NCT00071981|9598023|FG000|Eligible and Treated|Overall Study||41
8565954|NCT00071981|9598024|FG001|Eligible and Treated|Overall Study||33
8565955|NCT00071981|9598025|FG002|Eligible and Treated|Overall Study||32
8565956|NCT00071981|9598026|FG003|Eligible and Treated|Overall Study||42
8565957|NCT00071981|9598023|FG000|Have CTL Response Data|Overall Study||40
8565958|NCT00071981|9598024|FG001|Have CTL Response Data|Overall Study||30
8565959|NCT00071981|9598025|FG002|Have CTL Response Data|Overall Study||29
8565960|NCT00071981|9598026|FG003|Have CTL Response Data|Overall Study||41
8565961|NCT00071981|9598023|FG000|Have Helper T Cell Response Data|Overall Study||37
8565962|NCT00071981|9598024|FG001|Have Helper T Cell Response Data|Overall Study||27
8565963|NCT00071981|9598025|FG002|Have Helper T Cell Response Data|Overall Study||25
8565964|NCT00071981|9598026|FG003|Have Helper T Cell Response Data|Overall Study||39
8565965|NCT00071981|9598023|FG000|COMPLETED|Overall Study||1
8565966|NCT00071981|9598024|FG001|COMPLETED|Overall Study||2
8565967|NCT00071981|9598025|FG002|COMPLETED|Overall Study||0
8565968|NCT00071981|9598026|FG003|COMPLETED|Overall Study||3
8565969|NCT00071981|9598023|FG000|NOT COMPLETED|Overall Study||46
8565970|NCT00071981|9598024|FG001|NOT COMPLETED|Overall Study||41
8565971|NCT00071981|9598025|FG002|NOT COMPLETED|Overall Study||37
8565972|NCT00071981|9598026|FG003|NOT COMPLETED|Overall Study||45
8538996|NCT01399658|9571658|FG000|STARTED|Overall Study||93
8538997|NCT01399658|9571658|FG000|COMPLETED|Overall Study||87
8538998|NCT01399658|9571658|FG000|NOT COMPLETED|Overall Study||6
8538999|NCT01397968|9571664|FG000|STARTED|Double-blind Period of Study YKP3089C013||113
8539000|NCT01397968|9571665|FG001|STARTED|Double-blind Period of Study YKP3089C013||109
8539001|NCT01397968|9571664|FG000|COMPLETED|Double-blind Period of Study YKP3089C013||102
8539002|NCT01397968|9571665|FG001|COMPLETED|Double-blind Period of Study YKP3089C013||99
8539003|NCT01397968|9571664|FG000|NOT COMPLETED|Double-blind Period of Study YKP3089C013||11
8539004|NCT01397968|9571665|FG001|NOT COMPLETED|Double-blind Period of Study YKP3089C013||10
8539005|NCT01397968|9571664|FG000|STARTED|Open-label Extension Study YKP3089C013|Not all subjects from double-blind rolled over to open-label.|76
8539006|NCT01397968|9571665|FG001|STARTED|Open-label Extension Study YKP3089C013|Not all subjects from double-blind rolled over to open-label.|73
8539007|NCT01397968|9571664|FG000|COMPLETED|Open-label Extension Study YKP3089C013||40
8539008|NCT01397968|9571665|FG001|COMPLETED|Open-label Extension Study YKP3089C013||37
8539009|NCT01397968|9571664|FG000|NOT COMPLETED|Open-label Extension Study YKP3089C013||36
8539010|NCT01397968|9571665|FG001|NOT COMPLETED|Open-label Extension Study YKP3089C013||36
8539020|NCT00966953|9571690|FG000|STARTED|1st Intervention||6
8539021|NCT00966953|9571691|FG001|STARTED|1st Intervention||6
8539022|NCT00966953|9571692|FG002|STARTED|1st Intervention||6
8539023|NCT00966953|9571693|FG003|STARTED|1st Intervention||7
8539024|NCT00966953|9571690|FG000|COMPLETED|1st Intervention||6
8539025|NCT00966953|9571691|FG001|COMPLETED|1st Intervention||6
8539026|NCT00966953|9571692|FG002|COMPLETED|1st Intervention||6
8539027|NCT00966953|9571693|FG003|COMPLETED|1st Intervention||7
8539028|NCT00966953|9571690|FG000|NOT COMPLETED|1st Intervention||0
8539029|NCT00966953|9571691|FG001|NOT COMPLETED|1st Intervention||0
8539030|NCT00966953|9571692|FG002|NOT COMPLETED|1st Intervention||0
8539031|NCT00966953|9571693|FG003|NOT COMPLETED|1st Intervention||0
8539032|NCT00966953|9571690|FG000|STARTED|1 Week Washout After 1st Intervention||6
8539033|NCT00966953|9571691|FG001|STARTED|1 Week Washout After 1st Intervention||6
8539034|NCT00966953|9571692|FG002|STARTED|1 Week Washout After 1st Intervention||6
8539035|NCT00966953|9571693|FG003|STARTED|1 Week Washout After 1st Intervention||7
8539036|NCT00966953|9571690|FG000|COMPLETED|1 Week Washout After 1st Intervention||6
8539037|NCT00966953|9571691|FG001|COMPLETED|1 Week Washout After 1st Intervention||6
8539038|NCT00966953|9571692|FG002|COMPLETED|1 Week Washout After 1st Intervention||6
8539039|NCT00966953|9571693|FG003|COMPLETED|1 Week Washout After 1st Intervention||7
8539040|NCT00966953|9571690|FG000|NOT COMPLETED|1 Week Washout After 1st Intervention||0
8539041|NCT00966953|9571691|FG001|NOT COMPLETED|1 Week Washout After 1st Intervention||0
8539042|NCT00966953|9571692|FG002|NOT COMPLETED|1 Week Washout After 1st Intervention||0
8539043|NCT00966953|9571693|FG003|NOT COMPLETED|1 Week Washout After 1st Intervention||0
8539044|NCT00966953|9571690|FG000|STARTED|2nd Intervention||6
8539045|NCT00966953|9571691|FG001|STARTED|2nd Intervention||6
8539046|NCT00966953|9571692|FG002|STARTED|2nd Intervention||6
8539047|NCT00966953|9571693|FG003|STARTED|2nd Intervention||7
8539048|NCT00966953|9571690|FG000|COMPLETED|2nd Intervention||6
8539049|NCT00966953|9571691|FG001|COMPLETED|2nd Intervention||6
8539050|NCT00966953|9571692|FG002|COMPLETED|2nd Intervention||6
8539051|NCT00966953|9571693|FG003|COMPLETED|2nd Intervention||7
8539052|NCT00966953|9571690|FG000|NOT COMPLETED|2nd Intervention||0
8539053|NCT00966953|9571691|FG001|NOT COMPLETED|2nd Intervention||0
8539054|NCT00966953|9571692|FG002|NOT COMPLETED|2nd Intervention||0
8539055|NCT00966953|9571693|FG003|NOT COMPLETED|2nd Intervention||0
8539056|NCT00966953|9571690|FG000|STARTED|1 Week Washout After 2nd Intervention||6
8539057|NCT00966953|9571691|FG001|STARTED|1 Week Washout After 2nd Intervention||6
8539058|NCT00966953|9571692|FG002|STARTED|1 Week Washout After 2nd Intervention||6
8539059|NCT00966953|9571693|FG003|STARTED|1 Week Washout After 2nd Intervention||7
8539060|NCT00966953|9571690|FG000|COMPLETED|1 Week Washout After 2nd Intervention||6
8539061|NCT00966953|9571691|FG001|COMPLETED|1 Week Washout After 2nd Intervention||6
8539062|NCT00966953|9571692|FG002|COMPLETED|1 Week Washout After 2nd Intervention||6
8539063|NCT00966953|9571693|FG003|COMPLETED|1 Week Washout After 2nd Intervention||7
8539064|NCT00966953|9571690|FG000|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
8539065|NCT00966953|9571691|FG001|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
8539066|NCT00966953|9571692|FG002|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
8539067|NCT00966953|9571693|FG003|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
8539068|NCT00966953|9571690|FG000|STARTED|3rd Intervention Order||6
8539069|NCT00966953|9571691|FG001|STARTED|3rd Intervention Order||6
8539070|NCT00966953|9571692|FG002|STARTED|3rd Intervention Order||6
8539071|NCT00966953|9571693|FG003|STARTED|3rd Intervention Order||7
8539072|NCT00966953|9571690|FG000|COMPLETED|3rd Intervention Order||6
8539073|NCT00966953|9571691|FG001|COMPLETED|3rd Intervention Order||6
8539074|NCT00966953|9571692|FG002|COMPLETED|3rd Intervention Order||6
8539075|NCT00966953|9571693|FG003|COMPLETED|3rd Intervention Order||7
8539076|NCT00966953|9571690|FG000|NOT COMPLETED|3rd Intervention Order||0
8539077|NCT00966953|9571691|FG001|NOT COMPLETED|3rd Intervention Order||0
8539078|NCT00966953|9571692|FG002|NOT COMPLETED|3rd Intervention Order||0
8539079|NCT00966953|9571693|FG003|NOT COMPLETED|3rd Intervention Order||0
8539080|NCT00966953|9571690|FG000|STARTED|1 Week Washout After 3rd Intervention||6
8539081|NCT00966953|9571691|FG001|STARTED|1 Week Washout After 3rd Intervention||6
8539082|NCT00966953|9571692|FG002|STARTED|1 Week Washout After 3rd Intervention||6
8539011|NCT01365195|9571676|FG000|STARTED|Overall Study||6
8539012|NCT01365195|9571677|FG001|STARTED|Overall Study||8
8539013|NCT01365195|9571678|FG002|STARTED|Overall Study||7
8539014|NCT01365195|9571676|FG000|COMPLETED|Overall Study||6
8539015|NCT01365195|9571677|FG001|COMPLETED|Overall Study||8
8539016|NCT01365195|9571678|FG002|COMPLETED|Overall Study||7
8539017|NCT01365195|9571676|FG000|NOT COMPLETED|Overall Study||0
8539018|NCT01365195|9571677|FG001|NOT COMPLETED|Overall Study||0
8539019|NCT01365195|9571678|FG002|NOT COMPLETED|Overall Study||0
8539083|NCT00966953|9571693|FG003|STARTED|1 Week Washout After 3rd Intervention||7
8539084|NCT00966953|9571690|FG000|COMPLETED|1 Week Washout After 3rd Intervention||6
8539085|NCT00966953|9571691|FG001|COMPLETED|1 Week Washout After 3rd Intervention||6
8539086|NCT00966953|9571692|FG002|COMPLETED|1 Week Washout After 3rd Intervention||6
8539087|NCT00966953|9571693|FG003|COMPLETED|1 Week Washout After 3rd Intervention||7
8539088|NCT00966953|9571690|FG000|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
8539089|NCT00966953|9571691|FG001|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
8539090|NCT00966953|9571692|FG002|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
8539091|NCT00966953|9571693|FG003|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
8539092|NCT00966953|9571690|FG000|STARTED|4th Intervention Order||6
8539093|NCT00966953|9571691|FG001|STARTED|4th Intervention Order||6
8539094|NCT00966953|9571692|FG002|STARTED|4th Intervention Order||6
8539095|NCT00966953|9571693|FG003|STARTED|4th Intervention Order||7
8539096|NCT00966953|9571690|FG000|COMPLETED|4th Intervention Order||6
8539097|NCT00966953|9571691|FG001|COMPLETED|4th Intervention Order||6
8539098|NCT00966953|9571692|FG002|COMPLETED|4th Intervention Order||6
8539099|NCT00966953|9571693|FG003|COMPLETED|4th Intervention Order||7
8539100|NCT00966953|9571690|FG000|NOT COMPLETED|4th Intervention Order||0
8539101|NCT00966953|9571691|FG001|NOT COMPLETED|4th Intervention Order||0
8539102|NCT00966953|9571692|FG002|NOT COMPLETED|4th Intervention Order||0
8539103|NCT00966953|9571693|FG003|NOT COMPLETED|4th Intervention Order||0
8539104|NCT00961805|9571701|FG000|STARTED|Overall Study||40
8539105|NCT00961805|9571702|FG001|STARTED|Overall Study||40
8539106|NCT00961805|9571701|FG000|COMPLETED|Overall Study||40
8539107|NCT00961805|9571702|FG001|COMPLETED|Overall Study||40
8539108|NCT00961805|9571701|FG000|NOT COMPLETED|Overall Study||0
8539109|NCT00961805|9571702|FG001|NOT COMPLETED|Overall Study||0
8539110|NCT00950937|9571708|FG000|STARTED|Overall Study||14
8539111|NCT00950937|9571709|FG001|STARTED|Overall Study||14
8539112|NCT00950937|9571708|FG000|COMPLETED|Overall Study||14
8539113|NCT00950937|9571709|FG001|COMPLETED|Overall Study||14
8539114|NCT00950937|9571708|FG000|NOT COMPLETED|Overall Study||0
8539115|NCT00950937|9571709|FG001|NOT COMPLETED|Overall Study||0
8539116|NCT00948753|9571716|FG000|STARTED|Phase 1||7
8539117|NCT00948753|9571717|FG001|STARTED|Phase 1||6
8539118|NCT00948753|9571718|FG002|STARTED|Phase 1||0
8539119|NCT00948753|9571716|FG000|COMPLETED|Phase 1||7
8539120|NCT00948753|9571717|FG001|COMPLETED|Phase 1||6
8539121|NCT00948753|9571718|FG002|COMPLETED|Phase 1||0
8539122|NCT00948753|9571716|FG000|NOT COMPLETED|Phase 1||0
8539123|NCT00948753|9571717|FG001|NOT COMPLETED|Phase 1||0
8539124|NCT00948753|9571718|FG002|NOT COMPLETED|Phase 1||0
8539125|NCT00948753|9571716|FG000|STARTED|Phase 2||0
8539126|NCT00948753|9571717|FG001|STARTED|Phase 2||0
8539127|NCT00948753|9571718|FG002|STARTED|Phase 2||25
8539128|NCT00948753|9571716|FG000|COMPLETED|Phase 2||0
8539129|NCT00948753|9571717|FG001|COMPLETED|Phase 2||0
8539130|NCT00948753|9571718|FG002|COMPLETED|Phase 2||25
8539131|NCT00948753|9571716|FG000|NOT COMPLETED|Phase 2||0
8539132|NCT00948753|9571717|FG001|NOT COMPLETED|Phase 2||0
8539133|NCT00948753|9571718|FG002|NOT COMPLETED|Phase 2||0
8539134|NCT00947518|9571730|FG000|STARTED|Overall Study||20
8539135|NCT00947518|9571731|FG001|STARTED|Overall Study||20
8539136|NCT00947518|9571732|FG002|STARTED|Overall Study||20
8539137|NCT00947518|9571730|FG000|COMPLETED|Overall Study||20
8539138|NCT00947518|9571731|FG001|COMPLETED|Overall Study||20
8539139|NCT00947518|9571732|FG002|COMPLETED|Overall Study||20
8539140|NCT00947518|9571730|FG000|NOT COMPLETED|Overall Study||0
8539141|NCT00947518|9571731|FG001|NOT COMPLETED|Overall Study||0
8539142|NCT00947518|9571732|FG002|NOT COMPLETED|Overall Study||0
8539143|NCT00934921|9571739|FG000|STARTED|First Intervention||12
8539144|NCT00934921|9571740|FG001|STARTED|First Intervention||12
8539145|NCT00934921|9571739|FG000|COMPLETED|First Intervention||12
8539146|NCT00934921|9571740|FG001|COMPLETED|First Intervention||12
8539147|NCT00934921|9571739|FG000|NOT COMPLETED|First Intervention||0
8539148|NCT00934921|9571740|FG001|NOT COMPLETED|First Intervention||0
8539149|NCT00934921|9571739|FG000|STARTED|Second Intervention||12
8539150|NCT00934921|9571740|FG001|STARTED|Second Intervention||12
8539151|NCT00934921|9571739|FG000|COMPLETED|Second Intervention||12
8539152|NCT00934921|9571740|FG001|COMPLETED|Second Intervention||12
8539153|NCT00934921|9571739|FG000|NOT COMPLETED|Second Intervention||0
8539154|NCT00934921|9571740|FG001|NOT COMPLETED|Second Intervention||0
8539155|NCT00934180|9571746|FG000|STARTED|First Intervention||12
8539156|NCT00934180|9571747|FG001|STARTED|First Intervention||12
8539157|NCT00934180|9571746|FG000|COMPLETED|First Intervention||12
8539158|NCT00934180|9571747|FG001|COMPLETED|First Intervention||12
8539159|NCT00934180|9571746|FG000|NOT COMPLETED|First Intervention||0
8539160|NCT00934180|9571747|FG001|NOT COMPLETED|First Intervention||0
8539161|NCT00934180|9571746|FG000|STARTED|Second Intervention||12
8539162|NCT00934180|9571747|FG001|STARTED|Second Intervention||12
8539163|NCT00934180|9571746|FG000|COMPLETED|Second Intervention||12
8539164|NCT00934180|9571747|FG001|COMPLETED|Second Intervention||12
8539165|NCT00934180|9571746|FG000|NOT COMPLETED|Second Intervention||0
8539166|NCT00934180|9571747|FG001|NOT COMPLETED|Second Intervention||0
8539167|NCT00924833|9571754|FG000|STARTED|Overall Study||9
8539168|NCT00924833|9571755|FG001|STARTED|Overall Study||9
8539169|NCT00924833|9571756|FG002|STARTED|Overall Study||9
8539170|NCT00924833|9571754|FG000|COMPLETED|Overall Study|7 subjects analyzed (2 were excluded for poor cardiopulmonary exercise stress test quality).|9
8539171|NCT00924833|9571755|FG001|COMPLETED|Overall Study|1 subject was excluded from the analysis for incomplete data.|9
8539172|NCT00924833|9571756|FG002|COMPLETED|Overall Study|1 subject was excluded from the analysis for medical problems unrelated to the study.|9
8539173|NCT00924833|9571754|FG000|NOT COMPLETED|Overall Study||0
8539174|NCT00924833|9571755|FG001|NOT COMPLETED|Overall Study||0
8539175|NCT00924833|9571756|FG002|NOT COMPLETED|Overall Study||0
8539176|NCT00919893|9571763|FG000|STARTED|Overall Study||70
8539177|NCT00919893|9571764|FG001|STARTED|Overall Study||69
8539178|NCT00919893|9571763|FG000|COMPLETED|Overall Study||51
8539179|NCT00919893|9571764|FG001|COMPLETED|Overall Study||60
8539180|NCT00919893|9571763|FG000|NOT COMPLETED|Overall Study||19
8539181|NCT00919893|9571764|FG001|NOT COMPLETED|Overall Study||9
8539182|NCT00912158|9571771|FG000|STARTED|Overall Study||44
8539183|NCT00912158|9571772|FG001|STARTED|Overall Study||44
8539184|NCT00912158|9571773|FG002|STARTED|Overall Study||41
8539185|NCT00912158|9571771|FG000|COMPLETED|Overall Study||44
8539186|NCT00912158|9571772|FG001|COMPLETED|Overall Study||44
8539187|NCT00912158|9571773|FG002|COMPLETED|Overall Study||41
8539188|NCT00912158|9571771|FG000|NOT COMPLETED|Overall Study||0
8539189|NCT00912158|9571772|FG001|NOT COMPLETED|Overall Study||0
8539190|NCT00912158|9571773|FG002|NOT COMPLETED|Overall Study||0
8539191|NCT00911443|9571783|FG000|STARTED|Overall Study||97
8539192|NCT00911443|9571784|FG001|STARTED|Overall Study||97
8539193|NCT00911443|9571785|FG002|STARTED|Overall Study||98
8539194|NCT00911443|9571786|FG003|STARTED|Overall Study||99
8539195|NCT00911443|9571787|FG004|STARTED|Overall Study||97
8539196|NCT00911443|9571783|FG000|COMPLETED|Overall Study||97
8539197|NCT00911443|9571784|FG001|COMPLETED|Overall Study||97
8539198|NCT00911443|9571785|FG002|COMPLETED|Overall Study||98
8539199|NCT00911443|9571786|FG003|COMPLETED|Overall Study||99
8539200|NCT00911443|9571787|FG004|COMPLETED|Overall Study||97
8539201|NCT00911443|9571783|FG000|NOT COMPLETED|Overall Study||0
8818018|NCT01555125|9871644|FG002|NOT COMPLETED|Follow-Up Period||1
8818019|NCT01555125|9871645|FG003|NOT COMPLETED|Follow-Up Period||1
8539202|NCT00911443|9571784|FG001|NOT COMPLETED|Overall Study||0
8539203|NCT00911443|9571785|FG002|NOT COMPLETED|Overall Study||0
8539204|NCT00911443|9571786|FG003|NOT COMPLETED|Overall Study||0
8539205|NCT00911443|9571787|FG004|NOT COMPLETED|Overall Study||0
8539206|NCT00911274|9571796|FG000|STARTED|Period 1||27
8539207|NCT00911274|9571797|FG001|STARTED|Period 1||26
8539208|NCT00911274|9571796|FG000|COMPLETED|Period 1||27
8539209|NCT00911274|9571797|FG001|COMPLETED|Period 1||26
8539210|NCT00911274|9571796|FG000|NOT COMPLETED|Period 1||0
8723043|NCT01021306|9770543|FG000|NOT COMPLETED|2 Month (Primary Outcome)||6
8723044|NCT01021306|9770544|FG001|NOT COMPLETED|2 Month (Primary Outcome)||6
8723045|NCT01021306|9770545|FG002|NOT COMPLETED|2 Month (Primary Outcome)||5
8539211|NCT00911274|9571797|FG001|NOT COMPLETED|Period 1||0
8539212|NCT00911274|9571796|FG000|STARTED|Period 2||27
8539213|NCT00911274|9571797|FG001|STARTED|Period 2||26
8539214|NCT00911274|9571796|FG000|COMPLETED|Period 2||27
8539215|NCT00911274|9571797|FG001|COMPLETED|Period 2||26
8539216|NCT00911274|9571796|FG000|NOT COMPLETED|Period 2||0
8539217|NCT00911274|9571797|FG001|NOT COMPLETED|Period 2||0
8539218|NCT00909753|9571803|FG000|STARTED|Period: First Intervention||46
8539219|NCT00909753|9571804|FG001|STARTED|Period: First Intervention||46
8539220|NCT00909753|9571803|FG000|COMPLETED|Period: First Intervention||46
8539221|NCT00909753|9571804|FG001|COMPLETED|Period: First Intervention||46
8539222|NCT00909753|9571803|FG000|NOT COMPLETED|Period: First Intervention||0
8539223|NCT00909753|9571804|FG001|NOT COMPLETED|Period: First Intervention||0
8539224|NCT00909753|9571803|FG000|STARTED|Period: Washout of 28 Days||46
8539225|NCT00909753|9571804|FG001|STARTED|Period: Washout of 28 Days||46
8539226|NCT00909753|9571803|FG000|COMPLETED|Period: Washout of 28 Days||44
8539227|NCT00909753|9571804|FG001|COMPLETED|Period: Washout of 28 Days||43
8539228|NCT00909753|9571803|FG000|NOT COMPLETED|Period: Washout of 28 Days||2
8539229|NCT00909753|9571804|FG001|NOT COMPLETED|Period: Washout of 28 Days||3
8539230|NCT00909753|9571803|FG000|STARTED|Period: Second Intervention||44
8539231|NCT00909753|9571804|FG001|STARTED|Period: Second Intervention||43
8539232|NCT00909753|9571803|FG000|COMPLETED|Period: Second Intervention||43
8539233|NCT00909753|9571804|FG001|COMPLETED|Period: Second Intervention||43
8723046|NCT01021306|9770546|FG003|NOT COMPLETED|2 Month (Primary Outcome)||4
8723047|NCT01021306|9770543|FG000|STARTED|6 Month (Follow-up)||14
8723048|NCT01021306|9770544|FG001|STARTED|6 Month (Follow-up)||14
8723049|NCT01021306|9770545|FG002|STARTED|6 Month (Follow-up)||14
8723050|NCT01021306|9770546|FG003|STARTED|6 Month (Follow-up)||17
8723051|NCT01021306|9770543|FG000|COMPLETED|6 Month (Follow-up)||11
8723052|NCT01021306|9770544|FG001|COMPLETED|6 Month (Follow-up)||13
8723053|NCT01021306|9770545|FG002|COMPLETED|6 Month (Follow-up)||14
8723054|NCT01021306|9770546|FG003|COMPLETED|6 Month (Follow-up)||14
8723055|NCT01021306|9770543|FG000|NOT COMPLETED|6 Month (Follow-up)||3
8723056|NCT01021306|9770544|FG001|NOT COMPLETED|6 Month (Follow-up)||1
8723057|NCT01021306|9770545|FG002|NOT COMPLETED|6 Month (Follow-up)||0
8539234|NCT00909753|9571803|FG000|NOT COMPLETED|Period: Second Intervention||1
8539235|NCT00909753|9571804|FG001|NOT COMPLETED|Period: Second Intervention||0
8539236|NCT00909649|9571810|FG000|STARTED|Overall Study||25
8539237|NCT00909649|9571811|FG001|STARTED|Overall Study||25
8539238|NCT00909649|9571810|FG000|COMPLETED|Overall Study||25
8539239|NCT00909649|9571811|FG001|COMPLETED|Overall Study||25
8539240|NCT00909649|9571810|FG000|NOT COMPLETED|Overall Study||0
8539241|NCT00909649|9571811|FG001|NOT COMPLETED|Overall Study||0
8539242|NCT00909610|9571817|FG000|STARTED|Period: First Intervention||40
8539243|NCT00909610|9571818|FG001|STARTED|Period: First Intervention||40
8539244|NCT00909610|9571817|FG000|COMPLETED|Period: First Intervention||40
8539245|NCT00909610|9571818|FG001|COMPLETED|Period: First Intervention||39
8539246|NCT00909610|9571817|FG000|NOT COMPLETED|Period: First Intervention||0
8539247|NCT00909610|9571818|FG001|NOT COMPLETED|Period: First Intervention||1
8539248|NCT00909610|9571817|FG000|STARTED|Period: Washout of 28 Days||40
8539249|NCT00909610|9571818|FG001|STARTED|Period: Washout of 28 Days||39
8539250|NCT00909610|9571817|FG000|COMPLETED|Period: Washout of 28 Days||37
8539251|NCT00909610|9571818|FG001|COMPLETED|Period: Washout of 28 Days||33
8539252|NCT00909610|9571817|FG000|NOT COMPLETED|Period: Washout of 28 Days||3
8539253|NCT00909610|9571818|FG001|NOT COMPLETED|Period: Washout of 28 Days||6
8539254|NCT00909610|9571817|FG000|STARTED|Period: Second Intervention||37
8539255|NCT00909610|9571818|FG001|STARTED|Period: Second Intervention||33
8539256|NCT00909610|9571817|FG000|COMPLETED|Period: Second Intervention||36
8539257|NCT00909610|9571818|FG001|COMPLETED|Period: Second Intervention||33
8539258|NCT00909610|9571817|FG000|NOT COMPLETED|Period: Second Intervention||1
8539259|NCT00909610|9571818|FG001|NOT COMPLETED|Period: Second Intervention||0
8565973|NCT00072176|9598038|FG000|STARTED|Overall Study||34
8565974|NCT00072176|9598039|FG001|STARTED|Overall Study||28
8565975|NCT00072176|9598038|FG000|COMPLETED|Overall Study||33
8565976|NCT00072176|9598039|FG001|COMPLETED|Overall Study||27
8565977|NCT00072176|9598038|FG000|NOT COMPLETED|Overall Study||1
8565978|NCT00072176|9598039|FG001|NOT COMPLETED|Overall Study||1
8621053|NCT00477490|9659933|FG002|COMPLETED|Part I: 4 Week Efficacy||148
8621054|NCT00477490|9659934|FG003|COMPLETED|Part I: 4 Week Efficacy||138
8621055|NCT00477490|9659935|FG004|COMPLETED|Part I: 4 Week Efficacy||135
8621056|NCT00477490|9659936|FG005|COMPLETED|Part I: 4 Week Efficacy||0
8621057|NCT00477490|9659937|FG006|COMPLETED|Part I: 4 Week Efficacy||0
8621058|NCT00477490|9659938|FG007|COMPLETED|Part I: 4 Week Efficacy||0
8565979|NCT00072189|9598045|FG000|STARTED|Overall Study||17
8565980|NCT00072189|9598045|FG000|COMPLETED|Overall Study||16
8565981|NCT00072189|9598045|FG000|NOT COMPLETED|Overall Study||1
8565982|NCT00072280|9598051|FG000|STARTED|Treatment||3
8565983|NCT00072280|9598052|FG001|STARTED|Treatment||4
8565984|NCT00072280|9598051|FG000|COMPLETED|Treatment||2
8565985|NCT00072280|9598052|FG001|COMPLETED|Treatment||2
8565986|NCT00072280|9598051|FG000|NOT COMPLETED|Treatment||1
8621059|NCT00477490|9659939|FG008|COMPLETED|Part I: 4 Week Efficacy||0
8621060|NCT00477490|9659931|FG000|NOT COMPLETED|Part I: 4 Week Efficacy||15
8621061|NCT00477490|9659932|FG001|NOT COMPLETED|Part I: 4 Week Efficacy||19
8621062|NCT00477490|9659933|FG002|NOT COMPLETED|Part I: 4 Week Efficacy||10
8621063|NCT00477490|9659934|FG003|NOT COMPLETED|Part I: 4 Week Efficacy||20
8621064|NCT00477490|9659935|FG004|NOT COMPLETED|Part I: 4 Week Efficacy||25
8621065|NCT00477490|9659936|FG005|NOT COMPLETED|Part I: 4 Week Efficacy||0
8621066|NCT00477490|9659937|FG006|NOT COMPLETED|Part I: 4 Week Efficacy||0
8565987|NCT00072280|9598052|FG001|NOT COMPLETED|Treatment||2
8565988|NCT00072280|9598051|FG000|STARTED|Follow-up||2
8565989|NCT00072280|9598052|FG001|STARTED|Follow-up||2
8565990|NCT00072280|9598051|FG000|COMPLETED|Follow-up||0
8565991|NCT00072280|9598052|FG001|COMPLETED|Follow-up||0
8565992|NCT00072280|9598051|FG000|NOT COMPLETED|Follow-up||2
8565993|NCT00072280|9598052|FG001|NOT COMPLETED|Follow-up||2
8565994|NCT00072293|9598059|FG000|STARTED|Overall Study||465
8565995|NCT00072293|9598060|FG001|STARTED|Overall Study||469
8621067|NCT00477490|9659938|FG007|NOT COMPLETED|Part I: 4 Week Efficacy||0
8621068|NCT00477490|9659939|FG008|NOT COMPLETED|Part I: 4 Week Efficacy||0
8621069|NCT00477490|9659931|FG000|STARTED|Part II: Extension Week 5 up to Day 169||0
8621070|NCT00477490|9659932|FG001|STARTED|Part II: Extension Week 5 up to Day 169||135
8621071|NCT00477490|9659933|FG002|STARTED|Part II: Extension Week 5 up to Day 169||135
8621072|NCT00477490|9659934|FG003|STARTED|Part II: Extension Week 5 up to Day 169||132
8621073|NCT00477490|9659935|FG004|STARTED|Part II: Extension Week 5 up to Day 169||127
8621074|NCT00477490|9659936|FG005|STARTED|Part II: Extension Week 5 up to Day 169||31
8565996|NCT00072293|9598059|FG000|COMPLETED|Overall Study||464
8565997|NCT00072293|9598060|FG001|COMPLETED|Overall Study||467
8565998|NCT00072293|9598059|FG000|NOT COMPLETED|Overall Study||1
8565999|NCT00072293|9598060|FG001|NOT COMPLETED|Overall Study||2
8566000|NCT00072384|9598066|FG000|STARTED|Overall Study||30
8566001|NCT00072384|9598066|FG000|COMPLETED|Overall Study||21
8566002|NCT00072384|9598066|FG000|NOT COMPLETED|Overall Study||9
8566003|NCT00072449|9598072|FG000|STARTED|Overall Study||12
8566004|NCT00072449|9598072|FG000|COMPLETED|Overall Study||12
8566005|NCT00072449|9598072|FG000|NOT COMPLETED|Overall Study||0
8566006|NCT00072475|9598076|FG000|STARTED|Overall Study||142
8566007|NCT00072475|9598076|FG000|COMPLETED|Overall Study||45
8566008|NCT00072475|9598076|FG000|NOT COMPLETED|Overall Study||97
8566009|NCT00072514|9598080|FG000|STARTED|Overall Study||55
8566010|NCT00072514|9598080|FG000|COMPLETED|Overall Study||51
8566011|NCT00072514|9598080|FG000|NOT COMPLETED|Overall Study||4
8539260|NCT00908648|9571825|FG000|STARTED|Overall Study||108
8539261|NCT00908648|9571826|FG001|STARTED|Overall Study||103
8539262|NCT00908648|9571825|FG000|COMPLETED|Overall Study||108
8539263|NCT00908648|9571826|FG001|COMPLETED|Overall Study||103
8539264|NCT00908648|9571825|FG000|NOT COMPLETED|Overall Study||0
8539265|NCT00908648|9571826|FG001|NOT COMPLETED|Overall Study||0
8539266|NCT00908128|9571832|FG000|STARTED|Period 1||20
8539267|NCT00908128|9571833|FG001|STARTED|Period 1||20
8539268|NCT00908128|9571832|FG000|COMPLETED|Period 1||20
8539269|NCT00908128|9571833|FG001|COMPLETED|Period 1||20
8539270|NCT00908128|9571832|FG000|NOT COMPLETED|Period 1||0
8539271|NCT00908128|9571833|FG001|NOT COMPLETED|Period 1||0
8539272|NCT00908128|9571832|FG000|STARTED|Period 2||20
8539273|NCT00908128|9571833|FG001|STARTED|Period 2||20
8539274|NCT00908128|9571832|FG000|COMPLETED|Period 2||20
8539275|NCT00908128|9571833|FG001|COMPLETED|Period 2||20
8539276|NCT00908128|9571832|FG000|NOT COMPLETED|Period 2||0
8539277|NCT00908128|9571833|FG001|NOT COMPLETED|Period 2||0
8539278|NCT00908128|9571832|FG000|STARTED|Period 3||20
8539279|NCT00908128|9571833|FG001|STARTED|Period 3||20
8539280|NCT00908128|9571832|FG000|COMPLETED|Period 3||20
8539281|NCT00908128|9571833|FG001|COMPLETED|Period 3||20
8539282|NCT00908128|9571832|FG000|NOT COMPLETED|Period 3||0
8539283|NCT00908128|9571833|FG001|NOT COMPLETED|Period 3||0
8539284|NCT00908128|9571832|FG000|STARTED|Period 4||20
8539285|NCT00908128|9571833|FG001|STARTED|Period 4|One subject withdrew prior to Period 4 dosing due to adverse events|19
8539286|NCT00908128|9571832|FG000|COMPLETED|Period 4||20
8539287|NCT00908128|9571833|FG001|COMPLETED|Period 4||19
8539288|NCT00908128|9571832|FG000|NOT COMPLETED|Period 4||0
8539289|NCT00908128|9571833|FG001|NOT COMPLETED|Period 4||0
8539290|NCT00907907|9571839|FG000|STARTED|Period 1||20
8539291|NCT00907907|9571840|FG001|STARTED|Period 1||20
8539292|NCT00907907|9571839|FG000|COMPLETED|Period 1||20
8539293|NCT00907907|9571840|FG001|COMPLETED|Period 1||20
8539294|NCT00907907|9571839|FG000|NOT COMPLETED|Period 1||0
8539295|NCT00907907|9571840|FG001|NOT COMPLETED|Period 1||0
8539296|NCT00907907|9571839|FG000|STARTED|Period 2||20
8539297|NCT00907907|9571840|FG001|STARTED|Period 2||20
8539298|NCT00907907|9571839|FG000|COMPLETED|Period 2||20
8539299|NCT00907907|9571840|FG001|COMPLETED|Period 2||20
8539300|NCT00907907|9571839|FG000|NOT COMPLETED|Period 2||0
8539301|NCT00907907|9571840|FG001|NOT COMPLETED|Period 2||0
8539302|NCT00907907|9571839|FG000|STARTED|Period 3||20
8539303|NCT00907907|9571840|FG001|STARTED|Period 3||20
8539304|NCT00907907|9571839|FG000|COMPLETED|Period 3||20
8539305|NCT00907907|9571840|FG001|COMPLETED|Period 3||20
8621075|NCT00477490|9659937|FG006|STARTED|Part II: Extension Week 5 up to Day 169||37
8621076|NCT00477490|9659938|FG007|STARTED|Part II: Extension Week 5 up to Day 169||34
8621077|NCT00477490|9659939|FG008|STARTED|Part II: Extension Week 5 up to Day 169||34
8539306|NCT00907907|9571839|FG000|NOT COMPLETED|Period 3||0
8539307|NCT00907907|9571840|FG001|NOT COMPLETED|Period 3||0
8539308|NCT00907907|9571839|FG000|STARTED|Period 4|one subject withdrew prior to Period 4 dosing|19
8539309|NCT00907907|9571840|FG001|STARTED|Period 4|two subjects were withdrawn prior to Period 4 dosing|18
8539310|NCT00907907|9571839|FG000|COMPLETED|Period 4||19
8539311|NCT00907907|9571840|FG001|COMPLETED|Period 4||18
8539312|NCT00907907|9571839|FG000|NOT COMPLETED|Period 4||0
8539313|NCT00907907|9571840|FG001|NOT COMPLETED|Period 4||0
8539314|NCT00905606|9571846|FG000|STARTED|Period 1||15
8539315|NCT00905606|9571847|FG001|STARTED|Period 1||15
8539316|NCT00905606|9571846|FG000|COMPLETED|Period 1||15
8539317|NCT00905606|9571847|FG001|COMPLETED|Period 1||14
8539318|NCT00905606|9571846|FG000|NOT COMPLETED|Period 1||0
8539319|NCT00905606|9571847|FG001|NOT COMPLETED|Period 1||1
8539320|NCT00905606|9571846|FG000|STARTED|Washout||15
8539321|NCT00905606|9571847|FG001|STARTED|Washout||14
8539322|NCT00905606|9571846|FG000|COMPLETED|Washout||14
8539323|NCT00905606|9571847|FG001|COMPLETED|Washout||14
8539324|NCT00905606|9571846|FG000|NOT COMPLETED|Washout||1
8539325|NCT00905606|9571847|FG001|NOT COMPLETED|Washout||0
8539326|NCT00905606|9571846|FG000|STARTED|Period 2||14
8539327|NCT00905606|9571847|FG001|STARTED|Period 2||14
8539328|NCT00905606|9571846|FG000|COMPLETED|Period 2||14
8621078|NCT00477490|9659931|FG000|COMPLETED|Part II: Extension Week 5 up to Day 169||0
8621079|NCT00477490|9659932|FG001|COMPLETED|Part II: Extension Week 5 up to Day 169||107
8621080|NCT00477490|9659933|FG002|COMPLETED|Part II: Extension Week 5 up to Day 169||120
8621081|NCT00477490|9659934|FG003|COMPLETED|Part II: Extension Week 5 up to Day 169||120
8621082|NCT00477490|9659935|FG004|COMPLETED|Part II: Extension Week 5 up to Day 169||107
8621083|NCT00477490|9659936|FG005|COMPLETED|Part II: Extension Week 5 up to Day 169||25
8539329|NCT00905606|9571847|FG001|COMPLETED|Period 2||14
8539330|NCT00905606|9571846|FG000|NOT COMPLETED|Period 2||0
8539331|NCT00905606|9571847|FG001|NOT COMPLETED|Period 2||0
8539332|NCT00905567|9571853|FG000|STARTED|Period 1||12
8539333|NCT00905567|9571854|FG001|STARTED|Period 1||12
8539334|NCT00905567|9571853|FG000|COMPLETED|Period 1||12
8539335|NCT00905567|9571854|FG001|COMPLETED|Period 1||12
8539336|NCT00905567|9571853|FG000|NOT COMPLETED|Period 1||0
8539337|NCT00905567|9571854|FG001|NOT COMPLETED|Period 1||0
8539338|NCT00905567|9571853|FG000|STARTED|Washout||12
8621084|NCT00477490|9659937|FG006|COMPLETED|Part II: Extension Week 5 up to Day 169||32
8621085|NCT00477490|9659938|FG007|COMPLETED|Part II: Extension Week 5 up to Day 169||29
8539339|NCT00905567|9571854|FG001|STARTED|Washout||12
8539340|NCT00905567|9571853|FG000|COMPLETED|Washout||12
8539341|NCT00905567|9571854|FG001|COMPLETED|Washout||11
8539342|NCT00905567|9571853|FG000|NOT COMPLETED|Washout||0
8539343|NCT00905567|9571854|FG001|NOT COMPLETED|Washout||1
8539344|NCT00905567|9571853|FG000|STARTED|Period 2||12
8539345|NCT00905567|9571854|FG001|STARTED|Period 2||11
8539346|NCT00905567|9571853|FG000|COMPLETED|Period 2||12
8539347|NCT00905567|9571854|FG001|COMPLETED|Period 2||11
8539348|NCT00905567|9571853|FG000|NOT COMPLETED|Period 2||0
8539349|NCT00905567|9571854|FG001|NOT COMPLETED|Period 2||0
8539350|NCT00905346|9571860|FG000|STARTED|Period 1||12
8539351|NCT00905346|9571861|FG001|STARTED|Period 1||12
8539352|NCT00905346|9571860|FG000|COMPLETED|Period 1||11
8539353|NCT00905346|9571861|FG001|COMPLETED|Period 1||12
8539354|NCT00905346|9571860|FG000|NOT COMPLETED|Period 1||1
8539355|NCT00905346|9571861|FG001|NOT COMPLETED|Period 1||0
8539356|NCT00905346|9571860|FG000|STARTED|Period 2|one subject withdrew prior to Pd. 2 dosing|10
8539357|NCT00905346|9571861|FG001|STARTED|Period 2|one subject withdrew prior to Pd. 2 dosing|11
8539358|NCT00905346|9571860|FG000|COMPLETED|Period 2||10
8539359|NCT00905346|9571861|FG001|COMPLETED|Period 2||11
8539360|NCT00905346|9571860|FG000|NOT COMPLETED|Period 2||0
8539361|NCT00905346|9571861|FG001|NOT COMPLETED|Period 2||0
8539362|NCT00905164|9571867|FG000|STARTED|Period 1||12
8539363|NCT00905164|9571868|FG001|STARTED|Period 1||12
8539364|NCT00905164|9571867|FG000|COMPLETED|Period 1||12
8539365|NCT00905164|9571868|FG001|COMPLETED|Period 1||11
8539366|NCT00905164|9571867|FG000|NOT COMPLETED|Period 1||0
8539367|NCT00905164|9571868|FG001|NOT COMPLETED|Period 1||1
8539368|NCT00905164|9571867|FG000|STARTED|Period 2||12
8539369|NCT00905164|9571868|FG001|STARTED|Period 2||11
8539370|NCT00905164|9571867|FG000|COMPLETED|Period 2||12
8539371|NCT00905164|9571868|FG001|COMPLETED|Period 2||11
8539372|NCT00905164|9571867|FG000|NOT COMPLETED|Period 2||0
8539373|NCT00905164|9571868|FG001|NOT COMPLETED|Period 2||0
8539374|NCT00904943|9571874|FG000|STARTED|Period 1||9
8539375|NCT00904943|9571875|FG001|STARTED|Period 1||9
8539376|NCT00904943|9571874|FG000|COMPLETED|Period 1||9
8539377|NCT00904943|9571875|FG001|COMPLETED|Period 1||9
8539378|NCT00904943|9571874|FG000|NOT COMPLETED|Period 1||0
8539379|NCT00904943|9571875|FG001|NOT COMPLETED|Period 1||0
8539380|NCT00904943|9571874|FG000|STARTED|Period 2||9
8539381|NCT00904943|9571875|FG001|STARTED|Period 2|one subject was withdrawn prior to Pd. 2 dosing|8
8539382|NCT00904943|9571874|FG000|COMPLETED|Period 2||9
8539383|NCT00904943|9571875|FG001|COMPLETED|Period 2||8
8539384|NCT00904943|9571874|FG000|NOT COMPLETED|Period 2||0
8539385|NCT00904943|9571875|FG001|NOT COMPLETED|Period 2||0
8539386|NCT00890591|9571879|FG000|STARTED|Overall Study||144
8539387|NCT00890591|9571879|FG000|COMPLETED|Overall Study||124
8539388|NCT00890591|9571879|FG000|NOT COMPLETED|Overall Study||20
8539389|NCT00890409|9571887|FG000|STARTED|Overall Study||116
8539390|NCT00890409|9571888|FG001|STARTED|Overall Study||140
8539391|NCT00890409|9571887|FG000|COMPLETED|Overall Study||96
8539392|NCT00890409|9571888|FG001|COMPLETED|Overall Study||119
8539393|NCT00890409|9571887|FG000|NOT COMPLETED|Overall Study||20
8539394|NCT00890409|9571888|FG001|NOT COMPLETED|Overall Study||21
8539395|NCT00888355|9571896|FG000|STARTED|Overall Study||108
8539396|NCT00888355|9571897|FG001|STARTED|Overall Study||108
8539397|NCT00888355|9571898|FG002|STARTED|Overall Study||106
8539398|NCT00888355|9571899|FG003|STARTED|Overall Study||106
8621086|NCT00477490|9659939|FG008|COMPLETED|Part II: Extension Week 5 up to Day 169||26
8621087|NCT00477490|9659931|FG000|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||0
8621088|NCT00477490|9659932|FG001|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||28
8621089|NCT00477490|9659933|FG002|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||15
8621090|NCT00477490|9659934|FG003|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||12
8621091|NCT00477490|9659935|FG004|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||20
8621092|NCT00477490|9659936|FG005|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||6
8621093|NCT00477490|9659937|FG006|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||5
8621094|NCT00477490|9659938|FG007|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||5
8621095|NCT00477490|9659939|FG008|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||8
8621096|NCT00477594|9659969|FG000|STARTED|Year 1 and Year 2||16
8621097|NCT00477594|9659970|FG001|STARTED|Year 1 and Year 2||5
8621098|NCT00477594|9659969|FG000|COMPLETED|Year 1 and Year 2||7
8621099|NCT00477594|9659970|FG001|COMPLETED|Year 1 and Year 2||1
8621100|NCT00477594|9659969|FG000|NOT COMPLETED|Year 1 and Year 2||9
8621101|NCT00477594|9659970|FG001|NOT COMPLETED|Year 1 and Year 2||4
8621102|NCT00477594|9659969|FG000|STARTED|Year 3||4
8621103|NCT00477594|9659970|FG001|STARTED|Year 3||0
8621104|NCT00477594|9659969|FG000|COMPLETED|Year 3||2
8621105|NCT00477594|9659970|FG001|COMPLETED|Year 3||0
8621106|NCT00477594|9659969|FG000|NOT COMPLETED|Year 3||2
8621107|NCT00477594|9659970|FG001|NOT COMPLETED|Year 3||0
8621108|NCT00477594|9659969|FG000|STARTED|Follow-up Period||16
8621109|NCT00477594|9659970|FG001|STARTED|Follow-up Period||5
8539399|NCT00888355|9571896|FG000|COMPLETED|Overall Study||86
8539400|NCT00888355|9571897|FG001|COMPLETED|Overall Study||99
8539401|NCT00888355|9571898|FG002|COMPLETED|Overall Study||94
8539402|NCT00888355|9571899|FG003|COMPLETED|Overall Study||96
8539403|NCT00888355|9571896|FG000|NOT COMPLETED|Overall Study||22
8539404|NCT00888355|9571897|FG001|NOT COMPLETED|Overall Study||9
8539405|NCT00888355|9571898|FG002|NOT COMPLETED|Overall Study||12
8539406|NCT00888355|9571899|FG003|NOT COMPLETED|Overall Study||10
8539407|NCT00887250|9571908|FG000|STARTED|Overall Study||116
8539408|NCT00887250|9571909|FG001|STARTED|Overall Study||127
8539409|NCT00887250|9571910|FG002|STARTED|Overall Study||123
8539410|NCT00887250|9571908|FG000|COMPLETED|Overall Study||98
8621110|NCT00477594|9659969|FG000|COMPLETED|Follow-up Period||13
8539411|NCT00887250|9571909|FG001|COMPLETED|Overall Study||115
8539412|NCT00887250|9571910|FG002|COMPLETED|Overall Study||110
8539413|NCT00887250|9571908|FG000|NOT COMPLETED|Overall Study||18
8539414|NCT00887250|9571909|FG001|NOT COMPLETED|Overall Study||12
8539415|NCT00887250|9571910|FG002|NOT COMPLETED|Overall Study||13
8539416|NCT00886600|9571919|FG000|STARTED|Double-blind Monotherapy||32
8539417|NCT00886600|9571920|FG001|STARTED|Double-blind Monotherapy||29
8539418|NCT00886600|9571921|FG002|STARTED|Double-blind Monotherapy||30
8539419|NCT00886600|9571922|FG003|STARTED|Double-blind Monotherapy||31
8539420|NCT00886600|9571919|FG000|COMPLETED|Double-blind Monotherapy||30
8539421|NCT00886600|9571920|FG001|COMPLETED|Double-blind Monotherapy|1 pt discontinued after Wk 4 due to AE starting in placebo baseline and continuing into double-blind|28
8539422|NCT00886600|9571921|FG002|COMPLETED|Double-blind Monotherapy||29
8539423|NCT00886600|9571922|FG003|COMPLETED|Double-blind Monotherapy||29
8539424|NCT00886600|9571919|FG000|NOT COMPLETED|Double-blind Monotherapy||2
8539425|NCT00886600|9571920|FG001|NOT COMPLETED|Double-blind Monotherapy||1
8539426|NCT00886600|9571921|FG002|NOT COMPLETED|Double-blind Monotherapy||1
8539427|NCT00886600|9571922|FG003|NOT COMPLETED|Double-blind Monotherapy||2
8539428|NCT00886600|9571919|FG000|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 2-(Sitting Diastolic Blood Pressure (SiDBP) <85)|28
8539429|NCT00886600|9571920|FG001|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 4-(SiDBP <85); 3-(SiDBP ≥85)|21
8539430|NCT00886600|9571921|FG002|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 7-(SiDBP <85); 1-(SiDBP ≥85)|21
8539431|NCT00886600|9571922|FG003|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 5-(SiDBP <85); 1-(SiDBP ≥85)|23
8539432|NCT00886600|9571919|FG000|COMPLETED|Combination Therapy Period||28
8539433|NCT00886600|9571920|FG001|COMPLETED|Combination Therapy Period||21
8539434|NCT00886600|9571921|FG002|COMPLETED|Combination Therapy Period||19
8539435|NCT00886600|9571922|FG003|COMPLETED|Combination Therapy Period||23
8539436|NCT00886600|9571919|FG000|NOT COMPLETED|Combination Therapy Period||0
8539437|NCT00886600|9571920|FG001|NOT COMPLETED|Combination Therapy Period||0
8539438|NCT00886600|9571921|FG002|NOT COMPLETED|Combination Therapy Period||2
8539439|NCT00886600|9571922|FG003|NOT COMPLETED|Combination Therapy Period||0
8539440|NCT00882440|9571935|FG000|STARTED|Overall Study||78
8539441|NCT00882440|9571936|FG001|STARTED|Overall Study||80
8539442|NCT00882440|9571937|FG002|STARTED|Overall Study||82
8539443|NCT00882440|9571938|FG003|STARTED|Overall Study||79
8539444|NCT00882440|9571939|FG004|STARTED|Overall Study||90
8539445|NCT00882440|9571940|FG005|STARTED|Overall Study||84
8539446|NCT00882440|9571941|FG006|STARTED|Overall Study||83
8539447|NCT00882440|9571935|FG000|COMPLETED|Overall Study||67
8539448|NCT00882440|9571936|FG001|COMPLETED|Overall Study||72
8539449|NCT00882440|9571937|FG002|COMPLETED|Overall Study||75
8539450|NCT00882440|9571938|FG003|COMPLETED|Overall Study||76
8539451|NCT00882440|9571939|FG004|COMPLETED|Overall Study||80
8539452|NCT00882440|9571940|FG005|COMPLETED|Overall Study||77
8539453|NCT00882440|9571941|FG006|COMPLETED|Overall Study||79
8539454|NCT00882440|9571935|FG000|NOT COMPLETED|Overall Study||11
8539455|NCT00882440|9571936|FG001|NOT COMPLETED|Overall Study||8
8539456|NCT00882440|9571937|FG002|NOT COMPLETED|Overall Study||7
8539457|NCT00882440|9571938|FG003|NOT COMPLETED|Overall Study||3
8539458|NCT00882440|9571939|FG004|NOT COMPLETED|Overall Study||10
8539459|NCT00882440|9571940|FG005|NOT COMPLETED|Overall Study||7
8539460|NCT00882440|9571941|FG006|NOT COMPLETED|Overall Study||4
8539461|NCT00872430|9571952|FG000|STARTED|First Intervention||10
8539462|NCT00872430|9571953|FG001|STARTED|First Intervention||10
8539463|NCT00872430|9571952|FG000|COMPLETED|First Intervention||10
8539464|NCT00872430|9571953|FG001|COMPLETED|First Intervention||10
8539465|NCT00872430|9571952|FG000|NOT COMPLETED|First Intervention||0
8539466|NCT00872430|9571953|FG001|NOT COMPLETED|First Intervention||0
8539467|NCT00872430|9571952|FG000|STARTED|Washout Period||10
8539468|NCT00872430|9571953|FG001|STARTED|Washout Period||10
8539469|NCT00872430|9571952|FG000|COMPLETED|Washout Period||10
8539470|NCT00872430|9571953|FG001|COMPLETED|Washout Period||10
8539471|NCT00872430|9571952|FG000|NOT COMPLETED|Washout Period||0
8539472|NCT00872430|9571953|FG001|NOT COMPLETED|Washout Period||0
8539473|NCT00872430|9571952|FG000|STARTED|Second Intervention||10
8539474|NCT00872430|9571953|FG001|STARTED|Second Intervention||10
8539475|NCT00872430|9571952|FG000|COMPLETED|Second Intervention||10
8539476|NCT00872430|9571953|FG001|COMPLETED|Second Intervention||10
8539477|NCT00872430|9571952|FG000|NOT COMPLETED|Second Intervention||0
8539478|NCT00872430|9571953|FG001|NOT COMPLETED|Second Intervention||0
8539479|NCT00870688|9571957|FG000|STARTED|Overall Study||82
8539480|NCT00870688|9571957|FG000|COMPLETED|Overall Study||78
8539481|NCT00870688|9571957|FG000|NOT COMPLETED|Overall Study||4
8539482|NCT00869128|9571960|FG000|STARTED|Overall Study||18
8539483|NCT00869128|9571961|FG001|STARTED|Overall Study||18
8539484|NCT00869128|9571960|FG000|COMPLETED|Overall Study||12
8539485|NCT00869128|9571961|FG001|COMPLETED|Overall Study||12
8539486|NCT00869128|9571960|FG000|NOT COMPLETED|Overall Study||6
8539487|NCT00869128|9571961|FG001|NOT COMPLETED|Overall Study||6
8539488|NCT00861705|9571969|FG000|STARTED|Overall Study||115
8539489|NCT00861705|9571970|FG001|STARTED|Overall Study||113
8539490|NCT00861705|9571971|FG002|STARTED|Overall Study||113
8621111|NCT00477594|9659970|FG001|COMPLETED|Follow-up Period||4
8539491|NCT00861705|9571972|FG003|STARTED|Overall Study||113
8539492|NCT00861705|9571969|FG000|COMPLETED|Overall Study||108
8539493|NCT00861705|9571970|FG001|COMPLETED|Overall Study||110
8539494|NCT00861705|9571971|FG002|COMPLETED|Overall Study||113
8539495|NCT00861705|9571972|FG003|COMPLETED|Overall Study||112
8539496|NCT00861705|9571969|FG000|NOT COMPLETED|Overall Study||7
8539497|NCT00861705|9571970|FG001|NOT COMPLETED|Overall Study||3
8539498|NCT00861705|9571971|FG002|NOT COMPLETED|Overall Study||0
8539499|NCT00861705|9571972|FG003|NOT COMPLETED|Overall Study||1
8539500|NCT00859521|9571992|FG000|STARTED|First Intervention||15
8539501|NCT00859521|9571993|FG001|STARTED|First Intervention||15
8539502|NCT00859521|9571992|FG000|COMPLETED|First Intervention||15
8539503|NCT00859521|9571993|FG001|COMPLETED|First Intervention||15
8539504|NCT00859521|9571992|FG000|NOT COMPLETED|First Intervention||0
8539505|NCT00859521|9571993|FG001|NOT COMPLETED|First Intervention||0
8539506|NCT00859521|9571992|FG000|STARTED|Washout||15
8539507|NCT00859521|9571993|FG001|STARTED|Washout||15
8539508|NCT00859521|9571992|FG000|COMPLETED|Washout||15
8539509|NCT00859521|9571993|FG001|COMPLETED|Washout||14
8539510|NCT00859521|9571992|FG000|NOT COMPLETED|Washout||0
8539511|NCT00859521|9571993|FG001|NOT COMPLETED|Washout||1
8539512|NCT00859521|9571992|FG000|STARTED|Second Intervention||15
8539513|NCT00859521|9571993|FG001|STARTED|Second Intervention||14
8539514|NCT00859521|9571992|FG000|COMPLETED|Second Intervention||15
8539515|NCT00859521|9571993|FG001|COMPLETED|Second Intervention||14
8539516|NCT00859521|9571992|FG000|NOT COMPLETED|Second Intervention||0
8539517|NCT00859521|9571993|FG001|NOT COMPLETED|Second Intervention||0
8539518|NCT00859430|9571999|FG000|STARTED|First Intervention||11
8539519|NCT00859430|9572000|FG001|STARTED|First Intervention||11
8539520|NCT00859430|9571999|FG000|COMPLETED|First Intervention||11
8539521|NCT00859430|9572000|FG001|COMPLETED|First Intervention||10
8539522|NCT00859430|9571999|FG000|NOT COMPLETED|First Intervention||0
8539523|NCT00859430|9572000|FG001|NOT COMPLETED|First Intervention||1
8539524|NCT00859430|9571999|FG000|STARTED|Second Intervention||11
8539525|NCT00859430|9572000|FG001|STARTED|Second Intervention||10
8539526|NCT00859430|9571999|FG000|COMPLETED|Second Intervention||11
8539527|NCT00859430|9572000|FG001|COMPLETED|Second Intervention||10
8539528|NCT00859430|9571999|FG000|NOT COMPLETED|Second Intervention||0
8539529|NCT00859430|9572000|FG001|NOT COMPLETED|Second Intervention||0
8566012|NCT00072566|9598084|FG000|STARTED|Overall Study||70
8566013|NCT00072566|9598084|FG000|COMPLETED|Overall Study||70
8566014|NCT00072566|9598084|FG000|NOT COMPLETED|Overall Study||0
8566015|NCT00072761|9598090|FG000|STARTED|Overall Study||99
8566016|NCT00072761|9598091|FG001|STARTED|Overall Study||97
8566017|NCT00072761|9598090|FG000|COMPLETED|Overall Study||90
8566018|NCT00072761|9598091|FG001|COMPLETED|Overall Study||95
8566019|NCT00072761|9598090|FG000|NOT COMPLETED|Overall Study||9
8566020|NCT00072761|9598091|FG001|NOT COMPLETED|Overall Study||2
8566021|NCT00073008|9598099|FG000|STARTED|Overall Study||65
8566022|NCT00073008|9598100|FG001|STARTED|Overall Study||66
8566023|NCT00073008|9598099|FG000|COMPLETED|Overall Study||3
8566024|NCT00073008|9598100|FG001|COMPLETED|Overall Study||3
8566025|NCT00073008|9598099|FG000|NOT COMPLETED|Overall Study||62
8566026|NCT00073008|9598100|FG001|NOT COMPLETED|Overall Study||63
8566027|NCT00073021|9598108|FG000|STARTED|Overall Study|Subjects with Moderate Disease [PGA = 2] at Baseline|139
8566028|NCT00073021|9598109|FG001|STARTED|Overall Study|Subjects with Moderate Disease [PGA = 2] at Baseline|129
8566029|NCT00073021|9598108|FG000|COMPLETED|Overall Study||113
8566030|NCT00073021|9598109|FG001|COMPLETED|Overall Study||113
8566031|NCT00073021|9598108|FG000|NOT COMPLETED|Overall Study||26
8566032|NCT00073021|9598109|FG001|NOT COMPLETED|Overall Study||16
8566033|NCT00073073|9598115|FG000|STARTED|Overall Study||46
8566034|NCT00073073|9598115|FG000|COMPLETED|Overall Study||42
8566035|NCT00073073|9598115|FG000|NOT COMPLETED|Overall Study||4
8566036|NCT00073307|9598121|FG000|STARTED|Double-Blind (DB, as of ~31May2005)||451
8566037|NCT00073307|9598122|FG001|STARTED|Double-Blind (DB, as of ~31May2005)||452
8566038|NCT00073307|9598123|FG002|STARTED|Double-Blind (DB, as of ~31May2005)||0
8566039|NCT00073307|9598121|FG000|Participants Received Treatment|Double-Blind (DB, as of ~31May2005)||451
8566040|NCT00073307|9598122|FG001|Participants Received Treatment|Double-Blind (DB, as of ~31May2005)||451
8566041|NCT00073307|9598123|FG002|Participants Received Treatment|Double-Blind (DB, as of ~31May2005)||0
8566042|NCT00073307|9598121|FG000|COMPLETED|Double-Blind (DB, as of ~31May2005)||254
8566043|NCT00073307|9598122|FG001|COMPLETED|Double-Blind (DB, as of ~31May2005)||299
8566044|NCT00073307|9598123|FG002|COMPLETED|Double-Blind (DB, as of ~31May2005)||0
8566045|NCT00073307|9598121|FG000|NOT COMPLETED|Double-Blind (DB, as of ~31May2005)||197
8566046|NCT00073307|9598122|FG001|NOT COMPLETED|Double-Blind (DB, as of ~31May2005)||153
8566047|NCT00073307|9598123|FG002|NOT COMPLETED|Double-Blind (DB, as of ~31May2005)||0
8566048|NCT00073307|9598121|FG000|STARTED|Open Label-Sorafenib Only [30Jun2008]||254
8566049|NCT00073307|9598122|FG001|STARTED|Open Label-Sorafenib Only [30Jun2008]|Placebo treatment ended ~ 31May2005. Those who continued, switched to receive Sorafenib.|0
8566050|NCT00073307|9598123|FG002|STARTED|Open Label-Sorafenib Only [30Jun2008]||299
8566051|NCT00073307|9598121|FG000|Entered OL With Sorafenib Only Phase|Open Label-Sorafenib Only [30Jun2008]||219
8566052|NCT00073307|9598122|FG001|Entered OL With Sorafenib Only Phase|Open Label-Sorafenib Only [30Jun2008]||0
8566053|NCT00073307|9598123|FG002|Entered OL With Sorafenib Only Phase|Open Label-Sorafenib Only [30Jun2008]||216
8566054|NCT00073307|9598121|FG000|COMPLETED|Open Label-Sorafenib Only [30Jun2008]||120
8566055|NCT00073307|9598122|FG001|COMPLETED|Open Label-Sorafenib Only [30Jun2008]||0
8566056|NCT00073307|9598123|FG002|COMPLETED|Open Label-Sorafenib Only [30Jun2008]||143
8539530|NCT00858702|9572006|FG000|STARTED|Overall Study||53
8539531|NCT00858702|9572007|FG001|STARTED|Overall Study||52
8539532|NCT00858702|9572006|FG000|COMPLETED|Overall Study||48
8539533|NCT00858702|9572007|FG001|COMPLETED|Overall Study||50
8539534|NCT00858702|9572006|FG000|NOT COMPLETED|Overall Study||5
8539535|NCT00858702|9572007|FG001|NOT COMPLETED|Overall Study||2
8539536|NCT00857285|9572015|FG000|STARTED|Overall Study||65
8539537|NCT00857285|9572016|FG001|STARTED|Overall Study||65
8539538|NCT00857285|9572015|FG000|COMPLETED|Overall Study||53
8539539|NCT00857285|9572016|FG001|COMPLETED|Overall Study||59
8539540|NCT00857285|9572015|FG000|NOT COMPLETED|Overall Study||12
8539541|NCT00857285|9572016|FG001|NOT COMPLETED|Overall Study||6
8539542|NCT00856934|9572023|FG000|STARTED|Overall Study||15
8539543|NCT00856934|9572024|FG001|STARTED|Overall Study||15
8539544|NCT00856934|9572025|FG002|STARTED|Overall Study||15
8539545|NCT00856934|9572023|FG000|COMPLETED|Overall Study||15
8539546|NCT00856934|9572024|FG001|COMPLETED|Overall Study||15
8539547|NCT00856934|9572025|FG002|COMPLETED|Overall Study||15
8539548|NCT00856934|9572023|FG000|NOT COMPLETED|Overall Study||0
8539549|NCT00856934|9572024|FG001|NOT COMPLETED|Overall Study||0
8539550|NCT00856934|9572025|FG002|NOT COMPLETED|Overall Study||0
8539551|NCT00850174|9572032|FG000|STARTED|First Intervention||30
8539552|NCT00850174|9572033|FG001|STARTED|First Intervention||30
8539553|NCT00850174|9572032|FG000|COMPLETED|First Intervention||30
8539554|NCT00850174|9572033|FG001|COMPLETED|First Intervention||30
8539555|NCT00850174|9572032|FG000|NOT COMPLETED|First Intervention||0
8539556|NCT00850174|9572033|FG001|NOT COMPLETED|First Intervention||0
8539557|NCT00850174|9572032|FG000|STARTED|Washout: One Week||30
8539558|NCT00850174|9572033|FG001|STARTED|Washout: One Week||30
8539559|NCT00850174|9572032|FG000|COMPLETED|Washout: One Week||30
8539560|NCT00850174|9572033|FG001|COMPLETED|Washout: One Week||28
8539561|NCT00850174|9572032|FG000|NOT COMPLETED|Washout: One Week||0
8539562|NCT00850174|9572033|FG001|NOT COMPLETED|Washout: One Week||2
8539563|NCT00850174|9572032|FG000|STARTED|Second Intervention||30
8539564|NCT00850174|9572033|FG001|STARTED|Second Intervention||28
8539565|NCT00850174|9572032|FG000|COMPLETED|Second Intervention||29
8539566|NCT00850174|9572033|FG001|COMPLETED|Second Intervention||28
8539567|NCT00850174|9572032|FG000|NOT COMPLETED|Second Intervention||1
8539568|NCT00850174|9572033|FG001|NOT COMPLETED|Second Intervention||0
8539569|NCT00849862|9572039|FG000|STARTED|First Intervention||11
8539570|NCT00849862|9572040|FG001|STARTED|First Intervention||11
8539571|NCT00849862|9572039|FG000|COMPLETED|First Intervention||11
8539572|NCT00849862|9572040|FG001|COMPLETED|First Intervention||11
8539573|NCT00849862|9572039|FG000|NOT COMPLETED|First Intervention||0
8539574|NCT00849862|9572040|FG001|NOT COMPLETED|First Intervention||0
8539575|NCT00849862|9572039|FG000|STARTED|Washout: 7 Days||11
8539576|NCT00849862|9572040|FG001|STARTED|Washout: 7 Days||11
8539577|NCT00849862|9572039|FG000|COMPLETED|Washout: 7 Days||11
8539578|NCT00849862|9572040|FG001|COMPLETED|Washout: 7 Days||11
8539579|NCT00849862|9572039|FG000|NOT COMPLETED|Washout: 7 Days||0
8539580|NCT00849862|9572040|FG001|NOT COMPLETED|Washout: 7 Days||0
8539581|NCT00849862|9572039|FG000|STARTED|Second Intervention||11
8539582|NCT00849862|9572040|FG001|STARTED|Second Intervention||11
8539583|NCT00849862|9572039|FG000|COMPLETED|Second Intervention||11
8539584|NCT00849862|9572040|FG001|COMPLETED|Second Intervention||11
8539585|NCT00849862|9572039|FG000|NOT COMPLETED|Second Intervention||0
8539586|NCT00849862|9572040|FG001|NOT COMPLETED|Second Intervention||0
8539587|NCT00849797|9572046|FG000|STARTED|First Intervention||60
8539588|NCT00849797|9572047|FG001|STARTED|First Intervention||60
8539589|NCT00849797|9572046|FG000|COMPLETED|First Intervention||59
8539590|NCT00849797|9572047|FG001|COMPLETED|First Intervention||59
8539591|NCT00849797|9572046|FG000|NOT COMPLETED|First Intervention||1
8539592|NCT00849797|9572047|FG001|NOT COMPLETED|First Intervention||1
8539593|NCT00849797|9572046|FG000|STARTED|Washout: One Week||59
8539594|NCT00849797|9572047|FG001|STARTED|Washout: One Week||59
8539595|NCT00849797|9572046|FG000|COMPLETED|Washout: One Week||59
8539596|NCT00849797|9572047|FG001|COMPLETED|Washout: One Week||57
8539597|NCT00849797|9572046|FG000|NOT COMPLETED|Washout: One Week||0
8539598|NCT00849797|9572047|FG001|NOT COMPLETED|Washout: One Week||2
8539599|NCT00849797|9572046|FG000|STARTED|Second Intervention||59
8539600|NCT00849797|9572047|FG001|STARTED|Second Intervention||57
8539601|NCT00849797|9572046|FG000|COMPLETED|Second Intervention||59
8539602|NCT00849797|9572047|FG001|COMPLETED|Second Intervention||57
8539603|NCT00849797|9572046|FG000|NOT COMPLETED|Second Intervention||0
8539604|NCT00849797|9572047|FG001|NOT COMPLETED|Second Intervention||0
8539605|NCT00849485|9572054|FG000|STARTED|First Intervention||11
8539606|NCT00849485|9572055|FG001|STARTED|First Intervention||11
8539607|NCT00849485|9572054|FG000|COMPLETED|First Intervention||11
8539608|NCT00849485|9572055|FG001|COMPLETED|First Intervention||11
8539609|NCT00849485|9572054|FG000|NOT COMPLETED|First Intervention||0
8539610|NCT00849485|9572055|FG001|NOT COMPLETED|First Intervention||0
8539611|NCT00849485|9572054|FG000|STARTED|Washout: 7 Days||11
8539612|NCT00849485|9572055|FG001|STARTED|Washout: 7 Days||11
8539613|NCT00849485|9572054|FG000|COMPLETED|Washout: 7 Days||11
8539614|NCT00849485|9572055|FG001|COMPLETED|Washout: 7 Days||11
8539615|NCT00849485|9572054|FG000|NOT COMPLETED|Washout: 7 Days||0
8539616|NCT00849485|9572055|FG001|NOT COMPLETED|Washout: 7 Days||0
8539617|NCT00849485|9572054|FG000|STARTED|Second Intervention||11
8539618|NCT00849485|9572055|FG001|STARTED|Second Intervention||11
8539619|NCT00849485|9572054|FG000|COMPLETED|Second Intervention||11
8539620|NCT00849485|9572055|FG001|COMPLETED|Second Intervention||11
8539621|NCT00849485|9572054|FG000|NOT COMPLETED|Second Intervention||0
8539622|NCT00849485|9572055|FG001|NOT COMPLETED|Second Intervention||0
8539623|NCT00847405|9572061|FG000|STARTED|First Intervention||14
8539624|NCT00847405|9572062|FG001|STARTED|First Intervention||14
8539625|NCT00847405|9572061|FG000|COMPLETED|First Intervention||14
8539626|NCT00847405|9572062|FG001|COMPLETED|First Intervention||13
8539627|NCT00847405|9572061|FG000|NOT COMPLETED|First Intervention||0
8539628|NCT00847405|9572062|FG001|NOT COMPLETED|First Intervention||1
8539629|NCT00847405|9572061|FG000|STARTED|Washout of 7 Days||14
8539630|NCT00847405|9572062|FG001|STARTED|Washout of 7 Days||13
8539631|NCT00847405|9572061|FG000|COMPLETED|Washout of 7 Days||13
8539632|NCT00847405|9572062|FG001|COMPLETED|Washout of 7 Days||13
8539633|NCT00847405|9572061|FG000|NOT COMPLETED|Washout of 7 Days||1
8539634|NCT00847405|9572062|FG001|NOT COMPLETED|Washout of 7 Days||0
8539635|NCT00847405|9572061|FG000|STARTED|Second Intervention||13
8539636|NCT00847405|9572062|FG001|STARTED|Second Intervention||13
8539637|NCT00847405|9572061|FG000|COMPLETED|Second Intervention||13
8539638|NCT00847405|9572062|FG001|COMPLETED|Second Intervention||13
8539639|NCT00847405|9572061|FG000|NOT COMPLETED|Second Intervention||0
8539640|NCT00847405|9572062|FG001|NOT COMPLETED|Second Intervention||0
8539641|NCT00846885|9572068|FG000|STARTED|First Intervention||14
8539642|NCT00846885|9572069|FG001|STARTED|First Intervention||14
8539643|NCT00846885|9572068|FG000|COMPLETED|First Intervention||14
8539644|NCT00846885|9572069|FG001|COMPLETED|First Intervention||14
8539645|NCT00846885|9572068|FG000|NOT COMPLETED|First Intervention||0
8539646|NCT00846885|9572069|FG001|NOT COMPLETED|First Intervention||0
8539647|NCT00846885|9572068|FG000|STARTED|Washout of 7 Days||14
8539648|NCT00846885|9572069|FG001|STARTED|Washout of 7 Days||14
8539649|NCT00846885|9572068|FG000|COMPLETED|Washout of 7 Days||14
8539650|NCT00846885|9572069|FG001|COMPLETED|Washout of 7 Days||14
8539651|NCT00846885|9572068|FG000|NOT COMPLETED|Washout of 7 Days||0
8539652|NCT00846885|9572069|FG001|NOT COMPLETED|Washout of 7 Days||0
8539653|NCT00846885|9572068|FG000|STARTED|Second Intervention||14
8539654|NCT00846885|9572069|FG001|STARTED|Second Intervention||14
8539655|NCT00846885|9572068|FG000|COMPLETED|Second Intervention||14
8539656|NCT00846885|9572069|FG001|COMPLETED|Second Intervention||14
8539657|NCT00846885|9572068|FG000|NOT COMPLETED|Second Intervention||0
8539658|NCT00846885|9572069|FG001|NOT COMPLETED|Second Intervention||0
8539659|NCT00841815|9572075|FG000|STARTED|Period 1||14
8539660|NCT00841815|9572076|FG001|STARTED|Period 1||14
8539661|NCT00841815|9572075|FG000|COMPLETED|Period 1||14
8539662|NCT00841815|9572076|FG001|COMPLETED|Period 1||14
8539663|NCT00841815|9572075|FG000|NOT COMPLETED|Period 1||0
8539664|NCT00841815|9572076|FG001|NOT COMPLETED|Period 1||0
8539665|NCT00841815|9572075|FG000|STARTED|Washout||14
8539666|NCT00841815|9572076|FG001|STARTED|Washout||14
8539667|NCT00841815|9572075|FG000|COMPLETED|Washout||14
8539668|NCT00841815|9572076|FG001|COMPLETED|Washout||13
8539669|NCT00841815|9572075|FG000|NOT COMPLETED|Washout||0
8539670|NCT00841815|9572076|FG001|NOT COMPLETED|Washout||1
8539671|NCT00841815|9572075|FG000|STARTED|Period 2||14
8539672|NCT00841815|9572076|FG001|STARTED|Period 2||13
8539673|NCT00841815|9572075|FG000|COMPLETED|Period 2||14
8539674|NCT00841815|9572076|FG001|COMPLETED|Period 2||13
8539675|NCT00841815|9572075|FG000|NOT COMPLETED|Period 2||0
8539676|NCT00841815|9572076|FG001|NOT COMPLETED|Period 2||0
8539677|NCT00841698|9572083|FG000|STARTED|First Intervention||25
8539678|NCT00841698|9572084|FG001|STARTED|First Intervention||25
8539679|NCT00841698|9572083|FG000|COMPLETED|First Intervention||24
8539680|NCT00841698|9572084|FG001|COMPLETED|First Intervention||25
8539681|NCT00841698|9572083|FG000|NOT COMPLETED|First Intervention||1
8539682|NCT00841698|9572084|FG001|NOT COMPLETED|First Intervention||0
8539683|NCT00841698|9572083|FG000|STARTED|Washout: 2 Weeks||24
8539684|NCT00841698|9572084|FG001|STARTED|Washout: 2 Weeks||25
8539685|NCT00841698|9572083|FG000|COMPLETED|Washout: 2 Weeks||24
8539686|NCT00841698|9572084|FG001|COMPLETED|Washout: 2 Weeks||25
8539687|NCT00841698|9572083|FG000|NOT COMPLETED|Washout: 2 Weeks||0
8539688|NCT00841698|9572084|FG001|NOT COMPLETED|Washout: 2 Weeks||0
8539689|NCT00841698|9572083|FG000|STARTED|Second Intervention||24
8539690|NCT00841698|9572084|FG001|STARTED|Second Intervention||25
8539691|NCT00841698|9572083|FG000|COMPLETED|Second Intervention||24
8539692|NCT00841698|9572084|FG001|COMPLETED|Second Intervention||25
8539693|NCT00841698|9572083|FG000|NOT COMPLETED|Second Intervention||0
8539694|NCT00841698|9572084|FG001|NOT COMPLETED|Second Intervention||0
8539695|NCT00841659|9572090|FG000|STARTED|First Intervention||12
8539696|NCT00841659|9572091|FG001|STARTED|First Intervention||12
8539697|NCT00841659|9572090|FG000|COMPLETED|First Intervention||12
8539698|NCT00841659|9572091|FG001|COMPLETED|First Intervention||12
8539699|NCT00841659|9572090|FG000|NOT COMPLETED|First Intervention||0
8539700|NCT00841659|9572091|FG001|NOT COMPLETED|First Intervention||0
8539701|NCT00841659|9572090|FG000|STARTED|Washout: 2 Weeks||12
8539702|NCT00841659|9572091|FG001|STARTED|Washout: 2 Weeks||12
8539703|NCT00841659|9572090|FG000|COMPLETED|Washout: 2 Weeks||11
8539704|NCT00841659|9572091|FG001|COMPLETED|Washout: 2 Weeks||12
8539705|NCT00841659|9572090|FG000|NOT COMPLETED|Washout: 2 Weeks||1
8539706|NCT00841659|9572091|FG001|NOT COMPLETED|Washout: 2 Weeks||0
8539707|NCT00841659|9572090|FG000|STARTED|Second Intervention||11
8539708|NCT00841659|9572091|FG001|STARTED|Second Intervention||12
8539709|NCT00841659|9572090|FG000|COMPLETED|Second Intervention||11
8539710|NCT00841659|9572091|FG001|COMPLETED|Second Intervention||12
8539711|NCT00841659|9572090|FG000|NOT COMPLETED|Second Intervention||0
8539712|NCT00841659|9572091|FG001|NOT COMPLETED|Second Intervention||0
8539713|NCT00841542|9572097|FG000|STARTED|Period 1||14
8539714|NCT00841542|9572098|FG001|STARTED|Period 1||14
8539715|NCT00841542|9572097|FG000|COMPLETED|Period 1||13
8539716|NCT00841542|9572098|FG001|COMPLETED|Period 1||14
8539717|NCT00841542|9572097|FG000|NOT COMPLETED|Period 1||1
8539718|NCT00841542|9572098|FG001|NOT COMPLETED|Period 1||0
8539719|NCT00841542|9572097|FG000|STARTED|Period 2||13
8539720|NCT00841542|9572098|FG001|STARTED|Period 2||14
8539721|NCT00841542|9572097|FG000|COMPLETED|Period 2||13
8539722|NCT00841542|9572098|FG001|COMPLETED|Period 2||14
8539723|NCT00841542|9572097|FG000|NOT COMPLETED|Period 2||0
8539724|NCT00841542|9572098|FG001|NOT COMPLETED|Period 2||0
8539725|NCT00840879|9572104|FG000|STARTED|First Intervention||14
8539726|NCT00840879|9572105|FG001|STARTED|First Intervention||14
8539727|NCT00840879|9572104|FG000|COMPLETED|First Intervention||14
8539728|NCT00840879|9572105|FG001|COMPLETED|First Intervention||14
8539729|NCT00840879|9572104|FG000|NOT COMPLETED|First Intervention||0
8539730|NCT00840879|9572105|FG001|NOT COMPLETED|First Intervention||0
8539731|NCT00840879|9572104|FG000|STARTED|Washout: 14 Days||14
8539732|NCT00840879|9572105|FG001|STARTED|Washout: 14 Days||14
8539733|NCT00840879|9572104|FG000|COMPLETED|Washout: 14 Days||14
8539734|NCT00840879|9572105|FG001|COMPLETED|Washout: 14 Days||14
8539735|NCT00840879|9572104|FG000|NOT COMPLETED|Washout: 14 Days||0
8539736|NCT00840879|9572105|FG001|NOT COMPLETED|Washout: 14 Days||0
8539737|NCT00840879|9572104|FG000|STARTED|Second Intervention||14
8539738|NCT00840879|9572105|FG001|STARTED|Second Intervention||14
8539739|NCT00840879|9572104|FG000|COMPLETED|Second Intervention||13
8539740|NCT00840879|9572105|FG001|COMPLETED|Second Intervention||14
8539741|NCT00840879|9572104|FG000|NOT COMPLETED|Second Intervention||1
8539742|NCT00840879|9572105|FG001|NOT COMPLETED|Second Intervention||0
8539743|NCT00840866|9572111|FG000|STARTED|First Intervention||20
8539744|NCT00840866|9572112|FG001|STARTED|First Intervention||19
8539745|NCT00840866|9572111|FG000|COMPLETED|First Intervention||20
8539746|NCT00840866|9572112|FG001|COMPLETED|First Intervention||19
8539747|NCT00840866|9572111|FG000|NOT COMPLETED|First Intervention||0
8539748|NCT00840866|9572112|FG001|NOT COMPLETED|First Intervention||0
8539749|NCT00840866|9572111|FG000|STARTED|Washout of 7 Days||20
8539750|NCT00840866|9572112|FG001|STARTED|Washout of 7 Days||19
8539751|NCT00840866|9572111|FG000|COMPLETED|Washout of 7 Days||20
8539752|NCT00840866|9572112|FG001|COMPLETED|Washout of 7 Days||19
8539753|NCT00840866|9572111|FG000|NOT COMPLETED|Washout of 7 Days||0
8539754|NCT00840866|9572112|FG001|NOT COMPLETED|Washout of 7 Days||0
8539755|NCT00840866|9572111|FG000|STARTED|Second Intervention||20
8539756|NCT00840866|9572112|FG001|STARTED|Second Intervention||19
8539757|NCT00840866|9572111|FG000|COMPLETED|Second Intervention||20
8539758|NCT00840866|9572112|FG001|COMPLETED|Second Intervention||19
8539759|NCT00840866|9572111|FG000|NOT COMPLETED|Second Intervention||0
8539760|NCT00840866|9572112|FG001|NOT COMPLETED|Second Intervention||0
8539761|NCT00840840|9572118|FG000|STARTED|Period 1||24
8539762|NCT00840840|9572119|FG001|STARTED|Period 1||24
8539763|NCT00840840|9572118|FG000|COMPLETED|Period 1||24
8539764|NCT00840840|9572119|FG001|COMPLETED|Period 1||24
8539765|NCT00840840|9572118|FG000|NOT COMPLETED|Period 1||0
8539766|NCT00840840|9572119|FG001|NOT COMPLETED|Period 1||0
8539767|NCT00840840|9572118|FG000|STARTED|Period 2|One subject was withdrawn due to AE after Period 1|23
8539768|NCT00840840|9572119|FG001|STARTED|Period 2||24
8539769|NCT00840840|9572118|FG000|COMPLETED|Period 2||23
8539770|NCT00840840|9572119|FG001|COMPLETED|Period 2||24
8539771|NCT00840840|9572118|FG000|NOT COMPLETED|Period 2||0
8539772|NCT00840840|9572119|FG001|NOT COMPLETED|Period 2||0
8539773|NCT00840632|9572125|FG000|STARTED|First Intervention||20
8539774|NCT00840632|9572126|FG001|STARTED|First Intervention||20
8539775|NCT00840632|9572125|FG000|COMPLETED|First Intervention||20
8539776|NCT00840632|9572126|FG001|COMPLETED|First Intervention||19
8539777|NCT00840632|9572125|FG000|NOT COMPLETED|First Intervention||0
8539778|NCT00840632|9572126|FG001|NOT COMPLETED|First Intervention||1
8539779|NCT00840632|9572125|FG000|STARTED|Washout||20
8539780|NCT00840632|9572126|FG001|STARTED|Washout||19
8539781|NCT00840632|9572125|FG000|COMPLETED|Washout||19
8539782|NCT00840632|9572126|FG001|COMPLETED|Washout||18
8539783|NCT00840632|9572125|FG000|NOT COMPLETED|Washout||1
8539784|NCT00840632|9572126|FG001|NOT COMPLETED|Washout||1
8539785|NCT00840632|9572125|FG000|STARTED|Second Intervention||19
8539786|NCT00840632|9572126|FG001|STARTED|Second Intervention||18
8539787|NCT00840632|9572125|FG000|COMPLETED|Second Intervention||19
8539788|NCT00840632|9572126|FG001|COMPLETED|Second Intervention||18
8539789|NCT00840632|9572125|FG000|NOT COMPLETED|Second Intervention||0
8539790|NCT00840632|9572126|FG001|NOT COMPLETED|Second Intervention||0
8539791|NCT00840476|9572132|FG000|STARTED|First Intervention||14
8539792|NCT00840476|9572133|FG001|STARTED|First Intervention||14
8539793|NCT00840476|9572132|FG000|COMPLETED|First Intervention||14
8539794|NCT00840476|9572133|FG001|COMPLETED|First Intervention||14
8539795|NCT00840476|9572132|FG000|NOT COMPLETED|First Intervention||0
8539796|NCT00840476|9572133|FG001|NOT COMPLETED|First Intervention||0
8539797|NCT00840476|9572132|FG000|STARTED|Washout: 14 Days||14
8539798|NCT00840476|9572133|FG001|STARTED|Washout: 14 Days||14
8539799|NCT00840476|9572132|FG000|COMPLETED|Washout: 14 Days||14
8539800|NCT00840476|9572133|FG001|COMPLETED|Washout: 14 Days||14
8539801|NCT00840476|9572132|FG000|NOT COMPLETED|Washout: 14 Days||0
8539802|NCT00840476|9572133|FG001|NOT COMPLETED|Washout: 14 Days||0
8539803|NCT00840476|9572132|FG000|STARTED|Second Intervention||14
8539804|NCT00840476|9572133|FG001|STARTED|Second Intervention||14
8539805|NCT00840476|9572132|FG000|COMPLETED|Second Intervention||14
8539806|NCT00840476|9572133|FG001|COMPLETED|Second Intervention||14
8539807|NCT00840476|9572132|FG000|NOT COMPLETED|Second Intervention||0
8539808|NCT00840476|9572133|FG001|NOT COMPLETED|Second Intervention||0
8539809|NCT00840411|9572139|FG000|STARTED|First Intervention||33
8539810|NCT00840411|9572140|FG001|STARTED|First Intervention||33
8621112|NCT00477594|9659969|FG000|NOT COMPLETED|Follow-up Period||3
8621113|NCT00477594|9659970|FG001|NOT COMPLETED|Follow-up Period||1
8621114|NCT00477607|9659978|FG000|STARTED|Overall Study||19
8539811|NCT00840411|9572139|FG000|COMPLETED|First Intervention||32
8539812|NCT00840411|9572140|FG001|COMPLETED|First Intervention||33
8539813|NCT00840411|9572139|FG000|NOT COMPLETED|First Intervention||1
8539814|NCT00840411|9572140|FG001|NOT COMPLETED|First Intervention||0
8539815|NCT00840411|9572139|FG000|STARTED|Washout||32
8539816|NCT00840411|9572140|FG001|STARTED|Washout||33
8539817|NCT00840411|9572139|FG000|COMPLETED|Washout||31
8539818|NCT00840411|9572140|FG001|COMPLETED|Washout||33
8539819|NCT00840411|9572139|FG000|NOT COMPLETED|Washout||1
8539820|NCT00840411|9572140|FG001|NOT COMPLETED|Washout||0
8539821|NCT00840411|9572139|FG000|STARTED|Second Intervention||31
8539822|NCT00840411|9572140|FG001|STARTED|Second Intervention||33
8539823|NCT00840411|9572139|FG000|COMPLETED|Second Intervention||31
8539824|NCT00840411|9572140|FG001|COMPLETED|Second Intervention||33
8539825|NCT00840411|9572139|FG000|NOT COMPLETED|Second Intervention||0
8539826|NCT00840411|9572140|FG001|NOT COMPLETED|Second Intervention||0
8539827|NCT00840281|9572146|FG000|STARTED|First Intervention||19
8539828|NCT00840281|9572147|FG001|STARTED|First Intervention||19
8539829|NCT00840281|9572146|FG000|COMPLETED|First Intervention||19
8539830|NCT00840281|9572147|FG001|COMPLETED|First Intervention||19
8539831|NCT00840281|9572146|FG000|NOT COMPLETED|First Intervention||0
8539832|NCT00840281|9572147|FG001|NOT COMPLETED|First Intervention||0
8539833|NCT00840281|9572146|FG000|STARTED|Washout of 7 Days||19
8539834|NCT00840281|9572147|FG001|STARTED|Washout of 7 Days||19
8539835|NCT00840281|9572146|FG000|COMPLETED|Washout of 7 Days||19
8539836|NCT00840281|9572147|FG001|COMPLETED|Washout of 7 Days||19
8539837|NCT00840281|9572146|FG000|NOT COMPLETED|Washout of 7 Days||0
8539838|NCT00840281|9572147|FG001|NOT COMPLETED|Washout of 7 Days||0
8539839|NCT00840281|9572146|FG000|STARTED|Second Intervention||19
8539840|NCT00840281|9572147|FG001|STARTED|Second Intervention||19
8539841|NCT00840281|9572146|FG000|COMPLETED|Second Intervention||19
8539842|NCT00840281|9572147|FG001|COMPLETED|Second Intervention||19
8539843|NCT00840281|9572146|FG000|NOT COMPLETED|Second Intervention||0
8539844|NCT00840281|9572147|FG001|NOT COMPLETED|Second Intervention||0
8539845|NCT00840216|9572153|FG000|STARTED|First Intervention||11
8539846|NCT00840216|9572154|FG001|STARTED|First Intervention||11
8539847|NCT00840216|9572153|FG000|COMPLETED|First Intervention||11
8539848|NCT00840216|9572154|FG001|COMPLETED|First Intervention||11
8539849|NCT00840216|9572153|FG000|NOT COMPLETED|First Intervention||0
8539850|NCT00840216|9572154|FG001|NOT COMPLETED|First Intervention||0
8539851|NCT00840216|9572153|FG000|STARTED|Washout: 7 Days||11
8539852|NCT00840216|9572154|FG001|STARTED|Washout: 7 Days||11
8539853|NCT00840216|9572153|FG000|COMPLETED|Washout: 7 Days||10
8539854|NCT00840216|9572154|FG001|COMPLETED|Washout: 7 Days||11
8539855|NCT00840216|9572153|FG000|NOT COMPLETED|Washout: 7 Days||1
8539856|NCT00840216|9572154|FG001|NOT COMPLETED|Washout: 7 Days||0
8539857|NCT00840216|9572153|FG000|STARTED|Second Intervention||10
8539858|NCT00840216|9572154|FG001|STARTED|Second Intervention||11
8539859|NCT00840216|9572153|FG000|COMPLETED|Second Intervention||10
8539860|NCT00840216|9572154|FG001|COMPLETED|Second Intervention||11
8539861|NCT00840216|9572153|FG000|NOT COMPLETED|Second Intervention||0
8539862|NCT00840216|9572154|FG001|NOT COMPLETED|Second Intervention||0
8539863|NCT00840203|9572160|FG000|STARTED|First Intervention||37
8539864|NCT00840203|9572161|FG001|STARTED|First Intervention||35
8539865|NCT00840203|9572160|FG000|COMPLETED|First Intervention||36
8539866|NCT00840203|9572161|FG001|COMPLETED|First Intervention||34
8539867|NCT00840203|9572160|FG000|NOT COMPLETED|First Intervention||1
8539868|NCT00840203|9572161|FG001|NOT COMPLETED|First Intervention||1
8539869|NCT00840203|9572160|FG000|STARTED|Washout||36
8539870|NCT00840203|9572161|FG001|STARTED|Washout||34
8539871|NCT00840203|9572160|FG000|COMPLETED|Washout||35
8539872|NCT00840203|9572161|FG001|COMPLETED|Washout||34
8539873|NCT00840203|9572160|FG000|NOT COMPLETED|Washout||1
8539874|NCT00840203|9572161|FG001|NOT COMPLETED|Washout||0
8539875|NCT00840203|9572160|FG000|STARTED|Second Intervention||35
8539876|NCT00840203|9572161|FG001|STARTED|Second Intervention||34
8539877|NCT00840203|9572160|FG000|COMPLETED|Second Intervention||35
8539878|NCT00840203|9572161|FG001|COMPLETED|Second Intervention||34
8539879|NCT00840203|9572160|FG000|NOT COMPLETED|Second Intervention||0
8539880|NCT00840203|9572161|FG001|NOT COMPLETED|Second Intervention||0
8539881|NCT00840099|9572167|FG000|STARTED|Period 1||24
8539882|NCT00840099|9572168|FG001|STARTED|Period 1||24
8539883|NCT00840099|9572167|FG000|COMPLETED|Period 1||24
8539884|NCT00840099|9572168|FG001|COMPLETED|Period 1||24
8539885|NCT00840099|9572167|FG000|NOT COMPLETED|Period 1||0
8539886|NCT00840099|9572168|FG001|NOT COMPLETED|Period 1||0
8621115|NCT00477607|9659979|FG001|STARTED|Overall Study||20
8539887|NCT00840099|9572167|FG000|STARTED|Period 2|3 subjects were dismissed from study prior to period 2 dosing|21
8621116|NCT00477607|9659978|FG000|COMPLETED|Overall Study||12
8539888|NCT00840099|9572168|FG001|STARTED|Period 2||24
8539889|NCT00840099|9572167|FG000|COMPLETED|Period 2||21
8539890|NCT00840099|9572168|FG001|COMPLETED|Period 2||24
8539891|NCT00840099|9572167|FG000|NOT COMPLETED|Period 2||0
8539892|NCT00840099|9572168|FG001|NOT COMPLETED|Period 2||0
8539893|NCT00840073|9572174|FG000|STARTED|First Intervention||25
8539894|NCT00840073|9572175|FG001|STARTED|First Intervention||25
8539895|NCT00840073|9572174|FG000|COMPLETED|First Intervention||25
8539896|NCT00840073|9572175|FG001|COMPLETED|First Intervention||25
8539897|NCT00840073|9572174|FG000|NOT COMPLETED|First Intervention||0
8539898|NCT00840073|9572175|FG001|NOT COMPLETED|First Intervention||0
8539899|NCT00840073|9572174|FG000|STARTED|Second Intervention||25
8539900|NCT00840073|9572175|FG001|STARTED|Second Intervention||25
8539901|NCT00840073|9572174|FG000|COMPLETED|Second Intervention||24
8539902|NCT00840073|9572175|FG001|COMPLETED|Second Intervention||24
8539903|NCT00840073|9572174|FG000|NOT COMPLETED|Second Intervention||1
8539904|NCT00840073|9572175|FG001|NOT COMPLETED|Second Intervention||1
8539905|NCT00839930|9572181|FG000|STARTED|First Intervention||15
8539906|NCT00839930|9572182|FG001|STARTED|First Intervention||15
8539907|NCT00839930|9572181|FG000|COMPLETED|First Intervention||15
8539908|NCT00839930|9572182|FG001|COMPLETED|First Intervention||15
8539909|NCT00839930|9572181|FG000|NOT COMPLETED|First Intervention||0
8539910|NCT00839930|9572182|FG001|NOT COMPLETED|First Intervention||0
8539911|NCT00839930|9572181|FG000|STARTED|Washout: 7 Days||15
8539912|NCT00839930|9572182|FG001|STARTED|Washout: 7 Days||15
8539913|NCT00839930|9572181|FG000|COMPLETED|Washout: 7 Days||15
8539914|NCT00839930|9572182|FG001|COMPLETED|Washout: 7 Days||15
8539915|NCT00839930|9572181|FG000|NOT COMPLETED|Washout: 7 Days||0
8539916|NCT00839930|9572182|FG001|NOT COMPLETED|Washout: 7 Days||0
8539917|NCT00839930|9572181|FG000|STARTED|Second Intervention||15
8539918|NCT00839930|9572182|FG001|STARTED|Second Intervention||15
8539919|NCT00839930|9572181|FG000|COMPLETED|Second Intervention||15
8539920|NCT00839930|9572182|FG001|COMPLETED|Second Intervention||15
8539921|NCT00839930|9572181|FG000|NOT COMPLETED|Second Intervention||0
8539922|NCT00839930|9572182|FG001|NOT COMPLETED|Second Intervention||0
8539923|NCT00838630|9572188|FG000|STARTED|First Intervention||18
8539924|NCT00838630|9572189|FG001|STARTED|First Intervention||18
8539925|NCT00838630|9572188|FG000|COMPLETED|First Intervention||17
8539926|NCT00838630|9572189|FG001|COMPLETED|First Intervention||18
8539927|NCT00838630|9572188|FG000|NOT COMPLETED|First Intervention||1
8539928|NCT00838630|9572189|FG001|NOT COMPLETED|First Intervention||0
8539929|NCT00838630|9572188|FG000|STARTED|Washout: 7 Days||17
8539930|NCT00838630|9572189|FG001|STARTED|Washout: 7 Days||18
8539931|NCT00838630|9572188|FG000|COMPLETED|Washout: 7 Days||16
8539932|NCT00838630|9572189|FG001|COMPLETED|Washout: 7 Days||18
8539933|NCT00838630|9572188|FG000|NOT COMPLETED|Washout: 7 Days||1
8539934|NCT00838630|9572189|FG001|NOT COMPLETED|Washout: 7 Days||0
8539935|NCT00838630|9572188|FG000|STARTED|Second Intervention||16
8539936|NCT00838630|9572189|FG001|STARTED|Second Intervention||18
8539937|NCT00838630|9572188|FG000|COMPLETED|Second Intervention||16
8539938|NCT00838630|9572189|FG001|COMPLETED|Second Intervention||18
8539939|NCT00838630|9572188|FG000|NOT COMPLETED|Second Intervention||0
8539940|NCT00838630|9572189|FG001|NOT COMPLETED|Second Intervention||0
8539941|NCT00838279|9572195|FG000|STARTED|First Intervention||16
8539942|NCT00838279|9572196|FG001|STARTED|First Intervention||16
8539943|NCT00838279|9572195|FG000|COMPLETED|First Intervention||16
8539944|NCT00838279|9572196|FG001|COMPLETED|First Intervention||16
8539945|NCT00838279|9572195|FG000|NOT COMPLETED|First Intervention||0
8539946|NCT00838279|9572196|FG001|NOT COMPLETED|First Intervention||0
8539947|NCT00838279|9572195|FG000|STARTED|Washout||16
8539948|NCT00838279|9572196|FG001|STARTED|Washout||16
8539949|NCT00838279|9572195|FG000|COMPLETED|Washout||15
8539950|NCT00838279|9572196|FG001|COMPLETED|Washout||15
8539951|NCT00838279|9572195|FG000|NOT COMPLETED|Washout||1
8539952|NCT00838279|9572196|FG001|NOT COMPLETED|Washout||1
8539953|NCT00838279|9572195|FG000|STARTED|Second Intervention||15
8539954|NCT00838279|9572196|FG001|STARTED|Second Intervention||15
8539955|NCT00838279|9572195|FG000|COMPLETED|Second Intervention||15
8539956|NCT00838279|9572196|FG001|COMPLETED|Second Intervention||15
8539957|NCT00838279|9572195|FG000|NOT COMPLETED|Second Intervention||0
8539958|NCT00838279|9572196|FG001|NOT COMPLETED|Second Intervention||0
8539959|NCT00838136|9572202|FG000|STARTED|First Intervention||16
8539960|NCT00838136|9572203|FG001|STARTED|First Intervention||16
8539961|NCT00838136|9572202|FG000|COMPLETED|First Intervention||16
8539962|NCT00838136|9572203|FG001|COMPLETED|First Intervention||16
8539963|NCT00838136|9572202|FG000|NOT COMPLETED|First Intervention||0
8539964|NCT00838136|9572203|FG001|NOT COMPLETED|First Intervention||0
8539965|NCT00838136|9572202|FG000|STARTED|Second Intervention||16
8539966|NCT00838136|9572203|FG001|STARTED|Second Intervention||16
8539967|NCT00838136|9572202|FG000|COMPLETED|Second Intervention||16
8539968|NCT00838136|9572203|FG001|COMPLETED|Second Intervention||15
8539969|NCT00838136|9572202|FG000|NOT COMPLETED|Second Intervention||0
8539970|NCT00838136|9572203|FG001|NOT COMPLETED|Second Intervention||1
8539971|NCT00836901|9572209|FG000|STARTED|First Intervention||24
8539972|NCT00836901|9572210|FG001|STARTED|First Intervention||28
8539973|NCT00836901|9572209|FG000|COMPLETED|First Intervention||23
8539974|NCT00836901|9572210|FG001|COMPLETED|First Intervention||28
8539975|NCT00836901|9572209|FG000|NOT COMPLETED|First Intervention||1
8539976|NCT00836901|9572210|FG001|NOT COMPLETED|First Intervention||0
8539977|NCT00836901|9572209|FG000|STARTED|Second Intervention||23
8539978|NCT00836901|9572210|FG001|STARTED|Second Intervention||28
8539979|NCT00836901|9572209|FG000|COMPLETED|Second Intervention||23
8539980|NCT00836901|9572210|FG001|COMPLETED|Second Intervention||28
8539981|NCT00836901|9572209|FG000|NOT COMPLETED|Second Intervention||0
8539982|NCT00836901|9572210|FG001|NOT COMPLETED|Second Intervention||0
8539983|NCT00836706|9572216|FG000|STARTED|First Intervention||11
8539984|NCT00836706|9572217|FG001|STARTED|First Intervention||12
8539985|NCT00836706|9572216|FG000|COMPLETED|First Intervention||11
8539986|NCT00836706|9572217|FG001|COMPLETED|First Intervention||12
8539987|NCT00836706|9572216|FG000|NOT COMPLETED|First Intervention||0
8539988|NCT00836706|9572217|FG001|NOT COMPLETED|First Intervention||0
8539989|NCT00836706|9572216|FG000|STARTED|Washout: 7 Days||11
8621117|NCT00477607|9659979|FG001|COMPLETED|Overall Study||13
8621118|NCT00477607|9659978|FG000|NOT COMPLETED|Overall Study||7
8621119|NCT00477607|9659979|FG001|NOT COMPLETED|Overall Study||7
8621120|NCT00477633|9659985|FG000|STARTED|Overall Study||1700
8539990|NCT00836706|9572217|FG001|STARTED|Washout: 7 Days||12
8539991|NCT00836706|9572216|FG000|COMPLETED|Washout: 7 Days||11
8539992|NCT00836706|9572217|FG001|COMPLETED|Washout: 7 Days||11
8539993|NCT00836706|9572216|FG000|NOT COMPLETED|Washout: 7 Days||0
8539994|NCT00836706|9572217|FG001|NOT COMPLETED|Washout: 7 Days||1
8539995|NCT00836706|9572216|FG000|STARTED|Second Intervention||11
8539996|NCT00836706|9572217|FG001|STARTED|Second Intervention||11
8539997|NCT00836706|9572216|FG000|COMPLETED|Second Intervention||11
8539998|NCT00836706|9572217|FG001|COMPLETED|Second Intervention||11
8539999|NCT00836706|9572216|FG000|NOT COMPLETED|Second Intervention||0
8540000|NCT00836706|9572217|FG001|NOT COMPLETED|Second Intervention||0
8540001|NCT00836472|9572223|FG000|STARTED|First Intervention||30
8540002|NCT00836472|9572224|FG001|STARTED|First Intervention||30
8540003|NCT00836472|9572223|FG000|COMPLETED|First Intervention||30
8540004|NCT00836472|9572224|FG001|COMPLETED|First Intervention||30
8540005|NCT00836472|9572223|FG000|NOT COMPLETED|First Intervention||0
8540006|NCT00836472|9572224|FG001|NOT COMPLETED|First Intervention||0
8540007|NCT00836472|9572223|FG000|STARTED|Washout||30
8540008|NCT00836472|9572224|FG001|STARTED|Washout||30
8540009|NCT00836472|9572223|FG000|COMPLETED|Washout||28
8540010|NCT00836472|9572224|FG001|COMPLETED|Washout||27
8540011|NCT00836472|9572223|FG000|NOT COMPLETED|Washout||2
8540012|NCT00836472|9572224|FG001|NOT COMPLETED|Washout||3
8540013|NCT00836472|9572223|FG000|STARTED|Second Intervention||28
8540014|NCT00836472|9572224|FG001|STARTED|Second Intervention||27
8540015|NCT00836472|9572223|FG000|COMPLETED|Second Intervention||28
8540016|NCT00836472|9572224|FG001|COMPLETED|Second Intervention||27
8540017|NCT00836472|9572223|FG000|NOT COMPLETED|Second Intervention||0
8540018|NCT00836472|9572224|FG001|NOT COMPLETED|Second Intervention||0
8540019|NCT00836056|9572230|FG000|STARTED|First Intervention||12
8540020|NCT00836056|9572231|FG001|STARTED|First Intervention||12
8540021|NCT00836056|9572230|FG000|COMPLETED|First Intervention||11
8540022|NCT00836056|9572231|FG001|COMPLETED|First Intervention||12
8540023|NCT00836056|9572230|FG000|NOT COMPLETED|First Intervention||1
8540024|NCT00836056|9572231|FG001|NOT COMPLETED|First Intervention||0
8540025|NCT00836056|9572230|FG000|STARTED|Washout: 7 Days||11
8540026|NCT00836056|9572231|FG001|STARTED|Washout: 7 Days||12
8540027|NCT00836056|9572230|FG000|COMPLETED|Washout: 7 Days||11
8540028|NCT00836056|9572231|FG001|COMPLETED|Washout: 7 Days||12
8540029|NCT00836056|9572230|FG000|NOT COMPLETED|Washout: 7 Days||0
8540030|NCT00836056|9572231|FG001|NOT COMPLETED|Washout: 7 Days||0
8540031|NCT00836056|9572230|FG000|STARTED|Second Intervention||11
8540032|NCT00836056|9572231|FG001|STARTED|Second Intervention||12
8540033|NCT00836056|9572230|FG000|COMPLETED|Second Intervention||11
8540034|NCT00836056|9572231|FG001|COMPLETED|Second Intervention||12
8540035|NCT00836056|9572230|FG000|NOT COMPLETED|Second Intervention||0
8540036|NCT00836056|9572231|FG001|NOT COMPLETED|Second Intervention||0
8540037|NCT00836004|9572237|FG000|STARTED|First Intervention||12
8540038|NCT00836004|9572238|FG001|STARTED|First Intervention||12
8540039|NCT00836004|9572237|FG000|COMPLETED|First Intervention||12
8540040|NCT00836004|9572238|FG001|COMPLETED|First Intervention||12
8540041|NCT00836004|9572237|FG000|NOT COMPLETED|First Intervention||0
8540042|NCT00836004|9572238|FG001|NOT COMPLETED|First Intervention||0
8540043|NCT00836004|9572237|FG000|STARTED|Washout: 7 Days||12
8540044|NCT00836004|9572238|FG001|STARTED|Washout: 7 Days||12
8540045|NCT00836004|9572237|FG000|COMPLETED|Washout: 7 Days||12
8540046|NCT00836004|9572238|FG001|COMPLETED|Washout: 7 Days||12
8540047|NCT00836004|9572237|FG000|NOT COMPLETED|Washout: 7 Days||0
8540048|NCT00836004|9572238|FG001|NOT COMPLETED|Washout: 7 Days||0
8540049|NCT00836004|9572237|FG000|STARTED|Second Intervention||12
8540050|NCT00836004|9572238|FG001|STARTED|Second Intervention||12
8540051|NCT00836004|9572237|FG000|COMPLETED|Second Intervention||12
8540052|NCT00836004|9572238|FG001|COMPLETED|Second Intervention||12
8540053|NCT00836004|9572237|FG000|NOT COMPLETED|Second Intervention||0
8540054|NCT00836004|9572238|FG001|NOT COMPLETED|Second Intervention||0
8540055|NCT00835991|9572244|FG000|STARTED|First Intervention||30
8540056|NCT00835991|9572245|FG001|STARTED|First Intervention||30
8540057|NCT00835991|9572244|FG000|COMPLETED|First Intervention||30
8540058|NCT00835991|9572245|FG001|COMPLETED|First Intervention||29
8540059|NCT00835991|9572244|FG000|NOT COMPLETED|First Intervention||0
8540060|NCT00835991|9572245|FG001|NOT COMPLETED|First Intervention||1
8540061|NCT00835991|9572244|FG000|STARTED|Washout||30
8540062|NCT00835991|9572245|FG001|STARTED|Washout||29
8540063|NCT00835991|9572244|FG000|COMPLETED|Washout||27
8621121|NCT00477633|9659985|FG000|COMPLETED|Overall Study||991
8540064|NCT00835991|9572245|FG001|COMPLETED|Washout||26
8540065|NCT00835991|9572244|FG000|NOT COMPLETED|Washout||3
8540066|NCT00835991|9572245|FG001|NOT COMPLETED|Washout||3
8540067|NCT00835991|9572244|FG000|STARTED|Second Intervention||27
8540068|NCT00835991|9572245|FG001|STARTED|Second Intervention||26
8540069|NCT00835991|9572244|FG000|COMPLETED|Second Intervention||27
8540070|NCT00835991|9572245|FG001|COMPLETED|Second Intervention||26
8540071|NCT00835991|9572244|FG000|NOT COMPLETED|Second Intervention||0
8540072|NCT00835991|9572245|FG001|NOT COMPLETED|Second Intervention||0
8540073|NCT00835796|9572251|FG000|STARTED|First Intervention||10
8540074|NCT00835796|9572252|FG001|STARTED|First Intervention||10
8540075|NCT00835796|9572251|FG000|COMPLETED|First Intervention||10
8540076|NCT00835796|9572252|FG001|COMPLETED|First Intervention||9
8540077|NCT00835796|9572251|FG000|NOT COMPLETED|First Intervention||0
8540078|NCT00835796|9572252|FG001|NOT COMPLETED|First Intervention||1
8540079|NCT00835796|9572251|FG000|STARTED|Washout||10
8540080|NCT00835796|9572252|FG001|STARTED|Washout||9
8540081|NCT00835796|9572251|FG000|COMPLETED|Washout||10
8540082|NCT00835796|9572252|FG001|COMPLETED|Washout||9
8540083|NCT00835796|9572251|FG000|NOT COMPLETED|Washout||0
8540084|NCT00835796|9572252|FG001|NOT COMPLETED|Washout||0
8540085|NCT00835796|9572251|FG000|STARTED|Second Intervention||10
8540086|NCT00835796|9572252|FG001|STARTED|Second Intervention||9
8540087|NCT00835796|9572251|FG000|COMPLETED|Second Intervention||10
8540088|NCT00835796|9572252|FG001|COMPLETED|Second Intervention||9
8540089|NCT00835796|9572251|FG000|NOT COMPLETED|Second Intervention||0
8540090|NCT00835796|9572252|FG001|NOT COMPLETED|Second Intervention||0
8540091|NCT00835705|9572258|FG000|STARTED|First Intervention||24
8540092|NCT00835705|9572259|FG001|STARTED|First Intervention||28
8540093|NCT00835705|9572258|FG000|COMPLETED|First Intervention||23
8540094|NCT00835705|9572259|FG001|COMPLETED|First Intervention||28
8540095|NCT00835705|9572258|FG000|NOT COMPLETED|First Intervention||1
8540096|NCT00835705|9572259|FG001|NOT COMPLETED|First Intervention||0
8540097|NCT00835705|9572258|FG000|STARTED|Second Intervention||23
8540098|NCT00835705|9572259|FG001|STARTED|Second Intervention||28
8540099|NCT00835705|9572258|FG000|COMPLETED|Second Intervention||22
8540100|NCT00835705|9572259|FG001|COMPLETED|Second Intervention||28
8540101|NCT00835705|9572258|FG000|NOT COMPLETED|Second Intervention||1
8540102|NCT00835705|9572259|FG001|NOT COMPLETED|Second Intervention||0
8540103|NCT00835692|9572265|FG000|STARTED|First Intervention||28
8540104|NCT00835692|9572266|FG001|STARTED|First Intervention||28
8818020|NCT01555125|9871646|FG004|NOT COMPLETED|Follow-Up Period||0
8818021|NCT01555138|9871663|FG000|STARTED|Overall Study||293
8818022|NCT01555138|9871664|FG001|STARTED|Overall Study||288
8540105|NCT00835692|9572265|FG000|COMPLETED|First Intervention||27
8540106|NCT00835692|9572266|FG001|COMPLETED|First Intervention||28
8540107|NCT00835692|9572265|FG000|NOT COMPLETED|First Intervention||1
8540108|NCT00835692|9572266|FG001|NOT COMPLETED|First Intervention||0
8540109|NCT00835692|9572265|FG000|STARTED|Washout||27
8540110|NCT00835692|9572266|FG001|STARTED|Washout||28
8540111|NCT00835692|9572265|FG000|COMPLETED|Washout||27
8540112|NCT00835692|9572266|FG001|COMPLETED|Washout||28
8540113|NCT00835692|9572265|FG000|NOT COMPLETED|Washout||0
8540114|NCT00835692|9572266|FG001|NOT COMPLETED|Washout||0
8540115|NCT00835692|9572265|FG000|STARTED|Second Intervention||27
8540116|NCT00835692|9572266|FG001|STARTED|Second Intervention||28
8540117|NCT00835692|9572265|FG000|COMPLETED|Second Intervention||27
8540118|NCT00835692|9572266|FG001|COMPLETED|Second Intervention||28
8540119|NCT00835692|9572265|FG000|NOT COMPLETED|Second Intervention||0
8540120|NCT00835692|9572266|FG001|NOT COMPLETED|Second Intervention||0
8540121|NCT00835666|9572272|FG000|STARTED|First Intervention||16
8540122|NCT00835666|9572273|FG001|STARTED|First Intervention||16
8540123|NCT00835666|9572272|FG000|COMPLETED|First Intervention||16
8540124|NCT00835666|9572273|FG001|COMPLETED|First Intervention||16
8540125|NCT00835666|9572272|FG000|NOT COMPLETED|First Intervention||0
8540126|NCT00835666|9572273|FG001|NOT COMPLETED|First Intervention||0
8540127|NCT00835666|9572272|FG000|STARTED|Washout||16
8540128|NCT00835666|9572273|FG001|STARTED|Washout||16
8540129|NCT00835666|9572272|FG000|COMPLETED|Washout||14
8540130|NCT00835666|9572273|FG001|COMPLETED|Washout||16
8540131|NCT00835666|9572272|FG000|NOT COMPLETED|Washout||2
8540132|NCT00835666|9572273|FG001|NOT COMPLETED|Washout||0
8540133|NCT00835666|9572272|FG000|STARTED|Second Intervention||14
8540134|NCT00835666|9572273|FG001|STARTED|Second Intervention||16
8540135|NCT00835666|9572272|FG000|COMPLETED|Second Intervention||14
8540136|NCT00835666|9572273|FG001|COMPLETED|Second Intervention||16
8540137|NCT00835666|9572272|FG000|NOT COMPLETED|Second Intervention||0
8540138|NCT00835666|9572273|FG001|NOT COMPLETED|Second Intervention||0
8818023|NCT01555138|9871663|FG000|COMPLETED|Overall Study||246
8818024|NCT01555138|9871664|FG001|COMPLETED|Overall Study||250
8540139|NCT00835640|9572279|FG000|STARTED|First Intervention||12
8540140|NCT00835640|9572280|FG001|STARTED|First Intervention||12
8540141|NCT00835640|9572279|FG000|COMPLETED|First Intervention||12
8540142|NCT00835640|9572280|FG001|COMPLETED|First Intervention||12
8540143|NCT00835640|9572279|FG000|NOT COMPLETED|First Intervention||0
8540144|NCT00835640|9572280|FG001|NOT COMPLETED|First Intervention||0
8540145|NCT00835640|9572279|FG000|STARTED|Washout of 7 Days||12
8540146|NCT00835640|9572280|FG001|STARTED|Washout of 7 Days||12
8540147|NCT00835640|9572279|FG000|COMPLETED|Washout of 7 Days||12
8540148|NCT00835640|9572280|FG001|COMPLETED|Washout of 7 Days||12
8818025|NCT01555138|9871663|FG000|NOT COMPLETED|Overall Study||47
8818026|NCT01555138|9871664|FG001|NOT COMPLETED|Overall Study||38
8540149|NCT00835640|9572279|FG000|NOT COMPLETED|Washout of 7 Days||0
8540150|NCT00835640|9572280|FG001|NOT COMPLETED|Washout of 7 Days||0
8540151|NCT00835640|9572279|FG000|STARTED|Second Intervention||12
8540152|NCT00835640|9572280|FG001|STARTED|Second Intervention||12
8540153|NCT00835640|9572279|FG000|COMPLETED|Second Intervention||11
8540154|NCT00835640|9572280|FG001|COMPLETED|Second Intervention||12
8540155|NCT00835640|9572279|FG000|NOT COMPLETED|Second Intervention||1
8540156|NCT00835640|9572280|FG001|NOT COMPLETED|Second Intervention||0
8540157|NCT00835614|9572286|FG000|STARTED|First Intervention||13
8540158|NCT00835614|9572287|FG001|STARTED|First Intervention||13
8540159|NCT00835614|9572286|FG000|COMPLETED|First Intervention||13
8540160|NCT00835614|9572287|FG001|COMPLETED|First Intervention||13
8540161|NCT00835614|9572286|FG000|NOT COMPLETED|First Intervention||0
8540162|NCT00835614|9572287|FG001|NOT COMPLETED|First Intervention||0
8540163|NCT00835614|9572286|FG000|STARTED|Washout of 7 Days||13
8540164|NCT00835614|9572287|FG001|STARTED|Washout of 7 Days||13
8540165|NCT00835614|9572286|FG000|COMPLETED|Washout of 7 Days||13
8540166|NCT00835614|9572287|FG001|COMPLETED|Washout of 7 Days||13
8540167|NCT00835614|9572286|FG000|NOT COMPLETED|Washout of 7 Days||0
8540168|NCT00835614|9572287|FG001|NOT COMPLETED|Washout of 7 Days||0
8540169|NCT00835614|9572286|FG000|STARTED|Second Intervention||13
8540170|NCT00835614|9572287|FG001|STARTED|Second Intervention||13
8540171|NCT00835614|9572286|FG000|COMPLETED|Second Intervention||13
8540172|NCT00835614|9572287|FG001|COMPLETED|Second Intervention||13
8540173|NCT00835614|9572286|FG000|NOT COMPLETED|Second Intervention||0
8540174|NCT00835614|9572287|FG001|NOT COMPLETED|Second Intervention||0
8540175|NCT00835588|9572293|FG000|STARTED|First Intervention||50
8540176|NCT00835588|9572294|FG001|STARTED|First Intervention||50
8540177|NCT00835588|9572293|FG000|COMPLETED|First Intervention||50
8540178|NCT00835588|9572294|FG001|COMPLETED|First Intervention||50
8540179|NCT00835588|9572293|FG000|NOT COMPLETED|First Intervention||0
8540180|NCT00835588|9572294|FG001|NOT COMPLETED|First Intervention||0
8540181|NCT00835588|9572293|FG000|STARTED|Washout: 5 Days||50
8540182|NCT00835588|9572294|FG001|STARTED|Washout: 5 Days||50
8540183|NCT00835588|9572293|FG000|COMPLETED|Washout: 5 Days||50
8540184|NCT00835588|9572294|FG001|COMPLETED|Washout: 5 Days||50
8540185|NCT00835588|9572293|FG000|NOT COMPLETED|Washout: 5 Days||0
8540186|NCT00835588|9572294|FG001|NOT COMPLETED|Washout: 5 Days||0
8540187|NCT00835588|9572293|FG000|STARTED|Second Intervention||50
8540188|NCT00835588|9572294|FG001|STARTED|Second Intervention||50
8540189|NCT00835588|9572293|FG000|COMPLETED|Second Intervention||50
8540190|NCT00835588|9572294|FG001|COMPLETED|Second Intervention||50
8540191|NCT00835588|9572293|FG000|NOT COMPLETED|Second Intervention||0
8540192|NCT00835588|9572294|FG001|NOT COMPLETED|Second Intervention||0
8540193|NCT00835575|9572300|FG000|STARTED|First Intervention||16
8540194|NCT00835575|9572301|FG001|STARTED|First Intervention||16
8540195|NCT00835575|9572300|FG000|COMPLETED|First Intervention||16
8540196|NCT00835575|9572301|FG001|COMPLETED|First Intervention||16
8540197|NCT00835575|9572300|FG000|NOT COMPLETED|First Intervention||0
8540198|NCT00835575|9572301|FG001|NOT COMPLETED|First Intervention||0
8540199|NCT00835575|9572300|FG000|STARTED|Washout of 14 Days||16
8540200|NCT00835575|9572301|FG001|STARTED|Washout of 14 Days||16
8540201|NCT00835575|9572300|FG000|COMPLETED|Washout of 14 Days||15
8540202|NCT00835575|9572301|FG001|COMPLETED|Washout of 14 Days||16
8540203|NCT00835575|9572300|FG000|NOT COMPLETED|Washout of 14 Days||1
8540204|NCT00835575|9572301|FG001|NOT COMPLETED|Washout of 14 Days||0
8540205|NCT00835575|9572300|FG000|STARTED|Second Intervention||15
8540206|NCT00835575|9572301|FG001|STARTED|Second Intervention||16
8540207|NCT00835575|9572300|FG000|COMPLETED|Second Intervention||15
8540208|NCT00835575|9572301|FG001|COMPLETED|Second Intervention||16
8540209|NCT00835575|9572300|FG000|NOT COMPLETED|Second Intervention||0
8540210|NCT00835575|9572301|FG001|NOT COMPLETED|Second Intervention||0
8540211|NCT00835549|9572307|FG000|STARTED|First Intervention||16
8540212|NCT00835549|9572308|FG001|STARTED|First Intervention||16
8540213|NCT00835549|9572307|FG000|COMPLETED|First Intervention||16
8540214|NCT00835549|9572308|FG001|COMPLETED|First Intervention||16
8540215|NCT00835549|9572307|FG000|NOT COMPLETED|First Intervention||0
8540216|NCT00835549|9572308|FG001|NOT COMPLETED|First Intervention||0
8540217|NCT00835549|9572307|FG000|STARTED|Washout of 7 Days||16
8540218|NCT00835549|9572308|FG001|STARTED|Washout of 7 Days||16
8540219|NCT00835549|9572307|FG000|COMPLETED|Washout of 7 Days||14
8540220|NCT00835549|9572308|FG001|COMPLETED|Washout of 7 Days||16
8540221|NCT00835549|9572307|FG000|NOT COMPLETED|Washout of 7 Days||2
8540222|NCT00835549|9572308|FG001|NOT COMPLETED|Washout of 7 Days||0
8540223|NCT00835549|9572307|FG000|STARTED|Second Intervention||14
8540224|NCT00835549|9572308|FG001|STARTED|Second Intervention||16
8540225|NCT00835549|9572307|FG000|COMPLETED|Second Intervention||14
8540226|NCT00835549|9572308|FG001|COMPLETED|Second Intervention||16
8540227|NCT00835549|9572307|FG000|NOT COMPLETED|Second Intervention||0
8540228|NCT00835549|9572308|FG001|NOT COMPLETED|Second Intervention||0
8540229|NCT00835536|9572314|FG000|STARTED|First Intervention||13
8540230|NCT00835536|9572315|FG001|STARTED|First Intervention||14
8540231|NCT00835536|9572314|FG000|COMPLETED|First Intervention||13
8540232|NCT00835536|9572315|FG001|COMPLETED|First Intervention||14
8540233|NCT00835536|9572314|FG000|NOT COMPLETED|First Intervention||0
8540234|NCT00835536|9572315|FG001|NOT COMPLETED|First Intervention||0
8540235|NCT00835536|9572314|FG000|STARTED|Washout of 5 Weeks||13
8540236|NCT00835536|9572315|FG001|STARTED|Washout of 5 Weeks||14
8540237|NCT00835536|9572314|FG000|COMPLETED|Washout of 5 Weeks||12
8540238|NCT00835536|9572315|FG001|COMPLETED|Washout of 5 Weeks||14
8540239|NCT00835536|9572314|FG000|NOT COMPLETED|Washout of 5 Weeks||1
8540240|NCT00835536|9572315|FG001|NOT COMPLETED|Washout of 5 Weeks||0
8540241|NCT00835536|9572314|FG000|STARTED|Second Intervention||12
8540242|NCT00835536|9572315|FG001|STARTED|Second Intervention||14
8540243|NCT00835536|9572314|FG000|COMPLETED|Second Intervention||12
8540244|NCT00835536|9572315|FG001|COMPLETED|Second Intervention||14
8540245|NCT00835536|9572314|FG000|NOT COMPLETED|Second Intervention||0
8540246|NCT00835536|9572315|FG001|NOT COMPLETED|Second Intervention||0
8540247|NCT00835497|9572321|FG000|STARTED|First Intervention||20
8540248|NCT00835497|9572322|FG001|STARTED|First Intervention||20
8540249|NCT00835497|9572321|FG000|COMPLETED|First Intervention||20
8540250|NCT00835497|9572322|FG001|COMPLETED|First Intervention||20
8540251|NCT00835497|9572321|FG000|NOT COMPLETED|First Intervention||0
8540252|NCT00835497|9572322|FG001|NOT COMPLETED|First Intervention||0
8540253|NCT00835497|9572321|FG000|STARTED|Washout: 7 Days||20
8540254|NCT00835497|9572322|FG001|STARTED|Washout: 7 Days||20
8540255|NCT00835497|9572321|FG000|COMPLETED|Washout: 7 Days||20
8540256|NCT00835497|9572322|FG001|COMPLETED|Washout: 7 Days||20
8540257|NCT00835497|9572321|FG000|NOT COMPLETED|Washout: 7 Days||0
8540258|NCT00835497|9572322|FG001|NOT COMPLETED|Washout: 7 Days||0
8540259|NCT00835497|9572321|FG000|STARTED|Second Intervention||20
8540260|NCT00835497|9572322|FG001|STARTED|Second Intervention||20
8540261|NCT00835497|9572321|FG000|COMPLETED|Second Intervention||20
8540262|NCT00835497|9572322|FG001|COMPLETED|Second Intervention||20
8540263|NCT00835497|9572321|FG000|NOT COMPLETED|Second Intervention||0
8540264|NCT00835497|9572322|FG001|NOT COMPLETED|Second Intervention||0
8540265|NCT00835484|9572328|FG000|STARTED|First Intervention||16
8540266|NCT00835484|9572329|FG001|STARTED|First Intervention||16
8540267|NCT00835484|9572328|FG000|COMPLETED|First Intervention||16
8540268|NCT00835484|9572329|FG001|COMPLETED|First Intervention||16
8540269|NCT00835484|9572328|FG000|NOT COMPLETED|First Intervention||0
8540270|NCT00835484|9572329|FG001|NOT COMPLETED|First Intervention||0
8540271|NCT00835484|9572328|FG000|STARTED|Washout of 7 Days||16
8540272|NCT00835484|9572329|FG001|STARTED|Washout of 7 Days||16
8540273|NCT00835484|9572328|FG000|COMPLETED|Washout of 7 Days||16
8540274|NCT00835484|9572329|FG001|COMPLETED|Washout of 7 Days||16
8540275|NCT00835484|9572328|FG000|NOT COMPLETED|Washout of 7 Days||0
8540276|NCT00835484|9572329|FG001|NOT COMPLETED|Washout of 7 Days||0
8540277|NCT00835484|9572328|FG000|STARTED|Second Intervention||16
8540278|NCT00835484|9572329|FG001|STARTED|Second Intervention||16
8540279|NCT00835484|9572328|FG000|COMPLETED|Second Intervention||16
8540280|NCT00835484|9572329|FG001|COMPLETED|Second Intervention||16
8540281|NCT00835484|9572328|FG000|NOT COMPLETED|Second Intervention||0
8540282|NCT00835484|9572329|FG001|NOT COMPLETED|Second Intervention||0
8540283|NCT00835406|9572335|FG000|STARTED|Period: First Intervention||70
8540284|NCT00835406|9572336|FG001|STARTED|Period: First Intervention||70
8540285|NCT00835406|9572335|FG000|COMPLETED|Period: First Intervention||68
8540286|NCT00835406|9572336|FG001|COMPLETED|Period: First Intervention||69
8540287|NCT00835406|9572335|FG000|NOT COMPLETED|Period: First Intervention||2
8540288|NCT00835406|9572336|FG001|NOT COMPLETED|Period: First Intervention||1
8540289|NCT00835406|9572335|FG000|STARTED|Period: Washout of 7 Days||68
8540290|NCT00835406|9572336|FG001|STARTED|Period: Washout of 7 Days||69
8540291|NCT00835406|9572335|FG000|COMPLETED|Period: Washout of 7 Days||68
8540292|NCT00835406|9572336|FG001|COMPLETED|Period: Washout of 7 Days||67
8540293|NCT00835406|9572335|FG000|NOT COMPLETED|Period: Washout of 7 Days||0
8621122|NCT00477633|9659985|FG000|NOT COMPLETED|Overall Study||709
8621123|NCT00477659|9659989|FG000|STARTED|Overall Study||14
8621124|NCT00477659|9659989|FG000|COMPLETED|Overall Study||14
8540294|NCT00835406|9572336|FG001|NOT COMPLETED|Period: Washout of 7 Days||2
8540295|NCT00835406|9572335|FG000|STARTED|Period: Second Intervention||68
8540296|NCT00835406|9572336|FG001|STARTED|Period: Second Intervention||67
8540297|NCT00835406|9572335|FG000|COMPLETED|Period: Second Intervention||68
8540298|NCT00835406|9572336|FG001|COMPLETED|Period: Second Intervention||67
8540299|NCT00835406|9572335|FG000|NOT COMPLETED|Period: Second Intervention||0
8540300|NCT00835406|9572336|FG001|NOT COMPLETED|Period: Second Intervention||0
8540301|NCT00835367|9572342|FG000|STARTED|First Intervention||34
8540302|NCT00835367|9572343|FG001|STARTED|First Intervention||34
8540303|NCT00835367|9572342|FG000|COMPLETED|First Intervention||34
8540304|NCT00835367|9572343|FG001|COMPLETED|First Intervention||34
8540305|NCT00835367|9572342|FG000|NOT COMPLETED|First Intervention||0
8540306|NCT00835367|9572343|FG001|NOT COMPLETED|First Intervention||0
8540307|NCT00835367|9572342|FG000|STARTED|Washout||34
8540308|NCT00835367|9572343|FG001|STARTED|Washout||34
8540309|NCT00835367|9572342|FG000|COMPLETED|Washout||31
8540310|NCT00835367|9572343|FG001|COMPLETED|Washout||34
8540311|NCT00835367|9572342|FG000|NOT COMPLETED|Washout||3
8621125|NCT00477659|9659989|FG000|NOT COMPLETED|Overall Study||0
8540312|NCT00835367|9572343|FG001|NOT COMPLETED|Washout||0
8540313|NCT00835367|9572342|FG000|STARTED|Second Intervention||31
8540314|NCT00835367|9572343|FG001|STARTED|Second Intervention||34
8540315|NCT00835367|9572342|FG000|COMPLETED|Second Intervention||30
8540316|NCT00835367|9572343|FG001|COMPLETED|Second Intervention||33
8540317|NCT00835367|9572342|FG000|NOT COMPLETED|Second Intervention||1
8540318|NCT00835367|9572343|FG001|NOT COMPLETED|Second Intervention||1
8540319|NCT00835354|9572349|FG000|STARTED|First Intervention||13
8540320|NCT00835354|9572350|FG001|STARTED|First Intervention||13
8540321|NCT00835354|9572349|FG000|COMPLETED|First Intervention||13
8540322|NCT00835354|9572350|FG001|COMPLETED|First Intervention||12
8540323|NCT00835354|9572349|FG000|NOT COMPLETED|First Intervention||0
8540324|NCT00835354|9572350|FG001|NOT COMPLETED|First Intervention||1
8540325|NCT00835354|9572349|FG000|STARTED|Washout of 7 Days||13
8540326|NCT00835354|9572350|FG001|STARTED|Washout of 7 Days||12
8540327|NCT00835354|9572349|FG000|COMPLETED|Washout of 7 Days||13
8540328|NCT00835354|9572350|FG001|COMPLETED|Washout of 7 Days||12
8540329|NCT00835354|9572349|FG000|NOT COMPLETED|Washout of 7 Days||0
8540330|NCT00835354|9572350|FG001|NOT COMPLETED|Washout of 7 Days||0
8540331|NCT00835354|9572349|FG000|STARTED|Second Intervention||13
8540332|NCT00835354|9572350|FG001|STARTED|Second Intervention||12
8540333|NCT00835354|9572349|FG000|COMPLETED|Second Intervention||13
8540334|NCT00835354|9572350|FG001|COMPLETED|Second Intervention||12
8540335|NCT00835354|9572349|FG000|NOT COMPLETED|Second Intervention||0
8540336|NCT00835354|9572350|FG001|NOT COMPLETED|Second Intervention||0
8540337|NCT00835276|9572356|FG000|STARTED|First Intervention||24
8540338|NCT00835276|9572357|FG001|STARTED|First Intervention||24
8540339|NCT00835276|9572356|FG000|COMPLETED|First Intervention||24
8540340|NCT00835276|9572357|FG001|COMPLETED|First Intervention||24
8540341|NCT00835276|9572356|FG000|NOT COMPLETED|First Intervention||0
8540342|NCT00835276|9572357|FG001|NOT COMPLETED|First Intervention||0
8540343|NCT00835276|9572356|FG000|STARTED|Washout of 7 Days||24
8540344|NCT00835276|9572357|FG001|STARTED|Washout of 7 Days||24
8540345|NCT00835276|9572356|FG000|COMPLETED|Washout of 7 Days||24
8540346|NCT00835276|9572357|FG001|COMPLETED|Washout of 7 Days||24
8540347|NCT00835276|9572356|FG000|NOT COMPLETED|Washout of 7 Days||0
8540348|NCT00835276|9572357|FG001|NOT COMPLETED|Washout of 7 Days||0
8540349|NCT00835276|9572356|FG000|STARTED|Second Intervention||24
8540350|NCT00835276|9572357|FG001|STARTED|Second Intervention||24
8540351|NCT00835276|9572356|FG000|COMPLETED|Second Intervention||24
8540352|NCT00835276|9572357|FG001|COMPLETED|Second Intervention||24
8540353|NCT00835276|9572356|FG000|NOT COMPLETED|Second Intervention||0
8540354|NCT00835276|9572357|FG001|NOT COMPLETED|Second Intervention||0
8540355|NCT00835263|9572363|FG000|STARTED|First Intervention||16
8540356|NCT00835263|9572364|FG001|STARTED|First Intervention||16
8540357|NCT00835263|9572363|FG000|COMPLETED|First Intervention||16
8540358|NCT00835263|9572364|FG001|COMPLETED|First Intervention||16
8540359|NCT00835263|9572363|FG000|NOT COMPLETED|First Intervention||0
8540360|NCT00835263|9572364|FG001|NOT COMPLETED|First Intervention||0
8540361|NCT00835263|9572363|FG000|STARTED|Second Intervention||16
8540362|NCT00835263|9572364|FG001|STARTED|Second Intervention||16
8540363|NCT00835263|9572363|FG000|COMPLETED|Second Intervention||15
8540364|NCT00835263|9572364|FG001|COMPLETED|Second Intervention||16
8540365|NCT00835263|9572363|FG000|NOT COMPLETED|Second Intervention||1
8540366|NCT00835263|9572364|FG001|NOT COMPLETED|Second Intervention||0
8540367|NCT00835211|9572370|FG000|STARTED|First Intervention||24
8540368|NCT00835211|9572371|FG001|STARTED|First Intervention||24
8540369|NCT00835211|9572370|FG000|COMPLETED|First Intervention||24
8540370|NCT00835211|9572371|FG001|COMPLETED|First Intervention||23
8540371|NCT00835211|9572370|FG000|NOT COMPLETED|First Intervention||0
8540372|NCT00835211|9572371|FG001|NOT COMPLETED|First Intervention||1
8540373|NCT00835211|9572370|FG000|STARTED|Washout: 7 Days||24
8540374|NCT00835211|9572371|FG001|STARTED|Washout: 7 Days||23
8540375|NCT00835211|9572370|FG000|COMPLETED|Washout: 7 Days||21
8540376|NCT00835211|9572371|FG001|COMPLETED|Washout: 7 Days||22
8540377|NCT00835211|9572370|FG000|NOT COMPLETED|Washout: 7 Days||3
8540378|NCT00835211|9572371|FG001|NOT COMPLETED|Washout: 7 Days||1
8540379|NCT00835211|9572370|FG000|STARTED|Second Intervention||21
8540380|NCT00835211|9572371|FG001|STARTED|Second Intervention||22
8540381|NCT00835211|9572370|FG000|COMPLETED|Second Intervention||21
8540382|NCT00835211|9572371|FG001|COMPLETED|Second Intervention||22
8540383|NCT00835211|9572370|FG000|NOT COMPLETED|Second Intervention||0
8540384|NCT00835211|9572371|FG001|NOT COMPLETED|Second Intervention||0
8540385|NCT00835172|9572377|FG000|STARTED|First Intervention||16
8540386|NCT00835172|9572378|FG001|STARTED|First Intervention||16
8540387|NCT00835172|9572377|FG000|COMPLETED|First Intervention||16
8540388|NCT00835172|9572378|FG001|COMPLETED|First Intervention||16
8540389|NCT00835172|9572377|FG000|NOT COMPLETED|First Intervention||0
8540390|NCT00835172|9572378|FG001|NOT COMPLETED|First Intervention||0
8540391|NCT00835172|9572377|FG000|STARTED|Washout||16
8540392|NCT00835172|9572378|FG001|STARTED|Washout||16
8540393|NCT00835172|9572377|FG000|COMPLETED|Washout||16
8540394|NCT00835172|9572378|FG001|COMPLETED|Washout||15
8540395|NCT00835172|9572377|FG000|NOT COMPLETED|Washout||0
8540396|NCT00835172|9572378|FG001|NOT COMPLETED|Washout||1
8540397|NCT00835172|9572377|FG000|STARTED|Second Intervention||16
8540398|NCT00835172|9572378|FG001|STARTED|Second Intervention||15
8540399|NCT00835172|9572377|FG000|COMPLETED|Second Intervention||16
8540400|NCT00835172|9572378|FG001|COMPLETED|Second Intervention||15
8540401|NCT00835172|9572377|FG000|NOT COMPLETED|Second Intervention||0
8540402|NCT00835172|9572378|FG001|NOT COMPLETED|Second Intervention||0
8540403|NCT00835146|9572384|FG000|STARTED|First Intervention||14
8540404|NCT00835146|9572385|FG001|STARTED|First Intervention||14
8540405|NCT00835146|9572384|FG000|COMPLETED|First Intervention||14
8540406|NCT00835146|9572385|FG001|COMPLETED|First Intervention||14
8540407|NCT00835146|9572384|FG000|NOT COMPLETED|First Intervention||0
8540408|NCT00835146|9572385|FG001|NOT COMPLETED|First Intervention||0
8540409|NCT00835146|9572384|FG000|STARTED|Washout of 5 Weeks||14
8540410|NCT00835146|9572385|FG001|STARTED|Washout of 5 Weeks||14
8540411|NCT00835146|9572384|FG000|COMPLETED|Washout of 5 Weeks||14
8540412|NCT00835146|9572385|FG001|COMPLETED|Washout of 5 Weeks||14
8540413|NCT00835146|9572384|FG000|NOT COMPLETED|Washout of 5 Weeks||0
8540414|NCT00835146|9572385|FG001|NOT COMPLETED|Washout of 5 Weeks||0
8540415|NCT00835146|9572384|FG000|STARTED|Second Intervention||14
8540416|NCT00835146|9572385|FG001|STARTED|Second Intervention||14
8540417|NCT00835146|9572384|FG000|COMPLETED|Second Intervention||14
8540418|NCT00835146|9572385|FG001|COMPLETED|Second Intervention||14
8540419|NCT00835146|9572384|FG000|NOT COMPLETED|Second Intervention||0
8540420|NCT00835146|9572385|FG001|NOT COMPLETED|Second Intervention||0
8540421|NCT00835081|9572391|FG000|STARTED|First Intervention||13
8540422|NCT00835081|9572392|FG001|STARTED|First Intervention||13
8540423|NCT00835081|9572391|FG000|COMPLETED|First Intervention||13
8540424|NCT00835081|9572392|FG001|COMPLETED|First Intervention||13
8540425|NCT00835081|9572391|FG000|NOT COMPLETED|First Intervention||0
8621126|NCT00477672|9659996|FG000|STARTED|Overall Study||98
8540426|NCT00835081|9572392|FG001|NOT COMPLETED|First Intervention||0
8540427|NCT00835081|9572391|FG000|STARTED|Washout of 7 Days||13
8540428|NCT00835081|9572392|FG001|STARTED|Washout of 7 Days||13
8540429|NCT00835081|9572391|FG000|COMPLETED|Washout of 7 Days||12
8540430|NCT00835081|9572392|FG001|COMPLETED|Washout of 7 Days||13
8540431|NCT00835081|9572391|FG000|NOT COMPLETED|Washout of 7 Days||1
8540432|NCT00835081|9572392|FG001|NOT COMPLETED|Washout of 7 Days||0
8540433|NCT00835081|9572391|FG000|STARTED|Second Intervention||12
8540434|NCT00835081|9572392|FG001|STARTED|Second Intervention||13
8540435|NCT00835081|9572391|FG000|COMPLETED|Second Intervention||12
8540436|NCT00835081|9572392|FG001|COMPLETED|Second Intervention||13
8540437|NCT00835081|9572391|FG000|NOT COMPLETED|Second Intervention||0
8540438|NCT00835081|9572392|FG001|NOT COMPLETED|Second Intervention||0
8540439|NCT00835042|9572398|FG000|STARTED|First Intervention||30
8540440|NCT00835042|9572399|FG001|STARTED|First Intervention||28
8540441|NCT00835042|9572398|FG000|COMPLETED|First Intervention||26
8540442|NCT00835042|9572399|FG001|COMPLETED|First Intervention||26
8540443|NCT00835042|9572398|FG000|NOT COMPLETED|First Intervention||4
8540444|NCT00835042|9572399|FG001|NOT COMPLETED|First Intervention||2
8540445|NCT00835042|9572398|FG000|STARTED|Washout of 21 Days||26
8540446|NCT00835042|9572399|FG001|STARTED|Washout of 21 Days||26
8540447|NCT00835042|9572398|FG000|COMPLETED|Washout of 21 Days||26
8540448|NCT00835042|9572399|FG001|COMPLETED|Washout of 21 Days||24
8540449|NCT00835042|9572398|FG000|NOT COMPLETED|Washout of 21 Days||0
8540450|NCT00835042|9572399|FG001|NOT COMPLETED|Washout of 21 Days||2
8540451|NCT00835042|9572398|FG000|STARTED|Second Intervention||26
8540452|NCT00835042|9572399|FG001|STARTED|Second Intervention||24
8540453|NCT00835042|9572398|FG000|COMPLETED|Second Intervention||26
8540454|NCT00835042|9572399|FG001|COMPLETED|Second Intervention||24
8540455|NCT00835042|9572398|FG000|NOT COMPLETED|Second Intervention||0
8540456|NCT00835042|9572399|FG001|NOT COMPLETED|Second Intervention||0
8540457|NCT00834990|9572405|FG000|STARTED|First Intervention||12
8540458|NCT00834990|9572406|FG001|STARTED|First Intervention||11
8540459|NCT00834990|9572405|FG000|COMPLETED|First Intervention||12
8540460|NCT00834990|9572406|FG001|COMPLETED|First Intervention||11
8540461|NCT00834990|9572405|FG000|NOT COMPLETED|First Intervention||0
8540462|NCT00834990|9572406|FG001|NOT COMPLETED|First Intervention||0
8540463|NCT00834990|9572405|FG000|STARTED|Washout of 7 Days||12
8540464|NCT00834990|9572406|FG001|STARTED|Washout of 7 Days||11
8540465|NCT00834990|9572405|FG000|COMPLETED|Washout of 7 Days||12
8540466|NCT00834990|9572406|FG001|COMPLETED|Washout of 7 Days||11
8540467|NCT00834990|9572405|FG000|NOT COMPLETED|Washout of 7 Days||0
8540468|NCT00834990|9572406|FG001|NOT COMPLETED|Washout of 7 Days||0
8540469|NCT00834990|9572405|FG000|STARTED|Second Intervention||12
8540470|NCT00834990|9572406|FG001|STARTED|Second Intervention||11
8540471|NCT00834990|9572405|FG000|COMPLETED|Second Intervention||12
8540472|NCT00834990|9572406|FG001|COMPLETED|Second Intervention||11
8540473|NCT00834990|9572405|FG000|NOT COMPLETED|Second Intervention||0
8540474|NCT00834990|9572406|FG001|NOT COMPLETED|Second Intervention||0
8540475|NCT00834977|9572412|FG000|STARTED|First Intervention||24
8540476|NCT00834977|9572413|FG001|STARTED|First Intervention||24
8540477|NCT00834977|9572412|FG000|COMPLETED|First Intervention||24
8540478|NCT00834977|9572413|FG001|COMPLETED|First Intervention||24
8540479|NCT00834977|9572412|FG000|NOT COMPLETED|First Intervention||0
8540480|NCT00834977|9572413|FG001|NOT COMPLETED|First Intervention||0
8540481|NCT00834977|9572412|FG000|STARTED|Second Intervention||24
8540482|NCT00834977|9572413|FG001|STARTED|Second Intervention||24
8540483|NCT00834977|9572412|FG000|COMPLETED|Second Intervention||24
8540484|NCT00834977|9572413|FG001|COMPLETED|Second Intervention||24
8540485|NCT00834977|9572412|FG000|NOT COMPLETED|Second Intervention||0
8540486|NCT00834977|9572413|FG001|NOT COMPLETED|Second Intervention||0
8540487|NCT00834964|9572419|FG000|STARTED|First Intervention||15
8540488|NCT00834964|9572420|FG001|STARTED|First Intervention||15
8540489|NCT00834964|9572419|FG000|COMPLETED|First Intervention||15
8540490|NCT00834964|9572420|FG001|COMPLETED|First Intervention||15
8540491|NCT00834964|9572419|FG000|NOT COMPLETED|First Intervention||0
8540492|NCT00834964|9572420|FG001|NOT COMPLETED|First Intervention||0
8540493|NCT00834964|9572419|FG000|STARTED|Washout: 7 Days||15
8540494|NCT00834964|9572420|FG001|STARTED|Washout: 7 Days||15
8540495|NCT00834964|9572419|FG000|COMPLETED|Washout: 7 Days||15
8621127|NCT00477672|9659997|FG001|STARTED|Overall Study||101
8540496|NCT00834964|9572420|FG001|COMPLETED|Washout: 7 Days||15
8540497|NCT00834964|9572419|FG000|NOT COMPLETED|Washout: 7 Days||0
8540498|NCT00834964|9572420|FG001|NOT COMPLETED|Washout: 7 Days||0
8540499|NCT00834964|9572419|FG000|STARTED|Second Intervention||15
8540500|NCT00834964|9572420|FG001|STARTED|Second Intervention||15
8540501|NCT00834964|9572419|FG000|COMPLETED|Second Intervention||15
8540502|NCT00834964|9572420|FG001|COMPLETED|Second Intervention||15
8540503|NCT00834964|9572419|FG000|NOT COMPLETED|Second Intervention||0
8540504|NCT00834964|9572420|FG001|NOT COMPLETED|Second Intervention||0
8540505|NCT00834873|9572426|FG000|STARTED|First Intervention||12
8540506|NCT00834873|9572427|FG001|STARTED|First Intervention||12
8540507|NCT00834873|9572426|FG000|COMPLETED|First Intervention||12
8540508|NCT00834873|9572427|FG001|COMPLETED|First Intervention||11
8540509|NCT00834873|9572426|FG000|NOT COMPLETED|First Intervention||0
8540510|NCT00834873|9572427|FG001|NOT COMPLETED|First Intervention||1
8540511|NCT00834873|9572426|FG000|STARTED|Washout: 7 Days||12
8540512|NCT00834873|9572427|FG001|STARTED|Washout: 7 Days||11
8540513|NCT00834873|9572426|FG000|COMPLETED|Washout: 7 Days||12
8540514|NCT00834873|9572427|FG001|COMPLETED|Washout: 7 Days||11
8540515|NCT00834873|9572426|FG000|NOT COMPLETED|Washout: 7 Days||0
8540516|NCT00834873|9572427|FG001|NOT COMPLETED|Washout: 7 Days||0
8540517|NCT00834873|9572426|FG000|STARTED|Second Intervention||12
8540518|NCT00834873|9572427|FG001|STARTED|Second Intervention||11
8540519|NCT00834873|9572426|FG000|COMPLETED|Second Intervention||12
8540520|NCT00834873|9572427|FG001|COMPLETED|Second Intervention||11
8540521|NCT00834873|9572426|FG000|NOT COMPLETED|Second Intervention||0
8540522|NCT00834873|9572427|FG001|NOT COMPLETED|Second Intervention||0
8540523|NCT00834795|9572433|FG000|STARTED|First Intervention||18
8540524|NCT00834795|9572434|FG001|STARTED|First Intervention||18
8540525|NCT00834795|9572433|FG000|COMPLETED|First Intervention||18
8540526|NCT00834795|9572434|FG001|COMPLETED|First Intervention||18
8540527|NCT00834795|9572433|FG000|NOT COMPLETED|First Intervention||0
8540528|NCT00834795|9572434|FG001|NOT COMPLETED|First Intervention||0
8540529|NCT00834795|9572433|FG000|STARTED|Washout: 7 Days||18
8540530|NCT00834795|9572434|FG001|STARTED|Washout: 7 Days||18
8540531|NCT00834795|9572433|FG000|COMPLETED|Washout: 7 Days||18
8540532|NCT00834795|9572434|FG001|COMPLETED|Washout: 7 Days||17
8540533|NCT00834795|9572433|FG000|NOT COMPLETED|Washout: 7 Days||0
8540534|NCT00834795|9572434|FG001|NOT COMPLETED|Washout: 7 Days||1
8540535|NCT00834795|9572433|FG000|STARTED|Second Intervention||18
8540536|NCT00834795|9572434|FG001|STARTED|Second Intervention||17
8540537|NCT00834795|9572433|FG000|COMPLETED|Second Intervention||17
8540538|NCT00834795|9572434|FG001|COMPLETED|Second Intervention||17
8540539|NCT00834795|9572433|FG000|NOT COMPLETED|Second Intervention||1
8540540|NCT00834795|9572434|FG001|NOT COMPLETED|Second Intervention||0
8540541|NCT00834756|9572440|FG000|STARTED|First Intervention||18
8540542|NCT00834756|9572441|FG001|STARTED|First Intervention||18
8540543|NCT00834756|9572440|FG000|COMPLETED|First Intervention||17
8540544|NCT00834756|9572441|FG001|COMPLETED|First Intervention||18
8540545|NCT00834756|9572440|FG000|NOT COMPLETED|First Intervention||1
8540546|NCT00834756|9572441|FG001|NOT COMPLETED|First Intervention||0
8540547|NCT00834756|9572440|FG000|STARTED|Washout: 21 Days||17
8540548|NCT00834756|9572441|FG001|STARTED|Washout: 21 Days||18
8540549|NCT00834756|9572440|FG000|COMPLETED|Washout: 21 Days||16
8540550|NCT00834756|9572441|FG001|COMPLETED|Washout: 21 Days||18
8540551|NCT00834756|9572440|FG000|NOT COMPLETED|Washout: 21 Days||1
8540552|NCT00834756|9572441|FG001|NOT COMPLETED|Washout: 21 Days||0
8540553|NCT00834756|9572440|FG000|STARTED|Second Intervention||16
8540554|NCT00834756|9572441|FG001|STARTED|Second Intervention||18
8540555|NCT00834756|9572440|FG000|COMPLETED|Second Intervention||16
8540556|NCT00834756|9572441|FG001|COMPLETED|Second Intervention||18
8540557|NCT00834756|9572440|FG000|NOT COMPLETED|Second Intervention||0
8540558|NCT00834756|9572441|FG001|NOT COMPLETED|Second Intervention||0
8540559|NCT00834743|9572447|FG000|STARTED|First Intervention||16
8540560|NCT00834743|9572448|FG001|STARTED|First Intervention||16
8540561|NCT00834743|9572447|FG000|COMPLETED|First Intervention||16
8540562|NCT00834743|9572448|FG001|COMPLETED|First Intervention||16
8540563|NCT00834743|9572447|FG000|NOT COMPLETED|First Intervention||0
8540564|NCT00834743|9572448|FG001|NOT COMPLETED|First Intervention||0
8540565|NCT00834743|9572447|FG000|STARTED|Washout of 7 Days||16
8540566|NCT00834743|9572448|FG001|STARTED|Washout of 7 Days||16
8540567|NCT00834743|9572447|FG000|COMPLETED|Washout of 7 Days||16
8540568|NCT00834743|9572448|FG001|COMPLETED|Washout of 7 Days||16
8540569|NCT00834743|9572447|FG000|NOT COMPLETED|Washout of 7 Days||0
8540570|NCT00834743|9572448|FG001|NOT COMPLETED|Washout of 7 Days||0
8540571|NCT00834743|9572447|FG000|STARTED|Second Intervention||16
8540572|NCT00834743|9572448|FG001|STARTED|Second Intervention||16
8540573|NCT00834743|9572447|FG000|COMPLETED|Second Intervention||15
8540574|NCT00834743|9572448|FG001|COMPLETED|Second Intervention||16
8540575|NCT00834743|9572447|FG000|NOT COMPLETED|Second Intervention||1
8540576|NCT00834743|9572448|FG001|NOT COMPLETED|Second Intervention||0
8540577|NCT00834717|9572454|FG000|STARTED|First Intervention||20
8540578|NCT00834717|9572455|FG001|STARTED|First Intervention||20
8540579|NCT00834717|9572454|FG000|COMPLETED|First Intervention||19
8540580|NCT00834717|9572455|FG001|COMPLETED|First Intervention||19
8540581|NCT00834717|9572454|FG000|NOT COMPLETED|First Intervention||1
8540582|NCT00834717|9572455|FG001|NOT COMPLETED|First Intervention||1
8540583|NCT00834717|9572454|FG000|STARTED|Second Intervention||19
8540584|NCT00834717|9572455|FG001|STARTED|Second Intervention||19
8540585|NCT00834717|9572454|FG000|COMPLETED|Second Intervention||19
8540586|NCT00834717|9572455|FG001|COMPLETED|Second Intervention||19
8540587|NCT00834717|9572454|FG000|NOT COMPLETED|Second Intervention||0
8540588|NCT00834717|9572455|FG001|NOT COMPLETED|Second Intervention||0
8540589|NCT00834639|9572461|FG000|STARTED|First Intervention||12
8540590|NCT00834639|9572462|FG001|STARTED|First Intervention||12
8540591|NCT00834639|9572461|FG000|COMPLETED|First Intervention||12
8540592|NCT00834639|9572462|FG001|COMPLETED|First Intervention||12
8540593|NCT00834639|9572461|FG000|NOT COMPLETED|First Intervention||0
8540594|NCT00834639|9572462|FG001|NOT COMPLETED|First Intervention||0
8540595|NCT00834639|9572461|FG000|STARTED|Washout of 7 Days||12
8540596|NCT00834639|9572462|FG001|STARTED|Washout of 7 Days||12
8540597|NCT00834639|9572461|FG000|COMPLETED|Washout of 7 Days||12
8540598|NCT00834639|9572462|FG001|COMPLETED|Washout of 7 Days||12
8540599|NCT00834639|9572461|FG000|NOT COMPLETED|Washout of 7 Days||0
8540600|NCT00834639|9572462|FG001|NOT COMPLETED|Washout of 7 Days||0
8540601|NCT00834639|9572461|FG000|STARTED|Second Intervention||12
8540602|NCT00834639|9572462|FG001|STARTED|Second Intervention||12
8540603|NCT00834639|9572461|FG000|COMPLETED|Second Intervention||12
8540604|NCT00834639|9572462|FG001|COMPLETED|Second Intervention||10
8540605|NCT00834639|9572461|FG000|NOT COMPLETED|Second Intervention||0
8540606|NCT00834639|9572462|FG001|NOT COMPLETED|Second Intervention||2
8540607|NCT00834613|9572468|FG000|STARTED|First Intervention||16
8540608|NCT00834613|9572469|FG001|STARTED|First Intervention||16
8540609|NCT00834613|9572468|FG000|COMPLETED|First Intervention||15
8540610|NCT00834613|9572469|FG001|COMPLETED|First Intervention||16
8540611|NCT00834613|9572468|FG000|NOT COMPLETED|First Intervention||1
8540612|NCT00834613|9572469|FG001|NOT COMPLETED|First Intervention||0
8540613|NCT00834613|9572468|FG000|STARTED|Washout of 7 Days||15
8540614|NCT00834613|9572469|FG001|STARTED|Washout of 7 Days||16
8540615|NCT00834613|9572468|FG000|COMPLETED|Washout of 7 Days||15
8540616|NCT00834613|9572469|FG001|COMPLETED|Washout of 7 Days||16
8540617|NCT00834613|9572468|FG000|NOT COMPLETED|Washout of 7 Days||0
8540618|NCT00834613|9572469|FG001|NOT COMPLETED|Washout of 7 Days||0
8540619|NCT00834613|9572468|FG000|STARTED|Second Intervention||15
8540620|NCT00834613|9572469|FG001|STARTED|Second Intervention||16
8540621|NCT00834613|9572468|FG000|COMPLETED|Second Intervention||15
8540622|NCT00834613|9572469|FG001|COMPLETED|Second Intervention||16
8540623|NCT00834613|9572468|FG000|NOT COMPLETED|Second Intervention||0
8540624|NCT00834613|9572469|FG001|NOT COMPLETED|Second Intervention||0
8540625|NCT00834587|9572475|FG000|STARTED|First Intervention||20
8540626|NCT00834587|9572476|FG001|STARTED|First Intervention||20
8540627|NCT00834587|9572475|FG000|COMPLETED|First Intervention||20
8540628|NCT00834587|9572476|FG001|COMPLETED|First Intervention||20
8540629|NCT00834587|9572475|FG000|NOT COMPLETED|First Intervention||0
8540630|NCT00834587|9572476|FG001|NOT COMPLETED|First Intervention||0
8540631|NCT00834587|9572475|FG000|STARTED|Washout: 7 Days||20
8540632|NCT00834587|9572476|FG001|STARTED|Washout: 7 Days||20
8540633|NCT00834587|9572475|FG000|COMPLETED|Washout: 7 Days||19
8540634|NCT00834587|9572476|FG001|COMPLETED|Washout: 7 Days||20
8540635|NCT00834587|9572475|FG000|NOT COMPLETED|Washout: 7 Days||1
8540636|NCT00834587|9572476|FG001|NOT COMPLETED|Washout: 7 Days||0
8540637|NCT00834587|9572475|FG000|STARTED|Second Intervention||19
8540638|NCT00834587|9572476|FG001|STARTED|Second Intervention||20
8540639|NCT00834587|9572475|FG000|COMPLETED|Second Intervention||19
8540640|NCT00834587|9572476|FG001|COMPLETED|Second Intervention||20
8540641|NCT00834587|9572475|FG000|NOT COMPLETED|Second Intervention||0
8540642|NCT00834587|9572476|FG001|NOT COMPLETED|Second Intervention||0
8540643|NCT00834574|9572482|FG000|STARTED|First Intervention||16
8540644|NCT00834574|9572483|FG001|STARTED|First Intervention||16
8540645|NCT00834574|9572482|FG000|COMPLETED|First Intervention||16
8540646|NCT00834574|9572483|FG001|COMPLETED|First Intervention||16
8540647|NCT00834574|9572482|FG000|NOT COMPLETED|First Intervention||0
8540648|NCT00834574|9572483|FG001|NOT COMPLETED|First Intervention||0
8540649|NCT00834574|9572482|FG000|STARTED|Washout of 7 Days||16
8540650|NCT00834574|9572483|FG001|STARTED|Washout of 7 Days||16
8540651|NCT00834574|9572482|FG000|COMPLETED|Washout of 7 Days||16
8540652|NCT00834574|9572483|FG001|COMPLETED|Washout of 7 Days||16
8540653|NCT00834574|9572482|FG000|NOT COMPLETED|Washout of 7 Days||0
8540654|NCT00834574|9572483|FG001|NOT COMPLETED|Washout of 7 Days||0
8540655|NCT00834574|9572482|FG000|STARTED|Second Intervention||16
8540656|NCT00834574|9572483|FG001|STARTED|Second Intervention||16
8540657|NCT00834574|9572482|FG000|COMPLETED|Second Intervention||16
8540658|NCT00834574|9572483|FG001|COMPLETED|Second Intervention||16
8540659|NCT00834574|9572482|FG000|NOT COMPLETED|Second Intervention||0
8540660|NCT00834574|9572483|FG001|NOT COMPLETED|Second Intervention||0
8540661|NCT00834561|9572489|FG000|STARTED|First Intervention||16
8540662|NCT00834561|9572490|FG001|STARTED|First Intervention||16
8540663|NCT00834561|9572489|FG000|COMPLETED|First Intervention||16
8540664|NCT00834561|9572490|FG001|COMPLETED|First Intervention||16
8540665|NCT00834561|9572489|FG000|NOT COMPLETED|First Intervention||0
8540666|NCT00834561|9572490|FG001|NOT COMPLETED|First Intervention||0
8540667|NCT00834561|9572489|FG000|STARTED|Second Intervention||16
8818027|NCT01555151|9871674|FG000|STARTED|Overall Study||188
8818028|NCT01555151|9871675|FG001|STARTED|Overall Study||181
8818029|NCT01555151|9871676|FG002|STARTED|Overall Study||184
8540668|NCT00834561|9572490|FG001|STARTED|Second Intervention||16
8540669|NCT00834561|9572489|FG000|COMPLETED|Second Intervention||16
8540670|NCT00834561|9572490|FG001|COMPLETED|Second Intervention||16
8540671|NCT00834561|9572489|FG000|NOT COMPLETED|Second Intervention||0
8818030|NCT01555151|9871677|FG003|STARTED|Overall Study||186
8818031|NCT01555151|9871674|FG000|Safety Set (SAF)|Overall Study||186
8818032|NCT01555151|9871675|FG001|Safety Set (SAF)|Overall Study||180
8540672|NCT00834561|9572490|FG001|NOT COMPLETED|Second Intervention||0
8540673|NCT00834535|9572496|FG000|STARTED|First Intervention||16
8540674|NCT00834535|9572497|FG001|STARTED|First Intervention||16
8540675|NCT00834535|9572496|FG000|COMPLETED|First Intervention||16
8540676|NCT00834535|9572497|FG001|COMPLETED|First Intervention||16
8540677|NCT00834535|9572496|FG000|NOT COMPLETED|First Intervention||0
8540678|NCT00834535|9572497|FG001|NOT COMPLETED|First Intervention||0
8540679|NCT00834535|9572496|FG000|STARTED|Washout of 7 Days||16
8540680|NCT00834535|9572497|FG001|STARTED|Washout of 7 Days||16
8540681|NCT00834535|9572496|FG000|COMPLETED|Washout of 7 Days||16
8540682|NCT00834535|9572497|FG001|COMPLETED|Washout of 7 Days||16
8540683|NCT00834535|9572496|FG000|NOT COMPLETED|Washout of 7 Days||0
8540684|NCT00834535|9572497|FG001|NOT COMPLETED|Washout of 7 Days||0
8540685|NCT00834535|9572496|FG000|STARTED|Second Intervention||16
8540686|NCT00834535|9572497|FG001|STARTED|Second Intervention||16
8540687|NCT00834535|9572496|FG000|COMPLETED|Second Intervention||16
8540688|NCT00834535|9572497|FG001|COMPLETED|Second Intervention||16
8540689|NCT00834535|9572496|FG000|NOT COMPLETED|Second Intervention||0
8540690|NCT00834535|9572497|FG001|NOT COMPLETED|Second Intervention||0
8540691|NCT00834522|9572503|FG000|STARTED|First Intervention||40
8540692|NCT00834522|9572504|FG001|STARTED|First Intervention||40
8540693|NCT00834522|9572503|FG000|COMPLETED|First Intervention||40
8540694|NCT00834522|9572504|FG001|COMPLETED|First Intervention||40
8540695|NCT00834522|9572503|FG000|NOT COMPLETED|First Intervention||0
8540696|NCT00834522|9572504|FG001|NOT COMPLETED|First Intervention||0
8540697|NCT00834522|9572503|FG000|STARTED|Washout||40
8621128|NCT00477672|9659998|FG002|STARTED|Overall Study||99
8621129|NCT00477672|9659996|FG000|COMPLETED|Overall Study||91
8621130|NCT00477672|9659997|FG001|COMPLETED|Overall Study||85
8621131|NCT00477672|9659998|FG002|COMPLETED|Overall Study||83
8621132|NCT00477672|9659996|FG000|NOT COMPLETED|Overall Study||7
8621133|NCT00477672|9659997|FG001|NOT COMPLETED|Overall Study||16
8621134|NCT00477672|9659998|FG002|NOT COMPLETED|Overall Study||16
8621135|NCT00477685|9660006|FG000|STARTED|Overall Study||10
8621136|NCT00477685|9660006|FG000|COMPLETED|Overall Study||10
8621137|NCT00477685|9660006|FG000|NOT COMPLETED|Overall Study||0
8621138|NCT00477750|9660010|FG000|STARTED|Overall Study||26
8621139|NCT00477750|9660010|FG000|COMPLETED|Overall Study||15
8621140|NCT00477750|9660010|FG000|NOT COMPLETED|Overall Study||11
8621141|NCT00477971|9660018|FG000|STARTED|Overall Study||34
8621142|NCT00477971|9660019|FG001|STARTED|Overall Study||55
8621143|NCT00477971|9660018|FG000|COMPLETED|Overall Study||17
8621144|NCT00477971|9660019|FG001|COMPLETED|Overall Study||49
8621145|NCT00477971|9660018|FG000|NOT COMPLETED|Overall Study||17
8621146|NCT00477971|9660019|FG001|NOT COMPLETED|Overall Study||6
8621147|NCT00478023|9660030|FG000|STARTED|Overall Study||170
8621148|NCT00478023|9660031|FG001|STARTED|Overall Study||168
8621149|NCT00478023|9660032|FG002|STARTED|Overall Study||171
8540698|NCT00834522|9572504|FG001|STARTED|Washout||40
8540699|NCT00834522|9572503|FG000|COMPLETED|Washout||37
8540700|NCT00834522|9572504|FG001|COMPLETED|Washout||39
8540701|NCT00834522|9572503|FG000|NOT COMPLETED|Washout||3
8540702|NCT00834522|9572504|FG001|NOT COMPLETED|Washout||1
8540703|NCT00834522|9572503|FG000|STARTED|Second Intervention||37
8540704|NCT00834522|9572504|FG001|STARTED|Second Intervention||39
8540705|NCT00834522|9572503|FG000|COMPLETED|Second Intervention||37
8540706|NCT00834522|9572504|FG001|COMPLETED|Second Intervention||39
8540707|NCT00834522|9572503|FG000|NOT COMPLETED|Second Intervention||0
8540708|NCT00834522|9572504|FG001|NOT COMPLETED|Second Intervention||0
8566057|NCT00073307|9598121|FG000|NOT COMPLETED|Open Label-Sorafenib Only [30Jun2008]||134
8566058|NCT00073307|9598122|FG001|NOT COMPLETED|Open Label-Sorafenib Only [30Jun2008]||0
8621150|NCT00478023|9660033|FG003|STARTED|Overall Study||176
8621151|NCT00478023|9660034|FG004|STARTED|Overall Study||169
8621152|NCT00478023|9660030|FG000|COMPLETED|Overall Study||135
8566059|NCT00073307|9598123|FG002|NOT COMPLETED|Open Label-Sorafenib Only [30Jun2008]||156
8566060|NCT00073333|9598135|FG000|STARTED|Overall Study||46
8566061|NCT00073333|9598136|FG001|STARTED|Overall Study||41
8621153|NCT00478023|9660031|FG001|COMPLETED|Overall Study||144
8621154|NCT00478023|9660032|FG002|COMPLETED|Overall Study||151
8818033|NCT01555151|9871676|FG002|Safety Set (SAF)|Overall Study||183
8621155|NCT00478023|9660033|FG003|COMPLETED|Overall Study||146
8621156|NCT00478023|9660034|FG004|COMPLETED|Overall Study||114
8621157|NCT00478023|9660030|FG000|NOT COMPLETED|Overall Study||35
8621158|NCT00478023|9660031|FG001|NOT COMPLETED|Overall Study||24
8621159|NCT00478023|9660032|FG002|NOT COMPLETED|Overall Study||20
8621160|NCT00478023|9660033|FG003|NOT COMPLETED|Overall Study||30
8621161|NCT00478023|9660034|FG004|NOT COMPLETED|Overall Study||55
8818034|NCT01555151|9871677|FG003|Safety Set (SAF)|Overall Study||186
8818035|NCT01555151|9871674|FG000|COMPLETED|Overall Study||175
8566062|NCT00073333|9598137|FG002|STARTED|Overall Study||19
8566063|NCT00073333|9598135|FG000|COMPLETED|Overall Study||32
8566064|NCT00073333|9598136|FG001|COMPLETED|Overall Study||27
8566065|NCT00073333|9598137|FG002|COMPLETED|Overall Study||19
8566066|NCT00073333|9598135|FG000|NOT COMPLETED|Overall Study||14
8566067|NCT00073333|9598136|FG001|NOT COMPLETED|Overall Study||14
8566068|NCT00073333|9598137|FG002|NOT COMPLETED|Overall Study||0
8818036|NCT01555151|9871675|FG001|COMPLETED|Overall Study||173
8818037|NCT01555151|9871676|FG002|COMPLETED|Overall Study||178
8818038|NCT01555151|9871677|FG003|COMPLETED|Overall Study||176
8818039|NCT01555151|9871674|FG000|NOT COMPLETED|Overall Study||13
8621162|NCT00478036|9660049|FG000|STARTED|Overall Study||10
8621163|NCT00478036|9660050|FG001|STARTED|Overall Study||7
8621164|NCT00478036|9660051|FG002|STARTED|Overall Study||14
8540709|NCT00834444|9572510|FG000|STARTED|First Intervention||18
8540710|NCT00834444|9572511|FG001|STARTED|First Intervention||18
8540711|NCT00834444|9572510|FG000|COMPLETED|First Intervention||17
8540712|NCT00834444|9572511|FG001|COMPLETED|First Intervention||17
8540713|NCT00834444|9572510|FG000|NOT COMPLETED|First Intervention||1
8540714|NCT00834444|9572511|FG001|NOT COMPLETED|First Intervention||1
8540715|NCT00834444|9572510|FG000|STARTED|Washout of 7 Days||17
8540716|NCT00834444|9572511|FG001|STARTED|Washout of 7 Days||17
8540717|NCT00834444|9572510|FG000|COMPLETED|Washout of 7 Days||17
8540718|NCT00834444|9572511|FG001|COMPLETED|Washout of 7 Days||16
8540719|NCT00834444|9572510|FG000|NOT COMPLETED|Washout of 7 Days||0
8540720|NCT00834444|9572511|FG001|NOT COMPLETED|Washout of 7 Days||1
8540721|NCT00834444|9572510|FG000|STARTED|Second Intervention||17
8540722|NCT00834444|9572511|FG001|STARTED|Second Intervention||16
8540723|NCT00834444|9572510|FG000|COMPLETED|Second Intervention||16
8540724|NCT00834444|9572511|FG001|COMPLETED|Second Intervention||16
8540725|NCT00834444|9572510|FG000|NOT COMPLETED|Second Intervention||1
8540726|NCT00834444|9572511|FG001|NOT COMPLETED|Second Intervention||0
8540727|NCT00834431|9572517|FG000|STARTED|First Intervention||18
8540728|NCT00834431|9572518|FG001|STARTED|First Intervention||18
8540729|NCT00834431|9572517|FG000|COMPLETED|First Intervention||18
8540730|NCT00834431|9572518|FG001|COMPLETED|First Intervention||17
8540731|NCT00834431|9572517|FG000|NOT COMPLETED|First Intervention||0
8540732|NCT00834431|9572518|FG001|NOT COMPLETED|First Intervention||1
8540733|NCT00834431|9572517|FG000|STARTED|Washout of 7 Days||18
8540734|NCT00834431|9572518|FG001|STARTED|Washout of 7 Days||17
8540735|NCT00834431|9572517|FG000|COMPLETED|Washout of 7 Days||18
8540736|NCT00834431|9572518|FG001|COMPLETED|Washout of 7 Days||16
8540737|NCT00834431|9572517|FG000|NOT COMPLETED|Washout of 7 Days||0
8540738|NCT00834431|9572518|FG001|NOT COMPLETED|Washout of 7 Days||1
8540739|NCT00834431|9572517|FG000|STARTED|Second Intervention||18
8540740|NCT00834431|9572518|FG001|STARTED|Second Intervention||16
8540741|NCT00834431|9572517|FG000|COMPLETED|Second Intervention||18
8540742|NCT00834431|9572518|FG001|COMPLETED|Second Intervention||16
8540743|NCT00834431|9572517|FG000|NOT COMPLETED|Second Intervention||0
8540744|NCT00834431|9572518|FG001|NOT COMPLETED|Second Intervention||0
8540745|NCT00834418|9572524|FG000|STARTED|Overall Study||42
8540746|NCT00834418|9572525|FG001|STARTED|Overall Study||42
8540747|NCT00834418|9572524|FG000|COMPLETED|Overall Study||42
8540748|NCT00834418|9572525|FG001|COMPLETED|Overall Study||40
8540749|NCT00834418|9572524|FG000|NOT COMPLETED|Overall Study||0
8540750|NCT00834418|9572525|FG001|NOT COMPLETED|Overall Study||2
8540751|NCT00834405|9572531|FG000|STARTED|Overall Study||20
8540752|NCT00834405|9572532|FG001|STARTED|Overall Study||17
8540753|NCT00834405|9572531|FG000|COMPLETED|Overall Study||20
8540754|NCT00834405|9572532|FG001|COMPLETED|Overall Study||17
8540755|NCT00834405|9572531|FG000|NOT COMPLETED|Overall Study||0
8540756|NCT00834405|9572532|FG001|NOT COMPLETED|Overall Study||0
8540757|NCT00834340|9572538|FG000|STARTED|First Intervention||16
8540758|NCT00834340|9572539|FG001|STARTED|First Intervention||16
8540759|NCT00834340|9572538|FG000|COMPLETED|First Intervention||16
8540760|NCT00834340|9572539|FG001|COMPLETED|First Intervention||16
8540761|NCT00834340|9572538|FG000|NOT COMPLETED|First Intervention||0
8540762|NCT00834340|9572539|FG001|NOT COMPLETED|First Intervention||0
8540763|NCT00834340|9572538|FG000|STARTED|Washout||16
8540764|NCT00834340|9572539|FG001|STARTED|Washout||16
8540765|NCT00834340|9572538|FG000|COMPLETED|Washout||14
8540766|NCT00834340|9572539|FG001|COMPLETED|Washout||16
8540767|NCT00834340|9572538|FG000|NOT COMPLETED|Washout||2
8540768|NCT00834340|9572539|FG001|NOT COMPLETED|Washout||0
8540769|NCT00834340|9572538|FG000|STARTED|Second Intervention||14
8540770|NCT00834340|9572539|FG001|STARTED|Second Intervention||16
8540771|NCT00834340|9572538|FG000|COMPLETED|Second Intervention||14
8540772|NCT00834340|9572539|FG001|COMPLETED|Second Intervention||16
8540773|NCT00834340|9572538|FG000|NOT COMPLETED|Second Intervention||0
8540774|NCT00834340|9572539|FG001|NOT COMPLETED|Second Intervention||0
8540775|NCT00834275|9572545|FG000|STARTED|First Intervention||13
8621165|NCT00478036|9660049|FG000|COMPLETED|Overall Study||10
8621166|NCT00478036|9660050|FG001|COMPLETED|Overall Study||7
8723058|NCT01021306|9770546|FG003|NOT COMPLETED|6 Month (Follow-up)||3
8723059|NCT01021332|9770556|FG000|STARTED|Overall Study|Took ≥ 1 dose of FDC open-label study drug|1066
8540776|NCT00834275|9572546|FG001|STARTED|First Intervention||13
8540777|NCT00834275|9572545|FG000|COMPLETED|First Intervention||13
8540778|NCT00834275|9572546|FG001|COMPLETED|First Intervention||13
8540779|NCT00834275|9572545|FG000|NOT COMPLETED|First Intervention||0
8540780|NCT00834275|9572546|FG001|NOT COMPLETED|First Intervention||0
8540781|NCT00834275|9572545|FG000|STARTED|Washout of 7 Days||13
8540782|NCT00834275|9572546|FG001|STARTED|Washout of 7 Days||13
8540783|NCT00834275|9572545|FG000|COMPLETED|Washout of 7 Days||13
8540784|NCT00834275|9572546|FG001|COMPLETED|Washout of 7 Days||13
8621167|NCT00478036|9660051|FG002|COMPLETED|Overall Study||14
8621168|NCT00478036|9660049|FG000|NOT COMPLETED|Overall Study||0
8621169|NCT00478036|9660050|FG001|NOT COMPLETED|Overall Study||0
8621170|NCT00478036|9660051|FG002|NOT COMPLETED|Overall Study||0
8621171|NCT00478140|9660059|FG000|STARTED|Overall Study||4
8621172|NCT00478140|9660059|FG000|COMPLETED|Overall Study||3
8540785|NCT00834275|9572545|FG000|NOT COMPLETED|Washout of 7 Days||0
8540786|NCT00834275|9572546|FG001|NOT COMPLETED|Washout of 7 Days||0
8540787|NCT00834275|9572545|FG000|STARTED|Second Intervention||13
8540788|NCT00834275|9572546|FG001|STARTED|Second Intervention||13
8540789|NCT00834275|9572545|FG000|COMPLETED|Second Intervention||13
8540790|NCT00834275|9572546|FG001|COMPLETED|Second Intervention||13
8540791|NCT00834275|9572545|FG000|NOT COMPLETED|Second Intervention||0
8540792|NCT00834275|9572546|FG001|NOT COMPLETED|Second Intervention||0
8540793|NCT00834249|9572552|FG000|STARTED|First Intervention||9
8540794|NCT00834249|9572553|FG001|STARTED|First Intervention||9
8540795|NCT00834249|9572552|FG000|COMPLETED|First Intervention||9
8540796|NCT00834249|9572553|FG001|COMPLETED|First Intervention||9
8540797|NCT00834249|9572552|FG000|NOT COMPLETED|First Intervention||0
8540798|NCT00834249|9572553|FG001|NOT COMPLETED|First Intervention||0
8540799|NCT00834249|9572552|FG000|STARTED|Washout: 7 Days||9
8540800|NCT00834249|9572553|FG001|STARTED|Washout: 7 Days||9
8540801|NCT00834249|9572552|FG000|COMPLETED|Washout: 7 Days||8
8540802|NCT00834249|9572553|FG001|COMPLETED|Washout: 7 Days||8
8540803|NCT00834249|9572552|FG000|NOT COMPLETED|Washout: 7 Days||1
8540804|NCT00834249|9572553|FG001|NOT COMPLETED|Washout: 7 Days||1
8540805|NCT00834249|9572552|FG000|STARTED|Second Intervention||8
8540806|NCT00834249|9572553|FG001|STARTED|Second Intervention||8
8540807|NCT00834249|9572552|FG000|COMPLETED|Second Intervention||7
8540808|NCT00834249|9572553|FG001|COMPLETED|Second Intervention||8
8540809|NCT00834249|9572552|FG000|NOT COMPLETED|Second Intervention||1
8540810|NCT00834249|9572553|FG001|NOT COMPLETED|Second Intervention||0
8540811|NCT00834197|9572559|FG000|STARTED|First Intervention||16
8540812|NCT00834197|9572560|FG001|STARTED|First Intervention||16
8540813|NCT00834197|9572559|FG000|COMPLETED|First Intervention||16
8540814|NCT00834197|9572560|FG001|COMPLETED|First Intervention||16
8540815|NCT00834197|9572559|FG000|NOT COMPLETED|First Intervention||0
8540816|NCT00834197|9572560|FG001|NOT COMPLETED|First Intervention||0
8540817|NCT00834197|9572559|FG000|STARTED|Washout of 14 Days||16
8540818|NCT00834197|9572560|FG001|STARTED|Washout of 14 Days||16
8540819|NCT00834197|9572559|FG000|COMPLETED|Washout of 14 Days||16
8540820|NCT00834197|9572560|FG001|COMPLETED|Washout of 14 Days||16
8540821|NCT00834197|9572559|FG000|NOT COMPLETED|Washout of 14 Days||0
8540822|NCT00834197|9572560|FG001|NOT COMPLETED|Washout of 14 Days||0
8540823|NCT00834197|9572559|FG000|STARTED|Second Intervention||16
8540824|NCT00834197|9572560|FG001|STARTED|Second Intervention||16
8540825|NCT00834197|9572559|FG000|COMPLETED|Second Intervention||16
8540826|NCT00834197|9572560|FG001|COMPLETED|Second Intervention||16
8540827|NCT00834197|9572559|FG000|NOT COMPLETED|Second Intervention||0
8540828|NCT00834197|9572560|FG001|NOT COMPLETED|Second Intervention||0
8540829|NCT00834132|9572566|FG000|STARTED|First Intervention||12
8540830|NCT00834132|9572567|FG001|STARTED|First Intervention||12
8540831|NCT00834132|9572566|FG000|COMPLETED|First Intervention||12
8540832|NCT00834132|9572567|FG001|COMPLETED|First Intervention||12
8540833|NCT00834132|9572566|FG000|NOT COMPLETED|First Intervention||0
8540834|NCT00834132|9572567|FG001|NOT COMPLETED|First Intervention||0
8540835|NCT00834132|9572566|FG000|STARTED|Washout: 21 Days||12
8540836|NCT00834132|9572567|FG001|STARTED|Washout: 21 Days||12
8540837|NCT00834132|9572566|FG000|COMPLETED|Washout: 21 Days||12
8540838|NCT00834132|9572567|FG001|COMPLETED|Washout: 21 Days||12
8540839|NCT00834132|9572566|FG000|NOT COMPLETED|Washout: 21 Days||0
8540840|NCT00834132|9572567|FG001|NOT COMPLETED|Washout: 21 Days||0
8540841|NCT00834132|9572566|FG000|STARTED|Second Intervention||12
8540842|NCT00834132|9572567|FG001|STARTED|Second Intervention||12
8540843|NCT00834132|9572566|FG000|COMPLETED|Second Intervention||12
8540844|NCT00834132|9572567|FG001|COMPLETED|Second Intervention||12
8540845|NCT00834132|9572566|FG000|NOT COMPLETED|Second Intervention||0
8540846|NCT00834132|9572567|FG001|NOT COMPLETED|Second Intervention||0
8540847|NCT00834067|9572573|FG000|STARTED|First Intervention||30
8540848|NCT00834067|9572574|FG001|STARTED|First Intervention||30
8540849|NCT00834067|9572573|FG000|COMPLETED|First Intervention||30
8540850|NCT00834067|9572574|FG001|COMPLETED|First Intervention||30
8540851|NCT00834067|9572573|FG000|NOT COMPLETED|First Intervention||0
8540852|NCT00834067|9572574|FG001|NOT COMPLETED|First Intervention||0
8540853|NCT00834067|9572573|FG000|STARTED|Washout of 21 Days||30
8540854|NCT00834067|9572574|FG001|STARTED|Washout of 21 Days||30
8540855|NCT00834067|9572573|FG000|COMPLETED|Washout of 21 Days||30
8540856|NCT00834067|9572574|FG001|COMPLETED|Washout of 21 Days||29
8540857|NCT00834067|9572573|FG000|NOT COMPLETED|Washout of 21 Days||0
8540858|NCT00834067|9572574|FG001|NOT COMPLETED|Washout of 21 Days||1
8540859|NCT00834067|9572573|FG000|STARTED|Second Intervention||30
8540860|NCT00834067|9572574|FG001|STARTED|Second Intervention||29
8540861|NCT00834067|9572573|FG000|COMPLETED|Second Intervention||30
8540862|NCT00834067|9572574|FG001|COMPLETED|Second Intervention||29
8540863|NCT00834067|9572573|FG000|NOT COMPLETED|Second Intervention||0
8540864|NCT00834067|9572574|FG001|NOT COMPLETED|Second Intervention||0
8540865|NCT00833937|9572580|FG000|STARTED|First Intervention||12
8540866|NCT00833937|9572581|FG001|STARTED|First Intervention||12
8540867|NCT00833937|9572580|FG000|COMPLETED|First Intervention||12
8540868|NCT00833937|9572581|FG001|COMPLETED|First Intervention||12
8540869|NCT00833937|9572580|FG000|NOT COMPLETED|First Intervention||0
8540870|NCT00833937|9572581|FG001|NOT COMPLETED|First Intervention||0
8540871|NCT00833937|9572580|FG000|STARTED|Washout||12
8540872|NCT00833937|9572581|FG001|STARTED|Washout||12
8540873|NCT00833937|9572580|FG000|COMPLETED|Washout||11
8540874|NCT00833937|9572581|FG001|COMPLETED|Washout||12
8540875|NCT00833937|9572580|FG000|NOT COMPLETED|Washout||1
8540876|NCT00833937|9572581|FG001|NOT COMPLETED|Washout||0
8540877|NCT00833937|9572580|FG000|STARTED|Second Intervention||11
8540878|NCT00833937|9572581|FG001|STARTED|Second Intervention||12
8540879|NCT00833937|9572580|FG000|COMPLETED|Second Intervention||11
8540880|NCT00833937|9572581|FG001|COMPLETED|Second Intervention||12
8540881|NCT00833937|9572580|FG000|NOT COMPLETED|Second Intervention||0
8540882|NCT00833937|9572581|FG001|NOT COMPLETED|Second Intervention||0
8540883|NCT00833664|9572587|FG000|STARTED|First Intervention||11
8540884|NCT00833664|9572588|FG001|STARTED|First Intervention||11
8540885|NCT00833664|9572587|FG000|COMPLETED|First Intervention||11
8540886|NCT00833664|9572588|FG001|COMPLETED|First Intervention||11
8540887|NCT00833664|9572587|FG000|NOT COMPLETED|First Intervention||0
8540888|NCT00833664|9572588|FG001|NOT COMPLETED|First Intervention||0
8540889|NCT00833664|9572587|FG000|STARTED|Washout: 14 Days||11
8540890|NCT00833664|9572588|FG001|STARTED|Washout: 14 Days||11
8540891|NCT00833664|9572587|FG000|COMPLETED|Washout: 14 Days||10
8540892|NCT00833664|9572588|FG001|COMPLETED|Washout: 14 Days||11
8540893|NCT00833664|9572587|FG000|NOT COMPLETED|Washout: 14 Days||1
8540894|NCT00833664|9572588|FG001|NOT COMPLETED|Washout: 14 Days||0
8540895|NCT00833664|9572587|FG000|STARTED|Second Intervention||10
8540896|NCT00833664|9572588|FG001|STARTED|Second Intervention||11
8540897|NCT00833664|9572587|FG000|COMPLETED|Second Intervention||10
8540898|NCT00833664|9572588|FG001|COMPLETED|Second Intervention||11
8540899|NCT00833664|9572587|FG000|NOT COMPLETED|Second Intervention||0
8540900|NCT00833664|9572588|FG001|NOT COMPLETED|Second Intervention||0
8540901|NCT00833586|9572594|FG000|STARTED|First Intervention||14
8540902|NCT00833586|9572595|FG001|STARTED|First Intervention||14
8540903|NCT00833586|9572594|FG000|COMPLETED|First Intervention||14
8540904|NCT00833586|9572595|FG001|COMPLETED|First Intervention||14
8540905|NCT00833586|9572594|FG000|NOT COMPLETED|First Intervention||0
8540906|NCT00833586|9572595|FG001|NOT COMPLETED|First Intervention||0
8540907|NCT00833586|9572594|FG000|STARTED|Washout: 14 Days||14
8540908|NCT00833586|9572595|FG001|STARTED|Washout: 14 Days||14
8540909|NCT00833586|9572594|FG000|COMPLETED|Washout: 14 Days||14
8540910|NCT00833586|9572595|FG001|COMPLETED|Washout: 14 Days||14
8540911|NCT00833586|9572594|FG000|NOT COMPLETED|Washout: 14 Days||0
8540912|NCT00833586|9572595|FG001|NOT COMPLETED|Washout: 14 Days||0
8540913|NCT00833586|9572594|FG000|STARTED|Second Intervention||14
8540914|NCT00833586|9572595|FG001|STARTED|Second Intervention||14
8540915|NCT00833586|9572594|FG000|COMPLETED|Second Intervention||14
8540916|NCT00833586|9572595|FG001|COMPLETED|Second Intervention||14
8540917|NCT00833586|9572594|FG000|NOT COMPLETED|Second Intervention||0
8540918|NCT00833586|9572595|FG001|NOT COMPLETED|Second Intervention||0
8540919|NCT00833521|9572601|FG000|STARTED|First Intervention||19
8540920|NCT00833521|9572602|FG001|STARTED|First Intervention||19
8540921|NCT00833521|9572601|FG000|COMPLETED|First Intervention||19
8540922|NCT00833521|9572602|FG001|COMPLETED|First Intervention||19
8540923|NCT00833521|9572601|FG000|NOT COMPLETED|First Intervention||0
8540924|NCT00833521|9572602|FG001|NOT COMPLETED|First Intervention||0
8540925|NCT00833521|9572601|FG000|STARTED|Second Intervention||19
8540926|NCT00833521|9572602|FG001|STARTED|Second Intervention||19
8540927|NCT00833521|9572601|FG000|COMPLETED|Second Intervention||19
8540928|NCT00833521|9572602|FG001|COMPLETED|Second Intervention||19
8540929|NCT00833521|9572601|FG000|NOT COMPLETED|Second Intervention||0
8540930|NCT00833521|9572602|FG001|NOT COMPLETED|Second Intervention||0
8540931|NCT00830336|9572608|FG000|STARTED|First Intervention||40
8540932|NCT00830336|9572609|FG001|STARTED|First Intervention||40
8540933|NCT00830336|9572608|FG000|COMPLETED|First Intervention||40
8540934|NCT00830336|9572609|FG001|COMPLETED|First Intervention||40
8540935|NCT00830336|9572608|FG000|NOT COMPLETED|First Intervention||0
8540936|NCT00830336|9572609|FG001|NOT COMPLETED|First Intervention||0
8540937|NCT00830336|9572608|FG000|STARTED|Washout: 21 Days||40
8540938|NCT00830336|9572609|FG001|STARTED|Washout: 21 Days||40
8540939|NCT00830336|9572608|FG000|COMPLETED|Washout: 21 Days||39
8818040|NCT01555151|9871675|FG001|NOT COMPLETED|Overall Study||8
8818041|NCT01555151|9871676|FG002|NOT COMPLETED|Overall Study||6
8818042|NCT01555151|9871677|FG003|NOT COMPLETED|Overall Study||10
8818043|NCT01555164|9871690|FG000|STARTED|Overall Study||222
8818044|NCT01555164|9871691|FG001|STARTED|Overall Study||220
8818045|NCT01555164|9871690|FG000|COMPLETED|Overall Study||182
8818046|NCT01555164|9871691|FG001|COMPLETED|Overall Study||185
8540940|NCT00830336|9572609|FG001|COMPLETED|Washout: 21 Days||40
8540941|NCT00830336|9572608|FG000|NOT COMPLETED|Washout: 21 Days||1
8540942|NCT00830336|9572609|FG001|NOT COMPLETED|Washout: 21 Days||0
8540943|NCT00830336|9572608|FG000|STARTED|Second Intervention||39
8540944|NCT00830336|9572609|FG001|STARTED|Second Intervention||40
8540945|NCT00830336|9572608|FG000|COMPLETED|Second Intervention||39
8540946|NCT00830336|9572609|FG001|COMPLETED|Second Intervention||40
8540947|NCT00830336|9572608|FG000|NOT COMPLETED|Second Intervention||0
8540948|NCT00830336|9572609|FG001|NOT COMPLETED|Second Intervention||0
8540949|NCT00830258|9572615|FG000|STARTED|First Intervention||30
8540950|NCT00830258|9572616|FG001|STARTED|First Intervention||30
8540951|NCT00830258|9572615|FG000|COMPLETED|First Intervention||29
8540952|NCT00830258|9572616|FG001|COMPLETED|First Intervention||30
8540953|NCT00830258|9572615|FG000|NOT COMPLETED|First Intervention||1
8818047|NCT01555164|9871690|FG000|NOT COMPLETED|Overall Study||40
8818048|NCT01555164|9871691|FG001|NOT COMPLETED|Overall Study||35
8818049|NCT01555463|9871699|FG000|STARTED|Treatment||483
8540954|NCT00830258|9572616|FG001|NOT COMPLETED|First Intervention||0
8540955|NCT00830258|9572615|FG000|STARTED|Washout: 7 Days||29
8540956|NCT00830258|9572616|FG001|STARTED|Washout: 7 Days||30
8818050|NCT01555463|9871700|FG001|STARTED|Treatment||478
8818051|NCT01555463|9871699|FG000|COMPLETED|Treatment||419
8818052|NCT01555463|9871700|FG001|COMPLETED|Treatment||399
8621173|NCT00478140|9660059|FG000|NOT COMPLETED|Overall Study||1
8621174|NCT00478192|9660066|FG000|STARTED|Overall Study||20
8621175|NCT00478192|9660067|FG001|STARTED|Overall Study||20
8621176|NCT00478192|9660068|FG002|STARTED|Overall Study||10
8621177|NCT00478192|9660066|FG000|Full Analysis Set / Safety Analysis Set|Overall Study||20
8621178|NCT00478192|9660067|FG001|Full Analysis Set / Safety Analysis Set|Overall Study||20
8621179|NCT00478192|9660068|FG002|Full Analysis Set / Safety Analysis Set|Overall Study||9
8621180|NCT00478192|9660066|FG000|End of Treatment|Overall Study||18
8621181|NCT00478192|9660067|FG001|End of Treatment|Overall Study||16
8621182|NCT00478192|9660068|FG002|End of Treatment|Overall Study||8
8621183|NCT00478192|9660066|FG000|COMPLETED|Overall Study||16
8621184|NCT00478192|9660067|FG001|COMPLETED|Overall Study||15
8621185|NCT00478192|9660068|FG002|COMPLETED|Overall Study||8
8621186|NCT00478192|9660066|FG000|NOT COMPLETED|Overall Study||4
8621187|NCT00478192|9660067|FG001|NOT COMPLETED|Overall Study||5
8540957|NCT00830258|9572615|FG000|COMPLETED|Washout: 7 Days||28
8540958|NCT00830258|9572616|FG001|COMPLETED|Washout: 7 Days||30
8540959|NCT00830258|9572615|FG000|NOT COMPLETED|Washout: 7 Days||1
8540960|NCT00830258|9572616|FG001|NOT COMPLETED|Washout: 7 Days||0
8540961|NCT00830258|9572615|FG000|STARTED|Second Intervention||28
8540962|NCT00830258|9572616|FG001|STARTED|Second Intervention||30
8540963|NCT00830258|9572615|FG000|COMPLETED|Second Intervention||28
8540964|NCT00830258|9572616|FG001|COMPLETED|Second Intervention||30
8540965|NCT00830258|9572615|FG000|NOT COMPLETED|Second Intervention||0
8540966|NCT00830258|9572616|FG001|NOT COMPLETED|Second Intervention||0
8540967|NCT00830219|9572622|FG000|STARTED|First Intervention||23
8540968|NCT00830219|9572623|FG001|STARTED|First Intervention||23
8540969|NCT00830219|9572622|FG000|COMPLETED|First Intervention||23
8540970|NCT00830219|9572623|FG001|COMPLETED|First Intervention||23
8540971|NCT00830219|9572622|FG000|NOT COMPLETED|First Intervention||0
8540972|NCT00830219|9572623|FG001|NOT COMPLETED|First Intervention||0
8540973|NCT00830219|9572622|FG000|STARTED|Washout of 7 Days||23
8540974|NCT00830219|9572623|FG001|STARTED|Washout of 7 Days||23
8540975|NCT00830219|9572622|FG000|COMPLETED|Washout of 7 Days||22
8540976|NCT00830219|9572623|FG001|COMPLETED|Washout of 7 Days||22
8540977|NCT00830219|9572622|FG000|NOT COMPLETED|Washout of 7 Days||1
8540978|NCT00830219|9572623|FG001|NOT COMPLETED|Washout of 7 Days||1
8540979|NCT00830219|9572622|FG000|STARTED|Second Intervention||22
8540980|NCT00830219|9572623|FG001|STARTED|Second Intervention||22
8540981|NCT00830219|9572622|FG000|COMPLETED|Second Intervention||22
8540982|NCT00830219|9572623|FG001|COMPLETED|Second Intervention||22
8540983|NCT00830219|9572622|FG000|NOT COMPLETED|Second Intervention||0
8540984|NCT00830219|9572623|FG001|NOT COMPLETED|Second Intervention||0
8540985|NCT00830206|9572629|FG000|STARTED|First Intervention||40
8540986|NCT00830206|9572630|FG001|STARTED|First Intervention||40
8540987|NCT00830206|9572629|FG000|COMPLETED|First Intervention||40
8540988|NCT00830206|9572630|FG001|COMPLETED|First Intervention||40
8540989|NCT00830206|9572629|FG000|NOT COMPLETED|First Intervention||0
8540990|NCT00830206|9572630|FG001|NOT COMPLETED|First Intervention||0
8540991|NCT00830206|9572629|FG000|STARTED|Washout: 21 Days||40
8540992|NCT00830206|9572630|FG001|STARTED|Washout: 21 Days||40
8540993|NCT00830206|9572629|FG000|COMPLETED|Washout: 21 Days||39
8540994|NCT00830206|9572630|FG001|COMPLETED|Washout: 21 Days||39
8540995|NCT00830206|9572629|FG000|NOT COMPLETED|Washout: 21 Days||1
8540996|NCT00830206|9572630|FG001|NOT COMPLETED|Washout: 21 Days||1
8540997|NCT00830206|9572629|FG000|STARTED|Second Intervention||39
8540998|NCT00830206|9572630|FG001|STARTED|Second Intervention||39
8540999|NCT00830206|9572629|FG000|COMPLETED|Second Intervention||39
8541000|NCT00830206|9572630|FG001|COMPLETED|Second Intervention||39
8541001|NCT00830206|9572629|FG000|NOT COMPLETED|Second Intervention||0
8541002|NCT00830206|9572630|FG001|NOT COMPLETED|Second Intervention||0
8541003|NCT00830024|9572636|FG000|STARTED|First Intervention||18
8541004|NCT00830024|9572637|FG001|STARTED|First Intervention||18
8541005|NCT00830024|9572636|FG000|COMPLETED|First Intervention||18
8541006|NCT00830024|9572637|FG001|COMPLETED|First Intervention||18
8541007|NCT00830024|9572636|FG000|NOT COMPLETED|First Intervention||0
8541008|NCT00830024|9572637|FG001|NOT COMPLETED|First Intervention||0
8541009|NCT00830024|9572636|FG000|STARTED|Washout: 7 Days||18
8541010|NCT00830024|9572637|FG001|STARTED|Washout: 7 Days||18
8541011|NCT00830024|9572636|FG000|COMPLETED|Washout: 7 Days||17
8541012|NCT00830024|9572637|FG001|COMPLETED|Washout: 7 Days||18
8541013|NCT00830024|9572636|FG000|NOT COMPLETED|Washout: 7 Days||1
8541014|NCT00830024|9572637|FG001|NOT COMPLETED|Washout: 7 Days||0
8818053|NCT01555463|9871699|FG000|NOT COMPLETED|Treatment||64
8541015|NCT00830024|9572636|FG000|STARTED|Second Intervention||17
8541016|NCT00830024|9572637|FG001|STARTED|Second Intervention||18
8541017|NCT00830024|9572636|FG000|COMPLETED|Second Intervention||17
8541018|NCT00830024|9572637|FG001|COMPLETED|Second Intervention||18
8541019|NCT00830024|9572636|FG000|NOT COMPLETED|Second Intervention||0
8541020|NCT00830024|9572637|FG001|NOT COMPLETED|Second Intervention||0
8541021|NCT00829998|9572643|FG000|STARTED|First Intervention||21
8621188|NCT00478192|9660068|FG002|NOT COMPLETED|Overall Study||2
8621189|NCT00478205|9660079|FG000|STARTED|Overall Study||981
8541022|NCT00829998|9572644|FG001|STARTED|First Intervention||20
8541023|NCT00829998|9572643|FG000|COMPLETED|First Intervention||21
8541024|NCT00829998|9572644|FG001|COMPLETED|First Intervention||20
8541025|NCT00829998|9572643|FG000|NOT COMPLETED|First Intervention||0
8541026|NCT00829998|9572644|FG001|NOT COMPLETED|First Intervention||0
8541027|NCT00829998|9572643|FG000|STARTED|Washout||21
8541028|NCT00829998|9572644|FG001|STARTED|Washout||20
8541029|NCT00829998|9572643|FG000|COMPLETED|Washout||21
8541030|NCT00829998|9572644|FG001|COMPLETED|Washout||19
8541031|NCT00829998|9572643|FG000|NOT COMPLETED|Washout||0
8541032|NCT00829998|9572644|FG001|NOT COMPLETED|Washout||1
8541033|NCT00829998|9572643|FG000|STARTED|Second Intervention||21
8541034|NCT00829998|9572644|FG001|STARTED|Second Intervention||19
8541035|NCT00829998|9572643|FG000|COMPLETED|Second Intervention||21
8541036|NCT00829998|9572644|FG001|COMPLETED|Second Intervention||19
8541037|NCT00829998|9572643|FG000|NOT COMPLETED|Second Intervention||0
8541038|NCT00829998|9572644|FG001|NOT COMPLETED|Second Intervention||0
8541039|NCT00829868|9572650|FG000|STARTED|First Intervention||21
8541040|NCT00829868|9572651|FG001|STARTED|First Intervention||21
8541041|NCT00829868|9572650|FG000|COMPLETED|First Intervention||21
8541042|NCT00829868|9572651|FG001|COMPLETED|First Intervention||21
8541043|NCT00829868|9572650|FG000|NOT COMPLETED|First Intervention||0
8541044|NCT00829868|9572651|FG001|NOT COMPLETED|First Intervention||0
8541045|NCT00829868|9572650|FG000|STARTED|Washout||21
8541046|NCT00829868|9572651|FG001|STARTED|Washout||21
8541047|NCT00829868|9572650|FG000|COMPLETED|Washout||20
8541048|NCT00829868|9572651|FG001|COMPLETED|Washout||21
8541049|NCT00829868|9572650|FG000|NOT COMPLETED|Washout||1
8541050|NCT00829868|9572651|FG001|NOT COMPLETED|Washout||0
8541051|NCT00829868|9572650|FG000|STARTED|Second Intervention||20
8541052|NCT00829868|9572651|FG001|STARTED|Second Intervention||21
8541053|NCT00829868|9572650|FG000|COMPLETED|Second Intervention||20
8541054|NCT00829868|9572651|FG001|COMPLETED|Second Intervention||21
8541055|NCT00829868|9572650|FG000|NOT COMPLETED|Second Intervention||0
8541056|NCT00829868|9572651|FG001|NOT COMPLETED|Second Intervention||0
8541057|NCT00829790|9572657|FG000|STARTED|First Intervention||15
8541058|NCT00829790|9572658|FG001|STARTED|First Intervention||15
8541059|NCT00829790|9572657|FG000|COMPLETED|First Intervention||15
8541060|NCT00829790|9572658|FG001|COMPLETED|First Intervention||15
8541061|NCT00829790|9572657|FG000|NOT COMPLETED|First Intervention||0
8541062|NCT00829790|9572658|FG001|NOT COMPLETED|First Intervention||0
8541063|NCT00829790|9572657|FG000|STARTED|Washout of 14 Days||15
8541064|NCT00829790|9572658|FG001|STARTED|Washout of 14 Days||15
8541065|NCT00829790|9572657|FG000|COMPLETED|Washout of 14 Days||15
8541066|NCT00829790|9572658|FG001|COMPLETED|Washout of 14 Days||14
8541067|NCT00829790|9572657|FG000|NOT COMPLETED|Washout of 14 Days||0
8541068|NCT00829790|9572658|FG001|NOT COMPLETED|Washout of 14 Days||1
8541069|NCT00829790|9572657|FG000|STARTED|Second Intervention||15
8541070|NCT00829790|9572658|FG001|STARTED|Second Intervention||14
8541071|NCT00829790|9572657|FG000|COMPLETED|Second Intervention||15
8541072|NCT00829790|9572658|FG001|COMPLETED|Second Intervention||14
8541073|NCT00829790|9572657|FG000|NOT COMPLETED|Second Intervention||0
8541074|NCT00829790|9572658|FG001|NOT COMPLETED|Second Intervention||0
8541075|NCT00829764|9572664|FG000|STARTED|First Intervention||15
8541076|NCT00829764|9572665|FG001|STARTED|First Intervention||15
8541077|NCT00829764|9572664|FG000|COMPLETED|First Intervention||13
8541078|NCT00829764|9572665|FG001|COMPLETED|First Intervention||14
8541079|NCT00829764|9572664|FG000|NOT COMPLETED|First Intervention||2
8541080|NCT00829764|9572665|FG001|NOT COMPLETED|First Intervention||1
8541081|NCT00829764|9572664|FG000|STARTED|Washout of 14 Days||13
8541082|NCT00829764|9572665|FG001|STARTED|Washout of 14 Days||14
8541083|NCT00829764|9572664|FG000|COMPLETED|Washout of 14 Days||13
8541084|NCT00829764|9572665|FG001|COMPLETED|Washout of 14 Days||14
8541085|NCT00829764|9572664|FG000|NOT COMPLETED|Washout of 14 Days||0
8541086|NCT00829764|9572665|FG001|NOT COMPLETED|Washout of 14 Days||0
8541087|NCT00829764|9572664|FG000|STARTED|Second Intervention||13
8541088|NCT00829764|9572665|FG001|STARTED|Second Intervention||14
8541089|NCT00829764|9572664|FG000|COMPLETED|Second Intervention||13
8541090|NCT00829764|9572665|FG001|COMPLETED|Second Intervention||14
8541091|NCT00829764|9572664|FG000|NOT COMPLETED|Second Intervention||0
8541092|NCT00829764|9572665|FG001|NOT COMPLETED|Second Intervention||0
8541093|NCT00829712|9572671|FG000|STARTED|First Intervention||12
8541094|NCT00829712|9572672|FG001|STARTED|First Intervention||12
8541095|NCT00829712|9572671|FG000|COMPLETED|First Intervention||12
8541096|NCT00829712|9572672|FG001|COMPLETED|First Intervention||12
8541097|NCT00829712|9572671|FG000|NOT COMPLETED|First Intervention||0
8541098|NCT00829712|9572672|FG001|NOT COMPLETED|First Intervention||0
8541099|NCT00829712|9572671|FG000|STARTED|Washout of 7 Days||12
8541100|NCT00829712|9572672|FG001|STARTED|Washout of 7 Days||12
8541101|NCT00829712|9572671|FG000|COMPLETED|Washout of 7 Days||12
8541102|NCT00829712|9572672|FG001|COMPLETED|Washout of 7 Days||11
8541103|NCT00829712|9572671|FG000|NOT COMPLETED|Washout of 7 Days||0
8541104|NCT00829712|9572672|FG001|NOT COMPLETED|Washout of 7 Days||1
8541105|NCT00829712|9572671|FG000|STARTED|Second Intervention||12
8541106|NCT00829712|9572672|FG001|STARTED|Second Intervention||11
8541107|NCT00829712|9572671|FG000|COMPLETED|Second Intervention||12
8541108|NCT00829712|9572672|FG001|COMPLETED|Second Intervention||11
8541109|NCT00829712|9572671|FG000|NOT COMPLETED|Second Intervention||0
8541110|NCT00829712|9572672|FG001|NOT COMPLETED|Second Intervention||0
8541111|NCT00829686|9572678|FG000|STARTED|Overall Study||13
8541112|NCT00829686|9572679|FG001|STARTED|Overall Study||18
8541113|NCT00829686|9572678|FG000|COMPLETED|Overall Study||13
8541114|NCT00829686|9572679|FG001|COMPLETED|Overall Study||18
8541115|NCT00829686|9572678|FG000|NOT COMPLETED|Overall Study||0
8541116|NCT00829686|9572679|FG001|NOT COMPLETED|Overall Study||0
8541117|NCT00829673|9572685|FG000|STARTED|First Intervention||12
8541118|NCT00829673|9572686|FG001|STARTED|First Intervention||12
8541119|NCT00829673|9572685|FG000|COMPLETED|First Intervention||12
8541120|NCT00829673|9572686|FG001|COMPLETED|First Intervention||12
8541121|NCT00829673|9572685|FG000|NOT COMPLETED|First Intervention||0
8541122|NCT00829673|9572686|FG001|NOT COMPLETED|First Intervention||0
8541123|NCT00829673|9572685|FG000|STARTED|Washout of 7 Days||12
8541124|NCT00829673|9572686|FG001|STARTED|Washout of 7 Days||12
8541125|NCT00829673|9572685|FG000|COMPLETED|Washout of 7 Days||11
8541126|NCT00829673|9572686|FG001|COMPLETED|Washout of 7 Days||12
8541127|NCT00829673|9572685|FG000|NOT COMPLETED|Washout of 7 Days||1
8541128|NCT00829673|9572686|FG001|NOT COMPLETED|Washout of 7 Days||0
8541129|NCT00829673|9572685|FG000|STARTED|Second Intervention||11
8541130|NCT00829673|9572686|FG001|STARTED|Second Intervention||12
8541131|NCT00829673|9572685|FG000|COMPLETED|Second Intervention||11
8541132|NCT00829673|9572686|FG001|COMPLETED|Second Intervention||12
8541133|NCT00829673|9572685|FG000|NOT COMPLETED|Second Intervention||0
8541134|NCT00829673|9572686|FG001|NOT COMPLETED|Second Intervention||0
8541135|NCT00829530|9572692|FG000|STARTED|First Intervention||20
8541136|NCT00829530|9572693|FG001|STARTED|First Intervention||20
8541137|NCT00829530|9572692|FG000|COMPLETED|First Intervention||20
8541138|NCT00829530|9572693|FG001|COMPLETED|First Intervention||18
8541139|NCT00829530|9572692|FG000|NOT COMPLETED|First Intervention||0
8541140|NCT00829530|9572693|FG001|NOT COMPLETED|First Intervention||2
8541141|NCT00829530|9572692|FG000|STARTED|Washout of 42 Days||20
8541142|NCT00829530|9572693|FG001|STARTED|Washout of 42 Days||18
8541143|NCT00829530|9572692|FG000|COMPLETED|Washout of 42 Days||20
8541144|NCT00829530|9572693|FG001|COMPLETED|Washout of 42 Days||18
8541145|NCT00829530|9572692|FG000|NOT COMPLETED|Washout of 42 Days||0
8541146|NCT00829530|9572693|FG001|NOT COMPLETED|Washout of 42 Days||0
8541147|NCT00829530|9572692|FG000|STARTED|Second Intervention||20
8541148|NCT00829530|9572693|FG001|STARTED|Second Intervention||18
8541149|NCT00829530|9572692|FG000|COMPLETED|Second Intervention||19
8541150|NCT00829530|9572693|FG001|COMPLETED|Second Intervention||18
8541151|NCT00829530|9572692|FG000|NOT COMPLETED|Second Intervention||1
8541152|NCT00829530|9572693|FG001|NOT COMPLETED|Second Intervention||0
8541153|NCT00829504|9572699|FG000|STARTED|First Intervention||22
8541154|NCT00829504|9572700|FG001|STARTED|First Intervention||22
8541155|NCT00829504|9572699|FG000|COMPLETED|First Intervention||21
8541156|NCT00829504|9572700|FG001|COMPLETED|First Intervention||22
8541157|NCT00829504|9572699|FG000|NOT COMPLETED|First Intervention||1
8541158|NCT00829504|9572700|FG001|NOT COMPLETED|First Intervention||0
8541159|NCT00829504|9572699|FG000|STARTED|Washout of 7 Days||21
8541160|NCT00829504|9572700|FG001|STARTED|Washout of 7 Days||22
8541161|NCT00829504|9572699|FG000|COMPLETED|Washout of 7 Days||20
8541162|NCT00829504|9572700|FG001|COMPLETED|Washout of 7 Days||22
8541163|NCT00829504|9572699|FG000|NOT COMPLETED|Washout of 7 Days||1
8541164|NCT00829504|9572700|FG001|NOT COMPLETED|Washout of 7 Days||0
8541165|NCT00829504|9572699|FG000|STARTED|Second Intervention||20
8541166|NCT00829504|9572700|FG001|STARTED|Second Intervention||22
8541167|NCT00829504|9572699|FG000|COMPLETED|Second Intervention||19
8541168|NCT00829504|9572700|FG001|COMPLETED|Second Intervention||22
8541169|NCT00829504|9572699|FG000|NOT COMPLETED|Second Intervention||1
8541170|NCT00829504|9572700|FG001|NOT COMPLETED|Second Intervention||0
8541171|NCT00829452|9572706|FG000|STARTED|First Intervention||20
8541172|NCT00829452|9572707|FG001|STARTED|First Intervention||20
8541173|NCT00829452|9572706|FG000|COMPLETED|First Intervention||20
8541174|NCT00829452|9572707|FG001|COMPLETED|First Intervention||19
8541175|NCT00829452|9572706|FG000|NOT COMPLETED|First Intervention||0
8541176|NCT00829452|9572707|FG001|NOT COMPLETED|First Intervention||1
8541177|NCT00829452|9572706|FG000|STARTED|Washout of 42 Days||20
8541178|NCT00829452|9572707|FG001|STARTED|Washout of 42 Days||19
8541179|NCT00829452|9572706|FG000|COMPLETED|Washout of 42 Days||20
8541180|NCT00829452|9572707|FG001|COMPLETED|Washout of 42 Days||18
8541181|NCT00829452|9572706|FG000|NOT COMPLETED|Washout of 42 Days||0
8621190|NCT00478205|9660080|FG001|STARTED|Overall Study||486
8621191|NCT00478205|9660079|FG000|COMPLETED|Overall Study||685
8621192|NCT00478205|9660080|FG001|COMPLETED|Overall Study||399
8541182|NCT00829452|9572707|FG001|NOT COMPLETED|Washout of 42 Days||1
8541183|NCT00829452|9572706|FG000|STARTED|Second Intervention||20
8541184|NCT00829452|9572707|FG001|STARTED|Second Intervention||18
8621193|NCT00478205|9660079|FG000|NOT COMPLETED|Overall Study||296
8541185|NCT00829452|9572706|FG000|COMPLETED|Second Intervention||20
8541186|NCT00829452|9572707|FG001|COMPLETED|Second Intervention||17
8541187|NCT00829452|9572706|FG000|NOT COMPLETED|Second Intervention||0
8541188|NCT00829452|9572707|FG001|NOT COMPLETED|Second Intervention||1
8541189|NCT00829426|9572713|FG000|STARTED|First Intervention||16
8541190|NCT00829426|9572714|FG001|STARTED|First Intervention||16
8541191|NCT00829426|9572713|FG000|COMPLETED|First Intervention||16
8541192|NCT00829426|9572714|FG001|COMPLETED|First Intervention||16
8541193|NCT00829426|9572713|FG000|NOT COMPLETED|First Intervention||0
8541194|NCT00829426|9572714|FG001|NOT COMPLETED|First Intervention||0
8541195|NCT00829426|9572713|FG000|STARTED|Washout: 7 Days||16
8541196|NCT00829426|9572714|FG001|STARTED|Washout: 7 Days||16
8541197|NCT00829426|9572713|FG000|COMPLETED|Washout: 7 Days||15
8541198|NCT00829426|9572714|FG001|COMPLETED|Washout: 7 Days||16
8541199|NCT00829426|9572713|FG000|NOT COMPLETED|Washout: 7 Days||1
8541200|NCT00829426|9572714|FG001|NOT COMPLETED|Washout: 7 Days||0
8541201|NCT00829426|9572713|FG000|STARTED|Second Intervention||15
8541202|NCT00829426|9572714|FG001|STARTED|Second Intervention||16
8541203|NCT00829426|9572713|FG000|COMPLETED|Second Intervention||15
8541204|NCT00829426|9572714|FG001|COMPLETED|Second Intervention||16
8541205|NCT00829426|9572713|FG000|NOT COMPLETED|Second Intervention||0
8541206|NCT00829426|9572714|FG001|NOT COMPLETED|Second Intervention||0
8541207|NCT00829309|9572720|FG000|STARTED|First Intervention||8
8541208|NCT00829309|9572721|FG001|STARTED|First Intervention||8
8541209|NCT00829309|9572720|FG000|COMPLETED|First Intervention||8
8541210|NCT00829309|9572721|FG001|COMPLETED|First Intervention||8
8541211|NCT00829309|9572720|FG000|NOT COMPLETED|First Intervention||0
8541212|NCT00829309|9572721|FG001|NOT COMPLETED|First Intervention||0
8541213|NCT00829309|9572720|FG000|STARTED|Washout: 7 Days||8
8541214|NCT00829309|9572721|FG001|STARTED|Washout: 7 Days||8
8541215|NCT00829309|9572720|FG000|COMPLETED|Washout: 7 Days||7
8541216|NCT00829309|9572721|FG001|COMPLETED|Washout: 7 Days||8
8541217|NCT00829309|9572720|FG000|NOT COMPLETED|Washout: 7 Days||1
8541218|NCT00829309|9572721|FG001|NOT COMPLETED|Washout: 7 Days||0
8541219|NCT00829309|9572720|FG000|STARTED|Second Intervention||7
8541220|NCT00829309|9572721|FG001|STARTED|Second Intervention||8
8541221|NCT00829309|9572720|FG000|COMPLETED|Second Intervention||7
8541222|NCT00829309|9572721|FG001|COMPLETED|Second Intervention||8
8541223|NCT00829309|9572720|FG000|NOT COMPLETED|Second Intervention||0
8541224|NCT00829309|9572721|FG001|NOT COMPLETED|Second Intervention||0
8541225|NCT00828321|9572727|FG000|STARTED|First Intervention||20
8541226|NCT00828321|9572728|FG001|STARTED|First Intervention||20
8541227|NCT00828321|9572727|FG000|COMPLETED|First Intervention||20
8541228|NCT00828321|9572728|FG001|COMPLETED|First Intervention||20
8541229|NCT00828321|9572727|FG000|NOT COMPLETED|First Intervention||0
8541230|NCT00828321|9572728|FG001|NOT COMPLETED|First Intervention||0
8541231|NCT00828321|9572727|FG000|STARTED|Washout of 42 Days||20
8541232|NCT00828321|9572728|FG001|STARTED|Washout of 42 Days||20
8541233|NCT00828321|9572727|FG000|COMPLETED|Washout of 42 Days||18
8541234|NCT00828321|9572728|FG001|COMPLETED|Washout of 42 Days||20
8541235|NCT00828321|9572727|FG000|NOT COMPLETED|Washout of 42 Days||2
8541236|NCT00828321|9572728|FG001|NOT COMPLETED|Washout of 42 Days||0
8541237|NCT00828321|9572727|FG000|STARTED|Second Intervention||18
8541238|NCT00828321|9572728|FG001|STARTED|Second Intervention||20
8541239|NCT00828321|9572727|FG000|COMPLETED|Second Intervention||18
8541240|NCT00828321|9572728|FG001|COMPLETED|Second Intervention||19
8541241|NCT00828321|9572727|FG000|NOT COMPLETED|Second Intervention||0
8541242|NCT00828321|9572728|FG001|NOT COMPLETED|Second Intervention||1
8541243|NCT00806403|9572734|FG000|STARTED|Overall Study||104
8541244|NCT00806403|9572735|FG001|STARTED|Overall Study||101
8541245|NCT00806403|9572734|FG000|COMPLETED|Overall Study||100
8541246|NCT00806403|9572735|FG001|COMPLETED|Overall Study||98
8621194|NCT00478205|9660080|FG001|NOT COMPLETED|Overall Study||87
8621195|NCT00478218|9660088|FG000|STARTED|Overall Study||34
8621196|NCT00478218|9660089|FG001|STARTED|Overall Study||19
8621197|NCT00478218|9660088|FG000|COMPLETED|Overall Study||34
8621198|NCT00478218|9660089|FG001|COMPLETED|Overall Study||19
8621199|NCT00478218|9660088|FG000|NOT COMPLETED|Overall Study||0
8621200|NCT00478218|9660089|FG001|NOT COMPLETED|Overall Study||0
8541247|NCT00806403|9572734|FG000|NOT COMPLETED|Overall Study||4
8541248|NCT00806403|9572735|FG001|NOT COMPLETED|Overall Study||3
8541249|NCT00803517|9572741|FG000|STARTED|Overall Study||12
8541250|NCT00803517|9572742|FG001|STARTED|Overall Study||12
8541251|NCT00803517|9572741|FG000|COMPLETED|Overall Study||12
8541252|NCT00803517|9572742|FG001|COMPLETED|Overall Study||12
8541253|NCT00803517|9572741|FG000|NOT COMPLETED|Overall Study||0
8541254|NCT00803517|9572742|FG001|NOT COMPLETED|Overall Study||0
8541255|NCT00803413|9572750|FG000|STARTED|Overall Period||28
8541256|NCT00803413|9572751|FG001|STARTED|Overall Period||32
8541257|NCT00803413|9572752|FG002|STARTED|Overall Period||29
8541258|NCT00803413|9572753|FG003|STARTED|Overall Period||30
8541259|NCT00803413|9572750|FG000|COMPLETED|Overall Period||28
8541260|NCT00803413|9572751|FG001|COMPLETED|Overall Period||32
8541261|NCT00803413|9572752|FG002|COMPLETED|Overall Period||29
8541262|NCT00803413|9572753|FG003|COMPLETED|Overall Period||30
8541263|NCT00803413|9572750|FG000|NOT COMPLETED|Overall Period||0
8541264|NCT00803413|9572751|FG001|NOT COMPLETED|Overall Period||0
8541265|NCT00803413|9572752|FG002|NOT COMPLETED|Overall Period||0
8541266|NCT00803413|9572753|FG003|NOT COMPLETED|Overall Period||0
8541267|NCT00803114|9572761|FG000|STARTED|Overall Study||113
8541268|NCT00803114|9572762|FG001|STARTED|Overall Study||115
8621201|NCT00478231|9660095|FG000|STARTED|Overall Study||209
8621202|NCT00478231|9660095|FG000|Treated|Overall Study||206
8621203|NCT00478231|9660095|FG000|COMPLETED|Overall Study||125
8541269|NCT00803114|9572761|FG000|COMPLETED|Overall Study||113
8541270|NCT00803114|9572762|FG001|COMPLETED|Overall Study||115
8541271|NCT00803114|9572761|FG000|NOT COMPLETED|Overall Study||0
8541272|NCT00803114|9572762|FG001|NOT COMPLETED|Overall Study||0
8541273|NCT00799292|9572768|FG000|STARTED|Overall Study||29
8541274|NCT00799292|9572769|FG001|STARTED|Overall Study||29
8541275|NCT00799292|9572768|FG000|COMPLETED|Overall Study||29
8541276|NCT00799292|9572769|FG001|COMPLETED|Overall Study||29
8541277|NCT00799292|9572768|FG000|NOT COMPLETED|Overall Study||0
8541278|NCT00799292|9572769|FG001|NOT COMPLETED|Overall Study||0
8541279|NCT00796523|9572775|FG000|STARTED|Overall Study||27
8541280|NCT00796523|9572776|FG001|STARTED|Overall Study||24
8541281|NCT00796523|9572775|FG000|COMPLETED|Overall Study||18
8541282|NCT00796523|9572776|FG001|COMPLETED|Overall Study||17
8541283|NCT00796523|9572775|FG000|NOT COMPLETED|Overall Study||9
8541284|NCT00796523|9572776|FG001|NOT COMPLETED|Overall Study||7
8541285|NCT00794924|9572782|FG000|STARTED|Overall Study|14 patients refused to start the study|174
8541286|NCT00794924|9572783|FG001|STARTED|Overall Study|14 patients refused to start the study|171
8541287|NCT00794924|9572782|FG000|COMPLETED|Overall Study||114
8541288|NCT00794924|9572783|FG001|COMPLETED|Overall Study||101
8541289|NCT00794924|9572782|FG000|NOT COMPLETED|Overall Study||60
8541290|NCT00794924|9572783|FG001|NOT COMPLETED|Overall Study||70
8541291|NCT00794677|9572789|FG000|STARTED|First Intervention||13
8541292|NCT00794677|9572790|FG001|STARTED|First Intervention||13
8541293|NCT00794677|9572789|FG000|COMPLETED|First Intervention||11
8541294|NCT00794677|9572790|FG001|COMPLETED|First Intervention||13
8541295|NCT00794677|9572789|FG000|NOT COMPLETED|First Intervention||2
8541296|NCT00794677|9572790|FG001|NOT COMPLETED|First Intervention||0
8541297|NCT00794677|9572789|FG000|STARTED|Second Intervention||11
8541298|NCT00794677|9572790|FG001|STARTED|Second Intervention||13
8541299|NCT00794677|9572789|FG000|COMPLETED|Second Intervention||11
8541300|NCT00794677|9572790|FG001|COMPLETED|Second Intervention||13
8541301|NCT00794677|9572789|FG000|NOT COMPLETED|Second Intervention||0
8541302|NCT00794677|9572790|FG001|NOT COMPLETED|Second Intervention||0
8566069|NCT00073528|9598147|FG000|STARTED|Overall Study||644
8566070|NCT00073528|9598148|FG001|STARTED|Overall Study||642
8566071|NCT00073528|9598147|FG000|COMPLETED|Overall Study||14
8566072|NCT00073528|9598148|FG001|COMPLETED|Overall Study||14
8566073|NCT00073528|9598147|FG000|NOT COMPLETED|Overall Study||630
8566074|NCT00073528|9598148|FG001|NOT COMPLETED|Overall Study||628
8566075|NCT00073749|9598161|FG000|STARTED|Overall Study||2
8566076|NCT00073749|9598162|FG001|STARTED|Overall Study||5
8566077|NCT00073749|9598163|FG002|STARTED|Overall Study||11
8566078|NCT00073749|9598164|FG003|STARTED|Overall Study||6
8566079|NCT00073749|9598165|FG004|STARTED|Overall Study||6
8566080|NCT00073749|9598166|FG005|STARTED|Overall Study||6
8566081|NCT00073749|9598167|FG006|STARTED|Overall Study||43
8566082|NCT00073749|9598161|FG000|COMPLETED|Overall Study||0
8566083|NCT00073749|9598162|FG001|COMPLETED|Overall Study||0
8566084|NCT00073749|9598163|FG002|COMPLETED|Overall Study||0
8566085|NCT00073749|9598164|FG003|COMPLETED|Overall Study||0
8566086|NCT00073749|9598165|FG004|COMPLETED|Overall Study||0
8566087|NCT00073749|9598166|FG005|COMPLETED|Overall Study||0
8566088|NCT00073749|9598167|FG006|COMPLETED|Overall Study||3
8566089|NCT00073749|9598161|FG000|NOT COMPLETED|Overall Study||2
8566090|NCT00073749|9598162|FG001|NOT COMPLETED|Overall Study||5
8566091|NCT00073749|9598163|FG002|NOT COMPLETED|Overall Study||11
8566092|NCT00073749|9598164|FG003|NOT COMPLETED|Overall Study||6
8566093|NCT00073749|9598165|FG004|NOT COMPLETED|Overall Study||6
8566094|NCT00073749|9598166|FG005|NOT COMPLETED|Overall Study||6
8566095|NCT00073749|9598167|FG006|NOT COMPLETED|Overall Study||40
8566096|NCT00073918|9598186|FG000|STARTED|Overall Study||111
8566097|NCT00073918|9598186|FG000|COMPLETED|Overall Study||107
8566098|NCT00073918|9598186|FG000|NOT COMPLETED|Overall Study||4
8566099|NCT00073957|9598190|FG000|STARTED|Overall Study||25
8566100|NCT00073957|9598190|FG000|COMPLETED|Overall Study||25
8566101|NCT00073957|9598190|FG000|NOT COMPLETED|Overall Study||0
8566102|NCT00073983|9598196|FG000|STARTED|Overall Study||54
8566103|NCT00073983|9598196|FG000|COMPLETED|Overall Study|One patient in the chondrosarcoma subtype was not evaluable.|53
8566104|NCT00073983|9598196|FG000|NOT COMPLETED|Overall Study||1
8566105|NCT00074035|9598202|FG000|STARTED|Overall Study||38
8566106|NCT00074035|9598202|FG000|COMPLETED|Overall Study||38
8566107|NCT00074035|9598202|FG000|NOT COMPLETED|Overall Study||0
8566108|NCT00074152|9598208|FG000|STARTED|Overall Study||77
8566109|NCT00074152|9598209|FG001|STARTED|Overall Study||85
8566110|NCT00074152|9598208|FG000|COMPLETED|Overall Study||22
8566111|NCT00074152|9598209|FG001|COMPLETED|Overall Study||52
8566112|NCT00074152|9598208|FG000|NOT COMPLETED|Overall Study||55
8566113|NCT00074152|9598209|FG001|NOT COMPLETED|Overall Study||33
8566114|NCT00074165|9598216|FG000|STARTED|Overall Study||17
8566115|NCT00074165|9598216|FG000|COMPLETED|Overall Study||17
8566116|NCT00074165|9598216|FG000|NOT COMPLETED|Overall Study||0
8566117|NCT00074269|9598220|FG000|STARTED|Overall Study||5
8566118|NCT00074269|9598220|FG000|COMPLETED|Overall Study||5
8566119|NCT00074269|9598220|FG000|NOT COMPLETED|Overall Study||0
8566120|NCT00074282|9598228|FG000|STARTED|Step 1||102
8566121|NCT00074282|9598229|FG001|STARTED|Step 1||0
8566122|NCT00074282|9598230|FG002|STARTED|Step 1||0
8566123|NCT00074282|9598228|FG000|Eligible|Step 1||98
8566124|NCT00074282|9598229|FG001|Eligible|Step 1||0
8566125|NCT00074282|9598230|FG002|Eligible|Step 1||0
8566126|NCT00074282|9598228|FG000|Started Treatment|Step 1||96
8566127|NCT00074282|9598229|FG001|Started Treatment|Step 1||0
8566128|NCT00074282|9598230|FG002|Started Treatment|Step 1||0
8566129|NCT00074282|9598228|FG000|COMPLETED|Step 1||44
8566130|NCT00074282|9598229|FG001|COMPLETED|Step 1||0
8566131|NCT00074282|9598230|FG002|COMPLETED|Step 1||0
8566132|NCT00074282|9598228|FG000|NOT COMPLETED|Step 1||58
8566133|NCT00074282|9598229|FG001|NOT COMPLETED|Step 1||0
8566134|NCT00074282|9598230|FG002|NOT COMPLETED|Step 1||0
8566135|NCT00074282|9598228|FG000|STARTED|Step 2||0
8566136|NCT00074282|9598229|FG001|STARTED|Step 2||9
8541303|NCT00792116|9572796|FG000|STARTED|Overall Study||53
8541304|NCT00792116|9572797|FG001|STARTED|Overall Study||55
8541305|NCT00792116|9572796|FG000|COMPLETED|Overall Study||52
8541306|NCT00792116|9572797|FG001|COMPLETED|Overall Study||54
8541307|NCT00792116|9572796|FG000|NOT COMPLETED|Overall Study||1
8541308|NCT00792116|9572797|FG001|NOT COMPLETED|Overall Study||1
8541309|NCT00758563|9572803|FG000|STARTED|Overall Study||7
8541310|NCT00758563|9572804|FG001|STARTED|Overall Study||8
8541311|NCT00758563|9572803|FG000|COMPLETED|Overall Study||7
8541312|NCT00758563|9572804|FG001|COMPLETED|Overall Study||8
8541313|NCT00758563|9572803|FG000|NOT COMPLETED|Overall Study||0
8541314|NCT00758563|9572804|FG001|NOT COMPLETED|Overall Study||0
8541315|NCT00758290|9572810|FG000|STARTED|Overall Study||11
8541316|NCT00758290|9572811|FG001|STARTED|Overall Study||12
8541317|NCT00758290|9572810|FG000|COMPLETED|Overall Study||11
8541318|NCT00758290|9572811|FG001|COMPLETED|Overall Study||12
8541319|NCT00758290|9572810|FG000|NOT COMPLETED|Overall Study||0
8541320|NCT00758290|9572811|FG001|NOT COMPLETED|Overall Study||0
8541321|NCT00756574|9572817|FG000|STARTED|Overall Study||225
8541322|NCT00756574|9572818|FG001|STARTED|Overall Study||221
8541323|NCT00756574|9572817|FG000|COMPLETED|Overall Study||212
8541324|NCT00756574|9572818|FG001|COMPLETED|Overall Study||210
8541325|NCT00756574|9572817|FG000|NOT COMPLETED|Overall Study||13
8541326|NCT00756574|9572818|FG001|NOT COMPLETED|Overall Study||11
8541339|NCT00676494|9572834|FG000|STARTED|Overall Study||172
8541340|NCT00676494|9572834|FG000|COMPLETED|Overall Study||158
8541341|NCT00676494|9572834|FG000|NOT COMPLETED|Overall Study||14
8541342|NCT00662389|9572837|FG000|STARTED|Overall Study||4
8541343|NCT00662389|9572837|FG000|COMPLETED|Overall Study||4
8541344|NCT00662389|9572837|FG000|NOT COMPLETED|Overall Study||0
8541345|NCT00659061|9572842|FG000|STARTED|Overall Study||308
8541346|NCT00659061|9572843|FG001|STARTED|Overall Study||302
8541347|NCT00659061|9572842|FG000|COMPLETED|Overall Study|Those with either complete or partial biochemical and anthropometric data|287
8541348|NCT00659061|9572843|FG001|COMPLETED|Overall Study|Those with either complete or partial biochemical and anthropometric data|287
8541349|NCT00659061|9572842|FG000|NOT COMPLETED|Overall Study||21
8541350|NCT00659061|9572843|FG001|NOT COMPLETED|Overall Study||15
8541351|NCT00654992|9572849|FG000|STARTED|Overall Study||36
8541352|NCT00654992|9572850|FG001|STARTED|Overall Study||35
8541353|NCT00654992|9572849|FG000|COMPLETED|Overall Study||36
8541354|NCT00654992|9572850|FG001|COMPLETED|Overall Study||35
8541355|NCT00654992|9572849|FG000|NOT COMPLETED|Overall Study||0
8541356|NCT00654992|9572850|FG001|NOT COMPLETED|Overall Study||0
8541357|NCT00581477|9572854|FG000|STARTED|Overall Study|8 patients were enrolled|8
8541358|NCT00581477|9572854|FG000|Dose Selection Trial With Droxidopa|Overall Study|2 patients had been treated with droxidopa prior to enrollment and their data is not included. Since droxidopa restores the norepinephrine that is absent in untreated patients with DBH deficiency, we present only the results for naive patients.|6
8541359|NCT00581477|9572854|FG000|Droxidopa 25 mg|Overall Study|Because dosing was individualized for the participants, only 5 of the 6 patients were administered 25 mg of Droxidopa.|6
8541360|NCT00581477|9572854|FG000|Droxidopa 50 mg|Overall Study|Because dosing was individualized for the participants, only 5 of the 6 patients were administered 50 mg of Droxidopa.|6
8541361|NCT00581477|9572854|FG000|Droxidopa 100 mg|Overall Study|Because dosing was individualized for the participants, only 4 of the 6 patients were administered 100 mg of Droxidopa.|6
8566137|NCT00074282|9598230|FG002|STARTED|Step 2||31
8566138|NCT00074282|9598228|FG000|COMPLETED|Step 2||0
8818054|NCT01555463|9871700|FG001|NOT COMPLETED|Treatment||79
8818055|NCT01555463|9871699|FG000|STARTED|Follow up|Treatment completers and non-completers were asked to participate in the follow-up phase.|447
8818056|NCT01555463|9871700|FG001|STARTED|Follow up|Treatment completers and non-completers were asked to participate in the follow-up phase.|439
8818057|NCT01555463|9871699|FG000|COMPLETED|Follow up||409
8818058|NCT01555463|9871700|FG001|COMPLETED|Follow up||394
8818059|NCT01555463|9871699|FG000|NOT COMPLETED|Follow up||38
8818060|NCT01555463|9871700|FG001|NOT COMPLETED|Follow up||45
8818061|NCT01555541|9871706|FG000|STARTED|Salvage Response Assessment||19
8818062|NCT01555541|9871706|FG000|COMPLETED|Salvage Response Assessment||19
8818063|NCT01555541|9871706|FG000|NOT COMPLETED|Salvage Response Assessment||0
8818064|NCT01555541|9871706|FG000|STARTED|OVA Treatment||19
8818065|NCT01555541|9871706|FG000|COMPLETED|OVA Treatment||19
8818066|NCT01555541|9871706|FG000|NOT COMPLETED|OVA Treatment||0
8818067|NCT01555541|9871706|FG000|STARTED|Autologous Stem Cell Transplantation|7 patients didn't move forward due to non-response/progression on last line of therapy prior to ASCT|12
8818068|NCT01555541|9871706|FG000|COMPLETED|Autologous Stem Cell Transplantation||12
8818069|NCT01555541|9871706|FG000|NOT COMPLETED|Autologous Stem Cell Transplantation||0
8818070|NCT01555567|9871715|FG000|STARTED|12 Week||12
8818071|NCT01555567|9871716|FG001|STARTED|12 Week||13
8818072|NCT01555567|9871717|FG002|STARTED|12 Week||9
8818073|NCT01555567|9871718|FG003|STARTED|12 Week||9
8818074|NCT01555567|9871715|FG000|COMPLETED|12 Week||11
8818075|NCT01555567|9871716|FG001|COMPLETED|12 Week||12
8818076|NCT01555567|9871717|FG002|COMPLETED|12 Week||8
8818077|NCT01555567|9871718|FG003|COMPLETED|12 Week||9
8818078|NCT01555567|9871715|FG000|NOT COMPLETED|12 Week||1
8818079|NCT01555567|9871716|FG001|NOT COMPLETED|12 Week||1
8818080|NCT01555567|9871717|FG002|NOT COMPLETED|12 Week||1
8818081|NCT01555567|9871718|FG003|NOT COMPLETED|12 Week||0
8818082|NCT01555567|9871715|FG000|STARTED|Return to Activity||11
8818083|NCT01555567|9871716|FG001|STARTED|Return to Activity||12
8818084|NCT01555567|9871717|FG002|STARTED|Return to Activity||8
8818085|NCT01555567|9871718|FG003|STARTED|Return to Activity||9
8541327|NCT00740727|9572822|FG000|STARTED|Overall Study||18
8541328|NCT00740727|9572822|FG000|COMPLETED|Overall Study||18
8541329|NCT00740727|9572822|FG000|NOT COMPLETED|Overall Study||0
8541330|NCT00740480|9572825|FG000|STARTED|Overall Study||25
8541331|NCT00740480|9572825|FG000|COMPLETED|Overall Study||23
8541332|NCT00740480|9572825|FG000|NOT COMPLETED|Overall Study||2
8541333|NCT00724698|9572828|FG000|STARTED|Overall Study||3011
8541334|NCT00724698|9572828|FG000|COMPLETED|Overall Study||2921
8541335|NCT00724698|9572828|FG000|NOT COMPLETED|Overall Study||90
8541336|NCT00711555|9572831|FG000|STARTED|Overall Study||22
8541337|NCT00711555|9572831|FG000|COMPLETED|Overall Study||19
8541338|NCT00711555|9572831|FG000|NOT COMPLETED|Overall Study||3
8541362|NCT00581477|9572854|FG000|Droxidopa 200 mg|Overall Study|Because dosing was individualized for the participants, only 5 of the 6 patients were administered 200 mg of Droxidopa.|6
8541363|NCT00581477|9572854|FG000|Droxidopa 250 mg|Overall Study|Because dosing was individualized for the participants, only 2 of the 6 patients were administered 250 mg of Droxidopa.|6
8541364|NCT00581477|9572854|FG000|Droxidopa 300 mg|Overall Study|Because dosing was individualized for the participants, only 1 of the 6 patients was administered 300 mg of Droxidopa.|6
8541365|NCT00581477|9572854|FG000|COMPLETED|Overall Study||6
8541366|NCT00581477|9572854|FG000|NOT COMPLETED|Overall Study||2
8541367|NCT00554294|9572870|FG000|STARTED|Overall Study||1469
8541368|NCT00554294|9572871|FG001|STARTED|Overall Study||1721
8541369|NCT00554294|9572870|FG000|COMPLETED|Overall Study||1309
8541370|NCT00554294|9572871|FG001|COMPLETED|Overall Study||1641
8541371|NCT00554294|9572870|FG000|NOT COMPLETED|Overall Study||160
8541372|NCT00554294|9572871|FG001|NOT COMPLETED|Overall Study||80
8541373|NCT00554190|9572875|FG000|STARTED|Overall Study|29 subjects treated.|29
8541374|NCT00554190|9572875|FG000|COMPLETED|Overall Study|10 subjects did not complete the Termination Study Forms|19
8541375|NCT00554190|9572875|FG000|NOT COMPLETED|Overall Study||10
8541376|NCT00546273|9572884|FG000|STARTED|I||4
8541377|NCT00546273|9572885|FG001|STARTED|I||0
8541378|NCT00546273|9572886|FG002|STARTED|I||0
8541379|NCT00546273|9572887|FG003|STARTED|I||0
8818086|NCT01555567|9871715|FG000|COMPLETED|Return to Activity||10
8818087|NCT01555567|9871716|FG001|COMPLETED|Return to Activity||10
8818088|NCT01555567|9871717|FG002|COMPLETED|Return to Activity||8
8818089|NCT01555567|9871718|FG003|COMPLETED|Return to Activity||8
8541380|NCT00546273|9572888|FG004|STARTED|I||2
8541381|NCT00546273|9572884|FG000|COMPLETED|I||4
8541382|NCT00546273|9572885|FG001|COMPLETED|I||0
8541383|NCT00546273|9572886|FG002|COMPLETED|I||0
8541384|NCT00546273|9572887|FG003|COMPLETED|I||0
8541385|NCT00546273|9572888|FG004|COMPLETED|I||2
8541386|NCT00546273|9572884|FG000|NOT COMPLETED|I||0
8541387|NCT00546273|9572885|FG001|NOT COMPLETED|I||0
8541388|NCT00546273|9572886|FG002|NOT COMPLETED|I||0
8541389|NCT00546273|9572887|FG003|NOT COMPLETED|I||0
8541390|NCT00546273|9572888|FG004|NOT COMPLETED|I||0
8541391|NCT00546273|9572884|FG000|STARTED|II||0
8541392|NCT00546273|9572885|FG001|STARTED|II||4
8541393|NCT00546273|9572886|FG002|STARTED|II||0
8541394|NCT00546273|9572887|FG003|STARTED|II||0
8541395|NCT00546273|9572888|FG004|STARTED|II||2
8541396|NCT00546273|9572884|FG000|COMPLETED|II||0
8541397|NCT00546273|9572885|FG001|COMPLETED|II||4
8541398|NCT00546273|9572886|FG002|COMPLETED|II||0
8541399|NCT00546273|9572887|FG003|COMPLETED|II||0
8541400|NCT00546273|9572888|FG004|COMPLETED|II||2
8541401|NCT00546273|9572884|FG000|NOT COMPLETED|II||0
8541402|NCT00546273|9572885|FG001|NOT COMPLETED|II||0
8541403|NCT00546273|9572886|FG002|NOT COMPLETED|II||0
8541404|NCT00546273|9572887|FG003|NOT COMPLETED|II||0
8541405|NCT00546273|9572888|FG004|NOT COMPLETED|II||0
8541406|NCT00546273|9572884|FG000|STARTED|III||0
8541407|NCT00546273|9572885|FG001|STARTED|III||0
8541408|NCT00546273|9572886|FG002|STARTED|III||4
8541409|NCT00546273|9572887|FG003|STARTED|III||0
8541410|NCT00546273|9572888|FG004|STARTED|III||2
8541411|NCT00546273|9572884|FG000|COMPLETED|III||0
8541412|NCT00546273|9572885|FG001|COMPLETED|III||0
8818090|NCT01555567|9871715|FG000|NOT COMPLETED|Return to Activity||1
8818091|NCT01555567|9871716|FG001|NOT COMPLETED|Return to Activity||2
8818092|NCT01555567|9871717|FG002|NOT COMPLETED|Return to Activity||0
8818093|NCT01555567|9871718|FG003|NOT COMPLETED|Return to Activity||1
8541413|NCT00546273|9572886|FG002|COMPLETED|III||4
8541414|NCT00546273|9572887|FG003|COMPLETED|III||0
8541415|NCT00546273|9572888|FG004|COMPLETED|III||2
8541416|NCT00546273|9572884|FG000|NOT COMPLETED|III||0
8541417|NCT00546273|9572885|FG001|NOT COMPLETED|III||0
8541418|NCT00546273|9572886|FG002|NOT COMPLETED|III||0
8541419|NCT00546273|9572887|FG003|NOT COMPLETED|III||0
8541420|NCT00546273|9572888|FG004|NOT COMPLETED|III||0
8541421|NCT00546273|9572884|FG000|STARTED|IV||0
8541422|NCT00546273|9572885|FG001|STARTED|IV||0
8541423|NCT00546273|9572886|FG002|STARTED|IV||0
8541424|NCT00546273|9572887|FG003|STARTED|IV||4
8541425|NCT00546273|9572888|FG004|STARTED|IV||2
8541426|NCT00546273|9572884|FG000|COMPLETED|IV||0
8541427|NCT00546273|9572885|FG001|COMPLETED|IV||0
8541428|NCT00546273|9572886|FG002|COMPLETED|IV||0
8541429|NCT00546273|9572887|FG003|COMPLETED|IV||4
8541430|NCT00546273|9572888|FG004|COMPLETED|IV||2
8541431|NCT00546273|9572884|FG000|NOT COMPLETED|IV||0
8541432|NCT00546273|9572885|FG001|NOT COMPLETED|IV||0
8541433|NCT00546273|9572886|FG002|NOT COMPLETED|IV||0
8541434|NCT00546273|9572887|FG003|NOT COMPLETED|IV||0
8541435|NCT00546273|9572888|FG004|NOT COMPLETED|IV||0
8566139|NCT00074282|9598229|FG001|COMPLETED|Step 2||7
8566140|NCT00074282|9598230|FG002|COMPLETED|Step 2||7
8541436|NCT00529152|9572895|FG000|STARTED|Overall Study||100
8541437|NCT00529152|9572895|FG000|COMPLETED|Overall Study||95
8541438|NCT00529152|9572895|FG000|NOT COMPLETED|Overall Study||5
8541439|NCT00526227|9572898|FG000|STARTED|Overall Study||81
8541440|NCT00526227|9572898|FG000|COMPLETED|Overall Study||79
8541441|NCT00526227|9572898|FG000|NOT COMPLETED|Overall Study||2
8541442|NCT00513617|9572906|FG000|STARTED|Overall Study||36
8541443|NCT00513617|9572907|FG001|STARTED|Overall Study||35
8541444|NCT00513617|9572908|FG002|STARTED|Overall Study||38
8541445|NCT00513617|9572906|FG000|COMPLETED|Overall Study||25
8541446|NCT00513617|9572907|FG001|COMPLETED|Overall Study||25
8541447|NCT00513617|9572908|FG002|COMPLETED|Overall Study||30
8541448|NCT00513617|9572906|FG000|NOT COMPLETED|Overall Study||11
8541449|NCT00513617|9572907|FG001|NOT COMPLETED|Overall Study||10
8541450|NCT00513617|9572908|FG002|NOT COMPLETED|Overall Study||8
8541451|NCT00495222|9572913|FG000|STARTED|Overall Study||9
8541452|NCT00495222|9572913|FG000|COMPLETED|Overall Study||9
8541453|NCT00495222|9572913|FG000|NOT COMPLETED|Overall Study||0
8541454|NCT00495131|9572918|FG000|STARTED|Overall Study||154
8541455|NCT00495131|9572919|FG001|STARTED|Overall Study||154
8541456|NCT00495131|9572918|FG000|COMPLETED|Overall Study||147
8541457|NCT00495131|9572919|FG001|COMPLETED|Overall Study||148
8541458|NCT00495131|9572918|FG000|NOT COMPLETED|Overall Study||7
8541459|NCT00495131|9572919|FG001|NOT COMPLETED|Overall Study||6
8541460|NCT00491738|9572925|FG000|STARTED|Overall Study||7
8541461|NCT00491738|9572926|FG001|STARTED|Overall Study||9
8541462|NCT00491738|9572925|FG000|COMPLETED|Overall Study||7
8541463|NCT00491738|9572926|FG001|COMPLETED|Overall Study||9
8541464|NCT00491738|9572925|FG000|NOT COMPLETED|Overall Study||0
8541465|NCT00491738|9572926|FG001|NOT COMPLETED|Overall Study||0
8541466|NCT00484419|9572933|FG000|STARTED|Overall Study||57
8541467|NCT00484419|9572934|FG001|STARTED|Overall Study||56
8541468|NCT00484419|9572935|FG002|STARTED|Overall Study||56
8541469|NCT00484419|9572933|FG000|COMPLETED|Overall Study||45
8541470|NCT00484419|9572934|FG001|COMPLETED|Overall Study||51
8541471|NCT00484419|9572935|FG002|COMPLETED|Overall Study||45
8541472|NCT00484419|9572933|FG000|NOT COMPLETED|Overall Study||12
8541473|NCT00484419|9572934|FG001|NOT COMPLETED|Overall Study||5
8541474|NCT00484419|9572935|FG002|NOT COMPLETED|Overall Study||11
8541475|NCT00479258|9572942|FG000|STARTED|Overall Study||0
8541476|NCT00479258|9572943|FG001|STARTED|Overall Study||0
8541477|NCT00479258|9572942|FG000|COMPLETED|Overall Study||0
8541478|NCT00479258|9572943|FG001|COMPLETED|Overall Study||0
8541479|NCT00479258|9572942|FG000|NOT COMPLETED|Overall Study||0
8541480|NCT00479258|9572943|FG001|NOT COMPLETED|Overall Study||0
8541481|NCT00474188|9572947|FG000|STARTED|Overall Study||26
8541482|NCT00474188|9572947|FG000|COMPLETED|Overall Study|Disease progression=15, adverse event=4, death=1|20
8541483|NCT00474188|9572947|FG000|NOT COMPLETED|Overall Study||6
8541484|NCT00440531|9572953|FG000|STARTED|Overall Study||185
8541485|NCT00440531|9572954|FG001|STARTED|Overall Study||183
8541486|NCT00440531|9572955|FG002|STARTED|Overall Study||172
8541487|NCT00440531|9572953|FG000|Vaccination 1|Overall Study||183
8541488|NCT00440531|9572954|FG001|Vaccination 1|Overall Study||183
8541489|NCT00440531|9572955|FG002|Vaccination 1|Overall Study||172
8541490|NCT00440531|9572953|FG000|Vaccination 2|Overall Study||181
8541491|NCT00440531|9572954|FG001|Vaccination 2|Overall Study||182
8541492|NCT00440531|9572955|FG002|Vaccination 2|Overall Study||171
8541493|NCT00440531|9572953|FG000|Vaccination 3|Overall Study||176
8541494|NCT00440531|9572954|FG001|Vaccination 3|Overall Study||178
8541495|NCT00440531|9572955|FG002|Vaccination 3|Overall Study||166
8541496|NCT00440531|9572953|FG000|COMPLETED|Overall Study||175
8541497|NCT00440531|9572954|FG001|COMPLETED|Overall Study||178
8541498|NCT00440531|9572955|FG002|COMPLETED|Overall Study||165
8818094|NCT01555671|9871730|FG000|STARTED|Overall Study||125
8818095|NCT01555671|9871731|FG001|STARTED|Overall Study||125
8818096|NCT01555671|9871730|FG000|COMPLETED|Overall Study||105
8818097|NCT01555671|9871731|FG001|COMPLETED|Overall Study||100
8818098|NCT01555671|9871730|FG000|NOT COMPLETED|Overall Study||20
8541499|NCT00440531|9572953|FG000|NOT COMPLETED|Overall Study||10
8541500|NCT00440531|9572954|FG001|NOT COMPLETED|Overall Study||5
8541501|NCT00440531|9572955|FG002|NOT COMPLETED|Overall Study||7
8541502|NCT00439738|9572963|FG000|STARTED|Overall Study||206
8541503|NCT00439738|9572964|FG001|STARTED|Overall Study||206
8541504|NCT00439738|9572963|FG000|COMPLETED|Overall Study||170
8541505|NCT00439738|9572964|FG001|COMPLETED|Overall Study||178
8541506|NCT00439738|9572963|FG000|NOT COMPLETED|Overall Study||36
8541507|NCT00439738|9572964|FG001|NOT COMPLETED|Overall Study||28
8541508|NCT00434226|9572970|FG000|STARTED|Overall Study||30
8541509|NCT00434226|9572971|FG001|STARTED|Overall Study||26
8541510|NCT00434226|9572970|FG000|COMPLETED|Overall Study||0
8541511|NCT00434226|9572971|FG001|COMPLETED|Overall Study||0
8541512|NCT00434226|9572970|FG000|NOT COMPLETED|Overall Study||30
8541513|NCT00434226|9572971|FG001|NOT COMPLETED|Overall Study||26
8541514|NCT00430950|9572977|FG000|STARTED|Overall Study||502
8541515|NCT00430950|9572978|FG001|STARTED|Overall Study||508
8541516|NCT00430950|9572977|FG000|COMPLETED|Overall Study||489
8541517|NCT00430950|9572978|FG001|COMPLETED|Overall Study||495
8541518|NCT00430950|9572977|FG000|NOT COMPLETED|Overall Study||13
8541519|NCT00430950|9572978|FG001|NOT COMPLETED|Overall Study||13
8541520|NCT00430508|9572986|FG000|STARTED|Overall Study||140
8541521|NCT00430508|9572987|FG001|STARTED|Overall Study||278
8541522|NCT00430508|9572988|FG002|STARTED|Overall Study||279
8541523|NCT00430508|9572989|FG003|STARTED|Overall Study||274
8541524|NCT00430508|9572986|FG000|COMPLETED|Overall Study||137
8541525|NCT00430508|9572987|FG001|COMPLETED|Overall Study||272
8541526|NCT00430508|9572988|FG002|COMPLETED|Overall Study||266
8541527|NCT00430508|9572989|FG003|COMPLETED|Overall Study||269
8541528|NCT00430508|9572986|FG000|NOT COMPLETED|Overall Study||3
8541529|NCT00430508|9572987|FG001|NOT COMPLETED|Overall Study||6
8541530|NCT00430508|9572988|FG002|NOT COMPLETED|Overall Study||13
8541531|NCT00430508|9572989|FG003|NOT COMPLETED|Overall Study||5
8541532|NCT00430092|9572998|FG000|STARTED|Overall Study||54
8541533|NCT00430092|9572999|FG001|STARTED|Overall Study||52
8541534|NCT00430092|9573000|FG002|STARTED|Overall Study||113
8541535|NCT00430092|9572998|FG000|COMPLETED|Overall Study||48
8541536|NCT00430092|9572999|FG001|COMPLETED|Overall Study||48
8541537|NCT00430092|9573000|FG002|COMPLETED|Overall Study||56
8541538|NCT00430092|9572998|FG000|NOT COMPLETED|Overall Study||6
8541539|NCT00430092|9572999|FG001|NOT COMPLETED|Overall Study||4
8541540|NCT00430092|9573000|FG002|NOT COMPLETED|Overall Study||57
8566141|NCT00074282|9598228|FG000|NOT COMPLETED|Step 2||0
8566142|NCT00074282|9598229|FG001|NOT COMPLETED|Step 2||2
8566143|NCT00074282|9598230|FG002|NOT COMPLETED|Step 2||24
8566144|NCT00074308|9598240|FG000|STARTED|Overall Study||3
8566145|NCT00074308|9598241|FG001|STARTED|Overall Study||3
8566146|NCT00074308|9598242|FG002|STARTED|Overall Study||3
8566147|NCT00074308|9598243|FG003|STARTED|Overall Study||8
8566148|NCT00074308|9598244|FG004|STARTED|Overall Study||23
8566149|NCT00074308|9598240|FG000|COMPLETED|Overall Study||3
8566150|NCT00074308|9598241|FG001|COMPLETED|Overall Study||3
8566151|NCT00074308|9598242|FG002|COMPLETED|Overall Study||3
8566152|NCT00074308|9598243|FG003|COMPLETED|Overall Study||8
8566153|NCT00074308|9598244|FG004|COMPLETED|Overall Study||23
8566154|NCT00074308|9598240|FG000|NOT COMPLETED|Overall Study||0
8566155|NCT00074308|9598241|FG001|NOT COMPLETED|Overall Study||0
8566156|NCT00074308|9598242|FG002|NOT COMPLETED|Overall Study||0
8566157|NCT00074308|9598243|FG003|NOT COMPLETED|Overall Study||0
8566158|NCT00074308|9598244|FG004|NOT COMPLETED|Overall Study||0
8566159|NCT00074412|9598256|FG000|STARTED|Overall Study|Number of infants randomized at 6 weeks.|763
8566160|NCT00074412|9598257|FG001|STARTED|Overall Study|Number of infants randomized at 6 weeks.|759
8566161|NCT00074412|9598256|FG000|Week 8 Visit|Overall Study||759
8566162|NCT00074412|9598257|FG001|Week 8 Visit|Overall Study||759
8566163|NCT00074412|9598256|FG000|Month 3 Visit|Overall Study||759
8566164|NCT00074412|9598257|FG001|Month 3 Visit|Overall Study||755
8566165|NCT00074412|9598256|FG000|Month 4 Visit|Overall Study||758
8566166|NCT00074412|9598257|FG001|Month 4 Visit|Overall Study||752
8566167|NCT00074412|9598256|FG000|Month 5 Visit|Overall Study||756
8566168|NCT00074412|9598257|FG001|Month 5 Visit|Overall Study||750
8566169|NCT00074412|9598256|FG000|Month 6 Visit|Overall Study||748
8566170|NCT00074412|9598257|FG001|Month 6 Visit|Overall Study||748
8566171|NCT00074412|9598256|FG000|Month 9 Visit|Overall Study||741
8566172|NCT00074412|9598257|FG001|Month 9 Visit|Overall Study||741
8566173|NCT00074412|9598256|FG000|Month 12 Visit|Overall Study||733
8566174|NCT00074412|9598257|FG001|Month 12 Visit|Overall Study||735
8566175|NCT00074412|9598256|FG000|COMPLETED|Overall Study|Number of infants who completed final 18 month visit: out of 733 infants who were expected.|681
8566176|NCT00074412|9598257|FG001|COMPLETED|Overall Study|Number of infants who completed final 18 month visit: out of 733 infants who were expected.|675
8566177|NCT00074412|9598256|FG000|NOT COMPLETED|Overall Study||82
8566178|NCT00074412|9598257|FG001|NOT COMPLETED|Overall Study||84
8566179|NCT00074490|9598269|FG000|STARTED|Overall Study||1
8566180|NCT00074490|9598270|FG001|STARTED|Overall Study||34
8566181|NCT00074490|9598271|FG002|STARTED|Overall Study||40
8566182|NCT00074490|9598272|FG003|STARTED|Overall Study||44
8566183|NCT00074490|9598273|FG004|STARTED|Overall Study||45
8566184|NCT00074490|9598274|FG005|STARTED|Overall Study||221
8566185|NCT00074490|9598269|FG000|COMPLETED|Overall Study||1
8566186|NCT00074490|9598270|FG001|COMPLETED|Overall Study||27
8566187|NCT00074490|9598271|FG002|COMPLETED|Overall Study||40
8566188|NCT00074490|9598272|FG003|COMPLETED|Overall Study||44
8566189|NCT00074490|9598273|FG004|COMPLETED|Overall Study||42
8566190|NCT00074490|9598274|FG005|COMPLETED|Overall Study||221
8566191|NCT00074490|9598269|FG000|NOT COMPLETED|Overall Study||0
8566192|NCT00074490|9598270|FG001|NOT COMPLETED|Overall Study||7
8566193|NCT00074490|9598271|FG002|NOT COMPLETED|Overall Study||0
8566194|NCT00074490|9598272|FG003|NOT COMPLETED|Overall Study||0
8566195|NCT00074490|9598273|FG004|NOT COMPLETED|Overall Study||3
8566196|NCT00074490|9598274|FG005|NOT COMPLETED|Overall Study||0
8566197|NCT00074581|9598289|FG000|STARTED|Overall Study|886 HIV-infected index cases and 903 HIV-uninfected partners|1789
8566198|NCT00074581|9598290|FG001|STARTED|Overall Study|877 HIV-infected index cases and 890 HIV-uninfected partners|1767
8566199|NCT00074581|9598289|FG000|COMPLETED|Overall Study||1545
8566200|NCT00074581|9598290|FG001|COMPLETED|Overall Study||1541
8566201|NCT00074581|9598289|FG000|NOT COMPLETED|Overall Study||244
8566202|NCT00074581|9598290|FG001|NOT COMPLETED|Overall Study||226
8566203|NCT00074711|9598298|FG000|STARTED|Overall Study||120
8566204|NCT00074711|9598299|FG001|STARTED|Overall Study||121
8566205|NCT00074711|9598298|FG000|COMPLETED|Overall Study||105
8566206|NCT00074711|9598299|FG001|COMPLETED|Overall Study||106
8566207|NCT00074711|9598298|FG000|NOT COMPLETED|Overall Study||15
8566208|NCT00074711|9598299|FG001|NOT COMPLETED|Overall Study||15
8566209|NCT00074802|9598307|FG000|STARTED|Overall Study||29
8566210|NCT00074802|9598308|FG001|STARTED|Overall Study||32
8566211|NCT00074802|9598307|FG000|COMPLETED|Overall Study||20
8541541|NCT00429923|9573008|FG000|STARTED|Overall Study||57
8541542|NCT00429923|9573009|FG001|STARTED|Overall Study||55
8541543|NCT00429923|9573010|FG002|STARTED|Overall Study||107
8541544|NCT00429923|9573008|FG000|COMPLETED|Overall Study||52
8541545|NCT00429923|9573009|FG001|COMPLETED|Overall Study||51
8541546|NCT00429923|9573010|FG002|COMPLETED|Overall Study||68
8541547|NCT00429923|9573008|FG000|NOT COMPLETED|Overall Study||5
8541548|NCT00429923|9573009|FG001|NOT COMPLETED|Overall Study||4
8541549|NCT00429923|9573010|FG002|NOT COMPLETED|Overall Study||39
8541550|NCT00425100|9573015|FG000|STARTED|Overall Study||516
8541551|NCT00425100|9573015|FG000|COMPLETED|Overall Study||463
8541552|NCT00425100|9573015|FG000|NOT COMPLETED|Overall Study||53
8541553|NCT00415623|9573022|FG000|STARTED|Overall Study||154
8541554|NCT00415623|9573023|FG001|STARTED|Overall Study||151
8541555|NCT00415623|9573022|FG000|COMPLETED|Overall Study||149
8541556|NCT00415623|9573023|FG001|COMPLETED|Overall Study||146
8621204|NCT00478231|9660095|FG000|NOT COMPLETED|Overall Study||84
8621205|NCT00478244|9660099|FG000|STARTED|Overall Study||7
8541557|NCT00415623|9573022|FG000|NOT COMPLETED|Overall Study||5
8541558|NCT00415623|9573023|FG001|NOT COMPLETED|Overall Study||5
8541559|NCT00412932|9573030|FG000|STARTED|Olmesartan (Olm) 20 mg||178
8541560|NCT00412932|9573030|FG000|COMPLETED|Olmesartan (Olm) 20 mg||171
8541561|NCT00412932|9573030|FG000|NOT COMPLETED|Olmesartan (Olm) 20 mg||7
8541562|NCT00412932|9573030|FG000|STARTED|Olmesartan 40 mg|171 -1 met blood pressure goal (stayed on olmesartan 20) -1 who erroneously skipped this step = 169.|169
8541563|NCT00412932|9573030|FG000|COMPLETED|Olmesartan 40 mg||161
8541564|NCT00412932|9573030|FG000|NOT COMPLETED|Olmesartan 40 mg||8
8541565|NCT00412932|9573030|FG000|STARTED|Olm+Hydrochlorothiazide 12.5 mg|161 -2 met blood pressure goal (stayed on olmesartan 40) = 159|159
8541566|NCT00412932|9573030|FG000|COMPLETED|Olm+Hydrochlorothiazide 12.5 mg||153
8541567|NCT00412932|9573030|FG000|NOT COMPLETED|Olm+Hydrochlorothiazide 12.5 mg||6
8541568|NCT00412932|9573030|FG000|STARTED|Olm+ Hydrochlorothiazide 25 mg|153 -28 met their blood pressure goal (stayed on olmesartan 40/hydrochlorothiazide 12.5) = 125|125
8541569|NCT00412932|9573030|FG000|COMPLETED|Olm+ Hydrochlorothiazide 25 mg||123
8541570|NCT00412932|9573030|FG000|NOT COMPLETED|Olm+ Hydrochlorothiazide 25 mg||2
8541571|NCT00397254|9573033|FG000|STARTED|Overall Study||79
8541572|NCT00397254|9573034|FG001|STARTED|Overall Study||76
8541573|NCT00397254|9573033|FG000|COMPLETED|Overall Study||77
8541574|NCT00397254|9573034|FG001|COMPLETED|Overall Study||74
8541575|NCT00397254|9573033|FG000|NOT COMPLETED|Overall Study||2
8541576|NCT00397254|9573034|FG001|NOT COMPLETED|Overall Study||2
8541577|NCT00393068|9573038|FG000|STARTED|Overall Study||62
8541578|NCT00393068|9573038|FG000|COMPLETED|Overall Study||44
8541579|NCT00393068|9573038|FG000|NOT COMPLETED|Overall Study||18
8541580|NCT00385515|9573044|FG000|STARTED|Overall Study||57
8541581|NCT00385515|9573045|FG001|STARTED|Overall Study||24
8541582|NCT00385515|9573044|FG000|COMPLETED|Overall Study||53
8541583|NCT00385515|9573045|FG001|COMPLETED|Overall Study||21
8541584|NCT00385515|9573044|FG000|NOT COMPLETED|Overall Study||4
8541585|NCT00385515|9573045|FG001|NOT COMPLETED|Overall Study||3
8566212|NCT00074802|9598308|FG001|COMPLETED|Overall Study||25
8566213|NCT00074802|9598307|FG000|NOT COMPLETED|Overall Study||9
8566214|NCT00074802|9598308|FG001|NOT COMPLETED|Overall Study||7
8566215|NCT00074815|9598317|FG000|STARTED|Overall Study||42
8566216|NCT00074815|9598318|FG001|STARTED|Overall Study||40
8566217|NCT00074815|9598319|FG002|STARTED|Overall Study||42
8566218|NCT00074815|9598317|FG000|COMPLETED|Overall Study||37
8566219|NCT00074815|9598318|FG001|COMPLETED|Overall Study||34
8566220|NCT00074815|9598319|FG002|COMPLETED|Overall Study||30
8566221|NCT00074815|9598317|FG000|NOT COMPLETED|Overall Study||5
8566222|NCT00074815|9598318|FG001|NOT COMPLETED|Overall Study||6
8566223|NCT00074815|9598319|FG002|NOT COMPLETED|Overall Study||12
8566224|NCT00074958|9598327|FG000|STARTED|Overall Study||16
8566225|NCT00074958|9598327|FG000|COMPLETED|Overall Study||15
8566226|NCT00074958|9598327|FG000|NOT COMPLETED|Overall Study||1
8566227|NCT00074984|9598333|FG000|STARTED|Overall Study||31
8566228|NCT00074984|9598334|FG001|STARTED|Overall Study||51
8566229|NCT00074984|9598333|FG000|COMPLETED|Overall Study||28
8566230|NCT00074984|9598334|FG001|COMPLETED|Overall Study||43
8566231|NCT00074984|9598333|FG000|NOT COMPLETED|Overall Study||3
8566232|NCT00074984|9598334|FG001|NOT COMPLETED|Overall Study||8
8566233|NCT00075023|9598343|FG000|STARTED|Pilot Study||5
8621206|NCT00478244|9660099|FG000|COMPLETED|Overall Study||6
8566234|NCT00075023|9598344|FG001|STARTED|Pilot Study||5
8566235|NCT00075023|9598343|FG000|COMPLETED|Pilot Study||3
8566236|NCT00075023|9598344|FG001|COMPLETED|Pilot Study||3
8566237|NCT00075023|9598343|FG000|NOT COMPLETED|Pilot Study||2
8566238|NCT00075023|9598344|FG001|NOT COMPLETED|Pilot Study||2
8566239|NCT00075023|9598343|FG000|STARTED|Part Two|Study was terminated after the pilot study. No participants entered Part Two.|0
8566240|NCT00075023|9598344|FG001|STARTED|Part Two|Study was terminated after the pilot study. No participants entered Part Two.|0
8566241|NCT00075023|9598343|FG000|COMPLETED|Part Two||0
8566242|NCT00075023|9598344|FG001|COMPLETED|Part Two||0
8566243|NCT00075023|9598343|FG000|NOT COMPLETED|Part Two||0
8566244|NCT00075023|9598344|FG001|NOT COMPLETED|Part Two||0
8566245|NCT00075088|9598353|FG000|STARTED|Overall Study||403
8566246|NCT00075088|9598354|FG001|STARTED|Overall Study||391
8566247|NCT00075088|9598353|FG000|COMPLETED|Overall Study||403
8566248|NCT00075088|9598354|FG001|COMPLETED|Overall Study||391
8621207|NCT00478244|9660099|FG000|NOT COMPLETED|Overall Study||1
8566249|NCT00075088|9598353|FG000|NOT COMPLETED|Overall Study||0
8541586|NCT00362401|9573052|FG000|STARTED|Overall Study||15
8541587|NCT00362401|9573053|FG001|STARTED|Overall Study||29
8541588|NCT00362401|9573054|FG002|STARTED|Overall Study||40
8541589|NCT00362401|9573052|FG000|COMPLETED|Overall Study||15
8541590|NCT00362401|9573053|FG001|COMPLETED|Overall Study||29
8541591|NCT00362401|9573054|FG002|COMPLETED|Overall Study||40
8541592|NCT00362401|9573052|FG000|NOT COMPLETED|Overall Study||0
8541593|NCT00362401|9573053|FG001|NOT COMPLETED|Overall Study||0
8541594|NCT00362401|9573054|FG002|NOT COMPLETED|Overall Study||0
8541595|NCT00338104|9573062|FG000|STARTED|Overall Study||25
8541596|NCT00338104|9573063|FG001|STARTED|Overall Study||25
8541597|NCT00338104|9573064|FG002|STARTED|Overall Study||25
8541598|NCT00338104|9573062|FG000|COMPLETED|Overall Study||23
8541599|NCT00338104|9573063|FG001|COMPLETED|Overall Study||24
8541600|NCT00338104|9573064|FG002|COMPLETED|Overall Study||22
8541601|NCT00338104|9573062|FG000|NOT COMPLETED|Overall Study||2
8541602|NCT00338104|9573063|FG001|NOT COMPLETED|Overall Study||1
8541603|NCT00338104|9573064|FG002|NOT COMPLETED|Overall Study||3
8541604|NCT00336973|9573069|FG000|STARTED|Overall Study||66
8541605|NCT00336973|9573069|FG000|COMPLETED|Overall Study||33
8541606|NCT00336973|9573069|FG000|NOT COMPLETED|Overall Study||33
8541607|NCT00326183|9573074|FG000|STARTED|Overall Study||1453
8541608|NCT00326183|9573075|FG001|STARTED|Overall Study||347
8541609|NCT00326183|9573074|FG000|Vaccination 1 + Safety Follow-up|Overall Study||1453
8541610|NCT00326183|9573075|FG001|Vaccination 1 + Safety Follow-up|Overall Study||347
8541611|NCT00326183|9573074|FG000|Postvaccination 1 Post-safety Follow-up|Overall Study||1393
8541612|NCT00326183|9573075|FG001|Postvaccination 1 Post-safety Follow-up|Overall Study||325
8541613|NCT00326183|9573074|FG000|Vaccination 2 + Safety Follow-up|Overall Study||1301
8541614|NCT00326183|9573075|FG001|Vaccination 2 + Safety Follow-up|Overall Study||292
8541615|NCT00326183|9573074|FG000|Postvaccination 2 Post-safety Follow-up|Overall Study||1265
8541616|NCT00326183|9573075|FG001|Postvaccination 2 Post-safety Follow-up|Overall Study||271
8541617|NCT00326183|9573074|FG000|COMPLETED|Overall Study||1253
8541618|NCT00326183|9573075|FG001|COMPLETED|Overall Study||264
8541619|NCT00326183|9573074|FG000|NOT COMPLETED|Overall Study||200
8541620|NCT00326183|9573075|FG001|NOT COMPLETED|Overall Study||83
8541621|NCT00323037|9573081|FG000|STARTED|Overall Study|Number randomized|165
8541622|NCT00323037|9573082|FG001|STARTED|Overall Study|Number randomized|153
8541623|NCT00323037|9573081|FG000|COMPLETED|Overall Study||132
8541624|NCT00323037|9573082|FG001|COMPLETED|Overall Study||126
8541625|NCT00323037|9573081|FG000|NOT COMPLETED|Overall Study||33
8541626|NCT00323037|9573082|FG001|NOT COMPLETED|Overall Study||27
8541627|NCT00318656|9573088|FG000|STARTED|Overall Study||12
8541628|NCT00318656|9573089|FG001|STARTED|Overall Study||11
8541629|NCT00318656|9573088|FG000|COMPLETED|Overall Study||12
8541630|NCT00318656|9573089|FG001|COMPLETED|Overall Study|1 patient received by error avandamet treatment and 1 patient did not receive any treatment.|9
8541631|NCT00318656|9573088|FG000|NOT COMPLETED|Overall Study||0
8541632|NCT00318656|9573089|FG001|NOT COMPLETED|Overall Study||2
8541633|NCT00301262|9573095|FG000|STARTED|Double Blind Phase (DB)||94
8541634|NCT00301262|9573096|FG001|STARTED|Double Blind Phase (DB)||82
8541635|NCT00301262|9573095|FG000|COMPLETED|Double Blind Phase (DB)||84
8541636|NCT00301262|9573096|FG001|COMPLETED|Double Blind Phase (DB)||69
8541637|NCT00301262|9573095|FG000|NOT COMPLETED|Double Blind Phase (DB)||10
8541638|NCT00301262|9573096|FG001|NOT COMPLETED|Double Blind Phase (DB)||13
8541639|NCT00301262|9573095|FG000|STARTED|Open Label Phase (OL)||83
8621208|NCT00478257|9660105|FG000|STARTED|Overall Study||23
8621209|NCT00478257|9660106|FG001|STARTED|Overall Study||16
8621210|NCT00478257|9660105|FG000|COMPLETED|Overall Study||15
8621211|NCT00478257|9660106|FG001|COMPLETED|Overall Study||13
8621212|NCT00478257|9660105|FG000|NOT COMPLETED|Overall Study||8
8621213|NCT00478257|9660106|FG001|NOT COMPLETED|Overall Study||3
8621214|NCT00478335|9660114|FG000|STARTED|Period 1 (4 Days)||2
8621215|NCT00478335|9660115|FG001|STARTED|Period 1 (4 Days)||2
8621216|NCT00478335|9660114|FG000|COMPLETED|Period 1 (4 Days)||2
8621217|NCT00478335|9660115|FG001|COMPLETED|Period 1 (4 Days)||2
8621218|NCT00478335|9660114|FG000|NOT COMPLETED|Period 1 (4 Days)||0
8621219|NCT00478335|9660115|FG001|NOT COMPLETED|Period 1 (4 Days)||0
8621220|NCT00478335|9660114|FG000|STARTED|Period 2 (4 Days)||2
8621221|NCT00478335|9660115|FG001|STARTED|Period 2 (4 Days)||2
8621222|NCT00478335|9660114|FG000|COMPLETED|Period 2 (4 Days)||2
8621223|NCT00478335|9660115|FG001|COMPLETED|Period 2 (4 Days)||2
8621224|NCT00478335|9660114|FG000|NOT COMPLETED|Period 2 (4 Days)||0
8541640|NCT00301262|9573096|FG001|STARTED|Open Label Phase (OL)||69
8541641|NCT00301262|9573095|FG000|COMPLETED|Open Label Phase (OL)||79
8541642|NCT00301262|9573096|FG001|COMPLETED|Open Label Phase (OL)||67
8541643|NCT00301262|9573095|FG000|NOT COMPLETED|Open Label Phase (OL)||4
8541644|NCT00301262|9573096|FG001|NOT COMPLETED|Open Label Phase (OL)||2
8541645|NCT00283868|9573123|FG000|STARTED|Overall Study||111
8621225|NCT00478335|9660115|FG001|NOT COMPLETED|Period 2 (4 Days)||0
8621226|NCT00478361|9660121|FG000|STARTED|Overall Study||39
8541646|NCT00283868|9573124|FG001|STARTED|Overall Study||111
8541647|NCT00283868|9573123|FG000|COMPLETED|Overall Study||104
8541648|NCT00283868|9573124|FG001|COMPLETED|Overall Study||103
8541649|NCT00283868|9573123|FG000|NOT COMPLETED|Overall Study||7
8541650|NCT00283868|9573124|FG001|NOT COMPLETED|Overall Study||8
8541651|NCT00282867|9573131|FG000|STARTED|Overall Study||24
8541652|NCT00282867|9573132|FG001|STARTED|Overall Study||25
8541653|NCT00282867|9573133|FG002|STARTED|Overall Study||25
8541654|NCT00282867|9573131|FG000|COMPLETED|Overall Study||23
8541655|NCT00282867|9573132|FG001|COMPLETED|Overall Study||24
8541656|NCT00282867|9573133|FG002|COMPLETED|Overall Study||25
8541657|NCT00282867|9573131|FG000|NOT COMPLETED|Overall Study||1
8541658|NCT00282867|9573132|FG001|NOT COMPLETED|Overall Study||1
8541659|NCT00282867|9573133|FG002|NOT COMPLETED|Overall Study||0
8541660|NCT00275340|9573140|FG000|STARTED|Overall Study||52
8541661|NCT00275340|9573141|FG001|STARTED|Overall Study||49
8541662|NCT00275340|9573140|FG000|COMPLETED|Overall Study||50
8541663|NCT00275340|9573141|FG001|COMPLETED|Overall Study||45
8541664|NCT00275340|9573140|FG000|NOT COMPLETED|Overall Study||2
8541665|NCT00275340|9573141|FG001|NOT COMPLETED|Overall Study||4
8541666|NCT00271544|9573145|FG000|STARTED|Overall Study|Total number of subjects enrolled.|190
8541667|NCT00271544|9573145|FG000|Implant Attempted|Overall Study|Total number of subjects completed baseline and underwent system implant attempt.|186
8541668|NCT00271544|9573145|FG000|Model 4196 Lead Attempted|Overall Study|Total number of subjects attempted Model 4196 lead.|177
8541669|NCT00271544|9573145|FG000|COMPLETED|Overall Study|Total number subjects successfully implanted 4196 lead.|170
8541670|NCT00271544|9573145|FG000|NOT COMPLETED|Overall Study||20
8541671|NCT00240500|9573167|FG000|STARTED|Overall Study||17
8541672|NCT00240500|9573168|FG001|STARTED|Overall Study||20
8541673|NCT00240500|9573169|FG002|STARTED|Overall Study||17
8541674|NCT00240500|9573170|FG003|STARTED|Overall Study||23
8541675|NCT00240500|9573171|FG004|STARTED|Overall Study||29
8541676|NCT00240500|9573172|FG005|STARTED|Overall Study||3
8541677|NCT00240500|9573167|FG000|COMPLETED|Overall Study||16
8541678|NCT00240500|9573168|FG001|COMPLETED|Overall Study||17
8541679|NCT00240500|9573169|FG002|COMPLETED|Overall Study||14
8541680|NCT00240500|9573170|FG003|COMPLETED|Overall Study||19
8541681|NCT00240500|9573171|FG004|COMPLETED|Overall Study||26
8541682|NCT00240500|9573172|FG005|COMPLETED|Overall Study||2
8541683|NCT00240500|9573167|FG000|NOT COMPLETED|Overall Study||1
8541684|NCT00240500|9573168|FG001|NOT COMPLETED|Overall Study||3
8541685|NCT00240500|9573169|FG002|NOT COMPLETED|Overall Study||3
8541686|NCT00240500|9573170|FG003|NOT COMPLETED|Overall Study||4
8541687|NCT00240500|9573171|FG004|NOT COMPLETED|Overall Study||3
8541688|NCT00240500|9573172|FG005|NOT COMPLETED|Overall Study||1
8541689|NCT00235326|9573182|FG000|STARTED|Overall Study||1575
8541690|NCT00235326|9573183|FG001|STARTED|Overall Study||2986
8541691|NCT00235326|9573182|FG000|COMPLETED|Overall Study||829
8541692|NCT00235326|9573183|FG001|COMPLETED|Overall Study||1586
8541693|NCT00235326|9573182|FG000|NOT COMPLETED|Overall Study||746
8541694|NCT00235326|9573183|FG001|NOT COMPLETED|Overall Study||1400
8541695|NCT00232141|9573189|FG000|STARTED|Overall Study||151
8541696|NCT00232141|9573190|FG001|STARTED|Overall Study||151
8541697|NCT00232141|9573189|FG000|COMPLETED|Overall Study||120
8541698|NCT00232141|9573190|FG001|COMPLETED|Overall Study||125
8541699|NCT00232141|9573189|FG000|NOT COMPLETED|Overall Study||31
8541700|NCT00232141|9573190|FG001|NOT COMPLETED|Overall Study||26
8541701|NCT00231153|9573196|FG000|STARTED|Overall Study|Subjects randomized to omiganan 1% gel who received at least one dose of study treatment.|907
8541702|NCT00231153|9573197|FG001|STARTED|Overall Study|Subjects randomized to povidone-iodine who received at least one dose of study treatment.|908
8541703|NCT00231153|9573196|FG000|COMPLETED|Overall Study||690
8541704|NCT00231153|9573197|FG001|COMPLETED|Overall Study||720
8541705|NCT00231153|9573196|FG000|NOT COMPLETED|Overall Study||217
8541706|NCT00231153|9573197|FG001|NOT COMPLETED|Overall Study||188
8541707|NCT00224003|9573201|FG000|STARTED|Overall Study|First patient in: April 2, 2003|23
8541708|NCT00224003|9573201|FG000|COMPLETED|Overall Study|Last patient out: March 31, 2004|16
8541709|NCT00224003|9573201|FG000|NOT COMPLETED|Overall Study||7
8566250|NCT00075088|9598354|FG001|NOT COMPLETED|Overall Study||0
8566251|NCT00075218|9598363|FG000|STARTED|Double-Blind Treatment|Intent To Treat Population (ITT)|243
8566252|NCT00075218|9598364|FG001|STARTED|Double-Blind Treatment|Intent To Treat Population (ITT)|118
8566253|NCT00075218|9598365|FG002|STARTED|Double-Blind Treatment||0
8566254|NCT00075218|9598363|FG000|Received Double-Blind Treatment|Double-Blind Treatment|As Treated Population (AT)|228
8566255|NCT00075218|9598364|FG001|Received Double-Blind Treatment|Double-Blind Treatment|As Treated Population (AT)|114
8566256|NCT00075218|9598365|FG002|Received Double-Blind Treatment|Double-Blind Treatment||0
8566257|NCT00075218|9598363|FG000|Crossed Over to Open-Label Treatment|Double-Blind Treatment||152
8566258|NCT00075218|9598364|FG001|Crossed Over to Open-Label Treatment|Double-Blind Treatment||103
8566259|NCT00075218|9598365|FG002|Crossed Over to Open-Label Treatment|Double-Blind Treatment||0
8566260|NCT00075218|9598363|FG000|COMPLETED|Double-Blind Treatment|Defined:subjects completed double-blind treatment phase and/or entered open-label treatment phase.|152
8566261|NCT00075218|9598364|FG001|COMPLETED|Double-Blind Treatment|Defined:subjects completed double-blind treatment phase and/or entered open-label treatment phase.|103
8566262|NCT00075218|9598365|FG002|COMPLETED|Double-Blind Treatment||0
8566263|NCT00075218|9598363|FG000|NOT COMPLETED|Double-Blind Treatment||91
8566264|NCT00075218|9598364|FG001|NOT COMPLETED|Double-Blind Treatment||15
8566265|NCT00075218|9598365|FG002|NOT COMPLETED|Double-Blind Treatment||0
8566266|NCT00075218|9598363|FG000|STARTED|Open-Label Treatment||0
8566267|NCT00075218|9598364|FG001|STARTED|Open-Label Treatment||0
8566268|NCT00075218|9598365|FG002|STARTED|Open-Label Treatment||255
8566269|NCT00075218|9598363|FG000|COMPLETED|Open-Label Treatment||0
8566270|NCT00075218|9598364|FG001|COMPLETED|Open-Label Treatment||0
8566271|NCT00075218|9598365|FG002|COMPLETED|Open-Label Treatment||0
8566272|NCT00075218|9598363|FG000|NOT COMPLETED|Open-Label Treatment||0
8566273|NCT00075218|9598364|FG001|NOT COMPLETED|Open-Label Treatment||0
8566274|NCT00075218|9598365|FG002|NOT COMPLETED|Open-Label Treatment||255
8541710|NCT00162942|9573206|FG000|STARTED|Overall Study||157
8541711|NCT00162942|9573207|FG001|STARTED|Overall Study||78
8541712|NCT00162942|9573206|FG000|Week 12|Overall Study||127
8541713|NCT00162942|9573207|FG001|Week 12|Overall Study||61
8541714|NCT00162942|9573206|FG000|COMPLETED|Overall Study||51
8541715|NCT00162942|9573207|FG001|COMPLETED|Overall Study||26
8541716|NCT00162942|9573206|FG000|NOT COMPLETED|Overall Study||106
8541717|NCT00162942|9573207|FG001|NOT COMPLETED|Overall Study||52
8541718|NCT00147290|9573213|FG000|STARTED|Overall Study||266
8541719|NCT00147290|9573214|FG001|STARTED|Overall Study||260
8541720|NCT00147290|9573213|FG000|COMPLETED|Overall Study||266
8541721|NCT00147290|9573214|FG001|COMPLETED|Overall Study||260
8541722|NCT00147290|9573213|FG000|NOT COMPLETED|Overall Study||0
8541723|NCT00147290|9573214|FG001|NOT COMPLETED|Overall Study||0
8541724|NCT00147277|9573220|FG000|STARTED|Overall Study||475
8541725|NCT00147277|9573221|FG001|STARTED|Overall Study||450
8541726|NCT00147277|9573220|FG000|COMPLETED|Overall Study||475
8541727|NCT00147277|9573221|FG001|COMPLETED|Overall Study||450
8541728|NCT00147277|9573220|FG000|NOT COMPLETED|Overall Study||0
8541729|NCT00147277|9573221|FG001|NOT COMPLETED|Overall Study||0
8541730|NCT00126776|9573227|FG000|STARTED|Overall Study||372
8541731|NCT00126776|9573228|FG001|STARTED|Overall Study||371
8541732|NCT00126776|9573227|FG000|COMPLETED|Overall Study||372
8541733|NCT00126776|9573228|FG001|COMPLETED|Overall Study||371
8541734|NCT00126776|9573227|FG000|NOT COMPLETED|Overall Study||0
8541735|NCT00126776|9573228|FG001|NOT COMPLETED|Overall Study||0
8541736|NCT00120042|9573235|FG000|STARTED|Overall Study||85
8541737|NCT00120042|9573236|FG001|STARTED|Overall Study||83
8541738|NCT00120042|9573237|FG002|STARTED|Overall Study||83
8541739|NCT00120042|9573235|FG000|COMPLETED|Overall Study||85
8541740|NCT00120042|9573236|FG001|COMPLETED|Overall Study||83
8541741|NCT00120042|9573237|FG002|COMPLETED|Overall Study||83
8541742|NCT00120042|9573235|FG000|NOT COMPLETED|Overall Study||0
8541743|NCT00120042|9573236|FG001|NOT COMPLETED|Overall Study||0
8541744|NCT00120042|9573237|FG002|NOT COMPLETED|Overall Study||0
8541745|NCT00106626|9573246|FG000|STARTED|Overall Study||13
8541746|NCT00106626|9573247|FG001|STARTED|Overall Study||9
8541747|NCT00106626|9573248|FG002|STARTED|Overall Study||14
8541748|NCT00106626|9573249|FG003|STARTED|Overall Study||16
8541749|NCT00106626|9573246|FG000|COMPLETED|Overall Study||3
8541750|NCT00106626|9573247|FG001|COMPLETED|Overall Study||3
8541751|NCT00106626|9573248|FG002|COMPLETED|Overall Study||2
8541752|NCT00106626|9573249|FG003|COMPLETED|Overall Study||3
8541753|NCT00106626|9573246|FG000|NOT COMPLETED|Overall Study||10
8541754|NCT00106626|9573247|FG001|NOT COMPLETED|Overall Study||6
8541755|NCT00106626|9573248|FG002|NOT COMPLETED|Overall Study||12
8541756|NCT00106626|9573249|FG003|NOT COMPLETED|Overall Study||13
8541757|NCT00089141|9573266|FG000|STARTED|Overall Study||74
8541758|NCT00089141|9573267|FG001|STARTED|Overall Study||77
8541759|NCT00089141|9573266|FG000|COMPLETED|Overall Study||56
8541760|NCT00089141|9573267|FG001|COMPLETED|Overall Study||53
8541761|NCT00089141|9573266|FG000|NOT COMPLETED|Overall Study||18
8541762|NCT00089141|9573267|FG001|NOT COMPLETED|Overall Study||24
8541763|NCT00083759|9573273|FG000|STARTED|Overall Study|150 subjects enrolled, 137 (Modified Intention-to-Treat [MITT] Population) for efficacy analyses|150
8541764|NCT00083759|9573274|FG001|STARTED|Overall Study|149 subjects enrolled, 136 (Modified Intention-to-Treat [MITT] Population) for efficacy analyses|149
8541765|NCT00083759|9573273|FG000|COMPLETED|Overall Study||66
8541766|NCT00083759|9573274|FG001|COMPLETED|Overall Study||66
8541767|NCT00083759|9573273|FG000|NOT COMPLETED|Overall Study||84
8541768|NCT00083759|9573274|FG001|NOT COMPLETED|Overall Study||83
8541769|NCT03513068|9573280|FG000|STARTED|Overall Study||54
8541770|NCT03513068|9573281|FG001|STARTED|Overall Study||54
8541771|NCT03513068|9573280|FG000|COMPLETED|Overall Study||49
8541772|NCT03513068|9573281|FG001|COMPLETED|Overall Study||48
8541773|NCT03513068|9573280|FG000|NOT COMPLETED|Overall Study||5
8541774|NCT03513068|9573281|FG001|NOT COMPLETED|Overall Study||6
8541775|NCT03507127|9573289|FG000|STARTED|Overall Study||3
8541776|NCT03507127|9573290|FG001|STARTED|Overall Study||2
8541777|NCT03507127|9573289|FG000|COMPLETED|Overall Study||1
8541778|NCT03507127|9573290|FG001|COMPLETED|Overall Study||1
8541779|NCT03507127|9573289|FG000|NOT COMPLETED|Overall Study||2
8541780|NCT03507127|9573290|FG001|NOT COMPLETED|Overall Study||1
8541781|NCT03502811|9573296|FG000|STARTED|Overall Study||1041
8541782|NCT03502811|9573296|FG000|COMPLETED|Overall Study||722
8541783|NCT03502811|9573296|FG000|NOT COMPLETED|Overall Study||319
8541784|NCT04789382|9573304|FG000|STARTED|First Wear Period (2 Hours)||9
8541785|NCT04789382|9573305|FG001|STARTED|First Wear Period (2 Hours)||9
8541786|NCT04789382|9573306|FG002|STARTED|First Wear Period (2 Hours)||9
8541787|NCT04789382|9573307|FG003|STARTED|First Wear Period (2 Hours)||9
8541788|NCT04789382|9573304|FG000|COMPLETED|First Wear Period (2 Hours)||9
8541789|NCT04789382|9573305|FG001|COMPLETED|First Wear Period (2 Hours)||9
8541790|NCT04789382|9573306|FG002|COMPLETED|First Wear Period (2 Hours)||9
8541791|NCT04789382|9573307|FG003|COMPLETED|First Wear Period (2 Hours)||9
8541792|NCT04789382|9573304|FG000|NOT COMPLETED|First Wear Period (2 Hours)||0
8541793|NCT04789382|9573305|FG001|NOT COMPLETED|First Wear Period (2 Hours)||0
8541794|NCT04789382|9573306|FG002|NOT COMPLETED|First Wear Period (2 Hours)||0
8541795|NCT04789382|9573307|FG003|NOT COMPLETED|First Wear Period (2 Hours)||0
8541796|NCT04789382|9573304|FG000|STARTED|Washout (Day of & Day Prior to Visit 3)||9
8541797|NCT04789382|9573305|FG001|STARTED|Washout (Day of & Day Prior to Visit 3)||9
8541798|NCT04789382|9573306|FG002|STARTED|Washout (Day of & Day Prior to Visit 3)||9
8541799|NCT04789382|9573307|FG003|STARTED|Washout (Day of & Day Prior to Visit 3)||9
8541800|NCT04789382|9573304|FG000|COMPLETED|Washout (Day of & Day Prior to Visit 3)||9
8541801|NCT04789382|9573305|FG001|COMPLETED|Washout (Day of & Day Prior to Visit 3)||9
8541802|NCT04789382|9573306|FG002|COMPLETED|Washout (Day of & Day Prior to Visit 3)||9
8541803|NCT04789382|9573307|FG003|COMPLETED|Washout (Day of & Day Prior to Visit 3)||9
8541804|NCT04789382|9573304|FG000|NOT COMPLETED|Washout (Day of & Day Prior to Visit 3)||0
8541805|NCT04789382|9573305|FG001|NOT COMPLETED|Washout (Day of & Day Prior to Visit 3)||0
8541806|NCT04789382|9573306|FG002|NOT COMPLETED|Washout (Day of & Day Prior to Visit 3)||0
8541807|NCT04789382|9573307|FG003|NOT COMPLETED|Washout (Day of & Day Prior to Visit 3)||0
8541808|NCT04789382|9573304|FG000|STARTED|Second Wear Period (2 Hours)||9
8541809|NCT04789382|9573305|FG001|STARTED|Second Wear Period (2 Hours)||9
8541810|NCT04789382|9573306|FG002|STARTED|Second Wear Period (2 Hours)||9
8541811|NCT04789382|9573307|FG003|STARTED|Second Wear Period (2 Hours)||9
8541812|NCT04789382|9573304|FG000|COMPLETED|Second Wear Period (2 Hours)||9
8541813|NCT04789382|9573305|FG001|COMPLETED|Second Wear Period (2 Hours)||9
8541814|NCT04789382|9573306|FG002|COMPLETED|Second Wear Period (2 Hours)||9
8541815|NCT04789382|9573307|FG003|COMPLETED|Second Wear Period (2 Hours)||9
8541816|NCT04789382|9573304|FG000|NOT COMPLETED|Second Wear Period (2 Hours)||0
8541817|NCT04789382|9573305|FG001|NOT COMPLETED|Second Wear Period (2 Hours)||0
8541818|NCT04789382|9573306|FG002|NOT COMPLETED|Second Wear Period (2 Hours)||0
8541819|NCT04789382|9573307|FG003|NOT COMPLETED|Second Wear Period (2 Hours)||0
8541820|NCT04428333|9573321|FG000|STARTED|Overall Study||57
8541821|NCT04428333|9573322|FG001|STARTED|Overall Study||59
8541822|NCT04428333|9573321|FG000|Modified Intent-to-Treat (mITT) Population|Overall Study||52
8541823|NCT04428333|9573322|FG001|Modified Intent-to-Treat (mITT) Population|Overall Study||55
8541824|NCT04428333|9573321|FG000|Safety Population|Overall Study||50
8541825|NCT04428333|9573322|FG001|Safety Population|Overall Study||65
8541826|NCT04428333|9573321|FG000|COMPLETED|Overall Study||3
8541827|NCT04428333|9573322|FG001|COMPLETED|Overall Study||1
8541828|NCT04428333|9573321|FG000|NOT COMPLETED|Overall Study||54
8541829|NCT04428333|9573322|FG001|NOT COMPLETED|Overall Study||58
8541830|NCT03909607|9573331|FG000|STARTED|Overall Study||40
8541831|NCT03909607|9573332|FG001|STARTED|Overall Study||40
8541832|NCT03909607|9573333|FG002|STARTED|Overall Study||40
8541833|NCT03909607|9573331|FG000|COMPLETED|Overall Study||35
8541834|NCT03909607|9573332|FG001|COMPLETED|Overall Study||36
8541835|NCT03909607|9573333|FG002|COMPLETED|Overall Study||38
8541836|NCT03909607|9573331|FG000|NOT COMPLETED|Overall Study||5
8541837|NCT03909607|9573332|FG001|NOT COMPLETED|Overall Study||4
8541838|NCT03909607|9573333|FG002|NOT COMPLETED|Overall Study||2
8541839|NCT03530995|9573343|FG000|STARTED|Part 1 Period 1; Part 2 Period 1||35
8541840|NCT03530995|9573344|FG001|STARTED|Part 1 Period 1; Part 2 Period 1||38
8541841|NCT03530995|9573343|FG000|COMPLETED|Part 1 Period 1; Part 2 Period 1||35
8541842|NCT03530995|9573344|FG001|COMPLETED|Part 1 Period 1; Part 2 Period 1||38
8541843|NCT03530995|9573343|FG000|NOT COMPLETED|Part 1 Period 1; Part 2 Period 1||0
8541844|NCT03530995|9573344|FG001|NOT COMPLETED|Part 1 Period 1; Part 2 Period 1||0
8541845|NCT03530995|9573343|FG000|STARTED|Part 1 Period 2; Part 2 Period 2||35
8541846|NCT03530995|9573344|FG001|STARTED|Part 1 Period 2; Part 2 Period 2||38
8541847|NCT03530995|9573343|FG000|COMPLETED|Part 1 Period 2; Part 2 Period 2||35
8541848|NCT03530995|9573344|FG001|COMPLETED|Part 1 Period 2; Part 2 Period 2||38
8541849|NCT03530995|9573343|FG000|NOT COMPLETED|Part 1 Period 2; Part 2 Period 2||0
8541850|NCT03530995|9573344|FG001|NOT COMPLETED|Part 1 Period 2; Part 2 Period 2||0
8541851|NCT03530995|9573343|FG000|STARTED|Part 1 Period 3||35
8541852|NCT03530995|9573344|FG001|STARTED|Part 1 Period 3|Period 3 is not applicable to part 2 of the study.|0
8541853|NCT03530995|9573343|FG000|COMPLETED|Part 1 Period 3||32
8541854|NCT03530995|9573344|FG001|COMPLETED|Part 1 Period 3|Period 3 is not applicable to part 2 of the study.|0
8541855|NCT03530995|9573343|FG000|NOT COMPLETED|Part 1 Period 3||3
8541856|NCT03530995|9573344|FG001|NOT COMPLETED|Part 1 Period 3||0
8541857|NCT03530995|9573343|FG000|STARTED|Part 1 Period 4||32
8541858|NCT03530995|9573344|FG001|STARTED|Part 1 Period 4|Period 4 is not applicable to part 2 of the study.|0
8541859|NCT03530995|9573343|FG000|COMPLETED|Part 1 Period 4||30
8541860|NCT03530995|9573344|FG001|COMPLETED|Part 1 Period 4|Period 4 is not applicable to part 2 of the study.|0
8541861|NCT03530995|9573343|FG000|NOT COMPLETED|Part 1 Period 4||2
8541862|NCT03530995|9573344|FG001|NOT COMPLETED|Part 1 Period 4||0
8541863|NCT03373006|9573366|FG000|STARTED|Overall Study||20
8541864|NCT03373006|9573366|FG000|COMPLETED|Overall Study||20
8541865|NCT03373006|9573366|FG000|NOT COMPLETED|Overall Study||0
8541866|NCT03368937|9573370|FG000|STARTED|Overall Study||5
8541867|NCT03368937|9573370|FG000|COMPLETED|Overall Study||5
8541868|NCT03368937|9573370|FG000|NOT COMPLETED|Overall Study||0
8541869|NCT03204812|9573374|FG000|STARTED|Overall Study||26
8541870|NCT03204812|9573374|FG000|COMPLETED|Overall Study||23
8541871|NCT03204812|9573374|FG000|NOT COMPLETED|Overall Study||3
8541872|NCT03199391|9573378|FG000|STARTED|Overall Study||71
8541873|NCT03199391|9573378|FG000|COMPLETED|Overall Study||55
8541874|NCT03199391|9573378|FG000|NOT COMPLETED|Overall Study||16
8541875|NCT03084471|9573382|FG000|STARTED|Overall Study||867
8541876|NCT03084471|9573382|FG000|COMPLETED|Overall Study||0
8541877|NCT03084471|9573382|FG000|NOT COMPLETED|Overall Study||867
8541878|NCT03072459|9573389|FG000|STARTED|Overall Study||128
8541879|NCT03072459|9573389|FG000|COMPLETED|Overall Study||126
8541880|NCT03072459|9573389|FG000|NOT COMPLETED|Overall Study||2
8541881|NCT03029234|9573393|FG000|STARTED|Overall Study||126
8541882|NCT03029234|9573393|FG000|Received Carfilzomib|Overall Study||123
8541883|NCT03029234|9573393|FG000|COMPLETED|Overall Study||27
8541884|NCT03029234|9573393|FG000|NOT COMPLETED|Overall Study||99
8541885|NCT03019406|9573401|FG000|STARTED|PAP: up to 25 Weeks||6
8541886|NCT03019406|9573402|FG001|STARTED|PAP: up to 25 Weeks||5
8541887|NCT03019406|9573403|FG002|STARTED|PAP: up to 25 Weeks||5
8541888|NCT03019406|9573404|FG003|STARTED|PAP: up to 25 Weeks||6
8541889|NCT03019406|9573401|FG000|Treated|PAP: up to 25 Weeks||6
8541890|NCT03019406|9573402|FG001|Treated|PAP: up to 25 Weeks||5
8541891|NCT03019406|9573403|FG002|Treated|PAP: up to 25 Weeks||5
8541892|NCT03019406|9573404|FG003|Treated|PAP: up to 25 Weeks||6
8541893|NCT03019406|9573401|FG000|COMPLETED|PAP: up to 25 Weeks||6
8541894|NCT03019406|9573402|FG001|COMPLETED|PAP: up to 25 Weeks||5
8541895|NCT03019406|9573403|FG002|COMPLETED|PAP: up to 25 Weeks||5
8541896|NCT03019406|9573404|FG003|COMPLETED|PAP: up to 25 Weeks||6
8541897|NCT03019406|9573401|FG000|NOT COMPLETED|PAP: up to 25 Weeks||0
8541898|NCT03019406|9573402|FG001|NOT COMPLETED|PAP: up to 25 Weeks||0
8541899|NCT03019406|9573403|FG002|NOT COMPLETED|PAP: up to 25 Weeks||0
8541900|NCT03019406|9573404|FG003|NOT COMPLETED|PAP: up to 25 Weeks||0
8541901|NCT03019406|9573401|FG000|STARTED|ETP: Ongoing From Week 26||6
8541902|NCT03019406|9573402|FG001|STARTED|ETP: Ongoing From Week 26||5
8541903|NCT03019406|9573403|FG002|STARTED|ETP: Ongoing From Week 26||5
8541904|NCT03019406|9573404|FG003|STARTED|ETP: Ongoing From Week 26|Participants who completed PAP and accepted to receive avalglucosidase alfa treatment in ETP.|3
8541905|NCT03019406|9573401|FG000|COMPLETED|ETP: Ongoing From Week 26||0
8541906|NCT03019406|9573402|FG001|COMPLETED|ETP: Ongoing From Week 26||0
8541907|NCT03019406|9573403|FG002|COMPLETED|ETP: Ongoing From Week 26||0
8541908|NCT03019406|9573404|FG003|COMPLETED|ETP: Ongoing From Week 26||0
8541909|NCT03019406|9573401|FG000|NOT COMPLETED|ETP: Ongoing From Week 26||6
8541910|NCT03019406|9573402|FG001|NOT COMPLETED|ETP: Ongoing From Week 26||5
8541911|NCT03019406|9573403|FG002|NOT COMPLETED|ETP: Ongoing From Week 26||5
8541912|NCT03019406|9573404|FG003|NOT COMPLETED|ETP: Ongoing From Week 26||3
8541913|NCT02874144|9573419|FG000|STARTED|Overall Study||22
8541914|NCT02874144|9573420|FG001|STARTED|Overall Study||21
8541915|NCT02874144|9573419|FG000|COMPLETED|Overall Study||19
8541916|NCT02874144|9573420|FG001|COMPLETED|Overall Study||16
8541917|NCT02874144|9573419|FG000|NOT COMPLETED|Overall Study||3
8541918|NCT02874144|9573420|FG001|NOT COMPLETED|Overall Study||5
8541919|NCT02652949|9573426|FG000|STARTED|30-Day Follow-up for Primary Endpoint|The 30-day primary endpoint was evaluated when 87 subjects completed 30-day follow-up.|87
8541920|NCT02652949|9573426|FG000|COMPLETED|30-Day Follow-up for Primary Endpoint||86
8541921|NCT02652949|9573426|FG000|NOT COMPLETED|30-Day Follow-up for Primary Endpoint||1
8541922|NCT02652949|9573426|FG000|STARTED|30-Day Follow-up for Secondary Endpoint|The 30-day secondary endpoint was evaluated when 100 subjects completed 30-day follow-up.|100
8541923|NCT02652949|9573426|FG000|COMPLETED|30-Day Follow-up for Secondary Endpoint||99
8541924|NCT02652949|9573426|FG000|NOT COMPLETED|30-Day Follow-up for Secondary Endpoint||1
8541925|NCT02652949|9573426|FG000|STARTED|6-Month Follow-up Secondary Endpoint|Note that 6-month follow up is not mandatory for OUS subjects.|99
8541926|NCT02652949|9573426|FG000|COMPLETED|6-Month Follow-up Secondary Endpoint||91
8541927|NCT02652949|9573426|FG000|NOT COMPLETED|6-Month Follow-up Secondary Endpoint||8
8541928|NCT02652949|9573426|FG000|STARTED|12-Month Follow-up Secondary Endpoint||91
8541929|NCT02652949|9573426|FG000|COMPLETED|12-Month Follow-up Secondary Endpoint||87
8541930|NCT02652949|9573426|FG000|NOT COMPLETED|12-Month Follow-up Secondary Endpoint||4
8541931|NCT02652949|9573426|FG000|STARTED|24-Month Follow-up Secondary Endpoint||87
8541932|NCT02652949|9573426|FG000|COMPLETED|24-Month Follow-up Secondary Endpoint||53
8541933|NCT02652949|9573426|FG000|NOT COMPLETED|24-Month Follow-up Secondary Endpoint||34
8541934|NCT02652949|9573426|FG000|STARTED|36-Month Follow-up Secondary Endpoint||53
8541935|NCT02652949|9573426|FG000|COMPLETED|36-Month Follow-up Secondary Endpoint||49
8541936|NCT02652949|9573426|FG000|NOT COMPLETED|36-Month Follow-up Secondary Endpoint||4
8541937|NCT02625324|9573436|FG000|STARTED|30-Day Follow-up for Primary Endpoint|The 30-day primary endpoint was evaluated when 87 subjects completed 30-day follow-up.|87
8541938|NCT02625324|9573436|FG000|COMPLETED|30-Day Follow-up for Primary Endpoint||86
8541939|NCT02625324|9573436|FG000|NOT COMPLETED|30-Day Follow-up for Primary Endpoint||1
8541940|NCT02625324|9573436|FG000|STARTED|30-Day Follow-up for Secondary Endpoint|The 30-day secondary endpoint was evaluated when 100 subjects completed 30-day follow-up.|100
8541941|NCT02625324|9573436|FG000|COMPLETED|30-Day Follow-up for Secondary Endpoint||99
8541942|NCT02625324|9573436|FG000|NOT COMPLETED|30-Day Follow-up for Secondary Endpoint||1
8541943|NCT02625324|9573436|FG000|STARTED|6-Month Follow-up Subject Accountability|Note that 6-month follow up is not mandatory for OUS subjects|99
8541944|NCT02625324|9573436|FG000|COMPLETED|6-Month Follow-up Subject Accountability||91
8541945|NCT02625324|9573436|FG000|NOT COMPLETED|6-Month Follow-up Subject Accountability||8
8541946|NCT02625324|9573436|FG000|STARTED|12-Month Follow-up Secondary Endpoint||91
8541947|NCT02625324|9573436|FG000|COMPLETED|12-Month Follow-up Secondary Endpoint||87
8541948|NCT02625324|9573436|FG000|NOT COMPLETED|12-Month Follow-up Secondary Endpoint||4
8541949|NCT02625324|9573436|FG000|STARTED|24-Month Follow-up Secondary Endpoint||87
8541950|NCT02625324|9573436|FG000|COMPLETED|24-Month Follow-up Secondary Endpoint||53
8541951|NCT02625324|9573436|FG000|NOT COMPLETED|24-Month Follow-up Secondary Endpoint||34
8541952|NCT02625324|9573436|FG000|STARTED|36-Month Follow-up Secondary Endpoint||53
8541953|NCT02625324|9573436|FG000|COMPLETED|36-Month Follow-up Secondary Endpoint||49
8566275|NCT00075270|9598374|FG000|STARTED|Overall Study||291
8541954|NCT02625324|9573436|FG000|NOT COMPLETED|36-Month Follow-up Secondary Endpoint||4
8541955|NCT02611830|9573451|FG000|STARTED|OL Induction Phase||383
8541956|NCT02611830|9573452|FG001|STARTED|OL Induction Phase||0
8541957|NCT02611830|9573453|FG002|STARTED|OL Induction Phase||0
8541958|NCT02611830|9573454|FG003|STARTED|OL Induction Phase||0
8541959|NCT02611830|9573451|FG000|COMPLETED|OL Induction Phase||353
8541960|NCT02611830|9573452|FG001|COMPLETED|OL Induction Phase||0
8541961|NCT02611830|9573453|FG002|COMPLETED|OL Induction Phase||0
8541962|NCT02611830|9573454|FG003|COMPLETED|OL Induction Phase||0
8541963|NCT02611830|9573451|FG000|NOT COMPLETED|OL Induction Phase||30
8541964|NCT02611830|9573452|FG001|NOT COMPLETED|OL Induction Phase||0
8541965|NCT02611830|9573453|FG002|NOT COMPLETED|OL Induction Phase||0
8541966|NCT02611830|9573454|FG003|NOT COMPLETED|OL Induction Phase||0
8541967|NCT02611830|9573451|FG000|STARTED|Maintenance Phase||0
8541968|NCT02611830|9573452|FG001|STARTED|Maintenance Phase||56
8541969|NCT02611830|9573453|FG002|STARTED|Maintenance Phase||106
8541970|NCT02611830|9573454|FG003|STARTED|Maintenance Phase||54
8541971|NCT02611830|9573451|FG000|COMPLETED|Maintenance Phase||0
8541972|NCT02611830|9573452|FG001|COMPLETED|Maintenance Phase||20
8541973|NCT02611830|9573453|FG002|COMPLETED|Maintenance Phase||75
8541974|NCT02611830|9573454|FG003|COMPLETED|Maintenance Phase||39
8541975|NCT02611830|9573451|FG000|NOT COMPLETED|Maintenance Phase||0
8541976|NCT02611830|9573452|FG001|NOT COMPLETED|Maintenance Phase||36
8541977|NCT02611830|9573453|FG002|NOT COMPLETED|Maintenance Phase||31
8541978|NCT02611830|9573454|FG003|NOT COMPLETED|Maintenance Phase||15
8541979|NCT02611817|9573466|FG000|STARTED|Open-label Induction Phase||644
8541980|NCT02611817|9573467|FG001|STARTED|Open-label Induction Phase||0
8541981|NCT02611817|9573468|FG002|STARTED|Open-label Induction Phase||0
8541982|NCT02611817|9573466|FG000|COMPLETED|Open-label Induction Phase||594
8541983|NCT02611817|9573467|FG001|COMPLETED|Open-label Induction Phase||0
8541984|NCT02611817|9573468|FG002|COMPLETED|Open-label Induction Phase||0
8541985|NCT02611817|9573466|FG000|NOT COMPLETED|Open-label Induction Phase||50
8541986|NCT02611817|9573467|FG001|NOT COMPLETED|Open-label Induction Phase||0
8541987|NCT02611817|9573468|FG002|NOT COMPLETED|Open-label Induction Phase||0
8541988|NCT02611817|9573466|FG000|STARTED|Double-blind Maintenance Phase||0
8541989|NCT02611817|9573467|FG001|STARTED|Double-blind Maintenance Phase||135
8541990|NCT02611817|9573468|FG002|STARTED|Double-blind Maintenance Phase||275
8541991|NCT02611817|9573466|FG000|COMPLETED|Double-blind Maintenance Phase||0
8541992|NCT02611817|9573467|FG001|COMPLETED|Double-blind Maintenance Phase||73
8541993|NCT02611817|9573468|FG002|COMPLETED|Double-blind Maintenance Phase||168
8541994|NCT02611817|9573466|FG000|NOT COMPLETED|Double-blind Maintenance Phase||0
8541995|NCT02611817|9573467|FG001|NOT COMPLETED|Double-blind Maintenance Phase||62
8541996|NCT02611817|9573468|FG002|NOT COMPLETED|Double-blind Maintenance Phase||107
8541997|NCT02557139|9573478|FG000|STARTED|Overall Study||8
8541998|NCT02557139|9573479|FG001|STARTED|Overall Study||8
8541999|NCT02557139|9573480|FG002|STARTED|Overall Study||7
8542000|NCT02557139|9573478|FG000|COMPLETED|Overall Study||6
8542001|NCT02557139|9573479|FG001|COMPLETED|Overall Study||8
8542002|NCT02557139|9573480|FG002|COMPLETED|Overall Study||5
8542003|NCT02557139|9573478|FG000|NOT COMPLETED|Overall Study||2
8542004|NCT02557139|9573479|FG001|NOT COMPLETED|Overall Study||0
8542005|NCT02557139|9573480|FG002|NOT COMPLETED|Overall Study||2
8542006|NCT02488759|9573503|FG000|STARTED|Overall Study||113
8542007|NCT02488759|9573504|FG001|STARTED|Overall Study||195
8542008|NCT02488759|9573505|FG002|STARTED|Overall Study||133
8542009|NCT02488759|9573506|FG003|STARTED|Overall Study||8
8542010|NCT02488759|9573507|FG004|STARTED|Overall Study||6
8542011|NCT02488759|9573508|FG005|STARTED|Overall Study||123
8542012|NCT02488759|9573503|FG000|COMPLETED|Overall Study||2
8542013|NCT02488759|9573504|FG001|COMPLETED|Overall Study||0
8542014|NCT02488759|9573505|FG002|COMPLETED|Overall Study||2
8542015|NCT02488759|9573506|FG003|COMPLETED|Overall Study||0
8542016|NCT02488759|9573507|FG004|COMPLETED|Overall Study||0
8542017|NCT02488759|9573508|FG005|COMPLETED|Overall Study||0
8542018|NCT02488759|9573503|FG000|NOT COMPLETED|Overall Study||111
8542019|NCT02488759|9573504|FG001|NOT COMPLETED|Overall Study||195
8542020|NCT02488759|9573505|FG002|NOT COMPLETED|Overall Study||131
8542021|NCT02488759|9573506|FG003|NOT COMPLETED|Overall Study||8
8542022|NCT02488759|9573507|FG004|NOT COMPLETED|Overall Study||6
8542023|NCT02488759|9573508|FG005|NOT COMPLETED|Overall Study||123
8542024|NCT02211131|9573524|FG000|STARTED|Overall Study||74
8542025|NCT02211131|9573525|FG001|STARTED|Overall Study||76
8542026|NCT02211131|9573524|FG000|COMPLETED|Overall Study||0
8542027|NCT02211131|9573525|FG001|COMPLETED|Overall Study||0
8542028|NCT02211131|9573524|FG000|NOT COMPLETED|Overall Study||74
8542029|NCT02211131|9573525|FG001|NOT COMPLETED|Overall Study||76
8542030|NCT02186847|9573540|FG000|STARTED|Overall Study||84
8542031|NCT02186847|9573541|FG001|STARTED|Overall Study||86
8542032|NCT02186847|9573540|FG000|Eligible Population|Overall Study||81
8542033|NCT02186847|9573541|FG001|Eligible Population|Overall Study||86
8542034|NCT02186847|9573540|FG000|Eligible and Started Protocol Treatment|Overall Study||76
8542035|NCT02186847|9573541|FG001|Eligible and Started Protocol Treatment|Overall Study||82
8542036|NCT02186847|9573540|FG000|COMPLETED|Overall Study||81
8542037|NCT02186847|9573541|FG001|COMPLETED|Overall Study||86
8542038|NCT02186847|9573540|FG000|NOT COMPLETED|Overall Study||3
8542039|NCT02186847|9573541|FG001|NOT COMPLETED|Overall Study||0
8542040|NCT02101034|9573552|FG000|STARTED|Overall Study||3
8542041|NCT02101034|9573553|FG001|STARTED|Overall Study||6
8542042|NCT02101034|9573554|FG002|STARTED|Overall Study||31
8542043|NCT02101034|9573555|FG003|STARTED|Overall Study||32
8542044|NCT02101034|9573556|FG004|STARTED|Overall Study||24
8542045|NCT02101034|9573552|FG000|COMPLETED|Overall Study||3
8542046|NCT02101034|9573553|FG001|COMPLETED|Overall Study||6
8542047|NCT02101034|9573554|FG002|COMPLETED|Overall Study||30
8542048|NCT02101034|9573555|FG003|COMPLETED|Overall Study||32
8542049|NCT02101034|9573556|FG004|COMPLETED|Overall Study||24
8542050|NCT02101034|9573552|FG000|NOT COMPLETED|Overall Study||0
8542051|NCT02101034|9573553|FG001|NOT COMPLETED|Overall Study||0
8542052|NCT02101034|9573554|FG002|NOT COMPLETED|Overall Study||1
8542053|NCT02101034|9573555|FG003|NOT COMPLETED|Overall Study||0
8542054|NCT02101034|9573556|FG004|NOT COMPLETED|Overall Study||0
8542055|NCT02041533|9573576|FG000|STARTED|Overall Study||271
8542056|NCT02041533|9573577|FG001|STARTED|Overall Study||270
8542057|NCT02041533|9573576|FG000|Began Treatment|Overall Study||267
8542058|NCT02041533|9573577|FG001|Began Treatment|Overall Study||263
8542059|NCT02041533|9573576|FG000|COMPLETED|Overall Study|Completed = Participants continuing in the treatment period|43
8542060|NCT02041533|9573577|FG001|COMPLETED|Overall Study|Completed = Participants continuing in the treatment period|12
8542061|NCT02041533|9573576|FG000|NOT COMPLETED|Overall Study||228
8542062|NCT02041533|9573577|FG001|NOT COMPLETED|Overall Study||258
8542063|NCT01865617|9573596|FG000|STARTED|Overall Study||39
8542064|NCT01865617|9573597|FG001|STARTED|Overall Study||5
8542065|NCT01865617|9573598|FG002|STARTED|Overall Study||2
8542066|NCT01865617|9573599|FG003|STARTED|Overall Study||1
8542067|NCT01865617|9573600|FG004|STARTED|Overall Study||18
8621227|NCT00478361|9660121|FG000|COMPLETED|Overall Study||39
8621228|NCT00478361|9660121|FG000|NOT COMPLETED|Overall Study||0
8621229|NCT00478426|9660125|FG000|STARTED|Overall Study||34
8542068|NCT01865617|9573601|FG005|STARTED|Overall Study||5
8542069|NCT01865617|9573602|FG006|STARTED|Overall Study||22
8542070|NCT01865617|9573603|FG007|STARTED|Overall Study||1
8542071|NCT01865617|9573604|FG008|STARTED|Overall Study||20
8542072|NCT01865617|9573605|FG009|STARTED|Overall Study||5
8542073|NCT01865617|9573606|FG010|STARTED|Overall Study||49
8542074|NCT01865617|9573607|FG011|STARTED|Overall Study||10
8542075|NCT01865617|9573608|FG012|STARTED|Overall Study||20
8542076|NCT01865617|9573596|FG000|COMPLETED|Overall Study||9
8542077|NCT01865617|9573597|FG001|COMPLETED|Overall Study||2
8542078|NCT01865617|9573598|FG002|COMPLETED|Overall Study||1
8542079|NCT01865617|9573599|FG003|COMPLETED|Overall Study||0
8542080|NCT01865617|9573600|FG004|COMPLETED|Overall Study||11
8542081|NCT01865617|9573601|FG005|COMPLETED|Overall Study||4
8542082|NCT01865617|9573602|FG006|COMPLETED|Overall Study||10
8542083|NCT01865617|9573603|FG007|COMPLETED|Overall Study||0
8542084|NCT01865617|9573604|FG008|COMPLETED|Overall Study||9
8542085|NCT01865617|9573605|FG009|COMPLETED|Overall Study||2
8542086|NCT01865617|9573606|FG010|COMPLETED|Overall Study||17
8542087|NCT01865617|9573607|FG011|COMPLETED|Overall Study||4
8542088|NCT01865617|9573608|FG012|COMPLETED|Overall Study||7
8542089|NCT01865617|9573596|FG000|NOT COMPLETED|Overall Study||30
8621230|NCT00478426|9660125|FG000|COMPLETED|Overall Study||33
8621231|NCT00478426|9660125|FG000|NOT COMPLETED|Overall Study||1
8621232|NCT00478556|9660131|FG000|STARTED|Overall Study||151
8621233|NCT00478556|9660132|FG001|STARTED|Overall Study||149
8621234|NCT00478556|9660131|FG000|COMPLETED|Overall Study||151
8542090|NCT01865617|9573597|FG001|NOT COMPLETED|Overall Study||3
8542091|NCT01865617|9573598|FG002|NOT COMPLETED|Overall Study||1
8542092|NCT01865617|9573599|FG003|NOT COMPLETED|Overall Study||1
8542093|NCT01865617|9573600|FG004|NOT COMPLETED|Overall Study||7
8542094|NCT01865617|9573601|FG005|NOT COMPLETED|Overall Study||1
8542095|NCT01865617|9573602|FG006|NOT COMPLETED|Overall Study||12
8542096|NCT01865617|9573603|FG007|NOT COMPLETED|Overall Study||1
8542097|NCT01865617|9573604|FG008|NOT COMPLETED|Overall Study||11
8542098|NCT01865617|9573605|FG009|NOT COMPLETED|Overall Study||3
8542099|NCT01865617|9573606|FG010|NOT COMPLETED|Overall Study||32
8542100|NCT01865617|9573607|FG011|NOT COMPLETED|Overall Study||6
8542101|NCT01865617|9573608|FG012|NOT COMPLETED|Overall Study||13
8542102|NCT01828112|9573641|FG000|STARTED|Overall Study||115
8542103|NCT01828112|9573642|FG001|STARTED|Overall Study||116
8542104|NCT01828112|9573641|FG000|Entered Extension Treatment Phase|Overall Study||0
8542105|NCT01828112|9573642|FG001|Entered Extension Treatment Phase|Overall Study||74
8542106|NCT01828112|9573641|FG000|Entered Post-treatment Follow-up Phase|Overall Study||7
8621235|NCT00478556|9660132|FG001|COMPLETED|Overall Study||149
8621236|NCT00478556|9660131|FG000|NOT COMPLETED|Overall Study||0
8542107|NCT01828112|9573642|FG001|Entered Post-treatment Follow-up Phase|Overall Study||5
8542108|NCT01828112|9573641|FG000|Entered Survival Follow-up Phase|Overall Study||61
8542109|NCT01828112|9573642|FG001|Entered Survival Follow-up Phase|Overall Study||19
8542110|NCT01828112|9573641|FG000|Discontinued From Study|Overall Study||14
8542111|NCT01828112|9573642|FG001|Discontinued From Study|Overall Study||10
8542112|NCT01828112|9573641|FG000|Untreated Patients|Overall Study||0
8542113|NCT01828112|9573642|FG001|Untreated Patients|Overall Study|untreated = did not receive study drug|3
8542114|NCT01828112|9573641|FG000|Untreated|Overall Study||0
8542115|NCT01828112|9573642|FG001|Untreated|Overall Study||3
8542116|NCT01828112|9573641|FG000|Treated|Overall Study||115
8542117|NCT01828112|9573642|FG001|Treated|Overall Study||113
8542118|NCT01828112|9573641|FG000|COMPLETED|Overall Study|Completed = Ongoing at time of data cut-off of 26-Jan-2016|33
8542119|NCT01828112|9573642|FG001|COMPLETED|Overall Study|Completed = Ongoing at time of data cut-off of 26-Jan-2016|8
8542120|NCT01828112|9573641|FG000|NOT COMPLETED|Overall Study||82
8542121|NCT01828112|9573642|FG001|NOT COMPLETED|Overall Study||108
8542122|NCT01733888|9573652|FG000|STARTED|Overall Study||20
8542123|NCT01733888|9573653|FG001|STARTED|Overall Study||20
8542124|NCT01733888|9573654|FG002|STARTED|Overall Study||20
8542125|NCT01733888|9573655|FG003|STARTED|Overall Study||20
8542126|NCT01733888|9573652|FG000|COMPLETED|Overall Study||20
8542127|NCT01733888|9573653|FG001|COMPLETED|Overall Study||20
8542128|NCT01733888|9573654|FG002|COMPLETED|Overall Study||20
8542129|NCT01733888|9573655|FG003|COMPLETED|Overall Study||20
8542130|NCT01733888|9573652|FG000|NOT COMPLETED|Overall Study||0
8542131|NCT01733888|9573653|FG001|NOT COMPLETED|Overall Study||0
8542132|NCT01733888|9573654|FG002|NOT COMPLETED|Overall Study||0
8542133|NCT01733888|9573655|FG003|NOT COMPLETED|Overall Study||0
8542134|NCT01709981|9573667|FG000|STARTED|Overall Study||141
8542135|NCT01709981|9573668|FG001|STARTED|Overall Study||139
8542136|NCT01709981|9573667|FG000|COMPLETED|Overall Study||141
8542137|NCT01709981|9573668|FG001|COMPLETED|Overall Study||139
8542138|NCT01709981|9573667|FG000|NOT COMPLETED|Overall Study||0
8542139|NCT01709981|9573668|FG001|NOT COMPLETED|Overall Study||0
8542140|NCT01670500|9573676|FG000|STARTED|Overall Study||58
8542141|NCT01670500|9573677|FG001|STARTED|Overall Study||60
8542142|NCT01670500|9573676|FG000|COMPLETED|Overall Study|1 patient withdrew after 3 cycles; 5 patients received additional non-protocol chemo before surgery|57
8542143|NCT01670500|9573677|FG001|COMPLETED|Overall Study|4 pts received <4 cycles of assigned chemo; 2 pts received add'l non-protocol chemo before surgery|60
8542144|NCT01670500|9573676|FG000|NOT COMPLETED|Overall Study||1
8542145|NCT01670500|9573677|FG001|NOT COMPLETED|Overall Study||0
8542146|NCT01593254|9573685|FG000|STARTED|Treatment Period||86
8542147|NCT01593254|9573686|FG001|STARTED|Treatment Period||174
8542148|NCT01593254|9573685|FG000|Crossed Over to Dasatinib|Treatment Period||42
8542149|NCT01593254|9573686|FG001|Crossed Over to Dasatinib|Treatment Period||0
8542150|NCT01593254|9573685|FG000|COMPLETED|Treatment Period||72
8542151|NCT01593254|9573686|FG001|COMPLETED|Treatment Period||143
8542152|NCT01593254|9573685|FG000|NOT COMPLETED|Treatment Period||14
8542153|NCT01593254|9573686|FG001|NOT COMPLETED|Treatment Period||31
8542154|NCT01593254|9573685|FG000|STARTED|Follow-Up Period||14
8542155|NCT01593254|9573686|FG001|STARTED|Follow-Up Period||28
8542156|NCT01593254|9573685|FG000|COMPLETED|Follow-Up Period||11
8542157|NCT01593254|9573686|FG001|COMPLETED|Follow-Up Period||17
8542158|NCT01593254|9573685|FG000|NOT COMPLETED|Follow-Up Period||3
8542159|NCT01593254|9573686|FG001|NOT COMPLETED|Follow-Up Period||11
8542160|NCT01453101|9573693|FG000|STARTED|Overall Study||54
8542161|NCT01453101|9573693|FG000|COMPLETED|Overall Study||54
8542162|NCT01453101|9573693|FG000|NOT COMPLETED|Overall Study||0
8566276|NCT00075270|9598375|FG001|STARTED|Overall Study||288
8566277|NCT00075270|9598374|FG000|Missing|Overall Study|These participants have no completion status information recorded on the case report forms.|26
8566278|NCT00075270|9598375|FG001|Missing|Overall Study|These participants have no completion status information recorded on the case report forms.|13
8566279|NCT00075270|9598374|FG000|COMPLETED|Overall Study||5
8566280|NCT00075270|9598375|FG001|COMPLETED|Overall Study||4
8566281|NCT00075270|9598374|FG000|NOT COMPLETED|Overall Study||286
8566282|NCT00075270|9598375|FG001|NOT COMPLETED|Overall Study||284
8566283|NCT00075335|9598382|FG000|STARTED|Overall Study||8
8566284|NCT00075335|9598382|FG000|COMPLETED|Overall Study||8
8566285|NCT00075335|9598382|FG000|NOT COMPLETED|Overall Study||0
8566286|NCT00075400|9598386|FG000|STARTED|Overall Study||26
8566287|NCT00075400|9598386|FG000|COMPLETED|Overall Study|Eligible and treated patients.|23
8566288|NCT00075400|9598386|FG000|NOT COMPLETED|Overall Study||3
8566289|NCT00075478|9598397|FG000|STARTED|Overall Study||42
8566290|NCT00075478|9598398|FG001|STARTED|Overall Study||45
8566291|NCT00075478|9598397|FG000|COMPLETED|Overall Study||41
8566292|NCT00075478|9598398|FG001|COMPLETED|Overall Study||44
8566293|NCT00075478|9598397|FG000|NOT COMPLETED|Overall Study||1
8566294|NCT00075478|9598398|FG001|NOT COMPLETED|Overall Study||1
8566295|NCT00075504|9598406|FG000|STARTED|Overall Study||23
8566296|NCT00075504|9598407|FG001|STARTED|Overall Study||10
8566297|NCT00075504|9598406|FG000|COMPLETED|Overall Study||14
8566298|NCT00075504|9598407|FG001|COMPLETED|Overall Study||3
8566299|NCT00075504|9598406|FG000|NOT COMPLETED|Overall Study||9
8566300|NCT00075504|9598407|FG001|NOT COMPLETED|Overall Study||7
8566301|NCT00075582|9598415|FG000|STARTED|Overall Study||305
8566302|NCT00075582|9598416|FG001|STARTED|Overall Study||85
8566303|NCT00075582|9598415|FG000|COMPLETED|Overall Study||255
8566304|NCT00075582|9598416|FG001|COMPLETED|Overall Study||50
8566305|NCT00075582|9598415|FG000|NOT COMPLETED|Overall Study||50
8566306|NCT00075582|9598416|FG001|NOT COMPLETED|Overall Study||35
8566307|NCT00075725|9598438|FG000|STARTED|Overall Study||246
8566308|NCT00075725|9598439|FG001|STARTED|Overall Study||106
8566309|NCT00075725|9598440|FG002|STARTED|Overall Study||296
8566310|NCT00075725|9598441|FG003|STARTED|Overall Study||246
8566311|NCT00075725|9598442|FG004|STARTED|Overall Study||232
8566312|NCT00075725|9598443|FG005|STARTED|Overall Study||710
8566313|NCT00075725|9598444|FG006|STARTED|Overall Study||246
8566314|NCT00075725|9598445|FG007|STARTED|Overall Study||696
8566315|NCT00075725|9598446|FG008|STARTED|Overall Study||302
8566316|NCT00075725|9598447|FG009|STARTED|Overall Study||34
8566317|NCT00075725|9598448|FG010|STARTED|Overall Study||12
8566318|NCT00075725|9598449|FG011|STARTED|Overall Study||28
8566319|NCT00075725|9598438|FG000|COMPLETED|Overall Study||172
8566320|NCT00075725|9598439|FG001|COMPLETED|Overall Study||57
8542163|NCT04604184|9573699|FG000|STARTED|Overall Study||67
8542164|NCT04604184|9573700|FG001|STARTED|Overall Study||66
8542165|NCT04604184|9573699|FG000|Treated|Overall Study||65
8542166|NCT04604184|9573700|FG001|Treated|Overall Study||64
8542167|NCT04604184|9573699|FG000|COMPLETED|Overall Study||47
8542168|NCT04604184|9573700|FG001|COMPLETED|Overall Study||47
8542169|NCT04604184|9573699|FG000|NOT COMPLETED|Overall Study||20
8542170|NCT04604184|9573700|FG001|NOT COMPLETED|Overall Study||19
8542171|NCT04368429|9573708|FG000|STARTED|Overall Study||180
8542172|NCT04368429|9573709|FG001|STARTED|Overall Study||180
8542173|NCT04368429|9573708|FG000|Safety Analysis Set|Overall Study||179
8542174|NCT04368429|9573709|FG001|Safety Analysis Set|Overall Study||180
8542175|NCT04368429|9573708|FG000|COMPLETED|Overall Study||179
8542176|NCT04368429|9573709|FG001|COMPLETED|Overall Study||180
8542177|NCT04368429|9573708|FG000|NOT COMPLETED|Overall Study||1
8542178|NCT04368429|9573709|FG001|NOT COMPLETED|Overall Study||0
8542179|NCT04267276|9573715|FG000|STARTED|Overall Study||7
8542180|NCT04267276|9573715|FG000|Treated|Overall Study||7
8542181|NCT04267276|9573715|FG000|COMPLETED|Overall Study||7
8542182|NCT04267276|9573715|FG000|NOT COMPLETED|Overall Study||0
8542183|NCT04266158|9573719|FG000|STARTED|Overall Study||0
8542184|NCT04266158|9573719|FG000|COMPLETED|Overall Study||0
8542185|NCT04266158|9573719|FG000|NOT COMPLETED|Overall Study||0
8542186|NCT04155840|9573723|FG000|STARTED|Overall Study||1
8542187|NCT04155840|9573723|FG000|COMPLETED|Overall Study||1
8542188|NCT04155840|9573723|FG000|NOT COMPLETED|Overall Study||0
8542189|NCT03865316|9573727|FG000|STARTED|Overall Study||108
8542190|NCT03865316|9573727|FG000|COMPLETED|Overall Study||100
8542191|NCT03865316|9573727|FG000|NOT COMPLETED|Overall Study||8
8542192|NCT03688555|9573733|FG000|STARTED|Run-in Period||10
8542193|NCT03688555|9573734|FG001|STARTED|Run-in Period||0
8542194|NCT03688555|9573735|FG002|STARTED|Run-in Period||0
8542195|NCT03688555|9573733|FG000|COMPLETED|Run-in Period||10
8542196|NCT03688555|9573734|FG001|COMPLETED|Run-in Period||0
8542197|NCT03688555|9573735|FG002|COMPLETED|Run-in Period||0
8542198|NCT03688555|9573733|FG000|NOT COMPLETED|Run-in Period||0
8542199|NCT03688555|9573734|FG001|NOT COMPLETED|Run-in Period||0
8542200|NCT03688555|9573735|FG002|NOT COMPLETED|Run-in Period||0
8542201|NCT03688555|9573733|FG000|STARTED|Treatment Period|All 10 participants that completed the run-in period were eligible to be randomized to ACT-774312 or placebo.|0
8542202|NCT03688555|9573734|FG001|STARTED|Treatment Period||7
8542203|NCT03688555|9573735|FG002|STARTED|Treatment Period||3
8542204|NCT03688555|9573733|FG000|COMPLETED|Treatment Period||0
8542205|NCT03688555|9573734|FG001|COMPLETED|Treatment Period||7
8542206|NCT03688555|9573735|FG002|COMPLETED|Treatment Period||2
8542207|NCT03688555|9573733|FG000|NOT COMPLETED|Treatment Period||0
8542208|NCT03688555|9573734|FG001|NOT COMPLETED|Treatment Period||0
8542209|NCT03688555|9573735|FG002|NOT COMPLETED|Treatment Period||1
8542210|NCT03593213|9573745|FG000|STARTED|Open-label Treatment Period (18 Weeks)|Out of 162 participants who completed Open-label Treatment Period, 159 participants were randomized to Double-blind treatment Period.|587
8542211|NCT03593213|9573746|FG001|STARTED|Open-label Treatment Period (18 Weeks)||0
8542212|NCT03593213|9573747|FG002|STARTED|Open-label Treatment Period (18 Weeks)||0
8542213|NCT03593213|9573748|FG003|STARTED|Open-label Treatment Period (18 Weeks)||0
8542214|NCT03593213|9573745|FG000|COMPLETED|Open-label Treatment Period (18 Weeks)||162
8621237|NCT00478556|9660132|FG001|NOT COMPLETED|Overall Study||0
8621238|NCT00478569|9660138|FG000|STARTED|Overall Study||1170
8621239|NCT00478569|9660138|FG000|COMPLETED|Overall Study||761
8621240|NCT00478569|9660138|FG000|NOT COMPLETED|Overall Study||409
8542215|NCT03593213|9573746|FG001|COMPLETED|Open-label Treatment Period (18 Weeks)||0
8542216|NCT03593213|9573747|FG002|COMPLETED|Open-label Treatment Period (18 Weeks)||0
8542217|NCT03593213|9573748|FG003|COMPLETED|Open-label Treatment Period (18 Weeks)||0
8542218|NCT03593213|9573745|FG000|NOT COMPLETED|Open-label Treatment Period (18 Weeks)||425
8542219|NCT03593213|9573746|FG001|NOT COMPLETED|Open-label Treatment Period (18 Weeks)||0
8542220|NCT03593213|9573747|FG002|NOT COMPLETED|Open-label Treatment Period (18 Weeks)||0
8542221|NCT03593213|9573748|FG003|NOT COMPLETED|Open-label Treatment Period (18 Weeks)||0
8542222|NCT03593213|9573745|FG000|STARTED|Double-blind Treatment Period (26 Weeks)||0
8542223|NCT03593213|9573746|FG001|STARTED|Double-blind Treatment Period (26 Weeks)||54
8542224|NCT03593213|9573747|FG002|STARTED|Double-blind Treatment Period (26 Weeks)||49
8542225|NCT03593213|9573748|FG003|STARTED|Double-blind Treatment Period (26 Weeks)||56
8542226|NCT03593213|9573745|FG000|Safety Population|Double-blind Treatment Period (26 Weeks)||0
8542227|NCT03593213|9573746|FG001|Safety Population|Double-blind Treatment Period (26 Weeks)||53
8542228|NCT03593213|9573747|FG002|Safety Population|Double-blind Treatment Period (26 Weeks)||49
8542229|NCT03593213|9573748|FG003|Safety Population|Double-blind Treatment Period (26 Weeks)||54
8542230|NCT03593213|9573745|FG000|COMPLETED|Double-blind Treatment Period (26 Weeks)||0
8621241|NCT00478608|9660150|FG000|STARTED|Overall Study||79
8542231|NCT03593213|9573746|FG001|COMPLETED|Double-blind Treatment Period (26 Weeks)||14
8542232|NCT03593213|9573747|FG002|COMPLETED|Double-blind Treatment Period (26 Weeks)||16
8542233|NCT03593213|9573748|FG003|COMPLETED|Double-blind Treatment Period (26 Weeks)||21
8542234|NCT03593213|9573745|FG000|NOT COMPLETED|Double-blind Treatment Period (26 Weeks)||0
8542235|NCT03593213|9573746|FG001|NOT COMPLETED|Double-blind Treatment Period (26 Weeks)||40
8542236|NCT03593213|9573747|FG002|NOT COMPLETED|Double-blind Treatment Period (26 Weeks)||33
8542237|NCT03593213|9573748|FG003|NOT COMPLETED|Double-blind Treatment Period (26 Weeks)||35
8621242|NCT00478608|9660150|FG000|COMPLETED|Overall Study||59
8542238|NCT03349723|9573769|FG000|STARTED|Overall Study||6
8542239|NCT03349723|9573770|FG001|STARTED|Overall Study||6
8542240|NCT03349723|9573771|FG002|STARTED|Overall Study||6
8542241|NCT03349723|9573772|FG003|STARTED|Overall Study||6
8542242|NCT03349723|9573773|FG004|STARTED|Overall Study||6
8542243|NCT03349723|9573774|FG005|STARTED|Overall Study||6
8542244|NCT03349723|9573775|FG006|STARTED|Overall Study||6
8542245|NCT03349723|9573776|FG007|STARTED|Overall Study||14
8542246|NCT03349723|9573769|FG000|COMPLETED|Overall Study||6
8542247|NCT03349723|9573770|FG001|COMPLETED|Overall Study||6
8542248|NCT03349723|9573771|FG002|COMPLETED|Overall Study||6
8542249|NCT03349723|9573772|FG003|COMPLETED|Overall Study||6
8542250|NCT03349723|9573773|FG004|COMPLETED|Overall Study||6
8542251|NCT03349723|9573774|FG005|COMPLETED|Overall Study||6
8542252|NCT03349723|9573775|FG006|COMPLETED|Overall Study||6
8542253|NCT03349723|9573776|FG007|COMPLETED|Overall Study||14
8542254|NCT03349723|9573769|FG000|NOT COMPLETED|Overall Study||0
8542255|NCT03349723|9573770|FG001|NOT COMPLETED|Overall Study||0
8542256|NCT03349723|9573771|FG002|NOT COMPLETED|Overall Study||0
8542257|NCT03349723|9573772|FG003|NOT COMPLETED|Overall Study||0
8542258|NCT03349723|9573773|FG004|NOT COMPLETED|Overall Study||0
8542259|NCT03349723|9573774|FG005|NOT COMPLETED|Overall Study||0
8542260|NCT03349723|9573775|FG006|NOT COMPLETED|Overall Study||0
8542261|NCT03349723|9573776|FG007|NOT COMPLETED|Overall Study||0
8566321|NCT00075725|9598440|FG002|COMPLETED|Overall Study||175
8566322|NCT00075725|9598441|FG003|COMPLETED|Overall Study||168
8566323|NCT00075725|9598442|FG004|COMPLETED|Overall Study||166
8566324|NCT00075725|9598443|FG005|COMPLETED|Overall Study||397
8566325|NCT00075725|9598444|FG006|COMPLETED|Overall Study||171
8566326|NCT00075725|9598445|FG007|COMPLETED|Overall Study||401
8566327|NCT00075725|9598446|FG008|COMPLETED|Overall Study||185
8566328|NCT00075725|9598447|FG009|COMPLETED|Overall Study||16
8566329|NCT00075725|9598448|FG010|COMPLETED|Overall Study||3
8566330|NCT00075725|9598449|FG011|COMPLETED|Overall Study||10
8566331|NCT00075725|9598438|FG000|NOT COMPLETED|Overall Study||74
8566332|NCT00075725|9598439|FG001|NOT COMPLETED|Overall Study||49
8566333|NCT00075725|9598440|FG002|NOT COMPLETED|Overall Study||121
8566334|NCT00075725|9598441|FG003|NOT COMPLETED|Overall Study||78
8818099|NCT01555671|9871731|FG001|NOT COMPLETED|Overall Study||25
8818100|NCT01555697|9871747|FG000|STARTED|Overall Study||10
8818101|NCT01555697|9871748|FG001|STARTED|Overall Study||10
8818102|NCT01555697|9871749|FG002|STARTED|Overall Study||10
8818103|NCT01555697|9871750|FG003|STARTED|Overall Study||10
8818104|NCT01555697|9871751|FG004|STARTED|Overall Study||10
8818105|NCT01555697|9871752|FG005|STARTED|Overall Study||10
8818106|NCT01555697|9871753|FG006|STARTED|Overall Study||10
8818107|NCT01555697|9871754|FG007|STARTED|Overall Study||10
8818108|NCT01555697|9871747|FG000|6 Hours Lab Testing Day 1|Overall Study||10
8818109|NCT01555697|9871748|FG001|6 Hours Lab Testing Day 1|Overall Study||10
8818110|NCT01555697|9871749|FG002|6 Hours Lab Testing Day 1|Overall Study||10
8818111|NCT01555697|9871750|FG003|6 Hours Lab Testing Day 1|Overall Study||10
8818112|NCT01555697|9871751|FG004|6 Hours Lab Testing Day 1|Overall Study||10
8818113|NCT01555697|9871752|FG005|6 Hours Lab Testing Day 1|Overall Study||10
8818114|NCT01555697|9871753|FG006|6 Hours Lab Testing Day 1|Overall Study||10
8818115|NCT01555697|9871754|FG007|6 Hours Lab Testing Day 1|Overall Study||10
8818116|NCT01555697|9871747|FG000|Approx 7 Day Washout|Overall Study||10
8818117|NCT01555697|9871748|FG001|Approx 7 Day Washout|Overall Study||10
8818118|NCT01555697|9871749|FG002|Approx 7 Day Washout|Overall Study||10
8818119|NCT01555697|9871750|FG003|Approx 7 Day Washout|Overall Study||10
8818120|NCT01555697|9871751|FG004|Approx 7 Day Washout|Overall Study||10
8818121|NCT01555697|9871752|FG005|Approx 7 Day Washout|Overall Study||10
8818122|NCT01555697|9871753|FG006|Approx 7 Day Washout|Overall Study||10
8818123|NCT01555697|9871754|FG007|Approx 7 Day Washout|Overall Study||10
8818124|NCT01555697|9871747|FG000|6 Hours Lab Testing Day 2|Overall Study||10
8818125|NCT01555697|9871748|FG001|6 Hours Lab Testing Day 2|Overall Study||10
8818126|NCT01555697|9871749|FG002|6 Hours Lab Testing Day 2|Overall Study||10
8818127|NCT01555697|9871750|FG003|6 Hours Lab Testing Day 2|Overall Study||10
8818128|NCT01555697|9871751|FG004|6 Hours Lab Testing Day 2|Overall Study||10
8818129|NCT01555697|9871752|FG005|6 Hours Lab Testing Day 2|Overall Study||10
8818130|NCT01555697|9871753|FG006|6 Hours Lab Testing Day 2|Overall Study||10
8818131|NCT01555697|9871754|FG007|6 Hours Lab Testing Day 2|Overall Study||10
8818132|NCT01555697|9871747|FG000|COMPLETED|Overall Study||10
8818133|NCT01555697|9871748|FG001|COMPLETED|Overall Study||10
8818134|NCT01555697|9871749|FG002|COMPLETED|Overall Study||10
8818135|NCT01555697|9871750|FG003|COMPLETED|Overall Study||10
8818136|NCT01555697|9871751|FG004|COMPLETED|Overall Study||10
8818137|NCT01555697|9871752|FG005|COMPLETED|Overall Study||10
8818138|NCT01555697|9871753|FG006|COMPLETED|Overall Study||10
8818139|NCT01555697|9871754|FG007|COMPLETED|Overall Study||10
8566335|NCT00075725|9598442|FG004|NOT COMPLETED|Overall Study||66
8566336|NCT00075725|9598443|FG005|NOT COMPLETED|Overall Study||313
8566337|NCT00075725|9598444|FG006|NOT COMPLETED|Overall Study||75
8566338|NCT00075725|9598445|FG007|NOT COMPLETED|Overall Study||295
8566339|NCT00075725|9598446|FG008|NOT COMPLETED|Overall Study||117
8566340|NCT00075725|9598447|FG009|NOT COMPLETED|Overall Study||18
8566341|NCT00075725|9598448|FG010|NOT COMPLETED|Overall Study||9
8566342|NCT00075725|9598449|FG011|NOT COMPLETED|Overall Study||18
8818140|NCT01555697|9871747|FG000|NOT COMPLETED|Overall Study||0
8818141|NCT01555697|9871748|FG001|NOT COMPLETED|Overall Study||0
8818142|NCT01555697|9871749|FG002|NOT COMPLETED|Overall Study||0
8542262|NCT03248531|9573797|FG000|STARTED|Overall Study||22
8542263|NCT03248531|9573798|FG001|STARTED|Overall Study||22
8542264|NCT03248531|9573799|FG002|STARTED|Overall Study||46
8542265|NCT03248531|9573797|FG000|Completed Week 12|Overall Study||19
8542266|NCT03248531|9573798|FG001|Completed Week 12|Overall Study||18
8542267|NCT03248531|9573799|FG002|Completed Week 12|Overall Study||42
8542268|NCT03248531|9573797|FG000|COMPLETED|Overall Study||18
8818143|NCT01555697|9871750|FG003|NOT COMPLETED|Overall Study||0
8818144|NCT01555697|9871751|FG004|NOT COMPLETED|Overall Study||0
8818145|NCT01555697|9871752|FG005|NOT COMPLETED|Overall Study||0
8818146|NCT01555697|9871753|FG006|NOT COMPLETED|Overall Study||0
8818147|NCT01555697|9871754|FG007|NOT COMPLETED|Overall Study||0
8542269|NCT03248531|9573798|FG001|COMPLETED|Overall Study||17
8542270|NCT03248531|9573799|FG002|COMPLETED|Overall Study||38
8542271|NCT03248531|9573797|FG000|NOT COMPLETED|Overall Study||4
8542272|NCT03248531|9573798|FG001|NOT COMPLETED|Overall Study||5
8542273|NCT03248531|9573799|FG002|NOT COMPLETED|Overall Study||8
8542274|NCT03205605|9573814|FG000|STARTED|Overall Study||13
8542275|NCT03205605|9573814|FG000|COMPLETED|Overall Study||12
8542276|NCT03205605|9573814|FG000|NOT COMPLETED|Overall Study||1
8542277|NCT02556736|9573824|FG000|STARTED|Overall Study||14
8542278|NCT02556736|9573824|FG000|COMPLETED|Overall Study||14
8542279|NCT02556736|9573824|FG000|NOT COMPLETED|Overall Study||0
8542280|NCT02484456|9573830|FG000|STARTED|First Treatment Period: Week 1||10
8542281|NCT02484456|9573831|FG001|STARTED|First Treatment Period: Week 1||9
8542282|NCT02484456|9573830|FG000|COMPLETED|First Treatment Period: Week 1||10
8542283|NCT02484456|9573831|FG001|COMPLETED|First Treatment Period: Week 1||9
8542284|NCT02484456|9573830|FG000|NOT COMPLETED|First Treatment Period: Week 1||0
8542285|NCT02484456|9573831|FG001|NOT COMPLETED|First Treatment Period: Week 1||0
8542286|NCT02484456|9573830|FG000|STARTED|First Treatment Period: Week 2||10
8542287|NCT02484456|9573831|FG001|STARTED|First Treatment Period: Week 2||9
8542288|NCT02484456|9573830|FG000|COMPLETED|First Treatment Period: Week 2||10
8542289|NCT02484456|9573831|FG001|COMPLETED|First Treatment Period: Week 2||9
8542290|NCT02484456|9573830|FG000|NOT COMPLETED|First Treatment Period: Week 2||0
8542291|NCT02484456|9573831|FG001|NOT COMPLETED|First Treatment Period: Week 2||0
8542292|NCT02484456|9573830|FG000|STARTED|Washout Period||10
8542293|NCT02484456|9573831|FG001|STARTED|Washout Period||9
8542294|NCT02484456|9573830|FG000|COMPLETED|Washout Period||10
8542295|NCT02484456|9573831|FG001|COMPLETED|Washout Period||8
8542296|NCT02484456|9573830|FG000|NOT COMPLETED|Washout Period||0
8542297|NCT02484456|9573831|FG001|NOT COMPLETED|Washout Period||1
8542298|NCT02484456|9573830|FG000|STARTED|Second Treatment Period: Week 1||10
8542299|NCT02484456|9573831|FG001|STARTED|Second Treatment Period: Week 1||8
8542300|NCT02484456|9573830|FG000|COMPLETED|Second Treatment Period: Week 1||9
8542301|NCT02484456|9573831|FG001|COMPLETED|Second Treatment Period: Week 1||7
8542302|NCT02484456|9573830|FG000|NOT COMPLETED|Second Treatment Period: Week 1||1
8542303|NCT02484456|9573831|FG001|NOT COMPLETED|Second Treatment Period: Week 1||1
8542304|NCT02484456|9573830|FG000|STARTED|Second Treatment Period: Week 2||9
8542305|NCT02484456|9573831|FG001|STARTED|Second Treatment Period: Week 2||7
8542306|NCT02484456|9573830|FG000|COMPLETED|Second Treatment Period: Week 2||9
8542307|NCT02484456|9573831|FG001|COMPLETED|Second Treatment Period: Week 2||6
8542308|NCT02484456|9573830|FG000|NOT COMPLETED|Second Treatment Period: Week 2||0
8542309|NCT02484456|9573831|FG001|NOT COMPLETED|Second Treatment Period: Week 2||1
8542310|NCT02481830|9573840|FG000|STARTED|Overall Study||284
8542311|NCT02481830|9573841|FG001|STARTED|Overall Study||285
8818148|NCT01555762|9871766|FG000|STARTED|Overall Study||402
8818149|NCT01555762|9871766|FG000|Safety Population|Overall Study||383
8818150|NCT01555762|9871766|FG000|Efficacy Population|Overall Study||358
8818151|NCT01555762|9871766|FG000|COMPLETED|Overall Study||128
8818152|NCT01555762|9871766|FG000|NOT COMPLETED|Overall Study||274
8818153|NCT01555931|9871772|FG000|STARTED|Overall Study||17
8818154|NCT01555931|9871773|FG001|STARTED|Overall Study||18
8818155|NCT01555931|9871772|FG000|COMPLETED|Overall Study||15
8818156|NCT01555931|9871773|FG001|COMPLETED|Overall Study||13
8818157|NCT01555931|9871772|FG000|NOT COMPLETED|Overall Study||2
8818158|NCT01555931|9871773|FG001|NOT COMPLETED|Overall Study||5
8818159|NCT01555957|9871781|FG000|STARTED|Overall Study||20
8818160|NCT01555957|9871782|FG001|STARTED|Overall Study||20
8818161|NCT01555957|9871781|FG000|COMPLETED|Overall Study||20
8818162|NCT01555957|9871782|FG001|COMPLETED|Overall Study||20
8818163|NCT01555957|9871781|FG000|NOT COMPLETED|Overall Study||0
8818164|NCT01555957|9871782|FG001|NOT COMPLETED|Overall Study||0
8818165|NCT01555983|9871788|FG000|STARTED|Overall Study||9
8818166|NCT01555983|9871789|FG001|STARTED|Overall Study||7
8818167|NCT01555983|9871790|FG002|STARTED|Overall Study||7
8818168|NCT01555983|9871791|FG003|STARTED|Overall Study||7
8542312|NCT02481830|9573840|FG000|COMPLETED|Overall Study||282
8542313|NCT02481830|9573841|FG001|COMPLETED|Overall Study||265
8542314|NCT02481830|9573840|FG000|NOT COMPLETED|Overall Study||2
8542315|NCT02481830|9573841|FG001|NOT COMPLETED|Overall Study||20
8542316|NCT02234323|9573847|FG000|STARTED|All Enrolled||108
8818169|NCT01555983|9871792|FG004|STARTED|Overall Study||5
8818170|NCT01555983|9871793|FG005|STARTED|Overall Study||7
8818171|NCT01555983|9871788|FG000|COMPLETED|Overall Study|One subject only finished the placebo session, then dropped out of study|8
8818172|NCT01555983|9871789|FG001|COMPLETED|Overall Study||7
8818173|NCT01555983|9871790|FG002|COMPLETED|Overall Study||7
8818174|NCT01555983|9871791|FG003|COMPLETED|Overall Study||7
8542317|NCT02234323|9573847|FG000|COMPLETED|All Enrolled|These participants received at least one dose of study drug.|103
8542318|NCT02234323|9573847|FG000|NOT COMPLETED|All Enrolled||5
8542319|NCT02234323|9573847|FG000|STARTED|All Treated||103
8542320|NCT02234323|9573847|FG000|Episodic Treatment Regimen|All Treated|Participants were treated in more than one regimen and counted in all categories wherever applicable|81
8542321|NCT02234323|9573847|FG000|Prophylactic Treatment Regimen|All Treated|69 participants among the 81 who started in episodic regimen, switched to the prophylactic regimen.|89
8542322|NCT02234323|9573847|FG000|Immune Tolerance Induction (ITI)|All Treated|1/81 on episodic and 14/89 on prophylactic regimen had inhibitors and were switched directly to ITI.|15
8542323|NCT02234323|9573847|FG000|COMPLETED|All Treated||85
8542324|NCT02234323|9573847|FG000|NOT COMPLETED|All Treated||18
8542325|NCT02220855|9573853|FG000|STARTED|Overall Study||14
8542326|NCT02220855|9573853|FG000|COMPLETED|Overall Study||0
8542327|NCT02220855|9573853|FG000|NOT COMPLETED|Overall Study||14
8542328|NCT01791595|9573864|FG000|STARTED|Part 1 AZD3965 Cohort 1 (5 mg OD)||3
8542329|NCT01791595|9573865|FG001|STARTED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
8542330|NCT01791595|9573866|FG002|STARTED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
8542331|NCT01791595|9573867|FG003|STARTED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
8542332|NCT01791595|9573868|FG004|STARTED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
8542333|NCT01791595|9573869|FG005|STARTED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
8542334|NCT01791595|9573870|FG006|STARTED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
8542335|NCT01791595|9573864|FG000|COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
8542336|NCT01791595|9573865|FG001|COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
8542337|NCT01791595|9573866|FG002|COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
8542338|NCT01791595|9573867|FG003|COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
8542339|NCT01791595|9573868|FG004|COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
8542340|NCT01791595|9573869|FG005|COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
8542341|NCT01791595|9573870|FG006|COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
8542342|NCT01791595|9573864|FG000|NOT COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||3
8542343|NCT01791595|9573865|FG001|NOT COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
8542344|NCT01791595|9573866|FG002|NOT COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
8542345|NCT01791595|9573867|FG003|NOT COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
8542346|NCT01791595|9573868|FG004|NOT COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
8542347|NCT01791595|9573869|FG005|NOT COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
8542348|NCT01791595|9573870|FG006|NOT COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
8542349|NCT01791595|9573864|FG000|STARTED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
8542350|NCT01791595|9573865|FG001|STARTED|Part 1 AZD3965 Cohort 2 (10 mg OD)||5
8542351|NCT01791595|9573866|FG002|STARTED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
8542352|NCT01791595|9573867|FG003|STARTED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
8542353|NCT01791595|9573868|FG004|STARTED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
8542354|NCT01791595|9573869|FG005|STARTED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
8542355|NCT01791595|9573870|FG006|STARTED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
8542356|NCT01791595|9573864|FG000|COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
8542357|NCT01791595|9573865|FG001|COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
8542358|NCT01791595|9573866|FG002|COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
8542359|NCT01791595|9573867|FG003|COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
8542360|NCT01791595|9573868|FG004|COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
8542361|NCT01791595|9573869|FG005|COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
8542362|NCT01791595|9573870|FG006|COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
8542363|NCT01791595|9573864|FG000|NOT COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
8542364|NCT01791595|9573865|FG001|NOT COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||5
8542365|NCT01791595|9573866|FG002|NOT COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
8542366|NCT01791595|9573867|FG003|NOT COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
8542367|NCT01791595|9573868|FG004|NOT COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
8542368|NCT01791595|9573869|FG005|NOT COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
8542369|NCT01791595|9573870|FG006|NOT COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
8542370|NCT01791595|9573864|FG000|STARTED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
8542371|NCT01791595|9573865|FG001|STARTED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
8542372|NCT01791595|9573866|FG002|STARTED|Part 1 AZD3965 Cohort 3 (20 mg OD)||8
8542373|NCT01791595|9573867|FG003|STARTED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
8542374|NCT01791595|9573868|FG004|STARTED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
8542375|NCT01791595|9573869|FG005|STARTED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
8542376|NCT01791595|9573870|FG006|STARTED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
8542377|NCT01791595|9573864|FG000|COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
8542378|NCT01791595|9573865|FG001|COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
8542379|NCT01791595|9573866|FG002|COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
8542380|NCT01791595|9573867|FG003|COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
8542381|NCT01791595|9573868|FG004|COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
8542382|NCT01791595|9573869|FG005|COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
8542383|NCT01791595|9573870|FG006|COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
8542384|NCT01791595|9573864|FG000|NOT COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
8542385|NCT01791595|9573865|FG001|NOT COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
8542386|NCT01791595|9573866|FG002|NOT COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||8
8542387|NCT01791595|9573867|FG003|NOT COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
8542388|NCT01791595|9573868|FG004|NOT COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
8542389|NCT01791595|9573869|FG005|NOT COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
8818175|NCT01555983|9871792|FG004|COMPLETED|Overall Study|One subject complete 6.7%THC and placebo sessions, then dropped out|4
8818176|NCT01555983|9871793|FG005|COMPLETED|Overall Study|One subject completed the 6.7%THC session, then dropped out.|6
8818177|NCT01555983|9871788|FG000|NOT COMPLETED|Overall Study||1
8818178|NCT01555983|9871789|FG001|NOT COMPLETED|Overall Study||0
8818179|NCT01555983|9871790|FG002|NOT COMPLETED|Overall Study||0
8542390|NCT01791595|9573870|FG006|NOT COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
8542391|NCT01791595|9573864|FG000|STARTED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
8542392|NCT01791595|9573865|FG001|STARTED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
8542393|NCT01791595|9573866|FG002|STARTED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
8542394|NCT01791595|9573867|FG003|STARTED|Part 1 AZD3965 Cohort 4 (30 mg OD)||5
8542395|NCT01791595|9573868|FG004|STARTED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
8542396|NCT01791595|9573869|FG005|STARTED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
8542397|NCT01791595|9573870|FG006|STARTED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
8542398|NCT01791595|9573864|FG000|COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
8542399|NCT01791595|9573865|FG001|COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
8542400|NCT01791595|9573866|FG002|COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
8542401|NCT01791595|9573867|FG003|COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||1
8542402|NCT01791595|9573868|FG004|COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
8542403|NCT01791595|9573869|FG005|COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
8542404|NCT01791595|9573870|FG006|COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
8542405|NCT01791595|9573864|FG000|NOT COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
8542406|NCT01791595|9573865|FG001|NOT COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
8542407|NCT01791595|9573866|FG002|NOT COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
8542408|NCT01791595|9573867|FG003|NOT COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||4
8542409|NCT01791595|9573868|FG004|NOT COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
8542410|NCT01791595|9573869|FG005|NOT COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
8542411|NCT01791595|9573870|FG006|NOT COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
8542412|NCT01791595|9573864|FG000|STARTED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
8542413|NCT01791595|9573865|FG001|STARTED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
8542414|NCT01791595|9573866|FG002|STARTED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
8542415|NCT01791595|9573867|FG003|STARTED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
8542416|NCT01791595|9573868|FG004|STARTED|Part 1 AZD3965 Cohort 5 (15 mg BD)||11
8542417|NCT01791595|9573869|FG005|STARTED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
8542418|NCT01791595|9573870|FG006|STARTED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
8542419|NCT01791595|9573864|FG000|COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
8542420|NCT01791595|9573865|FG001|COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
8542421|NCT01791595|9573866|FG002|COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
8542422|NCT01791595|9573867|FG003|COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
8542423|NCT01791595|9573868|FG004|COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
8542424|NCT01791595|9573869|FG005|COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
8542425|NCT01791595|9573870|FG006|COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
8542426|NCT01791595|9573864|FG000|NOT COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
8542427|NCT01791595|9573865|FG001|NOT COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
8542428|NCT01791595|9573866|FG002|NOT COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
8542429|NCT01791595|9573867|FG003|NOT COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
8542430|NCT01791595|9573868|FG004|NOT COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||11
8542431|NCT01791595|9573869|FG005|NOT COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
8542432|NCT01791595|9573870|FG006|NOT COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
8542433|NCT01791595|9573864|FG000|STARTED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
8542434|NCT01791595|9573865|FG001|STARTED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
8542435|NCT01791595|9573866|FG002|STARTED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
8542436|NCT01791595|9573867|FG003|STARTED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
8542437|NCT01791595|9573868|FG004|STARTED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
8542438|NCT01791595|9573869|FG005|STARTED|Part 1 AZD3965 Cohort 6 (10 mg BD)||8
8542439|NCT01791595|9573870|FG006|STARTED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
8542440|NCT01791595|9573864|FG000|COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
8542441|NCT01791595|9573865|FG001|COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
8542442|NCT01791595|9573866|FG002|COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
8542443|NCT01791595|9573867|FG003|COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
8542444|NCT01791595|9573868|FG004|COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
8542445|NCT01791595|9573869|FG005|COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
8542446|NCT01791595|9573870|FG006|COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
8542447|NCT01791595|9573864|FG000|NOT COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
8542448|NCT01791595|9573865|FG001|NOT COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
8542449|NCT01791595|9573866|FG002|NOT COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
8542450|NCT01791595|9573867|FG003|NOT COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
8542451|NCT01791595|9573868|FG004|NOT COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
8818180|NCT01555983|9871791|FG003|NOT COMPLETED|Overall Study||0
8818181|NCT01555983|9871792|FG004|NOT COMPLETED|Overall Study||1
8818182|NCT01555983|9871793|FG005|NOT COMPLETED|Overall Study||1
8818183|NCT01556061|9871803|FG000|STARTED|Overall Study||25
8818184|NCT01556061|9871804|FG001|STARTED|Overall Study||25
8818185|NCT01556061|9871803|FG000|COMPLETED|Overall Study||25
8818186|NCT01556061|9871804|FG001|COMPLETED|Overall Study||25
8818187|NCT01556061|9871803|FG000|NOT COMPLETED|Overall Study||0
8818188|NCT01556061|9871804|FG001|NOT COMPLETED|Overall Study||0
8542452|NCT01791595|9573869|FG005|NOT COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||8
8542453|NCT01791595|9573870|FG006|NOT COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
8542454|NCT01791595|9573864|FG000|STARTED|Part 2 AZD3965 Expansion (10 mg BD)||0
8542455|NCT01791595|9573865|FG001|STARTED|Part 2 AZD3965 Expansion (10 mg BD)||0
8542456|NCT01791595|9573866|FG002|STARTED|Part 2 AZD3965 Expansion (10 mg BD)||0
8542457|NCT01791595|9573867|FG003|STARTED|Part 2 AZD3965 Expansion (10 mg BD)||0
8542458|NCT01791595|9573868|FG004|STARTED|Part 2 AZD3965 Expansion (10 mg BD)||0
8542459|NCT01791595|9573869|FG005|STARTED|Part 2 AZD3965 Expansion (10 mg BD)||0
8542460|NCT01791595|9573870|FG006|STARTED|Part 2 AZD3965 Expansion (10 mg BD)||11
8542461|NCT01791595|9573864|FG000|COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0
8542462|NCT01791595|9573865|FG001|COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0
8542463|NCT01791595|9573866|FG002|COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0
8542464|NCT01791595|9573867|FG003|COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0
8542465|NCT01791595|9573868|FG004|COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0
8542466|NCT01791595|9573869|FG005|COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0
8542467|NCT01791595|9573870|FG006|COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||1
8542468|NCT01791595|9573864|FG000|NOT COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0
8542469|NCT01791595|9573865|FG001|NOT COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0
8542470|NCT01791595|9573866|FG002|NOT COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0
8621243|NCT00478608|9660150|FG000|NOT COMPLETED|Overall Study||20
8621244|NCT00478647|9660154|FG000|STARTED|Overall Study||40
8621245|NCT00478647|9660154|FG000|COMPLETED|Overall Study|Intent-to-Treat (ITT)=participants who have received at least 1 full or partial dose of study drug.|38
8621246|NCT00478647|9660154|FG000|NOT COMPLETED|Overall Study||2
8542471|NCT01791595|9573867|FG003|NOT COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0
8542472|NCT01791595|9573868|FG004|NOT COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0
8542473|NCT01791595|9573869|FG005|NOT COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0
8542474|NCT01791595|9573870|FG006|NOT COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||10
8566343|NCT00075764|9598482|FG000|STARTED|Overall Study||345
8566344|NCT00075764|9598483|FG001|STARTED|Overall Study||349
8566345|NCT00075764|9598482|FG000|COMPLETED|Overall Study||0
8566346|NCT00075764|9598483|FG001|COMPLETED|Overall Study||0
8566347|NCT00075764|9598482|FG000|NOT COMPLETED|Overall Study||345
8566348|NCT00075764|9598483|FG001|NOT COMPLETED|Overall Study||349
8566349|NCT00075803|9598493|FG000|STARTED|Overall Study||295
8566350|NCT00075803|9598494|FG001|STARTED|Overall Study||305
8566351|NCT00075803|9598493|FG000|COMPLETED|Overall Study||295
8566352|NCT00075803|9598494|FG001|COMPLETED|Overall Study||305
8566353|NCT00075803|9598493|FG000|NOT COMPLETED|Overall Study||0
8566354|NCT00075803|9598494|FG001|NOT COMPLETED|Overall Study||0
8566355|NCT00075816|9598502|FG000|STARTED|Overall Study||278
8566356|NCT00075816|9598503|FG001|STARTED|Overall Study||273
8566357|NCT00075816|9598502|FG000|COMPLETED|Overall Study||264
8566358|NCT00075816|9598503|FG001|COMPLETED|Overall Study||262
8566359|NCT00075816|9598502|FG000|NOT COMPLETED|Overall Study||14
8566360|NCT00075816|9598503|FG001|NOT COMPLETED|Overall Study||11
8566361|NCT00075829|9598515|FG000|STARTED|Overall Study||436
8566362|NCT00075829|9598516|FG001|STARTED|Overall Study||189
8566363|NCT00075829|9598517|FG002|STARTED|Overall Study||48
8566364|NCT00075829|9598518|FG003|STARTED|Overall Study||37
8566365|NCT00075829|9598515|FG000|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|178
8566366|NCT00075829|9598516|FG001|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|71
8566367|NCT00075829|9598517|FG002|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|14
8566368|NCT00075829|9598518|FG003|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|13
8566369|NCT00075829|9598515|FG000|NOT COMPLETED|Overall Study||258
8566370|NCT00075829|9598516|FG001|NOT COMPLETED|Overall Study||118
8566371|NCT00075829|9598517|FG002|NOT COMPLETED|Overall Study||34
8566372|NCT00075829|9598518|FG003|NOT COMPLETED|Overall Study||24
8566373|NCT00075881|9598531|FG000|STARTED|Overall Study||44
8566374|NCT00075881|9598531|FG000|Eligible|Overall Study||43
8566375|NCT00075881|9598531|FG000|Treated|Overall Study||42
8566376|NCT00075881|9598531|FG000|Induction Treatment|Overall Study||42
8566377|NCT00075881|9598531|FG000|Maintenance Treatment|Overall Study||15
8566378|NCT00075881|9598531|FG000|Reinduction Treatment|Overall Study||7
8566379|NCT00075881|9598531|FG000|COMPLETED|Overall Study||1
8566380|NCT00075881|9598531|FG000|NOT COMPLETED|Overall Study||43
8566381|NCT00075946|9598541|FG000|STARTED|Overall Study||148
8566382|NCT00075946|9598542|FG001|STARTED|Overall Study||151
8566383|NCT00075946|9598543|FG002|STARTED|Overall Study||28
8566384|NCT00075946|9598544|FG003|STARTED|Overall Study||30
8566385|NCT00075946|9598545|FG004|STARTED|Overall Study||188
8566386|NCT00075946|9598541|FG000|Treated and With Toxicity Data Available|Overall Study||142
8566387|NCT00075946|9598542|FG001|Treated and With Toxicity Data Available|Overall Study||148
8566388|NCT00075946|9598543|FG002|Treated and With Toxicity Data Available|Overall Study||27
8566389|NCT00075946|9598544|FG003|Treated and With Toxicity Data Available|Overall Study||29
8566390|NCT00075946|9598545|FG004|Treated and With Toxicity Data Available|Overall Study||154
8566391|NCT00075946|9598541|FG000|Included in Primary Analysis|Overall Study||143
8566392|NCT00075946|9598542|FG001|Included in Primary Analysis|Overall Study||146
8566393|NCT00075946|9598543|FG002|Included in Primary Analysis|Overall Study||23
8621247|NCT00478673|9660158|FG000|STARTED|30-Days Post-Procedure||298
8542475|NCT01192776|9573894|FG000|STARTED|Overall Study||95
8621248|NCT00478673|9660158|FG000|COMPLETED|30-Days Post-Procedure|"7 participants who did not complete this Period due to Missed Visit still continued on to Period 2"|288
8621249|NCT00478673|9660158|FG000|NOT COMPLETED|30-Days Post-Procedure||10
8621250|NCT00478673|9660158|FG000|STARTED|12-Months Post-Procedure|3 participants who did not complete Period 1 due to death (2) and withdrawal (1) are not included.|295
8621251|NCT00478673|9660158|FG000|COMPLETED|12-Months Post-Procedure||231
8621252|NCT00478673|9660158|FG000|NOT COMPLETED|12-Months Post-Procedure||64
8621253|NCT00478777|9660162|FG000|STARTED|Overall Study||150
8621254|NCT00478777|9660162|FG000|Safety and Full Analysis Set (FAS)|Overall Study|6 enrolled participants did not receive lenalidomide.|144
8621255|NCT00478777|9660162|FG000|COMPLETED|Overall Study|10 participants had >= 6 months and 63 participants < 6 months treatment prior to study termination.|73
8621256|NCT00478777|9660162|FG000|NOT COMPLETED|Overall Study||77
8542476|NCT01192776|9573895|FG001|STARTED|Overall Study||90
8542477|NCT01192776|9573896|FG002|STARTED|Overall Study||96
8542478|NCT01192776|9573897|FG003|STARTED|Overall Study||83
8542479|NCT01192776|9573894|FG000|Died Prior to Discharge|Overall Study||7
8542480|NCT01192776|9573895|FG001|Died Prior to Discharge|Overall Study||13
8542481|NCT01192776|9573896|FG002|Died Prior to Discharge|Overall Study||15
8542482|NCT01192776|9573897|FG003|Died Prior to Discharge|Overall Study||14
8542483|NCT01192776|9573894|FG000|Died After Discharge|Overall Study||1
8542484|NCT01192776|9573895|FG001|Died After Discharge|Overall Study||2
8542485|NCT01192776|9573896|FG002|Died After Discharge|Overall Study||3
8542486|NCT01192776|9573897|FG003|Died After Discharge|Overall Study||1
8542487|NCT01192776|9573894|FG000|COMPLETED|Overall Study||84
8542488|NCT01192776|9573895|FG001|COMPLETED|Overall Study||69
8542489|NCT01192776|9573896|FG002|COMPLETED|Overall Study||75
8542490|NCT01192776|9573897|FG003|COMPLETED|Overall Study||63
8542491|NCT01192776|9573894|FG000|NOT COMPLETED|Overall Study||11
8542492|NCT01192776|9573895|FG001|NOT COMPLETED|Overall Study||21
8542493|NCT01192776|9573896|FG002|NOT COMPLETED|Overall Study||21
8542494|NCT01192776|9573897|FG003|NOT COMPLETED|Overall Study||20
8542495|NCT01030575|9573913|FG000|STARTED|Overall Study||29
8542496|NCT01030575|9573914|FG001|STARTED|Overall Study||30
8542497|NCT01030575|9573915|FG002|STARTED|Overall Study||28
8542498|NCT01030575|9573916|FG003|STARTED|Overall Study||35
8621257|NCT00478881|9660168|FG000|STARTED|Overall Study||199
8621258|NCT00478881|9660169|FG001|STARTED|Overall Study||198
8621259|NCT00478881|9660168|FG000|Received Medication|Overall Study||198
8621260|NCT00478881|9660169|FG001|Received Medication|Overall Study||198
8621261|NCT00478881|9660168|FG000|COMPLETED|Overall Study||160
8621262|NCT00478881|9660169|FG001|COMPLETED|Overall Study||176
8621263|NCT00478881|9660168|FG000|NOT COMPLETED|Overall Study||39
8621264|NCT00478881|9660169|FG001|NOT COMPLETED|Overall Study||22
8621265|NCT00478933|9660175|FG000|STARTED|Overall Study||1223
8621266|NCT00478933|9660175|FG000|COMPLETED|Overall Study||1145
8621267|NCT00478933|9660175|FG000|NOT COMPLETED|Overall Study||78
8621268|NCT00479037|9660201|FG000|STARTED|Overall Study||41
8621269|NCT00479037|9660202|FG001|STARTED|Overall Study||40
8621270|NCT00479037|9660201|FG000|COMPLETED|Overall Study||38
8542499|NCT01030575|9573913|FG000|COMPLETED|Overall Study|1 infant randomized to the placebo arm incorrectly received the low dose. The infant was included in the low dose arm for the pharmacokinetics analyses and as randomized to the placebo arm for all other analyzes.|29
8542500|NCT01030575|9573914|FG001|COMPLETED|Overall Study||30
8542501|NCT01030575|9573915|FG002|COMPLETED|Overall Study||28
8542502|NCT01030575|9573916|FG003|COMPLETED|Overall Study|1 infant randomized to the placebo arm incorrectly received the low dose. The infant was included in the low dose arm for the pharmacokinetics analyses and as randomized to the placebo arm for all other analyzes.|35
8542503|NCT01030575|9573913|FG000|NOT COMPLETED|Overall Study||0
8542504|NCT01030575|9573914|FG001|NOT COMPLETED|Overall Study||0
8542505|NCT01030575|9573915|FG002|NOT COMPLETED|Overall Study||0
8542506|NCT01030575|9573916|FG003|NOT COMPLETED|Overall Study||0
8542507|NCT00089791|9573929|FG000|STARTED|Overall Study||3906
8542508|NCT00089791|9573930|FG001|STARTED|Overall Study||3902
8542509|NCT00089791|9573929|FG000|Received Study Medication|Overall Study||3883
8542510|NCT00089791|9573930|FG001|Received Study Medication|Overall Study||3879
8542511|NCT00089791|9573929|FG000|Safety Analysis Set|Overall Study|7 participants in the placebo arm received ≥1 dose of denosumab & were analyzed in the denosumab arm|3876
8542512|NCT00089791|9573930|FG001|Safety Analysis Set|Overall Study||3886
8542513|NCT00089791|9573929|FG000|COMPLETED|Overall Study||3206
8542514|NCT00089791|9573930|FG001|COMPLETED|Overall Study||3272
8542515|NCT00089791|9573929|FG000|NOT COMPLETED|Overall Study||700
8542516|NCT00089791|9573930|FG001|NOT COMPLETED|Overall Study||630
8566394|NCT00075946|9598544|FG003|Included in Primary Analysis|Overall Study||29
8566395|NCT00075946|9598545|FG004|Included in Primary Analysis|Overall Study||0
8566396|NCT00075946|9598541|FG000|COMPLETED|Overall Study||0
8566397|NCT00075946|9598542|FG001|COMPLETED|Overall Study||0
8566398|NCT00075946|9598543|FG002|COMPLETED|Overall Study||0
8566399|NCT00075946|9598544|FG003|COMPLETED|Overall Study||0
8566400|NCT00075946|9598545|FG004|COMPLETED|Overall Study||0
8566401|NCT00075946|9598541|FG000|NOT COMPLETED|Overall Study||148
8566402|NCT00075946|9598542|FG001|NOT COMPLETED|Overall Study||151
8566403|NCT00075946|9598543|FG002|NOT COMPLETED|Overall Study||28
8566404|NCT00075946|9598544|FG003|NOT COMPLETED|Overall Study||30
8566405|NCT00075946|9598545|FG004|NOT COMPLETED|Overall Study||188
8621271|NCT00479037|9660202|FG001|COMPLETED|Overall Study||34
8621272|NCT00479037|9660201|FG000|NOT COMPLETED|Overall Study||3
8542517|NCT03392883|9573939|FG000|STARTED|Overall Study||1264
8542518|NCT03392883|9573940|FG001|STARTED|Overall Study||45
8542519|NCT03392883|9573941|FG002|STARTED|Overall Study||39
8542520|NCT03392883|9573939|FG000|COMPLETED|Overall Study||928
8542521|NCT03392883|9573940|FG001|COMPLETED|Overall Study||32
8542522|NCT03392883|9573941|FG002|COMPLETED|Overall Study||30
8542523|NCT03392883|9573939|FG000|NOT COMPLETED|Overall Study||336
8542524|NCT03392883|9573940|FG001|NOT COMPLETED|Overall Study||13
8542525|NCT03392883|9573941|FG002|NOT COMPLETED|Overall Study||9
8542526|NCT03376789|9573949|FG000|STARTED|Overall Study||108
8542527|NCT03376789|9573950|FG001|STARTED|Overall Study||111
8542528|NCT03376789|9573949|FG000|COMPLETED|Overall Study||103
8542529|NCT03376789|9573950|FG001|COMPLETED|Overall Study||102
8542530|NCT03376789|9573949|FG000|NOT COMPLETED|Overall Study||5
8542531|NCT03376789|9573950|FG001|NOT COMPLETED|Overall Study||9
8542532|NCT03342742|9573958|FG000|STARTED|Overall Study||15
8542533|NCT03342742|9573959|FG001|STARTED|Overall Study||13
8542534|NCT03342742|9573958|FG000|COMPLETED|Overall Study||13
8542535|NCT03342742|9573959|FG001|COMPLETED|Overall Study||11
8542536|NCT03342742|9573958|FG000|NOT COMPLETED|Overall Study||2
8542537|NCT03342742|9573959|FG001|NOT COMPLETED|Overall Study||2
8542538|NCT03333590|9573969|FG000|STARTED|Overall Study||1
8542539|NCT03333590|9573970|FG001|STARTED|Overall Study||1
8542540|NCT03333590|9573969|FG000|COMPLETED|Overall Study||1
8542541|NCT03333590|9573970|FG001|COMPLETED|Overall Study||1
8621273|NCT00479037|9660202|FG001|NOT COMPLETED|Overall Study||6
8621274|NCT00479089|9660210|FG000|STARTED|Overall Study||25
8621275|NCT00479089|9660211|FG001|STARTED|Overall Study||25
8621276|NCT00479089|9660210|FG000|COMPLETED|Overall Study||25
8542542|NCT03333590|9573969|FG000|NOT COMPLETED|Overall Study||0
8542543|NCT03333590|9573970|FG001|NOT COMPLETED|Overall Study||0
8542544|NCT03307967|9573978|FG000|STARTED|Overall Study||40
8542545|NCT03307967|9573978|FG000|COMPLETED|Overall Study||36
8542546|NCT03307967|9573978|FG000|NOT COMPLETED|Overall Study||4
8542547|NCT03290326|9573982|FG000|STARTED|Overall Study||10
8542548|NCT03290326|9573982|FG000|COMPLETED|Overall Study||10
8542549|NCT03290326|9573982|FG000|NOT COMPLETED|Overall Study||0
8542553|NCT03272711|9573994|FG000|STARTED|Overall Study||51
8542554|NCT03272711|9573995|FG001|STARTED|Overall Study||49
8542555|NCT03272711|9573994|FG000|COMPLETED|Overall Study||44
8542556|NCT03272711|9573995|FG001|COMPLETED|Overall Study||41
8542557|NCT03272711|9573994|FG000|NOT COMPLETED|Overall Study||7
8542558|NCT03272711|9573995|FG001|NOT COMPLETED|Overall Study||8
8542559|NCT03271983|9574001|FG000|STARTED|Overall Study|The plan was to do n=12 volunteers; however, funding was terminated due to pandemic so only 7 volunteers were completed.|7
8542560|NCT03271983|9574001|FG000|COMPLETED|Overall Study||7
8542561|NCT03271983|9574001|FG000|NOT COMPLETED|Overall Study||0
8542562|NCT03246789|9574011|FG000|STARTED|Overall Study||24
8542563|NCT03246789|9574012|FG001|STARTED|Overall Study||15
8542564|NCT03246789|9574011|FG000|COMPLETED|Overall Study||24
8542565|NCT03246789|9574012|FG001|COMPLETED|Overall Study||15
8542566|NCT03246789|9574011|FG000|NOT COMPLETED|Overall Study||0
8542567|NCT03246789|9574012|FG001|NOT COMPLETED|Overall Study||0
8542568|NCT03241225|9574020|FG000|STARTED|Overall Study||24
8542569|NCT03241225|9574021|FG001|STARTED|Overall Study||16
8542570|NCT03241225|9574020|FG000|COMPLETED|Overall Study||17
8542571|NCT03241225|9574021|FG001|COMPLETED|Overall Study||14
8542572|NCT03241225|9574020|FG000|NOT COMPLETED|Overall Study||7
8542573|NCT03241225|9574021|FG001|NOT COMPLETED|Overall Study||2
8542574|NCT03225846|9574034|FG000|STARTED|Overall Study||22
8542575|NCT03225846|9574035|FG001|STARTED|Overall Study||9
8542576|NCT03225846|9574036|FG002|STARTED|Overall Study||12
8542577|NCT03225846|9574037|FG003|STARTED|Overall Study||15
8542578|NCT03225846|9574038|FG004|STARTED|Overall Study||8
8542579|NCT03225846|9574039|FG005|STARTED|Overall Study||9
8542580|NCT03225846|9574040|FG006|STARTED|Overall Study||13
8542581|NCT03225846|9574034|FG000|Single Dose Period Only|Overall Study||6
8542582|NCT03225846|9574035|FG001|Single Dose Period Only|Overall Study||3
8542583|NCT03225846|9574036|FG002|Single Dose Period Only|Overall Study||4
8542584|NCT03225846|9574037|FG003|Single Dose Period Only|Overall Study||7
8542585|NCT03225846|9574038|FG004|Single Dose Period Only|Overall Study||8
8542586|NCT03225846|9574039|FG005|Single Dose Period Only|Overall Study||0
8542587|NCT03225846|9574040|FG006|Single Dose Period Only|Overall Study||4
8542588|NCT03225846|9574034|FG000|Multiple Dose Period Only|Overall Study||3
8542589|NCT03225846|9574035|FG001|Multiple Dose Period Only|Overall Study||0
8542590|NCT03225846|9574036|FG002|Multiple Dose Period Only|Overall Study||3
8621277|NCT00479089|9660211|FG001|COMPLETED|Overall Study||25
8621278|NCT00479089|9660210|FG000|NOT COMPLETED|Overall Study||0
8542591|NCT03225846|9574037|FG003|Multiple Dose Period Only|Overall Study||6
8542592|NCT03225846|9574038|FG004|Multiple Dose Period Only|Overall Study||0
8542593|NCT03225846|9574039|FG005|Multiple Dose Period Only|Overall Study||0
8542594|NCT03225846|9574040|FG006|Multiple Dose Period Only|Overall Study||4
8542595|NCT03225846|9574034|FG000|Single Dose and Multiple Dose|Overall Study||13
8542596|NCT03225846|9574035|FG001|Single Dose and Multiple Dose|Overall Study||6
8542597|NCT03225846|9574036|FG002|Single Dose and Multiple Dose|Overall Study||5
8542598|NCT03225846|9574037|FG003|Single Dose and Multiple Dose|Overall Study||2
8542599|NCT03225846|9574038|FG004|Single Dose and Multiple Dose|Overall Study||0
8542600|NCT03225846|9574039|FG005|Single Dose and Multiple Dose|Overall Study||9
8542601|NCT03225846|9574040|FG006|Single Dose and Multiple Dose|Overall Study||5
8542550|NCT03288129|9573988|FG000|STARTED|Overall Study||54
8542551|NCT03288129|9573988|FG000|COMPLETED|Overall Study||32
8542552|NCT03288129|9573988|FG000|NOT COMPLETED|Overall Study||22
8542602|NCT03225846|9574034|FG000|COMPLETED|Overall Study||22
8542603|NCT03225846|9574035|FG001|COMPLETED|Overall Study||7
8542604|NCT03225846|9574036|FG002|COMPLETED|Overall Study||11
8542605|NCT03225846|9574037|FG003|COMPLETED|Overall Study||15
8542606|NCT03225846|9574038|FG004|COMPLETED|Overall Study||8
8542607|NCT03225846|9574039|FG005|COMPLETED|Overall Study||9
8542608|NCT03225846|9574040|FG006|COMPLETED|Overall Study||6
8542609|NCT03225846|9574034|FG000|NOT COMPLETED|Overall Study||0
8542610|NCT03225846|9574035|FG001|NOT COMPLETED|Overall Study||2
8542611|NCT03225846|9574036|FG002|NOT COMPLETED|Overall Study||1
8542612|NCT03225846|9574037|FG003|NOT COMPLETED|Overall Study||0
8542613|NCT03225846|9574038|FG004|NOT COMPLETED|Overall Study||0
8542614|NCT03225846|9574039|FG005|NOT COMPLETED|Overall Study||0
8542615|NCT03225846|9574040|FG006|NOT COMPLETED|Overall Study||7
8566406|NCT00076011|9598556|FG000|STARTED|Overall Study||52
8566407|NCT00076011|9598556|FG000|COMPLETED|Overall Study||0
8566408|NCT00076011|9598556|FG000|NOT COMPLETED|Overall Study||52
8566409|NCT00076024|9598563|FG000|STARTED|Phase 1, Lead-in||6
8566410|NCT00076024|9598564|FG001|STARTED|Phase 1, Lead-in||0
8566411|NCT00076024|9598565|FG002|STARTED|Phase 1, Lead-in||0
8566412|NCT00076024|9598566|FG003|STARTED|Phase 1, Lead-in||0
8566413|NCT00076024|9598563|FG000|COMPLETED|Phase 1, Lead-in||0
8818189|NCT01556100|9871812|FG000|STARTED|Overall Study||40
8818190|NCT01556100|9871812|FG000|COMPLETED|Overall Study||34
8818191|NCT01556100|9871812|FG000|NOT COMPLETED|Overall Study||6
8818192|NCT01556165|9871818|FG000|STARTED|Overall Study||65
8566414|NCT00076024|9598564|FG001|COMPLETED|Phase 1, Lead-in||0
8566415|NCT00076024|9598565|FG002|COMPLETED|Phase 1, Lead-in||0
8566416|NCT00076024|9598566|FG003|COMPLETED|Phase 1, Lead-in||0
8566417|NCT00076024|9598563|FG000|NOT COMPLETED|Phase 1, Lead-in||6
8566418|NCT00076024|9598564|FG001|NOT COMPLETED|Phase 1, Lead-in||0
8566419|NCT00076024|9598565|FG002|NOT COMPLETED|Phase 1, Lead-in||0
8566420|NCT00076024|9598566|FG003|NOT COMPLETED|Phase 1, Lead-in||0
8566421|NCT00076024|9598563|FG000|STARTED|Phase 2, Double-blind||0
8566422|NCT00076024|9598564|FG001|STARTED|Phase 2, Double-blind||112
8566423|NCT00076024|9598565|FG002|STARTED|Phase 2, Double-blind||56
8566424|NCT00076024|9598566|FG003|STARTED|Phase 2, Double-blind||0
8566425|NCT00076024|9598563|FG000|Treated|Phase 2, Double-blind||0
8566426|NCT00076024|9598564|FG001|Treated|Phase 2, Double-blind||111
8566427|NCT00076024|9598565|FG002|Treated|Phase 2, Double-blind||56
8566428|NCT00076024|9598566|FG003|Treated|Phase 2, Double-blind||0
8566429|NCT00076024|9598563|FG000|COMPLETED|Phase 2, Double-blind||0
8566430|NCT00076024|9598564|FG001|COMPLETED|Phase 2, Double-blind||0
8566431|NCT00076024|9598565|FG002|COMPLETED|Phase 2, Double-blind||0
8566432|NCT00076024|9598566|FG003|COMPLETED|Phase 2, Double-blind||0
8566433|NCT00076024|9598563|FG000|NOT COMPLETED|Phase 2, Double-blind||0
8566434|NCT00076024|9598564|FG001|NOT COMPLETED|Phase 2, Double-blind||112
8566435|NCT00076024|9598565|FG002|NOT COMPLETED|Phase 2, Double-blind||56
8566436|NCT00076024|9598566|FG003|NOT COMPLETED|Phase 2, Double-blind||0
8566437|NCT00076024|9598563|FG000|STARTED|Phase 2, Open-label||0
8566438|NCT00076024|9598564|FG001|STARTED|Phase 2, Open-label||0
8566439|NCT00076024|9598565|FG002|STARTED|Phase 2, Open-label||0
8566440|NCT00076024|9598566|FG003|STARTED|Phase 2, Open-label||16
8566441|NCT00076024|9598563|FG000|COMPLETED|Phase 2, Open-label||0
8566442|NCT00076024|9598564|FG001|COMPLETED|Phase 2, Open-label||0
8566443|NCT00076024|9598565|FG002|COMPLETED|Phase 2, Open-label||0
8566444|NCT00076024|9598566|FG003|COMPLETED|Phase 2, Open-label||0
8566445|NCT00076024|9598563|FG000|NOT COMPLETED|Phase 2, Open-label||0
8566446|NCT00076024|9598564|FG001|NOT COMPLETED|Phase 2, Open-label||0
8566447|NCT00076024|9598565|FG002|NOT COMPLETED|Phase 2, Open-label||0
8566448|NCT00076024|9598566|FG003|NOT COMPLETED|Phase 2, Open-label||16
8566449|NCT00076050|9598577|FG000|STARTED|Overall Study||122
8566450|NCT00076050|9598578|FG001|STARTED|Overall Study||126
8566451|NCT00076050|9598577|FG000|COMPLETED|Overall Study||99
8566452|NCT00076050|9598578|FG001|COMPLETED|Overall Study||83
8566453|NCT00076050|9598577|FG000|NOT COMPLETED|Overall Study||23
8566454|NCT00076050|9598578|FG001|NOT COMPLETED|Overall Study||43
8566455|NCT00076102|9598584|FG000|STARTED|Overall Study||36
8566456|NCT00076102|9598584|FG000|COMPLETED|Overall Study||31
8566457|NCT00076102|9598584|FG000|NOT COMPLETED|Overall Study||5
8566458|NCT00076219|9598592|FG000|STARTED|Overall Study||563
8566459|NCT00076219|9598593|FG001|STARTED|Overall Study||561
8566460|NCT00076219|9598592|FG000|COMPLETED|Overall Study||545
8566461|NCT00076219|9598593|FG001|COMPLETED|Overall Study||550
8566462|NCT00076219|9598592|FG000|NOT COMPLETED|Overall Study||18
8566463|NCT00076219|9598593|FG001|NOT COMPLETED|Overall Study||11
8566464|NCT00076245|9598603|FG000|STARTED|Overall Study||16
8566465|NCT00076245|9598604|FG001|STARTED|Overall Study||15
8566466|NCT00076245|9598605|FG002|STARTED|Overall Study||15
8566467|NCT00076245|9598606|FG003|STARTED|Overall Study||15
8566468|NCT00076245|9598603|FG000|COMPLETED|Overall Study||16
8566469|NCT00076245|9598604|FG001|COMPLETED|Overall Study||15
8566470|NCT00076245|9598605|FG002|COMPLETED|Overall Study||15
8566471|NCT00076245|9598606|FG003|COMPLETED|Overall Study||14
8566472|NCT00076245|9598603|FG000|NOT COMPLETED|Overall Study||0
8566473|NCT00076245|9598604|FG001|NOT COMPLETED|Overall Study||0
8566474|NCT00076245|9598605|FG002|NOT COMPLETED|Overall Study||0
8566475|NCT00076245|9598606|FG003|NOT COMPLETED|Overall Study||1
8542616|NCT03221270|9574067|FG000|STARTED|Overall Study||8
8542617|NCT03221270|9574068|FG001|STARTED|Overall Study||6
8542618|NCT03221270|9574069|FG002|STARTED|Overall Study||5
8542619|NCT03221270|9574070|FG003|STARTED|Overall Study||6
8542620|NCT03221270|9574067|FG000|Completed 5-Day Treatment|Overall Study||8
8542621|NCT03221270|9574068|FG001|Completed 5-Day Treatment|Overall Study||6
8542622|NCT03221270|9574069|FG002|Completed 5-Day Treatment|Overall Study||5
8542623|NCT03221270|9574070|FG003|Completed 5-Day Treatment|Overall Study||6
8542624|NCT03221270|9574067|FG000|Completed 8-Week Maintenance|Overall Study||4
8542625|NCT03221270|9574068|FG001|Completed 8-Week Maintenance|Overall Study||6
8542626|NCT03221270|9574069|FG002|Completed 8-Week Maintenance|Overall Study||5
8542627|NCT03221270|9574070|FG003|Completed 8-Week Maintenance|Overall Study||5
8542628|NCT03221270|9574067|FG000|COMPLETED|Overall Study||4
8542629|NCT03221270|9574068|FG001|COMPLETED|Overall Study||6
8621279|NCT00479089|9660211|FG001|NOT COMPLETED|Overall Study||0
8621280|NCT00479115|9660217|FG000|STARTED|Overall Study||1
8542630|NCT03221270|9574069|FG002|COMPLETED|Overall Study||5
8542631|NCT03221270|9574070|FG003|COMPLETED|Overall Study||5
8542632|NCT03221270|9574067|FG000|NOT COMPLETED|Overall Study||4
8542633|NCT03221270|9574068|FG001|NOT COMPLETED|Overall Study||0
8542634|NCT03221270|9574069|FG002|NOT COMPLETED|Overall Study||0
8542635|NCT03221270|9574070|FG003|NOT COMPLETED|Overall Study||1
8542636|NCT03191903|9574083|FG000|STARTED|Overall Study||251
8542637|NCT03191903|9574084|FG001|STARTED|Overall Study||251
8542638|NCT03191903|9574085|FG002|STARTED|Overall Study||74
8542639|NCT03191903|9574083|FG000|Intent to Treat Population|Overall Study||251
8542640|NCT03191903|9574084|FG001|Intent to Treat Population|Overall Study||251
8542641|NCT03191903|9574085|FG002|Intent to Treat Population|Overall Study||74
8542642|NCT03191903|9574083|FG000|COMPLETED|Overall Study||244
8542643|NCT03191903|9574084|FG001|COMPLETED|Overall Study||246
8542644|NCT03191903|9574085|FG002|COMPLETED|Overall Study||70
8542645|NCT03191903|9574083|FG000|NOT COMPLETED|Overall Study||7
8542646|NCT03191903|9574084|FG001|NOT COMPLETED|Overall Study||5
8542647|NCT03191903|9574085|FG002|NOT COMPLETED|Overall Study||4
8542648|NCT03186794|9574098|FG000|STARTED|Overall Study||20
8542649|NCT03186794|9574098|FG000|COMPLETED|Overall Study||16
8542650|NCT03186794|9574098|FG000|NOT COMPLETED|Overall Study||4
8542651|NCT04289051|9574103|FG000|STARTED|Overall Study||13
8542652|NCT04289051|9574104|FG001|STARTED|Overall Study||13
8542653|NCT04289051|9574105|FG002|STARTED|Overall Study||13
8542654|NCT04289051|9574103|FG000|First Intervention (2 Weeks)|Overall Study||13
8542655|NCT04289051|9574104|FG001|First Intervention (2 Weeks)|Overall Study||13
8542656|NCT04289051|9574105|FG002|First Intervention (2 Weeks)|Overall Study||11
8542657|NCT04289051|9574103|FG000|Washout (1 Week)|Overall Study||13
8542658|NCT04289051|9574104|FG001|Washout (1 Week)|Overall Study||13
8542659|NCT04289051|9574105|FG002|Washout (1 Week)|Overall Study||11
8542660|NCT04289051|9574103|FG000|Second Intervention (2 Weeks)|Overall Study||13
8542661|NCT04289051|9574104|FG001|Second Intervention (2 Weeks)|Overall Study||13
8542662|NCT04289051|9574105|FG002|Second Intervention (2 Weeks)|Overall Study||11
8542663|NCT04289051|9574103|FG000|Washout (1 Week)|Overall Study||13
8542664|NCT04289051|9574104|FG001|Washout (1 Week)|Overall Study||13
8542665|NCT04289051|9574105|FG002|Washout (1 Week)|Overall Study||11
8542666|NCT04289051|9574103|FG000|Third Intervention (2 Weeks)|Overall Study||13
8542667|NCT04289051|9574104|FG001|Third Intervention (2 Weeks)|Overall Study||13
8542668|NCT04289051|9574105|FG002|Third Intervention (2 Weeks)|Overall Study||11
8542669|NCT04289051|9574103|FG000|COMPLETED|Overall Study||13
8542670|NCT04289051|9574104|FG001|COMPLETED|Overall Study||13
8542671|NCT04289051|9574105|FG002|COMPLETED|Overall Study||11
8542672|NCT04289051|9574103|FG000|NOT COMPLETED|Overall Study||0
8542673|NCT04289051|9574104|FG001|NOT COMPLETED|Overall Study||0
8542674|NCT04289051|9574105|FG002|NOT COMPLETED|Overall Study||2
8542675|NCT04210180|9574113|FG000|STARTED|Overall Study||25
8542676|NCT04210180|9574113|FG000|COMPLETED|Overall Study||23
8542677|NCT04210180|9574113|FG000|NOT COMPLETED|Overall Study||2
8542678|NCT04097223|9574117|FG000|STARTED|Overall Study||17464
8542679|NCT04097223|9574117|FG000|COMPLETED|Overall Study||17464
8542680|NCT04097223|9574117|FG000|NOT COMPLETED|Overall Study||0
8542681|NCT03675308|9574156|FG000|STARTED|Overall Study||481
8542682|NCT03675308|9574157|FG001|STARTED|Overall Study||483
8542683|NCT03675308|9574156|FG000|COMPLETED|Overall Study||467
8542684|NCT03675308|9574157|FG001|COMPLETED|Overall Study||473
8542685|NCT03675308|9574156|FG000|NOT COMPLETED|Overall Study||14
8542686|NCT03675308|9574157|FG001|NOT COMPLETED|Overall Study||10
8542687|NCT03573817|9574165|FG000|STARTED|Overall Study||63
8621281|NCT00479115|9660217|FG000|COMPLETED|Overall Study||1
8542688|NCT03573817|9574166|FG001|STARTED|Overall Study||59
8542689|NCT03573817|9574165|FG000|Randomized and Treated With Study Drug|Overall Study||63
8542690|NCT03573817|9574166|FG001|Randomized and Treated With Study Drug|Overall Study||59
8542691|NCT03573817|9574165|FG000|COMPLETED|Overall Study||62
8542692|NCT03573817|9574166|FG001|COMPLETED|Overall Study||55
8542693|NCT03573817|9574165|FG000|NOT COMPLETED|Overall Study||1
8542694|NCT03573817|9574166|FG001|NOT COMPLETED|Overall Study||4
8542695|NCT03318861|9574182|FG000|STARTED|Overall Study||3
8542696|NCT03318861|9574183|FG001|STARTED|Overall Study||4
8542697|NCT03318861|9574184|FG002|STARTED|Overall Study||3
8542698|NCT03318861|9574185|FG003|STARTED|Overall Study||4
8542699|NCT03318861|9574186|FG004|STARTED|Overall Study||3
8542700|NCT03318861|9574182|FG000|COMPLETED|Overall Study||0
8542701|NCT03318861|9574183|FG001|COMPLETED|Overall Study||0
8542702|NCT03318861|9574184|FG002|COMPLETED|Overall Study||0
8542703|NCT03318861|9574185|FG003|COMPLETED|Overall Study||0
8542704|NCT03318861|9574186|FG004|COMPLETED|Overall Study||0
8542705|NCT03318861|9574182|FG000|NOT COMPLETED|Overall Study||3
8542706|NCT03318861|9574183|FG001|NOT COMPLETED|Overall Study||4
8542707|NCT03318861|9574184|FG002|NOT COMPLETED|Overall Study||3
8542708|NCT03318861|9574185|FG003|NOT COMPLETED|Overall Study||4
8542709|NCT03318861|9574186|FG004|NOT COMPLETED|Overall Study||3
8542710|NCT03170349|9574198|FG000|STARTED|At 30 Days Follow-up||124
8542711|NCT03170349|9574198|FG000|COMPLETED|At 30 Days Follow-up||123
8542712|NCT03170349|9574198|FG000|NOT COMPLETED|At 30 Days Follow-up||1
8542713|NCT03170349|9574198|FG000|STARTED|At 6 Months Follow-up||123
8542714|NCT03170349|9574198|FG000|COMPLETED|At 6 Months Follow-up||114
8542715|NCT03170349|9574198|FG000|NOT COMPLETED|At 6 Months Follow-up||9
8542716|NCT03119064|9574204|FG000|STARTED|Overall Study||9
8542717|NCT03119064|9574205|FG001|STARTED|Overall Study||3
8542718|NCT03119064|9574206|FG002|STARTED|Overall Study||0
8542719|NCT03119064|9574204|FG000|COMPLETED|Overall Study||9
8542720|NCT03119064|9574205|FG001|COMPLETED|Overall Study||3
8542721|NCT03119064|9574206|FG002|COMPLETED|Overall Study||0
8542722|NCT03119064|9574204|FG000|NOT COMPLETED|Overall Study||0
8542723|NCT03119064|9574205|FG001|NOT COMPLETED|Overall Study||0
8542724|NCT03119064|9574206|FG002|NOT COMPLETED|Overall Study||0
8542725|NCT03095456|9574215|FG000|STARTED|Overall Study||103
8542726|NCT03095456|9574216|FG001|STARTED|Overall Study||104
8542727|NCT03095456|9574215|FG000|COMPLETED|Overall Study||99
8542728|NCT03095456|9574216|FG001|COMPLETED|Overall Study||96
8542729|NCT03095456|9574215|FG000|NOT COMPLETED|Overall Study||4
8542730|NCT03095456|9574216|FG001|NOT COMPLETED|Overall Study||8
8542731|NCT03064113|9574226|FG000|STARTED|Intervention 1 (2 Days)||8
8542732|NCT03064113|9574227|FG001|STARTED|Intervention 1 (2 Days)||8
8542733|NCT03064113|9574228|FG002|STARTED|Intervention 1 (2 Days)||8
8542734|NCT03064113|9574229|FG003|STARTED|Intervention 1 (2 Days)||8
8542735|NCT03064113|9574226|FG000|COMPLETED|Intervention 1 (2 Days)||8
8542736|NCT03064113|9574227|FG001|COMPLETED|Intervention 1 (2 Days)||8
8542737|NCT03064113|9574228|FG002|COMPLETED|Intervention 1 (2 Days)||8
8542738|NCT03064113|9574229|FG003|COMPLETED|Intervention 1 (2 Days)||8
8542739|NCT03064113|9574226|FG000|NOT COMPLETED|Intervention 1 (2 Days)||0
8542740|NCT03064113|9574227|FG001|NOT COMPLETED|Intervention 1 (2 Days)||0
8542741|NCT03064113|9574228|FG002|NOT COMPLETED|Intervention 1 (2 Days)||0
8542742|NCT03064113|9574229|FG003|NOT COMPLETED|Intervention 1 (2 Days)||0
8542743|NCT03064113|9574226|FG000|STARTED|Washout (7 Days)||8
8542744|NCT03064113|9574227|FG001|STARTED|Washout (7 Days)||8
8542745|NCT03064113|9574228|FG002|STARTED|Washout (7 Days)||8
8542746|NCT03064113|9574229|FG003|STARTED|Washout (7 Days)||8
8542747|NCT03064113|9574226|FG000|COMPLETED|Washout (7 Days)||8
8542748|NCT03064113|9574227|FG001|COMPLETED|Washout (7 Days)||8
8542749|NCT03064113|9574228|FG002|COMPLETED|Washout (7 Days)||8
8542750|NCT03064113|9574229|FG003|COMPLETED|Washout (7 Days)||8
8542751|NCT03064113|9574226|FG000|NOT COMPLETED|Washout (7 Days)||0
8542752|NCT03064113|9574227|FG001|NOT COMPLETED|Washout (7 Days)||0
8542753|NCT03064113|9574228|FG002|NOT COMPLETED|Washout (7 Days)||0
8542754|NCT03064113|9574229|FG003|NOT COMPLETED|Washout (7 Days)||0
8542755|NCT03064113|9574226|FG000|STARTED|Intervention 2 (2 Days)||8
8542756|NCT03064113|9574227|FG001|STARTED|Intervention 2 (2 Days)||8
8542757|NCT03064113|9574228|FG002|STARTED|Intervention 2 (2 Days)||8
8542758|NCT03064113|9574229|FG003|STARTED|Intervention 2 (2 Days)||8
8542759|NCT03064113|9574226|FG000|COMPLETED|Intervention 2 (2 Days)||8
8542760|NCT03064113|9574227|FG001|COMPLETED|Intervention 2 (2 Days)||8
8542761|NCT03064113|9574228|FG002|COMPLETED|Intervention 2 (2 Days)||8
8542762|NCT03064113|9574229|FG003|COMPLETED|Intervention 2 (2 Days)||8
8542763|NCT03064113|9574226|FG000|NOT COMPLETED|Intervention 2 (2 Days)||0
8542764|NCT03064113|9574227|FG001|NOT COMPLETED|Intervention 2 (2 Days)||0
8542765|NCT03064113|9574228|FG002|NOT COMPLETED|Intervention 2 (2 Days)||0
8542766|NCT03064113|9574229|FG003|NOT COMPLETED|Intervention 2 (2 Days)||0
8542767|NCT03064113|9574226|FG000|STARTED|Washout (7 Days)||8
8542768|NCT03064113|9574227|FG001|STARTED|Washout (7 Days)||8
8542769|NCT03064113|9574228|FG002|STARTED|Washout (7 Days)||8
8542770|NCT03064113|9574229|FG003|STARTED|Washout (7 Days)||8
8621282|NCT00479115|9660217|FG000|NOT COMPLETED|Overall Study||0
8621283|NCT00479154|9660223|FG000|STARTED|Overall Study||3
8542771|NCT03064113|9574226|FG000|COMPLETED|Washout (7 Days)||8
8542772|NCT03064113|9574227|FG001|COMPLETED|Washout (7 Days)||8
8621284|NCT00479154|9660224|FG001|STARTED|Overall Study||3
8542773|NCT03064113|9574228|FG002|COMPLETED|Washout (7 Days)||8
8542774|NCT03064113|9574229|FG003|COMPLETED|Washout (7 Days)||8
8542775|NCT03064113|9574226|FG000|NOT COMPLETED|Washout (7 Days)||0
8542776|NCT03064113|9574227|FG001|NOT COMPLETED|Washout (7 Days)||0
8542777|NCT03064113|9574228|FG002|NOT COMPLETED|Washout (7 Days)||0
8542778|NCT03064113|9574229|FG003|NOT COMPLETED|Washout (7 Days)||0
8542779|NCT03064113|9574226|FG000|STARTED|Intervention 3 (2 Days)||8
8542780|NCT03064113|9574227|FG001|STARTED|Intervention 3 (2 Days)||8
8542781|NCT03064113|9574228|FG002|STARTED|Intervention 3 (2 Days)||8
8542782|NCT03064113|9574229|FG003|STARTED|Intervention 3 (2 Days)||8
8542783|NCT03064113|9574226|FG000|COMPLETED|Intervention 3 (2 Days)||8
8542784|NCT03064113|9574227|FG001|COMPLETED|Intervention 3 (2 Days)||8
8542785|NCT03064113|9574228|FG002|COMPLETED|Intervention 3 (2 Days)||8
8542786|NCT03064113|9574229|FG003|COMPLETED|Intervention 3 (2 Days)||8
8542787|NCT03064113|9574226|FG000|NOT COMPLETED|Intervention 3 (2 Days)||0
8542788|NCT03064113|9574227|FG001|NOT COMPLETED|Intervention 3 (2 Days)||0
8542789|NCT03064113|9574228|FG002|NOT COMPLETED|Intervention 3 (2 Days)||0
8542790|NCT03064113|9574229|FG003|NOT COMPLETED|Intervention 3 (2 Days)||0
8542791|NCT03064113|9574226|FG000|STARTED|Washout (7 Days)||8
8621285|NCT00479154|9660223|FG000|COMPLETED|Overall Study||3
8621286|NCT00479154|9660224|FG001|COMPLETED|Overall Study||3
8621287|NCT00479154|9660223|FG000|NOT COMPLETED|Overall Study||0
8542792|NCT03064113|9574227|FG001|STARTED|Washout (7 Days)||8
8542793|NCT03064113|9574228|FG002|STARTED|Washout (7 Days)||8
8542794|NCT03064113|9574229|FG003|STARTED|Washout (7 Days)||8
8542795|NCT03064113|9574226|FG000|COMPLETED|Washout (7 Days)||8
8542796|NCT03064113|9574227|FG001|COMPLETED|Washout (7 Days)||8
8818193|NCT01556165|9871819|FG001|STARTED|Overall Study||65
8818194|NCT01556165|9871818|FG000|COMPLETED|Overall Study||53
8818195|NCT01556165|9871819|FG001|COMPLETED|Overall Study||58
8818196|NCT01556165|9871818|FG000|NOT COMPLETED|Overall Study||12
8818197|NCT01556165|9871819|FG001|NOT COMPLETED|Overall Study||7
8818198|NCT01556204|9871827|FG000|STARTED|Overall Study||35
8818199|NCT01556204|9871828|FG001|STARTED|Overall Study||38
8818200|NCT01556204|9871827|FG000|COMPLETED|Overall Study||35
8542797|NCT03064113|9574228|FG002|COMPLETED|Washout (7 Days)||8
8542798|NCT03064113|9574229|FG003|COMPLETED|Washout (7 Days)||8
8542799|NCT03064113|9574226|FG000|NOT COMPLETED|Washout (7 Days)||0
8542800|NCT03064113|9574227|FG001|NOT COMPLETED|Washout (7 Days)||0
8542801|NCT03064113|9574228|FG002|NOT COMPLETED|Washout (7 Days)||0
8542802|NCT03064113|9574229|FG003|NOT COMPLETED|Washout (7 Days)||0
8542803|NCT03064113|9574226|FG000|STARTED|Intervention 4 (2 Days)||8
8542804|NCT03064113|9574227|FG001|STARTED|Intervention 4 (2 Days)||8
8542805|NCT03064113|9574228|FG002|STARTED|Intervention 4 (2 Days)||8
8542806|NCT03064113|9574229|FG003|STARTED|Intervention 4 (2 Days)||8
8542807|NCT03064113|9574226|FG000|COMPLETED|Intervention 4 (2 Days)||8
8542808|NCT03064113|9574227|FG001|COMPLETED|Intervention 4 (2 Days)||8
8542809|NCT03064113|9574228|FG002|COMPLETED|Intervention 4 (2 Days)||8
8542810|NCT03064113|9574229|FG003|COMPLETED|Intervention 4 (2 Days)||8
8542811|NCT03064113|9574226|FG000|NOT COMPLETED|Intervention 4 (2 Days)||0
8542812|NCT03064113|9574227|FG001|NOT COMPLETED|Intervention 4 (2 Days)||0
8542813|NCT03064113|9574228|FG002|NOT COMPLETED|Intervention 4 (2 Days)||0
8542814|NCT03064113|9574229|FG003|NOT COMPLETED|Intervention 4 (2 Days)||0
8542815|NCT03064113|9574226|FG000|STARTED|Washout (7 Days)||8
8542816|NCT03064113|9574227|FG001|STARTED|Washout (7 Days)||8
8542817|NCT03064113|9574228|FG002|STARTED|Washout (7 Days)||8
8542818|NCT03064113|9574229|FG003|STARTED|Washout (7 Days)||8
8542819|NCT03064113|9574226|FG000|COMPLETED|Washout (7 Days)||8
8542820|NCT03064113|9574227|FG001|COMPLETED|Washout (7 Days)||8
8542821|NCT03064113|9574228|FG002|COMPLETED|Washout (7 Days)||8
8542822|NCT03064113|9574229|FG003|COMPLETED|Washout (7 Days)||8
8542823|NCT03064113|9574226|FG000|NOT COMPLETED|Washout (7 Days)||0
8542824|NCT03064113|9574227|FG001|NOT COMPLETED|Washout (7 Days)||0
8542825|NCT03064113|9574228|FG002|NOT COMPLETED|Washout (7 Days)||0
8542826|NCT03064113|9574229|FG003|NOT COMPLETED|Washout (7 Days)||0
8542827|NCT02938013|9574242|FG000|STARTED|Overall Study||5
8542828|NCT02938013|9574243|FG001|STARTED|Overall Study||5
8542829|NCT02938013|9574244|FG002|STARTED|Overall Study||5
8542830|NCT02938013|9574242|FG000|COMPLETED|Overall Study||5
8542831|NCT02938013|9574243|FG001|COMPLETED|Overall Study||5
8542832|NCT02938013|9574244|FG002|COMPLETED|Overall Study||5
8542833|NCT02938013|9574242|FG000|NOT COMPLETED|Overall Study||0
8542834|NCT02938013|9574243|FG001|NOT COMPLETED|Overall Study||0
8542835|NCT02938013|9574244|FG002|NOT COMPLETED|Overall Study||0
8542836|NCT02919683|9574254|FG000|STARTED|Pre-Surgery Intervention||15
8542837|NCT02919683|9574255|FG001|STARTED|Pre-Surgery Intervention||15
8542838|NCT02919683|9574254|FG000|COMPLETED|Pre-Surgery Intervention||15
8542839|NCT02919683|9574255|FG001|COMPLETED|Pre-Surgery Intervention||15
8542840|NCT02919683|9574254|FG000|NOT COMPLETED|Pre-Surgery Intervention||0
8542841|NCT02919683|9574255|FG001|NOT COMPLETED|Pre-Surgery Intervention||0
8542842|NCT02919683|9574254|FG000|STARTED|Post-Surgery Follow-Up||15
8542843|NCT02919683|9574255|FG001|STARTED|Post-Surgery Follow-Up||15
8542844|NCT02919683|9574254|FG000|COMPLETED|Post-Surgery Follow-Up||12
8542845|NCT02919683|9574255|FG001|COMPLETED|Post-Surgery Follow-Up||13
8542846|NCT02919683|9574254|FG000|NOT COMPLETED|Post-Surgery Follow-Up||3
8542847|NCT02919683|9574255|FG001|NOT COMPLETED|Post-Surgery Follow-Up||2
8621288|NCT00479154|9660224|FG001|NOT COMPLETED|Overall Study||0
8621289|NCT00479232|9660232|FG000|STARTED|Overall Study||3
8818201|NCT01556204|9871828|FG001|COMPLETED|Overall Study||38
8818202|NCT01556204|9871827|FG000|NOT COMPLETED|Overall Study||0
8818203|NCT01556204|9871828|FG001|NOT COMPLETED|Overall Study||0
8818204|NCT01556347|9871834|FG000|STARTED|Induction Immunotherapy||2
8542848|NCT02901548|9574262|FG000|STARTED|Overall Study||17
8542849|NCT02901548|9574262|FG000|COMPLETED|Overall Study||13
8542850|NCT02901548|9574262|FG000|NOT COMPLETED|Overall Study||4
8542851|NCT02790138|9574268|FG000|STARTED|Overall Study||51
8542852|NCT02790138|9574269|FG001|STARTED|Overall Study||51
8542853|NCT02790138|9574268|FG000|COMPLETED|Overall Study||30
8542854|NCT02790138|9574269|FG001|COMPLETED|Overall Study||32
8542855|NCT02790138|9574268|FG000|NOT COMPLETED|Overall Study||21
8542856|NCT02790138|9574269|FG001|NOT COMPLETED|Overall Study||19
8542857|NCT02642315|9574276|FG000|STARTED|Overall Study||10
8621290|NCT00479232|9660233|FG001|STARTED|Overall Study||3
8621291|NCT00479232|9660234|FG002|STARTED|Overall Study||28
8542858|NCT02642315|9574276|FG000|COMPLETED|Overall Study||8
8542859|NCT02642315|9574276|FG000|NOT COMPLETED|Overall Study||2
8542860|NCT02518139|9574283|FG000|STARTED|Overall Study||364
8542861|NCT02518139|9574284|FG001|STARTED|Overall Study||335
8542862|NCT02518139|9574285|FG002|STARTED|Overall Study||356
8542863|NCT02518139|9574283|FG000|COMPLETED|Overall Study||219
8542864|NCT02518139|9574284|FG001|COMPLETED|Overall Study||191
8542865|NCT02518139|9574285|FG002|COMPLETED|Overall Study||262
8542866|NCT02518139|9574283|FG000|NOT COMPLETED|Overall Study||145
8542867|NCT02518139|9574284|FG001|NOT COMPLETED|Overall Study||144
8542868|NCT02518139|9574285|FG002|NOT COMPLETED|Overall Study||94
8542869|NCT02514239|9574303|FG000|STARTED|Overall Study||5
8542870|NCT02514239|9574304|FG001|STARTED|Overall Study||4
8542871|NCT02514239|9574305|FG002|STARTED|Overall Study||3
8542872|NCT02514239|9574306|FG003|STARTED|Overall Study||3
8542873|NCT02514239|9574307|FG004|STARTED|Overall Study||3
8542874|NCT02514239|9574308|FG005|STARTED|Overall Study||5
8542875|NCT02514239|9574309|FG006|STARTED|Overall Study||4
8542876|NCT02514239|9574310|FG007|STARTED|Overall Study||3
8542877|NCT02514239|9574311|FG008|STARTED|Overall Study||10
8542878|NCT02514239|9574312|FG009|STARTED|Overall Study||3
8542879|NCT02514239|9574303|FG000|Treated|Overall Study||5
8542880|NCT02514239|9574304|FG001|Treated|Overall Study||3
8542881|NCT02514239|9574305|FG002|Treated|Overall Study||3
8542882|NCT02514239|9574306|FG003|Treated|Overall Study||3
8542883|NCT02514239|9574307|FG004|Treated|Overall Study||3
8542884|NCT02514239|9574308|FG005|Treated|Overall Study||5
8542885|NCT02514239|9574309|FG006|Treated|Overall Study||4
8542886|NCT02514239|9574310|FG007|Treated|Overall Study||3
8542887|NCT02514239|9574311|FG008|Treated|Overall Study||10
8542888|NCT02514239|9574312|FG009|Treated|Overall Study||3
8542889|NCT02514239|9574303|FG000|COMPLETED|Overall Study||0
8542890|NCT02514239|9574304|FG001|COMPLETED|Overall Study||0
8542891|NCT02514239|9574305|FG002|COMPLETED|Overall Study||1
8542892|NCT02514239|9574306|FG003|COMPLETED|Overall Study||0
8542893|NCT02514239|9574307|FG004|COMPLETED|Overall Study||0
8542894|NCT02514239|9574308|FG005|COMPLETED|Overall Study||1
8542895|NCT02514239|9574309|FG006|COMPLETED|Overall Study||0
8542896|NCT02514239|9574310|FG007|COMPLETED|Overall Study||0
8542897|NCT02514239|9574311|FG008|COMPLETED|Overall Study||2
8542898|NCT02514239|9574312|FG009|COMPLETED|Overall Study||0
8621292|NCT00479232|9660235|FG003|STARTED|Overall Study||3
8621293|NCT00479232|9660236|FG004|STARTED|Overall Study||4
8621294|NCT00479232|9660237|FG005|STARTED|Overall Study||30
8621295|NCT00479232|9660232|FG000|COMPLETED|Overall Study||0
8621296|NCT00479232|9660233|FG001|COMPLETED|Overall Study||0
8621297|NCT00479232|9660234|FG002|COMPLETED|Overall Study||0
8621298|NCT00479232|9660235|FG003|COMPLETED|Overall Study||0
8621299|NCT00479232|9660236|FG004|COMPLETED|Overall Study||0
8621300|NCT00479232|9660237|FG005|COMPLETED|Overall Study||0
8621301|NCT00479232|9660232|FG000|NOT COMPLETED|Overall Study||3
8621302|NCT00479232|9660233|FG001|NOT COMPLETED|Overall Study||3
8621303|NCT00479232|9660234|FG002|NOT COMPLETED|Overall Study||28
8621304|NCT00479232|9660235|FG003|NOT COMPLETED|Overall Study||3
8621305|NCT00479232|9660236|FG004|NOT COMPLETED|Overall Study||4
8621306|NCT00479232|9660237|FG005|NOT COMPLETED|Overall Study||30
8621307|NCT00479336|9660259|FG000|STARTED|Overall Study||27
8621308|NCT00479336|9660260|FG001|STARTED|Overall Study||26
8621309|NCT00479336|9660261|FG002|STARTED|Overall Study||25
8621310|NCT00479336|9660262|FG003|STARTED|Overall Study||26
8621311|NCT00479336|9660259|FG000|COMPLETED|Overall Study||23
8621312|NCT00479336|9660260|FG001|COMPLETED|Overall Study||20
8621313|NCT00479336|9660261|FG002|COMPLETED|Overall Study||24
8621314|NCT00479336|9660262|FG003|COMPLETED|Overall Study||21
8621315|NCT00479336|9660259|FG000|NOT COMPLETED|Overall Study||4
8621316|NCT00479336|9660260|FG001|NOT COMPLETED|Overall Study||6
8621317|NCT00479336|9660261|FG002|NOT COMPLETED|Overall Study||1
8621318|NCT00479336|9660262|FG003|NOT COMPLETED|Overall Study||5
8621319|NCT00479388|9660274|FG000|STARTED|Overall Study||606
8621320|NCT00479388|9660275|FG001|STARTED|Overall Study||610
8621321|NCT00479388|9660274|FG000|COMPLETED|Overall Study||474
8621322|NCT00479388|9660275|FG001|COMPLETED|Overall Study||537
8621323|NCT00479388|9660274|FG000|NOT COMPLETED|Overall Study||132
8621324|NCT00479388|9660275|FG001|NOT COMPLETED|Overall Study||73
8542899|NCT02514239|9574303|FG000|NOT COMPLETED|Overall Study||5
8542900|NCT02514239|9574304|FG001|NOT COMPLETED|Overall Study||4
8542901|NCT02514239|9574305|FG002|NOT COMPLETED|Overall Study||2
8542902|NCT02514239|9574306|FG003|NOT COMPLETED|Overall Study||3
8542903|NCT02514239|9574307|FG004|NOT COMPLETED|Overall Study||3
8542904|NCT02514239|9574308|FG005|NOT COMPLETED|Overall Study||4
8542905|NCT02514239|9574309|FG006|NOT COMPLETED|Overall Study||4
8542906|NCT02514239|9574310|FG007|NOT COMPLETED|Overall Study||3
8542907|NCT02514239|9574311|FG008|NOT COMPLETED|Overall Study||8
8542908|NCT02514239|9574312|FG009|NOT COMPLETED|Overall Study||3
8621325|NCT00479401|9660284|FG000|STARTED|Overall Study||223
8621326|NCT00479401|9660285|FG001|STARTED|Overall Study||213
8621327|NCT00479401|9660286|FG002|STARTED|Overall Study||103
8621328|NCT00479401|9660284|FG000|COMPLETED|Overall Study||174
8621329|NCT00479401|9660285|FG001|COMPLETED|Overall Study||176
8621330|NCT00479401|9660286|FG002|COMPLETED|Overall Study||91
8621331|NCT00479401|9660284|FG000|NOT COMPLETED|Overall Study||49
8621332|NCT00479401|9660285|FG001|NOT COMPLETED|Overall Study||37
8542909|NCT02512510|9574355|FG000|STARTED|Overall Study||205
8621333|NCT00479401|9660286|FG002|NOT COMPLETED|Overall Study||12
9065792|NCT04142450|10126268|FG000|Safety Population|Overall Study||49
8542910|NCT02512510|9574356|FG001|STARTED|Overall Study||197
8542911|NCT02512510|9574357|FG002|STARTED|Overall Study||209
8542912|NCT02512510|9574355|FG000|COMPLETED|Overall Study||163
8542913|NCT02512510|9574356|FG001|COMPLETED|Overall Study||162
8542914|NCT02512510|9574357|FG002|COMPLETED|Overall Study||157
8542915|NCT02512510|9574355|FG000|NOT COMPLETED|Overall Study||42
8542916|NCT02512510|9574356|FG001|NOT COMPLETED|Overall Study||35
8542917|NCT02512510|9574357|FG002|NOT COMPLETED|Overall Study||52
8542918|NCT02459080|9574368|FG000|STARTED|Overall Study||212
8542919|NCT02459080|9574369|FG001|STARTED|Overall Study||198
8542920|NCT02459080|9574370|FG002|STARTED|Overall Study||209
8542921|NCT02459080|9574368|FG000|COMPLETED|Overall Study||168
8542922|NCT02459080|9574369|FG001|COMPLETED|Overall Study||158
8542923|NCT02459080|9574370|FG002|COMPLETED|Overall Study||151
8542924|NCT02459080|9574368|FG000|NOT COMPLETED|Overall Study||44
8542925|NCT02459080|9574369|FG001|NOT COMPLETED|Overall Study||40
8542926|NCT02459080|9574370|FG002|NOT COMPLETED|Overall Study||58
8542927|NCT02245672|9574381|FG000|STARTED|Overall Study||512
8542928|NCT02245672|9574382|FG001|STARTED|Overall Study||513
8542929|NCT02245672|9574383|FG002|STARTED|Overall Study||103
8542930|NCT02245672|9574381|FG000|COMPLETED|Overall Study||499
8542931|NCT02245672|9574382|FG001|COMPLETED|Overall Study||500
8542932|NCT02245672|9574383|FG002|COMPLETED|Overall Study||98
8542933|NCT02245672|9574381|FG000|NOT COMPLETED|Overall Study||13
8542934|NCT02245672|9574382|FG001|NOT COMPLETED|Overall Study||13
9065793|NCT04142450|10126268|FG000|COMPLETED|Overall Study||48
9065794|NCT04142450|10126268|FG000|NOT COMPLETED|Overall Study||2
9065795|NCT04140890|10126274|FG000|STARTED|Overall Study||9
9065796|NCT04140890|10126275|FG001|STARTED|Overall Study||12
9065797|NCT04140890|10126274|FG000|COMPLETED|Overall Study||9
9065798|NCT04140890|10126275|FG001|COMPLETED|Overall Study||11
9065799|NCT04140890|10126274|FG000|NOT COMPLETED|Overall Study||0
9065800|NCT04140890|10126275|FG001|NOT COMPLETED|Overall Study||1
9065801|NCT04139018|10126286|FG000|STARTED|Overall Study||14
9065802|NCT04139018|10126287|FG001|STARTED|Overall Study||13
9065803|NCT04139018|10126286|FG000|COMPLETED|Overall Study||11
9065804|NCT04139018|10126287|FG001|COMPLETED|Overall Study||12
9065805|NCT04139018|10126286|FG000|NOT COMPLETED|Overall Study||3
9065806|NCT04139018|10126287|FG001|NOT COMPLETED|Overall Study||1
9065807|NCT04138810|10126295|FG000|STARTED|Overall Study||27
9065808|NCT04138810|10126296|FG001|STARTED|Overall Study||27
9065809|NCT04138810|10126295|FG000|COMPLETED|Overall Study||26
9065810|NCT04138810|10126296|FG001|COMPLETED|Overall Study||26
9065811|NCT04138810|10126295|FG000|NOT COMPLETED|Overall Study||1
9065812|NCT04138810|10126296|FG001|NOT COMPLETED|Overall Study||1
9065813|NCT04131556|10126302|FG000|STARTED|Overall Study||20
9065814|NCT04131556|10126302|FG000|COMPLETED|Overall Study||18
9065815|NCT04131556|10126302|FG000|NOT COMPLETED|Overall Study||2
9065816|NCT04126174|10126309|FG000|STARTED|Overall Study||41
8542935|NCT02245672|9574383|FG002|NOT COMPLETED|Overall Study||5
8542936|NCT02109172|9574391|FG000|STARTED|Overall Study||11
8542937|NCT02109172|9574392|FG001|STARTED|Overall Study||11
8542938|NCT02109172|9574393|FG002|STARTED|Overall Study||10
8542939|NCT02109172|9574394|FG003|STARTED|Overall Study||11
8542940|NCT02109172|9574395|FG004|STARTED|Overall Study||10
8542941|NCT02109172|9574396|FG005|STARTED|Overall Study||11
8542942|NCT02109172|9574391|FG000|COMPLETED|Overall Study||10
8542943|NCT02109172|9574392|FG001|COMPLETED|Overall Study||11
8542944|NCT02109172|9574393|FG002|COMPLETED|Overall Study||9
8542945|NCT02109172|9574394|FG003|COMPLETED|Overall Study||10
8542946|NCT02109172|9574395|FG004|COMPLETED|Overall Study||9
8542947|NCT02109172|9574396|FG005|COMPLETED|Overall Study||10
8542948|NCT02109172|9574391|FG000|NOT COMPLETED|Overall Study||1
8542949|NCT02109172|9574392|FG001|NOT COMPLETED|Overall Study||0
8542950|NCT02109172|9574393|FG002|NOT COMPLETED|Overall Study||1
8542951|NCT02109172|9574394|FG003|NOT COMPLETED|Overall Study||1
8542952|NCT02109172|9574395|FG004|NOT COMPLETED|Overall Study||1
8542953|NCT02109172|9574396|FG005|NOT COMPLETED|Overall Study||1
8542954|NCT02040792|9574409|FG000|STARTED|Overall Study||70
8542955|NCT02040792|9574410|FG001|STARTED|Overall Study||68
8542956|NCT02040792|9574411|FG002|STARTED|Overall Study||71
8542957|NCT02040792|9574412|FG003|STARTED|Overall Study||71
8542958|NCT02040792|9574413|FG004|STARTED|Overall Study||74
9065817|NCT04126174|10126310|FG001|STARTED|Overall Study||41
9065818|NCT04126174|10126309|FG000|COMPLETED|Overall Study||38
9065819|NCT04126174|10126310|FG001|COMPLETED|Overall Study||38
9065820|NCT04126174|10126309|FG000|NOT COMPLETED|Overall Study||3
9065821|NCT04126174|10126310|FG001|NOT COMPLETED|Overall Study||3
9065822|NCT04134429|10126316|FG000|STARTED|Overall Study||20
9065823|NCT04134429|10126316|FG000|COMPLETED|Overall Study||19
9065824|NCT04134429|10126316|FG000|NOT COMPLETED|Overall Study||1
9065825|NCT04130425|10126320|FG000|STARTED|Overall Study||30
9065826|NCT04130425|10126320|FG000|COMPLETED|Overall Study||30
9065827|NCT04130425|10126320|FG000|NOT COMPLETED|Overall Study||0
9065828|NCT04138498|10126335|FG000|STARTED|Overall Study||11
9065829|NCT04138498|10126336|FG001|STARTED|Overall Study||10
9065830|NCT04138498|10126337|FG002|STARTED|Overall Study||12
9065831|NCT04138498|10126338|FG003|STARTED|Overall Study||12
9065832|NCT04138498|10126335|FG000|COMPLETED|Overall Study||10
9065833|NCT04138498|10126336|FG001|COMPLETED|Overall Study||10
9065834|NCT04138498|10126337|FG002|COMPLETED|Overall Study||10
9065835|NCT04138498|10126338|FG003|COMPLETED|Overall Study||9
9065836|NCT04138498|10126335|FG000|NOT COMPLETED|Overall Study||1
8542959|NCT02040792|9574409|FG000|COMPLETED|Overall Study||64
8542960|NCT02040792|9574410|FG001|COMPLETED|Overall Study||65
8542961|NCT02040792|9574411|FG002|COMPLETED|Overall Study||68
8542962|NCT02040792|9574412|FG003|COMPLETED|Overall Study||64
8542963|NCT02040792|9574413|FG004|COMPLETED|Overall Study||67
8542964|NCT02040792|9574409|FG000|NOT COMPLETED|Overall Study||6
8542965|NCT02040792|9574410|FG001|NOT COMPLETED|Overall Study||3
8542966|NCT02040792|9574411|FG002|NOT COMPLETED|Overall Study||3
8542967|NCT02040792|9574412|FG003|NOT COMPLETED|Overall Study||7
8542968|NCT02040792|9574413|FG004|NOT COMPLETED|Overall Study||7
8542969|NCT01979003|9574425|FG000|STARTED|Overall Study||100
8542970|NCT01979003|9574425|FG000|COMPLETED|Overall Study||72
8542971|NCT01979003|9574425|FG000|NOT COMPLETED|Overall Study||28
8542972|NCT01704404|9574429|FG000|STARTED|Overall Study||11
8542973|NCT01704404|9574430|FG001|STARTED|Overall Study||10
8542974|NCT01704404|9574431|FG002|STARTED|Overall Study||10
8542975|NCT01704404|9574432|FG003|STARTED|Overall Study||11
8542976|NCT01704404|9574433|FG004|STARTED|Overall Study||11
8542977|NCT01704404|9574434|FG005|STARTED|Overall Study||9
8542978|NCT01704404|9574429|FG000|COMPLETED|Overall Study||10
8542979|NCT01704404|9574430|FG001|COMPLETED|Overall Study||9
8542980|NCT01704404|9574431|FG002|COMPLETED|Overall Study||9
8542981|NCT01704404|9574432|FG003|COMPLETED|Overall Study||8
8542982|NCT01704404|9574433|FG004|COMPLETED|Overall Study||10
8542983|NCT01704404|9574434|FG005|COMPLETED|Overall Study||9
8542984|NCT01704404|9574429|FG000|NOT COMPLETED|Overall Study||1
8542985|NCT01704404|9574430|FG001|NOT COMPLETED|Overall Study||1
8542986|NCT01704404|9574431|FG002|NOT COMPLETED|Overall Study||1
8542987|NCT01704404|9574432|FG003|NOT COMPLETED|Overall Study||3
8542988|NCT01704404|9574433|FG004|NOT COMPLETED|Overall Study||1
8542989|NCT01704404|9574434|FG005|NOT COMPLETED|Overall Study||0
8542990|NCT01307813|9574450|FG000|STARTED|Overall Study||4
8542991|NCT01307813|9574450|FG000|COMPLETED|Overall Study||4
8542992|NCT01307813|9574450|FG000|NOT COMPLETED|Overall Study||0
8566476|NCT00076258|9598618|FG000|STARTED|Overall Study||62
8566477|NCT00076258|9598619|FG001|STARTED|Overall Study||64
8566478|NCT00076258|9598618|FG000|COMPLETED|Overall Study||61
8566479|NCT00076258|9598619|FG001|COMPLETED|Overall Study||61
8566480|NCT00076258|9598618|FG000|NOT COMPLETED|Overall Study||1
8566481|NCT00076258|9598619|FG001|NOT COMPLETED|Overall Study||3
8566482|NCT00076336|9598627|FG000|STARTED|Overall Study||116
8566483|NCT00076336|9598628|FG001|STARTED|Overall Study||116
8566484|NCT00076336|9598627|FG000|Safety Population|Overall Study|1 patient was randomized but never received study drug and not included in safety population.|115
8566485|NCT00076336|9598628|FG001|Safety Population|Overall Study||116
8566486|NCT00076336|9598627|FG000|Intent to Treat (ITT) Population|Overall Study|1 patient had no HBV DNA assessments after baseline and was excluded from ITT population.|114
8566487|NCT00076336|9598628|FG001|Intent to Treat (ITT) Population|Overall Study|2 patients had no HBV DNA assessments after baseline and were excluded from ITT population.|114
8566488|NCT00076336|9598627|FG000|Completed Week 52|Overall Study||97
8566489|NCT00076336|9598628|FG001|Completed Week 52|Overall Study||94
8566490|NCT00076336|9598627|FG000|Completed Week 104|Overall Study||70
8566491|NCT00076336|9598628|FG001|Completed Week 104|Overall Study||62
8566492|NCT00076336|9598627|FG000|COMPLETED|Overall Study||64
8566493|NCT00076336|9598628|FG001|COMPLETED|Overall Study||60
8566494|NCT00076336|9598627|FG000|NOT COMPLETED|Overall Study||52
8566495|NCT00076336|9598628|FG001|NOT COMPLETED|Overall Study||56
8566496|NCT00076570|9598636|FG000|STARTED|Overall Study||15
8566497|NCT00076570|9598637|FG001|STARTED|Overall Study||16
8566498|NCT00076570|9598636|FG000|COMPLETED|Overall Study||7
8566499|NCT00076570|9598637|FG001|COMPLETED|Overall Study||8
8566500|NCT00076570|9598636|FG000|NOT COMPLETED|Overall Study||8
8566501|NCT00076570|9598637|FG001|NOT COMPLETED|Overall Study||8
8566502|NCT00076622|9598647|FG000|STARTED|Overall Study||23
8566503|NCT00076622|9598648|FG001|STARTED|Overall Study||13
8566504|NCT00076622|9598649|FG002|STARTED|Overall Study||40
8566505|NCT00076622|9598650|FG003|STARTED|Overall Study||18
8566506|NCT00076622|9598647|FG000|COMPLETED|Overall Study||23
8566507|NCT00076622|9598648|FG001|COMPLETED|Overall Study||13
8566508|NCT00076622|9598649|FG002|COMPLETED|Overall Study||40
8566509|NCT00076622|9598650|FG003|COMPLETED|Overall Study||18
8566510|NCT00076622|9598647|FG000|NOT COMPLETED|Overall Study||0
8566511|NCT00076622|9598648|FG001|NOT COMPLETED|Overall Study||0
8566512|NCT00076622|9598649|FG002|NOT COMPLETED|Overall Study||0
8566513|NCT00076622|9598650|FG003|NOT COMPLETED|Overall Study||0
8566514|NCT00076687|9598667|FG000|STARTED|Overall Study||48
8566515|NCT00076687|9598668|FG001|STARTED|Overall Study||52
8566516|NCT00076687|9598669|FG002|STARTED|Overall Study||55
8566517|NCT00076687|9598667|FG000|COMPLETED|Overall Study||42
8566518|NCT00076687|9598668|FG001|COMPLETED|Overall Study||47
8566519|NCT00076687|9598669|FG002|COMPLETED|Overall Study||51
8566520|NCT00076687|9598667|FG000|NOT COMPLETED|Overall Study||6
8566521|NCT00076687|9598668|FG001|NOT COMPLETED|Overall Study||5
8566522|NCT00076687|9598669|FG002|NOT COMPLETED|Overall Study||4
8566523|NCT00076752|9598677|FG000|STARTED|Overall Study||9
8566524|NCT00076752|9598677|FG000|COMPLETED|Overall Study||6
8566525|NCT00076752|9598677|FG000|NOT COMPLETED|Overall Study||3
8566526|NCT00076804|9598684|FG000|STARTED|Overall Study||137
8566527|NCT00076804|9598685|FG001|STARTED|Overall Study||137
8566528|NCT00076804|9598684|FG000|COMPLETED|Overall Study|111 completed week 48, 77 completed week 96.|77
8566529|NCT00076804|9598685|FG001|COMPLETED|Overall Study|102 completed week 48, 68 completed week 96|68
8542993|NCT00799396|9574454|FG000|STARTED|Clopidogrel Treatment||682
8542994|NCT00799396|9574454|FG000|COMPLETED|Clopidogrel Treatment||669
8542995|NCT00799396|9574454|FG000|NOT COMPLETED|Clopidogrel Treatment||13
8542996|NCT00799396|9574454|FG000|STARTED|Clopidogrel Plus Aspirin||669
8542997|NCT00799396|9574454|FG000|COMPLETED|Clopidogrel Plus Aspirin||663
8542998|NCT00799396|9574454|FG000|NOT COMPLETED|Clopidogrel Plus Aspirin||6
8542999|NCT00069238|9574458|FG000|STARTED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||25
8543000|NCT00069238|9574459|FG001|STARTED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
8543001|NCT00069238|9574460|FG002|STARTED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
8543002|NCT00069238|9574458|FG000|COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||16
8543003|NCT00069238|9574459|FG001|COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
8543004|NCT00069238|9574460|FG002|COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
8543005|NCT00069238|9574458|FG000|NOT COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||9
8543006|NCT00069238|9574459|FG001|NOT COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
8543007|NCT00069238|9574460|FG002|NOT COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
8621334|NCT00479466|9660300|FG000|STARTED|Overall Study||57
8621335|NCT00479466|9660301|FG001|STARTED|Overall Study||57
8621336|NCT00479466|9660302|FG002|STARTED|Overall Study||57
8943800|NCT02391948|10005623|FG002|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 28 of the Not Completed remained active.|77
8943801|NCT02391948|10005624|FG003|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 41 of the Not Completed remained active.|125
8943802|NCT02391948|10005625|FG004|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 24 of the Not Completed remained active.|109
8943803|NCT02391948|10005621|FG000|COMPLETED|12-month Assessment||217
8943804|NCT02391948|10005622|FG001|COMPLETED|12-month Assessment||147
8543008|NCT00069238|9574458|FG000|STARTED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
8543009|NCT00069238|9574459|FG001|STARTED|Cohort 2 - Dose Level 2 (Weeks 1-18)||3
8543010|NCT00069238|9574460|FG002|STARTED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
8543011|NCT00069238|9574458|FG000|COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
8543012|NCT00069238|9574459|FG001|COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||1
8543013|NCT00069238|9574460|FG002|COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
8543014|NCT00069238|9574458|FG000|NOT COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
8543015|NCT00069238|9574459|FG001|NOT COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||2
8543016|NCT00069238|9574460|FG002|NOT COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
8543017|NCT00069238|9574458|FG000|STARTED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
8543018|NCT00069238|9574459|FG001|STARTED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
8543019|NCT00069238|9574460|FG002|STARTED|Cohort 3 - Dose Level 3 (Weeks 1-18)||3
8543020|NCT00069238|9574458|FG000|COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
8543021|NCT00069238|9574459|FG001|COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
8543022|NCT00069238|9574460|FG002|COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||1
8543023|NCT00069238|9574458|FG000|NOT COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
8543024|NCT00069238|9574459|FG001|NOT COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
8543025|NCT00069238|9574460|FG002|NOT COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||2
8566530|NCT00076804|9598684|FG000|NOT COMPLETED|Overall Study||60
8566531|NCT00076804|9598685|FG001|NOT COMPLETED|Overall Study||69
8566532|NCT00076999|9598695|FG000|STARTED|Overall Study||25
8566533|NCT00076999|9598696|FG001|STARTED|Overall Study||31
8566534|NCT00076999|9598697|FG002|STARTED|Overall Study||19
8566535|NCT00076999|9598698|FG003|STARTED|Overall Study||6
8566536|NCT00076999|9598699|FG004|STARTED|Overall Study||34
8566537|NCT00076999|9598695|FG000|COMPLETED|Overall Study||13
8566538|NCT00076999|9598696|FG001|COMPLETED|Overall Study||7
8566539|NCT00076999|9598697|FG002|COMPLETED|Overall Study||2
8566540|NCT00076999|9598698|FG003|COMPLETED|Overall Study||5
8566541|NCT00076999|9598699|FG004|COMPLETED|Overall Study||9
8566542|NCT00076999|9598695|FG000|NOT COMPLETED|Overall Study||12
8566543|NCT00076999|9598696|FG001|NOT COMPLETED|Overall Study||24
8566544|NCT00076999|9598697|FG002|NOT COMPLETED|Overall Study||17
8566545|NCT00076999|9598698|FG003|NOT COMPLETED|Overall Study||1
8566546|NCT00076999|9598699|FG004|NOT COMPLETED|Overall Study||25
8566547|NCT00077064|9598714|FG000|STARTED|Overall Study||17
8566548|NCT00077064|9598715|FG001|STARTED|Overall Study||16
8566549|NCT00077064|9598714|FG000|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|17
8566550|NCT00077064|9598715|FG001|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|10
8566551|NCT00077064|9598714|FG000|NOT COMPLETED|Overall Study||0
8566552|NCT00077064|9598715|FG001|NOT COMPLETED|Overall Study||6
8566553|NCT00077207|9598722|FG000|STARTED|Overall Study||66
8566554|NCT00077207|9598722|FG000|COMPLETED|Overall Study||36
8566555|NCT00077207|9598722|FG000|NOT COMPLETED|Overall Study||30
8566556|NCT00077376|9598727|FG000|STARTED|Overall Study||61
8566557|NCT00077376|9598727|FG000|Treated|Overall Study||59
8566558|NCT00077376|9598727|FG000|HER2+ in Central Testing|Overall Study||39
8566559|NCT00077376|9598727|FG000|COMPLETED|Overall Study||39
8566560|NCT00077376|9598727|FG000|NOT COMPLETED|Overall Study||22
8566561|NCT00077610|9598734|FG000|STARTED|Overall Study||223
8566562|NCT00077610|9598735|FG001|STARTED|Overall Study||224
8566563|NCT00077610|9598736|FG002|STARTED|Overall Study||226
8566564|NCT00077610|9598734|FG000|Started Treatment|Overall Study||221
8566565|NCT00077610|9598735|FG001|Started Treatment|Overall Study||220
8566566|NCT00077610|9598736|FG002|Started Treatment|Overall Study||225
8621337|NCT00479466|9660303|FG003|STARTED|Overall Study||58
8621338|NCT00479466|9660304|FG004|STARTED|Overall Study||56
8621339|NCT00479466|9660305|FG005|STARTED|Overall Study||57
8621340|NCT00479466|9660300|FG000|COMPLETED|Overall Study||44
8621341|NCT00479466|9660301|FG001|COMPLETED|Overall Study||49
8621342|NCT00479466|9660302|FG002|COMPLETED|Overall Study||54
8621343|NCT00479466|9660303|FG003|COMPLETED|Overall Study||55
8621344|NCT00479466|9660304|FG004|COMPLETED|Overall Study||48
8621345|NCT00479466|9660305|FG005|COMPLETED|Overall Study||53
8621346|NCT00479466|9660300|FG000|NOT COMPLETED|Overall Study||13
8621347|NCT00479466|9660301|FG001|NOT COMPLETED|Overall Study||8
8621348|NCT00479466|9660302|FG002|NOT COMPLETED|Overall Study||3
8621349|NCT00479466|9660303|FG003|NOT COMPLETED|Overall Study||3
8621350|NCT00479466|9660304|FG004|NOT COMPLETED|Overall Study||8
8621351|NCT00479466|9660305|FG005|NOT COMPLETED|Overall Study||4
8621352|NCT00479557|9660326|FG000|STARTED|Overall Study||36
8621353|NCT00479557|9660327|FG001|STARTED|Overall Study||61
8621354|NCT00479557|9660328|FG002|STARTED|Overall Study||40
8621355|NCT00479557|9660329|FG003|STARTED|Overall Study||35
8621356|NCT00479557|9660330|FG004|STARTED|Overall Study||12
8621357|NCT00479557|9660331|FG005|STARTED|Overall Study||44
8621358|NCT00479557|9660332|FG006|STARTED|Overall Study||17
8621359|NCT00479557|9660326|FG000|Treated|Overall Study||36
8543026|NCT03138499|9574467|FG000|STARTED|Overall Study||12
8543027|NCT03138499|9574468|FG001|STARTED|Overall Study||11
8543028|NCT03138499|9574467|FG000|COMPLETED|Overall Study||3
8543029|NCT03138499|9574468|FG001|COMPLETED|Overall Study||1
8543030|NCT03138499|9574467|FG000|NOT COMPLETED|Overall Study||9
8543031|NCT03138499|9574468|FG001|NOT COMPLETED|Overall Study||10
8543032|NCT03107208|9574477|FG000|STARTED|Overall Study||30
8543033|NCT03107208|9574478|FG001|STARTED|Overall Study||27
8543034|NCT03107208|9574477|FG000|Received Intervention|Overall Study||26
8543035|NCT03107208|9574478|FG001|Received Intervention|Overall Study||24
8543036|NCT03107208|9574477|FG000|COMPLETED|Overall Study||26
8543037|NCT03107208|9574478|FG001|COMPLETED|Overall Study||24
8543038|NCT03107208|9574477|FG000|NOT COMPLETED|Overall Study||4
8543039|NCT03107208|9574478|FG001|NOT COMPLETED|Overall Study||3
8543040|NCT04509739|9574484|FG000|STARTED|Overall Study||16
8543041|NCT04509739|9574484|FG000|COMPLETED|Overall Study||15
8543042|NCT04509739|9574484|FG000|NOT COMPLETED|Overall Study||1
8543043|NCT04391959|9574490|FG000|STARTED|Overall Study||16
8543044|NCT04391959|9574491|FG001|STARTED|Overall Study|One subject should have been excluded based upon Schirmer test = 0 mm at baseline < 5mm. Subject was removed from the study.|15
8543045|NCT04391959|9574490|FG000|COMPLETED|Overall Study||15
8543046|NCT04391959|9574491|FG001|COMPLETED|Overall Study||10
8543047|NCT04391959|9574490|FG000|NOT COMPLETED|Overall Study||1
8543048|NCT04391959|9574491|FG001|NOT COMPLETED|Overall Study||5
8543049|NCT04368364|9574500|FG000|STARTED|Overall Study||1
8543050|NCT04368364|9574501|FG001|STARTED|Overall Study||1
8543051|NCT04368364|9574502|FG002|STARTED|Overall Study||1
8543052|NCT04368364|9574500|FG000|COMPLETED|Overall Study||1
8543053|NCT04368364|9574501|FG001|COMPLETED|Overall Study||1
8543054|NCT04368364|9574502|FG002|COMPLETED|Overall Study||1
8543055|NCT04368364|9574500|FG000|NOT COMPLETED|Overall Study||0
8543056|NCT04368364|9574501|FG001|NOT COMPLETED|Overall Study||0
8543057|NCT04368364|9574502|FG002|NOT COMPLETED|Overall Study||0
8543058|NCT04244084|9574512|FG000|STARTED|Overall Study||118
8543059|NCT04244084|9574513|FG001|STARTED|Overall Study||122
8543060|NCT04244084|9574512|FG000|COMPLETED|Overall Study||118
8543061|NCT04244084|9574513|FG001|COMPLETED|Overall Study||122
8543062|NCT04244084|9574512|FG000|NOT COMPLETED|Overall Study||0
8543063|NCT04244084|9574513|FG001|NOT COMPLETED|Overall Study||0
8543064|NCT04189588|9574521|FG000|STARTED|Overall Study||17
8543065|NCT04189588|9574522|FG001|STARTED|Overall Study||17
8543066|NCT04189588|9574521|FG000|Completed Treatment|Overall Study||17
8543067|NCT04189588|9574522|FG001|Completed Treatment|Overall Study||17
8543068|NCT04189588|9574521|FG000|COMPLETED|Overall Study||17
8543069|NCT04189588|9574522|FG001|COMPLETED|Overall Study||15
8543070|NCT04189588|9574521|FG000|NOT COMPLETED|Overall Study||0
8543071|NCT04189588|9574522|FG001|NOT COMPLETED|Overall Study||2
8543072|NCT04150562|9574528|FG000|STARTED|Overall Study||2
8543073|NCT04150562|9574529|FG001|STARTED|Overall Study||0
8543074|NCT04150562|9574528|FG000|COMPLETED|Overall Study||2
8543075|NCT04150562|9574529|FG001|COMPLETED|Overall Study||0
8543076|NCT04150562|9574528|FG000|NOT COMPLETED|Overall Study||0
8543077|NCT04150562|9574529|FG001|NOT COMPLETED|Overall Study||0
8543078|NCT04115748|9574537|FG000|STARTED|Main Study (Up to 16 Weeks)||19
8543079|NCT04115748|9574538|FG001|STARTED|Main Study (Up to 16 Weeks)||19
8621360|NCT00479557|9660327|FG001|Treated|Overall Study|One participant discontinued due to an AE, with an outcome of death.|60
8621361|NCT00479557|9660328|FG002|Treated|Overall Study||40
8543080|NCT04115748|9574539|FG002|STARTED|Main Study (Up to 16 Weeks)||9
8543081|NCT04115748|9574540|FG003|STARTED|Main Study (Up to 16 Weeks)||20
8543082|NCT04115748|9574541|FG004|STARTED|Main Study (Up to 16 Weeks)||0
8543083|NCT04115748|9574542|FG005|STARTED|Main Study (Up to 16 Weeks)||0
8543084|NCT04115748|9574543|FG006|STARTED|Main Study (Up to 16 Weeks)||0
8543085|NCT04115748|9574544|FG007|STARTED|Main Study (Up to 16 Weeks)||0
8543086|NCT04115748|9574545|FG008|STARTED|Main Study (Up to 16 Weeks)||0
8543087|NCT04115748|9574546|FG009|STARTED|Main Study (Up to 16 Weeks)||0
8543088|NCT04115748|9574537|FG000|COMPLETED|Main Study (Up to 16 Weeks)||4
8621362|NCT00479557|9660329|FG003|Treated|Overall Study||35
8621363|NCT00479557|9660330|FG004|Treated|Overall Study||12
8543089|NCT04115748|9574538|FG001|COMPLETED|Main Study (Up to 16 Weeks)||3
8543090|NCT04115748|9574539|FG002|COMPLETED|Main Study (Up to 16 Weeks)||2
8543091|NCT04115748|9574540|FG003|COMPLETED|Main Study (Up to 16 Weeks)||4
8543092|NCT04115748|9574541|FG004|COMPLETED|Main Study (Up to 16 Weeks)||0
8543093|NCT04115748|9574542|FG005|COMPLETED|Main Study (Up to 16 Weeks)||0
8543094|NCT04115748|9574543|FG006|COMPLETED|Main Study (Up to 16 Weeks)||0
8543095|NCT04115748|9574544|FG007|COMPLETED|Main Study (Up to 16 Weeks)||0
8543096|NCT04115748|9574545|FG008|COMPLETED|Main Study (Up to 16 Weeks)||0
8543097|NCT04115748|9574546|FG009|COMPLETED|Main Study (Up to 16 Weeks)||0
8543098|NCT04115748|9574537|FG000|NOT COMPLETED|Main Study (Up to 16 Weeks)||15
8543099|NCT04115748|9574538|FG001|NOT COMPLETED|Main Study (Up to 16 Weeks)||16
8543100|NCT04115748|9574539|FG002|NOT COMPLETED|Main Study (Up to 16 Weeks)||7
8543101|NCT04115748|9574540|FG003|NOT COMPLETED|Main Study (Up to 16 Weeks)||16
8543102|NCT04115748|9574541|FG004|NOT COMPLETED|Main Study (Up to 16 Weeks)||0
8543103|NCT04115748|9574542|FG005|NOT COMPLETED|Main Study (Up to 16 Weeks)||0
8543104|NCT04115748|9574543|FG006|NOT COMPLETED|Main Study (Up to 16 Weeks)||0
8543105|NCT04115748|9574544|FG007|NOT COMPLETED|Main Study (Up to 16 Weeks)||0
8543106|NCT04115748|9574545|FG008|NOT COMPLETED|Main Study (Up to 16 Weeks)||0
8543107|NCT04115748|9574546|FG009|NOT COMPLETED|Main Study (Up to 16 Weeks)||0
8543108|NCT04115748|9574537|FG000|STARTED|LTE (After 16 Weeks to Week 50)|Participants who completed main study received filgotinib 200 mg.|0
8543109|NCT04115748|9574538|FG001|STARTED|LTE (After 16 Weeks to Week 50)|Participants who completed main study received filgotinib 100 mg.|0
8543110|NCT04115748|9574539|FG002|STARTED|LTE (After 16 Weeks to Week 50)|Participants who completed main study were randomized in LTE phase to receive filgotinib 200 mg or 100 mg.|0
8543111|NCT04115748|9574540|FG003|STARTED|LTE (After 16 Weeks to Week 50)|Participants who completed main study were randomized in LTE phase to receive filgotinib 200 mg or 100 mg.|0
8543112|NCT04115748|9574541|FG004|STARTED|LTE (After 16 Weeks to Week 50)|Participants who completed main study received filgotinib 200 mg.|4
8543113|NCT04115748|9574542|FG005|STARTED|LTE (After 16 Weeks to Week 50)|Participants who completed main study received filgotinib 100 mg.|3
8543114|NCT04115748|9574543|FG006|STARTED|LTE (After 16 Weeks to Week 50)|1 participant who received adalimumab injection and completed main study were randomised in LTE phase to receive filgotinib 200 mg.|1
8543115|NCT04115748|9574544|FG007|STARTED|LTE (After 16 Weeks to Week 50)|1 participant who received adalimumab injection and completed main study were randomised in LTE phase to receive filgotinib 100 mg.|1
8543116|NCT04115748|9574545|FG008|STARTED|LTE (After 16 Weeks to Week 50)|2 participants who received placebo and completed main study were randomised in LTE phase to receive filgotinib 200 mg.|2
8543117|NCT04115748|9574546|FG009|STARTED|LTE (After 16 Weeks to Week 50)|2 participants who received placebo and completed main study were randomised in LTE phase to receive filgotinib 100 mg.|2
8543118|NCT04115748|9574537|FG000|COMPLETED|LTE (After 16 Weeks to Week 50)||0
8543119|NCT04115748|9574538|FG001|COMPLETED|LTE (After 16 Weeks to Week 50)||0
8543120|NCT04115748|9574539|FG002|COMPLETED|LTE (After 16 Weeks to Week 50)||0
8543121|NCT04115748|9574540|FG003|COMPLETED|LTE (After 16 Weeks to Week 50)||0
8543122|NCT04115748|9574541|FG004|COMPLETED|LTE (After 16 Weeks to Week 50)||0
8543123|NCT04115748|9574542|FG005|COMPLETED|LTE (After 16 Weeks to Week 50)||0
8543124|NCT04115748|9574543|FG006|COMPLETED|LTE (After 16 Weeks to Week 50)||0
8543125|NCT04115748|9574544|FG007|COMPLETED|LTE (After 16 Weeks to Week 50)||0
8543126|NCT04115748|9574545|FG008|COMPLETED|LTE (After 16 Weeks to Week 50)||0
8543127|NCT04115748|9574546|FG009|COMPLETED|LTE (After 16 Weeks to Week 50)||0
8543128|NCT04115748|9574537|FG000|NOT COMPLETED|LTE (After 16 Weeks to Week 50)||0
8543129|NCT04115748|9574538|FG001|NOT COMPLETED|LTE (After 16 Weeks to Week 50)||0
8543130|NCT04115748|9574539|FG002|NOT COMPLETED|LTE (After 16 Weeks to Week 50)||0
8543131|NCT04115748|9574540|FG003|NOT COMPLETED|LTE (After 16 Weeks to Week 50)||0
8543132|NCT04115748|9574541|FG004|NOT COMPLETED|LTE (After 16 Weeks to Week 50)||4
8543133|NCT04115748|9574542|FG005|NOT COMPLETED|LTE (After 16 Weeks to Week 50)||3
8543134|NCT04115748|9574543|FG006|NOT COMPLETED|LTE (After 16 Weeks to Week 50)||1
8543135|NCT04115748|9574544|FG007|NOT COMPLETED|LTE (After 16 Weeks to Week 50)||1
8543136|NCT04115748|9574545|FG008|NOT COMPLETED|LTE (After 16 Weeks to Week 50)||2
8543137|NCT04115748|9574546|FG009|NOT COMPLETED|LTE (After 16 Weeks to Week 50)||2
8543138|NCT04044664|9574571|FG000|STARTED|Stage 1||103
8543139|NCT04044664|9574572|FG001|STARTED|Stage 1||26
8543140|NCT04044664|9574573|FG002|STARTED|Stage 1||23
8543141|NCT04044664|9574571|FG000|COMPLETED|Stage 1||86
8543142|NCT04044664|9574572|FG001|COMPLETED|Stage 1||19
8543143|NCT04044664|9574573|FG002|COMPLETED|Stage 1||20
8543144|NCT04044664|9574571|FG000|NOT COMPLETED|Stage 1||17
8543145|NCT04044664|9574572|FG001|NOT COMPLETED|Stage 1||7
8543146|NCT04044664|9574573|FG002|NOT COMPLETED|Stage 1||3
8543147|NCT04044664|9574571|FG000|STARTED|Stage 2||76
8543148|NCT04044664|9574572|FG001|STARTED|Stage 2||26
8543149|NCT04044664|9574573|FG002|STARTED|Stage 2||22
8543150|NCT04044664|9574571|FG000|From Placebo, Responder|Stage 2||20
8543151|NCT04044664|9574572|FG001|From Placebo, Responder|Stage 2||13
8543152|NCT04044664|9574573|FG002|From Placebo, Responder|Stage 2||11
8543153|NCT04044664|9574571|FG000|From Placebo, Non-Responder|Stage 2||18
8543154|NCT04044664|9574572|FG001|From Placebo, Non-Responder|Stage 2||13
8543155|NCT04044664|9574573|FG002|From Placebo, Non-Responder|Stage 2||11
8543156|NCT04044664|9574571|FG000|From NYX-783 (10 mg or 50 mg)|Stage 2||38
8543157|NCT04044664|9574572|FG001|From NYX-783 (10 mg or 50 mg)|Stage 2||0
8543158|NCT04044664|9574573|FG002|From NYX-783 (10 mg or 50 mg)|Stage 2||0
8543159|NCT04044664|9574571|FG000|COMPLETED|Stage 2||67
8543160|NCT04044664|9574572|FG001|COMPLETED|Stage 2||24
8543161|NCT04044664|9574573|FG002|COMPLETED|Stage 2||21
8543162|NCT04044664|9574571|FG000|NOT COMPLETED|Stage 2||9
8543163|NCT04044664|9574572|FG001|NOT COMPLETED|Stage 2||2
8543164|NCT04044664|9574573|FG002|NOT COMPLETED|Stage 2||1
8543165|NCT04025632|9574583|FG000|STARTED|Overall Study||15
8543166|NCT04025632|9574584|FG001|STARTED|Overall Study||12
8543167|NCT04025632|9574583|FG000|Completed Main Portion|Overall Study||15
8543168|NCT04025632|9574584|FG001|Completed Main Portion|Overall Study||12
8543169|NCT04025632|9574583|FG000|Started Main Portion Safety Follow-up|Overall Study||2
8543170|NCT04025632|9574584|FG001|Started Main Portion Safety Follow-up|Overall Study||0
8543171|NCT04025632|9574583|FG000|Completed Main Portion Safety Follow-up|Overall Study||0
8543172|NCT04025632|9574584|FG001|Completed Main Portion Safety Follow-up|Overall Study||0
8543173|NCT04025632|9574583|FG000|Started Extension Portion|Overall Study||13
8543174|NCT04025632|9574584|FG001|Started Extension Portion|Overall Study||12
8543175|NCT04025632|9574583|FG000|COMPLETED|Overall Study||0
8543176|NCT04025632|9574584|FG001|COMPLETED|Overall Study||0
8543177|NCT04025632|9574583|FG000|NOT COMPLETED|Overall Study||15
8543178|NCT04025632|9574584|FG001|NOT COMPLETED|Overall Study||12
8543179|NCT04009850|9574595|FG000|STARTED|Overall Study||3
8543180|NCT04009850|9574596|FG001|STARTED|Overall Study||0
8543181|NCT04009850|9574595|FG000|COMPLETED|Overall Study||3
8543182|NCT04009850|9574596|FG001|COMPLETED|Overall Study||0
8543183|NCT04009850|9574595|FG000|NOT COMPLETED|Overall Study||0
8543184|NCT04009850|9574596|FG001|NOT COMPLETED|Overall Study||0
8543185|NCT03994731|9574604|FG000|STARTED|Run-in Period (From Week -4 to Day 1)||100
8543186|NCT03994731|9574605|FG001|STARTED|Run-in Period (From Week -4 to Day 1)||52
8543187|NCT03994731|9574604|FG000|Took at Least 1 Dose of MTX or Placebo|Run-in Period (From Week -4 to Day 1)||98
8543188|NCT03994731|9574605|FG001|Took at Least 1 Dose of MTX or Placebo|Run-in Period (From Week -4 to Day 1)||51
8543189|NCT03994731|9574604|FG000|COMPLETED|Run-in Period (From Week -4 to Day 1)||96
8543190|NCT03994731|9574605|FG001|COMPLETED|Run-in Period (From Week -4 to Day 1)||49
8543191|NCT03994731|9574604|FG000|NOT COMPLETED|Run-in Period (From Week -4 to Day 1)||4
8543192|NCT03994731|9574605|FG001|NOT COMPLETED|Run-in Period (From Week -4 to Day 1)||3
8543193|NCT03994731|9574604|FG000|STARTED|Pegloticase + IMM Period||96
8543194|NCT03994731|9574605|FG001|STARTED|Pegloticase + IMM Period||49
8543195|NCT03994731|9574604|FG000|Discontinued Study Treatment Early|Pegloticase + IMM Period||38
8543196|NCT03994731|9574605|FG001|Discontinued Study Treatment Early|Pegloticase + IMM Period||33
8543197|NCT03994731|9574604|FG000|COMPLETED|Pegloticase + IMM Period||76
8543198|NCT03994731|9574605|FG001|COMPLETED|Pegloticase + IMM Period||34
8543199|NCT03994731|9574604|FG000|NOT COMPLETED|Pegloticase + IMM Period||20
8543200|NCT03994731|9574605|FG001|NOT COMPLETED|Pegloticase + IMM Period||15
8566567|NCT00077610|9598734|FG000|COMPLETED|Overall Study||169
8566568|NCT00077610|9598735|FG001|COMPLETED|Overall Study||168
8566569|NCT00077610|9598736|FG002|COMPLETED|Overall Study||180
8566570|NCT00077610|9598734|FG000|NOT COMPLETED|Overall Study||54
8566571|NCT00077610|9598735|FG001|NOT COMPLETED|Overall Study||56
8566572|NCT00077610|9598736|FG002|NOT COMPLETED|Overall Study||46
8566573|NCT00077623|9598752|FG000|STARTED|Overall Study||190
8566574|NCT00077623|9598753|FG001|STARTED|Overall Study||191
8566575|NCT00077623|9598754|FG002|STARTED|Overall Study||191
8566576|NCT00077623|9598752|FG000|COMPLETED|Overall Study||154
8566577|NCT00077623|9598753|FG001|COMPLETED|Overall Study||148
8566578|NCT00077623|9598754|FG002|COMPLETED|Overall Study||159
8566579|NCT00077623|9598752|FG000|NOT COMPLETED|Overall Study||36
8566580|NCT00077623|9598753|FG001|NOT COMPLETED|Overall Study||43
8566581|NCT00077623|9598754|FG002|NOT COMPLETED|Overall Study||32
8566582|NCT00077636|9598764|FG000|STARTED|Overall Study||736
8566583|NCT00077636|9598765|FG001|STARTED|Overall Study||733
8566584|NCT00077636|9598764|FG000|COMPLETED|Overall Study||692
8566585|NCT00077636|9598765|FG001|COMPLETED|Overall Study||641
8566586|NCT00077636|9598764|FG000|NOT COMPLETED|Overall Study||44
8566587|NCT00077636|9598765|FG001|NOT COMPLETED|Overall Study||92
8566588|NCT00077649|9598776|FG000|STARTED|Overall Study||47
8566589|NCT00077649|9598777|FG001|STARTED|Overall Study||47
8566590|NCT00077649|9598778|FG002|STARTED|Overall Study||47
8566591|NCT00077649|9598779|FG003|STARTED|Overall Study||47
8566592|NCT00077649|9598776|FG000|Completed 24 Weeks of Follow-up|Overall Study||36
8566593|NCT00077649|9598777|FG001|Completed 24 Weeks of Follow-up|Overall Study||40
8566594|NCT00077649|9598778|FG002|Completed 24 Weeks of Follow-up|Overall Study||36
8566595|NCT00077649|9598779|FG003|Completed 24 Weeks of Follow-up|Overall Study||31
8566596|NCT00077649|9598776|FG000|COMPLETED|Overall Study||33
8566597|NCT00077649|9598777|FG001|COMPLETED|Overall Study||38
8566598|NCT00077649|9598778|FG002|COMPLETED|Overall Study||32
8566599|NCT00077649|9598779|FG003|COMPLETED|Overall Study||30
8566600|NCT00077649|9598776|FG000|NOT COMPLETED|Overall Study||14
8566601|NCT00077649|9598777|FG001|NOT COMPLETED|Overall Study||9
8566602|NCT00077649|9598778|FG002|NOT COMPLETED|Overall Study||15
8566603|NCT00077649|9598779|FG003|NOT COMPLETED|Overall Study||17
8566604|NCT00077675|9598795|FG000|STARTED|Overall Study||103
8566605|NCT00077675|9598796|FG001|STARTED|Overall Study||98
8566606|NCT00077675|9598795|FG000|COMPLETED|Overall Study||92
8566607|NCT00077675|9598796|FG001|COMPLETED|Overall Study||89
8566608|NCT00077675|9598795|FG000|NOT COMPLETED|Overall Study||11
8566609|NCT00077675|9598796|FG001|NOT COMPLETED|Overall Study||9
8566610|NCT00077766|9598804|FG000|STARTED|Overall Study||157
8566611|NCT00077766|9598805|FG001|STARTED|Overall Study||156
8566612|NCT00077766|9598804|FG000|COMPLETED|Overall Study||118
8566613|NCT00077766|9598805|FG001|COMPLETED|Overall Study||131
8543201|NCT03963895|9574617|FG000|STARTED|Pre-dose Period (Study Days -7, -5, -2)||12
8543202|NCT03963895|9574618|FG001|STARTED|Pre-dose Period (Study Days -7, -5, -2)||12
8543203|NCT03963895|9574619|FG002|STARTED|Pre-dose Period (Study Days -7, -5, -2)||12
8543204|NCT03963895|9574617|FG000|COMPLETED|Pre-dose Period (Study Days -7, -5, -2)||12
8543205|NCT03963895|9574618|FG001|COMPLETED|Pre-dose Period (Study Days -7, -5, -2)||12
8543206|NCT03963895|9574619|FG002|COMPLETED|Pre-dose Period (Study Days -7, -5, -2)||12
8543207|NCT03963895|9574617|FG000|NOT COMPLETED|Pre-dose Period (Study Days -7, -5, -2)||0
8543208|NCT03963895|9574618|FG001|NOT COMPLETED|Pre-dose Period (Study Days -7, -5, -2)||0
8543209|NCT03963895|9574619|FG002|NOT COMPLETED|Pre-dose Period (Study Days -7, -5, -2)||0
8543210|NCT03963895|9574617|FG000|STARTED|Dosing Period (Study Day 1)||12
8543211|NCT03963895|9574618|FG001|STARTED|Dosing Period (Study Day 1)||12
8543212|NCT03963895|9574619|FG002|STARTED|Dosing Period (Study Day 1)||12
8543213|NCT03963895|9574617|FG000|COMPLETED|Dosing Period (Study Day 1)||12
8543214|NCT03963895|9574618|FG001|COMPLETED|Dosing Period (Study Day 1)||12
8543215|NCT03963895|9574619|FG002|COMPLETED|Dosing Period (Study Day 1)||12
8543216|NCT03963895|9574617|FG000|NOT COMPLETED|Dosing Period (Study Day 1)||0
8543217|NCT03963895|9574618|FG001|NOT COMPLETED|Dosing Period (Study Day 1)||0
8543218|NCT03963895|9574619|FG002|NOT COMPLETED|Dosing Period (Study Day 1)||0
8543219|NCT03963895|9574617|FG000|STARTED|Recovery Period (Study Day 3)||12
8543220|NCT03963895|9574618|FG001|STARTED|Recovery Period (Study Day 3)||12
8543221|NCT03963895|9574619|FG002|STARTED|Recovery Period (Study Day 3)||12
8543222|NCT03963895|9574617|FG000|COMPLETED|Recovery Period (Study Day 3)||12
8543223|NCT03963895|9574618|FG001|COMPLETED|Recovery Period (Study Day 3)||12
8543224|NCT03963895|9574619|FG002|COMPLETED|Recovery Period (Study Day 3)||12
8543225|NCT03963895|9574617|FG000|NOT COMPLETED|Recovery Period (Study Day 3)||0
8543226|NCT03963895|9574618|FG001|NOT COMPLETED|Recovery Period (Study Day 3)||0
8543227|NCT03963895|9574619|FG002|NOT COMPLETED|Recovery Period (Study Day 3)||0
8543228|NCT03963895|9574617|FG000|STARTED|Follow-up Period (Study Day 14)||12
8543229|NCT03963895|9574618|FG001|STARTED|Follow-up Period (Study Day 14)||12
8543230|NCT03963895|9574619|FG002|STARTED|Follow-up Period (Study Day 14)||12
8818205|NCT01556347|9871834|FG000|COMPLETED|Induction Immunotherapy||2
8818206|NCT01556347|9871834|FG000|NOT COMPLETED|Induction Immunotherapy||0
8818207|NCT01556347|9871834|FG000|STARTED|Bortezomib Treatment Phase||2
8818208|NCT01556347|9871834|FG000|COMPLETED|Bortezomib Treatment Phase||2
8818209|NCT01556347|9871834|FG000|NOT COMPLETED|Bortezomib Treatment Phase||0
8621364|NCT00479557|9660331|FG005|Treated|Overall Study||44
8621365|NCT00479557|9660332|FG006|Treated|Overall Study||17
8621366|NCT00479557|9660326|FG000|COMPLETED|Overall Study||26
8543231|NCT03963895|9574617|FG000|COMPLETED|Follow-up Period (Study Day 14)||12
8543232|NCT03963895|9574618|FG001|COMPLETED|Follow-up Period (Study Day 14)||11
8543233|NCT03963895|9574619|FG002|COMPLETED|Follow-up Period (Study Day 14)||12
8543234|NCT03963895|9574617|FG000|NOT COMPLETED|Follow-up Period (Study Day 14)||0
8543235|NCT03963895|9574618|FG001|NOT COMPLETED|Follow-up Period (Study Day 14)||1
8543236|NCT03963895|9574619|FG002|NOT COMPLETED|Follow-up Period (Study Day 14)||0
8543237|NCT03924622|9574633|FG000|STARTED|Overall Study||12
8543238|NCT03924622|9574634|FG001|STARTED|Overall Study||12
8543239|NCT03924622|9574635|FG002|STARTED|Overall Study||12
8543240|NCT03924622|9574636|FG003|STARTED|Overall Study||12
8543241|NCT03924622|9574637|FG004|STARTED|Overall Study||12
8543242|NCT03924622|9574638|FG005|STARTED|Overall Study||12
8543243|NCT03924622|9574633|FG000|COMPLETED|Overall Study||10
8543244|NCT03924622|9574634|FG001|COMPLETED|Overall Study||9
8543245|NCT03924622|9574635|FG002|COMPLETED|Overall Study||9
8543246|NCT03924622|9574636|FG003|COMPLETED|Overall Study||8
8543247|NCT03924622|9574637|FG004|COMPLETED|Overall Study||9
8543248|NCT03924622|9574638|FG005|COMPLETED|Overall Study||9
8543249|NCT03924622|9574633|FG000|NOT COMPLETED|Overall Study||2
8543250|NCT03924622|9574634|FG001|NOT COMPLETED|Overall Study||3
8543251|NCT03924622|9574635|FG002|NOT COMPLETED|Overall Study||3
8543252|NCT03924622|9574636|FG003|NOT COMPLETED|Overall Study||4
8543253|NCT03924622|9574637|FG004|NOT COMPLETED|Overall Study||3
8543254|NCT03924622|9574638|FG005|NOT COMPLETED|Overall Study||3
8543255|NCT03905811|9574654|FG000|STARTED|Overall Study||8
8543256|NCT03905811|9574655|FG001|STARTED|Overall Study||5
8543257|NCT03905811|9574654|FG000|COMPLETED|Overall Study||6
8543258|NCT03905811|9574655|FG001|COMPLETED|Overall Study||5
8543259|NCT03905811|9574654|FG000|NOT COMPLETED|Overall Study||2
8543260|NCT03905811|9574655|FG001|NOT COMPLETED|Overall Study||0
8543261|NCT03867396|9574661|FG000|STARTED|Intervention 1||8
8543262|NCT03867396|9574662|FG001|STARTED|Intervention 1||8
8543263|NCT03867396|9574663|FG002|STARTED|Intervention 1||7
8543264|NCT03867396|9574664|FG003|STARTED|Intervention 1||5
8543265|NCT03867396|9574665|FG004|STARTED|Intervention 1||7
8543266|NCT03867396|9574666|FG005|STARTED|Intervention 1||5
8543267|NCT03867396|9574661|FG000|Data Collection|Intervention 1||8
8543268|NCT03867396|9574662|FG001|Data Collection|Intervention 1||5
8543269|NCT03867396|9574663|FG002|Data Collection|Intervention 1||7
8543270|NCT03867396|9574664|FG003|Data Collection|Intervention 1||5
8543271|NCT03867396|9574665|FG004|Data Collection|Intervention 1||0
8543272|NCT03867396|9574666|FG005|Data Collection|Intervention 1||0
8543273|NCT03867396|9574661|FG000|COMPLETED|Intervention 1||8
8543274|NCT03867396|9574662|FG001|COMPLETED|Intervention 1||5
8543275|NCT03867396|9574663|FG002|COMPLETED|Intervention 1||7
8543276|NCT03867396|9574664|FG003|COMPLETED|Intervention 1||5
8543277|NCT03867396|9574665|FG004|COMPLETED|Intervention 1||0
8543278|NCT03867396|9574666|FG005|COMPLETED|Intervention 1||0
8543279|NCT03867396|9574661|FG000|NOT COMPLETED|Intervention 1||0
8543280|NCT03867396|9574662|FG001|NOT COMPLETED|Intervention 1||3
8543281|NCT03867396|9574663|FG002|NOT COMPLETED|Intervention 1||0
8543282|NCT03867396|9574664|FG003|NOT COMPLETED|Intervention 1||0
8543283|NCT03867396|9574665|FG004|NOT COMPLETED|Intervention 1||7
8543284|NCT03867396|9574666|FG005|NOT COMPLETED|Intervention 1||5
8543285|NCT03867396|9574661|FG000|STARTED|Intervention 2||8
8543286|NCT03867396|9574662|FG001|STARTED|Intervention 2||5
8543287|NCT03867396|9574663|FG002|STARTED|Intervention 2||7
8543288|NCT03867396|9574664|FG003|STARTED|Intervention 2||5
8543289|NCT03867396|9574665|FG004|STARTED|Intervention 2||0
8543290|NCT03867396|9574666|FG005|STARTED|Intervention 2||0
8543291|NCT03867396|9574661|FG000|COMPLETED|Intervention 2||8
8543292|NCT03867396|9574662|FG001|COMPLETED|Intervention 2||5
8543293|NCT03867396|9574663|FG002|COMPLETED|Intervention 2||7
8543294|NCT03867396|9574664|FG003|COMPLETED|Intervention 2||5
8543295|NCT03867396|9574665|FG004|COMPLETED|Intervention 2||0
8543296|NCT03867396|9574666|FG005|COMPLETED|Intervention 2||0
8543297|NCT03867396|9574661|FG000|NOT COMPLETED|Intervention 2||0
8543298|NCT03867396|9574662|FG001|NOT COMPLETED|Intervention 2||0
8543299|NCT03867396|9574663|FG002|NOT COMPLETED|Intervention 2||0
8543300|NCT03867396|9574664|FG003|NOT COMPLETED|Intervention 2||0
8543301|NCT03867396|9574665|FG004|NOT COMPLETED|Intervention 2||0
8543302|NCT03867396|9574666|FG005|NOT COMPLETED|Intervention 2||0
8543303|NCT03867396|9574661|FG000|STARTED|Intervention 3||8
8543304|NCT03867396|9574662|FG001|STARTED|Intervention 3||5
8543305|NCT03867396|9574663|FG002|STARTED|Intervention 3||7
8543306|NCT03867396|9574664|FG003|STARTED|Intervention 3||5
8543307|NCT03867396|9574665|FG004|STARTED|Intervention 3||0
8543308|NCT03867396|9574666|FG005|STARTED|Intervention 3||0
8543309|NCT03867396|9574661|FG000|COMPLETED|Intervention 3||8
8543310|NCT03867396|9574662|FG001|COMPLETED|Intervention 3||5
8543311|NCT03867396|9574663|FG002|COMPLETED|Intervention 3||7
8543312|NCT03867396|9574664|FG003|COMPLETED|Intervention 3||5
8543313|NCT03867396|9574665|FG004|COMPLETED|Intervention 3||0
8543314|NCT03867396|9574666|FG005|COMPLETED|Intervention 3||0
8543315|NCT03867396|9574661|FG000|NOT COMPLETED|Intervention 3||0
8543316|NCT03867396|9574662|FG001|NOT COMPLETED|Intervention 3||0
8543317|NCT03867396|9574663|FG002|NOT COMPLETED|Intervention 3||0
8543318|NCT03867396|9574664|FG003|NOT COMPLETED|Intervention 3||0
8543319|NCT03867396|9574665|FG004|NOT COMPLETED|Intervention 3||0
8543320|NCT03867396|9574666|FG005|NOT COMPLETED|Intervention 3||0
8543321|NCT03807843|9574679|FG000|STARTED|Overall Study||21
8543322|NCT03807843|9574680|FG001|STARTED|Overall Study||20
8543323|NCT03807843|9574679|FG000|COMPLETED|Overall Study||20
8543324|NCT03807843|9574680|FG001|COMPLETED|Overall Study||20
8543325|NCT03807843|9574679|FG000|NOT COMPLETED|Overall Study||1
8543326|NCT03807843|9574680|FG001|NOT COMPLETED|Overall Study||0
8543327|NCT03802513|9574686|FG000|STARTED|Overall Study||10
8543328|NCT03802513|9574686|FG000|COMPLETED|Overall Study||9
8543329|NCT03802513|9574686|FG000|NOT COMPLETED|Overall Study||1
8543330|NCT03681184|9574692|FG000|STARTED|6-Month Double-Blind Period||13
8543331|NCT03681184|9574693|FG001|STARTED|6-Month Double-Blind Period||26
8543332|NCT03681184|9574692|FG000|COMPLETED|6-Month Double-Blind Period||13
8543333|NCT03681184|9574693|FG001|COMPLETED|6-Month Double-Blind Period||25
8543334|NCT03681184|9574692|FG000|NOT COMPLETED|6-Month Double-Blind Period||0
8543335|NCT03681184|9574693|FG001|NOT COMPLETED|6-Month Double-Blind Period||1
8543336|NCT03681184|9574692|FG000|STARTED|3-Month Blinded Extension Period||13
8543337|NCT03681184|9574693|FG001|STARTED|3-Month Blinded Extension Period|1 participant discontinued study drug and entered safety follow up after the DB period.|24
8543338|NCT03681184|9574692|FG000|COMPLETED|3-Month Blinded Extension Period||1
8543339|NCT03681184|9574693|FG001|COMPLETED|3-Month Blinded Extension Period||1
8543340|NCT03681184|9574692|FG000|NOT COMPLETED|3-Month Blinded Extension Period||12
8543341|NCT03681184|9574693|FG001|NOT COMPLETED|3-Month Blinded Extension Period||23
8543342|NCT03681184|9574692|FG000|STARTED|Open-Label Extension Period||1
8543343|NCT03681184|9574693|FG001|STARTED|Open-Label Extension Period||1
8543344|NCT03681184|9574692|FG000|COMPLETED|Open-Label Extension Period||0
8543345|NCT03681184|9574693|FG001|COMPLETED|Open-Label Extension Period||0
8543346|NCT03681184|9574692|FG000|NOT COMPLETED|Open-Label Extension Period||1
8543347|NCT03681184|9574693|FG001|NOT COMPLETED|Open-Label Extension Period||1
8566614|NCT00077766|9598804|FG000|NOT COMPLETED|Overall Study||39
8566615|NCT00077766|9598805|FG001|NOT COMPLETED|Overall Study||25
8566616|NCT00077857|9598814|FG000|STARTED|Overall Study||235
8566617|NCT00077857|9598815|FG001|STARTED|Overall Study||235
8566618|NCT00077857|9598814|FG000|Received Study Drug|Overall Study||231
8566619|NCT00077857|9598815|FG001|Received Study Drug|Overall Study||234
8566620|NCT00077857|9598814|FG000|Safety Population: Actual Dose Received|Overall Study|14 patients in the 1250 dose arm received a lower dose and were included in the 825 arm for Safety.|217
8566621|NCT00077857|9598815|FG001|Safety Population: Actual Dose Received|Overall Study||248
8566622|NCT00077857|9598814|FG000|COMPLETED|Overall Study||34
8566623|NCT00077857|9598815|FG001|COMPLETED|Overall Study||31
8566624|NCT00077857|9598814|FG000|NOT COMPLETED|Overall Study||201
8566625|NCT00077857|9598815|FG001|NOT COMPLETED|Overall Study||204
8566626|NCT00077922|9598821|FG000|STARTED|Overall Study||15
8566627|NCT00077922|9598821|FG000|COMPLETED|Overall Study||15
8566628|NCT00077922|9598821|FG000|NOT COMPLETED|Overall Study||0
8569291|NCT00096031|9601488|FG000|Eligible and Began Protocol Therapy|Overall Study||55
8543348|NCT03679767|9574703|FG000|STARTED|Overall Study||35
8543349|NCT03679767|9574704|FG001|STARTED|Overall Study||23
8543350|NCT03679767|9574705|FG002|STARTED|Overall Study||29
8543351|NCT03679767|9574706|FG003|STARTED|Overall Study||34
8543352|NCT03679767|9574703|FG000|COMPLETED|Overall Study||0
8543353|NCT03679767|9574704|FG001|COMPLETED|Overall Study||0
8543354|NCT03679767|9574705|FG002|COMPLETED|Overall Study||0
8543355|NCT03679767|9574706|FG003|COMPLETED|Overall Study||0
8543356|NCT03679767|9574703|FG000|NOT COMPLETED|Overall Study||35
8543357|NCT03679767|9574704|FG001|NOT COMPLETED|Overall Study||23
8543358|NCT03679767|9574705|FG002|NOT COMPLETED|Overall Study||29
8543359|NCT03679767|9574706|FG003|NOT COMPLETED|Overall Study||34
8543360|NCT03576716|9574720|FG000|STARTED|Overall Study||10
8543361|NCT03576716|9574721|FG001|STARTED|Overall Study||9
8543362|NCT03576716|9574720|FG000|COMPLETED|Overall Study||10
8543363|NCT03576716|9574721|FG001|COMPLETED|Overall Study||8
8543364|NCT03576716|9574720|FG000|NOT COMPLETED|Overall Study||0
8543365|NCT03576716|9574721|FG001|NOT COMPLETED|Overall Study||1
8543366|NCT03500692|9574727|FG000|STARTED|Overall Study||500
8543367|NCT03500692|9574727|FG000|COMPLETED|Overall Study||391
8543368|NCT03500692|9574727|FG000|NOT COMPLETED|Overall Study||109
8543369|NCT03367819|9574733|FG000|STARTED|Overall Study||24
8543370|NCT03367819|9574734|FG001|STARTED|Overall Study||20
8543371|NCT03367819|9574733|FG000|COMPLETED|Overall Study||0
8543372|NCT03367819|9574734|FG001|COMPLETED|Overall Study||1
8543373|NCT03367819|9574733|FG000|NOT COMPLETED|Overall Study||24
8543374|NCT03367819|9574734|FG001|NOT COMPLETED|Overall Study||19
8543375|NCT03182868|9574750|FG000|STARTED|Overall Study||12
8543376|NCT03182868|9574751|FG001|STARTED|Overall Study||20
8543377|NCT03182868|9574752|FG002|STARTED|Overall Study||21
8543378|NCT03182868|9574753|FG003|STARTED|Overall Study||1
8543379|NCT03182868|9574754|FG004|STARTED|Overall Study||24
8543380|NCT03182868|9574750|FG000|COMPLETED|Overall Study||9
8543381|NCT03182868|9574751|FG001|COMPLETED|Overall Study||20
8543382|NCT03182868|9574752|FG002|COMPLETED|Overall Study||17
8543383|NCT03182868|9574753|FG003|COMPLETED|Overall Study||0
8543384|NCT03182868|9574754|FG004|COMPLETED|Overall Study||16
8543385|NCT03182868|9574750|FG000|NOT COMPLETED|Overall Study||3
8543386|NCT03182868|9574751|FG001|NOT COMPLETED|Overall Study||0
8543387|NCT03182868|9574752|FG002|NOT COMPLETED|Overall Study||4
8543388|NCT03182868|9574753|FG003|NOT COMPLETED|Overall Study||1
8543389|NCT03182868|9574754|FG004|NOT COMPLETED|Overall Study||8
8543390|NCT03125902|9574767|FG000|STARTED|Overall Study||220
8543391|NCT03125902|9574768|FG001|STARTED|Overall Study||431
8543392|NCT03125902|9574767|FG000|COMPLETED|Overall Study||0
8543393|NCT03125902|9574768|FG001|COMPLETED|Overall Study||0
8543394|NCT03125902|9574767|FG000|NOT COMPLETED|Overall Study||220
8543395|NCT03125902|9574768|FG001|NOT COMPLETED|Overall Study||431
8543396|NCT03077620|9574779|FG000|STARTED|Overall Study||14
8543397|NCT03077620|9574780|FG001|STARTED|Overall Study||14
8543398|NCT03077620|9574781|FG002|STARTED|Overall Study||14
8543399|NCT03077620|9574782|FG003|STARTED|Overall Study||6
8543400|NCT03077620|9574779|FG000|COMPLETED|Overall Study||13
8543401|NCT03077620|9574780|FG001|COMPLETED|Overall Study||13
8543402|NCT03077620|9574781|FG002|COMPLETED|Overall Study||12
8543403|NCT03077620|9574782|FG003|COMPLETED|Overall Study||6
8543404|NCT03077620|9574779|FG000|NOT COMPLETED|Overall Study||1
8543405|NCT03077620|9574780|FG001|NOT COMPLETED|Overall Study||1
8543406|NCT03077620|9574781|FG002|NOT COMPLETED|Overall Study||2
8543407|NCT03077620|9574782|FG003|NOT COMPLETED|Overall Study||0
8543408|NCT03027414|9574795|FG000|STARTED|Overall Study||28
8543409|NCT03027414|9574796|FG001|STARTED|Overall Study||0
8543410|NCT03027414|9574797|FG002|STARTED|Overall Study||26
8543411|NCT03027414|9574795|FG000|COMPLETED|Overall Study||19
8543412|NCT03027414|9574796|FG001|COMPLETED|Overall Study||0
8543413|NCT03027414|9574797|FG002|COMPLETED|Overall Study||20
8543414|NCT03027414|9574795|FG000|NOT COMPLETED|Overall Study||9
8543415|NCT03027414|9574796|FG001|NOT COMPLETED|Overall Study||0
8543416|NCT03027414|9574797|FG002|NOT COMPLETED|Overall Study||6
8543417|NCT02951052|9574807|FG000|STARTED|Overall Study||308
8543418|NCT02951052|9574808|FG001|STARTED|Overall Study||308
8543419|NCT02951052|9574807|FG000|COMPLETED|Overall Study||281
8543420|NCT02951052|9574808|FG001|COMPLETED|Overall Study||290
8543421|NCT02951052|9574807|FG000|NOT COMPLETED|Overall Study||27
8543422|NCT02951052|9574808|FG001|NOT COMPLETED|Overall Study||18
8543423|NCT02724410|9574820|FG000|STARTED|Overall Study||44
8543424|NCT02724410|9574821|FG001|STARTED|Overall Study||38
8543425|NCT02724410|9574820|FG000|COMPLETED|Overall Study||44
8543426|NCT02724410|9574821|FG001|COMPLETED|Overall Study||38
8543427|NCT02724410|9574820|FG000|NOT COMPLETED|Overall Study||0
8543428|NCT02724410|9574821|FG001|NOT COMPLETED|Overall Study||0
8543429|NCT02598583|9574829|FG000|STARTED|Primary Evaluation Period||6
8543430|NCT02598583|9574830|FG001|STARTED|Primary Evaluation Period||7
8543431|NCT02598583|9574829|FG000|COMPLETED|Primary Evaluation Period||6
8543432|NCT02598583|9574830|FG001|COMPLETED|Primary Evaluation Period||7
8543433|NCT02598583|9574829|FG000|NOT COMPLETED|Primary Evaluation Period||0
8543434|NCT02598583|9574830|FG001|NOT COMPLETED|Primary Evaluation Period||0
8543435|NCT02598583|9574829|FG000|STARTED|Extension Period||6
8543436|NCT02598583|9574830|FG001|STARTED|Extension Period||7
8543437|NCT02598583|9574829|FG000|COMPLETED|Extension Period||5
8543438|NCT02598583|9574830|FG001|COMPLETED|Extension Period||7
8543439|NCT02598583|9574829|FG000|NOT COMPLETED|Extension Period||1
8543440|NCT02598583|9574830|FG001|NOT COMPLETED|Extension Period||0
8543441|NCT02574481|9574840|FG000|STARTED|Overall Study||309
8543442|NCT02574481|9574841|FG001|STARTED|Overall Study||156
8543443|NCT02574481|9574842|FG002|STARTED|Overall Study||50
8543444|NCT02574481|9574843|FG003|STARTED|Overall Study||13
8543445|NCT02574481|9574840|FG000|COMPLETED|Overall Study||282
8543446|NCT02574481|9574841|FG001|COMPLETED|Overall Study||142
8543447|NCT02574481|9574842|FG002|COMPLETED|Overall Study||47
8543448|NCT02574481|9574843|FG003|COMPLETED|Overall Study||13
8543449|NCT02574481|9574840|FG000|NOT COMPLETED|Overall Study||27
8543450|NCT02574481|9574841|FG001|NOT COMPLETED|Overall Study||14
8543451|NCT02574481|9574842|FG002|NOT COMPLETED|Overall Study||3
8543452|NCT02574481|9574843|FG003|NOT COMPLETED|Overall Study||0
8543453|NCT02550093|9574856|FG000|STARTED|Intervention 1||10
8543454|NCT02550093|9574857|FG001|STARTED|Intervention 1||10
8543455|NCT02550093|9574856|FG000|COMPLETED|Intervention 1||10
8543456|NCT02550093|9574857|FG001|COMPLETED|Intervention 1||10
8543457|NCT02550093|9574856|FG000|NOT COMPLETED|Intervention 1||0
8543458|NCT02550093|9574857|FG001|NOT COMPLETED|Intervention 1||0
8543459|NCT02550093|9574856|FG000|STARTED|Wash-out Period||10
8543460|NCT02550093|9574857|FG001|STARTED|Wash-out Period||10
8543461|NCT02550093|9574856|FG000|COMPLETED|Wash-out Period||10
8543462|NCT02550093|9574857|FG001|COMPLETED|Wash-out Period||10
8543463|NCT02550093|9574856|FG000|NOT COMPLETED|Wash-out Period||0
8543464|NCT02550093|9574857|FG001|NOT COMPLETED|Wash-out Period||0
8543465|NCT02550093|9574856|FG000|STARTED|Intervention 2||10
8543466|NCT02550093|9574857|FG001|STARTED|Intervention 2||10
8543467|NCT02550093|9574856|FG000|COMPLETED|Intervention 2||10
8621367|NCT00479557|9660327|FG001|COMPLETED|Overall Study||51
8621368|NCT00479557|9660328|FG002|COMPLETED|Overall Study||32
8621369|NCT00479557|9660329|FG003|COMPLETED|Overall Study||30
8621370|NCT00479557|9660330|FG004|COMPLETED|Overall Study||8
8621371|NCT00479557|9660331|FG005|COMPLETED|Overall Study||31
8543468|NCT02550093|9574857|FG001|COMPLETED|Intervention 2||10
8543469|NCT02550093|9574856|FG000|NOT COMPLETED|Intervention 2||0
8543470|NCT02550093|9574857|FG001|NOT COMPLETED|Intervention 2||0
8543471|NCT02536794|9574865|FG000|STARTED|Reached 1st Response Assessment||30
8543472|NCT02536794|9574865|FG000|Started Treatment|Reached 1st Response Assessment||30
8543473|NCT02536794|9574865|FG000|Attempted First Cycle|Reached 1st Response Assessment||30
8543474|NCT02536794|9574865|FG000|Attempted Second Cycle|Reached 1st Response Assessment||24
8543475|NCT02536794|9574865|FG000|Reached First Response|Reached 1st Response Assessment||24
8543476|NCT02536794|9574865|FG000|COMPLETED|Reached 1st Response Assessment||24
8543477|NCT02536794|9574865|FG000|NOT COMPLETED|Reached 1st Response Assessment||6
8543478|NCT02536794|9574865|FG000|STARTED|Continued Treatment After 1st Response||24
8543479|NCT02536794|9574865|FG000|Went on to Start Cycle 3|Continued Treatment After 1st Response||16
8543480|NCT02536794|9574865|FG000|COMPLETED|Continued Treatment After 1st Response||16
8543481|NCT02536794|9574865|FG000|NOT COMPLETED|Continued Treatment After 1st Response||8
8543482|NCT02536794|9574865|FG000|STARTED|Follow up for 3 Years or Death|one patient did not go into follow up as treatment was discontinued due to a protocol violation|29
8543483|NCT02536794|9574865|FG000|COMPLETED|Follow up for 3 Years or Death||29
8543484|NCT02536794|9574865|FG000|NOT COMPLETED|Follow up for 3 Years or Death||0
8543485|NCT02463773|9574869|FG000|STARTED|Overall Study||14
8543486|NCT02463773|9574869|FG000|COMPLETED|Overall Study||14
8543487|NCT02463773|9574869|FG000|NOT COMPLETED|Overall Study||0
8543488|NCT02356575|9574875|FG000|STARTED|Overall Study||80
8543489|NCT02356575|9574876|FG001|STARTED|Overall Study||80
8543490|NCT02356575|9574875|FG000|COMPLETED|Overall Study||80
8543491|NCT02356575|9574876|FG001|COMPLETED|Overall Study||80
8543492|NCT02356575|9574875|FG000|NOT COMPLETED|Overall Study||0
8543493|NCT02356575|9574876|FG001|NOT COMPLETED|Overall Study||0
8543494|NCT02285114|9574885|FG000|STARTED|Overall Study||29
8543495|NCT02285114|9574886|FG001|STARTED|Overall Study||9
8543496|NCT02285114|9574887|FG002|STARTED|Overall Study||3
8543497|NCT02285114|9574885|FG000|COMPLETED|Overall Study||7
8543498|NCT02285114|9574886|FG001|COMPLETED|Overall Study||2
8543499|NCT02285114|9574887|FG002|COMPLETED|Overall Study||0
8543500|NCT02285114|9574885|FG000|NOT COMPLETED|Overall Study||22
8543501|NCT02285114|9574886|FG001|NOT COMPLETED|Overall Study||7
8543502|NCT02285114|9574887|FG002|NOT COMPLETED|Overall Study||3
8543503|NCT02263508|9574904|FG000|STARTED|Overall Study||21
8543504|NCT02263508|9574905|FG001|STARTED|Overall Study||346
8543505|NCT02263508|9574906|FG002|STARTED|Overall Study||346
8543506|NCT02263508|9574904|FG000|Received Talimogene Laherparepvec/Placebo|Overall Study||21
8543507|NCT02263508|9574905|FG001|Received Talimogene Laherparepvec/Placebo|Overall Study||345
8543508|NCT02263508|9574906|FG002|Received Talimogene Laherparepvec/Placebo|Overall Study||343
8543509|NCT02263508|9574904|FG000|Received Pembrolizumab|Overall Study||21
8543510|NCT02263508|9574905|FG001|Received Pembrolizumab|Overall Study||345
8543511|NCT02263508|9574906|FG002|Received Pembrolizumab|Overall Study||343
8543512|NCT02263508|9574904|FG000|COMPLETED|Overall Study||0
8543513|NCT02263508|9574905|FG001|COMPLETED|Overall Study||0
8543514|NCT02263508|9574906|FG002|COMPLETED|Overall Study||0
8543515|NCT02263508|9574904|FG000|NOT COMPLETED|Overall Study||21
8543516|NCT02263508|9574905|FG001|NOT COMPLETED|Overall Study||346
8543517|NCT02263508|9574906|FG002|NOT COMPLETED|Overall Study||346
8543518|NCT02246530|9574919|FG000|STARTED|Overall Study||9
8543519|NCT02246530|9574920|FG001|STARTED|Overall Study||2
8543520|NCT02246530|9574919|FG000|COMPLETED|Overall Study||5
8621372|NCT00479557|9660332|FG006|COMPLETED|Overall Study||15
8543521|NCT02246530|9574920|FG001|COMPLETED|Overall Study||2
8543522|NCT02246530|9574919|FG000|NOT COMPLETED|Overall Study||4
8543523|NCT02246530|9574920|FG001|NOT COMPLETED|Overall Study||0
8543524|NCT02002819|9574928|FG000|STARTED|Overall Study||17
8543525|NCT02002819|9574929|FG001|STARTED|Overall Study||17
8543526|NCT02002819|9574928|FG000|COMPLETED|Overall Study|4 Discontinued intervention because of participant's decision|13
8543527|NCT02002819|9574929|FG001|COMPLETED|Overall Study|"1 Discontinued intervention because of participant's decision~1 Excluded per protocol because of biomarkers inconsistent with AD"|15
8543528|NCT02002819|9574928|FG000|NOT COMPLETED|Overall Study||4
8543529|NCT02002819|9574929|FG001|NOT COMPLETED|Overall Study||2
8543530|NCT01936857|9574953|FG000|STARTED|Overall Study||141
8543531|NCT01936857|9574954|FG001|STARTED|Overall Study||140
8543532|NCT01936857|9574953|FG000|COMPLETED|Overall Study||107
8543533|NCT01936857|9574954|FG001|COMPLETED|Overall Study||115
8543534|NCT01936857|9574953|FG000|NOT COMPLETED|Overall Study||34
8543535|NCT01936857|9574954|FG001|NOT COMPLETED|Overall Study||25
8543536|NCT01865539|9574962|FG000|STARTED|Overall Study||21
8543537|NCT01865539|9574963|FG001|STARTED|Overall Study||30
8543538|NCT01865539|9574962|FG000|COMPLETED|Overall Study||21
8543539|NCT01865539|9574963|FG001|COMPLETED|Overall Study||30
8543540|NCT01865539|9574962|FG000|NOT COMPLETED|Overall Study||0
8543541|NCT01865539|9574963|FG001|NOT COMPLETED|Overall Study||0
8543542|NCT01856192|9574971|FG000|STARTED|Overall Study||173
8543543|NCT01856192|9574972|FG001|STARTED|Overall Study||176
8543544|NCT01856192|9574971|FG000|Treated Patients|Overall Study||166
8543545|NCT01856192|9574972|FG001|Treated Patients|Overall Study||171
8543546|NCT01856192|9574971|FG000|Evaluable Patients (Eligible and Treated)|Overall Study||145
8543547|NCT01856192|9574972|FG001|Evaluable Patients (Eligible and Treated)|Overall Study||135
8543548|NCT01856192|9574971|FG000|COMPLETED|Overall Study||124
8543549|NCT01856192|9574972|FG001|COMPLETED|Overall Study||116
8543550|NCT01856192|9574971|FG000|NOT COMPLETED|Overall Study||49
8543551|NCT01856192|9574972|FG001|NOT COMPLETED|Overall Study||60
8543552|NCT01715285|9574980|FG000|STARTED|Treatment Period||597
8543553|NCT01715285|9574981|FG001|STARTED|Treatment Period||602
8543554|NCT01715285|9574982|FG002|STARTED|Treatment Period||0
8543555|NCT01715285|9574980|FG000|ITT Population|Treatment Period||597
8543556|NCT01715285|9574981|FG001|ITT Population|Treatment Period||602
8543557|NCT01715285|9574982|FG002|ITT Population|Treatment Period||0
8543558|NCT01715285|9574980|FG000|Safety Population|Treatment Period||597
8543559|NCT01715285|9574981|FG001|Safety Population|Treatment Period||602
8543560|NCT01715285|9574982|FG002|Safety Population|Treatment Period||0
8543561|NCT01715285|9574980|FG000|COMPLETED|Treatment Period||0
8543562|NCT01715285|9574981|FG001|COMPLETED|Treatment Period||0
8543563|NCT01715285|9574982|FG002|COMPLETED|Treatment Period||0
8543564|NCT01715285|9574980|FG000|NOT COMPLETED|Treatment Period||597
8543565|NCT01715285|9574981|FG001|NOT COMPLETED|Treatment Period||602
8543566|NCT01715285|9574982|FG002|NOT COMPLETED|Treatment Period||0
8543567|NCT01715285|9574980|FG000|STARTED|Open-label (OL) Extension Phase||157
8543568|NCT01715285|9574981|FG001|STARTED|Open-label (OL) Extension Phase||0
8543569|NCT01715285|9574982|FG002|STARTED|Open-label (OL) Extension Phase||72
8543570|NCT01715285|9574980|FG000|COMPLETED|Open-label (OL) Extension Phase||0
8543571|NCT01715285|9574981|FG001|COMPLETED|Open-label (OL) Extension Phase||0
8543572|NCT01715285|9574982|FG002|COMPLETED|Open-label (OL) Extension Phase||0
8543573|NCT01715285|9574980|FG000|NOT COMPLETED|Open-label (OL) Extension Phase||157
8543574|NCT01715285|9574981|FG001|NOT COMPLETED|Open-label (OL) Extension Phase||0
8543575|NCT01715285|9574982|FG002|NOT COMPLETED|Open-label (OL) Extension Phase||72
8566629|NCT00077974|9598825|FG000|STARTED|Overall Study||106
8566630|NCT00077974|9598825|FG000|COMPLETED|Overall Study||2
8566631|NCT00077974|9598825|FG000|NOT COMPLETED|Overall Study||104
8566632|NCT00078286|9598831|FG000|STARTED|Overall Study||234
8566633|NCT00078286|9598832|FG001|STARTED|Overall Study||235
8566634|NCT00078286|9598831|FG000|COMPLETED|Overall Study||138
8566635|NCT00078286|9598832|FG001|COMPLETED|Overall Study||152
8566636|NCT00078286|9598831|FG000|NOT COMPLETED|Overall Study||96
8566637|NCT00078286|9598832|FG001|NOT COMPLETED|Overall Study||83
8566638|NCT00078312|9598838|FG000|STARTED|Overall Study||328
8566639|NCT00078312|9598838|FG000|COMPLETED|Overall Study||151
8566640|NCT00078312|9598838|FG000|NOT COMPLETED|Overall Study||177
8566641|NCT00078325|9598845|FG000|STARTED|Overall Study||131
8566642|NCT00078325|9598846|FG001|STARTED|Overall Study||133
8566643|NCT00078325|9598847|FG002|STARTED|Overall Study||131
8566644|NCT00078325|9598845|FG000|COMPLETED|Overall Study||110
8566645|NCT00078325|9598846|FG001|COMPLETED|Overall Study||114
8566646|NCT00078325|9598847|FG002|COMPLETED|Overall Study||120
8566647|NCT00078325|9598845|FG000|NOT COMPLETED|Overall Study||21
8566648|NCT00078325|9598846|FG001|NOT COMPLETED|Overall Study||19
8566649|NCT00078325|9598847|FG002|NOT COMPLETED|Overall Study||11
8566650|NCT00078338|9598857|FG000|STARTED|Overall Study||386
8566651|NCT00078338|9598858|FG001|STARTED|Overall Study||378
8566652|NCT00078338|9598857|FG000|Safety Population|Overall Study|Safety population=subjects who received at least 1 dose of treatment and had followup safety data.|381
8566653|NCT00078338|9598858|FG001|Safety Population|Overall Study|Safety population=subjects who received at least 1 dose of treatment and had followup safety data.|375
8566654|NCT00078338|9598857|FG000|COMPLETED|Overall Study||301
8566655|NCT00078338|9598858|FG001|COMPLETED|Overall Study||324
8566656|NCT00078338|9598857|FG000|NOT COMPLETED|Overall Study||85
8566657|NCT00078338|9598858|FG001|NOT COMPLETED|Overall Study||54
8566658|NCT00078377|9598867|FG000|STARTED|Overall Study||67
8543576|NCT01646814|9574991|FG000|STARTED|Overall Study||121
8543577|NCT01646814|9574992|FG001|STARTED|Overall Study||126
8543578|NCT01646814|9574991|FG000|COMPLETED|Overall Study||110
8543579|NCT01646814|9574992|FG001|COMPLETED|Overall Study||120
8543580|NCT01646814|9574991|FG000|NOT COMPLETED|Overall Study||11
8543581|NCT01646814|9574992|FG001|NOT COMPLETED|Overall Study||6
8621373|NCT00479557|9660326|FG000|NOT COMPLETED|Overall Study||10
8621374|NCT00479557|9660327|FG001|NOT COMPLETED|Overall Study||10
8543582|NCT01613118|9575002|FG000|STARTED|Double-blind||13
8543583|NCT01613118|9575003|FG001|STARTED|Double-blind||26
8543584|NCT01613118|9575004|FG002|STARTED|Double-blind||34
8543585|NCT01613118|9575005|FG003|STARTED|Double-blind||36
8543586|NCT01613118|9575002|FG000|COMPLETED|Double-blind||13
8543587|NCT01613118|9575003|FG001|COMPLETED|Double-blind||23
8543588|NCT01613118|9575004|FG002|COMPLETED|Double-blind||32
8543589|NCT01613118|9575005|FG003|COMPLETED|Double-blind||35
8543590|NCT01613118|9575002|FG000|NOT COMPLETED|Double-blind||0
8543591|NCT01613118|9575003|FG001|NOT COMPLETED|Double-blind||3
8543592|NCT01613118|9575004|FG002|NOT COMPLETED|Double-blind||2
8543593|NCT01613118|9575005|FG003|NOT COMPLETED|Double-blind||1
8543594|NCT01613118|9575002|FG000|STARTED|Open-label Extension|Arm includes subjects from the Irbesartan Arm in the Double-blind period.|21
8543595|NCT01613118|9575003|FG001|STARTED|Open-label Extension|Arm includes subjects from the Irbesartan Arm in the Double-blind period.|42
8543596|NCT01613118|9575004|FG002|STARTED|Open-label Extension|Arm includes subjects from the Irbesartan Arm in the Double-blind period.|40
8543597|NCT01613118|9575005|FG003|STARTED|Open-label Extension||0
8543598|NCT01613118|9575002|FG000|COMPLETED|Open-label Extension|OLE ongoing|0
8543599|NCT01613118|9575003|FG001|COMPLETED|Open-label Extension|OLE ongoing|0
8543600|NCT01613118|9575004|FG002|COMPLETED|Open-label Extension|OLE ongoing|0
8543601|NCT01613118|9575005|FG003|COMPLETED|Open-label Extension||0
8543602|NCT01613118|9575002|FG000|NOT COMPLETED|Open-label Extension||21
8543603|NCT01613118|9575003|FG001|NOT COMPLETED|Open-label Extension||42
8543604|NCT01613118|9575004|FG002|NOT COMPLETED|Open-label Extension||40
8543605|NCT01613118|9575005|FG003|NOT COMPLETED|Open-label Extension||0
8543606|NCT01295944|9575016|FG000|STARTED|Overall Study||35
8543607|NCT01295944|9575016|FG000|COMPLETED|Overall Study||17
8543608|NCT01295944|9575016|FG000|NOT COMPLETED|Overall Study||18
8543609|NCT01285557|9575022|FG000|STARTED|Overall Study||239
8543610|NCT01285557|9575023|FG001|STARTED|Overall Study||122
8543611|NCT01285557|9575022|FG000|Treated|Overall Study||238
8543612|NCT01285557|9575023|FG001|Treated|Overall Study||121
8543613|NCT01285557|9575022|FG000|As Treated (AT) Population|Overall Study||230
8543614|NCT01285557|9575023|FG001|As Treated (AT) Population|Overall Study||118
8543615|NCT01285557|9575022|FG000|COMPLETED|Overall Study||0
8543616|NCT01285557|9575023|FG001|COMPLETED|Overall Study||0
8543617|NCT01285557|9575022|FG000|NOT COMPLETED|Overall Study||239
8621375|NCT00479557|9660328|FG002|NOT COMPLETED|Overall Study||8
8621376|NCT00479557|9660329|FG003|NOT COMPLETED|Overall Study||5
9065837|NCT04138498|10126336|FG001|NOT COMPLETED|Overall Study||0
9065838|NCT04138498|10126337|FG002|NOT COMPLETED|Overall Study||2
9065839|NCT04138498|10126338|FG003|NOT COMPLETED|Overall Study||3
9065840|NCT04138043|10126354|FG000|STARTED|Overall Study||2
9065841|NCT04138043|10126355|FG001|STARTED|Overall Study||7
9065842|NCT04138043|10126354|FG000|COMPLETED|Overall Study||2
9065843|NCT04138043|10126355|FG001|COMPLETED|Overall Study||6
9065844|NCT04138043|10126354|FG000|NOT COMPLETED|Overall Study||0
9065845|NCT04138043|10126355|FG001|NOT COMPLETED|Overall Study||1
9065846|NCT04137627|10126364|FG000|STARTED|Overall Study||25
9065847|NCT04137627|10126365|FG001|STARTED|Overall Study||25
9065848|NCT04137627|10126364|FG000|COMPLETED|Overall Study||13
9065849|NCT04137627|10126365|FG001|COMPLETED|Overall Study||12
9065850|NCT04137627|10126364|FG000|NOT COMPLETED|Overall Study||12
9065851|NCT04137627|10126365|FG001|NOT COMPLETED|Overall Study||13
9065852|NCT04136145|10126373|FG000|STARTED|Overall Study||12
9065853|NCT04136145|10126374|FG001|STARTED|Overall Study||24
9065854|NCT04136145|10126373|FG000|COMPLETED|Overall Study||12
9065855|NCT04136145|10126374|FG001|COMPLETED|Overall Study||24
9065856|NCT04136145|10126373|FG000|NOT COMPLETED|Overall Study||0
9065857|NCT04136145|10126374|FG001|NOT COMPLETED|Overall Study||0
9065858|NCT04132336|10126388|FG000|STARTED|Overall Study||32
9065859|NCT04132336|10126389|FG001|STARTED|Overall Study||32
9065860|NCT04132336|10126390|FG002|STARTED|Overall Study||32
9065861|NCT04132336|10126391|FG003|STARTED|Overall Study||32
9065862|NCT04132336|10126392|FG004|STARTED|Overall Study||32
9065863|NCT04132336|10126393|FG005|STARTED|Overall Study||16
9065864|NCT04132336|10126394|FG006|STARTED|Overall Study||17
9065865|NCT04132336|10126388|FG000|COMPLETED|Overall Study||32
9065866|NCT04132336|10126389|FG001|COMPLETED|Overall Study||31
9065867|NCT04132336|10126390|FG002|COMPLETED|Overall Study||32
9065868|NCT04132336|10126391|FG003|COMPLETED|Overall Study||32
9065869|NCT04132336|10126392|FG004|COMPLETED|Overall Study||32
9065870|NCT04132336|10126393|FG005|COMPLETED|Overall Study||16
9065871|NCT04132336|10126394|FG006|COMPLETED|Overall Study||17
9065872|NCT04132336|10126388|FG000|NOT COMPLETED|Overall Study||0
9065873|NCT04132336|10126389|FG001|NOT COMPLETED|Overall Study||1
8543618|NCT01285557|9575023|FG001|NOT COMPLETED|Overall Study||122
8621377|NCT00479557|9660330|FG004|NOT COMPLETED|Overall Study||4
8621378|NCT00479557|9660331|FG005|NOT COMPLETED|Overall Study||13
8621379|NCT00479557|9660332|FG006|NOT COMPLETED|Overall Study||2
8621380|NCT00479674|9660354|FG000|STARTED|Overall Study||41
8621381|NCT00479674|9660354|FG000|COMPLETED|Overall Study||0
8621382|NCT00479674|9660354|FG000|NOT COMPLETED|Overall Study||41
8621383|NCT00479687|9660360|FG000|STARTED|Ph 1: Blinded, Randomized, Controlled||150
8621384|NCT00479687|9660361|FG001|STARTED|Ph 1: Blinded, Randomized, Controlled||150
8621385|NCT00479687|9660362|FG002|STARTED|Ph 1: Blinded, Randomized, Controlled||0
8621386|NCT00479687|9660360|FG000|COMPLETED|Ph 1: Blinded, Randomized, Controlled||125
8621387|NCT00479687|9660361|FG001|COMPLETED|Ph 1: Blinded, Randomized, Controlled||131
8621388|NCT00479687|9660362|FG002|COMPLETED|Ph 1: Blinded, Randomized, Controlled||0
8621389|NCT00479687|9660360|FG000|NOT COMPLETED|Ph 1: Blinded, Randomized, Controlled||25
8621390|NCT00479687|9660361|FG001|NOT COMPLETED|Ph 1: Blinded, Randomized, Controlled||19
8621391|NCT00479687|9660362|FG002|NOT COMPLETED|Ph 1: Blinded, Randomized, Controlled||0
8621392|NCT00479687|9660360|FG000|STARTED|Ph 2: Open Label, Single (Supartz) Arm||0
8621393|NCT00479687|9660361|FG001|STARTED|Ph 2: Open Label, Single (Supartz) Arm||0
8621394|NCT00479687|9660362|FG002|STARTED|Ph 2: Open Label, Single (Supartz) Arm|Four did not continue to Ph2; 224 received at least 1 inj. and 28 received no trt. (only follow-up)|224
8621395|NCT00479687|9660360|FG000|COMPLETED|Ph 2: Open Label, Single (Supartz) Arm||0
8621396|NCT00479687|9660361|FG001|COMPLETED|Ph 2: Open Label, Single (Supartz) Arm||0
8621397|NCT00479687|9660362|FG002|COMPLETED|Ph 2: Open Label, Single (Supartz) Arm||215
9065874|NCT04132336|10126390|FG002|NOT COMPLETED|Overall Study||0
9065875|NCT04132336|10126391|FG003|NOT COMPLETED|Overall Study||0
9065876|NCT04132336|10126392|FG004|NOT COMPLETED|Overall Study||0
9065877|NCT04132336|10126393|FG005|NOT COMPLETED|Overall Study||0
9065878|NCT04132336|10126394|FG006|NOT COMPLETED|Overall Study||0
9065879|NCT04131517|10126412|FG000|STARTED|Overall Study||7
8543647|NCT01032603|9575048|FG000|STARTED|Overall Study||101
8543648|NCT01032603|9575049|FG001|STARTED|Overall Study||96
8543649|NCT01032603|9575048|FG000|COMPLETED|Overall Study||86
8543650|NCT01032603|9575049|FG001|COMPLETED|Overall Study||77
8543651|NCT01032603|9575048|FG000|NOT COMPLETED|Overall Study||15
8543652|NCT01032603|9575049|FG001|NOT COMPLETED|Overall Study||19
8543653|NCT00977691|9575058|FG000|STARTED|Overall Study||3
8543654|NCT00977691|9575059|FG001|STARTED|Overall Study||8
8543655|NCT00977691|9575060|FG002|STARTED|Overall Study||12
8543656|NCT00977691|9575058|FG000|COMPLETED|Overall Study||3
8543657|NCT00977691|9575059|FG001|COMPLETED|Overall Study||7
8543658|NCT00977691|9575060|FG002|COMPLETED|Overall Study||12
8543659|NCT00977691|9575058|FG000|NOT COMPLETED|Overall Study||0
8543660|NCT00977691|9575059|FG001|NOT COMPLETED|Overall Study||1
8543661|NCT00977691|9575060|FG002|NOT COMPLETED|Overall Study||0
8543662|NCT00964002|9575070|FG000|STARTED|Overall Study||61
8543663|NCT00964002|9575070|FG000|Assessable for Safety|Overall Study|59 patients were assessable for safety, they received treatment at least once.|59
8543664|NCT00964002|9575070|FG000|COMPLETED|Overall Study||53
8543665|NCT00964002|9575070|FG000|NOT COMPLETED|Overall Study||8
8543666|NCT00887783|9575076|FG000|STARTED|Overall Study||58
8543667|NCT00887783|9575077|FG001|STARTED|Overall Study||59
9065880|NCT04131517|10126413|FG001|STARTED|Overall Study||7
9065881|NCT04131517|10126412|FG000|COMPLETED|Overall Study||7
9065882|NCT04131517|10126413|FG001|COMPLETED|Overall Study||7
9065883|NCT04131517|10126412|FG000|NOT COMPLETED|Overall Study||0
9065884|NCT04131517|10126413|FG001|NOT COMPLETED|Overall Study||0
9065885|NCT04128293|10126434|FG000|STARTED|Treatment Period 1 (1 Day)||4
9065886|NCT04128293|10126435|FG001|STARTED|Treatment Period 1 (1 Day)||4
9065887|NCT04128293|10126436|FG002|STARTED|Treatment Period 1 (1 Day)||4
8543668|NCT00887783|9575076|FG000|COMPLETED|Overall Study||58
8543669|NCT00887783|9575077|FG001|COMPLETED|Overall Study||59
8543670|NCT00887783|9575076|FG000|NOT COMPLETED|Overall Study||0
8543671|NCT00887783|9575077|FG001|NOT COMPLETED|Overall Study||0
8543672|NCT00790218|9575083|FG000|STARTED|Overall Study||6
8543673|NCT00790218|9575084|FG001|STARTED|Overall Study||6
8543674|NCT00790218|9575085|FG002|STARTED|Overall Study||7
8543675|NCT00790218|9575083|FG000|COMPLETED|Overall Study||5
8543676|NCT00790218|9575084|FG001|COMPLETED|Overall Study||6
8543677|NCT00790218|9575085|FG002|COMPLETED|Overall Study||7
8543678|NCT00790218|9575083|FG000|NOT COMPLETED|Overall Study||1
8543679|NCT00790218|9575084|FG001|NOT COMPLETED|Overall Study||0
8543680|NCT00790218|9575085|FG002|NOT COMPLETED|Overall Study||0
8543681|NCT00583778|9575095|FG000|STARTED|Overall Study||74
8543682|NCT00583778|9575096|FG001|STARTED|Overall Study||67
8543683|NCT00583778|9575095|FG000|COMPLETED|Overall Study||74
8543684|NCT00583778|9575096|FG001|COMPLETED|Overall Study||67
8543685|NCT00583778|9575095|FG000|NOT COMPLETED|Overall Study||0
8543686|NCT00583778|9575096|FG001|NOT COMPLETED|Overall Study||0
8543687|NCT00485693|9575104|FG000|STARTED|Overall Study||34
8543688|NCT00485693|9575105|FG001|STARTED|Overall Study||104
8543689|NCT00485693|9575104|FG000|COMPLETED|Overall Study||34
8543690|NCT00485693|9575105|FG001|COMPLETED|Overall Study||104
8543691|NCT00485693|9575104|FG000|NOT COMPLETED|Overall Study||0
8543692|NCT00485693|9575105|FG001|NOT COMPLETED|Overall Study||0
8543693|NCT00432094|9575114|FG000|STARTED|Overall Study||14
8543694|NCT00432094|9575115|FG001|STARTED|Overall Study||9
8543695|NCT00432094|9575114|FG000|COMPLETED|Overall Study||14
8543696|NCT00432094|9575115|FG001|COMPLETED|Overall Study||9
8543697|NCT00432094|9575114|FG000|NOT COMPLETED|Overall Study||0
8543698|NCT00432094|9575115|FG001|NOT COMPLETED|Overall Study||0
8543699|NCT00416351|9575125|FG000|STARTED|Overall Study||1
8543700|NCT00416351|9575126|FG001|STARTED|Overall Study||3
8543701|NCT00416351|9575127|FG002|STARTED|Overall Study||4
8543702|NCT00416351|9575128|FG003|STARTED|Overall Study||17
8543703|NCT00416351|9575129|FG004|STARTED|Overall Study||4
8543704|NCT00416351|9575125|FG000|COMPLETED|Overall Study||1
8543705|NCT00416351|9575126|FG001|COMPLETED|Overall Study||3
8543706|NCT00416351|9575127|FG002|COMPLETED|Overall Study||4
8543707|NCT00416351|9575128|FG003|COMPLETED|Overall Study||17
8543708|NCT00416351|9575129|FG004|COMPLETED|Overall Study||4
8543709|NCT00416351|9575125|FG000|NOT COMPLETED|Overall Study||0
8543710|NCT00416351|9575126|FG001|NOT COMPLETED|Overall Study||0
8543711|NCT00416351|9575127|FG002|NOT COMPLETED|Overall Study||0
8543712|NCT00416351|9575128|FG003|NOT COMPLETED|Overall Study||0
8543713|NCT00416351|9575129|FG004|NOT COMPLETED|Overall Study||0
8543714|NCT00352027|9575146|FG000|STARTED|Overall Study||80
8543715|NCT00352027|9575146|FG000|COMPLETED|Overall Study||77
8543716|NCT00352027|9575146|FG000|NOT COMPLETED|Overall Study||3
8543717|NCT00334815|9575174|FG000|STARTED|Overall Study||16
8543718|NCT00334815|9575175|FG001|STARTED|Overall Study||13
8543719|NCT00334815|9575174|FG000|COMPLETED|Overall Study||9
8543720|NCT00334815|9575175|FG001|COMPLETED|Overall Study||3
8543721|NCT00334815|9575174|FG000|NOT COMPLETED|Overall Study||7
8543722|NCT00334815|9575175|FG001|NOT COMPLETED|Overall Study||10
8543723|NCT00145600|9575187|FG000|STARTED|Overall Study||91
8543724|NCT00145600|9575188|FG001|STARTED|Overall Study||46
8543725|NCT00145600|9575189|FG002|STARTED|Overall Study||13
8818210|NCT01556347|9871834|FG000|STARTED|Recovery Phase||2
8818211|NCT01556347|9871834|FG000|COMPLETED|Recovery Phase||2
8818212|NCT01556347|9871834|FG000|NOT COMPLETED|Recovery Phase||0
8818213|NCT01556425|9871866|FG000|STARTED|Overall Study||25
8818214|NCT01556425|9871867|FG001|STARTED|Overall Study||23
8818215|NCT01556425|9871868|FG002|STARTED|Overall Study||18
8818216|NCT01556425|9871869|FG003|STARTED|Overall Study||18
8818217|NCT01556425|9871866|FG000|COMPLETED|Overall Study||25
8818218|NCT01556425|9871867|FG001|COMPLETED|Overall Study||23
8818219|NCT01556425|9871868|FG002|COMPLETED|Overall Study||18
8818220|NCT01556425|9871869|FG003|COMPLETED|Overall Study||18
8818221|NCT01556425|9871866|FG000|NOT COMPLETED|Overall Study||0
8818222|NCT01556425|9871867|FG001|NOT COMPLETED|Overall Study||0
8818223|NCT01556425|9871868|FG002|NOT COMPLETED|Overall Study||0
8818224|NCT01556425|9871869|FG003|NOT COMPLETED|Overall Study||0
8818225|NCT01556438|9871881|FG000|STARTED|Overall Study||4
8818226|NCT01556438|9871882|FG001|STARTED|Overall Study||12
8818227|NCT01556438|9871881|FG000|Received at Least 1 Dose of Study Drug|Overall Study|100 mg tabalumab IV|4
8818228|NCT01556438|9871882|FG001|Received at Least 1 Dose of Study Drug|Overall Study|300 mg tabalumab IV|12
8818229|NCT01556438|9871881|FG000|Received BTZ IV|Overall Study||4
8818230|NCT01556438|9871882|FG001|Received BTZ IV|Overall Study||4
8818231|NCT01556438|9871881|FG000|Received BTZ SC|Overall Study||0
8818232|NCT01556438|9871882|FG001|Received BTZ SC|Overall Study||8
8818233|NCT01556438|9871881|FG000|COMPLETED|Overall Study||0
8818234|NCT01556438|9871882|FG001|COMPLETED|Overall Study||1
8818235|NCT01556438|9871881|FG000|NOT COMPLETED|Overall Study||4
8818236|NCT01556438|9871882|FG001|NOT COMPLETED|Overall Study||11
8818237|NCT01556451|9871896|FG000|STARTED|Overall Study||180
8818238|NCT01556451|9871896|FG000|COMPLETED|Overall Study||180
8818239|NCT01556451|9871896|FG000|NOT COMPLETED|Overall Study||0
8818240|NCT01556581|9871902|FG000|STARTED|Overall Study||61
8818241|NCT01556581|9871903|FG001|STARTED|Overall Study||58
8818242|NCT01556581|9871902|FG000|COMPLETED|Overall Study||61
8818243|NCT01556581|9871903|FG001|COMPLETED|Overall Study||58
8818244|NCT01556581|9871902|FG000|NOT COMPLETED|Overall Study||0
8818245|NCT01556581|9871903|FG001|NOT COMPLETED|Overall Study||0
8818246|NCT01556594|9871912|FG000|STARTED|Overall Study||10
8818247|NCT01556594|9871913|FG001|STARTED|Overall Study||2
8818248|NCT01556594|9871914|FG002|STARTED|Overall Study||6
8818249|NCT01556594|9871912|FG000|COMPLETED|Overall Study||10
8818250|NCT01556594|9871913|FG001|COMPLETED|Overall Study||2
8818251|NCT01556594|9871914|FG002|COMPLETED|Overall Study||6
8818252|NCT01556594|9871912|FG000|NOT COMPLETED|Overall Study||0
8818253|NCT01556594|9871913|FG001|NOT COMPLETED|Overall Study||0
8818254|NCT01556594|9871914|FG002|NOT COMPLETED|Overall Study||0
8818255|NCT01556633|9871926|FG000|STARTED|Overall Study||10
8818256|NCT01556633|9871927|FG001|STARTED|Overall Study||6
8818257|NCT01556633|9871926|FG000|COMPLETED|Overall Study||10
8818258|NCT01556633|9871927|FG001|COMPLETED|Overall Study||6
8818259|NCT01556633|9871926|FG000|NOT COMPLETED|Overall Study||0
8818260|NCT01556633|9871927|FG001|NOT COMPLETED|Overall Study||0
8818261|NCT01556724|9871938|FG000|STARTED|Overall Study||16
8818262|NCT01556724|9871939|FG001|STARTED|Overall Study||14
8818263|NCT01556724|9871938|FG000|COMPLETED|Overall Study||16
8543726|NCT00145600|9575190|FG003|STARTED|Overall Study||146
8543727|NCT00145600|9575187|FG000|COMPLETED|Overall Study||83
8543728|NCT00145600|9575188|FG001|COMPLETED|Overall Study||36
8818264|NCT01556724|9871939|FG001|COMPLETED|Overall Study||14
8818265|NCT01556724|9871938|FG000|NOT COMPLETED|Overall Study||0
8543729|NCT00145600|9575189|FG002|COMPLETED|Overall Study||8
8543730|NCT00145600|9575190|FG003|COMPLETED|Overall Study||130
8818266|NCT01556724|9871939|FG001|NOT COMPLETED|Overall Study||0
8818267|NCT01556763|9871951|FG000|STARTED|Overall Study||4
8818268|NCT01556763|9871952|FG001|STARTED|Overall Study||9
8543731|NCT00145600|9575187|FG000|NOT COMPLETED|Overall Study||8
8543732|NCT00145600|9575188|FG001|NOT COMPLETED|Overall Study||10
8543733|NCT00145600|9575189|FG002|NOT COMPLETED|Overall Study||5
8818269|NCT01556763|9871953|FG002|STARTED|Overall Study||8
8818270|NCT01556763|9871951|FG000|COMPLETED|Overall Study||4
8543734|NCT00145600|9575190|FG003|NOT COMPLETED|Overall Study||16
8543735|NCT00072358|9575214|FG000|STARTED|Overall Study||291
8543736|NCT00072358|9575214|FG000|COMPLETED|Overall Study||291
8543737|NCT00072358|9575214|FG000|NOT COMPLETED|Overall Study||0
8566659|NCT00078377|9598868|FG001|STARTED|Overall Study||65
8566660|NCT00078377|9598869|FG002|STARTED|Overall Study||64
8566661|NCT00078377|9598867|FG000|COMPLETED|Overall Study||56
8566662|NCT00078377|9598868|FG001|COMPLETED|Overall Study||49
8566663|NCT00078377|9598869|FG002|COMPLETED|Overall Study||55
8566664|NCT00078377|9598867|FG000|NOT COMPLETED|Overall Study||11
8566665|NCT00078377|9598868|FG001|NOT COMPLETED|Overall Study||16
8566666|NCT00078377|9598869|FG002|NOT COMPLETED|Overall Study||9
8566667|NCT00078403|9598881|FG000|STARTED|Overall Study|Eligible at pre-assignment (40), direct (2), Arm C week 36 non-response (1), EVR inadvertently (1).|44
8566668|NCT00078403|9598882|FG001|STARTED|Overall Study|Eligible at pre-assignment (40), direct (1), Arm C week 36 non-response (1).|42
8566669|NCT00078403|9598883|FG002|STARTED|Overall Study||169
8566670|NCT00078403|9598881|FG000|COMPLETED|Overall Study||26
8566671|NCT00078403|9598882|FG001|COMPLETED|Overall Study||26
8566672|NCT00078403|9598883|FG002|COMPLETED|Overall Study||141
8566673|NCT00078403|9598881|FG000|NOT COMPLETED|Overall Study||18
8566674|NCT00078403|9598882|FG001|NOT COMPLETED|Overall Study||16
8566675|NCT00078403|9598883|FG002|NOT COMPLETED|Overall Study||28
8566676|NCT00078559|9598892|FG000|STARTED|Overall Study||10
8566677|NCT00078559|9598892|FG000|COMPLETED|Overall Study|1 subject stopped study drug due to a severe but non-serious AE, and completed the trial|10
8566678|NCT00078559|9598892|FG000|NOT COMPLETED|Overall Study||0
8566679|NCT00078715|9598899|FG000|STARTED|First Intervention||2
8566680|NCT00078715|9598900|FG001|STARTED|First Intervention||4
8621398|NCT00479687|9660360|FG000|NOT COMPLETED|Ph 2: Open Label, Single (Supartz) Arm||0
8621399|NCT00479687|9660361|FG001|NOT COMPLETED|Ph 2: Open Label, Single (Supartz) Arm||0
8621400|NCT00479687|9660362|FG002|NOT COMPLETED|Ph 2: Open Label, Single (Supartz) Arm||9
8566681|NCT00078715|9598899|FG000|COMPLETED|First Intervention||2
8566682|NCT00078715|9598900|FG001|COMPLETED|First Intervention||4
8566683|NCT00078715|9598899|FG000|NOT COMPLETED|First Intervention||0
8566684|NCT00078715|9598900|FG001|NOT COMPLETED|First Intervention||0
8566685|NCT00078715|9598899|FG000|STARTED|Second Intervention||2
8566686|NCT00078715|9598900|FG001|STARTED|Second Intervention||4
8566687|NCT00078715|9598899|FG000|COMPLETED|Second Intervention||2
8566688|NCT00078715|9598900|FG001|COMPLETED|Second Intervention||4
8566689|NCT00078715|9598899|FG000|NOT COMPLETED|Second Intervention||0
8566690|NCT00078715|9598900|FG001|NOT COMPLETED|Second Intervention||0
8566691|NCT00078728|9598908|FG000|STARTED|Overall Study||20
8566692|NCT00078728|9598909|FG001|STARTED|Overall Study||20
8566693|NCT00078728|9598908|FG000|COMPLETED|Overall Study||16
8566694|NCT00078728|9598909|FG001|COMPLETED|Overall Study||17
8566695|NCT00078728|9598908|FG000|NOT COMPLETED|Overall Study||4
8566696|NCT00078728|9598909|FG001|NOT COMPLETED|Overall Study||3
8566697|NCT00078754|9598919|FG000|STARTED|Overall Study||29
8566698|NCT00078754|9598920|FG001|STARTED|Overall Study||30
8566699|NCT00078754|9598921|FG002|STARTED|Overall Study||31
8566700|NCT00078754|9598919|FG000|COMPLETED|Overall Study||14
8566701|NCT00078754|9598920|FG001|COMPLETED|Overall Study||11
8566702|NCT00078754|9598921|FG002|COMPLETED|Overall Study||16
8566703|NCT00078754|9598919|FG000|NOT COMPLETED|Overall Study||15
8566704|NCT00078754|9598920|FG001|NOT COMPLETED|Overall Study||19
8566705|NCT00078754|9598921|FG002|NOT COMPLETED|Overall Study||15
8566706|NCT00078767|9598934|FG000|STARTED|Overall Study||12
8566707|NCT00078767|9598935|FG001|STARTED|Overall Study||12
8566708|NCT00078767|9598934|FG000|COMPLETED|Overall Study||11
8566709|NCT00078767|9598935|FG001|COMPLETED|Overall Study||11
8566710|NCT00078767|9598934|FG000|NOT COMPLETED|Overall Study||1
8566711|NCT00078767|9598935|FG001|NOT COMPLETED|Overall Study||1
8566712|NCT00078819|9598943|FG000|STARTED|Double-blind Treatment Period: Week 1-12||105
8566713|NCT00078819|9598944|FG001|STARTED|Double-blind Treatment Period: Week 1-12||106
8818271|NCT01556763|9871952|FG001|COMPLETED|Overall Study||8
8818272|NCT01556763|9871953|FG002|COMPLETED|Overall Study||8
8818273|NCT01556763|9871951|FG000|NOT COMPLETED|Overall Study||0
8818274|NCT01556763|9871952|FG001|NOT COMPLETED|Overall Study||1
8818275|NCT01556763|9871953|FG002|NOT COMPLETED|Overall Study||0
8818276|NCT01556906|9871963|FG000|STARTED|Overall Study||6
8818277|NCT01556906|9871963|FG000|COMPLETED|Overall Study||6
8566714|NCT00078819|9598945|FG002|STARTED|Double-blind Treatment Period: Week 1-12||0
8566715|NCT00078819|9598946|FG003|STARTED|Double-blind Treatment Period: Week 1-12||0
8566716|NCT00078819|9598943|FG000|Entered Escape|Double-blind Treatment Period: Week 1-12||27
8566717|NCT00078819|9598944|FG001|Entered Escape|Double-blind Treatment Period: Week 1-12||5
8566718|NCT00078819|9598945|FG002|Entered Escape|Double-blind Treatment Period: Week 1-12||0
8566719|NCT00078819|9598946|FG003|Entered Escape|Double-blind Treatment Period: Week 1-12||0
8566720|NCT00078819|9598943|FG000|COMPLETED|Double-blind Treatment Period: Week 1-12||104
8621401|NCT00479856|9660369|FG000|STARTED|Overall Study||9
8818278|NCT01556906|9871963|FG000|NOT COMPLETED|Overall Study||0
8566721|NCT00078819|9598944|FG001|COMPLETED|Double-blind Treatment Period: Week 1-12||105
8818279|NCT01556932|9871967|FG000|STARTED|Baseline First Treatment||13
8566722|NCT00078819|9598945|FG002|COMPLETED|Double-blind Treatment Period: Week 1-12||0
8566723|NCT00078819|9598946|FG003|COMPLETED|Double-blind Treatment Period: Week 1-12||0
8566724|NCT00078819|9598943|FG000|NOT COMPLETED|Double-blind Treatment Period: Week 1-12||1
8566725|NCT00078819|9598944|FG001|NOT COMPLETED|Double-blind Treatment Period: Week 1-12||1
8818280|NCT01556932|9871968|FG001|STARTED|Baseline First Treatment||9
8818281|NCT01556932|9871967|FG000|Recieved|Baseline First Treatment||13
8818282|NCT01556932|9871968|FG001|Recieved|Baseline First Treatment||9
8818283|NCT01556932|9871967|FG000|COMPLETED|Baseline First Treatment||13
8818284|NCT01556932|9871968|FG001|COMPLETED|Baseline First Treatment||9
8543738|NCT03089281|9575220|FG000|STARTED|Overall Study||225
8543739|NCT03089281|9575221|FG001|STARTED|Overall Study||215
8543740|NCT03089281|9575220|FG000|COMPLETED|Overall Study||197
8543741|NCT03089281|9575221|FG001|COMPLETED|Overall Study||198
8543742|NCT03089281|9575220|FG000|NOT COMPLETED|Overall Study||28
8543743|NCT03089281|9575221|FG001|NOT COMPLETED|Overall Study||17
8543744|NCT03085563|9575229|FG000|STARTED|Overall Study||19
8543745|NCT03085563|9575230|FG001|STARTED|Overall Study||41
8543746|NCT03085563|9575229|FG000|COMPLETED|Overall Study||19
8543747|NCT03085563|9575230|FG001|COMPLETED|Overall Study||41
8543748|NCT03085563|9575229|FG000|NOT COMPLETED|Overall Study||0
8543749|NCT03085563|9575230|FG001|NOT COMPLETED|Overall Study||0
8543766|NCT03056443|9575264|FG000|STARTED|Overall Study||13
8543767|NCT03056443|9575264|FG000|COMPLETED|Overall Study||13
8543768|NCT03056443|9575264|FG000|NOT COMPLETED|Overall Study||0
8543769|NCT03020225|9575271|FG000|STARTED|Overall Study||12
8543770|NCT03020225|9575272|FG001|STARTED|Overall Study||11
8543771|NCT03020225|9575273|FG002|STARTED|Overall Study||13
8543772|NCT03020225|9575271|FG000|COMPLETED|Overall Study||12
8543773|NCT03020225|9575272|FG001|COMPLETED|Overall Study||11
8543774|NCT03020225|9575273|FG002|COMPLETED|Overall Study||13
8543775|NCT03020225|9575271|FG000|NOT COMPLETED|Overall Study||0
8543776|NCT03020225|9575272|FG001|NOT COMPLETED|Overall Study||0
8543777|NCT03020225|9575273|FG002|NOT COMPLETED|Overall Study||0
8543778|NCT05110014|9575307|FG000|STARTED|Overall Study||12239
8543779|NCT05110014|9575308|FG001|STARTED|Overall Study||10787
8543780|NCT05110014|9575307|FG000|COMPLETED|Overall Study||12239
8543781|NCT05110014|9575308|FG001|COMPLETED|Overall Study||10787
8543782|NCT05110014|9575307|FG000|NOT COMPLETED|Overall Study||0
8543783|NCT05110014|9575308|FG001|NOT COMPLETED|Overall Study||0
8543784|NCT04980040|9575316|FG000|STARTED|Overall Study||3623
8543785|NCT04980040|9575316|FG000|COMPLETED|Overall Study||3131
8543786|NCT04980040|9575316|FG000|NOT COMPLETED|Overall Study||492
8543787|NCT04218279|9575322|FG000|STARTED|Overall Study||316
8543788|NCT04218279|9575323|FG001|STARTED|Overall Study||362
8543789|NCT04218279|9575322|FG000|COMPLETED|Overall Study||211
8543790|NCT04218279|9575323|FG001|COMPLETED|Overall Study||225
8543791|NCT04218279|9575322|FG000|NOT COMPLETED|Overall Study||105
8543792|NCT04218279|9575323|FG001|NOT COMPLETED|Overall Study||137
8543793|NCT04167670|9575332|FG000|STARTED|Overall Study||349
8543794|NCT04167670|9575333|FG001|STARTED|Overall Study||349
8543795|NCT04167670|9575334|FG002|STARTED|Overall Study||348
8543796|NCT04167670|9575332|FG000|Received Study Drugs|Overall Study||348
8543797|NCT04167670|9575333|FG001|Received Study Drugs|Overall Study||346
8543798|NCT04167670|9575334|FG002|Received Study Drugs|Overall Study||345
8543799|NCT04167670|9575332|FG000|COMPLETED|Overall Study||334
8543800|NCT04167670|9575333|FG001|COMPLETED|Overall Study||331
8543801|NCT04167670|9575334|FG002|COMPLETED|Overall Study||334
8543802|NCT04167670|9575332|FG000|NOT COMPLETED|Overall Study||15
8543803|NCT04167670|9575333|FG001|NOT COMPLETED|Overall Study||18
8543804|NCT04167670|9575334|FG002|NOT COMPLETED|Overall Study||14
8543805|NCT04076917|9575342|FG000|STARTED|Overall Study||84
8543806|NCT04076917|9575342|FG000|COMPLETED|Overall Study||15
8543807|NCT04076917|9575342|FG000|NOT COMPLETED|Overall Study||69
8543808|NCT04000009|9575346|FG000|STARTED|Overall Study||235
8543809|NCT04000009|9575346|FG000|COMPLETED|Overall Study||70
8543810|NCT04000009|9575346|FG000|NOT COMPLETED|Overall Study||165
8543811|NCT03988335|9575352|FG000|STARTED|Overall Study||16
8543812|NCT03988335|9575353|FG001|STARTED|Overall Study||19
8543813|NCT03988335|9575352|FG000|COMPLETED|Overall Study||14
8543814|NCT03988335|9575353|FG001|COMPLETED|Overall Study||18
8543815|NCT03988335|9575352|FG000|NOT COMPLETED|Overall Study||2
8818285|NCT01556932|9871967|FG000|NOT COMPLETED|Baseline First Treatment||0
8818286|NCT01556932|9871968|FG001|NOT COMPLETED|Baseline First Treatment||0
8543816|NCT03988335|9575353|FG001|NOT COMPLETED|Overall Study||1
8543817|NCT03792737|9575362|FG000|STARTED|Overall Study||166
8543818|NCT03792737|9575363|FG001|STARTED|Overall Study||167
8543819|NCT03792737|9575364|FG002|STARTED|Overall Study||167
8543820|NCT03792737|9575362|FG000|Safety Analysis Set|Overall Study||162
8543821|NCT03792737|9575363|FG001|Safety Analysis Set|Overall Study|one subject didn't participate screen visit or randomize, but receive IP treatment by mistake.|161
8543822|NCT03792737|9575364|FG002|Safety Analysis Set|Overall Study||162
8543823|NCT03792737|9575362|FG000|Full Analysis Set|Overall Study||162
8543824|NCT03792737|9575363|FG001|Full Analysis Set|Overall Study||160
8543825|NCT03792737|9575364|FG002|Full Analysis Set|Overall Study||162
8543826|NCT03792737|9575362|FG000|COMPLETED|Overall Study||160
8543827|NCT03792737|9575363|FG001|COMPLETED|Overall Study||159
8543828|NCT03792737|9575364|FG002|COMPLETED|Overall Study||158
8543829|NCT03792737|9575362|FG000|NOT COMPLETED|Overall Study||6
8543830|NCT03792737|9575363|FG001|NOT COMPLETED|Overall Study||8
8543831|NCT03792737|9575364|FG002|NOT COMPLETED|Overall Study||9
8543832|NCT03674112|9575374|FG000|STARTED|Overall Study||80
8543833|NCT03674112|9575375|FG001|STARTED|Overall Study||80
8849317|NCT01739699|9904469|FG001|COMPLETED|Overall Study||65
8543834|NCT03674112|9575374|FG000|Completed Cross-Over Treatment (Cycles 1 to 6)|Overall Study||80
8543835|NCT03674112|9575375|FG001|Completed Cross-Over Treatment (Cycles 1 to 6)|Overall Study||80
8723060|NCT01021332|9770556|FG000|Safety Analysis Set (SAF)|Overall Study||1066
8723061|NCT01021332|9770556|FG000|Full Analysis Set (FAS)|Overall Study||1009
8723062|NCT01021332|9770556|FG000|COMPLETED|Overall Study||960
8723063|NCT01021332|9770556|FG000|NOT COMPLETED|Overall Study||106
8723064|NCT01021423|9770564|FG000|STARTED|Overall Study|One participant discontinued treatment (continued in the study) due to an AE|4
8818287|NCT01556932|9871967|FG000|STARTED|Time Point 60 Minutes|1 subject withdrew and never started second treatment.|13
8543750|NCT03084367|9575236|FG000|STARTED|Overall Study||500
8543751|NCT03084367|9575236|FG000|Analyzable iFR Pullback Assessment Post Angiographically Successful PCI|Overall Study||467
8543752|NCT03084367|9575236|FG000|COMPLETED|Overall Study||463
8543753|NCT03084367|9575236|FG000|NOT COMPLETED|Overall Study||37
8543754|NCT03082898|9575247|FG000|STARTED|Overall Study||27
8543755|NCT03082898|9575248|FG001|STARTED|Overall Study||12
8543756|NCT03082898|9575247|FG000|COMPLETED|Overall Study||24
8543757|NCT03082898|9575248|FG001|COMPLETED|Overall Study||11
8543758|NCT03082898|9575247|FG000|NOT COMPLETED|Overall Study||3
8543759|NCT03082898|9575248|FG001|NOT COMPLETED|Overall Study||1
8543836|NCT03674112|9575374|FG000|Completed Continuation Treatment (Cycles 7 up to 18 Total)|Overall Study||34
8543837|NCT03674112|9575375|FG001|Completed Continuation Treatment (Cycles 7 up to 18 Total)|Overall Study||36
8543838|NCT03674112|9575374|FG000|Completed Post-Treatment Follow-Up (Up to 3 Years)|Overall Study||0
8543839|NCT03674112|9575375|FG001|Completed Post-Treatment Follow-Up (Up to 3 Years)|Overall Study||0
8849318|NCT01739699|9904468|FG000|NOT COMPLETED|Overall Study||4
8543840|NCT03674112|9575374|FG000|COMPLETED|Overall Study||0
8543841|NCT03674112|9575375|FG001|COMPLETED|Overall Study||0
8543842|NCT03674112|9575374|FG000|NOT COMPLETED|Overall Study||80
8543843|NCT03674112|9575375|FG001|NOT COMPLETED|Overall Study||80
8543844|NCT03618641|9575401|FG000|STARTED|Overall Study||34
8543845|NCT03618641|9575401|FG000|COMPLETED|Overall Study||34
8543846|NCT03618641|9575401|FG000|NOT COMPLETED|Overall Study||0
8543847|NCT03584464|9575405|FG000|STARTED|Overall Study||205
8543848|NCT03584464|9575405|FG000|COMPLETED|Overall Study|Number of subjects that competed 1 year follow up or had a CEC event|204
8543849|NCT03584464|9575405|FG000|NOT COMPLETED|Overall Study||1
8543850|NCT03441477|9575409|FG000|STARTED|Overall Study||225
8543851|NCT03441477|9575409|FG000|COMPLETED|Overall Study||224
8543852|NCT03441477|9575409|FG000|NOT COMPLETED|Overall Study||1
8543853|NCT03205371|9575427|FG000|STARTED|Overall Study||107
8543854|NCT03205371|9575428|FG001|STARTED|Overall Study||53
8543855|NCT03205371|9575429|FG002|STARTED|Overall Study||53
8543856|NCT03205371|9575430|FG003|STARTED|Overall Study||86
8543857|NCT03205371|9575431|FG004|STARTED|Overall Study||42
8543858|NCT03205371|9575432|FG005|STARTED|Overall Study||42
8543859|NCT03205371|9575433|FG006|STARTED|Overall Study||200
8543860|NCT03205371|9575434|FG007|STARTED|Overall Study||100
8543861|NCT03205371|9575435|FG008|STARTED|Overall Study||100
8543862|NCT03205371|9575436|FG009|STARTED|Overall Study||200
8543863|NCT03205371|9575437|FG010|STARTED|Overall Study||100
8543864|NCT03205371|9575438|FG011|STARTED|Overall Study||100
8543865|NCT03205371|9575427|FG000|Safety Analysis Set (SafAS)|Overall Study||103
8543866|NCT03205371|9575428|FG001|Safety Analysis Set (SafAS)|Overall Study||52
8543867|NCT03205371|9575429|FG002|Safety Analysis Set (SafAS)|Overall Study||53
8543868|NCT03205371|9575430|FG003|Safety Analysis Set (SafAS)|Overall Study||86
8543869|NCT03205371|9575431|FG004|Safety Analysis Set (SafAS)|Overall Study||42
8543870|NCT03205371|9575432|FG005|Safety Analysis Set (SafAS)|Overall Study||42
8543871|NCT03205371|9575433|FG006|Safety Analysis Set (SafAS)|Overall Study||200
8543872|NCT03205371|9575434|FG007|Safety Analysis Set (SafAS)|Overall Study||100
8543873|NCT03205371|9575435|FG008|Safety Analysis Set (SafAS)|Overall Study||100
8543874|NCT03205371|9575436|FG009|Safety Analysis Set (SafAS)|Overall Study||200
8543875|NCT03205371|9575437|FG010|Safety Analysis Set (SafAS)|Overall Study||100
8543876|NCT03205371|9575438|FG011|Safety Analysis Set (SafAS)|Overall Study||99
8543877|NCT03205371|9575427|FG000|Per-protocol Analysis Set (PPAS)|Overall Study||92
8543878|NCT03205371|9575428|FG001|Per-protocol Analysis Set (PPAS)|Overall Study||45
8543879|NCT03205371|9575429|FG002|Per-protocol Analysis Set (PPAS)|Overall Study||50
8543880|NCT03205371|9575430|FG003|Per-protocol Analysis Set (PPAS)|Overall Study||85
8543881|NCT03205371|9575431|FG004|Per-protocol Analysis Set (PPAS)|Overall Study||42
8543882|NCT03205371|9575432|FG005|Per-protocol Analysis Set (PPAS)|Overall Study||42
8543883|NCT03205371|9575433|FG006|Per-protocol Analysis Set (PPAS)|Overall Study||155
8543884|NCT03205371|9575434|FG007|Per-protocol Analysis Set (PPAS)|Overall Study||79
8543885|NCT03205371|9575435|FG008|Per-protocol Analysis Set (PPAS)|Overall Study||68
8543886|NCT03205371|9575436|FG009|Per-protocol Analysis Set (PPAS)|Overall Study||196
8543887|NCT03205371|9575437|FG010|Per-protocol Analysis Set (PPAS)|Overall Study||96
8543888|NCT03205371|9575438|FG011|Per-protocol Analysis Set (PPAS)|Overall Study||92
8543889|NCT03205371|9575427|FG000|COMPLETED|Overall Study||103
8543890|NCT03205371|9575428|FG001|COMPLETED|Overall Study||52
8543891|NCT03205371|9575429|FG002|COMPLETED|Overall Study||53
8543892|NCT03205371|9575430|FG003|COMPLETED|Overall Study||86
8543893|NCT03205371|9575431|FG004|COMPLETED|Overall Study||42
8543894|NCT03205371|9575432|FG005|COMPLETED|Overall Study||42
8723065|NCT01021423|9770565|FG001|STARTED|Overall Study|One participant discontinued treatment (continued in the study) due to disease progression|5
8543895|NCT03205371|9575433|FG006|COMPLETED|Overall Study||190
8543896|NCT03205371|9575434|FG007|COMPLETED|Overall Study||97
8543897|NCT03205371|9575435|FG008|COMPLETED|Overall Study||95
8543898|NCT03205371|9575436|FG009|COMPLETED|Overall Study||200
8543899|NCT03205371|9575437|FG010|COMPLETED|Overall Study||100
8723066|NCT01021423|9770564|FG000|COMPLETED|Overall Study||0
8543760|NCT03082313|9575254|FG000|STARTED|Overall Study||12
8543761|NCT03082313|9575254|FG000|COMPLETED|Overall Study||12
8543762|NCT03082313|9575254|FG000|NOT COMPLETED|Overall Study||0
8543763|NCT03081767|9575258|FG000|STARTED|Overall Study||199
8543764|NCT03081767|9575258|FG000|COMPLETED|Overall Study||199
8543765|NCT03081767|9575258|FG000|NOT COMPLETED|Overall Study||0
8543900|NCT03205371|9575438|FG011|COMPLETED|Overall Study||99
8543901|NCT03205371|9575427|FG000|NOT COMPLETED|Overall Study||4
8543902|NCT03205371|9575428|FG001|NOT COMPLETED|Overall Study||1
8543903|NCT03205371|9575429|FG002|NOT COMPLETED|Overall Study||0
8543904|NCT03205371|9575430|FG003|NOT COMPLETED|Overall Study||0
8543905|NCT03205371|9575431|FG004|NOT COMPLETED|Overall Study||0
8543906|NCT03205371|9575432|FG005|NOT COMPLETED|Overall Study||0
8543907|NCT03205371|9575433|FG006|NOT COMPLETED|Overall Study||10
8543908|NCT03205371|9575434|FG007|NOT COMPLETED|Overall Study||3
8543909|NCT03205371|9575435|FG008|NOT COMPLETED|Overall Study||5
8543910|NCT03205371|9575436|FG009|NOT COMPLETED|Overall Study||0
8543911|NCT03205371|9575437|FG010|NOT COMPLETED|Overall Study||0
8543912|NCT03205371|9575438|FG011|NOT COMPLETED|Overall Study||1
8543913|NCT03165721|9575487|FG000|STARTED|Overall Study||7
8543914|NCT03165721|9575488|FG001|STARTED|Overall Study||1
8543915|NCT03165721|9575489|FG002|STARTED|Overall Study||1
8543916|NCT03165721|9575487|FG000|COMPLETED|Overall Study||3
8543917|NCT03165721|9575488|FG001|COMPLETED|Overall Study||1
8543918|NCT03165721|9575489|FG002|COMPLETED|Overall Study||1
8543919|NCT03165721|9575487|FG000|NOT COMPLETED|Overall Study||4
8543920|NCT03165721|9575488|FG001|NOT COMPLETED|Overall Study||0
8543921|NCT03165721|9575489|FG002|NOT COMPLETED|Overall Study||0
8543922|NCT03130959|9575509|FG000|STARTED|Treatment Period||23
8543923|NCT03130959|9575510|FG001|STARTED|Treatment Period||22
8543924|NCT03130959|9575511|FG002|STARTED|Treatment Period||16
8543925|NCT03130959|9575512|FG003|STARTED|Treatment Period||15
8543926|NCT03130959|9575513|FG004|STARTED|Treatment Period||15
8543927|NCT03130959|9575514|FG005|STARTED|Treatment Period||15
8543928|NCT03130959|9575515|FG006|STARTED|Treatment Period||12
8543929|NCT03130959|9575516|FG007|STARTED|Treatment Period||10
8543930|NCT03130959|9575517|FG008|STARTED|Treatment Period||19
8543931|NCT03130959|9575518|FG009|STARTED|Treatment Period||19
8543932|NCT03130959|9575509|FG000|COMPLETED|Treatment Period||2
8543933|NCT03130959|9575510|FG001|COMPLETED|Treatment Period||1
8543934|NCT03130959|9575511|FG002|COMPLETED|Treatment Period||1
8543935|NCT03130959|9575512|FG003|COMPLETED|Treatment Period||0
8543936|NCT03130959|9575513|FG004|COMPLETED|Treatment Period||0
8543937|NCT03130959|9575514|FG005|COMPLETED|Treatment Period||0
8543938|NCT03130959|9575515|FG006|COMPLETED|Treatment Period||0
8543939|NCT03130959|9575516|FG007|COMPLETED|Treatment Period||0
8543940|NCT03130959|9575517|FG008|COMPLETED|Treatment Period||0
8543941|NCT03130959|9575518|FG009|COMPLETED|Treatment Period||1
8543942|NCT03130959|9575509|FG000|NOT COMPLETED|Treatment Period||21
8543943|NCT03130959|9575510|FG001|NOT COMPLETED|Treatment Period||21
8543944|NCT03130959|9575511|FG002|NOT COMPLETED|Treatment Period||15
8543945|NCT03130959|9575512|FG003|NOT COMPLETED|Treatment Period||15
8543946|NCT03130959|9575513|FG004|NOT COMPLETED|Treatment Period||15
8543947|NCT03130959|9575514|FG005|NOT COMPLETED|Treatment Period||15
8543948|NCT03130959|9575515|FG006|NOT COMPLETED|Treatment Period||12
8543949|NCT03130959|9575516|FG007|NOT COMPLETED|Treatment Period||10
8543950|NCT03130959|9575517|FG008|NOT COMPLETED|Treatment Period||19
8543951|NCT03130959|9575518|FG009|NOT COMPLETED|Treatment Period||18
8543952|NCT03130959|9575509|FG000|STARTED|Follow-up Period||23
8543953|NCT03130959|9575510|FG001|STARTED|Follow-up Period||22
8543954|NCT03130959|9575511|FG002|STARTED|Follow-up Period||16
8543955|NCT03130959|9575512|FG003|STARTED|Follow-up Period||15
8543956|NCT03130959|9575513|FG004|STARTED|Follow-up Period||15
8543957|NCT03130959|9575514|FG005|STARTED|Follow-up Period||15
8543958|NCT03130959|9575515|FG006|STARTED|Follow-up Period||12
8543959|NCT03130959|9575516|FG007|STARTED|Follow-up Period||10
8543960|NCT03130959|9575517|FG008|STARTED|Follow-up Period||19
8543961|NCT03130959|9575518|FG009|STARTED|Follow-up Period||19
8543962|NCT03130959|9575509|FG000|COMPLETED|Follow-up Period||3
8543963|NCT03130959|9575510|FG001|COMPLETED|Follow-up Period||2
8543964|NCT03130959|9575511|FG002|COMPLETED|Follow-up Period||4
8543965|NCT03130959|9575512|FG003|COMPLETED|Follow-up Period||1
8543966|NCT03130959|9575513|FG004|COMPLETED|Follow-up Period||1
8543967|NCT03130959|9575514|FG005|COMPLETED|Follow-up Period||5
8543968|NCT03130959|9575515|FG006|COMPLETED|Follow-up Period||3
8543969|NCT03130959|9575516|FG007|COMPLETED|Follow-up Period||2
8543970|NCT03130959|9575517|FG008|COMPLETED|Follow-up Period||1
8543971|NCT03130959|9575518|FG009|COMPLETED|Follow-up Period||3
8543972|NCT03130959|9575509|FG000|NOT COMPLETED|Follow-up Period||20
8543973|NCT03130959|9575510|FG001|NOT COMPLETED|Follow-up Period||20
8543974|NCT03130959|9575511|FG002|NOT COMPLETED|Follow-up Period||12
8543975|NCT03130959|9575512|FG003|NOT COMPLETED|Follow-up Period||14
8543976|NCT03130959|9575513|FG004|NOT COMPLETED|Follow-up Period||14
8543977|NCT03130959|9575514|FG005|NOT COMPLETED|Follow-up Period||10
8543978|NCT03130959|9575515|FG006|NOT COMPLETED|Follow-up Period||9
8543979|NCT03130959|9575516|FG007|NOT COMPLETED|Follow-up Period||8
8543980|NCT03130959|9575517|FG008|NOT COMPLETED|Follow-up Period||18
8543981|NCT03130959|9575518|FG009|NOT COMPLETED|Follow-up Period||16
8543982|NCT02955797|9575557|FG000|STARTED|Overall Study||306
8543983|NCT02955797|9575558|FG001|STARTED|Overall Study||306
8543984|NCT02955797|9575559|FG002|STARTED|Overall Study||203
8543985|NCT02955797|9575560|FG003|STARTED|Overall Study||103
8543986|NCT02955797|9575557|FG000|Safety Analysis Set (SafAS)|Overall Study||303
8543987|NCT02955797|9575558|FG001|Safety Analysis Set (SafAS)|Overall Study||306
8543988|NCT02955797|9575559|FG002|Safety Analysis Set (SafAS)|Overall Study||203
8543989|NCT02955797|9575560|FG003|Safety Analysis Set (SafAS)|Overall Study||102
8543990|NCT02955797|9575557|FG000|Per Protocol Analysis Set (PPAS)|Overall Study||293
8543991|NCT02955797|9575558|FG001|Per Protocol Analysis Set (PPAS)|Overall Study||296
8543992|NCT02955797|9575559|FG002|Per Protocol Analysis Set (PPAS)|Overall Study||198
8543993|NCT02955797|9575560|FG003|Per Protocol Analysis Set (PPAS)|Overall Study||99
8543994|NCT02955797|9575557|FG000|COMPLETED|Overall Study||303
8543995|NCT02955797|9575558|FG001|COMPLETED|Overall Study||303
8543996|NCT02955797|9575559|FG002|COMPLETED|Overall Study||203
8543997|NCT02955797|9575560|FG003|COMPLETED|Overall Study||101
8543998|NCT02955797|9575557|FG000|NOT COMPLETED|Overall Study||3
8543999|NCT02955797|9575558|FG001|NOT COMPLETED|Overall Study||3
8544000|NCT02955797|9575559|FG002|NOT COMPLETED|Overall Study||0
8544001|NCT02955797|9575560|FG003|NOT COMPLETED|Overall Study||2
8544002|NCT02859415|9575575|FG000|STARTED|Overall Study||1
8544003|NCT02859415|9575576|FG001|STARTED|Overall Study||2
8544004|NCT02859415|9575575|FG000|COMPLETED|Overall Study||0
8544005|NCT02859415|9575576|FG001|COMPLETED|Overall Study||1
8544006|NCT02859415|9575575|FG000|NOT COMPLETED|Overall Study||1
8544007|NCT02859415|9575576|FG001|NOT COMPLETED|Overall Study||1
8544008|NCT02842866|9575585|FG000|STARTED|Overall Study||451
8544009|NCT02842866|9575586|FG001|STARTED|Overall Study||455
8544010|NCT02842866|9575585|FG000|Vaccinated|Overall Study||448
8544011|NCT02842866|9575586|FG001|Vaccinated|Overall Study||453
8544012|NCT02842866|9575585|FG000|COMPLETED|Overall Study||444
8544013|NCT02842866|9575586|FG001|COMPLETED|Overall Study||452
8544014|NCT02842866|9575585|FG000|NOT COMPLETED|Overall Study||7
8544015|NCT02842866|9575586|FG001|NOT COMPLETED|Overall Study||3
8544016|NCT02842853|9575596|FG000|STARTED|Overall Study||902
8544017|NCT02842853|9575597|FG001|STARTED|Overall Study||895
8544018|NCT02842853|9575598|FG002|STARTED|Overall Study||906
8544019|NCT02842853|9575599|FG003|STARTED|Overall Study||641
8544020|NCT02842853|9575596|FG000|Vaccinated|Overall Study||895
8544021|NCT02842853|9575597|FG001|Vaccinated|Overall Study||886
8544022|NCT02842853|9575598|FG002|Vaccinated|Overall Study||900
8544023|NCT02842853|9575599|FG003|Vaccinated|Overall Study||636
8544024|NCT02842853|9575596|FG000|Safety Analysis Set (SafAS)|Overall Study||895
8544025|NCT02842853|9575597|FG001|Safety Analysis Set (SafAS)|Overall Study||883
8544026|NCT02842853|9575598|FG002|Safety Analysis Set (SafAS)|Overall Study||898
8544027|NCT02842853|9575599|FG003|Safety Analysis Set (SafAS)|Overall Study||635
8544028|NCT02842853|9575596|FG000|COMPLETED|Overall Study||879
8544029|NCT02842853|9575597|FG001|COMPLETED|Overall Study||861
8544030|NCT02842853|9575598|FG002|COMPLETED|Overall Study||885
8544031|NCT02842853|9575599|FG003|COMPLETED|Overall Study||617
8544032|NCT02842853|9575596|FG000|NOT COMPLETED|Overall Study||23
8544033|NCT02842853|9575597|FG001|NOT COMPLETED|Overall Study||34
8544034|NCT02842853|9575598|FG002|NOT COMPLETED|Overall Study||21
8544035|NCT02842853|9575599|FG003|NOT COMPLETED|Overall Study||24
8544036|NCT02752906|9575613|FG000|STARTED|Overall Study||403
8544037|NCT02752906|9575614|FG001|STARTED|Overall Study||407
8544038|NCT02752906|9575613|FG000|Vaccinated|Overall Study||402
8544039|NCT02752906|9575614|FG001|Vaccinated|Overall Study||407
8544040|NCT02752906|9575613|FG000|COMPLETED|Overall Study||396
8544041|NCT02752906|9575614|FG001|COMPLETED|Overall Study||402
8544042|NCT02752906|9575613|FG000|NOT COMPLETED|Overall Study||7
8544043|NCT02752906|9575614|FG001|NOT COMPLETED|Overall Study||5
8544044|NCT02693691|9575620|FG000|STARTED|Primary Endpoint Analysis (First 12M)||234
8544045|NCT02693691|9575620|FG000|COMPLETED|Primary Endpoint Analysis (First 12M)||184
8544046|NCT02693691|9575620|FG000|NOT COMPLETED|Primary Endpoint Analysis (First 12M)||50
8544047|NCT02693691|9575620|FG000|STARTED|Extended Follow-Up (Until Last pt 12M)||184
8544048|NCT02693691|9575620|FG000|COMPLETED|Extended Follow-Up (Until Last pt 12M)||160
8544049|NCT02693691|9575620|FG000|NOT COMPLETED|Extended Follow-Up (Until Last pt 12M)||24
8544050|NCT02540330|9575626|FG000|STARTED|Overall Study||2
8544051|NCT02540330|9575627|FG001|STARTED|Overall Study||1
8544052|NCT02540330|9575626|FG000|COMPLETED|Overall Study||2
8544053|NCT02540330|9575627|FG001|COMPLETED|Overall Study||1
8544054|NCT02540330|9575626|FG000|NOT COMPLETED|Overall Study||0
8544055|NCT02540330|9575627|FG001|NOT COMPLETED|Overall Study||0
8544056|NCT02417701|9575633|FG000|STARTED|Overall Study||34
8544057|NCT02417701|9575633|FG000|COMPLETED|Overall Study||34
8544058|NCT02417701|9575633|FG000|NOT COMPLETED|Overall Study||0
8566726|NCT00078819|9598945|FG002|NOT COMPLETED|Double-blind Treatment Period: Week 1-12||0
8566727|NCT00078819|9598946|FG003|NOT COMPLETED|Double-blind Treatment Period: Week 1-12||0
8566728|NCT00078819|9598943|FG000|STARTED|Open-label Treatment Period: Weeks 13-36|One participant discontinued before starting the open-label period|103
8566729|NCT00078819|9598944|FG001|STARTED|Open-label Treatment Period: Weeks 13-36||105
8566730|NCT00078819|9598945|FG002|STARTED|Open-label Treatment Period: Weeks 13-36||0
8566731|NCT00078819|9598946|FG003|STARTED|Open-label Treatment Period: Weeks 13-36||0
8566732|NCT00078819|9598943|FG000|COMPLETED|Open-label Treatment Period: Weeks 13-36||63
8566733|NCT00078819|9598944|FG001|COMPLETED|Open-label Treatment Period: Weeks 13-36||75
8566734|NCT00078819|9598945|FG002|COMPLETED|Open-label Treatment Period: Weeks 13-36||0
8566735|NCT00078819|9598946|FG003|COMPLETED|Open-label Treatment Period: Weeks 13-36||0
8566736|NCT00078819|9598943|FG000|NOT COMPLETED|Open-label Treatment Period: Weeks 13-36||40
8544059|NCT02388906|9575642|FG000|STARTED|Pre-Treatment Period||453
8544060|NCT02388906|9575643|FG001|STARTED|Pre-Treatment Period||453
8544061|NCT02388906|9575642|FG000|COMPLETED|Pre-Treatment Period||452
8544062|NCT02388906|9575643|FG001|COMPLETED|Pre-Treatment Period||453
8544063|NCT02388906|9575642|FG000|NOT COMPLETED|Pre-Treatment Period||1
8544064|NCT02388906|9575643|FG001|NOT COMPLETED|Pre-Treatment Period||0
8544065|NCT02388906|9575642|FG000|STARTED|Treatment Period||452
8544066|NCT02388906|9575643|FG001|STARTED|Treatment Period||453
8544067|NCT02388906|9575642|FG000|COMPLETED|Treatment Period||275
8544068|NCT02388906|9575643|FG001|COMPLETED|Treatment Period||122
8544069|NCT02388906|9575642|FG000|NOT COMPLETED|Treatment Period||177
8544070|NCT02388906|9575643|FG001|NOT COMPLETED|Treatment Period||331
8544071|NCT02384993|9575651|FG000|STARTED|Overall Study||12
8544072|NCT02384993|9575652|FG001|STARTED|Overall Study||12
8544073|NCT02384993|9575651|FG000|COMPLETED|Overall Study||12
8544074|NCT02384993|9575652|FG001|COMPLETED|Overall Study||11
8544075|NCT02384993|9575651|FG000|NOT COMPLETED|Overall Study||0
8544076|NCT02384993|9575652|FG001|NOT COMPLETED|Overall Study||1
8544077|NCT02304302|9575661|FG000|STARTED|Overall Study||79
8544078|NCT02304302|9575662|FG001|STARTED|Overall Study||81
8544079|NCT02304302|9575661|FG000|COMPLETED|Overall Study||76
8544080|NCT02304302|9575662|FG001|COMPLETED|Overall Study||73
8544081|NCT02304302|9575661|FG000|NOT COMPLETED|Overall Study||3
8544082|NCT02304302|9575662|FG001|NOT COMPLETED|Overall Study||8
8544083|NCT02294461|9575674|FG000|STARTED|Double-blind Period (up to 29.4 Months)||202
8544084|NCT02294461|9575675|FG001|STARTED|Double-blind Period (up to 29.4 Months)||193
8544085|NCT02294461|9575674|FG000|Treated/Received Study Drug|Double-blind Period (up to 29.4 Months)||202
8544086|NCT02294461|9575675|FG001|Treated/Received Study Drug|Double-blind Period (up to 29.4 Months)||193
8544087|NCT02294461|9575674|FG000|COMPLETED|Double-blind Period (up to 29.4 Months)||84
8544088|NCT02294461|9575675|FG001|COMPLETED|Double-blind Period (up to 29.4 Months)||1
8544089|NCT02294461|9575674|FG000|NOT COMPLETED|Double-blind Period (up to 29.4 Months)||118
8544090|NCT02294461|9575675|FG001|NOT COMPLETED|Double-blind Period (up to 29.4 Months)||192
8544091|NCT02294461|9575674|FG000|STARTED|Open-label Period (up to 54.3 Months)|Eligible participants who provided consent took part in open-label period.|85
8544092|NCT02294461|9575675|FG001|STARTED|Open-label Period (up to 54.3 Months)|Eligible participants who provided consent took part in open-label period.|51
8544093|NCT02294461|9575674|FG000|COMPLETED|Open-label Period (up to 54.3 Months)||0
8544094|NCT02294461|9575675|FG001|COMPLETED|Open-label Period (up to 54.3 Months)||0
8544095|NCT02294461|9575674|FG000|NOT COMPLETED|Open-label Period (up to 54.3 Months)||85
8544096|NCT02294461|9575675|FG001|NOT COMPLETED|Open-label Period (up to 54.3 Months)||51
8544097|NCT02269670|9575693|FG000|STARTED|Overall Study||3
8544098|NCT02269670|9575693|FG000|COMPLETED|Overall Study||0
8544099|NCT02269670|9575693|FG000|NOT COMPLETED|Overall Study||3
8544100|NCT02086175|9575697|FG000|STARTED|Overall Study||25
8544101|NCT02086175|9575697|FG000|COMPLETED|Overall Study||25
8544102|NCT02086175|9575697|FG000|NOT COMPLETED|Overall Study||0
8544103|NCT01860976|9575703|FG000|STARTED|Blinded Treatment||213
8544104|NCT01860976|9575704|FG001|STARTED|Blinded Treatment||211
8544105|NCT01860976|9575703|FG000|COMPLETED|Blinded Treatment||125
8544106|NCT01860976|9575704|FG001|COMPLETED|Blinded Treatment||98
8544107|NCT01860976|9575703|FG000|NOT COMPLETED|Blinded Treatment||88
8544108|NCT01860976|9575704|FG001|NOT COMPLETED|Blinded Treatment||113
8544109|NCT01860976|9575703|FG000|STARTED|Open-Label||197
8544110|NCT01860976|9575704|FG001|STARTED|Open-Label||185
8544111|NCT01860976|9575703|FG000|COMPLETED|Open-Label||169
8544112|NCT01860976|9575704|FG001|COMPLETED|Open-Label||166
8544113|NCT01860976|9575703|FG000|NOT COMPLETED|Open-Label||28
8544114|NCT01860976|9575704|FG001|NOT COMPLETED|Open-Label||19
8544115|NCT01860976|9575703|FG000|STARTED|Long Term Extension||106
8544116|NCT01860976|9575704|FG001|STARTED|Long Term Extension||0
8544117|NCT01860976|9575703|FG000|COMPLETED|Long Term Extension||81
8544118|NCT01860976|9575704|FG001|COMPLETED|Long Term Extension||0
8544119|NCT01860976|9575703|FG000|NOT COMPLETED|Long Term Extension||25
8544120|NCT01860976|9575704|FG001|NOT COMPLETED|Long Term Extension||0
8544121|NCT01761266|9575715|FG000|STARTED|Overall Study||478
8544122|NCT01761266|9575716|FG001|STARTED|Overall Study||476
8544123|NCT01761266|9575715|FG000|Treated|Overall Study||476
8544124|NCT01761266|9575716|FG001|Treated|Overall Study||475
8544125|NCT01761266|9575715|FG000|COMPLETED|Overall Study||0
8544126|NCT01761266|9575716|FG001|COMPLETED|Overall Study||0
8544127|NCT01761266|9575715|FG000|NOT COMPLETED|Overall Study||478
8544128|NCT01761266|9575716|FG001|NOT COMPLETED|Overall Study||476
8544129|NCT01550289|9575727|FG000|STARTED|Overall Study||128
8544130|NCT01550289|9575728|FG001|STARTED|Overall Study||61
8621402|NCT00479856|9660369|FG000|COMPLETED|Overall Study||6
8621403|NCT00479856|9660369|FG000|NOT COMPLETED|Overall Study||3
8621404|NCT00479882|9660377|FG000|STARTED|Precrossover: Periods I/II (Weeks 1-12)||610
8621405|NCT00479882|9660378|FG001|STARTED|Precrossover: Periods I/II (Weeks 1-12)||602
8621406|NCT00479882|9660379|FG002|STARTED|Precrossover: Periods I/II (Weeks 1-12)||597
8621407|NCT00479882|9660380|FG003|STARTED|Precrossover: Periods I/II (Weeks 1-12)||605
8621408|NCT00479882|9660377|FG000|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||472
8544131|NCT01550289|9575727|FG000|COMPLETED|Overall Study||115
8544132|NCT01550289|9575728|FG001|COMPLETED|Overall Study||57
8544133|NCT01550289|9575727|FG000|NOT COMPLETED|Overall Study||13
8544134|NCT01550289|9575728|FG001|NOT COMPLETED|Overall Study||4
8544135|NCT01346709|9575736|FG000|STARTED|Overall Study||5450
8544136|NCT01346709|9575736|FG000|COMPLETED|Overall Study||5099
8621409|NCT00479882|9660378|FG001|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||440
8621410|NCT00479882|9660379|FG002|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||440
8621411|NCT00479882|9660380|FG003|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||465
8621412|NCT00479882|9660377|FG000|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||138
8544137|NCT01346709|9575736|FG000|NOT COMPLETED|Overall Study||351
8544138|NCT01157091|9575740|FG000|STARTED|Overall Study||28
8544139|NCT01157091|9575740|FG000|COMPLETED|Overall Study||28
8544140|NCT01157091|9575740|FG000|NOT COMPLETED|Overall Study||0
8544141|NCT01081951|9575746|FG000|STARTED|Overall Study||81
8544142|NCT01081951|9575747|FG001|STARTED|Overall Study||81
8544143|NCT01081951|9575746|FG000|Received Study Treatment|Overall Study||81
8544144|NCT01081951|9575747|FG001|Received Study Treatment|Overall Study||75
8544145|NCT01081951|9575746|FG000|Entered Maintenance Phase|Overall Study||66
8544146|NCT01081951|9575747|FG001|Entered Maintenance Phase|Overall Study||55
8544147|NCT01081951|9575746|FG000|Ongoing Study Treatment at Data Cut-off|Overall Study||11
8544148|NCT01081951|9575747|FG001|Ongoing Study Treatment at Data Cut-off|Overall Study||0
8544149|NCT01081951|9575746|FG000|COMPLETED|Overall Study|Completed is ongoing study at DCO (Data cut-off),either on-treatment or in survival follow-up|25
8544150|NCT01081951|9575747|FG001|COMPLETED|Overall Study|Completed is ongoing study at DCO (Data cut-off), either on-treatment or in survival follow-up|26
8544151|NCT01081951|9575746|FG000|NOT COMPLETED|Overall Study||56
8544152|NCT01081951|9575747|FG001|NOT COMPLETED|Overall Study||55
8544153|NCT01074190|9575756|FG000|STARTED|Overall Study||115
8544154|NCT01074190|9575757|FG001|STARTED|Overall Study||115
8544155|NCT01074190|9575758|FG002|STARTED|Overall Study||115
8544156|NCT01074190|9575756|FG000|COMPLETED|Overall Study||111
8544157|NCT01074190|9575757|FG001|COMPLETED|Overall Study||109
8544158|NCT01074190|9575758|FG002|COMPLETED|Overall Study||112
8544159|NCT01074190|9575756|FG000|NOT COMPLETED|Overall Study||4
8544160|NCT01074190|9575757|FG001|NOT COMPLETED|Overall Study||6
8544161|NCT01074190|9575758|FG002|NOT COMPLETED|Overall Study||3
8544162|NCT00875524|9575771|FG000|STARTED|Overall Study||120
8544163|NCT00875524|9575772|FG001|STARTED|Overall Study||60
8544164|NCT00875524|9575771|FG000|Received Vaccination 1|Overall Study||120
8544165|NCT00875524|9575772|FG001|Received Vaccination 1|Overall Study||60
8544166|NCT00875524|9575771|FG000|Received Vaccination 2|Overall Study||116
8544167|NCT00875524|9575772|FG001|Received Vaccination 2|Overall Study||58
8544168|NCT00875524|9575771|FG000|Received Vaccination 3|Overall Study||114
8544169|NCT00875524|9575772|FG001|Received Vaccination 3|Overall Study||58
8544170|NCT00875524|9575771|FG000|COMPLETED|Overall Study||112
8544171|NCT00875524|9575772|FG001|COMPLETED|Overall Study||54
8544172|NCT00875524|9575771|FG000|NOT COMPLETED|Overall Study||8
8544173|NCT00875524|9575772|FG001|NOT COMPLETED|Overall Study||6
8544174|NCT00842530|9575780|FG000|STARTED|Overall Study||2669
8544175|NCT00842530|9575781|FG001|STARTED|Overall Study||1333
8544176|NCT00842530|9575780|FG000|Received Vaccination 1|Overall Study||2666
8544177|NCT00842530|9575781|FG001|Received Vaccination 1|Overall Study||1331
8544178|NCT00842530|9575780|FG000|Received Vaccination 2|Overall Study||2584
8544179|NCT00842530|9575781|FG001|Received Vaccination 2|Overall Study||1300
8544180|NCT00842530|9575780|FG000|Received Vaccination 3|Overall Study||2557
8544181|NCT00842530|9575781|FG001|Received Vaccination 3|Overall Study||1282
8544182|NCT00842530|9575780|FG000|COMPLETED|Overall Study||2552
8544183|NCT00842530|9575781|FG001|COMPLETED|Overall Study||1276
8544184|NCT00842530|9575780|FG000|NOT COMPLETED|Overall Study||117
8544185|NCT00842530|9575781|FG001|NOT COMPLETED|Overall Study||57
8544186|NCT00788151|9575790|FG000|STARTED|Overall Study||200
8544187|NCT00788151|9575791|FG001|STARTED|Overall Study||100
8544188|NCT00788151|9575790|FG000|Received Vaccination 1|Overall Study||199
8544189|NCT00788151|9575791|FG001|Received Vaccination 1|Overall Study||99
8544190|NCT00788151|9575790|FG000|Received Vaccination 2|Overall Study||188
8544191|NCT00788151|9575791|FG001|Received Vaccination 2|Overall Study||92
8544192|NCT00788151|9575790|FG000|Received Vaccination 3|Overall Study||186
8544193|NCT00788151|9575791|FG001|Received Vaccination 3|Overall Study||90
8544194|NCT00788151|9575790|FG000|COMPLETED|Overall Study||186
8544195|NCT00788151|9575791|FG001|COMPLETED|Overall Study||90
8544196|NCT00788151|9575790|FG000|NOT COMPLETED|Overall Study||14
8544197|NCT00788151|9575791|FG001|NOT COMPLETED|Overall Study||10
8544198|NCT00539591|9575800|FG000|STARTED|Overall Study||23
8544199|NCT00539591|9575801|FG001|STARTED|Overall Study||2
8544200|NCT00539591|9575802|FG002|STARTED|Overall Study||4
8544201|NCT00539591|9575800|FG000|COMPLETED|Overall Study||18
8544202|NCT00539591|9575801|FG001|COMPLETED|Overall Study||0
8544203|NCT00539591|9575802|FG002|COMPLETED|Overall Study||1
8544204|NCT00539591|9575800|FG000|NOT COMPLETED|Overall Study||5
8544205|NCT00539591|9575801|FG001|NOT COMPLETED|Overall Study||2
8544206|NCT00539591|9575802|FG002|NOT COMPLETED|Overall Study||3
8566737|NCT00078819|9598944|FG001|NOT COMPLETED|Open-label Treatment Period: Weeks 13-36||30
8566738|NCT00078819|9598945|FG002|NOT COMPLETED|Open-label Treatment Period: Weeks 13-36||0
8566739|NCT00078819|9598946|FG003|NOT COMPLETED|Open-label Treatment Period: Weeks 13-36||0
8566740|NCT00078819|9598943|FG000|STARTED|Withdrawal Period: Weeks 37-48||0
8566741|NCT00078819|9598944|FG001|STARTED|Withdrawal Period: Weeks 37-48||0
8566742|NCT00078819|9598945|FG002|STARTED|Withdrawal Period: Weeks 37-48|Participants who completed week 36 with a PASI response|69
8566743|NCT00078819|9598946|FG003|STARTED|Withdrawal Period: Weeks 37-48|Participants who completed week 36 with a PASI response|69
8566744|NCT00078819|9598943|FG000|Received Study Drug|Withdrawal Period: Weeks 37-48||0
8544207|NCT02892955|9575838|FG000|STARTED|Overall Study||1685
8544208|NCT02892955|9575838|FG000|COMPLETED|Overall Study||1685
8544209|NCT02892955|9575838|FG000|NOT COMPLETED|Overall Study||0
8544210|NCT02883673|9575842|FG000|STARTED|Overall Study||107
8544211|NCT02883673|9575842|FG000|COMPLETED|Overall Study||107
8544212|NCT02883673|9575842|FG000|NOT COMPLETED|Overall Study||0
8544213|NCT04794270|9575847|FG000|STARTED|Period 1||35
8544214|NCT04794270|9575848|FG001|STARTED|Period 1||36
8544215|NCT04794270|9575847|FG000|COMPLETED|Period 1||33
8544216|NCT04794270|9575848|FG001|COMPLETED|Period 1||36
8544217|NCT04794270|9575847|FG000|NOT COMPLETED|Period 1||2
8544218|NCT04794270|9575848|FG001|NOT COMPLETED|Period 1||0
8544219|NCT04794270|9575847|FG000|STARTED|Period 2||33
8544220|NCT04794270|9575848|FG001|STARTED|Period 2||36
8544221|NCT04794270|9575847|FG000|COMPLETED|Period 2||32
8544222|NCT04794270|9575848|FG001|COMPLETED|Period 2||36
8544223|NCT04794270|9575847|FG000|NOT COMPLETED|Period 2||1
8544224|NCT04794270|9575848|FG001|NOT COMPLETED|Period 2||0
8544225|NCT04701814|9575856|FG000|STARTED|Overall Study||20
8544226|NCT04701814|9575857|FG001|STARTED|Overall Study||18
8544227|NCT04701814|9575856|FG000|COMPLETED|Overall Study||15
8544228|NCT04701814|9575857|FG001|COMPLETED|Overall Study||15
8544229|NCT04701814|9575856|FG000|NOT COMPLETED|Overall Study||5
8544230|NCT04701814|9575857|FG001|NOT COMPLETED|Overall Study||3
8544231|NCT04650282|9575867|FG000|STARTED|Overall Study||1
8544232|NCT04650282|9575868|FG001|STARTED|Overall Study||1
8544233|NCT04650282|9575867|FG000|COMPLETED|Overall Study||1
8544234|NCT04650282|9575868|FG001|COMPLETED|Overall Study||1
8544235|NCT04650282|9575867|FG000|NOT COMPLETED|Overall Study||0
8544236|NCT04650282|9575868|FG001|NOT COMPLETED|Overall Study||0
8544237|NCT04458467|9575876|FG000|STARTED|Overall Study||35
8544238|NCT04458467|9575877|FG001|STARTED|Overall Study||35
8544239|NCT04458467|9575876|FG000|COMPLETED|Overall Study||35
8544240|NCT04458467|9575877|FG001|COMPLETED|Overall Study||35
8544241|NCT04458467|9575876|FG000|NOT COMPLETED|Overall Study||0
8544242|NCT04458467|9575877|FG001|NOT COMPLETED|Overall Study||0
8544273|NCT04086121|9575919|FG000|STARTED|Overall Study||14
8544274|NCT04086121|9575919|FG000|COMPLETED|Overall Study||1
8544275|NCT04086121|9575919|FG000|NOT COMPLETED|Overall Study||13
8544276|NCT04067843|9575925|FG000|STARTED|Overall Study||10
8544277|NCT04067843|9575926|FG001|STARTED|Overall Study||10
8544278|NCT04067843|9575925|FG000|COMPLETED|Overall Study||10
8544279|NCT04067843|9575926|FG001|COMPLETED|Overall Study||10
8544280|NCT04067843|9575925|FG000|NOT COMPLETED|Overall Study||0
8544281|NCT04067843|9575926|FG001|NOT COMPLETED|Overall Study||0
8544282|NCT04066738|9575934|FG000|STARTED|Overall Study||2
8544283|NCT04066738|9575934|FG000|COMPLETED|Overall Study||2
8544284|NCT04066738|9575934|FG000|NOT COMPLETED|Overall Study||0
8544285|NCT03933020|9575938|FG000|STARTED|Overall Study||0
8544286|NCT03933020|9575938|FG000|Received an Intervention|Overall Study||0
8544287|NCT03933020|9575938|FG000|COMPLETED|Overall Study||0
8544288|NCT03933020|9575938|FG000|NOT COMPLETED|Overall Study||0
8544289|NCT03793608|9575944|FG000|STARTED|Overall Study||1
8544290|NCT03793608|9575945|FG001|STARTED|Overall Study||24
8544291|NCT03793608|9575944|FG000|Treated|Overall Study||1
8544292|NCT03793608|9575945|FG001|Treated|Overall Study||24
8544293|NCT03793608|9575944|FG000|Safety Analysis Set (SAF)|Overall Study|1 participant randomized to placebo was not analyzed and thus excluded from analyses.|0
8544294|NCT03793608|9575945|FG001|Safety Analysis Set (SAF)|Overall Study||24
8544295|NCT03793608|9575944|FG000|COMPLETED|Overall Study||1
8544296|NCT03793608|9575945|FG001|COMPLETED|Overall Study||24
8544297|NCT03793608|9575944|FG000|NOT COMPLETED|Overall Study||0
8544298|NCT03793608|9575945|FG001|NOT COMPLETED|Overall Study||0
8544299|NCT03655054|9575950|FG000|STARTED|Overall Study||23
8544300|NCT03655054|9575950|FG000|COMPLETED|Overall Study||22
8544301|NCT03655054|9575950|FG000|NOT COMPLETED|Overall Study||1
8544302|NCT03601117|9575956|FG000|STARTED|Overall Study||20
8544303|NCT03601117|9575957|FG001|STARTED|Overall Study||2
8544304|NCT03601117|9575956|FG000|COMPLETED|Overall Study||17
8544305|NCT03601117|9575957|FG001|COMPLETED|Overall Study||1
8544306|NCT03601117|9575956|FG000|NOT COMPLETED|Overall Study||3
8544307|NCT03601117|9575957|FG001|NOT COMPLETED|Overall Study||1
8544308|NCT03586050|9575965|FG000|STARTED|Overall Study||33
8544309|NCT03586050|9575965|FG000|COMPLETED|Overall Study||33
8544310|NCT03586050|9575965|FG000|NOT COMPLETED|Overall Study||0
8544311|NCT03542266|9575969|FG000|STARTED|Treatment Phase||21
8818288|NCT01556932|9871968|FG001|STARTED|Time Point 60 Minutes|1 subject withdrew and never started second treatment.|9
8818289|NCT01556932|9871967|FG000|Recieved|Time Point 60 Minutes||12
8818290|NCT01556932|9871968|FG001|Recieved|Time Point 60 Minutes||8
8818291|NCT01556932|9871967|FG000|COMPLETED|Time Point 60 Minutes||12
8818292|NCT01556932|9871968|FG001|COMPLETED|Time Point 60 Minutes||8
8544312|NCT03542266|9575969|FG000|COMPLETED|Treatment Phase||18
8544313|NCT03542266|9575969|FG000|NOT COMPLETED|Treatment Phase||3
8544314|NCT03542266|9575969|FG000|STARTED|Post-treatment Follow-up Phase|Three subjects did not enter follow-up: 1 had PD at EOT, 2 withdrew consent|15
8544315|NCT03542266|9575969|FG000|COMPLETED|Post-treatment Follow-up Phase||0
8544316|NCT03542266|9575969|FG000|NOT COMPLETED|Post-treatment Follow-up Phase||15
8544317|NCT03529409|9575976|FG000|STARTED|Randomized||30
8544318|NCT03529409|9575977|FG001|STARTED|Randomized||31
8544319|NCT03529409|9575978|FG002|STARTED|Randomized||5
8544320|NCT03529409|9575976|FG000|COMPLETED|Randomized||30
8544321|NCT03529409|9575977|FG001|COMPLETED|Randomized||31
8544322|NCT03529409|9575978|FG002|COMPLETED|Randomized||0
8544243|NCT04394286|9575886|FG000|STARTED|Overall Study||0
8544244|NCT04394286|9575887|FG001|STARTED|Overall Study||0
8544245|NCT04394286|9575888|FG002|STARTED|Overall Study||0
8544246|NCT04394286|9575886|FG000|COMPLETED|Overall Study||0
8544247|NCT04394286|9575887|FG001|COMPLETED|Overall Study||0
8544248|NCT04394286|9575888|FG002|COMPLETED|Overall Study||0
8544249|NCT04394286|9575886|FG000|NOT COMPLETED|Overall Study||0
8544250|NCT04394286|9575887|FG001|NOT COMPLETED|Overall Study||0
8544251|NCT04394286|9575888|FG002|NOT COMPLETED|Overall Study||0
8544252|NCT04392583|9575896|FG000|STARTED|Overall Study||40
8544253|NCT04392583|9575896|FG000|COMPLETED|Overall Study||39
8544254|NCT04392583|9575896|FG000|NOT COMPLETED|Overall Study||1
8544255|NCT04351269|9575903|FG000|STARTED|Overall Study||237
8544256|NCT04351269|9575904|FG001|STARTED|Overall Study||260
8544257|NCT04351269|9575905|FG002|STARTED|Overall Study||100
8544258|NCT04351269|9575903|FG000|COMPLETED|Overall Study||165
8544259|NCT04351269|9575904|FG001|COMPLETED|Overall Study||219
8544260|NCT04351269|9575905|FG002|COMPLETED|Overall Study||71
8544261|NCT04351269|9575903|FG000|NOT COMPLETED|Overall Study||72
8544262|NCT04351269|9575904|FG001|NOT COMPLETED|Overall Study||41
8544263|NCT04351269|9575905|FG002|NOT COMPLETED|Overall Study||29
8544264|NCT04327986|9575913|FG000|STARTED|Overall Study||3
8544265|NCT04327986|9575914|FG001|STARTED|Overall Study||0
8544266|NCT04327986|9575915|FG002|STARTED|Overall Study||0
8544267|NCT04327986|9575913|FG000|COMPLETED|Overall Study||0
8544268|NCT04327986|9575914|FG001|COMPLETED|Overall Study||0
8544269|NCT04327986|9575915|FG002|COMPLETED|Overall Study||0
8544270|NCT04327986|9575913|FG000|NOT COMPLETED|Overall Study||3
8544271|NCT04327986|9575914|FG001|NOT COMPLETED|Overall Study||0
8544272|NCT04327986|9575915|FG002|NOT COMPLETED|Overall Study||0
8544323|NCT03529409|9575976|FG000|NOT COMPLETED|Randomized||0
8544324|NCT03529409|9575977|FG001|NOT COMPLETED|Randomized||0
8544325|NCT03529409|9575978|FG002|NOT COMPLETED|Randomized||5
8544326|NCT03529409|9575976|FG000|STARTED|Post-treatment Assessment||30
8723067|NCT01021423|9770565|FG001|COMPLETED|Overall Study||0
8723068|NCT01021423|9770564|FG000|NOT COMPLETED|Overall Study||4
8723069|NCT01021423|9770565|FG001|NOT COMPLETED|Overall Study||5
8723070|NCT01021553|9770574|FG000|STARTED|Overall Study||27
8723071|NCT01021553|9770575|FG001|STARTED|Overall Study||22
8723072|NCT01021553|9770576|FG002|STARTED|Overall Study||28
8544327|NCT03529409|9575977|FG001|STARTED|Post-treatment Assessment||31
8544328|NCT03529409|9575978|FG002|STARTED|Post-treatment Assessment||0
8544329|NCT03529409|9575976|FG000|COMPLETED|Post-treatment Assessment||26
8544330|NCT03529409|9575977|FG001|COMPLETED|Post-treatment Assessment||26
8544331|NCT03529409|9575978|FG002|COMPLETED|Post-treatment Assessment||0
8544332|NCT03529409|9575976|FG000|NOT COMPLETED|Post-treatment Assessment||4
8544333|NCT03529409|9575977|FG001|NOT COMPLETED|Post-treatment Assessment||5
8544334|NCT03529409|9575978|FG002|NOT COMPLETED|Post-treatment Assessment||0
8544335|NCT03529409|9575976|FG000|STARTED|Follow-up Assessment|All participants were eligible for Follow-Up regardless of Post-Treatment attendance.|28
8544336|NCT03529409|9575977|FG001|STARTED|Follow-up Assessment|All participants (n=31) were eligible for Follow-Up regardless of Post-Treatment attendance|30
8544337|NCT03529409|9575978|FG002|STARTED|Follow-up Assessment||0
8544338|NCT03529409|9575976|FG000|COMPLETED|Follow-up Assessment||27
8544339|NCT03529409|9575977|FG001|COMPLETED|Follow-up Assessment||29
8544340|NCT03529409|9575978|FG002|COMPLETED|Follow-up Assessment||0
8544341|NCT03529409|9575976|FG000|NOT COMPLETED|Follow-up Assessment||1
8544342|NCT03529409|9575977|FG001|NOT COMPLETED|Follow-up Assessment||1
8544343|NCT03529409|9575978|FG002|NOT COMPLETED|Follow-up Assessment||0
8544344|NCT03516812|9575985|FG000|STARTED|Overall Study||36
8544345|NCT03516812|9575985|FG000|COMPLETED|Overall Study||30
8544346|NCT03516812|9575985|FG000|NOT COMPLETED|Overall Study||6
8544347|NCT03477396|9575989|FG000|STARTED|Overall Study||2
8544348|NCT03477396|9575989|FG000|COMPLETED|Overall Study||2
8544349|NCT03477396|9575989|FG000|NOT COMPLETED|Overall Study||0
8544350|NCT03463577|9575999|FG000|STARTED|Overall Study||16606
8544351|NCT03463577|9576000|FG001|STARTED|Overall Study||16606
8544352|NCT03463577|9576001|FG002|STARTED|Overall Study||65
8544353|NCT03463577|9576002|FG003|STARTED|Overall Study||16350
8544354|NCT03463577|9576003|FG004|STARTED|Overall Study||16088
8544355|NCT03463577|9576004|FG005|STARTED|Overall Study||68
8544356|NCT03463577|9575999|FG000|COMPLETED|Overall Study||16366
8544357|NCT03463577|9576000|FG001|COMPLETED|Overall Study||16166
8544358|NCT03463577|9576001|FG002|COMPLETED|Overall Study||65
8544359|NCT03463577|9576002|FG003|COMPLETED|Overall Study||16335
8544360|NCT03463577|9576003|FG004|COMPLETED|Overall Study||16071
8544361|NCT03463577|9576004|FG005|COMPLETED|Overall Study||68
8544362|NCT03463577|9575999|FG000|NOT COMPLETED|Overall Study||240
8544363|NCT03463577|9576000|FG001|NOT COMPLETED|Overall Study||440
8544364|NCT03463577|9576001|FG002|NOT COMPLETED|Overall Study||0
8544365|NCT03463577|9576002|FG003|NOT COMPLETED|Overall Study||15
8544366|NCT03463577|9576003|FG004|NOT COMPLETED|Overall Study||17
8544367|NCT03463577|9576004|FG005|NOT COMPLETED|Overall Study||0
8566745|NCT00078819|9598944|FG001|Received Study Drug|Withdrawal Period: Weeks 37-48||0
8566746|NCT00078819|9598945|FG002|Received Study Drug|Withdrawal Period: Weeks 37-48||69
8566747|NCT00078819|9598946|FG003|Received Study Drug|Withdrawal Period: Weeks 37-48||68
8566748|NCT00078819|9598943|FG000|COMPLETED|Withdrawal Period: Weeks 37-48||0
8566749|NCT00078819|9598944|FG001|COMPLETED|Withdrawal Period: Weeks 37-48||0
8569292|NCT00096031|9601488|FG000|COMPLETED|Overall Study||0
8723073|NCT01021553|9770574|FG000|COMPLETED|Overall Study||23
8544368|NCT03373760|9576020|FG000|STARTED|Overall Study||58
8544369|NCT03373760|9576020|FG000|COMPLETED|Overall Study||0
8544370|NCT03373760|9576020|FG000|NOT COMPLETED|Overall Study||58
8544371|NCT03338790|9576031|FG000|STARTED|Overall Study||88
8544372|NCT03338790|9576032|FG001|STARTED|Overall Study||71
8544373|NCT03338790|9576033|FG002|STARTED|Overall Study||84
8544374|NCT03338790|9576034|FG003|STARTED|Overall Study||49
8544375|NCT03338790|9576031|FG000|COMPLETED|Overall Study||4
8544376|NCT03338790|9576032|FG001|COMPLETED|Overall Study||4
8544377|NCT03338790|9576033|FG002|COMPLETED|Overall Study||8
8544378|NCT03338790|9576034|FG003|COMPLETED|Overall Study||4
8544379|NCT03338790|9576031|FG000|NOT COMPLETED|Overall Study||84
8544380|NCT03338790|9576032|FG001|NOT COMPLETED|Overall Study||67
8544381|NCT03338790|9576033|FG002|NOT COMPLETED|Overall Study||76
8544382|NCT03338790|9576034|FG003|NOT COMPLETED|Overall Study||45
8544383|NCT03253627|9576046|FG000|STARTED|Overall Study||12
8544384|NCT03253627|9576047|FG001|STARTED|Overall Study||11
8544385|NCT03253627|9576046|FG000|Post-intervention|Overall Study||11
8544386|NCT03253627|9576047|FG001|Post-intervention|Overall Study||9
8544387|NCT03253627|9576046|FG000|COMPLETED|Overall Study||10
8544388|NCT03253627|9576047|FG001|COMPLETED|Overall Study||7
8544389|NCT03253627|9576046|FG000|NOT COMPLETED|Overall Study||2
8544390|NCT03253627|9576047|FG001|NOT COMPLETED|Overall Study||4
8544391|NCT03219333|9576055|FG000|STARTED|Overall Study||128
8544392|NCT03219333|9576056|FG001|STARTED|Overall Study||91
8544393|NCT03219333|9576055|FG000|Treated|Overall Study||125
8544394|NCT03219333|9576056|FG001|Treated|Overall Study||89
8544395|NCT03219333|9576055|FG000|COMPLETED|Overall Study|Cohort 1 Completed includes 4 participants on treatment and 19 participants in follow-up.|23
8544396|NCT03219333|9576056|FG001|COMPLETED|Overall Study|Cohort 2 Completed includes 16 participants on treatment and 26 participants in follow-up.|42
8544397|NCT03219333|9576055|FG000|NOT COMPLETED|Overall Study||105
8544398|NCT03219333|9576056|FG001|NOT COMPLETED|Overall Study||49
8544399|NCT03202628|9576062|FG000|STARTED|Overall Study||8
8544400|NCT03202628|9576062|FG000|COMPLETED|Overall Study||8
8544401|NCT03202628|9576062|FG000|NOT COMPLETED|Overall Study||0
8544402|NCT03168555|9576066|FG000|STARTED|Visit 1 (Pro-operative)||23
8544403|NCT03168555|9576066|FG000|COMPLETED|Visit 1 (Pro-operative)||22
8544404|NCT03168555|9576066|FG000|NOT COMPLETED|Visit 1 (Pro-operative)||1
8544405|NCT03168555|9576066|FG000|STARTED|Visit 2 (Post-operative)||22
8544406|NCT03168555|9576066|FG000|COMPLETED|Visit 2 (Post-operative)||18
8544407|NCT03168555|9576066|FG000|NOT COMPLETED|Visit 2 (Post-operative)||4
8544408|NCT03135119|9576075|FG000|STARTED|Overall Study||16
8544409|NCT03135119|9576076|FG001|STARTED|Overall Study||17
8544410|NCT03135119|9576075|FG000|COMPLETED|Overall Study||11
8544411|NCT03135119|9576076|FG001|COMPLETED|Overall Study||14
8544412|NCT03135119|9576075|FG000|NOT COMPLETED|Overall Study||5
8544413|NCT03135119|9576076|FG001|NOT COMPLETED|Overall Study||3
8544414|NCT03128411|9576082|FG000|STARTED|Treatment Phase||60
8544415|NCT03128411|9576082|FG000|Received Treatment|Treatment Phase||60
8544416|NCT03128411|9576082|FG000|COMPLETED|Treatment Phase||36
8544417|NCT03128411|9576082|FG000|NOT COMPLETED|Treatment Phase||24
8544418|NCT03128411|9576082|FG000|STARTED|Long Term Follow-up Phase|Participants who discontinued treatment phase, entered in long term follow up phase.|24
8544419|NCT03128411|9576082|FG000|COMPLETED|Long Term Follow-up Phase||22
8544420|NCT03128411|9576082|FG000|NOT COMPLETED|Long Term Follow-up Phase||2
8544421|NCT03097328|9576086|FG000|STARTED|Overall Study||39
8544422|NCT03097328|9576086|FG000|Treated|Overall Study||38
8544423|NCT03097328|9576086|FG000|COMPLETED|Overall Study||0
8544424|NCT03097328|9576086|FG000|NOT COMPLETED|Overall Study||39
8544425|NCT03070600|9576092|FG000|STARTED|Overall Study||2250
8544426|NCT03070600|9576093|FG001|STARTED|Overall Study||2197
8544427|NCT03070600|9576092|FG000|COMPLETED|Overall Study||2156
8544428|NCT03070600|9576093|FG001|COMPLETED|Overall Study||2032
8544429|NCT03070600|9576092|FG000|NOT COMPLETED|Overall Study||94
8544430|NCT03070600|9576093|FG001|NOT COMPLETED|Overall Study||165
8544431|NCT03068715|9576105|FG000|STARTED|Overall Study||15
8544432|NCT03068715|9576106|FG001|STARTED|Overall Study||15
8544433|NCT03068715|9576105|FG000|COMPLETED|Overall Study||14
8544434|NCT03068715|9576106|FG001|COMPLETED|Overall Study||15
8544435|NCT03068715|9576105|FG000|NOT COMPLETED|Overall Study||1
8544436|NCT03068715|9576106|FG001|NOT COMPLETED|Overall Study||0
8544437|NCT02981472|9576116|FG000|STARTED|Pre-Treatment Period||129
8544438|NCT02981472|9576117|FG001|STARTED|Pre-Treatment Period||63
8544439|NCT02981472|9576116|FG000|COMPLETED|Pre-Treatment Period||126
8544440|NCT02981472|9576117|FG001|COMPLETED|Pre-Treatment Period||62
8544441|NCT02981472|9576116|FG000|NOT COMPLETED|Pre-Treatment Period||3
8544442|NCT02981472|9576117|FG001|NOT COMPLETED|Pre-Treatment Period||1
8544443|NCT02981472|9576116|FG000|STARTED|Treatment Period||126
8544444|NCT02981472|9576117|FG001|STARTED|Treatment Period||62
8544445|NCT02981472|9576116|FG000|COMPLETED|Treatment Period||119
8544446|NCT02981472|9576117|FG001|COMPLETED|Treatment Period||60
8544447|NCT02981472|9576116|FG000|NOT COMPLETED|Treatment Period||7
8544448|NCT02981472|9576117|FG001|NOT COMPLETED|Treatment Period||2
8544449|NCT02961374|9576129|FG000|STARTED|Overall Study||46
8544450|NCT02961374|9576129|FG000|COMPLETED|Overall Study||42
8544451|NCT02961374|9576129|FG000|NOT COMPLETED|Overall Study||4
8569293|NCT00096031|9601488|FG000|NOT COMPLETED|Overall Study||63
8569294|NCT00096044|9601492|FG000|STARTED|Overall Study||45
8569295|NCT00096044|9601492|FG000|COMPLETED|Overall Study||11
8569296|NCT00096044|9601492|FG000|NOT COMPLETED|Overall Study||34
8544452|NCT02856698|9576135|FG000|STARTED|Overall Study|There is no relevant information to include for the Units Assigned, therefore delete the Type of Units Assigned|55
8544453|NCT02856698|9576136|FG001|STARTED|Overall Study|There is no relevant information to include for the Units Assigned, therefore delete the Type of Units Assigned|56
8544454|NCT02856698|9576135|FG000|COMPLETED|Overall Study|There is no relevant information to include for the Units Assigned, therefore delete the Type of Units Assigned|48
8544455|NCT02856698|9576136|FG001|COMPLETED|Overall Study|There is no relevant information to include for the Units Assigned, therefore delete the Type of Units Assigned|46
8544456|NCT02856698|9576135|FG000|NOT COMPLETED|Overall Study||7
8544457|NCT02856698|9576136|FG001|NOT COMPLETED|Overall Study||10
8544458|NCT02853760|9576142|FG000|STARTED|First Intervention (3 Hours)||7
8544459|NCT02853760|9576143|FG001|STARTED|First Intervention (3 Hours)||10
8544460|NCT02853760|9576144|FG002|STARTED|First Intervention (3 Hours)||7
8544461|NCT02853760|9576145|FG003|STARTED|First Intervention (3 Hours)||8
8544462|NCT02853760|9576146|FG004|STARTED|First Intervention (3 Hours)||8
8544463|NCT02853760|9576147|FG005|STARTED|First Intervention (3 Hours)||7
8544464|NCT02853760|9576142|FG000|COMPLETED|First Intervention (3 Hours)||7
8544465|NCT02853760|9576143|FG001|COMPLETED|First Intervention (3 Hours)||10
8544466|NCT02853760|9576144|FG002|COMPLETED|First Intervention (3 Hours)||7
8544467|NCT02853760|9576145|FG003|COMPLETED|First Intervention (3 Hours)||8
8544468|NCT02853760|9576146|FG004|COMPLETED|First Intervention (3 Hours)||8
8544469|NCT02853760|9576147|FG005|COMPLETED|First Intervention (3 Hours)||7
8544470|NCT02853760|9576142|FG000|NOT COMPLETED|First Intervention (3 Hours)||0
8544471|NCT02853760|9576143|FG001|NOT COMPLETED|First Intervention (3 Hours)||0
8544472|NCT02853760|9576144|FG002|NOT COMPLETED|First Intervention (3 Hours)||0
8544473|NCT02853760|9576145|FG003|NOT COMPLETED|First Intervention (3 Hours)||0
8544474|NCT02853760|9576146|FG004|NOT COMPLETED|First Intervention (3 Hours)||0
8544475|NCT02853760|9576147|FG005|NOT COMPLETED|First Intervention (3 Hours)||0
8544476|NCT02853760|9576142|FG000|STARTED|Washout (1 Week)||7
8544477|NCT02853760|9576143|FG001|STARTED|Washout (1 Week)||10
8544478|NCT02853760|9576144|FG002|STARTED|Washout (1 Week)||7
8544479|NCT02853760|9576145|FG003|STARTED|Washout (1 Week)||8
8544480|NCT02853760|9576146|FG004|STARTED|Washout (1 Week)||8
8544481|NCT02853760|9576147|FG005|STARTED|Washout (1 Week)||7
8544482|NCT02853760|9576142|FG000|COMPLETED|Washout (1 Week)||7
8544483|NCT02853760|9576143|FG001|COMPLETED|Washout (1 Week)||10
8544484|NCT02853760|9576144|FG002|COMPLETED|Washout (1 Week)||6
8544485|NCT02853760|9576145|FG003|COMPLETED|Washout (1 Week)||6
8544486|NCT02853760|9576146|FG004|COMPLETED|Washout (1 Week)||8
8544487|NCT02853760|9576147|FG005|COMPLETED|Washout (1 Week)||5
8544488|NCT02853760|9576142|FG000|NOT COMPLETED|Washout (1 Week)||0
8544489|NCT02853760|9576143|FG001|NOT COMPLETED|Washout (1 Week)||0
8544490|NCT02853760|9576144|FG002|NOT COMPLETED|Washout (1 Week)||1
8544491|NCT02853760|9576145|FG003|NOT COMPLETED|Washout (1 Week)||2
8544492|NCT02853760|9576146|FG004|NOT COMPLETED|Washout (1 Week)||0
8544493|NCT02853760|9576147|FG005|NOT COMPLETED|Washout (1 Week)||2
8544494|NCT02853760|9576142|FG000|STARTED|Second Intervention (3 Hours)||7
8544495|NCT02853760|9576143|FG001|STARTED|Second Intervention (3 Hours)||10
8544496|NCT02853760|9576144|FG002|STARTED|Second Intervention (3 Hours)||6
8544497|NCT02853760|9576145|FG003|STARTED|Second Intervention (3 Hours)||6
8544498|NCT02853760|9576146|FG004|STARTED|Second Intervention (3 Hours)||8
8544499|NCT02853760|9576147|FG005|STARTED|Second Intervention (3 Hours)||5
8544500|NCT02853760|9576142|FG000|COMPLETED|Second Intervention (3 Hours)||7
8544501|NCT02853760|9576143|FG001|COMPLETED|Second Intervention (3 Hours)||10
8544502|NCT02853760|9576144|FG002|COMPLETED|Second Intervention (3 Hours)||6
8544503|NCT02853760|9576145|FG003|COMPLETED|Second Intervention (3 Hours)||6
8544504|NCT02853760|9576146|FG004|COMPLETED|Second Intervention (3 Hours)||8
8544505|NCT02853760|9576147|FG005|COMPLETED|Second Intervention (3 Hours)||5
8544506|NCT02853760|9576142|FG000|NOT COMPLETED|Second Intervention (3 Hours)||0
8544507|NCT02853760|9576143|FG001|NOT COMPLETED|Second Intervention (3 Hours)||0
8544508|NCT02853760|9576144|FG002|NOT COMPLETED|Second Intervention (3 Hours)||0
8544509|NCT02853760|9576145|FG003|NOT COMPLETED|Second Intervention (3 Hours)||0
8544510|NCT02853760|9576146|FG004|NOT COMPLETED|Second Intervention (3 Hours)||0
8544511|NCT02853760|9576147|FG005|NOT COMPLETED|Second Intervention (3 Hours)||0
8544512|NCT02853760|9576142|FG000|STARTED|Washout (1 Week)||7
8544513|NCT02853760|9576143|FG001|STARTED|Washout (1 Week)||10
8544514|NCT02853760|9576144|FG002|STARTED|Washout (1 Week)||6
8544515|NCT02853760|9576145|FG003|STARTED|Washout (1 Week)||6
8544516|NCT02853760|9576146|FG004|STARTED|Washout (1 Week)||8
8544517|NCT02853760|9576147|FG005|STARTED|Washout (1 Week)||5
8544518|NCT02853760|9576142|FG000|COMPLETED|Washout (1 Week)||7
8544519|NCT02853760|9576143|FG001|COMPLETED|Washout (1 Week)||10
8544520|NCT02853760|9576144|FG002|COMPLETED|Washout (1 Week)||6
8544521|NCT02853760|9576145|FG003|COMPLETED|Washout (1 Week)||6
8544522|NCT02853760|9576146|FG004|COMPLETED|Washout (1 Week)||8
8544523|NCT02853760|9576147|FG005|COMPLETED|Washout (1 Week)||5
8544524|NCT02853760|9576142|FG000|NOT COMPLETED|Washout (1 Week)||0
8544525|NCT02853760|9576143|FG001|NOT COMPLETED|Washout (1 Week)||0
8544526|NCT02853760|9576144|FG002|NOT COMPLETED|Washout (1 Week)||0
8544527|NCT02853760|9576145|FG003|NOT COMPLETED|Washout (1 Week)||0
8544528|NCT02853760|9576146|FG004|NOT COMPLETED|Washout (1 Week)||0
8544529|NCT02853760|9576147|FG005|NOT COMPLETED|Washout (1 Week)||0
8544530|NCT02853760|9576142|FG000|STARTED|Third Intervention (3 Hours)||7
8544531|NCT02853760|9576143|FG001|STARTED|Third Intervention (3 Hours)||10
8544532|NCT02853760|9576144|FG002|STARTED|Third Intervention (3 Hours)||6
8544533|NCT02853760|9576145|FG003|STARTED|Third Intervention (3 Hours)||6
8544534|NCT02853760|9576146|FG004|STARTED|Third Intervention (3 Hours)||8
8544535|NCT02853760|9576147|FG005|STARTED|Third Intervention (3 Hours)||5
8544536|NCT02853760|9576142|FG000|COMPLETED|Third Intervention (3 Hours)||7
8544537|NCT02853760|9576143|FG001|COMPLETED|Third Intervention (3 Hours)||10
8544538|NCT02853760|9576144|FG002|COMPLETED|Third Intervention (3 Hours)||6
8544539|NCT02853760|9576145|FG003|COMPLETED|Third Intervention (3 Hours)||6
8544540|NCT02853760|9576146|FG004|COMPLETED|Third Intervention (3 Hours)||8
8544541|NCT02853760|9576147|FG005|COMPLETED|Third Intervention (3 Hours)||5
8544542|NCT02853760|9576142|FG000|NOT COMPLETED|Third Intervention (3 Hours)||0
8544543|NCT02853760|9576143|FG001|NOT COMPLETED|Third Intervention (3 Hours)||0
8544544|NCT02853760|9576144|FG002|NOT COMPLETED|Third Intervention (3 Hours)||0
8544545|NCT02853760|9576145|FG003|NOT COMPLETED|Third Intervention (3 Hours)||0
8544546|NCT02853760|9576146|FG004|NOT COMPLETED|Third Intervention (3 Hours)||0
8544547|NCT02853760|9576147|FG005|NOT COMPLETED|Third Intervention (3 Hours)||0
8544548|NCT02789657|9576159|FG000|STARTED|Overall Study||27
8544549|NCT02789657|9576160|FG001|STARTED|Overall Study||3
8544550|NCT02789657|9576161|FG002|STARTED|Overall Study||0
8544551|NCT02789657|9576162|FG003|STARTED|Overall Study||2
8544552|NCT02789657|9576159|FG000|COMPLETED|Overall Study||25
8544553|NCT02789657|9576160|FG001|COMPLETED|Overall Study||3
8544554|NCT02789657|9576161|FG002|COMPLETED|Overall Study||0
8544555|NCT02789657|9576162|FG003|COMPLETED|Overall Study||2
8544556|NCT02789657|9576159|FG000|NOT COMPLETED|Overall Study||2
8544557|NCT02789657|9576160|FG001|NOT COMPLETED|Overall Study||0
8544558|NCT02789657|9576161|FG002|NOT COMPLETED|Overall Study||0
8544559|NCT02789657|9576162|FG003|NOT COMPLETED|Overall Study||0
8544560|NCT02743871|9576185|FG000|STARTED|Overall Study||6
8544561|NCT02743871|9576186|FG001|STARTED|Overall Study||6
8544562|NCT02743871|9576187|FG002|STARTED|Overall Study||6
8544563|NCT02743871|9576188|FG003|STARTED|Overall Study||3
8544564|NCT02743871|9576189|FG004|STARTED|Overall Study||4
8544565|NCT02743871|9576190|FG005|STARTED|Overall Study||6
8544566|NCT02743871|9576191|FG006|STARTED|Overall Study||6
8544567|NCT02743871|9576192|FG007|STARTED|Overall Study||8
8544568|NCT02743871|9576193|FG008|STARTED|Overall Study||2
8544569|NCT02743871|9576194|FG009|STARTED|Overall Study||2
8544570|NCT02743871|9576195|FG010|STARTED|Overall Study||11
8544571|NCT02743871|9576196|FG011|STARTED|Overall Study||9
8544572|NCT02743871|9576197|FG012|STARTED|Overall Study||20
8544573|NCT02743871|9576198|FG013|STARTED|Overall Study||8
8544574|NCT02743871|9576185|FG000|COMPLETED|Overall Study||5
8544575|NCT02743871|9576186|FG001|COMPLETED|Overall Study||6
8544576|NCT02743871|9576187|FG002|COMPLETED|Overall Study||6
8544577|NCT02743871|9576188|FG003|COMPLETED|Overall Study||2
8544578|NCT02743871|9576189|FG004|COMPLETED|Overall Study||4
8544579|NCT02743871|9576190|FG005|COMPLETED|Overall Study||6
8544580|NCT02743871|9576191|FG006|COMPLETED|Overall Study||5
8544581|NCT02743871|9576192|FG007|COMPLETED|Overall Study||8
8544582|NCT02743871|9576193|FG008|COMPLETED|Overall Study||2
8544583|NCT02743871|9576194|FG009|COMPLETED|Overall Study||2
8544584|NCT02743871|9576195|FG010|COMPLETED|Overall Study||10
8544585|NCT02743871|9576196|FG011|COMPLETED|Overall Study||6
8544586|NCT02743871|9576197|FG012|COMPLETED|Overall Study||5
8544587|NCT02743871|9576198|FG013|COMPLETED|Overall Study||1
8544588|NCT02743871|9576185|FG000|NOT COMPLETED|Overall Study||1
8544589|NCT02743871|9576186|FG001|NOT COMPLETED|Overall Study||0
8544590|NCT02743871|9576187|FG002|NOT COMPLETED|Overall Study||0
8544591|NCT02743871|9576188|FG003|NOT COMPLETED|Overall Study||1
8544592|NCT02743871|9576189|FG004|NOT COMPLETED|Overall Study||0
8544593|NCT02743871|9576190|FG005|NOT COMPLETED|Overall Study||0
8544594|NCT02743871|9576191|FG006|NOT COMPLETED|Overall Study||1
8544595|NCT02743871|9576192|FG007|NOT COMPLETED|Overall Study||0
8544596|NCT02743871|9576193|FG008|NOT COMPLETED|Overall Study||0
8544597|NCT02743871|9576194|FG009|NOT COMPLETED|Overall Study||0
8544598|NCT02743871|9576195|FG010|NOT COMPLETED|Overall Study||1
8544599|NCT02743871|9576196|FG011|NOT COMPLETED|Overall Study||3
8544600|NCT02743871|9576197|FG012|NOT COMPLETED|Overall Study||15
8544601|NCT02743871|9576198|FG013|NOT COMPLETED|Overall Study||7
8544602|NCT02707198|9576243|FG000|STARTED|Overall Study||2
8544603|NCT02707198|9576244|FG001|STARTED|Overall Study||0
8544604|NCT02707198|9576245|FG002|STARTED|Overall Study||0
8544605|NCT02707198|9576243|FG000|COMPLETED|Overall Study||2
8544606|NCT02707198|9576244|FG001|COMPLETED|Overall Study||0
8544607|NCT02707198|9576245|FG002|COMPLETED|Overall Study||0
8544608|NCT02707198|9576243|FG000|NOT COMPLETED|Overall Study||0
8544609|NCT02707198|9576244|FG001|NOT COMPLETED|Overall Study||0
8544610|NCT02707198|9576245|FG002|NOT COMPLETED|Overall Study||0
8544611|NCT02673398|9576253|FG000|STARTED|Overall Study||25
8544612|NCT02673398|9576253|FG000|COMPLETED|Overall Study||25
8544613|NCT02673398|9576253|FG000|NOT COMPLETED|Overall Study||0
8566750|NCT00078819|9598945|FG002|COMPLETED|Withdrawal Period: Weeks 37-48|Defined as continuing to receive blinded study drug through week 48|40
8566751|NCT00078819|9598946|FG003|COMPLETED|Withdrawal Period: Weeks 37-48|Defined as continuing to receive blinded study drug through week 48|55
8566752|NCT00078819|9598943|FG000|NOT COMPLETED|Withdrawal Period: Weeks 37-48||0
8566753|NCT00078819|9598944|FG001|NOT COMPLETED|Withdrawal Period: Weeks 37-48||0
8566754|NCT00078819|9598945|FG002|NOT COMPLETED|Withdrawal Period: Weeks 37-48||29
8566755|NCT00078819|9598946|FG003|NOT COMPLETED|Withdrawal Period: Weeks 37-48||14
8544614|NCT02614261|9576260|FG000|STARTED|Double-Blind Treatment Phase||559
8544615|NCT02614261|9576261|FG001|STARTED|Double-Blind Treatment Phase||279
8544616|NCT02614261|9576262|FG002|STARTED|Double-Blind Treatment Phase||279
8544617|NCT02614261|9576263|FG003|STARTED|Double-Blind Treatment Phase||0
8544618|NCT02614261|9576260|FG000|Received at Least One Dose of Study Drug|Double-Blind Treatment Phase||558
8544619|NCT02614261|9576261|FG001|Received at Least One Dose of Study Drug|Double-Blind Treatment Phase||278
8544620|NCT02614261|9576262|FG002|Received at Least One Dose of Study Drug|Double-Blind Treatment Phase||277
8544621|NCT02614261|9576263|FG003|Received at Least One Dose of Study Drug|Double-Blind Treatment Phase||0
8544622|NCT02614261|9576260|FG000|Safety Population|Double-Blind Treatment Phase||558
8544623|NCT02614261|9576261|FG001|Safety Population|Double-Blind Treatment Phase|5 participants discontinued after receiving loading dose of 240mg. They were included under 240mg arm for safety analysis.|273
8544624|NCT02614261|9576262|FG002|Safety Population|Double-Blind Treatment Phase||282
8544625|NCT02614261|9576263|FG003|Safety Population|Double-Blind Treatment Phase||0
8544626|NCT02614261|9576260|FG000|COMPLETED|Double-Blind Treatment Phase||509
8544627|NCT02614261|9576261|FG001|COMPLETED|Double-Blind Treatment Phase||262
8544628|NCT02614261|9576262|FG002|COMPLETED|Double-Blind Treatment Phase||266
8544629|NCT02614261|9576263|FG003|COMPLETED|Double-Blind Treatment Phase||0
8544630|NCT02614261|9576260|FG000|NOT COMPLETED|Double-Blind Treatment Phase||50
8544631|NCT02614261|9576261|FG001|NOT COMPLETED|Double-Blind Treatment Phase||17
8544632|NCT02614261|9576262|FG002|NOT COMPLETED|Double-Blind Treatment Phase||13
8544633|NCT02614261|9576263|FG003|NOT COMPLETED|Double-Blind Treatment Phase||0
8544634|NCT02614261|9576260|FG000|STARTED|Open-Label Extension Phase|Participants from double-blind treatment phase had the option to enter the open-label extension phase or proceed directly to the follow-up phase.|501
8544635|NCT02614261|9576261|FG001|STARTED|Open-Label Extension Phase|Participants from double-blind treatment phase had the option to enter the open-label extension phase or proceed directly to the follow-up phase.|259
8544636|NCT02614261|9576262|FG002|STARTED|Open-Label Extension Phase|Participants from double-blind treatment phase had the option to enter the open-label extension phase or proceed directly to the follow-up phase.|262
8544637|NCT02614261|9576263|FG003|STARTED|Open-Label Extension Phase||0
8544638|NCT02614261|9576260|FG000|Safety Population|Open-Label Extension Phase||501
8544639|NCT02614261|9576261|FG001|Safety Population|Open-Label Extension Phase||259
8544640|NCT02614261|9576262|FG002|Safety Population|Open-Label Extension Phase||262
8544641|NCT02614261|9576263|FG003|Safety Population|Open-Label Extension Phase||0
8544642|NCT02614261|9576260|FG000|COMPLETED|Open-Label Extension Phase||413
8544643|NCT02614261|9576261|FG001|COMPLETED|Open-Label Extension Phase||204
8544644|NCT02614261|9576262|FG002|COMPLETED|Open-Label Extension Phase||208
8544645|NCT02614261|9576263|FG003|COMPLETED|Open-Label Extension Phase||0
8544646|NCT02614261|9576260|FG000|NOT COMPLETED|Open-Label Extension Phase||88
8544647|NCT02614261|9576261|FG001|NOT COMPLETED|Open-Label Extension Phase||55
8544648|NCT02614261|9576262|FG002|NOT COMPLETED|Open-Label Extension Phase||54
8544649|NCT02614261|9576263|FG003|NOT COMPLETED|Open-Label Extension Phase||0
8544650|NCT02614261|9576260|FG000|STARTED|Follow-up Phase|Participants from double-blind treatment or open-label extension phases entered the follow-up phase.|453
8544651|NCT02614261|9576261|FG001|STARTED|Follow-up Phase|Participants from double-blind treatment or open-label extension phases entered the follow-up phase.|228
8544652|NCT02614261|9576262|FG002|STARTED|Follow-up Phase|Participants from double-blind treatment or open-label extension phases entered the follow-up phase.|231
8544653|NCT02614261|9576263|FG003|STARTED|Follow-up Phase||0
8544654|NCT02614261|9576260|FG000|Entered From Double-blind Treatment Phase|Follow-up Phase||15
8544655|NCT02614261|9576261|FG001|Entered From Double-blind Treatment Phase|Follow-up Phase|1 among these participants discontinued from double-blind treatment phase after receiving 240mg loading dose and entered Follow-up phase.|5
8544656|NCT02614261|9576262|FG002|Entered From Double-blind Treatment Phase|Follow-up Phase||3
8544657|NCT02614261|9576263|FG003|Entered From Double-blind Treatment Phase|Follow-up Phase||0
8544658|NCT02614261|9576260|FG000|Safety Population (Entered From Double-blind Treatment Phase)|Follow-up Phase||15
8544659|NCT02614261|9576261|FG001|Safety Population (Entered From Double-blind Treatment Phase)|Follow-up Phase|1 participant who discontinued from double-blind treatment phase after receiving 240mg loading dose and entered Follow-up phase was included under 240mg arm for safety analysis.|4
8544660|NCT02614261|9576262|FG002|Safety Population (Entered From Double-blind Treatment Phase)|Follow-up Phase||4
8544661|NCT02614261|9576263|FG003|Safety Population (Entered From Double-blind Treatment Phase)|Follow-up Phase||0
8544662|NCT02614261|9576260|FG000|Entered From Open-label Extension Phase|Follow-up Phase||438
8544663|NCT02614261|9576261|FG001|Entered From Open-label Extension Phase|Follow-up Phase||223
8544664|NCT02614261|9576262|FG002|Entered From Open-label Extension Phase|Follow-up Phase||228
8544665|NCT02614261|9576263|FG003|Entered From Open-label Extension Phase|Follow-up Phase||0
8544666|NCT02614261|9576260|FG000|Safety Population (Entered From Open-label Extension Phase)|Follow-up Phase||438
8544667|NCT02614261|9576261|FG001|Safety Population (Entered From Open-label Extension Phase)|Follow-up Phase||223
8544668|NCT02614261|9576262|FG002|Safety Population (Entered From Open-label Extension Phase)|Follow-up Phase||228
8544669|NCT02614261|9576263|FG003|Safety Population (Entered From Open-label Extension Phase)|Follow-up Phase||0
8544670|NCT02614261|9576260|FG000|COMPLETED|Follow-up Phase||421
8544671|NCT02614261|9576261|FG001|COMPLETED|Follow-up Phase||217
8544672|NCT02614261|9576262|FG002|COMPLETED|Follow-up Phase||217
8544673|NCT02614261|9576263|FG003|COMPLETED|Follow-up Phase||0
8544674|NCT02614261|9576260|FG000|NOT COMPLETED|Follow-up Phase||32
8544675|NCT02614261|9576261|FG001|NOT COMPLETED|Follow-up Phase||11
8544676|NCT02614261|9576262|FG002|NOT COMPLETED|Follow-up Phase||14
8544677|NCT02614261|9576263|FG003|NOT COMPLETED|Follow-up Phase||0
8544678|NCT02614261|9576260|FG000|STARTED|Israel Addendum|Main study arm.|0
8544679|NCT02614261|9576261|FG001|STARTED|Israel Addendum|Main study arm.|0
8544680|NCT02614261|9576262|FG002|STARTED|Israel Addendum|Main study arm.|0
8544681|NCT02614261|9576263|FG003|STARTED|Israel Addendum|Eligible participants from main study enrolled in Israel addendum.|29
8544682|NCT02614261|9576260|FG000|Safety Population|Israel Addendum||0
8544683|NCT02614261|9576261|FG001|Safety Population|Israel Addendum||0
8544684|NCT02614261|9576262|FG002|Safety Population|Israel Addendum||0
8544685|NCT02614261|9576263|FG003|Safety Population|Israel Addendum||29
8544686|NCT02614261|9576260|FG000|COMPLETED|Israel Addendum||0
8544687|NCT02614261|9576261|FG001|COMPLETED|Israel Addendum||0
8544688|NCT02614261|9576262|FG002|COMPLETED|Israel Addendum||0
8544689|NCT02614261|9576263|FG003|COMPLETED|Israel Addendum||25
8544690|NCT02614261|9576260|FG000|NOT COMPLETED|Israel Addendum||0
8544691|NCT02614261|9576261|FG001|NOT COMPLETED|Israel Addendum||0
8544692|NCT02614261|9576262|FG002|NOT COMPLETED|Israel Addendum||0
8544693|NCT02614261|9576263|FG003|NOT COMPLETED|Israel Addendum||4
8544694|NCT02527434|9576292|FG000|STARTED|Overall Study||32
8544695|NCT02527434|9576293|FG001|STARTED|Overall Study||12
8544696|NCT02527434|9576294|FG002|STARTED|Overall Study||20
8544697|NCT02527434|9576292|FG000|Started Retreatment Phase (COMBO)|Overall Study||7
8544698|NCT02527434|9576293|FG001|Started Retreatment Phase (COMBO)|Overall Study||5
8544699|NCT02527434|9576294|FG002|Started Retreatment Phase (COMBO)|Overall Study||4
8544700|NCT02527434|9576292|FG000|Started Retreatment Phase (MEDI)|Overall Study||4
8544701|NCT02527434|9576293|FG001|Started Retreatment Phase (MEDI)|Overall Study||0
8544702|NCT02527434|9576294|FG002|Started Retreatment Phase (MEDI)|Overall Study||1
8544703|NCT02527434|9576292|FG000|COMPLETED|Overall Study||4
8544704|NCT02527434|9576293|FG001|COMPLETED|Overall Study||1
8544705|NCT02527434|9576294|FG002|COMPLETED|Overall Study||0
8544706|NCT02527434|9576292|FG000|NOT COMPLETED|Overall Study||28
8544707|NCT02527434|9576293|FG001|NOT COMPLETED|Overall Study||11
8544708|NCT02527434|9576294|FG002|NOT COMPLETED|Overall Study||20
8544709|NCT02513667|9576314|FG000|STARTED|Overall Study||8
8544710|NCT02513667|9576315|FG001|STARTED|Overall Study||6
8544711|NCT02513667|9576314|FG000|COMPLETED|Overall Study||8
8544712|NCT02513667|9576315|FG001|COMPLETED|Overall Study||5
8544713|NCT02513667|9576314|FG000|NOT COMPLETED|Overall Study||0
8544714|NCT02513667|9576315|FG001|NOT COMPLETED|Overall Study||1
8544715|NCT02446600|9576325|FG000|STARTED|Overall Study||187
8544716|NCT02446600|9576326|FG001|STARTED|Overall Study|Duplicate enrollment patient has been excluded from all analyses.|190
8544717|NCT02446600|9576327|FG002|STARTED|Overall Study||189
8544718|NCT02446600|9576328|FG003|STARTED|Overall Study||13
8544719|NCT02446600|9576325|FG000|COMPLETED|Overall Study|Completed status includes all clinical reasons for suspending treatment, including disease progression, death and adverse events.|147
8544720|NCT02446600|9576326|FG001|COMPLETED|Overall Study|Completed status includes all clinical reasons for suspending treatment, including disease progression, death and adverse events.|178
8544721|NCT02446600|9576327|FG002|COMPLETED|Overall Study|Completed status includes all clinical reasons for suspending treatment, including disease progression, death and adverse events.|162
8544722|NCT02446600|9576328|FG003|COMPLETED|Overall Study|Completed status includes all clinical reasons for suspending treatment, including disease progression, death and adverse events.|12
8544723|NCT02446600|9576325|FG000|NOT COMPLETED|Overall Study||40
8544724|NCT02446600|9576326|FG001|NOT COMPLETED|Overall Study||12
8544725|NCT02446600|9576327|FG002|NOT COMPLETED|Overall Study||27
8544726|NCT02446600|9576328|FG003|NOT COMPLETED|Overall Study||1
8544727|NCT02422615|9576340|FG000|STARTED|Overall Study||484
8544728|NCT02422615|9576341|FG001|STARTED|Overall Study||242
8544729|NCT02422615|9576340|FG000|Untreated|Overall Study||1
8544730|NCT02422615|9576341|FG001|Untreated|Overall Study||1
8544731|NCT02422615|9576340|FG000|COMPLETED|Overall Study||204
8544732|NCT02422615|9576341|FG001|COMPLETED|Overall Study||76
8621413|NCT00479882|9660378|FG001|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||162
8621414|NCT00479882|9660379|FG002|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||157
8621415|NCT00479882|9660380|FG003|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||140
8544733|NCT02422615|9576340|FG000|NOT COMPLETED|Overall Study||280
8544734|NCT02422615|9576341|FG001|NOT COMPLETED|Overall Study||166
8544735|NCT02415556|9576351|FG000|STARTED|Overall Study||57
8544736|NCT02415556|9576352|FG001|STARTED|Overall Study||58
8544737|NCT02415556|9576353|FG002|STARTED|Overall Study||65
8544738|NCT02415556|9576354|FG003|STARTED|Overall Study||64
8544739|NCT02415556|9576351|FG000|COMPLETED|Overall Study||32
8544740|NCT02415556|9576352|FG001|COMPLETED|Overall Study||37
8544741|NCT02415556|9576353|FG002|COMPLETED|Overall Study||43
8544742|NCT02415556|9576354|FG003|COMPLETED|Overall Study||44
8544743|NCT02415556|9576351|FG000|NOT COMPLETED|Overall Study||25
8544744|NCT02415556|9576352|FG001|NOT COMPLETED|Overall Study||21
8621416|NCT00479882|9660377|FG000|STARTED|Crossover: Period III (Weeks 13-20)||472
8544745|NCT02415556|9576353|FG002|NOT COMPLETED|Overall Study||22
8544746|NCT02415556|9576354|FG003|NOT COMPLETED|Overall Study||20
8544747|NCT02389374|9576367|FG000|STARTED|Overall Study||55
8544748|NCT02389374|9576368|FG001|STARTED|Overall Study||115
8544749|NCT02389374|9576369|FG002|STARTED|Overall Study||11
8544750|NCT02389374|9576367|FG000|COMPLETED|Overall Study||46
8544751|NCT02389374|9576368|FG001|COMPLETED|Overall Study||87
8544752|NCT02389374|9576369|FG002|COMPLETED|Overall Study||10
8544753|NCT02389374|9576367|FG000|NOT COMPLETED|Overall Study||9
8544754|NCT02389374|9576368|FG001|NOT COMPLETED|Overall Study||28
8544755|NCT02389374|9576369|FG002|NOT COMPLETED|Overall Study||1
8544756|NCT02386839|9576380|FG000|STARTED|Overall Study||36
8544757|NCT02386839|9576381|FG001|STARTED|Overall Study||40
8544758|NCT02386839|9576380|FG000|COMPLETED|Overall Study||20
8544759|NCT02386839|9576381|FG001|COMPLETED|Overall Study||25
8544760|NCT02386839|9576380|FG000|NOT COMPLETED|Overall Study||16
8544761|NCT02386839|9576381|FG001|NOT COMPLETED|Overall Study||15
8544762|NCT02362503|9576394|FG000|STARTED|Double-blind Period-Up to 8 Days||69
8544763|NCT02362503|9576395|FG001|STARTED|Double-blind Period-Up to 8 Days||203
8544764|NCT02362503|9576396|FG002|STARTED|Double-blind Period-Up to 8 Days||0
8544765|NCT02362503|9576394|FG000|COMPLETED|Double-blind Period-Up to 8 Days||68
8544766|NCT02362503|9576395|FG001|COMPLETED|Double-blind Period-Up to 8 Days||199
8544767|NCT02362503|9576396|FG002|COMPLETED|Double-blind Period-Up to 8 Days||0
8544768|NCT02362503|9576394|FG000|NOT COMPLETED|Double-blind Period-Up to 8 Days||1
8544769|NCT02362503|9576395|FG001|NOT COMPLETED|Double-blind Period-Up to 8 Days||4
8544770|NCT02362503|9576396|FG002|NOT COMPLETED|Double-blind Period-Up to 8 Days||0
8544771|NCT02362503|9576394|FG000|STARTED|Open Label Period-Up to 96 Weeks||68
8544772|NCT02362503|9576395|FG001|STARTED|Open Label Period-Up to 96 Weeks||199
8544773|NCT02362503|9576396|FG002|STARTED|Open Label Period-Up to 96 Weeks||99
8544774|NCT02362503|9576394|FG000|COMPLETED|Open Label Period-Up to 96 Weeks||0
8544775|NCT02362503|9576395|FG001|COMPLETED|Open Label Period-Up to 96 Weeks||0
8544776|NCT02362503|9576396|FG002|COMPLETED|Open Label Period-Up to 96 Weeks||0
8544777|NCT02362503|9576394|FG000|NOT COMPLETED|Open Label Period-Up to 96 Weeks||68
8544778|NCT02362503|9576395|FG001|NOT COMPLETED|Open Label Period-Up to 96 Weeks||199
8544779|NCT02362503|9576396|FG002|NOT COMPLETED|Open Label Period-Up to 96 Weeks||99
8544780|NCT02318264|9576409|FG000|STARTED|Overall Study||8
8544781|NCT02318264|9576410|FG001|STARTED|Overall Study||7
8544782|NCT02318264|9576409|FG000|COMPLETED|Overall Study||8
8544783|NCT02318264|9576410|FG001|COMPLETED|Overall Study||7
8544784|NCT02318264|9576409|FG000|NOT COMPLETED|Overall Study||0
8544785|NCT02318264|9576410|FG001|NOT COMPLETED|Overall Study||0
8544786|NCT02312258|9576421|FG000|STARTED|Overall Study||281
8544787|NCT02312258|9576422|FG001|STARTED|Overall Study||425
8544788|NCT02312258|9576421|FG000|COMPLETED|Overall Study||30
8544789|NCT02312258|9576422|FG001|COMPLETED|Overall Study||66
8544790|NCT02312258|9576421|FG000|NOT COMPLETED|Overall Study||251
8544791|NCT02312258|9576422|FG001|NOT COMPLETED|Overall Study||359
8544792|NCT02243605|9576430|FG000|STARTED|Stage 1 - Interim Analysis Population||23
8544793|NCT02243605|9576431|FG001|STARTED|Stage 1 - Interim Analysis Population||22
8544794|NCT02243605|9576430|FG000|COMPLETED|Stage 1 - Interim Analysis Population||21
8544795|NCT02243605|9576431|FG001|COMPLETED|Stage 1 - Interim Analysis Population||21
8544796|NCT02243605|9576430|FG000|NOT COMPLETED|Stage 1 - Interim Analysis Population||2
8544797|NCT02243605|9576431|FG001|NOT COMPLETED|Stage 1 - Interim Analysis Population||1
8544798|NCT02243605|9576430|FG000|STARTED|Stage 2 - Final Analysis Population||45
8544799|NCT02243605|9576431|FG001|STARTED|Stage 2 - Final Analysis Population||45
8544800|NCT02243605|9576430|FG000|COMPLETED|Stage 2 - Final Analysis Population||39
8544801|NCT02243605|9576431|FG001|COMPLETED|Stage 2 - Final Analysis Population||42
8544802|NCT02243605|9576430|FG000|NOT COMPLETED|Stage 2 - Final Analysis Population||6
8544803|NCT02243605|9576431|FG001|NOT COMPLETED|Stage 2 - Final Analysis Population||3
8544804|NCT02218164|9576437|FG000|STARTED|Overall Study||8
8544805|NCT02218164|9576437|FG000|COMPLETED|Overall Study||8
8544806|NCT02218164|9576437|FG000|NOT COMPLETED|Overall Study||0
8544807|NCT02213380|9576443|FG000|STARTED|Underwent Randomization||476
8544808|NCT02213380|9576444|FG001|STARTED|Underwent Randomization||474
8544809|NCT02213380|9576443|FG000|COMPLETED|Underwent Randomization||471
8544810|NCT02213380|9576444|FG001|COMPLETED|Underwent Randomization||471
8544811|NCT02213380|9576443|FG000|NOT COMPLETED|Underwent Randomization||5
8544812|NCT02213380|9576444|FG001|NOT COMPLETED|Underwent Randomization||3
8544813|NCT02213380|9576443|FG000|STARTED|Per-protocol Analysis||471
8544814|NCT02213380|9576444|FG001|STARTED|Per-protocol Analysis||471
8544815|NCT02213380|9576443|FG000|COMPLETED|Per-protocol Analysis||439
8544816|NCT02213380|9576444|FG001|COMPLETED|Per-protocol Analysis||435
8544817|NCT02213380|9576443|FG000|NOT COMPLETED|Per-protocol Analysis||32
8544818|NCT02213380|9576444|FG001|NOT COMPLETED|Per-protocol Analysis||36
8544819|NCT02184195|9576452|FG000|STARTED|Overall Study||92
8544820|NCT02184195|9576453|FG001|STARTED|Overall Study||62
8544821|NCT02184195|9576452|FG000|COMPLETED|Overall Study||49
8544822|NCT02184195|9576453|FG001|COMPLETED|Overall Study||27
8544823|NCT02184195|9576452|FG000|NOT COMPLETED|Overall Study||43
8544824|NCT02184195|9576453|FG001|NOT COMPLETED|Overall Study||35
8544825|NCT02113592|9576461|FG000|STARTED|Overall Study||433
8544826|NCT02113592|9576462|FG001|STARTED|Overall Study||417
8544827|NCT02113592|9576461|FG000|COMPLETED|Overall Study||414
8544828|NCT02113592|9576462|FG001|COMPLETED|Overall Study||402
8544829|NCT02113592|9576461|FG000|NOT COMPLETED|Overall Study||19
8544830|NCT02113592|9576462|FG001|NOT COMPLETED|Overall Study||15
8544831|NCT02089685|9576474|FG000|STARTED|Overall Study||23
8544832|NCT02089685|9576475|FG001|STARTED|Overall Study||14
8544833|NCT02089685|9576476|FG002|STARTED|Overall Study||3
8544834|NCT02089685|9576477|FG003|STARTED|Overall Study||153
8544835|NCT02089685|9576478|FG004|STARTED|Overall Study||51
8544836|NCT02089685|9576479|FG005|STARTED|Overall Study||51
8544837|NCT02089685|9576474|FG000|Treated|Overall Study||22
8544838|NCT02089685|9576475|FG001|Treated|Overall Study||14
8544839|NCT02089685|9576476|FG002|Treated|Overall Study||3
8544840|NCT02089685|9576477|FG003|Treated|Overall Study||153
8544841|NCT02089685|9576478|FG004|Treated|Overall Study||51
8544842|NCT02089685|9576479|FG005|Treated|Overall Study||51
8544843|NCT02089685|9576474|FG000|COMPLETED|Overall Study||0
8544844|NCT02089685|9576475|FG001|COMPLETED|Overall Study||0
8544845|NCT02089685|9576476|FG002|COMPLETED|Overall Study||0
8544846|NCT02089685|9576477|FG003|COMPLETED|Overall Study||0
8544847|NCT02089685|9576478|FG004|COMPLETED|Overall Study||0
8544848|NCT02089685|9576479|FG005|COMPLETED|Overall Study||0
8544849|NCT02089685|9576474|FG000|NOT COMPLETED|Overall Study||23
8544850|NCT02089685|9576475|FG001|NOT COMPLETED|Overall Study||14
8544851|NCT02089685|9576476|FG002|NOT COMPLETED|Overall Study||3
8544852|NCT02089685|9576477|FG003|NOT COMPLETED|Overall Study||153
8544853|NCT02089685|9576478|FG004|NOT COMPLETED|Overall Study||51
8544854|NCT02089685|9576479|FG005|NOT COMPLETED|Overall Study||51
8566756|NCT00078819|9598943|FG000|STARTED|Re-treatment Period||0
8566757|NCT00078819|9598944|FG001|STARTED|Re-treatment Period||0
8566758|NCT00078819|9598945|FG002|STARTED|Re-treatment Period||29
8566759|NCT00078819|9598946|FG003|STARTED|Re-treatment Period||13
8566760|NCT00078819|9598943|FG000|Received Study Drug|Re-treatment Period||0
8566761|NCT00078819|9598944|FG001|Received Study Drug|Re-treatment Period||0
8566762|NCT00078819|9598945|FG002|Received Study Drug|Re-treatment Period|One additional participant received re-treatment without having disease relapse|30
8566763|NCT00078819|9598946|FG003|Received Study Drug|Re-treatment Period||12
8566764|NCT00078819|9598943|FG000|COMPLETED|Re-treatment Period||0
8566765|NCT00078819|9598944|FG001|COMPLETED|Re-treatment Period||0
8566766|NCT00078819|9598945|FG002|COMPLETED|Re-treatment Period||29
8566767|NCT00078819|9598946|FG003|COMPLETED|Re-treatment Period||13
8566768|NCT00078819|9598943|FG000|NOT COMPLETED|Re-treatment Period||0
8566769|NCT00078819|9598944|FG001|NOT COMPLETED|Re-treatment Period||0
8566770|NCT00078819|9598945|FG002|NOT COMPLETED|Re-treatment Period||0
8566771|NCT00078819|9598946|FG003|NOT COMPLETED|Re-treatment Period||0
8566772|NCT00078897|9598965|FG000|STARTED|Overall Study||809
8566773|NCT00078897|9598966|FG001|STARTED|Overall Study||812
8566774|NCT00078897|9598965|FG000|COMPLETED|Overall Study||685
8566775|NCT00078897|9598966|FG001|COMPLETED|Overall Study||689
8566776|NCT00078897|9598965|FG000|NOT COMPLETED|Overall Study||124
8566777|NCT00078897|9598966|FG001|NOT COMPLETED|Overall Study||123
8566778|NCT00078949|9598976|FG000|STARTED|Overall Study||310
8566779|NCT00078949|9598977|FG001|STARTED|Overall Study||309
8566780|NCT00078949|9598978|FG002|STARTED|Overall Study||115
8566781|NCT00078949|9598979|FG003|STARTED|Overall Study||115
8566782|NCT00078949|9598976|FG000|COMPLETED|Overall Study||306
8566783|NCT00078949|9598977|FG001|COMPLETED|Overall Study||304
8566784|NCT00078949|9598978|FG002|COMPLETED|Overall Study||112
8566785|NCT00078949|9598979|FG003|COMPLETED|Overall Study||112
8566786|NCT00078949|9598976|FG000|NOT COMPLETED|Overall Study||4
8566787|NCT00078949|9598977|FG001|NOT COMPLETED|Overall Study||5
8566788|NCT00078949|9598978|FG002|NOT COMPLETED|Overall Study||3
8566789|NCT00078949|9598979|FG003|NOT COMPLETED|Overall Study||3
8566790|NCT00079001|9598993|FG000|STARTED|Overall Study||323
8566791|NCT00079001|9598994|FG001|STARTED|Overall Study||322
8566792|NCT00079001|9598993|FG000|COMPLETED|Overall Study||323
8566793|NCT00079001|9598994|FG001|COMPLETED|Overall Study||322
8566794|NCT00079001|9598993|FG000|NOT COMPLETED|Overall Study||0
8566795|NCT00079001|9598994|FG001|NOT COMPLETED|Overall Study||0
8566796|NCT00079040|9599000|FG000|STARTED|Overall Study||65
8566797|NCT00079040|9599000|FG000|COMPLETED|Overall Study||63
8566798|NCT00079040|9599000|FG000|NOT COMPLETED|Overall Study||2
8566799|NCT00079183|9599004|FG000|STARTED|Overall Study||44
8566800|NCT00079183|9599004|FG000|Drop Outs|Overall Study||7
8566801|NCT00079183|9599004|FG000|COMPLETED|Overall Study||37
8566802|NCT00079183|9599004|FG000|NOT COMPLETED|Overall Study||7
8566803|NCT00079274|9599016|FG000|STARTED|Overall Study||1402
8566804|NCT00079274|9599017|FG001|STARTED|Overall Study||111
8566805|NCT00079274|9599018|FG002|STARTED|Overall Study||111
8566806|NCT00079274|9599019|FG003|STARTED|Overall Study||1350
8566807|NCT00079274|9599020|FG004|STARTED|Overall Study||45
8566808|NCT00079274|9599021|FG005|STARTED|Overall Study||46
8566809|NCT00079274|9599022|FG006|STARTED|Overall Study||332
8566810|NCT00079274|9599016|FG000|COMPLETED|Overall Study||1081
8566811|NCT00079274|9599017|FG001|COMPLETED|Overall Study||84
8566812|NCT00079274|9599018|FG002|COMPLETED|Overall Study||84
8566813|NCT00079274|9599019|FG003|COMPLETED|Overall Study||906
8566814|NCT00079274|9599020|FG004|COMPLETED|Overall Study||30
8566815|NCT00079274|9599021|FG005|COMPLETED|Overall Study||26
8566816|NCT00079274|9599022|FG006|COMPLETED|Overall Study||332
8566817|NCT00079274|9599016|FG000|NOT COMPLETED|Overall Study||321
8566818|NCT00079274|9599017|FG001|NOT COMPLETED|Overall Study||27
8566819|NCT00079274|9599018|FG002|NOT COMPLETED|Overall Study||27
8566820|NCT00079274|9599019|FG003|NOT COMPLETED|Overall Study||444
8566821|NCT00079274|9599020|FG004|NOT COMPLETED|Overall Study||15
8566822|NCT00079274|9599021|FG005|NOT COMPLETED|Overall Study||20
8566823|NCT00079274|9599022|FG006|NOT COMPLETED|Overall Study||0
8566824|NCT00079326|9599037|FG000|STARTED|Overall Study||15
8566825|NCT00079326|9599038|FG001|STARTED|Overall Study||24
8566826|NCT00079326|9599037|FG000|COMPLETED|Overall Study||15
8566827|NCT00079326|9599038|FG001|COMPLETED|Overall Study||24
8566828|NCT00079326|9599037|FG000|NOT COMPLETED|Overall Study||0
8566829|NCT00079326|9599038|FG001|NOT COMPLETED|Overall Study||0
8566830|NCT00079339|9599046|FG000|STARTED|Overall Study||5
8544855|NCT02075320|9576503|FG000|STARTED|Overall Study||50
8544856|NCT02075320|9576503|FG000|COMPLETED|Overall Study||48
8544857|NCT02075320|9576503|FG000|NOT COMPLETED|Overall Study||2
8544858|NCT02007512|9576511|FG000|STARTED|Double Blind Treatment Period||63
8544859|NCT02007512|9576512|FG001|STARTED|Double Blind Treatment Period||64
8544860|NCT02007512|9576513|FG002|STARTED|Double Blind Treatment Period||60
8544861|NCT02007512|9576514|FG003|STARTED|Double Blind Treatment Period||60
8544862|NCT02007512|9576511|FG000|Treated|Double Blind Treatment Period||62
8544863|NCT02007512|9576512|FG001|Treated|Double Blind Treatment Period||63
8544864|NCT02007512|9576513|FG002|Treated|Double Blind Treatment Period||60
8544865|NCT02007512|9576514|FG003|Treated|Double Blind Treatment Period||60
8544866|NCT02007512|9576511|FG000|COMPLETED|Double Blind Treatment Period||0
8544867|NCT02007512|9576512|FG001|COMPLETED|Double Blind Treatment Period||0
8544868|NCT02007512|9576513|FG002|COMPLETED|Double Blind Treatment Period||0
8544869|NCT02007512|9576514|FG003|COMPLETED|Double Blind Treatment Period||0
8544870|NCT02007512|9576511|FG000|NOT COMPLETED|Double Blind Treatment Period||63
8544871|NCT02007512|9576512|FG001|NOT COMPLETED|Double Blind Treatment Period||64
8544872|NCT02007512|9576513|FG002|NOT COMPLETED|Double Blind Treatment Period||60
8544873|NCT02007512|9576514|FG003|NOT COMPLETED|Double Blind Treatment Period||60
8544874|NCT02007512|9576511|FG000|STARTED|Open Label Treatment Period||0
8544875|NCT02007512|9576512|FG001|STARTED|Open Label Treatment Period|Of the participants with disease progression in double blind period, 21 entered open label period.|21
8544876|NCT02007512|9576513|FG002|STARTED|Open Label Treatment Period||0
8544877|NCT02007512|9576514|FG003|STARTED|Open Label Treatment Period|Of the participants with disease progression in double blind period, 12 entered open label period.|12
8544878|NCT02007512|9576511|FG000|COMPLETED|Open Label Treatment Period||0
8544879|NCT02007512|9576512|FG001|COMPLETED|Open Label Treatment Period||0
8544880|NCT02007512|9576513|FG002|COMPLETED|Open Label Treatment Period||0
8544881|NCT02007512|9576514|FG003|COMPLETED|Open Label Treatment Period||0
8544882|NCT02007512|9576511|FG000|NOT COMPLETED|Open Label Treatment Period||0
8544883|NCT02007512|9576512|FG001|NOT COMPLETED|Open Label Treatment Period||21
8544884|NCT02007512|9576513|FG002|NOT COMPLETED|Open Label Treatment Period||0
8544885|NCT02007512|9576514|FG003|NOT COMPLETED|Open Label Treatment Period||12
8544886|NCT01999179|9576527|FG000|STARTED|Overall Study||27
8544887|NCT01999179|9576527|FG000|COMPLETED|Overall Study||20
8544888|NCT01999179|9576527|FG000|NOT COMPLETED|Overall Study||7
8544889|NCT01858688|9576531|FG000|STARTED|Overall Study||101
8544890|NCT01858688|9576531|FG000|Biopsied at Baseline|Overall Study||97
8544891|NCT01858688|9576531|FG000|MRI Assessed|Overall Study||91
8544892|NCT01858688|9576531|FG000|COMPLETED|Overall Study||81
8544893|NCT01858688|9576531|FG000|NOT COMPLETED|Overall Study||20
8544894|NCT01796197|9576535|FG000|STARTED|Overall Study||23
8544895|NCT01796197|9576535|FG000|COMPLETED|Overall Study||21
8544896|NCT01796197|9576535|FG000|NOT COMPLETED|Overall Study||2
8544897|NCT01751906|9576541|FG000|STARTED|Overall Study||1322
8544898|NCT01751906|9576542|FG001|STARTED|Overall Study||686
8544899|NCT01751906|9576541|FG000|COMPLETED|Overall Study||1059
8544900|NCT01751906|9576542|FG001|COMPLETED|Overall Study||555
8544901|NCT01751906|9576541|FG000|NOT COMPLETED|Overall Study||263
8544902|NCT01751906|9576542|FG001|NOT COMPLETED|Overall Study||131
8544903|NCT01665144|9576550|FG000|STARTED|Overall Study||1105
8621417|NCT00479882|9660378|FG001|STARTED|Crossover: Period III (Weeks 13-20)||440
8621418|NCT00479882|9660379|FG002|STARTED|Crossover: Period III (Weeks 13-20)||440
8621419|NCT00479882|9660380|FG003|STARTED|Crossover: Period III (Weeks 13-20)||465
8621420|NCT00479882|9660377|FG000|COMPLETED|Crossover: Period III (Weeks 13-20)||447
8621421|NCT00479882|9660378|FG001|COMPLETED|Crossover: Period III (Weeks 13-20)||419
8544904|NCT01665144|9576551|FG001|STARTED|Overall Study||546
8544905|NCT01665144|9576550|FG000|Safety Set|Overall Study||1099
8544906|NCT01665144|9576551|FG001|Safety Set|Overall Study||546
8544907|NCT01665144|9576550|FG000|Full Analysis Set|Overall Study||1099
8544908|NCT01665144|9576551|FG001|Full Analysis Set|Overall Study||546
8544909|NCT01665144|9576550|FG000|COMPLETED|Overall Study||903
8544910|NCT01665144|9576551|FG001|COMPLETED|Overall Study||424
8544911|NCT01665144|9576550|FG000|NOT COMPLETED|Overall Study||202
8544912|NCT01665144|9576551|FG001|NOT COMPLETED|Overall Study||122
8544913|NCT01585103|9576557|FG000|STARTED|Overall Study||86
8544914|NCT01585103|9576557|FG000|COMPLETED|Overall Study||80
8544915|NCT01585103|9576557|FG000|NOT COMPLETED|Overall Study||6
8544916|NCT01551550|9576563|FG000|STARTED|Overall Study||41
8544917|NCT01551550|9576564|FG001|STARTED|Overall Study||41
8544918|NCT01551550|9576563|FG000|COMPLETED|Overall Study||41
8544919|NCT01551550|9576564|FG001|COMPLETED|Overall Study||40
8544920|NCT01551550|9576563|FG000|NOT COMPLETED|Overall Study||0
8544921|NCT01551550|9576564|FG001|NOT COMPLETED|Overall Study||1
8544922|NCT01372254|9576572|FG000|STARTED|Overall Study||47
8544923|NCT01372254|9576573|FG001|STARTED|Overall Study||49
8544924|NCT01372254|9576572|FG000|COMPLETED|Overall Study||43
8544925|NCT01372254|9576573|FG001|COMPLETED|Overall Study||46
8544926|NCT01372254|9576572|FG000|NOT COMPLETED|Overall Study||4
8544927|NCT01372254|9576573|FG001|NOT COMPLETED|Overall Study||3
8544928|NCT01351766|9576579|FG000|STARTED|Overall Study||39
8621422|NCT00479882|9660379|FG002|COMPLETED|Crossover: Period III (Weeks 13-20)||420
8629452|NCT00530335|9669198|FG000|STARTED|Overall Study||45
8544929|NCT01351766|9576579|FG000|COMPLETED|Overall Study||36
8544930|NCT01351766|9576579|FG000|NOT COMPLETED|Overall Study||3
8544931|NCT01199380|9576585|FG000|STARTED|Overall Study||88
8544932|NCT01199380|9576586|FG001|STARTED|Overall Study||96
8544933|NCT01199380|9576585|FG000|COMPLETED|Overall Study||78
8544934|NCT01199380|9576586|FG001|COMPLETED|Overall Study||81
8544935|NCT01199380|9576585|FG000|NOT COMPLETED|Overall Study||10
8544936|NCT01199380|9576586|FG001|NOT COMPLETED|Overall Study||15
8544937|NCT00810017|9576592|FG000|STARTED|Overall Study||2
8544938|NCT00810017|9576592|FG000|COMPLETED|Overall Study||0
8544939|NCT00810017|9576592|FG000|NOT COMPLETED|Overall Study||2
8544940|NCT00669669|9576596|FG000|STARTED|Overall Study||12
8544941|NCT00669669|9576596|FG000|COMPLETED|Overall Study||11
8544942|NCT00669669|9576596|FG000|NOT COMPLETED|Overall Study||1
8544943|NCT00601900|9576602|FG000|STARTED|Overall Study||195
8544944|NCT00601900|9576603|FG001|STARTED|Overall Study||199
8544945|NCT00601900|9576602|FG000|COMPLETED|Overall Study||195
8544946|NCT00601900|9576603|FG001|COMPLETED|Overall Study||196
8544947|NCT00601900|9576602|FG000|NOT COMPLETED|Overall Study||0
8544948|NCT00601900|9576603|FG001|NOT COMPLETED|Overall Study||3
8544949|NCT00549848|9576612|FG000|STARTED|Overall Study||206
8544950|NCT00549848|9576613|FG001|STARTED|Overall Study||208
8544951|NCT00549848|9576614|FG002|STARTED|Overall Study||184
8544952|NCT00549848|9576612|FG000|COMPLETED|Overall Study||194
8544953|NCT00549848|9576613|FG001|COMPLETED|Overall Study||188
8544954|NCT00549848|9576614|FG002|COMPLETED|Overall Study||133
8544955|NCT00549848|9576612|FG000|NOT COMPLETED|Overall Study||12
8544956|NCT00549848|9576613|FG001|NOT COMPLETED|Overall Study||20
8544957|NCT00549848|9576614|FG002|NOT COMPLETED|Overall Study||51
8544958|NCT00504712|9576632|FG000|STARTED|Overall Study||11
8544959|NCT00504712|9576633|FG001|STARTED|Overall Study||13
8544960|NCT00504712|9576632|FG000|COMPLETED|Overall Study||11
8544961|NCT00504712|9576633|FG001|COMPLETED|Overall Study||13
8544962|NCT00504712|9576632|FG000|NOT COMPLETED|Overall Study||0
8544963|NCT00504712|9576633|FG001|NOT COMPLETED|Overall Study||0
8544964|NCT00433511|9576642|FG000|STARTED|Step 1||1000
8544965|NCT00433511|9576643|FG001|STARTED|Step 1||1986
8544966|NCT00433511|9576644|FG002|STARTED|Step 1||2008
8544967|NCT00433511|9576642|FG000|Patients Who Received Treatment|Step 1||972
8544968|NCT00433511|9576643|FG001|Patients Who Received Treatment|Step 1||1922
8544969|NCT00433511|9576644|FG002|Patients Who Received Treatment|Step 1||1942
8544970|NCT00433511|9576642|FG000|Patients in Genetic Ancestry Analysis|Step 1||575
8544971|NCT00433511|9576643|FG001|Patients in Genetic Ancestry Analysis|Step 1||1126
8544972|NCT00433511|9576644|FG002|Patients in Genetic Ancestry Analysis|Step 1||1158
8544973|NCT00433511|9576642|FG000|COMPLETED|Step 1||864
8544974|NCT00433511|9576643|FG001|COMPLETED|Step 1||1601
8544975|NCT00433511|9576644|FG002|COMPLETED|Step 1||1618
8544976|NCT00433511|9576642|FG000|NOT COMPLETED|Step 1||136
8544977|NCT00433511|9576643|FG001|NOT COMPLETED|Step 1||385
8544978|NCT00433511|9576644|FG002|NOT COMPLETED|Step 1||390
8544979|NCT00433511|9576642|FG000|STARTED|Step 2 (Arm D)|Only Arm C patients at Step 1 who did not end protocol therapy early were eligible for Step 2, Arm D|0
8544980|NCT00433511|9576643|FG001|STARTED|Step 2 (Arm D)|Only Arm C patients at Step 1 who did not end protocol therapy early were eligible for Step 2, Arm D|0
8544981|NCT00433511|9576644|FG002|STARTED|Step 2 (Arm D)|Only Arm C patients at Step 1 who did not end protocol therapy early were eligible for Step 2, Arm D|1316
8544982|NCT00433511|9576642|FG000|Patients Who Received Treatment|Step 2 (Arm D)||0
8544983|NCT00433511|9576643|FG001|Patients Who Received Treatment|Step 2 (Arm D)||0
8544984|NCT00433511|9576644|FG002|Patients Who Received Treatment|Step 2 (Arm D)||1168
8544985|NCT00433511|9576642|FG000|COMPLETED|Step 2 (Arm D)||0
8544986|NCT00433511|9576643|FG001|COMPLETED|Step 2 (Arm D)||0
8544987|NCT00433511|9576644|FG002|COMPLETED|Step 2 (Arm D)||825
8544988|NCT00433511|9576642|FG000|NOT COMPLETED|Step 2 (Arm D)||0
8544989|NCT00433511|9576643|FG001|NOT COMPLETED|Step 2 (Arm D)||0
8544990|NCT00433511|9576644|FG002|NOT COMPLETED|Step 2 (Arm D)||491
8544991|NCT00390325|9576657|FG000|STARTED|Overall Study||5
8544992|NCT00390325|9576658|FG001|STARTED|Overall Study||16
8544993|NCT00390325|9576657|FG000|COMPLETED|Overall Study||5
8544994|NCT00390325|9576658|FG001|COMPLETED|Overall Study||16
8544995|NCT00390325|9576657|FG000|NOT COMPLETED|Overall Study||0
8544996|NCT00390325|9576658|FG001|NOT COMPLETED|Overall Study||0
8566831|NCT00079339|9599047|FG001|STARTED|Overall Study||40
8566832|NCT00079339|9599048|FG002|STARTED|Overall Study||6
8566833|NCT00079339|9599046|FG000|Enrolled in Phase I|Overall Study||5
8566834|NCT00079339|9599047|FG001|Enrolled in Phase I|Overall Study||6
8566835|NCT00079339|9599048|FG002|Enrolled in Phase I|Overall Study||6
8566836|NCT00079339|9599046|FG000|Maximum Tolerated Dose (MTD) Estimation|Overall Study|2 participants enrolled in the phase I part did not complete the 8 week MTD estimation period.|3
8566837|NCT00079339|9599047|FG001|Maximum Tolerated Dose (MTD) Estimation|Overall Study||6
8566838|NCT00079339|9599048|FG002|Maximum Tolerated Dose (MTD) Estimation|Overall Study|One participant enrolled in the phase I part did not complete the 8 week MTD estimation period.|5
8566839|NCT00079339|9599046|FG000|Enrolled in Phase II|Overall Study|Participants treated at the 100 mg/m2 dose level did not participate in the phase II part.|0
8566840|NCT00079339|9599047|FG001|Enrolled in Phase II|Overall Study|This number includes the 6 patients enrolled on the phase I part.|40
8566841|NCT00079339|9599048|FG002|Enrolled in Phase II|Overall Study|Participants treated at the 150 mg/m2 dose level did not participate in the phase II part.|0
8566842|NCT00079339|9599046|FG000|COMPLETED|Overall Study||0
8566843|NCT00079339|9599047|FG001|COMPLETED|Overall Study||1
8566844|NCT00079339|9599048|FG002|COMPLETED|Overall Study||0
8566845|NCT00079339|9599046|FG000|NOT COMPLETED|Overall Study||5
8566846|NCT00079339|9599047|FG001|NOT COMPLETED|Overall Study||39
8566847|NCT00079339|9599048|FG002|NOT COMPLETED|Overall Study||6
8566848|NCT00079391|9599061|FG000|STARTED|Overall Study|1 of these withdrew after consent.|50
8544997|NCT00314366|9576670|FG000|STARTED|Overall Study||11
8621423|NCT00479882|9660380|FG003|COMPLETED|Crossover: Period III (Weeks 13-20)||447
8621424|NCT00479882|9660377|FG000|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||25
8621425|NCT00479882|9660378|FG001|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||21
8621426|NCT00479882|9660379|FG002|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||20
8621427|NCT00479882|9660380|FG003|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||18
8621428|NCT00480025|9660408|FG000|STARTED|Overall Study||1515
8621429|NCT00480025|9660409|FG001|STARTED|Overall Study||757
8621430|NCT00480025|9660408|FG000|COMPLETED|Overall Study||763
8621431|NCT00480025|9660409|FG001|COMPLETED|Overall Study||388
8621432|NCT00480025|9660408|FG000|NOT COMPLETED|Overall Study||752
8544998|NCT00314366|9576671|FG001|STARTED|Overall Study||10
8544999|NCT00314366|9576670|FG000|COMPLETED|Overall Study||10
8545000|NCT00314366|9576671|FG001|COMPLETED|Overall Study||10
8545001|NCT00314366|9576670|FG000|NOT COMPLETED|Overall Study||1
8545002|NCT00314366|9576671|FG001|NOT COMPLETED|Overall Study||0
8545003|NCT00187226|9576686|FG000|STARTED|Overall Study||88
8545004|NCT00187226|9576687|FG001|STARTED|Overall Study||49
8545005|NCT00187226|9576688|FG002|STARTED|Overall Study||28
8545006|NCT00187226|9576689|FG003|STARTED|Overall Study||2
8545007|NCT00187226|9576690|FG004|STARTED|Overall Study||34
8545008|NCT00187226|9576691|FG005|STARTED|Overall Study||1
8545009|NCT00187226|9576686|FG000|COMPLETED|Overall Study||88
8545010|NCT00187226|9576687|FG001|COMPLETED|Overall Study||49
8545011|NCT00187226|9576688|FG002|COMPLETED|Overall Study||28
8545012|NCT00187226|9576689|FG003|COMPLETED|Overall Study||2
8545013|NCT00187226|9576690|FG004|COMPLETED|Overall Study||34
8545014|NCT00187226|9576691|FG005|COMPLETED|Overall Study||1
8545015|NCT00187226|9576686|FG000|NOT COMPLETED|Overall Study||0
8545016|NCT00187226|9576687|FG001|NOT COMPLETED|Overall Study||0
8545017|NCT00187226|9576688|FG002|NOT COMPLETED|Overall Study||0
8545018|NCT00187226|9576689|FG003|NOT COMPLETED|Overall Study||0
8545019|NCT00187226|9576690|FG004|NOT COMPLETED|Overall Study||0
8545020|NCT00187226|9576691|FG005|NOT COMPLETED|Overall Study||0
8545021|NCT00119847|9576707|FG000|STARTED|Overall Study||149
8545022|NCT00119847|9576708|FG001|STARTED|Overall Study||151
8545023|NCT00119847|9576707|FG000|COMPLETED|Overall Study||118
8545024|NCT00119847|9576708|FG001|COMPLETED|Overall Study||119
8545025|NCT00119847|9576707|FG000|NOT COMPLETED|Overall Study||31
8545026|NCT00119847|9576708|FG001|NOT COMPLETED|Overall Study||32
8545027|NCT04748783|9576719|FG000|STARTED|Overall Study||0
8545028|NCT04748783|9576720|FG001|STARTED|Overall Study||1
8545029|NCT04748783|9576721|FG002|STARTED|Overall Study||0
8545030|NCT04748783|9576722|FG003|STARTED|Overall Study||0
8545031|NCT04748783|9576723|FG004|STARTED|Overall Study||1
8545032|NCT04748783|9576719|FG000|COMPLETED|Overall Study||0
8545033|NCT04748783|9576720|FG001|COMPLETED|Overall Study||1
8545034|NCT04748783|9576721|FG002|COMPLETED|Overall Study||0
8545035|NCT04748783|9576722|FG003|COMPLETED|Overall Study||0
8545036|NCT04748783|9576723|FG004|COMPLETED|Overall Study||1
8545037|NCT04748783|9576719|FG000|NOT COMPLETED|Overall Study||0
8545038|NCT04748783|9576720|FG001|NOT COMPLETED|Overall Study||0
8545039|NCT04748783|9576721|FG002|NOT COMPLETED|Overall Study||0
8545040|NCT04748783|9576722|FG003|NOT COMPLETED|Overall Study||0
8545041|NCT04748783|9576723|FG004|NOT COMPLETED|Overall Study||0
8545069|NCT04135937|9576760|FG000|STARTED|Overall Study||12
8545070|NCT04135937|9576760|FG000|COMPLETED|Overall Study||9
8545071|NCT04135937|9576760|FG000|NOT COMPLETED|Overall Study||3
8545072|NCT03989232|9576766|FG000|STARTED|Overall Study||481
8545073|NCT03989232|9576767|FG001|STARTED|Overall Study||480
8545074|NCT03989232|9576766|FG000|Exposed|Overall Study||480
8545075|NCT03989232|9576767|FG001|Exposed|Overall Study||479
8545076|NCT03989232|9576766|FG000|Safety Analysis Set (SAS)|Overall Study||480
8545077|NCT03989232|9576767|FG001|Safety Analysis Set (SAS)|Overall Study||479
8545078|NCT03989232|9576766|FG000|Full Analysis Set (FAS)|Overall Study||481
8545079|NCT03989232|9576767|FG001|Full Analysis Set (FAS)|Overall Study||480
8545080|NCT03989232|9576766|FG000|COMPLETED|Overall Study||471
8545081|NCT03989232|9576767|FG001|COMPLETED|Overall Study||462
8545082|NCT03989232|9576766|FG000|NOT COMPLETED|Overall Study||10
8545083|NCT03989232|9576767|FG001|NOT COMPLETED|Overall Study||18
8545084|NCT03896295|9576775|FG000|STARTED|Overall Study||7
8545085|NCT03896295|9576776|FG001|STARTED|Overall Study||30
8545086|NCT03896295|9576775|FG000|COMPLETED|Overall Study||0
8545087|NCT03896295|9576776|FG001|COMPLETED|Overall Study||0
8545088|NCT03896295|9576775|FG000|NOT COMPLETED|Overall Study||7
8545089|NCT03896295|9576776|FG001|NOT COMPLETED|Overall Study||30
8545090|NCT03213457|9576790|FG000|STARTED|Overall Study||194
8545091|NCT03213457|9576791|FG001|STARTED|Overall Study||98
8545092|NCT03213457|9576792|FG002|STARTED|Overall Study||389
8545093|NCT03213457|9576790|FG000|Randomized and Treated|Overall Study||193
8545094|NCT03213457|9576791|FG001|Randomized and Treated|Overall Study||97
8545095|NCT03213457|9576792|FG002|Randomized and Treated|Overall Study||389
8621433|NCT00480025|9660409|FG001|NOT COMPLETED|Overall Study||369
8545096|NCT03213457|9576790|FG000|COMPLETED|Overall Study||106
8545097|NCT03213457|9576791|FG001|COMPLETED|Overall Study||59
8545098|NCT03213457|9576792|FG002|COMPLETED|Overall Study||215
8545099|NCT03213457|9576790|FG000|NOT COMPLETED|Overall Study||88
8545100|NCT03213457|9576791|FG001|NOT COMPLETED|Overall Study||39
8545101|NCT03213457|9576792|FG002|NOT COMPLETED|Overall Study||174
8545102|NCT02982720|9576800|FG000|STARTED|Overall Study||4
8545103|NCT02982720|9576800|FG000|COMPLETED|Overall Study||0
8545042|NCT04482647|9576736|FG000|STARTED|Overall Study||100
8545043|NCT04482647|9576736|FG000|COMPLETED|Overall Study||88
8545044|NCT04482647|9576736|FG000|NOT COMPLETED|Overall Study||12
8818293|NCT01556932|9871967|FG000|NOT COMPLETED|Time Point 60 Minutes||1
8818294|NCT01556932|9871968|FG001|NOT COMPLETED|Time Point 60 Minutes||1
8818295|NCT01556932|9871967|FG000|STARTED|Second Treament||12
8818296|NCT01556932|9871968|FG001|STARTED|Second Treament||8
8818297|NCT01556932|9871967|FG000|Recieved|Second Treament||12
8818298|NCT01556932|9871968|FG001|Recieved|Second Treament||8
8818299|NCT01556932|9871967|FG000|COMPLETED|Second Treament||12
8818300|NCT01556932|9871968|FG001|COMPLETED|Second Treament||8
8818301|NCT01556932|9871967|FG000|NOT COMPLETED|Second Treament||0
8818302|NCT01556932|9871968|FG001|NOT COMPLETED|Second Treament||0
8818303|NCT01556997|9871976|FG000|STARTED|Overall Study||279
8818304|NCT01556997|9871977|FG001|STARTED|Overall Study||280
8818305|NCT01556997|9871978|FG002|STARTED|Overall Study||278
8818306|NCT01556997|9871976|FG000|COMPLETED|Overall Study||253
8818307|NCT01556997|9871977|FG001|COMPLETED|Overall Study||252
8818308|NCT01556997|9871978|FG002|COMPLETED|Overall Study||246
8818309|NCT01556997|9871976|FG000|NOT COMPLETED|Overall Study||26
8818310|NCT01556997|9871977|FG001|NOT COMPLETED|Overall Study||28
8818311|NCT01556997|9871978|FG002|NOT COMPLETED|Overall Study||32
8818312|NCT01557166|9871988|FG000|STARTED|Overall Study||180
8818313|NCT01557166|9871989|FG001|STARTED|Overall Study||179
8818314|NCT01557166|9871988|FG000|Exposed|Overall Study||176
8818315|NCT01557166|9871989|FG001|Exposed|Overall Study||179
8818316|NCT01557166|9871988|FG000|COMPLETED|Overall Study||134
8818317|NCT01557166|9871989|FG001|COMPLETED|Overall Study||142
8818318|NCT01557166|9871988|FG000|NOT COMPLETED|Overall Study||46
8818319|NCT01557166|9871989|FG001|NOT COMPLETED|Overall Study||37
8818320|NCT01557244|9872000|FG000|STARTED|Active Comparator/Efficacy Phase:12Weeks||42
8818321|NCT01557244|9872001|FG001|STARTED|Active Comparator/Efficacy Phase:12Weeks||42
8545045|NCT04405570|9576744|FG000|STARTED|Overall Study||23
8545046|NCT04405570|9576745|FG001|STARTED|Overall Study||64
8545047|NCT04405570|9576746|FG002|STARTED|Overall Study||55
8545048|NCT04405570|9576747|FG003|STARTED|Overall Study||62
8545049|NCT04405570|9576744|FG000|Number of Subjects Randomized Not Dosed|Overall Study||0
8545050|NCT04405570|9576745|FG001|Number of Subjects Randomized Not Dosed|Overall Study||2
8545051|NCT04405570|9576746|FG002|Number of Subjects Randomized Not Dosed|Overall Study||0
8545052|NCT04405570|9576747|FG003|Number of Subjects Randomized Not Dosed|Overall Study||0
8545053|NCT04405570|9576744|FG000|Number of Subjects in the Safety Population|Overall Study||23
8545054|NCT04405570|9576745|FG001|Number of Subjects in the Safety Population|Overall Study||62
8545055|NCT04405570|9576746|FG002|Number of Subjects in the Safety Population|Overall Study||55
8545056|NCT04405570|9576747|FG003|Number of Subjects in the Safety Population|Overall Study||62
8545057|NCT04405570|9576744|FG000|Number of Subjects in the mITT Population|Overall Study||23
8545058|NCT04405570|9576745|FG001|Number of Subjects in the mITT Population|Overall Study||61
8545059|NCT04405570|9576746|FG002|Number of Subjects in the mITT Population|Overall Study||53
8545060|NCT04405570|9576747|FG003|Number of Subjects in the mITT Population|Overall Study||61
8545061|NCT04405570|9576744|FG000|COMPLETED|Overall Study||23
8545062|NCT04405570|9576745|FG001|COMPLETED|Overall Study||59
8545063|NCT04405570|9576746|FG002|COMPLETED|Overall Study||52
8545064|NCT04405570|9576747|FG003|COMPLETED|Overall Study||61
8545065|NCT04405570|9576744|FG000|NOT COMPLETED|Overall Study||0
8545066|NCT04405570|9576745|FG001|NOT COMPLETED|Overall Study||5
8545067|NCT04405570|9576746|FG002|NOT COMPLETED|Overall Study||3
8545068|NCT04405570|9576747|FG003|NOT COMPLETED|Overall Study||1
8545104|NCT02982720|9576800|FG000|NOT COMPLETED|Overall Study||4
8566849|NCT00079391|9599061|FG000|COMPLETED|Overall Study||49
8566850|NCT00079391|9599061|FG000|NOT COMPLETED|Overall Study||1
8566851|NCT00079417|9599067|FG000|STARTED|Overall Study||28
8566852|NCT00079417|9599067|FG000|COMPLETED|Overall Study||19
8566853|NCT00079417|9599067|FG000|NOT COMPLETED|Overall Study||9
8566854|NCT00079677|9599073|FG000|STARTED|Overall Study||131
8566855|NCT00079677|9599074|FG001|STARTED|Overall Study||132
8566856|NCT00079677|9599073|FG000|COMPLETED|Overall Study||111
8566857|NCT00079677|9599074|FG001|COMPLETED|Overall Study||118
8566858|NCT00079677|9599073|FG000|NOT COMPLETED|Overall Study||20
8566859|NCT00079677|9599074|FG001|NOT COMPLETED|Overall Study||14
8566860|NCT00079781|9599083|FG000|STARTED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|45
8566861|NCT00079781|9599084|FG001|STARTED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|10
8566862|NCT00079781|9599085|FG002|STARTED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|15
8566863|NCT00079781|9599083|FG000|COMPLETED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|42
8566864|NCT00079781|9599084|FG001|COMPLETED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|9
8566865|NCT00079781|9599085|FG002|COMPLETED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|14
8566866|NCT00079781|9599083|FG000|NOT COMPLETED|Pre-implant Period||3
8566867|NCT00079781|9599084|FG001|NOT COMPLETED|Pre-implant Period||1
8818322|NCT01557244|9872002|FG002|STARTED|Active Comparator/Efficacy Phase:12Weeks||40
8818323|NCT01557244|9872003|FG003|STARTED|Active Comparator/Efficacy Phase:12Weeks||0
8818324|NCT01557244|9872004|FG004|STARTED|Active Comparator/Efficacy Phase:12Weeks||0
8818325|NCT01557244|9872005|FG005|STARTED|Active Comparator/Efficacy Phase:12Weeks||28
8818326|NCT01557244|9872006|FG006|STARTED|Active Comparator/Efficacy Phase:12Weeks||29
8818327|NCT01557244|9872000|FG000|Treated|Active Comparator/Efficacy Phase:12Weeks||42
8545105|NCT02548754|9576806|FG000|STARTED|Overall Study||26
8545106|NCT02548754|9576807|FG001|STARTED|Overall Study||27
8545107|NCT02548754|9576806|FG000|COMPLETED|Overall Study||24
8545108|NCT02548754|9576807|FG001|COMPLETED|Overall Study||23
8545109|NCT02548754|9576806|FG000|NOT COMPLETED|Overall Study||2
8545110|NCT02548754|9576807|FG001|NOT COMPLETED|Overall Study||4
8545111|NCT02375672|9576813|FG000|STARTED|Overall Study||30
8545112|NCT02375672|9576813|FG000|COMPLETED|Overall Study||10
8545113|NCT02375672|9576813|FG000|NOT COMPLETED|Overall Study||20
8545114|NCT02329327|9576819|FG000|STARTED|Overall Study||477
8545115|NCT02329327|9576820|FG001|STARTED|Overall Study||2
8545116|NCT02329327|9576819|FG000|Received At Least 1 Dose of Study Drug|Overall Study||477
8545117|NCT02329327|9576820|FG001|Received At Least 1 Dose of Study Drug|Overall Study||2
8545118|NCT02329327|9576819|FG000|Efficacy Population|Overall Study||347
8545119|NCT02329327|9576820|FG001|Efficacy Population|Overall Study||2
8545120|NCT02329327|9576819|FG000|Death|Overall Study||3
8545121|NCT02329327|9576820|FG001|Death|Overall Study||0
8545122|NCT02329327|9576819|FG000|COMPLETED|Overall Study||392
8545123|NCT02329327|9576820|FG001|COMPLETED|Overall Study||2
8545124|NCT02329327|9576819|FG000|NOT COMPLETED|Overall Study||85
8545125|NCT02329327|9576820|FG001|NOT COMPLETED|Overall Study||0
8545126|NCT02153645|9576842|FG000|STARTED|Overall Study||30
8545127|NCT02153645|9576843|FG001|STARTED|Overall Study||29
8621434|NCT00480077|9660423|FG000|STARTED|Overall Study||168
8621435|NCT00480077|9660424|FG001|STARTED|Overall Study||167
8545128|NCT02153645|9576844|FG002|STARTED|Overall Study||28
8545129|NCT02153645|9576842|FG000|COMPLETED|Overall Study||17
8545130|NCT02153645|9576843|FG001|COMPLETED|Overall Study||19
8545131|NCT02153645|9576844|FG002|COMPLETED|Overall Study||18
8545132|NCT02153645|9576842|FG000|NOT COMPLETED|Overall Study||13
8545133|NCT02153645|9576843|FG001|NOT COMPLETED|Overall Study||10
8545134|NCT02153645|9576844|FG002|NOT COMPLETED|Overall Study||10
8545135|NCT02153632|9576855|FG000|STARTED|Overall Study||45
8545136|NCT02153632|9576856|FG001|STARTED|Overall Study||46
8545137|NCT02153632|9576857|FG002|STARTED|Overall Study||44
8545138|NCT02153632|9576855|FG000|COMPLETED|Overall Study||27
8545139|NCT02153632|9576856|FG001|COMPLETED|Overall Study||27
8545140|NCT02153632|9576857|FG002|COMPLETED|Overall Study||25
8545141|NCT02153632|9576855|FG000|NOT COMPLETED|Overall Study||18
8545142|NCT02153632|9576856|FG001|NOT COMPLETED|Overall Study||19
8545143|NCT02153632|9576857|FG002|NOT COMPLETED|Overall Study||19
8545144|NCT02063724|9576865|FG000|STARTED|Overall Study||15
8545145|NCT02063724|9576865|FG000|COMPLETED|Overall Study||14
8545146|NCT02063724|9576865|FG000|NOT COMPLETED|Overall Study||1
8545147|NCT01942135|9576871|FG000|STARTED|Overall Study||347
8545148|NCT01942135|9576872|FG001|STARTED|Overall Study||174
8545149|NCT01942135|9576871|FG000|COMPLETED|Overall Study||0
8545150|NCT01942135|9576872|FG001|COMPLETED|Overall Study||0
8545151|NCT01942135|9576871|FG000|NOT COMPLETED|Overall Study||347
8545152|NCT01942135|9576872|FG001|NOT COMPLETED|Overall Study||174
8545153|NCT01689909|9576880|FG000|STARTED|Overall Study||51
8545154|NCT01689909|9576881|FG001|STARTED|Overall Study||52
8545155|NCT01689909|9576880|FG000|COMPLETED|Overall Study||51
8545156|NCT01689909|9576881|FG001|COMPLETED|Overall Study||52
8545157|NCT01689909|9576880|FG000|NOT COMPLETED|Overall Study||0
8545158|NCT01689909|9576881|FG001|NOT COMPLETED|Overall Study||0
8545159|NCT01566149|9576891|FG000|STARTED|Overall Study||24
8545160|NCT01566149|9576892|FG001|STARTED|Overall Study||25
8545161|NCT01566149|9576891|FG000|COMPLETED|Overall Study||21
8545162|NCT01566149|9576892|FG001|COMPLETED|Overall Study||23
8545163|NCT01566149|9576891|FG000|NOT COMPLETED|Overall Study||3
8545164|NCT01566149|9576892|FG001|NOT COMPLETED|Overall Study||2
8545165|NCT01481935|9576900|FG000|STARTED|Overall Study||97
8545166|NCT01481935|9576901|FG001|STARTED|Overall Study||93
8545167|NCT01481935|9576900|FG000|COMPLETED|Overall Study||97
8545168|NCT01481935|9576901|FG001|COMPLETED|Overall Study||93
8545169|NCT01481935|9576900|FG000|NOT COMPLETED|Overall Study||0
8545170|NCT01481935|9576901|FG001|NOT COMPLETED|Overall Study||0
8545171|NCT01386125|9576909|FG000|STARTED|Overall Study||375
8545172|NCT01386125|9576910|FG001|STARTED|Overall Study||373
8545173|NCT01386125|9576909|FG000|COMPLETED|Overall Study||350
8545174|NCT01386125|9576910|FG001|COMPLETED|Overall Study||336
8545175|NCT01386125|9576909|FG000|NOT COMPLETED|Overall Study||25
8545176|NCT01386125|9576910|FG001|NOT COMPLETED|Overall Study||37
8545177|NCT01257568|9576916|FG000|STARTED|Overall Study||40
8545178|NCT01257568|9576916|FG000|COMPLETED|Overall Study||7
8545179|NCT01257568|9576916|FG000|NOT COMPLETED|Overall Study||33
8545180|NCT01165424|9576922|FG000|STARTED|Overall Study||80
8545181|NCT01165424|9576922|FG000|COMPLETED|Overall Study||76
8545182|NCT01165424|9576922|FG000|NOT COMPLETED|Overall Study||4
8545183|NCT01135134|9576928|FG000|STARTED|Overall Study||220
8545184|NCT01135134|9576929|FG001|STARTED|Overall Study||113
8545185|NCT01135134|9576928|FG000|COMPLETED|Overall Study||218
8545186|NCT01135134|9576929|FG001|COMPLETED|Overall Study||112
8545187|NCT01135134|9576928|FG000|NOT COMPLETED|Overall Study||2
8545188|NCT01135134|9576929|FG001|NOT COMPLETED|Overall Study||1
8545189|NCT00867165|9576937|FG000|STARTED|Overall Study||93
8545190|NCT00867165|9576938|FG001|STARTED|Overall Study||45
8545191|NCT00867165|9576937|FG000|COMPLETED|Overall Study||89
8545192|NCT00867165|9576938|FG001|COMPLETED|Overall Study||45
8545193|NCT00867165|9576937|FG000|NOT COMPLETED|Overall Study||4
8545194|NCT00867165|9576938|FG001|NOT COMPLETED|Overall Study||0
8545195|NCT00733005|9576946|FG000|STARTED|Overall Study||162
8818328|NCT01557244|9872001|FG001|Treated|Active Comparator/Efficacy Phase:12Weeks||42
8818329|NCT01557244|9872002|FG002|Treated|Active Comparator/Efficacy Phase:12Weeks||40
8818330|NCT01557244|9872003|FG003|Treated|Active Comparator/Efficacy Phase:12Weeks||0
8818331|NCT01557244|9872004|FG004|Treated|Active Comparator/Efficacy Phase:12Weeks||0
8818332|NCT01557244|9872005|FG005|Treated|Active Comparator/Efficacy Phase:12Weeks||28
8818333|NCT01557244|9872006|FG006|Treated|Active Comparator/Efficacy Phase:12Weeks||29
8818334|NCT01557244|9872000|FG000|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||33
8818335|NCT01557244|9872001|FG001|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||40
8818336|NCT01557244|9872002|FG002|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||36
8818337|NCT01557244|9872003|FG003|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||0
8818338|NCT01557244|9872004|FG004|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||0
8818339|NCT01557244|9872005|FG005|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||21
8818340|NCT01557244|9872006|FG006|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||28
8545196|NCT00733005|9576947|FG001|STARTED|Overall Study||162
8545197|NCT00733005|9576946|FG000|COMPLETED|Overall Study||160
8545198|NCT00733005|9576947|FG001|COMPLETED|Overall Study||159
8545199|NCT00733005|9576946|FG000|NOT COMPLETED|Overall Study||2
8545200|NCT00733005|9576947|FG001|NOT COMPLETED|Overall Study||3
8545201|NCT00732381|9576955|FG000|STARTED|Overall Study||176
8545202|NCT00732381|9576956|FG001|STARTED|Overall Study||175
8545203|NCT00732381|9576955|FG000|COMPLETED|Overall Study||174
8545204|NCT00732381|9576956|FG001|COMPLETED|Overall Study||174
8545205|NCT00732381|9576955|FG000|NOT COMPLETED|Overall Study||2
8545206|NCT00732381|9576956|FG001|NOT COMPLETED|Overall Study||1
8545207|NCT00654095|9576962|FG000|STARTED|Overall Study||146
8545208|NCT00654095|9576962|FG000|COMPLETED|Overall Study||114
8545209|NCT00654095|9576962|FG000|NOT COMPLETED|Overall Study||32
8545210|NCT00653523|9576966|FG000|STARTED|Overall Study||151
8545211|NCT00653523|9576966|FG000|COMPLETED|Overall Study||132
8545212|NCT00653523|9576966|FG000|NOT COMPLETED|Overall Study||19
8545213|NCT00599027|9576972|FG000|STARTED|Overall Study||26
8545214|NCT00599027|9576973|FG001|STARTED|Overall Study||25
8545215|NCT00599027|9576972|FG000|COMPLETED|Overall Study||25
8545216|NCT00599027|9576973|FG001|COMPLETED|Overall Study||22
8545217|NCT00599027|9576972|FG000|NOT COMPLETED|Overall Study||1
8545218|NCT00599027|9576973|FG001|NOT COMPLETED|Overall Study||3
8545219|NCT00552032|9576981|FG000|STARTED|Overall Study||66
8545220|NCT00552032|9576982|FG001|STARTED|Overall Study||66
8545221|NCT00552032|9576981|FG000|COMPLETED|Overall Study||49
8545222|NCT00552032|9576982|FG001|COMPLETED|Overall Study||47
8545223|NCT00552032|9576981|FG000|NOT COMPLETED|Overall Study||17
8545224|NCT00552032|9576982|FG001|NOT COMPLETED|Overall Study||19
8545225|NCT00546052|9576988|FG000|STARTED|Overall Study||1738
8545226|NCT00546052|9576988|FG000|Week 4|Overall Study||1714
8545227|NCT00546052|9576988|FG000|Week 8|Overall Study||1680
8545228|NCT00546052|9576988|FG000|Week 12|Overall Study||1650
8545229|NCT00546052|9576988|FG000|Week 32|Overall Study||1583
8545230|NCT00546052|9576988|FG000|Week 52|Overall Study||1511
8545231|NCT00546052|9576988|FG000|COMPLETED|Overall Study||1511
8545232|NCT00546052|9576988|FG000|NOT COMPLETED|Overall Study||227
8545233|NCT00442117|9576997|FG000|STARTED|Overall Study||85
8545234|NCT00442117|9576998|FG001|STARTED|Overall Study||87
8545235|NCT00442117|9576997|FG000|COMPLETED|Overall Study||47
8545236|NCT00442117|9576998|FG001|COMPLETED|Overall Study||49
8545237|NCT00442117|9576997|FG000|NOT COMPLETED|Overall Study||38
8545238|NCT00442117|9576998|FG001|NOT COMPLETED|Overall Study||38
8545239|NCT00424008|9577006|FG000|STARTED|Overall Study||371
8545240|NCT00424008|9577007|FG001|STARTED|Overall Study||351
8545241|NCT00424008|9577006|FG000|COMPLETED|Overall Study||22
8545242|NCT00424008|9577007|FG001|COMPLETED|Overall Study||16
8545243|NCT00424008|9577006|FG000|NOT COMPLETED|Overall Study||349
8545244|NCT00424008|9577007|FG001|NOT COMPLETED|Overall Study||335
8545245|NCT00423176|9577016|FG000|STARTED|Overall Study||114
8545246|NCT00423176|9577017|FG001|STARTED|Overall Study||123
8545247|NCT00423176|9577016|FG000|COMPLETED|Overall Study||98
8545248|NCT00423176|9577017|FG001|COMPLETED|Overall Study||94
8545249|NCT00423176|9577016|FG000|NOT COMPLETED|Overall Study||16
8545250|NCT00423176|9577017|FG001|NOT COMPLETED|Overall Study||29
8545251|NCT00383240|9577027|FG000|STARTED|Overall Study||191
8545252|NCT00383240|9577028|FG001|STARTED|Overall Study||192
8545253|NCT00383240|9577029|FG002|STARTED|Overall Study||202
8545254|NCT00383240|9577030|FG003|STARTED|Overall Study||196
8545255|NCT00383240|9577027|FG000|COMPLETED|Overall Study||156
8545256|NCT00383240|9577028|FG001|COMPLETED|Overall Study||159
8545257|NCT00383240|9577029|FG002|COMPLETED|Overall Study||117
8545258|NCT00383240|9577030|FG003|COMPLETED|Overall Study||119
8545259|NCT00383240|9577027|FG000|NOT COMPLETED|Overall Study||35
8545260|NCT00383240|9577028|FG001|NOT COMPLETED|Overall Study||33
8545261|NCT00383240|9577029|FG002|NOT COMPLETED|Overall Study||85
8545262|NCT00383240|9577030|FG003|NOT COMPLETED|Overall Study||77
8566868|NCT00079781|9599085|FG002|NOT COMPLETED|Pre-implant Period||1
8566869|NCT00079781|9599083|FG000|STARTED|Evaluation Period||42
8566870|NCT00079781|9599084|FG001|STARTED|Evaluation Period||9
8566871|NCT00079781|9599085|FG002|STARTED|Evaluation Period||14
8566872|NCT00079781|9599083|FG000|COMPLETED|Evaluation Period||42
8566873|NCT00079781|9599084|FG001|COMPLETED|Evaluation Period||9
8566874|NCT00079781|9599085|FG002|COMPLETED|Evaluation Period||14
8566875|NCT00079781|9599083|FG000|NOT COMPLETED|Evaluation Period||0
8566876|NCT00079781|9599084|FG001|NOT COMPLETED|Evaluation Period||0
8545263|NCT02797067|9577043|FG000|STARTED|Overall Study||685
8545264|NCT02797067|9577044|FG001|STARTED|Overall Study||685
8545265|NCT02797067|9577043|FG000|COMPLETED|Overall Study||685
8545266|NCT02797067|9577044|FG001|COMPLETED|Overall Study||685
8545267|NCT02797067|9577043|FG000|NOT COMPLETED|Overall Study||0
8545268|NCT02797067|9577044|FG001|NOT COMPLETED|Overall Study||0
8545269|NCT02787499|9577052|FG000|STARTED|Overall Study||423
8545270|NCT02787499|9577053|FG001|STARTED|Overall Study||417
8545271|NCT02787499|9577052|FG000|COMPLETED|Overall Study||423
8545272|NCT02787499|9577053|FG001|COMPLETED|Overall Study||417
8545273|NCT02787499|9577052|FG000|NOT COMPLETED|Overall Study||0
8545274|NCT02787499|9577053|FG001|NOT COMPLETED|Overall Study||0
8545275|NCT02765399|9577061|FG000|STARTED|Overall Study||16
8545276|NCT02765399|9577062|FG001|STARTED|Overall Study||7
8545277|NCT02765399|9577061|FG000|COMPLETED|Overall Study||15
8545278|NCT02765399|9577062|FG001|COMPLETED|Overall Study||7
8545279|NCT02765399|9577061|FG000|NOT COMPLETED|Overall Study||1
8545280|NCT02765399|9577062|FG001|NOT COMPLETED|Overall Study||0
8545281|NCT04539262|9577076|FG000|STARTED|Overall Study||12
8545282|NCT04539262|9577077|FG001|STARTED|Overall Study||13
8545283|NCT04539262|9577078|FG002|STARTED|Overall Study||12
8545284|NCT04539262|9577079|FG003|STARTED|Overall Study||12
8545285|NCT04539262|9577080|FG004|STARTED|Overall Study||12
8545286|NCT04539262|9577081|FG005|STARTED|Overall Study||13
8545287|NCT04539262|9577082|FG006|STARTED|Overall Study||62
8545288|NCT04539262|9577083|FG007|STARTED|Overall Study||20
8545289|NCT04539262|9577076|FG000|COMPLETED|Overall Study||12
8545290|NCT04539262|9577077|FG001|COMPLETED|Overall Study||12
8545291|NCT04539262|9577078|FG002|COMPLETED|Overall Study||11
8545292|NCT04539262|9577079|FG003|COMPLETED|Overall Study||11
8545293|NCT04539262|9577080|FG004|COMPLETED|Overall Study||12
8545294|NCT04539262|9577081|FG005|COMPLETED|Overall Study||13
8545295|NCT04539262|9577082|FG006|COMPLETED|Overall Study||61
8545296|NCT04539262|9577083|FG007|COMPLETED|Overall Study||20
8545297|NCT04539262|9577076|FG000|NOT COMPLETED|Overall Study||0
8545298|NCT04539262|9577077|FG001|NOT COMPLETED|Overall Study||1
8545299|NCT04539262|9577078|FG002|NOT COMPLETED|Overall Study||1
8545300|NCT04539262|9577079|FG003|NOT COMPLETED|Overall Study||1
8545301|NCT04539262|9577080|FG004|NOT COMPLETED|Overall Study||0
8545302|NCT04539262|9577081|FG005|NOT COMPLETED|Overall Study||0
8545303|NCT04539262|9577082|FG006|NOT COMPLETED|Overall Study||1
8545304|NCT04539262|9577083|FG007|NOT COMPLETED|Overall Study||0
8545305|NCT04482439|9577104|FG000|STARTED|Overall Study||35
8545306|NCT04482439|9577104|FG000|COMPLETED|Overall Study||33
8545307|NCT04482439|9577104|FG000|NOT COMPLETED|Overall Study||2
8545308|NCT04465162|9577109|FG000|STARTED|Overall Study||73
8545309|NCT04465162|9577109|FG000|COMPLETED|Overall Study||73
8545310|NCT04465162|9577109|FG000|NOT COMPLETED|Overall Study||0
8545350|NCT04079881|9577153|FG000|STARTED|Overall Study||1
8545351|NCT04079881|9577154|FG001|STARTED|Overall Study||0
8545352|NCT04079881|9577153|FG000|COMPLETED|Overall Study||1
8545353|NCT04079881|9577154|FG001|COMPLETED|Overall Study||0
8545354|NCT04079881|9577153|FG000|NOT COMPLETED|Overall Study||0
8545355|NCT04079881|9577154|FG001|NOT COMPLETED|Overall Study||0
8545356|NCT03950674|9577163|FG000|STARTED|Overall Study||25
8545357|NCT03950674|9577164|FG001|STARTED|Overall Study||15
8545358|NCT03950674|9577163|FG000|Treated|Overall Study||25
8545359|NCT03950674|9577164|FG001|Treated|Overall Study||15
8545360|NCT03950674|9577163|FG000|Switched to Pembrolizumab|Overall Study||0
8545361|NCT03950674|9577164|FG001|Switched to Pembrolizumab|Overall Study||4
8545362|NCT03950674|9577163|FG000|COMPLETED|Overall Study||0
8545363|NCT03950674|9577164|FG001|COMPLETED|Overall Study||0
8545364|NCT03950674|9577163|FG000|NOT COMPLETED|Overall Study||25
8545365|NCT03950674|9577164|FG001|NOT COMPLETED|Overall Study||15
8545366|NCT03868839|9577171|FG000|STARTED|Overall Study||6
8545367|NCT03868839|9577171|FG000|COMPLETED|Overall Study||5
8545368|NCT03868839|9577171|FG000|NOT COMPLETED|Overall Study||1
8545369|NCT03847974|9577175|FG000|STARTED|Overall Study||32
8545370|NCT03847974|9577175|FG000|COMPLETED|Overall Study||26
8545371|NCT03847974|9577175|FG000|NOT COMPLETED|Overall Study||6
8545372|NCT03846427|9577179|FG000|STARTED|Overall Study||68
8545373|NCT03846427|9577179|FG000|COMPLETED|Overall Study||0
8545374|NCT03846427|9577179|FG000|NOT COMPLETED|Overall Study||68
8545375|NCT03787095|9577185|FG000|STARTED|Overall Study||4
8545376|NCT03787095|9577186|FG001|STARTED|Overall Study||1
8545377|NCT03787095|9577185|FG000|COMPLETED|Overall Study||4
8545378|NCT03787095|9577186|FG001|COMPLETED|Overall Study|Participant had final visit at study week 7 in accordance with decision from team after the study was closed.|1
8545379|NCT03787095|9577185|FG000|NOT COMPLETED|Overall Study||0
8545380|NCT03787095|9577186|FG001|NOT COMPLETED|Overall Study||0
8545381|NCT03746951|9577195|FG000|STARTED|Overall Study||8
8545382|NCT03746951|9577196|FG001|STARTED|Overall Study||7
8545383|NCT03746951|9577195|FG000|COMPLETED|Overall Study||8
8545384|NCT03746951|9577196|FG001|COMPLETED|Overall Study||7
8545385|NCT03746951|9577195|FG000|NOT COMPLETED|Overall Study||0
8545386|NCT03746951|9577196|FG001|NOT COMPLETED|Overall Study||0
8545387|NCT03685747|9577202|FG000|STARTED|Overall Study||4
8545388|NCT03685747|9577202|FG000|COMPLETED|Overall Study||4
8545389|NCT03685747|9577202|FG000|NOT COMPLETED|Overall Study||0
8545390|NCT03671148|9577208|FG000|STARTED|Overall Study||220
8545391|NCT03671148|9577209|FG001|STARTED|Overall Study||224
8545392|NCT03671148|9577208|FG000|Received Study Drug|Overall Study||219
8545393|NCT03671148|9577209|FG001|Received Study Drug|Overall Study||224
8545311|NCT04404725|9577113|FG000|STARTED|First Intervention||32
8545312|NCT04404725|9577114|FG001|STARTED|First Intervention||31
8545313|NCT04404725|9577113|FG000|COMPLETED|First Intervention||32
8545314|NCT04404725|9577114|FG001|COMPLETED|First Intervention||29
8545315|NCT04404725|9577113|FG000|NOT COMPLETED|First Intervention||0
8545316|NCT04404725|9577114|FG001|NOT COMPLETED|First Intervention||2
8545317|NCT04404725|9577113|FG000|STARTED|Second Intervention||32
8545318|NCT04404725|9577114|FG001|STARTED|Second Intervention||29
8545319|NCT04404725|9577113|FG000|COMPLETED|Second Intervention||31
8545320|NCT04404725|9577114|FG001|COMPLETED|Second Intervention||27
8545321|NCT04404725|9577113|FG000|NOT COMPLETED|Second Intervention||1
8545322|NCT04404725|9577114|FG001|NOT COMPLETED|Second Intervention||2
8545323|NCT04382586|9577122|FG000|STARTED|Overall Study||30
8545324|NCT04382586|9577123|FG001|STARTED|Overall Study||33
8545325|NCT04382586|9577122|FG000|COMPLETED|Overall Study||13
8545326|NCT04382586|9577123|FG001|COMPLETED|Overall Study||17
8545327|NCT04382586|9577122|FG000|NOT COMPLETED|Overall Study||17
8545328|NCT04382586|9577123|FG001|NOT COMPLETED|Overall Study||16
8545329|NCT04348656|9577131|FG000|STARTED|Overall Study||627
8545330|NCT04348656|9577132|FG001|STARTED|Overall Study||313
8545331|NCT04348656|9577131|FG000|Baseline Population|Overall Study||625
8545332|NCT04348656|9577132|FG001|Baseline Population|Overall Study||313
8545333|NCT04348656|9577131|FG000|Intention to Treat Analysis|Overall Study||614
8545334|NCT04348656|9577132|FG001|Intention to Treat Analysis|Overall Study||307
8545335|NCT04348656|9577131|FG000|Per Protocol Analysis|Overall Study||548
8545336|NCT04348656|9577132|FG001|Per Protocol Analysis|Overall Study||303
8545337|NCT04348656|9577131|FG000|COMPLETED|Overall Study||614
8545338|NCT04348656|9577132|FG001|COMPLETED|Overall Study||307
8545339|NCT04348656|9577131|FG000|NOT COMPLETED|Overall Study||13
8545340|NCT04348656|9577132|FG001|NOT COMPLETED|Overall Study||6
8545341|NCT04283253|9577138|FG000|STARTED|Overall Study||1
8545342|NCT04283253|9577138|FG000|COMPLETED|Overall Study||1
8545343|NCT04283253|9577138|FG000|NOT COMPLETED|Overall Study||0
8545344|NCT04246541|9577144|FG000|STARTED|Overall Study||25
8545345|NCT04246541|9577145|FG001|STARTED|Overall Study||23
8818341|NCT01557244|9872000|FG000|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||9
8818342|NCT01557244|9872001|FG001|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||2
8818343|NCT01557244|9872002|FG002|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||4
8818344|NCT01557244|9872003|FG003|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||0
8818345|NCT01557244|9872004|FG004|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||0
8818346|NCT01557244|9872005|FG005|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||7
8545346|NCT04246541|9577144|FG000|COMPLETED|Overall Study||22
8545347|NCT04246541|9577145|FG001|COMPLETED|Overall Study||20
8545348|NCT04246541|9577144|FG000|NOT COMPLETED|Overall Study||3
8545349|NCT04246541|9577145|FG001|NOT COMPLETED|Overall Study||3
8545394|NCT03671148|9577208|FG000|COMPLETED|Overall Study||199
8545395|NCT03671148|9577209|FG001|COMPLETED|Overall Study||215
8545396|NCT03671148|9577208|FG000|NOT COMPLETED|Overall Study||21
8545397|NCT03671148|9577209|FG001|NOT COMPLETED|Overall Study||9
8545398|NCT03640949|9577217|FG000|STARTED|Overall Study||237
8545399|NCT03640949|9577218|FG001|STARTED|Overall Study||264
8545400|NCT03640949|9577217|FG000|COMPLETED|Overall Study||237
8545401|NCT03640949|9577218|FG001|COMPLETED|Overall Study||264
8545402|NCT03640949|9577217|FG000|NOT COMPLETED|Overall Study||0
8545403|NCT03640949|9577218|FG001|NOT COMPLETED|Overall Study||0
8545404|NCT03615508|9577224|FG000|STARTED|Overall Study||1
8545405|NCT03615508|9577224|FG000|COMPLETED|Overall Study||1
8545406|NCT03615508|9577224|FG000|NOT COMPLETED|Overall Study||0
8621436|NCT00480077|9660423|FG000|COMPLETED|Overall Study||137
8621437|NCT00480077|9660424|FG001|COMPLETED|Overall Study||141
8621438|NCT00480077|9660423|FG000|NOT COMPLETED|Overall Study||31
8545425|NCT03607487|9577245|FG000|STARTED|Overall Study||9
8545426|NCT03607487|9577246|FG001|STARTED|Overall Study||9
8545427|NCT03607487|9577247|FG002|STARTED|Overall Study||9
8545428|NCT03607487|9577248|FG003|STARTED|Overall Study||8
8545429|NCT03607487|9577245|FG000|COMPLETED|Overall Study||7
8545430|NCT03607487|9577246|FG001|COMPLETED|Overall Study||9
8545431|NCT03607487|9577247|FG002|COMPLETED|Overall Study||9
8545432|NCT03607487|9577248|FG003|COMPLETED|Overall Study||7
8545433|NCT03607487|9577245|FG000|NOT COMPLETED|Overall Study||2
8545434|NCT03607487|9577246|FG001|NOT COMPLETED|Overall Study||0
8545435|NCT03607487|9577247|FG002|NOT COMPLETED|Overall Study||0
8545436|NCT03607487|9577248|FG003|NOT COMPLETED|Overall Study||1
8545437|NCT03586687|9577263|FG000|STARTED|Overall Study||6
8545438|NCT03586687|9577264|FG001|STARTED|Overall Study||9
8545439|NCT03586687|9577265|FG002|STARTED|Overall Study||4
8545440|NCT03586687|9577263|FG000|COMPLETED|Overall Study||6
8545441|NCT03586687|9577264|FG001|COMPLETED|Overall Study||9
8545442|NCT03586687|9577265|FG002|COMPLETED|Overall Study||4
8545443|NCT03586687|9577263|FG000|NOT COMPLETED|Overall Study||0
8545444|NCT03586687|9577264|FG001|NOT COMPLETED|Overall Study||0
8545445|NCT03586687|9577265|FG002|NOT COMPLETED|Overall Study||0
8545446|NCT03529773|9577313|FG000|STARTED|Overall Study||12
8545447|NCT03529773|9577314|FG001|STARTED|Overall Study||12
8545448|NCT03529773|9577315|FG002|STARTED|Overall Study||12
8545449|NCT03529773|9577316|FG003|STARTED|Overall Study||12
8545450|NCT03529773|9577317|FG004|STARTED|Overall Study||12
8545451|NCT03529773|9577318|FG005|STARTED|Overall Study||12
8545452|NCT03529773|9577319|FG006|STARTED|Overall Study||12
8545453|NCT03529773|9577320|FG007|STARTED|Overall Study||12
8545454|NCT03529773|9577321|FG008|STARTED|Overall Study||12
8545455|NCT03529773|9577322|FG009|STARTED|Overall Study||12
8545456|NCT03529773|9577323|FG010|STARTED|Overall Study||12
8545457|NCT03529773|9577324|FG011|STARTED|Overall Study||12
8545458|NCT03529773|9577325|FG012|STARTED|Overall Study||12
8545459|NCT03529773|9577326|FG013|STARTED|Overall Study||12
8545460|NCT03529773|9577327|FG014|STARTED|Overall Study||41
8545461|NCT03529773|9577328|FG015|STARTED|Overall Study||42
8545462|NCT03529773|9577329|FG016|STARTED|Overall Study||41
8545463|NCT03529773|9577330|FG017|STARTED|Overall Study||41
8545464|NCT03529773|9577331|FG018|STARTED|Overall Study||41
8545465|NCT03529773|9577332|FG019|STARTED|Overall Study||41
8545466|NCT03529773|9577333|FG020|STARTED|Overall Study||41
8545467|NCT03529773|9577334|FG021|STARTED|Overall Study||41
8545468|NCT03529773|9577335|FG022|STARTED|Overall Study||41
8545469|NCT03529773|9577336|FG023|STARTED|Overall Study||41
8545470|NCT03529773|9577337|FG024|STARTED|Overall Study||41
8545471|NCT03529773|9577338|FG025|STARTED|Overall Study||41
8545472|NCT03529773|9577339|FG026|STARTED|Overall Study||41
8545473|NCT03529773|9577340|FG027|STARTED|Overall Study||41
8545474|NCT03529773|9577341|FG028|STARTED|Overall Study||41
8545475|NCT03529773|9577342|FG029|STARTED|Overall Study||40
8545476|NCT03529773|9577343|FG030|STARTED|Overall Study||42
8545477|NCT03529773|9577344|FG031|STARTED|Overall Study||40
8545478|NCT03529773|9577345|FG032|STARTED|Overall Study||40
8545479|NCT03529773|9577346|FG033|STARTED|Overall Study||41
8545480|NCT03529773|9577347|FG034|STARTED|Overall Study||41
8545481|NCT03529773|9577348|FG035|STARTED|Overall Study||40
8545482|NCT03529773|9577349|FG036|STARTED|Overall Study||41
8545483|NCT03529773|9577350|FG037|STARTED|Overall Study||42
8545484|NCT03529773|9577351|FG038|STARTED|Overall Study||43
8545485|NCT03529773|9577352|FG039|STARTED|Overall Study||41
8545486|NCT03529773|9577313|FG000|COMPLETED|Overall Study||12
8545487|NCT03529773|9577314|FG001|COMPLETED|Overall Study||12
8545488|NCT03529773|9577315|FG002|COMPLETED|Overall Study||11
8545489|NCT03529773|9577316|FG003|COMPLETED|Overall Study||12
8545490|NCT03529773|9577317|FG004|COMPLETED|Overall Study||11
8545491|NCT03529773|9577318|FG005|COMPLETED|Overall Study||11
8545492|NCT03529773|9577319|FG006|COMPLETED|Overall Study||12
8545493|NCT03529773|9577320|FG007|COMPLETED|Overall Study||11
8545494|NCT03529773|9577321|FG008|COMPLETED|Overall Study||12
8545495|NCT03529773|9577322|FG009|COMPLETED|Overall Study||11
8545496|NCT03529773|9577323|FG010|COMPLETED|Overall Study||11
8545497|NCT03529773|9577324|FG011|COMPLETED|Overall Study||12
8545498|NCT03529773|9577325|FG012|COMPLETED|Overall Study||10
8545499|NCT03529773|9577326|FG013|COMPLETED|Overall Study||11
8545500|NCT03529773|9577327|FG014|COMPLETED|Overall Study||35
8545501|NCT03529773|9577328|FG015|COMPLETED|Overall Study||38
8545502|NCT03529773|9577329|FG016|COMPLETED|Overall Study||40
8545503|NCT03529773|9577330|FG017|COMPLETED|Overall Study||35
8545504|NCT03529773|9577331|FG018|COMPLETED|Overall Study||37
8545505|NCT03529773|9577332|FG019|COMPLETED|Overall Study||37
8545506|NCT03529773|9577333|FG020|COMPLETED|Overall Study||34
8545507|NCT03529773|9577334|FG021|COMPLETED|Overall Study||36
8545508|NCT03529773|9577335|FG022|COMPLETED|Overall Study||34
8545509|NCT03529773|9577336|FG023|COMPLETED|Overall Study||35
8545510|NCT03529773|9577337|FG024|COMPLETED|Overall Study||33
8545511|NCT03529773|9577338|FG025|COMPLETED|Overall Study||30
8545512|NCT03529773|9577339|FG026|COMPLETED|Overall Study||32
8545513|NCT03529773|9577340|FG027|COMPLETED|Overall Study||39
8545514|NCT03529773|9577341|FG028|COMPLETED|Overall Study||40
8545515|NCT03529773|9577342|FG029|COMPLETED|Overall Study||40
8545516|NCT03529773|9577343|FG030|COMPLETED|Overall Study||39
8545517|NCT03529773|9577344|FG031|COMPLETED|Overall Study||40
8545518|NCT03529773|9577345|FG032|COMPLETED|Overall Study||40
8545519|NCT03529773|9577346|FG033|COMPLETED|Overall Study||39
8545520|NCT03529773|9577347|FG034|COMPLETED|Overall Study||37
8545521|NCT03529773|9577348|FG035|COMPLETED|Overall Study||36
8545522|NCT03529773|9577349|FG036|COMPLETED|Overall Study||39
8545523|NCT03529773|9577350|FG037|COMPLETED|Overall Study||36
8545524|NCT03529773|9577351|FG038|COMPLETED|Overall Study||39
8545525|NCT03529773|9577352|FG039|COMPLETED|Overall Study||37
8545526|NCT03529773|9577313|FG000|NOT COMPLETED|Overall Study||0
8545527|NCT03529773|9577314|FG001|NOT COMPLETED|Overall Study||0
8545528|NCT03529773|9577315|FG002|NOT COMPLETED|Overall Study||1
8545529|NCT03529773|9577316|FG003|NOT COMPLETED|Overall Study||0
8545530|NCT03529773|9577317|FG004|NOT COMPLETED|Overall Study||1
8545531|NCT03529773|9577318|FG005|NOT COMPLETED|Overall Study||1
8545532|NCT03529773|9577319|FG006|NOT COMPLETED|Overall Study||0
8545533|NCT03529773|9577320|FG007|NOT COMPLETED|Overall Study||1
8545534|NCT03529773|9577321|FG008|NOT COMPLETED|Overall Study||0
8545535|NCT03529773|9577322|FG009|NOT COMPLETED|Overall Study||1
8545536|NCT03529773|9577323|FG010|NOT COMPLETED|Overall Study||1
8545537|NCT03529773|9577324|FG011|NOT COMPLETED|Overall Study||0
8545538|NCT03529773|9577325|FG012|NOT COMPLETED|Overall Study||2
8545539|NCT03529773|9577326|FG013|NOT COMPLETED|Overall Study||1
8545540|NCT03529773|9577327|FG014|NOT COMPLETED|Overall Study||6
8545541|NCT03529773|9577328|FG015|NOT COMPLETED|Overall Study||4
8545542|NCT03529773|9577329|FG016|NOT COMPLETED|Overall Study||1
8545543|NCT03529773|9577330|FG017|NOT COMPLETED|Overall Study||6
8545544|NCT03529773|9577331|FG018|NOT COMPLETED|Overall Study||4
8545545|NCT03529773|9577332|FG019|NOT COMPLETED|Overall Study||4
8545546|NCT03529773|9577333|FG020|NOT COMPLETED|Overall Study||7
8545547|NCT03529773|9577334|FG021|NOT COMPLETED|Overall Study||5
8545548|NCT03529773|9577335|FG022|NOT COMPLETED|Overall Study||7
8545549|NCT03529773|9577336|FG023|NOT COMPLETED|Overall Study||6
8545550|NCT03529773|9577337|FG024|NOT COMPLETED|Overall Study||8
8545551|NCT03529773|9577338|FG025|NOT COMPLETED|Overall Study||11
8545552|NCT03529773|9577339|FG026|NOT COMPLETED|Overall Study||9
8545553|NCT03529773|9577340|FG027|NOT COMPLETED|Overall Study||2
8545554|NCT03529773|9577341|FG028|NOT COMPLETED|Overall Study||1
8545555|NCT03529773|9577342|FG029|NOT COMPLETED|Overall Study||0
8545556|NCT03529773|9577343|FG030|NOT COMPLETED|Overall Study||3
8545557|NCT03529773|9577344|FG031|NOT COMPLETED|Overall Study||0
8545558|NCT03529773|9577345|FG032|NOT COMPLETED|Overall Study||0
8545559|NCT03529773|9577346|FG033|NOT COMPLETED|Overall Study||2
8545560|NCT03529773|9577347|FG034|NOT COMPLETED|Overall Study||4
8545561|NCT03529773|9577348|FG035|NOT COMPLETED|Overall Study||4
8818347|NCT01557244|9872006|FG006|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||1
8818348|NCT01557244|9872000|FG000|STARTED|Safety Extension Phase: 12 Weeks||33
8818349|NCT01557244|9872001|FG001|STARTED|Safety Extension Phase: 12 Weeks||40
8818350|NCT01557244|9872002|FG002|STARTED|Safety Extension Phase: 12 Weeks|Did not receive oxybutynin in safety extension phase.|0
8849319|NCT01739699|9904469|FG001|NOT COMPLETED|Overall Study||5
8545562|NCT03529773|9577349|FG036|NOT COMPLETED|Overall Study||2
8545563|NCT03529773|9577350|FG037|NOT COMPLETED|Overall Study||6
8545564|NCT03529773|9577351|FG038|NOT COMPLETED|Overall Study||4
8545565|NCT03529773|9577352|FG039|NOT COMPLETED|Overall Study||4
8545566|NCT03502070|9577455|FG000|STARTED|Overall Study||47
8545567|NCT03502070|9577455|FG000|COMPLETED|Overall Study||45
8545568|NCT03502070|9577455|FG000|NOT COMPLETED|Overall Study||2
8566877|NCT00079781|9599085|FG002|NOT COMPLETED|Evaluation Period||0
8566878|NCT00079781|9599083|FG000|STARTED|Follow-up Period||42
8566879|NCT00079781|9599084|FG001|STARTED|Follow-up Period||9
8566880|NCT00079781|9599085|FG002|STARTED|Follow-up Period||14
8566881|NCT00079781|9599083|FG000|COMPLETED|Follow-up Period||38
8566882|NCT00079781|9599084|FG001|COMPLETED|Follow-up Period||9
8566883|NCT00079781|9599085|FG002|COMPLETED|Follow-up Period||12
8566884|NCT00079781|9599083|FG000|NOT COMPLETED|Follow-up Period||4
8566885|NCT00079781|9599084|FG001|NOT COMPLETED|Follow-up Period||0
8566886|NCT00079781|9599085|FG002|NOT COMPLETED|Follow-up Period||2
8566887|NCT00079937|9599093|FG000|STARTED|Overall Study||421
8566888|NCT00079937|9599094|FG001|STARTED|Overall Study||207
8566889|NCT00079937|9599093|FG000|COMPLETED|Overall Study||352
8566890|NCT00079937|9599094|FG001|COMPLETED|Overall Study||175
8566891|NCT00079937|9599093|FG000|NOT COMPLETED|Overall Study||69
8566892|NCT00079937|9599094|FG001|NOT COMPLETED|Overall Study||32
8566893|NCT00080119|9599104|FG000|STARTED|Overall Study||403
8566894|NCT00080119|9599105|FG001|STARTED|Overall Study||401
8566895|NCT00080119|9599106|FG002|STARTED|Overall Study||273
8566896|NCT00080119|9599107|FG003|STARTED|Overall Study||274
8566897|NCT00080119|9599104|FG000|COMPLETED|Overall Study||347
8566898|NCT00080119|9599105|FG001|COMPLETED|Overall Study||339
8566899|NCT00080119|9599106|FG002|COMPLETED|Overall Study||108
8566900|NCT00080119|9599107|FG003|COMPLETED|Overall Study||111
8566901|NCT00080119|9599104|FG000|NOT COMPLETED|Overall Study||56
8566902|NCT00080119|9599105|FG001|NOT COMPLETED|Overall Study||62
8566903|NCT00080119|9599106|FG002|NOT COMPLETED|Overall Study||165
8566904|NCT00080119|9599107|FG003|NOT COMPLETED|Overall Study||163
8566905|NCT00080223|9599119|FG000|STARTED|Overall Study||83
8566906|NCT00080223|9599119|FG000|COMPLETED|Overall Study||7
8566907|NCT00080223|9599119|FG000|NOT COMPLETED|Overall Study||76
8566908|NCT00080288|9599125|FG000|STARTED|Overall Study||127
8566909|NCT00080288|9599126|FG001|STARTED|Overall Study||127
8566910|NCT00080288|9599125|FG000|COMPLETED|Overall Study||97
8566911|NCT00080288|9599126|FG001|COMPLETED|Overall Study||89
8566912|NCT00080288|9599125|FG000|NOT COMPLETED|Overall Study||30
8566913|NCT00080288|9599126|FG001|NOT COMPLETED|Overall Study||38
8566914|NCT00080301|9599134|FG000|STARTED|Overall Study||375
8566915|NCT00080301|9599135|FG001|STARTED|Overall Study||377
8566916|NCT00080301|9599134|FG000|Never Treated|Overall Study||5
8566917|NCT00080301|9599135|FG001|Never Treated|Overall Study||10
8566918|NCT00080301|9599134|FG000|Still on Treatment|Overall Study||0
8566919|NCT00080301|9599135|FG001|Still on Treatment|Overall Study||1
8566920|NCT00080301|9599134|FG000|COMPLETED|Overall Study|Participants who are off treatment|370
8566921|NCT00080301|9599135|FG001|COMPLETED|Overall Study|Participants who are off treatment|366
8566922|NCT00080301|9599134|FG000|NOT COMPLETED|Overall Study||5
8545569|NCT03485911|9577462|FG000|STARTED|Overall Study||41
8545570|NCT03485911|9577463|FG001|STARTED|Overall Study||40
8545571|NCT03485911|9577464|FG002|STARTED|Overall Study||40
8545572|NCT03485911|9577462|FG000|COMPLETED|Overall Study||40
8545573|NCT03485911|9577463|FG001|COMPLETED|Overall Study||38
8545574|NCT03485911|9577464|FG002|COMPLETED|Overall Study||36
8545575|NCT03485911|9577462|FG000|NOT COMPLETED|Overall Study||1
8545576|NCT03485911|9577463|FG001|NOT COMPLETED|Overall Study||2
8545577|NCT03485911|9577464|FG002|NOT COMPLETED|Overall Study||4
8545578|NCT03403634|9577472|FG000|STARTED|Overall Study|19 patients were accrued and completed consent.|19
8545579|NCT03403634|9577472|FG000|Treated|Overall Study|4 patients became ineligible prior to the start of treatment.|15
8545580|NCT03403634|9577472|FG000|COMPLETED|Overall Study||12
8545581|NCT03403634|9577472|FG000|NOT COMPLETED|Overall Study||7
8545582|NCT03382041|9577478|FG000|STARTED|Overall Study||7
8545583|NCT03382041|9577479|FG001|STARTED|Overall Study||13
8545584|NCT03382041|9577478|FG000|COMPLETED|Overall Study||3
8545585|NCT03382041|9577479|FG001|COMPLETED|Overall Study||4
8545586|NCT03382041|9577478|FG000|NOT COMPLETED|Overall Study||4
8545587|NCT03382041|9577479|FG001|NOT COMPLETED|Overall Study||9
8545588|NCT03332095|9577487|FG000|STARTED|Overall Study||10
8545589|NCT03332095|9577488|FG001|STARTED|Overall Study||45
8545590|NCT03332095|9577487|FG000|Received at Least One Dose of Study Treatment|Overall Study||9
8545591|NCT03332095|9577488|FG001|Received at Least One Dose of Study Treatment|Overall Study||45
8545592|NCT03332095|9577487|FG000|COMPLETED|Overall Study||9
8545593|NCT03332095|9577488|FG001|COMPLETED|Overall Study||44
8545594|NCT03332095|9577487|FG000|NOT COMPLETED|Overall Study||1
8545595|NCT03332095|9577488|FG001|NOT COMPLETED|Overall Study||1
8545596|NCT03201419|9577503|FG000|STARTED|Overall Study||60
8545597|NCT03201419|9577504|FG001|STARTED|Overall Study||27
8545598|NCT03201419|9577505|FG002|STARTED|Overall Study||24
8545599|NCT03201419|9577506|FG003|STARTED|Overall Study||14
8545600|NCT03201419|9577507|FG004|STARTED|Overall Study||13
8545601|NCT03201419|9577508|FG005|STARTED|Overall Study||34
8545602|NCT03201419|9577509|FG006|STARTED|Overall Study||87
8545603|NCT03201419|9577510|FG007|STARTED|Overall Study||26
8545604|NCT03201419|9577511|FG008|STARTED|Overall Study||17
8545605|NCT03201419|9577503|FG000|COMPLETED|Overall Study||52
8545606|NCT03201419|9577504|FG001|COMPLETED|Overall Study||24
8545607|NCT03201419|9577505|FG002|COMPLETED|Overall Study||22
8545608|NCT03201419|9577506|FG003|COMPLETED|Overall Study||14
8545609|NCT03201419|9577507|FG004|COMPLETED|Overall Study||12
8545610|NCT03201419|9577508|FG005|COMPLETED|Overall Study||33
8545611|NCT03201419|9577509|FG006|COMPLETED|Overall Study||81
8545612|NCT03201419|9577510|FG007|COMPLETED|Overall Study||25
8545613|NCT03201419|9577511|FG008|COMPLETED|Overall Study||15
8545614|NCT03201419|9577503|FG000|NOT COMPLETED|Overall Study||8
8545615|NCT03201419|9577504|FG001|NOT COMPLETED|Overall Study||3
8545616|NCT03201419|9577505|FG002|NOT COMPLETED|Overall Study||2
8545617|NCT03201419|9577506|FG003|NOT COMPLETED|Overall Study||0
8545618|NCT03201419|9577507|FG004|NOT COMPLETED|Overall Study||1
8545619|NCT03201419|9577508|FG005|NOT COMPLETED|Overall Study||1
8545620|NCT03201419|9577509|FG006|NOT COMPLETED|Overall Study||6
8545621|NCT03201419|9577510|FG007|NOT COMPLETED|Overall Study||1
8545622|NCT03201419|9577511|FG008|NOT COMPLETED|Overall Study||2
8545623|NCT03197766|9577547|FG000|STARTED|Overall Study||60
8545624|NCT03197766|9577548|FG001|STARTED|Overall Study||61
8545625|NCT03197766|9577547|FG000|COMPLETED|Overall Study||58
8545626|NCT03197766|9577548|FG001|COMPLETED|Overall Study||61
8545627|NCT03197766|9577547|FG000|NOT COMPLETED|Overall Study||2
8545628|NCT03197766|9577548|FG001|NOT COMPLETED|Overall Study||0
8566923|NCT00080301|9599135|FG001|NOT COMPLETED|Overall Study||11
8566924|NCT00080470|9599144|FG000|STARTED|Overall Study||45
8566925|NCT00080470|9599145|FG001|STARTED|Overall Study||42
8566926|NCT00080470|9599144|FG000|COMPLETED|Overall Study||11
8566927|NCT00080470|9599145|FG001|COMPLETED|Overall Study||14
8566928|NCT00080470|9599144|FG000|NOT COMPLETED|Overall Study||34
8566929|NCT00080470|9599145|FG001|NOT COMPLETED|Overall Study||28
8566930|NCT00080483|9599155|FG000|STARTED|Overall Study||17
8566931|NCT00080483|9599156|FG001|STARTED|Overall Study||18
8566932|NCT00080483|9599155|FG000|COMPLETED|Overall Study||15
8566933|NCT00080483|9599156|FG001|COMPLETED|Overall Study||16
8566934|NCT00080483|9599155|FG000|NOT COMPLETED|Overall Study||2
8566935|NCT00080483|9599156|FG001|NOT COMPLETED|Overall Study||2
8566936|NCT00080535|9599162|FG000|STARTED|Overall Study||10
8566937|NCT00080535|9599162|FG000|COMPLETED|Overall Study||10
8566938|NCT00080535|9599162|FG000|NOT COMPLETED|Overall Study||0
8566939|NCT00080899|9599166|FG000|STARTED|Overall Study||23
8566940|NCT00080899|9599166|FG000|COMPLETED|Overall Study||22
8566941|NCT00080899|9599166|FG000|NOT COMPLETED|Overall Study||1
8566942|NCT00080912|9599172|FG000|STARTED|Overall Study||425
8566943|NCT00080912|9599173|FG001|STARTED|Overall Study||425
8566944|NCT00080912|9599172|FG000|COMPLETED|Overall Study||425
8566945|NCT00080912|9599173|FG001|COMPLETED|Overall Study||425
8566946|NCT00080912|9599172|FG000|NOT COMPLETED|Overall Study||0
8566947|NCT00080912|9599173|FG001|NOT COMPLETED|Overall Study||0
8566948|NCT00080938|9599179|FG000|STARTED|Overall Study||26
8566949|NCT00080938|9599179|FG000|Began Protocol Therapy|Overall Study||25
8566950|NCT00080938|9599179|FG000|Eligible and Treated|Overall Study||21
8566951|NCT00080938|9599179|FG000|COMPLETED|Overall Study||2
8566952|NCT00080938|9599179|FG000|NOT COMPLETED|Overall Study||24
8566953|NCT00081159|9599185|FG000|STARTED|Overall Study||39
8545629|NCT05143801|9577554|FG000|STARTED|Overall Study||10
8545630|NCT05143801|9577554|FG000|COMPLETED|Overall Study||10
8545631|NCT05143801|9577554|FG000|NOT COMPLETED|Overall Study||0
8545632|NCT04516759|9577566|FG000|STARTED|Overall Study|excluding 2 subjects who were randomized but did not start treatment|80
8545633|NCT04516759|9577567|FG001|STARTED|Overall Study|excluding 1 subject who was randomized but did not start treatment|73
8545634|NCT04516759|9577566|FG000|COMPLETED|Overall Study||79
8545635|NCT04516759|9577567|FG001|COMPLETED|Overall Study||71
8545636|NCT04516759|9577566|FG000|NOT COMPLETED|Overall Study||1
8545637|NCT04516759|9577567|FG001|NOT COMPLETED|Overall Study||2
8545638|NCT03930446|9577575|FG000|STARTED|Overall Study||40
8545639|NCT03930446|9577576|FG001|STARTED|Overall Study||40
8545640|NCT03930446|9577575|FG000|COMPLETED|Overall Study||40
8545641|NCT03930446|9577576|FG001|COMPLETED|Overall Study||40
8545642|NCT03930446|9577575|FG000|NOT COMPLETED|Overall Study||0
8545643|NCT03930446|9577576|FG001|NOT COMPLETED|Overall Study||0
8545644|NCT03892642|9577582|FG000|STARTED|Overall Study||18
8545645|NCT03892642|9577582|FG000|COMPLETED|Overall Study||18
8545646|NCT03892642|9577582|FG000|NOT COMPLETED|Overall Study||0
8545647|NCT03492099|9577586|FG000|STARTED|Overall Study||47
8545648|NCT03492099|9577586|FG000|COMPLETED|Overall Study||43
8545649|NCT03492099|9577586|FG000|NOT COMPLETED|Overall Study||4
8545650|NCT03409276|9577596|FG000|STARTED|Overall Study||2
8545651|NCT03409276|9577597|FG001|STARTED|Overall Study||10
8545652|NCT03409276|9577598|FG002|STARTED|Overall Study||6
8545653|NCT03409276|9577599|FG003|STARTED|Overall Study||21
8545654|NCT03409276|9577600|FG004|STARTED|Overall Study||21
8545655|NCT03409276|9577596|FG000|Month 2.5 Immunogenicity Cohort|Overall Study||2
8545656|NCT03409276|9577597|FG001|Month 2.5 Immunogenicity Cohort|Overall Study||10
8545657|NCT03409276|9577598|FG002|Month 2.5 Immunogenicity Cohort|Overall Study||0
8545658|NCT03409276|9577599|FG003|Month 2.5 Immunogenicity Cohort|Overall Study||0
8545659|NCT03409276|9577600|FG004|Month 2.5 Immunogenicity Cohort|Overall Study||0
8545660|NCT03409276|9577596|FG000|Month 8.5 Immunogenicity Cohort|Overall Study||0
8545661|NCT03409276|9577597|FG001|Month 8.5 Immunogenicity Cohort|Overall Study||0
8545662|NCT03409276|9577598|FG002|Month 8.5 Immunogenicity Cohort|Overall Study||6
8545663|NCT03409276|9577599|FG003|Month 8.5 Immunogenicity Cohort|Overall Study||19
8545664|NCT03409276|9577600|FG004|Month 8.5 Immunogenicity Cohort|Overall Study||16
8545665|NCT03409276|9577596|FG000|COMPLETED|Overall Study||2
8545666|NCT03409276|9577597|FG001|COMPLETED|Overall Study||10
8545667|NCT03409276|9577598|FG002|COMPLETED|Overall Study||6
8545668|NCT03409276|9577599|FG003|COMPLETED|Overall Study||19
8545669|NCT03409276|9577600|FG004|COMPLETED|Overall Study||18
8545670|NCT03409276|9577596|FG000|NOT COMPLETED|Overall Study||0
8545671|NCT03409276|9577597|FG001|NOT COMPLETED|Overall Study||0
8545672|NCT03409276|9577598|FG002|NOT COMPLETED|Overall Study||0
8545673|NCT03409276|9577599|FG003|NOT COMPLETED|Overall Study||2
8545674|NCT03409276|9577600|FG004|NOT COMPLETED|Overall Study||3
8545675|NCT03312907|9577619|FG000|STARTED|Overall Study||72
8545676|NCT03312907|9577620|FG001|STARTED|Overall Study||144
8545677|NCT03312907|9577621|FG002|STARTED|Overall Study||76
8545678|NCT03312907|9577619|FG000|COMPLETED|Overall Study||55
8545679|NCT03312907|9577620|FG001|COMPLETED|Overall Study||114
8545680|NCT03312907|9577621|FG002|COMPLETED|Overall Study||57
8545681|NCT03312907|9577619|FG000|NOT COMPLETED|Overall Study||17
8545682|NCT03312907|9577620|FG001|NOT COMPLETED|Overall Study||30
8545683|NCT03312907|9577621|FG002|NOT COMPLETED|Overall Study||19
8545684|NCT03148756|9577631|FG000|STARTED|Overall Study||0
8545685|NCT03148756|9577632|FG001|STARTED|Overall Study||2
8545686|NCT03148756|9577631|FG000|COMPLETED|Overall Study||0
8545687|NCT03148756|9577632|FG001|COMPLETED|Overall Study||1
8545688|NCT03148756|9577631|FG000|NOT COMPLETED|Overall Study||0
8545689|NCT03148756|9577632|FG001|NOT COMPLETED|Overall Study||1
8545690|NCT03079102|9577640|FG000|STARTED|Overall Study||30
8545691|NCT03079102|9577641|FG001|STARTED|Overall Study||27
8545692|NCT03079102|9577640|FG000|COMPLETED|Overall Study||30
8818351|NCT01557244|9872003|FG003|STARTED|Safety Extension Phase: 12 Weeks|Allocated from oxybutynin arm to this arm by investigator in safety extension phase.|16
8818352|NCT01557244|9872004|FG004|STARTED|Safety Extension Phase: 12 Weeks|Allocated from oxybutynin arm to this arm by investigator in safety extension phase.|20
8818353|NCT01557244|9872005|FG005|STARTED|Safety Extension Phase: 12 Weeks||21
8621439|NCT00480077|9660424|FG001|NOT COMPLETED|Overall Study||26
8621440|NCT00480324|9660432|FG000|STARTED|Overall Study||508
8621441|NCT00480324|9660433|FG001|STARTED|Overall Study||257
8621442|NCT00480324|9660432|FG000|COMPLETED|Overall Study||476
8545693|NCT03079102|9577641|FG001|COMPLETED|Overall Study|One subject had study drug discontinued by the PI after 3h of therapy due to progressive hemodynamic deterioration (worsening hypotension and shock). Discontinuation of study drug did not impact this deterioration.|26
8621443|NCT00480324|9660433|FG001|COMPLETED|Overall Study||241
8545694|NCT03079102|9577640|FG000|NOT COMPLETED|Overall Study||0
8545695|NCT03079102|9577641|FG001|NOT COMPLETED|Overall Study||1
8545696|NCT02944513|9577649|FG000|STARTED|Overall Study||35
8545697|NCT02944513|9577650|FG001|STARTED|Overall Study||33
8545698|NCT02944513|9577649|FG000|COMPLETED|Overall Study||31
8545699|NCT02944513|9577650|FG001|COMPLETED|Overall Study||32
8545700|NCT02944513|9577649|FG000|NOT COMPLETED|Overall Study||4
8545701|NCT02944513|9577650|FG001|NOT COMPLETED|Overall Study||1
8545702|NCT02913222|9577658|FG000|STARTED|Overall Study||23
8545703|NCT02913222|9577659|FG001|STARTED|Overall Study||23
8545704|NCT02913222|9577658|FG000|COMPLETED|Overall Study||22
8545705|NCT02913222|9577659|FG001|COMPLETED|Overall Study||21
8545706|NCT02913222|9577658|FG000|NOT COMPLETED|Overall Study||1
8545707|NCT02913222|9577659|FG001|NOT COMPLETED|Overall Study||2
8545708|NCT02734433|9577667|FG000|STARTED|Overall Study||3
8545709|NCT02734433|9577668|FG001|STARTED|Overall Study||8
8545710|NCT02734433|9577667|FG000|COMPLETED|Overall Study||1
8545711|NCT02734433|9577668|FG001|COMPLETED|Overall Study||0
8545712|NCT02734433|9577667|FG000|NOT COMPLETED|Overall Study||2
8545713|NCT02734433|9577668|FG001|NOT COMPLETED|Overall Study||8
8545714|NCT02474927|9577674|FG000|STARTED|Overall Study||22
8545715|NCT02474927|9577674|FG000|COMPLETED|Overall Study||22
8545716|NCT02474927|9577674|FG000|NOT COMPLETED|Overall Study||0
8545717|NCT02145507|9577680|FG000|STARTED|First Donation||82
8545718|NCT02145507|9577681|FG001|STARTED|First Donation||88
8545719|NCT02145507|9577680|FG000|Randomized to Have Blood Processed With SOLX (IP)|First Donation||52
8545720|NCT02145507|9577681|FG001|Randomized to Have Blood Processed With SOLX (IP)|First Donation||51
8545721|NCT02145507|9577680|FG000|Randomized to Have Blood Processed With AS-3 (CP)|First Donation||30
8545722|NCT02145507|9577681|FG001|Randomized to Have Blood Processed With AS-3 (CP)|First Donation||37
8545723|NCT02145507|9577680|FG000|COMPLETED|First Donation||70
8545724|NCT02145507|9577681|FG001|COMPLETED|First Donation||67
8545725|NCT02145507|9577680|FG000|NOT COMPLETED|First Donation||12
8545726|NCT02145507|9577681|FG001|NOT COMPLETED|First Donation||21
8545727|NCT02145507|9577680|FG000|STARTED|Second Donation||65
8545728|NCT02145507|9577681|FG001|STARTED|Second Donation|Note: Of the 65 participants who started the second period in Arm 2, there were 3 screen failures, therefore only n=62 participants received their alternate procedure.|65
8545729|NCT02145507|9577680|FG000|Blood Processed With AS-3 (CP)|Second Donation||39
8545730|NCT02145507|9577681|FG001|Blood Processed With AS-3 (CP)|Second Donation||35
8545731|NCT02145507|9577680|FG000|Blood Processed With SOLX (IP)|Second Donation||26
8545732|NCT02145507|9577681|FG001|Blood Processed With SOLX (IP)|Second Donation||27
8545733|NCT02145507|9577680|FG000|COMPLETED|Second Donation||63
8545734|NCT02145507|9577681|FG001|COMPLETED|Second Donation||60
8545735|NCT02145507|9577680|FG000|NOT COMPLETED|Second Donation||2
8545736|NCT02145507|9577681|FG001|NOT COMPLETED|Second Donation||5
8545737|NCT02120469|9577695|FG000|STARTED|Overall Study||13
8545738|NCT02120469|9577696|FG001|STARTED|Overall Study||10
8545739|NCT02120469|9577697|FG002|STARTED|Overall Study||4
8545740|NCT02120469|9577695|FG000|COMPLETED|Overall Study||12
8545741|NCT02120469|9577696|FG001|COMPLETED|Overall Study||10
8545742|NCT02120469|9577697|FG002|COMPLETED|Overall Study||3
8545743|NCT02120469|9577695|FG000|NOT COMPLETED|Overall Study||1
8545744|NCT02120469|9577696|FG001|NOT COMPLETED|Overall Study||0
8545745|NCT02120469|9577697|FG002|NOT COMPLETED|Overall Study||1
8545746|NCT02091960|9577707|FG000|STARTED|Overall Study||103
8545747|NCT02091960|9577707|FG000|Received Treatment|Overall Study||103
8545748|NCT02091960|9577707|FG000|COMPLETED|Overall Study|Completed indicates participants with disease progression|52
8545749|NCT02091960|9577707|FG000|NOT COMPLETED|Overall Study||51
8545750|NCT02048722|9577711|FG000|STARTED|2 Cycles of Treatment||31
8545751|NCT02048722|9577711|FG000|Attempted 1st Cycle|2 Cycles of Treatment||31
8545752|NCT02048722|9577711|FG000|Attempted 2nd Cycle|2 Cycles of Treatment||23
8545753|NCT02048722|9577711|FG000|COMPLETED|2 Cycles of Treatment||23
8545754|NCT02048722|9577711|FG000|NOT COMPLETED|2 Cycles of Treatment||8
8545755|NCT02048722|9577711|FG000|STARTED|Reached 1st Response/Continued Treatment||23
8545756|NCT02048722|9577711|FG000|Assessed for First Response|Reached 1st Response/Continued Treatment||23
8545757|NCT02048722|9577711|FG000|Went on to Cycle 3 and Beyond|Reached 1st Response/Continued Treatment||13
8545758|NCT02048722|9577711|FG000|COMPLETED|Reached 1st Response/Continued Treatment||13
8545759|NCT02048722|9577711|FG000|NOT COMPLETED|Reached 1st Response/Continued Treatment||10
8545760|NCT02048722|9577711|FG000|STARTED|Follow up 5 Years or Cut of Timepoint||31
8545761|NCT02048722|9577711|FG000|COMPLETED|Follow up 5 Years or Cut of Timepoint||4
8545762|NCT02048722|9577711|FG000|NOT COMPLETED|Follow up 5 Years or Cut of Timepoint||27
8545763|NCT01896102|9577715|FG000|STARTED|Overall Study||32
8545764|NCT01896102|9577715|FG000|COMPLETED|Overall Study||29
8545765|NCT01896102|9577715|FG000|NOT COMPLETED|Overall Study||3
8566954|NCT00081159|9599186|FG001|STARTED|Overall Study||40
8566955|NCT00081159|9599185|FG000|COMPLETED|Overall Study||37
8566956|NCT00081159|9599186|FG001|COMPLETED|Overall Study||35
8566957|NCT00081159|9599185|FG000|NOT COMPLETED|Overall Study||2
8566958|NCT00081159|9599186|FG001|NOT COMPLETED|Overall Study||5
8566959|NCT00081263|9599194|FG000|STARTED|Overall Study||67
8566960|NCT00081263|9599195|FG001|STARTED|Overall Study||63
8566961|NCT00081263|9599194|FG000|COMPLETED|Overall Study||50
8566962|NCT00081263|9599195|FG001|COMPLETED|Overall Study||41
8566963|NCT00081263|9599194|FG000|NOT COMPLETED|Overall Study||17
8566964|NCT00081263|9599195|FG001|NOT COMPLETED|Overall Study||22
8566965|NCT00081289|9599203|FG000|STARTED|Overall Study||73
8566966|NCT00081289|9599204|FG001|STARTED|Overall Study||73
8566967|NCT00081289|9599203|FG000|Primary Endpoint Population|Overall Study||48
8566968|NCT00081289|9599204|FG001|Primary Endpoint Population|Overall Study||48
8566969|NCT00081289|9599203|FG000|General Analysis Population|Overall Study||52
8566970|NCT00081289|9599204|FG001|General Analysis Population|Overall Study||52
8566971|NCT00081289|9599203|FG000|Full AE Population|Overall Study||70
8566972|NCT00081289|9599204|FG001|Full AE Population|Overall Study||68
8566973|NCT00081289|9599203|FG000|Surgery|Overall Study||47
8566974|NCT00081289|9599204|FG001|Surgery|Overall Study||51
8569297|NCT00096109|9601496|FG000|STARTED|Overall Study||11
8569298|NCT00096109|9601496|FG000|COMPLETED|Overall Study||11
8545766|NCT01885078|9577728|FG000|STARTED|Treatment Period||451
8545767|NCT01885078|9577729|FG001|STARTED|Treatment Period||1091
8545768|NCT01885078|9577730|FG002|STARTED|Treatment Period||180
8545769|NCT01885078|9577731|FG003|STARTED|Treatment Period||403
8545770|NCT01885078|9577732|FG004|STARTED|Treatment Period||117
8545771|NCT01885078|9577733|FG005|STARTED|Treatment Period||331
8545772|NCT01885078|9577734|FG006|STARTED|Treatment Period||221
8545773|NCT01885078|9577735|FG007|STARTED|Treatment Period||83
8545774|NCT01885078|9577736|FG008|STARTED|Treatment Period||0
8545775|NCT01885078|9577737|FG009|STARTED|Treatment Period||0
8545776|NCT01885078|9577728|FG000|Received at Least Once Dose of Study Drug|Treatment Period||451
8545777|NCT01885078|9577729|FG001|Received at Least Once Dose of Study Drug|Treatment Period||1090
8545778|NCT01885078|9577730|FG002|Received at Least Once Dose of Study Drug|Treatment Period||180
8545779|NCT01885078|9577731|FG003|Received at Least Once Dose of Study Drug|Treatment Period||403
8545780|NCT01885078|9577732|FG004|Received at Least Once Dose of Study Drug|Treatment Period||117
8545781|NCT01885078|9577733|FG005|Received at Least Once Dose of Study Drug|Treatment Period||331
8545782|NCT01885078|9577734|FG006|Received at Least Once Dose of Study Drug|Treatment Period||221
8545783|NCT01885078|9577735|FG007|Received at Least Once Dose of Study Drug|Treatment Period||83
8545784|NCT01885078|9577736|FG008|Received at Least Once Dose of Study Drug|Treatment Period||0
8545785|NCT01885078|9577737|FG009|Received at Least Once Dose of Study Drug|Treatment Period||0
8545786|NCT01885078|9577728|FG000|COMPLETED|Treatment Period||19
8545787|NCT01885078|9577729|FG001|COMPLETED|Treatment Period||64
8545788|NCT01885078|9577730|FG002|COMPLETED|Treatment Period||49
8545789|NCT01885078|9577731|FG003|COMPLETED|Treatment Period||120
8545790|NCT01885078|9577732|FG004|COMPLETED|Treatment Period||27
8545791|NCT01885078|9577733|FG005|COMPLETED|Treatment Period||81
8545792|NCT01885078|9577734|FG006|COMPLETED|Treatment Period||0
8545793|NCT01885078|9577735|FG007|COMPLETED|Treatment Period||55
8545794|NCT01885078|9577736|FG008|COMPLETED|Treatment Period||0
8545795|NCT01885078|9577737|FG009|COMPLETED|Treatment Period||0
8545796|NCT01885078|9577728|FG000|NOT COMPLETED|Treatment Period||432
8545797|NCT01885078|9577729|FG001|NOT COMPLETED|Treatment Period||1027
8545798|NCT01885078|9577730|FG002|NOT COMPLETED|Treatment Period||131
8545799|NCT01885078|9577731|FG003|NOT COMPLETED|Treatment Period||283
8545800|NCT01885078|9577732|FG004|NOT COMPLETED|Treatment Period||90
8545801|NCT01885078|9577733|FG005|NOT COMPLETED|Treatment Period||250
8545802|NCT01885078|9577734|FG006|NOT COMPLETED|Treatment Period||221
8545803|NCT01885078|9577735|FG007|NOT COMPLETED|Treatment Period||28
8545804|NCT01885078|9577736|FG008|NOT COMPLETED|Treatment Period||0
8545805|NCT01885078|9577737|FG009|NOT COMPLETED|Treatment Period||0
8545806|NCT01885078|9577728|FG000|STARTED|Step-down Period|Not all participants were eligible to enter the Step-Down Period.|0
8545807|NCT01885078|9577729|FG001|STARTED|Step-down Period|Not all participants were eligible to enter the Step-Down Period.|0
8545808|NCT01885078|9577730|FG002|STARTED|Step-down Period|Not all participants were eligible to enter the Step-Down Period.|0
8545809|NCT01885078|9577731|FG003|STARTED|Step-down Period|Not all participants were eligible to enter the Step-Down Period.|0
8545810|NCT01885078|9577732|FG004|STARTED|Step-down Period|Not all participants were eligible to enter the Step-Down Period.|0
8545811|NCT01885078|9577733|FG005|STARTED|Step-down Period|Not all participants were eligible to enter the Step-Down Period.|0
8545812|NCT01885078|9577734|FG006|STARTED|Step-down Period||0
8545813|NCT01885078|9577735|FG007|STARTED|Step-down Period|Not all participants were eligible to enter the Step-Down Period.|0
8545814|NCT01885078|9577736|FG008|STARTED|Step-down Period|Eligible participants were offered the option of participating in the Step-Down Period.|592
8545815|NCT01885078|9577737|FG009|STARTED|Step-down Period|Eligible participants were offered the option of participating in the Step-Down Period.|594
8545816|NCT01885078|9577728|FG000|Complete Through Week 96|Step-down Period||0
8545817|NCT01885078|9577729|FG001|Complete Through Week 96|Step-down Period||0
8545818|NCT01885078|9577730|FG002|Complete Through Week 96|Step-down Period||0
8545819|NCT01885078|9577731|FG003|Complete Through Week 96|Step-down Period||0
8545820|NCT01885078|9577732|FG004|Complete Through Week 96|Step-down Period||0
8545821|NCT01885078|9577733|FG005|Complete Through Week 96|Step-down Period||0
8545822|NCT01885078|9577734|FG006|Complete Through Week 96|Step-down Period||0
8545823|NCT01885078|9577735|FG007|Complete Through Week 96|Step-down Period||0
8545824|NCT01885078|9577736|FG008|Complete Through Week 96|Step-down Period||407
8545825|NCT01885078|9577737|FG009|Complete Through Week 96|Step-down Period||455
8545826|NCT01885078|9577728|FG000|COMPLETED|Step-down Period||0
8545827|NCT01885078|9577729|FG001|COMPLETED|Step-down Period||0
8545828|NCT01885078|9577730|FG002|COMPLETED|Step-down Period||0
8545829|NCT01885078|9577731|FG003|COMPLETED|Step-down Period||0
8545830|NCT01885078|9577732|FG004|COMPLETED|Step-down Period||0
8545831|NCT01885078|9577733|FG005|COMPLETED|Step-down Period||0
8545832|NCT01885078|9577734|FG006|COMPLETED|Step-down Period||0
8545833|NCT01885078|9577735|FG007|COMPLETED|Step-down Period||0
8545834|NCT01885078|9577736|FG008|COMPLETED|Step-down Period||523
8545835|NCT01885078|9577737|FG009|COMPLETED|Step-down Period||533
8545836|NCT01885078|9577728|FG000|NOT COMPLETED|Step-down Period||0
8818354|NCT01557244|9872006|FG006|STARTED|Safety Extension Phase: 12 Weeks||28
8818355|NCT01557244|9872000|FG000|Treated|Safety Extension Phase: 12 Weeks||30
8818356|NCT01557244|9872001|FG001|Treated|Safety Extension Phase: 12 Weeks||37
8818357|NCT01557244|9872002|FG002|Treated|Safety Extension Phase: 12 Weeks||0
8818358|NCT01557244|9872003|FG003|Treated|Safety Extension Phase: 12 Weeks||16
8818359|NCT01557244|9872004|FG004|Treated|Safety Extension Phase: 12 Weeks||20
8545837|NCT01885078|9577729|FG001|NOT COMPLETED|Step-down Period||0
8545838|NCT01885078|9577730|FG002|NOT COMPLETED|Step-down Period||0
8545839|NCT01885078|9577731|FG003|NOT COMPLETED|Step-down Period||0
8545840|NCT01885078|9577732|FG004|NOT COMPLETED|Step-down Period||0
8545841|NCT01885078|9577733|FG005|NOT COMPLETED|Step-down Period||0
8545842|NCT01885078|9577734|FG006|NOT COMPLETED|Step-down Period||0
8545843|NCT01885078|9577735|FG007|NOT COMPLETED|Step-down Period||0
8545844|NCT01885078|9577736|FG008|NOT COMPLETED|Step-down Period||69
8545845|NCT01885078|9577737|FG009|NOT COMPLETED|Step-down Period||61
8545846|NCT01047683|9577761|FG000|STARTED|Overall Study||76
8545847|NCT01047683|9577762|FG001|STARTED|Overall Study||76
8545848|NCT01047683|9577763|FG002|STARTED|Overall Study||77
8545849|NCT01047683|9577761|FG000|COMPLETED|Overall Study||71
8545850|NCT01047683|9577762|FG001|COMPLETED|Overall Study||70
8545851|NCT01047683|9577763|FG002|COMPLETED|Overall Study||74
8545852|NCT01047683|9577761|FG000|NOT COMPLETED|Overall Study||5
8545853|NCT01047683|9577762|FG001|NOT COMPLETED|Overall Study||6
8545854|NCT01047683|9577763|FG002|NOT COMPLETED|Overall Study||3
8545855|NCT01047501|9577774|FG000|STARTED|Overall Study||233
8545856|NCT01047501|9577775|FG001|STARTED|Overall Study||236
8545857|NCT01047501|9577776|FG002|STARTED|Overall Study||233
8545858|NCT01047501|9577774|FG000|COMPLETED|Overall Study||217
8545859|NCT01047501|9577775|FG001|COMPLETED|Overall Study||225
8545860|NCT01047501|9577776|FG002|COMPLETED|Overall Study||221
8545861|NCT01047501|9577774|FG000|NOT COMPLETED|Overall Study||16
8545862|NCT01047501|9577775|FG001|NOT COMPLETED|Overall Study||11
8545863|NCT01047501|9577776|FG002|NOT COMPLETED|Overall Study||12
8545864|NCT00981656|9577784|FG000|STARTED|Overall Study||37
8545865|NCT00981656|9577784|FG000|Eligible and Started Study Treatment|Overall Study||34
8545866|NCT00981656|9577784|FG000|COMPLETED|Overall Study||34
8545867|NCT00981656|9577784|FG000|NOT COMPLETED|Overall Study||3
8545868|NCT00838526|9577790|FG000|STARTED|Overall Study|Treated|59
8545869|NCT00838526|9577791|FG001|STARTED|Overall Study|Treated|176
8545870|NCT00838526|9577790|FG000|COMPLETED|Overall Study||35
8545871|NCT00838526|9577791|FG001|COMPLETED|Overall Study||137
8545872|NCT00838526|9577790|FG000|NOT COMPLETED|Overall Study||24
8545873|NCT00838526|9577791|FG001|NOT COMPLETED|Overall Study||39
8545874|NCT00126672|9577797|FG000|STARTED|Overall Study||36
8545875|NCT00126672|9577797|FG000|COMPLETED|Overall Study||28
8545876|NCT00126672|9577797|FG000|NOT COMPLETED|Overall Study||8
8545877|NCT03172780|9577804|FG000|STARTED|Overall Study||406
8545878|NCT03172780|9577805|FG001|STARTED|Overall Study||409
8545879|NCT03172780|9577806|FG002|STARTED|Overall Study||405
8545880|NCT03172780|9577804|FG000|COMPLETED|Overall Study||388
8545881|NCT03172780|9577805|FG001|COMPLETED|Overall Study||389
8545882|NCT03172780|9577806|FG002|COMPLETED|Overall Study||389
8545883|NCT03172780|9577804|FG000|NOT COMPLETED|Overall Study||18
8545884|NCT03172780|9577805|FG001|NOT COMPLETED|Overall Study||20
8545885|NCT03172780|9577806|FG002|NOT COMPLETED|Overall Study||16
8545886|NCT03151304|9577814|FG000|STARTED|Overall Study||64
8545887|NCT03151304|9577814|FG000|COMPLETED|Overall Study||0
8545888|NCT03151304|9577814|FG000|NOT COMPLETED|Overall Study||64
8545889|NCT03113409|9577818|FG000|STARTED|Overall Study||10
8545890|NCT03113409|9577819|FG001|STARTED|Overall Study|Study procedure was never started|0
8545891|NCT03113409|9577820|FG002|STARTED|Overall Study|Study procedure was never started|0
8545892|NCT03113409|9577818|FG000|COMPLETED|Overall Study||5
8545893|NCT03113409|9577819|FG001|COMPLETED|Overall Study||0
8545894|NCT03113409|9577820|FG002|COMPLETED|Overall Study||0
8545895|NCT03113409|9577818|FG000|NOT COMPLETED|Overall Study||5
8545896|NCT03113409|9577819|FG001|NOT COMPLETED|Overall Study||0
8545897|NCT03113409|9577820|FG002|NOT COMPLETED|Overall Study||0
8545898|NCT03007979|9577824|FG000|STARTED|Overall Study||55
8545899|NCT03007979|9577824|FG000|COMPLETED|Overall Study||54
8545900|NCT03007979|9577824|FG000|NOT COMPLETED|Overall Study||1
8545901|NCT02953340|9577830|FG000|STARTED|Overall Study||118
8545902|NCT02953340|9577831|FG001|STARTED|Overall Study||119
8545903|NCT02953340|9577830|FG000|Safety Population|Overall Study||117
8545904|NCT02953340|9577831|FG001|Safety Population|Overall Study||118
8545905|NCT02953340|9577830|FG000|Entered Safety Follow-up Period|Overall Study||117
8545906|NCT02953340|9577831|FG001|Entered Safety Follow-up Period|Overall Study||118
8545907|NCT02953340|9577830|FG000|COMPLETED|Overall Study||96
8545908|NCT02953340|9577831|FG001|COMPLETED|Overall Study||85
8545909|NCT02953340|9577830|FG000|NOT COMPLETED|Overall Study||22
8545910|NCT02953340|9577831|FG001|NOT COMPLETED|Overall Study||34
8545911|NCT02870920|9577845|FG000|STARTED|Overall Study||61
8545912|NCT02870920|9577846|FG001|STARTED|Overall Study||119
8545913|NCT02870920|9577845|FG000|COMPLETED|Overall Study||61
8545914|NCT02870920|9577846|FG001|COMPLETED|Overall Study||119
8545915|NCT02870920|9577845|FG000|NOT COMPLETED|Overall Study||0
8545916|NCT02870920|9577846|FG001|NOT COMPLETED|Overall Study||0
8545917|NCT02855944|9577854|FG000|STARTED|Period 1: Treatment||233
8545918|NCT02855944|9577855|FG001|STARTED|Period 1: Treatment||116
8545919|NCT02855944|9577854|FG000|COMPLETED|Period 1: Treatment||188
8545920|NCT02855944|9577855|FG001|COMPLETED|Period 1: Treatment||108
8545921|NCT02855944|9577854|FG000|NOT COMPLETED|Period 1: Treatment||45
8545922|NCT02855944|9577855|FG001|NOT COMPLETED|Period 1: Treatment||8
8545923|NCT02855944|9577854|FG000|STARTED|Period 2: Crossover to Rucaparib||0
8545924|NCT02855944|9577855|FG001|STARTED|Period 2: Crossover to Rucaparib||74
8545925|NCT02855944|9577854|FG000|COMPLETED|Period 2: Crossover to Rucaparib||0
8545926|NCT02855944|9577855|FG001|COMPLETED|Period 2: Crossover to Rucaparib||47
8545927|NCT02855944|9577854|FG000|NOT COMPLETED|Period 2: Crossover to Rucaparib||0
8545928|NCT02855944|9577855|FG001|NOT COMPLETED|Period 2: Crossover to Rucaparib||27
8545929|NCT02851407|9577864|FG000|STARTED|Overall Study||190
8545930|NCT02851407|9577865|FG001|STARTED|Overall Study||182
8545931|NCT02851407|9577864|FG000|COMPLETED|Overall Study||120
8545932|NCT02851407|9577865|FG001|COMPLETED|Overall Study||121
8545933|NCT02851407|9577864|FG000|NOT COMPLETED|Overall Study||70
8545934|NCT02851407|9577865|FG001|NOT COMPLETED|Overall Study||61
8545935|NCT02707276|9577875|FG000|STARTED|Overall Study||3
8545936|NCT02707276|9577876|FG001|STARTED|Overall Study||5
8545937|NCT02707276|9577877|FG002|STARTED|Overall Study||3
8545938|NCT02707276|9577878|FG003|STARTED|Overall Study||2
8545939|NCT02707276|9577875|FG000|COMPLETED|Overall Study||3
8545940|NCT02707276|9577876|FG001|COMPLETED|Overall Study||5
8545941|NCT02707276|9577877|FG002|COMPLETED|Overall Study||3
8545942|NCT02707276|9577878|FG003|COMPLETED|Overall Study||2
8545943|NCT02707276|9577875|FG000|NOT COMPLETED|Overall Study||0
8545944|NCT02707276|9577876|FG001|NOT COMPLETED|Overall Study||0
8545945|NCT02707276|9577877|FG002|NOT COMPLETED|Overall Study||0
8545946|NCT02707276|9577878|FG003|NOT COMPLETED|Overall Study||0
8545947|NCT02666430|9577890|FG000|STARTED|Baseline||64
8545948|NCT02666430|9577891|FG001|STARTED|Baseline||63
8545949|NCT02666430|9577890|FG000|COMPLETED|Baseline||64
8545950|NCT02666430|9577891|FG001|COMPLETED|Baseline||63
8545951|NCT02666430|9577890|FG000|NOT COMPLETED|Baseline||0
8545952|NCT02666430|9577891|FG001|NOT COMPLETED|Baseline||0
8545953|NCT02666430|9577890|FG000|STARTED|Period 1||64
8545954|NCT02666430|9577891|FG001|STARTED|Period 1||63
8545955|NCT02666430|9577890|FG000|COMPLETED|Period 1||63
8545956|NCT02666430|9577891|FG001|COMPLETED|Period 1||62
8545957|NCT02666430|9577890|FG000|NOT COMPLETED|Period 1||1
8545958|NCT02666430|9577891|FG001|NOT COMPLETED|Period 1||1
8545959|NCT02666430|9577890|FG000|STARTED|Period 2||63
8545960|NCT02666430|9577891|FG001|STARTED|Period 2||62
8545961|NCT02666430|9577890|FG000|COMPLETED|Period 2||62
8545962|NCT02666430|9577891|FG001|COMPLETED|Period 2||58
8545963|NCT02666430|9577890|FG000|NOT COMPLETED|Period 2||1
8545964|NCT02666430|9577891|FG001|NOT COMPLETED|Period 2||4
8545965|NCT02666430|9577890|FG000|STARTED|Period 3||62
8545966|NCT02666430|9577891|FG001|STARTED|Period 3||58
8545967|NCT02666430|9577890|FG000|COMPLETED|Period 3||61
8545968|NCT02666430|9577891|FG001|COMPLETED|Period 3||58
8545969|NCT02666430|9577890|FG000|NOT COMPLETED|Period 3||1
8545970|NCT02666430|9577891|FG001|NOT COMPLETED|Period 3||0
8545971|NCT02643420|9577899|FG000|STARTED|Overall Study||196
8545972|NCT02643420|9577900|FG001|STARTED|Overall Study||210
8545973|NCT02643420|9577899|FG000|Safety Population|Overall Study|One participant was randomized to the Arm 2: Pegfilgrastim and TC but was inadvertently administered SPI-2012 on Cycle 1, Day 2 and was included in the Arm 1: SPI-2012 and TC for the Safety Population.|197
8545974|NCT02643420|9577900|FG001|Safety Population|Overall Study||208
8545975|NCT02643420|9577899|FG000|COMPLETED|Overall Study||142
8545976|NCT02643420|9577900|FG001|COMPLETED|Overall Study||145
8545977|NCT02643420|9577899|FG000|NOT COMPLETED|Overall Study||54
8545978|NCT02643420|9577900|FG001|NOT COMPLETED|Overall Study||65
8545979|NCT02639559|9577914|FG000|STARTED|Overall Study||25
8545980|NCT02639559|9577915|FG001|STARTED|Overall Study||25
8545981|NCT02639559|9577914|FG000|COMPLETED|Overall Study||24
8545982|NCT02639559|9577915|FG001|COMPLETED|Overall Study||22
8545983|NCT02639559|9577914|FG000|NOT COMPLETED|Overall Study||1
8545984|NCT02639559|9577915|FG001|NOT COMPLETED|Overall Study||3
8545985|NCT02569476|9577921|FG000|STARTED|Overall Study||119
8545986|NCT02569476|9577921|FG000|COMPLETED|Overall Study||0
8545987|NCT02569476|9577921|FG000|NOT COMPLETED|Overall Study||119
8545988|NCT02549209|9577931|FG000|STARTED|Overall Study||46
8545989|NCT02549209|9577931|FG000|COMPLETED|Overall Study||46
8545990|NCT02549209|9577931|FG000|NOT COMPLETED|Overall Study||0
8545991|NCT02496676|9577937|FG000|STARTED|Phase 1 - Period 1||2
8545992|NCT02496676|9577938|FG001|STARTED|Phase 1 - Period 1||3
8545993|NCT02496676|9577937|FG000|COMPLETED|Phase 1 - Period 1||2
8545994|NCT02496676|9577938|FG001|COMPLETED|Phase 1 - Period 1||2
8545995|NCT02496676|9577937|FG000|NOT COMPLETED|Phase 1 - Period 1||0
8545996|NCT02496676|9577938|FG001|NOT COMPLETED|Phase 1 - Period 1||1
8545997|NCT02496676|9577937|FG000|STARTED|Phase 1 - Period 2||2
8545998|NCT02496676|9577938|FG001|STARTED|Phase 1 - Period 2||2
8545999|NCT02496676|9577937|FG000|COMPLETED|Phase 1 - Period 2||2
8546000|NCT02496676|9577938|FG001|COMPLETED|Phase 1 - Period 2||2
8546001|NCT02496676|9577937|FG000|NOT COMPLETED|Phase 1 - Period 2||0
8546002|NCT02496676|9577938|FG001|NOT COMPLETED|Phase 1 - Period 2||0
8546003|NCT02496676|9577937|FG000|STARTED|Washout Period||2
8546004|NCT02496676|9577938|FG001|STARTED|Washout Period||2
8546005|NCT02496676|9577937|FG000|COMPLETED|Washout Period||2
8546006|NCT02496676|9577938|FG001|COMPLETED|Washout Period||2
8546007|NCT02496676|9577937|FG000|NOT COMPLETED|Washout Period||0
8546008|NCT02496676|9577938|FG001|NOT COMPLETED|Washout Period||0
8546009|NCT02496676|9577937|FG000|STARTED|Phase 2 - IV MgSO4||2
8546010|NCT02496676|9577938|FG001|STARTED|Phase 2 - IV MgSO4||2
8546011|NCT02496676|9577937|FG000|COMPLETED|Phase 2 - IV MgSO4||2
8546012|NCT02496676|9577938|FG001|COMPLETED|Phase 2 - IV MgSO4||1
8546013|NCT02496676|9577937|FG000|NOT COMPLETED|Phase 2 - IV MgSO4||0
8546014|NCT02496676|9577938|FG001|NOT COMPLETED|Phase 2 - IV MgSO4||1
8546015|NCT02496676|9577937|FG000|STARTED|Phase 2 - Oral Magnesium||2
8546016|NCT02496676|9577938|FG001|STARTED|Phase 2 - Oral Magnesium||1
8546017|NCT02496676|9577937|FG000|COMPLETED|Phase 2 - Oral Magnesium||2
8546018|NCT02496676|9577938|FG001|COMPLETED|Phase 2 - Oral Magnesium||1
8546019|NCT02496676|9577937|FG000|NOT COMPLETED|Phase 2 - Oral Magnesium||0
8546020|NCT02496676|9577938|FG001|NOT COMPLETED|Phase 2 - Oral Magnesium||0
8566975|NCT00081289|9599203|FG000|Global Health Status Score at End of CR|Overall Study|European Organization for Research & Treatment of Cancer Quality of Life Questionnaire [EORTC QLQ]|34
8566976|NCT00081289|9599204|FG001|Global Health Status Score at End of CR|Overall Study||32
8566977|NCT00081289|9599203|FG000|GHS at End of Post-op CT|Overall Study||20
8566978|NCT00081289|9599204|FG001|GHS at End of Post-op CT|Overall Study||28
8566979|NCT00081289|9599203|FG000|GHS at Two Years|Overall Study||21
8566980|NCT00081289|9599204|FG001|GHS at Two Years|Overall Study||20
8566981|NCT00081289|9599203|FG000|GI Symptom Score at End of CR|Overall Study||34
8566982|NCT00081289|9599204|FG001|GI Symptom Score at End of CR|Overall Study||33
8566983|NCT00081289|9599203|FG000|GI Symptom Score at End of Post-op CT|Overall Study||22
8566984|NCT00081289|9599204|FG001|GI Symptom Score at End of Post-op CT|Overall Study||27
8566985|NCT00081289|9599203|FG000|GI Symptom Score at Two Years|Overall Study||21
8566986|NCT00081289|9599204|FG001|GI Symptom Score at Two Years|Overall Study||20
8566987|NCT00081289|9599203|FG000|Defecation Symptom Score at End of CR|Overall Study||32
8566988|NCT00081289|9599204|FG001|Defecation Symptom Score at End of CR|Overall Study||32
8566989|NCT00081289|9599203|FG000|DS Score at End of Post-op CT|Overall Study||12
8566990|NCT00081289|9599204|FG001|DS Score at End of Post-op CT|Overall Study||14
8566991|NCT00081289|9599203|FG000|Defecation Symptom Score at Two Years|Overall Study||13
8566992|NCT00081289|9599204|FG001|Defecation Symptom Score at Two Years|Overall Study||15
8566993|NCT00081289|9599203|FG000|COMPLETED|Overall Study||52
8566994|NCT00081289|9599204|FG001|COMPLETED|Overall Study||52
8566995|NCT00081289|9599203|FG000|NOT COMPLETED|Overall Study||21
8566996|NCT00081289|9599204|FG001|NOT COMPLETED|Overall Study||21
8566997|NCT00081328|9599214|FG000|STARTED|Overall Study||232
8566998|NCT00081328|9599215|FG001|STARTED|Overall Study||233
8566999|NCT00081328|9599216|FG002|STARTED|Overall Study||234
8567000|NCT00081328|9599214|FG000|COMPLETED|Overall Study||232
8567001|NCT00081328|9599215|FG001|COMPLETED|Overall Study||233
8567002|NCT00081328|9599216|FG002|COMPLETED|Overall Study||234
8567003|NCT00081328|9599214|FG000|NOT COMPLETED|Overall Study||0
8567004|NCT00081328|9599215|FG001|NOT COMPLETED|Overall Study||0
8567005|NCT00081328|9599216|FG002|NOT COMPLETED|Overall Study||0
8567006|NCT00081458|9599228|FG000|STARTED|Overall Study||16
8567007|NCT00081458|9599229|FG001|STARTED|Overall Study||35
8567008|NCT00081458|9599230|FG002|STARTED|Overall Study||33
8567009|NCT00081458|9599228|FG000|Received Treatment|Overall Study||16
8567010|NCT00081458|9599229|FG001|Received Treatment|Overall Study||35
8567011|NCT00081458|9599230|FG002|Received Treatment|Overall Study|1 subject was randomized but did not receive the study drug|32
8567012|NCT00081458|9599228|FG000|COMPLETED|Overall Study||15
8567013|NCT00081458|9599229|FG001|COMPLETED|Overall Study||27
8567014|NCT00081458|9599230|FG002|COMPLETED|Overall Study||29
8567015|NCT00081458|9599228|FG000|NOT COMPLETED|Overall Study||1
8567016|NCT00081458|9599229|FG001|NOT COMPLETED|Overall Study||8
8567017|NCT00081458|9599230|FG002|NOT COMPLETED|Overall Study||4
8567018|NCT00081497|9599241|FG000|STARTED|Overall Study|Patients who were randomized to placebo in AGAL-008-00 (NCT00074984).|28
8567019|NCT00081497|9599242|FG001|STARTED|Overall Study|Patients who were randomized to Fabrazyme in AGAL-008-00 (NCT00074984).|39
8567020|NCT00081497|9599241|FG000|COMPLETED|Overall Study||25
8567021|NCT00081497|9599242|FG001|COMPLETED|Overall Study||37
8567022|NCT00081497|9599241|FG000|NOT COMPLETED|Overall Study||3
8567023|NCT00081497|9599242|FG001|NOT COMPLETED|Overall Study||2
8567024|NCT00081653|9599256|FG000|STARTED|Overall Study|Patients entering Study MA17903 from Study BM16549|358
8567025|NCT00081653|9599257|FG001|STARTED|Overall Study|Patients entering Study MA17903 from Study BM16549|361
8567026|NCT00081653|9599256|FG000|COMPLETED|Overall Study|Completed 3 years of treatment|311
8567027|NCT00081653|9599257|FG001|COMPLETED|Overall Study|Completed 3 years of treatment|324
8567028|NCT00081653|9599256|FG000|NOT COMPLETED|Overall Study||47
8567029|NCT00081653|9599257|FG001|NOT COMPLETED|Overall Study||37
8567030|NCT00081731|9599266|FG000|STARTED|Overall Study||480
8567031|NCT00081731|9599267|FG001|STARTED|Overall Study||467
8567032|NCT00081731|9599266|FG000|COMPLETED|Overall Study||472
8567033|NCT00081731|9599267|FG001|COMPLETED|Overall Study||459
8567034|NCT00081731|9599266|FG000|NOT COMPLETED|Overall Study||8
8567035|NCT00081731|9599267|FG001|NOT COMPLETED|Overall Study||8
8567036|NCT00081770|9599276|FG000|STARTED|Overall Study||1019
8567037|NCT00081770|9599277|FG001|STARTED|Overall Study||1016
8567038|NCT00081770|9599278|FG002|STARTED|Overall Study||1035
8567039|NCT00081770|9599276|FG000|COMPLETED|Overall Study|Patients who discontinued treatment but continued in study are considered Not Completed|517
8567040|NCT00081770|9599277|FG001|COMPLETED|Overall Study|Patients who discontinued treatment but continued in study are considered Not Completed|470
8567041|NCT00081770|9599278|FG002|COMPLETED|Overall Study|Patients who discontinued treatment but continued in study are considered Not Completed|579
8567042|NCT00081770|9599276|FG000|NOT COMPLETED|Overall Study||502
8567043|NCT00081770|9599277|FG001|NOT COMPLETED|Overall Study||546
8567044|NCT00081770|9599278|FG002|NOT COMPLETED|Overall Study||456
8567045|NCT00081861|9599286|FG000|STARTED|Overall Study||13
8567046|NCT00081861|9599286|FG000|COMPLETED|Overall Study||13
8567047|NCT00081861|9599286|FG000|NOT COMPLETED|Overall Study||0
8567048|NCT00081939|9599290|FG000|STARTED|Overall Study||303
8567049|NCT00081939|9599290|FG000|COMPLETED|Overall Study||303
8567050|NCT00081939|9599290|FG000|NOT COMPLETED|Overall Study||0
8546021|NCT02494141|9577954|FG000|STARTED|Overall Study||34
8546022|NCT02494141|9577955|FG001|STARTED|Overall Study||34
8546023|NCT02494141|9577954|FG000|COMPLETED|Overall Study||28
8546024|NCT02494141|9577955|FG001|COMPLETED|Overall Study||29
8546025|NCT02494141|9577954|FG000|NOT COMPLETED|Overall Study||6
8546026|NCT02494141|9577955|FG001|NOT COMPLETED|Overall Study||5
8546027|NCT02412618|9577963|FG000|STARTED|Overall Study||50
8546028|NCT02412618|9577964|FG001|STARTED|Overall Study||50
8546029|NCT02412618|9577963|FG000|COMPLETED|Overall Study||48
8546030|NCT02412618|9577964|FG001|COMPLETED|Overall Study||48
8546031|NCT02412618|9577963|FG000|NOT COMPLETED|Overall Study||2
8546032|NCT02412618|9577964|FG001|NOT COMPLETED|Overall Study||2
8546033|NCT02373683|9577972|FG000|STARTED|Overall Study||6
8546034|NCT02373683|9577973|FG001|STARTED|Overall Study||4
8546035|NCT02373683|9577972|FG000|COMPLETED|Overall Study||6
8546036|NCT02373683|9577973|FG001|COMPLETED|Overall Study||4
8546037|NCT02373683|9577972|FG000|NOT COMPLETED|Overall Study||0
8546038|NCT02373683|9577973|FG001|NOT COMPLETED|Overall Study||0
8546039|NCT02351180|9577981|FG000|STARTED|Overall Study||8
8546040|NCT02351180|9577982|FG001|STARTED|Overall Study||8
8546041|NCT02351180|9577981|FG000|COMPLETED|Overall Study||7
8546042|NCT02351180|9577982|FG001|COMPLETED|Overall Study||8
8546043|NCT02351180|9577981|FG000|NOT COMPLETED|Overall Study||1
8546044|NCT02351180|9577982|FG001|NOT COMPLETED|Overall Study||0
8546045|NCT02337764|9577988|FG000|STARTED|Overall Study||222
8546046|NCT02337764|9577988|FG000|COMPLETED|Overall Study||162
8546047|NCT02337764|9577988|FG000|NOT COMPLETED|Overall Study||60
8546048|NCT02337738|9577995|FG000|STARTED|Overall Study||141
8546049|NCT02337738|9577996|FG001|STARTED|Overall Study||134
8546050|NCT02337738|9577997|FG002|STARTED|Overall Study||129
8546051|NCT02337738|9577995|FG000|COMPLETED|Overall Study||119
8546052|NCT02337738|9577996|FG001|COMPLETED|Overall Study||104
8546053|NCT02337738|9577997|FG002|COMPLETED|Overall Study||103
8546054|NCT02337738|9577995|FG000|NOT COMPLETED|Overall Study||22
8546055|NCT02337738|9577996|FG001|NOT COMPLETED|Overall Study||30
8546056|NCT02337738|9577997|FG002|NOT COMPLETED|Overall Study||26
8546057|NCT02332187|9578007|FG000|STARTED|Overall Study||5
8546058|NCT02332187|9578008|FG001|STARTED|Overall Study||10
8546059|NCT02332187|9578007|FG000|COMPLETED|Overall Study||3
8546060|NCT02332187|9578008|FG001|COMPLETED|Overall Study||7
8546061|NCT02332187|9578007|FG000|NOT COMPLETED|Overall Study||2
8546062|NCT02332187|9578008|FG001|NOT COMPLETED|Overall Study||3
8546063|NCT02227875|9578016|FG000|STARTED|Overall Study||277
8546064|NCT02227875|9578017|FG001|STARTED|Overall Study||283
8546065|NCT02227875|9578016|FG000|COMPLETED|Overall Study||240
8546066|NCT02227875|9578017|FG001|COMPLETED|Overall Study||250
8546067|NCT02227875|9578016|FG000|NOT COMPLETED|Overall Study||37
8546068|NCT02227875|9578017|FG001|NOT COMPLETED|Overall Study||33
8546069|NCT02227862|9578025|FG000|STARTED|Overall Study||280
8546070|NCT02227862|9578026|FG001|STARTED|Overall Study||278
8546071|NCT02227862|9578025|FG000|Week 24|Overall Study||269
8546072|NCT02227862|9578026|FG001|Week 24|Overall Study||263
8546073|NCT02227862|9578025|FG000|COMPLETED|Overall Study||261
8546074|NCT02227862|9578026|FG001|COMPLETED|Overall Study||256
8546075|NCT02227862|9578025|FG000|NOT COMPLETED|Overall Study||19
8546076|NCT02227862|9578026|FG001|NOT COMPLETED|Overall Study||22
8546077|NCT02200939|9578034|FG000|STARTED|Overall Study||33
8546078|NCT02200939|9578035|FG001|STARTED|Overall Study||115
8546079|NCT02200939|9578034|FG000|COMPLETED|Overall Study||31
8546080|NCT02200939|9578035|FG001|COMPLETED|Overall Study||104
8546081|NCT02200939|9578034|FG000|NOT COMPLETED|Overall Study||2
8546082|NCT02200939|9578035|FG001|NOT COMPLETED|Overall Study||11
8546083|NCT02108964|9578053|FG000|STARTED|Overall Study||17
8546084|NCT02108964|9578054|FG001|STARTED|Overall Study||38
8546085|NCT02108964|9578055|FG002|STARTED|Overall Study||73
8546086|NCT02108964|9578056|FG003|STARTED|Overall Study||8
8546087|NCT02108964|9578057|FG004|STARTED|Overall Study||28
8546088|NCT02108964|9578058|FG005|STARTED|Overall Study||5
8546089|NCT02108964|9578059|FG006|STARTED|Overall Study||11
8546090|NCT02108964|9578060|FG007|STARTED|Overall Study||45
8546091|NCT02108964|9578053|FG000|COMPLETED|Overall Study||3
8546092|NCT02108964|9578054|FG001|COMPLETED|Overall Study||6
8546093|NCT02108964|9578055|FG002|COMPLETED|Overall Study||8
8546094|NCT02108964|9578056|FG003|COMPLETED|Overall Study||2
8546095|NCT02108964|9578057|FG004|COMPLETED|Overall Study||3
8546096|NCT02108964|9578058|FG005|COMPLETED|Overall Study||0
8546097|NCT02108964|9578059|FG006|COMPLETED|Overall Study||0
8546098|NCT02108964|9578060|FG007|COMPLETED|Overall Study||33
8546099|NCT02108964|9578053|FG000|NOT COMPLETED|Overall Study||14
8546100|NCT02108964|9578054|FG001|NOT COMPLETED|Overall Study||32
8546101|NCT02108964|9578055|FG002|NOT COMPLETED|Overall Study||65
8546102|NCT02108964|9578056|FG003|NOT COMPLETED|Overall Study||6
8546103|NCT02108964|9578057|FG004|NOT COMPLETED|Overall Study||25
8546104|NCT02108964|9578058|FG005|NOT COMPLETED|Overall Study||5
8546105|NCT02108964|9578059|FG006|NOT COMPLETED|Overall Study||11
8546106|NCT02108964|9578060|FG007|NOT COMPLETED|Overall Study||12
8546107|NCT02022566|9578081|FG000|STARTED|Overall Study||227
8546108|NCT02022566|9578082|FG001|STARTED|Overall Study||90
8546109|NCT02022566|9578081|FG000|COMPLETED|Overall Study||169
8546110|NCT02022566|9578082|FG001|COMPLETED|Overall Study||49
8546111|NCT02022566|9578081|FG000|NOT COMPLETED|Overall Study||58
8546112|NCT02022566|9578082|FG001|NOT COMPLETED|Overall Study||41
8567051|NCT00082017|9599294|FG000|STARTED|Overall Study||11
8567052|NCT00082017|9599295|FG001|STARTED|Overall Study||9
8546113|NCT01989598|9578088|FG000|STARTED|Overall Study|Includes pts receiving Single agent Trametinib and pts who are receiving Trametinib with AKT Inhibitor GSK2141795|25
8546114|NCT01989598|9578088|FG000|Dual Therapy With Trametinib and GSK2141795|Overall Study|Patients with progressive disease or who achieve less than PR after 4 courses also received Akt inhibitor GSK2141795 PO daily on days 1-28 along with Tremetinib|12
8546115|NCT01989598|9578088|FG000|COMPLETED|Overall Study|Note: 25 patients enrolled, however, one patient unevaluable was not included in analysis|25
8546116|NCT01989598|9578088|FG000|NOT COMPLETED|Overall Study||0
8546117|NCT01939275|9578097|FG000|STARTED|Overall Study||8
8546118|NCT01939275|9578097|FG000|COMPLETED|Overall Study||8
8546119|NCT01939275|9578097|FG000|NOT COMPLETED|Overall Study||0
8546120|NCT01922895|9578103|FG000|STARTED|Overall Study||24
8546121|NCT01922895|9578104|FG001|STARTED|Overall Study||21
8546122|NCT01922895|9578103|FG000|COMPLETED|Overall Study||18
8546123|NCT01922895|9578104|FG001|COMPLETED|Overall Study||7
8546124|NCT01922895|9578103|FG000|NOT COMPLETED|Overall Study||6
8546125|NCT01922895|9578104|FG001|NOT COMPLETED|Overall Study||14
8546126|NCT01901289|9578110|FG000|STARTED|Overall Study||200
8546127|NCT01901289|9578110|FG000|12-Month Follow-up|Overall Study||194
8546128|NCT01901289|9578110|FG000|COMPLETED|Overall Study||115
8546129|NCT01901289|9578110|FG000|NOT COMPLETED|Overall Study||85
8546130|NCT01831895|9578114|FG000|STARTED|Overall Study||17
8546131|NCT01831895|9578114|FG000|COMPLETED|Overall Study||15
8546132|NCT01831895|9578114|FG000|NOT COMPLETED|Overall Study||2
8546133|NCT01831076|9578120|FG000|STARTED|Overall Study||31
8546134|NCT01831076|9578121|FG001|STARTED|Overall Study||5
8546135|NCT01831076|9578120|FG000|COMPLETED|Overall Study||30
8546136|NCT01831076|9578121|FG001|COMPLETED|Overall Study||4
8546137|NCT01831076|9578120|FG000|NOT COMPLETED|Overall Study||1
8546138|NCT01831076|9578121|FG001|NOT COMPLETED|Overall Study||1
8546139|NCT01595581|9578129|FG000|STARTED|Overall Study||7
8546140|NCT01595581|9578130|FG001|STARTED|Overall Study||7
8546141|NCT01595581|9578129|FG000|COMPLETED|Overall Study||6
8546142|NCT01595581|9578130|FG001|COMPLETED|Overall Study||7
8546143|NCT01595581|9578129|FG000|NOT COMPLETED|Overall Study||1
8546144|NCT01595581|9578130|FG001|NOT COMPLETED|Overall Study||0
8546145|NCT01514682|9578140|FG000|STARTED|Overall Study||19
8546146|NCT01514682|9578141|FG001|STARTED|Overall Study||20
8546147|NCT01514682|9578140|FG000|COMPLETED|Overall Study||13
8546148|NCT01514682|9578141|FG001|COMPLETED|Overall Study||14
8546149|NCT01514682|9578140|FG000|NOT COMPLETED|Overall Study||6
8546150|NCT01514682|9578141|FG001|NOT COMPLETED|Overall Study||6
8546151|NCT01453140|9578147|FG000|STARTED|Overall Study|3 patients were enrolled|3
8546152|NCT01453140|9578147|FG000|COMPLETED|Overall Study|All three patients experienced grade 4 limiting toxicities (possible treatment related)|0
8546153|NCT01453140|9578147|FG000|NOT COMPLETED|Overall Study||3
8546154|NCT01408641|9578157|FG000|STARTED|Overall Study||1
8546155|NCT01408641|9578158|FG001|STARTED|Overall Study||0
8546156|NCT01408641|9578157|FG000|COMPLETED|Overall Study||0
8546157|NCT01408641|9578158|FG001|COMPLETED|Overall Study||0
8546158|NCT01408641|9578157|FG000|NOT COMPLETED|Overall Study||1
8546159|NCT01408641|9578158|FG001|NOT COMPLETED|Overall Study||0
8546160|NCT01032265|9578166|FG000|STARTED|Overall Study||126
8546161|NCT01032265|9578167|FG001|STARTED|Overall Study||124
8546162|NCT01032265|9578166|FG000|COMPLETED|Overall Study||113
8546163|NCT01032265|9578167|FG001|COMPLETED|Overall Study||107
8546164|NCT01032265|9578166|FG000|NOT COMPLETED|Overall Study||13
8546165|NCT01032265|9578167|FG001|NOT COMPLETED|Overall Study||17
8546166|NCT00679783|9578180|FG000|STARTED|Overall Study|Gave Informed consent and passed screening|4
8546167|NCT00679783|9578181|FG001|STARTED|Overall Study|Gave Informed consent and passed screening|13
8546168|NCT00679783|9578182|FG002|STARTED|Overall Study|Gave Informed consent and passed screening|3
8546169|NCT00679783|9578183|FG003|STARTED|Overall Study|Gave Informed consent and passed screening|45
8546170|NCT00679783|9578184|FG004|STARTED|Overall Study|Gave Informed consent and passed screening|5
8546171|NCT00679783|9578185|FG005|STARTED|Overall Study|Gave Informed consent and passed screening|5
8546172|NCT00679783|9578186|FG006|STARTED|Overall Study|Gave Informed consent and passed screening|16
8546173|NCT00679783|9578180|FG000|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|2
8546174|NCT00679783|9578181|FG001|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|10
8546175|NCT00679783|9578182|FG002|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|2
8546176|NCT00679783|9578183|FG003|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|25
8546177|NCT00679783|9578184|FG004|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|4
8546178|NCT00679783|9578185|FG005|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|5
8546179|NCT00679783|9578186|FG006|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|15
8546180|NCT00679783|9578180|FG000|NOT COMPLETED|Overall Study||2
8546181|NCT00679783|9578181|FG001|NOT COMPLETED|Overall Study||3
8546182|NCT00679783|9578182|FG002|NOT COMPLETED|Overall Study||1
8546183|NCT00679783|9578183|FG003|NOT COMPLETED|Overall Study||20
8546184|NCT00679783|9578184|FG004|NOT COMPLETED|Overall Study||1
8621444|NCT00480324|9660432|FG000|NOT COMPLETED|Overall Study||32
8546185|NCT00679783|9578185|FG005|NOT COMPLETED|Overall Study||0
8546186|NCT00679783|9578186|FG006|NOT COMPLETED|Overall Study||1
8546187|NCT00653068|9578206|FG000|STARTED|Overall Study||70
8546188|NCT00653068|9578206|FG000|COMPLETED|Overall Study||20
8546189|NCT00653068|9578206|FG000|NOT COMPLETED|Overall Study||50
8546190|NCT00193479|9578213|FG000|STARTED|Induction Chemotherapy||51
8546191|NCT00193479|9578213|FG000|COMPLETED|Induction Chemotherapy||48
8546192|NCT00193479|9578213|FG000|NOT COMPLETED|Induction Chemotherapy||3
8546193|NCT00193479|9578213|FG000|STARTED|Maintenance Rituximab||48
8546194|NCT00193479|9578213|FG000|COMPLETED|Maintenance Rituximab||44
8546195|NCT00193479|9578213|FG000|NOT COMPLETED|Maintenance Rituximab||4
8546196|NCT00193427|9578217|FG000|STARTED|Overall Study||75
8546197|NCT00193427|9578217|FG000|COMPLETED|Overall Study||26
8546198|NCT00193427|9578217|FG000|NOT COMPLETED|Overall Study||49
8546199|NCT00193414|9578222|FG000|STARTED|Overall Study||72
8546200|NCT00193414|9578222|FG000|COMPLETED|Overall Study||14
8546201|NCT00193414|9578222|FG000|NOT COMPLETED|Overall Study||58
8546202|NCT00085735|9578232|FG000|STARTED|Overall Study||64
8546203|NCT00085735|9578233|FG001|STARTED|Overall Study||64
8546204|NCT00085735|9578234|FG002|STARTED|Overall Study||63
8546205|NCT00085735|9578235|FG003|STARTED|Overall Study||65
8546206|NCT00085735|9578236|FG004|STARTED|Overall Study||147
8546207|NCT00085735|9578237|FG005|STARTED|Overall Study||146
8546208|NCT00085735|9578232|FG000|COMPLETED|Overall Study||52
8546209|NCT00085735|9578233|FG001|COMPLETED|Overall Study||54
8546210|NCT00085735|9578234|FG002|COMPLETED|Overall Study||46
8546211|NCT00085735|9578235|FG003|COMPLETED|Overall Study||46
8546212|NCT00085735|9578236|FG004|COMPLETED|Overall Study||105
8546213|NCT00085735|9578237|FG005|COMPLETED|Overall Study||115
8546214|NCT00085735|9578232|FG000|NOT COMPLETED|Overall Study||12
8546215|NCT00085735|9578233|FG001|NOT COMPLETED|Overall Study||10
8546216|NCT00085735|9578234|FG002|NOT COMPLETED|Overall Study||17
8546217|NCT00085735|9578235|FG003|NOT COMPLETED|Overall Study||19
8546218|NCT00085735|9578236|FG004|NOT COMPLETED|Overall Study||42
8546219|NCT00085735|9578237|FG005|NOT COMPLETED|Overall Study||31
8546220|NCT00003042|9578266|FG000|STARTED|Overall Study||14
8546221|NCT00003042|9578267|FG001|STARTED|Overall Study||27
8546222|NCT00003042|9578266|FG000|COMPLETED|Overall Study||14
8546223|NCT00003042|9578267|FG001|COMPLETED|Overall Study||27
8546224|NCT00003042|9578266|FG000|NOT COMPLETED|Overall Study||0
8546225|NCT00003042|9578267|FG001|NOT COMPLETED|Overall Study||0
8546226|NCT00002874|9578275|FG000|STARTED|Overall Study||421
8546227|NCT00002874|9578276|FG001|STARTED|Overall Study||419
8546228|NCT00002874|9578275|FG000|COMPLETED|Overall Study||376
8546229|NCT00002874|9578276|FG001|COMPLETED|Overall Study||384
8546230|NCT00002874|9578275|FG000|NOT COMPLETED|Overall Study||45
8546231|NCT00002874|9578276|FG001|NOT COMPLETED|Overall Study||35
8567053|NCT00082017|9599294|FG000|COMPLETED|Overall Study||11
8567054|NCT00082017|9599295|FG001|COMPLETED|Overall Study||9
8567055|NCT00082017|9599294|FG000|NOT COMPLETED|Overall Study||0
8567056|NCT00082017|9599295|FG001|NOT COMPLETED|Overall Study||0
8567057|NCT00082173|9599303|FG000|STARTED|Overall Study||74
8567058|NCT00082173|9599304|FG001|STARTED|Overall Study||72
8567059|NCT00082173|9599303|FG000|COMPLETED|Overall Study||64
8567060|NCT00082173|9599304|FG001|COMPLETED|Overall Study||61
8567061|NCT00082173|9599303|FG000|NOT COMPLETED|Overall Study||10
8567062|NCT00082173|9599304|FG001|NOT COMPLETED|Overall Study||11
8567063|NCT00082329|9599310|FG000|STARTED|Overall Study||9
8567064|NCT00082329|9599310|FG000|COMPLETED|Overall Study||9
8621445|NCT00480324|9660433|FG001|NOT COMPLETED|Overall Study||16
8621446|NCT00480441|9660441|FG000|STARTED|Screening||61
8567065|NCT00082329|9599310|FG000|NOT COMPLETED|Overall Study||0
8567066|NCT00082342|9599316|FG000|STARTED|Overall Study||13
8567067|NCT00082342|9599317|FG001|STARTED|Overall Study||12
8567068|NCT00082342|9599316|FG000|COMPLETED|Overall Study||13
8567069|NCT00082342|9599317|FG001|COMPLETED|Overall Study||12
8567070|NCT00082342|9599316|FG000|NOT COMPLETED|Overall Study||0
8567071|NCT00082342|9599317|FG001|NOT COMPLETED|Overall Study||0
8567072|NCT00082355|9599337|FG000|STARTED|Initial Results of Thrombolytic Therapy||30
8567073|NCT00082355|9599337|FG000|COMPLETED|Initial Results of Thrombolytic Therapy||28
8567074|NCT00082355|9599337|FG000|NOT COMPLETED|Initial Results of Thrombolytic Therapy||2
8567075|NCT00082355|9599337|FG000|STARTED|5 Year Recurrent Thromboembolism Rate||28
8567076|NCT00082355|9599337|FG000|COMPLETED|5 Year Recurrent Thromboembolism Rate|data will not be complied until 2014|0
8567077|NCT00082355|9599337|FG000|NOT COMPLETED|5 Year Recurrent Thromboembolism Rate||28
8567078|NCT00082368|9599341|FG000|STARTED|Overall Study||12
8567079|NCT00082368|9599341|FG000|COMPLETED|Overall Study||11
8567080|NCT00082368|9599341|FG000|NOT COMPLETED|Overall Study||1
8567081|NCT00082381|9599347|FG000|STARTED|Overall Study||283
8567082|NCT00082381|9599348|FG001|STARTED|Overall Study||268
8567083|NCT00082381|9599347|FG000|Received Treatment (Intent to Treat)|Overall Study||282
8567084|NCT00082381|9599348|FG001|Received Treatment (Intent to Treat)|Overall Study||267
8567085|NCT00082381|9599347|FG000|COMPLETED|Overall Study||228
8567086|NCT00082381|9599348|FG001|COMPLETED|Overall Study||242
8567087|NCT00082381|9599347|FG000|NOT COMPLETED|Overall Study||55
8567088|NCT00082381|9599348|FG001|NOT COMPLETED|Overall Study||26
8567089|NCT00082407|9599356|FG000|STARTED|Overall Study||255
8621447|NCT00480441|9660442|FG001|STARTED|Screening|"Participants did not enter this arm until period 3 randomization"|0
8567090|NCT00082407|9599357|FG001|STARTED|Overall Study||250
8629453|NCT00530335|9669198|FG000|COMPLETED|Overall Study||39
8567091|NCT00082407|9599356|FG000|Received Treatment (Intent to Treat)|Overall Study||253
8567092|NCT00082407|9599357|FG001|Received Treatment (Intent to Treat)|Overall Study||248
8567093|NCT00082407|9599356|FG000|COMPLETED|Overall Study||199
8567094|NCT00082407|9599357|FG001|COMPLETED|Overall Study||223
8567095|NCT00082407|9599356|FG000|NOT COMPLETED|Overall Study||56
8546232|NCT04399356|9578284|FG000|STARTED|Overall Study||36
8546233|NCT04399356|9578285|FG001|STARTED|Overall Study||37
8546234|NCT04399356|9578284|FG000|COMPLETED|Overall Study||33
8546235|NCT04399356|9578285|FG001|COMPLETED|Overall Study||34
8546236|NCT04399356|9578284|FG000|NOT COMPLETED|Overall Study||3
8546237|NCT04399356|9578285|FG001|NOT COMPLETED|Overall Study||3
8546289|NCT03933449|9578343|FG000|STARTED|Overall Study||62
8546290|NCT03933449|9578344|FG001|STARTED|Overall Study||61
8546291|NCT03933449|9578343|FG000|Treated|Overall Study||62
8546292|NCT03933449|9578344|FG001|Treated|Overall Study||59
8546293|NCT03933449|9578343|FG000|COMPLETED|Overall Study||0
8546294|NCT03933449|9578344|FG001|COMPLETED|Overall Study||0
8546295|NCT03933449|9578343|FG000|NOT COMPLETED|Overall Study||62
8546296|NCT03933449|9578344|FG001|NOT COMPLETED|Overall Study||61
8546297|NCT03826667|9578350|FG000|STARTED|Overall Study||464
8546298|NCT03826667|9578350|FG000|HEALICOIL™ PK Preloaded Suture Anchors|Overall Study||193
8546299|NCT03826667|9578350|FG000|BIORAPTOR™ 2.3 PK Suture Anchors/BIORAPTOR™ Curved 2.3 PK Suture Anchors|Overall Study||41
8546300|NCT03826667|9578350|FG000|MULTIFIX™ S Ultra Knotless Fixation System|Overall Study||78
8546301|NCT03826667|9578350|FG000|FOOTPRINT™ Ultra PK Suture Anchors|Overall Study||136
8546302|NCT03826667|9578350|FG000|TWINFIX™ Ultra PK Suture Anchors/TWINFIX™ Ultra Preloaded and With Needles|Overall Study||57
8546303|NCT03826667|9578350|FG000|SPEEDSCREW™ Knotless Fixation System|Overall Study||59
8546304|NCT03826667|9578350|FG000|SpeedLock Knotless Fixation Device|Overall Study||18
8546305|NCT03826667|9578350|FG000|COMPLETED|Overall Study||443
8546306|NCT03826667|9578350|FG000|NOT COMPLETED|Overall Study||21
8546307|NCT03600909|9578363|FG000|STARTED|Overall Study||0
8546308|NCT03600909|9578364|FG001|STARTED|Overall Study||3
8546309|NCT03600909|9578365|FG002|STARTED|Overall Study||0
8546310|NCT03600909|9578363|FG000|COMPLETED|Overall Study||0
8546311|NCT03600909|9578364|FG001|COMPLETED|Overall Study||0
8546312|NCT03600909|9578365|FG002|COMPLETED|Overall Study||0
8546313|NCT03600909|9578363|FG000|NOT COMPLETED|Overall Study||0
8546314|NCT03600909|9578364|FG001|NOT COMPLETED|Overall Study||3
8546315|NCT03600909|9578365|FG002|NOT COMPLETED|Overall Study||0
8546316|NCT03368781|9578373|FG000|STARTED|Overall Study||128
8546317|NCT03368781|9578373|FG000|COMPLETED|Overall Study||103
8546318|NCT03368781|9578373|FG000|NOT COMPLETED|Overall Study||25
8546319|NCT03366428|9578381|FG000|STARTED|Overall Study||51
8546320|NCT03366428|9578381|FG000|COMPLETED|Overall Study||0
8546321|NCT03366428|9578381|FG000|NOT COMPLETED|Overall Study||51
8546322|NCT03221660|9578387|FG000|STARTED|Overall Study||50
8546323|NCT03221660|9578387|FG000|COMPLETED|Overall Study||50
8546324|NCT03221660|9578387|FG000|NOT COMPLETED|Overall Study||0
8546325|NCT03131219|9578393|FG000|STARTED|Initial Evaluation Period||21
8546326|NCT03131219|9578394|FG001|STARTED|Initial Evaluation Period||10
8546327|NCT03131219|9578393|FG000|Received At Least 1 Dose of Study Drug|Initial Evaluation Period||21
8546328|NCT03131219|9578394|FG001|Received At Least 1 Dose of Study Drug|Initial Evaluation Period||10
8546329|NCT03131219|9578393|FG000|COMPLETED|Initial Evaluation Period||17
8546330|NCT03131219|9578394|FG001|COMPLETED|Initial Evaluation Period||10
8546331|NCT03131219|9578393|FG000|NOT COMPLETED|Initial Evaluation Period||4
8546332|NCT03131219|9578394|FG001|NOT COMPLETED|Initial Evaluation Period||0
8546333|NCT03131219|9578393|FG000|STARTED|Extension Period||17
8546334|NCT03131219|9578394|FG001|STARTED|Extension Period||10
8546335|NCT03131219|9578393|FG000|Received At Least 1 Dose of Study Drug|Extension Period||17
8546336|NCT03131219|9578394|FG001|Received At Least 1 Dose of Study Drug|Extension Period||10
8546337|NCT03131219|9578393|FG000|Ongoing|Extension Period||16
8546338|NCT03131219|9578394|FG001|Ongoing|Extension Period||10
8546339|NCT03131219|9578393|FG000|COMPLETED|Extension Period||0
8546340|NCT03131219|9578394|FG001|COMPLETED|Extension Period||0
8546341|NCT03131219|9578393|FG000|NOT COMPLETED|Extension Period||17
8546342|NCT03131219|9578394|FG001|NOT COMPLETED|Extension Period||10
8546343|NCT03075527|9578400|FG000|STARTED|Overall Study||19
8546344|NCT03075527|9578400|FG000|COMPLETED|Overall Study||17
8546345|NCT03075527|9578400|FG000|NOT COMPLETED|Overall Study||2
8546346|NCT02756611|9578404|FG000|STARTED|Overall Study||258
8546347|NCT02756611|9578404|FG000|COMPLETED|Overall Study||2
8546348|NCT02756611|9578404|FG000|NOT COMPLETED|Overall Study||256
8546349|NCT02724878|9578408|FG000|STARTED|Overall Study||65
8546350|NCT02724878|9578408|FG000|Treated|Overall Study||60
8546351|NCT02724878|9578408|FG000|Responders|Overall Study||20
8546352|NCT02724878|9578408|FG000|COMPLETED|Overall Study||0
8546353|NCT02724878|9578408|FG000|NOT COMPLETED|Overall Study||65
8546354|NCT02605993|9578416|FG000|STARTED|Treatment Period||6
8546355|NCT02605993|9578417|FG001|STARTED|Treatment Period||6
8546356|NCT02605993|9578418|FG002|STARTED|Treatment Period||7
8546357|NCT02605993|9578419|FG003|STARTED|Treatment Period||7
8546358|NCT02605993|9578416|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||6
8546359|NCT02605993|9578417|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||6
8546360|NCT02605993|9578418|FG002|Received at Least 1 Dose of Study Drug|Treatment Period||7
8546361|NCT02605993|9578419|FG003|Received at Least 1 Dose of Study Drug|Treatment Period||7
8546362|NCT02605993|9578416|FG000|COMPLETED|Treatment Period||6
8546363|NCT02605993|9578417|FG001|COMPLETED|Treatment Period||6
8546364|NCT02605993|9578418|FG002|COMPLETED|Treatment Period||7
8546365|NCT02605993|9578419|FG003|COMPLETED|Treatment Period||7
8546366|NCT02605993|9578416|FG000|NOT COMPLETED|Treatment Period||0
8546367|NCT02605993|9578417|FG001|NOT COMPLETED|Treatment Period||0
8546368|NCT02605993|9578418|FG002|NOT COMPLETED|Treatment Period||0
8546238|NCT04350905|9578291|FG000|STARTED|Overall Study||42
8546239|NCT04350905|9578291|FG000|COMPLETED|Overall Study||41
8546240|NCT04350905|9578291|FG000|NOT COMPLETED|Overall Study||1
8546241|NCT04236635|9578295|FG000|STARTED|Overall Study||2
8546242|NCT04236635|9578296|FG001|STARTED|Overall Study||1
8546243|NCT04236635|9578297|FG002|STARTED|Overall Study||1
8546244|NCT04236635|9578298|FG003|STARTED|Overall Study||4
8546245|NCT04236635|9578299|FG004|STARTED|Overall Study||1
8546246|NCT04236635|9578300|FG005|STARTED|Overall Study||1
8546247|NCT04236635|9578295|FG000|Safety Population|Overall Study||2
8546248|NCT04236635|9578296|FG001|Safety Population|Overall Study||1
8546249|NCT04236635|9578297|FG002|Safety Population|Overall Study||1
8546250|NCT04236635|9578298|FG003|Safety Population|Overall Study||4
8546251|NCT04236635|9578299|FG004|Safety Population|Overall Study||1
8546252|NCT04236635|9578300|FG005|Safety Population|Overall Study||1
8546253|NCT04236635|9578295|FG000|Evaluable Population|Overall Study||2
8546254|NCT04236635|9578296|FG001|Evaluable Population|Overall Study||1
8546255|NCT04236635|9578297|FG002|Evaluable Population|Overall Study||1
8546256|NCT04236635|9578298|FG003|Evaluable Population|Overall Study||2
8546257|NCT04236635|9578299|FG004|Evaluable Population|Overall Study||1
8546258|NCT04236635|9578300|FG005|Evaluable Population|Overall Study||1
8546259|NCT04236635|9578295|FG000|COMPLETED|Overall Study||2
8546260|NCT04236635|9578296|FG001|COMPLETED|Overall Study||1
8546261|NCT04236635|9578297|FG002|COMPLETED|Overall Study||1
8546262|NCT04236635|9578298|FG003|COMPLETED|Overall Study||4
8546263|NCT04236635|9578299|FG004|COMPLETED|Overall Study||1
8546264|NCT04236635|9578300|FG005|COMPLETED|Overall Study||1
8546265|NCT04236635|9578295|FG000|NOT COMPLETED|Overall Study||0
8546266|NCT04236635|9578296|FG001|NOT COMPLETED|Overall Study||0
8546267|NCT04236635|9578297|FG002|NOT COMPLETED|Overall Study||0
8621448|NCT00480441|9660443|FG002|STARTED|Screening|"Participants did not enter this arm until period 3 randomization"|0
8621449|NCT00480441|9660441|FG000|COMPLETED|Screening||24
8621450|NCT00480441|9660442|FG001|COMPLETED|Screening|"Participants did not enter this arm until period 3 randomization"|0
8546268|NCT04236635|9578298|FG003|NOT COMPLETED|Overall Study||0
8546269|NCT04236635|9578299|FG004|NOT COMPLETED|Overall Study||0
8546270|NCT04236635|9578300|FG005|NOT COMPLETED|Overall Study||0
8546271|NCT04156399|9578315|FG000|STARTED|Overall Study||6
8546272|NCT04156399|9578315|FG000|COMPLETED|Overall Study|Of the six participants who started the study, two completed all 10 acupuncture sessions, two completed 9 sessions, and one completed 8 sessions. The three who completed 8 or 9 sessions were unable to complete due to the COVID-19 lockdowns, however, we were able to collect post-test measures for them. Finally, one participant was hospitalized (unrelated to acupuncture) and could not complete the study nor provide post-test measures.|2
8546273|NCT04156399|9578315|FG000|NOT COMPLETED|Overall Study||4
8546274|NCT04148521|9578321|FG000|STARTED|Overall Study||534
8546275|NCT04148521|9578322|FG001|STARTED|Overall Study||555
8546276|NCT04148521|9578321|FG000|COMPLETED|Overall Study||534
8546277|NCT04148521|9578322|FG001|COMPLETED|Overall Study||555
8546278|NCT04148521|9578321|FG000|NOT COMPLETED|Overall Study||0
8546279|NCT04148521|9578322|FG001|NOT COMPLETED|Overall Study||0
8546280|NCT04115228|9578328|FG000|STARTED|Overall Study||10
8546281|NCT04115228|9578328|FG000|COMPLETED|Overall Study||10
8546282|NCT04115228|9578328|FG000|NOT COMPLETED|Overall Study||0
8546283|NCT04052620|9578334|FG000|STARTED|Overall Study||150
8546284|NCT04052620|9578335|FG001|STARTED|Overall Study||152
8546285|NCT04052620|9578334|FG000|COMPLETED|Overall Study||143
8546286|NCT04052620|9578335|FG001|COMPLETED|Overall Study||145
8546287|NCT04052620|9578334|FG000|NOT COMPLETED|Overall Study||7
8546288|NCT04052620|9578335|FG001|NOT COMPLETED|Overall Study||7
8546369|NCT02605993|9578419|FG003|NOT COMPLETED|Treatment Period||0
8546370|NCT02605993|9578416|FG000|STARTED|Extension Period||6
8546371|NCT02605993|9578417|FG001|STARTED|Extension Period||6
8546372|NCT02605993|9578418|FG002|STARTED|Extension Period||7
8546373|NCT02605993|9578419|FG003|STARTED|Extension Period||7
8546374|NCT02605993|9578416|FG000|COMPLETED|Extension Period||0
8546375|NCT02605993|9578417|FG001|COMPLETED|Extension Period||0
8546376|NCT02605993|9578418|FG002|COMPLETED|Extension Period||0
8546377|NCT02605993|9578419|FG003|COMPLETED|Extension Period||0
8546378|NCT02605993|9578416|FG000|NOT COMPLETED|Extension Period||6
8546379|NCT02605993|9578417|FG001|NOT COMPLETED|Extension Period||6
8546380|NCT02605993|9578418|FG002|NOT COMPLETED|Extension Period||7
8546381|NCT02605993|9578419|FG003|NOT COMPLETED|Extension Period||7
8546382|NCT02562235|9578429|FG000|STARTED|Overall Study||24
8546383|NCT02562235|9578429|FG000|COMPLETED|Overall Study||21
8546384|NCT02562235|9578429|FG000|NOT COMPLETED|Overall Study||3
8546385|NCT02522715|9578440|FG000|STARTED|Overall Study||3
8546386|NCT02522715|9578441|FG001|STARTED|Overall Study|+1 early withdrawal|33
8546387|NCT02522715|9578440|FG000|COMPLETED|Overall Study||3
8546388|NCT02522715|9578441|FG001|COMPLETED|Overall Study||33
8546389|NCT02522715|9578440|FG000|NOT COMPLETED|Overall Study||0
8546390|NCT02522715|9578441|FG001|NOT COMPLETED|Overall Study||0
8546391|NCT02487095|9578452|FG000|STARTED|Phase I Dose Escalation||6
8546392|NCT02487095|9578453|FG001|STARTED|Phase I Dose Escalation||6
8546393|NCT02487095|9578454|FG002|STARTED|Phase I Dose Escalation||3
8546394|NCT02487095|9578455|FG003|STARTED|Phase I Dose Escalation||6
8546395|NCT02487095|9578456|FG004|STARTED|Phase I Dose Escalation||0
8546396|NCT02487095|9578452|FG000|COMPLETED|Phase I Dose Escalation||6
8546397|NCT02487095|9578453|FG001|COMPLETED|Phase I Dose Escalation||6
8546398|NCT02487095|9578454|FG002|COMPLETED|Phase I Dose Escalation||3
8546399|NCT02487095|9578455|FG003|COMPLETED|Phase I Dose Escalation||6
8546400|NCT02487095|9578456|FG004|COMPLETED|Phase I Dose Escalation||0
8546401|NCT02487095|9578452|FG000|NOT COMPLETED|Phase I Dose Escalation||0
8546402|NCT02487095|9578453|FG001|NOT COMPLETED|Phase I Dose Escalation||0
8546403|NCT02487095|9578454|FG002|NOT COMPLETED|Phase I Dose Escalation||0
8546404|NCT02487095|9578455|FG003|NOT COMPLETED|Phase I Dose Escalation||0
8546405|NCT02487095|9578456|FG004|NOT COMPLETED|Phase I Dose Escalation||0
8546406|NCT02487095|9578452|FG000|STARTED|Dose Expansion||0
8546407|NCT02487095|9578453|FG001|STARTED|Dose Expansion||0
8546408|NCT02487095|9578454|FG002|STARTED|Dose Expansion||0
8546409|NCT02487095|9578455|FG003|STARTED|Dose Expansion||0
8546410|NCT02487095|9578456|FG004|STARTED|Dose Expansion||41
8546411|NCT02487095|9578452|FG000|COMPLETED|Dose Expansion||0
8546412|NCT02487095|9578453|FG001|COMPLETED|Dose Expansion||0
8546413|NCT02487095|9578454|FG002|COMPLETED|Dose Expansion||0
8546414|NCT02487095|9578455|FG003|COMPLETED|Dose Expansion||0
8546415|NCT02487095|9578456|FG004|COMPLETED|Dose Expansion||40
8546416|NCT02487095|9578452|FG000|NOT COMPLETED|Dose Expansion||0
8546417|NCT02487095|9578453|FG001|NOT COMPLETED|Dose Expansion||0
8546418|NCT02487095|9578454|FG002|NOT COMPLETED|Dose Expansion||0
8546419|NCT02487095|9578455|FG003|NOT COMPLETED|Dose Expansion||0
8546420|NCT02487095|9578456|FG004|NOT COMPLETED|Dose Expansion||1
8546421|NCT02347917|9578478|FG000|STARTED|Overall Study||4
8546422|NCT02347917|9578479|FG001|STARTED|Overall Study||24
8546423|NCT02347917|9578478|FG000|Discontinued beforeBBI608 Administration|Overall Study||0
8546424|NCT02347917|9578479|FG001|Discontinued beforeBBI608 Administration|Overall Study||0
8546425|NCT02347917|9578478|FG000|Start BBI608 Administration|Overall Study||4
8546426|NCT02347917|9578479|FG001|Start BBI608 Administration|Overall Study||24
8546427|NCT02347917|9578478|FG000|Discontinued in DLT Evaluation Period|Overall Study||1
8546428|NCT02347917|9578479|FG001|Discontinued in DLT Evaluation Period|Overall Study||0
8546429|NCT02347917|9578478|FG000|Complete DLT Evaluation Period|Overall Study||3
8546430|NCT02347917|9578479|FG001|Complete DLT Evaluation Period|Overall Study||0
8546431|NCT02347917|9578478|FG000|Discontinued After BBI608 Administration|Overall Study||4
8546432|NCT02347917|9578479|FG001|Discontinued After BBI608 Administration|Overall Study||24
8546433|NCT02347917|9578478|FG000|Discontinued Before Survival Observation|Overall Study||0
8546434|NCT02347917|9578479|FG001|Discontinued Before Survival Observation|Overall Study||1
8546435|NCT02347917|9578478|FG000|COMPLETED|Overall Study||4
8546436|NCT02347917|9578479|FG001|COMPLETED|Overall Study||23
8546437|NCT02347917|9578478|FG000|NOT COMPLETED|Overall Study||0
8546438|NCT02347917|9578479|FG001|NOT COMPLETED|Overall Study||1
8546439|NCT02344108|9578493|FG000|STARTED|Overall Study||42
8546440|NCT02344108|9578493|FG000|COMPLETED|Overall Study||42
8546441|NCT02344108|9578493|FG000|NOT COMPLETED|Overall Study||0
8546442|NCT02335658|9578503|FG000|STARTED|Overall Study|97 subjects in Cohort 1 and 103 subjects in Cohort 2 started to receive DSP-5423P.|97
8546443|NCT02335658|9578504|FG001|STARTED|Overall Study||103
8546444|NCT02335658|9578503|FG000|COMPLETED|Overall Study|57 subjects in Cohort 1 and 59 subjects in Cohort 2 completed the study.|57
8546445|NCT02335658|9578504|FG001|COMPLETED|Overall Study||59
8546446|NCT02335658|9578503|FG000|NOT COMPLETED|Overall Study||40
8546447|NCT02335658|9578504|FG001|NOT COMPLETED|Overall Study||44
8546448|NCT02287584|9578515|FG000|STARTED|the Double-blind Phase||190
8546449|NCT02287584|9578516|FG001|STARTED|the Double-blind Phase||196
8546450|NCT02287584|9578517|FG002|STARTED|the Double-blind Phase||194
8546451|NCT02287584|9578518|FG003|STARTED|the Double-blind Phase||0
8546452|NCT02287584|9578519|FG004|STARTED|the Double-blind Phase||0
8546453|NCT02287584|9578520|FG005|STARTED|the Double-blind Phase||0
8546454|NCT02287584|9578515|FG000|COMPLETED|the Double-blind Phase||138
8546455|NCT02287584|9578516|FG001|COMPLETED|the Double-blind Phase||149
8546456|NCT02287584|9578517|FG002|COMPLETED|the Double-blind Phase||161
8546457|NCT02287584|9578518|FG003|COMPLETED|the Double-blind Phase||0
8546458|NCT02287584|9578519|FG004|COMPLETED|the Double-blind Phase||0
8546459|NCT02287584|9578520|FG005|COMPLETED|the Double-blind Phase||0
8546460|NCT02287584|9578515|FG000|NOT COMPLETED|the Double-blind Phase||52
8546461|NCT02287584|9578516|FG001|NOT COMPLETED|the Double-blind Phase||47
8546462|NCT02287584|9578517|FG002|NOT COMPLETED|the Double-blind Phase||33
8546463|NCT02287584|9578518|FG003|NOT COMPLETED|the Double-blind Phase||0
8546464|NCT02287584|9578519|FG004|NOT COMPLETED|the Double-blind Phase||0
8546465|NCT02287584|9578520|FG005|NOT COMPLETED|the Double-blind Phase||0
8546466|NCT02287584|9578515|FG000|STARTED|the Open-label Phase||0
8546467|NCT02287584|9578516|FG001|STARTED|the Open-label Phase||0
8546468|NCT02287584|9578517|FG002|STARTED|the Open-label Phase||0
8546469|NCT02287584|9578518|FG003|STARTED|the Open-label Phase||138
8546470|NCT02287584|9578519|FG004|STARTED|the Open-label Phase||149
8546471|NCT02287584|9578520|FG005|STARTED|the Open-label Phase||161
8546472|NCT02287584|9578515|FG000|Treated|the Open-label Phase||0
8546473|NCT02287584|9578516|FG001|Treated|the Open-label Phase||0
8546474|NCT02287584|9578517|FG002|Treated|the Open-label Phase||0
8546475|NCT02287584|9578518|FG003|Treated|the Open-label Phase||131
8546476|NCT02287584|9578519|FG004|Treated|the Open-label Phase||143
8546477|NCT02287584|9578520|FG005|Treated|the Open-label Phase||157
8546478|NCT02287584|9578515|FG000|COMPLETED|the Open-label Phase||0
8546479|NCT02287584|9578516|FG001|COMPLETED|the Open-label Phase||0
8546480|NCT02287584|9578517|FG002|COMPLETED|the Open-label Phase||0
8546481|NCT02287584|9578518|FG003|COMPLETED|the Open-label Phase||81
8546482|NCT02287584|9578519|FG004|COMPLETED|the Open-label Phase||87
8546483|NCT02287584|9578520|FG005|COMPLETED|the Open-label Phase||104
8546484|NCT02287584|9578515|FG000|NOT COMPLETED|the Open-label Phase||0
8546485|NCT02287584|9578516|FG001|NOT COMPLETED|the Open-label Phase||0
8546486|NCT02287584|9578517|FG002|NOT COMPLETED|the Open-label Phase||0
8546487|NCT02287584|9578518|FG003|NOT COMPLETED|the Open-label Phase||57
8546488|NCT02287584|9578519|FG004|NOT COMPLETED|the Open-label Phase||62
8546489|NCT02287584|9578520|FG005|NOT COMPLETED|the Open-label Phase||57
8546490|NCT02178566|9578536|FG000|STARTED|Overall Study||0
8546491|NCT02178566|9578537|FG001|STARTED|Overall Study|no data available|1
8546492|NCT02178566|9578536|FG000|COMPLETED|Overall Study||0
8546493|NCT02178566|9578537|FG001|COMPLETED|Overall Study|no data available|0
8546494|NCT02178566|9578536|FG000|NOT COMPLETED|Overall Study||0
8546495|NCT02178566|9578537|FG001|NOT COMPLETED|Overall Study||1
8567096|NCT00082407|9599357|FG001|NOT COMPLETED|Overall Study||27
8567097|NCT00082433|9599365|FG000|STARTED|Overall Study||609
8567098|NCT00082433|9599366|FG001|STARTED|Overall Study||612
8567099|NCT00082433|9599365|FG000|COMPLETED|Overall Study|Participants who received 18 or more cycles of treatment.|15
8567100|NCT00082433|9599366|FG001|COMPLETED|Overall Study|Participants who received 18 or more cycles of treatment.|15
8567101|NCT00082433|9599365|FG000|NOT COMPLETED|Overall Study||594
8567102|NCT00082433|9599366|FG001|NOT COMPLETED|Overall Study||597
8567103|NCT00082628|9599374|FG000|STARTED|Treatment Period I (Week 1 to Week 12)||81
8567104|NCT00082628|9599375|FG001|STARTED|Treatment Period I (Week 1 to Week 12)||245
8567105|NCT00082628|9599376|FG002|STARTED|Treatment Period I (Week 1 to Week 12)||0
8567106|NCT00082628|9599377|FG003|STARTED|Treatment Period I (Week 1 to Week 12)||0
8567107|NCT00082628|9599378|FG004|STARTED|Treatment Period I (Week 1 to Week 12)||0
8567108|NCT00082628|9599374|FG000|COMPLETED|Treatment Period I (Week 1 to Week 12)||73
8567109|NCT00082628|9599375|FG001|COMPLETED|Treatment Period I (Week 1 to Week 12)||185
8567110|NCT00082628|9599376|FG002|COMPLETED|Treatment Period I (Week 1 to Week 12)||0
8567111|NCT00082628|9599377|FG003|COMPLETED|Treatment Period I (Week 1 to Week 12)||0
8567112|NCT00082628|9599378|FG004|COMPLETED|Treatment Period I (Week 1 to Week 12)||0
8567113|NCT00082628|9599374|FG000|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||8
8567114|NCT00082628|9599375|FG001|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||60
8567115|NCT00082628|9599376|FG002|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||0
8567116|NCT00082628|9599377|FG003|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||0
8567117|NCT00082628|9599378|FG004|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||0
8567118|NCT00082628|9599374|FG000|STARTED|Treatment Period II: Week 12 to Week 36||0
8567119|NCT00082628|9599375|FG001|STARTED|Treatment Period II: Week 12 to Week 36||0
8567120|NCT00082628|9599376|FG002|STARTED|Treatment Period II: Week 12 to Week 36||93
8567121|NCT00082628|9599377|FG003|STARTED|Treatment Period II: Week 12 to Week 36||92
8567122|NCT00082628|9599378|FG004|STARTED|Treatment Period II: Week 12 to Week 36||73
8567123|NCT00082628|9599374|FG000|COMPLETED|Treatment Period II: Week 12 to Week 36||0
8567124|NCT00082628|9599375|FG001|COMPLETED|Treatment Period II: Week 12 to Week 36||0
8567125|NCT00082628|9599376|FG002|COMPLETED|Treatment Period II: Week 12 to Week 36||78
8567126|NCT00082628|9599377|FG003|COMPLETED|Treatment Period II: Week 12 to Week 36||76
8567127|NCT00082628|9599378|FG004|COMPLETED|Treatment Period II: Week 12 to Week 36||55
8567128|NCT00082628|9599374|FG000|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||0
8567129|NCT00082628|9599375|FG001|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||0
8567130|NCT00082628|9599376|FG002|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||15
8567131|NCT00082628|9599377|FG003|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||16
8567132|NCT00082628|9599378|FG004|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||18
8567133|NCT00082641|9599392|FG000|STARTED|Overall Study||11
8567134|NCT00082641|9599393|FG001|STARTED|Overall Study||12
8567135|NCT00082641|9599392|FG000|COMPLETED|Overall Study||11
8567136|NCT00082641|9599393|FG001|COMPLETED|Overall Study||12
8567137|NCT00082641|9599392|FG000|NOT COMPLETED|Overall Study||0
8567138|NCT00082641|9599393|FG001|NOT COMPLETED|Overall Study||0
8567139|NCT00082758|9599403|FG000|STARTED|Overall Study||15
8567140|NCT00082758|9599404|FG001|STARTED|Overall Study||24
8567141|NCT00082758|9599405|FG002|STARTED|Overall Study||0
8567142|NCT00082758|9599403|FG000|COMPLETED|Overall Study||0
8567143|NCT00082758|9599404|FG001|COMPLETED|Overall Study||7
8567144|NCT00082758|9599405|FG002|COMPLETED|Overall Study||0
8567145|NCT00082758|9599403|FG000|NOT COMPLETED|Overall Study||15
8567146|NCT00082758|9599404|FG001|NOT COMPLETED|Overall Study||17
8567147|NCT00082758|9599405|FG002|NOT COMPLETED|Overall Study||0
8567148|NCT00082810|9599413|FG000|STARTED|Overall Study||33
8567149|NCT00082810|9599413|FG000|COMPLETED|Overall Study||2
8567150|NCT00082810|9599413|FG000|NOT COMPLETED|Overall Study||31
8567151|NCT00082888|9599421|FG000|STARTED|Overall Study||42
8567152|NCT00082888|9599422|FG001|STARTED|Overall Study||15
8567153|NCT00082888|9599423|FG002|STARTED|Overall Study||36
8567154|NCT00082888|9599421|FG000|COMPLETED|Overall Study||41
8567155|NCT00082888|9599422|FG001|COMPLETED|Overall Study||15
8567156|NCT00082888|9599423|FG002|COMPLETED|Overall Study||36
8567157|NCT00082888|9599421|FG000|NOT COMPLETED|Overall Study||1
8567158|NCT00082888|9599422|FG001|NOT COMPLETED|Overall Study||0
8567159|NCT00082888|9599423|FG002|NOT COMPLETED|Overall Study||0
8567160|NCT00083122|9599434|FG000|STARTED|Overall Study||40
8567161|NCT00083122|9599435|FG001|STARTED|Overall Study||5
8567162|NCT00083122|9599434|FG000|COMPLETED|Overall Study||40
8567163|NCT00083122|9599435|FG001|COMPLETED|Overall Study||5
8567164|NCT00083122|9599434|FG000|NOT COMPLETED|Overall Study||0
8546496|NCT02173301|9578547|FG000|STARTED|Overall Study||49
8546497|NCT02173301|9578548|FG001|STARTED|Overall Study||55
8546498|NCT02173301|9578549|FG002|STARTED|Overall Study||48
8546499|NCT02173301|9578550|FG003|STARTED|Overall Study||48
8546500|NCT02173301|9578547|FG000|COMPLETED|Overall Study||29
8546501|NCT02173301|9578548|FG001|COMPLETED|Overall Study||32
8546502|NCT02173301|9578549|FG002|COMPLETED|Overall Study||28
8546503|NCT02173301|9578550|FG003|COMPLETED|Overall Study||33
8546504|NCT02173301|9578547|FG000|NOT COMPLETED|Overall Study||20
8546505|NCT02173301|9578548|FG001|NOT COMPLETED|Overall Study||23
8546506|NCT02173301|9578549|FG002|NOT COMPLETED|Overall Study||20
8546507|NCT02173301|9578550|FG003|NOT COMPLETED|Overall Study||15
8546508|NCT02043678|9578562|FG000|STARTED|Overall Study||401
8546509|NCT02043678|9578563|FG001|STARTED|Overall Study||405
8546510|NCT02043678|9578562|FG000|Treated|Overall Study||390
8546511|NCT02043678|9578563|FG001|Treated|Overall Study||396
8546512|NCT02043678|9578562|FG000|COMPLETED|Overall Study||0
8546513|NCT02043678|9578563|FG001|COMPLETED|Overall Study||0
8546514|NCT02043678|9578562|FG000|NOT COMPLETED|Overall Study||401
8546515|NCT02043678|9578563|FG001|NOT COMPLETED|Overall Study||405
8546516|NCT01986114|9578569|FG000|STARTED|Overall Study||495
8546517|NCT01986114|9578569|FG000|COMPLETED|Overall Study||339
8546518|NCT01986114|9578569|FG000|NOT COMPLETED|Overall Study||156
8546519|NCT01986101|9578578|FG000|STARTED|Overall Study||172
8546520|NCT01986101|9578579|FG001|STARTED|Overall Study||184
8546521|NCT01986101|9578580|FG002|STARTED|Overall Study||169
8546522|NCT01986101|9578578|FG000|Intent-to-Treat Population|Overall Study||171
8546523|NCT01986101|9578579|FG001|Intent-to-Treat Population|Overall Study||182
8546524|NCT01986101|9578580|FG002|Intent-to-Treat Population|Overall Study||169
8546525|NCT01986101|9578578|FG000|Safety Population|Overall Study||172
8546526|NCT01986101|9578579|FG001|Safety Population|Overall Study||184
8546527|NCT01986101|9578580|FG002|Safety Population|Overall Study||169
8546528|NCT01986101|9578578|FG000|COMPLETED|Overall Study||139
8546529|NCT01986101|9578579|FG001|COMPLETED|Overall Study||157
8546530|NCT01986101|9578580|FG002|COMPLETED|Overall Study||137
8546531|NCT01986101|9578578|FG000|NOT COMPLETED|Overall Study||33
8546532|NCT01986101|9578579|FG001|NOT COMPLETED|Overall Study||27
8546533|NCT01986101|9578580|FG002|NOT COMPLETED|Overall Study||32
8546534|NCT01972035|9578593|FG000|STARTED|Overall Study||66
8546535|NCT01972035|9578594|FG001|STARTED|Overall Study||71
8546536|NCT01972035|9578593|FG000|COMPLETED|Overall Study||27
8546537|NCT01972035|9578594|FG001|COMPLETED|Overall Study||44
8546538|NCT01972035|9578593|FG000|NOT COMPLETED|Overall Study||39
8546539|NCT01972035|9578594|FG001|NOT COMPLETED|Overall Study||27
8546540|NCT01955980|9578602|FG000|STARTED|Overall Study||10
8546541|NCT01955980|9578603|FG001|STARTED|Overall Study||9
8546542|NCT01955980|9578602|FG000|COMPLETED|Overall Study||10
8546543|NCT01955980|9578603|FG001|COMPLETED|Overall Study||9
8546544|NCT01955980|9578602|FG000|NOT COMPLETED|Overall Study||0
8546545|NCT01955980|9578603|FG001|NOT COMPLETED|Overall Study||0
8546546|NCT01946711|9578612|FG000|STARTED|Overall Study||8
8546547|NCT01946711|9578613|FG001|STARTED|Overall Study||6
8546548|NCT01946711|9578612|FG000|COMPLETED|Overall Study||8
8546549|NCT01946711|9578613|FG001|COMPLETED|Overall Study||6
8546550|NCT01946711|9578612|FG000|NOT COMPLETED|Overall Study||0
8546551|NCT01946711|9578613|FG001|NOT COMPLETED|Overall Study||0
8546552|NCT01891994|9578619|FG000|STARTED|Overall Study||40
8546553|NCT01891994|9578619|FG000|COMPLETED|Overall Study||40
8546554|NCT01891994|9578619|FG000|NOT COMPLETED|Overall Study||0
8546555|NCT01839396|9578625|FG000|STARTED|Overall Study||121
8818360|NCT01557244|9872005|FG005|Treated|Safety Extension Phase: 12 Weeks||20
8818361|NCT01557244|9872006|FG006|Treated|Safety Extension Phase: 12 Weeks||28
8546556|NCT01839396|9578626|FG001|STARTED|Overall Study||39
8546557|NCT01839396|9578625|FG000|COMPLETED|Overall Study||121
8546558|NCT01839396|9578626|FG001|COMPLETED|Overall Study||39
8546559|NCT01839396|9578625|FG000|NOT COMPLETED|Overall Study||0
8546560|NCT01839396|9578626|FG001|NOT COMPLETED|Overall Study||0
8546561|NCT01813305|9578634|FG000|STARTED|Overall Study||98
8546562|NCT01813305|9578635|FG001|STARTED|Overall Study||26
8546563|NCT01813305|9578634|FG000|COMPLETED|Overall Study||63
8546564|NCT01813305|9578635|FG001|COMPLETED|Overall Study||18
8546565|NCT01813305|9578634|FG000|NOT COMPLETED|Overall Study||35
8546566|NCT01813305|9578635|FG001|NOT COMPLETED|Overall Study||8
8546567|NCT01740427|9578645|FG000|STARTED|Overall Study||444
8546568|NCT01740427|9578646|FG001|STARTED|Overall Study||222
8546569|NCT01740427|9578645|FG000|COMPLETED|Overall Study||0
8546570|NCT01740427|9578646|FG001|COMPLETED|Overall Study||0
8546571|NCT01740427|9578645|FG000|NOT COMPLETED|Overall Study||444
8546572|NCT01740427|9578646|FG001|NOT COMPLETED|Overall Study||222
8546573|NCT01680965|9578656|FG000|STARTED|Overall Study||3
8546574|NCT01680965|9578657|FG001|STARTED|Overall Study||3
8546575|NCT01680965|9578658|FG002|STARTED|Overall Study||6
8546576|NCT01680965|9578659|FG003|STARTED|Overall Study||32
8546577|NCT01680965|9578656|FG000|COMPLETED|Overall Study||3
8546578|NCT01680965|9578657|FG001|COMPLETED|Overall Study||3
8546579|NCT01680965|9578658|FG002|COMPLETED|Overall Study||6
8546580|NCT01680965|9578659|FG003|COMPLETED|Overall Study||26
8546581|NCT01680965|9578656|FG000|NOT COMPLETED|Overall Study||0
8818362|NCT01557244|9872000|FG000|COMPLETED|Safety Extension Phase: 12 Weeks||30
8546582|NCT01680965|9578657|FG001|NOT COMPLETED|Overall Study||0
8546583|NCT01680965|9578658|FG002|NOT COMPLETED|Overall Study||0
8818363|NCT01557244|9872001|FG001|COMPLETED|Safety Extension Phase: 12 Weeks||36
8546584|NCT01680965|9578659|FG003|NOT COMPLETED|Overall Study||6
8546585|NCT01614912|9578667|FG000|STARTED|Overall Study||284
8546586|NCT01614912|9578667|FG000|COMPLETED|Overall Study||159
8546587|NCT01614912|9578667|FG000|NOT COMPLETED|Overall Study||125
8546588|NCT01614899|9578674|FG000|STARTED|Overall Study||150
8546589|NCT01614899|9578675|FG001|STARTED|Overall Study||155
8546590|NCT01614899|9578676|FG002|STARTED|Overall Study||152
8546591|NCT01614899|9578674|FG000|COMPLETED|Overall Study||106
8546592|NCT01614899|9578675|FG001|COMPLETED|Overall Study||116
8546593|NCT01614899|9578676|FG002|COMPLETED|Overall Study||110
8546594|NCT01614899|9578674|FG000|NOT COMPLETED|Overall Study||44
8546595|NCT01614899|9578675|FG001|NOT COMPLETED|Overall Study||39
8546596|NCT01614899|9578676|FG002|NOT COMPLETED|Overall Study||42
8546597|NCT01592370|9578691|FG000|STARTED|Overall Study||105
8546598|NCT01592370|9578692|FG001|STARTED|Overall Study||65
8546599|NCT01592370|9578693|FG002|STARTED|Overall Study||72
8546600|NCT01592370|9578694|FG003|STARTED|Overall Study||6
8546601|NCT01592370|9578695|FG004|STARTED|Overall Study||5
8546602|NCT01592370|9578696|FG005|STARTED|Overall Study||41
8546603|NCT01592370|9578697|FG006|STARTED|Overall Study||22
8546604|NCT01592370|9578691|FG000|COMPLETED|Overall Study||1
8546605|NCT01592370|9578692|FG001|COMPLETED|Overall Study||40
8546606|NCT01592370|9578693|FG002|COMPLETED|Overall Study||0
8546607|NCT01592370|9578694|FG003|COMPLETED|Overall Study||1
8546608|NCT01592370|9578695|FG004|COMPLETED|Overall Study||1
8546609|NCT01592370|9578696|FG005|COMPLETED|Overall Study||7
8546610|NCT01592370|9578697|FG006|COMPLETED|Overall Study||6
8546611|NCT01592370|9578691|FG000|NOT COMPLETED|Overall Study||104
8546612|NCT01592370|9578692|FG001|NOT COMPLETED|Overall Study||25
8546613|NCT01592370|9578693|FG002|NOT COMPLETED|Overall Study||72
8546614|NCT01592370|9578694|FG003|NOT COMPLETED|Overall Study||5
8546615|NCT01592370|9578695|FG004|NOT COMPLETED|Overall Study||4
8546616|NCT01592370|9578696|FG005|NOT COMPLETED|Overall Study||34
8546617|NCT01592370|9578697|FG006|NOT COMPLETED|Overall Study||16
8546618|NCT00711269|9578721|FG000|STARTED|Overall Study||131
8546619|NCT00711269|9578722|FG001|STARTED|Overall Study||131
8546620|NCT00711269|9578723|FG002|STARTED|Overall Study||133
8546621|NCT00711269|9578724|FG003|STARTED|Overall Study||65
8546622|NCT00711269|9578721|FG000|COMPLETED|Overall Study||87
8546623|NCT00711269|9578722|FG001|COMPLETED|Overall Study||83
8546624|NCT00711269|9578723|FG002|COMPLETED|Overall Study||83
8546625|NCT00711269|9578724|FG003|COMPLETED|Overall Study||51
8546626|NCT00711269|9578721|FG000|NOT COMPLETED|Overall Study||44
8546627|NCT00711269|9578722|FG001|NOT COMPLETED|Overall Study||48
8546628|NCT00711269|9578723|FG002|NOT COMPLETED|Overall Study||50
8546629|NCT00711269|9578724|FG003|NOT COMPLETED|Overall Study||14
8546630|NCT00152477|9578738|FG000|STARTED|Chemotherapy Period||50
8546631|NCT00152477|9578739|FG001|STARTED|Chemotherapy Period||56
8546632|NCT00152477|9578740|FG002|STARTED|Chemotherapy Period||59
8546633|NCT00152477|9578738|FG000|Part II|Chemotherapy Period||50
8546634|NCT00152477|9578739|FG001|Part II|Chemotherapy Period||53
8546635|NCT00152477|9578740|FG002|Part II|Chemotherapy Period||53
8546636|NCT00152477|9578738|FG000|COMPLETED|Chemotherapy Period||22
8546637|NCT00152477|9578739|FG001|COMPLETED|Chemotherapy Period||34
8546638|NCT00152477|9578740|FG002|COMPLETED|Chemotherapy Period||39
8546639|NCT00152477|9578738|FG000|NOT COMPLETED|Chemotherapy Period||28
8546640|NCT00152477|9578739|FG001|NOT COMPLETED|Chemotherapy Period||22
8546641|NCT00152477|9578740|FG002|NOT COMPLETED|Chemotherapy Period||20
8546642|NCT00152477|9578738|FG000|STARTED|Monotherapy Period|7 subjects completed the Chemotherapy period but did not enter the Monotherapy period.|15
8546643|NCT00152477|9578739|FG001|STARTED|Monotherapy Period|5 subjects completed the Chemotherapy period but did not enter the Monotherapy period.|29
8546644|NCT00152477|9578740|FG002|STARTED|Monotherapy Period|5 subjects completed the Chemotherapy period but did not enter the Monotherapy period.|34
8546645|NCT00152477|9578738|FG000|Part II|Monotherapy Period||13
8546646|NCT00152477|9578739|FG001|Part II|Monotherapy Period||26
8546647|NCT00152477|9578740|FG002|Part II|Monotherapy Period||29
8546648|NCT00152477|9578738|FG000|COMPLETED|Monotherapy Period||0
8546649|NCT00152477|9578739|FG001|COMPLETED|Monotherapy Period||0
8546650|NCT00152477|9578740|FG002|COMPLETED|Monotherapy Period||0
8546651|NCT00152477|9578738|FG000|NOT COMPLETED|Monotherapy Period||15
8546652|NCT00152477|9578739|FG001|NOT COMPLETED|Monotherapy Period||29
8546653|NCT00152477|9578740|FG002|NOT COMPLETED|Monotherapy Period||34
8567165|NCT00083122|9599435|FG001|NOT COMPLETED|Overall Study||0
8567166|NCT00083174|9599443|FG000|STARTED|Randomization Period||2285
8567167|NCT00083174|9599444|FG001|STARTED|Randomization Period||2275
8567168|NCT00083174|9599445|FG002|STARTED|Randomization Period||0
8567169|NCT00083174|9599443|FG000|COMPLETED|Randomization Period|All women randomized were included in the analysis based on intent-to-treat principle.|2285
8567170|NCT00083174|9599444|FG001|COMPLETED|Randomization Period|All women randomized were included in the analysis based on intent-to-treat principle.|2275
8567171|NCT00083174|9599445|FG002|COMPLETED|Randomization Period||0
8567172|NCT00083174|9599443|FG000|NOT COMPLETED|Randomization Period||0
8567173|NCT00083174|9599444|FG001|NOT COMPLETED|Randomization Period||0
8567174|NCT00083174|9599445|FG002|NOT COMPLETED|Randomization Period||0
8567175|NCT00083174|9599443|FG000|STARTED|Open-label Extension||0
8567176|NCT00083174|9599444|FG001|STARTED|Open-label Extension||0
8567177|NCT00083174|9599445|FG002|STARTED|Open-label Extension||2831
8567178|NCT00083174|9599443|FG000|COMPLETED|Open-label Extension||0
8567179|NCT00083174|9599444|FG001|COMPLETED|Open-label Extension||0
8567180|NCT00083174|9599445|FG002|COMPLETED|Open-label Extension||2831
8546654|NCT04747808|9578751|FG000|STARTED|Overall Study||5
8546655|NCT04747808|9578751|FG000|COMPLETED|Overall Study||5
8546656|NCT04747808|9578751|FG000|NOT COMPLETED|Overall Study||0
8546657|NCT04585646|9578755|FG000|STARTED|First Intervention||32
8546658|NCT04585646|9578756|FG001|STARTED|First Intervention||32
8546659|NCT04585646|9578755|FG000|COMPLETED|First Intervention||31
8546660|NCT04585646|9578756|FG001|COMPLETED|First Intervention||28
8546661|NCT04585646|9578755|FG000|NOT COMPLETED|First Intervention||1
8546662|NCT04585646|9578756|FG001|NOT COMPLETED|First Intervention||4
8546663|NCT04585646|9578755|FG000|STARTED|Second Intervention||31
8546664|NCT04585646|9578756|FG001|STARTED|Second Intervention||28
8546665|NCT04585646|9578755|FG000|COMPLETED|Second Intervention||31
8546666|NCT04585646|9578756|FG001|COMPLETED|Second Intervention||28
8546667|NCT04585646|9578755|FG000|NOT COMPLETED|Second Intervention||0
8546668|NCT04585646|9578756|FG001|NOT COMPLETED|Second Intervention||0
8546669|NCT04584645|9578765|FG000|STARTED|Overall Study||24570
8546670|NCT04584645|9578766|FG001|STARTED|Overall Study||24568
8546671|NCT04584645|9578765|FG000|COMPLETED|Overall Study||5575
8546672|NCT04584645|9578766|FG001|COMPLETED|Overall Study||5662
8546673|NCT04584645|9578765|FG000|NOT COMPLETED|Overall Study||18995
8546674|NCT04584645|9578766|FG001|NOT COMPLETED|Overall Study||18906
8546675|NCT04451330|9578792|FG000|STARTED|Overall Study||133
8546676|NCT04451330|9578793|FG001|STARTED|Overall Study||69
8546677|NCT04451330|9578792|FG000|COMPLETED|Overall Study||123
8546678|NCT04451330|9578793|FG001|COMPLETED|Overall Study||65
8546679|NCT04451330|9578792|FG000|NOT COMPLETED|Overall Study||10
8546680|NCT04451330|9578793|FG001|NOT COMPLETED|Overall Study||4
8546681|NCT04300010|9578802|FG000|STARTED|Overall Study||20
8546682|NCT04300010|9578803|FG001|STARTED|Overall Study||20
8546683|NCT04300010|9578804|FG002|STARTED|Overall Study||20
8546684|NCT04300010|9578805|FG003|STARTED|Overall Study||60
8546685|NCT04300010|9578802|FG000|COMPLETED|Overall Study||20
8546686|NCT04300010|9578803|FG001|COMPLETED|Overall Study||20
8546687|NCT04300010|9578804|FG002|COMPLETED|Overall Study||20
8546688|NCT04300010|9578805|FG003|COMPLETED|Overall Study||60
8546689|NCT04300010|9578802|FG000|NOT COMPLETED|Overall Study||0
8546690|NCT04300010|9578803|FG001|NOT COMPLETED|Overall Study||0
8546691|NCT04300010|9578804|FG002|NOT COMPLETED|Overall Study||0
8546692|NCT04300010|9578805|FG003|NOT COMPLETED|Overall Study||0
8546693|NCT04206670|9578816|FG000|STARTED|Overall Study||148
8546694|NCT04206670|9578817|FG001|STARTED|Overall Study||68
8546695|NCT04206670|9578816|FG000|COMPLETED|Overall Study||124
8546696|NCT04206670|9578817|FG001|COMPLETED|Overall Study||65
8546697|NCT04206670|9578816|FG000|NOT COMPLETED|Overall Study||24
8546698|NCT04206670|9578817|FG001|NOT COMPLETED|Overall Study||3
8546699|NCT04173962|9578826|FG000|STARTED|Overall Study||12
8546700|NCT04173962|9578827|FG001|STARTED|Overall Study||12
8546701|NCT04173962|9578826|FG000|COMPLETED|Overall Study||12
8546702|NCT04173962|9578827|FG001|COMPLETED|Overall Study||12
8546703|NCT04173962|9578826|FG000|NOT COMPLETED|Overall Study||0
8546704|NCT04173962|9578827|FG001|NOT COMPLETED|Overall Study||0
8546705|NCT04115189|9578835|FG000|STARTED|Overall Study||42
8546706|NCT04115189|9578836|FG001|STARTED|Overall Study||15
8546707|NCT04115189|9578835|FG000|COMPLETED|Overall Study||42
8546708|NCT04115189|9578836|FG001|COMPLETED|Overall Study||15
8546709|NCT04115189|9578835|FG000|NOT COMPLETED|Overall Study||0
8546710|NCT04115189|9578836|FG001|NOT COMPLETED|Overall Study||0
8546711|NCT04010695|9578846|FG000|STARTED|Overall Study||250
8546712|NCT04010695|9578846|FG000|COMPLETED|Overall Study||250
8546713|NCT04010695|9578846|FG000|NOT COMPLETED|Overall Study||0
8546714|NCT04003623|9578853|FG000|STARTED|Overall Study||1
8546715|NCT04003623|9578854|FG001|STARTED|Overall Study||0
8546716|NCT04003623|9578853|FG000|COMPLETED|Overall Study||0
8546717|NCT04003623|9578854|FG001|COMPLETED|Overall Study||0
8546718|NCT04003623|9578853|FG000|NOT COMPLETED|Overall Study||1
8546719|NCT04003623|9578854|FG001|NOT COMPLETED|Overall Study||0
8546720|NCT03967847|9578862|FG000|STARTED|Overall Study||21
8546721|NCT03967847|9578863|FG001|STARTED|Overall Study||23
8546722|NCT03967847|9578862|FG000|COMPLETED|Overall Study||21
8546723|NCT03967847|9578863|FG001|COMPLETED|Overall Study||23
8546724|NCT03967847|9578862|FG000|NOT COMPLETED|Overall Study||0
8546725|NCT03967847|9578863|FG001|NOT COMPLETED|Overall Study||0
8546726|NCT03905694|9578870|FG000|STARTED|Primary Analysis Period||18
8546727|NCT03905694|9578870|FG000|COMPLETED|Primary Analysis Period||18
8546728|NCT03905694|9578870|FG000|NOT COMPLETED|Primary Analysis Period||0
8546729|NCT03905694|9578870|FG000|STARTED|Long-term Extension Period||18
8546730|NCT03905694|9578870|FG000|COMPLETED|Long-term Extension Period||0
8546731|NCT03905694|9578870|FG000|NOT COMPLETED|Long-term Extension Period||18
8546732|NCT03828383|9578876|FG000|STARTED|Overall Study||41
8546733|NCT03828383|9578877|FG001|STARTED|Overall Study||37
8546734|NCT03828383|9578876|FG000|COMPLETED|Overall Study||34
8546735|NCT03828383|9578877|FG001|COMPLETED|Overall Study||30
8546736|NCT03828383|9578876|FG000|NOT COMPLETED|Overall Study||7
8546737|NCT03828383|9578877|FG001|NOT COMPLETED|Overall Study||7
8546738|NCT03817853|9578883|FG000|STARTED|Induction Phase||113
8546739|NCT03817853|9578884|FG001|STARTED|Induction Phase||0
8546740|NCT03817853|9578885|FG002|STARTED|Induction Phase||0
8546741|NCT03817853|9578883|FG000|COMPLETED|Induction Phase||62
8546742|NCT03817853|9578884|FG001|COMPLETED|Induction Phase||0
8546743|NCT03817853|9578885|FG002|COMPLETED|Induction Phase||0
8546744|NCT03817853|9578883|FG000|NOT COMPLETED|Induction Phase||51
8546745|NCT03817853|9578884|FG001|NOT COMPLETED|Induction Phase||0
8546746|NCT03817853|9578885|FG002|NOT COMPLETED|Induction Phase||0
8546747|NCT03817853|9578883|FG000|STARTED|Maintenance/ Follow-up Phase||0
8546748|NCT03817853|9578884|FG001|STARTED|Maintenance/ Follow-up Phase||56
8546749|NCT03817853|9578885|FG002|STARTED|Maintenance/ Follow-up Phase||17
8546750|NCT03817853|9578883|FG000|COMPLETED|Maintenance/ Follow-up Phase||0
8546751|NCT03817853|9578884|FG001|COMPLETED|Maintenance/ Follow-up Phase||0
8546752|NCT03817853|9578885|FG002|COMPLETED|Maintenance/ Follow-up Phase||11
8546753|NCT03817853|9578883|FG000|NOT COMPLETED|Maintenance/ Follow-up Phase||0
8546754|NCT03817853|9578884|FG001|NOT COMPLETED|Maintenance/ Follow-up Phase||56
8546755|NCT03817853|9578885|FG002|NOT COMPLETED|Maintenance/ Follow-up Phase||6
8546756|NCT03717480|9578893|FG000|STARTED|Overall Study||2
8546757|NCT03717480|9578893|FG000|Receipt of Investigational Product/Study Treatment|Overall Study||1
8546758|NCT03717480|9578893|FG000|COMPLETED|Overall Study||1
8546759|NCT03717480|9578893|FG000|NOT COMPLETED|Overall Study||1
8546760|NCT03624036|9578901|FG000|STARTED|Overall Study||7
8546761|NCT03624036|9578902|FG001|STARTED|Overall Study||3
8546762|NCT03624036|9578903|FG002|STARTED|Overall Study||3
8546763|NCT03624036|9578904|FG003|STARTED|Overall Study||3
8546764|NCT03624036|9578901|FG000|COMPLETED|Overall Study||0
8546765|NCT03624036|9578902|FG001|COMPLETED|Overall Study||0
8546766|NCT03624036|9578903|FG002|COMPLETED|Overall Study||0
8546767|NCT03624036|9578904|FG003|COMPLETED|Overall Study||0
8546768|NCT03624036|9578901|FG000|NOT COMPLETED|Overall Study||7
8546769|NCT03624036|9578902|FG001|NOT COMPLETED|Overall Study||3
8546770|NCT03624036|9578903|FG002|NOT COMPLETED|Overall Study||3
8546771|NCT03624036|9578904|FG003|NOT COMPLETED|Overall Study||3
8546772|NCT03615066|9578917|FG000|STARTED|Main Study||26
8546773|NCT03615066|9578918|FG001|STARTED|Main Study||28
8546774|NCT03615066|9578919|FG002|STARTED|Main Study||13
8546775|NCT03615066|9578917|FG000|COMPLETED|Main Study|2 participants did not receive all doses of study treatments but were considered to have completed the Main Study because the participants entered the TFFU Phase.|26
8546776|NCT03615066|9578918|FG001|COMPLETED|Main Study|1 participant did not receive all doses of study treatments but was considered to have completed the Main Study because the participant entered the TFFU Phase.|27
8546777|NCT03615066|9578919|FG002|COMPLETED|Main Study||11
8546778|NCT03615066|9578917|FG000|NOT COMPLETED|Main Study||0
8546779|NCT03615066|9578918|FG001|NOT COMPLETED|Main Study||1
8546780|NCT03615066|9578919|FG002|NOT COMPLETED|Main Study||2
8546781|NCT03615066|9578917|FG000|STARTED|Treatment-free Follow-up (TFFU) Phase|13 participants who completed Main study did not enter TFFU phase.|13
8546782|NCT03615066|9578918|FG001|STARTED|Treatment-free Follow-up (TFFU) Phase|15 participants who completed Main study did not enter TFFU phase.|12
8546783|NCT03615066|9578919|FG002|STARTED|Treatment-free Follow-up (TFFU) Phase|9 participants who completed Main study did not enter TFFU phase.|2
8546784|NCT03615066|9578917|FG000|COMPLETED|Treatment-free Follow-up (TFFU) Phase||11
8546785|NCT03615066|9578918|FG001|COMPLETED|Treatment-free Follow-up (TFFU) Phase||11
8546786|NCT03615066|9578919|FG002|COMPLETED|Treatment-free Follow-up (TFFU) Phase||2
8546787|NCT03615066|9578917|FG000|NOT COMPLETED|Treatment-free Follow-up (TFFU) Phase||2
8546788|NCT03615066|9578918|FG001|NOT COMPLETED|Treatment-free Follow-up (TFFU) Phase||1
8546789|NCT03615066|9578919|FG002|NOT COMPLETED|Treatment-free Follow-up (TFFU) Phase||0
8546790|NCT03589469|9578931|FG000|STARTED|Overall Study||145
8546791|NCT03589469|9578931|FG000|Received Treatment|Overall Study||145
8546792|NCT03589469|9578931|FG000|COMPLETED|Overall Study||0
8546793|NCT03589469|9578931|FG000|NOT COMPLETED|Overall Study||145
8546794|NCT03557931|9578938|FG000|STARTED|Overall Study||100
8546795|NCT03557931|9578939|FG001|STARTED|Overall Study||65
8546796|NCT03557931|9578940|FG002|STARTED|Overall Study||68
8546797|NCT03557931|9578938|FG000|COMPLETED|Overall Study||69
8546798|NCT03557931|9578939|FG001|COMPLETED|Overall Study||46
8546799|NCT03557931|9578940|FG002|COMPLETED|Overall Study||55
8546800|NCT03557931|9578938|FG000|NOT COMPLETED|Overall Study||31
8546801|NCT03557931|9578939|FG001|NOT COMPLETED|Overall Study||19
8546802|NCT03557931|9578940|FG002|NOT COMPLETED|Overall Study||13
8567181|NCT00083174|9599443|FG000|NOT COMPLETED|Open-label Extension||0
8567182|NCT00083174|9599444|FG001|NOT COMPLETED|Open-label Extension||0
8567183|NCT00083174|9599445|FG002|NOT COMPLETED|Open-label Extension||0
8567184|NCT00083226|9599455|FG000|STARTED|Overall Study||42
8567185|NCT00083226|9599455|FG000|COMPLETED|Overall Study||0
8567186|NCT00083226|9599455|FG000|NOT COMPLETED|Overall Study||42
8567187|NCT00083382|9599459|FG000|STARTED|Overall Study||83
8567188|NCT00083382|9599459|FG000|COMPLETED|Overall Study||83
8567189|NCT00083382|9599459|FG000|NOT COMPLETED|Overall Study||0
8567190|NCT00083551|9599465|FG000|STARTED|Overall Study||323
8567191|NCT00083551|9599466|FG001|STARTED|Overall Study||345
8567192|NCT00083551|9599465|FG000|COMPLETED|Overall Study||323
8567193|NCT00083551|9599466|FG001|COMPLETED|Overall Study||345
8567194|NCT00083551|9599465|FG000|NOT COMPLETED|Overall Study||0
8567195|NCT00083551|9599466|FG001|NOT COMPLETED|Overall Study||0
8567196|NCT00083616|9599472|FG000|STARTED|Overall Study||185
8567197|NCT00083616|9599472|FG000|Received Study Medication|Overall Study||182
8567198|NCT00083616|9599472|FG000|COMPLETED|Overall Study|Completed safety followup or died on study as of the data cut-off date of 22 December 2006|154
8567199|NCT00083616|9599472|FG000|NOT COMPLETED|Overall Study||31
8567200|NCT00083720|9599476|FG000|STARTED|Overall Study|Patients analyzed for efficacy who met the epidermal growth factor receptor (EGFR) negative criteria|85
8567201|NCT00083720|9599476|FG000|COMPLETED|Overall Study|Two patients died prior to receiving cetuximab.|85
8567202|NCT00083720|9599476|FG000|NOT COMPLETED|Overall Study||0
8546803|NCT03251144|9578952|FG000|STARTED|Overall Study||15
8546804|NCT03251144|9578953|FG001|STARTED|Overall Study||11
8546805|NCT03251144|9578952|FG000|COMPLETED|Overall Study||15
8546806|NCT03251144|9578953|FG001|COMPLETED|Overall Study||11
8546807|NCT03251144|9578952|FG000|NOT COMPLETED|Overall Study||0
8546808|NCT03251144|9578953|FG001|NOT COMPLETED|Overall Study||0
8546809|NCT02886572|9578959|FG000|STARTED|Overall Study Period||40
8546810|NCT02886572|9578959|FG000|Survival Analysis Population|Overall Study Period||40
8546811|NCT02886572|9578959|FG000|COMPLETED|Overall Study Period||40
8546812|NCT02886572|9578959|FG000|NOT COMPLETED|Overall Study Period||0
8546813|NCT02886572|9578959|FG000|STARTED|Baseline Through Follow up MRI||40
8546814|NCT02886572|9578959|FG000|Distant Recurrence Population|Baseline Through Follow up MRI||32
8546815|NCT02886572|9578959|FG000|Local Recurrence Population|Baseline Through Follow up MRI||32
8546816|NCT02886572|9578959|FG000|COMPLETED|Baseline Through Follow up MRI||32
8546817|NCT02886572|9578959|FG000|NOT COMPLETED|Baseline Through Follow up MRI||8
8546818|NCT02596035|9578966|FG000|STARTED|Overall Study||97
8546819|NCT02596035|9578967|FG001|STARTED|Overall Study||44
8621451|NCT00480441|9660443|FG002|COMPLETED|Screening|"Participants did not enter this arm until period 3 randomization"|0
8621452|NCT00480441|9660441|FG000|NOT COMPLETED|Screening||37
8621453|NCT00480441|9660442|FG001|NOT COMPLETED|Screening||0
8621454|NCT00480441|9660443|FG002|NOT COMPLETED|Screening||0
8621455|NCT00480441|9660441|FG000|STARTED|Baseline Functional MRI|All non-randomized participants who also met specific eligibility for baseline functional MRI|24
8621456|NCT00480441|9660442|FG001|STARTED|Baseline Functional MRI|"Participants did not enter this arm until period 3 randomization"|0
8621457|NCT00480441|9660443|FG002|STARTED|Baseline Functional MRI|"Participants did not enter this arm until period 3 randomization"|0
8546820|NCT02596035|9578968|FG002|STARTED|Overall Study||1
8546821|NCT02596035|9578966|FG000|COMPLETED|Overall Study||11
8546822|NCT02596035|9578967|FG001|COMPLETED|Overall Study||0
8546823|NCT02596035|9578968|FG002|COMPLETED|Overall Study||0
8546824|NCT02596035|9578966|FG000|NOT COMPLETED|Overall Study||86
8546825|NCT02596035|9578967|FG001|NOT COMPLETED|Overall Study||44
8546826|NCT02596035|9578968|FG002|NOT COMPLETED|Overall Study||1
8546827|NCT02576509|9578977|FG000|STARTED|Pre-Treatment Period||371
8546828|NCT02576509|9578978|FG001|STARTED|Pre-Treatment Period||372
8546829|NCT02576509|9578977|FG000|COMPLETED|Pre-Treatment Period||367
8546830|NCT02576509|9578978|FG001|COMPLETED|Pre-Treatment Period||363
8546831|NCT02576509|9578977|FG000|NOT COMPLETED|Pre-Treatment Period||4
8546832|NCT02576509|9578978|FG001|NOT COMPLETED|Pre-Treatment Period||9
8546833|NCT02576509|9578977|FG000|STARTED|Treatment Period||367
8546834|NCT02576509|9578978|FG001|STARTED|Treatment Period||363
8546835|NCT02576509|9578977|FG000|COMPLETED|Treatment Period||38
8546836|NCT02576509|9578978|FG001|COMPLETED|Treatment Period||8
8546837|NCT02576509|9578977|FG000|NOT COMPLETED|Treatment Period||329
8546838|NCT02576509|9578978|FG001|NOT COMPLETED|Treatment Period||355
8546839|NCT02576509|9578977|FG000|STARTED|Follow-up Period||367
8546840|NCT02576509|9578978|FG001|STARTED|Follow-up Period||363
8546841|NCT02576509|9578977|FG000|COMPLETED|Follow-up Period||318
8546842|NCT02576509|9578978|FG001|COMPLETED|Follow-up Period||311
8546843|NCT02576509|9578977|FG000|NOT COMPLETED|Follow-up Period||49
8546844|NCT02576509|9578978|FG001|NOT COMPLETED|Follow-up Period||52
8546845|NCT02498600|9578986|FG000|STARTED|Overall Study||49
8546846|NCT02498600|9578987|FG001|STARTED|Overall Study||51
8546847|NCT02498600|9578986|FG000|COMPLETED|Overall Study||49
8546848|NCT02498600|9578987|FG001|COMPLETED|Overall Study||51
8546849|NCT02498600|9578986|FG000|NOT COMPLETED|Overall Study||0
8546850|NCT02498600|9578987|FG001|NOT COMPLETED|Overall Study||0
8546851|NCT02476916|9578995|FG000|STARTED|Core Period||27
8546852|NCT02476916|9578996|FG001|STARTED|Core Period||25
8546853|NCT02476916|9578995|FG000|COMPLETED|Core Period||21
8546854|NCT02476916|9578996|FG001|COMPLETED|Core Period||22
8546855|NCT02476916|9578995|FG000|NOT COMPLETED|Core Period||6
8546856|NCT02476916|9578996|FG001|NOT COMPLETED|Core Period||3
8546857|NCT02476916|9578995|FG000|STARTED|Extension Period||18
8546858|NCT02476916|9578996|FG001|STARTED|Extension Period||18
8546859|NCT02476916|9578995|FG000|COMPLETED|Extension Period||0
8546860|NCT02476916|9578996|FG001|COMPLETED|Extension Period||0
8546861|NCT02476916|9578995|FG000|NOT COMPLETED|Extension Period||18
8546862|NCT02476916|9578996|FG001|NOT COMPLETED|Extension Period||18
8546863|NCT02448225|9579003|FG000|STARTED|Overall Study||46
8546864|NCT02448225|9579003|FG000|COMPLETED|Overall Study||26
8546865|NCT02448225|9579003|FG000|NOT COMPLETED|Overall Study||20
8546866|NCT02352948|9579016|FG000|STARTED|Overall Study||62
8546867|NCT02352948|9579017|FG001|STARTED|Overall Study||64
8546868|NCT02352948|9579018|FG002|STARTED|Overall Study||174
8546869|NCT02352948|9579019|FG003|STARTED|Overall Study||118
8546870|NCT02352948|9579020|FG004|STARTED|Overall Study||117
8546871|NCT02352948|9579021|FG005|STARTED|Overall Study||60
8546872|NCT02352948|9579016|FG000|Received Treatment|Overall Study||62
8546873|NCT02352948|9579017|FG001|Received Treatment|Overall Study||63
8546874|NCT02352948|9579018|FG002|Received Treatment|Overall Study||173
8546875|NCT02352948|9579019|FG003|Received Treatment|Overall Study||110
8546876|NCT02352948|9579020|FG004|Received Treatment|Overall Study||117
8546877|NCT02352948|9579021|FG005|Received Treatment|Overall Study||60
8546878|NCT02352948|9579016|FG000|Completed Study Treatment|Overall Study||15
8546879|NCT02352948|9579017|FG001|Completed Study Treatment|Overall Study||0
8546880|NCT02352948|9579018|FG002|Completed Study Treatment|Overall Study||36
8546881|NCT02352948|9579019|FG003|Completed Study Treatment|Overall Study||0
8546882|NCT02352948|9579020|FG004|Completed Study Treatment|Overall Study||23
8546883|NCT02352948|9579021|FG005|Completed Study Treatment|Overall Study||4
8546884|NCT02352948|9579016|FG000|COMPLETED|Overall Study||13
8546885|NCT02352948|9579017|FG001|COMPLETED|Overall Study||5
8546886|NCT02352948|9579018|FG002|COMPLETED|Overall Study||45
8546887|NCT02352948|9579019|FG003|COMPLETED|Overall Study||19
8546888|NCT02352948|9579020|FG004|COMPLETED|Overall Study||29
8546889|NCT02352948|9579021|FG005|COMPLETED|Overall Study||11
8546890|NCT02352948|9579016|FG000|NOT COMPLETED|Overall Study||49
8546891|NCT02352948|9579017|FG001|NOT COMPLETED|Overall Study||59
8546892|NCT02352948|9579018|FG002|NOT COMPLETED|Overall Study||129
8546893|NCT02352948|9579019|FG003|NOT COMPLETED|Overall Study||99
8546894|NCT02352948|9579020|FG004|NOT COMPLETED|Overall Study||88
8546895|NCT02352948|9579021|FG005|NOT COMPLETED|Overall Study||49
8546896|NCT02318095|9579041|FG000|STARTED|Overall Study||40
8546897|NCT02318095|9579041|FG000|COMPLETED|Overall Study||39
8546898|NCT02318095|9579041|FG000|NOT COMPLETED|Overall Study||1
8546899|NCT02257528|9579046|FG000|STARTED|Overall Study||26
8546900|NCT02257528|9579046|FG000|COMPLETED|Overall Study||25
8546901|NCT02257528|9579046|FG000|NOT COMPLETED|Overall Study||1
8546902|NCT02155647|9579052|FG000|STARTED|Overall Study||88
8546903|NCT02155647|9579053|FG001|STARTED|Overall Study||116
8546904|NCT02155647|9579052|FG000|COMPLETED|Overall Study||47
8546905|NCT02155647|9579053|FG001|COMPLETED|Overall Study||64
8546906|NCT02155647|9579052|FG000|NOT COMPLETED|Overall Study||41
8546907|NCT02155647|9579053|FG001|NOT COMPLETED|Overall Study||52
8546908|NCT02059265|9579059|FG000|STARTED|Overall Study||32
8546909|NCT02059265|9579059|FG000|COMPLETED|Overall Study||28
8546910|NCT02059265|9579059|FG000|NOT COMPLETED|Overall Study||4
8546911|NCT02032810|9579065|FG000|STARTED|Overall Study||6
8546912|NCT02032810|9579066|FG001|STARTED|Overall Study||11
8546913|NCT02032810|9579065|FG000|COMPLETED|Overall Study||6
8546914|NCT02032810|9579066|FG001|COMPLETED|Overall Study||11
8546915|NCT02032810|9579065|FG000|NOT COMPLETED|Overall Study||0
8546916|NCT02032810|9579066|FG001|NOT COMPLETED|Overall Study||0
8546917|NCT01979211|9579076|FG000|STARTED|Overall Study||24
8546918|NCT01979211|9579076|FG000|COMPLETED|Overall Study||24
8546919|NCT01979211|9579076|FG000|NOT COMPLETED|Overall Study||0
8546920|NCT01965704|9579084|FG000|STARTED|Overall Study||48
8546921|NCT01965704|9579085|FG001|STARTED|Overall Study||48
8546922|NCT01965704|9579086|FG002|STARTED|Overall Study||50
8546923|NCT01965704|9579087|FG003|STARTED|Overall Study||50
8546924|NCT01965704|9579084|FG000|Received Intervention|Overall Study||45
8546925|NCT01965704|9579085|FG001|Received Intervention|Overall Study||45
8546926|NCT01965704|9579086|FG002|Received Intervention|Overall Study||47
8546927|NCT01965704|9579087|FG003|Received Intervention|Overall Study||47
8546928|NCT01965704|9579084|FG000|Analyzable Population|Overall Study||45
8546929|NCT01965704|9579085|FG001|Analyzable Population|Overall Study||45
8546930|NCT01965704|9579086|FG002|Analyzable Population|Overall Study||41
8546931|NCT01965704|9579087|FG003|Analyzable Population|Overall Study||41
8546932|NCT01965704|9579084|FG000|COMPLETED|Overall Study||45
8546933|NCT01965704|9579085|FG001|COMPLETED|Overall Study||45
8546934|NCT01965704|9579086|FG002|COMPLETED|Overall Study||45
8546935|NCT01965704|9579087|FG003|COMPLETED|Overall Study||45
8546936|NCT01965704|9579084|FG000|NOT COMPLETED|Overall Study||3
8546937|NCT01965704|9579085|FG001|NOT COMPLETED|Overall Study||3
8546938|NCT01965704|9579086|FG002|NOT COMPLETED|Overall Study||5
8546939|NCT01965704|9579087|FG003|NOT COMPLETED|Overall Study||5
8546940|NCT01904903|9579095|FG000|STARTED|Overall Study||31
8546941|NCT01904903|9579095|FG000|COMPLETED|Overall Study||30
8546942|NCT01904903|9579095|FG000|NOT COMPLETED|Overall Study||1
8546943|NCT01827384|9579113|FG000|STARTED|Overall Study||13
8546944|NCT01827384|9579114|FG001|STARTED|Overall Study||1
8546945|NCT01827384|9579115|FG002|STARTED|Overall Study||9
8546946|NCT01827384|9579116|FG003|STARTED|Overall Study||1
8546947|NCT01827384|9579117|FG004|STARTED|Overall Study||1
8546948|NCT01827384|9579118|FG005|STARTED|Overall Study||22
8546949|NCT01827384|9579119|FG006|STARTED|Overall Study||2
8546950|NCT01827384|9579120|FG007|STARTED|Overall Study||1
8546951|NCT01827384|9579121|FG008|STARTED|Overall Study||2
8546952|NCT01827384|9579122|FG009|STARTED|Overall Study||15
8546953|NCT01827384|9579123|FG010|STARTED|Overall Study||7
8546954|NCT01827384|9579124|FG011|STARTED|Overall Study||1
8546955|NCT01827384|9579125|FG012|STARTED|Overall Study||2
8546956|NCT01827384|9579126|FG013|STARTED|Overall Study||131
8546957|NCT01827384|9579113|FG000|COMPLETED|Overall Study||13
8546958|NCT01827384|9579114|FG001|COMPLETED|Overall Study||1
8546959|NCT01827384|9579115|FG002|COMPLETED|Overall Study||9
8546960|NCT01827384|9579116|FG003|COMPLETED|Overall Study||1
8546961|NCT01827384|9579117|FG004|COMPLETED|Overall Study||1
8546962|NCT01827384|9579118|FG005|COMPLETED|Overall Study||22
8546963|NCT01827384|9579119|FG006|COMPLETED|Overall Study||2
8546964|NCT01827384|9579120|FG007|COMPLETED|Overall Study||1
8546965|NCT01827384|9579121|FG008|COMPLETED|Overall Study||2
8546966|NCT01827384|9579122|FG009|COMPLETED|Overall Study||15
8546967|NCT01827384|9579123|FG010|COMPLETED|Overall Study||7
8546968|NCT01827384|9579124|FG011|COMPLETED|Overall Study||1
8546969|NCT01827384|9579125|FG012|COMPLETED|Overall Study||2
8546970|NCT01827384|9579126|FG013|COMPLETED|Overall Study||0
8546971|NCT01827384|9579113|FG000|NOT COMPLETED|Overall Study||0
8546972|NCT01827384|9579114|FG001|NOT COMPLETED|Overall Study||0
8546973|NCT01827384|9579115|FG002|NOT COMPLETED|Overall Study||0
8546974|NCT01827384|9579116|FG003|NOT COMPLETED|Overall Study||0
8546975|NCT01827384|9579117|FG004|NOT COMPLETED|Overall Study||0
8546976|NCT01827384|9579118|FG005|NOT COMPLETED|Overall Study||0
8546977|NCT01827384|9579119|FG006|NOT COMPLETED|Overall Study||0
8546978|NCT01827384|9579120|FG007|NOT COMPLETED|Overall Study||0
8546979|NCT01827384|9579121|FG008|NOT COMPLETED|Overall Study||0
8621458|NCT00480441|9660441|FG000|COMPLETED|Baseline Functional MRI||12
8621459|NCT00480441|9660442|FG001|COMPLETED|Baseline Functional MRI|"Participants did not enter this arm until period 3 randomization"|0
8818364|NCT01557244|9872002|FG002|COMPLETED|Safety Extension Phase: 12 Weeks||0
8818365|NCT01557244|9872003|FG003|COMPLETED|Safety Extension Phase: 12 Weeks||15
8818366|NCT01557244|9872004|FG004|COMPLETED|Safety Extension Phase: 12 Weeks||20
8546980|NCT01827384|9579122|FG009|NOT COMPLETED|Overall Study||0
8621460|NCT00480441|9660443|FG002|COMPLETED|Baseline Functional MRI|"Participants did not enter this arm until period 3 randomization"|0
8621461|NCT00480441|9660441|FG000|NOT COMPLETED|Baseline Functional MRI||12
8621462|NCT00480441|9660442|FG001|NOT COMPLETED|Baseline Functional MRI||0
8621463|NCT00480441|9660443|FG002|NOT COMPLETED|Baseline Functional MRI||0
8621464|NCT00480441|9660441|FG000|STARTED|Randomization||0
8621465|NCT00480441|9660442|FG001|STARTED|Randomization||13
8546981|NCT01827384|9579123|FG010|NOT COMPLETED|Overall Study||0
8546982|NCT01827384|9579124|FG011|NOT COMPLETED|Overall Study||0
8546983|NCT01827384|9579125|FG012|NOT COMPLETED|Overall Study||0
8546984|NCT01827384|9579126|FG013|NOT COMPLETED|Overall Study||131
8546985|NCT01778946|9579156|FG000|STARTED|Overall Study||7
8546986|NCT01778946|9579156|FG000|COMPLETED|Overall Study||4
8546987|NCT01778946|9579156|FG000|NOT COMPLETED|Overall Study||3
8546988|NCT01636258|9579162|FG000|STARTED|Overall Study||13
8546989|NCT01636258|9579163|FG001|STARTED|Overall Study||14
8546990|NCT01636258|9579162|FG000|COMPLETED|Overall Study||12
8546991|NCT01636258|9579163|FG001|COMPLETED|Overall Study||14
8546992|NCT01636258|9579162|FG000|NOT COMPLETED|Overall Study||1
8546993|NCT01636258|9579163|FG001|NOT COMPLETED|Overall Study||0
8546994|NCT01597388|9579179|FG000|STARTED|Overall Study||6
8546995|NCT01597388|9579180|FG001|STARTED|Overall Study||13
8546996|NCT01597388|9579181|FG002|STARTED|Overall Study||14
8546997|NCT01597388|9579182|FG003|STARTED|Overall Study||10
8546998|NCT01597388|9579183|FG004|STARTED|Overall Study||37
8546999|NCT01597388|9579184|FG005|STARTED|Overall Study||4
8547000|NCT01597388|9579185|FG006|STARTED|Overall Study||8
8547001|NCT01597388|9579186|FG007|STARTED|Overall Study||5
8547002|NCT01597388|9579187|FG008|STARTED|Overall Study||2
8547003|NCT01597388|9579179|FG000|COMPLETED|Overall Study||6
8547004|NCT01597388|9579180|FG001|COMPLETED|Overall Study||13
8547005|NCT01597388|9579181|FG002|COMPLETED|Overall Study||14
8547006|NCT01597388|9579182|FG003|COMPLETED|Overall Study||10
8547007|NCT01597388|9579183|FG004|COMPLETED|Overall Study||37
8547008|NCT01597388|9579184|FG005|COMPLETED|Overall Study||4
8547009|NCT01597388|9579185|FG006|COMPLETED|Overall Study||8
8547010|NCT01597388|9579186|FG007|COMPLETED|Overall Study||5
8547011|NCT01597388|9579187|FG008|COMPLETED|Overall Study||2
8547012|NCT01597388|9579179|FG000|NOT COMPLETED|Overall Study||0
8547013|NCT01597388|9579180|FG001|NOT COMPLETED|Overall Study||0
8547014|NCT01597388|9579181|FG002|NOT COMPLETED|Overall Study||0
8547015|NCT01597388|9579182|FG003|NOT COMPLETED|Overall Study||0
8547016|NCT01597388|9579183|FG004|NOT COMPLETED|Overall Study||0
8547017|NCT01597388|9579184|FG005|NOT COMPLETED|Overall Study||0
8547018|NCT01597388|9579185|FG006|NOT COMPLETED|Overall Study||0
8547019|NCT01597388|9579186|FG007|NOT COMPLETED|Overall Study||0
8547020|NCT01597388|9579187|FG008|NOT COMPLETED|Overall Study||0
8547021|NCT01517802|9579224|FG000|STARTED|Overall Study||31
8547022|NCT01517802|9579224|FG000|COMPLETED|Overall Study||30
8547023|NCT01517802|9579224|FG000|NOT COMPLETED|Overall Study||1
8547024|NCT01134614|9579230|FG000|STARTED|Overall Study||123
8547025|NCT01134614|9579231|FG001|STARTED|Overall Study||122
8621466|NCT00480441|9660443|FG002|STARTED|Randomization||11
8621467|NCT00480441|9660441|FG000|COMPLETED|Randomization||0
8621468|NCT00480441|9660442|FG001|COMPLETED|Randomization||6
8547026|NCT01134614|9579230|FG000|Treated|Overall Study||119
8547027|NCT01134614|9579231|FG001|Treated|Overall Study||121
8547028|NCT01134614|9579230|FG000|Treated and Toxicity Assessed|Overall Study||118
8547029|NCT01134614|9579231|FG001|Treated and Toxicity Assessed|Overall Study||120
8547030|NCT01134614|9579230|FG000|COMPLETED|Overall Study|Treatment continues until disease progression or unacceptable toxicity.|0
8547031|NCT01134614|9579231|FG001|COMPLETED|Overall Study|Treatment continues until disease progression or unacceptable toxicities|0
8547032|NCT01134614|9579230|FG000|NOT COMPLETED|Overall Study||123
8547033|NCT01134614|9579231|FG001|NOT COMPLETED|Overall Study||122
8547034|NCT01081262|9579241|FG000|STARTED|Overall Study||13
8547035|NCT01081262|9579242|FG001|STARTED|Overall Study||13
8547036|NCT01081262|9579243|FG002|STARTED|Overall Study||13
8547037|NCT01081262|9579244|FG003|STARTED|Overall Study||11
8547038|NCT01081262|9579241|FG000|COMPLETED|Overall Study||13
8621469|NCT00480441|9660443|FG002|COMPLETED|Randomization||9
8547039|NCT01081262|9579242|FG001|COMPLETED|Overall Study||13
8547040|NCT01081262|9579243|FG002|COMPLETED|Overall Study||13
8621470|NCT00480441|9660441|FG000|NOT COMPLETED|Randomization||0
8547041|NCT01081262|9579244|FG003|COMPLETED|Overall Study||11
8547042|NCT01081262|9579241|FG000|NOT COMPLETED|Overall Study||0
8547043|NCT01081262|9579242|FG001|NOT COMPLETED|Overall Study||0
8547044|NCT01081262|9579243|FG002|NOT COMPLETED|Overall Study||0
8547045|NCT01081262|9579244|FG003|NOT COMPLETED|Overall Study||0
8547046|NCT01038778|9579256|FG000|STARTED|Overall Study||3
8547047|NCT01038778|9579257|FG001|STARTED|Overall Study||8
8547048|NCT01038778|9579258|FG002|STARTED|Overall Study||36
8547049|NCT01038778|9579256|FG000|COMPLETED|Overall Study||3
8547050|NCT01038778|9579257|FG001|COMPLETED|Overall Study||6
8547051|NCT01038778|9579258|FG002|COMPLETED|Overall Study||33
8547052|NCT01038778|9579256|FG000|NOT COMPLETED|Overall Study||0
8547053|NCT01038778|9579257|FG001|NOT COMPLETED|Overall Study||2
8547054|NCT01038778|9579258|FG002|NOT COMPLETED|Overall Study||3
8547055|NCT00972478|9579267|FG000|STARTED|Overall Study||11
8547056|NCT00972478|9579268|FG001|STARTED|Overall Study||72
8547057|NCT00972478|9579267|FG000|Eligible and Began Protocol Therapy|Overall Study||9
8547058|NCT00972478|9579268|FG001|Eligible and Began Protocol Therapy|Overall Study||63
8547059|NCT00972478|9579267|FG000|COMPLETED|Overall Study||4
8547060|NCT00972478|9579268|FG001|COMPLETED|Overall Study||34
8547061|NCT00972478|9579267|FG000|NOT COMPLETED|Overall Study||7
8547062|NCT00972478|9579268|FG001|NOT COMPLETED|Overall Study||38
8547063|NCT00455325|9579275|FG000|STARTED|Cohort 1: Placebo||35
8547064|NCT00455325|9579276|FG001|STARTED|Cohort 1: Placebo||0
8547065|NCT00455325|9579277|FG002|STARTED|Cohort 1: Placebo||0
8547066|NCT00455325|9579278|FG003|STARTED|Cohort 1: Placebo||0
8547067|NCT00455325|9579275|FG000|COMPLETED|Cohort 1: Placebo||27
8547068|NCT00455325|9579276|FG001|COMPLETED|Cohort 1: Placebo||0
8547069|NCT00455325|9579277|FG002|COMPLETED|Cohort 1: Placebo||0
8547070|NCT00455325|9579278|FG003|COMPLETED|Cohort 1: Placebo||0
8547071|NCT00455325|9579275|FG000|NOT COMPLETED|Cohort 1: Placebo||8
8547072|NCT00455325|9579276|FG001|NOT COMPLETED|Cohort 1: Placebo||0
8547073|NCT00455325|9579277|FG002|NOT COMPLETED|Cohort 1: Placebo||0
8547074|NCT00455325|9579278|FG003|NOT COMPLETED|Cohort 1: Placebo||0
8547075|NCT00455325|9579275|FG000|STARTED|Cohort 2: 80 mg Chloroquine Weekly||0
8547076|NCT00455325|9579276|FG001|STARTED|Cohort 2: 80 mg Chloroquine Weekly||27
8547077|NCT00455325|9579277|FG002|STARTED|Cohort 2: 80 mg Chloroquine Weekly||0
8547078|NCT00455325|9579278|FG003|STARTED|Cohort 2: 80 mg Chloroquine Weekly||0
8547079|NCT00455325|9579275|FG000|COMPLETED|Cohort 2: 80 mg Chloroquine Weekly||0
8547080|NCT00455325|9579276|FG001|COMPLETED|Cohort 2: 80 mg Chloroquine Weekly||26
8547081|NCT00455325|9579277|FG002|COMPLETED|Cohort 2: 80 mg Chloroquine Weekly||0
8547082|NCT00455325|9579278|FG003|COMPLETED|Cohort 2: 80 mg Chloroquine Weekly||0
8547083|NCT00455325|9579275|FG000|NOT COMPLETED|Cohort 2: 80 mg Chloroquine Weekly||0
8547084|NCT00455325|9579276|FG001|NOT COMPLETED|Cohort 2: 80 mg Chloroquine Weekly||1
8547085|NCT00455325|9579277|FG002|NOT COMPLETED|Cohort 2: 80 mg Chloroquine Weekly||0
8547086|NCT00455325|9579278|FG003|NOT COMPLETED|Cohort 2: 80 mg Chloroquine Weekly||0
8547087|NCT00455325|9579275|FG000|STARTED|Cohort 3: 80 mg Chloroquine Daily||0
8547088|NCT00455325|9579276|FG001|STARTED|Cohort 3: 80 mg Chloroquine Daily||0
8547089|NCT00455325|9579277|FG002|STARTED|Cohort 3: 80 mg Chloroquine Daily||26
8547090|NCT00455325|9579278|FG003|STARTED|Cohort 3: 80 mg Chloroquine Daily||0
8547091|NCT00455325|9579275|FG000|COMPLETED|Cohort 3: 80 mg Chloroquine Daily||0
8547092|NCT00455325|9579276|FG001|COMPLETED|Cohort 3: 80 mg Chloroquine Daily||0
8547093|NCT00455325|9579277|FG002|COMPLETED|Cohort 3: 80 mg Chloroquine Daily||25
8547094|NCT00455325|9579278|FG003|COMPLETED|Cohort 3: 80 mg Chloroquine Daily||0
8547095|NCT00455325|9579275|FG000|NOT COMPLETED|Cohort 3: 80 mg Chloroquine Daily||0
8547096|NCT00455325|9579276|FG001|NOT COMPLETED|Cohort 3: 80 mg Chloroquine Daily||0
8547097|NCT00455325|9579277|FG002|NOT COMPLETED|Cohort 3: 80 mg Chloroquine Daily||1
8547098|NCT00455325|9579278|FG003|NOT COMPLETED|Cohort 3: 80 mg Chloroquine Daily||0
8547099|NCT00455325|9579275|FG000|STARTED|Cohort 4: 250mg Chloroquine Daily||0
8547100|NCT00455325|9579276|FG001|STARTED|Cohort 4: 250mg Chloroquine Daily||0
8621471|NCT00480441|9660442|FG001|NOT COMPLETED|Randomization||7
8621472|NCT00480441|9660443|FG002|NOT COMPLETED|Randomization||2
8621473|NCT00480493|9660452|FG000|STARTED|Overall Study||32
8547101|NCT00455325|9579277|FG002|STARTED|Cohort 4: 250mg Chloroquine Daily||0
8547102|NCT00455325|9579278|FG003|STARTED|Cohort 4: 250mg Chloroquine Daily||25
8547103|NCT00455325|9579275|FG000|COMPLETED|Cohort 4: 250mg Chloroquine Daily||0
8547104|NCT00455325|9579276|FG001|COMPLETED|Cohort 4: 250mg Chloroquine Daily||0
8547105|NCT00455325|9579277|FG002|COMPLETED|Cohort 4: 250mg Chloroquine Daily||0
8547106|NCT00455325|9579278|FG003|COMPLETED|Cohort 4: 250mg Chloroquine Daily||25
8547107|NCT00455325|9579275|FG000|NOT COMPLETED|Cohort 4: 250mg Chloroquine Daily||0
8547108|NCT00455325|9579276|FG001|NOT COMPLETED|Cohort 4: 250mg Chloroquine Daily||0
8547109|NCT00455325|9579277|FG002|NOT COMPLETED|Cohort 4: 250mg Chloroquine Daily||0
8547110|NCT00455325|9579278|FG003|NOT COMPLETED|Cohort 4: 250mg Chloroquine Daily||0
8547111|NCT00321555|9579289|FG000|STARTED|Overall Study||15
8547112|NCT00321555|9579289|FG000|COMPLETED|Overall Study||9
8547113|NCT00321555|9579289|FG000|NOT COMPLETED|Overall Study||6
8547114|NCT00098475|9579295|FG000|STARTED|Step 1||223
8547115|NCT00098475|9579296|FG001|STARTED|Step 1||222
8547116|NCT00098475|9579297|FG002|STARTED|Step 1||4
8547117|NCT00098475|9579298|FG003|STARTED|Step 1||3
8547118|NCT00098475|9579295|FG000|Treated|Step 1||223
8723074|NCT01021553|9770575|FG001|COMPLETED|Overall Study||17
8547119|NCT00098475|9579296|FG001|Treated|Step 1||220
8621474|NCT00480493|9660453|FG001|STARTED|Overall Study||28
8723075|NCT01021553|9770576|FG002|COMPLETED|Overall Study||25
8547120|NCT00098475|9579297|FG002|Treated|Step 1||4
8547121|NCT00098475|9579298|FG003|Treated|Step 1||3
8621475|NCT00480493|9660452|FG000|Randomized|Overall Study||32
8621476|NCT00480493|9660453|FG001|Randomized|Overall Study||28
8723076|NCT01021553|9770574|FG000|NOT COMPLETED|Overall Study||4
8723077|NCT01021553|9770575|FG001|NOT COMPLETED|Overall Study||5
8723078|NCT01021553|9770576|FG002|NOT COMPLETED|Overall Study||3
8723079|NCT01021618|9770591|FG000|STARTED|Overall Study||44
8723080|NCT01021618|9770592|FG001|STARTED|Overall Study||96
8723081|NCT01021618|9770591|FG000|COMPLETED|Overall Study||44
8723082|NCT01021618|9770592|FG001|COMPLETED|Overall Study||96
8723083|NCT01021618|9770591|FG000|NOT COMPLETED|Overall Study||0
8723084|NCT01021618|9770592|FG001|NOT COMPLETED|Overall Study||0
8547122|NCT00098475|9579295|FG000|Eligible|Step 1|Some patients were considered eligible at registration but found ineligible in the analysis.|214
8547123|NCT00098475|9579296|FG001|Eligible|Step 1|Some patients were considered eligible at registration but found ineligible in the analysis.|208
8547124|NCT00098475|9579297|FG002|Eligible|Step 1||4
8547125|NCT00098475|9579298|FG003|Eligible|Step 1||3
8547126|NCT00098475|9579295|FG000|COMPLETED|Step 1||52
8547127|NCT00098475|9579296|FG001|COMPLETED|Step 1||49
8547128|NCT00098475|9579297|FG002|COMPLETED|Step 1||0
8547129|NCT00098475|9579298|FG003|COMPLETED|Step 1||0
8547130|NCT00098475|9579295|FG000|NOT COMPLETED|Step 1||171
8547131|NCT00098475|9579296|FG001|NOT COMPLETED|Step 1||173
8547132|NCT00098475|9579297|FG002|NOT COMPLETED|Step 1||4
8547133|NCT00098475|9579298|FG003|NOT COMPLETED|Step 1||3
8547134|NCT00098475|9579295|FG000|STARTED|Step 2|Step 2 treatment was an option but not required for patients who ended step 1 treatment.|5
8547135|NCT00098475|9579296|FG001|STARTED|Step 2|Step 2 treatment was an option but not required for patients who ended step 1 treatment.|15
8547136|NCT00098475|9579297|FG002|STARTED|Step 2||0
8547137|NCT00098475|9579298|FG003|STARTED|Step 2||0
8547138|NCT00098475|9579295|FG000|Treated|Step 2||4
8547139|NCT00098475|9579296|FG001|Treated|Step 2||14
8547140|NCT00098475|9579297|FG002|Treated|Step 2||0
8547141|NCT00098475|9579298|FG003|Treated|Step 2||0
8547142|NCT00098475|9579295|FG000|Eligible|Step 2|Some patients were considered eligible at registration but found ineligible in the analysis.|2
8547143|NCT00098475|9579296|FG001|Eligible|Step 2|Some patients were considered eligible at registration but found ineligible in the analysis.|9
8547144|NCT00098475|9579297|FG002|Eligible|Step 2||0
8547145|NCT00098475|9579298|FG003|Eligible|Step 2||0
8547146|NCT00098475|9579295|FG000|COMPLETED|Step 2||0
8547147|NCT00098475|9579296|FG001|COMPLETED|Step 2||5
8547148|NCT00098475|9579297|FG002|COMPLETED|Step 2||0
8547149|NCT00098475|9579298|FG003|COMPLETED|Step 2||0
8547150|NCT00098475|9579295|FG000|NOT COMPLETED|Step 2||5
8547151|NCT00098475|9579296|FG001|NOT COMPLETED|Step 2||10
8547152|NCT00098475|9579297|FG002|NOT COMPLETED|Step 2||0
8547153|NCT00098475|9579298|FG003|NOT COMPLETED|Step 2||0
8567203|NCT00083889|9599482|FG000|STARTED|Overall Study||375
8567204|NCT00083889|9599483|FG001|STARTED|Overall Study||375
8567205|NCT00083889|9599482|FG000|Received Treatment|Overall Study||375
8567206|NCT00083889|9599483|FG001|Received Treatment|Overall Study|15 subjects randomized to IFN-α discontinued before receiving their first dose of study medication.|360
8567207|NCT00083889|9599482|FG000|COMPLETED|Overall Study||0
8567208|NCT00083889|9599483|FG001|COMPLETED|Overall Study|Discontinuation crossover subjects: AEs 5,consent withdrawn 2, lack efficacy 13, sponsor decision 5.|0
8567209|NCT00083889|9599482|FG000|NOT COMPLETED|Overall Study||375
8567210|NCT00083889|9599483|FG001|NOT COMPLETED|Overall Study||375
8567211|NCT00084084|9599492|FG000|STARTED|Phase 1 (Treatment With Replagal RB)||17
8567212|NCT00084084|9599492|FG000|COMPLETED|Phase 1 (Treatment With Replagal RB)||16
8567213|NCT00084084|9599492|FG000|NOT COMPLETED|Phase 1 (Treatment With Replagal RB)||1
8567214|NCT00084084|9599492|FG000|STARTED|Phase 2 (Transition to Replagal AF)|The 11 patients remaining in TKT029 at the time Replagal AF was made available continued to Phase 2.|11
8567215|NCT00084084|9599492|FG000|COMPLETED|Phase 2 (Transition to Replagal AF)||10
8567216|NCT00084084|9599492|FG000|NOT COMPLETED|Phase 2 (Transition to Replagal AF)||1
8567217|NCT00084136|9599500|FG000|STARTED|PI Comparison||519
8567218|NCT00084136|9599501|FG001|STARTED|PI Comparison||526
8567219|NCT00084136|9599502|FG002|STARTED|PI Comparison||0
8567220|NCT00084136|9599500|FG000|COMPLETED|PI Comparison|Follow-up was until ddI+FTC+ATV arm was closed per DSMB recommendation on May 23, 2008.|464
8567221|NCT00084136|9599501|FG001|COMPLETED|PI Comparison|Follow-up was until ddI+FTC+ATV arm was closed per DSMB recommendation on May 23, 2008.|479
8567222|NCT00084136|9599502|FG002|COMPLETED|PI Comparison||0
8567223|NCT00084136|9599500|FG000|NOT COMPLETED|PI Comparison||55
8567224|NCT00084136|9599501|FG001|NOT COMPLETED|PI Comparison||47
8567225|NCT00084136|9599502|FG002|NOT COMPLETED|PI Comparison||0
8567226|NCT00084136|9599500|FG000|STARTED|NRTI Comparison||519
8567227|NCT00084136|9599501|FG001|STARTED|NRTI Comparison||0
8567228|NCT00084136|9599502|FG002|STARTED|NRTI Comparison||526
8567229|NCT00084136|9599500|FG000|COMPLETED|NRTI Comparison|Follow-up though study closeout period (final visit between April 1 and May 31, 2010).|418
8567230|NCT00084136|9599501|FG001|COMPLETED|NRTI Comparison||0
8567231|NCT00084136|9599502|FG002|COMPLETED|NRTI Comparison|Follow-up though study closeout period (final visit between April 1 and May 31, 2010).|444
8567232|NCT00084136|9599500|FG000|NOT COMPLETED|NRTI Comparison||101
8567233|NCT00084136|9599501|FG001|NOT COMPLETED|NRTI Comparison||0
8567234|NCT00084136|9599502|FG002|NOT COMPLETED|NRTI Comparison||82
8567235|NCT00084149|9599513|FG000|STARTED|Overall Study||36
8567236|NCT00084149|9599514|FG001|STARTED|Overall Study||18
8567237|NCT00084149|9599513|FG000|COMPLETED|Overall Study||28
8567238|NCT00084149|9599514|FG001|COMPLETED|Overall Study||13
8567239|NCT00084149|9599513|FG000|NOT COMPLETED|Overall Study||8
8567240|NCT00084149|9599514|FG001|NOT COMPLETED|Overall Study||5
8567241|NCT00084266|9599526|FG000|STARTED|Overall Study||618
8547154|NCT04471935|9579308|FG000|STARTED|Overall Study||10
8547155|NCT04471935|9579308|FG000|COMPLETED|Overall Study||8
8547156|NCT04471935|9579308|FG000|NOT COMPLETED|Overall Study||2
8547157|NCT04439344|9579312|FG000|STARTED|Overall Study||53
8547158|NCT04439344|9579312|FG000|Started Protocol Therapy|Overall Study||50
8547159|NCT04439344|9579312|FG000|Eligible|Overall Study||47
8547160|NCT04439344|9579312|FG000|COMPLETED|Overall Study||0
8547161|NCT04439344|9579312|FG000|NOT COMPLETED|Overall Study||53
8547162|NCT04439279|9579316|FG000|STARTED|Overall Study||35
8547163|NCT04439279|9579316|FG000|Started Protocol Therapy|Overall Study||35
8547164|NCT04439279|9579316|FG000|Eligible|Overall Study||33
8547165|NCT04439279|9579316|FG000|Reported Adverse Events Data|Overall Study|Adverse event was not assessed on one patient before discontinuing therapy due to withdraw/refusal|34
8547166|NCT04439279|9579316|FG000|COMPLETED|Overall Study|Treatment continued until disease progression or intolerability.|0
8547167|NCT04439279|9579316|FG000|NOT COMPLETED|Overall Study||35
8547168|NCT04439123|9579320|FG000|STARTED|Overall Study|All 35 patients enrolled were eligible and treated in the arm|35
8547169|NCT04439123|9579320|FG000|COMPLETED|Overall Study||0
8547170|NCT04439123|9579320|FG000|NOT COMPLETED|Overall Study||35
8547171|NCT04439110|9579324|FG000|STARTED|Overall Study||38
8547172|NCT04439110|9579324|FG000|Eligible|Overall Study||36
8547173|NCT04439110|9579324|FG000|COMPLETED|Overall Study||0
8547174|NCT04439110|9579324|FG000|NOT COMPLETED|Overall Study||38
8547184|NCT04551677|9579344|FG000|STARTED|Overall Study||29
8547185|NCT04551677|9579345|FG001|STARTED|Overall Study||31
8547186|NCT04551677|9579346|FG002|STARTED|Overall Study||30
8547187|NCT04551677|9579344|FG000|Vaccinated|Overall Study||29
8547188|NCT04551677|9579345|FG001|Vaccinated|Overall Study||31
8547189|NCT04551677|9579346|FG002|Vaccinated|Overall Study||30
8547190|NCT04551677|9579344|FG000|COMPLETED|Overall Study||29
8547191|NCT04551677|9579345|FG001|COMPLETED|Overall Study||31
8547192|NCT04551677|9579346|FG002|COMPLETED|Overall Study||30
8547193|NCT04551677|9579344|FG000|NOT COMPLETED|Overall Study||0
8547194|NCT04551677|9579345|FG001|NOT COMPLETED|Overall Study||0
8547195|NCT04551677|9579346|FG002|NOT COMPLETED|Overall Study||0
8547196|NCT04498832|9579356|FG000|STARTED|Overall Study||1049
8547197|NCT04498832|9579357|FG001|STARTED|Overall Study||1051
8547198|NCT04498832|9579356|FG000|COMPLETED|Overall Study||1048
8547199|NCT04498832|9579357|FG001|COMPLETED|Overall Study||1047
8547200|NCT04498832|9579356|FG000|NOT COMPLETED|Overall Study||1
8547201|NCT04498832|9579357|FG001|NOT COMPLETED|Overall Study||4
8547202|NCT04109222|9579366|FG000|STARTED|Overall Study||30
8547203|NCT04109222|9579367|FG001|STARTED|Overall Study||30
8547204|NCT04109222|9579368|FG002|STARTED|Overall Study||30
8547205|NCT04109222|9579366|FG000|COMPLETED|Overall Study||29
8547206|NCT04109222|9579367|FG001|COMPLETED|Overall Study||30
8547207|NCT04109222|9579368|FG002|COMPLETED|Overall Study||30
8547208|NCT04109222|9579366|FG000|NOT COMPLETED|Overall Study||1
8547209|NCT04109222|9579367|FG001|NOT COMPLETED|Overall Study||0
8547210|NCT04109222|9579368|FG002|NOT COMPLETED|Overall Study||0
8547211|NCT04046939|9579380|FG000|STARTED|Screening Period||534
8547212|NCT04046939|9579381|FG001|STARTED|Screening Period||0
8547213|NCT04046939|9579382|FG002|STARTED|Screening Period||0
8547214|NCT04046939|9579383|FG003|STARTED|Screening Period||0
8547215|NCT04046939|9579380|FG000|Received Placebo During Run-In Period|Screening Period||144
8547216|NCT04046939|9579381|FG001|Received Placebo During Run-In Period|Screening Period||0
8547217|NCT04046939|9579382|FG002|Received Placebo During Run-In Period|Screening Period||0
8547218|NCT04046939|9579383|FG003|Received Placebo During Run-In Period|Screening Period||0
8547219|NCT04046939|9579380|FG000|COMPLETED|Screening Period||103
8547220|NCT04046939|9579381|FG001|COMPLETED|Screening Period||0
8547221|NCT04046939|9579382|FG002|COMPLETED|Screening Period||0
8547222|NCT04046939|9579383|FG003|COMPLETED|Screening Period||0
8547223|NCT04046939|9579380|FG000|NOT COMPLETED|Screening Period||431
8547224|NCT04046939|9579381|FG001|NOT COMPLETED|Screening Period||0
8547225|NCT04046939|9579382|FG002|NOT COMPLETED|Screening Period||0
8547226|NCT04046939|9579383|FG003|NOT COMPLETED|Screening Period||0
8547227|NCT04046939|9579380|FG000|STARTED|Primary Assessment Period||27
8547228|NCT04046939|9579381|FG001|STARTED|Primary Assessment Period||22
8547229|NCT04046939|9579382|FG002|STARTED|Primary Assessment Period||26
8547230|NCT04046939|9579383|FG003|STARTED|Primary Assessment Period||28
8547231|NCT04046939|9579380|FG000|COMPLETED|Primary Assessment Period||25
8547232|NCT04046939|9579381|FG001|COMPLETED|Primary Assessment Period||22
8547233|NCT04046939|9579382|FG002|COMPLETED|Primary Assessment Period||24
8547234|NCT04046939|9579383|FG003|COMPLETED|Primary Assessment Period||28
8547235|NCT04046939|9579380|FG000|NOT COMPLETED|Primary Assessment Period||2
8547236|NCT04046939|9579381|FG001|NOT COMPLETED|Primary Assessment Period||0
8547237|NCT04046939|9579382|FG002|NOT COMPLETED|Primary Assessment Period||2
8547238|NCT04046939|9579383|FG003|NOT COMPLETED|Primary Assessment Period||0
8547239|NCT04046939|9579380|FG000|STARTED|Eosinophil Recovery Period||25
8547240|NCT04046939|9579381|FG001|STARTED|Eosinophil Recovery Period||22
8547241|NCT04046939|9579382|FG002|STARTED|Eosinophil Recovery Period||24
8547242|NCT04046939|9579383|FG003|STARTED|Eosinophil Recovery Period||28
8547243|NCT04046939|9579380|FG000|COMPLETED|Eosinophil Recovery Period||24
8547244|NCT04046939|9579381|FG001|COMPLETED|Eosinophil Recovery Period||22
8547245|NCT04046939|9579382|FG002|COMPLETED|Eosinophil Recovery Period||24
8547246|NCT04046939|9579383|FG003|COMPLETED|Eosinophil Recovery Period||27
8547247|NCT04046939|9579380|FG000|NOT COMPLETED|Eosinophil Recovery Period||1
8547248|NCT04046939|9579381|FG001|NOT COMPLETED|Eosinophil Recovery Period||0
8547175|NCT04180540|9579330|FG000|STARTED|Overall Study||55
8547176|NCT04180540|9579331|FG001|STARTED|Overall Study||54
8547177|NCT04180540|9579330|FG000|COMPLETED|Overall Study||53
8547178|NCT04180540|9579331|FG001|COMPLETED|Overall Study||54
8547179|NCT04180540|9579330|FG000|NOT COMPLETED|Overall Study||2
8547180|NCT04180540|9579331|FG001|NOT COMPLETED|Overall Study||0
8547181|NCT03912298|9579337|FG000|STARTED|Overall Study||7
8547182|NCT03912298|9579337|FG000|COMPLETED|Overall Study||7
8547183|NCT03912298|9579337|FG000|NOT COMPLETED|Overall Study||0
8547249|NCT04046939|9579382|FG002|NOT COMPLETED|Eosinophil Recovery Period||0
8547250|NCT04046939|9579383|FG003|NOT COMPLETED|Eosinophil Recovery Period||1
8547251|NCT03912259|9579401|FG000|STARTED|Overall Study||83
8547252|NCT03912259|9579402|FG001|STARTED|Overall Study||82
8547253|NCT03912259|9579401|FG000|COMPLETED|Overall Study||66
8547254|NCT03912259|9579402|FG001|COMPLETED|Overall Study||76
8547255|NCT03912259|9579401|FG000|NOT COMPLETED|Overall Study||17
8547256|NCT03912259|9579402|FG001|NOT COMPLETED|Overall Study||6
8547257|NCT03890367|9579412|FG000|STARTED|Overall Study||232
8547258|NCT03890367|9579413|FG001|STARTED|Overall Study||235
8547259|NCT03890367|9579414|FG002|STARTED|Overall Study||240
8547260|NCT03890367|9579412|FG000|Safety Analysis Set|Overall Study||230
8547261|NCT03890367|9579413|FG001|Safety Analysis Set|Overall Study||232
8547262|NCT03890367|9579414|FG002|Safety Analysis Set|Overall Study||239
8547263|NCT03890367|9579412|FG000|COMPLETED|Overall Study||228
8547264|NCT03890367|9579413|FG001|COMPLETED|Overall Study||229
8547265|NCT03890367|9579414|FG002|COMPLETED|Overall Study||239
8547266|NCT03890367|9579412|FG000|NOT COMPLETED|Overall Study||4
8547267|NCT03890367|9579413|FG001|NOT COMPLETED|Overall Study||6
8547268|NCT03890367|9579414|FG002|NOT COMPLETED|Overall Study||1
8547269|NCT03784898|9579422|FG000|STARTED|Overall Study||13
8547270|NCT03784898|9579422|FG000|COMPLETED|Overall Study||13
8547271|NCT03784898|9579422|FG000|NOT COMPLETED|Overall Study||0
8567242|NCT00084266|9599527|FG001|STARTED|Overall Study||607
8567243|NCT00084266|9599526|FG000|Treated|Overall Study||597
8567244|NCT00084266|9599527|FG001|Treated|Overall Study||587
8567245|NCT00084266|9599526|FG000|COMPLETED|Overall Study||177
8567246|NCT00084266|9599527|FG001|COMPLETED|Overall Study||184
8567247|NCT00084266|9599526|FG000|NOT COMPLETED|Overall Study||441
8567248|NCT00084266|9599527|FG001|NOT COMPLETED|Overall Study||423
8567249|NCT00084318|9599535|FG000|STARTED|Overall Study||119
8567250|NCT00084318|9599536|FG001|STARTED|Overall Study||119
8567251|NCT00084318|9599535|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|97
8567252|NCT00084318|9599536|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|106
8567253|NCT00084318|9599535|FG000|NOT COMPLETED|Overall Study||22
8567254|NCT00084318|9599536|FG001|NOT COMPLETED|Overall Study||13
8567255|NCT00084383|9599544|FG000|STARTED|Overall Study||60
8567256|NCT00084383|9599544|FG000|COMPLETED|Overall Study||13
8567257|NCT00084383|9599544|FG000|NOT COMPLETED|Overall Study||47
8567258|NCT00084409|9599550|FG000|STARTED|Overall Study|40 Current, 35 former|75
8818367|NCT01557244|9872005|FG005|COMPLETED|Safety Extension Phase: 12 Weeks||20
8818368|NCT01557244|9872006|FG006|COMPLETED|Safety Extension Phase: 12 Weeks||28
8818369|NCT01557244|9872000|FG000|NOT COMPLETED|Safety Extension Phase: 12 Weeks||3
8818370|NCT01557244|9872001|FG001|NOT COMPLETED|Safety Extension Phase: 12 Weeks||4
8818371|NCT01557244|9872002|FG002|NOT COMPLETED|Safety Extension Phase: 12 Weeks||0
8818372|NCT01557244|9872003|FG003|NOT COMPLETED|Safety Extension Phase: 12 Weeks||1
8818373|NCT01557244|9872004|FG004|NOT COMPLETED|Safety Extension Phase: 12 Weeks||0
8818374|NCT01557244|9872005|FG005|NOT COMPLETED|Safety Extension Phase: 12 Weeks||1
8818375|NCT01557244|9872006|FG006|NOT COMPLETED|Safety Extension Phase: 12 Weeks||0
8818376|NCT01557283|9872034|FG000|STARTED|Overall Study||140
8818377|NCT01557283|9872034|FG000|COMPLETED|Overall Study||96
8818378|NCT01557283|9872034|FG000|NOT COMPLETED|Overall Study||44
8818379|NCT01557322|9872040|FG000|STARTED|Overall Study||211
8818380|NCT01557322|9872041|FG001|STARTED|Overall Study||1543
8818381|NCT01557322|9872040|FG000|COMPLETED|Overall Study||211
8567259|NCT00084409|9599551|FG001|STARTED|Overall Study|41 current, 36 former|77
8567260|NCT00084409|9599550|FG000|COMPLETED|Overall Study|9 current, 6 former|60
8567261|NCT00084409|9599551|FG001|COMPLETED|Overall Study|4 Current, 8 former|65
8567262|NCT00084409|9599550|FG000|NOT COMPLETED|Overall Study||15
8567263|NCT00084409|9599551|FG001|NOT COMPLETED|Overall Study||12
8567264|NCT00084487|9599559|FG000|STARTED|Overall Study||21
8567265|NCT00084487|9599559|FG000|COMPLETED|Overall Study||20
8567266|NCT00084487|9599559|FG000|NOT COMPLETED|Overall Study||1
8567267|NCT00084552|9599565|FG000|STARTED|Overall Study||54
8567268|NCT00084552|9599566|FG001|STARTED|Overall Study||62
8567269|NCT00084552|9599565|FG000|COMPLETED|Overall Study||54
8567270|NCT00084552|9599566|FG001|COMPLETED|Overall Study||62
8567271|NCT00084552|9599565|FG000|NOT COMPLETED|Overall Study||0
8567272|NCT00084552|9599566|FG001|NOT COMPLETED|Overall Study||0
8567273|NCT00084617|9599572|FG000|STARTED|Overall Study||39
8567274|NCT00084617|9599572|FG000|COMPLETED|Overall Study||30
8567275|NCT00084617|9599572|FG000|NOT COMPLETED|Overall Study||9
8567276|NCT00084682|9599576|FG000|STARTED|Overall Study||14
8567277|NCT00084682|9599576|FG000|COMPLETED|Overall Study||13
8567278|NCT00084682|9599576|FG000|NOT COMPLETED|Overall Study||1
8567279|NCT00084747|9599581|FG000|STARTED|Overall Study||30
8567280|NCT00084747|9599581|FG000|COMPLETED|Overall Study||17
8567281|NCT00084747|9599581|FG000|NOT COMPLETED|Overall Study||13
8567282|NCT00084838|9599586|FG000|STARTED|Overall Study||25
8547272|NCT03607422|9579432|FG000|STARTED|Overall Study||242
8547273|NCT03607422|9579433|FG001|STARTED|Overall Study||243
8547274|NCT03607422|9579434|FG002|STARTED|Overall Study||247
8547275|NCT03607422|9579435|FG003|STARTED|Overall Study||60
8547276|NCT03607422|9579436|FG004|STARTED|Overall Study||58
8547277|NCT03607422|9579437|FG005|STARTED|Overall Study||62
8547278|NCT03607422|9579432|FG000|COMPLETED|Overall Study||204
8547279|NCT03607422|9579433|FG001|COMPLETED|Overall Study||233
8547280|NCT03607422|9579434|FG002|COMPLETED|Overall Study||235
8547281|NCT03607422|9579435|FG003|COMPLETED|Overall Study||55
8547282|NCT03607422|9579436|FG004|COMPLETED|Overall Study||55
8547283|NCT03607422|9579437|FG005|COMPLETED|Overall Study||59
8547284|NCT03607422|9579432|FG000|NOT COMPLETED|Overall Study||38
8547285|NCT03607422|9579433|FG001|NOT COMPLETED|Overall Study||10
8547286|NCT03607422|9579434|FG002|NOT COMPLETED|Overall Study||12
8547287|NCT03607422|9579435|FG003|NOT COMPLETED|Overall Study||5
8547288|NCT03607422|9579436|FG004|NOT COMPLETED|Overall Study||3
8547289|NCT03607422|9579437|FG005|NOT COMPLETED|Overall Study||3
8547290|NCT03600805|9579455|FG000|STARTED|Overall Study||28
8547291|NCT03600805|9579456|FG001|STARTED|Overall Study||14
8547292|NCT03600805|9579457|FG002|STARTED|Overall Study||14
8547293|NCT03600805|9579458|FG003|STARTED|Overall Study||27
8547294|NCT03600805|9579455|FG000|Week 52 Analysis Set Population|Overall Study||10
8547295|NCT03600805|9579456|FG001|Week 52 Analysis Set Population|Overall Study||6
8547296|NCT03600805|9579457|FG002|Week 52 Analysis Set Population|Overall Study||7
8547297|NCT03600805|9579458|FG003|Week 52 Analysis Set Population|Overall Study||13
8547298|NCT03600805|9579455|FG000|COMPLETED|Overall Study||9
8547299|NCT03600805|9579456|FG001|COMPLETED|Overall Study||6
8547300|NCT03600805|9579457|FG002|COMPLETED|Overall Study||6
8547301|NCT03600805|9579458|FG003|COMPLETED|Overall Study||8
8547302|NCT03600805|9579455|FG000|NOT COMPLETED|Overall Study||19
8547303|NCT03600805|9579456|FG001|NOT COMPLETED|Overall Study||8
8547304|NCT03600805|9579457|FG002|NOT COMPLETED|Overall Study||8
8547305|NCT03600805|9579458|FG003|NOT COMPLETED|Overall Study||19
8547306|NCT03584724|9579472|FG000|STARTED|Overall Study||25
8547307|NCT03584724|9579473|FG001|STARTED|Overall Study||24
8547308|NCT03584724|9579472|FG000|COMPLETED|Overall Study||18
8547309|NCT03584724|9579473|FG001|COMPLETED|Overall Study||23
8547310|NCT03584724|9579472|FG000|NOT COMPLETED|Overall Study||7
8547311|NCT03584724|9579473|FG001|NOT COMPLETED|Overall Study||1
8547312|NCT03434119|9579481|FG000|STARTED|Overall Study||116
8547313|NCT03434119|9579482|FG001|STARTED|Overall Study||125
8547314|NCT03434119|9579481|FG000|Treated|Overall Study||115
8547315|NCT03434119|9579482|FG001|Treated|Overall Study||125
8547316|NCT03434119|9579481|FG000|COMPLETED|Overall Study||9
8547317|NCT03434119|9579482|FG001|COMPLETED|Overall Study||12
8547318|NCT03434119|9579481|FG000|NOT COMPLETED|Overall Study||107
8547319|NCT03434119|9579482|FG001|NOT COMPLETED|Overall Study||113
8547320|NCT03417245|9579490|FG000|STARTED|Overall Study||40
8547321|NCT03417245|9579491|FG001|STARTED|Overall Study||80
8547322|NCT03417245|9579490|FG000|Treated|Overall Study||40
8547323|NCT03417245|9579491|FG001|Treated|Overall Study||79
8547324|NCT03417245|9579490|FG000|COMPLETED|Overall Study||37
8547325|NCT03417245|9579491|FG001|COMPLETED|Overall Study||79
8547326|NCT03417245|9579490|FG000|NOT COMPLETED|Overall Study||3
8547327|NCT03417245|9579491|FG001|NOT COMPLETED|Overall Study||1
8547328|NCT03417102|9579499|FG000|STARTED|Overall Study||19
8547329|NCT03417102|9579500|FG001|STARTED|Overall Study||38
8547330|NCT03417102|9579499|FG000|Safety Analysis Set|Overall Study||19
8547331|NCT03417102|9579500|FG001|Safety Analysis Set|Overall Study|3 participants were non-randomized but treated with Fitusiran considered in this arm for safety.|41
8547332|NCT03417102|9579499|FG000|COMPLETED|Overall Study||19
8547333|NCT03417102|9579500|FG001|COMPLETED|Overall Study||33
8547334|NCT03417102|9579499|FG000|NOT COMPLETED|Overall Study||0
8547335|NCT03417102|9579500|FG001|NOT COMPLETED|Overall Study||5
8547336|NCT03402230|9579506|FG000|STARTED|Overall Study||25
8547337|NCT03402230|9579507|FG001|STARTED|Overall Study||24
8547338|NCT03402230|9579506|FG000|COMPLETED|Overall Study||25
8547339|NCT03402230|9579507|FG001|COMPLETED|Overall Study||23
8547340|NCT03402230|9579506|FG000|NOT COMPLETED|Overall Study||0
8547341|NCT03402230|9579507|FG001|NOT COMPLETED|Overall Study||1
8547342|NCT03278626|9579512|FG000|STARTED|Overall Study||12
8547343|NCT03278626|9579512|FG000|COMPLETED|Overall Study||7
8547344|NCT03278626|9579512|FG000|NOT COMPLETED|Overall Study||5
8547345|NCT03211858|9579518|FG000|STARTED|Overall Study||301
8547346|NCT03211858|9579519|FG001|STARTED|Overall Study||296
8547347|NCT03211858|9579518|FG000|Treated|Overall Study||301
8547348|NCT03211858|9579519|FG001|Treated|Overall Study||296
8547349|NCT03211858|9579518|FG000|COMPLETED|Overall Study||264
8547350|NCT03211858|9579519|FG001|COMPLETED|Overall Study||263
8547351|NCT03211858|9579518|FG000|NOT COMPLETED|Overall Study||37
8547352|NCT03211858|9579519|FG001|NOT COMPLETED|Overall Study||33
8547353|NCT03093480|9579529|FG000|STARTED|Overall Study||16
8547354|NCT03093480|9579529|FG000|Tapering Period|Overall Study||10
8547355|NCT03093480|9579529|FG000|Follow-up Period|Overall Study||10
8547356|NCT03093480|9579529|FG000|COMPLETED|Overall Study||16
8547357|NCT03093480|9579529|FG000|NOT COMPLETED|Overall Study||0
8547358|NCT03077438|9579535|FG000|STARTED|Overall Study||499
8547359|NCT03077438|9579536|FG001|STARTED|Overall Study||501
8547360|NCT03077438|9579535|FG000|Safety Analysis Set (SafAS)|Overall Study||498
8547361|NCT03077438|9579536|FG001|Safety Analysis Set (SafAS)|Overall Study||494
8547362|NCT03077438|9579535|FG000|COMPLETED|Overall Study||487
8547363|NCT03077438|9579536|FG001|COMPLETED|Overall Study||487
8547364|NCT03077438|9579535|FG000|NOT COMPLETED|Overall Study||12
8547365|NCT03077438|9579536|FG001|NOT COMPLETED|Overall Study||14
8547366|NCT03045653|9579546|FG000|STARTED|Overall Study||30
8547367|NCT03045653|9579546|FG000|COMPLETED|Overall Study||30
8547368|NCT03045653|9579546|FG000|NOT COMPLETED|Overall Study||0
8547369|NCT02948959|9579552|FG000|STARTED|52 Weeks Treatment Period||135
8547370|NCT02948959|9579553|FG001|STARTED|52 Weeks Treatment Period||273
8621477|NCT00480493|9660452|FG000|COMPLETED|Overall Study||30
8547371|NCT02948959|9579552|FG000|Treated|52 Weeks Treatment Period||135
8547372|NCT02948959|9579553|FG001|Treated|52 Weeks Treatment Period||270
8547373|NCT02948959|9579552|FG000|Safety Population|52 Weeks Treatment Period|1 participant randomized to placebo received dupilumab; counted in dupilumab arm for safety analysis.|134
8547374|NCT02948959|9579553|FG001|Safety Population|52 Weeks Treatment Period|1 participant randomized to placebo received dupilumab; counted in dupilumab arm for safety analysis.|271
8547375|NCT02948959|9579552|FG000|Type 2 Inflammatory Asthma Phenotype Population|52 Weeks Treatment Period||114
8547376|NCT02948959|9579553|FG001|Type 2 Inflammatory Asthma Phenotype Population|52 Weeks Treatment Period||236
8547377|NCT02948959|9579552|FG000|Baseline Blood Eosinophils Count >=300 Cells Per Microlitre Population|52 Weeks Treatment Period||84
8547378|NCT02948959|9579553|FG001|Baseline Blood Eosinophils Count >=300 Cells Per Microlitre Population|52 Weeks Treatment Period||175
8547379|NCT02948959|9579552|FG000|COMPLETED|52 Weeks Treatment Period||130
8547380|NCT02948959|9579553|FG001|COMPLETED|52 Weeks Treatment Period||248
8547381|NCT02948959|9579552|FG000|NOT COMPLETED|52 Weeks Treatment Period||5
8547382|NCT02948959|9579553|FG001|NOT COMPLETED|52 Weeks Treatment Period||25
8547383|NCT02948959|9579552|FG000|STARTED|12 Weeks Follow-up Period||9
8547384|NCT02948959|9579553|FG001|STARTED|12 Weeks Follow-up Period||31
8547385|NCT02948959|9579552|FG000|COMPLETED|12 Weeks Follow-up Period||4
8547386|NCT02948959|9579553|FG001|COMPLETED|12 Weeks Follow-up Period||19
8547387|NCT02948959|9579552|FG000|NOT COMPLETED|12 Weeks Follow-up Period||5
8547388|NCT02948959|9579553|FG001|NOT COMPLETED|12 Weeks Follow-up Period||12
8547389|NCT02878603|9579569|FG000|STARTED|Overall Study||29
8547390|NCT02878603|9579570|FG001|STARTED|Overall Study||75
8547391|NCT02878603|9579569|FG000|COMPLETED|Overall Study||23
8547392|NCT02878603|9579570|FG001|COMPLETED|Overall Study||70
8547393|NCT02878603|9579569|FG000|NOT COMPLETED|Overall Study||6
8547394|NCT02878603|9579570|FG001|NOT COMPLETED|Overall Study||5
8547395|NCT02864407|9579576|FG000|STARTED|Overall Study||3223
8547396|NCT02864407|9579576|FG000|Effectiveness Analysis Set|Overall Study||2105
8547397|NCT02864407|9579576|FG000|Long-term Safety Analysis Set|Overall Study||813
8547398|NCT02864407|9579576|FG000|Long-term Effectiveness Analysis Set|Overall Study||767
8547399|NCT02864407|9579576|FG000|COMPLETED|Overall Study||3100
8547400|NCT02864407|9579576|FG000|NOT COMPLETED|Overall Study||123
8547401|NCT02846532|9579583|FG000|STARTED|Overall Study||12
8547402|NCT02846532|9579584|FG001|STARTED|Overall Study||66
8547403|NCT02846532|9579585|FG002|STARTED|Overall Study||34
8547404|NCT02846532|9579583|FG000|COMPLETED|Overall Study||11
8547405|NCT02846532|9579584|FG001|COMPLETED|Overall Study||63
8547406|NCT02846532|9579585|FG002|COMPLETED|Overall Study||33
8547407|NCT02846532|9579583|FG000|NOT COMPLETED|Overall Study||1
8547408|NCT02846532|9579584|FG001|NOT COMPLETED|Overall Study||3
8547409|NCT02846532|9579585|FG002|NOT COMPLETED|Overall Study||1
8567283|NCT00084838|9599586|FG000|Eligible and Treated|Overall Study|4 ineligible pts upon central path review (n=3) and per DFCI IRB (n=1); 1 pt withdrew before rcv trt|20
8567284|NCT00084838|9599586|FG000|COMPLETED|Overall Study||12
8567285|NCT00084838|9599586|FG000|NOT COMPLETED|Overall Study||13
8567286|NCT00084864|9599596|FG000|STARTED|Overall Study||10
8567287|NCT00084864|9599597|FG001|STARTED|Overall Study||7
8567288|NCT00084864|9599598|FG002|STARTED|Overall Study||4
8567289|NCT00084864|9599599|FG003|STARTED|Overall Study||4
8567290|NCT00084864|9599596|FG000|COMPLETED|Overall Study||9
8567291|NCT00084864|9599597|FG001|COMPLETED|Overall Study||7
8567292|NCT00084864|9599598|FG002|COMPLETED|Overall Study||4
8567293|NCT00084864|9599599|FG003|COMPLETED|Overall Study||4
8567294|NCT00084864|9599596|FG000|NOT COMPLETED|Overall Study||1
8567295|NCT00084864|9599597|FG001|NOT COMPLETED|Overall Study||0
8567296|NCT00084864|9599598|FG002|NOT COMPLETED|Overall Study||0
8567297|NCT00084864|9599599|FG003|NOT COMPLETED|Overall Study||0
8567298|NCT00084929|9599609|FG000|STARTED|Overall Study||2600
8567299|NCT00084929|9599609|FG000|COMPLETED|Overall Study||2531
8567300|NCT00084929|9599609|FG000|NOT COMPLETED|Overall Study||69
8567301|NCT00085098|9599619|FG000|STARTED|Overall Study||11
8567302|NCT00085098|9599620|FG001|STARTED|Overall Study||13
8567303|NCT00085098|9599619|FG000|COMPLETED|Overall Study||10
8567304|NCT00085098|9599620|FG001|COMPLETED|Overall Study||11
8567305|NCT00085098|9599619|FG000|NOT COMPLETED|Overall Study||1
8567306|NCT00085098|9599620|FG001|NOT COMPLETED|Overall Study||2
8567307|NCT00085254|9599632|FG000|STARTED|Overall Study||18
8567308|NCT00085254|9599633|FG001|STARTED|Overall Study||46
8567309|NCT00085254|9599634|FG002|STARTED|Overall Study||48
8567310|NCT00085254|9599632|FG000|COMPLETED|Overall Study||18
8567311|NCT00085254|9599633|FG001|COMPLETED|Overall Study||46
8567312|NCT00085254|9599634|FG002|COMPLETED|Overall Study||48
8567313|NCT00085254|9599632|FG000|NOT COMPLETED|Overall Study||0
8567314|NCT00085254|9599633|FG001|NOT COMPLETED|Overall Study||0
8567315|NCT00085254|9599634|FG002|NOT COMPLETED|Overall Study||0
8567316|NCT00085293|9599648|FG000|STARTED|Overall Study||12
8567317|NCT00085293|9599648|FG000|COMPLETED|Overall Study||12
8621478|NCT00480493|9660453|FG001|COMPLETED|Overall Study||21
8547410|NCT02688933|9579595|FG000|STARTED|Overall Study||320
8547411|NCT02688933|9579596|FG001|STARTED|Overall Study||318
8547412|NCT02688933|9579595|FG000|COMPLETED|Overall Study||291
8547413|NCT02688933|9579596|FG001|COMPLETED|Overall Study||281
8547414|NCT02688933|9579595|FG000|NOT COMPLETED|Overall Study||29
8547415|NCT02688933|9579596|FG001|NOT COMPLETED|Overall Study||37
8547416|NCT02550197|9579604|FG000|STARTED|Overall Study||200
8547417|NCT02550197|9579605|FG001|STARTED|Overall Study||100
8547418|NCT02550197|9579604|FG000|COMPLETED|Overall Study||200
8547419|NCT02550197|9579605|FG001|COMPLETED|Overall Study||100
8547420|NCT02550197|9579604|FG000|NOT COMPLETED|Overall Study||0
8547421|NCT02550197|9579605|FG001|NOT COMPLETED|Overall Study||0
8547422|NCT02492165|9579615|FG000|STARTED|Overall Study||100
8547423|NCT02492165|9579616|FG001|STARTED|Overall Study||60
8547424|NCT02492165|9579617|FG002|STARTED|Overall Study||60
8547425|NCT02492165|9579618|FG003|STARTED|Overall Study||30
8547426|NCT02492165|9579615|FG000|COMPLETED|Overall Study||100
8547427|NCT02492165|9579616|FG001|COMPLETED|Overall Study||59
8547428|NCT02492165|9579617|FG002|COMPLETED|Overall Study||60
8547429|NCT02492165|9579618|FG003|COMPLETED|Overall Study||30
8547430|NCT02492165|9579615|FG000|NOT COMPLETED|Overall Study||0
8547431|NCT02492165|9579616|FG001|NOT COMPLETED|Overall Study||1
8547432|NCT02492165|9579617|FG002|NOT COMPLETED|Overall Study||0
8547433|NCT02492165|9579618|FG003|NOT COMPLETED|Overall Study||0
8547434|NCT02476006|9579628|FG000|STARTED|Overall Study||998
8547435|NCT02476006|9579628|FG000|Treated|Overall Study||994
8547436|NCT02476006|9579628|FG000|COMPLETED|Overall Study||878
8547437|NCT02476006|9579628|FG000|NOT COMPLETED|Overall Study||120
8547438|NCT02468414|9579634|FG000|STARTED|Overall Study||3
8547439|NCT02468414|9579635|FG001|STARTED|Overall Study||0
8547440|NCT02468414|9579634|FG000|Successfully Screened|Overall Study||2
8547441|NCT02468414|9579635|FG001|Successfully Screened|Overall Study||0
8547442|NCT02468414|9579634|FG000|Harvesting|Overall Study||1
8547443|NCT02468414|9579635|FG001|Harvesting|Overall Study||0
8547444|NCT02468414|9579634|FG000|Implantation|Overall Study||1
8547445|NCT02468414|9579635|FG001|Implantation|Overall Study||0
8547446|NCT02468414|9579634|FG000|Safety Follow-up|Overall Study||0
8547447|NCT02468414|9579635|FG001|Safety Follow-up|Overall Study||0
8547448|NCT02468414|9579634|FG000|COMPLETED|Overall Study||0
8547449|NCT02468414|9579635|FG001|COMPLETED|Overall Study||0
8547450|NCT02468414|9579634|FG000|NOT COMPLETED|Overall Study||3
8547451|NCT02468414|9579635|FG001|NOT COMPLETED|Overall Study||0
8621479|NCT00480493|9660452|FG000|NOT COMPLETED|Overall Study||2
8621480|NCT00480493|9660453|FG001|NOT COMPLETED|Overall Study||7
8621481|NCT00480532|9660465|FG000|STARTED|Overall Study||33
8621482|NCT00480532|9660466|FG001|STARTED|Overall Study||33
8621483|NCT00480532|9660467|FG002|STARTED|Overall Study||33
8621484|NCT00480532|9660468|FG003|STARTED|Overall Study||32
8621485|NCT00480532|9660465|FG000|COMPLETED|Overall Study||31
8621486|NCT00480532|9660466|FG001|COMPLETED|Overall Study||29
8621487|NCT00480532|9660467|FG002|COMPLETED|Overall Study||29
8547452|NCT02462876|9579641|FG000|STARTED|Overall Study||60
8547453|NCT02462876|9579641|FG000|COMPLETED|Overall Study||33
8547454|NCT02462876|9579641|FG000|NOT COMPLETED|Overall Study||27
8547455|NCT02332590|9579647|FG000|STARTED|DB Period (up to 24 Weeks)||185
8547456|NCT02332590|9579648|FG001|STARTED|DB Period (up to 24 Weeks)||184
8547457|NCT02332590|9579647|FG000|Treated|DB Period (up to 24 Weeks)||184
8621488|NCT00480532|9660468|FG003|COMPLETED|Overall Study||31
8621489|NCT00480532|9660465|FG000|NOT COMPLETED|Overall Study||2
8621490|NCT00480532|9660466|FG001|NOT COMPLETED|Overall Study||4
8621491|NCT00480532|9660467|FG002|NOT COMPLETED|Overall Study||4
8621492|NCT00480532|9660468|FG003|NOT COMPLETED|Overall Study||1
8621493|NCT00480636|9660478|FG000|STARTED|Overall Study||102
8621494|NCT00480636|9660478|FG000|COMPLETED|Overall Study||83
8547458|NCT02332590|9579648|FG001|Treated|DB Period (up to 24 Weeks)||184
8547459|NCT02332590|9579647|FG000|COMPLETED|DB Period (up to 24 Weeks)|155 participants entered OLE period and 1 did not enroll.|156
8547460|NCT02332590|9579648|FG001|COMPLETED|DB Period (up to 24 Weeks)||165
8547461|NCT02332590|9579647|FG000|NOT COMPLETED|DB Period (up to 24 Weeks)||29
8547462|NCT02332590|9579648|FG001|NOT COMPLETED|DB Period (up to 24 Weeks)||19
8621495|NCT00480636|9660478|FG000|NOT COMPLETED|Overall Study||19
8621496|NCT00480740|9660485|FG000|STARTED|Overall Study||26
8621497|NCT00480740|9660486|FG001|STARTED|Overall Study||9
8547463|NCT02332590|9579647|FG000|STARTED|OLE Period (Week 24 up to Week 300)||155
8547464|NCT02332590|9579648|FG001|STARTED|OLE Period (Week 24 up to Week 300)||165
8547465|NCT02332590|9579647|FG000|COMPLETED|OLE Period (Week 24 up to Week 300)||108
8547466|NCT02332590|9579648|FG001|COMPLETED|OLE Period (Week 24 up to Week 300)||120
8547467|NCT02332590|9579647|FG000|NOT COMPLETED|OLE Period (Week 24 up to Week 300)||47
8547468|NCT02332590|9579648|FG001|NOT COMPLETED|OLE Period (Week 24 up to Week 300)||45
8547469|NCT02255656|9579656|FG000|STARTED|Overall Study||1062
8547470|NCT02255656|9579656|FG000|COMPLETED|Overall Study||592
8547471|NCT02255656|9579656|FG000|NOT COMPLETED|Overall Study||470
8547472|NCT02134028|9579675|FG000|STARTED|Overall Study||111
8547473|NCT02134028|9579676|FG001|STARTED|Overall Study||421
8547474|NCT02134028|9579677|FG002|STARTED|Overall Study||517
8547475|NCT02134028|9579678|FG003|STARTED|Overall Study||1013
8547476|NCT02134028|9579679|FG004|STARTED|Overall Study||97
8547477|NCT02134028|9579680|FG005|STARTED|Overall Study||90
8547478|NCT02134028|9579681|FG006|STARTED|Overall Study||19
8547479|NCT02134028|9579682|FG007|STARTED|Overall Study||14
8547480|NCT02134028|9579675|FG000|COMPLETED|Overall Study||102
8547481|NCT02134028|9579676|FG001|COMPLETED|Overall Study||379
8547482|NCT02134028|9579677|FG002|COMPLETED|Overall Study||465
8547483|NCT02134028|9579678|FG003|COMPLETED|Overall Study||908
8547484|NCT02134028|9579679|FG004|COMPLETED|Overall Study||83
8547485|NCT02134028|9579680|FG005|COMPLETED|Overall Study||76
8547486|NCT02134028|9579681|FG006|COMPLETED|Overall Study||15
8547487|NCT02134028|9579682|FG007|COMPLETED|Overall Study||11
8547488|NCT02134028|9579675|FG000|NOT COMPLETED|Overall Study||9
8547489|NCT02134028|9579676|FG001|NOT COMPLETED|Overall Study||42
8547490|NCT02134028|9579677|FG002|NOT COMPLETED|Overall Study||52
8547491|NCT02134028|9579678|FG003|NOT COMPLETED|Overall Study||105
8547492|NCT02134028|9579679|FG004|NOT COMPLETED|Overall Study||14
8547493|NCT02134028|9579680|FG005|NOT COMPLETED|Overall Study||14
8547494|NCT02134028|9579681|FG006|NOT COMPLETED|Overall Study||4
8547495|NCT02134028|9579682|FG007|NOT COMPLETED|Overall Study||3
8567318|NCT00085293|9599648|FG000|NOT COMPLETED|Overall Study||0
8567319|NCT00085410|9599652|FG000|STARTED|Overall Study||20
8567320|NCT00085410|9599652|FG000|COMPLETED|Overall Study||20
8567321|NCT00085410|9599652|FG000|NOT COMPLETED|Overall Study||0
8567322|NCT00085423|9599657|FG000|STARTED|Overall Study||20
8567323|NCT00085423|9599657|FG000|COMPLETED|Overall Study||18
8567324|NCT00085423|9599657|FG000|NOT COMPLETED|Overall Study||2
8567325|NCT00085436|9599661|FG000|STARTED|Overall Study||18
8621498|NCT00480740|9660487|FG002|STARTED|Overall Study||6
8621499|NCT00480740|9660485|FG000|COMPLETED|Overall Study||26
8818382|NCT01557322|9872041|FG001|COMPLETED|Overall Study||1543
8567326|NCT00085436|9599661|FG000|COMPLETED|Overall Study||18
8621500|NCT00480740|9660486|FG001|COMPLETED|Overall Study||9
8621501|NCT00480740|9660487|FG002|COMPLETED|Overall Study||6
8621502|NCT00480740|9660485|FG000|NOT COMPLETED|Overall Study||0
8621503|NCT00480740|9660486|FG001|NOT COMPLETED|Overall Study||0
8621504|NCT00480740|9660487|FG002|NOT COMPLETED|Overall Study||0
8621505|NCT00480779|9660497|FG000|STARTED|Overall Study||26
8621506|NCT00480779|9660498|FG001|STARTED|Overall Study||22
8621507|NCT00480779|9660497|FG000|COMPLETED|Overall Study||24
8621508|NCT00480779|9660498|FG001|COMPLETED|Overall Study||19
8621509|NCT00480779|9660497|FG000|NOT COMPLETED|Overall Study||2
8621510|NCT00480779|9660498|FG001|NOT COMPLETED|Overall Study||3
8621511|NCT00480857|9660504|FG000|STARTED|Overall Study||19
8621512|NCT00480857|9660504|FG000|COMPLETED|Overall Study||17
8621513|NCT00480857|9660504|FG000|NOT COMPLETED|Overall Study||2
8567327|NCT00085436|9599661|FG000|NOT COMPLETED|Overall Study||0
8567328|NCT00085540|9599668|FG000|STARTED|Overall Study||8
8567329|NCT00085540|9599669|FG001|STARTED|Overall Study||42
8567330|NCT00085540|9599668|FG000|COMPLETED|Overall Study||8
8567331|NCT00085540|9599669|FG001|COMPLETED|Overall Study||40
8567332|NCT00085540|9599668|FG000|NOT COMPLETED|Overall Study||0
8567333|NCT00085540|9599669|FG001|NOT COMPLETED|Overall Study||2
8567334|NCT00085566|9599678|FG000|STARTED|Overall Study||3
8567335|NCT00085566|9599679|FG001|STARTED|Overall Study||3
8567336|NCT00085566|9599680|FG002|STARTED|Overall Study||57
8567337|NCT00085566|9599678|FG000|COMPLETED|Overall Study||3
8567338|NCT00085566|9599679|FG001|COMPLETED|Overall Study||3
8567339|NCT00085566|9599680|FG002|COMPLETED|Overall Study||43
8567340|NCT00085566|9599678|FG000|NOT COMPLETED|Overall Study||0
8567341|NCT00085566|9599679|FG001|NOT COMPLETED|Overall Study||0
8567342|NCT00085566|9599680|FG002|NOT COMPLETED|Overall Study||14
8567343|NCT00085644|9599690|FG000|STARTED|Double-Blind Period||208
8567344|NCT00085644|9599691|FG001|STARTED|Double-Blind Period||107
8567345|NCT00085644|9599692|FG002|STARTED|Double-Blind Period|This treatment group is not applicable to the Double-Blind Period.|0
8567346|NCT00085644|9599690|FG000|COMPLETED|Double-Blind Period||195
8567347|NCT00085644|9599691|FG001|COMPLETED|Double-Blind Period||101
8567348|NCT00085644|9599692|FG002|COMPLETED|Double-Blind Period||0
8567349|NCT00085644|9599690|FG000|NOT COMPLETED|Double-Blind Period||13
8567350|NCT00085644|9599691|FG001|NOT COMPLETED|Double-Blind Period||6
8567351|NCT00085644|9599692|FG002|NOT COMPLETED|Double-Blind Period||0
8567352|NCT00085644|9599690|FG000|STARTED|Open-Label Period|This treatment group is not applicable to the Open-Label Period.|0
8567353|NCT00085644|9599691|FG001|STARTED|Open-Label Period|This treatment group is not applicable to the Open-Label Period.|0
8567354|NCT00085644|9599692|FG002|STARTED|Open-Label Period|1 subject who discontinued for personal reasons subsequently died 450 days after last dose.|311
8567355|NCT00085644|9599690|FG000|COMPLETED|Open-Label Period||0
8567356|NCT00085644|9599691|FG001|COMPLETED|Open-Label Period||0
8567357|NCT00085644|9599692|FG002|COMPLETED|Open-Label Period||202
8567358|NCT00085644|9599690|FG000|NOT COMPLETED|Open-Label Period||0
8567359|NCT00085644|9599691|FG001|NOT COMPLETED|Open-Label Period||0
8567360|NCT00085644|9599692|FG002|NOT COMPLETED|Open-Label Period||109
8567361|NCT00085709|9599701|FG000|STARTED|Overall Study||317
8567362|NCT00085709|9599702|FG001|STARTED|Overall Study||320
8567363|NCT00085709|9599701|FG000|Eligible|Overall Study||298
8567364|NCT00085709|9599702|FG001|Eligible|Overall Study||301
8567365|NCT00085709|9599701|FG000|Eligible and Did Not Withdraw Consent|Overall Study||296
8621514|NCT00480987|9660508|FG000|STARTED|Overall Study||27
8818383|NCT01557322|9872040|FG000|NOT COMPLETED|Overall Study||0
8567366|NCT00085709|9599702|FG001|Eligible and Did Not Withdraw Consent|Overall Study||300
8567367|NCT00085709|9599701|FG000|COMPLETED|Overall Study||264
8567368|NCT00085709|9599702|FG001|COMPLETED|Overall Study||270
8621515|NCT00480987|9660508|FG000|COMPLETED|Overall Study||27
8621516|NCT00480987|9660508|FG000|NOT COMPLETED|Overall Study||0
8621517|NCT00481065|9660520|FG000|STARTED|Overall Study||51
8547496|NCT02037620|9579702|FG000|STARTED|Overall Study||5
8621518|NCT00481065|9660521|FG001|STARTED|Overall Study||50
8621519|NCT00481065|9660522|FG002|STARTED|Overall Study||51
8621520|NCT00481065|9660523|FG003|STARTED|Overall Study||52
8621521|NCT00481065|9660524|FG004|STARTED|Overall Study||51
8621522|NCT00481065|9660525|FG005|STARTED|Overall Study||51
8621523|NCT00481065|9660526|FG006|STARTED|Overall Study||50
8621524|NCT00481065|9660527|FG007|STARTED|Overall Study||49
8621525|NCT00481065|9660520|FG000|COMPLETED|Overall Study||29
8547497|NCT02037620|9579702|FG000|COMPLETED|Overall Study||4
8547498|NCT02037620|9579702|FG000|NOT COMPLETED|Overall Study||1
8547499|NCT01902173|9579712|FG000|STARTED|Phase 1 Doublet Regimen Cohort 1||3
8547500|NCT01902173|9579713|FG001|STARTED|Phase 1 Doublet Regimen Cohort 1||0
8547501|NCT01902173|9579714|FG002|STARTED|Phase 1 Doublet Regimen Cohort 1||0
8547502|NCT01902173|9579715|FG003|STARTED|Phase 1 Doublet Regimen Cohort 1||0
8547503|NCT01902173|9579716|FG004|STARTED|Phase 1 Doublet Regimen Cohort 1||0
8547504|NCT01902173|9579717|FG005|STARTED|Phase 1 Doublet Regimen Cohort 1||0
8547505|NCT01902173|9579712|FG000|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
8547506|NCT01902173|9579713|FG001|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
8547507|NCT01902173|9579714|FG002|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
8547508|NCT01902173|9579715|FG003|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
8547509|NCT01902173|9579716|FG004|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
8547510|NCT01902173|9579717|FG005|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
8547511|NCT01902173|9579712|FG000|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||3
8547512|NCT01902173|9579713|FG001|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
8547513|NCT01902173|9579714|FG002|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
8547514|NCT01902173|9579715|FG003|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
8547515|NCT01902173|9579716|FG004|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
8547516|NCT01902173|9579717|FG005|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
8547517|NCT01902173|9579712|FG000|STARTED|Phase 1 Doublet Regimen Cohort 2||0
8547518|NCT01902173|9579713|FG001|STARTED|Phase 1 Doublet Regimen Cohort 2||9
8547519|NCT01902173|9579714|FG002|STARTED|Phase 1 Doublet Regimen Cohort 2||0
8547520|NCT01902173|9579715|FG003|STARTED|Phase 1 Doublet Regimen Cohort 2||0
8547521|NCT01902173|9579716|FG004|STARTED|Phase 1 Doublet Regimen Cohort 2||0
8547522|NCT01902173|9579717|FG005|STARTED|Phase 1 Doublet Regimen Cohort 2||0
8547523|NCT01902173|9579712|FG000|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
8547524|NCT01902173|9579713|FG001|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
8547525|NCT01902173|9579714|FG002|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
8547526|NCT01902173|9579715|FG003|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
8547527|NCT01902173|9579716|FG004|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
8547528|NCT01902173|9579717|FG005|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
8547529|NCT01902173|9579712|FG000|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
8547530|NCT01902173|9579713|FG001|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||9
8547531|NCT01902173|9579714|FG002|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
8547532|NCT01902173|9579715|FG003|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
8547533|NCT01902173|9579716|FG004|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
8547534|NCT01902173|9579717|FG005|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
8547535|NCT01902173|9579712|FG000|STARTED|Phase 1 Triplet Regimen Cohort 1||0
8547536|NCT01902173|9579713|FG001|STARTED|Phase 1 Triplet Regimen Cohort 1||0
8547537|NCT01902173|9579714|FG002|STARTED|Phase 1 Triplet Regimen Cohort 1||4
8547538|NCT01902173|9579715|FG003|STARTED|Phase 1 Triplet Regimen Cohort 1||0
8547539|NCT01902173|9579716|FG004|STARTED|Phase 1 Triplet Regimen Cohort 1||0
8547540|NCT01902173|9579717|FG005|STARTED|Phase 1 Triplet Regimen Cohort 1||0
8547541|NCT01902173|9579712|FG000|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
8547542|NCT01902173|9579713|FG001|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
8547543|NCT01902173|9579714|FG002|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
8547544|NCT01902173|9579715|FG003|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
8547545|NCT01902173|9579716|FG004|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
8547546|NCT01902173|9579717|FG005|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
8547547|NCT01902173|9579712|FG000|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
8547548|NCT01902173|9579713|FG001|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
8547549|NCT01902173|9579714|FG002|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||4
8547550|NCT01902173|9579715|FG003|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
8547551|NCT01902173|9579716|FG004|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
8547552|NCT01902173|9579717|FG005|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
8547553|NCT01902173|9579712|FG000|STARTED|Phase 1 Triplet Regimen Cohort 2||0
8547554|NCT01902173|9579713|FG001|STARTED|Phase 1 Triplet Regimen Cohort 2||0
8547555|NCT01902173|9579714|FG002|STARTED|Phase 1 Triplet Regimen Cohort 2||0
8547556|NCT01902173|9579715|FG003|STARTED|Phase 1 Triplet Regimen Cohort 2||3
8547557|NCT01902173|9579716|FG004|STARTED|Phase 1 Triplet Regimen Cohort 2||0
8547558|NCT01902173|9579717|FG005|STARTED|Phase 1 Triplet Regimen Cohort 2||0
8547559|NCT01902173|9579712|FG000|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
8621526|NCT00481065|9660521|FG001|COMPLETED|Overall Study||33
8621527|NCT00481065|9660522|FG002|COMPLETED|Overall Study||32
8547560|NCT01902173|9579713|FG001|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
8547561|NCT01902173|9579714|FG002|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
8547562|NCT01902173|9579715|FG003|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
8547563|NCT01902173|9579716|FG004|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
8547564|NCT01902173|9579717|FG005|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
8547565|NCT01902173|9579712|FG000|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
8547566|NCT01902173|9579713|FG001|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
8547567|NCT01902173|9579714|FG002|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
8547568|NCT01902173|9579715|FG003|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||3
8547569|NCT01902173|9579716|FG004|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
8547570|NCT01902173|9579717|FG005|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
8547571|NCT01902173|9579712|FG000|STARTED|Phase 1 Triplet Regimen Cohort 3||0
8547572|NCT01902173|9579713|FG001|STARTED|Phase 1 Triplet Regimen Cohort 3||0
8723085|NCT01021683|9770598|FG000|STARTED|Overall Study||203
8723086|NCT01021683|9770598|FG000|COMPLETED|Overall Study||132
8723087|NCT01021683|9770598|FG000|NOT COMPLETED|Overall Study||71
8723088|NCT01021748|9770611|FG000|STARTED|Overall Study||6
8723089|NCT01021748|9770612|FG001|STARTED|Overall Study||5
8547573|NCT01902173|9579714|FG002|STARTED|Phase 1 Triplet Regimen Cohort 3||0
8547574|NCT01902173|9579715|FG003|STARTED|Phase 1 Triplet Regimen Cohort 3||0
8547575|NCT01902173|9579716|FG004|STARTED|Phase 1 Triplet Regimen Cohort 3||3
8547576|NCT01902173|9579717|FG005|STARTED|Phase 1 Triplet Regimen Cohort 3||0
8547577|NCT01902173|9579712|FG000|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
8547578|NCT01902173|9579713|FG001|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
8547579|NCT01902173|9579714|FG002|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
8547580|NCT01902173|9579715|FG003|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
8547581|NCT01902173|9579716|FG004|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
8547582|NCT01902173|9579717|FG005|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
8547583|NCT01902173|9579712|FG000|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
8547584|NCT01902173|9579713|FG001|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
8547585|NCT01902173|9579714|FG002|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
8547586|NCT01902173|9579715|FG003|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
8547587|NCT01902173|9579716|FG004|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||3
8547588|NCT01902173|9579717|FG005|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
8547589|NCT01902173|9579712|FG000|STARTED|Phase 1 Triplet Regimen Cohort 4||0
8547590|NCT01902173|9579713|FG001|STARTED|Phase 1 Triplet Regimen Cohort 4||0
8547591|NCT01902173|9579714|FG002|STARTED|Phase 1 Triplet Regimen Cohort 4||0
8547592|NCT01902173|9579715|FG003|STARTED|Phase 1 Triplet Regimen Cohort 4||0
8547593|NCT01902173|9579716|FG004|STARTED|Phase 1 Triplet Regimen Cohort 4||0
8547594|NCT01902173|9579717|FG005|STARTED|Phase 1 Triplet Regimen Cohort 4||5
8547595|NCT01902173|9579712|FG000|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
8547596|NCT01902173|9579713|FG001|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
8547597|NCT01902173|9579714|FG002|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
8547598|NCT01902173|9579715|FG003|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
8547599|NCT01902173|9579716|FG004|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
8547600|NCT01902173|9579717|FG005|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
8547601|NCT01902173|9579712|FG000|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
8547602|NCT01902173|9579713|FG001|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
8547603|NCT01902173|9579714|FG002|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
8547604|NCT01902173|9579715|FG003|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
8547605|NCT01902173|9579716|FG004|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
8547606|NCT01902173|9579717|FG005|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||5
8547607|NCT01902173|9579712|FG000|STARTED|Phase II||0
8547608|NCT01902173|9579713|FG001|STARTED|Phase II||0
8547609|NCT01902173|9579714|FG002|STARTED|Phase II||0
8547610|NCT01902173|9579715|FG003|STARTED|Phase II||0
8547611|NCT01902173|9579716|FG004|STARTED|Phase II||0
8547612|NCT01902173|9579717|FG005|STARTED|Phase II||0
8547613|NCT01902173|9579712|FG000|COMPLETED|Phase II||0
8547614|NCT01902173|9579713|FG001|COMPLETED|Phase II||0
8547615|NCT01902173|9579714|FG002|COMPLETED|Phase II||0
8547616|NCT01902173|9579715|FG003|COMPLETED|Phase II||0
8547617|NCT01902173|9579716|FG004|COMPLETED|Phase II||0
8547618|NCT01902173|9579717|FG005|COMPLETED|Phase II||0
8547619|NCT01902173|9579712|FG000|NOT COMPLETED|Phase II||0
8547620|NCT01902173|9579713|FG001|NOT COMPLETED|Phase II||0
8547621|NCT01902173|9579714|FG002|NOT COMPLETED|Phase II||0
8547622|NCT01902173|9579715|FG003|NOT COMPLETED|Phase II||0
8547623|NCT01902173|9579716|FG004|NOT COMPLETED|Phase II||0
8547624|NCT01902173|9579717|FG005|NOT COMPLETED|Phase II||0
8547625|NCT01900444|9579734|FG000|STARTED|Overall Study||119
8547626|NCT01900444|9579734|FG000|COMPLETED|Overall Study||116
8547627|NCT01900444|9579734|FG000|NOT COMPLETED|Overall Study||3
8547628|NCT01887912|9579740|FG000|STARTED|Overall Study||6201
8547629|NCT01887912|9579741|FG001|STARTED|Overall Study||3101
8547630|NCT01887912|9579740|FG000|Safety Population|Overall Study||6113
8547631|NCT01887912|9579741|FG001|Safety Population|Overall Study||3057
8547632|NCT01887912|9579740|FG000|COMPLETED|Overall Study||4809
8547633|NCT01887912|9579741|FG001|COMPLETED|Overall Study||2370
8547634|NCT01887912|9579740|FG000|NOT COMPLETED|Overall Study||1392
8547635|NCT01887912|9579741|FG001|NOT COMPLETED|Overall Study||731
8547636|NCT01751126|9579750|FG000|STARTED|Period I||57
8547637|NCT01751126|9579751|FG001|STARTED|Period I||54
8547638|NCT01751126|9579752|FG002|STARTED|Period I||58
8547639|NCT01751126|9579750|FG000|COMPLETED|Period I||51
8547640|NCT01751126|9579751|FG001|COMPLETED|Period I||43
8547641|NCT01751126|9579752|FG002|COMPLETED|Period I||49
8547642|NCT01751126|9579750|FG000|NOT COMPLETED|Period I||6
8547643|NCT01751126|9579751|FG001|NOT COMPLETED|Period I||11
8547644|NCT01751126|9579752|FG002|NOT COMPLETED|Period I||9
8723090|NCT01021748|9770613|FG002|STARTED|Overall Study||7
8547645|NCT01751126|9579750|FG000|STARTED|Period II||72
8547646|NCT01751126|9579751|FG001|STARTED|Period II||70
8547647|NCT01751126|9579752|FG002|STARTED|Period II|Following completion of the first period of the trial, all patients were to be administered NOVA22007 (High or Low dose) for a safety 8-month follow-up period.|0
8547648|NCT01751126|9579750|FG000|COMPLETED|Period II||72
8547649|NCT01751126|9579751|FG001|COMPLETED|Period II||70
8547650|NCT01751126|9579752|FG002|COMPLETED|Period II||0
8547651|NCT01751126|9579750|FG000|NOT COMPLETED|Period II||0
8547652|NCT01751126|9579751|FG001|NOT COMPLETED|Period II||0
8547653|NCT01751126|9579752|FG002|NOT COMPLETED|Period II||0
8547654|NCT01468896|9579776|FG000|STARTED|Overall Study||6
8547655|NCT01468896|9579777|FG001|STARTED|Overall Study||17
8547656|NCT01468896|9579776|FG000|COMPLETED|Overall Study||6
8547657|NCT01468896|9579777|FG001|COMPLETED|Overall Study||17
8547658|NCT01468896|9579776|FG000|NOT COMPLETED|Overall Study||0
8547659|NCT01468896|9579777|FG001|NOT COMPLETED|Overall Study||0
8547660|NCT01437423|9579784|FG000|STARTED|Overall Study||662
8547661|NCT01437423|9579784|FG000|COMPLETED|Overall Study||647
8547662|NCT01437423|9579784|FG000|NOT COMPLETED|Overall Study||15
8547663|NCT01410890|9579790|FG000|STARTED|Overall Study||10
8547664|NCT01410890|9579791|FG001|STARTED|Overall Study||11
8547665|NCT01410890|9579790|FG000|Treated|Overall Study||10
8547666|NCT01410890|9579791|FG001|Treated|Overall Study||10
8547667|NCT01410890|9579790|FG000|COMPLETED|Overall Study||10
8547668|NCT01410890|9579791|FG001|COMPLETED|Overall Study||10
8547669|NCT01410890|9579790|FG000|NOT COMPLETED|Overall Study||0
8547670|NCT01410890|9579791|FG001|NOT COMPLETED|Overall Study||1
8547671|NCT01251861|9579801|FG000|STARTED|Overall Study||54
8547672|NCT01251861|9579802|FG001|STARTED|Overall Study||54
8547673|NCT01251861|9579801|FG000|Pts Who Received Protocol Therapy|Overall Study||50
8547674|NCT01251861|9579802|FG001|Pts Who Received Protocol Therapy|Overall Study||53
8547675|NCT01251861|9579801|FG000|Pts w/ Follow-up PSA Lower Than Baseline|Overall Study||49
8547676|NCT01251861|9579802|FG001|Pts w/ Follow-up PSA Lower Than Baseline|Overall Study||47
8547677|NCT01251861|9579801|FG000|Pts With PSA Response|Overall Study||44
8547678|NCT01251861|9579802|FG001|Pts With PSA Response|Overall Study||36
8547679|NCT01251861|9579801|FG000|COMPLETED|Overall Study||36
8547680|NCT01251861|9579802|FG001|COMPLETED|Overall Study||26
8547681|NCT01251861|9579801|FG000|NOT COMPLETED|Overall Study||18
8547682|NCT01251861|9579802|FG001|NOT COMPLETED|Overall Study||28
8547683|NCT01190228|9579811|FG000|STARTED|Overall Study||349
8547684|NCT01190228|9579812|FG001|STARTED|Overall Study||46
8547685|NCT01190228|9579813|FG002|STARTED|Overall Study||59
8547686|NCT01190228|9579811|FG000|COMPLETED|Overall Study||344
8547687|NCT01190228|9579812|FG001|COMPLETED|Overall Study||46
8547688|NCT01190228|9579813|FG002|COMPLETED|Overall Study||59
8547689|NCT01190228|9579811|FG000|NOT COMPLETED|Overall Study||5
8547690|NCT01190228|9579812|FG001|NOT COMPLETED|Overall Study||0
8547691|NCT01190228|9579813|FG002|NOT COMPLETED|Overall Study||0
8547692|NCT01146652|9579825|FG000|STARTED|Overall Study||1912
8547693|NCT01146652|9579826|FG001|STARTED|Overall Study||111
8547694|NCT01146652|9579825|FG000|Treated|Overall Study||1910
8547695|NCT01146652|9579826|FG001|Treated|Overall Study||111
8547696|NCT01146652|9579825|FG000|Enrolled in the Sub-study|Overall Study||110
8547697|NCT01146652|9579826|FG001|Enrolled in the Sub-study|Overall Study||14
8547698|NCT01146652|9579825|FG000|Discontinued From the Sub-study|Overall Study||1
8547699|NCT01146652|9579826|FG001|Discontinued From the Sub-study|Overall Study||2
8547700|NCT01146652|9579825|FG000|Switched Back to Main Study|Overall Study||108
8547701|NCT01146652|9579826|FG001|Switched Back to Main Study|Overall Study||13
8547702|NCT01146652|9579825|FG000|COMPLETED|Overall Study||961
8547703|NCT01146652|9579826|FG001|COMPLETED|Overall Study||66
8547704|NCT01146652|9579825|FG000|NOT COMPLETED|Overall Study||951
8547705|NCT01146652|9579826|FG001|NOT COMPLETED|Overall Study||45
8547706|NCT01049035|9579846|FG000|STARTED|Overall Study||107
8547707|NCT01049035|9579847|FG001|STARTED|Overall Study||108
8547708|NCT01049035|9579848|FG002|STARTED|Overall Study||107
8547709|NCT01049035|9579849|FG003|STARTED|Overall Study||75
8547710|NCT01049035|9579850|FG004|STARTED|Overall Study||75
8547711|NCT01049035|9579851|FG005|STARTED|Overall Study||54
8547712|NCT01049035|9579852|FG006|STARTED|Overall Study||54
8547713|NCT01049035|9579846|FG000|Safety Population|Overall Study||104
8547714|NCT01049035|9579847|FG001|Safety Population|Overall Study||102
8547715|NCT01049035|9579848|FG002|Safety Population|Overall Study||100
8547716|NCT01049035|9579849|FG003|Safety Population|Overall Study||74
8547717|NCT01049035|9579850|FG004|Safety Population|Overall Study||70
8547718|NCT01049035|9579851|FG005|Safety Population|Overall Study||52
8547719|NCT01049035|9579852|FG006|Safety Population|Overall Study||49
8547720|NCT01049035|9579846|FG000|COMPLETED|Overall Study||74
8547721|NCT01049035|9579847|FG001|COMPLETED|Overall Study||87
8547722|NCT01049035|9579848|FG002|COMPLETED|Overall Study||80
8547723|NCT01049035|9579849|FG003|COMPLETED|Overall Study||64
8547724|NCT01049035|9579850|FG004|COMPLETED|Overall Study||71
8547725|NCT01049035|9579851|FG005|COMPLETED|Overall Study||42
8547726|NCT01049035|9579852|FG006|COMPLETED|Overall Study||39
8547727|NCT01049035|9579846|FG000|NOT COMPLETED|Overall Study||33
8547728|NCT01049035|9579847|FG001|NOT COMPLETED|Overall Study||21
8547729|NCT01049035|9579848|FG002|NOT COMPLETED|Overall Study||27
8547730|NCT01049035|9579849|FG003|NOT COMPLETED|Overall Study||11
8547731|NCT01049035|9579850|FG004|NOT COMPLETED|Overall Study||4
8547732|NCT01049035|9579851|FG005|NOT COMPLETED|Overall Study||12
8547733|NCT01049035|9579852|FG006|NOT COMPLETED|Overall Study||15
8547734|NCT00728884|9579878|FG000|STARTED|Implant Placement Surgery||162
8547735|NCT00728884|9579878|FG000|COMPLETED|Implant Placement Surgery||162
8547736|NCT00728884|9579878|FG000|NOT COMPLETED|Implant Placement Surgery||0
8547737|NCT00728884|9579878|FG000|STARTED|Permanent Prosthesis Placement||162
8547738|NCT00728884|9579878|FG000|COMPLETED|Permanent Prosthesis Placement||149
8547739|NCT00728884|9579878|FG000|NOT COMPLETED|Permanent Prosthesis Placement||13
8547740|NCT00728884|9579878|FG000|STARTED|One Year Post Placement Follow-up||149
8547741|NCT00728884|9579878|FG000|COMPLETED|One Year Post Placement Follow-up||145
8547742|NCT00728884|9579878|FG000|NOT COMPLETED|One Year Post Placement Follow-up||4
8547743|NCT00728884|9579878|FG000|STARTED|Two Year Post Placement Follow-up||145
8547744|NCT00728884|9579878|FG000|COMPLETED|Two Year Post Placement Follow-up||145
8547745|NCT00728884|9579878|FG000|NOT COMPLETED|Two Year Post Placement Follow-up||0
8547746|NCT00727090|9579884|FG000|STARTED|Overall Study||3
8547747|NCT00727090|9579885|FG001|STARTED|Overall Study||3
8547748|NCT00727090|9579884|FG000|COMPLETED|Overall Study||3
8547749|NCT00727090|9579885|FG001|COMPLETED|Overall Study||3
8547750|NCT00727090|9579884|FG000|NOT COMPLETED|Overall Study||0
8547751|NCT00727090|9579885|FG001|NOT COMPLETED|Overall Study||0
8547752|NCT00726063|9579895|FG000|STARTED|Overall Study|Number of implants= 239|122
8547753|NCT00726063|9579896|FG001|STARTED|Overall Study|Number of implants= 246|119
8547754|NCT00726063|9579895|FG000|COMPLETED|Overall Study|Number of implants =230|113
8547755|NCT00726063|9579896|FG001|COMPLETED|Overall Study|Number of implants = 239|112
8547756|NCT00726063|9579895|FG000|NOT COMPLETED|Overall Study||9
8547757|NCT00726063|9579896|FG001|NOT COMPLETED|Overall Study||7
8547758|NCT00725049|9579904|FG000|STARTED|Overall Study||17
8547759|NCT00725049|9579905|FG001|STARTED|Overall Study||20
8547760|NCT00725049|9579904|FG000|COMPLETED|Overall Study||17
8547761|NCT00725049|9579905|FG001|COMPLETED|Overall Study||20
8547762|NCT00725049|9579904|FG000|NOT COMPLETED|Overall Study||0
8547763|NCT00725049|9579905|FG001|NOT COMPLETED|Overall Study||0
8547764|NCT00713206|9579913|FG000|STARTED|Overall Study||65
8547765|NCT00713206|9579914|FG001|STARTED|Overall Study||57
8547766|NCT00713206|9579913|FG000|COMPLETED|Overall Study||60
8547767|NCT00713206|9579914|FG001|COMPLETED|Overall Study||53
8547768|NCT00713206|9579913|FG000|NOT COMPLETED|Overall Study||5
8547769|NCT00713206|9579914|FG001|NOT COMPLETED|Overall Study||4
8547770|NCT00658814|9579922|FG000|STARTED|Remission Induction Chemotherapy||83
8547771|NCT00658814|9579923|FG001|STARTED|Remission Induction Chemotherapy||59
8547772|NCT00658814|9579922|FG000|Eligible|Remission Induction Chemotherapy||82
8547773|NCT00658814|9579923|FG001|Eligible|Remission Induction Chemotherapy||57
8547774|NCT00658814|9579922|FG000|Eligible and Began Protocol Therapy|Remission Induction Chemotherapy||79
8547775|NCT00658814|9579923|FG001|Eligible and Began Protocol Therapy|Remission Induction Chemotherapy||54
8547776|NCT00658814|9579922|FG000|COMPLETED|Remission Induction Chemotherapy||75
8547777|NCT00658814|9579923|FG001|COMPLETED|Remission Induction Chemotherapy||41
8547778|NCT00658814|9579922|FG000|NOT COMPLETED|Remission Induction Chemotherapy||8
8547779|NCT00658814|9579923|FG001|NOT COMPLETED|Remission Induction Chemotherapy||18
8547780|NCT00658814|9579922|FG000|STARTED|Consolidation Therapy||24
8547781|NCT00658814|9579923|FG001|STARTED|Consolidation Therapy||13
8547782|NCT00658814|9579922|FG000|Eligible|Consolidation Therapy||22
8547783|NCT00658814|9579923|FG001|Eligible|Consolidation Therapy||11
8547784|NCT00658814|9579922|FG000|COMPLETED|Consolidation Therapy||22
8547785|NCT00658814|9579923|FG001|COMPLETED|Consolidation Therapy||10
8547786|NCT00658814|9579922|FG000|NOT COMPLETED|Consolidation Therapy||2
8547787|NCT00658814|9579923|FG001|NOT COMPLETED|Consolidation Therapy||3
8547788|NCT00658814|9579922|FG000|STARTED|Maintenance Therapy||20
8547789|NCT00658814|9579923|FG001|STARTED|Maintenance Therapy||8
8547790|NCT00658814|9579922|FG000|Eligible|Maintenance Therapy||19
8547791|NCT00658814|9579923|FG001|Eligible|Maintenance Therapy||8
8547792|NCT00658814|9579922|FG000|COMPLETED|Maintenance Therapy||17
8547793|NCT00658814|9579923|FG001|COMPLETED|Maintenance Therapy||7
8547794|NCT00658814|9579922|FG000|NOT COMPLETED|Maintenance Therapy||3
8547795|NCT00658814|9579923|FG001|NOT COMPLETED|Maintenance Therapy||1
8547796|NCT00569127|9579935|FG000|STARTED|Overall Study||214
8547797|NCT00569127|9579936|FG001|STARTED|Overall Study||213
8547798|NCT00569127|9579935|FG000|Eligible|Overall Study||200
8547799|NCT00569127|9579936|FG001|Eligible|Overall Study||202
8547800|NCT00569127|9579935|FG000|COMPLETED|Overall Study||0
8547801|NCT00569127|9579936|FG001|COMPLETED|Overall Study||0
8547802|NCT00569127|9579935|FG000|NOT COMPLETED|Overall Study||214
8547803|NCT00569127|9579936|FG001|NOT COMPLETED|Overall Study||213
8567369|NCT00085709|9599701|FG000|NOT COMPLETED|Overall Study||53
8567370|NCT00085709|9599702|FG001|NOT COMPLETED|Overall Study||50
8567371|NCT00085839|9599718|FG000|STARTED|Overall Study||52
8567372|NCT00085839|9599719|FG001|STARTED|Overall Study||51
8567373|NCT00085839|9599718|FG000|COMPLETED|Overall Study||52
8567374|NCT00085839|9599719|FG001|COMPLETED|Overall Study||51
8567375|NCT00085839|9599718|FG000|NOT COMPLETED|Overall Study||0
8567376|NCT00085839|9599719|FG001|NOT COMPLETED|Overall Study||0
8567377|NCT00085917|9599727|FG000|STARTED|Overall Study||15
8567378|NCT00085917|9599728|FG001|STARTED|Overall Study||14
8567379|NCT00085917|9599727|FG000|COMPLETED|Overall Study||11
8567380|NCT00085917|9599728|FG001|COMPLETED|Overall Study||11
8567381|NCT00085917|9599727|FG000|NOT COMPLETED|Overall Study||4
8567382|NCT00085917|9599728|FG001|NOT COMPLETED|Overall Study||3
8567383|NCT00086047|9599736|FG000|STARTED|Overall Study||57
8567384|NCT00086047|9599737|FG001|STARTED|Overall Study||57
8547804|NCT04654351|9579942|FG000|STARTED|Overall Study||2
8547805|NCT04654351|9579942|FG000|COMPLETED|Overall Study||2
8547806|NCT04654351|9579942|FG000|NOT COMPLETED|Overall Study||0
8547807|NCT04422990|9579949|FG000|STARTED|Overall Study||50
8547808|NCT04422990|9579950|FG001|STARTED|Overall Study||97
8547809|NCT04422990|9579949|FG000|COMPLETED|Overall Study||47
8547810|NCT04422990|9579950|FG001|COMPLETED|Overall Study||96
8547811|NCT04422990|9579949|FG000|NOT COMPLETED|Overall Study||3
8547812|NCT04422990|9579950|FG001|NOT COMPLETED|Overall Study||1
8547813|NCT04388319|9579959|FG000|STARTED|Enrolled in Study||26
8547814|NCT04388319|9579959|FG000|COMPLETED|Enrolled in Study||24
8547815|NCT04388319|9579959|FG000|NOT COMPLETED|Enrolled in Study||2
8547816|NCT04388319|9579959|FG000|STARTED|Treatment Period||24
8547817|NCT04388319|9579959|FG000|COMPLETED|Treatment Period||23
8547818|NCT04388319|9579959|FG000|NOT COMPLETED|Treatment Period||1
8547819|NCT04358549|9579965|FG000|STARTED|Overall Study||25
8547820|NCT04358549|9579966|FG001|STARTED|Overall Study||25
8547821|NCT04358549|9579965|FG000|ITT Population (Randomized Subjects)|Overall Study||25
8547822|NCT04358549|9579966|FG001|ITT Population (Randomized Subjects)|Overall Study||25
8547823|NCT04358549|9579965|FG000|Safety Population (Patients Who Received Either Favipiravir + SOC or SOC Alone)|Overall Study||24
8547824|NCT04358549|9579966|FG001|Safety Population (Patients Who Received Either Favipiravir + SOC or SOC Alone)|Overall Study||25
8547825|NCT04358549|9579965|FG000|COMPLETED|Overall Study||15
8547826|NCT04358549|9579966|FG001|COMPLETED|Overall Study||17
8547827|NCT04358549|9579965|FG000|NOT COMPLETED|Overall Study||10
8547828|NCT04358549|9579966|FG001|NOT COMPLETED|Overall Study||8
8547829|NCT04229888|9579972|FG000|STARTED|Overall Study||14
8547830|NCT04229888|9579972|FG000|COMPLETED|Overall Study||14
8547831|NCT04229888|9579972|FG000|NOT COMPLETED|Overall Study||0
8547832|NCT04221828|9579979|FG000|STARTED|Overall Study||1
8547833|NCT04221828|9579979|FG000|COMPLETED|Overall Study||1
8547834|NCT04221828|9579979|FG000|NOT COMPLETED|Overall Study||0
8547835|NCT04095416|9579985|FG000|STARTED|Overall Study||13
8547836|NCT04095416|9579986|FG001|STARTED|Overall Study||19
8547837|NCT04095416|9579985|FG000|COMPLETED|Overall Study||10
8547838|NCT04095416|9579986|FG001|COMPLETED|Overall Study||19
8547839|NCT04095416|9579985|FG000|NOT COMPLETED|Overall Study||3
8547840|NCT04095416|9579986|FG001|NOT COMPLETED|Overall Study||0
8547841|NCT04532099|9579995|FG000|STARTED|First Wear Period (30 Days)||33
8547842|NCT04532099|9579996|FG001|STARTED|First Wear Period (30 Days)||33
8547843|NCT04532099|9579997|FG002|STARTED|First Wear Period (30 Days)||66
8547844|NCT04532099|9579995|FG000|COMPLETED|First Wear Period (30 Days)||32
8547845|NCT04532099|9579996|FG001|COMPLETED|First Wear Period (30 Days)||33
8547846|NCT04532099|9579997|FG002|COMPLETED|First Wear Period (30 Days)||66
8547847|NCT04532099|9579995|FG000|NOT COMPLETED|First Wear Period (30 Days)||1
8547848|NCT04532099|9579996|FG001|NOT COMPLETED|First Wear Period (30 Days)||0
8547849|NCT04532099|9579997|FG002|NOT COMPLETED|First Wear Period (30 Days)||0
8547850|NCT04532099|9579995|FG000|STARTED|Second Wear Period (30 Days)||32
8547851|NCT04532099|9579996|FG001|STARTED|Second Wear Period (30 Days)||33
8547852|NCT04532099|9579997|FG002|STARTED|Second Wear Period (30 Days)|Part B is single product; therefore, only one wear period.|0
8547853|NCT04532099|9579995|FG000|COMPLETED|Second Wear Period (30 Days)||32
8547854|NCT04532099|9579996|FG001|COMPLETED|Second Wear Period (30 Days)||33
8547855|NCT04532099|9579997|FG002|COMPLETED|Second Wear Period (30 Days)||0
8547856|NCT04532099|9579995|FG000|NOT COMPLETED|Second Wear Period (30 Days)||0
8547857|NCT04532099|9579996|FG001|NOT COMPLETED|Second Wear Period (30 Days)||0
8547858|NCT04532099|9579997|FG002|NOT COMPLETED|Second Wear Period (30 Days)||0
8547859|NCT04385199|9580011|FG000|STARTED|Overall Study||20
8547860|NCT04385199|9580012|FG001|STARTED|Overall Study||10
8547861|NCT04385199|9580011|FG000|COMPLETED|Overall Study||19
8547862|NCT04385199|9580012|FG001|COMPLETED|Overall Study||10
8547863|NCT04385199|9580011|FG000|NOT COMPLETED|Overall Study||1
8547864|NCT04385199|9580012|FG001|NOT COMPLETED|Overall Study||0
8547865|NCT04382053|9580020|FG000|STARTED|Overall Study||71
8547866|NCT04382053|9580021|FG001|STARTED|Overall Study||72
8547867|NCT04382053|9580020|FG000|Safety Analysis Set|Overall Study|One participant that was randomized to the DFV890 + SoC arm did not attend any post-baseline visit|70
8547868|NCT04382053|9580021|FG001|Safety Analysis Set|Overall Study||72
8547869|NCT04382053|9580020|FG000|PD Analysis Set|Overall Study||62
8547870|NCT04382053|9580021|FG001|PD Analysis Set|Overall Study||68
8547871|NCT04382053|9580020|FG000|COMPLETED|Overall Study||62
8547872|NCT04382053|9580021|FG001|COMPLETED|Overall Study||59
8547873|NCT04382053|9580020|FG000|NOT COMPLETED|Overall Study||9
8547874|NCT04382053|9580021|FG001|NOT COMPLETED|Overall Study||13
8547875|NCT04360187|9580030|FG000|STARTED|Double-Blind Treatment||131
8547876|NCT04360187|9580031|FG001|STARTED|Double-Blind Treatment||260
8547877|NCT04360187|9580030|FG000|COMPLETED|Double-Blind Treatment||108
8547878|NCT04360187|9580031|FG001|COMPLETED|Double-Blind Treatment||245
8547879|NCT04360187|9580030|FG000|NOT COMPLETED|Double-Blind Treatment||23
8547880|NCT04360187|9580031|FG001|NOT COMPLETED|Double-Blind Treatment||15
8547881|NCT04360187|9580030|FG000|STARTED|Follow-Up||114
8547882|NCT04360187|9580031|FG001|STARTED|Follow-Up||232
8547883|NCT04360187|9580030|FG000|COMPLETED|Follow-Up||113
8547884|NCT04360187|9580031|FG001|COMPLETED|Follow-Up||232
8547885|NCT04360187|9580030|FG000|NOT COMPLETED|Follow-Up||1
8547886|NCT04360187|9580031|FG001|NOT COMPLETED|Follow-Up||0
8547887|NCT04311177|9580039|FG000|STARTED|Overall Study||58
8547888|NCT04311177|9580040|FG001|STARTED|Overall Study||59
8547889|NCT04311177|9580039|FG000|COMPLETED|Overall Study||50
8547890|NCT04311177|9580040|FG001|COMPLETED|Overall Study||55
8547891|NCT04311177|9580039|FG000|NOT COMPLETED|Overall Study||8
8547892|NCT04311177|9580040|FG001|NOT COMPLETED|Overall Study||4
8567385|NCT00086047|9599736|FG000|COMPLETED|Overall Study||50
8567386|NCT00086047|9599737|FG001|COMPLETED|Overall Study||50
8567387|NCT00086047|9599736|FG000|NOT COMPLETED|Overall Study||7
8567388|NCT00086047|9599737|FG001|NOT COMPLETED|Overall Study||7
8567389|NCT00086138|9599745|FG000|STARTED|Overall Study||64
8567390|NCT00086138|9599746|FG001|STARTED|Overall Study||67
8567391|NCT00086138|9599745|FG000|COMPLETED|Overall Study||60
8567392|NCT00086138|9599746|FG001|COMPLETED|Overall Study||64
8567393|NCT00086138|9599745|FG000|NOT COMPLETED|Overall Study||4
8567394|NCT00086138|9599746|FG001|NOT COMPLETED|Overall Study||3
8567395|NCT00086190|9599755|FG000|STARTED|Overall Study||42
8567396|NCT00086190|9599756|FG001|STARTED|Overall Study||34
8567397|NCT00086190|9599757|FG002|STARTED|Overall Study||39
8567398|NCT00086190|9599755|FG000|COMPLETED|Overall Study||34
8621528|NCT00481065|9660523|FG003|COMPLETED|Overall Study||37
8621529|NCT00481065|9660524|FG004|COMPLETED|Overall Study||28
8621530|NCT00481065|9660525|FG005|COMPLETED|Overall Study||27
8621531|NCT00481065|9660526|FG006|COMPLETED|Overall Study||34
8621532|NCT00481065|9660527|FG007|COMPLETED|Overall Study||30
8567399|NCT00086190|9599756|FG001|COMPLETED|Overall Study||30
8567400|NCT00086190|9599757|FG002|COMPLETED|Overall Study||33
8567401|NCT00086190|9599755|FG000|NOT COMPLETED|Overall Study||8
8567402|NCT00086190|9599756|FG001|NOT COMPLETED|Overall Study||4
8567403|NCT00086190|9599757|FG002|NOT COMPLETED|Overall Study||6
8567404|NCT00086281|9599780|FG000|STARTED|Phase 1||11
8567405|NCT00086281|9599781|FG001|STARTED|Phase 1||12
8567406|NCT00086281|9599782|FG002|STARTED|Phase 1||8
8567407|NCT00086281|9599783|FG003|STARTED|Phase 1||11
8567408|NCT00086281|9599784|FG004|STARTED|Phase 1||1
8567409|NCT00086281|9599785|FG005|STARTED|Phase 1||3
8567410|NCT00086281|9599786|FG006|STARTED|Phase 1||1
8567411|NCT00086281|9599787|FG007|STARTED|Phase 1||1
8567412|NCT00086281|9599788|FG008|STARTED|Phase 1||2
8567413|NCT00086281|9599789|FG009|STARTED|Phase 1||1
8567414|NCT00086281|9599790|FG010|STARTED|Phase 1||3
8567415|NCT00086281|9599791|FG011|STARTED|Phase 1||1
8567416|NCT00086281|9599792|FG012|STARTED|Phase 1||1
8567417|NCT00086281|9599793|FG013|STARTED|Phase 1||1
8567418|NCT00086281|9599794|FG014|STARTED|Phase 1||3
8567419|NCT00086281|9599780|FG000|COMPLETED|Phase 1||11
8567420|NCT00086281|9599781|FG001|COMPLETED|Phase 1||12
8567421|NCT00086281|9599782|FG002|COMPLETED|Phase 1||8
8567422|NCT00086281|9599783|FG003|COMPLETED|Phase 1||11
8567423|NCT00086281|9599784|FG004|COMPLETED|Phase 1||1
8567424|NCT00086281|9599785|FG005|COMPLETED|Phase 1||3
8567425|NCT00086281|9599786|FG006|COMPLETED|Phase 1||1
8567426|NCT00086281|9599787|FG007|COMPLETED|Phase 1||1
8567427|NCT00086281|9599788|FG008|COMPLETED|Phase 1||2
8567428|NCT00086281|9599789|FG009|COMPLETED|Phase 1||0
8567429|NCT00086281|9599790|FG010|COMPLETED|Phase 1||0
8567430|NCT00086281|9599791|FG011|COMPLETED|Phase 1||0
8567431|NCT00086281|9599792|FG012|COMPLETED|Phase 1||0
8567432|NCT00086281|9599793|FG013|COMPLETED|Phase 1||0
8567433|NCT00086281|9599794|FG014|COMPLETED|Phase 1||0
8567434|NCT00086281|9599780|FG000|NOT COMPLETED|Phase 1||0
8567435|NCT00086281|9599781|FG001|NOT COMPLETED|Phase 1||0
8567436|NCT00086281|9599782|FG002|NOT COMPLETED|Phase 1||0
8567437|NCT00086281|9599783|FG003|NOT COMPLETED|Phase 1||0
8567438|NCT00086281|9599784|FG004|NOT COMPLETED|Phase 1||0
8567439|NCT00086281|9599785|FG005|NOT COMPLETED|Phase 1||0
8567440|NCT00086281|9599786|FG006|NOT COMPLETED|Phase 1||0
8567441|NCT00086281|9599787|FG007|NOT COMPLETED|Phase 1||0
8567442|NCT00086281|9599788|FG008|NOT COMPLETED|Phase 1||0
8567443|NCT00086281|9599789|FG009|NOT COMPLETED|Phase 1||1
8567444|NCT00086281|9599790|FG010|NOT COMPLETED|Phase 1||3
8567445|NCT00086281|9599791|FG011|NOT COMPLETED|Phase 1||1
8567446|NCT00086281|9599792|FG012|NOT COMPLETED|Phase 1||1
8567447|NCT00086281|9599793|FG013|NOT COMPLETED|Phase 1||1
8567448|NCT00086281|9599794|FG014|NOT COMPLETED|Phase 1||3
8567449|NCT00086281|9599780|FG000|STARTED|Phase 2||0
8567450|NCT00086281|9599781|FG001|STARTED|Phase 2||0
8567451|NCT00086281|9599782|FG002|STARTED|Phase 2||0
8621533|NCT00481065|9660520|FG000|NOT COMPLETED|Overall Study||22
8567452|NCT00086281|9599783|FG003|STARTED|Phase 2||0
8567453|NCT00086281|9599784|FG004|STARTED|Phase 2||0
8567454|NCT00086281|9599785|FG005|STARTED|Phase 2||0
8567455|NCT00086281|9599786|FG006|STARTED|Phase 2||0
8567456|NCT00086281|9599787|FG007|STARTED|Phase 2||0
8567457|NCT00086281|9599788|FG008|STARTED|Phase 2||0
8567458|NCT00086281|9599789|FG009|STARTED|Phase 2||0
8567459|NCT00086281|9599790|FG010|STARTED|Phase 2||0
8567460|NCT00086281|9599791|FG011|STARTED|Phase 2||0
8567461|NCT00086281|9599792|FG012|STARTED|Phase 2||23
8567462|NCT00086281|9599793|FG013|STARTED|Phase 2||27
8567463|NCT00086281|9599794|FG014|STARTED|Phase 2||0
8567464|NCT00086281|9599780|FG000|COMPLETED|Phase 2||0
8567465|NCT00086281|9599781|FG001|COMPLETED|Phase 2||0
8567466|NCT00086281|9599782|FG002|COMPLETED|Phase 2||0
8567467|NCT00086281|9599783|FG003|COMPLETED|Phase 2||0
8567468|NCT00086281|9599784|FG004|COMPLETED|Phase 2||0
8567469|NCT00086281|9599785|FG005|COMPLETED|Phase 2||0
8567470|NCT00086281|9599786|FG006|COMPLETED|Phase 2||0
8567471|NCT00086281|9599787|FG007|COMPLETED|Phase 2||0
8567472|NCT00086281|9599788|FG008|COMPLETED|Phase 2||0
8567473|NCT00086281|9599789|FG009|COMPLETED|Phase 2||0
8567474|NCT00086281|9599790|FG010|COMPLETED|Phase 2||0
8567475|NCT00086281|9599791|FG011|COMPLETED|Phase 2||0
8547893|NCT04241133|9580048|FG000|STARTED|Overall Study||44
8547894|NCT04241133|9580049|FG001|STARTED|Overall Study||34
8547895|NCT04241133|9580048|FG000|COMPLETED|Overall Study||30
8547896|NCT04241133|9580049|FG001|COMPLETED|Overall Study||0
8547897|NCT04241133|9580048|FG000|NOT COMPLETED|Overall Study||14
8547898|NCT04241133|9580049|FG001|NOT COMPLETED|Overall Study||34
8547899|NCT04190693|9580059|FG000|STARTED|Overall Study||4
8547900|NCT04190693|9580060|FG001|STARTED|Overall Study||7
8547901|NCT04190693|9580061|FG002|STARTED|Overall Study||12
8547902|NCT04190693|9580062|FG003|STARTED|Overall Study||7
8547903|NCT04190693|9580059|FG000|COMPLETED|Overall Study||4
8547904|NCT04190693|9580060|FG001|COMPLETED|Overall Study||7
8547905|NCT04190693|9580061|FG002|COMPLETED|Overall Study||12
8547906|NCT04190693|9580062|FG003|COMPLETED|Overall Study||7
8547907|NCT04190693|9580059|FG000|NOT COMPLETED|Overall Study||0
8547908|NCT04190693|9580060|FG001|NOT COMPLETED|Overall Study||0
8547909|NCT04190693|9580061|FG002|NOT COMPLETED|Overall Study||0
8547910|NCT04190693|9580062|FG003|NOT COMPLETED|Overall Study||0
8547911|NCT04170608|9580072|FG000|STARTED|Overall Study||10
8547912|NCT04170608|9580072|FG000|COMPLETED|Overall Study||10
8547913|NCT04170608|9580072|FG000|NOT COMPLETED|Overall Study||0
8547914|NCT04150068|9580079|FG000|STARTED|Functional Mono/Oral Lead-in (14 Days)||24
8547915|NCT04150068|9580080|FG001|STARTED|Functional Mono/Oral Lead-in (14 Days)||12
8547916|NCT04150068|9580081|FG002|STARTED|Functional Mono/Oral Lead-in (14 Days)||36
8547917|NCT04150068|9580079|FG000|COMPLETED|Functional Mono/Oral Lead-in (14 Days)||24
8547918|NCT04150068|9580080|FG001|COMPLETED|Functional Mono/Oral Lead-in (14 Days)||12
8547919|NCT04150068|9580081|FG002|COMPLETED|Functional Mono/Oral Lead-in (14 Days)||36
8547920|NCT04150068|9580079|FG000|NOT COMPLETED|Functional Mono/Oral Lead-in (14 Days)||0
8547921|NCT04150068|9580080|FG001|NOT COMPLETED|Functional Mono/Oral Lead-in (14 Days)||0
8547922|NCT04150068|9580081|FG002|NOT COMPLETED|Functional Mono/Oral Lead-in (14 Days)||0
8547923|NCT04150068|9580079|FG000|STARTED|Maintenance Period (Week 26 Analysis)||24
8547924|NCT04150068|9580080|FG001|STARTED|Maintenance Period (Week 26 Analysis)||12
8547925|NCT04150068|9580081|FG002|STARTED|Maintenance Period (Week 26 Analysis)||36
8547926|NCT04150068|9580079|FG000|COMPLETED|Maintenance Period (Week 26 Analysis)||0
8547927|NCT04150068|9580080|FG001|COMPLETED|Maintenance Period (Week 26 Analysis)||0
8547928|NCT04150068|9580081|FG002|COMPLETED|Maintenance Period (Week 26 Analysis)||0
8547929|NCT04150068|9580079|FG000|NOT COMPLETED|Maintenance Period (Week 26 Analysis)||24
8547930|NCT04150068|9580080|FG001|NOT COMPLETED|Maintenance Period (Week 26 Analysis)||12
8547931|NCT04150068|9580081|FG002|NOT COMPLETED|Maintenance Period (Week 26 Analysis)||36
8547932|NCT04133519|9580090|FG000|STARTED|Overall Study||188
8547933|NCT04133519|9580091|FG001|STARTED|Overall Study||190
8547934|NCT04133519|9580090|FG000|COMPLETED|Overall Study||182
8547935|NCT04133519|9580091|FG001|COMPLETED|Overall Study||184
8547936|NCT04133519|9580090|FG000|NOT COMPLETED|Overall Study||6
8547937|NCT04133519|9580091|FG001|NOT COMPLETED|Overall Study||6
8547938|NCT04118270|9580099|FG000|STARTED|Overall Study||37
8547939|NCT04118270|9580100|FG001|STARTED|Overall Study||13
8547940|NCT04118270|9580099|FG000|Completed Provider Accuracy Assessment|Overall Study|Only the Providers were eligible for completing the Provider Accuracy Assessment.|0
8547941|NCT04118270|9580100|FG001|Completed Provider Accuracy Assessment|Overall Study||10
8547942|NCT04118270|9580099|FG000|COMPLETED|Overall Study||37
8547943|NCT04118270|9580100|FG001|COMPLETED|Overall Study||13
8547944|NCT04118270|9580099|FG000|NOT COMPLETED|Overall Study||0
8547945|NCT04118270|9580100|FG001|NOT COMPLETED|Overall Study||0
8547946|NCT04098367|9580111|FG000|STARTED|Overall Study||63
8547947|NCT04098367|9580112|FG001|STARTED|Overall Study||65
8547948|NCT04098367|9580113|FG002|STARTED|Overall Study||65
8547949|NCT04098367|9580111|FG000|First Eye Implanted|Overall Study||63
8547950|NCT04098367|9580112|FG001|First Eye Implanted|Overall Study||65
8547951|NCT04098367|9580113|FG002|First Eye Implanted|Overall Study||65
8547952|NCT04098367|9580111|FG000|Second Eye Implanted|Overall Study||63
8547953|NCT04098367|9580112|FG001|Second Eye Implanted|Overall Study||65
8547954|NCT04098367|9580113|FG002|Second Eye Implanted|Overall Study||63
8547955|NCT04098367|9580111|FG000|COMPLETED|Overall Study||61
8547956|NCT04098367|9580112|FG001|COMPLETED|Overall Study||60
8547957|NCT04098367|9580113|FG002|COMPLETED|Overall Study||61
8547958|NCT04098367|9580111|FG000|NOT COMPLETED|Overall Study||2
8547959|NCT04098367|9580112|FG001|NOT COMPLETED|Overall Study||5
8547960|NCT04098367|9580113|FG002|NOT COMPLETED|Overall Study||4
8547961|NCT04091087|9580130|FG000|STARTED|Overall Study||33
8547962|NCT04091087|9580131|FG001|STARTED|Overall Study||33
8547963|NCT04091087|9580130|FG000|Treated|Overall Study||32
8547964|NCT04091087|9580131|FG001|Treated|Overall Study||33
8547965|NCT04091087|9580130|FG000|COMPLETED|Overall Study||23
8547966|NCT04091087|9580131|FG001|COMPLETED|Overall Study||26
8547967|NCT04091087|9580130|FG000|NOT COMPLETED|Overall Study||10
8547968|NCT04091087|9580131|FG001|NOT COMPLETED|Overall Study||7
8547969|NCT04066023|9580140|FG000|STARTED|Overall Study||12
8547970|NCT04066023|9580141|FG001|STARTED|Overall Study||17
8547971|NCT04066023|9580142|FG002|STARTED|Overall Study||13
8547972|NCT04066023|9580140|FG000|COMPLETED|Overall Study||9
8547973|NCT04066023|9580141|FG001|COMPLETED|Overall Study||9
8547974|NCT04066023|9580142|FG002|COMPLETED|Overall Study||7
8547975|NCT04066023|9580140|FG000|NOT COMPLETED|Overall Study||3
8547976|NCT04066023|9580141|FG001|NOT COMPLETED|Overall Study||8
8547977|NCT04066023|9580142|FG002|NOT COMPLETED|Overall Study||6
8547978|NCT04009629|9580152|FG000|STARTED|Overall Study||23
8547979|NCT04009629|9580153|FG001|STARTED|Overall Study||38
8547980|NCT04009629|9580152|FG000|COMPLETED|Overall Study||21
8547981|NCT04009629|9580153|FG001|COMPLETED|Overall Study||38
8547982|NCT04009629|9580152|FG000|NOT COMPLETED|Overall Study||2
8547983|NCT04009629|9580153|FG001|NOT COMPLETED|Overall Study||0
8547984|NCT03982043|9580164|FG000|STARTED|Overall Study||43
8547985|NCT03982043|9580165|FG001|STARTED|Overall Study||4
8547986|NCT03982043|9580164|FG000|COMPLETED|Overall Study||43
8547987|NCT03982043|9580165|FG001|COMPLETED|Overall Study||4
8547988|NCT03982043|9580164|FG000|NOT COMPLETED|Overall Study||0
8547989|NCT03982043|9580165|FG001|NOT COMPLETED|Overall Study||0
8547990|NCT03937908|9580172|FG000|STARTED|Overall Study||2
8547991|NCT03937908|9580173|FG001|STARTED|Overall Study||3
8547992|NCT03937908|9580172|FG000|COMPLETED|Overall Study||2
8547993|NCT03937908|9580173|FG001|COMPLETED|Overall Study||2
8547994|NCT03937908|9580172|FG000|NOT COMPLETED|Overall Study||0
8547995|NCT03937908|9580173|FG001|NOT COMPLETED|Overall Study||1
8567476|NCT00086281|9599792|FG012|COMPLETED|Phase 2||22
8567477|NCT00086281|9599793|FG013|COMPLETED|Phase 2||26
8567478|NCT00086281|9599794|FG014|COMPLETED|Phase 2||0
8567479|NCT00086281|9599780|FG000|NOT COMPLETED|Phase 2||0
8567480|NCT00086281|9599781|FG001|NOT COMPLETED|Phase 2||0
8567481|NCT00086281|9599782|FG002|NOT COMPLETED|Phase 2||0
8567482|NCT00086281|9599783|FG003|NOT COMPLETED|Phase 2||0
8567483|NCT00086281|9599784|FG004|NOT COMPLETED|Phase 2||0
8567484|NCT00086281|9599785|FG005|NOT COMPLETED|Phase 2||0
8567485|NCT00086281|9599786|FG006|NOT COMPLETED|Phase 2||0
8567486|NCT00086281|9599787|FG007|NOT COMPLETED|Phase 2||0
8567487|NCT00086281|9599788|FG008|NOT COMPLETED|Phase 2||0
8567488|NCT00086281|9599789|FG009|NOT COMPLETED|Phase 2||0
8567489|NCT00086281|9599790|FG010|NOT COMPLETED|Phase 2||0
8567490|NCT00086281|9599791|FG011|NOT COMPLETED|Phase 2||0
8567491|NCT00086281|9599792|FG012|NOT COMPLETED|Phase 2||1
8567492|NCT00086281|9599793|FG013|NOT COMPLETED|Phase 2||1
8567493|NCT00086281|9599794|FG014|NOT COMPLETED|Phase 2||0
8569299|NCT00096109|9601496|FG000|NOT COMPLETED|Overall Study||0
8569300|NCT00096122|9601500|FG000|STARTED|Overall Study||95
8569301|NCT00096122|9601500|FG000|COMPLETED|Overall Study||95
8569302|NCT00096122|9601500|FG000|NOT COMPLETED|Overall Study||0
8569303|NCT00096135|9601506|FG000|STARTED|Overall Study||126
8569304|NCT00096135|9601507|FG001|STARTED|Overall Study||42
8569305|NCT00096135|9601506|FG000|COMPLETED|Overall Study||63
8569306|NCT00096135|9601507|FG001|COMPLETED|Overall Study||27
8569307|NCT00096135|9601506|FG000|NOT COMPLETED|Overall Study||63
8569308|NCT00096135|9601507|FG001|NOT COMPLETED|Overall Study||15
8569309|NCT00096161|9601517|FG000|STARTED|Overall Study||20
8569310|NCT00096161|9601518|FG001|STARTED|Overall Study||10
8569311|NCT00096161|9601519|FG002|STARTED|Overall Study||6
8569312|NCT00096161|9601520|FG003|STARTED|Overall Study||0
8569313|NCT00096161|9601517|FG000|COMPLETED|Overall Study||20
8569314|NCT00096161|9601518|FG001|COMPLETED|Overall Study||10
8569315|NCT00096161|9601519|FG002|COMPLETED|Overall Study||6
8569316|NCT00096161|9601520|FG003|COMPLETED|Overall Study||0
8569317|NCT00096161|9601517|FG000|NOT COMPLETED|Overall Study||0
8569318|NCT00096161|9601518|FG001|NOT COMPLETED|Overall Study||0
8569319|NCT00096161|9601519|FG002|NOT COMPLETED|Overall Study||0
8569320|NCT00096161|9601520|FG003|NOT COMPLETED|Overall Study||0
8569321|NCT00096174|9601530|FG000|STARTED|Overall Study||69
8569322|NCT00096174|9601530|FG000|Began Protocol Therapy|Overall Study|3 patients never started treatment|66
8569323|NCT00096174|9601530|FG000|Eligible and Treated|Overall Study|6 treated patients were ineligible|60
8621534|NCT00481065|9660521|FG001|NOT COMPLETED|Overall Study||17
8621535|NCT00481065|9660522|FG002|NOT COMPLETED|Overall Study||19
8621536|NCT00481065|9660523|FG003|NOT COMPLETED|Overall Study||15
8621537|NCT00481065|9660524|FG004|NOT COMPLETED|Overall Study||23
8621538|NCT00481065|9660525|FG005|NOT COMPLETED|Overall Study||24
8569324|NCT00096174|9601530|FG000|COMPLETED|Overall Study||7
8569325|NCT00096174|9601530|FG000|NOT COMPLETED|Overall Study||62
8569326|NCT00096226|9601534|FG000|STARTED|Overall Study||60
8569327|NCT00096226|9601534|FG000|Eligible|Overall Study||57
8569328|NCT00096226|9601534|FG000|Eligible and Underwent Surgery|Overall Study||37
8569329|NCT00096226|9601534|FG000|COMPLETED|Overall Study|Subjects contributing any data to analysis are considered to have completed the study|57
8569330|NCT00096226|9601534|FG000|NOT COMPLETED|Overall Study||3
8569331|NCT00096265|9601541|FG000|STARTED|Overall Study||45
8569332|NCT00096265|9601542|FG001|STARTED|Overall Study||40
8569333|NCT00096265|9601543|FG002|STARTED|Overall Study||41
8569334|NCT00096265|9601541|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|44
8569335|NCT00096265|9601542|FG001|COMPLETED|Overall Study||40
8621539|NCT00481065|9660526|FG006|NOT COMPLETED|Overall Study||16
8569336|NCT00096265|9601543|FG002|COMPLETED|Overall Study||41
8569337|NCT00096265|9601541|FG000|NOT COMPLETED|Overall Study||1
8569338|NCT00096265|9601542|FG001|NOT COMPLETED|Overall Study||0
8569339|NCT00096265|9601543|FG002|NOT COMPLETED|Overall Study||0
8569340|NCT00096278|9601554|FG000|STARTED|Overall Study||1356
8569341|NCT00096278|9601555|FG001|STARTED|Overall Study||1354
8569342|NCT00096278|9601554|FG000|COMPLETED|Overall Study||1338
8569343|NCT00096278|9601555|FG001|COMPLETED|Overall Study||1334
8569344|NCT00096278|9601554|FG000|NOT COMPLETED|Overall Study||18
8569345|NCT00096278|9601555|FG001|NOT COMPLETED|Overall Study||20
8569346|NCT00096356|9601565|FG000|STARTED|Overall Study||122
8569347|NCT00096356|9601566|FG001|STARTED|Overall Study||114
8569348|NCT00096356|9601565|FG000|COMPLETED|Overall Study||78
8547996|NCT03891264|9580179|FG000|STARTED|Overall Study||7
8547997|NCT03891264|9580179|FG000|Received Intervention|Overall Study||3
8547998|NCT03891264|9580179|FG000|COMPLETED|Overall Study||2
8547999|NCT03891264|9580179|FG000|NOT COMPLETED|Overall Study||5
8548000|NCT03839082|9580185|FG000|STARTED|Initial Randomization||33
8548001|NCT03839082|9580186|FG001|STARTED|Initial Randomization||37
8548002|NCT03839082|9580185|FG000|COMPLETED|Initial Randomization||7
8548003|NCT03839082|9580186|FG001|COMPLETED|Initial Randomization||12
8548004|NCT03839082|9580185|FG000|NOT COMPLETED|Initial Randomization||26
8548005|NCT03839082|9580186|FG001|NOT COMPLETED|Initial Randomization||25
8548006|NCT03839082|9580185|FG000|STARTED|Crossover to Other Arm||7
8548007|NCT03839082|9580186|FG001|STARTED|Crossover to Other Arm||12
8548008|NCT03839082|9580185|FG000|COMPLETED|Crossover to Other Arm||0
8548009|NCT03839082|9580186|FG001|COMPLETED|Crossover to Other Arm||0
8548010|NCT03839082|9580185|FG000|NOT COMPLETED|Crossover to Other Arm||7
8548011|NCT03839082|9580186|FG001|NOT COMPLETED|Crossover to Other Arm||12
8548012|NCT03835351|9580194|FG000|STARTED|Overall Study||241
8548013|NCT03835351|9580195|FG001|STARTED|Overall Study||250
8548014|NCT03835351|9580194|FG000|COMPLETED|Overall Study||241
8548015|NCT03835351|9580195|FG001|COMPLETED|Overall Study||250
8548016|NCT03835351|9580194|FG000|NOT COMPLETED|Overall Study||0
8548017|NCT03835351|9580195|FG001|NOT COMPLETED|Overall Study||0
8548018|NCT03823300|9580203|FG000|STARTED|Overall Study||331
8548019|NCT03823300|9580204|FG001|STARTED|Overall Study||327
8548020|NCT03823300|9580203|FG000|Received at Least One Dose of Study Drug|Overall Study||331
8548021|NCT03823300|9580204|FG001|Received at Least One Dose of Study Drug|Overall Study||326
8548022|NCT03823300|9580203|FG000|Completed up to Week 48|Overall Study||321
8548023|NCT03823300|9580204|FG001|Completed up to Week 48|Overall Study||309
8548024|NCT03823300|9580203|FG000|COMPLETED|Overall Study||0
8548025|NCT03823300|9580204|FG001|COMPLETED|Overall Study||0
8548026|NCT03823300|9580203|FG000|NOT COMPLETED|Overall Study||331
8548027|NCT03823300|9580204|FG001|NOT COMPLETED|Overall Study||327
8548028|NCT03823287|9580212|FG000|STARTED|Overall Study||334
8548029|NCT03823287|9580213|FG001|STARTED|Overall Study||337
8548030|NCT03823287|9580212|FG000|Received at Least One Dose of Study Drug|Overall Study||333
8548031|NCT03823287|9580213|FG001|Received at Least One Dose of Study Drug|Overall Study||336
8548032|NCT03823287|9580212|FG000|Completed up to Week 48|Overall Study||319
8548033|NCT03823287|9580213|FG001|Completed up to Week 48|Overall Study||323
8548034|NCT03823287|9580212|FG000|COMPLETED|Overall Study||0
8548035|NCT03823287|9580213|FG001|COMPLETED|Overall Study||0
8548036|NCT03823287|9580212|FG000|NOT COMPLETED|Overall Study||334
8548037|NCT03823287|9580213|FG001|NOT COMPLETED|Overall Study||337
8548038|NCT03815175|9580219|FG000|STARTED|Overall Study||1605
8548039|NCT03815175|9580219|FG000|COMPLETED|Overall Study||1439
8548040|NCT03815175|9580219|FG000|NOT COMPLETED|Overall Study||166
8548041|NCT03812224|9580225|FG000|STARTED|Double-blind Treatment Period||131
8548042|NCT03812224|9580226|FG001|STARTED|Double-blind Treatment Period||130
8548043|NCT03812224|9580225|FG000|COMPLETED|Double-blind Treatment Period||127
8548044|NCT03812224|9580226|FG001|COMPLETED|Double-blind Treatment Period||127
8548045|NCT03812224|9580225|FG000|NOT COMPLETED|Double-blind Treatment Period||4
8548046|NCT03812224|9580226|FG001|NOT COMPLETED|Double-blind Treatment Period||3
8548047|NCT03812224|9580225|FG000|STARTED|Open-label Treatment Period||127
8548048|NCT03812224|9580226|FG001|STARTED|Open-label Treatment Period||127
8548049|NCT03812224|9580225|FG000|COMPLETED|Open-label Treatment Period||125
8548050|NCT03812224|9580226|FG001|COMPLETED|Open-label Treatment Period||124
8548051|NCT03812224|9580225|FG000|NOT COMPLETED|Open-label Treatment Period||2
8548052|NCT03812224|9580226|FG001|NOT COMPLETED|Open-label Treatment Period||3
8548053|NCT03794024|9580235|FG000|STARTED|Overall Study||1
8548054|NCT03794024|9580236|FG001|STARTED|Overall Study||0
8548055|NCT03794024|9580235|FG000|COMPLETED|Overall Study||0
8548056|NCT03794024|9580236|FG001|COMPLETED|Overall Study||0
8548057|NCT03794024|9580235|FG000|NOT COMPLETED|Overall Study||1
8548058|NCT03794024|9580236|FG001|NOT COMPLETED|Overall Study||0
8548059|NCT03770455|9580242|FG000|STARTED|Overall Study||5
8548060|NCT03770455|9580242|FG000|COMPLETED|Overall Study||5
8548061|NCT03770455|9580242|FG000|NOT COMPLETED|Overall Study||0
8548062|NCT03714178|9580246|FG000|STARTED|Overall Study||71
8548063|NCT03714178|9580246|FG000|COMPLETED|Overall Study||71
8548064|NCT03714178|9580246|FG000|NOT COMPLETED|Overall Study||0
8548065|NCT03709342|9580250|FG000|STARTED|Overall Study||7
8548066|NCT03709342|9580250|FG000|COMPLETED|Overall Study||7
8548067|NCT03709342|9580250|FG000|NOT COMPLETED|Overall Study||0
8548068|NCT03691623|9580260|FG000|STARTED|Overall Study||39
8548069|NCT03691623|9580261|FG001|STARTED|Overall Study||38
8548070|NCT03691623|9580262|FG002|STARTED|Overall Study||38
8548071|NCT03691623|9580263|FG003|STARTED|Overall Study||21
8548072|NCT03691623|9580264|FG004|STARTED|Overall Study||21
8548073|NCT03691623|9580265|FG005|STARTED|Overall Study||21
8548074|NCT03691623|9580260|FG000|Inoculated With Challenge Virus|Overall Study||39
8548075|NCT03691623|9580261|FG001|Inoculated With Challenge Virus|Overall Study||38
8548076|NCT03691623|9580262|FG002|Inoculated With Challenge Virus|Overall Study||38
8548077|NCT03691623|9580263|FG003|Inoculated With Challenge Virus|Overall Study||21
8548078|NCT03691623|9580264|FG004|Inoculated With Challenge Virus|Overall Study||21
8548079|NCT03691623|9580265|FG005|Inoculated With Challenge Virus|Overall Study||21
8548080|NCT03691623|9580260|FG000|Received Treatment|Overall Study||38
8548081|NCT03691623|9580261|FG001|Received Treatment|Overall Study||38
8548082|NCT03691623|9580262|FG002|Received Treatment|Overall Study||38
8548083|NCT03691623|9580263|FG003|Received Treatment|Overall Study||21
8548084|NCT03691623|9580264|FG004|Received Treatment|Overall Study||21
8548085|NCT03691623|9580265|FG005|Received Treatment|Overall Study||21
8548086|NCT03691623|9580260|FG000|COMPLETED|Overall Study||39
8548087|NCT03691623|9580261|FG001|COMPLETED|Overall Study||38
8548088|NCT03691623|9580262|FG002|COMPLETED|Overall Study||38
8548089|NCT03691623|9580263|FG003|COMPLETED|Overall Study||21
8548090|NCT03691623|9580264|FG004|COMPLETED|Overall Study||21
8548091|NCT03691623|9580265|FG005|COMPLETED|Overall Study||21
8548092|NCT03691623|9580260|FG000|NOT COMPLETED|Overall Study||0
8548093|NCT03691623|9580261|FG001|NOT COMPLETED|Overall Study||0
8548094|NCT03691623|9580262|FG002|NOT COMPLETED|Overall Study||0
8548095|NCT03691623|9580263|FG003|NOT COMPLETED|Overall Study||0
8548096|NCT03691623|9580264|FG004|NOT COMPLETED|Overall Study||0
8548097|NCT03691623|9580265|FG005|NOT COMPLETED|Overall Study||0
8548098|NCT03689374|9580284|FG000|STARTED|Run-in Period (12 Weeks)||2274
8548099|NCT03689374|9580285|FG001|STARTED|Run-in Period (12 Weeks)||0
8548100|NCT03689374|9580286|FG002|STARTED|Run-in Period (12 Weeks)||0
8548101|NCT03689374|9580284|FG000|COMPLETED|Run-in Period (12 Weeks)||1748
8548102|NCT03689374|9580285|FG001|COMPLETED|Run-in Period (12 Weeks)||0
8548103|NCT03689374|9580286|FG002|COMPLETED|Run-in Period (12 Weeks)||0
8548104|NCT03689374|9580284|FG000|NOT COMPLETED|Run-in Period (12 Weeks)||526
8548105|NCT03689374|9580285|FG001|NOT COMPLETED|Run-in Period (12 Weeks)||0
8548106|NCT03689374|9580286|FG002|NOT COMPLETED|Run-in Period (12 Weeks)||0
8548107|NCT03689374|9580284|FG000|STARTED|Treatment Period (Week 0 to 52)||0
8548108|NCT03689374|9580285|FG001|STARTED|Treatment Period (Week 0 to 52)||874
8548109|NCT03689374|9580286|FG002|STARTED|Treatment Period (Week 0 to 52)||874
8548110|NCT03689374|9580284|FG000|Treated|Treatment Period (Week 0 to 52)||0
8548111|NCT03689374|9580285|FG001|Treated|Treatment Period (Week 0 to 52)||874
8548112|NCT03689374|9580286|FG002|Treated|Treatment Period (Week 0 to 52)||864
8548113|NCT03689374|9580284|FG000|Full Analysis Set|Treatment Period (Week 0 to 52)||0
8548114|NCT03689374|9580285|FG001|Full Analysis Set|Treatment Period (Week 0 to 52)||874
8548115|NCT03689374|9580286|FG002|Full Analysis Set|Treatment Period (Week 0 to 52)||874
8548116|NCT03689374|9580284|FG000|Safety Analysis Set|Treatment Period (Week 0 to 52)||0
8548117|NCT03689374|9580285|FG001|Safety Analysis Set|Treatment Period (Week 0 to 52)||874
8548118|NCT03689374|9580286|FG002|Safety Analysis Set|Treatment Period (Week 0 to 52)||864
8548119|NCT03689374|9580284|FG000|COMPLETED|Treatment Period (Week 0 to 52)||0
8548120|NCT03689374|9580285|FG001|COMPLETED|Treatment Period (Week 0 to 52)||850
8548121|NCT03689374|9580286|FG002|COMPLETED|Treatment Period (Week 0 to 52)||831
8548122|NCT03689374|9580284|FG000|NOT COMPLETED|Treatment Period (Week 0 to 52)||0
8548123|NCT03689374|9580285|FG001|NOT COMPLETED|Treatment Period (Week 0 to 52)||24
8548124|NCT03689374|9580286|FG002|NOT COMPLETED|Treatment Period (Week 0 to 52)||43
8548125|NCT03604549|9580294|FG000|STARTED|Overall Study||29
8548126|NCT03604549|9580295|FG001|STARTED|Overall Study||29
8548127|NCT03604549|9580294|FG000|COMPLETED|Overall Study||24
8548128|NCT03604549|9580295|FG001|COMPLETED|Overall Study||24
8548129|NCT03604549|9580294|FG000|NOT COMPLETED|Overall Study||5
8548130|NCT03604549|9580295|FG001|NOT COMPLETED|Overall Study||5
8548131|NCT03603639|9580301|FG000|STARTED|Treatment Period 1 (Day 1)||1
8548132|NCT03603639|9580302|FG001|STARTED|Treatment Period 1 (Day 1)||1
8548133|NCT03603639|9580303|FG002|STARTED|Treatment Period 1 (Day 1)||1
8548134|NCT03603639|9580304|FG003|STARTED|Treatment Period 1 (Day 1)||1
8548135|NCT03603639|9580305|FG004|STARTED|Treatment Period 1 (Day 1)||1
8548136|NCT03603639|9580306|FG005|STARTED|Treatment Period 1 (Day 1)||1
8548137|NCT03603639|9580301|FG000|COMPLETED|Treatment Period 1 (Day 1)||1
8548138|NCT03603639|9580302|FG001|COMPLETED|Treatment Period 1 (Day 1)||1
8548139|NCT03603639|9580303|FG002|COMPLETED|Treatment Period 1 (Day 1)||1
8548140|NCT03603639|9580304|FG003|COMPLETED|Treatment Period 1 (Day 1)||1
8548141|NCT03603639|9580305|FG004|COMPLETED|Treatment Period 1 (Day 1)||1
8548142|NCT03603639|9580306|FG005|COMPLETED|Treatment Period 1 (Day 1)||1
8548143|NCT03603639|9580301|FG000|NOT COMPLETED|Treatment Period 1 (Day 1)||0
8548144|NCT03603639|9580302|FG001|NOT COMPLETED|Treatment Period 1 (Day 1)||0
8548145|NCT03603639|9580303|FG002|NOT COMPLETED|Treatment Period 1 (Day 1)||0
8548146|NCT03603639|9580304|FG003|NOT COMPLETED|Treatment Period 1 (Day 1)||0
8548147|NCT03603639|9580305|FG004|NOT COMPLETED|Treatment Period 1 (Day 1)||0
8548148|NCT03603639|9580306|FG005|NOT COMPLETED|Treatment Period 1 (Day 1)||0
8548149|NCT03603639|9580301|FG000|STARTED|Washout Period (at Least 3 Weeks)||1
8548150|NCT03603639|9580302|FG001|STARTED|Washout Period (at Least 3 Weeks)||1
8548151|NCT03603639|9580303|FG002|STARTED|Washout Period (at Least 3 Weeks)||1
8548152|NCT03603639|9580304|FG003|STARTED|Washout Period (at Least 3 Weeks)||1
8548153|NCT03603639|9580305|FG004|STARTED|Washout Period (at Least 3 Weeks)||1
8548154|NCT03603639|9580306|FG005|STARTED|Washout Period (at Least 3 Weeks)||1
8548155|NCT03603639|9580301|FG000|COMPLETED|Washout Period (at Least 3 Weeks)||1
8548156|NCT03603639|9580302|FG001|COMPLETED|Washout Period (at Least 3 Weeks)||1
8548157|NCT03603639|9580303|FG002|COMPLETED|Washout Period (at Least 3 Weeks)||1
8548158|NCT03603639|9580304|FG003|COMPLETED|Washout Period (at Least 3 Weeks)||1
8548159|NCT03603639|9580305|FG004|COMPLETED|Washout Period (at Least 3 Weeks)||1
8548160|NCT03603639|9580306|FG005|COMPLETED|Washout Period (at Least 3 Weeks)||1
8548161|NCT03603639|9580301|FG000|NOT COMPLETED|Washout Period (at Least 3 Weeks)||0
8548162|NCT03603639|9580302|FG001|NOT COMPLETED|Washout Period (at Least 3 Weeks)||0
8548163|NCT03603639|9580303|FG002|NOT COMPLETED|Washout Period (at Least 3 Weeks)||0
8548164|NCT03603639|9580304|FG003|NOT COMPLETED|Washout Period (at Least 3 Weeks)||0
8548165|NCT03603639|9580305|FG004|NOT COMPLETED|Washout Period (at Least 3 Weeks)||0
8548166|NCT03603639|9580306|FG005|NOT COMPLETED|Washout Period (at Least 3 Weeks)||0
8548167|NCT03603639|9580301|FG000|STARTED|Treatment Period 2 (Day 1)||1
8548168|NCT03603639|9580302|FG001|STARTED|Treatment Period 2 (Day 1)||1
8548169|NCT03603639|9580303|FG002|STARTED|Treatment Period 2 (Day 1)||1
8548170|NCT03603639|9580304|FG003|STARTED|Treatment Period 2 (Day 1)||1
8548171|NCT03603639|9580305|FG004|STARTED|Treatment Period 2 (Day 1)||1
8548172|NCT03603639|9580306|FG005|STARTED|Treatment Period 2 (Day 1)||1
8548173|NCT03603639|9580301|FG000|COMPLETED|Treatment Period 2 (Day 1)||1
8548174|NCT03603639|9580302|FG001|COMPLETED|Treatment Period 2 (Day 1)||1
8548175|NCT03603639|9580303|FG002|COMPLETED|Treatment Period 2 (Day 1)||1
8548176|NCT03603639|9580304|FG003|COMPLETED|Treatment Period 2 (Day 1)||1
8548177|NCT03603639|9580305|FG004|COMPLETED|Treatment Period 2 (Day 1)||1
8548178|NCT03603639|9580306|FG005|COMPLETED|Treatment Period 2 (Day 1)||1
8548179|NCT03603639|9580301|FG000|NOT COMPLETED|Treatment Period 2 (Day 1)||0
8548180|NCT03603639|9580302|FG001|NOT COMPLETED|Treatment Period 2 (Day 1)||0
8548181|NCT03603639|9580303|FG002|NOT COMPLETED|Treatment Period 2 (Day 1)||0
8548182|NCT03603639|9580304|FG003|NOT COMPLETED|Treatment Period 2 (Day 1)||0
8548183|NCT03603639|9580305|FG004|NOT COMPLETED|Treatment Period 2 (Day 1)||0
8548184|NCT03603639|9580306|FG005|NOT COMPLETED|Treatment Period 2 (Day 1)||0
8548185|NCT03603639|9580301|FG000|STARTED|Washout Period (at Least 3 Weeks)||1
8818384|NCT01557322|9872041|FG001|NOT COMPLETED|Overall Study||0
8818385|NCT01557348|9872049|FG000|STARTED|Overall Study||604
8818386|NCT01557348|9872050|FG001|STARTED|Overall Study||507
8548186|NCT03603639|9580302|FG001|STARTED|Washout Period (at Least 3 Weeks)||1
8548187|NCT03603639|9580303|FG002|STARTED|Washout Period (at Least 3 Weeks)||1
8548188|NCT03603639|9580304|FG003|STARTED|Washout Period (at Least 3 Weeks)||1
8548189|NCT03603639|9580305|FG004|STARTED|Washout Period (at Least 3 Weeks)||1
8548190|NCT03603639|9580306|FG005|STARTED|Washout Period (at Least 3 Weeks)||1
8548191|NCT03603639|9580301|FG000|COMPLETED|Washout Period (at Least 3 Weeks)||1
8548192|NCT03603639|9580302|FG001|COMPLETED|Washout Period (at Least 3 Weeks)||1
8548193|NCT03603639|9580303|FG002|COMPLETED|Washout Period (at Least 3 Weeks)||0
8548194|NCT03603639|9580304|FG003|COMPLETED|Washout Period (at Least 3 Weeks)||0
8548195|NCT03603639|9580305|FG004|COMPLETED|Washout Period (at Least 3 Weeks)||0
8548196|NCT03603639|9580306|FG005|COMPLETED|Washout Period (at Least 3 Weeks)||0
8548197|NCT03603639|9580301|FG000|NOT COMPLETED|Washout Period (at Least 3 Weeks)||0
8548198|NCT03603639|9580302|FG001|NOT COMPLETED|Washout Period (at Least 3 Weeks)||0
8621540|NCT00481065|9660527|FG007|NOT COMPLETED|Overall Study||19
8621541|NCT00481078|9660549|FG000|STARTED|Overall Study||62
8621542|NCT00481078|9660550|FG001|STARTED|Overall Study||32
8621543|NCT00481078|9660549|FG000|COMPLETED|Overall Study||20
8621544|NCT00481078|9660550|FG001|COMPLETED|Overall Study||12
8621545|NCT00481078|9660549|FG000|NOT COMPLETED|Overall Study||42
8621546|NCT00481078|9660550|FG001|NOT COMPLETED|Overall Study||20
8621547|NCT00481195|9660558|FG000|STARTED|Overall Study|Two of these subjects were randomized but never received study medication.|128
8621548|NCT00481195|9660559|FG001|STARTED|Overall Study|Four of these subjects were randomized but never received study medication.|129
8621549|NCT00481195|9660558|FG000|COMPLETED|Overall Study||89
8621550|NCT00481195|9660559|FG001|COMPLETED|Overall Study||90
8621551|NCT00481195|9660558|FG000|NOT COMPLETED|Overall Study||39
8548199|NCT03603639|9580303|FG002|NOT COMPLETED|Washout Period (at Least 3 Weeks)||1
8548200|NCT03603639|9580304|FG003|NOT COMPLETED|Washout Period (at Least 3 Weeks)||1
8548201|NCT03603639|9580305|FG004|NOT COMPLETED|Washout Period (at Least 3 Weeks)||1
8548202|NCT03603639|9580306|FG005|NOT COMPLETED|Washout Period (at Least 3 Weeks)||1
8548203|NCT03603639|9580301|FG000|STARTED|Treatment Period 3 (Day 1)||1
8548204|NCT03603639|9580302|FG001|STARTED|Treatment Period 3 (Day 1)||1
8548205|NCT03603639|9580303|FG002|STARTED|Treatment Period 3 (Day 1)||0
8548206|NCT03603639|9580304|FG003|STARTED|Treatment Period 3 (Day 1)||0
8548207|NCT03603639|9580305|FG004|STARTED|Treatment Period 3 (Day 1)||0
8548208|NCT03603639|9580306|FG005|STARTED|Treatment Period 3 (Day 1)||0
8548209|NCT03603639|9580301|FG000|COMPLETED|Treatment Period 3 (Day 1)||1
8548210|NCT03603639|9580302|FG001|COMPLETED|Treatment Period 3 (Day 1)||1
8548211|NCT03603639|9580303|FG002|COMPLETED|Treatment Period 3 (Day 1)||0
8548212|NCT03603639|9580304|FG003|COMPLETED|Treatment Period 3 (Day 1)||0
8548213|NCT03603639|9580305|FG004|COMPLETED|Treatment Period 3 (Day 1)||0
8548214|NCT03603639|9580306|FG005|COMPLETED|Treatment Period 3 (Day 1)||0
8548215|NCT03603639|9580301|FG000|NOT COMPLETED|Treatment Period 3 (Day 1)||0
8548216|NCT03603639|9580302|FG001|NOT COMPLETED|Treatment Period 3 (Day 1)||0
8548217|NCT03603639|9580303|FG002|NOT COMPLETED|Treatment Period 3 (Day 1)||0
8548218|NCT03603639|9580304|FG003|NOT COMPLETED|Treatment Period 3 (Day 1)||0
8548219|NCT03603639|9580305|FG004|NOT COMPLETED|Treatment Period 3 (Day 1)||0
8548220|NCT03603639|9580306|FG005|NOT COMPLETED|Treatment Period 3 (Day 1)||0
8548221|NCT03587636|9580318|FG000|STARTED|Overall Study||39
8548222|NCT03587636|9580319|FG001|STARTED|Overall Study||38
8621552|NCT00481195|9660559|FG001|NOT COMPLETED|Overall Study||39
8818387|NCT01557348|9872049|FG000|Safety Population|Overall Study||604
8548223|NCT03587636|9580318|FG000|COMPLETED|Overall Study||37
8548224|NCT03587636|9580319|FG001|COMPLETED|Overall Study||33
8548225|NCT03587636|9580318|FG000|NOT COMPLETED|Overall Study||2
8621553|NCT00481247|9660567|FG000|STARTED|Overall Study|Randomized|259
8621554|NCT00481247|9660568|FG001|STARTED|Overall Study|Randomized|260
8818388|NCT01557348|9872050|FG001|Safety Population|Overall Study||507
8548226|NCT03587636|9580319|FG001|NOT COMPLETED|Overall Study||5
8548227|NCT03574129|9580327|FG000|STARTED|Overall Study||578
8548228|NCT03574129|9580328|FG001|STARTED|Overall Study||488
8548229|NCT03574129|9580327|FG000|COMPLETED|Overall Study||506
8548230|NCT03574129|9580328|FG001|COMPLETED|Overall Study||440
8548231|NCT03574129|9580327|FG000|NOT COMPLETED|Overall Study||72
8548232|NCT03574129|9580328|FG001|NOT COMPLETED|Overall Study||48
8548233|NCT03573336|9580349|FG000|STARTED|Overall Study||2
8548234|NCT03573336|9580350|FG001|STARTED|Overall Study||4
8548235|NCT03573336|9580351|FG002|STARTED|Overall Study||2
8548236|NCT03573336|9580349|FG000|Treated|Overall Study||2
8548237|NCT03573336|9580350|FG001|Treated|Overall Study||4
8548238|NCT03573336|9580351|FG002|Treated|Overall Study||2
8548239|NCT03573336|9580349|FG000|COMPLETED|Overall Study||0
8548240|NCT03573336|9580350|FG001|COMPLETED|Overall Study||0
8548241|NCT03573336|9580351|FG002|COMPLETED|Overall Study||0
8548242|NCT03573336|9580349|FG000|NOT COMPLETED|Overall Study||2
8548243|NCT03573336|9580350|FG001|NOT COMPLETED|Overall Study||4
8548244|NCT03573336|9580351|FG002|NOT COMPLETED|Overall Study||2
8548245|NCT03570697|9580361|FG000|STARTED|Overall Study||82
8548246|NCT03570697|9580362|FG001|STARTED|Overall Study||82
8548247|NCT03570697|9580361|FG000|Received at Least 1 Dose of Study Drug|Overall Study||81
8548248|NCT03570697|9580362|FG001|Received at Least 1 Dose of Study Drug|Overall Study||80
8548249|NCT03570697|9580361|FG000|COMPLETED|Overall Study||76
8548250|NCT03570697|9580362|FG001|COMPLETED|Overall Study||79
8548251|NCT03570697|9580361|FG000|NOT COMPLETED|Overall Study||6
8548252|NCT03570697|9580362|FG001|NOT COMPLETED|Overall Study||3
8548253|NCT03548051|9580370|FG000|STARTED|Overall Study||6
8548254|NCT03548051|9580371|FG001|STARTED|Overall Study||4
8548255|NCT03548051|9580370|FG000|COMPLETED|Overall Study||4
8548256|NCT03548051|9580371|FG001|COMPLETED|Overall Study||3
8548257|NCT03548051|9580370|FG000|NOT COMPLETED|Overall Study||2
8548258|NCT03548051|9580371|FG001|NOT COMPLETED|Overall Study||1
8548259|NCT03525886|9580381|FG000|STARTED|Cohort 1 (50 mg QHS)||8
8548260|NCT03525886|9580382|FG001|STARTED|Cohort 1 (50 mg QHS)||0
8548261|NCT03525886|9580383|FG002|STARTED|Cohort 1 (50 mg QHS)||0
8548262|NCT03525886|9580384|FG003|STARTED|Cohort 1 (50 mg QHS)||0
8548263|NCT03525886|9580381|FG000|COMPLETED|Cohort 1 (50 mg QHS)||8
8548264|NCT03525886|9580382|FG001|COMPLETED|Cohort 1 (50 mg QHS)||0
8548265|NCT03525886|9580383|FG002|COMPLETED|Cohort 1 (50 mg QHS)||0
8548266|NCT03525886|9580384|FG003|COMPLETED|Cohort 1 (50 mg QHS)||0
8548267|NCT03525886|9580381|FG000|NOT COMPLETED|Cohort 1 (50 mg QHS)||0
8548268|NCT03525886|9580382|FG001|NOT COMPLETED|Cohort 1 (50 mg QHS)||0
8548269|NCT03525886|9580383|FG002|NOT COMPLETED|Cohort 1 (50 mg QHS)||0
8548270|NCT03525886|9580384|FG003|NOT COMPLETED|Cohort 1 (50 mg QHS)||0
8548271|NCT03525886|9580381|FG000|STARTED|Cohort 2 (100 mg QHS)||0
8548272|NCT03525886|9580382|FG001|STARTED|Cohort 2 (100 mg QHS)||7
8548273|NCT03525886|9580383|FG002|STARTED|Cohort 2 (100 mg QHS)||0
8548274|NCT03525886|9580384|FG003|STARTED|Cohort 2 (100 mg QHS)||0
8548275|NCT03525886|9580381|FG000|COMPLETED|Cohort 2 (100 mg QHS)||0
8548276|NCT03525886|9580382|FG001|COMPLETED|Cohort 2 (100 mg QHS)||7
8548277|NCT03525886|9580383|FG002|COMPLETED|Cohort 2 (100 mg QHS)||0
8548278|NCT03525886|9580384|FG003|COMPLETED|Cohort 2 (100 mg QHS)||0
8548279|NCT03525886|9580381|FG000|NOT COMPLETED|Cohort 2 (100 mg QHS)||0
8548280|NCT03525886|9580382|FG001|NOT COMPLETED|Cohort 2 (100 mg QHS)||0
8548281|NCT03525886|9580383|FG002|NOT COMPLETED|Cohort 2 (100 mg QHS)||0
8548282|NCT03525886|9580384|FG003|NOT COMPLETED|Cohort 2 (100 mg QHS)||0
8548283|NCT03525886|9580381|FG000|STARTED|Cohort 3 (100 mg QPM)||0
8548284|NCT03525886|9580382|FG001|STARTED|Cohort 3 (100 mg QPM)||0
8548285|NCT03525886|9580383|FG002|STARTED|Cohort 3 (100 mg QPM)||8
8548286|NCT03525886|9580384|FG003|STARTED|Cohort 3 (100 mg QPM)||0
8548287|NCT03525886|9580381|FG000|COMPLETED|Cohort 3 (100 mg QPM)||0
8548288|NCT03525886|9580382|FG001|COMPLETED|Cohort 3 (100 mg QPM)||0
8548289|NCT03525886|9580383|FG002|COMPLETED|Cohort 3 (100 mg QPM)||8
8548290|NCT03525886|9580384|FG003|COMPLETED|Cohort 3 (100 mg QPM)||0
8548291|NCT03525886|9580381|FG000|NOT COMPLETED|Cohort 3 (100 mg QPM)||0
8548292|NCT03525886|9580382|FG001|NOT COMPLETED|Cohort 3 (100 mg QPM)||0
8548293|NCT03525886|9580383|FG002|NOT COMPLETED|Cohort 3 (100 mg QPM)||0
8548294|NCT03525886|9580384|FG003|NOT COMPLETED|Cohort 3 (100 mg QPM)||0
8548295|NCT03525886|9580381|FG000|STARTED|Cohort 4 (100 mg BID)||0
8548296|NCT03525886|9580382|FG001|STARTED|Cohort 4 (100 mg BID)||0
8548297|NCT03525886|9580383|FG002|STARTED|Cohort 4 (100 mg BID)||0
8548298|NCT03525886|9580384|FG003|STARTED|Cohort 4 (100 mg BID)||8
8548299|NCT03525886|9580381|FG000|COMPLETED|Cohort 4 (100 mg BID)||0
8548300|NCT03525886|9580382|FG001|COMPLETED|Cohort 4 (100 mg BID)||0
8548301|NCT03525886|9580383|FG002|COMPLETED|Cohort 4 (100 mg BID)||0
8548302|NCT03525886|9580384|FG003|COMPLETED|Cohort 4 (100 mg BID)||8
8548303|NCT03525886|9580381|FG000|NOT COMPLETED|Cohort 4 (100 mg BID)||0
8548304|NCT03525886|9580382|FG001|NOT COMPLETED|Cohort 4 (100 mg BID)||0
8548305|NCT03525886|9580383|FG002|NOT COMPLETED|Cohort 4 (100 mg BID)||0
8548306|NCT03525886|9580384|FG003|NOT COMPLETED|Cohort 4 (100 mg BID)||0
8548307|NCT03503318|9580397|FG000|STARTED|Overall Study||181
8548308|NCT03503318|9580398|FG001|STARTED|Overall Study||183
8548309|NCT03503318|9580399|FG002|STARTED|Overall Study||180
8548310|NCT03503318|9580397|FG000|Received at Least 1 Dose of Study Drug|Overall Study||179
8548311|NCT03503318|9580398|FG001|Received at Least 1 Dose of Study Drug|Overall Study||183
8548312|NCT03503318|9580399|FG002|Received at Least 1 Dose of Study Drug|Overall Study||180
8548313|NCT03503318|9580397|FG000|COMPLETED|Overall Study||142
8548314|NCT03503318|9580398|FG001|COMPLETED|Overall Study||144
8548315|NCT03503318|9580399|FG002|COMPLETED|Overall Study||140
8548316|NCT03503318|9580397|FG000|NOT COMPLETED|Overall Study||39
8548317|NCT03503318|9580398|FG001|NOT COMPLETED|Overall Study||39
8548318|NCT03503318|9580399|FG002|NOT COMPLETED|Overall Study||40
8567494|NCT00086307|9599807|FG000|STARTED|Overall Study||13
8567495|NCT00086307|9599808|FG001|STARTED|Overall Study||13
8567496|NCT00086307|9599809|FG002|STARTED|Overall Study||13
8567497|NCT00086307|9599807|FG000|COMPLETED|Overall Study||11
8567498|NCT00086307|9599808|FG001|COMPLETED|Overall Study||12
8567499|NCT00086307|9599809|FG002|COMPLETED|Overall Study||5
8567500|NCT00086307|9599807|FG000|NOT COMPLETED|Overall Study||2
8567501|NCT00086307|9599808|FG001|NOT COMPLETED|Overall Study||1
8567502|NCT00086307|9599809|FG002|NOT COMPLETED|Overall Study||8
8567503|NCT00086346|9599819|FG000|STARTED|Randomization||393
8567504|NCT00086346|9599820|FG001|STARTED|Randomization||214
8567505|NCT00086346|9599819|FG000|COMPLETED|Randomization||389
8567506|NCT00086346|9599820|FG001|COMPLETED|Randomization||210
8567507|NCT00086346|9599819|FG000|NOT COMPLETED|Randomization||4
8567508|NCT00086346|9599820|FG001|NOT COMPLETED|Randomization||4
8567509|NCT00086346|9599819|FG000|STARTED|Patients Dosed With Test Article||389
8567510|NCT00086346|9599820|FG001|STARTED|Patients Dosed With Test Article||210
8567511|NCT00086346|9599819|FG000|COMPLETED|Patients Dosed With Test Article||249
8567512|NCT00086346|9599820|FG001|COMPLETED|Patients Dosed With Test Article||187
8567513|NCT00086346|9599819|FG000|NOT COMPLETED|Patients Dosed With Test Article||140
8567514|NCT00086346|9599820|FG001|NOT COMPLETED|Patients Dosed With Test Article||23
8567515|NCT00086385|9599830|FG000|STARTED|Overall Study||100
8567516|NCT00086385|9599831|FG001|STARTED|Overall Study||99
8567517|NCT00086385|9599832|FG002|STARTED|Overall Study||104
8567518|NCT00086385|9599833|FG003|STARTED|Overall Study||99
8567519|NCT00086385|9599830|FG000|COMPLETED|Overall Study||98
8567520|NCT00086385|9599831|FG001|COMPLETED|Overall Study||97
8567521|NCT00086385|9599832|FG002|COMPLETED|Overall Study||103
8567522|NCT00086385|9599833|FG003|COMPLETED|Overall Study||98
8567523|NCT00086385|9599830|FG000|NOT COMPLETED|Overall Study||2
8567524|NCT00086385|9599831|FG001|NOT COMPLETED|Overall Study||2
8567525|NCT00086385|9599832|FG002|NOT COMPLETED|Overall Study||1
8567526|NCT00086385|9599833|FG003|NOT COMPLETED|Overall Study||1
8567527|NCT00086411|9599847|FG000|STARTED|Overall Study||70
8567528|NCT00086411|9599848|FG001|STARTED|Overall Study||63
8567529|NCT00086411|9599849|FG002|STARTED|Overall Study||62
8567530|NCT00086411|9599850|FG003|STARTED|Overall Study||65
8567531|NCT00086411|9599847|FG000|COMPLETED|Overall Study||59
8567532|NCT00086411|9599848|FG001|COMPLETED|Overall Study||52
8567533|NCT00086411|9599849|FG002|COMPLETED|Overall Study||49
8567534|NCT00086411|9599850|FG003|COMPLETED|Overall Study||53
8567535|NCT00086411|9599847|FG000|NOT COMPLETED|Overall Study||11
8567536|NCT00086411|9599848|FG001|NOT COMPLETED|Overall Study||11
8567537|NCT00086411|9599849|FG002|NOT COMPLETED|Overall Study||13
8567538|NCT00086411|9599850|FG003|NOT COMPLETED|Overall Study||12
8567539|NCT00086450|9599863|FG000|STARTED|Overall Study||953
8567540|NCT00086450|9599864|FG001|STARTED|Overall Study||947
8567541|NCT00086450|9599863|FG000|COMPLETED|Overall Study||953
8567542|NCT00086450|9599864|FG001|COMPLETED|Overall Study||947
8567543|NCT00086450|9599863|FG000|NOT COMPLETED|Overall Study||0
8567544|NCT00086450|9599864|FG001|NOT COMPLETED|Overall Study||0
8567545|NCT00086502|9599872|FG000|STARTED|Overall Study||175
8567546|NCT00086502|9599873|FG001|STARTED|Overall Study||178
8567547|NCT00086502|9599872|FG000|COMPLETED|Overall Study||149
8567548|NCT00086502|9599873|FG001|COMPLETED|Overall Study||158
8567549|NCT00086502|9599872|FG000|NOT COMPLETED|Overall Study||26
8567550|NCT00086502|9599873|FG001|NOT COMPLETED|Overall Study||20
8567551|NCT00086515|9599881|FG000|STARTED|Phase A (Weeks 0-24)||464
8567552|NCT00086515|9599882|FG001|STARTED|Phase A (Weeks 0-24)||237
8567553|NCT00086515|9599881|FG000|COMPLETED|Phase A (Weeks 0-24)||415
8567554|NCT00086515|9599882|FG001|COMPLETED|Phase A (Weeks 0-24)||192
8567555|NCT00086515|9599881|FG000|NOT COMPLETED|Phase A (Weeks 0-24)||49
8567556|NCT00086515|9599882|FG001|NOT COMPLETED|Phase A (Weeks 0-24)||45
8567557|NCT00086515|9599881|FG000|STARTED|Phase A to Phase B Transition Period||415
8567558|NCT00086515|9599882|FG001|STARTED|Phase A to Phase B Transition Period||192
8567559|NCT00086515|9599881|FG000|COMPLETED|Phase A to Phase B Transition Period||391
8567560|NCT00086515|9599882|FG001|COMPLETED|Phase A to Phase B Transition Period||164
8567561|NCT00086515|9599881|FG000|NOT COMPLETED|Phase A to Phase B Transition Period||24
8567562|NCT00086515|9599882|FG001|NOT COMPLETED|Phase A to Phase B Transition Period||28
8567563|NCT00086515|9599881|FG000|STARTED|Phase B (Weeks 24-104)||391
8567564|NCT00086515|9599882|FG001|STARTED|Phase B (Weeks 24-104)||164
8567565|NCT00086515|9599881|FG000|COMPLETED|Phase B (Weeks 24-104)||201
8567566|NCT00086515|9599882|FG001|COMPLETED|Phase B (Weeks 24-104)||109
8567567|NCT00086515|9599881|FG000|NOT COMPLETED|Phase B (Weeks 24-104)||190
8567568|NCT00086515|9599882|FG001|NOT COMPLETED|Phase B (Weeks 24-104)||55
8567569|NCT00086580|9599890|FG000|STARTED|Treatment Period||168
8567570|NCT00086580|9599891|FG001|STARTED|Treatment Period||167
8567571|NCT00086580|9599890|FG000|Safety Population|Treatment Period|Four participants did not receive treatment|164
8567572|NCT00086580|9599891|FG001|Safety Population|Treatment Period|Two participants did not receive treatment|165
8567573|NCT00086580|9599890|FG000|COMPLETED|Treatment Period|Finished 6 cycles of study drugs|103
8567574|NCT00086580|9599891|FG001|COMPLETED|Treatment Period|Finished 6 cycles of study drug|107
8567575|NCT00086580|9599890|FG000|NOT COMPLETED|Treatment Period||65
8548319|NCT03493854|9580409|FG000|STARTED|Neoadjuvant Treatment Phase (24 Weeks)|This includes all randomized participants.|252
8548320|NCT03493854|9580410|FG001|STARTED|Neoadjuvant Treatment Phase (24 Weeks)|This includes all randomized participants.|248
8548321|NCT03493854|9580409|FG000|Received at Least One Dose of Study Drug|Neoadjuvant Treatment Phase (24 Weeks)||252
8548322|NCT03493854|9580410|FG001|Received at Least One Dose of Study Drug|Neoadjuvant Treatment Phase (24 Weeks)||248
8621555|NCT00481247|9660567|FG000|Received Treatment|Overall Study||258
8621556|NCT00481247|9660568|FG001|Received Treatment|Overall Study||258
8621557|NCT00481247|9660567|FG000|COMPLETED|Overall Study||0
8621558|NCT00481247|9660568|FG001|COMPLETED|Overall Study||0
8621559|NCT00481247|9660567|FG000|NOT COMPLETED|Overall Study||259
8621560|NCT00481247|9660568|FG001|NOT COMPLETED|Overall Study||260
8621561|NCT00481351|9660576|FG000|STARTED|Overall Study||13
8621562|NCT00481351|9660577|FG001|STARTED|Overall Study||12
8621563|NCT00481351|9660576|FG000|COMPLETED|Overall Study||13
8621564|NCT00481351|9660577|FG001|COMPLETED|Overall Study||12
8621565|NCT00481351|9660576|FG000|NOT COMPLETED|Overall Study||0
8621566|NCT00481351|9660577|FG001|NOT COMPLETED|Overall Study||0
8621567|NCT00481507|9660585|FG000|STARTED|Overall Study||64
8621568|NCT00481507|9660586|FG001|STARTED|Overall Study||61
8621569|NCT00481507|9660585|FG000|COMPLETED|Overall Study||64
8548323|NCT03493854|9580409|FG000|COMPLETED|Neoadjuvant Treatment Phase (24 Weeks)||242
8548324|NCT03493854|9580410|FG001|COMPLETED|Neoadjuvant Treatment Phase (24 Weeks)||234
8548325|NCT03493854|9580409|FG000|NOT COMPLETED|Neoadjuvant Treatment Phase (24 Weeks)||10
8548326|NCT03493854|9580410|FG001|NOT COMPLETED|Neoadjuvant Treatment Phase (24 Weeks)||14
8548327|NCT03493854|9580409|FG000|STARTED|Surgery & Adjuvant Treatment (42 Weeks)||242
8548328|NCT03493854|9580410|FG001|STARTED|Surgery & Adjuvant Treatment (42 Weeks)||234
8548329|NCT03493854|9580409|FG000|Completed Surgery|Surgery & Adjuvant Treatment (42 Weeks)||239
8548330|NCT03493854|9580410|FG001|Completed Surgery|Surgery & Adjuvant Treatment (42 Weeks)||234
8548331|NCT03493854|9580409|FG000|COMPLETED|Surgery & Adjuvant Treatment (42 Weeks)||0
8548332|NCT03493854|9580410|FG001|COMPLETED|Surgery & Adjuvant Treatment (42 Weeks)||0
8548333|NCT03493854|9580409|FG000|NOT COMPLETED|Surgery & Adjuvant Treatment (42 Weeks)||242
8548334|NCT03493854|9580410|FG001|NOT COMPLETED|Surgery & Adjuvant Treatment (42 Weeks)||234
8548335|NCT03493854|9580409|FG000|STARTED|Treatment-Free Follow-Up (up to 3 Years)|Participants prematurely withdrew from treatment in other periods and entered the follow-up phase.|19
8548336|NCT03493854|9580410|FG001|STARTED|Treatment-Free Follow-Up (up to 3 Years)|Participants prematurely withdrew from treatment in other periods and entered the follow-up phase.|17
8548337|NCT03493854|9580409|FG000|COMPLETED|Treatment-Free Follow-Up (up to 3 Years)||0
8548338|NCT03493854|9580410|FG001|COMPLETED|Treatment-Free Follow-Up (up to 3 Years)||0
8548339|NCT03493854|9580409|FG000|NOT COMPLETED|Treatment-Free Follow-Up (up to 3 Years)||19
8548340|NCT03493854|9580410|FG001|NOT COMPLETED|Treatment-Free Follow-Up (up to 3 Years)||17
8548341|NCT03493451|9580419|FG000|STARTED|Overall Study||22
8548342|NCT03493451|9580420|FG001|STARTED|Overall Study||44
8548343|NCT03493451|9580421|FG002|STARTED|Overall Study||11
8548344|NCT03493451|9580419|FG000|COMPLETED|Overall Study||0
8548345|NCT03493451|9580420|FG001|COMPLETED|Overall Study||0
8548346|NCT03493451|9580421|FG002|COMPLETED|Overall Study||0
8548347|NCT03493451|9580419|FG000|NOT COMPLETED|Overall Study||22
8548348|NCT03493451|9580420|FG001|NOT COMPLETED|Overall Study||44
8548349|NCT03493451|9580421|FG002|NOT COMPLETED|Overall Study||11
8548350|NCT03476239|9580429|FG000|STARTED|Overall Study||121
8548351|NCT03476239|9580429|FG000|Received Blinatumomab|Overall Study||120
8548352|NCT03476239|9580429|FG000|Interim Analysis Set|Overall Study||90
8548353|NCT03476239|9580429|FG000|COMPLETED|Overall Study||23
8548354|NCT03476239|9580429|FG000|NOT COMPLETED|Overall Study||98
8548355|NCT03431168|9580435|FG000|STARTED|Overall Study||155
8548356|NCT03431168|9580436|FG001|STARTED|Overall Study||153
8548357|NCT03431168|9580435|FG000|COMPLETED|Overall Study||132
8548358|NCT03431168|9580436|FG001|COMPLETED|Overall Study||129
8548359|NCT03431168|9580435|FG000|NOT COMPLETED|Overall Study||23
8548360|NCT03431168|9580436|FG001|NOT COMPLETED|Overall Study||24
8548361|NCT03401749|9580445|FG000|STARTED|Overall Study||59
8548362|NCT03401749|9580446|FG001|STARTED|Overall Study||67
8548363|NCT03401749|9580447|FG002|STARTED|Overall Study||77
8548364|NCT03401749|9580445|FG000|COMPLETED|Overall Study||39
8548365|NCT03401749|9580446|FG001|COMPLETED|Overall Study||51
8548366|NCT03401749|9580447|FG002|COMPLETED|Overall Study||51
8548367|NCT03401749|9580445|FG000|NOT COMPLETED|Overall Study||20
8548368|NCT03401749|9580446|FG001|NOT COMPLETED|Overall Study||16
8548369|NCT03401749|9580447|FG002|NOT COMPLETED|Overall Study||26
8548370|NCT03337113|9580459|FG000|STARTED|Overall Study||13
8548371|NCT03337113|9580460|FG001|STARTED|Overall Study||12
8548372|NCT03337113|9580461|FG002|STARTED|Overall Study||12
8548373|NCT03337113|9580462|FG003|STARTED|Overall Study||13
8548374|NCT03337113|9580459|FG000|COMPLETED|Overall Study||12
8548375|NCT03337113|9580460|FG001|COMPLETED|Overall Study||9
8548376|NCT03337113|9580461|FG002|COMPLETED|Overall Study||11
8548377|NCT03337113|9580462|FG003|COMPLETED|Overall Study||11
8548378|NCT03337113|9580459|FG000|NOT COMPLETED|Overall Study||1
8621570|NCT00481507|9660586|FG001|COMPLETED|Overall Study||61
8621571|NCT00481507|9660585|FG000|NOT COMPLETED|Overall Study||0
8548379|NCT03337113|9580460|FG001|NOT COMPLETED|Overall Study||3
8621572|NCT00481507|9660586|FG001|NOT COMPLETED|Overall Study||0
8621573|NCT00481676|9660594|FG000|STARTED|Overall Study||27
8621574|NCT00481676|9660595|FG001|STARTED|Overall Study||22
8621575|NCT00481676|9660594|FG000|COMPLETED|Overall Study||25
8621576|NCT00481676|9660595|FG001|COMPLETED|Overall Study||17
8548380|NCT03337113|9580461|FG002|NOT COMPLETED|Overall Study||1
8548381|NCT03337113|9580462|FG003|NOT COMPLETED|Overall Study||2
8548382|NCT03299049|9580474|FG000|STARTED|Overall Study||522
8548383|NCT03299049|9580475|FG001|STARTED|Overall Study||523
8548384|NCT03299049|9580474|FG000|COMPLETED|Overall Study||0
8548385|NCT03299049|9580475|FG001|COMPLETED|Overall Study||0
8548386|NCT03299049|9580474|FG000|NOT COMPLETED|Overall Study||522
8548387|NCT03299049|9580475|FG001|NOT COMPLETED|Overall Study||523
8548388|NCT03257631|9580492|FG000|STARTED|Overall Study||11
8548389|NCT03257631|9580493|FG001|STARTED|Overall Study||9
8548390|NCT03257631|9580494|FG002|STARTED|Overall Study||23
8548391|NCT03257631|9580495|FG003|STARTED|Overall Study||10
8548392|NCT03257631|9580492|FG000|Received Study Drug|Overall Study||11
8548393|NCT03257631|9580493|FG001|Received Study Drug|Overall Study||9
8548394|NCT03257631|9580494|FG002|Received Study Drug|Overall Study||22
8548395|NCT03257631|9580495|FG003|Received Study Drug|Overall Study||10
8548396|NCT03257631|9580492|FG000|COMPLETED|Overall Study||0
8548397|NCT03257631|9580493|FG001|COMPLETED|Overall Study||0
8548398|NCT03257631|9580494|FG002|COMPLETED|Overall Study||0
8548399|NCT03257631|9580495|FG003|COMPLETED|Overall Study||0
8548400|NCT03257631|9580492|FG000|NOT COMPLETED|Overall Study||11
8548401|NCT03257631|9580493|FG001|NOT COMPLETED|Overall Study||9
8548402|NCT03257631|9580494|FG002|NOT COMPLETED|Overall Study||23
8548403|NCT03257631|9580495|FG003|NOT COMPLETED|Overall Study||10
8548404|NCT03253796|9580510|FG000|STARTED|Period 1: Run-In||323
8548405|NCT03253796|9580511|FG001|STARTED|Period 1: Run-In||0
8548406|NCT03253796|9580512|FG002|STARTED|Period 1: Run-In||0
8548407|NCT03253796|9580513|FG003|STARTED|Period 1: Run-In||0
8548408|NCT03253796|9580514|FG004|STARTED|Period 1: Run-In||0
8548409|NCT03253796|9580510|FG000|COMPLETED|Period 1: Run-In||207
8548410|NCT03253796|9580511|FG001|COMPLETED|Period 1: Run-In||0
8548411|NCT03253796|9580512|FG002|COMPLETED|Period 1: Run-In||0
8548412|NCT03253796|9580513|FG003|COMPLETED|Period 1: Run-In||0
8548413|NCT03253796|9580514|FG004|COMPLETED|Period 1: Run-In||0
8548414|NCT03253796|9580510|FG000|NOT COMPLETED|Period 1: Run-In||116
8548415|NCT03253796|9580511|FG001|NOT COMPLETED|Period 1: Run-In||0
8548416|NCT03253796|9580512|FG002|NOT COMPLETED|Period 1: Run-In||0
8548417|NCT03253796|9580513|FG003|NOT COMPLETED|Period 1: Run-In||0
8548418|NCT03253796|9580514|FG004|NOT COMPLETED|Period 1: Run-In||0
8548419|NCT03253796|9580510|FG000|STARTED|Period 2: Withdrawal vs Continued Tx||0
8548420|NCT03253796|9580511|FG001|STARTED|Period 2: Withdrawal vs Continued Tx||63
8548421|NCT03253796|9580512|FG002|STARTED|Period 2: Withdrawal vs Continued Tx||64
8548422|NCT03253796|9580513|FG003|STARTED|Period 2: Withdrawal vs Continued Tx||62
8548423|NCT03253796|9580514|FG004|STARTED|Period 2: Withdrawal vs Continued Tx||0
8548424|NCT03253796|9580510|FG000|COMPLETED|Period 2: Withdrawal vs Continued Tx||0
8548425|NCT03253796|9580511|FG001|COMPLETED|Period 2: Withdrawal vs Continued Tx||53
8548426|NCT03253796|9580512|FG002|COMPLETED|Period 2: Withdrawal vs Continued Tx||43
8548427|NCT03253796|9580513|FG003|COMPLETED|Period 2: Withdrawal vs Continued Tx||21
8548428|NCT03253796|9580514|FG004|COMPLETED|Period 2: Withdrawal vs Continued Tx||0
8548429|NCT03253796|9580510|FG000|NOT COMPLETED|Period 2: Withdrawal vs Continued Tx||0
8548430|NCT03253796|9580511|FG001|NOT COMPLETED|Period 2: Withdrawal vs Continued Tx||10
8548431|NCT03253796|9580512|FG002|NOT COMPLETED|Period 2: Withdrawal vs Continued Tx||21
8548432|NCT03253796|9580513|FG003|NOT COMPLETED|Period 2: Withdrawal vs Continued Tx||41
8548433|NCT03253796|9580514|FG004|NOT COMPLETED|Period 2: Withdrawal vs Continued Tx||0
8548434|NCT03253796|9580510|FG000|STARTED|Period 2: Open-Label Retreatment||0
8548435|NCT03253796|9580511|FG001|STARTED|Period 2: Open-Label Retreatment||0
8548436|NCT03253796|9580512|FG002|STARTED|Period 2: Open-Label Retreatment||0
8548437|NCT03253796|9580513|FG003|STARTED|Period 2: Open-Label Retreatment||0
8548438|NCT03253796|9580514|FG004|STARTED|Period 2: Open-Label Retreatment||63
8548439|NCT03253796|9580510|FG000|COMPLETED|Period 2: Open-Label Retreatment||0
8548440|NCT03253796|9580511|FG001|COMPLETED|Period 2: Open-Label Retreatment||0
8548441|NCT03253796|9580512|FG002|COMPLETED|Period 2: Open-Label Retreatment||0
8548442|NCT03253796|9580513|FG003|COMPLETED|Period 2: Open-Label Retreatment||0
8548443|NCT03253796|9580514|FG004|COMPLETED|Period 2: Open-Label Retreatment||58
8548444|NCT03253796|9580510|FG000|NOT COMPLETED|Period 2: Open-Label Retreatment||0
8548445|NCT03253796|9580511|FG001|NOT COMPLETED|Period 2: Open-Label Retreatment||0
8548446|NCT03253796|9580512|FG002|NOT COMPLETED|Period 2: Open-Label Retreatment||0
8548447|NCT03253796|9580513|FG003|NOT COMPLETED|Period 2: Open-Label Retreatment||0
8548448|NCT03253796|9580514|FG004|NOT COMPLETED|Period 2: Open-Label Retreatment||5
8567576|NCT00086580|9599891|FG001|NOT COMPLETED|Treatment Period||60
8567577|NCT00086580|9599890|FG000|STARTED|Follow-up Period||141
8567578|NCT00086580|9599891|FG001|STARTED|Follow-up Period||137
8567579|NCT00086580|9599890|FG000|COMPLETED|Follow-up Period||37
8567580|NCT00086580|9599891|FG001|COMPLETED|Follow-up Period||18
8567581|NCT00086580|9599890|FG000|NOT COMPLETED|Follow-up Period||104
8567582|NCT00086580|9599891|FG001|NOT COMPLETED|Follow-up Period||119
8567583|NCT00086580|9599890|FG000|STARTED|Observation Period||95
8567584|NCT00086580|9599891|FG001|STARTED|Observation Period||121
8567585|NCT00086580|9599890|FG000|COMPLETED|Observation Period||49
8567586|NCT00086580|9599891|FG001|COMPLETED|Observation Period||56
8567587|NCT00086580|9599890|FG000|NOT COMPLETED|Observation Period||46
8567588|NCT00086580|9599891|FG001|NOT COMPLETED|Observation Period||65
8567589|NCT00086619|9599899|FG000|STARTED|Overall Study||40
8567590|NCT00086619|9599900|FG001|STARTED|Overall Study||40
8567591|NCT00086619|9599899|FG000|Completed Baseline Visit|Overall Study||34
8548449|NCT03233048|9580529|FG000|STARTED|Overall Study||5
8548450|NCT03233048|9580529|FG000|COMPLETED|Overall Study||4
8548451|NCT03233048|9580529|FG000|NOT COMPLETED|Overall Study||1
8548452|NCT03194646|9580537|FG000|STARTED|Overall Study||363
8548453|NCT03194646|9580538|FG001|STARTED|Overall Study||361
8548454|NCT03194646|9580539|FG002|STARTED|Overall Study||183
8548455|NCT03194646|9580540|FG003|STARTED|Overall Study||365
8548456|NCT03194646|9580537|FG000|Treated|Overall Study||349
8548457|NCT03194646|9580538|FG001|Treated|Overall Study||347
8818389|NCT01557348|9872049|FG000|COMPLETED|Overall Study||524
8818390|NCT01557348|9872050|FG001|COMPLETED|Overall Study||417
8548458|NCT03194646|9580539|FG002|Treated|Overall Study||177
8548459|NCT03194646|9580540|FG003|Treated|Overall Study||365
8548460|NCT03194646|9580537|FG000|COMPLETED|Overall Study||61
8548461|NCT03194646|9580538|FG001|COMPLETED|Overall Study||93
8548462|NCT03194646|9580539|FG002|COMPLETED|Overall Study||44
8548463|NCT03194646|9580540|FG003|COMPLETED|Overall Study||85
8548464|NCT03194646|9580537|FG000|NOT COMPLETED|Overall Study||302
8548465|NCT03194646|9580538|FG001|NOT COMPLETED|Overall Study||268
8548466|NCT03194646|9580539|FG002|NOT COMPLETED|Overall Study||139
8548467|NCT03194646|9580540|FG003|NOT COMPLETED|Overall Study||280
8548468|NCT03138252|9580557|FG000|STARTED|Overall Study||90
8548469|NCT03138252|9580558|FG001|STARTED|Overall Study||90
8548470|NCT03138252|9580557|FG000|COMPLETED|Overall Study||90
8548471|NCT03138252|9580558|FG001|COMPLETED|Overall Study||90
8548472|NCT03138252|9580557|FG000|NOT COMPLETED|Overall Study||0
8548473|NCT03138252|9580558|FG001|NOT COMPLETED|Overall Study||0
8548474|NCT03116399|9580566|FG000|STARTED|Overall Study||128
8548475|NCT03116399|9580567|FG001|STARTED|Overall Study||120
8548476|NCT03116399|9580566|FG000|6-month|Overall Study||98
8548477|NCT03116399|9580567|FG001|6-month|Overall Study||108
8548478|NCT03116399|9580566|FG000|9-month|Overall Study||91
8548479|NCT03116399|9580567|FG001|9-month|Overall Study||101
8548480|NCT03116399|9580566|FG000|COMPLETED|Overall Study||88
8548481|NCT03116399|9580567|FG001|COMPLETED|Overall Study||96
8548482|NCT03116399|9580566|FG000|NOT COMPLETED|Overall Study||40
8548483|NCT03116399|9580567|FG001|NOT COMPLETED|Overall Study||24
8548484|NCT03064126|9580577|FG000|STARTED|Overall Study||278
8548485|NCT03064126|9580578|FG001|STARTED|Overall Study||98
8548486|NCT03064126|9580579|FG002|STARTED|Overall Study||52
8548487|NCT03064126|9580580|FG003|STARTED|Overall Study||12
8548488|NCT03064126|9580577|FG000|COMPLETED|Overall Study||252
8548489|NCT03064126|9580578|FG001|COMPLETED|Overall Study||91
8548490|NCT03064126|9580579|FG002|COMPLETED|Overall Study||49
8548491|NCT03064126|9580580|FG003|COMPLETED|Overall Study||11
8548492|NCT03064126|9580577|FG000|NOT COMPLETED|Overall Study||26
8548493|NCT03064126|9580578|FG001|NOT COMPLETED|Overall Study||7
8548494|NCT03064126|9580579|FG002|NOT COMPLETED|Overall Study||3
8548495|NCT03064126|9580580|FG003|NOT COMPLETED|Overall Study||1
8548496|NCT03020160|9580593|FG000|STARTED|Overall Study||7
8548497|NCT03020160|9580594|FG001|STARTED|Overall Study||41
8548498|NCT03020160|9580593|FG000|Completed 24 Weeks in the Study|Overall Study||7
8548499|NCT03020160|9580594|FG001|Completed 24 Weeks in the Study|Overall Study||41
8548500|NCT03020160|9580593|FG000|COMPLETED|Overall Study||0
8548501|NCT03020160|9580594|FG001|COMPLETED|Overall Study||0
8548502|NCT03020160|9580593|FG000|NOT COMPLETED|Overall Study||7
8548503|NCT03020160|9580594|FG001|NOT COMPLETED|Overall Study||41
8548504|NCT02943993|9580601|FG000|STARTED|Overall Study|Disposition data are based on Baseline Analysis Set (BAS) defined as All-Documented Patient Set participants with any documentation at the Baseline data collection point who fulfil the BAS criteria.|2655
8548505|NCT02943993|9580601|FG000|COMPLETED|Overall Study||2325
8548506|NCT02943993|9580601|FG000|NOT COMPLETED|Overall Study||330
8548507|NCT02939989|9580607|FG000|STARTED|Overall Study||5
8548508|NCT02939989|9580608|FG001|STARTED|Overall Study||28
8548509|NCT02939989|9580607|FG000|COMPLETED|Overall Study||5
8548510|NCT02939989|9580608|FG001|COMPLETED|Overall Study||28
8548511|NCT02939989|9580607|FG000|NOT COMPLETED|Overall Study||0
8548512|NCT02939989|9580608|FG001|NOT COMPLETED|Overall Study||0
8548513|NCT02893930|9580616|FG000|STARTED|Overall Study||13
8548514|NCT02893930|9580616|FG000|Eligible and Treated|Overall Study||12
8548515|NCT02893930|9580616|FG000|COMPLETED|Overall Study||0
8548516|NCT02893930|9580616|FG000|NOT COMPLETED|Overall Study||13
8548517|NCT02890355|9580622|FG000|STARTED|Overall Study||59
8548518|NCT02890355|9580623|FG001|STARTED|Overall Study||58
8548519|NCT02890355|9580622|FG000|Treated & Assessed for AEs|Overall Study||56
8548520|NCT02890355|9580623|FG001|Treated & Assessed for AEs|Overall Study||50
8548521|NCT02890355|9580622|FG000|COMPLETED|Overall Study||0
8548522|NCT02890355|9580623|FG001|COMPLETED|Overall Study||0
8548523|NCT02890355|9580622|FG000|NOT COMPLETED|Overall Study||59
8548524|NCT02890355|9580623|FG001|NOT COMPLETED|Overall Study||58
8548525|NCT02877134|9580638|FG000|STARTED|Overall Study||72
8548526|NCT02877134|9580639|FG001|STARTED|Overall Study||73
8548527|NCT02877134|9580640|FG002|STARTED|Overall Study||48
8548528|NCT02877134|9580641|FG003|STARTED|Overall Study||50
8548529|NCT02877134|9580642|FG004|STARTED|Overall Study||49
8548530|NCT02877134|9580643|FG005|STARTED|Overall Study||49
8548531|NCT02877134|9580644|FG006|STARTED|Overall Study||47
8548532|NCT02877134|9580638|FG000|Placebo Non Responders at Week 12|Overall Study||44
8548533|NCT02877134|9580639|FG001|Placebo Non Responders at Week 12|Overall Study||0
8548534|NCT02877134|9580640|FG002|Placebo Non Responders at Week 12|Overall Study||31
8548535|NCT02877134|9580641|FG003|Placebo Non Responders at Week 12|Overall Study||0
8818391|NCT01557348|9872049|FG000|NOT COMPLETED|Overall Study||80
8548536|NCT02877134|9580642|FG004|Placebo Non Responders at Week 12|Overall Study||0
8548537|NCT02877134|9580643|FG005|Placebo Non Responders at Week 12|Overall Study||0
8548538|NCT02877134|9580644|FG006|Placebo Non Responders at Week 12|Overall Study||0
8548539|NCT02877134|9580638|FG000|COMPLETED|Overall Study||58
8548540|NCT02877134|9580639|FG001|COMPLETED|Overall Study||48
8548541|NCT02877134|9580640|FG002|COMPLETED|Overall Study||42
8548542|NCT02877134|9580641|FG003|COMPLETED|Overall Study||37
8548543|NCT02877134|9580642|FG004|COMPLETED|Overall Study||43
8548544|NCT02877134|9580643|FG005|COMPLETED|Overall Study||42
8548545|NCT02877134|9580644|FG006|COMPLETED|Overall Study||46
8548546|NCT02877134|9580638|FG000|NOT COMPLETED|Overall Study||14
8548547|NCT02877134|9580639|FG001|NOT COMPLETED|Overall Study||25
8548548|NCT02877134|9580640|FG002|NOT COMPLETED|Overall Study||6
8548549|NCT02877134|9580641|FG003|NOT COMPLETED|Overall Study||13
8548550|NCT02877134|9580642|FG004|NOT COMPLETED|Overall Study||6
8548551|NCT02877134|9580643|FG005|NOT COMPLETED|Overall Study||7
8548552|NCT02877134|9580644|FG006|NOT COMPLETED|Overall Study||1
8548553|NCT02847637|9580666|FG000|STARTED|Overall Study||18
8548554|NCT02847637|9580667|FG001|STARTED|Overall Study||36
8548555|NCT02847637|9580668|FG002|STARTED|Overall Study||35
8548556|NCT02847637|9580669|FG003|STARTED|Overall Study||63
8548557|NCT02847637|9580666|FG000|Completed 24 Weeks on No Prophylaxis|Overall Study|One participant switched to emicizumab prior to completing 24 weeks No Prophylaxis (at 23.5 weeks).|16
8548558|NCT02847637|9580667|FG001|Completed 24 Weeks on No Prophylaxis|Overall Study||0
8548559|NCT02847637|9580668|FG002|Completed 24 Weeks on No Prophylaxis|Overall Study||0
8548560|NCT02847637|9580669|FG003|Completed 24 Weeks on No Prophylaxis|Overall Study||0
8548561|NCT02847637|9580666|FG000|Switched to Emicizumab 3 mg/kg/2 Weeks|Overall Study||16
8548562|NCT02847637|9580667|FG001|Switched to Emicizumab 3 mg/kg/2 Weeks|Overall Study||0
8548563|NCT02847637|9580668|FG002|Switched to Emicizumab 3 mg/kg/2 Weeks|Overall Study||0
8548564|NCT02847637|9580669|FG003|Switched to Emicizumab 3 mg/kg/2 Weeks|Overall Study||0
8548565|NCT02847637|9580666|FG000|Completed 24 Weeks Emicizumab Treatment|Overall Study|Participants started on 24 weeks No Prophylaxis first before switching to emicizumab.|1
8548566|NCT02847637|9580667|FG001|Completed 24 Weeks Emicizumab Treatment|Overall Study||35
8548567|NCT02847637|9580668|FG002|Completed 24 Weeks Emicizumab Treatment|Overall Study||34
8548568|NCT02847637|9580669|FG003|Completed 24 Weeks Emicizumab Treatment|Overall Study||58
8548569|NCT02847637|9580666|FG000|COMPLETED|Overall Study||1
8548570|NCT02847637|9580667|FG001|COMPLETED|Overall Study||1
8548571|NCT02847637|9580668|FG002|COMPLETED|Overall Study||0
8548572|NCT02847637|9580669|FG003|COMPLETED|Overall Study||0
8548573|NCT02847637|9580666|FG000|NOT COMPLETED|Overall Study||17
8548574|NCT02847637|9580667|FG001|NOT COMPLETED|Overall Study||35
8548575|NCT02847637|9580668|FG002|NOT COMPLETED|Overall Study||35
8548576|NCT02847637|9580669|FG003|NOT COMPLETED|Overall Study||63
8548589|NCT02763579|9580710|FG000|STARTED|Overall Study||201
8548590|NCT02763579|9580711|FG001|STARTED|Overall Study||202
8548591|NCT02763579|9580710|FG000|COMPLETED|Overall Study||0
8548592|NCT02763579|9580711|FG001|COMPLETED|Overall Study||0
8548593|NCT02763579|9580710|FG000|NOT COMPLETED|Overall Study||201
8548594|NCT02763579|9580711|FG001|NOT COMPLETED|Overall Study||202
8548595|NCT02762708|9580721|FG000|STARTED|Study 1 - RYGB vs Caloric Restriction||3
8548596|NCT02762708|9580722|FG001|STARTED|Study 1 - RYGB vs Caloric Restriction||9
8548597|NCT02762708|9580723|FG002|STARTED|Study 1 - RYGB vs Caloric Restriction||0
8548598|NCT02762708|9580724|FG003|STARTED|Study 1 - RYGB vs Caloric Restriction||0
8548599|NCT02762708|9580721|FG000|COMPLETED|Study 1 - RYGB vs Caloric Restriction||3
8548600|NCT02762708|9580722|FG001|COMPLETED|Study 1 - RYGB vs Caloric Restriction||7
8548601|NCT02762708|9580723|FG002|COMPLETED|Study 1 - RYGB vs Caloric Restriction||0
8548602|NCT02762708|9580724|FG003|COMPLETED|Study 1 - RYGB vs Caloric Restriction||0
8548603|NCT02762708|9580721|FG000|NOT COMPLETED|Study 1 - RYGB vs Caloric Restriction||0
8548604|NCT02762708|9580722|FG001|NOT COMPLETED|Study 1 - RYGB vs Caloric Restriction||2
8548605|NCT02762708|9580723|FG002|NOT COMPLETED|Study 1 - RYGB vs Caloric Restriction||0
8548606|NCT02762708|9580724|FG003|NOT COMPLETED|Study 1 - RYGB vs Caloric Restriction||0
8548607|NCT02762708|9580721|FG000|STARTED|Study 2 - Exendin (9,39) Amide Study||0
8548608|NCT02762708|9580722|FG001|STARTED|Study 2 - Exendin (9,39) Amide Study||0
8548609|NCT02762708|9580723|FG002|STARTED|Study 2 - Exendin (9,39) Amide Study||1
8548610|NCT02762708|9580724|FG003|STARTED|Study 2 - Exendin (9,39) Amide Study||0
8548611|NCT02762708|9580721|FG000|COMPLETED|Study 2 - Exendin (9,39) Amide Study||0
8548612|NCT02762708|9580722|FG001|COMPLETED|Study 2 - Exendin (9,39) Amide Study||0
8548613|NCT02762708|9580723|FG002|COMPLETED|Study 2 - Exendin (9,39) Amide Study||1
8548614|NCT02762708|9580724|FG003|COMPLETED|Study 2 - Exendin (9,39) Amide Study||0
8548615|NCT02762708|9580721|FG000|NOT COMPLETED|Study 2 - Exendin (9,39) Amide Study||0
8548616|NCT02762708|9580722|FG001|NOT COMPLETED|Study 2 - Exendin (9,39) Amide Study||0
8548617|NCT02762708|9580723|FG002|NOT COMPLETED|Study 2 - Exendin (9,39) Amide Study||0
8548618|NCT02762708|9580724|FG003|NOT COMPLETED|Study 2 - Exendin (9,39) Amide Study||0
8548619|NCT02743494|9580736|FG000|STARTED|Pre-treatment Period||532
8548620|NCT02743494|9580737|FG001|STARTED|Pre-treatment Period||262
8548621|NCT02743494|9580736|FG000|COMPLETED|Pre-treatment Period||532
8548622|NCT02743494|9580737|FG001|COMPLETED|Pre-treatment Period||260
8548623|NCT02743494|9580736|FG000|NOT COMPLETED|Pre-treatment Period||0
8548624|NCT02743494|9580737|FG001|NOT COMPLETED|Pre-treatment Period||2
8548625|NCT02743494|9580736|FG000|STARTED|Treatment Period||532
8548626|NCT02743494|9580737|FG001|STARTED|Treatment Period||260
8548627|NCT02743494|9580736|FG000|COMPLETED|Treatment Period||31
8548628|NCT02743494|9580737|FG001|COMPLETED|Treatment Period||19
8548629|NCT02743494|9580736|FG000|NOT COMPLETED|Treatment Period||501
8548630|NCT02743494|9580737|FG001|NOT COMPLETED|Treatment Period||241
8548631|NCT02741570|9580745|FG000|STARTED|Pre-Treatment Period||472
8548632|NCT02741570|9580746|FG001|STARTED|Pre-Treatment Period||475
8548633|NCT02741570|9580745|FG000|COMPLETED|Pre-Treatment Period||468
8548634|NCT02741570|9580746|FG001|COMPLETED|Pre-Treatment Period||441
8548635|NCT02741570|9580745|FG000|NOT COMPLETED|Pre-Treatment Period||4
8548636|NCT02741570|9580746|FG001|NOT COMPLETED|Pre-Treatment Period||34
8548637|NCT02741570|9580745|FG000|STARTED|Treatment Period||468
8548638|NCT02741570|9580746|FG001|STARTED|Treatment Period||441
8548639|NCT02741570|9580745|FG000|COMPLETED|Treatment Period||0
8548640|NCT02741570|9580746|FG001|COMPLETED|Treatment Period||7
8548641|NCT02741570|9580745|FG000|NOT COMPLETED|Treatment Period||468
8548642|NCT02741570|9580746|FG001|NOT COMPLETED|Treatment Period||434
8548643|NCT02720952|9580752|FG000|STARTED|Overall Study||24
8548644|NCT02720952|9580752|FG000|COMPLETED|Overall Study||24
8548645|NCT02720952|9580752|FG000|NOT COMPLETED|Overall Study||0
8548646|NCT02677896|9580762|FG000|STARTED|Double Blind Period (up to 35 Months)||574
8548647|NCT02677896|9580763|FG001|STARTED|Double Blind Period (up to 35 Months)||576
8548648|NCT02677896|9580762|FG000|Treated|Double Blind Period (up to 35 Months)||572
8548649|NCT02677896|9580763|FG001|Treated|Double Blind Period (up to 35 Months)||574
8548650|NCT02677896|9580762|FG000|COMPLETED|Double Blind Period (up to 35 Months)||0
8548651|NCT02677896|9580763|FG001|COMPLETED|Double Blind Period (up to 35 Months)||0
8548652|NCT02677896|9580762|FG000|NOT COMPLETED|Double Blind Period (up to 35 Months)||574
8548653|NCT02677896|9580763|FG001|NOT COMPLETED|Double Blind Period (up to 35 Months)||576
8548654|NCT02677896|9580762|FG000|STARTED|Open-Label Extension (up to 25 Months)|Eligible participants who provided consent took part in open-label period|365
8548655|NCT02677896|9580763|FG001|STARTED|Open-Label Extension (up to 25 Months)|Eligible participants who provided consent took part in open-label period|180
8548656|NCT02677896|9580762|FG000|COMPLETED|Open-Label Extension (up to 25 Months)||0
8548657|NCT02677896|9580763|FG001|COMPLETED|Open-Label Extension (up to 25 Months)||0
8548658|NCT02677896|9580762|FG000|NOT COMPLETED|Open-Label Extension (up to 25 Months)||365
8548659|NCT02677896|9580763|FG001|NOT COMPLETED|Open-Label Extension (up to 25 Months)||180
8548660|NCT02667587|9580772|FG000|STARTED|Pre-Treatment||358
8548661|NCT02667587|9580773|FG001|STARTED|Pre-Treatment||358
8548662|NCT02667587|9580772|FG000|COMPLETED|Pre-Treatment||354
8548663|NCT02667587|9580773|FG001|COMPLETED|Pre-Treatment||355
8548664|NCT02667587|9580772|FG000|NOT COMPLETED|Pre-Treatment||4
8548665|NCT02667587|9580773|FG001|NOT COMPLETED|Pre-Treatment||3
8548666|NCT02667587|9580772|FG000|STARTED|End of Treatment|1 participant was randomized to Radiotherapy, Temozolomide plus Placebo but received Radiotherapy, Temozolomide plus Nivolumab.|355
8548667|NCT02667587|9580773|FG001|STARTED|End of Treatment|1 participant was randomized to Radiotherapy, Temozolomide plus Placebo but received Radiotherapy, Temozolomide plus Nivolumab.|354
8548668|NCT02667587|9580772|FG000|COMPLETED|End of Treatment||37
8548669|NCT02667587|9580773|FG001|COMPLETED|End of Treatment||44
8548670|NCT02667587|9580772|FG000|NOT COMPLETED|End of Treatment||318
8548671|NCT02667587|9580773|FG001|NOT COMPLETED|End of Treatment||310
8548672|NCT02621606|9580782|FG000|STARTED|Overall Study||3
8548673|NCT02621606|9580783|FG001|STARTED|Overall Study||7
8548674|NCT02621606|9580784|FG002|STARTED|Overall Study||10
8548675|NCT02621606|9580782|FG000|Treated|Overall Study||3
8548676|NCT02621606|9580783|FG001|Treated|Overall Study||7
8548677|NCT02621606|9580784|FG002|Treated|Overall Study||10
8548678|NCT02621606|9580782|FG000|COMPLETED|Overall Study||3
8548679|NCT02621606|9580783|FG001|COMPLETED|Overall Study||6
8548680|NCT02621606|9580784|FG002|COMPLETED|Overall Study||10
8548681|NCT02621606|9580782|FG000|NOT COMPLETED|Overall Study||0
8548682|NCT02621606|9580783|FG001|NOT COMPLETED|Overall Study||1
8548683|NCT02621606|9580784|FG002|NOT COMPLETED|Overall Study||0
8548684|NCT02613507|9580794|FG000|STARTED|Overall Study||338
8548685|NCT02613507|9580795|FG001|STARTED|Overall Study||166
8548686|NCT02613507|9580794|FG000|COMPLETED|Overall Study||50
8548687|NCT02613507|9580795|FG001|COMPLETED|Overall Study||2
8548688|NCT02613507|9580794|FG000|NOT COMPLETED|Overall Study||288
8548689|NCT02613507|9580795|FG001|NOT COMPLETED|Overall Study||164
8548690|NCT02568566|9580801|FG000|STARTED|Overall Study||201
8548691|NCT02568566|9580801|FG000|COMPLETED|Overall Study||187
8548692|NCT02568566|9580801|FG000|NOT COMPLETED|Overall Study||14
8548693|NCT02557945|9580807|FG000|STARTED|Overall Study||3
8548694|NCT02557945|9580808|FG001|STARTED|Overall Study||3
8548695|NCT02557945|9580807|FG000|COMPLETED|Overall Study||3
8548696|NCT02557945|9580808|FG001|COMPLETED|Overall Study||3
8548697|NCT02557945|9580807|FG000|NOT COMPLETED|Overall Study||0
8548698|NCT02557945|9580808|FG001|NOT COMPLETED|Overall Study||0
8548699|NCT02553915|9580818|FG000|STARTED|Overall Study||15
8548700|NCT02553915|9580819|FG001|STARTED|Overall Study||15
8548701|NCT02553915|9580820|FG002|STARTED|Overall Study||15
8548702|NCT02553915|9580821|FG003|STARTED|Overall Study||16
8548703|NCT02553915|9580818|FG000|COMPLETED|Overall Study||11
8548704|NCT02553915|9580819|FG001|COMPLETED|Overall Study||14
8548705|NCT02553915|9580820|FG002|COMPLETED|Overall Study||12
8548706|NCT02553915|9580821|FG003|COMPLETED|Overall Study||13
8548707|NCT02553915|9580818|FG000|NOT COMPLETED|Overall Study||4
8548708|NCT02553915|9580819|FG001|NOT COMPLETED|Overall Study||1
8548709|NCT02553915|9580820|FG002|NOT COMPLETED|Overall Study||3
8548710|NCT02553915|9580821|FG003|NOT COMPLETED|Overall Study||3
8548711|NCT02550873|9580833|FG000|STARTED|Randomized Double Blind||78
8548712|NCT02550873|9580834|FG001|STARTED|Randomized Double Blind||39
8548713|NCT02550873|9580835|FG002|STARTED|Randomized Double Blind||0
8548714|NCT02550873|9580833|FG000|Received Treatment|Randomized Double Blind||77
8548715|NCT02550873|9580834|FG001|Received Treatment|Randomized Double Blind||39
8548716|NCT02550873|9580835|FG002|Received Treatment|Randomized Double Blind||0
8548717|NCT02550873|9580833|FG000|Continue to Open Label Extension|Randomized Double Blind||74
8548718|NCT02550873|9580834|FG001|Continue to Open Label Extension|Randomized Double Blind||37
8548719|NCT02550873|9580835|FG002|Continue to Open Label Extension|Randomized Double Blind||0
8548720|NCT02550873|9580833|FG000|COMPLETED|Randomized Double Blind||74
8548721|NCT02550873|9580834|FG001|COMPLETED|Randomized Double Blind||37
8548722|NCT02550873|9580835|FG002|COMPLETED|Randomized Double Blind||0
8548723|NCT02550873|9580833|FG000|NOT COMPLETED|Randomized Double Blind||4
8548724|NCT02550873|9580834|FG001|NOT COMPLETED|Randomized Double Blind||2
8548725|NCT02550873|9580835|FG002|NOT COMPLETED|Randomized Double Blind||0
8548726|NCT02550873|9580833|FG000|STARTED|Open Label Extension||0
8548727|NCT02550873|9580834|FG001|STARTED|Open Label Extension||0
8548728|NCT02550873|9580835|FG002|STARTED|Open Label Extension||111
8548729|NCT02550873|9580833|FG000|COMPLETED|Open Label Extension||0
8548730|NCT02550873|9580834|FG001|COMPLETED|Open Label Extension||0
8548731|NCT02550873|9580835|FG002|COMPLETED|Open Label Extension|Open Label extension is ongoing|0
8548732|NCT02550873|9580833|FG000|NOT COMPLETED|Open Label Extension||0
8548733|NCT02550873|9580834|FG001|NOT COMPLETED|Open Label Extension||0
8548734|NCT02550873|9580835|FG002|NOT COMPLETED|Open Label Extension||111
8548735|NCT02542267|9580857|FG000|STARTED|Overall Study||108
8548736|NCT02542267|9580857|FG000|COMPLETED|Overall Study||53
8548737|NCT02542267|9580857|FG000|NOT COMPLETED|Overall Study||55
8548738|NCT02500797|9580869|FG000|STARTED|Overall Study||43
8548739|NCT02500797|9580870|FG001|STARTED|Overall Study||42
8548740|NCT02500797|9580871|FG002|STARTED|Overall Study||15
8548741|NCT02500797|9580872|FG003|STARTED|Overall Study||14
8548742|NCT02500797|9580873|FG004|STARTED|Overall Study||14
8548743|NCT02500797|9580874|FG005|STARTED|Overall Study||15
8548744|NCT02500797|9580875|FG006|STARTED|Overall Study||10
8548745|NCT02500797|9580876|FG007|STARTED|Overall Study||11
8548746|NCT02500797|9580869|FG000|Arm I Crossover|Overall Study||4
8548747|NCT02500797|9580870|FG001|Arm I Crossover|Overall Study||0
8548748|NCT02500797|9580871|FG002|Arm I Crossover|Overall Study||6
8548749|NCT02500797|9580872|FG003|Arm I Crossover|Overall Study||0
8548750|NCT02500797|9580873|FG004|Arm I Crossover|Overall Study||1
8548751|NCT02500797|9580874|FG005|Arm I Crossover|Overall Study||0
8548752|NCT02500797|9580875|FG006|Arm I Crossover|Overall Study||2
8548753|NCT02500797|9580876|FG007|Arm I Crossover|Overall Study||0
8548754|NCT02500797|9580869|FG000|COMPLETED|Overall Study||42
8548755|NCT02500797|9580870|FG001|COMPLETED|Overall Study||42
8548756|NCT02500797|9580871|FG002|COMPLETED|Overall Study||15
8548757|NCT02500797|9580872|FG003|COMPLETED|Overall Study||14
8548758|NCT02500797|9580873|FG004|COMPLETED|Overall Study||13
8548759|NCT02500797|9580874|FG005|COMPLETED|Overall Study||14
8548760|NCT02500797|9580875|FG006|COMPLETED|Overall Study||10
8548761|NCT02500797|9580876|FG007|COMPLETED|Overall Study||11
8548762|NCT02500797|9580869|FG000|NOT COMPLETED|Overall Study||1
8548763|NCT02500797|9580870|FG001|NOT COMPLETED|Overall Study||0
8548764|NCT02500797|9580871|FG002|NOT COMPLETED|Overall Study||0
8548765|NCT02500797|9580872|FG003|NOT COMPLETED|Overall Study||0
8548766|NCT02500797|9580873|FG004|NOT COMPLETED|Overall Study||1
8548767|NCT02500797|9580874|FG005|NOT COMPLETED|Overall Study||1
8548768|NCT02500797|9580875|FG006|NOT COMPLETED|Overall Study||0
8548769|NCT02500797|9580876|FG007|NOT COMPLETED|Overall Study||0
8548770|NCT02483585|9580903|FG000|STARTED|Double-blind Treatment Phase||291
8548771|NCT02483585|9580904|FG001|STARTED|Double-blind Treatment Phase||286
8548772|NCT02483585|9580903|FG000|Received Treatment|Double-blind Treatment Phase||289
8548773|NCT02483585|9580904|FG001|Received Treatment|Double-blind Treatment Phase||283
8548774|NCT02483585|9580903|FG000|COMPLETED|Double-blind Treatment Phase||275
8548775|NCT02483585|9580904|FG001|COMPLETED|Double-blind Treatment Phase||271
8548776|NCT02483585|9580903|FG000|NOT COMPLETED|Double-blind Treatment Phase||16
8548777|NCT02483585|9580904|FG001|NOT COMPLETED|Double-blind Treatment Phase||15
8548778|NCT02483585|9580903|FG000|STARTED|Open-label Treatment Phase|Five participants who completed the double-blind phase did not enter the open-label treatment phase|270
8548779|NCT02483585|9580904|FG001|STARTED|Open-label Treatment Phase|Three participants who completed the double-blind phase did not enter the open-label treatment phase|268
8548780|NCT02483585|9580903|FG000|COMPLETED|Open-label Treatment Phase||243
8548781|NCT02483585|9580904|FG001|COMPLETED|Open-label Treatment Phase||243
8548782|NCT02483585|9580903|FG000|NOT COMPLETED|Open-label Treatment Phase||27
8548783|NCT02483585|9580904|FG001|NOT COMPLETED|Open-label Treatment Phase||25
8548784|NCT02462603|9580914|FG000|STARTED|Overall Study||44
8548785|NCT02462603|9580914|FG000|Received at Least 1 Dose of Study Drug|Overall Study||41
8548786|NCT02462603|9580914|FG000|EITT Population|Overall Study||40
8548787|NCT02462603|9580914|FG000|COMPLETED|Overall Study||40
8548788|NCT02462603|9580914|FG000|NOT COMPLETED|Overall Study||4
8548789|NCT02456740|9580921|FG000|STARTED|Double-blind Treatment Phase (24 Weeks)||319
8548790|NCT02456740|9580922|FG001|STARTED|Double-blind Treatment Phase (24 Weeks)||317
8548791|NCT02456740|9580923|FG002|STARTED|Double-blind Treatment Phase (24 Weeks)||319
8548792|NCT02456740|9580924|FG003|STARTED|Double-blind Treatment Phase (24 Weeks)||0
8548793|NCT02456740|9580925|FG004|STARTED|Double-blind Treatment Phase (24 Weeks)||0
8818392|NCT01557348|9872050|FG001|NOT COMPLETED|Overall Study||90
8818393|NCT01557400|9872057|FG000|STARTED|Overall Study||94
8818394|NCT01557400|9872057|FG000|Received at Least 1 Dose of Study Drug|Overall Study||94
8548794|NCT02456740|9580926|FG005|STARTED|Double-blind Treatment Phase (24 Weeks)||0
8621577|NCT00481676|9660594|FG000|NOT COMPLETED|Overall Study||2
8621578|NCT00481676|9660595|FG001|NOT COMPLETED|Overall Study||5
8621579|NCT00481767|9660603|FG000|STARTED|Overall Study||450
8548795|NCT02456740|9580927|FG006|STARTED|Double-blind Treatment Phase (24 Weeks)||0
8548796|NCT02456740|9580928|FG007|STARTED|Double-blind Treatment Phase (24 Weeks)||0
8548797|NCT02456740|9580929|FG008|STARTED|Double-blind Treatment Phase (24 Weeks)||0
8548798|NCT02456740|9580921|FG000|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||319
8548799|NCT02456740|9580922|FG001|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||314
8548800|NCT02456740|9580923|FG002|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||319
8548801|NCT02456740|9580924|FG003|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
8548802|NCT02456740|9580925|FG004|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
8548803|NCT02456740|9580926|FG005|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
8548804|NCT02456740|9580927|FG006|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
8548805|NCT02456740|9580928|FG007|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
8548806|NCT02456740|9580929|FG008|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
8548807|NCT02456740|9580921|FG000|COMPLETED|Double-blind Treatment Phase (24 Weeks)||282
8548808|NCT02456740|9580922|FG001|COMPLETED|Double-blind Treatment Phase (24 Weeks)||284
8548809|NCT02456740|9580923|FG002|COMPLETED|Double-blind Treatment Phase (24 Weeks)||292
8548810|NCT02456740|9580924|FG003|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
8548811|NCT02456740|9580925|FG004|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
8548812|NCT02456740|9580926|FG005|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
8548813|NCT02456740|9580927|FG006|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
8548814|NCT02456740|9580928|FG007|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
8548815|NCT02456740|9580929|FG008|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
8548816|NCT02456740|9580921|FG000|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||37
8548817|NCT02456740|9580922|FG001|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||33
8548818|NCT02456740|9580923|FG002|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||27
8548819|NCT02456740|9580924|FG003|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
8548820|NCT02456740|9580925|FG004|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
8548821|NCT02456740|9580926|FG005|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
8548822|NCT02456740|9580927|FG006|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
8548823|NCT02456740|9580928|FG007|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
8548824|NCT02456740|9580929|FG008|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
8548825|NCT02456740|9580921|FG000|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
8548826|NCT02456740|9580922|FG001|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
8548827|NCT02456740|9580923|FG002|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
8548828|NCT02456740|9580924|FG003|STARTED|Active Treatment Phase (Weeks 24 - 52)||138
8548829|NCT02456740|9580925|FG004|STARTED|Active Treatment Phase (Weeks 24 - 52)||140
8548830|NCT02456740|9580926|FG005|STARTED|Active Treatment Phase (Weeks 24 - 52)||143
8548831|NCT02456740|9580927|FG006|STARTED|Active Treatment Phase (Weeks 24 - 52)||140
8548832|NCT02456740|9580928|FG007|STARTED|Active Treatment Phase (Weeks 24 - 52)||140
8548833|NCT02456740|9580929|FG008|STARTED|Active Treatment Phase (Weeks 24 - 52)||144
8548834|NCT02456740|9580921|FG000|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
8548835|NCT02456740|9580922|FG001|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
8548836|NCT02456740|9580923|FG002|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
8548837|NCT02456740|9580924|FG003|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||124
8548838|NCT02456740|9580925|FG004|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||123
8548839|NCT02456740|9580926|FG005|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||130
8548840|NCT02456740|9580927|FG006|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||131
8548841|NCT02456740|9580928|FG007|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||128
8548842|NCT02456740|9580929|FG008|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||126
8548843|NCT02456740|9580921|FG000|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
8548844|NCT02456740|9580922|FG001|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
8548845|NCT02456740|9580923|FG002|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
8621580|NCT00481767|9660604|FG001|STARTED|Overall Study||226
8621581|NCT00481767|9660603|FG000|COMPLETED|Overall Study||418
8621582|NCT00481767|9660604|FG001|COMPLETED|Overall Study||205
8621583|NCT00481767|9660603|FG000|NOT COMPLETED|Overall Study||32
8818395|NCT01557400|9872057|FG000|COMPLETED|Overall Study||37
8548846|NCT02456740|9580924|FG003|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||14
8548847|NCT02456740|9580925|FG004|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||17
8548848|NCT02456740|9580926|FG005|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||13
8548849|NCT02456740|9580927|FG006|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||9
8548850|NCT02456740|9580928|FG007|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||12
8548851|NCT02456740|9580929|FG008|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||18
8567592|NCT00086619|9599900|FG001|Completed Baseline Visit|Overall Study||36
8567593|NCT00086619|9599899|FG000|Completed 12 Month Visit|Overall Study||26
8567594|NCT00086619|9599900|FG001|Completed 12 Month Visit|Overall Study||26
8567595|NCT00086619|9599899|FG000|COMPLETED|Overall Study||25
8567596|NCT00086619|9599900|FG001|COMPLETED|Overall Study||23
8567597|NCT00086619|9599899|FG000|NOT COMPLETED|Overall Study||15
8567598|NCT00086619|9599900|FG001|NOT COMPLETED|Overall Study||17
8567599|NCT00086684|9599909|FG000|STARTED|Overall Study||118
8567600|NCT00086684|9599910|FG001|STARTED|Overall Study||129
8567601|NCT00086684|9599911|FG002|STARTED|Overall Study||122
8567602|NCT00086684|9599909|FG000|COMPLETED|Overall Study||63
8567603|NCT00086684|9599910|FG001|COMPLETED|Overall Study||74
8567604|NCT00086684|9599911|FG002|COMPLETED|Overall Study||69
8567605|NCT00086684|9599909|FG000|NOT COMPLETED|Overall Study||55
8818396|NCT01557400|9872057|FG000|NOT COMPLETED|Overall Study||57
8818397|NCT01557452|9872061|FG000|STARTED|Overall Study||1
8818398|NCT01557452|9872061|FG000|COMPLETED|Overall Study||1
8818399|NCT01557452|9872061|FG000|NOT COMPLETED|Overall Study||0
8818400|NCT01557504|9872068|FG000|STARTED|Overall Study||13
8818401|NCT01557504|9872069|FG001|STARTED|Overall Study||12
8818402|NCT01557504|9872068|FG000|COMPLETED|Overall Study||12
8818403|NCT01557504|9872069|FG001|COMPLETED|Overall Study||12
8818404|NCT01557504|9872068|FG000|NOT COMPLETED|Overall Study||1
8818405|NCT01557504|9872069|FG001|NOT COMPLETED|Overall Study||0
8818406|NCT01557517|9872083|FG000|STARTED|Overall Study||19
8818407|NCT01557517|9872084|FG001|STARTED|Overall Study||21
8818408|NCT01557517|9872083|FG000|COMPLETED|Overall Study||17
8818409|NCT01557517|9872084|FG001|COMPLETED|Overall Study||17
8818410|NCT01557517|9872083|FG000|NOT COMPLETED|Overall Study||2
8818411|NCT01557517|9872084|FG001|NOT COMPLETED|Overall Study||4
8818412|NCT01557569|9872099|FG000|STARTED|Overall Study|Those who received at least one dose of medication|6
8818413|NCT01557569|9872100|FG001|STARTED|Overall Study|Those who received at least one dose of medication|7
8818414|NCT01557569|9872099|FG000|Completed 2-wk Residential Stay|Overall Study||3
8818415|NCT01557569|9872100|FG001|Completed 2-wk Residential Stay|Overall Study||1
8818416|NCT01557569|9872099|FG000|COMPLETED|Overall Study||1
8818417|NCT01557569|9872100|FG001|COMPLETED|Overall Study||0
8818418|NCT01557569|9872099|FG000|NOT COMPLETED|Overall Study||5
8818419|NCT01557569|9872100|FG001|NOT COMPLETED|Overall Study||7
8818420|NCT01557582|9872106|FG000|STARTED|Overall Study||103
8818421|NCT01557582|9872106|FG000|COMPLETED|Overall Study||97
8818422|NCT01557582|9872106|FG000|NOT COMPLETED|Overall Study||6
8818423|NCT01557595|9872110|FG000|STARTED|Overall Study||22
8818424|NCT01557595|9872110|FG000|COMPLETED|Overall Study||14
8818425|NCT01557595|9872110|FG000|NOT COMPLETED|Overall Study||8
8818426|NCT01557699|9872117|FG000|STARTED|Overall Study||20
8818427|NCT01557699|9872118|FG001|STARTED|Overall Study||20
8818428|NCT01557699|9872119|FG002|STARTED|Overall Study||20
8818429|NCT01557699|9872117|FG000|COMPLETED|Overall Study||20
8818430|NCT01557699|9872118|FG001|COMPLETED|Overall Study||20
8818431|NCT01557699|9872119|FG002|COMPLETED|Overall Study||20
8818432|NCT01557699|9872117|FG000|NOT COMPLETED|Overall Study||0
8818433|NCT01557699|9872118|FG001|NOT COMPLETED|Overall Study||0
8818434|NCT01557699|9872119|FG002|NOT COMPLETED|Overall Study||0
8818435|NCT01557790|9872130|FG000|STARTED|Overall Study||5
8818436|NCT01557790|9872130|FG000|COMPLETED|Overall Study||4
8818437|NCT01557790|9872130|FG000|NOT COMPLETED|Overall Study||1
8818438|NCT01557842|9872136|FG000|STARTED|Overall Study||9
8818439|NCT01557842|9872137|FG001|STARTED|Overall Study||6
8818440|NCT01557842|9872136|FG000|COMPLETED|Overall Study||0
8818441|NCT01557842|9872137|FG001|COMPLETED|Overall Study||0
8818442|NCT01557842|9872136|FG000|NOT COMPLETED|Overall Study||9
8818443|NCT01557842|9872137|FG001|NOT COMPLETED|Overall Study||6
8818444|NCT01557868|9872145|FG000|STARTED|Overall Study||103
8818445|NCT01557868|9872146|FG001|STARTED|Overall Study||95
8818446|NCT01557868|9872145|FG000|COMPLETED|Overall Study||76
8818447|NCT01557868|9872146|FG001|COMPLETED|Overall Study||65
8818448|NCT01557868|9872145|FG000|NOT COMPLETED|Overall Study||27
8818449|NCT01557868|9872146|FG001|NOT COMPLETED|Overall Study||30
8818450|NCT01557894|9872154|FG000|STARTED|Overall Study||38
8818451|NCT01557894|9872155|FG001|STARTED|Overall Study||38
8818452|NCT01557894|9872154|FG000|COMPLETED|Overall Study||35
8818453|NCT01557894|9872155|FG001|COMPLETED|Overall Study||33
8818454|NCT01557894|9872154|FG000|NOT COMPLETED|Overall Study||3
8818455|NCT01557894|9872155|FG001|NOT COMPLETED|Overall Study||5
8818456|NCT01557920|9872162|FG000|STARTED|Overall Study||9
8818457|NCT01557920|9872163|FG001|STARTED|Overall Study||9
8818458|NCT01557920|9872162|FG000|COMPLETED|Overall Study||6
8818459|NCT01557920|9872163|FG001|COMPLETED|Overall Study||6
8818460|NCT01557920|9872162|FG000|NOT COMPLETED|Overall Study||3
8567606|NCT00086684|9599910|FG001|NOT COMPLETED|Overall Study||55
8818461|NCT01557920|9872163|FG001|NOT COMPLETED|Overall Study||3
8818462|NCT01557946|9872198|FG000|STARTED|Overall Study||20
8818463|NCT01557946|9872199|FG001|STARTED|Overall Study||12
8548852|NCT02438410|9580939|FG000|STARTED|Overall Study||13
8548853|NCT02438410|9580939|FG000|COMPLETED|Overall Study||13
8548854|NCT02438410|9580939|FG000|NOT COMPLETED|Overall Study||0
8548855|NCT02428192|9580945|FG000|STARTED|Overall Study||12
8621584|NCT00481767|9660604|FG001|NOT COMPLETED|Overall Study||21
8621585|NCT00481832|9660610|FG000|STARTED|Enrollment||50
8621586|NCT00481832|9660610|FG000|COMPLETED|Enrollment||40
8621587|NCT00481832|9660610|FG000|NOT COMPLETED|Enrollment||10
8621588|NCT00481832|9660610|FG000|STARTED|Autologous Hematopoietic Cell Transplant||40
8621589|NCT00481832|9660610|FG000|COMPLETED|Autologous Hematopoietic Cell Transplant||40
8548856|NCT02428192|9580946|FG001|STARTED|Overall Study||8
8548857|NCT02428192|9580945|FG000|COMPLETED|Overall Study||0
8548858|NCT02428192|9580946|FG001|COMPLETED|Overall Study||7
8548859|NCT02428192|9580945|FG000|NOT COMPLETED|Overall Study||12
8548860|NCT02428192|9580946|FG001|NOT COMPLETED|Overall Study||1
8548861|NCT02420717|9580956|FG000|STARTED|Overall Study||5
8621590|NCT00481832|9660610|FG000|NOT COMPLETED|Autologous Hematopoietic Cell Transplant||0
8621591|NCT00481832|9660610|FG000|STARTED|Inter-transplant Period||40
8621592|NCT00481832|9660610|FG000|COMPLETED|Inter-transplant Period||13
8621593|NCT00481832|9660610|FG000|NOT COMPLETED|Inter-transplant Period||27
8621594|NCT00481832|9660610|FG000|STARTED|Allogenic Hematopoietic Cell Transplant||13
8621595|NCT00481832|9660610|FG000|COMPLETED|Allogenic Hematopoietic Cell Transplant||13
8548862|NCT02420717|9580957|FG001|STARTED|Overall Study||3
8548863|NCT02420717|9580958|FG002|STARTED|Overall Study||3
8548864|NCT02420717|9580956|FG000|COMPLETED|Overall Study||3
8548865|NCT02420717|9580957|FG001|COMPLETED|Overall Study||3
8548866|NCT02420717|9580958|FG002|COMPLETED|Overall Study||3
8548867|NCT02420717|9580956|FG000|NOT COMPLETED|Overall Study||2
8548868|NCT02420717|9580957|FG001|NOT COMPLETED|Overall Study||0
8548869|NCT02420717|9580958|FG002|NOT COMPLETED|Overall Study||0
8548870|NCT02408068|9580966|FG000|STARTED|Treatment 1 (1.5 Days)||3
8548871|NCT02408068|9580967|FG001|STARTED|Treatment 1 (1.5 Days)||3
8548872|NCT02408068|9580968|FG002|STARTED|Treatment 1 (1.5 Days)||3
8548873|NCT02408068|9580969|FG003|STARTED|Treatment 1 (1.5 Days)||3
8548874|NCT02408068|9580970|FG004|STARTED|Treatment 1 (1.5 Days)||3
8548875|NCT02408068|9580971|FG005|STARTED|Treatment 1 (1.5 Days)||3
8548876|NCT02408068|9580966|FG000|COMPLETED|Treatment 1 (1.5 Days)||3
8548877|NCT02408068|9580967|FG001|COMPLETED|Treatment 1 (1.5 Days)||3
8548878|NCT02408068|9580968|FG002|COMPLETED|Treatment 1 (1.5 Days)||3
8548879|NCT02408068|9580969|FG003|COMPLETED|Treatment 1 (1.5 Days)||3
8548880|NCT02408068|9580970|FG004|COMPLETED|Treatment 1 (1.5 Days)||3
8548881|NCT02408068|9580971|FG005|COMPLETED|Treatment 1 (1.5 Days)||3
8548882|NCT02408068|9580966|FG000|NOT COMPLETED|Treatment 1 (1.5 Days)||0
8548883|NCT02408068|9580967|FG001|NOT COMPLETED|Treatment 1 (1.5 Days)||0
8548884|NCT02408068|9580968|FG002|NOT COMPLETED|Treatment 1 (1.5 Days)||0
8548885|NCT02408068|9580969|FG003|NOT COMPLETED|Treatment 1 (1.5 Days)||0
8548886|NCT02408068|9580970|FG004|NOT COMPLETED|Treatment 1 (1.5 Days)||0
8548887|NCT02408068|9580971|FG005|NOT COMPLETED|Treatment 1 (1.5 Days)||0
8548888|NCT02408068|9580966|FG000|STARTED|Washout Period 1 (7 Days)||3
8548889|NCT02408068|9580967|FG001|STARTED|Washout Period 1 (7 Days)||3
8548890|NCT02408068|9580968|FG002|STARTED|Washout Period 1 (7 Days)||3
8548891|NCT02408068|9580969|FG003|STARTED|Washout Period 1 (7 Days)||3
8548892|NCT02408068|9580970|FG004|STARTED|Washout Period 1 (7 Days)||3
8548893|NCT02408068|9580971|FG005|STARTED|Washout Period 1 (7 Days)||3
8548894|NCT02408068|9580966|FG000|COMPLETED|Washout Period 1 (7 Days)||3
8548895|NCT02408068|9580967|FG001|COMPLETED|Washout Period 1 (7 Days)||3
8548896|NCT02408068|9580968|FG002|COMPLETED|Washout Period 1 (7 Days)||3
8548897|NCT02408068|9580969|FG003|COMPLETED|Washout Period 1 (7 Days)||3
8621596|NCT00481832|9660610|FG000|NOT COMPLETED|Allogenic Hematopoietic Cell Transplant||0
8621597|NCT00481845|9660616|FG000|STARTED|Overall Study||1
8621598|NCT00481845|9660617|FG001|STARTED|Overall Study||0
8621599|NCT00481845|9660616|FG000|COMPLETED|Overall Study||1
8548898|NCT02408068|9580970|FG004|COMPLETED|Washout Period 1 (7 Days)||3
8548899|NCT02408068|9580971|FG005|COMPLETED|Washout Period 1 (7 Days)||3
8548900|NCT02408068|9580966|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
8548901|NCT02408068|9580967|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
8548902|NCT02408068|9580968|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
8548903|NCT02408068|9580969|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
8548904|NCT02408068|9580970|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||0
8548905|NCT02408068|9580971|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||0
8548906|NCT02408068|9580966|FG000|STARTED|Treatment 2 (1.5 Days)||3
8548907|NCT02408068|9580967|FG001|STARTED|Treatment 2 (1.5 Days)||3
8548908|NCT02408068|9580968|FG002|STARTED|Treatment 2 (1.5 Days)||3
8548909|NCT02408068|9580969|FG003|STARTED|Treatment 2 (1.5 Days)||3
8621600|NCT00481845|9660617|FG001|COMPLETED|Overall Study||0
8621601|NCT00481845|9660616|FG000|NOT COMPLETED|Overall Study||0
8548910|NCT02408068|9580970|FG004|STARTED|Treatment 2 (1.5 Days)||3
8548911|NCT02408068|9580971|FG005|STARTED|Treatment 2 (1.5 Days)||3
8548912|NCT02408068|9580966|FG000|COMPLETED|Treatment 2 (1.5 Days)||3
8548913|NCT02408068|9580967|FG001|COMPLETED|Treatment 2 (1.5 Days)||3
8548914|NCT02408068|9580968|FG002|COMPLETED|Treatment 2 (1.5 Days)||3
8548915|NCT02408068|9580969|FG003|COMPLETED|Treatment 2 (1.5 Days)||3
8548916|NCT02408068|9580970|FG004|COMPLETED|Treatment 2 (1.5 Days)||3
8548917|NCT02408068|9580971|FG005|COMPLETED|Treatment 2 (1.5 Days)||3
8548918|NCT02408068|9580966|FG000|NOT COMPLETED|Treatment 2 (1.5 Days)||0
8548919|NCT02408068|9580967|FG001|NOT COMPLETED|Treatment 2 (1.5 Days)||0
8548920|NCT02408068|9580968|FG002|NOT COMPLETED|Treatment 2 (1.5 Days)||0
8548921|NCT02408068|9580969|FG003|NOT COMPLETED|Treatment 2 (1.5 Days)||0
8548922|NCT02408068|9580970|FG004|NOT COMPLETED|Treatment 2 (1.5 Days)||0
8548923|NCT02408068|9580971|FG005|NOT COMPLETED|Treatment 2 (1.5 Days)||0
8548924|NCT02408068|9580966|FG000|STARTED|Washout Period 2 (7 Days)||3
8548925|NCT02408068|9580967|FG001|STARTED|Washout Period 2 (7 Days)||3
8548926|NCT02408068|9580968|FG002|STARTED|Washout Period 2 (7 Days)||3
8548927|NCT02408068|9580969|FG003|STARTED|Washout Period 2 (7 Days)||3
8548928|NCT02408068|9580970|FG004|STARTED|Washout Period 2 (7 Days)||3
8548929|NCT02408068|9580971|FG005|STARTED|Washout Period 2 (7 Days)||3
8548930|NCT02408068|9580966|FG000|COMPLETED|Washout Period 2 (7 Days)||3
8548931|NCT02408068|9580967|FG001|COMPLETED|Washout Period 2 (7 Days)||3
8548932|NCT02408068|9580968|FG002|COMPLETED|Washout Period 2 (7 Days)||3
8548933|NCT02408068|9580969|FG003|COMPLETED|Washout Period 2 (7 Days)||3
8548934|NCT02408068|9580970|FG004|COMPLETED|Washout Period 2 (7 Days)||3
8548935|NCT02408068|9580971|FG005|COMPLETED|Washout Period 2 (7 Days)||3
8548936|NCT02408068|9580966|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
8548937|NCT02408068|9580967|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
8548938|NCT02408068|9580968|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
8548939|NCT02408068|9580969|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
8548940|NCT02408068|9580970|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0
8548941|NCT02408068|9580971|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0
8548942|NCT02408068|9580966|FG000|STARTED|Treatment 3 (1.5 Days)||3
8548943|NCT02408068|9580967|FG001|STARTED|Treatment 3 (1.5 Days)||3
8548944|NCT02408068|9580968|FG002|STARTED|Treatment 3 (1.5 Days)||3
8548945|NCT02408068|9580969|FG003|STARTED|Treatment 3 (1.5 Days)||3
8548946|NCT02408068|9580970|FG004|STARTED|Treatment 3 (1.5 Days)||3
8548947|NCT02408068|9580971|FG005|STARTED|Treatment 3 (1.5 Days)||3
8548948|NCT02408068|9580966|FG000|COMPLETED|Treatment 3 (1.5 Days)||3
8548949|NCT02408068|9580967|FG001|COMPLETED|Treatment 3 (1.5 Days)||3
8548950|NCT02408068|9580968|FG002|COMPLETED|Treatment 3 (1.5 Days)||2
8548951|NCT02408068|9580969|FG003|COMPLETED|Treatment 3 (1.5 Days)||3
8548952|NCT02408068|9580970|FG004|COMPLETED|Treatment 3 (1.5 Days)||3
8548953|NCT02408068|9580971|FG005|COMPLETED|Treatment 3 (1.5 Days)||3
8548954|NCT02408068|9580966|FG000|NOT COMPLETED|Treatment 3 (1.5 Days)||0
8548955|NCT02408068|9580967|FG001|NOT COMPLETED|Treatment 3 (1.5 Days)||0
8548956|NCT02408068|9580968|FG002|NOT COMPLETED|Treatment 3 (1.5 Days)||1
8548957|NCT02408068|9580969|FG003|NOT COMPLETED|Treatment 3 (1.5 Days)||0
8548958|NCT02408068|9580970|FG004|NOT COMPLETED|Treatment 3 (1.5 Days)||0
8548959|NCT02408068|9580971|FG005|NOT COMPLETED|Treatment 3 (1.5 Days)||0
8548960|NCT02315703|9580990|FG000|STARTED|Overall Study||50
8548961|NCT02315703|9580991|FG001|STARTED|Overall Study||49
8548962|NCT02315703|9580992|FG002|STARTED|Overall Study||49
8548963|NCT02315703|9580993|FG003|STARTED|Overall Study||48
8548964|NCT02315703|9580994|FG004|STARTED|Overall Study||49
8548965|NCT02315703|9580995|FG005|STARTED|Overall Study||49
8548966|NCT02315703|9580996|FG006|STARTED|Overall Study||50
8548967|NCT02315703|9580997|FG007|STARTED|Overall Study||49
8548968|NCT02315703|9580990|FG000|COMPLETED|Overall Study||44
8548969|NCT02315703|9580991|FG001|COMPLETED|Overall Study||39
8548970|NCT02315703|9580992|FG002|COMPLETED|Overall Study||44
8548971|NCT02315703|9580993|FG003|COMPLETED|Overall Study||39
8548972|NCT02315703|9580994|FG004|COMPLETED|Overall Study||41
8548973|NCT02315703|9580995|FG005|COMPLETED|Overall Study||43
8548974|NCT02315703|9580996|FG006|COMPLETED|Overall Study||37
8548975|NCT02315703|9580997|FG007|COMPLETED|Overall Study||42
8548976|NCT02315703|9580990|FG000|NOT COMPLETED|Overall Study||6
8548977|NCT02315703|9580991|FG001|NOT COMPLETED|Overall Study||10
8548978|NCT02315703|9580992|FG002|NOT COMPLETED|Overall Study||5
8548979|NCT02315703|9580993|FG003|NOT COMPLETED|Overall Study||9
8548980|NCT02315703|9580994|FG004|NOT COMPLETED|Overall Study||8
8548981|NCT02315703|9580995|FG005|NOT COMPLETED|Overall Study||6
8548982|NCT02315703|9580996|FG006|NOT COMPLETED|Overall Study||13
8548983|NCT02315703|9580997|FG007|NOT COMPLETED|Overall Study||7
8818464|NCT01557946|9872198|FG000|COMPLETED|Overall Study|20 consented and scanned - 1 subject's data not used due to ongoing neurological condition.|17
8548984|NCT02288247|9581015|FG000|STARTED|Period 1: OL Treatment (Max: 315 Weeks)||688
8548985|NCT02288247|9581016|FG001|STARTED|Period 1: OL Treatment (Max: 315 Weeks)||0
8548986|NCT02288247|9581015|FG000|Treated|Period 1: OL Treatment (Max: 315 Weeks)||687
8548987|NCT02288247|9581016|FG001|Treated|Period 1: OL Treatment (Max: 315 Weeks)||0
8548988|NCT02288247|9581015|FG000|COMPLETED|Period 1: OL Treatment (Max: 315 Weeks)||41
8548989|NCT02288247|9581016|FG001|COMPLETED|Period 1: OL Treatment (Max: 315 Weeks)||0
8548990|NCT02288247|9581015|FG000|NOT COMPLETED|Period 1: OL Treatment (Max: 315 Weeks)||647
8548991|NCT02288247|9581016|FG001|NOT COMPLETED|Period 1: OL Treatment (Max: 315 Weeks)||0
8548992|NCT02288247|9581015|FG000|STARTED|Period 2: DB Treatment (Max: 180 Weeks)|137 participants from period 1 were randomized to period 2.|137
8548993|NCT02288247|9581016|FG001|STARTED|Period 2: DB Treatment (Max: 180 Weeks)|136 participants from period 1 were randomized to period 2.|136
8548994|NCT02288247|9581015|FG000|Treated|Period 2: DB Treatment (Max: 180 Weeks)||136
8548995|NCT02288247|9581016|FG001|Treated|Period 2: DB Treatment (Max: 180 Weeks)||135
8548996|NCT02288247|9581015|FG000|COMPLETED|Period 2: DB Treatment (Max: 180 Weeks)||1
8548997|NCT02288247|9581016|FG001|COMPLETED|Period 2: DB Treatment (Max: 180 Weeks)||1
8548998|NCT02288247|9581015|FG000|NOT COMPLETED|Period 2: DB Treatment (Max: 180 Weeks)||136
8548999|NCT02288247|9581016|FG001|NOT COMPLETED|Period 2: DB Treatment (Max: 180 Weeks)||135
8549000|NCT02181413|9581026|FG000|STARTED|Overall Study||261
8549001|NCT02181413|9581027|FG001|STARTED|Overall Study||395
8549002|NCT02181413|9581026|FG000|Intent-to-Treat (ITT) Population|Overall Study||261
8549003|NCT02181413|9581027|FG001|Intent-to-Treat (ITT) Population|Overall Study||395
8549004|NCT02181413|9581026|FG000|Safety Population|Overall Study||259
8549005|NCT02181413|9581027|FG001|Safety Population|Overall Study||394
8549006|NCT02181413|9581026|FG000|Per Protocol (PP) Population|Overall Study||256
8723091|NCT01021748|9770614|FG003|STARTED|Overall Study||7
8723092|NCT01021748|9770615|FG004|STARTED|Overall Study||9
8723093|NCT01021748|9770616|FG005|STARTED|Overall Study||3
8723094|NCT01021748|9770617|FG006|STARTED|Overall Study||3
8723095|NCT01021748|9770618|FG007|STARTED|Overall Study||6
8723096|NCT01021748|9770619|FG008|STARTED|Overall Study||17
8723097|NCT01021748|9770611|FG000|Treated|Overall Study||6
8549007|NCT02181413|9581027|FG001|Per Protocol (PP) Population|Overall Study||387
8549008|NCT02181413|9581026|FG000|COMPLETED|Overall Study||109
8549009|NCT02181413|9581027|FG001|COMPLETED|Overall Study||198
8549010|NCT02181413|9581026|FG000|NOT COMPLETED|Overall Study||152
8549011|NCT02181413|9581027|FG001|NOT COMPLETED|Overall Study||197
8549012|NCT02174861|9581033|FG000|STARTED|Overall Study||609
8549013|NCT02174861|9581033|FG000|Enrolled in CHU Substudy|Overall Study||53
8549014|NCT02174861|9581033|FG000|COMPLETED|Overall Study||451
8549015|NCT02174861|9581033|FG000|NOT COMPLETED|Overall Study||158
8549016|NCT02052739|9581041|FG000|STARTED|Overall Study||19
8549017|NCT02052739|9581042|FG001|STARTED|Overall Study||6
8549018|NCT02052739|9581041|FG000|COMPLETED|Overall Study||14
8549019|NCT02052739|9581042|FG001|COMPLETED|Overall Study||5
8549020|NCT02052739|9581041|FG000|NOT COMPLETED|Overall Study||5
8549021|NCT02052739|9581042|FG001|NOT COMPLETED|Overall Study||1
8549022|NCT01958021|9581052|FG000|STARTED|Overall Study||334
8549023|NCT01958021|9581053|FG001|STARTED|Overall Study||334
8549024|NCT01958021|9581052|FG000|Patients Untreated|Overall Study||0
8549025|NCT01958021|9581053|FG001|Patients Untreated|Overall Study||4
8549026|NCT01958021|9581052|FG000|Patients Treated|Overall Study||334
8549027|NCT01958021|9581053|FG001|Patients Treated|Overall Study||330
8549028|NCT01958021|9581052|FG000|COMPLETED|Overall Study|Completed = Treatment ongoing|195
8549029|NCT01958021|9581053|FG001|COMPLETED|Overall Study|Completed = Treatment ongoing|154
8549030|NCT01958021|9581052|FG000|NOT COMPLETED|Overall Study||139
8549031|NCT01958021|9581053|FG001|NOT COMPLETED|Overall Study||180
8549032|NCT01944020|9581061|FG000|STARTED|Overall Study||17
8549033|NCT01944020|9581062|FG001|STARTED|Overall Study||12
8549034|NCT01944020|9581061|FG000|COMPLETED|Overall Study||12
8549035|NCT01944020|9581062|FG001|COMPLETED|Overall Study||12
8549036|NCT01944020|9581061|FG000|NOT COMPLETED|Overall Study||5
8549037|NCT01944020|9581062|FG001|NOT COMPLETED|Overall Study||0
8549038|NCT01935934|9581070|FG000|STARTED|Overall Study||70
8549039|NCT01935934|9581071|FG001|STARTED|Overall Study||32
8549040|NCT01935934|9581070|FG000|COMPLETED|Overall Study||70
8549041|NCT01935934|9581071|FG001|COMPLETED|Overall Study||32
8549042|NCT01935934|9581070|FG000|NOT COMPLETED|Overall Study||0
8549043|NCT01935934|9581071|FG001|NOT COMPLETED|Overall Study||0
8549044|NCT01920932|9581080|FG000|STARTED|Overall Study||77
8549045|NCT01920932|9581080|FG000|COMPLETED|Overall Study||75
8549046|NCT01920932|9581080|FG000|NOT COMPLETED|Overall Study||2
8549047|NCT01844505|9581104|FG000|STARTED|Overall Study||313
8549048|NCT01844505|9581105|FG001|STARTED|Overall Study||313
8549049|NCT01844505|9581106|FG002|STARTED|Overall Study||311
8549050|NCT01844505|9581104|FG000|COMPLETED|Overall Study|Completed = Number of subjects continuing in the treatment period|64
8549051|NCT01844505|9581105|FG001|COMPLETED|Overall Study|Completed = Number of subjects continuing in the treatment period|44
8549052|NCT01844505|9581106|FG002|COMPLETED|Overall Study|Completed = Number of subjects continuing in the treatment period|16
8549053|NCT01844505|9581104|FG000|NOT COMPLETED|Overall Study||249
8549054|NCT01844505|9581105|FG001|NOT COMPLETED|Overall Study||269
8549055|NCT01844505|9581106|FG002|NOT COMPLETED|Overall Study||295
8549056|NCT01689519|9581116|FG000|STARTED|Intent to Treat||247
8549057|NCT01689519|9581117|FG001|STARTED|Intent to Treat||248
8549058|NCT01689519|9581116|FG000|COMPLETED|Intent to Treat||0
8549059|NCT01689519|9581117|FG001|COMPLETED|Intent to Treat||0
8549060|NCT01689519|9581116|FG000|NOT COMPLETED|Intent to Treat||247
8549061|NCT01689519|9581117|FG001|NOT COMPLETED|Intent to Treat||248
8549062|NCT01689519|9581116|FG000|STARTED|Safety Population||248
8549063|NCT01689519|9581117|FG001|STARTED|Safety Population||245
8549064|NCT01689519|9581116|FG000|COMPLETED|Safety Population||0
8549065|NCT01689519|9581117|FG001|COMPLETED|Safety Population||0
8549066|NCT01689519|9581116|FG000|NOT COMPLETED|Safety Population||248
8549067|NCT01689519|9581117|FG001|NOT COMPLETED|Safety Population||245
8549068|NCT01622088|9581123|FG000|STARTED|Overall Study||616
8549069|NCT01622088|9581123|FG000|COMPLETED|Overall Study||0
8549070|NCT01622088|9581123|FG000|NOT COMPLETED|Overall Study||616
8567607|NCT00086684|9599911|FG002|NOT COMPLETED|Overall Study||53
8567608|NCT00086957|9599919|FG000|STARTED|Overall Study||2
8567609|NCT00086957|9599920|FG001|STARTED|Overall Study||7
8567610|NCT00086957|9599921|FG002|STARTED|Overall Study||22
8567611|NCT00086957|9599919|FG000|COMPLETED|Overall Study||2
8567612|NCT00086957|9599920|FG001|COMPLETED|Overall Study||7
8567613|NCT00086957|9599921|FG002|COMPLETED|Overall Study||22
8567614|NCT00086957|9599919|FG000|NOT COMPLETED|Overall Study||0
8567615|NCT00086957|9599920|FG001|NOT COMPLETED|Overall Study||0
8567616|NCT00086957|9599921|FG002|NOT COMPLETED|Overall Study||0
8723098|NCT01021748|9770612|FG001|Treated|Overall Study|One participant was allocated, but not treated.|4
8549071|NCT01486264|9581130|FG000|STARTED|Overall Study||142
8549072|NCT01486264|9581131|FG001|STARTED|Overall Study||141
8549073|NCT01486264|9581130|FG000|Treated|Overall Study||142
8549074|NCT01486264|9581131|FG001|Treated|Overall Study||140
8549075|NCT01486264|9581130|FG000|COMPLETED|Overall Study||113
8549076|NCT01486264|9581131|FG001|COMPLETED|Overall Study||94
8549077|NCT01486264|9581130|FG000|NOT COMPLETED|Overall Study||29
8549078|NCT01486264|9581131|FG001|NOT COMPLETED|Overall Study||47
8549079|NCT01419080|9581137|FG000|STARTED|Overall Study||797
8549080|NCT01419080|9581137|FG000|COMPLETED|Overall Study||666
8549081|NCT01419080|9581137|FG000|NOT COMPLETED|Overall Study||131
8549082|NCT01317160|9581145|FG000|STARTED|Overall Study||75
8549083|NCT01317160|9581146|FG001|STARTED|Overall Study||75
8549084|NCT01317160|9581145|FG000|Allocation to Treatment|Overall Study|1 patient was incorrect included|74
8549085|NCT01317160|9581146|FG001|Allocation to Treatment|Overall Study|1 patient was incorrect included|74
8549086|NCT01317160|9581145|FG000|COMPLETED|Overall Study||71
8549087|NCT01317160|9581146|FG001|COMPLETED|Overall Study||69
8549088|NCT01317160|9581145|FG000|NOT COMPLETED|Overall Study||4
8549089|NCT01317160|9581146|FG001|NOT COMPLETED|Overall Study||6
8549090|NCT01256398|9581152|FG000|STARTED|Overall Study||66
8549091|NCT01256398|9581152|FG000|COMPLETED|Overall Study||65
8549092|NCT01256398|9581152|FG000|NOT COMPLETED|Overall Study||1
8549093|NCT01234532|9581156|FG000|STARTED|Overall Study||5
8549094|NCT01234532|9581156|FG000|COMPLETED|Overall Study||5
8549095|NCT01234532|9581156|FG000|NOT COMPLETED|Overall Study||0
8549096|NCT01196390|9581162|FG000|STARTED|Overall Study||102
8549097|NCT01196390|9581163|FG001|STARTED|Overall Study||101
8549098|NCT01196390|9581162|FG000|Eligible|Overall Study||98
8549099|NCT01196390|9581163|FG001|Eligible|Overall Study||96
8549100|NCT01196390|9581162|FG000|Eligible and Started Study Treatment|Overall Study||95
8549101|NCT01196390|9581163|FG001|Eligible and Started Study Treatment|Overall Study||96
8549102|NCT01196390|9581162|FG000|Eligible and Had Surgery|Overall Study||82
8549103|NCT01196390|9581163|FG001|Eligible and Had Surgery|Overall Study||78
8549104|NCT01196390|9581162|FG000|COMPLETED|Overall Study||98
8549105|NCT01196390|9581163|FG001|COMPLETED|Overall Study||96
8549106|NCT01196390|9581162|FG000|NOT COMPLETED|Overall Study||4
8549107|NCT01196390|9581163|FG001|NOT COMPLETED|Overall Study||5
8549108|NCT01154335|9581174|FG000|STARTED|Overall Study||7
8549109|NCT01154335|9581175|FG001|STARTED|Overall Study||6
8549110|NCT01154335|9581176|FG002|STARTED|Overall Study||5
8549111|NCT01154335|9581174|FG000|COMPLETED|Overall Study|Patients continued treatment until disease progression or unacceptable toxicity occurred.|0
8549112|NCT01154335|9581175|FG001|COMPLETED|Overall Study|Patients continued treatment until disease progression or unacceptable toxicity occurred.|0
8549113|NCT01154335|9581176|FG002|COMPLETED|Overall Study|Patients continued treatment until disease progression or unacceptable toxicity occurred.|0
8549114|NCT01154335|9581174|FG000|NOT COMPLETED|Overall Study||7
8549115|NCT01154335|9581175|FG001|NOT COMPLETED|Overall Study||6
8549116|NCT01154335|9581176|FG002|NOT COMPLETED|Overall Study||5
8549117|NCT01145495|9581186|FG000|STARTED|Overall Study||63
8549118|NCT01145495|9581186|FG000|COMPLETED|Overall Study||51
8549119|NCT01145495|9581186|FG000|NOT COMPLETED|Overall Study||12
8549120|NCT01143116|9581192|FG000|STARTED|Overall Study||10
8549121|NCT01143116|9581193|FG001|STARTED|Overall Study||10
8549122|NCT01143116|9581192|FG000|COMPLETED|Overall Study||10
8549123|NCT01143116|9581193|FG001|COMPLETED|Overall Study||10
8549124|NCT01143116|9581192|FG000|NOT COMPLETED|Overall Study||0
8549125|NCT01143116|9581193|FG001|NOT COMPLETED|Overall Study||0
8549126|NCT01116648|9581214|FG000|STARTED|Phase 1 Dose Level 0||3
8549127|NCT01116648|9581215|FG001|STARTED|Phase 1 Dose Level 0||0
8549128|NCT01116648|9581216|FG002|STARTED|Phase 1 Dose Level 0||0
8549129|NCT01116648|9581217|FG003|STARTED|Phase 1 Dose Level 0||0
8549130|NCT01116648|9581218|FG004|STARTED|Phase 1 Dose Level 0||0
8549131|NCT01116648|9581219|FG005|STARTED|Phase 1 Dose Level 0||0
8549132|NCT01116648|9581220|FG006|STARTED|Phase 1 Dose Level 0||0
8549133|NCT01116648|9581221|FG007|STARTED|Phase 1 Dose Level 0||0
8549134|NCT01116648|9581222|FG008|STARTED|Phase 1 Dose Level 0||0
8549135|NCT01116648|9581223|FG009|STARTED|Phase 1 Dose Level 0||0
8549136|NCT01116648|9581224|FG010|STARTED|Phase 1 Dose Level 0||0
8549137|NCT01116648|9581225|FG011|STARTED|Phase 1 Dose Level 0||0
8549138|NCT01116648|9581226|FG012|STARTED|Phase 1 Dose Level 0||0
8549139|NCT01116648|9581227|FG013|STARTED|Phase 1 Dose Level 0||0
8549140|NCT01116648|9581228|FG014|STARTED|Phase 1 Dose Level 0||0
8549141|NCT01116648|9581214|FG000|COMPLETED|Phase 1 Dose Level 0||3
8549142|NCT01116648|9581215|FG001|COMPLETED|Phase 1 Dose Level 0||0
8549143|NCT01116648|9581216|FG002|COMPLETED|Phase 1 Dose Level 0||0
8549144|NCT01116648|9581217|FG003|COMPLETED|Phase 1 Dose Level 0||0
8549145|NCT01116648|9581218|FG004|COMPLETED|Phase 1 Dose Level 0||0
8549146|NCT01116648|9581219|FG005|COMPLETED|Phase 1 Dose Level 0||0
8549147|NCT01116648|9581220|FG006|COMPLETED|Phase 1 Dose Level 0||0
8549148|NCT01116648|9581221|FG007|COMPLETED|Phase 1 Dose Level 0||0
8549149|NCT01116648|9581222|FG008|COMPLETED|Phase 1 Dose Level 0||0
8549150|NCT01116648|9581223|FG009|COMPLETED|Phase 1 Dose Level 0||0
8549151|NCT01116648|9581224|FG010|COMPLETED|Phase 1 Dose Level 0||0
8549152|NCT01116648|9581225|FG011|COMPLETED|Phase 1 Dose Level 0||0
8549153|NCT01116648|9581226|FG012|COMPLETED|Phase 1 Dose Level 0||0
8549154|NCT01116648|9581227|FG013|COMPLETED|Phase 1 Dose Level 0||0
8549155|NCT01116648|9581228|FG014|COMPLETED|Phase 1 Dose Level 0||0
8549156|NCT01116648|9581214|FG000|NOT COMPLETED|Phase 1 Dose Level 0||0
8549157|NCT01116648|9581215|FG001|NOT COMPLETED|Phase 1 Dose Level 0||0
8549158|NCT01116648|9581216|FG002|NOT COMPLETED|Phase 1 Dose Level 0||0
8549159|NCT01116648|9581217|FG003|NOT COMPLETED|Phase 1 Dose Level 0||0
8549160|NCT01116648|9581218|FG004|NOT COMPLETED|Phase 1 Dose Level 0||0
8549161|NCT01116648|9581219|FG005|NOT COMPLETED|Phase 1 Dose Level 0||0
8549162|NCT01116648|9581220|FG006|NOT COMPLETED|Phase 1 Dose Level 0||0
8549163|NCT01116648|9581221|FG007|NOT COMPLETED|Phase 1 Dose Level 0||0
8549164|NCT01116648|9581222|FG008|NOT COMPLETED|Phase 1 Dose Level 0||0
8549165|NCT01116648|9581223|FG009|NOT COMPLETED|Phase 1 Dose Level 0||0
8549166|NCT01116648|9581224|FG010|NOT COMPLETED|Phase 1 Dose Level 0||0
8549167|NCT01116648|9581225|FG011|NOT COMPLETED|Phase 1 Dose Level 0||0
8549168|NCT01116648|9581226|FG012|NOT COMPLETED|Phase 1 Dose Level 0||0
8549169|NCT01116648|9581227|FG013|NOT COMPLETED|Phase 1 Dose Level 0||0
8549170|NCT01116648|9581228|FG014|NOT COMPLETED|Phase 1 Dose Level 0||0
8549171|NCT01116648|9581214|FG000|STARTED|Phase 1 Dose Level 1||0
8549172|NCT01116648|9581215|FG001|STARTED|Phase 1 Dose Level 1||3
8549173|NCT01116648|9581216|FG002|STARTED|Phase 1 Dose Level 1||0
8549174|NCT01116648|9581217|FG003|STARTED|Phase 1 Dose Level 1||0
8549175|NCT01116648|9581218|FG004|STARTED|Phase 1 Dose Level 1||0
8549176|NCT01116648|9581219|FG005|STARTED|Phase 1 Dose Level 1||0
8549177|NCT01116648|9581220|FG006|STARTED|Phase 1 Dose Level 1||0
8549178|NCT01116648|9581221|FG007|STARTED|Phase 1 Dose Level 1||0
8549179|NCT01116648|9581222|FG008|STARTED|Phase 1 Dose Level 1||0
8549180|NCT01116648|9581223|FG009|STARTED|Phase 1 Dose Level 1||0
8549181|NCT01116648|9581224|FG010|STARTED|Phase 1 Dose Level 1||0
8549182|NCT01116648|9581225|FG011|STARTED|Phase 1 Dose Level 1||0
8549183|NCT01116648|9581226|FG012|STARTED|Phase 1 Dose Level 1||0
8549184|NCT01116648|9581227|FG013|STARTED|Phase 1 Dose Level 1||0
8549185|NCT01116648|9581228|FG014|STARTED|Phase 1 Dose Level 1||0
8549186|NCT01116648|9581214|FG000|COMPLETED|Phase 1 Dose Level 1||0
8549187|NCT01116648|9581215|FG001|COMPLETED|Phase 1 Dose Level 1||3
8549188|NCT01116648|9581216|FG002|COMPLETED|Phase 1 Dose Level 1||0
8549189|NCT01116648|9581217|FG003|COMPLETED|Phase 1 Dose Level 1||0
8549190|NCT01116648|9581218|FG004|COMPLETED|Phase 1 Dose Level 1||0
8549191|NCT01116648|9581219|FG005|COMPLETED|Phase 1 Dose Level 1||0
8549192|NCT01116648|9581220|FG006|COMPLETED|Phase 1 Dose Level 1||0
8549193|NCT01116648|9581221|FG007|COMPLETED|Phase 1 Dose Level 1||0
8549194|NCT01116648|9581222|FG008|COMPLETED|Phase 1 Dose Level 1||0
8549195|NCT01116648|9581223|FG009|COMPLETED|Phase 1 Dose Level 1||0
8549196|NCT01116648|9581224|FG010|COMPLETED|Phase 1 Dose Level 1||0
8549197|NCT01116648|9581225|FG011|COMPLETED|Phase 1 Dose Level 1||0
8549198|NCT01116648|9581226|FG012|COMPLETED|Phase 1 Dose Level 1||0
8549199|NCT01116648|9581227|FG013|COMPLETED|Phase 1 Dose Level 1||0
8549200|NCT01116648|9581228|FG014|COMPLETED|Phase 1 Dose Level 1||0
8549201|NCT01116648|9581214|FG000|NOT COMPLETED|Phase 1 Dose Level 1||0
8549202|NCT01116648|9581215|FG001|NOT COMPLETED|Phase 1 Dose Level 1||0
8549203|NCT01116648|9581216|FG002|NOT COMPLETED|Phase 1 Dose Level 1||0
8549204|NCT01116648|9581217|FG003|NOT COMPLETED|Phase 1 Dose Level 1||0
8549205|NCT01116648|9581218|FG004|NOT COMPLETED|Phase 1 Dose Level 1||0
8549206|NCT01116648|9581219|FG005|NOT COMPLETED|Phase 1 Dose Level 1||0
8549207|NCT01116648|9581220|FG006|NOT COMPLETED|Phase 1 Dose Level 1||0
8549208|NCT01116648|9581221|FG007|NOT COMPLETED|Phase 1 Dose Level 1||0
8549209|NCT01116648|9581222|FG008|NOT COMPLETED|Phase 1 Dose Level 1||0
8549210|NCT01116648|9581223|FG009|NOT COMPLETED|Phase 1 Dose Level 1||0
8549211|NCT01116648|9581224|FG010|NOT COMPLETED|Phase 1 Dose Level 1||0
8549212|NCT01116648|9581225|FG011|NOT COMPLETED|Phase 1 Dose Level 1||0
8549213|NCT01116648|9581226|FG012|NOT COMPLETED|Phase 1 Dose Level 1||0
8549214|NCT01116648|9581227|FG013|NOT COMPLETED|Phase 1 Dose Level 1||0
8549215|NCT01116648|9581228|FG014|NOT COMPLETED|Phase 1 Dose Level 1||0
8549216|NCT01116648|9581214|FG000|STARTED|Phase 1 Dose Level 2||0
8549217|NCT01116648|9581215|FG001|STARTED|Phase 1 Dose Level 2||0
8549218|NCT01116648|9581216|FG002|STARTED|Phase 1 Dose Level 2||7
8549219|NCT01116648|9581217|FG003|STARTED|Phase 1 Dose Level 2||0
8549220|NCT01116648|9581218|FG004|STARTED|Phase 1 Dose Level 2||0
8549221|NCT01116648|9581219|FG005|STARTED|Phase 1 Dose Level 2||0
8549222|NCT01116648|9581220|FG006|STARTED|Phase 1 Dose Level 2||0
8549223|NCT01116648|9581221|FG007|STARTED|Phase 1 Dose Level 2||0
8549224|NCT01116648|9581222|FG008|STARTED|Phase 1 Dose Level 2||0
8549225|NCT01116648|9581223|FG009|STARTED|Phase 1 Dose Level 2||0
8549226|NCT01116648|9581224|FG010|STARTED|Phase 1 Dose Level 2||0
8549227|NCT01116648|9581225|FG011|STARTED|Phase 1 Dose Level 2||0
8549228|NCT01116648|9581226|FG012|STARTED|Phase 1 Dose Level 2||0
8549229|NCT01116648|9581227|FG013|STARTED|Phase 1 Dose Level 2||0
8549230|NCT01116648|9581228|FG014|STARTED|Phase 1 Dose Level 2||0
8549231|NCT01116648|9581214|FG000|COMPLETED|Phase 1 Dose Level 2||0
8549232|NCT01116648|9581215|FG001|COMPLETED|Phase 1 Dose Level 2||0
8549233|NCT01116648|9581216|FG002|COMPLETED|Phase 1 Dose Level 2||7
8549234|NCT01116648|9581217|FG003|COMPLETED|Phase 1 Dose Level 2||0
8549235|NCT01116648|9581218|FG004|COMPLETED|Phase 1 Dose Level 2||0
8549236|NCT01116648|9581219|FG005|COMPLETED|Phase 1 Dose Level 2||0
8549237|NCT01116648|9581220|FG006|COMPLETED|Phase 1 Dose Level 2||0
8549238|NCT01116648|9581221|FG007|COMPLETED|Phase 1 Dose Level 2||0
8549239|NCT01116648|9581222|FG008|COMPLETED|Phase 1 Dose Level 2||0
8549240|NCT01116648|9581223|FG009|COMPLETED|Phase 1 Dose Level 2||0
8549241|NCT01116648|9581224|FG010|COMPLETED|Phase 1 Dose Level 2||0
8549242|NCT01116648|9581225|FG011|COMPLETED|Phase 1 Dose Level 2||0
8549243|NCT01116648|9581226|FG012|COMPLETED|Phase 1 Dose Level 2||0
8549244|NCT01116648|9581227|FG013|COMPLETED|Phase 1 Dose Level 2||0
8549245|NCT01116648|9581228|FG014|COMPLETED|Phase 1 Dose Level 2||0
8549246|NCT01116648|9581214|FG000|NOT COMPLETED|Phase 1 Dose Level 2||0
8549247|NCT01116648|9581215|FG001|NOT COMPLETED|Phase 1 Dose Level 2||0
8549248|NCT01116648|9581216|FG002|NOT COMPLETED|Phase 1 Dose Level 2||0
8549249|NCT01116648|9581217|FG003|NOT COMPLETED|Phase 1 Dose Level 2||0
8549250|NCT01116648|9581218|FG004|NOT COMPLETED|Phase 1 Dose Level 2||0
8549251|NCT01116648|9581219|FG005|NOT COMPLETED|Phase 1 Dose Level 2||0
8549252|NCT01116648|9581220|FG006|NOT COMPLETED|Phase 1 Dose Level 2||0
8549253|NCT01116648|9581221|FG007|NOT COMPLETED|Phase 1 Dose Level 2||0
8549254|NCT01116648|9581222|FG008|NOT COMPLETED|Phase 1 Dose Level 2||0
8549255|NCT01116648|9581223|FG009|NOT COMPLETED|Phase 1 Dose Level 2||0
8549256|NCT01116648|9581224|FG010|NOT COMPLETED|Phase 1 Dose Level 2||0
8549257|NCT01116648|9581225|FG011|NOT COMPLETED|Phase 1 Dose Level 2||0
8549258|NCT01116648|9581226|FG012|NOT COMPLETED|Phase 1 Dose Level 2||0
8549259|NCT01116648|9581227|FG013|NOT COMPLETED|Phase 1 Dose Level 2||0
8549260|NCT01116648|9581228|FG014|NOT COMPLETED|Phase 1 Dose Level 2||0
8549261|NCT01116648|9581214|FG000|STARTED|Phase 1 Dose Level 3||0
8549262|NCT01116648|9581215|FG001|STARTED|Phase 1 Dose Level 3||0
8549263|NCT01116648|9581216|FG002|STARTED|Phase 1 Dose Level 3||0
8549264|NCT01116648|9581217|FG003|STARTED|Phase 1 Dose Level 3||6
8549265|NCT01116648|9581218|FG004|STARTED|Phase 1 Dose Level 3||0
8549266|NCT01116648|9581219|FG005|STARTED|Phase 1 Dose Level 3||0
8549267|NCT01116648|9581220|FG006|STARTED|Phase 1 Dose Level 3||0
8549268|NCT01116648|9581221|FG007|STARTED|Phase 1 Dose Level 3||0
8549269|NCT01116648|9581222|FG008|STARTED|Phase 1 Dose Level 3||0
8549270|NCT01116648|9581223|FG009|STARTED|Phase 1 Dose Level 3||0
8549271|NCT01116648|9581224|FG010|STARTED|Phase 1 Dose Level 3||0
8549272|NCT01116648|9581225|FG011|STARTED|Phase 1 Dose Level 3||0
8549273|NCT01116648|9581226|FG012|STARTED|Phase 1 Dose Level 3||0
8549274|NCT01116648|9581227|FG013|STARTED|Phase 1 Dose Level 3||0
8549275|NCT01116648|9581228|FG014|STARTED|Phase 1 Dose Level 3||0
8549276|NCT01116648|9581214|FG000|COMPLETED|Phase 1 Dose Level 3||0
8549277|NCT01116648|9581215|FG001|COMPLETED|Phase 1 Dose Level 3||0
8549278|NCT01116648|9581216|FG002|COMPLETED|Phase 1 Dose Level 3||0
8549279|NCT01116648|9581217|FG003|COMPLETED|Phase 1 Dose Level 3||4
8549280|NCT01116648|9581218|FG004|COMPLETED|Phase 1 Dose Level 3||0
8549281|NCT01116648|9581219|FG005|COMPLETED|Phase 1 Dose Level 3||0
8549282|NCT01116648|9581220|FG006|COMPLETED|Phase 1 Dose Level 3||0
8549283|NCT01116648|9581221|FG007|COMPLETED|Phase 1 Dose Level 3||0
8549284|NCT01116648|9581222|FG008|COMPLETED|Phase 1 Dose Level 3||0
8549285|NCT01116648|9581223|FG009|COMPLETED|Phase 1 Dose Level 3||0
8549286|NCT01116648|9581224|FG010|COMPLETED|Phase 1 Dose Level 3||0
8549287|NCT01116648|9581225|FG011|COMPLETED|Phase 1 Dose Level 3||0
8818465|NCT01557946|9872199|FG001|COMPLETED|Overall Study|2 subjects with unusable imaging data.|12
8818466|NCT01557946|9872198|FG000|NOT COMPLETED|Overall Study||3
8818467|NCT01557946|9872199|FG001|NOT COMPLETED|Overall Study||0
8818468|NCT01557959|9872204|FG000|STARTED|Overall Study||45
8818469|NCT01557959|9872204|FG000|COMPLETED|Overall Study||45
8818470|NCT01557959|9872204|FG000|NOT COMPLETED|Overall Study||0
8549288|NCT01116648|9581226|FG012|COMPLETED|Phase 1 Dose Level 3||0
8549289|NCT01116648|9581227|FG013|COMPLETED|Phase 1 Dose Level 3||0
8549290|NCT01116648|9581228|FG014|COMPLETED|Phase 1 Dose Level 3||0
8549291|NCT01116648|9581214|FG000|NOT COMPLETED|Phase 1 Dose Level 3||0
8549292|NCT01116648|9581215|FG001|NOT COMPLETED|Phase 1 Dose Level 3||0
8549293|NCT01116648|9581216|FG002|NOT COMPLETED|Phase 1 Dose Level 3||0
8549294|NCT01116648|9581217|FG003|NOT COMPLETED|Phase 1 Dose Level 3||2
8549295|NCT01116648|9581218|FG004|NOT COMPLETED|Phase 1 Dose Level 3||0
8549296|NCT01116648|9581219|FG005|NOT COMPLETED|Phase 1 Dose Level 3||0
8549297|NCT01116648|9581220|FG006|NOT COMPLETED|Phase 1 Dose Level 3||0
8549298|NCT01116648|9581221|FG007|NOT COMPLETED|Phase 1 Dose Level 3||0
8549299|NCT01116648|9581222|FG008|NOT COMPLETED|Phase 1 Dose Level 3||0
8549300|NCT01116648|9581223|FG009|NOT COMPLETED|Phase 1 Dose Level 3||0
8549301|NCT01116648|9581224|FG010|NOT COMPLETED|Phase 1 Dose Level 3||0
8549302|NCT01116648|9581225|FG011|NOT COMPLETED|Phase 1 Dose Level 3||0
8549303|NCT01116648|9581226|FG012|NOT COMPLETED|Phase 1 Dose Level 3||0
8549304|NCT01116648|9581227|FG013|NOT COMPLETED|Phase 1 Dose Level 3||0
8549305|NCT01116648|9581228|FG014|NOT COMPLETED|Phase 1 Dose Level 3||0
8549306|NCT01116648|9581214|FG000|STARTED|Expansion at Maximum Tolerated Dose||0
8621602|NCT00481845|9660617|FG001|NOT COMPLETED|Overall Study||0
8621603|NCT00481871|9660628|FG000|STARTED|Overall Study||7
8621604|NCT00481871|9660629|FG001|STARTED|Overall Study||10
8621605|NCT00481871|9660630|FG002|STARTED|Overall Study||18
8818471|NCT01558063|9872216|FG000|STARTED|Overall Study||5
8549307|NCT01116648|9581215|FG001|STARTED|Expansion at Maximum Tolerated Dose||0
8549308|NCT01116648|9581216|FG002|STARTED|Expansion at Maximum Tolerated Dose||0
8549309|NCT01116648|9581217|FG003|STARTED|Expansion at Maximum Tolerated Dose||0
8549310|NCT01116648|9581218|FG004|STARTED|Expansion at Maximum Tolerated Dose||9
8549311|NCT01116648|9581219|FG005|STARTED|Expansion at Maximum Tolerated Dose||0
8549312|NCT01116648|9581220|FG006|STARTED|Expansion at Maximum Tolerated Dose||0
8621606|NCT00481871|9660631|FG003|STARTED|Overall Study||38
8621607|NCT00481871|9660632|FG004|STARTED|Overall Study||34
8818472|NCT01558063|9872217|FG001|STARTED|Overall Study||6
8549313|NCT01116648|9581221|FG007|STARTED|Expansion at Maximum Tolerated Dose||0
8549314|NCT01116648|9581222|FG008|STARTED|Expansion at Maximum Tolerated Dose||0
8549315|NCT01116648|9581223|FG009|STARTED|Expansion at Maximum Tolerated Dose||0
8549316|NCT01116648|9581224|FG010|STARTED|Expansion at Maximum Tolerated Dose||0
8549317|NCT01116648|9581225|FG011|STARTED|Expansion at Maximum Tolerated Dose||0
8549318|NCT01116648|9581226|FG012|STARTED|Expansion at Maximum Tolerated Dose||0
8549319|NCT01116648|9581227|FG013|STARTED|Expansion at Maximum Tolerated Dose||0
8549320|NCT01116648|9581228|FG014|STARTED|Expansion at Maximum Tolerated Dose||0
8549321|NCT01116648|9581214|FG000|COMPLETED|Expansion at Maximum Tolerated Dose||0
8549322|NCT01116648|9581215|FG001|COMPLETED|Expansion at Maximum Tolerated Dose||0
8549323|NCT01116648|9581216|FG002|COMPLETED|Expansion at Maximum Tolerated Dose||0
8549324|NCT01116648|9581217|FG003|COMPLETED|Expansion at Maximum Tolerated Dose||0
8549325|NCT01116648|9581218|FG004|COMPLETED|Expansion at Maximum Tolerated Dose||9
8549326|NCT01116648|9581219|FG005|COMPLETED|Expansion at Maximum Tolerated Dose||0
8549327|NCT01116648|9581220|FG006|COMPLETED|Expansion at Maximum Tolerated Dose||0
8549328|NCT01116648|9581221|FG007|COMPLETED|Expansion at Maximum Tolerated Dose||0
8549329|NCT01116648|9581222|FG008|COMPLETED|Expansion at Maximum Tolerated Dose||0
8549330|NCT01116648|9581223|FG009|COMPLETED|Expansion at Maximum Tolerated Dose||0
8549331|NCT01116648|9581224|FG010|COMPLETED|Expansion at Maximum Tolerated Dose||0
8549332|NCT01116648|9581225|FG011|COMPLETED|Expansion at Maximum Tolerated Dose||0
8549333|NCT01116648|9581226|FG012|COMPLETED|Expansion at Maximum Tolerated Dose||0
8549334|NCT01116648|9581227|FG013|COMPLETED|Expansion at Maximum Tolerated Dose||0
8549335|NCT01116648|9581228|FG014|COMPLETED|Expansion at Maximum Tolerated Dose||0
8549336|NCT01116648|9581214|FG000|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
8549337|NCT01116648|9581215|FG001|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
8549338|NCT01116648|9581216|FG002|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
8549339|NCT01116648|9581217|FG003|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
8549340|NCT01116648|9581218|FG004|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
8549341|NCT01116648|9581219|FG005|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
8549342|NCT01116648|9581220|FG006|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
8549343|NCT01116648|9581221|FG007|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
8549344|NCT01116648|9581222|FG008|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
8549345|NCT01116648|9581223|FG009|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
8549346|NCT01116648|9581224|FG010|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
8549347|NCT01116648|9581225|FG011|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
8549348|NCT01116648|9581226|FG012|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
8549349|NCT01116648|9581227|FG013|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
8549350|NCT01116648|9581228|FG014|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
8549351|NCT01116648|9581214|FG000|STARTED|Phase 2||0
8549352|NCT01116648|9581215|FG001|STARTED|Phase 2||0
8549353|NCT01116648|9581216|FG002|STARTED|Phase 2||0
8549354|NCT01116648|9581217|FG003|STARTED|Phase 2||0
8549355|NCT01116648|9581218|FG004|STARTED|Phase 2||0
8549356|NCT01116648|9581219|FG005|STARTED|Phase 2||46
8549357|NCT01116648|9581220|FG006|STARTED|Phase 2||44
8549358|NCT01116648|9581221|FG007|STARTED|Phase 2||0
8549359|NCT01116648|9581222|FG008|STARTED|Phase 2||0
8549360|NCT01116648|9581223|FG009|STARTED|Phase 2||0
8549361|NCT01116648|9581224|FG010|STARTED|Phase 2||0
8549362|NCT01116648|9581225|FG011|STARTED|Phase 2||0
8549363|NCT01116648|9581226|FG012|STARTED|Phase 2||0
8549364|NCT01116648|9581227|FG013|STARTED|Phase 2||0
8549365|NCT01116648|9581228|FG014|STARTED|Phase 2||0
8549366|NCT01116648|9581214|FG000|COMPLETED|Phase 2||0
8549367|NCT01116648|9581215|FG001|COMPLETED|Phase 2||0
8549368|NCT01116648|9581216|FG002|COMPLETED|Phase 2||0
8549369|NCT01116648|9581217|FG003|COMPLETED|Phase 2||0
8549370|NCT01116648|9581218|FG004|COMPLETED|Phase 2||0
8549371|NCT01116648|9581219|FG005|COMPLETED|Phase 2||46
8549372|NCT01116648|9581220|FG006|COMPLETED|Phase 2||44
8549373|NCT01116648|9581221|FG007|COMPLETED|Phase 2||0
8621608|NCT00481871|9660628|FG000|COMPLETED|Overall Study||7
8621609|NCT00481871|9660629|FG001|COMPLETED|Overall Study||10
8621610|NCT00481871|9660630|FG002|COMPLETED|Overall Study||17
8621611|NCT00481871|9660631|FG003|COMPLETED|Overall Study||38
8818473|NCT01558063|9872218|FG002|STARTED|Overall Study||8
8818474|NCT01558063|9872219|FG003|STARTED|Overall Study||5
8818475|NCT01558063|9872220|FG004|STARTED|Overall Study||9
8818476|NCT01558063|9872221|FG005|STARTED|Overall Study||5
8818477|NCT01558063|9872216|FG000|COMPLETED|Overall Study||5
8818478|NCT01558063|9872217|FG001|COMPLETED|Overall Study||6
9065888|NCT04128293|10126437|FG003|STARTED|Treatment Period 1 (1 Day)||4
9065889|NCT04128293|10126434|FG000|COMPLETED|Treatment Period 1 (1 Day)||4
9065890|NCT04128293|10126435|FG001|COMPLETED|Treatment Period 1 (1 Day)||4
9065891|NCT04128293|10126436|FG002|COMPLETED|Treatment Period 1 (1 Day)||4
9065892|NCT04128293|10126437|FG003|COMPLETED|Treatment Period 1 (1 Day)||4
9065893|NCT04128293|10126434|FG000|NOT COMPLETED|Treatment Period 1 (1 Day)||0
8818479|NCT01558063|9872218|FG002|COMPLETED|Overall Study||8
8818480|NCT01558063|9872219|FG003|COMPLETED|Overall Study||5
8818481|NCT01558063|9872220|FG004|COMPLETED|Overall Study||9
8818482|NCT01558063|9872221|FG005|COMPLETED|Overall Study||5
8818483|NCT01558063|9872216|FG000|NOT COMPLETED|Overall Study||0
8549374|NCT01116648|9581222|FG008|COMPLETED|Phase 2||0
8621612|NCT00481871|9660632|FG004|COMPLETED|Overall Study||34
8549375|NCT01116648|9581223|FG009|COMPLETED|Phase 2||0
8818484|NCT01558063|9872217|FG001|NOT COMPLETED|Overall Study||0
8549376|NCT01116648|9581224|FG010|COMPLETED|Phase 2||0
8549377|NCT01116648|9581225|FG011|COMPLETED|Phase 2||0
8549378|NCT01116648|9581226|FG012|COMPLETED|Phase 2||0
8549379|NCT01116648|9581227|FG013|COMPLETED|Phase 2||0
8549380|NCT01116648|9581228|FG014|COMPLETED|Phase 2||0
8549381|NCT01116648|9581214|FG000|NOT COMPLETED|Phase 2||0
8549382|NCT01116648|9581215|FG001|NOT COMPLETED|Phase 2||0
8549383|NCT01116648|9581216|FG002|NOT COMPLETED|Phase 2||0
8549384|NCT01116648|9581217|FG003|NOT COMPLETED|Phase 2||0
8549385|NCT01116648|9581218|FG004|NOT COMPLETED|Phase 2||0
8549386|NCT01116648|9581219|FG005|NOT COMPLETED|Phase 2||0
8549387|NCT01116648|9581220|FG006|NOT COMPLETED|Phase 2||0
8549388|NCT01116648|9581221|FG007|NOT COMPLETED|Phase 2||0
8549389|NCT01116648|9581222|FG008|NOT COMPLETED|Phase 2||0
8549390|NCT01116648|9581223|FG009|NOT COMPLETED|Phase 2||0
8549391|NCT01116648|9581224|FG010|NOT COMPLETED|Phase 2||0
8549392|NCT01116648|9581225|FG011|NOT COMPLETED|Phase 2||0
8549393|NCT01116648|9581226|FG012|NOT COMPLETED|Phase 2||0
8549394|NCT01116648|9581227|FG013|NOT COMPLETED|Phase 2||0
8549395|NCT01116648|9581228|FG014|NOT COMPLETED|Phase 2||0
8549396|NCT01116648|9581214|FG000|STARTED|Phase 1-T Dose Level 0-TA||0
8549397|NCT01116648|9581215|FG001|STARTED|Phase 1-T Dose Level 0-TA||0
8549398|NCT01116648|9581216|FG002|STARTED|Phase 1-T Dose Level 0-TA||0
8549399|NCT01116648|9581217|FG003|STARTED|Phase 1-T Dose Level 0-TA||0
8549400|NCT01116648|9581218|FG004|STARTED|Phase 1-T Dose Level 0-TA||0
8549401|NCT01116648|9581219|FG005|STARTED|Phase 1-T Dose Level 0-TA||0
8549402|NCT01116648|9581220|FG006|STARTED|Phase 1-T Dose Level 0-TA||0
8549403|NCT01116648|9581221|FG007|STARTED|Phase 1-T Dose Level 0-TA||3
8549404|NCT01116648|9581222|FG008|STARTED|Phase 1-T Dose Level 0-TA||0
8549405|NCT01116648|9581223|FG009|STARTED|Phase 1-T Dose Level 0-TA||0
8549406|NCT01116648|9581224|FG010|STARTED|Phase 1-T Dose Level 0-TA||0
8549407|NCT01116648|9581225|FG011|STARTED|Phase 1-T Dose Level 0-TA||0
8549408|NCT01116648|9581226|FG012|STARTED|Phase 1-T Dose Level 0-TA||0
8549409|NCT01116648|9581227|FG013|STARTED|Phase 1-T Dose Level 0-TA||0
8549410|NCT01116648|9581228|FG014|STARTED|Phase 1-T Dose Level 0-TA||0
8549411|NCT01116648|9581214|FG000|COMPLETED|Phase 1-T Dose Level 0-TA||0
8549412|NCT01116648|9581215|FG001|COMPLETED|Phase 1-T Dose Level 0-TA||0
8549413|NCT01116648|9581216|FG002|COMPLETED|Phase 1-T Dose Level 0-TA||0
8549414|NCT01116648|9581217|FG003|COMPLETED|Phase 1-T Dose Level 0-TA||0
8549415|NCT01116648|9581218|FG004|COMPLETED|Phase 1-T Dose Level 0-TA||0
8549416|NCT01116648|9581219|FG005|COMPLETED|Phase 1-T Dose Level 0-TA||0
8549417|NCT01116648|9581220|FG006|COMPLETED|Phase 1-T Dose Level 0-TA||0
8549418|NCT01116648|9581221|FG007|COMPLETED|Phase 1-T Dose Level 0-TA||3
8549419|NCT01116648|9581222|FG008|COMPLETED|Phase 1-T Dose Level 0-TA||0
8549420|NCT01116648|9581223|FG009|COMPLETED|Phase 1-T Dose Level 0-TA||0
8549421|NCT01116648|9581224|FG010|COMPLETED|Phase 1-T Dose Level 0-TA||0
8549422|NCT01116648|9581225|FG011|COMPLETED|Phase 1-T Dose Level 0-TA||0
8549423|NCT01116648|9581226|FG012|COMPLETED|Phase 1-T Dose Level 0-TA||0
8549424|NCT01116648|9581227|FG013|COMPLETED|Phase 1-T Dose Level 0-TA||0
8549425|NCT01116648|9581228|FG014|COMPLETED|Phase 1-T Dose Level 0-TA||0
8549426|NCT01116648|9581214|FG000|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
8549427|NCT01116648|9581215|FG001|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
8549428|NCT01116648|9581216|FG002|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
8549429|NCT01116648|9581217|FG003|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
8549430|NCT01116648|9581218|FG004|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
8549431|NCT01116648|9581219|FG005|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
8549432|NCT01116648|9581220|FG006|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
8549433|NCT01116648|9581221|FG007|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
8549434|NCT01116648|9581222|FG008|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
8549435|NCT01116648|9581223|FG009|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
8549436|NCT01116648|9581224|FG010|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
8549437|NCT01116648|9581225|FG011|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
8549438|NCT01116648|9581226|FG012|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
8549439|NCT01116648|9581227|FG013|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
8549440|NCT01116648|9581228|FG014|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
8549441|NCT01116648|9581214|FG000|STARTED|Phase 1-T Dose Level 1-TA||0
8549442|NCT01116648|9581215|FG001|STARTED|Phase 1-T Dose Level 1-TA||0
8549443|NCT01116648|9581216|FG002|STARTED|Phase 1-T Dose Level 1-TA||0
8549444|NCT01116648|9581217|FG003|STARTED|Phase 1-T Dose Level 1-TA||0
8549445|NCT01116648|9581218|FG004|STARTED|Phase 1-T Dose Level 1-TA||0
8549446|NCT01116648|9581219|FG005|STARTED|Phase 1-T Dose Level 1-TA||0
8549447|NCT01116648|9581220|FG006|STARTED|Phase 1-T Dose Level 1-TA||0
8549448|NCT01116648|9581221|FG007|STARTED|Phase 1-T Dose Level 1-TA||0
8549449|NCT01116648|9581222|FG008|STARTED|Phase 1-T Dose Level 1-TA||6
8549450|NCT01116648|9581223|FG009|STARTED|Phase 1-T Dose Level 1-TA||0
8549451|NCT01116648|9581224|FG010|STARTED|Phase 1-T Dose Level 1-TA||0
8549452|NCT01116648|9581225|FG011|STARTED|Phase 1-T Dose Level 1-TA||0
8549453|NCT01116648|9581226|FG012|STARTED|Phase 1-T Dose Level 1-TA||0
8549454|NCT01116648|9581227|FG013|STARTED|Phase 1-T Dose Level 1-TA||0
8549455|NCT01116648|9581228|FG014|STARTED|Phase 1-T Dose Level 1-TA||0
8549456|NCT01116648|9581214|FG000|COMPLETED|Phase 1-T Dose Level 1-TA||0
8549457|NCT01116648|9581215|FG001|COMPLETED|Phase 1-T Dose Level 1-TA||0
8549458|NCT01116648|9581216|FG002|COMPLETED|Phase 1-T Dose Level 1-TA||0
8549459|NCT01116648|9581217|FG003|COMPLETED|Phase 1-T Dose Level 1-TA||0
8549460|NCT01116648|9581218|FG004|COMPLETED|Phase 1-T Dose Level 1-TA||0
8549461|NCT01116648|9581219|FG005|COMPLETED|Phase 1-T Dose Level 1-TA||0
8549462|NCT01116648|9581220|FG006|COMPLETED|Phase 1-T Dose Level 1-TA||0
8549463|NCT01116648|9581221|FG007|COMPLETED|Phase 1-T Dose Level 1-TA||0
8549464|NCT01116648|9581222|FG008|COMPLETED|Phase 1-T Dose Level 1-TA||6
8549465|NCT01116648|9581223|FG009|COMPLETED|Phase 1-T Dose Level 1-TA||0
8549466|NCT01116648|9581224|FG010|COMPLETED|Phase 1-T Dose Level 1-TA||0
8549467|NCT01116648|9581225|FG011|COMPLETED|Phase 1-T Dose Level 1-TA||0
8549468|NCT01116648|9581226|FG012|COMPLETED|Phase 1-T Dose Level 1-TA||0
8549469|NCT01116648|9581227|FG013|COMPLETED|Phase 1-T Dose Level 1-TA||0
8549470|NCT01116648|9581228|FG014|COMPLETED|Phase 1-T Dose Level 1-TA||0
8549471|NCT01116648|9581214|FG000|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
8549472|NCT01116648|9581215|FG001|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
8549473|NCT01116648|9581216|FG002|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
8549474|NCT01116648|9581217|FG003|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
8549475|NCT01116648|9581218|FG004|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
8549476|NCT01116648|9581219|FG005|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
8549477|NCT01116648|9581220|FG006|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
8549478|NCT01116648|9581221|FG007|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
8549479|NCT01116648|9581222|FG008|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
8549480|NCT01116648|9581223|FG009|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
8549481|NCT01116648|9581224|FG010|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
8549482|NCT01116648|9581225|FG011|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
8549483|NCT01116648|9581226|FG012|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
8549484|NCT01116648|9581227|FG013|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
8549485|NCT01116648|9581228|FG014|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
8549486|NCT01116648|9581214|FG000|STARTED|Phase 1-T Dose Level 2-TA||0
8549487|NCT01116648|9581215|FG001|STARTED|Phase 1-T Dose Level 2-TA||0
8549488|NCT01116648|9581216|FG002|STARTED|Phase 1-T Dose Level 2-TA||0
8549489|NCT01116648|9581217|FG003|STARTED|Phase 1-T Dose Level 2-TA||0
8549490|NCT01116648|9581218|FG004|STARTED|Phase 1-T Dose Level 2-TA||0
8549491|NCT01116648|9581219|FG005|STARTED|Phase 1-T Dose Level 2-TA||0
8549492|NCT01116648|9581220|FG006|STARTED|Phase 1-T Dose Level 2-TA||0
8549493|NCT01116648|9581221|FG007|STARTED|Phase 1-T Dose Level 2-TA||0
8549494|NCT01116648|9581222|FG008|STARTED|Phase 1-T Dose Level 2-TA||0
8549495|NCT01116648|9581223|FG009|STARTED|Phase 1-T Dose Level 2-TA||3
8549496|NCT01116648|9581224|FG010|STARTED|Phase 1-T Dose Level 2-TA||0
8549497|NCT01116648|9581225|FG011|STARTED|Phase 1-T Dose Level 2-TA||0
8549498|NCT01116648|9581226|FG012|STARTED|Phase 1-T Dose Level 2-TA||0
8549499|NCT01116648|9581227|FG013|STARTED|Phase 1-T Dose Level 2-TA||0
8549500|NCT01116648|9581228|FG014|STARTED|Phase 1-T Dose Level 2-TA||0
8549501|NCT01116648|9581214|FG000|COMPLETED|Phase 1-T Dose Level 2-TA||0
8549502|NCT01116648|9581215|FG001|COMPLETED|Phase 1-T Dose Level 2-TA||0
8549503|NCT01116648|9581216|FG002|COMPLETED|Phase 1-T Dose Level 2-TA||0
8549504|NCT01116648|9581217|FG003|COMPLETED|Phase 1-T Dose Level 2-TA||0
8549505|NCT01116648|9581218|FG004|COMPLETED|Phase 1-T Dose Level 2-TA||0
8549506|NCT01116648|9581219|FG005|COMPLETED|Phase 1-T Dose Level 2-TA||0
8549507|NCT01116648|9581220|FG006|COMPLETED|Phase 1-T Dose Level 2-TA||0
8549508|NCT01116648|9581221|FG007|COMPLETED|Phase 1-T Dose Level 2-TA||0
8549509|NCT01116648|9581222|FG008|COMPLETED|Phase 1-T Dose Level 2-TA||0
8549510|NCT01116648|9581223|FG009|COMPLETED|Phase 1-T Dose Level 2-TA||3
8549511|NCT01116648|9581224|FG010|COMPLETED|Phase 1-T Dose Level 2-TA||0
8549512|NCT01116648|9581225|FG011|COMPLETED|Phase 1-T Dose Level 2-TA||0
8549513|NCT01116648|9581226|FG012|COMPLETED|Phase 1-T Dose Level 2-TA||0
8549514|NCT01116648|9581227|FG013|COMPLETED|Phase 1-T Dose Level 2-TA||0
8549515|NCT01116648|9581228|FG014|COMPLETED|Phase 1-T Dose Level 2-TA||0
8549516|NCT01116648|9581214|FG000|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
8549517|NCT01116648|9581215|FG001|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
8549518|NCT01116648|9581216|FG002|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
8549519|NCT01116648|9581217|FG003|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
8549520|NCT01116648|9581218|FG004|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
8549521|NCT01116648|9581219|FG005|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
8549522|NCT01116648|9581220|FG006|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
8549523|NCT01116648|9581221|FG007|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
8549524|NCT01116648|9581222|FG008|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
8549525|NCT01116648|9581223|FG009|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
8549526|NCT01116648|9581224|FG010|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
8549527|NCT01116648|9581225|FG011|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
8549528|NCT01116648|9581226|FG012|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
8549529|NCT01116648|9581227|FG013|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
8549530|NCT01116648|9581228|FG014|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
8549531|NCT01116648|9581214|FG000|STARTED|Phase 1-T Dose Level 0-TB||0
8549532|NCT01116648|9581215|FG001|STARTED|Phase 1-T Dose Level 0-TB||0
8549533|NCT01116648|9581216|FG002|STARTED|Phase 1-T Dose Level 0-TB||0
8549534|NCT01116648|9581217|FG003|STARTED|Phase 1-T Dose Level 0-TB||0
8549535|NCT01116648|9581218|FG004|STARTED|Phase 1-T Dose Level 0-TB||0
8549536|NCT01116648|9581219|FG005|STARTED|Phase 1-T Dose Level 0-TB||0
8549537|NCT01116648|9581220|FG006|STARTED|Phase 1-T Dose Level 0-TB||0
8549538|NCT01116648|9581221|FG007|STARTED|Phase 1-T Dose Level 0-TB||0
8549539|NCT01116648|9581222|FG008|STARTED|Phase 1-T Dose Level 0-TB||0
8549540|NCT01116648|9581223|FG009|STARTED|Phase 1-T Dose Level 0-TB||0
8549541|NCT01116648|9581224|FG010|STARTED|Phase 1-T Dose Level 0-TB||3
8549542|NCT01116648|9581225|FG011|STARTED|Phase 1-T Dose Level 0-TB||0
8549543|NCT01116648|9581226|FG012|STARTED|Phase 1-T Dose Level 0-TB||0
8549544|NCT01116648|9581227|FG013|STARTED|Phase 1-T Dose Level 0-TB||0
8549545|NCT01116648|9581228|FG014|STARTED|Phase 1-T Dose Level 0-TB||0
8549546|NCT01116648|9581214|FG000|COMPLETED|Phase 1-T Dose Level 0-TB||0
8549547|NCT01116648|9581215|FG001|COMPLETED|Phase 1-T Dose Level 0-TB||0
8549548|NCT01116648|9581216|FG002|COMPLETED|Phase 1-T Dose Level 0-TB||0
8549549|NCT01116648|9581217|FG003|COMPLETED|Phase 1-T Dose Level 0-TB||0
8549550|NCT01116648|9581218|FG004|COMPLETED|Phase 1-T Dose Level 0-TB||0
8549551|NCT01116648|9581219|FG005|COMPLETED|Phase 1-T Dose Level 0-TB||0
8549552|NCT01116648|9581220|FG006|COMPLETED|Phase 1-T Dose Level 0-TB||0
8549553|NCT01116648|9581221|FG007|COMPLETED|Phase 1-T Dose Level 0-TB||0
8549554|NCT01116648|9581222|FG008|COMPLETED|Phase 1-T Dose Level 0-TB||0
8549555|NCT01116648|9581223|FG009|COMPLETED|Phase 1-T Dose Level 0-TB||0
8549556|NCT01116648|9581224|FG010|COMPLETED|Phase 1-T Dose Level 0-TB||3
8549557|NCT01116648|9581225|FG011|COMPLETED|Phase 1-T Dose Level 0-TB||0
8549558|NCT01116648|9581226|FG012|COMPLETED|Phase 1-T Dose Level 0-TB||0
8549559|NCT01116648|9581227|FG013|COMPLETED|Phase 1-T Dose Level 0-TB||0
8549560|NCT01116648|9581228|FG014|COMPLETED|Phase 1-T Dose Level 0-TB||0
8549561|NCT01116648|9581214|FG000|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
8549562|NCT01116648|9581215|FG001|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
8549563|NCT01116648|9581216|FG002|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
8549564|NCT01116648|9581217|FG003|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
8549565|NCT01116648|9581218|FG004|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
8549566|NCT01116648|9581219|FG005|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
8549567|NCT01116648|9581220|FG006|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
8549568|NCT01116648|9581221|FG007|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
8549569|NCT01116648|9581222|FG008|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
8549570|NCT01116648|9581223|FG009|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
8549571|NCT01116648|9581224|FG010|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
8549572|NCT01116648|9581225|FG011|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
8549573|NCT01116648|9581226|FG012|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
8549574|NCT01116648|9581227|FG013|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
8549575|NCT01116648|9581228|FG014|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
8549576|NCT01116648|9581214|FG000|STARTED|Phase 1-T Dose Level 1-TB||0
8549577|NCT01116648|9581215|FG001|STARTED|Phase 1-T Dose Level 1-TB||0
8818485|NCT01558063|9872218|FG002|NOT COMPLETED|Overall Study||0
8818486|NCT01558063|9872219|FG003|NOT COMPLETED|Overall Study||0
8818487|NCT01558063|9872220|FG004|NOT COMPLETED|Overall Study||0
8818488|NCT01558063|9872221|FG005|NOT COMPLETED|Overall Study||0
8818489|NCT01558089|9872230|FG000|STARTED|Overall Study||76
8818490|NCT01558089|9872230|FG000|COMPLETED|Overall Study||63
8818491|NCT01558089|9872230|FG000|NOT COMPLETED|Overall Study||13
8818492|NCT01558128|9872234|FG000|STARTED|Overall Study||1
8818493|NCT01558128|9872234|FG000|COMPLETED|Overall Study||1
8818494|NCT01558128|9872234|FG000|NOT COMPLETED|Overall Study||0
8818495|NCT01558271|9872241|FG000|STARTED|Overall Study||281
8818496|NCT01558271|9872242|FG001|STARTED|Overall Study||70
8818497|NCT01558271|9872243|FG002|STARTED|Overall Study||141
8818498|NCT01558271|9872241|FG000|Received at Least 1 Dose of Study Drug|Overall Study||280
8549578|NCT01116648|9581216|FG002|STARTED|Phase 1-T Dose Level 1-TB||0
8549579|NCT01116648|9581217|FG003|STARTED|Phase 1-T Dose Level 1-TB||0
8549580|NCT01116648|9581218|FG004|STARTED|Phase 1-T Dose Level 1-TB||0
8549581|NCT01116648|9581219|FG005|STARTED|Phase 1-T Dose Level 1-TB||0
8549582|NCT01116648|9581220|FG006|STARTED|Phase 1-T Dose Level 1-TB||0
8549583|NCT01116648|9581221|FG007|STARTED|Phase 1-T Dose Level 1-TB||0
8549584|NCT01116648|9581222|FG008|STARTED|Phase 1-T Dose Level 1-TB||0
8549585|NCT01116648|9581223|FG009|STARTED|Phase 1-T Dose Level 1-TB||0
8549586|NCT01116648|9581224|FG010|STARTED|Phase 1-T Dose Level 1-TB||0
8549587|NCT01116648|9581225|FG011|STARTED|Phase 1-T Dose Level 1-TB||3
8549588|NCT01116648|9581226|FG012|STARTED|Phase 1-T Dose Level 1-TB||0
8549589|NCT01116648|9581227|FG013|STARTED|Phase 1-T Dose Level 1-TB||0
8549590|NCT01116648|9581228|FG014|STARTED|Phase 1-T Dose Level 1-TB||0
8549591|NCT01116648|9581214|FG000|COMPLETED|Phase 1-T Dose Level 1-TB||0
8549592|NCT01116648|9581215|FG001|COMPLETED|Phase 1-T Dose Level 1-TB||0
8549593|NCT01116648|9581216|FG002|COMPLETED|Phase 1-T Dose Level 1-TB||0
8549594|NCT01116648|9581217|FG003|COMPLETED|Phase 1-T Dose Level 1-TB||0
8549595|NCT01116648|9581218|FG004|COMPLETED|Phase 1-T Dose Level 1-TB||0
8549596|NCT01116648|9581219|FG005|COMPLETED|Phase 1-T Dose Level 1-TB||0
8549597|NCT01116648|9581220|FG006|COMPLETED|Phase 1-T Dose Level 1-TB||0
8549598|NCT01116648|9581221|FG007|COMPLETED|Phase 1-T Dose Level 1-TB||0
8549599|NCT01116648|9581222|FG008|COMPLETED|Phase 1-T Dose Level 1-TB||0
8549600|NCT01116648|9581223|FG009|COMPLETED|Phase 1-T Dose Level 1-TB||0
8549601|NCT01116648|9581224|FG010|COMPLETED|Phase 1-T Dose Level 1-TB||0
8549602|NCT01116648|9581225|FG011|COMPLETED|Phase 1-T Dose Level 1-TB||3
8549603|NCT01116648|9581226|FG012|COMPLETED|Phase 1-T Dose Level 1-TB||0
8549604|NCT01116648|9581227|FG013|COMPLETED|Phase 1-T Dose Level 1-TB||0
8549605|NCT01116648|9581228|FG014|COMPLETED|Phase 1-T Dose Level 1-TB||0
8549606|NCT01116648|9581214|FG000|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
8549607|NCT01116648|9581215|FG001|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
8549608|NCT01116648|9581216|FG002|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
8549609|NCT01116648|9581217|FG003|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
8818499|NCT01558271|9872242|FG001|Received at Least 1 Dose of Study Drug|Overall Study||70
8549610|NCT01116648|9581218|FG004|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
8549611|NCT01116648|9581219|FG005|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
8549612|NCT01116648|9581220|FG006|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
8818500|NCT01558271|9872243|FG002|Received at Least 1 Dose of Study Drug|Overall Study||137
8549613|NCT01116648|9581221|FG007|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
8549614|NCT01116648|9581222|FG008|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
8549615|NCT01116648|9581223|FG009|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
8549616|NCT01116648|9581224|FG010|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
8549617|NCT01116648|9581225|FG011|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
8549618|NCT01116648|9581226|FG012|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
8549619|NCT01116648|9581227|FG013|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
8549620|NCT01116648|9581228|FG014|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
8549621|NCT01116648|9581214|FG000|STARTED|Phase 1-T Dose Level 2-TB||0
8549622|NCT01116648|9581215|FG001|STARTED|Phase 1-T Dose Level 2-TB||0
8549623|NCT01116648|9581216|FG002|STARTED|Phase 1-T Dose Level 2-TB||0
8549624|NCT01116648|9581217|FG003|STARTED|Phase 1-T Dose Level 2-TB||0
8549625|NCT01116648|9581218|FG004|STARTED|Phase 1-T Dose Level 2-TB||0
8549626|NCT01116648|9581219|FG005|STARTED|Phase 1-T Dose Level 2-TB||0
8549627|NCT01116648|9581220|FG006|STARTED|Phase 1-T Dose Level 2-TB||0
8549628|NCT01116648|9581221|FG007|STARTED|Phase 1-T Dose Level 2-TB||0
8549629|NCT01116648|9581222|FG008|STARTED|Phase 1-T Dose Level 2-TB||0
8549630|NCT01116648|9581223|FG009|STARTED|Phase 1-T Dose Level 2-TB||0
8549631|NCT01116648|9581224|FG010|STARTED|Phase 1-T Dose Level 2-TB||0
8549632|NCT01116648|9581225|FG011|STARTED|Phase 1-T Dose Level 2-TB||0
8549633|NCT01116648|9581226|FG012|STARTED|Phase 1-T Dose Level 2-TB||6
8549634|NCT01116648|9581227|FG013|STARTED|Phase 1-T Dose Level 2-TB||0
8549635|NCT01116648|9581228|FG014|STARTED|Phase 1-T Dose Level 2-TB||0
8549636|NCT01116648|9581214|FG000|COMPLETED|Phase 1-T Dose Level 2-TB||0
8549637|NCT01116648|9581215|FG001|COMPLETED|Phase 1-T Dose Level 2-TB||0
8549638|NCT01116648|9581216|FG002|COMPLETED|Phase 1-T Dose Level 2-TB||0
8549639|NCT01116648|9581217|FG003|COMPLETED|Phase 1-T Dose Level 2-TB||0
8549640|NCT01116648|9581218|FG004|COMPLETED|Phase 1-T Dose Level 2-TB||0
8549641|NCT01116648|9581219|FG005|COMPLETED|Phase 1-T Dose Level 2-TB||0
8549642|NCT01116648|9581220|FG006|COMPLETED|Phase 1-T Dose Level 2-TB||0
8549643|NCT01116648|9581221|FG007|COMPLETED|Phase 1-T Dose Level 2-TB||0
8549644|NCT01116648|9581222|FG008|COMPLETED|Phase 1-T Dose Level 2-TB||0
8549645|NCT01116648|9581223|FG009|COMPLETED|Phase 1-T Dose Level 2-TB||0
8549646|NCT01116648|9581224|FG010|COMPLETED|Phase 1-T Dose Level 2-TB||0
8549647|NCT01116648|9581225|FG011|COMPLETED|Phase 1-T Dose Level 2-TB||0
8549648|NCT01116648|9581226|FG012|COMPLETED|Phase 1-T Dose Level 2-TB||6
8549649|NCT01116648|9581227|FG013|COMPLETED|Phase 1-T Dose Level 2-TB||0
8549650|NCT01116648|9581228|FG014|COMPLETED|Phase 1-T Dose Level 2-TB||0
8549651|NCT01116648|9581214|FG000|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
8549652|NCT01116648|9581215|FG001|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
8549653|NCT01116648|9581216|FG002|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
8549654|NCT01116648|9581217|FG003|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
8549655|NCT01116648|9581218|FG004|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
8549656|NCT01116648|9581219|FG005|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
8549657|NCT01116648|9581220|FG006|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
8549658|NCT01116648|9581221|FG007|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
8549659|NCT01116648|9581222|FG008|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
8549660|NCT01116648|9581223|FG009|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
8549661|NCT01116648|9581224|FG010|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
8549662|NCT01116648|9581225|FG011|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
8549663|NCT01116648|9581226|FG012|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
8549664|NCT01116648|9581227|FG013|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
8549665|NCT01116648|9581228|FG014|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
8549666|NCT01116648|9581214|FG000|STARTED|Phase 1-T PKOlap Expansion||0
8549667|NCT01116648|9581215|FG001|STARTED|Phase 1-T PKOlap Expansion||0
8549668|NCT01116648|9581216|FG002|STARTED|Phase 1-T PKOlap Expansion||0
8549669|NCT01116648|9581217|FG003|STARTED|Phase 1-T PKOlap Expansion||0
8549670|NCT01116648|9581218|FG004|STARTED|Phase 1-T PKOlap Expansion||0
8549671|NCT01116648|9581219|FG005|STARTED|Phase 1-T PKOlap Expansion||0
8549672|NCT01116648|9581220|FG006|STARTED|Phase 1-T PKOlap Expansion||0
8549673|NCT01116648|9581221|FG007|STARTED|Phase 1-T PKOlap Expansion||0
8549674|NCT01116648|9581222|FG008|STARTED|Phase 1-T PKOlap Expansion||0
8549675|NCT01116648|9581223|FG009|STARTED|Phase 1-T PKOlap Expansion||0
8549676|NCT01116648|9581224|FG010|STARTED|Phase 1-T PKOlap Expansion||0
8549677|NCT01116648|9581225|FG011|STARTED|Phase 1-T PKOlap Expansion||0
8549678|NCT01116648|9581226|FG012|STARTED|Phase 1-T PKOlap Expansion||0
8549679|NCT01116648|9581227|FG013|STARTED|Phase 1-T PKOlap Expansion||6
8549680|NCT01116648|9581228|FG014|STARTED|Phase 1-T PKOlap Expansion||0
8549681|NCT01116648|9581214|FG000|COMPLETED|Phase 1-T PKOlap Expansion||0
8549682|NCT01116648|9581215|FG001|COMPLETED|Phase 1-T PKOlap Expansion||0
8549683|NCT01116648|9581216|FG002|COMPLETED|Phase 1-T PKOlap Expansion||0
8549684|NCT01116648|9581217|FG003|COMPLETED|Phase 1-T PKOlap Expansion||0
8549685|NCT01116648|9581218|FG004|COMPLETED|Phase 1-T PKOlap Expansion||0
8549686|NCT01116648|9581219|FG005|COMPLETED|Phase 1-T PKOlap Expansion||0
8549687|NCT01116648|9581220|FG006|COMPLETED|Phase 1-T PKOlap Expansion||0
8549688|NCT01116648|9581221|FG007|COMPLETED|Phase 1-T PKOlap Expansion||0
8549689|NCT01116648|9581222|FG008|COMPLETED|Phase 1-T PKOlap Expansion||0
8549690|NCT01116648|9581223|FG009|COMPLETED|Phase 1-T PKOlap Expansion||0
8549691|NCT01116648|9581224|FG010|COMPLETED|Phase 1-T PKOlap Expansion||0
8549692|NCT01116648|9581225|FG011|COMPLETED|Phase 1-T PKOlap Expansion||0
8549693|NCT01116648|9581226|FG012|COMPLETED|Phase 1-T PKOlap Expansion||0
8549694|NCT01116648|9581227|FG013|COMPLETED|Phase 1-T PKOlap Expansion||6
8549695|NCT01116648|9581228|FG014|COMPLETED|Phase 1-T PKOlap Expansion||0
8549696|NCT01116648|9581214|FG000|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
8549697|NCT01116648|9581215|FG001|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
8549698|NCT01116648|9581216|FG002|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
8549699|NCT01116648|9581217|FG003|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
8549700|NCT01116648|9581218|FG004|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
8549701|NCT01116648|9581219|FG005|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
8549702|NCT01116648|9581220|FG006|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
8549703|NCT01116648|9581221|FG007|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
8549704|NCT01116648|9581222|FG008|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
8549705|NCT01116648|9581223|FG009|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
8549706|NCT01116648|9581224|FG010|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
8549707|NCT01116648|9581225|FG011|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
8549708|NCT01116648|9581226|FG012|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
8549709|NCT01116648|9581227|FG013|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
8549710|NCT01116648|9581228|FG014|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
8549711|NCT01116648|9581214|FG000|STARTED|Phase 1-T PKCed Expansion||0
8549712|NCT01116648|9581215|FG001|STARTED|Phase 1-T PKCed Expansion||0
8549713|NCT01116648|9581216|FG002|STARTED|Phase 1-T PKCed Expansion||0
8549714|NCT01116648|9581217|FG003|STARTED|Phase 1-T PKCed Expansion||0
8549715|NCT01116648|9581218|FG004|STARTED|Phase 1-T PKCed Expansion||0
8549716|NCT01116648|9581219|FG005|STARTED|Phase 1-T PKCed Expansion||0
8549717|NCT01116648|9581220|FG006|STARTED|Phase 1-T PKCed Expansion||0
8549718|NCT01116648|9581221|FG007|STARTED|Phase 1-T PKCed Expansion||0
8549719|NCT01116648|9581222|FG008|STARTED|Phase 1-T PKCed Expansion||0
8549720|NCT01116648|9581223|FG009|STARTED|Phase 1-T PKCed Expansion||0
8549721|NCT01116648|9581224|FG010|STARTED|Phase 1-T PKCed Expansion||0
8549722|NCT01116648|9581225|FG011|STARTED|Phase 1-T PKCed Expansion||0
8549723|NCT01116648|9581226|FG012|STARTED|Phase 1-T PKCed Expansion||0
8549724|NCT01116648|9581227|FG013|STARTED|Phase 1-T PKCed Expansion||0
8549725|NCT01116648|9581228|FG014|STARTED|Phase 1-T PKCed Expansion||7
8549726|NCT01116648|9581214|FG000|COMPLETED|Phase 1-T PKCed Expansion||0
8549727|NCT01116648|9581215|FG001|COMPLETED|Phase 1-T PKCed Expansion||0
8549728|NCT01116648|9581216|FG002|COMPLETED|Phase 1-T PKCed Expansion||0
8549729|NCT01116648|9581217|FG003|COMPLETED|Phase 1-T PKCed Expansion||0
8549730|NCT01116648|9581218|FG004|COMPLETED|Phase 1-T PKCed Expansion||0
8549731|NCT01116648|9581219|FG005|COMPLETED|Phase 1-T PKCed Expansion||0
8549732|NCT01116648|9581220|FG006|COMPLETED|Phase 1-T PKCed Expansion||0
8549733|NCT01116648|9581221|FG007|COMPLETED|Phase 1-T PKCed Expansion||0
8549734|NCT01116648|9581222|FG008|COMPLETED|Phase 1-T PKCed Expansion||0
8549735|NCT01116648|9581223|FG009|COMPLETED|Phase 1-T PKCed Expansion||0
8549736|NCT01116648|9581224|FG010|COMPLETED|Phase 1-T PKCed Expansion||0
8549737|NCT01116648|9581225|FG011|COMPLETED|Phase 1-T PKCed Expansion||0
8549738|NCT01116648|9581226|FG012|COMPLETED|Phase 1-T PKCed Expansion||0
8549739|NCT01116648|9581227|FG013|COMPLETED|Phase 1-T PKCed Expansion||0
8549740|NCT01116648|9581228|FG014|COMPLETED|Phase 1-T PKCed Expansion||7
8549741|NCT01116648|9581214|FG000|NOT COMPLETED|Phase 1-T PKCed Expansion||0
8549742|NCT01116648|9581215|FG001|NOT COMPLETED|Phase 1-T PKCed Expansion||0
8549743|NCT01116648|9581216|FG002|NOT COMPLETED|Phase 1-T PKCed Expansion||0
8549744|NCT01116648|9581217|FG003|NOT COMPLETED|Phase 1-T PKCed Expansion||0
8549745|NCT01116648|9581218|FG004|NOT COMPLETED|Phase 1-T PKCed Expansion||0
8549746|NCT01116648|9581219|FG005|NOT COMPLETED|Phase 1-T PKCed Expansion||0
8549747|NCT01116648|9581220|FG006|NOT COMPLETED|Phase 1-T PKCed Expansion||0
8549748|NCT01116648|9581221|FG007|NOT COMPLETED|Phase 1-T PKCed Expansion||0
8549749|NCT01116648|9581222|FG008|NOT COMPLETED|Phase 1-T PKCed Expansion||0
8549750|NCT01116648|9581223|FG009|NOT COMPLETED|Phase 1-T PKCed Expansion||0
8549751|NCT01116648|9581224|FG010|NOT COMPLETED|Phase 1-T PKCed Expansion||0
8549752|NCT01116648|9581225|FG011|NOT COMPLETED|Phase 1-T PKCed Expansion||0
8549753|NCT01116648|9581226|FG012|NOT COMPLETED|Phase 1-T PKCed Expansion||0
8549754|NCT01116648|9581227|FG013|NOT COMPLETED|Phase 1-T PKCed Expansion||0
8549755|NCT01116648|9581228|FG014|NOT COMPLETED|Phase 1-T PKCed Expansion||0
8549756|NCT01094782|9581259|FG000|STARTED|Overall Study||39
8549757|NCT01094782|9581260|FG001|STARTED|Overall Study||39
8549758|NCT01094782|9581261|FG002|STARTED|Overall Study||34
8549759|NCT01094782|9581262|FG003|STARTED|Overall Study||56
8549760|NCT01094782|9581263|FG004|STARTED|Overall Study||42
8549761|NCT01094782|9581264|FG005|STARTED|Overall Study||38
8549762|NCT01094782|9581259|FG000|COMPLETED|Overall Study||31
8549763|NCT01094782|9581260|FG001|COMPLETED|Overall Study||29
8549764|NCT01094782|9581261|FG002|COMPLETED|Overall Study||31
8549765|NCT01094782|9581262|FG003|COMPLETED|Overall Study||45
8549766|NCT01094782|9581263|FG004|COMPLETED|Overall Study||31
8549767|NCT01094782|9581264|FG005|COMPLETED|Overall Study||30
8549768|NCT01094782|9581259|FG000|NOT COMPLETED|Overall Study||8
8549769|NCT01094782|9581260|FG001|NOT COMPLETED|Overall Study||10
8549770|NCT01094782|9581261|FG002|NOT COMPLETED|Overall Study||3
8549771|NCT01094782|9581262|FG003|NOT COMPLETED|Overall Study||11
8549772|NCT01094782|9581263|FG004|NOT COMPLETED|Overall Study||11
8549773|NCT01094782|9581264|FG005|NOT COMPLETED|Overall Study||8
8818501|NCT01558271|9872241|FG000|Completed 26 Weeks|Overall Study||271
8818502|NCT01558271|9872242|FG001|Completed 26 Weeks|Overall Study||63
8818503|NCT01558271|9872243|FG002|Completed 26 Weeks|Overall Study||128
8818504|NCT01558271|9872241|FG000|COMPLETED|Overall Study||263
8818505|NCT01558271|9872242|FG001|COMPLETED|Overall Study||59
8818506|NCT01558271|9872243|FG002|COMPLETED|Overall Study||124
8818507|NCT01558271|9872241|FG000|NOT COMPLETED|Overall Study||18
8818508|NCT01558271|9872242|FG001|NOT COMPLETED|Overall Study||11
8818509|NCT01558271|9872243|FG002|NOT COMPLETED|Overall Study||17
8818510|NCT01558297|9872258|FG000|STARTED|Overall Study||30
8818511|NCT01558297|9872259|FG001|STARTED|Overall Study||29
8818512|NCT01558297|9872260|FG002|STARTED|Overall Study||30
8818513|NCT01558297|9872258|FG000|COMPLETED|Overall Study||28
8818514|NCT01558297|9872259|FG001|COMPLETED|Overall Study||27
8818515|NCT01558297|9872260|FG002|COMPLETED|Overall Study||29
8818516|NCT01558297|9872258|FG000|NOT COMPLETED|Overall Study||2
8818517|NCT01558297|9872259|FG001|NOT COMPLETED|Overall Study||2
8818518|NCT01558297|9872260|FG002|NOT COMPLETED|Overall Study||1
8818519|NCT01558596|9872270|FG000|STARTED|Overall Study||104
8818520|NCT01558596|9872271|FG001|STARTED|Overall Study||101
8818521|NCT01558596|9872270|FG000|COMPLETED|Overall Study||101
8818522|NCT01558596|9872271|FG001|COMPLETED|Overall Study||100
8818523|NCT01558596|9872270|FG000|NOT COMPLETED|Overall Study||3
8818524|NCT01558596|9872271|FG001|NOT COMPLETED|Overall Study||1
8818525|NCT01558635|9872277|FG000|STARTED|Overall Study||17
8818526|NCT01558635|9872277|FG000|Treated|Overall Study||17
8818527|NCT01558635|9872277|FG000|Discharge /1 Month Post-procedure|Overall Study||15
8818528|NCT01558635|9872277|FG000|3 Months Post-procedure|Overall Study||14
8818529|NCT01558635|9872277|FG000|6 Months Post-procedure|Overall Study||14
8818530|NCT01558635|9872277|FG000|COMPLETED|Overall Study||11
8818531|NCT01558635|9872277|FG000|NOT COMPLETED|Overall Study||6
8818532|NCT01558661|9872288|FG000|STARTED|Overall Study||33
8818533|NCT01558661|9872288|FG000|First Stage|Overall Study||18
8818534|NCT01558661|9872288|FG000|Second Stage|Overall Study||15
8818535|NCT01558661|9872288|FG000|COMPLETED|Overall Study||33
8818536|NCT01558661|9872288|FG000|NOT COMPLETED|Overall Study||0
8818537|NCT01558674|9872294|FG000|STARTED|Part 1||11
8818538|NCT01558674|9872295|FG001|STARTED|Part 1||0
8818539|NCT01558674|9872294|FG000|COMPLETED|Part 1||0
8818540|NCT01558674|9872295|FG001|COMPLETED|Part 1||0
8818541|NCT01558674|9872294|FG000|NOT COMPLETED|Part 1||11
8818542|NCT01558674|9872295|FG001|NOT COMPLETED|Part 1||0
8818543|NCT01558674|9872294|FG000|STARTED|Part 2||0
8818544|NCT01558674|9872295|FG001|STARTED|Part 2||0
8818545|NCT01558674|9872294|FG000|COMPLETED|Part 2||0
8818546|NCT01558674|9872295|FG001|COMPLETED|Part 2||0
8818547|NCT01558674|9872294|FG000|NOT COMPLETED|Part 2||0
8818548|NCT01558674|9872295|FG001|NOT COMPLETED|Part 2||0
8818549|NCT01558700|9872316|FG000|STARTED|Overall Study||19
8818550|NCT01558700|9872317|FG001|STARTED|Overall Study||21
8818551|NCT01558700|9872316|FG000|COMPLETED|Overall Study||19
8818552|NCT01558700|9872317|FG001|COMPLETED|Overall Study||21
8818553|NCT01558700|9872316|FG000|NOT COMPLETED|Overall Study||0
8818554|NCT01558700|9872317|FG001|NOT COMPLETED|Overall Study||0
8818555|NCT01558739|9872323|FG000|STARTED|Overall Study||48
8818556|NCT01558739|9872323|FG000|COMPLETED|Overall Study||31
8818557|NCT01558739|9872323|FG000|NOT COMPLETED|Overall Study||17
8818558|NCT01558752|9872329|FG000|STARTED|Overall Study||42
8818559|NCT01558752|9872330|FG001|STARTED|Overall Study||46
8818560|NCT01558752|9872329|FG000|COMPLETED|Overall Study||40
8818561|NCT01558752|9872330|FG001|COMPLETED|Overall Study||46
8818562|NCT01558752|9872329|FG000|NOT COMPLETED|Overall Study||2
8818563|NCT01558752|9872330|FG001|NOT COMPLETED|Overall Study||0
8818564|NCT01558791|9872338|FG000|STARTED|Overall Study||607
8818565|NCT01558791|9872339|FG001|STARTED|Overall Study||629
8818566|NCT01558791|9872338|FG000|COMPLETED|Overall Study||607
8818567|NCT01558791|9872339|FG001|COMPLETED|Overall Study||629
8818568|NCT01558791|9872338|FG000|NOT COMPLETED|Overall Study||0
8818569|NCT01558791|9872339|FG001|NOT COMPLETED|Overall Study||0
8818570|NCT01559012|9872349|FG000|STARTED|Overall Study||6
8818571|NCT01559012|9872350|FG001|STARTED|Overall Study|1 more patient added to randomization list to reach the pre-assignment number of treated patients|7
8818572|NCT01559012|9872349|FG000|COMPLETED|Overall Study||6
8818573|NCT01559012|9872350|FG001|COMPLETED|Overall Study|Patient N. 2 withdrew from study for alleged side effects at day 1 of placebo cycle.|6
8818574|NCT01559012|9872349|FG000|NOT COMPLETED|Overall Study||0
8818575|NCT01559012|9872350|FG001|NOT COMPLETED|Overall Study||1
8818576|NCT01559064|9872374|FG000|STARTED|Overall Study||16
8818577|NCT01559064|9872375|FG001|STARTED|Overall Study||40
8818578|NCT01559064|9872376|FG002|STARTED|Overall Study||59
8818579|NCT01559064|9872374|FG000|COMPLETED|Overall Study||15
8818580|NCT01559064|9872375|FG001|COMPLETED|Overall Study||39
8818581|NCT01559064|9872376|FG002|COMPLETED|Overall Study||57
8818582|NCT01559064|9872374|FG000|NOT COMPLETED|Overall Study||1
8818583|NCT01559064|9872375|FG001|NOT COMPLETED|Overall Study||1
8818584|NCT01559064|9872376|FG002|NOT COMPLETED|Overall Study||2
8818585|NCT01559090|9872387|FG000|STARTED|Stage I||6
8818586|NCT01559090|9872388|FG001|STARTED|Stage I||5
8818587|NCT01559090|9872389|FG002|STARTED|Stage I||6
8818588|NCT01559090|9872387|FG000|COMPLETED|Stage I||4
8818589|NCT01559090|9872388|FG001|COMPLETED|Stage I||3
8818590|NCT01559090|9872389|FG002|COMPLETED|Stage I||3
8818591|NCT01559090|9872387|FG000|NOT COMPLETED|Stage I||2
8818592|NCT01559090|9872388|FG001|NOT COMPLETED|Stage I||2
8818593|NCT01559090|9872389|FG002|NOT COMPLETED|Stage I||3
8818594|NCT01559090|9872387|FG000|STARTED|Stage II||4
8818595|NCT01559090|9872388|FG001|STARTED|Stage II||3
8818596|NCT01559090|9872389|FG002|STARTED|Stage II|One subject who completed Stage I did not agree to participate in Stage II|2
8818597|NCT01559090|9872387|FG000|COMPLETED|Stage II||3
8818598|NCT01559090|9872388|FG001|COMPLETED|Stage II||3
8818599|NCT01559090|9872389|FG002|COMPLETED|Stage II||2
8818600|NCT01559090|9872387|FG000|NOT COMPLETED|Stage II||1
8818601|NCT01559090|9872388|FG001|NOT COMPLETED|Stage II||0
8818602|NCT01559090|9872389|FG002|NOT COMPLETED|Stage II||0
8818603|NCT01559116|9872397|FG000|STARTED|Overall Study|Randomised|219
8818604|NCT01559116|9872397|FG000|COMPLETED|Overall Study|Completed all 4 treatment periods|193
8818605|NCT01559116|9872397|FG000|NOT COMPLETED|Overall Study||26
8818606|NCT01559129|9872416|FG000|STARTED|Treatment Phase||12
8818607|NCT01559129|9872417|FG001|STARTED|Treatment Phase||11
8818608|NCT01559129|9872416|FG000|Received Treatment|Treatment Phase||12
8818609|NCT01559129|9872417|FG001|Received Treatment|Treatment Phase||10
8549810|NCT01033032|9581302|FG000|STARTED|Overall Study||3
8549811|NCT01033032|9581303|FG001|STARTED|Overall Study||3
8549812|NCT01033032|9581304|FG002|STARTED|Overall Study||3
8549813|NCT01033032|9581305|FG003|STARTED|Overall Study||6
8549814|NCT01033032|9581306|FG004|STARTED|Overall Study||63
8549815|NCT01033032|9581302|FG000|COMPLETED|Overall Study|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
8549816|NCT01033032|9581303|FG001|COMPLETED|Overall Study|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
8549817|NCT01033032|9581304|FG002|COMPLETED|Overall Study||3
8549818|NCT01033032|9581305|FG003|COMPLETED|Overall Study|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
8549819|NCT01033032|9581306|FG004|COMPLETED|Overall Study||0
8549820|NCT01033032|9581302|FG000|NOT COMPLETED|Overall Study||3
8549821|NCT01033032|9581303|FG001|NOT COMPLETED|Overall Study||3
8549822|NCT01033032|9581304|FG002|NOT COMPLETED|Overall Study||0
8549823|NCT01033032|9581305|FG003|NOT COMPLETED|Overall Study||6
8549824|NCT01033032|9581306|FG004|NOT COMPLETED|Overall Study||63
8549825|NCT01015833|9581319|FG000|STARTED|Overall Study||180
8549826|NCT01015833|9581320|FG001|STARTED|Overall Study||176
8549827|NCT01015833|9581319|FG000|COMPLETED|Overall Study||167
8549828|NCT01015833|9581320|FG001|COMPLETED|Overall Study||171
8549829|NCT01015833|9581319|FG000|NOT COMPLETED|Overall Study||13
8549830|NCT01015833|9581320|FG001|NOT COMPLETED|Overall Study||5
8549831|NCT00942331|9581328|FG000|STARTED|Overall Study||252
8549832|NCT00942331|9581329|FG001|STARTED|Overall Study||254
8549833|NCT00942331|9581328|FG000|COMPLETED|Overall Study||237
8549834|NCT00942331|9581329|FG001|COMPLETED|Overall Study||232
8549835|NCT00942331|9581328|FG000|NOT COMPLETED|Overall Study||15
8549836|NCT00942331|9581329|FG001|NOT COMPLETED|Overall Study||22
8818610|NCT01559129|9872416|FG000|COMPLETED|Treatment Phase||7
8818611|NCT01559129|9872417|FG001|COMPLETED|Treatment Phase||4
8549837|NCT00932737|9581337|FG000|STARTED|Overall Study||87
8549838|NCT00932737|9581338|FG001|STARTED|Overall Study||88
8549839|NCT00932737|9581337|FG000|COMPLETED|Overall Study||86
8549840|NCT00932737|9581338|FG001|COMPLETED|Overall Study||87
8549841|NCT00932737|9581337|FG000|NOT COMPLETED|Overall Study||1
8549842|NCT00932737|9581338|FG001|NOT COMPLETED|Overall Study||1
8549843|NCT00893516|9581346|FG000|STARTED|Overall Study||0
8818612|NCT01559129|9872416|FG000|NOT COMPLETED|Treatment Phase||5
8818613|NCT01559129|9872417|FG001|NOT COMPLETED|Treatment Phase||7
8849320|NCT01739764|9904478|FG000|STARTED|Overall Study||29
8549844|NCT00893516|9581347|FG001|STARTED|Overall Study||0
8549845|NCT00893516|9581346|FG000|COMPLETED|Overall Study||0
8549846|NCT00893516|9581347|FG001|COMPLETED|Overall Study||0
8549847|NCT00893516|9581346|FG000|NOT COMPLETED|Overall Study||0
8549848|NCT00893516|9581347|FG001|NOT COMPLETED|Overall Study||0
8549849|NCT00848757|9581355|FG000|STARTED|Overall Study||65
8549850|NCT00848757|9581356|FG001|STARTED|Overall Study||65
8549851|NCT00848757|9581355|FG000|COMPLETED|Overall Study||61
8549852|NCT00848757|9581356|FG001|COMPLETED|Overall Study||61
8549853|NCT00848757|9581355|FG000|NOT COMPLETED|Overall Study||4
8549854|NCT00848757|9581356|FG001|NOT COMPLETED|Overall Study||4
8549855|NCT00792948|9581362|FG000|STARTED|Overall Study|Patients registered to induction/consolidation step|97
8549856|NCT00792948|9581362|FG000|COMPLETED|Overall Study|Patients who completed induction/consolidation step|69
8549857|NCT00792948|9581362|FG000|NOT COMPLETED|Overall Study||28
8549858|NCT00769379|9581371|FG000|STARTED|Overall Study||1008
8549859|NCT00769379|9581372|FG001|STARTED|Overall Study||1006
8549860|NCT00769379|9581371|FG000|COMPLETED|Overall Study||1005
8549861|NCT00769379|9581372|FG001|COMPLETED|Overall Study||993
8549862|NCT00769379|9581371|FG000|NOT COMPLETED|Overall Study||3
8549863|NCT00769379|9581372|FG001|NOT COMPLETED|Overall Study||13
8549864|NCT00710710|9581380|FG000|STARTED|Overall Study||45
8549865|NCT00710710|9581381|FG001|STARTED|Overall Study||44
8549866|NCT00710710|9581380|FG000|Treated|Overall Study||43
8621613|NCT00481871|9660628|FG000|NOT COMPLETED|Overall Study||0
8621614|NCT00481871|9660629|FG001|NOT COMPLETED|Overall Study||0
8621615|NCT00481871|9660630|FG002|NOT COMPLETED|Overall Study||1
8621616|NCT00481871|9660631|FG003|NOT COMPLETED|Overall Study||0
8621617|NCT00481871|9660632|FG004|NOT COMPLETED|Overall Study||0
8621618|NCT00481988|9660642|FG000|STARTED|Overall Study||12
8621619|NCT00481988|9660643|FG001|STARTED|Overall Study|one patient was dropped from the study before randomization|9
8621620|NCT00481988|9660642|FG000|Crossover|Overall Study|patient dropped out of study after 5 sessions to pursue other treatment options|11
8621621|NCT00481988|9660643|FG001|Crossover|Overall Study|patient dropped out of study after 5 sessions to illness unrelated to study|8
8621622|NCT00481988|9660642|FG000|COMPLETED|Overall Study||11
8621623|NCT00481988|9660643|FG001|COMPLETED|Overall Study||8
8621624|NCT00481988|9660642|FG000|NOT COMPLETED|Overall Study||1
8621625|NCT00481988|9660643|FG001|NOT COMPLETED|Overall Study||1
8621626|NCT00482001|9660651|FG000|STARTED|Overall Study||11
8549867|NCT00710710|9581381|FG001|Treated|Overall Study||43
8549868|NCT00710710|9581380|FG000|COMPLETED|Overall Study||0
8549869|NCT00710710|9581381|FG001|COMPLETED|Overall Study||0
8549870|NCT00710710|9581380|FG000|NOT COMPLETED|Overall Study||45
8549871|NCT00710710|9581381|FG001|NOT COMPLETED|Overall Study||44
8549872|NCT00608023|9581390|FG000|STARTED|Overall Study||92
8549873|NCT00608023|9581391|FG001|STARTED|Overall Study||85
8549874|NCT00608023|9581392|FG002|STARTED|Overall Study||86
8549875|NCT00608023|9581390|FG000|COMPLETED|Overall Study||80
8549876|NCT00608023|9581391|FG001|COMPLETED|Overall Study||63
8549877|NCT00608023|9581392|FG002|COMPLETED|Overall Study||72
8549878|NCT00608023|9581390|FG000|NOT COMPLETED|Overall Study||12
8549879|NCT00608023|9581391|FG001|NOT COMPLETED|Overall Study||22
8549880|NCT00608023|9581392|FG002|NOT COMPLETED|Overall Study||14
8549881|NCT00551616|9581405|FG000|STARTED|Overall Study||1104
8549882|NCT00551616|9581406|FG001|STARTED|Overall Study||1117
8549883|NCT00551616|9581405|FG000|COMPLETED|Overall Study||1056
8549884|NCT00551616|9581406|FG001|COMPLETED|Overall Study||1077
8549885|NCT00551616|9581405|FG000|NOT COMPLETED|Overall Study||48
8549886|NCT00551616|9581406|FG001|NOT COMPLETED|Overall Study||40
8549887|NCT00520767|9581412|FG000|STARTED|Overall Study||35
8549888|NCT00520767|9581412|FG000|COMPLETED|Overall Study||33
8549889|NCT00520767|9581412|FG000|NOT COMPLETED|Overall Study||2
8549890|NCT00492050|9581416|FG000|STARTED|Overall Study||37
8549891|NCT00492050|9581416|FG000|Inadequate Response to First Two Cycles|Overall Study||25
8549892|NCT00492050|9581416|FG000|Inadequate Response to First 3 Cycles|Overall Study||12
8549893|NCT00492050|9581416|FG000|If Adequate Response to First Two Cycles-participants Proceed to Stem Cell Collection|Overall Study||30
8549894|NCT00492050|9581416|FG000|COMPLETED|Overall Study||28
8549895|NCT00492050|9581416|FG000|NOT COMPLETED|Overall Study||9
8549896|NCT00456261|9581422|FG000|STARTED|Combination Therapy||55
8549897|NCT00456261|9581423|FG001|STARTED|Combination Therapy||55
8549898|NCT00456261|9581422|FG000|COMPLETED|Combination Therapy||3
8549899|NCT00456261|9581423|FG001|COMPLETED|Combination Therapy||29
8549900|NCT00456261|9581422|FG000|NOT COMPLETED|Combination Therapy||52
8549901|NCT00456261|9581423|FG001|NOT COMPLETED|Combination Therapy||26
8549902|NCT00456261|9581422|FG000|STARTED|Maintenance Therapy||3
8549903|NCT00456261|9581423|FG001|STARTED|Maintenance Therapy||29
8549904|NCT00456261|9581422|FG000|COMPLETED|Maintenance Therapy||3
8549905|NCT00456261|9581423|FG001|COMPLETED|Maintenance Therapy||29
8549906|NCT00456261|9581422|FG000|NOT COMPLETED|Maintenance Therapy||0
8621627|NCT00482001|9660652|FG001|STARTED|Overall Study||11
8549907|NCT00456261|9581423|FG001|NOT COMPLETED|Maintenance Therapy||0
8621628|NCT00482001|9660651|FG000|COMPLETED|Overall Study||10
8621629|NCT00482001|9660652|FG001|COMPLETED|Overall Study||10
8621630|NCT00482001|9660651|FG000|NOT COMPLETED|Overall Study||1
8549908|NCT00448630|9581429|FG000|STARTED|Overall Study||328
8549909|NCT00448630|9581429|FG000|COMPLETED|Overall Study|Number of patients who remained on same medication to end of study.|301
8549910|NCT00448630|9581429|FG000|NOT COMPLETED|Overall Study||27
8549911|NCT00345345|9581446|FG000|STARTED|Overall Study||29
8549912|NCT00345345|9581446|FG000|COMPLETED|Overall Study||27
8549913|NCT00345345|9581446|FG000|NOT COMPLETED|Overall Study||2
8549914|NCT00127127|9581455|FG000|STARTED|Overall Study||3
8549915|NCT00127127|9581456|FG001|STARTED|Overall Study||6
8549916|NCT00127127|9581457|FG002|STARTED|Overall Study||3
8549917|NCT00127127|9581458|FG003|STARTED|Overall Study||6
8549918|NCT00127127|9581455|FG000|COMPLETED|Overall Study||2
8549919|NCT00127127|9581456|FG001|COMPLETED|Overall Study||1
8549920|NCT00127127|9581457|FG002|COMPLETED|Overall Study||3
8549921|NCT00127127|9581458|FG003|COMPLETED|Overall Study||3
8549922|NCT00127127|9581455|FG000|NOT COMPLETED|Overall Study||1
8549923|NCT00127127|9581456|FG001|NOT COMPLETED|Overall Study||5
8549924|NCT00127127|9581457|FG002|NOT COMPLETED|Overall Study||0
8549925|NCT00127127|9581458|FG003|NOT COMPLETED|Overall Study||3
8549926|NCT00085982|9581495|FG000|STARTED|Overall Study||11
8549927|NCT00085982|9581495|FG000|COMPLETED|Overall Study||5
8549928|NCT00085982|9581495|FG000|NOT COMPLETED|Overall Study||6
8549929|NCT00061945|9581501|FG000|STARTED|Registration Through Course 3||119
8549930|NCT00061945|9581502|FG001|STARTED|Registration Through Course 3||181
8549931|NCT00061945|9581501|FG000|COMPLETED|Registration Through Course 3||25
8549932|NCT00061945|9581502|FG001|COMPLETED|Registration Through Course 3||66
8549933|NCT00061945|9581501|FG000|NOT COMPLETED|Registration Through Course 3||94
8549934|NCT00061945|9581502|FG001|NOT COMPLETED|Registration Through Course 3||115
8549935|NCT00061945|9581501|FG000|STARTED|Course IV: Alemtuzumab||25
8549936|NCT00061945|9581502|FG001|STARTED|Course IV: Alemtuzumab||66
8549937|NCT00061945|9581501|FG000|COMPLETED|Course IV: Alemtuzumab||18
8549938|NCT00061945|9581502|FG001|COMPLETED|Course IV: Alemtuzumab||50
8549939|NCT00061945|9581501|FG000|NOT COMPLETED|Course IV: Alemtuzumab||7
8549940|NCT00061945|9581502|FG001|NOT COMPLETED|Course IV: Alemtuzumab||16
8549941|NCT04018612|9581514|FG000|STARTED|Overall Study||44
8549942|NCT04018612|9581515|FG001|STARTED|Overall Study||44
8549943|NCT04018612|9581516|FG002|STARTED|Overall Study||22
8549944|NCT04018612|9581514|FG000|COMPLETED|Overall Study||43
8549945|NCT04018612|9581515|FG001|COMPLETED|Overall Study||44
8549946|NCT04018612|9581516|FG002|COMPLETED|Overall Study||21
8549947|NCT04018612|9581514|FG000|NOT COMPLETED|Overall Study||1
8549948|NCT04018612|9581515|FG001|NOT COMPLETED|Overall Study||0
8549949|NCT04018612|9581516|FG002|NOT COMPLETED|Overall Study||1
8549950|NCT03976648|9581526|FG000|STARTED|Overall Study||21
8549951|NCT03976648|9581527|FG001|STARTED|Overall Study||10
8549952|NCT03976648|9581526|FG000|COMPLETED|Overall Study||0
8549953|NCT03976648|9581527|FG001|COMPLETED|Overall Study||0
8549954|NCT03976648|9581526|FG000|NOT COMPLETED|Overall Study||21
8549955|NCT03976648|9581527|FG001|NOT COMPLETED|Overall Study||10
8549956|NCT03944486|9581533|FG000|STARTED|Overall Study||24
8549957|NCT03944486|9581533|FG000|COMPLETED|Overall Study||12
8549958|NCT03944486|9581533|FG000|NOT COMPLETED|Overall Study||12
8567617|NCT00086996|9599930|FG000|STARTED|Overall Study||98
8567618|NCT00086996|9599930|FG000|Eligible|Overall Study||93
8567619|NCT00086996|9599930|FG000|Eligible and Began Protocol Therapy|Overall Study||93
8567620|NCT00086996|9599930|FG000|COMPLETED|Overall Study||34
8567621|NCT00086996|9599930|FG000|NOT COMPLETED|Overall Study||64
8567622|NCT00087022|9599936|FG000|STARTED|Overall Study||433
8567623|NCT00087022|9599937|FG001|STARTED|Overall Study||431
8567624|NCT00087022|9599936|FG000|Treated (Safety Population)|Overall Study||431
8567625|NCT00087022|9599937|FG001|Treated (Safety Population)|Overall Study||424
8567626|NCT00087022|9599936|FG000|COMPLETED|Overall Study||379
8567627|NCT00087022|9599937|FG001|COMPLETED|Overall Study||376
8567628|NCT00087022|9599936|FG000|NOT COMPLETED|Overall Study||54
8567629|NCT00087022|9599937|FG001|NOT COMPLETED|Overall Study||55
8567630|NCT00087126|9599943|FG000|STARTED|Overall Study||27
8567631|NCT00087126|9599943|FG000|COMPLETED|Overall Study||25
8567632|NCT00087126|9599943|FG000|NOT COMPLETED|Overall Study||2
8567633|NCT00087139|9599955|FG000|STARTED|Overall Study||39
8567634|NCT00087139|9599956|FG001|STARTED|Overall Study||49
8567635|NCT00087139|9599957|FG002|STARTED|Overall Study||36
8567636|NCT00087139|9599955|FG000|Treated|Overall Study||39
8567637|NCT00087139|9599956|FG001|Treated|Overall Study||48
8567638|NCT00087139|9599957|FG002|Treated|Overall Study||36
8567639|NCT00087139|9599955|FG000|Eligible and Treated|Overall Study||35
8567640|NCT00087139|9599956|FG001|Eligible and Treated|Overall Study||42
8567641|NCT00087139|9599957|FG002|Eligible and Treated|Overall Study||32
8567642|NCT00087139|9599955|FG000|Patients for the Analysis of PSA Respons|Overall Study||30
8567643|NCT00087139|9599956|FG001|Patients for the Analysis of PSA Respons|Overall Study||34
8567644|NCT00087139|9599957|FG002|Patients for the Analysis of PSA Respons|Overall Study||22
8567645|NCT00087139|9599955|FG000|Patients With Measurable Disease|Overall Study||22
8567646|NCT00087139|9599956|FG001|Patients With Measurable Disease|Overall Study||25
8567647|NCT00087139|9599957|FG002|Patients With Measurable Disease|Overall Study||24
8567648|NCT00087139|9599955|FG000|Patients With PSA Response|Overall Study||10
8567649|NCT00087139|9599956|FG001|Patients With PSA Response|Overall Study||8
8567650|NCT00087139|9599957|FG002|Patients With PSA Response|Overall Study||4
8567651|NCT00087139|9599955|FG000|Patients w/ Measurable Disease Response|Overall Study||5
8567652|NCT00087139|9599956|FG001|Patients w/ Measurable Disease Response|Overall Study||2
8567653|NCT00087139|9599957|FG002|Patients w/ Measurable Disease Response|Overall Study||0
8567654|NCT00087139|9599955|FG000|COMPLETED|Overall Study||0
8567655|NCT00087139|9599956|FG001|COMPLETED|Overall Study||0
8567656|NCT00087139|9599957|FG002|COMPLETED|Overall Study||0
8567657|NCT00087139|9599955|FG000|NOT COMPLETED|Overall Study||39
8567658|NCT00087139|9599956|FG001|NOT COMPLETED|Overall Study||49
8818614|NCT01559129|9872416|FG000|STARTED|Open-label Extension Period|One participant elected not to enter the Extension Phase.|6
8818615|NCT01559129|9872417|FG001|STARTED|Open-label Extension Period|Two participants elected not to enter the Extension Phase.|2
8818616|NCT01559129|9872416|FG000|COMPLETED|Open-label Extension Period||0
8549959|NCT03619902|9581537|FG000|STARTED|Overall Study||8
8549960|NCT03619902|9581537|FG000|COMPLETED|Overall Study||6
8549961|NCT03619902|9581537|FG000|NOT COMPLETED|Overall Study||2
8549962|NCT03617523|9581546|FG000|STARTED|Overall Study||30
8549963|NCT03617523|9581547|FG001|STARTED|Overall Study||30
8549964|NCT03617523|9581548|FG002|STARTED|Overall Study||61
8549965|NCT03617523|9581549|FG003|STARTED|Overall Study||59
8549966|NCT03617523|9581550|FG004|STARTED|Overall Study||60
8549967|NCT03617523|9581546|FG000|COMPLETED|Overall Study||30
8549968|NCT03617523|9581547|FG001|COMPLETED|Overall Study||30
8549969|NCT03617523|9581548|FG002|COMPLETED|Overall Study||61
8549970|NCT03617523|9581549|FG003|COMPLETED|Overall Study||59
8549971|NCT03617523|9581550|FG004|COMPLETED|Overall Study||60
8549972|NCT03617523|9581546|FG000|NOT COMPLETED|Overall Study||0
8549973|NCT03617523|9581547|FG001|NOT COMPLETED|Overall Study||0
8549974|NCT03617523|9581548|FG002|NOT COMPLETED|Overall Study||0
8549975|NCT03617523|9581549|FG003|NOT COMPLETED|Overall Study||0
8549976|NCT03617523|9581550|FG004|NOT COMPLETED|Overall Study||0
8549977|NCT03546192|9581569|FG000|STARTED|Overall Study||60
8549978|NCT03546192|9581570|FG001|STARTED|Overall Study||60
8549979|NCT03546192|9581569|FG000|COMPLETED|Overall Study||60
8549980|NCT03546192|9581570|FG001|COMPLETED|Overall Study||60
8549981|NCT03546192|9581569|FG000|NOT COMPLETED|Overall Study||0
8549982|NCT03546192|9581570|FG001|NOT COMPLETED|Overall Study||0
8549983|NCT03517449|9581578|FG000|STARTED|Overall Study||411
8549984|NCT03517449|9581579|FG001|STARTED|Overall Study||416
8549985|NCT03517449|9581578|FG000|Treated|Overall Study||406
8549986|NCT03517449|9581579|FG001|Treated|Overall Study||388
8549987|NCT03517449|9581578|FG000|COMPLETED|Overall Study||0
8549988|NCT03517449|9581579|FG001|COMPLETED|Overall Study||0
8549989|NCT03517449|9581578|FG000|NOT COMPLETED|Overall Study||411
8549990|NCT03517449|9581579|FG001|NOT COMPLETED|Overall Study||416
8549991|NCT03470922|9581587|FG000|STARTED|Overall Study||355
8549992|NCT03470922|9581588|FG001|STARTED|Overall Study||359
8549993|NCT03470922|9581587|FG000|COMPLETED|Overall Study||237
8549994|NCT03470922|9581588|FG001|COMPLETED|Overall Study||227
8549995|NCT03470922|9581587|FG000|NOT COMPLETED|Overall Study||118
8549996|NCT03470922|9581588|FG001|NOT COMPLETED|Overall Study||132
8549997|NCT03387852|9581598|FG000|STARTED|Overall Study||74
8549998|NCT03387852|9581599|FG001|STARTED|Overall Study||73
8549999|NCT03387852|9581600|FG002|STARTED|Overall Study||74
8550000|NCT03387852|9581601|FG003|STARTED|Overall Study||75
8550001|NCT03387852|9581598|FG000|Treated|Overall Study||74
8550002|NCT03387852|9581599|FG001|Treated|Overall Study||73
8550003|NCT03387852|9581600|FG002|Treated|Overall Study||74
8550004|NCT03387852|9581601|FG003|Treated|Overall Study||74
8550005|NCT03387852|9581598|FG000|COMPLETED|Overall Study||41
8550006|NCT03387852|9581599|FG001|COMPLETED|Overall Study||55
8550007|NCT03387852|9581600|FG002|COMPLETED|Overall Study||47
8550008|NCT03387852|9581601|FG003|COMPLETED|Overall Study||56
8550009|NCT03387852|9581598|FG000|NOT COMPLETED|Overall Study||33
8550010|NCT03387852|9581599|FG001|NOT COMPLETED|Overall Study||18
8550011|NCT03387852|9581600|FG002|NOT COMPLETED|Overall Study||27
8550012|NCT03387852|9581601|FG003|NOT COMPLETED|Overall Study||19
8818617|NCT01559129|9872417|FG001|COMPLETED|Open-label Extension Period||0
8818618|NCT01559129|9872416|FG000|NOT COMPLETED|Open-label Extension Period||6
8818619|NCT01559129|9872417|FG001|NOT COMPLETED|Open-label Extension Period||2
8818620|NCT01559259|9872434|FG000|STARTED|Overall Study||30
8818621|NCT01559259|9872435|FG001|STARTED|Overall Study||90
8818622|NCT01559259|9872436|FG002|STARTED|Overall Study||93
8818623|NCT01559259|9872437|FG003|STARTED|Overall Study||89
8818624|NCT01559259|9872438|FG004|STARTED|Overall Study||92
8550013|NCT03308825|9581616|FG000|STARTED|Overall Study|1 child in Group 1 received a 0.5mL dose instead of a 0.25 mL dose and is included in Group 2.|59
8550014|NCT03308825|9581617|FG001|STARTED|Overall Study|1 child in Group 1 received a 0.5mL dose instead of a 0.25 mL dose and is included in Group 2.|61
8550015|NCT03308825|9581618|FG002|STARTED|Overall Study||60
8550016|NCT03308825|9581619|FG003|STARTED|Overall Study||60
8550017|NCT03308825|9581616|FG000|COMPLETED|Overall Study||57
8550018|NCT03308825|9581617|FG001|COMPLETED|Overall Study||57
8550019|NCT03308825|9581618|FG002|COMPLETED|Overall Study||59
8550020|NCT03308825|9581619|FG003|COMPLETED|Overall Study||60
8550021|NCT03308825|9581616|FG000|NOT COMPLETED|Overall Study||2
8550022|NCT03308825|9581617|FG001|NOT COMPLETED|Overall Study||4
8550023|NCT03308825|9581618|FG002|NOT COMPLETED|Overall Study||1
8550024|NCT03308825|9581619|FG003|NOT COMPLETED|Overall Study||0
8550025|NCT02915302|9581635|FG000|STARTED|Overall Study||955
8550026|NCT02915302|9581636|FG001|STARTED|Overall Study||995
8818625|NCT01559259|9872434|FG000|COMPLETED|Overall Study||30
8550027|NCT02915302|9581635|FG000|Vaccinated (Safety Analysis Set)|Overall Study||949
8550028|NCT02915302|9581636|FG001|Vaccinated (Safety Analysis Set)|Overall Study||992
8550029|NCT02915302|9581635|FG000|COMPLETED|Overall Study||890
8550030|NCT02915302|9581636|FG001|COMPLETED|Overall Study||917
8550031|NCT02915302|9581635|FG000|NOT COMPLETED|Overall Study||65
8550032|NCT02915302|9581636|FG001|NOT COMPLETED|Overall Study||78
8550033|NCT02908269|9581645|FG000|STARTED|Overall Study||60
8550034|NCT02908269|9581646|FG001|STARTED|Overall Study||60
8550035|NCT02908269|9581647|FG002|STARTED|Overall Study||60
8550036|NCT02908269|9581645|FG000|COMPLETED|Overall Study||60
8550037|NCT02908269|9581646|FG001|COMPLETED|Overall Study||60
8550038|NCT02908269|9581647|FG002|COMPLETED|Overall Study||60
8550039|NCT02908269|9581645|FG000|NOT COMPLETED|Overall Study||0
8550040|NCT02908269|9581646|FG001|NOT COMPLETED|Overall Study||0
8550041|NCT02908269|9581647|FG002|NOT COMPLETED|Overall Study||0
8550042|NCT02744040|9581659|FG000|STARTED|Overall Study||28
8550043|NCT02744040|9581660|FG001|STARTED|Overall Study||51
8550044|NCT02744040|9581661|FG002|STARTED|Overall Study||72
8550045|NCT02744040|9581659|FG000|COMPLETED|Overall Study||22
8550046|NCT02744040|9581660|FG001|COMPLETED|Overall Study||40
8550047|NCT02744040|9581661|FG002|COMPLETED|Overall Study||50
8550048|NCT02744040|9581659|FG000|NOT COMPLETED|Overall Study||6
8550049|NCT02744040|9581660|FG001|NOT COMPLETED|Overall Study||11
8550050|NCT02744040|9581661|FG002|NOT COMPLETED|Overall Study||22
8550051|NCT02698826|9581669|FG000|STARTED|Overall Study||16
8550052|NCT02698826|9581669|FG000|COMPLETED|Overall Study||2
8550053|NCT02698826|9581669|FG000|NOT COMPLETED|Overall Study||14
8550054|NCT02617589|9581677|FG000|STARTED|All Randomized||280
8550055|NCT02617589|9581678|FG001|STARTED|All Randomized||280
8550056|NCT02617589|9581677|FG000|COMPLETED|All Randomized||278
8550057|NCT02617589|9581678|FG001|COMPLETED|All Randomized||275
8550058|NCT02617589|9581677|FG000|NOT COMPLETED|All Randomized||2
8550059|NCT02617589|9581678|FG001|NOT COMPLETED|All Randomized||5
8550060|NCT02617589|9581677|FG000|STARTED|Treatment Period||278
8550061|NCT02617589|9581678|FG001|STARTED|Treatment Period||275
8550062|NCT02617589|9581677|FG000|COMPLETED|Treatment Period||4
8550063|NCT02617589|9581678|FG001|COMPLETED|Treatment Period||1
8550064|NCT02617589|9581677|FG000|NOT COMPLETED|Treatment Period||274
8550065|NCT02617589|9581678|FG001|NOT COMPLETED|Treatment Period||274
8550066|NCT02614859|9581686|FG000|STARTED|Overall Study||9
8550067|NCT02614859|9581687|FG001|STARTED|Overall Study||20
8550068|NCT02614859|9581686|FG000|COMPLETED|Overall Study||9
8550069|NCT02614859|9581687|FG001|COMPLETED|Overall Study||19
8550070|NCT02614859|9581686|FG000|NOT COMPLETED|Overall Study||0
8550071|NCT02614859|9581687|FG001|NOT COMPLETED|Overall Study||1
8550072|NCT02614066|9581699|FG000|STARTED|Overall Study||6
8550073|NCT02614066|9581700|FG001|STARTED|Overall Study||28
8550074|NCT02614066|9581701|FG002|STARTED|Overall Study||20
8550075|NCT02614066|9581702|FG003|STARTED|Overall Study||71
8550076|NCT02614066|9581699|FG000|COMPLETED|Overall Study||0
8550077|NCT02614066|9581700|FG001|COMPLETED|Overall Study||0
8550078|NCT02614066|9581701|FG002|COMPLETED|Overall Study||0
8550079|NCT02614066|9581702|FG003|COMPLETED|Overall Study||0
8550080|NCT02614066|9581699|FG000|NOT COMPLETED|Overall Study||6
8550081|NCT02614066|9581700|FG001|NOT COMPLETED|Overall Study||28
8550082|NCT02614066|9581701|FG002|NOT COMPLETED|Overall Study||20
8550083|NCT02614066|9581702|FG003|NOT COMPLETED|Overall Study||71
8550084|NCT02558634|9581710|FG000|STARTED|Blinded: First Intervention (3 Months)||4
8550085|NCT02558634|9581711|FG001|STARTED|Blinded: First Intervention (3 Months)||2
8550086|NCT02558634|9581710|FG000|COMPLETED|Blinded: First Intervention (3 Months)||4
8550087|NCT02558634|9581711|FG001|COMPLETED|Blinded: First Intervention (3 Months)||2
8550088|NCT02558634|9581710|FG000|NOT COMPLETED|Blinded: First Intervention (3 Months)||0
8550089|NCT02558634|9581711|FG001|NOT COMPLETED|Blinded: First Intervention (3 Months)||0
8550090|NCT02558634|9581710|FG000|STARTED|Blinded: Second Intervention (3 Months)||4
8550091|NCT02558634|9581711|FG001|STARTED|Blinded: Second Intervention (3 Months)||2
8550092|NCT02558634|9581710|FG000|COMPLETED|Blinded: Second Intervention (3 Months)|Assessed after 2 weeks - 1 participant requested to have their DBS 'on'|3
8550093|NCT02558634|9581711|FG001|COMPLETED|Blinded: Second Intervention (3 Months)||2
8550094|NCT02558634|9581710|FG000|NOT COMPLETED|Blinded: Second Intervention (3 Months)||1
8550095|NCT02558634|9581711|FG001|NOT COMPLETED|Blinded: Second Intervention (3 Months)||0
8550096|NCT02558634|9581710|FG000|STARTED|Unblinded: DBS on (6 Months)||4
8550097|NCT02558634|9581711|FG001|STARTED|Unblinded: DBS on (6 Months)||2
8550098|NCT02558634|9581710|FG000|COMPLETED|Unblinded: DBS on (6 Months)||4
8550099|NCT02558634|9581711|FG001|COMPLETED|Unblinded: DBS on (6 Months)||2
8550100|NCT02558634|9581710|FG000|NOT COMPLETED|Unblinded: DBS on (6 Months)||0
8550101|NCT02558634|9581711|FG001|NOT COMPLETED|Unblinded: DBS on (6 Months)||0
8550102|NCT02519348|9581730|FG000|STARTED|Overall Study||40
8550103|NCT02519348|9581731|FG001|STARTED|Overall Study||104
8550104|NCT02519348|9581732|FG002|STARTED|Overall Study||75
8550105|NCT02519348|9581733|FG003|STARTED|Overall Study||69
8550106|NCT02519348|9581734|FG004|STARTED|Overall Study||84
8550107|NCT02519348|9581735|FG005|STARTED|Overall Study||47
8550108|NCT02519348|9581736|FG006|STARTED|Overall Study||3
8550109|NCT02519348|9581737|FG007|STARTED|Overall Study||5
8550110|NCT02519348|9581738|FG008|STARTED|Overall Study||6
8550111|NCT02519348|9581730|FG000|Treated|Overall Study||40
8550112|NCT02519348|9581731|FG001|Treated|Overall Study||101
8550113|NCT02519348|9581732|FG002|Treated|Overall Study||74
8550114|NCT02519348|9581733|FG003|Treated|Overall Study||69
8550115|NCT02519348|9581734|FG004|Treated|Overall Study||82
8550116|NCT02519348|9581735|FG005|Treated|Overall Study||47
8550117|NCT02519348|9581736|FG006|Treated|Overall Study||3
8550118|NCT02519348|9581737|FG007|Treated|Overall Study||5
8550119|NCT02519348|9581738|FG008|Treated|Overall Study||5
8550120|NCT02519348|9581730|FG000|COMPLETED|Overall Study||0
8550121|NCT02519348|9581731|FG001|COMPLETED|Overall Study||0
8550122|NCT02519348|9581732|FG002|COMPLETED|Overall Study||0
8550123|NCT02519348|9581733|FG003|COMPLETED|Overall Study||0
8550124|NCT02519348|9581734|FG004|COMPLETED|Overall Study||0
8550125|NCT02519348|9581735|FG005|COMPLETED|Overall Study||0
8550126|NCT02519348|9581736|FG006|COMPLETED|Overall Study||0
8550127|NCT02519348|9581737|FG007|COMPLETED|Overall Study||0
8550128|NCT02519348|9581738|FG008|COMPLETED|Overall Study||0
8550129|NCT02519348|9581730|FG000|NOT COMPLETED|Overall Study||40
8550130|NCT02519348|9581731|FG001|NOT COMPLETED|Overall Study||104
8550131|NCT02519348|9581732|FG002|NOT COMPLETED|Overall Study||75
8550132|NCT02519348|9581733|FG003|NOT COMPLETED|Overall Study||69
8550133|NCT02519348|9581734|FG004|NOT COMPLETED|Overall Study||84
8550134|NCT02519348|9581735|FG005|NOT COMPLETED|Overall Study||47
8550135|NCT02519348|9581736|FG006|NOT COMPLETED|Overall Study||3
8550136|NCT02519348|9581737|FG007|NOT COMPLETED|Overall Study||5
8550137|NCT02519348|9581738|FG008|NOT COMPLETED|Overall Study||6
8550138|NCT02429414|9581761|FG000|STARTED|Overall Study||42
8550139|NCT02429414|9581762|FG001|STARTED|Overall Study||38
8550140|NCT02429414|9581761|FG000|COMPLETED|Overall Study||42
8550141|NCT02429414|9581762|FG001|COMPLETED|Overall Study||37
8550142|NCT02429414|9581761|FG000|NOT COMPLETED|Overall Study||0
8550143|NCT02429414|9581762|FG001|NOT COMPLETED|Overall Study||1
8550144|NCT02267603|9581768|FG000|STARTED|Overall Study||50
8818626|NCT01559259|9872435|FG001|COMPLETED|Overall Study||89
8818627|NCT01559259|9872436|FG002|COMPLETED|Overall Study||92
8818628|NCT01559259|9872437|FG003|COMPLETED|Overall Study||88
8818629|NCT01559259|9872438|FG004|COMPLETED|Overall Study||92
8818630|NCT01559259|9872434|FG000|NOT COMPLETED|Overall Study||0
8818631|NCT01559259|9872435|FG001|NOT COMPLETED|Overall Study||1
8550145|NCT02267603|9581768|FG000|COMPLETED|Overall Study||6
8550146|NCT02267603|9581768|FG000|NOT COMPLETED|Overall Study||44
8550147|NCT02258659|9581772|FG000|STARTED|Overall Study||62
8550148|NCT02258659|9581772|FG000|COMPLETED|Overall Study||61
8550149|NCT02258659|9581772|FG000|NOT COMPLETED|Overall Study||1
8550150|NCT02111850|9581787|FG000|STARTED|Phase 1 Dose Escalation||1
8550151|NCT02111850|9581788|FG001|STARTED|Phase 1 Dose Escalation||1
8550152|NCT02111850|9581789|FG002|STARTED|Phase 1 Dose Escalation||1
8550153|NCT02111850|9581790|FG003|STARTED|Phase 1 Dose Escalation||1
8550154|NCT02111850|9581791|FG004|STARTED|Phase 1 Dose Escalation||2
8550155|NCT02111850|9581792|FG005|STARTED|Phase 1 Dose Escalation||1
8550156|NCT02111850|9581793|FG006|STARTED|Phase 1 Dose Escalation||1
8550157|NCT02111850|9581794|FG007|STARTED|Phase 1 Dose Escalation||1
8550158|NCT02111850|9581795|FG008|STARTED|Phase 1 Dose Escalation||6
8550159|NCT02111850|9581796|FG009|STARTED|Phase 1 Dose Escalation||0
8550160|NCT02111850|9581797|FG010|STARTED|Phase 1 Dose Escalation||0
8550161|NCT02111850|9581787|FG000|COMPLETED|Phase 1 Dose Escalation||1
8550162|NCT02111850|9581788|FG001|COMPLETED|Phase 1 Dose Escalation||1
8550163|NCT02111850|9581789|FG002|COMPLETED|Phase 1 Dose Escalation||1
8550164|NCT02111850|9581790|FG003|COMPLETED|Phase 1 Dose Escalation||1
8550165|NCT02111850|9581791|FG004|COMPLETED|Phase 1 Dose Escalation||1
8621631|NCT00482001|9660652|FG001|NOT COMPLETED|Overall Study||1
8621632|NCT00482014|9660664|FG000|STARTED|Overall Study||9
8621633|NCT00482014|9660665|FG001|STARTED|Overall Study||13
8621634|NCT00482014|9660666|FG002|STARTED|Overall Study||46
8621635|NCT00482014|9660667|FG003|STARTED|Overall Study||52
8621636|NCT00482014|9660664|FG000|COMPLETED|Overall Study||2
8621637|NCT00482014|9660665|FG001|COMPLETED|Overall Study||7
8621638|NCT00482014|9660666|FG002|COMPLETED|Overall Study||35
8621639|NCT00482014|9660667|FG003|COMPLETED|Overall Study||29
8621640|NCT00482014|9660664|FG000|NOT COMPLETED|Overall Study||7
8621641|NCT00482014|9660665|FG001|NOT COMPLETED|Overall Study||6
8621642|NCT00482014|9660666|FG002|NOT COMPLETED|Overall Study||11
8621643|NCT00482014|9660667|FG003|NOT COMPLETED|Overall Study||23
8818632|NCT01559259|9872436|FG002|NOT COMPLETED|Overall Study||1
8818633|NCT01559259|9872437|FG003|NOT COMPLETED|Overall Study||1
8818634|NCT01559259|9872438|FG004|NOT COMPLETED|Overall Study||0
8550166|NCT02111850|9581792|FG005|COMPLETED|Phase 1 Dose Escalation||1
8550167|NCT02111850|9581793|FG006|COMPLETED|Phase 1 Dose Escalation||1
8550168|NCT02111850|9581794|FG007|COMPLETED|Phase 1 Dose Escalation||1
8550169|NCT02111850|9581795|FG008|COMPLETED|Phase 1 Dose Escalation||6
8550170|NCT02111850|9581796|FG009|COMPLETED|Phase 1 Dose Escalation||0
8550171|NCT02111850|9581797|FG010|COMPLETED|Phase 1 Dose Escalation||0
8550172|NCT02111850|9581787|FG000|NOT COMPLETED|Phase 1 Dose Escalation||0
8550173|NCT02111850|9581788|FG001|NOT COMPLETED|Phase 1 Dose Escalation||0
8550174|NCT02111850|9581789|FG002|NOT COMPLETED|Phase 1 Dose Escalation||0
8550175|NCT02111850|9581790|FG003|NOT COMPLETED|Phase 1 Dose Escalation||0
8550176|NCT02111850|9581791|FG004|NOT COMPLETED|Phase 1 Dose Escalation||1
8550177|NCT02111850|9581792|FG005|NOT COMPLETED|Phase 1 Dose Escalation||0
8550178|NCT02111850|9581793|FG006|NOT COMPLETED|Phase 1 Dose Escalation||0
8550179|NCT02111850|9581794|FG007|NOT COMPLETED|Phase 1 Dose Escalation||0
8550180|NCT02111850|9581795|FG008|NOT COMPLETED|Phase 1 Dose Escalation||0
8550181|NCT02111850|9581796|FG009|NOT COMPLETED|Phase 1 Dose Escalation||0
8550182|NCT02111850|9581797|FG010|NOT COMPLETED|Phase 1 Dose Escalation||0
8550183|NCT02111850|9581787|FG000|STARTED|Phase 2 Maximum Tolerated Dose||0
8818635|NCT01559311|9872453|FG000|STARTED|Overall Study|Enrollment & Baseline|30
8550184|NCT02111850|9581788|FG001|STARTED|Phase 2 Maximum Tolerated Dose||0
8550185|NCT02111850|9581789|FG002|STARTED|Phase 2 Maximum Tolerated Dose||0
8621644|NCT00482053|9660679|FG000|STARTED|Autologous Peripheral Stem Cells||3
8621645|NCT00482053|9660679|FG000|COMPLETED|Autologous Peripheral Stem Cells||3
8818636|NCT01559311|9872454|FG001|STARTED|Overall Study|Enrollment & Baseline|34
8818637|NCT01559311|9872455|FG002|STARTED|Overall Study|Enrollment & Baseline|34
8550186|NCT02111850|9581790|FG003|STARTED|Phase 2 Maximum Tolerated Dose||0
8550187|NCT02111850|9581791|FG004|STARTED|Phase 2 Maximum Tolerated Dose||0
8550188|NCT02111850|9581792|FG005|STARTED|Phase 2 Maximum Tolerated Dose||0
8550189|NCT02111850|9581793|FG006|STARTED|Phase 2 Maximum Tolerated Dose||0
8550190|NCT02111850|9581794|FG007|STARTED|Phase 2 Maximum Tolerated Dose||0
8550191|NCT02111850|9581795|FG008|STARTED|Phase 2 Maximum Tolerated Dose||0
8550192|NCT02111850|9581796|FG009|STARTED|Phase 2 Maximum Tolerated Dose||5
8550193|NCT02111850|9581797|FG010|STARTED|Phase 2 Maximum Tolerated Dose||1
8550194|NCT02111850|9581787|FG000|COMPLETED|Phase 2 Maximum Tolerated Dose||0
8550195|NCT02111850|9581788|FG001|COMPLETED|Phase 2 Maximum Tolerated Dose||0
8550196|NCT02111850|9581789|FG002|COMPLETED|Phase 2 Maximum Tolerated Dose||0
8550197|NCT02111850|9581790|FG003|COMPLETED|Phase 2 Maximum Tolerated Dose||0
8550198|NCT02111850|9581791|FG004|COMPLETED|Phase 2 Maximum Tolerated Dose||0
8550199|NCT02111850|9581792|FG005|COMPLETED|Phase 2 Maximum Tolerated Dose||0
8550200|NCT02111850|9581793|FG006|COMPLETED|Phase 2 Maximum Tolerated Dose||0
8550201|NCT02111850|9581794|FG007|COMPLETED|Phase 2 Maximum Tolerated Dose||0
8550202|NCT02111850|9581795|FG008|COMPLETED|Phase 2 Maximum Tolerated Dose||0
8550203|NCT02111850|9581796|FG009|COMPLETED|Phase 2 Maximum Tolerated Dose||5
8550204|NCT02111850|9581797|FG010|COMPLETED|Phase 2 Maximum Tolerated Dose||1
8550205|NCT02111850|9581787|FG000|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0
8550206|NCT02111850|9581788|FG001|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0
8550207|NCT02111850|9581789|FG002|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0
8550208|NCT02111850|9581790|FG003|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0
8550209|NCT02111850|9581791|FG004|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0
8550210|NCT02111850|9581792|FG005|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0
8550211|NCT02111850|9581793|FG006|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0
8550212|NCT02111850|9581794|FG007|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0
8550213|NCT02111850|9581795|FG008|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0
8550214|NCT02111850|9581796|FG009|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0
8550215|NCT02111850|9581797|FG010|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0
8567659|NCT00087139|9599957|FG002|NOT COMPLETED|Overall Study||36
8567660|NCT00087152|9599963|FG000|STARTED|Overall Study||27
8567661|NCT00087152|9599963|FG000|COMPLETED|Overall Study||21
8567662|NCT00087152|9599963|FG000|NOT COMPLETED|Overall Study||6
8567663|NCT00087438|9599968|FG000|STARTED|Overall Study||59
8567664|NCT00087438|9599968|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|55
8567665|NCT00087438|9599968|FG000|NOT COMPLETED|Overall Study||4
8567666|NCT00087490|9599976|FG000|STARTED|Overall Study||544
8567667|NCT00087490|9599977|FG001|STARTED|Overall Study||533
8567668|NCT00087490|9599976|FG000|Treated|Overall Study||537
8567669|NCT00087490|9599977|FG001|Treated|Overall Study||515
8567670|NCT00087490|9599976|FG000|COMPLETED|Overall Study||286
8567671|NCT00087490|9599977|FG001|COMPLETED|Overall Study||264
8567672|NCT00087490|9599976|FG000|NOT COMPLETED|Overall Study||258
8567673|NCT00087490|9599977|FG001|NOT COMPLETED|Overall Study||269
8567674|NCT00087516|9599986|FG000|STARTED|Overall Study||238
8567675|NCT00087516|9599987|FG001|STARTED|Overall Study||250
8567676|NCT00087516|9599988|FG002|STARTED|Overall Study||130
8567677|NCT00087516|9599989|FG003|STARTED|Overall Study||123
8567678|NCT00087516|9599986|FG000|COMPLETED|Overall Study||77
8567679|NCT00087516|9599987|FG001|COMPLETED|Overall Study||81
8567680|NCT00087516|9599988|FG002|COMPLETED|Overall Study||33
8567681|NCT00087516|9599989|FG003|COMPLETED|Overall Study||38
8567682|NCT00087516|9599986|FG000|NOT COMPLETED|Overall Study||161
8567683|NCT00087516|9599987|FG001|NOT COMPLETED|Overall Study||169
8567684|NCT00087516|9599988|FG002|NOT COMPLETED|Overall Study||97
8567685|NCT00087516|9599989|FG003|NOT COMPLETED|Overall Study||85
8567686|NCT00087529|9600005|FG000|STARTED|Overall Study||147
8567687|NCT00087529|9600006|FG001|STARTED|Overall Study||292
8567688|NCT00087529|9600005|FG000|COMPLETED|Overall Study||116
8567689|NCT00087529|9600006|FG001|COMPLETED|Overall Study||224
8567690|NCT00087529|9600005|FG000|NOT COMPLETED|Overall Study||31
8567691|NCT00087529|9600006|FG001|NOT COMPLETED|Overall Study||68
8567692|NCT00087555|9600015|FG000|STARTED|Overall Study||66
8567693|NCT00087555|9600016|FG001|STARTED|Overall Study||62
8567694|NCT00087555|9600017|FG002|STARTED|Overall Study||67
8567695|NCT00087555|9600015|FG000|Treated|Overall Study||65
8567696|NCT00087555|9600016|FG001|Treated|Overall Study||60
8567697|NCT00087555|9600017|FG002|Treated|Overall Study||67
8567698|NCT00087555|9600015|FG000|COMPLETED|Overall Study||54
8567699|NCT00087555|9600016|FG001|COMPLETED|Overall Study||51
8567700|NCT00087555|9600017|FG002|COMPLETED|Overall Study||46
8567701|NCT00087555|9600015|FG000|NOT COMPLETED|Overall Study||12
8567702|NCT00087555|9600016|FG001|NOT COMPLETED|Overall Study||11
8567703|NCT00087555|9600017|FG002|NOT COMPLETED|Overall Study||21
8567704|NCT00087568|9600027|FG000|STARTED|Overall Study||32
8567705|NCT00087568|9600028|FG001|STARTED|Overall Study||25
8567706|NCT00087568|9600027|FG000|COMPLETED|Overall Study||2
8567707|NCT00087568|9600028|FG001|COMPLETED|Overall Study||23
8567708|NCT00087568|9600027|FG000|NOT COMPLETED|Overall Study||30
8567709|NCT00087568|9600028|FG001|NOT COMPLETED|Overall Study||2
8567710|NCT00087594|9600036|FG000|STARTED|Overall Study||24
8567711|NCT00087594|9600037|FG001|STARTED|Overall Study||24
8567712|NCT00087594|9600036|FG000|COMPLETED|Overall Study||16
8567713|NCT00087594|9600037|FG001|COMPLETED|Overall Study||12
8567714|NCT00087594|9600036|FG000|NOT COMPLETED|Overall Study||8
8567715|NCT00087594|9600037|FG001|NOT COMPLETED|Overall Study||12
8550216|NCT01983553|9581825|FG000|STARTED|Overall Study||2131
8550217|NCT01983553|9581826|FG001|STARTED|Overall Study||1072
8550218|NCT01983553|9581825|FG000|COMPLETED|Overall Study||2131
8550219|NCT01983553|9581826|FG001|COMPLETED|Overall Study||1072
8550220|NCT01983553|9581825|FG000|NOT COMPLETED|Overall Study||0
8550221|NCT01983553|9581826|FG001|NOT COMPLETED|Overall Study||0
8550222|NCT01760291|9581832|FG000|STARTED|Overall Study||576
8550223|NCT01760291|9581832|FG000|COMPLETED|Overall Study||340
8550224|NCT01760291|9581832|FG000|NOT COMPLETED|Overall Study||236
8550225|NCT01483027|9581838|FG000|STARTED|Overall Study||215
8550226|NCT01483027|9581839|FG001|STARTED|Overall Study||213
8550227|NCT01483027|9581838|FG000|COMPLETED|Overall Study||169
8550228|NCT01483027|9581839|FG001|COMPLETED|Overall Study||153
8550229|NCT01483027|9581838|FG000|NOT COMPLETED|Overall Study||46
8550230|NCT01483027|9581839|FG001|NOT COMPLETED|Overall Study||60
8550231|NCT01472562|9581845|FG000|STARTED|Induction Phase (Week 1- 48)||38
8550232|NCT01472562|9581845|FG000|COMPLETED|Induction Phase (Week 1- 48)||27
8550233|NCT01472562|9581845|FG000|NOT COMPLETED|Induction Phase (Week 1- 48)||11
8621646|NCT00482053|9660679|FG000|NOT COMPLETED|Autologous Peripheral Stem Cells||0
8621647|NCT00482053|9660679|FG000|STARTED|Inter-treatment Period||3
8621648|NCT00482053|9660679|FG000|COMPLETED|Inter-treatment Period||2
8621649|NCT00482053|9660679|FG000|NOT COMPLETED|Inter-treatment Period||1
8621650|NCT00482053|9660679|FG000|STARTED|Allogeneic Peripheral Stem Cells||2
8621651|NCT00482053|9660679|FG000|COMPLETED|Allogeneic Peripheral Stem Cells||2
8621652|NCT00482053|9660679|FG000|NOT COMPLETED|Allogeneic Peripheral Stem Cells||0
8550234|NCT01472562|9581845|FG000|STARTED|Maintenance Phase (Week 49 to PD)||27
8550235|NCT01472562|9581845|FG000|COMPLETED|Maintenance Phase (Week 49 to PD)||4
8550236|NCT01472562|9581845|FG000|NOT COMPLETED|Maintenance Phase (Week 49 to PD)||23
8550237|NCT01379781|9581851|FG000|STARTED|Overall Study||27
8550238|NCT01379781|9581852|FG001|STARTED|Overall Study||27
8550239|NCT01379781|9581851|FG000|COMPLETED|Overall Study||16
8550240|NCT01379781|9581852|FG001|COMPLETED|Overall Study||19
8550241|NCT01379781|9581851|FG000|NOT COMPLETED|Overall Study||11
8550242|NCT01379781|9581852|FG001|NOT COMPLETED|Overall Study||8
8550243|NCT00135200|9581858|FG000|STARTED|Overall Study||16
8550244|NCT00135200|9581858|FG000|COMPLETED|Overall Study||16
8550245|NCT00135200|9581858|FG000|NOT COMPLETED|Overall Study||0
8567716|NCT00087607|9600045|FG000|STARTED|Overall Study||192
8567717|NCT00087607|9600046|FG001|STARTED|Overall Study||193
8567718|NCT00087607|9600045|FG000|COMPLETED|Overall Study||70
8567719|NCT00087607|9600046|FG001|COMPLETED|Overall Study||71
8567720|NCT00087607|9600045|FG000|NOT COMPLETED|Overall Study||122
8567721|NCT00087607|9600046|FG001|NOT COMPLETED|Overall Study||122
8567722|NCT00087633|9600058|FG000|STARTED|Overall Study|Randomized|55
8567723|NCT00087633|9600059|FG001|STARTED|Overall Study|Randomized|60
8567724|NCT00087633|9600058|FG000|COMPLETED|Overall Study|Completed 48 weeks of treatment/observation|31
8567725|NCT00087633|9600059|FG001|COMPLETED|Overall Study|Completed 48 weeks of treatment/observation|43
8567726|NCT00087633|9600058|FG000|NOT COMPLETED|Overall Study||24
8567727|NCT00087633|9600059|FG001|NOT COMPLETED|Overall Study||17
8567728|NCT00087646|9600069|FG000|STARTED|Overall Study||317
8567729|NCT00087646|9600070|FG001|STARTED|Overall Study||156
8567730|NCT00087646|9600071|FG002|STARTED|Overall Study||156
8567731|NCT00087646|9600072|FG003|STARTED|Overall Study||313
8567732|NCT00087646|9600069|FG000|COMPLETED|Overall Study||182
8567733|NCT00087646|9600070|FG001|COMPLETED|Overall Study||114
8567734|NCT00087646|9600071|FG002|COMPLETED|Overall Study||91
8567735|NCT00087646|9600072|FG003|COMPLETED|Overall Study||229
8567736|NCT00087646|9600069|FG000|NOT COMPLETED|Overall Study||135
8567737|NCT00087646|9600070|FG001|NOT COMPLETED|Overall Study||42
8567738|NCT00087646|9600071|FG002|NOT COMPLETED|Overall Study||65
8567739|NCT00087646|9600072|FG003|NOT COMPLETED|Overall Study||84
8567740|NCT00087672|9600087|FG000|STARTED|Overall Study||41
8567741|NCT00087672|9600087|FG000|COMPLETED|Overall Study||41
8567742|NCT00087672|9600087|FG000|NOT COMPLETED|Overall Study||0
8567743|NCT00087685|9600091|FG000|STARTED|Overall Study||35
8567744|NCT00087685|9600091|FG000|COMPLETED|Overall Study||21
8567745|NCT00087685|9600091|FG000|NOT COMPLETED|Overall Study||14
8567746|NCT00087698|9600095|FG000|STARTED|Overall Study||77
8567747|NCT00087698|9600095|FG000|COMPLETED|Overall Study||41
8567748|NCT00087698|9600095|FG000|NOT COMPLETED|Overall Study||36
8567749|NCT00088153|9600101|FG000|STARTED|Overall Study||55
8567750|NCT00088153|9600102|FG001|STARTED|Overall Study||55
8567751|NCT00088153|9600101|FG000|COMPLETED|Overall Study||31
8567752|NCT00088153|9600102|FG001|COMPLETED|Overall Study||30
8567753|NCT00088153|9600101|FG000|NOT COMPLETED|Overall Study||24
8567754|NCT00088153|9600102|FG001|NOT COMPLETED|Overall Study||25
8567755|NCT00088166|9600110|FG000|STARTED|Overall Study||100
8567756|NCT00088166|9600111|FG001|STARTED|Overall Study||100
8567757|NCT00088166|9600110|FG000|COMPLETED|Overall Study||47
8567758|NCT00088166|9600111|FG001|COMPLETED|Overall Study||39
8567759|NCT00088166|9600110|FG000|NOT COMPLETED|Overall Study||53
8567760|NCT00088166|9600111|FG001|NOT COMPLETED|Overall Study||61
8567761|NCT00088205|9600117|FG000|STARTED|Overall Study||60
8567762|NCT00088205|9600117|FG000|Received at Least 1 Dose of Study Drug|Overall Study||60
8567763|NCT00088205|9600117|FG000|Efficacy Population|Overall Study|Participants with diagnosis of relapsed mantle cell lymphoma.|59
8621653|NCT00482170|9660685|FG000|STARTED|Overall Study||207
8621654|NCT00482170|9660686|FG001|STARTED|Overall Study||214
8621655|NCT00482170|9660685|FG000|Treated|Overall Study||207
8567764|NCT00088205|9600117|FG000|COMPLETED|Overall Study||0
8550246|NCT02513394|9581864|FG000|STARTED|Overall Study||2896
8550247|NCT02513394|9581865|FG001|STARTED|Overall Study||2900
8550248|NCT02513394|9581864|FG000|COMPLETED|Overall Study||2884
8550249|NCT02513394|9581865|FG001|COMPLETED|Overall Study||2877
8550250|NCT02513394|9581864|FG000|NOT COMPLETED|Overall Study||12
8621656|NCT00482170|9660686|FG001|Treated|Overall Study||211
8621657|NCT00482170|9660685|FG000|COMPLETED|Overall Study||192
8621658|NCT00482170|9660686|FG001|COMPLETED|Overall Study||194
8621659|NCT00482170|9660685|FG000|NOT COMPLETED|Overall Study||15
8621660|NCT00482170|9660686|FG001|NOT COMPLETED|Overall Study||20
8621661|NCT00482274|9660692|FG000|STARTED|Overall Study||3
8621662|NCT00482274|9660692|FG000|COMPLETED|Overall Study||2
8621663|NCT00482274|9660692|FG000|NOT COMPLETED|Overall Study||1
8621664|NCT00482391|9660696|FG000|STARTED|Overall Study||95
8621665|NCT00482391|9660696|FG000|COMPLETED|Overall Study||92
8621666|NCT00482391|9660696|FG000|NOT COMPLETED|Overall Study||3
8621667|NCT00482547|9660703|FG000|STARTED|Overall Study|599 subjects were enrolled in the silver-coated catheter group.|599
8621668|NCT00482547|9660704|FG001|STARTED|Overall Study|589 subjects were enrolled in the silicone-coated catheter group.|589
8621669|NCT00482547|9660703|FG000|Successful Catheterization|Overall Study|Out of the 599 AgCS subjects 565 (94.3%) had a successful catheterization.|565
8621670|NCT00482547|9660704|FG001|Successful Catheterization|Overall Study|Out of the 589 SiCS catheter subjects 568 (96.4%) had a successful catheterization.|568
8621671|NCT00482547|9660703|FG000|48 Hour Evaluation|Overall Study|426 went on to be included in the Silver-coated 48 hour efficacy evaluable population.|426
8621672|NCT00482547|9660704|FG001|48 Hour Evaluation|Overall Study|428 went on to be included in the Silicone-coated 48 hour efficacy evaluable population.|428
8550251|NCT02513394|9581865|FG001|NOT COMPLETED|Overall Study||23
8550252|NCT02498132|9581874|FG000|STARTED|Overall Study||24
8550253|NCT02498132|9581875|FG001|STARTED|Overall Study||19
8550254|NCT02498132|9581876|FG002|STARTED|Overall Study||9
8550255|NCT02498132|9581874|FG000|COMPLETED|Overall Study||22
8550256|NCT02498132|9581875|FG001|COMPLETED|Overall Study||18
8550257|NCT02498132|9581876|FG002|COMPLETED|Overall Study||9
8550258|NCT02498132|9581874|FG000|NOT COMPLETED|Overall Study||2
8550259|NCT02498132|9581875|FG001|NOT COMPLETED|Overall Study||1
8550260|NCT02498132|9581876|FG002|NOT COMPLETED|Overall Study||0
8550261|NCT02450760|9581886|FG000|STARTED|Overall Study||15
8550262|NCT02450760|9581887|FG001|STARTED|Overall Study||18
8550263|NCT02450760|9581886|FG000|COMPLETED|Overall Study||15
8550264|NCT02450760|9581887|FG001|COMPLETED|Overall Study||18
8550265|NCT02450760|9581886|FG000|NOT COMPLETED|Overall Study||0
8550266|NCT02450760|9581887|FG001|NOT COMPLETED|Overall Study||0
8550267|NCT02445339|9581900|FG000|STARTED|Overall Study||25
8550268|NCT02445339|9581901|FG001|STARTED|Overall Study||25
8550269|NCT02445339|9581900|FG000|COMPLETED|Overall Study||13
8550270|NCT02445339|9581901|FG001|COMPLETED|Overall Study||10
8550271|NCT02445339|9581900|FG000|NOT COMPLETED|Overall Study||12
8550272|NCT02445339|9581901|FG001|NOT COMPLETED|Overall Study||15
8550334|NCT03099486|9581964|FG000|STARTED|Overall Study||2
8550335|NCT03099486|9581964|FG000|COMPLETED|Overall Study||2
8550336|NCT03099486|9581964|FG000|NOT COMPLETED|Overall Study||0
8550337|NCT02991482|9581970|FG000|STARTED|Overall Study||73
8550338|NCT02991482|9581971|FG001|STARTED|Overall Study||71
8550339|NCT02991482|9581970|FG000|Crossed-over to Pembrolizumab at Progression|Overall Study||0
8550340|NCT02991482|9581971|FG001|Crossed-over to Pembrolizumab at Progression|Overall Study||45
8550341|NCT02991482|9581970|FG000|COMPLETED|Overall Study||8
8550342|NCT02991482|9581971|FG001|COMPLETED|Overall Study||5
8550343|NCT02991482|9581970|FG000|NOT COMPLETED|Overall Study||65
8550344|NCT02991482|9581971|FG001|NOT COMPLETED|Overall Study||66
8550345|NCT02768870|9581977|FG000|STARTED|Overall Study||26
8550346|NCT02768870|9581977|FG000|Implanted With Device|Overall Study||24
8550347|NCT02768870|9581977|FG000|COMPLETED|Overall Study||0
8550348|NCT02768870|9581977|FG000|NOT COMPLETED|Overall Study||26
8550349|NCT02648698|9581983|FG000|STARTED|Overall Study||60
8550350|NCT02648698|9581984|FG001|STARTED|Overall Study||60
8550351|NCT02648698|9581983|FG000|COMPLETED|Overall Study||59
8550352|NCT02648698|9581984|FG001|COMPLETED|Overall Study||55
8550353|NCT02648698|9581983|FG000|NOT COMPLETED|Overall Study||1
8550354|NCT02648698|9581984|FG001|NOT COMPLETED|Overall Study||5
8550355|NCT02432196|9581990|FG000|STARTED|Overall Study||26
8550356|NCT02432196|9581990|FG000|Implanted With Device|Overall Study||25
8550357|NCT02432196|9581990|FG000|COMPLETED|Overall Study||0
8550358|NCT02432196|9581990|FG000|NOT COMPLETED|Overall Study||26
8550359|NCT02340676|9581994|FG000|STARTED|Overall Study||25
8550360|NCT02340676|9581994|FG000|COMPLETED|Overall Study||25
8550361|NCT02340676|9581994|FG000|NOT COMPLETED|Overall Study||0
8550362|NCT02000882|9581998|FG000|STARTED|Overall Study||10
8550363|NCT02000882|9581998|FG000|COMPLETED|Overall Study||4
8550364|NCT02000882|9581998|FG000|NOT COMPLETED|Overall Study||6
8550365|NCT01654315|9582005|FG000|STARTED|Overall Study||15
8550366|NCT01654315|9582006|FG001|STARTED|Overall Study||10
8550367|NCT01654315|9582007|FG002|STARTED|Overall Study||9
8550368|NCT01654315|9582005|FG000|COMPLETED|Overall Study||15
8550369|NCT01654315|9582006|FG001|COMPLETED|Overall Study||10
8550370|NCT01654315|9582007|FG002|COMPLETED|Overall Study||9
8550371|NCT01654315|9582005|FG000|NOT COMPLETED|Overall Study||0
8550372|NCT01654315|9582006|FG001|NOT COMPLETED|Overall Study||0
8550373|NCT01654315|9582007|FG002|NOT COMPLETED|Overall Study||0
8550374|NCT01642004|9582017|FG000|STARTED|Randomization||135
8550375|NCT01642004|9582018|FG001|STARTED|Randomization||137
8621673|NCT00482547|9660703|FG000|COMPLETED|Overall Study||426
8621674|NCT00482547|9660704|FG001|COMPLETED|Overall Study||428
8550273|NCT03618056|9581907|FG000|STARTED|Overall Study||1
8550274|NCT03618056|9581907|FG000|COMPLETED|Overall Study||1
8550275|NCT03618056|9581907|FG000|NOT COMPLETED|Overall Study||0
8550276|NCT03503617|9581913|FG000|STARTED|Overall Study||14
8550277|NCT03503617|9581914|FG001|STARTED|Overall Study||13
8550278|NCT03503617|9581913|FG000|COMPLETED|Overall Study||14
8550279|NCT03503617|9581914|FG001|COMPLETED|Overall Study||10
8550280|NCT03503617|9581913|FG000|NOT COMPLETED|Overall Study||0
8550281|NCT03503617|9581914|FG001|NOT COMPLETED|Overall Study||3
8550282|NCT03298867|9581922|FG000|STARTED|Double-Masked 24-Week Treatment Period||42
8550283|NCT03298867|9581923|FG001|STARTED|Double-Masked 24-Week Treatment Period||41
8550284|NCT03298867|9581922|FG000|COMPLETED|Double-Masked 24-Week Treatment Period|36 participants who completed the double-masked treatment period as nonresponders chose to enroll in the OPTIC-X open-label extension study (NCT03461211).|40
8621675|NCT00482547|9660703|FG000|NOT COMPLETED|Overall Study||173
8621676|NCT00482547|9660704|FG001|NOT COMPLETED|Overall Study||161
8621677|NCT00482612|9660714|FG000|STARTED|In-treatment Period||137
8621678|NCT00482612|9660715|FG001|STARTED|In-treatment Period||125
8550285|NCT03298867|9581923|FG001|COMPLETED|Double-Masked 24-Week Treatment Period|3 participants who completed the double-masked treatment period as nonresponders chose to enroll in the OPTIC-X open-label extension study (NCT03461211).|39
8550286|NCT03298867|9581922|FG000|NOT COMPLETED|Double-Masked 24-Week Treatment Period||2
8550287|NCT03298867|9581923|FG001|NOT COMPLETED|Double-Masked 24-Week Treatment Period||2
8550288|NCT03298867|9581922|FG000|STARTED|48-Week Follow-Up Period (Weeks 24-72)||4
8550289|NCT03298867|9581923|FG001|STARTED|48-Week Follow-Up Period (Weeks 24-72)||36
8550290|NCT03298867|9581922|FG000|COMPLETED|48-Week Follow-Up Period (Weeks 24-72)||3
8550291|NCT03298867|9581923|FG001|COMPLETED|48-Week Follow-Up Period (Weeks 24-72)||20
8550292|NCT03298867|9581922|FG000|NOT COMPLETED|48-Week Follow-Up Period (Weeks 24-72)||1
8550293|NCT03298867|9581923|FG001|NOT COMPLETED|48-Week Follow-Up Period (Weeks 24-72)||16
8550294|NCT03298867|9581922|FG000|STARTED|48-Week Follow-Up Contact (Weeks 96-120)||3
8550295|NCT03298867|9581923|FG001|STARTED|48-Week Follow-Up Contact (Weeks 96-120)||20
8550296|NCT03298867|9581922|FG000|COMPLETED|48-Week Follow-Up Contact (Weeks 96-120)||3
8550297|NCT03298867|9581923|FG001|COMPLETED|48-Week Follow-Up Contact (Weeks 96-120)||19
8550298|NCT03298867|9581922|FG000|NOT COMPLETED|48-Week Follow-Up Contact (Weeks 96-120)||0
8550299|NCT03298867|9581923|FG001|NOT COMPLETED|48-Week Follow-Up Contact (Weeks 96-120)||1
8550300|NCT03227224|9581933|FG000|STARTED|Double-blind Treatment Period (6 Weeks)||138
8550301|NCT03227224|9581934|FG001|STARTED|Double-blind Treatment Period (6 Weeks)||33
8550302|NCT03227224|9581935|FG002|STARTED|Double-blind Treatment Period (6 Weeks)||63
8550303|NCT03227224|9581936|FG003|STARTED|Double-blind Treatment Period (6 Weeks)||53
8550304|NCT03227224|9581933|FG000|Treated|Double-blind Treatment Period (6 Weeks)||137
8550305|NCT03227224|9581934|FG001|Treated|Double-blind Treatment Period (6 Weeks)||33
8550306|NCT03227224|9581935|FG002|Treated|Double-blind Treatment Period (6 Weeks)||61
8550307|NCT03227224|9581936|FG003|Treated|Double-blind Treatment Period (6 Weeks)||52
8550308|NCT03227224|9581933|FG000|COMPLETED|Double-blind Treatment Period (6 Weeks)||123
8550309|NCT03227224|9581934|FG001|COMPLETED|Double-blind Treatment Period (6 Weeks)||27
8550310|NCT03227224|9581935|FG002|COMPLETED|Double-blind Treatment Period (6 Weeks)||55
8550311|NCT03227224|9581936|FG003|COMPLETED|Double-blind Treatment Period (6 Weeks)||46
8550312|NCT03227224|9581933|FG000|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||15
8550313|NCT03227224|9581934|FG001|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||6
8550314|NCT03227224|9581935|FG002|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||8
8550315|NCT03227224|9581936|FG003|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||7
8550316|NCT03227224|9581933|FG000|STARTED|Follow-up Phase (2 Weeks)|All participants that started the double-blind period were followed-up for follow-up phase.|138
8550317|NCT03227224|9581934|FG001|STARTED|Follow-up Phase (2 Weeks)|All participants that started the double-blind period were followed-up for follow-up phase.|33
8550318|NCT03227224|9581935|FG002|STARTED|Follow-up Phase (2 Weeks)|All participants that started the double-blind period were followed-up for follow-up phase.|63
8550319|NCT03227224|9581936|FG003|STARTED|Follow-up Phase (2 Weeks)|All participants that started the double-blind period were followed-up for follow-up phase.|53
8550320|NCT03227224|9581933|FG000|COMPLETED|Follow-up Phase (2 Weeks)||134
8550321|NCT03227224|9581934|FG001|COMPLETED|Follow-up Phase (2 Weeks)||29
8550322|NCT03227224|9581935|FG002|COMPLETED|Follow-up Phase (2 Weeks)||57
8550323|NCT03227224|9581936|FG003|COMPLETED|Follow-up Phase (2 Weeks)||50
8550324|NCT03227224|9581933|FG000|NOT COMPLETED|Follow-up Phase (2 Weeks)||4
8550325|NCT03227224|9581934|FG001|NOT COMPLETED|Follow-up Phase (2 Weeks)||4
8550326|NCT03227224|9581935|FG002|NOT COMPLETED|Follow-up Phase (2 Weeks)||6
8550327|NCT03227224|9581936|FG003|NOT COMPLETED|Follow-up Phase (2 Weeks)||3
8550328|NCT03220581|9581955|FG000|STARTED|Overall Study||28
8550329|NCT03220581|9581956|FG001|STARTED|Overall Study||32
8550330|NCT03220581|9581955|FG000|COMPLETED|Overall Study||25
8550331|NCT03220581|9581956|FG001|COMPLETED|Overall Study||25
8550332|NCT03220581|9581955|FG000|NOT COMPLETED|Overall Study||3
8550333|NCT03220581|9581956|FG001|NOT COMPLETED|Overall Study||7
8550376|NCT01642004|9582017|FG000|COMPLETED|Randomization||131
8550377|NCT01642004|9582018|FG001|COMPLETED|Randomization||129
8550378|NCT01642004|9582017|FG000|NOT COMPLETED|Randomization||4
8550379|NCT01642004|9582018|FG001|NOT COMPLETED|Randomization||8
8550380|NCT01642004|9582017|FG000|STARTED|Treatment||131
8621679|NCT00482612|9660716|FG002|STARTED|In-treatment Period||129
8550381|NCT01642004|9582018|FG001|STARTED|Treatment||129
8550382|NCT01642004|9582017|FG000|COMPLETED|Treatment||21
8550383|NCT01642004|9582018|FG001|COMPLETED|Treatment||2
8550384|NCT01642004|9582017|FG000|NOT COMPLETED|Treatment||110
8621680|NCT00482612|9660717|FG003|STARTED|In-treatment Period||135
8621681|NCT00482612|9660714|FG000|Treated|In-treatment Period||137
8621682|NCT00482612|9660715|FG001|Treated|In-treatment Period||125
8621683|NCT00482612|9660716|FG002|Treated|In-treatment Period||128
8621684|NCT00482612|9660717|FG003|Treated|In-treatment Period||135
8621685|NCT00482612|9660714|FG000|COMPLETED|In-treatment Period||137
8550385|NCT01642004|9582018|FG001|NOT COMPLETED|Treatment||127
8550386|NCT01366092|9582024|FG000|STARTED|Overall Study||35
8550387|NCT01366092|9582024|FG000|COMPLETED|Overall Study||31
8550388|NCT01366092|9582024|FG000|NOT COMPLETED|Overall Study||4
8550389|NCT01326104|9582030|FG000|STARTED|Overall Study||7
8550390|NCT01326104|9582031|FG001|STARTED|Overall Study||19
8550391|NCT01326104|9582030|FG000|COMPLETED|Overall Study||7
8550392|NCT01326104|9582031|FG001|COMPLETED|Overall Study||15
8550393|NCT01326104|9582030|FG000|NOT COMPLETED|Overall Study||0
8550394|NCT01326104|9582031|FG001|NOT COMPLETED|Overall Study||4
8550395|NCT01244815|9582041|FG000|STARTED|Overall Study|Randomized|101
8550396|NCT01244815|9582042|FG001|STARTED|Overall Study|Randomized|105
8550397|NCT01244815|9582043|FG002|STARTED|Overall Study|Randomized|99
8550398|NCT01244815|9582044|FG003|STARTED|Overall Study|Randomized|99
8550399|NCT01244815|9582041|FG000|Treated|Overall Study||101
8550400|NCT01244815|9582042|FG001|Treated|Overall Study||104
8550401|NCT01244815|9582043|FG002|Treated|Overall Study||99
8550402|NCT01244815|9582044|FG003|Treated|Overall Study||99
8550403|NCT01244815|9582041|FG000|COMPLETED|Overall Study||87
8550404|NCT01244815|9582042|FG001|COMPLETED|Overall Study||88
8550405|NCT01244815|9582043|FG002|COMPLETED|Overall Study||88
8550406|NCT01244815|9582044|FG003|COMPLETED|Overall Study||87
8550407|NCT01244815|9582041|FG000|NOT COMPLETED|Overall Study||14
8550408|NCT01244815|9582042|FG001|NOT COMPLETED|Overall Study||17
8550409|NCT01244815|9582043|FG002|NOT COMPLETED|Overall Study||11
8550410|NCT01244815|9582044|FG003|NOT COMPLETED|Overall Study||12
8550411|NCT01142596|9582056|FG000|STARTED|Overall Study||44
8550412|NCT01142596|9582057|FG001|STARTED|Overall Study||157
8550413|NCT01142596|9582056|FG000|COMPLETED|Overall Study||15
8550414|NCT01142596|9582057|FG001|COMPLETED|Overall Study||71
8550415|NCT01142596|9582056|FG000|NOT COMPLETED|Overall Study||29
8550416|NCT01142596|9582057|FG001|NOT COMPLETED|Overall Study||86
8550417|NCT01098110|9582066|FG000|STARTED|Overall Study|Randomized participants|176
8550418|NCT01098110|9582067|FG001|STARTED|Overall Study|Randomized participants|182
8550419|NCT01098110|9582068|FG002|STARTED|Overall Study|Randomized participants|174
8550420|NCT01098110|9582066|FG000|Treated|Overall Study|Received at least one dose of trial medication|175
8550421|NCT01098110|9582067|FG001|Treated|Overall Study|Received at least one dose of trial medication|181
8550422|NCT01098110|9582068|FG002|Treated|Overall Study|Received at least one dose of trial medication|174
8550423|NCT01098110|9582066|FG000|COMPLETED|Overall Study||114
8550424|NCT01098110|9582067|FG001|COMPLETED|Overall Study||109
8550425|NCT01098110|9582068|FG002|COMPLETED|Overall Study||80
8550426|NCT01098110|9582066|FG000|NOT COMPLETED|Overall Study||62
8550427|NCT01098110|9582067|FG001|NOT COMPLETED|Overall Study||73
8550428|NCT01098110|9582068|FG002|NOT COMPLETED|Overall Study||94
8550429|NCT01006265|9582080|FG000|STARTED|Overall Study||119
8550430|NCT01006265|9582081|FG001|STARTED|Overall Study||116
8550431|NCT01006265|9582082|FG002|STARTED|Overall Study||108
8550432|NCT01006265|9582083|FG003|STARTED|Overall Study||121
8550433|NCT01006265|9582080|FG000|Treated|Overall Study||119
8550434|NCT01006265|9582081|FG001|Treated|Overall Study||114
8550435|NCT01006265|9582082|FG002|Treated|Overall Study||108
8550436|NCT01006265|9582083|FG003|Treated|Overall Study||121
8550437|NCT01006265|9582080|FG000|COMPLETED|Overall Study||113
8550438|NCT01006265|9582081|FG001|COMPLETED|Overall Study||107
8550439|NCT01006265|9582082|FG002|COMPLETED|Overall Study||99
8550440|NCT01006265|9582083|FG003|COMPLETED|Overall Study||116
8550441|NCT01006265|9582080|FG000|NOT COMPLETED|Overall Study||6
8550442|NCT01006265|9582081|FG001|NOT COMPLETED|Overall Study||9
8550443|NCT01006265|9582082|FG002|NOT COMPLETED|Overall Study||9
8550444|NCT01006265|9582083|FG003|NOT COMPLETED|Overall Study||5
8550445|NCT00591227|9582095|FG000|STARTED|Overall Study||89
8550446|NCT00591227|9582096|FG001|STARTED|Overall Study||87
8621686|NCT00482612|9660715|FG001|COMPLETED|In-treatment Period||125
8621687|NCT00482612|9660716|FG002|COMPLETED|In-treatment Period||128
8550447|NCT00591227|9582095|FG000|COMPLETED|Overall Study||89
8550448|NCT00591227|9582096|FG001|COMPLETED|Overall Study||87
8550449|NCT00591227|9582095|FG000|NOT COMPLETED|Overall Study||0
8550450|NCT00591227|9582096|FG001|NOT COMPLETED|Overall Study||0
8550451|NCT00534976|9582105|FG000|STARTED|Period 1: Placebo Run-in||33
8550452|NCT00534976|9582106|FG001|STARTED|Period 1: Placebo Run-in||33
8550453|NCT00534976|9582105|FG000|COMPLETED|Period 1: Placebo Run-in||33
8550454|NCT00534976|9582106|FG001|COMPLETED|Period 1: Placebo Run-in||33
8550455|NCT00534976|9582105|FG000|NOT COMPLETED|Period 1: Placebo Run-in||0
8550456|NCT00534976|9582106|FG001|NOT COMPLETED|Period 1: Placebo Run-in||0
8550457|NCT00534976|9582105|FG000|STARTED|Period 2: Treatment Montelukast/ Placebo||33
8550458|NCT00534976|9582106|FG001|STARTED|Period 2: Treatment Montelukast/ Placebo||33
8550459|NCT00534976|9582105|FG000|COMPLETED|Period 2: Treatment Montelukast/ Placebo||33
8621688|NCT00482612|9660717|FG003|COMPLETED|In-treatment Period||135
8621689|NCT00482612|9660714|FG000|NOT COMPLETED|In-treatment Period||0
8550460|NCT00534976|9582106|FG001|COMPLETED|Period 2: Treatment Montelukast/ Placebo||32
8550461|NCT00534976|9582105|FG000|NOT COMPLETED|Period 2: Treatment Montelukast/ Placebo||0
8550462|NCT00534976|9582106|FG001|NOT COMPLETED|Period 2: Treatment Montelukast/ Placebo||1
8550463|NCT00534976|9582105|FG000|STARTED|Period 3: Crossover Placebo/ Montelukast||33
8550464|NCT00534976|9582106|FG001|STARTED|Period 3: Crossover Placebo/ Montelukast||32
8550465|NCT00534976|9582105|FG000|COMPLETED|Period 3: Crossover Placebo/ Montelukast||31
8550466|NCT00534976|9582106|FG001|COMPLETED|Period 3: Crossover Placebo/ Montelukast||32
8550467|NCT00534976|9582105|FG000|NOT COMPLETED|Period 3: Crossover Placebo/ Montelukast||2
8550468|NCT00534976|9582106|FG001|NOT COMPLETED|Period 3: Crossover Placebo/ Montelukast||0
8550469|NCT00337675|9582115|FG000|STARTED|Overall Study||589
8550470|NCT00337675|9582116|FG001|STARTED|Overall Study||591
8550471|NCT00337675|9582117|FG002|STARTED|Overall Study||591
8550472|NCT00337675|9582115|FG000|COMPLETED|Overall Study||492
8818638|NCT01559311|9872453|FG000|Implant|Overall Study||28
8818639|NCT01559311|9872454|FG001|Implant|Overall Study||34
8818640|NCT01559311|9872455|FG002|Implant|Overall Study||32
8818641|NCT01559311|9872453|FG000|1-Month|Overall Study||27
8818642|NCT01559311|9872454|FG001|1-Month|Overall Study||34
8818643|NCT01559311|9872455|FG002|1-Month|Overall Study||29
8550473|NCT00337675|9582116|FG001|COMPLETED|Overall Study||488
8550474|NCT00337675|9582117|FG002|COMPLETED|Overall Study||492
8550475|NCT00337675|9582115|FG000|NOT COMPLETED|Overall Study||97
8550476|NCT00337675|9582116|FG001|NOT COMPLETED|Overall Study||103
8550477|NCT00337675|9582117|FG002|NOT COMPLETED|Overall Study||99
8550478|NCT00317772|9582129|FG000|STARTED|Overall Study||3
8550479|NCT00317772|9582130|FG001|STARTED|Overall Study||3
8550480|NCT00317772|9582131|FG002|STARTED|Overall Study||3
8550481|NCT00317772|9582132|FG003|STARTED|Overall Study||10
8550482|NCT00317772|9582129|FG000|COMPLETED|Overall Study||1
8550483|NCT00317772|9582130|FG001|COMPLETED|Overall Study||1
8550484|NCT00317772|9582131|FG002|COMPLETED|Overall Study||2
8550485|NCT00317772|9582132|FG003|COMPLETED|Overall Study||1
8550486|NCT00317772|9582129|FG000|NOT COMPLETED|Overall Study||2
8550487|NCT00317772|9582130|FG001|NOT COMPLETED|Overall Study||2
8550488|NCT00317772|9582131|FG002|NOT COMPLETED|Overall Study||1
8550489|NCT00317772|9582132|FG003|NOT COMPLETED|Overall Study||9
8550490|NCT00291486|9582148|FG000|STARTED|Overall Study||3
8550491|NCT00291486|9582149|FG001|STARTED|Overall Study||6
8550492|NCT00291486|9582150|FG002|STARTED|Overall Study||3
8550493|NCT00291486|9582151|FG003|STARTED|Overall Study||3
8550494|NCT00291486|9582152|FG004|STARTED|Overall Study||4
8550495|NCT00291486|9582148|FG000|COMPLETED|Overall Study||2
8550496|NCT00291486|9582149|FG001|COMPLETED|Overall Study||3
8550497|NCT00291486|9582150|FG002|COMPLETED|Overall Study||2
8550498|NCT00291486|9582151|FG003|COMPLETED|Overall Study||2
8550499|NCT00291486|9582152|FG004|COMPLETED|Overall Study||3
8550500|NCT00291486|9582148|FG000|NOT COMPLETED|Overall Study||1
8550501|NCT00291486|9582149|FG001|NOT COMPLETED|Overall Study||3
8550502|NCT00291486|9582150|FG002|NOT COMPLETED|Overall Study||1
8550503|NCT00291486|9582151|FG003|NOT COMPLETED|Overall Study||1
8550504|NCT00291486|9582152|FG004|NOT COMPLETED|Overall Study||1
8550505|NCT00284856|9582176|FG000|STARTED|Overall Study||347
8550506|NCT00284856|9582177|FG001|STARTED|Overall Study||336
8550507|NCT00284856|9582178|FG002|STARTED|Overall Study||336
8550508|NCT00284856|9582176|FG000|COMPLETED|Overall Study||296
8550509|NCT00284856|9582177|FG001|COMPLETED|Overall Study||286
8550510|NCT00284856|9582178|FG002|COMPLETED|Overall Study||276
8550511|NCT00284856|9582176|FG000|NOT COMPLETED|Overall Study||51
8550512|NCT00284856|9582177|FG001|NOT COMPLETED|Overall Study||50
8550513|NCT00284856|9582178|FG002|NOT COMPLETED|Overall Study||60
8550514|NCT00070707|9582188|FG000|STARTED|Overall Study||113
8818644|NCT01559311|9872453|FG000|3-Month|Overall Study||27
8818645|NCT01559311|9872454|FG001|3-Month|Overall Study||34
8818646|NCT01559311|9872455|FG002|3-Month|Overall Study||29
8818647|NCT01559311|9872453|FG000|6-Month|Overall Study||27
8818648|NCT01559311|9872454|FG001|6-Month|Overall Study||33
8818649|NCT01559311|9872455|FG002|6-Month|Overall Study||28
8818650|NCT01559311|9872453|FG000|COMPLETED|Overall Study|12-Month|27
8818651|NCT01559311|9872454|FG001|COMPLETED|Overall Study|12-Month|28
8818652|NCT01559311|9872455|FG002|COMPLETED|Overall Study|12-Month|26
8550515|NCT00070707|9582189|FG001|STARTED|Overall Study||75
8550516|NCT00070707|9582188|FG000|COMPLETED|Overall Study||99
8550517|NCT00070707|9582189|FG001|COMPLETED|Overall Study||68
8550518|NCT00070707|9582188|FG000|NOT COMPLETED|Overall Study||14
8550519|NCT00070707|9582189|FG001|NOT COMPLETED|Overall Study||7
8567765|NCT00088205|9600117|FG000|NOT COMPLETED|Overall Study||60
8567766|NCT00088218|9600123|FG000|STARTED|Overall Study||16
8567767|NCT00088218|9600124|FG001|STARTED|Overall Study||79
8567768|NCT00088218|9600123|FG000|COMPLETED|Overall Study||16
8567769|NCT00088218|9600124|FG001|COMPLETED|Overall Study||79
8567770|NCT00088218|9600123|FG000|NOT COMPLETED|Overall Study||0
8567771|NCT00088218|9600124|FG001|NOT COMPLETED|Overall Study||0
8567772|NCT00088374|9600130|FG000|STARTED|Overall Study||9
8567773|NCT00088374|9600130|FG000|COMPLETED|Overall Study||7
8567774|NCT00088374|9600130|FG000|NOT COMPLETED|Overall Study||2
8567775|NCT00088413|9600138|FG000|STARTED|Overall Study||10
8567776|NCT00088413|9600139|FG001|STARTED|Overall Study||15
8567777|NCT00088413|9600140|FG002|STARTED|Overall Study||12
8567778|NCT00088413|9600141|FG003|STARTED|Overall Study||14
8567779|NCT00088413|9600138|FG000|COMPLETED|Overall Study||0
8567780|NCT00088413|9600139|FG001|COMPLETED|Overall Study||0
8550520|NCT02358993|9582197|FG000|STARTED|Overall Study||105
8550521|NCT02358993|9582198|FG001|STARTED|Overall Study||96
8550522|NCT02358993|9582197|FG000|COMPLETED|Overall Study||103
8550523|NCT02358993|9582198|FG001|COMPLETED|Overall Study||94
8550524|NCT02358993|9582197|FG000|NOT COMPLETED|Overall Study||2
8550525|NCT02358993|9582198|FG001|NOT COMPLETED|Overall Study||2
8550526|NCT03566199|9582204|FG000|STARTED|Overall Study||1
8550527|NCT03566199|9582205|FG001|STARTED|Overall Study||0
8550528|NCT03566199|9582206|FG002|STARTED|Overall Study||1
8550529|NCT03566199|9582207|FG003|STARTED|Overall Study||0
8621690|NCT00482612|9660715|FG001|NOT COMPLETED|In-treatment Period||0
8621691|NCT00482612|9660716|FG002|NOT COMPLETED|In-treatment Period||1
8621692|NCT00482612|9660717|FG003|NOT COMPLETED|In-treatment Period||0
8621693|NCT00482612|9660714|FG000|STARTED|Follow-up Period||137
8550530|NCT03566199|9582208|FG004|STARTED|Overall Study||1
8550531|NCT03566199|9582209|FG005|STARTED|Overall Study||0
8550532|NCT03566199|9582210|FG006|STARTED|Overall Study||4
8550533|NCT03566199|9582211|FG007|STARTED|Overall Study||0
8550534|NCT03566199|9582204|FG000|COMPLETED|Overall Study||1
8550535|NCT03566199|9582205|FG001|COMPLETED|Overall Study||0
8550536|NCT03566199|9582206|FG002|COMPLETED|Overall Study||1
8550537|NCT03566199|9582207|FG003|COMPLETED|Overall Study||0
8550538|NCT03566199|9582208|FG004|COMPLETED|Overall Study||1
8550539|NCT03566199|9582209|FG005|COMPLETED|Overall Study||0
8550540|NCT03566199|9582210|FG006|COMPLETED|Overall Study||4
8550541|NCT03566199|9582211|FG007|COMPLETED|Overall Study||0
8550542|NCT03566199|9582204|FG000|NOT COMPLETED|Overall Study||0
8550543|NCT03566199|9582205|FG001|NOT COMPLETED|Overall Study||0
8550544|NCT03566199|9582206|FG002|NOT COMPLETED|Overall Study||0
8550545|NCT03566199|9582207|FG003|NOT COMPLETED|Overall Study||0
8550546|NCT03566199|9582208|FG004|NOT COMPLETED|Overall Study||0
8550547|NCT03566199|9582209|FG005|NOT COMPLETED|Overall Study||0
8550548|NCT03566199|9582210|FG006|NOT COMPLETED|Overall Study||0
8550549|NCT03566199|9582211|FG007|NOT COMPLETED|Overall Study||0
8550550|NCT04474197|9582219|FG000|STARTED|Overall Study||7
8550551|NCT04474197|9582220|FG001|STARTED|Overall Study||10
8550552|NCT04474197|9582221|FG002|STARTED|Overall Study||9
8550553|NCT04474197|9582222|FG003|STARTED|Overall Study||18
8550554|NCT04474197|9582219|FG000|COMPLETED|Overall Study||7
8550555|NCT04474197|9582220|FG001|COMPLETED|Overall Study||9
8550556|NCT04474197|9582221|FG002|COMPLETED|Overall Study||9
8550557|NCT04474197|9582222|FG003|COMPLETED|Overall Study||18
8550558|NCT04474197|9582219|FG000|NOT COMPLETED|Overall Study||0
8550559|NCT04474197|9582220|FG001|NOT COMPLETED|Overall Study||1
8550560|NCT04474197|9582221|FG002|NOT COMPLETED|Overall Study||0
8550561|NCT04474197|9582222|FG003|NOT COMPLETED|Overall Study||0
8550562|NCT04391894|9582242|FG000|STARTED|Overall Study||111
8550563|NCT04391894|9582243|FG001|STARTED|Overall Study||112
8550564|NCT04391894|9582244|FG002|STARTED|Overall Study||112
8550565|NCT04391894|9582245|FG003|STARTED|Overall Study||109
8550566|NCT04391894|9582246|FG004|STARTED|Overall Study||114
8550567|NCT04391894|9582242|FG000|COMPLETED|Overall Study||107
8550568|NCT04391894|9582243|FG001|COMPLETED|Overall Study||111
8550569|NCT04391894|9582244|FG002|COMPLETED|Overall Study||108
8550570|NCT04391894|9582245|FG003|COMPLETED|Overall Study||107
8550571|NCT04391894|9582246|FG004|COMPLETED|Overall Study||111
8550572|NCT04391894|9582242|FG000|NOT COMPLETED|Overall Study||4
8550573|NCT04391894|9582243|FG001|NOT COMPLETED|Overall Study||1
8550574|NCT04391894|9582244|FG002|NOT COMPLETED|Overall Study||4
8550575|NCT04391894|9582245|FG003|NOT COMPLETED|Overall Study||2
8550576|NCT04391894|9582246|FG004|NOT COMPLETED|Overall Study||3
8550577|NCT04369950|9582260|FG000|STARTED|Overall Study||22
8550578|NCT04369950|9582261|FG001|STARTED|Overall Study||22
8550579|NCT04369950|9582260|FG000|COMPLETED|Overall Study||20
8550580|NCT04369950|9582261|FG001|COMPLETED|Overall Study||20
8550581|NCT04369950|9582260|FG000|NOT COMPLETED|Overall Study||2
8550582|NCT04369950|9582261|FG001|NOT COMPLETED|Overall Study||2
8550583|NCT04070326|9582269|FG000|STARTED|Baseline Observation-12 Weeks Before TP||4
8550584|NCT04070326|9582270|FG001|STARTED|Baseline Observation-12 Weeks Before TP||17
8550585|NCT04070326|9582269|FG000|COMPLETED|Baseline Observation-12 Weeks Before TP||4
8550586|NCT04070326|9582270|FG001|COMPLETED|Baseline Observation-12 Weeks Before TP||17
8550587|NCT04070326|9582269|FG000|NOT COMPLETED|Baseline Observation-12 Weeks Before TP||0
8550588|NCT04070326|9582270|FG001|NOT COMPLETED|Baseline Observation-12 Weeks Before TP||0
8550589|NCT04070326|9582269|FG000|STARTED|Treatment Period A (Weeks 1 to 26)||4
8550590|NCT04070326|9582270|FG001|STARTED|Treatment Period A (Weeks 1 to 26)||17
8550591|NCT04070326|9582269|FG000|COMPLETED|Treatment Period A (Weeks 1 to 26)||3
8550592|NCT04070326|9582270|FG001|COMPLETED|Treatment Period A (Weeks 1 to 26)||17
8550593|NCT04070326|9582269|FG000|NOT COMPLETED|Treatment Period A (Weeks 1 to 26)||1
8550594|NCT04070326|9582270|FG001|NOT COMPLETED|Treatment Period A (Weeks 1 to 26)||0
8550595|NCT04070326|9582269|FG000|STARTED|Treatment Period B (Weeks 27 to 52)||3
8550596|NCT04070326|9582270|FG001|STARTED|Treatment Period B (Weeks 27 to 52)||17
8550597|NCT04070326|9582269|FG000|COMPLETED|Treatment Period B (Weeks 27 to 52)||3
8550598|NCT04070326|9582270|FG001|COMPLETED|Treatment Period B (Weeks 27 to 52)||17
8550599|NCT04070326|9582269|FG000|NOT COMPLETED|Treatment Period B (Weeks 27 to 52)||0
8550600|NCT04070326|9582270|FG001|NOT COMPLETED|Treatment Period B (Weeks 27 to 52)||0
8550601|NCT04003610|9582281|FG000|STARTED|Overall Study||0
8550602|NCT04003610|9582282|FG001|STARTED|Overall Study||1
8550603|NCT04003610|9582283|FG002|STARTED|Overall Study||6
8621694|NCT00482612|9660715|FG001|STARTED|Follow-up Period||125
8550604|NCT04003610|9582281|FG000|COMPLETED|Overall Study||0
8550605|NCT04003610|9582282|FG001|COMPLETED|Overall Study||0
8550606|NCT04003610|9582283|FG002|COMPLETED|Overall Study||0
8550607|NCT04003610|9582281|FG000|NOT COMPLETED|Overall Study||0
8550608|NCT04003610|9582282|FG001|NOT COMPLETED|Overall Study||1
8550609|NCT04003610|9582283|FG002|NOT COMPLETED|Overall Study||6
8550610|NCT03920293|9582294|FG000|STARTED|Overall Study||86
8550611|NCT03920293|9582295|FG001|STARTED|Overall Study||89
8550612|NCT03920293|9582294|FG000|Received at Least 1 Dose of Study Drug|Overall Study||86
8550613|NCT03920293|9582295|FG001|Received at Least 1 Dose of Study Drug|Overall Study||89
8550614|NCT03920293|9582294|FG000|COMPLETED|Overall Study||79
8550615|NCT03920293|9582295|FG001|COMPLETED|Overall Study||83
8550616|NCT03920293|9582294|FG000|NOT COMPLETED|Overall Study||7
8550617|NCT03920293|9582295|FG001|NOT COMPLETED|Overall Study||6
8550618|NCT03907540|9582301|FG000|STARTED|Overall Study||5
8550619|NCT03907540|9582301|FG000|Completed Part 1|Overall Study||5
8550620|NCT03907540|9582301|FG000|Completed Part 2|Overall Study||5
8550621|NCT03907540|9582301|FG000|COMPLETED|Overall Study||5
8550622|NCT03907540|9582301|FG000|NOT COMPLETED|Overall Study||0
8550623|NCT03904108|9582314|FG000|STARTED|Overall Study||3
8550624|NCT03904108|9582314|FG000|COMPLETED|Overall Study||3
8550625|NCT03904108|9582314|FG000|NOT COMPLETED|Overall Study||0
8550626|NCT03712345|9582321|FG000|STARTED|Overall Study||6
8550627|NCT03712345|9582322|FG001|STARTED|Overall Study||7
8550628|NCT03712345|9582323|FG002|STARTED|Overall Study|One participant was mistakenly randomized, but never treated because the participant was a screening failure.|7
8550629|NCT03712345|9582321|FG000|COMPLETED|Overall Study||6
8550630|NCT03712345|9582322|FG001|COMPLETED|Overall Study||7
8550631|NCT03712345|9582323|FG002|COMPLETED|Overall Study||6
8550632|NCT03712345|9582321|FG000|NOT COMPLETED|Overall Study||0
8550633|NCT03712345|9582322|FG001|NOT COMPLETED|Overall Study||0
8550634|NCT03712345|9582323|FG002|NOT COMPLETED|Overall Study||1
8550635|NCT03694275|9582333|FG000|STARTED|Overall Study||8
8550636|NCT03694275|9582334|FG001|STARTED|Overall Study||12
8550637|NCT03694275|9582333|FG000|COMPLETED|Overall Study||8
8550638|NCT03694275|9582334|FG001|COMPLETED|Overall Study||10
8550639|NCT03694275|9582333|FG000|NOT COMPLETED|Overall Study||0
8550640|NCT03694275|9582334|FG001|NOT COMPLETED|Overall Study||2
8550641|NCT03391232|9582343|FG000|STARTED|Part A - First Dose (1-12weeks)||5
8550642|NCT03391232|9582344|FG001|STARTED|Part A - First Dose (1-12weeks)||6
8550643|NCT03391232|9582343|FG000|COMPLETED|Part A - First Dose (1-12weeks)|This cohort finished the trial here after 12 weeks.|5
8550644|NCT03391232|9582344|FG001|COMPLETED|Part A - First Dose (1-12weeks)|After interim analysis this cohort continued the trial.|6
8550645|NCT03391232|9582343|FG000|NOT COMPLETED|Part A - First Dose (1-12weeks)||0
8550646|NCT03391232|9582344|FG001|NOT COMPLETED|Part A - First Dose (1-12weeks)||0
8550647|NCT03391232|9582343|FG000|STARTED|Part B - Additional 2 Doses (13-38weeks)||0
8550648|NCT03391232|9582344|FG001|STARTED|Part B - Additional 2 Doses (13-38weeks)||6
8550649|NCT03391232|9582343|FG000|COMPLETED|Part B - Additional 2 Doses (13-38weeks)||0
8550650|NCT03391232|9582344|FG001|COMPLETED|Part B - Additional 2 Doses (13-38weeks)||3
8550651|NCT03391232|9582343|FG000|NOT COMPLETED|Part B - Additional 2 Doses (13-38weeks)||0
8550652|NCT03391232|9582344|FG001|NOT COMPLETED|Part B - Additional 2 Doses (13-38weeks)||3
8550653|NCT03323736|9582355|FG000|STARTED|Overall Study||241
8550654|NCT03323736|9582356|FG001|STARTED|Overall Study||59
8550655|NCT03323736|9582357|FG002|STARTED|Overall Study||70
8550656|NCT03323736|9582355|FG000|Treated|Overall Study||222
8550657|NCT03323736|9582356|FG001|Treated|Overall Study||47
8550658|NCT03323736|9582357|FG002|Treated|Overall Study||68
8550659|NCT03323736|9582355|FG000|COMPLETED|Overall Study||222
8550660|NCT03323736|9582356|FG001|COMPLETED|Overall Study||47
8621695|NCT00482612|9660716|FG002|STARTED|Follow-up Period||128
8621696|NCT00482612|9660717|FG003|STARTED|Follow-up Period||135
8621697|NCT00482612|9660714|FG000|COMPLETED|Follow-up Period||123
8621698|NCT00482612|9660715|FG001|COMPLETED|Follow-up Period||107
8621699|NCT00482612|9660716|FG002|COMPLETED|Follow-up Period||106
8621700|NCT00482612|9660717|FG003|COMPLETED|Follow-up Period||127
8621701|NCT00482612|9660714|FG000|NOT COMPLETED|Follow-up Period||14
8621702|NCT00482612|9660715|FG001|NOT COMPLETED|Follow-up Period||18
8621703|NCT00482612|9660716|FG002|NOT COMPLETED|Follow-up Period||22
8621704|NCT00482612|9660717|FG003|NOT COMPLETED|Follow-up Period||8
8621705|NCT00482625|9660731|FG000|STARTED|Overall Study||6
8550661|NCT03323736|9582357|FG002|COMPLETED|Overall Study||68
8550662|NCT03323736|9582355|FG000|NOT COMPLETED|Overall Study||19
8550663|NCT03323736|9582356|FG001|NOT COMPLETED|Overall Study||12
8550664|NCT03323736|9582357|FG002|NOT COMPLETED|Overall Study||2
8550665|NCT03179995|9582369|FG000|STARTED|Overall Study||20
8550666|NCT03179995|9582370|FG001|STARTED|Overall Study||4
8621706|NCT00482625|9660731|FG000|COMPLETED|Overall Study||6
8550667|NCT03179995|9582369|FG000|COMPLETED|Overall Study||4
8550668|NCT03179995|9582370|FG001|COMPLETED|Overall Study||1
8550669|NCT03179995|9582369|FG000|NOT COMPLETED|Overall Study||16
8550670|NCT03179995|9582370|FG001|NOT COMPLETED|Overall Study||3
8550671|NCT03073980|9582379|FG000|STARTED|Overall Study||53
8550672|NCT03073980|9582380|FG001|STARTED|Overall Study||54
8550673|NCT03073980|9582381|FG002|STARTED|Overall Study||54
8550674|NCT03073980|9582379|FG000|COMPLETED|Overall Study||43
8550675|NCT03073980|9582380|FG001|COMPLETED|Overall Study||52
8550676|NCT03073980|9582381|FG002|COMPLETED|Overall Study||43
8621707|NCT00482625|9660731|FG000|NOT COMPLETED|Overall Study||0
8621708|NCT00482677|9660737|FG000|STARTED|Overall Study||281
8550677|NCT03073980|9582379|FG000|NOT COMPLETED|Overall Study||10
8550678|NCT03073980|9582380|FG001|NOT COMPLETED|Overall Study||2
8550679|NCT03073980|9582381|FG002|NOT COMPLETED|Overall Study||11
8550680|NCT02879318|9582395|FG000|STARTED|Overall Study||61
8550681|NCT02879318|9582396|FG001|STARTED|Overall Study||119
8550682|NCT02879318|9582395|FG000|COMPLETED|Overall Study||61
8550683|NCT02879318|9582396|FG001|COMPLETED|Overall Study||119
8550684|NCT02879318|9582395|FG000|NOT COMPLETED|Overall Study||0
8550685|NCT02879318|9582396|FG001|NOT COMPLETED|Overall Study||0
8550686|NCT02544074|9582423|FG000|STARTED|Overall Study||1
8550687|NCT02544074|9582424|FG001|STARTED|Overall Study||1
8550688|NCT02544074|9582425|FG002|STARTED|Overall Study||1
8550689|NCT02544074|9582426|FG003|STARTED|Overall Study||1
8550690|NCT02544074|9582427|FG004|STARTED|Overall Study||4
8550691|NCT02544074|9582428|FG005|STARTED|Overall Study||1
8550692|NCT02544074|9582429|FG006|STARTED|Overall Study||2
8550693|NCT02544074|9582430|FG007|STARTED|Overall Study||4
8550694|NCT02544074|9582431|FG008|STARTED|Overall Study||6
8550695|NCT02544074|9582432|FG009|STARTED|Overall Study||2
8550696|NCT02544074|9582433|FG010|STARTED|Overall Study||2
8550697|NCT02544074|9582434|FG011|STARTED|Overall Study||3
8550698|NCT02544074|9582435|FG012|STARTED|Overall Study||4
8550699|NCT02544074|9582436|FG013|STARTED|Overall Study||5
8550700|NCT02544074|9582437|FG014|STARTED|Overall Study||5
8550701|NCT02544074|9582438|FG015|STARTED|Overall Study||8
8550702|NCT02544074|9582439|FG016|STARTED|Overall Study||6
8550703|NCT02544074|9582440|FG017|STARTED|Overall Study||3
8550704|NCT02544074|9582441|FG018|STARTED|Overall Study||4
8550705|NCT02544074|9582442|FG019|STARTED|Overall Study||3
8550706|NCT02544074|9582443|FG020|STARTED|Overall Study||3
8550707|NCT02544074|9582423|FG000|COMPLETED|Overall Study||1
8550708|NCT02544074|9582424|FG001|COMPLETED|Overall Study||0
8550709|NCT02544074|9582425|FG002|COMPLETED|Overall Study||1
8550710|NCT02544074|9582426|FG003|COMPLETED|Overall Study||1
8550711|NCT02544074|9582427|FG004|COMPLETED|Overall Study||4
8550712|NCT02544074|9582428|FG005|COMPLETED|Overall Study||0
8550713|NCT02544074|9582429|FG006|COMPLETED|Overall Study||2
8550714|NCT02544074|9582430|FG007|COMPLETED|Overall Study||4
8550715|NCT02544074|9582431|FG008|COMPLETED|Overall Study||6
8550716|NCT02544074|9582432|FG009|COMPLETED|Overall Study||1
8550717|NCT02544074|9582433|FG010|COMPLETED|Overall Study||2
8550718|NCT02544074|9582434|FG011|COMPLETED|Overall Study||3
8550719|NCT02544074|9582435|FG012|COMPLETED|Overall Study||4
8550720|NCT02544074|9582436|FG013|COMPLETED|Overall Study||5
8550721|NCT02544074|9582437|FG014|COMPLETED|Overall Study||5
8550722|NCT02544074|9582438|FG015|COMPLETED|Overall Study||8
8550723|NCT02544074|9582439|FG016|COMPLETED|Overall Study||6
8550724|NCT02544074|9582440|FG017|COMPLETED|Overall Study||3
8550725|NCT02544074|9582441|FG018|COMPLETED|Overall Study||4
8550726|NCT02544074|9582442|FG019|COMPLETED|Overall Study||3
8550727|NCT02544074|9582443|FG020|COMPLETED|Overall Study||3
8550728|NCT02544074|9582423|FG000|NOT COMPLETED|Overall Study||0
8550729|NCT02544074|9582424|FG001|NOT COMPLETED|Overall Study||1
8550730|NCT02544074|9582425|FG002|NOT COMPLETED|Overall Study||0
8550731|NCT02544074|9582426|FG003|NOT COMPLETED|Overall Study||0
8550732|NCT02544074|9582427|FG004|NOT COMPLETED|Overall Study||0
8550733|NCT02544074|9582428|FG005|NOT COMPLETED|Overall Study||1
8550734|NCT02544074|9582429|FG006|NOT COMPLETED|Overall Study||0
8550735|NCT02544074|9582430|FG007|NOT COMPLETED|Overall Study||0
8550736|NCT02544074|9582431|FG008|NOT COMPLETED|Overall Study||0
8550737|NCT02544074|9582432|FG009|NOT COMPLETED|Overall Study||1
8550738|NCT02544074|9582433|FG010|NOT COMPLETED|Overall Study||0
8550739|NCT02544074|9582434|FG011|NOT COMPLETED|Overall Study||0
8550740|NCT02544074|9582435|FG012|NOT COMPLETED|Overall Study||0
8550741|NCT02544074|9582436|FG013|NOT COMPLETED|Overall Study||0
8550742|NCT02544074|9582437|FG014|NOT COMPLETED|Overall Study||0
8550743|NCT02544074|9582438|FG015|NOT COMPLETED|Overall Study||0
8550744|NCT02544074|9582439|FG016|NOT COMPLETED|Overall Study||0
8550745|NCT02544074|9582440|FG017|NOT COMPLETED|Overall Study||0
8550746|NCT02544074|9582441|FG018|NOT COMPLETED|Overall Study||0
8550747|NCT02544074|9582442|FG019|NOT COMPLETED|Overall Study||0
8550748|NCT02544074|9582443|FG020|NOT COMPLETED|Overall Study||0
8818653|NCT01559311|9872453|FG000|NOT COMPLETED|Overall Study||3
8818654|NCT01559311|9872454|FG001|NOT COMPLETED|Overall Study||6
8818655|NCT01559311|9872455|FG002|NOT COMPLETED|Overall Study||8
8550749|NCT02367040|9582479|FG000|STARTED|Overall Study||307
8550750|NCT02367040|9582480|FG001|STARTED|Overall Study||151
8550751|NCT02367040|9582479|FG000|Received Treatment|Overall Study||304
8550752|NCT02367040|9582480|FG001|Received Treatment|Overall Study||149
8550753|NCT02367040|9582479|FG000|COMPLETED|Overall Study||70
8550754|NCT02367040|9582480|FG001|COMPLETED|Overall Study||29
8550755|NCT02367040|9582479|FG000|NOT COMPLETED|Overall Study||237
8550756|NCT02367040|9582480|FG001|NOT COMPLETED|Overall Study||122
8550757|NCT02317627|9582489|FG000|STARTED|Overall Study||13
8550758|NCT02317627|9582490|FG001|STARTED|Overall Study||13
8550759|NCT02317627|9582491|FG002|STARTED|Overall Study||12
8550760|NCT02317627|9582489|FG000|COMPLETED|Overall Study||11
8550761|NCT02317627|9582490|FG001|COMPLETED|Overall Study||8
8550762|NCT02317627|9582491|FG002|COMPLETED|Overall Study||8
8550763|NCT02317627|9582489|FG000|NOT COMPLETED|Overall Study||2
8550764|NCT02317627|9582490|FG001|NOT COMPLETED|Overall Study||5
8550765|NCT02317627|9582491|FG002|NOT COMPLETED|Overall Study||4
8550766|NCT01935128|9582505|FG000|STARTED|Overall Study||50
8550767|NCT01935128|9582505|FG000|COMPLETED|Overall Study||43
8550768|NCT01935128|9582505|FG000|NOT COMPLETED|Overall Study||7
8550769|NCT01915498|9582527|FG000|STARTED|Main Analysis (Sept 2013 - Sept 2017)||7
8550770|NCT01915498|9582528|FG001|STARTED|Main Analysis (Sept 2013 - Sept 2017)||7
8550771|NCT01915498|9582529|FG002|STARTED|Main Analysis (Sept 2013 - Sept 2017)||7
8550772|NCT01915498|9582530|FG003|STARTED|Main Analysis (Sept 2013 - Sept 2017)||8
8550773|NCT01915498|9582531|FG004|STARTED|Main Analysis (Sept 2013 - Sept 2017)||5
8550774|NCT01915498|9582532|FG005|STARTED|Main Analysis (Sept 2013 - Sept 2017)||9
8550775|NCT01915498|9582533|FG006|STARTED|Main Analysis (Sept 2013 - Sept 2017)||7
8550776|NCT01915498|9582534|FG007|STARTED|Main Analysis (Sept 2013 - Sept 2017)||22
8550777|NCT01915498|9582535|FG008|STARTED|Main Analysis (Sept 2013 - Sept 2017)||6
8550778|NCT01915498|9582536|FG009|STARTED|Main Analysis (Sept 2013 - Sept 2017)||14
8550779|NCT01915498|9582537|FG010|STARTED|Main Analysis (Sept 2013 - Sept 2017)||9
8550780|NCT01915498|9582538|FG011|STARTED|Main Analysis (Sept 2013 - Sept 2017)||5
8550781|NCT01915498|9582539|FG012|STARTED|Main Analysis (Sept 2013 - Sept 2017)||7
8550782|NCT01915498|9582540|FG013|STARTED|Main Analysis (Sept 2013 - Sept 2017)||49
8550783|NCT01915498|9582541|FG014|STARTED|Main Analysis (Sept 2013 - Sept 2017)||25
8550784|NCT01915498|9582542|FG015|STARTED|Main Analysis (Sept 2013 - Sept 2017)||25
8621709|NCT00482677|9660738|FG001|STARTED|Overall Study||281
8621710|NCT00482677|9660737|FG000|COMPLETED|Overall Study||281
8818656|NCT01559389|9872465|FG000|STARTED|Overall Study||69
8550785|NCT01915498|9582543|FG016|STARTED|Main Analysis (Sept 2013 - Sept 2017)||27
8550786|NCT01915498|9582544|FG017|STARTED|Main Analysis (Sept 2013 - Sept 2017)||106
8550787|NCT01915498|9582545|FG018|STARTED|Main Analysis (Sept 2013 - Sept 2017)||0
8550788|NCT01915498|9582527|FG000|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
8550789|NCT01915498|9582528|FG001|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
8550790|NCT01915498|9582529|FG002|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
8550791|NCT01915498|9582530|FG003|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
8550792|NCT01915498|9582531|FG004|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
8550793|NCT01915498|9582532|FG005|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
8550794|NCT01915498|9582533|FG006|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
8550795|NCT01915498|9582534|FG007|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||1
8550796|NCT01915498|9582535|FG008|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
8550797|NCT01915498|9582536|FG009|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
8550798|NCT01915498|9582537|FG010|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
8550799|NCT01915498|9582538|FG011|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||1
8550800|NCT01915498|9582539|FG012|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
8550801|NCT01915498|9582540|FG013|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||3
8550802|NCT01915498|9582541|FG014|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
8818657|NCT01559389|9872466|FG001|STARTED|Overall Study||69
8818658|NCT01559389|9872465|FG000|COMPLETED|Overall Study||49
8818659|NCT01559389|9872466|FG001|COMPLETED|Overall Study||49
8818660|NCT01559389|9872465|FG000|NOT COMPLETED|Overall Study||20
8818661|NCT01559389|9872466|FG001|NOT COMPLETED|Overall Study||20
8818662|NCT01559454|9872478|FG000|STARTED|Overall Study||9
8818663|NCT01559454|9872479|FG001|STARTED|Overall Study||10
8818664|NCT01559454|9872478|FG000|COMPLETED|Overall Study||6
8818665|NCT01559454|9872479|FG001|COMPLETED|Overall Study||4
8818666|NCT01559454|9872478|FG000|NOT COMPLETED|Overall Study||3
8818667|NCT01559454|9872479|FG001|NOT COMPLETED|Overall Study||6
8818668|NCT01559506|9872487|FG000|STARTED|Overall Study||20
8818669|NCT01559506|9872488|FG001|STARTED|Overall Study||21
8818670|NCT01559506|9872487|FG000|COMPLETED|Overall Study||20
8818671|NCT01559506|9872488|FG001|COMPLETED|Overall Study||18
8818672|NCT01559506|9872487|FG000|NOT COMPLETED|Overall Study||0
8818673|NCT01559506|9872488|FG001|NOT COMPLETED|Overall Study||3
8818674|NCT01559649|9872496|FG000|STARTED|Overall Study||269
8818675|NCT01559649|9872497|FG001|STARTED|Overall Study|Started with 10 nurses. As an RN dropped out due to scheduling, etc, RN replaced with another RN|15
8818676|NCT01559649|9872496|FG000|COMPLETED|Overall Study|Screening not completed in 11, VFSS not completed in 2, 6 excluded from analysis. N=250 analyzed|250
8818677|NCT01559649|9872497|FG001|COMPLETED|Overall Study||9
8818678|NCT01559649|9872496|FG000|NOT COMPLETED|Overall Study||19
8818679|NCT01559649|9872497|FG001|NOT COMPLETED|Overall Study||6
8818680|NCT01559675|9872506|FG000|STARTED|Overall Study||58
8818681|NCT01559675|9872507|FG001|STARTED|Overall Study||63
8818682|NCT01559675|9872506|FG000|COMPLETED|Overall Study||43
8818683|NCT01559675|9872507|FG001|COMPLETED|Overall Study||49
8818684|NCT01559675|9872506|FG000|NOT COMPLETED|Overall Study||15
8818685|NCT01559675|9872507|FG001|NOT COMPLETED|Overall Study||14
8818686|NCT01559844|9872513|FG000|STARTED|Overall Study||61
8818687|NCT01559844|9872513|FG000|COMPLETED|Overall Study||36
8818688|NCT01559844|9872513|FG000|NOT COMPLETED|Overall Study||25
8818689|NCT01559857|9872519|FG000|STARTED|Overall Study||19
8818690|NCT01559857|9872520|FG001|STARTED|Overall Study||18
8818691|NCT01559857|9872519|FG000|COMPLETED|Overall Study||19
8818692|NCT01559857|9872520|FG001|COMPLETED|Overall Study||18
8818693|NCT01559857|9872519|FG000|NOT COMPLETED|Overall Study||0
8818694|NCT01559857|9872520|FG001|NOT COMPLETED|Overall Study||0
8818695|NCT01559922|9872530|FG000|STARTED|Overall Study||50
8818696|NCT01559922|9872531|FG001|STARTED|Overall Study||97
8818697|NCT01559922|9872530|FG000|COMPLETED|Overall Study||46
8818698|NCT01559922|9872531|FG001|COMPLETED|Overall Study||87
8818699|NCT01559922|9872530|FG000|NOT COMPLETED|Overall Study||4
8818700|NCT01559922|9872531|FG001|NOT COMPLETED|Overall Study||10
8550803|NCT01915498|9582542|FG015|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||2
8550804|NCT01915498|9582543|FG016|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||3
8550805|NCT01915498|9582544|FG017|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||6
8550806|NCT01915498|9582545|FG018|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
8550807|NCT01915498|9582527|FG000|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||7
8550808|NCT01915498|9582528|FG001|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||7
8550809|NCT01915498|9582529|FG002|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||7
8550810|NCT01915498|9582530|FG003|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||8
8550811|NCT01915498|9582531|FG004|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||5
8550812|NCT01915498|9582532|FG005|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||9
8550813|NCT01915498|9582533|FG006|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||7
8550814|NCT01915498|9582534|FG007|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||21
8550815|NCT01915498|9582535|FG008|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||6
8550816|NCT01915498|9582536|FG009|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||14
8550817|NCT01915498|9582537|FG010|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||9
8550818|NCT01915498|9582538|FG011|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||4
8550819|NCT01915498|9582539|FG012|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||7
8550820|NCT01915498|9582540|FG013|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||46
8550821|NCT01915498|9582541|FG014|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||25
8550822|NCT01915498|9582542|FG015|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||23
8550823|NCT01915498|9582543|FG016|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||24
8550824|NCT01915498|9582544|FG017|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||100
8550825|NCT01915498|9582545|FG018|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
8550826|NCT01915498|9582527|FG000|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
8550827|NCT01915498|9582528|FG001|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
8550828|NCT01915498|9582529|FG002|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
8550829|NCT01915498|9582530|FG003|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
8550830|NCT01915498|9582531|FG004|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
8550831|NCT01915498|9582532|FG005|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
8550832|NCT01915498|9582533|FG006|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
8550833|NCT01915498|9582534|FG007|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
8550834|NCT01915498|9582535|FG008|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
8550835|NCT01915498|9582536|FG009|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
8550836|NCT01915498|9582537|FG010|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
8550837|NCT01915498|9582538|FG011|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
8550838|NCT01915498|9582539|FG012|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
8550839|NCT01915498|9582540|FG013|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
8550840|NCT01915498|9582541|FG014|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
8550841|NCT01915498|9582542|FG015|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
8550842|NCT01915498|9582543|FG016|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
8550843|NCT01915498|9582544|FG017|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
8550844|NCT01915498|9582545|FG018|STARTED|Safety Follow-up (Sept 2017 to July 2019||16
8550845|NCT01915498|9582527|FG000|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8550846|NCT01915498|9582528|FG001|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8550847|NCT01915498|9582529|FG002|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8550848|NCT01915498|9582530|FG003|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8550849|NCT01915498|9582531|FG004|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8550850|NCT01915498|9582532|FG005|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8550851|NCT01915498|9582533|FG006|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8550852|NCT01915498|9582534|FG007|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8550853|NCT01915498|9582535|FG008|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8550854|NCT01915498|9582536|FG009|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8550855|NCT01915498|9582537|FG010|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8550856|NCT01915498|9582538|FG011|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8550857|NCT01915498|9582539|FG012|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8550858|NCT01915498|9582540|FG013|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8550859|NCT01915498|9582541|FG014|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8550860|NCT01915498|9582542|FG015|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8550861|NCT01915498|9582543|FG016|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8550862|NCT01915498|9582544|FG017|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8550863|NCT01915498|9582545|FG018|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||14
8550864|NCT01915498|9582527|FG000|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8550865|NCT01915498|9582528|FG001|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8550866|NCT01915498|9582529|FG002|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8550867|NCT01915498|9582530|FG003|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8567781|NCT00088413|9600140|FG002|COMPLETED|Overall Study||0
8567782|NCT00088413|9600141|FG003|COMPLETED|Overall Study||0
8567783|NCT00088413|9600138|FG000|NOT COMPLETED|Overall Study||10
8567784|NCT00088413|9600139|FG001|NOT COMPLETED|Overall Study||15
8567785|NCT00088413|9600140|FG002|NOT COMPLETED|Overall Study||12
8567786|NCT00088413|9600141|FG003|NOT COMPLETED|Overall Study||14
8567787|NCT00088452|9600156|FG000|STARTED|Overall Study||156
8567788|NCT00088452|9600157|FG001|STARTED|Overall Study||149
8550868|NCT01915498|9582531|FG004|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8550869|NCT01915498|9582532|FG005|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8550870|NCT01915498|9582533|FG006|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8550871|NCT01915498|9582534|FG007|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8550872|NCT01915498|9582535|FG008|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8550873|NCT01915498|9582536|FG009|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8550874|NCT01915498|9582537|FG010|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8550875|NCT01915498|9582538|FG011|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8550876|NCT01915498|9582539|FG012|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8550877|NCT01915498|9582540|FG013|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8550878|NCT01915498|9582541|FG014|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8550879|NCT01915498|9582542|FG015|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8550880|NCT01915498|9582543|FG016|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8550881|NCT01915498|9582544|FG017|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8550882|NCT01915498|9582545|FG018|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||2
8550883|NCT01909934|9582633|FG000|STARTED|Overall Study||50
8550884|NCT01909934|9582633|FG000|COMPLETED|Overall Study||0
8550885|NCT01909934|9582633|FG000|NOT COMPLETED|Overall Study||50
8550886|NCT01841359|9582637|FG000|STARTED|Overall Study||22
8550887|NCT01841359|9582637|FG000|COMPLETED|Overall Study||14
8550888|NCT01841359|9582637|FG000|NOT COMPLETED|Overall Study||8
8550889|NCT01459666|9582646|FG000|STARTED|Overall Study||5
8550890|NCT01459666|9582647|FG001|STARTED|Overall Study||4
8550891|NCT01459666|9582646|FG000|COMPLETED|Overall Study||0
8550892|NCT01459666|9582647|FG001|COMPLETED|Overall Study||0
8550893|NCT01459666|9582646|FG000|NOT COMPLETED|Overall Study||5
8550894|NCT01459666|9582647|FG001|NOT COMPLETED|Overall Study||4
8550895|NCT01369199|9582653|FG000|STARTED|Overall Study||28
8550896|NCT01369199|9582653|FG000|End of Treatment (EOT)|Overall Study|1 withdrew consent before treatment,1 missed end of treatment (EOT) visit but completed follow-up.|26
8550897|NCT01369199|9582653|FG000|COMPLETED|Overall Study||25
8550898|NCT01369199|9582653|FG000|NOT COMPLETED|Overall Study||3
8550899|NCT01368497|9582657|FG000|STARTED|Overall Study||60
8550900|NCT01368497|9582657|FG000|End of Treatment|Overall Study|Five discontinued study drugs early and completed the follow-up period per protocol.|60
8550901|NCT01368497|9582657|FG000|COMPLETED|Overall Study||58
8550902|NCT01368497|9582657|FG000|NOT COMPLETED|Overall Study||2
8550903|NCT01065454|9582665|FG000|STARTED|Treatment||67
8550904|NCT01065454|9582666|FG001|STARTED|Treatment||33
8550905|NCT01065454|9582667|FG002|STARTED|Treatment||32
8550906|NCT01065454|9582668|FG003|STARTED|Treatment||69
8550907|NCT01065454|9582665|FG000|COMPLETED|Treatment||54
8550908|NCT01065454|9582666|FG001|COMPLETED|Treatment||28
8550909|NCT01065454|9582667|FG002|COMPLETED|Treatment||23
8550910|NCT01065454|9582668|FG003|COMPLETED|Treatment||57
8550911|NCT01065454|9582665|FG000|NOT COMPLETED|Treatment||13
8550912|NCT01065454|9582666|FG001|NOT COMPLETED|Treatment||5
8550913|NCT01065454|9582667|FG002|NOT COMPLETED|Treatment||9
8550914|NCT01065454|9582668|FG003|NOT COMPLETED|Treatment||12
8550915|NCT01065454|9582665|FG000|STARTED|Follow up||54
8550916|NCT01065454|9582666|FG001|STARTED|Follow up||28
8550917|NCT01065454|9582667|FG002|STARTED|Follow up||23
8550918|NCT01065454|9582668|FG003|STARTED|Follow up||57
8550919|NCT01065454|9582665|FG000|Entering Follow-up|Follow up||49
8550920|NCT01065454|9582666|FG001|Entering Follow-up|Follow up||27
8550921|NCT01065454|9582667|FG002|Entering Follow-up|Follow up||23
8550922|NCT01065454|9582668|FG003|Entering Follow-up|Follow up||51
8550923|NCT01065454|9582665|FG000|COMPLETED|Follow up||15
8550924|NCT01065454|9582666|FG001|COMPLETED|Follow up||4
8550925|NCT01065454|9582667|FG002|COMPLETED|Follow up||6
8550926|NCT01065454|9582668|FG003|COMPLETED|Follow up||13
8550927|NCT01065454|9582665|FG000|NOT COMPLETED|Follow up||39
8550928|NCT01065454|9582666|FG001|NOT COMPLETED|Follow up||24
8550929|NCT01065454|9582667|FG002|NOT COMPLETED|Follow up||17
8550930|NCT01065454|9582668|FG003|NOT COMPLETED|Follow up||44
8550931|NCT00977574|9582681|FG000|STARTED|Overall Study||116
8550932|NCT00977574|9582682|FG001|STARTED|Overall Study||115
8550933|NCT00977574|9582683|FG002|STARTED|Overall Study||118
8550934|NCT00977574|9582681|FG000|COMPLETED|Overall Study||112
8550935|NCT00977574|9582682|FG001|COMPLETED|Overall Study||113
8550936|NCT00977574|9582683|FG002|COMPLETED|Overall Study||114
8550937|NCT00977574|9582681|FG000|NOT COMPLETED|Overall Study||4
8550938|NCT00977574|9582682|FG001|NOT COMPLETED|Overall Study||2
8550939|NCT00977574|9582683|FG002|NOT COMPLETED|Overall Study||4
8567789|NCT00088452|9600158|FG002|STARTED|Overall Study||148
8567790|NCT00088452|9600156|FG000|COMPLETED|Overall Study||155
8567791|NCT00088452|9600157|FG001|COMPLETED|Overall Study||149
8567792|NCT00088452|9600158|FG002|COMPLETED|Overall Study||147
8567793|NCT00088452|9600156|FG000|NOT COMPLETED|Overall Study||1
8567794|NCT00088452|9600157|FG001|NOT COMPLETED|Overall Study||0
8567795|NCT00088452|9600158|FG002|NOT COMPLETED|Overall Study||1
8567796|NCT00088465|9600166|FG000|STARTED|Overall Study||931
8567797|NCT00088465|9600166|FG000|COMPLETED|Overall Study||370
8567798|NCT00088465|9600166|FG000|NOT COMPLETED|Overall Study||561
8567799|NCT00088530|9600172|FG000|STARTED|Overall Study||70
8567800|NCT00088530|9600173|FG001|STARTED|Overall Study||70
8567801|NCT00088530|9600172|FG000|COMPLETED|Overall Study||20
8567802|NCT00088530|9600173|FG001|COMPLETED|Overall Study||16
8567803|NCT00088530|9600172|FG000|NOT COMPLETED|Overall Study||50
8550940|NCT05096312|9582693|FG000|STARTED|Overall Study||11
8550941|NCT05096312|9582694|FG001|STARTED|Overall Study||12
8550942|NCT05096312|9582693|FG000|COMPLETED|Overall Study||8
8550943|NCT05096312|9582694|FG001|COMPLETED|Overall Study||8
8550944|NCT05096312|9582693|FG000|NOT COMPLETED|Overall Study||3
8550945|NCT05096312|9582694|FG001|NOT COMPLETED|Overall Study||4
8550946|NCT02853344|9582702|FG000|STARTED|Overall Study||110
8550947|NCT02853344|9582703|FG001|STARTED|Overall Study||165
8550948|NCT02853344|9582702|FG000|COMPLETED|Overall Study||0
8550949|NCT02853344|9582703|FG001|COMPLETED|Overall Study||0
8550950|NCT02853344|9582702|FG000|NOT COMPLETED|Overall Study||110
8550951|NCT02853344|9582703|FG001|NOT COMPLETED|Overall Study||165
8550952|NCT03560258|9582714|FG000|STARTED|Overall Study||22
8550953|NCT03560258|9582715|FG001|STARTED|Overall Study||11
8550954|NCT03560258|9582716|FG002|STARTED|Overall Study||12
8550955|NCT03560258|9582714|FG000|Received at Least 1 Dose of Treatment|Overall Study||22
8550956|NCT03560258|9582715|FG001|Received at Least 1 Dose of Treatment|Overall Study||10
8550957|NCT03560258|9582716|FG002|Received at Least 1 Dose of Treatment|Overall Study||12
8550958|NCT03560258|9582714|FG000|COMPLETED|Overall Study||19
8550959|NCT03560258|9582715|FG001|COMPLETED|Overall Study||10
8550960|NCT03560258|9582716|FG002|COMPLETED|Overall Study||11
8550961|NCT03560258|9582714|FG000|NOT COMPLETED|Overall Study||3
8550962|NCT03560258|9582715|FG001|NOT COMPLETED|Overall Study||1
8550963|NCT03560258|9582716|FG002|NOT COMPLETED|Overall Study||1
8550964|NCT03684304|9582726|FG000|STARTED|Overall Study||19
8550965|NCT03684304|9582727|FG001|STARTED|Overall Study||17
8550966|NCT03684304|9582726|FG000|COMPLETED|Overall Study||0
8550967|NCT03684304|9582727|FG001|COMPLETED|Overall Study||0
8550968|NCT03684304|9582726|FG000|NOT COMPLETED|Overall Study||19
8550969|NCT03684304|9582727|FG001|NOT COMPLETED|Overall Study||17
8550970|NCT03275168|9582735|FG000|STARTED|Overall Study||34
8550971|NCT03275168|9582736|FG001|STARTED|Overall Study||34
8550972|NCT03275168|9582735|FG000|COMPLETED|Overall Study||27
8550973|NCT03275168|9582736|FG001|COMPLETED|Overall Study||25
8550974|NCT03275168|9582735|FG000|NOT COMPLETED|Overall Study||7
8550975|NCT03275168|9582736|FG001|NOT COMPLETED|Overall Study||9
8550976|NCT04528641|9582748|FG000|STARTED|Overall Study||15
8550977|NCT04528641|9582749|FG001|STARTED|Overall Study||15
8550978|NCT04528641|9582750|FG002|STARTED|Overall Study||15
8621711|NCT00482677|9660738|FG001|COMPLETED|Overall Study||281
8621712|NCT00482677|9660737|FG000|NOT COMPLETED|Overall Study||0
8621713|NCT00482677|9660738|FG001|NOT COMPLETED|Overall Study||0
8621714|NCT00482703|9660746|FG000|STARTED|Overall Study|number enrolled, randomized and treated|11
8621715|NCT00482703|9660747|FG001|STARTED|Overall Study|number enrolled, randomized and treated|12
8818701|NCT01559948|9872539|FG000|STARTED|Overall Study||15
8550979|NCT04528641|9582751|FG003|STARTED|Overall Study||16
8550980|NCT04528641|9582752|FG004|STARTED|Overall Study||15
8550981|NCT04528641|9582753|FG005|STARTED|Overall Study||15
8550982|NCT04528641|9582748|FG000|COMPLETED|Overall Study||15
8550983|NCT04528641|9582749|FG001|COMPLETED|Overall Study||15
8550984|NCT04528641|9582750|FG002|COMPLETED|Overall Study||15
8818702|NCT01559948|9872540|FG001|STARTED|Overall Study||15
8818703|NCT01559948|9872539|FG000|COMPLETED|Overall Study||15
8818704|NCT01559948|9872540|FG001|COMPLETED|Overall Study||15
8818705|NCT01559948|9872539|FG000|NOT COMPLETED|Overall Study||0
8818706|NCT01559948|9872540|FG001|NOT COMPLETED|Overall Study||0
8818707|NCT01560143|9872550|FG000|STARTED|Overall Study||12
8550985|NCT04528641|9582751|FG003|COMPLETED|Overall Study||15
8550986|NCT04528641|9582752|FG004|COMPLETED|Overall Study||15
8550987|NCT04528641|9582753|FG005|COMPLETED|Overall Study||14
8550988|NCT04528641|9582748|FG000|NOT COMPLETED|Overall Study||0
8550989|NCT04528641|9582749|FG001|NOT COMPLETED|Overall Study||0
8550990|NCT04528641|9582750|FG002|NOT COMPLETED|Overall Study||0
8550991|NCT04528641|9582751|FG003|NOT COMPLETED|Overall Study||1
8550992|NCT04528641|9582752|FG004|NOT COMPLETED|Overall Study||0
8550993|NCT04528641|9582753|FG005|NOT COMPLETED|Overall Study||1
8818708|NCT01560143|9872550|FG000|COMPLETED|Overall Study||12
8818709|NCT01560143|9872550|FG000|NOT COMPLETED|Overall Study||0
8818710|NCT01560234|9872562|FG000|STARTED|Overall Study||16
8818711|NCT01560234|9872563|FG001|STARTED|Overall Study||4
8818712|NCT01560234|9872564|FG002|STARTED|Overall Study||4
8818713|NCT01560234|9872565|FG003|STARTED|Overall Study||3
8818714|NCT01560234|9872566|FG004|STARTED|Overall Study||4
8818715|NCT01560234|9872567|FG005|STARTED|Overall Study||4
8818716|NCT01560234|9872568|FG006|STARTED|Overall Study||4
8818717|NCT01560234|9872569|FG007|STARTED|Overall Study||8
8818718|NCT01560234|9872562|FG000|COMPLETED|Overall Study||13
8818719|NCT01560234|9872563|FG001|COMPLETED|Overall Study||4
8818720|NCT01560234|9872564|FG002|COMPLETED|Overall Study||3
8818721|NCT01560234|9872565|FG003|COMPLETED|Overall Study||3
8818722|NCT01560234|9872566|FG004|COMPLETED|Overall Study||4
8550994|NCT04497883|9582772|FG000|STARTED|Treatment Period 1 (2 Days)||12
8550995|NCT04497883|9582773|FG001|STARTED|Treatment Period 1 (2 Days)||12
8550996|NCT04497883|9582774|FG002|STARTED|Treatment Period 1 (2 Days)||0
8818723|NCT01560234|9872567|FG005|COMPLETED|Overall Study||2
8818724|NCT01560234|9872568|FG006|COMPLETED|Overall Study||4
8818725|NCT01560234|9872569|FG007|COMPLETED|Overall Study||6
8550997|NCT04497883|9582775|FG003|STARTED|Treatment Period 1 (2 Days)||0
8818726|NCT01560234|9872562|FG000|NOT COMPLETED|Overall Study||3
8550998|NCT04497883|9582772|FG000|COMPLETED|Treatment Period 1 (2 Days)||12
8550999|NCT04497883|9582773|FG001|COMPLETED|Treatment Period 1 (2 Days)||12
8551000|NCT04497883|9582774|FG002|COMPLETED|Treatment Period 1 (2 Days)||0
8551001|NCT04497883|9582775|FG003|COMPLETED|Treatment Period 1 (2 Days)||0
8551002|NCT04497883|9582772|FG000|NOT COMPLETED|Treatment Period 1 (2 Days)||0
8551003|NCT04497883|9582773|FG001|NOT COMPLETED|Treatment Period 1 (2 Days)||0
8551004|NCT04497883|9582774|FG002|NOT COMPLETED|Treatment Period 1 (2 Days)||0
8551005|NCT04497883|9582775|FG003|NOT COMPLETED|Treatment Period 1 (2 Days)||0
8551006|NCT04497883|9582772|FG000|STARTED|Washout Period 1 (72 Hours)||12
8551007|NCT04497883|9582773|FG001|STARTED|Washout Period 1 (72 Hours)||12
8551008|NCT04497883|9582774|FG002|STARTED|Washout Period 1 (72 Hours)||0
8551009|NCT04497883|9582775|FG003|STARTED|Washout Period 1 (72 Hours)||0
8551010|NCT04497883|9582772|FG000|COMPLETED|Washout Period 1 (72 Hours)||12
8551011|NCT04497883|9582773|FG001|COMPLETED|Washout Period 1 (72 Hours)||12
8551012|NCT04497883|9582774|FG002|COMPLETED|Washout Period 1 (72 Hours)||0
8551013|NCT04497883|9582775|FG003|COMPLETED|Washout Period 1 (72 Hours)||0
8551014|NCT04497883|9582772|FG000|NOT COMPLETED|Washout Period 1 (72 Hours)||0
8551015|NCT04497883|9582773|FG001|NOT COMPLETED|Washout Period 1 (72 Hours)||0
8551016|NCT04497883|9582774|FG002|NOT COMPLETED|Washout Period 1 (72 Hours)||0
8551017|NCT04497883|9582775|FG003|NOT COMPLETED|Washout Period 1 (72 Hours)||0
8551018|NCT04497883|9582772|FG000|STARTED|Treatment Period 2 (2 Days)||0
8551019|NCT04497883|9582773|FG001|STARTED|Treatment Period 2 (2 Days)||0
8551020|NCT04497883|9582774|FG002|STARTED|Treatment Period 2 (2 Days)||6
8551021|NCT04497883|9582775|FG003|STARTED|Treatment Period 2 (2 Days)||6
8551022|NCT04497883|9582772|FG000|COMPLETED|Treatment Period 2 (2 Days)||0
8551023|NCT04497883|9582773|FG001|COMPLETED|Treatment Period 2 (2 Days)||0
8551024|NCT04497883|9582774|FG002|COMPLETED|Treatment Period 2 (2 Days)||6
8551025|NCT04497883|9582775|FG003|COMPLETED|Treatment Period 2 (2 Days)||6
8551026|NCT04497883|9582772|FG000|NOT COMPLETED|Treatment Period 2 (2 Days)||0
8551027|NCT04497883|9582773|FG001|NOT COMPLETED|Treatment Period 2 (2 Days)||0
8551028|NCT04497883|9582774|FG002|NOT COMPLETED|Treatment Period 2 (2 Days)||0
8551029|NCT04497883|9582775|FG003|NOT COMPLETED|Treatment Period 2 (2 Days)||0
8551030|NCT04497883|9582772|FG000|STARTED|Washout Period 2 (72 Hours)||0
8551031|NCT04497883|9582773|FG001|STARTED|Washout Period 2 (72 Hours)||0
8551032|NCT04497883|9582774|FG002|STARTED|Washout Period 2 (72 Hours)||6
8551033|NCT04497883|9582775|FG003|STARTED|Washout Period 2 (72 Hours)||6
8551034|NCT04497883|9582772|FG000|COMPLETED|Washout Period 2 (72 Hours)||0
8551035|NCT04497883|9582773|FG001|COMPLETED|Washout Period 2 (72 Hours)||0
8551036|NCT04497883|9582774|FG002|COMPLETED|Washout Period 2 (72 Hours)||6
8551037|NCT04497883|9582775|FG003|COMPLETED|Washout Period 2 (72 Hours)||6
8551038|NCT04497883|9582772|FG000|NOT COMPLETED|Washout Period 2 (72 Hours)||0
8551039|NCT04497883|9582773|FG001|NOT COMPLETED|Washout Period 2 (72 Hours)||0
8551040|NCT04497883|9582774|FG002|NOT COMPLETED|Washout Period 2 (72 Hours)||0
8551041|NCT04497883|9582775|FG003|NOT COMPLETED|Washout Period 2 (72 Hours)||0
8551042|NCT04497883|9582772|FG000|STARTED|Treatment Period 3 (2 Days)||0
8551043|NCT04497883|9582773|FG001|STARTED|Treatment Period 3 (2 Days)||0
8551044|NCT04497883|9582774|FG002|STARTED|Treatment Period 3 (2 Days)||6
8551045|NCT04497883|9582775|FG003|STARTED|Treatment Period 3 (2 Days)||6
8551046|NCT04497883|9582772|FG000|COMPLETED|Treatment Period 3 (2 Days)||0
8551047|NCT04497883|9582773|FG001|COMPLETED|Treatment Period 3 (2 Days)||0
8551048|NCT04497883|9582774|FG002|COMPLETED|Treatment Period 3 (2 Days)||6
8551049|NCT04497883|9582775|FG003|COMPLETED|Treatment Period 3 (2 Days)||6
8551050|NCT04497883|9582772|FG000|NOT COMPLETED|Treatment Period 3 (2 Days)||0
8551051|NCT04497883|9582773|FG001|NOT COMPLETED|Treatment Period 3 (2 Days)||0
8551052|NCT04497883|9582774|FG002|NOT COMPLETED|Treatment Period 3 (2 Days)||0
8551053|NCT04497883|9582775|FG003|NOT COMPLETED|Treatment Period 3 (2 Days)||0
8551054|NCT04034238|9582789|FG000|STARTED|Dose Escalation Phase||7
8551055|NCT04034238|9582790|FG001|STARTED|Dose Escalation Phase||3
8551056|NCT04034238|9582791|FG002|STARTED|Dose Escalation Phase||0
8551057|NCT04034238|9582792|FG003|STARTED|Dose Escalation Phase||2
8551058|NCT04034238|9582789|FG000|COMPLETED|Dose Escalation Phase||6
8551059|NCT04034238|9582790|FG001|COMPLETED|Dose Escalation Phase||3
8818727|NCT01560234|9872563|FG001|NOT COMPLETED|Overall Study||0
8818728|NCT01560234|9872564|FG002|NOT COMPLETED|Overall Study||1
8818729|NCT01560234|9872565|FG003|NOT COMPLETED|Overall Study||0
8818730|NCT01560234|9872566|FG004|NOT COMPLETED|Overall Study||0
8818731|NCT01560234|9872567|FG005|NOT COMPLETED|Overall Study||2
8818732|NCT01560234|9872568|FG006|NOT COMPLETED|Overall Study||0
8818733|NCT01560234|9872569|FG007|NOT COMPLETED|Overall Study||2
8818734|NCT01560260|9872587|FG000|STARTED|Overall Study||20
8818735|NCT01560260|9872587|FG000|COMPLETED|Overall Study||20
8818736|NCT01560260|9872587|FG000|NOT COMPLETED|Overall Study||0
8551060|NCT04034238|9582791|FG002|COMPLETED|Dose Escalation Phase||0
8551061|NCT04034238|9582792|FG003|COMPLETED|Dose Escalation Phase||0
8551062|NCT04034238|9582789|FG000|NOT COMPLETED|Dose Escalation Phase||1
8551063|NCT04034238|9582790|FG001|NOT COMPLETED|Dose Escalation Phase||0
8551064|NCT04034238|9582791|FG002|NOT COMPLETED|Dose Escalation Phase||0
8551065|NCT04034238|9582792|FG003|NOT COMPLETED|Dose Escalation Phase||2
8551066|NCT04034238|9582789|FG000|STARTED|Dose Expansion Phase||0
8551067|NCT04034238|9582790|FG001|STARTED|Dose Expansion Phase||0
8551068|NCT04034238|9582791|FG002|STARTED|Dose Expansion Phase||6
8551069|NCT04034238|9582792|FG003|STARTED|Dose Expansion Phase||1
8551070|NCT04034238|9582789|FG000|COMPLETED|Dose Expansion Phase||0
8551071|NCT04034238|9582790|FG001|COMPLETED|Dose Expansion Phase||0
8818737|NCT01560286|9872593|FG000|STARTED|Overall Study||24
8551072|NCT04034238|9582791|FG002|COMPLETED|Dose Expansion Phase||5
8551073|NCT04034238|9582792|FG003|COMPLETED|Dose Expansion Phase||0
8551074|NCT04034238|9582789|FG000|NOT COMPLETED|Dose Expansion Phase||0
8551075|NCT04034238|9582790|FG001|NOT COMPLETED|Dose Expansion Phase||0
8551076|NCT04034238|9582791|FG002|NOT COMPLETED|Dose Expansion Phase||1
8551077|NCT04034238|9582792|FG003|NOT COMPLETED|Dose Expansion Phase||1
8567804|NCT00088530|9600173|FG001|NOT COMPLETED|Overall Study||54
8567805|NCT00088595|9600179|FG000|STARTED|Overall Study||45
8567806|NCT00088595|9600179|FG000|COMPLETED|Overall Study||17
8567807|NCT00088595|9600179|FG000|NOT COMPLETED|Overall Study||28
8567808|NCT00088621|9600193|FG000|STARTED|Overall Study||61
8567809|NCT00088621|9600193|FG000|COMPLETED|Overall Study||7
8567810|NCT00088621|9600193|FG000|NOT COMPLETED|Overall Study||54
8567811|NCT00088634|9600199|FG000|STARTED|Overall Study||90
8567812|NCT00088634|9600200|FG001|STARTED|Overall Study||90
8567813|NCT00088634|9600199|FG000|COMPLETED|Overall Study||52
8567814|NCT00088634|9600200|FG001|COMPLETED|Overall Study||47
8567815|NCT00088634|9600199|FG000|NOT COMPLETED|Overall Study||38
8567816|NCT00088634|9600200|FG001|NOT COMPLETED|Overall Study||43
8567817|NCT00088699|9600208|FG000|STARTED|Infusion 1||23
8567818|NCT00088699|9600209|FG001|STARTED|Infusion 1||19
8567819|NCT00088699|9600210|FG002|STARTED|Infusion 1||13
8567820|NCT00088699|9600211|FG003|STARTED|Infusion 1||12
8567821|NCT00088699|9600208|FG000|COMPLETED|Infusion 1||22
8567822|NCT00088699|9600209|FG001|COMPLETED|Infusion 1||19
8567823|NCT00088699|9600210|FG002|COMPLETED|Infusion 1||12
8567824|NCT00088699|9600211|FG003|COMPLETED|Infusion 1||10
8567825|NCT00088699|9600208|FG000|NOT COMPLETED|Infusion 1||1
8567826|NCT00088699|9600209|FG001|NOT COMPLETED|Infusion 1||0
8567827|NCT00088699|9600210|FG002|NOT COMPLETED|Infusion 1||1
8567828|NCT00088699|9600211|FG003|NOT COMPLETED|Infusion 1||2
8567829|NCT00088699|9600208|FG000|STARTED|Infusion 2||19
8567830|NCT00088699|9600209|FG001|STARTED|Infusion 2||18
8567831|NCT00088699|9600210|FG002|STARTED|Infusion 2||11
8567832|NCT00088699|9600211|FG003|STARTED|Infusion 2||11
8567833|NCT00088699|9600208|FG000|COMPLETED|Infusion 2||19
8567834|NCT00088699|9600209|FG001|COMPLETED|Infusion 2||18
8567835|NCT00088699|9600210|FG002|COMPLETED|Infusion 2||11
8567836|NCT00088699|9600211|FG003|COMPLETED|Infusion 2||10
8567837|NCT00088699|9600208|FG000|NOT COMPLETED|Infusion 2||0
8567838|NCT00088699|9600209|FG001|NOT COMPLETED|Infusion 2||0
8567839|NCT00088699|9600210|FG002|NOT COMPLETED|Infusion 2||0
8567840|NCT00088699|9600211|FG003|NOT COMPLETED|Infusion 2||1
8567841|NCT00088881|9600221|FG000|STARTED|Step 1 - R-CHOP||62
8567842|NCT00088881|9600221|FG000|Eligible and Treated|Step 1 - R-CHOP||53
8567843|NCT00088881|9600221|FG000|COMPLETED|Step 1 - R-CHOP||48
8567844|NCT00088881|9600221|FG000|NOT COMPLETED|Step 1 - R-CHOP||14
8567845|NCT00088881|9600221|FG000|STARTED|Step 2 - Zevalin™ Radioimmunotherapy|This includes all patients who received step 2 treatment regardless of eligibility.|56
8567846|NCT00088881|9600221|FG000|Eligible and Treated|Step 2 - Zevalin™ Radioimmunotherapy||48
8567847|NCT00088881|9600221|FG000|COMPLETED|Step 2 - Zevalin™ Radioimmunotherapy||45
8567848|NCT00088881|9600221|FG000|NOT COMPLETED|Step 2 - Zevalin™ Radioimmunotherapy||11
8567849|NCT00088881|9600221|FG000|STARTED|Step 3 - Radiation Therapy||1
8621716|NCT00482703|9660746|FG000|COMPLETED|Overall Study||10
8621717|NCT00482703|9660747|FG001|COMPLETED|Overall Study||12
8621718|NCT00482703|9660746|FG000|NOT COMPLETED|Overall Study||1
8818738|NCT01560286|9872593|FG000|COMPLETED|Overall Study||24
8818739|NCT01560286|9872593|FG000|NOT COMPLETED|Overall Study||0
8818740|NCT01560377|9872597|FG000|STARTED|Overall Study||147
8818741|NCT01560377|9872597|FG000|Eligible for Analysis|Overall Study||139
8818742|NCT01560377|9872597|FG000|COMPLETED|Overall Study||147
8818743|NCT01560377|9872597|FG000|NOT COMPLETED|Overall Study||0
8818744|NCT01560403|9872603|FG000|STARTED|Overall Study||5
8818745|NCT01560403|9872604|FG001|STARTED|Overall Study||9
8818746|NCT01560403|9872603|FG000|COMPLETED|Overall Study||5
8818747|NCT01560403|9872604|FG001|COMPLETED|Overall Study||8
8818748|NCT01560403|9872603|FG000|NOT COMPLETED|Overall Study||0
8818749|NCT01560403|9872604|FG001|NOT COMPLETED|Overall Study||1
8818750|NCT01560416|9872612|FG000|STARTED|Randomized Phase||15
8818751|NCT01560416|9872613|FG001|STARTED|Randomized Phase||35
8818752|NCT01560416|9872612|FG000|COMPLETED|Randomized Phase||8
8818753|NCT01560416|9872613|FG001|COMPLETED|Randomized Phase||35
8818754|NCT01560416|9872612|FG000|NOT COMPLETED|Randomized Phase||7
8567850|NCT00088881|9600221|FG000|COMPLETED|Step 3 - Radiation Therapy||1
8567851|NCT00088881|9600221|FG000|NOT COMPLETED|Step 3 - Radiation Therapy||0
8567852|NCT00088907|9600229|FG000|STARTED|Randomized Study (Step 1)||136
8567853|NCT00088907|9600230|FG001|STARTED|Randomized Study (Step 1)||134
8567854|NCT00088907|9600229|FG000|Treated|Randomized Study (Step 1)||129
8567855|NCT00088907|9600230|FG001|Treated|Randomized Study (Step 1)||124
8567856|NCT00088907|9600229|FG000|Eligible|Randomized Study (Step 1)||117
8567857|NCT00088907|9600230|FG001|Eligible|Randomized Study (Step 1)||122
8567858|NCT00088907|9600229|FG000|Eligible and Treated|Randomized Study (Step 1)||117
8621719|NCT00482703|9660747|FG001|NOT COMPLETED|Overall Study||0
8818755|NCT01560416|9872613|FG001|NOT COMPLETED|Randomized Phase||0
8818756|NCT01560416|9872612|FG000|STARTED|Crossover Phase||7
8567859|NCT00088907|9600230|FG001|Eligible and Treated|Randomized Study (Step 1)||122
8567860|NCT00088907|9600229|FG000|COMPLETED|Randomized Study (Step 1)|Treatment would continue until disease progression, no certain fixed number of cycles.|0
8569349|NCT00096356|9601566|FG001|COMPLETED|Overall Study||61
8818757|NCT01560416|9872613|FG001|STARTED|Crossover Phase||0
8551078|NCT03984305|9582805|FG000|STARTED|Overall Study||23
8551079|NCT03984305|9582806|FG001|STARTED|Overall Study||18
8551080|NCT03984305|9582805|FG000|COMPLETED|Overall Study||0
8551081|NCT03984305|9582806|FG001|COMPLETED|Overall Study||0
8551082|NCT03984305|9582805|FG000|NOT COMPLETED|Overall Study||23
8551083|NCT03984305|9582806|FG001|NOT COMPLETED|Overall Study||18
8551084|NCT03982368|9582815|FG000|STARTED|Overall Study||87
8551085|NCT03982368|9582816|FG001|STARTED|Overall Study||86
8551086|NCT03982368|9582817|FG002|STARTED|Overall Study||88
8551087|NCT03982368|9582815|FG000|FAS Popuation|Overall Study||81
8551088|NCT03982368|9582816|FG001|FAS Popuation|Overall Study||82
8551089|NCT03982368|9582817|FG002|FAS Popuation|Overall Study||84
8551090|NCT03982368|9582815|FG000|PP Population|Overall Study||72
8551091|NCT03982368|9582816|FG001|PP Population|Overall Study||71
8551092|NCT03982368|9582817|FG002|PP Population|Overall Study||80
8551093|NCT03982368|9582815|FG000|COMPLETED|Overall Study||74
8551094|NCT03982368|9582816|FG001|COMPLETED|Overall Study||79
8551095|NCT03982368|9582817|FG002|COMPLETED|Overall Study||83
8551096|NCT03982368|9582815|FG000|NOT COMPLETED|Overall Study||13
8551097|NCT03982368|9582816|FG001|NOT COMPLETED|Overall Study||7
8551098|NCT03982368|9582817|FG002|NOT COMPLETED|Overall Study||5
8551099|NCT03952143|9582830|FG000|STARTED|Lead-In Period||628
8551100|NCT03952143|9582831|FG001|STARTED|Lead-In Period||0
8551101|NCT03952143|9582832|FG002|STARTED|Lead-In Period||0
8551102|NCT03952143|9582830|FG000|Participants Who Received at Least One Dose|Lead-In Period||628
8551103|NCT03952143|9582831|FG001|Participants Who Received at Least One Dose|Lead-In Period||0
8551104|NCT03952143|9582832|FG002|Participants Who Received at Least One Dose|Lead-In Period||0
8551105|NCT03952143|9582830|FG000|COMPLETED|Lead-In Period||595
8551106|NCT03952143|9582831|FG001|COMPLETED|Lead-In Period||0
8551107|NCT03952143|9582832|FG002|COMPLETED|Lead-In Period||0
8551108|NCT03952143|9582830|FG000|NOT COMPLETED|Lead-In Period||33
8551109|NCT03952143|9582831|FG001|NOT COMPLETED|Lead-In Period||0
8551110|NCT03952143|9582832|FG002|NOT COMPLETED|Lead-In Period||0
8551111|NCT03952143|9582830|FG000|STARTED|Treatment Period|Participants received Insulin Lispro during Lead-in Period|0
8551112|NCT03952143|9582831|FG001|STARTED|Treatment Period|Participants were randomized to either Insulin lispro or LY900014 in Treatment Period.|200
8551113|NCT03952143|9582832|FG002|STARTED|Treatment Period|Participants were randomized to either Insulin lispro or LY900014 in Treatment Period.|395
8551114|NCT03952143|9582830|FG000|Participants Who Received at Least One Dose|Treatment Period||0
8551115|NCT03952143|9582831|FG001|Participants Who Received at Least One Dose|Treatment Period||200
8551116|NCT03952143|9582832|FG002|Participants Who Received at Least One Dose|Treatment Period||395
8551117|NCT03952143|9582830|FG000|COMPLETED|Treatment Period||0
8551118|NCT03952143|9582831|FG001|COMPLETED|Treatment Period||191
8551119|NCT03952143|9582832|FG002|COMPLETED|Treatment Period||359
8551120|NCT03952143|9582830|FG000|NOT COMPLETED|Treatment Period||0
8551121|NCT03952143|9582831|FG001|NOT COMPLETED|Treatment Period||9
8551122|NCT03952143|9582832|FG002|NOT COMPLETED|Treatment Period||36
8551123|NCT03924752|9582839|FG000|STARTED|Overall Study||10
8551124|NCT03924752|9582839|FG000|COMPLETED|Overall Study||10
8551125|NCT03924752|9582839|FG000|NOT COMPLETED|Overall Study||0
8551126|NCT03829514|9582843|FG000|STARTED|Overall Study||10
8551127|NCT03829514|9582843|FG000|COMPLETED|Overall Study||10
8551128|NCT03829514|9582843|FG000|NOT COMPLETED|Overall Study||0
8551129|NCT03691428|9582849|FG000|STARTED|Overall Study||48
8551130|NCT03691428|9582850|FG001|STARTED|Overall Study||42
8551131|NCT03691428|9582849|FG000|COMPLETED|Overall Study||42
8551132|NCT03691428|9582850|FG001|COMPLETED|Overall Study||34
8551133|NCT03691428|9582849|FG000|NOT COMPLETED|Overall Study||6
8551134|NCT03691428|9582850|FG001|NOT COMPLETED|Overall Study||8
8551135|NCT03685708|9582859|FG000|STARTED|Overall Study||14
8551136|NCT03685708|9582860|FG001|STARTED|Overall Study||18
8551137|NCT03685708|9582861|FG002|STARTED|Overall Study||46
8551138|NCT03685708|9582859|FG000|COMPLETED|Overall Study||13
8551139|NCT03685708|9582860|FG001|COMPLETED|Overall Study||16
8551140|NCT03685708|9582861|FG002|COMPLETED|Overall Study||37
8551141|NCT03685708|9582859|FG000|NOT COMPLETED|Overall Study||1
8551142|NCT03685708|9582860|FG001|NOT COMPLETED|Overall Study||2
8551143|NCT03685708|9582861|FG002|NOT COMPLETED|Overall Study||9
8551144|NCT03669588|9582871|FG000|STARTED|Overall Study||84
8551145|NCT03669588|9582872|FG001|STARTED|Overall Study||83
8551146|NCT03669588|9582871|FG000|COMPLETED|Overall Study||80
8551147|NCT03669588|9582872|FG001|COMPLETED|Overall Study||76
8551148|NCT03669588|9582871|FG000|NOT COMPLETED|Overall Study||4
8551149|NCT03669588|9582872|FG001|NOT COMPLETED|Overall Study||7
8551150|NCT03531632|9582881|FG000|STARTED|Overall Study||5
8551151|NCT03531632|9582882|FG001|STARTED|Overall Study||3
8551152|NCT03531632|9582883|FG002|STARTED|Overall Study||28
8551153|NCT03531632|9582881|FG000|Safety Population|Overall Study|At least 1 dose of study drug|5
8551154|NCT03531632|9582882|FG001|Safety Population|Overall Study||3
8551155|NCT03531632|9582883|FG002|Safety Population|Overall Study||28
8551156|NCT03531632|9582881|FG000|Response Evaluable Population|Overall Study|All patients who received at least one dose of any study drug, had baseline measurable disease, and had at least one post-baseline radiographic tumor assessment or discontinued treatment due to clearly documented, clinically progressive disease or death.|5
8551157|NCT03531632|9582882|FG001|Response Evaluable Population|Overall Study||3
8551158|NCT03531632|9582883|FG002|Response Evaluable Population|Overall Study||24
8551159|NCT03531632|9582881|FG000|COMPLETED|Overall Study||0
8551160|NCT03531632|9582882|FG001|COMPLETED|Overall Study||0
8551161|NCT03531632|9582883|FG002|COMPLETED|Overall Study||2
8551162|NCT03531632|9582881|FG000|NOT COMPLETED|Overall Study||5
8551163|NCT03531632|9582882|FG001|NOT COMPLETED|Overall Study||3
8551164|NCT03531632|9582883|FG002|NOT COMPLETED|Overall Study||26
8551165|NCT03488030|9582894|FG000|STARTED|Overall Study||101
8551166|NCT03488030|9582895|FG001|STARTED|Overall Study||145
8551167|NCT03488030|9582894|FG000|COMPLETED|Overall Study||101
8551168|NCT03488030|9582895|FG001|COMPLETED|Overall Study||145
8551169|NCT03488030|9582894|FG000|NOT COMPLETED|Overall Study||0
8551170|NCT03488030|9582895|FG001|NOT COMPLETED|Overall Study||0
8551171|NCT03412604|9582906|FG000|STARTED|Overall Study||5
8551172|NCT03412604|9582906|FG000|COMPLETED|Overall Study||4
8551173|NCT03412604|9582906|FG000|NOT COMPLETED|Overall Study||1
8567861|NCT00088907|9600230|FG001|COMPLETED|Randomized Study (Step 1)|Treatment would continue until disease progression, no certain fixed number of cycles|0
8567862|NCT00088907|9600229|FG000|NOT COMPLETED|Randomized Study (Step 1)||136
8567863|NCT00088907|9600230|FG001|NOT COMPLETED|Randomized Study (Step 1)||134
8567864|NCT00088907|9600229|FG000|STARTED|Single Gefitinib Treatment (Step 2)|Patients on Arm I could cross over to gefitinib after disease progression on step 1.|24
8567865|NCT00088907|9600230|FG001|STARTED|Single Gefitinib Treatment (Step 2)|Cross over to single gefitinib therapy at progression was allowed for patients on Arm I only.|0
8567866|NCT00088907|9600229|FG000|Treated|Single Gefitinib Treatment (Step 2)||19
8567867|NCT00088907|9600230|FG001|Treated|Single Gefitinib Treatment (Step 2)||0
8567868|NCT00088907|9600229|FG000|COMPLETED|Single Gefitinib Treatment (Step 2)||0
8567869|NCT00088907|9600230|FG001|COMPLETED|Single Gefitinib Treatment (Step 2)||0
8567870|NCT00088907|9600229|FG000|NOT COMPLETED|Single Gefitinib Treatment (Step 2)||24
8567871|NCT00088907|9600230|FG001|NOT COMPLETED|Single Gefitinib Treatment (Step 2)||0
8567872|NCT00088985|9600237|FG000|STARTED|Overall Study||7
8567873|NCT00088985|9600237|FG000|COMPLETED|Overall Study||4
8567874|NCT00088985|9600237|FG000|NOT COMPLETED|Overall Study||3
8567875|NCT00089011|9600243|FG000|STARTED|Overall Study||100
8567876|NCT00089011|9600244|FG001|STARTED|Overall Study||50
8567877|NCT00089011|9600243|FG000|COMPLETED|Overall Study||100
8567878|NCT00089011|9600244|FG001|COMPLETED|Overall Study||50
8567879|NCT00089011|9600243|FG000|NOT COMPLETED|Overall Study||0
8567880|NCT00089011|9600244|FG001|NOT COMPLETED|Overall Study||0
8567881|NCT00089024|9600250|FG000|STARTED|Overall Study||29
8567882|NCT00089024|9600250|FG000|Treated Subjects|Overall Study||29
8567883|NCT00089024|9600250|FG000|COMPLETED|Overall Study||24
8567884|NCT00089024|9600250|FG000|NOT COMPLETED|Overall Study||5
8567885|NCT00089076|9600254|FG000|STARTED|Overall Study||18
8567886|NCT00089076|9600254|FG000|COMPLETED|Overall Study||8
8567887|NCT00089076|9600254|FG000|NOT COMPLETED|Overall Study||10
8567888|NCT00089102|9600258|FG000|STARTED|Overall Study||9
8567889|NCT00089102|9600258|FG000|COMPLETED|Overall Study||9
8567890|NCT00089102|9600258|FG000|NOT COMPLETED|Overall Study||0
8567891|NCT00089284|9600267|FG000|STARTED|Overall Study||7
8567892|NCT00089284|9600268|FG001|STARTED|Overall Study||3
8567893|NCT00089284|9600269|FG002|STARTED|Overall Study||6
8567894|NCT00089284|9600270|FG003|STARTED|Overall Study||6
8567895|NCT00089284|9600271|FG004|STARTED|Overall Study|No patients were accrued to this cohort of 6-24% involvement due to lack of eligible patients.|0
8567896|NCT00089284|9600272|FG005|STARTED|Overall Study|No patients were accrued to this cohort of 6-24% involvement due to lack of eligible patients.|0
8567897|NCT00089284|9600273|FG006|STARTED|Overall Study||8
8567898|NCT00089284|9600267|FG000|COMPLETED|Overall Study||7
8567899|NCT00089284|9600268|FG001|COMPLETED|Overall Study||3
8567900|NCT00089284|9600269|FG002|COMPLETED|Overall Study||6
8567901|NCT00089284|9600270|FG003|COMPLETED|Overall Study||6
8567902|NCT00089284|9600271|FG004|COMPLETED|Overall Study||0
8567903|NCT00089284|9600272|FG005|COMPLETED|Overall Study||0
8621720|NCT00482729|9660762|FG000|STARTED|Overall Study|Site 079011301 was identified as non-compliant and 1 patient was excluded from all analysis|626
8621721|NCT00482729|9660763|FG001|STARTED|Overall Study|Site 079011301 was identified as non-compliant and 3 patients were excluded from all analysis|624
8621722|NCT00482729|9660762|FG000|Completed Phase A|Overall Study||484
8567904|NCT00089284|9600273|FG006|COMPLETED|Overall Study||7
8567905|NCT00089284|9600267|FG000|NOT COMPLETED|Overall Study||0
8567906|NCT00089284|9600268|FG001|NOT COMPLETED|Overall Study||0
8567907|NCT00089284|9600269|FG002|NOT COMPLETED|Overall Study||0
8567908|NCT00089284|9600270|FG003|NOT COMPLETED|Overall Study||0
8567909|NCT00089284|9600271|FG004|NOT COMPLETED|Overall Study||0
8567910|NCT00089284|9600272|FG005|NOT COMPLETED|Overall Study||0
8567911|NCT00089284|9600273|FG006|NOT COMPLETED|Overall Study||1
8567912|NCT00089297|9600295|FG000|STARTED|Overall Study||74
8567913|NCT00089297|9600295|FG000|Treated|Overall Study||70
8567914|NCT00089297|9600295|FG000|Eligible|Overall Study||63
8567915|NCT00089297|9600295|FG000|COMPLETED|Overall Study||36
8567916|NCT00089297|9600295|FG000|NOT COMPLETED|Overall Study||38
8567917|NCT00089479|9600301|FG000|STARTED|Overall Study||1304
8567918|NCT00089479|9600302|FG001|STARTED|Overall Study||1307
8567919|NCT00089479|9600301|FG000|Received Treatment|Overall Study|Safety Population (includes 19 patients randomized to ACXT, who received ACT)|1305
8567920|NCT00089479|9600302|FG001|Received Treatment|Overall Study|Safety Population (includes 5 patients randomized to ACT, who received ACXT)|1283
8567921|NCT00089479|9600301|FG000|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|973
8567922|NCT00089479|9600302|FG001|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|1018
8567923|NCT00089479|9600301|FG000|NOT COMPLETED|Overall Study||331
8567924|NCT00089479|9600302|FG001|NOT COMPLETED|Overall Study||289
8551174|NCT03206073|9582914|FG000|STARTED|Overall Study||4
8551175|NCT03206073|9582915|FG001|STARTED|Overall Study||12
8551176|NCT03206073|9582916|FG002|STARTED|Overall Study||4
8551177|NCT03206073|9582917|FG003|STARTED|Overall Study||14
8551178|NCT03206073|9582914|FG000|COMPLETED|Overall Study||3
8551179|NCT03206073|9582915|FG001|COMPLETED|Overall Study||11
8551180|NCT03206073|9582916|FG002|COMPLETED|Overall Study||0
8551181|NCT03206073|9582917|FG003|COMPLETED|Overall Study||14
8551182|NCT03206073|9582914|FG000|NOT COMPLETED|Overall Study||1
8551183|NCT03206073|9582915|FG001|NOT COMPLETED|Overall Study||1
8551184|NCT03206073|9582916|FG002|NOT COMPLETED|Overall Study||4
8551185|NCT03206073|9582917|FG003|NOT COMPLETED|Overall Study||0
8551186|NCT03195127|9582929|FG000|STARTED|Overall Study||15
8551187|NCT03195127|9582930|FG001|STARTED|Overall Study||18
8551188|NCT03195127|9582929|FG000|COMPLETED|Overall Study||15
8551189|NCT03195127|9582930|FG001|COMPLETED|Overall Study||17
8551190|NCT03195127|9582929|FG000|NOT COMPLETED|Overall Study||0
8551191|NCT03195127|9582930|FG001|NOT COMPLETED|Overall Study||1
8551192|NCT03102034|9582942|FG000|STARTED|Overall Study||21
8551193|NCT03102034|9582943|FG001|STARTED|Overall Study||11
8551194|NCT03102034|9582942|FG000|COMPLETED|Overall Study||20
8551195|NCT03102034|9582943|FG001|COMPLETED|Overall Study||11
8551196|NCT03102034|9582942|FG000|NOT COMPLETED|Overall Study||1
8551197|NCT03102034|9582943|FG001|NOT COMPLETED|Overall Study||0
8551198|NCT03076164|9582949|FG000|STARTED|Overall Study||24
8551199|NCT03076164|9582949|FG000|COMPLETED|Overall Study||24
8551200|NCT03076164|9582949|FG000|NOT COMPLETED|Overall Study||0
8551201|NCT02723864|9582960|FG000|STARTED|Overall Study||3
8551202|NCT02723864|9582961|FG001|STARTED|Overall Study||3
8551203|NCT02723864|9582962|FG002|STARTED|Overall Study||6
8551204|NCT02723864|9582963|FG003|STARTED|Overall Study||7
8551205|NCT02723864|9582964|FG004|STARTED|Overall Study||3
8551206|NCT02723864|9582965|FG005|STARTED|Overall Study||25
8551207|NCT02723864|9582966|FG006|STARTED|Overall Study||6
8818758|NCT01560416|9872612|FG000|COMPLETED|Crossover Phase||7
8818759|NCT01560416|9872613|FG001|COMPLETED|Crossover Phase||0
8818760|NCT01560416|9872612|FG000|NOT COMPLETED|Crossover Phase||0
8818761|NCT01560416|9872613|FG001|NOT COMPLETED|Crossover Phase||0
8818762|NCT01560429|9872623|FG000|STARTED|Overall Study||26
8818763|NCT01560429|9872624|FG001|STARTED|Overall Study||26
8818764|NCT01560429|9872623|FG000|COMPLETED|Overall Study||23
8818765|NCT01560429|9872624|FG001|COMPLETED|Overall Study||20
8818766|NCT01560429|9872623|FG000|NOT COMPLETED|Overall Study||3
8818767|NCT01560429|9872624|FG001|NOT COMPLETED|Overall Study||6
8818768|NCT01560624|9872634|FG000|STARTED|Overall Study||346
8818769|NCT01560624|9872635|FG001|STARTED|Overall Study||344
8818770|NCT01560624|9872634|FG000|Clinical Worsening Event|Overall Study||91
8818771|NCT01560624|9872635|FG001|Clinical Worsening Event|Overall Study||133
8818772|NCT01560624|9872634|FG000|Early Discontinuation From Treatment|Overall Study||107
8818773|NCT01560624|9872635|FG001|Early Discontinuation From Treatment|Overall Study||56
8818774|NCT01560624|9872634|FG000|COMPLETED|Overall Study||148
8818775|NCT01560624|9872635|FG001|COMPLETED|Overall Study||155
8818776|NCT01560624|9872634|FG000|NOT COMPLETED|Overall Study||198
8818777|NCT01560624|9872635|FG001|NOT COMPLETED|Overall Study||189
8818778|NCT01560780|9872643|FG000|STARTED|Overall Study||42
8818779|NCT01560780|9872644|FG001|STARTED|Overall Study||42
8818780|NCT01560780|9872643|FG000|Clinical Follow-Up at 12 Months|Overall Study||42
8818781|NCT01560780|9872644|FG001|Clinical Follow-Up at 12 Months|Overall Study||42
8818782|NCT01560780|9872643|FG000|Completed Study Drug for 12 Months|Overall Study||27
8818783|NCT01560780|9872644|FG001|Completed Study Drug for 12 Months|Overall Study||27
8818784|NCT01560780|9872643|FG000|COMPLETED|Overall Study||29
8818785|NCT01560780|9872644|FG001|COMPLETED|Overall Study||30
8818786|NCT01560780|9872643|FG000|NOT COMPLETED|Overall Study||13
8818787|NCT01560780|9872644|FG001|NOT COMPLETED|Overall Study||12
8818788|NCT01560819|9872652|FG000|STARTED|Overall Study||10
8818789|NCT01560819|9872653|FG001|STARTED|Overall Study||10
8818790|NCT01560819|9872652|FG000|COMPLETED|Overall Study||9
8818791|NCT01560819|9872653|FG001|COMPLETED|Overall Study||10
8818792|NCT01560819|9872652|FG000|NOT COMPLETED|Overall Study||1
8818793|NCT01560819|9872653|FG001|NOT COMPLETED|Overall Study||0
8818794|NCT01560871|9872659|FG000|STARTED|Overall Study||9
8818795|NCT01560871|9872660|FG001|STARTED|Overall Study||7
8551208|NCT02723864|9582960|FG000|COMPLETED|Overall Study||2
8551209|NCT02723864|9582961|FG001|COMPLETED|Overall Study||2
8551210|NCT02723864|9582962|FG002|COMPLETED|Overall Study||5
8551211|NCT02723864|9582963|FG003|COMPLETED|Overall Study||7
8551212|NCT02723864|9582964|FG004|COMPLETED|Overall Study||2
8551213|NCT02723864|9582965|FG005|COMPLETED|Overall Study||14
8551214|NCT02723864|9582966|FG006|COMPLETED|Overall Study||4
8818796|NCT01560871|9872659|FG000|COMPLETED|Overall Study||3
8818797|NCT01560871|9872660|FG001|COMPLETED|Overall Study||5
8551215|NCT02723864|9582960|FG000|NOT COMPLETED|Overall Study||1
8551216|NCT02723864|9582961|FG001|NOT COMPLETED|Overall Study||1
8818798|NCT01560871|9872659|FG000|NOT COMPLETED|Overall Study||6
8818799|NCT01560871|9872660|FG001|NOT COMPLETED|Overall Study||2
8818800|NCT01560923|9872669|FG000|STARTED|Overall Study||24
8818801|NCT01560923|9872670|FG001|STARTED|Overall Study||22
8818802|NCT01560923|9872669|FG000|COMPLETED|Overall Study||24
8818803|NCT01560923|9872670|FG001|COMPLETED|Overall Study||22
8818804|NCT01560923|9872669|FG000|NOT COMPLETED|Overall Study||0
8551217|NCT02723864|9582962|FG002|NOT COMPLETED|Overall Study||1
8551218|NCT02723864|9582963|FG003|NOT COMPLETED|Overall Study||0
8551219|NCT02723864|9582964|FG004|NOT COMPLETED|Overall Study||1
8551220|NCT02723864|9582965|FG005|NOT COMPLETED|Overall Study||11
8551221|NCT02723864|9582966|FG006|NOT COMPLETED|Overall Study||2
8551222|NCT02701556|9583005|FG000|STARTED|Overall Study||198
8551223|NCT02701556|9583006|FG001|STARTED|Overall Study||198
8551224|NCT02701556|9583005|FG000|COMPLETED|Overall Study||175
8551225|NCT02701556|9583006|FG001|COMPLETED|Overall Study||178
8551226|NCT02701556|9583005|FG000|NOT COMPLETED|Overall Study||23
8551227|NCT02701556|9583006|FG001|NOT COMPLETED|Overall Study||20
8551228|NCT02691013|9583014|FG000|STARTED|Overall Study||61
8551229|NCT02691013|9583015|FG001|STARTED|Overall Study||59
8551230|NCT02691013|9583014|FG000|COMPLETED|Overall Study||58
8551231|NCT02691013|9583015|FG001|COMPLETED|Overall Study||59
8551232|NCT02691013|9583014|FG000|NOT COMPLETED|Overall Study||3
8551233|NCT02691013|9583015|FG001|NOT COMPLETED|Overall Study||0
8551234|NCT02597062|9583023|FG000|STARTED|Overall Study||76
8551235|NCT02597062|9583023|FG000|COMPLETED|Overall Study||75
8551236|NCT02597062|9583023|FG000|NOT COMPLETED|Overall Study||1
8551237|NCT02130882|9583029|FG000|STARTED|Overall Study||10
8551238|NCT02130882|9583030|FG001|STARTED|Overall Study||10
8551239|NCT02130882|9583029|FG000|COMPLETED|Overall Study||10
8551240|NCT02130882|9583030|FG001|COMPLETED|Overall Study||9
8551241|NCT02130882|9583029|FG000|NOT COMPLETED|Overall Study||0
8551242|NCT02130882|9583030|FG001|NOT COMPLETED|Overall Study||1
8551243|NCT01850563|9583038|FG000|STARTED|Overall Study||22
8551244|NCT01850563|9583039|FG001|STARTED|Overall Study||19
8551245|NCT01850563|9583038|FG000|HBO Treatment Completed|Overall Study||19
8551246|NCT01850563|9583039|FG001|HBO Treatment Completed|Overall Study||0
8818805|NCT01560923|9872670|FG001|NOT COMPLETED|Overall Study||0
8818806|NCT01560949|9872676|FG000|STARTED|Systemic Phase: mFOLFIRINOX||33
8818807|NCT01560949|9872676|FG000|COMPLETED|Systemic Phase: mFOLFIRINOX||27
8818808|NCT01560949|9872676|FG000|NOT COMPLETED|Systemic Phase: mFOLFIRINOX||6
8818809|NCT01560949|9872676|FG000|STARTED|Chemoradiation Phase: With Gemcitabine||23
8818810|NCT01560949|9872676|FG000|COMPLETED|Chemoradiation Phase: With Gemcitabine||23
8818811|NCT01560949|9872676|FG000|NOT COMPLETED|Chemoradiation Phase: With Gemcitabine||0
8818812|NCT01560949|9872676|FG000|STARTED|Surgery Phase||18
8818813|NCT01560949|9872676|FG000|COMPLETED|Surgery Phase||15
8818814|NCT01560949|9872676|FG000|NOT COMPLETED|Surgery Phase||3
8818815|NCT01560975|9872684|FG000|STARTED|Overall Study||10
8818816|NCT01560975|9872684|FG000|COMPLETED|Overall Study||10
8818817|NCT01560975|9872684|FG000|NOT COMPLETED|Overall Study||0
8818818|NCT01560988|9872692|FG000|STARTED|First Intervention (Six Weeks)||32
8818819|NCT01560988|9872693|FG001|STARTED|First Intervention (Six Weeks)||30
8818820|NCT01560988|9872692|FG000|COMPLETED|First Intervention (Six Weeks)||22
8818821|NCT01560988|9872693|FG001|COMPLETED|First Intervention (Six Weeks)||26
8818822|NCT01560988|9872692|FG000|NOT COMPLETED|First Intervention (Six Weeks)||10
8818823|NCT01560988|9872693|FG001|NOT COMPLETED|First Intervention (Six Weeks)||4
8818824|NCT01560988|9872692|FG000|STARTED|Washout (Six Weeks)||22
8818825|NCT01560988|9872693|FG001|STARTED|Washout (Six Weeks)||26
8818826|NCT01560988|9872692|FG000|COMPLETED|Washout (Six Weeks)||20
8818827|NCT01560988|9872693|FG001|COMPLETED|Washout (Six Weeks)||24
8818828|NCT01560988|9872692|FG000|NOT COMPLETED|Washout (Six Weeks)||2
8818829|NCT01560988|9872693|FG001|NOT COMPLETED|Washout (Six Weeks)||2
8818830|NCT01560988|9872692|FG000|STARTED|Second Intervention (Six Weeks)||20
8818831|NCT01560988|9872693|FG001|STARTED|Second Intervention (Six Weeks)||24
8818832|NCT01560988|9872692|FG000|COMPLETED|Second Intervention (Six Weeks)||18
8818833|NCT01560988|9872693|FG001|COMPLETED|Second Intervention (Six Weeks)||22
8818834|NCT01560988|9872692|FG000|NOT COMPLETED|Second Intervention (Six Weeks)||2
8818835|NCT01560988|9872693|FG001|NOT COMPLETED|Second Intervention (Six Weeks)||2
8818836|NCT01561053|9872708|FG000|STARTED|Overall Study||86
8818837|NCT01561053|9872709|FG001|STARTED|Overall Study||92
8818838|NCT01561053|9872710|FG002|STARTED|Overall Study||82
8818839|NCT01561053|9872711|FG003|STARTED|Overall Study||87
8818840|NCT01561053|9872708|FG000|Patients With Baseline MMSE:18-21|Overall Study||47
8818841|NCT01561053|9872709|FG001|Patients With Baseline MMSE:18-21|Overall Study||40
8818842|NCT01561053|9872710|FG002|Patients With Baseline MMSE:18-21|Overall Study||47
8818843|NCT01561053|9872711|FG003|Patients With Baseline MMSE:18-21|Overall Study||42
8818844|NCT01561053|9872708|FG000|Patients With Baseline MMSE:22-26|Overall Study||39
8818845|NCT01561053|9872709|FG001|Patients With Baseline MMSE:22-26|Overall Study||52
8818846|NCT01561053|9872710|FG002|Patients With Baseline MMSE:22-26|Overall Study||35
8818847|NCT01561053|9872711|FG003|Patients With Baseline MMSE:22-26|Overall Study||45
8818848|NCT01561053|9872708|FG000|Randomized Not Treated|Overall Study||8
8818849|NCT01561053|9872709|FG001|Randomized Not Treated|Overall Study||6
8818850|NCT01561053|9872710|FG002|Randomized Not Treated|Overall Study||4
8818851|NCT01561053|9872711|FG003|Randomized Not Treated|Overall Study||7
8818852|NCT01561053|9872708|FG000|Evaluable Subjects|Overall Study||78
8818853|NCT01561053|9872709|FG001|Evaluable Subjects|Overall Study||86
8551247|NCT01850563|9583038|FG000|COMPLETED|Overall Study||19
8551248|NCT01850563|9583039|FG001|COMPLETED|Overall Study||19
8551249|NCT01850563|9583038|FG000|NOT COMPLETED|Overall Study||3
8551250|NCT01850563|9583039|FG001|NOT COMPLETED|Overall Study||0
8551251|NCT01827111|9583046|FG000|STARTED|Overall Study||19
8551252|NCT01827111|9583046|FG000|COMPLETED|Overall Study||18
8818854|NCT01561053|9872710|FG002|Evaluable Subjects|Overall Study||78
8818855|NCT01561053|9872711|FG003|Evaluable Subjects|Overall Study||80
8818856|NCT01561053|9872708|FG000|COMPLETED|Overall Study||51
8551253|NCT01827111|9583046|FG000|NOT COMPLETED|Overall Study||1
8551254|NCT01437111|9583050|FG000|STARTED|Overall Study||200
8551255|NCT01437111|9583050|FG000|Treated Participants|Overall Study||198
8551256|NCT01437111|9583050|FG000|COMPLETED|Overall Study||182
8551257|NCT01437111|9583050|FG000|NOT COMPLETED|Overall Study||18
8551258|NCT01057121|9583059|FG000|STARTED|Phase I: 10 mg/Day Lenalidomide||3
8551259|NCT01057121|9583060|FG001|STARTED|Phase I: 10 mg/Day Lenalidomide||0
8551260|NCT01057121|9583061|FG002|STARTED|Phase I: 10 mg/Day Lenalidomide||0
8551261|NCT01057121|9583062|FG003|STARTED|Phase I: 10 mg/Day Lenalidomide||0
8551262|NCT01057121|9583063|FG004|STARTED|Phase I: 10 mg/Day Lenalidomide||0
8551263|NCT01057121|9583059|FG000|COMPLETED|Phase I: 10 mg/Day Lenalidomide||3
8551264|NCT01057121|9583060|FG001|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
8551265|NCT01057121|9583061|FG002|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
8551266|NCT01057121|9583062|FG003|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
8551267|NCT01057121|9583063|FG004|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
8551268|NCT01057121|9583059|FG000|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
8551269|NCT01057121|9583060|FG001|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
8551270|NCT01057121|9583061|FG002|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
8551271|NCT01057121|9583062|FG003|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
8621723|NCT00482729|9660763|FG001|Completed Phase A|Overall Study||482
8621724|NCT00482729|9660762|FG000|Completed Phase B|Overall Study||409
8621725|NCT00482729|9660763|FG001|Completed Phase B|Overall Study||406
8621726|NCT00482729|9660762|FG000|COMPLETED|Overall Study||409
8621727|NCT00482729|9660763|FG001|COMPLETED|Overall Study||406
8621728|NCT00482729|9660762|FG000|NOT COMPLETED|Overall Study||217
8621729|NCT00482729|9660763|FG001|NOT COMPLETED|Overall Study||218
8621730|NCT00482911|9660771|FG000|STARTED|Dosing Schedule 1: Len & Cyc|All received Dose A-QD in cycle 1|3
8621731|NCT00482911|9660772|FG001|STARTED|Dosing Schedule 1: Len & Cyc||0
8818857|NCT01561053|9872709|FG001|COMPLETED|Overall Study||56
8551272|NCT01057121|9583063|FG004|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
8818858|NCT01561053|9872710|FG002|COMPLETED|Overall Study||61
8818859|NCT01561053|9872711|FG003|COMPLETED|Overall Study||64
8551273|NCT01057121|9583059|FG000|STARTED|Phase I: 15 mg/Day Lenolidomide||0
8551274|NCT01057121|9583060|FG001|STARTED|Phase I: 15 mg/Day Lenolidomide||3
8551275|NCT01057121|9583061|FG002|STARTED|Phase I: 15 mg/Day Lenolidomide||0
8551276|NCT01057121|9583062|FG003|STARTED|Phase I: 15 mg/Day Lenolidomide||0
8551277|NCT01057121|9583063|FG004|STARTED|Phase I: 15 mg/Day Lenolidomide||0
8551278|NCT01057121|9583059|FG000|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
8551279|NCT01057121|9583060|FG001|COMPLETED|Phase I: 15 mg/Day Lenolidomide||3
8551280|NCT01057121|9583061|FG002|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
8551281|NCT01057121|9583062|FG003|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
8551282|NCT01057121|9583063|FG004|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
8551283|NCT01057121|9583059|FG000|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
8551284|NCT01057121|9583060|FG001|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
8551285|NCT01057121|9583061|FG002|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
8551286|NCT01057121|9583062|FG003|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
8551287|NCT01057121|9583063|FG004|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
8551288|NCT01057121|9583059|FG000|STARTED|Phase I: 20 mg/Day Lenalidomide||0
8551289|NCT01057121|9583060|FG001|STARTED|Phase I: 20 mg/Day Lenalidomide||0
8551290|NCT01057121|9583061|FG002|STARTED|Phase I: 20 mg/Day Lenalidomide||3
8551291|NCT01057121|9583062|FG003|STARTED|Phase I: 20 mg/Day Lenalidomide||0
8551292|NCT01057121|9583063|FG004|STARTED|Phase I: 20 mg/Day Lenalidomide||0
8551293|NCT01057121|9583059|FG000|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
8551294|NCT01057121|9583060|FG001|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
8551295|NCT01057121|9583061|FG002|COMPLETED|Phase I: 20 mg/Day Lenalidomide||3
8551296|NCT01057121|9583062|FG003|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
8551297|NCT01057121|9583063|FG004|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
8551298|NCT01057121|9583059|FG000|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
8551299|NCT01057121|9583060|FG001|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
8551300|NCT01057121|9583061|FG002|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
8551301|NCT01057121|9583062|FG003|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
8551302|NCT01057121|9583063|FG004|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
8551303|NCT01057121|9583059|FG000|STARTED|Phase I: 25 mg/Day Lenalidomide||0
8551304|NCT01057121|9583060|FG001|STARTED|Phase I: 25 mg/Day Lenalidomide||0
8551305|NCT01057121|9583061|FG002|STARTED|Phase I: 25 mg/Day Lenalidomide||0
8551306|NCT01057121|9583062|FG003|STARTED|Phase I: 25 mg/Day Lenalidomide||6
8551307|NCT01057121|9583063|FG004|STARTED|Phase I: 25 mg/Day Lenalidomide||0
8551308|NCT01057121|9583059|FG000|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
8551309|NCT01057121|9583060|FG001|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
8551310|NCT01057121|9583061|FG002|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
8551311|NCT01057121|9583062|FG003|COMPLETED|Phase I: 25 mg/Day Lenalidomide||6
8551312|NCT01057121|9583063|FG004|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
8551313|NCT01057121|9583059|FG000|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
8551314|NCT01057121|9583060|FG001|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
8551315|NCT01057121|9583061|FG002|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
8551316|NCT01057121|9583062|FG003|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
8551317|NCT01057121|9583063|FG004|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
8621732|NCT00482911|9660771|FG000|COMPLETED|Dosing Schedule 1: Len & Cyc||3
8621733|NCT00482911|9660772|FG001|COMPLETED|Dosing Schedule 1: Len & Cyc||0
8621734|NCT00482911|9660771|FG000|NOT COMPLETED|Dosing Schedule 1: Len & Cyc||0
8551318|NCT01057121|9583059|FG000|STARTED|Phase II: 25 mg/Day Lenalidomide||0
8551319|NCT01057121|9583060|FG001|STARTED|Phase II: 25 mg/Day Lenalidomide||0
8551320|NCT01057121|9583061|FG002|STARTED|Phase II: 25 mg/Day Lenalidomide||0
8551321|NCT01057121|9583062|FG003|STARTED|Phase II: 25 mg/Day Lenalidomide||0
8551322|NCT01057121|9583063|FG004|STARTED|Phase II: 25 mg/Day Lenalidomide||23
8551323|NCT01057121|9583059|FG000|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
8551324|NCT01057121|9583060|FG001|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
8551325|NCT01057121|9583061|FG002|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
8551326|NCT01057121|9583062|FG003|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
8551327|NCT01057121|9583063|FG004|COMPLETED|Phase II: 25 mg/Day Lenalidomide||23
8551328|NCT01057121|9583059|FG000|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
8551329|NCT01057121|9583060|FG001|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
8551330|NCT01057121|9583061|FG002|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
8551331|NCT01057121|9583062|FG003|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
8551332|NCT01057121|9583063|FG004|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
8621735|NCT00482911|9660772|FG001|NOT COMPLETED|Dosing Schedule 1: Len & Cyc||0
8621736|NCT00482911|9660771|FG000|STARTED|Dosing Schedule 1: Len, Cyc, & Sun|All received Dose B-QD in cycle 2|3
8621737|NCT00482911|9660772|FG001|STARTED|Dosing Schedule 1: Len, Cyc, & Sun|All received Dose B-QD in cycle 1|2
8818860|NCT01561053|9872708|FG000|NOT COMPLETED|Overall Study||35
8818861|NCT01561053|9872709|FG001|NOT COMPLETED|Overall Study||36
8818862|NCT01561053|9872710|FG002|NOT COMPLETED|Overall Study||21
8551333|NCT01004263|9583087|FG000|STARTED|Overall Study|Participants who took study drug|606
8551334|NCT01004263|9583087|FG000|COMPLETED|Overall Study||427
8551335|NCT01004263|9583087|FG000|NOT COMPLETED|Overall Study||179
8551336|NCT01001234|9583096|FG000|STARTED|Overall Study|Participants who were randomized to study drug|492
8551337|NCT01001234|9583097|FG001|STARTED|Overall Study|Participants who were randomized to study drug|31
8551338|NCT01001234|9583098|FG002|STARTED|Overall Study|Participants who were randomized to study drug|409
8551339|NCT01001234|9583099|FG003|STARTED|Overall Study|Participants who were randomized to study drug|410
8551340|NCT01001234|9583100|FG004|STARTED|Overall Study|Participants who were randomized to study drug|40
8551341|NCT01001234|9583096|FG000|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|124
8551342|NCT01001234|9583097|FG001|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|8
8551343|NCT01001234|9583098|FG002|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|400
8551344|NCT01001234|9583099|FG003|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|405
8551345|NCT01001234|9583100|FG004|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|40
8551346|NCT01001234|9583096|FG000|Participants Not Treated|Overall Study|Participants who did not take study drug|368
8551347|NCT01001234|9583097|FG001|Participants Not Treated|Overall Study|Participants who did not take study drug|23
8551348|NCT01001234|9583098|FG002|Participants Not Treated|Overall Study|Participants who did not take study drug|9
8551349|NCT01001234|9583099|FG003|Participants Not Treated|Overall Study|Participants who did not take study drug|5
8551350|NCT01001234|9583100|FG004|Participants Not Treated|Overall Study|Participants who did not take study drug|0
8551351|NCT01001234|9583096|FG000|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|87
8551352|NCT01001234|9583097|FG001|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|5
8551353|NCT01001234|9583098|FG002|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|377
8551354|NCT01001234|9583099|FG003|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|385
8569350|NCT00096356|9601565|FG000|NOT COMPLETED|Overall Study||44
8629454|NCT00530335|9669198|FG000|NOT COMPLETED|Overall Study||6
8818863|NCT01561053|9872711|FG003|NOT COMPLETED|Overall Study||23
8818864|NCT01561079|9872722|FG000|STARTED|Overall Study||127
8818865|NCT01561079|9872722|FG000|COMPLETED|Overall Study||49
8818866|NCT01561079|9872722|FG000|NOT COMPLETED|Overall Study||78
8818867|NCT01561300|9872765|FG000|STARTED|Run in on Placebo||15
8818868|NCT01561300|9872766|FG001|STARTED|Run in on Placebo||15
8818869|NCT01561300|9872765|FG000|COMPLETED|Run in on Placebo||14
8818870|NCT01561300|9872766|FG001|COMPLETED|Run in on Placebo||15
8818871|NCT01561300|9872765|FG000|NOT COMPLETED|Run in on Placebo||1
8818872|NCT01561300|9872766|FG001|NOT COMPLETED|Run in on Placebo||0
8818873|NCT01561300|9872765|FG000|STARTED|First Intervention||14
8818874|NCT01561300|9872766|FG001|STARTED|First Intervention||15
8818875|NCT01561300|9872765|FG000|COMPLETED|First Intervention||14
8818876|NCT01561300|9872766|FG001|COMPLETED|First Intervention||15
8818877|NCT01561300|9872765|FG000|NOT COMPLETED|First Intervention||0
8818878|NCT01561300|9872766|FG001|NOT COMPLETED|First Intervention||0
8818879|NCT01561300|9872765|FG000|STARTED|Washout on Placebo||14
8818880|NCT01561300|9872766|FG001|STARTED|Washout on Placebo||15
8818881|NCT01561300|9872765|FG000|COMPLETED|Washout on Placebo||14
8818882|NCT01561300|9872766|FG001|COMPLETED|Washout on Placebo||15
8818883|NCT01561300|9872765|FG000|NOT COMPLETED|Washout on Placebo||0
8818884|NCT01561300|9872766|FG001|NOT COMPLETED|Washout on Placebo||0
8818885|NCT01561300|9872765|FG000|STARTED|Second Intervention||14
8818886|NCT01561300|9872766|FG001|STARTED|Second Intervention||15
8818887|NCT01561300|9872765|FG000|COMPLETED|Second Intervention||14
8818888|NCT01561300|9872766|FG001|COMPLETED|Second Intervention||15
8818889|NCT01561300|9872765|FG000|NOT COMPLETED|Second Intervention||0
8818890|NCT01561300|9872766|FG001|NOT COMPLETED|Second Intervention||0
8551355|NCT01001234|9583100|FG004|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|40
8551356|NCT01001234|9583096|FG000|NOT COMPLETED|Overall Study||405
8551357|NCT01001234|9583097|FG001|NOT COMPLETED|Overall Study||26
8551358|NCT01001234|9583098|FG002|NOT COMPLETED|Overall Study||32
8551359|NCT01001234|9583099|FG003|NOT COMPLETED|Overall Study||25
8551360|NCT01001234|9583100|FG004|NOT COMPLETED|Overall Study||0
8551361|NCT00924170|9583108|FG000|STARTED|Overall Study||10
8551362|NCT00924170|9583109|FG001|STARTED|Overall Study||8
8551363|NCT00924170|9583108|FG000|COMPLETED|Overall Study||3
8551364|NCT00924170|9583109|FG001|COMPLETED|Overall Study||0
8551365|NCT00924170|9583108|FG000|NOT COMPLETED|Overall Study||7
8551366|NCT00924170|9583109|FG001|NOT COMPLETED|Overall Study||8
8551367|NCT00894556|9583124|FG000|STARTED|Baseline Phase||0
8551368|NCT00894556|9583125|FG001|STARTED|Baseline Phase||0
8551369|NCT00894556|9583126|FG002|STARTED|Baseline Phase||0
8551370|NCT00894556|9583127|FG003|STARTED|Baseline Phase||194
8551371|NCT00894556|9583124|FG000|COMPLETED|Baseline Phase||0
8551372|NCT00894556|9583125|FG001|COMPLETED|Baseline Phase||0
8551373|NCT00894556|9583126|FG002|COMPLETED|Baseline Phase||0
8551374|NCT00894556|9583127|FG003|COMPLETED|Baseline Phase||109
8551375|NCT00894556|9583124|FG000|NOT COMPLETED|Baseline Phase||0
8551376|NCT00894556|9583125|FG001|NOT COMPLETED|Baseline Phase||0
8551377|NCT00894556|9583126|FG002|NOT COMPLETED|Baseline Phase||0
8551378|NCT00894556|9583127|FG003|NOT COMPLETED|Baseline Phase||85
8551379|NCT00894556|9583124|FG000|STARTED|Treatment Phase|Participants who were randomized into the treatment phase|37
8551380|NCT00894556|9583125|FG001|STARTED|Treatment Phase|Participants who were randomized into the treatment phase|36
8551381|NCT00894556|9583126|FG002|STARTED|Treatment Phase|Participants who were randomized into the treatment phase|36
8551382|NCT00894556|9583127|FG003|STARTED|Treatment Phase||0
8551383|NCT00894556|9583124|FG000|COMPLETED|Treatment Phase|Participants who treated 3 acute migraine attacks with study medication during the treatment phase|33
8551384|NCT00894556|9583125|FG001|COMPLETED|Treatment Phase|Participants who treated 3 acute migraine attacks with study medication during the treatment phase|32
8551385|NCT00894556|9583126|FG002|COMPLETED|Treatment Phase|Participants who treated 3 acute migraine attacks with study medication during the treatment phase|35
8551386|NCT00894556|9583127|FG003|COMPLETED|Treatment Phase||0
8551387|NCT00894556|9583124|FG000|NOT COMPLETED|Treatment Phase||4
8551388|NCT00894556|9583125|FG001|NOT COMPLETED|Treatment Phase||4
8551389|NCT00894556|9583126|FG002|NOT COMPLETED|Treatment Phase||1
8551390|NCT00894556|9583127|FG003|NOT COMPLETED|Treatment Phase||0
8551391|NCT00840177|9583137|FG000|STARTED|Overall Study||36
8551392|NCT00840177|9583138|FG001|STARTED|Overall Study||29
8551393|NCT00840177|9583139|FG002|STARTED|Overall Study||50
8551394|NCT00840177|9583137|FG000|Treated|Overall Study||36
8551395|NCT00840177|9583138|FG001|Treated|Overall Study||29
8551396|NCT00840177|9583139|FG002|Treated|Overall Study||46
8551397|NCT00840177|9583137|FG000|Assessed for AEs|Overall Study||35
8551398|NCT00840177|9583138|FG001|Assessed for AEs|Overall Study||29
8551399|NCT00840177|9583139|FG002|Assessed for AEs|Overall Study||46
8551400|NCT00840177|9583137|FG000|COMPLETED|Overall Study||18
8551401|NCT00840177|9583138|FG001|COMPLETED|Overall Study||20
8551402|NCT00840177|9583139|FG002|COMPLETED|Overall Study||39
8551403|NCT00840177|9583137|FG000|NOT COMPLETED|Overall Study||18
8551404|NCT00840177|9583138|FG001|NOT COMPLETED|Overall Study||9
8551405|NCT00840177|9583139|FG002|NOT COMPLETED|Overall Study||11
8551406|NCT00820950|9583152|FG000|STARTED|Overall Study||6
8551407|NCT00820950|9583153|FG001|STARTED|Overall Study||6
8551408|NCT00820950|9583154|FG002|STARTED|Overall Study||6
8551409|NCT00820950|9583155|FG003|STARTED|Overall Study||6
8551410|NCT00820950|9583156|FG004|STARTED|Overall Study||6
8551411|NCT00820950|9583157|FG005|STARTED|Overall Study||6
8621738|NCT00482911|9660771|FG000|COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun|1 stopped at Dose B-QD, 1 stopped at Dose C-QD, 1 stopped at Dose C-QOD|3
8621739|NCT00482911|9660772|FG001|COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun|1 stopped at Dose B-QD, 1 stopped at Dose C-QOD|2
8621740|NCT00482911|9660771|FG000|NOT COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun||0
8818891|NCT01561313|9872775|FG000|STARTED|Overall Study||33
8818892|NCT01561313|9872776|FG001|STARTED|Overall Study||31
8818893|NCT01561313|9872775|FG000|COMPLETED|Overall Study||31
8818894|NCT01561313|9872776|FG001|COMPLETED|Overall Study||31
8818895|NCT01561313|9872775|FG000|NOT COMPLETED|Overall Study||2
8818896|NCT01561313|9872776|FG001|NOT COMPLETED|Overall Study||0
8818897|NCT01561469|9872784|FG000|STARTED|Overall Study||101
8818898|NCT01561469|9872785|FG001|STARTED|Overall Study||87
8818899|NCT01561469|9872784|FG000|COMPLETED|Overall Study||101
8818900|NCT01561469|9872785|FG001|COMPLETED|Overall Study||87
8818901|NCT01561469|9872784|FG000|NOT COMPLETED|Overall Study||0
8818902|NCT01561469|9872785|FG001|NOT COMPLETED|Overall Study||0
8818903|NCT01561560|9872791|FG000|STARTED|First Two Weeks of Wear||60
8818904|NCT01561560|9872792|FG001|STARTED|First Two Weeks of Wear||61
8818905|NCT01561560|9872791|FG000|COMPLETED|First Two Weeks of Wear||60
8818906|NCT01561560|9872792|FG001|COMPLETED|First Two Weeks of Wear||59
8551412|NCT00820950|9583158|FG006|STARTED|Overall Study||6
8551413|NCT00820950|9583159|FG007|STARTED|Overall Study||6
8551414|NCT00820950|9583160|FG008|STARTED|Overall Study||5
8551415|NCT00820950|9583161|FG009|STARTED|Overall Study||5
8818907|NCT01561560|9872791|FG000|NOT COMPLETED|First Two Weeks of Wear||0
8551416|NCT00820950|9583152|FG000|COMPLETED|Overall Study||5
8818908|NCT01561560|9872792|FG001|NOT COMPLETED|First Two Weeks of Wear||2
8818909|NCT01561560|9872791|FG000|STARTED|Second Two Weeks of Wear||60
8818910|NCT01561560|9872792|FG001|STARTED|Second Two Weeks of Wear||59
8818911|NCT01561560|9872791|FG000|COMPLETED|Second Two Weeks of Wear||60
8818912|NCT01561560|9872792|FG001|COMPLETED|Second Two Weeks of Wear||58
8818913|NCT01561560|9872791|FG000|NOT COMPLETED|Second Two Weeks of Wear||0
8818914|NCT01561560|9872792|FG001|NOT COMPLETED|Second Two Weeks of Wear||1
8849321|NCT01739764|9904479|FG001|STARTED|Overall Study||40
8849322|NCT01739764|9904480|FG002|STARTED|Overall Study||146
8551417|NCT00820950|9583153|FG001|COMPLETED|Overall Study||5
8551418|NCT00820950|9583154|FG002|COMPLETED|Overall Study||6
8551419|NCT00820950|9583155|FG003|COMPLETED|Overall Study||6
8551420|NCT00820950|9583156|FG004|COMPLETED|Overall Study||6
8551421|NCT00820950|9583157|FG005|COMPLETED|Overall Study||6
8551422|NCT00820950|9583158|FG006|COMPLETED|Overall Study||5
8551423|NCT00820950|9583159|FG007|COMPLETED|Overall Study||5
8551424|NCT00820950|9583160|FG008|COMPLETED|Overall Study||5
8551425|NCT00820950|9583161|FG009|COMPLETED|Overall Study||5
8551426|NCT00820950|9583152|FG000|NOT COMPLETED|Overall Study||1
8551427|NCT00820950|9583153|FG001|NOT COMPLETED|Overall Study||1
8551428|NCT00820950|9583154|FG002|NOT COMPLETED|Overall Study||0
8551429|NCT00820950|9583155|FG003|NOT COMPLETED|Overall Study||0
8551430|NCT00820950|9583156|FG004|NOT COMPLETED|Overall Study||0
8551431|NCT00820950|9583157|FG005|NOT COMPLETED|Overall Study||0
8551432|NCT00820950|9583158|FG006|NOT COMPLETED|Overall Study||1
8551433|NCT00820950|9583159|FG007|NOT COMPLETED|Overall Study||1
8551434|NCT00820950|9583160|FG008|NOT COMPLETED|Overall Study||0
8551435|NCT00820950|9583161|FG009|NOT COMPLETED|Overall Study||0
8551436|NCT00806416|9583203|FG000|STARTED|Period 1 - Part I||107
8551437|NCT00806416|9583204|FG001|STARTED|Period 1 - Part I||107
8551438|NCT00806416|9583205|FG002|STARTED|Period 1 - Part I||0
8551439|NCT00806416|9583206|FG003|STARTED|Period 1 - Part I||0
8551440|NCT00806416|9583203|FG000|COMPLETED|Period 1 - Part I||104
8551441|NCT00806416|9583204|FG001|COMPLETED|Period 1 - Part I||103
8551442|NCT00806416|9583205|FG002|COMPLETED|Period 1 - Part I||0
8551443|NCT00806416|9583206|FG003|COMPLETED|Period 1 - Part I||0
8551444|NCT00806416|9583203|FG000|NOT COMPLETED|Period 1 - Part I||3
8551445|NCT00806416|9583204|FG001|NOT COMPLETED|Period 1 - Part I||4
8551446|NCT00806416|9583205|FG002|NOT COMPLETED|Period 1 - Part I||0
8551447|NCT00806416|9583206|FG003|NOT COMPLETED|Period 1 - Part I||0
8551448|NCT00806416|9583203|FG000|STARTED|Period 2 - Part I||104
8551449|NCT00806416|9583204|FG001|STARTED|Period 2 - Part I||103
8551450|NCT00806416|9583205|FG002|STARTED|Period 2 - Part I||0
8551451|NCT00806416|9583206|FG003|STARTED|Period 2 - Part I||0
8551452|NCT00806416|9583203|FG000|COMPLETED|Period 2 - Part I||104
8551453|NCT00806416|9583204|FG001|COMPLETED|Period 2 - Part I||103
8551454|NCT00806416|9583205|FG002|COMPLETED|Period 2 - Part I||0
8551455|NCT00806416|9583206|FG003|COMPLETED|Period 2 - Part I||0
8551456|NCT00806416|9583203|FG000|NOT COMPLETED|Period 2 - Part I||0
8551457|NCT00806416|9583204|FG001|NOT COMPLETED|Period 2 - Part I||0
8551458|NCT00806416|9583205|FG002|NOT COMPLETED|Period 2 - Part I||0
8551459|NCT00806416|9583206|FG003|NOT COMPLETED|Period 2 - Part I||0
8551460|NCT00806416|9583203|FG000|STARTED|Period 1 - Part II||0
8551461|NCT00806416|9583204|FG001|STARTED|Period 1 - Part II||0
8551462|NCT00806416|9583205|FG002|STARTED|Period 1 - Part II||14
8551463|NCT00806416|9583206|FG003|STARTED|Period 1 - Part II||16
8551464|NCT00806416|9583203|FG000|COMPLETED|Period 1 - Part II||0
8551465|NCT00806416|9583204|FG001|COMPLETED|Period 1 - Part II||0
8551466|NCT00806416|9583205|FG002|COMPLETED|Period 1 - Part II||14
8551467|NCT00806416|9583206|FG003|COMPLETED|Period 1 - Part II||14
8551468|NCT00806416|9583203|FG000|NOT COMPLETED|Period 1 - Part II||0
8551469|NCT00806416|9583204|FG001|NOT COMPLETED|Period 1 - Part II||0
8551470|NCT00806416|9583205|FG002|NOT COMPLETED|Period 1 - Part II||0
8551471|NCT00806416|9583206|FG003|NOT COMPLETED|Period 1 - Part II||2
8551472|NCT00806416|9583203|FG000|STARTED|Period 2 - Part II||0
8551473|NCT00806416|9583204|FG001|STARTED|Period 2 - Part II||0
8551474|NCT00806416|9583205|FG002|STARTED|Period 2 - Part II||14
8551475|NCT00806416|9583206|FG003|STARTED|Period 2 - Part II||14
8551476|NCT00806416|9583203|FG000|COMPLETED|Period 2 - Part II||0
8551477|NCT00806416|9583204|FG001|COMPLETED|Period 2 - Part II||0
8551478|NCT00806416|9583205|FG002|COMPLETED|Period 2 - Part II||14
8551479|NCT00806416|9583206|FG003|COMPLETED|Period 2 - Part II||14
8551480|NCT00806416|9583203|FG000|NOT COMPLETED|Period 2 - Part II||0
8551481|NCT00806416|9583204|FG001|NOT COMPLETED|Period 2 - Part II||0
8551482|NCT00806416|9583205|FG002|NOT COMPLETED|Period 2 - Part II||0
8551483|NCT00806416|9583206|FG003|NOT COMPLETED|Period 2 - Part II||0
8551484|NCT00729651|9583216|FG000|STARTED|Overall Study||173
8551485|NCT00729651|9583217|FG001|STARTED|Overall Study||170
8551486|NCT00729651|9583216|FG000|COMPLETED|Overall Study||154
8551487|NCT00729651|9583217|FG001|COMPLETED|Overall Study||152
8551488|NCT00729651|9583216|FG000|NOT COMPLETED|Overall Study||19
8551489|NCT00729651|9583217|FG001|NOT COMPLETED|Overall Study||18
8551490|NCT00698815|9583226|FG000|STARTED|Overall Study||42
8551491|NCT00698815|9583227|FG001|STARTED|Overall Study||47
8551492|NCT00698815|9583228|FG002|STARTED|Overall Study||41
8551493|NCT00698815|9583226|FG000|COMPLETED|Overall Study||32
8551494|NCT00698815|9583227|FG001|COMPLETED|Overall Study||33
8551495|NCT00698815|9583228|FG002|COMPLETED|Overall Study||31
8551496|NCT00698815|9583226|FG000|NOT COMPLETED|Overall Study||10
8849323|NCT01739764|9904478|FG000|COMPLETED|Overall Study||3
8551497|NCT00698815|9583227|FG001|NOT COMPLETED|Overall Study||14
8551498|NCT00698815|9583228|FG002|NOT COMPLETED|Overall Study||10
8849324|NCT01739764|9904479|FG001|COMPLETED|Overall Study||4
8551499|NCT00698022|9583239|FG000|STARTED|Overall Study||30
8551500|NCT00698022|9583240|FG001|STARTED|Overall Study||30
8551501|NCT00698022|9583241|FG002|STARTED|Overall Study||16
8551502|NCT00698022|9583239|FG000|COMPLETED|Overall Study||14
8551503|NCT00698022|9583240|FG001|COMPLETED|Overall Study||20
8551504|NCT00698022|9583241|FG002|COMPLETED|Overall Study||14
8551505|NCT00698022|9583239|FG000|NOT COMPLETED|Overall Study||16
8551506|NCT00698022|9583240|FG001|NOT COMPLETED|Overall Study||10
8551507|NCT00698022|9583241|FG002|NOT COMPLETED|Overall Study||2
8567925|NCT00089505|9600312|FG000|STARTED|Overall Study|2 women never started treatment and per protocol, were not followed and not included in analysis.|121
8567926|NCT00089505|9600313|FG001|STARTED|Overall Study||120
8567927|NCT00089505|9600314|FG002|STARTED|Overall Study|2 women never started treatment and per protocol, were not followed and not included in analysis.|249
8567928|NCT00089505|9600315|FG003|STARTED|Overall Study||251
8567929|NCT00089505|9600312|FG000|COMPLETED|Overall Study|The results for NVP/NVP were through database cutoff for DSMB review (by 6 October 2008).|112
8567930|NCT00089505|9600313|FG001|COMPLETED|Overall Study|The results for NVP/LPV_r were through database cutoff for DSMB review (by 6 October 2008).|118
8567931|NCT00089505|9600314|FG002|COMPLETED|Overall Study||228
8567932|NCT00089505|9600315|FG003|COMPLETED|Overall Study||230
8567933|NCT00089505|9600312|FG000|NOT COMPLETED|Overall Study||9
8567934|NCT00089505|9600313|FG001|NOT COMPLETED|Overall Study||2
8567935|NCT00089505|9600314|FG002|NOT COMPLETED|Overall Study||21
8567936|NCT00089505|9600315|FG003|NOT COMPLETED|Overall Study||21
8567937|NCT00089544|9600327|FG000|STARTED|Overall Study||16
8567938|NCT00089544|9600328|FG001|STARTED|Overall Study||7
8567939|NCT00089544|9600327|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|15
8567940|NCT00089544|9600328|FG001|COMPLETED|Overall Study||7
8818915|NCT01561703|9872800|FG000|STARTED|Overall Study||28
8818916|NCT01561703|9872801|FG001|STARTED|Overall Study||30
8818917|NCT01561703|9872800|FG000|COMPLETED|Overall Study||20
8818918|NCT01561703|9872801|FG001|COMPLETED|Overall Study||24
8818919|NCT01561703|9872800|FG000|NOT COMPLETED|Overall Study||8
8818920|NCT01561703|9872801|FG001|NOT COMPLETED|Overall Study||6
8818921|NCT01561716|9872813|FG000|STARTED|Overall Study||5
8818922|NCT01561716|9872814|FG001|STARTED|Overall Study||5
8818923|NCT01561716|9872815|FG002|STARTED|Overall Study||5
8818924|NCT01561716|9872816|FG003|STARTED|Overall Study||5
8818925|NCT01561716|9872817|FG004|STARTED|Overall Study||5
8818926|NCT01561716|9872818|FG005|STARTED|Overall Study||5
8818927|NCT01561716|9872813|FG000|COMPLETED|Overall Study||5
8818928|NCT01561716|9872814|FG001|COMPLETED|Overall Study||5
8818929|NCT01561716|9872815|FG002|COMPLETED|Overall Study||5
8818930|NCT01561716|9872816|FG003|COMPLETED|Overall Study||5
8818931|NCT01561716|9872817|FG004|COMPLETED|Overall Study||5
8818932|NCT01561716|9872818|FG005|COMPLETED|Overall Study||5
8818933|NCT01561716|9872813|FG000|NOT COMPLETED|Overall Study||0
8818934|NCT01561716|9872814|FG001|NOT COMPLETED|Overall Study||0
8818935|NCT01561716|9872815|FG002|NOT COMPLETED|Overall Study||0
8818936|NCT01561716|9872816|FG003|NOT COMPLETED|Overall Study||0
8818937|NCT01561716|9872817|FG004|NOT COMPLETED|Overall Study||0
8818938|NCT01561716|9872818|FG005|NOT COMPLETED|Overall Study||0
8818939|NCT01561755|9872834|FG000|STARTED|Overall Study||6
8818940|NCT01561755|9872835|FG001|STARTED|Overall Study||6
8818941|NCT01561755|9872834|FG000|COMPLETED|Overall Study||6
8818942|NCT01561755|9872835|FG001|COMPLETED|Overall Study||5
8818943|NCT01561755|9872834|FG000|NOT COMPLETED|Overall Study||0
8818944|NCT01561755|9872835|FG001|NOT COMPLETED|Overall Study||1
8818945|NCT01561833|9872841|FG000|STARTED|Overall Study||12
8818946|NCT01561833|9872841|FG000|COMPLETED|Overall Study||12
8818947|NCT01561833|9872841|FG000|NOT COMPLETED|Overall Study||0
8818948|NCT01561898|9872849|FG000|STARTED|Overall Study||7
8818949|NCT01561898|9872850|FG001|STARTED|Overall Study||92
8818950|NCT01561898|9872851|FG002|STARTED|Overall Study||97
8818951|NCT01561898|9872852|FG003|STARTED|Overall Study||32
8818952|NCT01561898|9872849|FG000|COMPLETED|Overall Study||5
8818953|NCT01561898|9872850|FG001|COMPLETED|Overall Study||51
8818954|NCT01561898|9872851|FG002|COMPLETED|Overall Study||53
8567941|NCT00089544|9600327|FG000|NOT COMPLETED|Overall Study||1
8567942|NCT00089544|9600328|FG001|NOT COMPLETED|Overall Study||0
8567943|NCT00089583|9600336|FG000|STARTED|Overall Study||20
8567944|NCT00089583|9600337|FG001|STARTED|Overall Study||89
8567945|NCT00089583|9600336|FG000|COMPLETED|Overall Study||13
8567946|NCT00089583|9600337|FG001|COMPLETED|Overall Study||51
8567947|NCT00089583|9600336|FG000|NOT COMPLETED|Overall Study||7
8567948|NCT00089583|9600337|FG001|NOT COMPLETED|Overall Study||38
8567949|NCT00089609|9600351|FG000|STARTED|Overall Study||60
8567950|NCT00089609|9600352|FG001|STARTED|Overall Study||13
8567951|NCT00089609|9600351|FG000|COMPLETED|Overall Study||57
8567952|NCT00089609|9600352|FG001|COMPLETED|Overall Study||12
8567953|NCT00089609|9600351|FG000|NOT COMPLETED|Overall Study||3
8818955|NCT01561898|9872852|FG003|COMPLETED|Overall Study||12
8818956|NCT01561898|9872849|FG000|NOT COMPLETED|Overall Study||2
8818957|NCT01561898|9872850|FG001|NOT COMPLETED|Overall Study||41
8818958|NCT01561898|9872851|FG002|NOT COMPLETED|Overall Study||44
8818959|NCT01561898|9872852|FG003|NOT COMPLETED|Overall Study||20
8818960|NCT01561963|9872860|FG000|STARTED|Overall Study||21
8818961|NCT01561963|9872860|FG000|Received Period 1 Treatment|Overall Study||21
8818962|NCT01561963|9872860|FG000|Received Period 2 Treatment|Overall Study||20
8818963|NCT01561963|9872860|FG000|Received Period 3 Treatment|Overall Study||20
8818964|NCT01561963|9872860|FG000|COMPLETED|Overall Study||20
8551508|NCT00692913|9583251|FG000|STARTED|Overall Study||257
8551509|NCT00692913|9583252|FG001|STARTED|Overall Study||258
8551510|NCT00692913|9583251|FG000|COMPLETED|Overall Study||228
8551511|NCT00692913|9583252|FG001|COMPLETED|Overall Study||228
8551512|NCT00692913|9583251|FG000|NOT COMPLETED|Overall Study||29
8551513|NCT00692913|9583252|FG001|NOT COMPLETED|Overall Study||30
8551514|NCT00617994|9583263|FG000|STARTED|Overall Study||5
8551515|NCT00617994|9583264|FG001|STARTED|Overall Study||5
8551516|NCT00617994|9583265|FG002|STARTED|Overall Study||5
8551517|NCT00617994|9583266|FG003|STARTED|Overall Study||5
8551518|NCT00617994|9583267|FG004|STARTED|Overall Study||5
8551519|NCT00617994|9583263|FG000|COMPLETED|Overall Study||5
8551520|NCT00617994|9583264|FG001|COMPLETED|Overall Study||5
8551521|NCT00617994|9583265|FG002|COMPLETED|Overall Study||5
8551522|NCT00617994|9583266|FG003|COMPLETED|Overall Study||5
8551523|NCT00617994|9583267|FG004|COMPLETED|Overall Study||5
8551524|NCT00617994|9583263|FG000|NOT COMPLETED|Overall Study||0
8551525|NCT00617994|9583264|FG001|NOT COMPLETED|Overall Study||0
8551526|NCT00617994|9583265|FG002|NOT COMPLETED|Overall Study||0
8551527|NCT00617994|9583266|FG003|NOT COMPLETED|Overall Study||0
8551528|NCT00617994|9583267|FG004|NOT COMPLETED|Overall Study||0
8551529|NCT00617708|9583298|FG000|STARTED|Overall Study||10
8551530|NCT00617708|9583299|FG001|STARTED|Overall Study||60
8551531|NCT00617708|9583300|FG002|STARTED|Overall Study||64
8551532|NCT00617708|9583298|FG000|Eligible and Began Protocol Therapy|Overall Study||9
8551533|NCT00617708|9583299|FG001|Eligible and Began Protocol Therapy|Overall Study||57
8551534|NCT00617708|9583300|FG002|Eligible and Began Protocol Therapy|Overall Study||59
8551535|NCT00617708|9583298|FG000|COMPLETED|Overall Study||0
8551536|NCT00617708|9583299|FG001|COMPLETED|Overall Study||0
8551537|NCT00617708|9583300|FG002|COMPLETED|Overall Study||0
8551538|NCT00617708|9583298|FG000|NOT COMPLETED|Overall Study||10
8551539|NCT00617708|9583299|FG001|NOT COMPLETED|Overall Study||60
8551540|NCT00617708|9583300|FG002|NOT COMPLETED|Overall Study||64
8551541|NCT00516737|9583312|FG000|STARTED|Overall Study||103
8551542|NCT00516737|9583313|FG001|STARTED|Overall Study||104
8551543|NCT00516737|9583312|FG000|COMPLETED|Overall Study||92
8551544|NCT00516737|9583313|FG001|COMPLETED|Overall Study||96
8551545|NCT00516737|9583312|FG000|NOT COMPLETED|Overall Study||11
8551546|NCT00516737|9583313|FG001|NOT COMPLETED|Overall Study||8
8551547|NCT00358527|9583321|FG000|STARTED|Overall Study||267
8551548|NCT00358527|9583322|FG001|STARTED|Overall Study||134
8551549|NCT00358527|9583321|FG000|COMPLETED|Overall Study||254
8551550|NCT00358527|9583322|FG001|COMPLETED|Overall Study||131
8551551|NCT00358527|9583321|FG000|NOT COMPLETED|Overall Study||13
8551552|NCT00358527|9583322|FG001|NOT COMPLETED|Overall Study||3
8551553|NCT00326898|9583331|FG000|STARTED|Overall Study||647
8551554|NCT00326898|9583332|FG001|STARTED|Overall Study||649
8551555|NCT00326898|9583333|FG002|STARTED|Overall Study||647
8551556|NCT00326898|9583331|FG000|Patients With Toxicity Data|Overall Study||625
8551557|NCT00326898|9583332|FG001|Patients With Toxicity Data|Overall Study||628
8551558|NCT00326898|9583333|FG002|Patients With Toxicity Data|Overall Study||626
8818965|NCT01561963|9872860|FG000|NOT COMPLETED|Overall Study||1
8818966|NCT01561976|9872875|FG000|STARTED|Period 1||5
8818967|NCT01561976|9872876|FG001|STARTED|Period 1||5
8818968|NCT01561976|9872877|FG002|STARTED|Period 1||5
8818969|NCT01561976|9872878|FG003|STARTED|Period 1||5
8818970|NCT01561976|9872879|FG004|STARTED|Period 1||5
8818971|NCT01561976|9872880|FG005|STARTED|Period 1||5
8818972|NCT01561976|9872875|FG000|COMPLETED|Period 1||5
8818973|NCT01561976|9872876|FG001|COMPLETED|Period 1||5
8818974|NCT01561976|9872877|FG002|COMPLETED|Period 1||4
8818975|NCT01561976|9872878|FG003|COMPLETED|Period 1||5
8818976|NCT01561976|9872879|FG004|COMPLETED|Period 1||5
8818977|NCT01561976|9872880|FG005|COMPLETED|Period 1||5
8818978|NCT01561976|9872875|FG000|NOT COMPLETED|Period 1||0
8818979|NCT01561976|9872876|FG001|NOT COMPLETED|Period 1||0
8818980|NCT01561976|9872877|FG002|NOT COMPLETED|Period 1||1
8818981|NCT01561976|9872878|FG003|NOT COMPLETED|Period 1||0
8818982|NCT01561976|9872879|FG004|NOT COMPLETED|Period 1||0
8818983|NCT01561976|9872880|FG005|NOT COMPLETED|Period 1||0
8818984|NCT01561976|9872875|FG000|STARTED|Washout Period 1 (7 Days)||5
8818985|NCT01561976|9872876|FG001|STARTED|Washout Period 1 (7 Days)||5
8818986|NCT01561976|9872877|FG002|STARTED|Washout Period 1 (7 Days)||4
8818987|NCT01561976|9872878|FG003|STARTED|Washout Period 1 (7 Days)||5
8818988|NCT01561976|9872879|FG004|STARTED|Washout Period 1 (7 Days)||5
8818989|NCT01561976|9872880|FG005|STARTED|Washout Period 1 (7 Days)||5
8551559|NCT00326898|9583331|FG000|Patients With Clear Cell Histology|Overall Study||542
8551560|NCT00326898|9583332|FG001|Patients With Clear Cell Histology|Overall Study||540
8551561|NCT00326898|9583333|FG002|Patients With Clear Cell Histology|Overall Study||540
8551562|NCT00326898|9583331|FG000|Patients With >=1 Follow-up MUGA Scan|Overall Study||513
8818990|NCT01561976|9872875|FG000|COMPLETED|Washout Period 1 (7 Days)||5
8551563|NCT00326898|9583332|FG001|Patients With >=1 Follow-up MUGA Scan|Overall Study||510
8818991|NCT01561976|9872876|FG001|COMPLETED|Washout Period 1 (7 Days)||5
8818992|NCT01561976|9872877|FG002|COMPLETED|Washout Period 1 (7 Days)||4
8818993|NCT01561976|9872878|FG003|COMPLETED|Washout Period 1 (7 Days)||4
8818994|NCT01561976|9872879|FG004|COMPLETED|Washout Period 1 (7 Days)||5
8818995|NCT01561976|9872880|FG005|COMPLETED|Washout Period 1 (7 Days)||4
8818996|NCT01561976|9872875|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
8818997|NCT01561976|9872876|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
8818998|NCT01561976|9872877|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
8551564|NCT00326898|9583333|FG002|Patients With >=1 Follow-up MUGA Scan|Overall Study||580
8551565|NCT00326898|9583331|FG000|COMPLETED|Overall Study||296
8551566|NCT00326898|9583332|FG001|COMPLETED|Overall Study||306
8551567|NCT00326898|9583333|FG002|COMPLETED|Overall Study||444
8551568|NCT00326898|9583331|FG000|NOT COMPLETED|Overall Study||351
8551569|NCT00326898|9583332|FG001|NOT COMPLETED|Overall Study||343
8551570|NCT00326898|9583333|FG002|NOT COMPLETED|Overall Study||203
8551571|NCT00156065|9583344|FG000|STARTED|Overall Study||51
8551572|NCT00156065|9583345|FG001|STARTED|Overall Study||93
8551573|NCT00156065|9583346|FG002|STARTED|Overall Study||43
8551574|NCT00156065|9583344|FG000|COMPLETED|Overall Study||20
8551575|NCT00156065|9583345|FG001|COMPLETED|Overall Study||30
8551576|NCT00156065|9583346|FG002|COMPLETED|Overall Study||16
8551577|NCT00156065|9583344|FG000|NOT COMPLETED|Overall Study||31
8551578|NCT00156065|9583345|FG001|NOT COMPLETED|Overall Study||63
8551579|NCT00156065|9583346|FG002|NOT COMPLETED|Overall Study||27
8551580|NCT00150176|9583356|FG000|STARTED|Overall Study|subjects who were screened and received at least one dose of double-blind trial medication|194
8551581|NCT00150176|9583357|FG001|STARTED|Overall Study|subjects who were screened and received at least one dose of double-blind trial medication|192
8551582|NCT00150176|9583356|FG000|COMPLETED|Overall Study||135
8551583|NCT00150176|9583357|FG001|COMPLETED|Overall Study||72
8551584|NCT00150176|9583356|FG000|NOT COMPLETED|Overall Study||59
8551585|NCT00150176|9583357|FG001|NOT COMPLETED|Overall Study||120
8551586|NCT00145509|9583366|FG000|STARTED|Overall Study||41
8551587|NCT00145509|9583367|FG001|STARTED|Overall Study||36
8551588|NCT00145509|9583366|FG000|COMPLETED|Overall Study||19
8551589|NCT00145509|9583367|FG001|COMPLETED|Overall Study||15
8551590|NCT00145509|9583366|FG000|NOT COMPLETED|Overall Study||22
8551591|NCT00145509|9583367|FG001|NOT COMPLETED|Overall Study||21
8551592|NCT00145496|9583375|FG000|STARTED|Overall Study|Subjects who received randomized treatment assignment and at least one dose of study medication.|244
8551593|NCT00145496|9583376|FG001|STARTED|Overall Study|Subjects who received randomized treatment assignment and at least one dose of study medication.|224
8551594|NCT00145496|9583375|FG000|COMPLETED|Overall Study||121
8551595|NCT00145496|9583376|FG001|COMPLETED|Overall Study||143
8551596|NCT00145496|9583375|FG000|NOT COMPLETED|Overall Study||123
8551597|NCT00145496|9583376|FG001|NOT COMPLETED|Overall Study||81
8551598|NCT00145470|9583384|FG000|STARTED|Overall Study||167
8551599|NCT00145470|9583385|FG001|STARTED|Overall Study||159
8629455|NCT00530348|9669204|FG000|STARTED|Overall Study|Randomized.|195
8818999|NCT01561976|9872878|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||1
8819000|NCT01561976|9872879|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||0
8819001|NCT01561976|9872880|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||1
8819002|NCT01561976|9872875|FG000|STARTED|Period 2||5
8819003|NCT01561976|9872876|FG001|STARTED|Period 2||5
8819004|NCT01561976|9872877|FG002|STARTED|Period 2||4
8819005|NCT01561976|9872878|FG003|STARTED|Period 2||4
8819006|NCT01561976|9872879|FG004|STARTED|Period 2||5
8819007|NCT01561976|9872880|FG005|STARTED|Period 2||4
8819008|NCT01561976|9872875|FG000|COMPLETED|Period 2||5
8819009|NCT01561976|9872876|FG001|COMPLETED|Period 2||5
8819010|NCT01561976|9872877|FG002|COMPLETED|Period 2||4
8819011|NCT01561976|9872878|FG003|COMPLETED|Period 2||4
8819012|NCT01561976|9872879|FG004|COMPLETED|Period 2||5
8819013|NCT01561976|9872880|FG005|COMPLETED|Period 2||4
8819014|NCT01561976|9872875|FG000|NOT COMPLETED|Period 2||0
8819015|NCT01561976|9872876|FG001|NOT COMPLETED|Period 2||0
8819016|NCT01561976|9872877|FG002|NOT COMPLETED|Period 2||0
8819017|NCT01561976|9872878|FG003|NOT COMPLETED|Period 2||0
8819018|NCT01561976|9872879|FG004|NOT COMPLETED|Period 2||0
8819019|NCT01561976|9872880|FG005|NOT COMPLETED|Period 2||0
8819020|NCT01561976|9872875|FG000|STARTED|Washout Period 2 (7 Days)||5
8819021|NCT01561976|9872876|FG001|STARTED|Washout Period 2 (7 Days)||5
8819022|NCT01561976|9872877|FG002|STARTED|Washout Period 2 (7 Days)||4
8819023|NCT01561976|9872878|FG003|STARTED|Washout Period 2 (7 Days)||4
8819024|NCT01561976|9872879|FG004|STARTED|Washout Period 2 (7 Days)||5
8819025|NCT01561976|9872880|FG005|STARTED|Washout Period 2 (7 Days)||4
8819026|NCT01561976|9872875|FG000|COMPLETED|Washout Period 2 (7 Days)||4
8819027|NCT01561976|9872876|FG001|COMPLETED|Washout Period 2 (7 Days)||5
8819028|NCT01561976|9872877|FG002|COMPLETED|Washout Period 2 (7 Days)||3
8819029|NCT01561976|9872878|FG003|COMPLETED|Washout Period 2 (7 Days)||4
8819030|NCT01561976|9872879|FG004|COMPLETED|Washout Period 2 (7 Days)||5
8819031|NCT01561976|9872880|FG005|COMPLETED|Washout Period 2 (7 Days)||4
8819032|NCT01561976|9872875|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||1
8551600|NCT00145470|9583384|FG000|Treated|Overall Study||166
8551601|NCT00145470|9583385|FG001|Treated|Overall Study||158
8551602|NCT00145470|9583384|FG000|COMPLETED|Overall Study||55
8551603|NCT00145470|9583385|FG001|COMPLETED|Overall Study||61
8551604|NCT00145470|9583384|FG000|NOT COMPLETED|Overall Study||112
8551605|NCT00145470|9583385|FG001|NOT COMPLETED|Overall Study||98
8551606|NCT00129402|9583393|FG000|STARTED|Start Period1 to End Period1 (Week 1-6)||43
8551607|NCT00129402|9583394|FG001|STARTED|Start Period1 to End Period1 (Week 1-6)||40
8551608|NCT00129402|9583395|FG002|STARTED|Start Period1 to End Period1 (Week 1-6)||43
8551609|NCT00129402|9583396|FG003|STARTED|Start Period1 to End Period1 (Week 1-6)||40
8819033|NCT01561976|9872876|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
8819034|NCT01561976|9872877|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||1
8819035|NCT01561976|9872878|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
8819036|NCT01561976|9872879|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0
8819037|NCT01561976|9872880|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0
8551610|NCT00129402|9583397|FG004|STARTED|Start Period1 to End Period1 (Week 1-6)||40
8551611|NCT00129402|9583398|FG005|STARTED|Start Period1 to End Period1 (Week 1-6)||42
8551612|NCT00129402|9583399|FG006|STARTED|Start Period1 to End Period1 (Week 1-6)||0
8551613|NCT00129402|9583393|FG000|COMPLETED|Start Period1 to End Period1 (Week 1-6)||43
8551614|NCT00129402|9583394|FG001|COMPLETED|Start Period1 to End Period1 (Week 1-6)||39
8551615|NCT00129402|9583395|FG002|COMPLETED|Start Period1 to End Period1 (Week 1-6)||41
8551616|NCT00129402|9583396|FG003|COMPLETED|Start Period1 to End Period1 (Week 1-6)||39
8551617|NCT00129402|9583397|FG004|COMPLETED|Start Period1 to End Period1 (Week 1-6)||39
8551618|NCT00129402|9583398|FG005|COMPLETED|Start Period1 to End Period1 (Week 1-6)||40
8551619|NCT00129402|9583399|FG006|COMPLETED|Start Period1 to End Period1 (Week 1-6)||0
8551620|NCT00129402|9583393|FG000|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||0
8551621|NCT00129402|9583394|FG001|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||1
8621741|NCT00482911|9660772|FG001|NOT COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun||0
8621742|NCT00482911|9660771|FG000|STARTED|Dosing Schedule 2: Len, Cyc, & Sun||0
8621743|NCT00482911|9660772|FG001|STARTED|Dosing Schedule 2: Len, Cyc, & Sun|All received Dose D-QD in cycle 1|7
8621744|NCT00482911|9660771|FG000|COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun||0
8621745|NCT00482911|9660772|FG001|COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun|5 stopped at Dose D-QOD, 2 stopped at Dose D-QD (1 after first increasing to Dose E-QD)|7
8621746|NCT00482911|9660771|FG000|NOT COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun||0
8723099|NCT01021748|9770613|FG002|Treated|Overall Study||7
8819038|NCT01561976|9872875|FG000|STARTED|Period 3||4
8819039|NCT01561976|9872876|FG001|STARTED|Period 3||5
8819040|NCT01561976|9872877|FG002|STARTED|Period 3||3
8819041|NCT01561976|9872878|FG003|STARTED|Period 3||4
8819042|NCT01561976|9872879|FG004|STARTED|Period 3||5
8819043|NCT01561976|9872880|FG005|STARTED|Period 3||4
8819044|NCT01561976|9872875|FG000|COMPLETED|Period 3||4
8819045|NCT01561976|9872876|FG001|COMPLETED|Period 3||5
8819046|NCT01561976|9872877|FG002|COMPLETED|Period 3||3
8819047|NCT01561976|9872878|FG003|COMPLETED|Period 3||4
8819048|NCT01561976|9872879|FG004|COMPLETED|Period 3||5
8819049|NCT01561976|9872880|FG005|COMPLETED|Period 3||4
8819050|NCT01561976|9872875|FG000|NOT COMPLETED|Period 3||0
8819051|NCT01561976|9872876|FG001|NOT COMPLETED|Period 3||0
8819052|NCT01561976|9872877|FG002|NOT COMPLETED|Period 3||0
8819053|NCT01561976|9872878|FG003|NOT COMPLETED|Period 3||0
8819054|NCT01561976|9872879|FG004|NOT COMPLETED|Period 3||0
8819055|NCT01561976|9872880|FG005|NOT COMPLETED|Period 3||0
8819056|NCT01562028|9872890|FG000|STARTED|Overall Study||37
8819057|NCT01562028|9872891|FG001|STARTED|Overall Study||72
8819058|NCT01562028|9872890|FG000|COMPLETED|Overall Study||34
8819059|NCT01562028|9872891|FG001|COMPLETED|Overall Study||70
8819060|NCT01562028|9872890|FG000|NOT COMPLETED|Overall Study||3
8819061|NCT01562028|9872891|FG001|NOT COMPLETED|Overall Study||2
8819062|NCT01562041|9872897|FG000|STARTED|Overall Study||14
8819063|NCT01562041|9872897|FG000|COMPLETED|Overall Study||14
8819064|NCT01562041|9872897|FG000|NOT COMPLETED|Overall Study||0
8819065|NCT01562132|9872903|FG000|STARTED|Overall Study||3
8819066|NCT01562132|9872904|FG001|STARTED|Overall Study||3
8819067|NCT01562132|9872903|FG000|COMPLETED|Overall Study||3
8819068|NCT01562132|9872904|FG001|COMPLETED|Overall Study||3
8819069|NCT01562132|9872903|FG000|NOT COMPLETED|Overall Study||0
8819070|NCT01562132|9872904|FG001|NOT COMPLETED|Overall Study||0
8819071|NCT01562275|9872923|FG000|STARTED|Stage 1||3
8819072|NCT01562275|9872924|FG001|STARTED|Stage 1||7
8621747|NCT00482911|9660772|FG001|NOT COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun||0
8621748|NCT00483002|9660778|FG000|STARTED|Overall Study||3719
8621749|NCT00483002|9660778|FG000|COMPLETED|Overall Study||1165
8723100|NCT01021748|9770614|FG003|Treated|Overall Study||7
8723101|NCT01021748|9770615|FG004|Treated|Overall Study||9
8723102|NCT01021748|9770616|FG005|Treated|Overall Study||3
8723103|NCT01021748|9770617|FG006|Treated|Overall Study||3
8723104|NCT01021748|9770618|FG007|Treated|Overall Study||6
8723105|NCT01021748|9770619|FG008|Treated|Overall Study||17
8723106|NCT01021748|9770611|FG000|COMPLETED|Overall Study||0
8723107|NCT01021748|9770612|FG001|COMPLETED|Overall Study||0
8723108|NCT01021748|9770613|FG002|COMPLETED|Overall Study||0
8723109|NCT01021748|9770614|FG003|COMPLETED|Overall Study||0
8723110|NCT01021748|9770615|FG004|COMPLETED|Overall Study||0
8819073|NCT01562275|9872925|FG002|STARTED|Stage 1||3
8819074|NCT01562275|9872926|FG003|STARTED|Stage 1||4
8819075|NCT01562275|9872927|FG004|STARTED|Stage 1||4
8819076|NCT01562275|9872928|FG005|STARTED|Stage 1||4
8819077|NCT01562275|9872929|FG006|STARTED|Stage 1||3
8551622|NCT00129402|9583395|FG002|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||2
8551623|NCT00129402|9583396|FG003|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||1
8551624|NCT00129402|9583397|FG004|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||1
8551625|NCT00129402|9583398|FG005|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||2
8551626|NCT00129402|9583399|FG006|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||0
8551627|NCT00129402|9583393|FG000|STARTED|Start Period2 to End Period2 (Week 7-33)||0
8551628|NCT00129402|9583394|FG001|STARTED|Start Period2 to End Period2 (Week 7-33)||0
8551629|NCT00129402|9583395|FG002|STARTED|Start Period2 to End Period2 (Week 7-33)|# of subjects were combined from the 3 arms in Period 1 who received ezetimibe with simvastatin|122
8819078|NCT01562275|9872930|FG007|STARTED|Stage 1||7
8819079|NCT01562275|9872931|FG008|STARTED|Stage 1||3
8819080|NCT01562275|9872932|FG009|STARTED|Stage 1||7
8819081|NCT01562275|9872933|FG010|STARTED|Stage 1||3
8819082|NCT01562275|9872934|FG011|STARTED|Stage 1||0
8551630|NCT00129402|9583396|FG003|STARTED|Start Period2 to End Period2 (Week 7-33)||0
8551631|NCT00129402|9583397|FG004|STARTED|Start Period2 to End Period2 (Week 7-33)||0
8551632|NCT00129402|9583398|FG005|STARTED|Start Period2 to End Period2 (Week 7-33)|# of subjects were combined from the 3 arms in Period 1 who received simvastatin monotherapy|118
8551633|NCT00129402|9583399|FG006|STARTED|Start Period2 to End Period2 (Week 7-33)||0
8551634|NCT00129402|9583393|FG000|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
8551635|NCT00129402|9583394|FG001|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
8551636|NCT00129402|9583395|FG002|COMPLETED|Start Period2 to End Period2 (Week 7-33)|One subject who completed Period 1, did not enter Period 2, but entered and completed Period 3.|114
8551637|NCT00129402|9583396|FG003|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
8551638|NCT00129402|9583397|FG004|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
8551639|NCT00129402|9583398|FG005|COMPLETED|Start Period2 to End Period2 (Week 7-33)|One subject who completed Period 1, did not enter Period 2, but entered and completed Period 3.|113
8551640|NCT00129402|9583399|FG006|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
8551641|NCT00129402|9583393|FG000|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
8551642|NCT00129402|9583394|FG001|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
8551643|NCT00129402|9583395|FG002|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||8
8551644|NCT00129402|9583396|FG003|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
8551645|NCT00129402|9583397|FG004|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
8551646|NCT00129402|9583398|FG005|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||5
8551647|NCT00129402|9583399|FG006|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
8551648|NCT00129402|9583393|FG000|STARTED|Start Period3 to End Period3(Week 34-53)||0
8551649|NCT00129402|9583394|FG001|STARTED|Start Period3 to End Period3(Week 34-53)||0
8551650|NCT00129402|9583395|FG002|STARTED|Start Period3 to End Period3(Week 34-53)||0
8551651|NCT00129402|9583396|FG003|STARTED|Start Period3 to End Period3(Week 34-53)||0
8551652|NCT00129402|9583397|FG004|STARTED|Start Period3 to End Period3(Week 34-53)||0
8551653|NCT00129402|9583398|FG005|STARTED|Start Period3 to End Period3(Week 34-53)||0
8551654|NCT00129402|9583399|FG006|STARTED|Start Period3 to End Period3(Week 34-53)|In Period 3, all subjects from Period 1 and Period 2 were combined into one treatment group.|228
8551655|NCT00129402|9583393|FG000|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
8551656|NCT00129402|9583394|FG001|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
8551657|NCT00129402|9583395|FG002|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
8551658|NCT00129402|9583396|FG003|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
8551659|NCT00129402|9583397|FG004|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
8551660|NCT00129402|9583398|FG005|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
8551661|NCT00129402|9583399|FG006|COMPLETED|Start Period3 to End Period3(Week 34-53)|One subject who completed Period 1, did not enter Period 2, but entered and completed Period 3.|222
8551662|NCT00129402|9583393|FG000|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
8551663|NCT00129402|9583394|FG001|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
8551664|NCT00129402|9583395|FG002|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
8551665|NCT00129402|9583396|FG003|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
8551666|NCT00129402|9583397|FG004|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
8551667|NCT00129402|9583398|FG005|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
8551668|NCT00129402|9583399|FG006|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||6
8551669|NCT00101439|9583409|FG000|STARTED|Period 1||28
8551670|NCT00101439|9583410|FG001|STARTED|Period 1||30
8551671|NCT00101439|9583409|FG000|COMPLETED|Period 1||28
8551672|NCT00101439|9583410|FG001|COMPLETED|Period 1||30
8551673|NCT00101439|9583409|FG000|NOT COMPLETED|Period 1||0
8551674|NCT00101439|9583410|FG001|NOT COMPLETED|Period 1||0
8551675|NCT00101439|9583409|FG000|STARTED|Period 2||28
8551676|NCT00101439|9583410|FG001|STARTED|Period 2||30
8551677|NCT00101439|9583409|FG000|COMPLETED|Period 2||28
8551678|NCT00101439|9583410|FG001|COMPLETED|Period 2||28
8551679|NCT00101439|9583409|FG000|NOT COMPLETED|Period 2||0
8551680|NCT00101439|9583410|FG001|NOT COMPLETED|Period 2||2
8551681|NCT00096200|9583419|FG000|STARTED|Overall Study||9
8551682|NCT00096200|9583420|FG001|STARTED|Overall Study||30
8551683|NCT00096200|9583421|FG002|STARTED|Overall Study||5
8551684|NCT00096200|9583419|FG000|COMPLETED|Overall Study||8
8551685|NCT00096200|9583420|FG001|COMPLETED|Overall Study||23
8551686|NCT00096200|9583421|FG002|COMPLETED|Overall Study||5
8551687|NCT00096200|9583419|FG000|NOT COMPLETED|Overall Study||1
8551688|NCT00096200|9583420|FG001|NOT COMPLETED|Overall Study||7
8551689|NCT00096200|9583421|FG002|NOT COMPLETED|Overall Study||0
8567954|NCT00089609|9600352|FG001|NOT COMPLETED|Overall Study||1
8567955|NCT00089635|9600361|FG000|STARTED|Overall Study||203
8567956|NCT00089635|9600361|FG000|COMPLETED|Overall Study||160
8567957|NCT00089635|9600361|FG000|NOT COMPLETED|Overall Study||43
8567958|NCT00089648|9600365|FG000|STARTED|Overall Study||61
8567959|NCT00089648|9600365|FG000|COMPLETED|Overall Study||20
8567960|NCT00089648|9600365|FG000|NOT COMPLETED|Overall Study||41
8567961|NCT00089661|9600371|FG000|STARTED|Overall Study||127
8567962|NCT00089661|9600372|FG001|STARTED|Overall Study||125
8567963|NCT00089661|9600371|FG000|COMPLETED|Overall Study||106
8567964|NCT00089661|9600372|FG001|COMPLETED|Overall Study||99
8567965|NCT00089661|9600371|FG000|NOT COMPLETED|Overall Study||21
8567966|NCT00089661|9600372|FG001|NOT COMPLETED|Overall Study||26
8567967|NCT00089674|9600380|FG000|STARTED|Overall Study||734
8567968|NCT00089674|9600381|FG001|STARTED|Overall Study||734
8567969|NCT00089674|9600380|FG000|Received Study Drug|Overall Study||730
8551690|NCT03257267|9583431|FG000|STARTED|Overall Study||304
8551691|NCT03257267|9583432|FG001|STARTED|Overall Study||304
8551692|NCT03257267|9583431|FG000|Full Analysis Set (FAS)|Overall Study||304
8551693|NCT03257267|9583432|FG001|Full Analysis Set (FAS)|Overall Study||304
8551694|NCT03257267|9583431|FG000|Safety Analysis Set (SAF)|Overall Study||300
8551695|NCT03257267|9583432|FG001|Safety Analysis Set (SAF)|Overall Study||290
8551696|NCT03257267|9583431|FG000|Completed Treatment|Overall Study||13
8551697|NCT03257267|9583432|FG001|Completed Treatment|Overall Study||0
8551698|NCT03257267|9583431|FG000|COMPLETED|Overall Study||7
8551699|NCT03257267|9583432|FG001|COMPLETED|Overall Study||0
8551700|NCT03257267|9583431|FG000|NOT COMPLETED|Overall Study||297
8551701|NCT03257267|9583432|FG001|NOT COMPLETED|Overall Study||304
8551702|NCT04581811|9583440|FG000|STARTED|Overall Study||26
8551703|NCT04581811|9583441|FG001|STARTED|Overall Study||26
8551704|NCT04581811|9583440|FG000|COMPLETED|Overall Study||26
8551705|NCT04581811|9583441|FG001|COMPLETED|Overall Study||26
8551706|NCT04581811|9583440|FG000|NOT COMPLETED|Overall Study||0
8551707|NCT04581811|9583441|FG001|NOT COMPLETED|Overall Study||0
8551708|NCT04456959|9583447|FG000|STARTED|Overall Study||28
8551709|NCT04456959|9583447|FG000|COMPLETED|Overall Study||28
8551710|NCT04456959|9583447|FG000|NOT COMPLETED|Overall Study||0
8551711|NCT04263987|9583453|FG000|STARTED|Overall Study||30
8551712|NCT04263987|9583454|FG001|STARTED|Overall Study||30
8551713|NCT04263987|9583453|FG000|COMPLETED|Overall Study||30
8551714|NCT04263987|9583454|FG001|COMPLETED|Overall Study||30
8551715|NCT04263987|9583453|FG000|NOT COMPLETED|Overall Study||0
8551716|NCT04263987|9583454|FG001|NOT COMPLETED|Overall Study||0
8551717|NCT04223830|9583460|FG000|STARTED|Overall Study||200
8551718|NCT04223830|9583460|FG000|COMPLETED|Overall Study||190
8551719|NCT04223830|9583460|FG000|NOT COMPLETED|Overall Study||10
8551720|NCT04153435|9583467|FG000|STARTED|Overall Study||197
8551721|NCT04153435|9583468|FG001|STARTED|Overall Study||200
8551722|NCT04153435|9583467|FG000|COMPLETED|Overall Study||197
8551723|NCT04153435|9583468|FG001|COMPLETED|Overall Study||200
8551724|NCT04153435|9583467|FG000|NOT COMPLETED|Overall Study||0
8551725|NCT04153435|9583468|FG001|NOT COMPLETED|Overall Study||0
8551726|NCT04153188|9583476|FG000|STARTED|Overall Study||17
8551727|NCT04153188|9583477|FG001|STARTED|Overall Study||13
8551728|NCT04153188|9583476|FG000|COMPLETED|Overall Study||14
8551729|NCT04153188|9583477|FG001|COMPLETED|Overall Study||11
8551730|NCT04153188|9583476|FG000|NOT COMPLETED|Overall Study||3
8551731|NCT04153188|9583477|FG001|NOT COMPLETED|Overall Study||2
8551732|NCT04108429|9583483|FG000|STARTED|Overall Study||117
8551733|NCT04108429|9583483|FG000|COMPLETED|Overall Study||117
8551734|NCT04108429|9583483|FG000|NOT COMPLETED|Overall Study||0
8551735|NCT04061915|9583491|FG000|STARTED|Overall Study||161
8551736|NCT04061915|9583492|FG001|STARTED|Overall Study||161
8551737|NCT04061915|9583491|FG000|COMPLETED|Overall Study||161
8551738|NCT04061915|9583492|FG001|COMPLETED|Overall Study||161
8551739|NCT04061915|9583491|FG000|NOT COMPLETED|Overall Study||0
8551740|NCT04061915|9583492|FG001|NOT COMPLETED|Overall Study||0
8551741|NCT03990766|9583501|FG000|STARTED|Overall Study||14
8551742|NCT03990766|9583502|FG001|STARTED|Overall Study||13
8551743|NCT03990766|9583501|FG000|COMPLETED|Overall Study||12
8551744|NCT03990766|9583502|FG001|COMPLETED|Overall Study||10
8551745|NCT03990766|9583501|FG000|NOT COMPLETED|Overall Study||2
8551746|NCT03990766|9583502|FG001|NOT COMPLETED|Overall Study||3
8551747|NCT03947333|9583510|FG000|STARTED|Overall Study||135
8551748|NCT03947333|9583511|FG001|STARTED|Overall Study||135
8551749|NCT03947333|9583510|FG000|COMPLETED|Overall Study||135
8551750|NCT03947333|9583511|FG001|COMPLETED|Overall Study||135
8551751|NCT03947333|9583510|FG000|NOT COMPLETED|Overall Study||0
8551752|NCT03947333|9583511|FG001|NOT COMPLETED|Overall Study||0
8551753|NCT03886220|9583520|FG000|STARTED|Treatment Period||28
8551754|NCT03886220|9583521|FG001|STARTED|Treatment Period||54
8551755|NCT03886220|9583520|FG000|COMPLETED|Treatment Period||23
8551756|NCT03886220|9583521|FG001|COMPLETED|Treatment Period||42
8551757|NCT03886220|9583520|FG000|NOT COMPLETED|Treatment Period||5
8551758|NCT03886220|9583521|FG001|NOT COMPLETED|Treatment Period||12
8551759|NCT03886220|9583520|FG000|STARTED|Post-Treatment Follow-Up Period||25
8551760|NCT03886220|9583521|FG001|STARTED|Post-Treatment Follow-Up Period||41
8551761|NCT03886220|9583520|FG000|COMPLETED|Post-Treatment Follow-Up Period||23
8551762|NCT03886220|9583521|FG001|COMPLETED|Post-Treatment Follow-Up Period||39
8551763|NCT03886220|9583520|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||2
8819083|NCT01562275|9872935|FG012|STARTED|Stage 1||0
8819084|NCT01562275|9872923|FG000|COMPLETED|Stage 1||0
8819085|NCT01562275|9872924|FG001|COMPLETED|Stage 1||0
8819086|NCT01562275|9872925|FG002|COMPLETED|Stage 1||0
8819087|NCT01562275|9872926|FG003|COMPLETED|Stage 1||0
8819088|NCT01562275|9872927|FG004|COMPLETED|Stage 1||0
8819089|NCT01562275|9872928|FG005|COMPLETED|Stage 1||0
8551764|NCT03886220|9583521|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||2
8551765|NCT03800979|9583527|FG000|STARTED|Overall Study||19
8551766|NCT03800979|9583527|FG000|COMPLETED|Overall Study||19
8551767|NCT03800979|9583527|FG000|NOT COMPLETED|Overall Study||0
8551768|NCT03794661|9583531|FG000|STARTED|Overall Study||8
8551769|NCT03794661|9583531|FG000|COMPLETED|Overall Study||8
8551770|NCT03794661|9583531|FG000|NOT COMPLETED|Overall Study||0
8551771|NCT03691909|9583535|FG000|STARTED|Overall Study||15
8551772|NCT03691909|9583535|FG000|Per Protocol Population Day 1|Overall Study||15
8551773|NCT03691909|9583535|FG000|Per Protocol Population Week 1|Overall Study||15
8819090|NCT01562275|9872929|FG006|COMPLETED|Stage 1||0
8551774|NCT03691909|9583535|FG000|Per Protocol Population Week 4|Overall Study||14
8551775|NCT03691909|9583535|FG000|Per Protocol Population Week 8|Overall Study||13
8551776|NCT03691909|9583535|FG000|Per Protocol Population Week 12|Overall Study||15
8551777|NCT03691909|9583535|FG000|Per Protocol Population Week 26|Overall Study||14
8551778|NCT03691909|9583535|FG000|Per Protocol Population Week 52|Overall Study||13
8551779|NCT03691909|9583535|FG000|COMPLETED|Overall Study||15
8551780|NCT03691909|9583535|FG000|NOT COMPLETED|Overall Study||0
8551781|NCT03627091|9583543|FG000|STARTED|Overall Study||19
8551782|NCT03627091|9583544|FG001|STARTED|Overall Study||10
8551783|NCT03627091|9583545|FG002|STARTED|Overall Study||11
8551784|NCT03627091|9583543|FG000|COMPLETED|Overall Study||7
8551785|NCT03627091|9583544|FG001|COMPLETED|Overall Study||4
8551786|NCT03627091|9583545|FG002|COMPLETED|Overall Study||6
8551787|NCT03627091|9583543|FG000|NOT COMPLETED|Overall Study||12
8551788|NCT03627091|9583544|FG001|NOT COMPLETED|Overall Study||6
8551789|NCT03627091|9583545|FG002|NOT COMPLETED|Overall Study||5
8551790|NCT03568318|9583560|FG000|STARTED|Overall Study||264
8551791|NCT03568318|9583561|FG001|STARTED|Overall Study||261
8551792|NCT03568318|9583562|FG002|STARTED|Overall Study||260
8551793|NCT03568318|9583563|FG003|STARTED|Overall Study||63
8551794|NCT03568318|9583564|FG004|STARTED|Overall Study||60
8551795|NCT03568318|9583565|FG005|STARTED|Overall Study||60
8551796|NCT03568318|9583560|FG000|Received Study Drug|Overall Study||264
8551797|NCT03568318|9583561|FG001|Received Study Drug|Overall Study||261
8551798|NCT03568318|9583562|FG002|Received Study Drug|Overall Study||260
8551799|NCT03568318|9583563|FG003|Received Study Drug|Overall Study||62
8551800|NCT03568318|9583564|FG004|Received Study Drug|Overall Study||60
8551801|NCT03568318|9583565|FG005|Received Study Drug|Overall Study||60
8551802|NCT03568318|9583560|FG000|COMPLETED|Overall Study||244
8551803|NCT03568318|9583561|FG001|COMPLETED|Overall Study||249
8551804|NCT03568318|9583562|FG002|COMPLETED|Overall Study||250
8551805|NCT03568318|9583563|FG003|COMPLETED|Overall Study||59
8551806|NCT03568318|9583564|FG004|COMPLETED|Overall Study||58
8551807|NCT03568318|9583565|FG005|COMPLETED|Overall Study||60
8551808|NCT03568318|9583560|FG000|NOT COMPLETED|Overall Study||20
8551809|NCT03568318|9583561|FG001|NOT COMPLETED|Overall Study||12
8551810|NCT03568318|9583562|FG002|NOT COMPLETED|Overall Study||10
8551811|NCT03568318|9583563|FG003|NOT COMPLETED|Overall Study||4
8551812|NCT03568318|9583564|FG004|NOT COMPLETED|Overall Study||2
8551813|NCT03568318|9583565|FG005|NOT COMPLETED|Overall Study||0
8551814|NCT03498560|9583579|FG000|STARTED|Overall Study||38
8551815|NCT03498560|9583579|FG000|Completed Baseline Assessment|Overall Study||32
8551816|NCT03498560|9583579|FG000|Completed PSG|Overall Study||25
8551817|NCT03498560|9583579|FG000|COMPLETED|Overall Study||17
8551818|NCT03498560|9583579|FG000|NOT COMPLETED|Overall Study||21
8551819|NCT03441360|9583587|FG000|STARTED|Overall Study||8
8551820|NCT03441360|9583588|FG001|STARTED|Overall Study||8
8551821|NCT03441360|9583589|FG002|STARTED|Overall Study||5
8551822|NCT03441360|9583587|FG000|COMPLETED|Overall Study||0
8551823|NCT03441360|9583588|FG001|COMPLETED|Overall Study||0
8551824|NCT03441360|9583589|FG002|COMPLETED|Overall Study||0
8551825|NCT03441360|9583587|FG000|NOT COMPLETED|Overall Study||8
8551826|NCT03441360|9583588|FG001|NOT COMPLETED|Overall Study||8
8551827|NCT03441360|9583589|FG002|NOT COMPLETED|Overall Study||5
8551828|NCT03434379|9583599|FG000|STARTED|Global Period||165
8551829|NCT03434379|9583600|FG001|STARTED|Global Period||336
8551830|NCT03434379|9583601|FG002|STARTED|Global Period||0
8551831|NCT03434379|9583602|FG003|STARTED|Global Period||0
8551832|NCT03434379|9583599|FG000|COMPLETED|Global Period||0
8551833|NCT03434379|9583600|FG001|COMPLETED|Global Period||0
8551834|NCT03434379|9583601|FG002|COMPLETED|Global Period||0
8551835|NCT03434379|9583602|FG003|COMPLETED|Global Period||0
8551836|NCT03434379|9583599|FG000|NOT COMPLETED|Global Period||165
8551837|NCT03434379|9583600|FG001|NOT COMPLETED|Global Period||336
8551838|NCT03434379|9583601|FG002|NOT COMPLETED|Global Period||0
8551839|NCT03434379|9583602|FG003|NOT COMPLETED|Global Period||0
8551840|NCT03434379|9583599|FG000|STARTED|China Extension Period||0
8551841|NCT03434379|9583600|FG001|STARTED|China Extension Period||0
8551842|NCT03434379|9583601|FG002|STARTED|China Extension Period|n=43 Chinese participants from the sorafenib Global population are included in the China population.|61
8551843|NCT03434379|9583602|FG003|STARTED|China Extension Period|n=94 Chinese participants from the Atezolizumab + Bevacizumab Global population are included in the China population.|133
8551844|NCT03434379|9583599|FG000|COMPLETED|China Extension Period||0
8819091|NCT01562275|9872930|FG007|COMPLETED|Stage 1||0
8819092|NCT01562275|9872931|FG008|COMPLETED|Stage 1||0
8819093|NCT01562275|9872932|FG009|COMPLETED|Stage 1||0
8819094|NCT01562275|9872933|FG010|COMPLETED|Stage 1||0
8819095|NCT01562275|9872934|FG011|COMPLETED|Stage 1||0
8819096|NCT01562275|9872935|FG012|COMPLETED|Stage 1||0
8819097|NCT01562275|9872923|FG000|NOT COMPLETED|Stage 1||3
8551845|NCT03434379|9583600|FG001|COMPLETED|China Extension Period||0
8551846|NCT03434379|9583601|FG002|COMPLETED|China Extension Period||0
8551847|NCT03434379|9583602|FG003|COMPLETED|China Extension Period||0
8551848|NCT03434379|9583599|FG000|NOT COMPLETED|China Extension Period||0
8551849|NCT03434379|9583600|FG001|NOT COMPLETED|China Extension Period||0
8551850|NCT03434379|9583601|FG002|NOT COMPLETED|China Extension Period||61
8551851|NCT03434379|9583602|FG003|NOT COMPLETED|China Extension Period||133
8567970|NCT00089674|9600381|FG001|Received Study Drug|Overall Study||726
8819098|NCT01562275|9872924|FG001|NOT COMPLETED|Stage 1||7
8819099|NCT01562275|9872925|FG002|NOT COMPLETED|Stage 1||3
8819100|NCT01562275|9872926|FG003|NOT COMPLETED|Stage 1||4
8819101|NCT01562275|9872927|FG004|NOT COMPLETED|Stage 1||4
8819102|NCT01562275|9872928|FG005|NOT COMPLETED|Stage 1||4
8819103|NCT01562275|9872929|FG006|NOT COMPLETED|Stage 1||3
8819104|NCT01562275|9872930|FG007|NOT COMPLETED|Stage 1||7
8551852|NCT03368170|9583616|FG000|STARTED|Overall Study||39
8551853|NCT03368170|9583617|FG001|STARTED|Overall Study||36
8551854|NCT03368170|9583616|FG000|COMPLETED|Overall Study||37
8551855|NCT03368170|9583617|FG001|COMPLETED|Overall Study||35
8551856|NCT03368170|9583616|FG000|NOT COMPLETED|Overall Study||2
8551857|NCT03368170|9583617|FG001|NOT COMPLETED|Overall Study||1
8551858|NCT03336528|9583625|FG000|STARTED|Overall Study||92
8551859|NCT03336528|9583626|FG001|STARTED|Overall Study||88
8551860|NCT03336528|9583625|FG000|Participated in Optional Outpatient Study|Overall Study||72
8551861|NCT03336528|9583626|FG001|Participated in Optional Outpatient Study|Overall Study||59
8551862|NCT03336528|9583625|FG000|COMPLETED|Overall Study||82
8551863|NCT03336528|9583626|FG001|COMPLETED|Overall Study||79
8551864|NCT03336528|9583625|FG000|NOT COMPLETED|Overall Study||10
8551865|NCT03336528|9583626|FG001|NOT COMPLETED|Overall Study||9
8551866|NCT03334409|9583636|FG000|STARTED|Overall Study||2
8551867|NCT03334409|9583637|FG001|STARTED|Overall Study||3
8551868|NCT03334409|9583636|FG000|COMPLETED|Overall Study||1
8551869|NCT03334409|9583637|FG001|COMPLETED|Overall Study||3
8551870|NCT03334409|9583636|FG000|NOT COMPLETED|Overall Study||1
8551871|NCT03334409|9583637|FG001|NOT COMPLETED|Overall Study||0
8551872|NCT03332498|9583646|FG000|STARTED|Overall Study||4
8551873|NCT03332498|9583647|FG001|STARTED|Overall Study||4
8551874|NCT03332498|9583648|FG002|STARTED|Overall Study||32
8551875|NCT03332498|9583646|FG000|COMPLETED|Overall Study||4
8551876|NCT03332498|9583647|FG001|COMPLETED|Overall Study||4
8551877|NCT03332498|9583648|FG002|COMPLETED|Overall Study||30
8551878|NCT03332498|9583646|FG000|NOT COMPLETED|Overall Study||0
8551879|NCT03332498|9583647|FG001|NOT COMPLETED|Overall Study||0
8551880|NCT03332498|9583648|FG002|NOT COMPLETED|Overall Study||2
8621750|NCT00483002|9660778|FG000|NOT COMPLETED|Overall Study||2554
8621751|NCT00483041|9660784|FG000|STARTED|Overall Study||5
8621752|NCT00483041|9660785|FG001|STARTED|Overall Study||6
8621753|NCT00483041|9660784|FG000|COMPLETED|Overall Study||5
8621754|NCT00483041|9660785|FG001|COMPLETED|Overall Study||5
8621755|NCT00483041|9660784|FG000|NOT COMPLETED|Overall Study||0
8551881|NCT03287843|9583657|FG000|STARTED|Overall Study||175
8551882|NCT03287843|9583658|FG001|STARTED|Overall Study||175
8551883|NCT03287843|9583657|FG000|Excluded|Overall Study|No surgery n=5 R2 resection n=5 Stage IV n=2|12
8551884|NCT03287843|9583658|FG001|Excluded|Overall Study|No surgery n=4 R2 resection n=2 Stage IV n=2|8
8551885|NCT03287843|9583657|FG000|Lost to Follow up|Overall Study||3
8551886|NCT03287843|9583658|FG001|Lost to Follow up|Overall Study||0
8551887|NCT03287843|9583657|FG000|COMPLETED|Overall Study||160
8551888|NCT03287843|9583658|FG001|COMPLETED|Overall Study||167
8551889|NCT03287843|9583657|FG000|NOT COMPLETED|Overall Study||15
8551890|NCT03287843|9583658|FG001|NOT COMPLETED|Overall Study||8
8551891|NCT03230292|9583664|FG000|STARTED|Overall Study||43
8551892|NCT03230292|9583664|FG000|COMPLETED|Overall Study||37
8551893|NCT03230292|9583664|FG000|NOT COMPLETED|Overall Study||6
8551894|NCT03226067|9583673|FG000|STARTED|Overall Study||36
8551895|NCT03226067|9583674|FG001|STARTED|Overall Study||38
8551896|NCT03226067|9583675|FG002|STARTED|Overall Study||37
8551897|NCT03226067|9583673|FG000|COMPLETED|Overall Study||36
8551898|NCT03226067|9583674|FG001|COMPLETED|Overall Study||38
8551899|NCT03226067|9583675|FG002|COMPLETED|Overall Study||37
8551900|NCT03226067|9583673|FG000|NOT COMPLETED|Overall Study||0
8551901|NCT03226067|9583674|FG001|NOT COMPLETED|Overall Study||0
8551902|NCT03226067|9583675|FG002|NOT COMPLETED|Overall Study||0
8551903|NCT03131960|9583685|FG000|STARTED|Overall Study|1 participant missed the day one visit (V5) but remained in the study and returned for the day 90 assessment (V7).|53
8621756|NCT00483041|9660785|FG001|NOT COMPLETED|Overall Study||1
8621757|NCT00483184|9660794|FG000|STARTED|Overall Study||27
8621758|NCT00483184|9660795|FG001|STARTED|Overall Study||31
8621759|NCT00483184|9660796|FG002|STARTED|Overall Study||26
8621760|NCT00483184|9660794|FG000|COMPLETED|Overall Study||22
8621761|NCT00483184|9660795|FG001|COMPLETED|Overall Study||27
8621762|NCT00483184|9660796|FG002|COMPLETED|Overall Study||23
8621763|NCT00483184|9660794|FG000|NOT COMPLETED|Overall Study||5
8621764|NCT00483184|9660795|FG001|NOT COMPLETED|Overall Study||4
8621765|NCT00483184|9660796|FG002|NOT COMPLETED|Overall Study||3
8629456|NCT00530348|9669205|FG001|STARTED|Overall Study|Randomized.|386
8629457|NCT00530348|9669204|FG000|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug.|187
8629458|NCT00530348|9669205|FG001|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug.|376
8551904|NCT03131960|9583686|FG001|STARTED|Overall Study|1 discontinued treatment due to adverse event and inability to tolerate rehabilitation.|55
8551905|NCT03131960|9583685|FG000|COMPLETED|Overall Study||53
8551906|NCT03131960|9583686|FG001|COMPLETED|Overall Study||54
8551907|NCT03131960|9583685|FG000|NOT COMPLETED|Overall Study||0
8551908|NCT03131960|9583686|FG001|NOT COMPLETED|Overall Study||1
8551909|NCT03084536|9583695|FG000|STARTED|Overall Study||53
8551910|NCT03084536|9583696|FG001|STARTED|Overall Study||54
8629459|NCT00530348|9669204|FG000|COMPLETED|Overall Study||173
8629460|NCT00530348|9669205|FG001|COMPLETED|Overall Study||367
8629461|NCT00530348|9669204|FG000|NOT COMPLETED|Overall Study||22
8819105|NCT01562275|9872931|FG008|NOT COMPLETED|Stage 1||3
8551911|NCT03084536|9583697|FG002|STARTED|Overall Study||27
8551912|NCT03084536|9583695|FG000|COMPLETED|Overall Study||53
8551913|NCT03084536|9583696|FG001|COMPLETED|Overall Study||54
8551914|NCT03084536|9583697|FG002|COMPLETED|Overall Study||0
8551915|NCT03084536|9583695|FG000|NOT COMPLETED|Overall Study||0
8551916|NCT03084536|9583696|FG001|NOT COMPLETED|Overall Study||0
8551917|NCT03084536|9583697|FG002|NOT COMPLETED|Overall Study||27
8621766|NCT00483223|9660804|FG000|STARTED|Overall Study||86
8819106|NCT01562275|9872932|FG009|NOT COMPLETED|Stage 1||7
8819107|NCT01562275|9872933|FG010|NOT COMPLETED|Stage 1||3
8819108|NCT01562275|9872934|FG011|NOT COMPLETED|Stage 1||0
8567971|NCT00089674|9600380|FG000|COMPLETED|Overall Study||445
8567972|NCT00089674|9600381|FG001|COMPLETED|Overall Study||467
8567973|NCT00089674|9600380|FG000|NOT COMPLETED|Overall Study||289
8567974|NCT00089674|9600381|FG001|NOT COMPLETED|Overall Study||267
8567975|NCT00089752|9600389|FG000|STARTED|Overall Study||141
8567976|NCT00089752|9600390|FG001|STARTED|Overall Study||140
8567977|NCT00089752|9600389|FG000|COMPLETED|Overall Study||121
8567978|NCT00089752|9600390|FG001|COMPLETED|Overall Study||118
8567979|NCT00089752|9600389|FG000|NOT COMPLETED|Overall Study||20
8567980|NCT00089752|9600390|FG001|NOT COMPLETED|Overall Study||22
8567981|NCT00089778|9600401|FG000|STARTED|Overall Study||2
8567982|NCT00089778|9600402|FG001|STARTED|Overall Study||1
8567983|NCT00089778|9600403|FG002|STARTED|Overall Study||8
8567984|NCT00089778|9600401|FG000|COMPLETED|Overall Study||2
8567985|NCT00089778|9600402|FG001|COMPLETED|Overall Study||1
8567986|NCT00089778|9600403|FG002|COMPLETED|Overall Study||7
8567987|NCT00089778|9600401|FG000|NOT COMPLETED|Overall Study||0
8567988|NCT00089778|9600402|FG001|NOT COMPLETED|Overall Study||0
8567989|NCT00089778|9600403|FG002|NOT COMPLETED|Overall Study||1
8567990|NCT00089843|9600417|FG000|STARTED|Overall Study||19
8567991|NCT00089843|9600418|FG001|STARTED|Overall Study||20
8567992|NCT00089843|9600419|FG002|STARTED|Overall Study||20
8567993|NCT00089843|9600420|FG003|STARTED|Overall Study||18
8567994|NCT00089843|9600417|FG000|COMPLETED|Overall Study||17
8567995|NCT00089843|9600418|FG001|COMPLETED|Overall Study||16
8567996|NCT00089843|9600419|FG002|COMPLETED|Overall Study||15
8567997|NCT00089843|9600420|FG003|COMPLETED|Overall Study||11
8567998|NCT00089843|9600417|FG000|NOT COMPLETED|Overall Study||2
8567999|NCT00089843|9600418|FG001|NOT COMPLETED|Overall Study||4
8568000|NCT00089843|9600419|FG002|NOT COMPLETED|Overall Study||5
8568001|NCT00089843|9600420|FG003|NOT COMPLETED|Overall Study||7
8568002|NCT00089973|9600430|FG000|STARTED|Overall Study||50
8568003|NCT00089973|9600430|FG000|COMPLETED|Overall Study||0
8819109|NCT01562275|9872935|FG012|NOT COMPLETED|Stage 1||0
8819110|NCT01562275|9872923|FG000|STARTED|Stage 2||0
8819111|NCT01562275|9872924|FG001|STARTED|Stage 2||0
8819112|NCT01562275|9872925|FG002|STARTED|Stage 2||0
8819113|NCT01562275|9872926|FG003|STARTED|Stage 2||0
8819114|NCT01562275|9872927|FG004|STARTED|Stage 2||0
8819115|NCT01562275|9872928|FG005|STARTED|Stage 2||0
8819116|NCT01562275|9872929|FG006|STARTED|Stage 2||0
8819117|NCT01562275|9872930|FG007|STARTED|Stage 2||0
8819118|NCT01562275|9872931|FG008|STARTED|Stage 2||0
8819119|NCT01562275|9872932|FG009|STARTED|Stage 2||0
8819120|NCT01562275|9872933|FG010|STARTED|Stage 2||0
8819121|NCT01562275|9872934|FG011|STARTED|Stage 2||14
8819122|NCT01562275|9872935|FG012|STARTED|Stage 2||5
8819123|NCT01562275|9872923|FG000|COMPLETED|Stage 2||0
8819124|NCT01562275|9872924|FG001|COMPLETED|Stage 2||0
8819125|NCT01562275|9872925|FG002|COMPLETED|Stage 2||0
8819126|NCT01562275|9872926|FG003|COMPLETED|Stage 2||0
8819127|NCT01562275|9872927|FG004|COMPLETED|Stage 2||0
8819128|NCT01562275|9872928|FG005|COMPLETED|Stage 2||0
8819129|NCT01562275|9872929|FG006|COMPLETED|Stage 2||0
8819130|NCT01562275|9872930|FG007|COMPLETED|Stage 2||0
8819131|NCT01562275|9872931|FG008|COMPLETED|Stage 2||0
8819132|NCT01562275|9872932|FG009|COMPLETED|Stage 2||0
8819133|NCT01562275|9872933|FG010|COMPLETED|Stage 2||0
8819134|NCT01562275|9872934|FG011|COMPLETED|Stage 2||0
8819135|NCT01562275|9872935|FG012|COMPLETED|Stage 2||0
8819136|NCT01562275|9872923|FG000|NOT COMPLETED|Stage 2||0
8819137|NCT01562275|9872924|FG001|NOT COMPLETED|Stage 2||0
8819138|NCT01562275|9872925|FG002|NOT COMPLETED|Stage 2||0
8819139|NCT01562275|9872926|FG003|NOT COMPLETED|Stage 2||0
8819140|NCT01562275|9872927|FG004|NOT COMPLETED|Stage 2||0
8819141|NCT01562275|9872928|FG005|NOT COMPLETED|Stage 2||0
8819142|NCT01562275|9872929|FG006|NOT COMPLETED|Stage 2||0
8819143|NCT01562275|9872930|FG007|NOT COMPLETED|Stage 2||0
8819144|NCT01562275|9872931|FG008|NOT COMPLETED|Stage 2||0
8568004|NCT00089973|9600430|FG000|NOT COMPLETED|Overall Study||50
8568005|NCT00089986|9600437|FG000|STARTED|Overall Study||599
8568006|NCT00089986|9600438|FG001|STARTED|Overall Study||598
8568007|NCT00089986|9600439|FG002|STARTED|Overall Study||182
8819145|NCT01562275|9872932|FG009|NOT COMPLETED|Stage 2||0
8819146|NCT01562275|9872933|FG010|NOT COMPLETED|Stage 2||0
8819147|NCT01562275|9872934|FG011|NOT COMPLETED|Stage 2||14
8819148|NCT01562275|9872935|FG012|NOT COMPLETED|Stage 2||5
8819149|NCT01562314|9872967|FG000|STARTED|Overall Study||29
8568008|NCT00089986|9600437|FG000|COMPLETED|Overall Study||584
8568009|NCT00089986|9600438|FG001|COMPLETED|Overall Study||574
8568010|NCT00089986|9600439|FG002|COMPLETED|Overall Study||172
8568011|NCT00089986|9600437|FG000|NOT COMPLETED|Overall Study||15
8819150|NCT01562314|9872968|FG001|STARTED|Overall Study||31
8819151|NCT01562314|9872967|FG000|Received at Least 1 Dose of Study Drug|Overall Study||29
8819152|NCT01562314|9872968|FG001|Received at Least 1 Dose of Study Drug|Overall Study||31
8819153|NCT01562314|9872967|FG000|Intent-to-Treat (ITT) Analysis Set|Overall Study||29
8819154|NCT01562314|9872968|FG001|Intent-to-Treat (ITT) Analysis Set|Overall Study||31
8551918|NCT02996305|9583707|FG000|STARTED|Overall Study||29
8551919|NCT02996305|9583708|FG001|STARTED|Overall Study||29
8551920|NCT02996305|9583709|FG002|STARTED|Overall Study||30
8551921|NCT02996305|9583707|FG000|COMPLETED|Overall Study||26
8551922|NCT02996305|9583708|FG001|COMPLETED|Overall Study||27
8551923|NCT02996305|9583709|FG002|COMPLETED|Overall Study||25
8551924|NCT02996305|9583707|FG000|NOT COMPLETED|Overall Study||3
8551925|NCT02996305|9583708|FG001|NOT COMPLETED|Overall Study||2
8723111|NCT01021748|9770616|FG005|COMPLETED|Overall Study||0
8723112|NCT01021748|9770617|FG006|COMPLETED|Overall Study||0
8723113|NCT01021748|9770618|FG007|COMPLETED|Overall Study||0
8723114|NCT01021748|9770619|FG008|COMPLETED|Overall Study||1
8723115|NCT01021748|9770611|FG000|NOT COMPLETED|Overall Study||6
8723116|NCT01021748|9770612|FG001|NOT COMPLETED|Overall Study||5
8551926|NCT02996305|9583709|FG002|NOT COMPLETED|Overall Study||5
8551927|NCT02992119|9583724|FG000|STARTED|Overall Study||21
8551928|NCT02992119|9583725|FG001|STARTED|Overall Study||21
8551929|NCT02992119|9583726|FG002|STARTED|Overall Study||30
8551930|NCT02992119|9583727|FG003|STARTED|Overall Study||30
8551931|NCT02992119|9583728|FG004|STARTED|Overall Study||30
8551932|NCT02992119|9583729|FG005|STARTED|Overall Study||30
8551933|NCT02992119|9583730|FG006|STARTED|Overall Study||31
8551934|NCT02992119|9583724|FG000|COMPLETED|Overall Study||19
8551935|NCT02992119|9583725|FG001|COMPLETED|Overall Study||20
8551936|NCT02992119|9583726|FG002|COMPLETED|Overall Study||29
8551937|NCT02992119|9583727|FG003|COMPLETED|Overall Study||30
8551938|NCT02992119|9583728|FG004|COMPLETED|Overall Study||30
8551939|NCT02992119|9583729|FG005|COMPLETED|Overall Study||30
8551940|NCT02992119|9583730|FG006|COMPLETED|Overall Study||28
8551941|NCT02992119|9583724|FG000|NOT COMPLETED|Overall Study||2
8551942|NCT02992119|9583725|FG001|NOT COMPLETED|Overall Study||1
8551943|NCT02992119|9583726|FG002|NOT COMPLETED|Overall Study||1
8551944|NCT02992119|9583727|FG003|NOT COMPLETED|Overall Study||0
8551945|NCT02992119|9583728|FG004|NOT COMPLETED|Overall Study||0
8551946|NCT02992119|9583729|FG005|NOT COMPLETED|Overall Study||0
8551947|NCT02992119|9583730|FG006|NOT COMPLETED|Overall Study||3
8551948|NCT02988661|9583749|FG000|STARTED|Overall Study||168
8551949|NCT02988661|9583750|FG001|STARTED|Overall Study||531
8551950|NCT02988661|9583749|FG000|COMPLETED|Overall Study||165
8819155|NCT01562314|9872967|FG000|Per Protocol (PP) Analysis Set|Overall Study||17
8819156|NCT01562314|9872968|FG001|Per Protocol (PP) Analysis Set|Overall Study||27
8819157|NCT01562314|9872967|FG000|COMPLETED|Overall Study||16
8819158|NCT01562314|9872968|FG001|COMPLETED|Overall Study||23
8819159|NCT01562314|9872967|FG000|NOT COMPLETED|Overall Study||13
8819160|NCT01562314|9872968|FG001|NOT COMPLETED|Overall Study||8
8819161|NCT01562327|9872974|FG000|STARTED|Overall Study||50
8819162|NCT01562327|9872974|FG000|COMPLETED|Overall Study||42
8819163|NCT01562327|9872974|FG000|NOT COMPLETED|Overall Study||8
8819164|NCT01562379|9872984|FG000|STARTED|Overall Study||1438
8819165|NCT01562379|9872985|FG001|STARTED|Overall Study||1492
8819166|NCT01562379|9872986|FG002|STARTED|Overall Study||851
8819167|NCT01562379|9872987|FG003|STARTED|Overall Study||843
8819168|NCT01562379|9872988|FG004|STARTED|Overall Study||825
8819169|NCT01562379|9872984|FG000|COMPLETED|Overall Study||1312
8819170|NCT01562379|9872985|FG001|COMPLETED|Overall Study||1395
8819171|NCT01562379|9872986|FG002|COMPLETED|Overall Study||789
8819172|NCT01562379|9872987|FG003|COMPLETED|Overall Study||786
8819173|NCT01562379|9872988|FG004|COMPLETED|Overall Study||785
8819174|NCT01562379|9872984|FG000|NOT COMPLETED|Overall Study||126
8819175|NCT01562379|9872985|FG001|NOT COMPLETED|Overall Study||97
8819176|NCT01562379|9872986|FG002|NOT COMPLETED|Overall Study||62
8819177|NCT01562379|9872987|FG003|NOT COMPLETED|Overall Study||57
8819178|NCT01562379|9872988|FG004|NOT COMPLETED|Overall Study||40
8819179|NCT01562444|9873003|FG000|STARTED|Overall Study||48
8819180|NCT01562444|9873004|FG001|STARTED|Overall Study||51
8819181|NCT01562444|9873005|FG002|STARTED|Overall Study||106
8819182|NCT01562444|9873003|FG000|COMPLETED|Overall Study||43
8819183|NCT01562444|9873004|FG001|COMPLETED|Overall Study||49
8819184|NCT01562444|9873005|FG002|COMPLETED|Overall Study||99
8551951|NCT02988661|9583750|FG001|COMPLETED|Overall Study||447
8551952|NCT02988661|9583749|FG000|NOT COMPLETED|Overall Study||3
8551953|NCT02988661|9583750|FG001|NOT COMPLETED|Overall Study||84
8551954|NCT02951767|9583756|FG000|STARTED|Overall Study||119
8551955|NCT02951767|9583756|FG000|COMPLETED|Overall Study||0
8551956|NCT02951767|9583756|FG000|NOT COMPLETED|Overall Study||119
8551957|NCT02921776|9583766|FG000|STARTED|Overall Study||13
8551958|NCT02921776|9583767|FG001|STARTED|Overall Study||23
8551959|NCT02921776|9583768|FG002|STARTED|Overall Study||7
8723117|NCT01021748|9770613|FG002|NOT COMPLETED|Overall Study||7
8723118|NCT01021748|9770614|FG003|NOT COMPLETED|Overall Study||7
8723119|NCT01021748|9770615|FG004|NOT COMPLETED|Overall Study||9
8723120|NCT01021748|9770616|FG005|NOT COMPLETED|Overall Study||3
8723121|NCT01021748|9770617|FG006|NOT COMPLETED|Overall Study||3
8723122|NCT01021748|9770618|FG007|NOT COMPLETED|Overall Study||6
8723123|NCT01021748|9770619|FG008|NOT COMPLETED|Overall Study||16
8551960|NCT02921776|9583769|FG003|STARTED|Overall Study||31
8551961|NCT02921776|9583770|FG004|STARTED|Overall Study||32
8551962|NCT02921776|9583771|FG005|STARTED|Overall Study||7
8551963|NCT02921776|9583772|FG006|STARTED|Overall Study||18
8819185|NCT01562444|9873003|FG000|NOT COMPLETED|Overall Study||5
8819186|NCT01562444|9873004|FG001|NOT COMPLETED|Overall Study||2
8819187|NCT01562444|9873005|FG002|NOT COMPLETED|Overall Study||7
8819188|NCT01562548|9873017|FG000|STARTED|Overall Study||25
8551964|NCT02921776|9583773|FG007|STARTED|Overall Study||16
8551965|NCT02921776|9583766|FG000|COMPLETED|Overall Study||11
8551966|NCT02921776|9583767|FG001|COMPLETED|Overall Study||15
8551967|NCT02921776|9583768|FG002|COMPLETED|Overall Study||7
8551968|NCT02921776|9583769|FG003|COMPLETED|Overall Study|Completed Primary outcome (daily measures) = 27 Completed Secondary outcomes (@ICU discharge) = 23|23
8551969|NCT02921776|9583770|FG004|COMPLETED|Overall Study|Completed Primary outcome (daily measures) = 27 Completed Secondary outcomes (@ICU discharge) = 26|26
8551970|NCT02921776|9583771|FG005|COMPLETED|Overall Study||5
8551971|NCT02921776|9583772|FG006|COMPLETED|Overall Study|"At discharge/ extubation =11~1-mos post-discharge = 8 3-mos post-discharge = 8"|7
8551972|NCT02921776|9583773|FG007|COMPLETED|Overall Study|"At discharge/ extubation =15~1-mos post-discharge = 12 3-mos post-discharge = 11"|9
8551973|NCT02921776|9583766|FG000|NOT COMPLETED|Overall Study||2
8551974|NCT02921776|9583767|FG001|NOT COMPLETED|Overall Study||8
8551975|NCT02921776|9583768|FG002|NOT COMPLETED|Overall Study||0
8551976|NCT02921776|9583769|FG003|NOT COMPLETED|Overall Study||8
8551977|NCT02921776|9583770|FG004|NOT COMPLETED|Overall Study||6
8551978|NCT02921776|9583771|FG005|NOT COMPLETED|Overall Study||2
8551979|NCT02921776|9583772|FG006|NOT COMPLETED|Overall Study||11
8551980|NCT02921776|9583773|FG007|NOT COMPLETED|Overall Study||7
8551981|NCT02898259|9583802|FG000|STARTED|Overall Study||3
8551982|NCT02898259|9583803|FG001|STARTED|Overall Study||3
8551983|NCT02898259|9583804|FG002|STARTED|Overall Study||6
8551984|NCT02898259|9583805|FG003|STARTED|Overall Study||7
8551985|NCT02898259|9583806|FG004|STARTED|Overall Study||0
8551986|NCT02898259|9583802|FG000|COMPLETED|Overall Study||2
8551987|NCT02898259|9583803|FG001|COMPLETED|Overall Study||2
8551988|NCT02898259|9583804|FG002|COMPLETED|Overall Study||1
8551989|NCT02898259|9583805|FG003|COMPLETED|Overall Study||6
8551990|NCT02898259|9583806|FG004|COMPLETED|Overall Study||0
8551991|NCT02898259|9583802|FG000|NOT COMPLETED|Overall Study||1
8551992|NCT02898259|9583803|FG001|NOT COMPLETED|Overall Study||1
8551993|NCT02898259|9583804|FG002|NOT COMPLETED|Overall Study||5
8551994|NCT02898259|9583805|FG003|NOT COMPLETED|Overall Study||1
8551995|NCT02898259|9583806|FG004|NOT COMPLETED|Overall Study||0
8551996|NCT02870348|9583819|FG000|STARTED|Overall Study||4
8551997|NCT02870348|9583819|FG000|COMPLETED|Overall Study||0
8551998|NCT02870348|9583819|FG000|NOT COMPLETED|Overall Study||4
8551999|NCT02841280|9583825|FG000|STARTED|Overall Study||81
8552000|NCT02841280|9583826|FG001|STARTED|Overall Study||79
8552001|NCT02841280|9583825|FG000|COMPLETED|Overall Study||67
8552002|NCT02841280|9583826|FG001|COMPLETED|Overall Study||73
8552003|NCT02841280|9583825|FG000|NOT COMPLETED|Overall Study||14
8552004|NCT02841280|9583826|FG001|NOT COMPLETED|Overall Study||6
8552005|NCT02786498|9583836|FG000|STARTED|Overall Study||27
8552006|NCT02786498|9583837|FG001|STARTED|Overall Study||24
8552007|NCT02786498|9583838|FG002|STARTED|Overall Study||24
8552008|NCT02786498|9583839|FG003|STARTED|Overall Study||27
8552009|NCT02786498|9583836|FG000|COMPLETED|Overall Study||25
8552010|NCT02786498|9583837|FG001|COMPLETED|Overall Study||24
8552011|NCT02786498|9583838|FG002|COMPLETED|Overall Study||24
8552012|NCT02786498|9583839|FG003|COMPLETED|Overall Study||26
8552013|NCT02786498|9583836|FG000|NOT COMPLETED|Overall Study||2
8552014|NCT02786498|9583837|FG001|NOT COMPLETED|Overall Study||0
8552015|NCT02786498|9583838|FG002|NOT COMPLETED|Overall Study||0
8552016|NCT02786498|9583839|FG003|NOT COMPLETED|Overall Study||1
8552017|NCT02771275|9583849|FG000|STARTED|Overall Study||13
8552018|NCT02771275|9583849|FG000|COMPLETED|Overall Study||0
8552019|NCT02771275|9583849|FG000|NOT COMPLETED|Overall Study||13
8552020|NCT02675426|9583856|FG000|STARTED|Overall Study||221
8552021|NCT02675426|9583857|FG001|STARTED|Overall Study||221
8552022|NCT02675426|9583858|FG002|STARTED|Overall Study||219
8552023|NCT02675426|9583856|FG000|Treated|Overall Study||221
8552024|NCT02675426|9583857|FG001|Treated|Overall Study||221
8552025|NCT02675426|9583858|FG002|Treated|Overall Study||219
8552026|NCT02675426|9583856|FG000|COMPLETED|Overall Study||208
8552027|NCT02675426|9583857|FG001|COMPLETED|Overall Study||213
8552028|NCT02675426|9583858|FG002|COMPLETED|Overall Study||201
8552029|NCT02675426|9583856|FG000|NOT COMPLETED|Overall Study||13
8552030|NCT02675426|9583857|FG001|NOT COMPLETED|Overall Study||8
8552031|NCT02675426|9583858|FG002|NOT COMPLETED|Overall Study||18
8552032|NCT02639546|9583874|FG000|STARTED|Overall Study||6
8552033|NCT02639546|9583875|FG001|STARTED|Overall Study||6
8552034|NCT02639546|9583876|FG002|STARTED|Overall Study||6
8552035|NCT02639546|9583877|FG003|STARTED|Overall Study||6
8552036|NCT02639546|9583878|FG004|STARTED|Overall Study||7
8552037|NCT02639546|9583879|FG005|STARTED|Overall Study||8
8552038|NCT02639546|9583880|FG006|STARTED|Overall Study||5
8552039|NCT02639546|9583881|FG007|STARTED|Overall Study||12
8552040|NCT02639546|9583874|FG000|Tumor Type - Neuroblastoma|Overall Study||0
8552041|NCT02639546|9583875|FG001|Tumor Type - Neuroblastoma|Overall Study||0
8552042|NCT02639546|9583876|FG002|Tumor Type - Neuroblastoma|Overall Study||1
8552043|NCT02639546|9583877|FG003|Tumor Type - Neuroblastoma|Overall Study||0
8552044|NCT02639546|9583878|FG004|Tumor Type - Neuroblastoma|Overall Study||0
8552045|NCT02639546|9583879|FG005|Tumor Type - Neuroblastoma|Overall Study||0
8552046|NCT02639546|9583880|FG006|Tumor Type - Neuroblastoma|Overall Study||0
8552047|NCT02639546|9583881|FG007|Tumor Type - Neuroblastoma|Overall Study||0
8552048|NCT02639546|9583874|FG000|Tumor Type - High-Grade Glioma|Overall Study||3
8552049|NCT02639546|9583875|FG001|Tumor Type - High-Grade Glioma|Overall Study||1
8552050|NCT02639546|9583876|FG002|Tumor Type - High-Grade Glioma|Overall Study||0
8552051|NCT02639546|9583877|FG003|Tumor Type - High-Grade Glioma|Overall Study||0
8552052|NCT02639546|9583878|FG004|Tumor Type - High-Grade Glioma|Overall Study||1
8552053|NCT02639546|9583879|FG005|Tumor Type - High-Grade Glioma|Overall Study||0
8552054|NCT02639546|9583880|FG006|Tumor Type - High-Grade Glioma|Overall Study||0
8552055|NCT02639546|9583881|FG007|Tumor Type - High-Grade Glioma|Overall Study||0
8552056|NCT02639546|9583874|FG000|Tumor Type - Low-Grade Glioma|Overall Study||1
8552057|NCT02639546|9583875|FG001|Tumor Type - Low-Grade Glioma|Overall Study||2
8552058|NCT02639546|9583876|FG002|Tumor Type - Low-Grade Glioma|Overall Study||4
8552059|NCT02639546|9583877|FG003|Tumor Type - Low-Grade Glioma|Overall Study||5
8552060|NCT02639546|9583878|FG004|Tumor Type - Low-Grade Glioma|Overall Study||3
8552061|NCT02639546|9583879|FG005|Tumor Type - Low-Grade Glioma|Overall Study||2
8552062|NCT02639546|9583880|FG006|Tumor Type - Low-Grade Glioma|Overall Study||3
8552063|NCT02639546|9583881|FG007|Tumor Type - Low-Grade Glioma|Overall Study||12
8552064|NCT02639546|9583874|FG000|Tumor Type - Dnet In Noonan's Syndrome Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0
8552065|NCT02639546|9583875|FG001|Tumor Type - Dnet In Noonan's Syndrome Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0
8552066|NCT02639546|9583876|FG002|Tumor Type - Dnet In Noonan's Syndrome Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0
8552067|NCT02639546|9583877|FG003|Tumor Type - Dnet In Noonan's Syndrome Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0
8552068|NCT02639546|9583878|FG004|Tumor Type - Dnet In Noonan's Syndrome Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0
8552069|NCT02639546|9583879|FG005|Tumor Type - Dnet In Noonan's Syndrome Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0
8552070|NCT02639546|9583880|FG006|Tumor Type - Dnet In Noonan's Syndrome Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||1
8552071|NCT02639546|9583881|FG007|Tumor Type - Dnet In Noonan's Syndrome Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0
8552072|NCT02639546|9583874|FG000|Tumor Type - Malignant Peripheral Nerve Sheath Tumor|Overall Study||0
8552073|NCT02639546|9583875|FG001|Tumor Type - Malignant Peripheral Nerve Sheath Tumor|Overall Study||0
8552074|NCT02639546|9583876|FG002|Tumor Type - Malignant Peripheral Nerve Sheath Tumor|Overall Study||0
8552075|NCT02639546|9583877|FG003|Tumor Type - Malignant Peripheral Nerve Sheath Tumor|Overall Study||0
8552076|NCT02639546|9583878|FG004|Tumor Type - Malignant Peripheral Nerve Sheath Tumor|Overall Study||1
8552077|NCT02639546|9583879|FG005|Tumor Type - Malignant Peripheral Nerve Sheath Tumor|Overall Study||1
8552078|NCT02639546|9583880|FG006|Tumor Type - Malignant Peripheral Nerve Sheath Tumor|Overall Study||0
8552079|NCT02639546|9583881|FG007|Tumor Type - Malignant Peripheral Nerve Sheath Tumor|Overall Study||0
8552080|NCT02639546|9583874|FG000|Tumor Type - Metastatic Mediastinal Yolksac Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||1
8552081|NCT02639546|9583875|FG001|Tumor Type - Metastatic Mediastinal Yolksac Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0
8552082|NCT02639546|9583876|FG002|Tumor Type - Metastatic Mediastinal Yolksac Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0
8819189|NCT01562548|9873018|FG001|STARTED|Overall Study||15
8819190|NCT01562548|9873019|FG002|STARTED|Overall Study||25
8819191|NCT01562548|9873020|FG003|STARTED|Overall Study||14
8819192|NCT01562548|9873017|FG000|COMPLETED|Overall Study||25
8819193|NCT01562548|9873018|FG001|COMPLETED|Overall Study||15
8819194|NCT01562548|9873019|FG002|COMPLETED|Overall Study||24
8819195|NCT01562548|9873020|FG003|COMPLETED|Overall Study||14
8819196|NCT01562548|9873017|FG000|NOT COMPLETED|Overall Study||0
8819197|NCT01562548|9873018|FG001|NOT COMPLETED|Overall Study||0
8819198|NCT01562548|9873019|FG002|NOT COMPLETED|Overall Study||1
8819199|NCT01562548|9873020|FG003|NOT COMPLETED|Overall Study||0
8819200|NCT01562613|9873032|FG000|STARTED|Overall Study||533
8819201|NCT01562613|9873032|FG000|COMPLETED|Overall Study||529
8819202|NCT01562613|9873032|FG000|NOT COMPLETED|Overall Study||4
8819203|NCT01562678|9873038|FG000|STARTED|Overall Study||14
8819204|NCT01562678|9873039|FG001|STARTED|Overall Study||14
8819205|NCT01562678|9873038|FG000|COMPLETED|Overall Study||8
8819206|NCT01562678|9873039|FG001|COMPLETED|Overall Study||12
8819207|NCT01562678|9873038|FG000|NOT COMPLETED|Overall Study||6
8819208|NCT01562678|9873039|FG001|NOT COMPLETED|Overall Study||2
8819209|NCT01562743|9873045|FG000|STARTED|Overall Study||185
8819210|NCT01562743|9873045|FG000|COMPLETED|Overall Study||133
8819211|NCT01562743|9873045|FG000|NOT COMPLETED|Overall Study||52
8819212|NCT01562756|9873049|FG000|STARTED|Overall Study||6
8819213|NCT01562756|9873049|FG000|COMPLETED|Overall Study||6
8819214|NCT01562756|9873049|FG000|NOT COMPLETED|Overall Study||0
8819215|NCT01562782|9873055|FG000|STARTED|Overall Study||19
8819216|NCT01562782|9873056|FG001|STARTED|Overall Study||20
8819217|NCT01562782|9873055|FG000|COMPLETED|Overall Study||15
8819218|NCT01562782|9873056|FG001|COMPLETED|Overall Study||15
8819219|NCT01562782|9873055|FG000|NOT COMPLETED|Overall Study||4
8819220|NCT01562782|9873056|FG001|NOT COMPLETED|Overall Study||5
8819221|NCT01562873|9873062|FG000|STARTED|Overall Study||21
8819222|NCT01562873|9873063|FG001|STARTED|Overall Study|The observed number of objective responses in Cohort A was not sufficient for Cohort B to open.|0
8819223|NCT01562873|9873062|FG000|COMPLETED|Overall Study||0
8819224|NCT01562873|9873063|FG001|COMPLETED|Overall Study||0
8819225|NCT01562873|9873062|FG000|NOT COMPLETED|Overall Study||21
8819226|NCT01562873|9873063|FG001|NOT COMPLETED|Overall Study||0
8819227|NCT01562886|9873067|FG000|STARTED|Overall Study||14
8819228|NCT01562886|9873067|FG000|COMPLETED|Overall Study||13
8819229|NCT01562886|9873067|FG000|NOT COMPLETED|Overall Study||1
8819230|NCT01563003|9873073|FG000|STARTED|Overall Study||16
8819231|NCT01563003|9873074|FG001|STARTED|Overall Study||15
8552083|NCT02639546|9583877|FG003|Tumor Type - Metastatic Mediastinal Yolksac Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0
8552084|NCT02639546|9583878|FG004|Tumor Type - Metastatic Mediastinal Yolksac Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0
8552085|NCT02639546|9583879|FG005|Tumor Type - Metastatic Mediastinal Yolksac Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0
8552086|NCT02639546|9583880|FG006|Tumor Type - Metastatic Mediastinal Yolksac Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0
8552087|NCT02639546|9583881|FG007|Tumor Type - Metastatic Mediastinal Yolksac Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0
8552088|NCT02639546|9583874|FG000|Tumor Type - Non-Rhabdomyosarcoma Soft Tissue Sarcoma|Overall Study||0
8552089|NCT02639546|9583875|FG001|Tumor Type - Non-Rhabdomyosarcoma Soft Tissue Sarcoma|Overall Study||1
8552090|NCT02639546|9583876|FG002|Tumor Type - Non-Rhabdomyosarcoma Soft Tissue Sarcoma|Overall Study||0
8552091|NCT02639546|9583877|FG003|Tumor Type - Non-Rhabdomyosarcoma Soft Tissue Sarcoma|Overall Study||0
8552092|NCT02639546|9583878|FG004|Tumor Type - Non-Rhabdomyosarcoma Soft Tissue Sarcoma|Overall Study||0
8552093|NCT02639546|9583879|FG005|Tumor Type - Non-Rhabdomyosarcoma Soft Tissue Sarcoma|Overall Study||0
8552094|NCT02639546|9583880|FG006|Tumor Type - Non-Rhabdomyosarcoma Soft Tissue Sarcoma|Overall Study||0
8552095|NCT02639546|9583881|FG007|Tumor Type - Non-Rhabdomyosarcoma Soft Tissue Sarcoma|Overall Study||0
8552096|NCT02639546|9583874|FG000|Tumor Type - Plexiform Neurofibroma|Overall Study||1
8552097|NCT02639546|9583875|FG001|Tumor Type - Plexiform Neurofibroma|Overall Study||2
8552098|NCT02639546|9583876|FG002|Tumor Type - Plexiform Neurofibroma|Overall Study||1
8552099|NCT02639546|9583877|FG003|Tumor Type - Plexiform Neurofibroma|Overall Study||1
8552100|NCT02639546|9583878|FG004|Tumor Type - Plexiform Neurofibroma|Overall Study||2
8552101|NCT02639546|9583879|FG005|Tumor Type - Plexiform Neurofibroma|Overall Study||4
8552102|NCT02639546|9583880|FG006|Tumor Type - Plexiform Neurofibroma|Overall Study||1
8552103|NCT02639546|9583881|FG007|Tumor Type - Plexiform Neurofibroma|Overall Study||0
8552104|NCT02639546|9583874|FG000|Tumor Type - Rhabdoid Tumor/ATRT|Overall Study||0
8552105|NCT02639546|9583875|FG001|Tumor Type - Rhabdoid Tumor/ATRT|Overall Study||0
8552106|NCT02639546|9583876|FG002|Tumor Type - Rhabdoid Tumor/ATRT|Overall Study||0
8552107|NCT02639546|9583877|FG003|Tumor Type - Rhabdoid Tumor/ATRT|Overall Study||0
8552108|NCT02639546|9583878|FG004|Tumor Type - Rhabdoid Tumor/ATRT|Overall Study||0
8552109|NCT02639546|9583879|FG005|Tumor Type - Rhabdoid Tumor/ATRT|Overall Study||1
8552110|NCT02639546|9583880|FG006|Tumor Type - Rhabdoid Tumor/ATRT|Overall Study||0
8552111|NCT02639546|9583881|FG007|Tumor Type - Rhabdoid Tumor/ATRT|Overall Study||0
8552112|NCT02639546|9583874|FG000|COMPLETED|Overall Study||0
8552113|NCT02639546|9583875|FG001|COMPLETED|Overall Study||0
8552114|NCT02639546|9583876|FG002|COMPLETED|Overall Study||0
8552115|NCT02639546|9583877|FG003|COMPLETED|Overall Study||0
8552116|NCT02639546|9583878|FG004|COMPLETED|Overall Study||0
8552117|NCT02639546|9583879|FG005|COMPLETED|Overall Study||0
8552118|NCT02639546|9583880|FG006|COMPLETED|Overall Study||0
8552119|NCT02639546|9583881|FG007|COMPLETED|Overall Study||0
8552120|NCT02639546|9583874|FG000|NOT COMPLETED|Overall Study||6
8552121|NCT02639546|9583875|FG001|NOT COMPLETED|Overall Study||6
8552122|NCT02639546|9583876|FG002|NOT COMPLETED|Overall Study||6
8552123|NCT02639546|9583877|FG003|NOT COMPLETED|Overall Study||6
8552124|NCT02639546|9583878|FG004|NOT COMPLETED|Overall Study||7
8552125|NCT02639546|9583879|FG005|NOT COMPLETED|Overall Study||8
8552126|NCT02639546|9583880|FG006|NOT COMPLETED|Overall Study||5
8552127|NCT02639546|9583881|FG007|NOT COMPLETED|Overall Study||12
8552128|NCT02575339|9583916|FG000|STARTED|Study Treatment||7
8552129|NCT02575339|9583917|FG001|STARTED|Study Treatment|This study was terminated at Phase I.|4
8552130|NCT02575339|9583918|FG002|STARTED|Study Treatment|This study was terminated at Phase I.|0
8552131|NCT02575339|9583916|FG000|COMPLETED|Study Treatment||0
8552132|NCT02575339|9583917|FG001|COMPLETED|Study Treatment||0
8552133|NCT02575339|9583918|FG002|COMPLETED|Study Treatment||0
8552134|NCT02575339|9583916|FG000|NOT COMPLETED|Study Treatment||7
8552135|NCT02575339|9583917|FG001|NOT COMPLETED|Study Treatment||4
8552136|NCT02575339|9583918|FG002|NOT COMPLETED|Study Treatment||0
8552137|NCT02575339|9583916|FG000|STARTED|Follow up||7
8552138|NCT02575339|9583917|FG001|STARTED|Follow up||4
8552139|NCT02575339|9583918|FG002|STARTED|Follow up||0
8552140|NCT02575339|9583916|FG000|COMPLETED|Follow up||0
8819232|NCT01563003|9873073|FG000|COMPLETED|Overall Study||16
8819233|NCT01563003|9873074|FG001|COMPLETED|Overall Study||15
8819234|NCT01563003|9873073|FG000|NOT COMPLETED|Overall Study||0
8819235|NCT01563003|9873074|FG001|NOT COMPLETED|Overall Study||0
8819236|NCT01563029|9873085|FG000|STARTED|Overall Study||119
8819237|NCT01563029|9873086|FG001|STARTED|Overall Study||118
8819238|NCT01563029|9873087|FG002|STARTED|Overall Study||120
8819239|NCT01563029|9873088|FG003|STARTED|Overall Study||118
8819240|NCT01563029|9873089|FG004|STARTED|Overall Study||118
8552141|NCT02575339|9583917|FG001|COMPLETED|Follow up||0
8552142|NCT02575339|9583918|FG002|COMPLETED|Follow up||0
8552143|NCT02575339|9583916|FG000|NOT COMPLETED|Follow up||7
8552144|NCT02575339|9583917|FG001|NOT COMPLETED|Follow up||4
8552145|NCT02575339|9583918|FG002|NOT COMPLETED|Follow up||0
8552146|NCT02498444|9583930|FG000|STARTED|Overall Study||16
8552147|NCT02498444|9583931|FG001|STARTED|Overall Study||18
8552148|NCT02498444|9583930|FG000|COMPLETED|Overall Study||12
8552149|NCT02498444|9583931|FG001|COMPLETED|Overall Study||18
8552150|NCT02498444|9583930|FG000|NOT COMPLETED|Overall Study||4
8819241|NCT01563029|9873085|FG000|COMPLETED|Overall Study||66
8819242|NCT01563029|9873086|FG001|COMPLETED|Overall Study||94
8819243|NCT01563029|9873087|FG002|COMPLETED|Overall Study||87
8552151|NCT02498444|9583931|FG001|NOT COMPLETED|Overall Study||0
8552152|NCT02487108|9583941|FG000|STARTED|Overall Study||142
8552153|NCT02487108|9583942|FG001|STARTED|Overall Study||142
8552154|NCT02487108|9583943|FG002|STARTED|Overall Study||143
8552155|NCT02487108|9583944|FG003|STARTED|Overall Study||142
8552156|NCT02487108|9583941|FG000|Received at Least 1 Dose of Study Drug|Overall Study||142
8552157|NCT02487108|9583942|FG001|Received at Least 1 Dose of Study Drug|Overall Study||142
8552158|NCT02487108|9583943|FG002|Received at Least 1 Dose of Study Drug|Overall Study||141
8552159|NCT02487108|9583944|FG003|Received at Least 1 Dose of Study Drug|Overall Study||142
8552160|NCT02487108|9583941|FG000|COMPLETED|Overall Study||126
8552161|NCT02487108|9583942|FG001|COMPLETED|Overall Study||126
8552162|NCT02487108|9583943|FG002|COMPLETED|Overall Study||117
8552163|NCT02487108|9583944|FG003|COMPLETED|Overall Study||131
8552164|NCT02487108|9583941|FG000|NOT COMPLETED|Overall Study||16
8552165|NCT02487108|9583942|FG001|NOT COMPLETED|Overall Study||16
8552166|NCT02487108|9583943|FG002|NOT COMPLETED|Overall Study||26
8552167|NCT02487108|9583944|FG003|NOT COMPLETED|Overall Study||11
8552168|NCT02455557|9583954|FG000|STARTED|Overall Study||66
8552169|NCT02455557|9583954|FG000|COMPLETED|Overall Study||64
8552170|NCT02455557|9583954|FG000|NOT COMPLETED|Overall Study||2
8552171|NCT02435849|9583958|FG000|STARTED|Overall Study||97
8552172|NCT02435849|9583958|FG000|Enrolled and Infused|Overall Study||79
8552173|NCT02435849|9583958|FG000|Enrolled But Not Infused|Overall Study||18
8552174|NCT02435849|9583958|FG000|Discontinued Study Follow-up|Overall Study||34
8552175|NCT02435849|9583958|FG000|COMPLETED|Overall Study||0
8552176|NCT02435849|9583958|FG000|NOT COMPLETED|Overall Study||97
8568012|NCT00089986|9600438|FG001|NOT COMPLETED|Overall Study||24
8568013|NCT00089986|9600439|FG002|NOT COMPLETED|Overall Study||10
8568014|NCT00089999|9600449|FG000|STARTED|Overall Study||69
8568015|NCT00089999|9600450|FG001|STARTED|Overall Study||69
8568016|NCT00089999|9600449|FG000|COMPLETED|Overall Study||0
8568017|NCT00089999|9600450|FG001|COMPLETED|Overall Study||0
8568018|NCT00089999|9600449|FG000|NOT COMPLETED|Overall Study||69
8568019|NCT00089999|9600450|FG001|NOT COMPLETED|Overall Study||69
8568020|NCT00090051|9600459|FG000|STARTED|Overall Study||276
8568021|NCT00090051|9600460|FG001|STARTED|Overall Study||276
8568022|NCT00090051|9600459|FG000|Safety Population; Received Study Drug|Overall Study||272
8568023|NCT00090051|9600460|FG001|Safety Population; Received Study Drug|Overall Study||274
8568024|NCT00090051|9600459|FG000|COMPLETED|Overall Study|Completed 6 Cycles of Treatment|167
8568025|NCT00090051|9600460|FG001|COMPLETED|Overall Study|Completed 6 Cycles of Treatment|181
8568026|NCT00090051|9600459|FG000|NOT COMPLETED|Overall Study||109
8568027|NCT00090051|9600460|FG001|NOT COMPLETED|Overall Study||95
8568028|NCT00090064|9600468|FG000|STARTED|Overall Study||15
8568029|NCT00090064|9600469|FG001|STARTED|Overall Study||8
8568030|NCT00090064|9600468|FG000|COMPLETED|Overall Study||12
8568031|NCT00090064|9600469|FG001|COMPLETED|Overall Study||8
8568032|NCT00090064|9600468|FG000|NOT COMPLETED|Overall Study||3
8568033|NCT00090064|9600469|FG001|NOT COMPLETED|Overall Study||0
8568034|NCT00090103|9600481|FG000|STARTED|Four-Year Double-Blind Treatment Period||1610
8568035|NCT00090103|9600482|FG001|STARTED|Four-Year Double-Blind Treatment Period||1623
8568036|NCT00090103|9600483|FG002|STARTED|Four-Year Double-Blind Treatment Period||1611
8568037|NCT00090103|9600481|FG000|COMPLETED|Four-Year Double-Blind Treatment Period||1113
8568038|NCT00090103|9600482|FG001|COMPLETED|Four-Year Double-Blind Treatment Period||1093
8568039|NCT00090103|9600483|FG002|COMPLETED|Four-Year Double-Blind Treatment Period||989
8568040|NCT00090103|9600481|FG000|NOT COMPLETED|Four-Year Double-Blind Treatment Period||497
8568041|NCT00090103|9600482|FG001|NOT COMPLETED|Four-Year Double-Blind Treatment Period||530
8568042|NCT00090103|9600483|FG002|NOT COMPLETED|Four-Year Double-Blind Treatment Period||622
8568043|NCT00090103|9600481|FG000|STARTED|16-Week Safety Follow-up Period|Some par. didn't enter the Follow-up phase or dropped out before completing the treatment phase.|1598
8568044|NCT00090103|9600482|FG001|STARTED|16-Week Safety Follow-up Period|Some par. didn't enter the Follow-up phase or dropped out before completing the treatment phase.|1615
8568045|NCT00090103|9600483|FG002|STARTED|16-Week Safety Follow-up Period|Some par. didn't enter the Follow-up phase or dropped out before completing the treatment phase.|1600
8568046|NCT00090103|9600481|FG000|COMPLETED|16-Week Safety Follow-up Period||1224
8568047|NCT00090103|9600482|FG001|COMPLETED|16-Week Safety Follow-up Period||1205
8568048|NCT00090103|9600483|FG002|COMPLETED|16-Week Safety Follow-up Period||1143
8568049|NCT00090103|9600481|FG000|NOT COMPLETED|16-Week Safety Follow-up Period||374
8568050|NCT00090103|9600482|FG001|NOT COMPLETED|16-Week Safety Follow-up Period||410
8568051|NCT00090103|9600483|FG002|NOT COMPLETED|16-Week Safety Follow-up Period||457
8568052|NCT00090220|9600493|FG000|STARTED|Base Study Vaccination Period||1911
8568053|NCT00090220|9600494|FG001|STARTED|Base Study Vaccination Period||1908
8568054|NCT00090220|9600495|FG002|STARTED|Base Study Vaccination Period||0
8568055|NCT00090220|9600496|FG003|STARTED|Base Study Vaccination Period||0
8568056|NCT00090220|9600497|FG004|STARTED|Base Study Vaccination Period||0
8568057|NCT00090220|9600498|FG005|STARTED|Base Study Vaccination Period||0
8568058|NCT00090220|9600493|FG000|Vaccinated|Base Study Vaccination Period||1910
8568059|NCT00090220|9600494|FG001|Vaccinated|Base Study Vaccination Period||1907
8568060|NCT00090220|9600495|FG002|Vaccinated|Base Study Vaccination Period||0
8568061|NCT00090220|9600496|FG003|Vaccinated|Base Study Vaccination Period||0
8568062|NCT00090220|9600497|FG004|Vaccinated|Base Study Vaccination Period||0
8568063|NCT00090220|9600498|FG005|Vaccinated|Base Study Vaccination Period||0
8568064|NCT00090220|9600493|FG000|COMPLETED|Base Study Vaccination Period||1847
8568065|NCT00090220|9600494|FG001|COMPLETED|Base Study Vaccination Period||1845
8552177|NCT02393690|9583964|FG000|STARTED|Overall Study||29
8552178|NCT02393690|9583965|FG001|STARTED|Overall Study||31
8552179|NCT02393690|9583964|FG000|COMPLETED|Overall Study||29
8552180|NCT02393690|9583965|FG001|COMPLETED|Overall Study||31
8552181|NCT02393690|9583964|FG000|NOT COMPLETED|Overall Study||0
8552182|NCT02393690|9583965|FG001|NOT COMPLETED|Overall Study||0
8552183|NCT02387996|9583971|FG000|STARTED|Overall Study||270
8552184|NCT02387996|9583971|FG000|COMPLETED|Overall Study|Completed equals continuing in the Treatment Period|66
8552185|NCT02387996|9583971|FG000|NOT COMPLETED|Overall Study||204
8552186|NCT02363010|9583978|FG000|STARTED|Overall Study||110
8552187|NCT02363010|9583979|FG001|STARTED|Overall Study||105
8552188|NCT02363010|9583980|FG002|STARTED|Overall Study||105
8552189|NCT02363010|9583978|FG000|COMPLETED|Overall Study||88
8552190|NCT02363010|9583979|FG001|COMPLETED|Overall Study||94
8552191|NCT02363010|9583980|FG002|COMPLETED|Overall Study||89
8552192|NCT02363010|9583978|FG000|NOT COMPLETED|Overall Study||22
8552193|NCT02363010|9583979|FG001|NOT COMPLETED|Overall Study||11
8552194|NCT02363010|9583980|FG002|NOT COMPLETED|Overall Study||16
8819244|NCT01563029|9873088|FG003|COMPLETED|Overall Study||85
8819245|NCT01563029|9873089|FG004|COMPLETED|Overall Study||89
8819246|NCT01563029|9873085|FG000|NOT COMPLETED|Overall Study||53
8819247|NCT01563029|9873086|FG001|NOT COMPLETED|Overall Study||24
8819248|NCT01563029|9873087|FG002|NOT COMPLETED|Overall Study||33
8819249|NCT01563029|9873088|FG003|NOT COMPLETED|Overall Study||33
8819250|NCT01563029|9873089|FG004|NOT COMPLETED|Overall Study||29
8819251|NCT01563055|9873102|FG000|STARTED|Overall Study||10
8819252|NCT01563055|9873102|FG000|COMPLETED|Overall Study||10
8819253|NCT01563055|9873102|FG000|NOT COMPLETED|Overall Study||0
8819254|NCT01563081|9873111|FG000|STARTED|Overall Study||30
8819255|NCT01563081|9873112|FG001|STARTED|Overall Study||30
8819256|NCT01563081|9873111|FG000|COMPLETED|Overall Study||30
8819257|NCT01563081|9873112|FG001|COMPLETED|Overall Study||30
8819258|NCT01563081|9873111|FG000|NOT COMPLETED|Overall Study||0
8819259|NCT01563081|9873112|FG001|NOT COMPLETED|Overall Study||0
8819260|NCT01563172|9873122|FG000|STARTED|Overall Study||65
8819261|NCT01563172|9873122|FG000|Experimental Dentifrice 0.5g/2 Min|Overall Study||59
8819262|NCT01563172|9873122|FG000|Experimental Dentifrice 0.5g/45 Sec|Overall Study||59
8819263|NCT01563172|9873122|FG000|Experimental Dentifrice 1.5g/ 2min|Overall Study||58
8819264|NCT01563172|9873122|FG000|Experimental Dentifrice 1.5g/ 45 Sec|Overall Study||58
8819265|NCT01563172|9873122|FG000|Control Dentifrice|Overall Study||60
8819266|NCT01563172|9873122|FG000|COMPLETED|Overall Study||52
8819267|NCT01563172|9873122|FG000|NOT COMPLETED|Overall Study||13
8819268|NCT01563185|9873137|FG000|STARTED|Overall Study||12
8819269|NCT01563185|9873137|FG000|COMPLETED|Overall Study||10
8819270|NCT01563185|9873137|FG000|NOT COMPLETED|Overall Study||2
8819271|NCT01563198|9873141|FG000|STARTED|Baseline||49733
8819272|NCT01563198|9873141|FG000|COMPLETED|Baseline||49733
8819273|NCT01563198|9873141|FG000|NOT COMPLETED|Baseline||0
8819274|NCT01563198|9873141|FG000|STARTED|After Training||47979
8819275|NCT01563198|9873141|FG000|COMPLETED|After Training||47979
8819276|NCT01563198|9873141|FG000|NOT COMPLETED|After Training||0
8819277|NCT01563237|9873145|FG000|STARTED|Overall Study||64
8819278|NCT01563237|9873146|FG001|STARTED|Overall Study||5
8819279|NCT01563237|9873145|FG000|COMPLETED|Overall Study||54
8819280|NCT01563237|9873146|FG001|COMPLETED|Overall Study||5
8819281|NCT01563237|9873145|FG000|NOT COMPLETED|Overall Study||10
8819282|NCT01563237|9873146|FG001|NOT COMPLETED|Overall Study||0
8819283|NCT01563354|9873154|FG000|STARTED|Core Phase||41
8819284|NCT01563354|9873155|FG001|STARTED|Core Phase||42
8819285|NCT01563354|9873156|FG002|STARTED|Core Phase||41
8819286|NCT01563354|9873154|FG000|Entered Extension Phase|Core Phase||12
8819287|NCT01563354|9873155|FG001|Entered Extension Phase|Core Phase||14
8819288|NCT01563354|9873156|FG002|Entered Extension Phase|Core Phase||15
8819289|NCT01563354|9873154|FG000|COMPLETED|Core Phase||12
8819290|NCT01563354|9873155|FG001|COMPLETED|Core Phase||14
8819291|NCT01563354|9873156|FG002|COMPLETED|Core Phase||15
8819292|NCT01563354|9873154|FG000|NOT COMPLETED|Core Phase||29
8819293|NCT01563354|9873155|FG001|NOT COMPLETED|Core Phase||28
8819294|NCT01563354|9873156|FG002|NOT COMPLETED|Core Phase||26
8819295|NCT01563354|9873154|FG000|STARTED|Extension Phase|Criteria to enter Extension: continued clinical benefit and no unacceptable toxicity|12
8819296|NCT01563354|9873155|FG001|STARTED|Extension Phase|Criteria to enter Extension: continued clinical benefit and no unacceptable toxicity|14
8819297|NCT01563354|9873156|FG002|STARTED|Extension Phase||15
8819298|NCT01563354|9873154|FG000|COMPLETED|Extension Phase||0
8819299|NCT01563354|9873155|FG001|COMPLETED|Extension Phase||0
8819300|NCT01563354|9873156|FG002|COMPLETED|Extension Phase||0
8819301|NCT01563354|9873154|FG000|NOT COMPLETED|Extension Phase||12
8819302|NCT01563354|9873155|FG001|NOT COMPLETED|Extension Phase||14
8819303|NCT01563354|9873156|FG002|NOT COMPLETED|Extension Phase||15
8819304|NCT01563406|9873168|FG000|STARTED|Overall Study|194 hubs|60
8819305|NCT01563406|9873169|FG001|STARTED|Overall Study|102 hubs|30
8819306|NCT01563406|9873170|FG002|STARTED|Overall Study|101 hubs|30
8819307|NCT01563406|9873171|FG003|STARTED|Overall Study|112 hubs|29
8819308|NCT01563406|9873168|FG000|COMPLETED|Overall Study|194 hubs|60
8819309|NCT01563406|9873169|FG001|COMPLETED|Overall Study|102 hubs|30
8819310|NCT01563406|9873170|FG002|COMPLETED|Overall Study|101 hubs|30
8819311|NCT01563406|9873171|FG003|COMPLETED|Overall Study|112 hubs|29
8819312|NCT01563406|9873168|FG000|NOT COMPLETED|Overall Study||0
8819313|NCT01563406|9873169|FG001|NOT COMPLETED|Overall Study||0
8552195|NCT02351856|9583988|FG000|STARTED|Overall Study||8
8552196|NCT02351856|9583988|FG000|COMPLETED|Overall Study||0
8552197|NCT02351856|9583988|FG000|NOT COMPLETED|Overall Study||8
8552198|NCT02349386|9583996|FG000|STARTED|24-Week Double-Blind Main Study||9
8552199|NCT02349386|9583997|FG001|STARTED|24-Week Double-Blind Main Study||8
8552200|NCT02349386|9583998|FG002|STARTED|24-Week Double-Blind Main Study||9
8552201|NCT02349386|9583999|FG003|STARTED|24-Week Double-Blind Main Study||8
8552202|NCT02349386|9583996|FG000|COMPLETED|24-Week Double-Blind Main Study||3
8552203|NCT02349386|9583997|FG001|COMPLETED|24-Week Double-Blind Main Study||2
8552204|NCT02349386|9583998|FG002|COMPLETED|24-Week Double-Blind Main Study||4
8552205|NCT02349386|9583999|FG003|COMPLETED|24-Week Double-Blind Main Study||0
8552206|NCT02349386|9583996|FG000|NOT COMPLETED|24-Week Double-Blind Main Study||6
8552207|NCT02349386|9583997|FG001|NOT COMPLETED|24-Week Double-Blind Main Study||6
8552208|NCT02349386|9583998|FG002|NOT COMPLETED|24-Week Double-Blind Main Study||5
8552209|NCT02349386|9583999|FG003|NOT COMPLETED|24-Week Double-Blind Main Study||8
8552210|NCT02349386|9583996|FG000|STARTED|28-Week Double-Blind Optional Extension||3
8552211|NCT02349386|9583997|FG001|STARTED|28-Week Double-Blind Optional Extension||2
8552212|NCT02349386|9583998|FG002|STARTED|28-Week Double-Blind Optional Extension||4
8552213|NCT02349386|9583999|FG003|STARTED|28-Week Double-Blind Optional Extension||0
8552214|NCT02349386|9583996|FG000|COMPLETED|28-Week Double-Blind Optional Extension||1
8552215|NCT02349386|9583997|FG001|COMPLETED|28-Week Double-Blind Optional Extension||2
8552216|NCT02349386|9583998|FG002|COMPLETED|28-Week Double-Blind Optional Extension||1
8552217|NCT02349386|9583999|FG003|COMPLETED|28-Week Double-Blind Optional Extension||0
8552218|NCT02349386|9583996|FG000|NOT COMPLETED|28-Week Double-Blind Optional Extension||2
8552219|NCT02349386|9583997|FG001|NOT COMPLETED|28-Week Double-Blind Optional Extension||0
8552220|NCT02349386|9583998|FG002|NOT COMPLETED|28-Week Double-Blind Optional Extension||3
8552221|NCT02349386|9583999|FG003|NOT COMPLETED|28-Week Double-Blind Optional Extension||0
8552222|NCT02328014|9584013|FG000|STARTED|Overall Study||6
8552223|NCT02328014|9584014|FG001|STARTED|Overall Study||6
8552224|NCT02328014|9584015|FG002|STARTED|Overall Study||6
8552225|NCT02328014|9584016|FG003|STARTED|Overall Study||22
8552226|NCT02328014|9584013|FG000|COMPLETED|Overall Study||0
8552227|NCT02328014|9584014|FG001|COMPLETED|Overall Study||0
8552228|NCT02328014|9584015|FG002|COMPLETED|Overall Study||0
8552229|NCT02328014|9584016|FG003|COMPLETED|Overall Study||0
8552230|NCT02328014|9584013|FG000|NOT COMPLETED|Overall Study||6
8552231|NCT02328014|9584014|FG001|NOT COMPLETED|Overall Study||6
8552232|NCT02328014|9584015|FG002|NOT COMPLETED|Overall Study||6
8552233|NCT02328014|9584016|FG003|NOT COMPLETED|Overall Study||22
8552234|NCT02281500|9584026|FG000|STARTED|Overall Study||22
8552235|NCT02281500|9584026|FG000|COMPLETED|Overall Study||22
8552236|NCT02281500|9584026|FG000|NOT COMPLETED|Overall Study||0
8552237|NCT02243020|9584032|FG000|STARTED|Overall Study||8
8552238|NCT02243020|9584033|FG001|STARTED|Overall Study||9
8552239|NCT02243020|9584032|FG000|COMPLETED|Overall Study||8
8552240|NCT02243020|9584033|FG001|COMPLETED|Overall Study||9
8552241|NCT02243020|9584032|FG000|NOT COMPLETED|Overall Study||0
8552242|NCT02243020|9584033|FG001|NOT COMPLETED|Overall Study||0
8552243|NCT02108652|9584039|FG000|STARTED|Overall Study||310
8552244|NCT02108652|9584039|FG000|COMPLETED|Overall Study||0
8552245|NCT02108652|9584039|FG000|NOT COMPLETED|Overall Study||310
8552246|NCT01905384|9584045|FG000|STARTED|Overall Study||3
8552247|NCT01905384|9584046|FG001|STARTED|Overall Study||3
8552248|NCT01905384|9584045|FG000|COMPLETED|Overall Study||3
8552249|NCT01905384|9584046|FG001|COMPLETED|Overall Study||3
8552250|NCT01905384|9584045|FG000|NOT COMPLETED|Overall Study||0
8552251|NCT01905384|9584046|FG001|NOT COMPLETED|Overall Study||0
8552252|NCT01904032|9584054|FG000|STARTED|Overall Study||64
8552253|NCT01904032|9584055|FG001|STARTED|Overall Study||65
8552254|NCT01904032|9584054|FG000|COMPLETED|Overall Study||57
8552255|NCT01904032|9584055|FG001|COMPLETED|Overall Study||62
8552256|NCT01904032|9584054|FG000|NOT COMPLETED|Overall Study||7
8552257|NCT01904032|9584055|FG001|NOT COMPLETED|Overall Study||3
8552258|NCT01876953|9584063|FG000|STARTED|Overall Study||17
8552259|NCT01876953|9584064|FG001|STARTED|Overall Study||3
8552260|NCT01876953|9584063|FG000|COMPLETED|Overall Study||17
8552261|NCT01876953|9584064|FG001|COMPLETED|Overall Study||3
8552262|NCT01876953|9584063|FG000|NOT COMPLETED|Overall Study||0
8552263|NCT01876953|9584064|FG001|NOT COMPLETED|Overall Study||0
8552264|NCT01772472|9584072|FG000|STARTED|Overall Study||743
8552265|NCT01772472|9584073|FG001|STARTED|Overall Study||743
8552266|NCT01772472|9584072|FG000|COMPLETED|Overall Study||0
8552267|NCT01772472|9584073|FG001|COMPLETED|Overall Study||0
8552268|NCT01772472|9584072|FG000|NOT COMPLETED|Overall Study||743
8552269|NCT01772472|9584073|FG001|NOT COMPLETED|Overall Study||743
8552270|NCT01764711|9584081|FG000|STARTED|Overall Study||8
8552271|NCT01764711|9584082|FG001|STARTED|Overall Study||5
8552272|NCT01764711|9584081|FG000|COMPLETED|Overall Study||8
8552273|NCT01764711|9584082|FG001|COMPLETED|Overall Study||5
8552274|NCT01764711|9584081|FG000|NOT COMPLETED|Overall Study||0
8552275|NCT01764711|9584082|FG001|NOT COMPLETED|Overall Study||0
8552276|NCT01632878|9584090|FG000|STARTED|Screening||1531
8552277|NCT01632878|9584090|FG000|COMPLETED|Screening||1263
8552278|NCT01632878|9584090|FG000|NOT COMPLETED|Screening||268
8552279|NCT01632878|9584090|FG000|STARTED|Treatment||1263
8552280|NCT01632878|9584090|FG000|COMPLETED|Treatment||1105
8552281|NCT01632878|9584090|FG000|NOT COMPLETED|Treatment||158
8552282|NCT01275846|9584094|FG000|STARTED|Overall Study||26
8552283|NCT01275846|9584094|FG000|COMPLETED|Overall Study||25
8552284|NCT01275846|9584094|FG000|NOT COMPLETED|Overall Study||1
8552285|NCT01097005|9584098|FG000|STARTED|Overall Study|number of participants who were enrolled for this study.|466
8552286|NCT01097005|9584098|FG000|Analysis of Safety|Overall Study|number of participants who could be measured for Adverse Events|441
8552287|NCT01097005|9584098|FG000|Analysis of NTM Lung Disease|Overall Study|number of participants who contributed to the Baseline data|340
8552288|NCT01097005|9584098|FG000|Analysis of Bacilli Negative Conversion|Overall Study|number of participants who were analysed for bacilli negative conversion|285
8552289|NCT01097005|9584098|FG000|Analysis of CGI|Overall Study|number of participants who were measured for Clinical Global Improvement (CGI)|249
8552290|NCT01097005|9584098|FG000|COMPLETED|Overall Study||101
8552291|NCT01097005|9584098|FG000|NOT COMPLETED|Overall Study||365
8552292|NCT01072682|9584104|FG000|STARTED|Overall Study||35
8552293|NCT01072682|9584104|FG000|COMPLETED|Overall Study||35
8552294|NCT01072682|9584104|FG000|NOT COMPLETED|Overall Study||0
8552295|NCT00931255|9584110|FG000|STARTED|Overall Study||17
8552296|NCT00931255|9584111|FG001|STARTED|Overall Study||15
8552297|NCT00931255|9584110|FG000|COMPLETED|Overall Study||15
8552298|NCT00931255|9584111|FG001|COMPLETED|Overall Study||12
8552299|NCT00931255|9584110|FG000|NOT COMPLETED|Overall Study||2
8552300|NCT00931255|9584111|FG001|NOT COMPLETED|Overall Study||3
8552301|NCT00540995|9584119|FG000|STARTED|Overall Study||23
8552302|NCT00540995|9584120|FG001|STARTED|Overall Study||2
8552303|NCT00540995|9584119|FG000|COMPLETED|Overall Study||23
8552304|NCT00540995|9584120|FG001|COMPLETED|Overall Study||2
8552305|NCT00540995|9584119|FG000|NOT COMPLETED|Overall Study||0
8819314|NCT01563406|9873170|FG002|NOT COMPLETED|Overall Study||0
8819315|NCT01563406|9873171|FG003|NOT COMPLETED|Overall Study||0
8819316|NCT01563536|9873187|FG000|STARTED|Overall Study||6
8552306|NCT00540995|9584120|FG001|NOT COMPLETED|Overall Study||0
8552307|NCT00418301|9584125|FG000|STARTED|Overall Study||15
8552308|NCT00418301|9584125|FG000|COMPLETED|Overall Study||12
8552309|NCT00418301|9584125|FG000|NOT COMPLETED|Overall Study||3
8568066|NCT00090220|9600495|FG002|COMPLETED|Base Study Vaccination Period||0
8568067|NCT00090220|9600496|FG003|COMPLETED|Base Study Vaccination Period||0
8568068|NCT00090220|9600497|FG004|COMPLETED|Base Study Vaccination Period||0
8568069|NCT00090220|9600498|FG005|COMPLETED|Base Study Vaccination Period||0
8568070|NCT00090220|9600493|FG000|NOT COMPLETED|Base Study Vaccination Period||64
8568071|NCT00090220|9600494|FG001|NOT COMPLETED|Base Study Vaccination Period||63
8568072|NCT00090220|9600495|FG002|NOT COMPLETED|Base Study Vaccination Period||0
8568073|NCT00090220|9600496|FG003|NOT COMPLETED|Base Study Vaccination Period||0
8568074|NCT00090220|9600497|FG004|NOT COMPLETED|Base Study Vaccination Period||0
8568075|NCT00090220|9600498|FG005|NOT COMPLETED|Base Study Vaccination Period||0
8568076|NCT00090220|9600493|FG000|STARTED|Base Study Follow-up Period|8 participants did not complete the Vaccination Period but entered the Follow-up Period.|1855
8568077|NCT00090220|9600494|FG001|STARTED|Base Study Follow-up Period|5 participants did not complete the Vaccination Period but entered the Follow-up Period.|1851
8819317|NCT01563536|9873188|FG001|STARTED|Overall Study||6
8819318|NCT01563536|9873187|FG000|COMPLETED|Overall Study||5
8819319|NCT01563536|9873188|FG001|COMPLETED|Overall Study||4
8819320|NCT01563536|9873187|FG000|NOT COMPLETED|Overall Study||1
8819321|NCT01563536|9873188|FG001|NOT COMPLETED|Overall Study||2
8819322|NCT01563913|9873196|FG000|STARTED|Overall Study||15
8819323|NCT01563913|9873197|FG001|STARTED|Overall Study||15
8819324|NCT01563913|9873196|FG000|COMPLETED|Overall Study||13
8819325|NCT01563913|9873197|FG001|COMPLETED|Overall Study||15
8819326|NCT01563913|9873196|FG000|NOT COMPLETED|Overall Study||2
8819327|NCT01563913|9873197|FG001|NOT COMPLETED|Overall Study||0
8819328|NCT01563978|9873205|FG000|STARTED|Overall Study|Patients who received treatment.|68
8819329|NCT01563978|9873206|FG001|STARTED|Overall Study|Patients who received treatment.|67
8819330|NCT01563978|9873205|FG000|Randomised But Did Not Receive Treatment|Overall Study||0
8819331|NCT01563978|9873206|FG001|Randomised But Did Not Receive Treatment|Overall Study||0
8819332|NCT01563978|9873205|FG000|COMPLETED|Overall Study||64
8819333|NCT01563978|9873206|FG001|COMPLETED|Overall Study||65
8819334|NCT01563978|9873205|FG000|NOT COMPLETED|Overall Study||4
8819335|NCT01563978|9873206|FG001|NOT COMPLETED|Overall Study||2
8819336|NCT01564277|9873214|FG000|STARTED|Overall Study||12
8819337|NCT01564277|9873215|FG001|STARTED|Overall Study||12
8819338|NCT01564277|9873214|FG000|COMPLETED|Overall Study||11
8819339|NCT01564277|9873215|FG001|COMPLETED|Overall Study||11
8819340|NCT01564277|9873214|FG000|NOT COMPLETED|Overall Study||1
8819341|NCT01564277|9873215|FG001|NOT COMPLETED|Overall Study||1
8819342|NCT01564394|9873223|FG000|STARTED|Overall Study|Prostate cancer survivors n=20, family n=10. Only survivors were randomized.|30
8819343|NCT01564394|9873224|FG001|STARTED|Overall Study|Prostate cancer survivors n=20, family n=10. Only survivors were randomized.|30
8819344|NCT01564394|9873223|FG000|COMPLETED|Overall Study|Prostate cancer survivors n=16, family n=8.|24
8819345|NCT01564394|9873224|FG001|COMPLETED|Overall Study|Prostate cancer survivors n=13, family n=7.|20
8819346|NCT01564394|9873223|FG000|NOT COMPLETED|Overall Study||6
8819347|NCT01564394|9873224|FG001|NOT COMPLETED|Overall Study||10
8819348|NCT01564407|9873235|FG000|STARTED|Overall Study||4
8819349|NCT01564407|9873236|FG001|STARTED|Overall Study||5
8819350|NCT01564407|9873237|FG002|STARTED|Overall Study||4
8819351|NCT01564407|9873238|FG003|STARTED|Overall Study||2
8819352|NCT01564407|9873239|FG004|STARTED|Overall Study||0
8819353|NCT01564407|9873235|FG000|COMPLETED|Overall Study||4
8819354|NCT01564407|9873236|FG001|COMPLETED|Overall Study||3
8819355|NCT01564407|9873237|FG002|COMPLETED|Overall Study||4
8552310|NCT04498273|9584133|FG000|STARTED|Overall Study||165
8552311|NCT04498273|9584134|FG001|STARTED|Overall Study||164
8552312|NCT04498273|9584135|FG002|STARTED|Overall Study||164
8552313|NCT04498273|9584136|FG003|STARTED|Overall Study||164
8552314|NCT04498273|9584133|FG000|COMPLETED|Overall Study||134
8552315|NCT04498273|9584134|FG001|COMPLETED|Overall Study||140
8552316|NCT04498273|9584135|FG002|COMPLETED|Overall Study||143
8552317|NCT04498273|9584136|FG003|COMPLETED|Overall Study||133
8552318|NCT04498273|9584133|FG000|NOT COMPLETED|Overall Study||31
8552319|NCT04498273|9584134|FG001|NOT COMPLETED|Overall Study||24
8552320|NCT04498273|9584135|FG002|NOT COMPLETED|Overall Study||21
8552321|NCT04498273|9584136|FG003|NOT COMPLETED|Overall Study||31
8552322|NCT05224453|9584148|FG000|STARTED|Overall Study||38
8552323|NCT05224453|9584149|FG001|STARTED|Overall Study||38
8552324|NCT05224453|9584148|FG000|COMPLETED|Overall Study||36
8552325|NCT05224453|9584149|FG001|COMPLETED|Overall Study||35
8552326|NCT05224453|9584148|FG000|NOT COMPLETED|Overall Study||2
8552327|NCT05224453|9584149|FG001|NOT COMPLETED|Overall Study||3
8552328|NCT04537078|9584157|FG000|STARTED|Overall Study||45
8552329|NCT04537078|9584158|FG001|STARTED|Overall Study||45
8552330|NCT04537078|9584157|FG000|COMPLETED|Overall Study||41
8552331|NCT04537078|9584158|FG001|COMPLETED|Overall Study||42
8552332|NCT04537078|9584157|FG000|NOT COMPLETED|Overall Study||4
8552333|NCT04537078|9584158|FG001|NOT COMPLETED|Overall Study||3
8552334|NCT04425252|9584173|FG000|STARTED|Overall Study||8
8552335|NCT04425252|9584174|FG001|STARTED|Overall Study||15
8552336|NCT04425252|9584173|FG000|COMPLETED|Overall Study||4
8552337|NCT04425252|9584174|FG001|COMPLETED|Overall Study||13
8552338|NCT04425252|9584173|FG000|NOT COMPLETED|Overall Study||4
8552339|NCT04425252|9584174|FG001|NOT COMPLETED|Overall Study||2
8552340|NCT04368260|9584183|FG000|STARTED|Overall Study||40
8552341|NCT04368260|9584183|FG000|COMPLETED|Overall Study||40
8552342|NCT04368260|9584183|FG000|NOT COMPLETED|Overall Study||0
8552343|NCT03940326|9584191|FG000|STARTED|Overall Study||45
8621767|NCT00483223|9660804|FG000|COMPLETED|Overall Study||86
8621768|NCT00483223|9660804|FG000|NOT COMPLETED|Overall Study||0
8621769|NCT00483262|9660810|FG000|STARTED|Overall Study||20
8819356|NCT01564407|9873238|FG003|COMPLETED|Overall Study||1
8819357|NCT01564407|9873239|FG004|COMPLETED|Overall Study||0
8819358|NCT01564407|9873235|FG000|NOT COMPLETED|Overall Study||0
8819359|NCT01564407|9873236|FG001|NOT COMPLETED|Overall Study||2
8819360|NCT01564407|9873237|FG002|NOT COMPLETED|Overall Study||0
8819361|NCT01564407|9873238|FG003|NOT COMPLETED|Overall Study||1
8819362|NCT01564407|9873239|FG004|NOT COMPLETED|Overall Study||0
8819363|NCT01564459|9873263|FG000|STARTED|Run-In||12
8819364|NCT01564459|9873264|FG001|STARTED|Run-In|1 participant randomized to placebo arm received MK-6096 10 mg|87
8819365|NCT01564459|9873265|FG002|STARTED|Run-In|1 participant randomized to placebo arm received MK-6096 10 mg|83
8819366|NCT01564459|9873263|FG000|COMPLETED|Run-In||0
8819367|NCT01564459|9873264|FG001|COMPLETED|Run-In||87
8819368|NCT01564459|9873265|FG002|COMPLETED|Run-In||83
8819369|NCT01564459|9873263|FG000|NOT COMPLETED|Run-In||12
8819370|NCT01564459|9873264|FG001|NOT COMPLETED|Run-In||0
8819371|NCT01564459|9873265|FG002|NOT COMPLETED|Run-In||0
8819372|NCT01564459|9873263|FG000|STARTED|Double-blind Treatment||0
8819373|NCT01564459|9873264|FG001|STARTED|Double-blind Treatment|1 participant randomized to placebo arm received MK-6096 10 mg|87
8819374|NCT01564459|9873265|FG002|STARTED|Double-blind Treatment|1 participant randomized to placebo arm received MK-6096 10 mg|83
8819375|NCT01564459|9873263|FG000|COMPLETED|Double-blind Treatment||0
8819376|NCT01564459|9873264|FG001|COMPLETED|Double-blind Treatment||87
8819377|NCT01564459|9873265|FG002|COMPLETED|Double-blind Treatment||82
8819378|NCT01564459|9873263|FG000|NOT COMPLETED|Double-blind Treatment||0
8819379|NCT01564459|9873264|FG001|NOT COMPLETED|Double-blind Treatment||0
8819380|NCT01564459|9873265|FG002|NOT COMPLETED|Double-blind Treatment||1
8819381|NCT01564485|9873278|FG000|STARTED|Overall Study||92
8819382|NCT01564485|9873279|FG001|STARTED|Overall Study||101
8819383|NCT01564485|9873278|FG000|COMPLETED|Overall Study||84
8819384|NCT01564485|9873279|FG001|COMPLETED|Overall Study||78
8819385|NCT01564485|9873278|FG000|NOT COMPLETED|Overall Study||8
8819386|NCT01564485|9873279|FG001|NOT COMPLETED|Overall Study||23
8552344|NCT03940326|9584192|FG001|STARTED|Overall Study||58
8552345|NCT03940326|9584191|FG000|COMPLETED|Overall Study||45
8552346|NCT03940326|9584192|FG001|COMPLETED|Overall Study||58
8552347|NCT03940326|9584191|FG000|NOT COMPLETED|Overall Study||0
8552348|NCT03940326|9584192|FG001|NOT COMPLETED|Overall Study||0
8552349|NCT03875313|9584203|FG000|STARTED|Overall Study||3
8552350|NCT03875313|9584204|FG001|STARTED|Overall Study||16
8552351|NCT03875313|9584205|FG002|STARTED|Overall Study||6
8552352|NCT03875313|9584206|FG003|STARTED|Overall Study||4
8552353|NCT03875313|9584207|FG004|STARTED|Overall Study||4
8552354|NCT03875313|9584203|FG000|COMPLETED|Overall Study||0
8819387|NCT01564628|9873285|FG000|STARTED|Overall Study||185
8819388|NCT01564628|9873286|FG001|STARTED|Overall Study||58
8819389|NCT01564628|9873287|FG002|STARTED|Overall Study||63
8552355|NCT03875313|9584204|FG001|COMPLETED|Overall Study||0
8552356|NCT03875313|9584205|FG002|COMPLETED|Overall Study||0
8552357|NCT03875313|9584206|FG003|COMPLETED|Overall Study||0
8552358|NCT03875313|9584207|FG004|COMPLETED|Overall Study||0
8552359|NCT03875313|9584203|FG000|NOT COMPLETED|Overall Study||3
8552360|NCT03875313|9584204|FG001|NOT COMPLETED|Overall Study||16
8819390|NCT01564628|9873285|FG000|COMPLETED|Overall Study||181
8819391|NCT01564628|9873286|FG001|COMPLETED|Overall Study||56
8819392|NCT01564628|9873287|FG002|COMPLETED|Overall Study||61
8621770|NCT00483262|9660811|FG001|STARTED|Overall Study||43
8621771|NCT00483262|9660810|FG000|COMPLETED|Overall Study||20
8621772|NCT00483262|9660811|FG001|COMPLETED|Overall Study||43
8621773|NCT00483262|9660810|FG000|NOT COMPLETED|Overall Study||0
8621774|NCT00483262|9660811|FG001|NOT COMPLETED|Overall Study||0
8621775|NCT00483327|9660821|FG000|STARTED|Overall Study||30
8621776|NCT00483327|9660821|FG000|COMPLETED|Overall Study||20
8621777|NCT00483327|9660821|FG000|NOT COMPLETED|Overall Study||10
8621778|NCT00483379|9660829|FG000|STARTED|Treatment Period||6
8621779|NCT00483379|9660830|FG001|STARTED|Treatment Period||7
8621780|NCT00483379|9660829|FG000|COMPLETED|Treatment Period||4
8819393|NCT01564628|9873285|FG000|NOT COMPLETED|Overall Study||4
8819394|NCT01564628|9873286|FG001|NOT COMPLETED|Overall Study||2
8552361|NCT03875313|9584205|FG002|NOT COMPLETED|Overall Study||6
8552362|NCT03875313|9584206|FG003|NOT COMPLETED|Overall Study||4
8552363|NCT03875313|9584207|FG004|NOT COMPLETED|Overall Study||4
8552364|NCT03694353|9584219|FG000|STARTED|Overall Study||37
8552365|NCT03694353|9584219|FG000|COMPLETED|Overall Study||35
8552366|NCT03694353|9584219|FG000|NOT COMPLETED|Overall Study||2
8552367|NCT03583554|9584223|FG000|STARTED|Period 1||4
8552368|NCT03583554|9584224|FG001|STARTED|Period 1||4
8552369|NCT03583554|9584225|FG002|STARTED|Period 1||4
8552370|NCT03583554|9584223|FG000|COMPLETED|Period 1||4
8552371|NCT03583554|9584224|FG001|COMPLETED|Period 1||4
8552372|NCT03583554|9584225|FG002|COMPLETED|Period 1||4
8552373|NCT03583554|9584223|FG000|NOT COMPLETED|Period 1||0
8552374|NCT03583554|9584224|FG001|NOT COMPLETED|Period 1||0
8552375|NCT03583554|9584225|FG002|NOT COMPLETED|Period 1||0
8552376|NCT03583554|9584223|FG000|STARTED|Period 2||4
8552377|NCT03583554|9584224|FG001|STARTED|Period 2||4
8552378|NCT03583554|9584225|FG002|STARTED|Period 2||4
8552379|NCT03583554|9584223|FG000|COMPLETED|Period 2||3
8552380|NCT03583554|9584224|FG001|COMPLETED|Period 2||4
8552381|NCT03583554|9584225|FG002|COMPLETED|Period 2||3
8552382|NCT03583554|9584223|FG000|NOT COMPLETED|Period 2||1
8552383|NCT03583554|9584224|FG001|NOT COMPLETED|Period 2||0
8552384|NCT03583554|9584225|FG002|NOT COMPLETED|Period 2||1
8552385|NCT03583554|9584223|FG000|STARTED|Period 3||3
8552386|NCT03583554|9584224|FG001|STARTED|Period 3||4
8819395|NCT01564628|9873287|FG002|NOT COMPLETED|Overall Study||2
8819396|NCT01564654|9873291|FG000|STARTED|Overall Study|106 knees (bilateral)|89
8819397|NCT01564654|9873291|FG000|COMPLETED|Overall Study|106 knees (bilateral)|89
8819398|NCT01564654|9873291|FG000|NOT COMPLETED|Overall Study||0
8819399|NCT01564693|9873298|FG000|STARTED|Overall Study|Originally we planned to study 4 patients. We expanded to 9 to improve consistency of the results.|9
8819400|NCT01564693|9873299|FG001|STARTED|Overall Study||4
8819401|NCT01564693|9873300|FG002|STARTED|Overall Study|Only 2 patients were found necessary to give statistical relevance to the patients' results.|2
8819402|NCT01564693|9873298|FG000|COMPLETED|Overall Study||9
8819403|NCT01564693|9873299|FG001|COMPLETED|Overall Study||4
8819404|NCT01564693|9873300|FG002|COMPLETED|Overall Study||2
8819405|NCT01564693|9873298|FG000|NOT COMPLETED|Overall Study||0
8819406|NCT01564693|9873299|FG001|NOT COMPLETED|Overall Study||0
8819407|NCT01564693|9873300|FG002|NOT COMPLETED|Overall Study||0
8819408|NCT01564706|9873308|FG000|STARTED|Overall Study||9
8819409|NCT01564706|9873308|FG000|COMPLETED|Overall Study||9
8819410|NCT01564706|9873308|FG000|NOT COMPLETED|Overall Study||0
8819411|NCT01564758|9873312|FG000|STARTED|Overall Study||99
8819412|NCT01564758|9873312|FG000|COMPLETED|Overall Study||85
8819413|NCT01564758|9873312|FG000|NOT COMPLETED|Overall Study||14
8819414|NCT01564784|9873318|FG000|STARTED|Overall Study|Treated (164 randomized)|164
8819415|NCT01564784|9873319|FG001|STARTED|Overall Study|Treated (162 randomized)|143
8819416|NCT01564784|9873318|FG000|COMPLETED|Overall Study||30
8819417|NCT01564784|9873319|FG001|COMPLETED|Overall Study||10
8819418|NCT01564784|9873318|FG000|NOT COMPLETED|Overall Study||134
8819419|NCT01564784|9873319|FG001|NOT COMPLETED|Overall Study||133
8819420|NCT01564862|9873328|FG000|STARTED|Overall Study||198
8819421|NCT01564862|9873329|FG001|STARTED|Overall Study||210
8819422|NCT01564862|9873330|FG002|STARTED|Overall Study||194
8819423|NCT01564862|9873328|FG000|Received Treatment|Overall Study||196
8819424|NCT01564862|9873329|FG001|Received Treatment|Overall Study||207
8819425|NCT01564862|9873330|FG002|Received Treatment|Overall Study||191
8819426|NCT01564862|9873328|FG000|COMPLETED|Overall Study||168
8819427|NCT01564862|9873329|FG001|COMPLETED|Overall Study||176
8819428|NCT01564862|9873330|FG002|COMPLETED|Overall Study||164
8819429|NCT01564862|9873328|FG000|NOT COMPLETED|Overall Study||30
8819430|NCT01564862|9873329|FG001|NOT COMPLETED|Overall Study||34
8552387|NCT03583554|9584225|FG002|STARTED|Period 3||3
8552388|NCT03583554|9584223|FG000|COMPLETED|Period 3||3
8552389|NCT03583554|9584224|FG001|COMPLETED|Period 3||4
8552390|NCT03583554|9584225|FG002|COMPLETED|Period 3||3
8552391|NCT03583554|9584223|FG000|NOT COMPLETED|Period 3||0
8552392|NCT03583554|9584224|FG001|NOT COMPLETED|Period 3||0
8552393|NCT03583554|9584225|FG002|NOT COMPLETED|Period 3||0
8621781|NCT00483379|9660830|FG001|COMPLETED|Treatment Period||7
8819431|NCT01564862|9873330|FG002|NOT COMPLETED|Overall Study||30
8819432|NCT01564914|9873340|FG000|STARTED|Overall Study||16
8819433|NCT01564914|9873341|FG001|STARTED|Overall Study||6
8819434|NCT01564914|9873340|FG000|COMPLETED|Overall Study||16
8819435|NCT01564914|9873341|FG001|COMPLETED|Overall Study||6
8819436|NCT01564914|9873340|FG000|NOT COMPLETED|Overall Study||0
8552394|NCT03538717|9584236|FG000|STARTED|Overall Study||157
8552395|NCT03538717|9584236|FG000|COMPLETED|Overall Study||157
8552396|NCT03538717|9584236|FG000|NOT COMPLETED|Overall Study||0
8552397|NCT03408873|9584242|FG000|STARTED|Visit 1 Assessment (Baseline)||30
8552398|NCT03408873|9584242|FG000|COMPLETED|Visit 1 Assessment (Baseline)||27
8552399|NCT03408873|9584242|FG000|NOT COMPLETED|Visit 1 Assessment (Baseline)||3
8552400|NCT03408873|9584242|FG000|STARTED|Visit 2 Assessment||27
8552401|NCT03408873|9584242|FG000|COMPLETED|Visit 2 Assessment||26
8552402|NCT03408873|9584242|FG000|NOT COMPLETED|Visit 2 Assessment||1
8552403|NCT03408873|9584242|FG000|STARTED|Visit 3 Assessment||26
8552404|NCT03408873|9584242|FG000|COMPLETED|Visit 3 Assessment||25
8552405|NCT03408873|9584242|FG000|NOT COMPLETED|Visit 3 Assessment||1
8552406|NCT03408873|9584242|FG000|STARTED|Visit 4 Assessment||25
8552407|NCT03408873|9584242|FG000|COMPLETED|Visit 4 Assessment||23
8552408|NCT03408873|9584242|FG000|NOT COMPLETED|Visit 4 Assessment||2
8552409|NCT03408873|9584242|FG000|STARTED|Visit 5 Assessment||23
8552410|NCT03408873|9584242|FG000|COMPLETED|Visit 5 Assessment||22
8552411|NCT03408873|9584242|FG000|NOT COMPLETED|Visit 5 Assessment||1
8552412|NCT03408873|9584242|FG000|STARTED|Visit 6 Assessment||22
8819437|NCT01564914|9873341|FG001|NOT COMPLETED|Overall Study||0
8819438|NCT01564953|9873350|FG000|STARTED|Overall Study||143
8819439|NCT01564953|9873350|FG000|COMPLETED|Overall Study||143
8819440|NCT01564953|9873350|FG000|NOT COMPLETED|Overall Study||0
8819441|NCT01565083|9873360|FG000|STARTED|Overall Study||106
8819442|NCT01565083|9873361|FG001|STARTED|Overall Study||107
8819443|NCT01565083|9873360|FG000|COMPLETED|Overall Study||73
8819444|NCT01565083|9873361|FG001|COMPLETED|Overall Study||68
8819445|NCT01565083|9873360|FG000|NOT COMPLETED|Overall Study||33
8819446|NCT01565083|9873361|FG001|NOT COMPLETED|Overall Study||39
8819447|NCT01565148|9873371|FG000|STARTED|Overall Study||47
8819448|NCT01565148|9873372|FG001|STARTED|Overall Study||46
8819449|NCT01565148|9873373|FG002|STARTED|Overall Study||47
8819450|NCT01565148|9873374|FG003|STARTED|Overall Study||45
8819451|NCT01565148|9873371|FG000|COMPLETED|Overall Study||32
8819452|NCT01565148|9873372|FG001|COMPLETED|Overall Study||31
8819453|NCT01565148|9873373|FG002|COMPLETED|Overall Study||40
8819454|NCT01565148|9873374|FG003|COMPLETED|Overall Study||32
8819455|NCT01565148|9873371|FG000|NOT COMPLETED|Overall Study||15
8819456|NCT01565148|9873372|FG001|NOT COMPLETED|Overall Study||15
8819457|NCT01565148|9873373|FG002|NOT COMPLETED|Overall Study||7
8819458|NCT01565148|9873374|FG003|NOT COMPLETED|Overall Study||13
8819459|NCT01565291|9873390|FG000|STARTED|Overall Study||16
8819460|NCT01565291|9873391|FG001|STARTED|Overall Study||16
8819461|NCT01565291|9873390|FG000|COMPLETED|Overall Study||15
8819462|NCT01565291|9873391|FG001|COMPLETED|Overall Study||16
8819463|NCT01565291|9873390|FG000|NOT COMPLETED|Overall Study||1
8819464|NCT01565291|9873391|FG001|NOT COMPLETED|Overall Study||0
8819465|NCT01565330|9873401|FG000|STARTED|Overall Study||5
8819466|NCT01565330|9873402|FG001|STARTED|Overall Study||4
8819467|NCT01565330|9873403|FG002|STARTED|Overall Study||4
8819468|NCT01565330|9873404|FG003|STARTED|Overall Study||7
8819469|NCT01565330|9873401|FG000|COMPLETED|Overall Study||5
8819470|NCT01565330|9873402|FG001|COMPLETED|Overall Study||4
8819471|NCT01565330|9873403|FG002|COMPLETED|Overall Study||4
8819472|NCT01565330|9873404|FG003|COMPLETED|Overall Study||7
8819473|NCT01565330|9873401|FG000|NOT COMPLETED|Overall Study||0
8819474|NCT01565330|9873402|FG001|NOT COMPLETED|Overall Study||0
8819475|NCT01565330|9873403|FG002|NOT COMPLETED|Overall Study||0
8819476|NCT01565330|9873404|FG003|NOT COMPLETED|Overall Study||0
8819477|NCT01565343|9873418|FG000|STARTED|Overall Study||11
8819478|NCT01565343|9873419|FG001|STARTED|Overall Study||4
8819479|NCT01565343|9873420|FG002|STARTED|Overall Study||10
8819480|NCT01565343|9873418|FG000|COMPLETED|Overall Study||10
8819481|NCT01565343|9873419|FG001|COMPLETED|Overall Study||4
8819482|NCT01565343|9873420|FG002|COMPLETED|Overall Study||10
8819483|NCT01565343|9873418|FG000|NOT COMPLETED|Overall Study||1
8819484|NCT01565343|9873419|FG001|NOT COMPLETED|Overall Study||0
8819485|NCT01565343|9873420|FG002|NOT COMPLETED|Overall Study||0
8819486|NCT01565356|9873427|FG000|STARTED|Overall Study||41
8819487|NCT01565356|9873427|FG000|COMPLETED|Overall Study||41
8819488|NCT01565356|9873427|FG000|NOT COMPLETED|Overall Study||0
8819489|NCT01565369|9873431|FG000|STARTED|Overall Study||35
8819490|NCT01565369|9873431|FG000|COMPLETED|Overall Study||35
8819491|NCT01565369|9873431|FG000|NOT COMPLETED|Overall Study||0
8552413|NCT03408873|9584242|FG000|COMPLETED|Visit 6 Assessment||21
8552414|NCT03408873|9584242|FG000|NOT COMPLETED|Visit 6 Assessment||1
8552415|NCT03408873|9584242|FG000|STARTED|Visit 7 Assessment||21
8552416|NCT03408873|9584242|FG000|COMPLETED|Visit 7 Assessment||21
8819492|NCT01565382|9873436|FG000|STARTED|Overall Study||40
8819493|NCT01565382|9873437|FG001|STARTED|Overall Study||7
8819494|NCT01565382|9873436|FG000|COMPLETED|Overall Study||40
8819495|NCT01565382|9873437|FG001|COMPLETED|Overall Study||7
8819496|NCT01565382|9873436|FG000|NOT COMPLETED|Overall Study||0
8819497|NCT01565382|9873437|FG001|NOT COMPLETED|Overall Study||0
8552417|NCT03408873|9584242|FG000|NOT COMPLETED|Visit 7 Assessment||0
8819498|NCT01565499|9873442|FG000|STARTED|Overall Study||83
8819499|NCT01565499|9873442|FG000|COMPLETED|Overall Study||75
8819500|NCT01565499|9873442|FG000|NOT COMPLETED|Overall Study||8
8819501|NCT01565538|9873448|FG000|STARTED|Overall Study||61
8819502|NCT01565538|9873449|FG001|STARTED|Overall Study||62
8819503|NCT01565538|9873448|FG000|COMPLETED|Overall Study||61
8819504|NCT01565538|9873449|FG001|COMPLETED|Overall Study||62
8819505|NCT01565538|9873448|FG000|NOT COMPLETED|Overall Study||0
8819506|NCT01565538|9873449|FG001|NOT COMPLETED|Overall Study||0
8552418|NCT03132467|9584246|FG000|STARTED|Overall Study||8
8552419|NCT03132467|9584246|FG000|COMPLETED|Overall Study||4
8552420|NCT03132467|9584246|FG000|NOT COMPLETED|Overall Study||4
8568078|NCT00090220|9600495|FG002|STARTED|Base Study Follow-up Period||0
8568079|NCT00090220|9600496|FG003|STARTED|Base Study Follow-up Period||0
8568080|NCT00090220|9600497|FG004|STARTED|Base Study Follow-up Period||0
8568081|NCT00090220|9600498|FG005|STARTED|Base Study Follow-up Period||0
8568082|NCT00090220|9600493|FG000|COMPLETED|Base Study Follow-up Period||1695
8568083|NCT00090220|9600494|FG001|COMPLETED|Base Study Follow-up Period||1687
8568084|NCT00090220|9600495|FG002|COMPLETED|Base Study Follow-up Period||0
8568085|NCT00090220|9600496|FG003|COMPLETED|Base Study Follow-up Period||0
8568086|NCT00090220|9600497|FG004|COMPLETED|Base Study Follow-up Period||0
8568087|NCT00090220|9600498|FG005|COMPLETED|Base Study Follow-up Period||0
8568088|NCT00090220|9600493|FG000|NOT COMPLETED|Base Study Follow-up Period||160
8568089|NCT00090220|9600494|FG001|NOT COMPLETED|Base Study Follow-up Period||164
8568090|NCT00090220|9600495|FG002|NOT COMPLETED|Base Study Follow-up Period||0
8568091|NCT00090220|9600496|FG003|NOT COMPLETED|Base Study Follow-up Period||0
8568092|NCT00090220|9600497|FG004|NOT COMPLETED|Base Study Follow-up Period||0
8568093|NCT00090220|9600498|FG005|NOT COMPLETED|Base Study Follow-up Period||0
8568094|NCT00090220|9600493|FG000|STARTED|Extension 1 (EXT1)||0
8568095|NCT00090220|9600494|FG001|STARTED|Extension 1 (EXT1)||0
8568096|NCT00090220|9600495|FG002|STARTED|Extension 1 (EXT1)|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|1322
8568097|NCT00090220|9600496|FG003|STARTED|Extension 1 (EXT1)|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|7
8568098|NCT00090220|9600497|FG004|STARTED|Extension 1 (EXT1)||0
8568099|NCT00090220|9600498|FG005|STARTED|Extension 1 (EXT1)||0
8568100|NCT00090220|9600493|FG000|Vaccinated|Extension 1 (EXT1)||0
8568101|NCT00090220|9600494|FG001|Vaccinated|Extension 1 (EXT1)||0
8568102|NCT00090220|9600495|FG002|Vaccinated|Extension 1 (EXT1)||1321
8568103|NCT00090220|9600496|FG003|Vaccinated|Extension 1 (EXT1)||7
8568104|NCT00090220|9600497|FG004|Vaccinated|Extension 1 (EXT1)||0
8568105|NCT00090220|9600498|FG005|Vaccinated|Extension 1 (EXT1)||0
8568106|NCT00090220|9600493|FG000|COMPLETED|Extension 1 (EXT1)||0
8568107|NCT00090220|9600494|FG001|COMPLETED|Extension 1 (EXT1)||0
8568108|NCT00090220|9600495|FG002|COMPLETED|Extension 1 (EXT1)||1267
8568109|NCT00090220|9600496|FG003|COMPLETED|Extension 1 (EXT1)||5
8568110|NCT00090220|9600497|FG004|COMPLETED|Extension 1 (EXT1)||0
8568111|NCT00090220|9600498|FG005|COMPLETED|Extension 1 (EXT1)||0
8568112|NCT00090220|9600493|FG000|NOT COMPLETED|Extension 1 (EXT1)||0
8568113|NCT00090220|9600494|FG001|NOT COMPLETED|Extension 1 (EXT1)||0
8819507|NCT01565551|9873457|FG000|STARTED|Overall Study||586
8819508|NCT01565551|9873458|FG001|STARTED|Overall Study||51
8819509|NCT01565551|9873457|FG000|Clinical/Demographics|Overall Study||586
8819510|NCT01565551|9873458|FG001|Clinical/Demographics|Overall Study||51
8819511|NCT01565551|9873457|FG000|Biospecimens/Biomarkers|Overall Study||479
8819512|NCT01565551|9873458|FG001|Biospecimens/Biomarkers|Overall Study||22
8819513|NCT01565551|9873457|FG000|Neuroimaging|Overall Study||233
8819514|NCT01565551|9873458|FG001|Neuroimaging|Overall Study||25
8819515|NCT01565551|9873457|FG000|6-Month Outcomes|Overall Study||412
8819516|NCT01565551|9873458|FG001|6-Month Outcomes|Overall Study||30
8819517|NCT01565551|9873457|FG000|COMPLETED|Overall Study||586
8819518|NCT01565551|9873458|FG001|COMPLETED|Overall Study||51
8819519|NCT01565551|9873457|FG000|NOT COMPLETED|Overall Study||0
8819520|NCT01565551|9873458|FG001|NOT COMPLETED|Overall Study||0
8819521|NCT01565564|9873466|FG000|STARTED|Overall Study||344
8819522|NCT01565564|9873467|FG001|STARTED|Overall Study||362
8819523|NCT01565564|9873466|FG000|COMPLETED|Overall Study||339
8819524|NCT01565564|9873467|FG001|COMPLETED|Overall Study||361
8819525|NCT01565564|9873466|FG000|NOT COMPLETED|Overall Study||5
8819526|NCT01565564|9873467|FG001|NOT COMPLETED|Overall Study||1
8819527|NCT01565616|9873473|FG000|STARTED|Overall Study||22
8819528|NCT01565616|9873473|FG000|First Component: 5 Related Donors|Overall Study||5
8819529|NCT01565616|9873473|FG000|Second Component: Related or Unrelated|Overall Study||17
8819530|NCT01565616|9873473|FG000|COMPLETED|Overall Study||22
8819531|NCT01565616|9873473|FG000|NOT COMPLETED|Overall Study||0
8819532|NCT01565642|9873479|FG000|STARTED|Overall Study||151
8819533|NCT01565642|9873480|FG001|STARTED|Overall Study||151
8819534|NCT01565642|9873479|FG000|COMPLETED|Overall Study||149
8819535|NCT01565642|9873480|FG001|COMPLETED|Overall Study||150
8819536|NCT01565642|9873479|FG000|NOT COMPLETED|Overall Study||2
8819537|NCT01565642|9873480|FG001|NOT COMPLETED|Overall Study||1
8819538|NCT01565668|9873488|FG000|STARTED|Overall Study||38
8819539|NCT01565668|9873489|FG001|STARTED|Overall Study||38
8819540|NCT01565668|9873488|FG000|Completed Treatment Per Protocol|Overall Study||0
8819541|NCT01565668|9873489|FG001|Completed Treatment Per Protocol|Overall Study||0
8568114|NCT00090220|9600495|FG002|NOT COMPLETED|Extension 1 (EXT1)||55
8568115|NCT00090220|9600496|FG003|NOT COMPLETED|Extension 1 (EXT1)||2
8568116|NCT00090220|9600497|FG004|NOT COMPLETED|Extension 1 (EXT1)||0
8568117|NCT00090220|9600498|FG005|NOT COMPLETED|Extension 1 (EXT1)||0
8819542|NCT01565668|9873488|FG000|Started 30-day Follow-up|Overall Study||37
8819543|NCT01565668|9873489|FG001|Started 30-day Follow-up|Overall Study||37
8819544|NCT01565668|9873488|FG000|Completed 30-day Follow-up|Overall Study||11
8819545|NCT01565668|9873489|FG001|Completed 30-day Follow-up|Overall Study||5
8819546|NCT01565668|9873488|FG000|Started Long-term Follow-up|Overall Study||36
8819547|NCT01565668|9873489|FG001|Started Long-term Follow-up|Overall Study||33
8819548|NCT01565668|9873488|FG000|Completed Long-term Follow-up|Overall Study||0
8552421|NCT03096288|9584255|FG000|STARTED|Overall Study||19
8552422|NCT03096288|9584256|FG001|STARTED|Overall Study||18
8552423|NCT03096288|9584257|FG002|STARTED|Overall Study||22
8552424|NCT03096288|9584258|FG003|STARTED|Overall Study||25
8552425|NCT03096288|9584255|FG000|COMPLETED|Overall Study||19
8552426|NCT03096288|9584256|FG001|COMPLETED|Overall Study||17
8552427|NCT03096288|9584257|FG002|COMPLETED|Overall Study||22
8552428|NCT03096288|9584258|FG003|COMPLETED|Overall Study||24
8552429|NCT03096288|9584255|FG000|NOT COMPLETED|Overall Study||0
8552430|NCT03096288|9584256|FG001|NOT COMPLETED|Overall Study||1
8552431|NCT03096288|9584257|FG002|NOT COMPLETED|Overall Study||0
8552432|NCT03096288|9584258|FG003|NOT COMPLETED|Overall Study||1
8552433|NCT02919436|9584270|FG000|STARTED|Overall Study||305
8552434|NCT02919436|9584271|FG001|STARTED|Overall Study||305
8552435|NCT02919436|9584270|FG000|COMPLETED|Overall Study||245
8552436|NCT02919436|9584271|FG001|COMPLETED|Overall Study||252
8552437|NCT02919436|9584270|FG000|NOT COMPLETED|Overall Study||60
8552438|NCT02919436|9584271|FG001|NOT COMPLETED|Overall Study||53
8552439|NCT02135484|9584279|FG000|STARTED|Overall Study||25
8552440|NCT02135484|9584279|FG000|COMPLETED|Overall Study||25
8552441|NCT02135484|9584279|FG000|NOT COMPLETED|Overall Study||0
8552442|NCT02028884|9584285|FG000|STARTED|Double-blind Period||42
8819549|NCT01565668|9873489|FG001|Completed Long-term Follow-up|Overall Study||0
8819550|NCT01565668|9873488|FG000|COMPLETED|Overall Study||0
8819551|NCT01565668|9873489|FG001|COMPLETED|Overall Study||0
8819552|NCT01565668|9873488|FG000|NOT COMPLETED|Overall Study||38
8819553|NCT01565668|9873489|FG001|NOT COMPLETED|Overall Study||38
8819554|NCT01565694|9873495|FG000|STARTED|Dose-Titration Period||76
8819555|NCT01565694|9873495|FG000|COMPLETED|Dose-Titration Period||62
8819556|NCT01565694|9873495|FG000|NOT COMPLETED|Dose-Titration Period||14
8819557|NCT01565694|9873495|FG000|STARTED|Fixed-Dose Assessment Period||62
8819558|NCT01565694|9873495|FG000|COMPLETED|Fixed-Dose Assessment Period||58
8819559|NCT01565694|9873495|FG000|NOT COMPLETED|Fixed-Dose Assessment Period||4
8819560|NCT01565707|9873503|FG000|STARTED|Overall Study||75
8819561|NCT01565707|9873504|FG001|STARTED|Overall Study||73
8819562|NCT01565707|9873505|FG002|STARTED|Overall Study||19
8819563|NCT01565707|9873506|FG003|STARTED|Overall Study||22
8819564|NCT01565707|9873503|FG000|Treated|Overall Study||73
8819565|NCT01565707|9873504|FG001|Treated|Overall Study||73
8819566|NCT01565707|9873505|FG002|Treated|Overall Study||19
8819567|NCT01565707|9873506|FG003|Treated|Overall Study||22
8819568|NCT01565707|9873503|FG000|COMPLETED|Overall Study||66
8819569|NCT01565707|9873504|FG001|COMPLETED|Overall Study||65
8819570|NCT01565707|9873505|FG002|COMPLETED|Overall Study||16
8819571|NCT01565707|9873506|FG003|COMPLETED|Overall Study||17
8819572|NCT01565707|9873503|FG000|NOT COMPLETED|Overall Study||9
8819573|NCT01565707|9873504|FG001|NOT COMPLETED|Overall Study||8
8819574|NCT01565707|9873505|FG002|NOT COMPLETED|Overall Study||3
8819575|NCT01565707|9873506|FG003|NOT COMPLETED|Overall Study||5
8819576|NCT01565850|9873525|FG000|STARTED|Overall Study||103
8819577|NCT01565850|9873526|FG001|STARTED|Overall Study||50
8819578|NCT01565850|9873525|FG000|COMPLETED|Overall Study||83
8819579|NCT01565850|9873526|FG001|COMPLETED|Overall Study||42
8819580|NCT01565850|9873525|FG000|NOT COMPLETED|Overall Study||20
8819581|NCT01565850|9873526|FG001|NOT COMPLETED|Overall Study||8
8819582|NCT01565889|9873538|FG000|STARTED|Part A||12
8819583|NCT01565889|9873539|FG001|STARTED|Part A||4
8819584|NCT01565889|9873540|FG002|STARTED|Part A||8
8819585|NCT01565889|9873541|FG003|STARTED|Part A||7
8819586|NCT01565889|9873542|FG004|STARTED|Part A||7
8819587|NCT01565889|9873543|FG005|STARTED|Part A||0
8819588|NCT01565889|9873538|FG000|COMPLETED|Part A|3 participants from this group continued in the Part B: SOF+PEG+RBV group.|11
8819589|NCT01565889|9873539|FG001|COMPLETED|Part A|No participants from this group continued in the Part B: SOF+PEG+RBV group.|4
8819590|NCT01565889|9873540|FG002|COMPLETED|Part A|3 participants from this group continued in the Part B: SOF+PEG+RBV group.|8
8819591|NCT01565889|9873541|FG003|COMPLETED|Part A|2 participants from this group continued in the Part B: SOF+PEG+RBV group.|7
8819592|NCT01565889|9873542|FG004|COMPLETED|Part A|1 participant from this group continued in the Part B: SOF+PEG+RBV group.|7
8819593|NCT01565889|9873543|FG005|COMPLETED|Part A||0
8819594|NCT01565889|9873538|FG000|NOT COMPLETED|Part A||1
8819595|NCT01565889|9873539|FG001|NOT COMPLETED|Part A||0
8819596|NCT01565889|9873540|FG002|NOT COMPLETED|Part A||0
8819597|NCT01565889|9873541|FG003|NOT COMPLETED|Part A||0
8819598|NCT01565889|9873542|FG004|NOT COMPLETED|Part A||0
8552443|NCT02028884|9584286|FG001|STARTED|Double-blind Period||41
8552444|NCT02028884|9584285|FG000|COMPLETED|Double-blind Period||24
8552445|NCT02028884|9584286|FG001|COMPLETED|Double-blind Period||18
8819599|NCT01565889|9873543|FG005|NOT COMPLETED|Part A||0
8819600|NCT01565889|9873538|FG000|STARTED|Part B||0
8819601|NCT01565889|9873539|FG001|STARTED|Part B||0
8819602|NCT01565889|9873540|FG002|STARTED|Part B||0
8819603|NCT01565889|9873541|FG003|STARTED|Part B||0
8819604|NCT01565889|9873542|FG004|STARTED|Part B||0
8819605|NCT01565889|9873543|FG005|STARTED|Part B|9 participants in this group transferred from a Part A cohort, and 14 participants joined the study.|23
8819606|NCT01565889|9873538|FG000|COMPLETED|Part B||0
8819607|NCT01565889|9873539|FG001|COMPLETED|Part B||0
8819608|NCT01565889|9873540|FG002|COMPLETED|Part B||0
8819609|NCT01565889|9873541|FG003|COMPLETED|Part B||0
8819610|NCT01565889|9873542|FG004|COMPLETED|Part B||0
8552446|NCT02028884|9584285|FG000|NOT COMPLETED|Double-blind Period||18
8552447|NCT02028884|9584286|FG001|NOT COMPLETED|Double-blind Period||23
8552448|NCT02028884|9584285|FG000|STARTED|Open-label Extension Period||24
8552449|NCT02028884|9584286|FG001|STARTED|Open-label Extension Period||18
8552450|NCT02028884|9584285|FG000|COMPLETED|Open-label Extension Period||0
8621782|NCT00483379|9660829|FG000|NOT COMPLETED|Treatment Period||2
8621783|NCT00483379|9660830|FG001|NOT COMPLETED|Treatment Period||0
8819611|NCT01565889|9873543|FG005|COMPLETED|Part B||19
8552451|NCT02028884|9584286|FG001|COMPLETED|Open-label Extension Period||0
8552452|NCT02028884|9584285|FG000|NOT COMPLETED|Open-label Extension Period||24
8552453|NCT02028884|9584286|FG001|NOT COMPLETED|Open-label Extension Period||18
8552454|NCT01983774|9584297|FG000|STARTED|Overall Study||9
8552455|NCT01983774|9584298|FG001|STARTED|Overall Study||8
8552456|NCT01983774|9584297|FG000|COMPLETED|Overall Study||8
8552457|NCT01983774|9584298|FG001|COMPLETED|Overall Study||7
8552458|NCT01983774|9584297|FG000|NOT COMPLETED|Overall Study||1
8552459|NCT01983774|9584298|FG001|NOT COMPLETED|Overall Study||1
8552460|NCT01974206|9584308|FG000|STARTED|Overall Study||74
8552461|NCT01974206|9584309|FG001|STARTED|Overall Study||76
8552462|NCT01974206|9584308|FG000|Received Treatment|Overall Study||74
8552463|NCT01974206|9584309|FG001|Received Treatment|Overall Study||75
8552464|NCT01974206|9584308|FG000|COMPLETED|Overall Study||68
8552465|NCT01974206|9584309|FG001|COMPLETED|Overall Study||75
8552466|NCT01974206|9584308|FG000|NOT COMPLETED|Overall Study||6
8552467|NCT01974206|9584309|FG001|NOT COMPLETED|Overall Study||1
8552468|NCT01970865|9584332|FG000|STARTED|Overall Study||3
8552469|NCT01970865|9584333|FG001|STARTED|Overall Study||3
8552470|NCT01970865|9584334|FG002|STARTED|Overall Study||3
8552471|NCT01970865|9584335|FG003|STARTED|Overall Study||13
8552472|NCT01970865|9584336|FG004|STARTED|Overall Study||17
8552473|NCT01970865|9584337|FG005|STARTED|Overall Study||3
8629462|NCT00530348|9669205|FG001|NOT COMPLETED|Overall Study||19
8819612|NCT01565889|9873538|FG000|NOT COMPLETED|Part B||0
8819613|NCT01565889|9873539|FG001|NOT COMPLETED|Part B||0
8819614|NCT01565889|9873540|FG002|NOT COMPLETED|Part B||0
8819615|NCT01565889|9873541|FG003|NOT COMPLETED|Part B||0
8819616|NCT01565889|9873542|FG004|NOT COMPLETED|Part B||0
8819617|NCT01565889|9873543|FG005|NOT COMPLETED|Part B||4
8819618|NCT01565902|9873562|FG000|STARTED|Overall Study||8
8819619|NCT01565902|9873563|FG001|STARTED|Overall Study||8
8819620|NCT01565902|9873564|FG002|STARTED|Overall Study||8
8819621|NCT01565902|9873565|FG003|STARTED|Overall Study||16
8819622|NCT01565902|9873562|FG000|COMPLETED|Overall Study||8
8819623|NCT01565902|9873563|FG001|COMPLETED|Overall Study||8
8819624|NCT01565902|9873564|FG002|COMPLETED|Overall Study||8
8819625|NCT01565902|9873565|FG003|COMPLETED|Overall Study||16
8819626|NCT01565902|9873562|FG000|NOT COMPLETED|Overall Study||0
8819627|NCT01565902|9873563|FG001|NOT COMPLETED|Overall Study||0
8819628|NCT01565902|9873564|FG002|NOT COMPLETED|Overall Study||0
8819629|NCT01565902|9873565|FG003|NOT COMPLETED|Overall Study||0
8819630|NCT01565928|9873578|FG000|STARTED|Overall Study||22
8819631|NCT01565928|9873578|FG000|COMPLETED|Overall Study||0
8819632|NCT01565928|9873578|FG000|NOT COMPLETED|Overall Study||22
8819633|NCT01565941|9873587|FG000|STARTED|Overall Study||360
8819634|NCT01565941|9873588|FG001|STARTED|Overall Study||353
8819635|NCT01565941|9873587|FG000|COMPLETED|Overall Study||349
8819636|NCT01565941|9873588|FG001|COMPLETED|Overall Study||349
8819637|NCT01565941|9873587|FG000|NOT COMPLETED|Overall Study||11
8819638|NCT01565941|9873588|FG001|NOT COMPLETED|Overall Study||4
8819639|NCT01565980|9873598|FG000|STARTED|Overall Study||20
8819640|NCT01565980|9873599|FG001|STARTED|Overall Study|Three patients had started the intervention protocol at the time of study withdrawal.|20
8819641|NCT01565980|9873598|FG000|COMPLETED|Overall Study||16
8819642|NCT01565980|9873599|FG001|COMPLETED|Overall Study||16
8819643|NCT01565980|9873598|FG000|NOT COMPLETED|Overall Study||4
8819644|NCT01565980|9873599|FG001|NOT COMPLETED|Overall Study||4
8819645|NCT01565993|9873611|FG000|STARTED|Overall Study||66
8819646|NCT01565993|9873612|FG001|STARTED|Overall Study|3 patients were excluded for failing to meet the inclusion criteria|42
8819647|NCT01565993|9873611|FG000|COMPLETED|Overall Study|A total of 105 polypectomies were performed on 98 patients|66
8819648|NCT01565993|9873612|FG001|COMPLETED|Overall Study||39
8819649|NCT01565993|9873611|FG000|NOT COMPLETED|Overall Study||0
8819650|NCT01565993|9873612|FG001|NOT COMPLETED|Overall Study||3
8819651|NCT01566084|9873620|FG000|STARTED|Overall Study||7
8819652|NCT01566084|9873621|FG001|STARTED|Overall Study||10
8819653|NCT01566084|9873620|FG000|COMPLETED|Overall Study||7
8819654|NCT01566084|9873621|FG001|COMPLETED|Overall Study||10
8819655|NCT01566084|9873620|FG000|NOT COMPLETED|Overall Study||0
8819656|NCT01566084|9873621|FG001|NOT COMPLETED|Overall Study||0
8819657|NCT01566162|9873635|FG000|STARTED|Overall Study||191
8552474|NCT01970865|9584338|FG006|STARTED|Overall Study||3
8552475|NCT01970865|9584339|FG007|STARTED|Overall Study||3
8552476|NCT01970865|9584340|FG008|STARTED|Overall Study||3
8552477|NCT01970865|9584341|FG009|STARTED|Overall Study||4
8552478|NCT01970865|9584342|FG010|STARTED|Overall Study||30
8552479|NCT01970865|9584343|FG011|STARTED|Overall Study||27
8819658|NCT01566162|9873635|FG000|COMPLETED|Overall Study||155
8819659|NCT01566162|9873635|FG000|NOT COMPLETED|Overall Study||36
8819660|NCT01566214|9873641|FG000|STARTED|Overall Study||6
8819661|NCT01566214|9873642|FG001|STARTED|Overall Study||6
8819662|NCT01566214|9873641|FG000|COMPLETED|Overall Study||3
8819663|NCT01566214|9873642|FG001|COMPLETED|Overall Study||6
8819664|NCT01566214|9873641|FG000|NOT COMPLETED|Overall Study||3
8819665|NCT01566214|9873642|FG001|NOT COMPLETED|Overall Study||0
8552480|NCT01970865|9584344|FG012|STARTED|Overall Study||60
8552481|NCT01970865|9584345|FG013|STARTED|Overall Study||66
8552482|NCT01970865|9584346|FG014|STARTED|Overall Study||46
8552483|NCT01970865|9584347|FG015|STARTED|Overall Study||47
8552484|NCT01970865|9584348|FG016|STARTED|Overall Study||3
8552485|NCT01970865|9584332|FG000|Received Treatment|Overall Study||3
8552486|NCT01970865|9584333|FG001|Received Treatment|Overall Study||3
8552487|NCT01970865|9584334|FG002|Received Treatment|Overall Study||3
8552488|NCT01970865|9584335|FG003|Received Treatment|Overall Study||12
8552489|NCT01970865|9584336|FG004|Received Treatment|Overall Study||17
8552490|NCT01970865|9584337|FG005|Received Treatment|Overall Study||3
8552491|NCT01970865|9584338|FG006|Received Treatment|Overall Study||3
8552492|NCT01970865|9584339|FG007|Received Treatment|Overall Study||3
8552493|NCT01970865|9584340|FG008|Received Treatment|Overall Study||3
8552494|NCT01970865|9584341|FG009|Received Treatment|Overall Study||4
8723124|NCT01021761|9770642|FG000|STARTED|Overall Study||42
8723125|NCT01021761|9770643|FG001|STARTED|Overall Study||42
8723126|NCT01021761|9770644|FG002|STARTED|Overall Study||42
8552495|NCT01970865|9584342|FG010|Received Treatment|Overall Study||30
8552496|NCT01970865|9584343|FG011|Received Treatment|Overall Study||27
8552497|NCT01970865|9584344|FG012|Received Treatment|Overall Study||60
8552498|NCT01970865|9584345|FG013|Received Treatment|Overall Study||65
8552499|NCT01970865|9584346|FG014|Received Treatment|Overall Study||46
8552500|NCT01970865|9584347|FG015|Received Treatment|Overall Study||47
8552501|NCT01970865|9584348|FG016|Received Treatment|Overall Study||3
8552502|NCT01970865|9584332|FG000|COMPLETED|Overall Study||0
8552503|NCT01970865|9584333|FG001|COMPLETED|Overall Study||0
8552504|NCT01970865|9584334|FG002|COMPLETED|Overall Study||0
8552505|NCT01970865|9584335|FG003|COMPLETED|Overall Study||0
8552506|NCT01970865|9584336|FG004|COMPLETED|Overall Study||0
8552507|NCT01970865|9584337|FG005|COMPLETED|Overall Study||0
8552508|NCT01970865|9584338|FG006|COMPLETED|Overall Study||0
8819666|NCT01566331|9873650|FG000|STARTED|Overall Study||40
8819667|NCT01566331|9873651|FG001|STARTED|Overall Study||40
8819668|NCT01566331|9873650|FG000|COMPLETED|Overall Study||40
8819669|NCT01566331|9873651|FG001|COMPLETED|Overall Study||40
8819670|NCT01566331|9873650|FG000|NOT COMPLETED|Overall Study||0
8819671|NCT01566331|9873651|FG001|NOT COMPLETED|Overall Study||0
8819672|NCT01566409|9873659|FG000|STARTED|Overall Study||49
8819673|NCT01566409|9873660|FG001|STARTED|Overall Study||53
8819674|NCT01566409|9873659|FG000|COMPLETED|Overall Study||47
8819675|NCT01566409|9873660|FG001|COMPLETED|Overall Study||48
8819676|NCT01566409|9873659|FG000|NOT COMPLETED|Overall Study||2
8819677|NCT01566409|9873660|FG001|NOT COMPLETED|Overall Study||5
8819678|NCT01566435|9873666|FG000|STARTED|ACF Induction Therapy||30
8819679|NCT01566435|9873666|FG000|COMPLETED|ACF Induction Therapy||30
8819680|NCT01566435|9873666|FG000|NOT COMPLETED|ACF Induction Therapy||0
8819681|NCT01566435|9873666|FG000|STARTED|ACF Definitive Chemoradiation-cisplatin||28
8819682|NCT01566435|9873666|FG000|COMPLETED|ACF Definitive Chemoradiation-cisplatin||27
8819683|NCT01566435|9873666|FG000|NOT COMPLETED|ACF Definitive Chemoradiation-cisplatin||1
8819684|NCT01566435|9873666|FG000|STARTED|ACF Definitive Chemoradiation-cetuximab||2
8819685|NCT01566435|9873666|FG000|COMPLETED|ACF Definitive Chemoradiation-cetuximab||2
8819686|NCT01566435|9873666|FG000|NOT COMPLETED|ACF Definitive Chemoradiation-cetuximab||0
8819687|NCT01566448|9873674|FG000|STARTED|Overall Study||30
8819688|NCT01566448|9873674|FG000|COMPLETED|Overall Study||30
8819689|NCT01566448|9873674|FG000|NOT COMPLETED|Overall Study||0
8819690|NCT01566461|9873680|FG000|STARTED|IN.PACT SFA I Phase||99
8819691|NCT01566461|9873681|FG001|STARTED|IN.PACT SFA I Phase||51
8819692|NCT01566461|9873680|FG000|COMPLETED|IN.PACT SFA I Phase||88
8552509|NCT01970865|9584339|FG007|COMPLETED|Overall Study||0
8552510|NCT01970865|9584340|FG008|COMPLETED|Overall Study||0
8552511|NCT01970865|9584341|FG009|COMPLETED|Overall Study||0
8552512|NCT01970865|9584342|FG010|COMPLETED|Overall Study||0
8552513|NCT01970865|9584343|FG011|COMPLETED|Overall Study||0
8552514|NCT01970865|9584344|FG012|COMPLETED|Overall Study||0
8552515|NCT01970865|9584345|FG013|COMPLETED|Overall Study||0
8723127|NCT01021761|9770642|FG000|COMPLETED|Overall Study||41
8723128|NCT01021761|9770643|FG001|COMPLETED|Overall Study||38
8723129|NCT01021761|9770644|FG002|COMPLETED|Overall Study||42
8723130|NCT01021761|9770642|FG000|NOT COMPLETED|Overall Study||1
8723131|NCT01021761|9770643|FG001|NOT COMPLETED|Overall Study||4
8723132|NCT01021761|9770644|FG002|NOT COMPLETED|Overall Study||0
8723133|NCT01021813|9770654|FG000|STARTED|DB Treatment Phase||522
8723134|NCT01021813|9770655|FG001|STARTED|DB Treatment Phase||259
8723135|NCT01021813|9770656|FG002|STARTED|DB Treatment Phase||0
8723136|NCT01021813|9770657|FG003|STARTED|DB Treatment Phase||0
8723137|NCT01021813|9770658|FG004|STARTED|DB Treatment Phase||0
8552516|NCT01970865|9584346|FG014|COMPLETED|Overall Study||0
8552517|NCT01970865|9584347|FG015|COMPLETED|Overall Study||0
8552518|NCT01970865|9584348|FG016|COMPLETED|Overall Study||0
8552519|NCT01970865|9584332|FG000|NOT COMPLETED|Overall Study||3
8552520|NCT01970865|9584333|FG001|NOT COMPLETED|Overall Study||3
8552521|NCT01970865|9584334|FG002|NOT COMPLETED|Overall Study||3
8723138|NCT01021813|9770654|FG000|Treated|DB Treatment Phase||521
8819693|NCT01566461|9873681|FG001|COMPLETED|IN.PACT SFA I Phase||49
8819694|NCT01566461|9873680|FG000|NOT COMPLETED|IN.PACT SFA I Phase||11
8819695|NCT01566461|9873681|FG001|NOT COMPLETED|IN.PACT SFA I Phase||2
8819696|NCT01566461|9873680|FG000|STARTED|IN.PACT SFA II Phase||121
8819697|NCT01566461|9873681|FG001|STARTED|IN.PACT SFA II Phase||60
8819698|NCT01566461|9873680|FG000|COMPLETED|IN.PACT SFA II Phase||109
8552522|NCT01970865|9584335|FG003|NOT COMPLETED|Overall Study||13
8552523|NCT01970865|9584336|FG004|NOT COMPLETED|Overall Study||17
8552524|NCT01970865|9584337|FG005|NOT COMPLETED|Overall Study||3
8552525|NCT01970865|9584338|FG006|NOT COMPLETED|Overall Study||3
8552526|NCT01970865|9584339|FG007|NOT COMPLETED|Overall Study||3
8819699|NCT01566461|9873681|FG001|COMPLETED|IN.PACT SFA II Phase||55
8819700|NCT01566461|9873680|FG000|NOT COMPLETED|IN.PACT SFA II Phase||12
8819701|NCT01566461|9873681|FG001|NOT COMPLETED|IN.PACT SFA II Phase||5
8819702|NCT01566500|9873687|FG000|STARTED|Overall Study||140
8819703|NCT01566500|9873687|FG000|COMPLETED|Overall Study||140
8819704|NCT01566500|9873687|FG000|NOT COMPLETED|Overall Study||0
8819705|NCT01566526|9873691|FG000|STARTED|Overall Study||26
8819706|NCT01566526|9873691|FG000|COMPLETED|Overall Study||26
8819707|NCT01566526|9873691|FG000|NOT COMPLETED|Overall Study||0
8819708|NCT01566539|9873703|FG000|STARTED|Main Study Period||101
8819709|NCT01566539|9873704|FG001|STARTED|Main Study Period||100
8819710|NCT01566539|9873705|FG002|STARTED|Main Study Period||104
8819711|NCT01566539|9873706|FG003|STARTED|Main Study Period||0
8819712|NCT01566539|9873707|FG004|STARTED|Main Study Period||40
8819713|NCT01566539|9873708|FG005|STARTED|Main Study Period||43
8819714|NCT01566539|9873709|FG006|STARTED|Main Study Period||30
8819715|NCT01566539|9873710|FG007|STARTED|Main Study Period||30
8819716|NCT01566539|9873711|FG008|STARTED|Main Study Period||1
8819717|NCT01566539|9873703|FG000|COMPLETED|Main Study Period||100
8819718|NCT01566539|9873704|FG001|COMPLETED|Main Study Period||100
8819719|NCT01566539|9873705|FG002|COMPLETED|Main Study Period||104
8819720|NCT01566539|9873706|FG003|COMPLETED|Main Study Period||0
8819721|NCT01566539|9873707|FG004|COMPLETED|Main Study Period||40
8819722|NCT01566539|9873708|FG005|COMPLETED|Main Study Period||40
8819723|NCT01566539|9873709|FG006|COMPLETED|Main Study Period||30
8819724|NCT01566539|9873710|FG007|COMPLETED|Main Study Period||30
8819725|NCT01566539|9873711|FG008|COMPLETED|Main Study Period||1
8819726|NCT01566539|9873703|FG000|NOT COMPLETED|Main Study Period||1
8819727|NCT01566539|9873704|FG001|NOT COMPLETED|Main Study Period||0
8819728|NCT01566539|9873705|FG002|NOT COMPLETED|Main Study Period||0
8819729|NCT01566539|9873706|FG003|NOT COMPLETED|Main Study Period||0
8819730|NCT01566539|9873707|FG004|NOT COMPLETED|Main Study Period||0
8819731|NCT01566539|9873708|FG005|NOT COMPLETED|Main Study Period||3
8819732|NCT01566539|9873709|FG006|NOT COMPLETED|Main Study Period||0
8819733|NCT01566539|9873710|FG007|NOT COMPLETED|Main Study Period||0
8819734|NCT01566539|9873711|FG008|NOT COMPLETED|Main Study Period||0
8819735|NCT01566539|9873703|FG000|STARTED|Within Subject Group||0
8819736|NCT01566539|9873704|FG001|STARTED|Within Subject Group||0
8819737|NCT01566539|9873705|FG002|STARTED|Within Subject Group||0
8819738|NCT01566539|9873706|FG003|STARTED|Within Subject Group|Participants can move from Healthy Volunteers-AVP, OT and Placebo groups to the within subject group|156
8819739|NCT01566539|9873707|FG004|STARTED|Within Subject Group||0
8819740|NCT01566539|9873708|FG005|STARTED|Within Subject Group||0
8819741|NCT01566539|9873709|FG006|STARTED|Within Subject Group||0
8819742|NCT01566539|9873710|FG007|STARTED|Within Subject Group||0
8819743|NCT01566539|9873711|FG008|STARTED|Within Subject Group||0
8819744|NCT01566539|9873703|FG000|COMPLETED|Within Subject Group||0
8819745|NCT01566539|9873704|FG001|COMPLETED|Within Subject Group||0
8819746|NCT01566539|9873705|FG002|COMPLETED|Within Subject Group||0
8819747|NCT01566539|9873706|FG003|COMPLETED|Within Subject Group|Participants can move from Healthy Volunteers-AVP, OT and Placebo groups to the within subject group|153
8819748|NCT01566539|9873707|FG004|COMPLETED|Within Subject Group||0
8819749|NCT01566539|9873708|FG005|COMPLETED|Within Subject Group||0
8819750|NCT01566539|9873709|FG006|COMPLETED|Within Subject Group||0
8819751|NCT01566539|9873710|FG007|COMPLETED|Within Subject Group||0
8819752|NCT01566539|9873711|FG008|COMPLETED|Within Subject Group||0
8819753|NCT01566539|9873703|FG000|NOT COMPLETED|Within Subject Group||0
8819754|NCT01566539|9873704|FG001|NOT COMPLETED|Within Subject Group||0
8819755|NCT01566539|9873705|FG002|NOT COMPLETED|Within Subject Group||0
8819756|NCT01566539|9873706|FG003|NOT COMPLETED|Within Subject Group||3
8819757|NCT01566539|9873707|FG004|NOT COMPLETED|Within Subject Group||0
8819758|NCT01566539|9873708|FG005|NOT COMPLETED|Within Subject Group||0
8819759|NCT01566539|9873709|FG006|NOT COMPLETED|Within Subject Group||0
8819760|NCT01566539|9873710|FG007|NOT COMPLETED|Within Subject Group||0
8819761|NCT01566539|9873711|FG008|NOT COMPLETED|Within Subject Group||0
8819762|NCT01566604|9873735|FG000|STARTED|Overall Study||306
8819763|NCT01566604|9873736|FG001|STARTED|Overall Study||154
8552527|NCT01970865|9584340|FG008|NOT COMPLETED|Overall Study||3
8552528|NCT01970865|9584341|FG009|NOT COMPLETED|Overall Study||4
8552529|NCT01970865|9584342|FG010|NOT COMPLETED|Overall Study||30
8552530|NCT01970865|9584343|FG011|NOT COMPLETED|Overall Study||27
8819764|NCT01566604|9873735|FG000|Safety Set|Overall Study||305
8552531|NCT01970865|9584344|FG012|NOT COMPLETED|Overall Study||60
8819765|NCT01566604|9873736|FG001|Safety Set|Overall Study||154
8819766|NCT01566604|9873735|FG000|Full Analysis Set (FAS)|Overall Study||305
8819767|NCT01566604|9873736|FG001|Full Analysis Set (FAS)|Overall Study||154
8819768|NCT01566604|9873735|FG000|FAS, Serial Spirometry Subgroup|Overall Study||134
8819769|NCT01566604|9873736|FG001|FAS, Serial Spirometry Subgroup|Overall Study||58
8819770|NCT01566604|9873735|FG000|COMPLETED|Overall Study||282
8819771|NCT01566604|9873736|FG001|COMPLETED|Overall Study||143
8819772|NCT01566604|9873735|FG000|NOT COMPLETED|Overall Study||24
8819773|NCT01566604|9873736|FG001|NOT COMPLETED|Overall Study||11
8819774|NCT01566630|9873744|FG000|STARTED|Overall Study||2
8552532|NCT01970865|9584345|FG013|NOT COMPLETED|Overall Study||66
8552533|NCT01970865|9584346|FG014|NOT COMPLETED|Overall Study||46
8552534|NCT01970865|9584347|FG015|NOT COMPLETED|Overall Study||47
8552535|NCT01970865|9584348|FG016|NOT COMPLETED|Overall Study||3
8552536|NCT00589420|9584409|FG000|STARTED|Overall Study||18
8819775|NCT01566630|9873745|FG001|STARTED|Overall Study||1
8819776|NCT01566630|9873744|FG000|COMPLETED|Overall Study||2
8819777|NCT01566630|9873745|FG001|COMPLETED|Overall Study||1
8819778|NCT01566630|9873744|FG000|NOT COMPLETED|Overall Study||0
8819779|NCT01566630|9873745|FG001|NOT COMPLETED|Overall Study||0
8819780|NCT01566682|9873757|FG000|STARTED|Overall Study||420
8819781|NCT01566682|9873757|FG000|COMPLETED|Overall Study||374
8819782|NCT01566682|9873757|FG000|NOT COMPLETED|Overall Study||46
8819783|NCT01566721|9873763|FG000|STARTED|Treatment Period||1867
8819784|NCT01566721|9873764|FG001|STARTED|Treatment Period||710
8819785|NCT01566721|9873763|FG000|COMPLETED|Treatment Period||1670
8819786|NCT01566721|9873764|FG001|COMPLETED|Treatment Period||652
8819787|NCT01566721|9873763|FG000|NOT COMPLETED|Treatment Period||197
8819788|NCT01566721|9873764|FG001|NOT COMPLETED|Treatment Period||58
8819789|NCT01566721|9873763|FG000|STARTED|Safety Follow-up|Participants who discontinued treatment were allowed to join the SFU Period.|1865
8819790|NCT01566721|9873764|FG001|STARTED|Safety Follow-up|Participants who discontinued treatment were allowed to join the SFU Period.|708
8819791|NCT01566721|9873763|FG000|COMPLETED|Safety Follow-up||1318
8819792|NCT01566721|9873764|FG001|COMPLETED|Safety Follow-up||501
8819793|NCT01566721|9873763|FG000|NOT COMPLETED|Safety Follow-up||547
8819794|NCT01566721|9873764|FG001|NOT COMPLETED|Safety Follow-up||207
8819795|NCT01566773|9873777|FG000|STARTED|Overall Study||140
8819796|NCT01566773|9873777|FG000|GP MDI 18 µg BID|Overall Study||64
8819797|NCT01566773|9873777|FG000|GP MDI 9 µg BID|Overall Study||64
8819798|NCT01566773|9873777|FG000|GP MDI 4.6 µg BID|Overall Study||62
8819799|NCT01566773|9873777|FG000|GP MDI 2.4 µg BID|Overall Study||64
8819800|NCT01566773|9873777|FG000|GP MDI 1.2 µg BID|Overall Study||57
8819801|NCT01566773|9873777|FG000|GP MDI 0.6 µg BID|Overall Study||59
8819802|NCT01566773|9873777|FG000|Placebo MDI|Overall Study||62
8819803|NCT01566773|9873777|FG000|Spiriva® Handihaler®|Overall Study||62
8819804|NCT01566773|9873777|FG000|COMPLETED|Overall Study||110
8819805|NCT01566773|9873777|FG000|NOT COMPLETED|Overall Study||30
8819806|NCT01566838|9873799|FG000|STARTED|Overall Study||41
8819807|NCT01566838|9873800|FG001|STARTED|Overall Study||42
8819808|NCT01566838|9873799|FG000|COMPLETED|Overall Study||38
8819809|NCT01566838|9873800|FG001|COMPLETED|Overall Study||42
8819810|NCT01566838|9873799|FG000|NOT COMPLETED|Overall Study||3
8819811|NCT01566838|9873800|FG001|NOT COMPLETED|Overall Study||0
8819812|NCT01566981|9873808|FG000|STARTED|Overall Study||58
8819813|NCT01566981|9873809|FG001|STARTED|Overall Study||62
8819814|NCT01566981|9873808|FG000|COMPLETED|Overall Study||53
8819815|NCT01566981|9873809|FG001|COMPLETED|Overall Study||54
8819816|NCT01566981|9873808|FG000|NOT COMPLETED|Overall Study||5
8819817|NCT01566981|9873809|FG001|NOT COMPLETED|Overall Study||8
8819818|NCT01567020|9873821|FG000|STARTED|Overall Study||28
8819819|NCT01567020|9873822|FG001|STARTED|Overall Study||46
8819820|NCT01567020|9873823|FG002|STARTED|Overall Study||20
8819821|NCT01567020|9873824|FG003|STARTED|Overall Study||11
8819822|NCT01567020|9873821|FG000|COMPLETED|Overall Study||21
8819823|NCT01567020|9873822|FG001|COMPLETED|Overall Study||41
8819824|NCT01567020|9873823|FG002|COMPLETED|Overall Study||18
8819825|NCT01567020|9873824|FG003|COMPLETED|Overall Study||10
8819826|NCT01567020|9873821|FG000|NOT COMPLETED|Overall Study||7
8819827|NCT01567020|9873822|FG001|NOT COMPLETED|Overall Study||5
8819828|NCT01567020|9873823|FG002|NOT COMPLETED|Overall Study||2
8819829|NCT01567020|9873824|FG003|NOT COMPLETED|Overall Study||1
8819830|NCT01567085|9873834|FG000|STARTED|Overall Study||80
8819831|NCT01567085|9873834|FG000|Received at Least 1 Dose of Study Drug|Overall Study||80
8819832|NCT01567085|9873834|FG000|COMPLETED|Overall Study||60
8819833|NCT01567085|9873834|FG000|NOT COMPLETED|Overall Study||20
8819834|NCT01567150|9873840|FG000|STARTED|Overall Study||21
8819835|NCT01567150|9873841|FG001|STARTED|Overall Study||18
8819836|NCT01567150|9873840|FG000|COMPLETED|Overall Study||19
8819837|NCT01567150|9873841|FG001|COMPLETED|Overall Study||16
8819838|NCT01567150|9873840|FG000|NOT COMPLETED|Overall Study||2
8819839|NCT01567150|9873841|FG001|NOT COMPLETED|Overall Study||2
8819840|NCT01567163|9873847|FG000|STARTED|Overall Study||22
8819841|NCT01567163|9873847|FG000|Received at Least 1 Dose of Study Drug|Overall Study||22
8552537|NCT00589420|9584409|FG000|COMPLETED|Overall Study||17
8819842|NCT01567163|9873847|FG000|Drug-Drug Interaction Population|Overall Study|Completed Cycle 1, Day 1 and Cycle 2, Day 1 treatment with required assessments.|18
8819843|NCT01567163|9873847|FG000|COMPLETED|Overall Study||18
8819844|NCT01567163|9873847|FG000|NOT COMPLETED|Overall Study||4
8819845|NCT01567306|9873862|FG000|STARTED|Overall Study||27
8819846|NCT01567306|9873863|FG001|STARTED|Overall Study||25
8819847|NCT01567306|9873864|FG002|STARTED|Overall Study||24
8819848|NCT01567306|9873865|FG003|STARTED|Overall Study||24
8552538|NCT00589420|9584409|FG000|NOT COMPLETED|Overall Study||1
8819849|NCT01567306|9873866|FG004|STARTED|Overall Study||25
8819850|NCT01567306|9873867|FG005|STARTED|Overall Study||26
8819851|NCT01567306|9873862|FG000|COMPLETED|Overall Study||24
8819852|NCT01567306|9873863|FG001|COMPLETED|Overall Study||23
8819853|NCT01567306|9873864|FG002|COMPLETED|Overall Study||24
8819854|NCT01567306|9873865|FG003|COMPLETED|Overall Study||19
8819855|NCT01567306|9873866|FG004|COMPLETED|Overall Study||18
8819856|NCT01567306|9873867|FG005|COMPLETED|Overall Study||23
8552539|NCT05043142|9584413|FG000|STARTED|Overall Study||3632
8552540|NCT05043142|9584413|FG000|COMPLETED|Overall Study||3443
8552541|NCT05043142|9584413|FG000|NOT COMPLETED|Overall Study||189
8552542|NCT04993339|9584419|FG000|STARTED|Overall Study||14
8552543|NCT04993339|9584420|FG001|STARTED|Overall Study||12
8552544|NCT04993339|9584419|FG000|COMPLETED|Overall Study||11
8552545|NCT04993339|9584420|FG001|COMPLETED|Overall Study||10
8819857|NCT01567306|9873862|FG000|NOT COMPLETED|Overall Study||3
8819858|NCT01567306|9873863|FG001|NOT COMPLETED|Overall Study||2
8819859|NCT01567306|9873864|FG002|NOT COMPLETED|Overall Study||0
8819860|NCT01567306|9873865|FG003|NOT COMPLETED|Overall Study||5
8819861|NCT01567306|9873866|FG004|NOT COMPLETED|Overall Study||7
8819862|NCT01567306|9873867|FG005|NOT COMPLETED|Overall Study||3
8819863|NCT01567371|9873881|FG000|STARTED|Overall Study||30
8819864|NCT01567371|9873881|FG000|COMPLETED|Overall Study||30
8819865|NCT01567371|9873881|FG000|NOT COMPLETED|Overall Study||0
8819866|NCT01567462|9873887|FG000|STARTED|Overall Study||45
8819867|NCT01567462|9873888|FG001|STARTED|Overall Study||45
8819868|NCT01567462|9873887|FG000|COMPLETED|Overall Study||41
8819869|NCT01567462|9873888|FG001|COMPLETED|Overall Study||38
8819870|NCT01567462|9873887|FG000|NOT COMPLETED|Overall Study||4
8819871|NCT01567462|9873888|FG001|NOT COMPLETED|Overall Study||7
8819872|NCT01567527|9873896|FG000|STARTED|Conversion Phase.||466
8819873|NCT01567527|9873897|FG001|STARTED|Conversion Phase.|There were no subjects in this reporting group in this phase of the study.|0
8819874|NCT01567527|9873898|FG002|STARTED|Conversion Phase.|There were no subjects in this reporting group in this phase of the study.|0
8819875|NCT01567527|9873899|FG003|STARTED|Conversion Phase.|There were no subjects in this reporting group in this phase of the study.|0
8819876|NCT01567527|9873900|FG004|STARTED|Conversion Phase.|There were no subjects in this reporting group in this phase of the study.|0
8819877|NCT01567527|9873896|FG000|COMPLETED|Conversion Phase.||367
8819878|NCT01567527|9873897|FG001|COMPLETED|Conversion Phase.||0
8819879|NCT01567527|9873898|FG002|COMPLETED|Conversion Phase.||0
8819880|NCT01567527|9873899|FG003|COMPLETED|Conversion Phase.||0
8819881|NCT01567527|9873900|FG004|COMPLETED|Conversion Phase.||0
8819882|NCT01567527|9873896|FG000|NOT COMPLETED|Conversion Phase.||99
8819883|NCT01567527|9873897|FG001|NOT COMPLETED|Conversion Phase.||0
8819884|NCT01567527|9873898|FG002|NOT COMPLETED|Conversion Phase.||0
8819885|NCT01567527|9873899|FG003|NOT COMPLETED|Conversion Phase.||0
8819886|NCT01567527|9873900|FG004|NOT COMPLETED|Conversion Phase.||0
8819887|NCT01567527|9873896|FG000|STARTED|Oral Aripiprazole Stabilization Phase.|There were no subjects in this reporting group in this phase of the study.|0
8819888|NCT01567527|9873897|FG001|STARTED|Oral Aripiprazole Stabilization Phase.|265 of the 632 subjects who started this phase entered the Oral Stabilization Phase directly.|632
8819889|NCT01567527|9873898|FG002|STARTED|Oral Aripiprazole Stabilization Phase.|There were no subjects in this reporting group in this phase of the study.|0
8819890|NCT01567527|9873899|FG003|STARTED|Oral Aripiprazole Stabilization Phase.|There were no subjects in this reporting group in this phase of the study.|0
8819891|NCT01567527|9873900|FG004|STARTED|Oral Aripiprazole Stabilization Phase.|There were no subjects in this reporting group in this phase of the study.|0
8819892|NCT01567527|9873896|FG000|COMPLETED|Oral Aripiprazole Stabilization Phase.||0
8819893|NCT01567527|9873897|FG001|COMPLETED|Oral Aripiprazole Stabilization Phase.||425
8819894|NCT01567527|9873898|FG002|COMPLETED|Oral Aripiprazole Stabilization Phase.||0
8819895|NCT01567527|9873899|FG003|COMPLETED|Oral Aripiprazole Stabilization Phase.||0
8819896|NCT01567527|9873900|FG004|COMPLETED|Oral Aripiprazole Stabilization Phase.||0
8819897|NCT01567527|9873896|FG000|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||0
8819898|NCT01567527|9873897|FG001|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||207
8819899|NCT01567527|9873898|FG002|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||0
8819900|NCT01567527|9873899|FG003|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||0
8819901|NCT01567527|9873900|FG004|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||0
8819902|NCT01567527|9873896|FG000|STARTED|IM Depot Stabilization.|There were no subjects in this reporting group in this phase of the study.|0
8819903|NCT01567527|9873897|FG001|STARTED|IM Depot Stabilization.|There were no subjects in this reporting group in this phase of the study.|0
8819904|NCT01567527|9873898|FG002|STARTED|IM Depot Stabilization.||425
8819905|NCT01567527|9873899|FG003|STARTED|IM Depot Stabilization.|There were no subjects in this reporting group in this phase of the study.|0
8819906|NCT01567527|9873900|FG004|STARTED|IM Depot Stabilization.|There were no subjects in this reporting group in this phase of the study.|0
8819907|NCT01567527|9873896|FG000|COMPLETED|IM Depot Stabilization.||0
8819908|NCT01567527|9873897|FG001|COMPLETED|IM Depot Stabilization.||0
8819909|NCT01567527|9873898|FG002|COMPLETED|IM Depot Stabilization.||266
8819910|NCT01567527|9873899|FG003|COMPLETED|IM Depot Stabilization.||0
8819911|NCT01567527|9873900|FG004|COMPLETED|IM Depot Stabilization.||0
8819912|NCT01567527|9873896|FG000|NOT COMPLETED|IM Depot Stabilization.||0
8819913|NCT01567527|9873897|FG001|NOT COMPLETED|IM Depot Stabilization.||0
8819914|NCT01567527|9873898|FG002|NOT COMPLETED|IM Depot Stabilization.||159
8819915|NCT01567527|9873899|FG003|NOT COMPLETED|IM Depot Stabilization.||0
8819916|NCT01567527|9873900|FG004|NOT COMPLETED|IM Depot Stabilization.||0
8819917|NCT01567527|9873896|FG000|STARTED|Double-blind, Placebo-controlled Phase||0
8819918|NCT01567527|9873897|FG001|STARTED|Double-blind, Placebo-controlled Phase||0
8819919|NCT01567527|9873898|FG002|STARTED|Double-blind, Placebo-controlled Phase|Subjects were randomized to Aripiprazole IM Depot and placebo groups in this phase of the study|0
8552546|NCT04993339|9584419|FG000|NOT COMPLETED|Overall Study||3
8552547|NCT04993339|9584420|FG001|NOT COMPLETED|Overall Study||2
8552548|NCT04992442|9584426|FG000|STARTED|Treatment Period 1||6
8552549|NCT04992442|9584426|FG000|COMPLETED|Treatment Period 1||6
8552550|NCT04992442|9584426|FG000|NOT COMPLETED|Treatment Period 1||0
8552551|NCT04992442|9584426|FG000|STARTED|Washout Period||6
8552552|NCT04992442|9584426|FG000|COMPLETED|Washout Period||6
8552553|NCT04992442|9584426|FG000|NOT COMPLETED|Washout Period||0
8552554|NCT04992442|9584426|FG000|STARTED|Treatment Period 2||6
8552555|NCT04992442|9584426|FG000|COMPLETED|Treatment Period 2||6
8552556|NCT04992442|9584426|FG000|NOT COMPLETED|Treatment Period 2||0
8568118|NCT00090220|9600493|FG000|STARTED|Long-term Follow-up (EXT2)||0
8568119|NCT00090220|9600494|FG001|STARTED|Long-term Follow-up (EXT2)||0
8568120|NCT00090220|9600495|FG002|STARTED|Long-term Follow-up (EXT2)||0
8568121|NCT00090220|9600496|FG003|STARTED|Long-term Follow-up (EXT2)||0
8568122|NCT00090220|9600497|FG004|STARTED|Long-term Follow-up (EXT2)|Participation in LTFU was voluntary; not all participants eligible for LTFU enrolled.|685
8568123|NCT00090220|9600498|FG005|STARTED|Long-term Follow-up (EXT2)|Participation in LTFU was voluntary; not all participants eligible for LTFU enrolled.|651
8568124|NCT00090220|9600493|FG000|COMPLETED|Long-term Follow-up (EXT2)||0
8568125|NCT00090220|9600494|FG001|COMPLETED|Long-term Follow-up (EXT2)||0
8568126|NCT00090220|9600495|FG002|COMPLETED|Long-term Follow-up (EXT2)||0
8568127|NCT00090220|9600496|FG003|COMPLETED|Long-term Follow-up (EXT2)||0
8568128|NCT00090220|9600497|FG004|COMPLETED|Long-term Follow-up (EXT2)||641
8819920|NCT01567527|9873899|FG003|STARTED|Double-blind, Placebo-controlled Phase||133
8819921|NCT01567527|9873900|FG004|STARTED|Double-blind, Placebo-controlled Phase||133
8819922|NCT01567527|9873896|FG000|COMPLETED|Double-blind, Placebo-controlled Phase||0
8819923|NCT01567527|9873897|FG001|COMPLETED|Double-blind, Placebo-controlled Phase||0
8819924|NCT01567527|9873898|FG002|COMPLETED|Double-blind, Placebo-controlled Phase||0
8819925|NCT01567527|9873899|FG003|COMPLETED|Double-blind, Placebo-controlled Phase||64
8819926|NCT01567527|9873900|FG004|COMPLETED|Double-blind, Placebo-controlled Phase||38
8819927|NCT01567527|9873896|FG000|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
8819928|NCT01567527|9873897|FG001|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
8819929|NCT01567527|9873898|FG002|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
8819930|NCT01567527|9873899|FG003|NOT COMPLETED|Double-blind, Placebo-controlled Phase||69
8819931|NCT01567527|9873900|FG004|NOT COMPLETED|Double-blind, Placebo-controlled Phase||95
8849325|NCT01739764|9904480|FG002|COMPLETED|Overall Study||20
8849326|NCT01739764|9904478|FG000|NOT COMPLETED|Overall Study||26
8849327|NCT01739764|9904479|FG001|NOT COMPLETED|Overall Study||36
8849328|NCT01739764|9904480|FG002|NOT COMPLETED|Overall Study||126
8849329|NCT01739790|9904490|FG000|STARTED|Overall Study||24
8849330|NCT01739790|9904491|FG001|STARTED|Overall Study||27
8849331|NCT01739790|9904490|FG000|COMPLETED|Overall Study||22
8849332|NCT01739790|9904491|FG001|COMPLETED|Overall Study||23
8849333|NCT01739790|9904490|FG000|NOT COMPLETED|Overall Study||2
8849334|NCT01739790|9904491|FG001|NOT COMPLETED|Overall Study||4
8849335|NCT01739803|9904499|FG000|STARTED|Overall Study||76
8849336|NCT01739803|9904500|FG001|STARTED|Overall Study||74
8849337|NCT01739803|9904499|FG000|COMPLETED|Overall Study||67
8849338|NCT01739803|9904500|FG001|COMPLETED|Overall Study||68
8849339|NCT01739803|9904499|FG000|NOT COMPLETED|Overall Study||9
8849340|NCT01739803|9904500|FG001|NOT COMPLETED|Overall Study||6
8849341|NCT01739933|9904508|FG000|STARTED|Overall Study|Underwent randomization and received study drug|214
8849342|NCT01739933|9904509|FG001|STARTED|Overall Study|Underwent randomization and received study drug|208
8849343|NCT01739933|9904508|FG000|Discharged From Hospital and Eligible for Follow-up|Overall Study||140
8849344|NCT01739933|9904509|FG001|Discharged From Hospital and Eligible for Follow-up|Overall Study||147
8849345|NCT01739933|9904508|FG000|COMPLETED|Overall Study|97% of those eligible (alive and who did not withdraw)|108
8849346|NCT01739933|9904509|FG001|COMPLETED|Overall Study|91% of those eligible (alive and who did not withdraw)|101
8849347|NCT01739933|9904508|FG000|NOT COMPLETED|Overall Study||106
8849348|NCT01739933|9904509|FG001|NOT COMPLETED|Overall Study||107
8849349|NCT01740089|9904518|FG000|STARTED|First 12 Weeks of Treatment||50
8849350|NCT01740089|9904519|FG001|STARTED|First 12 Weeks of Treatment||50
8849351|NCT01740089|9904520|FG002|STARTED|First 12 Weeks of Treatment||50
8849352|NCT01740089|9904518|FG000|COMPLETED|First 12 Weeks of Treatment||50
8849353|NCT01740089|9904519|FG001|COMPLETED|First 12 Weeks of Treatment|"Withdrawn due to:~AE before W12 (n=1) Withdrew consent before W12 (n=1)"|48
8849354|NCT01740089|9904520|FG002|COMPLETED|First 12 Weeks of Treatment|"Withdrawn due to:~AE before W12 (n=2)"|48
8849355|NCT01740089|9904518|FG000|NOT COMPLETED|First 12 Weeks of Treatment||0
8849356|NCT01740089|9904519|FG001|NOT COMPLETED|First 12 Weeks of Treatment||2
8849357|NCT01740089|9904520|FG002|NOT COMPLETED|First 12 Weeks of Treatment||2
8849358|NCT01740089|9904518|FG000|STARTED|After 12 Weeks||50
8849359|NCT01740089|9904519|FG001|STARTED|After 12 Weeks||48
8849360|NCT01740089|9904520|FG002|STARTED|After 12 Weeks||48
8849361|NCT01740089|9904518|FG000|COMPLETED|After 12 Weeks|"Withdrawn due to:~No EVR (n=3) AE (n=2) No EOT (n=1) Non-compliance (n=1)"|43
8849362|NCT01740089|9904519|FG001|COMPLETED|After 12 Weeks|"Withdrawn due to:~Withdrawn consent (n=1) No EVR (n=1) Non-compliance (n=1)"|45
8849363|NCT01740089|9904520|FG002|COMPLETED|After 12 Weeks|"Withdrawn due to:~No EVR (n=4) AE (n=5) Non-attendance of visit (n=1) Withdrawn consent (n=1)"|37
8849364|NCT01740089|9904518|FG000|NOT COMPLETED|After 12 Weeks||7
8849365|NCT01740089|9904519|FG001|NOT COMPLETED|After 12 Weeks||3
8849366|NCT01740089|9904520|FG002|NOT COMPLETED|After 12 Weeks||11
8849367|NCT01740128|9904531|FG000|STARTED|Overall Study||10
8568129|NCT00090220|9600498|FG005|COMPLETED|Long-term Follow-up (EXT2)||623
8849368|NCT01740128|9904532|FG001|STARTED|Overall Study||11
8849369|NCT01740128|9904531|FG000|COMPLETED|Overall Study||4
8552557|NCT04929522|9584442|FG000|STARTED|Overall Study||40
8552558|NCT04929522|9584443|FG001|STARTED|Overall Study||40
8552559|NCT04929522|9584444|FG002|STARTED|Overall Study||40
8552560|NCT04929522|9584445|FG003|STARTED|Overall Study||40
8552561|NCT04929522|9584442|FG000|COMPLETED|Overall Study||40
8552562|NCT04929522|9584443|FG001|COMPLETED|Overall Study||40
8552563|NCT04929522|9584444|FG002|COMPLETED|Overall Study||40
8552564|NCT04929522|9584445|FG003|COMPLETED|Overall Study||40
8552565|NCT04929522|9584442|FG000|NOT COMPLETED|Overall Study||0
8552566|NCT04929522|9584443|FG001|NOT COMPLETED|Overall Study||0
8552567|NCT04929522|9584444|FG002|NOT COMPLETED|Overall Study||0
8552568|NCT04929522|9584445|FG003|NOT COMPLETED|Overall Study||0
8552573|NCT04919161|9584462|FG000|STARTED|Overall Study||16
8552574|NCT04919161|9584463|FG001|STARTED|Overall Study||16
8552575|NCT04919161|9584462|FG000|COMPLETED|Overall Study||15
8552576|NCT04919161|9584463|FG001|COMPLETED|Overall Study||14
8552577|NCT04919161|9584462|FG000|NOT COMPLETED|Overall Study||1
8552578|NCT04919161|9584463|FG001|NOT COMPLETED|Overall Study||2
8552579|NCT04912700|9584494|FG000|STARTED|Overall Study||10880
8552580|NCT04912700|9584495|FG001|STARTED|Overall Study||825
8552581|NCT04912700|9584496|FG002|STARTED|Overall Study||129
8552582|NCT04912700|9584494|FG000|COMPLETED|Overall Study||10880
8552583|NCT04912700|9584495|FG001|COMPLETED|Overall Study||825
8552584|NCT04912700|9584496|FG002|COMPLETED|Overall Study||129
8552585|NCT04912700|9584494|FG000|NOT COMPLETED|Overall Study||0
8552586|NCT04912700|9584495|FG001|NOT COMPLETED|Overall Study||0
8552587|NCT04912700|9584496|FG002|NOT COMPLETED|Overall Study||0
8552588|NCT04912297|9584506|FG000|STARTED|Overall Study||99
8552589|NCT04912297|9584507|FG001|STARTED|Overall Study||87
8552590|NCT04912297|9584506|FG000|COMPLETED|Overall Study||68
8552591|NCT04912297|9584507|FG001|COMPLETED|Overall Study||54
8552592|NCT04912297|9584506|FG000|NOT COMPLETED|Overall Study||31
8552593|NCT04912297|9584507|FG001|NOT COMPLETED|Overall Study||33
8552600|NCT04904640|9584522|FG000|STARTED|Overall Study||150
8552601|NCT04904640|9584522|FG000|COMPLETED|Overall Study||150
8552602|NCT04904640|9584522|FG000|NOT COMPLETED|Overall Study||0
8552612|NCT04891874|9584545|FG000|STARTED|Overall Study|Participants in this period were recruited from August 1, 2015 to December 31, 2016.|38
8552613|NCT04891874|9584546|FG001|STARTED|Overall Study||38
8552614|NCT04891874|9584545|FG000|COMPLETED|Overall Study||38
8552615|NCT04891874|9584546|FG001|COMPLETED|Overall Study||38
8552616|NCT04891874|9584545|FG000|NOT COMPLETED|Overall Study||0
8552617|NCT04891874|9584546|FG001|NOT COMPLETED|Overall Study||0
8552618|NCT04883541|9584554|FG000|STARTED|Overall Study||46
8552619|NCT04883541|9584555|FG001|STARTED|Overall Study||69
8552620|NCT04883541|9584554|FG000|COMPLETED|Overall Study||30
8552621|NCT04883541|9584555|FG001|COMPLETED|Overall Study||60
8552622|NCT04883541|9584554|FG000|NOT COMPLETED|Overall Study||16
8552623|NCT04883541|9584555|FG001|NOT COMPLETED|Overall Study||9
8552624|NCT04881968|9584561|FG000|STARTED|Overall Study||1261
8552625|NCT04881968|9584561|FG000|COMPLETED|Overall Study||1261
8552626|NCT04881968|9584561|FG000|NOT COMPLETED|Overall Study||0
8552627|NCT04486560|9584565|FG000|STARTED|Overall Study||51
8552628|NCT04486560|9584565|FG000|COMPLETED|Overall Study||50
8552629|NCT04486560|9584565|FG000|NOT COMPLETED|Overall Study||1
8552630|NCT04357782|9584571|FG000|STARTED|Overall Study||10
8552631|NCT04357782|9584572|FG001|STARTED|Overall Study||10
8552632|NCT04357782|9584571|FG000|COMPLETED|Overall Study||9
8552633|NCT04357782|9584572|FG001|COMPLETED|Overall Study||8
8552634|NCT04357782|9584571|FG000|NOT COMPLETED|Overall Study||1
8552635|NCT04357782|9584572|FG001|NOT COMPLETED|Overall Study||2
8552636|NCT04090658|9584580|FG000|STARTED|Overall Study||20
8552637|NCT04090658|9584581|FG001|STARTED|Overall Study||20
8552638|NCT04090658|9584580|FG000|COMPLETED|Overall Study||20
8552639|NCT04090658|9584581|FG001|COMPLETED|Overall Study||20
8552640|NCT04090658|9584580|FG000|NOT COMPLETED|Overall Study||0
8552641|NCT04090658|9584581|FG001|NOT COMPLETED|Overall Study||0
8552642|NCT03811028|9584589|FG000|STARTED|Overall Study||3
8552643|NCT03811028|9584590|FG001|STARTED|Overall Study||3
8552644|NCT03811028|9584589|FG000|COMPLETED|Overall Study||3
8552645|NCT03811028|9584590|FG001|COMPLETED|Overall Study||3
8552646|NCT03811028|9584589|FG000|NOT COMPLETED|Overall Study||0
8552647|NCT03811028|9584590|FG001|NOT COMPLETED|Overall Study||0
8552648|NCT03760068|9584599|FG000|STARTED|Overall Study||238
8552649|NCT03760068|9584600|FG001|STARTED|Overall Study||240
8552650|NCT03760068|9584599|FG000|COMPLETED|Overall Study||224
8552651|NCT03760068|9584600|FG001|COMPLETED|Overall Study||217
8552652|NCT03760068|9584599|FG000|NOT COMPLETED|Overall Study||14
8552653|NCT03760068|9584600|FG001|NOT COMPLETED|Overall Study||23
8552654|NCT03742986|9584609|FG000|STARTED|Overall Study||4
8552655|NCT03742986|9584610|FG001|STARTED|Overall Study||4
8552656|NCT03742986|9584609|FG000|COMPLETED|Overall Study||4
8552657|NCT03742986|9584610|FG001|COMPLETED|Overall Study||4
8552658|NCT03742986|9584609|FG000|NOT COMPLETED|Overall Study||0
8552659|NCT03742986|9584610|FG001|NOT COMPLETED|Overall Study||0
8552660|NCT03628781|9584618|FG000|STARTED|Overall Study||85
8552661|NCT03628781|9584619|FG001|STARTED|Overall Study||84
8552662|NCT03628781|9584618|FG000|6-month Timepoint|Overall Study||63
8552663|NCT03628781|9584619|FG001|6-month Timepoint|Overall Study||79
8552664|NCT03628781|9584618|FG000|12-month Timepoint|Overall Study||53
8552665|NCT03628781|9584619|FG001|12-month Timepoint|Overall Study||75
8552666|NCT03628781|9584618|FG000|COMPLETED|Overall Study||53
8552667|NCT03628781|9584619|FG001|COMPLETED|Overall Study||75
8552668|NCT03628781|9584618|FG000|NOT COMPLETED|Overall Study||32
8552569|NCT04927858|9584455|FG000|STARTED|Overall Study||460558
8552570|NCT04927858|9584455|FG000|Treated With Empagliflozin|Overall Study||16985
8552571|NCT04927858|9584455|FG000|COMPLETED|Overall Study||460558
8552572|NCT04927858|9584455|FG000|NOT COMPLETED|Overall Study||0
8552594|NCT04910165|9584515|FG000|STARTED|Overall Study||50
8552595|NCT04910165|9584516|FG001|STARTED|Overall Study||50
8552596|NCT04910165|9584515|FG000|COMPLETED|Overall Study||50
8552597|NCT04910165|9584516|FG001|COMPLETED|Overall Study||50
8552598|NCT04910165|9584515|FG000|NOT COMPLETED|Overall Study||0
8552599|NCT04910165|9584516|FG001|NOT COMPLETED|Overall Study||0
8552603|NCT04901897|9584533|FG000|STARTED|Overall Study||398
8552604|NCT04901897|9584534|FG001|STARTED|Overall Study||202
8552605|NCT04901897|9584535|FG002|STARTED|Overall Study||205
8552606|NCT04901897|9584533|FG000|COMPLETED|Overall Study||393
8552607|NCT04901897|9584534|FG001|COMPLETED|Overall Study||200
8552608|NCT04901897|9584535|FG002|COMPLETED|Overall Study||203
8552609|NCT04901897|9584533|FG000|NOT COMPLETED|Overall Study||5
8552610|NCT04901897|9584534|FG001|NOT COMPLETED|Overall Study||2
8552611|NCT04901897|9584535|FG002|NOT COMPLETED|Overall Study||2
8552669|NCT03628781|9584619|FG001|NOT COMPLETED|Overall Study||9
8552670|NCT03560206|9584627|FG000|STARTED|Overall Study||158
8552671|NCT03560206|9584628|FG001|STARTED|Overall Study||158
8552672|NCT03560206|9584627|FG000|COMPLETED|Overall Study||108
8552673|NCT03560206|9584628|FG001|COMPLETED|Overall Study||140
8552674|NCT03560206|9584627|FG000|NOT COMPLETED|Overall Study||50
8621784|NCT00483379|9660829|FG000|STARTED|Extension Period|Extension allowed late-onset participants access to treatment until commercially available.|1
8621785|NCT00483379|9660830|FG001|STARTED|Extension Period|Extension allowed late-onset participants access to treatment until commercially available.|2
8621786|NCT00483379|9660829|FG000|COMPLETED|Extension Period||1
8552675|NCT03560206|9584628|FG001|NOT COMPLETED|Overall Study||18
8552676|NCT03340766|9584637|FG000|STARTED|Overall Study||12
8552677|NCT03340766|9584638|FG001|STARTED|Overall Study||10
8552678|NCT03340766|9584639|FG002|STARTED|Overall Study||9
8552679|NCT03340766|9584637|FG000|Received Blinatumomab|Overall Study||12
8552680|NCT03340766|9584638|FG001|Received Blinatumomab|Overall Study||10
8552681|NCT03340766|9584639|FG002|Received Blinatumomab|Overall Study||9
8552682|NCT03340766|9584637|FG000|Received Pembrolizumab|Overall Study||10
8552683|NCT03340766|9584638|FG001|Received Pembrolizumab|Overall Study||7
8552684|NCT03340766|9584639|FG002|Received Pembrolizumab|Overall Study||7
8552685|NCT03340766|9584637|FG000|COMPLETED|Overall Study||1
8552686|NCT03340766|9584638|FG001|COMPLETED|Overall Study||0
8552687|NCT03340766|9584639|FG002|COMPLETED|Overall Study||0
8552688|NCT03340766|9584637|FG000|NOT COMPLETED|Overall Study||11
8552689|NCT03340766|9584638|FG001|NOT COMPLETED|Overall Study||10
8552690|NCT03340766|9584639|FG002|NOT COMPLETED|Overall Study||9
8552691|NCT03043599|9584653|FG000|STARTED|Overall Study||21
8552692|NCT03043599|9584653|FG000|COMPLETED|Overall Study||21
8552693|NCT03043599|9584653|FG000|NOT COMPLETED|Overall Study||0
8552694|NCT02968381|9584659|FG000|STARTED|Overall Study||61
8552695|NCT02968381|9584660|FG001|STARTED|Overall Study||60
8552696|NCT02968381|9584659|FG000|COMPLETED|Overall Study||56
8552697|NCT02968381|9584660|FG001|COMPLETED|Overall Study||50
8552698|NCT02968381|9584659|FG000|NOT COMPLETED|Overall Study||5
8552699|NCT02968381|9584660|FG001|NOT COMPLETED|Overall Study||10
8552700|NCT02720185|9584666|FG000|STARTED|Overall Study||5
8552701|NCT02720185|9584666|FG000|COMPLETED|Overall Study||5
8552702|NCT02720185|9584666|FG000|NOT COMPLETED|Overall Study||0
8552703|NCT02706847|9584673|FG000|STARTED|Day 1 to Week 12||85
8552704|NCT02706847|9584674|FG001|STARTED|Day 1 to Week 12||84
8552705|NCT02706847|9584675|FG002|STARTED|Day 1 to Week 12||165
8552706|NCT02706847|9584676|FG003|STARTED|Day 1 to Week 12||165
8552707|NCT02706847|9584673|FG000|Received Study Treatment|Day 1 to Week 12||85
8552708|NCT02706847|9584674|FG001|Received Study Treatment|Day 1 to Week 12||84
8552709|NCT02706847|9584675|FG002|Received Study Treatment|Day 1 to Week 12||164
8552710|NCT02706847|9584676|FG003|Received Study Treatment|Day 1 to Week 12||165
8552711|NCT02706847|9584673|FG000|COMPLETED|Day 1 to Week 12||75
8552712|NCT02706847|9584674|FG001|COMPLETED|Day 1 to Week 12||76
8552713|NCT02706847|9584675|FG002|COMPLETED|Day 1 to Week 12||157
8552714|NCT02706847|9584676|FG003|COMPLETED|Day 1 to Week 12||149
8552715|NCT02706847|9584673|FG000|NOT COMPLETED|Day 1 to Week 12||10
8552716|NCT02706847|9584674|FG001|NOT COMPLETED|Day 1 to Week 12||8
8552717|NCT02706847|9584675|FG002|NOT COMPLETED|Day 1 to Week 12||8
8552718|NCT02706847|9584676|FG003|NOT COMPLETED|Day 1 to Week 12||16
8552719|NCT02706847|9584673|FG000|STARTED|Week 12 to Week 24||75
8552720|NCT02706847|9584674|FG001|STARTED|Week 12 to Week 24||76
8552721|NCT02706847|9584675|FG002|STARTED|Week 12 to Week 24||157
8552722|NCT02706847|9584676|FG003|STARTED|Week 12 to Week 24||149
8552723|NCT02706847|9584673|FG000|Received Study Treatment|Week 12 to Week 24||72
8552724|NCT02706847|9584674|FG001|Received Study Treatment|Week 12 to Week 24||75
8552725|NCT02706847|9584675|FG002|Received Study Treatment|Week 12 to Week 24||156
8552726|NCT02706847|9584676|FG003|Received Study Treatment|Week 12 to Week 24||148
8552727|NCT02706847|9584673|FG000|COMPLETED|Week 12 to Week 24||72
8552728|NCT02706847|9584674|FG001|COMPLETED|Week 12 to Week 24||74
8552729|NCT02706847|9584675|FG002|COMPLETED|Week 12 to Week 24||153
8552730|NCT02706847|9584676|FG003|COMPLETED|Week 12 to Week 24||135
8552731|NCT02706847|9584673|FG000|NOT COMPLETED|Week 12 to Week 24||3
8552732|NCT02706847|9584674|FG001|NOT COMPLETED|Week 12 to Week 24||2
8552733|NCT02706847|9584675|FG002|NOT COMPLETED|Week 12 to Week 24||4
8552734|NCT02706847|9584676|FG003|NOT COMPLETED|Week 12 to Week 24||14
8552735|NCT02701777|9584690|FG000|STARTED|Overall Study||17
8552736|NCT02701777|9584691|FG001|STARTED|Overall Study||16
8552737|NCT02701777|9584692|FG002|STARTED|Overall Study||16
8552738|NCT02701777|9584693|FG003|STARTED|Overall Study||13
8552739|NCT02701777|9584690|FG000|COMPLETED|Overall Study||13
8552740|NCT02701777|9584691|FG001|COMPLETED|Overall Study||13
8552741|NCT02701777|9584692|FG002|COMPLETED|Overall Study||12
8552742|NCT02701777|9584693|FG003|COMPLETED|Overall Study||11
8552743|NCT02701777|9584690|FG000|NOT COMPLETED|Overall Study||4
8552744|NCT02701777|9584691|FG001|NOT COMPLETED|Overall Study||3
8552745|NCT02701777|9584692|FG002|NOT COMPLETED|Overall Study||4
8552746|NCT02701777|9584693|FG003|NOT COMPLETED|Overall Study||2
8552747|NCT02564900|9584722|FG000|STARTED|Dose Escalation||3
8552748|NCT02564900|9584723|FG001|STARTED|Dose Escalation||3
8552749|NCT02564900|9584724|FG002|STARTED|Dose Escalation||3
8552750|NCT02564900|9584725|FG003|STARTED|Dose Escalation||6
8552751|NCT02564900|9584726|FG004|STARTED|Dose Escalation||6
8552752|NCT02564900|9584727|FG005|STARTED|Dose Escalation||6
8552753|NCT02564900|9584728|FG006|STARTED|Dose Escalation||0
8552754|NCT02564900|9584729|FG007|STARTED|Dose Escalation||0
8552755|NCT02564900|9584730|FG008|STARTED|Dose Escalation||0
8552756|NCT02564900|9584731|FG009|STARTED|Dose Escalation||0
8552757|NCT02564900|9584732|FG010|STARTED|Dose Escalation||0
8552758|NCT02564900|9584733|FG011|STARTED|Dose Escalation||0
8552759|NCT02564900|9584734|FG012|STARTED|Dose Escalation||0
8552760|NCT02564900|9584735|FG013|STARTED|Dose Escalation||0
8552761|NCT02564900|9584736|FG014|STARTED|Dose Escalation||0
8552762|NCT02564900|9584722|FG000|COMPLETED|Dose Escalation||0
8552763|NCT02564900|9584723|FG001|COMPLETED|Dose Escalation||0
8552764|NCT02564900|9584724|FG002|COMPLETED|Dose Escalation||0
8552765|NCT02564900|9584725|FG003|COMPLETED|Dose Escalation||0
8552766|NCT02564900|9584726|FG004|COMPLETED|Dose Escalation||0
8552767|NCT02564900|9584727|FG005|COMPLETED|Dose Escalation||0
8552768|NCT02564900|9584728|FG006|COMPLETED|Dose Escalation||0
8552769|NCT02564900|9584729|FG007|COMPLETED|Dose Escalation||0
8552770|NCT02564900|9584730|FG008|COMPLETED|Dose Escalation||0
8552771|NCT02564900|9584731|FG009|COMPLETED|Dose Escalation||0
8552772|NCT02564900|9584732|FG010|COMPLETED|Dose Escalation||0
8552773|NCT02564900|9584733|FG011|COMPLETED|Dose Escalation||0
8552774|NCT02564900|9584734|FG012|COMPLETED|Dose Escalation||0
8552775|NCT02564900|9584735|FG013|COMPLETED|Dose Escalation||0
8552776|NCT02564900|9584736|FG014|COMPLETED|Dose Escalation||0
8552777|NCT02564900|9584722|FG000|NOT COMPLETED|Dose Escalation||3
8552778|NCT02564900|9584723|FG001|NOT COMPLETED|Dose Escalation||3
8552779|NCT02564900|9584724|FG002|NOT COMPLETED|Dose Escalation||3
8552780|NCT02564900|9584725|FG003|NOT COMPLETED|Dose Escalation||6
8552781|NCT02564900|9584726|FG004|NOT COMPLETED|Dose Escalation||6
8552782|NCT02564900|9584727|FG005|NOT COMPLETED|Dose Escalation||6
8552783|NCT02564900|9584728|FG006|NOT COMPLETED|Dose Escalation||0
8552784|NCT02564900|9584729|FG007|NOT COMPLETED|Dose Escalation||0
8552785|NCT02564900|9584730|FG008|NOT COMPLETED|Dose Escalation||0
8552786|NCT02564900|9584731|FG009|NOT COMPLETED|Dose Escalation||0
8552787|NCT02564900|9584732|FG010|NOT COMPLETED|Dose Escalation||0
8552788|NCT02564900|9584733|FG011|NOT COMPLETED|Dose Escalation||0
8552789|NCT02564900|9584734|FG012|NOT COMPLETED|Dose Escalation||0
8552790|NCT02564900|9584735|FG013|NOT COMPLETED|Dose Escalation||0
8552791|NCT02564900|9584736|FG014|NOT COMPLETED|Dose Escalation||0
8552792|NCT02564900|9584722|FG000|STARTED|Dose Expansion||0
8552793|NCT02564900|9584723|FG001|STARTED|Dose Expansion||0
8552794|NCT02564900|9584724|FG002|STARTED|Dose Expansion||0
8552795|NCT02564900|9584725|FG003|STARTED|Dose Expansion||0
8552796|NCT02564900|9584726|FG004|STARTED|Dose Expansion||0
8552797|NCT02564900|9584727|FG005|STARTED|Dose Expansion||0
8552798|NCT02564900|9584728|FG006|STARTED|Dose Expansion||49
8552799|NCT02564900|9584729|FG007|STARTED|Dose Expansion||62
8552800|NCT02564900|9584730|FG008|STARTED|Dose Expansion||20
8552801|NCT02564900|9584731|FG009|STARTED|Dose Expansion||33
8552802|NCT02564900|9584732|FG010|STARTED|Dose Expansion||17
8552803|NCT02564900|9584733|FG011|STARTED|Dose Expansion||24
8552804|NCT02564900|9584734|FG012|STARTED|Dose Expansion||18
8552805|NCT02564900|9584735|FG013|STARTED|Dose Expansion||20
8552806|NCT02564900|9584736|FG014|STARTED|Dose Expansion||22
8552807|NCT02564900|9584722|FG000|Enrolled, But Not Dosed|Dose Expansion||0
8552808|NCT02564900|9584723|FG001|Enrolled, But Not Dosed|Dose Expansion||0
8552809|NCT02564900|9584724|FG002|Enrolled, But Not Dosed|Dose Expansion||0
8552810|NCT02564900|9584725|FG003|Enrolled, But Not Dosed|Dose Expansion||0
8552811|NCT02564900|9584726|FG004|Enrolled, But Not Dosed|Dose Expansion||0
8552812|NCT02564900|9584727|FG005|Enrolled, But Not Dosed|Dose Expansion||0
8552813|NCT02564900|9584728|FG006|Enrolled, But Not Dosed|Dose Expansion||1
8552814|NCT02564900|9584729|FG007|Enrolled, But Not Dosed|Dose Expansion||1
8552815|NCT02564900|9584730|FG008|Enrolled, But Not Dosed|Dose Expansion||0
8552816|NCT02564900|9584731|FG009|Enrolled, But Not Dosed|Dose Expansion||0
8552817|NCT02564900|9584732|FG010|Enrolled, But Not Dosed|Dose Expansion||0
8552818|NCT02564900|9584733|FG011|Enrolled, But Not Dosed|Dose Expansion||0
8552819|NCT02564900|9584734|FG012|Enrolled, But Not Dosed|Dose Expansion||0
8552820|NCT02564900|9584735|FG013|Enrolled, But Not Dosed|Dose Expansion||0
8552821|NCT02564900|9584736|FG014|Enrolled, But Not Dosed|Dose Expansion||1
8552822|NCT02564900|9584722|FG000|COMPLETED|Dose Expansion||0
8552823|NCT02564900|9584723|FG001|COMPLETED|Dose Expansion||0
8552824|NCT02564900|9584724|FG002|COMPLETED|Dose Expansion||0
8552825|NCT02564900|9584725|FG003|COMPLETED|Dose Expansion||0
8552826|NCT02564900|9584726|FG004|COMPLETED|Dose Expansion||0
8552827|NCT02564900|9584727|FG005|COMPLETED|Dose Expansion||0
8552828|NCT02564900|9584728|FG006|COMPLETED|Dose Expansion||0
8552829|NCT02564900|9584729|FG007|COMPLETED|Dose Expansion||0
8552830|NCT02564900|9584730|FG008|COMPLETED|Dose Expansion||0
8552831|NCT02564900|9584731|FG009|COMPLETED|Dose Expansion||0
8552832|NCT02564900|9584732|FG010|COMPLETED|Dose Expansion||0
8552833|NCT02564900|9584733|FG011|COMPLETED|Dose Expansion||0
8552834|NCT02564900|9584734|FG012|COMPLETED|Dose Expansion||0
8552835|NCT02564900|9584735|FG013|COMPLETED|Dose Expansion||0
8552836|NCT02564900|9584736|FG014|COMPLETED|Dose Expansion||0
8552837|NCT02564900|9584722|FG000|NOT COMPLETED|Dose Expansion||0
8552838|NCT02564900|9584723|FG001|NOT COMPLETED|Dose Expansion||0
8552839|NCT02564900|9584724|FG002|NOT COMPLETED|Dose Expansion||0
8552840|NCT02564900|9584725|FG003|NOT COMPLETED|Dose Expansion||0
8552841|NCT02564900|9584726|FG004|NOT COMPLETED|Dose Expansion||0
8552842|NCT02564900|9584727|FG005|NOT COMPLETED|Dose Expansion||0
8552843|NCT02564900|9584728|FG006|NOT COMPLETED|Dose Expansion||49
8552844|NCT02564900|9584729|FG007|NOT COMPLETED|Dose Expansion||62
8552845|NCT02564900|9584730|FG008|NOT COMPLETED|Dose Expansion||20
8552846|NCT02564900|9584731|FG009|NOT COMPLETED|Dose Expansion||33
8552847|NCT02564900|9584732|FG010|NOT COMPLETED|Dose Expansion||17
8552848|NCT02564900|9584733|FG011|NOT COMPLETED|Dose Expansion||24
8552849|NCT02564900|9584734|FG012|NOT COMPLETED|Dose Expansion||18
8552850|NCT02564900|9584735|FG013|NOT COMPLETED|Dose Expansion||20
8552851|NCT02564900|9584736|FG014|NOT COMPLETED|Dose Expansion||22
8552852|NCT02561299|9584779|FG000|STARTED|Overall Study||32
8552853|NCT02561299|9584780|FG001|STARTED|Overall Study||34
8552854|NCT02561299|9584779|FG000|COMPLETED|Overall Study||27
8552855|NCT02561299|9584780|FG001|COMPLETED|Overall Study||28
8552856|NCT02561299|9584779|FG000|NOT COMPLETED|Overall Study||5
8552857|NCT02561299|9584780|FG001|NOT COMPLETED|Overall Study||6
8552858|NCT02548143|9584788|FG000|STARTED|Overall Study||6
8552859|NCT02548143|9584789|FG001|STARTED|Overall Study||6
8552860|NCT02548143|9584788|FG000|COMPLETED|Overall Study||5
8552861|NCT02548143|9584789|FG001|COMPLETED|Overall Study||5
8552862|NCT02548143|9584788|FG000|NOT COMPLETED|Overall Study||1
8552863|NCT02548143|9584789|FG001|NOT COMPLETED|Overall Study||1
8552864|NCT02448680|9584797|FG000|STARTED|Overall Study||12
8552865|NCT02448680|9584798|FG001|STARTED|Overall Study||13
8552866|NCT02448680|9584797|FG000|COMPLETED|Overall Study||11
8552867|NCT02448680|9584798|FG001|COMPLETED|Overall Study||10
8552868|NCT02448680|9584797|FG000|NOT COMPLETED|Overall Study||1
8552869|NCT02448680|9584798|FG001|NOT COMPLETED|Overall Study||3
8552870|NCT02393859|9584808|FG000|STARTED|Overall Study||54
8552871|NCT02393859|9584809|FG001|STARTED|Overall Study||54
8552872|NCT02393859|9584808|FG000|COMPLETED|Overall Study||0
8552873|NCT02393859|9584809|FG001|COMPLETED|Overall Study||0
8552874|NCT02393859|9584808|FG000|NOT COMPLETED|Overall Study||54
8552875|NCT02393859|9584809|FG001|NOT COMPLETED|Overall Study||54
8552876|NCT02352103|9584818|FG000|STARTED|Overall Study||60
8552877|NCT02352103|9584819|FG001|STARTED|Overall Study||60
8552878|NCT02352103|9584818|FG000|COMPLETED|Overall Study||60
8552879|NCT02352103|9584819|FG001|COMPLETED|Overall Study||59
8552880|NCT02352103|9584818|FG000|NOT COMPLETED|Overall Study||0
8552881|NCT02352103|9584819|FG001|NOT COMPLETED|Overall Study||1
8552882|NCT02273362|9584828|FG000|STARTED|Overall Study||5
8552883|NCT02273362|9584829|FG001|STARTED|Overall Study||6
8552884|NCT02273362|9584830|FG002|STARTED|Overall Study||14
8552885|NCT02273362|9584828|FG000|COMPLETED|Overall Study||5
8552886|NCT02273362|9584829|FG001|COMPLETED|Overall Study||6
8552887|NCT02273362|9584830|FG002|COMPLETED|Overall Study||14
8552888|NCT02273362|9584828|FG000|NOT COMPLETED|Overall Study||0
8552889|NCT02273362|9584829|FG001|NOT COMPLETED|Overall Study||0
8552890|NCT02273362|9584830|FG002|NOT COMPLETED|Overall Study||0
8552891|NCT02178358|9584841|FG000|STARTED|Overall Study||20
8552892|NCT02178358|9584842|FG001|STARTED|Overall Study||74
8552893|NCT02178358|9584843|FG002|STARTED|Overall Study||38
8552894|NCT02178358|9584841|FG000|Received at Least 1 Dose of Study Drug|Overall Study||20
8552895|NCT02178358|9584842|FG001|Received at Least 1 Dose of Study Drug|Overall Study||74
8552896|NCT02178358|9584843|FG002|Received at Least 1 Dose of Study Drug|Overall Study||38
8552897|NCT02178358|9584841|FG000|COMPLETED|Overall Study||19
8552898|NCT02178358|9584842|FG001|COMPLETED|Overall Study||72
8552899|NCT02178358|9584843|FG002|COMPLETED|Overall Study||36
8552900|NCT02178358|9584841|FG000|NOT COMPLETED|Overall Study||1
8552901|NCT02178358|9584842|FG001|NOT COMPLETED|Overall Study||2
8552902|NCT02178358|9584843|FG002|NOT COMPLETED|Overall Study||2
8552903|NCT02073279|9584854|FG000|STARTED|Double-blind Period||32
8552904|NCT02073279|9584855|FG001|STARTED|Double-blind Period||63
8552905|NCT02073279|9584854|FG000|COMPLETED|Double-blind Period||17
8552906|NCT02073279|9584855|FG001|COMPLETED|Double-blind Period||16
8552907|NCT02073279|9584854|FG000|NOT COMPLETED|Double-blind Period||15
8552908|NCT02073279|9584855|FG001|NOT COMPLETED|Double-blind Period||47
8552909|NCT02073279|9584854|FG000|STARTED|Open-label Extension Period||17
8552910|NCT02073279|9584855|FG001|STARTED|Open-label Extension Period||16
8552911|NCT02073279|9584854|FG000|COMPLETED|Open-label Extension Period||0
8552912|NCT02073279|9584855|FG001|COMPLETED|Open-label Extension Period||0
8552913|NCT02073279|9584854|FG000|NOT COMPLETED|Open-label Extension Period||17
8552914|NCT02073279|9584855|FG001|NOT COMPLETED|Open-label Extension Period||16
8552915|NCT01544127|9584867|FG000|STARTED|Overall Study||33
8552916|NCT01544127|9584868|FG001|STARTED|Overall Study||33
8552917|NCT01544127|9584869|FG002|STARTED|Overall Study||66
8552918|NCT01544127|9584867|FG000|COMPLETED|Overall Study||22
8552919|NCT01544127|9584868|FG001|COMPLETED|Overall Study||27
8552920|NCT01544127|9584869|FG002|COMPLETED|Overall Study||52
8552921|NCT01544127|9584867|FG000|NOT COMPLETED|Overall Study||11
8552922|NCT01544127|9584868|FG001|NOT COMPLETED|Overall Study||6
8552923|NCT01544127|9584869|FG002|NOT COMPLETED|Overall Study||14
8552924|NCT00806390|9584880|FG000|STARTED|Overall Study||7
8552925|NCT00806390|9584881|FG001|STARTED|Overall Study||8
8552926|NCT00806390|9584880|FG000|COMPLETED|Overall Study||7
8552927|NCT00806390|9584881|FG001|COMPLETED|Overall Study||8
8552928|NCT00806390|9584880|FG000|NOT COMPLETED|Overall Study||0
8552929|NCT00806390|9584881|FG001|NOT COMPLETED|Overall Study||0
8552930|NCT00566618|9584887|FG000|STARTED|Overall Study||1
8552931|NCT00566618|9584888|FG001|STARTED|Overall Study||6
8552932|NCT00566618|9584889|FG002|STARTED|Overall Study||18
8552933|NCT00566618|9584887|FG000|COMPLETED|Overall Study||0
8552934|NCT00566618|9584888|FG001|COMPLETED|Overall Study||0
8552935|NCT00566618|9584889|FG002|COMPLETED|Overall Study||0
8552936|NCT00566618|9584887|FG000|NOT COMPLETED|Overall Study||1
8552937|NCT00566618|9584888|FG001|NOT COMPLETED|Overall Study||6
8552938|NCT00566618|9584889|FG002|NOT COMPLETED|Overall Study||18
8552939|NCT00442559|9584896|FG000|STARTED|Overall Study||100
8552940|NCT00442559|9584897|FG001|STARTED|Overall Study||91
8552941|NCT00442559|9584896|FG000|12 Weeks After Randomization|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|68
8552942|NCT00442559|9584897|FG001|12 Weeks After Randomization|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|60
8552943|NCT00442559|9584896|FG000|COMPLETED|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|66
8552944|NCT00442559|9584897|FG001|COMPLETED|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|56
8552945|NCT00442559|9584896|FG000|NOT COMPLETED|Overall Study||34
8552946|NCT00442559|9584897|FG001|NOT COMPLETED|Overall Study||35
8552947|NCT00117338|9584911|FG000|STARTED|Overall Study||145
8552948|NCT00117338|9584912|FG001|STARTED|Overall Study||131
8552949|NCT00117338|9584911|FG000|COMPLETED|Overall Study||140
8552950|NCT00117338|9584912|FG001|COMPLETED|Overall Study||127
8552951|NCT00117338|9584911|FG000|NOT COMPLETED|Overall Study||5
8552952|NCT00117338|9584912|FG001|NOT COMPLETED|Overall Study||4
8568130|NCT00090220|9600493|FG000|NOT COMPLETED|Long-term Follow-up (EXT2)||0
8568131|NCT00090220|9600494|FG001|NOT COMPLETED|Long-term Follow-up (EXT2)||0
8568132|NCT00090220|9600495|FG002|NOT COMPLETED|Long-term Follow-up (EXT2)||0
8568133|NCT00090220|9600496|FG003|NOT COMPLETED|Long-term Follow-up (EXT2)||0
8568134|NCT00090220|9600497|FG004|NOT COMPLETED|Long-term Follow-up (EXT2)||44
8568135|NCT00090220|9600498|FG005|NOT COMPLETED|Long-term Follow-up (EXT2)||28
8568136|NCT00090233|9600517|FG000|STARTED|Overall Study|Evaluated by data safety monitoring board (DSMB) when they recommended stopping enrollment|34644
8819932|NCT01567826|9873911|FG000|STARTED|Overall Study||43
8819933|NCT01567826|9873912|FG001|STARTED|Overall Study||44
8819934|NCT01567826|9873911|FG000|COMPLETED|Overall Study||40
8819935|NCT01567826|9873912|FG001|COMPLETED|Overall Study||42
8819936|NCT01567826|9873911|FG000|NOT COMPLETED|Overall Study||3
8819937|NCT01567826|9873912|FG001|NOT COMPLETED|Overall Study||2
8819938|NCT01567839|9873920|FG000|STARTED|Overall Study||60
8819939|NCT01567839|9873920|FG000|COMPLETED|Overall Study||60
8819940|NCT01567839|9873920|FG000|NOT COMPLETED|Overall Study||0
8819941|NCT01567852|9873930|FG000|STARTED|Overall Study||8
8819942|NCT01567852|9873931|FG001|STARTED|Overall Study||12
8819943|NCT01567852|9873930|FG000|COMPLETED|Overall Study||4
8819944|NCT01567852|9873931|FG001|COMPLETED|Overall Study||5
8819945|NCT01567852|9873930|FG000|NOT COMPLETED|Overall Study||4
8819946|NCT01567852|9873931|FG001|NOT COMPLETED|Overall Study||7
8819947|NCT01567865|9873941|FG000|STARTED|Enrolled and Vaccinated (Day 0)||163
8819948|NCT01567865|9873942|FG001|STARTED|Enrolled and Vaccinated (Day 0)||220
8819949|NCT01567865|9873943|FG002|STARTED|Enrolled and Vaccinated (Day 0)||211
8819950|NCT01567865|9873944|FG003|STARTED|Enrolled and Vaccinated (Day 0)||224
8819951|NCT01567865|9873941|FG000|COMPLETED|Enrolled and Vaccinated (Day 0)||163
8819952|NCT01567865|9873942|FG001|COMPLETED|Enrolled and Vaccinated (Day 0)||220
8819953|NCT01567865|9873943|FG002|COMPLETED|Enrolled and Vaccinated (Day 0)||211
8819954|NCT01567865|9873944|FG003|COMPLETED|Enrolled and Vaccinated (Day 0)||224
8819955|NCT01567865|9873941|FG000|NOT COMPLETED|Enrolled and Vaccinated (Day 0)||0
8819956|NCT01567865|9873942|FG001|NOT COMPLETED|Enrolled and Vaccinated (Day 0)||0
8819957|NCT01567865|9873943|FG002|NOT COMPLETED|Enrolled and Vaccinated (Day 0)||0
8819958|NCT01567865|9873944|FG003|NOT COMPLETED|Enrolled and Vaccinated (Day 0)||0
8819959|NCT01567865|9873941|FG000|STARTED|Evaluated for Immunogenicity||163
8819960|NCT01567865|9873942|FG001|STARTED|Evaluated for Immunogenicity||220
8819961|NCT01567865|9873943|FG002|STARTED|Evaluated for Immunogenicity||211
8568137|NCT00090233|9600518|FG001|STARTED|Overall Study|Evaluated by data safety monitoring board when they recommended stopping enrollment|34630
8568138|NCT00090233|9600517|FG000|Vaccinated at Visit 1|Overall Study|Randomized Not vaccinated 609|34035
8568139|NCT00090233|9600518|FG001|Vaccinated at Visit 1|Overall Study|Randomized Not vaccinated 627|34003
8568140|NCT00090233|9600517|FG000|Vaccinated at Visit 2|Overall Study||31052
8568141|NCT00090233|9600518|FG001|Vaccinated at Visit 2|Overall Study||31066
8568142|NCT00090233|9600517|FG000|Vaccinated at Visit 3|Overall Study||29667
8568143|NCT00090233|9600518|FG001|Vaccinated at Visit 3|Overall Study||29598
8569351|NCT00096356|9601566|FG001|NOT COMPLETED|Overall Study||53
8552953|NCT04851314|9584920|FG000|STARTED|Overall Study||55
8552954|NCT04851314|9584921|FG001|STARTED|Overall Study||55
8552955|NCT04851314|9584920|FG000|COMPLETED|Overall Study||52
8552956|NCT04851314|9584921|FG001|COMPLETED|Overall Study||51
8552957|NCT04851314|9584920|FG000|NOT COMPLETED|Overall Study||3
8552958|NCT04851314|9584921|FG001|NOT COMPLETED|Overall Study||4
8552959|NCT04845633|9584931|FG000|STARTED|Overall Study||12
8552960|NCT04845633|9584932|FG001|STARTED|Overall Study||12
8552961|NCT04845633|9584933|FG002|STARTED|Overall Study||12
8552962|NCT04845633|9584934|FG003|STARTED|Overall Study||12
8552963|NCT04845633|9584931|FG000|COMPLETED|Overall Study||12
8552964|NCT04845633|9584932|FG001|COMPLETED|Overall Study||12
8552965|NCT04845633|9584933|FG002|COMPLETED|Overall Study||12
8552966|NCT04845633|9584934|FG003|COMPLETED|Overall Study||12
8552967|NCT04845633|9584931|FG000|NOT COMPLETED|Overall Study||0
8552968|NCT04845633|9584932|FG001|NOT COMPLETED|Overall Study||0
8552969|NCT04845633|9584933|FG002|NOT COMPLETED|Overall Study||0
8552970|NCT04845633|9584934|FG003|NOT COMPLETED|Overall Study||0
8552971|NCT04823494|9584948|FG000|STARTED|Overall Study||21
8552972|NCT04823494|9584949|FG001|STARTED|Overall Study||19
8552973|NCT04823494|9584948|FG000|COMPLETED|Overall Study||19
8552974|NCT04823494|9584949|FG001|COMPLETED|Overall Study||18
8552975|NCT04823494|9584948|FG000|NOT COMPLETED|Overall Study||2
8552976|NCT04823494|9584949|FG001|NOT COMPLETED|Overall Study||1
8552980|NCT04814459|9584965|FG000|STARTED|Overall Study||72
8552981|NCT04814459|9584966|FG001|STARTED|Overall Study||72
8552982|NCT04814459|9584965|FG000|COMPLETED|Overall Study||72
8552983|NCT04814459|9584966|FG001|COMPLETED|Overall Study||72
8552984|NCT04814459|9584965|FG000|NOT COMPLETED|Overall Study||0
8552985|NCT04814459|9584966|FG001|NOT COMPLETED|Overall Study||0
8552986|NCT04799782|9584972|FG000|STARTED|First Intervention||8
8552987|NCT04799782|9584973|FG001|STARTED|First Intervention||7
8552988|NCT04799782|9584972|FG000|COMPLETED|First Intervention||8
8552989|NCT04799782|9584973|FG001|COMPLETED|First Intervention||7
8552990|NCT04799782|9584972|FG000|NOT COMPLETED|First Intervention||0
8552991|NCT04799782|9584973|FG001|NOT COMPLETED|First Intervention||0
8552992|NCT04799782|9584972|FG000|STARTED|Washout||8
8552993|NCT04799782|9584973|FG001|STARTED|Washout||7
8552994|NCT04799782|9584972|FG000|COMPLETED|Washout||6
8552995|NCT04799782|9584973|FG001|COMPLETED|Washout||4
8552996|NCT04799782|9584972|FG000|NOT COMPLETED|Washout||2
8552997|NCT04799782|9584973|FG001|NOT COMPLETED|Washout||3
8552998|NCT04799782|9584972|FG000|STARTED|Second Intervention||6
8552999|NCT04799782|9584973|FG001|STARTED|Second Intervention||4
8553000|NCT04799782|9584972|FG000|COMPLETED|Second Intervention||6
8553001|NCT04799782|9584973|FG001|COMPLETED|Second Intervention||4
8553002|NCT04799782|9584972|FG000|NOT COMPLETED|Second Intervention||0
8553003|NCT04799782|9584973|FG001|NOT COMPLETED|Second Intervention||0
8553004|NCT04780919|9584981|FG000|STARTED|Overall Study||9
8553005|NCT04780919|9584982|FG001|STARTED|Overall Study||9
8553006|NCT04780919|9584981|FG000|COMPLETED|Overall Study||9
8553007|NCT04780919|9584982|FG001|COMPLETED|Overall Study||9
8553008|NCT04780919|9584981|FG000|NOT COMPLETED|Overall Study||0
8553009|NCT04780919|9584982|FG001|NOT COMPLETED|Overall Study||0
8553022|NCT04773028|9585001|FG000|STARTED|Overall Study||24
8553023|NCT04773028|9585002|FG001|STARTED|Overall Study||24
8553024|NCT04773028|9585001|FG000|COMPLETED|Overall Study||24
8553025|NCT04773028|9585002|FG001|COMPLETED|Overall Study||24
8553026|NCT04773028|9585001|FG000|NOT COMPLETED|Overall Study||0
8553027|NCT04773028|9585002|FG001|NOT COMPLETED|Overall Study||0
8553028|NCT04755595|9585008|FG000|STARTED|Overall Study||20
8553029|NCT04755595|9585008|FG000|COMPLETED|Overall Study||19
8553030|NCT04755595|9585008|FG000|NOT COMPLETED|Overall Study||1
8553031|NCT04749745|9585013|FG000|STARTED|Overall Study||5
8553032|NCT04749745|9585014|FG001|STARTED|Overall Study||6
8553033|NCT04749745|9585013|FG000|First Intervention|Overall Study||4
8553034|NCT04749745|9585014|FG001|First Intervention|Overall Study||6
8553035|NCT04749745|9585013|FG000|Washout|Overall Study||4
8553036|NCT04749745|9585014|FG001|Washout|Overall Study||6
8553037|NCT04749745|9585013|FG000|Second Intervention|Overall Study||4
8553038|NCT04749745|9585014|FG001|Second Intervention|Overall Study||6
8553039|NCT04749745|9585013|FG000|COMPLETED|Overall Study||4
8553040|NCT04749745|9585014|FG001|COMPLETED|Overall Study||6
8553041|NCT04749745|9585013|FG000|NOT COMPLETED|Overall Study||1
8553042|NCT04749745|9585014|FG001|NOT COMPLETED|Overall Study||0
8553043|NCT04748341|9585022|FG000|STARTED|Overall Study||31
8553044|NCT04748341|9585023|FG001|STARTED|Overall Study||31
8553045|NCT04748341|9585022|FG000|COMPLETED|Overall Study||30
8553046|NCT04748341|9585023|FG001|COMPLETED|Overall Study||30
8553047|NCT04748341|9585022|FG000|NOT COMPLETED|Overall Study||1
8553048|NCT04748341|9585023|FG001|NOT COMPLETED|Overall Study||1
8553049|NCT04737278|9585031|FG000|STARTED|Overall Study||28
8553050|NCT04737278|9585032|FG001|STARTED|Overall Study||28
8553051|NCT04737278|9585031|FG000|COMPLETED|Overall Study||24
8553052|NCT04737278|9585032|FG001|COMPLETED|Overall Study||25
8553053|NCT04737278|9585031|FG000|NOT COMPLETED|Overall Study||4
8553054|NCT04737278|9585032|FG001|NOT COMPLETED|Overall Study||3
8553055|NCT04736069|9585040|FG000|STARTED|Overall Study||30
8553056|NCT04736069|9585041|FG001|STARTED|Overall Study||30
8553057|NCT04736069|9585040|FG000|COMPLETED|Overall Study||30
8553058|NCT04736069|9585041|FG001|COMPLETED|Overall Study||22
8553059|NCT04736069|9585040|FG000|NOT COMPLETED|Overall Study||0
8553060|NCT04736069|9585041|FG001|NOT COMPLETED|Overall Study||8
8621787|NCT00483379|9660830|FG001|COMPLETED|Extension Period||2
8621788|NCT00483379|9660829|FG000|NOT COMPLETED|Extension Period||0
8621789|NCT00483379|9660830|FG001|NOT COMPLETED|Extension Period||0
8621790|NCT00483405|9660838|FG000|STARTED|Overall Study||28
8621791|NCT00483405|9660838|FG000|COMPLETED|Overall Study||0
8621792|NCT00483405|9660838|FG000|NOT COMPLETED|Overall Study||28
8621793|NCT00483496|9660842|FG000|STARTED|Overall Study||16
8621794|NCT00483496|9660842|FG000|COMPLETED|Overall Study||15
8621795|NCT00483496|9660842|FG000|NOT COMPLETED|Overall Study||1
8552977|NCT04821245|9584957|FG000|STARTED|Overall Study||36
8552978|NCT04821245|9584957|FG000|COMPLETED|Overall Study||27
8552979|NCT04821245|9584957|FG000|NOT COMPLETED|Overall Study||9
8553010|NCT04779606|9584992|FG000|STARTED|First Phase: Tolerability and Safety||16
8553011|NCT04779606|9584993|FG001|STARTED|First Phase: Tolerability and Safety||4
8553012|NCT04779606|9584992|FG000|COMPLETED|First Phase: Tolerability and Safety||16
8553013|NCT04779606|9584993|FG001|COMPLETED|First Phase: Tolerability and Safety||4
8553014|NCT04779606|9584992|FG000|NOT COMPLETED|First Phase: Tolerability and Safety||0
8553015|NCT04779606|9584993|FG001|NOT COMPLETED|First Phase: Tolerability and Safety||0
8819962|NCT01567865|9873944|FG003|STARTED|Evaluated for Immunogenicity||224
8819963|NCT01567865|9873941|FG000|COMPLETED|Evaluated for Immunogenicity||146
8819964|NCT01567865|9873942|FG001|COMPLETED|Evaluated for Immunogenicity||195
8819965|NCT01567865|9873943|FG002|COMPLETED|Evaluated for Immunogenicity||192
8819966|NCT01567865|9873944|FG003|COMPLETED|Evaluated for Immunogenicity||194
8819967|NCT01567865|9873941|FG000|NOT COMPLETED|Evaluated for Immunogenicity||17
8819968|NCT01567865|9873942|FG001|NOT COMPLETED|Evaluated for Immunogenicity||25
8553016|NCT04779606|9584992|FG000|STARTED|Second Phase: Efficacy||68
8553017|NCT04779606|9584993|FG001|STARTED|Second Phase: Efficacy||17
8553018|NCT04779606|9584992|FG000|COMPLETED|Second Phase: Efficacy||68
8553019|NCT04779606|9584993|FG001|COMPLETED|Second Phase: Efficacy||17
8553020|NCT04779606|9584992|FG000|NOT COMPLETED|Second Phase: Efficacy||0
8553021|NCT04779606|9584993|FG001|NOT COMPLETED|Second Phase: Efficacy||0
8553061|NCT04600375|9585055|FG000|STARTED|Overall Study||12
8553062|NCT04600375|9585056|FG001|STARTED|Overall Study||10
8553063|NCT04600375|9585055|FG000|COMPLETED|Overall Study||12
8553064|NCT04600375|9585056|FG001|COMPLETED|Overall Study||10
8553065|NCT04600375|9585055|FG000|NOT COMPLETED|Overall Study||0
8553066|NCT04600375|9585056|FG001|NOT COMPLETED|Overall Study||0
8568144|NCT00090233|9600517|FG000|COMPLETED|Overall Study|Does not include participants who discontinued prior to the 42 day safety follow-up|29645
8568145|NCT00090233|9600518|FG001|COMPLETED|Overall Study|Does not include participants who discontinued prior to the 42 day safety follow-up|29565
8568146|NCT00090233|9600517|FG000|NOT COMPLETED|Overall Study||4999
8568147|NCT00090233|9600518|FG001|NOT COMPLETED|Overall Study||5065
8568148|NCT00090285|9600530|FG000|STARTED|Base Study Vaccination Period||2032
8568149|NCT00090285|9600531|FG001|STARTED|Base Study Vaccination Period||2033
8568150|NCT00090285|9600532|FG002|STARTED|Base Study Vaccination Period||0
8568151|NCT00090285|9600533|FG003|STARTED|Base Study Vaccination Period||0
8568152|NCT00090285|9600534|FG004|STARTED|Base Study Vaccination Period||0
8568153|NCT00090285|9600535|FG005|STARTED|Base Study Vaccination Period||0
8568154|NCT00090285|9600530|FG000|Vaccinated|Base Study Vaccination Period||2025
8568155|NCT00090285|9600531|FG001|Vaccinated|Base Study Vaccination Period||2030
8568156|NCT00090285|9600532|FG002|Vaccinated|Base Study Vaccination Period||0
8568157|NCT00090285|9600533|FG003|Vaccinated|Base Study Vaccination Period||0
8568158|NCT00090285|9600534|FG004|Vaccinated|Base Study Vaccination Period||0
8568159|NCT00090285|9600535|FG005|Vaccinated|Base Study Vaccination Period||0
8568160|NCT00090285|9600530|FG000|COMPLETED|Base Study Vaccination Period||1818
8568161|NCT00090285|9600531|FG001|COMPLETED|Base Study Vaccination Period||1814
8568162|NCT00090285|9600532|FG002|COMPLETED|Base Study Vaccination Period||0
8568163|NCT00090285|9600533|FG003|COMPLETED|Base Study Vaccination Period||0
8568164|NCT00090285|9600534|FG004|COMPLETED|Base Study Vaccination Period||0
8568165|NCT00090285|9600535|FG005|COMPLETED|Base Study Vaccination Period||0
8568166|NCT00090285|9600530|FG000|NOT COMPLETED|Base Study Vaccination Period||214
8568167|NCT00090285|9600531|FG001|NOT COMPLETED|Base Study Vaccination Period||219
8568168|NCT00090285|9600532|FG002|NOT COMPLETED|Base Study Vaccination Period||0
8568169|NCT00090285|9600533|FG003|NOT COMPLETED|Base Study Vaccination Period||0
8568170|NCT00090285|9600534|FG004|NOT COMPLETED|Base Study Vaccination Period||0
8568171|NCT00090285|9600535|FG005|NOT COMPLETED|Base Study Vaccination Period||0
8568172|NCT00090285|9600530|FG000|STARTED|Base Study Follow-up Period|4 subjects who did not receive 3 doses of vaccine in base study continued into the Follow-up Period|1822
8568173|NCT00090285|9600531|FG001|STARTED|Base Study Follow-up Period|7 subjects who did not receive 3 doses of placebo in base study continued into the Follow-up Period|1821
8621796|NCT00483509|9660854|FG000|STARTED|Overall Study||28
8621797|NCT00483509|9660854|FG000|COMPLETED|Overall Study||28
8621798|NCT00483509|9660854|FG000|NOT COMPLETED|Overall Study||0
8568174|NCT00090285|9600532|FG002|STARTED|Base Study Follow-up Period||0
8568175|NCT00090285|9600533|FG003|STARTED|Base Study Follow-up Period||0
8568176|NCT00090285|9600534|FG004|STARTED|Base Study Follow-up Period||0
8568177|NCT00090285|9600535|FG005|STARTED|Base Study Follow-up Period||0
8568178|NCT00090285|9600530|FG000|COMPLETED|Base Study Follow-up Period||1487
8568179|NCT00090285|9600531|FG001|COMPLETED|Base Study Follow-up Period||1479
8568180|NCT00090285|9600532|FG002|COMPLETED|Base Study Follow-up Period||0
8621799|NCT00483548|9660860|FG000|STARTED|Overall Study||148
8819969|NCT01567865|9873943|FG002|NOT COMPLETED|Evaluated for Immunogenicity||19
8553067|NCT04524598|9585066|FG000|STARTED|Phase I - Feasibility||35
8553068|NCT04524598|9585067|FG001|STARTED|Phase I - Feasibility||25
8553069|NCT04524598|9585068|FG002|STARTED|Phase I - Feasibility||0
8553070|NCT04524598|9585069|FG003|STARTED|Phase I - Feasibility||0
8553071|NCT04524598|9585070|FG004|STARTED|Phase I - Feasibility||0
8553072|NCT04524598|9585066|FG000|COMPLETED|Phase I - Feasibility||31
8553073|NCT04524598|9585067|FG001|COMPLETED|Phase I - Feasibility||20
8553074|NCT04524598|9585068|FG002|COMPLETED|Phase I - Feasibility||0
8553075|NCT04524598|9585069|FG003|COMPLETED|Phase I - Feasibility||0
8553076|NCT04524598|9585070|FG004|COMPLETED|Phase I - Feasibility||0
8553077|NCT04524598|9585066|FG000|NOT COMPLETED|Phase I - Feasibility||4
8553078|NCT04524598|9585067|FG001|NOT COMPLETED|Phase I - Feasibility||5
8553079|NCT04524598|9585068|FG002|NOT COMPLETED|Phase I - Feasibility||0
8553080|NCT04524598|9585069|FG003|NOT COMPLETED|Phase I - Feasibility||0
8553081|NCT04524598|9585070|FG004|NOT COMPLETED|Phase I - Feasibility||0
8553082|NCT04524598|9585066|FG000|STARTED|Phase II - Outcomes||0
8553083|NCT04524598|9585067|FG001|STARTED|Phase II - Outcomes||0
8553084|NCT04524598|9585068|FG002|STARTED|Phase II - Outcomes||80
8553085|NCT04524598|9585069|FG003|STARTED|Phase II - Outcomes||80
8553086|NCT04524598|9585070|FG004|STARTED|Phase II - Outcomes||0
8553087|NCT04524598|9585066|FG000|Met PHQ-8 Threshold (Baseline >/= 10)|Phase II - Outcomes||0
8553088|NCT04524598|9585067|FG001|Met PHQ-8 Threshold (Baseline >/= 10)|Phase II - Outcomes||0
8553089|NCT04524598|9585068|FG002|Met PHQ-8 Threshold (Baseline >/= 10)|Phase II - Outcomes||63
8553090|NCT04524598|9585069|FG003|Met PHQ-8 Threshold (Baseline >/= 10)|Phase II - Outcomes||58
8553091|NCT04524598|9585070|FG004|Met PHQ-8 Threshold (Baseline >/= 10)|Phase II - Outcomes||0
8553092|NCT04524598|9585066|FG000|COMPLETED|Phase II - Outcomes||0
8553093|NCT04524598|9585067|FG001|COMPLETED|Phase II - Outcomes||0
8553094|NCT04524598|9585068|FG002|COMPLETED|Phase II - Outcomes||54
8553095|NCT04524598|9585069|FG003|COMPLETED|Phase II - Outcomes||67
8553096|NCT04524598|9585070|FG004|COMPLETED|Phase II - Outcomes||0
8553097|NCT04524598|9585066|FG000|NOT COMPLETED|Phase II - Outcomes||0
8553098|NCT04524598|9585067|FG001|NOT COMPLETED|Phase II - Outcomes||0
8553099|NCT04524598|9585068|FG002|NOT COMPLETED|Phase II - Outcomes||26
8553100|NCT04524598|9585069|FG003|NOT COMPLETED|Phase II - Outcomes||13
8553101|NCT04524598|9585070|FG004|NOT COMPLETED|Phase II - Outcomes||0
8553102|NCT04524598|9585066|FG000|STARTED|Phase II - Control Extension||0
8553103|NCT04524598|9585067|FG001|STARTED|Phase II - Control Extension||0
8553104|NCT04524598|9585068|FG002|STARTED|Phase II - Control Extension||0
8553105|NCT04524598|9585069|FG003|STARTED|Phase II - Control Extension||0
8553106|NCT04524598|9585070|FG004|STARTED|Phase II - Control Extension||66
8553107|NCT04524598|9585066|FG000|COMPLETED|Phase II - Control Extension||0
8553108|NCT04524598|9585067|FG001|COMPLETED|Phase II - Control Extension||0
8553109|NCT04524598|9585068|FG002|COMPLETED|Phase II - Control Extension||0
8553110|NCT04524598|9585069|FG003|COMPLETED|Phase II - Control Extension||0
8553111|NCT04524598|9585070|FG004|COMPLETED|Phase II - Control Extension||54
8553112|NCT04524598|9585066|FG000|NOT COMPLETED|Phase II - Control Extension||0
8553113|NCT04524598|9585067|FG001|NOT COMPLETED|Phase II - Control Extension||0
8553114|NCT04524598|9585068|FG002|NOT COMPLETED|Phase II - Control Extension||0
8553115|NCT04524598|9585069|FG003|NOT COMPLETED|Phase II - Control Extension||0
8553116|NCT04524598|9585070|FG004|NOT COMPLETED|Phase II - Control Extension||12
8553117|NCT04334460|9585086|FG000|STARTED|Full Enrollment||81
8553118|NCT04334460|9585087|FG001|STARTED|Full Enrollment||39
8553119|NCT04334460|9585086|FG000|COMPLETED|Full Enrollment||81
8553120|NCT04334460|9585087|FG001|COMPLETED|Full Enrollment||39
8553121|NCT04334460|9585086|FG000|NOT COMPLETED|Full Enrollment||0
8553122|NCT04334460|9585087|FG001|NOT COMPLETED|Full Enrollment||0
8553123|NCT04334460|9585086|FG000|STARTED|Full Analysis Set (FAS)||81
8553124|NCT04334460|9585087|FG001|STARTED|Full Analysis Set (FAS)||39
8553125|NCT04334460|9585086|FG000|COMPLETED|Full Analysis Set (FAS)||77
8553126|NCT04334460|9585087|FG001|COMPLETED|Full Analysis Set (FAS)||38
8553127|NCT04334460|9585086|FG000|NOT COMPLETED|Full Analysis Set (FAS)||4
8553128|NCT04334460|9585087|FG001|NOT COMPLETED|Full Analysis Set (FAS)||1
8553129|NCT04334460|9585086|FG000|STARTED|Safety Analysis Population||81
8553130|NCT04334460|9585087|FG001|STARTED|Safety Analysis Population||39
8553131|NCT04334460|9585086|FG000|COMPLETED|Safety Analysis Population||77
8553132|NCT04334460|9585087|FG001|COMPLETED|Safety Analysis Population||38
8553133|NCT04334460|9585086|FG000|NOT COMPLETED|Safety Analysis Population||4
8553134|NCT04334460|9585087|FG001|NOT COMPLETED|Safety Analysis Population||1
8553135|NCT04247828|9585094|FG000|STARTED|Overall Study||30
8553136|NCT04247828|9585094|FG000|Started - Controls|Overall Study||19
8553137|NCT04247828|9585094|FG000|Started - Participants With SPI|Overall Study||11
8553138|NCT04247828|9585094|FG000|COMPLETED|Overall Study|16 controls and 5 participants with SPI completed the study|21
8553139|NCT04247828|9585094|FG000|NOT COMPLETED|Overall Study||9
8568181|NCT00090285|9600533|FG003|COMPLETED|Base Study Follow-up Period||0
8568182|NCT00090285|9600534|FG004|COMPLETED|Base Study Follow-up Period||0
8568183|NCT00090285|9600535|FG005|COMPLETED|Base Study Follow-up Period||0
8568184|NCT00090285|9600530|FG000|NOT COMPLETED|Base Study Follow-up Period||335
8568185|NCT00090285|9600531|FG001|NOT COMPLETED|Base Study Follow-up Period||342
8568186|NCT00090285|9600532|FG002|NOT COMPLETED|Base Study Follow-up Period||0
8568187|NCT00090285|9600533|FG003|NOT COMPLETED|Base Study Follow-up Period||0
8568188|NCT00090285|9600534|FG004|NOT COMPLETED|Base Study Follow-up Period||0
8568189|NCT00090285|9600535|FG005|NOT COMPLETED|Base Study Follow-up Period||0
8568190|NCT00090285|9600530|FG000|STARTED|Extension 1||0
8553140|NCT04084769|9585102|FG000|STARTED|Overall Study||191
8553141|NCT04084769|9585103|FG001|STARTED|Overall Study||190
8553142|NCT04084769|9585104|FG002|STARTED|Overall Study||95
8553143|NCT04084769|9585105|FG003|STARTED|Overall Study||94
8553144|NCT04084769|9585102|FG000|Safety Analysis Set (SAfAS)|Overall Study||186
8553145|NCT04084769|9585103|FG001|Safety Analysis Set (SAfAS)|Overall Study||184
8553146|NCT04084769|9585104|FG002|Safety Analysis Set (SAfAS)|Overall Study||93
8553147|NCT04084769|9585105|FG003|Safety Analysis Set (SAfAS)|Overall Study||92
8553148|NCT04084769|9585102|FG000|Full Analysis Set|Overall Study||191
8553149|NCT04084769|9585103|FG001|Full Analysis Set|Overall Study||190
8553150|NCT04084769|9585104|FG002|Full Analysis Set|Overall Study||95
8553151|NCT04084769|9585105|FG003|Full Analysis Set|Overall Study||94
8553152|NCT04084769|9585102|FG000|Per-Protocol Analysis Set 1 (PPAS1)|Overall Study||46
8553153|NCT04084769|9585103|FG001|Per-Protocol Analysis Set 1 (PPAS1)|Overall Study||45
8553154|NCT04084769|9585104|FG002|Per-Protocol Analysis Set 1 (PPAS1)|Overall Study||0
8553155|NCT04084769|9585105|FG003|Per-Protocol Analysis Set 1 (PPAS1)|Overall Study||0
8553156|NCT04084769|9585102|FG000|Per-Protocol Analysis Set 2 (PPAS2)|Overall Study||174
8553157|NCT04084769|9585103|FG001|Per-Protocol Analysis Set 2 (PPAS2)|Overall Study||176
8553158|NCT04084769|9585104|FG002|Per-Protocol Analysis Set 2 (PPAS2)|Overall Study||90
8553159|NCT04084769|9585105|FG003|Per-Protocol Analysis Set 2 (PPAS2)|Overall Study||89
8553160|NCT04084769|9585102|FG000|COMPLETED|Overall Study||187
8553161|NCT04084769|9585103|FG001|COMPLETED|Overall Study||186
8553162|NCT04084769|9585104|FG002|COMPLETED|Overall Study||95
8553163|NCT04084769|9585105|FG003|COMPLETED|Overall Study||92
8553164|NCT04084769|9585102|FG000|NOT COMPLETED|Overall Study||4
8553165|NCT04084769|9585103|FG001|NOT COMPLETED|Overall Study||4
8553166|NCT04084769|9585104|FG002|NOT COMPLETED|Overall Study||0
8553167|NCT04084769|9585105|FG003|NOT COMPLETED|Overall Study||2
8553168|NCT04024228|9585122|FG000|STARTED|Overall Study||774
8553169|NCT04024228|9585123|FG001|STARTED|Overall Study||765
8553170|NCT04024228|9585122|FG000|Vaccinated|Overall Study||772
8553171|NCT04024228|9585123|FG001|Vaccinated|Overall Study||761
8553172|NCT04024228|9585122|FG000|Full Analysis Set (FAS)|Overall Study|377 participants (60-64 years) and 392 participants (>=65 years).|769
8553173|NCT04024228|9585123|FG001|Full Analysis Set (FAS)|Overall Study|377 participants (60-64 years) and 381 participants (>=65 years).|758
8553174|NCT04024228|9585122|FG000|COMPLETED|Overall Study||770
8553175|NCT04024228|9585123|FG001|COMPLETED|Overall Study||759
8553176|NCT04024228|9585122|FG000|NOT COMPLETED|Overall Study||4
8553177|NCT04024228|9585123|FG001|NOT COMPLETED|Overall Study||6
8553178|NCT03996148|9585134|FG000|STARTED|Overall Study||7
8553179|NCT03996148|9585135|FG001|STARTED|Overall Study||7
8553180|NCT03996148|9585136|FG002|STARTED|Overall Study||7
8553181|NCT03996148|9585134|FG000|COMPLETED|Overall Study||7
8553182|NCT03996148|9585135|FG001|COMPLETED|Overall Study||6
8553183|NCT03996148|9585136|FG002|COMPLETED|Overall Study||7
8553184|NCT03996148|9585134|FG000|NOT COMPLETED|Overall Study||0
8553185|NCT03996148|9585135|FG001|NOT COMPLETED|Overall Study||1
8553186|NCT03996148|9585136|FG002|NOT COMPLETED|Overall Study||0
8553187|NCT03980938|9585146|FG000|STARTED|Treatment Period 1||7
8553188|NCT03980938|9585147|FG001|STARTED|Treatment Period 1||8
8553189|NCT03980938|9585146|FG000|COMPLETED|Treatment Period 1||6
8553190|NCT03980938|9585147|FG001|COMPLETED|Treatment Period 1||7
8553191|NCT03980938|9585146|FG000|NOT COMPLETED|Treatment Period 1||1
8553192|NCT03980938|9585147|FG001|NOT COMPLETED|Treatment Period 1||1
8553193|NCT03980938|9585146|FG000|STARTED|Treatment Period 2||3
8553194|NCT03980938|9585147|FG001|STARTED|Treatment Period 2||2
8553195|NCT03980938|9585146|FG000|COMPLETED|Treatment Period 2|One participant completed the study remotely. On-site visits were no longer permitted due to COVID-19 pandemic. Visits were conducted remotely for Weeks 8 and 10 of Treatment Period 2, and the follow-up visit.|1
8553196|NCT03980938|9585147|FG001|COMPLETED|Treatment Period 2||0
8553197|NCT03980938|9585146|FG000|NOT COMPLETED|Treatment Period 2||2
8553198|NCT03980938|9585147|FG001|NOT COMPLETED|Treatment Period 2||2
8553199|NCT03863353|9585155|FG000|STARTED|Overall Study||282
8553200|NCT03863353|9585156|FG001|STARTED|Overall Study||221
8553201|NCT03863353|9585155|FG000|COMPLETED|Overall Study||258
8553202|NCT03863353|9585156|FG001|COMPLETED|Overall Study||201
8553203|NCT03863353|9585155|FG000|NOT COMPLETED|Overall Study||24
8553204|NCT03863353|9585156|FG001|NOT COMPLETED|Overall Study||20
8553205|NCT03622593|9585165|FG000|STARTED|Overall Study||317
8553206|NCT03622593|9585166|FG001|STARTED|Overall Study||319
8553207|NCT03622593|9585167|FG002|STARTED|Overall Study||315
8553208|NCT03622593|9585165|FG000|Received at Least One Dose of Study Drug|Overall Study||317
8553209|NCT03622593|9585166|FG001|Received at Least One Dose of Study Drug|Overall Study||319
8553210|NCT03622593|9585167|FG002|Received at Least One Dose of Study Drug|Overall Study||314
8553211|NCT03622593|9585165|FG000|Completed up to Week 56|Overall Study||298
8553212|NCT03622593|9585166|FG001|Completed up to Week 56|Overall Study||312
8553213|NCT03622593|9585167|FG002|Completed up to Week 56|Overall Study||299
8553214|NCT03622593|9585165|FG000|COMPLETED|Overall Study||0
8553215|NCT03622593|9585166|FG001|COMPLETED|Overall Study||0
8553216|NCT03622593|9585167|FG002|COMPLETED|Overall Study||0
8553217|NCT03622593|9585165|FG000|NOT COMPLETED|Overall Study||317
8553218|NCT03622593|9585166|FG001|NOT COMPLETED|Overall Study||319
8553219|NCT03622593|9585167|FG002|NOT COMPLETED|Overall Study||315
8553220|NCT03622580|9585179|FG000|STARTED|Overall Study||315
8553221|NCT03622580|9585180|FG001|STARTED|Overall Study||313
8553222|NCT03622580|9585181|FG002|STARTED|Overall Study||312
8568191|NCT00090285|9600531|FG001|STARTED|Extension 1||0
8553223|NCT03622580|9585179|FG000|Received at Least One Dose of Study Drug|Overall Study||313
8553224|NCT03622580|9585180|FG001|Received at Least One Dose of Study Drug|Overall Study||313
8553225|NCT03622580|9585181|FG002|Received at Least One Dose of Study Drug|Overall Study||311
8553226|NCT03622580|9585179|FG000|Completed up to Week 56|Overall Study||291
8553227|NCT03622580|9585180|FG001|Completed up to Week 56|Overall Study||289
8553228|NCT03622580|9585181|FG002|Completed up to Week 56|Overall Study||292
8553229|NCT03622580|9585179|FG000|COMPLETED|Overall Study||0
8553230|NCT03622580|9585180|FG001|COMPLETED|Overall Study||0
8553231|NCT03622580|9585181|FG002|COMPLETED|Overall Study||0
8553232|NCT03622580|9585179|FG000|NOT COMPLETED|Overall Study||315
8553233|NCT03622580|9585180|FG001|NOT COMPLETED|Overall Study||313
8553234|NCT03622580|9585181|FG002|NOT COMPLETED|Overall Study||312
8553235|NCT03572634|9585192|FG000|STARTED|Overall Study||1
8553236|NCT03572634|9585193|FG001|STARTED|Overall Study||2
8553237|NCT03572634|9585192|FG000|COMPLETED|Overall Study||1
8553238|NCT03572634|9585193|FG001|COMPLETED|Overall Study||2
8553239|NCT03572634|9585192|FG000|NOT COMPLETED|Overall Study||0
8553240|NCT03572634|9585193|FG001|NOT COMPLETED|Overall Study||0
8553241|NCT03562156|9585202|FG000|STARTED|Overall Study||217
8553242|NCT03562156|9585203|FG001|STARTED|Overall Study||109
8553243|NCT03562156|9585202|FG000|COMPLETED|Overall Study||182
8553244|NCT03562156|9585203|FG001|COMPLETED|Overall Study||91
8553245|NCT03562156|9585202|FG000|NOT COMPLETED|Overall Study||35
8553246|NCT03562156|9585203|FG001|NOT COMPLETED|Overall Study||18
8553247|NCT03476135|9585211|FG000|STARTED|Overall Study||42
8553248|NCT03476135|9585212|FG001|STARTED|Overall Study||49
8553249|NCT03476135|9585211|FG000|COMPLETED|Overall Study||42
8553250|NCT03476135|9585212|FG001|COMPLETED|Overall Study||49
8553251|NCT03476135|9585211|FG000|NOT COMPLETED|Overall Study||0
8553252|NCT03476135|9585212|FG001|NOT COMPLETED|Overall Study||0
8553253|NCT03333928|9585221|FG000|STARTED|Initial Dosing Period (Period 1)||16
8553254|NCT03333928|9585222|FG001|STARTED|Initial Dosing Period (Period 1)||25
8553255|NCT03333928|9585223|FG002|STARTED|Initial Dosing Period (Period 1)||18
8553256|NCT03333928|9585221|FG000|COMPLETED|Initial Dosing Period (Period 1)||15
8553257|NCT03333928|9585222|FG001|COMPLETED|Initial Dosing Period (Period 1)||21
8553258|NCT03333928|9585223|FG002|COMPLETED|Initial Dosing Period (Period 1)||14
8553259|NCT03333928|9585221|FG000|NOT COMPLETED|Initial Dosing Period (Period 1)||1
8553260|NCT03333928|9585222|FG001|NOT COMPLETED|Initial Dosing Period (Period 1)||4
8553261|NCT03333928|9585223|FG002|NOT COMPLETED|Initial Dosing Period (Period 1)||4
8553262|NCT03333928|9585221|FG000|STARTED|Dose-controlled Extension (Period 2)||22
8553263|NCT03333928|9585222|FG001|STARTED|Dose-controlled Extension (Period 2)||29
8553264|NCT03333928|9585223|FG002|STARTED|Dose-controlled Extension (Period 2)||0
8553265|NCT03333928|9585221|FG000|COMPLETED|Dose-controlled Extension (Period 2)||19
8553266|NCT03333928|9585222|FG001|COMPLETED|Dose-controlled Extension (Period 2)||28
8553267|NCT03333928|9585223|FG002|COMPLETED|Dose-controlled Extension (Period 2)||0
8553268|NCT03333928|9585221|FG000|NOT COMPLETED|Dose-controlled Extension (Period 2)||3
8553269|NCT03333928|9585222|FG001|NOT COMPLETED|Dose-controlled Extension (Period 2)||1
8553270|NCT03333928|9585223|FG002|NOT COMPLETED|Dose-controlled Extension (Period 2)||0
8553271|NCT03333928|9585221|FG000|STARTED|Randomized Withdrawal (Period 3)||10
8553272|NCT03333928|9585222|FG001|STARTED|Randomized Withdrawal (Period 3)||14
8553273|NCT03333928|9585223|FG002|STARTED|Randomized Withdrawal (Period 3)||26
8553274|NCT03333928|9585221|FG000|COMPLETED|Randomized Withdrawal (Period 3)||8
8553275|NCT03333928|9585222|FG001|COMPLETED|Randomized Withdrawal (Period 3)||14
9065894|NCT04128293|10126435|FG001|NOT COMPLETED|Treatment Period 1 (1 Day)||0
9065895|NCT04128293|10126436|FG002|NOT COMPLETED|Treatment Period 1 (1 Day)||0
9065896|NCT04128293|10126437|FG003|NOT COMPLETED|Treatment Period 1 (1 Day)||0
9065897|NCT04128293|10126434|FG000|STARTED|Washout Period 1 (Up to 7 Days)||4
9065898|NCT04128293|10126435|FG001|STARTED|Washout Period 1 (Up to 7 Days)||4
9065899|NCT04128293|10126436|FG002|STARTED|Washout Period 1 (Up to 7 Days)||4
9065900|NCT04128293|10126437|FG003|STARTED|Washout Period 1 (Up to 7 Days)||4
9065901|NCT04128293|10126434|FG000|COMPLETED|Washout Period 1 (Up to 7 Days)||4
8553276|NCT03333928|9585223|FG002|COMPLETED|Randomized Withdrawal (Period 3)||25
8553277|NCT03333928|9585221|FG000|NOT COMPLETED|Randomized Withdrawal (Period 3)||2
8553278|NCT03333928|9585222|FG001|NOT COMPLETED|Randomized Withdrawal (Period 3)||0
8553279|NCT03333928|9585223|FG002|NOT COMPLETED|Randomized Withdrawal (Period 3)||1
8553280|NCT03298984|9585243|FG000|STARTED|Overall Study||3
8553281|NCT03298984|9585244|FG001|STARTED|Overall Study||3
8553282|NCT03298984|9585245|FG002|STARTED|Overall Study||3
8553283|NCT03298984|9585246|FG003|STARTED|Overall Study||23
8553284|NCT03298984|9585243|FG000|COMPLETED|Overall Study||2
8553285|NCT03298984|9585244|FG001|COMPLETED|Overall Study||2
8553286|NCT03298984|9585245|FG002|COMPLETED|Overall Study||1
8819970|NCT01567865|9873944|FG003|NOT COMPLETED|Evaluated for Immunogenicity||30
8819971|NCT01567891|9873955|FG000|STARTED|Overall Study||9
8819972|NCT01567891|9873955|FG000|Received T-cell|Overall Study||6
8819973|NCT01567891|9873955|FG000|COMPLETED|Overall Study||6
8553287|NCT03298984|9585246|FG003|COMPLETED|Overall Study||8
8553288|NCT03298984|9585243|FG000|NOT COMPLETED|Overall Study||1
8553289|NCT03298984|9585244|FG001|NOT COMPLETED|Overall Study||1
8553290|NCT03298984|9585245|FG002|NOT COMPLETED|Overall Study||2
8553291|NCT03298984|9585246|FG003|NOT COMPLETED|Overall Study||15
8568192|NCT00090285|9600532|FG002|STARTED|Extension 1|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|1098
8819974|NCT01567891|9873955|FG000|NOT COMPLETED|Overall Study||3
8553292|NCT03175198|9585257|FG000|STARTED|Overall Study||5565
8553293|NCT03175198|9585257|FG000|Safety Set 1|Overall Study||5436
8553294|NCT03175198|9585257|FG000|COMPLETED|Overall Study||3238
8553295|NCT03175198|9585257|FG000|NOT COMPLETED|Overall Study||2327
8553296|NCT03158727|9585263|FG000|STARTED|Overall Study||42
8553297|NCT03158727|9585264|FG001|STARTED|Overall Study||42
8553298|NCT03158727|9585263|FG000|Enrolled, Not Treated|Overall Study||1
8553299|NCT03158727|9585264|FG001|Enrolled, Not Treated|Overall Study||0
8553300|NCT03158727|9585263|FG000|COMPLETED|Overall Study||25
8553301|NCT03158727|9585264|FG001|COMPLETED|Overall Study||23
8553302|NCT03158727|9585263|FG000|NOT COMPLETED|Overall Study||17
8553303|NCT03158727|9585264|FG001|NOT COMPLETED|Overall Study||19
8553304|NCT03075826|9585270|FG000|STARTED|Overall Study||22
8553305|NCT03075826|9585270|FG000|COMPLETED|Overall Study||16
8553306|NCT03075826|9585270|FG000|NOT COMPLETED|Overall Study||6
8553307|NCT02993731|9585276|FG000|STARTED|Overall Study||565
8553308|NCT02993731|9585277|FG001|STARTED|Overall Study||569
8553309|NCT02993731|9585276|FG000|COMPLETED|Overall Study||464
8553310|NCT02993731|9585277|FG001|COMPLETED|Overall Study||464
8553311|NCT02993731|9585276|FG000|NOT COMPLETED|Overall Study||101
8553312|NCT02993731|9585277|FG001|NOT COMPLETED|Overall Study||105
8553313|NCT02831764|9585295|FG000|STARTED|Overall Study||360
8553314|NCT02831764|9585296|FG001|STARTED|Overall Study||359
8553315|NCT02831764|9585295|FG000|COMPLETED|Overall Study||0
8553316|NCT02831764|9585296|FG001|COMPLETED|Overall Study||0
8553317|NCT02831764|9585295|FG000|NOT COMPLETED|Overall Study||360
8553318|NCT02831764|9585296|FG001|NOT COMPLETED|Overall Study||359
8553319|NCT02826161|9585304|FG000|STARTED|Overall Study||1
8553320|NCT02826161|9585305|FG001|STARTED|Overall Study||3
8553321|NCT02826161|9585304|FG000|Discontinued Due to Treatment Related AE|Overall Study||1
8621800|NCT00483548|9660861|FG001|STARTED|Overall Study||150
8621801|NCT00483548|9660860|FG000|Received Study Treatment|Overall Study|1 subject randomized but lost to follow up; no treatment data.|147
8553322|NCT02826161|9585305|FG001|Discontinued Due to Treatment Related AE|Overall Study||0
8553323|NCT02826161|9585304|FG000|Discontinued Due to Death|Overall Study||0
8553324|NCT02826161|9585305|FG001|Discontinued Due to Death|Overall Study||1
8553325|NCT02826161|9585304|FG000|Discontinued Due to Patient Withdrawal|Overall Study||0
8553326|NCT02826161|9585305|FG001|Discontinued Due to Patient Withdrawal|Overall Study||1
8553327|NCT02826161|9585304|FG000|Discontinued Due to Withdrawal of ICF From Further FU|Overall Study||1
8553328|NCT02826161|9585305|FG001|Discontinued Due to Withdrawal of ICF From Further FU|Overall Study||1
8553329|NCT02826161|9585304|FG000|COMPLETED|Overall Study||1
8553330|NCT02826161|9585305|FG001|COMPLETED|Overall Study||3
8553331|NCT02826161|9585304|FG000|NOT COMPLETED|Overall Study||0
8553332|NCT02826161|9585305|FG001|NOT COMPLETED|Overall Study||0
8553333|NCT02586025|9585312|FG000|STARTED|Neoadjuvant Treatment||219
8553334|NCT02586025|9585313|FG001|STARTED|Neoadjuvant Treatment||110
8553335|NCT02586025|9585312|FG000|Received at Least One Dose of Study Drug|Neoadjuvant Treatment||218
8553336|NCT02586025|9585313|FG001|Received at Least One Dose of Study Drug|Neoadjuvant Treatment||110
8553337|NCT02586025|9585312|FG000|Completed Neoadjuvant Treatment|Neoadjuvant Treatment||214
8553338|NCT02586025|9585313|FG001|Completed Neoadjuvant Treatment|Neoadjuvant Treatment||108
8553339|NCT02586025|9585312|FG000|Underwent Surgery|Neoadjuvant Treatment||210
8553340|NCT02586025|9585313|FG001|Underwent Surgery|Neoadjuvant Treatment||105
8553341|NCT02586025|9585312|FG000|COMPLETED|Neoadjuvant Treatment||208
8553342|NCT02586025|9585313|FG001|COMPLETED|Neoadjuvant Treatment||103
8553343|NCT02586025|9585312|FG000|NOT COMPLETED|Neoadjuvant Treatment||11
8553344|NCT02586025|9585313|FG001|NOT COMPLETED|Neoadjuvant Treatment||7
8553345|NCT02586025|9585312|FG000|STARTED|Adjuvant Treatment||208
8553346|NCT02586025|9585313|FG001|STARTED|Adjuvant Treatment||103
8553347|NCT02586025|9585312|FG000|Started Adjuvant FEC Treatment|Adjuvant Treatment||208
8553348|NCT02586025|9585313|FG001|Started Adjuvant FEC Treatment|Adjuvant Treatment||103
8553349|NCT02586025|9585312|FG000|Started Adjuvant HER2 Treatment|Adjuvant Treatment||204
8553350|NCT02586025|9585313|FG001|Started Adjuvant HER2 Treatment|Adjuvant Treatment||99
8553351|NCT02586025|9585312|FG000|COMPLETED|Adjuvant Treatment||69
8553352|NCT02586025|9585313|FG001|COMPLETED|Adjuvant Treatment||34
8553353|NCT02586025|9585312|FG000|NOT COMPLETED|Adjuvant Treatment||139
8553354|NCT02586025|9585313|FG001|NOT COMPLETED|Adjuvant Treatment||69
8553355|NCT02586025|9585312|FG000|STARTED|Treatment-Free Follow-Up||59
8553356|NCT02586025|9585313|FG001|STARTED|Treatment-Free Follow-Up||38
8553357|NCT02586025|9585312|FG000|COMPLETED|Treatment-Free Follow-Up||3
8553358|NCT02586025|9585313|FG001|COMPLETED|Treatment-Free Follow-Up||3
8553359|NCT02586025|9585312|FG000|NOT COMPLETED|Treatment-Free Follow-Up||56
8553360|NCT02586025|9585313|FG001|NOT COMPLETED|Treatment-Free Follow-Up||35
8553361|NCT02520011|9585322|FG000|STARTED|Overall Study||11
8553362|NCT02520011|9585323|FG001|STARTED|Overall Study||79
8553363|NCT02520011|9585324|FG002|STARTED|Overall Study||14
8553364|NCT02520011|9585322|FG000|Stage 1|Overall Study||0
8553365|NCT02520011|9585323|FG001|Stage 1|Overall Study||32
8553366|NCT02520011|9585324|FG002|Stage 1|Overall Study||10
8553367|NCT02520011|9585322|FG000|Stage 2|Overall Study||11
8553368|NCT02520011|9585323|FG001|Stage 2|Overall Study||47
8553369|NCT02520011|9585324|FG002|Stage 2|Overall Study||4
8553370|NCT02520011|9585322|FG000|COMPLETED|Overall Study||6
8553371|NCT02520011|9585323|FG001|COMPLETED|Overall Study||33
8553372|NCT02520011|9585324|FG002|COMPLETED|Overall Study||5
8553373|NCT02520011|9585322|FG000|NOT COMPLETED|Overall Study||5
8629463|NCT00530439|9669213|FG000|STARTED|Overall Study||180
8553374|NCT02520011|9585323|FG001|NOT COMPLETED|Overall Study||46
8553375|NCT02520011|9585324|FG002|NOT COMPLETED|Overall Study||9
8553376|NCT02315534|9585339|FG000|STARTED|Overall Study||4
8553377|NCT02315534|9585340|FG001|STARTED|Overall Study||30
8553378|NCT02315534|9585339|FG000|Assessment of Dose-limiting Toxicity (DLT)|Overall Study||0
8553379|NCT02315534|9585340|FG001|Assessment of Dose-limiting Toxicity (DLT)|Overall Study||0
8553380|NCT02315534|9585339|FG000|Off Treatment Due to Radiologic Disease Progression (PD)|Overall Study||2
8553381|NCT02315534|9585340|FG001|Off Treatment Due to Radiologic Disease Progression (PD)|Overall Study||20
8553382|NCT02315534|9585339|FG000|Off Treatment Due to Clinically Unacceptable Toxicities|Overall Study||1
8553383|NCT02315534|9585340|FG001|Off Treatment Due to Clinically Unacceptable Toxicities|Overall Study||7
8553384|NCT02315534|9585339|FG000|Off Treatment Due to Patient Request|Overall Study||1
8553385|NCT02315534|9585340|FG001|Off Treatment Due to Patient Request|Overall Study||2
8553386|NCT02315534|9585339|FG000|Off Treatment Due to Clinical PD|Overall Study||0
8553387|NCT02315534|9585340|FG001|Off Treatment Due to Clinical PD|Overall Study||1
8553388|NCT02315534|9585339|FG000|COMPLETED|Overall Study||4
8553389|NCT02315534|9585340|FG001|COMPLETED|Overall Study||30
8553390|NCT02315534|9585339|FG000|NOT COMPLETED|Overall Study||0
8553391|NCT02315534|9585340|FG001|NOT COMPLETED|Overall Study||0
8553392|NCT02279719|9585361|FG000|STARTED|Overall Study||5
8553393|NCT02279719|9585362|FG001|STARTED|Overall Study||10
8553394|NCT02279719|9585363|FG002|STARTED|Overall Study||4
8553395|NCT02279719|9585364|FG003|STARTED|Overall Study||9
8553396|NCT02279719|9585365|FG004|STARTED|Overall Study||28
8553397|NCT02279719|9585366|FG005|STARTED|Overall Study||10
8553398|NCT02279719|9585367|FG006|STARTED|Overall Study||31
8553399|NCT02279719|9585361|FG000|COMPLETED|Overall Study||5
8553400|NCT02279719|9585362|FG001|COMPLETED|Overall Study||10
8553401|NCT02279719|9585363|FG002|COMPLETED|Overall Study||4
8553402|NCT02279719|9585364|FG003|COMPLETED|Overall Study||9
8553403|NCT02279719|9585365|FG004|COMPLETED|Overall Study||25
8819975|NCT01567943|9873970|FG000|STARTED|Overall Study||40
8819976|NCT01567943|9873971|FG001|STARTED|Overall Study||39
8819977|NCT01567943|9873972|FG002|STARTED|Overall Study||44
8819978|NCT01567943|9873970|FG000|COMPLETED|Overall Study||26
8819979|NCT01567943|9873971|FG001|COMPLETED|Overall Study||29
8819980|NCT01567943|9873972|FG002|COMPLETED|Overall Study||44
8819981|NCT01567943|9873970|FG000|NOT COMPLETED|Overall Study||14
8819982|NCT01567943|9873971|FG001|NOT COMPLETED|Overall Study||10
8553404|NCT02279719|9585366|FG005|COMPLETED|Overall Study||10
8553405|NCT02279719|9585367|FG006|COMPLETED|Overall Study||28
8553406|NCT02279719|9585361|FG000|NOT COMPLETED|Overall Study||0
8553407|NCT02279719|9585362|FG001|NOT COMPLETED|Overall Study||0
8553408|NCT02279719|9585363|FG002|NOT COMPLETED|Overall Study||0
8553409|NCT02279719|9585364|FG003|NOT COMPLETED|Overall Study||0
8553410|NCT02279719|9585365|FG004|NOT COMPLETED|Overall Study||3
8553411|NCT02279719|9585366|FG005|NOT COMPLETED|Overall Study||0
8553412|NCT02279719|9585367|FG006|NOT COMPLETED|Overall Study||3
8553413|NCT02178956|9585402|FG000|STARTED|Overall Study||357
8553414|NCT02178956|9585403|FG001|STARTED|Overall Study||357
8553415|NCT02178956|9585402|FG000|COMPLETED|Overall Study||286
8553416|NCT02178956|9585403|FG001|COMPLETED|Overall Study||279
8553417|NCT02178956|9585402|FG000|NOT COMPLETED|Overall Study||71
8553418|NCT02178956|9585403|FG001|NOT COMPLETED|Overall Study||78
8553419|NCT02167945|9585413|FG000|STARTED|Overall Study||615
8553420|NCT02167945|9585413|FG000|COMPLETED|Overall Study||366
8553421|NCT02167945|9585413|FG000|NOT COMPLETED|Overall Study||249
8553422|NCT02097420|9585425|FG000|STARTED|Overall Study||20
8553423|NCT02097420|9585425|FG000|COMPLETED|Overall Study||6
8553424|NCT02097420|9585425|FG000|NOT COMPLETED|Overall Study||14
8553425|NCT02024607|9585436|FG000|STARTED|Overall Study||115
8553426|NCT02024607|9585437|FG001|STARTED|Overall Study||41
8553427|NCT02024607|9585438|FG002|STARTED|Overall Study||87
8553428|NCT02024607|9585439|FG003|STARTED|Overall Study||156
8553429|NCT02024607|9585440|FG004|STARTED|Overall Study||40
8553430|NCT02024607|9585441|FG005|STARTED|Overall Study||54
8553431|NCT02024607|9585442|FG006|STARTED|Overall Study||2
8553432|NCT02024607|9585436|FG000|COMPLETED|Overall Study||115
8553433|NCT02024607|9585437|FG001|COMPLETED|Overall Study||41
8553434|NCT02024607|9585438|FG002|COMPLETED|Overall Study||87
8553435|NCT02024607|9585439|FG003|COMPLETED|Overall Study||156
8553436|NCT02024607|9585440|FG004|COMPLETED|Overall Study||40
8553437|NCT02024607|9585441|FG005|COMPLETED|Overall Study||54
8553438|NCT02024607|9585442|FG006|COMPLETED|Overall Study||2
8553439|NCT02024607|9585436|FG000|NOT COMPLETED|Overall Study||0
8553440|NCT02024607|9585437|FG001|NOT COMPLETED|Overall Study||0
8553441|NCT02024607|9585438|FG002|NOT COMPLETED|Overall Study||0
8553442|NCT02024607|9585439|FG003|NOT COMPLETED|Overall Study||0
8553443|NCT02024607|9585440|FG004|NOT COMPLETED|Overall Study||0
8553444|NCT02024607|9585441|FG005|NOT COMPLETED|Overall Study||0
8553445|NCT02024607|9585442|FG006|NOT COMPLETED|Overall Study||0
8568193|NCT00090285|9600533|FG003|STARTED|Extension 1|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|16
8568194|NCT00090285|9600534|FG004|STARTED|Extension 1||0
8568195|NCT00090285|9600535|FG005|STARTED|Extension 1||0
8568196|NCT00090285|9600530|FG000|COMPLETED|Extension 1||0
8568197|NCT00090285|9600531|FG001|COMPLETED|Extension 1||0
8568198|NCT00090285|9600532|FG002|COMPLETED|Extension 1||1041
8819983|NCT01567943|9873972|FG002|NOT COMPLETED|Overall Study||0
8819984|NCT01568008|9873978|FG000|STARTED|Overall Study||933
8819985|NCT01568008|9873978|FG000|COMPLETED|Overall Study||699
8553446|NCT01925131|9585482|FG000|STARTED|Overall Study||5
8553447|NCT01925131|9585483|FG001|STARTED|Overall Study||4
8819986|NCT01568008|9873978|FG000|NOT COMPLETED|Overall Study||234
8819987|NCT01568021|9873982|FG000|STARTED|Overall Study||99
8819988|NCT01568021|9873982|FG000|COMPLETED|Overall Study||83
8819989|NCT01568021|9873982|FG000|NOT COMPLETED|Overall Study||16
8819990|NCT01568034|9873986|FG000|STARTED|Overall Study||2
8553448|NCT01925131|9585484|FG002|STARTED|Overall Study||10
8553449|NCT01925131|9585485|FG003|STARTED|Overall Study||5
8553450|NCT01925131|9585486|FG004|STARTED|Overall Study||11
8553451|NCT01925131|9585487|FG005|STARTED|Overall Study||13
8553452|NCT01925131|9585482|FG000|COMPLETED|Overall Study||0
8553453|NCT01925131|9585483|FG001|COMPLETED|Overall Study||2
8553454|NCT01925131|9585484|FG002|COMPLETED|Overall Study||1
8553455|NCT01925131|9585485|FG003|COMPLETED|Overall Study||0
8553456|NCT01925131|9585486|FG004|COMPLETED|Overall Study||0
8553457|NCT01925131|9585487|FG005|COMPLETED|Overall Study||3
8553458|NCT01925131|9585482|FG000|NOT COMPLETED|Overall Study||5
8553459|NCT01925131|9585483|FG001|NOT COMPLETED|Overall Study||2
8553460|NCT01925131|9585484|FG002|NOT COMPLETED|Overall Study||9
8553461|NCT01925131|9585485|FG003|NOT COMPLETED|Overall Study||5
8553462|NCT01925131|9585486|FG004|NOT COMPLETED|Overall Study||11
8553463|NCT01925131|9585487|FG005|NOT COMPLETED|Overall Study||10
8553464|NCT01776307|9585506|FG000|STARTED|Overall Study||49
8553465|NCT01776307|9585507|FG001|STARTED|Overall Study||75
8553466|NCT01776307|9585508|FG002|STARTED|Overall Study||76
8553467|NCT01776307|9585506|FG000|COMPLETED|Overall Study||49
8553468|NCT01776307|9585507|FG001|COMPLETED|Overall Study||75
8553469|NCT01776307|9585508|FG002|COMPLETED|Overall Study||75
8553470|NCT01776307|9585506|FG000|NOT COMPLETED|Overall Study||0
8553471|NCT01776307|9585507|FG001|NOT COMPLETED|Overall Study||0
8553472|NCT01776307|9585508|FG002|NOT COMPLETED|Overall Study||1
8553473|NCT01623167|9585540|FG000|STARTED|Overall Study||30
8553474|NCT01623167|9585541|FG001|STARTED|Overall Study||31
8553475|NCT01623167|9585542|FG002|STARTED|Overall Study||31
8553476|NCT01623167|9585540|FG000|COMPLETED|Overall Study||13
8553477|NCT01623167|9585541|FG001|COMPLETED|Overall Study||17
8553478|NCT01623167|9585542|FG002|COMPLETED|Overall Study||18
8553479|NCT01623167|9585540|FG000|NOT COMPLETED|Overall Study||17
8553480|NCT01623167|9585541|FG001|NOT COMPLETED|Overall Study||14
8553481|NCT01623167|9585542|FG002|NOT COMPLETED|Overall Study||13
8553482|NCT01535274|9585552|FG000|STARTED|Overall Study||28
8553483|NCT01535274|9585553|FG001|STARTED|Overall Study|"29 participants were initially randomized to receive desflurane treatment. One participant initially randomized to the desflurane arm was misallocated to the propofol arm and received propofol treatment, as shown in the reason not completed section below."|29
8553484|NCT01535274|9585552|FG000|Received Propofol|Overall Study||28
8553485|NCT01535274|9585553|FG001|Received Propofol|Overall Study|"Of the 29 participants initially randomized to receive desflurane treatment, one was misallocated to the propofol arm and received propofol treatment, as shown in the reason not completed section below. That participant is included in the baseline characteristics, outcome measures, and adverse events with the propofol arm."|1
8553486|NCT01535274|9585552|FG000|Received Desflurane|Overall Study||0
8553487|NCT01535274|9585553|FG001|Received Desflurane|Overall Study||28
8553488|NCT01535274|9585552|FG000|COMPLETED|Overall Study||28
8553489|NCT01535274|9585553|FG001|COMPLETED|Overall Study||27
8553490|NCT01535274|9585552|FG000|NOT COMPLETED|Overall Study||0
8553491|NCT01535274|9585553|FG001|NOT COMPLETED|Overall Study||2
8553492|NCT00544830|9585561|FG000|STARTED|Overall Study||29
8553493|NCT00544830|9585561|FG000|COMPLETED|Overall Study||29
8553494|NCT00544830|9585561|FG000|NOT COMPLETED|Overall Study||0
8553495|NCT00539981|9585567|FG000|STARTED|Overall Study||2344
8553496|NCT00539981|9585568|FG001|STARTED|Overall Study||2304
8553497|NCT00539981|9585567|FG000|COMPLETED|Overall Study||2049
8553498|NCT00539981|9585568|FG001|COMPLETED|Overall Study||2022
8553499|NCT00539981|9585567|FG000|NOT COMPLETED|Overall Study||295
8553500|NCT00539981|9585568|FG001|NOT COMPLETED|Overall Study||282
8553501|NCT04732819|9585579|FG000|STARTED|Overall Study||12582
8553502|NCT04732819|9585580|FG001|STARTED|Overall Study||11186
8553503|NCT04732819|9585579|FG000|COMPLETED|Overall Study||12582
8553504|NCT04732819|9585580|FG001|COMPLETED|Overall Study||11186
8553505|NCT04732819|9585579|FG000|NOT COMPLETED|Overall Study||0
8553506|NCT04732819|9585580|FG001|NOT COMPLETED|Overall Study||0
8553507|NCT04732338|9585588|FG000|STARTED|Overall Study||13
8553508|NCT04732338|9585589|FG001|STARTED|Overall Study||13
8553509|NCT04732338|9585588|FG000|COMPLETED|Overall Study||10
8553510|NCT04732338|9585589|FG001|COMPLETED|Overall Study||10
8553511|NCT04732338|9585588|FG000|NOT COMPLETED|Overall Study||3
8553512|NCT04732338|9585589|FG001|NOT COMPLETED|Overall Study||3
8553543|NCT04716426|9585634|FG000|STARTED|Overall Study||50
8553544|NCT04716426|9585635|FG001|STARTED|Overall Study||50
8553545|NCT04716426|9585634|FG000|COMPLETED|Overall Study||48
8553546|NCT04716426|9585635|FG001|COMPLETED|Overall Study||49
8553547|NCT04716426|9585634|FG000|NOT COMPLETED|Overall Study||2
8553548|NCT04716426|9585635|FG001|NOT COMPLETED|Overall Study||1
8553549|NCT04709068|9585641|FG000|STARTED|Overall Study||8
8553550|NCT04709068|9585641|FG000|COMPLETED|Overall Study||8
8553551|NCT04709068|9585641|FG000|NOT COMPLETED|Overall Study||0
8553552|NCT04704713|9585647|FG000|STARTED|Overall Study||15
8553553|NCT04704713|9585648|FG001|STARTED|Overall Study||16
8553554|NCT04704713|9585647|FG000|COMPLETED|Overall Study||11
8553555|NCT04704713|9585648|FG001|COMPLETED|Overall Study||12
8819991|NCT01568034|9873987|FG001|STARTED|Overall Study||2
8553513|NCT04728802|9585597|FG000|STARTED|Overall Study||317
8553514|NCT04728802|9585598|FG001|STARTED|Overall Study||328
8553515|NCT04728802|9585597|FG000|COMPLETED|Overall Study||288
8553516|NCT04728802|9585598|FG001|COMPLETED|Overall Study||292
8553517|NCT04728802|9585597|FG000|NOT COMPLETED|Overall Study||29
8553518|NCT04728802|9585598|FG001|NOT COMPLETED|Overall Study||36
8553556|NCT04704713|9585647|FG000|NOT COMPLETED|Overall Study||4
8553557|NCT04704713|9585648|FG001|NOT COMPLETED|Overall Study||4
8568199|NCT00090285|9600533|FG003|COMPLETED|Extension 1||15
8568200|NCT00090285|9600534|FG004|COMPLETED|Extension 1||0
8568201|NCT00090285|9600535|FG005|COMPLETED|Extension 1||0
8568202|NCT00090285|9600530|FG000|NOT COMPLETED|Extension 1||0
8568203|NCT00090285|9600531|FG001|NOT COMPLETED|Extension 1||0
8568204|NCT00090285|9600532|FG002|NOT COMPLETED|Extension 1||57
8568205|NCT00090285|9600533|FG003|NOT COMPLETED|Extension 1||1
8568206|NCT00090285|9600534|FG004|NOT COMPLETED|Extension 1||0
8568207|NCT00090285|9600535|FG005|NOT COMPLETED|Extension 1||0
8568208|NCT00090285|9600530|FG000|STARTED|Long-term Follow-up (EXT2)||0
8568209|NCT00090285|9600531|FG001|STARTED|Long-term Follow-up (EXT2)||0
8568210|NCT00090285|9600532|FG002|STARTED|Long-term Follow-up (EXT2)||0
8568211|NCT00090285|9600533|FG003|STARTED|Long-term Follow-up (EXT2)||0
8568212|NCT00090285|9600534|FG004|STARTED|Long-term Follow-up (EXT2)|Not all eligible participants enrolled in LTFU (EXT2)|936
8568213|NCT00090285|9600535|FG005|STARTED|Long-term Follow-up (EXT2)|Not all eligible participants enrolled in LTFU (EXT2)|867
8568214|NCT00090285|9600530|FG000|COMPLETED|Long-term Follow-up (EXT2)||0
8568215|NCT00090285|9600531|FG001|COMPLETED|Long-term Follow-up (EXT2)||0
8568216|NCT00090285|9600532|FG002|COMPLETED|Long-term Follow-up (EXT2)||0
8568217|NCT00090285|9600533|FG003|COMPLETED|Long-term Follow-up (EXT2)||0
8568218|NCT00090285|9600534|FG004|COMPLETED|Long-term Follow-up (EXT2)||709
8568219|NCT00090285|9600535|FG005|COMPLETED|Long-term Follow-up (EXT2)||664
8568220|NCT00090285|9600530|FG000|NOT COMPLETED|Long-term Follow-up (EXT2)||0
8568221|NCT00090285|9600531|FG001|NOT COMPLETED|Long-term Follow-up (EXT2)||0
8568222|NCT00090285|9600532|FG002|NOT COMPLETED|Long-term Follow-up (EXT2)||0
8568223|NCT00090285|9600533|FG003|NOT COMPLETED|Long-term Follow-up (EXT2)||0
8568224|NCT00090285|9600534|FG004|NOT COMPLETED|Long-term Follow-up (EXT2)||227
8568225|NCT00090285|9600535|FG005|NOT COMPLETED|Long-term Follow-up (EXT2)||203
8568226|NCT00090363|9600553|FG000|STARTED|Overall Study||107
8568227|NCT00090363|9600554|FG001|STARTED|Overall Study||107
8568228|NCT00090363|9600555|FG002|STARTED|Overall Study||98
8568229|NCT00090363|9600553|FG000|Received Study Treatment.|Overall Study||107
8568230|NCT00090363|9600554|FG001|Received Study Treatment.|Overall Study||107
8568231|NCT00090363|9600555|FG002|Received Study Treatment.|Overall Study||98
8568232|NCT00090363|9600553|FG000|COMPLETED|Overall Study|Number of patients receiving study treatment at data cut-off (18th December 2008).|1
8568233|NCT00090363|9600554|FG001|COMPLETED|Overall Study|Number of patients receiving study treatment at data cut-off (18th December 2008).|0
8568234|NCT00090363|9600555|FG002|COMPLETED|Overall Study|Number of patients receiving study treatment at data cut-off (18th December 2008).|2
8568235|NCT00090363|9600553|FG000|NOT COMPLETED|Overall Study||106
8568236|NCT00090363|9600554|FG001|NOT COMPLETED|Overall Study||107
8568237|NCT00090363|9600555|FG002|NOT COMPLETED|Overall Study||96
8568238|NCT00090402|9600566|FG000|STARTED|Overall Study||13
8568239|NCT00090402|9600567|FG001|STARTED|Overall Study||13
8568240|NCT00090402|9600568|FG002|STARTED|Overall Study||13
8568241|NCT00090402|9600566|FG000|COMPLETED|Overall Study||11
8568242|NCT00090402|9600567|FG001|COMPLETED|Overall Study||11
8568243|NCT00090402|9600568|FG002|COMPLETED|Overall Study||12
8568244|NCT00090402|9600566|FG000|NOT COMPLETED|Overall Study||2
8568245|NCT00090402|9600567|FG001|NOT COMPLETED|Overall Study||2
8568246|NCT00090402|9600568|FG002|NOT COMPLETED|Overall Study||1
8568247|NCT00090493|9600579|FG000|STARTED|Overall Study||4
8568248|NCT00090493|9600579|FG000|COMPLETED|Overall Study||2
8568249|NCT00090493|9600579|FG000|NOT COMPLETED|Overall Study||2
8568250|NCT00090519|9600585|FG000|STARTED|Overall Study||371
8568251|NCT00090519|9600586|FG001|STARTED|Overall Study||360
8568252|NCT00090519|9600585|FG000|COMPLETED|Overall Study||298
8568253|NCT00090519|9600586|FG001|COMPLETED|Overall Study||285
8568254|NCT00090519|9600585|FG000|NOT COMPLETED|Overall Study||73
8568255|NCT00090519|9600586|FG001|NOT COMPLETED|Overall Study||75
8568256|NCT00090545|9600594|FG000|STARTED|Overall Study||22
8568257|NCT00090545|9600595|FG001|STARTED|Overall Study||24
8568258|NCT00090545|9600594|FG000|COMPLETED|Overall Study||0
8568259|NCT00090545|9600595|FG001|COMPLETED|Overall Study||0
8568260|NCT00090545|9600594|FG000|NOT COMPLETED|Overall Study||22
8568261|NCT00090545|9600595|FG001|NOT COMPLETED|Overall Study||24
8568262|NCT00090584|9600605|FG000|STARTED|Baseline to 10 Weeks||154
8568263|NCT00090584|9600606|FG001|STARTED|Baseline to 10 Weeks||153
8568264|NCT00090584|9600605|FG000|COMPLETED|Baseline to 10 Weeks||139
8568265|NCT00090584|9600606|FG001|COMPLETED|Baseline to 10 Weeks||141
8568266|NCT00090584|9600605|FG000|NOT COMPLETED|Baseline to 10 Weeks||15
8568267|NCT00090584|9600606|FG001|NOT COMPLETED|Baseline to 10 Weeks||12
8568268|NCT00090584|9600605|FG000|STARTED|Baseline to 8 Months||154
8568269|NCT00090584|9600606|FG001|STARTED|Baseline to 8 Months||153
8568270|NCT00090584|9600605|FG000|COMPLETED|Baseline to 8 Months||110
8568271|NCT00090584|9600606|FG001|COMPLETED|Baseline to 8 Months||112
8568272|NCT00090584|9600605|FG000|NOT COMPLETED|Baseline to 8 Months||44
8568273|NCT00090584|9600606|FG001|NOT COMPLETED|Baseline to 8 Months||41
8568274|NCT00090610|9600622|FG000|STARTED|Overall Study||75
8568275|NCT00090610|9600623|FG001|STARTED|Overall Study||75
8621802|NCT00483548|9660861|FG001|Received Study Treatment|Overall Study|3 subjects randomized but not treated.|147
8621803|NCT00483548|9660860|FG000|COMPLETED|Overall Study||88
8621804|NCT00483548|9660861|FG001|COMPLETED|Overall Study||104
8621805|NCT00483548|9660860|FG000|NOT COMPLETED|Overall Study||60
8621806|NCT00483548|9660861|FG001|NOT COMPLETED|Overall Study||46
8553519|NCT04728594|9585607|FG000|STARTED|Overall Study|The number of participants who were sent a follow up email (delayed, three days after the other two arms) was used to see how many started.|3178
8553520|NCT04728594|9585608|FG001|STARTED|Overall Study||3198
8553521|NCT04728594|9585609|FG002|STARTED|Overall Study||3190
8553522|NCT04728594|9585607|FG000|COMPLETED|Overall Study||3178
8553523|NCT04728594|9585608|FG001|COMPLETED|Overall Study||3198
8553524|NCT04728594|9585609|FG002|COMPLETED|Overall Study||3190
8553525|NCT04728594|9585607|FG000|NOT COMPLETED|Overall Study||0
8553526|NCT04728594|9585608|FG001|NOT COMPLETED|Overall Study||0
8553527|NCT04728594|9585609|FG002|NOT COMPLETED|Overall Study||0
8553558|NCT04698993|9585656|FG000|STARTED|Overall Study||275
8553559|NCT04698993|9585657|FG001|STARTED|Overall Study||113
8553560|NCT04698993|9585656|FG000|COMPLETED|Overall Study||272
8553561|NCT04698993|9585657|FG001|COMPLETED|Overall Study||106
8553562|NCT04698993|9585656|FG000|NOT COMPLETED|Overall Study||3
8553563|NCT04698993|9585657|FG001|NOT COMPLETED|Overall Study||7
8553564|NCT04697888|9585663|FG000|STARTED|Overall Study||2
8553565|NCT04697888|9585663|FG000|COMPLETED|Overall Study||2
8553566|NCT04697888|9585663|FG000|NOT COMPLETED|Overall Study||0
8553567|NCT04693078|9585667|FG000|STARTED|Overall Study||100
8553568|NCT04693078|9585667|FG000|COMPLETED|Overall Study||100
8553569|NCT04693078|9585667|FG000|NOT COMPLETED|Overall Study||0
8553570|NCT04688346|9585673|FG000|STARTED|Overall Study||6
8553571|NCT04688346|9585674|FG001|STARTED|Overall Study||7
8553572|NCT04688346|9585673|FG000|First Intervention|Overall Study||6
8553573|NCT04688346|9585674|FG001|First Intervention|Overall Study||7
8553574|NCT04688346|9585673|FG000|Second Intervention|Overall Study||6
8553575|NCT04688346|9585674|FG001|Second Intervention|Overall Study||7
8553576|NCT04688346|9585673|FG000|COMPLETED|Overall Study||6
8553577|NCT04688346|9585674|FG001|COMPLETED|Overall Study||7
8553578|NCT04688346|9585673|FG000|NOT COMPLETED|Overall Study||0
8553579|NCT04688346|9585674|FG001|NOT COMPLETED|Overall Study||0
8553583|NCT04674644|9585684|FG000|STARTED|Overall Study||850
8553584|NCT04674644|9585684|FG000|COMPLETED|Overall Study||813
8553585|NCT04674644|9585684|FG000|NOT COMPLETED|Overall Study||37
8553594|NCT04668989|9585702|FG000|STARTED|First Intervention||36
8553595|NCT04668989|9585703|FG001|STARTED|First Intervention||30
8553596|NCT04668989|9585702|FG000|COMPLETED|First Intervention||36
8553597|NCT04668989|9585703|FG001|COMPLETED|First Intervention||29
8553598|NCT04668989|9585702|FG000|NOT COMPLETED|First Intervention||0
8553599|NCT04668989|9585703|FG001|NOT COMPLETED|First Intervention||1
8553600|NCT04668989|9585702|FG000|STARTED|Second Intervention||36
8553601|NCT04668989|9585703|FG001|STARTED|Second Intervention||29
8553602|NCT04668989|9585702|FG000|COMPLETED|Second Intervention||36
8553603|NCT04668989|9585703|FG001|COMPLETED|Second Intervention||28
8553604|NCT04668989|9585702|FG000|NOT COMPLETED|Second Intervention||0
8553605|NCT04668989|9585703|FG001|NOT COMPLETED|Second Intervention||1
8553606|NCT04668352|9585711|FG000|STARTED|Overall Study||511
8553607|NCT04668352|9585712|FG001|STARTED|Overall Study||513
8553608|NCT04668352|9585711|FG000|COMPLETED|Overall Study||510
8553609|NCT04668352|9585712|FG001|COMPLETED|Overall Study||511
8553610|NCT04668352|9585711|FG000|NOT COMPLETED|Overall Study||1
8553611|NCT04668352|9585712|FG001|NOT COMPLETED|Overall Study||2
8553612|NCT04653766|9585723|FG000|STARTED|Overall Study||6
8553613|NCT04653766|9585724|FG001|STARTED|Overall Study||6
8553614|NCT04653766|9585725|FG002|STARTED|Overall Study||6
8553615|NCT04653766|9585726|FG003|STARTED|Overall Study||6
8553616|NCT04653766|9585727|FG004|STARTED|Overall Study||8
8553617|NCT04653766|9585723|FG000|COMPLETED|Overall Study||6
8553618|NCT04653766|9585724|FG001|COMPLETED|Overall Study||6
8553619|NCT04653766|9585725|FG002|COMPLETED|Overall Study||6
8553620|NCT04653766|9585726|FG003|COMPLETED|Overall Study||6
8553621|NCT04653766|9585727|FG004|COMPLETED|Overall Study||8
8553622|NCT04653766|9585723|FG000|NOT COMPLETED|Overall Study||0
8553623|NCT04653766|9585724|FG001|NOT COMPLETED|Overall Study||0
8553624|NCT04653766|9585725|FG002|NOT COMPLETED|Overall Study||0
8553625|NCT04653766|9585726|FG003|NOT COMPLETED|Overall Study||0
8553626|NCT04653766|9585727|FG004|NOT COMPLETED|Overall Study||0
8553627|NCT04646291|9585751|FG000|STARTED|Overall Study||272
8553628|NCT04646291|9585752|FG001|STARTED|Overall Study||70
8553629|NCT04646291|9585753|FG002|STARTED|Overall Study||8
8553630|NCT04646291|9585751|FG000|COMPLETED|Overall Study||272
8553631|NCT04646291|9585752|FG001|COMPLETED|Overall Study||70
8553632|NCT04646291|9585753|FG002|COMPLETED|Overall Study||8
8553633|NCT04646291|9585751|FG000|NOT COMPLETED|Overall Study||0
8553634|NCT04646291|9585752|FG001|NOT COMPLETED|Overall Study||0
8553635|NCT04646291|9585753|FG002|NOT COMPLETED|Overall Study||0
8553636|NCT04646109|9585769|FG000|STARTED|Overall Study||30
8553637|NCT04646109|9585770|FG001|STARTED|Overall Study||36
8553638|NCT04646109|9585769|FG000|COMPLETED|Overall Study||30
8553639|NCT04646109|9585770|FG001|COMPLETED|Overall Study||30
8553640|NCT04646109|9585769|FG000|NOT COMPLETED|Overall Study||0
8553641|NCT04646109|9585770|FG001|NOT COMPLETED|Overall Study||6
8553642|NCT04637997|9585779|FG000|STARTED|Overall Study||9
8553643|NCT04637997|9585780|FG001|STARTED|Overall Study||9
8553644|NCT04637997|9585779|FG000|COMPLETED|Overall Study||9
8553528|NCT04725500|9585619|FG000|STARTED|Screening||42
8553529|NCT04725500|9585619|FG000|COMPLETED|Screening||15
8553530|NCT04725500|9585619|FG000|NOT COMPLETED|Screening||27
8553531|NCT04725500|9585619|FG000|STARTED|Overnight Polysomnography (PSG)||15
8553532|NCT04725500|9585619|FG000|COMPLETED|Overnight Polysomnography (PSG)||15
8553533|NCT04725500|9585619|FG000|NOT COMPLETED|Overnight Polysomnography (PSG)||0
8553534|NCT04725500|9585619|FG000|STARTED|2 Week Take Home||15
8553535|NCT04725500|9585619|FG000|COMPLETED|2 Week Take Home||10
8553536|NCT04725500|9585619|FG000|NOT COMPLETED|2 Week Take Home||5
8553580|NCT04684992|9585680|FG000|STARTED|Overall Study||36
8553581|NCT04684992|9585680|FG000|COMPLETED|Overall Study||34
8553582|NCT04684992|9585680|FG000|NOT COMPLETED|Overall Study||2
8553586|NCT04673214|9585691|FG000|STARTED|Overall Study||67
8553587|NCT04673214|9585692|FG001|STARTED|Overall Study||47
8553588|NCT04673214|9585691|FG000|Lost to Follow up|Overall Study|These patients were discontinued, given in the first days of their follow-up by video call, they presented major symptoms such as dyspnea of movement, dyspnea at rest, and chest pain; Following the protocol's follow-up criteria, patients were informed of their clinical care at the hospital level immediately, and the protocol was no longer followed. Subsequently, when capturing information in the data analysis, the clinical status of the patients is searched, registering their death.|2
8553589|NCT04673214|9585692|FG001|Lost to Follow up|Overall Study|This patient was stopped being followed up in the first days of his follow-up by video call. He presented major symptoms such as dyspnea of movement, dyspnea at rest, and chest pain; With the follow-up criteria of the protocol, the patient was informed of their clinical care at the hospital level immediately, and the protocol was no longer followed. Subsequently, when capturing information in the data analysis, the clinical status of the patient is searched, registering death.|1
8553590|NCT04673214|9585691|FG000|COMPLETED|Overall Study||65
8553591|NCT04673214|9585692|FG001|COMPLETED|Overall Study||46
8553592|NCT04673214|9585691|FG000|NOT COMPLETED|Overall Study||2
8553593|NCT04673214|9585692|FG001|NOT COMPLETED|Overall Study||1
8553645|NCT04637997|9585780|FG001|COMPLETED|Overall Study||9
8553646|NCT04637997|9585779|FG000|NOT COMPLETED|Overall Study||0
8553647|NCT04637997|9585780|FG001|NOT COMPLETED|Overall Study||0
8568276|NCT00090610|9600622|FG000|COMPLETED|Overall Study||74
8568277|NCT00090610|9600623|FG001|COMPLETED|Overall Study||74
8568278|NCT00090610|9600622|FG000|NOT COMPLETED|Overall Study||1
8568279|NCT00090610|9600623|FG001|NOT COMPLETED|Overall Study||1
8568280|NCT00090753|9600631|FG000|STARTED|First Treatment Period||748
8568281|NCT00090753|9600632|FG001|STARTED|First Treatment Period||480
8568282|NCT00090753|9600631|FG000|COMPLETED|First Treatment Period||492
8568283|NCT00090753|9600632|FG001|COMPLETED|First Treatment Period||302
8568284|NCT00090753|9600631|FG000|NOT COMPLETED|First Treatment Period||256
8568285|NCT00090753|9600632|FG001|NOT COMPLETED|First Treatment Period||178
8568286|NCT00090753|9600631|FG000|STARTED|Extended Treatment Period|39 patients who completed the first treatment period refused to enter the extended treatment period.|453
8568287|NCT00090753|9600632|FG001|STARTED|Extended Treatment Period|52 patients who completed the first treatment period refused to enter the extended treatment period.|250
8568288|NCT00090753|9600631|FG000|COMPLETED|Extended Treatment Period||94
8568289|NCT00090753|9600632|FG001|COMPLETED|Extended Treatment Period||59
8568290|NCT00090753|9600631|FG000|NOT COMPLETED|Extended Treatment Period||359
8568291|NCT00090753|9600632|FG001|NOT COMPLETED|Extended Treatment Period||191
8568292|NCT00090766|9600641|FG000|STARTED|Overall Study||17
8568293|NCT00090766|9600642|FG001|STARTED|Overall Study||21
8568294|NCT00090766|9600643|FG002|STARTED|Overall Study||25
8568295|NCT00090766|9600641|FG000|COMPLETED|Overall Study||14
8568296|NCT00090766|9600642|FG001|COMPLETED|Overall Study||19
8568297|NCT00090766|9600643|FG002|COMPLETED|Overall Study||22
8568298|NCT00090766|9600641|FG000|NOT COMPLETED|Overall Study||3
8568299|NCT00090766|9600642|FG001|NOT COMPLETED|Overall Study||2
8568300|NCT00090766|9600643|FG002|NOT COMPLETED|Overall Study||3
8568301|NCT00090779|9600655|FG000|STARTED|Step 1||66
8568302|NCT00090779|9600656|FG001|STARTED|Step 1||64
8568303|NCT00090779|9600655|FG000|COMPLETED|Step 1|Results are based on the database frozen on July 2, 2009 per DSMB recommendation of study closure.|55
8568304|NCT00090779|9600656|FG001|COMPLETED|Step 1|Results are based on the database frozen on July 2, 2009 per DSMB recommendation of study closure.|49
8568305|NCT00090779|9600655|FG000|NOT COMPLETED|Step 1||11
8621807|NCT00483561|9660867|FG000|STARTED|Overall Study||26
8621808|NCT00483561|9660867|FG000|COMPLETED|Overall Study||15
8621809|NCT00483561|9660867|FG000|NOT COMPLETED|Overall Study||11
8621810|NCT00483574|9660873|FG000|STARTED|Overall Study||1053
8621811|NCT00483574|9660874|FG001|STARTED|Overall Study||321
8621812|NCT00483574|9660873|FG000|COMPLETED|Overall Study||951
8568306|NCT00090779|9600656|FG001|NOT COMPLETED|Step 1||15
8568307|NCT00090779|9600655|FG000|STARTED|Step 2|One subject who had two consecutive CD4<350cells/mm^3 did not enter step 2.|6
8568308|NCT00090779|9600656|FG001|STARTED|Step 2|Three with two consecutive CD4<350cells/mm^3 and one with CDC category B event didn't enter step 2.|19
8568309|NCT00090779|9600655|FG000|COMPLETED|Step 2||0
8568310|NCT00090779|9600656|FG001|COMPLETED|Step 2||1
8568311|NCT00090779|9600655|FG000|NOT COMPLETED|Step 2||6
8568312|NCT00090779|9600656|FG001|NOT COMPLETED|Step 2||18
8568313|NCT00090779|9600655|FG000|STARTED|Step 3||7
8568314|NCT00090779|9600656|FG001|STARTED|Step 3||5
8568315|NCT00090779|9600655|FG000|COMPLETED|Step 3||0
8568316|NCT00090779|9600656|FG001|COMPLETED|Step 3||0
8568317|NCT00090779|9600655|FG000|NOT COMPLETED|Step 3||7
8568318|NCT00090779|9600656|FG001|NOT COMPLETED|Step 3||5
8621813|NCT00483574|9660874|FG001|COMPLETED|Overall Study||308
8621814|NCT00483574|9660873|FG000|NOT COMPLETED|Overall Study||102
8553537|NCT04724538|9585625|FG000|STARTED|Overall Study||11
8553538|NCT04724538|9585626|FG001|STARTED|Overall Study||14
8553539|NCT04724538|9585625|FG000|COMPLETED|Overall Study||11
8553540|NCT04724538|9585626|FG001|COMPLETED|Overall Study||14
8553541|NCT04724538|9585625|FG000|NOT COMPLETED|Overall Study||0
8553542|NCT04724538|9585626|FG001|NOT COMPLETED|Overall Study||0
8553648|NCT04634903|9585793|FG000|STARTED|Overall Study||818
8553649|NCT04634903|9585794|FG001|STARTED|Overall Study||821
8553650|NCT04634903|9585795|FG002|STARTED|Overall Study||813
8621815|NCT00483574|9660874|FG001|NOT COMPLETED|Overall Study||13
8819992|NCT01568034|9873988|FG002|STARTED|Overall Study||3
8819993|NCT01568034|9873989|FG003|STARTED|Overall Study||3
8553651|NCT04634903|9585793|FG000|COMPLETED|Overall Study||669
8553652|NCT04634903|9585794|FG001|COMPLETED|Overall Study||732
8553653|NCT04634903|9585795|FG002|COMPLETED|Overall Study||653
8553654|NCT04634903|9585793|FG000|NOT COMPLETED|Overall Study||149
8553655|NCT04634903|9585794|FG001|NOT COMPLETED|Overall Study||89
8553656|NCT04634903|9585795|FG002|NOT COMPLETED|Overall Study||160
8553666|NCT04628221|9585817|FG000|STARTED|Overall Study||40
8553667|NCT04628221|9585817|FG000|COMPLETED|Overall Study||40
8553668|NCT04628221|9585817|FG000|NOT COMPLETED|Overall Study||0
8553678|NCT04617509|9585834|FG000|STARTED|Period 1: Part 1 Formulation A||14
8553679|NCT04617509|9585835|FG001|STARTED|Period 1: Part 1 Formulation A||0
8553680|NCT04617509|9585836|FG002|STARTED|Period 1: Part 1 Formulation A|Subjects were expected to participate in both Part I and Part II, seven visits in total. Subject 112 was prematurely withdrawn from the study due to self-reported Covid-19-like symptoms via phone after Visit 5, i.e. after receiving both GS-248 formulations but prior to the food interaction part. This means subject 112 was withdrawn after Part I Formulation B but before Part II which cannot be visualized in the Period section. The correct number of subjects started Part II is thus 13.|0
8553681|NCT04617509|9585834|FG000|COMPLETED|Period 1: Part 1 Formulation A||14
8553682|NCT04617509|9585835|FG001|COMPLETED|Period 1: Part 1 Formulation A||0
8553683|NCT04617509|9585836|FG002|COMPLETED|Period 1: Part 1 Formulation A||0
8553684|NCT04617509|9585834|FG000|NOT COMPLETED|Period 1: Part 1 Formulation A||0
8553685|NCT04617509|9585835|FG001|NOT COMPLETED|Period 1: Part 1 Formulation A||0
8553686|NCT04617509|9585836|FG002|NOT COMPLETED|Period 1: Part 1 Formulation A||0
8553687|NCT04617509|9585834|FG000|STARTED|Period 2: Part 1 Formulation B||0
8553688|NCT04617509|9585835|FG001|STARTED|Period 2: Part 1 Formulation B||14
8553689|NCT04617509|9585836|FG002|STARTED|Period 2: Part 1 Formulation B||0
8553690|NCT04617509|9585834|FG000|COMPLETED|Period 2: Part 1 Formulation B||0
8553691|NCT04617509|9585835|FG001|COMPLETED|Period 2: Part 1 Formulation B||14
8553692|NCT04617509|9585836|FG002|COMPLETED|Period 2: Part 1 Formulation B||0
8553693|NCT04617509|9585834|FG000|NOT COMPLETED|Period 2: Part 1 Formulation B||0
8553694|NCT04617509|9585835|FG001|NOT COMPLETED|Period 2: Part 1 Formulation B||0
8553695|NCT04617509|9585836|FG002|NOT COMPLETED|Period 2: Part 1 Formulation B||0
8553696|NCT04617509|9585834|FG000|STARTED|Period 3: Part 2 Formulation A Fed Cond.||0
8553697|NCT04617509|9585835|FG001|STARTED|Period 3: Part 2 Formulation A Fed Cond.||0
8553698|NCT04617509|9585836|FG002|STARTED|Period 3: Part 2 Formulation A Fed Cond.||14
8553699|NCT04617509|9585834|FG000|COMPLETED|Period 3: Part 2 Formulation A Fed Cond.||0
8553700|NCT04617509|9585835|FG001|COMPLETED|Period 3: Part 2 Formulation A Fed Cond.||0
8553701|NCT04617509|9585836|FG002|COMPLETED|Period 3: Part 2 Formulation A Fed Cond.||13
8553702|NCT04617509|9585834|FG000|NOT COMPLETED|Period 3: Part 2 Formulation A Fed Cond.||0
8553703|NCT04617509|9585835|FG001|NOT COMPLETED|Period 3: Part 2 Formulation A Fed Cond.||0
8553704|NCT04617509|9585836|FG002|NOT COMPLETED|Period 3: Part 2 Formulation A Fed Cond.||1
8553705|NCT04616430|9585849|FG000|STARTED|Overall Study||30
8553706|NCT04616430|9585850|FG001|STARTED|Overall Study||30
8553707|NCT04616430|9585851|FG002|STARTED|Overall Study||30
8553708|NCT04616430|9585849|FG000|COMPLETED|Overall Study||23
8553709|NCT04616430|9585850|FG001|COMPLETED|Overall Study||2
8553710|NCT04616430|9585851|FG002|COMPLETED|Overall Study||0
8553711|NCT04616430|9585849|FG000|NOT COMPLETED|Overall Study||7
8553712|NCT04616430|9585850|FG001|NOT COMPLETED|Overall Study||28
8553713|NCT04616430|9585851|FG002|NOT COMPLETED|Overall Study||30
8553714|NCT04615507|9585861|FG000|STARTED|Period 1||34
8553715|NCT04615507|9585862|FG001|STARTED|Period 1||34
8819994|NCT01568034|9873986|FG000|25 mg BIA 9-1067|Overall Study||2
8819995|NCT01568034|9873987|FG001|25 mg BIA 9-1067|Overall Study||2
8819996|NCT01568034|9873988|FG002|25 mg BIA 9-1067|Overall Study||3
8819997|NCT01568034|9873989|FG003|25 mg BIA 9-1067|Overall Study||3
8553716|NCT04615507|9585861|FG000|COMPLETED|Period 1||32
8553717|NCT04615507|9585862|FG001|COMPLETED|Period 1||33
8553718|NCT04615507|9585861|FG000|NOT COMPLETED|Period 1||2
8553719|NCT04615507|9585862|FG001|NOT COMPLETED|Period 1||1
8553720|NCT04615507|9585861|FG000|STARTED|Period 2||32
8553721|NCT04615507|9585862|FG001|STARTED|Period 2||33
8553722|NCT04615507|9585861|FG000|COMPLETED|Period 2||30
8553723|NCT04615507|9585862|FG001|COMPLETED|Period 2||31
8819998|NCT01568034|9873986|FG000|50 mg BIA 9-1067|Overall Study||2
8553724|NCT04615507|9585861|FG000|NOT COMPLETED|Period 2||2
8553725|NCT04615507|9585862|FG001|NOT COMPLETED|Period 2||2
8553726|NCT04615507|9585861|FG000|STARTED|Period 3||30
8553727|NCT04615507|9585862|FG001|STARTED|Period 3||31
8553728|NCT04615507|9585861|FG000|COMPLETED|Period 3||30
8553729|NCT04615507|9585862|FG001|COMPLETED|Period 3||30
8553730|NCT04615507|9585861|FG000|NOT COMPLETED|Period 3||0
8553731|NCT04615507|9585862|FG001|NOT COMPLETED|Period 3||1
8553732|NCT04610489|9585868|FG000|STARTED|Overall Study||117
8553733|NCT04610489|9585868|FG000|COMPLETED|Overall Study||117
8553657|NCT04633642|9585805|FG000|STARTED|Overall Study|27 participants|27
8553658|NCT04633642|9585806|FG001|STARTED|Overall Study|24 participants|24
8553659|NCT04633642|9585805|FG000|COMPLETED|Overall Study|26 participants|26
8553660|NCT04633642|9585806|FG001|COMPLETED|Overall Study|22 participants|22
8553661|NCT04633642|9585805|FG000|NOT COMPLETED|Overall Study||1
8553662|NCT04633642|9585806|FG001|NOT COMPLETED|Overall Study||2
8553663|NCT04633174|9585812|FG000|STARTED|Overall Study||1
8553664|NCT04633174|9585812|FG000|COMPLETED|Overall Study||1
8553665|NCT04633174|9585812|FG000|NOT COMPLETED|Overall Study||0
8553669|NCT04625426|9585824|FG000|STARTED|Overall Study||23
8553670|NCT04625426|9585825|FG001|STARTED|Overall Study||37
8553671|NCT04625426|9585826|FG002|STARTED|Overall Study||24
8553672|NCT04625426|9585824|FG000|COMPLETED|Overall Study||9
8553673|NCT04625426|9585825|FG001|COMPLETED|Overall Study||12
8553674|NCT04625426|9585826|FG002|COMPLETED|Overall Study||12
8553675|NCT04625426|9585824|FG000|NOT COMPLETED|Overall Study||14
8553676|NCT04625426|9585825|FG001|NOT COMPLETED|Overall Study||25
8553677|NCT04625426|9585826|FG002|NOT COMPLETED|Overall Study||12
8553734|NCT04610489|9585868|FG000|NOT COMPLETED|Overall Study||0
8568319|NCT00090844|9600664|FG000|STARTED|Overall Study||27
8568320|NCT00090844|9600665|FG001|STARTED|Overall Study||22
8568321|NCT00090844|9600664|FG000|COMPLETED|Overall Study||26
8568322|NCT00090844|9600665|FG001|COMPLETED|Overall Study||21
8568323|NCT00090844|9600664|FG000|NOT COMPLETED|Overall Study||1
8568324|NCT00090844|9600665|FG001|NOT COMPLETED|Overall Study||1
8568325|NCT00090857|9600674|FG000|STARTED|Overall Study||33
8568326|NCT00090857|9600675|FG001|STARTED|Overall Study||16
8568327|NCT00090857|9600674|FG000|COMPLETED|Overall Study||29
8568328|NCT00090857|9600675|FG001|COMPLETED|Overall Study||13
8568329|NCT00090857|9600674|FG000|NOT COMPLETED|Overall Study||4
8568330|NCT00090857|9600675|FG001|NOT COMPLETED|Overall Study||3
8568331|NCT00090987|9600681|FG000|STARTED|Overall Study||30
8568332|NCT00090987|9600681|FG000|COMPLETED|Overall Study||9
8568333|NCT00090987|9600681|FG000|NOT COMPLETED|Overall Study||21
8568334|NCT00091026|9600687|FG000|STARTED|Overall Study||72
8568335|NCT00091026|9600688|FG001|STARTED|Overall Study||71
8568336|NCT00091026|9600687|FG000|COMPLETED|Overall Study||71
8568337|NCT00091026|9600688|FG001|COMPLETED|Overall Study||68
8568338|NCT00091026|9600687|FG000|NOT COMPLETED|Overall Study||1
8568339|NCT00091026|9600688|FG001|NOT COMPLETED|Overall Study||3
8621816|NCT00483652|9660884|FG000|STARTED|Double-blind Treatment Period||120
8621817|NCT00483652|9660885|FG001|STARTED|Double-blind Treatment Period||119
8621818|NCT00483652|9660884|FG000|COMPLETED|Double-blind Treatment Period||113
8621819|NCT00483652|9660885|FG001|COMPLETED|Double-blind Treatment Period||114
8621820|NCT00483652|9660884|FG000|NOT COMPLETED|Double-blind Treatment Period||7
8819999|NCT01568034|9873987|FG001|50 mg BIA 9-1067|Overall Study||2
8568340|NCT00091169|9600696|FG000|STARTED|Overall Study||189
8568341|NCT00091169|9600697|FG001|STARTED|Overall Study||187
8820000|NCT01568034|9873988|FG002|50 mg BIA 9-1067|Overall Study||3
8820001|NCT01568034|9873989|FG003|50 mg BIA 9-1067|Overall Study||3
8820002|NCT01568034|9873986|FG000|100 mg BIA 9-1067|Overall Study||2
8820003|NCT01568034|9873987|FG001|100 mg BIA 9-1067|Overall Study||2
8820004|NCT01568034|9873988|FG002|100 mg BIA 9-1067|Overall Study||3
8568342|NCT00091169|9600696|FG000|Treated|Overall Study||163
8568343|NCT00091169|9600697|FG001|Treated|Overall Study||170
8568344|NCT00091169|9600696|FG000|COMPLETED|Overall Study||132
8568345|NCT00091169|9600697|FG001|COMPLETED|Overall Study||134
8568346|NCT00091169|9600696|FG000|NOT COMPLETED|Overall Study||57
8568347|NCT00091169|9600697|FG001|NOT COMPLETED|Overall Study||53
8568348|NCT00091260|9600705|FG000|STARTED|Overall Study||82
8568349|NCT00091260|9600705|FG000|COMPLETED|Overall Study||82
8568350|NCT00091260|9600705|FG000|NOT COMPLETED|Overall Study||0
8568351|NCT00091273|9600710|FG000|STARTED|Overall Study||9
8568352|NCT00091273|9600710|FG000|COMPLETED|Overall Study||9
8568353|NCT00091273|9600710|FG000|NOT COMPLETED|Overall Study||0
8568354|NCT00091390|9600714|FG000|STARTED|Overall Study||129
8568355|NCT00091390|9600714|FG000|Eligible and Started Study Treatment|Overall Study||125
8568356|NCT00091390|9600714|FG000|Eligible, Started Treatment, Has AE Data|Overall Study||115
8568357|NCT00091390|9600714|FG000|COMPLETED|Overall Study|Subjects contributing data to results are considered to have completed the study.|125
8568358|NCT00091390|9600714|FG000|NOT COMPLETED|Overall Study||4
8568359|NCT00091442|9600720|FG000|STARTED|Overall Study||373
8621821|NCT00483652|9660885|FG001|NOT COMPLETED|Double-blind Treatment Period||5
8820005|NCT01568034|9873989|FG003|100 mg BIA 9-1067|Overall Study||3
8820006|NCT01568034|9873986|FG000|Placebo|Overall Study||1
8568360|NCT00091442|9600721|FG001|STARTED|Overall Study||378
8568361|NCT00091442|9600720|FG000|COMPLETED|Overall Study|Indicates number of participants on study treatment at time of the primary objective|4
8568362|NCT00091442|9600721|FG001|COMPLETED|Overall Study|Indicates number of participants on study treatment at time of the primary objective|5
8568363|NCT00091442|9600720|FG000|NOT COMPLETED|Overall Study||369
8568364|NCT00091442|9600721|FG001|NOT COMPLETED|Overall Study||373
8568365|NCT00091507|9600729|FG000|STARTED|Overall Study||432
8568366|NCT00091507|9600730|FG001|STARTED|Overall Study||479
8568367|NCT00091507|9600729|FG000|COMPLETED|Overall Study||411
8568368|NCT00091507|9600730|FG001|COMPLETED|Overall Study||460
8568369|NCT00091507|9600729|FG000|NOT COMPLETED|Overall Study||21
8568370|NCT00091507|9600730|FG001|NOT COMPLETED|Overall Study||19
8568371|NCT00091572|9600738|FG000|STARTED|Overall Study|10 subjects in temozolomide group not treated.|429
8569352|NCT00096382|9601575|FG000|STARTED|Overall Study||23
8553735|NCT04608500|9585875|FG000|STARTED|Overall Study||514
8553736|NCT04608500|9585876|FG001|STARTED|Overall Study||257
8553737|NCT04608500|9585875|FG000|COMPLETED|Overall Study||479
8553738|NCT04608500|9585876|FG001|COMPLETED|Overall Study||239
8553739|NCT04608500|9585875|FG000|NOT COMPLETED|Overall Study||35
8553740|NCT04608500|9585876|FG001|NOT COMPLETED|Overall Study||18
8553741|NCT04607291|9585882|FG000|STARTED|Overall Study||183
8553742|NCT04607291|9585882|FG000|COMPLETED|Overall Study||183
8553743|NCT04607291|9585882|FG000|NOT COMPLETED|Overall Study||0
8568372|NCT00091572|9600739|FG001|STARTED|Overall Study|9 subjects in dacarbazine group not treated.|430
8568373|NCT00091572|9600738|FG000|COMPLETED|Overall Study|Progressive disease/relapse/death due to progressive disease|334
8568374|NCT00091572|9600739|FG001|COMPLETED|Overall Study|Progressive disease/relapse/death due to progressive disease|348
8568375|NCT00091572|9600738|FG000|NOT COMPLETED|Overall Study||95
8568376|NCT00091572|9600739|FG001|NOT COMPLETED|Overall Study||82
8568377|NCT00091793|9600747|FG000|STARTED|Overall Study||166
8568378|NCT00091793|9600748|FG001|STARTED|Overall Study||166
8568379|NCT00091793|9600747|FG000|COMPLETED|Overall Study||142
8568380|NCT00091793|9600748|FG001|COMPLETED|Overall Study||144
8568381|NCT00091793|9600747|FG000|NOT COMPLETED|Overall Study||24
8568382|NCT00091793|9600748|FG001|NOT COMPLETED|Overall Study||22
8568383|NCT00091819|9600756|FG000|STARTED|Overall Study||429
8568384|NCT00091819|9600757|FG001|STARTED|Overall Study||433
8568385|NCT00091819|9600756|FG000|COMPLETED|Overall Study||387
8568386|NCT00091819|9600757|FG001|COMPLETED|Overall Study||387
8568387|NCT00091819|9600756|FG000|NOT COMPLETED|Overall Study||42
8568388|NCT00091819|9600757|FG001|NOT COMPLETED|Overall Study||46
8568389|NCT00091832|9600769|FG000|STARTED|Overall Study||43
8568390|NCT00091832|9600770|FG001|STARTED|Overall Study||42
8568391|NCT00091832|9600771|FG002|STARTED|Overall Study||42
8568392|NCT00091832|9600772|FG003|STARTED|Overall Study||43
8568393|NCT00091832|9600773|FG004|STARTED|Overall Study||42
8568394|NCT00091832|9600774|FG005|STARTED|Overall Study||43
8568395|NCT00091832|9600769|FG000|Received Study Medication|Overall Study||43
8568396|NCT00091832|9600770|FG001|Received Study Medication|Overall Study||42
8568397|NCT00091832|9600771|FG002|Received Study Medication|Overall Study||41
8568398|NCT00091832|9600772|FG003|Received Study Medication|Overall Study||43
8568399|NCT00091832|9600773|FG004|Received Study Medication|Overall Study||42
8568400|NCT00091832|9600774|FG005|Received Study Medication|Overall Study||43
8568401|NCT00091832|9600769|FG000|COMPLETED|Overall Study||29
8568402|NCT00091832|9600770|FG001|COMPLETED|Overall Study||31
8568403|NCT00091832|9600771|FG002|COMPLETED|Overall Study||30
8568404|NCT00091832|9600772|FG003|COMPLETED|Overall Study||29
8568405|NCT00091832|9600773|FG004|COMPLETED|Overall Study||27
8568406|NCT00091832|9600774|FG005|COMPLETED|Overall Study||32
8568407|NCT00091832|9600769|FG000|NOT COMPLETED|Overall Study||14
8568408|NCT00091832|9600770|FG001|NOT COMPLETED|Overall Study||11
8568409|NCT00091832|9600771|FG002|NOT COMPLETED|Overall Study||12
8568410|NCT00091832|9600772|FG003|NOT COMPLETED|Overall Study||14
8568411|NCT00091832|9600773|FG004|NOT COMPLETED|Overall Study||15
8568412|NCT00091832|9600774|FG005|NOT COMPLETED|Overall Study||11
8568413|NCT00091949|9600790|FG000|STARTED|Overall Study||1939
8568414|NCT00091949|9600791|FG001|STARTED|Overall Study||1937
8568415|NCT00091949|9600790|FG000|COMPLETED|Overall Study||1764
8568416|NCT00091949|9600791|FG001|COMPLETED|Overall Study||1786
8568417|NCT00091949|9600790|FG000|NOT COMPLETED|Overall Study||175
8568418|NCT00091949|9600791|FG001|NOT COMPLETED|Overall Study||151
8568419|NCT00091962|9600800|FG000|STARTED|Overall Study||150
8568420|NCT00091962|9600801|FG001|STARTED|Overall Study||152
8568421|NCT00091962|9600802|FG002|STARTED|Overall Study||151
8568422|NCT00091962|9600800|FG000|COMPLETED|Overall Study||150
8568423|NCT00091962|9600801|FG001|COMPLETED|Overall Study||152
8568424|NCT00091962|9600802|FG002|COMPLETED|Overall Study||151
8568425|NCT00091962|9600800|FG000|NOT COMPLETED|Overall Study||0
8568426|NCT00091962|9600801|FG001|NOT COMPLETED|Overall Study||0
8568427|NCT00091962|9600802|FG002|NOT COMPLETED|Overall Study||0
8568428|NCT00092417|9600815|FG000|STARTED|Overall Study|Started Period Group 1|464
8568429|NCT00092417|9600816|FG001|STARTED|Overall Study|Started Period Group 2|234
8568430|NCT00092417|9600815|FG000|Vaccinated|Overall Study|3 participants were allocated,not vaccinated; they are not reported in the Baseline Characteristics|461
8568431|NCT00092417|9600816|FG001|Vaccinated|Overall Study||234
8568432|NCT00092417|9600815|FG000|COMPLETED|Overall Study|Received the higher potency zoster vaccine & completed 42 days of safety follow-up post vaccination|459
8820007|NCT01568034|9873987|FG001|Placebo|Overall Study||2
8820008|NCT01568034|9873988|FG002|Placebo|Overall Study||3
8820009|NCT01568034|9873989|FG003|Placebo|Overall Study||3
8568433|NCT00092417|9600816|FG001|COMPLETED|Overall Study|Received the lower potency zoster vaccine & completed 42 days of safety follow-up post vaccination|233
8568434|NCT00092417|9600815|FG000|NOT COMPLETED|Overall Study||5
8568435|NCT00092417|9600816|FG001|NOT COMPLETED|Overall Study||1
8568436|NCT00092443|9600824|FG000|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|651
8568437|NCT00092443|9600825|FG001|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|661
8568438|NCT00092443|9600824|FG000|Vaccinated at Visit 1|Overall Study||650
8568439|NCT00092443|9600825|FG001|Vaccinated at Visit 1|Overall Study||660
8568440|NCT00092443|9600824|FG000|Vaccinated at Visit 2|Overall Study||618
8568441|NCT00092443|9600825|FG001|Vaccinated at Visit 2|Overall Study||627
8568442|NCT00092443|9600824|FG000|Vaccinated at Visit 3|Overall Study||593
8820010|NCT01568034|9873986|FG000|COMPLETED|Overall Study||1
8553744|NCT04605588|9585888|FG000|STARTED|Overall Study||2
8553745|NCT04605588|9585889|FG001|STARTED|Overall Study||5
8553746|NCT04605588|9585888|FG000|COMPLETED|Overall Study||1
8553747|NCT04605588|9585889|FG001|COMPLETED|Overall Study||5
8553748|NCT04605588|9585888|FG000|NOT COMPLETED|Overall Study||1
8553749|NCT04605588|9585889|FG001|NOT COMPLETED|Overall Study||0
8553750|NCT04599959|9585895|FG000|STARTED|Overall Study||151
8553751|NCT04599959|9585895|FG000|COMPLETED|Overall Study||151
8553752|NCT04599959|9585895|FG000|NOT COMPLETED|Overall Study||0
8553753|NCT04596085|9585903|FG000|STARTED|Overall Study||59
8553754|NCT04596085|9585904|FG001|STARTED|Overall Study||59
8553755|NCT04596085|9585903|FG000|COMPLETED|Overall Study||59
8553756|NCT04596085|9585904|FG001|COMPLETED|Overall Study||59
8553757|NCT04596085|9585903|FG000|NOT COMPLETED|Overall Study||0
8553758|NCT04596085|9585904|FG001|NOT COMPLETED|Overall Study||0
8553759|NCT04590027|9585914|FG000|STARTED|Overall Study||47
8553760|NCT04590027|9585915|FG001|STARTED|Overall Study||39
8553761|NCT04590027|9585914|FG000|COMPLETED|Overall Study||30
8553762|NCT04590027|9585915|FG001|COMPLETED|Overall Study||22
8553763|NCT04590027|9585914|FG000|NOT COMPLETED|Overall Study||17
8553764|NCT04590027|9585915|FG001|NOT COMPLETED|Overall Study||17
8553765|NCT04578457|9585925|FG000|STARTED|Hearing Aid Without NR Enabled (0)||19
8553766|NCT04578457|9585925|FG000|COMPLETED|Hearing Aid Without NR Enabled (0)||17
8553767|NCT04578457|9585925|FG000|NOT COMPLETED|Hearing Aid Without NR Enabled (0)||2
8553768|NCT04578457|9585925|FG000|STARTED|Hearing Aid With NR (1)||19
8553769|NCT04578457|9585925|FG000|COMPLETED|Hearing Aid With NR (1)||17
8553770|NCT04578457|9585925|FG000|NOT COMPLETED|Hearing Aid With NR (1)||2
8553771|NCT04578457|9585925|FG000|STARTED|Hearing Aid With NR (2)||19
8553772|NCT04578457|9585925|FG000|COMPLETED|Hearing Aid With NR (2)||17
8553773|NCT04578457|9585925|FG000|NOT COMPLETED|Hearing Aid With NR (2)||2
8553774|NCT04578457|9585925|FG000|STARTED|Hearing Aid With NR (4)||19
8553775|NCT04578457|9585925|FG000|COMPLETED|Hearing Aid With NR (4)||17
8553776|NCT04578457|9585925|FG000|NOT COMPLETED|Hearing Aid With NR (4)||2
8553792|NCT04563767|9585958|FG000|STARTED|Overall Study||4
8553793|NCT04563767|9585958|FG000|COMPLETED|Overall Study||4
8553794|NCT04563767|9585958|FG000|NOT COMPLETED|Overall Study||0
8553801|NCT04555525|9585975|FG000|STARTED|Overall Study||75
8553802|NCT04555525|9585976|FG001|STARTED|Overall Study||25
8553803|NCT04555525|9585975|FG000|COMPLETED|Overall Study||72
8553804|NCT04555525|9585976|FG001|COMPLETED|Overall Study||25
8553805|NCT04555525|9585975|FG000|NOT COMPLETED|Overall Study||3
8553806|NCT04555525|9585976|FG001|NOT COMPLETED|Overall Study||0
8553813|NCT04548622|9585994|FG000|STARTED|Overall Study||15
8553814|NCT04548622|9585994|FG000|COMPLETED|Overall Study||15
8553815|NCT04548622|9585994|FG000|NOT COMPLETED|Overall Study||0
8553870|NCT04534764|9586065|FG000|STARTED|Period 1||18
8553871|NCT04534764|9586066|FG001|STARTED|Period 1||17
8553872|NCT04534764|9586065|FG000|COMPLETED|Period 1||18
8553873|NCT04534764|9586066|FG001|COMPLETED|Period 1||17
8553874|NCT04534764|9586065|FG000|NOT COMPLETED|Period 1||0
8621822|NCT00483652|9660884|FG000|STARTED|Post-study Follow-up||113
8621823|NCT00483652|9660885|FG001|STARTED|Post-study Follow-up||114
8553875|NCT04534764|9586066|FG001|NOT COMPLETED|Period 1||0
8553876|NCT04534764|9586065|FG000|STARTED|Period 2||18
8553877|NCT04534764|9586066|FG001|STARTED|Period 2||17
8553878|NCT04534764|9586065|FG000|COMPLETED|Period 2||18
8553879|NCT04534764|9586066|FG001|COMPLETED|Period 2||17
8553880|NCT04534764|9586065|FG000|NOT COMPLETED|Period 2||0
8553881|NCT04534764|9586066|FG001|NOT COMPLETED|Period 2||0
8553882|NCT04534491|9586072|FG000|STARTED|Overall Study||855
8553883|NCT04534491|9586072|FG000|Treated|Overall Study||727
8553884|NCT04534491|9586072|FG000|COMPLETED|Overall Study||703
8553885|NCT04534491|9586072|FG000|NOT COMPLETED|Overall Study||152
8553886|NCT04534465|9586076|FG000|STARTED|Overall Study||10
8553887|NCT04534465|9586077|FG001|STARTED|Overall Study||10
8553888|NCT04534465|9586078|FG002|STARTED|Overall Study||10
8553889|NCT04534465|9586079|FG003|STARTED|Overall Study||10
8553890|NCT04534465|9586080|FG004|STARTED|Overall Study||10
8553891|NCT04534465|9586076|FG000|COMPLETED|Overall Study||10
8553892|NCT04534465|9586077|FG001|COMPLETED|Overall Study||10
8553893|NCT04534465|9586078|FG002|COMPLETED|Overall Study||10
8553894|NCT04534465|9586079|FG003|COMPLETED|Overall Study||10
8553895|NCT04534465|9586080|FG004|COMPLETED|Overall Study||10
8553896|NCT04534465|9586076|FG000|NOT COMPLETED|Overall Study||0
8553897|NCT04534465|9586077|FG001|NOT COMPLETED|Overall Study||0
8553898|NCT04534465|9586078|FG002|NOT COMPLETED|Overall Study||0
8553899|NCT04534465|9586079|FG003|NOT COMPLETED|Overall Study||0
8553900|NCT04534465|9586080|FG004|NOT COMPLETED|Overall Study||0
8553926|NCT04615832|9586122|FG000|STARTED|Overall Study||44
8553927|NCT04615832|9586122|FG000|COMPLETED|Overall Study||44
8553928|NCT04615832|9586122|FG000|NOT COMPLETED|Overall Study||0
8553929|NCT04093258|9586126|FG000|STARTED|Period 1||21
8553930|NCT04093258|9586127|FG001|STARTED|Period 1||20
8553931|NCT04093258|9586126|FG000|COMPLETED|Period 1||21
8553932|NCT04093258|9586127|FG001|COMPLETED|Period 1||20
8553933|NCT04093258|9586126|FG000|NOT COMPLETED|Period 1||0
8553934|NCT04093258|9586127|FG001|NOT COMPLETED|Period 1||0
8553935|NCT04093258|9586126|FG000|STARTED|Period 2||21
8553936|NCT04093258|9586127|FG001|STARTED|Period 2||20
8553937|NCT04093258|9586126|FG000|COMPLETED|Period 2||20
8553938|NCT04093258|9586127|FG001|COMPLETED|Period 2||20
8553939|NCT04093258|9586126|FG000|NOT COMPLETED|Period 2||1
8553940|NCT04093258|9586127|FG001|NOT COMPLETED|Period 2||0
8553777|NCT04578496|9585933|FG000|STARTED|Overall Study||16
8553778|NCT04578496|9585933|FG000|COMPLETED|Overall Study||12
8553779|NCT04578496|9585933|FG000|NOT COMPLETED|Overall Study||4
8553780|NCT04577183|9585937|FG000|STARTED|Overall Study||13
8553781|NCT04577183|9585937|FG000|COMPLETED|Overall Study||7
8553782|NCT04577183|9585937|FG000|NOT COMPLETED|Overall Study||6
8553795|NCT04560374|9585964|FG000|STARTED|Overall Study||50
8553796|NCT04560374|9585965|FG001|STARTED|Overall Study||50
8553797|NCT04560374|9585964|FG000|COMPLETED|Overall Study||50
8553798|NCT04560374|9585965|FG001|COMPLETED|Overall Study||50
8553799|NCT04560374|9585964|FG000|NOT COMPLETED|Overall Study||0
8553800|NCT04560374|9585965|FG001|NOT COMPLETED|Overall Study||0
8553807|NCT04553497|9585984|FG000|STARTED|Overall Study||17
8553808|NCT04553497|9585985|FG001|STARTED|Overall Study||18
8553809|NCT04553497|9585984|FG000|COMPLETED|Overall Study||15
8553810|NCT04553497|9585985|FG001|COMPLETED|Overall Study||17
8553811|NCT04553497|9585984|FG000|NOT COMPLETED|Overall Study||2
8553812|NCT04553497|9585985|FG001|NOT COMPLETED|Overall Study||1
8553816|NCT04547036|9585998|FG000|STARTED|Overall Study||129
8553817|NCT04547036|9585998|FG000|COMPLETED|Overall Study||129
8553818|NCT04547036|9585998|FG000|NOT COMPLETED|Overall Study||0
8553901|NCT04533204|9586094|FG000|STARTED|Overall Study||29
8553902|NCT04533204|9586095|FG001|STARTED|Overall Study||30
8723139|NCT01021813|9770655|FG001|Treated|DB Treatment Phase||258
8723140|NCT01021813|9770656|FG002|Treated|DB Treatment Phase||0
8723141|NCT01021813|9770657|FG003|Treated|DB Treatment Phase||0
8723142|NCT01021813|9770658|FG004|Treated|DB Treatment Phase||0
8723143|NCT01021813|9770654|FG000|COMPLETED|DB Treatment Phase||322
8723144|NCT01021813|9770655|FG001|COMPLETED|DB Treatment Phase||162
8723145|NCT01021813|9770656|FG002|COMPLETED|DB Treatment Phase||0
8723146|NCT01021813|9770657|FG003|COMPLETED|DB Treatment Phase||0
8723147|NCT01021813|9770658|FG004|COMPLETED|DB Treatment Phase||0
8723148|NCT01021813|9770654|FG000|NOT COMPLETED|DB Treatment Phase||200
8723149|NCT01021813|9770655|FG001|NOT COMPLETED|DB Treatment Phase||97
8553903|NCT04533204|9586094|FG000|COMPLETED|Overall Study||28
8553904|NCT04533204|9586095|FG001|COMPLETED|Overall Study||29
8553905|NCT04533204|9586094|FG000|NOT COMPLETED|Overall Study||1
8553906|NCT04533204|9586095|FG001|NOT COMPLETED|Overall Study||1
8553907|NCT04532164|9586101|FG000|STARTED|Overall Study||137
8553908|NCT04532164|9586101|FG000|Treated|Overall Study||132
8553909|NCT04532164|9586101|FG000|COMPLETED|Overall Study||113
8553910|NCT04532164|9586101|FG000|NOT COMPLETED|Overall Study||24
8553911|NCT04531813|9586106|FG000|STARTED|Overall Study||32
8553912|NCT04531813|9586106|FG000|Treated|Overall Study||31
8553913|NCT04531813|9586106|FG000|COMPLETED|Overall Study||30
8553914|NCT04531813|9586106|FG000|NOT COMPLETED|Overall Study||2
8553915|NCT04531527|9586110|FG000|STARTED|Overall Study||32
8553916|NCT04531527|9586110|FG000|Treated|Overall Study||29
8553917|NCT04531527|9586110|FG000|COMPLETED|Overall Study||29
8553918|NCT04531527|9586110|FG000|NOT COMPLETED|Overall Study||3
8553941|NCT04011826|9586133|FG000|STARTED|Overall Study||45
8553942|NCT04011826|9586133|FG000|COMPLETED|Overall Study||45
8553943|NCT04011826|9586133|FG000|NOT COMPLETED|Overall Study||0
8553944|NCT03993379|9586141|FG000|STARTED|Overall Study||0
8553945|NCT03993379|9586142|FG001|STARTED|Overall Study||3
8553946|NCT03993379|9586143|FG002|STARTED|Overall Study||0
8553947|NCT03993379|9586144|FG003|STARTED|Overall Study||0
8553948|NCT03993379|9586141|FG000|COMPLETED|Overall Study|No subjects enrolled in this arm/group.|0
8553949|NCT03993379|9586142|FG001|COMPLETED|Overall Study|Subjects did not complete due to early termination of the study due to business reasons.|0
8553950|NCT03993379|9586143|FG002|COMPLETED|Overall Study|No subjects enrolled in this arm/group.|0
8553951|NCT03993379|9586144|FG003|COMPLETED|Overall Study|No subjects enrolled in this arm/group.|0
8553952|NCT03993379|9586141|FG000|NOT COMPLETED|Overall Study||0
8553953|NCT03993379|9586142|FG001|NOT COMPLETED|Overall Study||3
8553954|NCT03993379|9586143|FG002|NOT COMPLETED|Overall Study||0
8553955|NCT03993379|9586144|FG003|NOT COMPLETED|Overall Study||0
8553956|NCT03956615|9586154|FG000|STARTED|Overall Study||10
8553957|NCT03956615|9586154|FG000|COMPLETED|Overall Study||3
8553958|NCT03956615|9586154|FG000|NOT COMPLETED|Overall Study||7
8553959|NCT03803059|9586158|FG000|STARTED|Overall Study||35
8553960|NCT03803059|9586158|FG000|COMPLETED|Overall Study||32
8553961|NCT03803059|9586158|FG000|NOT COMPLETED|Overall Study||3
8553962|NCT03723590|9586163|FG000|STARTED|Overall Study||5
8553963|NCT03723590|9586163|FG000|COMPLETED|Overall Study||2
8553964|NCT03723590|9586163|FG000|NOT COMPLETED|Overall Study||3
8553965|NCT03720392|9586169|FG000|STARTED|Overall Study||3
8553966|NCT03720392|9586170|FG001|STARTED|Overall Study||3
8553967|NCT03720392|9586169|FG000|COMPLETED|Overall Study||3
8553968|NCT03720392|9586170|FG001|COMPLETED|Overall Study||3
8553969|NCT03720392|9586169|FG000|NOT COMPLETED|Overall Study||0
8553970|NCT03720392|9586170|FG001|NOT COMPLETED|Overall Study||0
8553971|NCT03515226|9586178|FG000|STARTED|Overall Study||10
8553972|NCT03515226|9586179|FG001|STARTED|Overall Study||15
8553973|NCT03515226|9586178|FG000|COMPLETED|Overall Study||8
8553974|NCT03515226|9586179|FG001|COMPLETED|Overall Study||11
8553975|NCT03515226|9586178|FG000|NOT COMPLETED|Overall Study||2
8553976|NCT03515226|9586179|FG001|NOT COMPLETED|Overall Study||4
8553977|NCT03430895|9586186|FG000|STARTED|Overall Study||15
8553978|NCT03430895|9586186|FG000|COMPLETED|Overall Study||13
8553979|NCT03430895|9586186|FG000|NOT COMPLETED|Overall Study||2
8568443|NCT00092443|9600825|FG001|Vaccinated at Visit 3|Overall Study||608
8553783|NCT04574999|9585943|FG000|STARTED|Overall Study||114
8553784|NCT04574999|9585944|FG001|STARTED|Overall Study||53
8553785|NCT04574999|9585943|FG000|COMPLETED|Overall Study||105
8553786|NCT04574999|9585944|FG001|COMPLETED|Overall Study||48
8553787|NCT04574999|9585943|FG000|NOT COMPLETED|Overall Study||9
8553788|NCT04574999|9585944|FG001|NOT COMPLETED|Overall Study||5
8553819|NCT04544566|9586008|FG000|STARTED|Overall Study||2
8553820|NCT04544566|9586009|FG001|STARTED|Overall Study||2
8553821|NCT04544566|9586010|FG002|STARTED|Overall Study||2
8553822|NCT04544566|9586011|FG003|STARTED|Overall Study||2
8553823|NCT04544566|9586012|FG004|STARTED|Overall Study||2
8553824|NCT04544566|9586013|FG005|STARTED|Overall Study||2
8553825|NCT04544566|9586008|FG000|COMPLETED|Overall Study||2
8553826|NCT04544566|9586009|FG001|COMPLETED|Overall Study||2
8553827|NCT04544566|9586010|FG002|COMPLETED|Overall Study||2
8553828|NCT04544566|9586011|FG003|COMPLETED|Overall Study||2
8553829|NCT04544566|9586012|FG004|COMPLETED|Overall Study||2
8553830|NCT04544566|9586013|FG005|COMPLETED|Overall Study||2
8553831|NCT04544566|9586008|FG000|NOT COMPLETED|Overall Study||0
8553832|NCT04544566|9586009|FG001|NOT COMPLETED|Overall Study||0
8553833|NCT04544566|9586010|FG002|NOT COMPLETED|Overall Study||0
8553834|NCT04544566|9586011|FG003|NOT COMPLETED|Overall Study||0
8553835|NCT04544566|9586012|FG004|NOT COMPLETED|Overall Study||0
8553836|NCT04544566|9586013|FG005|NOT COMPLETED|Overall Study||0
8553919|NCT04531540|9586114|FG000|STARTED|Overall Study||225
8553920|NCT04531540|9586114|FG000|Treated|Overall Study||222
8553921|NCT04531540|9586114|FG000|COMPLETED|Overall Study||216
8553922|NCT04531540|9586114|FG000|NOT COMPLETED|Overall Study||9
8553923|NCT04530591|9586118|FG000|STARTED|Overall Study||97
8553924|NCT04530591|9586118|FG000|COMPLETED|Overall Study||97
8553925|NCT04530591|9586118|FG000|NOT COMPLETED|Overall Study||0
8553980|NCT03321617|9586194|FG000|STARTED|Overall Study||3
8723150|NCT01021813|9770656|FG002|NOT COMPLETED|DB Treatment Phase||0
8723151|NCT01021813|9770657|FG003|NOT COMPLETED|DB Treatment Phase||0
8723152|NCT01021813|9770658|FG004|NOT COMPLETED|DB Treatment Phase||0
8723153|NCT01021813|9770654|FG000|STARTED|DB Randomized Discontinuation Phase||0
8723154|NCT01021813|9770655|FG001|STARTED|DB Randomized Discontinuation Phase||0
8723155|NCT01021813|9770656|FG002|STARTED|DB Randomized Discontinuation Phase||156
8723156|NCT01021813|9770657|FG003|STARTED|DB Randomized Discontinuation Phase||166
8723157|NCT01021813|9770658|FG004|STARTED|DB Randomized Discontinuation Phase||162
8723158|NCT01021813|9770654|FG000|COMPLETED|DB Randomized Discontinuation Phase||0
8723159|NCT01021813|9770655|FG001|COMPLETED|DB Randomized Discontinuation Phase||0
8723160|NCT01021813|9770656|FG002|COMPLETED|DB Randomized Discontinuation Phase||152
8723161|NCT01021813|9770657|FG003|COMPLETED|DB Randomized Discontinuation Phase||161
8723162|NCT01021813|9770658|FG004|COMPLETED|DB Randomized Discontinuation Phase||157
8723163|NCT01021813|9770654|FG000|NOT COMPLETED|DB Randomized Discontinuation Phase||0
8553981|NCT03321617|9586195|FG001|STARTED|Overall Study||3
8553982|NCT03321617|9586196|FG002|STARTED|Overall Study||2
8553983|NCT03321617|9586197|FG003|STARTED|Overall Study||3
8553984|NCT03321617|9586194|FG000|COMPLETED|Overall Study||2
8553985|NCT03321617|9586195|FG001|COMPLETED|Overall Study||3
8553986|NCT03321617|9586196|FG002|COMPLETED|Overall Study||2
8553987|NCT03321617|9586197|FG003|COMPLETED|Overall Study||2
8553988|NCT03321617|9586194|FG000|NOT COMPLETED|Overall Study||1
8553989|NCT03321617|9586195|FG001|NOT COMPLETED|Overall Study||0
8553990|NCT03321617|9586196|FG002|NOT COMPLETED|Overall Study||0
8553991|NCT03321617|9586197|FG003|NOT COMPLETED|Overall Study||1
8553992|NCT03230838|9586209|FG000|STARTED|Overall Study||101
8553993|NCT03230838|9586210|FG001|STARTED|Overall Study||33
8553994|NCT03230838|9586209|FG000|Treated|Overall Study||100
8553995|NCT03230838|9586210|FG001|Treated|Overall Study||33
8553996|NCT03230838|9586209|FG000|COMPLETED|Overall Study||97
8553997|NCT03230838|9586210|FG001|COMPLETED|Overall Study||33
8553998|NCT03230838|9586209|FG000|NOT COMPLETED|Overall Study||4
8553999|NCT03230838|9586210|FG001|NOT COMPLETED|Overall Study||0
8554000|NCT03183778|9586216|FG000|STARTED|Overall Study||3
8554001|NCT03183778|9586216|FG000|COMPLETED|Overall Study||2
8554002|NCT03183778|9586216|FG000|NOT COMPLETED|Overall Study||1
8554003|NCT03113955|9586220|FG000|STARTED|Overall Study||109
8554004|NCT03113955|9586220|FG000|COMPLETED|Overall Study||92
8723164|NCT01021813|9770655|FG001|NOT COMPLETED|DB Randomized Discontinuation Phase||0
8725203|NCT01029704|9772386|FG008|NOT COMPLETED|Overall Study||1
8554005|NCT03113955|9586220|FG000|NOT COMPLETED|Overall Study||17
8554006|NCT02995694|9586227|FG000|STARTED|Overall Study||215
8554007|NCT02995694|9586228|FG001|STARTED|Overall Study||211
8554008|NCT02995694|9586229|FG002|STARTED|Overall Study||109
8554009|NCT02995694|9586227|FG000|COMPLETED|Overall Study||181
8554010|NCT02995694|9586228|FG001|COMPLETED|Overall Study||183
8554011|NCT02995694|9586229|FG002|COMPLETED|Overall Study||94
8554012|NCT02995694|9586227|FG000|NOT COMPLETED|Overall Study||34
8554013|NCT02995694|9586228|FG001|NOT COMPLETED|Overall Study||28
8554014|NCT02995694|9586229|FG002|NOT COMPLETED|Overall Study||15
8554015|NCT02700698|9586242|FG000|STARTED|Overall Study||17
8554016|NCT02700698|9586243|FG001|STARTED|Overall Study||18
8554017|NCT02700698|9586242|FG000|COMPLETED|Overall Study||16
8554018|NCT02700698|9586243|FG001|COMPLETED|Overall Study||18
8554019|NCT02700698|9586242|FG000|NOT COMPLETED|Overall Study||1
8554020|NCT02700698|9586243|FG001|NOT COMPLETED|Overall Study||0
8554021|NCT02699086|9586249|FG000|STARTED|Overall Study||0
8554022|NCT02699086|9586250|FG001|STARTED|Overall Study||6
8554023|NCT02699086|9586249|FG000|COMPLETED|Overall Study||0
8553789|NCT04572997|9585950|FG000|STARTED|Overall Study||21
8553790|NCT04572997|9585950|FG000|COMPLETED|Overall Study||20
8553791|NCT04572997|9585950|FG000|NOT COMPLETED|Overall Study||1
8553837|NCT04542694|9586029|FG000|STARTED|Overall Study||100
8553838|NCT04542694|9586030|FG001|STARTED|Overall Study||100
8553839|NCT04542694|9586029|FG000|COMPLETED|Overall Study||96
8553840|NCT04542694|9586030|FG001|COMPLETED|Overall Study||100
8553841|NCT04542694|9586029|FG000|NOT COMPLETED|Overall Study||4
8553842|NCT04542694|9586030|FG001|NOT COMPLETED|Overall Study||0
8553843|NCT04542226|9586036|FG000|STARTED|Overall Study||81
8553844|NCT04542226|9586036|FG000|COMPLETED|Overall Study||81
8553845|NCT04542226|9586036|FG000|NOT COMPLETED|Overall Study||0
8554024|NCT02699086|9586250|FG001|COMPLETED|Overall Study||6
8554025|NCT02699086|9586249|FG000|NOT COMPLETED|Overall Study||0
8554026|NCT02699086|9586250|FG001|NOT COMPLETED|Overall Study||0
8554027|NCT02698865|9586260|FG000|STARTED|Overall Study||140
8554028|NCT02698865|9586261|FG001|STARTED|Overall Study||80
8554029|NCT02698865|9586260|FG000|Treated|Overall Study||140
8554030|NCT02698865|9586261|FG001|Treated|Overall Study||80
8554031|NCT02698865|9586260|FG000|COMPLETED|Overall Study||105
8554032|NCT02698865|9586261|FG001|COMPLETED|Overall Study||47
8554033|NCT02698865|9586260|FG000|NOT COMPLETED|Overall Study||35
8554034|NCT02698865|9586261|FG001|NOT COMPLETED|Overall Study||33
8554035|NCT02660086|9586269|FG000|STARTED|Overall Study- 12-month||299
8554036|NCT02660086|9586270|FG001|STARTED|Overall Study- 12-month||303
8554037|NCT02660086|9586269|FG000|COMPLETED|Overall Study- 12-month||273
8554038|NCT02660086|9586270|FG001|COMPLETED|Overall Study- 12-month||274
8554039|NCT02660086|9586269|FG000|NOT COMPLETED|Overall Study- 12-month||26
8554040|NCT02660086|9586270|FG001|NOT COMPLETED|Overall Study- 12-month||29
8554041|NCT02660086|9586269|FG000|STARTED|Overall Study: 24-month Follow-up||281
8554042|NCT02660086|9586270|FG001|STARTED|Overall Study: 24-month Follow-up||278
8554043|NCT02660086|9586269|FG000|COMPLETED|Overall Study: 24-month Follow-up||255
8554044|NCT02660086|9586270|FG001|COMPLETED|Overall Study: 24-month Follow-up||254
8554045|NCT02660086|9586269|FG000|NOT COMPLETED|Overall Study: 24-month Follow-up||26
8554046|NCT02660086|9586270|FG001|NOT COMPLETED|Overall Study: 24-month Follow-up||24
8554047|NCT02335749|9586276|FG000|STARTED|Overall Study||40
8554048|NCT02335749|9586276|FG000|COMPLETED|Overall Study||40
8554049|NCT02335749|9586276|FG000|NOT COMPLETED|Overall Study||0
8554050|NCT02129647|9586280|FG000|STARTED|Overall Study||13
8554051|NCT02129647|9586280|FG000|COMPLETED|Overall Study||10
8554052|NCT02129647|9586280|FG000|NOT COMPLETED|Overall Study||3
8554053|NCT02071901|9586284|FG000|STARTED|Overall Study||31
8554054|NCT02071901|9586284|FG000|COMPLETED|Overall Study||31
8554055|NCT02071901|9586284|FG000|NOT COMPLETED|Overall Study||0
8554056|NCT01959139|9586292|FG000|STARTED|Phase I: Cohort 1||5
8554057|NCT01959139|9586293|FG001|STARTED|Phase I: Cohort 1||0
8554058|NCT01959139|9586294|FG002|STARTED|Phase I: Cohort 1||0
8554059|NCT01959139|9586295|FG003|STARTED|Phase I: Cohort 1||0
8554060|NCT01959139|9586292|FG000|COMPLETED|Phase I: Cohort 1||5
8554061|NCT01959139|9586293|FG001|COMPLETED|Phase I: Cohort 1||0
8554062|NCT01959139|9586294|FG002|COMPLETED|Phase I: Cohort 1||0
8554063|NCT01959139|9586295|FG003|COMPLETED|Phase I: Cohort 1||0
8554064|NCT01959139|9586292|FG000|NOT COMPLETED|Phase I: Cohort 1||0
8554065|NCT01959139|9586293|FG001|NOT COMPLETED|Phase I: Cohort 1||0
8554066|NCT01959139|9586294|FG002|NOT COMPLETED|Phase I: Cohort 1||0
8554067|NCT01959139|9586295|FG003|NOT COMPLETED|Phase I: Cohort 1||0
8554068|NCT01959139|9586292|FG000|STARTED|Phase I: Cohort 2||0
8554069|NCT01959139|9586293|FG001|STARTED|Phase I: Cohort 2||6
8554070|NCT01959139|9586294|FG002|STARTED|Phase I: Cohort 2||0
8554071|NCT01959139|9586295|FG003|STARTED|Phase I: Cohort 2||0
8554072|NCT01959139|9586292|FG000|COMPLETED|Phase I: Cohort 2||0
8554073|NCT01959139|9586293|FG001|COMPLETED|Phase I: Cohort 2||6
8554074|NCT01959139|9586294|FG002|COMPLETED|Phase I: Cohort 2||0
8554075|NCT01959139|9586295|FG003|COMPLETED|Phase I: Cohort 2||0
8554076|NCT01959139|9586292|FG000|NOT COMPLETED|Phase I: Cohort 2||0
8554077|NCT01959139|9586293|FG001|NOT COMPLETED|Phase I: Cohort 2||0
8554078|NCT01959139|9586294|FG002|NOT COMPLETED|Phase I: Cohort 2||0
8554079|NCT01959139|9586295|FG003|NOT COMPLETED|Phase I: Cohort 2||0
8554080|NCT01959139|9586292|FG000|STARTED|Phase II||0
8554081|NCT01959139|9586293|FG001|STARTED|Phase II||0
8554082|NCT01959139|9586294|FG002|STARTED|Phase II||56
8554083|NCT01959139|9586295|FG003|STARTED|Phase II||55
8554084|NCT01959139|9586292|FG000|Assessed for AEs|Phase II||0
8554085|NCT01959139|9586293|FG001|Assessed for AEs|Phase II||0
8554086|NCT01959139|9586294|FG002|Assessed for AEs|Phase II||54
8554087|NCT01959139|9586295|FG003|Assessed for AEs|Phase II||51
8554088|NCT01959139|9586292|FG000|COMPLETED|Phase II||0
8554089|NCT01959139|9586293|FG001|COMPLETED|Phase II||0
8554090|NCT01959139|9586294|FG002|COMPLETED|Phase II||0
8554091|NCT01959139|9586295|FG003|COMPLETED|Phase II||0
8554092|NCT01959139|9586292|FG000|NOT COMPLETED|Phase II||0
8554093|NCT01959139|9586293|FG001|NOT COMPLETED|Phase II||0
8554094|NCT01959139|9586294|FG002|NOT COMPLETED|Phase II||56
8554095|NCT01959139|9586295|FG003|NOT COMPLETED|Phase II||55
8554096|NCT01597778|9586312|FG000|STARTED|Overall Study||186
8554097|NCT01597778|9586313|FG001|STARTED|Overall Study||182
8554098|NCT01597778|9586312|FG000|COMPLETED|Overall Study||172
8554099|NCT01597778|9586313|FG001|COMPLETED|Overall Study||153
8554100|NCT01597778|9586312|FG000|NOT COMPLETED|Overall Study||14
8554101|NCT01597778|9586313|FG001|NOT COMPLETED|Overall Study||29
8554102|NCT01522976|9586322|FG000|STARTED|Overall Study||97
8554103|NCT01522976|9586323|FG001|STARTED|Overall Study||92
8553846|NCT04540627|9586043|FG000|STARTED|Open-label Treatment: PK Sentinel|Participants were not enrolled in this arm in the double-blind period.|6
8553847|NCT04540627|9586044|FG001|STARTED|Open-label Treatment: PK Sentinel|Participants were not enrolled in this arm in the open-label period.|0
8553848|NCT04540627|9586045|FG002|STARTED|Open-label Treatment: PK Sentinel|Participants were not enrolled in this arm in the open-label period.|0
8553849|NCT04540627|9586043|FG000|COMPLETED|Open-label Treatment: PK Sentinel||6
8553850|NCT04540627|9586044|FG001|COMPLETED|Open-label Treatment: PK Sentinel||0
8553851|NCT04540627|9586045|FG002|COMPLETED|Open-label Treatment: PK Sentinel||0
8553852|NCT04540627|9586043|FG000|NOT COMPLETED|Open-label Treatment: PK Sentinel||0
8553853|NCT04540627|9586044|FG001|NOT COMPLETED|Open-label Treatment: PK Sentinel||0
8553854|NCT04540627|9586045|FG002|NOT COMPLETED|Open-label Treatment: PK Sentinel||0
8553855|NCT04540627|9586043|FG000|STARTED|Double-blind Treatment: Viral Challenge|Participants were not enrolled in this arm in the double-blind period.|0
8553856|NCT04540627|9586044|FG001|STARTED|Double-blind Treatment: Viral Challenge|Participants were not enrolled in this arm in the open-label period.|25
8553857|NCT04540627|9586045|FG002|STARTED|Double-blind Treatment: Viral Challenge|Participants were not enrolled in this arm in the open-label period.|25
8553858|NCT04540627|9586043|FG000|COMPLETED|Double-blind Treatment: Viral Challenge||0
8553859|NCT04540627|9586044|FG001|COMPLETED|Double-blind Treatment: Viral Challenge||25
8553860|NCT04540627|9586045|FG002|COMPLETED|Double-blind Treatment: Viral Challenge||25
8553861|NCT04540627|9586043|FG000|NOT COMPLETED|Double-blind Treatment: Viral Challenge||0
8553862|NCT04540627|9586044|FG001|NOT COMPLETED|Double-blind Treatment: Viral Challenge||0
8553863|NCT04540627|9586045|FG002|NOT COMPLETED|Double-blind Treatment: Viral Challenge||0
8553864|NCT04540510|9586058|FG000|STARTED|Overall Study||5
8553865|NCT04540510|9586059|FG001|STARTED|Overall Study||6
8553866|NCT04540510|9586058|FG000|COMPLETED|Overall Study||5
8553867|NCT04540510|9586059|FG001|COMPLETED|Overall Study||6
8553868|NCT04540510|9586058|FG000|NOT COMPLETED|Overall Study||0
8553869|NCT04540510|9586059|FG001|NOT COMPLETED|Overall Study||0
8554104|NCT01522976|9586324|FG002|STARTED|Overall Study||93
8554105|NCT01522976|9586322|FG000|COMPLETED|Overall Study||0
8554106|NCT01522976|9586323|FG001|COMPLETED|Overall Study||0
8554107|NCT01522976|9586324|FG002|COMPLETED|Overall Study||0
8554108|NCT01522976|9586322|FG000|NOT COMPLETED|Overall Study||97
8554109|NCT01522976|9586323|FG001|NOT COMPLETED|Overall Study||92
8554110|NCT01522976|9586324|FG002|NOT COMPLETED|Overall Study||93
8554111|NCT01286272|9586337|FG000|STARTED|Overall Study||67
8554112|NCT01286272|9586338|FG001|STARTED|Overall Study||65
8554113|NCT01286272|9586337|FG000|COMPLETED|Overall Study||66
8554114|NCT01286272|9586338|FG001|COMPLETED|Overall Study||62
8554115|NCT01286272|9586337|FG000|NOT COMPLETED|Overall Study||1
8554116|NCT01286272|9586338|FG001|NOT COMPLETED|Overall Study||3
8554117|NCT01134601|9586344|FG000|STARTED|Overall Study||1
8554118|NCT01134601|9586344|FG000|COMPLETED|Overall Study||1
8554119|NCT01134601|9586344|FG000|NOT COMPLETED|Overall Study||0
8554120|NCT01118026|9586348|FG000|STARTED|Overall Study||101
8554121|NCT01118026|9586348|FG000|COMPLETED|Overall Study||101
8554122|NCT01118026|9586348|FG000|NOT COMPLETED|Overall Study||0
8554123|NCT00879086|9586355|FG000|STARTED|Overall Study||52
8554124|NCT00879086|9586356|FG001|STARTED|Overall Study||52
8554125|NCT00879086|9586355|FG000|Safety Analysis Set (SAS)|Overall Study||51
8554126|NCT00879086|9586356|FG001|Safety Analysis Set (SAS)|Overall Study||50
8554127|NCT00879086|9586355|FG000|COMPLETED|Overall Study||0
8554128|NCT00879086|9586356|FG001|COMPLETED|Overall Study||0
8554129|NCT00879086|9586355|FG000|NOT COMPLETED|Overall Study||52
8554130|NCT00879086|9586356|FG001|NOT COMPLETED|Overall Study||52
8554131|NCT00864227|9586362|FG000|STARTED|Overall Study||54
8554132|NCT00864227|9586362|FG000|COMPLETED|Overall Study||50
8554133|NCT00864227|9586362|FG000|NOT COMPLETED|Overall Study||4
8554134|NCT00731731|9586369|FG000|STARTED|Overall Study||12
8554135|NCT00731731|9586370|FG001|STARTED|Overall Study||3
8554136|NCT00731731|9586371|FG002|STARTED|Overall Study||110
8554137|NCT00731731|9586369|FG000|COMPLETED|Overall Study||12
8554138|NCT00731731|9586370|FG001|COMPLETED|Overall Study||3
8554139|NCT00731731|9586371|FG002|COMPLETED|Overall Study||107
8554140|NCT00731731|9586369|FG000|NOT COMPLETED|Overall Study||0
8554141|NCT00731731|9586370|FG001|NOT COMPLETED|Overall Study||0
8554142|NCT00731731|9586371|FG002|NOT COMPLETED|Overall Study||3
8554143|NCT00685360|9586387|FG000|STARTED|Overall Study||161
8554144|NCT00685360|9586388|FG001|STARTED|Overall Study||160
8554145|NCT00685360|9586389|FG002|STARTED|Overall Study||160
8554146|NCT00685360|9586387|FG000|Modified Intent-to-Treat (MITT)|Overall Study||141
8554147|NCT00685360|9586388|FG001|Modified Intent-to-Treat (MITT)|Overall Study||136
8554148|NCT00685360|9586389|FG002|Modified Intent-to-Treat (MITT)|Overall Study||125
8554149|NCT00685360|9586387|FG000|MITT (Solid Culture)|Overall Study||119
8554150|NCT00685360|9586388|FG001|MITT (Solid Culture)|Overall Study||115
8554151|NCT00685360|9586389|FG002|MITT (Solid Culture)|Overall Study||113
8554152|NCT00685360|9586387|FG000|COMPLETED|Overall Study||143
8554153|NCT00685360|9586388|FG001|COMPLETED|Overall Study||146
8554154|NCT00685360|9586389|FG002|COMPLETED|Overall Study||145
8554155|NCT00685360|9586387|FG000|NOT COMPLETED|Overall Study||18
8554156|NCT00685360|9586388|FG001|NOT COMPLETED|Overall Study||14
8554157|NCT00685360|9586389|FG002|NOT COMPLETED|Overall Study||15
8554158|NCT00299728|9586399|FG000|STARTED|Overall Study||11
8554159|NCT00299728|9586400|FG001|STARTED|Overall Study||11
8554160|NCT00299728|9586399|FG000|COMPLETED|Overall Study||11
8554161|NCT00299728|9586400|FG001|COMPLETED|Overall Study||8
8554162|NCT00299728|9586399|FG000|NOT COMPLETED|Overall Study||0
8554163|NCT00299728|9586400|FG001|NOT COMPLETED|Overall Study||3
8554164|NCT00095784|9586406|FG000|STARTED|Overall Study||21
8554165|NCT00095784|9586406|FG000|COMPLETED|Overall Study||21
8554166|NCT00095784|9586406|FG000|NOT COMPLETED|Overall Study||0
8554167|NCT00070499|9586415|FG000|STARTED|Overall Study||75
8554168|NCT00070499|9586416|FG001|STARTED|Overall Study||78
8554169|NCT00070499|9586417|FG002|STARTED|Overall Study||126
8554170|NCT00070499|9586418|FG003|STARTED|Overall Study||127
8554171|NCT00070499|9586415|FG000|Eligible|Overall Study||73
8554172|NCT00070499|9586416|FG001|Eligible|Overall Study||73
8554173|NCT00070499|9586417|FG002|Eligible|Overall Study||123
8554174|NCT00070499|9586418|FG003|Eligible|Overall Study||125
8554175|NCT00070499|9586415|FG000|Eligible and Treated|Overall Study||72
8554176|NCT00070499|9586416|FG001|Eligible and Treated|Overall Study||73
8554177|NCT00070499|9586417|FG002|Eligible and Treated|Overall Study||123
8554178|NCT00070499|9586418|FG003|Eligible and Treated|Overall Study||123
8554179|NCT00070499|9586415|FG000|COMPLETED|Overall Study||37
8820011|NCT01568034|9873987|FG001|COMPLETED|Overall Study||2
8820012|NCT01568034|9873988|FG002|COMPLETED|Overall Study||3
8554180|NCT00070499|9586416|FG001|COMPLETED|Overall Study||52
8554181|NCT00070499|9586417|FG002|COMPLETED|Overall Study||6
8554182|NCT00070499|9586418|FG003|COMPLETED|Overall Study||17
8554183|NCT00070499|9586415|FG000|NOT COMPLETED|Overall Study||38
8554184|NCT00070499|9586416|FG001|NOT COMPLETED|Overall Study||26
8554185|NCT00070499|9586417|FG002|NOT COMPLETED|Overall Study||120
8554186|NCT00070499|9586418|FG003|NOT COMPLETED|Overall Study||110
8568444|NCT00092443|9600824|FG000|COMPLETED|Overall Study|Subjects vaccinated and followed up 42 days after each dose, thru 1st rotavirus season post study|593
8568445|NCT00092443|9600825|FG001|COMPLETED|Overall Study|Subjects vaccinated and followed up 42 days after each dose, thru 1st rotavirus season post study|607
8568446|NCT00092443|9600824|FG000|NOT COMPLETED|Overall Study||58
8568447|NCT00092443|9600825|FG001|NOT COMPLETED|Overall Study||54
8569353|NCT00096382|9601576|FG001|STARTED|Overall Study||3
8569354|NCT00096382|9601575|FG000|COMPLETED|Overall Study||21
8569355|NCT00096382|9601576|FG001|COMPLETED|Overall Study||3
8569356|NCT00096382|9601575|FG000|NOT COMPLETED|Overall Study||2
8569357|NCT00096382|9601576|FG001|NOT COMPLETED|Overall Study||0
8569358|NCT00096447|9601582|FG000|STARTED|Overall Study||31
8569359|NCT00096447|9601582|FG000|COMPLETED|Overall Study|Eligible and treated patients.|30
8569360|NCT00096447|9601582|FG000|NOT COMPLETED|Overall Study||1
8569361|NCT00096460|9601593|FG000|STARTED|Overall Study||22
8569362|NCT00096460|9601594|FG001|STARTED|Overall Study||8
8569363|NCT00096460|9601593|FG000|COMPLETED|Overall Study||15
8569364|NCT00096460|9601594|FG001|COMPLETED|Overall Study||7
8569365|NCT00096460|9601593|FG000|NOT COMPLETED|Overall Study||7
8569366|NCT00096460|9601594|FG001|NOT COMPLETED|Overall Study||1
8569367|NCT00096486|9601604|FG000|STARTED|Overall Study||4
8569368|NCT00096486|9601605|FG001|STARTED|Overall Study||6
8569369|NCT00096486|9601606|FG002|STARTED|Overall Study||26
8569370|NCT00096486|9601607|FG003|STARTED|Overall Study||38
8569371|NCT00096486|9601604|FG000|COMPLETED|Overall Study||4
8569372|NCT00096486|9601605|FG001|COMPLETED|Overall Study||6
8569373|NCT00096486|9601606|FG002|COMPLETED|Overall Study||24
8569374|NCT00096486|9601607|FG003|COMPLETED|Overall Study||36
8569375|NCT00096486|9601604|FG000|NOT COMPLETED|Overall Study||0
8569376|NCT00096486|9601605|FG001|NOT COMPLETED|Overall Study||0
8569377|NCT00096486|9601606|FG002|NOT COMPLETED|Overall Study||2
8569378|NCT00096486|9601607|FG003|NOT COMPLETED|Overall Study||2
8569379|NCT00096538|9601617|FG000|STARTED|Overall Study||6
8569380|NCT00096538|9601617|FG000|COMPLETED|Overall Study||5
8569381|NCT00096538|9601617|FG000|NOT COMPLETED|Overall Study||1
8569382|NCT00096681|9601621|FG000|STARTED|Overall Study||762
8569383|NCT00096681|9601621|FG000|COMPLETED|Overall Study||762
8569384|NCT00096681|9601621|FG000|NOT COMPLETED|Overall Study||0
8569385|NCT00096785|9601627|FG000|STARTED|Overall Study|1 participant randomized to ADV, treated with ETV. (As randomized= 35; as treated=36)|35
8569386|NCT00096785|9601628|FG001|STARTED|Overall Study|1 participant randomized to ADV, treated with ETV. (As randomized= 34; as treated=33)|34
8569387|NCT00096785|9601627|FG000|As-Randomized Population|Overall Study||35
8569388|NCT00096785|9601628|FG001|As-Randomized Population|Overall Study||34
8569389|NCT00096785|9601627|FG000|As-Treated Population|Overall Study||36
8569390|NCT00096785|9601628|FG001|As-Treated Population|Overall Study||33
8569391|NCT00096785|9601627|FG000|COMPLETED|Overall Study|As randomized cohort|33
8569392|NCT00096785|9601628|FG001|COMPLETED|Overall Study|As randomized cohort|33
8569393|NCT00096785|9601627|FG000|NOT COMPLETED|Overall Study||2
8569394|NCT00096785|9601628|FG001|NOT COMPLETED|Overall Study||1
8569395|NCT00096941|9601634|FG000|STARTED|Overall Study||3
8569396|NCT00096941|9601634|FG000|COMPLETED|Overall Study||0
8569397|NCT00096941|9601634|FG000|NOT COMPLETED|Overall Study||3
8569398|NCT00096954|9601640|FG000|STARTED|Overall Study||159
8820013|NCT01568034|9873989|FG003|COMPLETED|Overall Study||3
8820014|NCT01568034|9873986|FG000|NOT COMPLETED|Overall Study||1
8569399|NCT00096954|9601641|FG001|STARTED|Overall Study||174
8569400|NCT00096954|9601640|FG000|Received Study Drug|Overall Study||157
8569401|NCT00096954|9601641|FG001|Received Study Drug|Overall Study||171
8569402|NCT00096954|9601640|FG000|COMPLETED|Overall Study||135
8569403|NCT00096954|9601641|FG001|COMPLETED|Overall Study||154
8569404|NCT00096954|9601640|FG000|NOT COMPLETED|Overall Study||24
8569405|NCT00096954|9601641|FG001|NOT COMPLETED|Overall Study||20
8569406|NCT00096993|9601649|FG000|STARTED|Overall Study||66
8554187|NCT04450823|9586436|FG000|STARTED|Overall Study||61
8554188|NCT04450823|9586436|FG000|COMPLETED|Overall Study||58
8554189|NCT04450823|9586436|FG000|NOT COMPLETED|Overall Study||3
8554190|NCT04446247|9586440|FG000|STARTED|Overall Study||14
8554191|NCT04446247|9586440|FG000|COMPLETED|Overall Study||14
8554192|NCT04446247|9586440|FG000|NOT COMPLETED|Overall Study||0
8554193|NCT04386785|9586446|FG000|STARTED|Overall Study||27
8554194|NCT04386785|9586446|FG000|COMPLETED|Overall Study||27
8554195|NCT04386785|9586446|FG000|NOT COMPLETED|Overall Study||0
8554196|NCT04347564|9586450|FG000|STARTED|Overall Study||45
8554197|NCT04347564|9586450|FG000|COMPLETED|Overall Study||45
8554198|NCT04347564|9586450|FG000|NOT COMPLETED|Overall Study||0
8554199|NCT04330157|9586457|FG000|STARTED|Overall Study||50
8554200|NCT04330157|9586457|FG000|COMPLETED|Overall Study||43
8554201|NCT04330157|9586457|FG000|NOT COMPLETED|Overall Study||7
8554202|NCT04317690|9586471|FG000|STARTED|Overall Study||100
8554203|NCT04317690|9586472|FG001|STARTED|Overall Study||100
8554204|NCT04317690|9586473|FG002|STARTED|Overall Study||140
8554205|NCT04317690|9586474|FG003|STARTED|Overall Study||100
8554206|NCT04317690|9586475|FG004|STARTED|Overall Study||99
8554207|NCT04317690|9586471|FG000|COMPLETED|Overall Study||100
8554208|NCT04317690|9586472|FG001|COMPLETED|Overall Study||96
8554209|NCT04317690|9586473|FG002|COMPLETED|Overall Study||140
8554210|NCT04317690|9586474|FG003|COMPLETED|Overall Study||98
8554211|NCT04317690|9586475|FG004|COMPLETED|Overall Study||99
8554212|NCT04317690|9586471|FG000|NOT COMPLETED|Overall Study||0
8554213|NCT04317690|9586472|FG001|NOT COMPLETED|Overall Study||4
8554214|NCT04317690|9586473|FG002|NOT COMPLETED|Overall Study||0
8554215|NCT04317690|9586474|FG003|NOT COMPLETED|Overall Study||2
8554216|NCT04317690|9586475|FG004|NOT COMPLETED|Overall Study||0
8554217|NCT04274556|9586487|FG000|STARTED|Overall Study||86
8554218|NCT04274556|9586487|FG000|COMPLETED|Overall Study||86
8554219|NCT04274556|9586487|FG000|NOT COMPLETED|Overall Study||0
8554220|NCT04270292|9586491|FG000|STARTED|Overall Study||164
8554221|NCT04270292|9586491|FG000|COMPLETED|Overall Study||164
8554222|NCT04270292|9586491|FG000|NOT COMPLETED|Overall Study||0
8554223|NCT04182217|9586495|FG000|STARTED|Overall Study||91
8554224|NCT04182217|9586495|FG000|COMPLETED|Overall Study||91
8554225|NCT04182217|9586495|FG000|NOT COMPLETED|Overall Study||0
8554229|NCT04083404|9586504|FG000|STARTED|Overall Study||202
8554230|NCT04083404|9586504|FG000|COMPLETED|Overall Study||202
8554231|NCT04083404|9586504|FG000|NOT COMPLETED|Overall Study||0
8554232|NCT04079114|9586508|FG000|STARTED|Overall Study||166
8554233|NCT04079114|9586508|FG000|COMPLETED|Overall Study|Study prematurely terminated.|0
8554234|NCT04079114|9586508|FG000|NOT COMPLETED|Overall Study||166
8554260|NCT03977818|9586541|FG000|STARTED|Overall Study||2165
8554261|NCT03977818|9586541|FG000|COMPLETED|Overall Study||2165
8554262|NCT03977818|9586541|FG000|NOT COMPLETED|Overall Study||0
8554263|NCT03976531|9586545|FG000|STARTED|Overall Study||42
8554264|NCT03976531|9586545|FG000|COMPLETED|Overall Study||42
8554265|NCT03976531|9586545|FG000|NOT COMPLETED|Overall Study||0
8554302|NCT03889028|9586602|FG000|STARTED|Overall Study||144
8554303|NCT03889028|9586603|FG001|STARTED|Overall Study||422
8554304|NCT03889028|9586604|FG002|STARTED|Overall Study||312
8554305|NCT03889028|9586602|FG000|COMPLETED|Overall Study||144
8554306|NCT03889028|9586603|FG001|COMPLETED|Overall Study||422
8554307|NCT03889028|9586604|FG002|COMPLETED|Overall Study||312
8554308|NCT03889028|9586602|FG000|NOT COMPLETED|Overall Study||0
8554309|NCT03889028|9586603|FG001|NOT COMPLETED|Overall Study||0
8554310|NCT03889028|9586604|FG002|NOT COMPLETED|Overall Study||0
8554311|NCT03842683|9586611|FG000|STARTED|Overall Study||472
8554312|NCT03842683|9586611|FG000|COMPLETED|Overall Study||472
8554313|NCT03842683|9586611|FG000|NOT COMPLETED|Overall Study||0
8554314|NCT03839511|9586616|FG000|STARTED|Overall Study||4
8554315|NCT03839511|9586616|FG000|COMPLETED|Overall Study||4
8554316|NCT03839511|9586616|FG000|NOT COMPLETED|Overall Study||0
8554317|NCT03835546|9586623|FG000|STARTED|Overall Study||15
8554318|NCT03835546|9586624|FG001|STARTED|Overall Study||15
8554319|NCT03835546|9586625|FG002|STARTED|Overall Study||15
8554320|NCT03835546|9586623|FG000|COMPLETED|Overall Study||12
8554321|NCT03835546|9586624|FG001|COMPLETED|Overall Study||15
8554322|NCT03835546|9586625|FG002|COMPLETED|Overall Study||15
8554323|NCT03835546|9586623|FG000|NOT COMPLETED|Overall Study||3
8554324|NCT03835546|9586624|FG001|NOT COMPLETED|Overall Study||0
8554325|NCT03835546|9586625|FG002|NOT COMPLETED|Overall Study||0
8554326|NCT04461795|9586633|FG000|STARTED|Overall Study||40
8554327|NCT04461795|9586633|FG000|COMPLETED|Overall Study||35
8554328|NCT04461795|9586633|FG000|NOT COMPLETED|Overall Study||5
8554329|NCT04405999|9586640|FG000|STARTED|Overall Study||25
8554330|NCT04405999|9586641|FG001|STARTED|Overall Study||25
8554331|NCT04405999|9586640|FG000|COMPLETED|Overall Study||25
8554332|NCT04405999|9586641|FG001|COMPLETED|Overall Study||25
8554333|NCT04405999|9586640|FG000|NOT COMPLETED|Overall Study||0
8554334|NCT04405999|9586641|FG001|NOT COMPLETED|Overall Study||0
8554335|NCT04383587|9586647|FG000|STARTED|Overall Study||300
8554336|NCT04383587|9586647|FG000|COMPLETED|Overall Study||292
8554337|NCT04383587|9586647|FG000|NOT COMPLETED|Overall Study||8
8554338|NCT04035473|9586654|FG000|STARTED|Screening/Baseline||20
8554339|NCT04035473|9586655|FG001|STARTED|Screening/Baseline||22
8554340|NCT04035473|9586654|FG000|COMPLETED|Screening/Baseline||20
8554341|NCT04035473|9586655|FG001|COMPLETED|Screening/Baseline||20
8554342|NCT04035473|9586654|FG000|NOT COMPLETED|Screening/Baseline||0
8554343|NCT04035473|9586655|FG001|NOT COMPLETED|Screening/Baseline||2
8554226|NCT04160988|9586499|FG000|STARTED|Overall Study||703
8554227|NCT04160988|9586499|FG000|COMPLETED|Overall Study||675
8554228|NCT04160988|9586499|FG000|NOT COMPLETED|Overall Study||28
8554235|NCT04075279|9586512|FG000|STARTED|Overall Study||19
8554236|NCT04075279|9586512|FG000|COMPLETED|Overall Study||19
8554237|NCT04075279|9586512|FG000|NOT COMPLETED|Overall Study||0
8554238|NCT04066686|9586518|FG000|STARTED|Overall Study||14
8554239|NCT04066686|9586519|FG001|STARTED|Overall Study||13
8554240|NCT04066686|9586518|FG000|COMPLETED|Overall Study||12
8554241|NCT04066686|9586519|FG001|COMPLETED|Overall Study||13
8554242|NCT04066686|9586518|FG000|NOT COMPLETED|Overall Study||2
8554243|NCT04066686|9586519|FG001|NOT COMPLETED|Overall Study||0
8554244|NCT04058626|9586525|FG000|STARTED|Overall Study||305
8554245|NCT04058626|9586525|FG000|COMPLETED|Overall Study||305
8554246|NCT04058626|9586525|FG000|NOT COMPLETED|Overall Study||0
8554247|NCT04057235|9586529|FG000|STARTED|Overall Study||129
8554248|NCT04057235|9586529|FG000|Had Radiographic Data|Overall Study||58
8554249|NCT04057235|9586529|FG000|Had ODI Data|Overall Study||43
8554250|NCT04057235|9586529|FG000|Had VAS Back Data|Overall Study||45
8554251|NCT04057235|9586529|FG000|Had VAS Leg Data|Overall Study||45
8554252|NCT04057235|9586529|FG000|COMPLETED|Overall Study|All 129 participants had data for at least one of the primary/secondary outcomes or adverse events|129
8554253|NCT04057235|9586529|FG000|NOT COMPLETED|Overall Study||0
8554266|NCT03964649|9586559|FG000|STARTED|Overall Study||349
8554267|NCT03964649|9586560|FG001|STARTED|Overall Study||304
8621824|NCT00483652|9660884|FG000|COMPLETED|Post-study Follow-up||113
8621825|NCT00483652|9660885|FG001|COMPLETED|Post-study Follow-up||114
8621826|NCT00483652|9660884|FG000|NOT COMPLETED|Post-study Follow-up||0
8621827|NCT00483652|9660885|FG001|NOT COMPLETED|Post-study Follow-up||0
8621828|NCT00483704|9660894|FG000|STARTED|Randomization||644
8621829|NCT00483704|9660895|FG001|STARTED|Randomization||645
8554268|NCT03964649|9586561|FG002|STARTED|Overall Study||2728
8554269|NCT03964649|9586562|FG003|STARTED|Overall Study||192
8554270|NCT03964649|9586563|FG004|STARTED|Overall Study||1948
8554271|NCT03964649|9586564|FG005|STARTED|Overall Study||349
8554272|NCT03964649|9586565|FG006|STARTED|Overall Study||376
8554273|NCT03964649|9586566|FG007|STARTED|Overall Study||325
8554274|NCT03964649|9586567|FG008|STARTED|Overall Study||204
8554275|NCT03964649|9586568|FG009|STARTED|Overall Study||533
8554276|NCT03964649|9586559|FG000|COMPLETED|Overall Study||349
8554277|NCT03964649|9586560|FG001|COMPLETED|Overall Study||304
8554278|NCT03964649|9586561|FG002|COMPLETED|Overall Study||2728
8554279|NCT03964649|9586562|FG003|COMPLETED|Overall Study||192
8554280|NCT03964649|9586563|FG004|COMPLETED|Overall Study||1948
8554281|NCT03964649|9586564|FG005|COMPLETED|Overall Study||349
8554282|NCT03964649|9586565|FG006|COMPLETED|Overall Study||376
8554283|NCT03964649|9586566|FG007|COMPLETED|Overall Study||325
8554284|NCT03964649|9586567|FG008|COMPLETED|Overall Study||204
8554285|NCT03964649|9586568|FG009|COMPLETED|Overall Study||533
8554286|NCT03964649|9586559|FG000|NOT COMPLETED|Overall Study||0
8554287|NCT03964649|9586560|FG001|NOT COMPLETED|Overall Study||0
8554288|NCT03964649|9586561|FG002|NOT COMPLETED|Overall Study||0
8554289|NCT03964649|9586562|FG003|NOT COMPLETED|Overall Study||0
8554290|NCT03964649|9586563|FG004|NOT COMPLETED|Overall Study||0
8554291|NCT03964649|9586564|FG005|NOT COMPLETED|Overall Study||0
8554292|NCT03964649|9586565|FG006|NOT COMPLETED|Overall Study||0
8554293|NCT03964649|9586566|FG007|NOT COMPLETED|Overall Study||0
8554294|NCT03964649|9586567|FG008|NOT COMPLETED|Overall Study||0
8554295|NCT03964649|9586568|FG009|NOT COMPLETED|Overall Study||0
8554344|NCT04035473|9586654|FG000|STARTED|Treatment Period 1||20
8554345|NCT04035473|9586655|FG001|STARTED|Treatment Period 1||20
8554346|NCT04035473|9586654|FG000|COMPLETED|Treatment Period 1||20
8554347|NCT04035473|9586655|FG001|COMPLETED|Treatment Period 1||20
8554348|NCT04035473|9586654|FG000|NOT COMPLETED|Treatment Period 1||0
8554349|NCT04035473|9586655|FG001|NOT COMPLETED|Treatment Period 1||0
8554350|NCT04035473|9586654|FG000|STARTED|Treatment Period 2|2 subjects withdrew before starting treatment period 2 due to diease progression and withdrawal from study treatment and procedure.|18
8554351|NCT04035473|9586655|FG001|STARTED|Treatment Period 2|1 subject withdrew before starting treatment period 2 due to SAE and investigator's decision.|19
8554352|NCT04035473|9586654|FG000|COMPLETED|Treatment Period 2||18
8554353|NCT04035473|9586655|FG001|COMPLETED|Treatment Period 2||19
8554354|NCT04035473|9586654|FG000|NOT COMPLETED|Treatment Period 2||0
8554355|NCT04035473|9586655|FG001|NOT COMPLETED|Treatment Period 2||0
8554356|NCT04035473|9586654|FG000|STARTED|Follow-up Period||18
8554357|NCT04035473|9586655|FG001|STARTED|Follow-up Period||19
8621830|NCT00483704|9660896|FG002|STARTED|Randomization||646
8621831|NCT00483704|9660894|FG000|COMPLETED|Randomization||573
8621832|NCT00483704|9660895|FG001|COMPLETED|Randomization||549
8621833|NCT00483704|9660896|FG002|COMPLETED|Randomization||555
8621834|NCT00483704|9660894|FG000|NOT COMPLETED|Randomization||71
8621835|NCT00483704|9660895|FG001|NOT COMPLETED|Randomization||96
8621836|NCT00483704|9660896|FG002|NOT COMPLETED|Randomization||91
8554358|NCT04035473|9586654|FG000|COMPLETED|Follow-up Period||16
8554359|NCT04035473|9586655|FG001|COMPLETED|Follow-up Period||19
8554360|NCT04035473|9586654|FG000|NOT COMPLETED|Follow-up Period||2
8554361|NCT04035473|9586655|FG001|NOT COMPLETED|Follow-up Period||0
8568448|NCT00092456|9600845|FG000|STARTED|Overall Study|Subject assigned to ~8.81 X 10^7 IU/Dose of RotaTeq™ - Lot 1|226
8568449|NCT00092456|9600846|FG001|STARTED|Overall Study|Subject assigned to ~8.01 X 10^7 IU/Dose of RotaTeq™ - Lot 2|225
8569407|NCT00096993|9601650|FG001|STARTED|Overall Study||65
8621837|NCT00483704|9660894|FG000|STARTED|Treatment||573
8554254|NCT04041037|9586533|FG000|STARTED|Overall Study||2
8554255|NCT04041037|9586533|FG000|COMPLETED|Overall Study||2
8554256|NCT04041037|9586533|FG000|NOT COMPLETED|Overall Study||0
8554296|NCT03941015|9586592|FG000|STARTED|Overall Study||38
8554297|NCT03941015|9586593|FG001|STARTED|Overall Study||207
8554298|NCT03941015|9586592|FG000|COMPLETED|Overall Study||38
8554299|NCT03941015|9586593|FG001|COMPLETED|Overall Study||204
8554300|NCT03941015|9586592|FG000|NOT COMPLETED|Overall Study||0
8554301|NCT03941015|9586593|FG001|NOT COMPLETED|Overall Study||3
8554362|NCT03796676|9586664|FG000|STARTED|Overall Study||96
8554363|NCT03796676|9586665|FG001|STARTED|Overall Study||95
8554364|NCT03796676|9586666|FG002|STARTED|Overall Study||94
8554365|NCT03796676|9586664|FG000|COMPLETED|Overall Study||90
8554366|NCT03796676|9586665|FG001|COMPLETED|Overall Study||92
8554367|NCT03796676|9586666|FG002|COMPLETED|Overall Study||91
8554368|NCT03796676|9586664|FG000|NOT COMPLETED|Overall Study||6
8554369|NCT03796676|9586665|FG001|NOT COMPLETED|Overall Study||3
8554370|NCT03796676|9586666|FG002|NOT COMPLETED|Overall Study||3
8554371|NCT03366220|9586679|FG000|STARTED|Overall Study||4
8554372|NCT03366220|9586680|FG001|STARTED|Overall Study||4
8554373|NCT03366220|9586679|FG000|COMPLETED|Overall Study||4
8554374|NCT03366220|9586680|FG001|COMPLETED|Overall Study||4
8554375|NCT03366220|9586679|FG000|NOT COMPLETED|Overall Study||0
8554376|NCT03366220|9586680|FG001|NOT COMPLETED|Overall Study||0
8554377|NCT03215810|9586686|FG000|STARTED|Overall Study||20
8554378|NCT03215810|9586686|FG000|COMPLETED|Overall Study||16
8554379|NCT03215810|9586686|FG000|NOT COMPLETED|Overall Study||4
8554380|NCT02989857|9586692|FG000|STARTED|Randomization Phase||126
8554381|NCT02989857|9586693|FG001|STARTED|Randomization Phase||61
8554382|NCT02989857|9586694|FG002|STARTED|Randomization Phase||0
8554383|NCT02989857|9586692|FG000|COMPLETED|Randomization Phase|Completed implies the participants who completed the study treatment.|0
8554384|NCT02989857|9586693|FG001|COMPLETED|Randomization Phase|Completed implies the participants who completed the study treatment.|0
8554385|NCT02989857|9586694|FG002|COMPLETED|Randomization Phase||0
8554386|NCT02989857|9586692|FG000|NOT COMPLETED|Randomization Phase||126
8554387|NCT02989857|9586693|FG001|NOT COMPLETED|Randomization Phase||61
8554388|NCT02989857|9586694|FG002|NOT COMPLETED|Randomization Phase||0
8554389|NCT02989857|9586692|FG000|STARTED|Cross Over Phase||0
8554390|NCT02989857|9586693|FG001|STARTED|Cross Over Phase||0
8554391|NCT02989857|9586694|FG002|STARTED|Cross Over Phase|Participants who had experienced disease progression and received placebo were allowed to cross over to receive AG-120.|43
8554392|NCT02989857|9586692|FG000|COMPLETED|Cross Over Phase||0
8554393|NCT02989857|9586693|FG001|COMPLETED|Cross Over Phase||0
8554394|NCT02989857|9586694|FG002|COMPLETED|Cross Over Phase|Completed implies the participants who completed the study treatment.|0
8554395|NCT02989857|9586692|FG000|NOT COMPLETED|Cross Over Phase||0
8554396|NCT02989857|9586693|FG001|NOT COMPLETED|Cross Over Phase||0
8554397|NCT02989857|9586694|FG002|NOT COMPLETED|Cross Over Phase||43
8554398|NCT02983799|9586706|FG000|STARTED|Overall Study||75
8554399|NCT02983799|9586707|FG001|STARTED|Overall Study||26
8554400|NCT02983799|9586708|FG002|STARTED|Overall Study||68
8554401|NCT02983799|9586709|FG003|STARTED|Overall Study||90
8554402|NCT02983799|9586710|FG004|STARTED|Overall Study||13
8554403|NCT02983799|9586706|FG000|COMPLETED|Overall Study||25
8554404|NCT02983799|9586707|FG001|COMPLETED|Overall Study||8
8554405|NCT02983799|9586708|FG002|COMPLETED|Overall Study||18
8554406|NCT02983799|9586709|FG003|COMPLETED|Overall Study||14
8554407|NCT02983799|9586710|FG004|COMPLETED|Overall Study||3
8554408|NCT02983799|9586706|FG000|NOT COMPLETED|Overall Study||50
8554409|NCT02983799|9586707|FG001|NOT COMPLETED|Overall Study||18
8554410|NCT02983799|9586708|FG002|NOT COMPLETED|Overall Study||50
8554411|NCT02983799|9586709|FG003|NOT COMPLETED|Overall Study||76
8554412|NCT02983799|9586710|FG004|NOT COMPLETED|Overall Study||10
8554413|NCT02971683|9586728|FG000|STARTED|Overall Study||75
8554414|NCT02971683|9586729|FG001|STARTED|Overall Study||73
8554415|NCT02971683|9586728|FG000|COMPLETED|Overall Study||69
8554416|NCT02971683|9586729|FG001|COMPLETED|Overall Study||65
8554417|NCT02971683|9586728|FG000|NOT COMPLETED|Overall Study||6
8554418|NCT02971683|9586729|FG001|NOT COMPLETED|Overall Study||8
8554419|NCT02682992|9586735|FG000|STARTED|Overall Study||47
8554420|NCT02682992|9586735|FG000|COMPLETED|Overall Study||47
8554421|NCT02682992|9586735|FG000|NOT COMPLETED|Overall Study||0
8554422|NCT02631577|9586741|FG000|STARTED|Overall Study||4
8554423|NCT02631577|9586742|FG001|STARTED|Overall Study||34
8554424|NCT02631577|9586741|FG000|COMPLETED|Overall Study||3
8554425|NCT02631577|9586742|FG001|COMPLETED|Overall Study||24
8554426|NCT02631577|9586741|FG000|NOT COMPLETED|Overall Study||1
8554427|NCT02631577|9586742|FG001|NOT COMPLETED|Overall Study||10
8554428|NCT02573779|9586750|FG000|STARTED|Overall Study||74
8554429|NCT02573779|9586751|FG001|STARTED|Overall Study||43
8621838|NCT00483704|9660895|FG001|STARTED|Treatment||549
8621839|NCT00483704|9660896|FG002|STARTED|Treatment||555
8621840|NCT00483704|9660894|FG000|COMPLETED|Treatment||444
8621841|NCT00483704|9660895|FG001|COMPLETED|Treatment||420
8554430|NCT02573779|9586750|FG000|COMPLETED|Overall Study||74
8554431|NCT02573779|9586751|FG001|COMPLETED|Overall Study||43
8554432|NCT02573779|9586750|FG000|NOT COMPLETED|Overall Study||0
8554433|NCT02573779|9586751|FG001|NOT COMPLETED|Overall Study||0
8554434|NCT02408315|9586759|FG000|STARTED|Overall Study||148
8554435|NCT02408315|9586760|FG001|STARTED|Overall Study||152
8554436|NCT02408315|9586759|FG000|COMPLETED|Overall Study||148
8621842|NCT00483704|9660896|FG002|COMPLETED|Treatment||399
8554257|NCT04034043|9586537|FG000|STARTED|Overall Study||68
8554258|NCT04034043|9586537|FG000|COMPLETED|Overall Study||68
8554259|NCT04034043|9586537|FG000|NOT COMPLETED|Overall Study||0
8554437|NCT02408315|9586760|FG001|COMPLETED|Overall Study||152
8554438|NCT02408315|9586759|FG000|NOT COMPLETED|Overall Study||0
8554439|NCT02408315|9586760|FG001|NOT COMPLETED|Overall Study||0
8554440|NCT02300233|9586769|FG000|STARTED|Overall Study||38
8554441|NCT02300233|9586770|FG001|STARTED|Overall Study||25
8554442|NCT02300233|9586771|FG002|STARTED|Overall Study||50
8554443|NCT02300233|9586769|FG000|COMPLETED|Overall Study||34
8554444|NCT02300233|9586770|FG001|COMPLETED|Overall Study||24
8554445|NCT02300233|9586771|FG002|COMPLETED|Overall Study||27
8554446|NCT02300233|9586769|FG000|NOT COMPLETED|Overall Study||4
8554447|NCT02300233|9586770|FG001|NOT COMPLETED|Overall Study||1
8554448|NCT02300233|9586771|FG002|NOT COMPLETED|Overall Study||23
8554449|NCT02211209|9586782|FG000|STARTED|Overall Study||34
8554450|NCT02211209|9586783|FG001|STARTED|Overall Study||33
8554451|NCT02211209|9586782|FG000|Dosed|Overall Study||33
8554452|NCT02211209|9586783|FG001|Dosed|Overall Study||33
8554453|NCT02211209|9586782|FG000|COMPLETED|Overall Study||32
8554454|NCT02211209|9586783|FG001|COMPLETED|Overall Study||19
8554455|NCT02211209|9586782|FG000|NOT COMPLETED|Overall Study||2
8554456|NCT02211209|9586783|FG001|NOT COMPLETED|Overall Study||14
8621843|NCT00483704|9660894|FG000|NOT COMPLETED|Treatment||129
8621844|NCT00483704|9660895|FG001|NOT COMPLETED|Treatment||129
8621845|NCT00483704|9660896|FG002|NOT COMPLETED|Treatment||156
8554457|NCT02125461|9586791|FG000|STARTED|Overall Study||476
8554458|NCT02125461|9586792|FG001|STARTED|Overall Study||237
8554459|NCT02125461|9586791|FG000|Full Analysis Set (FAS)|Overall Study||476
8554460|NCT02125461|9586792|FG001|Full Analysis Set (FAS)|Overall Study||237
8554461|NCT02125461|9586791|FG000|Received Treatment|Overall Study||473
8554462|NCT02125461|9586792|FG001|Received Treatment|Overall Study||236
8554463|NCT02125461|9586791|FG000|Safety Analysis Set|Overall Study||475
8554464|NCT02125461|9586792|FG001|Safety Analysis Set|Overall Study||234
8554465|NCT02125461|9586791|FG000|Completed 12 Months of Treatment|Overall Study||232
8554466|NCT02125461|9586792|FG001|Completed 12 Months of Treatment|Overall Study||82
8554467|NCT02125461|9586791|FG000|COMPLETED|Overall Study||178
8554468|NCT02125461|9586792|FG001|COMPLETED|Overall Study||68
8554469|NCT02125461|9586791|FG000|NOT COMPLETED|Overall Study||298
8554470|NCT02125461|9586792|FG001|NOT COMPLETED|Overall Study||169
8554471|NCT02000115|9586801|FG000|STARTED|Overall Study||381
8554472|NCT02000115|9586802|FG001|STARTED|Overall Study||369
8554473|NCT02000115|9586803|FG002|STARTED|Overall Study||100
8554474|NCT02000115|9586804|FG003|STARTED|Overall Study||53
8554475|NCT02000115|9586801|FG000|COMPLETED|Overall Study|6 subjects missed the One-year follow-up visit|302
8554476|NCT02000115|9586802|FG001|COMPLETED|Overall Study|8 subjects missed the One-year follow-up visit|301
8554477|NCT02000115|9586803|FG002|COMPLETED|Overall Study|1 subject missed the 30 day follow-up visit|99
8554478|NCT02000115|9586804|FG003|COMPLETED|Overall Study||0
8554479|NCT02000115|9586801|FG000|NOT COMPLETED|Overall Study||79
8554480|NCT02000115|9586802|FG001|NOT COMPLETED|Overall Study||68
8554481|NCT02000115|9586803|FG002|NOT COMPLETED|Overall Study||1
8554482|NCT02000115|9586804|FG003|NOT COMPLETED|Overall Study||53
8554483|NCT01888653|9586815|FG000|STARTED|Overall Study||24
8554484|NCT01888653|9586816|FG001|STARTED|Overall Study||26
8554485|NCT01888653|9586815|FG000|COMPLETED|Overall Study||24
8554486|NCT01888653|9586816|FG001|COMPLETED|Overall Study||26
8554487|NCT01888653|9586815|FG000|NOT COMPLETED|Overall Study||0
8554488|NCT01888653|9586816|FG001|NOT COMPLETED|Overall Study||0
8554489|NCT01813227|9586822|FG000|STARTED|Overall Study||7
8554490|NCT01813227|9586822|FG000|COMPLETED|Overall Study||7
8554491|NCT01813227|9586822|FG000|NOT COMPLETED|Overall Study||0
8554492|NCT01695317|9586828|FG000|STARTED|Period 1 in the Cross-over Design||36
8554493|NCT01695317|9586829|FG001|STARTED|Period 1 in the Cross-over Design||36
8554494|NCT01695317|9586828|FG000|COMPLETED|Period 1 in the Cross-over Design||34
8554495|NCT01695317|9586829|FG001|COMPLETED|Period 1 in the Cross-over Design||35
8554496|NCT01695317|9586828|FG000|NOT COMPLETED|Period 1 in the Cross-over Design||2
8554497|NCT01695317|9586829|FG001|NOT COMPLETED|Period 1 in the Cross-over Design||1
8554498|NCT01695317|9586828|FG000|STARTED|Cross-over to Period 2||34
8554499|NCT01695317|9586829|FG001|STARTED|Cross-over to Period 2||35
8554500|NCT01695317|9586828|FG000|COMPLETED|Cross-over to Period 2||30
8554501|NCT01695317|9586829|FG001|COMPLETED|Cross-over to Period 2||1
8554502|NCT01695317|9586828|FG000|NOT COMPLETED|Cross-over to Period 2||4
8554503|NCT01695317|9586829|FG001|NOT COMPLETED|Cross-over to Period 2||34
8554504|NCT01683825|9586838|FG000|STARTED|Overall Study||10
8554505|NCT01683825|9586839|FG001|STARTED|Overall Study||6
8554506|NCT01683825|9586840|FG002|STARTED|Overall Study||7
8554507|NCT01683825|9586838|FG000|COMPLETED|Overall Study||10
8554508|NCT01683825|9586839|FG001|COMPLETED|Overall Study||6
8554509|NCT01683825|9586840|FG002|COMPLETED|Overall Study||7
8554510|NCT01683825|9586838|FG000|NOT COMPLETED|Overall Study||0
8554511|NCT01683825|9586839|FG001|NOT COMPLETED|Overall Study||0
8554512|NCT01683825|9586840|FG002|NOT COMPLETED|Overall Study||0
8554513|NCT01196936|9586851|FG000|STARTED|Overall Study||34
8554514|NCT01196936|9586852|FG001|STARTED|Overall Study||38
8554515|NCT01196936|9586851|FG000|Year One Post Treatment|Overall Study||27
8554516|NCT01196936|9586852|FG001|Year One Post Treatment|Overall Study||28
8554517|NCT01196936|9586851|FG000|COMPLETED|Overall Study||23
8554518|NCT01196936|9586852|FG001|COMPLETED|Overall Study||21
8621846|NCT00483717|9660909|FG000|STARTED|Overall Study||87
8554519|NCT01196936|9586851|FG000|NOT COMPLETED|Overall Study||11
8554520|NCT01196936|9586852|FG001|NOT COMPLETED|Overall Study||17
8554521|NCT01127451|9586860|FG000|STARTED|Overall Study||43
8554522|NCT01127451|9586861|FG001|STARTED|Overall Study||32
8554523|NCT01127451|9586860|FG000|Safety Analysis Set|Overall Study||43
8554524|NCT01127451|9586861|FG001|Safety Analysis Set|Overall Study||32
8554525|NCT01127451|9586860|FG000|Modified Intent-to-Treat (MITT)|Overall Study||42
8554526|NCT01127451|9586861|FG001|Modified Intent-to-Treat (MITT)|Overall Study||32
8554527|NCT01127451|9586860|FG000|COMPLETED|Overall Study||0
8554528|NCT01127451|9586861|FG001|COMPLETED|Overall Study||0
8554529|NCT01127451|9586860|FG000|NOT COMPLETED|Overall Study||43
8554530|NCT01127451|9586861|FG001|NOT COMPLETED|Overall Study||32
8554531|NCT01004874|9586867|FG000|STARTED|Overall Study||80
8554532|NCT01004874|9586867|FG000|COMPLETED|Overall Study||80
8554533|NCT01004874|9586867|FG000|NOT COMPLETED|Overall Study||0
8568450|NCT00092456|9600847|FG002|STARTED|Overall Study|Subject assigned to ~6.91 X 10^7 IU/Dose of RotaTeq™ - Lot 3|229
8568451|NCT00092456|9600848|FG003|STARTED|Overall Study|Subjects assigned to Placebo-matching RotaTeq™|113
8568452|NCT00092456|9600845|FG000|Vaccinated at Visit 1|Overall Study||226
8568453|NCT00092456|9600846|FG001|Vaccinated at Visit 1|Overall Study||225
8568454|NCT00092456|9600847|FG002|Vaccinated at Visit 1|Overall Study||229
8568455|NCT00092456|9600848|FG003|Vaccinated at Visit 1|Overall Study||113
8568456|NCT00092456|9600845|FG000|Vaccinated at Visit 2|Overall Study||208
8568457|NCT00092456|9600846|FG001|Vaccinated at Visit 2|Overall Study||217
8568458|NCT00092456|9600847|FG002|Vaccinated at Visit 2|Overall Study||210
8568459|NCT00092456|9600848|FG003|Vaccinated at Visit 2|Overall Study||104
8568460|NCT00092456|9600845|FG000|Vaccinated at Visit 3|Overall Study||202
8568461|NCT00092456|9600846|FG001|Vaccinated at Visit 3|Overall Study||210
8568462|NCT00092456|9600847|FG002|Vaccinated at Visit 3|Overall Study||200
8568463|NCT00092456|9600848|FG003|Vaccinated at Visit 3|Overall Study||98
8568464|NCT00092456|9600845|FG000|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|201
8568465|NCT00092456|9600846|FG001|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|208
8568466|NCT00092456|9600847|FG002|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|200
8568467|NCT00092456|9600848|FG003|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|97
8568468|NCT00092456|9600845|FG000|NOT COMPLETED|Overall Study||25
8568469|NCT00092456|9600846|FG001|NOT COMPLETED|Overall Study||17
8568470|NCT00092456|9600847|FG002|NOT COMPLETED|Overall Study||29
8568471|NCT00092456|9600848|FG003|NOT COMPLETED|Overall Study||16
8568472|NCT00092495|9600862|FG000|STARTED|Base Study Vaccination Period||504
8568473|NCT00092495|9600863|FG001|STARTED|Base Study Vaccination Period||514
8568474|NCT00092495|9600864|FG002|STARTED|Base Study Vaccination Period||508
8568475|NCT00092495|9600865|FG003|STARTED|Base Study Vaccination Period||1529
8568476|NCT00092495|9600866|FG004|STARTED|Base Study Vaccination Period||0
8568477|NCT00092495|9600862|FG000|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|2
8568478|NCT00092495|9600863|FG001|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|2
8568479|NCT00092495|9600864|FG002|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|6
8568480|NCT00092495|9600865|FG003|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|10
8568481|NCT00092495|9600866|FG004|With Long-term Follow-up *|Base Study Vaccination Period||0
8568482|NCT00092495|9600862|FG000|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|34
8568483|NCT00092495|9600863|FG001|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|20
8568484|NCT00092495|9600864|FG002|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|28
8568485|NCT00092495|9600865|FG003|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|73
8568486|NCT00092495|9600866|FG004|Without Long-term Follow-up|Base Study Vaccination Period||0
8568487|NCT00092495|9600862|FG000|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|467
8568488|NCT00092495|9600863|FG001|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|492
8568489|NCT00092495|9600864|FG002|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|474
8568490|NCT00092495|9600865|FG003|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|1441
8568491|NCT00092495|9600866|FG004|COMPLETED|Base Study Vaccination Period||0
8568492|NCT00092495|9600862|FG000|NOT COMPLETED|Base Study Vaccination Period||37
8568493|NCT00092495|9600863|FG001|NOT COMPLETED|Base Study Vaccination Period||22
8568494|NCT00092495|9600864|FG002|NOT COMPLETED|Base Study Vaccination Period||34
8621847|NCT00483717|9660910|FG001|STARTED|Overall Study||86
8621848|NCT00483717|9660909|FG000|COMPLETED|Overall Study||63
8621849|NCT00483717|9660910|FG001|COMPLETED|Overall Study||65
8621850|NCT00483717|9660909|FG000|NOT COMPLETED|Overall Study||24
8621851|NCT00483717|9660910|FG001|NOT COMPLETED|Overall Study||21
8554534|NCT04762771|9586873|FG000|STARTED|Overall Study||1
8554535|NCT04762771|9586874|FG001|STARTED|Overall Study||1
8554536|NCT04762771|9586873|FG000|COMPLETED|Overall Study||1
8554537|NCT04762771|9586874|FG001|COMPLETED|Overall Study||1
8554538|NCT04762771|9586873|FG000|NOT COMPLETED|Overall Study||0
8554539|NCT04762771|9586874|FG001|NOT COMPLETED|Overall Study||0
8554540|NCT04748120|9586882|FG000|STARTED|Overall Study||1
8554541|NCT04748120|9586883|FG001|STARTED|Overall Study||1
8554542|NCT04748120|9586882|FG000|COMPLETED|Overall Study||1
8554543|NCT04748120|9586883|FG001|COMPLETED|Overall Study||1
8554544|NCT04748120|9586882|FG000|NOT COMPLETED|Overall Study||0
8554545|NCT04748120|9586883|FG001|NOT COMPLETED|Overall Study||0
8554597|NCT04208750|9586946|FG001|STARTED|Overall Study||61
8554598|NCT04208750|9586945|FG000|Visit 2|Overall Study||58
8554599|NCT04208750|9586946|FG001|Visit 2|Overall Study||61
8554600|NCT04208750|9586945|FG000|Visit 3|Overall Study||58
8554601|NCT04208750|9586946|FG001|Visit 3|Overall Study||53
8554602|NCT04208750|9586945|FG000|Visit 4|Overall Study||43
8554603|NCT04208750|9586946|FG001|Visit 4|Overall Study||47
8554604|NCT04208750|9586945|FG000|COMPLETED|Overall Study||42
8554605|NCT04208750|9586946|FG001|COMPLETED|Overall Study||46
8554606|NCT04208750|9586945|FG000|NOT COMPLETED|Overall Study||16
8554607|NCT04208750|9586946|FG001|NOT COMPLETED|Overall Study||15
8568495|NCT00092495|9600865|FG003|NOT COMPLETED|Base Study Vaccination Period||88
8568496|NCT00092495|9600866|FG004|NOT COMPLETED|Base Study Vaccination Period||0
8568497|NCT00092495|9600862|FG000|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|115
8568498|NCT00092495|9600863|FG001|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|125
8568499|NCT00092495|9600864|FG002|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|130
8568500|NCT00092495|9600865|FG003|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|460
8568501|NCT00092495|9600866|FG004|STARTED|Base Study Follow-up Period||0
8568502|NCT00092495|9600862|FG000|COMPLETED|Base Study Follow-up Period||112
8568503|NCT00092495|9600863|FG001|COMPLETED|Base Study Follow-up Period||122
8568504|NCT00092495|9600864|FG002|COMPLETED|Base Study Follow-up Period||126
8568505|NCT00092495|9600865|FG003|COMPLETED|Base Study Follow-up Period||446
8568506|NCT00092495|9600866|FG004|COMPLETED|Base Study Follow-up Period||0
8568507|NCT00092495|9600862|FG000|NOT COMPLETED|Base Study Follow-up Period||3
8568508|NCT00092495|9600863|FG001|NOT COMPLETED|Base Study Follow-up Period||3
8568509|NCT00092495|9600864|FG002|NOT COMPLETED|Base Study Follow-up Period||4
8568510|NCT00092495|9600865|FG003|NOT COMPLETED|Base Study Follow-up Period||14
8568511|NCT00092495|9600866|FG004|NOT COMPLETED|Base Study Follow-up Period||0
8568512|NCT00092495|9600862|FG000|STARTED|Extension Study||0
8568513|NCT00092495|9600863|FG001|STARTED|Extension Study||0
8568514|NCT00092495|9600864|FG002|STARTED|Extension Study||0
8568515|NCT00092495|9600865|FG003|STARTED|Extension Study||0
8568516|NCT00092495|9600866|FG004|STARTED|Extension Study||12
8568517|NCT00092495|9600862|FG000|COMPLETED|Extension Study||0
8568518|NCT00092495|9600863|FG001|COMPLETED|Extension Study||0
8568519|NCT00092495|9600864|FG002|COMPLETED|Extension Study||0
8568520|NCT00092495|9600865|FG003|COMPLETED|Extension Study||0
8568521|NCT00092495|9600866|FG004|COMPLETED|Extension Study||12
8568522|NCT00092495|9600862|FG000|NOT COMPLETED|Extension Study||0
8568523|NCT00092495|9600863|FG001|NOT COMPLETED|Extension Study||0
8568524|NCT00092495|9600864|FG002|NOT COMPLETED|Extension Study||0
8568525|NCT00092495|9600865|FG003|NOT COMPLETED|Extension Study||0
8568526|NCT00092495|9600866|FG004|NOT COMPLETED|Extension Study||0
8820015|NCT01568034|9873987|FG001|NOT COMPLETED|Overall Study||0
8820016|NCT01568034|9873988|FG002|NOT COMPLETED|Overall Study||0
8820017|NCT01568034|9873989|FG003|NOT COMPLETED|Overall Study||0
8820018|NCT01568047|9874003|FG000|STARTED|Overall Study||10
8820019|NCT01568047|9874004|FG001|STARTED|Overall Study||10
8820020|NCT01568047|9874005|FG002|STARTED|Overall Study||10
8820021|NCT01568047|9874006|FG003|STARTED|Overall Study||10
8820022|NCT01568047|9874003|FG000|COMPLETED|Overall Study||9
8820023|NCT01568047|9874004|FG001|COMPLETED|Overall Study||9
8820024|NCT01568047|9874005|FG002|COMPLETED|Overall Study||9
8820025|NCT01568047|9874006|FG003|COMPLETED|Overall Study||9
8820026|NCT01568047|9874003|FG000|NOT COMPLETED|Overall Study||1
8820027|NCT01568047|9874004|FG001|NOT COMPLETED|Overall Study||1
8820028|NCT01568047|9874005|FG002|NOT COMPLETED|Overall Study||1
8820029|NCT01568047|9874006|FG003|NOT COMPLETED|Overall Study||1
8820030|NCT01568073|9874021|FG000|STARTED|Overall Study||121
8820031|NCT01568073|9874022|FG001|STARTED|Overall Study||122
8820032|NCT01568073|9874023|FG002|STARTED|Overall Study||122
8820033|NCT01568073|9874024|FG003|STARTED|Overall Study||119
8820034|NCT01568073|9874025|FG004|STARTED|Overall Study||116
8820035|NCT01568073|9874021|FG000|COMPLETED|Overall Study||110
8568527|NCT00092521|9600882|FG000|STARTED|Vaccination (Day 1 Through Month 7)||2723
8568528|NCT00092521|9600883|FG001|STARTED|Vaccination (Day 1 Through Month 7)||304
8568529|NCT00092521|9600884|FG002|STARTED|Vaccination (Day 1 Through Month 7)||2732
8568530|NCT00092521|9600885|FG003|STARTED|Vaccination (Day 1 Through Month 7)||0
8820036|NCT01568073|9874022|FG001|COMPLETED|Overall Study||107
8820037|NCT01568073|9874023|FG002|COMPLETED|Overall Study||110
8568531|NCT00092521|9600882|FG000|COMPLETED|Vaccination (Day 1 Through Month 7)||2583
8820038|NCT01568073|9874024|FG003|COMPLETED|Overall Study||108
8820039|NCT01568073|9874025|FG004|COMPLETED|Overall Study||107
8554546|NCT04559698|9586893|FG000|STARTED|Overall Study||61
8554547|NCT04559698|9586894|FG001|STARTED|Overall Study||60
8554548|NCT04559698|9586893|FG000|Four-month Pre-intervention|Overall Study|Participants in this arm started training immediately after randomization, and therefore, did not have a four-month waiting period prior to receiving the training.|0
8554549|NCT04559698|9586894|FG001|Four-month Pre-intervention|Overall Study||60
8554550|NCT04559698|9586893|FG000|Immediate Pre-intervention|Overall Study||61
8554551|NCT04559698|9586894|FG001|Immediate Pre-intervention|Overall Study||55
8554552|NCT04559698|9586893|FG000|Immediate Post-intervention|Overall Study||52
8554553|NCT04559698|9586894|FG001|Immediate Post-intervention|Overall Study||44
8554554|NCT04559698|9586893|FG000|Four-month Post-intervention|Overall Study||47
8554555|NCT04559698|9586894|FG001|Four-month Post-intervention|Overall Study|Participants in this arm started training four months after randomization (waitlist) and therefore, were not assessed at the four-month follow-up time point due to completion of the study.|0
8554556|NCT04559698|9586893|FG000|COMPLETED|Overall Study||47
8554557|NCT04559698|9586894|FG001|COMPLETED|Overall Study||44
8554558|NCT04559698|9586893|FG000|NOT COMPLETED|Overall Study||14
8554559|NCT04559698|9586894|FG001|NOT COMPLETED|Overall Study||16
8554560|NCT04492475|9586902|FG000|STARTED|Overall Study||487
8554561|NCT04492475|9586903|FG001|STARTED|Overall Study||482
8554562|NCT04492475|9586902|FG000|ITT and Modified ITT Population|Overall Study||487
8554563|NCT04492475|9586903|FG001|ITT and Modified ITT Population|Overall Study||482
8554564|NCT04492475|9586902|FG000|As Treated Population|Overall Study||477
8554565|NCT04492475|9586903|FG001|As Treated Population|Overall Study||468
8554566|NCT04492475|9586902|FG000|COMPLETED|Overall Study||473
8554567|NCT04492475|9586903|FG001|COMPLETED|Overall Study||474
8554568|NCT04492475|9586902|FG000|NOT COMPLETED|Overall Study||14
8554569|NCT04492475|9586903|FG001|NOT COMPLETED|Overall Study||8
8554570|NCT04401579|9586918|FG000|STARTED|Overall Study||515
8554571|NCT04401579|9586919|FG001|STARTED|Overall Study||518
8554572|NCT04401579|9586918|FG000|Treated|Overall Study||507
8554573|NCT04401579|9586919|FG001|Treated|Overall Study||509
8554574|NCT04401579|9586918|FG000|COMPLETED|Overall Study||431
8554575|NCT04401579|9586919|FG001|COMPLETED|Overall Study||408
8554576|NCT04401579|9586918|FG000|NOT COMPLETED|Overall Study||84
8554577|NCT04401579|9586919|FG001|NOT COMPLETED|Overall Study||110
8554578|NCT04321460|9586927|FG000|STARTED|Overall Study||260
8554579|NCT04321460|9586928|FG001|STARTED|Overall Study||260
8554580|NCT04321460|9586927|FG000|Intention to Treat (ITT) Population|Overall Study||260
8554581|NCT04321460|9586928|FG001|Intention to Treat (ITT) Population|Overall Study||260
8554582|NCT04321460|9586927|FG000|Per-protocol (PP) Population|Overall Study||252
8554583|NCT04321460|9586928|FG001|Per-protocol (PP) Population|Overall Study||248
8554584|NCT04321460|9586927|FG000|COMPLETED|Overall Study||259
8554585|NCT04321460|9586928|FG001|COMPLETED|Overall Study||259
8554586|NCT04321460|9586927|FG000|NOT COMPLETED|Overall Study||1
8554587|NCT04321460|9586928|FG001|NOT COMPLETED|Overall Study||1
8554588|NCT04280705|9586936|FG000|STARTED|Overall Study||521
8554589|NCT04280705|9586937|FG001|STARTED|Overall Study||541
8554590|NCT04280705|9586936|FG000|Received Treatment|Overall Study||517
8554591|NCT04280705|9586937|FG001|Received Treatment|Overall Study||531
8820040|NCT01568073|9874021|FG000|NOT COMPLETED|Overall Study||11
8820041|NCT01568073|9874022|FG001|NOT COMPLETED|Overall Study||15
8820042|NCT01568073|9874023|FG002|NOT COMPLETED|Overall Study||12
8820043|NCT01568073|9874024|FG003|NOT COMPLETED|Overall Study||11
8820044|NCT01568073|9874025|FG004|NOT COMPLETED|Overall Study||9
8820045|NCT01568112|9874041|FG000|STARTED|Overall Study||44
8820046|NCT01568112|9874042|FG001|STARTED|Overall Study||44
8820047|NCT01568112|9874043|FG002|STARTED|Overall Study||43
8820048|NCT01568112|9874044|FG003|STARTED|Overall Study||42
8820049|NCT01568112|9874041|FG000|COMPLETED|Overall Study||39
8820050|NCT01568112|9874042|FG001|COMPLETED|Overall Study||36
8820051|NCT01568112|9874043|FG002|COMPLETED|Overall Study||36
8820052|NCT01568112|9874044|FG003|COMPLETED|Overall Study||30
8820053|NCT01568112|9874041|FG000|NOT COMPLETED|Overall Study||5
8820054|NCT01568112|9874042|FG001|NOT COMPLETED|Overall Study||8
8820055|NCT01568112|9874043|FG002|NOT COMPLETED|Overall Study||7
8820056|NCT01568112|9874044|FG003|NOT COMPLETED|Overall Study||12
8820057|NCT01568255|9874057|FG000|STARTED|Overall Study||5
8820058|NCT01568255|9874058|FG001|STARTED|Overall Study||6
8820059|NCT01568255|9874057|FG000|COMPLETED|Overall Study||5
8820060|NCT01568255|9874058|FG001|COMPLETED|Overall Study||6
8820061|NCT01568255|9874057|FG000|NOT COMPLETED|Overall Study||0
8820062|NCT01568255|9874058|FG001|NOT COMPLETED|Overall Study||0
8820063|NCT01568320|9874064|FG000|STARTED|Overall Study||73
8820064|NCT01568320|9874064|FG000|5-Year|Overall Study|Patients eligible for Follow-up at 5 year|36
8820065|NCT01568320|9874064|FG000|COMPLETED|Overall Study||32
8820066|NCT01568320|9874064|FG000|NOT COMPLETED|Overall Study||41
8820067|NCT01568424|9874068|FG000|STARTED|Overall Study||25
8554592|NCT04280705|9586936|FG000|COMPLETED|Overall Study||508
8554593|NCT04280705|9586937|FG001|COMPLETED|Overall Study||517
8554594|NCT04280705|9586936|FG000|NOT COMPLETED|Overall Study||13
8554595|NCT04280705|9586937|FG001|NOT COMPLETED|Overall Study||24
8554596|NCT04208750|9586945|FG000|STARTED|Overall Study||58
8820068|NCT01568424|9874068|FG000|COMPLETED|Overall Study||25
8820069|NCT01568424|9874068|FG000|NOT COMPLETED|Overall Study||0
8820070|NCT01568528|9874075|FG000|STARTED|Overall Study||19
8820071|NCT01568528|9874076|FG001|STARTED|Overall Study||11
8820072|NCT01568528|9874077|FG002|STARTED|Overall Study||9
8820073|NCT01568528|9874075|FG000|COMPLETED|Overall Study||19
8554608|NCT03713281|9586952|FG000|STARTED|Overall Study||28
8554609|NCT03713281|9586952|FG000|COMPLETED|Overall Study||25
8554610|NCT03713281|9586952|FG000|NOT COMPLETED|Overall Study||3
8554611|NCT03608254|9586956|FG000|STARTED|Overall Study||11
8554612|NCT03608254|9586956|FG000|COMPLETED|Overall Study||8
8554613|NCT03608254|9586956|FG000|NOT COMPLETED|Overall Study||3
8554614|NCT03512275|9586962|FG000|STARTED|Overall Study||24
8554615|NCT03512275|9586963|FG001|STARTED|Overall Study||18
8554616|NCT03512275|9586962|FG000|COMPLETED|Overall Study||22
8554617|NCT03512275|9586963|FG001|COMPLETED|Overall Study||11
8554618|NCT03512275|9586962|FG000|NOT COMPLETED|Overall Study||2
8554619|NCT03512275|9586963|FG001|NOT COMPLETED|Overall Study||7
8554620|NCT03414983|9586971|FG000|STARTED|Pre-Treatment||127
8554621|NCT03414983|9586972|FG001|STARTED|Pre-Treatment||68
8554622|NCT03414983|9586971|FG000|COMPLETED|Pre-Treatment||123
8554623|NCT03414983|9586972|FG001|COMPLETED|Pre-Treatment||62
8554624|NCT03414983|9586971|FG000|NOT COMPLETED|Pre-Treatment||4
8554625|NCT03414983|9586972|FG001|NOT COMPLETED|Pre-Treatment||6
8554626|NCT03414983|9586971|FG000|STARTED|Treatment||123
8554627|NCT03414983|9586972|FG001|STARTED|Treatment||62
8554628|NCT03414983|9586971|FG000|COMPLETED|Treatment||4
8554629|NCT03414983|9586972|FG001|COMPLETED|Treatment||2
8554630|NCT03414983|9586971|FG000|NOT COMPLETED|Treatment||119
8554631|NCT03414983|9586972|FG001|NOT COMPLETED|Treatment||60
8554632|NCT03383692|9586980|FG000|STARTED|Overall Study||17
8554633|NCT03383692|9586981|FG001|STARTED|Overall Study||23
8554634|NCT03383692|9586980|FG000|COMPLETED|Overall Study||11
8554635|NCT03383692|9586981|FG001|COMPLETED|Overall Study||19
8554636|NCT03383692|9586980|FG000|NOT COMPLETED|Overall Study||6
8554637|NCT03383692|9586981|FG001|NOT COMPLETED|Overall Study||4
8554638|NCT03371251|9586995|FG000|STARTED|Overall Study||7
8554639|NCT03371251|9586996|FG001|STARTED|Overall Study||5
8554640|NCT03371251|9586997|FG002|STARTED|Overall Study||9
8554641|NCT03371251|9586998|FG003|STARTED|Overall Study||9
8554642|NCT03371251|9586999|FG004|STARTED|Overall Study||37
8554643|NCT03371251|9587000|FG005|STARTED|Overall Study||76
8554644|NCT03371251|9586995|FG000|COMPLETED|Overall Study||5
8554645|NCT03371251|9586996|FG001|COMPLETED|Overall Study||5
8554646|NCT03371251|9586997|FG002|COMPLETED|Overall Study||8
8554647|NCT03371251|9586998|FG003|COMPLETED|Overall Study||9
8554648|NCT03371251|9586999|FG004|COMPLETED|Overall Study||30
8554649|NCT03371251|9587000|FG005|COMPLETED|Overall Study||71
8554650|NCT03371251|9586995|FG000|NOT COMPLETED|Overall Study||2
8554651|NCT03371251|9586996|FG001|NOT COMPLETED|Overall Study||0
8554652|NCT03371251|9586997|FG002|NOT COMPLETED|Overall Study||1
8554653|NCT03371251|9586998|FG003|NOT COMPLETED|Overall Study||0
8554654|NCT03371251|9586999|FG004|NOT COMPLETED|Overall Study||7
8554655|NCT03371251|9587000|FG005|NOT COMPLETED|Overall Study||5
8554656|NCT03349268|9587020|FG000|STARTED|Overall Study||9117
8554657|NCT03349268|9587021|FG001|STARTED|Overall Study||10296
8554658|NCT03349268|9587022|FG002|STARTED|Overall Study||6319
8554659|NCT03349268|9587020|FG000|COMPLETED|Overall Study||9117
8554660|NCT03349268|9587021|FG001|COMPLETED|Overall Study||10296
8554661|NCT03349268|9587022|FG002|COMPLETED|Overall Study||6319
8554662|NCT03349268|9587020|FG000|NOT COMPLETED|Overall Study||0
8554663|NCT03349268|9587021|FG001|NOT COMPLETED|Overall Study||0
8554664|NCT03349268|9587022|FG002|NOT COMPLETED|Overall Study||0
8554665|NCT03307785|9587040|FG000|STARTED|Part A: Up to 28.5 Months||16
8554666|NCT03307785|9587041|FG001|STARTED|Part A: Up to 28.5 Months||6
8554667|NCT03307785|9587042|FG002|STARTED|Part A: Up to 28.5 Months||0
8554668|NCT03307785|9587043|FG003|STARTED|Part A: Up to 28.5 Months||0
8554669|NCT03307785|9587044|FG004|STARTED|Part A: Up to 28.5 Months||0
8554670|NCT03307785|9587045|FG005|STARTED|Part A: Up to 28.5 Months||0
8554671|NCT03307785|9587046|FG006|STARTED|Part A: Up to 28.5 Months||0
8554672|NCT03307785|9587047|FG007|STARTED|Part A: Up to 28.5 Months||0
8554673|NCT03307785|9587048|FG008|STARTED|Part A: Up to 28.5 Months||0
8554674|NCT03307785|9587049|FG009|STARTED|Part A: Up to 28.5 Months||0
8554675|NCT03307785|9587050|FG010|STARTED|Part A: Up to 28.5 Months||0
8554676|NCT03307785|9587040|FG000|COMPLETED|Part A: Up to 28.5 Months||0
8554677|NCT03307785|9587041|FG001|COMPLETED|Part A: Up to 28.5 Months||0
8554678|NCT03307785|9587042|FG002|COMPLETED|Part A: Up to 28.5 Months||0
8554679|NCT03307785|9587043|FG003|COMPLETED|Part A: Up to 28.5 Months||0
8554680|NCT03307785|9587044|FG004|COMPLETED|Part A: Up to 28.5 Months||0
8554681|NCT03307785|9587045|FG005|COMPLETED|Part A: Up to 28.5 Months||0
8554682|NCT03307785|9587046|FG006|COMPLETED|Part A: Up to 28.5 Months||0
8554683|NCT03307785|9587047|FG007|COMPLETED|Part A: Up to 28.5 Months||0
8554684|NCT03307785|9587048|FG008|COMPLETED|Part A: Up to 28.5 Months||0
8554685|NCT03307785|9587049|FG009|COMPLETED|Part A: Up to 28.5 Months||0
8554686|NCT03307785|9587050|FG010|COMPLETED|Part A: Up to 28.5 Months||0
8554687|NCT03307785|9587040|FG000|NOT COMPLETED|Part A: Up to 28.5 Months||16
8554688|NCT03307785|9587041|FG001|NOT COMPLETED|Part A: Up to 28.5 Months||6
8554689|NCT03307785|9587042|FG002|NOT COMPLETED|Part A: Up to 28.5 Months||0
8554690|NCT03307785|9587043|FG003|NOT COMPLETED|Part A: Up to 28.5 Months||0
8554691|NCT03307785|9587044|FG004|NOT COMPLETED|Part A: Up to 28.5 Months||0
8554692|NCT03307785|9587045|FG005|NOT COMPLETED|Part A: Up to 28.5 Months||0
8554693|NCT03307785|9587046|FG006|NOT COMPLETED|Part A: Up to 28.5 Months||0
8554694|NCT03307785|9587047|FG007|NOT COMPLETED|Part A: Up to 28.5 Months||0
8554695|NCT03307785|9587048|FG008|NOT COMPLETED|Part A: Up to 28.5 Months||0
8554696|NCT03307785|9587049|FG009|NOT COMPLETED|Part A: Up to 28.5 Months||0
8554697|NCT03307785|9587050|FG010|NOT COMPLETED|Part A: Up to 28.5 Months||0
8554698|NCT03307785|9587040|FG000|STARTED|Part B: Up to 28.5 Months||0
8554699|NCT03307785|9587041|FG001|STARTED|Part B: Up to 28.5 Months||0
8554700|NCT03307785|9587042|FG002|STARTED|Part B: Up to 28.5 Months||14
8554701|NCT03307785|9587043|FG003|STARTED|Part B: Up to 28.5 Months||0
8554702|NCT03307785|9587044|FG004|STARTED|Part B: Up to 28.5 Months||0
8554703|NCT03307785|9587045|FG005|STARTED|Part B: Up to 28.5 Months||0
8554704|NCT03307785|9587046|FG006|STARTED|Part B: Up to 28.5 Months||0
8554705|NCT03307785|9587047|FG007|STARTED|Part B: Up to 28.5 Months||0
8554706|NCT03307785|9587048|FG008|STARTED|Part B: Up to 28.5 Months||0
8554707|NCT03307785|9587049|FG009|STARTED|Part B: Up to 28.5 Months||0
8554708|NCT03307785|9587050|FG010|STARTED|Part B: Up to 28.5 Months||0
8554709|NCT03307785|9587040|FG000|COMPLETED|Part B: Up to 28.5 Months||0
8554710|NCT03307785|9587041|FG001|COMPLETED|Part B: Up to 28.5 Months||0
8554711|NCT03307785|9587042|FG002|COMPLETED|Part B: Up to 28.5 Months||0
8554712|NCT03307785|9587043|FG003|COMPLETED|Part B: Up to 28.5 Months||0
8554713|NCT03307785|9587044|FG004|COMPLETED|Part B: Up to 28.5 Months||0
8554714|NCT03307785|9587045|FG005|COMPLETED|Part B: Up to 28.5 Months||0
8554715|NCT03307785|9587046|FG006|COMPLETED|Part B: Up to 28.5 Months||0
8554716|NCT03307785|9587047|FG007|COMPLETED|Part B: Up to 28.5 Months||0
8554717|NCT03307785|9587048|FG008|COMPLETED|Part B: Up to 28.5 Months||0
8554718|NCT03307785|9587049|FG009|COMPLETED|Part B: Up to 28.5 Months||0
8554719|NCT03307785|9587050|FG010|COMPLETED|Part B: Up to 28.5 Months||0
8554720|NCT03307785|9587040|FG000|NOT COMPLETED|Part B: Up to 28.5 Months||0
8554721|NCT03307785|9587041|FG001|NOT COMPLETED|Part B: Up to 28.5 Months||0
8554722|NCT03307785|9587042|FG002|NOT COMPLETED|Part B: Up to 28.5 Months||14
8554723|NCT03307785|9587043|FG003|NOT COMPLETED|Part B: Up to 28.5 Months||0
8554724|NCT03307785|9587044|FG004|NOT COMPLETED|Part B: Up to 28.5 Months||0
8554725|NCT03307785|9587045|FG005|NOT COMPLETED|Part B: Up to 28.5 Months||0
8554726|NCT03307785|9587046|FG006|NOT COMPLETED|Part B: Up to 28.5 Months||0
8554727|NCT03307785|9587047|FG007|NOT COMPLETED|Part B: Up to 28.5 Months||0
8554728|NCT03307785|9587048|FG008|NOT COMPLETED|Part B: Up to 28.5 Months||0
8554729|NCT03307785|9587049|FG009|NOT COMPLETED|Part B: Up to 28.5 Months||0
8554730|NCT03307785|9587050|FG010|NOT COMPLETED|Part B: Up to 28.5 Months||0
8554731|NCT03307785|9587040|FG000|STARTED|Part C: Up to 22.5 Months||0
8554732|NCT03307785|9587041|FG001|STARTED|Part C: Up to 22.5 Months||0
8554733|NCT03307785|9587042|FG002|STARTED|Part C: Up to 22.5 Months||0
8554734|NCT03307785|9587043|FG003|STARTED|Part C: Up to 22.5 Months||6
8554735|NCT03307785|9587044|FG004|STARTED|Part C: Up to 22.5 Months||7
8554736|NCT03307785|9587045|FG005|STARTED|Part C: Up to 22.5 Months||0
8554737|NCT03307785|9587046|FG006|STARTED|Part C: Up to 22.5 Months||0
8554738|NCT03307785|9587047|FG007|STARTED|Part C: Up to 22.5 Months||0
8554739|NCT03307785|9587048|FG008|STARTED|Part C: Up to 22.5 Months||0
8554740|NCT03307785|9587049|FG009|STARTED|Part C: Up to 22.5 Months||0
8554741|NCT03307785|9587050|FG010|STARTED|Part C: Up to 22.5 Months||0
8554742|NCT03307785|9587040|FG000|COMPLETED|Part C: Up to 22.5 Months||0
8554743|NCT03307785|9587041|FG001|COMPLETED|Part C: Up to 22.5 Months||0
8554744|NCT03307785|9587042|FG002|COMPLETED|Part C: Up to 22.5 Months||0
8554745|NCT03307785|9587043|FG003|COMPLETED|Part C: Up to 22.5 Months||0
8554746|NCT03307785|9587044|FG004|COMPLETED|Part C: Up to 22.5 Months||0
8554747|NCT03307785|9587045|FG005|COMPLETED|Part C: Up to 22.5 Months||0
8554748|NCT03307785|9587046|FG006|COMPLETED|Part C: Up to 22.5 Months||0
8554749|NCT03307785|9587047|FG007|COMPLETED|Part C: Up to 22.5 Months||0
8554750|NCT03307785|9587048|FG008|COMPLETED|Part C: Up to 22.5 Months||0
8621852|NCT00483756|9660919|FG000|STARTED|Overall Study||110
8621853|NCT00483756|9660920|FG001|STARTED|Overall Study||110
8621854|NCT00483756|9660921|FG002|STARTED|Overall Study||111
8621855|NCT00483756|9660919|FG000|Treated|Overall Study||109
8621856|NCT00483756|9660920|FG001|Treated|Overall Study||106
8621857|NCT00483756|9660921|FG002|Treated|Overall Study||107
8621858|NCT00483756|9660919|FG000|COMPLETED|Overall Study||77
8554751|NCT03307785|9587049|FG009|COMPLETED|Part C: Up to 22.5 Months||0
8554752|NCT03307785|9587050|FG010|COMPLETED|Part C: Up to 22.5 Months||0
8554753|NCT03307785|9587040|FG000|NOT COMPLETED|Part C: Up to 22.5 Months||0
8554754|NCT03307785|9587041|FG001|NOT COMPLETED|Part C: Up to 22.5 Months||0
8554755|NCT03307785|9587042|FG002|NOT COMPLETED|Part C: Up to 22.5 Months||0
8554756|NCT03307785|9587043|FG003|NOT COMPLETED|Part C: Up to 22.5 Months||6
8554757|NCT03307785|9587044|FG004|NOT COMPLETED|Part C: Up to 22.5 Months||7
8554758|NCT03307785|9587045|FG005|NOT COMPLETED|Part C: Up to 22.5 Months||0
8554759|NCT03307785|9587046|FG006|NOT COMPLETED|Part C: Up to 22.5 Months||0
8554760|NCT03307785|9587047|FG007|NOT COMPLETED|Part C: Up to 22.5 Months||0
8554761|NCT03307785|9587048|FG008|NOT COMPLETED|Part C: Up to 22.5 Months||0
8554762|NCT03307785|9587049|FG009|NOT COMPLETED|Part C: Up to 22.5 Months||0
8554763|NCT03307785|9587050|FG010|NOT COMPLETED|Part C: Up to 22.5 Months||0
8554764|NCT03307785|9587040|FG000|STARTED|Part D: Up to 9.5 Months||0
8554765|NCT03307785|9587041|FG001|STARTED|Part D: Up to 9.5 Months||0
8554766|NCT03307785|9587042|FG002|STARTED|Part D: Up to 9.5 Months||0
8554767|NCT03307785|9587043|FG003|STARTED|Part D: Up to 9.5 Months||0
8621859|NCT00483756|9660920|FG001|COMPLETED|Overall Study||60
8554768|NCT03307785|9587044|FG004|STARTED|Part D: Up to 9.5 Months||0
8554769|NCT03307785|9587045|FG005|STARTED|Part D: Up to 9.5 Months||6
8554770|NCT03307785|9587046|FG006|STARTED|Part D: Up to 9.5 Months||0
8554771|NCT03307785|9587047|FG007|STARTED|Part D: Up to 9.5 Months||0
8554772|NCT03307785|9587048|FG008|STARTED|Part D: Up to 9.5 Months||0
8554773|NCT03307785|9587049|FG009|STARTED|Part D: Up to 9.5 Months||0
8554774|NCT03307785|9587050|FG010|STARTED|Part D: Up to 9.5 Months||0
8554775|NCT03307785|9587040|FG000|COMPLETED|Part D: Up to 9.5 Months||0
8554776|NCT03307785|9587041|FG001|COMPLETED|Part D: Up to 9.5 Months||0
8554777|NCT03307785|9587042|FG002|COMPLETED|Part D: Up to 9.5 Months||0
8554778|NCT03307785|9587043|FG003|COMPLETED|Part D: Up to 9.5 Months||0
8554779|NCT03307785|9587044|FG004|COMPLETED|Part D: Up to 9.5 Months||0
8554780|NCT03307785|9587045|FG005|COMPLETED|Part D: Up to 9.5 Months||3
8554781|NCT03307785|9587046|FG006|COMPLETED|Part D: Up to 9.5 Months||0
8554782|NCT03307785|9587047|FG007|COMPLETED|Part D: Up to 9.5 Months||0
8554783|NCT03307785|9587048|FG008|COMPLETED|Part D: Up to 9.5 Months||0
8554784|NCT03307785|9587049|FG009|COMPLETED|Part D: Up to 9.5 Months||0
8554785|NCT03307785|9587050|FG010|COMPLETED|Part D: Up to 9.5 Months||0
8554786|NCT03307785|9587040|FG000|NOT COMPLETED|Part D: Up to 9.5 Months||0
8554787|NCT03307785|9587041|FG001|NOT COMPLETED|Part D: Up to 9.5 Months||0
8554788|NCT03307785|9587042|FG002|NOT COMPLETED|Part D: Up to 9.5 Months||0
8554789|NCT03307785|9587043|FG003|NOT COMPLETED|Part D: Up to 9.5 Months||0
8554790|NCT03307785|9587044|FG004|NOT COMPLETED|Part D: Up to 9.5 Months||0
8554791|NCT03307785|9587045|FG005|NOT COMPLETED|Part D: Up to 9.5 Months||3
8554792|NCT03307785|9587046|FG006|NOT COMPLETED|Part D: Up to 9.5 Months||0
8554793|NCT03307785|9587047|FG007|NOT COMPLETED|Part D: Up to 9.5 Months||0
8554794|NCT03307785|9587048|FG008|NOT COMPLETED|Part D: Up to 9.5 Months||0
8554795|NCT03307785|9587049|FG009|NOT COMPLETED|Part D: Up to 9.5 Months||0
8554796|NCT03307785|9587050|FG010|NOT COMPLETED|Part D: Up to 9.5 Months||0
8554797|NCT03307785|9587040|FG000|STARTED|Part E: Up to 4.4 Months||0
8554798|NCT03307785|9587041|FG001|STARTED|Part E: Up to 4.4 Months||0
8554799|NCT03307785|9587042|FG002|STARTED|Part E: Up to 4.4 Months||0
8554800|NCT03307785|9587043|FG003|STARTED|Part E: Up to 4.4 Months||0
8554801|NCT03307785|9587044|FG004|STARTED|Part E: Up to 4.4 Months||0
8554802|NCT03307785|9587045|FG005|STARTED|Part E: Up to 4.4 Months||0
8554803|NCT03307785|9587046|FG006|STARTED|Part E: Up to 4.4 Months||2
8554804|NCT03307785|9587047|FG007|STARTED|Part E: Up to 4.4 Months||0
8554805|NCT03307785|9587048|FG008|STARTED|Part E: Up to 4.4 Months||0
8554806|NCT03307785|9587049|FG009|STARTED|Part E: Up to 4.4 Months||0
8554807|NCT03307785|9587050|FG010|STARTED|Part E: Up to 4.4 Months||0
8554808|NCT03307785|9587040|FG000|COMPLETED|Part E: Up to 4.4 Months||0
8554809|NCT03307785|9587041|FG001|COMPLETED|Part E: Up to 4.4 Months||0
8554810|NCT03307785|9587042|FG002|COMPLETED|Part E: Up to 4.4 Months||0
8554811|NCT03307785|9587043|FG003|COMPLETED|Part E: Up to 4.4 Months||0
8554812|NCT03307785|9587044|FG004|COMPLETED|Part E: Up to 4.4 Months||0
8554813|NCT03307785|9587045|FG005|COMPLETED|Part E: Up to 4.4 Months||0
8554814|NCT03307785|9587046|FG006|COMPLETED|Part E: Up to 4.4 Months||0
8554815|NCT03307785|9587047|FG007|COMPLETED|Part E: Up to 4.4 Months||0
8554816|NCT03307785|9587048|FG008|COMPLETED|Part E: Up to 4.4 Months||0
8554817|NCT03307785|9587049|FG009|COMPLETED|Part E: Up to 4.4 Months||0
8554818|NCT03307785|9587050|FG010|COMPLETED|Part E: Up to 4.4 Months||0
8554819|NCT03307785|9587040|FG000|NOT COMPLETED|Part E: Up to 4.4 Months||0
8554820|NCT03307785|9587041|FG001|NOT COMPLETED|Part E: Up to 4.4 Months||0
8554821|NCT03307785|9587042|FG002|NOT COMPLETED|Part E: Up to 4.4 Months||0
8554822|NCT03307785|9587043|FG003|NOT COMPLETED|Part E: Up to 4.4 Months||0
8554823|NCT03307785|9587044|FG004|NOT COMPLETED|Part E: Up to 4.4 Months||0
8554824|NCT03307785|9587045|FG005|NOT COMPLETED|Part E: Up to 4.4 Months||0
8554825|NCT03307785|9587046|FG006|NOT COMPLETED|Part E: Up to 4.4 Months||2
8554826|NCT03307785|9587047|FG007|NOT COMPLETED|Part E: Up to 4.4 Months||0
8621860|NCT00483756|9660921|FG002|COMPLETED|Overall Study||59
8621861|NCT00483756|9660919|FG000|NOT COMPLETED|Overall Study||33
8820074|NCT01568528|9874076|FG001|COMPLETED|Overall Study||11
8554827|NCT03307785|9587048|FG008|NOT COMPLETED|Part E: Up to 4.4 Months||0
8554828|NCT03307785|9587049|FG009|NOT COMPLETED|Part E: Up to 4.4 Months||0
8554829|NCT03307785|9587050|FG010|NOT COMPLETED|Part E: Up to 4.4 Months||0
8554830|NCT03307785|9587040|FG000|STARTED|Part F: Up to 3.5 Months||0
8554831|NCT03307785|9587041|FG001|STARTED|Part F: Up to 3.5 Months||0
8554832|NCT03307785|9587042|FG002|STARTED|Part F: Up to 3.5 Months||0
8554833|NCT03307785|9587043|FG003|STARTED|Part F: Up to 3.5 Months||0
8554834|NCT03307785|9587044|FG004|STARTED|Part F: Up to 3.5 Months||0
8554835|NCT03307785|9587045|FG005|STARTED|Part F: Up to 3.5 Months||0
8554836|NCT03307785|9587046|FG006|STARTED|Part F: Up to 3.5 Months||0
8554837|NCT03307785|9587047|FG007|STARTED|Part F: Up to 3.5 Months||1
8554838|NCT03307785|9587048|FG008|STARTED|Part F: Up to 3.5 Months||0
8554839|NCT03307785|9587049|FG009|STARTED|Part F: Up to 3.5 Months||0
8554840|NCT03307785|9587050|FG010|STARTED|Part F: Up to 3.5 Months||0
8554841|NCT03307785|9587040|FG000|COMPLETED|Part F: Up to 3.5 Months||0
8621862|NCT00483756|9660920|FG001|NOT COMPLETED|Overall Study||50
8820075|NCT01568528|9874077|FG002|COMPLETED|Overall Study||9
8820076|NCT01568528|9874075|FG000|NOT COMPLETED|Overall Study||0
8820077|NCT01568528|9874076|FG001|NOT COMPLETED|Overall Study||0
8820078|NCT01568528|9874077|FG002|NOT COMPLETED|Overall Study||0
8820079|NCT01568593|9874087|FG000|STARTED|Overall Study||48
8820080|NCT01568593|9874088|FG001|STARTED|Overall Study||45
8820081|NCT01568593|9874087|FG000|COMPLETED|Overall Study||41
8820082|NCT01568593|9874088|FG001|COMPLETED|Overall Study||42
8820083|NCT01568593|9874087|FG000|NOT COMPLETED|Overall Study||7
8554842|NCT03307785|9587041|FG001|COMPLETED|Part F: Up to 3.5 Months||0
8554843|NCT03307785|9587042|FG002|COMPLETED|Part F: Up to 3.5 Months||0
8820084|NCT01568593|9874088|FG001|NOT COMPLETED|Overall Study||3
8820085|NCT01568606|9874094|FG000|STARTED|Overall Study||20
8554844|NCT03307785|9587043|FG003|COMPLETED|Part F: Up to 3.5 Months||0
8554845|NCT03307785|9587044|FG004|COMPLETED|Part F: Up to 3.5 Months||0
8554846|NCT03307785|9587045|FG005|COMPLETED|Part F: Up to 3.5 Months||0
8554847|NCT03307785|9587046|FG006|COMPLETED|Part F: Up to 3.5 Months||0
8554848|NCT03307785|9587047|FG007|COMPLETED|Part F: Up to 3.5 Months||0
8554849|NCT03307785|9587048|FG008|COMPLETED|Part F: Up to 3.5 Months||0
8554850|NCT03307785|9587049|FG009|COMPLETED|Part F: Up to 3.5 Months||0
8554851|NCT03307785|9587050|FG010|COMPLETED|Part F: Up to 3.5 Months||0
8554852|NCT03307785|9587040|FG000|NOT COMPLETED|Part F: Up to 3.5 Months||0
8554853|NCT03307785|9587041|FG001|NOT COMPLETED|Part F: Up to 3.5 Months||0
8554854|NCT03307785|9587042|FG002|NOT COMPLETED|Part F: Up to 3.5 Months||0
8554855|NCT03307785|9587043|FG003|NOT COMPLETED|Part F: Up to 3.5 Months||0
8554856|NCT03307785|9587044|FG004|NOT COMPLETED|Part F: Up to 3.5 Months||0
8554857|NCT03307785|9587045|FG005|NOT COMPLETED|Part F: Up to 3.5 Months||0
8554858|NCT03307785|9587046|FG006|NOT COMPLETED|Part F: Up to 3.5 Months||0
8554859|NCT03307785|9587047|FG007|NOT COMPLETED|Part F: Up to 3.5 Months||1
8554860|NCT03307785|9587048|FG008|NOT COMPLETED|Part F: Up to 3.5 Months||0
8554861|NCT03307785|9587049|FG009|NOT COMPLETED|Part F: Up to 3.5 Months||0
8554862|NCT03307785|9587050|FG010|NOT COMPLETED|Part F: Up to 3.5 Months||0
8554863|NCT03307785|9587040|FG000|STARTED|Part G: Up to 24 Months||0
8554864|NCT03307785|9587041|FG001|STARTED|Part G: Up to 24 Months||0
8554865|NCT03307785|9587042|FG002|STARTED|Part G: Up to 24 Months||0
8554866|NCT03307785|9587043|FG003|STARTED|Part G: Up to 24 Months||0
8621863|NCT00483756|9660921|FG002|NOT COMPLETED|Overall Study||52
8621864|NCT00483938|9660936|FG000|STARTED|Overall Study||41
8621865|NCT00483938|9660937|FG001|STARTED|Overall Study||43
8554867|NCT03307785|9587044|FG004|STARTED|Part G: Up to 24 Months||0
8554868|NCT03307785|9587045|FG005|STARTED|Part G: Up to 24 Months||0
8554869|NCT03307785|9587046|FG006|STARTED|Part G: Up to 24 Months||0
8554870|NCT03307785|9587047|FG007|STARTED|Part G: Up to 24 Months||0
8554871|NCT03307785|9587048|FG008|STARTED|Part G: Up to 24 Months||0
8554872|NCT03307785|9587049|FG009|STARTED|Part G: Up to 24 Months||0
8554873|NCT03307785|9587050|FG010|STARTED|Part G: Up to 24 Months||0
8554874|NCT03307785|9587040|FG000|COMPLETED|Part G: Up to 24 Months||0
8554875|NCT03307785|9587041|FG001|COMPLETED|Part G: Up to 24 Months||0
8554876|NCT03307785|9587042|FG002|COMPLETED|Part G: Up to 24 Months||0
8554877|NCT03307785|9587043|FG003|COMPLETED|Part G: Up to 24 Months||0
8554878|NCT03307785|9587044|FG004|COMPLETED|Part G: Up to 24 Months||0
8554879|NCT03307785|9587045|FG005|COMPLETED|Part G: Up to 24 Months||0
8554880|NCT03307785|9587046|FG006|COMPLETED|Part G: Up to 24 Months||0
8554881|NCT03307785|9587047|FG007|COMPLETED|Part G: Up to 24 Months||0
8554882|NCT03307785|9587048|FG008|COMPLETED|Part G: Up to 24 Months||0
8554883|NCT03307785|9587049|FG009|COMPLETED|Part G: Up to 24 Months||0
8554884|NCT03307785|9587050|FG010|COMPLETED|Part G: Up to 24 Months||0
8554885|NCT03307785|9587040|FG000|NOT COMPLETED|Part G: Up to 24 Months||0
8554886|NCT03307785|9587041|FG001|NOT COMPLETED|Part G: Up to 24 Months||0
8554887|NCT03307785|9587042|FG002|NOT COMPLETED|Part G: Up to 24 Months||0
8554888|NCT03307785|9587043|FG003|NOT COMPLETED|Part G: Up to 24 Months||0
8554889|NCT03307785|9587044|FG004|NOT COMPLETED|Part G: Up to 24 Months||0
8554890|NCT03307785|9587045|FG005|NOT COMPLETED|Part G: Up to 24 Months||0
8554891|NCT03307785|9587046|FG006|NOT COMPLETED|Part G: Up to 24 Months||0
8554892|NCT03307785|9587047|FG007|NOT COMPLETED|Part G: Up to 24 Months||0
8554893|NCT03307785|9587048|FG008|NOT COMPLETED|Part G: Up to 24 Months||0
8554894|NCT03307785|9587049|FG009|NOT COMPLETED|Part G: Up to 24 Months||0
8554895|NCT03307785|9587050|FG010|NOT COMPLETED|Part G: Up to 24 Months||0
8554896|NCT03307785|9587040|FG000|STARTED|Part H: Up to 24 Months||0
8554897|NCT03307785|9587041|FG001|STARTED|Part H: Up to 24 Months||0
8554898|NCT03307785|9587042|FG002|STARTED|Part H: Up to 24 Months||0
8554899|NCT03307785|9587043|FG003|STARTED|Part H: Up to 24 Months||0
8554900|NCT03307785|9587044|FG004|STARTED|Part H: Up to 24 Months||0
8554901|NCT03307785|9587045|FG005|STARTED|Part H: Up to 24 Months||0
8554902|NCT03307785|9587046|FG006|STARTED|Part H: Up to 24 Months||0
8621866|NCT00483938|9660938|FG002|STARTED|Overall Study||30
8554903|NCT03307785|9587047|FG007|STARTED|Part H: Up to 24 Months||0
8554904|NCT03307785|9587048|FG008|STARTED|Part H: Up to 24 Months||0
8554905|NCT03307785|9587049|FG009|STARTED|Part H: Up to 24 Months||0
8554906|NCT03307785|9587050|FG010|STARTED|Part H: Up to 24 Months||0
8554907|NCT03307785|9587040|FG000|COMPLETED|Part H: Up to 24 Months||0
8554908|NCT03307785|9587041|FG001|COMPLETED|Part H: Up to 24 Months||0
8554909|NCT03307785|9587042|FG002|COMPLETED|Part H: Up to 24 Months||0
8554910|NCT03307785|9587043|FG003|COMPLETED|Part H: Up to 24 Months||0
8554911|NCT03307785|9587044|FG004|COMPLETED|Part H: Up to 24 Months||0
8554912|NCT03307785|9587045|FG005|COMPLETED|Part H: Up to 24 Months||0
8554913|NCT03307785|9587046|FG006|COMPLETED|Part H: Up to 24 Months||0
8554914|NCT03307785|9587047|FG007|COMPLETED|Part H: Up to 24 Months||0
8554915|NCT03307785|9587048|FG008|COMPLETED|Part H: Up to 24 Months||0
8554916|NCT03307785|9587049|FG009|COMPLETED|Part H: Up to 24 Months||0
8554917|NCT03307785|9587050|FG010|COMPLETED|Part H: Up to 24 Months||0
8554918|NCT03307785|9587040|FG000|NOT COMPLETED|Part H: Up to 24 Months||0
8621867|NCT00483938|9660939|FG003|STARTED|Overall Study||31
8621868|NCT00483938|9660940|FG004|STARTED|Overall Study||25
8554919|NCT03307785|9587041|FG001|NOT COMPLETED|Part H: Up to 24 Months||0
8554920|NCT03307785|9587042|FG002|NOT COMPLETED|Part H: Up to 24 Months||0
8554921|NCT03307785|9587043|FG003|NOT COMPLETED|Part H: Up to 24 Months||0
8554922|NCT03307785|9587044|FG004|NOT COMPLETED|Part H: Up to 24 Months||0
8554923|NCT03307785|9587045|FG005|NOT COMPLETED|Part H: Up to 24 Months||0
8554924|NCT03307785|9587046|FG006|NOT COMPLETED|Part H: Up to 24 Months||0
8554925|NCT03307785|9587047|FG007|NOT COMPLETED|Part H: Up to 24 Months||0
8554926|NCT03307785|9587048|FG008|NOT COMPLETED|Part H: Up to 24 Months||0
8554927|NCT03307785|9587049|FG009|NOT COMPLETED|Part H: Up to 24 Months||0
8554928|NCT03307785|9587050|FG010|NOT COMPLETED|Part H: Up to 24 Months||0
8554929|NCT03307785|9587040|FG000|STARTED|Part I: Up to 24 Months||0
8554930|NCT03307785|9587041|FG001|STARTED|Part I: Up to 24 Months||0
8554931|NCT03307785|9587042|FG002|STARTED|Part I: Up to 24 Months||0
8554932|NCT03307785|9587043|FG003|STARTED|Part I: Up to 24 Months||0
8554933|NCT03307785|9587044|FG004|STARTED|Part I: Up to 24 Months||0
8554934|NCT03307785|9587045|FG005|STARTED|Part I: Up to 24 Months||0
8554935|NCT03307785|9587046|FG006|STARTED|Part I: Up to 24 Months||0
8554936|NCT03307785|9587047|FG007|STARTED|Part I: Up to 24 Months||0
8554937|NCT03307785|9587048|FG008|STARTED|Part I: Up to 24 Months||0
8554938|NCT03307785|9587049|FG009|STARTED|Part I: Up to 24 Months||0
8554939|NCT03307785|9587050|FG010|STARTED|Part I: Up to 24 Months||0
8554940|NCT03307785|9587040|FG000|COMPLETED|Part I: Up to 24 Months||0
8554941|NCT03307785|9587041|FG001|COMPLETED|Part I: Up to 24 Months||0
8554942|NCT03307785|9587042|FG002|COMPLETED|Part I: Up to 24 Months||0
8554943|NCT03307785|9587043|FG003|COMPLETED|Part I: Up to 24 Months||0
8554944|NCT03307785|9587044|FG004|COMPLETED|Part I: Up to 24 Months||0
8554945|NCT03307785|9587045|FG005|COMPLETED|Part I: Up to 24 Months||0
8554946|NCT03307785|9587046|FG006|COMPLETED|Part I: Up to 24 Months||0
8554947|NCT03307785|9587047|FG007|COMPLETED|Part I: Up to 24 Months||0
8820086|NCT01568606|9874094|FG000|COMPLETED|Overall Study||20
8820087|NCT01568606|9874094|FG000|NOT COMPLETED|Overall Study||0
8820088|NCT01568827|9874100|FG000|STARTED|First Intervention (6 Days)||5
8820089|NCT01568827|9874101|FG001|STARTED|First Intervention (6 Days)||5
8820090|NCT01568827|9874100|FG000|COMPLETED|First Intervention (6 Days)||5
8820091|NCT01568827|9874101|FG001|COMPLETED|First Intervention (6 Days)||5
8820092|NCT01568827|9874100|FG000|NOT COMPLETED|First Intervention (6 Days)||0
8820093|NCT01568827|9874101|FG001|NOT COMPLETED|First Intervention (6 Days)||0
8820094|NCT01568827|9874100|FG000|STARTED|Washout (2 Days)||5
8820095|NCT01568827|9874101|FG001|STARTED|Washout (2 Days)||5
8820096|NCT01568827|9874100|FG000|COMPLETED|Washout (2 Days)||5
8820097|NCT01568827|9874101|FG001|COMPLETED|Washout (2 Days)||5
8820098|NCT01568827|9874100|FG000|NOT COMPLETED|Washout (2 Days)||0
8820099|NCT01568827|9874101|FG001|NOT COMPLETED|Washout (2 Days)||0
8820100|NCT01568827|9874100|FG000|STARTED|Intervention 2 (5 Days)||5
8820101|NCT01568827|9874101|FG001|STARTED|Intervention 2 (5 Days)||5
8820102|NCT01568827|9874100|FG000|COMPLETED|Intervention 2 (5 Days)||5
8820103|NCT01568827|9874101|FG001|COMPLETED|Intervention 2 (5 Days)||5
8820104|NCT01568827|9874100|FG000|NOT COMPLETED|Intervention 2 (5 Days)||0
8820105|NCT01568827|9874101|FG001|NOT COMPLETED|Intervention 2 (5 Days)||0
8820106|NCT01568866|9874109|FG000|STARTED|Overall Study||465
8820107|NCT01568866|9874110|FG001|STARTED|Overall Study||464
8820108|NCT01568866|9874109|FG000|Received Treatment|Overall Study||456
8820109|NCT01568866|9874110|FG001|Received Treatment|Overall Study||463
8820110|NCT01568866|9874109|FG000|COMPLETED|Overall Study|Indicates participants still receiving treatment|27
8820111|NCT01568866|9874110|FG001|COMPLETED|Overall Study|Indicates participants still receiving treatment|48
8820112|NCT01568866|9874109|FG000|NOT COMPLETED|Overall Study||438
8820113|NCT01568866|9874110|FG001|NOT COMPLETED|Overall Study||416
8820114|NCT01568892|9874118|FG000|STARTED|Double-blind Phase||14
8820115|NCT01568892|9874119|FG001|STARTED|Double-blind Phase||16
8820116|NCT01568892|9874118|FG000|COMPLETED|Double-blind Phase||14
8820117|NCT01568892|9874119|FG001|COMPLETED|Double-blind Phase||16
8820118|NCT01568892|9874118|FG000|NOT COMPLETED|Double-blind Phase||0
8820119|NCT01568892|9874119|FG001|NOT COMPLETED|Double-blind Phase||0
8820120|NCT01568892|9874118|FG000|STARTED|Open-label Phase|One participant completing the DB Phase withdrew on Day 8 and did not enter the Open-label Phase.|13
8820121|NCT01568892|9874119|FG001|STARTED|Open-label Phase||16
8820122|NCT01568892|9874118|FG000|COMPLETED|Open-label Phase||7
8820123|NCT01568892|9874119|FG001|COMPLETED|Open-label Phase||13
8820124|NCT01568892|9874118|FG000|NOT COMPLETED|Open-label Phase||6
8820125|NCT01568892|9874119|FG001|NOT COMPLETED|Open-label Phase||3
8820126|NCT01568905|9874129|FG000|STARTED|Overall Study||13
8820127|NCT01568905|9874130|FG001|STARTED|Overall Study||11
8820128|NCT01568905|9874131|FG002|STARTED|Overall Study||12
8820129|NCT01568905|9874129|FG000|COMPLETED|Overall Study||12
8820130|NCT01568905|9874130|FG001|COMPLETED|Overall Study||11
8820131|NCT01568905|9874131|FG002|COMPLETED|Overall Study||12
8943805|NCT02391948|10005623|FG002|COMPLETED|12-month Assessment||73
8943806|NCT02391948|10005624|FG003|COMPLETED|12-month Assessment||116
8943807|NCT02391948|10005625|FG004|COMPLETED|12-month Assessment||103
8943808|NCT02391948|10005621|FG000|NOT COMPLETED|12-month Assessment||8
8943809|NCT02391948|10005622|FG001|NOT COMPLETED|12-month Assessment||9
8943810|NCT02391948|10005623|FG002|NOT COMPLETED|12-month Assessment||4
8554948|NCT03307785|9587048|FG008|COMPLETED|Part I: Up to 24 Months||0
8820132|NCT01568905|9874129|FG000|NOT COMPLETED|Overall Study||1
8820133|NCT01568905|9874130|FG001|NOT COMPLETED|Overall Study||0
8820134|NCT01568905|9874131|FG002|NOT COMPLETED|Overall Study||0
8820135|NCT01568944|9874141|FG000|STARTED|Overall Study||8
8820136|NCT01568944|9874142|FG001|STARTED|Overall Study||10
8820137|NCT01568944|9874141|FG000|COMPLETED|Overall Study||8
8820138|NCT01568944|9874142|FG001|COMPLETED|Overall Study||10
8820139|NCT01568944|9874141|FG000|NOT COMPLETED|Overall Study||0
8554949|NCT03307785|9587049|FG009|COMPLETED|Part I: Up to 24 Months||0
8554950|NCT03307785|9587050|FG010|COMPLETED|Part I: Up to 24 Months||0
8554951|NCT03307785|9587040|FG000|NOT COMPLETED|Part I: Up to 24 Months||0
8554952|NCT03307785|9587041|FG001|NOT COMPLETED|Part I: Up to 24 Months||0
8554953|NCT03307785|9587042|FG002|NOT COMPLETED|Part I: Up to 24 Months||0
8554954|NCT03307785|9587043|FG003|NOT COMPLETED|Part I: Up to 24 Months||0
8554955|NCT03307785|9587044|FG004|NOT COMPLETED|Part I: Up to 24 Months||0
8554956|NCT03307785|9587045|FG005|NOT COMPLETED|Part I: Up to 24 Months||0
8554957|NCT03307785|9587046|FG006|NOT COMPLETED|Part I: Up to 24 Months||0
8554958|NCT03307785|9587047|FG007|NOT COMPLETED|Part I: Up to 24 Months||0
8554959|NCT03307785|9587048|FG008|NOT COMPLETED|Part I: Up to 24 Months||0
8554960|NCT03307785|9587049|FG009|NOT COMPLETED|Part I: Up to 24 Months||0
8554961|NCT03307785|9587050|FG010|NOT COMPLETED|Part I: Up to 24 Months||0
8568532|NCT00092521|9600883|FG001|COMPLETED|Vaccination (Day 1 Through Month 7)||290
8568533|NCT00092521|9600884|FG002|COMPLETED|Vaccination (Day 1 Through Month 7)||2586
8568534|NCT00092521|9600885|FG003|COMPLETED|Vaccination (Day 1 Through Month 7)||0
8568535|NCT00092521|9600882|FG000|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||140
8568536|NCT00092521|9600883|FG001|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||14
8568537|NCT00092521|9600884|FG002|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||146
8568538|NCT00092521|9600885|FG003|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||0
8568539|NCT00092521|9600882|FG000|STARTED|Follow-Up (After Month 7)|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up|2599
8568540|NCT00092521|9600883|FG001|STARTED|Follow-Up (After Month 7)|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up|291
8568541|NCT00092521|9600884|FG002|STARTED|Follow-Up (After Month 7)|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up|2607
8568542|NCT00092521|9600885|FG003|STARTED|Follow-Up (After Month 7)||0
8568543|NCT00092521|9600882|FG000|COMPLETED|Follow-Up (After Month 7)||2353
8568544|NCT00092521|9600883|FG001|COMPLETED|Follow-Up (After Month 7)||155
8568545|NCT00092521|9600884|FG002|COMPLETED|Follow-Up (After Month 7)||1959
8568546|NCT00092521|9600885|FG003|COMPLETED|Follow-Up (After Month 7)||0
8568547|NCT00092521|9600882|FG000|NOT COMPLETED|Follow-Up (After Month 7)||246
8568548|NCT00092521|9600883|FG001|NOT COMPLETED|Follow-Up (After Month 7)||136
8568549|NCT00092521|9600884|FG002|NOT COMPLETED|Follow-Up (After Month 7)||648
8568550|NCT00092521|9600885|FG003|NOT COMPLETED|Follow-Up (After Month 7)||0
8568551|NCT00092521|9600882|FG000|STARTED|Extension Study (Group 4)||0
8568552|NCT00092521|9600883|FG001|STARTED|Extension Study (Group 4)||0
8568553|NCT00092521|9600884|FG002|STARTED|Extension Study (Group 4)||0
8568554|NCT00092521|9600885|FG003|STARTED|Extension Study (Group 4)||844
8568555|NCT00092521|9600882|FG000|Initiated Extension Study|Extension Study (Group 4)||0
8568556|NCT00092521|9600883|FG001|Initiated Extension Study|Extension Study (Group 4)||0
8568557|NCT00092521|9600884|FG002|Initiated Extension Study|Extension Study (Group 4)||0
8568558|NCT00092521|9600885|FG003|Initiated Extension Study|Extension Study (Group 4)||829
8568559|NCT00092521|9600882|FG000|Received >=1 Dose in Extension Study|Extension Study (Group 4)||0
8568560|NCT00092521|9600883|FG001|Received >=1 Dose in Extension Study|Extension Study (Group 4)||0
8568561|NCT00092521|9600884|FG002|Received >=1 Dose in Extension Study|Extension Study (Group 4)||0
8568562|NCT00092521|9600885|FG003|Received >=1 Dose in Extension Study|Extension Study (Group 4)||801
8568563|NCT00092521|9600882|FG000|COMPLETED|Extension Study (Group 4)||0
8568564|NCT00092521|9600883|FG001|COMPLETED|Extension Study (Group 4)||0
8568565|NCT00092521|9600884|FG002|COMPLETED|Extension Study (Group 4)||0
8568566|NCT00092521|9600885|FG003|COMPLETED|Extension Study (Group 4)||635
8568567|NCT00092521|9600882|FG000|NOT COMPLETED|Extension Study (Group 4)||0
8568568|NCT00092521|9600883|FG001|NOT COMPLETED|Extension Study (Group 4)||0
8568569|NCT00092521|9600884|FG002|NOT COMPLETED|Extension Study (Group 4)||0
8568570|NCT00092521|9600885|FG003|NOT COMPLETED|Extension Study (Group 4)||209
8568571|NCT00092534|9600895|FG000|STARTED|Base Study Vaccination Period||6087
8568572|NCT00092534|9600896|FG001|STARTED|Base Study Vaccination Period||6080
8568573|NCT00092534|9600897|FG002|STARTED|Base Study Vaccination Period||0
8568574|NCT00092534|9600898|FG003|STARTED|Base Study Vaccination Period||0
8568575|NCT00092534|9600899|FG004|STARTED|Base Study Vaccination Period||0
8568576|NCT00092534|9600895|FG000|COMPLETED|Base Study Vaccination Period||5916
8568577|NCT00092534|9600896|FG001|COMPLETED|Base Study Vaccination Period||5954
8568578|NCT00092534|9600897|FG002|COMPLETED|Base Study Vaccination Period||0
8568579|NCT00092534|9600898|FG003|COMPLETED|Base Study Vaccination Period||0
8568580|NCT00092534|9600899|FG004|COMPLETED|Base Study Vaccination Period||0
8568581|NCT00092534|9600895|FG000|NOT COMPLETED|Base Study Vaccination Period||171
8568582|NCT00092534|9600896|FG001|NOT COMPLETED|Base Study Vaccination Period||126
8568583|NCT00092534|9600897|FG002|NOT COMPLETED|Base Study Vaccination Period||0
8568584|NCT00092534|9600898|FG003|NOT COMPLETED|Base Study Vaccination Period||0
8568585|NCT00092534|9600899|FG004|NOT COMPLETED|Base Study Vaccination Period||0
8568586|NCT00092534|9600895|FG000|STARTED|Base Study Follow-Up Period|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up.|5942
8568587|NCT00092534|9600896|FG001|STARTED|Base Study Follow-Up Period|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up.|5971
8568588|NCT00092534|9600897|FG002|STARTED|Base Study Follow-Up Period||0
8568589|NCT00092534|9600898|FG003|STARTED|Base Study Follow-Up Period||0
8568590|NCT00092534|9600899|FG004|STARTED|Base Study Follow-Up Period||0
8568591|NCT00092534|9600895|FG000|COMPLETED|Base Study Follow-Up Period||5626
8568592|NCT00092534|9600896|FG001|COMPLETED|Base Study Follow-Up Period||5277
8554962|NCT03090737|9587071|FG000|STARTED|Overall Study||129
8554963|NCT03090737|9587071|FG000|COMPLETED|Overall Study||98
8554964|NCT03090737|9587071|FG000|NOT COMPLETED|Overall Study||31
8554965|NCT03088826|9587077|FG000|STARTED|Overall Study||40
8554966|NCT03088826|9587078|FG001|STARTED|Overall Study||40
8554967|NCT03088826|9587077|FG000|COMPLETED|Overall Study||40
8554968|NCT03088826|9587078|FG001|COMPLETED|Overall Study||40
8554969|NCT03088826|9587077|FG000|NOT COMPLETED|Overall Study||0
8554970|NCT03088826|9587078|FG001|NOT COMPLETED|Overall Study||0
8554971|NCT03043872|9587087|FG000|STARTED|Overall Study||329
8554972|NCT03043872|9587088|FG001|STARTED|Overall Study||328
8554973|NCT03043872|9587089|FG002|STARTED|Overall Study||330
8554974|NCT03043872|9587087|FG000|Randomized and Included in Global Cohort Analysis|Overall Study||268
8554975|NCT03043872|9587088|FG001|Randomized and Included in Global Cohort Analysis|Overall Study||268
8554976|NCT03043872|9587089|FG002|Randomized and Included in Global Cohort Analysis|Overall Study||269
8554977|NCT03043872|9587087|FG000|Received Treatment in Global Cohort|Overall Study||266
8554978|NCT03043872|9587088|FG001|Received Treatment in Global Cohort|Overall Study||265
8554979|NCT03043872|9587089|FG002|Received Treatment in Global Cohort|Overall Study||266
8554980|NCT03043872|9587087|FG000|Randomized and Included in China Cohort Analysis|Overall Study||65
8621869|NCT00483938|9660941|FG005|STARTED|Overall Study||26
8621870|NCT00483938|9660942|FG006|STARTED|Overall Study||40
8621871|NCT00483938|9660936|FG000|COMPLETED|Overall Study||36
8554981|NCT03043872|9587088|FG001|Randomized and Included in China Cohort Analysis|Overall Study||61
8554982|NCT03043872|9587089|FG002|Randomized and Included in China Cohort Analysis|Overall Study||62
8554983|NCT03043872|9587087|FG000|Received Treatment in China Cohort|Overall Study||65
8554984|NCT03043872|9587088|FG001|Received Treatment in China Cohort|Overall Study||61
8554985|NCT03043872|9587089|FG002|Received Treatment in China Cohort|Overall Study||62
8554986|NCT03043872|9587087|FG000|Included in Both Cohorts (Global + China)|Overall Study||4
8554987|NCT03043872|9587088|FG001|Included in Both Cohorts (Global + China)|Overall Study||1
8554988|NCT03043872|9587089|FG002|Included in Both Cohorts (Global + China)|Overall Study||1
8554989|NCT03043872|9587087|FG000|Ongoing Study at Global Cohort Final Analysis Data Cut-off (DCO)|Overall Study||56
8554990|NCT03043872|9587088|FG001|Ongoing Study at Global Cohort Final Analysis Data Cut-off (DCO)|Overall Study||56
8554991|NCT03043872|9587089|FG002|Ongoing Study at Global Cohort Final Analysis Data Cut-off (DCO)|Overall Study||31
8554992|NCT03043872|9587087|FG000|Ongoing Study at China Cohort Second (Final) Analysis DCO|Overall Study||16
8554993|NCT03043872|9587088|FG001|Ongoing Study at China Cohort Second (Final) Analysis DCO|Overall Study||11
8554994|NCT03043872|9587089|FG002|Ongoing Study at China Cohort Second (Final) Analysis DCO|Overall Study||7
8554995|NCT03043872|9587087|FG000|COMPLETED|Overall Study||51
8554996|NCT03043872|9587088|FG001|COMPLETED|Overall Study||52
8554997|NCT03043872|9587089|FG002|COMPLETED|Overall Study||18
8554998|NCT03043872|9587087|FG000|NOT COMPLETED|Overall Study||278
8554999|NCT03043872|9587088|FG001|NOT COMPLETED|Overall Study||276
8555000|NCT03043872|9587089|FG002|NOT COMPLETED|Overall Study||312
8555001|NCT03034018|9587109|FG000|STARTED|Overall Study||30
8555002|NCT03034018|9587110|FG001|STARTED|Overall Study||30
8555003|NCT03034018|9587109|FG000|Initiated Assigned Treatment|Overall Study||27
8555004|NCT03034018|9587110|FG001|Initiated Assigned Treatment|Overall Study||29
8555005|NCT03034018|9587109|FG000|COMPLETED|Overall Study||25
8555006|NCT03034018|9587110|FG001|COMPLETED|Overall Study||28
8555007|NCT03034018|9587109|FG000|NOT COMPLETED|Overall Study||5
8555008|NCT03034018|9587110|FG001|NOT COMPLETED|Overall Study||2
8555009|NCT02750215|9587116|FG000|STARTED|Overall Study||20
8555010|NCT02750215|9587116|FG000|COMPLETED|Overall Study||20
8555011|NCT02750215|9587116|FG000|NOT COMPLETED|Overall Study||0
8555012|NCT02673333|9587120|FG000|STARTED|Overall Study||39
8555013|NCT02673333|9587120|FG000|COMPLETED|Overall Study||39
8555014|NCT02673333|9587120|FG000|NOT COMPLETED|Overall Study||0
8555015|NCT01984346|9587126|FG000|STARTED|Overall Study|Date of full approval was 8/22/13. Date of first treated patient was 01/08/14|115
8555016|NCT01984346|9587127|FG001|STARTED|Overall Study||55
8555017|NCT01984346|9587126|FG000|Treated|Overall Study||102
8555018|NCT01984346|9587127|FG001|Treated|Overall Study||51
8555019|NCT01984346|9587126|FG000|COMPLETED|Overall Study||98
8555020|NCT01984346|9587127|FG001|COMPLETED|Overall Study||50
8555021|NCT01984346|9587126|FG000|NOT COMPLETED|Overall Study||17
8555022|NCT01984346|9587127|FG001|NOT COMPLETED|Overall Study||5
8555023|NCT01750281|9587136|FG000|STARTED|Overall Study||43
8555024|NCT01750281|9587137|FG001|STARTED|Overall Study||85
8555025|NCT01750281|9587138|FG002|STARTED|Overall Study||84
8555026|NCT01750281|9587136|FG000|Received Treatment|Overall Study||43
8555027|NCT01750281|9587137|FG001|Received Treatment|Overall Study||84
8555028|NCT01750281|9587138|FG002|Received Treatment|Overall Study||84
8555029|NCT01750281|9587136|FG000|Did Not Receive Treatment|Overall Study||0
8555030|NCT01750281|9587137|FG001|Did Not Receive Treatment|Overall Study||1
8555031|NCT01750281|9587138|FG002|Did Not Receive Treatment|Overall Study||0
8555032|NCT01750281|9587136|FG000|COMPLETED|Overall Study||0
8555033|NCT01750281|9587137|FG001|COMPLETED|Overall Study||0
8555034|NCT01750281|9587138|FG002|COMPLETED|Overall Study||0
8555035|NCT01750281|9587136|FG000|NOT COMPLETED|Overall Study||43
8555036|NCT01750281|9587137|FG001|NOT COMPLETED|Overall Study||85
8621872|NCT00483938|9660937|FG001|COMPLETED|Overall Study||24
8621873|NCT00483938|9660938|FG002|COMPLETED|Overall Study||30
8621874|NCT00483938|9660939|FG003|COMPLETED|Overall Study||25
8621875|NCT00483938|9660940|FG004|COMPLETED|Overall Study||23
8621876|NCT00483938|9660941|FG005|COMPLETED|Overall Study||18
8555037|NCT01750281|9587138|FG002|NOT COMPLETED|Overall Study||84
8555038|NCT01353118|9587148|FG000|STARTED|Overall Study||21
8555039|NCT01353118|9587149|FG001|STARTED|Overall Study||20
8555040|NCT01353118|9587148|FG000|COMPLETED|Overall Study||21
8555041|NCT01353118|9587149|FG001|COMPLETED|Overall Study||20
8555042|NCT01353118|9587148|FG000|NOT COMPLETED|Overall Study||0
8555043|NCT01353118|9587149|FG001|NOT COMPLETED|Overall Study||0
8555044|NCT01252953|9587157|FG000|STARTED|Overall Study||15225
8555045|NCT01252953|9587158|FG001|STARTED|Overall Study||15224
8555046|NCT01252953|9587157|FG000|COMPLETED|Overall Study||15187
8555047|NCT01252953|9587158|FG001|COMPLETED|Overall Study||15186
8555048|NCT01252953|9587157|FG000|NOT COMPLETED|Overall Study||38
8555049|NCT01252953|9587158|FG001|NOT COMPLETED|Overall Study||38
8555050|NCT01012609|9587167|FG000|STARTED|Overall Study||21
8555051|NCT01012609|9587168|FG001|STARTED|Overall Study||26
8555052|NCT01012609|9587167|FG000|COMPLETED|Overall Study||20
8555053|NCT01012609|9587168|FG001|COMPLETED|Overall Study||25
8555054|NCT01012609|9587167|FG000|NOT COMPLETED|Overall Study||1
8555055|NCT01012609|9587168|FG001|NOT COMPLETED|Overall Study||1
8555056|NCT00920387|9587177|FG000|STARTED|Stage 1||8
8555057|NCT00920387|9587178|FG001|STARTED|Stage 1||4
8555058|NCT00920387|9587179|FG002|STARTED|Stage 1||0
8555059|NCT00920387|9587177|FG000|COMPLETED|Stage 1||7
8555060|NCT00920387|9587178|FG001|COMPLETED|Stage 1||4
8555061|NCT00920387|9587179|FG002|COMPLETED|Stage 1||0
8555062|NCT00920387|9587177|FG000|NOT COMPLETED|Stage 1||1
8555063|NCT00920387|9587178|FG001|NOT COMPLETED|Stage 1||0
8555064|NCT00920387|9587179|FG002|NOT COMPLETED|Stage 1||0
8555065|NCT00920387|9587177|FG000|STARTED|Stage 2||0
8555066|NCT00920387|9587178|FG001|STARTED|Stage 2||0
8555067|NCT00920387|9587179|FG002|STARTED|Stage 2||3
8555068|NCT00920387|9587177|FG000|COMPLETED|Stage 2||0
8555069|NCT00920387|9587178|FG001|COMPLETED|Stage 2||0
8555070|NCT00920387|9587179|FG002|COMPLETED|Stage 2||3
8555071|NCT00920387|9587177|FG000|NOT COMPLETED|Stage 2||0
8555072|NCT00920387|9587178|FG001|NOT COMPLETED|Stage 2||0
8555073|NCT00920387|9587179|FG002|NOT COMPLETED|Stage 2||0
8555074|NCT00494234|9587188|FG000|STARTED|Overall Study||27
8555075|NCT00494234|9587189|FG001|STARTED|Overall Study||27
8555076|NCT00494234|9587188|FG000|COMPLETED|Overall Study||12
8555077|NCT00494234|9587189|FG001|COMPLETED|Overall Study||17
8555078|NCT00494234|9587188|FG000|NOT COMPLETED|Overall Study||15
8555079|NCT00494234|9587189|FG001|NOT COMPLETED|Overall Study||10
8555080|NCT00458835|9587205|FG000|STARTED|Overall Study||5
8555081|NCT00458835|9587206|FG001|STARTED|Overall Study||5
8555082|NCT00458835|9587207|FG002|STARTED|Overall Study||5
8555083|NCT00458835|9587208|FG003|STARTED|Overall Study||5
8555084|NCT00458835|9587209|FG004|STARTED|Overall Study||5
8555085|NCT00458835|9587210|FG005|STARTED|Overall Study||5
8555086|NCT00458835|9587205|FG000|COMPLETED|Overall Study||5
8621877|NCT00483938|9660942|FG006|COMPLETED|Overall Study||0
8621878|NCT00483938|9660936|FG000|NOT COMPLETED|Overall Study||5
8621879|NCT00483938|9660937|FG001|NOT COMPLETED|Overall Study||19
8621880|NCT00483938|9660938|FG002|NOT COMPLETED|Overall Study||0
8555087|NCT00458835|9587206|FG001|COMPLETED|Overall Study||5
8555088|NCT00458835|9587207|FG002|COMPLETED|Overall Study||5
8555089|NCT00458835|9587208|FG003|COMPLETED|Overall Study||5
8555090|NCT00458835|9587209|FG004|COMPLETED|Overall Study||5
8555091|NCT00458835|9587210|FG005|COMPLETED|Overall Study||4
8555092|NCT00458835|9587205|FG000|NOT COMPLETED|Overall Study||0
8555093|NCT00458835|9587206|FG001|NOT COMPLETED|Overall Study||0
8555094|NCT00458835|9587207|FG002|NOT COMPLETED|Overall Study||0
8555095|NCT00458835|9587208|FG003|NOT COMPLETED|Overall Study||0
8555096|NCT00458835|9587209|FG004|NOT COMPLETED|Overall Study||0
8555097|NCT00458835|9587210|FG005|NOT COMPLETED|Overall Study||1
8555098|NCT00403559|9587220|FG000|STARTED|Overall Study||56
8555099|NCT00403559|9587221|FG001|STARTED|Overall Study||56
8555100|NCT00403559|9587220|FG000|COMPLETED|Overall Study||52
8555101|NCT00403559|9587221|FG001|COMPLETED|Overall Study||52
8555102|NCT00403559|9587220|FG000|NOT COMPLETED|Overall Study||4
8555103|NCT00403559|9587221|FG001|NOT COMPLETED|Overall Study||4
8555104|NCT00353938|9587231|FG000|STARTED|Stage 1||9
8555105|NCT00353938|9587232|FG001|STARTED|Stage 1||5
8555106|NCT00353938|9587233|FG002|STARTED|Stage 1||0
8555107|NCT00353938|9587234|FG003|STARTED|Stage 1||0
8555108|NCT00353938|9587231|FG000|COMPLETED|Stage 1||8
8555109|NCT00353938|9587232|FG001|COMPLETED|Stage 1||5
8555110|NCT00353938|9587233|FG002|COMPLETED|Stage 1||0
8555111|NCT00353938|9587234|FG003|COMPLETED|Stage 1||0
8555112|NCT00353938|9587231|FG000|NOT COMPLETED|Stage 1||1
8555113|NCT00353938|9587232|FG001|NOT COMPLETED|Stage 1||0
8621881|NCT00483938|9660939|FG003|NOT COMPLETED|Overall Study||6
8555114|NCT00353938|9587233|FG002|NOT COMPLETED|Stage 1||0
8555115|NCT00353938|9587234|FG003|NOT COMPLETED|Stage 1||0
8555116|NCT00353938|9587231|FG000|STARTED|Stage 2||0
8555117|NCT00353938|9587232|FG001|STARTED|Stage 2||0
8555118|NCT00353938|9587233|FG002|STARTED|Stage 2||4
8555119|NCT00353938|9587234|FG003|STARTED|Stage 2||0
8555120|NCT00353938|9587231|FG000|COMPLETED|Stage 2||0
8555121|NCT00353938|9587232|FG001|COMPLETED|Stage 2||0
8555122|NCT00353938|9587233|FG002|COMPLETED|Stage 2||4
8555123|NCT00353938|9587234|FG003|COMPLETED|Stage 2||0
8555124|NCT00353938|9587231|FG000|NOT COMPLETED|Stage 2||0
8555125|NCT00353938|9587232|FG001|NOT COMPLETED|Stage 2||0
8555126|NCT00353938|9587233|FG002|NOT COMPLETED|Stage 2||0
8555127|NCT00353938|9587234|FG003|NOT COMPLETED|Stage 2||0
8555128|NCT00353938|9587231|FG000|STARTED|Stage 3||0
8555129|NCT00353938|9587232|FG001|STARTED|Stage 3||0
8555130|NCT00353938|9587233|FG002|STARTED|Stage 3||0
8555131|NCT00353938|9587234|FG003|STARTED|Stage 3||3
8555132|NCT00353938|9587231|FG000|COMPLETED|Stage 3||0
8555133|NCT00353938|9587232|FG001|COMPLETED|Stage 3||0
8555134|NCT00353938|9587233|FG002|COMPLETED|Stage 3||0
8555135|NCT00353938|9587234|FG003|COMPLETED|Stage 3||3
8555136|NCT00353938|9587231|FG000|NOT COMPLETED|Stage 3||0
8555137|NCT00353938|9587232|FG001|NOT COMPLETED|Stage 3||0
8555138|NCT00353938|9587233|FG002|NOT COMPLETED|Stage 3||0
8555139|NCT00353938|9587234|FG003|NOT COMPLETED|Stage 3||0
8555140|NCT00176436|9587244|FG000|STARTED|Overall Study||20
8555141|NCT00176436|9587245|FG001|STARTED|Overall Study||17
8555142|NCT00176436|9587244|FG000|COMPLETED|Overall Study||14
8555143|NCT00176436|9587245|FG001|COMPLETED|Overall Study||12
8555144|NCT00176436|9587244|FG000|NOT COMPLETED|Overall Study||6
8621882|NCT00483938|9660940|FG004|NOT COMPLETED|Overall Study||2
8621883|NCT00483938|9660941|FG005|NOT COMPLETED|Overall Study||8
9065902|NCT04128293|10126435|FG001|COMPLETED|Washout Period 1 (Up to 7 Days)||4
9065903|NCT04128293|10126436|FG002|COMPLETED|Washout Period 1 (Up to 7 Days)||4
9065904|NCT04128293|10126437|FG003|COMPLETED|Washout Period 1 (Up to 7 Days)||4
9065905|NCT04128293|10126434|FG000|NOT COMPLETED|Washout Period 1 (Up to 7 Days)||0
9065906|NCT04128293|10126435|FG001|NOT COMPLETED|Washout Period 1 (Up to 7 Days)||0
9065907|NCT04128293|10126436|FG002|NOT COMPLETED|Washout Period 1 (Up to 7 Days)||0
9065908|NCT04128293|10126437|FG003|NOT COMPLETED|Washout Period 1 (Up to 7 Days)||0
9065909|NCT04128293|10126434|FG000|STARTED|Treatment Period 2 (1 Day)||4
9065910|NCT04128293|10126435|FG001|STARTED|Treatment Period 2 (1 Day)||4
9065911|NCT04128293|10126436|FG002|STARTED|Treatment Period 2 (1 Day)||4
9065912|NCT04128293|10126437|FG003|STARTED|Treatment Period 2 (1 Day)||4
9065913|NCT04128293|10126434|FG000|COMPLETED|Treatment Period 2 (1 Day)||4
8555145|NCT00176436|9587245|FG001|NOT COMPLETED|Overall Study||5
8568593|NCT00092534|9600897|FG002|COMPLETED|Base Study Follow-Up Period||0
8568594|NCT00092534|9600898|FG003|COMPLETED|Base Study Follow-Up Period||0
8568595|NCT00092534|9600899|FG004|COMPLETED|Base Study Follow-Up Period||0
8568596|NCT00092534|9600895|FG000|NOT COMPLETED|Base Study Follow-Up Period||316
8568597|NCT00092534|9600896|FG001|NOT COMPLETED|Base Study Follow-Up Period||694
8568598|NCT00092534|9600897|FG002|NOT COMPLETED|Base Study Follow-Up Period||0
8568599|NCT00092534|9600898|FG003|NOT COMPLETED|Base Study Follow-Up Period||0
8568600|NCT00092534|9600899|FG004|NOT COMPLETED|Base Study Follow-Up Period||0
8568601|NCT00092534|9600895|FG000|STARTED|Base Study EXT||0
8568602|NCT00092534|9600896|FG001|STARTED|Base Study EXT||0
8568603|NCT00092534|9600897|FG002|STARTED|Base Study EXT||594
8568604|NCT00092534|9600898|FG003|STARTED|Base Study EXT||0
8568605|NCT00092534|9600899|FG004|STARTED|Base Study EXT||0
8568606|NCT00092534|9600895|FG000|COMPLETED|Base Study EXT||0
8568607|NCT00092534|9600896|FG001|COMPLETED|Base Study EXT||0
8568608|NCT00092534|9600897|FG002|COMPLETED|Base Study EXT||449
8568609|NCT00092534|9600898|FG003|COMPLETED|Base Study EXT||0
8568610|NCT00092534|9600899|FG004|COMPLETED|Base Study EXT||0
8568611|NCT00092534|9600895|FG000|NOT COMPLETED|Base Study EXT||0
8568612|NCT00092534|9600896|FG001|NOT COMPLETED|Base Study EXT||0
8568613|NCT00092534|9600897|FG002|NOT COMPLETED|Base Study EXT||145
8568614|NCT00092534|9600898|FG003|NOT COMPLETED|Base Study EXT||0
8568615|NCT00092534|9600899|FG004|NOT COMPLETED|Base Study EXT||0
8568616|NCT00092534|9600895|FG000|STARTED|Long-Term Follow-Up (LTFU) Study||0
8568617|NCT00092534|9600896|FG001|STARTED|Long-Term Follow-Up (LTFU) Study||0
8568618|NCT00092534|9600897|FG002|STARTED|Long-Term Follow-Up (LTFU) Study||0
8568619|NCT00092534|9600898|FG003|STARTED|Long-Term Follow-Up (LTFU) Study|Some Base Study participants did not consent for inclusion in the LTFU.|2750
8568620|NCT00092534|9600899|FG004|STARTED|Long-Term Follow-Up (LTFU) Study|Some Base Study participants did not consent for inclusion in the LTFU.|2097
8568621|NCT00092534|9600895|FG000|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||0
8568622|NCT00092534|9600896|FG001|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||0
8568623|NCT00092534|9600897|FG002|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||0
8568624|NCT00092534|9600898|FG003|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||2650
8568625|NCT00092534|9600899|FG004|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||2050
8568626|NCT00092534|9600895|FG000|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||0
8568627|NCT00092534|9600896|FG001|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||0
8568628|NCT00092534|9600897|FG002|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||0
8568629|NCT00092534|9600898|FG003|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||2385
8568630|NCT00092534|9600899|FG004|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||1849
8568631|NCT00092534|9600895|FG000|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||0
8568632|NCT00092534|9600896|FG001|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||0
8568633|NCT00092534|9600897|FG002|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||0
8568634|NCT00092534|9600898|FG003|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||2448
8568635|NCT00092534|9600899|FG004|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||1888
8568636|NCT00092534|9600895|FG000|COMPLETED|Long-Term Follow-Up (LTFU) Study||0
8568637|NCT00092534|9600896|FG001|COMPLETED|Long-Term Follow-Up (LTFU) Study||0
8568638|NCT00092534|9600897|FG002|COMPLETED|Long-Term Follow-Up (LTFU) Study||0
8568639|NCT00092534|9600898|FG003|COMPLETED|Long-Term Follow-Up (LTFU) Study||2749
9065914|NCT04128293|10126435|FG001|COMPLETED|Treatment Period 2 (1 Day)||4
9065915|NCT04128293|10126436|FG002|COMPLETED|Treatment Period 2 (1 Day)||4
9065916|NCT04128293|10126437|FG003|COMPLETED|Treatment Period 2 (1 Day)||4
8555146|NCT04749459|9587251|FG000|STARTED|Overall Study||14
8555147|NCT04749459|9587251|FG000|CSM Classic|Overall Study||12
8555148|NCT04749459|9587251|FG000|CSM Strawberry Flavor|Overall Study||10
8555149|NCT04749459|9587251|FG000|P2 Control Standard|Overall Study||14
8555150|NCT04749459|9587251|FG000|COMPLETED|Overall Study||14
8555151|NCT04749459|9587251|FG000|NOT COMPLETED|Overall Study||0
8555167|NCT04481035|9587279|FG000|STARTED|Period 1||3
8555168|NCT04481035|9587280|FG001|STARTED|Period 1||2
8555169|NCT04481035|9587279|FG000|COMPLETED|Period 1||3
8555170|NCT04481035|9587280|FG001|COMPLETED|Period 1||2
8555171|NCT04481035|9587279|FG000|NOT COMPLETED|Period 1||0
8555172|NCT04481035|9587280|FG001|NOT COMPLETED|Period 1||0
8555173|NCT04481035|9587279|FG000|STARTED|Period 2||3
8555174|NCT04481035|9587280|FG001|STARTED|Period 2||2
8555175|NCT04481035|9587279|FG000|COMPLETED|Period 2||3
8555176|NCT04481035|9587280|FG001|COMPLETED|Period 2||2
8555177|NCT04481035|9587279|FG000|NOT COMPLETED|Period 2||0
8555178|NCT04481035|9587280|FG001|NOT COMPLETED|Period 2||0
8555179|NCT04195958|9587286|FG000|STARTED|Overall Study||3
8555180|NCT04195958|9587286|FG000|COMPLETED|Overall Study||1
8555181|NCT04195958|9587286|FG000|NOT COMPLETED|Overall Study||2
8555182|NCT04191148|9587292|FG000|STARTED|Overall Study||24
8555183|NCT04191148|9587293|FG001|STARTED|Overall Study||12
8555184|NCT04191148|9587292|FG000|COMPLETED|Overall Study||22
8555185|NCT04191148|9587293|FG001|COMPLETED|Overall Study||12
8555186|NCT04191148|9587292|FG000|NOT COMPLETED|Overall Study||2
8555187|NCT04191148|9587293|FG001|NOT COMPLETED|Overall Study||0
8555188|NCT04151628|9587303|FG000|STARTED|Overall Study||8
8555189|NCT04151628|9587304|FG001|STARTED|Overall Study||64
8555190|NCT04151628|9587303|FG000|COMPLETED|Overall Study||8
8555191|NCT04151628|9587304|FG001|COMPLETED|Overall Study||64
8555192|NCT04151628|9587303|FG000|NOT COMPLETED|Overall Study||0
8555193|NCT04151628|9587304|FG001|NOT COMPLETED|Overall Study||0
8555194|NCT04130802|9587312|FG000|STARTED|Overall Study||51
8555195|NCT04130802|9587313|FG001|STARTED|Overall Study||51
8555196|NCT04130802|9587314|FG002|STARTED|Overall Study||51
8555197|NCT04130802|9587312|FG000|COMPLETED|Overall Study||50
8555198|NCT04130802|9587313|FG001|COMPLETED|Overall Study||50
8555199|NCT04130802|9587314|FG002|COMPLETED|Overall Study||48
8555200|NCT04130802|9587312|FG000|NOT COMPLETED|Overall Study||1
8555201|NCT04130802|9587313|FG001|NOT COMPLETED|Overall Study||1
8555202|NCT04130802|9587314|FG002|NOT COMPLETED|Overall Study||3
8555221|NCT03830359|9587350|FG000|STARTED|Overall Study||62
8555222|NCT03830359|9587350|FG000|COMPLETED|Overall Study||62
8555223|NCT03830359|9587350|FG000|NOT COMPLETED|Overall Study||0
8555224|NCT03675516|9587356|FG000|STARTED|Overall Study||6591
8555225|NCT03675516|9587357|FG001|STARTED|Overall Study||6591
8555226|NCT03675516|9587356|FG000|COMPLETED|Overall Study||6591
8555227|NCT03675516|9587357|FG001|COMPLETED|Overall Study||6591
8555228|NCT03675516|9587356|FG000|NOT COMPLETED|Overall Study||0
8555229|NCT03675516|9587357|FG001|NOT COMPLETED|Overall Study||0
8555230|NCT03605680|9587368|FG000|STARTED|SB Placebo Run-in Period (1 Week)||604
8555231|NCT03605680|9587369|FG001|STARTED|SB Placebo Run-in Period (1 Week)||0
8555232|NCT03605680|9587370|FG002|STARTED|SB Placebo Run-in Period (1 Week)||0
8555233|NCT03605680|9587371|FG003|STARTED|SB Placebo Run-in Period (1 Week)||0
8555234|NCT03605680|9587368|FG000|Treated|SB Placebo Run-in Period (1 Week)||584
8555235|NCT03605680|9587369|FG001|Treated|SB Placebo Run-in Period (1 Week)||0
8555236|NCT03605680|9587370|FG002|Treated|SB Placebo Run-in Period (1 Week)||0
8555237|NCT03605680|9587371|FG003|Treated|SB Placebo Run-in Period (1 Week)||0
8555238|NCT03605680|9587368|FG000|COMPLETED|SB Placebo Run-in Period (1 Week)||466
8555239|NCT03605680|9587369|FG001|COMPLETED|SB Placebo Run-in Period (1 Week)||0
8555240|NCT03605680|9587370|FG002|COMPLETED|SB Placebo Run-in Period (1 Week)||0
8555241|NCT03605680|9587371|FG003|COMPLETED|SB Placebo Run-in Period (1 Week)||0
8555242|NCT03605680|9587368|FG000|NOT COMPLETED|SB Placebo Run-in Period (1 Week)||138
8555243|NCT03605680|9587369|FG001|NOT COMPLETED|SB Placebo Run-in Period (1 Week)||0
8555244|NCT03605680|9587370|FG002|NOT COMPLETED|SB Placebo Run-in Period (1 Week)||0
8555245|NCT03605680|9587371|FG003|NOT COMPLETED|SB Placebo Run-in Period (1 Week)||0
8555246|NCT03605680|9587368|FG000|STARTED|Double-blind Treatment Period (6 Weeks)||0
8555247|NCT03605680|9587369|FG001|STARTED|Double-blind Treatment Period (6 Weeks)||154
8555248|NCT03605680|9587370|FG002|STARTED|Double-blind Treatment Period (6 Weeks)||156
8555249|NCT03605680|9587371|FG003|STARTED|Double-blind Treatment Period (6 Weeks)||156
8555250|NCT03605680|9587368|FG000|COMPLETED|Double-blind Treatment Period (6 Weeks)||0
8555251|NCT03605680|9587369|FG001|COMPLETED|Double-blind Treatment Period (6 Weeks)||110
8555252|NCT03605680|9587370|FG002|COMPLETED|Double-blind Treatment Period (6 Weeks)||117
8555253|NCT03605680|9587371|FG003|COMPLETED|Double-blind Treatment Period (6 Weeks)||121
8555254|NCT03605680|9587368|FG000|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||0
8555255|NCT03605680|9587369|FG001|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||44
8555256|NCT03605680|9587370|FG002|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||39
8555257|NCT03605680|9587371|FG003|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||35
8555258|NCT03485950|9587382|FG000|STARTED|Overall Study||50
8555259|NCT03485950|9587383|FG001|STARTED|Overall Study||50
8555260|NCT03485950|9587382|FG000|COMPLETED|Overall Study||43
8555261|NCT03485950|9587383|FG001|COMPLETED|Overall Study||48
8555262|NCT03485950|9587382|FG000|NOT COMPLETED|Overall Study||7
8555263|NCT03485950|9587383|FG001|NOT COMPLETED|Overall Study||2
8555264|NCT03404518|9587391|FG000|STARTED|Overall Study||97
8555265|NCT03404518|9587392|FG001|STARTED|Overall Study||88
8555266|NCT03404518|9587391|FG000|COMPLETED|Overall Study||56
8555152|NCT04702984|9587262|FG000|STARTED|Overall Study||39
8555153|NCT04702984|9587262|FG000|COMPLETED|Overall Study||38
8555154|NCT04702984|9587262|FG000|NOT COMPLETED|Overall Study||1
8555155|NCT04633564|9587270|FG000|STARTED|Period 1||335
8555156|NCT04633564|9587271|FG001|STARTED|Period 1||329
8555157|NCT04633564|9587270|FG000|COMPLETED|Period 1||227
8555158|NCT04633564|9587271|FG001|COMPLETED|Period 1||220
8555159|NCT04633564|9587270|FG000|NOT COMPLETED|Period 1||108
8555160|NCT04633564|9587271|FG001|NOT COMPLETED|Period 1||109
8555161|NCT04633564|9587270|FG000|STARTED|Period 2||200
8555162|NCT04633564|9587271|FG001|STARTED|Period 2||199
8555163|NCT04633564|9587270|FG000|COMPLETED|Period 2||107
8555164|NCT04633564|9587271|FG001|COMPLETED|Period 2||102
8555165|NCT04633564|9587270|FG000|NOT COMPLETED|Period 2||93
8555166|NCT04633564|9587271|FG001|NOT COMPLETED|Period 2||97
8555203|NCT04105738|9587325|FG000|STARTED|Overall Study||13
8555204|NCT04105738|9587326|FG001|STARTED|Overall Study||0
8555205|NCT04105738|9587325|FG000|COMPLETED|Overall Study||13
8555206|NCT04105738|9587326|FG001|COMPLETED|Overall Study||0
8555207|NCT04105738|9587325|FG000|NOT COMPLETED|Overall Study||0
8555208|NCT04105738|9587326|FG001|NOT COMPLETED|Overall Study||0
8555209|NCT04022733|9587334|FG000|STARTED|Overall Study||67
8555210|NCT04022733|9587335|FG001|STARTED|Overall Study||67
8820140|NCT01568944|9874142|FG001|NOT COMPLETED|Overall Study||0
8820141|NCT01569022|9874148|FG000|STARTED|First Intervention||21
8820142|NCT01569022|9874149|FG001|STARTED|First Intervention||21
8820143|NCT01569022|9874148|FG000|COMPLETED|First Intervention||19
8820144|NCT01569022|9874149|FG001|COMPLETED|First Intervention||20
8820145|NCT01569022|9874148|FG000|NOT COMPLETED|First Intervention||2
8820146|NCT01569022|9874149|FG001|NOT COMPLETED|First Intervention||1
8820147|NCT01569022|9874148|FG000|STARTED|Second Intervention||19
8820148|NCT01569022|9874149|FG001|STARTED|Second Intervention||20
8820149|NCT01569022|9874148|FG000|COMPLETED|Second Intervention||17
8820150|NCT01569022|9874149|FG001|COMPLETED|Second Intervention||18
8820151|NCT01569022|9874148|FG000|NOT COMPLETED|Second Intervention||2
8555211|NCT04022733|9587334|FG000|COMPLETED|Overall Study||64
8555212|NCT04022733|9587335|FG001|COMPLETED|Overall Study||64
8555213|NCT04022733|9587334|FG000|NOT COMPLETED|Overall Study||3
8555214|NCT04022733|9587335|FG001|NOT COMPLETED|Overall Study||3
8555215|NCT04021524|9587343|FG000|STARTED|Overall Study||25
8555216|NCT04021524|9587344|FG001|STARTED|Overall Study||25
8555217|NCT04021524|9587343|FG000|COMPLETED|Overall Study||25
8555218|NCT04021524|9587344|FG001|COMPLETED|Overall Study||24
8555219|NCT04021524|9587343|FG000|NOT COMPLETED|Overall Study||0
8555220|NCT04021524|9587344|FG001|NOT COMPLETED|Overall Study||1
8555267|NCT03404518|9587392|FG001|COMPLETED|Overall Study||52
8555268|NCT03404518|9587391|FG000|NOT COMPLETED|Overall Study||41
8555269|NCT03404518|9587392|FG001|NOT COMPLETED|Overall Study||36
8555270|NCT03402841|9587398|FG000|STARTED|Overall Study||279
8555271|NCT03402841|9587398|FG000|COMPLETED|Overall Study||187
8555272|NCT03402841|9587398|FG000|NOT COMPLETED|Overall Study||92
8555273|NCT03370757|9587404|FG000|STARTED|Overall Study||20
8555274|NCT03370757|9587405|FG001|STARTED|Overall Study||28
8555275|NCT03370757|9587404|FG000|COMPLETED|Overall Study||20
8555276|NCT03370757|9587405|FG001|COMPLETED|Overall Study||26
8555277|NCT03370757|9587404|FG000|NOT COMPLETED|Overall Study||0
8555278|NCT03370757|9587405|FG001|NOT COMPLETED|Overall Study||2
8555279|NCT03303989|9587415|FG000|STARTED|Overall Study||24
8555280|NCT03303989|9587416|FG001|STARTED|Overall Study||11
8555281|NCT03303989|9587415|FG000|COMPLETED|Overall Study||22
8555282|NCT03303989|9587416|FG001|COMPLETED|Overall Study||10
8555283|NCT03303989|9587415|FG000|NOT COMPLETED|Overall Study||2
8555284|NCT03303989|9587416|FG001|NOT COMPLETED|Overall Study||1
8555285|NCT03289143|9587426|FG000|STARTED|Overall Study||135
9065917|NCT04128293|10126434|FG000|NOT COMPLETED|Treatment Period 2 (1 Day)||0
9065918|NCT04128293|10126435|FG001|NOT COMPLETED|Treatment Period 2 (1 Day)||0
9065919|NCT04128293|10126436|FG002|NOT COMPLETED|Treatment Period 2 (1 Day)||0
9065920|NCT04128293|10126437|FG003|NOT COMPLETED|Treatment Period 2 (1 Day)||0
8820152|NCT01569022|9874149|FG001|NOT COMPLETED|Second Intervention||2
8820153|NCT01569074|9874162|FG000|STARTED|Overall Study|Patients who received treatment|31
8820154|NCT01569074|9874163|FG001|STARTED|Overall Study|Patients who received treatment|33
8820155|NCT01569074|9874164|FG002|STARTED|Overall Study|Patients who received treatment|33
8820156|NCT01569074|9874165|FG003|STARTED|Overall Study|Patients who received treatment|33
9065921|NCT04128293|10126434|FG000|STARTED|Washout Period 2 (Up to 7 Days)||4
8555286|NCT03289143|9587427|FG001|STARTED|Overall Study||94
8555287|NCT03289143|9587428|FG002|STARTED|Overall Study||136
8555288|NCT03289143|9587429|FG003|STARTED|Overall Study||92
8555289|NCT03289143|9587426|FG000|COMPLETED|Overall Study||1
8555290|NCT03289143|9587427|FG001|COMPLETED|Overall Study||0
8555291|NCT03289143|9587428|FG002|COMPLETED|Overall Study||2
8820157|NCT01569074|9874166|FG004|STARTED|Overall Study|Patients who received treatment|33
8820158|NCT01569074|9874162|FG000|Randomised But Did Not Receive Treatment|Overall Study||0
8820159|NCT01569074|9874163|FG001|Randomised But Did Not Receive Treatment|Overall Study||0
8820160|NCT01569074|9874164|FG002|Randomised But Did Not Receive Treatment|Overall Study||0
8849370|NCT01740128|9904532|FG001|COMPLETED|Overall Study||4
8555292|NCT03289143|9587429|FG003|COMPLETED|Overall Study||0
8555293|NCT03289143|9587426|FG000|NOT COMPLETED|Overall Study||134
8555294|NCT03289143|9587427|FG001|NOT COMPLETED|Overall Study||94
8555295|NCT03289143|9587428|FG002|NOT COMPLETED|Overall Study||134
8555296|NCT03289143|9587429|FG003|NOT COMPLETED|Overall Study||92
8555297|NCT03156504|9587444|FG000|STARTED|Overall Study||75
8555298|NCT03156504|9587444|FG000|COMPLETED|Overall Study||74
8555299|NCT03156504|9587444|FG000|NOT COMPLETED|Overall Study||1
8555300|NCT03006926|9587450|FG000|STARTED|Overall Study||6
8555301|NCT03006926|9587451|FG001|STARTED|Overall Study||98
8555302|NCT03006926|9587450|FG000|COMPLETED|Overall Study||6
8555303|NCT03006926|9587451|FG001|COMPLETED|Overall Study||0
8555304|NCT03006926|9587450|FG000|NOT COMPLETED|Overall Study||0
8555305|NCT03006926|9587451|FG001|NOT COMPLETED|Overall Study||98
8555306|NCT02993926|9587459|FG000|STARTED|Enantone Treatment Phase||108
8555307|NCT02993926|9587460|FG001|STARTED|Enantone Treatment Phase||0
8555308|NCT02993926|9587461|FG002|STARTED|Enantone Treatment Phase||0
8555309|NCT02993926|9587459|FG000|COMPLETED|Enantone Treatment Phase||76
8555310|NCT02993926|9587460|FG001|COMPLETED|Enantone Treatment Phase||0
8555311|NCT02993926|9587461|FG002|COMPLETED|Enantone Treatment Phase||0
8555312|NCT02993926|9587459|FG000|NOT COMPLETED|Enantone Treatment Phase||32
8555313|NCT02993926|9587460|FG001|NOT COMPLETED|Enantone Treatment Phase||0
8555314|NCT02993926|9587461|FG002|NOT COMPLETED|Enantone Treatment Phase||0
8555315|NCT02993926|9587459|FG000|STARTED|Follow-Up Phase||0
8555316|NCT02993926|9587460|FG001|STARTED|Follow-Up Phase||44
8555317|NCT02993926|9587461|FG002|STARTED|Follow-Up Phase||26
8555318|NCT02993926|9587459|FG000|COMPLETED|Follow-Up Phase||0
8555319|NCT02993926|9587460|FG001|COMPLETED|Follow-Up Phase||44
8555320|NCT02993926|9587461|FG002|COMPLETED|Follow-Up Phase||26
8555321|NCT02993926|9587459|FG000|NOT COMPLETED|Follow-Up Phase||0
8555322|NCT02993926|9587460|FG001|NOT COMPLETED|Follow-Up Phase||0
8555323|NCT02993926|9587461|FG002|NOT COMPLETED|Follow-Up Phase||0
8555324|NCT02932579|9587473|FG000|STARTED|Overall Study||33
8555325|NCT02932579|9587474|FG001|STARTED|Overall Study||26
8555326|NCT02932579|9587473|FG000|COMPLETED|Overall Study||29
8555327|NCT02932579|9587474|FG001|COMPLETED|Overall Study||25
8555328|NCT02932579|9587473|FG000|NOT COMPLETED|Overall Study||4
8555329|NCT02932579|9587474|FG001|NOT COMPLETED|Overall Study||1
8555330|NCT02928224|9587484|FG000|STARTED|Overall Study||37
8555331|NCT02928224|9587485|FG001|STARTED|Overall Study||224
8555332|NCT02928224|9587486|FG002|STARTED|Overall Study||220
8555333|NCT02928224|9587487|FG003|STARTED|Overall Study||221
8555334|NCT02928224|9587484|FG000|COMPLETED|Overall Study||0
8555335|NCT02928224|9587485|FG001|COMPLETED|Overall Study||0
8555336|NCT02928224|9587486|FG002|COMPLETED|Overall Study||0
8555337|NCT02928224|9587487|FG003|COMPLETED|Overall Study||0
9065922|NCT04128293|10126435|FG001|STARTED|Washout Period 2 (Up to 7 Days)||4
9065923|NCT04128293|10126436|FG002|STARTED|Washout Period 2 (Up to 7 Days)||4
8555338|NCT02928224|9587484|FG000|NOT COMPLETED|Overall Study||37
8555339|NCT02928224|9587485|FG001|NOT COMPLETED|Overall Study||224
8555340|NCT02928224|9587486|FG002|NOT COMPLETED|Overall Study||220
8555341|NCT02928224|9587487|FG003|NOT COMPLETED|Overall Study||221
8555342|NCT02858154|9587502|FG000|STARTED|HFNC 3-4 Hours||9
8555343|NCT02858154|9587502|FG000|COMPLETED|HFNC 3-4 Hours||9
8555344|NCT02858154|9587502|FG000|NOT COMPLETED|HFNC 3-4 Hours||0
8555345|NCT02858154|9587502|FG000|STARTED|Clinically Ordered PSG/Low Flow Oxygen||9
8555346|NCT02858154|9587502|FG000|COMPLETED|Clinically Ordered PSG/Low Flow Oxygen||9
8555347|NCT02858154|9587502|FG000|NOT COMPLETED|Clinically Ordered PSG/Low Flow Oxygen||0
8555348|NCT02852967|9587512|FG000|STARTED|Overall Study||23
8555349|NCT02852967|9587513|FG001|STARTED|Overall Study||22
8555350|NCT02852967|9587514|FG002|STARTED|Overall Study||21
8555351|NCT02852967|9587515|FG003|STARTED|Overall Study||26
8555352|NCT02852967|9587516|FG004|STARTED|Overall Study||18
8555353|NCT02852967|9587512|FG000|Completed Period 1: Double-blind|Overall Study||14
8555354|NCT02852967|9587513|FG001|Completed Period 1: Double-blind|Overall Study||15
8555355|NCT02852967|9587514|FG002|Completed Period 1: Double-blind|Overall Study||17
8555356|NCT02852967|9587515|FG003|Completed Period 1: Double-blind|Overall Study||16
8555357|NCT02852967|9587516|FG004|Completed Period 1: Double-blind|Overall Study||10
8555358|NCT02852967|9587512|FG000|Completed Period 2: Open-label|Overall Study||11
8555359|NCT02852967|9587513|FG001|Completed Period 2: Open-label|Overall Study||8
8555360|NCT02852967|9587514|FG002|Completed Period 2: Open-label|Overall Study||13
8555361|NCT02852967|9587515|FG003|Completed Period 2: Open-label|Overall Study||11
8555362|NCT02852967|9587516|FG004|Completed Period 2: Open-label|Overall Study||14
8555363|NCT02852967|9587512|FG000|COMPLETED|Overall Study||9
8555364|NCT02852967|9587513|FG001|COMPLETED|Overall Study||6
8555365|NCT02852967|9587514|FG002|COMPLETED|Overall Study||9
8555366|NCT02852967|9587515|FG003|COMPLETED|Overall Study||4
8555367|NCT02852967|9587516|FG004|COMPLETED|Overall Study||2
8555368|NCT02852967|9587512|FG000|NOT COMPLETED|Overall Study||14
8555369|NCT02852967|9587513|FG001|NOT COMPLETED|Overall Study||16
8555370|NCT02852967|9587514|FG002|NOT COMPLETED|Overall Study||12
8555371|NCT02852967|9587515|FG003|NOT COMPLETED|Overall Study||22
8555372|NCT02852967|9587516|FG004|NOT COMPLETED|Overall Study||16
9065924|NCT04128293|10126437|FG003|STARTED|Washout Period 2 (Up to 7 Days)||4
9065925|NCT04128293|10126434|FG000|COMPLETED|Washout Period 2 (Up to 7 Days)||0
9065926|NCT04128293|10126435|FG001|COMPLETED|Washout Period 2 (Up to 7 Days)||0
9065927|NCT04128293|10126436|FG002|COMPLETED|Washout Period 2 (Up to 7 Days)||0
8555373|NCT02810418|9587543|FG000|STARTED|Arm A Dose Escalation||6
8555374|NCT02810418|9587544|FG001|STARTED|Arm A Dose Escalation||8
8555375|NCT02810418|9587545|FG002|STARTED|Arm A Dose Escalation||0
8555376|NCT02810418|9587546|FG003|STARTED|Arm A Dose Escalation||0
8555377|NCT02810418|9587547|FG004|STARTED|Arm A Dose Escalation||0
8555378|NCT02810418|9587548|FG005|STARTED|Arm A Dose Escalation||0
8555379|NCT02810418|9587549|FG006|STARTED|Arm A Dose Escalation||0
8555380|NCT02810418|9587543|FG000|COMPLETED|Arm A Dose Escalation||4
8555381|NCT02810418|9587544|FG001|COMPLETED|Arm A Dose Escalation||7
8555382|NCT02810418|9587545|FG002|COMPLETED|Arm A Dose Escalation||0
8555383|NCT02810418|9587546|FG003|COMPLETED|Arm A Dose Escalation||0
8555384|NCT02810418|9587547|FG004|COMPLETED|Arm A Dose Escalation||0
8555385|NCT02810418|9587548|FG005|COMPLETED|Arm A Dose Escalation||0
8555386|NCT02810418|9587549|FG006|COMPLETED|Arm A Dose Escalation||0
8555387|NCT02810418|9587543|FG000|NOT COMPLETED|Arm A Dose Escalation||2
8555388|NCT02810418|9587544|FG001|NOT COMPLETED|Arm A Dose Escalation||1
8555389|NCT02810418|9587545|FG002|NOT COMPLETED|Arm A Dose Escalation||0
8555390|NCT02810418|9587546|FG003|NOT COMPLETED|Arm A Dose Escalation||0
8555391|NCT02810418|9587547|FG004|NOT COMPLETED|Arm A Dose Escalation||0
8555392|NCT02810418|9587548|FG005|NOT COMPLETED|Arm A Dose Escalation||0
8555393|NCT02810418|9587549|FG006|NOT COMPLETED|Arm A Dose Escalation||0
8555394|NCT02810418|9587543|FG000|STARTED|Dose Expansion||0
8555395|NCT02810418|9587544|FG001|STARTED|Dose Expansion||8
8555396|NCT02810418|9587545|FG002|STARTED|Dose Expansion||6
8555397|NCT02810418|9587546|FG003|STARTED|Dose Expansion||0
8555398|NCT02810418|9587547|FG004|STARTED|Dose Expansion||0
8555399|NCT02810418|9587548|FG005|STARTED|Dose Expansion||0
8555400|NCT02810418|9587549|FG006|STARTED|Dose Expansion||0
8555401|NCT02810418|9587543|FG000|COMPLETED|Dose Expansion||0
8555402|NCT02810418|9587544|FG001|COMPLETED|Dose Expansion||7
8555403|NCT02810418|9587545|FG002|COMPLETED|Dose Expansion||3
8555404|NCT02810418|9587546|FG003|COMPLETED|Dose Expansion||0
8555405|NCT02810418|9587547|FG004|COMPLETED|Dose Expansion||0
8555406|NCT02810418|9587548|FG005|COMPLETED|Dose Expansion||0
8555407|NCT02810418|9587549|FG006|COMPLETED|Dose Expansion||0
8555408|NCT02810418|9587543|FG000|NOT COMPLETED|Dose Expansion||0
8555409|NCT02810418|9587544|FG001|NOT COMPLETED|Dose Expansion||1
8555410|NCT02810418|9587545|FG002|NOT COMPLETED|Dose Expansion||3
8555411|NCT02810418|9587546|FG003|NOT COMPLETED|Dose Expansion||0
8555412|NCT02810418|9587547|FG004|NOT COMPLETED|Dose Expansion||0
8555413|NCT02810418|9587548|FG005|NOT COMPLETED|Dose Expansion||0
8555414|NCT02810418|9587549|FG006|NOT COMPLETED|Dose Expansion||0
8555415|NCT02810418|9587543|FG000|STARTED|Arm B Dose Escalation||0
8555416|NCT02810418|9587544|FG001|STARTED|Arm B Dose Escalation||0
8555417|NCT02810418|9587545|FG002|STARTED|Arm B Dose Escalation||0
8555418|NCT02810418|9587546|FG003|STARTED|Arm B Dose Escalation||6
8555419|NCT02810418|9587547|FG004|STARTED|Arm B Dose Escalation||3
8555420|NCT02810418|9587548|FG005|STARTED|Arm B Dose Escalation||6
8555421|NCT02810418|9587549|FG006|STARTED|Arm B Dose Escalation||0
8555422|NCT02810418|9587543|FG000|COMPLETED|Arm B Dose Escalation||0
8555423|NCT02810418|9587544|FG001|COMPLETED|Arm B Dose Escalation||0
8555424|NCT02810418|9587545|FG002|COMPLETED|Arm B Dose Escalation||0
8555425|NCT02810418|9587546|FG003|COMPLETED|Arm B Dose Escalation||6
8555426|NCT02810418|9587547|FG004|COMPLETED|Arm B Dose Escalation||2
8555427|NCT02810418|9587548|FG005|COMPLETED|Arm B Dose Escalation||4
8555428|NCT02810418|9587549|FG006|COMPLETED|Arm B Dose Escalation||0
8555429|NCT02810418|9587543|FG000|NOT COMPLETED|Arm B Dose Escalation||0
8555430|NCT02810418|9587544|FG001|NOT COMPLETED|Arm B Dose Escalation||0
8555431|NCT02810418|9587545|FG002|NOT COMPLETED|Arm B Dose Escalation||0
8555432|NCT02810418|9587546|FG003|NOT COMPLETED|Arm B Dose Escalation||0
8555433|NCT02810418|9587547|FG004|NOT COMPLETED|Arm B Dose Escalation||1
8555434|NCT02810418|9587548|FG005|NOT COMPLETED|Arm B Dose Escalation||2
8555435|NCT02810418|9587549|FG006|NOT COMPLETED|Arm B Dose Escalation||0
8555436|NCT02810418|9587543|FG000|STARTED|Arm B Combination Therapy||0
8555437|NCT02810418|9587544|FG001|STARTED|Arm B Combination Therapy||0
8555438|NCT02810418|9587545|FG002|STARTED|Arm B Combination Therapy||0
8555439|NCT02810418|9587546|FG003|STARTED|Arm B Combination Therapy||0
8555440|NCT02810418|9587547|FG004|STARTED|Arm B Combination Therapy||0
8555441|NCT02810418|9587548|FG005|STARTED|Arm B Combination Therapy||0
8555442|NCT02810418|9587549|FG006|STARTED|Arm B Combination Therapy||5
8555443|NCT02810418|9587543|FG000|COMPLETED|Arm B Combination Therapy||0
8555444|NCT02810418|9587544|FG001|COMPLETED|Arm B Combination Therapy||0
8555445|NCT02810418|9587545|FG002|COMPLETED|Arm B Combination Therapy||0
8555446|NCT02810418|9587546|FG003|COMPLETED|Arm B Combination Therapy||0
8555447|NCT02810418|9587547|FG004|COMPLETED|Arm B Combination Therapy||0
8555448|NCT02810418|9587548|FG005|COMPLETED|Arm B Combination Therapy||0
8555449|NCT02810418|9587549|FG006|COMPLETED|Arm B Combination Therapy||5
8555450|NCT02810418|9587543|FG000|NOT COMPLETED|Arm B Combination Therapy||0
8555451|NCT02810418|9587544|FG001|NOT COMPLETED|Arm B Combination Therapy||0
8555452|NCT02810418|9587545|FG002|NOT COMPLETED|Arm B Combination Therapy||0
8555453|NCT02810418|9587546|FG003|NOT COMPLETED|Arm B Combination Therapy||0
8555454|NCT02810418|9587547|FG004|NOT COMPLETED|Arm B Combination Therapy||0
8555455|NCT02810418|9587548|FG005|NOT COMPLETED|Arm B Combination Therapy||0
8555456|NCT02810418|9587549|FG006|NOT COMPLETED|Arm B Combination Therapy||0
8555457|NCT02785991|9587612|FG000|STARTED|Overall Study||1742
8555458|NCT02785991|9587612|FG000|COMPLETED|Overall Study||1741
8555459|NCT02785991|9587612|FG000|NOT COMPLETED|Overall Study||1
8555460|NCT02781584|9587630|FG000|STARTED|Pre-treatment Phase||0
8555461|NCT02781584|9587631|FG001|STARTED|Pre-treatment Phase||0
8555462|NCT02781584|9587632|FG002|STARTED|Pre-treatment Phase||0
8555463|NCT02781584|9587633|FG003|STARTED|Pre-treatment Phase||0
8555464|NCT02781584|9587634|FG004|STARTED|Pre-treatment Phase||0
8555465|NCT02781584|9587635|FG005|STARTED|Pre-treatment Phase||0
8555466|NCT02781584|9587636|FG006|STARTED|Pre-treatment Phase||0
8555467|NCT02781584|9587637|FG007|STARTED|Pre-treatment Phase||0
8555468|NCT02781584|9587638|FG008|STARTED|Pre-treatment Phase||0
8555469|NCT02781584|9587639|FG009|STARTED|Pre-treatment Phase||15
8555470|NCT02781584|9587640|FG010|STARTED|Pre-treatment Phase||16
8555471|NCT02781584|9587641|FG011|STARTED|Pre-treatment Phase||33
8555472|NCT02781584|9587642|FG012|STARTED|Pre-treatment Phase||33
8555473|NCT02781584|9587630|FG000|COMPLETED|Pre-treatment Phase||0
8555474|NCT02781584|9587631|FG001|COMPLETED|Pre-treatment Phase||0
8555475|NCT02781584|9587632|FG002|COMPLETED|Pre-treatment Phase||0
8555476|NCT02781584|9587633|FG003|COMPLETED|Pre-treatment Phase||0
8555477|NCT02781584|9587634|FG004|COMPLETED|Pre-treatment Phase||0
8555478|NCT02781584|9587635|FG005|COMPLETED|Pre-treatment Phase||0
8555479|NCT02781584|9587636|FG006|COMPLETED|Pre-treatment Phase||0
8555480|NCT02781584|9587637|FG007|COMPLETED|Pre-treatment Phase||0
8555481|NCT02781584|9587638|FG008|COMPLETED|Pre-treatment Phase||0
8555482|NCT02781584|9587639|FG009|COMPLETED|Pre-treatment Phase||15
8555483|NCT02781584|9587640|FG010|COMPLETED|Pre-treatment Phase||16
8555484|NCT02781584|9587641|FG011|COMPLETED|Pre-treatment Phase||30
8555485|NCT02781584|9587642|FG012|COMPLETED|Pre-treatment Phase||32
8555486|NCT02781584|9587630|FG000|NOT COMPLETED|Pre-treatment Phase||0
8555487|NCT02781584|9587631|FG001|NOT COMPLETED|Pre-treatment Phase||0
8555488|NCT02781584|9587632|FG002|NOT COMPLETED|Pre-treatment Phase||0
8555489|NCT02781584|9587633|FG003|NOT COMPLETED|Pre-treatment Phase||0
8555490|NCT02781584|9587634|FG004|NOT COMPLETED|Pre-treatment Phase||0
8555491|NCT02781584|9587635|FG005|NOT COMPLETED|Pre-treatment Phase||0
8555492|NCT02781584|9587636|FG006|NOT COMPLETED|Pre-treatment Phase||0
8555493|NCT02781584|9587637|FG007|NOT COMPLETED|Pre-treatment Phase||0
8555494|NCT02781584|9587638|FG008|NOT COMPLETED|Pre-treatment Phase||0
8555495|NCT02781584|9587639|FG009|NOT COMPLETED|Pre-treatment Phase||0
8555496|NCT02781584|9587640|FG010|NOT COMPLETED|Pre-treatment Phase||0
8555497|NCT02781584|9587641|FG011|NOT COMPLETED|Pre-treatment Phase||3
8555498|NCT02781584|9587642|FG012|NOT COMPLETED|Pre-treatment Phase||1
8555499|NCT02781584|9587630|FG000|STARTED|Treatment Phase|Only participants in Cohorts 10-13 received pre-treatment.|10
8555500|NCT02781584|9587631|FG001|STARTED|Treatment Phase|Only participants in Cohorts 10-13 received pre-treatment.|10
8555501|NCT02781584|9587632|FG002|STARTED|Treatment Phase|Only participants in Cohorts 10-13 received pre-treatment.|10
8555502|NCT02781584|9587633|FG003|STARTED|Treatment Phase|Only participants in Cohorts 10-13 received pre-treatment.|20
8555503|NCT02781584|9587634|FG004|STARTED|Treatment Phase|Only participants in Cohorts 10-13 received pre-treatment.|20
8555504|NCT02781584|9587635|FG005|STARTED|Treatment Phase|Only participants in Cohorts 10-13 received pre-treatment.|20
8555505|NCT02781584|9587636|FG006|STARTED|Treatment Phase|Only participants in Cohorts 10-13 received pre-treatment.|10
8555506|NCT02781584|9587637|FG007|STARTED|Treatment Phase|Only participants in Cohorts 10-13 received pre-treatment.|10
8555507|NCT02781584|9587638|FG008|STARTED|Treatment Phase|Only participants in Cohorts 10-13 received pre-treatment.|13
8555508|NCT02781584|9587639|FG009|STARTED|Treatment Phase||15
8555509|NCT02781584|9587640|FG010|STARTED|Treatment Phase||16
8555510|NCT02781584|9587641|FG011|STARTED|Treatment Phase||30
8555511|NCT02781584|9587642|FG012|STARTED|Treatment Phase||32
8555512|NCT02781584|9587630|FG000|COMPLETED|Treatment Phase||10
8555513|NCT02781584|9587631|FG001|COMPLETED|Treatment Phase||10
8555514|NCT02781584|9587632|FG002|COMPLETED|Treatment Phase||10
8555515|NCT02781584|9587633|FG003|COMPLETED|Treatment Phase||20
8555516|NCT02781584|9587634|FG004|COMPLETED|Treatment Phase||20
8555517|NCT02781584|9587635|FG005|COMPLETED|Treatment Phase||19
8555518|NCT02781584|9587636|FG006|COMPLETED|Treatment Phase||10
8555519|NCT02781584|9587637|FG007|COMPLETED|Treatment Phase||9
8555520|NCT02781584|9587638|FG008|COMPLETED|Treatment Phase||13
8555521|NCT02781584|9587639|FG009|COMPLETED|Treatment Phase||15
8555522|NCT02781584|9587640|FG010|COMPLETED|Treatment Phase||15
8555523|NCT02781584|9587641|FG011|COMPLETED|Treatment Phase||28
8555524|NCT02781584|9587642|FG012|COMPLETED|Treatment Phase||32
8555525|NCT02781584|9587630|FG000|NOT COMPLETED|Treatment Phase||0
8555526|NCT02781584|9587631|FG001|NOT COMPLETED|Treatment Phase||0
8555527|NCT02781584|9587632|FG002|NOT COMPLETED|Treatment Phase||0
8555528|NCT02781584|9587633|FG003|NOT COMPLETED|Treatment Phase||0
8555529|NCT02781584|9587634|FG004|NOT COMPLETED|Treatment Phase||0
8555530|NCT02781584|9587635|FG005|NOT COMPLETED|Treatment Phase||1
8555531|NCT02781584|9587636|FG006|NOT COMPLETED|Treatment Phase||0
8555532|NCT02781584|9587637|FG007|NOT COMPLETED|Treatment Phase||1
8555533|NCT02781584|9587638|FG008|NOT COMPLETED|Treatment Phase||0
8555534|NCT02781584|9587639|FG009|NOT COMPLETED|Treatment Phase||0
8555535|NCT02781584|9587640|FG010|NOT COMPLETED|Treatment Phase||1
8555536|NCT02781584|9587641|FG011|NOT COMPLETED|Treatment Phase||2
8555537|NCT02781584|9587642|FG012|NOT COMPLETED|Treatment Phase||0
8555538|NCT02730130|9587670|FG000|STARTED|Overall Study||17
8555539|NCT02730130|9587670|FG000|COMPLETED|Overall Study||17
8555540|NCT02730130|9587670|FG000|NOT COMPLETED|Overall Study||0
8555541|NCT02714062|9587677|FG000|STARTED|Overall Study||14
8555542|NCT02714062|9587678|FG001|STARTED|Overall Study||15
8555543|NCT02714062|9587679|FG002|STARTED|Overall Study||13
8555544|NCT02714062|9587677|FG000|COMPLETED|Overall Study||13
8555545|NCT02714062|9587678|FG001|COMPLETED|Overall Study||14
8555546|NCT02714062|9587679|FG002|COMPLETED|Overall Study||10
8555547|NCT02714062|9587677|FG000|NOT COMPLETED|Overall Study||1
8555548|NCT02714062|9587678|FG001|NOT COMPLETED|Overall Study||1
8555549|NCT02714062|9587679|FG002|NOT COMPLETED|Overall Study||3
8555550|NCT02707055|9587691|FG000|STARTED|Phase 1||18
8555551|NCT02707055|9587692|FG001|STARTED|Phase 1||19
8555552|NCT02707055|9587691|FG000|COMPLETED|Phase 1||17
8555553|NCT02707055|9587692|FG001|COMPLETED|Phase 1||16
8555554|NCT02707055|9587691|FG000|NOT COMPLETED|Phase 1||1
8555555|NCT02707055|9587692|FG001|NOT COMPLETED|Phase 1||3
8555556|NCT02707055|9587691|FG000|STARTED|Washout Period||17
8555557|NCT02707055|9587692|FG001|STARTED|Washout Period||16
8555558|NCT02707055|9587691|FG000|COMPLETED|Washout Period||17
8555559|NCT02707055|9587692|FG001|COMPLETED|Washout Period||16
8555560|NCT02707055|9587691|FG000|NOT COMPLETED|Washout Period||0
8555561|NCT02707055|9587692|FG001|NOT COMPLETED|Washout Period||0
8555562|NCT02707055|9587691|FG000|STARTED|Phase 2||17
8555563|NCT02707055|9587692|FG001|STARTED|Phase 2||16
8555564|NCT02707055|9587691|FG000|COMPLETED|Phase 2||16
8555565|NCT02707055|9587692|FG001|COMPLETED|Phase 2||14
8555566|NCT02707055|9587691|FG000|NOT COMPLETED|Phase 2||1
8555567|NCT02707055|9587692|FG001|NOT COMPLETED|Phase 2||2
8555568|NCT02696759|9587698|FG000|STARTED|Overall Study||15
8555569|NCT02696759|9587698|FG000|COMPLETED|Overall Study||15
8555570|NCT02696759|9587698|FG000|NOT COMPLETED|Overall Study||0
8555571|NCT02656290|9587702|FG000|STARTED|Overall Study||26
8555572|NCT02656290|9587702|FG000|1 Year|Overall Study|One subject missed the 1 year follow-up visit.|25
8555573|NCT02656290|9587702|FG000|2 Year|Overall Study||17
8555574|NCT02656290|9587702|FG000|3 Year|Overall Study||6
8555575|NCT02656290|9587702|FG000|COMPLETED|Overall Study||0
8555576|NCT02656290|9587702|FG000|NOT COMPLETED|Overall Study||26
8555577|NCT02652130|9587706|FG000|STARTED|Overall Study||32
8555578|NCT02652130|9587706|FG000|COMPLETED|Overall Study||31
8555579|NCT02652130|9587706|FG000|NOT COMPLETED|Overall Study||1
8555580|NCT02616393|9587713|FG000|STARTED|Overall Study||13
8555581|NCT02616393|9587714|FG001|STARTED|Overall Study||20
8555582|NCT02616393|9587715|FG002|STARTED|Overall Study||3
8555583|NCT02616393|9587713|FG000|COMPLETED|Overall Study||0
8555584|NCT02616393|9587714|FG001|COMPLETED|Overall Study||0
8555585|NCT02616393|9587715|FG002|COMPLETED|Overall Study||0
8555586|NCT02616393|9587713|FG000|NOT COMPLETED|Overall Study||13
8555587|NCT02616393|9587714|FG001|NOT COMPLETED|Overall Study||20
8555588|NCT02616393|9587715|FG002|NOT COMPLETED|Overall Study||3
8555589|NCT02602288|9587741|FG000|STARTED|End of Treatment/3 Month Follow-up||199
8555590|NCT02602288|9587742|FG001|STARTED|End of Treatment/3 Month Follow-up||197
8555591|NCT02602288|9587741|FG000|COMPLETED|End of Treatment/3 Month Follow-up||174
8555592|NCT02602288|9587742|FG001|COMPLETED|End of Treatment/3 Month Follow-up||179
8555593|NCT02602288|9587741|FG000|NOT COMPLETED|End of Treatment/3 Month Follow-up||25
8555594|NCT02602288|9587742|FG001|NOT COMPLETED|End of Treatment/3 Month Follow-up||18
8555595|NCT02602288|9587741|FG000|STARTED|12 Month Follow-up||174
8555596|NCT02602288|9587742|FG001|STARTED|12 Month Follow-up||179
8555597|NCT02602288|9587741|FG000|COMPLETED|12 Month Follow-up||172
8555598|NCT02602288|9587742|FG001|COMPLETED|12 Month Follow-up||175
8555599|NCT02602288|9587741|FG000|NOT COMPLETED|12 Month Follow-up||2
8555600|NCT02602288|9587742|FG001|NOT COMPLETED|12 Month Follow-up||4
8555601|NCT02577523|9587750|FG000|STARTED|Overall Study||19
8555602|NCT02577523|9587751|FG001|STARTED|Overall Study||19
8555603|NCT02577523|9587750|FG000|COMPLETED|Overall Study||16
8555604|NCT02577523|9587751|FG001|COMPLETED|Overall Study||17
8555605|NCT02577523|9587750|FG000|NOT COMPLETED|Overall Study||3
8555606|NCT02577523|9587751|FG001|NOT COMPLETED|Overall Study||2
8568640|NCT00092534|9600899|FG004|COMPLETED|Long-Term Follow-Up (LTFU) Study||2097
8568641|NCT00092534|9600895|FG000|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||0
8568642|NCT00092534|9600896|FG001|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||0
8568643|NCT00092534|9600897|FG002|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||0
8568644|NCT00092534|9600898|FG003|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||1
8568645|NCT00092534|9600899|FG004|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||0
8568646|NCT00092547|9600911|FG000|STARTED|Base Vaccine Phase (Day 1 to Month 7)||1184
8568647|NCT00092547|9600912|FG001|STARTED|Base Vaccine Phase (Day 1 to Month 7)||597
8568648|NCT00092547|9600913|FG002|STARTED|Base Vaccine Phase (Day 1 to Month 7)||0
8568649|NCT00092547|9600911|FG000|Vaccinated|Base Vaccine Phase (Day 1 to Month 7)||1179
8568650|NCT00092547|9600912|FG001|Vaccinated|Base Vaccine Phase (Day 1 to Month 7)||596
8568651|NCT00092547|9600913|FG002|Vaccinated|Base Vaccine Phase (Day 1 to Month 7)||0
8568652|NCT00092547|9600911|FG000|COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||1121
8568653|NCT00092547|9600912|FG001|COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||561
8568654|NCT00092547|9600913|FG002|COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||0
8568655|NCT00092547|9600911|FG000|NOT COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||63
8568656|NCT00092547|9600912|FG001|NOT COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||36
8568657|NCT00092547|9600913|FG002|NOT COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||0
8568658|NCT00092547|9600911|FG000|STARTED|Base Follow-up Phase (Month 7 to 18)|Includes participants continuing and who previously discontinued who re-entered the study|1128
8568659|NCT00092547|9600912|FG001|STARTED|Base Follow-up Phase (Month 7 to 18)|Includes participants continuing and who previously discontinued who re-entered the study|565
8568660|NCT00092547|9600913|FG002|STARTED|Base Follow-up Phase (Month 7 to 18)||0
8568661|NCT00092547|9600911|FG000|COMPLETED|Base Follow-up Phase (Month 7 to 18)||1108
8568662|NCT00092547|9600912|FG001|COMPLETED|Base Follow-up Phase (Month 7 to 18)||551
8568663|NCT00092547|9600913|FG002|COMPLETED|Base Follow-up Phase (Month 7 to 18)||0
8568664|NCT00092547|9600911|FG000|NOT COMPLETED|Base Follow-up Phase (Month 7 to 18)||20
8568665|NCT00092547|9600912|FG001|NOT COMPLETED|Base Follow-up Phase (Month 7 to 18)||14
8568666|NCT00092547|9600913|FG002|NOT COMPLETED|Base Follow-up Phase (Month 7 to 18)||0
8555607|NCT02563002|9587759|FG000|STARTED|Overall Study||153
8555608|NCT02563002|9587760|FG001|STARTED|Overall Study||154
8555609|NCT02563002|9587759|FG000|Treated|Overall Study||153
8555610|NCT02563002|9587760|FG001|Treated|Overall Study||143
8555611|NCT02563002|9587759|FG000|Received Second Course of Pembrolizumab|Overall Study||8
8555612|NCT02563002|9587760|FG001|Received Second Course of Pembrolizumab|Overall Study||4
8555613|NCT02563002|9587759|FG000|Switched Over to Pembrolizumab|Overall Study||0
8555614|NCT02563002|9587760|FG001|Switched Over to Pembrolizumab|Overall Study||56
8555615|NCT02563002|9587759|FG000|COMPLETED|Overall Study||0
8555616|NCT02563002|9587760|FG001|COMPLETED|Overall Study||0
8555617|NCT02563002|9587759|FG000|NOT COMPLETED|Overall Study||153
8555618|NCT02563002|9587760|FG001|NOT COMPLETED|Overall Study||154
8555619|NCT02461225|9587771|FG000|STARTED|Overall Study||19
8555620|NCT02461225|9587772|FG001|STARTED|Overall Study||11
8555621|NCT02461225|9587771|FG000|COMPLETED|Overall Study||19
8555622|NCT02461225|9587772|FG001|COMPLETED|Overall Study||11
8555623|NCT02461225|9587771|FG000|NOT COMPLETED|Overall Study||0
8555624|NCT02461225|9587772|FG001|NOT COMPLETED|Overall Study||0
8555625|NCT02427958|9587778|FG000|STARTED|Overall Study||307
8555626|NCT02427958|9587778|FG000|COMPLETED|Overall Study||283
8555627|NCT02427958|9587778|FG000|NOT COMPLETED|Overall Study||24
8555628|NCT02425826|9587784|FG000|STARTED|Placebo-controlled Phase (Week 0 - 16)||148
8555629|NCT02425826|9587785|FG001|STARTED|Placebo-controlled Phase (Week 0 - 16)||73
8555630|NCT02425826|9587786|FG002|STARTED|Placebo-controlled Phase (Week 0 - 16)||0
8555631|NCT02425826|9587784|FG000|Intent to Treat|Placebo-controlled Phase (Week 0 - 16)|ITT = includes participants who received at least one dose of study drug.|147
8555632|NCT02425826|9587785|FG001|Intent to Treat|Placebo-controlled Phase (Week 0 - 16)|ITT = includes participants who received at least one dose of study drug.|73
8555633|NCT02425826|9587786|FG002|Intent to Treat|Placebo-controlled Phase (Week 0 - 16)||0
8555634|NCT02425826|9587784|FG000|COMPLETED|Placebo-controlled Phase (Week 0 - 16)|Completed = participants who completed Week 16|121
8555635|NCT02425826|9587785|FG001|COMPLETED|Placebo-controlled Phase (Week 0 - 16)|Completed = participants who completed Week 16|64
8555636|NCT02425826|9587786|FG002|COMPLETED|Placebo-controlled Phase (Week 0 - 16)||0
8555637|NCT02425826|9587784|FG000|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 16)||27
8555638|NCT02425826|9587785|FG001|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 16)||9
8555639|NCT02425826|9587786|FG002|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 16)||0
8555640|NCT02425826|9587784|FG000|STARTED|Apremilast Extension Phase (Weeks 16-52)||121
8555641|NCT02425826|9587785|FG001|STARTED|Apremilast Extension Phase (Weeks 16-52)||0
8555642|NCT02425826|9587786|FG002|STARTED|Apremilast Extension Phase (Weeks 16-52)||64
8555643|NCT02425826|9587784|FG000|Received Treatment|Apremilast Extension Phase (Weeks 16-52)||121
8555644|NCT02425826|9587785|FG001|Received Treatment|Apremilast Extension Phase (Weeks 16-52)||0
8555645|NCT02425826|9587786|FG002|Received Treatment|Apremilast Extension Phase (Weeks 16-52)||64
8555646|NCT02425826|9587784|FG000|COMPLETED|Apremilast Extension Phase (Weeks 16-52)||86
8555647|NCT02425826|9587785|FG001|COMPLETED|Apremilast Extension Phase (Weeks 16-52)||0
8555648|NCT02425826|9587786|FG002|COMPLETED|Apremilast Extension Phase (Weeks 16-52)||50
8555649|NCT02425826|9587784|FG000|NOT COMPLETED|Apremilast Extension Phase (Weeks 16-52)||35
8555650|NCT02425826|9587785|FG001|NOT COMPLETED|Apremilast Extension Phase (Weeks 16-52)||0
8555651|NCT02425826|9587786|FG002|NOT COMPLETED|Apremilast Extension Phase (Weeks 16-52)||14
8555652|NCT02425826|9587784|FG000|STARTED|Post-Treatment Observational Follow-Up||81
8555653|NCT02425826|9587785|FG001|STARTED|Post-Treatment Observational Follow-Up||0
8555654|NCT02425826|9587786|FG002|STARTED|Post-Treatment Observational Follow-Up||49
8555655|NCT02425826|9587784|FG000|COMPLETED|Post-Treatment Observational Follow-Up||80
8555656|NCT02425826|9587785|FG001|COMPLETED|Post-Treatment Observational Follow-Up||0
8555657|NCT02425826|9587786|FG002|COMPLETED|Post-Treatment Observational Follow-Up||49
8555658|NCT02425826|9587784|FG000|NOT COMPLETED|Post-Treatment Observational Follow-Up||1
8555659|NCT02425826|9587785|FG001|NOT COMPLETED|Post-Treatment Observational Follow-Up||0
8555660|NCT02425826|9587786|FG002|NOT COMPLETED|Post-Treatment Observational Follow-Up||0
8555661|NCT02384239|9587798|FG000|STARTED|Overall Study||36
8555662|NCT02384239|9587799|FG001|STARTED|Overall Study||34
8555663|NCT02384239|9587798|FG000|COMPLETED|Overall Study||36
8555664|NCT02384239|9587799|FG001|COMPLETED|Overall Study||34
8555665|NCT02384239|9587798|FG000|NOT COMPLETED|Overall Study||0
8820161|NCT01569074|9874165|FG003|Randomised But Did Not Receive Treatment|Overall Study||0
8820162|NCT01569074|9874166|FG004|Randomised But Did Not Receive Treatment|Overall Study||0
8820163|NCT01569074|9874162|FG000|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|24
8820164|NCT01569074|9874163|FG001|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|24
8820165|NCT01569074|9874164|FG002|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|21
8820166|NCT01569074|9874165|FG003|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|25
8820167|NCT01569074|9874166|FG004|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|25
8820168|NCT01569074|9874162|FG000|NOT COMPLETED|Overall Study||7
8820169|NCT01569074|9874163|FG001|NOT COMPLETED|Overall Study||9
8820170|NCT01569074|9874164|FG002|NOT COMPLETED|Overall Study||12
8820171|NCT01569074|9874165|FG003|NOT COMPLETED|Overall Study||8
8555666|NCT02384239|9587799|FG001|NOT COMPLETED|Overall Study||0
8555667|NCT02356705|9587809|FG000|STARTED|Overall Study||14
8555668|NCT02356705|9587810|FG001|STARTED|Overall Study||14
8555669|NCT02356705|9587811|FG002|STARTED|Overall Study||14
8555670|NCT02356705|9587809|FG000|COMPLETED|Overall Study||14
8555671|NCT02356705|9587810|FG001|COMPLETED|Overall Study||14
8555672|NCT02356705|9587811|FG002|COMPLETED|Overall Study||14
8555673|NCT02356705|9587809|FG000|NOT COMPLETED|Overall Study||0
8555674|NCT02356705|9587810|FG001|NOT COMPLETED|Overall Study||0
8555675|NCT02356705|9587811|FG002|NOT COMPLETED|Overall Study||0
8555676|NCT02353247|9587824|FG000|STARTED|Overall Study||30
8555677|NCT02353247|9587825|FG001|STARTED|Overall Study||23
8555678|NCT02353247|9587826|FG002|STARTED|Overall Study||35
8555679|NCT02353247|9587824|FG000|COMPLETED|Overall Study||21
8555680|NCT02353247|9587825|FG001|COMPLETED|Overall Study||18
8555681|NCT02353247|9587826|FG002|COMPLETED|Overall Study||0
8555682|NCT02353247|9587824|FG000|NOT COMPLETED|Overall Study||9
8555683|NCT02353247|9587825|FG001|NOT COMPLETED|Overall Study||5
8555684|NCT02353247|9587826|FG002|NOT COMPLETED|Overall Study||35
8555685|NCT02316002|9587840|FG000|STARTED|Overall Study||51
8555686|NCT02316002|9587840|FG000|COMPLETED|Overall Study||45
8555687|NCT02316002|9587840|FG000|NOT COMPLETED|Overall Study||6
8555688|NCT02021071|9587846|FG000|STARTED|Overall Study||12
8555689|NCT02021071|9587847|FG001|STARTED|Overall Study||12
8555690|NCT02021071|9587846|FG000|COMPLETED|Overall Study||12
8555691|NCT02021071|9587847|FG001|COMPLETED|Overall Study||12
8555692|NCT02021071|9587846|FG000|NOT COMPLETED|Overall Study||0
8555693|NCT02021071|9587847|FG001|NOT COMPLETED|Overall Study||0
8555694|NCT02000622|9587856|FG000|STARTED|Overall Study||205
8555695|NCT02000622|9587857|FG001|STARTED|Overall Study||97
8555696|NCT02000622|9587856|FG000|COMPLETED|Overall Study||36
8555697|NCT02000622|9587857|FG001|COMPLETED|Overall Study||17
8555698|NCT02000622|9587856|FG000|NOT COMPLETED|Overall Study||169
8555699|NCT02000622|9587857|FG001|NOT COMPLETED|Overall Study||80
8555700|NCT01933932|9587865|FG000|STARTED|Overall Study||254
8555701|NCT01933932|9587866|FG001|STARTED|Overall Study||256
8555702|NCT01933932|9587865|FG000|COMPLETED|Overall Study|These were the number of patients who were still ongoing at data cut-off|70
8555703|NCT01933932|9587866|FG001|COMPLETED|Overall Study|These were the number of patients who were still ongoing at data cut-off|78
8555704|NCT01933932|9587865|FG000|NOT COMPLETED|Overall Study||184
8555705|NCT01933932|9587866|FG001|NOT COMPLETED|Overall Study||178
8555706|NCT01927068|9587874|FG000|STARTED|Overall Study||370
8555707|NCT01927068|9587875|FG001|STARTED|Overall Study||129
8555708|NCT01927068|9587874|FG000|COMPLETED|Overall Study||262
8555709|NCT01927068|9587875|FG001|COMPLETED|Overall Study||121
8555710|NCT01927068|9587874|FG000|NOT COMPLETED|Overall Study||108
8555711|NCT01927068|9587875|FG001|NOT COMPLETED|Overall Study||8
8555712|NCT01883817|9587884|FG000|STARTED|Overall Study||14
8555713|NCT01883817|9587885|FG001|STARTED|Overall Study||16
8555714|NCT01883817|9587884|FG000|COMPLETED|Overall Study||10
8555715|NCT01883817|9587885|FG001|COMPLETED|Overall Study||9
8555716|NCT01883817|9587884|FG000|NOT COMPLETED|Overall Study||4
8555717|NCT01883817|9587885|FG001|NOT COMPLETED|Overall Study||7
8555718|NCT01813435|9587893|FG000|STARTED|Overall Study|12 participants withdrew consent or objected to use further use of data|7980
8555719|NCT01813435|9587894|FG001|STARTED|Overall Study|11 participants withdrew consent or objected to use further use of data|7988
8555720|NCT01813435|9587893|FG000|COMPLETED|Overall Study||5810
8555721|NCT01813435|9587894|FG001|COMPLETED|Overall Study||6981
8555722|NCT01813435|9587893|FG000|NOT COMPLETED|Overall Study||2170
8555723|NCT01813435|9587894|FG001|NOT COMPLETED|Overall Study||1007
8820172|NCT01569074|9874166|FG004|NOT COMPLETED|Overall Study||8
8820173|NCT01569087|9874185|FG000|STARTED|Overall Study||21
8820174|NCT01569087|9874186|FG001|STARTED|Overall Study||20
8820175|NCT01569087|9874187|FG002|STARTED|Overall Study||19
8820176|NCT01569087|9874185|FG000|COMPLETED|Overall Study||20
8820177|NCT01569087|9874186|FG001|COMPLETED|Overall Study||20
8820178|NCT01569087|9874187|FG002|COMPLETED|Overall Study||18
8820179|NCT01569087|9874185|FG000|NOT COMPLETED|Overall Study||1
8820180|NCT01569087|9874186|FG001|NOT COMPLETED|Overall Study||0
8820181|NCT01569087|9874187|FG002|NOT COMPLETED|Overall Study||1
8820182|NCT01569126|9874201|FG000|STARTED|Overall Study||8
8820183|NCT01569126|9874202|FG001|STARTED|Overall Study||8
8820184|NCT01569126|9874203|FG002|STARTED|Overall Study||8
8820185|NCT01569126|9874204|FG003|STARTED|Overall Study||8
8820186|NCT01569126|9874205|FG004|STARTED|Overall Study||12
8555724|NCT01700439|9587900|FG000|STARTED|Overall Study||889
8555725|NCT01700439|9587900|FG000|Study Valve Group|Overall Study|Received the Edwards INTUITY surgical aortic heart valve.|839
8555726|NCT01700439|9587900|FG000|Discharge|Overall Study||831
8555727|NCT01700439|9587900|FG000|3 Month|Overall Study||778
8555728|NCT01700439|9587900|FG000|1 Year|Overall Study||573
8555729|NCT01700439|9587900|FG000|2 Year|Overall Study||215
8555730|NCT01700439|9587900|FG000|COMPLETED|Overall Study||0
8555731|NCT01700439|9587900|FG000|NOT COMPLETED|Overall Study||889
8555732|NCT01690299|9587908|FG000|STARTED|Placebo-controlled Phase (Weeks 0-16)||84
8555733|NCT01690299|9587909|FG001|STARTED|Placebo-controlled Phase (Weeks 0-16)||83
8555734|NCT01690299|9587910|FG002|STARTED|Placebo-controlled Phase (Weeks 0-16)||83
8569408|NCT00096993|9601649|FG000|COMPLETED|Overall Study||1
8820187|NCT01569126|9874206|FG005|STARTED|Overall Study||12
8820188|NCT01569126|9874201|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
8820189|NCT01569126|9874202|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8
8820190|NCT01569126|9874203|FG002|Received at Least 1 Dose of Study Drug|Overall Study||8
8849371|NCT01740128|9904531|FG000|NOT COMPLETED|Overall Study||6
8555735|NCT01690299|9587911|FG003|STARTED|Placebo-controlled Phase (Weeks 0-16)||0
8555736|NCT01690299|9587912|FG004|STARTED|Placebo-controlled Phase (Weeks 0-16)||0
8555737|NCT01690299|9587913|FG005|STARTED|Placebo-controlled Phase (Weeks 0-16)||0
8555738|NCT01690299|9587908|FG000|Safety Population|Placebo-controlled Phase (Weeks 0-16)|Safety population includes all participants who received at least one dose of study drug.|84
8555739|NCT01690299|9587909|FG001|Safety Population|Placebo-controlled Phase (Weeks 0-16)|Safety population includes all participants who received at least one dose of study drug.|83
8555740|NCT01690299|9587910|FG002|Safety Population|Placebo-controlled Phase (Weeks 0-16)|Safety population includes all participants who received at least one dose of study drug.|83
8555741|NCT01690299|9587911|FG003|Safety Population|Placebo-controlled Phase (Weeks 0-16)||0
8555742|NCT01690299|9587912|FG004|Safety Population|Placebo-controlled Phase (Weeks 0-16)||0
8555743|NCT01690299|9587913|FG005|Safety Population|Placebo-controlled Phase (Weeks 0-16)||0
8555744|NCT01690299|9587908|FG000|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||75
8555745|NCT01690299|9587909|FG001|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||77
8555746|NCT01690299|9587910|FG002|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||81
8555747|NCT01690299|9587911|FG003|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
8555748|NCT01690299|9587912|FG004|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
8555749|NCT01690299|9587913|FG005|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
8555750|NCT01690299|9587908|FG000|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||9
8555751|NCT01690299|9587909|FG001|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||6
8555752|NCT01690299|9587910|FG002|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||2
8555753|NCT01690299|9587911|FG003|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
8555754|NCT01690299|9587912|FG004|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
8555755|NCT01690299|9587913|FG005|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
8555756|NCT01690299|9587908|FG000|STARTED|Apremilast Extension Phase (Weeks16-104)||0
8555757|NCT01690299|9587909|FG001|STARTED|Apremilast Extension Phase (Weeks16-104)||0
8555758|NCT01690299|9587910|FG002|STARTED|Apremilast Extension Phase (Weeks16-104)||0
8555759|NCT01690299|9587911|FG003|STARTED|Apremilast Extension Phase (Weeks16-104)|There are fewer participants in this period because some stopped the study at or prior to Week 16.|73
8555760|NCT01690299|9587912|FG004|STARTED|Apremilast Extension Phase (Weeks16-104)|There are fewer participants in this period because some stopped the study at or prior to Week 16.|74
8555761|NCT01690299|9587913|FG005|STARTED|Apremilast Extension Phase (Weeks16-104)|There are fewer participants in this period because some stopped the study at or prior to Week 16.|80
8555762|NCT01690299|9587908|FG000|Safety Population|Apremilast Extension Phase (Weeks16-104)||0
8555763|NCT01690299|9587909|FG001|Safety Population|Apremilast Extension Phase (Weeks16-104)||0
8555764|NCT01690299|9587910|FG002|Safety Population|Apremilast Extension Phase (Weeks16-104)||0
8555765|NCT01690299|9587911|FG003|Safety Population|Apremilast Extension Phase (Weeks16-104)|Safety population includes all participants who received at least one dose of study drug.|73
8555766|NCT01690299|9587912|FG004|Safety Population|Apremilast Extension Phase (Weeks16-104)|Safety population includes all participants who received at least one dose of study drug.|74
8555767|NCT01690299|9587913|FG005|Safety Population|Apremilast Extension Phase (Weeks16-104)|Safety population includes all participants who received at least one dose of study drug.|79
8555768|NCT01690299|9587908|FG000|COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
8555769|NCT01690299|9587909|FG001|COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
8555770|NCT01690299|9587910|FG002|COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
8555771|NCT01690299|9587911|FG003|COMPLETED|Apremilast Extension Phase (Weeks16-104)||47
8555772|NCT01690299|9587912|FG004|COMPLETED|Apremilast Extension Phase (Weeks16-104)||41
8555773|NCT01690299|9587913|FG005|COMPLETED|Apremilast Extension Phase (Weeks16-104)||50
8555774|NCT01690299|9587908|FG000|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
8555775|NCT01690299|9587909|FG001|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
8555776|NCT01690299|9587910|FG002|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
8555777|NCT01690299|9587911|FG003|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||26
8555778|NCT01690299|9587912|FG004|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||33
8555779|NCT01690299|9587913|FG005|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||30
8555780|NCT01525329|9587936|FG000|STARTED|Overall Study||4
8555781|NCT01525329|9587937|FG001|STARTED|Overall Study||14
8555782|NCT01525329|9587936|FG000|COMPLETED|Overall Study||4
8555783|NCT01525329|9587937|FG001|COMPLETED|Overall Study||14
8555784|NCT01525329|9587936|FG000|NOT COMPLETED|Overall Study||0
8555785|NCT01525329|9587937|FG001|NOT COMPLETED|Overall Study||0
8555786|NCT01482286|9587951|FG000|STARTED|Overall Study||7
8555787|NCT01482286|9587952|FG001|STARTED|Overall Study||7
8555788|NCT01482286|9587953|FG002|STARTED|Overall Study||8
8555789|NCT01482286|9587954|FG003|STARTED|Overall Study||10
8555790|NCT01482286|9587951|FG000|COMPLETED|Overall Study||4
8555791|NCT01482286|9587952|FG001|COMPLETED|Overall Study||4
8555792|NCT01482286|9587953|FG002|COMPLETED|Overall Study||4
8555793|NCT01482286|9587954|FG003|COMPLETED|Overall Study||5
8555794|NCT01482286|9587951|FG000|NOT COMPLETED|Overall Study||3
8555795|NCT01482286|9587952|FG001|NOT COMPLETED|Overall Study||3
8555796|NCT01482286|9587953|FG002|NOT COMPLETED|Overall Study||4
8555797|NCT01482286|9587954|FG003|NOT COMPLETED|Overall Study||5
8555798|NCT01452152|9587967|FG000|STARTED|Overall Study||5
8555799|NCT01452152|9587968|FG001|STARTED|Overall Study||0
8555800|NCT01452152|9587969|FG002|STARTED|Overall Study||4
8555801|NCT01452152|9587967|FG000|COMPLETED|Overall Study||0
8555802|NCT01452152|9587968|FG001|COMPLETED|Overall Study||0
8555803|NCT01452152|9587969|FG002|COMPLETED|Overall Study||0
8555804|NCT01452152|9587967|FG000|NOT COMPLETED|Overall Study||5
8555805|NCT01452152|9587968|FG001|NOT COMPLETED|Overall Study||0
8555806|NCT01452152|9587969|FG002|NOT COMPLETED|Overall Study||4
8555807|NCT01420926|9587979|FG000|STARTED|Overall Study||82
8555808|NCT01420926|9587980|FG001|STARTED|Overall Study||81
8555809|NCT01420926|9587979|FG000|COMPLETED|Overall Study||22
8555810|NCT01420926|9587980|FG001|COMPLETED|Overall Study||16
8555811|NCT01420926|9587979|FG000|NOT COMPLETED|Overall Study||60
8555812|NCT01420926|9587980|FG001|NOT COMPLETED|Overall Study||65
8555813|NCT01386385|9587991|FG000|STARTED|Phase I 40mg: Concurrent CRT||8
8555814|NCT01386385|9587992|FG001|STARTED|Phase I 40mg: Concurrent CRT||0
8555815|NCT01386385|9587993|FG002|STARTED|Phase I 40mg: Concurrent CRT||0
8555816|NCT01386385|9587994|FG003|STARTED|Phase I 40mg: Concurrent CRT||0
8555817|NCT01386385|9587995|FG004|STARTED|Phase I 40mg: Concurrent CRT||0
8555818|NCT01386385|9587996|FG005|STARTED|Phase I 40mg: Concurrent CRT||0
8555819|NCT01386385|9587997|FG006|STARTED|Phase I 40mg: Concurrent CRT||0
8555820|NCT01386385|9587998|FG007|STARTED|Phase I 40mg: Concurrent CRT||0
8555821|NCT01386385|9587991|FG000|COMPLETED|Phase I 40mg: Concurrent CRT||6
8555822|NCT01386385|9587992|FG001|COMPLETED|Phase I 40mg: Concurrent CRT||0
8555823|NCT01386385|9587993|FG002|COMPLETED|Phase I 40mg: Concurrent CRT||0
8555824|NCT01386385|9587994|FG003|COMPLETED|Phase I 40mg: Concurrent CRT||0
8555825|NCT01386385|9587995|FG004|COMPLETED|Phase I 40mg: Concurrent CRT||0
8555826|NCT01386385|9587996|FG005|COMPLETED|Phase I 40mg: Concurrent CRT||0
8555827|NCT01386385|9587997|FG006|COMPLETED|Phase I 40mg: Concurrent CRT||0
8555828|NCT01386385|9587998|FG007|COMPLETED|Phase I 40mg: Concurrent CRT||0
8555829|NCT01386385|9587991|FG000|NOT COMPLETED|Phase I 40mg: Concurrent CRT||2
8555830|NCT01386385|9587992|FG001|NOT COMPLETED|Phase I 40mg: Concurrent CRT||0
8555831|NCT01386385|9587993|FG002|NOT COMPLETED|Phase I 40mg: Concurrent CRT||0
8555832|NCT01386385|9587994|FG003|NOT COMPLETED|Phase I 40mg: Concurrent CRT||0
8555833|NCT01386385|9587995|FG004|NOT COMPLETED|Phase I 40mg: Concurrent CRT||0
8555834|NCT01386385|9587996|FG005|NOT COMPLETED|Phase I 40mg: Concurrent CRT||0
8555835|NCT01386385|9587997|FG006|NOT COMPLETED|Phase I 40mg: Concurrent CRT||0
8555836|NCT01386385|9587998|FG007|NOT COMPLETED|Phase I 40mg: Concurrent CRT||0
8555837|NCT01386385|9587991|FG000|STARTED|Phase I 40mg: Consolidation Therapy||0
8555838|NCT01386385|9587992|FG001|STARTED|Phase I 40mg: Consolidation Therapy||4
8555839|NCT01386385|9587993|FG002|STARTED|Phase I 40mg: Consolidation Therapy||0
8555840|NCT01386385|9587994|FG003|STARTED|Phase I 40mg: Consolidation Therapy||0
8555841|NCT01386385|9587995|FG004|STARTED|Phase I 40mg: Consolidation Therapy||0
8555842|NCT01386385|9587996|FG005|STARTED|Phase I 40mg: Consolidation Therapy||0
8555843|NCT01386385|9587997|FG006|STARTED|Phase I 40mg: Consolidation Therapy||0
8555844|NCT01386385|9587998|FG007|STARTED|Phase I 40mg: Consolidation Therapy||0
8555845|NCT01386385|9587991|FG000|COMPLETED|Phase I 40mg: Consolidation Therapy||0
8555846|NCT01386385|9587992|FG001|COMPLETED|Phase I 40mg: Consolidation Therapy||4
8555847|NCT01386385|9587993|FG002|COMPLETED|Phase I 40mg: Consolidation Therapy||0
8555848|NCT01386385|9587994|FG003|COMPLETED|Phase I 40mg: Consolidation Therapy||0
8555849|NCT01386385|9587995|FG004|COMPLETED|Phase I 40mg: Consolidation Therapy||0
8555850|NCT01386385|9587996|FG005|COMPLETED|Phase I 40mg: Consolidation Therapy||0
8555851|NCT01386385|9587997|FG006|COMPLETED|Phase I 40mg: Consolidation Therapy||0
8555852|NCT01386385|9587998|FG007|COMPLETED|Phase I 40mg: Consolidation Therapy||0
8555853|NCT01386385|9587991|FG000|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0
8555854|NCT01386385|9587992|FG001|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0
8555855|NCT01386385|9587993|FG002|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0
8555856|NCT01386385|9587994|FG003|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0
8555857|NCT01386385|9587995|FG004|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0
8555858|NCT01386385|9587996|FG005|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0
8555859|NCT01386385|9587997|FG006|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0
8555860|NCT01386385|9587998|FG007|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0
8555861|NCT01386385|9587991|FG000|STARTED|Phase I 80mg: Concurrent CRT||0
8555862|NCT01386385|9587992|FG001|STARTED|Phase I 80mg: Concurrent CRT||0
8555863|NCT01386385|9587993|FG002|STARTED|Phase I 80mg: Concurrent CRT||7
8555864|NCT01386385|9587994|FG003|STARTED|Phase I 80mg: Concurrent CRT||0
8555865|NCT01386385|9587995|FG004|STARTED|Phase I 80mg: Concurrent CRT||0
8555866|NCT01386385|9587996|FG005|STARTED|Phase I 80mg: Concurrent CRT||0
8555867|NCT01386385|9587997|FG006|STARTED|Phase I 80mg: Concurrent CRT||0
8555868|NCT01386385|9587998|FG007|STARTED|Phase I 80mg: Concurrent CRT||0
8555869|NCT01386385|9587991|FG000|COMPLETED|Phase I 80mg: Concurrent CRT||0
8555870|NCT01386385|9587992|FG001|COMPLETED|Phase I 80mg: Concurrent CRT||0
8555871|NCT01386385|9587993|FG002|COMPLETED|Phase I 80mg: Concurrent CRT||5
8555872|NCT01386385|9587994|FG003|COMPLETED|Phase I 80mg: Concurrent CRT||0
8555873|NCT01386385|9587995|FG004|COMPLETED|Phase I 80mg: Concurrent CRT||0
8555874|NCT01386385|9587996|FG005|COMPLETED|Phase I 80mg: Concurrent CRT||0
8555875|NCT01386385|9587997|FG006|COMPLETED|Phase I 80mg: Concurrent CRT||0
8555876|NCT01386385|9587998|FG007|COMPLETED|Phase I 80mg: Concurrent CRT||0
8555877|NCT01386385|9587991|FG000|NOT COMPLETED|Phase I 80mg: Concurrent CRT||0
8555878|NCT01386385|9587992|FG001|NOT COMPLETED|Phase I 80mg: Concurrent CRT||0
8555879|NCT01386385|9587993|FG002|NOT COMPLETED|Phase I 80mg: Concurrent CRT||2
8555880|NCT01386385|9587994|FG003|NOT COMPLETED|Phase I 80mg: Concurrent CRT||0
8555881|NCT01386385|9587995|FG004|NOT COMPLETED|Phase I 80mg: Concurrent CRT||0
8555882|NCT01386385|9587996|FG005|NOT COMPLETED|Phase I 80mg: Concurrent CRT||0
8555883|NCT01386385|9587997|FG006|NOT COMPLETED|Phase I 80mg: Concurrent CRT||0
8555884|NCT01386385|9587998|FG007|NOT COMPLETED|Phase I 80mg: Concurrent CRT||0
8555885|NCT01386385|9587991|FG000|STARTED|Phase I 80mg: Consolidation Therapy||0
8555886|NCT01386385|9587992|FG001|STARTED|Phase I 80mg: Consolidation Therapy||0
8555887|NCT01386385|9587993|FG002|STARTED|Phase I 80mg: Consolidation Therapy||0
8555888|NCT01386385|9587994|FG003|STARTED|Phase I 80mg: Consolidation Therapy||5
8555889|NCT01386385|9587995|FG004|STARTED|Phase I 80mg: Consolidation Therapy||0
8555890|NCT01386385|9587996|FG005|STARTED|Phase I 80mg: Consolidation Therapy||0
8555891|NCT01386385|9587997|FG006|STARTED|Phase I 80mg: Consolidation Therapy||0
8555892|NCT01386385|9587998|FG007|STARTED|Phase I 80mg: Consolidation Therapy||0
8555893|NCT01386385|9587991|FG000|COMPLETED|Phase I 80mg: Consolidation Therapy||0
8555894|NCT01386385|9587992|FG001|COMPLETED|Phase I 80mg: Consolidation Therapy||0
8555895|NCT01386385|9587993|FG002|COMPLETED|Phase I 80mg: Consolidation Therapy||0
8555896|NCT01386385|9587994|FG003|COMPLETED|Phase I 80mg: Consolidation Therapy||5
8555897|NCT01386385|9587995|FG004|COMPLETED|Phase I 80mg: Consolidation Therapy||0
8555898|NCT01386385|9587996|FG005|COMPLETED|Phase I 80mg: Consolidation Therapy||0
8555899|NCT01386385|9587997|FG006|COMPLETED|Phase I 80mg: Consolidation Therapy||0
8555900|NCT01386385|9587998|FG007|COMPLETED|Phase I 80mg: Consolidation Therapy||0
8555901|NCT01386385|9587991|FG000|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0
8555902|NCT01386385|9587992|FG001|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0
8555903|NCT01386385|9587993|FG002|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0
8555904|NCT01386385|9587994|FG003|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0
8555905|NCT01386385|9587995|FG004|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0
8555906|NCT01386385|9587996|FG005|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0
8555907|NCT01386385|9587997|FG006|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0
8555908|NCT01386385|9587998|FG007|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0
8555909|NCT01386385|9587991|FG000|STARTED|Phase I 120mg: Concurrent CRT||0
8555910|NCT01386385|9587992|FG001|STARTED|Phase I 120mg: Concurrent CRT||0
8555911|NCT01386385|9587993|FG002|STARTED|Phase I 120mg: Concurrent CRT||0
8555912|NCT01386385|9587994|FG003|STARTED|Phase I 120mg: Concurrent CRT||0
8555913|NCT01386385|9587995|FG004|STARTED|Phase I 120mg: Concurrent CRT||6
8555914|NCT01386385|9587996|FG005|STARTED|Phase I 120mg: Concurrent CRT||0
8555915|NCT01386385|9587997|FG006|STARTED|Phase I 120mg: Concurrent CRT||0
8555916|NCT01386385|9587998|FG007|STARTED|Phase I 120mg: Concurrent CRT||0
8555917|NCT01386385|9587991|FG000|COMPLETED|Phase I 120mg: Concurrent CRT||0
8555918|NCT01386385|9587992|FG001|COMPLETED|Phase I 120mg: Concurrent CRT||0
8555919|NCT01386385|9587993|FG002|COMPLETED|Phase I 120mg: Concurrent CRT||0
8555920|NCT01386385|9587994|FG003|COMPLETED|Phase I 120mg: Concurrent CRT||0
8555921|NCT01386385|9587995|FG004|COMPLETED|Phase I 120mg: Concurrent CRT||5
8555922|NCT01386385|9587996|FG005|COMPLETED|Phase I 120mg: Concurrent CRT||0
8555923|NCT01386385|9587997|FG006|COMPLETED|Phase I 120mg: Concurrent CRT||0
8555924|NCT01386385|9587998|FG007|COMPLETED|Phase I 120mg: Concurrent CRT||0
8555925|NCT01386385|9587991|FG000|NOT COMPLETED|Phase I 120mg: Concurrent CRT||0
8555926|NCT01386385|9587992|FG001|NOT COMPLETED|Phase I 120mg: Concurrent CRT||0
8555927|NCT01386385|9587993|FG002|NOT COMPLETED|Phase I 120mg: Concurrent CRT||0
8555928|NCT01386385|9587994|FG003|NOT COMPLETED|Phase I 120mg: Concurrent CRT||0
8555929|NCT01386385|9587995|FG004|NOT COMPLETED|Phase I 120mg: Concurrent CRT||1
8555930|NCT01386385|9587996|FG005|NOT COMPLETED|Phase I 120mg: Concurrent CRT||0
8555931|NCT01386385|9587997|FG006|NOT COMPLETED|Phase I 120mg: Concurrent CRT||0
8555932|NCT01386385|9587998|FG007|NOT COMPLETED|Phase I 120mg: Concurrent CRT||0
8555933|NCT01386385|9587991|FG000|STARTED|Phase I 120mg: Consolidation Therapy||0
8555934|NCT01386385|9587992|FG001|STARTED|Phase I 120mg: Consolidation Therapy||0
8555935|NCT01386385|9587993|FG002|STARTED|Phase I 120mg: Consolidation Therapy||0
8555936|NCT01386385|9587994|FG003|STARTED|Phase I 120mg: Consolidation Therapy||0
8555937|NCT01386385|9587995|FG004|STARTED|Phase I 120mg: Consolidation Therapy||0
8555938|NCT01386385|9587996|FG005|STARTED|Phase I 120mg: Consolidation Therapy||5
8555939|NCT01386385|9587997|FG006|STARTED|Phase I 120mg: Consolidation Therapy||0
8555940|NCT01386385|9587998|FG007|STARTED|Phase I 120mg: Consolidation Therapy||0
8555941|NCT01386385|9587991|FG000|COMPLETED|Phase I 120mg: Consolidation Therapy||0
8555942|NCT01386385|9587992|FG001|COMPLETED|Phase I 120mg: Consolidation Therapy||0
8555943|NCT01386385|9587993|FG002|COMPLETED|Phase I 120mg: Consolidation Therapy||0
8555944|NCT01386385|9587994|FG003|COMPLETED|Phase I 120mg: Consolidation Therapy||0
8555945|NCT01386385|9587995|FG004|COMPLETED|Phase I 120mg: Consolidation Therapy||0
8555946|NCT01386385|9587996|FG005|COMPLETED|Phase I 120mg: Consolidation Therapy||5
8555947|NCT01386385|9587997|FG006|COMPLETED|Phase I 120mg: Consolidation Therapy||0
8820191|NCT01569126|9874204|FG003|Received at Least 1 Dose of Study Drug|Overall Study||8
8820192|NCT01569126|9874205|FG004|Received at Least 1 Dose of Study Drug|Overall Study||12
8820193|NCT01569126|9874206|FG005|Received at Least 1 Dose of Study Drug|Overall Study||12
8820194|NCT01569126|9874201|FG000|COMPLETED|Overall Study||8
8820195|NCT01569126|9874202|FG001|COMPLETED|Overall Study||8
8820196|NCT01569126|9874203|FG002|COMPLETED|Overall Study||8
8820197|NCT01569126|9874204|FG003|COMPLETED|Overall Study||8
8820198|NCT01569126|9874205|FG004|COMPLETED|Overall Study||12
8820199|NCT01569126|9874206|FG005|COMPLETED|Overall Study||12
8820200|NCT01569126|9874201|FG000|NOT COMPLETED|Overall Study||0
8820201|NCT01569126|9874202|FG001|NOT COMPLETED|Overall Study||0
8555948|NCT01386385|9587998|FG007|COMPLETED|Phase I 120mg: Consolidation Therapy||0
8555949|NCT01386385|9587991|FG000|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0
8555950|NCT01386385|9587992|FG001|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0
8555951|NCT01386385|9587993|FG002|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0
8555952|NCT01386385|9587994|FG003|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0
8555953|NCT01386385|9587995|FG004|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0
8555954|NCT01386385|9587996|FG005|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0
8555955|NCT01386385|9587997|FG006|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0
8555956|NCT01386385|9587998|FG007|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0
8555957|NCT01386385|9587991|FG000|STARTED|Phase II Concurrent CRT||0
8723165|NCT01021813|9770656|FG002|NOT COMPLETED|DB Randomized Discontinuation Phase||4
8723166|NCT01021813|9770657|FG003|NOT COMPLETED|DB Randomized Discontinuation Phase||5
8723167|NCT01021813|9770658|FG004|NOT COMPLETED|DB Randomized Discontinuation Phase||5
8723168|NCT01021852|9770683|FG000|STARTED|Treatment Period 1||40
8723169|NCT01021852|9770684|FG001|STARTED|Treatment Period 1||40
8723170|NCT01021852|9770685|FG002|STARTED|Treatment Period 1||41
8723171|NCT01021852|9770686|FG003|STARTED|Treatment Period 1||40
8723172|NCT01021852|9770687|FG004|STARTED|Treatment Period 1||42
8723173|NCT01021852|9770688|FG005|STARTED|Treatment Period 1||41
8723174|NCT01021852|9770689|FG006|STARTED|Treatment Period 1||41
8723175|NCT01021852|9770690|FG007|STARTED|Treatment Period 1||41
8723176|NCT01021852|9770683|FG000|Treated|Treatment Period 1||40
8723177|NCT01021852|9770684|FG001|Treated|Treatment Period 1||40
8820202|NCT01569126|9874203|FG002|NOT COMPLETED|Overall Study||0
8820203|NCT01569126|9874204|FG003|NOT COMPLETED|Overall Study||0
8555958|NCT01386385|9587992|FG001|STARTED|Phase II Concurrent CRT||0
8555959|NCT01386385|9587993|FG002|STARTED|Phase II Concurrent CRT||0
8555960|NCT01386385|9587994|FG003|STARTED|Phase II Concurrent CRT||0
8555961|NCT01386385|9587995|FG004|STARTED|Phase II Concurrent CRT||0
8555962|NCT01386385|9587996|FG005|STARTED|Phase II Concurrent CRT||0
8555963|NCT01386385|9587997|FG006|STARTED|Phase II Concurrent CRT||18
8555964|NCT01386385|9587998|FG007|STARTED|Phase II Concurrent CRT||13
8555965|NCT01386385|9587991|FG000|COMPLETED|Phase II Concurrent CRT||0
8555966|NCT01386385|9587992|FG001|COMPLETED|Phase II Concurrent CRT||0
8555967|NCT01386385|9587993|FG002|COMPLETED|Phase II Concurrent CRT||0
8555968|NCT01386385|9587994|FG003|COMPLETED|Phase II Concurrent CRT||0
8555969|NCT01386385|9587995|FG004|COMPLETED|Phase II Concurrent CRT||0
8555970|NCT01386385|9587996|FG005|COMPLETED|Phase II Concurrent CRT||0
8555971|NCT01386385|9587997|FG006|COMPLETED|Phase II Concurrent CRT||12
8555972|NCT01386385|9587998|FG007|COMPLETED|Phase II Concurrent CRT||10
8555973|NCT01386385|9587991|FG000|NOT COMPLETED|Phase II Concurrent CRT||0
8555974|NCT01386385|9587992|FG001|NOT COMPLETED|Phase II Concurrent CRT||0
8555975|NCT01386385|9587993|FG002|NOT COMPLETED|Phase II Concurrent CRT||0
8555976|NCT01386385|9587994|FG003|NOT COMPLETED|Phase II Concurrent CRT||0
8820204|NCT01569126|9874205|FG004|NOT COMPLETED|Overall Study||0
8820205|NCT01569126|9874206|FG005|NOT COMPLETED|Overall Study||0
8820206|NCT01569152|9874227|FG000|STARTED|Phase IIa, Period 1||41
8820207|NCT01569152|9874228|FG001|STARTED|Phase IIa, Period 1||41
8820208|NCT01569152|9874229|FG002|STARTED|Phase IIa, Period 1||0
8820209|NCT01569152|9874227|FG000|COMPLETED|Phase IIa, Period 1||20
8820210|NCT01569152|9874228|FG001|COMPLETED|Phase IIa, Period 1||9
8820211|NCT01569152|9874229|FG002|COMPLETED|Phase IIa, Period 1||0
8820212|NCT01569152|9874227|FG000|NOT COMPLETED|Phase IIa, Period 1||21
8820213|NCT01569152|9874228|FG001|NOT COMPLETED|Phase IIa, Period 1||32
8820214|NCT01569152|9874229|FG002|NOT COMPLETED|Phase IIa, Period 1||0
8820215|NCT01569152|9874227|FG000|STARTED|Safety Extension, Period 3||0
8820216|NCT01569152|9874228|FG001|STARTED|Safety Extension, Period 3||0
8820217|NCT01569152|9874229|FG002|STARTED|Safety Extension, Period 3|Includes 29 completers and 26 early escapees from Base Study Phase IIa|55
8820218|NCT01569152|9874227|FG000|COMPLETED|Safety Extension, Period 3||0
8820219|NCT01569152|9874228|FG001|COMPLETED|Safety Extension, Period 3||0
8820220|NCT01569152|9874229|FG002|COMPLETED|Safety Extension, Period 3||0
8820221|NCT01569152|9874227|FG000|NOT COMPLETED|Safety Extension, Period 3||0
8820222|NCT01569152|9874228|FG001|NOT COMPLETED|Safety Extension, Period 3||0
8820223|NCT01569152|9874229|FG002|NOT COMPLETED|Safety Extension, Period 3||55
8820224|NCT01569191|9874238|FG000|STARTED|Overall Study||11
8820225|NCT01569191|9874239|FG001|STARTED|Overall Study||7
8820226|NCT01569191|9874238|FG000|COMPLETED|Overall Study||11
8820227|NCT01569191|9874239|FG001|COMPLETED|Overall Study||7
8820228|NCT01569191|9874238|FG000|NOT COMPLETED|Overall Study||0
8820229|NCT01569191|9874239|FG001|NOT COMPLETED|Overall Study||0
8820230|NCT01569295|9874251|FG000|STARTED|Overall Study||207
8820231|NCT01569295|9874252|FG001|STARTED|Overall Study||209
8820232|NCT01569295|9874251|FG000|Long-Term Follow-up|Overall Study||109
8555977|NCT01386385|9587995|FG004|NOT COMPLETED|Phase II Concurrent CRT||0
8820233|NCT01569295|9874252|FG001|Long-Term Follow-up|Overall Study||161
8820234|NCT01569295|9874251|FG000|COMPLETED|Overall Study||0
8820235|NCT01569295|9874252|FG001|COMPLETED|Overall Study||0
8820236|NCT01569295|9874251|FG000|NOT COMPLETED|Overall Study||207
8820237|NCT01569295|9874252|FG001|NOT COMPLETED|Overall Study||209
8820238|NCT01569438|9874261|FG000|STARTED|Overall Study||52
8820239|NCT01569438|9874262|FG001|STARTED|Overall Study||55
8820240|NCT01569438|9874261|FG000|Treated|Overall Study||51
8820241|NCT01569438|9874262|FG001|Treated|Overall Study||54
8820242|NCT01569438|9874261|FG000|Titration Set|Overall Study||38
8555978|NCT01386385|9587996|FG005|NOT COMPLETED|Phase II Concurrent CRT||0
8555979|NCT01386385|9587997|FG006|NOT COMPLETED|Phase II Concurrent CRT||6
8555980|NCT01386385|9587998|FG007|NOT COMPLETED|Phase II Concurrent CRT||3
8555981|NCT01386385|9587991|FG000|STARTED|Phase II: Consolidation Therapy||0
8555982|NCT01386385|9587992|FG001|STARTED|Phase II: Consolidation Therapy||0
8555983|NCT01386385|9587993|FG002|STARTED|Phase II: Consolidation Therapy||0
8555984|NCT01386385|9587994|FG003|STARTED|Phase II: Consolidation Therapy||0
8555985|NCT01386385|9587995|FG004|STARTED|Phase II: Consolidation Therapy||0
8555986|NCT01386385|9587996|FG005|STARTED|Phase II: Consolidation Therapy||0
8555987|NCT01386385|9587997|FG006|STARTED|Phase II: Consolidation Therapy||13
8820243|NCT01569438|9874262|FG001|Titration Set|Overall Study||36
8820244|NCT01569438|9874261|FG000|COMPLETED|Overall Study||45
8820245|NCT01569438|9874262|FG001|COMPLETED|Overall Study||33
8820246|NCT01569438|9874261|FG000|NOT COMPLETED|Overall Study||7
8820247|NCT01569438|9874262|FG001|NOT COMPLETED|Overall Study||22
8820248|NCT01569451|9874270|FG000|STARTED|Overall Study||26
8621884|NCT00483938|9660942|FG006|NOT COMPLETED|Overall Study||40
8621885|NCT00484094|9660961|FG000|STARTED|Overall Study||209
8621886|NCT00484094|9660961|FG000|COMPLETED|Overall Study||167
8621887|NCT00484094|9660961|FG000|NOT COMPLETED|Overall Study||42
8820249|NCT01569451|9874271|FG001|STARTED|Overall Study||27
8820250|NCT01569451|9874270|FG000|COMPLETED|Overall Study||12
8555988|NCT01386385|9587998|FG007|STARTED|Phase II: Consolidation Therapy||10
8555989|NCT01386385|9587991|FG000|COMPLETED|Phase II: Consolidation Therapy||0
8555990|NCT01386385|9587992|FG001|COMPLETED|Phase II: Consolidation Therapy||0
8555991|NCT01386385|9587993|FG002|COMPLETED|Phase II: Consolidation Therapy||0
8555992|NCT01386385|9587994|FG003|COMPLETED|Phase II: Consolidation Therapy||0
8555993|NCT01386385|9587995|FG004|COMPLETED|Phase II: Consolidation Therapy||0
8555994|NCT01386385|9587996|FG005|COMPLETED|Phase II: Consolidation Therapy||0
8555995|NCT01386385|9587997|FG006|COMPLETED|Phase II: Consolidation Therapy||8
8555996|NCT01386385|9587998|FG007|COMPLETED|Phase II: Consolidation Therapy||8
8555997|NCT01386385|9587991|FG000|NOT COMPLETED|Phase II: Consolidation Therapy||0
8555998|NCT01386385|9587992|FG001|NOT COMPLETED|Phase II: Consolidation Therapy||0
8555999|NCT01386385|9587993|FG002|NOT COMPLETED|Phase II: Consolidation Therapy||0
8556000|NCT01386385|9587994|FG003|NOT COMPLETED|Phase II: Consolidation Therapy||0
8556001|NCT01386385|9587995|FG004|NOT COMPLETED|Phase II: Consolidation Therapy||0
8556002|NCT01386385|9587996|FG005|NOT COMPLETED|Phase II: Consolidation Therapy||0
8556003|NCT01386385|9587997|FG006|NOT COMPLETED|Phase II: Consolidation Therapy||5
8556004|NCT01386385|9587998|FG007|NOT COMPLETED|Phase II: Consolidation Therapy||2
8556005|NCT01358877|9588021|FG000|STARTED|Overall Study||2400
8556006|NCT01358877|9588022|FG001|STARTED|Overall Study||2404
8556007|NCT01358877|9588021|FG000|Did Not Receive Study Drug|Overall Study||22
8556008|NCT01358877|9588022|FG001|Did Not Receive Study Drug|Overall Study||13
8556009|NCT01358877|9588021|FG000|Received Study Drug (Safety Population)|Overall Study|24 placebo participants received at least 1 dose of pertuzumab and were included in pertuzumab arm.|2364
8556010|NCT01358877|9588022|FG001|Received Study Drug (Safety Population)|Overall Study|38 pertuzumab participants did not receive pertuzumab and were included in placebo arm.|2405
8556011|NCT01358877|9588021|FG000|COMPLETED|Overall Study||0
8556012|NCT01358877|9588022|FG001|COMPLETED|Overall Study||0
8556013|NCT01358877|9588021|FG000|NOT COMPLETED|Overall Study||2400
8556014|NCT01358877|9588022|FG001|NOT COMPLETED|Overall Study||2404
8556015|NCT01313351|9588028|FG000|STARTED|Overall Study||206
8556016|NCT01313351|9588028|FG000|COMPLETED|Overall Study||206
8556017|NCT01313351|9588028|FG000|NOT COMPLETED|Overall Study||0
8820251|NCT01569451|9874271|FG001|COMPLETED|Overall Study||14
8820252|NCT01569451|9874270|FG000|NOT COMPLETED|Overall Study||14
8820253|NCT01569451|9874271|FG001|NOT COMPLETED|Overall Study||13
8820254|NCT01569464|9874281|FG000|STARTED|Overall Study||101
8820255|NCT01569464|9874282|FG001|STARTED|Overall Study||49
8820256|NCT01569464|9874281|FG000|COMPLETED|Overall Study||91
8820257|NCT01569464|9874282|FG001|COMPLETED|Overall Study||44
8820258|NCT01569464|9874281|FG000|NOT COMPLETED|Overall Study||10
8820259|NCT01569464|9874282|FG001|NOT COMPLETED|Overall Study||5
8820260|NCT01569529|9874292|FG000|STARTED|Overall Study||2676
8820261|NCT01569529|9874293|FG001|STARTED|Overall Study||394
8820262|NCT01569529|9874292|FG000|COMPLETED|Overall Study||2676
8820263|NCT01569529|9874293|FG001|COMPLETED|Overall Study||394
8820264|NCT01569529|9874292|FG000|NOT COMPLETED|Overall Study||0
8820265|NCT01569529|9874293|FG001|NOT COMPLETED|Overall Study||0
8820266|NCT01569568|9874301|FG000|STARTED|Overall Study||20
8820267|NCT01569568|9874302|FG001|STARTED|Overall Study||29
8820268|NCT01569568|9874301|FG000|COMPLETED|Overall Study||20
8820269|NCT01569568|9874302|FG001|COMPLETED|Overall Study||27
8820270|NCT01569568|9874301|FG000|NOT COMPLETED|Overall Study||0
8820271|NCT01569568|9874302|FG001|NOT COMPLETED|Overall Study||2
8820272|NCT01569594|9874308|FG000|STARTED|Overall Study||230
8820273|NCT01569594|9874308|FG000|COMPLETED|Overall Study||163
8820274|NCT01569594|9874308|FG000|NOT COMPLETED|Overall Study||67
8820275|NCT01569607|9874314|FG000|STARTED|Overall Study||11
8820276|NCT01569607|9874315|FG001|STARTED|Overall Study||11
8820277|NCT01569607|9874314|FG000|COMPLETED|Overall Study||10
8820278|NCT01569607|9874315|FG001|COMPLETED|Overall Study||10
8820279|NCT01569607|9874314|FG000|NOT COMPLETED|Overall Study||1
8820280|NCT01569607|9874315|FG001|NOT COMPLETED|Overall Study||1
8820281|NCT01569737|9874321|FG000|STARTED|Overall Study||98
8820282|NCT01569737|9874321|FG000|COMPLETED|Overall Study||95
8820283|NCT01569737|9874321|FG000|NOT COMPLETED|Overall Study||3
8556018|NCT01267955|9588033|FG000|STARTED|Stage 1 (6 Months)||20
8556019|NCT01267955|9588033|FG000|COMPLETED|Stage 1 (6 Months)||17
8556020|NCT01267955|9588033|FG000|NOT COMPLETED|Stage 1 (6 Months)||3
8556021|NCT01267955|9588033|FG000|STARTED|Stage 2 (6 Months)||45
8556022|NCT01267955|9588033|FG000|COMPLETED|Stage 2 (6 Months)||39
8556023|NCT01267955|9588033|FG000|NOT COMPLETED|Stage 2 (6 Months)||6
8568667|NCT00092547|9600911|FG000|STARTED|Base Follow-up Phase (Month 18 to 30)|Includes participants continuing and who previously discontinued who re-entered the study|964
8568668|NCT00092547|9600912|FG001|STARTED|Base Follow-up Phase (Month 18 to 30)|Includes participants continuing and who previously discontinued who re-entered the study|490
8568669|NCT00092547|9600913|FG002|STARTED|Base Follow-up Phase (Month 18 to 30)||0
8568670|NCT00092547|9600911|FG000|COMPLETED|Base Follow-up Phase (Month 18 to 30)||956
8568671|NCT00092547|9600912|FG001|COMPLETED|Base Follow-up Phase (Month 18 to 30)||485
8568672|NCT00092547|9600913|FG002|COMPLETED|Base Follow-up Phase (Month 18 to 30)||0
8568673|NCT00092547|9600911|FG000|NOT COMPLETED|Base Follow-up Phase (Month 18 to 30)||8
8568674|NCT00092547|9600912|FG001|NOT COMPLETED|Base Follow-up Phase (Month 18 to 30)||5
8568675|NCT00092547|9600913|FG002|NOT COMPLETED|Base Follow-up Phase (Month 18 to 30)||0
8568676|NCT00092547|9600911|FG000|STARTED|Extension Vaccine Phase (Month 30 to 37)|Includes participants continuing and who previously discontinued who re-entered the study|956
8568677|NCT00092547|9600912|FG001|STARTED|Extension Vaccine Phase (Month 30 to 37)||0
8568678|NCT00092547|9600913|FG002|STARTED|Extension Vaccine Phase (Month 30 to 37)|Includes participants continuing and who previously discontinued who re-entered the study|485
8568679|NCT00092547|9600911|FG000|Vaccinated in Extension Study|Extension Vaccine Phase (Month 30 to 37)||0
8568680|NCT00092547|9600912|FG001|Vaccinated in Extension Study|Extension Vaccine Phase (Month 30 to 37)||0
8568681|NCT00092547|9600913|FG002|Vaccinated in Extension Study|Extension Vaccine Phase (Month 30 to 37)||482
8568682|NCT00092547|9600911|FG000|COMPLETED|Extension Vaccine Phase (Month 30 to 37)||933
8568683|NCT00092547|9600912|FG001|COMPLETED|Extension Vaccine Phase (Month 30 to 37)||0
8568684|NCT00092547|9600913|FG002|COMPLETED|Extension Vaccine Phase (Month 30 to 37)||469
8568685|NCT00092547|9600911|FG000|NOT COMPLETED|Extension Vaccine Phase (Month 30 to 37)||23
8568686|NCT00092547|9600912|FG001|NOT COMPLETED|Extension Vaccine Phase (Month 30 to 37)||0
8568687|NCT00092547|9600913|FG002|NOT COMPLETED|Extension Vaccine Phase (Month 30 to 37)||16
8568688|NCT00092547|9600911|FG000|STARTED|Long-term Follow-up (Month 42 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|612
8568689|NCT00092547|9600912|FG001|STARTED|Long-term Follow-up (Month 42 Visit)||0
8568690|NCT00092547|9600913|FG002|STARTED|Long-term Follow-up (Month 42 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|308
8568691|NCT00092547|9600911|FG000|COMPLETED|Long-term Follow-up (Month 42 Visit)||611
8568692|NCT00092547|9600912|FG001|COMPLETED|Long-term Follow-up (Month 42 Visit)||0
8568693|NCT00092547|9600913|FG002|COMPLETED|Long-term Follow-up (Month 42 Visit)||308
8568694|NCT00092547|9600911|FG000|NOT COMPLETED|Long-term Follow-up (Month 42 Visit)||1
8568695|NCT00092547|9600912|FG001|NOT COMPLETED|Long-term Follow-up (Month 42 Visit)||0
8568696|NCT00092547|9600913|FG002|NOT COMPLETED|Long-term Follow-up (Month 42 Visit)||0
8568697|NCT00092547|9600911|FG000|STARTED|Long-term Follow-up (Month 72 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|550
8820284|NCT01569763|9874327|FG000|STARTED|Overall Study||102
8820285|NCT01569763|9874328|FG001|STARTED|Overall Study||51
8820286|NCT01569763|9874327|FG000|Treated|Overall Study||102
8820287|NCT01569763|9874328|FG001|Treated|Overall Study||51
8820288|NCT01569763|9874327|FG000|COMPLETED|Overall Study|Completed 12 Months of Follow-up|99
8820289|NCT01569763|9874328|FG001|COMPLETED|Overall Study|Completed 12 Months of Follow-up|44
8820290|NCT01569763|9874327|FG000|NOT COMPLETED|Overall Study||3
8820291|NCT01569763|9874328|FG001|NOT COMPLETED|Overall Study||7
8820292|NCT01569815|9874338|FG000|STARTED|Overall Study||8
8820293|NCT01569815|9874339|FG001|STARTED|Overall Study||8
8820294|NCT01569815|9874340|FG002|STARTED|Overall Study||8
8820295|NCT01569815|9874341|FG003|STARTED|Overall Study||8
8820296|NCT01569815|9874338|FG000|COMPLETED|Overall Study||8
8820297|NCT01569815|9874339|FG001|COMPLETED|Overall Study||8
8820298|NCT01569815|9874340|FG002|COMPLETED|Overall Study||8
8820299|NCT01569815|9874341|FG003|COMPLETED|Overall Study||8
8820300|NCT01569815|9874338|FG000|NOT COMPLETED|Overall Study||0
8820301|NCT01569815|9874339|FG001|NOT COMPLETED|Overall Study||0
8820302|NCT01569815|9874340|FG002|NOT COMPLETED|Overall Study||0
8820303|NCT01569815|9874341|FG003|NOT COMPLETED|Overall Study||0
8820304|NCT01569828|9874354|FG000|STARTED|Overall Study||6
8820305|NCT01569828|9874355|FG001|STARTED|Overall Study||6
8820306|NCT01569828|9874354|FG000|COMPLETED|Overall Study||6
8820307|NCT01569828|9874355|FG001|COMPLETED|Overall Study||6
8820308|NCT01569828|9874354|FG000|NOT COMPLETED|Overall Study||0
8820309|NCT01569828|9874355|FG001|NOT COMPLETED|Overall Study||0
8820310|NCT01569841|9874362|FG000|STARTED|Period A (6 Weeks)||12
8820311|NCT01569841|9874363|FG001|STARTED|Period A (6 Weeks)||12
8820312|NCT01569841|9874362|FG000|Exposed|Period A (6 Weeks)||12
8820313|NCT01569841|9874363|FG001|Exposed|Period A (6 Weeks)||12
8820314|NCT01569841|9874362|FG000|COMPLETED|Period A (6 Weeks)||12
8820315|NCT01569841|9874363|FG001|COMPLETED|Period A (6 Weeks)||11
8820316|NCT01569841|9874362|FG000|NOT COMPLETED|Period A (6 Weeks)||0
8820317|NCT01569841|9874363|FG001|NOT COMPLETED|Period A (6 Weeks)||1
8820318|NCT01569841|9874362|FG000|STARTED|Period B (6 Weeks)||12
8820319|NCT01569841|9874363|FG001|STARTED|Period B (6 Weeks)||11
8820320|NCT01569841|9874362|FG000|Exposed|Period B (6 Weeks)||12
8556024|NCT01253070|9588037|FG000|STARTED|Overall Study||54
8556025|NCT01253070|9588037|FG000|COMPLETED|Overall Study||54
8556026|NCT01253070|9588037|FG000|NOT COMPLETED|Overall Study||0
8556027|NCT01232283|9588044|FG000|STARTED|Placebo Controlled Phase (Weeks 0-16)||275
8556028|NCT01232283|9588045|FG001|STARTED|Placebo Controlled Phase (Weeks 0-16)||138
8556029|NCT01232283|9588046|FG002|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
8556030|NCT01232283|9588047|FG003|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
8556031|NCT01232283|9588048|FG004|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
8556032|NCT01232283|9588049|FG005|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
8556033|NCT01232283|9588050|FG006|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
8556034|NCT01232283|9588051|FG007|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
8556035|NCT01232283|9588052|FG008|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
8556036|NCT01232283|9588053|FG009|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
8556037|NCT01232283|9588044|FG000|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)|1 protocol violation occurred|272
8556038|NCT01232283|9588045|FG001|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)|1 protocol violation occurred|136
8556039|NCT01232283|9588046|FG002|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
8556040|NCT01232283|9588047|FG003|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
8556041|NCT01232283|9588048|FG004|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
8556042|NCT01232283|9588049|FG005|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
8556043|NCT01232283|9588050|FG006|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
8556044|NCT01232283|9588051|FG007|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
8556045|NCT01232283|9588052|FG008|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
8556046|NCT01232283|9588053|FG009|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
8556047|NCT01232283|9588044|FG000|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||239
8556048|NCT01232283|9588045|FG001|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||112
8556049|NCT01232283|9588046|FG002|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
8556050|NCT01232283|9588047|FG003|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
8556051|NCT01232283|9588048|FG004|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
8556052|NCT01232283|9588049|FG005|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
8556053|NCT01232283|9588050|FG006|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
8556054|NCT01232283|9588051|FG007|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
8556055|NCT01232283|9588052|FG008|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
8556056|NCT01232283|9588053|FG009|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
8556057|NCT01232283|9588044|FG000|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||36
8556058|NCT01232283|9588045|FG001|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||26
8556059|NCT01232283|9588046|FG002|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
8556060|NCT01232283|9588047|FG003|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
8556061|NCT01232283|9588048|FG004|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
8556062|NCT01232283|9588049|FG005|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
8556063|NCT01232283|9588050|FG006|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
8556064|NCT01232283|9588051|FG007|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
8556065|NCT01232283|9588052|FG008|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
8556066|NCT01232283|9588053|FG009|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
8556067|NCT01232283|9588044|FG000|STARTED|Maintenance Phase (Weeks16-32)||0
8556068|NCT01232283|9588045|FG001|STARTED|Maintenance Phase (Weeks16-32)||0
8556069|NCT01232283|9588046|FG002|STARTED|Maintenance Phase (Weeks16-32)|5 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|234
8556070|NCT01232283|9588047|FG003|STARTED|Maintenance Phase (Weeks16-32)|4 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|108
8556071|NCT01232283|9588048|FG004|STARTED|Maintenance Phase (Weeks16-32)||0
8556072|NCT01232283|9588049|FG005|STARTED|Maintenance Phase (Weeks16-32)||0
8556073|NCT01232283|9588050|FG006|STARTED|Maintenance Phase (Weeks16-32)||0
8556074|NCT01232283|9588051|FG007|STARTED|Maintenance Phase (Weeks16-32)||0
8556075|NCT01232283|9588052|FG008|STARTED|Maintenance Phase (Weeks16-32)||0
8556076|NCT01232283|9588053|FG009|STARTED|Maintenance Phase (Weeks16-32)||0
8556077|NCT01232283|9588044|FG000|COMPLETED|Maintenance Phase (Weeks16-32)||0
8556078|NCT01232283|9588045|FG001|COMPLETED|Maintenance Phase (Weeks16-32)||0
8556079|NCT01232283|9588046|FG002|COMPLETED|Maintenance Phase (Weeks16-32)||194
8556080|NCT01232283|9588047|FG003|COMPLETED|Maintenance Phase (Weeks16-32)||100
8556081|NCT01232283|9588048|FG004|COMPLETED|Maintenance Phase (Weeks16-32)||0
8556082|NCT01232283|9588049|FG005|COMPLETED|Maintenance Phase (Weeks16-32)||0
8621888|NCT00484159|9660968|FG000|STARTED|Overall Study||50
8621889|NCT00484159|9660969|FG001|STARTED|Overall Study||50
8621890|NCT00484159|9660970|FG002|STARTED|Overall Study||51
8820321|NCT01569841|9874363|FG001|Exposed|Period B (6 Weeks)||11
8820322|NCT01569841|9874362|FG000|COMPLETED|Period B (6 Weeks)||12
8820323|NCT01569841|9874363|FG001|COMPLETED|Period B (6 Weeks)||11
8820324|NCT01569841|9874362|FG000|NOT COMPLETED|Period B (6 Weeks)||0
8820325|NCT01569841|9874363|FG001|NOT COMPLETED|Period B (6 Weeks)||0
8820326|NCT01570036|9874373|FG000|STARTED|Overall Study||136
8820327|NCT01570036|9874374|FG001|STARTED|Overall Study||139
8820328|NCT01570036|9874373|FG000|Primary Vaccine Series Completed|Overall Study||121
8820329|NCT01570036|9874374|FG001|Primary Vaccine Series Completed|Overall Study||132
8820330|NCT01570036|9874373|FG000|Booster Series Completed|Overall Study||40
8820331|NCT01570036|9874374|FG001|Booster Series Completed|Overall Study||30
8820332|NCT01570036|9874373|FG000|COMPLETED|Overall Study||18
8820333|NCT01570036|9874374|FG001|COMPLETED|Overall Study||17
8556083|NCT01232283|9588050|FG006|COMPLETED|Maintenance Phase (Weeks16-32)||0
8556084|NCT01232283|9588051|FG007|COMPLETED|Maintenance Phase (Weeks16-32)||0
8556085|NCT01232283|9588052|FG008|COMPLETED|Maintenance Phase (Weeks16-32)||0
8556086|NCT01232283|9588053|FG009|COMPLETED|Maintenance Phase (Weeks16-32)||0
8556087|NCT01232283|9588044|FG000|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
8556088|NCT01232283|9588045|FG001|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
8556089|NCT01232283|9588046|FG002|NOT COMPLETED|Maintenance Phase (Weeks16-32)||40
8556090|NCT01232283|9588047|FG003|NOT COMPLETED|Maintenance Phase (Weeks16-32)||8
8556091|NCT01232283|9588048|FG004|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
8556092|NCT01232283|9588049|FG005|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
8556093|NCT01232283|9588050|FG006|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
8556094|NCT01232283|9588051|FG007|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
8556095|NCT01232283|9588052|FG008|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
8556096|NCT01232283|9588053|FG009|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
8556097|NCT01232283|9588044|FG000|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
8556098|NCT01232283|9588045|FG001|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
8556099|NCT01232283|9588046|FG002|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
8556100|NCT01232283|9588047|FG003|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
8556101|NCT01232283|9588048|FG004|STARTED|Randomized Withdrawal Phase(Weeks 32-52)|4 participants discontinued after Week 32 but prior to entry into the Randomized Withdrawal Phase|62
8556102|NCT01232283|9588049|FG005|STARTED|Randomized Withdrawal Phase(Weeks 32-52)|13 participants discontinued after Week 32 but prior to entry into the Randomized Withdrawal Phase|61
8556103|NCT01232283|9588050|FG006|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||58
8556104|NCT01232283|9588051|FG007|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||96
8556105|NCT01232283|9588052|FG008|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
8556106|NCT01232283|9588053|FG009|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
8556107|NCT01232283|9588044|FG000|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
8556108|NCT01232283|9588045|FG001|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
8556109|NCT01232283|9588046|FG002|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
8556110|NCT01232283|9588047|FG003|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
8556111|NCT01232283|9588048|FG004|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
8556112|NCT01232283|9588049|FG005|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
8556113|NCT01232283|9588050|FG006|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||28
8556114|NCT01232283|9588051|FG007|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||17
8556115|NCT01232283|9588052|FG008|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
8556116|NCT01232283|9588053|FG009|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
8556117|NCT01232283|9588044|FG000|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
8556118|NCT01232283|9588045|FG001|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
8556119|NCT01232283|9588046|FG002|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
8556120|NCT01232283|9588047|FG003|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
8556121|NCT01232283|9588048|FG004|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||50
8556122|NCT01232283|9588049|FG005|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||56
8556123|NCT01232283|9588050|FG006|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||41
8556124|NCT01232283|9588051|FG007|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||84
8556125|NCT01232283|9588052|FG008|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
8556126|NCT01232283|9588053|FG009|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
8556127|NCT01232283|9588044|FG000|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
8556128|NCT01232283|9588045|FG001|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
8556129|NCT01232283|9588046|FG002|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
8556130|NCT01232283|9588047|FG003|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
8556131|NCT01232283|9588048|FG004|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||12
8556132|NCT01232283|9588049|FG005|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||5
8556133|NCT01232283|9588050|FG006|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||17
8556134|NCT01232283|9588051|FG007|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||12
8556135|NCT01232283|9588052|FG008|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
8556136|NCT01232283|9588053|FG009|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
8556137|NCT01232283|9588044|FG000|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
8556138|NCT01232283|9588045|FG001|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
8556139|NCT01232283|9588046|FG002|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
8556140|NCT01232283|9588047|FG003|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
8556141|NCT01232283|9588048|FG004|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
8556142|NCT01232283|9588049|FG005|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
8556143|NCT01232283|9588050|FG006|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
8556144|NCT01232283|9588051|FG007|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
8556145|NCT01232283|9588052|FG008|STARTED|Long-Term Extension Phase (Weeks 52-260)||137
8556146|NCT01232283|9588053|FG009|STARTED|Long-Term Extension Phase (Weeks 52-260)||80
8556147|NCT01232283|9588044|FG000|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
8556148|NCT01232283|9588045|FG001|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
8556149|NCT01232283|9588046|FG002|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
8556150|NCT01232283|9588047|FG003|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
8556151|NCT01232283|9588048|FG004|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
8556152|NCT01232283|9588049|FG005|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
8556153|NCT01232283|9588050|FG006|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
8556154|NCT01232283|9588051|FG007|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
8556155|NCT01232283|9588052|FG008|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||29
8556156|NCT01232283|9588053|FG009|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||19
8556157|NCT01232283|9588044|FG000|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
8556158|NCT01232283|9588045|FG001|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
8556159|NCT01232283|9588046|FG002|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
8556160|NCT01232283|9588047|FG003|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
8556161|NCT01232283|9588048|FG004|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
8556162|NCT01232283|9588049|FG005|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
8621891|NCT00484159|9660968|FG000|COMPLETED|Overall Study||49
8621892|NCT00484159|9660969|FG001|COMPLETED|Overall Study||49
8621893|NCT00484159|9660970|FG002|COMPLETED|Overall Study||51
8621894|NCT00484159|9660968|FG000|NOT COMPLETED|Overall Study||1
8621895|NCT00484159|9660969|FG001|NOT COMPLETED|Overall Study||1
8621896|NCT00484159|9660970|FG002|NOT COMPLETED|Overall Study||0
8820334|NCT01570036|9874373|FG000|NOT COMPLETED|Overall Study||118
8820335|NCT01570036|9874374|FG001|NOT COMPLETED|Overall Study||122
8820336|NCT01570192|9874382|FG000|STARTED|Overall Study||13
8820337|NCT01570192|9874383|FG001|STARTED|Overall Study||30
8820338|NCT01570192|9874382|FG000|COMPLETED|Overall Study||6
8820339|NCT01570192|9874383|FG001|COMPLETED|Overall Study||17
8820340|NCT01570192|9874382|FG000|NOT COMPLETED|Overall Study||7
8820341|NCT01570192|9874383|FG001|NOT COMPLETED|Overall Study||13
8820342|NCT01570244|9874394|FG000|STARTED|Microgynon||16
8820343|NCT01570244|9874394|FG000|COMPLETED|Microgynon||16
8820344|NCT01570244|9874394|FG000|NOT COMPLETED|Microgynon||0
8820345|NCT01570244|9874394|FG000|STARTED|Microgynon+Faldaprevir||16
8820346|NCT01570244|9874394|FG000|COMPLETED|Microgynon+Faldaprevir||15
8820347|NCT01570244|9874394|FG000|NOT COMPLETED|Microgynon+Faldaprevir||1
8820348|NCT01570283|9874403|FG000|STARTED|Cohort 1: Dose Level 1||1
8820349|NCT01570283|9874404|FG001|STARTED|Cohort 1: Dose Level 1||3
8820350|NCT01570283|9874405|FG002|STARTED|Cohort 1: Dose Level 1||0
8820351|NCT01570283|9874406|FG003|STARTED|Cohort 1: Dose Level 1||0
8820352|NCT01570283|9874407|FG004|STARTED|Cohort 1: Dose Level 1||0
8820353|NCT01570283|9874408|FG005|STARTED|Cohort 1: Dose Level 1||0
8820354|NCT01570283|9874403|FG000|COMPLETED|Cohort 1: Dose Level 1||1
8820355|NCT01570283|9874404|FG001|COMPLETED|Cohort 1: Dose Level 1||1
8820356|NCT01570283|9874405|FG002|COMPLETED|Cohort 1: Dose Level 1||0
8820357|NCT01570283|9874406|FG003|COMPLETED|Cohort 1: Dose Level 1||0
8820358|NCT01570283|9874407|FG004|COMPLETED|Cohort 1: Dose Level 1||0
8820359|NCT01570283|9874408|FG005|COMPLETED|Cohort 1: Dose Level 1||0
8820360|NCT01570283|9874403|FG000|NOT COMPLETED|Cohort 1: Dose Level 1||0
8820361|NCT01570283|9874404|FG001|NOT COMPLETED|Cohort 1: Dose Level 1||2
8820362|NCT01570283|9874405|FG002|NOT COMPLETED|Cohort 1: Dose Level 1||0
8820363|NCT01570283|9874406|FG003|NOT COMPLETED|Cohort 1: Dose Level 1||0
8820364|NCT01570283|9874407|FG004|NOT COMPLETED|Cohort 1: Dose Level 1||0
8820365|NCT01570283|9874408|FG005|NOT COMPLETED|Cohort 1: Dose Level 1||0
8820366|NCT01570283|9874403|FG000|STARTED|Cohort 2: Dose Level 2||0
8820367|NCT01570283|9874404|FG001|STARTED|Cohort 2: Dose Level 2||0
8820368|NCT01570283|9874405|FG002|STARTED|Cohort 2: Dose Level 2||2
8820369|NCT01570283|9874406|FG003|STARTED|Cohort 2: Dose Level 2||2
8820370|NCT01570283|9874407|FG004|STARTED|Cohort 2: Dose Level 2||0
8820371|NCT01570283|9874408|FG005|STARTED|Cohort 2: Dose Level 2||0
8820372|NCT01570283|9874403|FG000|COMPLETED|Cohort 2: Dose Level 2||0
8820373|NCT01570283|9874404|FG001|COMPLETED|Cohort 2: Dose Level 2||0
8820374|NCT01570283|9874405|FG002|COMPLETED|Cohort 2: Dose Level 2||1
8820375|NCT01570283|9874406|FG003|COMPLETED|Cohort 2: Dose Level 2||1
8820376|NCT01570283|9874407|FG004|COMPLETED|Cohort 2: Dose Level 2||0
8820377|NCT01570283|9874408|FG005|COMPLETED|Cohort 2: Dose Level 2||0
8820378|NCT01570283|9874403|FG000|NOT COMPLETED|Cohort 2: Dose Level 2||0
8820379|NCT01570283|9874404|FG001|NOT COMPLETED|Cohort 2: Dose Level 2||0
8820380|NCT01570283|9874405|FG002|NOT COMPLETED|Cohort 2: Dose Level 2||1
8820381|NCT01570283|9874406|FG003|NOT COMPLETED|Cohort 2: Dose Level 2||1
8820382|NCT01570283|9874407|FG004|NOT COMPLETED|Cohort 2: Dose Level 2||0
8820383|NCT01570283|9874408|FG005|NOT COMPLETED|Cohort 2: Dose Level 2||0
8820384|NCT01570283|9874403|FG000|STARTED|Cohort 3: Dose Level 3||0
8820385|NCT01570283|9874404|FG001|STARTED|Cohort 3: Dose Level 3||0
8820386|NCT01570283|9874405|FG002|STARTED|Cohort 3: Dose Level 3||0
8820387|NCT01570283|9874406|FG003|STARTED|Cohort 3: Dose Level 3||0
8820388|NCT01570283|9874407|FG004|STARTED|Cohort 3: Dose Level 3||1
8820389|NCT01570283|9874408|FG005|STARTED|Cohort 3: Dose Level 3||12
8820390|NCT01570283|9874403|FG000|COMPLETED|Cohort 3: Dose Level 3||0
8820391|NCT01570283|9874404|FG001|COMPLETED|Cohort 3: Dose Level 3||0
8820392|NCT01570283|9874405|FG002|COMPLETED|Cohort 3: Dose Level 3||0
8820393|NCT01570283|9874406|FG003|COMPLETED|Cohort 3: Dose Level 3||0
8820394|NCT01570283|9874407|FG004|COMPLETED|Cohort 3: Dose Level 3||1
8820395|NCT01570283|9874408|FG005|COMPLETED|Cohort 3: Dose Level 3||10
8820396|NCT01570283|9874403|FG000|NOT COMPLETED|Cohort 3: Dose Level 3||0
8820397|NCT01570283|9874404|FG001|NOT COMPLETED|Cohort 3: Dose Level 3||0
8556163|NCT01232283|9588050|FG006|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
8556164|NCT01232283|9588051|FG007|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
8556165|NCT01232283|9588052|FG008|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||108
8556166|NCT01232283|9588053|FG009|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||61
8556167|NCT01231516|9588077|FG000|STARTED|Double-blind Phase (Up to Week [Wk] 48)||360
8556168|NCT01231516|9588078|FG001|STARTED|Double-blind Phase (Up to Week [Wk] 48)||364
8556169|NCT01231516|9588077|FG000|ITT-E Population|Double-blind Phase (Up to Week [Wk] 48)||357
8556170|NCT01231516|9588078|FG001|ITT-E Population|Double-blind Phase (Up to Week [Wk] 48)||362
8556171|NCT01231516|9588077|FG000|Modified (m)ITT-E Population|Double-blind Phase (Up to Week [Wk] 48)||354
8556172|NCT01231516|9588078|FG001|Modified (m)ITT-E Population|Double-blind Phase (Up to Week [Wk] 48)||361
8556173|NCT01231516|9588077|FG000|COMPLETED|Double-blind Phase (Up to Week [Wk] 48)||299
8556174|NCT01231516|9588078|FG001|COMPLETED|Double-blind Phase (Up to Week [Wk] 48)||283
8556175|NCT01231516|9588077|FG000|NOT COMPLETED|Double-blind Phase (Up to Week [Wk] 48)||61
8556176|NCT01231516|9588078|FG001|NOT COMPLETED|Double-blind Phase (Up to Week [Wk] 48)||81
8556177|NCT01231516|9588077|FG000|STARTED|Open-label Phase:From Wk 48 up to Wk 480|4 participants completed the Double-blind Phase but did not enter the Open-label Phase.|295
8556178|NCT01231516|9588078|FG001|STARTED|Open-label Phase:From Wk 48 up to Wk 480|157 participants completed the Double-blind Phase but did not enter the Open-label Phase.|126
8556179|NCT01231516|9588077|FG000|COMPLETED|Open-label Phase:From Wk 48 up to Wk 480||227
8556180|NCT01231516|9588078|FG001|COMPLETED|Open-label Phase:From Wk 48 up to Wk 480||109
8556181|NCT01231516|9588077|FG000|NOT COMPLETED|Open-label Phase:From Wk 48 up to Wk 480||68
8556182|NCT01231516|9588078|FG001|NOT COMPLETED|Open-label Phase:From Wk 48 up to Wk 480||17
8556183|NCT01229943|9588086|FG000|STARTED|Overall Study||75
8556184|NCT01229943|9588087|FG001|STARTED|Overall Study||75
8556185|NCT01229943|9588086|FG000|COMPLETED|Overall Study||57
8556186|NCT01229943|9588087|FG001|COMPLETED|Overall Study||58
8556187|NCT01229943|9588086|FG000|NOT COMPLETED|Overall Study||18
8820398|NCT01570283|9874405|FG002|NOT COMPLETED|Cohort 3: Dose Level 3||0
8820399|NCT01570283|9874406|FG003|NOT COMPLETED|Cohort 3: Dose Level 3||0
8820400|NCT01570283|9874407|FG004|NOT COMPLETED|Cohort 3: Dose Level 3||0
8820401|NCT01570283|9874408|FG005|NOT COMPLETED|Cohort 3: Dose Level 3||2
8820402|NCT01570309|9874424|FG000|STARTED|Overall Study||48
8820403|NCT01570309|9874425|FG001|STARTED|Overall Study||48
8820404|NCT01570309|9874424|FG000|COMPLETED|Overall Study||45
8820405|NCT01570309|9874425|FG001|COMPLETED|Overall Study||45
8820406|NCT01570309|9874424|FG000|NOT COMPLETED|Overall Study||3
8820407|NCT01570309|9874425|FG001|NOT COMPLETED|Overall Study||3
8820408|NCT01570348|9874435|FG000|STARTED|Overall Study||2
8820409|NCT01570348|9874435|FG000|COMPLETED|Overall Study||2
8820410|NCT01570348|9874435|FG000|NOT COMPLETED|Overall Study||0
8820411|NCT01570361|9874441|FG000|STARTED|Overall Study||128
8820412|NCT01570361|9874442|FG001|STARTED|Overall Study||127
8820413|NCT01570361|9874441|FG000|Received Study Treatment|Overall Study||102
8820414|NCT01570361|9874442|FG001|Received Study Treatment|Overall Study||123
8820415|NCT01570361|9874441|FG000|Cross-over (AAD Therapy to RF Ablation)|Overall Study||0
8820416|NCT01570361|9874442|FG001|Cross-over (AAD Therapy to RF Ablation)|Overall Study||15
8820417|NCT01570361|9874441|FG000|AAD Therapy Only|Overall Study||0
8820418|NCT01570361|9874442|FG001|AAD Therapy Only|Overall Study||108
8820419|NCT01570361|9874441|FG000|COMPLETED|Overall Study||46
8820420|NCT01570361|9874442|FG001|COMPLETED|Overall Study||52
8820421|NCT01570361|9874441|FG000|NOT COMPLETED|Overall Study||82
8820422|NCT01570361|9874442|FG001|NOT COMPLETED|Overall Study||75
8820423|NCT01570387|9874455|FG000|STARTED|Overall Study||6
8820424|NCT01570387|9874456|FG001|STARTED|Overall Study||3
8820425|NCT01570387|9874457|FG002|STARTED|Overall Study||6
8820426|NCT01570387|9874458|FG003|STARTED|Overall Study||12
8820427|NCT01570387|9874455|FG000|Dose Limiting Toxicity|Overall Study||0
8820428|NCT01570387|9874456|FG001|Dose Limiting Toxicity|Overall Study||0
8820429|NCT01570387|9874457|FG002|Dose Limiting Toxicity|Overall Study||6
8820430|NCT01570387|9874458|FG003|Dose Limiting Toxicity|Overall Study||12
8820431|NCT01570387|9874455|FG000|Response to Maximal Tolerated Dose|Overall Study||0
8820432|NCT01570387|9874456|FG001|Response to Maximal Tolerated Dose|Overall Study||0
8820433|NCT01570387|9874457|FG002|Response to Maximal Tolerated Dose|Overall Study||3
8820434|NCT01570387|9874458|FG003|Response to Maximal Tolerated Dose|Overall Study||6
8820435|NCT01570387|9874455|FG000|COMPLETED|Overall Study||5
8820436|NCT01570387|9874456|FG001|COMPLETED|Overall Study||3
8820437|NCT01570387|9874457|FG002|COMPLETED|Overall Study||6
8820438|NCT01570387|9874458|FG003|COMPLETED|Overall Study||10
8820439|NCT01570387|9874455|FG000|NOT COMPLETED|Overall Study||1
8820440|NCT01570387|9874456|FG001|NOT COMPLETED|Overall Study||0
8820441|NCT01570387|9874457|FG002|NOT COMPLETED|Overall Study||0
8820442|NCT01570387|9874458|FG003|NOT COMPLETED|Overall Study||2
8820443|NCT01570491|9874467|FG000|STARTED|Overall Study||19
8820444|NCT01570491|9874468|FG001|STARTED|Overall Study||19
8820445|NCT01570491|9874467|FG000|COMPLETED|Overall Study||14
8820446|NCT01570491|9874468|FG001|COMPLETED|Overall Study||18
8820447|NCT01570491|9874467|FG000|NOT COMPLETED|Overall Study||5
8820448|NCT01570491|9874468|FG001|NOT COMPLETED|Overall Study||1
8820449|NCT01570686|9874476|FG000|STARTED|Overall Study||296
8820450|NCT01570686|9874477|FG001|STARTED|Overall Study||294
8820451|NCT01570686|9874476|FG000|Safety and Full Analysis Set (FAS)|Overall Study|One patient was mis-randomized and never received study drug. Hence not included in Safety or FAS.|295
8820452|NCT01570686|9874477|FG001|Safety and Full Analysis Set (FAS)|Overall Study||294
8820453|NCT01570686|9874476|FG000|COMPLETED|Overall Study||274
8556188|NCT01229943|9588087|FG001|NOT COMPLETED|Overall Study||17
8556189|NCT01194219|9588097|FG000|STARTED|Placebo-Controlled Phase Weeks 0-16||562
8556190|NCT01194219|9588098|FG001|STARTED|Placebo-Controlled Phase Weeks 0-16||282
8556191|NCT01194219|9588099|FG002|STARTED|Placebo-Controlled Phase Weeks 0-16||0
8556192|NCT01194219|9588100|FG003|STARTED|Placebo-Controlled Phase Weeks 0-16||0
8556193|NCT01194219|9588101|FG004|STARTED|Placebo-Controlled Phase Weeks 0-16||0
8556194|NCT01194219|9588102|FG005|STARTED|Placebo-Controlled Phase Weeks 0-16||0
8556195|NCT01194219|9588103|FG006|STARTED|Placebo-Controlled Phase Weeks 0-16||0
8556196|NCT01194219|9588104|FG007|STARTED|Placebo-Controlled Phase Weeks 0-16||0
8556197|NCT01194219|9588105|FG008|STARTED|Placebo-Controlled Phase Weeks 0-16||0
8556198|NCT01194219|9588106|FG009|STARTED|Placebo-Controlled Phase Weeks 0-16||0
8556199|NCT01194219|9588097|FG000|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||560
8556200|NCT01194219|9588098|FG001|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||282
8556201|NCT01194219|9588099|FG002|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
8556202|NCT01194219|9588100|FG003|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
8556203|NCT01194219|9588101|FG004|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
8556204|NCT01194219|9588102|FG005|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
8556205|NCT01194219|9588103|FG006|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
8556206|NCT01194219|9588104|FG007|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
8556207|NCT01194219|9588105|FG008|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
8556208|NCT01194219|9588106|FG009|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
8556209|NCT01194219|9588097|FG000|COMPLETED|Placebo-Controlled Phase Weeks 0-16||503
8556210|NCT01194219|9588098|FG001|COMPLETED|Placebo-Controlled Phase Weeks 0-16||249
8556211|NCT01194219|9588099|FG002|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
8556212|NCT01194219|9588100|FG003|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
8556213|NCT01194219|9588101|FG004|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
8556214|NCT01194219|9588102|FG005|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
8556215|NCT01194219|9588103|FG006|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
8556216|NCT01194219|9588104|FG007|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
8820454|NCT01570686|9874477|FG001|COMPLETED|Overall Study||278
8820455|NCT01570686|9874476|FG000|NOT COMPLETED|Overall Study||22
8820456|NCT01570686|9874477|FG001|NOT COMPLETED|Overall Study||16
8820457|NCT01570751|9874485|FG000|STARTED|Period A (16 Weeks)||73
8820458|NCT01570751|9874486|FG001|STARTED|Period A (16 Weeks)||72
8820459|NCT01570751|9874485|FG000|Exposed|Period A (16 Weeks)||73
8820460|NCT01570751|9874486|FG001|Exposed|Period A (16 Weeks)||72
8820461|NCT01570751|9874485|FG000|COMPLETED|Period A (16 Weeks)||70
8820462|NCT01570751|9874486|FG001|COMPLETED|Period A (16 Weeks)||67
8820463|NCT01570751|9874485|FG000|NOT COMPLETED|Period A (16 Weeks)||3
8820464|NCT01570751|9874486|FG001|NOT COMPLETED|Period A (16 Weeks)||5
8820465|NCT01570751|9874485|FG000|STARTED|Period B (16 Weeks)||70
8820466|NCT01570751|9874486|FG001|STARTED|Period B (16 Weeks)||67
8820467|NCT01570751|9874485|FG000|Exposed|Period B (16 Weeks)||70
8820468|NCT01570751|9874486|FG001|Exposed|Period B (16 Weeks)||67
8820469|NCT01570751|9874485|FG000|COMPLETED|Period B (16 Weeks)||69
8820470|NCT01570751|9874486|FG001|COMPLETED|Period B (16 Weeks)||66
8820471|NCT01570751|9874485|FG000|NOT COMPLETED|Period B (16 Weeks)||1
8820472|NCT01570751|9874486|FG001|NOT COMPLETED|Period B (16 Weeks)||1
8820473|NCT01570829|9874496|FG000|STARTED|Overall Study||164
8820474|NCT01570829|9874497|FG001|STARTED|Overall Study||167
8820475|NCT01570829|9874496|FG000|COMPLETED|Overall Study||164
8820476|NCT01570829|9874497|FG001|COMPLETED|Overall Study||167
8820477|NCT01570829|9874496|FG000|NOT COMPLETED|Overall Study||0
8820478|NCT01570829|9874497|FG001|NOT COMPLETED|Overall Study||0
8820479|NCT01570868|9874505|FG000|STARTED|Overall Study||43
8820480|NCT01570868|9874506|FG001|STARTED|Overall Study||8
8820481|NCT01570868|9874505|FG000|COMPLETED|Overall Study||0
8820482|NCT01570868|9874506|FG001|COMPLETED|Overall Study||0
8820483|NCT01570868|9874505|FG000|NOT COMPLETED|Overall Study||43
8820484|NCT01570868|9874506|FG001|NOT COMPLETED|Overall Study||8
8820485|NCT01571232|9874518|FG000|STARTED|Overall Study||10
8820486|NCT01571232|9874519|FG001|STARTED|Overall Study||10
8820487|NCT01571232|9874518|FG000|COMPLETED|Overall Study||9
8820488|NCT01571232|9874519|FG001|COMPLETED|Overall Study||9
8820489|NCT01571232|9874518|FG000|NOT COMPLETED|Overall Study||1
8820490|NCT01571232|9874519|FG001|NOT COMPLETED|Overall Study||1
8820491|NCT01571284|9874526|FG000|STARTED|Overall Study||781
8820492|NCT01571284|9874526|FG000|Safety Population|Overall Study||779
8820493|NCT01571284|9874526|FG000|COMPLETED|Overall Study|403 participants with DP and 209 with adverse events were considered as completed.|612
8820494|NCT01571284|9874526|FG000|NOT COMPLETED|Overall Study||169
8820495|NCT01571362|9874530|FG000|STARTED|Open-Label Conversion + Titration Period||410
8820496|NCT01571362|9874531|FG001|STARTED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
8820497|NCT01571362|9874532|FG002|STARTED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
8820498|NCT01571362|9874530|FG000|COMPLETED|Open-Label Conversion + Titration Period||281
8820499|NCT01571362|9874531|FG001|COMPLETED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
8556217|NCT01194219|9588105|FG008|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
8556218|NCT01194219|9588106|FG009|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
8556219|NCT01194219|9588097|FG000|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||59
8556220|NCT01194219|9588098|FG001|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||33
8556221|NCT01194219|9588099|FG002|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
8556222|NCT01194219|9588100|FG003|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
8556223|NCT01194219|9588101|FG004|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
8556224|NCT01194219|9588102|FG005|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
8556225|NCT01194219|9588103|FG006|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
8556226|NCT01194219|9588104|FG007|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
8556227|NCT01194219|9588105|FG008|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
8556228|NCT01194219|9588106|FG009|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
8556229|NCT01194219|9588097|FG000|STARTED|Maintenance Phase Weeks16-32||0
8556230|NCT01194219|9588098|FG001|STARTED|Maintenance Phase Weeks16-32||0
8556231|NCT01194219|9588099|FG002|STARTED|Maintenance Phase Weeks16-32|9 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|494
8556232|NCT01194219|9588100|FG003|STARTED|Maintenance Phase Weeks16-32|4 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|245
8556233|NCT01194219|9588101|FG004|STARTED|Maintenance Phase Weeks16-32||0
8556234|NCT01194219|9588102|FG005|STARTED|Maintenance Phase Weeks16-32||0
8556235|NCT01194219|9588103|FG006|STARTED|Maintenance Phase Weeks16-32||0
8556236|NCT01194219|9588104|FG007|STARTED|Maintenance Phase Weeks16-32||0
8556237|NCT01194219|9588105|FG008|STARTED|Maintenance Phase Weeks16-32||0
8820500|NCT01571362|9874532|FG002|COMPLETED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
8820501|NCT01571362|9874530|FG000|NOT COMPLETED|Open-Label Conversion + Titration Period||129
8820502|NCT01571362|9874531|FG001|NOT COMPLETED|Open-Label Conversion + Titration Period||0
8820503|NCT01571362|9874532|FG002|NOT COMPLETED|Open-Label Conversion + Titration Period||0
8820504|NCT01571362|9874530|FG000|STARTED|Double-Blind Treatment Period|This phase preceded the Double-Blind Treatment Period.|0
8820505|NCT01571362|9874531|FG001|STARTED|Double-Blind Treatment Period||134
8820506|NCT01571362|9874532|FG002|STARTED|Double-Blind Treatment Period||146
8820507|NCT01571362|9874530|FG000|COMPLETED|Double-Blind Treatment Period|This phase preceded the Double-Blind Treatment Period.|0
8820508|NCT01571362|9874531|FG001|COMPLETED|Double-Blind Treatment Period||81
8820509|NCT01571362|9874532|FG002|COMPLETED|Double-Blind Treatment Period||107
8820510|NCT01571362|9874530|FG000|NOT COMPLETED|Double-Blind Treatment Period||0
8820511|NCT01571362|9874531|FG001|NOT COMPLETED|Double-Blind Treatment Period||53
8820512|NCT01571362|9874532|FG002|NOT COMPLETED|Double-Blind Treatment Period||39
8820513|NCT01571427|9874542|FG000|STARTED|Overall Study||41
8820514|NCT01571427|9874543|FG001|STARTED|Overall Study||42
8820515|NCT01571427|9874542|FG000|COMPLETED|Overall Study||41
8820516|NCT01571427|9874543|FG001|COMPLETED|Overall Study||42
8820517|NCT01571427|9874542|FG000|NOT COMPLETED|Overall Study||0
8820518|NCT01571427|9874543|FG001|NOT COMPLETED|Overall Study||0
8820519|NCT01571453|9874551|FG000|STARTED|Overall Study||211
8820520|NCT01571453|9874552|FG001|STARTED|Overall Study||226
8820521|NCT01571453|9874551|FG000|COMPLETED|Overall Study||173
8820522|NCT01571453|9874552|FG001|COMPLETED|Overall Study||164
8820523|NCT01571453|9874551|FG000|NOT COMPLETED|Overall Study||38
8820524|NCT01571453|9874552|FG001|NOT COMPLETED|Overall Study||62
8820525|NCT01571557|9874558|FG000|STARTED|Overall Study||573
8820526|NCT01571557|9874558|FG000|COMPLETED|Overall Study||573
8820527|NCT01571557|9874558|FG000|NOT COMPLETED|Overall Study||0
8820528|NCT01571596|9874565|FG000|STARTED|Overall Study||21
8820529|NCT01571596|9874566|FG001|STARTED|Overall Study||1
8820530|NCT01571596|9874567|FG002|STARTED|Overall Study||1
8820531|NCT01571596|9874565|FG000|COMPLETED|Overall Study||19
8820532|NCT01571596|9874566|FG001|COMPLETED|Overall Study||0
8820533|NCT01571596|9874567|FG002|COMPLETED|Overall Study||0
8820534|NCT01571596|9874565|FG000|NOT COMPLETED|Overall Study||2
8820535|NCT01571596|9874566|FG001|NOT COMPLETED|Overall Study||1
8820536|NCT01571596|9874567|FG002|NOT COMPLETED|Overall Study||1
8820537|NCT01572038|9874577|FG000|STARTED|Overall Study|All participants who were enrolled in the study.|1436
8820538|NCT01572038|9874577|FG000|Received at Least One Dose of Study Drug|Overall Study||1436
8820539|NCT01572038|9874577|FG000|COMPLETED|Overall Study||445
8820540|NCT01572038|9874577|FG000|NOT COMPLETED|Overall Study||991
8820541|NCT01572298|9874605|FG000|STARTED|Overall Study||14
8820542|NCT01572298|9874606|FG001|STARTED|Overall Study||13
8820543|NCT01572298|9874605|FG000|COMPLETED|Overall Study||12
8820544|NCT01572298|9874606|FG001|COMPLETED|Overall Study||12
8820545|NCT01572298|9874605|FG000|NOT COMPLETED|Overall Study||2
8820546|NCT01572298|9874606|FG001|NOT COMPLETED|Overall Study||1
8820547|NCT01572389|9874616|FG000|STARTED|Overall Study||136
8820548|NCT01572389|9874617|FG001|STARTED|Overall Study||89
8820549|NCT01572389|9874616|FG000|COMPLETED|Overall Study||90
8820550|NCT01572389|9874617|FG001|COMPLETED|Overall Study||68
8820551|NCT01572389|9874616|FG000|NOT COMPLETED|Overall Study||46
8820552|NCT01572389|9874617|FG001|NOT COMPLETED|Overall Study||21
8820553|NCT01572428|9874625|FG000|STARTED|Overall Study||402
8820554|NCT01572428|9874626|FG001|STARTED|Overall Study||402
8820555|NCT01572428|9874625|FG000|COMPLETED|Overall Study||399
8820556|NCT01572428|9874626|FG001|COMPLETED|Overall Study||401
8820557|NCT01572428|9874625|FG000|NOT COMPLETED|Overall Study||3
8820558|NCT01572428|9874626|FG001|NOT COMPLETED|Overall Study||1
8556238|NCT01194219|9588106|FG009|STARTED|Maintenance Phase Weeks16-32||0
8556239|NCT01194219|9588097|FG000|Received Apremilast|Maintenance Phase Weeks16-32||0
8820559|NCT01572727|9874634|FG000|STARTED|Overall Study||207
8820560|NCT01572727|9874635|FG001|STARTED|Overall Study||209
8849372|NCT01740128|9904532|FG001|NOT COMPLETED|Overall Study||7
8556240|NCT01194219|9588098|FG001|Received Apremilast|Maintenance Phase Weeks16-32||0
8556241|NCT01194219|9588099|FG002|Received Apremilast|Maintenance Phase Weeks16-32|1 participant elected not to participate at the time the first dose was dispensed.|493
8556242|NCT01194219|9588100|FG003|Received Apremilast|Maintenance Phase Weeks16-32|1 participant elected not to participate at the time the first dose was dispensed.|244
8556243|NCT01194219|9588101|FG004|Received Apremilast|Maintenance Phase Weeks16-32||0
8556244|NCT01194219|9588102|FG005|Received Apremilast|Maintenance Phase Weeks16-32||0
8556245|NCT01194219|9588103|FG006|Received Apremilast|Maintenance Phase Weeks16-32||0
8556246|NCT01194219|9588104|FG007|Received Apremilast|Maintenance Phase Weeks16-32||0
8556247|NCT01194219|9588105|FG008|Received Apremilast|Maintenance Phase Weeks16-32||0
8621897|NCT00484185|9660978|FG000|STARTED|Overall Study||183
8621898|NCT00484185|9660978|FG000|Treated|Overall Study||178
8621899|NCT00484185|9660978|FG000|COMPLETED|Overall Study||112
8621900|NCT00484185|9660978|FG000|NOT COMPLETED|Overall Study||71
8621901|NCT00484198|9660986|FG000|STARTED|Overall Study||137
8621902|NCT00484198|9660987|FG001|STARTED|Overall Study||274
8621903|NCT00484198|9660988|FG002|STARTED|Overall Study||750
8621904|NCT00484198|9660989|FG003|STARTED|Overall Study||751
8621905|NCT00484198|9660986|FG000|COMPLETED|Overall Study||96
8820561|NCT01572727|9874634|FG000|Pts With Treatment + Safety Assessment|Overall Study|patients who received study treatment and had at least one post-baseline safety assessment|202
8820562|NCT01572727|9874635|FG001|Pts With Treatment + Safety Assessment|Overall Study|patients who received study treatment and had at least one post-baseline safety assessment|201
8820563|NCT01572727|9874634|FG000|COMPLETED|Overall Study||0
8820564|NCT01572727|9874635|FG001|COMPLETED|Overall Study||0
8820565|NCT01572727|9874634|FG000|NOT COMPLETED|Overall Study||207
8820566|NCT01572727|9874635|FG001|NOT COMPLETED|Overall Study||209
8820567|NCT01572740|9874643|FG000|STARTED|Overall Study||127
8820568|NCT01572740|9874644|FG001|STARTED|Overall Study||130
8820569|NCT01572740|9874643|FG000|COMPLETED|Overall Study||121
8820570|NCT01572740|9874644|FG001|COMPLETED|Overall Study||125
8820571|NCT01572740|9874643|FG000|NOT COMPLETED|Overall Study||6
8820572|NCT01572740|9874644|FG001|NOT COMPLETED|Overall Study||5
8820573|NCT01572792|9874655|FG000|STARTED|Lead-in Study||337
8820574|NCT01572792|9874656|FG001|STARTED|Lead-in Study||338
8820575|NCT01572792|9874657|FG002|STARTED|Lead-in Study||338
8820576|NCT01572792|9874658|FG003|STARTED|Lead-in Study||340
8820577|NCT01572792|9874659|FG004|STARTED|Lead-in Study||339
8820578|NCT01572792|9874655|FG000|COMPLETED|Lead-in Study||236
8820579|NCT01572792|9874656|FG001|COMPLETED|Lead-in Study||272
8820580|NCT01572792|9874657|FG002|COMPLETED|Lead-in Study||276
8820581|NCT01572792|9874658|FG003|COMPLETED|Lead-in Study||268
8820582|NCT01572792|9874659|FG004|COMPLETED|Lead-in Study||270
8820583|NCT01572792|9874655|FG000|NOT COMPLETED|Lead-in Study||101
8820584|NCT01572792|9874656|FG001|NOT COMPLETED|Lead-in Study||66
8820585|NCT01572792|9874657|FG002|NOT COMPLETED|Lead-in Study||62
8820586|NCT01572792|9874658|FG003|NOT COMPLETED|Lead-in Study||72
8820587|NCT01572792|9874659|FG004|NOT COMPLETED|Lead-in Study||69
8820588|NCT01572792|9874655|FG000|STARTED|Extension Study||146
8820589|NCT01572792|9874656|FG001|STARTED|Extension Study||184
8820590|NCT01572792|9874657|FG002|STARTED|Extension Study||205
8820591|NCT01572792|9874658|FG003|STARTED|Extension Study||194
8820592|NCT01572792|9874659|FG004|STARTED|Extension Study||192
8820593|NCT01572792|9874655|FG000|COMPLETED|Extension Study||121
8820594|NCT01572792|9874656|FG001|COMPLETED|Extension Study||155
8820595|NCT01572792|9874657|FG002|COMPLETED|Extension Study||179
8820596|NCT01572792|9874658|FG003|COMPLETED|Extension Study||165
8820597|NCT01572792|9874659|FG004|COMPLETED|Extension Study||160
8820598|NCT01572792|9874655|FG000|NOT COMPLETED|Extension Study||25
8820599|NCT01572792|9874656|FG001|NOT COMPLETED|Extension Study||29
8820600|NCT01572792|9874657|FG002|NOT COMPLETED|Extension Study||26
8820601|NCT01572792|9874658|FG003|NOT COMPLETED|Extension Study||29
8820602|NCT01572792|9874659|FG004|NOT COMPLETED|Extension Study||32
8820603|NCT01572844|9874672|FG000|STARTED|Overall Study||3
8820604|NCT01572844|9874673|FG001|STARTED|Overall Study||3
8820605|NCT01572844|9874672|FG000|COMPLETED|Overall Study||2
8820606|NCT01572844|9874673|FG001|COMPLETED|Overall Study||2
8820607|NCT01572844|9874672|FG000|NOT COMPLETED|Overall Study||1
8820608|NCT01572844|9874673|FG001|NOT COMPLETED|Overall Study||1
8820609|NCT01572909|9874684|FG000|STARTED|Overall Study||152
8820610|NCT01572909|9874685|FG001|STARTED|Overall Study||148
8820611|NCT01572909|9874684|FG000|COMPLETED|Overall Study||120
9065928|NCT04128293|10126437|FG003|COMPLETED|Washout Period 2 (Up to 7 Days)||0
9065929|NCT04128293|10126434|FG000|NOT COMPLETED|Washout Period 2 (Up to 7 Days)||4
9065930|NCT04128293|10126435|FG001|NOT COMPLETED|Washout Period 2 (Up to 7 Days)||4
9065931|NCT04128293|10126436|FG002|NOT COMPLETED|Washout Period 2 (Up to 7 Days)||4
9065932|NCT04128293|10126437|FG003|NOT COMPLETED|Washout Period 2 (Up to 7 Days)||4
9065933|NCT04128293|10126434|FG000|STARTED|Treatment Period 3 (1 Day)||0
9065934|NCT04128293|10126435|FG001|STARTED|Treatment Period 3 (1 Day)||0
9065935|NCT04128293|10126436|FG002|STARTED|Treatment Period 3 (1 Day)||0
9065936|NCT04128293|10126437|FG003|STARTED|Treatment Period 3 (1 Day)||0
9065937|NCT04128293|10126434|FG000|COMPLETED|Treatment Period 3 (1 Day)||0
9065938|NCT04128293|10126435|FG001|COMPLETED|Treatment Period 3 (1 Day)||0
8556248|NCT01194219|9588106|FG009|Received Apremilast|Maintenance Phase Weeks16-32||0
8820612|NCT01572909|9874685|FG001|COMPLETED|Overall Study||123
8820613|NCT01572909|9874684|FG000|NOT COMPLETED|Overall Study||32
8820614|NCT01572909|9874685|FG001|NOT COMPLETED|Overall Study||25
8820615|NCT01572922|9874693|FG000|STARTED|Overall Study||142
8556249|NCT01194219|9588097|FG000|COMPLETED|Maintenance Phase Weeks16-32||0
8556250|NCT01194219|9588098|FG001|COMPLETED|Maintenance Phase Weeks16-32||0
8556251|NCT01194219|9588099|FG002|COMPLETED|Maintenance Phase Weeks16-32||424
8556252|NCT01194219|9588100|FG003|COMPLETED|Maintenance Phase Weeks16-32||215
8556253|NCT01194219|9588101|FG004|COMPLETED|Maintenance Phase Weeks16-32||0
8556254|NCT01194219|9588102|FG005|COMPLETED|Maintenance Phase Weeks16-32||0
8556255|NCT01194219|9588103|FG006|COMPLETED|Maintenance Phase Weeks16-32||0
8556256|NCT01194219|9588104|FG007|COMPLETED|Maintenance Phase Weeks16-32||0
8556257|NCT01194219|9588105|FG008|COMPLETED|Maintenance Phase Weeks16-32||0
8556258|NCT01194219|9588106|FG009|COMPLETED|Maintenance Phase Weeks16-32||0
8556259|NCT01194219|9588097|FG000|NOT COMPLETED|Maintenance Phase Weeks16-32||0
8556260|NCT01194219|9588098|FG001|NOT COMPLETED|Maintenance Phase Weeks16-32||0
8556261|NCT01194219|9588099|FG002|NOT COMPLETED|Maintenance Phase Weeks16-32||70
8556262|NCT01194219|9588100|FG003|NOT COMPLETED|Maintenance Phase Weeks16-32||30
8556263|NCT01194219|9588101|FG004|NOT COMPLETED|Maintenance Phase Weeks16-32||0
8556264|NCT01194219|9588102|FG005|NOT COMPLETED|Maintenance Phase Weeks16-32||0
8556265|NCT01194219|9588103|FG006|NOT COMPLETED|Maintenance Phase Weeks16-32||0
8556266|NCT01194219|9588104|FG007|NOT COMPLETED|Maintenance Phase Weeks16-32||0
8556267|NCT01194219|9588105|FG008|NOT COMPLETED|Maintenance Phase Weeks16-32||0
8556268|NCT01194219|9588106|FG009|NOT COMPLETED|Maintenance Phase Weeks16-32||0
8556269|NCT01194219|9588097|FG000|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
8556270|NCT01194219|9588098|FG001|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
8556271|NCT01194219|9588099|FG002|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
8556272|NCT01194219|9588100|FG003|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
8556273|NCT01194219|9588101|FG004|STARTED|Randomized Withdrawal Phase-Weeks 32-52|7 participants discontinued after week 32 but prior to entry into the Randomized withdrawal Phase|77
8556274|NCT01194219|9588102|FG005|STARTED|Randomized Withdrawal Phase-Weeks 32-52|25 participants discontinued after week 32 but prior to entry into the Randomized withdrawal Phase|77
8556275|NCT01194219|9588103|FG006|STARTED|Randomized Withdrawal Phase-Weeks 32-52||245
8556276|NCT01194219|9588104|FG007|STARTED|Randomized Withdrawal Phase-Weeks 32-52||208
8556277|NCT01194219|9588105|FG008|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
8556278|NCT01194219|9588106|FG009|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
8556279|NCT01194219|9588097|FG000|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
8556280|NCT01194219|9588098|FG001|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
8556281|NCT01194219|9588099|FG002|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
8556282|NCT01194219|9588100|FG003|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
8556283|NCT01194219|9588101|FG004|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
8556284|NCT01194219|9588102|FG005|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
8556285|NCT01194219|9588103|FG006|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||126
8556286|NCT01194219|9588104|FG007|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||91
8556287|NCT01194219|9588105|FG008|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
8556288|NCT01194219|9588106|FG009|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
8556289|NCT01194219|9588097|FG000|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
8556290|NCT01194219|9588098|FG001|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
8556291|NCT01194219|9588099|FG002|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
8556292|NCT01194219|9588100|FG003|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
8556293|NCT01194219|9588101|FG004|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52|1 participant discontinued after Week 52 but prior to entry into the long term extension study|73
8556294|NCT01194219|9588102|FG005|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52|5 participants discontinued after Week 52 but prior to entry into the long term extension study|73
8556295|NCT01194219|9588103|FG006|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52|18 participants discontinued after Week 52 but prior to entry into the long term extension study|184
8556296|NCT01194219|9588104|FG007|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52|10 participants discontinued after Week 52 but prior to entry into the long term extension study|163
8556297|NCT01194219|9588105|FG008|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
8556298|NCT01194219|9588106|FG009|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
8820616|NCT01572922|9874693|FG000|COMPLETED|Overall Study||139
8820617|NCT01572922|9874693|FG000|NOT COMPLETED|Overall Study||3
8820618|NCT01572948|9874704|FG000|STARTED|Overall Study||11
8820619|NCT01572948|9874705|FG001|STARTED|Overall Study||16
8820620|NCT01572948|9874704|FG000|COMPLETED|Overall Study||10
8820621|NCT01572948|9874705|FG001|COMPLETED|Overall Study||15
8820622|NCT01572948|9874704|FG000|NOT COMPLETED|Overall Study||1
8820623|NCT01572948|9874705|FG001|NOT COMPLETED|Overall Study||1
8820624|NCT01573000|9874717|FG000|STARTED|Dosimetric and Therapeutic Treatment||42
8820625|NCT01573000|9874718|FG001|STARTED|Dosimetric and Therapeutic Treatment||36
8820626|NCT01573000|9874717|FG000|COMPLETED|Dosimetric and Therapeutic Treatment|These participants completed 2 years of follow up and enrolled in BEX104526.|7
8820627|NCT01573000|9874718|FG001|COMPLETED|Dosimetric and Therapeutic Treatment|These participants completed 2 years of follow up and enrolled in BEX104526.|1
8820628|NCT01573000|9874717|FG000|NOT COMPLETED|Dosimetric and Therapeutic Treatment||35
8820629|NCT01573000|9874718|FG001|NOT COMPLETED|Dosimetric and Therapeutic Treatment||35
8820630|NCT01573000|9874717|FG000|STARTED|Crossover Phase||0
8820631|NCT01573000|9874718|FG001|STARTED|Crossover Phase|19 of 36 par. randomized to receive Unlabeled TST crossed over to receive TST and Iodine I 131 TST.|19
8820632|NCT01573000|9874717|FG000|COMPLETED|Crossover Phase||0
8556299|NCT01194219|9588097|FG000|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
8556300|NCT01194219|9588098|FG001|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
8556301|NCT01194219|9588099|FG002|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
8556302|NCT01194219|9588100|FG003|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
8556303|NCT01194219|9588101|FG004|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||4
8556304|NCT01194219|9588102|FG005|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||4
8556305|NCT01194219|9588103|FG006|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||61
8556306|NCT01194219|9588104|FG007|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||45
8556307|NCT01194219|9588105|FG008|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
8556308|NCT01194219|9588106|FG009|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
8556309|NCT01194219|9588097|FG000|STARTED|Long-Term Extension Weeks 52 to 260||0
8556310|NCT01194219|9588098|FG001|STARTED|Long-Term Extension Weeks 52 to 260||0
8556311|NCT01194219|9588099|FG002|STARTED|Long-Term Extension Weeks 52 to 260||0
8556312|NCT01194219|9588100|FG003|STARTED|Long-Term Extension Weeks 52 to 260||0
8556313|NCT01194219|9588101|FG004|STARTED|Long-Term Extension Weeks 52 to 260||0
8556314|NCT01194219|9588102|FG005|STARTED|Long-Term Extension Weeks 52 to 260||0
8556315|NCT01194219|9588103|FG006|STARTED|Long-Term Extension Weeks 52 to 260||0
8556316|NCT01194219|9588104|FG007|STARTED|Long-Term Extension Weeks 52 to 260||0
8556317|NCT01194219|9588105|FG008|STARTED|Long-Term Extension Weeks 52 to 260||306
8556318|NCT01194219|9588106|FG009|STARTED|Long-Term Extension Weeks 52 to 260||153
8556319|NCT01194219|9588097|FG000|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
8556320|NCT01194219|9588098|FG001|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
8556321|NCT01194219|9588099|FG002|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
8556322|NCT01194219|9588100|FG003|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
8556323|NCT01194219|9588101|FG004|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
8556324|NCT01194219|9588102|FG005|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
8556325|NCT01194219|9588103|FG006|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
8556326|NCT01194219|9588104|FG007|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
8556327|NCT01194219|9588105|FG008|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||304
8556328|NCT01194219|9588106|FG009|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||153
8556329|NCT01194219|9588097|FG000|COMPLETED|Long-Term Extension Weeks 52 to 260||0
8556330|NCT01194219|9588098|FG001|COMPLETED|Long-Term Extension Weeks 52 to 260||0
8556331|NCT01194219|9588099|FG002|COMPLETED|Long-Term Extension Weeks 52 to 260||0
8556332|NCT01194219|9588100|FG003|COMPLETED|Long-Term Extension Weeks 52 to 260||0
8556333|NCT01194219|9588101|FG004|COMPLETED|Long-Term Extension Weeks 52 to 260||0
8556334|NCT01194219|9588102|FG005|COMPLETED|Long-Term Extension Weeks 52 to 260||0
8556335|NCT01194219|9588103|FG006|COMPLETED|Long-Term Extension Weeks 52 to 260||0
8556336|NCT01194219|9588104|FG007|COMPLETED|Long-Term Extension Weeks 52 to 260||0
8556337|NCT01194219|9588105|FG008|COMPLETED|Long-Term Extension Weeks 52 to 260||86
8556338|NCT01194219|9588106|FG009|COMPLETED|Long-Term Extension Weeks 52 to 260||41
8556339|NCT01194219|9588097|FG000|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
8556340|NCT01194219|9588098|FG001|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
8621906|NCT00484198|9660987|FG001|COMPLETED|Overall Study||208
8621907|NCT00484198|9660988|FG002|COMPLETED|Overall Study||599
8621908|NCT00484198|9660989|FG003|COMPLETED|Overall Study||579
8621909|NCT00484198|9660986|FG000|NOT COMPLETED|Overall Study||41
8621910|NCT00484198|9660987|FG001|NOT COMPLETED|Overall Study||66
8621911|NCT00484198|9660988|FG002|NOT COMPLETED|Overall Study||151
8621912|NCT00484198|9660989|FG003|NOT COMPLETED|Overall Study||172
8621913|NCT00484289|9661007|FG000|STARTED|Long Term Phase||13
8621914|NCT00484289|9661008|FG001|STARTED|Long Term Phase||178
8820633|NCT01573000|9874718|FG001|COMPLETED|Crossover Phase|This participant completed 2 years of follow up and enrolled in BEX104526.|1
8820634|NCT01573000|9874717|FG000|NOT COMPLETED|Crossover Phase||0
8820635|NCT01573000|9874718|FG001|NOT COMPLETED|Crossover Phase||18
8820636|NCT01573000|9874717|FG000|STARTED|Long-Term Follow-Up|14 of the 35 participants withdrawing from Study BEX104515 enrolled in long-term follow-up study.|14
8820637|NCT01573000|9874718|FG001|STARTED|Long-Term Follow-Up|5 of the 35 participants withdrawing from Study BEX104515 enrolled in long-term follow-up study.|5
8820638|NCT01573000|9874717|FG000|COMPLETED|Long-Term Follow-Up||11
8820639|NCT01573000|9874718|FG001|COMPLETED|Long-Term Follow-Up|One participant who received crossover treatment was lost to follow up.|4
8820640|NCT01573000|9874717|FG000|NOT COMPLETED|Long-Term Follow-Up||3
8820641|NCT01573000|9874718|FG001|NOT COMPLETED|Long-Term Follow-Up||1
8820642|NCT01573052|9874730|FG000|STARTED|Overall Study||9
8820643|NCT01573052|9874731|FG001|STARTED|Overall Study||17
8820644|NCT01573052|9874730|FG000|COMPLETED|Overall Study||6
8820645|NCT01573052|9874731|FG001|COMPLETED|Overall Study||11
8820646|NCT01573052|9874730|FG000|NOT COMPLETED|Overall Study||3
8820647|NCT01573052|9874731|FG001|NOT COMPLETED|Overall Study||6
8820648|NCT01573169|9874740|FG000|STARTED|Overall Study||38
8820649|NCT01573169|9874741|FG001|STARTED|Overall Study||35
8820650|NCT01573169|9874740|FG000|COMPLETED|Overall Study||38
8820651|NCT01573169|9874741|FG001|COMPLETED|Overall Study||35
8820652|NCT01573169|9874740|FG000|NOT COMPLETED|Overall Study||0
8820653|NCT01573169|9874741|FG001|NOT COMPLETED|Overall Study||0
8820654|NCT01573260|9874749|FG000|STARTED|Overall Study||18
8820655|NCT01573260|9874750|FG001|STARTED|Overall Study||15
8556341|NCT01194219|9588099|FG002|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
8556342|NCT01194219|9588100|FG003|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
8556343|NCT01194219|9588101|FG004|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
8556344|NCT01194219|9588102|FG005|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
8556345|NCT01194219|9588103|FG006|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
8556346|NCT01194219|9588104|FG007|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
8556347|NCT01194219|9588105|FG008|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||220
8556348|NCT01194219|9588106|FG009|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||112
8556349|NCT01193842|9588134|FG000|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||3
8556350|NCT01193842|9588135|FG001|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
8556351|NCT01193842|9588136|FG002|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
8556352|NCT01193842|9588137|FG003|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
8556353|NCT01193842|9588138|FG004|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
8556354|NCT01193842|9588134|FG000|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||3
8556355|NCT01193842|9588135|FG001|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
8556356|NCT01193842|9588136|FG002|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
8556357|NCT01193842|9588137|FG003|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
8556358|NCT01193842|9588138|FG004|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
8556359|NCT01193842|9588134|FG000|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
8556360|NCT01193842|9588135|FG001|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
8556361|NCT01193842|9588136|FG002|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
8556362|NCT01193842|9588137|FG003|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
8556363|NCT01193842|9588138|FG004|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
8556364|NCT01193842|9588134|FG000|STARTED|Phase I: VR-DA-EPOCH, DL 2||0
8556365|NCT01193842|9588135|FG001|STARTED|Phase I: VR-DA-EPOCH, DL 2||7
8556366|NCT01193842|9588136|FG002|STARTED|Phase I: VR-DA-EPOCH, DL 2||0
8556367|NCT01193842|9588137|FG003|STARTED|Phase I: VR-DA-EPOCH, DL 2||0
8556368|NCT01193842|9588138|FG004|STARTED|Phase I: VR-DA-EPOCH, DL 2||0
8556369|NCT01193842|9588134|FG000|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
8556370|NCT01193842|9588135|FG001|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||6
8556371|NCT01193842|9588136|FG002|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
8820656|NCT01573260|9874749|FG000|COMPLETED|Overall Study||18
8820657|NCT01573260|9874750|FG001|COMPLETED|Overall Study||15
8820658|NCT01573260|9874749|FG000|NOT COMPLETED|Overall Study||0
8820659|NCT01573260|9874750|FG001|NOT COMPLETED|Overall Study||0
8820660|NCT01573273|9874762|FG000|STARTED|TSST : Trier Social Stress Task||24
8820661|NCT01573273|9874763|FG001|STARTED|TSST : Trier Social Stress Task||25
8820662|NCT01573273|9874764|FG002|STARTED|TSST : Trier Social Stress Task||0
8820663|NCT01573273|9874765|FG003|STARTED|TSST : Trier Social Stress Task||0
8820664|NCT01573273|9874766|FG004|STARTED|TSST : Trier Social Stress Task||0
8820665|NCT01573273|9874767|FG005|STARTED|TSST : Trier Social Stress Task||0
8820666|NCT01573273|9874768|FG006|STARTED|TSST : Trier Social Stress Task||32
8820667|NCT01573273|9874769|FG007|STARTED|TSST : Trier Social Stress Task||31
8820668|NCT01573273|9874770|FG008|STARTED|TSST : Trier Social Stress Task||0
8820669|NCT01573273|9874771|FG009|STARTED|TSST : Trier Social Stress Task||0
8820670|NCT01573273|9874772|FG010|STARTED|TSST : Trier Social Stress Task||0
8820671|NCT01573273|9874773|FG011|STARTED|TSST : Trier Social Stress Task||0
8820672|NCT01573273|9874762|FG000|COMPLETED|TSST : Trier Social Stress Task||24
8820673|NCT01573273|9874763|FG001|COMPLETED|TSST : Trier Social Stress Task||25
8820674|NCT01573273|9874764|FG002|COMPLETED|TSST : Trier Social Stress Task||0
8820675|NCT01573273|9874765|FG003|COMPLETED|TSST : Trier Social Stress Task||0
8820676|NCT01573273|9874766|FG004|COMPLETED|TSST : Trier Social Stress Task||0
8820677|NCT01573273|9874767|FG005|COMPLETED|TSST : Trier Social Stress Task||0
8820678|NCT01573273|9874768|FG006|COMPLETED|TSST : Trier Social Stress Task||32
8820679|NCT01573273|9874769|FG007|COMPLETED|TSST : Trier Social Stress Task||31
8820680|NCT01573273|9874770|FG008|COMPLETED|TSST : Trier Social Stress Task||0
8820681|NCT01573273|9874771|FG009|COMPLETED|TSST : Trier Social Stress Task||0
8820682|NCT01573273|9874772|FG010|COMPLETED|TSST : Trier Social Stress Task||0
8820683|NCT01573273|9874773|FG011|COMPLETED|TSST : Trier Social Stress Task||0
8820684|NCT01573273|9874762|FG000|NOT COMPLETED|TSST : Trier Social Stress Task||0
8820685|NCT01573273|9874763|FG001|NOT COMPLETED|TSST : Trier Social Stress Task||0
8820686|NCT01573273|9874764|FG002|NOT COMPLETED|TSST : Trier Social Stress Task||0
8820687|NCT01573273|9874765|FG003|NOT COMPLETED|TSST : Trier Social Stress Task||0
8820688|NCT01573273|9874766|FG004|NOT COMPLETED|TSST : Trier Social Stress Task||0
8820689|NCT01573273|9874767|FG005|NOT COMPLETED|TSST : Trier Social Stress Task||0
8820690|NCT01573273|9874768|FG006|NOT COMPLETED|TSST : Trier Social Stress Task||0
8820691|NCT01573273|9874769|FG007|NOT COMPLETED|TSST : Trier Social Stress Task||0
8820692|NCT01573273|9874770|FG008|NOT COMPLETED|TSST : Trier Social Stress Task||0
8820693|NCT01573273|9874771|FG009|NOT COMPLETED|TSST : Trier Social Stress Task||0
8820694|NCT01573273|9874772|FG010|NOT COMPLETED|TSST : Trier Social Stress Task||0
8820695|NCT01573273|9874773|FG011|NOT COMPLETED|TSST : Trier Social Stress Task||0
8820696|NCT01573273|9874762|FG000|STARTED|MRI 1||0
8820697|NCT01573273|9874763|FG001|STARTED|MRI 1||0
8556372|NCT01193842|9588137|FG003|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
8556373|NCT01193842|9588138|FG004|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
8820698|NCT01573273|9874764|FG002|STARTED|MRI 1||19
8820699|NCT01573273|9874765|FG003|STARTED|MRI 1||23
8820700|NCT01573273|9874766|FG004|STARTED|MRI 1||0
8820701|NCT01573273|9874767|FG005|STARTED|MRI 1||0
8820702|NCT01573273|9874768|FG006|STARTED|MRI 1||0
8556374|NCT01193842|9588134|FG000|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
8556375|NCT01193842|9588135|FG001|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||1
8556376|NCT01193842|9588136|FG002|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
8556377|NCT01193842|9588137|FG003|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
8556378|NCT01193842|9588138|FG004|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
8556379|NCT01193842|9588134|FG000|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||4
8556380|NCT01193842|9588135|FG001|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
8556381|NCT01193842|9588136|FG002|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
8556382|NCT01193842|9588137|FG003|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
8556383|NCT01193842|9588138|FG004|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
8556384|NCT01193842|9588134|FG000|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||3
8556385|NCT01193842|9588135|FG001|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
8556386|NCT01193842|9588136|FG002|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
8556387|NCT01193842|9588137|FG003|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
8556388|NCT01193842|9588138|FG004|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
8556389|NCT01193842|9588134|FG000|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||1
8556390|NCT01193842|9588135|FG001|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
8556391|NCT01193842|9588136|FG002|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
8556392|NCT01193842|9588137|FG003|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
8556393|NCT01193842|9588138|FG004|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
8556394|NCT01193842|9588134|FG000|STARTED|Phase I: VR-CHOP, DL 1||0
8556395|NCT01193842|9588135|FG001|STARTED|Phase I: VR-CHOP, DL 1||0
8556396|NCT01193842|9588136|FG002|STARTED|Phase I: VR-CHOP, DL 1||2
8556397|NCT01193842|9588137|FG003|STARTED|Phase I: VR-CHOP, DL 1||0
8556398|NCT01193842|9588138|FG004|STARTED|Phase I: VR-CHOP, DL 1||0
8556399|NCT01193842|9588134|FG000|COMPLETED|Phase I: VR-CHOP, DL 1||0
8820703|NCT01573273|9874769|FG007|STARTED|MRI 1||0
8820704|NCT01573273|9874770|FG008|STARTED|MRI 1||28
8820705|NCT01573273|9874771|FG009|STARTED|MRI 1||29
8820706|NCT01573273|9874772|FG010|STARTED|MRI 1||0
8820707|NCT01573273|9874773|FG011|STARTED|MRI 1||0
8820708|NCT01573273|9874762|FG000|COMPLETED|MRI 1||0
8820709|NCT01573273|9874763|FG001|COMPLETED|MRI 1||0
8820710|NCT01573273|9874764|FG002|COMPLETED|MRI 1||19
8820711|NCT01573273|9874765|FG003|COMPLETED|MRI 1||23
8820712|NCT01573273|9874766|FG004|COMPLETED|MRI 1||0
8820713|NCT01573273|9874767|FG005|COMPLETED|MRI 1||0
8820714|NCT01573273|9874768|FG006|COMPLETED|MRI 1||0
8820715|NCT01573273|9874769|FG007|COMPLETED|MRI 1||0
8820716|NCT01573273|9874770|FG008|COMPLETED|MRI 1||28
8820717|NCT01573273|9874771|FG009|COMPLETED|MRI 1||29
8820718|NCT01573273|9874772|FG010|COMPLETED|MRI 1||0
8820719|NCT01573273|9874773|FG011|COMPLETED|MRI 1||0
8820720|NCT01573273|9874762|FG000|NOT COMPLETED|MRI 1||0
8820721|NCT01573273|9874763|FG001|NOT COMPLETED|MRI 1||0
8820722|NCT01573273|9874764|FG002|NOT COMPLETED|MRI 1||0
8820723|NCT01573273|9874765|FG003|NOT COMPLETED|MRI 1||0
8820724|NCT01573273|9874766|FG004|NOT COMPLETED|MRI 1||0
8820725|NCT01573273|9874767|FG005|NOT COMPLETED|MRI 1||0
8820726|NCT01573273|9874768|FG006|NOT COMPLETED|MRI 1||0
8820727|NCT01573273|9874769|FG007|NOT COMPLETED|MRI 1||0
8820728|NCT01573273|9874770|FG008|NOT COMPLETED|MRI 1||0
8820729|NCT01573273|9874771|FG009|NOT COMPLETED|MRI 1||0
8820730|NCT01573273|9874772|FG010|NOT COMPLETED|MRI 1||0
8820731|NCT01573273|9874773|FG011|NOT COMPLETED|MRI 1||0
8820732|NCT01573273|9874762|FG000|STARTED|MRI 2||0
8820733|NCT01573273|9874763|FG001|STARTED|MRI 2||0
8820734|NCT01573273|9874764|FG002|STARTED|MRI 2||0
8820735|NCT01573273|9874765|FG003|STARTED|MRI 2||0
8820736|NCT01573273|9874766|FG004|STARTED|MRI 2||23
8820737|NCT01573273|9874767|FG005|STARTED|MRI 2||18
8820738|NCT01573273|9874768|FG006|STARTED|MRI 2||0
8820739|NCT01573273|9874769|FG007|STARTED|MRI 2||0
8820740|NCT01573273|9874770|FG008|STARTED|MRI 2||0
8820741|NCT01573273|9874771|FG009|STARTED|MRI 2||0
8820742|NCT01573273|9874772|FG010|STARTED|MRI 2||27
8820743|NCT01573273|9874773|FG011|STARTED|MRI 2||28
8820744|NCT01573273|9874762|FG000|COMPLETED|MRI 2||0
8820745|NCT01573273|9874763|FG001|COMPLETED|MRI 2||0
8820746|NCT01573273|9874764|FG002|COMPLETED|MRI 2||0
8820747|NCT01573273|9874765|FG003|COMPLETED|MRI 2||0
8556400|NCT01193842|9588135|FG001|COMPLETED|Phase I: VR-CHOP, DL 1||0
8556401|NCT01193842|9588136|FG002|COMPLETED|Phase I: VR-CHOP, DL 1||1
8556402|NCT01193842|9588137|FG003|COMPLETED|Phase I: VR-CHOP, DL 1||0
8820748|NCT01573273|9874766|FG004|COMPLETED|MRI 2||23
8820749|NCT01573273|9874767|FG005|COMPLETED|MRI 2||18
8820750|NCT01573273|9874768|FG006|COMPLETED|MRI 2||0
8820751|NCT01573273|9874769|FG007|COMPLETED|MRI 2||0
8820752|NCT01573273|9874770|FG008|COMPLETED|MRI 2||0
8820753|NCT01573273|9874771|FG009|COMPLETED|MRI 2||0
8820754|NCT01573273|9874772|FG010|COMPLETED|MRI 2||27
8820755|NCT01573273|9874773|FG011|COMPLETED|MRI 2||28
8820756|NCT01573273|9874762|FG000|NOT COMPLETED|MRI 2||0
8820757|NCT01573273|9874763|FG001|NOT COMPLETED|MRI 2||0
8820758|NCT01573273|9874764|FG002|NOT COMPLETED|MRI 2||0
8820759|NCT01573273|9874765|FG003|NOT COMPLETED|MRI 2||0
8820760|NCT01573273|9874766|FG004|NOT COMPLETED|MRI 2||0
8820761|NCT01573273|9874767|FG005|NOT COMPLETED|MRI 2||0
8820762|NCT01573273|9874768|FG006|NOT COMPLETED|MRI 2||0
8820763|NCT01573273|9874769|FG007|NOT COMPLETED|MRI 2||0
8820764|NCT01573273|9874770|FG008|NOT COMPLETED|MRI 2||0
8820765|NCT01573273|9874771|FG009|NOT COMPLETED|MRI 2||0
8820766|NCT01573273|9874772|FG010|NOT COMPLETED|MRI 2||0
8820767|NCT01573273|9874773|FG011|NOT COMPLETED|MRI 2||0
8556403|NCT01193842|9588138|FG004|COMPLETED|Phase I: VR-CHOP, DL 1||0
8556404|NCT01193842|9588134|FG000|NOT COMPLETED|Phase I: VR-CHOP, DL 1||0
8556405|NCT01193842|9588135|FG001|NOT COMPLETED|Phase I: VR-CHOP, DL 1||0
8556406|NCT01193842|9588136|FG002|NOT COMPLETED|Phase I: VR-CHOP, DL 1||1
8556407|NCT01193842|9588137|FG003|NOT COMPLETED|Phase I: VR-CHOP, DL 1||0
8556408|NCT01193842|9588138|FG004|NOT COMPLETED|Phase I: VR-CHOP, DL 1||0
8556409|NCT01193842|9588134|FG000|STARTED|Phase II: Randomized Groups||0
8556410|NCT01193842|9588135|FG001|STARTED|Phase II: Randomized Groups||0
8556411|NCT01193842|9588136|FG002|STARTED|Phase II: Randomized Groups||0
8556412|NCT01193842|9588137|FG003|STARTED|Phase II: Randomized Groups||45
8556413|NCT01193842|9588138|FG004|STARTED|Phase II: Randomized Groups||46
8556414|NCT01193842|9588134|FG000|COMPLETED|Phase II: Randomized Groups||0
8556415|NCT01193842|9588135|FG001|COMPLETED|Phase II: Randomized Groups||0
8556416|NCT01193842|9588136|FG002|COMPLETED|Phase II: Randomized Groups||0
8556417|NCT01193842|9588137|FG003|COMPLETED|Phase II: Randomized Groups||33
8556418|NCT01193842|9588138|FG004|COMPLETED|Phase II: Randomized Groups||36
8556419|NCT01193842|9588134|FG000|NOT COMPLETED|Phase II: Randomized Groups||0
8556420|NCT01193842|9588135|FG001|NOT COMPLETED|Phase II: Randomized Groups||0
8621915|NCT00484289|9661009|FG002|STARTED|Long Term Phase||26
8621916|NCT00484289|9661007|FG000|COMPLETED|Long Term Phase|Completed participants entered postmarketing phase.|10
8621917|NCT00484289|9661008|FG001|COMPLETED|Long Term Phase|Completed participants entered postmarketing phase.|142
8621918|NCT00484289|9661009|FG002|COMPLETED|Long Term Phase|Completed participants entered postmarketing phase.|10
8820768|NCT01573325|9874799|FG000|STARTED|Overall Study||50
8820769|NCT01573325|9874799|FG000|COMPLETED|Overall Study||50
8820770|NCT01573325|9874799|FG000|NOT COMPLETED|Overall Study||0
8820771|NCT01573442|9874806|FG000|STARTED|Overall Study||113
8820772|NCT01573442|9874807|FG001|STARTED|Overall Study||114
8820773|NCT01573442|9874806|FG000|COMPLETED|Overall Study||104
8820774|NCT01573442|9874807|FG001|COMPLETED|Overall Study||104
8820775|NCT01573442|9874806|FG000|NOT COMPLETED|Overall Study||9
8820776|NCT01573442|9874807|FG001|NOT COMPLETED|Overall Study||10
8820777|NCT01573533|9874813|FG000|STARTED|Overall Study||9
8820778|NCT01573533|9874813|FG000|COMPLETED|Overall Study||9
8820779|NCT01573533|9874813|FG000|NOT COMPLETED|Overall Study||0
8820780|NCT01573572|9874817|FG000|STARTED|Overall Study||131
8820781|NCT01573572|9874817|FG000|COMPLETED|Overall Study||103
8820782|NCT01573572|9874817|FG000|NOT COMPLETED|Overall Study||28
8820783|NCT01573624|9874821|FG000|STARTED|Period 1 : Treatment Period 1 (14 Days)||64
8820784|NCT01573624|9874822|FG001|STARTED|Period 1 : Treatment Period 1 (14 Days)||62
8820785|NCT01573624|9874823|FG002|STARTED|Period 1 : Treatment Period 1 (14 Days)||60
8820786|NCT01573624|9874824|FG003|STARTED|Period 1 : Treatment Period 1 (14 Days)||63
8820787|NCT01573624|9874825|FG004|STARTED|Period 1 : Treatment Period 1 (14 Days)||58
8820788|NCT01573624|9874826|FG005|STARTED|Period 1 : Treatment Period 1 (14 Days)||55
8820789|NCT01573624|9874827|FG006|STARTED|Period 1 : Treatment Period 1 (14 Days)||59
8820790|NCT01573624|9874821|FG000|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||58
8820791|NCT01573624|9874822|FG001|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||59
8820792|NCT01573624|9874823|FG002|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||51
8820793|NCT01573624|9874824|FG003|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||61
8820794|NCT01573624|9874825|FG004|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||56
8820795|NCT01573624|9874826|FG005|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||51
8820796|NCT01573624|9874827|FG006|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||57
8820797|NCT01573624|9874821|FG000|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||6
8820798|NCT01573624|9874822|FG001|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||3
8820799|NCT01573624|9874823|FG002|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||9
8820800|NCT01573624|9874824|FG003|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||2
8820801|NCT01573624|9874825|FG004|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||2
8820802|NCT01573624|9874826|FG005|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||4
8820803|NCT01573624|9874827|FG006|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||2
8820804|NCT01573624|9874821|FG000|STARTED|Period 2 : Washout Period 1 (12-14 Days)||58
8820805|NCT01573624|9874822|FG001|STARTED|Period 2 : Washout Period 1 (12-14 Days)||59
8820806|NCT01573624|9874823|FG002|STARTED|Period 2 : Washout Period 1 (12-14 Days)||51
8820807|NCT01573624|9874824|FG003|STARTED|Period 2 : Washout Period 1 (12-14 Days)||61
8820808|NCT01573624|9874825|FG004|STARTED|Period 2 : Washout Period 1 (12-14 Days)||56
8943811|NCT02391948|10005624|FG003|NOT COMPLETED|12-month Assessment||9
8943812|NCT02391948|10005625|FG004|NOT COMPLETED|12-month Assessment||6
8943813|NCT02391948|10005621|FG000|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 2 of the Not Completed remained active.|219
8943814|NCT02391948|10005622|FG001|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 4 of the Not Completed remained active.|151
8943815|NCT02391948|10005623|FG002|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 1 of the Not Completed remained active.|74
8948745|NCT02432274|10011220|FG003|Underwent Run-in Period|Overall Study||0
8556421|NCT01193842|9588136|FG002|NOT COMPLETED|Phase II: Randomized Groups||0
8820809|NCT01573624|9874826|FG005|STARTED|Period 2 : Washout Period 1 (12-14 Days)||51
8820810|NCT01573624|9874827|FG006|STARTED|Period 2 : Washout Period 1 (12-14 Days)||57
8820811|NCT01573624|9874821|FG000|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||57
8820812|NCT01573624|9874822|FG001|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||58
8556422|NCT01193842|9588137|FG003|NOT COMPLETED|Phase II: Randomized Groups||12
8820813|NCT01573624|9874823|FG002|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||48
8556423|NCT01193842|9588138|FG004|NOT COMPLETED|Phase II: Randomized Groups||10
8556424|NCT00855803|9588155|FG000|STARTED|Overall Study||35
8556425|NCT00855803|9588155|FG000|COMPLETED|Overall Study||21
8556426|NCT00855803|9588155|FG000|NOT COMPLETED|Overall Study||14
8556427|NCT00790803|9588159|FG000|STARTED|Overall Study||5
8556428|NCT00790803|9588159|FG000|COMPLETED|Overall Study||5
8556429|NCT00790803|9588159|FG000|NOT COMPLETED|Overall Study||0
8556430|NCT00740116|9588165|FG000|STARTED|Overall Study||50
8556431|NCT00740116|9588166|FG001|STARTED|Overall Study||50
8556432|NCT00740116|9588165|FG000|COMPLETED|Overall Study||48
8556433|NCT00740116|9588166|FG001|COMPLETED|Overall Study||45
8556434|NCT00740116|9588165|FG000|NOT COMPLETED|Overall Study||2
8556435|NCT00740116|9588166|FG001|NOT COMPLETED|Overall Study||5
8556436|NCT00565617|9588174|FG000|STARTED|Overall Study||6
8556437|NCT00565617|9588174|FG000|COMPLETED|Overall Study||5
8556438|NCT00565617|9588174|FG000|NOT COMPLETED|Overall Study||1
8556439|NCT00470704|9588180|FG000|STARTED|Overall Study||41
8556440|NCT00470704|9588181|FG001|STARTED|Overall Study||46
8621919|NCT00484289|9661007|FG000|NOT COMPLETED|Long Term Phase||3
8621920|NCT00484289|9661008|FG001|NOT COMPLETED|Long Term Phase||36
8820814|NCT01573624|9874824|FG003|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||56
8820815|NCT01573624|9874825|FG004|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||56
8820816|NCT01573624|9874826|FG005|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||48
8820817|NCT01573624|9874827|FG006|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||55
8820818|NCT01573624|9874821|FG000|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||1
8820819|NCT01573624|9874822|FG001|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||1
8820820|NCT01573624|9874823|FG002|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||3
8820821|NCT01573624|9874824|FG003|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||5
8820822|NCT01573624|9874825|FG004|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||0
8820823|NCT01573624|9874826|FG005|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||3
8820824|NCT01573624|9874827|FG006|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||2
8820825|NCT01573624|9874821|FG000|STARTED|Period 3 : Treatment Period 2 (14 Days)||57
8820826|NCT01573624|9874822|FG001|STARTED|Period 3 : Treatment Period 2 (14 Days)||58
8820827|NCT01573624|9874823|FG002|STARTED|Period 3 : Treatment Period 2 (14 Days)||48
8820828|NCT01573624|9874824|FG003|STARTED|Period 3 : Treatment Period 2 (14 Days)||56
8820829|NCT01573624|9874825|FG004|STARTED|Period 3 : Treatment Period 2 (14 Days)||56
8820830|NCT01573624|9874826|FG005|STARTED|Period 3 : Treatment Period 2 (14 Days)||48
8820831|NCT01573624|9874827|FG006|STARTED|Period 3 : Treatment Period 2 (14 Days)||55
8820832|NCT01573624|9874821|FG000|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||50
8820833|NCT01573624|9874822|FG001|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||52
8820834|NCT01573624|9874823|FG002|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||45
8820835|NCT01573624|9874824|FG003|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||55
8820836|NCT01573624|9874825|FG004|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||53
8820837|NCT01573624|9874826|FG005|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||43
8820838|NCT01573624|9874827|FG006|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||55
8820839|NCT01573624|9874821|FG000|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||7
8820840|NCT01573624|9874822|FG001|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||6
8820841|NCT01573624|9874823|FG002|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||3
8820842|NCT01573624|9874824|FG003|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||1
8820843|NCT01573624|9874825|FG004|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||3
8820844|NCT01573624|9874826|FG005|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||5
8820845|NCT01573624|9874827|FG006|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||0
8820846|NCT01573624|9874821|FG000|STARTED|Period 4 : Washout Period 2 (12-14 Days)||50
8820847|NCT01573624|9874822|FG001|STARTED|Period 4 : Washout Period 2 (12-14 Days)||52
8820848|NCT01573624|9874823|FG002|STARTED|Period 4 : Washout Period 2 (12-14 Days)||45
8820849|NCT01573624|9874824|FG003|STARTED|Period 4 : Washout Period 2 (12-14 Days)||55
8820850|NCT01573624|9874825|FG004|STARTED|Period 4 : Washout Period 2 (12-14 Days)||53
8820851|NCT01573624|9874826|FG005|STARTED|Period 4 : Washout Period 2 (12-14 Days)||43
8820852|NCT01573624|9874827|FG006|STARTED|Period 4 : Washout Period 2 (12-14 Days)||55
8820853|NCT01573624|9874821|FG000|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||49
8820854|NCT01573624|9874822|FG001|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||48
8820855|NCT01573624|9874823|FG002|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||43
8820856|NCT01573624|9874824|FG003|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||53
8820857|NCT01573624|9874825|FG004|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||52
8820858|NCT01573624|9874826|FG005|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||41
8820859|NCT01573624|9874827|FG006|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||52
8820860|NCT01573624|9874821|FG000|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||1
8820861|NCT01573624|9874822|FG001|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||4
8820862|NCT01573624|9874823|FG002|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||2
8820863|NCT01573624|9874824|FG003|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||2
8820864|NCT01573624|9874825|FG004|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||1
8556441|NCT00470704|9588180|FG000|Safety Population|Overall Study||41
8556442|NCT00470704|9588181|FG001|Safety Population|Overall Study||45
8556443|NCT00470704|9588180|FG000|Treated|Overall Study||40
8556444|NCT00470704|9588181|FG001|Treated|Overall Study||45
8556445|NCT00470704|9588180|FG000|COMPLETED|Overall Study||0
8556446|NCT00470704|9588181|FG001|COMPLETED|Overall Study||0
8556447|NCT00470704|9588180|FG000|NOT COMPLETED|Overall Study||41
8556448|NCT00470704|9588181|FG001|NOT COMPLETED|Overall Study||46
8556449|NCT00427193|9588189|FG000|STARTED|Overall Study||143
8556450|NCT00427193|9588190|FG001|STARTED|Overall Study||75
8556451|NCT00427193|9588189|FG000|COMPLETED|Overall Study||117
8556452|NCT00427193|9588190|FG001|COMPLETED|Overall Study||71
8556453|NCT00427193|9588189|FG000|NOT COMPLETED|Overall Study||26
8556454|NCT00427193|9588190|FG001|NOT COMPLETED|Overall Study||4
8556455|NCT00148733|9588200|FG000|STARTED|Overall Study||1314
8556456|NCT00148733|9588201|FG001|STARTED|Overall Study||1314
8556457|NCT00148733|9588200|FG000|COMPLETED|Overall Study||1300
8556458|NCT00148733|9588201|FG001|COMPLETED|Overall Study||1299
8556459|NCT00148733|9588200|FG000|NOT COMPLETED|Overall Study||14
8556460|NCT00148733|9588201|FG001|NOT COMPLETED|Overall Study||15
8556461|NCT00142584|9588209|FG000|STARTED|Overall Study||252
8556462|NCT00142584|9588210|FG001|STARTED|Overall Study||84
8556463|NCT00142584|9588209|FG000|COMPLETED|Overall Study||108
8556464|NCT00142584|9588210|FG001|COMPLETED|Overall Study||28
8556465|NCT00142584|9588209|FG000|NOT COMPLETED|Overall Study||144
8556466|NCT00142584|9588210|FG001|NOT COMPLETED|Overall Study||56
8568698|NCT00092547|9600912|FG001|STARTED|Long-term Follow-up (Month 72 Visit)||0
8568699|NCT00092547|9600913|FG002|STARTED|Long-term Follow-up (Month 72 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|276
8568700|NCT00092547|9600911|FG000|COMPLETED|Long-term Follow-up (Month 72 Visit)||550
8568701|NCT00092547|9600912|FG001|COMPLETED|Long-term Follow-up (Month 72 Visit)||0
8621921|NCT00484289|9661009|FG002|NOT COMPLETED|Long Term Phase||16
8621922|NCT00484289|9661007|FG000|STARTED|Post Marketing Phase||10
8621923|NCT00484289|9661008|FG001|STARTED|Post Marketing Phase||142
8621924|NCT00484289|9661009|FG002|STARTED|Post Marketing Phase||10
8621925|NCT00484289|9661007|FG000|COMPLETED|Post Marketing Phase||10
8621926|NCT00484289|9661008|FG001|COMPLETED|Post Marketing Phase||141
8621927|NCT00484289|9661009|FG002|COMPLETED|Post Marketing Phase||10
8621928|NCT00484289|9661007|FG000|NOT COMPLETED|Post Marketing Phase||0
8621929|NCT00484289|9661008|FG001|NOT COMPLETED|Post Marketing Phase||1
8820865|NCT01573624|9874826|FG005|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||2
8820866|NCT01573624|9874827|FG006|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||3
8820867|NCT01573624|9874821|FG000|STARTED|Period 5 : Treatment Period 3 (14 Days)||49
8820868|NCT01573624|9874822|FG001|STARTED|Period 5 : Treatment Period 3 (14 Days)||48
8820869|NCT01573624|9874823|FG002|STARTED|Period 5 : Treatment Period 3 (14 Days)||43
8820870|NCT01573624|9874824|FG003|STARTED|Period 5 : Treatment Period 3 (14 Days)||53
8820871|NCT01573624|9874825|FG004|STARTED|Period 5 : Treatment Period 3 (14 Days)||52
8820872|NCT01573624|9874826|FG005|STARTED|Period 5 : Treatment Period 3 (14 Days)||41
8820873|NCT01573624|9874827|FG006|STARTED|Period 5 : Treatment Period 3 (14 Days)||52
8820874|NCT01573624|9874821|FG000|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||46
8820875|NCT01573624|9874822|FG001|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||47
8820876|NCT01573624|9874823|FG002|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||43
8820877|NCT01573624|9874824|FG003|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||53
8820878|NCT01573624|9874825|FG004|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||51
8820879|NCT01573624|9874826|FG005|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||39
8820880|NCT01573624|9874827|FG006|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||48
8820881|NCT01573624|9874821|FG000|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||3
8820882|NCT01573624|9874822|FG001|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||1
8820883|NCT01573624|9874823|FG002|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||0
8820884|NCT01573624|9874824|FG003|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||0
8820885|NCT01573624|9874825|FG004|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||1
8820886|NCT01573624|9874826|FG005|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||2
8820887|NCT01573624|9874827|FG006|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||4
8820888|NCT01573624|9874821|FG000|STARTED|Period 6 : Follow-up Period (7 Days)||46
8820889|NCT01573624|9874822|FG001|STARTED|Period 6 : Follow-up Period (7 Days)||47
8820890|NCT01573624|9874823|FG002|STARTED|Period 6 : Follow-up Period (7 Days)||43
8820891|NCT01573624|9874824|FG003|STARTED|Period 6 : Follow-up Period (7 Days)||53
8820892|NCT01573624|9874825|FG004|STARTED|Period 6 : Follow-up Period (7 Days)||51
8820893|NCT01573624|9874826|FG005|STARTED|Period 6 : Follow-up Period (7 Days)||39
8820894|NCT01573624|9874827|FG006|STARTED|Period 6 : Follow-up Period (7 Days)||48
8820895|NCT01573624|9874821|FG000|COMPLETED|Period 6 : Follow-up Period (7 Days)||45
8820896|NCT01573624|9874822|FG001|COMPLETED|Period 6 : Follow-up Period (7 Days)||47
8820897|NCT01573624|9874823|FG002|COMPLETED|Period 6 : Follow-up Period (7 Days)||43
8820898|NCT01573624|9874824|FG003|COMPLETED|Period 6 : Follow-up Period (7 Days)||53
8820899|NCT01573624|9874825|FG004|COMPLETED|Period 6 : Follow-up Period (7 Days)||49
8849373|NCT01740206|9904540|FG000|STARTED|Overall Study||14
8568702|NCT00092547|9600913|FG002|COMPLETED|Long-term Follow-up (Month 72 Visit)||276
8568703|NCT00092547|9600911|FG000|NOT COMPLETED|Long-term Follow-up (Month 72 Visit)||0
8568704|NCT00092547|9600912|FG001|NOT COMPLETED|Long-term Follow-up (Month 72 Visit)||0
8568705|NCT00092547|9600913|FG002|NOT COMPLETED|Long-term Follow-up (Month 72 Visit)||0
8569409|NCT00096993|9601650|FG001|COMPLETED|Overall Study||0
8621930|NCT00484289|9661009|FG002|NOT COMPLETED|Post Marketing Phase||0
8621931|NCT00484315|9661020|FG000|STARTED|12-Month Clinical Follow-up||942
8621932|NCT00484315|9661021|FG001|STARTED|12-Month Clinical Follow-up||320
8621933|NCT00484315|9661020|FG000|COMPLETED|12-Month Clinical Follow-up||914
8621934|NCT00484315|9661021|FG001|COMPLETED|12-Month Clinical Follow-up||311
8621935|NCT00484315|9661020|FG000|NOT COMPLETED|12-Month Clinical Follow-up||28
8621936|NCT00484315|9661021|FG001|NOT COMPLETED|12-Month Clinical Follow-up||9
8621937|NCT00484315|9661020|FG000|STARTED|9-Month Angiographic Follow-up||256
8621938|NCT00484315|9661021|FG001|STARTED|9-Month Angiographic Follow-up||74
8621939|NCT00484315|9661020|FG000|COMPLETED|9-Month Angiographic Follow-up||228
8621940|NCT00484315|9661021|FG001|COMPLETED|9-Month Angiographic Follow-up||61
8820900|NCT01573624|9874826|FG005|COMPLETED|Period 6 : Follow-up Period (7 Days)||38
8820901|NCT01573624|9874827|FG006|COMPLETED|Period 6 : Follow-up Period (7 Days)||48
8820902|NCT01573624|9874821|FG000|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||1
8820903|NCT01573624|9874822|FG001|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
8820904|NCT01573624|9874823|FG002|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
8820905|NCT01573624|9874824|FG003|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
8820906|NCT01573624|9874825|FG004|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||2
8820907|NCT01573624|9874826|FG005|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||1
8820908|NCT01573624|9874827|FG006|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
8820909|NCT01573702|9874849|FG000|STARTED|Overall Study||25
8820910|NCT01573702|9874849|FG000|COMPLETED|Overall Study||25
8820911|NCT01573702|9874849|FG000|NOT COMPLETED|Overall Study||0
8820912|NCT01573767|9874858|FG000|STARTED|Overall Study||115
8820913|NCT01573767|9874859|FG001|STARTED|Overall Study||114
8820914|NCT01573767|9874860|FG002|STARTED|Overall Study||113
8820915|NCT01573767|9874861|FG003|STARTED|Overall Study||114
8820916|NCT01573767|9874858|FG000|COMPLETED|Overall Study||93
8820917|NCT01573767|9874859|FG001|COMPLETED|Overall Study||93
8820918|NCT01573767|9874860|FG002|COMPLETED|Overall Study||99
8820919|NCT01573767|9874861|FG003|COMPLETED|Overall Study||90
8820920|NCT01573767|9874858|FG000|NOT COMPLETED|Overall Study||22
8820921|NCT01573767|9874859|FG001|NOT COMPLETED|Overall Study||21
8820922|NCT01573767|9874860|FG002|NOT COMPLETED|Overall Study||14
8820923|NCT01573767|9874861|FG003|NOT COMPLETED|Overall Study||24
8820924|NCT01573910|9874873|FG000|STARTED|Overall Study||489
8820925|NCT01573910|9874874|FG001|STARTED|Overall Study||493
8820926|NCT01573910|9874873|FG000|COMPLETED|Overall Study||469
8820927|NCT01573910|9874874|FG001|COMPLETED|Overall Study||476
8820928|NCT01573910|9874873|FG000|NOT COMPLETED|Overall Study||20
8820929|NCT01573910|9874874|FG001|NOT COMPLETED|Overall Study||17
8820930|NCT01573949|9874880|FG000|STARTED|Overall Study||7
8820931|NCT01573949|9874880|FG000|COMPLETED|Overall Study||7
8820932|NCT01573949|9874880|FG000|NOT COMPLETED|Overall Study||0
8820933|NCT01574079|9874886|FG000|STARTED|Overall Study||18
8820934|NCT01574079|9874887|FG001|STARTED|Overall Study||15
8820935|NCT01574079|9874886|FG000|COMPLETED|Overall Study||17
8820936|NCT01574079|9874887|FG001|COMPLETED|Overall Study||13
8820937|NCT01574079|9874886|FG000|NOT COMPLETED|Overall Study||1
8820938|NCT01574079|9874887|FG001|NOT COMPLETED|Overall Study||2
8820939|NCT01574105|9874895|FG000|STARTED|Overall Study||29
8820940|NCT01574105|9874896|FG001|STARTED|Overall Study||37
8820941|NCT01574105|9874895|FG000|COMPLETED|Overall Study||29
8820942|NCT01574105|9874896|FG001|COMPLETED|Overall Study||37
8820943|NCT01574105|9874895|FG000|NOT COMPLETED|Overall Study||0
8820944|NCT01574105|9874896|FG001|NOT COMPLETED|Overall Study||0
8820945|NCT01574144|9874902|FG000|STARTED|Overall Study||70
8820946|NCT01574144|9874902|FG000|COMPLETED|Overall Study||70
8820947|NCT01574144|9874902|FG000|NOT COMPLETED|Overall Study||0
8820948|NCT01574157|9874909|FG000|STARTED|Overall Study||35
8820949|NCT01574157|9874910|FG001|STARTED|Overall Study||39
8820950|NCT01574157|9874909|FG000|Month 3|Overall Study||31
8820951|NCT01574157|9874910|FG001|Month 3|Overall Study||33
8820952|NCT01574157|9874909|FG000|COMPLETED|Overall Study||31
8820953|NCT01574157|9874910|FG001|COMPLETED|Overall Study||31
8820954|NCT01574157|9874909|FG000|NOT COMPLETED|Overall Study||4
8820955|NCT01574157|9874910|FG001|NOT COMPLETED|Overall Study||8
8820956|NCT01574183|9874922|FG000|STARTED|Overall Study||41
8820957|NCT01574183|9874923|FG001|STARTED|Overall Study||35
8820958|NCT01574183|9874922|FG000|COMPLETED|Overall Study||14
8820959|NCT01574183|9874923|FG001|COMPLETED|Overall Study||17
8820960|NCT01574183|9874922|FG000|NOT COMPLETED|Overall Study||27
8820961|NCT01574183|9874923|FG001|NOT COMPLETED|Overall Study||18
8820962|NCT01574248|9874933|FG000|STARTED|Overall Study||15
8820963|NCT01574248|9874934|FG001|STARTED|Overall Study||18
8820964|NCT01574248|9874933|FG000|COMPLETED|Overall Study||12
8820965|NCT01574248|9874934|FG001|COMPLETED|Overall Study||18
8820966|NCT01574248|9874933|FG000|NOT COMPLETED|Overall Study||3
8621941|NCT00484315|9661020|FG000|NOT COMPLETED|9-Month Angiographic Follow-up||28
8621942|NCT00484315|9661021|FG001|NOT COMPLETED|9-Month Angiographic Follow-up||13
8621943|NCT00484354|9661029|FG000|STARTED|Overall Study||64
8820967|NCT01574248|9874934|FG001|NOT COMPLETED|Overall Study||0
8820968|NCT01574287|9874940|FG000|STARTED|Overall Study||4
8820969|NCT01574287|9874940|FG000|COMPLETED|Overall Study||4
8820970|NCT01574287|9874940|FG000|NOT COMPLETED|Overall Study||0
8820971|NCT01574326|9874946|FG000|STARTED|Overall Study||51
8820972|NCT01574326|9874947|FG001|STARTED|Overall Study||50
8820973|NCT01574326|9874946|FG000|Treated|Overall Study||51
8820974|NCT01574326|9874947|FG001|Treated|Overall Study||49
8820975|NCT01574326|9874946|FG000|COMPLETED|Overall Study||35
8621944|NCT00484354|9661030|FG001|STARTED|Overall Study||59
8621945|NCT00484354|9661029|FG000|COMPLETED|Overall Study||63
8621946|NCT00484354|9661030|FG001|COMPLETED|Overall Study||57
8621947|NCT00484354|9661029|FG000|NOT COMPLETED|Overall Study||1
8621948|NCT00484354|9661030|FG001|NOT COMPLETED|Overall Study||2
8621949|NCT00484393|9661038|FG000|STARTED|Overall Study||4
8621950|NCT00484393|9661039|FG001|STARTED|Overall Study||3
8621951|NCT00484393|9661038|FG000|COMPLETED|Overall Study||4
8621952|NCT00484393|9661039|FG001|COMPLETED|Overall Study||3
8621953|NCT00484393|9661038|FG000|NOT COMPLETED|Overall Study||0
8621954|NCT00484393|9661039|FG001|NOT COMPLETED|Overall Study||0
8621955|NCT00484679|9661045|FG000|STARTED|Overall Study||18
8621956|NCT00484679|9661045|FG000|COMPLETED|Overall Study||15
8621957|NCT00484679|9661045|FG000|NOT COMPLETED|Overall Study||3
8621958|NCT00484874|9661049|FG000|STARTED|Overall Study||12
8621959|NCT00484874|9661049|FG000|COMPLETED|Overall Study||12
8621960|NCT00484874|9661049|FG000|NOT COMPLETED|Overall Study||0
8621961|NCT00484939|9661058|FG000|STARTED|Overall Study||140
8621962|NCT00484939|9661059|FG001|STARTED|Overall Study||140
8621963|NCT00484939|9661058|FG000|COMPLETED|Overall Study||0
8621964|NCT00484939|9661059|FG001|COMPLETED|Overall Study||0
8621965|NCT00484939|9661058|FG000|NOT COMPLETED|Overall Study||140
8621966|NCT00484939|9661059|FG001|NOT COMPLETED|Overall Study||140
8621967|NCT00485069|9661067|FG000|STARTED|Overall Study||65
8621968|NCT00485069|9661068|FG001|STARTED|Overall Study||58
8820976|NCT01574326|9874947|FG001|COMPLETED|Overall Study||31
8820977|NCT01574326|9874946|FG000|NOT COMPLETED|Overall Study||16
8820978|NCT01574326|9874947|FG001|NOT COMPLETED|Overall Study||19
8556467|NCT04753710|9588220|FG000|STARTED|Overall||67
8556468|NCT04753710|9588221|FG001|STARTED|Overall||29
8556469|NCT04753710|9588220|FG000|COMPLETED|Overall||67
8556470|NCT04753710|9588221|FG001|COMPLETED|Overall||29
8556471|NCT04753710|9588220|FG000|NOT COMPLETED|Overall||0
8556472|NCT04753710|9588221|FG001|NOT COMPLETED|Overall||0
8556473|NCT04753710|9588220|FG000|STARTED|First Phase||27
8556474|NCT04753710|9588221|FG001|STARTED|First Phase||9
8556475|NCT04753710|9588220|FG000|COMPLETED|First Phase||27
8556476|NCT04753710|9588221|FG001|COMPLETED|First Phase||9
8556477|NCT04753710|9588220|FG000|NOT COMPLETED|First Phase||0
8556478|NCT04753710|9588221|FG001|NOT COMPLETED|First Phase||0
8556479|NCT04753710|9588220|FG000|STARTED|Second Phase||40
8556480|NCT04753710|9588221|FG001|STARTED|Second Phase||20
8556481|NCT04753710|9588220|FG000|COMPLETED|Second Phase||40
8556482|NCT04753710|9588221|FG001|COMPLETED|Second Phase||20
8556483|NCT04753710|9588220|FG000|NOT COMPLETED|Second Phase||0
8556484|NCT04753710|9588221|FG001|NOT COMPLETED|Second Phase||0
8556485|NCT04570605|9588229|FG000|STARTED|Overall Study||15
8556486|NCT04570605|9588230|FG001|STARTED|Overall Study||15
8820979|NCT01574352|9874960|FG000|STARTED|Overall Study|59 participants where randomized, but 4 dropped out prior to baseline measurements.|55
8820980|NCT01574352|9874961|FG001|STARTED|Overall Study|56 participants where randomized, but 5 dropped out prior to baseline measurements.|51
8820981|NCT01574352|9874960|FG000|COMPLETED|Overall Study|Participated in the last follow up measurement.|48
8820982|NCT01574352|9874961|FG001|COMPLETED|Overall Study|Participated in the last follow up measurement.|38
8820983|NCT01574352|9874960|FG000|NOT COMPLETED|Overall Study||7
8820984|NCT01574352|9874961|FG001|NOT COMPLETED|Overall Study||13
8820985|NCT01574612|9874967|FG000|STARTED|Overall Study|patients who were identified as having the appropriate medical history of herpes labialis|54
8820986|NCT01574612|9874967|FG000|COMPLETED|Overall Study||46
8820987|NCT01574612|9874967|FG000|NOT COMPLETED|Overall Study||8
8820988|NCT01574651|9874973|FG000|STARTED|Overall Study||476
8820989|NCT01574651|9874974|FG001|STARTED|Overall Study||458
8820990|NCT01574651|9874973|FG000|Full Analysis Set (FAS)|Overall Study||476
8820991|NCT01574651|9874974|FG001|Full Analysis Set (FAS)|Overall Study||458
8820992|NCT01574651|9874973|FG000|Per Protocol Set (PPS)|Overall Study||373
8820993|NCT01574651|9874974|FG001|Per Protocol Set (PPS)|Overall Study||374
8820994|NCT01574651|9874973|FG000|COMPLETED|Overall Study||415
8820995|NCT01574651|9874974|FG001|COMPLETED|Overall Study||406
8820996|NCT01574651|9874973|FG000|NOT COMPLETED|Overall Study||61
8820997|NCT01574651|9874974|FG001|NOT COMPLETED|Overall Study||52
8820998|NCT01574703|9874984|FG000|STARTED|Overall Study||1192
8556487|NCT04570605|9588229|FG000|COMPLETED|Overall Study||11
8556488|NCT04570605|9588230|FG001|COMPLETED|Overall Study||13
8556489|NCT04570605|9588229|FG000|NOT COMPLETED|Overall Study||4
8556490|NCT04570605|9588230|FG001|NOT COMPLETED|Overall Study||2
8556491|NCT04551898|9588240|FG000|STARTED|Overall Study||47
8556492|NCT04551898|9588241|FG001|STARTED|Overall Study||45
8556493|NCT04551898|9588242|FG002|STARTED|Overall Study||43
8556494|NCT04551898|9588243|FG003|STARTED|Overall Study||46
8556495|NCT04551898|9588240|FG000|COMPLETED|Overall Study||39
8556496|NCT04551898|9588241|FG001|COMPLETED|Overall Study||42
8556497|NCT04551898|9588242|FG002|COMPLETED|Overall Study||35
8621969|NCT00485069|9661067|FG000|COMPLETED|Overall Study||47
8621970|NCT00485069|9661068|FG001|COMPLETED|Overall Study||46
8820999|NCT01574703|9874985|FG001|STARTED|Overall Study||1166
8821000|NCT01574703|9874986|FG002|STARTED|Overall Study||1116
8556498|NCT04551898|9588243|FG003|COMPLETED|Overall Study||41
8621971|NCT00485069|9661067|FG000|NOT COMPLETED|Overall Study||18
8621972|NCT00485069|9661068|FG001|NOT COMPLETED|Overall Study||12
8556499|NCT04551898|9588240|FG000|NOT COMPLETED|Overall Study||8
8556500|NCT04551898|9588241|FG001|NOT COMPLETED|Overall Study||3
8556501|NCT04551898|9588242|FG002|NOT COMPLETED|Overall Study||8
8556502|NCT04551898|9588243|FG003|NOT COMPLETED|Overall Study||5
8556503|NCT04402866|9588265|FG000|STARTED|Overall Study||6
8556504|NCT04402866|9588266|FG001|STARTED|Overall Study||6
8621973|NCT00485134|9661089|FG000|STARTED|Overall Study||12
8556505|NCT04402866|9588267|FG002|STARTED|Overall Study||7
8556506|NCT04402866|9588268|FG003|STARTED|Overall Study||6
8556507|NCT04402866|9588269|FG004|STARTED|Overall Study||104
8556508|NCT04402866|9588270|FG005|STARTED|Overall Study||106
8621974|NCT00485134|9661090|FG001|STARTED|Overall Study||12
8621975|NCT00485134|9661091|FG002|STARTED|Overall Study||12
8821001|NCT01574703|9874987|FG003|STARTED|Overall Study||1121
8821002|NCT01574703|9874984|FG000|COMPLETED|Overall Study||1067
8821003|NCT01574703|9874985|FG001|COMPLETED|Overall Study||1054
8821004|NCT01574703|9874986|FG002|COMPLETED|Overall Study||1011
8821005|NCT01574703|9874987|FG003|COMPLETED|Overall Study||1007
8821006|NCT01574703|9874984|FG000|NOT COMPLETED|Overall Study||125
8821007|NCT01574703|9874985|FG001|NOT COMPLETED|Overall Study||112
8821008|NCT01574703|9874986|FG002|NOT COMPLETED|Overall Study||105
8821009|NCT01574703|9874987|FG003|NOT COMPLETED|Overall Study||114
8821010|NCT01574716|9875002|FG000|STARTED|Part 1||3
8821011|NCT01574716|9875003|FG001|STARTED|Part 1||4
8821012|NCT01574716|9875004|FG002|STARTED|Part 1||9
8821013|NCT01574716|9875005|FG003|STARTED|Part 1||0
8821014|NCT01574716|9875006|FG004|STARTED|Part 1||0
8821015|NCT01574716|9875002|FG000|COMPLETED|Part 1||0
8821016|NCT01574716|9875003|FG001|COMPLETED|Part 1||0
8821017|NCT01574716|9875004|FG002|COMPLETED|Part 1||0
8821018|NCT01574716|9875005|FG003|COMPLETED|Part 1||0
8821019|NCT01574716|9875006|FG004|COMPLETED|Part 1||0
8821020|NCT01574716|9875002|FG000|NOT COMPLETED|Part 1||3
8821021|NCT01574716|9875003|FG001|NOT COMPLETED|Part 1||4
8821022|NCT01574716|9875004|FG002|NOT COMPLETED|Part 1||9
8821023|NCT01574716|9875005|FG003|NOT COMPLETED|Part 1||0
8821024|NCT01574716|9875006|FG004|NOT COMPLETED|Part 1||0
8821025|NCT01574716|9875002|FG000|STARTED|Part 2||0
8821026|NCT01574716|9875003|FG001|STARTED|Part 2||0
8821027|NCT01574716|9875004|FG002|STARTED|Part 2||0
8821028|NCT01574716|9875005|FG003|STARTED|Part 2||139
8821029|NCT01574716|9875006|FG004|STARTED|Part 2||70
8821030|NCT01574716|9875002|FG000|Treated Participants|Part 2||0
8821031|NCT01574716|9875003|FG001|Treated Participants|Part 2||0
8821032|NCT01574716|9875004|FG002|Treated Participants|Part 2||0
8821033|NCT01574716|9875005|FG003|Treated Participants|Part 2||140
8821034|NCT01574716|9875006|FG004|Treated Participants|Part 2||67
8821035|NCT01574716|9875002|FG000|COMPLETED|Part 2||0
8821036|NCT01574716|9875003|FG001|COMPLETED|Part 2||0
8821037|NCT01574716|9875004|FG002|COMPLETED|Part 2||0
8821038|NCT01574716|9875005|FG003|COMPLETED|Part 2||2
8821039|NCT01574716|9875006|FG004|COMPLETED|Part 2||0
8821040|NCT01574716|9875002|FG000|NOT COMPLETED|Part 2||0
8821041|NCT01574716|9875003|FG001|NOT COMPLETED|Part 2||0
8821042|NCT01574716|9875004|FG002|NOT COMPLETED|Part 2||0
8821043|NCT01574716|9875005|FG003|NOT COMPLETED|Part 2||137
8821044|NCT01574716|9875006|FG004|NOT COMPLETED|Part 2||70
8849374|NCT01740206|9904541|FG001|STARTED|Overall Study||34
8849375|NCT01740206|9904540|FG000|COMPLETED|Overall Study||14
8849376|NCT01740206|9904541|FG001|COMPLETED|Overall Study||34
8849377|NCT01740206|9904540|FG000|NOT COMPLETED|Overall Study||0
8849378|NCT01740206|9904541|FG001|NOT COMPLETED|Overall Study||0
8849379|NCT01740258|9904547|FG000|STARTED|Overall Study||68
8849380|NCT01740258|9904547|FG000|Entered Part A|Overall Study||68
8849381|NCT01740258|9904547|FG000|Entered Part B|Overall Study||62
8849382|NCT01740258|9904547|FG000|Entered Part C|Overall Study||20
8849383|NCT01740258|9904547|FG000|Entered Part D|Overall Study||42
8849384|NCT01740258|9904547|FG000|COMPLETED|Overall Study||68
8849385|NCT01740258|9904547|FG000|NOT COMPLETED|Overall Study||0
8849386|NCT01740323|9904553|FG000|STARTED|Overall Study||15
8849387|NCT01740323|9904554|FG001|STARTED|Overall Study||15
8849388|NCT01740323|9904553|FG000|COMPLETED|Overall Study||13
8849389|NCT01740323|9904554|FG001|COMPLETED|Overall Study||15
8849390|NCT01740323|9904553|FG000|NOT COMPLETED|Overall Study||2
8849391|NCT01740323|9904554|FG001|NOT COMPLETED|Overall Study||0
8849392|NCT01740362|9904564|FG000|STARTED|Overall Study||6
8849393|NCT01740362|9904565|FG001|STARTED|Overall Study||6
8849394|NCT01740362|9904566|FG002|STARTED|Overall Study||6
8849395|NCT01740362|9904567|FG003|STARTED|Overall Study||6
8849396|NCT01740362|9904564|FG000|COMPLETED|Overall Study||6
8849397|NCT01740362|9904565|FG001|COMPLETED|Overall Study||6
8849398|NCT01740362|9904566|FG002|COMPLETED|Overall Study||6
8849399|NCT01740362|9904567|FG003|COMPLETED|Overall Study||6
8849400|NCT01740362|9904564|FG000|NOT COMPLETED|Overall Study||0
8556509|NCT04402866|9588265|FG000|Randomized and Treated With Study Drug|Overall Study||6
8556510|NCT04402866|9588266|FG001|Randomized and Treated With Study Drug|Overall Study||6
8556511|NCT04402866|9588267|FG002|Randomized and Treated With Study Drug|Overall Study||7
8556512|NCT04402866|9588268|FG003|Randomized and Treated With Study Drug|Overall Study||6
8556513|NCT04402866|9588269|FG004|Randomized and Treated With Study Drug|Overall Study||102
8556514|NCT04402866|9588270|FG005|Randomized and Treated With Study Drug|Overall Study||103
8621976|NCT00485134|9661092|FG003|STARTED|Overall Study||8
8849401|NCT01740362|9904565|FG001|NOT COMPLETED|Overall Study||0
8849402|NCT01740362|9904566|FG002|NOT COMPLETED|Overall Study||0
8849403|NCT01740362|9904567|FG003|NOT COMPLETED|Overall Study||0
8849404|NCT01740388|9904579|FG000|STARTED|Overall Study||64
8849405|NCT01740388|9904580|FG001|STARTED|Overall Study||72
8849406|NCT01740388|9904579|FG000|COMPLETED|Overall Study||18
8849407|NCT01740388|9904580|FG001|COMPLETED|Overall Study||28
8849408|NCT01740388|9904579|FG000|NOT COMPLETED|Overall Study||46
8849409|NCT01740388|9904580|FG001|NOT COMPLETED|Overall Study||44
8849410|NCT01740401|9904586|FG000|STARTED|Overall Study||10
8556515|NCT04402866|9588265|FG000|COMPLETED|Overall Study||4
8821045|NCT01574807|9875015|FG000|STARTED|First Appointment||50
8821046|NCT01574807|9875016|FG001|STARTED|First Appointment||50
8821047|NCT01574807|9875015|FG000|COMPLETED|First Appointment||50
8821048|NCT01574807|9875016|FG001|COMPLETED|First Appointment||50
8821049|NCT01574807|9875015|FG000|NOT COMPLETED|First Appointment||0
8821050|NCT01574807|9875016|FG001|NOT COMPLETED|First Appointment||0
8821051|NCT01574807|9875015|FG000|STARTED|Wash Out Period 2 Weeks||50
8821052|NCT01574807|9875016|FG001|STARTED|Wash Out Period 2 Weeks||50
8821053|NCT01574807|9875015|FG000|COMPLETED|Wash Out Period 2 Weeks||50
8821054|NCT01574807|9875016|FG001|COMPLETED|Wash Out Period 2 Weeks||50
8821055|NCT01574807|9875015|FG000|NOT COMPLETED|Wash Out Period 2 Weeks||0
8821056|NCT01574807|9875016|FG001|NOT COMPLETED|Wash Out Period 2 Weeks||0
8821057|NCT01574807|9875015|FG000|STARTED|Second Appointment||50
8821058|NCT01574807|9875016|FG001|STARTED|Second Appointment||50
8821059|NCT01574807|9875015|FG000|COMPLETED|Second Appointment||50
8821060|NCT01574807|9875016|FG001|COMPLETED|Second Appointment||50
8821061|NCT01574807|9875015|FG000|NOT COMPLETED|Second Appointment||0
8821062|NCT01574807|9875016|FG001|NOT COMPLETED|Second Appointment||0
8821063|NCT01575054|9875023|FG000|STARTED|Overall Study||233
8821064|NCT01575054|9875024|FG001|STARTED|Overall Study||235
8821065|NCT01575054|9875023|FG000|COMPLETED|Overall Study||204
8821066|NCT01575054|9875024|FG001|COMPLETED|Overall Study||209
8821067|NCT01575054|9875023|FG000|NOT COMPLETED|Overall Study||29
8821068|NCT01575054|9875024|FG001|NOT COMPLETED|Overall Study||26
8821069|NCT01575080|9875030|FG000|STARTED|Overall Study||102
8821070|NCT01575080|9875030|FG000|COMPLETED|Overall Study||102
8821071|NCT01575080|9875030|FG000|NOT COMPLETED|Overall Study||0
8821072|NCT01575106|9875034|FG000|STARTED|Overall Study||38
8821073|NCT01575106|9875034|FG000|COMPLETED|Overall Study||24
8821074|NCT01575106|9875034|FG000|NOT COMPLETED|Overall Study||14
8821075|NCT01575197|9875042|FG000|STARTED|Overall Study||152
8821076|NCT01575197|9875043|FG001|STARTED|Overall Study||152
8821077|NCT01575197|9875044|FG002|STARTED|Overall Study||152
8821078|NCT01575197|9875042|FG000|COMPLETED|Overall Study||149
8821079|NCT01575197|9875043|FG001|COMPLETED|Overall Study||143
8821080|NCT01575197|9875044|FG002|COMPLETED|Overall Study||146
8821081|NCT01575197|9875042|FG000|NOT COMPLETED|Overall Study||3
8821082|NCT01575197|9875043|FG001|NOT COMPLETED|Overall Study||9
8821083|NCT01575197|9875044|FG002|NOT COMPLETED|Overall Study||6
8821084|NCT01575275|9875052|FG000|STARTED|Overall Study||8
8821085|NCT01575275|9875052|FG000|COMPLETED|Overall Study||8
8821086|NCT01575275|9875052|FG000|NOT COMPLETED|Overall Study||0
8821087|NCT01575522|9875056|FG000|STARTED|Overall Study||22
8821088|NCT01575522|9875056|FG000|COMPLETED|Overall Study||22
8821089|NCT01575522|9875056|FG000|NOT COMPLETED|Overall Study||0
8821090|NCT01575561|9875063|FG000|STARTED|Overall Study||377
8821091|NCT01575561|9875063|FG000|COMPLETED|Overall Study||338
8821092|NCT01575561|9875063|FG000|NOT COMPLETED|Overall Study||39
8821093|NCT01575756|9875067|FG000|STARTED|Treatment Period 1||11
8821094|NCT01575756|9875068|FG001|STARTED|Treatment Period 1||11
8821095|NCT01575756|9875067|FG000|COMPLETED|Treatment Period 1||11
8821096|NCT01575756|9875068|FG001|COMPLETED|Treatment Period 1||11
8821097|NCT01575756|9875067|FG000|NOT COMPLETED|Treatment Period 1||0
8821098|NCT01575756|9875068|FG001|NOT COMPLETED|Treatment Period 1||0
8821099|NCT01575756|9875067|FG000|STARTED|Treatment Period 2||11
8821100|NCT01575756|9875068|FG001|STARTED|Treatment Period 2||11
8821101|NCT01575756|9875067|FG000|COMPLETED|Treatment Period 2||11
8821102|NCT01575756|9875068|FG001|COMPLETED|Treatment Period 2||11
8821103|NCT01575756|9875067|FG000|NOT COMPLETED|Treatment Period 2||0
8821104|NCT01575756|9875068|FG001|NOT COMPLETED|Treatment Period 2||0
8821105|NCT01575769|9875075|FG000|STARTED|Overall Study||41
8821106|NCT01575769|9875075|FG000|COMPLETED|Overall Study||0
8821107|NCT01575769|9875075|FG000|NOT COMPLETED|Overall Study||41
8821108|NCT01575808|9875083|FG000|STARTED|Overall Study||103
8821109|NCT01575808|9875084|FG001|STARTED|Overall Study||68
8821110|NCT01575808|9875083|FG000|COMPLETED|Overall Study|Study ongoing. All 103 assessed for primary invasiveness endpoints,100 for primary efficacy endpoint|100
8821111|NCT01575808|9875084|FG001|COMPLETED|Overall Study||68
8821112|NCT01575808|9875083|FG000|NOT COMPLETED|Overall Study||3
8821113|NCT01575808|9875084|FG001|NOT COMPLETED|Overall Study||0
8821114|NCT01575834|9875094|FG000|STARTED|Overall Study||3591
8821115|NCT01575834|9875095|FG001|STARTED|Overall Study||3589
8821116|NCT01575834|9875094|FG000|Received Double-blind Treatment|Overall Study|Six participants received a dose of romosozumab in error during the double-blind period.|3582
8821117|NCT01575834|9875095|FG001|Received Double-blind Treatment|Overall Study||3575
8821118|NCT01575834|9875094|FG000|Completed Double-blind Period|Overall Study||3205
8821119|NCT01575834|9875095|FG001|Completed Double-blind Period|Overall Study||3185
8821120|NCT01575834|9875094|FG000|Completed 24-month Study Period|Overall Study||3032
8821121|NCT01575834|9875095|FG001|Completed 24-month Study Period|Overall Study||2994
8821122|NCT01575834|9875094|FG000|COMPLETED|Overall Study|Completed 36-month study period|2892
8821123|NCT01575834|9875095|FG001|COMPLETED|Overall Study|Completed 36-month study period|2851
8821124|NCT01575834|9875094|FG000|NOT COMPLETED|Overall Study||699
8821125|NCT01575834|9875095|FG001|NOT COMPLETED|Overall Study||738
8821126|NCT01575860|9875105|FG000|STARTED|Overall Study||8
8821127|NCT01575860|9875105|FG000|COMPLETED|Overall Study||6
8821128|NCT01575860|9875105|FG000|NOT COMPLETED|Overall Study||2
8821129|NCT01575873|9875114|FG000|STARTED|Overall Study||145
8821130|NCT01575873|9875115|FG001|STARTED|Overall Study||145
8556516|NCT04402866|9588266|FG001|COMPLETED|Overall Study||5
8556517|NCT04402866|9588267|FG002|COMPLETED|Overall Study||6
8556518|NCT04402866|9588268|FG003|COMPLETED|Overall Study||6
8556519|NCT04402866|9588269|FG004|COMPLETED|Overall Study||89
8821131|NCT01575873|9875116|FG002|STARTED|Overall Study||252
8821132|NCT01575873|9875117|FG003|STARTED|Overall Study||253
8821133|NCT01575873|9875114|FG000|Received Study Drug|Overall Study|Participants who received oral risedronate|140
8821134|NCT01575873|9875115|FG001|Received Study Drug|Overall Study|Participants who received subcutaneous denosumab|142
8821135|NCT01575873|9875116|FG002|Received Study Drug|Overall Study|Participants who received oral risedronate|246
8821136|NCT01575873|9875117|FG003|Received Study Drug|Overall Study|Participants who received subcutaneous denosumab|251
8821137|NCT01575873|9875114|FG000|COMPLETED|Overall Study||117
8821138|NCT01575873|9875115|FG001|COMPLETED|Overall Study||109
8821139|NCT01575873|9875116|FG002|COMPLETED|Overall Study||178
8821140|NCT01575873|9875117|FG003|COMPLETED|Overall Study||186
8821141|NCT01575873|9875114|FG000|NOT COMPLETED|Overall Study||28
8821142|NCT01575873|9875115|FG001|NOT COMPLETED|Overall Study||36
8821143|NCT01575873|9875116|FG002|NOT COMPLETED|Overall Study||74
8821144|NCT01575873|9875117|FG003|NOT COMPLETED|Overall Study||67
8821145|NCT01575899|9875128|FG000|STARTED|Overall Study||73
8821146|NCT01575899|9875129|FG001|STARTED|Overall Study||73
8821147|NCT01575899|9875130|FG002|STARTED|Overall Study|Included patients still with Hp infection after previous therapy without levofloxacin and Augmentin.|62
8821148|NCT01575899|9875128|FG000|COMPLETED|Overall Study||68
8821149|NCT01575899|9875129|FG001|COMPLETED|Overall Study||68
8821150|NCT01575899|9875130|FG002|COMPLETED|Overall Study||60
8821151|NCT01575899|9875128|FG000|NOT COMPLETED|Overall Study||5
8821152|NCT01575899|9875129|FG001|NOT COMPLETED|Overall Study||5
8821153|NCT01575899|9875130|FG002|NOT COMPLETED|Overall Study||2
8821154|NCT01575912|9875143|FG000|STARTED|Overall Study||30
8821155|NCT01575912|9875144|FG001|STARTED|Overall Study||32
8821156|NCT01575912|9875145|FG002|STARTED|Overall Study||30
8821157|NCT01575912|9875143|FG000|COMPLETED|Overall Study||30
8821158|NCT01575912|9875144|FG001|COMPLETED|Overall Study||32
8821159|NCT01575912|9875145|FG002|COMPLETED|Overall Study||30
8821160|NCT01575912|9875143|FG000|NOT COMPLETED|Overall Study||0
8821161|NCT01575912|9875144|FG001|NOT COMPLETED|Overall Study||0
8821162|NCT01575912|9875145|FG002|NOT COMPLETED|Overall Study||0
8821163|NCT01576003|9875156|FG000|STARTED|Overall Study||2
8821164|NCT01576003|9875157|FG001|STARTED|Overall Study||3
8821165|NCT01576003|9875158|FG002|STARTED|Overall Study||4
8821166|NCT01576003|9875156|FG000|COMPLETED|Overall Study||1
8821167|NCT01576003|9875157|FG001|COMPLETED|Overall Study||1
8821168|NCT01576003|9875158|FG002|COMPLETED|Overall Study||4
8821169|NCT01576003|9875156|FG000|NOT COMPLETED|Overall Study||1
8821170|NCT01576003|9875157|FG001|NOT COMPLETED|Overall Study||2
8821171|NCT01576003|9875158|FG002|NOT COMPLETED|Overall Study||0
8821172|NCT01576016|9875168|FG000|STARTED|Lead Safety||920
8821173|NCT01576016|9875169|FG001|STARTED|Lead Safety||0
8821174|NCT01576016|9875168|FG000|COMPLETED|Lead Safety||647
8821175|NCT01576016|9875169|FG001|COMPLETED|Lead Safety||0
8821176|NCT01576016|9875168|FG000|NOT COMPLETED|Lead Safety||273
8821177|NCT01576016|9875169|FG001|NOT COMPLETED|Lead Safety||0
8821178|NCT01576016|9875168|FG000|STARTED|MRI Safety||0
8821179|NCT01576016|9875169|FG001|STARTED|MRI Safety|255 enrollments includes 30 supplemental scans performed in Australia using the same scan protocol.|255
8821180|NCT01576016|9875168|FG000|COMPLETED|MRI Safety||0
8821181|NCT01576016|9875169|FG001|COMPLETED|MRI Safety||181
8821182|NCT01576016|9875168|FG000|NOT COMPLETED|MRI Safety||0
8821183|NCT01576016|9875169|FG001|NOT COMPLETED|MRI Safety||74
8821184|NCT01576042|9875179|FG000|STARTED|Overall Study||13
8821185|NCT01576042|9875180|FG001|STARTED|Overall Study||14
8821186|NCT01576042|9875179|FG000|Switched to the Other Arm|Overall Study||5
8821187|NCT01576042|9875180|FG001|Switched to the Other Arm|Overall Study||1
8821188|NCT01576042|9875179|FG000|COMPLETED|Overall Study||11
8821189|NCT01576042|9875180|FG001|COMPLETED|Overall Study||14
8821190|NCT01576042|9875179|FG000|NOT COMPLETED|Overall Study||2
8821191|NCT01576042|9875180|FG001|NOT COMPLETED|Overall Study||0
8821192|NCT01576055|9875188|FG000|STARTED|Overall Study||197
8821193|NCT01576055|9875189|FG001|STARTED|Overall Study||70
8821194|NCT01576055|9875188|FG000|COMPLETED|Overall Study||178
8821195|NCT01576055|9875189|FG001|COMPLETED|Overall Study||64
8821196|NCT01576055|9875188|FG000|NOT COMPLETED|Overall Study||19
8821197|NCT01576055|9875189|FG001|NOT COMPLETED|Overall Study||6
8821198|NCT01576120|9875197|FG000|STARTED|Overall Study||21
8821199|NCT01576120|9875198|FG001|STARTED|Overall Study||19
8556520|NCT04402866|9588270|FG005|COMPLETED|Overall Study||92
8556521|NCT04402866|9588265|FG000|NOT COMPLETED|Overall Study||2
8556522|NCT04402866|9588266|FG001|NOT COMPLETED|Overall Study||1
8821200|NCT01576120|9875197|FG000|COMPLETED|Overall Study||21
8821201|NCT01576120|9875198|FG001|COMPLETED|Overall Study||19
8821202|NCT01576120|9875197|FG000|NOT COMPLETED|Overall Study||0
8821203|NCT01576120|9875198|FG001|NOT COMPLETED|Overall Study||0
8821204|NCT01576146|9875204|FG000|STARTED|Extension Period 1||30
8821205|NCT01576146|9875204|FG000|COMPLETED|Extension Period 1||20
8821206|NCT01576146|9875204|FG000|NOT COMPLETED|Extension Period 1||10
8821207|NCT01576146|9875204|FG000|STARTED|Extension Period 2|Three participants who completed Extension Period 1 did not enroll in Period 2|17
8821208|NCT01576146|9875204|FG000|COMPLETED|Extension Period 2||0
8821209|NCT01576146|9875204|FG000|NOT COMPLETED|Extension Period 2||17
8821210|NCT01576159|9875212|FG000|STARTED|Overall Study||12
8556523|NCT04402866|9588267|FG002|NOT COMPLETED|Overall Study||1
8556524|NCT04402866|9588268|FG003|NOT COMPLETED|Overall Study||0
8821211|NCT01576159|9875213|FG001|STARTED|Overall Study||12
8821212|NCT01576159|9875214|FG002|STARTED|Overall Study||12
8821213|NCT01576159|9875215|FG003|STARTED|Overall Study||12
8821214|NCT01576159|9875212|FG000|COMPLETED|Overall Study||11
8821215|NCT01576159|9875213|FG001|COMPLETED|Overall Study||11
8821216|NCT01576159|9875214|FG002|COMPLETED|Overall Study||11
8821217|NCT01576159|9875215|FG003|COMPLETED|Overall Study||11
8821218|NCT01576159|9875212|FG000|NOT COMPLETED|Overall Study||1
8821219|NCT01576159|9875213|FG001|NOT COMPLETED|Overall Study||1
8821220|NCT01576159|9875214|FG002|NOT COMPLETED|Overall Study||1
8821221|NCT01576159|9875215|FG003|NOT COMPLETED|Overall Study||1
8821222|NCT01576172|9875234|FG000|STARTED|Overall Study||79
8821223|NCT01576172|9875235|FG001|STARTED|Overall Study||80
8821224|NCT01576172|9875234|FG000|COMPLETED|Overall Study||74
8821225|NCT01576172|9875235|FG001|COMPLETED|Overall Study||79
8821226|NCT01576172|9875234|FG000|NOT COMPLETED|Overall Study||5
8821227|NCT01576172|9875235|FG001|NOT COMPLETED|Overall Study||1
8821228|NCT01576276|9875245|FG000|STARTED|Overall Study||22
8821229|NCT01576276|9875246|FG001|STARTED|Overall Study||29
8821230|NCT01576276|9875245|FG000|COMPLETED|Overall Study||14
8821231|NCT01576276|9875246|FG001|COMPLETED|Overall Study||18
8821232|NCT01576276|9875245|FG000|NOT COMPLETED|Overall Study||8
8821233|NCT01576276|9875246|FG001|NOT COMPLETED|Overall Study||11
8821234|NCT01576341|9875253|FG000|STARTED|Overall Study||417
8821235|NCT01576341|9875253|FG000|COMPLETED|Overall Study||324
8821236|NCT01576341|9875253|FG000|NOT COMPLETED|Overall Study||93
8821237|NCT01576367|9875260|FG000|STARTED|Overall Study||17
8821238|NCT01576367|9875260|FG000|COMPLETED|Overall Study||14
8821239|NCT01576367|9875260|FG000|NOT COMPLETED|Overall Study||3
8821240|NCT01576406|9875270|FG000|STARTED|Overall Study||11
8821241|NCT01576406|9875271|FG001|STARTED|Overall Study||15
8821242|NCT01576406|9875272|FG002|STARTED|Overall Study||20
8821243|NCT01576406|9875273|FG003|STARTED|Overall Study||10
8821244|NCT01576406|9875274|FG004|STARTED|Overall Study||16
8821245|NCT01576406|9875275|FG005|STARTED|Overall Study||16
8821246|NCT01576406|9875270|FG000|COMPLETED|Overall Study||5
8821247|NCT01576406|9875271|FG001|COMPLETED|Overall Study||7
8821248|NCT01576406|9875272|FG002|COMPLETED|Overall Study||4
8821249|NCT01576406|9875273|FG003|COMPLETED|Overall Study||1
8821250|NCT01576406|9875274|FG004|COMPLETED|Overall Study||8
8821251|NCT01576406|9875275|FG005|COMPLETED|Overall Study||4
8821252|NCT01576406|9875270|FG000|NOT COMPLETED|Overall Study||6
8821253|NCT01576406|9875271|FG001|NOT COMPLETED|Overall Study||8
8821254|NCT01576406|9875272|FG002|NOT COMPLETED|Overall Study||16
8821255|NCT01576406|9875273|FG003|NOT COMPLETED|Overall Study||9
8821256|NCT01576406|9875274|FG004|NOT COMPLETED|Overall Study||8
8821257|NCT01576406|9875275|FG005|NOT COMPLETED|Overall Study||12
8821258|NCT01576471|9875291|FG000|STARTED|Overall Study||125
8821259|NCT01576471|9875292|FG001|STARTED|Overall Study||125
8821260|NCT01576471|9875291|FG000|COMPLETED|Overall Study||117
8821261|NCT01576471|9875292|FG001|COMPLETED|Overall Study||116
8821262|NCT01576471|9875291|FG000|NOT COMPLETED|Overall Study||8
8821263|NCT01576471|9875292|FG001|NOT COMPLETED|Overall Study||9
8821264|NCT01576484|9875300|FG000|STARTED|Overall Study||12
8821265|NCT01576484|9875301|FG001|STARTED|Overall Study||46
8821266|NCT01576484|9875300|FG000|COMPLETED|Overall Study||7
8821267|NCT01576484|9875301|FG001|COMPLETED|Overall Study||27
8821268|NCT01576484|9875300|FG000|NOT COMPLETED|Overall Study||5
8821269|NCT01576484|9875301|FG001|NOT COMPLETED|Overall Study||19
8821270|NCT01576523|9875315|FG000|STARTED|Dosing Period 1||3
8821271|NCT01576523|9875316|FG001|STARTED|Dosing Period 1||3
8821272|NCT01576523|9875317|FG002|STARTED|Dosing Period 1||3
8821273|NCT01576523|9875318|FG003|STARTED|Dosing Period 1||3
8821274|NCT01576523|9875319|FG004|STARTED|Dosing Period 1||3
8821275|NCT01576523|9875320|FG005|STARTED|Dosing Period 1||3
8821276|NCT01576523|9875315|FG000|COMPLETED|Dosing Period 1||3
8821277|NCT01576523|9875316|FG001|COMPLETED|Dosing Period 1||3
8821278|NCT01576523|9875317|FG002|COMPLETED|Dosing Period 1||3
8821279|NCT01576523|9875318|FG003|COMPLETED|Dosing Period 1||3
8556525|NCT04402866|9588269|FG004|NOT COMPLETED|Overall Study||15
8821280|NCT01576523|9875319|FG004|COMPLETED|Dosing Period 1||3
8821281|NCT01576523|9875320|FG005|COMPLETED|Dosing Period 1||3
8821282|NCT01576523|9875315|FG000|NOT COMPLETED|Dosing Period 1||0
8821283|NCT01576523|9875316|FG001|NOT COMPLETED|Dosing Period 1||0
8821284|NCT01576523|9875317|FG002|NOT COMPLETED|Dosing Period 1||0
8821285|NCT01576523|9875318|FG003|NOT COMPLETED|Dosing Period 1||0
8821286|NCT01576523|9875319|FG004|NOT COMPLETED|Dosing Period 1||0
8821287|NCT01576523|9875320|FG005|NOT COMPLETED|Dosing Period 1||0
8821288|NCT01576523|9875315|FG000|STARTED|Dosing Period 2||3
8821289|NCT01576523|9875316|FG001|STARTED|Dosing Period 2||3
8821290|NCT01576523|9875317|FG002|STARTED|Dosing Period 2||3
8821291|NCT01576523|9875318|FG003|STARTED|Dosing Period 2||3
8821292|NCT01576523|9875319|FG004|STARTED|Dosing Period 2||3
8821293|NCT01576523|9875320|FG005|STARTED|Dosing Period 2||3
8821294|NCT01576523|9875315|FG000|COMPLETED|Dosing Period 2||3
8556526|NCT04402866|9588270|FG005|NOT COMPLETED|Overall Study||14
8821295|NCT01576523|9875316|FG001|COMPLETED|Dosing Period 2||3
8821296|NCT01576523|9875317|FG002|COMPLETED|Dosing Period 2||3
8821297|NCT01576523|9875318|FG003|COMPLETED|Dosing Period 2||3
8821298|NCT01576523|9875319|FG004|COMPLETED|Dosing Period 2||3
8821299|NCT01576523|9875320|FG005|COMPLETED|Dosing Period 2||3
8821300|NCT01576523|9875315|FG000|NOT COMPLETED|Dosing Period 2||0
8821301|NCT01576523|9875316|FG001|NOT COMPLETED|Dosing Period 2||0
8821302|NCT01576523|9875317|FG002|NOT COMPLETED|Dosing Period 2||0
8821303|NCT01576523|9875318|FG003|NOT COMPLETED|Dosing Period 2||0
8821304|NCT01576523|9875319|FG004|NOT COMPLETED|Dosing Period 2||0
8821305|NCT01576523|9875320|FG005|NOT COMPLETED|Dosing Period 2||0
8821306|NCT01576536|9875329|FG000|STARTED|Overall Study||117
8821307|NCT01576536|9875329|FG000|COMPLETED|Overall Study||117
8821308|NCT01576536|9875329|FG000|NOT COMPLETED|Overall Study||0
8821309|NCT01576588|9875333|FG000|STARTED|Overall Study||25
8821310|NCT01576588|9875333|FG000|COMPLETED|Overall Study||23
8821311|NCT01576588|9875333|FG000|NOT COMPLETED|Overall Study||2
8821312|NCT01576705|9875342|FG000|STARTED|Overall Study||43
8821313|NCT01576705|9875343|FG001|STARTED|Overall Study||45
8821314|NCT01576705|9875344|FG002|STARTED|Overall Study||43
8821315|NCT01576705|9875345|FG003|STARTED|Overall Study||44
8821316|NCT01576705|9875342|FG000|COMPLETED|Overall Study||40
8821317|NCT01576705|9875343|FG001|COMPLETED|Overall Study||37
8821318|NCT01576705|9875344|FG002|COMPLETED|Overall Study||38
8821319|NCT01576705|9875345|FG003|COMPLETED|Overall Study||41
8821320|NCT01576705|9875342|FG000|NOT COMPLETED|Overall Study||3
8821321|NCT01576705|9875343|FG001|NOT COMPLETED|Overall Study||8
8821322|NCT01576705|9875344|FG002|NOT COMPLETED|Overall Study||5
8821323|NCT01576705|9875345|FG003|NOT COMPLETED|Overall Study||3
8821324|NCT01576718|9875361|FG000|STARTED|Pre-Assignment Period (Run-In Placebo)||889
8821325|NCT01576718|9875362|FG001|STARTED|Pre-Assignment Period (Run-In Placebo)||0
8821326|NCT01576718|9875363|FG002|STARTED|Pre-Assignment Period (Run-In Placebo)||0
8821327|NCT01576718|9875364|FG003|STARTED|Pre-Assignment Period (Run-In Placebo)||0
8821328|NCT01576718|9875365|FG004|STARTED|Pre-Assignment Period (Run-In Placebo)||0
8821329|NCT01576718|9875366|FG005|STARTED|Pre-Assignment Period (Run-In Placebo)||0
8821330|NCT01576718|9875367|FG006|STARTED|Pre-Assignment Period (Run-In Placebo)||0
8821331|NCT01576718|9875361|FG000|COMPLETED|Pre-Assignment Period (Run-In Placebo)|Participants randomized into the Treatment Period|640
8821332|NCT01576718|9875362|FG001|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
8821333|NCT01576718|9875363|FG002|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
8821334|NCT01576718|9875364|FG003|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
8821335|NCT01576718|9875365|FG004|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
8821336|NCT01576718|9875366|FG005|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
8821337|NCT01576718|9875367|FG006|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
8821338|NCT01576718|9875361|FG000|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||249
8821339|NCT01576718|9875362|FG001|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
8821340|NCT01576718|9875363|FG002|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
8821341|NCT01576718|9875364|FG003|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
8821342|NCT01576718|9875365|FG004|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
8821343|NCT01576718|9875366|FG005|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
8821344|NCT01576718|9875367|FG006|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
8821345|NCT01576718|9875361|FG000|STARTED|Treatment Period||0
8821346|NCT01576718|9875362|FG001|STARTED|Treatment Period||107
8621977|NCT00485134|9661093|FG004|STARTED|Overall Study||10
8621978|NCT00485134|9661094|FG005|STARTED|Overall Study||7
8621979|NCT00485134|9661095|FG006|STARTED|Overall Study||31
8821347|NCT01576718|9875363|FG002|STARTED|Treatment Period||107
8821348|NCT01576718|9875364|FG003|STARTED|Treatment Period||106
8821349|NCT01576718|9875365|FG004|STARTED|Treatment Period||107
8821350|NCT01576718|9875366|FG005|STARTED|Treatment Period||106
8821351|NCT01576718|9875367|FG006|STARTED|Treatment Period||107
8821352|NCT01576718|9875361|FG000|Safety Population|Treatment Period||0
8821353|NCT01576718|9875362|FG001|Safety Population|Treatment Period||107
8821354|NCT01576718|9875363|FG002|Safety Population|Treatment Period||107
8821355|NCT01576718|9875364|FG003|Safety Population|Treatment Period||106
8821356|NCT01576718|9875365|FG004|Safety Population|Treatment Period||107
8821357|NCT01576718|9875366|FG005|Safety Population|Treatment Period||106
8821358|NCT01576718|9875367|FG006|Safety Population|Treatment Period||106
8821359|NCT01576718|9875361|FG000|Efficacy Population (Full Analysis Set)|Treatment Period||0
8821360|NCT01576718|9875362|FG001|Efficacy Population (Full Analysis Set)|Treatment Period||107
8821361|NCT01576718|9875363|FG002|Efficacy Population (Full Analysis Set)|Treatment Period||106
8821362|NCT01576718|9875364|FG003|Efficacy Population (Full Analysis Set)|Treatment Period||102
8821363|NCT01576718|9875365|FG004|Efficacy Population (Full Analysis Set)|Treatment Period||107
8821364|NCT01576718|9875366|FG005|Efficacy Population (Full Analysis Set)|Treatment Period||105
8821365|NCT01576718|9875367|FG006|Efficacy Population (Full Analysis Set)|Treatment Period||103
8821366|NCT01576718|9875361|FG000|COMPLETED|Treatment Period||0
8821367|NCT01576718|9875362|FG001|COMPLETED|Treatment Period||82
8821368|NCT01576718|9875363|FG002|COMPLETED|Treatment Period||87
8821369|NCT01576718|9875364|FG003|COMPLETED|Treatment Period||75
8821370|NCT01576718|9875365|FG004|COMPLETED|Treatment Period||80
8821371|NCT01576718|9875366|FG005|COMPLETED|Treatment Period||58
8821372|NCT01576718|9875367|FG006|COMPLETED|Treatment Period||77
8821373|NCT01576718|9875361|FG000|NOT COMPLETED|Treatment Period||0
8821374|NCT01576718|9875362|FG001|NOT COMPLETED|Treatment Period||25
8821375|NCT01576718|9875363|FG002|NOT COMPLETED|Treatment Period||20
8821376|NCT01576718|9875364|FG003|NOT COMPLETED|Treatment Period||31
8821377|NCT01576718|9875365|FG004|NOT COMPLETED|Treatment Period||27
8621980|NCT00485134|9661096|FG007|STARTED|Overall Study||21
8821378|NCT01576718|9875366|FG005|NOT COMPLETED|Treatment Period||48
8821379|NCT01576718|9875367|FG006|NOT COMPLETED|Treatment Period||30
8821380|NCT01576783|9875383|FG000|STARTED|Overall Study||189
8821381|NCT01576783|9875384|FG001|STARTED|Overall Study||188
8821382|NCT01576783|9875383|FG000|COMPLETED|Overall Study||169
8821383|NCT01576783|9875384|FG001|COMPLETED|Overall Study||171
8821384|NCT01576783|9875383|FG000|NOT COMPLETED|Overall Study||20
8821385|NCT01576783|9875384|FG001|NOT COMPLETED|Overall Study||17
8821386|NCT01576809|9875390|FG000|STARTED|Overall Study||51
8821387|NCT01576809|9875390|FG000|COMPLETED|Overall Study||51
8821388|NCT01576809|9875390|FG000|NOT COMPLETED|Overall Study||0
8821389|NCT01576874|9875396|FG000|STARTED|Overall Study||72
8821390|NCT01576874|9875397|FG001|STARTED|Overall Study||72
8821391|NCT01576874|9875396|FG000|COMPLETED|Overall Study||72
8821392|NCT01576874|9875397|FG001|COMPLETED|Overall Study||72
8821393|NCT01576874|9875396|FG000|NOT COMPLETED|Overall Study||0
8821394|NCT01576874|9875397|FG001|NOT COMPLETED|Overall Study||0
8821395|NCT01576939|9875403|FG000|STARTED|Overall Study||30
8821396|NCT01576939|9875403|FG000|COMPLETED|Overall Study||30
8821397|NCT01576939|9875403|FG000|NOT COMPLETED|Overall Study||0
8821398|NCT01576952|9875409|FG000|STARTED|Overall Study||180
8821399|NCT01576952|9875410|FG001|STARTED|Overall Study||88
8821400|NCT01576952|9875409|FG000|Safety Population|Overall Study||169
8821401|NCT01576952|9875410|FG001|Safety Population|Overall Study||85
8821402|NCT01576952|9875409|FG000|mITT Population|Overall Study||168
8821403|NCT01576952|9875410|FG001|mITT Population|Overall Study||85
8821404|NCT01576952|9875409|FG000|COMPLETED|Overall Study||139
8821405|NCT01576952|9875410|FG001|COMPLETED|Overall Study||33
8821406|NCT01576952|9875409|FG000|NOT COMPLETED|Overall Study||41
8821407|NCT01576952|9875410|FG001|NOT COMPLETED|Overall Study||55
8821408|NCT01577108|9875418|FG000|STARTED|Overall Study||54
8821409|NCT01577108|9875419|FG001|STARTED|Overall Study||56
8821410|NCT01577108|9875418|FG000|COMPLETED|Overall Study||49
8821411|NCT01577108|9875419|FG001|COMPLETED|Overall Study||50
8821412|NCT01577108|9875418|FG000|NOT COMPLETED|Overall Study||5
8821413|NCT01577108|9875419|FG001|NOT COMPLETED|Overall Study||6
8821414|NCT01577160|9875425|FG000|STARTED|Overall Study||353
8821415|NCT01577160|9875425|FG000|COMPLETED|Overall Study||255
8821416|NCT01577160|9875425|FG000|NOT COMPLETED|Overall Study||98
8821417|NCT01577186|9875429|FG000|STARTED|Overall Study||480
8821418|NCT01577186|9875429|FG000|COMPLETED|Overall Study||350
8821419|NCT01577186|9875429|FG000|NOT COMPLETED|Overall Study||130
8821420|NCT01577238|9875435|FG000|STARTED|Overall Study||127
8821421|NCT01577238|9875436|FG001|STARTED|Overall Study||123
8821422|NCT01577238|9875435|FG000|COMPLETED|Overall Study||117
8821423|NCT01577238|9875436|FG001|COMPLETED|Overall Study||111
8821424|NCT01577238|9875435|FG000|NOT COMPLETED|Overall Study||10
8821425|NCT01577238|9875436|FG001|NOT COMPLETED|Overall Study||12
8821426|NCT01577329|9875444|FG000|STARTED|Overall Study||19
8821427|NCT01577329|9875445|FG001|STARTED|Overall Study||22
8821428|NCT01577329|9875444|FG000|COMPLETED|Overall Study||16
8821429|NCT01577329|9875445|FG001|COMPLETED|Overall Study||22
8821430|NCT01577329|9875444|FG000|NOT COMPLETED|Overall Study||3
8821431|NCT01577329|9875445|FG001|NOT COMPLETED|Overall Study||0
8821432|NCT01577381|9875455|FG000|STARTED|Overall Study||2
8821433|NCT01577381|9875456|FG001|STARTED|Overall Study||3
8821434|NCT01577381|9875457|FG002|STARTED|Overall Study||3
8821435|NCT01577381|9875458|FG003|STARTED|Overall Study||2
8821436|NCT01577381|9875455|FG000|COMPLETED|Overall Study||0
8821437|NCT01577381|9875456|FG001|COMPLETED|Overall Study||0
8821438|NCT01577381|9875457|FG002|COMPLETED|Overall Study||0
8821439|NCT01577381|9875458|FG003|COMPLETED|Overall Study||0
8821440|NCT01577381|9875455|FG000|NOT COMPLETED|Overall Study||2
8821441|NCT01577381|9875456|FG001|NOT COMPLETED|Overall Study||3
8821442|NCT01577381|9875457|FG002|NOT COMPLETED|Overall Study||3
8821443|NCT01577381|9875458|FG003|NOT COMPLETED|Overall Study||2
8821444|NCT01577537|9875470|FG000|STARTED|Overall Study||128
8821445|NCT01577537|9875471|FG001|STARTED|Overall Study||123
8821446|NCT01577537|9875470|FG000|COMPLETED|Overall Study||120
8821447|NCT01577537|9875471|FG001|COMPLETED|Overall Study||116
8821448|NCT01577537|9875470|FG000|NOT COMPLETED|Overall Study||8
8821449|NCT01577537|9875471|FG001|NOT COMPLETED|Overall Study||7
8821450|NCT01577706|9875477|FG000|STARTED|First Intervention (1 Day)||3
8821451|NCT01577706|9875478|FG001|STARTED|First Intervention (1 Day)||1
8821452|NCT01577706|9875479|FG002|STARTED|First Intervention (1 Day)||3
8821453|NCT01577706|9875477|FG000|COMPLETED|First Intervention (1 Day)||3
8821454|NCT01577706|9875478|FG001|COMPLETED|First Intervention (1 Day)||1
8821455|NCT01577706|9875479|FG002|COMPLETED|First Intervention (1 Day)||3
8821456|NCT01577706|9875477|FG000|NOT COMPLETED|First Intervention (1 Day)||0
8821457|NCT01577706|9875478|FG001|NOT COMPLETED|First Intervention (1 Day)||0
8821458|NCT01577706|9875479|FG002|NOT COMPLETED|First Intervention (1 Day)||0
8821459|NCT01577706|9875477|FG000|STARTED|Washout (at Least 1 Week)||3
8821460|NCT01577706|9875478|FG001|STARTED|Washout (at Least 1 Week)||1
8821461|NCT01577706|9875479|FG002|STARTED|Washout (at Least 1 Week)||3
8821462|NCT01577706|9875477|FG000|COMPLETED|Washout (at Least 1 Week)||3
8821463|NCT01577706|9875478|FG001|COMPLETED|Washout (at Least 1 Week)||1
8821464|NCT01577706|9875479|FG002|COMPLETED|Washout (at Least 1 Week)||3
8821465|NCT01577706|9875477|FG000|NOT COMPLETED|Washout (at Least 1 Week)||0
8821466|NCT01577706|9875478|FG001|NOT COMPLETED|Washout (at Least 1 Week)||0
8821467|NCT01577706|9875479|FG002|NOT COMPLETED|Washout (at Least 1 Week)||0
8821468|NCT01577706|9875477|FG000|STARTED|Second Intervention (1 Day)||3
8821469|NCT01577706|9875478|FG001|STARTED|Second Intervention (1 Day)||1
8821470|NCT01577706|9875479|FG002|STARTED|Second Intervention (1 Day)||3
8821471|NCT01577706|9875477|FG000|COMPLETED|Second Intervention (1 Day)||3
8821472|NCT01577706|9875478|FG001|COMPLETED|Second Intervention (1 Day)||1
8821473|NCT01577706|9875479|FG002|COMPLETED|Second Intervention (1 Day)||3
8821474|NCT01577706|9875477|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
8821475|NCT01577706|9875478|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
8821476|NCT01577706|9875479|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
8821477|NCT01577706|9875477|FG000|STARTED|Washout (at Least 1 Week)||3
8821478|NCT01577706|9875478|FG001|STARTED|Washout (at Least 1 Week)||1
8821479|NCT01577706|9875479|FG002|STARTED|Washout (at Least 1 Week)||3
8821480|NCT01577706|9875477|FG000|COMPLETED|Washout (at Least 1 Week)||3
8821481|NCT01577706|9875478|FG001|COMPLETED|Washout (at Least 1 Week)||1
8821482|NCT01577706|9875479|FG002|COMPLETED|Washout (at Least 1 Week)||3
8821483|NCT01577706|9875477|FG000|NOT COMPLETED|Washout (at Least 1 Week)||0
8821484|NCT01577706|9875478|FG001|NOT COMPLETED|Washout (at Least 1 Week)||0
8821485|NCT01577706|9875479|FG002|NOT COMPLETED|Washout (at Least 1 Week)||0
8821486|NCT01577706|9875477|FG000|STARTED|Third Intervention (1 Day)||3
8821487|NCT01577706|9875478|FG001|STARTED|Third Intervention (1 Day)||1
8821488|NCT01577706|9875479|FG002|STARTED|Third Intervention (1 Day)||3
8821489|NCT01577706|9875477|FG000|COMPLETED|Third Intervention (1 Day)||3
8821490|NCT01577706|9875478|FG001|COMPLETED|Third Intervention (1 Day)||1
8821491|NCT01577706|9875479|FG002|COMPLETED|Third Intervention (1 Day)||3
8821492|NCT01577706|9875477|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
8821493|NCT01577706|9875478|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
8821494|NCT01577706|9875479|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
8821495|NCT01577732|9875487|FG000|STARTED|Overall Study||300
8821496|NCT01577732|9875487|FG000|COMPLETED|Overall Study||300
8821497|NCT01577732|9875487|FG000|NOT COMPLETED|Overall Study||0
8821498|NCT01577745|9875497|FG000|STARTED|Overall Study||3
8821499|NCT01577745|9875498|FG001|STARTED|Overall Study||3
8821500|NCT01577745|9875499|FG002|STARTED|Overall Study||3
8821501|NCT01577745|9875500|FG003|STARTED|Overall Study||6
8821502|NCT01577745|9875501|FG004|STARTED|Overall Study||5
8821503|NCT01577745|9875502|FG005|STARTED|Overall Study||5
8821504|NCT01577745|9875497|FG000|COMPLETED|Overall Study||0
8821505|NCT01577745|9875498|FG001|COMPLETED|Overall Study||0
8821506|NCT01577745|9875499|FG002|COMPLETED|Overall Study||1
8821507|NCT01577745|9875500|FG003|COMPLETED|Overall Study||0
8821508|NCT01577745|9875501|FG004|COMPLETED|Overall Study||0
8821509|NCT01577745|9875502|FG005|COMPLETED|Overall Study||1
8821510|NCT01577745|9875497|FG000|NOT COMPLETED|Overall Study||3
8821511|NCT01577745|9875498|FG001|NOT COMPLETED|Overall Study||3
8821512|NCT01577745|9875499|FG002|NOT COMPLETED|Overall Study||2
8821513|NCT01577745|9875500|FG003|NOT COMPLETED|Overall Study||6
8821514|NCT01577745|9875501|FG004|NOT COMPLETED|Overall Study||5
8821515|NCT01577745|9875502|FG005|NOT COMPLETED|Overall Study||4
8821516|NCT01577758|9875521|FG000|STARTED|Dose Escalation Phase||2
8821517|NCT01577758|9875522|FG001|STARTED|Dose Escalation Phase||2
8821518|NCT01577758|9875523|FG002|STARTED|Dose Escalation Phase||2
8821519|NCT01577758|9875524|FG003|STARTED|Dose Escalation Phase||2
8821520|NCT01577758|9875525|FG004|STARTED|Dose Escalation Phase||6
8821521|NCT01577758|9875526|FG005|STARTED|Dose Escalation Phase||4
8821522|NCT01577758|9875527|FG006|STARTED|Dose Escalation Phase||1
8821523|NCT01577758|9875528|FG007|STARTED|Dose Escalation Phase||0
8821524|NCT01577758|9875521|FG000|COMPLETED|Dose Escalation Phase||0
8821525|NCT01577758|9875522|FG001|COMPLETED|Dose Escalation Phase||0
8821526|NCT01577758|9875523|FG002|COMPLETED|Dose Escalation Phase||0
8821527|NCT01577758|9875524|FG003|COMPLETED|Dose Escalation Phase||0
8821528|NCT01577758|9875525|FG004|COMPLETED|Dose Escalation Phase||0
8821529|NCT01577758|9875526|FG005|COMPLETED|Dose Escalation Phase||0
8821530|NCT01577758|9875527|FG006|COMPLETED|Dose Escalation Phase||0
8821531|NCT01577758|9875528|FG007|COMPLETED|Dose Escalation Phase||0
8821532|NCT01577758|9875521|FG000|NOT COMPLETED|Dose Escalation Phase||2
8821533|NCT01577758|9875522|FG001|NOT COMPLETED|Dose Escalation Phase||2
8821534|NCT01577758|9875523|FG002|NOT COMPLETED|Dose Escalation Phase||2
8821535|NCT01577758|9875524|FG003|NOT COMPLETED|Dose Escalation Phase||2
8821536|NCT01577758|9875525|FG004|NOT COMPLETED|Dose Escalation Phase||6
8821537|NCT01577758|9875526|FG005|NOT COMPLETED|Dose Escalation Phase||4
8821538|NCT01577758|9875527|FG006|NOT COMPLETED|Dose Escalation Phase||1
8821539|NCT01577758|9875528|FG007|NOT COMPLETED|Dose Escalation Phase||0
8821540|NCT01577758|9875521|FG000|STARTED|mCRC Expansion Phase||0
8821541|NCT01577758|9875522|FG001|STARTED|mCRC Expansion Phase||0
8821542|NCT01577758|9875523|FG002|STARTED|mCRC Expansion Phase||0
8821543|NCT01577758|9875524|FG003|STARTED|mCRC Expansion Phase||0
8821544|NCT01577758|9875525|FG004|STARTED|mCRC Expansion Phase||0
8821545|NCT01577758|9875526|FG005|STARTED|mCRC Expansion Phase||0
8821546|NCT01577758|9875527|FG006|STARTED|mCRC Expansion Phase||0
8821547|NCT01577758|9875528|FG007|STARTED|mCRC Expansion Phase||25
8821548|NCT01577758|9875521|FG000|COMPLETED|mCRC Expansion Phase||0
8821549|NCT01577758|9875522|FG001|COMPLETED|mCRC Expansion Phase||0
8821550|NCT01577758|9875523|FG002|COMPLETED|mCRC Expansion Phase||0
8821551|NCT01577758|9875524|FG003|COMPLETED|mCRC Expansion Phase||0
8821552|NCT01577758|9875525|FG004|COMPLETED|mCRC Expansion Phase||0
8821553|NCT01577758|9875526|FG005|COMPLETED|mCRC Expansion Phase||0
8821554|NCT01577758|9875527|FG006|COMPLETED|mCRC Expansion Phase||0
8556527|NCT04327388|9588283|FG000|STARTED|Overall Study||161
8556528|NCT04327388|9588284|FG001|STARTED|Overall Study||173
8556529|NCT04327388|9588285|FG002|STARTED|Overall Study||86
8556530|NCT04327388|9588283|FG000|Treated|Overall Study||159
8556531|NCT04327388|9588284|FG001|Treated|Overall Study||173
8556532|NCT04327388|9588285|FG002|Treated|Overall Study||84
8556533|NCT04327388|9588283|FG000|Participants Who Received Second Dose|Overall Study||13
8821555|NCT01577758|9875528|FG007|COMPLETED|mCRC Expansion Phase||0
8821556|NCT01577758|9875521|FG000|NOT COMPLETED|mCRC Expansion Phase||0
8821557|NCT01577758|9875522|FG001|NOT COMPLETED|mCRC Expansion Phase||0
8821558|NCT01577758|9875523|FG002|NOT COMPLETED|mCRC Expansion Phase||0
8821559|NCT01577758|9875524|FG003|NOT COMPLETED|mCRC Expansion Phase||0
8821560|NCT01577758|9875525|FG004|NOT COMPLETED|mCRC Expansion Phase||0
8821561|NCT01577758|9875526|FG005|NOT COMPLETED|mCRC Expansion Phase||0
8821562|NCT01577758|9875527|FG006|NOT COMPLETED|mCRC Expansion Phase||0
8821563|NCT01577758|9875528|FG007|NOT COMPLETED|mCRC Expansion Phase||25
8821564|NCT01577966|9875548|FG000|STARTED|Overall Study||9
8821565|NCT01577966|9875548|FG000|COMPLETED|Overall Study||9
8821566|NCT01577966|9875548|FG000|NOT COMPLETED|Overall Study||0
8821567|NCT01578031|9875556|FG000|STARTED|Overall Study||129
8821568|NCT01578031|9875557|FG001|STARTED|Overall Study||69
8821569|NCT01578031|9875558|FG002|STARTED|Overall Study||12
8821570|NCT01578031|9875559|FG003|STARTED|Overall Study||30
8821571|NCT01578031|9875556|FG000|COMPLETED|Overall Study|Follow-up obtained only in subjects with average PAP use at least 4 hr/day|67
8821572|NCT01578031|9875557|FG001|COMPLETED|Overall Study|Follow-up obtained only in subjects with average PAP use at least 4 hr/day|35
8821573|NCT01578031|9875558|FG002|COMPLETED|Overall Study|Only baseline data collected|12
8821574|NCT01578031|9875559|FG003|COMPLETED|Overall Study|Only baseline data collected|30
8821575|NCT01578031|9875556|FG000|NOT COMPLETED|Overall Study||62
8821576|NCT01578031|9875557|FG001|NOT COMPLETED|Overall Study||34
8821577|NCT01578031|9875558|FG002|NOT COMPLETED|Overall Study||0
8821578|NCT01578031|9875559|FG003|NOT COMPLETED|Overall Study||0
8821579|NCT01578044|9875569|FG000|STARTED|Overall Study||6
8821580|NCT01578044|9875570|FG001|STARTED|Overall Study||6
8821581|NCT01578044|9875569|FG000|COMPLETED|Overall Study||6
8821582|NCT01578044|9875570|FG001|COMPLETED|Overall Study||6
8821583|NCT01578044|9875569|FG000|NOT COMPLETED|Overall Study||0
8821584|NCT01578044|9875570|FG001|NOT COMPLETED|Overall Study||0
8821585|NCT01578187|9875576|FG000|STARTED|Label Comprehension Phase||63
8821586|NCT01578187|9875576|FG000|COMPLETED|Label Comprehension Phase||63
8821587|NCT01578187|9875576|FG000|NOT COMPLETED|Label Comprehension Phase||0
8821588|NCT01578187|9875576|FG000|STARTED|Usability Phase||48
8821589|NCT01578187|9875576|FG000|COMPLETED|Usability Phase||47
8821590|NCT01578187|9875576|FG000|NOT COMPLETED|Usability Phase||1
8821591|NCT01578278|9875586|FG000|STARTED|Overall Study||152
8821592|NCT01578278|9875587|FG001|STARTED|Overall Study||152
8821593|NCT01578278|9875588|FG002|STARTED|Overall Study||154
8821594|NCT01578278|9875589|FG003|STARTED|Overall Study||148
8821595|NCT01578278|9875586|FG000|COMPLETED|Overall Study||148
8821596|NCT01578278|9875587|FG001|COMPLETED|Overall Study||150
8821597|NCT01578278|9875588|FG002|COMPLETED|Overall Study||150
8821598|NCT01578278|9875589|FG003|COMPLETED|Overall Study||139
8821599|NCT01578278|9875586|FG000|NOT COMPLETED|Overall Study||4
8821600|NCT01578278|9875587|FG001|NOT COMPLETED|Overall Study||2
8821601|NCT01578278|9875588|FG002|NOT COMPLETED|Overall Study||4
8821602|NCT01578278|9875589|FG003|NOT COMPLETED|Overall Study||9
8821603|NCT01578317|9875601|FG000|STARTED|Overall Study||22
8821604|NCT01578317|9875602|FG001|STARTED|Overall Study||21
8821605|NCT01578317|9875601|FG000|Analysis Population|Overall Study||22
8821606|NCT01578317|9875602|FG001|Analysis Population|Overall Study||20
8821607|NCT01578317|9875601|FG000|COMPLETED|Overall Study||22
8821608|NCT01578317|9875602|FG001|COMPLETED|Overall Study||20
8821609|NCT01578317|9875601|FG000|NOT COMPLETED|Overall Study||0
8821610|NCT01578317|9875602|FG001|NOT COMPLETED|Overall Study||1
8821611|NCT01578330|9875608|FG000|STARTED|Overall Study||42
8821612|NCT01578330|9875608|FG000|Per Protocol Population|Overall Study||35
8821613|NCT01578330|9875608|FG000|COMPLETED|Overall Study||35
8821614|NCT01578330|9875608|FG000|NOT COMPLETED|Overall Study||7
8821615|NCT01578486|9875612|FG000|STARTED|Overall Study||13
8821616|NCT01578486|9875612|FG000|COMPLETED|Overall Study||8
8821617|NCT01578486|9875612|FG000|NOT COMPLETED|Overall Study||5
8821618|NCT01578499|9875618|FG000|STARTED|Overall Study||66
8821619|NCT01578499|9875619|FG001|STARTED|Overall Study||65
8821620|NCT01578499|9875618|FG000|Safety Population: Treated|Overall Study||66
8821621|NCT01578499|9875619|FG001|Safety Population: Treated|Overall Study||62
8821622|NCT01578499|9875618|FG000|Intent to Treat Population: CD30+|Overall Study||64
8821623|NCT01578499|9875619|FG001|Intent to Treat Population: CD30+|Overall Study||64
8821624|NCT01578499|9875618|FG000|COMPLETED|Overall Study||32
8821625|NCT01578499|9875619|FG001|COMPLETED|Overall Study||22
8821626|NCT01578499|9875618|FG000|NOT COMPLETED|Overall Study||34
8556534|NCT04327388|9588284|FG001|Participants Who Received Second Dose|Overall Study||11
8821627|NCT01578499|9875619|FG001|NOT COMPLETED|Overall Study||43
8821628|NCT01578551|9875631|FG000|STARTED|Overall Study||19
8821629|NCT01578551|9875632|FG001|STARTED|Overall Study||6
8821630|NCT01578551|9875631|FG000|COMPLETED|Overall Study||18
8821631|NCT01578551|9875632|FG001|COMPLETED|Overall Study||6
8821632|NCT01578551|9875631|FG000|NOT COMPLETED|Overall Study||1
8821633|NCT01578551|9875632|FG001|NOT COMPLETED|Overall Study||0
8821634|NCT01578577|9875642|FG000|STARTED|Overall Study||305
8821635|NCT01578577|9875643|FG001|STARTED|Overall Study||302
8821636|NCT01578577|9875644|FG002|STARTED|Overall Study||313
8821637|NCT01578577|9875642|FG000|COMPLETED|Overall Study||254
8821638|NCT01578577|9875643|FG001|COMPLETED|Overall Study||262
8821639|NCT01578577|9875644|FG002|COMPLETED|Overall Study||278
8821640|NCT01578577|9875642|FG000|NOT COMPLETED|Overall Study||51
8821641|NCT01578577|9875643|FG001|NOT COMPLETED|Overall Study||40
8821642|NCT01578577|9875644|FG002|NOT COMPLETED|Overall Study||35
8821643|NCT01578707|9875664|FG000|STARTED|Overall Study||196
8821644|NCT01578707|9875665|FG001|STARTED|Overall Study||195
8821645|NCT01578707|9875664|FG000|COMPLETED|Overall Study||196
8821646|NCT01578707|9875665|FG001|COMPLETED|Overall Study||195
8821647|NCT01578707|9875664|FG000|NOT COMPLETED|Overall Study||0
8821648|NCT01578707|9875665|FG001|NOT COMPLETED|Overall Study||0
8821649|NCT01578772|9875671|FG000|STARTED|Overall Study||17
8821650|NCT01578772|9875671|FG000|COMPLETED|Overall Study||17
8821651|NCT01578772|9875671|FG000|NOT COMPLETED|Overall Study||0
8821652|NCT01578850|9875678|FG000|STARTED|Period 1|491 participants were enrolled in open-label treatment but 2 did not receive study medication.|489
8821653|NCT01578850|9875679|FG001|STARTED|Period 1||0
8821654|NCT01578850|9875680|FG002|STARTED|Period 1||0
8821655|NCT01578850|9875678|FG000|COMPLETED|Period 1||452
8821656|NCT01578850|9875679|FG001|COMPLETED|Period 1||0
8821657|NCT01578850|9875680|FG002|COMPLETED|Period 1||0
8821658|NCT01578850|9875678|FG000|NOT COMPLETED|Period 1||37
8821659|NCT01578850|9875679|FG001|NOT COMPLETED|Period 1||0
8821660|NCT01578850|9875680|FG002|NOT COMPLETED|Period 1||0
8821661|NCT01578850|9875678|FG000|STARTED|Period 2||0
8821662|NCT01578850|9875679|FG001|STARTED|Period 2|Two participants in ETN did not receive treatment.|167
8621981|NCT00485134|9661089|FG000|COMPLETED|Overall Study||11
8621982|NCT00485134|9661090|FG001|COMPLETED|Overall Study||10
8621983|NCT00485134|9661091|FG002|COMPLETED|Overall Study||9
8821663|NCT01578850|9875680|FG002|STARTED|Period 2|One participants in PBO did not receive treatment.|176
8821664|NCT01578850|9875678|FG000|COMPLETED|Period 2||0
8821665|NCT01578850|9875679|FG001|COMPLETED|Period 2||154
8821666|NCT01578850|9875680|FG002|COMPLETED|Period 2||162
8821667|NCT01578850|9875678|FG000|NOT COMPLETED|Period 2||0
8821668|NCT01578850|9875679|FG001|NOT COMPLETED|Period 2||13
8621984|NCT00485134|9661092|FG003|COMPLETED|Overall Study||7
8621985|NCT00485134|9661093|FG004|COMPLETED|Overall Study||7
8621986|NCT00485134|9661094|FG005|COMPLETED|Overall Study||3
8621987|NCT00485134|9661095|FG006|COMPLETED|Overall Study||28
8621988|NCT00485134|9661096|FG007|COMPLETED|Overall Study||20
8621989|NCT00485134|9661089|FG000|NOT COMPLETED|Overall Study||1
8621990|NCT00485134|9661090|FG001|NOT COMPLETED|Overall Study||2
8621991|NCT00485134|9661091|FG002|NOT COMPLETED|Overall Study||3
8621992|NCT00485134|9661092|FG003|NOT COMPLETED|Overall Study||1
8621993|NCT00485134|9661093|FG004|NOT COMPLETED|Overall Study||3
8621994|NCT00485134|9661094|FG005|NOT COMPLETED|Overall Study||4
8621995|NCT00485134|9661095|FG006|NOT COMPLETED|Overall Study||3
8821669|NCT01578850|9875680|FG002|NOT COMPLETED|Period 2||14
8821670|NCT01578902|9875688|FG000|STARTED|Overall Study||84
8821671|NCT01578902|9875688|FG000|COMPLETED|Overall Study||84
8821672|NCT01578902|9875688|FG000|NOT COMPLETED|Overall Study||0
8821673|NCT01578980|9875695|FG000|STARTED|Overall Study||20
8821674|NCT01578980|9875695|FG000|COMPLETED|Overall Study||20
8821675|NCT01578980|9875695|FG000|NOT COMPLETED|Overall Study||0
8821676|NCT01578993|9875699|FG000|STARTED|Overall Study||101
8821677|NCT01578993|9875699|FG000|COMPLETED|Overall Study||101
8821678|NCT01578993|9875699|FG000|NOT COMPLETED|Overall Study||0
8821679|NCT01579006|9875703|FG000|STARTED|Overall Study||184
8821680|NCT01579006|9875703|FG000|COMPLETED|Overall Study||151
8821681|NCT01579006|9875703|FG000|NOT COMPLETED|Overall Study||33
8821682|NCT01579045|9875707|FG000|STARTED|Overall Study||24
8821683|NCT01579045|9875707|FG000|COMPLETED|Overall Study||24
8821684|NCT01579045|9875707|FG000|NOT COMPLETED|Overall Study||0
8821685|NCT01579084|9875729|FG000|STARTED|Overall Study||8
8821686|NCT01579084|9875730|FG001|STARTED|Overall Study||8
8821687|NCT01579084|9875731|FG002|STARTED|Overall Study||8
8821688|NCT01579084|9875732|FG003|STARTED|Overall Study||8
8821689|NCT01579084|9875733|FG004|STARTED|Overall Study||8
8821690|NCT01579084|9875734|FG005|STARTED|Overall Study||8
8821691|NCT01579084|9875735|FG006|STARTED|Overall Study||4
8821692|NCT01579084|9875736|FG007|STARTED|Overall Study||4
8821693|NCT01579084|9875737|FG008|STARTED|Overall Study||4
8821694|NCT01579084|9875738|FG009|STARTED|Overall Study||4
8821695|NCT01579084|9875729|FG000|COMPLETED|Overall Study||8
8821696|NCT01579084|9875730|FG001|COMPLETED|Overall Study||8
8821697|NCT01579084|9875731|FG002|COMPLETED|Overall Study||8
8621996|NCT00485134|9661096|FG007|NOT COMPLETED|Overall Study||1
8621997|NCT00485173|9661110|FG000|STARTED|Overall Study||224
8621998|NCT00485173|9661111|FG001|STARTED|Overall Study||486
8821698|NCT01579084|9875732|FG003|COMPLETED|Overall Study||8
8621999|NCT00485173|9661110|FG000|COMPLETED|Overall Study|The number of completed participants is reported the number of subjects who had any 24-month data.|188
8622000|NCT00485173|9661111|FG001|COMPLETED|Overall Study|The number of completed participants is reported the number of subjects who had any 24-month data.|422
8821699|NCT01579084|9875733|FG004|COMPLETED|Overall Study||8
8821700|NCT01579084|9875734|FG005|COMPLETED|Overall Study||8
8821701|NCT01579084|9875735|FG006|COMPLETED|Overall Study||4
8821702|NCT01579084|9875736|FG007|COMPLETED|Overall Study||4
8821703|NCT01579084|9875737|FG008|COMPLETED|Overall Study||4
8821704|NCT01579084|9875738|FG009|COMPLETED|Overall Study||4
8821705|NCT01579084|9875729|FG000|NOT COMPLETED|Overall Study||0
8821706|NCT01579084|9875730|FG001|NOT COMPLETED|Overall Study||0
8821707|NCT01579084|9875731|FG002|NOT COMPLETED|Overall Study||0
8821708|NCT01579084|9875732|FG003|NOT COMPLETED|Overall Study||0
8821709|NCT01579084|9875733|FG004|NOT COMPLETED|Overall Study||0
8821710|NCT01579084|9875734|FG005|NOT COMPLETED|Overall Study||0
8821711|NCT01579084|9875735|FG006|NOT COMPLETED|Overall Study||0
8821712|NCT01579084|9875736|FG007|NOT COMPLETED|Overall Study||0
8821713|NCT01579084|9875737|FG008|NOT COMPLETED|Overall Study||0
8821714|NCT01579084|9875738|FG009|NOT COMPLETED|Overall Study||0
8821715|NCT01579162|9875759|FG000|STARTED|Overall Study||16
8821716|NCT01579162|9875760|FG001|STARTED|Overall Study||8
8821717|NCT01579162|9875761|FG002|STARTED|Overall Study||8
8821718|NCT01579162|9875762|FG003|STARTED|Overall Study||8
8821719|NCT01579162|9875763|FG004|STARTED|Overall Study||8
8821720|NCT01579162|9875759|FG000|COMPLETED|Overall Study||16
8821721|NCT01579162|9875760|FG001|COMPLETED|Overall Study||8
8821722|NCT01579162|9875761|FG002|COMPLETED|Overall Study||8
8821723|NCT01579162|9875762|FG003|COMPLETED|Overall Study||8
8821724|NCT01579162|9875763|FG004|COMPLETED|Overall Study||8
8821725|NCT01579162|9875759|FG000|NOT COMPLETED|Overall Study||0
8821726|NCT01579162|9875760|FG001|NOT COMPLETED|Overall Study||0
8821727|NCT01579162|9875761|FG002|NOT COMPLETED|Overall Study||0
8821728|NCT01579162|9875762|FG003|NOT COMPLETED|Overall Study||0
8821729|NCT01579162|9875763|FG004|NOT COMPLETED|Overall Study||0
8821730|NCT01579214|9875778|FG000|STARTED|Overall Study||45
8821731|NCT01579214|9875779|FG001|STARTED|Overall Study||138
8821732|NCT01579214|9875778|FG000|COMPLETED|Overall Study||45
8821733|NCT01579214|9875779|FG001|COMPLETED|Overall Study||138
8821734|NCT01579214|9875778|FG000|NOT COMPLETED|Overall Study||0
8821735|NCT01579214|9875779|FG001|NOT COMPLETED|Overall Study||0
8821736|NCT01579305|9875787|FG000|STARTED|Overall Study|Subjects that signed Informed Consent, passed screening criteria, and were randomized.|139
8821737|NCT01579305|9875788|FG001|STARTED|Overall Study|Subjects that signed Informed Consent, passed screening criteria, and were randomized.|142
8821738|NCT01579305|9875787|FG000|Discontinued Before Treatment|Overall Study||0
8821739|NCT01579305|9875788|FG001|Discontinued Before Treatment|Overall Study||1
8821740|NCT01579305|9875787|FG000|Continued After Treatment|Overall Study||139
8821741|NCT01579305|9875788|FG001|Continued After Treatment|Overall Study||141
8821742|NCT01579305|9875787|FG000|COMPLETED|Overall Study||118
8821743|NCT01579305|9875788|FG001|COMPLETED|Overall Study||115
8821744|NCT01579305|9875787|FG000|NOT COMPLETED|Overall Study||21
8821745|NCT01579305|9875788|FG001|NOT COMPLETED|Overall Study||27
8821746|NCT01579318|9875794|FG000|STARTED|Overall Study||2
8821747|NCT01579318|9875794|FG000|COMPLETED|Overall Study||1
8821748|NCT01579318|9875794|FG000|NOT COMPLETED|Overall Study||1
8821749|NCT01579474|9875804|FG000|STARTED|Overall Study||44
8821750|NCT01579474|9875805|FG001|STARTED|Overall Study||43
8821751|NCT01579474|9875806|FG002|STARTED|Overall Study||29
8821752|NCT01579474|9875807|FG003|STARTED|Overall Study||3
8821753|NCT01579474|9875808|FG004|STARTED|Overall Study||10
8821754|NCT01579474|9875809|FG005|STARTED|Overall Study||2
8821755|NCT01579474|9875804|FG000|COMPLETED|Overall Study||41
8821756|NCT01579474|9875805|FG001|COMPLETED|Overall Study||30
8821757|NCT01579474|9875806|FG002|COMPLETED|Overall Study||27
8821758|NCT01579474|9875807|FG003|COMPLETED|Overall Study||3
8821759|NCT01579474|9875808|FG004|COMPLETED|Overall Study||9
8821760|NCT01579474|9875809|FG005|COMPLETED|Overall Study||1
8821761|NCT01579474|9875804|FG000|NOT COMPLETED|Overall Study||3
8821762|NCT01579474|9875805|FG001|NOT COMPLETED|Overall Study||13
8821763|NCT01579474|9875806|FG002|NOT COMPLETED|Overall Study||2
8821764|NCT01579474|9875807|FG003|NOT COMPLETED|Overall Study||0
8821765|NCT01579474|9875808|FG004|NOT COMPLETED|Overall Study||1
8821766|NCT01579474|9875809|FG005|NOT COMPLETED|Overall Study||1
8821767|NCT01579513|9875824|FG000|STARTED|Primary Hospitalization||91
8821768|NCT01579513|9875825|FG001|STARTED|Primary Hospitalization||99
8821769|NCT01579513|9875824|FG000|COMPLETED|Primary Hospitalization||81
8821770|NCT01579513|9875825|FG001|COMPLETED|Primary Hospitalization||95
8821771|NCT01579513|9875824|FG000|NOT COMPLETED|Primary Hospitalization||10
8821772|NCT01579513|9875825|FG001|NOT COMPLETED|Primary Hospitalization||4
8821773|NCT01579513|9875824|FG000|STARTED|1 Year Neurodevelopmental Follow up||81
8821774|NCT01579513|9875825|FG001|STARTED|1 Year Neurodevelopmental Follow up||95
8821775|NCT01579513|9875824|FG000|COMPLETED|1 Year Neurodevelopmental Follow up||61
8821776|NCT01579513|9875825|FG001|COMPLETED|1 Year Neurodevelopmental Follow up||68
8821777|NCT01579513|9875824|FG000|NOT COMPLETED|1 Year Neurodevelopmental Follow up||20
8821778|NCT01579513|9875825|FG001|NOT COMPLETED|1 Year Neurodevelopmental Follow up||27
8821779|NCT01579565|9875833|FG000|STARTED|Randomized||207
8821780|NCT01579565|9875834|FG001|STARTED|Randomized||209
8821781|NCT01579565|9875833|FG000|COMPLETED|Randomized||202
8821782|NCT01579565|9875834|FG001|COMPLETED|Randomized||204
8821783|NCT01579565|9875833|FG000|NOT COMPLETED|Randomized||5
8821784|NCT01579565|9875834|FG001|NOT COMPLETED|Randomized||5
8821785|NCT01579565|9875833|FG000|STARTED|Treated||202
8821786|NCT01579565|9875834|FG001|STARTED|Treated||204
8821787|NCT01579565|9875833|FG000|COMPLETED|Treated||200
8821788|NCT01579565|9875834|FG001|COMPLETED|Treated||201
8821789|NCT01579565|9875833|FG000|NOT COMPLETED|Treated||2
8821790|NCT01579565|9875834|FG001|NOT COMPLETED|Treated||3
8821791|NCT01579578|9875844|FG000|STARTED|Overall Study||13
8821792|NCT01579578|9875845|FG001|STARTED|Overall Study||12
8821793|NCT01579578|9875844|FG000|Ongoing|Overall Study||3
8821794|NCT01579578|9875845|FG001|Ongoing|Overall Study||0
8821795|NCT01579578|9875844|FG000|COMPLETED|Overall Study||0
8821796|NCT01579578|9875845|FG001|COMPLETED|Overall Study||0
8821797|NCT01579578|9875844|FG000|NOT COMPLETED|Overall Study||13
8821798|NCT01579578|9875845|FG001|NOT COMPLETED|Overall Study||12
8821799|NCT01579669|9875853|FG000|STARTED|Overall Study||170
8821800|NCT01579669|9875854|FG001|STARTED|Overall Study||41
8821801|NCT01579669|9875853|FG000|COMPLETED|Overall Study||134
8821802|NCT01579669|9875854|FG001|COMPLETED|Overall Study||41
8821803|NCT01579669|9875853|FG000|NOT COMPLETED|Overall Study||36
8821804|NCT01579669|9875854|FG001|NOT COMPLETED|Overall Study||0
8821805|NCT01579747|9875862|FG000|STARTED|Overall Study||12
8821806|NCT01579747|9875863|FG001|STARTED|Overall Study||12
8821807|NCT01579747|9875862|FG000|COMPLETED|Overall Study||12
8821808|NCT01579747|9875863|FG001|COMPLETED|Overall Study||12
8821809|NCT01579747|9875862|FG000|NOT COMPLETED|Overall Study||0
8821810|NCT01579747|9875863|FG001|NOT COMPLETED|Overall Study||0
8821811|NCT01579812|9875869|FG000|STARTED|Overall Study||90
8821812|NCT01579812|9875869|FG000|COMPLETED|Overall Study||38
8821813|NCT01579812|9875869|FG000|NOT COMPLETED|Overall Study||52
8821814|NCT01579916|9875878|FG000|STARTED|Overall Study||242
8821815|NCT01579916|9875879|FG001|STARTED|Overall Study||61
8821816|NCT01579916|9875878|FG000|COMPLETED|Overall Study||234
8821817|NCT01579916|9875879|FG001|COMPLETED|Overall Study||59
8821818|NCT01579916|9875878|FG000|NOT COMPLETED|Overall Study||8
8821819|NCT01579916|9875879|FG001|NOT COMPLETED|Overall Study||2
8821820|NCT01580020|9875887|FG000|STARTED|Overall Study||52
8821821|NCT01580020|9875888|FG001|STARTED|Overall Study||40
8821822|NCT01580020|9875889|FG002|STARTED|Overall Study||61
8821823|NCT01580020|9875890|FG003|STARTED|Overall Study||22
8821824|NCT01580020|9875887|FG000|COMPLETED|Overall Study||51
8821825|NCT01580020|9875888|FG001|COMPLETED|Overall Study||33
8821826|NCT01580020|9875889|FG002|COMPLETED|Overall Study||57
8821827|NCT01580020|9875890|FG003|COMPLETED|Overall Study||20
8821828|NCT01580020|9875887|FG000|NOT COMPLETED|Overall Study||1
8821829|NCT01580020|9875888|FG001|NOT COMPLETED|Overall Study||7
8821830|NCT01580020|9875889|FG002|NOT COMPLETED|Overall Study||4
8821831|NCT01580020|9875890|FG003|NOT COMPLETED|Overall Study||2
8821832|NCT01580072|9875903|FG000|STARTED|Overall Study||28
8821833|NCT01580072|9875904|FG001|STARTED|Overall Study||37
8821834|NCT01580072|9875905|FG002|STARTED|Overall Study||0
8821835|NCT01580072|9875903|FG000|COMPLETED|Overall Study||16
8821836|NCT01580072|9875904|FG001|COMPLETED|Overall Study||28
8821837|NCT01580072|9875905|FG002|COMPLETED|Overall Study||0
8821838|NCT01580072|9875903|FG000|NOT COMPLETED|Overall Study||12
8821839|NCT01580072|9875904|FG001|NOT COMPLETED|Overall Study||9
8821840|NCT01580072|9875905|FG002|NOT COMPLETED|Overall Study||0
8821841|NCT01580098|9875915|FG000|STARTED|Overall Study||76
8821842|NCT01580098|9875916|FG001|STARTED|Overall Study||114
8821843|NCT01580098|9875917|FG002|STARTED|Overall Study||3
8821844|NCT01580098|9875915|FG000|COMPLETED|Overall Study||61
8821845|NCT01580098|9875916|FG001|COMPLETED|Overall Study||101
8821846|NCT01580098|9875917|FG002|COMPLETED|Overall Study|Due to high age and bad health conditions no patients finished (nursing)|0
8821847|NCT01580098|9875915|FG000|NOT COMPLETED|Overall Study||15
8821848|NCT01580098|9875916|FG001|NOT COMPLETED|Overall Study||13
8821849|NCT01580098|9875917|FG002|NOT COMPLETED|Overall Study||3
8821850|NCT01580293|9875931|FG000|STARTED|Part A_Main Trial||20
8821851|NCT01580293|9875932|FG001|STARTED|Part A_Main Trial||114
8821852|NCT01580293|9875933|FG002|STARTED|Part A_Main Trial|Participants in Part B were not counted for Part A|0
8821853|NCT01580293|9875931|FG000|COMPLETED|Part A_Main Trial||18
8821854|NCT01580293|9875932|FG001|COMPLETED|Part A_Main Trial||108
8821855|NCT01580293|9875933|FG002|COMPLETED|Part A_Main Trial||0
8821856|NCT01580293|9875931|FG000|NOT COMPLETED|Part A_Main Trial||2
8821857|NCT01580293|9875932|FG001|NOT COMPLETED|Part A_Main Trial||6
8821858|NCT01580293|9875933|FG002|NOT COMPLETED|Part A_Main Trial||0
8821859|NCT01580293|9875931|FG000|STARTED|Part A_Extension|Not all participants from main trial entered extension or remained in the same arm.|14
8821860|NCT01580293|9875932|FG001|STARTED|Part A_Extension|Not all participants from main trial entered extension or remained in the same arm.|107
8821861|NCT01580293|9875933|FG002|STARTED|Part A_Extension|Participants in Part B were not counted for part A|0
8821862|NCT01580293|9875931|FG000|COMPLETED|Part A_Extension||14
8821863|NCT01580293|9875932|FG001|COMPLETED|Part A_Extension||95
8821864|NCT01580293|9875933|FG002|COMPLETED|Part A_Extension||0
8821865|NCT01580293|9875931|FG000|NOT COMPLETED|Part A_Extension||0
8821866|NCT01580293|9875932|FG001|NOT COMPLETED|Part A_Extension||12
8622001|NCT00485173|9661110|FG000|NOT COMPLETED|Overall Study||36
8622002|NCT00485173|9661111|FG001|NOT COMPLETED|Overall Study||64
8622003|NCT00485264|9661123|FG000|STARTED|Overall Study||71
8622004|NCT00485264|9661124|FG001|STARTED|Overall Study||16
8622005|NCT00485264|9661125|FG002|STARTED|Overall Study||18
8622006|NCT00485264|9661126|FG003|STARTED|Overall Study||21
8821867|NCT01580293|9875933|FG002|NOT COMPLETED|Part A_Extension||0
8821868|NCT01580293|9875931|FG000|STARTED|Part B|Time in Part A for 8 participants coming from Part A was not counted in part B.|0
8821869|NCT01580293|9875932|FG001|STARTED|Part B|Time in Part A for 8 participants coming from Part A was not counted in part B.|0
8821870|NCT01580293|9875933|FG002|STARTED|Part B|11 participants were enrolled in Part B only, 8 participants switched from Part A to Part B.|19
8821871|NCT01580293|9875931|FG000|COMPLETED|Part B||0
8821872|NCT01580293|9875932|FG001|COMPLETED|Part B||0
8821873|NCT01580293|9875933|FG002|COMPLETED|Part B||17
8821874|NCT01580293|9875931|FG000|NOT COMPLETED|Part B||0
8821875|NCT01580293|9875932|FG001|NOT COMPLETED|Part B||0
8821876|NCT01580293|9875933|FG002|NOT COMPLETED|Part B||2
8821877|NCT01580306|9875964|FG000|STARTED|Overall Study||8
8821878|NCT01580306|9875965|FG001|STARTED|Overall Study||8
8821879|NCT01580306|9875966|FG002|STARTED|Overall Study||8
8821880|NCT01580306|9875967|FG003|STARTED|Overall Study||8
8821881|NCT01580306|9875964|FG000|COMPLETED|Overall Study||8
8821882|NCT01580306|9875965|FG001|COMPLETED|Overall Study||8
8821883|NCT01580306|9875966|FG002|COMPLETED|Overall Study||8
8821884|NCT01580306|9875967|FG003|COMPLETED|Overall Study||8
8821885|NCT01580306|9875964|FG000|NOT COMPLETED|Overall Study||0
8821886|NCT01580306|9875965|FG001|NOT COMPLETED|Overall Study||0
8821887|NCT01580306|9875966|FG002|NOT COMPLETED|Overall Study||0
8821888|NCT01580306|9875967|FG003|NOT COMPLETED|Overall Study||0
8821889|NCT01580410|9875979|FG000|STARTED|Overall Study||68
8821890|NCT01580410|9875980|FG001|STARTED|Overall Study||68
8821891|NCT01580410|9875979|FG000|COMPLETED|Overall Study||57
8821892|NCT01580410|9875980|FG001|COMPLETED|Overall Study||60
8821893|NCT01580410|9875979|FG000|NOT COMPLETED|Overall Study||11
8821894|NCT01580410|9875980|FG001|NOT COMPLETED|Overall Study||8
8821895|NCT01580423|9875986|FG000|STARTED|First Intervention||8
8821896|NCT01580423|9875987|FG001|STARTED|First Intervention||8
8821897|NCT01580423|9875986|FG000|COMPLETED|First Intervention||8
8821898|NCT01580423|9875987|FG001|COMPLETED|First Intervention||8
8821899|NCT01580423|9875986|FG000|NOT COMPLETED|First Intervention||0
8821900|NCT01580423|9875987|FG001|NOT COMPLETED|First Intervention||0
8821901|NCT01580423|9875986|FG000|STARTED|Second Intervention||8
8821902|NCT01580423|9875987|FG001|STARTED|Second Intervention||8
8821903|NCT01580423|9875986|FG000|COMPLETED|Second Intervention||8
8821904|NCT01580423|9875987|FG001|COMPLETED|Second Intervention||8
8821905|NCT01580423|9875986|FG000|NOT COMPLETED|Second Intervention||0
8821906|NCT01580423|9875987|FG001|NOT COMPLETED|Second Intervention||0
8821907|NCT01580488|9875994|FG000|STARTED|Overall Study||24
8821908|NCT01580488|9875994|FG000|COMPLETED|Overall Study||23
8821909|NCT01580488|9875994|FG000|NOT COMPLETED|Overall Study||1
8821910|NCT01580592|9876011|FG000|STARTED|Overall Study||10
8821911|NCT01580592|9876012|FG001|STARTED|Overall Study||9
8821912|NCT01580592|9876013|FG002|STARTED|Overall Study||12
8821913|NCT01580592|9876011|FG000|COMPLETED|Overall Study||10
8821914|NCT01580592|9876012|FG001|COMPLETED|Overall Study||9
8821915|NCT01580592|9876013|FG002|COMPLETED|Overall Study||12
8821916|NCT01580592|9876011|FG000|NOT COMPLETED|Overall Study||0
8821917|NCT01580592|9876012|FG001|NOT COMPLETED|Overall Study||0
8821918|NCT01580592|9876013|FG002|NOT COMPLETED|Overall Study||0
8821919|NCT01580618|9876023|FG000|STARTED|Overall Study||8
8821920|NCT01580618|9876024|FG001|STARTED|Overall Study||12
8821921|NCT01580618|9876023|FG000|COMPLETED|Overall Study|One patient was switched from the normal saline to TNKase arm at attending physician request.|7
8821922|NCT01580618|9876024|FG001|COMPLETED|Overall Study||12
8821923|NCT01580618|9876023|FG000|NOT COMPLETED|Overall Study||1
8821924|NCT01580618|9876024|FG001|NOT COMPLETED|Overall Study||0
8821925|NCT01580670|9876030|FG000|STARTED|Induction Period (Week 0 to 14)||14
8821926|NCT01580670|9876030|FG000|COMPLETED|Induction Period (Week 0 to 14)||14
8821927|NCT01580670|9876030|FG000|NOT COMPLETED|Induction Period (Week 0 to 14)||0
8821928|NCT01580670|9876030|FG000|STARTED|Maintenance Period (Week 14 to 54)||14
8821929|NCT01580670|9876030|FG000|COMPLETED|Maintenance Period (Week 14 to 54)||12
8821930|NCT01580670|9876030|FG000|NOT COMPLETED|Maintenance Period (Week 14 to 54)||2
8821931|NCT01580904|9876036|FG000|STARTED|Overall Study||51
8821932|NCT01580904|9876037|FG001|STARTED|Overall Study||49
8821933|NCT01580904|9876036|FG000|COMPLETED|Overall Study||47
8821934|NCT01580904|9876037|FG001|COMPLETED|Overall Study||42
8821935|NCT01580904|9876036|FG000|NOT COMPLETED|Overall Study||4
8821936|NCT01580904|9876037|FG001|NOT COMPLETED|Overall Study||7
8821937|NCT01580969|9876047|FG000|STARTED|Overall Study||6
8821938|NCT01580969|9876048|FG001|STARTED|Overall Study||3
8821939|NCT01580969|9876049|FG002|STARTED|Overall Study||13
8821940|NCT01580969|9876047|FG000|COMPLETED|Overall Study||3
8821941|NCT01580969|9876048|FG001|COMPLETED|Overall Study||3
8821942|NCT01580969|9876049|FG002|COMPLETED|Overall Study||13
8821943|NCT01580969|9876047|FG000|NOT COMPLETED|Overall Study||3
8821944|NCT01580969|9876048|FG001|NOT COMPLETED|Overall Study||0
8821945|NCT01580969|9876049|FG002|NOT COMPLETED|Overall Study||0
8821946|NCT01580995|9876059|FG000|STARTED|Overall Study||10
8821947|NCT01580995|9876060|FG001|STARTED|Overall Study||9
8821948|NCT01580995|9876059|FG000|COMPLETED|Overall Study||8
8821949|NCT01580995|9876060|FG001|COMPLETED|Overall Study||7
8821950|NCT01580995|9876059|FG000|NOT COMPLETED|Overall Study||2
8821951|NCT01580995|9876060|FG001|NOT COMPLETED|Overall Study||2
8821952|NCT01581008|9876068|FG000|STARTED|Overall Study||17
8821953|NCT01581008|9876069|FG001|STARTED|Overall Study||13
8821954|NCT01581008|9876068|FG000|COMPLETED|Overall Study||16
8821955|NCT01581008|9876069|FG001|COMPLETED|Overall Study||7
8821956|NCT01581008|9876068|FG000|NOT COMPLETED|Overall Study||1
8821957|NCT01581008|9876069|FG001|NOT COMPLETED|Overall Study||6
8821958|NCT01581021|9876078|FG000|STARTED|Overall Study||29
8821959|NCT01581021|9876079|FG001|STARTED|Overall Study||29
8821960|NCT01581021|9876078|FG000|COMPLETED|Overall Study||19
8821961|NCT01581021|9876079|FG001|COMPLETED|Overall Study||18
8821962|NCT01581021|9876078|FG000|NOT COMPLETED|Overall Study||10
8821963|NCT01581021|9876079|FG001|NOT COMPLETED|Overall Study||11
8821964|NCT01581281|9876088|FG000|STARTED|Overall Study||145
8821965|NCT01581281|9876089|FG001|STARTED|Overall Study||72
8821966|NCT01581281|9876090|FG002|STARTED|Overall Study||144
8821967|NCT01581281|9876088|FG000|COMPLETED|Overall Study||130
8821968|NCT01581281|9876089|FG001|COMPLETED|Overall Study||66
8821969|NCT01581281|9876090|FG002|COMPLETED|Overall Study||132
8821970|NCT01581281|9876088|FG000|NOT COMPLETED|Overall Study||15
8821971|NCT01581281|9876089|FG001|NOT COMPLETED|Overall Study||6
8821972|NCT01581281|9876090|FG002|NOT COMPLETED|Overall Study||12
8849411|NCT01740401|9904586|FG000|COMPLETED|Overall Study||0
8849412|NCT01740401|9904586|FG000|NOT COMPLETED|Overall Study||10
8849413|NCT01740414|9904592|FG000|STARTED|Overall Study||12
8849414|NCT01740414|9904593|FG001|STARTED|Overall Study||16
8849415|NCT01740414|9904592|FG000|COMPLETED|Overall Study||3
8849416|NCT01740414|9904593|FG001|COMPLETED|Overall Study||8
8849417|NCT01740414|9904592|FG000|NOT COMPLETED|Overall Study||9
8849418|NCT01740414|9904593|FG001|NOT COMPLETED|Overall Study||8
8849419|NCT01740440|9904604|FG000|STARTED|Overall Study||30
8849420|NCT01740440|9904604|FG000|COMPLETED|Overall Study||27
8849421|NCT01740440|9904604|FG000|NOT COMPLETED|Overall Study||3
8849422|NCT01740713|9904612|FG000|STARTED|Overall Study||6
8849423|NCT01740713|9904613|FG001|STARTED|Overall Study||8
8849424|NCT01740713|9904614|FG002|STARTED|Overall Study||7
8849425|NCT01740713|9904612|FG000|COMPLETED|Overall Study||6
8849426|NCT01740713|9904613|FG001|COMPLETED|Overall Study||6
8849427|NCT01740713|9904614|FG002|COMPLETED|Overall Study||6
8849428|NCT01740713|9904612|FG000|NOT COMPLETED|Overall Study||0
8849429|NCT01740713|9904613|FG001|NOT COMPLETED|Overall Study||2
8849430|NCT01740713|9904614|FG002|NOT COMPLETED|Overall Study||1
8849431|NCT01740726|9904626|FG000|STARTED|Overall Study||0
8849432|NCT01740726|9904627|FG001|STARTED|Overall Study||1
8849433|NCT01740726|9904626|FG000|COMPLETED|Overall Study||0
8849434|NCT01740726|9904627|FG001|COMPLETED|Overall Study||1
8849435|NCT01740726|9904626|FG000|NOT COMPLETED|Overall Study||0
8849436|NCT01740726|9904627|FG001|NOT COMPLETED|Overall Study||0
8849437|NCT01740791|9904639|FG000|STARTED|Overall Study||22
8849438|NCT01740791|9904640|FG001|STARTED|Overall Study||7
8849439|NCT01740791|9904641|FG002|STARTED|Overall Study||17
8849440|NCT01740791|9904642|FG003|STARTED|Overall Study||14
8849441|NCT01740791|9904643|FG004|STARTED|Overall Study||9
8849442|NCT01740791|9904644|FG005|STARTED|Overall Study||34
8849443|NCT01740791|9904639|FG000|COMPLETED|Overall Study||10
8849444|NCT01740791|9904640|FG001|COMPLETED|Overall Study||4
8849445|NCT01740791|9904641|FG002|COMPLETED|Overall Study||11
8849446|NCT01740791|9904642|FG003|COMPLETED|Overall Study||7
8849447|NCT01740791|9904643|FG004|COMPLETED|Overall Study||6
8849448|NCT01740791|9904644|FG005|COMPLETED|Overall Study||23
8849449|NCT01740791|9904639|FG000|NOT COMPLETED|Overall Study||12
8849450|NCT01740791|9904640|FG001|NOT COMPLETED|Overall Study||3
8849451|NCT01740791|9904641|FG002|NOT COMPLETED|Overall Study||6
8849452|NCT01740791|9904642|FG003|NOT COMPLETED|Overall Study||7
8849453|NCT01740791|9904643|FG004|NOT COMPLETED|Overall Study||3
8849454|NCT01740791|9904644|FG005|NOT COMPLETED|Overall Study||11
8849455|NCT01740817|9904699|FG000|STARTED|First Intervention (48 h)||8
8849456|NCT01740817|9904700|FG001|STARTED|First Intervention (48 h)||4
8943816|NCT02391948|10005624|FG003|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 3 of the Not Completed remained active.|119
8849457|NCT01740817|9904699|FG000|COMPLETED|First Intervention (48 h)||8
8849458|NCT01740817|9904700|FG001|COMPLETED|First Intervention (48 h)||4
8849459|NCT01740817|9904699|FG000|NOT COMPLETED|First Intervention (48 h)||0
8849460|NCT01740817|9904700|FG001|NOT COMPLETED|First Intervention (48 h)||0
8849461|NCT01740817|9904699|FG000|STARTED|Washout (4-6 Weeks)||8
8849462|NCT01740817|9904700|FG001|STARTED|Washout (4-6 Weeks)||4
8849463|NCT01740817|9904699|FG000|COMPLETED|Washout (4-6 Weeks)||8
8849464|NCT01740817|9904700|FG001|COMPLETED|Washout (4-6 Weeks)||4
8849465|NCT01740817|9904699|FG000|NOT COMPLETED|Washout (4-6 Weeks)||0
8849466|NCT01740817|9904700|FG001|NOT COMPLETED|Washout (4-6 Weeks)||0
8849467|NCT01740817|9904699|FG000|STARTED|Second Intervention (48 h)||8
8849468|NCT01740817|9904700|FG001|STARTED|Second Intervention (48 h)||4
8849469|NCT01740817|9904699|FG000|COMPLETED|Second Intervention (48 h)||8
8849470|NCT01740817|9904700|FG001|COMPLETED|Second Intervention (48 h)||4
8849471|NCT01740817|9904699|FG000|NOT COMPLETED|Second Intervention (48 h)||0
8849472|NCT01740817|9904700|FG001|NOT COMPLETED|Second Intervention (48 h)||0
8849473|NCT01741012|9904706|FG000|STARTED|Overall Study||37
8849474|NCT01741012|9904706|FG000|COMPLETED|Overall Study||34
8849475|NCT01741012|9904706|FG000|NOT COMPLETED|Overall Study||3
8849476|NCT01741259|9904713|FG000|STARTED|Overall Study||133
8849477|NCT01741259|9904714|FG001|STARTED|Overall Study||135
8849478|NCT01741259|9904713|FG000|COMPLETED|Overall Study||127
8849479|NCT01741259|9904714|FG001|COMPLETED|Overall Study||129
8849480|NCT01741259|9904713|FG000|NOT COMPLETED|Overall Study||6
8849481|NCT01741259|9904714|FG001|NOT COMPLETED|Overall Study||6
8849482|NCT01741272|9904722|FG000|STARTED|Overall Study||92
8849483|NCT01741272|9904723|FG001|STARTED|Overall Study||97
8849484|NCT01741272|9904722|FG000|COMPLETED|Overall Study||92
8849485|NCT01741272|9904723|FG001|COMPLETED|Overall Study||97
8849486|NCT01741272|9904722|FG000|NOT COMPLETED|Overall Study||0
8849487|NCT01741272|9904723|FG001|NOT COMPLETED|Overall Study||0
8849488|NCT01741350|9904731|FG000|STARTED|Study Intervention||149
8849489|NCT01741350|9904732|FG001|STARTED|Study Intervention||155
8849490|NCT01741350|9904731|FG000|COMPLETED|Study Intervention||149
8821973|NCT01581307|9876099|FG000|STARTED|Overall Study||9
8821974|NCT01581307|9876099|FG000|COMPLETED|Overall Study||8
8821975|NCT01581307|9876099|FG000|NOT COMPLETED|Overall Study||1
8821976|NCT01581437|9876103|FG000|STARTED|Overall Study||78
8821977|NCT01581437|9876103|FG000|COMPLETED|Overall Study||78
8821978|NCT01581437|9876103|FG000|NOT COMPLETED|Overall Study||0
8821979|NCT01581541|9876111|FG000|STARTED|Overall Study||1
8821980|NCT01581541|9876112|FG001|STARTED|Overall Study||1
8821981|NCT01581541|9876113|FG002|STARTED|Overall Study||1
8821982|NCT01581541|9876114|FG003|STARTED|Overall Study||1
8821983|NCT01581541|9876115|FG004|STARTED|Overall Study||2
8821984|NCT01581541|9876116|FG005|STARTED|Overall Study||3
8821985|NCT01581541|9876117|FG006|STARTED|Overall Study||1
8821986|NCT01581541|9876118|FG007|STARTED|Overall Study||2
8821987|NCT01581541|9876119|FG008|STARTED|Overall Study||1
8821988|NCT01581541|9876120|FG009|STARTED|Overall Study||3
8821989|NCT01581541|9876121|FG010|STARTED|Overall Study||1
8821990|NCT01581541|9876111|FG000|COMPLETED|Overall Study||1
8821991|NCT01581541|9876112|FG001|COMPLETED|Overall Study||1
8821992|NCT01581541|9876113|FG002|COMPLETED|Overall Study||1
8821993|NCT01581541|9876114|FG003|COMPLETED|Overall Study||1
8821994|NCT01581541|9876115|FG004|COMPLETED|Overall Study||2
8821995|NCT01581541|9876116|FG005|COMPLETED|Overall Study||3
8821996|NCT01581541|9876117|FG006|COMPLETED|Overall Study||1
8821997|NCT01581541|9876118|FG007|COMPLETED|Overall Study||2
8821998|NCT01581541|9876119|FG008|COMPLETED|Overall Study||1
8821999|NCT01581541|9876120|FG009|COMPLETED|Overall Study||3
8822000|NCT01581541|9876121|FG010|COMPLETED|Overall Study||1
8822001|NCT01581541|9876111|FG000|NOT COMPLETED|Overall Study||0
8822002|NCT01581541|9876112|FG001|NOT COMPLETED|Overall Study||0
8822003|NCT01581541|9876113|FG002|NOT COMPLETED|Overall Study||0
8822004|NCT01581541|9876114|FG003|NOT COMPLETED|Overall Study||0
8822005|NCT01581541|9876115|FG004|NOT COMPLETED|Overall Study||0
8822006|NCT01581541|9876116|FG005|NOT COMPLETED|Overall Study||0
8822007|NCT01581541|9876117|FG006|NOT COMPLETED|Overall Study||0
8822008|NCT01581541|9876118|FG007|NOT COMPLETED|Overall Study||0
8822009|NCT01581541|9876119|FG008|NOT COMPLETED|Overall Study||0
8822010|NCT01581541|9876120|FG009|NOT COMPLETED|Overall Study||0
8822011|NCT01581541|9876121|FG010|NOT COMPLETED|Overall Study||0
8822012|NCT01581593|9876146|FG000|STARTED|Overall Study||45
8822013|NCT01581593|9876146|FG000|COMPLETED|Overall Study||44
8822014|NCT01581593|9876146|FG000|NOT COMPLETED|Overall Study||1
8822015|NCT01581619|9876154|FG000|STARTED|Overall Study||54
8822016|NCT01581619|9876154|FG000|COMPLETED|Overall Study||52
8822017|NCT01581619|9876154|FG000|NOT COMPLETED|Overall Study||2
8822018|NCT01581658|9876164|FG000|STARTED|Overall Study||8
8822019|NCT01581658|9876165|FG001|STARTED|Overall Study||8
8822020|NCT01581658|9876166|FG002|STARTED|Overall Study||8
8822021|NCT01581658|9876167|FG003|STARTED|Overall Study||8
8822022|NCT01581658|9876164|FG000|COMPLETED|Overall Study||8
8822023|NCT01581658|9876165|FG001|COMPLETED|Overall Study||8
8822024|NCT01581658|9876166|FG002|COMPLETED|Overall Study||8
8822025|NCT01581658|9876167|FG003|COMPLETED|Overall Study||8
8822026|NCT01581658|9876164|FG000|NOT COMPLETED|Overall Study||0
8822027|NCT01581658|9876165|FG001|NOT COMPLETED|Overall Study||0
8822028|NCT01581658|9876166|FG002|NOT COMPLETED|Overall Study||0
8822029|NCT01581658|9876167|FG003|NOT COMPLETED|Overall Study||0
8822030|NCT01581684|9876187|FG000|STARTED|Overall Study||14
8822031|NCT01581684|9876188|FG001|STARTED|Overall Study||6
8822032|NCT01581684|9876189|FG002|STARTED|Overall Study||6
8822033|NCT01581684|9876190|FG003|STARTED|Overall Study||6
8822034|NCT01581684|9876191|FG004|STARTED|Overall Study||6
8822035|NCT01581684|9876192|FG005|STARTED|Overall Study||6
8822036|NCT01581684|9876193|FG006|STARTED|Overall Study||6
8822037|NCT01581684|9876194|FG007|STARTED|Overall Study||6
8822038|NCT01581684|9876195|FG008|STARTED|Overall Study||1
8822039|NCT01581684|9876196|FG009|STARTED|Overall Study||5
8822040|NCT01581684|9876187|FG000|COMPLETED|Overall Study||14
8822041|NCT01581684|9876188|FG001|COMPLETED|Overall Study||6
8822042|NCT01581684|9876189|FG002|COMPLETED|Overall Study||6
8822043|NCT01581684|9876190|FG003|COMPLETED|Overall Study||6
8822044|NCT01581684|9876191|FG004|COMPLETED|Overall Study||6
8822045|NCT01581684|9876192|FG005|COMPLETED|Overall Study||6
8822046|NCT01581684|9876193|FG006|COMPLETED|Overall Study||6
8822047|NCT01581684|9876194|FG007|COMPLETED|Overall Study||6
8822048|NCT01581684|9876195|FG008|COMPLETED|Overall Study||0
8822049|NCT01581684|9876196|FG009|COMPLETED|Overall Study||5
8822050|NCT01581684|9876187|FG000|NOT COMPLETED|Overall Study||0
8822051|NCT01581684|9876188|FG001|NOT COMPLETED|Overall Study||0
8822052|NCT01581684|9876189|FG002|NOT COMPLETED|Overall Study||0
8822053|NCT01581684|9876190|FG003|NOT COMPLETED|Overall Study||0
8822054|NCT01581684|9876191|FG004|NOT COMPLETED|Overall Study||0
8822055|NCT01581684|9876192|FG005|NOT COMPLETED|Overall Study||0
8822056|NCT01581684|9876193|FG006|NOT COMPLETED|Overall Study||0
8822057|NCT01581684|9876194|FG007|NOT COMPLETED|Overall Study||0
8822058|NCT01581684|9876195|FG008|NOT COMPLETED|Overall Study||1
8822059|NCT01581684|9876196|FG009|NOT COMPLETED|Overall Study||0
8822060|NCT01581710|9876229|FG000|STARTED|First Intervention (14days)||18
8822061|NCT01581710|9876230|FG001|STARTED|First Intervention (14days)||14
8822062|NCT01581710|9876229|FG000|COMPLETED|First Intervention (14days)||18
8822063|NCT01581710|9876230|FG001|COMPLETED|First Intervention (14days)||14
8822064|NCT01581710|9876229|FG000|NOT COMPLETED|First Intervention (14days)||0
8822065|NCT01581710|9876230|FG001|NOT COMPLETED|First Intervention (14days)||0
8822066|NCT01581710|9876229|FG000|STARTED|Washout Period (14days)||18
8822067|NCT01581710|9876230|FG001|STARTED|Washout Period (14days)||14
8822068|NCT01581710|9876229|FG000|COMPLETED|Washout Period (14days)||18
8822069|NCT01581710|9876230|FG001|COMPLETED|Washout Period (14days)||14
8822070|NCT01581710|9876229|FG000|NOT COMPLETED|Washout Period (14days)||0
8822071|NCT01581710|9876230|FG001|NOT COMPLETED|Washout Period (14days)||0
8822072|NCT01581710|9876229|FG000|STARTED|Second Intervention (14days)||18
8822073|NCT01581710|9876230|FG001|STARTED|Second Intervention (14days)||14
8822074|NCT01581710|9876229|FG000|COMPLETED|Second Intervention (14days)||18
8822075|NCT01581710|9876230|FG001|COMPLETED|Second Intervention (14days)||12
8822076|NCT01581710|9876229|FG000|NOT COMPLETED|Second Intervention (14days)||0
8822077|NCT01581710|9876230|FG001|NOT COMPLETED|Second Intervention (14days)||2
8822078|NCT01581931|9876240|FG000|STARTED|First Period||16
8822079|NCT01581931|9876241|FG001|STARTED|First Period||16
8822080|NCT01581931|9876240|FG000|COMPLETED|First Period||16
8822081|NCT01581931|9876241|FG001|COMPLETED|First Period||16
8822082|NCT01581931|9876240|FG000|NOT COMPLETED|First Period||0
8822083|NCT01581931|9876241|FG001|NOT COMPLETED|First Period||0
8822084|NCT01581931|9876240|FG000|STARTED|Washout||16
8822085|NCT01581931|9876241|FG001|STARTED|Washout||16
8822086|NCT01581931|9876240|FG000|COMPLETED|Washout||16
8822087|NCT01581931|9876241|FG001|COMPLETED|Washout||15
8822088|NCT01581931|9876240|FG000|NOT COMPLETED|Washout||0
8822089|NCT01581931|9876241|FG001|NOT COMPLETED|Washout||1
8822090|NCT01581931|9876240|FG000|STARTED|Second Period||16
8822091|NCT01581931|9876241|FG001|STARTED|Second Period||15
8822092|NCT01581931|9876240|FG000|COMPLETED|Second Period||16
8822093|NCT01581931|9876241|FG001|COMPLETED|Second Period||15
8822094|NCT01581931|9876240|FG000|NOT COMPLETED|Second Period||0
8822095|NCT01581931|9876241|FG001|NOT COMPLETED|Second Period||0
8822096|NCT01581970|9876247|FG000|STARTED|Overall Study||7
8822097|NCT01581970|9876247|FG000|COMPLETED|Overall Study||7
8822098|NCT01581970|9876247|FG000|NOT COMPLETED|Overall Study||0
8822099|NCT01582009|9876251|FG000|STARTED|Overall Study||26
8822100|NCT01582009|9876251|FG000|COMPLETED|Overall Study||24
8822101|NCT01582009|9876251|FG000|NOT COMPLETED|Overall Study||2
8822102|NCT01582061|9876257|FG000|STARTED|Overall Study||49
8822103|NCT01582061|9876258|FG001|STARTED|Overall Study||55
8822104|NCT01582061|9876257|FG000|COMPLETED|Overall Study||21
8822105|NCT01582061|9876258|FG001|COMPLETED|Overall Study||19
8822106|NCT01582061|9876257|FG000|NOT COMPLETED|Overall Study||28
8822107|NCT01582061|9876258|FG001|NOT COMPLETED|Overall Study||36
8822108|NCT01582139|9876276|FG000|STARTED|Overall Study||6
8822109|NCT01582139|9876277|FG001|STARTED|Overall Study||6
8822110|NCT01582139|9876276|FG000|COMPLETED|Overall Study||6
8822111|NCT01582139|9876277|FG001|COMPLETED|Overall Study||6
8822112|NCT01582139|9876276|FG000|NOT COMPLETED|Overall Study||0
8822113|NCT01582139|9876277|FG001|NOT COMPLETED|Overall Study||0
8822114|NCT01582152|9876285|FG000|STARTED|Overall Study||6
8822115|NCT01582152|9876286|FG001|STARTED|Overall Study||6
8822116|NCT01582152|9876285|FG000|COMPLETED|Overall Study||0
8822117|NCT01582152|9876286|FG001|COMPLETED|Overall Study||0
8822118|NCT01582152|9876285|FG000|NOT COMPLETED|Overall Study||6
8822119|NCT01582152|9876286|FG001|NOT COMPLETED|Overall Study||6
8822120|NCT01582178|9876294|FG000|STARTED|Overall Study||106
8822121|NCT01582178|9876295|FG001|STARTED|Overall Study||106
8822122|NCT01582178|9876294|FG000|COMPLETED|Overall Study||100
8822123|NCT01582178|9876295|FG001|COMPLETED|Overall Study||101
8822124|NCT01582178|9876294|FG000|NOT COMPLETED|Overall Study||6
8822125|NCT01582178|9876295|FG001|NOT COMPLETED|Overall Study||5
8822126|NCT01582243|9876301|FG000|STARTED|Overall Study||40
8822127|NCT01582243|9876301|FG000|COMPLETED|Overall Study||37
8822128|NCT01582243|9876301|FG000|NOT COMPLETED|Overall Study||3
8822129|NCT01582282|9876308|FG000|STARTED|Overall Study||15
8822130|NCT01582282|9876309|FG001|STARTED|Overall Study||14
8822131|NCT01582282|9876310|FG002|STARTED|Overall Study||8
8822132|NCT01582282|9876308|FG000|COMPLETED|Overall Study||13
8822133|NCT01582282|9876309|FG001|COMPLETED|Overall Study||12
8822134|NCT01582282|9876310|FG002|COMPLETED|Overall Study||8
8822135|NCT01582282|9876308|FG000|NOT COMPLETED|Overall Study||2
8822136|NCT01582282|9876309|FG001|NOT COMPLETED|Overall Study||2
8822137|NCT01582282|9876310|FG002|NOT COMPLETED|Overall Study||0
8822138|NCT01582308|9876318|FG000|STARTED|Period 1||2
8822139|NCT01582308|9876319|FG001|STARTED|Period 1||2
8822140|NCT01582308|9876320|FG002|STARTED|Period 1||2
8822141|NCT01582308|9876321|FG003|STARTED|Period 1||2
8822142|NCT01582308|9876322|FG004|STARTED|Period 1|Includes replacement for a participant who discontinued after period 1|3
8822143|NCT01582308|9876323|FG005|STARTED|Period 1||2
8822144|NCT01582308|9876324|FG006|STARTED|Period 1|Includes replacement for a participant who discontinued during period 1|3
8822145|NCT01582308|9876325|FG007|STARTED|Period 1||2
8822146|NCT01582308|9876326|FG008|STARTED|Period 1||2
8822147|NCT01582308|9876327|FG009|STARTED|Period 1||2
8822148|NCT01582308|9876318|FG000|COMPLETED|Period 1||2
8822149|NCT01582308|9876319|FG001|COMPLETED|Period 1||2
8822150|NCT01582308|9876320|FG002|COMPLETED|Period 1||2
8822151|NCT01582308|9876321|FG003|COMPLETED|Period 1||2
8822152|NCT01582308|9876322|FG004|COMPLETED|Period 1||3
8822153|NCT01582308|9876323|FG005|COMPLETED|Period 1||2
8822154|NCT01582308|9876324|FG006|COMPLETED|Period 1||2
8822155|NCT01582308|9876325|FG007|COMPLETED|Period 1||2
8822156|NCT01582308|9876326|FG008|COMPLETED|Period 1||2
8822157|NCT01582308|9876327|FG009|COMPLETED|Period 1||2
8822158|NCT01582308|9876318|FG000|NOT COMPLETED|Period 1||0
8822159|NCT01582308|9876319|FG001|NOT COMPLETED|Period 1||0
8822160|NCT01582308|9876320|FG002|NOT COMPLETED|Period 1||0
8822161|NCT01582308|9876321|FG003|NOT COMPLETED|Period 1||0
8822162|NCT01582308|9876322|FG004|NOT COMPLETED|Period 1||0
8822163|NCT01582308|9876323|FG005|NOT COMPLETED|Period 1||0
8822164|NCT01582308|9876324|FG006|NOT COMPLETED|Period 1||1
8822165|NCT01582308|9876325|FG007|NOT COMPLETED|Period 1||0
8822166|NCT01582308|9876326|FG008|NOT COMPLETED|Period 1||0
8822167|NCT01582308|9876327|FG009|NOT COMPLETED|Period 1||0
8822168|NCT01582308|9876318|FG000|STARTED|10-day Washout Following Period 1||2
8822169|NCT01582308|9876319|FG001|STARTED|10-day Washout Following Period 1||2
8822170|NCT01582308|9876320|FG002|STARTED|10-day Washout Following Period 1||2
8822171|NCT01582308|9876321|FG003|STARTED|10-day Washout Following Period 1||2
8822172|NCT01582308|9876322|FG004|STARTED|10-day Washout Following Period 1||3
8822173|NCT01582308|9876323|FG005|STARTED|10-day Washout Following Period 1||2
8822174|NCT01582308|9876324|FG006|STARTED|10-day Washout Following Period 1||2
8822175|NCT01582308|9876325|FG007|STARTED|10-day Washout Following Period 1||2
8822176|NCT01582308|9876326|FG008|STARTED|10-day Washout Following Period 1||2
8822177|NCT01582308|9876327|FG009|STARTED|10-day Washout Following Period 1||2
8822178|NCT01582308|9876318|FG000|COMPLETED|10-day Washout Following Period 1||2
8822179|NCT01582308|9876319|FG001|COMPLETED|10-day Washout Following Period 1||2
8822180|NCT01582308|9876320|FG002|COMPLETED|10-day Washout Following Period 1||2
8822181|NCT01582308|9876321|FG003|COMPLETED|10-day Washout Following Period 1||2
8822182|NCT01582308|9876322|FG004|COMPLETED|10-day Washout Following Period 1||2
8822183|NCT01582308|9876323|FG005|COMPLETED|10-day Washout Following Period 1||2
8822184|NCT01582308|9876324|FG006|COMPLETED|10-day Washout Following Period 1||2
8822185|NCT01582308|9876325|FG007|COMPLETED|10-day Washout Following Period 1||2
8822186|NCT01582308|9876326|FG008|COMPLETED|10-day Washout Following Period 1||2
8822187|NCT01582308|9876327|FG009|COMPLETED|10-day Washout Following Period 1||2
8822188|NCT01582308|9876318|FG000|NOT COMPLETED|10-day Washout Following Period 1||0
8822189|NCT01582308|9876319|FG001|NOT COMPLETED|10-day Washout Following Period 1||0
8822190|NCT01582308|9876320|FG002|NOT COMPLETED|10-day Washout Following Period 1||0
8822191|NCT01582308|9876321|FG003|NOT COMPLETED|10-day Washout Following Period 1||0
8822192|NCT01582308|9876322|FG004|NOT COMPLETED|10-day Washout Following Period 1||1
8822193|NCT01582308|9876323|FG005|NOT COMPLETED|10-day Washout Following Period 1||0
8822194|NCT01582308|9876324|FG006|NOT COMPLETED|10-day Washout Following Period 1||0
8822195|NCT01582308|9876325|FG007|NOT COMPLETED|10-day Washout Following Period 1||0
8822196|NCT01582308|9876326|FG008|NOT COMPLETED|10-day Washout Following Period 1||0
8822197|NCT01582308|9876327|FG009|NOT COMPLETED|10-day Washout Following Period 1||0
8822198|NCT01582308|9876318|FG000|STARTED|Period 2||2
8822199|NCT01582308|9876319|FG001|STARTED|Period 2||2
8822200|NCT01582308|9876320|FG002|STARTED|Period 2||2
8822201|NCT01582308|9876321|FG003|STARTED|Period 2||2
8822202|NCT01582308|9876322|FG004|STARTED|Period 2||2
8822203|NCT01582308|9876323|FG005|STARTED|Period 2||2
8822204|NCT01582308|9876324|FG006|STARTED|Period 2||2
8822205|NCT01582308|9876325|FG007|STARTED|Period 2||2
8822206|NCT01582308|9876326|FG008|STARTED|Period 2||2
8822207|NCT01582308|9876327|FG009|STARTED|Period 2||2
8822208|NCT01582308|9876318|FG000|COMPLETED|Period 2||2
8822209|NCT01582308|9876319|FG001|COMPLETED|Period 2||2
8822210|NCT01582308|9876320|FG002|COMPLETED|Period 2||2
8822211|NCT01582308|9876321|FG003|COMPLETED|Period 2||2
8822212|NCT01582308|9876322|FG004|COMPLETED|Period 2||2
8822213|NCT01582308|9876323|FG005|COMPLETED|Period 2||2
8822214|NCT01582308|9876324|FG006|COMPLETED|Period 2||2
8822215|NCT01582308|9876325|FG007|COMPLETED|Period 2||2
8822216|NCT01582308|9876326|FG008|COMPLETED|Period 2||2
8822217|NCT01582308|9876327|FG009|COMPLETED|Period 2||2
8822218|NCT01582308|9876318|FG000|NOT COMPLETED|Period 2||0
8822219|NCT01582308|9876319|FG001|NOT COMPLETED|Period 2||0
8822220|NCT01582308|9876320|FG002|NOT COMPLETED|Period 2||0
8822221|NCT01582308|9876321|FG003|NOT COMPLETED|Period 2||0
8822222|NCT01582308|9876322|FG004|NOT COMPLETED|Period 2||0
8822223|NCT01582308|9876323|FG005|NOT COMPLETED|Period 2||0
8822224|NCT01582308|9876324|FG006|NOT COMPLETED|Period 2||0
8822225|NCT01582308|9876325|FG007|NOT COMPLETED|Period 2||0
8822226|NCT01582308|9876326|FG008|NOT COMPLETED|Period 2||0
8822227|NCT01582308|9876327|FG009|NOT COMPLETED|Period 2||0
8822228|NCT01582308|9876318|FG000|STARTED|10-day Washout Following Period 2||2
8822229|NCT01582308|9876319|FG001|STARTED|10-day Washout Following Period 2||2
8822230|NCT01582308|9876320|FG002|STARTED|10-day Washout Following Period 2||2
8822231|NCT01582308|9876321|FG003|STARTED|10-day Washout Following Period 2||2
8822232|NCT01582308|9876322|FG004|STARTED|10-day Washout Following Period 2||2
8822233|NCT01582308|9876323|FG005|STARTED|10-day Washout Following Period 2||2
8822234|NCT01582308|9876324|FG006|STARTED|10-day Washout Following Period 2||2
8822235|NCT01582308|9876325|FG007|STARTED|10-day Washout Following Period 2||2
8822236|NCT01582308|9876326|FG008|STARTED|10-day Washout Following Period 2||2
8822237|NCT01582308|9876327|FG009|STARTED|10-day Washout Following Period 2||2
8822238|NCT01582308|9876318|FG000|COMPLETED|10-day Washout Following Period 2||2
8822239|NCT01582308|9876319|FG001|COMPLETED|10-day Washout Following Period 2||2
8822240|NCT01582308|9876320|FG002|COMPLETED|10-day Washout Following Period 2||2
8822241|NCT01582308|9876321|FG003|COMPLETED|10-day Washout Following Period 2||2
8822242|NCT01582308|9876322|FG004|COMPLETED|10-day Washout Following Period 2||2
8822243|NCT01582308|9876323|FG005|COMPLETED|10-day Washout Following Period 2||2
8822244|NCT01582308|9876324|FG006|COMPLETED|10-day Washout Following Period 2||2
8822245|NCT01582308|9876325|FG007|COMPLETED|10-day Washout Following Period 2||2
8822246|NCT01582308|9876326|FG008|COMPLETED|10-day Washout Following Period 2||2
8822247|NCT01582308|9876327|FG009|COMPLETED|10-day Washout Following Period 2||2
8822248|NCT01582308|9876318|FG000|NOT COMPLETED|10-day Washout Following Period 2||0
8822249|NCT01582308|9876319|FG001|NOT COMPLETED|10-day Washout Following Period 2||0
8822250|NCT01582308|9876320|FG002|NOT COMPLETED|10-day Washout Following Period 2||0
8822251|NCT01582308|9876321|FG003|NOT COMPLETED|10-day Washout Following Period 2||0
8822252|NCT01582308|9876322|FG004|NOT COMPLETED|10-day Washout Following Period 2||0
8822253|NCT01582308|9876323|FG005|NOT COMPLETED|10-day Washout Following Period 2||0
8822254|NCT01582308|9876324|FG006|NOT COMPLETED|10-day Washout Following Period 2||0
8822255|NCT01582308|9876325|FG007|NOT COMPLETED|10-day Washout Following Period 2||0
8822256|NCT01582308|9876326|FG008|NOT COMPLETED|10-day Washout Following Period 2||0
8822257|NCT01582308|9876327|FG009|NOT COMPLETED|10-day Washout Following Period 2||0
8822258|NCT01582308|9876318|FG000|STARTED|Period 3||2
8822259|NCT01582308|9876319|FG001|STARTED|Period 3||2
8822260|NCT01582308|9876320|FG002|STARTED|Period 3||2
8822261|NCT01582308|9876321|FG003|STARTED|Period 3||2
8822262|NCT01582308|9876322|FG004|STARTED|Period 3||2
8822263|NCT01582308|9876323|FG005|STARTED|Period 3||2
8822264|NCT01582308|9876324|FG006|STARTED|Period 3||2
8822265|NCT01582308|9876325|FG007|STARTED|Period 3||2
8822266|NCT01582308|9876326|FG008|STARTED|Period 3||2
8822267|NCT01582308|9876327|FG009|STARTED|Period 3||2
8822268|NCT01582308|9876318|FG000|COMPLETED|Period 3||2
8822269|NCT01582308|9876319|FG001|COMPLETED|Period 3||2
8822270|NCT01582308|9876320|FG002|COMPLETED|Period 3||2
8822271|NCT01582308|9876321|FG003|COMPLETED|Period 3||2
8822272|NCT01582308|9876322|FG004|COMPLETED|Period 3||2
8822273|NCT01582308|9876323|FG005|COMPLETED|Period 3||2
8822274|NCT01582308|9876324|FG006|COMPLETED|Period 3||2
8822275|NCT01582308|9876325|FG007|COMPLETED|Period 3||2
8822276|NCT01582308|9876326|FG008|COMPLETED|Period 3||2
8822277|NCT01582308|9876327|FG009|COMPLETED|Period 3||2
8822278|NCT01582308|9876318|FG000|NOT COMPLETED|Period 3||0
8822279|NCT01582308|9876319|FG001|NOT COMPLETED|Period 3||0
8822280|NCT01582308|9876320|FG002|NOT COMPLETED|Period 3||0
8822281|NCT01582308|9876321|FG003|NOT COMPLETED|Period 3||0
8822282|NCT01582308|9876322|FG004|NOT COMPLETED|Period 3||0
8822283|NCT01582308|9876323|FG005|NOT COMPLETED|Period 3||0
8822284|NCT01582308|9876324|FG006|NOT COMPLETED|Period 3||0
8822285|NCT01582308|9876325|FG007|NOT COMPLETED|Period 3||0
8822286|NCT01582308|9876326|FG008|NOT COMPLETED|Period 3||0
8822287|NCT01582308|9876327|FG009|NOT COMPLETED|Period 3||0
8822288|NCT01582308|9876318|FG000|STARTED|10-day Washout Following Period 3||2
8822289|NCT01582308|9876319|FG001|STARTED|10-day Washout Following Period 3||2
8822290|NCT01582308|9876320|FG002|STARTED|10-day Washout Following Period 3||2
8822291|NCT01582308|9876321|FG003|STARTED|10-day Washout Following Period 3||2
8822292|NCT01582308|9876322|FG004|STARTED|10-day Washout Following Period 3||2
8822293|NCT01582308|9876323|FG005|STARTED|10-day Washout Following Period 3||2
8822294|NCT01582308|9876324|FG006|STARTED|10-day Washout Following Period 3||2
8822295|NCT01582308|9876325|FG007|STARTED|10-day Washout Following Period 3||2
8822296|NCT01582308|9876326|FG008|STARTED|10-day Washout Following Period 3||2
8822297|NCT01582308|9876327|FG009|STARTED|10-day Washout Following Period 3||2
8822298|NCT01582308|9876318|FG000|COMPLETED|10-day Washout Following Period 3||2
8822299|NCT01582308|9876319|FG001|COMPLETED|10-day Washout Following Period 3||2
8822300|NCT01582308|9876320|FG002|COMPLETED|10-day Washout Following Period 3||2
8822301|NCT01582308|9876321|FG003|COMPLETED|10-day Washout Following Period 3||2
8822302|NCT01582308|9876322|FG004|COMPLETED|10-day Washout Following Period 3||2
8822303|NCT01582308|9876323|FG005|COMPLETED|10-day Washout Following Period 3||2
8822304|NCT01582308|9876324|FG006|COMPLETED|10-day Washout Following Period 3||2
8822305|NCT01582308|9876325|FG007|COMPLETED|10-day Washout Following Period 3||2
8822306|NCT01582308|9876326|FG008|COMPLETED|10-day Washout Following Period 3||2
8822307|NCT01582308|9876327|FG009|COMPLETED|10-day Washout Following Period 3||2
8822308|NCT01582308|9876318|FG000|NOT COMPLETED|10-day Washout Following Period 3||0
8822309|NCT01582308|9876319|FG001|NOT COMPLETED|10-day Washout Following Period 3||0
8822310|NCT01582308|9876320|FG002|NOT COMPLETED|10-day Washout Following Period 3||0
8822311|NCT01582308|9876321|FG003|NOT COMPLETED|10-day Washout Following Period 3||0
8822312|NCT01582308|9876322|FG004|NOT COMPLETED|10-day Washout Following Period 3||0
8822313|NCT01582308|9876323|FG005|NOT COMPLETED|10-day Washout Following Period 3||0
8822314|NCT01582308|9876324|FG006|NOT COMPLETED|10-day Washout Following Period 3||0
8822315|NCT01582308|9876325|FG007|NOT COMPLETED|10-day Washout Following Period 3||0
8822316|NCT01582308|9876326|FG008|NOT COMPLETED|10-day Washout Following Period 3||0
8822317|NCT01582308|9876327|FG009|NOT COMPLETED|10-day Washout Following Period 3||0
8822318|NCT01582308|9876318|FG000|STARTED|Period 4||2
8822319|NCT01582308|9876319|FG001|STARTED|Period 4||2
8822320|NCT01582308|9876320|FG002|STARTED|Period 4||2
8822321|NCT01582308|9876321|FG003|STARTED|Period 4||2
8822322|NCT01582308|9876322|FG004|STARTED|Period 4||2
8822323|NCT01582308|9876323|FG005|STARTED|Period 4||2
8822324|NCT01582308|9876324|FG006|STARTED|Period 4||2
8822325|NCT01582308|9876325|FG007|STARTED|Period 4||2
8822326|NCT01582308|9876326|FG008|STARTED|Period 4||2
8822327|NCT01582308|9876327|FG009|STARTED|Period 4||2
8822328|NCT01582308|9876318|FG000|COMPLETED|Period 4||1
8822329|NCT01582308|9876319|FG001|COMPLETED|Period 4||2
8822330|NCT01582308|9876320|FG002|COMPLETED|Period 4||2
8822331|NCT01582308|9876321|FG003|COMPLETED|Period 4||2
8822332|NCT01582308|9876322|FG004|COMPLETED|Period 4||2
8822333|NCT01582308|9876323|FG005|COMPLETED|Period 4||1
8822334|NCT01582308|9876324|FG006|COMPLETED|Period 4||2
8822335|NCT01582308|9876325|FG007|COMPLETED|Period 4||2
8822336|NCT01582308|9876326|FG008|COMPLETED|Period 4||2
8822337|NCT01582308|9876327|FG009|COMPLETED|Period 4||1
8822338|NCT01582308|9876318|FG000|NOT COMPLETED|Period 4||1
8822339|NCT01582308|9876319|FG001|NOT COMPLETED|Period 4||0
8822340|NCT01582308|9876320|FG002|NOT COMPLETED|Period 4||0
8822341|NCT01582308|9876321|FG003|NOT COMPLETED|Period 4||0
8822342|NCT01582308|9876322|FG004|NOT COMPLETED|Period 4||0
8822343|NCT01582308|9876323|FG005|NOT COMPLETED|Period 4||1
8822344|NCT01582308|9876324|FG006|NOT COMPLETED|Period 4||0
8822345|NCT01582308|9876325|FG007|NOT COMPLETED|Period 4||0
8822346|NCT01582308|9876326|FG008|NOT COMPLETED|Period 4||0
8822347|NCT01582308|9876327|FG009|NOT COMPLETED|Period 4||1
8822348|NCT01582308|9876318|FG000|STARTED|10-day Washout Following Period 4||1
8822349|NCT01582308|9876319|FG001|STARTED|10-day Washout Following Period 4||2
8822350|NCT01582308|9876320|FG002|STARTED|10-day Washout Following Period 4||2
8822351|NCT01582308|9876321|FG003|STARTED|10-day Washout Following Period 4||2
8822352|NCT01582308|9876322|FG004|STARTED|10-day Washout Following Period 4||2
8822353|NCT01582308|9876323|FG005|STARTED|10-day Washout Following Period 4||1
8822354|NCT01582308|9876324|FG006|STARTED|10-day Washout Following Period 4||2
8822355|NCT01582308|9876325|FG007|STARTED|10-day Washout Following Period 4||2
8822356|NCT01582308|9876326|FG008|STARTED|10-day Washout Following Period 4||2
8822357|NCT01582308|9876327|FG009|STARTED|10-day Washout Following Period 4||1
8822358|NCT01582308|9876318|FG000|COMPLETED|10-day Washout Following Period 4||1
8822359|NCT01582308|9876319|FG001|COMPLETED|10-day Washout Following Period 4||2
8822360|NCT01582308|9876320|FG002|COMPLETED|10-day Washout Following Period 4||2
8822361|NCT01582308|9876321|FG003|COMPLETED|10-day Washout Following Period 4||2
8822362|NCT01582308|9876322|FG004|COMPLETED|10-day Washout Following Period 4||2
8822363|NCT01582308|9876323|FG005|COMPLETED|10-day Washout Following Period 4||1
8822364|NCT01582308|9876324|FG006|COMPLETED|10-day Washout Following Period 4||2
8822365|NCT01582308|9876325|FG007|COMPLETED|10-day Washout Following Period 4||2
8822366|NCT01582308|9876326|FG008|COMPLETED|10-day Washout Following Period 4||2
8822367|NCT01582308|9876327|FG009|COMPLETED|10-day Washout Following Period 4||1
8822368|NCT01582308|9876318|FG000|NOT COMPLETED|10-day Washout Following Period 4||0
8822369|NCT01582308|9876319|FG001|NOT COMPLETED|10-day Washout Following Period 4||0
8822370|NCT01582308|9876320|FG002|NOT COMPLETED|10-day Washout Following Period 4||0
8822371|NCT01582308|9876321|FG003|NOT COMPLETED|10-day Washout Following Period 4||0
8822372|NCT01582308|9876322|FG004|NOT COMPLETED|10-day Washout Following Period 4||0
8822373|NCT01582308|9876323|FG005|NOT COMPLETED|10-day Washout Following Period 4||0
8822374|NCT01582308|9876324|FG006|NOT COMPLETED|10-day Washout Following Period 4||0
8822375|NCT01582308|9876325|FG007|NOT COMPLETED|10-day Washout Following Period 4||0
8822376|NCT01582308|9876326|FG008|NOT COMPLETED|10-day Washout Following Period 4||0
8822377|NCT01582308|9876327|FG009|NOT COMPLETED|10-day Washout Following Period 4||0
8822378|NCT01582308|9876318|FG000|STARTED|Period 5||1
8822379|NCT01582308|9876319|FG001|STARTED|Period 5||2
8822380|NCT01582308|9876320|FG002|STARTED|Period 5||2
8822381|NCT01582308|9876321|FG003|STARTED|Period 5||2
8822382|NCT01582308|9876322|FG004|STARTED|Period 5||2
8822383|NCT01582308|9876323|FG005|STARTED|Period 5||1
8822384|NCT01582308|9876324|FG006|STARTED|Period 5||2
8822385|NCT01582308|9876325|FG007|STARTED|Period 5||2
8822386|NCT01582308|9876326|FG008|STARTED|Period 5||2
8822387|NCT01582308|9876327|FG009|STARTED|Period 5||1
8822388|NCT01582308|9876318|FG000|COMPLETED|Period 5||1
8822389|NCT01582308|9876319|FG001|COMPLETED|Period 5||2
8822390|NCT01582308|9876320|FG002|COMPLETED|Period 5||2
8822391|NCT01582308|9876321|FG003|COMPLETED|Period 5||2
8822392|NCT01582308|9876322|FG004|COMPLETED|Period 5||2
8822393|NCT01582308|9876323|FG005|COMPLETED|Period 5||1
8822394|NCT01582308|9876324|FG006|COMPLETED|Period 5||2
8822395|NCT01582308|9876325|FG007|COMPLETED|Period 5||2
8822396|NCT01582308|9876326|FG008|COMPLETED|Period 5||2
8822397|NCT01582308|9876327|FG009|COMPLETED|Period 5||1
8822398|NCT01582308|9876318|FG000|NOT COMPLETED|Period 5||0
8822399|NCT01582308|9876319|FG001|NOT COMPLETED|Period 5||0
8822400|NCT01582308|9876320|FG002|NOT COMPLETED|Period 5||0
8822401|NCT01582308|9876321|FG003|NOT COMPLETED|Period 5||0
8822402|NCT01582308|9876322|FG004|NOT COMPLETED|Period 5||0
8822403|NCT01582308|9876323|FG005|NOT COMPLETED|Period 5||0
8822404|NCT01582308|9876324|FG006|NOT COMPLETED|Period 5||0
8822405|NCT01582308|9876325|FG007|NOT COMPLETED|Period 5||0
8822406|NCT01582308|9876326|FG008|NOT COMPLETED|Period 5||0
8822407|NCT01582308|9876327|FG009|NOT COMPLETED|Period 5||0
8822408|NCT01582451|9876342|FG000|STARTED|Overall Study||307
8822409|NCT01582451|9876343|FG001|STARTED|Overall Study||159
8822410|NCT01582451|9876342|FG000|Received at Least 1 Dose of Study Drug|Overall Study||305
8822411|NCT01582451|9876343|FG001|Received at Least 1 Dose of Study Drug|Overall Study||159
8822412|NCT01582451|9876342|FG000|COMPLETED|Overall Study||275
8822413|NCT01582451|9876343|FG001|COMPLETED|Overall Study||139
8822414|NCT01582451|9876342|FG000|NOT COMPLETED|Overall Study||32
8822415|NCT01582451|9876343|FG001|NOT COMPLETED|Overall Study||20
8822416|NCT01582477|9876351|FG000|STARTED|Overall Study||12
8822417|NCT01582477|9876352|FG001|STARTED|Overall Study||12
8822418|NCT01582477|9876351|FG000|COMPLETED|Overall Study||12
8822419|NCT01582477|9876352|FG001|COMPLETED|Overall Study||12
8822420|NCT01582477|9876351|FG000|NOT COMPLETED|Overall Study||0
8822421|NCT01582477|9876352|FG001|NOT COMPLETED|Overall Study||0
8822422|NCT01582490|9876360|FG000|STARTED|Overall Study||9
8822423|NCT01582490|9876361|FG001|STARTED|Overall Study||10
8822424|NCT01582490|9876360|FG000|COMPLETED|Overall Study||8
8822425|NCT01582490|9876361|FG001|COMPLETED|Overall Study||9
8822426|NCT01582490|9876360|FG000|NOT COMPLETED|Overall Study||1
8822427|NCT01582490|9876361|FG001|NOT COMPLETED|Overall Study||1
8822428|NCT01582789|9876369|FG000|STARTED|First Intervention (14 Days)||34
8822429|NCT01582789|9876370|FG001|STARTED|First Intervention (14 Days)||27
8822430|NCT01582789|9876369|FG000|COMPLETED|First Intervention (14 Days)||34
8822431|NCT01582789|9876370|FG001|COMPLETED|First Intervention (14 Days)||27
8822432|NCT01582789|9876369|FG000|NOT COMPLETED|First Intervention (14 Days)||0
8822433|NCT01582789|9876370|FG001|NOT COMPLETED|First Intervention (14 Days)||0
8822434|NCT01582789|9876369|FG000|STARTED|Second Intervention (14 Days)||34
8822435|NCT01582789|9876370|FG001|STARTED|Second Intervention (14 Days)||27
8822436|NCT01582789|9876369|FG000|COMPLETED|Second Intervention (14 Days)||33
8822437|NCT01582789|9876370|FG001|COMPLETED|Second Intervention (14 Days)||27
8822438|NCT01582789|9876369|FG000|NOT COMPLETED|Second Intervention (14 Days)||1
8822439|NCT01582789|9876370|FG001|NOT COMPLETED|Second Intervention (14 Days)||0
8822440|NCT01582854|9876380|FG000|STARTED|Overall Study||248
8822441|NCT01582854|9876381|FG001|STARTED|Overall Study||255
8822442|NCT01582854|9876380|FG000|COMPLETED|Overall Study||212
8822443|NCT01582854|9876381|FG001|COMPLETED|Overall Study||221
8822444|NCT01582854|9876380|FG000|NOT COMPLETED|Overall Study||36
8822445|NCT01582854|9876381|FG001|NOT COMPLETED|Overall Study||34
8822446|NCT01582880|9876387|FG000|STARTED|Overall Study||1
8822447|NCT01582880|9876387|FG000|COMPLETED|Overall Study||1
8822448|NCT01582880|9876387|FG000|NOT COMPLETED|Overall Study||0
8822449|NCT01582945|9876391|FG000|STARTED|Overall Study||14
8822450|NCT01582945|9876391|FG000|COMPLETED|Overall Study||12
8822451|NCT01582945|9876391|FG000|NOT COMPLETED|Overall Study||2
8822452|NCT01582971|9876397|FG000|STARTED|Overall Study||128
8822453|NCT01582971|9876398|FG001|STARTED|Overall Study||128
8822454|NCT01582971|9876397|FG000|COMPLETED|Overall Study||89
8822455|NCT01582971|9876398|FG001|COMPLETED|Overall Study||91
8822456|NCT01582971|9876397|FG000|NOT COMPLETED|Overall Study||39
8822457|NCT01582971|9876398|FG001|NOT COMPLETED|Overall Study||37
8822458|NCT01583101|9876412|FG000|STARTED|Overall Study||1076
8822459|NCT01583101|9876413|FG001|STARTED|Overall Study||1161
8822460|NCT01583101|9876412|FG000|COMPLETED|Overall Study||1076
8822461|NCT01583101|9876413|FG001|COMPLETED|Overall Study||1161
8822462|NCT01583101|9876412|FG000|NOT COMPLETED|Overall Study||0
8822463|NCT01583101|9876413|FG001|NOT COMPLETED|Overall Study||0
8822464|NCT01583166|9876421|FG000|STARTED|Overall Study||45
8822465|NCT01583166|9876422|FG001|STARTED|Overall Study||45
8822466|NCT01583166|9876421|FG000|COMPLETED|Overall Study||41
8822467|NCT01583166|9876422|FG001|COMPLETED|Overall Study||39
8822468|NCT01583166|9876421|FG000|NOT COMPLETED|Overall Study||4
8822469|NCT01583166|9876422|FG001|NOT COMPLETED|Overall Study||6
8822470|NCT01583179|9876430|FG000|STARTED|Overall Study||14
8822471|NCT01583179|9876431|FG001|STARTED|Overall Study||12
8822472|NCT01583179|9876430|FG000|COMPLETED|Overall Study||13
8822473|NCT01583179|9876431|FG001|COMPLETED|Overall Study||10
8822474|NCT01583179|9876430|FG000|NOT COMPLETED|Overall Study||1
8822475|NCT01583179|9876431|FG001|NOT COMPLETED|Overall Study||2
8822476|NCT01583218|9876439|FG000|STARTED|Overall Study||3759
8822477|NCT01583218|9876440|FG001|STARTED|Overall Study||3754
8822478|NCT01583218|9876439|FG000|COMPLETED|Overall Study||3470
8822479|NCT01583218|9876440|FG001|COMPLETED|Overall Study||3471
8822480|NCT01583218|9876439|FG000|NOT COMPLETED|Overall Study||289
8822481|NCT01583218|9876440|FG001|NOT COMPLETED|Overall Study||283
8822482|NCT01583296|9876448|FG000|STARTED|Overall Study||27
8822483|NCT01583296|9876449|FG001|STARTED|Overall Study||26
8822484|NCT01583296|9876448|FG000|COMPLETED|Overall Study||16
9065939|NCT04128293|10126436|FG002|COMPLETED|Treatment Period 3 (1 Day)||0
8822485|NCT01583296|9876449|FG001|COMPLETED|Overall Study||16
8822486|NCT01583296|9876448|FG000|NOT COMPLETED|Overall Study||11
8822487|NCT01583296|9876449|FG001|NOT COMPLETED|Overall Study||10
8822488|NCT01583374|9876458|FG000|STARTED|Placebo-controlled Phase (Week 0-24)||164
8822489|NCT01583374|9876459|FG001|STARTED|Placebo-controlled Phase (Week 0-24)||163
8822490|NCT01583374|9876460|FG002|STARTED|Placebo-controlled Phase (Week 0-24)||163
8822491|NCT01583374|9876461|FG003|STARTED|Placebo-controlled Phase (Week 0-24)||0
8822492|NCT01583374|9876462|FG004|STARTED|Placebo-controlled Phase (Week 0-24)||0
8822493|NCT01583374|9876463|FG005|STARTED|Placebo-controlled Phase (Week 0-24)||0
8822494|NCT01583374|9876464|FG006|STARTED|Placebo-controlled Phase (Week 0-24)||0
8822495|NCT01583374|9876465|FG007|STARTED|Placebo-controlled Phase (Week 0-24)||0
8822496|NCT01583374|9876466|FG008|STARTED|Placebo-controlled Phase (Week 0-24)||0
8822497|NCT01583374|9876458|FG000|Received Treatment|Placebo-controlled Phase (Week 0-24)||164
8822498|NCT01583374|9876459|FG001|Received Treatment|Placebo-controlled Phase (Week 0-24)||163
8822499|NCT01583374|9876460|FG002|Received Treatment|Placebo-controlled Phase (Week 0-24)||163
8822500|NCT01583374|9876461|FG003|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
8822501|NCT01583374|9876462|FG004|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
8822502|NCT01583374|9876463|FG005|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
8822503|NCT01583374|9876464|FG006|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
8822504|NCT01583374|9876465|FG007|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
8822505|NCT01583374|9876466|FG008|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
8822506|NCT01583374|9876458|FG000|Completed Week 16|Placebo-controlled Phase (Week 0-24)||150
8822507|NCT01583374|9876459|FG001|Completed Week 16|Placebo-controlled Phase (Week 0-24)||151
8822508|NCT01583374|9876460|FG002|Completed Week 16|Placebo-controlled Phase (Week 0-24)||144
8822509|NCT01583374|9876461|FG003|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
8822510|NCT01583374|9876462|FG004|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
8822511|NCT01583374|9876463|FG005|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
8822512|NCT01583374|9876464|FG006|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
8822513|NCT01583374|9876465|FG007|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
8822514|NCT01583374|9876466|FG008|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
8822515|NCT01583374|9876458|FG000|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)|One participant who escaped early did not complete Week 24|51
8822516|NCT01583374|9876459|FG001|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||49
8822517|NCT01583374|9876460|FG002|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)|One participant who escaped early did not complete Week 24|49
8822518|NCT01583374|9876461|FG003|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
8822519|NCT01583374|9876462|FG004|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
8822520|NCT01583374|9876463|FG005|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
8822521|NCT01583374|9876464|FG006|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
8822522|NCT01583374|9876465|FG007|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
8822523|NCT01583374|9876466|FG008|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
8822524|NCT01583374|9876458|FG000|COMPLETED|Placebo-controlled Phase (Week 0-24)|Completed = participants who completed the Placebo-controlled Phase|145
8822525|NCT01583374|9876459|FG001|COMPLETED|Placebo-controlled Phase (Week 0-24)|Completed = participants who completed the Placebo-controlled Phase|147
8822526|NCT01583374|9876460|FG002|COMPLETED|Placebo-controlled Phase (Week 0-24)|Completed = participants who completed the Placebo-controlled Phase|138
8822527|NCT01583374|9876461|FG003|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
8822528|NCT01583374|9876462|FG004|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
8822529|NCT01583374|9876463|FG005|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
8822530|NCT01583374|9876464|FG006|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
8822531|NCT01583374|9876465|FG007|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
8822532|NCT01583374|9876466|FG008|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
8822533|NCT01583374|9876458|FG000|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||19
8822534|NCT01583374|9876459|FG001|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||16
8822535|NCT01583374|9876460|FG002|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||25
8822536|NCT01583374|9876461|FG003|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
8822537|NCT01583374|9876462|FG004|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
8822538|NCT01583374|9876463|FG005|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
8822539|NCT01583374|9876464|FG006|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
8822540|NCT01583374|9876465|FG007|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
8822541|NCT01583374|9876466|FG008|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
8822542|NCT01583374|9876458|FG000|STARTED|Extension Phase (Weeks 24 to 52)||0
8822543|NCT01583374|9876459|FG001|STARTED|Extension Phase (Weeks 24 to 52)||74
8822544|NCT01583374|9876460|FG002|STARTED|Extension Phase (Weeks 24 to 52)||65
8822545|NCT01583374|9876461|FG003|STARTED|Extension Phase (Weeks 24 to 52)||47
8822546|NCT01583374|9876462|FG004|STARTED|Extension Phase (Weeks 24 to 52)||91
8822547|NCT01583374|9876463|FG005|STARTED|Extension Phase (Weeks 24 to 52)||48
8822548|NCT01583374|9876464|FG006|STARTED|Extension Phase (Weeks 24 to 52)||48
8822549|NCT01583374|9876465|FG007|STARTED|Extension Phase (Weeks 24 to 52)||25
8822550|NCT01583374|9876466|FG008|STARTED|Extension Phase (Weeks 24 to 52)||23
8822551|NCT01583374|9876458|FG000|COMPLETED|Extension Phase (Weeks 24 to 52)||0
8822552|NCT01583374|9876459|FG001|COMPLETED|Extension Phase (Weeks 24 to 52)||69
8822553|NCT01583374|9876460|FG002|COMPLETED|Extension Phase (Weeks 24 to 52)||61
8822554|NCT01583374|9876461|FG003|COMPLETED|Extension Phase (Weeks 24 to 52)||41
8822555|NCT01583374|9876462|FG004|COMPLETED|Extension Phase (Weeks 24 to 52)||85
8822556|NCT01583374|9876463|FG005|COMPLETED|Extension Phase (Weeks 24 to 52)||43
8822557|NCT01583374|9876464|FG006|COMPLETED|Extension Phase (Weeks 24 to 52)||43
8822558|NCT01583374|9876465|FG007|COMPLETED|Extension Phase (Weeks 24 to 52)||22
8822559|NCT01583374|9876466|FG008|COMPLETED|Extension Phase (Weeks 24 to 52)||21
8822560|NCT01583374|9876458|FG000|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||0
8822561|NCT01583374|9876459|FG001|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||5
8822562|NCT01583374|9876460|FG002|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||4
8822563|NCT01583374|9876461|FG003|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||6
8822564|NCT01583374|9876462|FG004|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||6
8822565|NCT01583374|9876463|FG005|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||5
8822566|NCT01583374|9876464|FG006|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||5
8822567|NCT01583374|9876465|FG007|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||3
8822568|NCT01583374|9876466|FG008|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||2
8822569|NCT01583374|9876458|FG000|STARTED|Long-Term Extension Phase Weeks 52-260||0
8849491|NCT01741350|9904732|FG001|COMPLETED|Study Intervention||155
8622007|NCT00485264|9661127|FG004|STARTED|Overall Study||15
8622008|NCT00485264|9661128|FG005|STARTED|Overall Study||12
8622009|NCT00485264|9661123|FG000|Completed Week 24|Overall Study||67
8822570|NCT01583374|9876459|FG001|STARTED|Long-Term Extension Phase Weeks 52-260||66
8822571|NCT01583374|9876460|FG002|STARTED|Long-Term Extension Phase Weeks 52-260||61
8822572|NCT01583374|9876461|FG003|STARTED|Long-Term Extension Phase Weeks 52-260||35
8822573|NCT01583374|9876462|FG004|STARTED|Long-Term Extension Phase Weeks 52-260||81
8822574|NCT01583374|9876463|FG005|STARTED|Long-Term Extension Phase Weeks 52-260||39
8822575|NCT01583374|9876464|FG006|STARTED|Long-Term Extension Phase Weeks 52-260||38
8822576|NCT01583374|9876465|FG007|STARTED|Long-Term Extension Phase Weeks 52-260||21
8822577|NCT01583374|9876466|FG008|STARTED|Long-Term Extension Phase Weeks 52-260||20
8822578|NCT01583374|9876458|FG000|COMPLETED|Long-Term Extension Phase Weeks 52-260||0
8822579|NCT01583374|9876459|FG001|COMPLETED|Long-Term Extension Phase Weeks 52-260||40
8822580|NCT01583374|9876460|FG002|COMPLETED|Long-Term Extension Phase Weeks 52-260||41
8822581|NCT01583374|9876461|FG003|COMPLETED|Long-Term Extension Phase Weeks 52-260||22
8822582|NCT01583374|9876462|FG004|COMPLETED|Long-Term Extension Phase Weeks 52-260||50
8822583|NCT01583374|9876463|FG005|COMPLETED|Long-Term Extension Phase Weeks 52-260||22
8822584|NCT01583374|9876464|FG006|COMPLETED|Long-Term Extension Phase Weeks 52-260||20
8822585|NCT01583374|9876465|FG007|COMPLETED|Long-Term Extension Phase Weeks 52-260||12
8822586|NCT01583374|9876466|FG008|COMPLETED|Long-Term Extension Phase Weeks 52-260||10
8822587|NCT01583374|9876458|FG000|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||0
8822588|NCT01583374|9876459|FG001|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||26
8822589|NCT01583374|9876460|FG002|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||20
8822590|NCT01583374|9876461|FG003|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||13
8822591|NCT01583374|9876462|FG004|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||31
8723178|NCT01021852|9770685|FG002|Treated|Treatment Period 1||41
8723179|NCT01021852|9770686|FG003|Treated|Treatment Period 1||38
8723180|NCT01021852|9770687|FG004|Treated|Treatment Period 1||42
8723181|NCT01021852|9770688|FG005|Treated|Treatment Period 1|1 participant discontinued Treatment Period 1 (AE) but continued in Placebo Washout|41
8723182|NCT01021852|9770689|FG006|Treated|Treatment Period 1||41
8723183|NCT01021852|9770690|FG007|Treated|Treatment Period 1||41
8723184|NCT01021852|9770683|FG000|COMPLETED|Treatment Period 1||37
8723185|NCT01021852|9770684|FG001|COMPLETED|Treatment Period 1||39
8723186|NCT01021852|9770685|FG002|COMPLETED|Treatment Period 1||39
8723187|NCT01021852|9770686|FG003|COMPLETED|Treatment Period 1||38
8723188|NCT01021852|9770687|FG004|COMPLETED|Treatment Period 1||39
8723189|NCT01021852|9770688|FG005|COMPLETED|Treatment Period 1||39
8723190|NCT01021852|9770689|FG006|COMPLETED|Treatment Period 1||41
8723191|NCT01021852|9770690|FG007|COMPLETED|Treatment Period 1||40
8723192|NCT01021852|9770683|FG000|NOT COMPLETED|Treatment Period 1||3
8723193|NCT01021852|9770684|FG001|NOT COMPLETED|Treatment Period 1||1
8723194|NCT01021852|9770685|FG002|NOT COMPLETED|Treatment Period 1||2
8723195|NCT01021852|9770686|FG003|NOT COMPLETED|Treatment Period 1||2
8723196|NCT01021852|9770687|FG004|NOT COMPLETED|Treatment Period 1||3
8723197|NCT01021852|9770688|FG005|NOT COMPLETED|Treatment Period 1||2
8723198|NCT01021852|9770689|FG006|NOT COMPLETED|Treatment Period 1||0
8723199|NCT01021852|9770690|FG007|NOT COMPLETED|Treatment Period 1||1
8723200|NCT01021852|9770683|FG000|STARTED|Washout Period-Placebo||37
8723201|NCT01021852|9770684|FG001|STARTED|Washout Period-Placebo||39
8723202|NCT01021852|9770685|FG002|STARTED|Washout Period-Placebo||39
8723203|NCT01021852|9770686|FG003|STARTED|Washout Period-Placebo||38
8723204|NCT01021852|9770687|FG004|STARTED|Washout Period-Placebo|Includes 1 participant that discontinued Treatment Period 1 (AE).|40
8723205|NCT01021852|9770688|FG005|STARTED|Washout Period-Placebo|Excludes 1 participant who completed Treatment Period 1 but missed Placebo Washout|39
8723206|NCT01021852|9770689|FG006|STARTED|Washout Period-Placebo||41
8723207|NCT01021852|9770690|FG007|STARTED|Washout Period-Placebo||40
8723208|NCT01021852|9770683|FG000|COMPLETED|Washout Period-Placebo||37
8723209|NCT01021852|9770684|FG001|COMPLETED|Washout Period-Placebo||39
8723210|NCT01021852|9770685|FG002|COMPLETED|Washout Period-Placebo||39
8723211|NCT01021852|9770686|FG003|COMPLETED|Washout Period-Placebo||37
8723212|NCT01021852|9770687|FG004|COMPLETED|Washout Period-Placebo||39
8723213|NCT01021852|9770688|FG005|COMPLETED|Washout Period-Placebo||38
8723214|NCT01021852|9770689|FG006|COMPLETED|Washout Period-Placebo||40
8723215|NCT01021852|9770690|FG007|COMPLETED|Washout Period-Placebo||40
8723216|NCT01021852|9770683|FG000|NOT COMPLETED|Washout Period-Placebo||0
8723217|NCT01021852|9770684|FG001|NOT COMPLETED|Washout Period-Placebo||0
8723218|NCT01021852|9770685|FG002|NOT COMPLETED|Washout Period-Placebo||0
8723219|NCT01021852|9770686|FG003|NOT COMPLETED|Washout Period-Placebo||1
8723220|NCT01021852|9770687|FG004|NOT COMPLETED|Washout Period-Placebo||1
8723221|NCT01021852|9770688|FG005|NOT COMPLETED|Washout Period-Placebo||1
8723222|NCT01021852|9770689|FG006|NOT COMPLETED|Washout Period-Placebo||1
8723223|NCT01021852|9770690|FG007|NOT COMPLETED|Washout Period-Placebo||0
8723224|NCT01021852|9770683|FG000|STARTED|Washout Period-No Drug|Includes 1 participant who discontinued Treatment Period 1 (AE) and missed Placebo Washout.|38
8723225|NCT01021852|9770684|FG001|STARTED|Washout Period-No Drug||39
8723226|NCT01021852|9770685|FG002|STARTED|Washout Period-No Drug||39
8723227|NCT01021852|9770686|FG003|STARTED|Washout Period-No Drug||37
8723228|NCT01021852|9770687|FG004|STARTED|Washout Period-No Drug||39
8723229|NCT01021852|9770688|FG005|STARTED|Washout Period-No Drug|Includes 1 participant who completed Treatment Period 1 but missed Placebo Washout.|39
8723230|NCT01021852|9770689|FG006|STARTED|Washout Period-No Drug||40
8723231|NCT01021852|9770690|FG007|STARTED|Washout Period-No Drug||40
8822592|NCT01583374|9876463|FG005|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||17
8822593|NCT01583374|9876464|FG006|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||18
8822594|NCT01583374|9876465|FG007|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||9
8822595|NCT01583374|9876466|FG008|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||10
8822596|NCT01583452|9876487|FG000|STARTED|Overall Study||21
8822597|NCT01583452|9876488|FG001|STARTED|Overall Study||20
8822598|NCT01583452|9876487|FG000|COMPLETED|Overall Study||21
8822599|NCT01583452|9876488|FG001|COMPLETED|Overall Study||20
8822600|NCT01583452|9876487|FG000|NOT COMPLETED|Overall Study||0
8822601|NCT01583452|9876488|FG001|NOT COMPLETED|Overall Study||0
8822602|NCT01583530|9876503|FG000|STARTED|Overall Study||19
8822603|NCT01583530|9876504|FG001|STARTED|Overall Study||20
8822604|NCT01583530|9876505|FG002|STARTED|Overall Study||20
8822605|NCT01583530|9876506|FG003|STARTED|Overall Study||19
8822606|NCT01583530|9876507|FG004|STARTED|Overall Study||20
8822607|NCT01583530|9876508|FG005|STARTED|Overall Study||20
8822608|NCT01583530|9876503|FG000|COMPLETED|Overall Study||19
8822609|NCT01583530|9876504|FG001|COMPLETED|Overall Study||17
8822610|NCT01583530|9876505|FG002|COMPLETED|Overall Study||20
8822611|NCT01583530|9876506|FG003|COMPLETED|Overall Study||18
8822612|NCT01583530|9876507|FG004|COMPLETED|Overall Study||15
8822613|NCT01583530|9876508|FG005|COMPLETED|Overall Study||17
8822614|NCT01583530|9876503|FG000|NOT COMPLETED|Overall Study||0
8943817|NCT02391948|10005625|FG004|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 2 of the Not Completed remained active.|105
8943818|NCT02391948|10005621|FG000|COMPLETED|18-month Assessment||147
8943819|NCT02391948|10005622|FG001|COMPLETED|18-month Assessment||101
8943820|NCT02391948|10005623|FG002|COMPLETED|18-month Assessment||48
8943821|NCT02391948|10005624|FG003|COMPLETED|18-month Assessment||83
8943822|NCT02391948|10005625|FG004|COMPLETED|18-month Assessment||75
8943823|NCT02391948|10005621|FG000|NOT COMPLETED|18-month Assessment||72
8943824|NCT02391948|10005622|FG001|NOT COMPLETED|18-month Assessment||50
8943825|NCT02391948|10005623|FG002|NOT COMPLETED|18-month Assessment||26
8943826|NCT02391948|10005624|FG003|NOT COMPLETED|18-month Assessment||36
8943827|NCT02391948|10005625|FG004|NOT COMPLETED|18-month Assessment||30
8943828|NCT02391948|10005621|FG000|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 2 of the Not Completed remained active.|149
8943829|NCT02391948|10005622|FG001|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 6 of the Not Completed remained active.|107
8943830|NCT02391948|10005623|FG002|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 3 of the Not Completed remained active.|51
8943831|NCT02391948|10005624|FG003|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 1 of the Not Completed remained active.|84
8943832|NCT02391948|10005625|FG004|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 4 of the Not Completed remained active.|79
8943833|NCT02391948|10005621|FG000|COMPLETED|24-month Assessment||135
8943834|NCT02391948|10005622|FG001|COMPLETED|24-month Assessment||97
8943835|NCT02391948|10005623|FG002|COMPLETED|24-month Assessment||48
8943836|NCT02391948|10005624|FG003|COMPLETED|24-month Assessment||75
8943837|NCT02391948|10005625|FG004|COMPLETED|24-month Assessment||69
8943838|NCT02391948|10005621|FG000|NOT COMPLETED|24-month Assessment||14
8943839|NCT02391948|10005622|FG001|NOT COMPLETED|24-month Assessment||10
8943840|NCT02391948|10005623|FG002|NOT COMPLETED|24-month Assessment||3
8943841|NCT02391948|10005624|FG003|NOT COMPLETED|24-month Assessment||9
8943842|NCT02391948|10005625|FG004|NOT COMPLETED|24-month Assessment||10
8943843|NCT02391961|10005642|FG000|STARTED|First Intervention (4 Weeks)||10
8943844|NCT02391961|10005643|FG001|STARTED|First Intervention (4 Weeks)||9
8943845|NCT02391961|10005642|FG000|COMPLETED|First Intervention (4 Weeks)||8
8943846|NCT02391961|10005643|FG001|COMPLETED|First Intervention (4 Weeks)||9
8943847|NCT02391961|10005642|FG000|NOT COMPLETED|First Intervention (4 Weeks)||2
8943848|NCT02391961|10005643|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0
8943849|NCT02391961|10005642|FG000|STARTED|Washout (2 Weeks)||8
8943850|NCT02391961|10005643|FG001|STARTED|Washout (2 Weeks)||9
8943851|NCT02391961|10005642|FG000|COMPLETED|Washout (2 Weeks)||7
8943852|NCT02391961|10005643|FG001|COMPLETED|Washout (2 Weeks)||8
8943853|NCT02391961|10005642|FG000|NOT COMPLETED|Washout (2 Weeks)||1
8943854|NCT02391961|10005643|FG001|NOT COMPLETED|Washout (2 Weeks)||1
8943855|NCT02391961|10005642|FG000|STARTED|Second Intervention (4 Weeks)||7
8943856|NCT02391961|10005643|FG001|STARTED|Second Intervention (4 Weeks)||8
8943857|NCT02391961|10005642|FG000|COMPLETED|Second Intervention (4 Weeks)||6
8943858|NCT02391961|10005643|FG001|COMPLETED|Second Intervention (4 Weeks)||7
8943859|NCT02391961|10005642|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||1
8943860|NCT02391961|10005643|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||1
8943861|NCT02391987|10005651|FG000|STARTED|Overall Study||54
8622010|NCT00485264|9661124|FG001|Completed Week 24|Overall Study||16
8622011|NCT00485264|9661125|FG002|Completed Week 24|Overall Study||18
8622012|NCT00485264|9661126|FG003|Completed Week 24|Overall Study||21
8622013|NCT00485264|9661127|FG004|Completed Week 24|Overall Study||14
8622014|NCT00485264|9661128|FG005|Completed Week 24|Overall Study||11
8622015|NCT00485264|9661123|FG000|COMPLETED|Overall Study||35
8622016|NCT00485264|9661124|FG001|COMPLETED|Overall Study||9
8622017|NCT00485264|9661125|FG002|COMPLETED|Overall Study||12
8622018|NCT00485264|9661126|FG003|COMPLETED|Overall Study||17
8822615|NCT01583530|9876504|FG001|NOT COMPLETED|Overall Study||3
8822616|NCT01583530|9876505|FG002|NOT COMPLETED|Overall Study||0
8822617|NCT01583530|9876506|FG003|NOT COMPLETED|Overall Study||1
8622019|NCT00485264|9661127|FG004|COMPLETED|Overall Study||9
8822618|NCT01583530|9876507|FG004|NOT COMPLETED|Overall Study||5
8822619|NCT01583530|9876508|FG005|NOT COMPLETED|Overall Study||3
8822620|NCT01583543|9876525|FG000|STARTED|Overall Study||12
8822621|NCT01583543|9876525|FG000|COMPLETED|Overall Study||12
8822622|NCT01583543|9876525|FG000|NOT COMPLETED|Overall Study||0
8822623|NCT01583686|9876537|FG000|STARTED|Overall Study||3
8822624|NCT01583686|9876538|FG001|STARTED|Overall Study||3
8822625|NCT01583686|9876539|FG002|STARTED|Overall Study||3
8822626|NCT01583686|9876540|FG003|STARTED|Overall Study||3
8822627|NCT01583686|9876541|FG004|STARTED|Overall Study||3
8822628|NCT01583686|9876537|FG000|COMPLETED|Overall Study||3
8822629|NCT01583686|9876538|FG001|COMPLETED|Overall Study||3
8822630|NCT01583686|9876539|FG002|COMPLETED|Overall Study||3
8822631|NCT01583686|9876540|FG003|COMPLETED|Overall Study||3
8822632|NCT01583686|9876541|FG004|COMPLETED|Overall Study||3
8822633|NCT01583686|9876537|FG000|NOT COMPLETED|Overall Study||0
8822634|NCT01583686|9876538|FG001|NOT COMPLETED|Overall Study||0
8822635|NCT01583686|9876539|FG002|NOT COMPLETED|Overall Study||0
8822636|NCT01583686|9876540|FG003|NOT COMPLETED|Overall Study||0
8822637|NCT01583686|9876541|FG004|NOT COMPLETED|Overall Study||0
8822638|NCT01583868|9876558|FG000|STARTED|Overall Study||108
8822639|NCT01583868|9876559|FG001|STARTED|Overall Study||108
8822640|NCT01583868|9876558|FG000|COMPLETED|Overall Study||104
8822641|NCT01583868|9876559|FG001|COMPLETED|Overall Study||104
8822642|NCT01583868|9876558|FG000|NOT COMPLETED|Overall Study||4
8822643|NCT01583868|9876559|FG001|NOT COMPLETED|Overall Study||4
8822644|NCT01583894|9876569|FG000|STARTED|Overall Study||828
8822645|NCT01583894|9876569|FG000|COMPLETED|Overall Study||813
8822646|NCT01583894|9876569|FG000|NOT COMPLETED|Overall Study||15
8822647|NCT01583985|9876575|FG000|STARTED|Overall Study||120
8822648|NCT01583985|9876576|FG001|STARTED|Overall Study||120
8822649|NCT01583985|9876575|FG000|Included in Primary Analysis|Overall Study||119
8822650|NCT01583985|9876576|FG001|Included in Primary Analysis|Overall Study||119
8822651|NCT01583985|9876575|FG000|COMPLETED|Overall Study||117
8822652|NCT01583985|9876576|FG001|COMPLETED|Overall Study||117
8822653|NCT01583985|9876575|FG000|NOT COMPLETED|Overall Study||3
8822654|NCT01583985|9876576|FG001|NOT COMPLETED|Overall Study||3
8822655|NCT01584024|9876582|FG000|STARTED|Overall Study||42
8822656|NCT01584024|9876582|FG000|COMPLETED|Overall Study||29
8822657|NCT01584024|9876582|FG000|NOT COMPLETED|Overall Study||13
8822658|NCT01584232|9876589|FG000|STARTED|Overall Study||181
8822659|NCT01584232|9876590|FG001|STARTED|Overall Study||180
8822660|NCT01584232|9876589|FG000|Received at Least 1 Dose of Study Drug|Overall Study||181
8822661|NCT01584232|9876590|FG001|Received at Least 1 Dose of Study Drug|Overall Study||180
8822662|NCT01584232|9876589|FG000|COMPLETED|Overall Study||173
8822663|NCT01584232|9876590|FG001|COMPLETED|Overall Study||177
8822664|NCT01584232|9876589|FG000|NOT COMPLETED|Overall Study||8
8822665|NCT01584232|9876590|FG001|NOT COMPLETED|Overall Study||3
8822666|NCT01584388|9876596|FG000|STARTED|Overall Study||30
8822667|NCT01584388|9876596|FG000|COMPLETED|Overall Study||30
8822668|NCT01584388|9876596|FG000|NOT COMPLETED|Overall Study||0
8822669|NCT01584440|9876616|FG000|STARTED|Stage 1 (5 Weeks)||93
8822670|NCT01584440|9876617|FG001|STARTED|Stage 1 (5 Weeks)||127
8822671|NCT01584440|9876618|FG002|STARTED|Stage 1 (5 Weeks)||0
8822672|NCT01584440|9876619|FG003|STARTED|Stage 1 (5 Weeks)||0
8822673|NCT01584440|9876620|FG004|STARTED|Stage 1 (5 Weeks)||0
8822674|NCT01584440|9876616|FG000|COMPLETED|Stage 1 (5 Weeks)||83
8822675|NCT01584440|9876617|FG001|COMPLETED|Stage 1 (5 Weeks)||119
8822676|NCT01584440|9876618|FG002|COMPLETED|Stage 1 (5 Weeks)||0
8822677|NCT01584440|9876619|FG003|COMPLETED|Stage 1 (5 Weeks)||0
8822678|NCT01584440|9876620|FG004|COMPLETED|Stage 1 (5 Weeks)||0
8822679|NCT01584440|9876616|FG000|NOT COMPLETED|Stage 1 (5 Weeks)||10
8822680|NCT01584440|9876617|FG001|NOT COMPLETED|Stage 1 (5 Weeks)||8
8822681|NCT01584440|9876618|FG002|NOT COMPLETED|Stage 1 (5 Weeks)||0
8822682|NCT01584440|9876619|FG003|NOT COMPLETED|Stage 1 (5 Weeks)||0
8822683|NCT01584440|9876620|FG004|NOT COMPLETED|Stage 1 (5 Weeks)||0
8822684|NCT01584440|9876616|FG000|STARTED|Stage 2 (5 Weeks)||0
8822685|NCT01584440|9876617|FG001|STARTED|Stage 2 (5 Weeks)||0
8822686|NCT01584440|9876618|FG002|STARTED|Stage 2 (5 Weeks)||83
8822687|NCT01584440|9876619|FG003|STARTED|Stage 2 (5 Weeks)||59
8822688|NCT01584440|9876620|FG004|STARTED|Stage 2 (5 Weeks)||60
8822689|NCT01584440|9876616|FG000|COMPLETED|Stage 2 (5 Weeks)||0
8822690|NCT01584440|9876617|FG001|COMPLETED|Stage 2 (5 Weeks)||0
8822691|NCT01584440|9876618|FG002|COMPLETED|Stage 2 (5 Weeks)||80
8822692|NCT01584440|9876619|FG003|COMPLETED|Stage 2 (5 Weeks)||55
8822693|NCT01584440|9876620|FG004|COMPLETED|Stage 2 (5 Weeks)||59
8822694|NCT01584440|9876616|FG000|NOT COMPLETED|Stage 2 (5 Weeks)||0
8822695|NCT01584440|9876617|FG001|NOT COMPLETED|Stage 2 (5 Weeks)||0
8822696|NCT01584440|9876618|FG002|NOT COMPLETED|Stage 2 (5 Weeks)||3
8822697|NCT01584440|9876619|FG003|NOT COMPLETED|Stage 2 (5 Weeks)||4
8822698|NCT01584440|9876620|FG004|NOT COMPLETED|Stage 2 (5 Weeks)||1
8822699|NCT01584479|9876637|FG000|STARTED|Overall Study||732
8822700|NCT01584479|9876638|FG001|STARTED|Overall Study||1686
8822701|NCT01584479|9876639|FG002|STARTED|Overall Study||852
8822702|NCT01584479|9876640|FG003|STARTED|Overall Study||1847
8822703|NCT01584479|9876637|FG000|COMPLETED|Overall Study||732
8822704|NCT01584479|9876638|FG001|COMPLETED|Overall Study||1686
8822705|NCT01584479|9876639|FG002|COMPLETED|Overall Study||852
8822706|NCT01584479|9876640|FG003|COMPLETED|Overall Study||1847
8822707|NCT01584479|9876637|FG000|NOT COMPLETED|Overall Study||0
8822708|NCT01584479|9876638|FG001|NOT COMPLETED|Overall Study||0
8822709|NCT01584479|9876639|FG002|NOT COMPLETED|Overall Study||0
8822710|NCT01584479|9876640|FG003|NOT COMPLETED|Overall Study||0
8822711|NCT01584518|9876652|FG000|STARTED|Overall Study||25
8822712|NCT01584518|9876653|FG001|STARTED|Overall Study||25
8822713|NCT01584518|9876652|FG000|COMPLETED|Overall Study||25
8822714|NCT01584518|9876653|FG001|COMPLETED|Overall Study||25
8822715|NCT01584518|9876652|FG000|NOT COMPLETED|Overall Study||0
8822716|NCT01584518|9876653|FG001|NOT COMPLETED|Overall Study||0
8822717|NCT01584544|9876664|FG000|STARTED|Overall Study||3
8822718|NCT01584544|9876665|FG001|STARTED|Overall Study||6
8822719|NCT01584544|9876666|FG002|STARTED|Overall Study||6
8822720|NCT01584544|9876667|FG003|STARTED|Overall Study||3
8822721|NCT01584544|9876668|FG004|STARTED|Overall Study||6
8822722|NCT01584544|9876664|FG000|COMPLETED|Overall Study||3
8822723|NCT01584544|9876665|FG001|COMPLETED|Overall Study||6
8822724|NCT01584544|9876666|FG002|COMPLETED|Overall Study||6
8822725|NCT01584544|9876667|FG003|COMPLETED|Overall Study||3
8822726|NCT01584544|9876668|FG004|COMPLETED|Overall Study||6
8822727|NCT01584544|9876664|FG000|NOT COMPLETED|Overall Study||0
8822728|NCT01584544|9876665|FG001|NOT COMPLETED|Overall Study||0
8822729|NCT01584544|9876666|FG002|NOT COMPLETED|Overall Study||0
8822730|NCT01584544|9876667|FG003|NOT COMPLETED|Overall Study||0
8822731|NCT01584544|9876668|FG004|NOT COMPLETED|Overall Study||0
8822732|NCT01584609|9876682|FG000|STARTED|Overall Study||98
8822733|NCT01584609|9876683|FG001|STARTED|Overall Study||100
8822734|NCT01584609|9876682|FG000|COMPLETED|Overall Study||86
8822735|NCT01584609|9876683|FG001|COMPLETED|Overall Study||96
8822736|NCT01584609|9876682|FG000|NOT COMPLETED|Overall Study||12
8822737|NCT01584609|9876683|FG001|NOT COMPLETED|Overall Study||4
8822738|NCT01584648|9876691|FG000|STARTED|Overall Study||211
8822739|NCT01584648|9876692|FG001|STARTED|Overall Study||212
8822740|NCT01584648|9876691|FG000|Safety Set|Overall Study||209
8822741|NCT01584648|9876692|FG001|Safety Set|Overall Study||211
8822742|NCT01584648|9876691|FG000|Crossover Population|Overall Study||0
8822743|NCT01584648|9876692|FG001|Crossover Population|Overall Study||28
8822744|NCT01584648|9876691|FG000|COMPLETED|Overall Study||0
8822745|NCT01584648|9876692|FG001|COMPLETED|Overall Study||0
8822746|NCT01584648|9876691|FG000|NOT COMPLETED|Overall Study||211
8822747|NCT01584648|9876692|FG001|NOT COMPLETED|Overall Study||212
8822748|NCT01584843|9876705|FG000|STARTED|First Treatment Period||3
8822749|NCT01584843|9876706|FG001|STARTED|First Treatment Period||4
8822750|NCT01584843|9876707|FG002|STARTED|First Treatment Period||3
8822751|NCT01584843|9876708|FG003|STARTED|First Treatment Period||10
8822752|NCT01584843|9876709|FG004|STARTED|First Treatment Period||10
8822753|NCT01584843|9876710|FG005|STARTED|First Treatment Period||11
8822754|NCT01584843|9876705|FG000|COMPLETED|First Treatment Period||3
8622020|NCT00485264|9661128|FG005|COMPLETED|Overall Study||5
8622021|NCT00485264|9661123|FG000|NOT COMPLETED|Overall Study||36
8622022|NCT00485264|9661124|FG001|NOT COMPLETED|Overall Study||7
8622023|NCT00485264|9661125|FG002|NOT COMPLETED|Overall Study||6
8622024|NCT00485264|9661126|FG003|NOT COMPLETED|Overall Study||4
8622025|NCT00485264|9661127|FG004|NOT COMPLETED|Overall Study||6
8622026|NCT00485264|9661128|FG005|NOT COMPLETED|Overall Study||7
8622027|NCT00485303|9661147|FG000|STARTED|Overall Study||58
8622028|NCT00485303|9661147|FG000|COMPLETED|Overall Study||2
8622029|NCT00485303|9661147|FG000|NOT COMPLETED|Overall Study||56
8622030|NCT00485433|9661155|FG000|STARTED|Overall Study||24
8622031|NCT00485433|9661156|FG001|STARTED|Overall Study||25
8622032|NCT00485433|9661157|FG002|STARTED|Overall Study||24
8622033|NCT00485433|9661158|FG003|STARTED|Overall Study||25
8622034|NCT00485433|9661155|FG000|COMPLETED|Overall Study||24
8822755|NCT01584843|9876706|FG001|COMPLETED|First Treatment Period||4
8822756|NCT01584843|9876707|FG002|COMPLETED|First Treatment Period||2
8822757|NCT01584843|9876708|FG003|COMPLETED|First Treatment Period||10
8822758|NCT01584843|9876709|FG004|COMPLETED|First Treatment Period||10
8822759|NCT01584843|9876710|FG005|COMPLETED|First Treatment Period||9
8822760|NCT01584843|9876705|FG000|NOT COMPLETED|First Treatment Period||0
8822761|NCT01584843|9876706|FG001|NOT COMPLETED|First Treatment Period||0
8822762|NCT01584843|9876707|FG002|NOT COMPLETED|First Treatment Period||1
8822763|NCT01584843|9876708|FG003|NOT COMPLETED|First Treatment Period||0
8822764|NCT01584843|9876709|FG004|NOT COMPLETED|First Treatment Period||0
8822765|NCT01584843|9876710|FG005|NOT COMPLETED|First Treatment Period||2
8822766|NCT01584843|9876705|FG000|STARTED|Second Treatment Period||2
8622035|NCT00485433|9661156|FG001|COMPLETED|Overall Study||25
8622036|NCT00485433|9661157|FG002|COMPLETED|Overall Study||24
8622037|NCT00485433|9661158|FG003|COMPLETED|Overall Study||25
8622038|NCT00485433|9661155|FG000|NOT COMPLETED|Overall Study||0
8822767|NCT01584843|9876706|FG001|STARTED|Second Treatment Period||1
8822768|NCT01584843|9876707|FG002|STARTED|Second Treatment Period||2
8822769|NCT01584843|9876708|FG003|STARTED|Second Treatment Period||6
8822770|NCT01584843|9876709|FG004|STARTED|Second Treatment Period||3
8822771|NCT01584843|9876710|FG005|STARTED|Second Treatment Period||1
8822772|NCT01584843|9876705|FG000|COMPLETED|Second Treatment Period||2
8822773|NCT01584843|9876706|FG001|COMPLETED|Second Treatment Period||1
8822774|NCT01584843|9876707|FG002|COMPLETED|Second Treatment Period||2
8822775|NCT01584843|9876708|FG003|COMPLETED|Second Treatment Period||6
8822776|NCT01584843|9876709|FG004|COMPLETED|Second Treatment Period||3
8822777|NCT01584843|9876710|FG005|COMPLETED|Second Treatment Period||0
8822778|NCT01584843|9876705|FG000|NOT COMPLETED|Second Treatment Period||0
8822779|NCT01584843|9876706|FG001|NOT COMPLETED|Second Treatment Period||0
8822780|NCT01584843|9876707|FG002|NOT COMPLETED|Second Treatment Period||0
8822781|NCT01584843|9876708|FG003|NOT COMPLETED|Second Treatment Period||0
8822782|NCT01584843|9876709|FG004|NOT COMPLETED|Second Treatment Period||0
8822783|NCT01584843|9876710|FG005|NOT COMPLETED|Second Treatment Period||1
8822784|NCT01585025|9876729|FG000|STARTED|Overall Study||10
8822785|NCT01585025|9876730|FG001|STARTED|Overall Study||13
8822786|NCT01585025|9876731|FG002|STARTED|Overall Study||12
8822787|NCT01585025|9876729|FG000|COMPLETED|Overall Study||10
8822788|NCT01585025|9876730|FG001|COMPLETED|Overall Study||10
8822789|NCT01585025|9876731|FG002|COMPLETED|Overall Study||8
8822790|NCT01585025|9876729|FG000|NOT COMPLETED|Overall Study||0
8822791|NCT01585025|9876730|FG001|NOT COMPLETED|Overall Study||3
8822792|NCT01585025|9876731|FG002|NOT COMPLETED|Overall Study||4
8822793|NCT01585038|9876741|FG000|STARTED|Overall Study||20
8822794|NCT01585038|9876742|FG001|STARTED|Overall Study||20
8822795|NCT01585038|9876741|FG000|COMPLETED|Overall Study||18
8822796|NCT01585038|9876742|FG001|COMPLETED|Overall Study||18
8822797|NCT01585038|9876741|FG000|NOT COMPLETED|Overall Study||2
8822798|NCT01585038|9876742|FG001|NOT COMPLETED|Overall Study||2
8822799|NCT01585129|9876750|FG000|STARTED|Overall Study||41
8822800|NCT01585129|9876751|FG001|STARTED|Overall Study||39
8822801|NCT01585129|9876750|FG000|COMPLETED|Overall Study||41
8822802|NCT01585129|9876751|FG001|COMPLETED|Overall Study||39
8822803|NCT01585129|9876750|FG000|NOT COMPLETED|Overall Study||0
8822804|NCT01585129|9876751|FG001|NOT COMPLETED|Overall Study||0
8822805|NCT01585155|9876757|FG000|STARTED|Overall Study||21
8822806|NCT01585155|9876757|FG000|COMPLETED|Overall Study||16
8822807|NCT01585155|9876757|FG000|NOT COMPLETED|Overall Study||5
8822808|NCT01585168|9876763|FG000|STARTED|Overall Study||18
8822809|NCT01585168|9876764|FG001|STARTED|Overall Study||18
8822810|NCT01585168|9876765|FG002|STARTED|Overall Study||16
8822811|NCT01585168|9876766|FG003|STARTED|Overall Study||19
8822812|NCT01585168|9876763|FG000|COMPLETED|Overall Study||15
8822813|NCT01585168|9876764|FG001|COMPLETED|Overall Study||17
8822814|NCT01585168|9876765|FG002|COMPLETED|Overall Study||15
8822815|NCT01585168|9876766|FG003|COMPLETED|Overall Study||18
8822816|NCT01585168|9876763|FG000|NOT COMPLETED|Overall Study||3
8822817|NCT01585168|9876764|FG001|NOT COMPLETED|Overall Study||1
8822818|NCT01585168|9876765|FG002|NOT COMPLETED|Overall Study||1
8822819|NCT01585168|9876766|FG003|NOT COMPLETED|Overall Study||1
8822820|NCT01585194|9876774|FG000|STARTED|Overall Study||39
8822821|NCT01585194|9876774|FG000|COMPLETED|Overall Study||35
8822822|NCT01585194|9876774|FG000|NOT COMPLETED|Overall Study||4
8822823|NCT01585207|9876778|FG000|STARTED|Overall Study||4
8822824|NCT01585207|9876778|FG000|COMPLETED|Overall Study||4
8822825|NCT01585207|9876778|FG000|NOT COMPLETED|Overall Study||0
8822826|NCT01585246|9876787|FG000|STARTED|Overall Study||3
8822827|NCT01585246|9876788|FG001|STARTED|Overall Study||4
8822828|NCT01585246|9876789|FG002|STARTED|Overall Study||20
8822829|NCT01585246|9876790|FG003|STARTED|Overall Study||10
8822830|NCT01585246|9876791|FG004|STARTED|Overall Study||11
8822831|NCT01585246|9876787|FG000|COMPLETED|Overall Study||3
8822832|NCT01585246|9876788|FG001|COMPLETED|Overall Study||3
8822833|NCT01585246|9876789|FG002|COMPLETED|Overall Study||16
8822834|NCT01585246|9876790|FG003|COMPLETED|Overall Study||6
8822835|NCT01585246|9876791|FG004|COMPLETED|Overall Study||9
8822836|NCT01585246|9876787|FG000|NOT COMPLETED|Overall Study||0
8822837|NCT01585246|9876788|FG001|NOT COMPLETED|Overall Study||1
8822838|NCT01585246|9876789|FG002|NOT COMPLETED|Overall Study||4
8822839|NCT01585246|9876790|FG003|NOT COMPLETED|Overall Study||4
8822840|NCT01585246|9876791|FG004|NOT COMPLETED|Overall Study||2
8822841|NCT01585272|9876806|FG000|STARTED|Overall Study||121
8822842|NCT01585272|9876806|FG000|Safety Set|Overall Study|Subjects received 3 mg bid Exelon caps for more than 4 weeks & used at least 1 dose of Exelon patch.|102
8622039|NCT00485433|9661156|FG001|NOT COMPLETED|Overall Study||0
8622040|NCT00485433|9661157|FG002|NOT COMPLETED|Overall Study||0
8622041|NCT00485433|9661158|FG003|NOT COMPLETED|Overall Study||0
8622042|NCT00485472|9661168|FG000|STARTED|Overall Study||73
8622043|NCT00485472|9661169|FG001|STARTED|Overall Study||76
8622044|NCT00485472|9661168|FG000|Entered Maintenance Phase|Overall Study||65
8622045|NCT00485472|9661169|FG001|Entered Maintenance Phase|Overall Study||67
8622046|NCT00485472|9661168|FG000|COMPLETED|Overall Study||57
8622047|NCT00485472|9661169|FG001|COMPLETED|Overall Study||64
8622048|NCT00485472|9661168|FG000|NOT COMPLETED|Overall Study||16
8622049|NCT00485472|9661169|FG001|NOT COMPLETED|Overall Study||12
8822843|NCT01585272|9876806|FG000|Exelon Patch 5 cm2|Overall Study||114
8822844|NCT01585272|9876806|FG000|Exelon Patch 10 cm2|Overall Study||96
8822845|NCT01585272|9876806|FG000|COMPLETED|Overall Study||82
8822846|NCT01585272|9876806|FG000|NOT COMPLETED|Overall Study||39
8822847|NCT01585298|9876810|FG000|STARTED|Overall Study||6998
8822848|NCT01585298|9876810|FG000|COMPLETED|Overall Study||6961
8822849|NCT01585298|9876810|FG000|NOT COMPLETED|Overall Study||37
8822850|NCT01585324|9876814|FG000|STARTED|Overall Study||30
8822851|NCT01585324|9876814|FG000|COMPLETED|Overall Study||30
8822852|NCT01585324|9876814|FG000|NOT COMPLETED|Overall Study||0
8822853|NCT01585428|9876822|FG000|STARTED|Overall Study||18
8822854|NCT01585428|9876823|FG001|STARTED|Overall Study||11
8822855|NCT01585428|9876822|FG000|COMPLETED|Overall Study||17
8822856|NCT01585428|9876823|FG001|COMPLETED|Overall Study||11
8822857|NCT01585428|9876822|FG000|NOT COMPLETED|Overall Study||1
8822858|NCT01585428|9876823|FG001|NOT COMPLETED|Overall Study||0
8822859|NCT01585441|9876832|FG000|STARTED|Overall Study||3
8822860|NCT01585441|9876833|FG001|STARTED|Overall Study||3
8822861|NCT01585441|9876832|FG000|Month 3|Overall Study|One participant was not evaluated at Month 3 but at the final visit due to study terminating early.|2
8822862|NCT01585441|9876833|FG001|Month 3|Overall Study||3
8822863|NCT01585441|9876832|FG000|Received Finasteride at Month 3|Overall Study||2
8822864|NCT01585441|9876833|FG001|Received Finasteride at Month 3|Overall Study||2
8822865|NCT01585441|9876832|FG000|Final Study Safety Visit|Overall Study||3
8822866|NCT01585441|9876833|FG001|Final Study Safety Visit|Overall Study|A final study visit was not required for the placebo participant who completed the study at Month 3.|2
8822867|NCT01585441|9876832|FG000|COMPLETED|Overall Study|Defined as completing the Month 3 masked phase of the study and/or the final safety visit|3
8822868|NCT01585441|9876833|FG001|COMPLETED|Overall Study|Defined as completing the Month 3 masked phase of the study and/or the final safety visit|3
8822869|NCT01585441|9876832|FG000|NOT COMPLETED|Overall Study||0
8822870|NCT01585441|9876833|FG001|NOT COMPLETED|Overall Study||0
8822871|NCT01585558|9876842|FG000|STARTED|Overall Study||62
8822872|NCT01585558|9876843|FG001|STARTED|Overall Study||69
8822873|NCT01585558|9876844|FG002|STARTED|Overall Study||49
8822874|NCT01585558|9876842|FG000|COMPLETED|Overall Study||49
8822875|NCT01585558|9876843|FG001|COMPLETED|Overall Study||57
8822876|NCT01585558|9876844|FG002|COMPLETED|Overall Study||34
8822877|NCT01585558|9876842|FG000|NOT COMPLETED|Overall Study||13
8822878|NCT01585558|9876843|FG001|NOT COMPLETED|Overall Study||12
8822879|NCT01585558|9876844|FG002|NOT COMPLETED|Overall Study||15
8822880|NCT01585584|9876852|FG000|STARTED|Overall Study||10
8822881|NCT01585584|9876852|FG000|COMPLETED|Overall Study||6
8822882|NCT01585584|9876852|FG000|NOT COMPLETED|Overall Study||4
8822883|NCT01585597|9876856|FG000|STARTED|Overall Study||20
8822884|NCT01585597|9876856|FG000|COMPLETED|Overall Study||20
8822885|NCT01585597|9876856|FG000|NOT COMPLETED|Overall Study||0
8822886|NCT01585766|9876866|FG000|STARTED|Overall Study||7
8822887|NCT01585766|9876867|FG001|STARTED|Overall Study||5
8822888|NCT01585766|9876868|FG002|STARTED|Overall Study||3
8822889|NCT01585766|9876869|FG003|STARTED|Overall Study||4
8822890|NCT01585766|9876870|FG004|STARTED|Overall Study||3
8822891|NCT01585766|9876871|FG005|STARTED|Overall Study||6
8822892|NCT01585766|9876866|FG000|COMPLETED|Overall Study||7
8822893|NCT01585766|9876867|FG001|COMPLETED|Overall Study||3
8822894|NCT01585766|9876868|FG002|COMPLETED|Overall Study||1
8822895|NCT01585766|9876869|FG003|COMPLETED|Overall Study||4
8822896|NCT01585766|9876870|FG004|COMPLETED|Overall Study||3
8822897|NCT01585766|9876871|FG005|COMPLETED|Overall Study||6
8822898|NCT01585766|9876866|FG000|NOT COMPLETED|Overall Study||0
8822899|NCT01585766|9876867|FG001|NOT COMPLETED|Overall Study||2
8822900|NCT01585766|9876868|FG002|NOT COMPLETED|Overall Study||2
8822901|NCT01585766|9876869|FG003|NOT COMPLETED|Overall Study||0
8822902|NCT01585766|9876870|FG004|NOT COMPLETED|Overall Study||0
8822903|NCT01585766|9876871|FG005|NOT COMPLETED|Overall Study||0
8822904|NCT01585779|9876894|FG000|STARTED|Overall Study||36
8822905|NCT01585779|9876895|FG001|STARTED|Overall Study||28
8822906|NCT01585779|9876894|FG000|COMPLETED|Overall Study||26
8822907|NCT01585779|9876895|FG001|COMPLETED|Overall Study||21
8822908|NCT01585779|9876894|FG000|NOT COMPLETED|Overall Study||10
8822909|NCT01585779|9876895|FG001|NOT COMPLETED|Overall Study||7
8822910|NCT01585831|9876904|FG000|STARTED|Overall Study||28
8822911|NCT01585831|9876905|FG001|STARTED|Overall Study||20
8822912|NCT01585831|9876904|FG000|COMPLETED|Overall Study||26
8822913|NCT01585831|9876905|FG001|COMPLETED|Overall Study||18
8822914|NCT01585831|9876904|FG000|NOT COMPLETED|Overall Study||2
8822915|NCT01585831|9876905|FG001|NOT COMPLETED|Overall Study||2
8822916|NCT01585961|9876911|FG000|STARTED|Overall Study||511
8822917|NCT01585961|9876911|FG000|Safety|Overall Study|Patients ablated with study catheter|508
8822918|NCT01585961|9876911|FG000|COMPLETED|Overall Study||478
8822919|NCT01585961|9876911|FG000|NOT COMPLETED|Overall Study||33
8822920|NCT01585987|9876917|FG000|STARTED|Randomized||57
8822921|NCT01585987|9876918|FG001|STARTED|Randomized||57
8822922|NCT01585987|9876917|FG000|COMPLETED|Randomized||57
8822923|NCT01585987|9876918|FG001|COMPLETED|Randomized||51
8822924|NCT01585987|9876917|FG000|NOT COMPLETED|Randomized||0
8822925|NCT01585987|9876918|FG001|NOT COMPLETED|Randomized||6
8822926|NCT01585987|9876917|FG000|STARTED|Treated||57
8822927|NCT01585987|9876918|FG001|STARTED|Treated||51
8822928|NCT01585987|9876917|FG000|COMPLETED|Treated||3
8822929|NCT01585987|9876918|FG001|COMPLETED|Treated||2
8822930|NCT01585987|9876917|FG000|NOT COMPLETED|Treated||54
8822931|NCT01585987|9876918|FG001|NOT COMPLETED|Treated||49
8822932|NCT01586026|9876925|FG000|STARTED|Overall Study||350
8822933|NCT01586026|9876926|FG001|STARTED|Overall Study||414
8822934|NCT01586026|9876927|FG002|STARTED|Overall Study||271
8822935|NCT01586026|9876925|FG000|COMPLETED|Overall Study||350
8822936|NCT01586026|9876926|FG001|COMPLETED|Overall Study||414
8822937|NCT01586026|9876927|FG002|COMPLETED|Overall Study||271
8822938|NCT01586026|9876925|FG000|NOT COMPLETED|Overall Study||0
8822939|NCT01586026|9876926|FG001|NOT COMPLETED|Overall Study||0
8822940|NCT01586026|9876927|FG002|NOT COMPLETED|Overall Study||0
8822941|NCT01586039|9876939|FG000|STARTED|Overall Study||8
8822942|NCT01586039|9876940|FG001|STARTED|Overall Study||9
8822943|NCT01586039|9876941|FG002|STARTED|Overall Study||8
8822944|NCT01586039|9876942|FG003|STARTED|Overall Study||8
8822945|NCT01586039|9876939|FG000|COMPLETED|Overall Study||8
8822946|NCT01586039|9876940|FG001|COMPLETED|Overall Study||8
8822947|NCT01586039|9876941|FG002|COMPLETED|Overall Study||8
8822948|NCT01586039|9876942|FG003|COMPLETED|Overall Study||8
8822949|NCT01586039|9876939|FG000|NOT COMPLETED|Overall Study||0
8822950|NCT01586039|9876940|FG001|NOT COMPLETED|Overall Study||1
8822951|NCT01586039|9876941|FG002|NOT COMPLETED|Overall Study||0
8822952|NCT01586039|9876942|FG003|NOT COMPLETED|Overall Study||0
8822953|NCT01586091|9876955|FG000|STARTED|Overall Study|9 Caucasian and 9 Asian participants, each received Levocetiricine, fexofenadine and Placebo.|6
8822954|NCT01586091|9876956|FG001|STARTED|Overall Study|9 Caucasian and 9 Asian participants, each received Levocetiricine, fexofenadine and Placebo.|6
8822955|NCT01586091|9876957|FG002|STARTED|Overall Study||6
8822956|NCT01586091|9876955|FG000|COMPLETED|Overall Study|9 Caucasian and 9 Asian participants, each received Levocetiricine, fexofenadine and Placebo.|6
8822957|NCT01586091|9876956|FG001|COMPLETED|Overall Study|9 Caucasian and 9 Asian participants, each received Levocetiricine, fexofenadine and Placebo.|6
8822958|NCT01586091|9876957|FG002|COMPLETED|Overall Study||6
8822959|NCT01586091|9876955|FG000|NOT COMPLETED|Overall Study||0
8822960|NCT01586091|9876956|FG001|NOT COMPLETED|Overall Study||0
8622050|NCT00485485|9661175|FG000|STARTED|Overall Study||7
8622051|NCT00485485|9661175|FG000|COMPLETED|Overall Study||7
8622052|NCT00485485|9661175|FG000|NOT COMPLETED|Overall Study||0
8622053|NCT00485589|9661182|FG000|STARTED|Overall Study||210
8622054|NCT00485589|9661183|FG001|STARTED|Overall Study||200
8622055|NCT00485589|9661184|FG002|STARTED|Overall Study||203
8822961|NCT01586091|9876957|FG002|NOT COMPLETED|Overall Study||0
8822962|NCT01586156|9876971|FG000|STARTED|Overall Study||10
8822963|NCT01586156|9876972|FG001|STARTED|Overall Study||10
8822964|NCT01586156|9876973|FG002|STARTED|Overall Study||10
8822965|NCT01586156|9876971|FG000|COMPLETED|Overall Study||10
8822966|NCT01586156|9876972|FG001|COMPLETED|Overall Study||9
8822967|NCT01586156|9876973|FG002|COMPLETED|Overall Study||10
8822968|NCT01586156|9876971|FG000|NOT COMPLETED|Overall Study||0
8822969|NCT01586156|9876972|FG001|NOT COMPLETED|Overall Study||1
8822970|NCT01586156|9876973|FG002|NOT COMPLETED|Overall Study||0
8822971|NCT01586195|9876981|FG000|STARTED|Overall Study||31
8822972|NCT01586195|9876981|FG000|COMPLETED|Overall Study||5
8822973|NCT01586195|9876981|FG000|NOT COMPLETED|Overall Study||26
8822974|NCT01586312|9876987|FG000|STARTED|Overall Study||15
8822975|NCT01586312|9876988|FG001|STARTED|Overall Study||15
8822976|NCT01586312|9876987|FG000|COMPLETED|Overall Study||15
8822977|NCT01586312|9876988|FG001|COMPLETED|Overall Study||15
8822978|NCT01586312|9876987|FG000|NOT COMPLETED|Overall Study||0
8822979|NCT01586312|9876988|FG001|NOT COMPLETED|Overall Study||0
8822980|NCT01586338|9876994|FG000|STARTED|Overall Study||237
8822981|NCT01586338|9876994|FG000|COMPLETED|Overall Study||229
8822982|NCT01586338|9876994|FG000|NOT COMPLETED|Overall Study||8
8822983|NCT01586364|9876998|FG000|STARTED|Overall Study||301
8822984|NCT01586364|9876998|FG000|COMPLETED|Overall Study||184
8822985|NCT01586364|9876998|FG000|NOT COMPLETED|Overall Study||117
8822986|NCT01586624|9877010|FG000|STARTED|Overall Study||6
8822987|NCT01586624|9877011|FG001|STARTED|Overall Study||6
8822988|NCT01586624|9877012|FG002|STARTED|Overall Study||6
8822989|NCT01586624|9877013|FG003|STARTED|Overall Study||7
8822990|NCT01586624|9877014|FG004|STARTED|Overall Study||9
8822991|NCT01586624|9877015|FG005|STARTED|Overall Study||8
8822992|NCT01586624|9877016|FG006|STARTED|Overall Study||8
8822993|NCT01586624|9877017|FG007|STARTED|Overall Study||11
8622056|NCT00485589|9661182|FG000|COMPLETED|Overall Study||183
8822994|NCT01586624|9877010|FG000|COMPLETED|Overall Study||2
8822995|NCT01586624|9877011|FG001|COMPLETED|Overall Study||2
8822996|NCT01586624|9877012|FG002|COMPLETED|Overall Study||1
8822997|NCT01586624|9877013|FG003|COMPLETED|Overall Study||0
8822998|NCT01586624|9877014|FG004|COMPLETED|Overall Study||1
8822999|NCT01586624|9877015|FG005|COMPLETED|Overall Study||0
8823000|NCT01586624|9877016|FG006|COMPLETED|Overall Study||0
8823001|NCT01586624|9877017|FG007|COMPLETED|Overall Study||1
8823002|NCT01586624|9877010|FG000|NOT COMPLETED|Overall Study||4
8823003|NCT01586624|9877011|FG001|NOT COMPLETED|Overall Study||4
8823004|NCT01586624|9877012|FG002|NOT COMPLETED|Overall Study||5
8823005|NCT01586624|9877013|FG003|NOT COMPLETED|Overall Study||7
8823006|NCT01586624|9877014|FG004|NOT COMPLETED|Overall Study||8
8823007|NCT01586624|9877015|FG005|NOT COMPLETED|Overall Study||8
8622057|NCT00485589|9661183|FG001|COMPLETED|Overall Study||180
8622058|NCT00485589|9661184|FG002|COMPLETED|Overall Study||185
8622059|NCT00485589|9661182|FG000|NOT COMPLETED|Overall Study||27
8823008|NCT01586624|9877016|FG006|NOT COMPLETED|Overall Study||8
8823009|NCT01586624|9877017|FG007|NOT COMPLETED|Overall Study||10
8823010|NCT01586741|9877039|FG000|STARTED|Overall Study||28
8823011|NCT01586741|9877040|FG001|STARTED|Overall Study||29
8823012|NCT01586741|9877041|FG002|STARTED|Overall Study||32
8823013|NCT01586741|9877039|FG000|COMPLETED|Overall Study||27
8823014|NCT01586741|9877040|FG001|COMPLETED|Overall Study||29
8823015|NCT01586741|9877041|FG002|COMPLETED|Overall Study||30
8823016|NCT01586741|9877039|FG000|NOT COMPLETED|Overall Study||1
8823017|NCT01586741|9877040|FG001|NOT COMPLETED|Overall Study||0
8823018|NCT01586741|9877041|FG002|NOT COMPLETED|Overall Study||2
8823019|NCT01586806|9877052|FG000|STARTED|Overall Study||65
8823020|NCT01586806|9877053|FG001|STARTED|Overall Study||65
8823021|NCT01586806|9877054|FG002|STARTED|Overall Study||65
8823022|NCT01586806|9877052|FG000|COMPLETED|Overall Study||62
8823023|NCT01586806|9877053|FG001|COMPLETED|Overall Study||61
8823024|NCT01586806|9877054|FG002|COMPLETED|Overall Study||63
8823025|NCT01586806|9877052|FG000|NOT COMPLETED|Overall Study||3
8823026|NCT01586806|9877053|FG001|NOT COMPLETED|Overall Study||4
8823027|NCT01586806|9877054|FG002|NOT COMPLETED|Overall Study||2
8823028|NCT01586819|9877064|FG000|STARTED|Overall Study||12
8823029|NCT01586819|9877065|FG001|STARTED|Overall Study||14
8823030|NCT01586819|9877064|FG000|COMPLETED|Overall Study||11
8823031|NCT01586819|9877065|FG001|COMPLETED|Overall Study||14
8823032|NCT01586819|9877064|FG000|NOT COMPLETED|Overall Study||1
8823033|NCT01586819|9877065|FG001|NOT COMPLETED|Overall Study||0
8823034|NCT01586871|9877074|FG000|STARTED|Overall Study||560
8823035|NCT01586871|9877075|FG001|STARTED|Overall Study||554
8823036|NCT01586871|9877076|FG002|STARTED|Overall Study||33
8823037|NCT01586871|9877074|FG000|COMPLETED|Overall Study||560
8823038|NCT01586871|9877075|FG001|COMPLETED|Overall Study||554
8823039|NCT01586871|9877076|FG002|COMPLETED|Overall Study||33
8823040|NCT01586871|9877074|FG000|NOT COMPLETED|Overall Study||0
8823041|NCT01586871|9877075|FG001|NOT COMPLETED|Overall Study||0
8823042|NCT01586871|9877076|FG002|NOT COMPLETED|Overall Study||0
8823043|NCT01586897|9877086|FG000|STARTED|Overall Study||26
8823044|NCT01586897|9877087|FG001|STARTED|Overall Study||26
8823045|NCT01586897|9877086|FG000|COMPLETED|Overall Study||26
8823046|NCT01586897|9877087|FG001|COMPLETED|Overall Study||26
8823047|NCT01586897|9877086|FG000|NOT COMPLETED|Overall Study||0
8823048|NCT01586897|9877087|FG001|NOT COMPLETED|Overall Study||0
8823049|NCT01586962|9877095|FG000|STARTED|Overall Study||56
8823050|NCT01586962|9877095|FG000|COMPLETED|Overall Study||56
8823051|NCT01586962|9877095|FG000|NOT COMPLETED|Overall Study||0
8823052|NCT01586975|9877102|FG000|STARTED|Overall Study||15
8823053|NCT01586975|9877103|FG001|STARTED|Overall Study||32
8823054|NCT01586975|9877104|FG002|STARTED|Overall Study||46
8823055|NCT01586975|9877102|FG000|COMPLETED|Overall Study||15
8823056|NCT01586975|9877103|FG001|COMPLETED|Overall Study||32
8823057|NCT01586975|9877104|FG002|COMPLETED|Overall Study||46
8823058|NCT01586975|9877102|FG000|NOT COMPLETED|Overall Study||0
8823059|NCT01586975|9877103|FG001|NOT COMPLETED|Overall Study||0
8823060|NCT01586975|9877104|FG002|NOT COMPLETED|Overall Study||0
8823061|NCT01587001|9877114|FG000|STARTED|Overall Study||14
8823062|NCT01587001|9877115|FG001|STARTED|Overall Study||3
8823063|NCT01587001|9877114|FG000|COMPLETED|Overall Study||8
8823064|NCT01587001|9877115|FG001|COMPLETED|Overall Study||2
8823065|NCT01587001|9877114|FG000|NOT COMPLETED|Overall Study||6
8823066|NCT01587001|9877115|FG001|NOT COMPLETED|Overall Study||1
8823067|NCT01587014|9877122|FG000|STARTED|Overall Study||26
8823068|NCT01587014|9877122|FG000|COMPLETED|Overall Study||24
8823069|NCT01587014|9877122|FG000|NOT COMPLETED|Overall Study||2
8823070|NCT01587027|9877128|FG000|STARTED|First Intervention (1 Day)||8
8823071|NCT01587027|9877129|FG001|STARTED|First Intervention (1 Day)||8
8823072|NCT01587027|9877128|FG000|COMPLETED|First Intervention (1 Day)||8
8823073|NCT01587027|9877129|FG001|COMPLETED|First Intervention (1 Day)||8
8823074|NCT01587027|9877128|FG000|NOT COMPLETED|First Intervention (1 Day)||0
8823075|NCT01587027|9877129|FG001|NOT COMPLETED|First Intervention (1 Day)||0
8823076|NCT01587027|9877128|FG000|STARTED|Washout (1 Day)||8
8823077|NCT01587027|9877129|FG001|STARTED|Washout (1 Day)||8
8823078|NCT01587027|9877128|FG000|COMPLETED|Washout (1 Day)||8
8823079|NCT01587027|9877129|FG001|COMPLETED|Washout (1 Day)||8
8823080|NCT01587027|9877128|FG000|NOT COMPLETED|Washout (1 Day)||0
8823081|NCT01587027|9877129|FG001|NOT COMPLETED|Washout (1 Day)||0
8823082|NCT01587027|9877128|FG000|STARTED|Second Intervention (1 Day)||8
8823083|NCT01587027|9877129|FG001|STARTED|Second Intervention (1 Day)||8
8823084|NCT01587027|9877128|FG000|COMPLETED|Second Intervention (1 Day)||8
8823085|NCT01587027|9877129|FG001|COMPLETED|Second Intervention (1 Day)||8
8823086|NCT01587027|9877128|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
8823087|NCT01587027|9877129|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
8823088|NCT01587027|9877128|FG000|STARTED|Washout (1 Day)||8
8823089|NCT01587027|9877129|FG001|STARTED|Washout (1 Day)||8
8823090|NCT01587027|9877128|FG000|COMPLETED|Washout (1 Day)||8
8823091|NCT01587027|9877129|FG001|COMPLETED|Washout (1 Day)||8
8823092|NCT01587027|9877128|FG000|NOT COMPLETED|Washout (1 Day)||0
8823093|NCT01587027|9877129|FG001|NOT COMPLETED|Washout (1 Day)||0
8823094|NCT01587027|9877128|FG000|STARTED|Third Intervention (1 Day)||8
8823095|NCT01587027|9877129|FG001|STARTED|Third Intervention (1 Day)||8
8823096|NCT01587027|9877128|FG000|COMPLETED|Third Intervention (1 Day)||8
8823097|NCT01587027|9877129|FG001|COMPLETED|Third Intervention (1 Day)||8
8823098|NCT01587027|9877128|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
8823099|NCT01587027|9877129|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
8823100|NCT01587027|9877128|FG000|STARTED|Discharge (1 Day)||8
8823101|NCT01587027|9877129|FG001|STARTED|Discharge (1 Day)||8
8823102|NCT01587027|9877128|FG000|COMPLETED|Discharge (1 Day)||8
8823103|NCT01587027|9877129|FG001|COMPLETED|Discharge (1 Day)||8
8823104|NCT01587027|9877128|FG000|NOT COMPLETED|Discharge (1 Day)||0
8823105|NCT01587027|9877129|FG001|NOT COMPLETED|Discharge (1 Day)||0
8823106|NCT01587079|9877135|FG000|STARTED|Overall Study||159
8823107|NCT01587079|9877135|FG000|COMPLETED|Overall Study||120
8823108|NCT01587079|9877135|FG000|NOT COMPLETED|Overall Study||39
8823109|NCT01587105|9877171|FG000|STARTED|Overall Study||150
8823110|NCT01587105|9877172|FG001|STARTED|Overall Study||181
8823111|NCT01587105|9877171|FG000|COMPLETED|Overall Study||144
8823112|NCT01587105|9877172|FG001|COMPLETED|Overall Study||138
8823113|NCT01587105|9877171|FG000|NOT COMPLETED|Overall Study||6
8823114|NCT01587105|9877172|FG001|NOT COMPLETED|Overall Study||43
8823115|NCT01587118|9877178|FG000|STARTED|Overall Study|31 signed consent and 18 were deemed eligible and initiated treatment with adjunctive asenapine.|18
8823116|NCT01587118|9877178|FG000|COMPLETED|Overall Study||11
8823117|NCT01587118|9877178|FG000|NOT COMPLETED|Overall Study||7
8823118|NCT01587274|9877185|FG000|STARTED|Overall Study||108
8823119|NCT01587274|9877186|FG001|STARTED|Overall Study||108
8823120|NCT01587274|9877187|FG002|STARTED|Overall Study||107
8823121|NCT01587274|9877185|FG000|COMPLETED|Overall Study||104
8823122|NCT01587274|9877186|FG001|COMPLETED|Overall Study||103
8823123|NCT01587274|9877187|FG002|COMPLETED|Overall Study||104
8823124|NCT01587274|9877185|FG000|NOT COMPLETED|Overall Study||4
8823125|NCT01587274|9877186|FG001|NOT COMPLETED|Overall Study||5
8823126|NCT01587274|9877187|FG002|NOT COMPLETED|Overall Study||3
8823127|NCT01587651|9877198|FG000|STARTED|Overall Study||34
8823128|NCT01587651|9877199|FG001|STARTED|Overall Study||41
8823129|NCT01587651|9877200|FG002|STARTED|Overall Study||35
8823130|NCT01587651|9877198|FG000|COMPLETED|Overall Study||34
8823131|NCT01587651|9877199|FG001|COMPLETED|Overall Study||38
8823132|NCT01587651|9877200|FG002|COMPLETED|Overall Study||34
8823133|NCT01587651|9877198|FG000|NOT COMPLETED|Overall Study||0
8823134|NCT01587651|9877199|FG001|NOT COMPLETED|Overall Study||3
8823135|NCT01587651|9877200|FG002|NOT COMPLETED|Overall Study||1
8823136|NCT01587703|9877227|FG000|STARTED|Part1 QD(Median Exposure of 1.38months)||3
8823137|NCT01587703|9877228|FG001|STARTED|Part1 QD(Median Exposure of 1.38months)||4
8823138|NCT01587703|9877229|FG002|STARTED|Part1 QD(Median Exposure of 1.38months)||1
8823139|NCT01587703|9877230|FG003|STARTED|Part1 QD(Median Exposure of 1.38months)||3
8823140|NCT01587703|9877231|FG004|STARTED|Part1 QD(Median Exposure of 1.38months)||4
8823141|NCT01587703|9877232|FG005|STARTED|Part1 QD(Median Exposure of 1.38months)||9
8823142|NCT01587703|9877233|FG006|STARTED|Part1 QD(Median Exposure of 1.38months)||32
8823143|NCT01587703|9877234|FG007|STARTED|Part1 QD(Median Exposure of 1.38months)||9
8823144|NCT01587703|9877235|FG008|STARTED|Part1 QD(Median Exposure of 1.38months)||0
8823145|NCT01587703|9877236|FG009|STARTED|Part1 QD(Median Exposure of 1.38months)||0
8823146|NCT01587703|9877237|FG010|STARTED|Part1 QD(Median Exposure of 1.38months)||0
8823147|NCT01587703|9877238|FG011|STARTED|Part1 QD(Median Exposure of 1.38months)||0
8823148|NCT01587703|9877239|FG012|STARTED|Part1 QD(Median Exposure of 1.38months)||0
8823149|NCT01587703|9877240|FG013|STARTED|Part1 QD(Median Exposure of 1.38months)||0
8823150|NCT01587703|9877241|FG014|STARTED|Part1 QD(Median Exposure of 1.38months)||0
8823151|NCT01587703|9877242|FG015|STARTED|Part1 QD(Median Exposure of 1.38months)||0
8823152|NCT01587703|9877243|FG016|STARTED|Part1 QD(Median Exposure of 1.38months)||0
8823153|NCT01587703|9877244|FG017|STARTED|Part1 QD(Median Exposure of 1.38months)||0
8823154|NCT01587703|9877245|FG018|STARTED|Part1 QD(Median Exposure of 1.38months)||0
8823155|NCT01587703|9877227|FG000|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8823156|NCT01587703|9877228|FG001|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8823157|NCT01587703|9877229|FG002|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8823158|NCT01587703|9877230|FG003|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8823159|NCT01587703|9877231|FG004|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8823160|NCT01587703|9877232|FG005|COMPLETED|Part1 QD(Median Exposure of 1.38months)||1
8823161|NCT01587703|9877233|FG006|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8823162|NCT01587703|9877234|FG007|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8823163|NCT01587703|9877235|FG008|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8823164|NCT01587703|9877236|FG009|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8823165|NCT01587703|9877237|FG010|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8823166|NCT01587703|9877238|FG011|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8823167|NCT01587703|9877239|FG012|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8823168|NCT01587703|9877240|FG013|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8823169|NCT01587703|9877241|FG014|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8823170|NCT01587703|9877242|FG015|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8823171|NCT01587703|9877243|FG016|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8823172|NCT01587703|9877244|FG017|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8823173|NCT01587703|9877245|FG018|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8823174|NCT01587703|9877227|FG000|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||3
8823175|NCT01587703|9877228|FG001|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||4
8823176|NCT01587703|9877229|FG002|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||1
8823177|NCT01587703|9877230|FG003|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||3
8823178|NCT01587703|9877231|FG004|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||4
8823179|NCT01587703|9877232|FG005|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||8
8823180|NCT01587703|9877233|FG006|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||32
8823181|NCT01587703|9877234|FG007|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||9
8823182|NCT01587703|9877235|FG008|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8823183|NCT01587703|9877236|FG009|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8823184|NCT01587703|9877237|FG010|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8622060|NCT00485589|9661183|FG001|NOT COMPLETED|Overall Study||20
8622061|NCT00485589|9661184|FG002|NOT COMPLETED|Overall Study||18
8622062|NCT00485732|9661203|FG000|STARTED|Overall Study||149
8622063|NCT00485732|9661204|FG001|STARTED|Overall Study||76
8622064|NCT00485732|9661203|FG000|COMPLETED|Overall Study||141
8823185|NCT01587703|9877238|FG011|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8823186|NCT01587703|9877239|FG012|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8823187|NCT01587703|9877240|FG013|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8849492|NCT01741350|9904731|FG000|NOT COMPLETED|Study Intervention||0
8622065|NCT00485732|9661204|FG001|COMPLETED|Overall Study||67
8622066|NCT00485732|9661203|FG000|NOT COMPLETED|Overall Study||8
8622067|NCT00485732|9661204|FG001|NOT COMPLETED|Overall Study||9
8823188|NCT01587703|9877241|FG014|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8823189|NCT01587703|9877242|FG015|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8823190|NCT01587703|9877243|FG016|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8823191|NCT01587703|9877244|FG017|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8823192|NCT01587703|9877245|FG018|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8823193|NCT01587703|9877227|FG000|STARTED|Part1 BID(Median Exposure of 1.41months)||0
8823194|NCT01587703|9877228|FG001|STARTED|Part1 BID(Median Exposure of 1.41months)||0
8823195|NCT01587703|9877229|FG002|STARTED|Part1 BID(Median Exposure of 1.41months)||0
8823196|NCT01587703|9877230|FG003|STARTED|Part1 BID(Median Exposure of 1.41months)||0
8823197|NCT01587703|9877231|FG004|STARTED|Part1 BID(Median Exposure of 1.41months)||0
8823198|NCT01587703|9877232|FG005|STARTED|Part1 BID(Median Exposure of 1.41months)||0
8823199|NCT01587703|9877233|FG006|STARTED|Part1 BID(Median Exposure of 1.41months)||0
8823200|NCT01587703|9877234|FG007|STARTED|Part1 BID(Median Exposure of 1.41months)||0
8823201|NCT01587703|9877235|FG008|STARTED|Part1 BID(Median Exposure of 1.41months)||4
8823202|NCT01587703|9877236|FG009|STARTED|Part1 BID(Median Exposure of 1.41months)||10
8823203|NCT01587703|9877237|FG010|STARTED|Part1 BID(Median Exposure of 1.41months)||5
8823204|NCT01587703|9877238|FG011|STARTED|Part1 BID(Median Exposure of 1.41months)||0
8823205|NCT01587703|9877239|FG012|STARTED|Part1 BID(Median Exposure of 1.41months)||0
8823206|NCT01587703|9877240|FG013|STARTED|Part1 BID(Median Exposure of 1.41months)||0
8823207|NCT01587703|9877241|FG014|STARTED|Part1 BID(Median Exposure of 1.41months)||0
8823208|NCT01587703|9877242|FG015|STARTED|Part1 BID(Median Exposure of 1.41months)||0
8823209|NCT01587703|9877243|FG016|STARTED|Part1 BID(Median Exposure of 1.41months)||0
8823210|NCT01587703|9877244|FG017|STARTED|Part1 BID(Median Exposure of 1.41months)||0
8823211|NCT01587703|9877245|FG018|STARTED|Part1 BID(Median Exposure of 1.41months)||0
8823212|NCT01587703|9877227|FG000|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8823213|NCT01587703|9877228|FG001|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8823214|NCT01587703|9877229|FG002|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8823215|NCT01587703|9877230|FG003|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8823216|NCT01587703|9877231|FG004|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8823217|NCT01587703|9877232|FG005|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8823218|NCT01587703|9877233|FG006|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8823219|NCT01587703|9877234|FG007|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8823220|NCT01587703|9877235|FG008|COMPLETED|Part1 BID(Median Exposure of 1.41months)||1
8823221|NCT01587703|9877236|FG009|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8823222|NCT01587703|9877237|FG010|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8823223|NCT01587703|9877238|FG011|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8823224|NCT01587703|9877239|FG012|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8823225|NCT01587703|9877240|FG013|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8823226|NCT01587703|9877241|FG014|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8823227|NCT01587703|9877242|FG015|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8823228|NCT01587703|9877243|FG016|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8823229|NCT01587703|9877244|FG017|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8823230|NCT01587703|9877245|FG018|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8823231|NCT01587703|9877227|FG000|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8823232|NCT01587703|9877228|FG001|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8823233|NCT01587703|9877229|FG002|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8823234|NCT01587703|9877230|FG003|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8823235|NCT01587703|9877231|FG004|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8823236|NCT01587703|9877232|FG005|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8823237|NCT01587703|9877233|FG006|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8823238|NCT01587703|9877234|FG007|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8823239|NCT01587703|9877235|FG008|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||3
8823240|NCT01587703|9877236|FG009|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||10
8823241|NCT01587703|9877237|FG010|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||5
8823242|NCT01587703|9877238|FG011|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8823243|NCT01587703|9877239|FG012|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8823244|NCT01587703|9877240|FG013|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8823245|NCT01587703|9877241|FG014|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8823246|NCT01587703|9877242|FG015|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8823247|NCT01587703|9877243|FG016|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8823248|NCT01587703|9877244|FG017|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8823249|NCT01587703|9877245|FG018|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8823250|NCT01587703|9877227|FG000|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8823251|NCT01587703|9877228|FG001|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8823252|NCT01587703|9877229|FG002|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8823253|NCT01587703|9877230|FG003|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8823254|NCT01587703|9877231|FG004|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8823255|NCT01587703|9877232|FG005|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8823256|NCT01587703|9877233|FG006|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8823257|NCT01587703|9877234|FG007|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8823258|NCT01587703|9877235|FG008|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8823259|NCT01587703|9877236|FG009|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8823260|NCT01587703|9877237|FG010|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8823261|NCT01587703|9877238|FG011|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8823262|NCT01587703|9877239|FG012|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8823263|NCT01587703|9877240|FG013|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8823264|NCT01587703|9877241|FG014|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8823265|NCT01587703|9877242|FG015|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8823266|NCT01587703|9877243|FG016|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8823267|NCT01587703|9877244|FG017|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||5
8823268|NCT01587703|9877245|FG018|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||5
8823269|NCT01587703|9877227|FG000|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8823270|NCT01587703|9877228|FG001|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8823271|NCT01587703|9877229|FG002|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8823272|NCT01587703|9877230|FG003|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8823273|NCT01587703|9877231|FG004|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8823274|NCT01587703|9877232|FG005|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8823275|NCT01587703|9877233|FG006|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8823276|NCT01587703|9877234|FG007|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8823277|NCT01587703|9877235|FG008|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8823278|NCT01587703|9877236|FG009|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8823279|NCT01587703|9877237|FG010|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8823280|NCT01587703|9877238|FG011|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8823281|NCT01587703|9877239|FG012|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8823282|NCT01587703|9877240|FG013|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8823283|NCT01587703|9877241|FG014|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8823284|NCT01587703|9877242|FG015|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8823285|NCT01587703|9877243|FG016|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8823286|NCT01587703|9877244|FG017|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||5
8823287|NCT01587703|9877245|FG018|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||5
8823288|NCT01587703|9877227|FG000|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8823289|NCT01587703|9877228|FG001|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8823290|NCT01587703|9877229|FG002|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8823291|NCT01587703|9877230|FG003|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8823292|NCT01587703|9877231|FG004|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8823293|NCT01587703|9877232|FG005|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8823294|NCT01587703|9877233|FG006|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8823295|NCT01587703|9877234|FG007|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8823296|NCT01587703|9877235|FG008|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8823297|NCT01587703|9877236|FG009|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8823298|NCT01587703|9877237|FG010|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8823299|NCT01587703|9877238|FG011|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8823300|NCT01587703|9877239|FG012|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8823301|NCT01587703|9877240|FG013|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8823302|NCT01587703|9877241|FG014|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8823303|NCT01587703|9877242|FG015|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8823304|NCT01587703|9877243|FG016|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8823305|NCT01587703|9877244|FG017|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8823306|NCT01587703|9877245|FG018|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8823307|NCT01587703|9877227|FG000|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
8823308|NCT01587703|9877228|FG001|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
8823309|NCT01587703|9877229|FG002|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
8823310|NCT01587703|9877230|FG003|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
8823311|NCT01587703|9877231|FG004|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
8823312|NCT01587703|9877232|FG005|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
8823313|NCT01587703|9877233|FG006|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
8823314|NCT01587703|9877234|FG007|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
8823315|NCT01587703|9877235|FG008|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
8823316|NCT01587703|9877236|FG009|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
8823317|NCT01587703|9877237|FG010|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
8823318|NCT01587703|9877238|FG011|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
8823319|NCT01587703|9877239|FG012|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
8823320|NCT01587703|9877240|FG013|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
8823321|NCT01587703|9877241|FG014|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
8823322|NCT01587703|9877242|FG015|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
8823323|NCT01587703|9877243|FG016|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
8823324|NCT01587703|9877244|FG017|STARTED|Substudy-P2, Week1Day3 to Week2Day1||5
8823325|NCT01587703|9877245|FG018|STARTED|Substudy-P2, Week1Day3 to Week2Day1||5
8823326|NCT01587703|9877227|FG000|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8823327|NCT01587703|9877228|FG001|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8943862|NCT02391987|10005652|FG001|STARTED|Overall Study||58
8943863|NCT02391987|10005651|FG000|COMPLETED|Overall Study||54
8943864|NCT02391987|10005652|FG001|COMPLETED|Overall Study||58
8823328|NCT01587703|9877229|FG002|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8823329|NCT01587703|9877230|FG003|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8823330|NCT01587703|9877231|FG004|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8823331|NCT01587703|9877232|FG005|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8823332|NCT01587703|9877233|FG006|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8823333|NCT01587703|9877234|FG007|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8823334|NCT01587703|9877235|FG008|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8823335|NCT01587703|9877236|FG009|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8823336|NCT01587703|9877237|FG010|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8823337|NCT01587703|9877238|FG011|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8823338|NCT01587703|9877239|FG012|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8823339|NCT01587703|9877240|FG013|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8823340|NCT01587703|9877241|FG014|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8823341|NCT01587703|9877242|FG015|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8823342|NCT01587703|9877243|FG016|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8823343|NCT01587703|9877244|FG017|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||5
8823344|NCT01587703|9877245|FG018|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||5
8823345|NCT01587703|9877227|FG000|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8823346|NCT01587703|9877228|FG001|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8823347|NCT01587703|9877229|FG002|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8823348|NCT01587703|9877230|FG003|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8823349|NCT01587703|9877231|FG004|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8823350|NCT01587703|9877232|FG005|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8823351|NCT01587703|9877233|FG006|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8823352|NCT01587703|9877234|FG007|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8823353|NCT01587703|9877235|FG008|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8823354|NCT01587703|9877236|FG009|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8823355|NCT01587703|9877237|FG010|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8823356|NCT01587703|9877238|FG011|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8823357|NCT01587703|9877239|FG012|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8823358|NCT01587703|9877240|FG013|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8823359|NCT01587703|9877241|FG014|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8823360|NCT01587703|9877242|FG015|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8823361|NCT01587703|9877243|FG016|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8823362|NCT01587703|9877244|FG017|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8823363|NCT01587703|9877245|FG018|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8823364|NCT01587703|9877227|FG000|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
8823365|NCT01587703|9877228|FG001|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
8823366|NCT01587703|9877229|FG002|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
8823367|NCT01587703|9877230|FG003|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
8823368|NCT01587703|9877231|FG004|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
8823369|NCT01587703|9877232|FG005|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
8823370|NCT01587703|9877233|FG006|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
8823371|NCT01587703|9877234|FG007|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
9065940|NCT04128293|10126437|FG003|COMPLETED|Treatment Period 3 (1 Day)||0
9065941|NCT04128293|10126434|FG000|NOT COMPLETED|Treatment Period 3 (1 Day)||0
9065942|NCT04128293|10126435|FG001|NOT COMPLETED|Treatment Period 3 (1 Day)||0
9065943|NCT04128293|10126436|FG002|NOT COMPLETED|Treatment Period 3 (1 Day)||0
9065944|NCT04128293|10126437|FG003|NOT COMPLETED|Treatment Period 3 (1 Day)||0
9065945|NCT04128293|10126434|FG000|STARTED|Washout Period 3 (Up to 7 Days)||0
9065946|NCT04128293|10126435|FG001|STARTED|Washout Period 3 (Up to 7 Days)||0
8823372|NCT01587703|9877235|FG008|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
8823373|NCT01587703|9877236|FG009|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
8823374|NCT01587703|9877237|FG010|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
8823375|NCT01587703|9877238|FG011|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
8823376|NCT01587703|9877239|FG012|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
8823377|NCT01587703|9877240|FG013|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
8823378|NCT01587703|9877241|FG014|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
8823379|NCT01587703|9877242|FG015|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
8823380|NCT01587703|9877243|FG016|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
8823381|NCT01587703|9877244|FG017|STARTED|Substudy-P3, Week2Day1 to Week2Day3||5
8823382|NCT01587703|9877245|FG018|STARTED|Substudy-P3, Week2Day1 to Week2Day3||5
8823383|NCT01587703|9877227|FG000|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8823384|NCT01587703|9877228|FG001|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8823385|NCT01587703|9877229|FG002|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8823386|NCT01587703|9877230|FG003|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8823387|NCT01587703|9877231|FG004|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8823388|NCT01587703|9877232|FG005|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8823389|NCT01587703|9877233|FG006|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8823390|NCT01587703|9877234|FG007|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8823391|NCT01587703|9877235|FG008|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8823392|NCT01587703|9877236|FG009|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8823393|NCT01587703|9877237|FG010|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8823394|NCT01587703|9877238|FG011|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8823395|NCT01587703|9877239|FG012|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8823396|NCT01587703|9877240|FG013|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8823397|NCT01587703|9877241|FG014|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8823398|NCT01587703|9877242|FG015|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8823399|NCT01587703|9877243|FG016|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8823400|NCT01587703|9877244|FG017|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||5
8823401|NCT01587703|9877245|FG018|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||5
8823402|NCT01587703|9877227|FG000|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8823403|NCT01587703|9877228|FG001|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8823404|NCT01587703|9877229|FG002|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8823405|NCT01587703|9877230|FG003|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8823406|NCT01587703|9877231|FG004|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8823407|NCT01587703|9877232|FG005|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8823408|NCT01587703|9877233|FG006|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8823409|NCT01587703|9877234|FG007|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8823410|NCT01587703|9877235|FG008|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8823411|NCT01587703|9877236|FG009|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8823412|NCT01587703|9877237|FG010|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8823413|NCT01587703|9877238|FG011|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8823414|NCT01587703|9877239|FG012|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8823415|NCT01587703|9877240|FG013|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8823416|NCT01587703|9877241|FG014|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8823417|NCT01587703|9877242|FG015|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8823418|NCT01587703|9877243|FG016|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8823419|NCT01587703|9877244|FG017|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8823420|NCT01587703|9877245|FG018|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8823421|NCT01587703|9877227|FG000|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
8823422|NCT01587703|9877228|FG001|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
8823423|NCT01587703|9877229|FG002|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
8823424|NCT01587703|9877230|FG003|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
8823425|NCT01587703|9877231|FG004|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
8823426|NCT01587703|9877232|FG005|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
8823427|NCT01587703|9877233|FG006|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
8823428|NCT01587703|9877234|FG007|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
8823429|NCT01587703|9877235|FG008|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
8823430|NCT01587703|9877236|FG009|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
8823431|NCT01587703|9877237|FG010|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
8823432|NCT01587703|9877238|FG011|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
8823433|NCT01587703|9877239|FG012|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
8823434|NCT01587703|9877240|FG013|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
8823435|NCT01587703|9877241|FG014|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
8823436|NCT01587703|9877242|FG015|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
8823437|NCT01587703|9877243|FG016|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
8823438|NCT01587703|9877244|FG017|STARTED|Substudy-P4,Maximum Exposure of 5.5month||5
8823439|NCT01587703|9877245|FG018|STARTED|Substudy-P4,Maximum Exposure of 5.5month||5
8823440|NCT01587703|9877227|FG000|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8823441|NCT01587703|9877228|FG001|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8823442|NCT01587703|9877229|FG002|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8622068|NCT00485758|9661212|FG000|STARTED|Overall Study||454
8622069|NCT00485758|9661213|FG001|STARTED|Overall Study||342
8622070|NCT00485758|9661212|FG000|COMPLETED|Overall Study||298
8622071|NCT00485758|9661213|FG001|COMPLETED|Overall Study||277
8622072|NCT00485758|9661212|FG000|NOT COMPLETED|Overall Study||156
8622073|NCT00485758|9661213|FG001|NOT COMPLETED|Overall Study||65
8622074|NCT00485836|9661222|FG000|STARTED|Overall Study||130
8622075|NCT00485836|9661223|FG001|STARTED|Overall Study||132
8622076|NCT00485836|9661224|FG002|STARTED|Overall Study||130
8622077|NCT00485836|9661222|FG000|Received Study Drug (Safety Population)|Overall Study||129
8622078|NCT00485836|9661223|FG001|Received Study Drug (Safety Population)|Overall Study||132
8622079|NCT00485836|9661224|FG002|Received Study Drug (Safety Population)|Overall Study||129
8622080|NCT00485836|9661222|FG000|COMPLETED|Overall Study||115
8622081|NCT00485836|9661223|FG001|COMPLETED|Overall Study||129
8622082|NCT00485836|9661224|FG002|COMPLETED|Overall Study||119
8622083|NCT00485836|9661222|FG000|NOT COMPLETED|Overall Study||15
8622084|NCT00485836|9661223|FG001|NOT COMPLETED|Overall Study||3
8823443|NCT01587703|9877230|FG003|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8823444|NCT01587703|9877231|FG004|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8823445|NCT01587703|9877232|FG005|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8823446|NCT01587703|9877233|FG006|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8849493|NCT01741350|9904732|FG001|NOT COMPLETED|Study Intervention||0
8622085|NCT00485836|9661224|FG002|NOT COMPLETED|Overall Study||11
8622086|NCT00485953|9661234|FG000|STARTED|Overall Study||55
8622087|NCT00485953|9661235|FG001|STARTED|Overall Study||54
8622088|NCT00485953|9661234|FG000|COMPLETED|Overall Study||48
8622089|NCT00485953|9661235|FG001|COMPLETED|Overall Study||47
8622090|NCT00485953|9661234|FG000|NOT COMPLETED|Overall Study||7
8622091|NCT00485953|9661235|FG001|NOT COMPLETED|Overall Study||7
8622092|NCT00486018|9661246|FG000|STARTED|Overall Study||132
8622093|NCT00486018|9661247|FG001|STARTED|Overall Study||134
8622094|NCT00486018|9661248|FG002|STARTED|Overall Study||131
8823447|NCT01587703|9877234|FG007|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8823448|NCT01587703|9877235|FG008|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8823449|NCT01587703|9877236|FG009|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8823450|NCT01587703|9877237|FG010|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8823451|NCT01587703|9877238|FG011|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8823452|NCT01587703|9877239|FG012|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8823453|NCT01587703|9877240|FG013|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8823454|NCT01587703|9877241|FG014|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8823455|NCT01587703|9877242|FG015|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8823456|NCT01587703|9877243|FG016|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8823457|NCT01587703|9877244|FG017|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8823458|NCT01587703|9877245|FG018|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8823459|NCT01587703|9877227|FG000|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8823460|NCT01587703|9877228|FG001|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8823461|NCT01587703|9877229|FG002|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8823462|NCT01587703|9877230|FG003|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8823463|NCT01587703|9877231|FG004|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8823464|NCT01587703|9877232|FG005|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8823465|NCT01587703|9877233|FG006|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8823466|NCT01587703|9877234|FG007|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8823467|NCT01587703|9877235|FG008|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8823468|NCT01587703|9877236|FG009|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8823469|NCT01587703|9877237|FG010|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8823470|NCT01587703|9877238|FG011|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8823471|NCT01587703|9877239|FG012|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8823472|NCT01587703|9877240|FG013|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8823473|NCT01587703|9877241|FG014|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8823474|NCT01587703|9877242|FG015|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8823475|NCT01587703|9877243|FG016|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8823476|NCT01587703|9877244|FG017|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||5
8823477|NCT01587703|9877245|FG018|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||5
8823478|NCT01587703|9877227|FG000|STARTED|Part2(Median Exposure of 1.41 Months)||0
8823479|NCT01587703|9877228|FG001|STARTED|Part2(Median Exposure of 1.41 Months)||0
8823480|NCT01587703|9877229|FG002|STARTED|Part2(Median Exposure of 1.41 Months)||0
8823481|NCT01587703|9877230|FG003|STARTED|Part2(Median Exposure of 1.41 Months)||0
8823482|NCT01587703|9877231|FG004|STARTED|Part2(Median Exposure of 1.41 Months)||0
8823483|NCT01587703|9877232|FG005|STARTED|Part2(Median Exposure of 1.41 Months)||0
8823484|NCT01587703|9877233|FG006|STARTED|Part2(Median Exposure of 1.41 Months)||0
8823485|NCT01587703|9877234|FG007|STARTED|Part2(Median Exposure of 1.41 Months)||0
8823486|NCT01587703|9877235|FG008|STARTED|Part2(Median Exposure of 1.41 Months)||0
8823487|NCT01587703|9877236|FG009|STARTED|Part2(Median Exposure of 1.41 Months)||0
8823488|NCT01587703|9877237|FG010|STARTED|Part2(Median Exposure of 1.41 Months)||0
8823489|NCT01587703|9877238|FG011|STARTED|Part2(Median Exposure of 1.41 Months)||12
8823490|NCT01587703|9877239|FG012|STARTED|Part2(Median Exposure of 1.41 Months)||14
8823491|NCT01587703|9877240|FG013|STARTED|Part2(Median Exposure of 1.41 Months)||23
8823492|NCT01587703|9877241|FG014|STARTED|Part2(Median Exposure of 1.41 Months)||19
8823493|NCT01587703|9877242|FG015|STARTED|Part2(Median Exposure of 1.41 Months)||21
8823494|NCT01587703|9877243|FG016|STARTED|Part2(Median Exposure of 1.41 Months)||13
8823495|NCT01587703|9877244|FG017|STARTED|Part2(Median Exposure of 1.41 Months)||0
8823496|NCT01587703|9877245|FG018|STARTED|Part2(Median Exposure of 1.41 Months)||0
8823497|NCT01587703|9877227|FG000|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8823498|NCT01587703|9877228|FG001|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8823499|NCT01587703|9877229|FG002|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8823500|NCT01587703|9877230|FG003|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8823501|NCT01587703|9877231|FG004|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8823502|NCT01587703|9877232|FG005|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8823503|NCT01587703|9877233|FG006|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8823504|NCT01587703|9877234|FG007|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8823505|NCT01587703|9877235|FG008|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8823506|NCT01587703|9877236|FG009|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8823507|NCT01587703|9877237|FG010|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8823508|NCT01587703|9877238|FG011|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8823509|NCT01587703|9877239|FG012|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8823510|NCT01587703|9877240|FG013|COMPLETED|Part2(Median Exposure of 1.41 Months)||1
8823511|NCT01587703|9877241|FG014|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8823512|NCT01587703|9877242|FG015|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8823513|NCT01587703|9877243|FG016|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8823514|NCT01587703|9877244|FG017|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8823515|NCT01587703|9877245|FG018|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8823516|NCT01587703|9877227|FG000|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8823517|NCT01587703|9877228|FG001|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8823518|NCT01587703|9877229|FG002|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8823519|NCT01587703|9877230|FG003|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8823520|NCT01587703|9877231|FG004|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8823521|NCT01587703|9877232|FG005|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8823522|NCT01587703|9877233|FG006|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8823523|NCT01587703|9877234|FG007|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8823524|NCT01587703|9877235|FG008|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8823525|NCT01587703|9877236|FG009|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8823526|NCT01587703|9877237|FG010|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8823527|NCT01587703|9877238|FG011|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||12
8823528|NCT01587703|9877239|FG012|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||14
8823529|NCT01587703|9877240|FG013|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||22
8823530|NCT01587703|9877241|FG014|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||19
8823531|NCT01587703|9877242|FG015|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||21
8823532|NCT01587703|9877243|FG016|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||13
8823533|NCT01587703|9877244|FG017|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8823534|NCT01587703|9877245|FG018|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8823535|NCT01587885|9877304|FG000|STARTED|Treatment Period 1||26
8823536|NCT01587885|9877305|FG001|STARTED|Treatment Period 1||22
8823537|NCT01587885|9877304|FG000|COMPLETED|Treatment Period 1||26
8823538|NCT01587885|9877305|FG001|COMPLETED|Treatment Period 1||19
8823539|NCT01587885|9877304|FG000|NOT COMPLETED|Treatment Period 1||0
8823540|NCT01587885|9877305|FG001|NOT COMPLETED|Treatment Period 1||3
8823541|NCT01587885|9877304|FG000|STARTED|Treatment Period 2||26
8823542|NCT01587885|9877305|FG001|STARTED|Treatment Period 2||19
8823543|NCT01587885|9877304|FG000|COMPLETED|Treatment Period 2||26
8823544|NCT01587885|9877305|FG001|COMPLETED|Treatment Period 2||19
8823545|NCT01587885|9877304|FG000|NOT COMPLETED|Treatment Period 2||0
8823546|NCT01587885|9877305|FG001|NOT COMPLETED|Treatment Period 2||0
8823547|NCT01587898|9877316|FG000|STARTED|Overall Study||18
8823548|NCT01587898|9877317|FG001|STARTED|Overall Study||17
8823549|NCT01587898|9877318|FG002|STARTED|Overall Study||18
8823550|NCT01587898|9877319|FG003|STARTED|Overall Study||19
8823551|NCT01587898|9877316|FG000|COMPLETED|Overall Study||14
8823552|NCT01587898|9877317|FG001|COMPLETED|Overall Study||12
8823553|NCT01587898|9877318|FG002|COMPLETED|Overall Study||16
8823554|NCT01587898|9877319|FG003|COMPLETED|Overall Study||17
8823555|NCT01587898|9877316|FG000|NOT COMPLETED|Overall Study||4
8823556|NCT01587898|9877317|FG001|NOT COMPLETED|Overall Study||5
8823557|NCT01587898|9877318|FG002|NOT COMPLETED|Overall Study||2
8823558|NCT01587898|9877319|FG003|NOT COMPLETED|Overall Study||2
8823559|NCT01587924|9877336|FG000|STARTED|Overall Study||21
8823560|NCT01587924|9877337|FG001|STARTED|Overall Study||21
8823561|NCT01587924|9877338|FG002|STARTED|Overall Study||21
8823562|NCT01587924|9877339|FG003|STARTED|Overall Study||20
8823563|NCT01587924|9877336|FG000|COMPLETED|Overall Study||17
8823564|NCT01587924|9877337|FG001|COMPLETED|Overall Study||17
8823565|NCT01587924|9877338|FG002|COMPLETED|Overall Study||17
8823566|NCT01587924|9877339|FG003|COMPLETED|Overall Study||19
8823567|NCT01587924|9877336|FG000|NOT COMPLETED|Overall Study||4
8823568|NCT01587924|9877337|FG001|NOT COMPLETED|Overall Study||4
8823569|NCT01587924|9877338|FG002|NOT COMPLETED|Overall Study||4
8823570|NCT01587924|9877339|FG003|NOT COMPLETED|Overall Study||1
8823571|NCT01587950|9877349|FG000|STARTED|Period 1||12
8823572|NCT01587950|9877349|FG000|Received 5% KNO3 Solution (5 Minutes)|Period 1||5
8823573|NCT01587950|9877349|FG000|Received 5% KNO3 Solution (2 Minutes)|Period 1||3
8823574|NCT01587950|9877349|FG000|Received Sterile Water (2 Minutes)|Period 1||2
8823575|NCT01587950|9877349|FG000|Received 5% KNO3 Solution (10 Minutes)|Period 1||4
8823576|NCT01587950|9877349|FG000|Received 2.5% KNO3 Solution (2 Minutes)|Period 1||4
8823577|NCT01587950|9877349|FG000|Received 2.5% KNO3 Solution (10 Minutes)|Period 1||3
8823578|NCT01587950|9877349|FG000|Received Sterile Water (10 Minutes)|Period 1||5
8823579|NCT01587950|9877349|FG000|Received 2.5% KNO3 Solution (5 Minutes)|Period 1||5
8823580|NCT01587950|9877349|FG000|Received Sterile Water (5 Minutes)|Period 1||5
8823581|NCT01587950|9877349|FG000|COMPLETED|Period 1||12
8823582|NCT01587950|9877349|FG000|NOT COMPLETED|Period 1||0
8823583|NCT01587950|9877349|FG000|STARTED|Washout 1||12
8823584|NCT01587950|9877349|FG000|COMPLETED|Washout 1||12
8823585|NCT01587950|9877349|FG000|NOT COMPLETED|Washout 1||0
8823586|NCT01587950|9877349|FG000|STARTED|Period 2||12
8823587|NCT01587950|9877349|FG000|Received Sterile Water (2 Minutes)|Period 2||8
8823588|NCT01587950|9877349|FG000|Received 5% KNO3 Solution (10 Minutes)|Period 2||4
8823589|NCT01587950|9877349|FG000|Received 2.5% KNO3 Solution (5 Minutes)|Period 2||2
8823590|NCT01587950|9877349|FG000|Received 2.5% KNO3 Solution (10 Minutes)|Period 2||6
8823591|NCT01587950|9877349|FG000|Received 5% KNO3 Solution (2 Minutes)|Period 2||6
8823592|NCT01587950|9877349|FG000|Received Sterile Water (5 Minutes)|Period 2||2
8823593|NCT01587950|9877349|FG000|Received 2.5% KNO3 Solution (2 Minutes)|Period 2||4
8823594|NCT01587950|9877349|FG000|Received Sterile Water (10 Minutes)|Period 2||2
8823595|NCT01587950|9877349|FG000|Received 5% KNO3 Solution (5 Minutes)|Period 2||2
8823596|NCT01587950|9877349|FG000|COMPLETED|Period 2||12
8823597|NCT01587950|9877349|FG000|NOT COMPLETED|Period 2||0
8823598|NCT01587950|9877349|FG000|STARTED|Washout 2||12
8823599|NCT01587950|9877349|FG000|COMPLETED|Washout 2||12
8823600|NCT01587950|9877349|FG000|NOT COMPLETED|Washout 2||0
8823601|NCT01587950|9877349|FG000|STARTED|Period 3||12
8850427|NCT01746420|9905639|FG003|STARTED|Overall Study||20
8823602|NCT01587950|9877349|FG000|Received 2.5% KNO3 Solution (2 Minutes)|Period 3||4
8823603|NCT01587950|9877349|FG000|Received Sterile Water (10 Minutes)|Period 3||5
8823604|NCT01587950|9877349|FG000|Received Sterile Water (2 Minutes)|Period 3||2
8823605|NCT01587950|9877349|FG000|Received 5% KNO3 Solution (10 Minutes)|Period 3||4
8823606|NCT01587950|9877349|FG000|Received Sterile Water (5 Minutes)|Period 3||5
8823607|NCT01587950|9877349|FG000|Received 5% KNO3 Solution (5 Minutes)|Period 3||5
8823608|NCT01587950|9877349|FG000|Received 5% KNO3 Solution (2 Minutes)|Period 3||3
8823609|NCT01587950|9877349|FG000|Received 2.5% KNO3 Solution (10 Minutes)|Period 3||3
8823610|NCT01587950|9877349|FG000|Received 2.5% KNO3 Solution (5 Minutes)|Period 3||5
8823611|NCT01587950|9877349|FG000|COMPLETED|Period 3||12
8823612|NCT01587950|9877349|FG000|NOT COMPLETED|Period 3||0
8823613|NCT01587989|9877364|FG000|STARTED|12-Week Open-Label Run-In Period||77
8823614|NCT01587989|9877365|FG001|STARTED|12-Week Open-Label Run-In Period||0
8823615|NCT01587989|9877366|FG002|STARTED|12-Week Open-Label Run-In Period||0
8823616|NCT01587989|9877364|FG000|COMPLETED|12-Week Open-Label Run-In Period||65
8823617|NCT01587989|9877365|FG001|COMPLETED|12-Week Open-Label Run-In Period||0
8823618|NCT01587989|9877366|FG002|COMPLETED|12-Week Open-Label Run-In Period||0
8823619|NCT01587989|9877364|FG000|NOT COMPLETED|12-Week Open-Label Run-In Period||12
8823620|NCT01587989|9877365|FG001|NOT COMPLETED|12-Week Open-Label Run-In Period||0
8823621|NCT01587989|9877366|FG002|NOT COMPLETED|12-Week Open-Label Run-In Period||0
8823622|NCT01587989|9877364|FG000|STARTED|Randomized Study Treatment||0
8823623|NCT01587989|9877365|FG001|STARTED|Randomized Study Treatment||32
8823624|NCT01587989|9877366|FG002|STARTED|Randomized Study Treatment||33
8823625|NCT01587989|9877364|FG000|COMPLETED|Randomized Study Treatment||0
8823626|NCT01587989|9877365|FG001|COMPLETED|Randomized Study Treatment||30
8823627|NCT01587989|9877366|FG002|COMPLETED|Randomized Study Treatment||32
8823628|NCT01587989|9877364|FG000|NOT COMPLETED|Randomized Study Treatment||0
8823629|NCT01587989|9877365|FG001|NOT COMPLETED|Randomized Study Treatment||2
8823630|NCT01587989|9877366|FG002|NOT COMPLETED|Randomized Study Treatment||1
8849494|NCT01741350|9904731|FG000|STARTED|Post Intervention Assessment (at Week 4)||149
8849495|NCT01741350|9904732|FG001|STARTED|Post Intervention Assessment (at Week 4)||155
8849496|NCT01741350|9904731|FG000|COMPLETED|Post Intervention Assessment (at Week 4)||135
8849497|NCT01741350|9904732|FG001|COMPLETED|Post Intervention Assessment (at Week 4)||141
8849498|NCT01741350|9904731|FG000|NOT COMPLETED|Post Intervention Assessment (at Week 4)||14
8849499|NCT01741350|9904732|FG001|NOT COMPLETED|Post Intervention Assessment (at Week 4)||14
8849500|NCT01741350|9904731|FG000|STARTED|3-Month Follow-up Assessment||135
8849501|NCT01741350|9904732|FG001|STARTED|3-Month Follow-up Assessment||141
8849502|NCT01741350|9904731|FG000|COMPLETED|3-Month Follow-up Assessment||129
8849503|NCT01741350|9904732|FG001|COMPLETED|3-Month Follow-up Assessment||119
8849504|NCT01741350|9904731|FG000|NOT COMPLETED|3-Month Follow-up Assessment||6
8849505|NCT01741350|9904732|FG001|NOT COMPLETED|3-Month Follow-up Assessment||22
8849506|NCT01741350|9904731|FG000|STARTED|6-Month Follow-up Assessment||129
8849507|NCT01741350|9904732|FG001|STARTED|6-Month Follow-up Assessment||119
8849508|NCT01741350|9904731|FG000|COMPLETED|6-Month Follow-up Assessment||114
8849509|NCT01741350|9904732|FG001|COMPLETED|6-Month Follow-up Assessment||111
8849510|NCT01741350|9904731|FG000|NOT COMPLETED|6-Month Follow-up Assessment||15
8849511|NCT01741350|9904732|FG001|NOT COMPLETED|6-Month Follow-up Assessment||8
8849512|NCT01741350|9904731|FG000|STARTED|12-Month Follow-up Assessment||114
8849513|NCT01741350|9904732|FG001|STARTED|12-Month Follow-up Assessment||111
8849514|NCT01741350|9904731|FG000|COMPLETED|12-Month Follow-up Assessment||111
8849515|NCT01741350|9904732|FG001|COMPLETED|12-Month Follow-up Assessment||109
8849516|NCT01741350|9904731|FG000|NOT COMPLETED|12-Month Follow-up Assessment||3
8849517|NCT01741350|9904732|FG001|NOT COMPLETED|12-Month Follow-up Assessment||2
8849518|NCT01741454|9904742|FG000|STARTED|Overall Study||49
8849519|NCT01741454|9904743|FG001|STARTED|Overall Study||50
8849520|NCT01741454|9904744|FG002|STARTED|Overall Study||39
8849521|NCT01741454|9904745|FG003|STARTED|Overall Study||43
8849522|NCT01741454|9904742|FG000|COMPLETED|Overall Study||36
8849523|NCT01741454|9904743|FG001|COMPLETED|Overall Study||44
8849524|NCT01741454|9904744|FG002|COMPLETED|Overall Study||22
8849525|NCT01741454|9904745|FG003|COMPLETED|Overall Study||21
8849526|NCT01741454|9904742|FG000|NOT COMPLETED|Overall Study||13
8849527|NCT01741454|9904743|FG001|NOT COMPLETED|Overall Study||6
8849528|NCT01741454|9904744|FG002|NOT COMPLETED|Overall Study||17
8849529|NCT01741454|9904745|FG003|NOT COMPLETED|Overall Study||22
8849530|NCT01741532|9904761|FG000|STARTED|Overall Study||59
8849531|NCT01741532|9904762|FG001|STARTED|Overall Study||30
8556535|NCT04327388|9588285|FG002|Participants Who Received Second Dose|Overall Study||5
8556536|NCT04327388|9588283|FG000|COMPLETED|Overall Study||141
8556537|NCT04327388|9588284|FG001|COMPLETED|Overall Study||153
8849532|NCT01741532|9904761|FG000|Exposed|Overall Study||58
8849533|NCT01741532|9904762|FG001|Exposed|Overall Study||30
8849534|NCT01741532|9904761|FG000|Provided Post-baseline Efficacy Data|Overall Study||58
8849535|NCT01741532|9904762|FG001|Provided Post-baseline Efficacy Data|Overall Study||28
8849536|NCT01741532|9904761|FG000|COMPLETED|Overall Study||49
8849537|NCT01741532|9904762|FG001|COMPLETED|Overall Study||27
8849538|NCT01741532|9904761|FG000|NOT COMPLETED|Overall Study||10
8849539|NCT01741532|9904762|FG001|NOT COMPLETED|Overall Study||3
8849540|NCT01741545|9904774|FG000|STARTED|Treatment Period||12
8849541|NCT01741545|9904775|FG001|STARTED|Treatment Period||39
8849542|NCT01741545|9904774|FG000|COMPLETED|Treatment Period||11
8823631|NCT01588106|9877374|FG000|STARTED|Overall Study||78
8823632|NCT01588106|9877375|FG001|STARTED|Overall Study||76
8823633|NCT01588106|9877374|FG000|COMPLETED|Overall Study||73
8823634|NCT01588106|9877375|FG001|COMPLETED|Overall Study||72
8823635|NCT01588106|9877374|FG000|NOT COMPLETED|Overall Study||5
8823636|NCT01588106|9877375|FG001|NOT COMPLETED|Overall Study||4
8823637|NCT01588158|9877383|FG000|STARTED|Overall Study||4
8823638|NCT01588158|9877384|FG001|STARTED|Overall Study||3
8823639|NCT01588158|9877383|FG000|COMPLETED|Overall Study||4
8823640|NCT01588158|9877384|FG001|COMPLETED|Overall Study||3
8823641|NCT01588158|9877383|FG000|NOT COMPLETED|Overall Study||0
8823642|NCT01588158|9877384|FG001|NOT COMPLETED|Overall Study||0
8823643|NCT01588184|9877396|FG000|STARTED|Overall Study||11
8823644|NCT01588184|9877397|FG001|STARTED|Overall Study||41
8943865|NCT02391987|10005651|FG000|NOT COMPLETED|Overall Study||0
8943866|NCT02391987|10005652|FG001|NOT COMPLETED|Overall Study||0
8943867|NCT02392000|10005658|FG000|STARTED|Overall Study||38
8943868|NCT02392000|10005658|FG000|COMPLETED|Overall Study||11
8943869|NCT02392000|10005658|FG000|NOT COMPLETED|Overall Study||27
8943870|NCT02392104|10005663|FG000|STARTED|Overall Study|one participant enrolled but was removed prior to starting study protocol|50
8943871|NCT02392104|10005663|FG000|COMPLETED|Overall Study||39
8943872|NCT02392104|10005663|FG000|NOT COMPLETED|Overall Study||11
8943873|NCT02392195|10005667|FG000|STARTED|Overall Study||10
8943874|NCT02392195|10005667|FG000|COMPLETED|Overall Study||2
8943875|NCT02392195|10005667|FG000|NOT COMPLETED|Overall Study||8
8943876|NCT02392208|10005671|FG000|STARTED|Telavancin Before Hemodialysis||8
8943877|NCT02392208|10005671|FG000|COMPLETED|Telavancin Before Hemodialysis||8
8943878|NCT02392208|10005671|FG000|NOT COMPLETED|Telavancin Before Hemodialysis||0
8943879|NCT02392208|10005671|FG000|STARTED|Telavancin After Hemodialysis||8
8943880|NCT02392208|10005671|FG000|COMPLETED|Telavancin After Hemodialysis||8
8943881|NCT02392208|10005671|FG000|NOT COMPLETED|Telavancin After Hemodialysis||0
8943882|NCT02392234|10005682|FG000|STARTED|Treatment Period 1 (8 Weeks)||41
8943883|NCT02392234|10005683|FG001|STARTED|Treatment Period 1 (8 Weeks)||43
8943884|NCT02392234|10005684|FG002|STARTED|Treatment Period 1 (8 Weeks)||40
8943885|NCT02392234|10005685|FG003|STARTED|Treatment Period 1 (8 Weeks)||42
8943886|NCT02392234|10005686|FG004|STARTED|Treatment Period 1 (8 Weeks)||41
8943887|NCT02392234|10005687|FG005|STARTED|Treatment Period 1 (8 Weeks)||41
8943888|NCT02392234|10005682|FG000|Treated|Treatment Period 1 (8 Weeks)||41
8943889|NCT02392234|10005683|FG001|Treated|Treatment Period 1 (8 Weeks)||43
8943890|NCT02392234|10005684|FG002|Treated|Treatment Period 1 (8 Weeks)||39
8943891|NCT02392234|10005685|FG003|Treated|Treatment Period 1 (8 Weeks)||42
8943892|NCT02392234|10005686|FG004|Treated|Treatment Period 1 (8 Weeks)||40
8943893|NCT02392234|10005687|FG005|Treated|Treatment Period 1 (8 Weeks)||41
8943894|NCT02392234|10005682|FG000|COMPLETED|Treatment Period 1 (8 Weeks)||38
8943895|NCT02392234|10005683|FG001|COMPLETED|Treatment Period 1 (8 Weeks)||43
8943896|NCT02392234|10005684|FG002|COMPLETED|Treatment Period 1 (8 Weeks)||38
8943897|NCT02392234|10005685|FG003|COMPLETED|Treatment Period 1 (8 Weeks)||41
8943898|NCT02392234|10005686|FG004|COMPLETED|Treatment Period 1 (8 Weeks)||37
8943899|NCT02392234|10005687|FG005|COMPLETED|Treatment Period 1 (8 Weeks)||38
8943900|NCT02392234|10005682|FG000|NOT COMPLETED|Treatment Period 1 (8 Weeks)||3
8943901|NCT02392234|10005683|FG001|NOT COMPLETED|Treatment Period 1 (8 Weeks)||0
8943902|NCT02392234|10005684|FG002|NOT COMPLETED|Treatment Period 1 (8 Weeks)||2
8943903|NCT02392234|10005685|FG003|NOT COMPLETED|Treatment Period 1 (8 Weeks)||1
8943904|NCT02392234|10005686|FG004|NOT COMPLETED|Treatment Period 1 (8 Weeks)||4
8943905|NCT02392234|10005687|FG005|NOT COMPLETED|Treatment Period 1 (8 Weeks)||3
8943906|NCT02392234|10005682|FG000|STARTED|Treatment Period 2 (8 Weeks)||38
8943907|NCT02392234|10005683|FG001|STARTED|Treatment Period 2 (8 Weeks)||43
8943908|NCT02392234|10005684|FG002|STARTED|Treatment Period 2 (8 Weeks)||38
8943909|NCT02392234|10005685|FG003|STARTED|Treatment Period 2 (8 Weeks)||41
8622095|NCT00486018|9661246|FG000|Received Drug (Safety Population)|Overall Study||131
8622096|NCT00486018|9661247|FG001|Received Drug (Safety Population)|Overall Study||134
8622097|NCT00486018|9661248|FG002|Received Drug (Safety Population)|Overall Study||130
8622098|NCT00486018|9661246|FG000|COMPLETED|Overall Study||123
8622099|NCT00486018|9661247|FG001|COMPLETED|Overall Study||128
8622100|NCT00486018|9661248|FG002|COMPLETED|Overall Study||125
8622101|NCT00486018|9661246|FG000|NOT COMPLETED|Overall Study||9
8823645|NCT01588184|9877398|FG002|STARTED|Overall Study||7
8823646|NCT01588184|9877399|FG003|STARTED|Overall Study||6
8823647|NCT01588184|9877400|FG004|STARTED|Overall Study||16
8823648|NCT01588184|9877401|FG005|STARTED|Overall Study||14
8823649|NCT01588184|9877396|FG000|COMPLETED|Overall Study||8
8823650|NCT01588184|9877397|FG001|COMPLETED|Overall Study||28
8823651|NCT01588184|9877398|FG002|COMPLETED|Overall Study||5
8823652|NCT01588184|9877399|FG003|COMPLETED|Overall Study||3
8823653|NCT01588184|9877400|FG004|COMPLETED|Overall Study||14
8823654|NCT01588184|9877401|FG005|COMPLETED|Overall Study||10
8823655|NCT01588184|9877396|FG000|NOT COMPLETED|Overall Study||3
8823656|NCT01588184|9877397|FG001|NOT COMPLETED|Overall Study||13
8823657|NCT01588184|9877398|FG002|NOT COMPLETED|Overall Study||2
8823658|NCT01588184|9877399|FG003|NOT COMPLETED|Overall Study||3
8823659|NCT01588184|9877400|FG004|NOT COMPLETED|Overall Study||2
8823660|NCT01588184|9877401|FG005|NOT COMPLETED|Overall Study||4
8823661|NCT01588197|9877417|FG000|STARTED|Overall Study||10
8823662|NCT01588197|9877418|FG001|STARTED|Overall Study||10
8823663|NCT01588197|9877417|FG000|COMPLETED|Overall Study||9
8823664|NCT01588197|9877418|FG001|COMPLETED|Overall Study||9
8622102|NCT00486018|9661247|FG001|NOT COMPLETED|Overall Study||6
8622103|NCT00486018|9661248|FG002|NOT COMPLETED|Overall Study||6
8622104|NCT00486031|9661256|FG000|STARTED|Overall Study||443
9065947|NCT04128293|10126436|FG002|STARTED|Washout Period 3 (Up to 7 Days)||0
9065948|NCT04128293|10126437|FG003|STARTED|Washout Period 3 (Up to 7 Days)||0
9065949|NCT04128293|10126434|FG000|COMPLETED|Washout Period 3 (Up to 7 Days)||0
9065950|NCT04128293|10126435|FG001|COMPLETED|Washout Period 3 (Up to 7 Days)||0
9065951|NCT04128293|10126436|FG002|COMPLETED|Washout Period 3 (Up to 7 Days)||0
9065952|NCT04128293|10126437|FG003|COMPLETED|Washout Period 3 (Up to 7 Days)||0
9065953|NCT04128293|10126434|FG000|NOT COMPLETED|Washout Period 3 (Up to 7 Days)||0
8622105|NCT00486031|9661256|FG000|COMPLETED|Overall Study||440
8823665|NCT01588197|9877417|FG000|NOT COMPLETED|Overall Study||1
8823666|NCT01588197|9877418|FG001|NOT COMPLETED|Overall Study||1
8823667|NCT01588236|9877427|FG000|STARTED|Overall Study||92
8823668|NCT01588236|9877428|FG001|STARTED|Overall Study||94
8823669|NCT01588236|9877429|FG002|STARTED|Overall Study||94
8823670|NCT01588236|9877427|FG000|COMPLETED|Overall Study||76
8823671|NCT01588236|9877428|FG001|COMPLETED|Overall Study||66
8823672|NCT01588236|9877429|FG002|COMPLETED|Overall Study||69
8823673|NCT01588236|9877427|FG000|NOT COMPLETED|Overall Study||16
8823674|NCT01588236|9877428|FG001|NOT COMPLETED|Overall Study||28
8823675|NCT01588236|9877429|FG002|NOT COMPLETED|Overall Study||25
8823676|NCT01588353|9877440|FG000|STARTED|Step1||6
8823677|NCT01588353|9877441|FG001|STARTED|Step1||0
8823678|NCT01588353|9877442|FG002|STARTED|Step1||0
8823679|NCT01588353|9877440|FG000|COMPLETED|Step1||6
8823680|NCT01588353|9877441|FG001|COMPLETED|Step1||0
8823681|NCT01588353|9877442|FG002|COMPLETED|Step1||0
8823682|NCT01588353|9877440|FG000|NOT COMPLETED|Step1||0
8823683|NCT01588353|9877441|FG001|NOT COMPLETED|Step1||0
8823684|NCT01588353|9877442|FG002|NOT COMPLETED|Step1||0
8823685|NCT01588353|9877440|FG000|STARTED|Step2||0
8823686|NCT01588353|9877441|FG001|STARTED|Step2||71
8823687|NCT01588353|9877442|FG002|STARTED|Step2||0
8823688|NCT01588353|9877440|FG000|COMPLETED|Step2||0
8823689|NCT01588353|9877441|FG001|COMPLETED|Step2||70
8823690|NCT01588353|9877442|FG002|COMPLETED|Step2||0
8823691|NCT01588353|9877440|FG000|NOT COMPLETED|Step2||0
8823692|NCT01588353|9877441|FG001|NOT COMPLETED|Step2||1
8823693|NCT01588353|9877442|FG002|NOT COMPLETED|Step2||0
8823694|NCT01588353|9877440|FG000|STARTED|Step3||0
8823695|NCT01588353|9877441|FG001|STARTED|Step3||0
8823696|NCT01588353|9877442|FG002|STARTED|Step3||25
8823697|NCT01588353|9877440|FG000|COMPLETED|Step3||0
8823698|NCT01588353|9877441|FG001|COMPLETED|Step3||0
8823699|NCT01588353|9877442|FG002|COMPLETED|Step3||23
8823700|NCT01588353|9877440|FG000|NOT COMPLETED|Step3||0
8823701|NCT01588353|9877441|FG001|NOT COMPLETED|Step3||0
8823702|NCT01588353|9877442|FG002|NOT COMPLETED|Step3||2
8823703|NCT01588366|9877454|FG000|STARTED|Overall Study||2
8823704|NCT01588366|9877455|FG001|STARTED|Overall Study||7
8823705|NCT01588366|9877456|FG002|STARTED|Overall Study||2
8823706|NCT01588366|9877457|FG003|STARTED|Overall Study||7
8823707|NCT01588366|9877458|FG004|STARTED|Overall Study||3
8823708|NCT01588366|9877459|FG005|STARTED|Overall Study||9
8823709|NCT01588366|9877454|FG000|Received at Least One Dose of Study Drug|Overall Study||2
8823710|NCT01588366|9877455|FG001|Received at Least One Dose of Study Drug|Overall Study||7
8823711|NCT01588366|9877456|FG002|Received at Least One Dose of Study Drug|Overall Study||2
8823712|NCT01588366|9877457|FG003|Received at Least One Dose of Study Drug|Overall Study||7
8823713|NCT01588366|9877458|FG004|Received at Least One Dose of Study Drug|Overall Study||3
8823714|NCT01588366|9877459|FG005|Received at Least One Dose of Study Drug|Overall Study||9
8823715|NCT01588366|9877454|FG000|COMPLETED|Overall Study||2
8823716|NCT01588366|9877455|FG001|COMPLETED|Overall Study||6
8823717|NCT01588366|9877456|FG002|COMPLETED|Overall Study||2
8823718|NCT01588366|9877457|FG003|COMPLETED|Overall Study||6
8823719|NCT01588366|9877458|FG004|COMPLETED|Overall Study||3
8823720|NCT01588366|9877459|FG005|COMPLETED|Overall Study||7
8823721|NCT01588366|9877454|FG000|NOT COMPLETED|Overall Study||0
8823722|NCT01588366|9877455|FG001|NOT COMPLETED|Overall Study||1
8823723|NCT01588366|9877456|FG002|NOT COMPLETED|Overall Study||0
8823724|NCT01588366|9877457|FG003|NOT COMPLETED|Overall Study||1
8823725|NCT01588366|9877458|FG004|NOT COMPLETED|Overall Study||0
8823726|NCT01588366|9877459|FG005|NOT COMPLETED|Overall Study||2
8823727|NCT01588405|9877475|FG000|STARTED|Overall Study||33
8823728|NCT01588405|9877475|FG000|COMPLETED|Overall Study||31
8823729|NCT01588405|9877475|FG000|NOT COMPLETED|Overall Study||2
8823730|NCT01588418|9877482|FG000|STARTED|Overall Study||11
8823731|NCT01588418|9877483|FG001|STARTED|Overall Study||4
8823732|NCT01588418|9877482|FG000|COMPLETED|Overall Study||11
8823733|NCT01588418|9877483|FG001|COMPLETED|Overall Study||4
8823734|NCT01588418|9877482|FG000|NOT COMPLETED|Overall Study||0
8823735|NCT01588418|9877483|FG001|NOT COMPLETED|Overall Study||0
8823736|NCT01588444|9877491|FG000|STARTED|Overall Study||20
8823737|NCT01588444|9877492|FG001|STARTED|Overall Study||20
8823738|NCT01588444|9877491|FG000|COMPLETED|Overall Study||20
8823739|NCT01588444|9877492|FG001|COMPLETED|Overall Study||20
8823740|NCT01588444|9877491|FG000|NOT COMPLETED|Overall Study||0
8823741|NCT01588444|9877492|FG001|NOT COMPLETED|Overall Study||0
8823742|NCT01588457|9877500|FG000|STARTED|Randomization 1||53
8823743|NCT01588457|9877501|FG001|STARTED|Randomization 1||59
8823744|NCT01588457|9877502|FG002|STARTED|Randomization 1|No subject assigned during first randomization to monotherapy|0
9065954|NCT04128293|10126435|FG001|NOT COMPLETED|Washout Period 3 (Up to 7 Days)||0
8823745|NCT01588457|9877503|FG003|STARTED|Randomization 1|No subject assigned during first randomization to monotherapy|0
8823746|NCT01588457|9877500|FG000|COMPLETED|Randomization 1||30
8823747|NCT01588457|9877501|FG001|COMPLETED|Randomization 1||43
8823748|NCT01588457|9877502|FG002|COMPLETED|Randomization 1||0
8823749|NCT01588457|9877503|FG003|COMPLETED|Randomization 1||0
8823750|NCT01588457|9877500|FG000|NOT COMPLETED|Randomization 1||23
8823751|NCT01588457|9877501|FG001|NOT COMPLETED|Randomization 1||16
8823752|NCT01588457|9877502|FG002|NOT COMPLETED|Randomization 1||0
8823753|NCT01588457|9877503|FG003|NOT COMPLETED|Randomization 1||0
8823754|NCT01588457|9877500|FG000|STARTED|Randomization 2|Some subjects who completed the first randomization had QTP or LTG added to regimen|21
8823755|NCT01588457|9877501|FG001|STARTED|Randomization 2|Some subjects who completed the first randomization had QTP or LTG added to regimen|31
8823756|NCT01588457|9877502|FG002|STARTED|Randomization 2|Assignment of Quetiapine plus monotherapy for symptoms of depression|17
8823757|NCT01588457|9877503|FG003|STARTED|Randomization 2|Assignment of Lamotrigine plus monotherapy for symptoms of depression|18
8823758|NCT01588457|9877500|FG000|COMPLETED|Randomization 2||1
8823759|NCT01588457|9877501|FG001|COMPLETED|Randomization 2||3
8823760|NCT01588457|9877502|FG002|COMPLETED|Randomization 2||12
8823761|NCT01588457|9877503|FG003|COMPLETED|Randomization 2||13
8823762|NCT01588457|9877500|FG000|NOT COMPLETED|Randomization 2||20
8823763|NCT01588457|9877501|FG001|NOT COMPLETED|Randomization 2||28
8823764|NCT01588457|9877502|FG002|NOT COMPLETED|Randomization 2||5
8823765|NCT01588457|9877503|FG003|NOT COMPLETED|Randomization 2||5
8823766|NCT01588470|9877523|FG000|STARTED|Overall Study|First enrolled April 2007|130
8823767|NCT01588470|9877523|FG000|COMPLETED|Overall Study|Completed Dec. 2011|50
8823768|NCT01588470|9877523|FG000|NOT COMPLETED|Overall Study||80
8823769|NCT01588496|9877535|FG000|STARTED|Overall Study||8
8823770|NCT01588496|9877536|FG001|STARTED|Overall Study||17
8823771|NCT01588496|9877537|FG002|STARTED|Overall Study||33
8823772|NCT01588496|9877535|FG000|Received Treatment|Overall Study||8
8823773|NCT01588496|9877536|FG001|Received Treatment|Overall Study||16
8823774|NCT01588496|9877537|FG002|Received Treatment|Overall Study||33
8823775|NCT01588496|9877535|FG000|COMPLETED|Overall Study||8
8823776|NCT01588496|9877536|FG001|COMPLETED|Overall Study||16
8823777|NCT01588496|9877537|FG002|COMPLETED|Overall Study||33
8823778|NCT01588496|9877535|FG000|NOT COMPLETED|Overall Study||0
8823779|NCT01588496|9877536|FG001|NOT COMPLETED|Overall Study||1
8823780|NCT01588496|9877537|FG002|NOT COMPLETED|Overall Study||0
8823781|NCT01588509|9877547|FG000|STARTED|Overall Study||30
8823782|NCT01588509|9877548|FG001|STARTED|Overall Study||30
8823783|NCT01588509|9877547|FG000|Received Treatment|Overall Study||30
8823784|NCT01588509|9877548|FG001|Received Treatment|Overall Study||30
8823785|NCT01588509|9877547|FG000|COMPLETED|Overall Study||29
8823786|NCT01588509|9877548|FG001|COMPLETED|Overall Study||30
8823787|NCT01588509|9877547|FG000|NOT COMPLETED|Overall Study||1
8823788|NCT01588509|9877548|FG001|NOT COMPLETED|Overall Study||0
8823789|NCT01588548|9877560|FG000|STARTED|Overall Study||3
8823790|NCT01588548|9877561|FG001|STARTED|Overall Study||7
8823791|NCT01588548|9877562|FG002|STARTED|Overall Study||6
8823792|NCT01588548|9877563|FG003|STARTED|Overall Study||7
8823793|NCT01588548|9877564|FG004|STARTED|Overall Study||6
8823794|NCT01588548|9877565|FG005|STARTED|Overall Study||6
8823795|NCT01588548|9877560|FG000|Cycle 1 Day 21|Overall Study||3
8823796|NCT01588548|9877561|FG001|Cycle 1 Day 21|Overall Study||5
8823797|NCT01588548|9877562|FG002|Cycle 1 Day 21|Overall Study||2
8823798|NCT01588548|9877563|FG003|Cycle 1 Day 21|Overall Study||5
8823799|NCT01588548|9877564|FG004|Cycle 1 Day 21|Overall Study||3
8823800|NCT01588548|9877565|FG005|Cycle 1 Day 21|Overall Study||3
8622106|NCT00486031|9661256|FG000|NOT COMPLETED|Overall Study||3
8629464|NCT00530439|9669214|FG001|STARTED|Overall Study||180
8823801|NCT01588548|9877560|FG000|COMPLETED|Overall Study||0
8823802|NCT01588548|9877561|FG001|COMPLETED|Overall Study||0
8823803|NCT01588548|9877562|FG002|COMPLETED|Overall Study||0
8823804|NCT01588548|9877563|FG003|COMPLETED|Overall Study||0
8823805|NCT01588548|9877564|FG004|COMPLETED|Overall Study||0
8823806|NCT01588548|9877565|FG005|COMPLETED|Overall Study||0
8823807|NCT01588548|9877560|FG000|NOT COMPLETED|Overall Study||3
8823808|NCT01588548|9877561|FG001|NOT COMPLETED|Overall Study||7
8823809|NCT01588548|9877562|FG002|NOT COMPLETED|Overall Study||6
8823810|NCT01588548|9877563|FG003|NOT COMPLETED|Overall Study||7
8823811|NCT01588548|9877564|FG004|NOT COMPLETED|Overall Study||6
8823812|NCT01588548|9877565|FG005|NOT COMPLETED|Overall Study||6
8823813|NCT01588561|9877579|FG000|STARTED|Overall Study||14
8823814|NCT01588561|9877580|FG001|STARTED|Overall Study||1
8823815|NCT01588561|9877579|FG000|First Injection (Visit 1)|Overall Study||14
8823816|NCT01588561|9877580|FG001|First Injection (Visit 1)|Overall Study||1
8823817|NCT01588561|9877579|FG000|Rest Period|Overall Study||14
8823818|NCT01588561|9877580|FG001|Rest Period|Overall Study||1
8823819|NCT01588561|9877579|FG000|Second Injection (Visit 2)|Overall Study||14
8823820|NCT01588561|9877580|FG001|Second Injection (Visit 2)|Overall Study||1
8823821|NCT01588561|9877579|FG000|COMPLETED|Overall Study||14
8823822|NCT01588561|9877580|FG001|COMPLETED|Overall Study||1
8823823|NCT01588561|9877579|FG000|NOT COMPLETED|Overall Study||0
8823824|NCT01588561|9877580|FG001|NOT COMPLETED|Overall Study||0
8823825|NCT01588821|9877586|FG000|STARTED|Overall Study||37
8823826|NCT01588821|9877586|FG000|COMPLETED|Overall Study||37
8823827|NCT01588821|9877586|FG000|NOT COMPLETED|Overall Study||0
8823828|NCT01588951|9877594|FG000|STARTED|Overall Study||2
8823829|NCT01588951|9877595|FG001|STARTED|Overall Study||2
8823830|NCT01588951|9877596|FG002|STARTED|Overall Study||6
8823831|NCT01588951|9877594|FG000|COMPLETED|Overall Study||2
8823832|NCT01588951|9877595|FG001|COMPLETED|Overall Study||2
8823833|NCT01588951|9877596|FG002|COMPLETED|Overall Study||5
8823834|NCT01588951|9877594|FG000|NOT COMPLETED|Overall Study||0
8823835|NCT01588951|9877595|FG001|NOT COMPLETED|Overall Study||0
8823836|NCT01588951|9877596|FG002|NOT COMPLETED|Overall Study||1
8823837|NCT01588990|9877604|FG000|STARTED|Phase A||128
8823838|NCT01588990|9877604|FG000|COMPLETED|Phase A|A total of 58 participants had disease progression in Phase A and ended Phase A.|58
8823839|NCT01588990|9877604|FG000|NOT COMPLETED|Phase A||70
8823840|NCT01588990|9877604|FG000|STARTED|Phase B|Of 58 participants who had documented disease progression in Phase A, 53 entered in Phase B.|53
8823841|NCT01588990|9877604|FG000|COMPLETED|Phase B|A total of 37 participants had disease progression in Phase B and ended Phase B.|37
8823842|NCT01588990|9877604|FG000|NOT COMPLETED|Phase B||16
8823843|NCT01589094|9877612|FG000|STARTED|Overall Study||51
8823844|NCT01589094|9877612|FG000|COMPLETED|Overall Study||49
8823845|NCT01589094|9877612|FG000|NOT COMPLETED|Overall Study||2
8823846|NCT01589185|9877621|FG000|STARTED|Overall Study||6
8823847|NCT01589185|9877622|FG001|STARTED|Overall Study||8
8823848|NCT01589185|9877623|FG002|STARTED|Overall Study||10
8823849|NCT01589185|9877624|FG003|STARTED|Overall Study||8
8823850|NCT01589185|9877625|FG004|STARTED|Overall Study||16
8823851|NCT01589185|9877621|FG000|COMPLETED|Overall Study||4
8823852|NCT01589185|9877622|FG001|COMPLETED|Overall Study||6
8823853|NCT01589185|9877623|FG002|COMPLETED|Overall Study||6
8823854|NCT01589185|9877624|FG003|COMPLETED|Overall Study||5
8823855|NCT01589185|9877625|FG004|COMPLETED|Overall Study||15
8823856|NCT01589185|9877621|FG000|NOT COMPLETED|Overall Study||2
8823857|NCT01589185|9877622|FG001|NOT COMPLETED|Overall Study||2
8823858|NCT01589185|9877623|FG002|NOT COMPLETED|Overall Study||4
8823859|NCT01589185|9877624|FG003|NOT COMPLETED|Overall Study||3
8823860|NCT01589185|9877625|FG004|NOT COMPLETED|Overall Study||1
8823861|NCT01589237|9877642|FG000|STARTED|Part A (52 Weeks)|"Started = Full analysis set/safety set"|11
8823862|NCT01589237|9877643|FG001|STARTED|Part A (52 Weeks)||12
8823863|NCT01589237|9877644|FG002|STARTED|Part A (52 Weeks)||10
8823864|NCT01589237|9877645|FG003|STARTED|Part A (52 Weeks)||5
8823865|NCT01589237|9877642|FG000|COMPLETED|Part A (52 Weeks)||9
8823866|NCT01589237|9877643|FG001|COMPLETED|Part A (52 Weeks)||9
8823867|NCT01589237|9877644|FG002|COMPLETED|Part A (52 Weeks)||8
8823868|NCT01589237|9877645|FG003|COMPLETED|Part A (52 Weeks)||5
8823869|NCT01589237|9877642|FG000|NOT COMPLETED|Part A (52 Weeks)||2
8823870|NCT01589237|9877643|FG001|NOT COMPLETED|Part A (52 Weeks)||3
8823871|NCT01589237|9877644|FG002|NOT COMPLETED|Part A (52 Weeks)||2
8823872|NCT01589237|9877645|FG003|NOT COMPLETED|Part A (52 Weeks)||0
8823873|NCT01589237|9877642|FG000|STARTED|Part B (Planned for 78 Week-terminated)||5
8823874|NCT01589237|9877643|FG001|STARTED|Part B (Planned for 78 Week-terminated)||6
8823875|NCT01589237|9877644|FG002|STARTED|Part B (Planned for 78 Week-terminated)||4
8823876|NCT01589237|9877645|FG003|STARTED|Part B (Planned for 78 Week-terminated)||4
8823877|NCT01589237|9877642|FG000|COMPLETED|Part B (Planned for 78 Week-terminated)||0
8823878|NCT01589237|9877643|FG001|COMPLETED|Part B (Planned for 78 Week-terminated)||0
8823879|NCT01589237|9877644|FG002|COMPLETED|Part B (Planned for 78 Week-terminated)||0
8823880|NCT01589237|9877645|FG003|COMPLETED|Part B (Planned for 78 Week-terminated)||0
8823881|NCT01589237|9877642|FG000|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||5
8823882|NCT01589237|9877643|FG001|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||6
8823883|NCT01589237|9877644|FG002|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||4
8823884|NCT01589237|9877645|FG003|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||4
8823885|NCT01589263|9877661|FG000|STARTED|Overall Study||9
8823886|NCT01589263|9877662|FG001|STARTED|Overall Study||12
8823887|NCT01589263|9877661|FG000|COMPLETED|Overall Study||9
8823888|NCT01589263|9877662|FG001|COMPLETED|Overall Study||12
8823889|NCT01589263|9877661|FG000|NOT COMPLETED|Overall Study||0
8823890|NCT01589263|9877662|FG001|NOT COMPLETED|Overall Study||0
8823891|NCT01589302|9877668|FG000|STARTED|Overall Study||154
8823892|NCT01589302|9877668|FG000|Del17p Patients|Overall Study||76
8823893|NCT01589302|9877668|FG000|Non-Del17p Patients|Overall Study||76
8823894|NCT01589302|9877668|FG000|COMPLETED|Overall Study||152
8823895|NCT01589302|9877668|FG000|NOT COMPLETED|Overall Study||2
8823896|NCT01589315|9877673|FG000|STARTED|Overall Study||17
8823897|NCT01589315|9877673|FG000|COMPLETED|Overall Study||16
8823898|NCT01589315|9877673|FG000|NOT COMPLETED|Overall Study||1
8823899|NCT01589445|9877677|FG000|STARTED|001 (Pioglitazone) -3 Months||77
8823900|NCT01589445|9877677|FG000|COMPLETED|001 (Pioglitazone) -3 Months|dropped out 7 patients|70
8823901|NCT01589445|9877677|FG000|NOT COMPLETED|001 (Pioglitazone) -3 Months||7
8823902|NCT01589445|9877677|FG000|STARTED|002 (Metformin)-3 Months|70 patients participated for trial of drug 002.|70
8823903|NCT01589445|9877677|FG000|COMPLETED|002 (Metformin)-3 Months|61 patients completed the drug 002.9 patients dropped out.|61
8823904|NCT01589445|9877677|FG000|NOT COMPLETED|002 (Metformin)-3 Months||9
8823905|NCT01589484|9877685|FG000|STARTED|Overall Study||104
8823906|NCT01589484|9877685|FG000|COMPLETED|Overall Study||100
8823907|NCT01589484|9877685|FG000|NOT COMPLETED|Overall Study||4
8823908|NCT01589497|9877694|FG000|STARTED|Overall Study||18
8823909|NCT01589497|9877695|FG001|STARTED|Overall Study||17
8823910|NCT01589497|9877696|FG002|STARTED|Overall Study||16
8823911|NCT01589497|9877697|FG003|STARTED|Overall Study||18
8849543|NCT01741545|9904775|FG001|COMPLETED|Treatment Period||35
8849544|NCT01741545|9904774|FG000|NOT COMPLETED|Treatment Period||1
8823912|NCT01589497|9877694|FG000|COMPLETED|Overall Study|1 participant who completed study but had insufficient sputum volume was excluded from the analyses|17
8823913|NCT01589497|9877695|FG001|COMPLETED|Overall Study|1 participant who completed study but had insufficient sputum volume was excluded from the analyses|16
8823914|NCT01589497|9877696|FG002|COMPLETED|Overall Study||15
8823915|NCT01589497|9877697|FG003|COMPLETED|Overall Study||17
8823916|NCT01589497|9877694|FG000|NOT COMPLETED|Overall Study||1
8823917|NCT01589497|9877695|FG001|NOT COMPLETED|Overall Study||1
8823918|NCT01589497|9877696|FG002|NOT COMPLETED|Overall Study||1
8823919|NCT01589497|9877697|FG003|NOT COMPLETED|Overall Study||1
8823920|NCT01589510|9877712|FG000|STARTED|Overall Study||419
8823921|NCT01589510|9877712|FG000|COMPLETED|Overall Study||386
8823922|NCT01589510|9877712|FG000|NOT COMPLETED|Overall Study||33
8823923|NCT01589601|9877718|FG000|STARTED|Overall Study||75
8823924|NCT01589601|9877719|FG001|STARTED|Overall Study||75
8823925|NCT01589601|9877718|FG000|COMPLETED|Overall Study||28
8823926|NCT01589601|9877719|FG001|COMPLETED|Overall Study||26
8823927|NCT01589601|9877718|FG000|NOT COMPLETED|Overall Study||47
8823928|NCT01589601|9877719|FG001|NOT COMPLETED|Overall Study||49
8823929|NCT01589653|9877727|FG000|STARTED|Overall Study||76
8823930|NCT01589653|9877728|FG001|STARTED|Overall Study||79
8823931|NCT01589653|9877727|FG000|Exposed|Overall Study||76
8823932|NCT01589653|9877728|FG001|Exposed|Overall Study||78
8823933|NCT01589653|9877727|FG000|COMPLETED|Overall Study||69
8823934|NCT01589653|9877728|FG001|COMPLETED|Overall Study||68
8823935|NCT01589653|9877727|FG000|NOT COMPLETED|Overall Study||7
8823936|NCT01589653|9877728|FG001|NOT COMPLETED|Overall Study||11
8823937|NCT01589770|9877736|FG000|STARTED|Overall Study||67
8823938|NCT01589770|9877737|FG001|STARTED|Overall Study||61
8823939|NCT01589770|9877736|FG000|COMPLETED|Overall Study||59
8823940|NCT01589770|9877737|FG001|COMPLETED|Overall Study||56
8823941|NCT01589770|9877736|FG000|NOT COMPLETED|Overall Study||8
8823942|NCT01589770|9877737|FG001|NOT COMPLETED|Overall Study||5
8823943|NCT01589822|9877746|FG000|STARTED|Overall Study||84
8823944|NCT01589822|9877747|FG001|STARTED|Overall Study||89
8823945|NCT01589822|9877748|FG002|STARTED|Overall Study||41
8823946|NCT01589822|9877746|FG000|COMPLETED|Overall Study||80
8823947|NCT01589822|9877747|FG001|COMPLETED|Overall Study||86
8823948|NCT01589822|9877748|FG002|COMPLETED|Overall Study||40
8823949|NCT01589822|9877746|FG000|NOT COMPLETED|Overall Study||4
8823950|NCT01589822|9877747|FG001|NOT COMPLETED|Overall Study||3
8823951|NCT01589822|9877748|FG002|NOT COMPLETED|Overall Study||1
8823952|NCT01589978|9877758|FG000|STARTED|Overall Study||2681
8823953|NCT01589978|9877758|FG000|COMPLETED|Overall Study||2681
8823954|NCT01589978|9877758|FG000|NOT COMPLETED|Overall Study||0
8823955|NCT01590017|9877763|FG000|STARTED|Overall Study||41
8823956|NCT01590017|9877763|FG000|COMPLETED|Overall Study||37
8823957|NCT01590017|9877763|FG000|NOT COMPLETED|Overall Study||4
8823958|NCT01590082|9877769|FG000|STARTED|Overall Study||11
8823959|NCT01590082|9877770|FG001|STARTED|Overall Study||1
8823960|NCT01590082|9877769|FG000|COMPLETED|Overall Study||9
8823961|NCT01590082|9877770|FG001|COMPLETED|Overall Study||1
8823962|NCT01590082|9877769|FG000|NOT COMPLETED|Overall Study||2
8823963|NCT01590082|9877770|FG001|NOT COMPLETED|Overall Study||0
8823964|NCT01590212|9877779|FG000|STARTED|Overall Study||12
8823965|NCT01590212|9877780|FG001|STARTED|Overall Study||9
8823966|NCT01590212|9877781|FG002|STARTED|Overall Study||14
8823967|NCT01590212|9877779|FG000|Baseline (Pre-intervention)|Overall Study|withdrew=2|10
8823968|NCT01590212|9877780|FG001|Baseline (Pre-intervention)|Overall Study||9
8823969|NCT01590212|9877781|FG002|Baseline (Pre-intervention)|Overall Study|failed contact=2|12
8823970|NCT01590212|9877779|FG000|Post-intervention|Overall Study|failed contact=3|7
8823971|NCT01590212|9877780|FG001|Post-intervention|Overall Study|failed contact=2; withdrew=1|6
8823972|NCT01590212|9877781|FG002|Post-intervention|Overall Study|failed contact=1|10
8823973|NCT01590212|9877779|FG000|COMPLETED|Overall Study|Includes 2 contacted who failed contact at post-intervention data collection point|9
8823974|NCT01590212|9877780|FG001|COMPLETED|Overall Study||5
8823975|NCT01590212|9877781|FG002|COMPLETED|Overall Study||9
8823976|NCT01590212|9877779|FG000|NOT COMPLETED|Overall Study||3
8823977|NCT01590212|9877780|FG001|NOT COMPLETED|Overall Study||4
8823978|NCT01590212|9877781|FG002|NOT COMPLETED|Overall Study||5
8823979|NCT01590238|9877790|FG000|STARTED|Overall Study||15
8823980|NCT01590238|9877790|FG000|COMPLETED|Overall Study||13
8823981|NCT01590238|9877790|FG000|NOT COMPLETED|Overall Study||2
8823982|NCT01590264|9877794|FG000|STARTED|Overall Study||5
8823983|NCT01590264|9877794|FG000|COMPLETED|Overall Study||5
8823984|NCT01590264|9877794|FG000|NOT COMPLETED|Overall Study||0
8823985|NCT01590433|9877800|FG000|STARTED|Overall Study||127
8823986|NCT01590433|9877801|FG001|STARTED|Overall Study||55
8823987|NCT01590433|9877800|FG000|COMPLETED|Overall Study||75
8823988|NCT01590433|9877801|FG001|COMPLETED|Overall Study||33
8823989|NCT01590433|9877800|FG000|NOT COMPLETED|Overall Study||52
8823990|NCT01590433|9877801|FG001|NOT COMPLETED|Overall Study||22
8823991|NCT01590550|9877807|FG000|STARTED|Overall Study||18
8823992|NCT01590550|9877807|FG000|COMPLETED|Overall Study||18
8823993|NCT01590550|9877807|FG000|NOT COMPLETED|Overall Study||0
8823994|NCT01590563|9877812|FG000|STARTED|Overall Study||15
8823995|NCT01590563|9877812|FG000|COMPLETED|Overall Study||14
8823996|NCT01590563|9877812|FG000|NOT COMPLETED|Overall Study||1
8823997|NCT01590758|9877819|FG000|STARTED|Overall Study||85
8823998|NCT01590758|9877820|FG001|STARTED|Overall Study||104
8823999|NCT01590758|9877819|FG000|COMPLETED|Overall Study||80
8824000|NCT01590758|9877820|FG001|COMPLETED|Overall Study||97
8824001|NCT01590758|9877819|FG000|NOT COMPLETED|Overall Study||5
8824002|NCT01590758|9877820|FG001|NOT COMPLETED|Overall Study||7
8824003|NCT01590771|9877828|FG000|STARTED|Overall Study||249
8824004|NCT01590771|9877829|FG001|STARTED|Overall Study||249
8824005|NCT01590771|9877828|FG000|COMPLETED|Overall Study||230
8824006|NCT01590771|9877829|FG001|COMPLETED|Overall Study||210
8824007|NCT01590771|9877828|FG000|NOT COMPLETED|Overall Study||19
8824008|NCT01590771|9877829|FG001|NOT COMPLETED|Overall Study||39
8824009|NCT01590797|9877837|FG000|STARTED|Overall Study||234
8824010|NCT01590797|9877838|FG001|STARTED|Overall Study||233
8824011|NCT01590797|9877837|FG000|COMPLETED|Overall Study||217
8824012|NCT01590797|9877838|FG001|COMPLETED|Overall Study||217
8824013|NCT01590797|9877837|FG000|NOT COMPLETED|Overall Study||17
8824014|NCT01590797|9877838|FG001|NOT COMPLETED|Overall Study||16
8824015|NCT01590810|9877849|FG000|STARTED|Overall Study||8
8824016|NCT01590810|9877850|FG001|STARTED|Overall Study||8
8824017|NCT01590810|9877851|FG002|STARTED|Overall Study||8
8824018|NCT01590810|9877852|FG003|STARTED|Overall Study||8
8824019|NCT01590810|9877853|FG004|STARTED|Overall Study||2
8824020|NCT01590810|9877849|FG000|COMPLETED|Overall Study||8
8622107|NCT00486044|9661263|FG000|STARTED|Overall Study|50 received assigned intervention (1 withdrew during baseline) 27 in MRI sub-study|51
8622108|NCT00486044|9661264|FG001|STARTED|Overall Study|23 in MRI sub-study|49
8622109|NCT00486044|9661263|FG000|COMPLETED|Overall Study|27 completed MRI sub-study|49
8824021|NCT01590810|9877850|FG001|COMPLETED|Overall Study||7
8824022|NCT01590810|9877851|FG002|COMPLETED|Overall Study||7
8824023|NCT01590810|9877852|FG003|COMPLETED|Overall Study||8
8824024|NCT01590810|9877853|FG004|COMPLETED|Overall Study||2
8824025|NCT01590810|9877849|FG000|NOT COMPLETED|Overall Study||0
8824026|NCT01590810|9877850|FG001|NOT COMPLETED|Overall Study||1
8824027|NCT01590810|9877851|FG002|NOT COMPLETED|Overall Study||1
8824028|NCT01590810|9877852|FG003|NOT COMPLETED|Overall Study||0
8824029|NCT01590810|9877853|FG004|NOT COMPLETED|Overall Study||0
8824030|NCT01590875|9877888|FG000|STARTED|Overall Study||10
8824031|NCT01590875|9877889|FG001|STARTED|Overall Study||10
8824032|NCT01590875|9877888|FG000|COMPLETED|Overall Study||10
8824033|NCT01590875|9877889|FG001|COMPLETED|Overall Study||10
8824034|NCT01590875|9877888|FG000|NOT COMPLETED|Overall Study||0
8824035|NCT01590875|9877889|FG001|NOT COMPLETED|Overall Study||0
8824036|NCT01590888|9877900|FG000|STARTED|Overall Study||36
8824037|NCT01590888|9877901|FG001|STARTED|Overall Study||38
8824038|NCT01590888|9877902|FG002|STARTED|Overall Study||35
8824039|NCT01590888|9877900|FG000|COMPLETED|Overall Study||32
8824040|NCT01590888|9877901|FG001|COMPLETED|Overall Study||38
8824041|NCT01590888|9877902|FG002|COMPLETED|Overall Study||34
8824042|NCT01590888|9877900|FG000|NOT COMPLETED|Overall Study||4
8824043|NCT01590888|9877901|FG001|NOT COMPLETED|Overall Study||0
8824044|NCT01590888|9877902|FG002|NOT COMPLETED|Overall Study||1
8824045|NCT01590979|9877912|FG000|STARTED|Overall Study||27
8824046|NCT01590979|9877913|FG001|STARTED|Overall Study||27
8824047|NCT01590979|9877912|FG000|COMPLETED|Overall Study||27
8824048|NCT01590979|9877913|FG001|COMPLETED|Overall Study||27
8824049|NCT01590979|9877912|FG000|NOT COMPLETED|Overall Study||0
8824050|NCT01590979|9877913|FG001|NOT COMPLETED|Overall Study||0
8824051|NCT01591005|9877923|FG000|STARTED|Overall Study||53
8824052|NCT01591005|9877924|FG001|STARTED|Overall Study||53
8824053|NCT01591005|9877925|FG002|STARTED|Overall Study||68
8824054|NCT01591005|9877926|FG003|STARTED|Overall Study||68
8824055|NCT01591005|9877923|FG000|COMPLETED|Overall Study||53
8824056|NCT01591005|9877924|FG001|COMPLETED|Overall Study||53
8824057|NCT01591005|9877925|FG002|COMPLETED|Overall Study||68
8824058|NCT01591005|9877926|FG003|COMPLETED|Overall Study||68
8824059|NCT01591005|9877923|FG000|NOT COMPLETED|Overall Study||0
8824060|NCT01591005|9877924|FG001|NOT COMPLETED|Overall Study||0
8824061|NCT01591005|9877925|FG002|NOT COMPLETED|Overall Study||0
8824062|NCT01591005|9877926|FG003|NOT COMPLETED|Overall Study||0
8824063|NCT01591018|9877938|FG000|STARTED|Overall Study||60
8824064|NCT01591018|9877939|FG001|STARTED|Overall Study||60
8824065|NCT01591018|9877938|FG000|COMPLETED|Overall Study||60
8824066|NCT01591018|9877939|FG001|COMPLETED|Overall Study||60
8824067|NCT01591018|9877938|FG000|NOT COMPLETED|Overall Study||0
8824068|NCT01591018|9877939|FG001|NOT COMPLETED|Overall Study||0
8622110|NCT00486044|9661264|FG001|COMPLETED|Overall Study|21 completed MRI sub-study|46
8824069|NCT01591044|9877948|FG000|STARTED|Overall Study||101
8824070|NCT01591044|9877949|FG001|STARTED|Overall Study||100
8824071|NCT01591044|9877950|FG002|STARTED|Overall Study||100
8824072|NCT01591044|9877948|FG000|COMPLETED|Overall Study||94
8824073|NCT01591044|9877949|FG001|COMPLETED|Overall Study||91
8824074|NCT01591044|9877950|FG002|COMPLETED|Overall Study||96
8824075|NCT01591044|9877948|FG000|NOT COMPLETED|Overall Study||7
8824076|NCT01591044|9877949|FG001|NOT COMPLETED|Overall Study||9
8824077|NCT01591044|9877950|FG002|NOT COMPLETED|Overall Study||4
8824078|NCT01591161|9877960|FG000|STARTED|Overall Study||245
8824079|NCT01591161|9877961|FG001|STARTED|Overall Study||124
8824080|NCT01591161|9877960|FG000|COMPLETED|Overall Study||174
8824081|NCT01591161|9877961|FG001|COMPLETED|Overall Study||68
8824082|NCT01591161|9877960|FG000|NOT COMPLETED|Overall Study||71
8824083|NCT01591161|9877961|FG001|NOT COMPLETED|Overall Study||56
8824084|NCT01591317|9877970|FG000|STARTED|Overall Study||10
8824085|NCT01591317|9877971|FG001|STARTED|Overall Study||10
8824086|NCT01591317|9877972|FG002|STARTED|Overall Study||10
8824087|NCT01591317|9877970|FG000|COMPLETED|Overall Study||10
8824088|NCT01591317|9877971|FG001|COMPLETED|Overall Study||10
8824089|NCT01591317|9877972|FG002|COMPLETED|Overall Study||10
8824090|NCT01591317|9877970|FG000|NOT COMPLETED|Overall Study||0
8824091|NCT01591317|9877971|FG001|NOT COMPLETED|Overall Study||0
8824092|NCT01591317|9877972|FG002|NOT COMPLETED|Overall Study||0
8824093|NCT01591330|9877985|FG000|STARTED|Period 1||8
8824094|NCT01591330|9877986|FG001|STARTED|Period 1||9
8824095|NCT01591330|9877987|FG002|STARTED|Period 1||9
8824096|NCT01591330|9877988|FG003|STARTED|Period 1||9
8824097|NCT01591330|9877985|FG000|Received at Least 1 Dose of Study Drug|Period 1||8
8824098|NCT01591330|9877986|FG001|Received at Least 1 Dose of Study Drug|Period 1||9
8824099|NCT01591330|9877987|FG002|Received at Least 1 Dose of Study Drug|Period 1||9
8824100|NCT01591330|9877988|FG003|Received at Least 1 Dose of Study Drug|Period 1||9
8824101|NCT01591330|9877985|FG000|COMPLETED|Period 1||7
8824102|NCT01591330|9877986|FG001|COMPLETED|Period 1||9
8824103|NCT01591330|9877987|FG002|COMPLETED|Period 1||9
8824104|NCT01591330|9877988|FG003|COMPLETED|Period 1||9
8824105|NCT01591330|9877985|FG000|NOT COMPLETED|Period 1||1
8824106|NCT01591330|9877986|FG001|NOT COMPLETED|Period 1||0
8824107|NCT01591330|9877987|FG002|NOT COMPLETED|Period 1||0
8824108|NCT01591330|9877988|FG003|NOT COMPLETED|Period 1||0
8824109|NCT01591330|9877985|FG000|STARTED|Washout of at Least 3 Days||7
8824110|NCT01591330|9877986|FG001|STARTED|Washout of at Least 3 Days||9
8824111|NCT01591330|9877987|FG002|STARTED|Washout of at Least 3 Days||9
8824112|NCT01591330|9877988|FG003|STARTED|Washout of at Least 3 Days||9
8824113|NCT01591330|9877985|FG000|COMPLETED|Washout of at Least 3 Days||6
8824114|NCT01591330|9877986|FG001|COMPLETED|Washout of at Least 3 Days||9
8824115|NCT01591330|9877987|FG002|COMPLETED|Washout of at Least 3 Days||9
8824116|NCT01591330|9877988|FG003|COMPLETED|Washout of at Least 3 Days||9
8824117|NCT01591330|9877985|FG000|NOT COMPLETED|Washout of at Least 3 Days||1
8824118|NCT01591330|9877986|FG001|NOT COMPLETED|Washout of at Least 3 Days||0
8824119|NCT01591330|9877987|FG002|NOT COMPLETED|Washout of at Least 3 Days||0
8824120|NCT01591330|9877988|FG003|NOT COMPLETED|Washout of at Least 3 Days||0
8824121|NCT01591330|9877985|FG000|STARTED|Period 2||6
8824122|NCT01591330|9877986|FG001|STARTED|Period 2||9
8824123|NCT01591330|9877987|FG002|STARTED|Period 2||9
8824124|NCT01591330|9877988|FG003|STARTED|Period 2||9
8824125|NCT01591330|9877985|FG000|COMPLETED|Period 2||5
8824126|NCT01591330|9877986|FG001|COMPLETED|Period 2||9
8824127|NCT01591330|9877987|FG002|COMPLETED|Period 2||9
8824128|NCT01591330|9877988|FG003|COMPLETED|Period 2||9
8824129|NCT01591330|9877985|FG000|NOT COMPLETED|Period 2||1
8824130|NCT01591330|9877986|FG001|NOT COMPLETED|Period 2||0
8824131|NCT01591330|9877987|FG002|NOT COMPLETED|Period 2||0
8824132|NCT01591330|9877988|FG003|NOT COMPLETED|Period 2||0
8824133|NCT01591330|9877985|FG000|STARTED|Washout of at Least 3 Days||5
8824134|NCT01591330|9877986|FG001|STARTED|Washout of at Least 3 Days||9
8824135|NCT01591330|9877987|FG002|STARTED|Washout of at Least 3 Days||9
8824136|NCT01591330|9877988|FG003|STARTED|Washout of at Least 3 Days||9
8824137|NCT01591330|9877985|FG000|COMPLETED|Washout of at Least 3 Days||5
8824138|NCT01591330|9877986|FG001|COMPLETED|Washout of at Least 3 Days||9
8824139|NCT01591330|9877987|FG002|COMPLETED|Washout of at Least 3 Days||9
8824140|NCT01591330|9877988|FG003|COMPLETED|Washout of at Least 3 Days||9
8824141|NCT01591330|9877985|FG000|NOT COMPLETED|Washout of at Least 3 Days||0
8824142|NCT01591330|9877986|FG001|NOT COMPLETED|Washout of at Least 3 Days||0
8824143|NCT01591330|9877987|FG002|NOT COMPLETED|Washout of at Least 3 Days||0
8824144|NCT01591330|9877988|FG003|NOT COMPLETED|Washout of at Least 3 Days||0
8824145|NCT01591330|9877985|FG000|STARTED|Period 3||5
8824146|NCT01591330|9877986|FG001|STARTED|Period 3||9
8824147|NCT01591330|9877987|FG002|STARTED|Period 3||9
8824148|NCT01591330|9877988|FG003|STARTED|Period 3||9
8824149|NCT01591330|9877985|FG000|COMPLETED|Period 3||5
8824150|NCT01591330|9877986|FG001|COMPLETED|Period 3||9
8824151|NCT01591330|9877987|FG002|COMPLETED|Period 3||9
8824152|NCT01591330|9877988|FG003|COMPLETED|Period 3||9
8824153|NCT01591330|9877985|FG000|NOT COMPLETED|Period 3||0
8824154|NCT01591330|9877986|FG001|NOT COMPLETED|Period 3||0
8824155|NCT01591330|9877987|FG002|NOT COMPLETED|Period 3||0
8824156|NCT01591330|9877988|FG003|NOT COMPLETED|Period 3||0
8824157|NCT01591330|9877985|FG000|STARTED|Washout of at Least 3 Days||5
8824158|NCT01591330|9877986|FG001|STARTED|Washout of at Least 3 Days||9
8824159|NCT01591330|9877987|FG002|STARTED|Washout of at Least 3 Days||9
8824160|NCT01591330|9877988|FG003|STARTED|Washout of at Least 3 Days||9
8824161|NCT01591330|9877985|FG000|COMPLETED|Washout of at Least 3 Days||5
8824162|NCT01591330|9877986|FG001|COMPLETED|Washout of at Least 3 Days||9
8824163|NCT01591330|9877987|FG002|COMPLETED|Washout of at Least 3 Days||9
8824164|NCT01591330|9877988|FG003|COMPLETED|Washout of at Least 3 Days||9
8824165|NCT01591330|9877985|FG000|NOT COMPLETED|Washout of at Least 3 Days||0
8824166|NCT01591330|9877986|FG001|NOT COMPLETED|Washout of at Least 3 Days||0
8824167|NCT01591330|9877987|FG002|NOT COMPLETED|Washout of at Least 3 Days||0
8824168|NCT01591330|9877988|FG003|NOT COMPLETED|Washout of at Least 3 Days||0
8824169|NCT01591330|9877985|FG000|STARTED|Period 4||5
8824170|NCT01591330|9877986|FG001|STARTED|Period 4||9
8824171|NCT01591330|9877987|FG002|STARTED|Period 4||9
8824172|NCT01591330|9877988|FG003|STARTED|Period 4||9
8824173|NCT01591330|9877985|FG000|COMPLETED|Period 4||5
8824174|NCT01591330|9877986|FG001|COMPLETED|Period 4||9
8824175|NCT01591330|9877987|FG002|COMPLETED|Period 4||9
8824176|NCT01591330|9877988|FG003|COMPLETED|Period 4||9
8824177|NCT01591330|9877985|FG000|NOT COMPLETED|Period 4||0
8824178|NCT01591330|9877986|FG001|NOT COMPLETED|Period 4||0
8824179|NCT01591330|9877987|FG002|NOT COMPLETED|Period 4||0
8824180|NCT01591330|9877988|FG003|NOT COMPLETED|Period 4||0
8824181|NCT01591382|9878000|FG000|STARTED|Overall Study||32
8824182|NCT01591382|9878001|FG001|STARTED|Overall Study||32
8824183|NCT01591382|9878000|FG000|COMPLETED|Overall Study||29
8824184|NCT01591382|9878001|FG001|COMPLETED|Overall Study||30
8824185|NCT01591382|9878000|FG000|NOT COMPLETED|Overall Study||3
8824186|NCT01591382|9878001|FG001|NOT COMPLETED|Overall Study||2
8824187|NCT01591408|9878009|FG000|STARTED|Overall Study||36
8824188|NCT01591408|9878010|FG001|STARTED|Overall Study||32
8824189|NCT01591408|9878009|FG000|COMPLETED|Overall Study||24
8824190|NCT01591408|9878010|FG001|COMPLETED|Overall Study||24
8824191|NCT01591408|9878009|FG000|NOT COMPLETED|Overall Study||12
8824192|NCT01591408|9878010|FG001|NOT COMPLETED|Overall Study||8
8824193|NCT01591460|9878016|FG000|STARTED|Overall Study|Those with elevated (Week 12) or detectable (Week 24) virus discontinued due to the Futility Rule.|165
8824194|NCT01591460|9878016|FG000|COMPLETED|Overall Study|The number who completed PEG-IFN, as scheduled according to response-guided treatment, is presented.|139
8824195|NCT01591460|9878016|FG000|NOT COMPLETED|Overall Study||26
8824196|NCT01591499|9878028|FG000|STARTED|Baseline Visit||33
8824197|NCT01591499|9878029|FG001|STARTED|Baseline Visit||39
8824198|NCT01591499|9878030|FG002|STARTED|Baseline Visit||31
8824199|NCT01591499|9878031|FG003|STARTED|Baseline Visit||39
8824200|NCT01591499|9878028|FG000|COMPLETED|Baseline Visit||33
8824201|NCT01591499|9878029|FG001|COMPLETED|Baseline Visit||37
8824202|NCT01591499|9878030|FG002|COMPLETED|Baseline Visit||31
8824203|NCT01591499|9878031|FG003|COMPLETED|Baseline Visit||37
8824204|NCT01591499|9878028|FG000|NOT COMPLETED|Baseline Visit||0
8824205|NCT01591499|9878029|FG001|NOT COMPLETED|Baseline Visit||2
8824206|NCT01591499|9878030|FG002|NOT COMPLETED|Baseline Visit||0
8824207|NCT01591499|9878031|FG003|NOT COMPLETED|Baseline Visit||2
8824208|NCT01591499|9878028|FG000|STARTED|First Intervention (up to 24 Days)||33
8824209|NCT01591499|9878029|FG001|STARTED|First Intervention (up to 24 Days)||37
8824210|NCT01591499|9878030|FG002|STARTED|First Intervention (up to 24 Days)||31
8824211|NCT01591499|9878031|FG003|STARTED|First Intervention (up to 24 Days)||37
8824212|NCT01591499|9878028|FG000|COMPLETED|First Intervention (up to 24 Days)||33
8824213|NCT01591499|9878029|FG001|COMPLETED|First Intervention (up to 24 Days)||37
8824214|NCT01591499|9878030|FG002|COMPLETED|First Intervention (up to 24 Days)||31
8824215|NCT01591499|9878031|FG003|COMPLETED|First Intervention (up to 24 Days)||37
8824216|NCT01591499|9878028|FG000|NOT COMPLETED|First Intervention (up to 24 Days)||0
8824217|NCT01591499|9878029|FG001|NOT COMPLETED|First Intervention (up to 24 Days)||0
8824218|NCT01591499|9878030|FG002|NOT COMPLETED|First Intervention (up to 24 Days)||0
8824219|NCT01591499|9878031|FG003|NOT COMPLETED|First Intervention (up to 24 Days)||0
8824220|NCT01591499|9878028|FG000|STARTED|Second Intervention (up to 24 Days)||33
8824221|NCT01591499|9878029|FG001|STARTED|Second Intervention (up to 24 Days)||37
8824222|NCT01591499|9878030|FG002|STARTED|Second Intervention (up to 24 Days)||31
8824223|NCT01591499|9878031|FG003|STARTED|Second Intervention (up to 24 Days)||37
8824224|NCT01591499|9878028|FG000|COMPLETED|Second Intervention (up to 24 Days)||27
8824225|NCT01591499|9878029|FG001|COMPLETED|Second Intervention (up to 24 Days)||34
8824226|NCT01591499|9878030|FG002|COMPLETED|Second Intervention (up to 24 Days)||28
8824227|NCT01591499|9878031|FG003|COMPLETED|Second Intervention (up to 24 Days)||34
8824228|NCT01591499|9878028|FG000|NOT COMPLETED|Second Intervention (up to 24 Days)||6
8824229|NCT01591499|9878029|FG001|NOT COMPLETED|Second Intervention (up to 24 Days)||3
8824230|NCT01591499|9878030|FG002|NOT COMPLETED|Second Intervention (up to 24 Days)||3
8824231|NCT01591499|9878031|FG003|NOT COMPLETED|Second Intervention (up to 24 Days)||3
8824232|NCT01591616|9878055|FG000|STARTED|Overall Study||16
8824233|NCT01591616|9878055|FG000|COMPLETED|Overall Study||15
8824234|NCT01591616|9878055|FG000|NOT COMPLETED|Overall Study||1
8824235|NCT01591655|9878196|FG000|STARTED|Overall Study||240
8824236|NCT01591655|9878197|FG001|STARTED|Overall Study||120
8824237|NCT01591655|9878196|FG000|COMPLETED|Overall Study||168
8824238|NCT01591655|9878197|FG001|COMPLETED|Overall Study||57
8824239|NCT01591655|9878196|FG000|NOT COMPLETED|Overall Study||72
8824240|NCT01591655|9878197|FG001|NOT COMPLETED|Overall Study||63
8824241|NCT01591681|9878203|FG000|STARTED|Overall Study||49
8824242|NCT01591681|9878203|FG000|COMPLETED|Overall Study||45
8824243|NCT01591681|9878203|FG000|NOT COMPLETED|Overall Study||4
8824244|NCT01591733|9878209|FG000|STARTED|Overall Study||48
8824245|NCT01591733|9878209|FG000|COMPLETED|Overall Study||48
8824246|NCT01591733|9878209|FG000|NOT COMPLETED|Overall Study||0
8824247|NCT01591746|9878217|FG000|STARTED|Overall Study||68
8824248|NCT01591746|9878218|FG001|STARTED|Overall Study||63
8824249|NCT01591746|9878217|FG000|COMPLETED|Overall Study||68
8824250|NCT01591746|9878218|FG001|COMPLETED|Overall Study||63
8824251|NCT01591746|9878217|FG000|NOT COMPLETED|Overall Study||0
8824252|NCT01591746|9878218|FG001|NOT COMPLETED|Overall Study||0
8824253|NCT01591785|9878226|FG000|STARTED|Overall Study||30
8824254|NCT01591785|9878227|FG001|STARTED|Overall Study||30
8824255|NCT01591785|9878226|FG000|COMPLETED|Overall Study||26
8824256|NCT01591785|9878227|FG001|COMPLETED|Overall Study||28
8824257|NCT01591785|9878226|FG000|NOT COMPLETED|Overall Study||4
8824258|NCT01591785|9878227|FG001|NOT COMPLETED|Overall Study||2
8824259|NCT01591837|9878235|FG000|STARTED|Overall Study||60
8824260|NCT01591837|9878236|FG001|STARTED|Overall Study||60
8824261|NCT01591837|9878235|FG000|COMPLETED|Overall Study||60
8824262|NCT01591837|9878236|FG001|COMPLETED|Overall Study||60
8824263|NCT01591837|9878235|FG000|NOT COMPLETED|Overall Study||0
8824264|NCT01591837|9878236|FG001|NOT COMPLETED|Overall Study||0
8824265|NCT01591863|9878242|FG000|STARTED|Overall Study||38
8824266|NCT01591863|9878242|FG000|COMPLETED|Overall Study||24
8824267|NCT01591863|9878242|FG000|NOT COMPLETED|Overall Study||14
8824268|NCT01592006|9878246|FG000|STARTED|Overall Study||3
8824269|NCT01592006|9878246|FG000|COMPLETED|Overall Study||3
8824270|NCT01592006|9878246|FG000|NOT COMPLETED|Overall Study||0
8824271|NCT01592045|9878252|FG000|STARTED|Overall Study||14
8824272|NCT01592045|9878253|FG001|STARTED|Overall Study||14
8824273|NCT01592045|9878252|FG000|Completed Course 1|Overall Study||13
8824274|NCT01592045|9878253|FG001|Completed Course 1|Overall Study||14
8824275|NCT01592045|9878252|FG000|Completed Course 2|Overall Study||13
8824276|NCT01592045|9878253|FG001|Completed Course 2|Overall Study||13
8824277|NCT01592045|9878252|FG000|Completed Course 3|Overall Study||11
8824278|NCT01592045|9878253|FG001|Completed Course 3|Overall Study||13
8824279|NCT01592045|9878252|FG000|Completed Course 4|Overall Study||11
8824280|NCT01592045|9878253|FG001|Completed Course 4|Overall Study||12
8824281|NCT01592045|9878252|FG000|Completed Course 5|Overall Study||9
8824282|NCT01592045|9878253|FG001|Completed Course 5|Overall Study||12
8824283|NCT01592045|9878252|FG000|COMPLETED|Overall Study||9
8824284|NCT01592045|9878253|FG001|COMPLETED|Overall Study||12
8824285|NCT01592045|9878252|FG000|NOT COMPLETED|Overall Study||5
8824286|NCT01592045|9878253|FG001|NOT COMPLETED|Overall Study||2
8824287|NCT01592071|9878259|FG000|STARTED|Overall Study||120
8622111|NCT00486044|9661263|FG000|NOT COMPLETED|Overall Study||2
8824288|NCT01592071|9878259|FG000|COMPLETED|Overall Study||120
8824289|NCT01592071|9878259|FG000|NOT COMPLETED|Overall Study||0
8824290|NCT01592240|9878270|FG000|STARTED|Overall Study||50
8824291|NCT01592240|9878271|FG001|STARTED|Overall Study||50
8824292|NCT01592240|9878272|FG002|STARTED|Overall Study||52
8824293|NCT01592240|9878273|FG003|STARTED|Overall Study||50
8824294|NCT01592240|9878274|FG004|STARTED|Overall Study||51
8824295|NCT01592240|9878275|FG005|STARTED|Overall Study||50
8824296|NCT01592240|9878276|FG006|STARTED|Overall Study||51
8824297|NCT01592240|9878270|FG000|COMPLETED|Overall Study||47
8723232|NCT01021852|9770683|FG000|COMPLETED|Washout Period-No Drug||37
8723233|NCT01021852|9770684|FG001|COMPLETED|Washout Period-No Drug||39
8723234|NCT01021852|9770685|FG002|COMPLETED|Washout Period-No Drug||39
8723235|NCT01021852|9770686|FG003|COMPLETED|Washout Period-No Drug||37
8723236|NCT01021852|9770687|FG004|COMPLETED|Washout Period-No Drug||39
8723237|NCT01021852|9770688|FG005|COMPLETED|Washout Period-No Drug||38
8824298|NCT01592240|9878271|FG001|COMPLETED|Overall Study||39
8824299|NCT01592240|9878272|FG002|COMPLETED|Overall Study||45
8824300|NCT01592240|9878273|FG003|COMPLETED|Overall Study||47
8824301|NCT01592240|9878274|FG004|COMPLETED|Overall Study||44
8824302|NCT01592240|9878275|FG005|COMPLETED|Overall Study||47
8824303|NCT01592240|9878276|FG006|COMPLETED|Overall Study||48
8824304|NCT01592240|9878270|FG000|NOT COMPLETED|Overall Study||3
8824305|NCT01592240|9878271|FG001|NOT COMPLETED|Overall Study||11
8824306|NCT01592240|9878272|FG002|NOT COMPLETED|Overall Study||7
8824307|NCT01592240|9878273|FG003|NOT COMPLETED|Overall Study||3
8824308|NCT01592240|9878274|FG004|NOT COMPLETED|Overall Study||7
8824309|NCT01592240|9878275|FG005|NOT COMPLETED|Overall Study||3
8622112|NCT00486044|9661264|FG001|NOT COMPLETED|Overall Study||3
8622113|NCT00486226|9661270|FG000|STARTED|Overall Study||105
8622114|NCT00486226|9661270|FG000|COMPLETED|Overall Study||92
8723238|NCT01021852|9770689|FG006|COMPLETED|Washout Period-No Drug||40
8723239|NCT01021852|9770690|FG007|COMPLETED|Washout Period-No Drug||40
8723240|NCT01021852|9770683|FG000|NOT COMPLETED|Washout Period-No Drug||1
8723241|NCT01021852|9770684|FG001|NOT COMPLETED|Washout Period-No Drug||0
8723242|NCT01021852|9770685|FG002|NOT COMPLETED|Washout Period-No Drug||0
8622115|NCT00486226|9661270|FG000|NOT COMPLETED|Overall Study||13
8622116|NCT00486252|9661277|FG000|STARTED|Overall Study||996
8622117|NCT00486252|9661277|FG000|COMPLETED|Overall Study||938
8622118|NCT00486252|9661277|FG000|NOT COMPLETED|Overall Study||58
8622119|NCT00486265|9661283|FG000|STARTED|Overall Study|Partipants dosed on day 1.|9
8622120|NCT00486265|9661283|FG000|COMPLETED|Overall Study|Treatment is not for a fixed period and continues until a discontinuation criterion is met|0
8622121|NCT00486265|9661283|FG000|NOT COMPLETED|Overall Study||9
8629465|NCT00530439|9669213|FG000|COMPLETED|Overall Study||150
8723243|NCT01021852|9770686|FG003|NOT COMPLETED|Washout Period-No Drug||0
8723244|NCT01021852|9770687|FG004|NOT COMPLETED|Washout Period-No Drug||0
8723245|NCT01021852|9770688|FG005|NOT COMPLETED|Washout Period-No Drug||1
8723246|NCT01021852|9770689|FG006|NOT COMPLETED|Washout Period-No Drug||0
8723247|NCT01021852|9770690|FG007|NOT COMPLETED|Washout Period-No Drug||0
8723248|NCT01021852|9770683|FG000|STARTED|Treatment Period 2||37
8723249|NCT01021852|9770684|FG001|STARTED|Treatment Period 2||39
8723250|NCT01021852|9770685|FG002|STARTED|Treatment Period 2||39
8723251|NCT01021852|9770686|FG003|STARTED|Treatment Period 2||37
8723252|NCT01021852|9770687|FG004|STARTED|Treatment Period 2||39
8723253|NCT01021852|9770688|FG005|STARTED|Treatment Period 2||38
8723254|NCT01021852|9770689|FG006|STARTED|Treatment Period 2||40
8723255|NCT01021852|9770690|FG007|STARTED|Treatment Period 2||40
8723256|NCT01021852|9770683|FG000|COMPLETED|Treatment Period 2||37
8723257|NCT01021852|9770684|FG001|COMPLETED|Treatment Period 2||38
8723258|NCT01021852|9770685|FG002|COMPLETED|Treatment Period 2||38
8723259|NCT01021852|9770686|FG003|COMPLETED|Treatment Period 2||37
8723260|NCT01021852|9770687|FG004|COMPLETED|Treatment Period 2||37
8824310|NCT01592240|9878276|FG006|NOT COMPLETED|Overall Study||3
8824311|NCT01592292|9878299|FG000|STARTED|Overall Study||46
8824312|NCT01592292|9878300|FG001|STARTED|Overall Study||20
8824313|NCT01592292|9878301|FG002|STARTED|Overall Study||13
8824314|NCT01592292|9878302|FG003|STARTED|Overall Study||11
8824315|NCT01592292|9878299|FG000|Intention to Treat (ITT) Set|Overall Study|Excluding primary effect evaluation omission.|34
8824316|NCT01592292|9878300|FG001|Intention to Treat (ITT) Set|Overall Study||13
8824317|NCT01592292|9878301|FG002|Intention to Treat (ITT) Set|Overall Study||10
8824318|NCT01592292|9878302|FG003|Intention to Treat (ITT) Set|Overall Study||8
8824319|NCT01592292|9878299|FG000|Standard Population Set (SPS)|Overall Study|Excluding participants with change of administration drug or suspension of drug administration.|31
8824320|NCT01592292|9878300|FG001|Standard Population Set (SPS)|Overall Study||10
8824321|NCT01592292|9878301|FG002|Standard Population Set (SPS)|Overall Study||7
8824322|NCT01592292|9878302|FG003|Standard Population Set (SPS)|Overall Study||7
8824323|NCT01592292|9878299|FG000|COMPLETED|Overall Study|Participants who completed 12 months visit.|40
8824324|NCT01592292|9878300|FG001|COMPLETED|Overall Study||15
8824325|NCT01592292|9878301|FG002|COMPLETED|Overall Study||10
8824326|NCT01592292|9878302|FG003|COMPLETED|Overall Study||10
8824327|NCT01592292|9878299|FG000|NOT COMPLETED|Overall Study||6
8824328|NCT01592292|9878300|FG001|NOT COMPLETED|Overall Study||5
8824329|NCT01592292|9878301|FG002|NOT COMPLETED|Overall Study||3
8824330|NCT01592292|9878302|FG003|NOT COMPLETED|Overall Study||1
8824331|NCT01592344|9878310|FG000|STARTED|Overall Study||45
8824332|NCT01592344|9878311|FG001|STARTED|Overall Study||49
8824333|NCT01592344|9878310|FG000|COMPLETED|Overall Study||41
8824334|NCT01592344|9878311|FG001|COMPLETED|Overall Study||44
8824335|NCT01592344|9878310|FG000|NOT COMPLETED|Overall Study||4
8824336|NCT01592344|9878311|FG001|NOT COMPLETED|Overall Study||5
8824337|NCT01592396|9878319|FG000|STARTED|Overall Study||10
8824338|NCT01592396|9878320|FG001|STARTED|Overall Study||10
8824339|NCT01592396|9878319|FG000|COMPLETED|Overall Study||10
8824340|NCT01592396|9878320|FG001|COMPLETED|Overall Study||10
8824341|NCT01592396|9878319|FG000|NOT COMPLETED|Overall Study||0
8824342|NCT01592396|9878320|FG001|NOT COMPLETED|Overall Study||0
8824343|NCT01592409|9878329|FG000|STARTED|Overall Study||67
8824344|NCT01592409|9878330|FG001|STARTED|Overall Study||32
8824345|NCT01592409|9878329|FG000|COMPLETED|Overall Study||67
8824346|NCT01592409|9878330|FG001|COMPLETED|Overall Study||31
8824347|NCT01592409|9878329|FG000|NOT COMPLETED|Overall Study||0
8824348|NCT01592409|9878330|FG001|NOT COMPLETED|Overall Study||1
8824349|NCT01592435|9878336|FG000|STARTED|Overall Study||76
8824350|NCT01592435|9878336|FG000|COMPLETED|Overall Study||76
8824351|NCT01592435|9878336|FG000|NOT COMPLETED|Overall Study||0
8824352|NCT01592500|9878346|FG000|STARTED|Overall Study|Randomized Participants|14
8824353|NCT01592500|9878347|FG001|STARTED|Overall Study||15
8824354|NCT01592500|9878348|FG002|STARTED|Overall Study||14
8824355|NCT01592500|9878349|FG003|STARTED|Overall Study|Randomized Participants|13
8824356|NCT01592500|9878346|FG000|COMPLETED|Overall Study||13
8824357|NCT01592500|9878347|FG001|COMPLETED|Overall Study||15
8824358|NCT01592500|9878348|FG002|COMPLETED|Overall Study||14
8824359|NCT01592500|9878349|FG003|COMPLETED|Overall Study||11
8824360|NCT01592500|9878346|FG000|NOT COMPLETED|Overall Study||1
8824361|NCT01592500|9878347|FG001|NOT COMPLETED|Overall Study||0
8824362|NCT01592500|9878348|FG002|NOT COMPLETED|Overall Study||0
8824363|NCT01592500|9878349|FG003|NOT COMPLETED|Overall Study||2
8824364|NCT01592695|9878361|FG000|STARTED|Overall Study||31
8824365|NCT01592695|9878362|FG001|STARTED|Overall Study||32
8824366|NCT01592695|9878361|FG000|COMPLETED|Overall Study||23
8824367|NCT01592695|9878362|FG001|COMPLETED|Overall Study||28
8824368|NCT01592695|9878361|FG000|NOT COMPLETED|Overall Study||8
8824369|NCT01592695|9878362|FG001|NOT COMPLETED|Overall Study||4
8824370|NCT01592708|9878370|FG000|STARTED|Overall Study||96
8824371|NCT01592708|9878371|FG001|STARTED|Overall Study||137
8824372|NCT01592708|9878370|FG000|COMPLETED|Overall Study||93
8824373|NCT01592708|9878371|FG001|COMPLETED|Overall Study||137
8824374|NCT01592708|9878370|FG000|NOT COMPLETED|Overall Study||3
8824375|NCT01592708|9878371|FG001|NOT COMPLETED|Overall Study||0
8824376|NCT01592747|9878383|FG000|STARTED|Overall Study|Based on Randomized Population|160
8824377|NCT01592747|9878384|FG001|STARTED|Overall Study|Based on Randomized Population|161
8824378|NCT01592747|9878385|FG002|STARTED|Overall Study|Based on Randomized Population|158
8824379|NCT01592747|9878383|FG000|COMPLETED|Overall Study||44
8824380|NCT01592747|9878384|FG001|COMPLETED|Overall Study||50
8824381|NCT01592747|9878385|FG002|COMPLETED|Overall Study||50
8824382|NCT01592747|9878383|FG000|NOT COMPLETED|Overall Study||116
8824383|NCT01592747|9878384|FG001|NOT COMPLETED|Overall Study||111
8824384|NCT01592747|9878385|FG002|NOT COMPLETED|Overall Study||108
8824385|NCT01592760|9878397|FG000|STARTED|Perioperative to Discharge||90
8824386|NCT01592760|9878398|FG001|STARTED|Perioperative to Discharge||90
8824387|NCT01592760|9878399|FG002|STARTED|Perioperative to Discharge||45
8824388|NCT01592760|9878397|FG000|COMPLETED|Perioperative to Discharge||90
8824389|NCT01592760|9878398|FG001|COMPLETED|Perioperative to Discharge||90
8824390|NCT01592760|9878399|FG002|COMPLETED|Perioperative to Discharge||45
8824391|NCT01592760|9878397|FG000|NOT COMPLETED|Perioperative to Discharge||0
8824392|NCT01592760|9878398|FG001|NOT COMPLETED|Perioperative to Discharge||0
8824393|NCT01592760|9878399|FG002|NOT COMPLETED|Perioperative to Discharge||0
8824394|NCT01592760|9878397|FG000|STARTED|24-hour Follow-Up||90
8824395|NCT01592760|9878398|FG001|STARTED|24-hour Follow-Up||90
8824396|NCT01592760|9878399|FG002|STARTED|24-hour Follow-Up||45
8824397|NCT01592760|9878397|FG000|COMPLETED|24-hour Follow-Up||86
8824398|NCT01592760|9878398|FG001|COMPLETED|24-hour Follow-Up||87
8824399|NCT01592760|9878399|FG002|COMPLETED|24-hour Follow-Up||43
8824400|NCT01592760|9878397|FG000|NOT COMPLETED|24-hour Follow-Up||4
8824401|NCT01592760|9878398|FG001|NOT COMPLETED|24-hour Follow-Up||3
8824402|NCT01592760|9878399|FG002|NOT COMPLETED|24-hour Follow-Up||2
8824403|NCT01592773|9878410|FG000|STARTED|Overall Study|All enrolled patients received at least 1 dose of investigational product (Safety Population).|747
8824404|NCT01592773|9878410|FG000|COMPLETED|Overall Study||81
8824405|NCT01592773|9878410|FG000|NOT COMPLETED|Overall Study||666
8824406|NCT01592786|9878414|FG000|STARTED|Overall Study|Participants in the Safety Population are being presented.|903
8824407|NCT01592786|9878414|FG000|COMPLETED|Overall Study||765
8824408|NCT01592786|9878414|FG000|NOT COMPLETED|Overall Study||138
8824409|NCT01592799|9878418|FG000|STARTED|Overall Study||501
8824410|NCT01592799|9878418|FG000|COMPLETED|Overall Study||501
8824411|NCT01592799|9878418|FG000|NOT COMPLETED|Overall Study||0
8824412|NCT01592851|9878426|FG000|STARTED|Overall Study||56
8824413|NCT01592851|9878427|FG001|STARTED|Overall Study||57
8824414|NCT01592851|9878426|FG000|COMPLETED|Overall Study||56
8824415|NCT01592851|9878427|FG001|COMPLETED|Overall Study||57
8824416|NCT01592851|9878426|FG000|NOT COMPLETED|Overall Study||0
8824417|NCT01592851|9878427|FG001|NOT COMPLETED|Overall Study||0
8824418|NCT01592864|9878435|FG000|STARTED|Overall Study||60
8824419|NCT01592864|9878436|FG001|STARTED|Overall Study||58
8824420|NCT01592864|9878435|FG000|COMPLETED|Overall Study||60
8824421|NCT01592864|9878436|FG001|COMPLETED|Overall Study||57
8824422|NCT01592864|9878435|FG000|NOT COMPLETED|Overall Study||0
8824423|NCT01592864|9878436|FG001|NOT COMPLETED|Overall Study||1
8824424|NCT01593020|9878444|FG000|STARTED|Overall Study||28
8824425|NCT01593020|9878445|FG001|STARTED|Overall Study||23
8824426|NCT01593020|9878444|FG000|COMPLETED|Overall Study||26
8824427|NCT01593020|9878445|FG001|COMPLETED|Overall Study||21
8824428|NCT01593020|9878444|FG000|NOT COMPLETED|Overall Study||2
8824429|NCT01593020|9878445|FG001|NOT COMPLETED|Overall Study||2
8824430|NCT01593215|9878453|FG000|STARTED|Overall Study||25
8824431|NCT01593215|9878454|FG001|STARTED|Overall Study||25
8824432|NCT01593215|9878453|FG000|COMPLETED|Overall Study||24
8824433|NCT01593215|9878454|FG001|COMPLETED|Overall Study||25
8824434|NCT01593215|9878453|FG000|NOT COMPLETED|Overall Study||1
8824435|NCT01593215|9878454|FG001|NOT COMPLETED|Overall Study||0
8824436|NCT01593592|9878462|FG000|STARTED|Overall Study||35
8824437|NCT01593592|9878463|FG001|STARTED|Overall Study||35
8824438|NCT01593592|9878462|FG000|COMPLETED|Overall Study||35
8824439|NCT01593592|9878463|FG001|COMPLETED|Overall Study||35
8824440|NCT01593592|9878462|FG000|NOT COMPLETED|Overall Study||0
8824441|NCT01593592|9878463|FG001|NOT COMPLETED|Overall Study||0
8824442|NCT01593670|9878469|FG000|STARTED|Overall Study||9
8824443|NCT01593670|9878469|FG000|COMPLETED|Overall Study||9
8824444|NCT01593670|9878469|FG000|NOT COMPLETED|Overall Study||0
8824445|NCT01593696|9878477|FG000|STARTED|Dose Escalation||16
8824446|NCT01593696|9878478|FG001|STARTED|Dose Escalation||5
8824447|NCT01593696|9878479|FG002|STARTED|Dose Escalation||0
8824448|NCT01593696|9878480|FG003|STARTED|Dose Escalation||0
8824449|NCT01593696|9878477|FG000|Prior Transplant|Dose Escalation||7
8824450|NCT01593696|9878478|FG001|Prior Transplant|Dose Escalation||1
8824451|NCT01593696|9878479|FG002|Prior Transplant|Dose Escalation||0
8824452|NCT01593696|9878480|FG003|Prior Transplant|Dose Escalation||0
8824453|NCT01593696|9878477|FG000|No Prior Transplant|Dose Escalation||9
8824454|NCT01593696|9878478|FG001|No Prior Transplant|Dose Escalation||4
8622122|NCT00486278|9661287|FG000|STARTED|Overall Study|96 bleeds by 51 subjects, 77 were treated with vatreptacog alfa and 19 with rFVIIa|51
8622123|NCT00486278|9661287|FG000|COMPLETED|Overall Study||42
8622124|NCT00486278|9661287|FG000|NOT COMPLETED|Overall Study||9
8622125|NCT00486291|9661303|FG000|STARTED|Overall Study|3 subjects discontinued prior to first dose|105
8622126|NCT00486291|9661304|FG001|STARTED|Overall Study|1 subject discontinued prior to first dose|105
8824455|NCT01593696|9878479|FG002|No Prior Transplant|Dose Escalation||0
8824456|NCT01593696|9878480|FG003|No Prior Transplant|Dose Escalation||0
8824457|NCT01593696|9878477|FG000|COMPLETED|Dose Escalation||14
8824458|NCT01593696|9878478|FG001|COMPLETED|Dose Escalation||5
8824459|NCT01593696|9878479|FG002|COMPLETED|Dose Escalation||0
8824460|NCT01593696|9878480|FG003|COMPLETED|Dose Escalation||0
8943910|NCT02392234|10005686|FG004|STARTED|Treatment Period 2 (8 Weeks)||37
8943911|NCT02392234|10005687|FG005|STARTED|Treatment Period 2 (8 Weeks)||38
8943912|NCT02392234|10005682|FG000|COMPLETED|Treatment Period 2 (8 Weeks)||37
8943913|NCT02392234|10005683|FG001|COMPLETED|Treatment Period 2 (8 Weeks)||43
8943914|NCT02392234|10005684|FG002|COMPLETED|Treatment Period 2 (8 Weeks)||38
8943915|NCT02392234|10005685|FG003|COMPLETED|Treatment Period 2 (8 Weeks)||41
8943916|NCT02392234|10005686|FG004|COMPLETED|Treatment Period 2 (8 Weeks)||37
8824461|NCT01593696|9878477|FG000|NOT COMPLETED|Dose Escalation||2
8824462|NCT01593696|9878478|FG001|NOT COMPLETED|Dose Escalation||0
8824463|NCT01593696|9878479|FG002|NOT COMPLETED|Dose Escalation||0
8824464|NCT01593696|9878480|FG003|NOT COMPLETED|Dose Escalation||0
8824465|NCT01593696|9878477|FG000|STARTED|Dose Expansion||0
8622127|NCT00486291|9661303|FG000|COMPLETED|Overall Study||89
8824466|NCT01593696|9878478|FG001|STARTED|Dose Expansion||0
8824467|NCT01593696|9878479|FG002|STARTED|Dose Expansion||16
8824468|NCT01593696|9878480|FG003|STARTED|Dose Expansion||16
8824469|NCT01593696|9878477|FG000|COMPLETED|Dose Expansion||0
8824470|NCT01593696|9878478|FG001|COMPLETED|Dose Expansion||0
8824471|NCT01593696|9878479|FG002|COMPLETED|Dose Expansion||15
8824472|NCT01593696|9878480|FG003|COMPLETED|Dose Expansion||16
8824473|NCT01593696|9878477|FG000|NOT COMPLETED|Dose Expansion||0
8824474|NCT01593696|9878478|FG001|NOT COMPLETED|Dose Expansion||0
8824475|NCT01593696|9878479|FG002|NOT COMPLETED|Dose Expansion||1
8824476|NCT01593696|9878480|FG003|NOT COMPLETED|Dose Expansion||0
8824477|NCT01593722|9878492|FG000|STARTED|Overall Study||6
8824478|NCT01593722|9878493|FG001|STARTED|Overall Study||6
8824479|NCT01593722|9878492|FG000|COMPLETED|Overall Study||6
8824480|NCT01593722|9878493|FG001|COMPLETED|Overall Study||6
8824481|NCT01593722|9878492|FG000|NOT COMPLETED|Overall Study||0
8824482|NCT01593722|9878493|FG001|NOT COMPLETED|Overall Study||0
8824483|NCT01593748|9878503|FG000|STARTED|Overall Study||45
8824484|NCT01593748|9878504|FG001|STARTED|Overall Study||45
8824485|NCT01593748|9878503|FG000|COMPLETED|Overall Study||45
8824486|NCT01593748|9878504|FG001|COMPLETED|Overall Study||45
8824487|NCT01593748|9878503|FG000|NOT COMPLETED|Overall Study||0
8824488|NCT01593748|9878504|FG001|NOT COMPLETED|Overall Study||0
8824489|NCT01593787|9878513|FG000|STARTED|Overall Study||6
8824490|NCT01593787|9878514|FG001|STARTED|Overall Study||8
8824491|NCT01593787|9878515|FG002|STARTED|Overall Study||18
8824492|NCT01593787|9878513|FG000|COMPLETED|Overall Study||5
8824493|NCT01593787|9878514|FG001|COMPLETED|Overall Study||8
8824494|NCT01593787|9878515|FG002|COMPLETED|Overall Study||18
8824495|NCT01593787|9878513|FG000|NOT COMPLETED|Overall Study||1
8824496|NCT01593787|9878514|FG001|NOT COMPLETED|Overall Study||0
8824497|NCT01593787|9878515|FG002|NOT COMPLETED|Overall Study||0
8824498|NCT01593917|9878525|FG000|STARTED|Overall Study||329
8824499|NCT01593917|9878525|FG000|COMPLETED|Overall Study||159
8824500|NCT01593917|9878525|FG000|NOT COMPLETED|Overall Study||170
8824501|NCT01594125|9878534|FG000|STARTED|Overall Study||4
8824502|NCT01594125|9878535|FG001|STARTED|Overall Study||12
8824503|NCT01594125|9878536|FG002|STARTED|Overall Study||3
8824504|NCT01594125|9878537|FG003|STARTED|Overall Study||4
8824505|NCT01594125|9878538|FG004|STARTED|Overall Study||7
8824506|NCT01594125|9878534|FG000|COMPLETED|Overall Study||0
8824507|NCT01594125|9878535|FG001|COMPLETED|Overall Study||0
8824508|NCT01594125|9878536|FG002|COMPLETED|Overall Study||0
8824509|NCT01594125|9878537|FG003|COMPLETED|Overall Study||0
8824510|NCT01594125|9878538|FG004|COMPLETED|Overall Study||0
8824511|NCT01594125|9878534|FG000|NOT COMPLETED|Overall Study||4
8824512|NCT01594125|9878535|FG001|NOT COMPLETED|Overall Study||12
8824513|NCT01594125|9878536|FG002|NOT COMPLETED|Overall Study||3
8824514|NCT01594125|9878537|FG003|NOT COMPLETED|Overall Study||4
8824515|NCT01594125|9878538|FG004|NOT COMPLETED|Overall Study||7
8824516|NCT01594281|9878553|FG000|STARTED|Interventional Core Phase||36
8824517|NCT01594281|9878554|FG001|STARTED|Interventional Core Phase||36
8824518|NCT01594281|9878555|FG002|STARTED|Interventional Core Phase||36
8824519|NCT01594281|9878553|FG000|Full Analysis Set (FAS)|Interventional Core Phase||35
8824520|NCT01594281|9878554|FG001|Full Analysis Set (FAS)|Interventional Core Phase||35
8824521|NCT01594281|9878555|FG002|Full Analysis Set (FAS)|Interventional Core Phase||36
8824522|NCT01594281|9878553|FG000|COMPLETED|Interventional Core Phase||29
8824523|NCT01594281|9878554|FG001|COMPLETED|Interventional Core Phase||26
8824524|NCT01594281|9878555|FG002|COMPLETED|Interventional Core Phase||28
8824525|NCT01594281|9878553|FG000|NOT COMPLETED|Interventional Core Phase||7
8824526|NCT01594281|9878554|FG001|NOT COMPLETED|Interventional Core Phase||10
8824527|NCT01594281|9878555|FG002|NOT COMPLETED|Interventional Core Phase||8
8824528|NCT01594281|9878553|FG000|STARTED|Non-Interventional Follow Up Phase|1 patient exited after completing Core Phase and did not start the Follow-Up Phase|28
8824529|NCT01594281|9878554|FG001|STARTED|Non-Interventional Follow Up Phase|5 patients exited after completing Core Phase and did not start the Follow-Up Phase|21
8824530|NCT01594281|9878555|FG002|STARTED|Non-Interventional Follow Up Phase|3 patients exited after completing Core Phase and did not start the Follow-Up Phase|25
8824531|NCT01594281|9878553|FG000|Follow Up Set (FUS)|Non-Interventional Follow Up Phase||28
8824532|NCT01594281|9878554|FG001|Follow Up Set (FUS)|Non-Interventional Follow Up Phase||20
8824533|NCT01594281|9878555|FG002|Follow Up Set (FUS)|Non-Interventional Follow Up Phase||25
8824534|NCT01594281|9878553|FG000|COMPLETED|Non-Interventional Follow Up Phase||25
8824535|NCT01594281|9878554|FG001|COMPLETED|Non-Interventional Follow Up Phase||19
8824536|NCT01594281|9878555|FG002|COMPLETED|Non-Interventional Follow Up Phase||23
8824537|NCT01594281|9878553|FG000|NOT COMPLETED|Non-Interventional Follow Up Phase||3
8824538|NCT01594281|9878554|FG001|NOT COMPLETED|Non-Interventional Follow Up Phase||2
8824539|NCT01594281|9878555|FG002|NOT COMPLETED|Non-Interventional Follow Up Phase||2
8824540|NCT01594294|9878568|FG000|STARTED|Overall Study||39
8824541|NCT01594294|9878569|FG001|STARTED|Overall Study||40
8824542|NCT01594294|9878568|FG000|COMPLETED|Overall Study||36
8824543|NCT01594294|9878569|FG001|COMPLETED|Overall Study||36
8824544|NCT01594294|9878568|FG000|NOT COMPLETED|Overall Study||3
8824545|NCT01594294|9878569|FG001|NOT COMPLETED|Overall Study||4
8824546|NCT01594333|9878577|FG000|STARTED|Overall Study||2391
8824547|NCT01594333|9878578|FG001|STARTED|Overall Study||2395
8824548|NCT01594333|9878577|FG000|COMPLETED|Overall Study||2230
8824549|NCT01594333|9878578|FG001|COMPLETED|Overall Study||2244
8824550|NCT01594333|9878577|FG000|NOT COMPLETED|Overall Study||161
8824551|NCT01594333|9878578|FG001|NOT COMPLETED|Overall Study||151
8824552|NCT01594385|9878586|FG000|STARTED|Overall Study||17
8824553|NCT01594385|9878587|FG001|STARTED|Overall Study||13
8824554|NCT01594385|9878586|FG000|COMPLETED|Overall Study||17
8824555|NCT01594385|9878587|FG001|COMPLETED|Overall Study||13
8824556|NCT01594385|9878586|FG000|NOT COMPLETED|Overall Study||0
8824557|NCT01594385|9878587|FG001|NOT COMPLETED|Overall Study||0
8849545|NCT01741545|9904775|FG001|NOT COMPLETED|Treatment Period||4
8849546|NCT01741545|9904774|FG000|STARTED|Follow-up Period (24 Weeks)|1 participant re-joined Cohort A in follow-up period.|12
8849547|NCT01741545|9904775|FG001|STARTED|Follow-up Period (24 Weeks)|4 participants re-joined Cohort B in follow-up period.|39
8849548|NCT01741545|9904774|FG000|COMPLETED|Follow-up Period (24 Weeks)||11
8849549|NCT01741545|9904775|FG001|COMPLETED|Follow-up Period (24 Weeks)||37
8849550|NCT01741545|9904774|FG000|NOT COMPLETED|Follow-up Period (24 Weeks)||1
8849551|NCT01741545|9904775|FG001|NOT COMPLETED|Follow-up Period (24 Weeks)||2
8849552|NCT01741688|9904781|FG000|STARTED|Overall Study||16
8849553|NCT01741688|9904781|FG000|COMPLETED|Overall Study||13
8622128|NCT00486291|9661304|FG001|COMPLETED|Overall Study||76
8622129|NCT00486291|9661303|FG000|NOT COMPLETED|Overall Study||16
8622130|NCT00486291|9661304|FG001|NOT COMPLETED|Overall Study||29
8622131|NCT00486330|9661310|FG000|STARTED|Overall Study|Twelve subjects met inclusion/exclusion criteria|12
8622132|NCT00486330|9661310|FG000|COMPLETED|Overall Study|Of the 12 subjects treated, two developed adverse events leading to study drug discontinuation.|10
8622133|NCT00486330|9661310|FG000|NOT COMPLETED|Overall Study||2
8622134|NCT00486434|9661316|FG000|STARTED|Overall Study||588
8622135|NCT00486434|9661317|FG001|STARTED|Overall Study||588
8622136|NCT00486434|9661316|FG000|COMPLETED|Overall Study||394
8622137|NCT00486434|9661317|FG001|COMPLETED|Overall Study||454
8622138|NCT00486434|9661316|FG000|NOT COMPLETED|Overall Study||194
8622139|NCT00486434|9661317|FG001|NOT COMPLETED|Overall Study||134
8622140|NCT00486447|9661324|FG000|STARTED|Overall Study||249
8622141|NCT00486447|9661324|FG000|COMPLETED|Overall Study||249
8849554|NCT01741688|9904781|FG000|NOT COMPLETED|Overall Study||3
8849555|NCT01741701|9904788|FG000|STARTED|Overall Study||18
8849556|NCT01741701|9904789|FG001|STARTED|Overall Study||15
8849557|NCT01741701|9904788|FG000|COMPLETED|Overall Study||13
8849558|NCT01741701|9904789|FG001|COMPLETED|Overall Study||13
8849559|NCT01741701|9904788|FG000|NOT COMPLETED|Overall Study||5
8849560|NCT01741701|9904789|FG001|NOT COMPLETED|Overall Study||2
8849561|NCT01741792|9904798|FG000|STARTED|Overall Study|3 participants were not considered evaluable and were replaced as specified in the protocol.|9
8849562|NCT01741792|9904799|FG001|STARTED|Overall Study|Cohort 2 was closed to enrollment on recommendation of the data monitoring committee|2
8849563|NCT01741792|9904800|FG002|STARTED|Overall Study||14
8849564|NCT01741792|9904798|FG000|Efficacy Set|Overall Study|Completed > 7 days of infusion on the highest intended dose level or discontinued due to progression|7
8849565|NCT01741792|9904799|FG001|Efficacy Set|Overall Study|Completed > 7 days of infusion on the highest intended dose level or discontinued due to progression|1
8849566|NCT01741792|9904800|FG002|Efficacy Set|Overall Study|Completed > 7 days of infusion on the highest intended dose level or discontinued due to progression|13
8849567|NCT01741792|9904798|FG000|COMPLETED|Overall Study||3
8849568|NCT01741792|9904799|FG001|COMPLETED|Overall Study||1
8849569|NCT01741792|9904800|FG002|COMPLETED|Overall Study||2
8849570|NCT01741792|9904798|FG000|NOT COMPLETED|Overall Study||6
8849571|NCT01741792|9904799|FG001|NOT COMPLETED|Overall Study||1
8849572|NCT01741792|9904800|FG002|NOT COMPLETED|Overall Study||12
8849573|NCT01742065|9904816|FG000|STARTED|Overall Study|20059 patients were analyzed in 13 clinics.|20059
8849574|NCT01742065|9904817|FG001|STARTED|Overall Study|21134 patients were analyzed in 13 clinics.|21134
8849575|NCT01742065|9904816|FG000|COMPLETED|Overall Study|20059 patients were analyzed in 13 clinics.|20059
8849576|NCT01742065|9904817|FG001|COMPLETED|Overall Study|21134 patients were analyzed in 13 clinics.|21134
8849577|NCT01742065|9904816|FG000|NOT COMPLETED|Overall Study||0
8849578|NCT01742065|9904817|FG001|NOT COMPLETED|Overall Study||0
8849579|NCT01742078|9904832|FG000|STARTED|Overall Study||6
8849580|NCT01742078|9904833|FG001|STARTED|Overall Study||6
8849581|NCT01742078|9904834|FG002|STARTED|Overall Study||6
8849582|NCT01742078|9904835|FG003|STARTED|Overall Study||6
8849583|NCT01742078|9904836|FG004|STARTED|Overall Study||6
8849584|NCT01742078|9904837|FG005|STARTED|Overall Study||6
8849585|NCT01742078|9904838|FG006|STARTED|Overall Study||6
8849586|NCT01742078|9904839|FG007|STARTED|Overall Study||6
8849587|NCT01742078|9904840|FG008|STARTED|Overall Study||12
8849588|NCT01742078|9904832|FG000|RECEIVED STUDY DRUG|Overall Study||6
8849589|NCT01742078|9904833|FG001|RECEIVED STUDY DRUG|Overall Study||6
8849590|NCT01742078|9904834|FG002|RECEIVED STUDY DRUG|Overall Study||6
8849591|NCT01742078|9904835|FG003|RECEIVED STUDY DRUG|Overall Study||6
8849592|NCT01742078|9904836|FG004|RECEIVED STUDY DRUG|Overall Study||6
8849593|NCT01742078|9904837|FG005|RECEIVED STUDY DRUG|Overall Study||6
8849594|NCT01742078|9904838|FG006|RECEIVED STUDY DRUG|Overall Study||6
8849595|NCT01742078|9904839|FG007|RECEIVED STUDY DRUG|Overall Study||6
8849596|NCT01742078|9904840|FG008|RECEIVED STUDY DRUG|Overall Study||12
8849597|NCT01742078|9904832|FG000|COMPLETED|Overall Study||6
8849598|NCT01742078|9904833|FG001|COMPLETED|Overall Study||6
8622142|NCT00486447|9661324|FG000|NOT COMPLETED|Overall Study||0
8622143|NCT00486525|9661331|FG000|STARTED|Overall Study||100
8622144|NCT00486525|9661332|FG001|STARTED|Overall Study||100
8622145|NCT00486525|9661331|FG000|COMPLETED|Overall Study||94
8622146|NCT00486525|9661332|FG001|COMPLETED|Overall Study||87
8849599|NCT01742078|9904834|FG002|COMPLETED|Overall Study||6
8849600|NCT01742078|9904835|FG003|COMPLETED|Overall Study||5
8849601|NCT01742078|9904836|FG004|COMPLETED|Overall Study||6
8849602|NCT01742078|9904837|FG005|COMPLETED|Overall Study||6
8849603|NCT01742078|9904838|FG006|COMPLETED|Overall Study||6
8849604|NCT01742078|9904839|FG007|COMPLETED|Overall Study||6
8849605|NCT01742078|9904840|FG008|COMPLETED|Overall Study||12
8824558|NCT01594411|9878597|FG000|STARTED|Overall Study||251
8824559|NCT01594411|9878597|FG000|COMPLETED|Overall Study||249
8824560|NCT01594411|9878597|FG000|NOT COMPLETED|Overall Study||2
8824561|NCT01594424|9878604|FG000|STARTED|Overall Study||10
8824562|NCT01594424|9878604|FG000|COMPLETED|Overall Study||8
8824563|NCT01594424|9878604|FG000|NOT COMPLETED|Overall Study||2
8824564|NCT01594476|9878610|FG000|STARTED|Overall Study||101
8824565|NCT01594476|9878611|FG001|STARTED|Overall Study||100
8824566|NCT01594476|9878610|FG000|Received Intervention|Overall Study||66
8824567|NCT01594476|9878611|FG001|Received Intervention|Overall Study||73
8824568|NCT01594476|9878610|FG000|Excluded After Allocation|Overall Study||1
8824569|NCT01594476|9878611|FG001|Excluded After Allocation|Overall Study||3
8824570|NCT01594476|9878610|FG000|IUD Removal|Overall Study||3
8824571|NCT01594476|9878611|FG001|IUD Removal|Overall Study||5
8824572|NCT01594476|9878610|FG000|IUD Expulsion|Overall Study||2
8824573|NCT01594476|9878611|FG001|IUD Expulsion|Overall Study||0
8824574|NCT01594476|9878610|FG000|Pregnant|Overall Study||2
8824575|NCT01594476|9878611|FG001|Pregnant|Overall Study||5
8824576|NCT01594476|9878610|FG000|COMPLETED|Overall Study||100
8824577|NCT01594476|9878611|FG001|COMPLETED|Overall Study||97
8824578|NCT01594476|9878610|FG000|NOT COMPLETED|Overall Study||1
8824579|NCT01594476|9878611|FG001|NOT COMPLETED|Overall Study||3
8824580|NCT01594515|9878631|FG000|STARTED|Overall Study||6
8824581|NCT01594515|9878632|FG001|STARTED|Overall Study||6
8824582|NCT01594515|9878633|FG002|STARTED|Overall Study||6
8824583|NCT01594515|9878634|FG003|STARTED|Overall Study||6
8824584|NCT01594515|9878635|FG004|STARTED|Overall Study||6
8824585|NCT01594515|9878636|FG005|STARTED|Overall Study||6
8824586|NCT01594515|9878637|FG006|STARTED|Overall Study||6
8824587|NCT01594515|9878638|FG007|STARTED|Overall Study||6
8824588|NCT01594515|9878639|FG008|STARTED|Overall Study||6
8824589|NCT01594515|9878640|FG009|STARTED|Overall Study||16
8824590|NCT01594515|9878631|FG000|COMPLETED|Overall Study||6
8824591|NCT01594515|9878632|FG001|COMPLETED|Overall Study||6
8824592|NCT01594515|9878633|FG002|COMPLETED|Overall Study||6
8824593|NCT01594515|9878634|FG003|COMPLETED|Overall Study||6
8622147|NCT00486525|9661331|FG000|NOT COMPLETED|Overall Study||6
8622148|NCT00486525|9661332|FG001|NOT COMPLETED|Overall Study||13
8622149|NCT00486603|9661340|FG000|STARTED|Overall Study||3
8824594|NCT01594515|9878635|FG004|COMPLETED|Overall Study||6
8824595|NCT01594515|9878636|FG005|COMPLETED|Overall Study||6
8824596|NCT01594515|9878637|FG006|COMPLETED|Overall Study||6
8824597|NCT01594515|9878638|FG007|COMPLETED|Overall Study||6
8824598|NCT01594515|9878639|FG008|COMPLETED|Overall Study||6
8824599|NCT01594515|9878640|FG009|COMPLETED|Overall Study||16
8824600|NCT01594515|9878631|FG000|NOT COMPLETED|Overall Study||0
8824601|NCT01594515|9878632|FG001|NOT COMPLETED|Overall Study||0
8824602|NCT01594515|9878633|FG002|NOT COMPLETED|Overall Study||0
8824603|NCT01594515|9878634|FG003|NOT COMPLETED|Overall Study||0
8824604|NCT01594515|9878635|FG004|NOT COMPLETED|Overall Study||0
8824605|NCT01594515|9878636|FG005|NOT COMPLETED|Overall Study||0
8824606|NCT01594515|9878637|FG006|NOT COMPLETED|Overall Study||0
8824607|NCT01594515|9878638|FG007|NOT COMPLETED|Overall Study||0
8824608|NCT01594515|9878639|FG008|NOT COMPLETED|Overall Study||0
8824609|NCT01594515|9878640|FG009|NOT COMPLETED|Overall Study||0
8824610|NCT01594528|9878665|FG000|STARTED|Overall Study||16
8824611|NCT01594528|9878666|FG001|STARTED|Overall Study||17
8824612|NCT01594528|9878667|FG002|STARTED|Overall Study||16
8824613|NCT01594528|9878665|FG000|COMPLETED|Overall Study||16
8824614|NCT01594528|9878666|FG001|COMPLETED|Overall Study||17
8824615|NCT01594528|9878667|FG002|COMPLETED|Overall Study||16
8824616|NCT01594528|9878665|FG000|NOT COMPLETED|Overall Study||0
8824617|NCT01594528|9878666|FG001|NOT COMPLETED|Overall Study||0
8824618|NCT01594528|9878667|FG002|NOT COMPLETED|Overall Study||0
8824619|NCT01594749|9878675|FG000|STARTED|Overall Study||507
8824620|NCT01594749|9878676|FG001|STARTED|Overall Study||508
8824621|NCT01594749|9878675|FG000|Treated|Overall Study||503
8824622|NCT01594749|9878676|FG001|Treated|Overall Study||498
8824623|NCT01594749|9878675|FG000|COMPLETED|Overall Study||485
8824624|NCT01594749|9878676|FG001|COMPLETED|Overall Study||490
8824625|NCT01594749|9878675|FG000|NOT COMPLETED|Overall Study||22
8824626|NCT01594749|9878676|FG001|NOT COMPLETED|Overall Study||18
8824627|NCT01594762|9878684|FG000|STARTED|Overall Study||97
8824628|NCT01594762|9878685|FG001|STARTED|Overall Study||103
8824629|NCT01594762|9878684|FG000|COMPLETED|Overall Study||86
8824630|NCT01594762|9878685|FG001|COMPLETED|Overall Study||93
8824631|NCT01594762|9878684|FG000|NOT COMPLETED|Overall Study||11
8824632|NCT01594762|9878685|FG001|NOT COMPLETED|Overall Study||10
8824633|NCT01594827|9878693|FG000|STARTED|Overall Study||14
8824634|NCT01594827|9878694|FG001|STARTED|Overall Study||15
8824635|NCT01594827|9878693|FG000|COMPLETED|Overall Study||10
8824636|NCT01594827|9878694|FG001|COMPLETED|Overall Study||15
8824637|NCT01594827|9878693|FG000|NOT COMPLETED|Overall Study||4
8622150|NCT00486603|9661341|FG001|STARTED|Overall Study||7
8824638|NCT01594827|9878694|FG001|NOT COMPLETED|Overall Study||0
8824639|NCT01594853|9878704|FG000|STARTED|Overall Study||16
8824640|NCT01594853|9878705|FG001|STARTED|Overall Study||15
8824641|NCT01594853|9878704|FG000|COMPLETED|Overall Study||14
8824642|NCT01594853|9878705|FG001|COMPLETED|Overall Study||12
8824643|NCT01594853|9878704|FG000|NOT COMPLETED|Overall Study||2
8824644|NCT01594853|9878705|FG001|NOT COMPLETED|Overall Study||3
8824645|NCT01594931|9878714|FG000|STARTED|Overall Study||160
8824646|NCT01594931|9878715|FG001|STARTED|Overall Study||157
8824647|NCT01594931|9878716|FG002|STARTED|Overall Study|One randomized subject was not treated.|160
8824648|NCT01594931|9878714|FG000|COMPLETED|Overall Study||131
8824649|NCT01594931|9878715|FG001|COMPLETED|Overall Study||145
8824650|NCT01594931|9878716|FG002|COMPLETED|Overall Study||146
8824651|NCT01594931|9878714|FG000|NOT COMPLETED|Overall Study||29
8824652|NCT01594931|9878715|FG001|NOT COMPLETED|Overall Study||12
8824653|NCT01594931|9878716|FG002|NOT COMPLETED|Overall Study||14
8824654|NCT01594970|9878727|FG000|STARTED|Overall Study||295
8824655|NCT01594970|9878728|FG001|STARTED|Overall Study||248
8622151|NCT00486603|9661342|FG002|STARTED|Overall Study||3
8622152|NCT00486603|9661343|FG003|STARTED|Overall Study||3
8622153|NCT00486603|9661344|FG004|STARTED|Overall Study||76
8622154|NCT00486603|9661340|FG000|COMPLETED|Overall Study||2
8824656|NCT01594970|9878729|FG002|STARTED|Overall Study||257
8824657|NCT01594970|9878727|FG000|COMPLETED|Overall Study||220
8824658|NCT01594970|9878728|FG001|COMPLETED|Overall Study||166
8824659|NCT01594970|9878729|FG002|COMPLETED|Overall Study||191
8824660|NCT01594970|9878727|FG000|NOT COMPLETED|Overall Study||75
8824661|NCT01594970|9878728|FG001|NOT COMPLETED|Overall Study||82
8824662|NCT01594970|9878729|FG002|NOT COMPLETED|Overall Study||66
8824663|NCT01595282|9878739|FG000|STARTED|Overall Study||47
8824664|NCT01595282|9878740|FG001|STARTED|Overall Study||47
8824665|NCT01595282|9878739|FG000|COMPLETED|Overall Study||47
8824666|NCT01595282|9878740|FG001|COMPLETED|Overall Study||47
8824667|NCT01595282|9878739|FG000|NOT COMPLETED|Overall Study||0
8824668|NCT01595282|9878740|FG001|NOT COMPLETED|Overall Study||0
8824669|NCT01595386|9878748|FG000|STARTED|Overall Study||21
8824670|NCT01595386|9878749|FG001|STARTED|Overall Study||19
8824671|NCT01595386|9878748|FG000|COMPLETED|Overall Study||21
8824672|NCT01595386|9878749|FG001|COMPLETED|Overall Study||19
8824673|NCT01595386|9878748|FG000|NOT COMPLETED|Overall Study||0
8824674|NCT01595386|9878749|FG001|NOT COMPLETED|Overall Study||0
8824675|NCT01595438|9878757|FG000|STARTED|Overall Study||516
8824676|NCT01595438|9878758|FG001|STARTED|Overall Study||517
8824677|NCT01595438|9878757|FG000|COMPLETED|Overall Study||473
8824678|NCT01595438|9878758|FG001|COMPLETED|Overall Study||476
8824679|NCT01595438|9878757|FG000|NOT COMPLETED|Overall Study||43
8824680|NCT01595438|9878758|FG001|NOT COMPLETED|Overall Study||41
8824681|NCT01595516|9878767|FG000|STARTED|Overall Study||16
8824682|NCT01595516|9878768|FG001|STARTED|Overall Study||16
8824683|NCT01595516|9878769|FG002|STARTED|Overall Study||12
8824684|NCT01595516|9878767|FG000|COMPLETED|Overall Study||16
8824685|NCT01595516|9878768|FG001|COMPLETED|Overall Study||16
8824686|NCT01595516|9878769|FG002|COMPLETED|Overall Study||12
8824687|NCT01595516|9878767|FG000|NOT COMPLETED|Overall Study||0
8824688|NCT01595516|9878768|FG001|NOT COMPLETED|Overall Study||0
8824689|NCT01595516|9878769|FG002|NOT COMPLETED|Overall Study||0
8824690|NCT01595529|9878793|FG000|STARTED|Overall Study||348
8824691|NCT01595529|9878794|FG001|STARTED|Overall Study||345
8824692|NCT01595529|9878793|FG000|Treated|Overall Study||337
8824693|NCT01595529|9878794|FG001|Treated|Overall Study||340
8824694|NCT01595529|9878793|FG000|Evaluated for Primary Endpoint, ITT|Overall Study||328
8824695|NCT01595529|9878794|FG001|Evaluated for Primary Endpoint, ITT|Overall Study||336
8824696|NCT01595529|9878793|FG000|ITT Without Treatment Failure|Overall Study||326
8824697|NCT01595529|9878794|FG001|ITT Without Treatment Failure|Overall Study||322
8824698|NCT01595529|9878793|FG000|ITT With Stool Sample at TOC|Overall Study||298
8824699|NCT01595529|9878794|FG001|ITT With Stool Sample at TOC|Overall Study||310
8824700|NCT01595529|9878793|FG000|Per-protocol, Completed 80% of Dose|Overall Study||308
8824701|NCT01595529|9878794|FG001|Per-protocol, Completed 80% of Dose|Overall Study||314
8824702|NCT01595529|9878793|FG000|Per-protocol Without Treatment Failure|Overall Study||306
8824703|NCT01595529|9878794|FG001|Per-protocol Without Treatment Failure|Overall Study||305
8824704|NCT01595529|9878793|FG000|Per-protocol With Stool Sample at TOC|Overall Study||280
8824705|NCT01595529|9878794|FG001|Per-protocol With Stool Sample at TOC|Overall Study||289
8824706|NCT01595529|9878793|FG000|Completed All Milestones|Overall Study||318
8824707|NCT01595529|9878794|FG001|Completed All Milestones|Overall Study||318
8824708|NCT01595529|9878793|FG000|COMPLETED|Overall Study||324
8824709|NCT01595529|9878794|FG001|COMPLETED|Overall Study||325
8824710|NCT01595529|9878793|FG000|NOT COMPLETED|Overall Study||24
8824711|NCT01595529|9878794|FG001|NOT COMPLETED|Overall Study||20
8824712|NCT01595646|9878803|FG000|STARTED|Overall Study||13
8824713|NCT01595646|9878804|FG001|STARTED|Overall Study||12
8824714|NCT01595646|9878805|FG002|STARTED|Overall Study||12
8824715|NCT01595646|9878803|FG000|COMPLETED|Overall Study||12
8824716|NCT01595646|9878804|FG001|COMPLETED|Overall Study||12
8824717|NCT01595646|9878805|FG002|COMPLETED|Overall Study||12
8824718|NCT01595646|9878803|FG000|NOT COMPLETED|Overall Study||1
8824719|NCT01595646|9878804|FG001|NOT COMPLETED|Overall Study||0
8824720|NCT01595646|9878805|FG002|NOT COMPLETED|Overall Study||0
8824721|NCT01595854|9878821|FG000|STARTED|Overall Study||8
8824722|NCT01595854|9878822|FG001|STARTED|Overall Study||4
8824723|NCT01595854|9878823|FG002|STARTED|Overall Study||8
8824724|NCT01595854|9878824|FG003|STARTED|Overall Study||4
8824725|NCT01595854|9878825|FG004|STARTED|Overall Study||12
8824726|NCT01595854|9878821|FG000|COMPLETED|Overall Study||8
8824727|NCT01595854|9878822|FG001|COMPLETED|Overall Study||4
8824728|NCT01595854|9878823|FG002|COMPLETED|Overall Study||8
8824729|NCT01595854|9878824|FG003|COMPLETED|Overall Study||4
8622155|NCT00486603|9661341|FG001|COMPLETED|Overall Study||6
8824730|NCT01595854|9878825|FG004|COMPLETED|Overall Study||12
8824731|NCT01595854|9878821|FG000|NOT COMPLETED|Overall Study||0
8824732|NCT01595854|9878822|FG001|NOT COMPLETED|Overall Study||0
8824733|NCT01595854|9878823|FG002|NOT COMPLETED|Overall Study||0
8824734|NCT01595854|9878824|FG003|NOT COMPLETED|Overall Study||0
8824735|NCT01595854|9878825|FG004|NOT COMPLETED|Overall Study||0
8824736|NCT01596062|9878846|FG000|STARTED|Overall Study||3
8824737|NCT01596062|9878847|FG001|STARTED|Overall Study||6
8824738|NCT01596062|9878848|FG002|STARTED|Overall Study||7
8824739|NCT01596062|9878846|FG000|COMPLETED|Overall Study||2
8824740|NCT01596062|9878847|FG001|COMPLETED|Overall Study||6
8824741|NCT01596062|9878848|FG002|COMPLETED|Overall Study||4
8824742|NCT01596062|9878846|FG000|NOT COMPLETED|Overall Study||1
8824743|NCT01596062|9878847|FG001|NOT COMPLETED|Overall Study||0
8824744|NCT01596062|9878848|FG002|NOT COMPLETED|Overall Study||3
8824745|NCT01596088|9878856|FG000|STARTED|Overall Study||2
8824746|NCT01596088|9878856|FG000|COMPLETED|Overall Study||2
8824747|NCT01596088|9878856|FG000|NOT COMPLETED|Overall Study||0
8824748|NCT01596127|9878860|FG000|STARTED|Overall Study||4
8824749|NCT01596127|9878860|FG000|COMPLETED|Overall Study||3
8824750|NCT01596127|9878860|FG000|NOT COMPLETED|Overall Study||1
8824751|NCT01596231|9878866|FG000|STARTED|Overall Study||10
8824752|NCT01596231|9878867|FG001|STARTED|Overall Study||10
8824753|NCT01596231|9878866|FG000|COMPLETED|Overall Study||10
8824754|NCT01596231|9878867|FG001|COMPLETED|Overall Study||10
8824755|NCT01596231|9878866|FG000|NOT COMPLETED|Overall Study||0
8824756|NCT01596231|9878867|FG001|NOT COMPLETED|Overall Study||0
8824757|NCT01596283|9878875|FG000|STARTED|Overall Study||69
8824758|NCT01596283|9878876|FG001|STARTED|Overall Study||66
8824759|NCT01596283|9878875|FG000|COMPLETED|Overall Study||69
8824760|NCT01596283|9878876|FG001|COMPLETED|Overall Study||66
8824761|NCT01596283|9878875|FG000|NOT COMPLETED|Overall Study||0
8824762|NCT01596283|9878876|FG001|NOT COMPLETED|Overall Study||0
8824763|NCT01596335|9878886|FG000|STARTED|Overall Study||16
8824764|NCT01596335|9878887|FG001|STARTED|Overall Study||15
8824765|NCT01596335|9878886|FG000|COMPLETED|Overall Study||11
8824766|NCT01596335|9878887|FG001|COMPLETED|Overall Study||6
8824767|NCT01596335|9878886|FG000|NOT COMPLETED|Overall Study||5
8824768|NCT01596335|9878887|FG001|NOT COMPLETED|Overall Study||9
8824769|NCT01596504|9878896|FG000|STARTED|Overall Study||48
8824770|NCT01596504|9878897|FG001|STARTED|Overall Study||47
8824771|NCT01596504|9878898|FG002|STARTED|Overall Study||47
8824772|NCT01596504|9878896|FG000|COMPLETED|Overall Study||46
8824773|NCT01596504|9878897|FG001|COMPLETED|Overall Study||44
8824774|NCT01596504|9878898|FG002|COMPLETED|Overall Study||46
8824775|NCT01596504|9878896|FG000|NOT COMPLETED|Overall Study||2
8824776|NCT01596504|9878897|FG001|NOT COMPLETED|Overall Study||3
8824777|NCT01596504|9878898|FG002|NOT COMPLETED|Overall Study||1
8824778|NCT01596582|9878909|FG000|STARTED|Overall Study||172
8824779|NCT01596582|9878910|FG001|STARTED|Overall Study||180
8824780|NCT01596582|9878909|FG000|COMPLETED|Overall Study||168
8824781|NCT01596582|9878910|FG001|COMPLETED|Overall Study||173
8824782|NCT01596582|9878909|FG000|NOT COMPLETED|Overall Study||4
8824783|NCT01596582|9878910|FG001|NOT COMPLETED|Overall Study||7
8824784|NCT01596595|9878923|FG000|STARTED|Overall Study||1779
8824785|NCT01596595|9878923|FG000|COMPLETED|Overall Study||814
8824786|NCT01596595|9878923|FG000|NOT COMPLETED|Overall Study||965
8824787|NCT01596699|9878929|FG000|STARTED|Overall Study||10
8824788|NCT01596699|9878930|FG001|STARTED|Overall Study||6
8824789|NCT01596699|9878929|FG000|COMPLETED|Overall Study||10
8824790|NCT01596699|9878930|FG001|COMPLETED|Overall Study||6
8824791|NCT01596699|9878929|FG000|NOT COMPLETED|Overall Study||0
8824792|NCT01596699|9878930|FG001|NOT COMPLETED|Overall Study||0
8824793|NCT01596751|9878945|FG000|STARTED|Overall Study||5
8824794|NCT01596751|9878946|FG001|STARTED|Overall Study||4
8824795|NCT01596751|9878947|FG002|STARTED|Overall Study||3
8824796|NCT01596751|9878948|FG003|STARTED|Overall Study||6
8824797|NCT01596751|9878949|FG004|STARTED|Overall Study||4
8824798|NCT01596751|9878950|FG005|STARTED|Overall Study||6
8824799|NCT01596751|9878951|FG006|STARTED|Overall Study||17
8824800|NCT01596751|9878952|FG007|STARTED|Overall Study||22
8824801|NCT01596751|9878945|FG000|COMPLETED|Overall Study||5
8824802|NCT01596751|9878946|FG001|COMPLETED|Overall Study||4
8824803|NCT01596751|9878947|FG002|COMPLETED|Overall Study||3
8824804|NCT01596751|9878948|FG003|COMPLETED|Overall Study||6
8824805|NCT01596751|9878949|FG004|COMPLETED|Overall Study||4
8824806|NCT01596751|9878950|FG005|COMPLETED|Overall Study||6
8824807|NCT01596751|9878951|FG006|COMPLETED|Overall Study||17
8824808|NCT01596751|9878952|FG007|COMPLETED|Overall Study||22
8824809|NCT01596751|9878945|FG000|NOT COMPLETED|Overall Study||0
8824810|NCT01596751|9878946|FG001|NOT COMPLETED|Overall Study||0
8824811|NCT01596751|9878947|FG002|NOT COMPLETED|Overall Study||0
8824812|NCT01596751|9878948|FG003|NOT COMPLETED|Overall Study||0
8824813|NCT01596751|9878949|FG004|NOT COMPLETED|Overall Study||0
8824814|NCT01596751|9878950|FG005|NOT COMPLETED|Overall Study||0
8824815|NCT01596751|9878951|FG006|NOT COMPLETED|Overall Study||0
8824816|NCT01596751|9878952|FG007|NOT COMPLETED|Overall Study||0
8824817|NCT01596842|9878972|FG000|STARTED|Overall Study||10
8824818|NCT01596842|9878973|FG001|STARTED|Overall Study||7
8824819|NCT01596842|9878972|FG000|COMPLETED|Overall Study||8
8824820|NCT01596842|9878973|FG001|COMPLETED|Overall Study||7
8824821|NCT01596842|9878972|FG000|NOT COMPLETED|Overall Study||2
8824822|NCT01596842|9878973|FG001|NOT COMPLETED|Overall Study||0
8824823|NCT01596972|9878981|FG000|STARTED|Overall Study||25
8824824|NCT01596972|9878982|FG001|STARTED|Overall Study||26
8824825|NCT01596972|9878981|FG000|COMPLETED|Overall Study||24
8824826|NCT01596972|9878982|FG001|COMPLETED|Overall Study||12
8824827|NCT01596972|9878981|FG000|NOT COMPLETED|Overall Study||1
8824828|NCT01596972|9878982|FG001|NOT COMPLETED|Overall Study||14
8824829|NCT01597050|9878990|FG000|STARTED|Overall Study||36
8824830|NCT01597050|9878991|FG001|STARTED|Overall Study||18
8824831|NCT01597050|9878990|FG000|COMPLETED|Overall Study||35
8824832|NCT01597050|9878991|FG001|COMPLETED|Overall Study||18
8622156|NCT00486603|9661342|FG002|COMPLETED|Overall Study||3
8622157|NCT00486603|9661343|FG003|COMPLETED|Overall Study||3
8622158|NCT00486603|9661344|FG004|COMPLETED|Overall Study||76
8622159|NCT00486603|9661340|FG000|NOT COMPLETED|Overall Study||1
8622160|NCT00486603|9661341|FG001|NOT COMPLETED|Overall Study||1
8622161|NCT00486603|9661342|FG002|NOT COMPLETED|Overall Study||0
8622162|NCT00486603|9661343|FG003|NOT COMPLETED|Overall Study||0
8622163|NCT00486603|9661344|FG004|NOT COMPLETED|Overall Study||0
8622164|NCT00486642|9661361|FG000|STARTED|Overall Study||10
8622165|NCT00486642|9661362|FG001|STARTED|Overall Study||13
8622166|NCT00486642|9661361|FG000|COMPLETED|Overall Study||10
8622167|NCT00486642|9661362|FG001|COMPLETED|Overall Study||13
8622168|NCT00486642|9661361|FG000|NOT COMPLETED|Overall Study||0
8622169|NCT00486642|9661362|FG001|NOT COMPLETED|Overall Study||0
8622170|NCT00486720|9661372|FG000|STARTED|Overall Study|1 randomized patient was discontinued before receiving treatment due to a protocol violation|10
8824833|NCT01597050|9878990|FG000|NOT COMPLETED|Overall Study||1
8824834|NCT01597050|9878991|FG001|NOT COMPLETED|Overall Study||0
8824835|NCT01597128|9878999|FG000|STARTED|Overall Study||18
8824836|NCT01597128|9879000|FG001|STARTED|Overall Study||17
8824837|NCT01597128|9878999|FG000|COMPLETED|Overall Study||18
8824838|NCT01597128|9879000|FG001|COMPLETED|Overall Study||17
8824839|NCT01597128|9878999|FG000|NOT COMPLETED|Overall Study||0
8824840|NCT01597128|9879000|FG001|NOT COMPLETED|Overall Study||0
8824841|NCT01597141|9879008|FG000|STARTED|Overall Study||50
8824842|NCT01597141|9879009|FG001|STARTED|Overall Study||50
8824843|NCT01597141|9879008|FG000|COMPLETED|Overall Study||50
8824844|NCT01597141|9879009|FG001|COMPLETED|Overall Study||50
8824845|NCT01597141|9879008|FG000|NOT COMPLETED|Overall Study||0
8824846|NCT01597141|9879009|FG001|NOT COMPLETED|Overall Study||0
8824847|NCT01597193|9879024|FG000|STARTED|Stage 1: Dose Escalation (141 Days)||7
8824848|NCT01597193|9879025|FG001|STARTED|Stage 1: Dose Escalation (141 Days)||8
8824849|NCT01597193|9879026|FG002|STARTED|Stage 1: Dose Escalation (141 Days)||0
8824850|NCT01597193|9879027|FG003|STARTED|Stage 1: Dose Escalation (141 Days)||0
8824851|NCT01597193|9879028|FG004|STARTED|Stage 1: Dose Escalation (141 Days)||0
8824852|NCT01597193|9879029|FG005|STARTED|Stage 1: Dose Escalation (141 Days)||0
8824853|NCT01597193|9879030|FG006|STARTED|Stage 1: Dose Escalation (141 Days)||0
8824854|NCT01597193|9879024|FG000|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
8824855|NCT01597193|9879025|FG001|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
8824856|NCT01597193|9879026|FG002|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
8824857|NCT01597193|9879027|FG003|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
8824858|NCT01597193|9879028|FG004|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
8824859|NCT01597193|9879029|FG005|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
8824860|NCT01597193|9879030|FG006|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
8824861|NCT01597193|9879024|FG000|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||7
8824862|NCT01597193|9879025|FG001|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||8
8824863|NCT01597193|9879026|FG002|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0
8824864|NCT01597193|9879027|FG003|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0
8824865|NCT01597193|9879028|FG004|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0
8824866|NCT01597193|9879029|FG005|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0
8824867|NCT01597193|9879030|FG006|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0
8824868|NCT01597193|9879024|FG000|STARTED|Stage 2: Dose Expansion (1067 Days)||0
8824869|NCT01597193|9879025|FG001|STARTED|Stage 2: Dose Expansion (1067 Days)||0
8824870|NCT01597193|9879026|FG002|STARTED|Stage 2: Dose Expansion (1067 Days)||14
8824871|NCT01597193|9879027|FG003|STARTED|Stage 2: Dose Expansion (1067 Days)||20
8824872|NCT01597193|9879028|FG004|STARTED|Stage 2: Dose Expansion (1067 Days)||16
8824873|NCT01597193|9879029|FG005|STARTED|Stage 2: Dose Expansion (1067 Days)||23
8824874|NCT01597193|9879030|FG006|STARTED|Stage 2: Dose Expansion (1067 Days)||11
8824875|NCT01597193|9879024|FG000|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
8824876|NCT01597193|9879025|FG001|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
8824877|NCT01597193|9879026|FG002|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
8824878|NCT01597193|9879027|FG003|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
8824879|NCT01597193|9879028|FG004|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
8824880|NCT01597193|9879029|FG005|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
8824881|NCT01597193|9879030|FG006|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
8622171|NCT00486720|9661373|FG001|STARTED|Overall Study||12
8622172|NCT00486720|9661372|FG000|COMPLETED|Overall Study||0
8824882|NCT01597193|9879024|FG000|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
8824883|NCT01597193|9879025|FG001|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
8824884|NCT01597193|9879026|FG002|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||14
8824885|NCT01597193|9879027|FG003|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||20
8824886|NCT01597193|9879028|FG004|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||16
8824887|NCT01597193|9879029|FG005|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||23
8622173|NCT00486720|9661373|FG001|COMPLETED|Overall Study||0
8622174|NCT00486720|9661372|FG000|NOT COMPLETED|Overall Study||10
8824888|NCT01597193|9879030|FG006|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||11
8824889|NCT01597245|9879055|FG000|STARTED|Induction Period (Week 0 - Week 12)||168
8824890|NCT01597245|9879056|FG001|STARTED|Induction Period (Week 0 - Week 12)||358
8824891|NCT01597245|9879057|FG002|STARTED|Induction Period (Week 0 - Week 12)||347
8824892|NCT01597245|9879058|FG003|STARTED|Induction Period (Week 0 - Week 12)||351
8824893|NCT01597245|9879059|FG004|STARTED|Induction Period (Week 0 - Week 12)||0
8824894|NCT01597245|9879060|FG005|STARTED|Induction Period (Week 0 - Week 12)||0
8824895|NCT01597245|9879061|FG006|STARTED|Induction Period (Week 0 - Week 12)||0
8824896|NCT01597245|9879062|FG007|STARTED|Induction Period (Week 0 - Week 12)||0
8824897|NCT01597245|9879063|FG008|STARTED|Induction Period (Week 0 - Week 12)||0
8824898|NCT01597245|9879064|FG009|STARTED|Induction Period (Week 0 - Week 12)||0
8824899|NCT01597245|9879065|FG010|STARTED|Induction Period (Week 0 - Week 12)||0
8824900|NCT01597245|9879066|FG011|STARTED|Induction Period (Week 0 - Week 12)||0
8824901|NCT01597245|9879067|FG012|STARTED|Induction Period (Week 0 - Week 12)||0
8824902|NCT01597245|9879068|FG013|STARTED|Induction Period (Week 0 - Week 12)||0
8824903|NCT01597245|9879069|FG014|STARTED|Induction Period (Week 0 - Week 12)||0
8824904|NCT01597245|9879070|FG015|STARTED|Induction Period (Week 0 - Week 12)||0
8824905|NCT01597245|9879071|FG016|STARTED|Induction Period (Week 0 - Week 12)||0
8824906|NCT01597245|9879072|FG017|STARTED|Induction Period (Week 0 - Week 12)||0
8824907|NCT01597245|9879073|FG018|STARTED|Induction Period (Week 0 - Week 12)||0
8824908|NCT01597245|9879074|FG019|STARTED|Induction Period (Week 0 - Week 12)||0
8824909|NCT01597245|9879075|FG020|STARTED|Induction Period (Week 0 - Week 12)||0
8824910|NCT01597245|9879055|FG000|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||167
8824911|NCT01597245|9879056|FG001|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||357
8824912|NCT01597245|9879057|FG002|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||347
8824913|NCT01597245|9879058|FG003|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||350
8824914|NCT01597245|9879059|FG004|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
8824915|NCT01597245|9879060|FG005|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
8824916|NCT01597245|9879061|FG006|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
8824917|NCT01597245|9879062|FG007|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
8824918|NCT01597245|9879063|FG008|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
8824919|NCT01597245|9879064|FG009|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
8824920|NCT01597245|9879065|FG010|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
8824921|NCT01597245|9879066|FG011|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
8824922|NCT01597245|9879067|FG012|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
8824923|NCT01597245|9879068|FG013|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
8824924|NCT01597245|9879069|FG014|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
8824925|NCT01597245|9879070|FG015|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
8824926|NCT01597245|9879071|FG016|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
8824927|NCT01597245|9879072|FG017|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
8824928|NCT01597245|9879073|FG018|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
8824929|NCT01597245|9879074|FG019|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
8824930|NCT01597245|9879075|FG020|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
8824931|NCT01597245|9879055|FG000|COMPLETED|Induction Period (Week 0 - Week 12)||158
8824932|NCT01597245|9879056|FG001|COMPLETED|Induction Period (Week 0 - Week 12)|1 participant randomized to maintenance period but did not receive a dose in the maintenance period.|333
8824933|NCT01597245|9879057|FG002|COMPLETED|Induction Period (Week 0 - Week 12)||328
8824934|NCT01597245|9879058|FG003|COMPLETED|Induction Period (Week 0 - Week 12)|2 participants discontinued after IND completion and prior to randomizing into maintenance period.|342
8824935|NCT01597245|9879059|FG004|COMPLETED|Induction Period (Week 0 - Week 12)||0
8824936|NCT01597245|9879060|FG005|COMPLETED|Induction Period (Week 0 - Week 12)||0
8824937|NCT01597245|9879061|FG006|COMPLETED|Induction Period (Week 0 - Week 12)||0
8824938|NCT01597245|9879062|FG007|COMPLETED|Induction Period (Week 0 - Week 12)||0
8824939|NCT01597245|9879063|FG008|COMPLETED|Induction Period (Week 0 - Week 12)||0
8824940|NCT01597245|9879064|FG009|COMPLETED|Induction Period (Week 0 - Week 12)||0
8824941|NCT01597245|9879065|FG010|COMPLETED|Induction Period (Week 0 - Week 12)||0
8824942|NCT01597245|9879066|FG011|COMPLETED|Induction Period (Week 0 - Week 12)||0
8824943|NCT01597245|9879067|FG012|COMPLETED|Induction Period (Week 0 - Week 12)||0
8824944|NCT01597245|9879068|FG013|COMPLETED|Induction Period (Week 0 - Week 12)||0
8824945|NCT01597245|9879069|FG014|COMPLETED|Induction Period (Week 0 - Week 12)||0
8824946|NCT01597245|9879070|FG015|COMPLETED|Induction Period (Week 0 - Week 12)||0
8824947|NCT01597245|9879071|FG016|COMPLETED|Induction Period (Week 0 - Week 12)||0
8824948|NCT01597245|9879072|FG017|COMPLETED|Induction Period (Week 0 - Week 12)||0
8824949|NCT01597245|9879073|FG018|COMPLETED|Induction Period (Week 0 - Week 12)||0
8824950|NCT01597245|9879074|FG019|COMPLETED|Induction Period (Week 0 - Week 12)||0
8824951|NCT01597245|9879075|FG020|COMPLETED|Induction Period (Week 0 - Week 12)||0
8824952|NCT01597245|9879055|FG000|NOT COMPLETED|Induction Period (Week 0 - Week 12)||10
8824953|NCT01597245|9879056|FG001|NOT COMPLETED|Induction Period (Week 0 - Week 12)||25
8824954|NCT01597245|9879057|FG002|NOT COMPLETED|Induction Period (Week 0 - Week 12)||19
8824955|NCT01597245|9879058|FG003|NOT COMPLETED|Induction Period (Week 0 - Week 12)||9
8824956|NCT01597245|9879059|FG004|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
8824957|NCT01597245|9879060|FG005|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
8824958|NCT01597245|9879061|FG006|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
8824959|NCT01597245|9879062|FG007|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
8824960|NCT01597245|9879063|FG008|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
8824961|NCT01597245|9879064|FG009|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
8824962|NCT01597245|9879065|FG010|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
8824963|NCT01597245|9879066|FG011|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
8824964|NCT01597245|9879067|FG012|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
8824965|NCT01597245|9879068|FG013|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
8824966|NCT01597245|9879069|FG014|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
8824967|NCT01597245|9879070|FG015|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
8824968|NCT01597245|9879071|FG016|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
8824969|NCT01597245|9879072|FG017|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
8824970|NCT01597245|9879073|FG018|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
8824971|NCT01597245|9879074|FG019|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
8824972|NCT01597245|9879075|FG020|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
8824973|NCT01597245|9879055|FG000|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|0
8824974|NCT01597245|9879056|FG001|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|0
8824975|NCT01597245|9879057|FG002|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|0
8824976|NCT01597245|9879058|FG003|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|0
8824977|NCT01597245|9879059|FG004|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|176
8824978|NCT01597245|9879060|FG005|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|187
8824979|NCT01597245|9879061|FG006|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|181
8824980|NCT01597245|9879062|FG007|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|3
8824981|NCT01597245|9879063|FG008|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|155
8824982|NCT01597245|9879064|FG009|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|132
8824983|NCT01597245|9879065|FG010|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|200
8824984|NCT01597245|9879066|FG011|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|75
8824985|NCT01597245|9879067|FG012|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|49
8824986|NCT01597245|9879068|FG013|STARTED|Maintenance Period (Week 12 to Week 60)||0
8824987|NCT01597245|9879069|FG014|STARTED|Maintenance Period (Week 12 to Week 60)||0
8824988|NCT01597245|9879070|FG015|STARTED|Maintenance Period (Week 12 to Week 60)||0
8824989|NCT01597245|9879071|FG016|STARTED|Maintenance Period (Week 12 to Week 60)||0
8824990|NCT01597245|9879072|FG017|STARTED|Maintenance Period (Week 12 to Week 60)||0
8824991|NCT01597245|9879073|FG018|STARTED|Maintenance Period (Week 12 to Week 60)||0
8824992|NCT01597245|9879074|FG019|STARTED|Maintenance Period (Week 12 to Week 60)||0
8824993|NCT01597245|9879075|FG020|STARTED|Maintenance Period (Week 12 to Week 60)||0
8824994|NCT01597245|9879055|FG000|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
8824995|NCT01597245|9879056|FG001|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
8824996|NCT01597245|9879057|FG002|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
8824997|NCT01597245|9879058|FG003|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
8824998|NCT01597245|9879059|FG004|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||176
8824999|NCT01597245|9879060|FG005|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||187
8825000|NCT01597245|9879061|FG006|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||181
8825001|NCT01597245|9879062|FG007|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||3
8825002|NCT01597245|9879063|FG008|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||155
8825003|NCT01597245|9879064|FG009|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||132
8825004|NCT01597245|9879065|FG010|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||200
8825005|NCT01597245|9879066|FG011|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||75
8825006|NCT01597245|9879067|FG012|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||49
8825007|NCT01597245|9879068|FG013|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
8825008|NCT01597245|9879069|FG014|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
8825009|NCT01597245|9879070|FG015|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
8825010|NCT01597245|9879071|FG016|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
8825011|NCT01597245|9879072|FG017|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
8825012|NCT01597245|9879073|FG018|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
8825013|NCT01597245|9879074|FG019|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
8825014|NCT01597245|9879075|FG020|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
8825015|NCT01597245|9879055|FG000|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8825016|NCT01597245|9879056|FG001|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8825017|NCT01597245|9879057|FG002|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8825018|NCT01597245|9879058|FG003|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8825019|NCT01597245|9879059|FG004|COMPLETED|Maintenance Period (Week 12 to Week 60)||15
8825020|NCT01597245|9879060|FG005|COMPLETED|Maintenance Period (Week 12 to Week 60)||149
8825021|NCT01597245|9879061|FG006|COMPLETED|Maintenance Period (Week 12 to Week 60)||92
8825022|NCT01597245|9879062|FG007|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8825023|NCT01597245|9879063|FG008|COMPLETED|Maintenance Period (Week 12 to Week 60)||135
8825024|NCT01597245|9879064|FG009|COMPLETED|Maintenance Period (Week 12 to Week 60)||11
8825025|NCT01597245|9879065|FG010|COMPLETED|Maintenance Period (Week 12 to Week 60)||178
8825026|NCT01597245|9879066|FG011|COMPLETED|Maintenance Period (Week 12 to Week 60)||56
8825027|NCT01597245|9879067|FG012|COMPLETED|Maintenance Period (Week 12 to Week 60)||37
8825028|NCT01597245|9879068|FG013|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8825029|NCT01597245|9879069|FG014|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8825030|NCT01597245|9879070|FG015|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8825031|NCT01597245|9879071|FG016|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8825032|NCT01597245|9879072|FG017|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8825033|NCT01597245|9879073|FG018|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8825034|NCT01597245|9879074|FG019|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8825035|NCT01597245|9879075|FG020|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8825036|NCT01597245|9879055|FG000|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8825037|NCT01597245|9879056|FG001|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8825038|NCT01597245|9879057|FG002|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8825039|NCT01597245|9879058|FG003|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8825040|NCT01597245|9879059|FG004|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||161
8825041|NCT01597245|9879060|FG005|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||38
8825042|NCT01597245|9879061|FG006|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||89
8825043|NCT01597245|9879062|FG007|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||3
8825044|NCT01597245|9879063|FG008|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||20
8825045|NCT01597245|9879064|FG009|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||121
8825046|NCT01597245|9879065|FG010|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||22
8825047|NCT01597245|9879066|FG011|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||19
8825048|NCT01597245|9879067|FG012|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||12
8825049|NCT01597245|9879068|FG013|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8825050|NCT01597245|9879069|FG014|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8825051|NCT01597245|9879070|FG015|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8825052|NCT01597245|9879071|FG016|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8825053|NCT01597245|9879072|FG017|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8825054|NCT01597245|9879073|FG018|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8825055|NCT01597245|9879074|FG019|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8825056|NCT01597245|9879075|FG020|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8825057|NCT01597245|9879055|FG000|STARTED|Long Term Extension (Week 60 - Week 264)||0
8825058|NCT01597245|9879056|FG001|STARTED|Long Term Extension (Week 60 - Week 264)||0
8825059|NCT01597245|9879057|FG002|STARTED|Long Term Extension (Week 60 - Week 264)||0
8825060|NCT01597245|9879058|FG003|STARTED|Long Term Extension (Week 60 - Week 264)||0
8825061|NCT01597245|9879059|FG004|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
8825062|NCT01597245|9879060|FG005|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
8825063|NCT01597245|9879061|FG006|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
8825064|NCT01597245|9879062|FG007|STARTED|Long Term Extension (Week 60 - Week 264)||0
8825065|NCT01597245|9879063|FG008|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
8825066|NCT01597245|9879064|FG009|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
8825067|NCT01597245|9879065|FG010|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
8825068|NCT01597245|9879066|FG011|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
8825069|NCT01597245|9879067|FG012|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
8825070|NCT01597245|9879068|FG013|STARTED|Long Term Extension (Week 60 - Week 264)|Participants who received placebo at the start of the long-term extension period.|26
8825071|NCT01597245|9879069|FG014|STARTED|Long Term Extension (Week 60 - Week 264)|Participants received ixe at the start of the long-term extension.|979
8825072|NCT01597245|9879070|FG015|STARTED|Long Term Extension (Week 60 - Week 264)|Participants received ixe in all dosing regimens, including participants who switched PBO to ixe.|1002
8825073|NCT01597245|9879071|FG016|STARTED|Long Term Extension (Week 60 - Week 264)||0
8825074|NCT01597245|9879072|FG017|STARTED|Long Term Extension (Week 60 - Week 264)||0
8825075|NCT01597245|9879073|FG018|STARTED|Long Term Extension (Week 60 - Week 264)||0
8825076|NCT01597245|9879074|FG019|STARTED|Long Term Extension (Week 60 - Week 264)||0
8825077|NCT01597245|9879075|FG020|STARTED|Long Term Extension (Week 60 - Week 264)||0
8825078|NCT01597245|9879055|FG000|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8825079|NCT01597245|9879056|FG001|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8825080|NCT01597245|9879057|FG002|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8825081|NCT01597245|9879058|FG003|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8825082|NCT01597245|9879059|FG004|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8825083|NCT01597245|9879060|FG005|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8825084|NCT01597245|9879061|FG006|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8825085|NCT01597245|9879062|FG007|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8825086|NCT01597245|9879063|FG008|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8825087|NCT01597245|9879064|FG009|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8825088|NCT01597245|9879065|FG010|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8825089|NCT01597245|9879066|FG011|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8825090|NCT01597245|9879067|FG012|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8825091|NCT01597245|9879068|FG013|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8825092|NCT01597245|9879069|FG014|COMPLETED|Long Term Extension (Week 60 - Week 264)||754
8825093|NCT01597245|9879070|FG015|COMPLETED|Long Term Extension (Week 60 - Week 264)||774
8825094|NCT01597245|9879071|FG016|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8825095|NCT01597245|9879072|FG017|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8825096|NCT01597245|9879073|FG018|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8825097|NCT01597245|9879074|FG019|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8825098|NCT01597245|9879075|FG020|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8825099|NCT01597245|9879055|FG000|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8825100|NCT01597245|9879056|FG001|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8825101|NCT01597245|9879057|FG002|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8825102|NCT01597245|9879058|FG003|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8825103|NCT01597245|9879059|FG004|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8825104|NCT01597245|9879060|FG005|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8825105|NCT01597245|9879061|FG006|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8825106|NCT01597245|9879062|FG007|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8825107|NCT01597245|9879063|FG008|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8825108|NCT01597245|9879064|FG009|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8825109|NCT01597245|9879065|FG010|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8825110|NCT01597245|9879066|FG011|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8825111|NCT01597245|9879067|FG012|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8825112|NCT01597245|9879068|FG013|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||26
8825113|NCT01597245|9879069|FG014|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||225
8825114|NCT01597245|9879070|FG015|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||228
8825115|NCT01597245|9879071|FG016|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8825116|NCT01597245|9879072|FG017|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8825117|NCT01597245|9879073|FG018|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8825118|NCT01597245|9879074|FG019|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8825119|NCT01597245|9879075|FG020|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8825120|NCT01597245|9879055|FG000|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8825121|NCT01597245|9879056|FG001|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8825122|NCT01597245|9879057|FG002|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8825123|NCT01597245|9879058|FG003|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8825124|NCT01597245|9879059|FG004|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8825125|NCT01597245|9879060|FG005|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8825126|NCT01597245|9879061|FG006|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8825127|NCT01597245|9879062|FG007|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8825128|NCT01597245|9879063|FG008|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8825129|NCT01597245|9879064|FG009|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8825130|NCT01597245|9879065|FG010|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8825131|NCT01597245|9879066|FG011|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8825132|NCT01597245|9879067|FG012|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8825133|NCT01597245|9879068|FG013|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8825134|NCT01597245|9879069|FG014|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0
8825135|NCT01597245|9879070|FG015|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0
8825136|NCT01597245|9879071|FG016|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|16
8825137|NCT01597245|9879072|FG017|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|6
8825138|NCT01597245|9879073|FG018|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|24
8825139|NCT01597245|9879074|FG019|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|656
8849606|NCT01742078|9904832|FG000|NOT COMPLETED|Overall Study||0
8825140|NCT01597245|9879075|FG020|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|248
8825141|NCT01597245|9879055|FG000|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8825142|NCT01597245|9879056|FG001|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8825143|NCT01597245|9879057|FG002|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8825144|NCT01597245|9879058|FG003|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8825145|NCT01597245|9879059|FG004|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8825146|NCT01597245|9879060|FG005|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8825147|NCT01597245|9879061|FG006|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8825148|NCT01597245|9879062|FG007|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8825149|NCT01597245|9879063|FG008|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8825150|NCT01597245|9879064|FG009|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8825151|NCT01597245|9879065|FG010|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8825152|NCT01597245|9879066|FG011|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8825153|NCT01597245|9879067|FG012|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8825154|NCT01597245|9879068|FG013|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8825155|NCT01597245|9879069|FG014|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8825156|NCT01597245|9879070|FG015|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8825157|NCT01597245|9879071|FG016|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8825158|NCT01597245|9879072|FG017|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8825159|NCT01597245|9879073|FG018|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||14
8825160|NCT01597245|9879074|FG019|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||489
8825161|NCT01597245|9879075|FG020|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||212
8825162|NCT01597245|9879055|FG000|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8825163|NCT01597245|9879056|FG001|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8825164|NCT01597245|9879057|FG002|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8825165|NCT01597245|9879058|FG003|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8825166|NCT01597245|9879059|FG004|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8825167|NCT01597245|9879060|FG005|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8825168|NCT01597245|9879061|FG006|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8825169|NCT01597245|9879062|FG007|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8825170|NCT01597245|9879063|FG008|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8825171|NCT01597245|9879064|FG009|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8825172|NCT01597245|9879065|FG010|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8825173|NCT01597245|9879066|FG011|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8825174|NCT01597245|9879067|FG012|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8825175|NCT01597245|9879068|FG013|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8825176|NCT01597245|9879069|FG014|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8825177|NCT01597245|9879070|FG015|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8825178|NCT01597245|9879071|FG016|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||16
8825179|NCT01597245|9879072|FG017|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||6
8825180|NCT01597245|9879073|FG018|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||10
8825181|NCT01597245|9879074|FG019|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||167
8825182|NCT01597245|9879075|FG020|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||36
8825183|NCT01597258|9879108|FG000|STARTED|Overall Study||2029
8825184|NCT01597258|9879108|FG000|COMPLETED|Overall Study||2028
8825185|NCT01597258|9879108|FG000|NOT COMPLETED|Overall Study||1
8825186|NCT01597375|9879112|FG000|STARTED|First Intervention (4 Weeks)||23
8825187|NCT01597375|9879113|FG001|STARTED|First Intervention (4 Weeks)||23
8825188|NCT01597375|9879112|FG000|COMPLETED|First Intervention (4 Weeks)||21
8825189|NCT01597375|9879113|FG001|COMPLETED|First Intervention (4 Weeks)||22
8825190|NCT01597375|9879112|FG000|NOT COMPLETED|First Intervention (4 Weeks)||2
8825191|NCT01597375|9879113|FG001|NOT COMPLETED|First Intervention (4 Weeks)||1
8825192|NCT01597375|9879112|FG000|STARTED|Washout (2 Weeks)||21
8825193|NCT01597375|9879113|FG001|STARTED|Washout (2 Weeks)||22
8825194|NCT01597375|9879112|FG000|COMPLETED|Washout (2 Weeks)||20
8825195|NCT01597375|9879113|FG001|COMPLETED|Washout (2 Weeks)||22
8825196|NCT01597375|9879112|FG000|NOT COMPLETED|Washout (2 Weeks)||1
8825197|NCT01597375|9879113|FG001|NOT COMPLETED|Washout (2 Weeks)||0
8825198|NCT01597375|9879112|FG000|STARTED|Second Intervention||20
8825199|NCT01597375|9879113|FG001|STARTED|Second Intervention||22
8825200|NCT01597375|9879112|FG000|COMPLETED|Second Intervention||19
8723261|NCT01021852|9770688|FG005|COMPLETED|Treatment Period 2||37
8723262|NCT01021852|9770689|FG006|COMPLETED|Treatment Period 2||37
8723263|NCT01021852|9770690|FG007|COMPLETED|Treatment Period 2||38
8723264|NCT01021852|9770683|FG000|NOT COMPLETED|Treatment Period 2||0
8723265|NCT01021852|9770684|FG001|NOT COMPLETED|Treatment Period 2||1
8723266|NCT01021852|9770685|FG002|NOT COMPLETED|Treatment Period 2||1
8723267|NCT01021852|9770686|FG003|NOT COMPLETED|Treatment Period 2||0
8723268|NCT01021852|9770687|FG004|NOT COMPLETED|Treatment Period 2||2
8723269|NCT01021852|9770688|FG005|NOT COMPLETED|Treatment Period 2||1
8723270|NCT01021852|9770689|FG006|NOT COMPLETED|Treatment Period 2||3
8723271|NCT01021852|9770690|FG007|NOT COMPLETED|Treatment Period 2||2
8723272|NCT01021878|9770706|FG000|STARTED|Overall Study||33
8723273|NCT01021878|9770707|FG001|STARTED|Overall Study||27
8825201|NCT01597375|9879113|FG001|COMPLETED|Second Intervention||21
8723274|NCT01021878|9770706|FG000|Completed Follow-up|Overall Study||17
8723275|NCT01021878|9770707|FG001|Completed Follow-up|Overall Study||17
8723276|NCT01021878|9770706|FG000|COMPLETED|Overall Study||17
8723277|NCT01021878|9770707|FG001|COMPLETED|Overall Study||17
8723278|NCT01021878|9770706|FG000|NOT COMPLETED|Overall Study||16
8723279|NCT01021878|9770707|FG001|NOT COMPLETED|Overall Study||10
8723280|NCT01021956|9770720|FG000|STARTED|Overall Study||3
8723281|NCT01021956|9770721|FG001|STARTED|Overall Study||3
8723282|NCT01021956|9770722|FG002|STARTED|Overall Study||3
8723283|NCT01021956|9770723|FG003|STARTED|Overall Study||1
8723284|NCT01021956|9770720|FG000|COMPLETED|Overall Study||3
8723285|NCT01021956|9770721|FG001|COMPLETED|Overall Study||3
8723286|NCT01021956|9770722|FG002|COMPLETED|Overall Study||3
8723287|NCT01021956|9770723|FG003|COMPLETED|Overall Study||1
8723288|NCT01021956|9770720|FG000|NOT COMPLETED|Overall Study||0
8825202|NCT01597375|9879112|FG000|NOT COMPLETED|Second Intervention||1
8825203|NCT01597375|9879113|FG001|NOT COMPLETED|Second Intervention||1
8825204|NCT01597440|9879122|FG000|STARTED|Overall Study||1
8825205|NCT01597440|9879123|FG001|STARTED|Overall Study||0
8825206|NCT01597440|9879122|FG000|COMPLETED|Overall Study||1
8825207|NCT01597440|9879123|FG001|COMPLETED|Overall Study||0
8825208|NCT01597440|9879122|FG000|NOT COMPLETED|Overall Study||0
8825209|NCT01597440|9879123|FG001|NOT COMPLETED|Overall Study||0
8943917|NCT02392234|10005687|FG005|COMPLETED|Treatment Period 2 (8 Weeks)||38
8943918|NCT02392234|10005682|FG000|NOT COMPLETED|Treatment Period 2 (8 Weeks)||1
8943919|NCT02392234|10005683|FG001|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
8943920|NCT02392234|10005684|FG002|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
8943921|NCT02392234|10005685|FG003|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
8943922|NCT02392234|10005686|FG004|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
8943923|NCT02392234|10005687|FG005|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
8943924|NCT02392247|10005698|FG000|STARTED|Overall Study||52
8943925|NCT02392247|10005698|FG000|COMPLETED|Overall Study||50
8943926|NCT02392247|10005698|FG000|NOT COMPLETED|Overall Study||2
8943927|NCT02392286|10005704|FG000|STARTED|Overall Study||7
8943928|NCT02392286|10005705|FG001|STARTED|Overall Study||8
8943929|NCT02392286|10005704|FG000|COMPLETED|Overall Study||4
8943930|NCT02392286|10005705|FG001|COMPLETED|Overall Study||6
8943931|NCT02392286|10005704|FG000|NOT COMPLETED|Overall Study||3
8943932|NCT02392286|10005705|FG001|NOT COMPLETED|Overall Study||2
8943933|NCT02392351|10005713|FG000|STARTED|Overall Study||34
8943934|NCT02392351|10005714|FG001|STARTED|Overall Study||17
8943935|NCT02392351|10005713|FG000|COMPLETED|Overall Study|Primary endpoint: only observational results available.|0
8943936|NCT02392351|10005714|FG001|COMPLETED|Overall Study|Primary endpoint: only observational results available.|0
8943937|NCT02392351|10005713|FG000|NOT COMPLETED|Overall Study||34
8943938|NCT02392351|10005714|FG001|NOT COMPLETED|Overall Study||17
8943939|NCT02392403|10005720|FG000|STARTED|Overall Study||45
8943940|NCT02392403|10005720|FG000|COMPLETED|Overall Study||42
8943941|NCT02392403|10005720|FG000|NOT COMPLETED|Overall Study||3
8943942|NCT02392481|10005728|FG000|STARTED|Overall Study||10
8943943|NCT02392481|10005729|FG001|STARTED|Overall Study||12
8943944|NCT02392481|10005730|FG002|STARTED|Overall Study||20
8943945|NCT02392481|10005731|FG003|STARTED|Overall Study||27
8943946|NCT02392481|10005728|FG000|COMPLETED|Overall Study||10
8943947|NCT02392481|10005729|FG001|COMPLETED|Overall Study||12
8943948|NCT02392481|10005730|FG002|COMPLETED|Overall Study||18
8943949|NCT02392481|10005731|FG003|COMPLETED|Overall Study||25
8943950|NCT02392481|10005728|FG000|NOT COMPLETED|Overall Study||0
8943951|NCT02392481|10005729|FG001|NOT COMPLETED|Overall Study||0
8943952|NCT02392481|10005730|FG002|NOT COMPLETED|Overall Study||2
8943953|NCT02392481|10005731|FG003|NOT COMPLETED|Overall Study||2
8943954|NCT02392494|10005744|FG000|STARTED|Overall Study||3
8943955|NCT02392494|10005745|FG001|STARTED|Overall Study||3
8943956|NCT02392494|10005746|FG002|STARTED|Overall Study||3
8943957|NCT02392494|10005747|FG003|STARTED|Overall Study||0
8943958|NCT02392494|10005744|FG000|COMPLETED|Overall Study||3
8943959|NCT02392494|10005745|FG001|COMPLETED|Overall Study||3
8943960|NCT02392494|10005746|FG002|COMPLETED|Overall Study||3
8943961|NCT02392494|10005747|FG003|COMPLETED|Overall Study||0
8943962|NCT02392494|10005744|FG000|NOT COMPLETED|Overall Study||0
8943963|NCT02392494|10005745|FG001|NOT COMPLETED|Overall Study||0
8943964|NCT02392494|10005746|FG002|NOT COMPLETED|Overall Study||0
8943965|NCT02392494|10005747|FG003|NOT COMPLETED|Overall Study||0
8943966|NCT02392507|10005755|FG000|STARTED|Induction Regimen||54
8943967|NCT02392507|10005755|FG000|Received at Least 1 Dose of Study Drug|Induction Regimen||54
8943968|NCT02392507|10005755|FG000|COMPLETED|Induction Regimen||47
8943969|NCT02392507|10005755|FG000|NOT COMPLETED|Induction Regimen||7
8943970|NCT02392507|10005755|FG000|STARTED|Maintenance Regimen|After induction regimen participants with disease response are eligible for maintenance regimen.|34
8943971|NCT02392507|10005755|FG000|COMPLETED|Maintenance Regimen||32
8943972|NCT02392507|10005755|FG000|NOT COMPLETED|Maintenance Regimen||2
8943973|NCT02392559|10005766|FG000|STARTED|Overall Study||53
8943974|NCT02392559|10005767|FG001|STARTED|Overall Study||105
8943975|NCT02392559|10005766|FG000|Randomized and Dosed|Overall Study||53
8943976|NCT02392559|10005767|FG001|Randomized and Dosed|Overall Study||104
8943977|NCT02392559|10005766|FG000|COMPLETED|Overall Study||53
8723289|NCT01021956|9770721|FG001|NOT COMPLETED|Overall Study||0
8723290|NCT01021956|9770722|FG002|NOT COMPLETED|Overall Study||0
8723291|NCT01021956|9770723|FG003|NOT COMPLETED|Overall Study||0
8723292|NCT01022073|9770736|FG000|STARTED|Overall Study||86
8825210|NCT01597479|9879133|FG000|STARTED|Overall Study||26
8825211|NCT01597479|9879134|FG001|STARTED|Overall Study||26
8825212|NCT01597479|9879133|FG000|COMPLETED|Overall Study||24
8825213|NCT01597479|9879134|FG001|COMPLETED|Overall Study||26
8825214|NCT01597479|9879133|FG000|NOT COMPLETED|Overall Study||2
8825215|NCT01597479|9879134|FG001|NOT COMPLETED|Overall Study||0
8825216|NCT01597492|9879143|FG000|STARTED|Overall Study||34
8825217|NCT01597492|9879144|FG001|STARTED|Overall Study||45
8825218|NCT01597492|9879143|FG000|COMPLETED|Overall Study||28
8825219|NCT01597492|9879144|FG001|COMPLETED|Overall Study||41
8825220|NCT01597492|9879143|FG000|NOT COMPLETED|Overall Study||6
8825221|NCT01597492|9879144|FG001|NOT COMPLETED|Overall Study||4
8825222|NCT01597505|9879152|FG000|STARTED|Overall Study|Randomized participants|308
8825223|NCT01597505|9879153|FG001|STARTED|Overall Study|Randomized participants|298
8825224|NCT01597505|9879152|FG000|Treated|Overall Study|One participant was instead randomized to vancomycin|305
8825225|NCT01597505|9879153|FG001|Treated|Overall Study||286
8825226|NCT01597505|9879152|FG000|COMPLETED|Overall Study||264
8825227|NCT01597505|9879153|FG001|COMPLETED|Overall Study||265
8825228|NCT01597505|9879152|FG000|NOT COMPLETED|Overall Study||44
8825229|NCT01597505|9879153|FG001|NOT COMPLETED|Overall Study||33
8825230|NCT01597557|9879162|FG000|STARTED|Overall Study||132
8825231|NCT01597557|9879163|FG001|STARTED|Overall Study||129
8825232|NCT01597557|9879162|FG000|COMPLETED|Overall Study||128
8825233|NCT01597557|9879163|FG001|COMPLETED|Overall Study||126
8825234|NCT01597557|9879162|FG000|NOT COMPLETED|Overall Study||4
8825235|NCT01597557|9879163|FG001|NOT COMPLETED|Overall Study||3
8825236|NCT01597596|9879171|FG000|STARTED|Overall Study||1
8825237|NCT01597596|9879172|FG001|STARTED|Overall Study||3
8825238|NCT01597596|9879171|FG000|COMPLETED|Overall Study||0
8825239|NCT01597596|9879172|FG001|COMPLETED|Overall Study||2
8825240|NCT01597596|9879171|FG000|NOT COMPLETED|Overall Study||1
8825241|NCT01597596|9879172|FG001|NOT COMPLETED|Overall Study||1
8825242|NCT01597622|9879178|FG000|STARTED|Overall Study||142
8825243|NCT01597622|9879178|FG000|COMPLETED|Overall Study||104
8825244|NCT01597622|9879178|FG000|NOT COMPLETED|Overall Study||38
8825245|NCT01597635|9879185|FG000|STARTED|Part A||5
8825246|NCT01597635|9879186|FG001|STARTED|Part A||0
8825247|NCT01597635|9879187|FG002|STARTED|Part A||0
8825248|NCT01597635|9879185|FG000|COMPLETED|Part A||2
8825249|NCT01597635|9879186|FG001|COMPLETED|Part A||0
8825250|NCT01597635|9879187|FG002|COMPLETED|Part A||0
8825251|NCT01597635|9879185|FG000|NOT COMPLETED|Part A||3
8825252|NCT01597635|9879186|FG001|NOT COMPLETED|Part A||0
8825253|NCT01597635|9879187|FG002|NOT COMPLETED|Part A||0
8825254|NCT01597635|9879185|FG000|STARTED|Part B||0
8825255|NCT01597635|9879186|FG001|STARTED|Part B||20
8825256|NCT01597635|9879187|FG002|STARTED|Part B||19
8825257|NCT01597635|9879185|FG000|COMPLETED|Part B||0
8825258|NCT01597635|9879186|FG001|COMPLETED|Part B||14
8825259|NCT01597635|9879187|FG002|COMPLETED|Part B||15
8622175|NCT00486720|9661373|FG001|NOT COMPLETED|Overall Study||12
8622176|NCT00486759|9661381|FG000|STARTED|Treatment||390
8622177|NCT00486759|9661382|FG001|STARTED|Treatment||397
8622178|NCT00486759|9661381|FG000|COMPLETED|Treatment||203
8622179|NCT00486759|9661382|FG001|COMPLETED|Treatment||260
8622180|NCT00486759|9661381|FG000|NOT COMPLETED|Treatment||187
8825260|NCT01597635|9879185|FG000|NOT COMPLETED|Part B||0
8825261|NCT01597635|9879186|FG001|NOT COMPLETED|Part B||6
8825262|NCT01597635|9879187|FG002|NOT COMPLETED|Part B||4
8825263|NCT01597687|9879199|FG000|STARTED|Overall Study||76
8825264|NCT01597687|9879200|FG001|STARTED|Overall Study||89
8825265|NCT01597687|9879201|FG002|STARTED|Overall Study||147
8825266|NCT01597687|9879199|FG000|COMPLETED|Overall Study||76
8825267|NCT01597687|9879200|FG001|COMPLETED|Overall Study||89
8825268|NCT01597687|9879201|FG002|COMPLETED|Overall Study||147
8825269|NCT01597687|9879199|FG000|NOT COMPLETED|Overall Study||0
8825270|NCT01597687|9879200|FG001|NOT COMPLETED|Overall Study||0
8825271|NCT01597687|9879201|FG002|NOT COMPLETED|Overall Study||0
8825272|NCT01597791|9879227|FG000|STARTED|Overall Study||28
8825273|NCT01597791|9879228|FG001|STARTED|Overall Study||28
8825274|NCT01597791|9879227|FG000|COMPLETED|Overall Study||20
8825275|NCT01597791|9879228|FG001|COMPLETED|Overall Study||18
8825276|NCT01597791|9879227|FG000|NOT COMPLETED|Overall Study||8
8825277|NCT01597791|9879228|FG001|NOT COMPLETED|Overall Study||10
8825278|NCT01597843|9879237|FG000|STARTED|Overall Study||79
8825279|NCT01597843|9879238|FG001|STARTED|Overall Study||122
8825280|NCT01597843|9879239|FG002|STARTED|Overall Study||81
8825281|NCT01597843|9879237|FG000|Survey 1 Responses|Overall Study||45
8825282|NCT01597843|9879238|FG001|Survey 1 Responses|Overall Study||71
8825283|NCT01597843|9879239|FG002|Survey 1 Responses|Overall Study||59
8825284|NCT01597843|9879237|FG000|Survey 2 Responses|Overall Study||52
8825285|NCT01597843|9879238|FG001|Survey 2 Responses|Overall Study||42
8825286|NCT01597843|9879239|FG002|Survey 2 Responses|Overall Study||58
8825287|NCT01597843|9879237|FG000|Survey 3 Responses|Overall Study||65
8825288|NCT01597843|9879238|FG001|Survey 3 Responses|Overall Study||56
8825289|NCT01597843|9879239|FG002|Survey 3 Responses|Overall Study||76
8622181|NCT00486759|9661382|FG001|NOT COMPLETED|Treatment||137
8622182|NCT00486759|9661381|FG000|STARTED|Safety Follow-up||203
8825290|NCT01597843|9879237|FG000|COMPLETED|Overall Study||79
8825291|NCT01597843|9879238|FG001|COMPLETED|Overall Study||122
8825292|NCT01597843|9879239|FG002|COMPLETED|Overall Study||81
8825293|NCT01597843|9879237|FG000|NOT COMPLETED|Overall Study||0
8825294|NCT01597843|9879238|FG001|NOT COMPLETED|Overall Study||0
8825295|NCT01597843|9879239|FG002|NOT COMPLETED|Overall Study||0
8825296|NCT01597856|9879250|FG000|STARTED|Overall Study||85
8825297|NCT01597856|9879251|FG001|STARTED|Overall Study||87
8825298|NCT01597856|9879252|FG002|STARTED|Overall Study||174
8825299|NCT01597856|9879250|FG000|Week 4 Follow-up|Overall Study||62
8825300|NCT01597856|9879251|FG001|Week 4 Follow-up|Overall Study||67
8825301|NCT01597856|9879252|FG002|Week 4 Follow-up|Overall Study||129
8825302|NCT01597856|9879250|FG000|COMPLETED|Overall Study||63
8825303|NCT01597856|9879251|FG001|COMPLETED|Overall Study||61
8825304|NCT01597856|9879252|FG002|COMPLETED|Overall Study||120
8825305|NCT01597856|9879250|FG000|NOT COMPLETED|Overall Study||22
8825306|NCT01597856|9879251|FG001|NOT COMPLETED|Overall Study||26
8825307|NCT01597856|9879252|FG002|NOT COMPLETED|Overall Study||54
8825308|NCT01597908|9879263|FG000|STARTED|Randomized Phase||352
8825309|NCT01597908|9879264|FG001|STARTED|Randomized Phase||352
8825310|NCT01597908|9879265|FG002|STARTED|Randomized Phase||0
8825311|NCT01597908|9879263|FG000|Safety Set|Randomized Phase||350
8825312|NCT01597908|9879264|FG001|Safety Set|Randomized Phase||349
8825313|NCT01597908|9879265|FG002|Safety Set|Randomized Phase||0
8825314|NCT01597908|9879263|FG000|COMPLETED|Randomized Phase||1
8825315|NCT01597908|9879264|FG001|COMPLETED|Randomized Phase||0
8825316|NCT01597908|9879265|FG002|COMPLETED|Randomized Phase||0
8825317|NCT01597908|9879263|FG000|NOT COMPLETED|Randomized Phase||351
8825318|NCT01597908|9879264|FG001|NOT COMPLETED|Randomized Phase||352
8825319|NCT01597908|9879265|FG002|NOT COMPLETED|Randomized Phase||0
8825320|NCT01597908|9879263|FG000|STARTED|Crossover Phase||0
8825321|NCT01597908|9879264|FG001|STARTED|Crossover Phase||0
8825322|NCT01597908|9879265|FG002|STARTED|Crossover Phase||34
8825323|NCT01597908|9879263|FG000|COMPLETED|Crossover Phase||0
8825324|NCT01597908|9879264|FG001|COMPLETED|Crossover Phase||0
8825325|NCT01597908|9879265|FG002|COMPLETED|Crossover Phase||0
8825326|NCT01597908|9879263|FG000|NOT COMPLETED|Crossover Phase||0
8825327|NCT01597908|9879264|FG001|NOT COMPLETED|Crossover Phase||0
8825328|NCT01597908|9879265|FG002|NOT COMPLETED|Crossover Phase||34
8825329|NCT01597973|9879276|FG000|STARTED|Overall Study||234
8825330|NCT01597973|9879277|FG001|STARTED|Overall Study||230
8825331|NCT01597973|9879276|FG000|Began First Dose|Overall Study||230
8825332|NCT01597973|9879277|FG001|Began First Dose|Overall Study||228
8825333|NCT01597973|9879276|FG000|COMPLETED|Overall Study||214
8825334|NCT01597973|9879277|FG001|COMPLETED|Overall Study||211
8825335|NCT01597973|9879276|FG000|NOT COMPLETED|Overall Study||20
8825336|NCT01597973|9879277|FG001|NOT COMPLETED|Overall Study||19
8825337|NCT01598064|9879287|FG000|STARTED|Overall Study||25
8825338|NCT01598064|9879288|FG001|STARTED|Overall Study||24
8825339|NCT01598064|9879287|FG000|COMPLETED|Overall Study||25
8825340|NCT01598064|9879288|FG001|COMPLETED|Overall Study||24
8825341|NCT01598064|9879287|FG000|NOT COMPLETED|Overall Study||0
8825342|NCT01598064|9879288|FG001|NOT COMPLETED|Overall Study||0
8825343|NCT01598090|9879299|FG000|STARTED|Treatment Period||27
8825344|NCT01598090|9879300|FG001|STARTED|Treatment Period||411
8825345|NCT01598090|9879301|FG002|STARTED|Treatment Period||206
8825346|NCT01598090|9879299|FG000|COMPLETED|Treatment Period||16
8825347|NCT01598090|9879300|FG001|COMPLETED|Treatment Period||339
8825348|NCT01598090|9879301|FG002|COMPLETED|Treatment Period||171
8825349|NCT01598090|9879299|FG000|NOT COMPLETED|Treatment Period||11
8825350|NCT01598090|9879300|FG001|NOT COMPLETED|Treatment Period||72
8825351|NCT01598090|9879301|FG002|NOT COMPLETED|Treatment Period||35
8825352|NCT01598090|9879299|FG000|STARTED|Follow-up Period|Includes 10 participants who re-joined from treatment period to follow-up period.|26
8825353|NCT01598090|9879300|FG001|STARTED|Follow-up Period|Includes 60 participants who re-joined from treatment period to follow-up period.|399
8825354|NCT01598090|9879301|FG002|STARTED|Follow-up Period|Includes 28 participants who re-joined from treatment period to follow-up period.|199
8825355|NCT01598090|9879299|FG000|COMPLETED|Follow-up Period||21
8825356|NCT01598090|9879300|FG001|COMPLETED|Follow-up Period||364
8825357|NCT01598090|9879301|FG002|COMPLETED|Follow-up Period||171
8825358|NCT01598090|9879299|FG000|NOT COMPLETED|Follow-up Period||5
8825359|NCT01598090|9879300|FG001|NOT COMPLETED|Follow-up Period||35
8825360|NCT01598090|9879301|FG002|NOT COMPLETED|Follow-up Period||28
8825361|NCT01598129|9879312|FG000|STARTED|Overall Study||12
8825362|NCT01598129|9879312|FG000|COMPLETED|Overall Study||3
8825363|NCT01598129|9879312|FG000|NOT COMPLETED|Overall Study||9
8825364|NCT01598194|9879319|FG000|STARTED|Overall Study||30
8825365|NCT01598194|9879320|FG001|STARTED|Overall Study||30
8825366|NCT01598194|9879319|FG000|2 Passes With 25G for Cytology|Overall Study||30
8825367|NCT01598194|9879320|FG001|2 Passes With 25G for Cytology|Overall Study||30
8825368|NCT01598194|9879319|FG000|1 Pass With 22Gpc for Cytology|Overall Study|1 participant's pass could not be performed|29
8825369|NCT01598194|9879320|FG001|1 Pass With 22Gpc for Cytology|Overall Study||30
8825370|NCT01598194|9879319|FG000|1 Pass With 22Gpc for Histology|Overall Study|3 participants passes could not be performed|27
8825371|NCT01598194|9879320|FG001|1 Pass With 22Gpc for Histology|Overall Study|1 participant's pass could not be performed|29
8825372|NCT01598194|9879319|FG000|COMPLETED|Overall Study||30
8825373|NCT01598194|9879320|FG001|COMPLETED|Overall Study||30
8825374|NCT01598194|9879319|FG000|NOT COMPLETED|Overall Study||0
8825375|NCT01598194|9879320|FG001|NOT COMPLETED|Overall Study||0
8825376|NCT01598207|9879332|FG000|STARTED|Overall Study||7
8825377|NCT01598207|9879333|FG001|STARTED|Overall Study||6
8825378|NCT01598207|9879332|FG000|COMPLETED|Overall Study||6
8825379|NCT01598207|9879333|FG001|COMPLETED|Overall Study||6
8825380|NCT01598207|9879332|FG000|NOT COMPLETED|Overall Study||1
8825381|NCT01598207|9879333|FG001|NOT COMPLETED|Overall Study||0
8825382|NCT01598298|9879341|FG000|STARTED|Overall Study||150
8825383|NCT01598298|9879342|FG001|STARTED|Overall Study||149
8825384|NCT01598298|9879341|FG000|Patients Evaluable for Primary Endpoint|Overall Study||127
8825385|NCT01598298|9879342|FG001|Patients Evaluable for Primary Endpoint|Overall Study||128
8825386|NCT01598298|9879341|FG000|Patients Evaluable for Adverse Events|Overall Study||138
8825387|NCT01598298|9879342|FG001|Patients Evaluable for Adverse Events|Overall Study||141
8825388|NCT01598298|9879341|FG000|COMPLETED|Overall Study||110
8825389|NCT01598298|9879342|FG001|COMPLETED|Overall Study||108
8825390|NCT01598298|9879341|FG000|NOT COMPLETED|Overall Study||40
8825391|NCT01598298|9879342|FG001|NOT COMPLETED|Overall Study||41
8825392|NCT01598311|9879350|FG000|STARTED|Overall Study||303
8825393|NCT01598311|9879351|FG001|STARTED|Overall Study||305
8825394|NCT01598311|9879350|FG000|Treated|Overall Study||294
8825395|NCT01598311|9879351|FG001|Treated|Overall Study||301
8825396|NCT01598311|9879350|FG000|Treated and Confirmed CDAD|Overall Study||285
8825397|NCT01598311|9879351|FG001|Treated and Confirmed CDAD|Overall Study||292
8825398|NCT01598311|9879350|FG000|COMPLETED|Overall Study||256
8825399|NCT01598311|9879351|FG001|COMPLETED|Overall Study||244
8825400|NCT01598311|9879350|FG000|NOT COMPLETED|Overall Study||47
8825401|NCT01598311|9879351|FG001|NOT COMPLETED|Overall Study||61
8825402|NCT01598350|9879357|FG000|STARTED|Overall Study||6
8825403|NCT01598350|9879357|FG000|COMPLETED|Overall Study||6
8825404|NCT01598350|9879357|FG000|NOT COMPLETED|Overall Study||0
8825405|NCT01598428|9879361|FG000|STARTED|Overall Study||20
8825406|NCT01598428|9879361|FG000|COMPLETED|Overall Study||20
8825407|NCT01598428|9879361|FG000|NOT COMPLETED|Overall Study||0
8825408|NCT01598506|9879366|FG000|STARTED|Overall Study||22
8825409|NCT01598506|9879366|FG000|COMPLETED|Overall Study||20
8825410|NCT01598506|9879366|FG000|NOT COMPLETED|Overall Study||2
8825411|NCT01598532|9879371|FG000|STARTED|Overall Study||22
8825412|NCT01598532|9879371|FG000|COMPLETED|Overall Study||11
8825413|NCT01598532|9879371|FG000|NOT COMPLETED|Overall Study||11
8825414|NCT01598545|9879378|FG000|STARTED|Overall Study||20
8825415|NCT01598545|9879378|FG000|COMPLETED|Overall Study||20
8825416|NCT01598545|9879378|FG000|NOT COMPLETED|Overall Study||0
8825417|NCT01598610|9879382|FG000|STARTED|Overall Study||220
8825418|NCT01598610|9879382|FG000|COMPLETED|Overall Study||219
8825419|NCT01598610|9879382|FG000|NOT COMPLETED|Overall Study||1
8825420|NCT01598662|9879388|FG000|STARTED|Overall Study||11
8825421|NCT01598662|9879389|FG001|STARTED|Overall Study||21
8825422|NCT01598662|9879388|FG000|Patients Who Received IUD|Overall Study|Subjects did not return at 6 weeks for IUD insertion.|0
8825423|NCT01598662|9879389|FG001|Patients Who Received IUD|Overall Study||18
8825424|NCT01598662|9879388|FG000|Patients Returned for 6 wk Postpartum|Overall Study||0
8825425|NCT01598662|9879389|FG001|Patients Returned for 6 wk Postpartum|Overall Study||2
8825426|NCT01598662|9879388|FG000|COMPLETED|Overall Study||0
8825427|NCT01598662|9879389|FG001|COMPLETED|Overall Study||0
8825428|NCT01598662|9879388|FG000|NOT COMPLETED|Overall Study||11
8825429|NCT01598662|9879389|FG001|NOT COMPLETED|Overall Study||21
8825430|NCT01598701|9879397|FG000|STARTED|Overall Study||50
8825431|NCT01598701|9879398|FG001|STARTED|Overall Study||50
8825432|NCT01598701|9879397|FG000|COMPLETED|Overall Study||45
8825433|NCT01598701|9879398|FG001|COMPLETED|Overall Study||41
8825434|NCT01598701|9879397|FG000|NOT COMPLETED|Overall Study||5
8825435|NCT01598701|9879398|FG001|NOT COMPLETED|Overall Study||9
8825436|NCT01598740|9879406|FG000|STARTED|Period 1||9
8825437|NCT01598740|9879407|FG001|STARTED|Period 1||9
8825438|NCT01598740|9879406|FG000|COMPLETED|Period 1||9
8825439|NCT01598740|9879407|FG001|COMPLETED|Period 1||9
8825440|NCT01598740|9879406|FG000|NOT COMPLETED|Period 1||0
8825441|NCT01598740|9879407|FG001|NOT COMPLETED|Period 1||0
8825442|NCT01598740|9879406|FG000|STARTED|Period 2|1 subject discontinued during the washout period prior to starting treatment period 2.|8
8825443|NCT01598740|9879407|FG001|STARTED|Period 2||9
8825444|NCT01598740|9879406|FG000|COMPLETED|Period 2||7
8825445|NCT01598740|9879407|FG001|COMPLETED|Period 2||9
8825446|NCT01598740|9879406|FG000|NOT COMPLETED|Period 2||1
8825447|NCT01598740|9879407|FG001|NOT COMPLETED|Period 2||0
8825448|NCT01598753|9879418|FG000|STARTED|Overall Study||37
8825449|NCT01598753|9879419|FG001|STARTED|Overall Study||31
8825450|NCT01598753|9879420|FG002|STARTED|Overall Study||32
8825451|NCT01598753|9879421|FG003|STARTED|Overall Study||34
8825452|NCT01598753|9879418|FG000|COMPLETED|Overall Study||25
8825453|NCT01598753|9879419|FG001|COMPLETED|Overall Study||16
8825454|NCT01598753|9879420|FG002|COMPLETED|Overall Study||24
8825455|NCT01598753|9879421|FG003|COMPLETED|Overall Study||19
8825456|NCT01598753|9879418|FG000|NOT COMPLETED|Overall Study||12
8825457|NCT01598753|9879419|FG001|NOT COMPLETED|Overall Study||15
8825458|NCT01598753|9879420|FG002|NOT COMPLETED|Overall Study||8
8825459|NCT01598753|9879421|FG003|NOT COMPLETED|Overall Study||15
8825460|NCT01598779|9879431|FG000|STARTED|Overall Study||150
8825461|NCT01598779|9879431|FG000|COMPLETED|Overall Study||150
8825462|NCT01598779|9879431|FG000|NOT COMPLETED|Overall Study||0
8825463|NCT01598831|9879437|FG000|STARTED|Overall Study||402
8825464|NCT01598831|9879438|FG001|STARTED|Overall Study||414
8825465|NCT01598831|9879437|FG000|Received at Least 1 Dose Study Treatment|Overall Study||395
8825466|NCT01598831|9879438|FG001|Received at Least 1 Dose Study Treatment|Overall Study||405
8825467|NCT01598831|9879437|FG000|COMPLETED|Overall Study||283
8825468|NCT01598831|9879438|FG001|COMPLETED|Overall Study||278
8825469|NCT01598831|9879437|FG000|NOT COMPLETED|Overall Study||119
8825470|NCT01598831|9879438|FG001|NOT COMPLETED|Overall Study||136
8825471|NCT01598896|9879446|FG000|STARTED|Overall Study||3
8825472|NCT01598896|9879447|FG001|STARTED|Overall Study||4
8825473|NCT01598896|9879446|FG000|COMPLETED|Overall Study||3
8825474|NCT01598896|9879447|FG001|COMPLETED|Overall Study||2
8825475|NCT01598896|9879446|FG000|NOT COMPLETED|Overall Study||0
8825476|NCT01598896|9879447|FG001|NOT COMPLETED|Overall Study||2
8825477|NCT01598922|9879455|FG000|STARTED|Overall Study||37
8825478|NCT01598922|9879456|FG001|STARTED|Overall Study||40
8825479|NCT01598922|9879455|FG000|COMPLETED|Overall Study||34
8825480|NCT01598922|9879456|FG001|COMPLETED|Overall Study||30
8825481|NCT01598922|9879455|FG000|NOT COMPLETED|Overall Study||3
8825482|NCT01598922|9879456|FG001|NOT COMPLETED|Overall Study||10
8825483|NCT01598987|9879462|FG000|STARTED|Baseline to Month 12||56
8825484|NCT01598987|9879462|FG000|COMPLETED|Baseline to Month 12||50
8825485|NCT01598987|9879462|FG000|NOT COMPLETED|Baseline to Month 12||6
8825486|NCT01598987|9879462|FG000|STARTED|Baseline to 24 Month||56
8825487|NCT01598987|9879462|FG000|COMPLETED|Baseline to 24 Month||48
8825488|NCT01598987|9879462|FG000|NOT COMPLETED|Baseline to 24 Month||8
8825489|NCT01599104|9879476|FG000|STARTED|Overall Study||387
8825490|NCT01599104|9879477|FG001|STARTED|Overall Study||385
8825491|NCT01599104|9879478|FG002|STARTED|Overall Study||389
8825492|NCT01599104|9879476|FG000|COMPLETED|Overall Study||371
8825493|NCT01599104|9879477|FG001|COMPLETED|Overall Study||371
8825494|NCT01599104|9879478|FG002|COMPLETED|Overall Study||363
8825495|NCT01599104|9879476|FG000|NOT COMPLETED|Overall Study||16
8825496|NCT01599104|9879477|FG001|NOT COMPLETED|Overall Study||14
8825497|NCT01599104|9879478|FG002|NOT COMPLETED|Overall Study||26
8825498|NCT01599234|9879488|FG000|STARTED|Overall Study||167
8825499|NCT01599234|9879489|FG001|STARTED|Overall Study||170
8825500|NCT01599234|9879488|FG000|COMPLETED|Overall Study||150
8825501|NCT01599234|9879489|FG001|COMPLETED|Overall Study||155
8825502|NCT01599234|9879488|FG000|NOT COMPLETED|Overall Study||17
8825503|NCT01599234|9879489|FG001|NOT COMPLETED|Overall Study||15
8825504|NCT01599286|9879497|FG000|STARTED|Overall Study||24
8825505|NCT01599286|9879498|FG001|STARTED|Overall Study||23
8825506|NCT01599286|9879497|FG000|COMPLETED|Overall Study||24
8825507|NCT01599286|9879498|FG001|COMPLETED|Overall Study||23
8825508|NCT01599286|9879497|FG000|NOT COMPLETED|Overall Study||0
8825509|NCT01599286|9879498|FG001|NOT COMPLETED|Overall Study||0
8825510|NCT01599325|9879504|FG000|STARTED|Primary Parent Phase||72
8825511|NCT01599325|9879504|FG000|Intent to Treat (ITT) Population|Primary Parent Phase|Includes all participants who were enrolled into the study|72
8825512|NCT01599325|9879504|FG000|Pharmacokinetic (PK) Population|Primary Parent Phase|Includes all participants with evaluable azacitidine plasma PK profiles.|12
8825513|NCT01599325|9879504|FG000|COMPLETED|Primary Parent Phase|Participants still on study treatment at time of study closure|15
8825514|NCT01599325|9879504|FG000|NOT COMPLETED|Primary Parent Phase||57
8825515|NCT01599325|9879504|FG000|STARTED|Extension Phase||15
8825516|NCT01599325|9879504|FG000|COMPLETED|Extension Phase||0
8825517|NCT01599325|9879504|FG000|NOT COMPLETED|Extension Phase||15
8825518|NCT01599585|9879511|FG000|STARTED|Overall Study||62
8825519|NCT01599585|9879512|FG001|STARTED|Overall Study||59
8825520|NCT01599585|9879511|FG000|COMPLETED|Overall Study||40
8825521|NCT01599585|9879512|FG001|COMPLETED|Overall Study||42
8825522|NCT01599585|9879511|FG000|NOT COMPLETED|Overall Study||22
8825523|NCT01599585|9879512|FG001|NOT COMPLETED|Overall Study||17
8825524|NCT01599637|9879521|FG000|STARTED|Overall Study|" started indicates randomized safety, pharmacodynamics and pharmocokinetics set"|20
8825525|NCT01599637|9879522|FG001|STARTED|Overall Study||10
8825526|NCT01599637|9879523|FG002|STARTED|Overall Study||10
8825527|NCT01599637|9879521|FG000|COMPLETED|Overall Study||19
8825528|NCT01599637|9879522|FG001|COMPLETED|Overall Study||8
8825529|NCT01599637|9879523|FG002|COMPLETED|Overall Study||10
8825530|NCT01599637|9879521|FG000|NOT COMPLETED|Overall Study||1
8825531|NCT01599637|9879522|FG001|NOT COMPLETED|Overall Study||2
8825532|NCT01599637|9879523|FG002|NOT COMPLETED|Overall Study||0
8825533|NCT01599650|9879536|FG000|STARTED|Overall Study||183
8825534|NCT01599650|9879537|FG001|STARTED|Overall Study||180
8825535|NCT01599650|9879538|FG002|STARTED|Overall Study||92
8825536|NCT01599650|9879536|FG000|Completed 6 Mos|Overall Study||174
8825537|NCT01599650|9879537|FG001|Completed 6 Mos|Overall Study||170
8825538|NCT01599650|9879538|FG002|Completed 6 Mos|Overall Study||80
8825539|NCT01599650|9879536|FG000|COMPLETED|Overall Study||161
8825540|NCT01599650|9879537|FG001|COMPLETED|Overall Study||154
8825541|NCT01599650|9879538|FG002|COMPLETED|Overall Study||65
8825542|NCT01599650|9879536|FG000|NOT COMPLETED|Overall Study||22
8825543|NCT01599650|9879537|FG001|NOT COMPLETED|Overall Study||26
8825544|NCT01599650|9879538|FG002|NOT COMPLETED|Overall Study||27
8825545|NCT01599754|9879550|FG000|STARTED|Overall Study||363
8825546|NCT01599754|9879551|FG001|STARTED|Overall Study||361
8825547|NCT01599754|9879550|FG000|Treated|Overall Study||360
8825548|NCT01599754|9879551|FG001|Treated|Overall Study||360
8825549|NCT01599754|9879550|FG000|COMPLETED|Overall Study||0
8825550|NCT01599754|9879551|FG001|COMPLETED|Overall Study||1
8825551|NCT01599754|9879550|FG000|NOT COMPLETED|Overall Study||363
8825552|NCT01599754|9879551|FG001|NOT COMPLETED|Overall Study||360
8825553|NCT01599793|9879557|FG000|STARTED|Overall Study||19
8825554|NCT01599793|9879557|FG000|COMPLETED|Overall Study||17
8825555|NCT01599793|9879557|FG000|NOT COMPLETED|Overall Study||2
8825556|NCT01599806|9879563|FG000|STARTED|Overall Study||516
8825557|NCT01599806|9879564|FG001|STARTED|Overall Study||517
8825558|NCT01599806|9879563|FG000|COMPLETED|Overall Study||473
8825559|NCT01599806|9879564|FG001|COMPLETED|Overall Study||476
8825560|NCT01599806|9879563|FG000|NOT COMPLETED|Overall Study||43
8825561|NCT01599806|9879564|FG001|NOT COMPLETED|Overall Study||41
8825562|NCT01599832|9879570|FG000|STARTED|Overall Study||20
8825563|NCT01599832|9879570|FG000|COMPLETED|Overall Study||20
8825564|NCT01599832|9879570|FG000|NOT COMPLETED|Overall Study||0
8825565|NCT01600014|9879574|FG000|STARTED|1. Cycle & Observation Period D1 to W52|Subjects completing W52 without having been administered a 2nd cycle are counted as completers.|450
8825566|NCT01600014|9879575|FG001|STARTED|1. Cycle & Observation Period D1 to W52||0
8825567|NCT01600014|9879574|FG000|COMPLETED|1. Cycle & Observation Period D1 to W52||162
8825568|NCT01600014|9879575|FG001|COMPLETED|1. Cycle & Observation Period D1 to W52||0
8825569|NCT01600014|9879574|FG000|NOT COMPLETED|1. Cycle & Observation Period D1 to W52||288
8825570|NCT01600014|9879575|FG001|NOT COMPLETED|1. Cycle & Observation Period D1 to W52||0
8825571|NCT01600014|9879574|FG000|STARTED|2. Cycle Recalcitrant Subgroup W8 to W52||92
8825572|NCT01600014|9879575|FG001|STARTED|2. Cycle Recalcitrant Subgroup W8 to W52||49
8825573|NCT01600014|9879574|FG000|COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||80
8825574|NCT01600014|9879575|FG001|COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||39
8825575|NCT01600014|9879574|FG000|NOT COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||12
8825576|NCT01600014|9879575|FG001|NOT COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||10
8825577|NCT01600014|9879574|FG000|STARTED|2. Cycl Recurrent Subgroup W26/44 to W52||42
8825578|NCT01600014|9879575|FG001|STARTED|2. Cycl Recurrent Subgroup W26/44 to W52||20
8825579|NCT01600014|9879574|FG000|COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||39
8825580|NCT01600014|9879575|FG001|COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||20
8825581|NCT01600014|9879574|FG000|NOT COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||3
8825582|NCT01600014|9879575|FG001|NOT COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||0
8825583|NCT01600053|9879593|FG000|STARTED|Overall Study||11
8825584|NCT01600053|9879593|FG000|COMPLETED|Overall Study||0
8825585|NCT01600053|9879593|FG000|NOT COMPLETED|Overall Study||11
8825586|NCT01600092|9879599|FG000|STARTED|Overall Study||513
8825587|NCT01600092|9879600|FG001|STARTED|Overall Study||507
8825588|NCT01600092|9879599|FG000|Received at Least 1 Vaccination|Overall Study|1 participant received RotaTeq™ existing formulation as their first vaccination|510
8825589|NCT01600092|9879600|FG001|Received at Least 1 Vaccination|Overall Study||504
8825590|NCT01600092|9879599|FG000|Received All 3 Vaccinations|Overall Study||500
8825591|NCT01600092|9879600|FG001|Received All 3 Vaccinations|Overall Study||494
8825592|NCT01600092|9879599|FG000|COMPLETED|Overall Study||495
8825593|NCT01600092|9879600|FG001|COMPLETED|Overall Study||491
8825594|NCT01600092|9879599|FG000|NOT COMPLETED|Overall Study||18
8825595|NCT01600092|9879600|FG001|NOT COMPLETED|Overall Study||16
8825596|NCT01600105|9879608|FG000|STARTED|Total Participants||255
8825597|NCT01600105|9879609|FG001|STARTED|Total Participants||21
8825598|NCT01600105|9879608|FG000|COMPLETED|Total Participants||214
8825599|NCT01600105|9879609|FG001|COMPLETED|Total Participants||11
8825600|NCT01600105|9879608|FG000|NOT COMPLETED|Total Participants||41
8825601|NCT01600105|9879609|FG001|NOT COMPLETED|Total Participants||10
8825602|NCT01600105|9879608|FG000|STARTED|Sub Study I||19
8825603|NCT01600105|9879609|FG001|STARTED|Sub Study I||21
8825604|NCT01600105|9879608|FG000|COMPLETED|Sub Study I||19
8825605|NCT01600105|9879609|FG001|COMPLETED|Sub Study I||11
8825606|NCT01600105|9879608|FG000|NOT COMPLETED|Sub Study I||0
8825607|NCT01600105|9879609|FG001|NOT COMPLETED|Sub Study I||10
8825608|NCT01600105|9879608|FG000|STARTED|Sub Study II||65
8825609|NCT01600105|9879609|FG001|STARTED|Sub Study II||0
8825610|NCT01600105|9879608|FG000|COMPLETED|Sub Study II||60
8825611|NCT01600105|9879609|FG001|COMPLETED|Sub Study II||0
8825612|NCT01600105|9879608|FG000|NOT COMPLETED|Sub Study II||5
8825613|NCT01600105|9879609|FG001|NOT COMPLETED|Sub Study II||0
8825614|NCT01600105|9879608|FG000|STARTED|Sub Study III||39
8825615|NCT01600105|9879609|FG001|STARTED|Sub Study III||0
8825616|NCT01600105|9879608|FG000|COMPLETED|Sub Study III||34
8825617|NCT01600105|9879609|FG001|COMPLETED|Sub Study III||0
8825618|NCT01600105|9879608|FG000|NOT COMPLETED|Sub Study III||5
8825619|NCT01600105|9879609|FG001|NOT COMPLETED|Sub Study III||0
8825620|NCT01600105|9879608|FG000|STARTED|Sub Study IV||41
8825621|NCT01600105|9879609|FG001|STARTED|Sub Study IV||8
8825622|NCT01600105|9879608|FG000|COMPLETED|Sub Study IV||41
8825623|NCT01600105|9879609|FG001|COMPLETED|Sub Study IV||8
8825624|NCT01600105|9879608|FG000|NOT COMPLETED|Sub Study IV||0
8825625|NCT01600105|9879609|FG001|NOT COMPLETED|Sub Study IV||0
8825626|NCT01600105|9879608|FG000|STARTED|Sub Study V||52
8825627|NCT01600105|9879609|FG001|STARTED|Sub Study V||0
8825628|NCT01600105|9879608|FG000|COMPLETED|Sub Study V||50
8825629|NCT01600105|9879609|FG001|COMPLETED|Sub Study V||0
8825630|NCT01600105|9879608|FG000|NOT COMPLETED|Sub Study V||2
8825631|NCT01600105|9879609|FG001|NOT COMPLETED|Sub Study V||0
8825632|NCT01600170|9879621|FG000|STARTED|Period 1|Participants were assigned atorvastatin for 12 wks followed by a washout and then placebo.|6
8825633|NCT01600170|9879622|FG001|STARTED|Period 1|Participants were assigned placebo for 12 wks followed by a washout and then atorvastatin.|5
8825634|NCT01600170|9879621|FG000|COMPLETED|Period 1||6
8825635|NCT01600170|9879622|FG001|COMPLETED|Period 1||5
8825636|NCT01600170|9879621|FG000|NOT COMPLETED|Period 1||0
8825637|NCT01600170|9879622|FG001|NOT COMPLETED|Period 1||0
8825638|NCT01600170|9879621|FG000|STARTED|Period 2|These 6 were on atorvastatin in period 1 and on placebo in Period 2.|6
8825639|NCT01600170|9879622|FG001|STARTED|Period 2|These 5 were on placebo in Period 1 and on Atorvastatin in Period 2.|5
8825640|NCT01600170|9879621|FG000|COMPLETED|Period 2|One subject moved away from the area due to job responsibilities and dropped out of study.|5
8825641|NCT01600170|9879622|FG001|COMPLETED|Period 2||5
8825642|NCT01600170|9879621|FG000|NOT COMPLETED|Period 2||1
8825643|NCT01600170|9879622|FG001|NOT COMPLETED|Period 2||0
8825644|NCT01600222|9879630|FG000|STARTED|Overall Study||37
8825645|NCT01600222|9879630|FG000|COMPLETED|Overall Study||35
8825646|NCT01600222|9879630|FG000|NOT COMPLETED|Overall Study||2
8825647|NCT01600287|9879637|FG000|STARTED|Overall Study||20
8825648|NCT01600287|9879638|FG001|STARTED|Overall Study||20
8825649|NCT01600287|9879637|FG000|COMPLETED|Overall Study||20
8825650|NCT01600287|9879638|FG001|COMPLETED|Overall Study||20
8825651|NCT01600287|9879637|FG000|NOT COMPLETED|Overall Study||0
8825652|NCT01600287|9879638|FG001|NOT COMPLETED|Overall Study||0
8825653|NCT01600326|9879646|FG000|STARTED|Overall Study||15
8825654|NCT01600326|9879647|FG001|STARTED|Overall Study||15
8825655|NCT01600326|9879646|FG000|Primary Outcome Measure Data Collection|Overall Study||15
8825656|NCT01600326|9879647|FG001|Primary Outcome Measure Data Collection|Overall Study||15
8825657|NCT01600326|9879646|FG000|COMPLETED|Overall Study||14
8825658|NCT01600326|9879647|FG001|COMPLETED|Overall Study||14
8825659|NCT01600326|9879646|FG000|NOT COMPLETED|Overall Study||1
8825660|NCT01600326|9879647|FG001|NOT COMPLETED|Overall Study||1
8825661|NCT01600482|9879655|FG000|STARTED|Overall Study||148
8825662|NCT01600482|9879656|FG001|STARTED|Overall Study|Last 26 patients allocated to CELT ACD|59
8825663|NCT01600482|9879655|FG000|COMPLETED|Overall Study|Last 26 patients allocated to CELT ACD|148
8825664|NCT01600482|9879656|FG001|COMPLETED|Overall Study||59
8825665|NCT01600482|9879655|FG000|NOT COMPLETED|Overall Study||0
8825666|NCT01600482|9879656|FG001|NOT COMPLETED|Overall Study||0
8825667|NCT01600495|9879664|FG000|STARTED|Overall Study|We start with the prediction of collecting 20 patients in the treated group|23
8825668|NCT01600495|9879665|FG001|STARTED|Overall Study|We start with the prediction of collecting 20 control patients|23
8825669|NCT01600495|9879664|FG000|COMPLETED|Overall Study|We finished the job with 23 patients for each group (treated and control)|23
8825670|NCT01600495|9879665|FG001|COMPLETED|Overall Study|We finished the job with 23 patients for each group (treated and control)|23
8825671|NCT01600495|9879664|FG000|NOT COMPLETED|Overall Study||0
8825672|NCT01600495|9879665|FG001|NOT COMPLETED|Overall Study||0
8825673|NCT01600586|9879674|FG000|STARTED|Overall Study||49
8825674|NCT01600586|9879675|FG001|STARTED|Overall Study||51
8825675|NCT01600586|9879674|FG000|COMPLETED|Overall Study||46
8825676|NCT01600586|9879675|FG001|COMPLETED|Overall Study||48
8825677|NCT01600586|9879674|FG000|NOT COMPLETED|Overall Study||3
8825678|NCT01600586|9879675|FG001|NOT COMPLETED|Overall Study||3
8825679|NCT01600638|9879688|FG000|STARTED|Overall Study||25
8825680|NCT01600638|9879688|FG000|COMPLETED|Overall Study||25
8825681|NCT01600638|9879688|FG000|NOT COMPLETED|Overall Study||0
8825682|NCT01600677|9879694|FG000|STARTED|Overall Study||7
8825683|NCT01600677|9879695|FG001|STARTED|Overall Study||4
8825684|NCT01600677|9879694|FG000|COMPLETED|Overall Study||7
8825685|NCT01600677|9879695|FG001|COMPLETED|Overall Study||4
8825686|NCT01600677|9879694|FG000|NOT COMPLETED|Overall Study||0
8825687|NCT01600677|9879695|FG001|NOT COMPLETED|Overall Study||0
8825688|NCT01600703|9879701|FG000|STARTED|First Intervention||7
8825689|NCT01600703|9879702|FG001|STARTED|First Intervention||8
8825690|NCT01600703|9879701|FG000|COMPLETED|First Intervention||7
8622183|NCT00486759|9661382|FG001|STARTED|Safety Follow-up||260
8622184|NCT00486759|9661381|FG000|COMPLETED|Safety Follow-up||64
8622185|NCT00486759|9661382|FG001|COMPLETED|Safety Follow-up||142
8825691|NCT01600703|9879702|FG001|COMPLETED|First Intervention||8
8825692|NCT01600703|9879701|FG000|NOT COMPLETED|First Intervention||0
8825693|NCT01600703|9879702|FG001|NOT COMPLETED|First Intervention||0
8825694|NCT01600703|9879701|FG000|STARTED|Second Intervention||7
8825695|NCT01600703|9879702|FG001|STARTED|Second Intervention||8
8825696|NCT01600703|9879701|FG000|COMPLETED|Second Intervention||7
8825697|NCT01600703|9879702|FG001|COMPLETED|Second Intervention||8
8825698|NCT01600703|9879701|FG000|NOT COMPLETED|Second Intervention||0
8825699|NCT01600703|9879702|FG001|NOT COMPLETED|Second Intervention||0
8825700|NCT01600716|9879710|FG000|STARTED|Overall Study||66
8825701|NCT01600716|9879711|FG001|STARTED|Overall Study||78
8825702|NCT01600716|9879710|FG000|COMPLETED|Overall Study||59
8825703|NCT01600716|9879711|FG001|COMPLETED|Overall Study||71
8825704|NCT01600716|9879710|FG000|NOT COMPLETED|Overall Study||7
8825705|NCT01600716|9879711|FG001|NOT COMPLETED|Overall Study||7
8849607|NCT01742078|9904833|FG001|NOT COMPLETED|Overall Study||0
8849608|NCT01742078|9904834|FG002|NOT COMPLETED|Overall Study||0
8849609|NCT01742078|9904835|FG003|NOT COMPLETED|Overall Study||1
8849610|NCT01742078|9904836|FG004|NOT COMPLETED|Overall Study||0
8849611|NCT01742078|9904837|FG005|NOT COMPLETED|Overall Study||0
8849612|NCT01742078|9904838|FG006|NOT COMPLETED|Overall Study||0
8849613|NCT01742078|9904839|FG007|NOT COMPLETED|Overall Study||0
8849614|NCT01742078|9904840|FG008|NOT COMPLETED|Overall Study||0
8849615|NCT01742091|9904868|FG000|STARTED|Overall Study||9
8849616|NCT01742091|9904869|FG001|STARTED|Overall Study||11
8849617|NCT01742091|9904870|FG002|STARTED|Overall Study||10
8849618|NCT01742091|9904871|FG003|STARTED|Overall Study||9
8849619|NCT01742091|9904872|FG004|STARTED|Overall Study||8
8849620|NCT01742091|9904873|FG005|STARTED|Overall Study||12
8849621|NCT01742091|9904868|FG000|RECEIVED STUDY DRUG|Overall Study||9
8622186|NCT00486759|9661381|FG000|NOT COMPLETED|Safety Follow-up||139
8849622|NCT01742091|9904869|FG001|RECEIVED STUDY DRUG|Overall Study||11
8849623|NCT01742091|9904870|FG002|RECEIVED STUDY DRUG|Overall Study||10
8849624|NCT01742091|9904871|FG003|RECEIVED STUDY DRUG|Overall Study||9
8825706|NCT01600729|9879719|FG000|STARTED|Overall Study||66
8825707|NCT01600729|9879719|FG000|COMPLETED|Overall Study||65
8825708|NCT01600729|9879719|FG000|NOT COMPLETED|Overall Study||1
8825709|NCT01600885|9879723|FG000|STARTED|First Period||10
8825710|NCT01600885|9879724|FG001|STARTED|First Period||9
8825711|NCT01600885|9879723|FG000|COMPLETED|First Period||8
8825712|NCT01600885|9879724|FG001|COMPLETED|First Period||8
8825713|NCT01600885|9879723|FG000|NOT COMPLETED|First Period||2
8825714|NCT01600885|9879724|FG001|NOT COMPLETED|First Period||1
8825715|NCT01600885|9879723|FG000|STARTED|Wash Out Period||8
8825716|NCT01600885|9879724|FG001|STARTED|Wash Out Period||8
8825717|NCT01600885|9879723|FG000|COMPLETED|Wash Out Period||8
8825718|NCT01600885|9879724|FG001|COMPLETED|Wash Out Period||8
8825719|NCT01600885|9879723|FG000|NOT COMPLETED|Wash Out Period||0
8825720|NCT01600885|9879724|FG001|NOT COMPLETED|Wash Out Period||0
8825721|NCT01600885|9879723|FG000|STARTED|Second Period||8
8825722|NCT01600885|9879724|FG001|STARTED|Second Period||8
8825723|NCT01600885|9879723|FG000|COMPLETED|Second Period||8
8825724|NCT01600885|9879724|FG001|COMPLETED|Second Period||8
8825725|NCT01600885|9879723|FG000|NOT COMPLETED|Second Period||0
8825726|NCT01600885|9879724|FG001|NOT COMPLETED|Second Period||0
8825727|NCT01600950|9879730|FG000|STARTED|Period 1||10
8825728|NCT01600950|9879731|FG001|STARTED|Period 1||10
8825729|NCT01600950|9879730|FG000|COMPLETED|Period 1||10
8825730|NCT01600950|9879731|FG001|COMPLETED|Period 1||10
8825731|NCT01600950|9879730|FG000|NOT COMPLETED|Period 1||0
8825732|NCT01600950|9879731|FG001|NOT COMPLETED|Period 1||0
8825733|NCT01600950|9879730|FG000|STARTED|Period 2||10
8825734|NCT01600950|9879731|FG001|STARTED|Period 2||10
8825735|NCT01600950|9879730|FG000|COMPLETED|Period 2||10
8825736|NCT01600950|9879731|FG001|COMPLETED|Period 2||10
8825737|NCT01600950|9879730|FG000|NOT COMPLETED|Period 2||0
8825738|NCT01600950|9879731|FG001|NOT COMPLETED|Period 2||0
8825739|NCT01601067|9879739|FG000|STARTED|Overall Study||63
8825740|NCT01601067|9879740|FG001|STARTED|Overall Study||56
8825741|NCT01601067|9879739|FG000|COMPLETED|Overall Study||30
8825742|NCT01601067|9879740|FG001|COMPLETED|Overall Study||34
8825743|NCT01601067|9879739|FG000|NOT COMPLETED|Overall Study||33
8825744|NCT01601067|9879740|FG001|NOT COMPLETED|Overall Study||22
8825745|NCT01601132|9879746|FG000|STARTED|Overall Study||30
8825746|NCT01601132|9879746|FG000|COMPLETED|Overall Study||28
8825747|NCT01601132|9879746|FG000|NOT COMPLETED|Overall Study||2
8825748|NCT01601236|9879759|FG000|STARTED|Overall Study||7
8825749|NCT01601236|9879760|FG001|STARTED|Overall Study||3
8825750|NCT01601236|9879761|FG002|STARTED|Overall Study||14
8825751|NCT01601236|9879762|FG003|STARTED|Overall Study||6
8825752|NCT01601236|9879763|FG004|STARTED|Overall Study||3
8825753|NCT01601236|9879764|FG005|STARTED|Overall Study||1
8825754|NCT01601236|9879759|FG000|COMPLETED|Overall Study||2
8825755|NCT01601236|9879760|FG001|COMPLETED|Overall Study||2
8825756|NCT01601236|9879761|FG002|COMPLETED|Overall Study||8
8825757|NCT01601236|9879762|FG003|COMPLETED|Overall Study||4
8825758|NCT01601236|9879763|FG004|COMPLETED|Overall Study||0
8825759|NCT01601236|9879764|FG005|COMPLETED|Overall Study||0
8825760|NCT01601236|9879759|FG000|NOT COMPLETED|Overall Study||5
8825761|NCT01601236|9879760|FG001|NOT COMPLETED|Overall Study||1
8825762|NCT01601236|9879761|FG002|NOT COMPLETED|Overall Study||6
8825763|NCT01601236|9879762|FG003|NOT COMPLETED|Overall Study||2
8825764|NCT01601236|9879763|FG004|NOT COMPLETED|Overall Study||3
8825765|NCT01601236|9879764|FG005|NOT COMPLETED|Overall Study||1
8825766|NCT01601431|9879775|FG000|STARTED|Overall Study||223
8825767|NCT01601431|9879776|FG001|STARTED|Overall Study||217
8825768|NCT01601431|9879775|FG000|COMPLETED|Overall Study||211
8825769|NCT01601431|9879776|FG001|COMPLETED|Overall Study||214
8825770|NCT01601431|9879775|FG000|NOT COMPLETED|Overall Study||12
8825771|NCT01601431|9879776|FG001|NOT COMPLETED|Overall Study||3
8825772|NCT01601470|9879782|FG000|STARTED|Period 1 - Sildenafil||28
8943978|NCT02392559|10005767|FG001|COMPLETED|Overall Study||104
8825773|NCT01601470|9879782|FG000|PK Analysis Set|Period 1 - Sildenafil||28
8825774|NCT01601470|9879782|FG000|Safety Set|Period 1 - Sildenafil||28
8825775|NCT01601470|9879782|FG000|COMPLETED|Period 1 - Sildenafil||28
8825776|NCT01601470|9879782|FG000|NOT COMPLETED|Period 1 - Sildenafil||0
8825777|NCT01601470|9879782|FG000|STARTED|Period 2 - LCZ696||28
8825778|NCT01601470|9879782|FG000|PK Analysis Set|Period 2 - LCZ696||27
8825779|NCT01601470|9879782|FG000|Safety Set|Period 2 - LCZ696||27
8825780|NCT01601470|9879782|FG000|COMPLETED|Period 2 - LCZ696||27
8825781|NCT01601470|9879782|FG000|NOT COMPLETED|Period 2 - LCZ696||1
8825782|NCT01601470|9879782|FG000|STARTED|Period 3 - LCZ696+Sildenafil||27
8825783|NCT01601470|9879782|FG000|PK Analysis Set|Period 3 - LCZ696+Sildenafil||27
8825784|NCT01601470|9879782|FG000|Safety Set|Period 3 - LCZ696+Sildenafil||27
8825785|NCT01601470|9879782|FG000|COMPLETED|Period 3 - LCZ696+Sildenafil||27
8825786|NCT01601470|9879782|FG000|NOT COMPLETED|Period 3 - LCZ696+Sildenafil||0
8825787|NCT01601496|9879788|FG000|STARTED|Overall Study|Enrolled|117
8825788|NCT01601496|9879788|FG000|COMPLETED|Overall Study|Completed 12-M F/up|102
8825789|NCT01601496|9879788|FG000|NOT COMPLETED|Overall Study||15
8825790|NCT01601535|9879798|FG000|STARTED|Phase 1||6
8825791|NCT01601535|9879799|FG001|STARTED|Phase 1||6
8825792|NCT01601535|9879800|FG002|STARTED|Phase 1||6
8825793|NCT01601535|9879801|FG003|STARTED|Phase 1||4
8825794|NCT01601535|9879802|FG004|STARTED|Phase 1||0
8825795|NCT01601535|9879803|FG005|STARTED|Phase 1||0
8825796|NCT01601535|9879798|FG000|COMPLETED|Phase 1||0
8825797|NCT01601535|9879799|FG001|COMPLETED|Phase 1||0
8825798|NCT01601535|9879800|FG002|COMPLETED|Phase 1||1
8825799|NCT01601535|9879801|FG003|COMPLETED|Phase 1||0
8825800|NCT01601535|9879802|FG004|COMPLETED|Phase 1||0
8825801|NCT01601535|9879803|FG005|COMPLETED|Phase 1||0
8825802|NCT01601535|9879798|FG000|NOT COMPLETED|Phase 1||6
8825803|NCT01601535|9879799|FG001|NOT COMPLETED|Phase 1||6
8825804|NCT01601535|9879800|FG002|NOT COMPLETED|Phase 1||5
8825805|NCT01601535|9879801|FG003|NOT COMPLETED|Phase 1||4
8825806|NCT01601535|9879802|FG004|NOT COMPLETED|Phase 1||0
8825807|NCT01601535|9879803|FG005|NOT COMPLETED|Phase 1||0
8825808|NCT01601535|9879798|FG000|STARTED|Phase 2||0
8825809|NCT01601535|9879799|FG001|STARTED|Phase 2||0
8825810|NCT01601535|9879800|FG002|STARTED|Phase 2||0
8825811|NCT01601535|9879801|FG003|STARTED|Phase 2||0
8825812|NCT01601535|9879802|FG004|STARTED|Phase 2||20
8825813|NCT01601535|9879803|FG005|STARTED|Phase 2||12
8825814|NCT01601535|9879798|FG000|COMPLETED|Phase 2||0
8825815|NCT01601535|9879799|FG001|COMPLETED|Phase 2||0
8825816|NCT01601535|9879800|FG002|COMPLETED|Phase 2||0
8825817|NCT01601535|9879801|FG003|COMPLETED|Phase 2||0
8825818|NCT01601535|9879802|FG004|COMPLETED|Phase 2||1
8825819|NCT01601535|9879803|FG005|COMPLETED|Phase 2||0
8825820|NCT01601535|9879798|FG000|NOT COMPLETED|Phase 2||0
8825821|NCT01601535|9879799|FG001|NOT COMPLETED|Phase 2||0
8825822|NCT01601535|9879800|FG002|NOT COMPLETED|Phase 2||0
8825823|NCT01601535|9879801|FG003|NOT COMPLETED|Phase 2||0
8825824|NCT01601535|9879802|FG004|NOT COMPLETED|Phase 2||19
8825825|NCT01601535|9879803|FG005|NOT COMPLETED|Phase 2||12
8825826|NCT01601626|9879829|FG000|STARTED|Overall Study||24
8825827|NCT01601626|9879830|FG001|STARTED|Overall Study||24
8825828|NCT01601626|9879831|FG002|STARTED|Overall Study||23
8825829|NCT01601626|9879829|FG000|COMPLETED|Overall Study||21
8825830|NCT01601626|9879830|FG001|COMPLETED|Overall Study||19
8825831|NCT01601626|9879831|FG002|COMPLETED|Overall Study||21
8825832|NCT01601626|9879829|FG000|NOT COMPLETED|Overall Study||3
8825833|NCT01601626|9879830|FG001|NOT COMPLETED|Overall Study||5
8825834|NCT01601626|9879831|FG002|NOT COMPLETED|Overall Study||2
8825835|NCT01601652|9879839|FG000|STARTED|Overall Study||12
8825836|NCT01601652|9879839|FG000|COMPLETED|Overall Study||11
8825837|NCT01601652|9879839|FG000|NOT COMPLETED|Overall Study||1
8825838|NCT01601691|9879843|FG000|STARTED|Overall Study||10
8825839|NCT01601691|9879843|FG000|COMPLETED|Overall Study||10
8825840|NCT01601691|9879843|FG000|NOT COMPLETED|Overall Study||0
8825841|NCT01601704|9879849|FG000|STARTED|Overall Study||4456
8825842|NCT01601704|9879850|FG001|STARTED|Overall Study||4454
8825843|NCT01601704|9879849|FG000|Treated|Overall Study||4455
8825844|NCT01601704|9879850|FG001|Treated|Overall Study||4450
8825845|NCT01601704|9879849|FG000|COMPLETED|Overall Study||4455
8825846|NCT01601704|9879850|FG001|COMPLETED|Overall Study||4450
8825847|NCT01601704|9879849|FG000|NOT COMPLETED|Overall Study||1
8825848|NCT01601704|9879850|FG001|NOT COMPLETED|Overall Study||4
8825849|NCT01601782|9879856|FG000|STARTED|Overall Study||16
8825850|NCT01601782|9879856|FG000|COMPLETED|Overall Study||16
8825851|NCT01601782|9879856|FG000|NOT COMPLETED|Overall Study||0
8825852|NCT01601821|9879862|FG000|STARTED|Overall Study||125
8825853|NCT01601821|9879863|FG001|STARTED|Overall Study||120
8825854|NCT01601821|9879862|FG000|COMPLETED|Overall Study||96
8825855|NCT01601821|9879863|FG001|COMPLETED|Overall Study||91
8825856|NCT01601821|9879862|FG000|NOT COMPLETED|Overall Study||29
8825857|NCT01601821|9879863|FG001|NOT COMPLETED|Overall Study||29
8825858|NCT01601847|9879871|FG000|STARTED|Overall Study||153
8825859|NCT01601847|9879872|FG001|STARTED|Overall Study||147
8825860|NCT01601847|9879871|FG000|COMPLETED|Overall Study||140
8825861|NCT01601847|9879872|FG001|COMPLETED|Overall Study||137
8825862|NCT01601847|9879871|FG000|NOT COMPLETED|Overall Study||13
8825863|NCT01601847|9879872|FG001|NOT COMPLETED|Overall Study||10
8825864|NCT01601860|9879880|FG000|STARTED|Overall Study||40
8825865|NCT01601860|9879881|FG001|STARTED|Overall Study||40
8825866|NCT01601860|9879880|FG000|COMPLETED|Overall Study||19
8825867|NCT01601860|9879881|FG001|COMPLETED|Overall Study||31
8825868|NCT01601860|9879880|FG000|NOT COMPLETED|Overall Study||21
8825869|NCT01601860|9879881|FG001|NOT COMPLETED|Overall Study||9
8825870|NCT01601873|9879890|FG000|STARTED|Overall Study||50
8825871|NCT01601873|9879891|FG001|STARTED|Overall Study||47
8825872|NCT01601873|9879890|FG000|COMPLETED|Overall Study||48
8825873|NCT01601873|9879891|FG001|COMPLETED|Overall Study||44
8825874|NCT01601873|9879890|FG000|NOT COMPLETED|Overall Study||2
8825875|NCT01601873|9879891|FG001|NOT COMPLETED|Overall Study||3
8825876|NCT01601977|9879897|FG000|STARTED|Overall Study|5 patients consented for study participation but did not attend for study assessments.|10
8825877|NCT01601977|9879897|FG000|COMPLETED|Overall Study||10
8825878|NCT01601977|9879897|FG000|NOT COMPLETED|Overall Study||0
8825879|NCT01602068|9879905|FG000|STARTED|Overall Study|Day before surgery|23
8825880|NCT01602068|9879906|FG001|STARTED|Overall Study|Day before surgery|22
8825881|NCT01602068|9879905|FG000|COMPLETED|Overall Study||23
8825882|NCT01602068|9879906|FG001|COMPLETED|Overall Study||22
8825883|NCT01602068|9879905|FG000|NOT COMPLETED|Overall Study||0
8825884|NCT01602068|9879906|FG001|NOT COMPLETED|Overall Study||0
8825885|NCT01602120|9879916|FG000|STARTED|Overall Study||29
8825886|NCT01602120|9879917|FG001|STARTED|Overall Study||60
8825887|NCT01602120|9879918|FG002|STARTED|Overall Study||17
8825888|NCT01602120|9879919|FG003|STARTED|Overall Study||53
8825889|NCT01602120|9879916|FG000|COMPLETED|Overall Study||0
8825890|NCT01602120|9879917|FG001|COMPLETED|Overall Study||0
8825891|NCT01602120|9879918|FG002|COMPLETED|Overall Study||0
8825892|NCT01602120|9879919|FG003|COMPLETED|Overall Study||0
8825893|NCT01602120|9879916|FG000|NOT COMPLETED|Overall Study||29
8825894|NCT01602120|9879917|FG001|NOT COMPLETED|Overall Study||60
8825895|NCT01602120|9879918|FG002|NOT COMPLETED|Overall Study||17
8825896|NCT01602120|9879919|FG003|NOT COMPLETED|Overall Study||53
8825897|NCT01602172|9879934|FG000|STARTED|Overall Study||37
8825898|NCT01602172|9879935|FG001|STARTED|Overall Study||23
8825899|NCT01602172|9879936|FG002|STARTED|Overall Study||22
8825900|NCT01602172|9879934|FG000|COMPLETED|Overall Study||32
8825901|NCT01602172|9879935|FG001|COMPLETED|Overall Study||17
8825902|NCT01602172|9879936|FG002|COMPLETED|Overall Study||22
8825903|NCT01602172|9879934|FG000|NOT COMPLETED|Overall Study||5
8825904|NCT01602172|9879935|FG001|NOT COMPLETED|Overall Study||6
8825905|NCT01602172|9879936|FG002|NOT COMPLETED|Overall Study||0
8825906|NCT01602224|9879953|FG000|STARTED|Overall Study||74
8825907|NCT01602224|9879954|FG001|STARTED|Overall Study||74
8825908|NCT01602224|9879955|FG002|STARTED|Overall Study||72
8825909|NCT01602224|9879953|FG000|Received at Least 1 Dose of Study Drug|Overall Study||73
8825910|NCT01602224|9879954|FG001|Received at Least 1 Dose of Study Drug|Overall Study||74
8825911|NCT01602224|9879955|FG002|Received at Least 1 Dose of Study Drug|Overall Study||72
8825912|NCT01602224|9879953|FG000|COMPLETED|Overall Study||66
8825913|NCT01602224|9879954|FG001|COMPLETED|Overall Study||66
8825914|NCT01602224|9879955|FG002|COMPLETED|Overall Study||66
8825915|NCT01602224|9879953|FG000|NOT COMPLETED|Overall Study||8
8825916|NCT01602224|9879954|FG001|NOT COMPLETED|Overall Study||8
8825917|NCT01602224|9879955|FG002|NOT COMPLETED|Overall Study||6
8825918|NCT01602315|9879972|FG000|STARTED|Overall Study||16
8825919|NCT01602315|9879973|FG001|STARTED|Overall Study||5
8825920|NCT01602315|9879974|FG002|STARTED|Overall Study||18
8825921|NCT01602315|9879975|FG003|STARTED|Overall Study||6
8825922|NCT01602315|9879976|FG004|STARTED|Overall Study||71
8825923|NCT01602315|9879977|FG005|STARTED|Overall Study||35
8825924|NCT01602315|9879978|FG006|STARTED|Overall Study||29
8825925|NCT01602315|9879972|FG000|COMPLETED|Overall Study||0
8825926|NCT01602315|9879973|FG001|COMPLETED|Overall Study||0
8825927|NCT01602315|9879974|FG002|COMPLETED|Overall Study||0
8825928|NCT01602315|9879975|FG003|COMPLETED|Overall Study||0
8825929|NCT01602315|9879976|FG004|COMPLETED|Overall Study||0
8825930|NCT01602315|9879977|FG005|COMPLETED|Overall Study||0
8825931|NCT01602315|9879978|FG006|COMPLETED|Overall Study||0
8825932|NCT01602315|9879972|FG000|NOT COMPLETED|Overall Study||16
8825933|NCT01602315|9879973|FG001|NOT COMPLETED|Overall Study||5
8825934|NCT01602315|9879974|FG002|NOT COMPLETED|Overall Study||18
8825935|NCT01602315|9879975|FG003|NOT COMPLETED|Overall Study||6
8825936|NCT01602315|9879976|FG004|NOT COMPLETED|Overall Study||71
8825937|NCT01602315|9879977|FG005|NOT COMPLETED|Overall Study||35
8825938|NCT01602315|9879978|FG006|NOT COMPLETED|Overall Study||29
8825939|NCT01602341|9880016|FG000|STARTED|Overall Study||44
8825940|NCT01602341|9880017|FG001|STARTED|Overall Study||42
8825941|NCT01602341|9880016|FG000|COMPLETED|Overall Study||44
8825942|NCT01602341|9880017|FG001|COMPLETED|Overall Study||41
8825943|NCT01602341|9880016|FG000|NOT COMPLETED|Overall Study||0
8825944|NCT01602341|9880017|FG001|NOT COMPLETED|Overall Study||1
8825945|NCT01602419|9880027|FG000|STARTED|Overall Study||120
8825946|NCT01602419|9880027|FG000|SAF Population|Overall Study||111
8825947|NCT01602419|9880027|FG000|ITT Population|Overall Study||102
8825948|NCT01602419|9880027|FG000|EFF Population|Overall Study||91
8825949|NCT01602419|9880027|FG000|COMPLETED|Overall Study||91
8825950|NCT01602419|9880027|FG000|NOT COMPLETED|Overall Study||29
8825951|NCT01602484|9880074|FG000|STARTED|Overall Study||25
8825952|NCT01602484|9880075|FG001|STARTED|Overall Study||25
8825953|NCT01602484|9880074|FG000|COMPLETED|Overall Study||25
8825954|NCT01602484|9880075|FG001|COMPLETED|Overall Study||24
8825955|NCT01602484|9880074|FG000|NOT COMPLETED|Overall Study||0
8825956|NCT01602484|9880075|FG001|NOT COMPLETED|Overall Study||1
8825957|NCT01602510|9880081|FG000|STARTED|Open Label Phase||420
8825958|NCT01602510|9880082|FG001|STARTED|Open Label Phase||0
8825959|NCT01602510|9880083|FG002|STARTED|Open Label Phase||0
8825960|NCT01602510|9880081|FG000|COMPLETED|Open Label Phase||117
8825961|NCT01602510|9880082|FG001|COMPLETED|Open Label Phase||0
8825962|NCT01602510|9880083|FG002|COMPLETED|Open Label Phase||0
8825963|NCT01602510|9880081|FG000|NOT COMPLETED|Open Label Phase||303
8825964|NCT01602510|9880082|FG001|NOT COMPLETED|Open Label Phase||0
8825965|NCT01602510|9880083|FG002|NOT COMPLETED|Open Label Phase||0
8825966|NCT01602510|9880081|FG000|STARTED|Randomized Phase||0
8825967|NCT01602510|9880082|FG001|STARTED|Randomized Phase||133
8825968|NCT01602510|9880083|FG002|STARTED|Randomized Phase||131
8825969|NCT01602510|9880081|FG000|COMPLETED|Randomized Phase||0
8825970|NCT01602510|9880082|FG001|COMPLETED|Randomized Phase||59
8825971|NCT01602510|9880083|FG002|COMPLETED|Randomized Phase||58
8825972|NCT01602510|9880081|FG000|NOT COMPLETED|Randomized Phase||0
8825973|NCT01602510|9880082|FG001|NOT COMPLETED|Randomized Phase||74
8825974|NCT01602510|9880083|FG002|NOT COMPLETED|Randomized Phase||73
8825975|NCT01602549|9880091|FG000|STARTED|Overall Study||19
8825976|NCT01602549|9880092|FG001|STARTED|Overall Study||38
8825977|NCT01602549|9880091|FG000|COMPLETED|Overall Study||18
8825978|NCT01602549|9880092|FG001|COMPLETED|Overall Study||37
8825979|NCT01602549|9880091|FG000|NOT COMPLETED|Overall Study||1
8825980|NCT01602549|9880092|FG001|NOT COMPLETED|Overall Study||1
8825981|NCT01602562|9880102|FG000|STARTED|Overall Study||21
8825982|NCT01602562|9880103|FG001|STARTED|Overall Study||19
8825983|NCT01602562|9880102|FG000|COMPLETED|Overall Study||16
8825984|NCT01602562|9880103|FG001|COMPLETED|Overall Study||16
8825985|NCT01602562|9880102|FG000|NOT COMPLETED|Overall Study||5
8825986|NCT01602562|9880103|FG001|NOT COMPLETED|Overall Study||3
8825987|NCT01602614|9880114|FG000|STARTED|Overall Study||0
8825988|NCT01602614|9880115|FG001|STARTED|Overall Study||10
8825989|NCT01602614|9880116|FG002|STARTED|Overall Study||8
8825990|NCT01602614|9880117|FG003|STARTED|Overall Study||0
8825991|NCT01602614|9880114|FG000|COMPLETED|Overall Study||0
8825992|NCT01602614|9880115|FG001|COMPLETED|Overall Study||10
8622187|NCT00486759|9661382|FG001|NOT COMPLETED|Safety Follow-up||118
8622188|NCT00486811|9661391|FG000|STARTED|Overall Study||337
8622189|NCT00486811|9661392|FG001|STARTED|Overall Study|One participant was not eligible to be dosed.|320
8825993|NCT01602614|9880116|FG002|COMPLETED|Overall Study||8
8825994|NCT01602614|9880117|FG003|COMPLETED|Overall Study||0
8825995|NCT01602614|9880114|FG000|NOT COMPLETED|Overall Study||0
8825996|NCT01602614|9880115|FG001|NOT COMPLETED|Overall Study||0
8825997|NCT01602614|9880116|FG002|NOT COMPLETED|Overall Study||0
8825998|NCT01602614|9880117|FG003|NOT COMPLETED|Overall Study||0
8825999|NCT01602679|9880133|FG000|STARTED|Overall Study||4
8826000|NCT01602679|9880134|FG001|STARTED|Overall Study||3
8826001|NCT01602679|9880133|FG000|COMPLETED|Overall Study||4
8826002|NCT01602679|9880134|FG001|COMPLETED|Overall Study||3
8826003|NCT01602679|9880133|FG000|NOT COMPLETED|Overall Study||0
8826004|NCT01602679|9880134|FG001|NOT COMPLETED|Overall Study||0
8826005|NCT01602692|9880142|FG000|STARTED|Overall Study||20
8826006|NCT01602692|9880143|FG001|STARTED|Overall Study||20
8826007|NCT01602692|9880142|FG000|COMPLETED|Overall Study||20
8826008|NCT01602692|9880143|FG001|COMPLETED|Overall Study||20
8826009|NCT01602692|9880142|FG000|NOT COMPLETED|Overall Study||0
8826010|NCT01602692|9880143|FG001|NOT COMPLETED|Overall Study||0
8826011|NCT01602731|9880153|FG000|STARTED|Overall Study||45
8826012|NCT01602731|9880153|FG000|Cognitive Impairment|Overall Study|After repeat cognitive testing, additional 1 patient had no cognitive impairment and did not proceed|44
8826013|NCT01602731|9880153|FG000|Poor Medication Adherence|Overall Study|24 out of 35 patients who completed 1-month pill counts had medication adherence <88%.|24
8826014|NCT01602731|9880153|FG000|COMPLETED|Overall Study||15
8826015|NCT01602731|9880153|FG000|NOT COMPLETED|Overall Study||30
8826016|NCT01602744|9880161|FG000|STARTED|Overall Study||176
8826017|NCT01602744|9880162|FG001|STARTED|Overall Study||183
8826018|NCT01602744|9880161|FG000|COMPLETED|Overall Study||146
8826019|NCT01602744|9880162|FG001|COMPLETED|Overall Study||160
8826020|NCT01602744|9880161|FG000|NOT COMPLETED|Overall Study||30
8826021|NCT01602744|9880162|FG001|NOT COMPLETED|Overall Study||23
8826022|NCT01602965|9880170|FG000|STARTED|Overall Study||20
8826023|NCT01602965|9880171|FG001|STARTED|Overall Study||20
8826024|NCT01602965|9880170|FG000|COMPLETED|Overall Study||16
8826025|NCT01602965|9880171|FG001|COMPLETED|Overall Study||18
8826026|NCT01602965|9880170|FG000|NOT COMPLETED|Overall Study||4
8826027|NCT01602965|9880171|FG001|NOT COMPLETED|Overall Study||2
8826028|NCT01603056|9880179|FG000|STARTED|Overall Study||413
8826029|NCT01603056|9880180|FG001|STARTED|Overall Study||204
8826030|NCT01603056|9880179|FG000|COMPLETED|Overall Study||379
8826031|NCT01603056|9880180|FG001|COMPLETED|Overall Study||190
8826032|NCT01603056|9880179|FG000|NOT COMPLETED|Overall Study||34
8826033|NCT01603056|9880180|FG001|NOT COMPLETED|Overall Study||14
8826034|NCT01603082|9880188|FG000|STARTED|Overall Study|Randomized|51
8826035|NCT01603082|9880189|FG001|STARTED|Overall Study|Randomized|49
8826036|NCT01603082|9880188|FG000|COMPLETED|Overall Study|Completed the study.|49
8826037|NCT01603082|9880189|FG001|COMPLETED|Overall Study|Completed the study|48
8826038|NCT01603082|9880188|FG000|NOT COMPLETED|Overall Study||2
8826039|NCT01603082|9880189|FG001|NOT COMPLETED|Overall Study||1
8826040|NCT01603277|9880197|FG000|STARTED|Overall Study||78
8826041|NCT01603277|9880198|FG001|STARTED|Overall Study||82
8826042|NCT01603277|9880197|FG000|COMPLETED|Overall Study||64
8826043|NCT01603277|9880198|FG001|COMPLETED|Overall Study||64
8826044|NCT01603277|9880197|FG000|NOT COMPLETED|Overall Study||14
8622190|NCT00486811|9661393|FG002|STARTED|Overall Study|Two participants were not eligible to be dosed.|333
8622191|NCT00486811|9661391|FG000|COMPLETED|Overall Study||215
8826045|NCT01603277|9880198|FG001|NOT COMPLETED|Overall Study||18
8826046|NCT01603355|9880204|FG000|STARTED|Overall Study||3
8826047|NCT01603355|9880204|FG000|COMPLETED|Overall Study||1
8826048|NCT01603355|9880204|FG000|NOT COMPLETED|Overall Study||2
8826049|NCT01603368|9880210|FG000|STARTED|Overall Study||68
8826050|NCT01603368|9880211|FG001|STARTED|Overall Study||66
8826051|NCT01603368|9880210|FG000|COMPLETED|Overall Study||68
8826052|NCT01603368|9880211|FG001|COMPLETED|Overall Study||66
8826053|NCT01603368|9880210|FG000|NOT COMPLETED|Overall Study||0
8826054|NCT01603368|9880211|FG001|NOT COMPLETED|Overall Study||0
8826055|NCT01603420|9880219|FG000|STARTED|Overall Study||1
8826056|NCT01603420|9880220|FG001|STARTED|Overall Study||1
8826057|NCT01603420|9880219|FG000|COMPLETED|Overall Study||1
8826058|NCT01603420|9880220|FG001|COMPLETED|Overall Study||1
8826059|NCT01603420|9880219|FG000|NOT COMPLETED|Overall Study||0
8826060|NCT01603420|9880220|FG001|NOT COMPLETED|Overall Study||0
8826061|NCT01603459|9880229|FG000|STARTED|Overall Study||155
8826062|NCT01603459|9880229|FG000|COMPLETED|Overall Study||137
8826063|NCT01603459|9880229|FG000|NOT COMPLETED|Overall Study||18
8826064|NCT01603602|9880254|FG000|STARTED|Overall Study||77
8826065|NCT01603602|9880255|FG001|STARTED|Overall Study||78
8826066|NCT01603602|9880256|FG002|STARTED|Overall Study||80
8826067|NCT01603602|9880254|FG000|COMPLETED|Overall Study||75
8826068|NCT01603602|9880255|FG001|COMPLETED|Overall Study||78
8826069|NCT01603602|9880256|FG002|COMPLETED|Overall Study||79
8826070|NCT01603602|9880254|FG000|NOT COMPLETED|Overall Study||2
8826071|NCT01603602|9880255|FG001|NOT COMPLETED|Overall Study||0
8826072|NCT01603602|9880256|FG002|NOT COMPLETED|Overall Study||1
8826073|NCT01603615|9880264|FG000|STARTED|Overall Study||220
8826074|NCT01603615|9880264|FG000|Safety Population (Treated)|Overall Study||213
8826075|NCT01603615|9880264|FG000|COMPLETED|Overall Study||186
8826076|NCT01603615|9880264|FG000|NOT COMPLETED|Overall Study||34
8826077|NCT01603628|9880271|FG000|STARTED|Overall Study||128
8826078|NCT01603628|9880272|FG001|STARTED|Overall Study||126
8826079|NCT01603628|9880273|FG002|STARTED|Overall Study||130
8826080|NCT01603628|9880271|FG000|Safety Population: Received Treatment|Overall Study||128
8826081|NCT01603628|9880272|FG001|Safety Population: Received Treatment|Overall Study||126
8826082|NCT01603628|9880273|FG002|Safety Population: Received Treatment|Overall Study||128
8826083|NCT01603628|9880271|FG000|COMPLETED|Overall Study||125
8826084|NCT01603628|9880272|FG001|COMPLETED|Overall Study||123
8826085|NCT01603628|9880273|FG002|COMPLETED|Overall Study||128
8826086|NCT01603628|9880271|FG000|NOT COMPLETED|Overall Study||3
8826087|NCT01603628|9880272|FG001|NOT COMPLETED|Overall Study||3
8826088|NCT01603628|9880273|FG002|NOT COMPLETED|Overall Study||2
8826089|NCT01603641|9880281|FG000|STARTED|Overall Study||370
8826090|NCT01603641|9880281|FG000|Safety Population (Treated)|Overall Study||367
8826091|NCT01603641|9880281|FG000|Modified Intent-to-treat Population|Overall Study||366
8826092|NCT01603641|9880281|FG000|COMPLETED|Overall Study||335
8826093|NCT01603641|9880281|FG000|NOT COMPLETED|Overall Study||35
8826094|NCT01603875|9880288|FG000|STARTED|Overall Study||35
8826095|NCT01603875|9880289|FG001|STARTED|Overall Study||35
8826096|NCT01603875|9880290|FG002|STARTED|Overall Study||35
8826097|NCT01603875|9880288|FG000|COMPLETED|Overall Study||28
8826098|NCT01603875|9880289|FG001|COMPLETED|Overall Study||27
8826099|NCT01603875|9880290|FG002|COMPLETED|Overall Study||26
8826100|NCT01603875|9880288|FG000|NOT COMPLETED|Overall Study||7
8826101|NCT01603875|9880289|FG001|NOT COMPLETED|Overall Study||8
8826102|NCT01603875|9880290|FG002|NOT COMPLETED|Overall Study||9
8826103|NCT01603940|9880300|FG000|STARTED|Overall Study||16
8826104|NCT01603940|9880301|FG001|STARTED|Overall Study||14
8826105|NCT01603940|9880300|FG000|COMPLETED|Overall Study||16
8826106|NCT01603940|9880301|FG001|COMPLETED|Overall Study||14
8826107|NCT01603940|9880300|FG000|NOT COMPLETED|Overall Study||0
8826108|NCT01603940|9880301|FG001|NOT COMPLETED|Overall Study||0
8826109|NCT01604109|9880309|FG000|STARTED|Overall Study||150
8826110|NCT01604109|9880310|FG001|STARTED|Overall Study||146
8826111|NCT01604109|9880309|FG000|COMPLETED|Overall Study||117
8826112|NCT01604109|9880310|FG001|COMPLETED|Overall Study||112
8826113|NCT01604109|9880309|FG000|NOT COMPLETED|Overall Study||33
8826114|NCT01604109|9880310|FG001|NOT COMPLETED|Overall Study||34
8826115|NCT01604122|9880318|FG000|STARTED|Overall Study||60
8826116|NCT01604122|9880319|FG001|STARTED|Overall Study||32
8826117|NCT01604122|9880318|FG000|COMPLETED|Overall Study||60
8826118|NCT01604122|9880319|FG001|COMPLETED|Overall Study||32
8826119|NCT01604122|9880318|FG000|NOT COMPLETED|Overall Study||0
8826120|NCT01604122|9880319|FG001|NOT COMPLETED|Overall Study||0
8826121|NCT01604265|9880328|FG000|STARTED|Overall Study||34
8826122|NCT01604265|9880329|FG001|STARTED|Overall Study||32
8826123|NCT01604265|9880328|FG000|COMPLETED|Overall Study||32
8826124|NCT01604265|9880329|FG001|COMPLETED|Overall Study||32
8826125|NCT01604265|9880328|FG000|NOT COMPLETED|Overall Study||2
8826126|NCT01604265|9880329|FG001|NOT COMPLETED|Overall Study||0
8826127|NCT01604278|9880337|FG000|STARTED|Overall Study||226
8826128|NCT01604278|9880338|FG001|STARTED|Overall Study||223
8826129|NCT01604278|9880337|FG000|Safety Set|Overall Study||226
8826130|NCT01604278|9880338|FG001|Safety Set|Overall Study|Two randomized participants who did not receive study drug were excluded from this set.|221
8826131|NCT01604278|9880337|FG000|Full Analysis Set|Overall Study||226
8826132|NCT01604278|9880338|FG001|Full Analysis Set|Overall Study|Three randomized participants excluded: 2 who did not receive study drug; 1 with a major deviation.|220
8826133|NCT01604278|9880337|FG000|COMPLETED|Overall Study||212
8826134|NCT01604278|9880338|FG001|COMPLETED|Overall Study||210
8826135|NCT01604278|9880337|FG000|NOT COMPLETED|Overall Study||14
8826136|NCT01604278|9880338|FG001|NOT COMPLETED|Overall Study||13
8826137|NCT01604291|9880348|FG000|STARTED|Overall Study||311
8826138|NCT01604291|9880349|FG001|STARTED|Overall Study||443
8826139|NCT01604291|9880350|FG002|STARTED|Overall Study||193
8826140|NCT01604291|9880351|FG003|STARTED|Overall Study||44
8826141|NCT01604291|9880348|FG000|COMPLETED|Overall Study||311
8826142|NCT01604291|9880349|FG001|COMPLETED|Overall Study||443
8826143|NCT01604291|9880350|FG002|COMPLETED|Overall Study||193
8826144|NCT01604291|9880351|FG003|COMPLETED|Overall Study||44
8826145|NCT01604291|9880348|FG000|NOT COMPLETED|Overall Study||0
8826146|NCT01604291|9880349|FG001|NOT COMPLETED|Overall Study||0
8826147|NCT01604291|9880350|FG002|NOT COMPLETED|Overall Study||0
8826148|NCT01604291|9880351|FG003|NOT COMPLETED|Overall Study||0
8826149|NCT01604343|9880372|FG000|STARTED|Prior to W52 Administration(Through W52)||556
8826150|NCT01604343|9880373|FG001|STARTED|Prior to W52 Administration(Through W52)||0
8826151|NCT01604343|9880374|FG002|STARTED|Prior to W52 Administration(Through W52)||557
8826152|NCT01604343|9880375|FG003|STARTED|Prior to W52 Administration(Through W52)||0
8826153|NCT01604343|9880376|FG004|STARTED|Prior to W52 Administration(Through W52)||557
8826154|NCT01604343|9880372|FG000|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)|Out of 187, 95 were re-randomized to sirukumab 50 mg and 92 were re-randomized to 100 mg group.|187
8826155|NCT01604343|9880373|FG001|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0
8826156|NCT01604343|9880374|FG002|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0
8826157|NCT01604343|9880375|FG003|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0
8826158|NCT01604343|9880376|FG004|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0
8826159|NCT01604343|9880372|FG000|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)|Out of 24, 12 were re-randomized to sirukumab 50 mg and 12 were re-randomized to 100 mg group.|24
8826160|NCT01604343|9880373|FG001|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0
8826161|NCT01604343|9880374|FG002|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0
8826162|NCT01604343|9880375|FG003|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0
8826163|NCT01604343|9880376|FG004|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0
8826164|NCT01604343|9880372|FG000|COMPLETED|Prior to W52 Administration(Through W52)||458
8826165|NCT01604343|9880373|FG001|COMPLETED|Prior to W52 Administration(Through W52)||0
8826166|NCT01604343|9880374|FG002|COMPLETED|Prior to W52 Administration(Through W52)||481
8826167|NCT01604343|9880375|FG003|COMPLETED|Prior to W52 Administration(Through W52)||0
8826168|NCT01604343|9880376|FG004|COMPLETED|Prior to W52 Administration(Through W52)||470
8826169|NCT01604343|9880372|FG000|NOT COMPLETED|Prior to W52 Administration(Through W52)||98
8826170|NCT01604343|9880373|FG001|NOT COMPLETED|Prior to W52 Administration(Through W52)||0
8826171|NCT01604343|9880374|FG002|NOT COMPLETED|Prior to W52 Administration(Through W52)||76
8826172|NCT01604343|9880375|FG003|NOT COMPLETED|Prior to W52 Administration(Through W52)||0
8826173|NCT01604343|9880376|FG004|NOT COMPLETED|Prior to W52 Administration(Through W52)||87
8826174|NCT01604343|9880372|FG000|STARTED|Week 52 to Week 104||0
8826175|NCT01604343|9880373|FG001|STARTED|Week 52 to Week 104|Participants re-randomized at Week 18 (95), 40 (12) and 52 were included|243
8826176|NCT01604343|9880374|FG002|STARTED|Week 52 to Week 104||481
8826177|NCT01604343|9880375|FG003|STARTED|Week 52 to Week 104|Participants re-randomized at Week 18 (92), 40 (12) and 52 were included|241
8826178|NCT01604343|9880376|FG004|STARTED|Week 52 to Week 104||470
8826179|NCT01604343|9880372|FG000|Treated|Week 52 to Week 104||0
8826180|NCT01604343|9880373|FG001|Treated|Week 52 to Week 104||242
8826181|NCT01604343|9880374|FG002|Treated|Week 52 to Week 104||481
8826182|NCT01604343|9880375|FG003|Treated|Week 52 to Week 104||241
8826183|NCT01604343|9880376|FG004|Treated|Week 52 to Week 104||470
8826184|NCT01604343|9880372|FG000|COMPLETED|Week 52 to Week 104||0
8826185|NCT01604343|9880373|FG001|COMPLETED|Week 52 to Week 104||200
8826186|NCT01604343|9880374|FG002|COMPLETED|Week 52 to Week 104||414
8826187|NCT01604343|9880375|FG003|COMPLETED|Week 52 to Week 104||195
8826188|NCT01604343|9880376|FG004|COMPLETED|Week 52 to Week 104||429
8826189|NCT01604343|9880372|FG000|NOT COMPLETED|Week 52 to Week 104||0
8826190|NCT01604343|9880373|FG001|NOT COMPLETED|Week 52 to Week 104||43
8826191|NCT01604343|9880374|FG002|NOT COMPLETED|Week 52 to Week 104||67
8826192|NCT01604343|9880375|FG003|NOT COMPLETED|Week 52 to Week 104||46
8826193|NCT01604343|9880376|FG004|NOT COMPLETED|Week 52 to Week 104||41
8826194|NCT01604343|9880372|FG000|STARTED|Safety Follow-up Period (Week 104-120)||109
8826195|NCT01604343|9880373|FG001|STARTED|Safety Follow-up Period (Week 104-120)||27
8826196|NCT01604343|9880374|FG002|STARTED|Safety Follow-up Period (Week 104-120)||105
8826197|NCT01604343|9880375|FG003|STARTED|Safety Follow-up Period (Week 104-120)||36
8826198|NCT01604343|9880376|FG004|STARTED|Safety Follow-up Period (Week 104-120)||114
8826199|NCT01604343|9880372|FG000|Safety Population|Safety Follow-up Period (Week 104-120)||109
8826200|NCT01604343|9880373|FG001|Safety Population|Safety Follow-up Period (Week 104-120)||26
8826201|NCT01604343|9880374|FG002|Safety Population|Safety Follow-up Period (Week 104-120)||105
8943979|NCT02392559|10005766|FG000|NOT COMPLETED|Overall Study||0
8943980|NCT02392559|10005767|FG001|NOT COMPLETED|Overall Study||1
8943981|NCT02392611|10005783|FG000|STARTED|Overall Study||2
8943982|NCT02392611|10005784|FG001|STARTED|Overall Study||1
8943983|NCT02392611|10005785|FG002|STARTED|Overall Study||1
8943984|NCT02392611|10005786|FG003|STARTED|Overall Study||9
8943985|NCT02392611|10005787|FG004|STARTED|Overall Study||6
8943986|NCT02392611|10005788|FG005|STARTED|Overall Study||4
8943987|NCT02392611|10005789|FG006|STARTED|Overall Study||4
8943988|NCT02392611|10005790|FG007|STARTED|Overall Study||3
8943989|NCT02392611|10005791|FG008|STARTED|Overall Study||3
8943990|NCT02392611|10005783|FG000|COMPLETED|Overall Study||1
8943991|NCT02392611|10005784|FG001|COMPLETED|Overall Study||1
8943992|NCT02392611|10005785|FG002|COMPLETED|Overall Study||1
8943993|NCT02392611|10005786|FG003|COMPLETED|Overall Study||3
8943994|NCT02392611|10005787|FG004|COMPLETED|Overall Study||5
8943995|NCT02392611|10005788|FG005|COMPLETED|Overall Study||3
8943996|NCT02392611|10005789|FG006|COMPLETED|Overall Study||3
8943997|NCT02392611|10005790|FG007|COMPLETED|Overall Study||3
8943998|NCT02392611|10005791|FG008|COMPLETED|Overall Study||3
8943999|NCT02392611|10005783|FG000|NOT COMPLETED|Overall Study||1
8944000|NCT02392611|10005784|FG001|NOT COMPLETED|Overall Study||0
8944001|NCT02392611|10005785|FG002|NOT COMPLETED|Overall Study||0
8944002|NCT02392611|10005786|FG003|NOT COMPLETED|Overall Study||6
8944003|NCT02392611|10005787|FG004|NOT COMPLETED|Overall Study||1
8944004|NCT02392611|10005788|FG005|NOT COMPLETED|Overall Study||1
8944005|NCT02392611|10005789|FG006|NOT COMPLETED|Overall Study||1
8944006|NCT02392611|10005790|FG007|NOT COMPLETED|Overall Study||0
8944007|NCT02392611|10005791|FG008|NOT COMPLETED|Overall Study||0
8944008|NCT02392624|10005814|FG000|STARTED|Overall Study||71
8944009|NCT02392624|10005815|FG001|STARTED|Overall Study||81
8622192|NCT00486811|9661392|FG001|COMPLETED|Overall Study||179
8622193|NCT00486811|9661393|FG002|COMPLETED|Overall Study||119
8826202|NCT01604343|9880375|FG003|Safety Population|Safety Follow-up Period (Week 104-120)||36
8826203|NCT01604343|9880376|FG004|Safety Population|Safety Follow-up Period (Week 104-120)||114
8826204|NCT01604343|9880372|FG000|COMPLETED|Safety Follow-up Period (Week 104-120)||79
8826205|NCT01604343|9880373|FG001|COMPLETED|Safety Follow-up Period (Week 104-120)||20
8826206|NCT01604343|9880374|FG002|COMPLETED|Safety Follow-up Period (Week 104-120)||72
8826207|NCT01604343|9880375|FG003|COMPLETED|Safety Follow-up Period (Week 104-120)||26
8826208|NCT01604343|9880376|FG004|COMPLETED|Safety Follow-up Period (Week 104-120)||85
8826209|NCT01604343|9880372|FG000|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||30
8826210|NCT01604343|9880373|FG001|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||7
8826211|NCT01604343|9880374|FG002|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||33
8826212|NCT01604343|9880375|FG003|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||10
8826213|NCT01604343|9880376|FG004|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||29
8826214|NCT01604408|9880388|FG000|STARTED|Treatment Period 1||102
8826215|NCT01604408|9880389|FG001|STARTED|Treatment Period 1||99
8826216|NCT01604408|9880388|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1||102
8826217|NCT01604408|9880389|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1||99
8826218|NCT01604408|9880388|FG000|COMPLETED|Treatment Period 1||102
8826219|NCT01604408|9880389|FG001|COMPLETED|Treatment Period 1||98
8826220|NCT01604408|9880388|FG000|NOT COMPLETED|Treatment Period 1||0
8826221|NCT01604408|9880389|FG001|NOT COMPLETED|Treatment Period 1||1
8826222|NCT01604408|9880388|FG000|STARTED|Treatment Period 2||102
8826223|NCT01604408|9880389|FG001|STARTED|Treatment Period 2||98
8826224|NCT01604408|9880388|FG000|COMPLETED|Treatment Period 2||100
8826225|NCT01604408|9880389|FG001|COMPLETED|Treatment Period 2||96
8826226|NCT01604408|9880388|FG000|NOT COMPLETED|Treatment Period 2||2
8826227|NCT01604408|9880389|FG001|NOT COMPLETED|Treatment Period 2||2
8826228|NCT01604408|9880388|FG000|STARTED|Treatment Period 3||100
8826229|NCT01604408|9880389|FG001|STARTED|Treatment Period 3||96
8826230|NCT01604408|9880388|FG000|COMPLETED|Treatment Period 3||95
8826231|NCT01604408|9880389|FG001|COMPLETED|Treatment Period 3||91
8826232|NCT01604408|9880388|FG000|NOT COMPLETED|Treatment Period 3||5
8826233|NCT01604408|9880389|FG001|NOT COMPLETED|Treatment Period 3||5
8826234|NCT01604408|9880388|FG000|STARTED|Treatment Period 4||95
8826235|NCT01604408|9880389|FG001|STARTED|Treatment Period 4||91
8826236|NCT01604408|9880388|FG000|COMPLETED|Treatment Period 4||92
8826237|NCT01604408|9880389|FG001|COMPLETED|Treatment Period 4||89
8826238|NCT01604408|9880388|FG000|NOT COMPLETED|Treatment Period 4||3
8826239|NCT01604408|9880389|FG001|NOT COMPLETED|Treatment Period 4||2
8826240|NCT01604408|9880388|FG000|STARTED|Treatment Period 5||92
8826241|NCT01604408|9880389|FG001|STARTED|Treatment Period 5||89
8826242|NCT01604408|9880388|FG000|COMPLETED|Treatment Period 5||88
8826243|NCT01604408|9880389|FG001|COMPLETED|Treatment Period 5||89
8826244|NCT01604408|9880388|FG000|NOT COMPLETED|Treatment Period 5||4
8826245|NCT01604408|9880389|FG001|NOT COMPLETED|Treatment Period 5||0
8826246|NCT01604408|9880388|FG000|STARTED|Treatment Period 6||88
8826247|NCT01604408|9880389|FG001|STARTED|Treatment Period 6||89
8826248|NCT01604408|9880388|FG000|COMPLETED|Treatment Period 6||86
8826249|NCT01604408|9880389|FG001|COMPLETED|Treatment Period 6||87
8826250|NCT01604408|9880388|FG000|NOT COMPLETED|Treatment Period 6||2
8826251|NCT01604408|9880389|FG001|NOT COMPLETED|Treatment Period 6||2
8826252|NCT01604408|9880388|FG000|STARTED|Observation Period||86
8826253|NCT01604408|9880389|FG001|STARTED|Observation Period||87
8826254|NCT01604408|9880388|FG000|COMPLETED|Observation Period||85
8826255|NCT01604408|9880389|FG001|COMPLETED|Observation Period||84
8826256|NCT01604408|9880388|FG000|NOT COMPLETED|Observation Period||1
8826257|NCT01604408|9880389|FG001|NOT COMPLETED|Observation Period||3
8826258|NCT01604772|9880395|FG000|STARTED|Overall Study||16
8826259|NCT01604772|9880395|FG000|COMPLETED|Overall Study||16
8826260|NCT01604772|9880395|FG000|NOT COMPLETED|Overall Study||0
8826261|NCT01604785|9880402|FG000|STARTED|Overall Study||37
8826262|NCT01604785|9880403|FG001|STARTED|Overall Study||37
8826263|NCT01604785|9880402|FG000|COMPLETED|Overall Study||30
8826264|NCT01604785|9880403|FG001|COMPLETED|Overall Study||36
8622194|NCT00486811|9661391|FG000|NOT COMPLETED|Overall Study||122
8622195|NCT00486811|9661392|FG001|NOT COMPLETED|Overall Study||141
8826265|NCT01604785|9880402|FG000|NOT COMPLETED|Overall Study||7
8826266|NCT01604785|9880403|FG001|NOT COMPLETED|Overall Study||1
8826267|NCT01604824|9880413|FG000|STARTED|Double-blind (DB) Period||6
8826268|NCT01604824|9880414|FG001|STARTED|Double-blind (DB) Period||7
8826269|NCT01604824|9880415|FG002|STARTED|Double-blind (DB) Period||5
8826270|NCT01604824|9880416|FG003|STARTED|Double-blind (DB) Period||5
8826271|NCT01604824|9880417|FG004|STARTED|Double-blind (DB) Period||0
8826272|NCT01604824|9880418|FG005|STARTED|Double-blind (DB) Period||0
8826273|NCT01604824|9880413|FG000|Completed DB Period (Day 99)|Double-blind (DB) Period||6
8826274|NCT01604824|9880414|FG001|Completed DB Period (Day 99)|Double-blind (DB) Period||7
8826275|NCT01604824|9880415|FG002|Completed DB Period (Day 99)|Double-blind (DB) Period||5
8826276|NCT01604824|9880416|FG003|Completed DB Period (Day 99)|Double-blind (DB) Period||5
8826277|NCT01604824|9880417|FG004|Completed DB Period (Day 99)|Double-blind (DB) Period||0
8826278|NCT01604824|9880418|FG005|Completed DB Period (Day 99)|Double-blind (DB) Period||0
8826279|NCT01604824|9880413|FG000|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||6
8826280|NCT01604824|9880414|FG001|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||7
8826281|NCT01604824|9880415|FG002|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||5
8826282|NCT01604824|9880416|FG003|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||5
8826283|NCT01604824|9880417|FG004|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||0
8826284|NCT01604824|9880418|FG005|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||0
8826285|NCT01604824|9880413|FG000|COMPLETED|Double-blind (DB) Period||6
8826286|NCT01604824|9880414|FG001|COMPLETED|Double-blind (DB) Period||7
8826287|NCT01604824|9880415|FG002|COMPLETED|Double-blind (DB) Period||5
8826288|NCT01604824|9880416|FG003|COMPLETED|Double-blind (DB) Period||5
8826289|NCT01604824|9880417|FG004|COMPLETED|Double-blind (DB) Period||0
8826290|NCT01604824|9880418|FG005|COMPLETED|Double-blind (DB) Period||0
8826291|NCT01604824|9880413|FG000|NOT COMPLETED|Double-blind (DB) Period||0
8826292|NCT01604824|9880414|FG001|NOT COMPLETED|Double-blind (DB) Period||0
8826293|NCT01604824|9880415|FG002|NOT COMPLETED|Double-blind (DB) Period||0
8826294|NCT01604824|9880416|FG003|NOT COMPLETED|Double-blind (DB) Period||0
8826295|NCT01604824|9880417|FG004|NOT COMPLETED|Double-blind (DB) Period||0
8826296|NCT01604824|9880418|FG005|NOT COMPLETED|Double-blind (DB) Period||0
8826297|NCT01604824|9880413|FG000|STARTED|Open-label Extension (OLE) Period||0
8826298|NCT01604824|9880414|FG001|STARTED|Open-label Extension (OLE) Period||0
8826299|NCT01604824|9880415|FG002|STARTED|Open-label Extension (OLE) Period||0
8826300|NCT01604824|9880416|FG003|STARTED|Open-label Extension (OLE) Period||0
8826301|NCT01604824|9880417|FG004|STARTED|Open-label Extension (OLE) Period|Completed DB Period (Day 99)|13
8826302|NCT01604824|9880418|FG005|STARTED|Open-label Extension (OLE) Period|Completed DB follow-up (Day 155)|10
8826303|NCT01604824|9880413|FG000|Started Open-label Extension Period|Open-label Extension (OLE) Period||0
8826304|NCT01604824|9880414|FG001|Started Open-label Extension Period|Open-label Extension (OLE) Period||0
8826305|NCT01604824|9880415|FG002|Started Open-label Extension Period|Open-label Extension (OLE) Period||0
8826306|NCT01604824|9880416|FG003|Started Open-label Extension Period|Open-label Extension (OLE) Period||0
8826307|NCT01604824|9880417|FG004|Started Open-label Extension Period|Open-label Extension (OLE) Period|Two subjects chose not to enter OLE period|11
8826308|NCT01604824|9880418|FG005|Started Open-label Extension Period|Open-label Extension (OLE) Period||10
8826309|NCT01604824|9880413|FG000|Completed Study|Open-label Extension (OLE) Period||0
8826310|NCT01604824|9880414|FG001|Completed Study|Open-label Extension (OLE) Period||0
8826311|NCT01604824|9880415|FG002|Completed Study|Open-label Extension (OLE) Period||0
8826312|NCT01604824|9880416|FG003|Completed Study|Open-label Extension (OLE) Period||0
8826313|NCT01604824|9880417|FG004|Completed Study|Open-label Extension (OLE) Period||10
8826314|NCT01604824|9880418|FG005|Completed Study|Open-label Extension (OLE) Period||10
8826315|NCT01604824|9880413|FG000|COMPLETED|Open-label Extension (OLE) Period||0
8826316|NCT01604824|9880414|FG001|COMPLETED|Open-label Extension (OLE) Period||0
8826317|NCT01604824|9880415|FG002|COMPLETED|Open-label Extension (OLE) Period||0
8826318|NCT01604824|9880416|FG003|COMPLETED|Open-label Extension (OLE) Period||0
8826319|NCT01604824|9880417|FG004|COMPLETED|Open-label Extension (OLE) Period||10
8826320|NCT01604824|9880418|FG005|COMPLETED|Open-label Extension (OLE) Period||10
8622196|NCT00486811|9661393|FG002|NOT COMPLETED|Overall Study||214
8622197|NCT00486824|9661403|FG000|STARTED|Overall Study||5
8622198|NCT00486824|9661404|FG001|STARTED|Overall Study||5
8622199|NCT00486824|9661403|FG000|COMPLETED|Overall Study||3
8622200|NCT00486824|9661404|FG001|COMPLETED|Overall Study||3
8622201|NCT00486824|9661403|FG000|NOT COMPLETED|Overall Study||2
8622202|NCT00486824|9661404|FG001|NOT COMPLETED|Overall Study||2
8622203|NCT00486837|9661412|FG000|STARTED|Overall Study||37
8826321|NCT01604824|9880413|FG000|NOT COMPLETED|Open-label Extension (OLE) Period||0
8826322|NCT01604824|9880414|FG001|NOT COMPLETED|Open-label Extension (OLE) Period||0
8826323|NCT01604824|9880415|FG002|NOT COMPLETED|Open-label Extension (OLE) Period||0
8826324|NCT01604824|9880416|FG003|NOT COMPLETED|Open-label Extension (OLE) Period||0
8826325|NCT01604824|9880417|FG004|NOT COMPLETED|Open-label Extension (OLE) Period||3
8826326|NCT01604824|9880418|FG005|NOT COMPLETED|Open-label Extension (OLE) Period||0
8826327|NCT01604850|9880432|FG000|STARTED|Overall Study||103
8826328|NCT01604850|9880433|FG001|STARTED|Overall Study||99
8826329|NCT01604850|9880432|FG000|Enrolled and Treated|Overall Study||103
8826330|NCT01604850|9880433|FG001|Enrolled and Treated|Overall Study||98
8826331|NCT01604850|9880432|FG000|COMPLETED|Overall Study||51
8826332|NCT01604850|9880433|FG001|COMPLETED|Overall Study||69
8622204|NCT00486837|9661413|FG001|STARTED|Overall Study||35
8622205|NCT00486837|9661412|FG000|COMPLETED|Overall Study||28
8826333|NCT01604850|9880432|FG000|NOT COMPLETED|Overall Study||52
8826334|NCT01604850|9880433|FG001|NOT COMPLETED|Overall Study||30
8826335|NCT01604941|9880441|FG000|STARTED|Overall Study||11
8826336|NCT01604941|9880442|FG001|STARTED|Overall Study||4
8826337|NCT01604941|9880443|FG002|STARTED|Overall Study||3
8826338|NCT01604941|9880444|FG003|STARTED|Overall Study||3
8826339|NCT01604941|9880445|FG004|STARTED|Overall Study||4
8826340|NCT01604941|9880446|FG005|STARTED|Overall Study||7
8826341|NCT01604941|9880441|FG000|COMPLETED|Overall Study||0
8826342|NCT01604941|9880442|FG001|COMPLETED|Overall Study||0
8826343|NCT01604941|9880443|FG002|COMPLETED|Overall Study||0
8826344|NCT01604941|9880444|FG003|COMPLETED|Overall Study||0
8826345|NCT01604941|9880445|FG004|COMPLETED|Overall Study||3
8826346|NCT01604941|9880446|FG005|COMPLETED|Overall Study||0
8826347|NCT01604941|9880441|FG000|NOT COMPLETED|Overall Study||11
8826348|NCT01604941|9880442|FG001|NOT COMPLETED|Overall Study||4
8622206|NCT00486837|9661413|FG001|COMPLETED|Overall Study||28
8622207|NCT00486837|9661412|FG000|NOT COMPLETED|Overall Study||9
8826349|NCT01604941|9880443|FG002|NOT COMPLETED|Overall Study||3
8826350|NCT01604941|9880444|FG003|NOT COMPLETED|Overall Study||3
8826351|NCT01604941|9880445|FG004|NOT COMPLETED|Overall Study||1
8826352|NCT01604941|9880446|FG005|NOT COMPLETED|Overall Study||7
8826353|NCT01605032|9880452|FG000|STARTED|Overall Study||19
8826354|NCT01605032|9880452|FG000|COMPLETED|Overall Study||18
8826355|NCT01605032|9880452|FG000|NOT COMPLETED|Overall Study||1
8826356|NCT01605071|9880458|FG000|STARTED|Overall Study||27
8826357|NCT01605071|9880459|FG001|STARTED|Overall Study||26
8826358|NCT01605071|9880458|FG000|COMPLETED|Overall Study||24
8826359|NCT01605071|9880459|FG001|COMPLETED|Overall Study||24
8826360|NCT01605071|9880458|FG000|NOT COMPLETED|Overall Study||3
8826361|NCT01605071|9880459|FG001|NOT COMPLETED|Overall Study||2
8826362|NCT01605097|9880467|FG000|STARTED|Overall Study|One patient consented but was ineligible due to lack of lesion visible on mpMRI|26
8826363|NCT01605097|9880467|FG000|COMPLETED|Overall Study||25
8826364|NCT01605097|9880467|FG000|NOT COMPLETED|Overall Study||1
8826365|NCT01605136|9880474|FG000|STARTED|Study Period||48
8826366|NCT01605136|9880475|FG001|STARTED|Study Period||45
8826367|NCT01605136|9880474|FG000|COMPLETED|Study Period||45
8826368|NCT01605136|9880475|FG001|COMPLETED|Study Period||42
8826369|NCT01605136|9880474|FG000|NOT COMPLETED|Study Period||3
8826370|NCT01605136|9880475|FG001|NOT COMPLETED|Study Period||3
8826371|NCT01605136|9880474|FG000|STARTED|Safety Follow-Up Period||45
8826372|NCT01605136|9880475|FG001|STARTED|Safety Follow-Up Period||42
8826373|NCT01605136|9880474|FG000|COMPLETED|Safety Follow-Up Period||44
8826374|NCT01605136|9880475|FG001|COMPLETED|Safety Follow-Up Period||40
8826375|NCT01605136|9880474|FG000|NOT COMPLETED|Safety Follow-Up Period||1
8826376|NCT01605136|9880475|FG001|NOT COMPLETED|Safety Follow-Up Period||2
8826377|NCT01605227|9880483|FG000|STARTED|Overall Study||682
8826378|NCT01605227|9880484|FG001|STARTED|Overall Study||346
8826379|NCT01605227|9880483|FG000|COMPLETED|Overall Study||61
8826380|NCT01605227|9880484|FG001|COMPLETED|Overall Study||17
8826381|NCT01605227|9880483|FG000|NOT COMPLETED|Overall Study||621
8826382|NCT01605227|9880484|FG001|NOT COMPLETED|Overall Study||329
8826383|NCT01605292|9880492|FG000|STARTED|Overall Study||351
8826384|NCT01605292|9880493|FG001|STARTED|Overall Study||347
8826385|NCT01605292|9880492|FG000|COMPLETED|Overall Study||351
8826386|NCT01605292|9880493|FG001|COMPLETED|Overall Study||347
8826387|NCT01605292|9880492|FG000|NOT COMPLETED|Overall Study||0
8826388|NCT01605292|9880493|FG001|NOT COMPLETED|Overall Study||0
8826389|NCT01605396|9880501|FG000|STARTED|Overall Study||40
8826390|NCT01605396|9880502|FG001|STARTED|Overall Study||40
8826391|NCT01605396|9880501|FG000|Treated|Overall Study||39
8826392|NCT01605396|9880502|FG001|Treated|Overall Study||40
8826393|NCT01605396|9880501|FG000|COMPLETED|Overall Study||0
8826394|NCT01605396|9880502|FG001|COMPLETED|Overall Study||0
8826395|NCT01605396|9880501|FG000|NOT COMPLETED|Overall Study||40
8826396|NCT01605396|9880502|FG001|NOT COMPLETED|Overall Study||40
8826397|NCT01605435|9880508|FG000|STARTED|Overall Study||2
8826398|NCT01605435|9880509|FG001|STARTED|Overall Study||3
8826399|NCT01605435|9880508|FG000|COMPLETED|Overall Study||2
8826400|NCT01605435|9880509|FG001|COMPLETED|Overall Study||3
8826401|NCT01605435|9880508|FG000|NOT COMPLETED|Overall Study||0
8826402|NCT01605435|9880509|FG001|NOT COMPLETED|Overall Study||0
8826403|NCT01605461|9880526|FG000|STARTED|Overall Study||12
8826404|NCT01605461|9880526|FG000|COMPLETED|Overall Study||8
8826405|NCT01605461|9880526|FG000|NOT COMPLETED|Overall Study||4
8826406|NCT01605539|9880532|FG000|STARTED|Overall Study||3
8826407|NCT01605539|9880533|FG001|STARTED|Overall Study||3
8826408|NCT01605539|9880534|FG002|STARTED|Overall Study||4
8826409|NCT01605539|9880532|FG000|COMPLETED|Overall Study||3
8826410|NCT01605539|9880533|FG001|COMPLETED|Overall Study||2
8826411|NCT01605539|9880534|FG002|COMPLETED|Overall Study||4
8826412|NCT01605539|9880532|FG000|NOT COMPLETED|Overall Study||0
8826413|NCT01605539|9880533|FG001|NOT COMPLETED|Overall Study||1
8826414|NCT01605539|9880534|FG002|NOT COMPLETED|Overall Study||0
8826415|NCT01605552|9880545|FG000|STARTED|Overall Study||13
8826416|NCT01605552|9880546|FG001|STARTED|Overall Study||16
8826417|NCT01605552|9880545|FG000|COMPLETED|Overall Study|4 dropped out before the first BtB visit; it is unlikely that the treatment was the cause of dropout|7
8826418|NCT01605552|9880546|FG001|COMPLETED|Overall Study||14
8826419|NCT01605552|9880545|FG000|NOT COMPLETED|Overall Study||6
8826420|NCT01605552|9880546|FG001|NOT COMPLETED|Overall Study||2
8826421|NCT01605669|9880552|FG000|STARTED|Overall Study||50
8826422|NCT01605669|9880552|FG000|COMPLETED|Overall Study||50
8826423|NCT01605669|9880552|FG000|NOT COMPLETED|Overall Study||0
8826424|NCT01605799|9880559|FG000|STARTED|Overall Study||17
8826425|NCT01605799|9880560|FG001|STARTED|Overall Study||16
8826426|NCT01605799|9880559|FG000|COMPLETED|Overall Study||15
8826427|NCT01605799|9880560|FG001|COMPLETED|Overall Study||15
8826428|NCT01605799|9880559|FG000|NOT COMPLETED|Overall Study||2
8826429|NCT01605799|9880560|FG001|NOT COMPLETED|Overall Study||1
8826430|NCT01605825|9880568|FG000|STARTED|Overall Study||55
8826431|NCT01605825|9880569|FG001|STARTED|Overall Study||28
8826432|NCT01605825|9880568|FG000|COMPLETED|Overall Study||45
8826433|NCT01605825|9880569|FG001|COMPLETED|Overall Study||25
8826434|NCT01605825|9880568|FG000|NOT COMPLETED|Overall Study||10
8826435|NCT01605825|9880569|FG001|NOT COMPLETED|Overall Study||3
8826436|NCT01605877|9880575|FG000|STARTED|Overall Study||64
8826437|NCT01605877|9880575|FG000|COMPLETED|Overall Study||63
8826438|NCT01605877|9880575|FG000|NOT COMPLETED|Overall Study||1
8826439|NCT01605890|9880597|FG000|STARTED|Overall Study||30
8826440|NCT01605890|9880597|FG000|COMPLETED|Overall Study||28
8826441|NCT01605890|9880597|FG000|NOT COMPLETED|Overall Study||2
8826442|NCT01605903|9880603|FG000|STARTED|Overall Study||345
8826443|NCT01605903|9880604|FG001|STARTED|Overall Study||343
8826444|NCT01605903|9880603|FG000|COMPLETED|Overall Study||345
8826445|NCT01605903|9880604|FG001|COMPLETED|Overall Study||343
8826446|NCT01605903|9880603|FG000|NOT COMPLETED|Overall Study||0
8826447|NCT01605903|9880604|FG001|NOT COMPLETED|Overall Study||0
8826448|NCT01605916|9880615|FG000|STARTED|Overall Study||4
8826449|NCT01605916|9880616|FG001|STARTED|Overall Study||4
8826450|NCT01605916|9880617|FG002|STARTED|Overall Study||4
8826451|NCT01605916|9880618|FG003|STARTED|Overall Study||6
8826452|NCT01605916|9880619|FG004|STARTED|Overall Study||7
8826453|NCT01605916|9880615|FG000|COMPLETED|Overall Study||0
8826454|NCT01605916|9880616|FG001|COMPLETED|Overall Study||0
8826455|NCT01605916|9880617|FG002|COMPLETED|Overall Study|Subject ongoing the study at data cut off|1
8826456|NCT01605916|9880618|FG003|COMPLETED|Overall Study||0
8826457|NCT01605916|9880619|FG004|COMPLETED|Overall Study|Subject ongoing the study at data cut off|1
8826458|NCT01605916|9880615|FG000|NOT COMPLETED|Overall Study||4
8826459|NCT01605916|9880616|FG001|NOT COMPLETED|Overall Study||4
8826460|NCT01605916|9880617|FG002|NOT COMPLETED|Overall Study||3
8826461|NCT01605916|9880618|FG003|NOT COMPLETED|Overall Study||6
8826462|NCT01605916|9880619|FG004|NOT COMPLETED|Overall Study||6
8826463|NCT01605942|9880634|FG000|STARTED|Overall Study||6
8826464|NCT01605942|9880635|FG001|STARTED|Overall Study||2
8826465|NCT01605942|9880634|FG000|COMPLETED|Overall Study||6
8826466|NCT01605942|9880635|FG001|COMPLETED|Overall Study||2
8826467|NCT01605942|9880634|FG000|NOT COMPLETED|Overall Study||0
8826468|NCT01605942|9880635|FG001|NOT COMPLETED|Overall Study||0
8826469|NCT01606007|9880644|FG000|STARTED|Overall Study||176
8826470|NCT01606007|9880645|FG001|STARTED|Overall Study||179
8826471|NCT01606007|9880646|FG002|STARTED|Overall Study||179
8826472|NCT01606007|9880644|FG000|COMPLETED|Overall Study||161
8826473|NCT01606007|9880645|FG001|COMPLETED|Overall Study||160
8826474|NCT01606007|9880646|FG002|COMPLETED|Overall Study||169
8826475|NCT01606007|9880644|FG000|NOT COMPLETED|Overall Study||15
8826476|NCT01606007|9880645|FG001|NOT COMPLETED|Overall Study||19
8826477|NCT01606007|9880646|FG002|NOT COMPLETED|Overall Study||10
8826478|NCT01606124|9880656|FG000|STARTED|Overall Study||19
8826479|NCT01606124|9880657|FG001|STARTED|Overall Study||20
8826480|NCT01606124|9880656|FG000|COMPLETED|Overall Study||19
8826481|NCT01606124|9880657|FG001|COMPLETED|Overall Study||20
8826482|NCT01606124|9880656|FG000|NOT COMPLETED|Overall Study||0
8826483|NCT01606124|9880657|FG001|NOT COMPLETED|Overall Study||0
8826484|NCT01606137|9880663|FG000|STARTED|Overall Study||507
8826485|NCT01606137|9880663|FG000|COMPLETED|Overall Study||245
8826486|NCT01606137|9880663|FG000|NOT COMPLETED|Overall Study||262
8826487|NCT01606176|9880669|FG000|STARTED|Overall Study||36
8826488|NCT01606176|9880670|FG001|STARTED|Overall Study||34
8826489|NCT01606176|9880669|FG000|COMPLETED|Overall Study||32
8826490|NCT01606176|9880670|FG001|COMPLETED|Overall Study||31
8826491|NCT01606176|9880669|FG000|NOT COMPLETED|Overall Study||4
8826492|NCT01606176|9880670|FG001|NOT COMPLETED|Overall Study||3
8826493|NCT01606189|9880676|FG000|STARTED|First Intenvention (14-20 Days)||8
8826494|NCT01606189|9880677|FG001|STARTED|First Intenvention (14-20 Days)||8
8826495|NCT01606189|9880678|FG002|STARTED|First Intenvention (14-20 Days)||8
8826496|NCT01606189|9880679|FG003|STARTED|First Intenvention (14-20 Days)||8
8826497|NCT01606189|9880680|FG004|STARTED|First Intenvention (14-20 Days)||8
8826498|NCT01606189|9880681|FG005|STARTED|First Intenvention (14-20 Days)||8
8826499|NCT01606189|9880676|FG000|COMPLETED|First Intenvention (14-20 Days)||8
8826500|NCT01606189|9880677|FG001|COMPLETED|First Intenvention (14-20 Days)||8
8826501|NCT01606189|9880678|FG002|COMPLETED|First Intenvention (14-20 Days)||8
8826502|NCT01606189|9880679|FG003|COMPLETED|First Intenvention (14-20 Days)||8
8826503|NCT01606189|9880680|FG004|COMPLETED|First Intenvention (14-20 Days)||8
8826504|NCT01606189|9880681|FG005|COMPLETED|First Intenvention (14-20 Days)||8
8826505|NCT01606189|9880676|FG000|NOT COMPLETED|First Intenvention (14-20 Days)||0
8826506|NCT01606189|9880677|FG001|NOT COMPLETED|First Intenvention (14-20 Days)||0
8826507|NCT01606189|9880678|FG002|NOT COMPLETED|First Intenvention (14-20 Days)||0
8826508|NCT01606189|9880679|FG003|NOT COMPLETED|First Intenvention (14-20 Days)||0
8826509|NCT01606189|9880680|FG004|NOT COMPLETED|First Intenvention (14-20 Days)||0
8826510|NCT01606189|9880681|FG005|NOT COMPLETED|First Intenvention (14-20 Days)||0
8826511|NCT01606189|9880676|FG000|STARTED|Second Intenvention (14-20 Days)||8
8826512|NCT01606189|9880677|FG001|STARTED|Second Intenvention (14-20 Days)||8
8826513|NCT01606189|9880678|FG002|STARTED|Second Intenvention (14-20 Days)||8
8826514|NCT01606189|9880679|FG003|STARTED|Second Intenvention (14-20 Days)||8
8826515|NCT01606189|9880680|FG004|STARTED|Second Intenvention (14-20 Days)||8
8826516|NCT01606189|9880681|FG005|STARTED|Second Intenvention (14-20 Days)||8
8826517|NCT01606189|9880676|FG000|COMPLETED|Second Intenvention (14-20 Days)||8
8826518|NCT01606189|9880677|FG001|COMPLETED|Second Intenvention (14-20 Days)||8
8826519|NCT01606189|9880678|FG002|COMPLETED|Second Intenvention (14-20 Days)||8
8826520|NCT01606189|9880679|FG003|COMPLETED|Second Intenvention (14-20 Days)||8
8826521|NCT01606189|9880680|FG004|COMPLETED|Second Intenvention (14-20 Days)||8
8826522|NCT01606189|9880681|FG005|COMPLETED|Second Intenvention (14-20 Days)||7
8826523|NCT01606189|9880676|FG000|NOT COMPLETED|Second Intenvention (14-20 Days)||0
8826524|NCT01606189|9880677|FG001|NOT COMPLETED|Second Intenvention (14-20 Days)||0
8826525|NCT01606189|9880678|FG002|NOT COMPLETED|Second Intenvention (14-20 Days)||0
8826526|NCT01606189|9880679|FG003|NOT COMPLETED|Second Intenvention (14-20 Days)||0
8826527|NCT01606189|9880680|FG004|NOT COMPLETED|Second Intenvention (14-20 Days)||0
8826528|NCT01606189|9880681|FG005|NOT COMPLETED|Second Intenvention (14-20 Days)||1
8826529|NCT01606189|9880676|FG000|STARTED|Third Intenvention (14-20 Days)||8
8826530|NCT01606189|9880677|FG001|STARTED|Third Intenvention (14-20 Days)||8
8826531|NCT01606189|9880678|FG002|STARTED|Third Intenvention (14-20 Days)||8
8826532|NCT01606189|9880679|FG003|STARTED|Third Intenvention (14-20 Days)||8
8826533|NCT01606189|9880680|FG004|STARTED|Third Intenvention (14-20 Days)||8
8826534|NCT01606189|9880681|FG005|STARTED|Third Intenvention (14-20 Days)||7
8826535|NCT01606189|9880676|FG000|COMPLETED|Third Intenvention (14-20 Days)||8
8826536|NCT01606189|9880677|FG001|COMPLETED|Third Intenvention (14-20 Days)||8
8826537|NCT01606189|9880678|FG002|COMPLETED|Third Intenvention (14-20 Days)||8
8826538|NCT01606189|9880679|FG003|COMPLETED|Third Intenvention (14-20 Days)||8
8826539|NCT01606189|9880680|FG004|COMPLETED|Third Intenvention (14-20 Days)||8
8826540|NCT01606189|9880681|FG005|COMPLETED|Third Intenvention (14-20 Days)||6
8826541|NCT01606189|9880676|FG000|NOT COMPLETED|Third Intenvention (14-20 Days)||0
8826542|NCT01606189|9880677|FG001|NOT COMPLETED|Third Intenvention (14-20 Days)||0
8826543|NCT01606189|9880678|FG002|NOT COMPLETED|Third Intenvention (14-20 Days)||0
8826544|NCT01606189|9880679|FG003|NOT COMPLETED|Third Intenvention (14-20 Days)||0
8826545|NCT01606189|9880680|FG004|NOT COMPLETED|Third Intenvention (14-20 Days)||0
8826546|NCT01606189|9880681|FG005|NOT COMPLETED|Third Intenvention (14-20 Days)||1
8826547|NCT01606202|9880691|FG000|STARTED|Overall Study||56
8826548|NCT01606202|9880692|FG001|STARTED|Overall Study||60
8826549|NCT01606202|9880691|FG000|COMPLETED|Overall Study||49
8826550|NCT01606202|9880692|FG001|COMPLETED|Overall Study||57
8826551|NCT01606202|9880691|FG000|NOT COMPLETED|Overall Study||7
8826552|NCT01606202|9880692|FG001|NOT COMPLETED|Overall Study||3
8826553|NCT01606228|9880698|FG000|STARTED|Overall Study||188
8826554|NCT01606228|9880698|FG000|COMPLETED|Overall Study||159
8826555|NCT01606228|9880698|FG000|NOT COMPLETED|Overall Study||29
8826556|NCT01606254|9880706|FG000|STARTED|Overall Study||14
8826557|NCT01606254|9880707|FG001|STARTED|Overall Study||14
8826558|NCT01606254|9880708|FG002|STARTED|Overall Study||14
8826559|NCT01606254|9880709|FG003|STARTED|Overall Study||14
8826560|NCT01606254|9880706|FG000|COMPLETED|Overall Study||12
8826561|NCT01606254|9880707|FG001|COMPLETED|Overall Study||10
8826562|NCT01606254|9880708|FG002|COMPLETED|Overall Study||14
8826563|NCT01606254|9880709|FG003|COMPLETED|Overall Study||11
8826564|NCT01606254|9880706|FG000|NOT COMPLETED|Overall Study||2
8826565|NCT01606254|9880707|FG001|NOT COMPLETED|Overall Study||4
8826566|NCT01606254|9880708|FG002|NOT COMPLETED|Overall Study||0
8826567|NCT01606254|9880709|FG003|NOT COMPLETED|Overall Study||3
8826568|NCT01606306|9880725|FG000|STARTED|Overall Study||50
8826569|NCT01606306|9880726|FG001|STARTED|Overall Study||49
8826570|NCT01606306|9880727|FG002|STARTED|Overall Study||51
8826571|NCT01606306|9880728|FG003|STARTED|Overall Study||51
8826572|NCT01606306|9880729|FG004|STARTED|Overall Study||52
8826573|NCT01606306|9880730|FG005|STARTED|Overall Study||47
8826574|NCT01606306|9880725|FG000|Completed First Treatment Period|Overall Study||43
8826575|NCT01606306|9880726|FG001|Completed First Treatment Period|Overall Study||47
8826576|NCT01606306|9880727|FG002|Completed First Treatment Period|Overall Study||47
8826577|NCT01606306|9880728|FG003|Completed First Treatment Period|Overall Study||45
8826578|NCT01606306|9880729|FG004|Completed First Treatment Period|Overall Study||47
8826579|NCT01606306|9880730|FG005|Completed First Treatment Period|Overall Study||44
8826580|NCT01606306|9880725|FG000|Completed Second Treatment Period|Overall Study||41
8826581|NCT01606306|9880726|FG001|Completed Second Treatment Period|Overall Study||38
8826582|NCT01606306|9880727|FG002|Completed Second Treatment Period|Overall Study||43
8826583|NCT01606306|9880728|FG003|Completed Second Treatment Period|Overall Study||44
8826584|NCT01606306|9880729|FG004|Completed Second Treatment Period|Overall Study||46
8826585|NCT01606306|9880730|FG005|Completed Second Treatment Period|Overall Study||41
8826586|NCT01606306|9880725|FG000|Completed Third Treatment Period|Overall Study||35
8826587|NCT01606306|9880726|FG001|Completed Third Treatment Period|Overall Study||39
8826588|NCT01606306|9880727|FG002|Completed Third Treatment Period|Overall Study||37
8826589|NCT01606306|9880728|FG003|Completed Third Treatment Period|Overall Study||38
8826590|NCT01606306|9880729|FG004|Completed Third Treatment Period|Overall Study||41
8826591|NCT01606306|9880730|FG005|Completed Third Treatment Period|Overall Study||36
8826592|NCT01606306|9880725|FG000|COMPLETED|Overall Study||35
8826593|NCT01606306|9880726|FG001|COMPLETED|Overall Study||39
8826594|NCT01606306|9880727|FG002|COMPLETED|Overall Study||37
8826595|NCT01606306|9880728|FG003|COMPLETED|Overall Study||38
8826596|NCT01606306|9880729|FG004|COMPLETED|Overall Study||41
8826597|NCT01606306|9880730|FG005|COMPLETED|Overall Study||36
8826598|NCT01606306|9880725|FG000|NOT COMPLETED|Overall Study||15
8826599|NCT01606306|9880726|FG001|NOT COMPLETED|Overall Study||10
8826600|NCT01606306|9880727|FG002|NOT COMPLETED|Overall Study||14
8826601|NCT01606306|9880728|FG003|NOT COMPLETED|Overall Study||13
8826602|NCT01606306|9880729|FG004|NOT COMPLETED|Overall Study||11
8826603|NCT01606306|9880730|FG005|NOT COMPLETED|Overall Study||11
8826604|NCT01606319|9880738|FG000|STARTED|Overall Study||150
8826605|NCT01606319|9880739|FG001|STARTED|Overall Study||150
8826606|NCT01606319|9880738|FG000|COMPLETED|Overall Study||116
8826607|NCT01606319|9880739|FG001|COMPLETED|Overall Study||110
8826608|NCT01606319|9880738|FG000|NOT COMPLETED|Overall Study||34
8826609|NCT01606319|9880739|FG001|NOT COMPLETED|Overall Study||40
8826610|NCT01606670|9880745|FG000|STARTED|Overall Study||93
8826611|NCT01606670|9880745|FG000|Safety Set|Overall Study||93
8826612|NCT01606670|9880745|FG000|Full Analysis Set|Overall Study||70
8826613|NCT01606670|9880745|FG000|COMPLETED|Overall Study||77
8826614|NCT01606670|9880745|FG000|NOT COMPLETED|Overall Study||16
8826615|NCT01606735|9880752|FG000|STARTED|Overall Study||58
8826616|NCT01606735|9880753|FG001|STARTED|Overall Study||56
8826617|NCT01606735|9880754|FG002|STARTED|Overall Study||58
8826618|NCT01606735|9880752|FG000|COMPLETED|Overall Study||58
8826619|NCT01606735|9880753|FG001|COMPLETED|Overall Study||56
8826620|NCT01606735|9880754|FG002|COMPLETED|Overall Study||58
8622208|NCT00486837|9661413|FG001|NOT COMPLETED|Overall Study||7
8622209|NCT00486863|9661423|FG000|STARTED|Overall Study||184
8622210|NCT00486863|9661424|FG001|STARTED|Overall Study||186
8826621|NCT01606735|9880752|FG000|NOT COMPLETED|Overall Study||0
8826622|NCT01606735|9880753|FG001|NOT COMPLETED|Overall Study||0
8826623|NCT01606735|9880754|FG002|NOT COMPLETED|Overall Study||0
8826624|NCT01606748|9880764|FG000|STARTED|Overall Study||18
8826625|NCT01606748|9880765|FG001|STARTED|Overall Study||17
8826626|NCT01606748|9880764|FG000|Received at Least 1 Dose of Study Drug|Overall Study||18
8826627|NCT01606748|9880765|FG001|Received at Least 1 Dose of Study Drug|Overall Study||17
8826628|NCT01606748|9880764|FG000|COMPLETED|Overall Study||15
8826629|NCT01606748|9880765|FG001|COMPLETED|Overall Study||17
8826630|NCT01606748|9880764|FG000|NOT COMPLETED|Overall Study||3
8826631|NCT01606748|9880765|FG001|NOT COMPLETED|Overall Study||0
8826632|NCT01606761|9880786|FG000|STARTED|Prior to Week 24||294
8826633|NCT01606761|9880787|FG001|STARTED|Prior to Week 24||292
8826634|NCT01606761|9880788|FG002|STARTED|Prior to Week 24||292
8826635|NCT01606761|9880789|FG003|STARTED|Prior to Week 24||0
8826636|NCT01606761|9880790|FG004|STARTED|Prior to Week 24||0
8826637|NCT01606761|9880786|FG000|Participants Re-randomized at Week 18|Prior to Week 24|Out of 94, 46 were re-randomized to sirukumab 50 mg and 48 were re-randomized to 100 mg group.|94
8826638|NCT01606761|9880787|FG001|Participants Re-randomized at Week 18|Prior to Week 24||0
8826639|NCT01606761|9880788|FG002|Participants Re-randomized at Week 18|Prior to Week 24||0
8826640|NCT01606761|9880789|FG003|Participants Re-randomized at Week 18|Prior to Week 24||0
8826641|NCT01606761|9880790|FG004|Participants Re-randomized at Week 18|Prior to Week 24||0
8826642|NCT01606761|9880786|FG000|COMPLETED|Prior to Week 24||252
8826643|NCT01606761|9880787|FG001|COMPLETED|Prior to Week 24||237
8826644|NCT01606761|9880788|FG002|COMPLETED|Prior to Week 24||245
8826645|NCT01606761|9880789|FG003|COMPLETED|Prior to Week 24||0
8826646|NCT01606761|9880790|FG004|COMPLETED|Prior to Week 24||0
8826647|NCT01606761|9880786|FG000|NOT COMPLETED|Prior to Week 24||42
8826648|NCT01606761|9880787|FG001|NOT COMPLETED|Prior to Week 24||55
8826649|NCT01606761|9880788|FG002|NOT COMPLETED|Prior to Week 24||47
8826650|NCT01606761|9880789|FG003|NOT COMPLETED|Prior to Week 24||0
8826651|NCT01606761|9880790|FG004|NOT COMPLETED|Prior to Week 24||0
8826652|NCT01606761|9880786|FG000|STARTED|Week 24 to Week 52||0
8826653|NCT01606761|9880787|FG001|STARTED|Week 24 to Week 52||237
8826654|NCT01606761|9880788|FG002|STARTED|Week 24 to Week 52||245
8826655|NCT01606761|9880789|FG003|STARTED|Week 24 to Week 52|Participants re-randomized at Week 18 (46) and Week 24 (80) were included.|126
8826656|NCT01606761|9880790|FG004|STARTED|Week 24 to Week 52|Participants re-randomized at Week 18 (48) and Week 24 (78) were included.|126
8826657|NCT01606761|9880786|FG000|Treated|Week 24 to Week 52||0
8826658|NCT01606761|9880787|FG001|Treated|Week 24 to Week 52||237
8826659|NCT01606761|9880788|FG002|Treated|Week 24 to Week 52||245
8826660|NCT01606761|9880789|FG003|Treated|Week 24 to Week 52||124
8826661|NCT01606761|9880790|FG004|Treated|Week 24 to Week 52||126
8826662|NCT01606761|9880786|FG000|COMPLETED|Week 24 to Week 52||0
8826663|NCT01606761|9880787|FG001|COMPLETED|Week 24 to Week 52||204
8826664|NCT01606761|9880788|FG002|COMPLETED|Week 24 to Week 52||212
8826665|NCT01606761|9880789|FG003|COMPLETED|Week 24 to Week 52||109
8826666|NCT01606761|9880790|FG004|COMPLETED|Week 24 to Week 52||106
8826667|NCT01606761|9880786|FG000|NOT COMPLETED|Week 24 to Week 52||0
8826668|NCT01606761|9880787|FG001|NOT COMPLETED|Week 24 to Week 52||33
8826669|NCT01606761|9880788|FG002|NOT COMPLETED|Week 24 to Week 52||33
8826670|NCT01606761|9880789|FG003|NOT COMPLETED|Week 24 to Week 52||17
8826671|NCT01606761|9880790|FG004|NOT COMPLETED|Week 24 to Week 52||20
8826672|NCT01606761|9880786|FG000|STARTED|Safety Follow-up Period (Week 52-68)||28
8826673|NCT01606761|9880787|FG001|STARTED|Safety Follow-up Period (Week 52-68)||65
8826674|NCT01606761|9880788|FG002|STARTED|Safety Follow-up Period (Week 52-68)||62
8826675|NCT01606761|9880789|FG003|STARTED|Safety Follow-up Period (Week 52-68)||9
8826676|NCT01606761|9880790|FG004|STARTED|Safety Follow-up Period (Week 52-68)||19
8826677|NCT01606761|9880786|FG000|Safety Population|Safety Follow-up Period (Week 52-68)||28
8826678|NCT01606761|9880787|FG001|Safety Population|Safety Follow-up Period (Week 52-68)||65
8826679|NCT01606761|9880788|FG002|Safety Population|Safety Follow-up Period (Week 52-68)||62
8826680|NCT01606761|9880789|FG003|Safety Population|Safety Follow-up Period (Week 52-68)||7
8826681|NCT01606761|9880790|FG004|Safety Population|Safety Follow-up Period (Week 52-68)||19
8826682|NCT01606761|9880786|FG000|COMPLETED|Safety Follow-up Period (Week 52-68)||24
8826683|NCT01606761|9880787|FG001|COMPLETED|Safety Follow-up Period (Week 52-68)||55
8826684|NCT01606761|9880788|FG002|COMPLETED|Safety Follow-up Period (Week 52-68)||45
8826685|NCT01606761|9880789|FG003|COMPLETED|Safety Follow-up Period (Week 52-68)||7
8826686|NCT01606761|9880790|FG004|COMPLETED|Safety Follow-up Period (Week 52-68)||11
8622211|NCT00486863|9661423|FG000|COMPLETED|Overall Study||183
8826687|NCT01606761|9880786|FG000|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||4
8622212|NCT00486863|9661424|FG001|COMPLETED|Overall Study||183
8826688|NCT01606761|9880787|FG001|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||10
8826689|NCT01606761|9880788|FG002|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||17
8826690|NCT01606761|9880789|FG003|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||2
8826691|NCT01606761|9880790|FG004|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||8
8826692|NCT01606787|9880807|FG000|STARTED|Overall Study||105
8826693|NCT01606787|9880808|FG001|STARTED|Overall Study||105
8826694|NCT01606787|9880807|FG000|COMPLETED|Overall Study||101
8826695|NCT01606787|9880808|FG001|COMPLETED|Overall Study||98
8826696|NCT01606787|9880807|FG000|NOT COMPLETED|Overall Study||4
8826697|NCT01606787|9880808|FG001|NOT COMPLETED|Overall Study||7
8826698|NCT01606800|9880816|FG000|STARTED|Overall Study||22
8826699|NCT01606800|9880817|FG001|STARTED|Overall Study||23
8826700|NCT01606800|9880816|FG000|Treated|Overall Study||22
8826701|NCT01606800|9880817|FG001|Treated|Overall Study||23
8826702|NCT01606800|9880816|FG000|COMPLETED|Overall Study||17
8826703|NCT01606800|9880817|FG001|COMPLETED|Overall Study||21
8826704|NCT01606800|9880816|FG000|NOT COMPLETED|Overall Study||5
8826705|NCT01606800|9880817|FG001|NOT COMPLETED|Overall Study||2
8826706|NCT01606852|9880825|FG000|STARTED|Overall Study||7
8826707|NCT01606852|9880826|FG001|STARTED|Overall Study||8
8826708|NCT01606852|9880825|FG000|COMPLETED|Overall Study||7
8826709|NCT01606852|9880826|FG001|COMPLETED|Overall Study||8
8826710|NCT01606852|9880825|FG000|NOT COMPLETED|Overall Study||0
8826711|NCT01606852|9880826|FG001|NOT COMPLETED|Overall Study||0
8826712|NCT01607073|9880832|FG000|STARTED|Overall Study||2
8826713|NCT01607073|9880832|FG000|COMPLETED|Overall Study||1
8826714|NCT01607073|9880832|FG000|NOT COMPLETED|Overall Study||1
8826715|NCT01607112|9880841|FG000|STARTED|Overall Study||60
8826716|NCT01607112|9880842|FG001|STARTED|Overall Study||59
8826717|NCT01607112|9880841|FG000|COMPLETED|Overall Study||60
8826718|NCT01607112|9880842|FG001|COMPLETED|Overall Study||59
8826719|NCT01607112|9880841|FG000|NOT COMPLETED|Overall Study||0
8826720|NCT01607112|9880842|FG001|NOT COMPLETED|Overall Study||0
8849625|NCT01742091|9904872|FG004|RECEIVED STUDY DRUG|Overall Study||8
8849626|NCT01742091|9904873|FG005|RECEIVED STUDY DRUG|Overall Study||12
8849627|NCT01742091|9904868|FG000|COMPLETED|Overall Study||9
8849628|NCT01742091|9904869|FG001|COMPLETED|Overall Study||11
8849629|NCT01742091|9904870|FG002|COMPLETED|Overall Study||10
8849630|NCT01742091|9904871|FG003|COMPLETED|Overall Study||8
8849631|NCT01742091|9904872|FG004|COMPLETED|Overall Study||7
8849632|NCT01742091|9904873|FG005|COMPLETED|Overall Study||10
8849633|NCT01742091|9904868|FG000|NOT COMPLETED|Overall Study||0
8849634|NCT01742091|9904869|FG001|NOT COMPLETED|Overall Study||0
8849635|NCT01742091|9904870|FG002|NOT COMPLETED|Overall Study||0
8849636|NCT01742091|9904871|FG003|NOT COMPLETED|Overall Study||1
8849637|NCT01742091|9904872|FG004|NOT COMPLETED|Overall Study||1
8849638|NCT01742091|9904873|FG005|NOT COMPLETED|Overall Study||2
8849639|NCT01742117|9904889|FG000|STARTED|Overall Study||2641
8849640|NCT01742117|9904890|FG001|STARTED|Overall Study||2635
8849641|NCT01742117|9904889|FG000|COMPLETED|Overall Study||2641
8849642|NCT01742117|9904890|FG001|COMPLETED|Overall Study||2635
8849643|NCT01742117|9904889|FG000|NOT COMPLETED|Overall Study||0
8849644|NCT01742117|9904890|FG001|NOT COMPLETED|Overall Study||0
8849645|NCT01742208|9904899|FG000|STARTED|Overall Study||3
8849646|NCT01742208|9904900|FG001|STARTED|Overall Study||17
8849647|NCT01742208|9904901|FG002|STARTED|Overall Study||16
8849648|NCT01742208|9904899|FG000|COMPLETED|Overall Study||3
8849649|NCT01742208|9904900|FG001|COMPLETED|Overall Study||17
8849650|NCT01742208|9904901|FG002|COMPLETED|Overall Study||16
8849651|NCT01742208|9904899|FG000|NOT COMPLETED|Overall Study||0
8849652|NCT01742208|9904900|FG001|NOT COMPLETED|Overall Study||0
8849653|NCT01742208|9904901|FG002|NOT COMPLETED|Overall Study||0
8849654|NCT01742286|9904918|FG000|STARTED|Escalation Phase||5
8849655|NCT01742286|9904919|FG001|STARTED|Escalation Phase||12
8849656|NCT01742286|9904920|FG002|STARTED|Escalation Phase||6
8849657|NCT01742286|9904921|FG003|STARTED|Escalation Phase||2
8849658|NCT01742286|9904922|FG004|STARTED|Escalation Phase||4
8849659|NCT01742286|9904923|FG005|STARTED|Escalation Phase||5
8622213|NCT00486863|9661423|FG000|NOT COMPLETED|Overall Study||1
8622214|NCT00486863|9661424|FG001|NOT COMPLETED|Overall Study||3
8849660|NCT01742286|9904924|FG006|STARTED|Escalation Phase||6
8849661|NCT01742286|9904918|FG000|Ended Treatment = Not Completed)|Escalation Phase||5
8849662|NCT01742286|9904919|FG001|Ended Treatment = Not Completed)|Escalation Phase||12
8849663|NCT01742286|9904920|FG002|Ended Treatment = Not Completed)|Escalation Phase||6
8849664|NCT01742286|9904921|FG003|Ended Treatment = Not Completed)|Escalation Phase||2
8849665|NCT01742286|9904922|FG004|Ended Treatment = Not Completed)|Escalation Phase||4
8849666|NCT01742286|9904923|FG005|Ended Treatment = Not Completed)|Escalation Phase||5
8849667|NCT01742286|9904924|FG006|Ended Treatment = Not Completed)|Escalation Phase||6
8849668|NCT01742286|9904918|FG000|COMPLETED|Escalation Phase||0
8849669|NCT01742286|9904919|FG001|COMPLETED|Escalation Phase||0
8849670|NCT01742286|9904920|FG002|COMPLETED|Escalation Phase||0
8849671|NCT01742286|9904921|FG003|COMPLETED|Escalation Phase||0
8849672|NCT01742286|9904922|FG004|COMPLETED|Escalation Phase||0
8849673|NCT01742286|9904923|FG005|COMPLETED|Escalation Phase||0
8849674|NCT01742286|9904924|FG006|COMPLETED|Escalation Phase||0
8849675|NCT01742286|9904918|FG000|NOT COMPLETED|Escalation Phase||5
8849676|NCT01742286|9904919|FG001|NOT COMPLETED|Escalation Phase||12
8622215|NCT00486902|9661433|FG000|STARTED|Overall Study||94
8849677|NCT01742286|9904920|FG002|NOT COMPLETED|Escalation Phase||6
8849678|NCT01742286|9904921|FG003|NOT COMPLETED|Escalation Phase||2
8826721|NCT01607203|9880854|FG000|STARTED|Overall Study||59
8826722|NCT01607203|9880855|FG001|STARTED|Overall Study||61
8826723|NCT01607203|9880854|FG000|COMPLETED|Overall Study||59
8826724|NCT01607203|9880855|FG001|COMPLETED|Overall Study||61
8826725|NCT01607203|9880854|FG000|NOT COMPLETED|Overall Study||0
8826726|NCT01607203|9880855|FG001|NOT COMPLETED|Overall Study||0
8826727|NCT01607255|9880865|FG000|STARTED|Overall Study||161
8826728|NCT01607255|9880866|FG001|STARTED|Overall Study||160
8826729|NCT01607255|9880867|FG002|STARTED|Overall Study||159
8826730|NCT01607255|9880865|FG000|COMPLETED|Overall Study||161
8826731|NCT01607255|9880866|FG001|COMPLETED|Overall Study||160
8826732|NCT01607255|9880867|FG002|COMPLETED|Overall Study||159
8826733|NCT01607255|9880865|FG000|NOT COMPLETED|Overall Study||0
8826734|NCT01607255|9880866|FG001|NOT COMPLETED|Overall Study||0
8826735|NCT01607255|9880867|FG002|NOT COMPLETED|Overall Study||0
8826736|NCT01607346|9880875|FG000|STARTED|Overall Study||10
8826737|NCT01607346|9880875|FG000|COMPLETED|Overall Study||7
8826738|NCT01607346|9880875|FG000|NOT COMPLETED|Overall Study||3
8723293|NCT01022073|9770737|FG001|STARTED|Overall Study||70
8723294|NCT01022073|9770736|FG000|COMPLETED|Overall Study||67
8622216|NCT00486902|9661434|FG001|STARTED|Overall Study||94
8622217|NCT00486902|9661433|FG000|COMPLETED|Overall Study||85
8622218|NCT00486902|9661434|FG001|COMPLETED|Overall Study||89
8622219|NCT00486902|9661433|FG000|NOT COMPLETED|Overall Study||9
8622220|NCT00486902|9661434|FG001|NOT COMPLETED|Overall Study||5
8622221|NCT00486954|9661444|FG000|STARTED|Pilot Part||6
8622222|NCT00486954|9661445|FG001|STARTED|Pilot Part||0
8622223|NCT00486954|9661446|FG002|STARTED|Pilot Part||6
8622224|NCT00486954|9661447|FG003|STARTED|Pilot Part||0
8723295|NCT01022073|9770737|FG001|COMPLETED|Overall Study||52
8723296|NCT01022073|9770736|FG000|NOT COMPLETED|Overall Study||19
8723297|NCT01022073|9770737|FG001|NOT COMPLETED|Overall Study||18
8723298|NCT01022112|9770748|FG000|STARTED|Overall Study||82
8622225|NCT00486954|9661448|FG004|STARTED|Pilot Part||0
8622226|NCT00486954|9661444|FG000|COMPLETED|Pilot Part||0
8622227|NCT00486954|9661445|FG001|COMPLETED|Pilot Part||0
8622228|NCT00486954|9661446|FG002|COMPLETED|Pilot Part||0
8622229|NCT00486954|9661447|FG003|COMPLETED|Pilot Part||0
8622230|NCT00486954|9661448|FG004|COMPLETED|Pilot Part||0
8622231|NCT00486954|9661444|FG000|NOT COMPLETED|Pilot Part||6
8622232|NCT00486954|9661445|FG001|NOT COMPLETED|Pilot Part||0
8622233|NCT00486954|9661446|FG002|NOT COMPLETED|Pilot Part||6
8622234|NCT00486954|9661447|FG003|NOT COMPLETED|Pilot Part||0
8622235|NCT00486954|9661448|FG004|NOT COMPLETED|Pilot Part||0
8622236|NCT00486954|9661444|FG000|STARTED|Randomized Part||0
8622237|NCT00486954|9661445|FG001|STARTED|Randomized Part||0
8622238|NCT00486954|9661446|FG002|STARTED|Randomized Part||0
8622239|NCT00486954|9661447|FG003|STARTED|Randomized Part||132
8622240|NCT00486954|9661448|FG004|STARTED|Randomized Part||129
8622241|NCT00486954|9661444|FG000|COMPLETED|Randomized Part||0
8622242|NCT00486954|9661445|FG001|COMPLETED|Randomized Part||0
8622243|NCT00486954|9661446|FG002|COMPLETED|Randomized Part||0
8622244|NCT00486954|9661447|FG003|COMPLETED|Randomized Part||112
8622245|NCT00486954|9661448|FG004|COMPLETED|Randomized Part||115
8622246|NCT00486954|9661444|FG000|NOT COMPLETED|Randomized Part||0
8723299|NCT01022112|9770749|FG001|STARTED|Overall Study||74
8723300|NCT01022112|9770750|FG002|STARTED|Overall Study||77
8723301|NCT01022112|9770751|FG003|STARTED|Overall Study||75
8723302|NCT01022112|9770752|FG004|STARTED|Overall Study||75
8723303|NCT01022112|9770748|FG000|COMPLETED|Overall Study||79
8723304|NCT01022112|9770749|FG001|COMPLETED|Overall Study||71
8723305|NCT01022112|9770750|FG002|COMPLETED|Overall Study||74
8723306|NCT01022112|9770751|FG003|COMPLETED|Overall Study||72
8723307|NCT01022112|9770752|FG004|COMPLETED|Overall Study||65
8723308|NCT01022112|9770748|FG000|NOT COMPLETED|Overall Study||3
8723309|NCT01022112|9770749|FG001|NOT COMPLETED|Overall Study||3
8723310|NCT01022112|9770750|FG002|NOT COMPLETED|Overall Study||3
8723311|NCT01022112|9770751|FG003|NOT COMPLETED|Overall Study||3
8723312|NCT01022112|9770752|FG004|NOT COMPLETED|Overall Study||10
8723313|NCT01022190|9770764|FG000|STARTED|Overall Study||42
8723314|NCT01022190|9770764|FG000|COMPLETED|Overall Study||42
8723315|NCT01022190|9770764|FG000|NOT COMPLETED|Overall Study||0
8723316|NCT01022203|9770770|FG000|STARTED|PreTreatment Assessment||58
8723317|NCT01022203|9770771|FG001|STARTED|PreTreatment Assessment||56
8723318|NCT01022203|9770770|FG000|COMPLETED|PreTreatment Assessment||58
8723319|NCT01022203|9770771|FG001|COMPLETED|PreTreatment Assessment||56
8723320|NCT01022203|9770770|FG000|NOT COMPLETED|PreTreatment Assessment||0
8723321|NCT01022203|9770771|FG001|NOT COMPLETED|PreTreatment Assessment||0
8723322|NCT01022203|9770770|FG000|STARTED|Post Treatment Assessment||58
8723323|NCT01022203|9770771|FG001|STARTED|Post Treatment Assessment||56
8723324|NCT01022203|9770770|FG000|COMPLETED|Post Treatment Assessment||44
8723325|NCT01022203|9770771|FG001|COMPLETED|Post Treatment Assessment||42
8723326|NCT01022203|9770770|FG000|NOT COMPLETED|Post Treatment Assessment||14
8723327|NCT01022203|9770771|FG001|NOT COMPLETED|Post Treatment Assessment||14
8723328|NCT01022203|9770770|FG000|STARTED|Follow-Up Assessment||44
8723329|NCT01022203|9770771|FG001|STARTED|Follow-Up Assessment||42
8723330|NCT01022203|9770770|FG000|COMPLETED|Follow-Up Assessment||42
8723331|NCT01022203|9770771|FG001|COMPLETED|Follow-Up Assessment||40
8723332|NCT01022203|9770770|FG000|NOT COMPLETED|Follow-Up Assessment||2
8723333|NCT01022203|9770771|FG001|NOT COMPLETED|Follow-Up Assessment||2
8725164|NCT01029691|9772360|FG002|COMPLETED|APAP Initiation to Week 1 or Delivery||77
8622247|NCT00486954|9661445|FG001|NOT COMPLETED|Randomized Part||0
8622248|NCT00486954|9661446|FG002|NOT COMPLETED|Randomized Part||0
8622249|NCT00486954|9661447|FG003|NOT COMPLETED|Randomized Part||20
8622250|NCT00486954|9661448|FG004|NOT COMPLETED|Randomized Part||14
8622251|NCT00487084|9661461|FG000|STARTED|Overall Study||33
8622252|NCT00487084|9661462|FG001|STARTED|Overall Study||33
8622253|NCT00487084|9661463|FG002|STARTED|Overall Study||33
8622254|NCT00487084|9661461|FG000|COMPLETED|Overall Study||29
8622255|NCT00487084|9661462|FG001|COMPLETED|Overall Study||30
8622256|NCT00487084|9661463|FG002|COMPLETED|Overall Study||28
8622257|NCT00487084|9661461|FG000|NOT COMPLETED|Overall Study||4
8622258|NCT00487084|9661462|FG001|NOT COMPLETED|Overall Study||3
8622259|NCT00487084|9661463|FG002|NOT COMPLETED|Overall Study||5
8622260|NCT00487188|9661473|FG000|STARTED|Induction Phase||31
8622261|NCT00487188|9661474|FG001|STARTED|Induction Phase||16
8622262|NCT00487188|9661475|FG002|STARTED|Induction Phase|Participants were only randomized to this treatment arm in the Maintenance Phase|0
8622263|NCT00487188|9661473|FG000|Safety Population|Induction Phase||29
8622264|NCT00487188|9661474|FG001|Safety Population|Induction Phase|2 patients randomized to ENF + HARRT only received treatment with HAART|18
8622265|NCT00487188|9661475|FG002|Safety Population|Induction Phase||0
8622266|NCT00487188|9661473|FG000|COMPLETED|Induction Phase||22
8622267|NCT00487188|9661474|FG001|COMPLETED|Induction Phase||9
8622268|NCT00487188|9661475|FG002|COMPLETED|Induction Phase||0
8622269|NCT00487188|9661473|FG000|NOT COMPLETED|Induction Phase||9
8622270|NCT00487188|9661474|FG001|NOT COMPLETED|Induction Phase||7
8622271|NCT00487188|9661475|FG002|NOT COMPLETED|Induction Phase||0
8622272|NCT00487188|9661473|FG000|STARTED|Maintenance Phase||10
8622273|NCT00487188|9661474|FG001|STARTED|Maintenance Phase||8
8622274|NCT00487188|9661475|FG002|STARTED|Maintenance Phase||9
8622275|NCT00487188|9661473|FG000|COMPLETED|Maintenance Phase||7
8622276|NCT00487188|9661474|FG001|COMPLETED|Maintenance Phase||8
8622277|NCT00487188|9661475|FG002|COMPLETED|Maintenance Phase||8
8622278|NCT00487188|9661473|FG000|NOT COMPLETED|Maintenance Phase||3
8622279|NCT00487188|9661474|FG001|NOT COMPLETED|Maintenance Phase||0
8622280|NCT00487188|9661475|FG002|NOT COMPLETED|Maintenance Phase||1
8622281|NCT00487240|9661493|FG000|STARTED|Overall Study||195
8622282|NCT00487240|9661494|FG001|STARTED|Overall Study||192
8622283|NCT00487240|9661493|FG000|Full Analysis Set (ITT Population)|Overall Study||192
8622284|NCT00487240|9661494|FG001|Full Analysis Set (ITT Population)|Overall Study||189
8622285|NCT00487240|9661493|FG000|COMPLETED|Overall Study||164
8622286|NCT00487240|9661494|FG001|COMPLETED|Overall Study||166
8622287|NCT00487240|9661493|FG000|NOT COMPLETED|Overall Study||31
8622288|NCT00487240|9661494|FG001|NOT COMPLETED|Overall Study||26
8622289|NCT00487279|9661502|FG000|STARTED|Overall Study||44
8622290|NCT00487279|9661503|FG001|STARTED|Overall Study||37
8622291|NCT00487279|9661502|FG000|COMPLETED|Overall Study||43
8622292|NCT00487279|9661503|FG001|COMPLETED|Overall Study||35
8622293|NCT00487279|9661502|FG000|NOT COMPLETED|Overall Study||1
8622294|NCT00487279|9661503|FG001|NOT COMPLETED|Overall Study||2
8622295|NCT00487396|9661509|FG000|STARTED|Overall Study||98
8622296|NCT00487396|9661509|FG000|COMPLETED|Overall Study||95
8622297|NCT00487396|9661509|FG000|NOT COMPLETED|Overall Study||3
8622298|NCT00487435|9661518|FG000|STARTED|Overall Study|Patients who received at least one dose of Tapentadol (CG5503) Extended Release (ER)|1154
8622299|NCT00487435|9661518|FG000|COMPLETED|Overall Study||669
8622300|NCT00487435|9661518|FG000|NOT COMPLETED|Overall Study||485
8622301|NCT00487539|9661526|FG000|STARTED|Overall Study||331
8622302|NCT00487539|9661527|FG001|STARTED|Overall Study||72
8622303|NCT00487539|9661528|FG002|STARTED|Overall Study||331
8622304|NCT00487539|9661529|FG003|STARTED|Overall Study||331
8622305|NCT00487539|9661526|FG000|COMPLETED|Overall Study||324
8622306|NCT00487539|9661527|FG001|COMPLETED|Overall Study||69
8622307|NCT00487539|9661528|FG002|COMPLETED|Overall Study||328
8622308|NCT00487539|9661529|FG003|COMPLETED|Overall Study||327
8622309|NCT00487539|9661526|FG000|NOT COMPLETED|Overall Study||7
8622310|NCT00487539|9661527|FG001|NOT COMPLETED|Overall Study||3
8622311|NCT00487539|9661528|FG002|NOT COMPLETED|Overall Study||3
8622312|NCT00487539|9661529|FG003|NOT COMPLETED|Overall Study||4
8622313|NCT00487552|9661538|FG000|STARTED|Overall Study||18
8622314|NCT00487552|9661538|FG000|COMPLETED|Overall Study||12
8622315|NCT00487552|9661538|FG000|NOT COMPLETED|Overall Study||6
8622316|NCT00487565|9661543|FG000|STARTED|Overall Study||210
8622317|NCT00487565|9661543|FG000|COMPLETED|Overall Study||182
8622318|NCT00487565|9661543|FG000|NOT COMPLETED|Overall Study||28
8622319|NCT00487669|9661547|FG000|STARTED|Overall Study||12
8622320|NCT00487669|9661547|FG000|COMPLETED|Overall Study||12
8622321|NCT00487669|9661547|FG000|NOT COMPLETED|Overall Study||0
8622322|NCT00487695|9661553|FG000|STARTED|First Procedure||23
8622323|NCT00487695|9661554|FG001|STARTED|First Procedure||23
8622324|NCT00487695|9661553|FG000|COMPLETED|First Procedure||20
8622325|NCT00487695|9661554|FG001|COMPLETED|First Procedure||23
8622326|NCT00487695|9661553|FG000|NOT COMPLETED|First Procedure||3
8622327|NCT00487695|9661554|FG001|NOT COMPLETED|First Procedure||0
8622328|NCT00487695|9661553|FG000|STARTED|Second Procedure||20
8622329|NCT00487695|9661554|FG001|STARTED|Second Procedure||23
8622330|NCT00487695|9661553|FG000|COMPLETED|Second Procedure||19
8622331|NCT00487695|9661554|FG001|COMPLETED|Second Procedure||20
8622332|NCT00487695|9661553|FG000|NOT COMPLETED|Second Procedure||1
8622333|NCT00487695|9661554|FG001|NOT COMPLETED|Second Procedure||3
8622334|NCT00487721|9661562|FG000|STARTED|Overall Study||6
8622335|NCT00487721|9661563|FG001|STARTED|Overall Study||6
8622336|NCT00487721|9661562|FG000|COMPLETED|Overall Study||6
8622337|NCT00487721|9661563|FG001|COMPLETED|Overall Study||6
8622338|NCT00487721|9661562|FG000|NOT COMPLETED|Overall Study||0
8622339|NCT00487721|9661563|FG001|NOT COMPLETED|Overall Study||0
8622340|NCT00487747|9661568|FG000|STARTED|Overall Study||18
8622341|NCT00487747|9661568|FG000|COMPLETED|Overall Study||7
8622342|NCT00487747|9661568|FG000|NOT COMPLETED|Overall Study||11
8622343|NCT00487825|9661574|FG000|STARTED|Overall Study|"Started indicates Intent-to-treat population (ITT)"|52
8622344|NCT00487825|9661575|FG001|STARTED|Overall Study||26
8622345|NCT00487825|9661574|FG000|COMPLETED|Overall Study||46
8622346|NCT00487825|9661575|FG001|COMPLETED|Overall Study||21
8622347|NCT00487825|9661574|FG000|NOT COMPLETED|Overall Study||6
8622348|NCT00487825|9661575|FG001|NOT COMPLETED|Overall Study||5
8622349|NCT00487942|9661585|FG000|STARTED|Overall Study||15
8622350|NCT00487942|9661586|FG001|STARTED|Overall Study||15
8622351|NCT00487942|9661587|FG002|STARTED|Overall Study||15
8622352|NCT00487942|9661588|FG003|STARTED|Overall Study|One subject randomized to placebo discontinued prior to receiving any study drug, leaving 14.|15
8622353|NCT00487942|9661585|FG000|COMPLETED|Overall Study||12
8622354|NCT00487942|9661586|FG001|COMPLETED|Overall Study||12
8622355|NCT00487942|9661587|FG002|COMPLETED|Overall Study||12
8622356|NCT00487942|9661588|FG003|COMPLETED|Overall Study||13
8622357|NCT00487942|9661585|FG000|NOT COMPLETED|Overall Study||3
8622358|NCT00487942|9661586|FG001|NOT COMPLETED|Overall Study||3
8622359|NCT00487942|9661587|FG002|NOT COMPLETED|Overall Study||3
8622360|NCT00487942|9661588|FG003|NOT COMPLETED|Overall Study||2
8622361|NCT00488033|9661600|FG000|STARTED|Overall Study||448
8826739|NCT01607398|9880881|FG000|STARTED|Overall Study||28
8826740|NCT01607398|9880882|FG001|STARTED|Overall Study||28
8826741|NCT01607398|9880881|FG000|COMPLETED|Overall Study||26
8826742|NCT01607398|9880882|FG001|COMPLETED|Overall Study||26
8826743|NCT01607398|9880881|FG000|NOT COMPLETED|Overall Study||2
8826744|NCT01607398|9880882|FG001|NOT COMPLETED|Overall Study||2
8826745|NCT01607411|9880888|FG000|STARTED|Period I||14
8826746|NCT01607411|9880889|FG001|STARTED|Period I||13
8826747|NCT01607411|9880890|FG002|STARTED|Period I||14
8826748|NCT01607411|9880891|FG003|STARTED|Period I||14
8826749|NCT01607411|9880888|FG000|COMPLETED|Period I||14
8826750|NCT01607411|9880889|FG001|COMPLETED|Period I||13
8826751|NCT01607411|9880890|FG002|COMPLETED|Period I||14
8826752|NCT01607411|9880891|FG003|COMPLETED|Period I||14
8826753|NCT01607411|9880888|FG000|NOT COMPLETED|Period I||0
8826754|NCT01607411|9880889|FG001|NOT COMPLETED|Period I||0
8826755|NCT01607411|9880890|FG002|NOT COMPLETED|Period I||0
8826756|NCT01607411|9880891|FG003|NOT COMPLETED|Period I||0
8826757|NCT01607411|9880888|FG000|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|14
8826758|NCT01607411|9880889|FG001|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|14
8826759|NCT01607411|9880890|FG002|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|13
8826760|NCT01607411|9880891|FG003|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|14
8826761|NCT01607411|9880888|FG000|COMPLETED|Period II||14
8826762|NCT01607411|9880889|FG001|COMPLETED|Period II||14
8826763|NCT01607411|9880890|FG002|COMPLETED|Period II||13
8826764|NCT01607411|9880891|FG003|COMPLETED|Period II||14
8826765|NCT01607411|9880888|FG000|NOT COMPLETED|Period II||0
8826766|NCT01607411|9880889|FG001|NOT COMPLETED|Period II||0
8826767|NCT01607411|9880890|FG002|NOT COMPLETED|Period II||0
8826768|NCT01607411|9880891|FG003|NOT COMPLETED|Period II||0
8826769|NCT01607411|9880888|FG000|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
8826770|NCT01607411|9880889|FG001|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
8826771|NCT01607411|9880890|FG002|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
8826772|NCT01607411|9880891|FG003|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|13
8826773|NCT01607411|9880888|FG000|COMPLETED|Period III||14
8826774|NCT01607411|9880889|FG001|COMPLETED|Period III||14
8826775|NCT01607411|9880890|FG002|COMPLETED|Period III||14
8826776|NCT01607411|9880891|FG003|COMPLETED|Period III||13
8622362|NCT00488033|9661601|FG001|STARTED|Overall Study||452
8622363|NCT00488033|9661600|FG000|COMPLETED|Overall Study||447
8622364|NCT00488033|9661601|FG001|COMPLETED|Overall Study||452
8622365|NCT00488033|9661600|FG000|NOT COMPLETED|Overall Study||1
8622366|NCT00488033|9661601|FG001|NOT COMPLETED|Overall Study||0
8622367|NCT00488059|9661607|FG000|STARTED|Phase I: ENF 90mg SC BID||29
8622368|NCT00488059|9661608|FG001|STARTED|Phase I: ENF 90mg SC BID||0
8622369|NCT00488059|9661609|FG002|STARTED|Phase I: ENF 90mg SC BID||0
8622370|NCT00488059|9661607|FG000|COMPLETED|Phase I: ENF 90mg SC BID||14
8622371|NCT00488059|9661608|FG001|COMPLETED|Phase I: ENF 90mg SC BID||0
8826777|NCT01607411|9880888|FG000|NOT COMPLETED|Period III||0
8826778|NCT01607411|9880889|FG001|NOT COMPLETED|Period III||0
8826779|NCT01607411|9880890|FG002|NOT COMPLETED|Period III||0
8826780|NCT01607411|9880891|FG003|NOT COMPLETED|Period III||0
8826781|NCT01607411|9880888|FG000|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|13
8826782|NCT01607411|9880889|FG001|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|14
8826783|NCT01607411|9880890|FG002|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|14
8826784|NCT01607411|9880891|FG003|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|14
8826785|NCT01607411|9880888|FG000|COMPLETED|Period IV||13
8622372|NCT00488059|9661609|FG002|COMPLETED|Phase I: ENF 90mg SC BID||0
8622373|NCT00488059|9661607|FG000|NOT COMPLETED|Phase I: ENF 90mg SC BID||15
8826786|NCT01607411|9880889|FG001|COMPLETED|Period IV||14
8826787|NCT01607411|9880890|FG002|COMPLETED|Period IV||14
8826788|NCT01607411|9880891|FG003|COMPLETED|Period IV||14
8826789|NCT01607411|9880888|FG000|NOT COMPLETED|Period IV||0
8826790|NCT01607411|9880889|FG001|NOT COMPLETED|Period IV||0
8826791|NCT01607411|9880890|FG002|NOT COMPLETED|Period IV||0
8826792|NCT01607411|9880891|FG003|NOT COMPLETED|Period IV||0
8826793|NCT01607450|9880908|FG000|STARTED|Overall Study||6
8826794|NCT01607450|9880909|FG001|STARTED|Overall Study||8
8826795|NCT01607450|9880910|FG002|STARTED|Overall Study||7
8826796|NCT01607450|9880911|FG003|STARTED|Overall Study||11
8826797|NCT01607450|9880912|FG004|STARTED|Overall Study||1
8826798|NCT01607450|9880913|FG005|STARTED|Overall Study||0
8826799|NCT01607450|9880914|FG006|STARTED|Overall Study||0
8826800|NCT01607450|9880908|FG000|COMPLETED|Overall Study||6
8826801|NCT01607450|9880909|FG001|COMPLETED|Overall Study||8
8826802|NCT01607450|9880910|FG002|COMPLETED|Overall Study||7
8826803|NCT01607450|9880911|FG003|COMPLETED|Overall Study||11
8826804|NCT01607450|9880912|FG004|COMPLETED|Overall Study||1
8826805|NCT01607450|9880913|FG005|COMPLETED|Overall Study||0
8826806|NCT01607450|9880914|FG006|COMPLETED|Overall Study||0
8826807|NCT01607450|9880908|FG000|NOT COMPLETED|Overall Study||0
8826808|NCT01607450|9880909|FG001|NOT COMPLETED|Overall Study||0
8826809|NCT01607450|9880910|FG002|NOT COMPLETED|Overall Study||0
8826810|NCT01607450|9880911|FG003|NOT COMPLETED|Overall Study||0
8826811|NCT01607450|9880912|FG004|NOT COMPLETED|Overall Study||0
8826812|NCT01607450|9880913|FG005|NOT COMPLETED|Overall Study||0
8826813|NCT01607450|9880914|FG006|NOT COMPLETED|Overall Study||0
8826814|NCT01607476|9880938|FG000|STARTED|Overall Study||25
8826815|NCT01607476|9880939|FG001|STARTED|Overall Study||30
8826816|NCT01607476|9880940|FG002|STARTED|Overall Study||33
8826817|NCT01607476|9880938|FG000|COMPLETED|Overall Study||24
8826818|NCT01607476|9880939|FG001|COMPLETED|Overall Study||30
8826819|NCT01607476|9880940|FG002|COMPLETED|Overall Study||30
8826820|NCT01607476|9880938|FG000|NOT COMPLETED|Overall Study||1
8826821|NCT01607476|9880939|FG001|NOT COMPLETED|Overall Study||0
8826822|NCT01607476|9880940|FG002|NOT COMPLETED|Overall Study||3
8826823|NCT01607554|9880948|FG000|STARTED|Overall Study||2
8826824|NCT01607554|9880948|FG000|COMPLETED|Overall Study||0
8826825|NCT01607554|9880948|FG000|NOT COMPLETED|Overall Study||2
8826826|NCT01607593|9880952|FG000|STARTED|Overall Study||122
8826827|NCT01607593|9880952|FG000|COMPLETED|Overall Study||29
8826828|NCT01607593|9880952|FG000|NOT COMPLETED|Overall Study||93
8826829|NCT01607645|9880958|FG000|STARTED|Overall Study||4
8826830|NCT01607645|9880959|FG001|STARTED|Overall Study||3
8826831|NCT01607645|9880958|FG000|COMPLETED|Overall Study||4
8826832|NCT01607645|9880959|FG001|COMPLETED|Overall Study||3
8826833|NCT01607645|9880958|FG000|NOT COMPLETED|Overall Study||0
8826834|NCT01607645|9880959|FG001|NOT COMPLETED|Overall Study||0
8826835|NCT01607658|9880969|FG000|STARTED|Overall Study||65
8826836|NCT01607658|9880970|FG001|STARTED|Overall Study||67
8826837|NCT01607658|9880971|FG002|STARTED|Overall Study||58
8826838|NCT01607658|9880972|FG003|STARTED|Overall Study||63
8826839|NCT01607658|9880969|FG000|COMPLETED|Overall Study||56
8826840|NCT01607658|9880970|FG001|COMPLETED|Overall Study||56
8826841|NCT01607658|9880971|FG002|COMPLETED|Overall Study||47
8826842|NCT01607658|9880972|FG003|COMPLETED|Overall Study||52
8826843|NCT01607658|9880969|FG000|NOT COMPLETED|Overall Study||9
8826844|NCT01607658|9880970|FG001|NOT COMPLETED|Overall Study||11
8826845|NCT01607658|9880971|FG002|NOT COMPLETED|Overall Study||11
8826846|NCT01607658|9880972|FG003|NOT COMPLETED|Overall Study||11
8826847|NCT01607853|9880982|FG000|STARTED|Overall Study||24
8826848|NCT01607853|9880982|FG000|COMPLETED|Overall Study||24
8826849|NCT01607853|9880982|FG000|NOT COMPLETED|Overall Study||0
8826850|NCT01607892|9880994|FG000|STARTED|Overall Study||58
8826851|NCT01607892|9880995|FG001|STARTED|Overall Study||27
8826852|NCT01607892|9880996|FG002|STARTED|Overall Study||81
8826853|NCT01607892|9880997|FG003|STARTED|Overall Study||95
8826854|NCT01607892|9880998|FG004|STARTED|Overall Study||24
8826855|NCT01607892|9880994|FG000|COMPLETED|Overall Study||0
8622374|NCT00488059|9661608|FG001|NOT COMPLETED|Phase I: ENF 90mg SC BID||0
8826856|NCT01607892|9880995|FG001|COMPLETED|Overall Study||0
8826857|NCT01607892|9880996|FG002|COMPLETED|Overall Study||0
8826858|NCT01607892|9880997|FG003|COMPLETED|Overall Study||0
8826859|NCT01607892|9880998|FG004|COMPLETED|Overall Study||0
8826860|NCT01607892|9880994|FG000|NOT COMPLETED|Overall Study||58
8826861|NCT01607892|9880995|FG001|NOT COMPLETED|Overall Study||27
8826862|NCT01607892|9880996|FG002|NOT COMPLETED|Overall Study||81
8826863|NCT01607892|9880997|FG003|NOT COMPLETED|Overall Study||95
8826864|NCT01607892|9880998|FG004|NOT COMPLETED|Overall Study||24
8826865|NCT01607905|9881031|FG000|STARTED|Overall Study||60
8826866|NCT01607905|9881032|FG001|STARTED|Overall Study||20
8826867|NCT01607905|9881033|FG002|STARTED|Overall Study||21
8826868|NCT01607905|9881034|FG003|STARTED|Overall Study||21
8826869|NCT01607905|9881035|FG004|STARTED|Overall Study||7
8826870|NCT01607905|9881036|FG005|STARTED|Overall Study||15
8826871|NCT01607905|9881037|FG006|STARTED|Overall Study||47
8826872|NCT01607905|9881031|FG000|Received Study Drug|Overall Study||59
8826873|NCT01607905|9881032|FG001|Received Study Drug|Overall Study||20
8826874|NCT01607905|9881033|FG002|Received Study Drug|Overall Study||21
8826875|NCT01607905|9881034|FG003|Received Study Drug|Overall Study||21
8826876|NCT01607905|9881035|FG004|Received Study Drug|Overall Study||6
8826877|NCT01607905|9881036|FG005|Received Study Drug|Overall Study||15
8826878|NCT01607905|9881037|FG006|Received Study Drug|Overall Study||47
8826879|NCT01607905|9881031|FG000|Low Dose (<30 mg/m^2)|Overall Study||16
8826880|NCT01607905|9881032|FG001|Low Dose (<30 mg/m^2)|Overall Study||5
8826881|NCT01607905|9881033|FG002|Low Dose (<30 mg/m^2)|Overall Study||3
8826882|NCT01607905|9881034|FG003|Low Dose (<30 mg/m^2)|Overall Study||0
8826883|NCT01607905|9881035|FG004|Low Dose (<30 mg/m^2)|Overall Study||0
8826884|NCT01607905|9881036|FG005|Low Dose (<30 mg/m^2)|Overall Study||2
8826885|NCT01607905|9881037|FG006|Low Dose (<30 mg/m^2)|Overall Study||8
8826886|NCT01607905|9881031|FG000|Medium Dose (>=30 mg/m^2 and <55 mg/m^2)|Overall Study||27
8826887|NCT01607905|9881032|FG001|Medium Dose (>=30 mg/m^2 and <55 mg/m^2)|Overall Study||11
8826888|NCT01607905|9881033|FG002|Medium Dose (>=30 mg/m^2 and <55 mg/m^2)|Overall Study||15
8826889|NCT01607905|9881034|FG003|Medium Dose (>=30 mg/m^2 and <55 mg/m^2)|Overall Study||8
8826890|NCT01607905|9881035|FG004|Medium Dose (>=30 mg/m^2 and <55 mg/m^2)|Overall Study||6
8826891|NCT01607905|9881036|FG005|Medium Dose (>=30 mg/m^2 and <55 mg/m^2)|Overall Study||3
8826892|NCT01607905|9881037|FG006|Medium Dose (>=30 mg/m^2 and <55 mg/m^2)|Overall Study||21
8826893|NCT01607905|9881031|FG000|High Dose (>= 55 mg/m^2)|Overall Study||16
8826894|NCT01607905|9881032|FG001|High Dose (>= 55 mg/m^2)|Overall Study||4
8826895|NCT01607905|9881033|FG002|High Dose (>= 55 mg/m^2)|Overall Study||3
8826896|NCT01607905|9881034|FG003|High Dose (>= 55 mg/m^2)|Overall Study||13
8826897|NCT01607905|9881035|FG004|High Dose (>= 55 mg/m^2)|Overall Study||0
8826898|NCT01607905|9881036|FG005|High Dose (>= 55 mg/m^2)|Overall Study||10
8826899|NCT01607905|9881037|FG006|High Dose (>= 55 mg/m^2)|Overall Study||18
8826900|NCT01607905|9881031|FG000|COMPLETED|Overall Study||0
8826901|NCT01607905|9881032|FG001|COMPLETED|Overall Study||0
8826902|NCT01607905|9881033|FG002|COMPLETED|Overall Study||0
8826903|NCT01607905|9881034|FG003|COMPLETED|Overall Study||0
8826904|NCT01607905|9881035|FG004|COMPLETED|Overall Study||0
8826905|NCT01607905|9881036|FG005|COMPLETED|Overall Study||0
8826906|NCT01607905|9881037|FG006|COMPLETED|Overall Study||0
8826907|NCT01607905|9881031|FG000|NOT COMPLETED|Overall Study||60
8826908|NCT01607905|9881032|FG001|NOT COMPLETED|Overall Study||20
8826909|NCT01607905|9881033|FG002|NOT COMPLETED|Overall Study||21
8826910|NCT01607905|9881034|FG003|NOT COMPLETED|Overall Study||21
8826911|NCT01607905|9881035|FG004|NOT COMPLETED|Overall Study||7
8826912|NCT01607905|9881036|FG005|NOT COMPLETED|Overall Study||15
8826913|NCT01607905|9881037|FG006|NOT COMPLETED|Overall Study||47
8826914|NCT01607957|9881097|FG000|STARTED|Overall Study||534
8826915|NCT01607957|9881098|FG001|STARTED|Overall Study||266
8826916|NCT01607957|9881097|FG000|Treated|Overall Study||533
8826917|NCT01607957|9881098|FG001|Treated|Overall Study||265
8826918|NCT01607957|9881097|FG000|COMPLETED|Overall Study||162
8826919|NCT01607957|9881098|FG001|COMPLETED|Overall Study||51
8826920|NCT01607957|9881097|FG000|NOT COMPLETED|Overall Study||372
8826921|NCT01607957|9881098|FG001|NOT COMPLETED|Overall Study||215
8826922|NCT01608061|9881106|FG000|STARTED|Blinded Period||21
8826923|NCT01608061|9881107|FG001|STARTED|Blinded Period||21
8826924|NCT01608061|9881106|FG000|COMPLETED|Blinded Period||21
8826925|NCT01608061|9881107|FG001|COMPLETED|Blinded Period||21
8826926|NCT01608061|9881106|FG000|NOT COMPLETED|Blinded Period||0
8826927|NCT01608061|9881107|FG001|NOT COMPLETED|Blinded Period||0
8826928|NCT01608061|9881106|FG000|STARTED|Long Term Follow-Up||21
8826929|NCT01608061|9881107|FG001|STARTED|Long Term Follow-Up||21
8826930|NCT01608061|9881106|FG000|COMPLETED|Long Term Follow-Up||14
8826931|NCT01608061|9881107|FG001|COMPLETED|Long Term Follow-Up||16
8826932|NCT01608061|9881106|FG000|NOT COMPLETED|Long Term Follow-Up||7
8622375|NCT00488059|9661609|FG002|NOT COMPLETED|Phase I: ENF 90mg SC BID||0
8622376|NCT00488059|9661607|FG000|STARTED|Phase II Arm A:Phase I Then ENF 90mg BID||0
8622377|NCT00488059|9661608|FG001|STARTED|Phase II Arm A:Phase I Then ENF 90mg BID||9
8622378|NCT00488059|9661609|FG002|STARTED|Phase II Arm A:Phase I Then ENF 90mg BID||0
8622379|NCT00488059|9661607|FG000|COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
8622380|NCT00488059|9661608|FG001|COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||7
8622381|NCT00488059|9661609|FG002|COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
8622382|NCT00488059|9661607|FG000|NOT COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
8622383|NCT00488059|9661608|FG001|NOT COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||2
8622384|NCT00488059|9661609|FG002|NOT COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
8622385|NCT00488059|9661607|FG000|STARTED|Phase II Arm B:Phase I Then ENF 180mg QD||0
8622386|NCT00488059|9661608|FG001|STARTED|Phase II Arm B:Phase I Then ENF 180mg QD||0
8826933|NCT01608061|9881107|FG001|NOT COMPLETED|Long Term Follow-Up||5
8826934|NCT01608061|9881106|FG000|STARTED|Extension Period||14
8826935|NCT01608061|9881107|FG001|STARTED|Extension Period||16
8826936|NCT01608061|9881106|FG000|COMPLETED|Extension Period||14
8826937|NCT01608061|9881107|FG001|COMPLETED|Extension Period||14
8826938|NCT01608061|9881106|FG000|NOT COMPLETED|Extension Period||0
8826939|NCT01608061|9881107|FG001|NOT COMPLETED|Extension Period||2
8826940|NCT01608087|9881117|FG000|STARTED|Overall Study||30
8826941|NCT01608087|9881118|FG001|STARTED|Overall Study||30
8826942|NCT01608087|9881119|FG002|STARTED|Overall Study||31
8826943|NCT01608087|9881117|FG000|COMPLETED|Overall Study||30
8826944|NCT01608087|9881118|FG001|COMPLETED|Overall Study||28
8826945|NCT01608087|9881119|FG002|COMPLETED|Overall Study||31
8826946|NCT01608087|9881117|FG000|NOT COMPLETED|Overall Study||0
8826947|NCT01608087|9881118|FG001|NOT COMPLETED|Overall Study||2
8826948|NCT01608087|9881119|FG002|NOT COMPLETED|Overall Study||0
8826949|NCT01608100|9881127|FG000|STARTED|Overall Study||1101
8826950|NCT01608100|9881127|FG000|COMPLETED|Overall Study||1101
8826951|NCT01608100|9881127|FG000|NOT COMPLETED|Overall Study||0
8826952|NCT01608295|9881153|FG000|STARTED|Overall Study||26
8826953|NCT01608295|9881154|FG001|STARTED|Overall Study||30
8826954|NCT01608295|9881153|FG000|COMPLETED|Overall Study||20
8826955|NCT01608295|9881154|FG001|COMPLETED|Overall Study||25
8826956|NCT01608295|9881153|FG000|NOT COMPLETED|Overall Study||6
8826957|NCT01608295|9881154|FG001|NOT COMPLETED|Overall Study||5
8826958|NCT01608308|9881165|FG000|STARTED|Overall Study||31
8826959|NCT01608308|9881166|FG001|STARTED|Overall Study||31
8826960|NCT01608308|9881165|FG000|COMPLETED|Overall Study||31
8826961|NCT01608308|9881166|FG001|COMPLETED|Overall Study||29
8826962|NCT01608308|9881165|FG000|NOT COMPLETED|Overall Study||0
8826963|NCT01608308|9881166|FG001|NOT COMPLETED|Overall Study||2
8826964|NCT01608321|9881174|FG000|STARTED|Overall Study||13
8826965|NCT01608321|9881175|FG001|STARTED|Overall Study||4
8826966|NCT01608321|9881174|FG000|COMPLETED|Overall Study||12
8826967|NCT01608321|9881175|FG001|COMPLETED|Overall Study||4
8826968|NCT01608321|9881174|FG000|NOT COMPLETED|Overall Study||1
8826969|NCT01608321|9881175|FG001|NOT COMPLETED|Overall Study||0
8826970|NCT01608490|9881183|FG000|STARTED|Overall Study||158
8826971|NCT01608490|9881184|FG001|STARTED|Overall Study||157
8826972|NCT01608490|9881183|FG000|COMPLETED|Overall Study||141
8826973|NCT01608490|9881184|FG001|COMPLETED|Overall Study||142
8826974|NCT01608490|9881183|FG000|NOT COMPLETED|Overall Study||17
8826975|NCT01608490|9881184|FG001|NOT COMPLETED|Overall Study||15
8826976|NCT01608659|9881190|FG000|STARTED|Overall Study||110
8826977|NCT01608659|9881190|FG000|COMPLETED|Overall Study||94
8826978|NCT01608659|9881190|FG000|NOT COMPLETED|Overall Study||16
8826979|NCT01608672|9881194|FG000|STARTED|Overall Study||207
8826980|NCT01608672|9881194|FG000|COMPLETED|Overall Study||207
8826981|NCT01608672|9881194|FG000|NOT COMPLETED|Overall Study||0
8826982|NCT01608724|9881198|FG000|STARTED|Overall Study|One patient was excluded because the Informed Consent Form was destroyed by site staff by mistake.|1423
8826983|NCT01608724|9881198|FG000|Treated|Overall Study||1361
8826984|NCT01608724|9881198|FG000|COMPLETED|Overall Study||1180
8826985|NCT01608724|9881198|FG000|NOT COMPLETED|Overall Study||243
8826986|NCT01608815|9881205|FG000|STARTED|Overall Study||188
8826987|NCT01608815|9881206|FG001|STARTED|Overall Study||7
8826988|NCT01608815|9881207|FG002|STARTED|Overall Study||5
8826989|NCT01608815|9881205|FG000|COMPLETED|Overall Study||188
8826990|NCT01608815|9881206|FG001|COMPLETED|Overall Study||7
8826991|NCT01608815|9881207|FG002|COMPLETED|Overall Study||5
8826992|NCT01608815|9881205|FG000|NOT COMPLETED|Overall Study||0
8826993|NCT01608815|9881206|FG001|NOT COMPLETED|Overall Study||0
8826994|NCT01608815|9881207|FG002|NOT COMPLETED|Overall Study||0
8826995|NCT01608971|9881218|FG000|STARTED|Overall Study||15
8826996|NCT01608971|9881219|FG001|STARTED|Overall Study||15
8826997|NCT01608971|9881218|FG000|COMPLETED|Overall Study||15
8826998|NCT01608971|9881219|FG001|COMPLETED|Overall Study||15
8826999|NCT01608971|9881218|FG000|NOT COMPLETED|Overall Study||0
8827000|NCT01608971|9881219|FG001|NOT COMPLETED|Overall Study||0
8827001|NCT01609010|9881229|FG000|STARTED|Overall Study||156
8827002|NCT01609010|9881230|FG001|STARTED|Overall Study||157
8827003|NCT01609010|9881229|FG000|Entering Cycle 2|Overall Study||120
8827004|NCT01609010|9881230|FG001|Entering Cycle 2|Overall Study||124
8827005|NCT01609010|9881229|FG000|COMPLETED|Overall Study||113
8622387|NCT00488059|9661609|FG002|STARTED|Phase II Arm B:Phase I Then ENF 180mg QD||5
8622388|NCT00488059|9661607|FG000|COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
8622389|NCT00488059|9661608|FG001|COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
8622390|NCT00488059|9661609|FG002|COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||1
8622391|NCT00488059|9661607|FG000|NOT COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
8622392|NCT00488059|9661608|FG001|NOT COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
8622393|NCT00488059|9661609|FG002|NOT COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||4
8622394|NCT00488293|9661624|FG000|STARTED|Overall Study||196
8622395|NCT00488293|9661625|FG001|STARTED|Overall Study||196
8622396|NCT00488293|9661624|FG000|COMPLETED|Overall Study||160
8622397|NCT00488293|9661625|FG001|COMPLETED|Overall Study||166
8622398|NCT00488293|9661624|FG000|NOT COMPLETED|Overall Study||36
8827006|NCT01609010|9881230|FG001|COMPLETED|Overall Study||120
8827007|NCT01609010|9881229|FG000|NOT COMPLETED|Overall Study||43
8827008|NCT01609010|9881230|FG001|NOT COMPLETED|Overall Study||37
8827009|NCT01609023|9881236|FG000|STARTED|Overall Study||67
8827010|NCT01609023|9881236|FG000|COMPLETED|Overall Study||34
8827011|NCT01609023|9881236|FG000|NOT COMPLETED|Overall Study||33
8827012|NCT01609062|9881242|FG000|STARTED|Primary Phase||15
8827013|NCT01609062|9881243|FG001|STARTED|Primary Phase||10
8827014|NCT01609062|9881242|FG000|COMPLETED|Primary Phase||15
8827015|NCT01609062|9881243|FG001|COMPLETED|Primary Phase||10
8827016|NCT01609062|9881242|FG000|NOT COMPLETED|Primary Phase||0
8827017|NCT01609062|9881243|FG001|NOT COMPLETED|Primary Phase||0
8827018|NCT01609062|9881242|FG000|STARTED|Extension Phase||15
8827019|NCT01609062|9881243|FG001|STARTED|Extension Phase||10
8827020|NCT01609062|9881242|FG000|COMPLETED|Extension Phase||0
8827021|NCT01609062|9881243|FG001|COMPLETED|Extension Phase|EAP = Expanded Access Program|0
8827022|NCT01609062|9881242|FG000|NOT COMPLETED|Extension Phase||15
8827023|NCT01609062|9881243|FG001|NOT COMPLETED|Extension Phase||10
8827024|NCT01609218|9881250|FG000|STARTED|Period 1||13
8827025|NCT01609218|9881251|FG001|STARTED|Period 1||14
8827026|NCT01609218|9881250|FG000|Received LY2140023|Period 1||13
8827027|NCT01609218|9881251|FG001|Received LY2140023|Period 1||14
8827028|NCT01609218|9881250|FG000|Received Activated Charcoal|Period 1|Participants in this treatment sequence did not receive activated charcoal during Period 1.|0
8827029|NCT01609218|9881251|FG001|Received Activated Charcoal|Period 1|Two participants discontinued after receiving LY2140023 but prior to receiving activated charcoal.|12
8827030|NCT01609218|9881250|FG000|COMPLETED|Period 1||10
8827031|NCT01609218|9881251|FG001|COMPLETED|Period 1||8
8827032|NCT01609218|9881250|FG000|NOT COMPLETED|Period 1||3
8827033|NCT01609218|9881251|FG001|NOT COMPLETED|Period 1||6
8827034|NCT01609218|9881250|FG000|STARTED|Period 2||10
8827035|NCT01609218|9881251|FG001|STARTED|Period 2|One participant did not complete Period 1 but did continue onto Period 2.|9
8827036|NCT01609218|9881250|FG000|Received LY2140023|Period 2||10
8827037|NCT01609218|9881251|FG001|Received LY2140023|Period 2||9
8827038|NCT01609218|9881250|FG000|Received Activated Charcoal|Period 2||9
8827039|NCT01609218|9881251|FG001|Received Activated Charcoal|Period 2|Participants in this treatment sequence did not receive activated charcoal during Period 2.|0
8827040|NCT01609218|9881250|FG000|COMPLETED|Period 2||9
8827041|NCT01609218|9881251|FG001|COMPLETED|Period 2||9
8827042|NCT01609218|9881250|FG000|NOT COMPLETED|Period 2||1
8827043|NCT01609218|9881251|FG001|NOT COMPLETED|Period 2||0
8827044|NCT01609257|9881259|FG000|STARTED|Overall Study||67
8622399|NCT00488293|9661625|FG001|NOT COMPLETED|Overall Study||30
8622400|NCT00488319|9661634|FG000|STARTED|Overall Study||39
8622401|NCT00488319|9661635|FG001|STARTED|Overall Study||118
8827045|NCT01609257|9881260|FG001|STARTED|Overall Study||65
8827046|NCT01609257|9881259|FG000|Received 2 Doses|Overall Study||63
8827047|NCT01609257|9881260|FG001|Received 2 Doses|Overall Study||64
8827048|NCT01609257|9881259|FG000|Received Challenge Product|Overall Study||56
8827049|NCT01609257|9881260|FG001|Received Challenge Product|Overall Study||53
8827050|NCT01609257|9881259|FG000|COMPLETED|Overall Study||61
8827051|NCT01609257|9881260|FG001|COMPLETED|Overall Study||57
8827052|NCT01609257|9881259|FG000|NOT COMPLETED|Overall Study||6
8827053|NCT01609257|9881260|FG001|NOT COMPLETED|Overall Study||8
8827054|NCT01609296|9881269|FG000|STARTED|Overall Study||1406
8827055|NCT01609296|9881269|FG000|COMPLETED|Overall Study||918
8827056|NCT01609296|9881269|FG000|NOT COMPLETED|Overall Study||488
8827057|NCT01609348|9881279|FG000|STARTED|Overall Study||3
8827058|NCT01609348|9881280|FG001|STARTED|Overall Study||2
8827059|NCT01609348|9881279|FG000|COMPLETED|Overall Study||3
8827060|NCT01609348|9881280|FG001|COMPLETED|Overall Study||2
8827061|NCT01609348|9881279|FG000|NOT COMPLETED|Overall Study||0
8827062|NCT01609348|9881280|FG001|NOT COMPLETED|Overall Study||0
8827063|NCT01609478|9881289|FG000|STARTED|Overall Study||111
8827064|NCT01609478|9881290|FG001|STARTED|Overall Study||108
8622402|NCT00488319|9661636|FG002|STARTED|Overall Study||243
8622403|NCT00488319|9661634|FG000|COMPLETED|Overall Study||24
8622404|NCT00488319|9661635|FG001|COMPLETED|Overall Study||75
8622405|NCT00488319|9661636|FG002|COMPLETED|Overall Study||121
8622406|NCT00488319|9661634|FG000|NOT COMPLETED|Overall Study||15
8622407|NCT00488319|9661635|FG001|NOT COMPLETED|Overall Study||43
8622408|NCT00488319|9661636|FG002|NOT COMPLETED|Overall Study||122
8622409|NCT00488345|9661648|FG000|STARTED|Overall Study||17
8622410|NCT00488345|9661649|FG001|STARTED|Overall Study||21
8622411|NCT00488345|9661650|FG002|STARTED|Overall Study||20
8827065|NCT01609478|9881291|FG002|STARTED|Overall Study||116
8827066|NCT01609478|9881289|FG000|Full Analysis Set (FAS)|Overall Study||110
8827067|NCT01609478|9881290|FG001|Full Analysis Set (FAS)|Overall Study||108
8827068|NCT01609478|9881291|FG002|Full Analysis Set (FAS)|Overall Study||115
8827069|NCT01609478|9881289|FG000|COMPLETED|Overall Study||104
8827070|NCT01609478|9881290|FG001|COMPLETED|Overall Study||106
8827071|NCT01609478|9881291|FG002|COMPLETED|Overall Study||107
8827072|NCT01609478|9881289|FG000|NOT COMPLETED|Overall Study||7
8827073|NCT01609478|9881290|FG001|NOT COMPLETED|Overall Study||2
8827074|NCT01609478|9881291|FG002|NOT COMPLETED|Overall Study||9
8827075|NCT01609543|9881299|FG000|STARTED|Overall Study||62
8827076|NCT01609543|9881299|FG000|COMPLETED|Overall Study||20
8827077|NCT01609543|9881299|FG000|NOT COMPLETED|Overall Study||42
8827078|NCT01609556|9881320|FG000|STARTED|Dose Escalation: Maximum 101.3 Weeks||2
8827079|NCT01609556|9881321|FG001|STARTED|Dose Escalation: Maximum 101.3 Weeks||1
8827080|NCT01609556|9881322|FG002|STARTED|Dose Escalation: Maximum 101.3 Weeks||1
8827081|NCT01609556|9881323|FG003|STARTED|Dose Escalation: Maximum 101.3 Weeks||1
8827082|NCT01609556|9881324|FG004|STARTED|Dose Escalation: Maximum 101.3 Weeks||9
8827083|NCT01609556|9881325|FG005|STARTED|Dose Escalation: Maximum 101.3 Weeks||18
8827084|NCT01609556|9881326|FG006|STARTED|Dose Escalation: Maximum 101.3 Weeks||7
8622412|NCT00488345|9661648|FG000|COMPLETED|Overall Study||17
8622413|NCT00488345|9661649|FG001|COMPLETED|Overall Study||17
8622414|NCT00488345|9661650|FG002|COMPLETED|Overall Study||17
8723334|NCT01022242|9770782|FG000|STARTED|Overall Study|71 pat rand to placebo. 1 got incorrect mix of placebo. 70 patients treated with the correct mix.|70
8723335|NCT01022242|9770783|FG001|STARTED|Overall Study|67 pat rand to PXL01. 2 got incorrect mix of PXL01. 65 patients treated with the correct PXL01 mix.|65
8723336|NCT01022242|9770782|FG000|COMPLETED|Overall Study||49
8723337|NCT01022242|9770783|FG001|COMPLETED|Overall Study||46
8723338|NCT01022242|9770782|FG000|NOT COMPLETED|Overall Study||21
8723339|NCT01022242|9770783|FG001|NOT COMPLETED|Overall Study||19
8723340|NCT01022307|9770791|FG000|STARTED|Overall Study||184
8723341|NCT01022307|9770792|FG001|STARTED|Overall Study||28
8723342|NCT01022307|9770791|FG000|COMPLETED|Overall Study||184
8725165|NCT01029691|9772358|FG000|NOT COMPLETED|APAP Initiation to Week 1 or Delivery||0
8827085|NCT01609556|9881327|FG007|STARTED|Dose Escalation: Maximum 101.3 Weeks||5
8827086|NCT01609556|9881328|FG008|STARTED|Dose Escalation: Maximum 101.3 Weeks||5
8827087|NCT01609556|9881329|FG009|STARTED|Dose Escalation: Maximum 101.3 Weeks||4
8827088|NCT01609556|9881330|FG010|STARTED|Dose Escalation: Maximum 101.3 Weeks||9
8827089|NCT01609556|9881331|FG011|STARTED|Dose Escalation: Maximum 101.3 Weeks||7
8827090|NCT01609556|9881332|FG012|STARTED|Dose Escalation: Maximum 101.3 Weeks||0
8827091|NCT01609556|9881333|FG013|STARTED|Dose Escalation: Maximum 101.3 Weeks||0
8827092|NCT01609556|9881334|FG014|STARTED|Dose Escalation: Maximum 101.3 Weeks||0
8827093|NCT01609556|9881335|FG015|STARTED|Dose Escalation: Maximum 101.3 Weeks||0
8827094|NCT01609556|9881320|FG000|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||2
8827095|NCT01609556|9881321|FG001|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||1
8827096|NCT01609556|9881322|FG002|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||1
8622415|NCT00488345|9661648|FG000|NOT COMPLETED|Overall Study||0
8622416|NCT00488345|9661649|FG001|NOT COMPLETED|Overall Study||4
8622417|NCT00488345|9661650|FG002|NOT COMPLETED|Overall Study||3
8944010|NCT02392624|10005816|FG002|STARTED|Overall Study||53
8944011|NCT02392624|10005814|FG000|COMPLETED|Overall Study||0
8944012|NCT02392624|10005815|FG001|COMPLETED|Overall Study||66
8944013|NCT02392624|10005816|FG002|COMPLETED|Overall Study||40
8944014|NCT02392624|10005814|FG000|NOT COMPLETED|Overall Study||71
8944015|NCT02392624|10005815|FG001|NOT COMPLETED|Overall Study||15
8944016|NCT02392624|10005816|FG002|NOT COMPLETED|Overall Study||13
8944017|NCT02392767|10005826|FG000|STARTED|Overall Study||12
8944018|NCT02392767|10005827|FG001|STARTED|Overall Study||13
8944019|NCT02392767|10005826|FG000|COMPLETED|Overall Study||12
8944020|NCT02392767|10005827|FG001|COMPLETED|Overall Study||13
8944021|NCT02392767|10005826|FG000|NOT COMPLETED|Overall Study||0
8944022|NCT02392767|10005827|FG001|NOT COMPLETED|Overall Study||0
8944023|NCT02392806|10005837|FG000|STARTED|Overall Study||22
8944024|NCT02392806|10005838|FG001|STARTED|Overall Study||21
8622418|NCT00488475|9661659|FG000|STARTED|Overall Study||4945
8827097|NCT01609556|9881323|FG003|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||1
8827098|NCT01609556|9881324|FG004|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||9
8827099|NCT01609556|9881325|FG005|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||18
8827100|NCT01609556|9881326|FG006|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||7
8827101|NCT01609556|9881327|FG007|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||5
8827102|NCT01609556|9881328|FG008|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||5
8827103|NCT01609556|9881329|FG009|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||4
8827104|NCT01609556|9881330|FG010|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||9
8827105|NCT01609556|9881331|FG011|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||7
8827106|NCT01609556|9881332|FG012|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||0
8827107|NCT01609556|9881333|FG013|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||0
8827108|NCT01609556|9881334|FG014|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||0
8827109|NCT01609556|9881335|FG015|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||0
8827110|NCT01609556|9881320|FG000|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
8827111|NCT01609556|9881321|FG001|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
8827112|NCT01609556|9881322|FG002|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
8827113|NCT01609556|9881323|FG003|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
8827114|NCT01609556|9881324|FG004|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
8827115|NCT01609556|9881325|FG005|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
8827116|NCT01609556|9881326|FG006|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
8827117|NCT01609556|9881327|FG007|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
8827118|NCT01609556|9881328|FG008|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
8827119|NCT01609556|9881329|FG009|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
8827120|NCT01609556|9881330|FG010|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
8827121|NCT01609556|9881331|FG011|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
8827122|NCT01609556|9881332|FG012|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
8827123|NCT01609556|9881333|FG013|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
8827124|NCT01609556|9881334|FG014|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
8827125|NCT01609556|9881335|FG015|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
8827126|NCT01609556|9881320|FG000|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||2
8827127|NCT01609556|9881321|FG001|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||1
8827128|NCT01609556|9881322|FG002|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||1
8827129|NCT01609556|9881323|FG003|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||1
8827130|NCT01609556|9881324|FG004|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||9
8827131|NCT01609556|9881325|FG005|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||18
8827132|NCT01609556|9881326|FG006|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||7
8827133|NCT01609556|9881327|FG007|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||5
8827134|NCT01609556|9881328|FG008|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||5
8944025|NCT02392806|10005837|FG000|COMPLETED|Overall Study||22
8944026|NCT02392806|10005838|FG001|COMPLETED|Overall Study||21
8944027|NCT02392806|10005837|FG000|NOT COMPLETED|Overall Study||0
8827135|NCT01609556|9881329|FG009|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||4
8827136|NCT01609556|9881330|FG010|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||9
8827137|NCT01609556|9881331|FG011|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||7
8827138|NCT01609556|9881332|FG012|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
8827139|NCT01609556|9881333|FG013|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
8827140|NCT01609556|9881334|FG014|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
8827141|NCT01609556|9881335|FG015|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
8827142|NCT01609556|9881320|FG000|STARTED|Dose Expansion: Maximum 124 Weeks||0
8827143|NCT01609556|9881321|FG001|STARTED|Dose Expansion: Maximum 124 Weeks||0
8827144|NCT01609556|9881322|FG002|STARTED|Dose Expansion: Maximum 124 Weeks||0
8827145|NCT01609556|9881323|FG003|STARTED|Dose Expansion: Maximum 124 Weeks||0
8827146|NCT01609556|9881324|FG004|STARTED|Dose Expansion: Maximum 124 Weeks||0
8827147|NCT01609556|9881325|FG005|STARTED|Dose Expansion: Maximum 124 Weeks||0
8827148|NCT01609556|9881326|FG006|STARTED|Dose Expansion: Maximum 124 Weeks||0
8827149|NCT01609556|9881327|FG007|STARTED|Dose Expansion: Maximum 124 Weeks||0
8827150|NCT01609556|9881328|FG008|STARTED|Dose Expansion: Maximum 124 Weeks||0
8827151|NCT01609556|9881329|FG009|STARTED|Dose Expansion: Maximum 124 Weeks||0
8827152|NCT01609556|9881330|FG010|STARTED|Dose Expansion: Maximum 124 Weeks||0
8827153|NCT01609556|9881331|FG011|STARTED|Dose Expansion: Maximum 124 Weeks||0
8827154|NCT01609556|9881332|FG012|STARTED|Dose Expansion: Maximum 124 Weeks||46
8827155|NCT01609556|9881333|FG013|STARTED|Dose Expansion: Maximum 124 Weeks||24
8827156|NCT01609556|9881334|FG014|STARTED|Dose Expansion: Maximum 124 Weeks||27
8827157|NCT01609556|9881335|FG015|STARTED|Dose Expansion: Maximum 124 Weeks||40
8827158|NCT01609556|9881320|FG000|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8827159|NCT01609556|9881321|FG001|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8827160|NCT01609556|9881322|FG002|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8827161|NCT01609556|9881323|FG003|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8827162|NCT01609556|9881324|FG004|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8827163|NCT01609556|9881325|FG005|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8827164|NCT01609556|9881326|FG006|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8827165|NCT01609556|9881327|FG007|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8827166|NCT01609556|9881328|FG008|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8827167|NCT01609556|9881329|FG009|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8827168|NCT01609556|9881330|FG010|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8827169|NCT01609556|9881331|FG011|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8827170|NCT01609556|9881332|FG012|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8827171|NCT01609556|9881333|FG013|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8827172|NCT01609556|9881334|FG014|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8827173|NCT01609556|9881335|FG015|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8827174|NCT01609556|9881320|FG000|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8827175|NCT01609556|9881321|FG001|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8827176|NCT01609556|9881322|FG002|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8827177|NCT01609556|9881323|FG003|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8827178|NCT01609556|9881324|FG004|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8827179|NCT01609556|9881325|FG005|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8827180|NCT01609556|9881326|FG006|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8827181|NCT01609556|9881327|FG007|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8827182|NCT01609556|9881328|FG008|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8827183|NCT01609556|9881329|FG009|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8827184|NCT01609556|9881330|FG010|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8827185|NCT01609556|9881331|FG011|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8827186|NCT01609556|9881332|FG012|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||46
8827187|NCT01609556|9881333|FG013|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||24
8827188|NCT01609556|9881334|FG014|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||27
8827189|NCT01609556|9881335|FG015|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||40
8827190|NCT01609582|9881378|FG000|STARTED|Overall Study||1603
8827191|NCT01609582|9881379|FG001|STARTED|Overall Study||1604
8827192|NCT01609582|9881378|FG000|Treated|Overall Study||1603
8827193|NCT01609582|9881379|FG001|Treated|Overall Study||1601
8827194|NCT01609582|9881378|FG000|COMPLETED|Overall Study||0
8827195|NCT01609582|9881379|FG001|COMPLETED|Overall Study||0
8827196|NCT01609582|9881378|FG000|NOT COMPLETED|Overall Study||1603
8827197|NCT01609582|9881379|FG001|NOT COMPLETED|Overall Study||1604
8827198|NCT01609933|9881385|FG000|STARTED|Overall Study||32
8827199|NCT01609933|9881385|FG000|COMPLETED|Overall Study||28
8827200|NCT01609933|9881385|FG000|NOT COMPLETED|Overall Study||4
8827201|NCT01610011|9881393|FG000|STARTED|Overall Study||19
8827202|NCT01610011|9881394|FG001|STARTED|Overall Study||2
8827203|NCT01610011|9881393|FG000|COMPLETED|Overall Study||9
8827204|NCT01610011|9881394|FG001|COMPLETED|Overall Study||2
8827205|NCT01610011|9881393|FG000|NOT COMPLETED|Overall Study||10
8827206|NCT01610011|9881394|FG001|NOT COMPLETED|Overall Study||0
8827207|NCT01610037|9881403|FG000|STARTED|All Patients||407
8827208|NCT01610037|9881404|FG001|STARTED|All Patients||405
8827209|NCT01610037|9881405|FG002|STARTED|All Patients||404
8827210|NCT01610037|9881403|FG000|Randomized Set (RAN)|All Patients||407
8827211|NCT01610037|9881404|FG001|Randomized Set (RAN)|All Patients||405
8827212|NCT01610037|9881405|FG002|Randomized Set (RAN)|All Patients||404
8827213|NCT01610037|9881403|FG000|Full Analysis Set (FAS)|All Patients||407
8827214|NCT01610037|9881404|FG001|Full Analysis Set (FAS)|All Patients||405
8827215|NCT01610037|9881405|FG002|Full Analysis Set (FAS)|All Patients||403
8827216|NCT01610037|9881403|FG000|COMPLETED|All Patients||348
8827217|NCT01610037|9881404|FG001|COMPLETED|All Patients||354
8827218|NCT01610037|9881405|FG002|COMPLETED|All Patients||320
8827219|NCT01610037|9881403|FG000|NOT COMPLETED|All Patients||59
8827220|NCT01610037|9881404|FG001|NOT COMPLETED|All Patients||51
8827221|NCT01610037|9881405|FG002|NOT COMPLETED|All Patients||84
8827222|NCT01610037|9881403|FG000|STARTED|Treatment and Follow up Period||407
8827223|NCT01610037|9881404|FG001|STARTED|Treatment and Follow up Period||405
8827224|NCT01610037|9881405|FG002|STARTED|Treatment and Follow up Period||404
8827225|NCT01610037|9881403|FG000|COMPLETED|Treatment and Follow up Period||382
8827226|NCT01610037|9881404|FG001|COMPLETED|Treatment and Follow up Period||377
8827227|NCT01610037|9881405|FG002|COMPLETED|Treatment and Follow up Period||378
8827228|NCT01610037|9881403|FG000|NOT COMPLETED|Treatment and Follow up Period||25
8827229|NCT01610037|9881404|FG001|NOT COMPLETED|Treatment and Follow up Period||28
8827230|NCT01610037|9881405|FG002|NOT COMPLETED|Treatment and Follow up Period||26
8827231|NCT01610063|9881415|FG000|STARTED|Overall Study||114
8827232|NCT01610063|9881416|FG001|STARTED|Overall Study||113
8827233|NCT01610063|9881415|FG000|Baseline|Overall Study||114
8827234|NCT01610063|9881416|FG001|Baseline|Overall Study||113
8827235|NCT01610063|9881415|FG000|Completed 2-week|Overall Study||97
8827236|NCT01610063|9881416|FG001|Completed 2-week|Overall Study||105
8827237|NCT01610063|9881415|FG000|Completed 4-week|Overall Study||86
8827238|NCT01610063|9881416|FG001|Completed 4-week|Overall Study||98
8827239|NCT01610063|9881415|FG000|Completed 8-week|Overall Study||72
8827240|NCT01610063|9881416|FG001|Completed 8-week|Overall Study||93
8827241|NCT01610063|9881415|FG000|COMPLETED|Overall Study||72
8827242|NCT01610063|9881416|FG001|COMPLETED|Overall Study||93
8827243|NCT01610063|9881415|FG000|NOT COMPLETED|Overall Study||42
8827244|NCT01610063|9881416|FG001|NOT COMPLETED|Overall Study||20
8827245|NCT01610076|9881424|FG000|STARTED|Overall Study||103
8827246|NCT01610076|9881425|FG001|STARTED|Overall Study||105
8827247|NCT01610076|9881424|FG000|COMPLETED|Overall Study||100
8827248|NCT01610076|9881425|FG001|COMPLETED|Overall Study||100
8827249|NCT01610076|9881424|FG000|NOT COMPLETED|Overall Study||3
8827250|NCT01610076|9881425|FG001|NOT COMPLETED|Overall Study||5
8827251|NCT01610154|9881432|FG000|STARTED|Overall Study||85
8827252|NCT01610154|9881432|FG000|COMPLETED|Overall Study||84
8827253|NCT01610154|9881432|FG000|NOT COMPLETED|Overall Study||1
8827254|NCT01610167|9881441|FG000|STARTED|Overall Study||52
8827255|NCT01610167|9881442|FG001|STARTED|Overall Study||49
8827256|NCT01610167|9881443|FG002|STARTED|Overall Study||50
8827257|NCT01610167|9881441|FG000|COMPLETED|Overall Study||52
8827258|NCT01610167|9881442|FG001|COMPLETED|Overall Study||49
8827259|NCT01610167|9881443|FG002|COMPLETED|Overall Study||48
8827260|NCT01610167|9881441|FG000|NOT COMPLETED|Overall Study||0
8827261|NCT01610167|9881442|FG001|NOT COMPLETED|Overall Study||0
8827262|NCT01610167|9881443|FG002|NOT COMPLETED|Overall Study||2
8827263|NCT01610206|9881453|FG000|STARTED|Overall Study||73
8827264|NCT01610206|9881454|FG001|STARTED|Overall Study||75
8827265|NCT01610206|9881453|FG000|COMPLETED|Overall Study||63
8827266|NCT01610206|9881454|FG001|COMPLETED|Overall Study||45
8827267|NCT01610206|9881453|FG000|NOT COMPLETED|Overall Study||10
8827268|NCT01610206|9881454|FG001|NOT COMPLETED|Overall Study||30
8827269|NCT01610271|9881462|FG000|STARTED|Overall Study||150
8827270|NCT01610271|9881463|FG001|STARTED|Overall Study||150
9065955|NCT04128293|10126436|FG002|NOT COMPLETED|Washout Period 3 (Up to 7 Days)||0
9065956|NCT04128293|10126437|FG003|NOT COMPLETED|Washout Period 3 (Up to 7 Days)||0
8827271|NCT01610271|9881462|FG000|COMPLETED|Overall Study||148
8827272|NCT01610271|9881463|FG001|COMPLETED|Overall Study||146
8827273|NCT01610271|9881462|FG000|NOT COMPLETED|Overall Study||2
8827274|NCT01610271|9881463|FG001|NOT COMPLETED|Overall Study||4
8827275|NCT01610284|9881473|FG000|STARTED|Randomization Phase||576
8827276|NCT01610284|9881474|FG001|STARTED|Randomization Phase||571
8827277|NCT01610284|9881473|FG000|Safety Set (SS)|Randomization Phase||573
8827278|NCT01610284|9881474|FG001|Safety Set (SS)|Randomization Phase||570
8827279|NCT01610284|9881473|FG000|COMPLETED|Randomization Phase||574
8827280|NCT01610284|9881474|FG001|COMPLETED|Randomization Phase||569
8827281|NCT01610284|9881473|FG000|NOT COMPLETED|Randomization Phase||2
8827282|NCT01610284|9881474|FG001|NOT COMPLETED|Randomization Phase||2
8827283|NCT01610284|9881473|FG000|STARTED|Treatment Phase||574
8827284|NCT01610284|9881474|FG001|STARTED|Treatment Phase||569
8827285|NCT01610284|9881473|FG000|BKM120 Pharmacokinetic Analysis Set|Treatment Phase||93
8827286|NCT01610284|9881474|FG001|BKM120 Pharmacokinetic Analysis Set|Treatment Phase||0
8827287|NCT01610284|9881473|FG000|Full Pharmacokinetic Analysis Set (FPAS)|Treatment Phase||35
8827288|NCT01610284|9881474|FG001|Full Pharmacokinetic Analysis Set (FPAS)|Treatment Phase||0
8827289|NCT01610284|9881473|FG000|COMPLETED|Treatment Phase||0
8827290|NCT01610284|9881474|FG001|COMPLETED|Treatment Phase||0
8827291|NCT01610284|9881473|FG000|NOT COMPLETED|Treatment Phase||574
8827292|NCT01610284|9881474|FG001|NOT COMPLETED|Treatment Phase||569
8827293|NCT01610284|9881473|FG000|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|89
8827294|NCT01610284|9881474|FG001|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|29
8827295|NCT01610284|9881473|FG000|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
9065957|NCT04128293|10126434|FG000|STARTED|Treatment Period 4 (1 Day)||0
8827296|NCT01610284|9881474|FG001|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
8849679|NCT01742286|9904922|FG004|NOT COMPLETED|Escalation Phase||4
8827297|NCT01610284|9881473|FG000|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||89
8827298|NCT01610284|9881474|FG001|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||29
8827299|NCT01610297|9881480|FG000|STARTED|Overall Study||27
8827300|NCT01610297|9881480|FG000|COMPLETED|Overall Study||26
8827301|NCT01610297|9881480|FG000|NOT COMPLETED|Overall Study||1
8827302|NCT01610336|9881495|FG000|STARTED|Overall Study||5
8827303|NCT01610336|9881496|FG001|STARTED|Overall Study||7
8827304|NCT01610336|9881497|FG002|STARTED|Overall Study||6
8827305|NCT01610336|9881498|FG003|STARTED|Overall Study||7
8827306|NCT01610336|9881499|FG004|STARTED|Overall Study||4
8827307|NCT01610336|9881500|FG005|STARTED|Overall Study||12
8827308|NCT01610336|9881501|FG006|STARTED|Overall Study||5
8827309|NCT01610336|9881502|FG007|STARTED|Overall Study||7
8827310|NCT01610336|9881503|FG008|STARTED|Overall Study||8
8827311|NCT01610336|9881504|FG009|STARTED|Overall Study||53
8827312|NCT01610336|9881505|FG010|STARTED|Overall Study||47
8827313|NCT01610336|9881495|FG000|COMPLETED|Overall Study||0
8827314|NCT01610336|9881496|FG001|COMPLETED|Overall Study||0
8827315|NCT01610336|9881497|FG002|COMPLETED|Overall Study||0
8827316|NCT01610336|9881498|FG003|COMPLETED|Overall Study||0
8827317|NCT01610336|9881499|FG004|COMPLETED|Overall Study||0
8827318|NCT01610336|9881500|FG005|COMPLETED|Overall Study||0
8827319|NCT01610336|9881501|FG006|COMPLETED|Overall Study||0
8827320|NCT01610336|9881502|FG007|COMPLETED|Overall Study||0
8827321|NCT01610336|9881503|FG008|COMPLETED|Overall Study||0
8827322|NCT01610336|9881504|FG009|COMPLETED|Overall Study||0
8827323|NCT01610336|9881505|FG010|COMPLETED|Overall Study||0
8827324|NCT01610336|9881495|FG000|NOT COMPLETED|Overall Study||5
8827325|NCT01610336|9881496|FG001|NOT COMPLETED|Overall Study||7
8827326|NCT01610336|9881497|FG002|NOT COMPLETED|Overall Study||6
8827327|NCT01610336|9881498|FG003|NOT COMPLETED|Overall Study||7
8827328|NCT01610336|9881499|FG004|NOT COMPLETED|Overall Study||4
8827329|NCT01610336|9881500|FG005|NOT COMPLETED|Overall Study||12
8827330|NCT01610336|9881501|FG006|NOT COMPLETED|Overall Study||5
8827331|NCT01610336|9881502|FG007|NOT COMPLETED|Overall Study||7
8827332|NCT01610336|9881503|FG008|NOT COMPLETED|Overall Study||8
8827333|NCT01610336|9881504|FG009|NOT COMPLETED|Overall Study||53
8827334|NCT01610336|9881505|FG010|NOT COMPLETED|Overall Study||47
8827335|NCT01610414|9881535|FG000|STARTED|Study Start - Month 13||922
8827336|NCT01610414|9881536|FG001|STARTED|Study Start - Month 13||924
8827337|NCT01610414|9881535|FG000|COMPLETED|Study Start - Month 13||807
8827338|NCT01610414|9881536|FG001|COMPLETED|Study Start - Month 13||795
8827339|NCT01610414|9881535|FG000|NOT COMPLETED|Study Start - Month 13||115
8827340|NCT01610414|9881536|FG001|NOT COMPLETED|Study Start - Month 13||129
8827341|NCT01610414|9881535|FG000|STARTED|Month 13 - Month 25||922
8827342|NCT01610414|9881536|FG001|STARTED|Month 13 - Month 25||924
8827343|NCT01610414|9881535|FG000|COMPLETED|Month 13 - Month 25||857
8827344|NCT01610414|9881536|FG001|COMPLETED|Month 13 - Month 25||854
8827345|NCT01610414|9881535|FG000|NOT COMPLETED|Month 13 - Month 25||65
8827346|NCT01610414|9881536|FG001|NOT COMPLETED|Month 13 - Month 25||70
8827347|NCT01610414|9881535|FG000|STARTED|After Month 25||922
8827348|NCT01610414|9881536|FG001|STARTED|After Month 25||924
8827349|NCT01610414|9881535|FG000|COMPLETED|After Month 25||874
8827350|NCT01610414|9881536|FG001|COMPLETED|After Month 25||871
8827351|NCT01610414|9881535|FG000|NOT COMPLETED|After Month 25||48
8622419|NCT00488475|9661659|FG000|COMPLETED|Overall Study||3191
8622420|NCT00488475|9661659|FG000|NOT COMPLETED|Overall Study||1754
8622421|NCT00488488|9661663|FG000|STARTED|Overall Study||1028
8827352|NCT01610414|9881536|FG001|NOT COMPLETED|After Month 25||53
8827353|NCT01610427|9881543|FG000|STARTED|Overall Study||22
8827354|NCT01610427|9881543|FG000|COMPLETED|Overall Study||22
8827355|NCT01610427|9881543|FG000|NOT COMPLETED|Overall Study||0
8827356|NCT01610453|9881547|FG000|STARTED|Overall Study||150
8827357|NCT01610453|9881547|FG000|COMPLETED|Overall Study||150
8827358|NCT01610453|9881547|FG000|NOT COMPLETED|Overall Study||0
8827359|NCT01610492|9881552|FG000|STARTED|Overall Study||14
8827360|NCT01610492|9881552|FG000|COMPLETED|Overall Study||8
8827361|NCT01610492|9881552|FG000|NOT COMPLETED|Overall Study||6
8827362|NCT01610557|9881560|FG000|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 1: 14 unilateral and 2 bilateral (left eye assigned to Grp 3)|16
8827363|NCT01610557|9881561|FG001|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 2: 12 unilateral and 1 bilateral (left eye assigned to Grp 4)|13
8827364|NCT01610557|9881562|FG002|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 3: 13 unilateral and 1 bilateral (left eye assigned to Grp 1)|14
8827365|NCT01610557|9881563|FG003|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 4: 11 unilateral and 2 bilateral (left eye assigned to Grp 2)|13
8827366|NCT01610557|9881564|FG004|STARTED|36-Week Randomized Crossover Phase|Not applicable for 36-week double-masked randomized crossover phase|0
8827367|NCT01610557|9881560|FG000|COMPLETED|36-Week Randomized Crossover Phase||16
8827368|NCT01610557|9881561|FG001|COMPLETED|36-Week Randomized Crossover Phase|Unilateral participant unable to return for visits after Wk 4 due to recovery from an adverse event|12
8827369|NCT01610557|9881562|FG002|COMPLETED|36-Week Randomized Crossover Phase||14
8827370|NCT01610557|9881563|FG003|COMPLETED|36-Week Randomized Crossover Phase||13
8827371|NCT01610557|9881564|FG004|COMPLETED|36-Week Randomized Crossover Phase|Not applicable for 36-week double-masked randomized crossover phase|0
8827372|NCT01610557|9881560|FG000|NOT COMPLETED|36-Week Randomized Crossover Phase||0
8827373|NCT01610557|9881561|FG001|NOT COMPLETED|36-Week Randomized Crossover Phase||1
8827374|NCT01610557|9881562|FG002|NOT COMPLETED|36-Week Randomized Crossover Phase||0
8827375|NCT01610557|9881563|FG003|NOT COMPLETED|36-Week Randomized Crossover Phase||0
8827376|NCT01610557|9881564|FG004|NOT COMPLETED|36-Week Randomized Crossover Phase||0
8827377|NCT01610557|9881560|FG000|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
8827378|NCT01610557|9881561|FG001|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
8827379|NCT01610557|9881562|FG002|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
8827380|NCT01610557|9881563|FG003|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
8827381|NCT01610557|9881564|FG004|STARTED|Post-36-Week Extension Phase||55
8827382|NCT01610557|9881560|FG000|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
8827383|NCT01610557|9881561|FG001|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
8827384|NCT01610557|9881562|FG002|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
8827385|NCT01610557|9881563|FG003|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
8827386|NCT01610557|9881564|FG004|COMPLETED|Post-36-Week Extension Phase|2 bilateral participants withdrew before their first post-36-week extension visit|52
8827387|NCT01610557|9881560|FG000|NOT COMPLETED|Post-36-Week Extension Phase||0
8827388|NCT01610557|9881561|FG001|NOT COMPLETED|Post-36-Week Extension Phase||0
8827389|NCT01610557|9881562|FG002|NOT COMPLETED|Post-36-Week Extension Phase||0
8827390|NCT01610557|9881563|FG003|NOT COMPLETED|Post-36-Week Extension Phase||0
8827391|NCT01610557|9881564|FG004|NOT COMPLETED|Post-36-Week Extension Phase||3
8827392|NCT01610570|9881579|FG000|STARTED|Ph I >/= 12 mo. Children & Adolescents||0
8827393|NCT01610570|9881580|FG001|STARTED|Ph I >/= 12 mo. Children & Adolescents||2
8827394|NCT01610570|9881581|FG002|STARTED|Ph I >/= 12 mo. Children & Adolescents||0
8827395|NCT01610570|9881582|FG003|STARTED|Ph I >/= 12 mo. Children & Adolescents||0
8827396|NCT01610570|9881579|FG000|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
8827397|NCT01610570|9881580|FG001|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||2
8827398|NCT01610570|9881581|FG002|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
8827399|NCT01610570|9881582|FG003|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
8827400|NCT01610570|9881579|FG000|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
8827401|NCT01610570|9881580|FG001|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
8827402|NCT01610570|9881581|FG002|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
8827403|NCT01610570|9881582|FG003|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
8827404|NCT01610570|9881579|FG000|STARTED|Ph II >/= 18yrs of Age at Enrollment||0
8827405|NCT01610570|9881580|FG001|STARTED|Ph II >/= 18yrs of Age at Enrollment||0
8827406|NCT01610570|9881581|FG002|STARTED|Ph II >/= 18yrs of Age at Enrollment||0
8827407|NCT01610570|9881582|FG003|STARTED|Ph II >/= 18yrs of Age at Enrollment||6
8827408|NCT01610570|9881579|FG000|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
8827409|NCT01610570|9881580|FG001|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
8827410|NCT01610570|9881581|FG002|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
8827411|NCT01610570|9881582|FG003|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||6
8827412|NCT01610570|9881579|FG000|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
8827413|NCT01610570|9881580|FG001|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
8827414|NCT01610570|9881581|FG002|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
8827415|NCT01610570|9881582|FG003|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
8827416|NCT01610570|9881579|FG000|STARTED|Ph II >/= 12 mo. & </=17yrs||0
8827417|NCT01610570|9881580|FG001|STARTED|Ph II >/= 12 mo. & </=17yrs||0
8827418|NCT01610570|9881581|FG002|STARTED|Ph II >/= 12 mo. & </=17yrs||0
8827419|NCT01610570|9881582|FG003|STARTED|Ph II >/= 12 mo. & </=17yrs||0
8827420|NCT01610570|9881579|FG000|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
8827421|NCT01610570|9881580|FG001|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
8827422|NCT01610570|9881581|FG002|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
8827423|NCT01610570|9881582|FG003|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
8827424|NCT01610570|9881579|FG000|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
8827425|NCT01610570|9881580|FG001|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
8827426|NCT01610570|9881581|FG002|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
8827427|NCT01610570|9881582|FG003|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
8827428|NCT01610596|9881600|FG000|STARTED|Overall Study||36
8827429|NCT01610596|9881601|FG001|STARTED|Overall Study||36
8827430|NCT01610596|9881600|FG000|COMPLETED|Overall Study||36
8827431|NCT01610596|9881601|FG001|COMPLETED|Overall Study||35
8827432|NCT01610596|9881600|FG000|NOT COMPLETED|Overall Study||0
8827433|NCT01610596|9881601|FG001|NOT COMPLETED|Overall Study||1
8827434|NCT01610687|9881607|FG000|STARTED|Overall Study||137
8827435|NCT01610687|9881607|FG000|COMPLETED|Overall Study||70
8827436|NCT01610687|9881607|FG000|NOT COMPLETED|Overall Study||67
8827437|NCT01610700|9881613|FG000|STARTED|Overall Study||80
8827438|NCT01610700|9881614|FG001|STARTED|Overall Study||80
8827439|NCT01610700|9881613|FG000|COMPLETED|Overall Study||77
8827440|NCT01610700|9881614|FG001|COMPLETED|Overall Study||77
8827441|NCT01610700|9881613|FG000|NOT COMPLETED|Overall Study||3
8827442|NCT01610700|9881614|FG001|NOT COMPLETED|Overall Study||3
8827443|NCT01610713|9881623|FG000|STARTED|Overall Study||77
8827444|NCT01610713|9881624|FG001|STARTED|Overall Study||77
8827445|NCT01610713|9881623|FG000|COMPLETED|Overall Study||71
8827446|NCT01610713|9881624|FG001|COMPLETED|Overall Study||76
8827447|NCT01610713|9881623|FG000|NOT COMPLETED|Overall Study||6
8827448|NCT01610713|9881624|FG001|NOT COMPLETED|Overall Study||1
8827449|NCT01610752|9881633|FG000|STARTED|Overall Study||18
8827450|NCT01610752|9881634|FG001|STARTED|Overall Study||19
8827451|NCT01610752|9881635|FG002|STARTED|Overall Study||17
8827452|NCT01610752|9881633|FG000|COMPLETED|Overall Study||18
8827453|NCT01610752|9881634|FG001|COMPLETED|Overall Study||19
8827454|NCT01610752|9881635|FG002|COMPLETED|Overall Study||13
8827455|NCT01610752|9881633|FG000|NOT COMPLETED|Overall Study||0
8827456|NCT01610752|9881634|FG001|NOT COMPLETED|Overall Study||0
8827457|NCT01610752|9881635|FG002|NOT COMPLETED|Overall Study||4
8827458|NCT01610791|9881643|FG000|STARTED|Overall Study||121
8827459|NCT01610791|9881643|FG000|COMPLETED|Overall Study||100
8827460|NCT01610791|9881643|FG000|NOT COMPLETED|Overall Study||21
8827461|NCT01611090|9881649|FG000|STARTED|Randomized Period||289
8827462|NCT01611090|9881650|FG001|STARTED|Randomized Period||289
8827463|NCT01611090|9881651|FG002|STARTED|Randomized Period||0
8827464|NCT01611090|9881649|FG000|Treated|Randomized Period||287
8827465|NCT01611090|9881650|FG001|Treated|Randomized Period||287
8827466|NCT01611090|9881651|FG002|Treated|Randomized Period||0
8827467|NCT01611090|9881649|FG000|COMPLETED|Randomized Period||259
8827468|NCT01611090|9881650|FG001|COMPLETED|Randomized Period||260
8827469|NCT01611090|9881651|FG002|COMPLETED|Randomized Period||0
8827470|NCT01611090|9881649|FG000|NOT COMPLETED|Randomized Period||30
8827471|NCT01611090|9881650|FG001|NOT COMPLETED|Randomized Period||29
8827472|NCT01611090|9881651|FG002|NOT COMPLETED|Randomized Period||0
8827473|NCT01611090|9881649|FG000|STARTED|Cross Over (Placebo to Ibrutinib)||0
8827474|NCT01611090|9881650|FG001|STARTED|Cross Over (Placebo to Ibrutinib)||0
8827475|NCT01611090|9881651|FG002|STARTED|Cross Over (Placebo to Ibrutinib)||183
8827476|NCT01611090|9881649|FG000|Treated|Cross Over (Placebo to Ibrutinib)||0
8827477|NCT01611090|9881650|FG001|Treated|Cross Over (Placebo to Ibrutinib)||0
8827478|NCT01611090|9881651|FG002|Treated|Cross Over (Placebo to Ibrutinib)||183
8827479|NCT01611090|9881649|FG000|COMPLETED|Cross Over (Placebo to Ibrutinib)||0
8827480|NCT01611090|9881650|FG001|COMPLETED|Cross Over (Placebo to Ibrutinib)||0
8827481|NCT01611090|9881651|FG002|COMPLETED|Cross Over (Placebo to Ibrutinib)||178
8827482|NCT01611090|9881649|FG000|NOT COMPLETED|Cross Over (Placebo to Ibrutinib)||0
8827483|NCT01611090|9881650|FG001|NOT COMPLETED|Cross Over (Placebo to Ibrutinib)||0
8827484|NCT01611090|9881651|FG002|NOT COMPLETED|Cross Over (Placebo to Ibrutinib)||5
8827485|NCT01611155|9881660|FG000|STARTED|Overall Study||25
8827486|NCT01611155|9881661|FG001|STARTED|Overall Study||25
8827487|NCT01611155|9881660|FG000|Received Treatment|Overall Study||25
8827488|NCT01611155|9881661|FG001|Received Treatment|Overall Study||25
8622422|NCT00488488|9661663|FG000|Analyzed|Overall Study|3 participants were not analyzed due to retrospective documentation.|1025
8622423|NCT00488488|9661663|FG000|COMPLETED|Overall Study|Excludes 4 participants with missing information.|760
8622424|NCT00488488|9661663|FG000|NOT COMPLETED|Overall Study||268
8827489|NCT01611155|9881660|FG000|COMPLETED|Overall Study||16
8827490|NCT01611155|9881661|FG001|COMPLETED|Overall Study||18
8827491|NCT01611155|9881660|FG000|NOT COMPLETED|Overall Study||9
8827492|NCT01611155|9881661|FG001|NOT COMPLETED|Overall Study||7
8827493|NCT01611194|9881669|FG000|STARTED|Overall Study||36
8827494|NCT01611194|9881670|FG001|STARTED|Overall Study||35
8827495|NCT01611194|9881669|FG000|COMPLETED|Overall Study||36
8827496|NCT01611194|9881670|FG001|COMPLETED|Overall Study||32
8827497|NCT01611194|9881669|FG000|NOT COMPLETED|Overall Study||0
8827498|NCT01611194|9881670|FG001|NOT COMPLETED|Overall Study||3
8827499|NCT01611259|9881676|FG000|STARTED|Overall Study||48
8827500|NCT01611259|9881676|FG000|COMPLETED|Overall Study||34
8827501|NCT01611259|9881676|FG000|NOT COMPLETED|Overall Study||14
8827502|NCT01611298|9881680|FG000|STARTED|Overall Study||7
8827503|NCT01611298|9881680|FG000|COMPLETED|Overall Study||5
8827504|NCT01611298|9881680|FG000|NOT COMPLETED|Overall Study||2
8827505|NCT01611454|9881686|FG000|STARTED|Overall Study||58
8827506|NCT01611454|9881687|FG001|STARTED|Overall Study||48
8827507|NCT01611454|9881686|FG000|COMPLETED|Overall Study||40
8827508|NCT01611454|9881687|FG001|COMPLETED|Overall Study||38
8827509|NCT01611454|9881686|FG000|NOT COMPLETED|Overall Study||18
8827510|NCT01611454|9881687|FG001|NOT COMPLETED|Overall Study||10
8827511|NCT01611558|9881697|FG000|STARTED|Induction Phase||40
8827512|NCT01611558|9881697|FG000|COMPLETED|Induction Phase||2
8827513|NCT01611558|9881697|FG000|NOT COMPLETED|Induction Phase||38
8827514|NCT01611558|9881697|FG000|STARTED|Maintenance Phase||2
8827515|NCT01611558|9881697|FG000|COMPLETED|Maintenance Phase||0
8827516|NCT01611558|9881697|FG000|NOT COMPLETED|Maintenance Phase||2
8827517|NCT01611571|9881705|FG000|STARTED|Overall Study||11
8622425|NCT00488514|9661667|FG000|STARTED|Overall Study||656
8622426|NCT00488514|9661667|FG000|COMPLETED|Overall Study||363
8622427|NCT00488514|9661667|FG000|NOT COMPLETED|Overall Study||293
8622428|NCT00488592|9661688|FG000|STARTED|Overall Study|10 subjects were accrued|10
8827518|NCT01611571|9881706|FG001|STARTED|Overall Study||10
8827519|NCT01611571|9881707|FG002|STARTED|Overall Study||10
8827520|NCT01611571|9881705|FG000|COMPLETED|Overall Study||10
8827521|NCT01611571|9881706|FG001|COMPLETED|Overall Study||10
8827522|NCT01611571|9881707|FG002|COMPLETED|Overall Study||9
8827523|NCT01611571|9881705|FG000|NOT COMPLETED|Overall Study||1
8827524|NCT01611571|9881706|FG001|NOT COMPLETED|Overall Study||0
8827525|NCT01611571|9881707|FG002|NOT COMPLETED|Overall Study||1
8827526|NCT01611662|9881715|FG000|STARTED|Overall Study||32
8827527|NCT01611662|9881715|FG000|COMPLETED|Overall Study||31
8827528|NCT01611662|9881715|FG000|NOT COMPLETED|Overall Study||1
8827529|NCT01611779|9881719|FG000|STARTED|Overall Study||5
8827530|NCT01611779|9881719|FG000|COMPLETED|Overall Study||5
8827531|NCT01611779|9881719|FG000|NOT COMPLETED|Overall Study||0
8827532|NCT01611792|9881725|FG000|STARTED|Initial Period: Time 0||29
8827533|NCT01611792|9881726|FG001|STARTED|Initial Period: Time 0||29
8827534|NCT01611792|9881725|FG000|COMPLETED|Initial Period: Time 0||17
8827535|NCT01611792|9881726|FG001|COMPLETED|Initial Period: Time 0||20
8827536|NCT01611792|9881725|FG000|NOT COMPLETED|Initial Period: Time 0||12
8827537|NCT01611792|9881726|FG001|NOT COMPLETED|Initial Period: Time 0||9
8827538|NCT01611792|9881725|FG000|STARTED|Follow-up: at 11 Weeks||17
8827539|NCT01611792|9881726|FG001|STARTED|Follow-up: at 11 Weeks||20
8827540|NCT01611792|9881725|FG000|COMPLETED|Follow-up: at 11 Weeks||17
8827541|NCT01611792|9881726|FG001|COMPLETED|Follow-up: at 11 Weeks||20
8827542|NCT01611792|9881725|FG000|NOT COMPLETED|Follow-up: at 11 Weeks||0
8827543|NCT01611792|9881726|FG001|NOT COMPLETED|Follow-up: at 11 Weeks||0
8827544|NCT01611792|9881725|FG000|STARTED|Followup: at 6 Months||17
8827545|NCT01611792|9881726|FG001|STARTED|Followup: at 6 Months||20
8827546|NCT01611792|9881725|FG000|COMPLETED|Followup: at 6 Months||11
8827547|NCT01611792|9881726|FG001|COMPLETED|Followup: at 6 Months||7
8827548|NCT01611792|9881725|FG000|NOT COMPLETED|Followup: at 6 Months||6
8827549|NCT01611792|9881726|FG001|NOT COMPLETED|Followup: at 6 Months||13
8827550|NCT01611857|9881735|FG000|STARTED|Overall Study|Three dose levels of tivantinib (120 mg, 240 mg, and 360 mg) were evaluated to determine the MTD.|15
8827551|NCT01611857|9881736|FG001|STARTED|Overall Study||34
8827552|NCT01611857|9881735|FG000|Tivantinib 120 mg|Overall Study||5
8827553|NCT01611857|9881736|FG001|Tivantinib 120 mg|Overall Study||0
8827554|NCT01611857|9881735|FG000|Tivantinib 240 mg|Overall Study||3
8827555|NCT01611857|9881736|FG001|Tivantinib 240 mg|Overall Study||0
8827556|NCT01611857|9881735|FG000|Tivantinib 360 mg|Overall Study||7
8827557|NCT01611857|9881736|FG001|Tivantinib 360 mg|Overall Study|Two participants withdrew prior to receiving drug.|32
8827558|NCT01611857|9881735|FG000|COMPLETED|Overall Study||15
8827559|NCT01611857|9881736|FG001|COMPLETED|Overall Study||32
8827560|NCT01611857|9881735|FG000|NOT COMPLETED|Overall Study||0
8827561|NCT01611857|9881736|FG001|NOT COMPLETED|Overall Study||2
8827562|NCT01611935|9881746|FG000|STARTED|Overall Study||50
8827563|NCT01611935|9881747|FG001|STARTED|Overall Study||51
8827564|NCT01611935|9881746|FG000|COMPLETED|Overall Study||49
8827565|NCT01611935|9881747|FG001|COMPLETED|Overall Study||51
8827566|NCT01611935|9881746|FG000|NOT COMPLETED|Overall Study||1
8827567|NCT01611935|9881747|FG001|NOT COMPLETED|Overall Study||0
8827568|NCT01611948|9881755|FG000|STARTED|Overall Study||32
8827569|NCT01611948|9881756|FG001|STARTED|Overall Study||38
8827570|NCT01611948|9881755|FG000|COMPLETED|Overall Study||18
8827571|NCT01611948|9881756|FG001|COMPLETED|Overall Study||26
8827572|NCT01611948|9881755|FG000|NOT COMPLETED|Overall Study||14
8827573|NCT01611948|9881756|FG001|NOT COMPLETED|Overall Study||12
8827574|NCT01611974|9881765|FG000|STARTED|Overall Study||40
8827575|NCT01611974|9881766|FG001|STARTED|Overall Study||40
8827576|NCT01611974|9881767|FG002|STARTED|Overall Study||40
8827577|NCT01611974|9881765|FG000|COMPLETED|Overall Study||25
8827578|NCT01611974|9881766|FG001|COMPLETED|Overall Study||25
8827579|NCT01611974|9881767|FG002|COMPLETED|Overall Study||24
8827580|NCT01611974|9881765|FG000|NOT COMPLETED|Overall Study||15
8827581|NCT01611974|9881766|FG001|NOT COMPLETED|Overall Study||15
8827582|NCT01611974|9881767|FG002|NOT COMPLETED|Overall Study||16
8827583|NCT01612000|9881779|FG000|STARTED|Overall Study||84
8827584|NCT01612000|9881780|FG001|STARTED|Overall Study||86
8827585|NCT01612000|9881781|FG002|STARTED|Overall Study||85
8827586|NCT01612000|9881782|FG003|STARTED|Overall Study||86
8827587|NCT01612000|9881779|FG000|COMPLETED|Overall Study||75
8827588|NCT01612000|9881780|FG001|COMPLETED|Overall Study||81
8827589|NCT01612000|9881781|FG002|COMPLETED|Overall Study||78
8827590|NCT01612000|9881782|FG003|COMPLETED|Overall Study||76
8827591|NCT01612000|9881779|FG000|NOT COMPLETED|Overall Study||9
8827592|NCT01612000|9881780|FG001|NOT COMPLETED|Overall Study||5
8827593|NCT01612000|9881781|FG002|NOT COMPLETED|Overall Study||7
8827594|NCT01612000|9881782|FG003|NOT COMPLETED|Overall Study||10
8827595|NCT01612156|9881794|FG000|STARTED|Overall Study||42
8827596|NCT01612156|9881795|FG001|STARTED|Overall Study||48
8827597|NCT01612156|9881794|FG000|COMPLETED|Overall Study|Contraindication to urodynamics (urinary tract infection) diagnosed after randomization|40
8827598|NCT01612156|9881795|FG001|COMPLETED|Overall Study||48
8827599|NCT01612156|9881794|FG000|NOT COMPLETED|Overall Study||2
8827600|NCT01612156|9881795|FG001|NOT COMPLETED|Overall Study||0
8827601|NCT01612221|9881803|FG000|STARTED|Overall Study||50
8827602|NCT01612221|9881804|FG001|STARTED|Overall Study||50
8827603|NCT01612221|9881803|FG000|COMPLETED|Overall Study||50
8827604|NCT01612221|9881804|FG001|COMPLETED|Overall Study||50
8827605|NCT01612221|9881803|FG000|NOT COMPLETED|Overall Study||0
8827606|NCT01612221|9881804|FG001|NOT COMPLETED|Overall Study||0
8827607|NCT01612494|9881812|FG000|STARTED|Overall Study||21
8827608|NCT01612494|9881813|FG001|STARTED|Overall Study||23
8827609|NCT01612494|9881812|FG000|COMPLETED|Overall Study||21
8827610|NCT01612494|9881813|FG001|COMPLETED|Overall Study||23
8827611|NCT01612494|9881812|FG000|NOT COMPLETED|Overall Study||0
8827612|NCT01612494|9881813|FG001|NOT COMPLETED|Overall Study||0
8827613|NCT01612546|9881819|FG000|STARTED|Overall Study||10
8827614|NCT01612546|9881819|FG000|COMPLETED|Overall Study||10
8827615|NCT01612546|9881819|FG000|NOT COMPLETED|Overall Study||0
8827616|NCT01612676|9881827|FG000|STARTED|Overall Study||6
8827617|NCT01612676|9881828|FG001|STARTED|Overall Study||7
8827618|NCT01612676|9881829|FG002|STARTED|Overall Study||5
8827619|NCT01612676|9881830|FG003|STARTED|Overall Study||13
8827620|NCT01612676|9881827|FG000|Dosed|Overall Study||5
8827621|NCT01612676|9881828|FG001|Dosed|Overall Study||7
8827622|NCT01612676|9881829|FG002|Dosed|Overall Study||5
8827623|NCT01612676|9881830|FG003|Dosed|Overall Study||13
8827624|NCT01612676|9881827|FG000|COMPLETED|Overall Study||4
8827625|NCT01612676|9881828|FG001|COMPLETED|Overall Study||3
8827626|NCT01612676|9881829|FG002|COMPLETED|Overall Study||4
8827627|NCT01612676|9881830|FG003|COMPLETED|Overall Study||10
8827628|NCT01612676|9881827|FG000|NOT COMPLETED|Overall Study||2
8827629|NCT01612676|9881828|FG001|NOT COMPLETED|Overall Study||4
8827630|NCT01612676|9881829|FG002|NOT COMPLETED|Overall Study||1
8827631|NCT01612676|9881830|FG003|NOT COMPLETED|Overall Study||3
8827632|NCT01612702|9881844|FG000|STARTED|Overall Study||146
8827633|NCT01612702|9881845|FG001|STARTED|Overall Study||145
8827634|NCT01612702|9881844|FG000|COMPLETED|Overall Study||135
8827635|NCT01612702|9881845|FG001|COMPLETED|Overall Study||134
8827636|NCT01612702|9881844|FG000|NOT COMPLETED|Overall Study||11
8827637|NCT01612702|9881845|FG001|NOT COMPLETED|Overall Study||11
8827638|NCT01612767|9881851|FG000|STARTED|Overall Study||329
8827639|NCT01612767|9881851|FG000|COMPLETED|Overall Study||287
8827640|NCT01612767|9881851|FG000|NOT COMPLETED|Overall Study||42
8827641|NCT01612780|9881876|FG000|STARTED|Overall Study||82
8827642|NCT01612780|9881876|FG000|COMPLETED|Overall Study||76
8827643|NCT01612780|9881876|FG000|NOT COMPLETED|Overall Study||6
8827644|NCT01612793|9881882|FG000|STARTED|Overall Study||2
8827645|NCT01612793|9881883|FG001|STARTED|Overall Study||2
8827646|NCT01612793|9881882|FG000|COMPLETED|Overall Study||2
8827647|NCT01612793|9881883|FG001|COMPLETED|Overall Study||2
8827648|NCT01612793|9881882|FG000|NOT COMPLETED|Overall Study||0
8827649|NCT01612793|9881883|FG001|NOT COMPLETED|Overall Study||0
8827650|NCT01612858|9881891|FG000|STARTED|Overall Study||16
8827651|NCT01612858|9881892|FG001|STARTED|Overall Study||4
8827652|NCT01612858|9881891|FG000|COMPLETED|Overall Study||11
8827653|NCT01612858|9881892|FG001|COMPLETED|Overall Study||3
8827654|NCT01612858|9881891|FG000|NOT COMPLETED|Overall Study||5
8827655|NCT01612858|9881892|FG001|NOT COMPLETED|Overall Study||1
8827656|NCT01612884|9881900|FG000|STARTED|Overall Study||19
8827657|NCT01612884|9881901|FG001|STARTED|Overall Study||18
8827658|NCT01612884|9881900|FG000|COMPLETED|Overall Study||19
8827659|NCT01612884|9881901|FG001|COMPLETED|Overall Study||18
8827660|NCT01612884|9881900|FG000|NOT COMPLETED|Overall Study||0
8827661|NCT01612884|9881901|FG001|NOT COMPLETED|Overall Study||0
8827662|NCT01613014|9881909|FG000|STARTED|Overall Study||75
8827663|NCT01613014|9881910|FG001|STARTED|Overall Study||75
8827664|NCT01613014|9881909|FG000|COMPLETED|Overall Study||57
8827665|NCT01613014|9881910|FG001|COMPLETED|Overall Study||63
8827666|NCT01613014|9881909|FG000|NOT COMPLETED|Overall Study||18
8827667|NCT01613014|9881910|FG001|NOT COMPLETED|Overall Study||12
8827668|NCT01613027|9881916|FG000|STARTED|Overall Study||135
8827669|NCT01613027|9881916|FG000|COMPLETED|Overall Study||127
8827670|NCT01613027|9881916|FG000|NOT COMPLETED|Overall Study||8
8827671|NCT01613131|9881922|FG000|STARTED|Overall Study||20
8827672|NCT01613131|9881923|FG001|STARTED|Overall Study||18
8827673|NCT01613131|9881922|FG000|COMPLETED|Overall Study||17
8827674|NCT01613131|9881923|FG001|COMPLETED|Overall Study||13
8622429|NCT00488592|9661688|FG000|COMPLETED|Overall Study|7 completed the initial series of 6 vaccinations|7
8622430|NCT00488592|9661688|FG000|NOT COMPLETED|Overall Study||3
8622431|NCT00488618|9661694|FG000|STARTED|Overall Study||120
8622432|NCT00488618|9661695|FG001|STARTED|Overall Study||118
8622433|NCT00488618|9661694|FG000|Safety Population: Received Study Drug|Overall Study||118
8622434|NCT00488618|9661695|FG001|Safety Population: Received Study Drug|Overall Study||118
8622435|NCT00488618|9661694|FG000|COMPLETED|Overall Study||73
8622436|NCT00488618|9661695|FG001|COMPLETED|Overall Study||75
8622437|NCT00488618|9661694|FG000|NOT COMPLETED|Overall Study||47
8622438|NCT00488618|9661695|FG001|NOT COMPLETED|Overall Study||43
8622439|NCT00488631|9661707|FG000|STARTED|Double Blind Period (Week 0-54)||156
8622440|NCT00488631|9661708|FG001|STARTED|Double Blind Period (Week 0-54)||154
8622441|NCT00488631|9661709|FG002|STARTED|Double Blind Period (Week 0-54)||154
8622442|NCT00488631|9661710|FG003|STARTED|Double Blind Period (Week 0-54)||129
8622443|NCT00488631|9661711|FG004|STARTED|Double Blind Period (Week 0-54)||230
8622444|NCT00488631|9661712|FG005|STARTED|Double Blind Period (Week 0-54)||405
8622445|NCT00488631|9661713|FG006|STARTED|Double Blind Period (Week 0-54)||0
8622446|NCT00488631|9661714|FG007|STARTED|Double Blind Period (Week 0-54)||0
8622447|NCT00488631|9661715|FG008|STARTED|Double Blind Period (Week 0-54)||0
8827675|NCT01613131|9881922|FG000|NOT COMPLETED|Overall Study||3
8827676|NCT01613131|9881923|FG001|NOT COMPLETED|Overall Study||5
8827677|NCT01613222|9881929|FG000|STARTED|Overall Study||63
8827678|NCT01613222|9881929|FG000|COMPLETED|Overall Study||51
8827679|NCT01613222|9881929|FG000|NOT COMPLETED|Overall Study||12
8622448|NCT00488631|9661716|FG009|STARTED|Double Blind Period (Week 0-54)||0
8827680|NCT01613248|9881948|FG000|STARTED|Overall Study||139
8827681|NCT01613248|9881949|FG001|STARTED|Overall Study||138
8827682|NCT01613248|9881950|FG002|STARTED|Overall Study||139
8827683|NCT01613248|9881951|FG003|STARTED|Overall Study||139
8827684|NCT01613248|9881952|FG004|STARTED|Overall Study||139
8827685|NCT01613248|9881953|FG005|STARTED|Overall Study||140
8827686|NCT01613248|9881948|FG000|COMPLETED|Overall Study||110
8827687|NCT01613248|9881949|FG001|COMPLETED|Overall Study||104
8827688|NCT01613248|9881950|FG002|COMPLETED|Overall Study||106
8827689|NCT01613248|9881951|FG003|COMPLETED|Overall Study||101
8827690|NCT01613248|9881952|FG004|COMPLETED|Overall Study||104
8827691|NCT01613248|9881953|FG005|COMPLETED|Overall Study||102
8827692|NCT01613248|9881948|FG000|NOT COMPLETED|Overall Study||29
8827693|NCT01613248|9881949|FG001|NOT COMPLETED|Overall Study||34
8827694|NCT01613248|9881950|FG002|NOT COMPLETED|Overall Study||33
8827695|NCT01613248|9881951|FG003|NOT COMPLETED|Overall Study||38
8827696|NCT01613248|9881952|FG004|NOT COMPLETED|Overall Study||35
8827697|NCT01613248|9881953|FG005|NOT COMPLETED|Overall Study||38
8827698|NCT01613313|9881971|FG000|STARTED|Overall Study||2
8827699|NCT01613313|9881972|FG001|STARTED|Overall Study||4
8827700|NCT01613313|9881973|FG002|STARTED|Overall Study||4
8827701|NCT01613313|9881974|FG003|STARTED|Overall Study||4
8827702|NCT01613313|9881971|FG000|COMPLETED|Overall Study||2
8827703|NCT01613313|9881972|FG001|COMPLETED|Overall Study||4
8827704|NCT01613313|9881973|FG002|COMPLETED|Overall Study||4
8827705|NCT01613313|9881974|FG003|COMPLETED|Overall Study||4
8827706|NCT01613313|9881971|FG000|NOT COMPLETED|Overall Study||0
8827707|NCT01613313|9881972|FG001|NOT COMPLETED|Overall Study||0
8827708|NCT01613313|9881973|FG002|NOT COMPLETED|Overall Study||0
8827709|NCT01613313|9881974|FG003|NOT COMPLETED|Overall Study||0
8827710|NCT01613326|9881986|FG000|STARTED|Overall Study||327
8827711|NCT01613326|9881987|FG001|STARTED|Overall Study||330
8827712|NCT01613326|9881986|FG000|COMPLETED|Overall Study||314
8827713|NCT01613326|9881987|FG001|COMPLETED|Overall Study||316
8827714|NCT01613326|9881986|FG000|NOT COMPLETED|Overall Study||13
8827715|NCT01613326|9881987|FG001|NOT COMPLETED|Overall Study||14
8827716|NCT01613339|9881995|FG000|STARTED|Overall Study||24
8827717|NCT01613339|9881996|FG001|STARTED|Overall Study||22
8827718|NCT01613339|9881995|FG000|COMPLETED|Overall Study||21
8827719|NCT01613339|9881996|FG001|COMPLETED|Overall Study||21
8827720|NCT01613339|9881995|FG000|NOT COMPLETED|Overall Study||3
8827721|NCT01613339|9881996|FG001|NOT COMPLETED|Overall Study||1
8827722|NCT01613378|9882001|FG000|STARTED|Overall Study||200
8827723|NCT01613378|9882001|FG000|COMPLETED|Overall Study||161
8827724|NCT01613378|9882001|FG000|NOT COMPLETED|Overall Study||39
8827725|NCT01613417|9882007|FG000|STARTED|First Injection||113
8827726|NCT01613417|9882008|FG001|STARTED|First Injection||116
8827727|NCT01613417|9882007|FG000|COMPLETED|First Injection||113
8827728|NCT01613417|9882008|FG001|COMPLETED|First Injection||116
8827729|NCT01613417|9882007|FG000|NOT COMPLETED|First Injection||0
8827730|NCT01613417|9882008|FG001|NOT COMPLETED|First Injection||0
8827731|NCT01613417|9882007|FG000|STARTED|Washout (no Second Injection/MRI)||113
8827732|NCT01613417|9882008|FG001|STARTED|Washout (no Second Injection/MRI)||116
8827733|NCT01613417|9882007|FG000|COMPLETED|Washout (no Second Injection/MRI)||100
8827734|NCT01613417|9882008|FG001|COMPLETED|Washout (no Second Injection/MRI)||109
8827735|NCT01613417|9882007|FG000|NOT COMPLETED|Washout (no Second Injection/MRI)||13
8827736|NCT01613417|9882008|FG001|NOT COMPLETED|Washout (no Second Injection/MRI)||7
8827737|NCT01613417|9882007|FG000|STARTED|Second Injection||100
8827738|NCT01613417|9882008|FG001|STARTED|Second Injection||109
8827739|NCT01613417|9882007|FG000|COMPLETED|Second Injection||100
8827740|NCT01613417|9882008|FG001|COMPLETED|Second Injection||109
8827741|NCT01613417|9882007|FG000|NOT COMPLETED|Second Injection||0
8827742|NCT01613417|9882008|FG001|NOT COMPLETED|Second Injection||0
8827743|NCT01613599|9882024|FG000|STARTED|Overall Study||97
8827744|NCT01613599|9882024|FG000|COMPLETED|Overall Study||72
8827745|NCT01613599|9882024|FG000|NOT COMPLETED|Overall Study||25
8849680|NCT01742286|9904923|FG005|NOT COMPLETED|Escalation Phase||5
8849681|NCT01742286|9904924|FG006|NOT COMPLETED|Escalation Phase||6
8849682|NCT01742286|9904918|FG000|STARTED|Expansion Phase||0
8849683|NCT01742286|9904919|FG001|STARTED|Expansion Phase||0
8849684|NCT01742286|9904920|FG002|STARTED|Expansion Phase||7
8849685|NCT01742286|9904921|FG003|STARTED|Expansion Phase||0
8849686|NCT01742286|9904922|FG004|STARTED|Expansion Phase||0
8849687|NCT01742286|9904923|FG005|STARTED|Expansion Phase||0
8849688|NCT01742286|9904924|FG006|STARTED|Expansion Phase||36
8849689|NCT01742286|9904918|FG000|End of Treatment = Not Ccompleted|Expansion Phase||0
8849690|NCT01742286|9904919|FG001|End of Treatment = Not Ccompleted|Expansion Phase||0
8849691|NCT01742286|9904920|FG002|End of Treatment = Not Ccompleted|Expansion Phase||7
8849692|NCT01742286|9904921|FG003|End of Treatment = Not Ccompleted|Expansion Phase||0
8849693|NCT01742286|9904922|FG004|End of Treatment = Not Ccompleted|Expansion Phase||0
8849694|NCT01742286|9904923|FG005|End of Treatment = Not Ccompleted|Expansion Phase||0
8849695|NCT01742286|9904924|FG006|End of Treatment = Not Ccompleted|Expansion Phase||36
8849696|NCT01742286|9904918|FG000|COMPLETED|Expansion Phase||0
8849697|NCT01742286|9904919|FG001|COMPLETED|Expansion Phase||0
8849698|NCT01742286|9904920|FG002|COMPLETED|Expansion Phase||0
8849699|NCT01742286|9904921|FG003|COMPLETED|Expansion Phase||0
8849700|NCT01742286|9904922|FG004|COMPLETED|Expansion Phase||0
8849701|NCT01742286|9904923|FG005|COMPLETED|Expansion Phase||0
8849702|NCT01742286|9904924|FG006|COMPLETED|Expansion Phase||0
8849703|NCT01742286|9904918|FG000|NOT COMPLETED|Expansion Phase||0
8849704|NCT01742286|9904919|FG001|NOT COMPLETED|Expansion Phase||0
8849705|NCT01742286|9904920|FG002|NOT COMPLETED|Expansion Phase||7
8849706|NCT01742286|9904921|FG003|NOT COMPLETED|Expansion Phase||0
8849707|NCT01742286|9904922|FG004|NOT COMPLETED|Expansion Phase||0
8849708|NCT01742286|9904923|FG005|NOT COMPLETED|Expansion Phase||0
8849709|NCT01742286|9904924|FG006|NOT COMPLETED|Expansion Phase||36
8849710|NCT01742364|9904951|FG000|STARTED|Overall Study||33
8849711|NCT01742364|9904952|FG001|STARTED|Overall Study||33
8849712|NCT01742364|9904953|FG002|STARTED|Overall Study||15
8849713|NCT01742364|9904954|FG003|STARTED|Overall Study||15
8849714|NCT01742364|9904951|FG000|COMPLETED|Overall Study||33
8849715|NCT01742364|9904952|FG001|COMPLETED|Overall Study||33
8827746|NCT01613716|9882028|FG000|STARTED|Overall Study||30
8827747|NCT01613716|9882028|FG000|COMPLETED|Overall Study||23
8827748|NCT01613716|9882028|FG000|NOT COMPLETED|Overall Study||7
8827749|NCT01613768|9882032|FG000|STARTED|Overall Study||29
8827750|NCT01613768|9882032|FG000|COMPLETED|Overall Study||29
8827751|NCT01613768|9882032|FG000|NOT COMPLETED|Overall Study||0
8827752|NCT01614093|9882037|FG000|STARTED|Overall Study||17
8827753|NCT01614093|9882037|FG000|COMPLETED|Overall Study||16
8827754|NCT01614093|9882037|FG000|NOT COMPLETED|Overall Study||1
8827755|NCT01614210|9882042|FG000|STARTED|Overall Study||52
8827756|NCT01614210|9882042|FG000|COMPLETED|Overall Study||52
8827757|NCT01614210|9882042|FG000|NOT COMPLETED|Overall Study||0
8827758|NCT01614249|9882048|FG000|STARTED|Overall Study|Participants received every two-weeks supply and monitored regularly on cell-phone and face-to-face.|107
8827759|NCT01614249|9882049|FG001|STARTED|Overall Study|Participants received every two-week supply and monitored regularly on cell-phone and face-to-face.|109
8827760|NCT01614249|9882048|FG000|At Week-4|Overall Study|Participants received every two-week supply and monitored regularly on cell-phone and face-to-face.|98
8827761|NCT01614249|9882049|FG001|At Week-4|Overall Study|Participants received every two-week supply and monitored regularly on cell-phone and face-to-face.|92
8827762|NCT01614249|9882048|FG000|At Week-8 (End of Study Period)|Overall Study|End of study data collected for all participants who completed the 8-week trial period.|96
8827763|NCT01614249|9882049|FG001|At Week-8 (End of Study Period)|Overall Study|End of study data collected for all participants who completed the 8-week trial period.|86
8827764|NCT01614249|9882048|FG000|COMPLETED|Overall Study|End of study data analyzed for only participants who completed the 8-week trial period.|96
8827765|NCT01614249|9882049|FG001|COMPLETED|Overall Study|End of study data analyzed for only participants who completed the 8-week trial period.|86
8827766|NCT01614249|9882048|FG000|NOT COMPLETED|Overall Study||11
8827767|NCT01614249|9882049|FG001|NOT COMPLETED|Overall Study||23
8827768|NCT01614392|9882057|FG000|STARTED|Overall Study||25
8827769|NCT01614392|9882058|FG001|STARTED|Overall Study||27
8827770|NCT01614392|9882057|FG000|COMPLETED|Overall Study||24
8827771|NCT01614392|9882058|FG001|COMPLETED|Overall Study||24
8827772|NCT01614392|9882057|FG000|NOT COMPLETED|Overall Study||1
8827773|NCT01614392|9882058|FG001|NOT COMPLETED|Overall Study||3
8827774|NCT01614457|9882066|FG000|STARTED|Overall Study||34
8827775|NCT01614457|9882067|FG001|STARTED|Overall Study||35
8827776|NCT01614457|9882066|FG000|COMPLETED|Overall Study||32
8827777|NCT01614457|9882067|FG001|COMPLETED|Overall Study||35
8827778|NCT01614457|9882066|FG000|NOT COMPLETED|Overall Study||2
8827779|NCT01614457|9882067|FG001|NOT COMPLETED|Overall Study||0
8827780|NCT01614470|9882075|FG000|STARTED|Part 1: Treatment Period 1 (8 Weeks)||20
8827781|NCT01614470|9882076|FG001|STARTED|Part 1: Treatment Period 1 (8 Weeks)||19
8827782|NCT01614470|9882077|FG002|STARTED|Part 1: Treatment Period 1 (8 Weeks)||0
8827783|NCT01614470|9882075|FG000|COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||18
8827784|NCT01614470|9882076|FG001|COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||18
8827785|NCT01614470|9882077|FG002|COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||0
8827786|NCT01614470|9882075|FG000|NOT COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||2
8827787|NCT01614470|9882076|FG001|NOT COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||1
8827788|NCT01614470|9882077|FG002|NOT COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||0
8827789|NCT01614470|9882075|FG000|STARTED|Part 1: Washout Period (4 to 8 Weeks)||18
8827790|NCT01614470|9882076|FG001|STARTED|Part 1: Washout Period (4 to 8 Weeks)||18
8827791|NCT01614470|9882077|FG002|STARTED|Part 1: Washout Period (4 to 8 Weeks)||0
8827792|NCT01614470|9882075|FG000|COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||18
8827793|NCT01614470|9882076|FG001|COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||18
8827794|NCT01614470|9882077|FG002|COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
8827795|NCT01614470|9882075|FG000|NOT COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
8827796|NCT01614470|9882076|FG001|NOT COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
8827797|NCT01614470|9882077|FG002|NOT COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
8827798|NCT01614470|9882075|FG000|STARTED|Part 1: Treatment Period 2 (8 Weeks)||18
8827799|NCT01614470|9882076|FG001|STARTED|Part 1: Treatment Period 2 (8 Weeks)||18
8827800|NCT01614470|9882077|FG002|STARTED|Part 1: Treatment Period 2 (8 Weeks)||0
8827801|NCT01614470|9882075|FG000|COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||18
8622449|NCT00488631|9661707|FG000|COMPLETED|Double Blind Period (Week 0-54)||113
8622450|NCT00488631|9661708|FG001|COMPLETED|Double Blind Period (Week 0-54)||111
8622451|NCT00488631|9661709|FG002|COMPLETED|Double Blind Period (Week 0-54)||109
8622452|NCT00488631|9661710|FG003|COMPLETED|Double Blind Period (Week 0-54)||88
8622453|NCT00488631|9661711|FG004|COMPLETED|Double Blind Period (Week 0-54)||127
8622454|NCT00488631|9661712|FG005|COMPLETED|Double Blind Period (Week 0-54)||189
8622455|NCT00488631|9661713|FG006|COMPLETED|Double Blind Period (Week 0-54)||0
8827802|NCT01614470|9882076|FG001|COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||18
8827803|NCT01614470|9882077|FG002|COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
8827804|NCT01614470|9882075|FG000|NOT COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
8827805|NCT01614470|9882076|FG001|NOT COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
8827806|NCT01614470|9882077|FG002|NOT COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
8827807|NCT01614470|9882075|FG000|STARTED|Part 2: Open-label Period (16 Weeks)||0
8827808|NCT01614470|9882076|FG001|STARTED|Part 2: Open-label Period (16 Weeks)||0
8827809|NCT01614470|9882077|FG002|STARTED|Part 2: Open-label Period (16 Weeks)||36
8827810|NCT01614470|9882075|FG000|COMPLETED|Part 2: Open-label Period (16 Weeks)||0
8827811|NCT01614470|9882076|FG001|COMPLETED|Part 2: Open-label Period (16 Weeks)||0
8827812|NCT01614470|9882077|FG002|COMPLETED|Part 2: Open-label Period (16 Weeks)||36
8827813|NCT01614470|9882075|FG000|NOT COMPLETED|Part 2: Open-label Period (16 Weeks)||0
8827814|NCT01614470|9882076|FG001|NOT COMPLETED|Part 2: Open-label Period (16 Weeks)||0
8827815|NCT01614470|9882077|FG002|NOT COMPLETED|Part 2: Open-label Period (16 Weeks)||0
8827816|NCT01614509|9882088|FG000|STARTED|Overall Study||24
8827817|NCT01614509|9882089|FG001|STARTED|Overall Study||21
8827818|NCT01614509|9882088|FG000|COMPLETED|Overall Study||23
8827819|NCT01614509|9882089|FG001|COMPLETED|Overall Study||18
8827820|NCT01614509|9882088|FG000|NOT COMPLETED|Overall Study||1
8827821|NCT01614509|9882089|FG001|NOT COMPLETED|Overall Study||3
8827822|NCT01614574|9882095|FG000|STARTED|Overall Study||6
8827823|NCT01614574|9882095|FG000|COMPLETED|Overall Study||6
8827824|NCT01614574|9882095|FG000|NOT COMPLETED|Overall Study||0
8827825|NCT01614600|9882099|FG000|STARTED|Overall Study||88
8827826|NCT01614600|9882099|FG000|COMPLETED|Overall Study||84
8827827|NCT01614600|9882099|FG000|NOT COMPLETED|Overall Study||4
8827828|NCT01614613|9882103|FG000|STARTED|Overall Study||146
8827829|NCT01614613|9882103|FG000|COMPLETED|Overall Study||146
8827830|NCT01614613|9882103|FG000|NOT COMPLETED|Overall Study||0
8827831|NCT01614743|9882110|FG000|STARTED|Overall Study||4
8827832|NCT01614743|9882111|FG001|STARTED|Overall Study||5
8827833|NCT01614743|9882110|FG000|COMPLETED|Overall Study||3
8827834|NCT01614743|9882111|FG001|COMPLETED|Overall Study|Subject in the placebo group (5) also received the treatment (IncobotulinumtoxinA) at Visit 5.|5
8827835|NCT01614743|9882110|FG000|NOT COMPLETED|Overall Study||1
8827836|NCT01614743|9882111|FG001|NOT COMPLETED|Overall Study||0
8827837|NCT01614769|9882117|FG000|STARTED|Period 1||2
8827838|NCT01614769|9882118|FG001|STARTED|Period 1||1
8827839|NCT01614769|9882119|FG002|STARTED|Period 1||2
8827840|NCT01614769|9882120|FG003|STARTED|Period 1||2
8827841|NCT01614769|9882121|FG004|STARTED|Period 1||1
8827842|NCT01614769|9882122|FG005|STARTED|Period 1||2
8827843|NCT01614769|9882117|FG000|COMPLETED|Period 1||1
8827844|NCT01614769|9882118|FG001|COMPLETED|Period 1||1
8827845|NCT01614769|9882119|FG002|COMPLETED|Period 1||2
8827846|NCT01614769|9882120|FG003|COMPLETED|Period 1||0
8827847|NCT01614769|9882121|FG004|COMPLETED|Period 1||1
8827848|NCT01614769|9882122|FG005|COMPLETED|Period 1||1
8827849|NCT01614769|9882117|FG000|NOT COMPLETED|Period 1||1
8827850|NCT01614769|9882118|FG001|NOT COMPLETED|Period 1||0
8827851|NCT01614769|9882119|FG002|NOT COMPLETED|Period 1||0
8827852|NCT01614769|9882120|FG003|NOT COMPLETED|Period 1||2
8827853|NCT01614769|9882121|FG004|NOT COMPLETED|Period 1||0
8827854|NCT01614769|9882122|FG005|NOT COMPLETED|Period 1||1
8827855|NCT01614769|9882117|FG000|STARTED|7-Day Washout||1
8827856|NCT01614769|9882118|FG001|STARTED|7-Day Washout||1
8827857|NCT01614769|9882119|FG002|STARTED|7-Day Washout||2
8827858|NCT01614769|9882120|FG003|STARTED|7-Day Washout||0
8827859|NCT01614769|9882121|FG004|STARTED|7-Day Washout||1
8827860|NCT01614769|9882122|FG005|STARTED|7-Day Washout||1
8827861|NCT01614769|9882117|FG000|COMPLETED|7-Day Washout||1
8827862|NCT01614769|9882118|FG001|COMPLETED|7-Day Washout||1
8827863|NCT01614769|9882119|FG002|COMPLETED|7-Day Washout||2
8827864|NCT01614769|9882120|FG003|COMPLETED|7-Day Washout||0
8827865|NCT01614769|9882121|FG004|COMPLETED|7-Day Washout||1
8827866|NCT01614769|9882122|FG005|COMPLETED|7-Day Washout||1
8827867|NCT01614769|9882117|FG000|NOT COMPLETED|7-Day Washout||0
8827868|NCT01614769|9882118|FG001|NOT COMPLETED|7-Day Washout||0
8827869|NCT01614769|9882119|FG002|NOT COMPLETED|7-Day Washout||0
8827870|NCT01614769|9882120|FG003|NOT COMPLETED|7-Day Washout||0
8827871|NCT01614769|9882121|FG004|NOT COMPLETED|7-Day Washout||0
8827872|NCT01614769|9882122|FG005|NOT COMPLETED|7-Day Washout||0
8827873|NCT01614769|9882117|FG000|STARTED|Period 2||1
8827874|NCT01614769|9882118|FG001|STARTED|Period 2||1
8827875|NCT01614769|9882119|FG002|STARTED|Period 2||2
8622456|NCT00488631|9661714|FG007|COMPLETED|Double Blind Period (Week 0-54)||0
8622457|NCT00488631|9661715|FG008|COMPLETED|Double Blind Period (Week 0-54)||0
8622458|NCT00488631|9661716|FG009|COMPLETED|Double Blind Period (Week 0-54)||0
8622459|NCT00488631|9661707|FG000|NOT COMPLETED|Double Blind Period (Week 0-54)||43
8622460|NCT00488631|9661708|FG001|NOT COMPLETED|Double Blind Period (Week 0-54)||43
8622461|NCT00488631|9661709|FG002|NOT COMPLETED|Double Blind Period (Week 0-54)||45
8622462|NCT00488631|9661710|FG003|NOT COMPLETED|Double Blind Period (Week 0-54)||41
8622463|NCT00488631|9661711|FG004|NOT COMPLETED|Double Blind Period (Week 0-54)||103
8622464|NCT00488631|9661712|FG005|NOT COMPLETED|Double Blind Period (Week 0-54)||216
8622465|NCT00488631|9661713|FG006|NOT COMPLETED|Double Blind Period (Week 0-54)||0
8622466|NCT00488631|9661714|FG007|NOT COMPLETED|Double Blind Period (Week 0-54)||0
8622467|NCT00488631|9661715|FG008|NOT COMPLETED|Double Blind Period (Week 0-54)||0
8827876|NCT01614769|9882120|FG003|STARTED|Period 2||0
8827877|NCT01614769|9882121|FG004|STARTED|Period 2||1
8827878|NCT01614769|9882122|FG005|STARTED|Period 2||1
8827879|NCT01614769|9882117|FG000|COMPLETED|Period 2||1
8827880|NCT01614769|9882118|FG001|COMPLETED|Period 2||1
8827881|NCT01614769|9882119|FG002|COMPLETED|Period 2||2
8827882|NCT01614769|9882120|FG003|COMPLETED|Period 2||0
8622468|NCT00488631|9661716|FG009|NOT COMPLETED|Double Blind Period (Week 0-54)||0
8622469|NCT00488631|9661707|FG000|STARTED|Open Label Study Extension (Week 54-228)||0
8827883|NCT01614769|9882121|FG004|COMPLETED|Period 2||1
8827884|NCT01614769|9882122|FG005|COMPLETED|Period 2||1
8827885|NCT01614769|9882117|FG000|NOT COMPLETED|Period 2||0
8827886|NCT01614769|9882118|FG001|NOT COMPLETED|Period 2||0
8827887|NCT01614769|9882119|FG002|NOT COMPLETED|Period 2||0
8827888|NCT01614769|9882120|FG003|NOT COMPLETED|Period 2||0
8622470|NCT00488631|9661708|FG001|STARTED|Open Label Study Extension (Week 54-228)||0
8622471|NCT00488631|9661709|FG002|STARTED|Open Label Study Extension (Week 54-228)||0
8622472|NCT00488631|9661710|FG003|STARTED|Open Label Study Extension (Week 54-228)||0
8622473|NCT00488631|9661711|FG004|STARTED|Open Label Study Extension (Week 54-228)||0
8622474|NCT00488631|9661712|FG005|STARTED|Open Label Study Extension (Week 54-228)||0
8622475|NCT00488631|9661713|FG006|STARTED|Open Label Study Extension (Week 54-228)||96
8622476|NCT00488631|9661714|FG007|STARTED|Open Label Study Extension (Week 54-228)||93
8622477|NCT00488631|9661715|FG008|STARTED|Open Label Study Extension (Week 54-228)||470
8622478|NCT00488631|9661716|FG009|STARTED|Open Label Study Extension (Week 54-228)||7
8622479|NCT00488631|9661707|FG000|COMPLETED|Open Label Study Extension (Week 54-228)||0
8622480|NCT00488631|9661708|FG001|COMPLETED|Open Label Study Extension (Week 54-228)||0
8622481|NCT00488631|9661709|FG002|COMPLETED|Open Label Study Extension (Week 54-228)||0
8622482|NCT00488631|9661710|FG003|COMPLETED|Open Label Study Extension (Week 54-228)||0
8622483|NCT00488631|9661711|FG004|COMPLETED|Open Label Study Extension (Week 54-228)||0
8622484|NCT00488631|9661712|FG005|COMPLETED|Open Label Study Extension (Week 54-228)||0
8622485|NCT00488631|9661713|FG006|COMPLETED|Open Label Study Extension (Week 54-228)||16
8622486|NCT00488631|9661714|FG007|COMPLETED|Open Label Study Extension (Week 54-228)||66
8622487|NCT00488631|9661715|FG008|COMPLETED|Open Label Study Extension (Week 54-228)||288
8827889|NCT01614769|9882121|FG004|NOT COMPLETED|Period 2||0
8827890|NCT01614769|9882122|FG005|NOT COMPLETED|Period 2||0
8827891|NCT01614769|9882117|FG000|STARTED|7-Day Washout||1
8827892|NCT01614769|9882118|FG001|STARTED|7-Day Washout||1
8827893|NCT01614769|9882119|FG002|STARTED|7-Day Washout||2
8827894|NCT01614769|9882120|FG003|STARTED|7-Day Washout||0
8827895|NCT01614769|9882121|FG004|STARTED|7-Day Washout||1
8827896|NCT01614769|9882122|FG005|STARTED|7-Day Washout||1
8944028|NCT02392806|10005838|FG001|NOT COMPLETED|Overall Study||0
8944029|NCT02393209|10005846|FG000|STARTED|Overall Study||6
8944030|NCT02393209|10005847|FG001|STARTED|Overall Study||8
8944031|NCT02393209|10005848|FG002|STARTED|Overall Study||0
8944032|NCT02393209|10005849|FG003|STARTED|Overall Study||0
8944033|NCT02393209|10005846|FG000|COMPLETED|Overall Study||0
8944034|NCT02393209|10005847|FG001|COMPLETED|Overall Study||0
8944035|NCT02393209|10005848|FG002|COMPLETED|Overall Study||0
8944036|NCT02393209|10005849|FG003|COMPLETED|Overall Study||0
8944037|NCT02393209|10005846|FG000|NOT COMPLETED|Overall Study||6
8944038|NCT02393209|10005847|FG001|NOT COMPLETED|Overall Study||8
8944039|NCT02393209|10005848|FG002|NOT COMPLETED|Overall Study||0
8944040|NCT02393209|10005849|FG003|NOT COMPLETED|Overall Study||0
8944041|NCT02393339|10005860|FG000|STARTED|Overall Study||58
8944042|NCT02393339|10005861|FG001|STARTED|Overall Study||56
8944043|NCT02393339|10005860|FG000|COMPLETED|Overall Study||51
8944044|NCT02393339|10005861|FG001|COMPLETED|Overall Study||51
8944045|NCT02393339|10005860|FG000|NOT COMPLETED|Overall Study||7
8944046|NCT02393339|10005861|FG001|NOT COMPLETED|Overall Study||5
8944047|NCT02393378|10005869|FG000|STARTED|Overall Study||3
8944048|NCT02393378|10005870|FG001|STARTED|Overall Study||4
8944049|NCT02393378|10005869|FG000|COMPLETED|Overall Study||3
8944050|NCT02393378|10005870|FG001|COMPLETED|Overall Study||4
8944051|NCT02393378|10005869|FG000|NOT COMPLETED|Overall Study||0
8944052|NCT02393378|10005870|FG001|NOT COMPLETED|Overall Study||0
8944053|NCT02393417|10005880|FG000|STARTED|Overall Study||43
8944054|NCT02393417|10005881|FG001|STARTED|Overall Study||45
8944055|NCT02393417|10005882|FG002|STARTED|Overall Study||40
8944056|NCT02393417|10005883|FG003|STARTED|Overall Study||41
8944057|NCT02393417|10005880|FG000|Completed Treatment|Overall Study||30
8944058|NCT02393417|10005881|FG001|Completed Treatment|Overall Study||34
8944059|NCT02393417|10005882|FG002|Completed Treatment|Overall Study||32
8944060|NCT02393417|10005883|FG003|Completed Treatment|Overall Study||30
8944061|NCT02393417|10005880|FG000|COMPLETED|Overall Study||28
8944062|NCT02393417|10005881|FG001|COMPLETED|Overall Study||32
8944063|NCT02393417|10005882|FG002|COMPLETED|Overall Study||30
8944064|NCT02393417|10005883|FG003|COMPLETED|Overall Study||29
8944065|NCT02393417|10005880|FG000|NOT COMPLETED|Overall Study||15
8944066|NCT02393417|10005881|FG001|NOT COMPLETED|Overall Study||13
8944067|NCT02393417|10005882|FG002|NOT COMPLETED|Overall Study||10
8944068|NCT02393417|10005883|FG003|NOT COMPLETED|Overall Study||12
8944069|NCT02393547|10005894|FG000|STARTED|Overall Study||20
8944070|NCT02393547|10005894|FG000|COMPLETED|Overall Study||14
8944071|NCT02393547|10005894|FG000|NOT COMPLETED|Overall Study||6
8944072|NCT02393677|10005900|FG000|STARTED|Overall Study||40
8944073|NCT02393677|10005901|FG001|STARTED|Overall Study||40
8944074|NCT02393677|10005900|FG000|COMPLETED|Overall Study||40
8827897|NCT01614769|9882117|FG000|COMPLETED|7-Day Washout||1
8827898|NCT01614769|9882118|FG001|COMPLETED|7-Day Washout||1
8827899|NCT01614769|9882119|FG002|COMPLETED|7-Day Washout||2
8827900|NCT01614769|9882120|FG003|COMPLETED|7-Day Washout||0
8827901|NCT01614769|9882121|FG004|COMPLETED|7-Day Washout||1
8827902|NCT01614769|9882122|FG005|COMPLETED|7-Day Washout||1
8827903|NCT01614769|9882117|FG000|NOT COMPLETED|7-Day Washout||0
8827904|NCT01614769|9882118|FG001|NOT COMPLETED|7-Day Washout||0
8827905|NCT01614769|9882119|FG002|NOT COMPLETED|7-Day Washout||0
8827906|NCT01614769|9882120|FG003|NOT COMPLETED|7-Day Washout||0
8944075|NCT02393677|10005901|FG001|COMPLETED|Overall Study||40
8944076|NCT02393677|10005900|FG000|NOT COMPLETED|Overall Study||0
8944077|NCT02393677|10005901|FG001|NOT COMPLETED|Overall Study||0
8944078|NCT02393755|10005909|FG000|STARTED|Overall Study||3
8944079|NCT02393755|10005910|FG001|STARTED|Overall Study||39
8827907|NCT01614769|9882121|FG004|NOT COMPLETED|7-Day Washout||0
8827908|NCT01614769|9882122|FG005|NOT COMPLETED|7-Day Washout||0
8827909|NCT01614769|9882117|FG000|STARTED|Period 3||1
8827910|NCT01614769|9882118|FG001|STARTED|Period 3||1
8827911|NCT01614769|9882119|FG002|STARTED|Period 3||2
8827912|NCT01614769|9882120|FG003|STARTED|Period 3||0
8827913|NCT01614769|9882121|FG004|STARTED|Period 3||1
8827914|NCT01614769|9882122|FG005|STARTED|Period 3||1
8827915|NCT01614769|9882117|FG000|COMPLETED|Period 3||1
8827916|NCT01614769|9882118|FG001|COMPLETED|Period 3||1
8827917|NCT01614769|9882119|FG002|COMPLETED|Period 3||1
8827918|NCT01614769|9882120|FG003|COMPLETED|Period 3||0
8827919|NCT01614769|9882121|FG004|COMPLETED|Period 3||1
8827920|NCT01614769|9882122|FG005|COMPLETED|Period 3||1
8827921|NCT01614769|9882117|FG000|NOT COMPLETED|Period 3||0
8827922|NCT01614769|9882118|FG001|NOT COMPLETED|Period 3||0
8827923|NCT01614769|9882119|FG002|NOT COMPLETED|Period 3||1
8827924|NCT01614769|9882120|FG003|NOT COMPLETED|Period 3||0
8827925|NCT01614769|9882121|FG004|NOT COMPLETED|Period 3||0
8827926|NCT01614769|9882122|FG005|NOT COMPLETED|Period 3||0
8827927|NCT01614795|9882134|FG000|STARTED|Overall Study||11
8827928|NCT01614795|9882135|FG001|STARTED|Overall Study||12
8827929|NCT01614795|9882136|FG002|STARTED|Overall Study||11
8827930|NCT01614795|9882137|FG003|STARTED|Overall Study||12
8827931|NCT01614795|9882134|FG000|COMPLETED|Overall Study||0
8827932|NCT01614795|9882135|FG001|COMPLETED|Overall Study||0
8827933|NCT01614795|9882136|FG002|COMPLETED|Overall Study||0
8827934|NCT01614795|9882137|FG003|COMPLETED|Overall Study||0
8827935|NCT01614795|9882134|FG000|NOT COMPLETED|Overall Study||11
8827936|NCT01614795|9882135|FG001|NOT COMPLETED|Overall Study||12
8827937|NCT01614795|9882136|FG002|NOT COMPLETED|Overall Study||11
8827938|NCT01614795|9882137|FG003|NOT COMPLETED|Overall Study||12
8827939|NCT01614821|9882148|FG000|STARTED|Overall Study||63
8827940|NCT01614821|9882148|FG000|COMPLETED|Overall Study||63
8827941|NCT01614821|9882148|FG000|NOT COMPLETED|Overall Study||0
8827942|NCT01614847|9882154|FG000|STARTED|Day 1|Four subjects chosen at random received Drop A (hyaluronate) during Day 1.|4
8827943|NCT01614847|9882155|FG001|STARTED|Day 1|The other 4 subjects, not to Group 1, received Drop B (saline) on Day 1.|4
8827944|NCT01614847|9882154|FG000|COMPLETED|Day 1||4
8827945|NCT01614847|9882155|FG001|COMPLETED|Day 1|See Arm 1 comments.|4
8827946|NCT01614847|9882154|FG000|NOT COMPLETED|Day 1||0
8827947|NCT01614847|9882155|FG001|NOT COMPLETED|Day 1||0
8827948|NCT01614847|9882154|FG000|STARTED|Day 2 (24 Hours Later)|On Day 2, these subject will received Drop B (normal saline).|4
8827949|NCT01614847|9882155|FG001|STARTED|Day 2 (24 Hours Later)|On Day 2, these subjects received Drop A (hyaluronate).|4
8827950|NCT01614847|9882154|FG000|COMPLETED|Day 2 (24 Hours Later)||4
8827951|NCT01614847|9882155|FG001|COMPLETED|Day 2 (24 Hours Later)||4
8827952|NCT01614847|9882154|FG000|NOT COMPLETED|Day 2 (24 Hours Later)||0
8827953|NCT01614847|9882155|FG001|NOT COMPLETED|Day 2 (24 Hours Later)||0
8827954|NCT01614886|9882168|FG000|STARTED|Overall Study||107
8827955|NCT01614886|9882169|FG001|STARTED|Overall Study||109
8827956|NCT01614886|9882168|FG000|Safety Population (SAF)|Overall Study||107
8827957|NCT01614886|9882169|FG001|Safety Population (SAF)|Overall Study||108
8827958|NCT01614886|9882168|FG000|Full Analysis Set (FAS)|Overall Study||104
8827959|NCT01614886|9882169|FG001|Full Analysis Set (FAS)|Overall Study||105
8827960|NCT01614886|9882168|FG000|COMPLETED|Overall Study||87
8827961|NCT01614886|9882169|FG001|COMPLETED|Overall Study||83
8827962|NCT01614886|9882168|FG000|NOT COMPLETED|Overall Study||20
8827963|NCT01614886|9882169|FG001|NOT COMPLETED|Overall Study||26
8827964|NCT01614925|9882177|FG000|STARTED|Overall Study||18
8827965|NCT01614925|9882178|FG001|STARTED|Overall Study||17
8827966|NCT01614925|9882177|FG000|COMPLETED|Overall Study||14
8827967|NCT01614925|9882178|FG001|COMPLETED|Overall Study||15
8827968|NCT01614925|9882177|FG000|NOT COMPLETED|Overall Study||4
8827969|NCT01614925|9882178|FG001|NOT COMPLETED|Overall Study||2
8827970|NCT01615120|9882186|FG000|STARTED|Overall Study||38
8827971|NCT01615120|9882187|FG001|STARTED|Overall Study||39
8827972|NCT01615120|9882186|FG000|COMPLETED|Overall Study||23
8827973|NCT01615120|9882187|FG001|COMPLETED|Overall Study||19
8827974|NCT01615120|9882186|FG000|NOT COMPLETED|Overall Study||15
8827975|NCT01615120|9882187|FG001|NOT COMPLETED|Overall Study||20
8827976|NCT01615198|9882195|FG000|STARTED|Overall Study||296
8827977|NCT01615198|9882196|FG001|STARTED|Overall Study||292
8827978|NCT01615198|9882195|FG000|Full Analysis Set|Overall Study||296
8827979|NCT01615198|9882196|FG001|Full Analysis Set|Overall Study||292
8827980|NCT01615198|9882195|FG000|Ambulatory BP Monitoring (ABPM) Subset|Overall Study||154
8827981|NCT01615198|9882196|FG001|Ambulatory BP Monitoring (ABPM) Subset|Overall Study||157
8827982|NCT01615198|9882195|FG000|Safety Set|Overall Study||296
8827983|NCT01615198|9882196|FG001|Safety Set|Overall Study||292
8827984|NCT01615198|9882195|FG000|ABPM Dipper Status Subset|Overall Study||82
8827985|NCT01615198|9882196|FG001|ABPM Dipper Status Subset|Overall Study||84
8827986|NCT01615198|9882195|FG000|COMPLETED|Overall Study||272
8827987|NCT01615198|9882196|FG001|COMPLETED|Overall Study||273
8827988|NCT01615198|9882195|FG000|NOT COMPLETED|Overall Study||24
8827989|NCT01615198|9882196|FG001|NOT COMPLETED|Overall Study||19
8827990|NCT01615263|9882204|FG000|STARTED|Overall Study||20
8827991|NCT01615263|9882205|FG001|STARTED|Overall Study||20
8827992|NCT01615263|9882204|FG000|COMPLETED|Overall Study||20
8827993|NCT01615263|9882205|FG001|COMPLETED|Overall Study||18
8827994|NCT01615263|9882204|FG000|NOT COMPLETED|Overall Study||0
8827995|NCT01615263|9882205|FG001|NOT COMPLETED|Overall Study||2
8827996|NCT01615328|9882213|FG000|STARTED|Overall Study||42
8827997|NCT01615328|9882214|FG001|STARTED|Overall Study||43
8827998|NCT01615328|9882213|FG000|COMPLETED|Overall Study||39
8827999|NCT01615328|9882214|FG001|COMPLETED|Overall Study||38
8828000|NCT01615328|9882213|FG000|NOT COMPLETED|Overall Study||3
8828001|NCT01615328|9882214|FG001|NOT COMPLETED|Overall Study||5
8828002|NCT01615367|9882226|FG000|STARTED|Overall Study||19
8828003|NCT01615367|9882227|FG001|STARTED|Overall Study||19
8828004|NCT01615367|9882226|FG000|COMPLETED|Overall Study||14
8828005|NCT01615367|9882227|FG001|COMPLETED|Overall Study|11 TAU participants chose to participate in NEW Tx after the completion of the waitlist period.|13
8828006|NCT01615367|9882226|FG000|NOT COMPLETED|Overall Study||5
8828007|NCT01615367|9882227|FG001|NOT COMPLETED|Overall Study||6
8828008|NCT01615484|9882235|FG000|STARTED|Overall Study||0
8828009|NCT01615484|9882236|FG001|STARTED|Overall Study||24
8828010|NCT01615484|9882235|FG000|COMPLETED|Overall Study||0
8828011|NCT01615484|9882236|FG001|COMPLETED|Overall Study||24
8828012|NCT01615484|9882235|FG000|NOT COMPLETED|Overall Study||0
8828013|NCT01615484|9882236|FG001|NOT COMPLETED|Overall Study||0
8828014|NCT01615731|9882244|FG000|STARTED|Overall Study||24
8828015|NCT01615731|9882245|FG001|STARTED|Overall Study||26
8828016|NCT01615731|9882244|FG000|COMPLETED|Overall Study||21
8828017|NCT01615731|9882245|FG001|COMPLETED|Overall Study||24
8828018|NCT01615731|9882244|FG000|NOT COMPLETED|Overall Study||3
8828019|NCT01615731|9882245|FG001|NOT COMPLETED|Overall Study||2
8828020|NCT01615809|9882251|FG000|STARTED|Overall Study|basal visit|32
8828021|NCT01615809|9882251|FG000|COMPLETED|Overall Study||22
8828022|NCT01615809|9882251|FG000|NOT COMPLETED|Overall Study||10
8828023|NCT01615822|9882258|FG000|STARTED|Period 1||8
8828024|NCT01615822|9882259|FG001|STARTED|Period 1||11
8828025|NCT01615822|9882260|FG002|STARTED|Period 1||6
8828026|NCT01615822|9882258|FG000|COMPLETED|Period 1||7
8828027|NCT01615822|9882259|FG001|COMPLETED|Period 1||9
8828028|NCT01615822|9882260|FG002|COMPLETED|Period 1||6
8828029|NCT01615822|9882258|FG000|NOT COMPLETED|Period 1||1
8828030|NCT01615822|9882259|FG001|NOT COMPLETED|Period 1||2
8828031|NCT01615822|9882260|FG002|NOT COMPLETED|Period 1||0
8556538|NCT04327388|9588285|FG002|COMPLETED|Overall Study||75
8556539|NCT04327388|9588283|FG000|NOT COMPLETED|Overall Study||20
8556540|NCT04327388|9588284|FG001|NOT COMPLETED|Overall Study||20
8556541|NCT04327388|9588285|FG002|NOT COMPLETED|Overall Study||11
8828032|NCT01615822|9882258|FG000|STARTED|Period 2||7
8828033|NCT01615822|9882259|FG001|STARTED|Period 2||9
8828034|NCT01615822|9882260|FG002|STARTED|Period 2||6
8828035|NCT01615822|9882258|FG000|COMPLETED|Period 2||7
8828036|NCT01615822|9882259|FG001|COMPLETED|Period 2||8
8828037|NCT01615822|9882260|FG002|COMPLETED|Period 2||4
8828038|NCT01615822|9882258|FG000|NOT COMPLETED|Period 2||0
8828039|NCT01615822|9882259|FG001|NOT COMPLETED|Period 2||1
8828040|NCT01615822|9882260|FG002|NOT COMPLETED|Period 2||2
8828041|NCT01615939|9882273|FG000|STARTED|Overall Study||13
8828042|NCT01615939|9882274|FG001|STARTED|Overall Study||4
8828043|NCT01615939|9882273|FG000|COMPLETED|Overall Study||8
8828044|NCT01615939|9882274|FG001|COMPLETED|Overall Study||4
8828045|NCT01615939|9882273|FG000|NOT COMPLETED|Overall Study||5
8828046|NCT01615939|9882274|FG001|NOT COMPLETED|Overall Study||0
8828047|NCT01616056|9882280|FG000|STARTED|Overall Study||20
8828048|NCT01616056|9882280|FG000|COMPLETED|Overall Study||19
8828049|NCT01616056|9882280|FG000|NOT COMPLETED|Overall Study||1
8828050|NCT01616082|9882286|FG000|STARTED|Overall Study||19
8828051|NCT01616082|9882287|FG001|STARTED|Overall Study||20
8828052|NCT01616082|9882286|FG000|COMPLETED|Overall Study||19
8828053|NCT01616082|9882287|FG001|COMPLETED|Overall Study||18
8828054|NCT01616082|9882286|FG000|NOT COMPLETED|Overall Study||0
8828055|NCT01616082|9882287|FG001|NOT COMPLETED|Overall Study||2
8828056|NCT01616160|9882294|FG000|STARTED|Overall Study||11
8828057|NCT01616160|9882294|FG000|COMPLETED|Overall Study||9
8828058|NCT01616160|9882294|FG000|NOT COMPLETED|Overall Study||2
8828059|NCT01616173|9882301|FG000|STARTED|Overall Study||27
8828060|NCT01616173|9882302|FG001|STARTED|Overall Study||26
8828061|NCT01616173|9882303|FG002|STARTED|Overall Study||27
8828062|NCT01616173|9882301|FG000|COMPLETED|Overall Study||27
8828063|NCT01616173|9882302|FG001|COMPLETED|Overall Study||24
8828064|NCT01616173|9882303|FG002|COMPLETED|Overall Study||27
8828065|NCT01616173|9882301|FG000|NOT COMPLETED|Overall Study||0
8828066|NCT01616173|9882302|FG001|NOT COMPLETED|Overall Study||2
8828067|NCT01616173|9882303|FG002|NOT COMPLETED|Overall Study||0
8828068|NCT01616459|9882315|FG000|STARTED|Overall Study||240
8828069|NCT01616459|9882316|FG001|STARTED|Overall Study||240
8556542|NCT03860259|9588295|FG000|STARTED|Overall Study||25
8556543|NCT03860259|9588296|FG001|STARTED|Overall Study||25
8828070|NCT01616459|9882317|FG002|STARTED|Overall Study||230
8828071|NCT01616459|9882318|FG003|STARTED|Overall Study||241
8828072|NCT01616459|9882315|FG000|COMPLETED|Overall Study||236
8828073|NCT01616459|9882316|FG001|COMPLETED|Overall Study||223
8828074|NCT01616459|9882317|FG002|COMPLETED|Overall Study||220
8828075|NCT01616459|9882318|FG003|COMPLETED|Overall Study||233
8556544|NCT03860259|9588295|FG000|COMPLETED|Overall Study||19
8556545|NCT03860259|9588296|FG001|COMPLETED|Overall Study||20
8828076|NCT01616459|9882315|FG000|NOT COMPLETED|Overall Study||4
8828077|NCT01616459|9882316|FG001|NOT COMPLETED|Overall Study||17
8828078|NCT01616459|9882317|FG002|NOT COMPLETED|Overall Study||10
8828079|NCT01616459|9882318|FG003|NOT COMPLETED|Overall Study||8
8828080|NCT01616563|9882333|FG000|STARTED|Overall Study||293
8828081|NCT01616563|9882333|FG000|COMPLETED|Overall Study||253
8828082|NCT01616563|9882333|FG000|NOT COMPLETED|Overall Study||40
8828083|NCT01616576|9882340|FG000|STARTED|Overall Study||18
8828084|NCT01616576|9882341|FG001|STARTED|Overall Study||18
8828085|NCT01616576|9882340|FG000|COMPLETED|Overall Study||18
8828086|NCT01616576|9882341|FG001|COMPLETED|Overall Study||18
8828087|NCT01616576|9882340|FG000|NOT COMPLETED|Overall Study||0
8828088|NCT01616576|9882341|FG001|NOT COMPLETED|Overall Study||0
8828089|NCT01616654|9882355|FG000|STARTED|Overall Study||61
8828090|NCT01616654|9882356|FG001|STARTED|Overall Study||61
8828091|NCT01616654|9882357|FG002|STARTED|Overall Study||60
8828092|NCT01616654|9882358|FG003|STARTED|Overall Study||61
8828093|NCT01616654|9882359|FG004|STARTED|Overall Study||61
8828094|NCT01616654|9882355|FG000|COMPLETED|Overall Study||56
8828095|NCT01616654|9882356|FG001|COMPLETED|Overall Study||53
8828096|NCT01616654|9882357|FG002|COMPLETED|Overall Study||50
8828097|NCT01616654|9882358|FG003|COMPLETED|Overall Study||53
8828098|NCT01616654|9882359|FG004|COMPLETED|Overall Study||49
8828099|NCT01616654|9882355|FG000|NOT COMPLETED|Overall Study||5
8828100|NCT01616654|9882356|FG001|NOT COMPLETED|Overall Study||8
8828101|NCT01616654|9882357|FG002|NOT COMPLETED|Overall Study||10
8828102|NCT01616654|9882358|FG003|NOT COMPLETED|Overall Study||8
8828103|NCT01616654|9882359|FG004|NOT COMPLETED|Overall Study||12
8828104|NCT01616693|9882376|FG000|STARTED|Evaluated for Safety||155
8828105|NCT01616693|9882377|FG001|STARTED|Evaluated for Safety||155
8828106|NCT01616693|9882378|FG002|STARTED|Evaluated for Safety||155
8828107|NCT01616693|9882379|FG003|STARTED|Evaluated for Safety||155
8828108|NCT01616693|9882376|FG000|COMPLETED|Evaluated for Safety||154
8828109|NCT01616693|9882377|FG001|COMPLETED|Evaluated for Safety||155
8828110|NCT01616693|9882378|FG002|COMPLETED|Evaluated for Safety||154
8828111|NCT01616693|9882379|FG003|COMPLETED|Evaluated for Safety||155
8828112|NCT01616693|9882376|FG000|NOT COMPLETED|Evaluated for Safety||1
8828113|NCT01616693|9882377|FG001|NOT COMPLETED|Evaluated for Safety||0
8828114|NCT01616693|9882378|FG002|NOT COMPLETED|Evaluated for Safety||1
8828115|NCT01616693|9882379|FG003|NOT COMPLETED|Evaluated for Safety||0
8828116|NCT01616693|9882376|FG000|STARTED|Received Both Vaccines||154
8828117|NCT01616693|9882377|FG001|STARTED|Received Both Vaccines||155
8828118|NCT01616693|9882378|FG002|STARTED|Received Both Vaccines||154
8828119|NCT01616693|9882379|FG003|STARTED|Received Both Vaccines||155
8828120|NCT01616693|9882376|FG000|COMPLETED|Received Both Vaccines||141
8828121|NCT01616693|9882377|FG001|COMPLETED|Received Both Vaccines||145
8828122|NCT01616693|9882378|FG002|COMPLETED|Received Both Vaccines||142
8828123|NCT01616693|9882379|FG003|COMPLETED|Received Both Vaccines||136
8828124|NCT01616693|9882376|FG000|NOT COMPLETED|Received Both Vaccines||13
8828125|NCT01616693|9882377|FG001|NOT COMPLETED|Received Both Vaccines||10
8828126|NCT01616693|9882378|FG002|NOT COMPLETED|Received Both Vaccines||12
8828127|NCT01616693|9882379|FG003|NOT COMPLETED|Received Both Vaccines||19
8828128|NCT01616693|9882376|FG000|STARTED|Blood Analyzed for Immunogenicity||141
8828129|NCT01616693|9882377|FG001|STARTED|Blood Analyzed for Immunogenicity||145
8828130|NCT01616693|9882378|FG002|STARTED|Blood Analyzed for Immunogenicity||142
8828131|NCT01616693|9882379|FG003|STARTED|Blood Analyzed for Immunogenicity||136
8828132|NCT01616693|9882376|FG000|COMPLETED|Blood Analyzed for Immunogenicity||137
8828133|NCT01616693|9882377|FG001|COMPLETED|Blood Analyzed for Immunogenicity||143
8828134|NCT01616693|9882378|FG002|COMPLETED|Blood Analyzed for Immunogenicity||136
8828135|NCT01616693|9882379|FG003|COMPLETED|Blood Analyzed for Immunogenicity||135
8828136|NCT01616693|9882376|FG000|NOT COMPLETED|Blood Analyzed for Immunogenicity||4
8828137|NCT01616693|9882377|FG001|NOT COMPLETED|Blood Analyzed for Immunogenicity||2
8828138|NCT01616693|9882378|FG002|NOT COMPLETED|Blood Analyzed for Immunogenicity||6
8828139|NCT01616693|9882379|FG003|NOT COMPLETED|Blood Analyzed for Immunogenicity||1
8828140|NCT01616771|9882393|FG000|STARTED|Macintosh Laryngoscopy for 5 Sec||23
8828141|NCT01616771|9882393|FG000|COMPLETED|Macintosh Laryngoscopy for 5 Sec||23
8828142|NCT01616771|9882393|FG000|NOT COMPLETED|Macintosh Laryngoscopy for 5 Sec||0
8828143|NCT01616771|9882393|FG000|STARTED|GVL Selected by Weight for 5 Sec||23
8828144|NCT01616771|9882393|FG000|COMPLETED|GVL Selected by Weight for 5 Sec||23
8828145|NCT01616771|9882393|FG000|NOT COMPLETED|GVL Selected by Weight for 5 Sec||0
8828146|NCT01616771|9882393|FG000|STARTED|Smaller Sized GVL for 5 Sec|Four of 23 patients could not be evaluated by smaller sized GVL, because there was no smaller one.|23
8828147|NCT01616771|9882393|FG000|COMPLETED|Smaller Sized GVL for 5 Sec||19
8828148|NCT01616771|9882393|FG000|NOT COMPLETED|Smaller Sized GVL for 5 Sec||4
8828149|NCT01616953|9882404|FG000|STARTED|Overall Study||10
8828150|NCT01616953|9882405|FG001|STARTED|Overall Study||8
8828151|NCT01616953|9882404|FG000|Implant Placement Surgery|Overall Study||9
8828152|NCT01616953|9882405|FG001|Implant Placement Surgery|Overall Study||8
8828153|NCT01616953|9882404|FG000|Implant Uncovery|Overall Study||8
8828154|NCT01616953|9882405|FG001|Implant Uncovery|Overall Study||8
8828155|NCT01616953|9882404|FG000|6 Months Post-loading|Overall Study||8
8828156|NCT01616953|9882405|FG001|6 Months Post-loading|Overall Study||8
8828157|NCT01616953|9882404|FG000|COMPLETED|Overall Study||8
8828158|NCT01616953|9882405|FG001|COMPLETED|Overall Study||8
8828159|NCT01616953|9882404|FG000|NOT COMPLETED|Overall Study||2
8828160|NCT01616953|9882405|FG001|NOT COMPLETED|Overall Study||0
8828161|NCT01617005|9882411|FG000|STARTED|Overall Study||50
8828162|NCT01617005|9882411|FG000|COMPLETED|Overall Study||48
8828163|NCT01617005|9882411|FG000|NOT COMPLETED|Overall Study||2
8828164|NCT01617070|9882415|FG000|STARTED|LNAA (4 Weeks)||10
8828165|NCT01617070|9882415|FG000|COMPLETED|LNAA (4 Weeks)||10
8828166|NCT01617070|9882415|FG000|NOT COMPLETED|LNAA (4 Weeks)||0
8828167|NCT01617070|9882415|FG000|STARTED|Washout (4 Weeks)||10
8828168|NCT01617070|9882415|FG000|COMPLETED|Washout (4 Weeks)||10
8828169|NCT01617070|9882415|FG000|NOT COMPLETED|Washout (4 Weeks)||0
8828170|NCT01617070|9882415|FG000|STARTED|BH4 Therapy (4 Weeks)||10
8828171|NCT01617070|9882415|FG000|COMPLETED|BH4 Therapy (4 Weeks)||10
8828172|NCT01617070|9882415|FG000|NOT COMPLETED|BH4 Therapy (4 Weeks)||0
8828173|NCT01617070|9882415|FG000|STARTED|BH4 and LNAA (4 Weeks)||10
8828174|NCT01617070|9882415|FG000|COMPLETED|BH4 and LNAA (4 Weeks)||9
8828175|NCT01617070|9882415|FG000|NOT COMPLETED|BH4 and LNAA (4 Weeks)||1
8828176|NCT01617083|9882428|FG000|STARTED|Overall Study||18
8828177|NCT01617083|9882429|FG001|STARTED|Overall Study||14
8828178|NCT01617083|9882430|FG002|STARTED|Overall Study||15
8828179|NCT01617083|9882428|FG000|COMPLETED|Overall Study||18
8828180|NCT01617083|9882429|FG001|COMPLETED|Overall Study||14
8828181|NCT01617083|9882430|FG002|COMPLETED|Overall Study||15
8828182|NCT01617083|9882428|FG000|NOT COMPLETED|Overall Study||0
8828183|NCT01617083|9882429|FG001|NOT COMPLETED|Overall Study||0
8828184|NCT01617083|9882430|FG002|NOT COMPLETED|Overall Study||0
8828185|NCT01617148|9882437|FG000|STARTED|Overall Study||26
8828186|NCT01617148|9882437|FG000|COMPLETED|Overall Study||26
8828187|NCT01617148|9882437|FG000|NOT COMPLETED|Overall Study||0
8828188|NCT01617369|9882442|FG000|STARTED|Overall Study||12
8828189|NCT01617369|9882442|FG000|COMPLETED|Overall Study||12
8828190|NCT01617369|9882442|FG000|NOT COMPLETED|Overall Study||0
8828191|NCT01617421|9882448|FG000|STARTED|Overall Study||18
8828192|NCT01617421|9882448|FG000|COMPLETED|Overall Study||12
8828193|NCT01617421|9882448|FG000|NOT COMPLETED|Overall Study||6
8828194|NCT01617434|9882454|FG000|STARTED|Overall Study||226
8828195|NCT01617434|9882455|FG001|STARTED|Overall Study||225
8828196|NCT01617434|9882454|FG000|Exposed|Overall Study||225
8828197|NCT01617434|9882455|FG001|Exposed|Overall Study||225
8828198|NCT01617434|9882454|FG000|COMPLETED|Overall Study||191
8828199|NCT01617434|9882455|FG001|COMPLETED|Overall Study||174
8828200|NCT01617434|9882454|FG000|NOT COMPLETED|Overall Study||35
8828201|NCT01617434|9882455|FG001|NOT COMPLETED|Overall Study||51
8828202|NCT01617447|9882463|FG000|STARTED|Overall Study||47
8828203|NCT01617447|9882464|FG001|STARTED|Overall Study||45
8828204|NCT01617447|9882463|FG000|COMPLETED|Overall Study||47
8828205|NCT01617447|9882464|FG001|COMPLETED|Overall Study||42
8828206|NCT01617447|9882463|FG000|NOT COMPLETED|Overall Study||0
8828207|NCT01617447|9882464|FG001|NOT COMPLETED|Overall Study||3
8828208|NCT01617460|9882470|FG000|STARTED|Overall Study||86
8828209|NCT01617460|9882470|FG000|COMPLETED|Overall Study||46
8828210|NCT01617460|9882470|FG000|NOT COMPLETED|Overall Study||40
8828211|NCT01617577|9882476|FG000|STARTED|Overall Study||5
8828212|NCT01617577|9882477|FG001|STARTED|Overall Study||3
8828213|NCT01617577|9882476|FG000|COMPLETED|Overall Study||5
8828214|NCT01617577|9882477|FG001|COMPLETED|Overall Study||3
8828215|NCT01617577|9882476|FG000|NOT COMPLETED|Overall Study||0
8828216|NCT01617577|9882477|FG001|NOT COMPLETED|Overall Study||0
8828217|NCT01617603|9882487|FG000|STARTED|Overall Study||20
8828218|NCT01617603|9882488|FG001|STARTED|Overall Study||21
8828219|NCT01617603|9882489|FG002|STARTED|Overall Study||21
8828220|NCT01617603|9882487|FG000|COMPLETED|Overall Study||17
8828221|NCT01617603|9882488|FG001|COMPLETED|Overall Study||19
8828222|NCT01617603|9882489|FG002|COMPLETED|Overall Study||20
8828223|NCT01617603|9882487|FG000|NOT COMPLETED|Overall Study||3
8828224|NCT01617603|9882488|FG001|NOT COMPLETED|Overall Study||2
8828225|NCT01617603|9882489|FG002|NOT COMPLETED|Overall Study||1
8828226|NCT01617629|9882497|FG000|STARTED|Overall Study||9
8828227|NCT01617629|9882497|FG000|COMPLETED|Overall Study||3
8828228|NCT01617629|9882497|FG000|NOT COMPLETED|Overall Study||6
8828229|NCT01617655|9882503|FG000|STARTED|Overall Study|Randomized|35
8828230|NCT01617655|9882504|FG001|STARTED|Overall Study|Randomized|72
8828231|NCT01617655|9882503|FG000|Treated|Overall Study||35
8828232|NCT01617655|9882504|FG001|Treated|Overall Study||72
8828233|NCT01617655|9882503|FG000|COMPLETED|Overall Study||26
8828234|NCT01617655|9882504|FG001|COMPLETED|Overall Study||43
8828235|NCT01617655|9882503|FG000|NOT COMPLETED|Overall Study||9
8828236|NCT01617655|9882504|FG001|NOT COMPLETED|Overall Study||29
8828237|NCT01617668|9882514|FG000|STARTED|Overall Study||51
8828238|NCT01617668|9882515|FG001|STARTED|Overall Study|54 patients were randomized and only 50 received study treatment.|50
8828239|NCT01617668|9882516|FG002|STARTED|Overall Study||55
8828240|NCT01617668|9882517|FG003|STARTED|Overall Study|55 patients were randomized and only 53 received study treatment.|53
8828241|NCT01617668|9882514|FG000|Randomized Patients|Overall Study||51
8828242|NCT01617668|9882515|FG001|Randomized Patients|Overall Study||54
8828243|NCT01617668|9882516|FG002|Randomized Patients|Overall Study||55
8828244|NCT01617668|9882517|FG003|Randomized Patients|Overall Study||55
8828245|NCT01617668|9882514|FG000|COMPLETED|Overall Study||38
8828246|NCT01617668|9882515|FG001|COMPLETED|Overall Study||41
8828247|NCT01617668|9882516|FG002|COMPLETED|Overall Study||32
8828248|NCT01617668|9882517|FG003|COMPLETED|Overall Study||38
8828249|NCT01617668|9882514|FG000|NOT COMPLETED|Overall Study||13
8828250|NCT01617668|9882515|FG001|NOT COMPLETED|Overall Study||9
8828251|NCT01617668|9882516|FG002|NOT COMPLETED|Overall Study||23
8828252|NCT01617668|9882517|FG003|NOT COMPLETED|Overall Study||15
8828253|NCT01617681|9882535|FG000|STARTED|Period 1 Double Blind||32
8828254|NCT01617681|9882536|FG001|STARTED|Period 1 Double Blind||31
8828255|NCT01617681|9882537|FG002|STARTED|Period 1 Double Blind||33
8828256|NCT01617681|9882538|FG003|STARTED|Period 1 Double Blind||31
8828257|NCT01617681|9882539|FG004|STARTED|Period 1 Double Blind||0
8828258|NCT01617681|9882535|FG000|Full Analysis Set (FAS)|Period 1 Double Blind||31
8828259|NCT01617681|9882536|FG001|Full Analysis Set (FAS)|Period 1 Double Blind||31
8828260|NCT01617681|9882537|FG002|Full Analysis Set (FAS)|Period 1 Double Blind||33
8828261|NCT01617681|9882538|FG003|Full Analysis Set (FAS)|Period 1 Double Blind||31
8828262|NCT01617681|9882539|FG004|Full Analysis Set (FAS)|Period 1 Double Blind||0
8828263|NCT01617681|9882535|FG000|COMPLETED|Period 1 Double Blind||29
8828264|NCT01617681|9882536|FG001|COMPLETED|Period 1 Double Blind||30
8828265|NCT01617681|9882537|FG002|COMPLETED|Period 1 Double Blind||32
8828266|NCT01617681|9882538|FG003|COMPLETED|Period 1 Double Blind||29
8828267|NCT01617681|9882539|FG004|COMPLETED|Period 1 Double Blind||0
8828268|NCT01617681|9882535|FG000|NOT COMPLETED|Period 1 Double Blind||3
8828269|NCT01617681|9882536|FG001|NOT COMPLETED|Period 1 Double Blind||1
8828270|NCT01617681|9882537|FG002|NOT COMPLETED|Period 1 Double Blind||1
8828271|NCT01617681|9882538|FG003|NOT COMPLETED|Period 1 Double Blind||2
8828272|NCT01617681|9882539|FG004|NOT COMPLETED|Period 1 Double Blind||0
8828273|NCT01617681|9882535|FG000|STARTED|Period 2 Open Label||0
8828274|NCT01617681|9882536|FG001|STARTED|Period 2 Open Label||0
8828275|NCT01617681|9882537|FG002|STARTED|Period 2 Open Label||0
8828276|NCT01617681|9882538|FG003|STARTED|Period 2 Open Label||0
8828277|NCT01617681|9882539|FG004|STARTED|Period 2 Open Label||120
8828278|NCT01617681|9882535|FG000|COMPLETED|Period 2 Open Label||0
8828279|NCT01617681|9882536|FG001|COMPLETED|Period 2 Open Label||0
8828280|NCT01617681|9882537|FG002|COMPLETED|Period 2 Open Label||0
8828281|NCT01617681|9882538|FG003|COMPLETED|Period 2 Open Label||0
8828282|NCT01617681|9882539|FG004|COMPLETED|Period 2 Open Label||114
8828283|NCT01617681|9882535|FG000|NOT COMPLETED|Period 2 Open Label||0
8828284|NCT01617681|9882536|FG001|NOT COMPLETED|Period 2 Open Label||0
8828285|NCT01617681|9882537|FG002|NOT COMPLETED|Period 2 Open Label||0
8828286|NCT01617681|9882538|FG003|NOT COMPLETED|Period 2 Open Label||0
8828287|NCT01617681|9882539|FG004|NOT COMPLETED|Period 2 Open Label||6
8828288|NCT01617967|9882554|FG000|STARTED|Overall Study||4
8828289|NCT01617967|9882555|FG001|STARTED|Overall Study||3
8828290|NCT01617967|9882556|FG002|STARTED|Overall Study||3
8828291|NCT01617967|9882557|FG003|STARTED|Overall Study||7
8828292|NCT01617967|9882558|FG004|STARTED|Overall Study||3
8828293|NCT01617967|9882559|FG005|STARTED|Overall Study||9
8828294|NCT01617967|9882554|FG000|COMPLETED|Overall Study||3
8828295|NCT01617967|9882555|FG001|COMPLETED|Overall Study||3
8828296|NCT01617967|9882556|FG002|COMPLETED|Overall Study||3
8828297|NCT01617967|9882557|FG003|COMPLETED|Overall Study||6
8828298|NCT01617967|9882558|FG004|COMPLETED|Overall Study||3
8828299|NCT01617967|9882559|FG005|COMPLETED|Overall Study||8
8828300|NCT01617967|9882554|FG000|NOT COMPLETED|Overall Study||1
8828301|NCT01617967|9882555|FG001|NOT COMPLETED|Overall Study||0
8828302|NCT01617967|9882556|FG002|NOT COMPLETED|Overall Study||0
8828303|NCT01617967|9882557|FG003|NOT COMPLETED|Overall Study||1
8828304|NCT01617967|9882558|FG004|NOT COMPLETED|Overall Study||0
8828305|NCT01617967|9882559|FG005|NOT COMPLETED|Overall Study||1
8828306|NCT01618019|9882576|FG000|STARTED|Overall Study||55
8828307|NCT01618019|9882577|FG001|STARTED|Overall Study||54
8828308|NCT01618019|9882576|FG000|COMPLETED|Overall Study||41
8828309|NCT01618019|9882577|FG001|COMPLETED|Overall Study||40
8828310|NCT01618019|9882576|FG000|NOT COMPLETED|Overall Study||14
8828311|NCT01618019|9882577|FG001|NOT COMPLETED|Overall Study||14
8828312|NCT01618162|9882585|FG000|STARTED|Overall Study||289
8828313|NCT01618162|9882586|FG001|STARTED|Overall Study||146
8828314|NCT01618162|9882585|FG000|Exposed|Overall Study||288
8828315|NCT01618162|9882586|FG001|Exposed|Overall Study||146
8828316|NCT01618162|9882585|FG000|COMPLETED|Overall Study||251
8828317|NCT01618162|9882586|FG001|COMPLETED|Overall Study||111
8828318|NCT01618162|9882585|FG000|NOT COMPLETED|Overall Study||38
8828319|NCT01618162|9882586|FG001|NOT COMPLETED|Overall Study||35
8828320|NCT01618214|9882594|FG000|STARTED|Overall Study||172
8828321|NCT01618214|9882595|FG001|STARTED|Overall Study||172
8828322|NCT01618214|9882594|FG000|Exposed|Overall Study||172
8828323|NCT01618214|9882595|FG001|Exposed|Overall Study||172
8828324|NCT01618214|9882594|FG000|COMPLETED|Overall Study||162
8828325|NCT01618214|9882595|FG001|COMPLETED|Overall Study||159
8828326|NCT01618214|9882594|FG000|NOT COMPLETED|Overall Study||10
8828327|NCT01618214|9882595|FG001|NOT COMPLETED|Overall Study||13
8828328|NCT01618227|9882603|FG000|STARTED|Overall Study||2
8828329|NCT01618227|9882604|FG001|STARTED|Overall Study||2
8828330|NCT01618227|9882603|FG000|COMPLETED|Overall Study||2
8828331|NCT01618227|9882604|FG001|COMPLETED|Overall Study||0
8828332|NCT01618227|9882603|FG000|NOT COMPLETED|Overall Study||0
8828333|NCT01618227|9882604|FG001|NOT COMPLETED|Overall Study||2
8828334|NCT01618240|9882610|FG000|STARTED|Overall Study||30
8828335|NCT01618240|9882610|FG000|COMPLETED|Overall Study||30
8828336|NCT01618240|9882610|FG000|NOT COMPLETED|Overall Study||0
8828337|NCT01618266|9882614|FG000|STARTED|Overall Study||375
8828338|NCT01618266|9882614|FG000|COMPLETED|Overall Study||279
8828339|NCT01618266|9882614|FG000|NOT COMPLETED|Overall Study||96
8828340|NCT01618305|9882620|FG000|STARTED|Overall Study||202
8828341|NCT01618305|9882621|FG001|STARTED|Overall Study||206
8828342|NCT01618305|9882620|FG000|COMPLETED|Overall Study||187
8828343|NCT01618305|9882621|FG001|COMPLETED|Overall Study||196
8828344|NCT01618305|9882620|FG000|NOT COMPLETED|Overall Study||15
8828345|NCT01618305|9882621|FG001|NOT COMPLETED|Overall Study||10
8828346|NCT01618344|9882631|FG000|STARTED|Overall Study||32
8828347|NCT01618344|9882631|FG000|COMPLETED|Overall Study||23
8828348|NCT01618344|9882631|FG000|NOT COMPLETED|Overall Study||9
8828349|NCT01618422|9882637|FG000|STARTED|Overall Study||114
8828350|NCT01618422|9882638|FG001|STARTED|Overall Study||111
8828351|NCT01618422|9882637|FG000|COMPLETED|Overall Study||114
8828352|NCT01618422|9882638|FG001|COMPLETED|Overall Study||111
8828353|NCT01618422|9882637|FG000|NOT COMPLETED|Overall Study||0
8828354|NCT01618422|9882638|FG001|NOT COMPLETED|Overall Study||0
8828355|NCT01618669|9882646|FG000|STARTED|Overall Study||578
8828356|NCT01618669|9882647|FG001|STARTED|Overall Study||569
8828357|NCT01618669|9882646|FG000|Received Treatment|Overall Study||575
8828358|NCT01618669|9882647|FG001|Received Treatment|Overall Study||567
8828359|NCT01618669|9882646|FG000|COMPLETED|Overall Study||544
8828360|NCT01618669|9882647|FG001|COMPLETED|Overall Study||546
8828361|NCT01618669|9882646|FG000|NOT COMPLETED|Overall Study||34
8828362|NCT01618669|9882647|FG001|NOT COMPLETED|Overall Study||23
8828363|NCT01618695|9882669|FG000|STARTED|Core Phase||177
8828364|NCT01618695|9882670|FG001|STARTED|Core Phase||176
8828365|NCT01618695|9882671|FG002|STARTED|Core Phase||177
8828366|NCT01618695|9882672|FG003|STARTED|Core Phase||180
8828367|NCT01618695|9882669|FG000|Treated (Safety Analysis Set)|Core Phase||176
8828368|NCT01618695|9882670|FG001|Treated (Safety Analysis Set)|Core Phase||176
8828369|NCT01618695|9882671|FG002|Treated (Safety Analysis Set)|Core Phase||175
8828370|NCT01618695|9882672|FG003|Treated (Safety Analysis Set)|Core Phase||180
8828371|NCT01618695|9882669|FG000|COMPLETED|Core Phase||152
8828372|NCT01618695|9882670|FG001|COMPLETED|Core Phase||156
8828373|NCT01618695|9882671|FG002|COMPLETED|Core Phase||147
8828374|NCT01618695|9882672|FG003|COMPLETED|Core Phase||144
8828375|NCT01618695|9882669|FG000|NOT COMPLETED|Core Phase||25
8828376|NCT01618695|9882670|FG001|NOT COMPLETED|Core Phase||20
8828377|NCT01618695|9882671|FG002|NOT COMPLETED|Core Phase||30
8828378|NCT01618695|9882672|FG003|NOT COMPLETED|Core Phase||36
8828379|NCT01618695|9882669|FG000|STARTED|Extension Phase|Participants who completed Core Phase and gave consent, entered the Extension Phase.|151
8828380|NCT01618695|9882670|FG001|STARTED|Extension Phase||156
8828381|NCT01618695|9882671|FG002|STARTED|Extension Phase|Participants who completed Core Phase and gave consent, entered the Extension Phase.|146
8828382|NCT01618695|9882672|FG003|STARTED|Extension Phase|Participants who completed Core Phase and gave consent, entered the Extension Phase.|143
8828383|NCT01618695|9882669|FG000|COMPLETED|Extension Phase||56
8828384|NCT01618695|9882670|FG001|COMPLETED|Extension Phase||40
8828385|NCT01618695|9882671|FG002|COMPLETED|Extension Phase||54
8828386|NCT01618695|9882672|FG003|COMPLETED|Extension Phase||46
8828387|NCT01618695|9882669|FG000|NOT COMPLETED|Extension Phase||95
8828388|NCT01618695|9882670|FG001|NOT COMPLETED|Extension Phase||116
8828389|NCT01618695|9882671|FG002|NOT COMPLETED|Extension Phase||92
8828390|NCT01618695|9882672|FG003|NOT COMPLETED|Extension Phase||97
8828391|NCT01618708|9882685|FG000|STARTED|Overall Study||175
8828392|NCT01618708|9882686|FG001|STARTED|Overall Study||182
8828393|NCT01618708|9882685|FG000|Treated|Overall Study||172
8622488|NCT00488631|9661716|FG009|COMPLETED|Open Label Study Extension (Week 54-228)||4
8622489|NCT00488631|9661707|FG000|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
8622490|NCT00488631|9661708|FG001|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
8622491|NCT00488631|9661709|FG002|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
8622492|NCT00488631|9661710|FG003|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
8622493|NCT00488631|9661711|FG004|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
8622494|NCT00488631|9661712|FG005|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
8828394|NCT01618708|9882686|FG001|Treated|Overall Study||180
8828395|NCT01618708|9882685|FG000|COMPLETED|Overall Study||131
8828396|NCT01618708|9882686|FG001|COMPLETED|Overall Study||136
8828397|NCT01618708|9882685|FG000|NOT COMPLETED|Overall Study||44
8828398|NCT01618708|9882686|FG001|NOT COMPLETED|Overall Study||46
8828399|NCT01618838|9882693|FG000|STARTED|Overall Study||4
8828400|NCT01618838|9882693|FG000|COMPLETED|Overall Study||0
8828401|NCT01618838|9882693|FG000|NOT COMPLETED|Overall Study||4
8828402|NCT01618864|9882698|FG000|STARTED|Overall Study||23
8828403|NCT01618864|9882698|FG000|Completed 2 Weeks|Overall Study||19
8828404|NCT01618864|9882698|FG000|COMPLETED|Overall Study|Completed 4 weeks and 8 weeks of treatment|19
8828405|NCT01618864|9882698|FG000|NOT COMPLETED|Overall Study||4
8828406|NCT01618916|9882713|FG000|STARTED|Overall Study||12
8828407|NCT01618916|9882714|FG001|STARTED|Overall Study||10
8828408|NCT01618916|9882715|FG002|STARTED|Overall Study||11
8828409|NCT01618916|9882716|FG003|STARTED|Overall Study||9
8828410|NCT01618916|9882717|FG004|STARTED|Overall Study||5
8828411|NCT01618916|9882718|FG005|STARTED|Overall Study||4
8828412|NCT01618916|9882713|FG000|Received At Least 1 Dose of Study Drug|Overall Study||12
8828413|NCT01618916|9882714|FG001|Received At Least 1 Dose of Study Drug|Overall Study||10
8828414|NCT01618916|9882715|FG002|Received At Least 1 Dose of Study Drug|Overall Study||11
8828415|NCT01618916|9882716|FG003|Received At Least 1 Dose of Study Drug|Overall Study||9
8828416|NCT01618916|9882717|FG004|Received At Least 1 Dose of Study Drug|Overall Study||5
8828417|NCT01618916|9882718|FG005|Received At Least 1 Dose of Study Drug|Overall Study||4
8828418|NCT01618916|9882713|FG000|COMPLETED|Overall Study||10
8622495|NCT00488631|9661713|FG006|NOT COMPLETED|Open Label Study Extension (Week 54-228)||80
8828419|NCT01618916|9882714|FG001|COMPLETED|Overall Study||9
8828420|NCT01618916|9882715|FG002|COMPLETED|Overall Study||10
8828421|NCT01618916|9882716|FG003|COMPLETED|Overall Study||7
8828422|NCT01618916|9882717|FG004|COMPLETED|Overall Study||4
8828423|NCT01618916|9882718|FG005|COMPLETED|Overall Study||4
8828424|NCT01618916|9882713|FG000|NOT COMPLETED|Overall Study||2
8828425|NCT01618916|9882714|FG001|NOT COMPLETED|Overall Study||1
8828426|NCT01618916|9882715|FG002|NOT COMPLETED|Overall Study||1
8828427|NCT01618916|9882716|FG003|NOT COMPLETED|Overall Study||2
8828428|NCT01618916|9882717|FG004|NOT COMPLETED|Overall Study||1
8828429|NCT01618916|9882718|FG005|NOT COMPLETED|Overall Study||0
8828430|NCT01618942|9882733|FG000|STARTED|Overall Study||50
8828431|NCT01618942|9882734|FG001|STARTED|Overall Study||50
8828432|NCT01618942|9882733|FG000|COMPLETED|Overall Study||50
8828433|NCT01618942|9882734|FG001|COMPLETED|Overall Study||50
8828434|NCT01618942|9882733|FG000|NOT COMPLETED|Overall Study||0
8828435|NCT01618942|9882734|FG001|NOT COMPLETED|Overall Study||0
8828436|NCT01618955|9882744|FG000|STARTED|Overall Study||20
8828437|NCT01618955|9882745|FG001|STARTED|Overall Study||30
8828438|NCT01618955|9882746|FG002|STARTED|Overall Study||31
8828439|NCT01618955|9882747|FG003|STARTED|Overall Study||20
8828440|NCT01618955|9882744|FG000|COMPLETED|Overall Study||20
8828441|NCT01618955|9882745|FG001|COMPLETED|Overall Study||30
8828442|NCT01618955|9882746|FG002|COMPLETED|Overall Study||31
8828443|NCT01618955|9882747|FG003|COMPLETED|Overall Study||20
8828444|NCT01618955|9882744|FG000|NOT COMPLETED|Overall Study||0
8828445|NCT01618955|9882745|FG001|NOT COMPLETED|Overall Study||0
8828446|NCT01618955|9882746|FG002|NOT COMPLETED|Overall Study||0
8828447|NCT01618955|9882747|FG003|NOT COMPLETED|Overall Study||0
8828448|NCT01618968|9882761|FG000|STARTED|Overall Study||13
8828449|NCT01618968|9882762|FG001|STARTED|Overall Study||12
8828450|NCT01618968|9882763|FG002|STARTED|Overall Study||12
8828451|NCT01618968|9882764|FG003|STARTED|Overall Study||12
8828452|NCT01618968|9882761|FG000|Received Treatment A|Overall Study||12
8828453|NCT01618968|9882762|FG001|Received Treatment A|Overall Study||12
8828454|NCT01618968|9882763|FG002|Received Treatment A|Overall Study||12
8828455|NCT01618968|9882764|FG003|Received Treatment A|Overall Study||11
8828456|NCT01618968|9882761|FG000|Received Treatment B|Overall Study||13
8828457|NCT01618968|9882762|FG001|Received Treatment B|Overall Study||12
8828458|NCT01618968|9882763|FG002|Received Treatment B|Overall Study||12
8828459|NCT01618968|9882764|FG003|Received Treatment B|Overall Study||12
8828460|NCT01618968|9882761|FG000|Received Treatment C|Overall Study||12
8828461|NCT01618968|9882762|FG001|Received Treatment C|Overall Study||12
8828462|NCT01618968|9882763|FG002|Received Treatment C|Overall Study||12
8828463|NCT01618968|9882764|FG003|Received Treatment C|Overall Study||11
8828464|NCT01618968|9882761|FG000|COMPLETED|Overall Study||12
8828465|NCT01618968|9882762|FG001|COMPLETED|Overall Study||12
8828466|NCT01618968|9882763|FG002|COMPLETED|Overall Study||12
8828467|NCT01618968|9882764|FG003|COMPLETED|Overall Study||11
8828468|NCT01618968|9882761|FG000|NOT COMPLETED|Overall Study||1
8828469|NCT01618968|9882762|FG001|NOT COMPLETED|Overall Study||0
8828470|NCT01618968|9882763|FG002|NOT COMPLETED|Overall Study||0
8828471|NCT01618968|9882764|FG003|NOT COMPLETED|Overall Study||1
8828472|NCT01619059|9882775|FG000|STARTED|Short-Term (ST) Treatment Period||162
8828473|NCT01619059|9882776|FG001|STARTED|Short-Term (ST) Treatment Period||153
8828474|NCT01619059|9882775|FG000|COMPLETED|Short-Term (ST) Treatment Period||156
8828475|NCT01619059|9882776|FG001|COMPLETED|Short-Term (ST) Treatment Period||142
8828476|NCT01619059|9882775|FG000|NOT COMPLETED|Short-Term (ST) Treatment Period||6
8828477|NCT01619059|9882776|FG001|NOT COMPLETED|Short-Term (ST) Treatment Period||11
8828478|NCT01619059|9882775|FG000|STARTED|Long-Term (LT) Treatment Period||155
8828479|NCT01619059|9882776|FG001|STARTED|Long-Term (LT) Treatment Period||142
8828480|NCT01619059|9882775|FG000|COMPLETED|Long-Term (LT) Treatment Period||147
8828481|NCT01619059|9882776|FG001|COMPLETED|Long-Term (LT) Treatment Period||133
8828482|NCT01619059|9882775|FG000|NOT COMPLETED|Long-Term (LT) Treatment Period||8
8828483|NCT01619059|9882776|FG001|NOT COMPLETED|Long-Term (LT) Treatment Period||9
8828484|NCT01619410|9882784|FG000|STARTED|Overall Study||14
8828485|NCT01619410|9882785|FG001|STARTED|Overall Study||11
8828486|NCT01619410|9882784|FG000|COMPLETED|Overall Study||7
8828487|NCT01619410|9882785|FG001|COMPLETED|Overall Study||7
8828488|NCT01619410|9882784|FG000|NOT COMPLETED|Overall Study||7
8828489|NCT01619410|9882785|FG001|NOT COMPLETED|Overall Study||4
8828490|NCT01619423|9882795|FG000|STARTED|Part 1 (Dose Escalation)||0
8828491|NCT01619423|9882796|FG001|STARTED|Part 1 (Dose Escalation)||5
8828492|NCT01619423|9882797|FG002|STARTED|Part 1 (Dose Escalation)||3
8828493|NCT01619423|9882798|FG003|STARTED|Part 1 (Dose Escalation)||5
8828494|NCT01619423|9882795|FG000|COMPLETED|Part 1 (Dose Escalation)||0
8828495|NCT01619423|9882796|FG001|COMPLETED|Part 1 (Dose Escalation)||3
8828496|NCT01619423|9882797|FG002|COMPLETED|Part 1 (Dose Escalation)||3
8828497|NCT01619423|9882798|FG003|COMPLETED|Part 1 (Dose Escalation)||5
8828498|NCT01619423|9882795|FG000|NOT COMPLETED|Part 1 (Dose Escalation)||0
8828499|NCT01619423|9882796|FG001|NOT COMPLETED|Part 1 (Dose Escalation)||2
8828500|NCT01619423|9882797|FG002|NOT COMPLETED|Part 1 (Dose Escalation)||0
8828501|NCT01619423|9882798|FG003|NOT COMPLETED|Part 1 (Dose Escalation)||0
8828502|NCT01619423|9882795|FG000|STARTED|Part 2a||15
8944080|NCT02393755|10005909|FG000|COMPLETED|Overall Study||3
8828503|NCT01619423|9882796|FG001|STARTED|Part 2a||13
8828504|NCT01619423|9882797|FG002|STARTED|Part 2a||0
8828505|NCT01619423|9882798|FG003|STARTED|Part 2a||11
8828506|NCT01619423|9882795|FG000|COMPLETED|Part 2a||15
8828507|NCT01619423|9882796|FG001|COMPLETED|Part 2a||13
8828508|NCT01619423|9882797|FG002|COMPLETED|Part 2a||0
8828509|NCT01619423|9882798|FG003|COMPLETED|Part 2a||11
8828510|NCT01619423|9882795|FG000|NOT COMPLETED|Part 2a||0
8944081|NCT02393755|10005910|FG001|COMPLETED|Overall Study||32
8828511|NCT01619423|9882796|FG001|NOT COMPLETED|Part 2a||0
8828512|NCT01619423|9882797|FG002|NOT COMPLETED|Part 2a||0
8828513|NCT01619423|9882798|FG003|NOT COMPLETED|Part 2a||0
8828514|NCT01619423|9882795|FG000|STARTED|Part 2b||45
8828515|NCT01619423|9882796|FG001|STARTED|Part 2b||44
8828516|NCT01619423|9882797|FG002|STARTED|Part 2b||45
8828517|NCT01619423|9882798|FG003|STARTED|Part 2b||0
8828518|NCT01619423|9882795|FG000|COMPLETED|Part 2b||45
8828519|NCT01619423|9882796|FG001|COMPLETED|Part 2b||44
8828520|NCT01619423|9882797|FG002|COMPLETED|Part 2b||45
8828521|NCT01619423|9882798|FG003|COMPLETED|Part 2b||0
8828522|NCT01619423|9882795|FG000|NOT COMPLETED|Part 2b||0
8828523|NCT01619423|9882796|FG001|NOT COMPLETED|Part 2b||0
8828524|NCT01619423|9882797|FG002|NOT COMPLETED|Part 2b||0
8828525|NCT01619423|9882798|FG003|NOT COMPLETED|Part 2b||0
8828526|NCT01619579|9882811|FG000|STARTED|Overall Study||5
8828527|NCT01619579|9882812|FG001|STARTED|Overall Study||17
8828528|NCT01619579|9882811|FG000|COMPLETED|Overall Study||5
8828529|NCT01619579|9882812|FG001|COMPLETED|Overall Study||14
8828530|NCT01619579|9882811|FG000|NOT COMPLETED|Overall Study||0
8828531|NCT01619579|9882812|FG001|NOT COMPLETED|Overall Study||3
8828532|NCT01619774|9882818|FG000|STARTED|Overall Study||23
8828533|NCT01619774|9882818|FG000|COMPLETED|Overall Study||23
8828534|NCT01619774|9882818|FG000|NOT COMPLETED|Overall Study||0
8828535|NCT01619787|9882824|FG000|STARTED|Overall Study||217
8828536|NCT01619787|9882824|FG000|COMPLETED|Overall Study||212
8828537|NCT01619787|9882824|FG000|NOT COMPLETED|Overall Study||5
8828538|NCT01619839|9882835|FG000|STARTED|Overall Study||48
8828539|NCT01619839|9882836|FG001|STARTED|Overall Study||31
8828540|NCT01619839|9882837|FG002|STARTED|Overall Study||18
8828541|NCT01619839|9882838|FG003|STARTED|Overall Study||10
8828542|NCT01619839|9882839|FG004|STARTED|Overall Study||106
8828543|NCT01619839|9882835|FG000|COMPLETED|Overall Study||43
8828544|NCT01619839|9882836|FG001|COMPLETED|Overall Study||27
8828545|NCT01619839|9882837|FG002|COMPLETED|Overall Study||17
8828546|NCT01619839|9882838|FG003|COMPLETED|Overall Study||9
8828547|NCT01619839|9882839|FG004|COMPLETED|Overall Study||97
8828548|NCT01619839|9882835|FG000|NOT COMPLETED|Overall Study||5
8828549|NCT01619839|9882836|FG001|NOT COMPLETED|Overall Study||4
8828550|NCT01619839|9882837|FG002|NOT COMPLETED|Overall Study||1
8828551|NCT01619839|9882838|FG003|NOT COMPLETED|Overall Study||1
8828552|NCT01619839|9882839|FG004|NOT COMPLETED|Overall Study||9
8828553|NCT01619852|9882850|FG000|STARTED|24 Hour Assessment||75
8828554|NCT01619852|9882851|FG001|STARTED|24 Hour Assessment||75
8828555|NCT01619852|9882850|FG000|COMPLETED|24 Hour Assessment||74
8828556|NCT01619852|9882851|FG001|COMPLETED|24 Hour Assessment||74
8828557|NCT01619852|9882850|FG000|NOT COMPLETED|24 Hour Assessment||1
8828558|NCT01619852|9882851|FG001|NOT COMPLETED|24 Hour Assessment||1
8828559|NCT01619852|9882850|FG000|STARTED|3 Month Follow up||74
8828560|NCT01619852|9882851|FG001|STARTED|3 Month Follow up||74
8828561|NCT01619852|9882850|FG000|COMPLETED|3 Month Follow up||43
8828562|NCT01619852|9882851|FG001|COMPLETED|3 Month Follow up||40
8828563|NCT01619852|9882850|FG000|NOT COMPLETED|3 Month Follow up||31
8828564|NCT01619852|9882851|FG001|NOT COMPLETED|3 Month Follow up||34
8828565|NCT01619865|9882858|FG000|STARTED|Overall Study||223
8828566|NCT01619865|9882858|FG000|COMPLETED|Overall Study||219
8828567|NCT01619865|9882858|FG000|NOT COMPLETED|Overall Study||4
8828568|NCT01619878|9882863|FG000|STARTED|6 Week Follow-up Phase||20
8828569|NCT01619878|9882863|FG000|COMPLETED|6 Week Follow-up Phase||19
8828570|NCT01619878|9882863|FG000|NOT COMPLETED|6 Week Follow-up Phase||1
8828571|NCT01619878|9882863|FG000|STARTED|Follow-up at 12 Months of Age||20
8828572|NCT01619878|9882863|FG000|COMPLETED|Follow-up at 12 Months of Age||17
8828573|NCT01619878|9882863|FG000|NOT COMPLETED|Follow-up at 12 Months of Age||3
8828574|NCT01619982|9882869|FG000|STARTED|Overall Study||20
8828575|NCT01619982|9882870|FG001|STARTED|Overall Study||12
8828576|NCT01619982|9882869|FG000|COMPLETED|Overall Study||20
8828577|NCT01619982|9882870|FG001|COMPLETED|Overall Study||12
8828578|NCT01619982|9882869|FG000|NOT COMPLETED|Overall Study||0
8828579|NCT01619982|9882870|FG001|NOT COMPLETED|Overall Study||0
8828580|NCT01620047|9882883|FG000|STARTED|Overall Study||20
8828581|NCT01620047|9882884|FG001|STARTED|Overall Study||20
8828582|NCT01620047|9882885|FG002|STARTED|Overall Study||20
8828583|NCT01620047|9882883|FG000|COMPLETED|Overall Study||20
8828584|NCT01620047|9882884|FG001|COMPLETED|Overall Study||20
8828585|NCT01620047|9882885|FG002|COMPLETED|Overall Study||20
8828586|NCT01620047|9882883|FG000|NOT COMPLETED|Overall Study||0
8828587|NCT01620047|9882884|FG001|NOT COMPLETED|Overall Study||0
8828588|NCT01620047|9882885|FG002|NOT COMPLETED|Overall Study||0
8828589|NCT01620060|9882893|FG000|STARTED|Overall Study||105
8828590|NCT01620060|9882893|FG000|COMPLETED|Overall Study||90
8828591|NCT01620060|9882893|FG000|NOT COMPLETED|Overall Study||15
8828592|NCT01620086|9882899|FG000|STARTED|Overall Study||13
8828593|NCT01620086|9882900|FG001|STARTED|Overall Study||11
8828594|NCT01620086|9882901|FG002|STARTED|Overall Study||2
8828595|NCT01620086|9882899|FG000|COMPLETED|Overall Study||8
8828596|NCT01620086|9882900|FG001|COMPLETED|Overall Study||4
8828597|NCT01620086|9882901|FG002|COMPLETED|Overall Study||2
8828598|NCT01620086|9882899|FG000|NOT COMPLETED|Overall Study||5
8828599|NCT01620086|9882900|FG001|NOT COMPLETED|Overall Study||7
8828600|NCT01620086|9882901|FG002|NOT COMPLETED|Overall Study||0
8828601|NCT01620138|9882912|FG000|STARTED|Overall Study||12
8828602|NCT01620138|9882913|FG001|STARTED|Overall Study||9
8828603|NCT01620138|9882912|FG000|COMPLETED|Overall Study||6
8828604|NCT01620138|9882913|FG001|COMPLETED|Overall Study||9
8828605|NCT01620138|9882912|FG000|NOT COMPLETED|Overall Study||6
8828606|NCT01620138|9882913|FG001|NOT COMPLETED|Overall Study||0
8828607|NCT01620177|9882919|FG000|STARTED|Overall Study||98
8828608|NCT01620177|9882919|FG000|COMPLETED|Overall Study||19
8828609|NCT01620177|9882919|FG000|NOT COMPLETED|Overall Study||79
8828610|NCT01620190|9882936|FG000|STARTED|Overall Study||26
8828611|NCT01620190|9882936|FG000|COMPLETED|Overall Study||26
8828612|NCT01620190|9882936|FG000|NOT COMPLETED|Overall Study||0
8828613|NCT01620216|9882947|FG000|STARTED|Overall Study||4
8828614|NCT01620216|9882948|FG001|STARTED|Overall Study||2
8828615|NCT01620216|9882949|FG002|STARTED|Overall Study||6
8828616|NCT01620216|9882950|FG003|STARTED|Overall Study||0
8828617|NCT01620216|9882951|FG004|STARTED|Overall Study||0
8828618|NCT01620216|9882952|FG005|STARTED|Overall Study||0
8828619|NCT01620216|9882953|FG006|STARTED|Overall Study||0
8828620|NCT01620216|9882947|FG000|COMPLETED|Overall Study||4
8828621|NCT01620216|9882948|FG001|COMPLETED|Overall Study||2
8828622|NCT01620216|9882949|FG002|COMPLETED|Overall Study||6
8828623|NCT01620216|9882950|FG003|COMPLETED|Overall Study||0
8828624|NCT01620216|9882951|FG004|COMPLETED|Overall Study||0
8828625|NCT01620216|9882952|FG005|COMPLETED|Overall Study||0
8828626|NCT01620216|9882953|FG006|COMPLETED|Overall Study||0
8828627|NCT01620216|9882947|FG000|NOT COMPLETED|Overall Study||0
8828628|NCT01620216|9882948|FG001|NOT COMPLETED|Overall Study||0
8828629|NCT01620216|9882949|FG002|NOT COMPLETED|Overall Study||0
8828630|NCT01620216|9882950|FG003|NOT COMPLETED|Overall Study||0
8828631|NCT01620216|9882951|FG004|NOT COMPLETED|Overall Study||0
8828632|NCT01620216|9882952|FG005|NOT COMPLETED|Overall Study||0
8828633|NCT01620216|9882953|FG006|NOT COMPLETED|Overall Study||0
8828634|NCT01620255|9882974|FG000|STARTED|Overall Study||73
8828635|NCT01620255|9882975|FG001|STARTED|Overall Study||71
8828636|NCT01620255|9882976|FG002|STARTED|Overall Study||70
8828637|NCT01620255|9882977|FG003|STARTED|Overall Study||73
8828638|NCT01620255|9882978|FG004|STARTED|Overall Study||70
8828639|NCT01620255|9882974|FG000|Treated|Overall Study||73
8828640|NCT01620255|9882975|FG001|Treated|Overall Study||71
8828641|NCT01620255|9882976|FG002|Treated|Overall Study||70
8828642|NCT01620255|9882977|FG003|Treated|Overall Study||73
8828643|NCT01620255|9882978|FG004|Treated|Overall Study||70
8828644|NCT01620255|9882974|FG000|COMPLETED|Overall Study||69
8828645|NCT01620255|9882975|FG001|COMPLETED|Overall Study||65
8828646|NCT01620255|9882976|FG002|COMPLETED|Overall Study||68
8828647|NCT01620255|9882977|FG003|COMPLETED|Overall Study||70
8828648|NCT01620255|9882978|FG004|COMPLETED|Overall Study||64
8944082|NCT02393755|10005909|FG000|NOT COMPLETED|Overall Study||0
8944083|NCT02393755|10005910|FG001|NOT COMPLETED|Overall Study||7
8944084|NCT02393950|10005917|FG000|STARTED|Overall Study||9
8944085|NCT02393950|10005918|FG001|STARTED|Overall Study||9
8828649|NCT01620255|9882974|FG000|NOT COMPLETED|Overall Study||4
8828650|NCT01620255|9882975|FG001|NOT COMPLETED|Overall Study||6
8828651|NCT01620255|9882976|FG002|NOT COMPLETED|Overall Study||2
8828652|NCT01620255|9882977|FG003|NOT COMPLETED|Overall Study||3
8828653|NCT01620255|9882978|FG004|NOT COMPLETED|Overall Study||6
8828654|NCT01620489|9882992|FG000|STARTED|Overall Study||140
8828655|NCT01620489|9882993|FG001|STARTED|Overall Study||139
8828656|NCT01620489|9882992|FG000|Exposed|Overall Study||140
8828657|NCT01620489|9882993|FG001|Exposed|Overall Study|2 subjects did not take trial product|137
8828658|NCT01620489|9882992|FG000|COMPLETED|Overall Study||105
8828659|NCT01620489|9882993|FG001|COMPLETED|Overall Study|2 subjects did not take trial product|105
8828660|NCT01620489|9882992|FG000|NOT COMPLETED|Overall Study||35
8828661|NCT01620489|9882993|FG001|NOT COMPLETED|Overall Study||34
8828662|NCT01620528|9883002|FG000|STARTED|Treatment Period||374
8828663|NCT01620528|9883003|FG001|STARTED|Treatment Period||249
8828664|NCT01620528|9883004|FG002|STARTED|Treatment Period|1 subject did not receive study drug|249
8828665|NCT01620528|9883002|FG000|COMPLETED|Treatment Period||274
8828666|NCT01620528|9883003|FG001|COMPLETED|Treatment Period||196
8828667|NCT01620528|9883004|FG002|COMPLETED|Treatment Period||183
8828668|NCT01620528|9883002|FG000|NOT COMPLETED|Treatment Period||100
8828669|NCT01620528|9883003|FG001|NOT COMPLETED|Treatment Period||53
8828670|NCT01620528|9883004|FG002|NOT COMPLETED|Treatment Period||66
8828671|NCT01620528|9883002|FG000|STARTED|Post-Treatment Follow-Up Period|elected to enter the PTFU Period|68
8828672|NCT01620528|9883003|FG001|STARTED|Post-Treatment Follow-Up Period|elected to enter the PTFU Period|48
8828673|NCT01620528|9883004|FG002|STARTED|Post-Treatment Follow-Up Period|elected to enter the PTFU Period|51
8828674|NCT01620528|9883002|FG000|Completed PTFU Month 6|Post-Treatment Follow-Up Period||46
8828675|NCT01620528|9883003|FG001|Completed PTFU Month 6|Post-Treatment Follow-Up Period|Met criteria (reported a post-treatment menses, met the DXA criteria, and had a PTFU Month 6 visit).|26
8828676|NCT01620528|9883004|FG002|Completed PTFU Month 6|Post-Treatment Follow-Up Period|Met criteria (reported a post-treatment menses, met the DXA criteria, and had a PTFU Month 6 visit).|18
8828677|NCT01620528|9883002|FG000|Completed PTFU Month 12|Post-Treatment Follow-Up Period||2
8828678|NCT01620528|9883003|FG001|Completed PTFU Month 12|Post-Treatment Follow-Up Period||5
8828679|NCT01620528|9883004|FG002|Completed PTFU Month 12|Post-Treatment Follow-Up Period||19
8828680|NCT01620528|9883002|FG000|COMPLETED|Post-Treatment Follow-Up Period||48
8828681|NCT01620528|9883003|FG001|COMPLETED|Post-Treatment Follow-Up Period||31
8828682|NCT01620528|9883004|FG002|COMPLETED|Post-Treatment Follow-Up Period||37
8849716|NCT01742364|9904953|FG002|COMPLETED|Overall Study||15
8944086|NCT02393950|10005917|FG000|Period 1|Overall Study|6 subjects ODM-106 Capsule B 2 mg and 2 subjects on placebo|8
8828683|NCT01620528|9883002|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||20
8828684|NCT01620528|9883003|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||17
8828685|NCT01620528|9883004|FG002|NOT COMPLETED|Post-Treatment Follow-Up Period||14
8828686|NCT01620567|9883014|FG000|STARTED|Overall Study||23
8828687|NCT01620567|9883015|FG001|STARTED|Overall Study||25
8828688|NCT01620567|9883014|FG000|COMPLETED|Overall Study||20
8828689|NCT01620567|9883015|FG001|COMPLETED|Overall Study||20
8828690|NCT01620567|9883014|FG000|NOT COMPLETED|Overall Study||3
8828691|NCT01620567|9883015|FG001|NOT COMPLETED|Overall Study||5
8828692|NCT01620593|9883026|FG000|STARTED|Overall Study||21
8828693|NCT01620593|9883027|FG001|STARTED|Overall Study||20
8828694|NCT01620593|9883026|FG000|COMPLETED|Overall Study||17
8828695|NCT01620593|9883027|FG001|COMPLETED|Overall Study||19
8828696|NCT01620593|9883026|FG000|NOT COMPLETED|Overall Study||4
8828697|NCT01620593|9883027|FG001|NOT COMPLETED|Overall Study||1
8828698|NCT01620762|9883036|FG000|STARTED|Overall Study||468
8828699|NCT01620762|9883037|FG001|STARTED|Overall Study||470
8828700|NCT01620762|9883038|FG002|STARTED|Overall Study||470
8828701|NCT01620762|9883036|FG000|COMPLETED|Overall Study||420
8828702|NCT01620762|9883037|FG001|COMPLETED|Overall Study||412
8828703|NCT01620762|9883038|FG002|COMPLETED|Overall Study||417
8828704|NCT01620762|9883036|FG000|NOT COMPLETED|Overall Study||48
8828705|NCT01620762|9883037|FG001|NOT COMPLETED|Overall Study||58
8828706|NCT01620762|9883038|FG002|NOT COMPLETED|Overall Study||53
8828707|NCT01620983|9883049|FG000|STARTED|Overall Study||130
8828708|NCT01620983|9883050|FG001|STARTED|Overall Study||135
8828709|NCT01620983|9883051|FG002|STARTED|Overall Study||137
8828710|NCT01620983|9883049|FG000|COMPLETED|Overall Study||111
8828711|NCT01620983|9883050|FG001|COMPLETED|Overall Study||113
8828712|NCT01620983|9883051|FG002|COMPLETED|Overall Study||122
8828713|NCT01620983|9883049|FG000|NOT COMPLETED|Overall Study||19
8828714|NCT01620983|9883050|FG001|NOT COMPLETED|Overall Study||22
8828715|NCT01620983|9883051|FG002|NOT COMPLETED|Overall Study||15
8828716|NCT01621009|9883063|FG000|STARTED|Overall Study||113
8828717|NCT01621009|9883064|FG001|STARTED|Overall Study||116
8828718|NCT01621009|9883065|FG002|STARTED|Overall Study||121
8828719|NCT01621009|9883066|FG003|STARTED|Overall Study||113
8828720|NCT01621009|9883063|FG000|COMPLETED|Overall Study||70
8828721|NCT01621009|9883064|FG001|COMPLETED|Overall Study||65
8828722|NCT01621009|9883065|FG002|COMPLETED|Overall Study||58
8828723|NCT01621009|9883066|FG003|COMPLETED|Overall Study||60
8828724|NCT01621009|9883063|FG000|NOT COMPLETED|Overall Study||43
8828725|NCT01621009|9883064|FG001|NOT COMPLETED|Overall Study||51
8828726|NCT01621009|9883065|FG002|NOT COMPLETED|Overall Study||63
8828727|NCT01621009|9883066|FG003|NOT COMPLETED|Overall Study||53
8849717|NCT01742364|9904954|FG003|COMPLETED|Overall Study||15
8849718|NCT01742364|9904951|FG000|NOT COMPLETED|Overall Study||0
8849719|NCT01742364|9904952|FG001|NOT COMPLETED|Overall Study||0
8849720|NCT01742364|9904953|FG002|NOT COMPLETED|Overall Study||0
8849721|NCT01742364|9904954|FG003|NOT COMPLETED|Overall Study||0
8849722|NCT01742832|9904967|FG000|STARTED|Overall Study||20
8849723|NCT01742832|9904968|FG001|STARTED|Overall Study||28
8849724|NCT01742832|9904967|FG000|COMPLETED|Overall Study||19
8849725|NCT01742832|9904968|FG001|COMPLETED|Overall Study||23
8849726|NCT01742832|9904967|FG000|NOT COMPLETED|Overall Study||1
8849727|NCT01742832|9904968|FG001|NOT COMPLETED|Overall Study||5
8849728|NCT01742897|9904974|FG000|STARTED|Overall Study||35
8849729|NCT01742897|9904974|FG000|Treated|Overall Study||33
8849730|NCT01742897|9904974|FG000|COMPLETED|Overall Study||30
8849731|NCT01742897|9904974|FG000|NOT COMPLETED|Overall Study||5
8849732|NCT01742936|9904980|FG000|STARTED|Overall Study||50
8849733|NCT01742936|9904981|FG001|STARTED|Overall Study||50
8849734|NCT01742936|9904980|FG000|COMPLETED|Overall Study||50
8944087|NCT02393950|10005918|FG001|Period 1|Overall Study|6 subjects ODM-106 Capsule B 100 mg (1 x 100mg) and 2 subjects on placebo|8
8944088|NCT02393950|10005917|FG000|Period 2|Overall Study|6 subjects ODM-106 Capsule B 10 mg and 2 subjects on placebo|8
8944089|NCT02393950|10005918|FG001|Period 2|Overall Study|6 subjects ODM-106 Capsule B 100 mg (10 x 10mg) and 2 subjects on placebo|8
8944090|NCT02393950|10005917|FG000|Period 3|Overall Study|6 subjects ODM-106 Capsule B 25 mg and 2 subjects on placebo|8
8944091|NCT02393950|10005918|FG001|Period 3|Overall Study|6 subjects ODM-106 Capsule B 200 mg (20 x 10mg) and 2 subjects on placebo|8
8944092|NCT02393950|10005917|FG000|Period 4|Overall Study|6 subjects ODM-106 Capsule B 50 mg and 2 subjects on placebo|8
8944093|NCT02393950|10005918|FG001|Period 4|Overall Study|6 subjects ODM-106 Capsule A 100 mg (10 x 10mg) and 2 subjects on placebo|8
8944094|NCT02393950|10005917|FG000|COMPLETED|Overall Study||8
8944095|NCT02393950|10005918|FG001|COMPLETED|Overall Study||8
8944096|NCT02393950|10005917|FG000|NOT COMPLETED|Overall Study||1
8849735|NCT01742936|9904981|FG001|COMPLETED|Overall Study||50
8849736|NCT01742936|9904980|FG000|NOT COMPLETED|Overall Study||0
8849737|NCT01742936|9904981|FG001|NOT COMPLETED|Overall Study||0
8849738|NCT01742949|9904987|FG000|STARTED|Overall Study||20
8849739|NCT01742949|9904988|FG001|STARTED|Overall Study||20
8849740|NCT01742949|9904987|FG000|COMPLETED|Overall Study||20
8849741|NCT01742949|9904988|FG001|COMPLETED|Overall Study||20
8849742|NCT01742949|9904987|FG000|NOT COMPLETED|Overall Study||0
8849743|NCT01742949|9904988|FG001|NOT COMPLETED|Overall Study||0
8849744|NCT01743001|9904999|FG000|STARTED|Overall Study||114
8849745|NCT01743001|9905000|FG001|STARTED|Overall Study||112
8849746|NCT01743001|9904999|FG000|COMPLETED|Overall Study||111
8849747|NCT01743001|9905000|FG001|COMPLETED|Overall Study||112
8944097|NCT02393950|10005918|FG001|NOT COMPLETED|Overall Study||1
8828728|NCT01621126|9883074|FG000|STARTED|Overall Study||40
8828729|NCT01621126|9883074|FG000|COMPLETED|Overall Study||34
8828730|NCT01621126|9883074|FG000|NOT COMPLETED|Overall Study||6
8828731|NCT01621178|9883081|FG000|STARTED|Overall Study||194
8828732|NCT01621178|9883082|FG001|STARTED|Overall Study||190
8828733|NCT01621178|9883083|FG002|STARTED|Overall Study||193
8828734|NCT01621178|9883081|FG000|Received at Least One Dose of Study Drug|Overall Study||194
8828735|NCT01621178|9883082|FG001|Received at Least One Dose of Study Drug|Overall Study||190
8828736|NCT01621178|9883083|FG002|Received at Least One Dose of Study Drug|Overall Study||192
8828737|NCT01621178|9883081|FG000|Modified Intent to Treat Population|Overall Study||186
8828738|NCT01621178|9883082|FG001|Modified Intent to Treat Population|Overall Study||180
8828739|NCT01621178|9883083|FG002|Modified Intent to Treat Population|Overall Study||183
8828740|NCT01621178|9883081|FG000|COMPLETED|Overall Study||163
8828741|NCT01621178|9883082|FG001|COMPLETED|Overall Study||160
8828742|NCT01621178|9883083|FG002|COMPLETED|Overall Study||157
8828743|NCT01621178|9883081|FG000|NOT COMPLETED|Overall Study||31
8828744|NCT01621178|9883082|FG001|NOT COMPLETED|Overall Study||30
8828745|NCT01621178|9883083|FG002|NOT COMPLETED|Overall Study||36
8828746|NCT01621191|9883095|FG000|STARTED|Overall Study||149
8828747|NCT01621191|9883095|FG000|Received at Least 1 Dose of Study Drug|Overall Study||149
8828748|NCT01621191|9883095|FG000|Had at Least 1 Post-Baseline Observation|Overall Study||148
8828749|NCT01621191|9883095|FG000|COMPLETED|Overall Study||124
8828750|NCT01621191|9883095|FG000|NOT COMPLETED|Overall Study||25
8828751|NCT01621230|9883102|FG000|STARTED|Overall Study||154
8828752|NCT01621230|9883103|FG001|STARTED|Overall Study||156
8828753|NCT01621230|9883102|FG000|COMPLETED|Overall Study||154
8828754|NCT01621230|9883103|FG001|COMPLETED|Overall Study||156
8828755|NCT01621230|9883102|FG000|NOT COMPLETED|Overall Study||0
8828756|NCT01621230|9883103|FG001|NOT COMPLETED|Overall Study||0
8828757|NCT01621477|9883112|FG000|STARTED|Overall Study||17
8828758|NCT01621477|9883112|FG000|COMPLETED|Overall Study||17
8828759|NCT01621477|9883112|FG000|NOT COMPLETED|Overall Study||0
8828760|NCT01621490|9883125|FG000|STARTED|Overall Study||41
8828761|NCT01621490|9883126|FG001|STARTED|Overall Study||44
8828762|NCT01621490|9883127|FG002|STARTED|Overall Study||11
8828763|NCT01621490|9883128|FG003|STARTED|Overall Study||10
8828764|NCT01621490|9883129|FG004|STARTED|Overall Study||6
8828765|NCT01621490|9883130|FG005|STARTED|Overall Study||25
8828766|NCT01621490|9883131|FG006|STARTED|Overall Study||11
8828767|NCT01621490|9883132|FG007|STARTED|Overall Study||10
8828768|NCT01621490|9883133|FG008|STARTED|Overall Study||10
8828769|NCT01621490|9883125|FG000|COMPLETED|Overall Study||0
8828770|NCT01621490|9883126|FG001|COMPLETED|Overall Study||0
8828771|NCT01621490|9883127|FG002|COMPLETED|Overall Study||0
8828772|NCT01621490|9883128|FG003|COMPLETED|Overall Study||1
8723343|NCT01022307|9770792|FG001|COMPLETED|Overall Study|Some TBI patients could not undergo MR scanning due to contraindications.|24
8723344|NCT01022307|9770791|FG000|NOT COMPLETED|Overall Study||0
8723345|NCT01022307|9770792|FG001|NOT COMPLETED|Overall Study||4
8828773|NCT01621490|9883129|FG004|COMPLETED|Overall Study||0
8828774|NCT01621490|9883130|FG005|COMPLETED|Overall Study||1
8828775|NCT01621490|9883131|FG006|COMPLETED|Overall Study||0
8828776|NCT01621490|9883132|FG007|COMPLETED|Overall Study||0
8828777|NCT01621490|9883133|FG008|COMPLETED|Overall Study||2
8828778|NCT01621490|9883125|FG000|NOT COMPLETED|Overall Study||41
8828779|NCT01621490|9883126|FG001|NOT COMPLETED|Overall Study||44
8828780|NCT01621490|9883127|FG002|NOT COMPLETED|Overall Study||11
8828781|NCT01621490|9883128|FG003|NOT COMPLETED|Overall Study||9
8828782|NCT01621490|9883129|FG004|NOT COMPLETED|Overall Study||6
8828783|NCT01621490|9883130|FG005|NOT COMPLETED|Overall Study||24
8828784|NCT01621490|9883131|FG006|NOT COMPLETED|Overall Study||11
8828785|NCT01621490|9883132|FG007|NOT COMPLETED|Overall Study||10
8828786|NCT01621490|9883133|FG008|NOT COMPLETED|Overall Study||8
8828787|NCT01621542|9883252|FG000|STARTED|Overall Study||5
8828788|NCT01621542|9883253|FG001|STARTED|Overall Study||5
8828789|NCT01621542|9883254|FG002|STARTED|Overall Study||6
8828790|NCT01621542|9883255|FG003|STARTED|Overall Study||28
8828791|NCT01621542|9883256|FG004|STARTED|Overall Study||9
8828792|NCT01621542|9883257|FG005|STARTED|Overall Study||9
8828793|NCT01621542|9883252|FG000|COMPLETED|Overall Study||0
8828794|NCT01621542|9883253|FG001|COMPLETED|Overall Study||0
8828795|NCT01621542|9883254|FG002|COMPLETED|Overall Study||0
8828796|NCT01621542|9883255|FG003|COMPLETED|Overall Study||0
8828797|NCT01621542|9883256|FG004|COMPLETED|Overall Study||0
8828798|NCT01621542|9883257|FG005|COMPLETED|Overall Study||0
8723346|NCT01022359|9770800|FG000|STARTED|Overall Study||39
8723347|NCT01022359|9770801|FG001|STARTED|Overall Study||41
8723348|NCT01022359|9770800|FG000|COMPLETED|Overall Study||39
8723349|NCT01022359|9770801|FG001|COMPLETED|Overall Study||41
8723350|NCT01022359|9770800|FG000|NOT COMPLETED|Overall Study||0
8723351|NCT01022359|9770801|FG001|NOT COMPLETED|Overall Study||0
8723352|NCT01022424|9770807|FG000|STARTED|Overall Study||13
8723353|NCT01022424|9770807|FG000|COMPLETED|Overall Study||9
8723354|NCT01022424|9770807|FG000|NOT COMPLETED|Overall Study||4
8828799|NCT01621542|9883252|FG000|NOT COMPLETED|Overall Study||5
8828800|NCT01621542|9883253|FG001|NOT COMPLETED|Overall Study||5
8828801|NCT01621542|9883254|FG002|NOT COMPLETED|Overall Study||6
8828802|NCT01621542|9883255|FG003|NOT COMPLETED|Overall Study||28
8828803|NCT01621542|9883256|FG004|NOT COMPLETED|Overall Study||9
8723355|NCT01022502|9770815|FG000|STARTED|Overall Study|19 used the refined ointment on the right site, 19 used the crude ointment on the left site.|38
8828804|NCT01621542|9883257|FG005|NOT COMPLETED|Overall Study||9
8828805|NCT01621633|9883275|FG000|STARTED|Overall Study||8
8828806|NCT01621633|9883276|FG001|STARTED|Overall Study||8
8828807|NCT01621633|9883277|FG002|STARTED|Overall Study||8
8828808|NCT01621633|9883278|FG003|STARTED|Overall Study||8
8828809|NCT01621633|9883275|FG000|COMPLETED|Overall Study||8
8828810|NCT01621633|9883276|FG001|COMPLETED|Overall Study||8
8828811|NCT01621633|9883277|FG002|COMPLETED|Overall Study||8
8828812|NCT01621633|9883278|FG003|COMPLETED|Overall Study||8
8828813|NCT01621633|9883275|FG000|NOT COMPLETED|Overall Study||0
8828814|NCT01621633|9883276|FG001|NOT COMPLETED|Overall Study||0
8828815|NCT01621633|9883277|FG002|NOT COMPLETED|Overall Study||0
8828816|NCT01621633|9883278|FG003|NOT COMPLETED|Overall Study||0
8828817|NCT01621672|9883290|FG000|STARTED|Overall Study||25
8828818|NCT01621672|9883291|FG001|STARTED|Overall Study||17
8828819|NCT01621672|9883290|FG000|COMPLETED|Overall Study||25
8828820|NCT01621672|9883291|FG001|COMPLETED|Overall Study||17
8828821|NCT01621672|9883290|FG000|NOT COMPLETED|Overall Study||0
8828822|NCT01621672|9883291|FG001|NOT COMPLETED|Overall Study||0
8828823|NCT01621776|9883300|FG000|STARTED|Overall Study||41
8828824|NCT01621776|9883301|FG001|STARTED|Overall Study||40
8828825|NCT01621776|9883302|FG002|STARTED|Overall Study||18
8828826|NCT01621776|9883300|FG000|COMPLETED|Overall Study||41
8828827|NCT01621776|9883301|FG001|COMPLETED|Overall Study||40
8828828|NCT01621776|9883302|FG002|COMPLETED|Overall Study||18
8828829|NCT01621776|9883300|FG000|NOT COMPLETED|Overall Study||0
8828830|NCT01621776|9883301|FG001|NOT COMPLETED|Overall Study||0
8828831|NCT01621776|9883302|FG002|NOT COMPLETED|Overall Study||0
8828832|NCT01621802|9883316|FG000|STARTED|Overall Study||802
8828833|NCT01621802|9883317|FG001|STARTED|Overall Study||298
8828834|NCT01621802|9883318|FG002|STARTED|Overall Study||796
8828835|NCT01621802|9883319|FG003|STARTED|Overall Study||303
8828836|NCT01621802|9883320|FG004|STARTED|Overall Study||1319
8828837|NCT01621802|9883321|FG005|STARTED|Overall Study||489
8828838|NCT01621802|9883316|FG000|COMPLETED|Overall Study||755
8828839|NCT01621802|9883317|FG001|COMPLETED|Overall Study||275
8828840|NCT01621802|9883318|FG002|COMPLETED|Overall Study||763
8828841|NCT01621802|9883319|FG003|COMPLETED|Overall Study||292
8828842|NCT01621802|9883320|FG004|COMPLETED|Overall Study||1284
8828843|NCT01621802|9883321|FG005|COMPLETED|Overall Study||477
8828844|NCT01621802|9883316|FG000|NOT COMPLETED|Overall Study||47
8828845|NCT01621802|9883317|FG001|NOT COMPLETED|Overall Study||23
8828846|NCT01621802|9883318|FG002|NOT COMPLETED|Overall Study||33
8828847|NCT01621802|9883319|FG003|NOT COMPLETED|Overall Study||11
8828848|NCT01621802|9883320|FG004|NOT COMPLETED|Overall Study||35
8828849|NCT01621802|9883321|FG005|NOT COMPLETED|Overall Study||12
8828850|NCT01621880|9883340|FG000|STARTED|Overall Study||58
8828851|NCT01621880|9883341|FG001|STARTED|Overall Study||54
8828852|NCT01621880|9883340|FG000|COMPLETED|Overall Study||48
8828853|NCT01621880|9883341|FG001|COMPLETED|Overall Study||49
8828854|NCT01621880|9883340|FG000|NOT COMPLETED|Overall Study||10
8828855|NCT01621880|9883341|FG001|NOT COMPLETED|Overall Study||5
8828856|NCT01622010|9883350|FG000|STARTED|Overall Study||18
8828857|NCT01622010|9883351|FG001|STARTED|Overall Study||12
8828858|NCT01622010|9883350|FG000|COMPLETED|Overall Study||12
8828859|NCT01622010|9883351|FG001|COMPLETED|Overall Study||8
8828860|NCT01622010|9883350|FG000|NOT COMPLETED|Overall Study||6
8828861|NCT01622010|9883351|FG001|NOT COMPLETED|Overall Study||4
8828862|NCT01622231|9883359|FG000|STARTED|Overall Study||61
8828863|NCT01622231|9883359|FG000|COMPLETED|Overall Study||59
8828864|NCT01622231|9883359|FG000|NOT COMPLETED|Overall Study||2
8828865|NCT01622257|9883366|FG000|STARTED|Overall Study||66
8828866|NCT01622257|9883367|FG001|STARTED|Overall Study||66
8828867|NCT01622257|9883368|FG002|STARTED|Overall Study||66
8828868|NCT01622257|9883366|FG000|COMPLETED|Overall Study||66
8828869|NCT01622257|9883367|FG001|COMPLETED|Overall Study||66
8828870|NCT01622257|9883368|FG002|COMPLETED|Overall Study||66
8828871|NCT01622257|9883366|FG000|NOT COMPLETED|Overall Study||0
8828872|NCT01622257|9883367|FG001|NOT COMPLETED|Overall Study||0
8828873|NCT01622257|9883368|FG002|NOT COMPLETED|Overall Study||0
8828874|NCT01622296|9883376|FG000|STARTED|First Intervention||10
8828875|NCT01622296|9883377|FG001|STARTED|First Intervention||10
8828876|NCT01622296|9883376|FG000|COMPLETED|First Intervention||10
8828877|NCT01622296|9883377|FG001|COMPLETED|First Intervention||10
8828878|NCT01622296|9883376|FG000|NOT COMPLETED|First Intervention||0
8828879|NCT01622296|9883377|FG001|NOT COMPLETED|First Intervention||0
8828880|NCT01622296|9883376|FG000|STARTED|Washout Period of at Least 1 Week||10
8828881|NCT01622296|9883377|FG001|STARTED|Washout Period of at Least 1 Week||10
8828882|NCT01622296|9883376|FG000|COMPLETED|Washout Period of at Least 1 Week||10
8828883|NCT01622296|9883377|FG001|COMPLETED|Washout Period of at Least 1 Week||10
8828884|NCT01622296|9883376|FG000|NOT COMPLETED|Washout Period of at Least 1 Week||0
8828885|NCT01622296|9883377|FG001|NOT COMPLETED|Washout Period of at Least 1 Week||0
8828886|NCT01622296|9883376|FG000|STARTED|Second Intervention||10
8828887|NCT01622296|9883377|FG001|STARTED|Second Intervention||10
8828888|NCT01622296|9883376|FG000|COMPLETED|Second Intervention||10
8828889|NCT01622296|9883377|FG001|COMPLETED|Second Intervention||10
8828890|NCT01622296|9883376|FG000|NOT COMPLETED|Second Intervention||0
8828891|NCT01622296|9883377|FG001|NOT COMPLETED|Second Intervention||0
8828892|NCT01622348|9883385|FG000|STARTED|Overall Study||15
8828893|NCT01622348|9883386|FG001|STARTED|Overall Study||14
8828894|NCT01622348|9883387|FG002|STARTED|Overall Study||15
8828895|NCT01622348|9883385|FG000|COMPLETED|Overall Study||14
8828896|NCT01622348|9883386|FG001|COMPLETED|Overall Study||14
8828897|NCT01622348|9883387|FG002|COMPLETED|Overall Study||14
8828898|NCT01622348|9883385|FG000|NOT COMPLETED|Overall Study||1
8828899|NCT01622348|9883386|FG001|NOT COMPLETED|Overall Study||0
8828900|NCT01622348|9883387|FG002|NOT COMPLETED|Overall Study||1
8828901|NCT01622543|9883397|FG000|STARTED|Overall Study||51
8828902|NCT01622543|9883398|FG001|STARTED|Overall Study||52
8828903|NCT01622543|9883397|FG000|COMPLETED|Overall Study||51
8828904|NCT01622543|9883398|FG001|COMPLETED|Overall Study||52
8828905|NCT01622543|9883397|FG000|NOT COMPLETED|Overall Study||0
8828906|NCT01622543|9883398|FG001|NOT COMPLETED|Overall Study||0
8828907|NCT01622569|9883408|FG000|STARTED|Double-Blind Treatment Phase (Wks 1-16)||82
8828908|NCT01622569|9883409|FG001|STARTED|Double-Blind Treatment Phase (Wks 1-16)||81
8828909|NCT01622569|9883410|FG002|STARTED|Double-Blind Treatment Phase (Wks 1-16)||80
8828910|NCT01622569|9883411|FG003|STARTED|Double-Blind Treatment Phase (Wks 1-16)||80
8828911|NCT01622569|9883408|FG000|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||70
8828912|NCT01622569|9883409|FG001|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||75
8828913|NCT01622569|9883410|FG002|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||71
8828914|NCT01622569|9883411|FG003|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||76
8828915|NCT01622569|9883408|FG000|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||12
8828916|NCT01622569|9883409|FG001|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||6
8828917|NCT01622569|9883410|FG002|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||9
8828918|NCT01622569|9883411|FG003|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||4
8828919|NCT01622569|9883408|FG000|STARTED|Open-Label Extension Phase (Wks 17-24)||68
8828920|NCT01622569|9883409|FG001|STARTED|Open-Label Extension Phase (Wks 17-24)||72
8828921|NCT01622569|9883410|FG002|STARTED|Open-Label Extension Phase (Wks 17-24)||67
8828922|NCT01622569|9883411|FG003|STARTED|Open-Label Extension Phase (Wks 17-24)||75
8828923|NCT01622569|9883408|FG000|COMPLETED|Open-Label Extension Phase (Wks 17-24)||67
8828924|NCT01622569|9883409|FG001|COMPLETED|Open-Label Extension Phase (Wks 17-24)||70
8828925|NCT01622569|9883410|FG002|COMPLETED|Open-Label Extension Phase (Wks 17-24)||64
8828926|NCT01622569|9883411|FG003|COMPLETED|Open-Label Extension Phase (Wks 17-24)||73
8828927|NCT01622569|9883408|FG000|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||1
8828928|NCT01622569|9883409|FG001|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||2
8828929|NCT01622569|9883410|FG002|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||3
8828930|NCT01622569|9883411|FG003|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||2
8828931|NCT01622660|9883431|FG000|STARTED|Overall Study||2
8828932|NCT01622660|9883431|FG000|COMPLETED|Overall Study||1
8828933|NCT01622660|9883431|FG000|NOT COMPLETED|Overall Study||1
8828934|NCT01622673|9883441|FG000|STARTED|Treatment Period 1||4
8828935|NCT01622673|9883442|FG001|STARTED|Treatment Period 1||5
8828936|NCT01622673|9883443|FG002|STARTED|Treatment Period 1||4
8828937|NCT01622673|9883444|FG003|STARTED|Treatment Period 1||6
8828938|NCT01622673|9883445|FG004|STARTED|Treatment Period 1||4
8828939|NCT01622673|9883446|FG005|STARTED|Treatment Period 1||4
8828940|NCT01622673|9883441|FG000|COMPLETED|Treatment Period 1||4
8828941|NCT01622673|9883442|FG001|COMPLETED|Treatment Period 1||4
8828942|NCT01622673|9883443|FG002|COMPLETED|Treatment Period 1||4
8828943|NCT01622673|9883444|FG003|COMPLETED|Treatment Period 1||5
8828944|NCT01622673|9883445|FG004|COMPLETED|Treatment Period 1||4
8828945|NCT01622673|9883446|FG005|COMPLETED|Treatment Period 1||4
8828946|NCT01622673|9883441|FG000|NOT COMPLETED|Treatment Period 1||0
8828947|NCT01622673|9883442|FG001|NOT COMPLETED|Treatment Period 1||1
8828948|NCT01622673|9883443|FG002|NOT COMPLETED|Treatment Period 1||0
8828949|NCT01622673|9883444|FG003|NOT COMPLETED|Treatment Period 1||1
8828950|NCT01622673|9883445|FG004|NOT COMPLETED|Treatment Period 1||0
8828951|NCT01622673|9883446|FG005|NOT COMPLETED|Treatment Period 1||0
8828952|NCT01622673|9883441|FG000|STARTED|Treatment Period 2||4
8828953|NCT01622673|9883442|FG001|STARTED|Treatment Period 2||4
8828954|NCT01622673|9883443|FG002|STARTED|Treatment Period 2||4
8828955|NCT01622673|9883444|FG003|STARTED|Treatment Period 2||5
8828956|NCT01622673|9883445|FG004|STARTED|Treatment Period 2||4
8828957|NCT01622673|9883446|FG005|STARTED|Treatment Period 2||4
8828958|NCT01622673|9883441|FG000|COMPLETED|Treatment Period 2||4
8828959|NCT01622673|9883442|FG001|COMPLETED|Treatment Period 2||4
8828960|NCT01622673|9883443|FG002|COMPLETED|Treatment Period 2||4
8828961|NCT01622673|9883444|FG003|COMPLETED|Treatment Period 2||4
8828962|NCT01622673|9883445|FG004|COMPLETED|Treatment Period 2||4
8828963|NCT01622673|9883446|FG005|COMPLETED|Treatment Period 2||4
8828964|NCT01622673|9883441|FG000|NOT COMPLETED|Treatment Period 2||0
8828965|NCT01622673|9883442|FG001|NOT COMPLETED|Treatment Period 2||0
8828966|NCT01622673|9883443|FG002|NOT COMPLETED|Treatment Period 2||0
8828967|NCT01622673|9883444|FG003|NOT COMPLETED|Treatment Period 2||1
8828968|NCT01622673|9883445|FG004|NOT COMPLETED|Treatment Period 2||0
8828969|NCT01622673|9883446|FG005|NOT COMPLETED|Treatment Period 2||0
8828970|NCT01622673|9883441|FG000|STARTED|Treatment Period 3||4
8828971|NCT01622673|9883442|FG001|STARTED|Treatment Period 3||4
8828972|NCT01622673|9883443|FG002|STARTED|Treatment Period 3||4
8828973|NCT01622673|9883444|FG003|STARTED|Treatment Period 3||4
8828974|NCT01622673|9883445|FG004|STARTED|Treatment Period 3||4
8828975|NCT01622673|9883446|FG005|STARTED|Treatment Period 3||4
8828976|NCT01622673|9883441|FG000|COMPLETED|Treatment Period 3||4
8828977|NCT01622673|9883442|FG001|COMPLETED|Treatment Period 3||3
8828978|NCT01622673|9883443|FG002|COMPLETED|Treatment Period 3||4
8828979|NCT01622673|9883444|FG003|COMPLETED|Treatment Period 3||4
8622496|NCT00488631|9661714|FG007|NOT COMPLETED|Open Label Study Extension (Week 54-228)||27
8828980|NCT01622673|9883445|FG004|COMPLETED|Treatment Period 3||4
8828981|NCT01622673|9883446|FG005|COMPLETED|Treatment Period 3||4
8828982|NCT01622673|9883441|FG000|NOT COMPLETED|Treatment Period 3||0
8828983|NCT01622673|9883442|FG001|NOT COMPLETED|Treatment Period 3||1
8828984|NCT01622673|9883443|FG002|NOT COMPLETED|Treatment Period 3||0
8828985|NCT01622673|9883444|FG003|NOT COMPLETED|Treatment Period 3||0
8828986|NCT01622673|9883445|FG004|NOT COMPLETED|Treatment Period 3||0
8828987|NCT01622673|9883446|FG005|NOT COMPLETED|Treatment Period 3||0
8828988|NCT01622673|9883441|FG000|STARTED|Treatment Period 4||4
8828989|NCT01622673|9883442|FG001|STARTED|Treatment Period 4||3
8828990|NCT01622673|9883443|FG002|STARTED|Treatment Period 4||4
8828991|NCT01622673|9883444|FG003|STARTED|Treatment Period 4||4
8828992|NCT01622673|9883445|FG004|STARTED|Treatment Period 4||4
8828993|NCT01622673|9883446|FG005|STARTED|Treatment Period 4||4
8828994|NCT01622673|9883441|FG000|COMPLETED|Treatment Period 4||4
8828995|NCT01622673|9883442|FG001|COMPLETED|Treatment Period 4||3
8828996|NCT01622673|9883443|FG002|COMPLETED|Treatment Period 4||4
8828997|NCT01622673|9883444|FG003|COMPLETED|Treatment Period 4||4
8828998|NCT01622673|9883445|FG004|COMPLETED|Treatment Period 4||4
8828999|NCT01622673|9883446|FG005|COMPLETED|Treatment Period 4||4
8829000|NCT01622673|9883441|FG000|NOT COMPLETED|Treatment Period 4||0
8829001|NCT01622673|9883442|FG001|NOT COMPLETED|Treatment Period 4||0
8829002|NCT01622673|9883443|FG002|NOT COMPLETED|Treatment Period 4||0
8829003|NCT01622673|9883444|FG003|NOT COMPLETED|Treatment Period 4||0
8829004|NCT01622673|9883445|FG004|NOT COMPLETED|Treatment Period 4||0
8829005|NCT01622673|9883446|FG005|NOT COMPLETED|Treatment Period 4||0
8829006|NCT01622673|9883441|FG000|STARTED|Treatment Period 5||4
8829007|NCT01622673|9883442|FG001|STARTED|Treatment Period 5||3
8829008|NCT01622673|9883443|FG002|STARTED|Treatment Period 5||4
8829009|NCT01622673|9883444|FG003|STARTED|Treatment Period 5||4
8829010|NCT01622673|9883445|FG004|STARTED|Treatment Period 5||4
8829011|NCT01622673|9883446|FG005|STARTED|Treatment Period 5||4
8829012|NCT01622673|9883441|FG000|COMPLETED|Treatment Period 5||4
8829013|NCT01622673|9883442|FG001|COMPLETED|Treatment Period 5||3
8829014|NCT01622673|9883443|FG002|COMPLETED|Treatment Period 5||4
8829015|NCT01622673|9883444|FG003|COMPLETED|Treatment Period 5||4
8829016|NCT01622673|9883445|FG004|COMPLETED|Treatment Period 5||4
8829017|NCT01622673|9883446|FG005|COMPLETED|Treatment Period 5||4
8829018|NCT01622673|9883441|FG000|NOT COMPLETED|Treatment Period 5||0
8829019|NCT01622673|9883442|FG001|NOT COMPLETED|Treatment Period 5||0
8829020|NCT01622673|9883443|FG002|NOT COMPLETED|Treatment Period 5||0
8829021|NCT01622673|9883444|FG003|NOT COMPLETED|Treatment Period 5||0
8829022|NCT01622673|9883445|FG004|NOT COMPLETED|Treatment Period 5||0
8829023|NCT01622673|9883446|FG005|NOT COMPLETED|Treatment Period 5||0
8829024|NCT01622699|9883467|FG000|STARTED|Overall Study||213
8829025|NCT01622699|9883468|FG001|STARTED|Overall Study||217
8829026|NCT01622699|9883467|FG000|COMPLETED|Overall Study||213
8829027|NCT01622699|9883468|FG001|COMPLETED|Overall Study||217
8829028|NCT01622699|9883467|FG000|NOT COMPLETED|Overall Study||0
8829029|NCT01622699|9883468|FG001|NOT COMPLETED|Overall Study||0
8829030|NCT01623037|9883474|FG000|STARTED|Overall Study||15
8829031|NCT01623037|9883474|FG000|COMPLETED|Overall Study||15
8829032|NCT01623037|9883474|FG000|NOT COMPLETED|Overall Study||0
8829033|NCT01623050|9883480|FG000|STARTED|Overall Study||36
8829034|NCT01623050|9883480|FG000|Treated|Overall Study||34
8829035|NCT01623050|9883480|FG000|COMPLETED|Overall Study||27
8829036|NCT01623050|9883480|FG000|NOT COMPLETED|Overall Study||9
8829037|NCT01623115|9883486|FG000|STARTED|Overall Study|Randomized|163
8829038|NCT01623115|9883487|FG001|STARTED|Overall Study|Randomized|323
8829039|NCT01623115|9883486|FG000|Treated|Overall Study||163
8829040|NCT01623115|9883487|FG001|Treated|Overall Study||322
8829041|NCT01623115|9883486|FG000|COMPLETED|Overall Study||130
9065958|NCT04128293|10126435|FG001|STARTED|Treatment Period 4 (1 Day)||0
9065959|NCT04128293|10126436|FG002|STARTED|Treatment Period 4 (1 Day)||0
8829042|NCT01623115|9883487|FG001|COMPLETED|Overall Study||246
8829043|NCT01623115|9883486|FG000|NOT COMPLETED|Overall Study||33
8829044|NCT01623115|9883487|FG001|NOT COMPLETED|Overall Study||77
8829045|NCT01623154|9883493|FG000|STARTED|Overall Study||99
8829046|NCT01623154|9883493|FG000|Available for Analysis|Overall Study||95
8829047|NCT01623154|9883493|FG000|COMPLETED|Overall Study||95
8829048|NCT01623154|9883493|FG000|NOT COMPLETED|Overall Study||4
8829049|NCT01623271|9883499|FG000|STARTED|Overall Study||5
8829050|NCT01623271|9883499|FG000|COMPLETED|Overall Study||3
8829051|NCT01623271|9883499|FG000|NOT COMPLETED|Overall Study||2
8829052|NCT01623310|9883503|FG000|STARTED|Overall Study||223
8829053|NCT01623310|9883503|FG000|COMPLETED|Overall Study||144
8829054|NCT01623310|9883503|FG000|NOT COMPLETED|Overall Study||79
8829055|NCT01623323|9883507|FG000|STARTED|Overall Study||705
8829056|NCT01623323|9883507|FG000|COMPLETED|Overall Study||601
8829057|NCT01623323|9883507|FG000|NOT COMPLETED|Overall Study||104
8829058|NCT01623466|9883513|FG000|STARTED|Overall Study||18
8829059|NCT01623466|9883514|FG001|STARTED|Overall Study||18
8829060|NCT01623466|9883513|FG000|COMPLETED|Overall Study||17
8829061|NCT01623466|9883514|FG001|COMPLETED|Overall Study||18
8829062|NCT01623466|9883513|FG000|NOT COMPLETED|Overall Study||1
8829063|NCT01623466|9883514|FG001|NOT COMPLETED|Overall Study||0
8829064|NCT01623479|9883520|FG000|STARTED|Overall Study||585
8829065|NCT01623479|9883520|FG000|COMPLETED|Overall Study||585
8829066|NCT01623479|9883520|FG000|NOT COMPLETED|Overall Study||0
8829067|NCT01623531|9883526|FG000|STARTED|Overall Study||31
8829068|NCT01623531|9883527|FG001|STARTED|Overall Study||31
8829069|NCT01623531|9883526|FG000|COMPLETED|Overall Study||27
8829070|NCT01623531|9883527|FG001|COMPLETED|Overall Study||29
8829071|NCT01623531|9883526|FG000|NOT COMPLETED|Overall Study||4
8829072|NCT01623531|9883527|FG001|NOT COMPLETED|Overall Study||2
8829073|NCT01623596|9883538|FG000|STARTED|Overall Study||436
8829074|NCT01623596|9883539|FG001|STARTED|Overall Study||439
8829075|NCT01623596|9883538|FG000|On Randomized Treatment|Overall Study||352
8829076|NCT01623596|9883539|FG001|On Randomized Treatment|Overall Study||125
8829077|NCT01623596|9883538|FG000|On Switched Treatment|Overall Study||22
8829078|NCT01623596|9883539|FG001|On Switched Treatment|Overall Study||214
8829079|NCT01623596|9883538|FG000|COMPLETED|Overall Study||374
8829080|NCT01623596|9883539|FG001|COMPLETED|Overall Study||339
8829081|NCT01623596|9883538|FG000|NOT COMPLETED|Overall Study||62
8829082|NCT01623596|9883539|FG001|NOT COMPLETED|Overall Study||100
8829083|NCT01623739|9883549|FG000|STARTED|Overall Study||19
8829084|NCT01623739|9883550|FG001|STARTED|Overall Study||19
8829085|NCT01623739|9883549|FG000|COMPLETED|Overall Study||17
8829086|NCT01623739|9883550|FG001|COMPLETED|Overall Study||15
8829087|NCT01623739|9883549|FG000|NOT COMPLETED|Overall Study||2
8829088|NCT01623739|9883550|FG001|NOT COMPLETED|Overall Study||4
8829089|NCT01623752|9883560|FG000|STARTED|Phase 1 (78 Weeks)||1378
8829090|NCT01623752|9883561|FG001|STARTED|Phase 1 (78 Weeks)||440
8829091|NCT01623752|9883562|FG002|STARTED|Phase 1 (78 Weeks)||3
8622497|NCT00488631|9661715|FG008|NOT COMPLETED|Open Label Study Extension (Week 54-228)||182
8622498|NCT00488631|9661716|FG009|NOT COMPLETED|Open Label Study Extension (Week 54-228)||3
8622499|NCT00488644|9661739|FG000|STARTED|Overall Study||12
8622500|NCT00488644|9661739|FG000|COMPLETED|Overall Study||10
8622501|NCT00488644|9661739|FG000|NOT COMPLETED|Overall Study||2
8829092|NCT01623752|9883560|FG000|COMPLETED|Phase 1 (78 Weeks)||747
8829093|NCT01623752|9883561|FG001|COMPLETED|Phase 1 (78 Weeks)||233
8829094|NCT01623752|9883562|FG002|COMPLETED|Phase 1 (78 Weeks)||1
8829095|NCT01623752|9883560|FG000|NOT COMPLETED|Phase 1 (78 Weeks)||631
8829096|NCT01623752|9883561|FG001|NOT COMPLETED|Phase 1 (78 Weeks)||207
8829097|NCT01623752|9883562|FG002|NOT COMPLETED|Phase 1 (78 Weeks)||2
8829098|NCT01623752|9883560|FG000|STARTED|Phase 2 (78 Weeks)|Participants only who consented to continue in Period 2.|291
8829099|NCT01623752|9883561|FG001|STARTED|Phase 2 (78 Weeks)|Participants only who consented to continue in Period 2.|116
8829100|NCT01623752|9883562|FG002|STARTED|Phase 2 (78 Weeks)|Participants only who consented to continue in Period 2.|0
8829101|NCT01623752|9883560|FG000|COMPLETED|Phase 2 (78 Weeks)||225
8829102|NCT01623752|9883561|FG001|COMPLETED|Phase 2 (78 Weeks)||98
8829103|NCT01623752|9883562|FG002|COMPLETED|Phase 2 (78 Weeks)||0
8829104|NCT01623752|9883560|FG000|NOT COMPLETED|Phase 2 (78 Weeks)||66
8829105|NCT01623752|9883561|FG001|NOT COMPLETED|Phase 2 (78 Weeks)||18
8829106|NCT01623752|9883562|FG002|NOT COMPLETED|Phase 2 (78 Weeks)||0
8829107|NCT01623830|9883573|FG000|STARTED|Overall Study||45
8829108|NCT01623830|9883574|FG001|STARTED|Overall Study||44
8829109|NCT01623830|9883573|FG000|COMPLETED|Overall Study||38
8829110|NCT01623830|9883574|FG001|COMPLETED|Overall Study||35
8829111|NCT01623830|9883573|FG000|NOT COMPLETED|Overall Study||7
8829112|NCT01623830|9883574|FG001|NOT COMPLETED|Overall Study||9
8829113|NCT01623869|9883580|FG000|STARTED|Overall Study||16
8829114|NCT01623869|9883580|FG000|COMPLETED|Overall Study||16
8829115|NCT01623869|9883580|FG000|NOT COMPLETED|Overall Study||0
8829116|NCT01624090|9883588|FG000|STARTED|Overall Study||2
8829117|NCT01624090|9883589|FG001|STARTED|Overall Study||2
8829118|NCT01624090|9883590|FG002|STARTED|Overall Study||10
8829119|NCT01624090|9883591|FG003|STARTED|Overall Study||2
8829120|NCT01624090|9883588|FG000|COMPLETED|Overall Study||2
8829121|NCT01624090|9883589|FG001|COMPLETED|Overall Study||0
8829122|NCT01624090|9883590|FG002|COMPLETED|Overall Study||3
8829123|NCT01624090|9883591|FG003|COMPLETED|Overall Study||2
8829124|NCT01624090|9883588|FG000|NOT COMPLETED|Overall Study||0
8829125|NCT01624090|9883589|FG001|NOT COMPLETED|Overall Study||2
8829126|NCT01624090|9883590|FG002|NOT COMPLETED|Overall Study||7
8829127|NCT01624090|9883591|FG003|NOT COMPLETED|Overall Study||0
8829128|NCT01624142|9883603|FG000|STARTED|Overall Study||106
8829129|NCT01624142|9883604|FG001|STARTED|Overall Study||194
8829130|NCT01624142|9883603|FG000|COMPLETED|Overall Study||74
8829131|NCT01624142|9883604|FG001|COMPLETED|Overall Study||178
8829132|NCT01624142|9883603|FG000|NOT COMPLETED|Overall Study||32
8829133|NCT01624142|9883604|FG001|NOT COMPLETED|Overall Study||16
8829134|NCT01624168|9883614|FG000|STARTED|Overall Study||19
8829135|NCT01624168|9883615|FG001|STARTED|Overall Study||28
8829136|NCT01624168|9883616|FG002|STARTED|Overall Study||28
8829137|NCT01624168|9883614|FG000|COMPLETED|Overall Study||15
8829138|NCT01624168|9883615|FG001|COMPLETED|Overall Study||16
8829139|NCT01624168|9883616|FG002|COMPLETED|Overall Study||22
8829140|NCT01624168|9883614|FG000|NOT COMPLETED|Overall Study||4
8829141|NCT01624168|9883615|FG001|NOT COMPLETED|Overall Study||12
8622502|NCT00488683|9661746|FG000|STARTED|Overall Study||108
8622503|NCT00488683|9661747|FG001|STARTED|Overall Study||54
8622504|NCT00488683|9661748|FG002|STARTED|Overall Study||54
8829142|NCT01624168|9883616|FG002|NOT COMPLETED|Overall Study||6
8829143|NCT01624194|9883626|FG000|STARTED|Overall Study||16
8829144|NCT01624194|9883627|FG001|STARTED|Overall Study||18
8829145|NCT01624194|9883626|FG000|COMPLETED|Overall Study||14
8829146|NCT01624194|9883627|FG001|COMPLETED|Overall Study||18
8829147|NCT01624194|9883626|FG000|NOT COMPLETED|Overall Study||2
8829148|NCT01624194|9883627|FG001|NOT COMPLETED|Overall Study||0
8829149|NCT01624233|9883634|FG000|STARTED|Period 2 - Induction||91
8829150|NCT01624233|9883634|FG000|Received at Least 1 Dose of Study Drug|Period 2 - Induction||91
8829151|NCT01624233|9883634|FG000|Erythrodermic Psoriasis (Ps)|Period 2 - Induction||8
8829152|NCT01624233|9883634|FG000|Pustular Ps|Period 2 - Induction||5
8829153|NCT01624233|9883634|FG000|Plaque Ps|Period 2 - Induction||78
8829154|NCT01624233|9883634|FG000|COMPLETED|Period 2 - Induction||90
8829155|NCT01624233|9883634|FG000|NOT COMPLETED|Period 2 - Induction||1
8829156|NCT01624233|9883634|FG000|STARTED|Period 3 - Maintenance||90
8829157|NCT01624233|9883634|FG000|Received at Least 1 Dose of Study Drug|Period 3 - Maintenance||90
8829158|NCT01624233|9883634|FG000|COMPLETED|Period 3 - Maintenance||83
8829159|NCT01624233|9883634|FG000|NOT COMPLETED|Period 3 - Maintenance||7
8829160|NCT01624233|9883634|FG000|STARTED|Period 4 - Drug Free Period|Only responders in participants with plaque Ps moved to the Drug Free Period 4.|70
8829161|NCT01624233|9883634|FG000|Adverse Event|Period 4 - Drug Free Period|1 participant who discontinued due to adverse event is included in the participants who relapsed.|1
8829162|NCT01624233|9883634|FG000|Physician Decision|Period 4 - Drug Free Period|1 participant who discontinued due to physician decision is included in the participants relapsed.|1
8829163|NCT01624233|9883634|FG000|COMPLETED|Period 4 - Drug Free Period||9
8829164|NCT01624233|9883634|FG000|NOT COMPLETED|Period 4 - Drug Free Period||61
8829165|NCT01624233|9883634|FG000|STARTED|Period 5 - Retreatment Period|Period 5 included (participants with erythrodermic Ps or pustular Ps) or Period 4 completers.|80
8829166|NCT01624233|9883634|FG000|COMPLETED|Period 5 - Retreatment Period||70
8829167|NCT01624233|9883634|FG000|NOT COMPLETED|Period 5 - Retreatment Period||10
8829168|NCT01624233|9883634|FG000|STARTED|Period 6: Follow-up|Period 6 included participants received a dose of drug and exhibited the required neutrophil count.|88
8829169|NCT01624233|9883634|FG000|COMPLETED|Period 6: Follow-up||79
8829170|NCT01624233|9883634|FG000|NOT COMPLETED|Period 6: Follow-up||9
8829171|NCT01624259|9883644|FG000|STARTED|Overall Study||299
8829172|NCT01624259|9883645|FG001|STARTED|Overall Study||300
8829173|NCT01624259|9883644|FG000|Received at Least One Dose of Study Drug|Overall Study||299
8829174|NCT01624259|9883645|FG001|Received at Least One Dose of Study Drug|Overall Study||300
8829175|NCT01624259|9883644|FG000|COMPLETED|Overall Study|Completed the study on study treatment|269
8829176|NCT01624259|9883645|FG001|COMPLETED|Overall Study|Completed the study on study treatment|269
8829177|NCT01624259|9883644|FG000|NOT COMPLETED|Overall Study||30
8829178|NCT01624259|9883645|FG001|NOT COMPLETED|Overall Study||31
8829179|NCT01624350|9883653|FG000|STARTED|Overall Study||100
8829180|NCT01624350|9883653|FG000|COMPLETED|Overall Study||75
8829181|NCT01624350|9883653|FG000|NOT COMPLETED|Overall Study||25
8829182|NCT01624363|9883673|FG000|STARTED|Overall Study||341
8829183|NCT01624363|9883673|FG000|COMPLETED|Overall Study||341
8829184|NCT01624363|9883673|FG000|NOT COMPLETED|Overall Study||0
8829185|NCT01624467|9883677|FG000|STARTED|Overall Study||75
8829186|NCT01624467|9883677|FG000|Received at Least One Dose of Study Drug|Overall Study||75
8829187|NCT01624467|9883677|FG000|COMPLETED|Overall Study||44
8829188|NCT01624467|9883677|FG000|NOT COMPLETED|Overall Study||31
8829189|NCT01624506|9883685|FG000|STARTED|Overall Study||530
8829190|NCT01624506|9883686|FG001|STARTED|Overall Study||230
8829191|NCT01624506|9883685|FG000|COMPLETED|Overall Study||465
8829192|NCT01624506|9883686|FG001|COMPLETED|Overall Study||213
8829193|NCT01624506|9883685|FG000|NOT COMPLETED|Overall Study||65
8829194|NCT01624506|9883686|FG001|NOT COMPLETED|Overall Study||17
8829195|NCT01624662|9883696|FG000|STARTED|Double-Blind Treatment Phase (Wks 1-16)||80
8829196|NCT01624662|9883697|FG001|STARTED|Double-Blind Treatment Phase (Wks 1-16)||81
8829197|NCT01624662|9883698|FG002|STARTED|Double-Blind Treatment Phase (Wks 1-16)||80
8829198|NCT01624662|9883699|FG003|STARTED|Double-Blind Treatment Phase (Wks 1-16)||82
8829199|NCT01624662|9883696|FG000|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||70
8829200|NCT01624662|9883697|FG001|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||78
8829201|NCT01624662|9883698|FG002|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||76
8829202|NCT01624662|9883699|FG003|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||82
8829203|NCT01624662|9883696|FG000|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||10
8829204|NCT01624662|9883697|FG001|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||3
8829205|NCT01624662|9883698|FG002|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||4
8829206|NCT01624662|9883699|FG003|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||0
8829207|NCT01624662|9883696|FG000|STARTED|Open-Label Extension Phase (Wks 17-24)||70
8829208|NCT01624662|9883697|FG001|STARTED|Open-Label Extension Phase (Wks 17-24)||78
8829209|NCT01624662|9883698|FG002|STARTED|Open-Label Extension Phase (Wks 17-24)||72
8829210|NCT01624662|9883699|FG003|STARTED|Open-Label Extension Phase (Wks 17-24)||79
8829211|NCT01624662|9883696|FG000|COMPLETED|Open-Label Extension Phase (Wks 17-24)||69
8829212|NCT01624662|9883697|FG001|COMPLETED|Open-Label Extension Phase (Wks 17-24)||76
8829213|NCT01624662|9883698|FG002|COMPLETED|Open-Label Extension Phase (Wks 17-24)||71
8829214|NCT01624662|9883699|FG003|COMPLETED|Open-Label Extension Phase (Wks 17-24)||78
8829215|NCT01624662|9883696|FG000|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||1
8829216|NCT01624662|9883697|FG001|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||2
8829217|NCT01624662|9883698|FG002|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||1
8829218|NCT01624662|9883699|FG003|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||1
8829219|NCT01624870|9883720|FG000|STARTED|Overall Study|provided informed consent|200
8829220|NCT01624870|9883720|FG000|COMPLETED|Overall Study|Completed 6 month follow up|173
8829221|NCT01624870|9883720|FG000|NOT COMPLETED|Overall Study||27
8829222|NCT01624740|9883728|FG000|STARTED|First Intervention (3-4 Days)||9
8829223|NCT01624740|9883729|FG001|STARTED|First Intervention (3-4 Days)||9
8829224|NCT01624740|9883728|FG000|COMPLETED|First Intervention (3-4 Days)||9
8829225|NCT01624740|9883729|FG001|COMPLETED|First Intervention (3-4 Days)||9
8829226|NCT01624740|9883728|FG000|NOT COMPLETED|First Intervention (3-4 Days)||0
8829227|NCT01624740|9883729|FG001|NOT COMPLETED|First Intervention (3-4 Days)||0
8829228|NCT01624740|9883728|FG000|STARTED|Washout (1 Hour)||9
8829229|NCT01624740|9883729|FG001|STARTED|Washout (1 Hour)||9
8829230|NCT01624740|9883728|FG000|COMPLETED|Washout (1 Hour)||9
8829231|NCT01624740|9883729|FG001|COMPLETED|Washout (1 Hour)||9
8829232|NCT01624740|9883728|FG000|NOT COMPLETED|Washout (1 Hour)||0
8829233|NCT01624740|9883729|FG001|NOT COMPLETED|Washout (1 Hour)||0
8829234|NCT01624740|9883728|FG000|STARTED|Second Intervention (3-4 Days)||9
8829235|NCT01624740|9883729|FG001|STARTED|Second Intervention (3-4 Days)||9
8829236|NCT01624740|9883728|FG000|COMPLETED|Second Intervention (3-4 Days)||8
8829237|NCT01624740|9883729|FG001|COMPLETED|Second Intervention (3-4 Days)||9
8829238|NCT01624740|9883728|FG000|NOT COMPLETED|Second Intervention (3-4 Days)||1
8829239|NCT01624740|9883729|FG001|NOT COMPLETED|Second Intervention (3-4 Days)||0
8829240|NCT01624948|9883738|FG000|STARTED|Overall Study||20
8829241|NCT01624948|9883739|FG001|STARTED|Overall Study||20
8829242|NCT01624948|9883738|FG000|COMPLETED|Overall Study||20
8829243|NCT01624948|9883739|FG001|COMPLETED|Overall Study||20
8829244|NCT01624948|9883738|FG000|NOT COMPLETED|Overall Study||0
8829245|NCT01624948|9883739|FG001|NOT COMPLETED|Overall Study||0
8829246|NCT01624974|9883751|FG000|STARTED|Period III of Treatment (4 Weeks)||54
8829247|NCT01624974|9883752|FG001|STARTED|Period III of Treatment (4 Weeks)||53
8829248|NCT01624974|9883751|FG000|COMPLETED|Period III of Treatment (4 Weeks)||47
8829249|NCT01624974|9883752|FG001|COMPLETED|Period III of Treatment (4 Weeks)||45
8829250|NCT01624974|9883751|FG000|NOT COMPLETED|Period III of Treatment (4 Weeks)||7
8829251|NCT01624974|9883752|FG001|NOT COMPLETED|Period III of Treatment (4 Weeks)||8
8829252|NCT01624974|9883751|FG000|STARTED|Period IV Washout (4 Weeks)||47
8829253|NCT01624974|9883752|FG001|STARTED|Period IV Washout (4 Weeks)||45
8829254|NCT01624974|9883751|FG000|COMPLETED|Period IV Washout (4 Weeks)||44
8829255|NCT01624974|9883752|FG001|COMPLETED|Period IV Washout (4 Weeks)||42
8829256|NCT01624974|9883751|FG000|NOT COMPLETED|Period IV Washout (4 Weeks)||3
8829257|NCT01624974|9883752|FG001|NOT COMPLETED|Period IV Washout (4 Weeks)||3
8829258|NCT01624974|9883751|FG000|STARTED|Period V of Treatment (4 Weeks)||44
8829259|NCT01624974|9883752|FG001|STARTED|Period V of Treatment (4 Weeks)||42
8829260|NCT01624974|9883751|FG000|COMPLETED|Period V of Treatment (4 Weeks)||39
8829261|NCT01624974|9883752|FG001|COMPLETED|Period V of Treatment (4 Weeks)||42
8829262|NCT01624974|9883751|FG000|NOT COMPLETED|Period V of Treatment (4 Weeks)||5
8829263|NCT01624974|9883752|FG001|NOT COMPLETED|Period V of Treatment (4 Weeks)||0
8829264|NCT01625000|9883764|FG000|STARTED|Overall Study||126
8829265|NCT01625000|9883765|FG001|STARTED|Overall Study||133
8829266|NCT01625000|9883766|FG002|STARTED|Overall Study||67
8829267|NCT01625000|9883767|FG003|STARTED|Overall Study||56
8829268|NCT01625000|9883768|FG004|STARTED|Overall Study||126
8829269|NCT01625000|9883764|FG000|COMPLETED|Overall Study||74
8829270|NCT01625000|9883765|FG001|COMPLETED|Overall Study||81
8829271|NCT01625000|9883766|FG002|COMPLETED|Overall Study||34
8829272|NCT01625000|9883767|FG003|COMPLETED|Overall Study||37
8829273|NCT01625000|9883768|FG004|COMPLETED|Overall Study||71
8829274|NCT01625000|9883764|FG000|NOT COMPLETED|Overall Study||52
8829275|NCT01625000|9883765|FG001|NOT COMPLETED|Overall Study||52
8829276|NCT01625000|9883766|FG002|NOT COMPLETED|Overall Study||33
8829277|NCT01625000|9883767|FG003|NOT COMPLETED|Overall Study||19
8829278|NCT01625000|9883768|FG004|NOT COMPLETED|Overall Study||55
8829279|NCT01625013|9883780|FG000|STARTED|Overall Study||51
8829280|NCT01625013|9883780|FG000|COMPLETED|Overall Study||48
8829281|NCT01625013|9883780|FG000|NOT COMPLETED|Overall Study||3
8829282|NCT01625091|9883787|FG000|STARTED|Intervention||96
8829283|NCT01625091|9883788|FG001|STARTED|Intervention||98
8829284|NCT01625091|9883787|FG000|2 Months|Intervention||90
8829285|NCT01625091|9883788|FG001|2 Months|Intervention||93
8829286|NCT01625091|9883787|FG000|4 Months|Intervention||85
8829287|NCT01625091|9883788|FG001|4 Months|Intervention||87
8829288|NCT01625091|9883787|FG000|COMPLETED|Intervention||85
8829289|NCT01625091|9883788|FG001|COMPLETED|Intervention||87
8829290|NCT01625091|9883787|FG000|NOT COMPLETED|Intervention||11
8829291|NCT01625091|9883788|FG001|NOT COMPLETED|Intervention||11
8829292|NCT01625091|9883787|FG000|STARTED|Post-intervention||85
8829293|NCT01625091|9883788|FG001|STARTED|Post-intervention||87
8829294|NCT01625091|9883787|FG000|7 Months|Post-intervention||81
8829295|NCT01625091|9883788|FG001|7 Months|Post-intervention||85
8829296|NCT01625091|9883787|FG000|COMPLETED|Post-intervention||81
8829297|NCT01625091|9883788|FG001|COMPLETED|Post-intervention||85
8829298|NCT01625091|9883787|FG000|NOT COMPLETED|Post-intervention||4
8829299|NCT01625091|9883788|FG001|NOT COMPLETED|Post-intervention||2
8829300|NCT01625104|9883796|FG000|STARTED|Overall Study||448
8829301|NCT01625104|9883797|FG001|STARTED|Overall Study||434
8829302|NCT01625104|9883796|FG000|COMPLETED|Overall Study||448
8829303|NCT01625104|9883797|FG001|COMPLETED|Overall Study||434
8829304|NCT01625104|9883796|FG000|NOT COMPLETED|Overall Study||0
8829305|NCT01625104|9883797|FG001|NOT COMPLETED|Overall Study||0
8829306|NCT01625169|9883803|FG000|STARTED|Overall Study||9
8829307|NCT01625169|9883803|FG000|COMPLETED|Overall Study||9
8829308|NCT01625169|9883803|FG000|NOT COMPLETED|Overall Study||0
8829309|NCT01625182|9883809|FG000|STARTED|Overall Study||54
8829310|NCT01625182|9883810|FG001|STARTED|Overall Study||52
8829311|NCT01625182|9883809|FG000|COMPLETED|Overall Study||34
8829312|NCT01625182|9883810|FG001|COMPLETED|Overall Study||41
8829313|NCT01625182|9883809|FG000|NOT COMPLETED|Overall Study||20
8829314|NCT01625182|9883810|FG001|NOT COMPLETED|Overall Study||11
8829315|NCT01625221|9883817|FG000|STARTED|Overall Study||35
8829316|NCT01625221|9883817|FG000|COMPLETED|Overall Study||28
8829317|NCT01625221|9883817|FG000|NOT COMPLETED|Overall Study||7
8829318|NCT01625338|9883824|FG000|STARTED|Overall Study||114
8829319|NCT01625338|9883825|FG001|STARTED|Overall Study||200
8829320|NCT01625338|9883826|FG002|STARTED|Overall Study||220
8829321|NCT01625338|9883824|FG000|COMPLETED|Overall Study||82
8829322|NCT01625338|9883825|FG001|COMPLETED|Overall Study||156
8829323|NCT01625338|9883826|FG002|COMPLETED|Overall Study||181
8829324|NCT01625338|9883824|FG000|NOT COMPLETED|Overall Study||32
8829325|NCT01625338|9883825|FG001|NOT COMPLETED|Overall Study||44
8829326|NCT01625338|9883826|FG002|NOT COMPLETED|Overall Study||39
8829327|NCT01625377|9883836|FG000|STARTED|Overall Study|"Started indicates randomized patients."|95
8829328|NCT01625377|9883837|FG001|STARTED|Overall Study||93
8829329|NCT01625377|9883836|FG000|Safety Set of Population|Overall Study||94
8829330|NCT01625377|9883837|FG001|Safety Set of Population|Overall Study||90
8829331|NCT01625377|9883836|FG000|Intent to Treat Population|Overall Study||93
8829332|NCT01625377|9883837|FG001|Intent to Treat Population|Overall Study||90
8829333|NCT01625377|9883836|FG000|COMPLETED|Overall Study||88
8829334|NCT01625377|9883837|FG001|COMPLETED|Overall Study||71
8829335|NCT01625377|9883836|FG000|NOT COMPLETED|Overall Study||7
8829336|NCT01625377|9883837|FG001|NOT COMPLETED|Overall Study||22
8829337|NCT01625416|9883845|FG000|STARTED|Overall Study||60
8829338|NCT01625416|9883846|FG001|STARTED|Overall Study||61
8829339|NCT01625416|9883845|FG000|COMPLETED|Overall Study||51
8829340|NCT01625416|9883846|FG001|COMPLETED|Overall Study||54
8829341|NCT01625416|9883845|FG000|NOT COMPLETED|Overall Study||9
8829342|NCT01625416|9883846|FG001|NOT COMPLETED|Overall Study||7
8829343|NCT01625455|9883855|FG000|STARTED|Overall Study||2
8829344|NCT01625455|9883856|FG001|STARTED|Overall Study||3
8829345|NCT01625455|9883855|FG000|COMPLETED|Overall Study||2
8829346|NCT01625455|9883856|FG001|COMPLETED|Overall Study||3
8829347|NCT01625455|9883855|FG000|NOT COMPLETED|Overall Study||0
8829348|NCT01625455|9883856|FG001|NOT COMPLETED|Overall Study||0
8829349|NCT01625507|9883862|FG000|STARTED|Overall Study||73
8829350|NCT01625507|9883862|FG000|COMPLETED|Overall Study||63
8829351|NCT01625507|9883862|FG000|NOT COMPLETED|Overall Study||10
8829352|NCT01625689|9883869|FG000|STARTED|Overall Study||150
8829353|NCT01625689|9883870|FG001|STARTED|Overall Study||150
8829354|NCT01625689|9883869|FG000|COMPLETED|Overall Study||148
8829355|NCT01625689|9883870|FG001|COMPLETED|Overall Study||149
8829356|NCT01625689|9883869|FG000|NOT COMPLETED|Overall Study||2
8829357|NCT01625689|9883870|FG001|NOT COMPLETED|Overall Study||1
8829358|NCT01625845|9883878|FG000|STARTED|Overall Study||10
8829359|NCT01625845|9883879|FG001|STARTED|Overall Study||6
8829360|NCT01625845|9883878|FG000|COMPLETED|Overall Study||5
8829361|NCT01625845|9883879|FG001|COMPLETED|Overall Study||3
8622505|NCT00488683|9661746|FG000|COMPLETED|Overall Study||96
8829362|NCT01625845|9883878|FG000|NOT COMPLETED|Overall Study||5
8829363|NCT01625845|9883879|FG001|NOT COMPLETED|Overall Study||3
8829364|NCT01625897|9883887|FG000|STARTED|Overall Study||83
8829365|NCT01625897|9883888|FG001|STARTED|Overall Study||42
8829366|NCT01625897|9883887|FG000|COMPLETED|Overall Study||31
8829367|NCT01625897|9883888|FG001|COMPLETED|Overall Study||28
8829368|NCT01625897|9883887|FG000|NOT COMPLETED|Overall Study||52
8829369|NCT01625897|9883888|FG001|NOT COMPLETED|Overall Study||14
8829370|NCT01625910|9883896|FG000|STARTED|Overall Study||35
8829371|NCT01625910|9883897|FG001|STARTED|Overall Study||37
8829372|NCT01625910|9883896|FG000|COMPLETED|Overall Study||32
8556546|NCT03860259|9588295|FG000|NOT COMPLETED|Overall Study||6
8556547|NCT03860259|9588296|FG001|NOT COMPLETED|Overall Study||5
8568706|NCT00092547|9600911|FG000|STARTED|Long-term Follow-up (Month 96 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|508
8568707|NCT00092547|9600912|FG001|STARTED|Long-term Follow-up (Month 96 Visit)||0
8568708|NCT00092547|9600913|FG002|STARTED|Long-term Follow-up (Month 96 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|267
8568709|NCT00092547|9600911|FG000|COMPLETED|Long-term Follow-up (Month 96 Visit)||508
8568710|NCT00092547|9600912|FG001|COMPLETED|Long-term Follow-up (Month 96 Visit)||0
8622506|NCT00488683|9661747|FG001|COMPLETED|Overall Study||48
8622507|NCT00488683|9661748|FG002|COMPLETED|Overall Study||52
8829373|NCT01625910|9883897|FG001|COMPLETED|Overall Study||33
8829374|NCT01625910|9883896|FG000|NOT COMPLETED|Overall Study||3
8829375|NCT01625910|9883897|FG001|NOT COMPLETED|Overall Study||4
8829376|NCT01625923|9883905|FG000|STARTED|Overall Study||3
8829377|NCT01625923|9883905|FG000|COMPLETED|Overall Study||3
8829378|NCT01625923|9883905|FG000|NOT COMPLETED|Overall Study||0
8829379|NCT01625988|9883912|FG000|STARTED|Overall Study|One participant was randomized inappropriately and was discontinued before start of study treatment.|108
8829380|NCT01625988|9883913|FG001|STARTED|Overall Study||110
8829381|NCT01625988|9883912|FG000|Received at Least One Dose of Study Drug|Overall Study||107
8829382|NCT01625988|9883913|FG001|Received at Least One Dose of Study Drug|Overall Study||110
8829383|NCT01625988|9883912|FG000|COMPLETED|Overall Study||94
8829384|NCT01625988|9883913|FG001|COMPLETED|Overall Study||97
8829385|NCT01625988|9883912|FG000|NOT COMPLETED|Overall Study||14
8829386|NCT01625988|9883913|FG001|NOT COMPLETED|Overall Study||13
8829387|NCT01626092|9883922|FG000|STARTED|Overall Study||3
8829388|NCT01626092|9883922|FG000|COMPLETED|Overall Study||3
8829389|NCT01626092|9883922|FG000|NOT COMPLETED|Overall Study||0
8829390|NCT01626118|9883930|FG000|STARTED|Overall Study||94
8829391|NCT01626118|9883931|FG001|STARTED|Overall Study||93
8829392|NCT01626118|9883932|FG002|STARTED|Overall Study||92
8829393|NCT01626118|9883933|FG003|STARTED|Overall Study||94
8829394|NCT01626118|9883930|FG000|COMPLETED|Overall Study||92
8829395|NCT01626118|9883931|FG001|COMPLETED|Overall Study||91
8829396|NCT01626118|9883932|FG002|COMPLETED|Overall Study||90
8829397|NCT01626118|9883933|FG003|COMPLETED|Overall Study||91
8829398|NCT01626118|9883930|FG000|NOT COMPLETED|Overall Study||2
8829399|NCT01626118|9883931|FG001|NOT COMPLETED|Overall Study||2
8829400|NCT01626118|9883932|FG002|NOT COMPLETED|Overall Study||2
8829401|NCT01626118|9883933|FG003|NOT COMPLETED|Overall Study||3
8829402|NCT01626352|9883943|FG000|STARTED|Overall Study||22
8829403|NCT01626352|9883943|FG000|COMPLETED|Overall Study||12
8829404|NCT01626352|9883943|FG000|NOT COMPLETED|Overall Study||10
8829405|NCT01626391|9883952|FG000|STARTED|Overall Study||5
8829406|NCT01626391|9883953|FG001|STARTED|Overall Study||4
8829407|NCT01626391|9883952|FG000|COMPLETED|Overall Study||3
8829408|NCT01626391|9883953|FG001|COMPLETED|Overall Study||4
8829409|NCT01626391|9883952|FG000|NOT COMPLETED|Overall Study||2
8829410|NCT01626391|9883953|FG001|NOT COMPLETED|Overall Study||0
8829411|NCT01626456|9883961|FG000|STARTED|Overall Study||110
8829412|NCT01626456|9883962|FG001|STARTED|Overall Study||368
8829413|NCT01626456|9883961|FG000|COMPLETED|Overall Study||75
8829414|NCT01626456|9883962|FG001|COMPLETED|Overall Study||251
8829415|NCT01626456|9883961|FG000|NOT COMPLETED|Overall Study||35
8829416|NCT01626456|9883962|FG001|NOT COMPLETED|Overall Study||117
8829417|NCT01626495|9883977|FG000|STARTED|Overall Study|Number of enrolled subjects|73
8829418|NCT01626495|9883977|FG000|Intervention|Overall Study||62
8829419|NCT01626495|9883977|FG000|COMPLETED|Overall Study|Follow up phase completed as per protocol|21
8829420|NCT01626495|9883977|FG000|NOT COMPLETED|Overall Study||52
8829421|NCT01626664|9883983|FG000|STARTED|Randomization Period||47
8829422|NCT01626664|9883984|FG001|STARTED|Randomization Period||24
8829423|NCT01626664|9883985|FG002|STARTED|Randomization Period||0
8829424|NCT01626664|9883983|FG000|COMPLETED|Randomization Period||47
8829425|NCT01626664|9883984|FG001|COMPLETED|Randomization Period||24
8829426|NCT01626664|9883985|FG002|COMPLETED|Randomization Period||0
8829427|NCT01626664|9883983|FG000|NOT COMPLETED|Randomization Period||0
8829428|NCT01626664|9883984|FG001|NOT COMPLETED|Randomization Period||0
8829429|NCT01626664|9883985|FG002|NOT COMPLETED|Randomization Period||0
8829430|NCT01626664|9883983|FG000|STARTED|Crossover Period||0
8829431|NCT01626664|9883984|FG001|STARTED|Crossover Period||0
8829432|NCT01626664|9883985|FG002|STARTED|Crossover Period||18
8622508|NCT00488683|9661746|FG000|NOT COMPLETED|Overall Study||12
8622509|NCT00488683|9661747|FG001|NOT COMPLETED|Overall Study||6
8622510|NCT00488683|9661748|FG002|NOT COMPLETED|Overall Study||2
8622511|NCT00488774|9661764|FG000|STARTED|Overall Study||77
8622512|NCT00488774|9661765|FG001|STARTED|Overall Study||62
8829433|NCT01626664|9883983|FG000|COMPLETED|Crossover Period||0
8829434|NCT01626664|9883984|FG001|COMPLETED|Crossover Period||0
8829435|NCT01626664|9883985|FG002|COMPLETED|Crossover Period||18
8829436|NCT01626664|9883983|FG000|NOT COMPLETED|Crossover Period||0
8829437|NCT01626664|9883984|FG001|NOT COMPLETED|Crossover Period||0
8829438|NCT01626664|9883985|FG002|NOT COMPLETED|Crossover Period||0
8829439|NCT01626690|9883994|FG000|STARTED|Overall Study||49
8829440|NCT01626690|9883995|FG001|STARTED|Overall Study||51
8829441|NCT01626690|9883994|FG000|COMPLETED|Overall Study||47
8829442|NCT01626690|9883995|FG001|COMPLETED|Overall Study||51
8829443|NCT01626690|9883994|FG000|NOT COMPLETED|Overall Study||2
8829444|NCT01626690|9883995|FG001|NOT COMPLETED|Overall Study||0
8829445|NCT01626820|9884005|FG000|STARTED|Overall Study||56
8829446|NCT01626820|9884006|FG001|STARTED|Overall Study||57
8829447|NCT01626820|9884005|FG000|COMPLETED|Overall Study||56
8829448|NCT01626820|9884006|FG001|COMPLETED|Overall Study||57
8622513|NCT00488774|9661766|FG002|STARTED|Overall Study||75
8622514|NCT00488774|9661767|FG003|STARTED|Overall Study||77
8622515|NCT00488774|9661764|FG000|COMPLETED|Overall Study||69
8829449|NCT01626820|9884005|FG000|NOT COMPLETED|Overall Study||0
8829450|NCT01626820|9884006|FG001|NOT COMPLETED|Overall Study||0
8829451|NCT01626859|9884016|FG000|STARTED|Overall Study||11
8829452|NCT01626859|9884017|FG001|STARTED|Overall Study||16
8829453|NCT01626859|9884018|FG002|STARTED|Overall Study||11
8829454|NCT01626859|9884016|FG000|COMPLETED|Overall Study||9
8829455|NCT01626859|9884017|FG001|COMPLETED|Overall Study||8
8829456|NCT01626859|9884018|FG002|COMPLETED|Overall Study||7
8829457|NCT01626859|9884016|FG000|NOT COMPLETED|Overall Study||2
8829458|NCT01626859|9884017|FG001|NOT COMPLETED|Overall Study||8
8829459|NCT01626859|9884018|FG002|NOT COMPLETED|Overall Study||4
8829460|NCT01626872|9884029|FG000|STARTED|Overall Study||81
8829461|NCT01626872|9884030|FG001|STARTED|Overall Study||109
8829462|NCT01626872|9884031|FG002|STARTED|Overall Study||58
8829463|NCT01626872|9884029|FG000|COMPLETED|Overall Study||29
8829464|NCT01626872|9884030|FG001|COMPLETED|Overall Study||43
8829465|NCT01626872|9884031|FG002|COMPLETED|Overall Study||34
8829466|NCT01626872|9884029|FG000|NOT COMPLETED|Overall Study||52
8829467|NCT01626872|9884030|FG001|NOT COMPLETED|Overall Study||66
8829468|NCT01626872|9884031|FG002|NOT COMPLETED|Overall Study||24
8829469|NCT01626885|9884039|FG000|STARTED|Overall Study||42
8829470|NCT01626885|9884039|FG000|COMPLETED|Overall Study||30
8829471|NCT01626885|9884039|FG000|NOT COMPLETED|Overall Study||12
8829472|NCT01626989|9884043|FG000|STARTED|Screening Period||44
8829473|NCT01626989|9884044|FG001|STARTED|Screening Period||0
8944098|NCT02394275|10005953|FG000|STARTED|Overall Study||140
8944099|NCT02394275|10005953|FG000|Safety Population|Overall Study||133
8944100|NCT02394275|10005953|FG000|Evaluable at 13 Weeks|Overall Study||133
8944101|NCT02394275|10005953|FG000|COMPLETED|Overall Study||111
8944102|NCT02394275|10005953|FG000|NOT COMPLETED|Overall Study||29
8944103|NCT02394340|10005958|FG000|STARTED|Overall Study||20
8944104|NCT02394340|10005958|FG000|Received at Least 1 Dose of Study Drug|Overall Study||20
8944105|NCT02394340|10005958|FG000|COMPLETED|Overall Study||18
8944106|NCT02394340|10005958|FG000|NOT COMPLETED|Overall Study||2
8944107|NCT02394457|10005964|FG000|STARTED|Overall Study||15
8944108|NCT02394457|10005965|FG001|STARTED|Overall Study||13
8944109|NCT02394457|10005964|FG000|COMPLETED|Overall Study||15
8944110|NCT02394457|10005965|FG001|COMPLETED|Overall Study||13
8944111|NCT02394457|10005964|FG000|NOT COMPLETED|Overall Study||0
8944112|NCT02394457|10005965|FG001|NOT COMPLETED|Overall Study||0
8944113|NCT02394561|10005973|FG000|STARTED|CORE Phase||185
8944114|NCT02394561|10005974|FG001|STARTED|CORE Phase||246
8944115|NCT02394561|10005973|FG000|Full Analysis Set|CORE Phase||185
8944116|NCT02394561|10005974|FG001|Full Analysis Set|CORE Phase||246
8944117|NCT02394561|10005973|FG000|Safety Set|CORE Phase||185
8944118|NCT02394561|10005974|FG001|Safety Set|CORE Phase||246
8944119|NCT02394561|10005973|FG000|ITT Set|CORE Phase||184
8944120|NCT02394561|10005974|FG001|ITT Set|CORE Phase||246
8944121|NCT02394561|10005973|FG000|COMPLETED|CORE Phase||172
8944122|NCT02394561|10005974|FG001|COMPLETED|CORE Phase||227
8944123|NCT02394561|10005973|FG000|NOT COMPLETED|CORE Phase||13
8944124|NCT02394561|10005974|FG001|NOT COMPLETED|CORE Phase||19
8944125|NCT02394561|10005973|FG000|STARTED|Extension Phase||162
8944126|NCT02394561|10005974|FG001|STARTED|Extension Phase||219
8944127|NCT02394561|10005973|FG000|COMPLETED|Extension Phase||151
8944128|NCT02394561|10005974|FG001|COMPLETED|Extension Phase||207
8944129|NCT02394561|10005973|FG000|NOT COMPLETED|Extension Phase||11
8944130|NCT02394561|10005974|FG001|NOT COMPLETED|Extension Phase||12
8944131|NCT02394600|10005985|FG000|STARTED|Overall Study||47
8944132|NCT02394600|10005986|FG001|STARTED|Overall Study||46
8944133|NCT02394600|10005985|FG000|COMPLETED|Overall Study||43
8944134|NCT02394600|10005986|FG001|COMPLETED|Overall Study||44
8944135|NCT02394600|10005985|FG000|NOT COMPLETED|Overall Study||4
8944136|NCT02394600|10005986|FG001|NOT COMPLETED|Overall Study||2
8944137|NCT02394730|10005994|FG000|STARTED|Overall Study||34
8944138|NCT02394730|10005995|FG001|STARTED|Overall Study||31
8944139|NCT02394730|10005994|FG000|COMPLETED|Overall Study||33
8944140|NCT02394730|10005995|FG001|COMPLETED|Overall Study||30
8944141|NCT02394730|10005994|FG000|NOT COMPLETED|Overall Study||1
8944142|NCT02394730|10005995|FG001|NOT COMPLETED|Overall Study||1
8944143|NCT02394756|10006001|FG000|STARTED|Period 1||7
8944144|NCT02394756|10006002|FG001|STARTED|Period 1||7
8944145|NCT02394756|10006003|FG002|STARTED|Period 1||7
8944146|NCT02394756|10006004|FG003|STARTED|Period 1||7
8944147|NCT02394756|10006005|FG004|STARTED|Period 1||7
8944148|NCT02394756|10006006|FG005|STARTED|Period 1||7
8944149|NCT02394756|10006001|FG000|COMPLETED|Period 1||7
8944150|NCT02394756|10006002|FG001|COMPLETED|Period 1||6
8944151|NCT02394756|10006003|FG002|COMPLETED|Period 1||6
8944152|NCT02394756|10006004|FG003|COMPLETED|Period 1||6
8944153|NCT02394756|10006005|FG004|COMPLETED|Period 1||7
8944154|NCT02394756|10006006|FG005|COMPLETED|Period 1||6
8944155|NCT02394756|10006001|FG000|NOT COMPLETED|Period 1||0
8723356|NCT01022502|9770815|FG000|COMPLETED|Overall Study|3 participants withdrew at week 4,5,6,respectively.|35
8723357|NCT01022502|9770815|FG000|NOT COMPLETED|Overall Study||3
8723358|NCT01022567|9770823|FG000|STARTED|Overall Study||273
8723359|NCT01022567|9770824|FG001|STARTED|Overall Study||257
8723360|NCT01022567|9770823|FG000|COMPLETED|Overall Study||272
8723361|NCT01022567|9770824|FG001|COMPLETED|Overall Study||242
8723362|NCT01022567|9770823|FG000|NOT COMPLETED|Overall Study||1
8723363|NCT01022567|9770824|FG001|NOT COMPLETED|Overall Study||15
8723364|NCT01022580|9770832|FG000|STARTED|Overall Study||252
8723365|NCT01022580|9770833|FG001|STARTED|Overall Study||259
8723366|NCT01022580|9770832|FG000|COMPLETED|Overall Study|Survived to discharge|234
8723367|NCT01022580|9770833|FG001|COMPLETED|Overall Study|Survived to discharge.|237
8723368|NCT01022580|9770832|FG000|NOT COMPLETED|Overall Study||18
8723369|NCT01022580|9770833|FG001|NOT COMPLETED|Overall Study||22
8723370|NCT01022762|9770847|FG000|STARTED|Overall Study||218
8723371|NCT01022762|9770848|FG001|STARTED|Overall Study||222
8944156|NCT02394756|10006002|FG001|NOT COMPLETED|Period 1||1
8944157|NCT02394756|10006003|FG002|NOT COMPLETED|Period 1||1
8944158|NCT02394756|10006004|FG003|NOT COMPLETED|Period 1||1
8944159|NCT02394756|10006005|FG004|NOT COMPLETED|Period 1||0
8944160|NCT02394756|10006006|FG005|NOT COMPLETED|Period 1||1
8944161|NCT02394756|10006001|FG000|STARTED|Period 2||7
8944162|NCT02394756|10006002|FG001|STARTED|Period 2||6
8944163|NCT02394756|10006003|FG002|STARTED|Period 2||6
8944164|NCT02394756|10006004|FG003|STARTED|Period 2||6
8944165|NCT02394756|10006005|FG004|STARTED|Period 2||7
8944166|NCT02394756|10006006|FG005|STARTED|Period 2||6
8944167|NCT02394756|10006001|FG000|COMPLETED|Period 2||7
8944168|NCT02394756|10006002|FG001|COMPLETED|Period 2||6
8944169|NCT02394756|10006003|FG002|COMPLETED|Period 2||6
8944170|NCT02394756|10006004|FG003|COMPLETED|Period 2||6
8944171|NCT02394756|10006005|FG004|COMPLETED|Period 2||6
8944172|NCT02394756|10006006|FG005|COMPLETED|Period 2||6
8829474|NCT01626989|9884045|FG002|STARTED|Screening Period||0
8829475|NCT01626989|9884043|FG000|COMPLETED|Screening Period||27
8829476|NCT01626989|9884044|FG001|COMPLETED|Screening Period||0
8829477|NCT01626989|9884045|FG002|COMPLETED|Screening Period||0
8829478|NCT01626989|9884043|FG000|NOT COMPLETED|Screening Period||17
8829479|NCT01626989|9884044|FG001|NOT COMPLETED|Screening Period||0
8829480|NCT01626989|9884045|FG002|NOT COMPLETED|Screening Period||0
8829481|NCT01626989|9884043|FG000|STARTED|Fist Intervention (Night 1)||0
8829482|NCT01626989|9884044|FG001|STARTED|Fist Intervention (Night 1)||15
8829483|NCT01626989|9884045|FG002|STARTED|Fist Intervention (Night 1)||12
8829484|NCT01626989|9884043|FG000|COMPLETED|Fist Intervention (Night 1)||0
8829485|NCT01626989|9884044|FG001|COMPLETED|Fist Intervention (Night 1)||15
8829486|NCT01626989|9884045|FG002|COMPLETED|Fist Intervention (Night 1)||12
8829487|NCT01626989|9884043|FG000|NOT COMPLETED|Fist Intervention (Night 1)||0
8829488|NCT01626989|9884044|FG001|NOT COMPLETED|Fist Intervention (Night 1)||0
8829489|NCT01626989|9884045|FG002|NOT COMPLETED|Fist Intervention (Night 1)||0
8829490|NCT01626989|9884043|FG000|STARTED|Second Intervention (Night 2)||0
8829491|NCT01626989|9884044|FG001|STARTED|Second Intervention (Night 2)||15
8829492|NCT01626989|9884045|FG002|STARTED|Second Intervention (Night 2)||12
8829493|NCT01626989|9884043|FG000|COMPLETED|Second Intervention (Night 2)||0
8829494|NCT01626989|9884044|FG001|COMPLETED|Second Intervention (Night 2)||15
8829495|NCT01626989|9884045|FG002|COMPLETED|Second Intervention (Night 2)||12
8829496|NCT01626989|9884043|FG000|NOT COMPLETED|Second Intervention (Night 2)||0
8829497|NCT01626989|9884044|FG001|NOT COMPLETED|Second Intervention (Night 2)||0
8829498|NCT01626989|9884045|FG002|NOT COMPLETED|Second Intervention (Night 2)||0
8829499|NCT01627002|9884056|FG000|STARTED|Overall Study||4
8829500|NCT01627002|9884057|FG001|STARTED|Overall Study||4
8829501|NCT01627002|9884058|FG002|STARTED|Overall Study||4
8829502|NCT01627002|9884059|FG003|STARTED|Overall Study||4
8829503|NCT01627002|9884060|FG004|STARTED|Overall Study||2
8829504|NCT01627002|9884061|FG005|STARTED|Overall Study||9
8829505|NCT01627002|9884062|FG006|STARTED|Overall Study||10
8829506|NCT01627002|9884063|FG007|STARTED|Overall Study||5
8829507|NCT01627002|9884064|FG008|STARTED|Overall Study||7
8829508|NCT01627002|9884056|FG000|COMPLETED|Overall Study||4
8829509|NCT01627002|9884057|FG001|COMPLETED|Overall Study||4
8829510|NCT01627002|9884058|FG002|COMPLETED|Overall Study||4
8829511|NCT01627002|9884059|FG003|COMPLETED|Overall Study||4
8829512|NCT01627002|9884060|FG004|COMPLETED|Overall Study||2
8829513|NCT01627002|9884061|FG005|COMPLETED|Overall Study||9
8829514|NCT01627002|9884062|FG006|COMPLETED|Overall Study||10
8829515|NCT01627002|9884063|FG007|COMPLETED|Overall Study||5
8829516|NCT01627002|9884064|FG008|COMPLETED|Overall Study||7
8829517|NCT01627002|9884056|FG000|NOT COMPLETED|Overall Study||0
8829518|NCT01627002|9884057|FG001|NOT COMPLETED|Overall Study||0
8829519|NCT01627002|9884058|FG002|NOT COMPLETED|Overall Study||0
8829520|NCT01627002|9884059|FG003|NOT COMPLETED|Overall Study||0
8829521|NCT01627002|9884060|FG004|NOT COMPLETED|Overall Study||0
8829522|NCT01627002|9884061|FG005|NOT COMPLETED|Overall Study||0
8829523|NCT01627002|9884062|FG006|NOT COMPLETED|Overall Study||0
8829524|NCT01627002|9884063|FG007|NOT COMPLETED|Overall Study||0
8829525|NCT01627002|9884064|FG008|NOT COMPLETED|Overall Study||0
8829526|NCT01627067|9884091|FG000|STARTED|Overall Study||23
8829527|NCT01627067|9884091|FG000|COMPLETED|Overall Study||22
8829528|NCT01627067|9884091|FG000|NOT COMPLETED|Overall Study||1
8829529|NCT01627249|9884100|FG000|STARTED|Overall Study||224
8829530|NCT01627249|9884101|FG001|STARTED|Overall Study||218
8829531|NCT01627249|9884102|FG002|STARTED|Overall Study||218
8829532|NCT01627249|9884100|FG000|COMPLETED|Overall Study||208
8829533|NCT01627249|9884101|FG001|COMPLETED|Overall Study||206
8829534|NCT01627249|9884102|FG002|COMPLETED|Overall Study||206
8829535|NCT01627249|9884100|FG000|NOT COMPLETED|Overall Study||16
8829536|NCT01627249|9884101|FG001|NOT COMPLETED|Overall Study||12
8829537|NCT01627249|9884102|FG002|NOT COMPLETED|Overall Study||12
8829538|NCT01627288|9884114|FG000|STARTED|Overall Study||3
8829539|NCT01627288|9884115|FG001|STARTED|Overall Study||3
8829540|NCT01627288|9884116|FG002|STARTED|Overall Study||6
8829541|NCT01627288|9884117|FG003|STARTED|Overall Study||0
8829542|NCT01627288|9884114|FG000|COMPLETED|Overall Study||3
8829543|NCT01627288|9884115|FG001|COMPLETED|Overall Study||3
8829544|NCT01627288|9884116|FG002|COMPLETED|Overall Study||6
8829545|NCT01627288|9884117|FG003|COMPLETED|Overall Study||0
8829546|NCT01627288|9884114|FG000|NOT COMPLETED|Overall Study||0
8829547|NCT01627288|9884115|FG001|NOT COMPLETED|Overall Study||0
8829548|NCT01627288|9884116|FG002|NOT COMPLETED|Overall Study||0
8829549|NCT01627288|9884117|FG003|NOT COMPLETED|Overall Study||0
8829550|NCT01627327|9884131|FG000|STARTED|Overall Study||310
8829551|NCT01627327|9884132|FG001|STARTED|Overall Study||313
8829552|NCT01627327|9884131|FG000|COMPLETED|Overall Study||291
8829553|NCT01627327|9884132|FG001|COMPLETED|Overall Study||274
8829554|NCT01627327|9884131|FG000|NOT COMPLETED|Overall Study||19
8829555|NCT01627327|9884132|FG001|NOT COMPLETED|Overall Study||39
8829556|NCT01627340|9884140|FG000|STARTED|Overall Study||416
8829557|NCT01627340|9884141|FG001|STARTED|Overall Study||258
8829558|NCT01627340|9884140|FG000|COMPLETED|Overall Study||404
8829559|NCT01627340|9884141|FG001|COMPLETED|Overall Study||254
8829560|NCT01627340|9884140|FG000|NOT COMPLETED|Overall Study||12
8829561|NCT01627340|9884141|FG001|NOT COMPLETED|Overall Study||4
8829562|NCT01627574|9884151|FG000|STARTED|Overall Study||142
8829563|NCT01627574|9884152|FG001|STARTED|Overall Study||130
8829564|NCT01627574|9884151|FG000|COMPLETED|Overall Study||121
8829565|NCT01627574|9884152|FG001|COMPLETED|Overall Study||112
8829566|NCT01627574|9884151|FG000|NOT COMPLETED|Overall Study||21
8829567|NCT01627574|9884152|FG001|NOT COMPLETED|Overall Study||18
8829568|NCT01627691|9884158|FG000|STARTED|Overall Study||250
8829569|NCT01627691|9884158|FG000|Primary Endpoint (30days)|Overall Study||239
8829570|NCT01627691|9884158|FG000|COMPLETED|Overall Study||232
8829571|NCT01627691|9884158|FG000|NOT COMPLETED|Overall Study||18
8829572|NCT01627782|9884166|FG000|STARTED|Overall Study||17
8829573|NCT01627782|9884167|FG001|STARTED|Overall Study||18
8829574|NCT01627782|9884168|FG002|STARTED|Overall Study||16
8829575|NCT01627782|9884169|FG003|STARTED|Overall Study||17
8829576|NCT01627782|9884166|FG000|Treated|Overall Study||16
8829577|NCT01627782|9884167|FG001|Treated|Overall Study||18
8829578|NCT01627782|9884168|FG002|Treated|Overall Study||16
8829579|NCT01627782|9884169|FG003|Treated|Overall Study||17
8829580|NCT01627782|9884166|FG000|COMPLETED|Overall Study||1
8829581|NCT01627782|9884167|FG001|COMPLETED|Overall Study||12
8829582|NCT01627782|9884168|FG002|COMPLETED|Overall Study||1
8829583|NCT01627782|9884169|FG003|COMPLETED|Overall Study||11
8829584|NCT01627782|9884166|FG000|NOT COMPLETED|Overall Study||16
8829585|NCT01627782|9884167|FG001|NOT COMPLETED|Overall Study||6
8829586|NCT01627782|9884168|FG002|NOT COMPLETED|Overall Study||15
8829587|NCT01627782|9884169|FG003|NOT COMPLETED|Overall Study||6
8829588|NCT01627860|9884183|FG000|STARTED|Overall Study||35
8829589|NCT01627860|9884184|FG001|STARTED|Overall Study||20
8829590|NCT01627860|9884183|FG000|COMPLETED|Overall Study||23
8829591|NCT01627860|9884184|FG001|COMPLETED|Overall Study||14
8829592|NCT01627860|9884183|FG000|NOT COMPLETED|Overall Study||12
8829593|NCT01627860|9884184|FG001|NOT COMPLETED|Overall Study||6
8829594|NCT01628016|9884193|FG000|STARTED|Pretraining to Posttraining||27
8829595|NCT01628016|9884194|FG001|STARTED|Pretraining to Posttraining||27
8829596|NCT01628016|9884195|FG002|STARTED|Pretraining to Posttraining||23
8829597|NCT01628016|9884193|FG000|COMPLETED|Pretraining to Posttraining||27
8829598|NCT01628016|9884194|FG001|COMPLETED|Pretraining to Posttraining||27
8829599|NCT01628016|9884195|FG002|COMPLETED|Pretraining to Posttraining||23
8829600|NCT01628016|9884193|FG000|NOT COMPLETED|Pretraining to Posttraining||0
8829601|NCT01628016|9884194|FG001|NOT COMPLETED|Pretraining to Posttraining||0
8829602|NCT01628016|9884195|FG002|NOT COMPLETED|Pretraining to Posttraining||0
8829603|NCT01628016|9884193|FG000|STARTED|Posttraining to 5 Follow-ups||27
8829604|NCT01628016|9884194|FG001|STARTED|Posttraining to 5 Follow-ups||27
8829605|NCT01628016|9884195|FG002|STARTED|Posttraining to 5 Follow-ups||23
8829606|NCT01628016|9884193|FG000|COMPLETED|Posttraining to 5 Follow-ups||23
8829607|NCT01628016|9884194|FG001|COMPLETED|Posttraining to 5 Follow-ups||20
8829608|NCT01628016|9884195|FG002|COMPLETED|Posttraining to 5 Follow-ups||18
8829609|NCT01628016|9884193|FG000|NOT COMPLETED|Posttraining to 5 Follow-ups||4
8829610|NCT01628016|9884194|FG001|NOT COMPLETED|Posttraining to 5 Follow-ups||7
8829611|NCT01628016|9884195|FG002|NOT COMPLETED|Posttraining to 5 Follow-ups||5
8829612|NCT01628042|9884209|FG000|STARTED|Overall Study||8
8829613|NCT01628042|9884210|FG001|STARTED|Overall Study||8
8829614|NCT01628042|9884211|FG002|STARTED|Overall Study||8
8829615|NCT01628042|9884212|FG003|STARTED|Overall Study||8
8829616|NCT01628042|9884209|FG000|COMPLETED|Overall Study||8
8829617|NCT01628042|9884210|FG001|COMPLETED|Overall Study||8
8829618|NCT01628042|9884211|FG002|COMPLETED|Overall Study||8
8829619|NCT01628042|9884212|FG003|COMPLETED|Overall Study||8
8829620|NCT01628042|9884209|FG000|NOT COMPLETED|Overall Study||0
8829621|NCT01628042|9884210|FG001|NOT COMPLETED|Overall Study||0
8829622|NCT01628042|9884211|FG002|NOT COMPLETED|Overall Study||0
8829623|NCT01628042|9884212|FG003|NOT COMPLETED|Overall Study||0
8829624|NCT01628107|9884222|FG000|STARTED|Overall Study||414
8829625|NCT01628107|9884222|FG000|Treated|Overall Study||406
8829626|NCT01628107|9884222|FG000|COMPLETED|Overall Study||295
8829627|NCT01628107|9884222|FG000|NOT COMPLETED|Overall Study||119
8829628|NCT01628120|9884226|FG000|STARTED|Overall Study||173
8829629|NCT01628120|9884226|FG000|Treated|Overall Study||170
8829630|NCT01628120|9884226|FG000|COMPLETED|Overall Study||129
8829631|NCT01628120|9884226|FG000|NOT COMPLETED|Overall Study||44
8829632|NCT01628159|9884230|FG000|STARTED|Overall Study||657
8829633|NCT01628159|9884230|FG000|COMPLETED|Overall Study||493
8829634|NCT01628159|9884230|FG000|NOT COMPLETED|Overall Study||164
8829635|NCT01628198|9884234|FG000|STARTED|Overall Study||38
8829636|NCT01628198|9884234|FG000|COMPLETED|Overall Study||20
8829637|NCT01628198|9884234|FG000|NOT COMPLETED|Overall Study||18
8829638|NCT01628250|9884240|FG000|STARTED|Overall Study||49
8829639|NCT01628250|9884241|FG001|STARTED|Overall Study||50
8829640|NCT01628250|9884240|FG000|COMPLETED|Overall Study||49
8829641|NCT01628250|9884241|FG001|COMPLETED|Overall Study||50
8829642|NCT01628250|9884240|FG000|NOT COMPLETED|Overall Study||0
8829643|NCT01628250|9884241|FG001|NOT COMPLETED|Overall Study||0
8849748|NCT01743001|9904999|FG000|NOT COMPLETED|Overall Study||3
8849749|NCT01743001|9905000|FG001|NOT COMPLETED|Overall Study||0
8849750|NCT01743027|9905010|FG000|STARTED|Overall Study||98
8849751|NCT01743027|9905011|FG001|STARTED|Overall Study||99
8849752|NCT01743027|9905012|FG002|STARTED|Overall Study||99
8849753|NCT01743027|9905013|FG003|STARTED|Overall Study||49
8849754|NCT01743027|9905010|FG000|COMPLETED|Overall Study||93
8849755|NCT01743027|9905011|FG001|COMPLETED|Overall Study||94
8849756|NCT01743027|9905012|FG002|COMPLETED|Overall Study||90
8849757|NCT01743027|9905013|FG003|COMPLETED|Overall Study||48
8829644|NCT01628367|9884249|FG000|STARTED|Overall Study||16
8829645|NCT01628367|9884250|FG001|STARTED|Overall Study||16
8829646|NCT01628367|9884249|FG000|COMPLETED|Overall Study||15
8829647|NCT01628367|9884250|FG001|COMPLETED|Overall Study||16
8829648|NCT01628367|9884249|FG000|NOT COMPLETED|Overall Study||1
8829649|NCT01628367|9884250|FG001|NOT COMPLETED|Overall Study||0
8829650|NCT01628393|9884259|FG000|STARTED|Placebo-controlled Treatment Period||88
8829651|NCT01628393|9884260|FG001|STARTED|Placebo-controlled Treatment Period||87
8829652|NCT01628393|9884261|FG002|STARTED|Placebo-controlled Treatment Period||83
8829653|NCT01628393|9884262|FG003|STARTED|Placebo-controlled Treatment Period||0
8829654|NCT01628393|9884263|FG004|STARTED|Placebo-controlled Treatment Period||0
8829655|NCT01628393|9884259|FG000|COMPLETED|Placebo-controlled Treatment Period||85
8829656|NCT01628393|9884260|FG001|COMPLETED|Placebo-controlled Treatment Period||85
8829657|NCT01628393|9884261|FG002|COMPLETED|Placebo-controlled Treatment Period||82
8829658|NCT01628393|9884262|FG003|COMPLETED|Placebo-controlled Treatment Period||0
8829659|NCT01628393|9884263|FG004|COMPLETED|Placebo-controlled Treatment Period||0
8829660|NCT01628393|9884259|FG000|NOT COMPLETED|Placebo-controlled Treatment Period||3
8829661|NCT01628393|9884260|FG001|NOT COMPLETED|Placebo-controlled Treatment Period||2
8829662|NCT01628393|9884261|FG002|NOT COMPLETED|Placebo-controlled Treatment Period||1
8829663|NCT01628393|9884262|FG003|NOT COMPLETED|Placebo-controlled Treatment Period||0
8829664|NCT01628393|9884263|FG004|NOT COMPLETED|Placebo-controlled Treatment Period||0
8829665|NCT01628393|9884259|FG000|STARTED|Blinded Active Extension Period||0
8829666|NCT01628393|9884260|FG001|STARTED|Blinded Active Extension Period||85
8829667|NCT01628393|9884261|FG002|STARTED|Blinded Active Extension Period||81
8829668|NCT01628393|9884262|FG003|STARTED|Blinded Active Extension Period||41
8829669|NCT01628393|9884263|FG004|STARTED|Blinded Active Extension Period||42
8829670|NCT01628393|9884259|FG000|COMPLETED|Blinded Active Extension Period||0
8829671|NCT01628393|9884260|FG001|COMPLETED|Blinded Active Extension Period||75
8829672|NCT01628393|9884261|FG002|COMPLETED|Blinded Active Extension Period||75
8829673|NCT01628393|9884262|FG003|COMPLETED|Blinded Active Extension Period||37
8829674|NCT01628393|9884263|FG004|COMPLETED|Blinded Active Extension Period||36
8829675|NCT01628393|9884259|FG000|NOT COMPLETED|Blinded Active Extension Period||0
8829676|NCT01628393|9884260|FG001|NOT COMPLETED|Blinded Active Extension Period||10
8829677|NCT01628393|9884261|FG002|NOT COMPLETED|Blinded Active Extension Period||6
8829678|NCT01628393|9884262|FG003|NOT COMPLETED|Blinded Active Extension Period||4
8829679|NCT01628393|9884263|FG004|NOT COMPLETED|Blinded Active Extension Period||6
8829680|NCT01628510|9884279|FG000|STARTED|Overall Study||51
8829681|NCT01628510|9884280|FG001|STARTED|Overall Study||49
8829682|NCT01628510|9884279|FG000|COMPLETED|Overall Study||48
8829683|NCT01628510|9884280|FG001|COMPLETED|Overall Study||44
8829684|NCT01628510|9884279|FG000|NOT COMPLETED|Overall Study||3
8829685|NCT01628510|9884280|FG001|NOT COMPLETED|Overall Study||5
8829686|NCT01628523|9884288|FG000|STARTED|Overall Study||219
8829687|NCT01628523|9884288|FG000|COMPLETED|Overall Study||219
8829688|NCT01628523|9884288|FG000|NOT COMPLETED|Overall Study||0
8829689|NCT01628549|9884297|FG000|STARTED|Overall Study||73
8829690|NCT01628549|9884298|FG001|STARTED|Overall Study||76
8829691|NCT01628549|9884299|FG002|STARTED|Overall Study||70
8829692|NCT01628549|9884300|FG003|STARTED|Overall Study||66
8829693|NCT01628549|9884297|FG000|COMPLETED|Overall Study||64
8829694|NCT01628549|9884298|FG001|COMPLETED|Overall Study||64
8829695|NCT01628549|9884299|FG002|COMPLETED|Overall Study||60
8829696|NCT01628549|9884300|FG003|COMPLETED|Overall Study||57
8829697|NCT01628549|9884297|FG000|NOT COMPLETED|Overall Study||9
8829698|NCT01628549|9884298|FG001|NOT COMPLETED|Overall Study||12
8829699|NCT01628549|9884299|FG002|NOT COMPLETED|Overall Study||10
8829700|NCT01628549|9884300|FG003|NOT COMPLETED|Overall Study||9
8829701|NCT01628588|9884310|FG000|STARTED|Overall Study||854
8829702|NCT01628588|9884310|FG000|COMPLETED|Overall Study||838
8829703|NCT01628588|9884310|FG000|NOT COMPLETED|Overall Study||16
8829704|NCT01628601|9884314|FG000|STARTED|Overall Study||392
8829705|NCT01628601|9884314|FG000|COMPLETED|Overall Study||351
8829706|NCT01628601|9884314|FG000|NOT COMPLETED|Overall Study||41
8829707|NCT01628614|9884318|FG000|STARTED|Overall Study||4812
8829708|NCT01628614|9884318|FG000|COMPLETED|Overall Study||3037
8829709|NCT01628614|9884318|FG000|NOT COMPLETED|Overall Study||1775
8829710|NCT01628692|9884328|FG000|STARTED|Overall Study||53
8829711|NCT01628692|9884329|FG001|STARTED|Overall Study||23
8829712|NCT01628692|9884330|FG002|STARTED|Overall Study||51
8829713|NCT01628692|9884331|FG003|STARTED|Overall Study||20
8829714|NCT01628692|9884332|FG004|STARTED|Overall Study||12
8829715|NCT01628692|9884333|FG005|STARTED|Overall Study||9
8829716|NCT01628692|9884328|FG000|COMPLETED|Overall Study||46
8829717|NCT01628692|9884329|FG001|COMPLETED|Overall Study||17
8829718|NCT01628692|9884330|FG002|COMPLETED|Overall Study||43
8829719|NCT01628692|9884331|FG003|COMPLETED|Overall Study||19
8829720|NCT01628692|9884332|FG004|COMPLETED|Overall Study||8
8829721|NCT01628692|9884333|FG005|COMPLETED|Overall Study||0
8829722|NCT01628692|9884328|FG000|NOT COMPLETED|Overall Study||7
8829723|NCT01628692|9884329|FG001|NOT COMPLETED|Overall Study||6
8829724|NCT01628692|9884330|FG002|NOT COMPLETED|Overall Study||8
8829725|NCT01628692|9884331|FG003|NOT COMPLETED|Overall Study||1
8829726|NCT01628692|9884332|FG004|NOT COMPLETED|Overall Study||4
8829727|NCT01628692|9884333|FG005|NOT COMPLETED|Overall Study||9
8829728|NCT01628718|9884352|FG000|STARTED|Overall Study||60
8829729|NCT01628718|9884353|FG001|STARTED|Overall Study||62
8829730|NCT01628718|9884352|FG000|COMPLETED|Overall Study||33
8829731|NCT01628718|9884353|FG001|COMPLETED|Overall Study||37
8829732|NCT01628718|9884352|FG000|NOT COMPLETED|Overall Study||27
8829733|NCT01628718|9884353|FG001|NOT COMPLETED|Overall Study||25
8829734|NCT01628848|9884361|FG000|STARTED|Overall Study||87
8829735|NCT01628848|9884362|FG001|STARTED|Overall Study||87
8829736|NCT01628848|9884361|FG000|COMPLETED|Overall Study||75
8829737|NCT01628848|9884362|FG001|COMPLETED|Overall Study||73
8829738|NCT01628848|9884361|FG000|NOT COMPLETED|Overall Study||12
8829739|NCT01628848|9884362|FG001|NOT COMPLETED|Overall Study||14
8829740|NCT01628874|9884370|FG000|STARTED|Overall Study||34
8829741|NCT01628874|9884371|FG001|STARTED|Overall Study||32
8829742|NCT01628874|9884370|FG000|COMPLETED|Overall Study||29
8829743|NCT01628874|9884371|FG001|COMPLETED|Overall Study||29
8829744|NCT01628874|9884370|FG000|NOT COMPLETED|Overall Study||5
8829745|NCT01628874|9884371|FG001|NOT COMPLETED|Overall Study||3
8829746|NCT01628913|9884379|FG000|STARTED|Overall Study||31
8829747|NCT01628913|9884380|FG001|STARTED|Overall Study||31
8829748|NCT01628913|9884379|FG000|COMPLETED|Overall Study||0
8829749|NCT01628913|9884380|FG001|COMPLETED|Overall Study||0
8829750|NCT01628913|9884379|FG000|NOT COMPLETED|Overall Study||31
8829751|NCT01628913|9884380|FG001|NOT COMPLETED|Overall Study||31
8829752|NCT01628926|9884389|FG000|STARTED|Overall Study||168
8829753|NCT01628926|9884390|FG001|STARTED|Overall Study||167
8829754|NCT01628926|9884391|FG002|STARTED|Overall Study||85
8829755|NCT01628926|9884389|FG000|COMPLETED|Overall Study||142
8829756|NCT01628926|9884390|FG001|COMPLETED|Overall Study||144
8829757|NCT01628926|9884391|FG002|COMPLETED|Overall Study||68
8829758|NCT01628926|9884389|FG000|NOT COMPLETED|Overall Study||26
8829759|NCT01628926|9884390|FG001|NOT COMPLETED|Overall Study||23
8829760|NCT01628926|9884391|FG002|NOT COMPLETED|Overall Study||17
8829761|NCT01628965|9884400|FG000|STARTED|Overall Study||143
8829762|NCT01628965|9884400|FG000|COMPLETED|Overall Study||94
8829763|NCT01628965|9884400|FG000|NOT COMPLETED|Overall Study||49
8829764|NCT01629134|9884404|FG000|STARTED|Overall Study||62
8829765|NCT01629134|9884404|FG000|COMPLETED|Overall Study||62
8829766|NCT01629134|9884404|FG000|NOT COMPLETED|Overall Study||0
8829767|NCT01629290|9884408|FG000|STARTED|Overall Study||15
8829768|NCT01629290|9884408|FG000|COMPLETED|Overall Study||15
8829769|NCT01629290|9884408|FG000|NOT COMPLETED|Overall Study||0
8829770|NCT01629381|9884420|FG000|STARTED|Overall Study||122
8829771|NCT01629381|9884421|FG001|STARTED|Overall Study||119
8829772|NCT01629381|9884420|FG000|COMPLETED|Overall Study||120
8829773|NCT01629381|9884421|FG001|COMPLETED|Overall Study||114
8829774|NCT01629381|9884420|FG000|NOT COMPLETED|Overall Study||2
8829775|NCT01629381|9884421|FG001|NOT COMPLETED|Overall Study||5
8829776|NCT01629563|9884433|FG000|STARTED|Overall Study||228
8829777|NCT01629563|9884434|FG001|STARTED|Overall Study|2 subjects randomised to 10mg received 5mg treatment in error (FAS 1: 10mg, Safety Set: 5mg)|223
8829778|NCT01629563|9884433|FG000|Safety Population|Overall Study||230
8829779|NCT01629563|9884434|FG001|Safety Population|Overall Study||221
8829780|NCT01629563|9884433|FG000|Started Treatment Course 2|Overall Study||213
8829781|NCT01629563|9884434|FG001|Started Treatment Course 2|Overall Study||207
8829782|NCT01629563|9884433|FG000|Started Treatment Course 3|Overall Study||191
8829783|NCT01629563|9884434|FG001|Started Treatment Course 3|Overall Study||190
8829784|NCT01629563|9884433|FG000|Started Treatment Course 4|Overall Study||178
8829785|NCT01629563|9884434|FG001|Started Treatment Course 4|Overall Study||176
8829786|NCT01629563|9884433|FG000|COMPLETED|Overall Study||167
8829787|NCT01629563|9884434|FG001|COMPLETED|Overall Study||170
8829788|NCT01629563|9884433|FG000|NOT COMPLETED|Overall Study||61
8829789|NCT01629563|9884434|FG001|NOT COMPLETED|Overall Study||53
8829790|NCT01629589|9884442|FG000|STARTED|Overall Study||212
8829791|NCT01629589|9884443|FG001|STARTED|Overall Study||211
8829792|NCT01629589|9884442|FG000|COMPLETED|Overall Study|A participant received the Boostrix vaccine. Study data reported for the Boostrix vaccine group.|204
8829793|NCT01629589|9884443|FG001|COMPLETED|Overall Study||204
8829794|NCT01629589|9884442|FG000|NOT COMPLETED|Overall Study||8
8829795|NCT01629589|9884443|FG001|NOT COMPLETED|Overall Study||7
8829796|NCT01629615|9884449|FG000|STARTED|Overall Study||50
8829797|NCT01629615|9884449|FG000|COMPLETED|Overall Study||50
8829798|NCT01629615|9884449|FG000|NOT COMPLETED|Overall Study||0
8829799|NCT01629667|9884456|FG000|STARTED|Overall Study||59
8829800|NCT01629667|9884457|FG001|STARTED|Overall Study||58
8829801|NCT01629667|9884458|FG002|STARTED|Overall Study||59
8829802|NCT01629667|9884456|FG000|Randomized and Treated|Overall Study||57
8829803|NCT01629667|9884457|FG001|Randomized and Treated|Overall Study||57
8829804|NCT01629667|9884458|FG002|Randomized and Treated|Overall Study||59
8829805|NCT01629667|9884456|FG000|COMPLETED|Overall Study||12
8829806|NCT01629667|9884457|FG001|COMPLETED|Overall Study||17
8829807|NCT01629667|9884458|FG002|COMPLETED|Overall Study||14
8829808|NCT01629667|9884456|FG000|NOT COMPLETED|Overall Study||47
8829809|NCT01629667|9884457|FG001|NOT COMPLETED|Overall Study||41
8829810|NCT01629667|9884458|FG002|NOT COMPLETED|Overall Study||45
8829811|NCT01629693|9884470|FG000|STARTED|Overall Study||193
8829812|NCT01629693|9884471|FG001|STARTED|Overall Study||188
8829813|NCT01629693|9884470|FG000|COMPLETED|Overall Study||188
8829814|NCT01629693|9884471|FG001|COMPLETED|Overall Study||178
8829815|NCT01629693|9884470|FG000|NOT COMPLETED|Overall Study||5
8829816|NCT01629693|9884471|FG001|NOT COMPLETED|Overall Study||10
8829817|NCT01629706|9884477|FG000|STARTED|Phase 1 PureVision||44
8829818|NCT01629706|9884477|FG000|COMPLETED|Phase 1 PureVision||35
8829819|NCT01629706|9884477|FG000|NOT COMPLETED|Phase 1 PureVision||9
8829820|NCT01629706|9884477|FG000|STARTED|Phase 2 Habitual|Phase 2 enrolled 48 new participants, plus 10 participants from Phase 1|58
8829821|NCT01629706|9884477|FG000|COMPLETED|Phase 2 Habitual||48
8829822|NCT01629706|9884477|FG000|NOT COMPLETED|Phase 2 Habitual||10
8829823|NCT01629771|9884487|FG000|STARTED|Overall Study||36
8829824|NCT01629771|9884488|FG001|STARTED|Overall Study||36
8829825|NCT01629771|9884487|FG000|COMPLETED|Overall Study||36
8829826|NCT01629771|9884488|FG001|COMPLETED|Overall Study||36
8829827|NCT01629771|9884487|FG000|NOT COMPLETED|Overall Study||0
8829828|NCT01629771|9884488|FG001|NOT COMPLETED|Overall Study||0
8829829|NCT01629784|9884494|FG000|STARTED|Overall Study||31
8829830|NCT01629784|9884494|FG000|COMPLETED|Overall Study||25
8829831|NCT01629784|9884494|FG000|NOT COMPLETED|Overall Study||6
8829832|NCT01629797|9884501|FG000|STARTED|Overall Study||100
8829833|NCT01629797|9884501|FG000|COMPLETED|Overall Study||82
8829834|NCT01629797|9884501|FG000|NOT COMPLETED|Overall Study||18
8829835|NCT01629823|9884511|FG000|STARTED|Trial Period||66
8829836|NCT01629823|9884512|FG001|STARTED|Trial Period||69
8829837|NCT01629823|9884513|FG002|STARTED|Trial Period||59
8829838|NCT01629823|9884511|FG000|COMPLETED|Trial Period||53
8829839|NCT01629823|9884512|FG001|COMPLETED|Trial Period||56
8829840|NCT01629823|9884513|FG002|COMPLETED|Trial Period||49
8829841|NCT01629823|9884511|FG000|NOT COMPLETED|Trial Period||13
8829842|NCT01629823|9884512|FG001|NOT COMPLETED|Trial Period||13
8829843|NCT01629823|9884513|FG002|NOT COMPLETED|Trial Period||10
8829844|NCT01629823|9884511|FG000|STARTED|Washout Period||54
8829845|NCT01629823|9884512|FG001|STARTED|Washout Period||57
8829846|NCT01629823|9884513|FG002|STARTED|Washout Period||50
8829847|NCT01629823|9884511|FG000|COMPLETED|Washout Period||51
8829848|NCT01629823|9884512|FG001|COMPLETED|Washout Period||51
8829849|NCT01629823|9884513|FG002|COMPLETED|Washout Period||50
8829850|NCT01629823|9884511|FG000|NOT COMPLETED|Washout Period||3
8829851|NCT01629823|9884512|FG001|NOT COMPLETED|Washout Period||6
8829852|NCT01629823|9884513|FG002|NOT COMPLETED|Washout Period||0
8829853|NCT01629862|9884523|FG000|STARTED|Overall Study||28
8829854|NCT01629862|9884524|FG001|STARTED|Overall Study||25
8829855|NCT01629862|9884523|FG000|COMPLETED|Overall Study||26
8829856|NCT01629862|9884524|FG001|COMPLETED|Overall Study||23
8829857|NCT01629862|9884523|FG000|NOT COMPLETED|Overall Study||2
8829858|NCT01629862|9884524|FG001|NOT COMPLETED|Overall Study||2
8829859|NCT01629953|9884532|FG000|STARTED|Overall Study||65
8829860|NCT01629953|9884533|FG001|STARTED|Overall Study||75
8829861|NCT01629953|9884532|FG000|COMPLETED|Overall Study||52
8829862|NCT01629953|9884533|FG001|COMPLETED|Overall Study||60
8829863|NCT01629953|9884532|FG000|NOT COMPLETED|Overall Study||13
8829864|NCT01629953|9884533|FG001|NOT COMPLETED|Overall Study||15
8829865|NCT01629966|9884542|FG000|STARTED|Overall Study||221
8829866|NCT01629966|9884543|FG001|STARTED|Overall Study||227
8829867|NCT01629966|9884544|FG002|STARTED|Overall Study||225
8829868|NCT01629966|9884542|FG000|COMPLETED|Overall Study||180
8829869|NCT01629966|9884543|FG001|COMPLETED|Overall Study||175
8829870|NCT01629966|9884544|FG002|COMPLETED|Overall Study||159
8829871|NCT01629966|9884542|FG000|NOT COMPLETED|Overall Study||41
8829872|NCT01629966|9884543|FG001|NOT COMPLETED|Overall Study||52
8829873|NCT01629966|9884544|FG002|NOT COMPLETED|Overall Study||66
8829874|NCT01630109|9884555|FG000|STARTED|Overall Study||1
8829875|NCT01630109|9884556|FG001|STARTED|Overall Study||1
8829876|NCT01630109|9884557|FG002|STARTED|Overall Study||3
8829877|NCT01630109|9884555|FG000|COMPLETED|Overall Study||1
8829878|NCT01630109|9884556|FG001|COMPLETED|Overall Study||1
8829879|NCT01630109|9884557|FG002|COMPLETED|Overall Study||3
8829880|NCT01630109|9884555|FG000|NOT COMPLETED|Overall Study||0
8829881|NCT01630109|9884556|FG001|NOT COMPLETED|Overall Study||0
8829882|NCT01630109|9884557|FG002|NOT COMPLETED|Overall Study||0
8829883|NCT01630135|9884573|FG000|STARTED|Overall Study||131
8829884|NCT01630135|9884574|FG001|STARTED|Overall Study||130
8829885|NCT01630135|9884573|FG000|COMPLETED|Overall Study||131
8829886|NCT01630135|9884574|FG001|COMPLETED|Overall Study||128
8829887|NCT01630135|9884573|FG000|NOT COMPLETED|Overall Study||0
8829888|NCT01630135|9884574|FG001|NOT COMPLETED|Overall Study||2
8829889|NCT01630200|9884582|FG000|STARTED|Overall Study||40
8829890|NCT01630200|9884583|FG001|STARTED|Overall Study||40
8829891|NCT01630200|9884582|FG000|COMPLETED|Overall Study||33
8829892|NCT01630200|9884583|FG001|COMPLETED|Overall Study||34
8829893|NCT01630200|9884582|FG000|NOT COMPLETED|Overall Study||7
8829894|NCT01630200|9884583|FG001|NOT COMPLETED|Overall Study||6
8829895|NCT01630616|9884595|FG000|STARTED|Overall Study||5
8829896|NCT01630616|9884596|FG001|STARTED|Overall Study||3
8829897|NCT01630616|9884597|FG002|STARTED|Overall Study||3
8829898|NCT01630616|9884598|FG003|STARTED|Overall Study||12
8829899|NCT01630616|9884599|FG004|STARTED|Overall Study||6
8829900|NCT01630616|9884600|FG005|STARTED|Overall Study||2
8829901|NCT01630616|9884595|FG000|COMPLETED|Overall Study||5
8829902|NCT01630616|9884596|FG001|COMPLETED|Overall Study||3
8829903|NCT01630616|9884597|FG002|COMPLETED|Overall Study||3
8829904|NCT01630616|9884598|FG003|COMPLETED|Overall Study||9
8829905|NCT01630616|9884599|FG004|COMPLETED|Overall Study||6
8829906|NCT01630616|9884600|FG005|COMPLETED|Overall Study||2
8829907|NCT01630616|9884595|FG000|NOT COMPLETED|Overall Study||0
8829908|NCT01630616|9884596|FG001|NOT COMPLETED|Overall Study||0
8829909|NCT01630616|9884597|FG002|NOT COMPLETED|Overall Study||0
8829910|NCT01630616|9884598|FG003|NOT COMPLETED|Overall Study||3
8829911|NCT01630616|9884599|FG004|NOT COMPLETED|Overall Study||0
8829912|NCT01630616|9884600|FG005|NOT COMPLETED|Overall Study||0
8829913|NCT01630694|9884619|FG000|STARTED|Overall Study||12
8829914|NCT01630694|9884620|FG001|STARTED|Overall Study||16
8829915|NCT01630694|9884619|FG000|COMPLETED|Overall Study||12
8829916|NCT01630694|9884620|FG001|COMPLETED|Overall Study||16
8829917|NCT01630694|9884619|FG000|NOT COMPLETED|Overall Study||0
8829918|NCT01630694|9884620|FG001|NOT COMPLETED|Overall Study||0
8829919|NCT01630811|9884626|FG000|STARTED|First Intervention (8 Weeks)||7
8829920|NCT01630811|9884627|FG001|STARTED|First Intervention (8 Weeks)||6
8829921|NCT01630811|9884626|FG000|COMPLETED|First Intervention (8 Weeks)||7
8829922|NCT01630811|9884627|FG001|COMPLETED|First Intervention (8 Weeks)||6
8829923|NCT01630811|9884626|FG000|NOT COMPLETED|First Intervention (8 Weeks)||0
8829924|NCT01630811|9884627|FG001|NOT COMPLETED|First Intervention (8 Weeks)||0
8829925|NCT01630811|9884626|FG000|STARTED|Washout (4 Weeks)||7
8829926|NCT01630811|9884627|FG001|STARTED|Washout (4 Weeks)||6
8829927|NCT01630811|9884626|FG000|COMPLETED|Washout (4 Weeks)||7
8829928|NCT01630811|9884627|FG001|COMPLETED|Washout (4 Weeks)||6
8829929|NCT01630811|9884626|FG000|NOT COMPLETED|Washout (4 Weeks)||0
8829930|NCT01630811|9884627|FG001|NOT COMPLETED|Washout (4 Weeks)||0
8829931|NCT01630811|9884626|FG000|STARTED|Second Intervention (8 Weeks)||7
8829932|NCT01630811|9884627|FG001|STARTED|Second Intervention (8 Weeks)||6
8829933|NCT01630811|9884626|FG000|COMPLETED|Second Intervention (8 Weeks)||6
8829934|NCT01630811|9884627|FG001|COMPLETED|Second Intervention (8 Weeks)||6
8829935|NCT01630811|9884626|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||1
8829936|NCT01630811|9884627|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||0
8829937|NCT01630811|9884626|FG000|STARTED|Second Washout (4 Weeks)||6
8829938|NCT01630811|9884627|FG001|STARTED|Second Washout (4 Weeks)||6
8829939|NCT01630811|9884626|FG000|COMPLETED|Second Washout (4 Weeks)||6
8829940|NCT01630811|9884627|FG001|COMPLETED|Second Washout (4 Weeks)||6
8829941|NCT01630811|9884626|FG000|NOT COMPLETED|Second Washout (4 Weeks)||0
8829942|NCT01630811|9884627|FG001|NOT COMPLETED|Second Washout (4 Weeks)||0
8829943|NCT01630889|9884635|FG000|STARTED|Overall Study||15
8829944|NCT01630889|9884635|FG000|Received at Least 1 Dose of Study Drug|Overall Study||15
8829945|NCT01630889|9884635|FG000|COMPLETED|Overall Study||5
8829946|NCT01630889|9884635|FG000|NOT COMPLETED|Overall Study||10
8829947|NCT01631071|9884641|FG000|STARTED|Overall Study||55
8829948|NCT01631071|9884642|FG001|STARTED|Overall Study||55
8829949|NCT01631071|9884641|FG000|COMPLETED|Overall Study||55
8829950|NCT01631071|9884642|FG001|COMPLETED|Overall Study||55
8829951|NCT01631071|9884641|FG000|NOT COMPLETED|Overall Study||0
8829952|NCT01631071|9884642|FG001|NOT COMPLETED|Overall Study||0
8829953|NCT01631110|9884650|FG000|STARTED|Overall Study||55
8829954|NCT01631110|9884651|FG001|STARTED|Overall Study||55
8829955|NCT01631110|9884650|FG000|COMPLETED|Overall Study||55
8829956|NCT01631110|9884651|FG001|COMPLETED|Overall Study||55
8829957|NCT01631110|9884650|FG000|NOT COMPLETED|Overall Study||0
8829958|NCT01631110|9884651|FG001|NOT COMPLETED|Overall Study||0
8829959|NCT01631149|9884659|FG000|STARTED|Overall Study||12
8829960|NCT01631149|9884660|FG001|STARTED|Overall Study||12
8829961|NCT01631149|9884659|FG000|COMPLETED|Overall Study||12
8829962|NCT01631149|9884660|FG001|COMPLETED|Overall Study||12
8829963|NCT01631149|9884659|FG000|NOT COMPLETED|Overall Study||0
8829964|NCT01631149|9884660|FG001|NOT COMPLETED|Overall Study||0
8829965|NCT01631188|9884666|FG000|STARTED|Overall Study||100
8829966|NCT01631188|9884666|FG000|COMPLETED|Overall Study||25
8829967|NCT01631188|9884666|FG000|NOT COMPLETED|Overall Study||75
8829968|NCT01631214|9884672|FG000|STARTED|Overall Study||2047
8829969|NCT01631214|9884673|FG001|STARTED|Overall Study||2046
8829970|NCT01631214|9884672|FG000|Received Double-blind Treatment|Overall Study||2040
8829971|NCT01631214|9884673|FG001|Received Double-blind Treatment|Overall Study||2038
8829972|NCT01631214|9884672|FG000|Completed Double-blind Period|Overall Study||1823
8829973|NCT01631214|9884673|FG001|Completed Double-blind Period|Overall Study||1831
8829974|NCT01631214|9884672|FG000|Completed Primary Analysis Period|Overall Study||1576
8829975|NCT01631214|9884673|FG001|Completed Primary Analysis Period|Overall Study||1574
8829976|NCT01631214|9884672|FG000|COMPLETED|Overall Study||1503
8829977|NCT01631214|9884673|FG001|COMPLETED|Overall Study||1523
8829978|NCT01631214|9884672|FG000|NOT COMPLETED|Overall Study||544
8829979|NCT01631214|9884673|FG001|NOT COMPLETED|Overall Study||523
8829980|NCT01631227|9884683|FG000|STARTED|Overall Study||333
8829981|NCT01631227|9884684|FG001|STARTED|Overall Study||332
8829982|NCT01631227|9884683|FG000|Safety Subject Sample|Overall Study|1 patient was randomized by mistake and never received study medication.|332
8829983|NCT01631227|9884684|FG001|Safety Subject Sample|Overall Study||332
8829984|NCT01631227|9884683|FG000|Full Analysis Set Population|Overall Study|2 patients not eligible for the Full Analysis Set due to missing post-baseline efficacy measurement|330
8829985|NCT01631227|9884684|FG001|Full Analysis Set Population|Overall Study|1 patient not eligible for the Full Analysis Set due to missing post-baseline efficacy measurement|331
8829986|NCT01631227|9884683|FG000|COMPLETED|Overall Study||303
8829987|NCT01631227|9884684|FG001|COMPLETED|Overall Study||310
8829988|NCT01631227|9884683|FG000|NOT COMPLETED|Overall Study||30
8829989|NCT01631227|9884684|FG001|NOT COMPLETED|Overall Study||22
8829990|NCT01631331|9884690|FG000|STARTED|Overall Study||15
8829991|NCT01631331|9884690|FG000|COMPLETED|Overall Study||11
8829992|NCT01631331|9884690|FG000|NOT COMPLETED|Overall Study||4
8829993|NCT01631435|9884695|FG000|STARTED|Overall Study||75
8829994|NCT01631435|9884695|FG000|COMPLETED|Overall Study||66
8829995|NCT01631435|9884695|FG000|NOT COMPLETED|Overall Study||9
8829996|NCT01631474|9884705|FG000|STARTED|Overall Study||72
8829997|NCT01631474|9884706|FG001|STARTED|Overall Study||76
8829998|NCT01631474|9884707|FG002|STARTED|Overall Study||70
8829999|NCT01631474|9884708|FG003|STARTED|Overall Study||70
8830000|NCT01631474|9884709|FG004|STARTED|Overall Study||75
8830001|NCT01631474|9884705|FG000|COMPLETED|Overall Study||58
8830002|NCT01631474|9884706|FG001|COMPLETED|Overall Study||64
8830003|NCT01631474|9884707|FG002|COMPLETED|Overall Study||61
8830004|NCT01631474|9884708|FG003|COMPLETED|Overall Study||59
8830005|NCT01631474|9884709|FG004|COMPLETED|Overall Study||62
8830006|NCT01631474|9884705|FG000|NOT COMPLETED|Overall Study||14
8830007|NCT01631474|9884706|FG001|NOT COMPLETED|Overall Study||12
8830008|NCT01631474|9884707|FG002|NOT COMPLETED|Overall Study||9
8830009|NCT01631474|9884708|FG003|NOT COMPLETED|Overall Study||11
8830010|NCT01631474|9884709|FG004|NOT COMPLETED|Overall Study||13
8830011|NCT01631552|9884725|FG000|STARTED|Overall Study||83
8830012|NCT01631552|9884726|FG001|STARTED|Overall Study||420
8830013|NCT01631552|9884727|FG002|STARTED|Overall Study||9
8830014|NCT01631552|9884728|FG003|STARTED|Overall Study||3
8830015|NCT01631552|9884725|FG000|Enrolled and Treated|Overall Study||81
8830016|NCT01631552|9884726|FG001|Enrolled and Treated|Overall Study||402
8830017|NCT01631552|9884727|FG002|Enrolled and Treated|Overall Study||9
8830018|NCT01631552|9884728|FG003|Enrolled and Treated|Overall Study||3
8830019|NCT01631552|9884725|FG000|COMPLETED|Overall Study||81
8830020|NCT01631552|9884726|FG001|COMPLETED|Overall Study||400
8830021|NCT01631552|9884727|FG002|COMPLETED|Overall Study||9
8830022|NCT01631552|9884728|FG003|COMPLETED|Overall Study||3
8830023|NCT01631552|9884725|FG000|NOT COMPLETED|Overall Study||2
8830024|NCT01631552|9884726|FG001|NOT COMPLETED|Overall Study||20
8830025|NCT01631552|9884727|FG002|NOT COMPLETED|Overall Study||0
8830026|NCT01631552|9884728|FG003|NOT COMPLETED|Overall Study||0
8830027|NCT01631630|9884742|FG000|STARTED|Overall Study||8
8830028|NCT01631630|9884743|FG001|STARTED|Overall Study||8
8830029|NCT01631630|9884742|FG000|COMPLETED|Overall Study||5
8830030|NCT01631630|9884743|FG001|COMPLETED|Overall Study||8
8830031|NCT01631630|9884742|FG000|NOT COMPLETED|Overall Study||3
8830032|NCT01631630|9884743|FG001|NOT COMPLETED|Overall Study||0
8830033|NCT01631656|9884751|FG000|STARTED|Overall Study||5
8830034|NCT01631656|9884752|FG001|STARTED|Overall Study||5
8830035|NCT01631656|9884751|FG000|COMPLETED|Overall Study||5
8830036|NCT01631656|9884752|FG001|COMPLETED|Overall Study||5
8830037|NCT01631656|9884751|FG000|NOT COMPLETED|Overall Study||0
8830038|NCT01631656|9884752|FG001|NOT COMPLETED|Overall Study||0
8830039|NCT01631682|9884762|FG000|STARTED|Overall Study||55
8830040|NCT01631682|9884763|FG001|STARTED|Overall Study||66
8830041|NCT01631682|9884764|FG002|STARTED|Overall Study||44
8830042|NCT01631682|9884765|FG003|STARTED|Overall Study||7
8830043|NCT01631682|9884762|FG000|COMPLETED|Overall Study||24
8830044|NCT01631682|9884763|FG001|COMPLETED|Overall Study||21
8830045|NCT01631682|9884764|FG002|COMPLETED|Overall Study||13
8830046|NCT01631682|9884765|FG003|COMPLETED|Overall Study||5
8830047|NCT01631682|9884762|FG000|NOT COMPLETED|Overall Study||31
8830048|NCT01631682|9884763|FG001|NOT COMPLETED|Overall Study||45
8830049|NCT01631682|9884764|FG002|NOT COMPLETED|Overall Study||31
8830050|NCT01631682|9884765|FG003|NOT COMPLETED|Overall Study||2
8830051|NCT01631747|9884777|FG000|STARTED|Randomization Through End of Pregnancy||141
8830052|NCT01631747|9884778|FG001|STARTED|Randomization Through End of Pregnancy||140
8830053|NCT01631747|9884777|FG000|COMPLETED|Randomization Through End of Pregnancy||140
8830054|NCT01631747|9884778|FG001|COMPLETED|Randomization Through End of Pregnancy||140
8830055|NCT01631747|9884777|FG000|NOT COMPLETED|Randomization Through End of Pregnancy||1
8830056|NCT01631747|9884778|FG001|NOT COMPLETED|Randomization Through End of Pregnancy||0
8830057|NCT01631747|9884777|FG000|STARTED|Live Birth||140
8830058|NCT01631747|9884778|FG001|STARTED|Live Birth||140
8830059|NCT01631747|9884777|FG000|COMPLETED|Live Birth||136
8830060|NCT01631747|9884778|FG001|COMPLETED|Live Birth||139
8830061|NCT01631747|9884777|FG000|NOT COMPLETED|Live Birth||4
8830062|NCT01631747|9884778|FG001|NOT COMPLETED|Live Birth||1
8830063|NCT01631747|9884777|FG000|STARTED|One Year Infant Outcomes||136
8830064|NCT01631747|9884778|FG001|STARTED|One Year Infant Outcomes||139
8830065|NCT01631747|9884777|FG000|COMPLETED|One Year Infant Outcomes||123
8830066|NCT01631747|9884778|FG001|COMPLETED|One Year Infant Outcomes||130
8830067|NCT01631747|9884777|FG000|NOT COMPLETED|One Year Infant Outcomes||13
8830068|NCT01631747|9884778|FG001|NOT COMPLETED|One Year Infant Outcomes||9
8830069|NCT01631812|9884785|FG000|STARTED|Overall Study||130
8830070|NCT01631812|9884785|FG000|COMPLETED|Overall Study||93
8830071|NCT01631812|9884785|FG000|NOT COMPLETED|Overall Study||37
8830072|NCT01631825|9884789|FG000|STARTED|Overall Study||321
8830073|NCT01631825|9884789|FG000|COMPLETED|Overall Study||256
8830074|NCT01631825|9884789|FG000|NOT COMPLETED|Overall Study||65
8830075|NCT01631864|9884795|FG000|STARTED|Overall Study||50
8830076|NCT01631864|9884796|FG001|STARTED|Overall Study||48
8830077|NCT01631864|9884795|FG000|COMPLETED|Overall Study||48
8830078|NCT01631864|9884796|FG001|COMPLETED|Overall Study||44
8830079|NCT01631864|9884795|FG000|NOT COMPLETED|Overall Study||2
8830080|NCT01631864|9884796|FG001|NOT COMPLETED|Overall Study||4
8830081|NCT01631929|9884804|FG000|STARTED|Overall Study||6
8830082|NCT01631929|9884805|FG001|STARTED|Overall Study||6
8830083|NCT01631929|9884804|FG000|COMPLETED|Overall Study||6
8830084|NCT01631929|9884805|FG001|COMPLETED|Overall Study||6
8830085|NCT01631929|9884804|FG000|NOT COMPLETED|Overall Study||0
8830086|NCT01631929|9884805|FG001|NOT COMPLETED|Overall Study||0
8830087|NCT01632150|9884811|FG000|STARTED|Overall Study||40
8830088|NCT01632150|9884811|FG000|Received Cyclophosphamide|Overall Study||11
8830089|NCT01632150|9884811|FG000|COMPLETED|Overall Study|Completed=still receiving treatment|0
8830090|NCT01632150|9884811|FG000|NOT COMPLETED|Overall Study||40
8830091|NCT01632202|9884820|FG000|STARTED|Overall Study||1
8830092|NCT01632202|9884821|FG001|STARTED|Overall Study||7
8830093|NCT01632202|9884820|FG000|COMPLETED|Overall Study||1
8830094|NCT01632202|9884821|FG001|COMPLETED|Overall Study||7
8830095|NCT01632202|9884820|FG000|NOT COMPLETED|Overall Study||0
8830096|NCT01632202|9884821|FG001|NOT COMPLETED|Overall Study||0
8830097|NCT01632215|9884829|FG000|STARTED|Overall Study||20
8830098|NCT01632215|9884830|FG001|STARTED|Overall Study||20
8830099|NCT01632215|9884829|FG000|COMPLETED|Overall Study||18
8830100|NCT01632215|9884830|FG001|COMPLETED|Overall Study||19
8830101|NCT01632215|9884829|FG000|NOT COMPLETED|Overall Study||2
8830102|NCT01632215|9884830|FG001|NOT COMPLETED|Overall Study||1
8830103|NCT01632241|9884838|FG000|STARTED|Double-blinded (Up to Week 52)||165
8830104|NCT01632241|9884839|FG001|STARTED|Double-blinded (Up to Week 52)||331
8830105|NCT01632241|9884838|FG000|COMPLETED|Double-blinded (Up to Week 52)||121
8622516|NCT00488774|9661765|FG001|COMPLETED|Overall Study||57
8622517|NCT00488774|9661766|FG002|COMPLETED|Overall Study||70
8622518|NCT00488774|9661767|FG003|COMPLETED|Overall Study||74
8622519|NCT00488774|9661764|FG000|NOT COMPLETED|Overall Study||8
8622520|NCT00488774|9661765|FG001|NOT COMPLETED|Overall Study||5
8622521|NCT00488774|9661766|FG002|NOT COMPLETED|Overall Study||5
8830106|NCT01632241|9884839|FG001|COMPLETED|Double-blinded (Up to Week 52)||252
8830107|NCT01632241|9884838|FG000|NOT COMPLETED|Double-blinded (Up to Week 52)||44
8830108|NCT01632241|9884839|FG001|NOT COMPLETED|Double-blinded (Up to Week 52)||79
8830109|NCT01632241|9884838|FG000|STARTED|Open-label (Week 52 to Week 76)|As the OL phase was optional, participants did not choose to enter the OL Phase.|117
8830110|NCT01632241|9884839|FG001|STARTED|Open-label (Week 52 to Week 76)|As the OL phase was optional, participants did not choose to enter the OL Phase.|242
8622522|NCT00488774|9661767|FG003|NOT COMPLETED|Overall Study||3
8622523|NCT00488826|9661781|FG000|STARTED|Overall Study||300
8622524|NCT00488826|9661782|FG001|STARTED|Overall Study||296
8622525|NCT00488826|9661783|FG002|STARTED|Overall Study||204
8622526|NCT00488826|9661781|FG000|COMPLETED|Overall Study||244
8622527|NCT00488826|9661782|FG001|COMPLETED|Overall Study||244
8830111|NCT01632241|9884838|FG000|COMPLETED|Open-label (Week 52 to Week 76)||107
8830112|NCT01632241|9884839|FG001|COMPLETED|Open-label (Week 52 to Week 76)||220
8830113|NCT01632241|9884838|FG000|NOT COMPLETED|Open-label (Week 52 to Week 76)||10
8830114|NCT01632241|9884839|FG001|NOT COMPLETED|Open-label (Week 52 to Week 76)||22
8830115|NCT01632267|9884851|FG000|STARTED|Overall Study||104
8830116|NCT01632267|9884851|FG000|COMPLETED|Overall Study||97
8830117|NCT01632267|9884851|FG000|NOT COMPLETED|Overall Study||7
8622528|NCT00488826|9661783|FG002|COMPLETED|Overall Study||178
8622529|NCT00488826|9661781|FG000|NOT COMPLETED|Overall Study||56
8830118|NCT01632280|9884857|FG000|STARTED|Overall Study||6
8830119|NCT01632280|9884858|FG001|STARTED|Overall Study||6
8830120|NCT01632280|9884857|FG000|COMPLETED|Overall Study||5
8830121|NCT01632280|9884858|FG001|COMPLETED|Overall Study||6
8830122|NCT01632280|9884857|FG000|NOT COMPLETED|Overall Study||1
8830123|NCT01632280|9884858|FG001|NOT COMPLETED|Overall Study||0
8830124|NCT01632306|9884866|FG000|STARTED|Overall Study||3
8830125|NCT01632306|9884867|FG001|STARTED|Overall Study||10
8830126|NCT01632306|9884868|FG002|STARTED|Overall Study||0
8830127|NCT01632306|9884866|FG000|Received at Least One Dose of Study Drug|Overall Study||3
8830128|NCT01632306|9884867|FG001|Received at Least One Dose of Study Drug|Overall Study||10
8830129|NCT01632306|9884868|FG002|Received at Least One Dose of Study Drug|Overall Study||0
8830130|NCT01632306|9884866|FG000|COMPLETED|Overall Study||2
8830131|NCT01632306|9884867|FG001|COMPLETED|Overall Study||10
8830132|NCT01632306|9884868|FG002|COMPLETED|Overall Study||0
8830133|NCT01632306|9884866|FG000|NOT COMPLETED|Overall Study||1
8830134|NCT01632306|9884867|FG001|NOT COMPLETED|Overall Study||0
8830135|NCT01632306|9884868|FG002|NOT COMPLETED|Overall Study||0
8830136|NCT01632345|9884879|FG000|STARTED|Randomized Participants||41
8830137|NCT01632345|9884880|FG001|STARTED|Randomized Participants||43
8830138|NCT01632345|9884881|FG002|STARTED|Randomized Participants||42
8830139|NCT01632345|9884882|FG003|STARTED|Randomized Participants||41
8830140|NCT01632345|9884883|FG004|STARTED|Randomized Participants||43
8830141|NCT01632345|9884884|FG005|STARTED|Randomized Participants||66
8830142|NCT01632345|9884885|FG006|STARTED|Randomized Participants||66
8830143|NCT01632345|9884879|FG000|COMPLETED|Randomized Participants||41
8830144|NCT01632345|9884880|FG001|COMPLETED|Randomized Participants||43
8830145|NCT01632345|9884881|FG002|COMPLETED|Randomized Participants||42
8830146|NCT01632345|9884882|FG003|COMPLETED|Randomized Participants||41
8830147|NCT01632345|9884883|FG004|COMPLETED|Randomized Participants||43
8830148|NCT01632345|9884884|FG005|COMPLETED|Randomized Participants||66
8830149|NCT01632345|9884885|FG006|COMPLETED|Randomized Participants||66
8830150|NCT01632345|9884879|FG000|NOT COMPLETED|Randomized Participants||0
8830151|NCT01632345|9884880|FG001|NOT COMPLETED|Randomized Participants||0
8830152|NCT01632345|9884881|FG002|NOT COMPLETED|Randomized Participants||0
8830153|NCT01632345|9884882|FG003|NOT COMPLETED|Randomized Participants||0
8830154|NCT01632345|9884883|FG004|NOT COMPLETED|Randomized Participants||0
8944173|NCT02394756|10006001|FG000|NOT COMPLETED|Period 2||0
8622530|NCT00488826|9661782|FG001|NOT COMPLETED|Overall Study||52
8622531|NCT00488826|9661783|FG002|NOT COMPLETED|Overall Study||26
8622532|NCT00488865|9661791|FG000|STARTED|Overall Study||100
8622533|NCT00488865|9661791|FG000|COMPLETED|Overall Study||100
8830155|NCT01632345|9884884|FG005|NOT COMPLETED|Randomized Participants||0
8830156|NCT01632345|9884885|FG006|NOT COMPLETED|Randomized Participants||0
8830157|NCT01632345|9884879|FG000|STARTED|Treatment: Part I||41
8830158|NCT01632345|9884880|FG001|STARTED|Treatment: Part I||43
8830159|NCT01632345|9884881|FG002|STARTED|Treatment: Part I||42
8830160|NCT01632345|9884882|FG003|STARTED|Treatment: Part I||41
8830161|NCT01632345|9884883|FG004|STARTED|Treatment: Part I||43
8830162|NCT01632345|9884884|FG005|STARTED|Treatment: Part I|Participants in Part II did not participate in Part I.|0
8830163|NCT01632345|9884885|FG006|STARTED|Treatment: Part I|Participants in Part II did not participate in Part I.|0
8830164|NCT01632345|9884879|FG000|Treated|Treatment: Part I||40
8830165|NCT01632345|9884880|FG001|Treated|Treatment: Part I||43
8830166|NCT01632345|9884881|FG002|Treated|Treatment: Part I||42
8830167|NCT01632345|9884882|FG003|Treated|Treatment: Part I||41
8830168|NCT01632345|9884883|FG004|Treated|Treatment: Part I||43
8830169|NCT01632345|9884884|FG005|Treated|Treatment: Part I||0
8830170|NCT01632345|9884885|FG006|Treated|Treatment: Part I||0
8830171|NCT01632345|9884879|FG000|COMPLETED|Treatment: Part I||29
8830172|NCT01632345|9884880|FG001|COMPLETED|Treatment: Part I||28
8830173|NCT01632345|9884881|FG002|COMPLETED|Treatment: Part I||32
8830174|NCT01632345|9884882|FG003|COMPLETED|Treatment: Part I||33
8830175|NCT01632345|9884883|FG004|COMPLETED|Treatment: Part I||30
8830176|NCT01632345|9884884|FG005|COMPLETED|Treatment: Part I||0
8830177|NCT01632345|9884885|FG006|COMPLETED|Treatment: Part I||0
8830178|NCT01632345|9884879|FG000|NOT COMPLETED|Treatment: Part I||12
8830179|NCT01632345|9884880|FG001|NOT COMPLETED|Treatment: Part I||15
8830180|NCT01632345|9884881|FG002|NOT COMPLETED|Treatment: Part I||10
8830181|NCT01632345|9884882|FG003|NOT COMPLETED|Treatment: Part I||8
8830182|NCT01632345|9884883|FG004|NOT COMPLETED|Treatment: Part I||13
8830183|NCT01632345|9884884|FG005|NOT COMPLETED|Treatment: Part I||0
8830184|NCT01632345|9884885|FG006|NOT COMPLETED|Treatment: Part I||0
8830185|NCT01632345|9884879|FG000|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
8830186|NCT01632345|9884880|FG001|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
8830187|NCT01632345|9884881|FG002|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
8830188|NCT01632345|9884882|FG003|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
8830189|NCT01632345|9884883|FG004|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
8830190|NCT01632345|9884884|FG005|STARTED|Treatment: Part II|66 new participants enrolled at 100 mg dose in Part II.|66
8830191|NCT01632345|9884885|FG006|STARTED|Treatment: Part II|66 new participants enrolled at efavirenz treatment in Part II.|66
8830192|NCT01632345|9884879|FG000|Treated|Treatment: Part II||0
8830193|NCT01632345|9884880|FG001|Treated|Treatment: Part II||0
8830194|NCT01632345|9884881|FG002|Treated|Treatment: Part II||0
8830195|NCT01632345|9884882|FG003|Treated|Treatment: Part II||0
8830196|NCT01632345|9884883|FG004|Treated|Treatment: Part II||0
8830197|NCT01632345|9884884|FG005|Treated|Treatment: Part II||66
8830198|NCT01632345|9884885|FG006|Treated|Treatment: Part II||66
8830199|NCT01632345|9884879|FG000|COMPLETED|Treatment: Part II||0
8830200|NCT01632345|9884880|FG001|COMPLETED|Treatment: Part II||0
8830201|NCT01632345|9884881|FG002|COMPLETED|Treatment: Part II||0
8830202|NCT01632345|9884882|FG003|COMPLETED|Treatment: Part II||0
8830203|NCT01632345|9884883|FG004|COMPLETED|Treatment: Part II||0
8830204|NCT01632345|9884884|FG005|COMPLETED|Treatment: Part II||55
8830205|NCT01632345|9884885|FG006|COMPLETED|Treatment: Part II||55
8830206|NCT01632345|9884879|FG000|NOT COMPLETED|Treatment: Part II||0
8830207|NCT01632345|9884880|FG001|NOT COMPLETED|Treatment: Part II||0
8830208|NCT01632345|9884881|FG002|NOT COMPLETED|Treatment: Part II||0
8830209|NCT01632345|9884882|FG003|NOT COMPLETED|Treatment: Part II||0
8830210|NCT01632345|9884883|FG004|NOT COMPLETED|Treatment: Part II||0
8830211|NCT01632345|9884884|FG005|NOT COMPLETED|Treatment: Part II||11
8830212|NCT01632345|9884885|FG006|NOT COMPLETED|Treatment: Part II||11
8830213|NCT01632423|9884900|FG000|STARTED|Overall Study||10337
8830214|NCT01632423|9884900|FG000|COMPLETED|Overall Study||10091
8830215|NCT01632423|9884900|FG000|NOT COMPLETED|Overall Study||246
8830216|NCT01632566|9884909|FG000|STARTED|Overall Study||8
8830217|NCT01632566|9884910|FG001|STARTED|Overall Study||10
8830218|NCT01632566|9884911|FG002|STARTED|Overall Study||9
8830219|NCT01632566|9884912|FG003|STARTED|Overall Study||6
8830220|NCT01632566|9884913|FG004|STARTED|Overall Study||6
8830221|NCT01632566|9884909|FG000|Received at Least One Dose LY3031207|Overall Study||8
8830222|NCT01632566|9884910|FG001|Received at Least One Dose LY3031207|Overall Study||10
8830223|NCT01632566|9884911|FG002|Received at Least One Dose LY3031207|Overall Study||9
8830224|NCT01632566|9884912|FG003|Received at Least One Dose LY3031207|Overall Study||0
8830225|NCT01632566|9884913|FG004|Received at Least One Dose LY3031207|Overall Study||0
8830226|NCT01632566|9884909|FG000|Received at Least One Dose Simvastatin|Overall Study||0
8830227|NCT01632566|9884910|FG001|Received at Least One Dose Simvastatin|Overall Study||10
8830228|NCT01632566|9884911|FG002|Received at Least One Dose Simvastatin|Overall Study||9
8830229|NCT01632566|9884912|FG003|Received at Least One Dose Simvastatin|Overall Study||4
8830230|NCT01632566|9884913|FG004|Received at Least One Dose Simvastatin|Overall Study||4
8830231|NCT01632566|9884909|FG000|COMPLETED|Overall Study||8
8830232|NCT01632566|9884910|FG001|COMPLETED|Overall Study||7
8830233|NCT01632566|9884911|FG002|COMPLETED|Overall Study||0
8830234|NCT01632566|9884912|FG003|COMPLETED|Overall Study||4
8830235|NCT01632566|9884913|FG004|COMPLETED|Overall Study||4
8830236|NCT01632566|9884909|FG000|NOT COMPLETED|Overall Study||0
8830237|NCT01632566|9884910|FG001|NOT COMPLETED|Overall Study||3
8830238|NCT01632566|9884911|FG002|NOT COMPLETED|Overall Study||9
8830239|NCT01632566|9884912|FG003|NOT COMPLETED|Overall Study||2
8830240|NCT01632566|9884913|FG004|NOT COMPLETED|Overall Study||2
8830241|NCT01632579|9884929|FG000|STARTED|Period 1 (First Intervention)||2
8830242|NCT01632579|9884930|FG001|STARTED|Period 1 (First Intervention)||6
8830243|NCT01632579|9884931|FG002|STARTED|Period 1 (First Intervention)||2
8830244|NCT01632579|9884932|FG003|STARTED|Period 1 (First Intervention)||2
8830245|NCT01632579|9884933|FG004|STARTED|Period 1 (First Intervention)||6
8830246|NCT01632579|9884934|FG005|STARTED|Period 1 (First Intervention)||2
8830247|NCT01632579|9884935|FG006|STARTED|Period 1 (First Intervention)||2
8830248|NCT01632579|9884936|FG007|STARTED|Period 1 (First Intervention)||6
8830249|NCT01632579|9884937|FG008|STARTED|Period 1 (First Intervention)||2
8830250|NCT01632579|9884929|FG000|Received at Least 1 Dose|Period 1 (First Intervention)||2
8830251|NCT01632579|9884930|FG001|Received at Least 1 Dose|Period 1 (First Intervention)||6
8830252|NCT01632579|9884931|FG002|Received at Least 1 Dose|Period 1 (First Intervention)||2
8830253|NCT01632579|9884932|FG003|Received at Least 1 Dose|Period 1 (First Intervention)||2
8830254|NCT01632579|9884933|FG004|Received at Least 1 Dose|Period 1 (First Intervention)||6
8830255|NCT01632579|9884934|FG005|Received at Least 1 Dose|Period 1 (First Intervention)||2
8830256|NCT01632579|9884935|FG006|Received at Least 1 Dose|Period 1 (First Intervention)||2
8830257|NCT01632579|9884936|FG007|Received at Least 1 Dose|Period 1 (First Intervention)||6
8830258|NCT01632579|9884937|FG008|Received at Least 1 Dose|Period 1 (First Intervention)||2
8830259|NCT01632579|9884929|FG000|COMPLETED|Period 1 (First Intervention)||2
8830260|NCT01632579|9884930|FG001|COMPLETED|Period 1 (First Intervention)||6
8830261|NCT01632579|9884931|FG002|COMPLETED|Period 1 (First Intervention)||2
8830262|NCT01632579|9884932|FG003|COMPLETED|Period 1 (First Intervention)||2
8830263|NCT01632579|9884933|FG004|COMPLETED|Period 1 (First Intervention)||6
8830264|NCT01632579|9884934|FG005|COMPLETED|Period 1 (First Intervention)||2
8830265|NCT01632579|9884935|FG006|COMPLETED|Period 1 (First Intervention)||2
8830266|NCT01632579|9884936|FG007|COMPLETED|Period 1 (First Intervention)||6
8830267|NCT01632579|9884937|FG008|COMPLETED|Period 1 (First Intervention)||2
8830268|NCT01632579|9884929|FG000|NOT COMPLETED|Period 1 (First Intervention)||0
8830269|NCT01632579|9884930|FG001|NOT COMPLETED|Period 1 (First Intervention)||0
8830270|NCT01632579|9884931|FG002|NOT COMPLETED|Period 1 (First Intervention)||0
8830271|NCT01632579|9884932|FG003|NOT COMPLETED|Period 1 (First Intervention)||0
8830272|NCT01632579|9884933|FG004|NOT COMPLETED|Period 1 (First Intervention)||0
8830273|NCT01632579|9884934|FG005|NOT COMPLETED|Period 1 (First Intervention)||0
8830274|NCT01632579|9884935|FG006|NOT COMPLETED|Period 1 (First Intervention)||0
8830275|NCT01632579|9884936|FG007|NOT COMPLETED|Period 1 (First Intervention)||0
8830276|NCT01632579|9884937|FG008|NOT COMPLETED|Period 1 (First Intervention)||0
8830277|NCT01632579|9884929|FG000|STARTED|Washout Period||2
8830278|NCT01632579|9884930|FG001|STARTED|Washout Period||6
8830279|NCT01632579|9884931|FG002|STARTED|Washout Period||2
8830280|NCT01632579|9884932|FG003|STARTED|Washout Period||2
8830281|NCT01632579|9884933|FG004|STARTED|Washout Period||6
8830282|NCT01632579|9884934|FG005|STARTED|Washout Period||2
8830283|NCT01632579|9884935|FG006|STARTED|Washout Period||2
8830284|NCT01632579|9884936|FG007|STARTED|Washout Period||6
8830285|NCT01632579|9884937|FG008|STARTED|Washout Period||2
8830286|NCT01632579|9884929|FG000|COMPLETED|Washout Period||1
8830287|NCT01632579|9884930|FG001|COMPLETED|Washout Period||6
8830288|NCT01632579|9884931|FG002|COMPLETED|Washout Period||2
8830289|NCT01632579|9884932|FG003|COMPLETED|Washout Period||2
8830290|NCT01632579|9884933|FG004|COMPLETED|Washout Period||6
8830291|NCT01632579|9884934|FG005|COMPLETED|Washout Period||2
8830292|NCT01632579|9884935|FG006|COMPLETED|Washout Period||2
8830293|NCT01632579|9884936|FG007|COMPLETED|Washout Period||6
8830294|NCT01632579|9884937|FG008|COMPLETED|Washout Period||2
8830295|NCT01632579|9884929|FG000|NOT COMPLETED|Washout Period||1
8830296|NCT01632579|9884930|FG001|NOT COMPLETED|Washout Period||0
8830297|NCT01632579|9884931|FG002|NOT COMPLETED|Washout Period||0
8830298|NCT01632579|9884932|FG003|NOT COMPLETED|Washout Period||0
8830299|NCT01632579|9884933|FG004|NOT COMPLETED|Washout Period||0
8830300|NCT01632579|9884934|FG005|NOT COMPLETED|Washout Period||0
8830301|NCT01632579|9884935|FG006|NOT COMPLETED|Washout Period||0
8830302|NCT01632579|9884936|FG007|NOT COMPLETED|Washout Period||0
8830303|NCT01632579|9884937|FG008|NOT COMPLETED|Washout Period||0
8830304|NCT01632579|9884929|FG000|STARTED|Period 2 (Second Intervention)||1
8830305|NCT01632579|9884930|FG001|STARTED|Period 2 (Second Intervention)||6
8830306|NCT01632579|9884931|FG002|STARTED|Period 2 (Second Intervention)||2
8830307|NCT01632579|9884932|FG003|STARTED|Period 2 (Second Intervention)||2
8830308|NCT01632579|9884933|FG004|STARTED|Period 2 (Second Intervention)||6
8830309|NCT01632579|9884934|FG005|STARTED|Period 2 (Second Intervention)||2
8830310|NCT01632579|9884935|FG006|STARTED|Period 2 (Second Intervention)||2
8830311|NCT01632579|9884936|FG007|STARTED|Period 2 (Second Intervention)||6
8830312|NCT01632579|9884937|FG008|STARTED|Period 2 (Second Intervention)||2
8830313|NCT01632579|9884929|FG000|Received at Least 1 Dose|Period 2 (Second Intervention)||1
8830314|NCT01632579|9884930|FG001|Received at Least 1 Dose|Period 2 (Second Intervention)||6
8830315|NCT01632579|9884931|FG002|Received at Least 1 Dose|Period 2 (Second Intervention)||2
8830316|NCT01632579|9884932|FG003|Received at Least 1 Dose|Period 2 (Second Intervention)||2
8830317|NCT01632579|9884933|FG004|Received at Least 1 Dose|Period 2 (Second Intervention)||6
8830318|NCT01632579|9884934|FG005|Received at Least 1 Dose|Period 2 (Second Intervention)||2
8830319|NCT01632579|9884935|FG006|Received at Least 1 Dose|Period 2 (Second Intervention)||2
8830320|NCT01632579|9884936|FG007|Received at Least 1 Dose|Period 2 (Second Intervention)||6
8830321|NCT01632579|9884937|FG008|Received at Least 1 Dose|Period 2 (Second Intervention)||2
8830322|NCT01632579|9884929|FG000|COMPLETED|Period 2 (Second Intervention)||0
8830323|NCT01632579|9884930|FG001|COMPLETED|Period 2 (Second Intervention)||6
8830324|NCT01632579|9884931|FG002|COMPLETED|Period 2 (Second Intervention)||2
8830325|NCT01632579|9884932|FG003|COMPLETED|Period 2 (Second Intervention)||2
8830326|NCT01632579|9884933|FG004|COMPLETED|Period 2 (Second Intervention)||6
8830327|NCT01632579|9884934|FG005|COMPLETED|Period 2 (Second Intervention)||2
8830328|NCT01632579|9884935|FG006|COMPLETED|Period 2 (Second Intervention)||2
8830329|NCT01632579|9884936|FG007|COMPLETED|Period 2 (Second Intervention)||6
8830330|NCT01632579|9884937|FG008|COMPLETED|Period 2 (Second Intervention)||2
8830331|NCT01632579|9884929|FG000|NOT COMPLETED|Period 2 (Second Intervention)||1
8830332|NCT01632579|9884930|FG001|NOT COMPLETED|Period 2 (Second Intervention)||0
8830333|NCT01632579|9884931|FG002|NOT COMPLETED|Period 2 (Second Intervention)||0
8830334|NCT01632579|9884932|FG003|NOT COMPLETED|Period 2 (Second Intervention)||0
8830335|NCT01632579|9884933|FG004|NOT COMPLETED|Period 2 (Second Intervention)||0
8830336|NCT01632579|9884934|FG005|NOT COMPLETED|Period 2 (Second Intervention)||0
8830337|NCT01632579|9884935|FG006|NOT COMPLETED|Period 2 (Second Intervention)||0
8830338|NCT01632579|9884936|FG007|NOT COMPLETED|Period 2 (Second Intervention)||0
8830339|NCT01632579|9884937|FG008|NOT COMPLETED|Period 2 (Second Intervention)||0
8830340|NCT01632579|9884929|FG000|STARTED|Washout Period||0
8830341|NCT01632579|9884930|FG001|STARTED|Washout Period||6
8830342|NCT01632579|9884931|FG002|STARTED|Washout Period||2
8830343|NCT01632579|9884932|FG003|STARTED|Washout Period||2
8830344|NCT01632579|9884933|FG004|STARTED|Washout Period||6
8830345|NCT01632579|9884934|FG005|STARTED|Washout Period||2
8830346|NCT01632579|9884935|FG006|STARTED|Washout Period||2
8830347|NCT01632579|9884936|FG007|STARTED|Washout Period||6
8830348|NCT01632579|9884937|FG008|STARTED|Washout Period||2
8830349|NCT01632579|9884929|FG000|COMPLETED|Washout Period||0
8830350|NCT01632579|9884930|FG001|COMPLETED|Washout Period||6
8830351|NCT01632579|9884931|FG002|COMPLETED|Washout Period||2
8830352|NCT01632579|9884932|FG003|COMPLETED|Washout Period||2
8830353|NCT01632579|9884933|FG004|COMPLETED|Washout Period||6
8830354|NCT01632579|9884934|FG005|COMPLETED|Washout Period||2
8830355|NCT01632579|9884935|FG006|COMPLETED|Washout Period||2
8830356|NCT01632579|9884936|FG007|COMPLETED|Washout Period||6
8830357|NCT01632579|9884937|FG008|COMPLETED|Washout Period||2
8830358|NCT01632579|9884929|FG000|NOT COMPLETED|Washout Period||0
8830359|NCT01632579|9884930|FG001|NOT COMPLETED|Washout Period||0
8830360|NCT01632579|9884931|FG002|NOT COMPLETED|Washout Period||0
8830361|NCT01632579|9884932|FG003|NOT COMPLETED|Washout Period||0
8830362|NCT01632579|9884933|FG004|NOT COMPLETED|Washout Period||0
8830363|NCT01632579|9884934|FG005|NOT COMPLETED|Washout Period||0
8830364|NCT01632579|9884935|FG006|NOT COMPLETED|Washout Period||0
8830365|NCT01632579|9884936|FG007|NOT COMPLETED|Washout Period||0
8830366|NCT01632579|9884937|FG008|NOT COMPLETED|Washout Period||0
8830367|NCT01632579|9884929|FG000|STARTED|Period 3 (Third Intervention)||0
8830368|NCT01632579|9884930|FG001|STARTED|Period 3 (Third Intervention)||6
8830369|NCT01632579|9884931|FG002|STARTED|Period 3 (Third Intervention)||2
8830370|NCT01632579|9884932|FG003|STARTED|Period 3 (Third Intervention)||2
8830371|NCT01632579|9884933|FG004|STARTED|Period 3 (Third Intervention)||6
8830372|NCT01632579|9884934|FG005|STARTED|Period 3 (Third Intervention)||2
8830373|NCT01632579|9884935|FG006|STARTED|Period 3 (Third Intervention)||2
8830374|NCT01632579|9884936|FG007|STARTED|Period 3 (Third Intervention)||6
8830375|NCT01632579|9884937|FG008|STARTED|Period 3 (Third Intervention)||2
8830376|NCT01632579|9884929|FG000|Received at Least 1 Dose|Period 3 (Third Intervention)||0
8830377|NCT01632579|9884930|FG001|Received at Least 1 Dose|Period 3 (Third Intervention)||6
8830378|NCT01632579|9884931|FG002|Received at Least 1 Dose|Period 3 (Third Intervention)||2
8830379|NCT01632579|9884932|FG003|Received at Least 1 Dose|Period 3 (Third Intervention)||2
8830380|NCT01632579|9884933|FG004|Received at Least 1 Dose|Period 3 (Third Intervention)||6
8830381|NCT01632579|9884934|FG005|Received at Least 1 Dose|Period 3 (Third Intervention)||2
8830382|NCT01632579|9884935|FG006|Received at Least 1 Dose|Period 3 (Third Intervention)||2
8830383|NCT01632579|9884936|FG007|Received at Least 1 Dose|Period 3 (Third Intervention)||6
8830384|NCT01632579|9884937|FG008|Received at Least 1 Dose|Period 3 (Third Intervention)||2
8830385|NCT01632579|9884929|FG000|COMPLETED|Period 3 (Third Intervention)||0
8622534|NCT00488865|9661791|FG000|NOT COMPLETED|Overall Study||0
8622535|NCT00488982|9661795|FG000|STARTED|Induction Chemotherapy||125
8622536|NCT00488982|9661796|FG001|STARTED|Induction Chemotherapy||0
8622537|NCT00488982|9661797|FG002|STARTED|Induction Chemotherapy||0
8622538|NCT00488982|9661795|FG000|6 Cycles Completed|Induction Chemotherapy||94
8830386|NCT01632579|9884930|FG001|COMPLETED|Period 3 (Third Intervention)||6
8830387|NCT01632579|9884931|FG002|COMPLETED|Period 3 (Third Intervention)||2
8830388|NCT01632579|9884932|FG003|COMPLETED|Period 3 (Third Intervention)||2
8830389|NCT01632579|9884933|FG004|COMPLETED|Period 3 (Third Intervention)||6
8830390|NCT01632579|9884934|FG005|COMPLETED|Period 3 (Third Intervention)||2
8830391|NCT01632579|9884935|FG006|COMPLETED|Period 3 (Third Intervention)||2
8830392|NCT01632579|9884936|FG007|COMPLETED|Period 3 (Third Intervention)||6
8830393|NCT01632579|9884937|FG008|COMPLETED|Period 3 (Third Intervention)||2
8830394|NCT01632579|9884929|FG000|NOT COMPLETED|Period 3 (Third Intervention)||0
8830395|NCT01632579|9884930|FG001|NOT COMPLETED|Period 3 (Third Intervention)||0
8830396|NCT01632579|9884931|FG002|NOT COMPLETED|Period 3 (Third Intervention)||0
8830397|NCT01632579|9884932|FG003|NOT COMPLETED|Period 3 (Third Intervention)||0
8830398|NCT01632579|9884933|FG004|NOT COMPLETED|Period 3 (Third Intervention)||0
8830399|NCT01632579|9884934|FG005|NOT COMPLETED|Period 3 (Third Intervention)||0
8830400|NCT01632579|9884935|FG006|NOT COMPLETED|Period 3 (Third Intervention)||0
8830401|NCT01632579|9884936|FG007|NOT COMPLETED|Period 3 (Third Intervention)||0
8830402|NCT01632579|9884937|FG008|NOT COMPLETED|Period 3 (Third Intervention)||0
8830403|NCT01632683|9884963|FG000|STARTED|Overall Study||548
8830404|NCT01632683|9884964|FG001|STARTED|Overall Study||552
8830405|NCT01632683|9884963|FG000|COMPLETED|Overall Study||548
8830406|NCT01632683|9884964|FG001|COMPLETED|Overall Study||552
8830407|NCT01632683|9884963|FG000|NOT COMPLETED|Overall Study||0
8830408|NCT01632683|9884964|FG001|NOT COMPLETED|Overall Study||0
8830409|NCT01632709|9884974|FG000|STARTED|Overall Study||4
8830410|NCT01632709|9884975|FG001|STARTED|Overall Study||3
8830411|NCT01632709|9884976|FG002|STARTED|Overall Study||5
8830412|NCT01632709|9884977|FG003|STARTED|Overall Study||4
8830413|NCT01632709|9884974|FG000|Completed Visit 2 (Received Injection)|Overall Study||4
8830414|NCT01632709|9884975|FG001|Completed Visit 2 (Received Injection)|Overall Study||2
8830415|NCT01632709|9884976|FG002|Completed Visit 2 (Received Injection)|Overall Study||5
8830416|NCT01632709|9884977|FG003|Completed Visit 2 (Received Injection)|Overall Study||3
8830417|NCT01632709|9884974|FG000|COMPLETED|Overall Study||2
8830418|NCT01632709|9884975|FG001|COMPLETED|Overall Study||2
8830419|NCT01632709|9884976|FG002|COMPLETED|Overall Study||5
8830420|NCT01632709|9884977|FG003|COMPLETED|Overall Study||3
8830421|NCT01632709|9884974|FG000|NOT COMPLETED|Overall Study||2
8830422|NCT01632709|9884975|FG001|NOT COMPLETED|Overall Study||1
8830423|NCT01632709|9884976|FG002|NOT COMPLETED|Overall Study||0
8830424|NCT01632709|9884977|FG003|NOT COMPLETED|Overall Study||1
8830425|NCT01632735|9884987|FG000|STARTED|Overall Study||40
8830426|NCT01632735|9884988|FG001|STARTED|Overall Study||40
8830427|NCT01632735|9884987|FG000|COMPLETED|Overall Study||36
8830428|NCT01632735|9884988|FG001|COMPLETED|Overall Study||37
8830429|NCT01632735|9884987|FG000|NOT COMPLETED|Overall Study||4
8830430|NCT01632735|9884988|FG001|NOT COMPLETED|Overall Study||3
8830431|NCT01632800|9884994|FG000|STARTED|Overall Study||26
8830432|NCT01632800|9884994|FG000|COMPLETED|Overall Study||25
8830433|NCT01632800|9884994|FG000|NOT COMPLETED|Overall Study||1
8830434|NCT01632891|9885000|FG000|STARTED|Overall Study||26
8830435|NCT01632891|9885001|FG001|STARTED|Overall Study||26
8830436|NCT01632891|9885000|FG000|COMPLETED|Overall Study||25
8830437|NCT01632891|9885001|FG001|COMPLETED|Overall Study||25
8830438|NCT01632891|9885000|FG000|NOT COMPLETED|Overall Study||1
8830439|NCT01632891|9885001|FG001|NOT COMPLETED|Overall Study||1
8830440|NCT01632904|9885013|FG000|STARTED|Overall Study||54
8830441|NCT01632904|9885014|FG001|STARTED|Overall Study||56
8830442|NCT01632904|9885013|FG000|COMPLETED|Overall Study|Patients still in the study as of data cutoff, 27MAR2014.|47
8830443|NCT01632904|9885014|FG001|COMPLETED|Overall Study|Patients still in the study as of 27MAR2014, including those who crossed over to ruxolitinib|50
8830444|NCT01632904|9885013|FG000|NOT COMPLETED|Overall Study||7
8830445|NCT01632904|9885014|FG001|NOT COMPLETED|Overall Study||6
8830446|NCT01632995|9885020|FG000|STARTED|Pre-screening to Enrollment Period||1069
8830447|NCT01632995|9885020|FG000|COMPLETED|Pre-screening to Enrollment Period||557
8830448|NCT01632995|9885020|FG000|NOT COMPLETED|Pre-screening to Enrollment Period||512
8830449|NCT01632995|9885020|FG000|STARTED|Main Study Follow-up Period||557
8830450|NCT01632995|9885020|FG000|COMPLETED|Main Study Follow-up Period||437
8830451|NCT01632995|9885020|FG000|NOT COMPLETED|Main Study Follow-up Period||120
8830452|NCT01633060|9885028|FG000|STARTED|Randomization Phase|All randomized patients|289
8830453|NCT01633060|9885029|FG001|STARTED|Randomization Phase|All randomized patients|143
8830454|NCT01633060|9885028|FG000|COMPLETED|Randomization Phase||288
8830455|NCT01633060|9885029|FG001|COMPLETED|Randomization Phase||140
8830456|NCT01633060|9885028|FG000|NOT COMPLETED|Randomization Phase||1
8830457|NCT01633060|9885029|FG001|NOT COMPLETED|Randomization Phase||3
8830458|NCT01633060|9885028|FG000|STARTED|Treatment Phase||288
8830459|NCT01633060|9885029|FG001|STARTED|Treatment Phase||140
8830460|NCT01633060|9885028|FG000|FAS - ctDNA PIK3CA Mutant|Treatment Phase||100
8830461|NCT01633060|9885029|FG001|FAS - ctDNA PIK3CA Mutant|Treatment Phase||35
8830462|NCT01633060|9885028|FG000|FAS - ctDNA PIK3CA Non-mutant|Treatment Phase||132
8830463|NCT01633060|9885029|FG001|FAS - ctDNA PIK3CA Non-mutant|Treatment Phase||81
8830464|NCT01633060|9885028|FG000|Safety Set (SS)|Treatment Phase||288
8830465|NCT01633060|9885029|FG001|Safety Set (SS)|Treatment Phase||140
8830466|NCT01633060|9885028|FG000|Pharmacokinetic Analysis Set (PAS)|Treatment Phase||63
8830467|NCT01633060|9885029|FG001|Pharmacokinetic Analysis Set (PAS)|Treatment Phase||0
8830468|NCT01633060|9885028|FG000|COMPLETED|Treatment Phase||0
8830469|NCT01633060|9885029|FG001|COMPLETED|Treatment Phase||0
8830470|NCT01633060|9885028|FG000|NOT COMPLETED|Treatment Phase||288
8830471|NCT01633060|9885029|FG001|NOT COMPLETED|Treatment Phase||140
8830472|NCT01633060|9885028|FG000|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|16
8830473|NCT01633060|9885029|FG001|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|2
8830474|NCT01633060|9885028|FG000|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
8830475|NCT01633060|9885029|FG001|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
8830476|NCT01633060|9885028|FG000|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||16
8849758|NCT01743027|9905010|FG000|NOT COMPLETED|Overall Study||5
8830477|NCT01633060|9885029|FG001|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||2
8830478|NCT01633112|9885039|FG000|STARTED|Overall Study||352
8830479|NCT01633112|9885040|FG001|STARTED|Overall Study||370
8830480|NCT01633112|9885041|FG002|STARTED|Overall Study||342
8830481|NCT01633112|9885039|FG000|COMPLETED|Overall Study||299
8830482|NCT01633112|9885040|FG001|COMPLETED|Overall Study||310
8830483|NCT01633112|9885041|FG002|COMPLETED|Overall Study||250
8830484|NCT01633112|9885039|FG000|NOT COMPLETED|Overall Study||53
8830485|NCT01633112|9885040|FG001|NOT COMPLETED|Overall Study||60
8830486|NCT01633112|9885041|FG002|NOT COMPLETED|Overall Study||92
8830487|NCT01633320|9885052|FG000|STARTED|Overall Study||132
8830488|NCT01633320|9885053|FG001|STARTED|Overall Study||68
8830489|NCT01633320|9885052|FG000|COMPLETED|Overall Study||132
8830490|NCT01633320|9885053|FG001|COMPLETED|Overall Study||68
8830491|NCT01633320|9885052|FG000|NOT COMPLETED|Overall Study||0
8830492|NCT01633320|9885053|FG001|NOT COMPLETED|Overall Study||0
8830493|NCT01633398|9885061|FG000|STARTED|Overall Study||4779
8830494|NCT01633398|9885062|FG001|STARTED|Overall Study||1550
8830495|NCT01633398|9885061|FG000|COMPLETED|Overall Study||4779
8830496|NCT01633398|9885062|FG001|COMPLETED|Overall Study||1550
8830497|NCT01633398|9885061|FG000|NOT COMPLETED|Overall Study||0
8830498|NCT01633398|9885062|FG001|NOT COMPLETED|Overall Study||0
8830499|NCT01633788|9885072|FG000|STARTED|Overall Study||57
8830500|NCT01633788|9885073|FG001|STARTED|Overall Study||58
8830501|NCT01633788|9885074|FG002|STARTED|Overall Study||59
8830502|NCT01633788|9885075|FG003|STARTED|Overall Study||58
8830503|NCT01633788|9885072|FG000|COMPLETED|Overall Study||50
8830504|NCT01633788|9885073|FG001|COMPLETED|Overall Study||50
8830505|NCT01633788|9885074|FG002|COMPLETED|Overall Study||49
8830506|NCT01633788|9885075|FG003|COMPLETED|Overall Study||45
8830507|NCT01633788|9885072|FG000|NOT COMPLETED|Overall Study||7
8830508|NCT01633788|9885073|FG001|NOT COMPLETED|Overall Study||8
8830509|NCT01633788|9885074|FG002|NOT COMPLETED|Overall Study||10
8830510|NCT01633788|9885075|FG003|NOT COMPLETED|Overall Study||13
8830511|NCT01633827|9885085|FG000|STARTED|First Intervention||11
8830512|NCT01633827|9885086|FG001|STARTED|First Intervention||11
8830513|NCT01633827|9885085|FG000|COMPLETED|First Intervention||11
8830514|NCT01633827|9885086|FG001|COMPLETED|First Intervention||11
8830515|NCT01633827|9885085|FG000|NOT COMPLETED|First Intervention||0
8830516|NCT01633827|9885086|FG001|NOT COMPLETED|First Intervention||0
8830517|NCT01633827|9885085|FG000|STARTED|Washout Period||11
8830518|NCT01633827|9885086|FG001|STARTED|Washout Period||11
8830519|NCT01633827|9885085|FG000|COMPLETED|Washout Period||11
8830520|NCT01633827|9885086|FG001|COMPLETED|Washout Period||11
8830521|NCT01633827|9885085|FG000|NOT COMPLETED|Washout Period||0
8830522|NCT01633827|9885086|FG001|NOT COMPLETED|Washout Period||0
8830523|NCT01633827|9885085|FG000|STARTED|Second Intervention||11
8830524|NCT01633827|9885086|FG001|STARTED|Second Intervention||11
8830525|NCT01633827|9885085|FG000|COMPLETED|Second Intervention||11
8830526|NCT01633827|9885086|FG001|COMPLETED|Second Intervention||11
8830527|NCT01633827|9885085|FG000|NOT COMPLETED|Second Intervention||0
8830528|NCT01633827|9885086|FG001|NOT COMPLETED|Second Intervention||0
8830529|NCT01633853|9885101|FG000|STARTED|Overall Study||104
8830530|NCT01633853|9885102|FG001|STARTED|Overall Study||100
8830531|NCT01633853|9885101|FG000|COMPLETED|Overall Study||104
8830532|NCT01633853|9885102|FG001|COMPLETED|Overall Study||100
8830533|NCT01633853|9885101|FG000|NOT COMPLETED|Overall Study||0
8830534|NCT01633853|9885102|FG001|NOT COMPLETED|Overall Study||0
8830535|NCT01633892|9885109|FG000|STARTED|Overall Study||5
8830536|NCT01633892|9885109|FG000|COMPLETED|Overall Study||5
8830537|NCT01633892|9885109|FG000|NOT COMPLETED|Overall Study||0
8830538|NCT01633944|9885115|FG000|STARTED|Open-label Titration Phase||752
8830539|NCT01633944|9885116|FG001|STARTED|Open-label Titration Phase||0
8830540|NCT01633944|9885117|FG002|STARTED|Open-label Titration Phase||0
8830541|NCT01633944|9885115|FG000|COMPLETED|Open-label Titration Phase||462
8830542|NCT01633944|9885116|FG001|COMPLETED|Open-label Titration Phase||0
8830543|NCT01633944|9885117|FG002|COMPLETED|Open-label Titration Phase||0
8830544|NCT01633944|9885115|FG000|NOT COMPLETED|Open-label Titration Phase||290
8830545|NCT01633944|9885116|FG001|NOT COMPLETED|Open-label Titration Phase||0
8830546|NCT01633944|9885117|FG002|NOT COMPLETED|Open-label Titration Phase||0
8830547|NCT01633944|9885115|FG000|STARTED|Double-blind Treatment Phase|All subjects completing OL titration in the previous period were randomized to a DB treatment.|0
8830548|NCT01633944|9885116|FG001|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|230
8830549|NCT01633944|9885117|FG002|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|232
8830550|NCT01633944|9885115|FG000|COMPLETED|Double-blind Treatment Phase||0
8830551|NCT01633944|9885116|FG001|COMPLETED|Double-blind Treatment Phase||176
8830552|NCT01633944|9885117|FG002|COMPLETED|Double-blind Treatment Phase||174
8830553|NCT01633944|9885115|FG000|NOT COMPLETED|Double-blind Treatment Phase||0
8830554|NCT01633944|9885116|FG001|NOT COMPLETED|Double-blind Treatment Phase||54
8830555|NCT01633944|9885117|FG002|NOT COMPLETED|Double-blind Treatment Phase||58
8830556|NCT01634100|9885125|FG000|STARTED|Overall Study||3
8830557|NCT01634100|9885126|FG001|STARTED|Overall Study||3
8830558|NCT01634100|9885127|FG002|STARTED|Overall Study||3
8830559|NCT01634100|9885128|FG003|STARTED|Overall Study||3
8830560|NCT01634100|9885129|FG004|STARTED|Overall Study||3
8830561|NCT01634100|9885130|FG005|STARTED|Overall Study||3
8830562|NCT01634100|9885125|FG000|Received Empa Alone|Overall Study||3
8830563|NCT01634100|9885126|FG001|Received Empa Alone|Overall Study||3
8830564|NCT01634100|9885127|FG002|Received Empa Alone|Overall Study||3
8830565|NCT01634100|9885128|FG003|Received Empa Alone|Overall Study||3
8830566|NCT01634100|9885129|FG004|Received Empa Alone|Overall Study||3
8830567|NCT01634100|9885130|FG005|Received Empa Alone|Overall Study||3
8830568|NCT01634100|9885125|FG000|Received Empa + Rifampicin|Overall Study||3
8830569|NCT01634100|9885126|FG001|Received Empa + Rifampicin|Overall Study||3
8830570|NCT01634100|9885127|FG002|Received Empa + Rifampicin|Overall Study||3
8830571|NCT01634100|9885128|FG003|Received Empa + Rifampicin|Overall Study||3
8830572|NCT01634100|9885129|FG004|Received Empa + Rifampicin|Overall Study||3
8830573|NCT01634100|9885130|FG005|Received Empa + Rifampicin|Overall Study||3
8830574|NCT01634100|9885125|FG000|Received Empa + Probenecid|Overall Study||2
8830575|NCT01634100|9885126|FG001|Received Empa + Probenecid|Overall Study||3
8830576|NCT01634100|9885127|FG002|Received Empa + Probenecid|Overall Study||2
8830577|NCT01634100|9885128|FG003|Received Empa + Probenecid|Overall Study||3
8830578|NCT01634100|9885129|FG004|Received Empa + Probenecid|Overall Study||3
8830579|NCT01634100|9885130|FG005|Received Empa + Probenecid|Overall Study||3
8830580|NCT01634100|9885125|FG000|COMPLETED|Overall Study||2
8830581|NCT01634100|9885126|FG001|COMPLETED|Overall Study||3
8830582|NCT01634100|9885127|FG002|COMPLETED|Overall Study||2
8830583|NCT01634100|9885128|FG003|COMPLETED|Overall Study||3
8830584|NCT01634100|9885129|FG004|COMPLETED|Overall Study||3
8830585|NCT01634100|9885130|FG005|COMPLETED|Overall Study||3
8830586|NCT01634100|9885125|FG000|NOT COMPLETED|Overall Study||1
8830587|NCT01634100|9885126|FG001|NOT COMPLETED|Overall Study||0
8830588|NCT01634100|9885127|FG002|NOT COMPLETED|Overall Study||1
8830589|NCT01634100|9885128|FG003|NOT COMPLETED|Overall Study||0
8830590|NCT01634100|9885129|FG004|NOT COMPLETED|Overall Study||0
8830591|NCT01634100|9885130|FG005|NOT COMPLETED|Overall Study||0
8830592|NCT01634113|9885141|FG000|STARTED|Overall Study||34
8830593|NCT01634113|9885142|FG001|STARTED|Overall Study||36
8830594|NCT01634113|9885143|FG002|STARTED|Overall Study||32
8830595|NCT01634113|9885141|FG000|COMPLETED|Overall Study||34
8830596|NCT01634113|9885142|FG001|COMPLETED|Overall Study||36
8830597|NCT01634113|9885143|FG002|COMPLETED|Overall Study||31
8830598|NCT01634113|9885141|FG000|NOT COMPLETED|Overall Study||0
8830599|NCT01634113|9885142|FG001|NOT COMPLETED|Overall Study||0
8830600|NCT01634113|9885143|FG002|NOT COMPLETED|Overall Study||1
8830601|NCT01634139|9885154|FG000|STARTED|Overall Study||132
8830602|NCT01634139|9885155|FG001|STARTED|Overall Study||136
8830603|NCT01634139|9885156|FG002|STARTED|Overall Study||135
8830604|NCT01634139|9885154|FG000|COMPLETED|Overall Study||122
8830605|NCT01634139|9885155|FG001|COMPLETED|Overall Study||130
8830606|NCT01634139|9885156|FG002|COMPLETED|Overall Study||130
8830607|NCT01634139|9885154|FG000|NOT COMPLETED|Overall Study||10
8830608|NCT01634139|9885155|FG001|NOT COMPLETED|Overall Study||6
8830609|NCT01634139|9885156|FG002|NOT COMPLETED|Overall Study||5
8830610|NCT01634152|9885167|FG000|STARTED|Overall Study||134
8830611|NCT01634152|9885168|FG001|STARTED|Overall Study||137
8830612|NCT01634152|9885169|FG002|STARTED|Overall Study||130
8830613|NCT01634152|9885167|FG000|COMPLETED|Overall Study||130
8830614|NCT01634152|9885168|FG001|COMPLETED|Overall Study||136
8830615|NCT01634152|9885169|FG002|COMPLETED|Overall Study||126
8830616|NCT01634152|9885167|FG000|NOT COMPLETED|Overall Study||4
8830617|NCT01634152|9885168|FG001|NOT COMPLETED|Overall Study||1
8830618|NCT01634152|9885169|FG002|NOT COMPLETED|Overall Study||4
8830619|NCT01634165|9885177|FG000|STARTED|Period 1||6
8830620|NCT01634165|9885178|FG001|STARTED|Period 1||6
8830621|NCT01634165|9885179|FG002|STARTED|Period 1||6
8830622|NCT01634165|9885180|FG003|STARTED|Period 1||6
8830623|NCT01634165|9885177|FG000|Received at Least 1 Dose of Study Drug|Period 1||6
8830624|NCT01634165|9885178|FG001|Received at Least 1 Dose of Study Drug|Period 1||6
8830625|NCT01634165|9885179|FG002|Received at Least 1 Dose of Study Drug|Period 1||6
8830626|NCT01634165|9885180|FG003|Received at Least 1 Dose of Study Drug|Period 1||6
8830627|NCT01634165|9885177|FG000|COMPLETED|Period 1||6
8830628|NCT01634165|9885178|FG001|COMPLETED|Period 1||6
8830629|NCT01634165|9885179|FG002|COMPLETED|Period 1||6
8830630|NCT01634165|9885180|FG003|COMPLETED|Period 1||6
8830631|NCT01634165|9885177|FG000|NOT COMPLETED|Period 1||0
8830632|NCT01634165|9885178|FG001|NOT COMPLETED|Period 1||0
8830633|NCT01634165|9885179|FG002|NOT COMPLETED|Period 1||0
8830634|NCT01634165|9885180|FG003|NOT COMPLETED|Period 1||0
8830635|NCT01634165|9885177|FG000|STARTED|Period 2||6
8830636|NCT01634165|9885178|FG001|STARTED|Period 2||6
8830637|NCT01634165|9885179|FG002|STARTED|Period 2||6
8830638|NCT01634165|9885180|FG003|STARTED|Period 2||6
8830639|NCT01634165|9885177|FG000|COMPLETED|Period 2||6
8830640|NCT01634165|9885178|FG001|COMPLETED|Period 2||5
8830641|NCT01634165|9885179|FG002|COMPLETED|Period 2||6
8830642|NCT01634165|9885180|FG003|COMPLETED|Period 2||6
8830643|NCT01634165|9885177|FG000|NOT COMPLETED|Period 2||0
8830644|NCT01634165|9885178|FG001|NOT COMPLETED|Period 2||1
8830645|NCT01634165|9885179|FG002|NOT COMPLETED|Period 2||0
8830646|NCT01634165|9885180|FG003|NOT COMPLETED|Period 2||0
8830647|NCT01634165|9885177|FG000|STARTED|Period 3||6
8830648|NCT01634165|9885178|FG001|STARTED|Period 3||5
8830649|NCT01634165|9885179|FG002|STARTED|Period 3||6
8830650|NCT01634165|9885180|FG003|STARTED|Period 3||6
8830651|NCT01634165|9885177|FG000|COMPLETED|Period 3||6
8830652|NCT01634165|9885178|FG001|COMPLETED|Period 3||5
8830653|NCT01634165|9885179|FG002|COMPLETED|Period 3||6
8830654|NCT01634165|9885180|FG003|COMPLETED|Period 3||6
8830655|NCT01634165|9885177|FG000|NOT COMPLETED|Period 3||0
8830656|NCT01634165|9885178|FG001|NOT COMPLETED|Period 3||0
8830657|NCT01634165|9885179|FG002|NOT COMPLETED|Period 3||0
8830658|NCT01634165|9885180|FG003|NOT COMPLETED|Period 3||0
8830659|NCT01634165|9885177|FG000|STARTED|Period 4||6
8830660|NCT01634165|9885178|FG001|STARTED|Period 4||5
8830661|NCT01634165|9885179|FG002|STARTED|Period 4||6
8830662|NCT01634165|9885180|FG003|STARTED|Period 4||6
8830663|NCT01634165|9885177|FG000|COMPLETED|Period 4||6
8830664|NCT01634165|9885178|FG001|COMPLETED|Period 4||5
8830665|NCT01634165|9885179|FG002|COMPLETED|Period 4||6
8830666|NCT01634165|9885180|FG003|COMPLETED|Period 4||6
8830667|NCT01634165|9885177|FG000|NOT COMPLETED|Period 4||0
8830668|NCT01634165|9885178|FG001|NOT COMPLETED|Period 4||0
8830669|NCT01634165|9885179|FG002|NOT COMPLETED|Period 4||0
8830670|NCT01634165|9885180|FG003|NOT COMPLETED|Period 4||0
8830671|NCT01634178|9885190|FG000|STARTED|Treatment Period 1||23
8830672|NCT01634178|9885191|FG001|STARTED|Treatment Period 1||23
8830673|NCT01634178|9885190|FG000|COMPLETED|Treatment Period 1||23
8830674|NCT01634178|9885191|FG001|COMPLETED|Treatment Period 1||22
8830675|NCT01634178|9885190|FG000|NOT COMPLETED|Treatment Period 1||0
8830676|NCT01634178|9885191|FG001|NOT COMPLETED|Treatment Period 1||1
8830677|NCT01634178|9885190|FG000|STARTED|Treatment Period 2||23
8830678|NCT01634178|9885191|FG001|STARTED|Treatment Period 2||22
8830679|NCT01634178|9885190|FG000|COMPLETED|Treatment Period 2||22
8830680|NCT01634178|9885191|FG001|COMPLETED|Treatment Period 2||22
8830681|NCT01634178|9885190|FG000|NOT COMPLETED|Treatment Period 2||1
8830682|NCT01634178|9885191|FG001|NOT COMPLETED|Treatment Period 2||0
8830683|NCT01634191|9885202|FG000|STARTED|Overall Study||18
8830684|NCT01634191|9885203|FG001|STARTED|Overall Study||18
8830685|NCT01634191|9885202|FG000|COMPLETED|Overall Study||18
8830686|NCT01634191|9885203|FG001|COMPLETED|Overall Study||18
8830687|NCT01634191|9885202|FG000|NOT COMPLETED|Overall Study||0
8830688|NCT01634191|9885203|FG001|NOT COMPLETED|Overall Study||0
8830689|NCT01634243|9885222|FG000|STARTED|Overall Study||21
8830690|NCT01634243|9885223|FG001|STARTED|Overall Study||43
8830691|NCT01634243|9885222|FG000|COMPLETED|Overall Study||15
8830692|NCT01634243|9885223|FG001|COMPLETED|Overall Study||38
8830693|NCT01634243|9885222|FG000|NOT COMPLETED|Overall Study||6
8830694|NCT01634243|9885223|FG001|NOT COMPLETED|Overall Study||5
8944174|NCT02394756|10006002|FG001|NOT COMPLETED|Period 2||0
8944175|NCT02394756|10006003|FG002|NOT COMPLETED|Period 2||0
8944176|NCT02394756|10006004|FG003|NOT COMPLETED|Period 2||0
8944177|NCT02394756|10006005|FG004|NOT COMPLETED|Period 2||1
8944178|NCT02394756|10006006|FG005|NOT COMPLETED|Period 2||0
8944179|NCT02394756|10006001|FG000|STARTED|Period 3||7
8944180|NCT02394756|10006002|FG001|STARTED|Period 3||6
8944181|NCT02394756|10006003|FG002|STARTED|Period 3||6
8944182|NCT02394756|10006004|FG003|STARTED|Period 3||6
8944183|NCT02394756|10006005|FG004|STARTED|Period 3||6
8944184|NCT02394756|10006006|FG005|STARTED|Period 3||6
8944185|NCT02394756|10006001|FG000|COMPLETED|Period 3||7
8944186|NCT02394756|10006002|FG001|COMPLETED|Period 3||6
8944187|NCT02394756|10006003|FG002|COMPLETED|Period 3||6
8944188|NCT02394756|10006004|FG003|COMPLETED|Period 3||6
8944189|NCT02394756|10006005|FG004|COMPLETED|Period 3||6
8944190|NCT02394756|10006006|FG005|COMPLETED|Period 3||6
8944191|NCT02394756|10006001|FG000|NOT COMPLETED|Period 3||0
8944192|NCT02394756|10006002|FG001|NOT COMPLETED|Period 3||0
8944193|NCT02394756|10006003|FG002|NOT COMPLETED|Period 3||0
8944194|NCT02394756|10006004|FG003|NOT COMPLETED|Period 3||0
8944195|NCT02394756|10006005|FG004|NOT COMPLETED|Period 3||0
8944196|NCT02394756|10006006|FG005|NOT COMPLETED|Period 3||0
8944197|NCT02394769|10006017|FG000|STARTED|Overall Study||60
8944198|NCT02394769|10006018|FG001|STARTED|Overall Study||60
8944199|NCT02394769|10006019|FG002|STARTED|Overall Study||60
8944200|NCT02394769|10006017|FG000|COMPLETED|Overall Study||58
8944201|NCT02394769|10006018|FG001|COMPLETED|Overall Study||57
8944202|NCT02394769|10006019|FG002|COMPLETED|Overall Study||54
8944203|NCT02394769|10006017|FG000|NOT COMPLETED|Overall Study||2
8944204|NCT02394769|10006018|FG001|NOT COMPLETED|Overall Study||3
8944205|NCT02394769|10006019|FG002|NOT COMPLETED|Overall Study||6
8944206|NCT02394808|10006027|FG000|STARTED|Period 1||25
8944207|NCT02394808|10006028|FG001|STARTED|Period 1||29
8944208|NCT02394808|10006027|FG000|COMPLETED|Period 1||25
8944209|NCT02394808|10006028|FG001|COMPLETED|Period 1||28
8944210|NCT02394808|10006027|FG000|NOT COMPLETED|Period 1||0
8944211|NCT02394808|10006028|FG001|NOT COMPLETED|Period 1||1
8830695|NCT01634256|9885231|FG000|STARTED|Overall Study||30
8830696|NCT01634256|9885232|FG001|STARTED|Overall Study||30
8830697|NCT01634256|9885231|FG000|COMPLETED|Overall Study||26
8830698|NCT01634256|9885232|FG001|COMPLETED|Overall Study||22
8830699|NCT01634256|9885231|FG000|NOT COMPLETED|Overall Study||4
8944212|NCT02394808|10006027|FG000|STARTED|Period 2||25
8944213|NCT02394808|10006028|FG001|STARTED|Period 2||28
8944214|NCT02394808|10006027|FG000|COMPLETED|Period 2||24
8944215|NCT02394808|10006028|FG001|COMPLETED|Period 2||28
8944216|NCT02394808|10006027|FG000|NOT COMPLETED|Period 2||1
8944217|NCT02394808|10006028|FG001|NOT COMPLETED|Period 2||0
8944218|NCT02394912|10006034|FG000|STARTED|Overall Study||21
8944219|NCT02394912|10006034|FG000|COMPLETED|Overall Study||21
8944220|NCT02394912|10006034|FG000|NOT COMPLETED|Overall Study||0
8944221|NCT02394925|10006040|FG000|STARTED|Overall Study||108
8944222|NCT02394925|10006040|FG000|COMPLETED|Overall Study||79
8944223|NCT02394925|10006040|FG000|NOT COMPLETED|Overall Study||29
8944224|NCT02394951|10006046|FG000|STARTED|Period I||12
8830700|NCT01634256|9885232|FG001|NOT COMPLETED|Overall Study||8
8830701|NCT01634269|9885238|FG000|STARTED|Overall Study||20
8830702|NCT01634269|9885238|FG000|30 Days|Overall Study||20
8830703|NCT01634269|9885238|FG000|6 Month|Overall Study||20
8830704|NCT01634269|9885238|FG000|12 Month|Overall Study||20
8830705|NCT01634269|9885238|FG000|24 Month|Overall Study||18
8830706|NCT01634269|9885238|FG000|COMPLETED|Overall Study||18
8830707|NCT01634269|9885238|FG000|NOT COMPLETED|Overall Study||2
8830708|NCT01634360|9885250|FG000|STARTED|Overall Study||49
8830709|NCT01634360|9885251|FG001|STARTED|Overall Study||136
8830710|NCT01634360|9885250|FG000|COMPLETED|Overall Study||0
8830711|NCT01634360|9885251|FG001|COMPLETED|Overall Study||0
8830712|NCT01634360|9885250|FG000|NOT COMPLETED|Overall Study||49
8830713|NCT01634360|9885251|FG001|NOT COMPLETED|Overall Study||136
8830714|NCT01634555|9885257|FG000|STARTED|Overall Study||29
8830715|NCT01634555|9885257|FG000|Received at Least 1 Dose of Study Drug|Overall Study||29
8830716|NCT01634555|9885257|FG000|Drug-Drug Interaction (DDI) Population|Overall Study|Completed the required treatment in Cycle 1, Day 1 and Cycle 2, Day 1.|25
8830717|NCT01634555|9885257|FG000|COMPLETED|Overall Study|Completed the required treatment and assessment.|25
8830718|NCT01634555|9885257|FG000|NOT COMPLETED|Overall Study||4
8830719|NCT01634620|9885262|FG000|STARTED|Overall Study||200
8830720|NCT01634620|9885262|FG000|COMPLETED|Overall Study||200
8830721|NCT01634620|9885262|FG000|NOT COMPLETED|Overall Study||0
8830722|NCT01634659|9885273|FG000|STARTED|Period 1 - First 8 Days of Wear||155
8830723|NCT01634659|9885274|FG001|STARTED|Period 1 - First 8 Days of Wear||158
8830724|NCT01634659|9885273|FG000|COMPLETED|Period 1 - First 8 Days of Wear||155
8830725|NCT01634659|9885274|FG001|COMPLETED|Period 1 - First 8 Days of Wear||158
8830726|NCT01634659|9885273|FG000|NOT COMPLETED|Period 1 - First 8 Days of Wear||0
8830727|NCT01634659|9885274|FG001|NOT COMPLETED|Period 1 - First 8 Days of Wear||0
8830728|NCT01634659|9885273|FG000|STARTED|Period 2 - Second 8 Days of Wear||155
8830729|NCT01634659|9885274|FG001|STARTED|Period 2 - Second 8 Days of Wear||158
8830730|NCT01634659|9885273|FG000|COMPLETED|Period 2 - Second 8 Days of Wear||152
8830731|NCT01634659|9885274|FG001|COMPLETED|Period 2 - Second 8 Days of Wear||158
8830732|NCT01634659|9885273|FG000|NOT COMPLETED|Period 2 - Second 8 Days of Wear||3
8830733|NCT01634659|9885274|FG001|NOT COMPLETED|Period 2 - Second 8 Days of Wear||0
8830734|NCT01634854|9885282|FG000|STARTED|Overall Study||64
8830735|NCT01634854|9885283|FG001|STARTED|Overall Study||66
8830736|NCT01634854|9885282|FG000|COMPLETED|Overall Study||62
8830737|NCT01634854|9885283|FG001|COMPLETED|Overall Study||59
8830738|NCT01634854|9885282|FG000|NOT COMPLETED|Overall Study||2
8830739|NCT01634854|9885283|FG001|NOT COMPLETED|Overall Study||7
8830740|NCT01635062|9885291|FG000|STARTED|Overall Study||9
8830741|NCT01635062|9885292|FG001|STARTED|Overall Study||9
8830742|NCT01635062|9885291|FG000|Sodium Restriction Baseline Visit|Overall Study||9
8830743|NCT01635062|9885292|FG001|Sodium Restriction Baseline Visit|Overall Study||9
8830744|NCT01635062|9885291|FG000|Sodium Loading Baseline Visit|Overall Study||9
8830745|NCT01635062|9885292|FG001|Sodium Loading Baseline Visit|Overall Study||9
8830746|NCT01635062|9885291|FG000|Post-randomization Sodium Restriction|Overall Study||9
8830747|NCT01635062|9885292|FG001|Post-randomization Sodium Restriction|Overall Study||9
8830748|NCT01635062|9885291|FG000|Post-Randomization Sodium Loaded|Overall Study||9
8830749|NCT01635062|9885292|FG001|Post-Randomization Sodium Loaded|Overall Study||9
8830750|NCT01635062|9885291|FG000|COMPLETED|Overall Study||9
8830751|NCT01635062|9885292|FG001|COMPLETED|Overall Study||9
8830752|NCT01635062|9885291|FG000|NOT COMPLETED|Overall Study||0
8622539|NCT00488982|9661796|FG001|6 Cycles Completed|Induction Chemotherapy||0
8622540|NCT00488982|9661797|FG002|6 Cycles Completed|Induction Chemotherapy||0
8622541|NCT00488982|9661795|FG000|≥ 50% Prostate-specific Antigen Decline|Induction Chemotherapy||52
8622542|NCT00488982|9661796|FG001|≥ 50% Prostate-specific Antigen Decline|Induction Chemotherapy||0
8830753|NCT01635062|9885292|FG001|NOT COMPLETED|Overall Study||0
8830754|NCT01635101|9885305|FG000|STARTED|Overall Study||61
8830755|NCT01635101|9885306|FG001|STARTED|Overall Study||67
8830756|NCT01635101|9885307|FG002|STARTED|Overall Study||69
8830757|NCT01635101|9885305|FG000|Safety Population|Overall Study||61
8830758|NCT01635101|9885306|FG001|Safety Population|Overall Study||67
8830759|NCT01635101|9885307|FG002|Safety Population|Overall Study||69
8830760|NCT01635101|9885305|FG000|Modified Intent to Treat (mITT)|Overall Study||61
8830761|NCT01635101|9885306|FG001|Modified Intent to Treat (mITT)|Overall Study||67
8830762|NCT01635101|9885307|FG002|Modified Intent to Treat (mITT)|Overall Study||69
8830763|NCT01635101|9885305|FG000|Pharmacokinetics Evaluable Population|Overall Study||50
8830764|NCT01635101|9885306|FG001|Pharmacokinetics Evaluable Population|Overall Study||59
8830765|NCT01635101|9885307|FG002|Pharmacokinetics Evaluable Population|Overall Study||58
8830766|NCT01635101|9885305|FG000|COMPLETED|Overall Study||52
8830767|NCT01635101|9885306|FG001|COMPLETED|Overall Study||55
8830768|NCT01635101|9885307|FG002|COMPLETED|Overall Study||52
8830769|NCT01635101|9885305|FG000|NOT COMPLETED|Overall Study||9
8830770|NCT01635101|9885306|FG001|NOT COMPLETED|Overall Study||12
8830771|NCT01635101|9885307|FG002|NOT COMPLETED|Overall Study||17
8849759|NCT01743027|9905011|FG001|NOT COMPLETED|Overall Study||5
8849760|NCT01743027|9905012|FG002|NOT COMPLETED|Overall Study||9
8849761|NCT01743027|9905013|FG003|NOT COMPLETED|Overall Study||1
8849762|NCT01743040|9905023|FG000|STARTED|Overall Study||1014
8849763|NCT01743040|9905023|FG000|CADence Testing|Overall Study||1013
8849764|NCT01743040|9905023|FG000|Nuclear Stress Test|Overall Study||992
8849765|NCT01743040|9905023|FG000|CT and/or Standard Angiogram|Overall Study||785
8622543|NCT00488982|9661797|FG002|≥ 50% Prostate-specific Antigen Decline|Induction Chemotherapy||0
8622544|NCT00488982|9661795|FG000|COMPLETED|Induction Chemotherapy||52
8830772|NCT01635153|9885320|FG000|STARTED|Overall Study||72
8830773|NCT01635153|9885321|FG001|STARTED|Overall Study||79
8830774|NCT01635153|9885320|FG000|COMPLETED|Overall Study||32
8830775|NCT01635153|9885321|FG001|COMPLETED|Overall Study||36
8830776|NCT01635153|9885320|FG000|NOT COMPLETED|Overall Study||40
8830777|NCT01635153|9885321|FG001|NOT COMPLETED|Overall Study||43
8830778|NCT01635218|9885330|FG000|STARTED|Overall Study||44
8830779|NCT01635218|9885331|FG001|STARTED|Overall Study||46
8622545|NCT00488982|9661796|FG001|COMPLETED|Induction Chemotherapy||0
8830780|NCT01635218|9885332|FG002|STARTED|Overall Study||43
8830781|NCT01635218|9885330|FG000|COMPLETED|Overall Study||41
8830782|NCT01635218|9885331|FG001|COMPLETED|Overall Study||39
8830783|NCT01635218|9885332|FG002|COMPLETED|Overall Study||37
8830784|NCT01635218|9885330|FG000|NOT COMPLETED|Overall Study||3
8830785|NCT01635218|9885331|FG001|NOT COMPLETED|Overall Study||7
8830786|NCT01635218|9885332|FG002|NOT COMPLETED|Overall Study||6
8830787|NCT01635244|9885343|FG000|STARTED|Overall Study||18
8830788|NCT01635244|9885344|FG001|STARTED|Overall Study||22
8830789|NCT01635244|9885345|FG002|STARTED|Overall Study||20
8830790|NCT01635244|9885343|FG000|COMPLETED|Overall Study||17
8830791|NCT01635244|9885344|FG001|COMPLETED|Overall Study||21
8830792|NCT01635244|9885345|FG002|COMPLETED|Overall Study||18
8830793|NCT01635244|9885343|FG000|NOT COMPLETED|Overall Study||1
8830794|NCT01635244|9885344|FG001|NOT COMPLETED|Overall Study||1
8830795|NCT01635244|9885345|FG002|NOT COMPLETED|Overall Study||2
8830796|NCT01635283|9885353|FG000|STARTED|Overall Study||5
8830797|NCT01635283|9885353|FG000|COMPLETED|Overall Study||1
8830798|NCT01635283|9885353|FG000|NOT COMPLETED|Overall Study||4
8830799|NCT01635439|9885362|FG000|STARTED|Overall Study||100
8830800|NCT01635439|9885363|FG001|STARTED|Overall Study||100
8830801|NCT01635439|9885362|FG000|COMPLETED|Overall Study||100
8830802|NCT01635439|9885363|FG001|COMPLETED|Overall Study||100
8830803|NCT01635439|9885362|FG000|NOT COMPLETED|Overall Study||0
8830804|NCT01635439|9885363|FG001|NOT COMPLETED|Overall Study||0
8830805|NCT01635504|9885369|FG000|STARTED|Overall Study||5
8830806|NCT01635504|9885369|FG000|COMPLETED|Overall Study||5
8830807|NCT01635504|9885369|FG000|NOT COMPLETED|Overall Study||0
8830808|NCT01635764|9885378|FG000|STARTED|Overall Study||508
8830809|NCT01635764|9885378|FG000|COMPLETED|Overall Study||235
8830810|NCT01635764|9885378|FG000|NOT COMPLETED|Overall Study||273
8830811|NCT01635855|9885389|FG000|STARTED|Overall Study||117
8830812|NCT01635855|9885389|FG000|COMPLETED|Overall Study||113
8830813|NCT01635855|9885389|FG000|NOT COMPLETED|Overall Study||4
8830814|NCT01635881|9885393|FG000|STARTED|Overall Study||60
8830815|NCT01635881|9885393|FG000|COMPLETED|Overall Study||60
8830816|NCT01635881|9885393|FG000|NOT COMPLETED|Overall Study||0
8830817|NCT01635920|9885399|FG000|STARTED|Overall Study||125
8830818|NCT01635920|9885400|FG001|STARTED|Overall Study||126
8830819|NCT01635920|9885399|FG000|COMPLETED|Overall Study||122
8830820|NCT01635920|9885400|FG001|COMPLETED|Overall Study||125
8830821|NCT01635920|9885399|FG000|NOT COMPLETED|Overall Study||3
8830822|NCT01635920|9885400|FG001|NOT COMPLETED|Overall Study||1
8830823|NCT01635933|9885409|FG000|STARTED|Overall Study||178
8830824|NCT01635933|9885410|FG001|STARTED|Overall Study||185
8830825|NCT01635933|9885409|FG000|COMPLETED|Overall Study||176
8830826|NCT01635933|9885410|FG001|COMPLETED|Overall Study||177
8830827|NCT01635933|9885409|FG000|NOT COMPLETED|Overall Study||2
8830828|NCT01635933|9885410|FG001|NOT COMPLETED|Overall Study||8
8830829|NCT01635998|9885418|FG000|STARTED|Overall Study||28
8830830|NCT01635998|9885419|FG001|STARTED|Overall Study||22
8830831|NCT01635998|9885418|FG000|COMPLETED|Overall Study||24
8830832|NCT01635998|9885419|FG001|COMPLETED|Overall Study||15
8830833|NCT01635998|9885418|FG000|NOT COMPLETED|Overall Study||4
8830834|NCT01635998|9885419|FG001|NOT COMPLETED|Overall Study||7
8830835|NCT01636063|9885427|FG000|STARTED|Overall Study||21
8830836|NCT01636063|9885428|FG001|STARTED|Overall Study||21
8830837|NCT01636063|9885427|FG000|COMPLETED|Overall Study||21
8830838|NCT01636063|9885428|FG001|COMPLETED|Overall Study||21
8830839|NCT01636063|9885427|FG000|NOT COMPLETED|Overall Study||0
8830840|NCT01636063|9885428|FG001|NOT COMPLETED|Overall Study||0
8830841|NCT01636076|9885436|FG000|STARTED|Overall Study||316
8830842|NCT01636076|9885437|FG001|STARTED|Overall Study||313
8830843|NCT01636076|9885436|FG000|COMPLETED|Overall Study||299
8830844|NCT01636076|9885437|FG001|COMPLETED|Overall Study||288
8830845|NCT01636076|9885436|FG000|NOT COMPLETED|Overall Study||17
8830846|NCT01636076|9885437|FG001|NOT COMPLETED|Overall Study||25
8830847|NCT01636102|9885452|FG000|STARTED|Overall Study||63
8830848|NCT01636102|9885453|FG001|STARTED|Overall Study||63
8830849|NCT01636102|9885452|FG000|COMPLETED|Overall Study||63
8830850|NCT01636102|9885453|FG001|COMPLETED|Overall Study||63
8830851|NCT01636102|9885452|FG000|NOT COMPLETED|Overall Study||0
8830852|NCT01636102|9885453|FG001|NOT COMPLETED|Overall Study||0
8830853|NCT01636206|9885462|FG000|STARTED|Overall Study||111
8830854|NCT01636206|9885463|FG001|STARTED|Overall Study||221
8830855|NCT01636206|9885462|FG000|COMPLETED|Overall Study||92
8830856|NCT01636206|9885463|FG001|COMPLETED|Overall Study||170
8830857|NCT01636206|9885462|FG000|NOT COMPLETED|Overall Study||19
8830858|NCT01636206|9885463|FG001|NOT COMPLETED|Overall Study||51
8830859|NCT01636284|9885469|FG000|STARTED|Overall Study||16
8830860|NCT01636284|9885469|FG000|COMPLETED|Overall Study||16
8830861|NCT01636284|9885469|FG000|NOT COMPLETED|Overall Study||0
8830862|NCT01636297|9885476|FG000|STARTED|Overall Study||40
8830863|NCT01636297|9885477|FG001|STARTED|Overall Study||40
8830864|NCT01636297|9885478|FG002|STARTED|Overall Study||20
8830865|NCT01636297|9885476|FG000|COMPLETED|Overall Study||36
8830866|NCT01636297|9885477|FG001|COMPLETED|Overall Study||36
8830867|NCT01636297|9885478|FG002|COMPLETED|Overall Study||19
8830868|NCT01636297|9885476|FG000|NOT COMPLETED|Overall Study||4
8830869|NCT01636297|9885477|FG001|NOT COMPLETED|Overall Study||4
8830870|NCT01636297|9885478|FG002|NOT COMPLETED|Overall Study||1
8830871|NCT01636362|9885488|FG000|STARTED|Overall Study||45
8830872|NCT01636362|9885488|FG000|COMPLETED|Overall Study||37
8830873|NCT01636362|9885488|FG000|NOT COMPLETED|Overall Study||8
8830874|NCT01636414|9885495|FG000|STARTED|Overall Study||64
8830875|NCT01636414|9885496|FG001|STARTED|Overall Study||66
8830876|NCT01636414|9885497|FG002|STARTED|Overall Study||74
8830877|NCT01636414|9885495|FG000|COMPLETED|Overall Study||61
8830878|NCT01636414|9885496|FG001|COMPLETED|Overall Study||60
8830879|NCT01636414|9885497|FG002|COMPLETED|Overall Study||65
8830880|NCT01636414|9885495|FG000|NOT COMPLETED|Overall Study||3
8830881|NCT01636414|9885496|FG001|NOT COMPLETED|Overall Study||6
8830882|NCT01636414|9885497|FG002|NOT COMPLETED|Overall Study||9
8830883|NCT01636453|9885505|FG000|STARTED|Overall Study||120
8830884|NCT01636453|9885505|FG000|COMPLETED|Overall Study||112
8830885|NCT01636453|9885505|FG000|NOT COMPLETED|Overall Study||8
8830886|NCT01636661|9885511|FG000|STARTED|Overall Study||5
8830887|NCT01636661|9885512|FG001|STARTED|Overall Study||6
8830888|NCT01636661|9885511|FG000|COMPLETED|Overall Study||5
8830889|NCT01636661|9885512|FG001|COMPLETED|Overall Study||6
8830890|NCT01636661|9885511|FG000|NOT COMPLETED|Overall Study||0
8830891|NCT01636661|9885512|FG001|NOT COMPLETED|Overall Study||0
8830892|NCT01636687|9885521|FG000|STARTED|Induction Period||61
8830893|NCT01636687|9885522|FG001|STARTED|Induction Period||60
8830894|NCT01636687|9885523|FG002|STARTED|Induction Period||0
8830895|NCT01636687|9885524|FG003|STARTED|Induction Period||0
8830896|NCT01636687|9885525|FG004|STARTED|Induction Period||61
8830897|NCT01636687|9885521|FG000|COMPLETED|Induction Period||58
8830898|NCT01636687|9885522|FG001|COMPLETED|Induction Period||60
8830899|NCT01636687|9885523|FG002|COMPLETED|Induction Period||0
8830900|NCT01636687|9885524|FG003|COMPLETED|Induction Period||0
8830901|NCT01636687|9885525|FG004|COMPLETED|Induction Period||59
8830902|NCT01636687|9885521|FG000|NOT COMPLETED|Induction Period||3
8830903|NCT01636687|9885522|FG001|NOT COMPLETED|Induction Period||0
8830904|NCT01636687|9885523|FG002|NOT COMPLETED|Induction Period||0
8830905|NCT01636687|9885524|FG003|NOT COMPLETED|Induction Period||0
8830906|NCT01636687|9885525|FG004|NOT COMPLETED|Induction Period||2
8830907|NCT01636687|9885521|FG000|STARTED|Maintenance Period||58
8830908|NCT01636687|9885522|FG001|STARTED|Maintenance Period||60
8830909|NCT01636687|9885523|FG002|STARTED|Maintenance Period||28
8830910|NCT01636687|9885524|FG003|STARTED|Maintenance Period||28
8830911|NCT01636687|9885525|FG004|STARTED|Maintenance Period||3
8830912|NCT01636687|9885521|FG000|COMPLETED|Maintenance Period||50
8830913|NCT01636687|9885522|FG001|COMPLETED|Maintenance Period||58
8830914|NCT01636687|9885523|FG002|COMPLETED|Maintenance Period||26
8830915|NCT01636687|9885524|FG003|COMPLETED|Maintenance Period||28
8830916|NCT01636687|9885525|FG004|COMPLETED|Maintenance Period||1
8830917|NCT01636687|9885521|FG000|NOT COMPLETED|Maintenance Period||8
8622546|NCT00488982|9661797|FG002|COMPLETED|Induction Chemotherapy||0
8622547|NCT00488982|9661795|FG000|NOT COMPLETED|Induction Chemotherapy||73
8622548|NCT00488982|9661796|FG001|NOT COMPLETED|Induction Chemotherapy||0
8622549|NCT00488982|9661797|FG002|NOT COMPLETED|Induction Chemotherapy||0
8622550|NCT00488982|9661795|FG000|STARTED|Course 1||0
8830918|NCT01636687|9885522|FG001|NOT COMPLETED|Maintenance Period||2
8830919|NCT01636687|9885523|FG002|NOT COMPLETED|Maintenance Period||2
8830920|NCT01636687|9885524|FG003|NOT COMPLETED|Maintenance Period||0
8830921|NCT01636687|9885525|FG004|NOT COMPLETED|Maintenance Period||2
8830922|NCT01636687|9885521|FG000|STARTED|Extension Period||47
8830923|NCT01636687|9885522|FG001|STARTED|Extension Period||54
8830924|NCT01636687|9885523|FG002|STARTED|Extension Period||25
8830925|NCT01636687|9885524|FG003|STARTED|Extension Period||28
8830926|NCT01636687|9885525|FG004|STARTED|Extension Period||0
8830927|NCT01636687|9885521|FG000|COMPLETED|Extension Period||0
8830928|NCT01636687|9885522|FG001|COMPLETED|Extension Period||0
8830929|NCT01636687|9885523|FG002|COMPLETED|Extension Period||0
8830930|NCT01636687|9885524|FG003|COMPLETED|Extension Period||0
8830931|NCT01636687|9885525|FG004|COMPLETED|Extension Period||0
8830932|NCT01636687|9885521|FG000|NOT COMPLETED|Extension Period||47
8830933|NCT01636687|9885522|FG001|NOT COMPLETED|Extension Period||54
8830934|NCT01636687|9885523|FG002|NOT COMPLETED|Extension Period||25
8830935|NCT01636687|9885524|FG003|NOT COMPLETED|Extension Period||28
8830936|NCT01636687|9885525|FG004|NOT COMPLETED|Extension Period||0
8830937|NCT01636687|9885521|FG000|STARTED|Follow-up Period||38
8622551|NCT00488982|9661796|FG001|STARTED|Course 1||25
8830938|NCT01636687|9885522|FG001|STARTED|Follow-up Period||45
8830939|NCT01636687|9885523|FG002|STARTED|Follow-up Period||21
8830940|NCT01636687|9885524|FG003|STARTED|Follow-up Period||20
8830941|NCT01636687|9885525|FG004|STARTED|Follow-up Period||2
8830942|NCT01636687|9885521|FG000|COMPLETED|Follow-up Period||37
8830943|NCT01636687|9885522|FG001|COMPLETED|Follow-up Period||45
8830944|NCT01636687|9885523|FG002|COMPLETED|Follow-up Period||21
8830945|NCT01636687|9885524|FG003|COMPLETED|Follow-up Period||20
8830946|NCT01636687|9885525|FG004|COMPLETED|Follow-up Period||1
8830947|NCT01636687|9885521|FG000|NOT COMPLETED|Follow-up Period||1
8830948|NCT01636687|9885522|FG001|NOT COMPLETED|Follow-up Period||0
8830949|NCT01636687|9885523|FG002|NOT COMPLETED|Follow-up Period||0
8830950|NCT01636687|9885524|FG003|NOT COMPLETED|Follow-up Period||0
8830951|NCT01636687|9885525|FG004|NOT COMPLETED|Follow-up Period||1
8830952|NCT01636713|9885546|FG000|STARTED|Overall Study||193
8830953|NCT01636713|9885547|FG001|STARTED|Overall Study||194
8830954|NCT01636713|9885548|FG002|STARTED|Overall Study||193
8830955|NCT01636713|9885546|FG000|COMPLETED|Overall Study||161
8830956|NCT01636713|9885547|FG001|COMPLETED|Overall Study||166
8830957|NCT01636713|9885548|FG002|COMPLETED|Overall Study||170
8830958|NCT01636713|9885546|FG000|NOT COMPLETED|Overall Study||32
8830959|NCT01636713|9885547|FG001|NOT COMPLETED|Overall Study||28
8830960|NCT01636713|9885548|FG002|NOT COMPLETED|Overall Study||23
8830961|NCT01636765|9885556|FG000|STARTED|Overall Study||104
8830962|NCT01636765|9885556|FG000|COMPLETED|Overall Study||104
8830963|NCT01636765|9885556|FG000|NOT COMPLETED|Overall Study||0
8830964|NCT01636778|9885560|FG000|STARTED|Pre-Antiviral Treatment Period (Part 1)||45
8830965|NCT01636778|9885561|FG001|STARTED|Pre-Antiviral Treatment Period (Part 1)||0
8830966|NCT01636778|9885562|FG002|STARTED|Pre-Antiviral Treatment Period (Part 1)||0
8830967|NCT01636778|9885560|FG000|COMPLETED|Pre-Antiviral Treatment Period (Part 1)||41
8830968|NCT01636778|9885561|FG001|COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
8830969|NCT01636778|9885562|FG002|COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
8830970|NCT01636778|9885560|FG000|NOT COMPLETED|Pre-Antiviral Treatment Period (Part 1)||4
8830971|NCT01636778|9885561|FG001|NOT COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
8830972|NCT01636778|9885562|FG002|NOT COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
8830973|NCT01636778|9885560|FG000|STARTED|Antiviral Treatment Period (Part 2)||0
8830974|NCT01636778|9885561|FG001|STARTED|Antiviral Treatment Period (Part 2)||41
8830975|NCT01636778|9885562|FG002|STARTED|Antiviral Treatment Period (Part 2)||0
8830976|NCT01636778|9885560|FG000|COMPLETED|Antiviral Treatment Period (Part 2)||0
8830977|NCT01636778|9885561|FG001|COMPLETED|Antiviral Treatment Period (Part 2)||31
8830978|NCT01636778|9885562|FG002|COMPLETED|Antiviral Treatment Period (Part 2)||0
8830979|NCT01636778|9885560|FG000|NOT COMPLETED|Antiviral Treatment Period (Part 2)||0
8830980|NCT01636778|9885561|FG001|NOT COMPLETED|Antiviral Treatment Period (Part 2)||10
8830981|NCT01636778|9885562|FG002|NOT COMPLETED|Antiviral Treatment Period (Part 2)||0
8830982|NCT01636778|9885560|FG000|STARTED|Follow-up Period After Part 2||0
8830983|NCT01636778|9885561|FG001|STARTED|Follow-up Period After Part 2||0
8830984|NCT01636778|9885562|FG002|STARTED|Follow-up Period After Part 2||41
8830985|NCT01636778|9885560|FG000|COMPLETED|Follow-up Period After Part 2||0
8830986|NCT01636778|9885561|FG001|COMPLETED|Follow-up Period After Part 2||0
8830987|NCT01636778|9885562|FG002|COMPLETED|Follow-up Period After Part 2||37
8830988|NCT01636778|9885560|FG000|NOT COMPLETED|Follow-up Period After Part 2||0
8830989|NCT01636778|9885561|FG001|NOT COMPLETED|Follow-up Period After Part 2||0
8830990|NCT01636778|9885562|FG002|NOT COMPLETED|Follow-up Period After Part 2||4
8830991|NCT01636882|9885570|FG000|STARTED|Overall Study||16
8830992|NCT01636882|9885570|FG000|COMPLETED|Overall Study||16
8830993|NCT01636882|9885570|FG000|NOT COMPLETED|Overall Study||0
8830994|NCT01636934|9885576|FG000|STARTED|Overall Study||25
8830995|NCT01636934|9885577|FG001|STARTED|Overall Study||24
8830996|NCT01636934|9885576|FG000|COMPLETED|Overall Study||19
8830997|NCT01636934|9885577|FG001|COMPLETED|Overall Study||21
8830998|NCT01636934|9885576|FG000|NOT COMPLETED|Overall Study||6
8830999|NCT01636934|9885577|FG001|NOT COMPLETED|Overall Study||3
8831000|NCT01636947|9885585|FG000|STARTED|Overall Study||244
8831001|NCT01636947|9885586|FG001|STARTED|Overall Study||250
8831002|NCT01636947|9885585|FG000|Treated|Overall Study||242
8831003|NCT01636947|9885586|FG001|Treated|Overall Study||248
8831004|NCT01636947|9885585|FG000|COMPLETED|Overall Study||232
8831005|NCT01636947|9885586|FG001|COMPLETED|Overall Study||239
8831006|NCT01636947|9885585|FG000|NOT COMPLETED|Overall Study||12
8831007|NCT01636947|9885586|FG001|NOT COMPLETED|Overall Study||11
8831008|NCT01636960|9885592|FG000|STARTED|Induction Phase||9
8831009|NCT01636960|9885592|FG000|COMPLETED|Induction Phase|Participants continuing into Maintenance Phase|7
8831010|NCT01636960|9885592|FG000|NOT COMPLETED|Induction Phase||2
8831011|NCT01636960|9885592|FG000|STARTED|Maintenance Phase||7
8831012|NCT01636960|9885592|FG000|COMPLETED|Maintenance Phase||0
8831013|NCT01636960|9885592|FG000|NOT COMPLETED|Maintenance Phase||7
8831014|NCT01636986|9885598|FG000|STARTED|Overall Study||30
8831015|NCT01636986|9885599|FG001|STARTED|Overall Study||32
8831016|NCT01636986|9885598|FG000|COMPLETED|Overall Study||30
8831017|NCT01636986|9885599|FG001|COMPLETED|Overall Study||30
8831018|NCT01636986|9885598|FG000|NOT COMPLETED|Overall Study||0
8831019|NCT01636986|9885599|FG001|NOT COMPLETED|Overall Study||2
8831020|NCT01637077|9885607|FG000|STARTED|Overall Study||23
8831021|NCT01637077|9885608|FG001|STARTED|Overall Study||23
8831022|NCT01637077|9885607|FG000|COMPLETED|Overall Study||19
8831023|NCT01637077|9885608|FG001|COMPLETED|Overall Study||22
8831024|NCT01637077|9885607|FG000|NOT COMPLETED|Overall Study||4
8831025|NCT01637077|9885608|FG001|NOT COMPLETED|Overall Study||1
8831026|NCT01637090|9885614|FG000|STARTED|Overall Study||3
8831027|NCT01637090|9885614|FG000|COMPLETED|Overall Study||0
8831028|NCT01637090|9885614|FG000|NOT COMPLETED|Overall Study||3
8831029|NCT01637142|9885618|FG000|STARTED|Treatment Period 1||18
8831030|NCT01637142|9885618|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1||18
8831031|NCT01637142|9885618|FG000|COMPLETED|Treatment Period 1||18
8831032|NCT01637142|9885618|FG000|NOT COMPLETED|Treatment Period 1||0
8831033|NCT01637142|9885618|FG000|STARTED|Washout Period (at Least 3 Days)||18
8831034|NCT01637142|9885618|FG000|COMPLETED|Washout Period (at Least 3 Days)||17
8831035|NCT01637142|9885618|FG000|NOT COMPLETED|Washout Period (at Least 3 Days)||1
8831036|NCT01637142|9885618|FG000|STARTED|Treatment Period 2||17
8831037|NCT01637142|9885618|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 2||17
8831038|NCT01637142|9885618|FG000|COMPLETED|Treatment Period 2||17
8831039|NCT01637142|9885618|FG000|NOT COMPLETED|Treatment Period 2||0
8831040|NCT01637246|9885624|FG000|STARTED|Overall Study||4385
8831041|NCT01637246|9885624|FG000|COMPLETED|Overall Study||2246
8831042|NCT01637246|9885624|FG000|NOT COMPLETED|Overall Study||2139
8831043|NCT01637272|9885628|FG000|STARTED|Overall Study||43
8831044|NCT01637272|9885628|FG000|Completed sc Phase|Overall Study||33
8831045|NCT01637272|9885628|FG000|Completed Core Phase (sc + LAR)|Overall Study||31
8831046|NCT01637272|9885628|FG000|Entered Extension Phase|Overall Study||27
8831047|NCT01637272|9885628|FG000|Completed Core But Did no Enter Ext..|Overall Study||4
8831048|NCT01637272|9885628|FG000|COMPLETED|Overall Study||23
8831049|NCT01637272|9885628|FG000|NOT COMPLETED|Overall Study||20
8831050|NCT01637402|9885647|FG000|STARTED|Standard Dose Regimen||41
8831051|NCT01637402|9885648|FG001|STARTED|Standard Dose Regimen|Escalated dose not introduced as treatment option until after Week 12 evaluation|0
8831052|NCT01637402|9885647|FG000|COMPLETED|Standard Dose Regimen||38
8831053|NCT01637402|9885648|FG001|COMPLETED|Standard Dose Regimen||0
8831054|NCT01637402|9885647|FG000|NOT COMPLETED|Standard Dose Regimen||3
8831055|NCT01637402|9885648|FG001|NOT COMPLETED|Standard Dose Regimen||0
8831056|NCT01637402|9885647|FG000|STARTED|Week 12 Evaluation||38
8831057|NCT01637402|9885648|FG001|STARTED|Week 12 Evaluation|Escalated dose not introduced as treatment option until after Week 12 evaluation|0
8831058|NCT01637402|9885647|FG000|COMPLETED|Week 12 Evaluation||32
8831059|NCT01637402|9885648|FG001|COMPLETED|Week 12 Evaluation||0
8831060|NCT01637402|9885647|FG000|NOT COMPLETED|Week 12 Evaluation||6
8831061|NCT01637402|9885648|FG001|NOT COMPLETED|Week 12 Evaluation||0
8831062|NCT01637402|9885647|FG000|STARTED|Treatment Regiments Post Week 12|Patients continuing on standard dose|14
8831063|NCT01637402|9885648|FG001|STARTED|Treatment Regiments Post Week 12|Patients who progressed after decline on standard dose|18
8831064|NCT01637402|9885647|FG000|COMPLETED|Treatment Regiments Post Week 12||5
8831065|NCT01637402|9885648|FG001|COMPLETED|Treatment Regiments Post Week 12||14
8831066|NCT01637402|9885647|FG000|NOT COMPLETED|Treatment Regiments Post Week 12||9
8831067|NCT01637402|9885648|FG001|NOT COMPLETED|Treatment Regiments Post Week 12||4
8831068|NCT01637584|9885675|FG000|STARTED|Overall Study||20
8831069|NCT01637584|9885676|FG001|STARTED|Overall Study||20
8831070|NCT01637584|9885675|FG000|COMPLETED|Overall Study||19
8831071|NCT01637584|9885676|FG001|COMPLETED|Overall Study||17
8831072|NCT01637584|9885675|FG000|NOT COMPLETED|Overall Study||1
8831073|NCT01637584|9885676|FG001|NOT COMPLETED|Overall Study||3
8831074|NCT01637623|9885686|FG000|STARTED|Overall Study||29
8831075|NCT01637623|9885687|FG001|STARTED|Overall Study||30
8831076|NCT01637623|9885688|FG002|STARTED|Overall Study||28
8831077|NCT01637623|9885686|FG000|Received Intervention|Overall Study||28
8831078|NCT01637623|9885687|FG001|Received Intervention|Overall Study||30
8831079|NCT01637623|9885688|FG002|Received Intervention|Overall Study||27
8831080|NCT01637623|9885686|FG000|Did Not Receive Intervention|Overall Study||1
8831081|NCT01637623|9885687|FG001|Did Not Receive Intervention|Overall Study||0
8831082|NCT01637623|9885688|FG002|Did Not Receive Intervention|Overall Study||1
8831083|NCT01637623|9885686|FG000|Analyzed|Overall Study||28
8831084|NCT01637623|9885687|FG001|Analyzed|Overall Study||30
8831085|NCT01637623|9885688|FG002|Analyzed|Overall Study||28
8831086|NCT01637623|9885686|FG000|COMPLETED|Overall Study||28
8831087|NCT01637623|9885687|FG001|COMPLETED|Overall Study||30
8831088|NCT01637623|9885688|FG002|COMPLETED|Overall Study||25
8831089|NCT01637623|9885686|FG000|NOT COMPLETED|Overall Study||1
8831090|NCT01637623|9885687|FG001|NOT COMPLETED|Overall Study||0
8831091|NCT01637623|9885688|FG002|NOT COMPLETED|Overall Study||3
8831092|NCT01637870|9885696|FG000|STARTED|Overall Study||110
8831093|NCT01637870|9885696|FG000|COMPLETED|Overall Study||110
8831094|NCT01637870|9885696|FG000|NOT COMPLETED|Overall Study||0
8831095|NCT01637922|9885702|FG000|STARTED|Overall Study||15
8831096|NCT01637922|9885703|FG001|STARTED|Overall Study||19
8831097|NCT01637922|9885702|FG000|COMPLETED|Overall Study||13
8831098|NCT01637922|9885703|FG001|COMPLETED|Overall Study||14
8831099|NCT01637922|9885702|FG000|NOT COMPLETED|Overall Study||2
8831100|NCT01637922|9885703|FG001|NOT COMPLETED|Overall Study||5
8831101|NCT01637935|9885712|FG000|STARTED|Overall Study||34181
8831102|NCT01637935|9885713|FG001|STARTED|Overall Study||158918
8831103|NCT01637935|9885712|FG000|COMPLETED|Overall Study||34181
8831104|NCT01637935|9885713|FG001|COMPLETED|Overall Study||158918
8831105|NCT01637935|9885712|FG000|NOT COMPLETED|Overall Study||0
8831106|NCT01637935|9885713|FG001|NOT COMPLETED|Overall Study||0
8831107|NCT01637961|9885719|FG000|STARTED|Overall Study||23
8831108|NCT01637961|9885719|FG000|COMPLETED|Overall Study|Eligible and treated patients.|21
8831109|NCT01637961|9885719|FG000|NOT COMPLETED|Overall Study||2
8831110|NCT01638000|9885731|FG000|STARTED|Overall Study||943
8831111|NCT01638000|9885732|FG001|STARTED|Overall Study||944
8831112|NCT01638000|9885731|FG000|Received at Least 1 Double-Blind Dose|Overall Study||936
8831113|NCT01638000|9885732|FG001|Received at Least 1 Double-Blind Dose|Overall Study||934
8831114|NCT01638000|9885731|FG000|COMPLETED|Overall Study||883
8831115|NCT01638000|9885732|FG001|COMPLETED|Overall Study||873
8831116|NCT01638000|9885731|FG000|NOT COMPLETED|Overall Study||60
8831117|NCT01638000|9885732|FG001|NOT COMPLETED|Overall Study||71
8831118|NCT01638013|9885741|FG000|STARTED|Overall Study||201
8831119|NCT01638013|9885742|FG001|STARTED|Overall Study||225
8831120|NCT01638013|9885743|FG002|STARTED|Overall Study||417
8831121|NCT01638013|9885741|FG000|COMPLETED|Overall Study||70
8831122|NCT01638013|9885742|FG001|COMPLETED|Overall Study||147
8831123|NCT01638013|9885743|FG002|COMPLETED|Overall Study||296
8831124|NCT01638013|9885741|FG000|NOT COMPLETED|Overall Study||131
8831125|NCT01638013|9885742|FG001|NOT COMPLETED|Overall Study||78
8831126|NCT01638013|9885743|FG002|NOT COMPLETED|Overall Study||121
8831127|NCT01638052|9885757|FG000|STARTED|Overall Study||28
8831128|NCT01638052|9885758|FG001|STARTED|Overall Study||28
8831129|NCT01638052|9885757|FG000|COMPLETED|Overall Study||28
8831130|NCT01638052|9885758|FG001|COMPLETED|Overall Study||28
8831131|NCT01638052|9885757|FG000|NOT COMPLETED|Overall Study||0
8831132|NCT01638052|9885758|FG001|NOT COMPLETED|Overall Study||0
8831133|NCT01638312|9885766|FG000|STARTED|Overall Study||20
8831134|NCT01638312|9885767|FG001|STARTED|Overall Study||30
8831135|NCT01638312|9885766|FG000|COMPLETED|Overall Study||20
8831136|NCT01638312|9885767|FG001|COMPLETED|Overall Study||30
8831137|NCT01638312|9885766|FG000|NOT COMPLETED|Overall Study||0
8831138|NCT01638312|9885767|FG001|NOT COMPLETED|Overall Study||0
8831139|NCT01638390|9885773|FG000|STARTED|Overall Study|enrolled|357
8831140|NCT01638390|9885773|FG000|COMPLETED|Overall Study|treated eyes|336
8831141|NCT01638390|9885773|FG000|NOT COMPLETED|Overall Study||21
8831142|NCT01638416|9885786|FG000|STARTED|Overall Study||2490
8831143|NCT01638416|9885787|FG001|STARTED|Overall Study||2504
8831144|NCT01638416|9885786|FG000|COMPLETED|Overall Study||2457
8831145|NCT01638416|9885787|FG001|COMPLETED|Overall Study||2462
8831146|NCT01638416|9885786|FG000|NOT COMPLETED|Overall Study||33
8831147|NCT01638416|9885787|FG001|NOT COMPLETED|Overall Study||42
8831148|NCT01638429|9885794|FG000|STARTED|Overall Study||12
8831149|NCT01638429|9885794|FG000|Pre-treatment Testing|Overall Study||11
8831150|NCT01638429|9885794|FG000|Antibiotic Treatment|Overall Study||11
8831151|NCT01638429|9885794|FG000|Post-treatment Testing|Overall Study||11
8831152|NCT01638429|9885794|FG000|COMPLETED|Overall Study||11
8831153|NCT01638429|9885794|FG000|NOT COMPLETED|Overall Study||1
8831154|NCT01638468|9885802|FG000|STARTED|Overall Study||7
8831155|NCT01638468|9885802|FG000|COMPLETED|Overall Study||7
8831156|NCT01638468|9885802|FG000|NOT COMPLETED|Overall Study||0
8831157|NCT01638507|9885806|FG000|STARTED|Overall Study||230
8831158|NCT01638507|9885806|FG000|COMPLETED|Overall Study||224
8831159|NCT01638507|9885806|FG000|NOT COMPLETED|Overall Study||6
8831160|NCT01638546|9885814|FG000|STARTED|Overall Study||52
8831161|NCT01638546|9885815|FG001|STARTED|Overall Study||45
8831162|NCT01638546|9885814|FG000|COMPLETED|Overall Study||51
8831163|NCT01638546|9885815|FG001|COMPLETED|Overall Study||42
8831164|NCT01638546|9885814|FG000|NOT COMPLETED|Overall Study||1
8831165|NCT01638546|9885815|FG001|NOT COMPLETED|Overall Study||3
8831166|NCT01638559|9885823|FG000|STARTED|Overall Study||88
8831167|NCT01638559|9885823|FG000|COMPLETED|Overall Study|Completion through the time of the primary endpoint (outcome).|85
8831168|NCT01638559|9885823|FG000|NOT COMPLETED|Overall Study||3
8831169|NCT01638819|9885840|FG000|STARTED|Overall Study||15
8831170|NCT01638819|9885841|FG001|STARTED|Overall Study||15
8831171|NCT01638819|9885840|FG000|First Intervention (8 Weeks)|Overall Study||15
8831172|NCT01638819|9885841|FG001|First Intervention (8 Weeks)|Overall Study||15
8831173|NCT01638819|9885840|FG000|Second Intervention (24 Weeks)|Overall Study||14
8831174|NCT01638819|9885841|FG001|Second Intervention (24 Weeks)|Overall Study||15
8831175|NCT01638819|9885840|FG000|COMPLETED|Overall Study||14
8831176|NCT01638819|9885841|FG001|COMPLETED|Overall Study||15
8831177|NCT01638819|9885840|FG000|NOT COMPLETED|Overall Study||1
8831178|NCT01638819|9885841|FG001|NOT COMPLETED|Overall Study||0
8831179|NCT01639001|9885848|FG000|STARTED|Overall Study||104
8831180|NCT01639001|9885849|FG001|STARTED|Overall Study||103
8831181|NCT01639001|9885848|FG000|Treated|Overall Study||104
8831182|NCT01639001|9885849|FG001|Treated|Overall Study||101
8831183|NCT01639001|9885848|FG000|COMPLETED|Overall Study||29
8831184|NCT01639001|9885849|FG001|COMPLETED|Overall Study||26
8831185|NCT01639001|9885848|FG000|NOT COMPLETED|Overall Study||75
8831186|NCT01639001|9885849|FG001|NOT COMPLETED|Overall Study||77
8831187|NCT01639040|9885859|FG000|STARTED|Overall Study||10
8831188|NCT01639040|9885860|FG001|STARTED|Overall Study||21
8831189|NCT01639040|9885859|FG000|COMPLETED|Overall Study||9
8831190|NCT01639040|9885860|FG001|COMPLETED|Overall Study||21
8831191|NCT01639040|9885859|FG000|NOT COMPLETED|Overall Study||1
8831192|NCT01639040|9885860|FG001|NOT COMPLETED|Overall Study||0
8831193|NCT01639144|9885871|FG000|STARTED|Overall Study||260
8831194|NCT01639144|9885872|FG001|STARTED|Overall Study||255
8831195|NCT01639144|9885871|FG000|COMPLETED|Overall Study||250
8831196|NCT01639144|9885872|FG001|COMPLETED|Overall Study||250
8831197|NCT01639144|9885871|FG000|NOT COMPLETED|Overall Study||10
8831198|NCT01639144|9885872|FG001|NOT COMPLETED|Overall Study||5
8831199|NCT01639157|9885878|FG000|STARTED|Overall Study||4
8831200|NCT01639157|9885879|FG001|STARTED|Overall Study||5
8831201|NCT01639157|9885878|FG000|COMPLETED|Overall Study||4
8831202|NCT01639157|9885879|FG001|COMPLETED|Overall Study||5
8831203|NCT01639157|9885878|FG000|NOT COMPLETED|Overall Study||0
8831204|NCT01639157|9885879|FG001|NOT COMPLETED|Overall Study||0
8831205|NCT01639222|9885885|FG000|STARTED|Overall Study||55
8831206|NCT01639222|9885885|FG000|COMPLETED|Overall Study||55
8831207|NCT01639222|9885885|FG000|NOT COMPLETED|Overall Study||0
8831208|NCT01639339|9885893|FG000|STARTED|Double-blind Period (Up to Week 104)||224
8831209|NCT01639339|9885894|FG001|STARTED|Double-blind Period (Up to Week 104)||224
8831210|NCT01639339|9885893|FG000|COMPLETED|Double-blind Period (Up to Week 104)||170
8831211|NCT01639339|9885894|FG001|COMPLETED|Double-blind Period (Up to Week 104)||186
8831212|NCT01639339|9885893|FG000|NOT COMPLETED|Double-blind Period (Up to Week 104)||54
8831213|NCT01639339|9885894|FG001|NOT COMPLETED|Double-blind Period (Up to Week 104)||38
8831214|NCT01639339|9885893|FG000|STARTED|Open-label Period (Up to Week 28)|Of the 356 participants who completed the double-blind period, 279 were eligible for open-label treatment. As enrolling into the open-label period was optional, only 257 participants enrolled, of whom 255 started open-label treatment.|123
8831215|NCT01639339|9885894|FG001|STARTED|Open-label Period (Up to Week 28)||132
8831216|NCT01639339|9885893|FG000|COMPLETED|Open-label Period (Up to Week 28)||122
8831217|NCT01639339|9885894|FG001|COMPLETED|Open-label Period (Up to Week 28)||124
8831218|NCT01639339|9885893|FG000|NOT COMPLETED|Open-label Period (Up to Week 28)||1
8831219|NCT01639339|9885894|FG001|NOT COMPLETED|Open-label Period (Up to Week 28)||8
8831220|NCT01639352|9885904|FG000|STARTED|Overall Study||20
8831221|NCT01639352|9885904|FG000|COMPLETED|Overall Study||20
8831222|NCT01639352|9885904|FG000|NOT COMPLETED|Overall Study||0
8831223|NCT01639443|9885910|FG000|STARTED|Overall Study|These individuals opted into Fast-tracked group and were consented.|180
8831224|NCT01639443|9885911|FG001|STARTED|Overall Study|These individuals opted to not participate in Fast-tracked group, and were not consented.|4855
8831225|NCT01639443|9885910|FG000|COMPLETED|Overall Study|Intervention is limited to appointment booking, and all completed.|180
8831226|NCT01639443|9885911|FG001|COMPLETED|Overall Study|These individuals all booked appointments using typical booking.|4855
8831227|NCT01639443|9885910|FG000|NOT COMPLETED|Overall Study||0
8831228|NCT01639443|9885911|FG001|NOT COMPLETED|Overall Study||0
8831229|NCT01639469|9885919|FG000|STARTED|Overall Study||89
8831230|NCT01639469|9885920|FG001|STARTED|Overall Study||80
8831231|NCT01639469|9885919|FG000|COMPLETED|Overall Study||84
8831232|NCT01639469|9885920|FG001|COMPLETED|Overall Study||77
8831233|NCT01639469|9885919|FG000|NOT COMPLETED|Overall Study||5
8831234|NCT01639469|9885920|FG001|NOT COMPLETED|Overall Study||3
8831235|NCT01639495|9885926|FG000|STARTED|Overall Study|Patients who signed the informed consent.|148
8831236|NCT01639495|9885926|FG000|Safety Cohort|Overall Study||144
8831237|NCT01639495|9885926|FG000|Primary Effectiveness Cohort|Overall Study||138
8831238|NCT01639495|9885926|FG000|COMPLETED|Overall Study||132
8831239|NCT01639495|9885926|FG000|NOT COMPLETED|Overall Study||16
8831240|NCT01639560|9885932|FG000|STARTED|Overall Study||45
8831241|NCT01639560|9885933|FG001|STARTED|Overall Study||48
8831242|NCT01639560|9885932|FG000|End of Treatment|Overall Study||28
8831243|NCT01639560|9885933|FG001|End of Treatment|Overall Study||20
8831244|NCT01639560|9885932|FG000|COMPLETED|Overall Study||26
8831245|NCT01639560|9885933|FG001|COMPLETED|Overall Study||19
8831246|NCT01639560|9885932|FG000|NOT COMPLETED|Overall Study||19
8831247|NCT01639560|9885933|FG001|NOT COMPLETED|Overall Study||29
8831248|NCT01639599|9885942|FG000|STARTED|Overall Study||50
8831249|NCT01639599|9885943|FG001|STARTED|Overall Study||50
8831250|NCT01639599|9885944|FG002|STARTED|Overall Study||50
8831251|NCT01639599|9885942|FG000|COMPLETED|Overall Study||50
8831252|NCT01639599|9885943|FG001|COMPLETED|Overall Study||49
8831253|NCT01639599|9885944|FG002|COMPLETED|Overall Study||50
8831254|NCT01639599|9885942|FG000|NOT COMPLETED|Overall Study||0
8831255|NCT01639599|9885943|FG001|NOT COMPLETED|Overall Study||1
8831256|NCT01639599|9885944|FG002|NOT COMPLETED|Overall Study||0
8831257|NCT01639664|9885954|FG000|STARTED|Overall Study||63
8831258|NCT01639664|9885955|FG001|STARTED|Overall Study||52
8831259|NCT01639664|9885954|FG000|COMPLETED|Overall Study||63
8831260|NCT01639664|9885955|FG001|COMPLETED|Overall Study||52
8831261|NCT01639664|9885954|FG000|NOT COMPLETED|Overall Study||0
8831262|NCT01639664|9885955|FG001|NOT COMPLETED|Overall Study||0
8831263|NCT01639703|9885962|FG000|STARTED|Overall Study||96
8831264|NCT01639703|9885962|FG000|COMPLETED|Overall Study||84
8831265|NCT01639703|9885962|FG000|NOT COMPLETED|Overall Study||12
8831266|NCT01639729|9885978|FG000|STARTED|Overall Study||4
8831267|NCT01639729|9885979|FG001|STARTED|Overall Study||4
8831268|NCT01639729|9885980|FG002|STARTED|Overall Study||4
8831269|NCT01639729|9885981|FG003|STARTED|Overall Study||5
8831270|NCT01639729|9885982|FG004|STARTED|Overall Study||4
8831271|NCT01639729|9885983|FG005|STARTED|Overall Study||4
8831272|NCT01639729|9885978|FG000|COMPLETED|Overall Study||3
8831273|NCT01639729|9885979|FG001|COMPLETED|Overall Study||4
8831274|NCT01639729|9885980|FG002|COMPLETED|Overall Study||3
8831275|NCT01639729|9885981|FG003|COMPLETED|Overall Study||4
8831276|NCT01639729|9885982|FG004|COMPLETED|Overall Study||4
8831277|NCT01639729|9885983|FG005|COMPLETED|Overall Study||4
8831278|NCT01639729|9885978|FG000|NOT COMPLETED|Overall Study||1
8831279|NCT01639729|9885979|FG001|NOT COMPLETED|Overall Study||0
8831280|NCT01639729|9885980|FG002|NOT COMPLETED|Overall Study||1
8831281|NCT01639729|9885981|FG003|NOT COMPLETED|Overall Study||1
8831282|NCT01639729|9885982|FG004|NOT COMPLETED|Overall Study||0
8831283|NCT01639729|9885983|FG005|NOT COMPLETED|Overall Study||0
8831284|NCT01639742|9885993|FG000|STARTED|Overall Study||18
8831285|NCT01639742|9885993|FG000|COMPLETED|Overall Study||0
8831286|NCT01639742|9885993|FG000|NOT COMPLETED|Overall Study||18
8831287|NCT01639755|9885997|FG000|STARTED|Overall Study||19
8831288|NCT01639755|9885997|FG000|COMPLETED|Overall Study||0
8831289|NCT01639755|9885997|FG000|NOT COMPLETED|Overall Study||19
8831290|NCT01639833|9886003|FG000|STARTED|Overall Study||45
8831291|NCT01639833|9886004|FG001|STARTED|Overall Study||45
8831292|NCT01639833|9886003|FG000|COMPLETED|Overall Study||39
8831293|NCT01639833|9886004|FG001|COMPLETED|Overall Study||41
8831294|NCT01639833|9886003|FG000|NOT COMPLETED|Overall Study||6
8831295|NCT01639833|9886004|FG001|NOT COMPLETED|Overall Study||4
8831296|NCT01639872|9886012|FG000|STARTED|Overall Study||24
8831297|NCT01639872|9886013|FG001|STARTED|Overall Study||25
8831298|NCT01639872|9886012|FG000|COMPLETED|Overall Study||14
8831299|NCT01639872|9886013|FG001|COMPLETED|Overall Study||20
8831300|NCT01639872|9886012|FG000|NOT COMPLETED|Overall Study||10
8831301|NCT01639872|9886013|FG001|NOT COMPLETED|Overall Study||5
8831302|NCT01640054|9886019|FG000|STARTED|Overall Study|Patients who received treatment|115
8831303|NCT01640054|9886019|FG000|Did Not Receive Treatment|Overall Study||0
8831304|NCT01640054|9886019|FG000|COMPLETED|Overall Study|Number of patients on treatment when the study was stopped.|109
8831305|NCT01640054|9886019|FG000|NOT COMPLETED|Overall Study||6
8831306|NCT01640171|9886023|FG000|STARTED|Overall Study||57
8831307|NCT01640171|9886023|FG000|COMPLETED|Overall Study||57
8831308|NCT01640171|9886023|FG000|NOT COMPLETED|Overall Study||0
8831309|NCT01640184|9886031|FG000|STARTED|Overall Study||34
8831310|NCT01640184|9886032|FG001|STARTED|Overall Study||23
8831311|NCT01640184|9886033|FG002|STARTED|Overall Study||22
8831312|NCT01640184|9886031|FG000|COMPLETED|Overall Study||26
8831313|NCT01640184|9886032|FG001|COMPLETED|Overall Study||21
8831314|NCT01640184|9886033|FG002|COMPLETED|Overall Study||20
8831315|NCT01640184|9886031|FG000|NOT COMPLETED|Overall Study||8
8831316|NCT01640184|9886032|FG001|NOT COMPLETED|Overall Study||2
8831317|NCT01640184|9886033|FG002|NOT COMPLETED|Overall Study||2
8831318|NCT01640197|9886046|FG000|STARTED|Overall Study||30
8831319|NCT01640197|9886047|FG001|STARTED|Overall Study||30
8831320|NCT01640197|9886046|FG000|COMPLETED|Overall Study||30
8831321|NCT01640197|9886047|FG001|COMPLETED|Overall Study||30
8831322|NCT01640197|9886046|FG000|NOT COMPLETED|Overall Study||0
8831323|NCT01640197|9886047|FG001|NOT COMPLETED|Overall Study||0
8831324|NCT01640249|9886060|FG000|STARTED|Period 1||3
8831325|NCT01640249|9886061|FG001|STARTED|Period 1||2
8831326|NCT01640249|9886062|FG002|STARTED|Period 1||2
8831327|NCT01640249|9886063|FG003|STARTED|Period 1||2
8831328|NCT01640249|9886064|FG004|STARTED|Period 1||2
8831329|NCT01640249|9886065|FG005|STARTED|Period 1||5
8831330|NCT01640249|9886066|FG006|STARTED|Period 1||2
8831331|NCT01640249|9886060|FG000|Received at Least 1 Dose of Study Drug|Period 1||3
8831332|NCT01640249|9886061|FG001|Received at Least 1 Dose of Study Drug|Period 1||2
8831333|NCT01640249|9886062|FG002|Received at Least 1 Dose of Study Drug|Period 1||2
8831334|NCT01640249|9886063|FG003|Received at Least 1 Dose of Study Drug|Period 1||2
8831335|NCT01640249|9886064|FG004|Received at Least 1 Dose of Study Drug|Period 1||2
8831336|NCT01640249|9886065|FG005|Received at Least 1 Dose of Study Drug|Period 1||5
8831337|NCT01640249|9886066|FG006|Received at Least 1 Dose of Study Drug|Period 1||2
8831338|NCT01640249|9886060|FG000|COMPLETED|Period 1||2
8831339|NCT01640249|9886061|FG001|COMPLETED|Period 1||2
8831340|NCT01640249|9886062|FG002|COMPLETED|Period 1||2
8831341|NCT01640249|9886063|FG003|COMPLETED|Period 1||2
8831342|NCT01640249|9886064|FG004|COMPLETED|Period 1||2
8831343|NCT01640249|9886065|FG005|COMPLETED|Period 1||4
8831344|NCT01640249|9886066|FG006|COMPLETED|Period 1||2
8831345|NCT01640249|9886060|FG000|NOT COMPLETED|Period 1||1
8831346|NCT01640249|9886061|FG001|NOT COMPLETED|Period 1||0
8831347|NCT01640249|9886062|FG002|NOT COMPLETED|Period 1||0
8831348|NCT01640249|9886063|FG003|NOT COMPLETED|Period 1||0
8831349|NCT01640249|9886064|FG004|NOT COMPLETED|Period 1||0
8831350|NCT01640249|9886065|FG005|NOT COMPLETED|Period 1||1
8831351|NCT01640249|9886066|FG006|NOT COMPLETED|Period 1||0
8831352|NCT01640249|9886060|FG000|STARTED|Period 2||2
8831353|NCT01640249|9886061|FG001|STARTED|Period 2||2
8831354|NCT01640249|9886062|FG002|STARTED|Period 2||2
8831355|NCT01640249|9886063|FG003|STARTED|Period 2||2
8831356|NCT01640249|9886064|FG004|STARTED|Period 2||2
8831357|NCT01640249|9886065|FG005|STARTED|Period 2||4
8622552|NCT00488982|9661797|FG002|STARTED|Course 1||27
8622553|NCT00488982|9661795|FG000|COMPLETED|Course 1||0
8622554|NCT00488982|9661796|FG001|COMPLETED|Course 1||13
8622555|NCT00488982|9661797|FG002|COMPLETED|Course 1||13
8622556|NCT00488982|9661795|FG000|NOT COMPLETED|Course 1||0
8622557|NCT00488982|9661796|FG001|NOT COMPLETED|Course 1||12
8622558|NCT00488982|9661797|FG002|NOT COMPLETED|Course 1||14
8622559|NCT00488982|9661795|FG000|STARTED|Course 2||0
8831358|NCT01640249|9886066|FG006|STARTED|Period 2||2
8622560|NCT00488982|9661796|FG001|STARTED|Course 2||13
8622561|NCT00488982|9661797|FG002|STARTED|Course 2||13
8831359|NCT01640249|9886060|FG000|COMPLETED|Period 2||2
8831360|NCT01640249|9886061|FG001|COMPLETED|Period 2||2
8831361|NCT01640249|9886062|FG002|COMPLETED|Period 2||2
8831362|NCT01640249|9886063|FG003|COMPLETED|Period 2||2
8831363|NCT01640249|9886064|FG004|COMPLETED|Period 2||2
8831364|NCT01640249|9886065|FG005|COMPLETED|Period 2||4
8831365|NCT01640249|9886066|FG006|COMPLETED|Period 2||2
8831366|NCT01640249|9886060|FG000|NOT COMPLETED|Period 2||0
8831367|NCT01640249|9886061|FG001|NOT COMPLETED|Period 2||0
8831368|NCT01640249|9886062|FG002|NOT COMPLETED|Period 2||0
8831369|NCT01640249|9886063|FG003|NOT COMPLETED|Period 2||0
8831370|NCT01640249|9886064|FG004|NOT COMPLETED|Period 2||0
8831371|NCT01640249|9886065|FG005|NOT COMPLETED|Period 2||0
8831372|NCT01640249|9886066|FG006|NOT COMPLETED|Period 2||0
8831373|NCT01640249|9886060|FG000|STARTED|Period 3||2
8831374|NCT01640249|9886061|FG001|STARTED|Period 3||2
8831375|NCT01640249|9886062|FG002|STARTED|Period 3||2
8831376|NCT01640249|9886063|FG003|STARTED|Period 3||2
8831377|NCT01640249|9886064|FG004|STARTED|Period 3|Cohort 2 was planned for only 2 dosing periods.|0
8831378|NCT01640249|9886065|FG005|STARTED|Period 3|Cohort 2 was planned for only 2 dosing periods.|0
8831379|NCT01640249|9886066|FG006|STARTED|Period 3|Cohort 2 was planned for only 2 dosing periods.|0
8831380|NCT01640249|9886060|FG000|COMPLETED|Period 3||2
8831381|NCT01640249|9886061|FG001|COMPLETED|Period 3||2
8831382|NCT01640249|9886062|FG002|COMPLETED|Period 3||2
8831383|NCT01640249|9886063|FG003|COMPLETED|Period 3||1
8831384|NCT01640249|9886064|FG004|COMPLETED|Period 3||0
8831385|NCT01640249|9886065|FG005|COMPLETED|Period 3||0
8831386|NCT01640249|9886066|FG006|COMPLETED|Period 3||0
8831387|NCT01640249|9886060|FG000|NOT COMPLETED|Period 3||0
8831388|NCT01640249|9886061|FG001|NOT COMPLETED|Period 3||0
8831389|NCT01640249|9886062|FG002|NOT COMPLETED|Period 3||0
8831390|NCT01640249|9886063|FG003|NOT COMPLETED|Period 3||1
8831391|NCT01640249|9886064|FG004|NOT COMPLETED|Period 3||0
8831392|NCT01640249|9886065|FG005|NOT COMPLETED|Period 3||0
8831393|NCT01640249|9886066|FG006|NOT COMPLETED|Period 3||0
8831394|NCT01640288|9886087|FG000|STARTED|Overall Study||100
8831395|NCT01640288|9886088|FG001|STARTED|Overall Study||71
8831396|NCT01640288|9886087|FG000|Received Allocated Intervention|Overall Study|74 rec'd the gas (inc. 4 images were not obtained due to equipment failure = 70)|70
8831397|NCT01640288|9886088|FG001|Received Allocated Intervention|Overall Study|53 rec'd the gas (exc. 1 images not obtained due to equipment failure, 4 poor images = 48 )|48
8831398|NCT01640288|9886087|FG000|Did Not Receive Allocated Intervention|Overall Study||26
8831399|NCT01640288|9886088|FG001|Did Not Receive Allocated Intervention|Overall Study||18
8831400|NCT01640288|9886087|FG000|COMPLETED|Overall Study|One subject was lost to followup but rec'd the gas and images were obtained|70
8831401|NCT01640288|9886088|FG001|COMPLETED|Overall Study||48
8831402|NCT01640288|9886087|FG000|NOT COMPLETED|Overall Study||30
8831403|NCT01640288|9886088|FG001|NOT COMPLETED|Overall Study||23
8831404|NCT01640314|9886097|FG000|STARTED|Overall Study||63
8831405|NCT01640314|9886098|FG001|STARTED|Overall Study||63
8831406|NCT01640314|9886097|FG000|COMPLETED|Overall Study||63
8831407|NCT01640314|9886098|FG001|COMPLETED|Overall Study||62
8831408|NCT01640314|9886097|FG000|NOT COMPLETED|Overall Study||0
8831409|NCT01640314|9886098|FG001|NOT COMPLETED|Overall Study||1
8831410|NCT01640327|9886106|FG000|STARTED|Overall Study||63
8831411|NCT01640327|9886107|FG001|STARTED|Overall Study||63
8831412|NCT01640327|9886106|FG000|COMPLETED|Overall Study||63
8831413|NCT01640327|9886107|FG001|COMPLETED|Overall Study||63
8831414|NCT01640327|9886106|FG000|NOT COMPLETED|Overall Study||0
8831415|NCT01640327|9886107|FG001|NOT COMPLETED|Overall Study||0
8831416|NCT01640340|9886115|FG000|STARTED|Overall Study||20
8831417|NCT01640340|9886116|FG001|STARTED|Overall Study||20
8831418|NCT01640340|9886115|FG000|Overall Complete Response Rate|Overall Study||20
8831419|NCT01640340|9886116|FG001|Overall Complete Response Rate|Overall Study||20
8831420|NCT01640340|9886115|FG000|COMPLETED|Overall Study||20
8831421|NCT01640340|9886116|FG001|COMPLETED|Overall Study||20
8831422|NCT01640340|9886115|FG000|NOT COMPLETED|Overall Study||0
8831423|NCT01640340|9886116|FG001|NOT COMPLETED|Overall Study||0
8831424|NCT01640353|9886122|FG000|STARTED|Overall Study||194
8831425|NCT01640353|9886122|FG000|Treated|Overall Study||172
8831426|NCT01640353|9886122|FG000|Month 1|Overall Study||171
8831427|NCT01640353|9886122|FG000|Month 3|Overall Study||169
8831428|NCT01640353|9886122|FG000|Month 6|Overall Study||168
8831429|NCT01640353|9886122|FG000|Month 12|Overall Study||160
8831430|NCT01640353|9886122|FG000|Month 18|Overall Study||150
8831431|NCT01640353|9886122|FG000|COMPLETED|Overall Study||149
8831432|NCT01640353|9886122|FG000|NOT COMPLETED|Overall Study||45
8831433|NCT01640366|9886126|FG000|STARTED|Overall Study||200
8831434|NCT01640366|9886126|FG000|Day 21 Follow-up|Overall Study||185
8831435|NCT01640366|9886126|FG000|Day 42 Follow-up|Overall Study||177
8831436|NCT01640366|9886126|FG000|Day 90 Follow-up|Overall Study||178
8831437|NCT01640366|9886126|FG000|COMPLETED|Overall Study||178
8831438|NCT01640366|9886126|FG000|NOT COMPLETED|Overall Study||22
8831439|NCT01640379|9886134|FG000|STARTED|Overall Study||149
8831440|NCT01640379|9886135|FG001|STARTED|Overall Study||137
8831441|NCT01640379|9886134|FG000|COMPLETED|Overall Study||135
8831442|NCT01640379|9886135|FG001|COMPLETED|Overall Study||125
8831443|NCT01640379|9886134|FG000|NOT COMPLETED|Overall Study||14
8831444|NCT01640379|9886135|FG001|NOT COMPLETED|Overall Study||12
8831445|NCT01640548|9886142|FG000|STARTED|Overall Study||309
8831446|NCT01640548|9886142|FG000|COMPLETED|Overall Study||309
8831447|NCT01640548|9886142|FG000|NOT COMPLETED|Overall Study||0
8831448|NCT01640808|9886148|FG000|STARTED|Overall Study||309
8831449|NCT01640808|9886149|FG001|STARTED|Overall Study||307
8831450|NCT01640808|9886148|FG000|Subjects Received Treatment|Overall Study||305
8831451|NCT01640808|9886149|FG001|Subjects Received Treatment|Overall Study||305
8831452|NCT01640808|9886148|FG000|COMPLETED|Overall Study||251
8831453|NCT01640808|9886149|FG001|COMPLETED|Overall Study||291
8831454|NCT01640808|9886148|FG000|NOT COMPLETED|Overall Study||58
8831455|NCT01640808|9886149|FG001|NOT COMPLETED|Overall Study||16
8831456|NCT01640834|9886158|FG000|STARTED|Overall Study||8
8831457|NCT01640834|9886159|FG001|STARTED|Overall Study||8
8831458|NCT01640834|9886160|FG002|STARTED|Overall Study||4
8831459|NCT01640834|9886158|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
8831460|NCT01640834|9886159|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8
8831461|NCT01640834|9886160|FG002|Received at Least 1 Dose of Study Drug|Overall Study||4
8831462|NCT01640834|9886158|FG000|COMPLETED|Overall Study||8
8831463|NCT01640834|9886159|FG001|COMPLETED|Overall Study||8
8831464|NCT01640834|9886160|FG002|COMPLETED|Overall Study||4
8831465|NCT01640834|9886158|FG000|NOT COMPLETED|Overall Study||0
8831466|NCT01640834|9886159|FG001|NOT COMPLETED|Overall Study||0
8831467|NCT01640834|9886160|FG002|NOT COMPLETED|Overall Study||0
8944225|NCT02394951|10006047|FG001|STARTED|Period I||14
8944226|NCT02394951|10006046|FG000|COMPLETED|Period I||11
8944227|NCT02394951|10006047|FG001|COMPLETED|Period I||13
8944228|NCT02394951|10006046|FG000|NOT COMPLETED|Period I||1
8944229|NCT02394951|10006047|FG001|NOT COMPLETED|Period I||1
8944230|NCT02394951|10006046|FG000|STARTED|Period II||11
8944231|NCT02394951|10006047|FG001|STARTED|Period II||13
8944232|NCT02394951|10006046|FG000|COMPLETED|Period II||11
8944233|NCT02394951|10006047|FG001|COMPLETED|Period II||9
8944234|NCT02394951|10006046|FG000|NOT COMPLETED|Period II||0
8944235|NCT02394951|10006047|FG001|NOT COMPLETED|Period II||4
8944236|NCT02395042|10006056|FG000|STARTED|Treatment 1 Period||12
8944237|NCT02395042|10006057|FG001|STARTED|Treatment 1 Period||31
8944238|NCT02395042|10006058|FG002|STARTED|Treatment 1 Period||16
8622562|NCT00488982|9661795|FG000|COMPLETED|Course 2||0
8622563|NCT00488982|9661796|FG001|COMPLETED|Course 2||4
8622564|NCT00488982|9661797|FG002|COMPLETED|Course 2||8
8622565|NCT00488982|9661795|FG000|NOT COMPLETED|Course 2||0
8622566|NCT00488982|9661796|FG001|NOT COMPLETED|Course 2||9
8622567|NCT00488982|9661797|FG002|NOT COMPLETED|Course 2||5
8831468|NCT01640873|9886172|FG000|STARTED|Overall Study||22
8944239|NCT02395042|10006056|FG000|COMPLETED|Treatment 1 Period||9
8944240|NCT02395042|10006057|FG001|COMPLETED|Treatment 1 Period||25
8944241|NCT02395042|10006058|FG002|COMPLETED|Treatment 1 Period||14
8944242|NCT02395042|10006056|FG000|NOT COMPLETED|Treatment 1 Period||3
8944243|NCT02395042|10006057|FG001|NOT COMPLETED|Treatment 1 Period||6
8944244|NCT02395042|10006058|FG002|NOT COMPLETED|Treatment 1 Period||2
8944245|NCT02395042|10006056|FG000|STARTED|Treatment 2 Period|Not all participants participated in Treatment 2 Period.|10
8944246|NCT02395042|10006057|FG001|STARTED|Treatment 2 Period|Not all participants participated in Treatment 2 Period.|24
8944247|NCT02395042|10006058|FG002|STARTED|Treatment 2 Period|Not all participants participated in Treatment 2 Period.|13
8944248|NCT02395042|10006056|FG000|COMPLETED|Treatment 2 Period||9
8944249|NCT02395042|10006057|FG001|COMPLETED|Treatment 2 Period||23
8944250|NCT02395042|10006058|FG002|COMPLETED|Treatment 2 Period||13
8944251|NCT02395042|10006056|FG000|NOT COMPLETED|Treatment 2 Period||1
8944252|NCT02395042|10006057|FG001|NOT COMPLETED|Treatment 2 Period||1
8944253|NCT02395042|10006058|FG002|NOT COMPLETED|Treatment 2 Period||0
8944254|NCT02395055|10006071|FG000|STARTED|Overall Study||47
8944255|NCT02395055|10006072|FG001|STARTED|Overall Study||47
8944256|NCT02395055|10006071|FG000|COMPLETED|Overall Study||40
8944257|NCT02395055|10006072|FG001|COMPLETED|Overall Study||44
8944258|NCT02395055|10006071|FG000|NOT COMPLETED|Overall Study||7
8944259|NCT02395055|10006072|FG001|NOT COMPLETED|Overall Study||3
8944260|NCT02395081|10006081|FG000|STARTED|Overall Study||119
8944261|NCT02395081|10006082|FG001|STARTED|Overall Study||121
8944262|NCT02395081|10006083|FG002|STARTED|Overall Study||120
8944263|NCT02395081|10006081|FG000|COMPLETED|Overall Study||112
8944264|NCT02395081|10006082|FG001|COMPLETED|Overall Study||116
8944265|NCT02395081|10006083|FG002|COMPLETED|Overall Study||116
8944266|NCT02395081|10006081|FG000|NOT COMPLETED|Overall Study||7
8944267|NCT02395081|10006082|FG001|NOT COMPLETED|Overall Study||5
8944268|NCT02395081|10006083|FG002|NOT COMPLETED|Overall Study||4
8944269|NCT02395133|10006098|FG000|STARTED|Overall Study||83
8944270|NCT02395133|10006099|FG001|STARTED|Overall Study||84
8944271|NCT02395133|10006100|FG002|STARTED|Overall Study||86
8944272|NCT02395133|10006101|FG003|STARTED|Overall Study||169
8944273|NCT02395133|10006098|FG000|COMPLETED|Overall Study||69
8944274|NCT02395133|10006099|FG001|COMPLETED|Overall Study||75
8944275|NCT02395133|10006100|FG002|COMPLETED|Overall Study||76
8831469|NCT01640873|9886173|FG001|STARTED|Overall Study||11
8831470|NCT01640873|9886172|FG000|COMPLETED|Overall Study||20
8831471|NCT01640873|9886173|FG001|COMPLETED|Overall Study||10
8831472|NCT01640873|9886172|FG000|NOT COMPLETED|Overall Study||2
8831473|NCT01640873|9886173|FG001|NOT COMPLETED|Overall Study||1
8831474|NCT01640925|9886181|FG000|STARTED|Overall Study||175
8831475|NCT01640925|9886182|FG001|STARTED|Overall Study||175
8831476|NCT01640925|9886181|FG000|COMPLETED|Overall Study||161
8831477|NCT01640925|9886182|FG001|COMPLETED|Overall Study||164
8831478|NCT01640925|9886181|FG000|NOT COMPLETED|Overall Study||14
8831479|NCT01640925|9886182|FG001|NOT COMPLETED|Overall Study||11
8831480|NCT01640951|9886196|FG000|STARTED|Overall Study||77
8831481|NCT01640951|9886197|FG001|STARTED|Overall Study||75
8831482|NCT01640951|9886198|FG002|STARTED|Overall Study||168
8831483|NCT01640951|9886199|FG003|STARTED|Overall Study||55
8944276|NCT02395133|10006101|FG003|COMPLETED|Overall Study||155
8944277|NCT02395133|10006098|FG000|NOT COMPLETED|Overall Study||14
8944278|NCT02395133|10006099|FG001|NOT COMPLETED|Overall Study||9
8944279|NCT02395133|10006100|FG002|NOT COMPLETED|Overall Study||10
8622568|NCT00488982|9661795|FG000|STARTED|Course 3||0
8622569|NCT00488982|9661796|FG001|STARTED|Course 3||4
8831484|NCT01640951|9886200|FG004|STARTED|Overall Study||95
8831485|NCT01640951|9886201|FG005|STARTED|Overall Study||60
8831486|NCT01640951|9886202|FG006|STARTED|Overall Study||112
8831487|NCT01640951|9886203|FG007|STARTED|Overall Study||33
8831488|NCT01640951|9886196|FG000|COMPLETED|Overall Study||31
8831489|NCT01640951|9886197|FG001|COMPLETED|Overall Study||60
8831490|NCT01640951|9886198|FG002|COMPLETED|Overall Study||126
8831491|NCT01640951|9886199|FG003|COMPLETED|Overall Study||10
8831492|NCT01640951|9886200|FG004|COMPLETED|Overall Study||82
8831493|NCT01640951|9886201|FG005|COMPLETED|Overall Study||13
8831494|NCT01640951|9886202|FG006|COMPLETED|Overall Study||94
8831495|NCT01640951|9886203|FG007|COMPLETED|Overall Study||17
8831496|NCT01640951|9886196|FG000|NOT COMPLETED|Overall Study||46
8831497|NCT01640951|9886197|FG001|NOT COMPLETED|Overall Study||15
8831498|NCT01640951|9886198|FG002|NOT COMPLETED|Overall Study||42
8831499|NCT01640951|9886199|FG003|NOT COMPLETED|Overall Study||45
8831500|NCT01640951|9886200|FG004|NOT COMPLETED|Overall Study||13
8831501|NCT01640951|9886201|FG005|NOT COMPLETED|Overall Study||47
8831502|NCT01640951|9886202|FG006|NOT COMPLETED|Overall Study||18
8831503|NCT01640951|9886203|FG007|NOT COMPLETED|Overall Study||16
8831504|NCT01640964|9886226|FG000|STARTED|Overall Study||20
8622570|NCT00488982|9661797|FG002|STARTED|Course 3||8
8622571|NCT00488982|9661795|FG000|COMPLETED|Course 3||0
8622572|NCT00488982|9661796|FG001|COMPLETED|Course 3||2
8622573|NCT00488982|9661797|FG002|COMPLETED|Course 3||3
8622574|NCT00488982|9661795|FG000|NOT COMPLETED|Course 3||0
8831505|NCT01640964|9886227|FG001|STARTED|Overall Study||20
8831506|NCT01640964|9886228|FG002|STARTED|Overall Study||6
8831507|NCT01640964|9886226|FG000|COMPLETED|Overall Study||19
8831508|NCT01640964|9886227|FG001|COMPLETED|Overall Study||19
8831509|NCT01640964|9886228|FG002|COMPLETED|Overall Study||3
8831510|NCT01640964|9886226|FG000|NOT COMPLETED|Overall Study||1
8831511|NCT01640964|9886227|FG001|NOT COMPLETED|Overall Study||1
8831512|NCT01640964|9886228|FG002|NOT COMPLETED|Overall Study||3
8831513|NCT01641042|9886239|FG000|STARTED|Overall Study||43
8831514|NCT01641042|9886240|FG001|STARTED|Overall Study||43
8831515|NCT01641042|9886239|FG000|COMPLETED|Overall Study||43
8831516|NCT01641042|9886240|FG001|COMPLETED|Overall Study||43
8831517|NCT01641042|9886239|FG000|NOT COMPLETED|Overall Study||0
8831518|NCT01641042|9886240|FG001|NOT COMPLETED|Overall Study||0
8831519|NCT01641081|9886246|FG000|STARTED|Period 1||18
8831520|NCT01641081|9886247|FG001|STARTED|Period 1||18
8831521|NCT01641081|9886248|FG002|STARTED|Period 1||15
8831522|NCT01641081|9886249|FG003|STARTED|Period 1||22
8831523|NCT01641081|9886250|FG004|STARTED|Period 1||17
8831524|NCT01641081|9886251|FG005|STARTED|Period 1||19
8831525|NCT01641081|9886252|FG006|STARTED|Period 1||19
8831526|NCT01641081|9886253|FG007|STARTED|Period 1||17
8831527|NCT01641081|9886254|FG008|STARTED|Period 1||15
8831528|NCT01641081|9886255|FG009|STARTED|Period 1||14
8831529|NCT01641081|9886246|FG000|COMPLETED|Period 1||17
8831530|NCT01641081|9886247|FG001|COMPLETED|Period 1||18
8831531|NCT01641081|9886248|FG002|COMPLETED|Period 1||15
8831532|NCT01641081|9886249|FG003|COMPLETED|Period 1||22
8831533|NCT01641081|9886250|FG004|COMPLETED|Period 1||16
9065960|NCT04128293|10126437|FG003|STARTED|Treatment Period 4 (1 Day)||0
9065961|NCT04128293|10126434|FG000|COMPLETED|Treatment Period 4 (1 Day)||0
9065962|NCT04128293|10126435|FG001|COMPLETED|Treatment Period 4 (1 Day)||0
9065963|NCT04128293|10126436|FG002|COMPLETED|Treatment Period 4 (1 Day)||0
9065964|NCT04128293|10126437|FG003|COMPLETED|Treatment Period 4 (1 Day)||0
9065965|NCT04128293|10126434|FG000|NOT COMPLETED|Treatment Period 4 (1 Day)||0
9065966|NCT04128293|10126435|FG001|NOT COMPLETED|Treatment Period 4 (1 Day)||0
9065967|NCT04128293|10126436|FG002|NOT COMPLETED|Treatment Period 4 (1 Day)||0
9065968|NCT04128293|10126437|FG003|NOT COMPLETED|Treatment Period 4 (1 Day)||0
9065969|NCT04126343|10126458|FG000|STARTED|Overall Study||9
9065970|NCT04126343|10126459|FG001|STARTED|Overall Study||9
9065971|NCT04126343|10126460|FG002|STARTED|Overall Study||9
9065972|NCT04126343|10126461|FG003|STARTED|Overall Study||9
9065973|NCT04126343|10126462|FG004|STARTED|Overall Study||9
9065974|NCT04126343|10126463|FG005|STARTED|Overall Study||9
9065975|NCT04126343|10126458|FG000|Completed Padsevonil Period|Overall Study||9
9065976|NCT04126343|10126459|FG001|Completed Padsevonil Period|Overall Study||9
9065977|NCT04126343|10126460|FG002|Completed Padsevonil Period|Overall Study||9
9065978|NCT04126343|10126461|FG003|Completed Padsevonil Period|Overall Study||7
9065979|NCT04126343|10126462|FG004|Completed Padsevonil Period|Overall Study||9
8831534|NCT01641081|9886251|FG005|COMPLETED|Period 1||19
8831535|NCT01641081|9886252|FG006|COMPLETED|Period 1||18
8831536|NCT01641081|9886253|FG007|COMPLETED|Period 1||14
8831537|NCT01641081|9886254|FG008|COMPLETED|Period 1||15
9065980|NCT04126343|10126463|FG005|Completed Padsevonil Period|Overall Study||8
9065981|NCT04126343|10126458|FG000|Completed Placebo Period|Overall Study||9
8622575|NCT00488982|9661796|FG001|NOT COMPLETED|Course 3||2
8622576|NCT00488982|9661797|FG002|NOT COMPLETED|Course 3||5
8622577|NCT00488982|9661795|FG000|STARTED|Response to Course 3||0
8622578|NCT00488982|9661796|FG001|STARTED|Response to Course 3||2
8831538|NCT01641081|9886255|FG009|COMPLETED|Period 1||14
8831539|NCT01641081|9886246|FG000|NOT COMPLETED|Period 1||1
8831540|NCT01641081|9886247|FG001|NOT COMPLETED|Period 1||0
8831541|NCT01641081|9886248|FG002|NOT COMPLETED|Period 1||0
8831542|NCT01641081|9886249|FG003|NOT COMPLETED|Period 1||0
8831543|NCT01641081|9886250|FG004|NOT COMPLETED|Period 1||1
8831544|NCT01641081|9886251|FG005|NOT COMPLETED|Period 1||0
8622579|NCT00488982|9661797|FG002|STARTED|Response to Course 3||3
8831545|NCT01641081|9886252|FG006|NOT COMPLETED|Period 1||1
8831546|NCT01641081|9886253|FG007|NOT COMPLETED|Period 1||3
8831547|NCT01641081|9886254|FG008|NOT COMPLETED|Period 1||0
8831548|NCT01641081|9886255|FG009|NOT COMPLETED|Period 1||0
9065982|NCT04126343|10126459|FG001|Completed Placebo Period|Overall Study||7
8831549|NCT01641081|9886246|FG000|STARTED|Period 2||17
8831550|NCT01641081|9886247|FG001|STARTED|Period 2||18
8831551|NCT01641081|9886248|FG002|STARTED|Period 2||15
8831552|NCT01641081|9886249|FG003|STARTED|Period 2||22
8831553|NCT01641081|9886250|FG004|STARTED|Period 2||16
8831554|NCT01641081|9886251|FG005|STARTED|Period 2||19
8831555|NCT01641081|9886252|FG006|STARTED|Period 2||18
8831556|NCT01641081|9886253|FG007|STARTED|Period 2||14
8831557|NCT01641081|9886254|FG008|STARTED|Period 2||15
8831558|NCT01641081|9886255|FG009|STARTED|Period 2||14
8831559|NCT01641081|9886246|FG000|COMPLETED|Period 2||16
8831560|NCT01641081|9886247|FG001|COMPLETED|Period 2||18
8831561|NCT01641081|9886248|FG002|COMPLETED|Period 2||15
8831562|NCT01641081|9886249|FG003|COMPLETED|Period 2||21
8831563|NCT01641081|9886250|FG004|COMPLETED|Period 2||16
8831564|NCT01641081|9886251|FG005|COMPLETED|Period 2||18
8831565|NCT01641081|9886252|FG006|COMPLETED|Period 2||16
8831566|NCT01641081|9886253|FG007|COMPLETED|Period 2||14
8831567|NCT01641081|9886254|FG008|COMPLETED|Period 2||15
8831568|NCT01641081|9886255|FG009|COMPLETED|Period 2||14
8831569|NCT01641081|9886246|FG000|NOT COMPLETED|Period 2||1
8831570|NCT01641081|9886247|FG001|NOT COMPLETED|Period 2||0
8831571|NCT01641081|9886248|FG002|NOT COMPLETED|Period 2||0
8831572|NCT01641081|9886249|FG003|NOT COMPLETED|Period 2||1
8831573|NCT01641081|9886250|FG004|NOT COMPLETED|Period 2||0
8831574|NCT01641081|9886251|FG005|NOT COMPLETED|Period 2||1
8831575|NCT01641081|9886252|FG006|NOT COMPLETED|Period 2||2
8831576|NCT01641081|9886253|FG007|NOT COMPLETED|Period 2||0
8831577|NCT01641081|9886254|FG008|NOT COMPLETED|Period 2||0
8831578|NCT01641081|9886255|FG009|NOT COMPLETED|Period 2||0
8831579|NCT01641081|9886246|FG000|STARTED|Period 3||16
8831580|NCT01641081|9886247|FG001|STARTED|Period 3||18
8831581|NCT01641081|9886248|FG002|STARTED|Period 3||15
8831582|NCT01641081|9886249|FG003|STARTED|Period 3||21
8831583|NCT01641081|9886250|FG004|STARTED|Period 3||16
8831584|NCT01641081|9886251|FG005|STARTED|Period 3||18
8831585|NCT01641081|9886252|FG006|STARTED|Period 3||16
8831586|NCT01641081|9886253|FG007|STARTED|Period 3||14
8831587|NCT01641081|9886254|FG008|STARTED|Period 3||15
8831588|NCT01641081|9886255|FG009|STARTED|Period 3||14
8831589|NCT01641081|9886246|FG000|COMPLETED|Period 3||16
8831590|NCT01641081|9886247|FG001|COMPLETED|Period 3||18
8831591|NCT01641081|9886248|FG002|COMPLETED|Period 3||14
8831592|NCT01641081|9886249|FG003|COMPLETED|Period 3||21
8831593|NCT01641081|9886250|FG004|COMPLETED|Period 3||16
8831594|NCT01641081|9886251|FG005|COMPLETED|Period 3||18
8831595|NCT01641081|9886252|FG006|COMPLETED|Period 3||16
8831596|NCT01641081|9886253|FG007|COMPLETED|Period 3||14
8831597|NCT01641081|9886254|FG008|COMPLETED|Period 3||14
8831598|NCT01641081|9886255|FG009|COMPLETED|Period 3||14
8831599|NCT01641081|9886246|FG000|NOT COMPLETED|Period 3||0
8831600|NCT01641081|9886247|FG001|NOT COMPLETED|Period 3||0
8831601|NCT01641081|9886248|FG002|NOT COMPLETED|Period 3||1
8831602|NCT01641081|9886249|FG003|NOT COMPLETED|Period 3||0
8831603|NCT01641081|9886250|FG004|NOT COMPLETED|Period 3||0
8831604|NCT01641081|9886251|FG005|NOT COMPLETED|Period 3||0
8831605|NCT01641081|9886252|FG006|NOT COMPLETED|Period 3||0
8831606|NCT01641081|9886253|FG007|NOT COMPLETED|Period 3||0
8831607|NCT01641081|9886254|FG008|NOT COMPLETED|Period 3||1
8831608|NCT01641081|9886255|FG009|NOT COMPLETED|Period 3||0
8831609|NCT01641081|9886246|FG000|STARTED|Period 4||16
8831610|NCT01641081|9886247|FG001|STARTED|Period 4||18
8831611|NCT01641081|9886248|FG002|STARTED|Period 4||14
8831612|NCT01641081|9886249|FG003|STARTED|Period 4||21
8831613|NCT01641081|9886250|FG004|STARTED|Period 4||16
8831614|NCT01641081|9886251|FG005|STARTED|Period 4||18
8831615|NCT01641081|9886252|FG006|STARTED|Period 4||16
8831616|NCT01641081|9886253|FG007|STARTED|Period 4||14
8831617|NCT01641081|9886254|FG008|STARTED|Period 4||14
8831618|NCT01641081|9886255|FG009|STARTED|Period 4||14
8831619|NCT01641081|9886246|FG000|COMPLETED|Period 4||16
8831620|NCT01641081|9886247|FG001|COMPLETED|Period 4||17
8831621|NCT01641081|9886248|FG002|COMPLETED|Period 4||14
8831622|NCT01641081|9886249|FG003|COMPLETED|Period 4||20
8831623|NCT01641081|9886250|FG004|COMPLETED|Period 4||16
8831624|NCT01641081|9886251|FG005|COMPLETED|Period 4||18
8831625|NCT01641081|9886252|FG006|COMPLETED|Period 4||16
8831626|NCT01641081|9886253|FG007|COMPLETED|Period 4||14
8831627|NCT01641081|9886254|FG008|COMPLETED|Period 4||14
8831628|NCT01641081|9886255|FG009|COMPLETED|Period 4||14
8831629|NCT01641081|9886246|FG000|NOT COMPLETED|Period 4||0
8831630|NCT01641081|9886247|FG001|NOT COMPLETED|Period 4||1
8831631|NCT01641081|9886248|FG002|NOT COMPLETED|Period 4||0
8831632|NCT01641081|9886249|FG003|NOT COMPLETED|Period 4||1
8831633|NCT01641081|9886250|FG004|NOT COMPLETED|Period 4||0
8831634|NCT01641081|9886251|FG005|NOT COMPLETED|Period 4||0
8831635|NCT01641081|9886252|FG006|NOT COMPLETED|Period 4||0
8831636|NCT01641081|9886253|FG007|NOT COMPLETED|Period 4||0
8831637|NCT01641081|9886254|FG008|NOT COMPLETED|Period 4||0
8831638|NCT01641081|9886255|FG009|NOT COMPLETED|Period 4||0
8831639|NCT01641081|9886246|FG000|STARTED|Period 5||16
8831640|NCT01641081|9886247|FG001|STARTED|Period 5||17
8831641|NCT01641081|9886248|FG002|STARTED|Period 5||14
8831642|NCT01641081|9886249|FG003|STARTED|Period 5||20
8831643|NCT01641081|9886250|FG004|STARTED|Period 5||16
8831644|NCT01641081|9886251|FG005|STARTED|Period 5||18
8831645|NCT01641081|9886252|FG006|STARTED|Period 5||16
8831646|NCT01641081|9886253|FG007|STARTED|Period 5||14
8831647|NCT01641081|9886254|FG008|STARTED|Period 5||14
8831648|NCT01641081|9886255|FG009|STARTED|Period 5||14
8831649|NCT01641081|9886246|FG000|COMPLETED|Period 5||16
8831650|NCT01641081|9886247|FG001|COMPLETED|Period 5||17
8831651|NCT01641081|9886248|FG002|COMPLETED|Period 5||12
8831652|NCT01641081|9886249|FG003|COMPLETED|Period 5||20
8831653|NCT01641081|9886250|FG004|COMPLETED|Period 5||16
8831654|NCT01641081|9886251|FG005|COMPLETED|Period 5||18
8831655|NCT01641081|9886252|FG006|COMPLETED|Period 5||16
8831656|NCT01641081|9886253|FG007|COMPLETED|Period 5||14
8831657|NCT01641081|9886254|FG008|COMPLETED|Period 5||14
8831658|NCT01641081|9886255|FG009|COMPLETED|Period 5||14
8831659|NCT01641081|9886246|FG000|NOT COMPLETED|Period 5||0
8831660|NCT01641081|9886247|FG001|NOT COMPLETED|Period 5||0
8831661|NCT01641081|9886248|FG002|NOT COMPLETED|Period 5||2
8831662|NCT01641081|9886249|FG003|NOT COMPLETED|Period 5||0
8831663|NCT01641081|9886250|FG004|NOT COMPLETED|Period 5||0
8831664|NCT01641081|9886251|FG005|NOT COMPLETED|Period 5||0
8831665|NCT01641081|9886252|FG006|NOT COMPLETED|Period 5||0
8831666|NCT01641081|9886253|FG007|NOT COMPLETED|Period 5||0
8831667|NCT01641081|9886254|FG008|NOT COMPLETED|Period 5||0
8831668|NCT01641081|9886255|FG009|NOT COMPLETED|Period 5||0
8831669|NCT01641120|9886267|FG000|STARTED|25 Gauge Needle Weeks 1, 4, 5||20
8831670|NCT01641120|9886267|FG000|COMPLETED|25 Gauge Needle Weeks 1, 4, 5||20
8831671|NCT01641120|9886267|FG000|NOT COMPLETED|25 Gauge Needle Weeks 1, 4, 5||0
8831672|NCT01641120|9886267|FG000|STARTED|30 Gauge Needle Weeks 2 and 3||20
8831673|NCT01641120|9886267|FG000|COMPLETED|30 Gauge Needle Weeks 2 and 3||20
8831674|NCT01641120|9886267|FG000|NOT COMPLETED|30 Gauge Needle Weeks 2 and 3||0
8831675|NCT01641133|9886277|FG000|STARTED|Overall Study||97
8831676|NCT01641133|9886278|FG001|STARTED|Overall Study||99
8831677|NCT01641133|9886279|FG002|STARTED|Overall Study||98
8831678|NCT01641133|9886277|FG000|COMPLETED|Overall Study||87
8831679|NCT01641133|9886278|FG001|COMPLETED|Overall Study||90
8831680|NCT01641133|9886279|FG002|COMPLETED|Overall Study||90
8831681|NCT01641133|9886277|FG000|NOT COMPLETED|Overall Study||10
8831682|NCT01641133|9886278|FG001|NOT COMPLETED|Overall Study||9
8831683|NCT01641133|9886279|FG002|NOT COMPLETED|Overall Study||8
8831684|NCT01641159|9886289|FG000|STARTED|Overall Study||35
8831685|NCT01641159|9886290|FG001|STARTED|Overall Study||27
8831686|NCT01641159|9886289|FG000|COMPLETED|Overall Study||33
8831687|NCT01641159|9886290|FG001|COMPLETED|Overall Study||25
8831688|NCT01641159|9886289|FG000|NOT COMPLETED|Overall Study||2
8831689|NCT01641159|9886290|FG001|NOT COMPLETED|Overall Study||2
8831690|NCT01641198|9886299|FG000|STARTED|After 12 Months of Function||20
8831691|NCT01641198|9886300|FG001|STARTED|After 12 Months of Function||19
8831692|NCT01641198|9886301|FG002|STARTED|After 12 Months of Function||19
8831693|NCT01641198|9886299|FG000|COMPLETED|After 12 Months of Function|Participants: 3 interval violation, 1 protocol violation. Implants: 13 bone loss not measurable|16
8831694|NCT01641198|9886300|FG001|COMPLETED|After 12 Months of Function|Participants: 2 interval violation, 1 adverse event. Implants: 3 bone loss not measurable|16
8831695|NCT01641198|9886301|FG002|COMPLETED|After 12 Months of Function|Participants: 2 interval violation. Implants: 3 bone loss not measurable|17
8831696|NCT01641198|9886299|FG000|NOT COMPLETED|After 12 Months of Function||4
8831697|NCT01641198|9886300|FG001|NOT COMPLETED|After 12 Months of Function||3
8831698|NCT01641198|9886301|FG002|NOT COMPLETED|After 12 Months of Function||2
8831699|NCT01641198|9886299|FG000|STARTED|After 24 Months of Function||16
8622580|NCT00488982|9661795|FG000|COMPLETED|Response to Course 3||0
8622581|NCT00488982|9661796|FG001|COMPLETED|Response to Course 3||1
8622582|NCT00488982|9661797|FG002|COMPLETED|Response to Course 3||0
8622583|NCT00488982|9661795|FG000|NOT COMPLETED|Response to Course 3||0
8831700|NCT01641198|9886300|FG001|STARTED|After 24 Months of Function||16
8831701|NCT01641198|9886301|FG002|STARTED|After 24 Months of Function||17
8831702|NCT01641198|9886299|FG000|COMPLETED|After 24 Months of Function|Participants: 4 interval violation. Implants: 3 bone loss not measurable|12
8831703|NCT01641198|9886300|FG001|COMPLETED|After 24 Months of Function|Participants: 9 interval violation|7
8831704|NCT01641198|9886301|FG002|COMPLETED|After 24 Months of Function|Participants: 6 interval violation. Implants: 2 bone loss not measurable|11
8831705|NCT01641198|9886299|FG000|NOT COMPLETED|After 24 Months of Function||4
8831706|NCT01641198|9886300|FG001|NOT COMPLETED|After 24 Months of Function||9
8831707|NCT01641198|9886301|FG002|NOT COMPLETED|After 24 Months of Function||6
8831708|NCT01641198|9886299|FG000|STARTED|At 15-20 Years of Function||12
8831709|NCT01641198|9886300|FG001|STARTED|At 15-20 Years of Function||7
8831710|NCT01641198|9886301|FG002|STARTED|At 15-20 Years of Function||11
8831711|NCT01641198|9886299|FG000|COMPLETED|At 15-20 Years of Function|Participants: 5 interval violation, 1 death|6
8831712|NCT01641198|9886300|FG001|COMPLETED|At 15-20 Years of Function|Participants: 1 interval violation|6
8831713|NCT01641198|9886301|FG002|COMPLETED|At 15-20 Years of Function|Participants: 1 interval violation, 1 death|9
8831714|NCT01641198|9886299|FG000|NOT COMPLETED|At 15-20 Years of Function||6
8831715|NCT01641198|9886300|FG001|NOT COMPLETED|At 15-20 Years of Function||1
8831716|NCT01641198|9886301|FG002|NOT COMPLETED|At 15-20 Years of Function||2
8831717|NCT01641237|9886310|FG000|STARTED|Period I||16
8831718|NCT01641237|9886311|FG001|STARTED|Period I||16
8831719|NCT01641237|9886312|FG002|STARTED|Period I||15
8831720|NCT01641237|9886313|FG003|STARTED|Period I||15
8831721|NCT01641237|9886310|FG000|COMPLETED|Period I||16
8831722|NCT01641237|9886311|FG001|COMPLETED|Period I||16
8831723|NCT01641237|9886312|FG002|COMPLETED|Period I||15
8831724|NCT01641237|9886313|FG003|COMPLETED|Period I||15
8622584|NCT00488982|9661796|FG001|NOT COMPLETED|Response to Course 3||1
8831725|NCT01641237|9886310|FG000|NOT COMPLETED|Period I||0
8622585|NCT00488982|9661797|FG002|NOT COMPLETED|Response to Course 3||3
8831726|NCT01641237|9886311|FG001|NOT COMPLETED|Period I||0
8831727|NCT01641237|9886312|FG002|NOT COMPLETED|Period I||0
8831728|NCT01641237|9886313|FG003|NOT COMPLETED|Period I||0
8831729|NCT01641237|9886310|FG000|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|15
8831730|NCT01641237|9886311|FG001|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|16
8831731|NCT01641237|9886312|FG002|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|16
8831732|NCT01641237|9886313|FG003|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|15
8831733|NCT01641237|9886310|FG000|COMPLETED|Period II||14
8831734|NCT01641237|9886311|FG001|COMPLETED|Period II||16
8831735|NCT01641237|9886312|FG002|COMPLETED|Period II||16
8831736|NCT01641237|9886313|FG003|COMPLETED|Period II||15
8831737|NCT01641237|9886310|FG000|NOT COMPLETED|Period II||1
8831738|NCT01641237|9886311|FG001|NOT COMPLETED|Period II||0
8831739|NCT01641237|9886312|FG002|NOT COMPLETED|Period II||0
8831740|NCT01641237|9886313|FG003|NOT COMPLETED|Period II||0
8831741|NCT01641237|9886310|FG000|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|16
8831742|NCT01641237|9886311|FG001|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
8831743|NCT01641237|9886312|FG002|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|15
8831744|NCT01641237|9886313|FG003|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|16
8831745|NCT01641237|9886310|FG000|COMPLETED|Period III||15
8831746|NCT01641237|9886311|FG001|COMPLETED|Period III||14
8831747|NCT01641237|9886312|FG002|COMPLETED|Period III||15
8831748|NCT01641237|9886313|FG003|COMPLETED|Period III||16
8831749|NCT01641237|9886310|FG000|NOT COMPLETED|Period III||1
8831750|NCT01641237|9886311|FG001|NOT COMPLETED|Period III||0
8831751|NCT01641237|9886312|FG002|NOT COMPLETED|Period III||0
8831752|NCT01641237|9886313|FG003|NOT COMPLETED|Period III||0
8831753|NCT01641237|9886310|FG000|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
8831754|NCT01641237|9886311|FG001|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
8831755|NCT01641237|9886312|FG002|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
8831756|NCT01641237|9886313|FG003|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
8831757|NCT01641237|9886310|FG000|COMPLETED|Period IV||15
8831758|NCT01641237|9886311|FG001|COMPLETED|Period IV||15
8831759|NCT01641237|9886312|FG002|COMPLETED|Period IV||15
8831760|NCT01641237|9886313|FG003|COMPLETED|Period IV||15
8831761|NCT01641237|9886310|FG000|NOT COMPLETED|Period IV||0
8831762|NCT01641237|9886311|FG001|NOT COMPLETED|Period IV||0
8831763|NCT01641237|9886312|FG002|NOT COMPLETED|Period IV||0
8831764|NCT01641237|9886313|FG003|NOT COMPLETED|Period IV||0
8849766|NCT01743040|9905023|FG000|COMPLETED|Overall Study||785
8849767|NCT01743040|9905023|FG000|NOT COMPLETED|Overall Study||229
8849768|NCT01743092|9905029|FG000|STARTED|Overall Study||33
8849769|NCT01743092|9905030|FG001|STARTED|Overall Study||26
8849770|NCT01743092|9905029|FG000|COMPLETED|Overall Study||19
8849771|NCT01743092|9905030|FG001|COMPLETED|Overall Study||11
8849772|NCT01743092|9905029|FG000|NOT COMPLETED|Overall Study||14
8849773|NCT01743092|9905030|FG001|NOT COMPLETED|Overall Study||15
8849774|NCT01743131|9905040|FG000|STARTED|Overall Study||73
8849775|NCT01743131|9905041|FG001|STARTED|Overall Study||69
8849776|NCT01743131|9905042|FG002|STARTED|Overall Study||43
8849777|NCT01743131|9905043|FG003|STARTED|Overall Study||1
8849778|NCT01743131|9905044|FG004|STARTED|Overall Study||127
8849779|NCT01743131|9905040|FG000|Not Included in Analysis|Overall Study||0
8849780|NCT01743131|9905041|FG001|Not Included in Analysis|Overall Study||0
8849781|NCT01743131|9905042|FG002|Not Included in Analysis|Overall Study||0
8849782|NCT01743131|9905043|FG003|Not Included in Analysis|Overall Study||1
8849783|NCT01743131|9905044|FG004|Not Included in Analysis|Overall Study||0
8849784|NCT01743131|9905040|FG000|COMPLETED|Overall Study||73
8849785|NCT01743131|9905041|FG001|COMPLETED|Overall Study||69
8849786|NCT01743131|9905042|FG002|COMPLETED|Overall Study||43
8849787|NCT01743131|9905043|FG003|COMPLETED|Overall Study||1
8849788|NCT01743131|9905044|FG004|COMPLETED|Overall Study||127
8849789|NCT01743131|9905040|FG000|NOT COMPLETED|Overall Study||0
8849790|NCT01743131|9905041|FG001|NOT COMPLETED|Overall Study||0
8849791|NCT01743131|9905042|FG002|NOT COMPLETED|Overall Study||0
8849792|NCT01743131|9905043|FG003|NOT COMPLETED|Overall Study||0
8849793|NCT01743131|9905044|FG004|NOT COMPLETED|Overall Study||0
8849794|NCT01743469|9905057|FG000|STARTED|Active Treatment Phase||53
8849795|NCT01743469|9905058|FG001|STARTED|Active Treatment Phase||55
8849796|NCT01743469|9905059|FG002|STARTED|Active Treatment Phase||38
8849797|NCT01743469|9905060|FG003|STARTED|Active Treatment Phase||21
8849798|NCT01743469|9905057|FG000|COMPLETED|Active Treatment Phase||0
8849799|NCT01743469|9905058|FG001|COMPLETED|Active Treatment Phase||0
8849800|NCT01743469|9905059|FG002|COMPLETED|Active Treatment Phase||0
8849801|NCT01743469|9905060|FG003|COMPLETED|Active Treatment Phase||0
8849802|NCT01743469|9905057|FG000|NOT COMPLETED|Active Treatment Phase||53
8849803|NCT01743469|9905058|FG001|NOT COMPLETED|Active Treatment Phase||55
8849804|NCT01743469|9905059|FG002|NOT COMPLETED|Active Treatment Phase||38
8849805|NCT01743469|9905060|FG003|NOT COMPLETED|Active Treatment Phase||21
8849806|NCT01743469|9905057|FG000|STARTED|Follow-up Period - Post-Treatment||51
8849807|NCT01743469|9905058|FG001|STARTED|Follow-up Period - Post-Treatment||53
8849808|NCT01743469|9905059|FG002|STARTED|Follow-up Period - Post-Treatment||37
8849809|NCT01743469|9905060|FG003|STARTED|Follow-up Period - Post-Treatment||21
8831765|NCT01641367|9886329|FG000|STARTED|Cohorts||287
8831766|NCT01641367|9886330|FG001|STARTED|Cohorts||74
8831767|NCT01641367|9886331|FG002|STARTED|Cohorts||72
8831768|NCT01641367|9886332|FG003|STARTED|Cohorts||8
8831769|NCT01641367|9886333|FG004|STARTED|Cohorts||70
8831770|NCT01641367|9886334|FG005|STARTED|Cohorts||34
8831771|NCT01641367|9886335|FG006|STARTED|Cohorts||0
8831772|NCT01641367|9886336|FG007|STARTED|Cohorts||0
8831773|NCT01641367|9886329|FG000|Followed 72 Weeks on Step 1/2|Cohorts||211
8831774|NCT01641367|9886330|FG001|Followed 72 Weeks on Step 1/2|Cohorts||60
8831775|NCT01641367|9886331|FG002|Followed 72 Weeks on Step 1/2|Cohorts||60
8831776|NCT01641367|9886332|FG003|Followed 72 Weeks on Step 1/2|Cohorts||6
8831777|NCT01641367|9886333|FG004|Followed 72 Weeks on Step 1/2|Cohorts||52
8831778|NCT01641367|9886334|FG005|Followed 72 Weeks on Step 1/2|Cohorts||30
8831779|NCT01641367|9886335|FG006|Followed 72 Weeks on Step 1/2|Cohorts||0
8831780|NCT01641367|9886336|FG007|Followed 72 Weeks on Step 1/2|Cohorts||0
8831781|NCT01641367|9886329|FG000|COMPLETED|Cohorts||253
8831782|NCT01641367|9886330|FG001|COMPLETED|Cohorts||73
8831783|NCT01641367|9886331|FG002|COMPLETED|Cohorts||68
8831784|NCT01641367|9886332|FG003|COMPLETED|Cohorts||8
8831785|NCT01641367|9886333|FG004|COMPLETED|Cohorts||67
8831786|NCT01641367|9886334|FG005|COMPLETED|Cohorts||33
8831787|NCT01641367|9886335|FG006|COMPLETED|Cohorts||0
8831788|NCT01641367|9886336|FG007|COMPLETED|Cohorts||0
8831789|NCT01641367|9886329|FG000|NOT COMPLETED|Cohorts||34
8831790|NCT01641367|9886330|FG001|NOT COMPLETED|Cohorts||1
8831791|NCT01641367|9886331|FG002|NOT COMPLETED|Cohorts||4
8831792|NCT01641367|9886332|FG003|NOT COMPLETED|Cohorts||0
8831793|NCT01641367|9886333|FG004|NOT COMPLETED|Cohorts||3
8831794|NCT01641367|9886334|FG005|NOT COMPLETED|Cohorts||1
8831795|NCT01641367|9886335|FG006|NOT COMPLETED|Cohorts||0
8831796|NCT01641367|9886336|FG007|NOT COMPLETED|Cohorts||0
8831797|NCT01641367|9886329|FG000|STARTED|Randomized Adherence Intervention||0
8831798|NCT01641367|9886330|FG001|STARTED|Randomized Adherence Intervention||0
8831799|NCT01641367|9886331|FG002|STARTED|Randomized Adherence Intervention||0
8831800|NCT01641367|9886332|FG003|STARTED|Randomized Adherence Intervention||0
8831801|NCT01641367|9886333|FG004|STARTED|Randomized Adherence Intervention||0
8831802|NCT01641367|9886334|FG005|STARTED|Randomized Adherence Intervention||0
8831803|NCT01641367|9886335|FG006|STARTED|Randomized Adherence Intervention||257
8831804|NCT01641367|9886336|FG007|STARTED|Randomized Adherence Intervention||264
8831805|NCT01641367|9886329|FG000|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
8831806|NCT01641367|9886330|FG001|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
8831807|NCT01641367|9886331|FG002|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
8831808|NCT01641367|9886332|FG003|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
8831809|NCT01641367|9886333|FG004|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
8831810|NCT01641367|9886334|FG005|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
8831811|NCT01641367|9886335|FG006|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||196
8831812|NCT01641367|9886336|FG007|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||202
8831813|NCT01641367|9886329|FG000|COMPLETED|Randomized Adherence Intervention||0
8831814|NCT01641367|9886330|FG001|COMPLETED|Randomized Adherence Intervention||0
8831815|NCT01641367|9886331|FG002|COMPLETED|Randomized Adherence Intervention||0
8831816|NCT01641367|9886332|FG003|COMPLETED|Randomized Adherence Intervention||0
8831817|NCT01641367|9886333|FG004|COMPLETED|Randomized Adherence Intervention||0
8831818|NCT01641367|9886334|FG005|COMPLETED|Randomized Adherence Intervention||0
8831819|NCT01641367|9886335|FG006|COMPLETED|Randomized Adherence Intervention||238
8622586|NCT00489086|9661811|FG000|STARTED|Overall Study||36
8622587|NCT00489086|9661811|FG000|Completed 18 Months|Overall Study||23
8622588|NCT00489086|9661811|FG000|COMPLETED|Overall Study||13
8622589|NCT00489086|9661811|FG000|NOT COMPLETED|Overall Study||23
8622590|NCT00489216|9661815|FG000|STARTED|Overall Study||2
8622591|NCT00489216|9661815|FG000|COMPLETED|Overall Study||1
8622592|NCT00489216|9661815|FG000|NOT COMPLETED|Overall Study||1
8622593|NCT00489255|9661821|FG000|STARTED|Screening and Initial Randomization|Total randomized subjects to receive Tigan|145
8622594|NCT00489255|9661822|FG001|STARTED|Screening and Initial Randomization|Total randomized subjects to receive placebo|49
8622595|NCT00489255|9661821|FG000|COMPLETED|Screening and Initial Randomization||136
8622596|NCT00489255|9661822|FG001|COMPLETED|Screening and Initial Randomization||46
8622597|NCT00489255|9661821|FG000|NOT COMPLETED|Screening and Initial Randomization||9
8622598|NCT00489255|9661822|FG001|NOT COMPLETED|Screening and Initial Randomization||3
8831820|NCT01641367|9886336|FG007|COMPLETED|Randomized Adherence Intervention||240
8831821|NCT01641367|9886329|FG000|NOT COMPLETED|Randomized Adherence Intervention||0
8831822|NCT01641367|9886330|FG001|NOT COMPLETED|Randomized Adherence Intervention||0
8831823|NCT01641367|9886331|FG002|NOT COMPLETED|Randomized Adherence Intervention||0
8831824|NCT01641367|9886332|FG003|NOT COMPLETED|Randomized Adherence Intervention||0
8831825|NCT01641367|9886333|FG004|NOT COMPLETED|Randomized Adherence Intervention||0
8831826|NCT01641367|9886334|FG005|NOT COMPLETED|Randomized Adherence Intervention||0
8831827|NCT01641367|9886335|FG006|NOT COMPLETED|Randomized Adherence Intervention||19
8831828|NCT01641367|9886336|FG007|NOT COMPLETED|Randomized Adherence Intervention||24
8831829|NCT01641380|9886361|FG000|STARTED|First Injection Cycle||50
8831830|NCT01641380|9886362|FG001|STARTED|First Injection Cycle||50
8622599|NCT00489255|9661821|FG000|STARTED|Period 1: Days 1 to 28||136
8622600|NCT00489255|9661822|FG001|STARTED|Period 1: Days 1 to 28||46
8622601|NCT00489255|9661821|FG000|Completed and Follow Period 2|Period 1: Days 1 to 28||94
8831831|NCT01641380|9886361|FG000|COMPLETED|First Injection Cycle||43
8831832|NCT01641380|9886362|FG001|COMPLETED|First Injection Cycle||44
8831833|NCT01641380|9886361|FG000|NOT COMPLETED|First Injection Cycle||7
8831834|NCT01641380|9886362|FG001|NOT COMPLETED|First Injection Cycle||6
8831835|NCT01641380|9886361|FG000|STARTED|Second Injection Cycle||43
8831836|NCT01641380|9886362|FG001|STARTED|Second Injection Cycle||44
8831837|NCT01641380|9886361|FG000|COMPLETED|Second Injection Cycle||39
8831838|NCT01641380|9886362|FG001|COMPLETED|Second Injection Cycle||38
8831839|NCT01641380|9886361|FG000|NOT COMPLETED|Second Injection Cycle||4
8831840|NCT01641380|9886362|FG001|NOT COMPLETED|Second Injection Cycle||6
8831841|NCT01641380|9886361|FG000|STARTED|Third Injection Cycle||39
8831842|NCT01641380|9886362|FG001|STARTED|Third Injection Cycle||38
8831843|NCT01641380|9886361|FG000|COMPLETED|Third Injection Cycle||36
8831844|NCT01641380|9886362|FG001|COMPLETED|Third Injection Cycle||33
8831845|NCT01641380|9886361|FG000|NOT COMPLETED|Third Injection Cycle||3
8831846|NCT01641380|9886362|FG001|NOT COMPLETED|Third Injection Cycle||5
8831847|NCT01641445|9886371|FG000|STARTED|Overall Study||41
8831848|NCT01641445|9886372|FG001|STARTED|Overall Study||41
8831849|NCT01641445|9886371|FG000|COMPLETED|Overall Study||31
8831850|NCT01641445|9886372|FG001|COMPLETED|Overall Study||36
8831851|NCT01641445|9886371|FG000|NOT COMPLETED|Overall Study||10
8831852|NCT01641445|9886372|FG001|NOT COMPLETED|Overall Study||5
8831853|NCT01641471|9886380|FG000|STARTED|Overall Study||58
8831854|NCT01641471|9886381|FG001|STARTED|Overall Study||58
8831855|NCT01641471|9886380|FG000|COMPLETED|Overall Study||35
8831856|NCT01641471|9886381|FG001|COMPLETED|Overall Study||31
8831857|NCT01641471|9886380|FG000|NOT COMPLETED|Overall Study||23
8831858|NCT01641471|9886381|FG001|NOT COMPLETED|Overall Study||27
8831859|NCT01641640|9886387|FG000|STARTED|Overall Study||328
8831860|NCT01641640|9886387|FG000|Enrolled and Treated|Overall Study||327
8831861|NCT01641640|9886387|FG000|COMPLETED|Overall Study||292
8831862|NCT01641640|9886387|FG000|NOT COMPLETED|Overall Study||36
8831863|NCT01641653|9886393|FG000|STARTED|Overall Study||30
8831864|NCT01641653|9886394|FG001|STARTED|Overall Study||30
8831865|NCT01641653|9886393|FG000|COMPLETED|Overall Study||30
8831866|NCT01641653|9886394|FG001|COMPLETED|Overall Study||30
8831867|NCT01641653|9886393|FG000|NOT COMPLETED|Overall Study||0
8831868|NCT01641653|9886394|FG001|NOT COMPLETED|Overall Study||0
8622602|NCT00489255|9661822|FG001|Completed and Follow Period 2|Period 1: Days 1 to 28||29
8622603|NCT00489255|9661821|FG000|Completed But Discontinued Study|Period 1: Days 1 to 28||13
8622604|NCT00489255|9661822|FG001|Completed But Discontinued Study|Period 1: Days 1 to 28||5
8622605|NCT00489255|9661821|FG000|COMPLETED|Period 1: Days 1 to 28||107
8831869|NCT01641692|9886403|FG000|STARTED|Treatment Period 1||42
8831870|NCT01641692|9886404|FG001|STARTED|Treatment Period 1||45
8831871|NCT01641692|9886405|FG002|STARTED|Treatment Period 1||51
8831872|NCT01641692|9886406|FG003|STARTED|Treatment Period 1||41
8831873|NCT01641692|9886407|FG004|STARTED|Treatment Period 1||43
8831874|NCT01641692|9886408|FG005|STARTED|Treatment Period 1||39
8831875|NCT01641692|9886409|FG006|STARTED|Treatment Period 1||38
8831876|NCT01641692|9886410|FG007|STARTED|Treatment Period 1||51
8831877|NCT01641692|9886403|FG000|COMPLETED|Treatment Period 1||40
8831878|NCT01641692|9886404|FG001|COMPLETED|Treatment Period 1||45
8831879|NCT01641692|9886405|FG002|COMPLETED|Treatment Period 1||50
8831880|NCT01641692|9886406|FG003|COMPLETED|Treatment Period 1||41
8831881|NCT01641692|9886407|FG004|COMPLETED|Treatment Period 1||39
8831882|NCT01641692|9886408|FG005|COMPLETED|Treatment Period 1||37
8831883|NCT01641692|9886409|FG006|COMPLETED|Treatment Period 1||38
8831884|NCT01641692|9886410|FG007|COMPLETED|Treatment Period 1||48
8831885|NCT01641692|9886403|FG000|NOT COMPLETED|Treatment Period 1||2
8831886|NCT01641692|9886404|FG001|NOT COMPLETED|Treatment Period 1||0
8831887|NCT01641692|9886405|FG002|NOT COMPLETED|Treatment Period 1||1
8831888|NCT01641692|9886406|FG003|NOT COMPLETED|Treatment Period 1||0
8831889|NCT01641692|9886407|FG004|NOT COMPLETED|Treatment Period 1||4
8831890|NCT01641692|9886408|FG005|NOT COMPLETED|Treatment Period 1||2
8831891|NCT01641692|9886409|FG006|NOT COMPLETED|Treatment Period 1||0
8831892|NCT01641692|9886410|FG007|NOT COMPLETED|Treatment Period 1||3
8831893|NCT01641692|9886403|FG000|STARTED|Washout Period 1 (12-14 Days)||40
8831894|NCT01641692|9886404|FG001|STARTED|Washout Period 1 (12-14 Days)||45
8831895|NCT01641692|9886405|FG002|STARTED|Washout Period 1 (12-14 Days)||50
8831896|NCT01641692|9886406|FG003|STARTED|Washout Period 1 (12-14 Days)||41
8831897|NCT01641692|9886407|FG004|STARTED|Washout Period 1 (12-14 Days)||39
8831898|NCT01641692|9886408|FG005|STARTED|Washout Period 1 (12-14 Days)||37
8831899|NCT01641692|9886409|FG006|STARTED|Washout Period 1 (12-14 Days)||38
8831900|NCT01641692|9886410|FG007|STARTED|Washout Period 1 (12-14 Days)||48
8831901|NCT01641692|9886403|FG000|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|36
8831902|NCT01641692|9886404|FG001|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|44
8831903|NCT01641692|9886405|FG002|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|47
8831904|NCT01641692|9886406|FG003|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|39
8831905|NCT01641692|9886407|FG004|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|35
8831906|NCT01641692|9886408|FG005|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|37
8850428|NCT01746420|9905640|FG004|STARTED|Overall Study||20
8831907|NCT01641692|9886409|FG006|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|36
8831908|NCT01641692|9886410|FG007|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|47
8831909|NCT01641692|9886403|FG000|NOT COMPLETED|Washout Period 1 (12-14 Days)||4
8831910|NCT01641692|9886404|FG001|NOT COMPLETED|Washout Period 1 (12-14 Days)||1
8831911|NCT01641692|9886405|FG002|NOT COMPLETED|Washout Period 1 (12-14 Days)||3
8831912|NCT01641692|9886406|FG003|NOT COMPLETED|Washout Period 1 (12-14 Days)||2
8831913|NCT01641692|9886407|FG004|NOT COMPLETED|Washout Period 1 (12-14 Days)||4
8831914|NCT01641692|9886408|FG005|NOT COMPLETED|Washout Period 1 (12-14 Days)||0
8831915|NCT01641692|9886409|FG006|NOT COMPLETED|Washout Period 1 (12-14 Days)||2
8831916|NCT01641692|9886410|FG007|NOT COMPLETED|Washout Period 1 (12-14 Days)||1
8831917|NCT01641692|9886403|FG000|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|33
8831918|NCT01641692|9886404|FG001|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|46
8831919|NCT01641692|9886405|FG002|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|40
8831920|NCT01641692|9886406|FG003|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|41
8831921|NCT01641692|9886407|FG004|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|37
8831922|NCT01641692|9886408|FG005|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|45
8831923|NCT01641692|9886409|FG006|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|43
8831924|NCT01641692|9886410|FG007|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|36
8831925|NCT01641692|9886403|FG000|COMPLETED|Treatment Period 2||30
8831926|NCT01641692|9886404|FG001|COMPLETED|Treatment Period 2||46
8831927|NCT01641692|9886405|FG002|COMPLETED|Treatment Period 2||40
8831928|NCT01641692|9886406|FG003|COMPLETED|Treatment Period 2||41
8831929|NCT01641692|9886407|FG004|COMPLETED|Treatment Period 2||37
8831930|NCT01641692|9886408|FG005|COMPLETED|Treatment Period 2||43
8831931|NCT01641692|9886409|FG006|COMPLETED|Treatment Period 2||43
8831932|NCT01641692|9886410|FG007|COMPLETED|Treatment Period 2||35
8831933|NCT01641692|9886403|FG000|NOT COMPLETED|Treatment Period 2||3
8831934|NCT01641692|9886404|FG001|NOT COMPLETED|Treatment Period 2||0
8831935|NCT01641692|9886405|FG002|NOT COMPLETED|Treatment Period 2||0
8831936|NCT01641692|9886406|FG003|NOT COMPLETED|Treatment Period 2||0
8831937|NCT01641692|9886407|FG004|NOT COMPLETED|Treatment Period 2||0
8831938|NCT01641692|9886408|FG005|NOT COMPLETED|Treatment Period 2||2
8831939|NCT01641692|9886409|FG006|NOT COMPLETED|Treatment Period 2||0
8831940|NCT01641692|9886410|FG007|NOT COMPLETED|Treatment Period 2||1
8831941|NCT01641692|9886403|FG000|STARTED|Washout Period 2 (12-14 Days)||30
8831942|NCT01641692|9886404|FG001|STARTED|Washout Period 2 (12-14 Days)||46
8831943|NCT01641692|9886405|FG002|STARTED|Washout Period 2 (12-14 Days)||40
8831944|NCT01641692|9886406|FG003|STARTED|Washout Period 2 (12-14 Days)||41
8831945|NCT01641692|9886407|FG004|STARTED|Washout Period 2 (12-14 Days)||37
8831946|NCT01641692|9886408|FG005|STARTED|Washout Period 2 (12-14 Days)||43
8831947|NCT01641692|9886409|FG006|STARTED|Washout Period 2 (12-14 Days)||43
8831948|NCT01641692|9886410|FG007|STARTED|Washout Period 2 (12-14 Days)||35
8831949|NCT01641692|9886403|FG000|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|30
8831950|NCT01641692|9886404|FG001|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|46
8831951|NCT01641692|9886405|FG002|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|39
8831952|NCT01641692|9886406|FG003|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|41
8831953|NCT01641692|9886407|FG004|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|34
8831954|NCT01641692|9886408|FG005|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|42
8831955|NCT01641692|9886409|FG006|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|42
8831956|NCT01641692|9886410|FG007|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|34
8831957|NCT01641692|9886403|FG000|NOT COMPLETED|Washout Period 2 (12-14 Days)||0
8831958|NCT01641692|9886404|FG001|NOT COMPLETED|Washout Period 2 (12-14 Days)||0
8831959|NCT01641692|9886405|FG002|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
8831960|NCT01641692|9886406|FG003|NOT COMPLETED|Washout Period 2 (12-14 Days)||0
8831961|NCT01641692|9886407|FG004|NOT COMPLETED|Washout Period 2 (12-14 Days)||3
8831962|NCT01641692|9886408|FG005|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
8831963|NCT01641692|9886409|FG006|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
8831964|NCT01641692|9886410|FG007|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
8831965|NCT01641692|9886403|FG000|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|43
8831966|NCT01641692|9886404|FG001|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|33
8831967|NCT01641692|9886405|FG002|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|38
8849810|NCT01743469|9905057|FG000|COMPLETED|Follow-up Period - Post-Treatment||6
8831968|NCT01641692|9886406|FG003|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|42
8831969|NCT01641692|9886407|FG004|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|40
8831970|NCT01641692|9886408|FG005|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|39
8831971|NCT01641692|9886409|FG006|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|35
8831972|NCT01641692|9886410|FG007|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|38
8831973|NCT01641692|9886403|FG000|COMPLETED|Treatment Period 3||43
8831974|NCT01641692|9886404|FG001|COMPLETED|Treatment Period 3||32
8831975|NCT01641692|9886405|FG002|COMPLETED|Treatment Period 3||37
8831976|NCT01641692|9886406|FG003|COMPLETED|Treatment Period 3||42
8831977|NCT01641692|9886407|FG004|COMPLETED|Treatment Period 3||40
8831978|NCT01641692|9886408|FG005|COMPLETED|Treatment Period 3||39
8831979|NCT01641692|9886409|FG006|COMPLETED|Treatment Period 3||33
8831980|NCT01641692|9886410|FG007|COMPLETED|Treatment Period 3||38
8831981|NCT01641692|9886403|FG000|NOT COMPLETED|Treatment Period 3||0
8831982|NCT01641692|9886404|FG001|NOT COMPLETED|Treatment Period 3||1
8831983|NCT01641692|9886405|FG002|NOT COMPLETED|Treatment Period 3||1
8831984|NCT01641692|9886406|FG003|NOT COMPLETED|Treatment Period 3||0
8831985|NCT01641692|9886407|FG004|NOT COMPLETED|Treatment Period 3||0
8831986|NCT01641692|9886408|FG005|NOT COMPLETED|Treatment Period 3||0
8831987|NCT01641692|9886409|FG006|NOT COMPLETED|Treatment Period 3||2
8831988|NCT01641692|9886410|FG007|NOT COMPLETED|Treatment Period 3||0
8831989|NCT01641692|9886403|FG000|STARTED|Washout Period 3 or Follow-up||43
8831990|NCT01641692|9886404|FG001|STARTED|Washout Period 3 or Follow-up||32
8831991|NCT01641692|9886405|FG002|STARTED|Washout Period 3 or Follow-up||37
8831992|NCT01641692|9886406|FG003|STARTED|Washout Period 3 or Follow-up||42
8831993|NCT01641692|9886407|FG004|STARTED|Washout Period 3 or Follow-up||40
8831994|NCT01641692|9886408|FG005|STARTED|Washout Period 3 or Follow-up||39
8831995|NCT01641692|9886409|FG006|STARTED|Washout Period 3 or Follow-up||33
8831996|NCT01641692|9886410|FG007|STARTED|Washout Period 3 or Follow-up||38
8831997|NCT01641692|9886403|FG000|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|42
8831998|NCT01641692|9886404|FG001|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|32
8831999|NCT01641692|9886405|FG002|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|36
8832000|NCT01641692|9886406|FG003|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|41
8832001|NCT01641692|9886407|FG004|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|40
8832002|NCT01641692|9886408|FG005|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|37
8832003|NCT01641692|9886409|FG006|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|32
8832004|NCT01641692|9886410|FG007|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|38
8832005|NCT01641692|9886403|FG000|NOT COMPLETED|Washout Period 3 or Follow-up||1
8832006|NCT01641692|9886404|FG001|NOT COMPLETED|Washout Period 3 or Follow-up||0
8832007|NCT01641692|9886405|FG002|NOT COMPLETED|Washout Period 3 or Follow-up||1
8832008|NCT01641692|9886406|FG003|NOT COMPLETED|Washout Period 3 or Follow-up||1
8832009|NCT01641692|9886407|FG004|NOT COMPLETED|Washout Period 3 or Follow-up||0
8832010|NCT01641692|9886408|FG005|NOT COMPLETED|Washout Period 3 or Follow-up||2
8832011|NCT01641692|9886409|FG006|NOT COMPLETED|Washout Period 3 or Follow-up||1
8832012|NCT01641692|9886410|FG007|NOT COMPLETED|Washout Period 3 or Follow-up||0
8832013|NCT01641809|9886433|FG000|STARTED|Induction Phase (Day 1 to Week 24)||60
8832014|NCT01641809|9886434|FG001|STARTED|Induction Phase (Day 1 to Week 24)||60
8832015|NCT01641809|9886435|FG002|STARTED|Induction Phase (Day 1 to Week 24)||61
8832016|NCT01641809|9886436|FG003|STARTED|Induction Phase (Day 1 to Week 24)||62
8832017|NCT01641809|9886433|FG000|COMPLETED|Induction Phase (Day 1 to Week 24)||52
8832018|NCT01641809|9886434|FG001|COMPLETED|Induction Phase (Day 1 to Week 24)||53
8832019|NCT01641809|9886435|FG002|COMPLETED|Induction Phase (Day 1 to Week 24)||55
8832020|NCT01641809|9886436|FG003|COMPLETED|Induction Phase (Day 1 to Week 24)||47
8832021|NCT01641809|9886433|FG000|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||8
8832022|NCT01641809|9886434|FG001|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||7
8832023|NCT01641809|9886435|FG002|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||6
8832024|NCT01641809|9886436|FG003|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||15
8832025|NCT01641809|9886433|FG000|STARTED|Maintenance Phase (Week 24 to Week 96)||52
8944280|NCT02395133|10006101|FG003|NOT COMPLETED|Overall Study||14
8944281|NCT02395172|10006113|FG000|STARTED|Overall Study||396
8944282|NCT02395172|10006114|FG001|STARTED|Overall Study||396
8832026|NCT01641809|9886434|FG001|STARTED|Maintenance Phase (Week 24 to Week 96)||53
8832027|NCT01641809|9886435|FG002|STARTED|Maintenance Phase (Week 24 to Week 96)||55
8832028|NCT01641809|9886436|FG003|STARTED|Maintenance Phase (Week 24 to Week 96)||47
8832029|NCT01641809|9886433|FG000|COMPLETED|Maintenance Phase (Week 24 to Week 96)||46
8832030|NCT01641809|9886434|FG001|COMPLETED|Maintenance Phase (Week 24 to Week 96)||48
8832031|NCT01641809|9886435|FG002|COMPLETED|Maintenance Phase (Week 24 to Week 96)||52
8832032|NCT01641809|9886436|FG003|COMPLETED|Maintenance Phase (Week 24 to Week 96)||41
8850429|NCT01746420|9905636|FG000|COMPLETED|Overall Study||17
8832033|NCT01641809|9886433|FG000|NOT COMPLETED|Maintenance Phase (Week 24 to Week 96)||6
8832034|NCT01641809|9886434|FG001|NOT COMPLETED|Maintenance Phase (Week 24 to Week 96)||5
8832035|NCT01641809|9886435|FG002|NOT COMPLETED|Maintenance Phase (Week 24 to Week 96)||3
8832036|NCT01641809|9886436|FG003|NOT COMPLETED|Maintenance Phase (Week 24 to Week 96)||6
8832037|NCT01641809|9886433|FG000|STARTED|Open-label (Week 96 to Week 324)||46
8832038|NCT01641809|9886434|FG001|STARTED|Open-label (Week 96 to Week 324)|1 participant completed study as per protocol at Week 96 and opted to not enter open-label phase|47
8832039|NCT01641809|9886435|FG002|STARTED|Open-label (Week 96 to Week 324)|1 participant completed study as per protocol at Week 96 and opted to not enter open-label phase|51
8832040|NCT01641809|9886436|FG003|STARTED|Open-label (Week 96 to Week 324)|Participants completed study at Week 96 and did not enter open-label phase|0
8832041|NCT01641809|9886433|FG000|COMPLETED|Open-label (Week 96 to Week 324)||30
8832042|NCT01641809|9886434|FG001|COMPLETED|Open-label (Week 96 to Week 324)||35
8832043|NCT01641809|9886435|FG002|COMPLETED|Open-label (Week 96 to Week 324)||43
8832044|NCT01641809|9886436|FG003|COMPLETED|Open-label (Week 96 to Week 324)||0
8832045|NCT01641809|9886433|FG000|NOT COMPLETED|Open-label (Week 96 to Week 324)||16
8832046|NCT01641809|9886434|FG001|NOT COMPLETED|Open-label (Week 96 to Week 324)||12
8832047|NCT01641809|9886435|FG002|NOT COMPLETED|Open-label (Week 96 to Week 324)||8
8832048|NCT01641809|9886436|FG003|NOT COMPLETED|Open-label (Week 96 to Week 324)||0
8832049|NCT01641822|9886456|FG000|STARTED|Run-in Phase||107
8832050|NCT01641822|9886457|FG001|STARTED|Run-in Phase||0
8832051|NCT01641822|9886458|FG002|STARTED|Run-in Phase||0
8832052|NCT01641822|9886456|FG000|COMPLETED|Run-in Phase|3 participants who completed the TIS Run-In Phase did not continue to the Comparative Phase.|93
8832053|NCT01641822|9886457|FG001|COMPLETED|Run-in Phase||0
8832054|NCT01641822|9886458|FG002|COMPLETED|Run-in Phase||0
8832055|NCT01641822|9886456|FG000|NOT COMPLETED|Run-in Phase||14
8832056|NCT01641822|9886457|FG001|NOT COMPLETED|Run-in Phase||0
8832057|NCT01641822|9886458|FG002|NOT COMPLETED|Run-in Phase||0
8832058|NCT01641822|9886456|FG000|STARTED|Comparative Phase|Participants continuing into the Comparative Phase were randomized to the AZLI or Placebo group.|0
8832059|NCT01641822|9886457|FG001|STARTED|Comparative Phase||43
8832060|NCT01641822|9886458|FG002|STARTED|Comparative Phase||47
8832061|NCT01641822|9886456|FG000|Received Randomized Study Drug Treatment|Comparative Phase||0
8832062|NCT01641822|9886457|FG001|Received Randomized Study Drug Treatment|Comparative Phase||42
8832063|NCT01641822|9886458|FG002|Received Randomized Study Drug Treatment|Comparative Phase||46
8832064|NCT01641822|9886456|FG000|COMPLETED|Comparative Phase||0
8832065|NCT01641822|9886457|FG001|COMPLETED|Comparative Phase||37
8832066|NCT01641822|9886458|FG002|COMPLETED|Comparative Phase||37
8832067|NCT01641822|9886456|FG000|NOT COMPLETED|Comparative Phase||0
8832068|NCT01641822|9886457|FG001|NOT COMPLETED|Comparative Phase||6
8832069|NCT01641822|9886458|FG002|NOT COMPLETED|Comparative Phase||10
8832070|NCT01641835|9886465|FG000|STARTED|Overall Study||303
8832071|NCT01641835|9886465|FG000|COMPLETED|Overall Study||303
8832072|NCT01641835|9886465|FG000|NOT COMPLETED|Overall Study||0
8832073|NCT01641861|9886471|FG000|STARTED|Overall Study||246
8832074|NCT01641861|9886472|FG001|STARTED|Overall Study||242
8832075|NCT01641861|9886471|FG000|COMPLETED|Overall Study||211
8832076|NCT01641861|9886472|FG001|COMPLETED|Overall Study||217
8832077|NCT01641861|9886471|FG000|NOT COMPLETED|Overall Study||35
8832078|NCT01641861|9886472|FG001|NOT COMPLETED|Overall Study||25
8832079|NCT01641900|9886480|FG000|STARTED|Overall Study||28
8832080|NCT01641900|9886481|FG001|STARTED|Overall Study||31
8832081|NCT01641900|9886480|FG000|Completed Placebo Intervention|Overall Study|n=1,assigned to placebo intervention first, completed the session and dropped out of the study.|27
8832082|NCT01641900|9886481|FG001|Completed Placebo Intervention|Overall Study|n=2,both assigned to placebo intervention first, completed the session and dropped out of the study.|29
8832083|NCT01641900|9886480|FG000|Completed Drug Intervention|Overall Study|n=1,assigned to drug intervention first, completed the session and dropped out of the study.|26
8832084|NCT01641900|9886481|FG001|Completed Drug Intervention|Overall Study||29
8832085|NCT01641900|9886480|FG000|COMPLETED|Overall Study||26
8832086|NCT01641900|9886481|FG001|COMPLETED|Overall Study||29
8832087|NCT01641900|9886480|FG000|NOT COMPLETED|Overall Study||2
8832088|NCT01641900|9886481|FG001|NOT COMPLETED|Overall Study||2
8832089|NCT01641926|9886493|FG000|STARTED|Overall Study||143
8832090|NCT01641926|9886494|FG001|STARTED|Overall Study||145
8832091|NCT01641926|9886495|FG002|STARTED|Overall Study||57
8832092|NCT01641926|9886496|FG003|STARTED|Overall Study||57
8832093|NCT01641926|9886493|FG000|Treated (All Participants as Treated)|Overall Study||142
8832094|NCT01641926|9886494|FG001|Treated (All Participants as Treated)|Overall Study||144
8832095|NCT01641926|9886495|FG002|Treated (All Participants as Treated)|Overall Study||56
8832096|NCT01641926|9886496|FG003|Treated (All Participants as Treated)|Overall Study||57
8832097|NCT01641926|9886493|FG000|COMPLETED|Overall Study||115
8832098|NCT01641926|9886494|FG001|COMPLETED|Overall Study||130
8832099|NCT01641926|9886495|FG002|COMPLETED|Overall Study||46
8832100|NCT01641926|9886496|FG003|COMPLETED|Overall Study||53
8832101|NCT01641926|9886493|FG000|NOT COMPLETED|Overall Study||28
8832102|NCT01641926|9886494|FG001|NOT COMPLETED|Overall Study||15
8832103|NCT01641926|9886495|FG002|NOT COMPLETED|Overall Study||11
8832104|NCT01641926|9886496|FG003|NOT COMPLETED|Overall Study||4
8832105|NCT01641939|9886509|FG000|STARTED|Overall Study||117
8832106|NCT01641939|9886510|FG001|STARTED|Overall Study||228
8832107|NCT01641939|9886511|FG002|STARTED|Overall Study||70
8832108|NCT01641939|9886509|FG000|Stage 1|Overall Study||37
8832109|NCT01641939|9886510|FG001|Stage 1|Overall Study||75
8832110|NCT01641939|9886511|FG002|Stage 1|Overall Study||70
8832111|NCT01641939|9886509|FG000|Stage 2|Overall Study||80
8832112|NCT01641939|9886510|FG001|Stage 2|Overall Study||153
8832113|NCT01641939|9886511|FG002|Stage 2|Overall Study||0
8832114|NCT01641939|9886509|FG000|COMPLETED|Overall Study||0
8832115|NCT01641939|9886510|FG001|COMPLETED|Overall Study||0
8832116|NCT01641939|9886511|FG002|COMPLETED|Overall Study||0
8832117|NCT01641939|9886509|FG000|NOT COMPLETED|Overall Study||117
8832118|NCT01641939|9886510|FG001|NOT COMPLETED|Overall Study||228
8832119|NCT01641939|9886511|FG002|NOT COMPLETED|Overall Study||70
8832120|NCT01641952|9886521|FG000|STARTED|Overall Study||505
8832121|NCT01641952|9886521|FG000|Treated|Overall Study||504
8832122|NCT01641952|9886521|FG000|COMPLETED|Overall Study||471
8832123|NCT01641952|9886521|FG000|NOT COMPLETED|Overall Study||34
8832124|NCT01641978|9886525|FG000|STARTED|Overall Study||125
8832125|NCT01641978|9886525|FG000|COMPLETED|Overall Study||125
8832126|NCT01641978|9886525|FG000|NOT COMPLETED|Overall Study||0
8832127|NCT01641991|9886537|FG000|STARTED|Overall Study||82
8832128|NCT01641991|9886538|FG001|STARTED|Overall Study||82
8622606|NCT00489255|9661822|FG001|COMPLETED|Period 1: Days 1 to 28||34
8622607|NCT00489255|9661821|FG000|NOT COMPLETED|Period 1: Days 1 to 28||29
8622608|NCT00489255|9661822|FG001|NOT COMPLETED|Period 1: Days 1 to 28||12
8622609|NCT00489255|9661821|FG000|STARTED|Period 2: Days 29 to 56||64
8622610|NCT00489255|9661822|FG001|STARTED|Period 2: Days 29 to 56|Re-randomized participants is 26.Sample sizes differed due to withdrawal&re-randomization design.|59
8622611|NCT00489255|9661821|FG000|Completed and Follow Period 3|Period 2: Days 29 to 56||58
8622612|NCT00489255|9661822|FG001|Completed and Follow Period 3|Period 2: Days 29 to 56|Re-randomized participants is 26.Sample sizes differed due to withdrawal&re-randomization design.|52
8622613|NCT00489255|9661821|FG000|Completed But Discontinued Study|Period 2: Days 29 to 56||3
8622614|NCT00489255|9661822|FG001|Completed But Discontinued Study|Period 2: Days 29 to 56|Re-randomized participants is 2.Sample sizes differed due to withdrawal&re-randomization design.|3
8622615|NCT00489255|9661821|FG000|COMPLETED|Period 2: Days 29 to 56||61
8622616|NCT00489255|9661822|FG001|COMPLETED|Period 2: Days 29 to 56|Re-randomized participants is 26.Sample sizes differed due to withdrawal&re-randomization design.|55
8622617|NCT00489255|9661821|FG000|NOT COMPLETED|Period 2: Days 29 to 56||3
8622618|NCT00489255|9661822|FG001|NOT COMPLETED|Period 2: Days 29 to 56||4
8622619|NCT00489255|9661821|FG000|STARTED|Period 3: Days 57 to 84||28
8622620|NCT00489255|9661822|FG001|STARTED|Period 3: Days 57 to 84|Re-randomized participants is 30.Sample sizes differed due to withdrawal&re-randomization design.|82
8622621|NCT00489255|9661821|FG000|COMPLETED|Period 3: Days 57 to 84||24
8622622|NCT00489255|9661822|FG001|COMPLETED|Period 3: Days 57 to 84|Re-randomized participants is 27.Sample sizes differed due to withdrawal&re-randomization design.|78
8622623|NCT00489255|9661821|FG000|NOT COMPLETED|Period 3: Days 57 to 84||4
8622624|NCT00489255|9661822|FG001|NOT COMPLETED|Period 3: Days 57 to 84||4
8622625|NCT00489268|9661833|FG000|STARTED|Overall Study||1
8622626|NCT00489268|9661834|FG001|STARTED|Overall Study||10
8622627|NCT00489268|9661835|FG002|STARTED|Overall Study||10
8622628|NCT00489268|9661836|FG003|STARTED|Overall Study||11
8622629|NCT00489268|9661837|FG004|STARTED|Overall Study||70
8622630|NCT00489268|9661833|FG000|COMPLETED|Overall Study||1
8622631|NCT00489268|9661834|FG001|COMPLETED|Overall Study||10
8622632|NCT00489268|9661835|FG002|COMPLETED|Overall Study||9
8622633|NCT00489268|9661836|FG003|COMPLETED|Overall Study||11
8622634|NCT00489268|9661837|FG004|COMPLETED|Overall Study||50
8622635|NCT00489268|9661833|FG000|NOT COMPLETED|Overall Study||0
8622636|NCT00489268|9661834|FG001|NOT COMPLETED|Overall Study||0
8622637|NCT00489268|9661835|FG002|NOT COMPLETED|Overall Study||1
8832129|NCT01641991|9886539|FG002|STARTED|Overall Study||82
8832130|NCT01641991|9886540|FG003|STARTED|Overall Study||82
8832131|NCT01641991|9886537|FG000|COMPLETED|Overall Study||73
8832132|NCT01641991|9886538|FG001|COMPLETED|Overall Study||74
8832133|NCT01641991|9886539|FG002|COMPLETED|Overall Study||65
8832134|NCT01641991|9886540|FG003|COMPLETED|Overall Study||66
8832135|NCT01641991|9886537|FG000|NOT COMPLETED|Overall Study||9
8832136|NCT01641991|9886538|FG001|NOT COMPLETED|Overall Study||8
8832137|NCT01641991|9886539|FG002|NOT COMPLETED|Overall Study||17
8832138|NCT01641991|9886540|FG003|NOT COMPLETED|Overall Study||16
8832139|NCT01642056|9886555|FG000|STARTED|First Intervention||10
8832140|NCT01642056|9886556|FG001|STARTED|First Intervention||10
8832141|NCT01642056|9886555|FG000|COMPLETED|First Intervention||9
8832142|NCT01642056|9886556|FG001|COMPLETED|First Intervention||10
8832143|NCT01642056|9886555|FG000|NOT COMPLETED|First Intervention||1
8832144|NCT01642056|9886556|FG001|NOT COMPLETED|First Intervention||0
8832145|NCT01642056|9886555|FG000|STARTED|Second Intervention||9
8832146|NCT01642056|9886556|FG001|STARTED|Second Intervention||10
8832147|NCT01642056|9886555|FG000|COMPLETED|Second Intervention||8
8832148|NCT01642056|9886556|FG001|COMPLETED|Second Intervention||8
8832149|NCT01642056|9886555|FG000|NOT COMPLETED|Second Intervention||1
8832150|NCT01642056|9886556|FG001|NOT COMPLETED|Second Intervention||2
8622638|NCT00489268|9661836|FG003|NOT COMPLETED|Overall Study||0
8832151|NCT01642082|9886562|FG000|STARTED|Overall Study||28
8832152|NCT01642082|9886562|FG000|COMPLETED|Overall Study||28
8832153|NCT01642082|9886562|FG000|NOT COMPLETED|Overall Study||0
8832154|NCT01642147|9886575|FG000|STARTED|Overall Study||30
8832155|NCT01642147|9886576|FG001|STARTED|Overall Study||30
8832156|NCT01642147|9886575|FG000|COMPLETED|Overall Study||30
8832157|NCT01642147|9886576|FG001|COMPLETED|Overall Study||30
8832158|NCT01642147|9886575|FG000|NOT COMPLETED|Overall Study||0
8832159|NCT01642147|9886576|FG001|NOT COMPLETED|Overall Study||0
8622639|NCT00489268|9661837|FG004|NOT COMPLETED|Overall Study||20
8622640|NCT00489281|9661851|FG000|STARTED|Overall Study||29
8832160|NCT01642212|9886584|FG000|STARTED|Single-blind Baseline||119
8832161|NCT01642212|9886585|FG001|STARTED|Single-blind Baseline||0
8832162|NCT01642212|9886586|FG002|STARTED|Single-blind Baseline||0
8832163|NCT01642212|9886587|FG003|STARTED|Single-blind Baseline||0
8832164|NCT01642212|9886588|FG004|STARTED|Single-blind Baseline||0
8832165|NCT01642212|9886584|FG000|COMPLETED|Single-blind Baseline||93
8832166|NCT01642212|9886585|FG001|COMPLETED|Single-blind Baseline||0
8832167|NCT01642212|9886586|FG002|COMPLETED|Single-blind Baseline||0
8832168|NCT01642212|9886587|FG003|COMPLETED|Single-blind Baseline||0
8832169|NCT01642212|9886588|FG004|COMPLETED|Single-blind Baseline||0
8832170|NCT01642212|9886584|FG000|NOT COMPLETED|Single-blind Baseline||26
8832171|NCT01642212|9886585|FG001|NOT COMPLETED|Single-blind Baseline||0
8832172|NCT01642212|9886586|FG002|NOT COMPLETED|Single-blind Baseline||0
8832173|NCT01642212|9886587|FG003|NOT COMPLETED|Single-blind Baseline||0
8832174|NCT01642212|9886588|FG004|NOT COMPLETED|Single-blind Baseline||0
8832175|NCT01642212|9886584|FG000|STARTED|Double-blind Treatment||0
8832176|NCT01642212|9886585|FG001|STARTED|Double-blind Treatment||42
8832177|NCT01642212|9886586|FG002|STARTED|Double-blind Treatment||51
8832178|NCT01642212|9886587|FG003|STARTED|Double-blind Treatment||0
8832179|NCT01642212|9886588|FG004|STARTED|Double-blind Treatment||0
8832180|NCT01642212|9886584|FG000|COMPLETED|Double-blind Treatment||0
8832181|NCT01642212|9886585|FG001|COMPLETED|Double-blind Treatment||39
8832182|NCT01642212|9886586|FG002|COMPLETED|Double-blind Treatment||49
8832183|NCT01642212|9886587|FG003|COMPLETED|Double-blind Treatment||0
8832184|NCT01642212|9886588|FG004|COMPLETED|Double-blind Treatment||0
8832185|NCT01642212|9886584|FG000|NOT COMPLETED|Double-blind Treatment||0
8832186|NCT01642212|9886585|FG001|NOT COMPLETED|Double-blind Treatment||3
8832187|NCT01642212|9886586|FG002|NOT COMPLETED|Double-blind Treatment||2
8832188|NCT01642212|9886587|FG003|NOT COMPLETED|Double-blind Treatment||0
8832189|NCT01642212|9886588|FG004|NOT COMPLETED|Double-blind Treatment||0
8832190|NCT01642212|9886584|FG000|STARTED|Open-label Extension||0
8622641|NCT00489281|9661852|FG001|STARTED|Overall Study||13
8622642|NCT00489281|9661851|FG000|COMPLETED|Overall Study||29
8622643|NCT00489281|9661852|FG001|COMPLETED|Overall Study||13
8622644|NCT00489281|9661851|FG000|NOT COMPLETED|Overall Study||0
8622645|NCT00489281|9661852|FG001|NOT COMPLETED|Overall Study||0
8622646|NCT00489359|9661860|FG000|STARTED|Overall Study||20
8832191|NCT01642212|9886585|FG001|STARTED|Open-label Extension||0
8832192|NCT01642212|9886586|FG002|STARTED|Open-label Extension||0
8832193|NCT01642212|9886587|FG003|STARTED|Open-label Extension|Two participants completed double-blind treatment but did not enter the open-label extension.|37
8832194|NCT01642212|9886588|FG004|STARTED|Open-label Extension|Four participants completed double-blind treatment but did not enter the open-label extension.|45
8832195|NCT01642212|9886584|FG000|COMPLETED|Open-label Extension||0
8832196|NCT01642212|9886585|FG001|COMPLETED|Open-label Extension||0
8832197|NCT01642212|9886586|FG002|COMPLETED|Open-label Extension||0
8832198|NCT01642212|9886587|FG003|COMPLETED|Open-label Extension||27
8832199|NCT01642212|9886588|FG004|COMPLETED|Open-label Extension||37
8832200|NCT01642212|9886584|FG000|NOT COMPLETED|Open-label Extension||0
8832201|NCT01642212|9886585|FG001|NOT COMPLETED|Open-label Extension||0
8832202|NCT01642212|9886586|FG002|NOT COMPLETED|Open-label Extension||0
8832203|NCT01642212|9886587|FG003|NOT COMPLETED|Open-label Extension||10
8832204|NCT01642212|9886588|FG004|NOT COMPLETED|Open-label Extension||8
8832205|NCT01642238|9886596|FG000|STARTED|First Intervention (1 Day)||7
8832206|NCT01642238|9886597|FG001|STARTED|First Intervention (1 Day)||8
8832207|NCT01642238|9886596|FG000|COMPLETED|First Intervention (1 Day)||7
8832208|NCT01642238|9886597|FG001|COMPLETED|First Intervention (1 Day)||8
8832209|NCT01642238|9886596|FG000|NOT COMPLETED|First Intervention (1 Day)||0
8832210|NCT01642238|9886597|FG001|NOT COMPLETED|First Intervention (1 Day)||0
8832211|NCT01642238|9886596|FG000|STARTED|Washout (1-2 Weeks)||7
8832212|NCT01642238|9886597|FG001|STARTED|Washout (1-2 Weeks)||8
8832213|NCT01642238|9886596|FG000|COMPLETED|Washout (1-2 Weeks)||7
8832214|NCT01642238|9886597|FG001|COMPLETED|Washout (1-2 Weeks)||8
8832215|NCT01642238|9886596|FG000|NOT COMPLETED|Washout (1-2 Weeks)||0
8832216|NCT01642238|9886597|FG001|NOT COMPLETED|Washout (1-2 Weeks)||0
8832217|NCT01642238|9886596|FG000|STARTED|Second Intervention (1 Day)||7
8832218|NCT01642238|9886597|FG001|STARTED|Second Intervention (1 Day)||8
8832219|NCT01642238|9886596|FG000|COMPLETED|Second Intervention (1 Day)||7
8832220|NCT01642238|9886597|FG001|COMPLETED|Second Intervention (1 Day)||8
8832221|NCT01642238|9886596|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
8832222|NCT01642238|9886597|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
8832223|NCT01642251|9886606|FG000|STARTED|Overall Study||3
8832224|NCT01642251|9886607|FG001|STARTED|Overall Study||6
8832225|NCT01642251|9886608|FG002|STARTED|Overall Study||75
8832226|NCT01642251|9886609|FG003|STARTED|Overall Study||72
8832227|NCT01642251|9886606|FG000|Started Protocol Therapy|Overall Study||3
8832228|NCT01642251|9886607|FG001|Started Protocol Therapy|Overall Study||6
8832229|NCT01642251|9886608|FG002|Started Protocol Therapy|Overall Study||66
8832230|NCT01642251|9886609|FG003|Started Protocol Therapy|Overall Study||66
8832231|NCT01642251|9886606|FG000|Eligible|Overall Study||3
8832232|NCT01642251|9886607|FG001|Eligible|Overall Study||6
8622647|NCT00489359|9661861|FG001|STARTED|Overall Study||66
8622648|NCT00489359|9661860|FG000|COMPLETED|Overall Study|Received at least 6 cycles of therapy. Not completed implies participant received <6 cycles.|13
8832233|NCT01642251|9886608|FG002|Eligible|Overall Study||72
8832234|NCT01642251|9886609|FG003|Eligible|Overall Study||69
8832235|NCT01642251|9886606|FG000|Eligible and Treated|Overall Study||3
8832236|NCT01642251|9886607|FG001|Eligible and Treated|Overall Study||6
8832237|NCT01642251|9886608|FG002|Eligible and Treated|Overall Study||64
8832238|NCT01642251|9886609|FG003|Eligible and Treated|Overall Study||64
8944283|NCT02395172|10006113|FG000|Treated|Overall Study||393
8944284|NCT02395172|10006114|FG001|Treated|Overall Study||365
8944285|NCT02395172|10006113|FG000|COMPLETED|Overall Study||393
8944286|NCT02395172|10006114|FG001|COMPLETED|Overall Study||365
8944287|NCT02395172|10006113|FG000|NOT COMPLETED|Overall Study||3
8944288|NCT02395172|10006114|FG001|NOT COMPLETED|Overall Study||31
8944289|NCT02395185|10006120|FG000|STARTED|Overall Study|32 guardians participated with these infants. one infant did not have a guardian participate.|33
8944290|NCT02395185|10006120|FG000|Sequence 1 (s,s,m,m,w,w)|Overall Study|one of the participants in this milestone did not have a guardian enrolled due to age.|2
8944291|NCT02395185|10006120|FG000|Sequence 2 (w,s,s,m,m,w)|Overall Study||2
8944292|NCT02395185|10006120|FG000|Sequence 3 (w,w,s,s,m,m)|Overall Study||2
8944293|NCT02395185|10006120|FG000|Sequence 4 (m,w,w,s,s,m)|Overall Study||2
8944294|NCT02395185|10006120|FG000|Sequence 5 (m,m,w,w,s,s)|Overall Study||2
8944295|NCT02395185|10006120|FG000|Sequence 6 (s,m,m,w,w,s)|Overall Study||2
8944296|NCT02395185|10006120|FG000|Sequence 7 (s,s,w,w,m,m)|Overall Study||2
8944297|NCT02395185|10006120|FG000|Sequence 8 (m,s,s,w,w,m)|Overall Study||2
8944298|NCT02395185|10006120|FG000|Sequence 9 (m,m,s,s,w,w)|Overall Study||2
8944299|NCT02395185|10006120|FG000|Sequence 10 (w,m,m,s,s,w)|Overall Study||2
8944300|NCT02395185|10006120|FG000|Sequence 11 (w,w,m,m,s,s)|Overall Study||2
8944301|NCT02395185|10006120|FG000|Sequence 12 (s,w,w,m,m,s)|Overall Study||2
8944302|NCT02395185|10006120|FG000|Sequence 13 (s,m,w,m,s,w)|Overall Study||2
8944303|NCT02395185|10006120|FG000|Sequence 14 (w,s,m,w,m,s)|Overall Study||2
8944304|NCT02395185|10006120|FG000|Sequence 15 (s,w,s,m,w,m)|Overall Study||2
8944305|NCT02395185|10006120|FG000|Sequence 16 (m,s,w,s,m,w)|Overall Study||1
8944306|NCT02395185|10006120|FG000|Sequence 17 (w,m,s,w,s,m)|Overall Study||1
8944307|NCT02395185|10006120|FG000|Sequence 18 (m,w,m,s,w,s)|Overall Study||1
8944308|NCT02395185|10006120|FG000|COMPLETED|Overall Study||33
8944309|NCT02395185|10006120|FG000|NOT COMPLETED|Overall Study||0
8944310|NCT02395302|10006128|FG000|STARTED|Overall Study||28
8944311|NCT02395302|10006128|FG000|COMPLETED|Overall Study||14
8944312|NCT02395302|10006128|FG000|NOT COMPLETED|Overall Study||14
8944313|NCT02395471|10006134|FG000|STARTED|Overall Study||129
8944314|NCT02395471|10006135|FG001|STARTED|Overall Study||62
8944315|NCT02395471|10006134|FG000|COMPLETED|Overall Study||122
8944316|NCT02395471|10006135|FG001|COMPLETED|Overall Study||59
8944317|NCT02395471|10006134|FG000|NOT COMPLETED|Overall Study||7
8944318|NCT02395471|10006135|FG001|NOT COMPLETED|Overall Study||3
8944319|NCT02395536|10006152|FG000|STARTED|Overall Study||264
8944320|NCT02395536|10006153|FG001|STARTED|Overall Study||257
8944321|NCT02395536|10006152|FG000|REVEAL LINQ Insertion|Overall Study||251
8944322|NCT02395536|10006153|FG001|REVEAL LINQ Insertion|Overall Study||231
8944323|NCT02395536|10006152|FG000|COMPLETED|Overall Study||244
8944324|NCT02395536|10006153|FG001|COMPLETED|Overall Study||227
8944325|NCT02395536|10006152|FG000|NOT COMPLETED|Overall Study||20
8944326|NCT02395536|10006153|FG001|NOT COMPLETED|Overall Study||30
8832239|NCT01642251|9886606|FG000|COMPLETED|Overall Study||3
8832240|NCT01642251|9886607|FG001|COMPLETED|Overall Study||6
8832241|NCT01642251|9886608|FG002|COMPLETED|Overall Study||53
8832242|NCT01642251|9886609|FG003|COMPLETED|Overall Study||49
8832243|NCT01642251|9886606|FG000|NOT COMPLETED|Overall Study||0
8832244|NCT01642251|9886607|FG001|NOT COMPLETED|Overall Study||0
8832245|NCT01642251|9886608|FG002|NOT COMPLETED|Overall Study||22
8832246|NCT01642251|9886609|FG003|NOT COMPLETED|Overall Study||23
8832247|NCT01642277|9886620|FG000|STARTED|Overall Study||74
8832248|NCT01642277|9886621|FG001|STARTED|Overall Study||60
8832249|NCT01642277|9886620|FG000|COMPLETED|Overall Study||50
8832250|NCT01642277|9886621|FG001|COMPLETED|Overall Study||60
8832251|NCT01642277|9886620|FG000|NOT COMPLETED|Overall Study||24
8832252|NCT01642277|9886621|FG001|NOT COMPLETED|Overall Study||0
8832253|NCT01642407|9886628|FG000|STARTED|Part 1 (Screening Till Week 16)||6
8832254|NCT01642407|9886628|FG000|COMPLETED|Part 1 (Screening Till Week 16)||3
8832255|NCT01642407|9886628|FG000|NOT COMPLETED|Part 1 (Screening Till Week 16)||3
8832256|NCT01642407|9886628|FG000|STARTED|Part 2(Week17 to Maximum of 119.6 Weeks)||3
8832257|NCT01642407|9886628|FG000|COMPLETED|Part 2(Week17 to Maximum of 119.6 Weeks)||1
8832258|NCT01642407|9886628|FG000|NOT COMPLETED|Part 2(Week17 to Maximum of 119.6 Weeks)||2
8832259|NCT01642485|9886632|FG000|STARTED|Period 1, Day 1|crossover so all subjects had this treatment|4
8832260|NCT01642485|9886633|FG001|STARTED|Period 1, Day 1||4
8832261|NCT01642485|9886634|FG002|STARTED|Period 1, Day 1||4
8832262|NCT01642485|9886635|FG003|STARTED|Period 1, Day 1||4
8832263|NCT01642485|9886636|FG004|STARTED|Period 1, Day 1||4
8832264|NCT01642485|9886637|FG005|STARTED|Period 1, Day 1||4
8832265|NCT01642485|9886638|FG006|STARTED|Period 1, Day 1||4
8944327|NCT02395627|10006162|FG000|STARTED|Overall Study||18
8944328|NCT02395627|10006163|FG001|STARTED|Overall Study||16
8944329|NCT02395627|10006164|FG002|STARTED|Overall Study||4
8944330|NCT02395627|10006162|FG000|COMPLETED|Overall Study||15
8832266|NCT01642485|9886639|FG007|STARTED|Period 1, Day 1||4
8944331|NCT02395627|10006163|FG001|COMPLETED|Overall Study||13
8944332|NCT02395627|10006164|FG002|COMPLETED|Overall Study||4
8944333|NCT02395627|10006162|FG000|NOT COMPLETED|Overall Study||3
8944334|NCT02395627|10006163|FG001|NOT COMPLETED|Overall Study||3
8832267|NCT01642485|9886632|FG000|COMPLETED|Period 1, Day 1||4
8832268|NCT01642485|9886633|FG001|COMPLETED|Period 1, Day 1||4
8832269|NCT01642485|9886634|FG002|COMPLETED|Period 1, Day 1||4
8832270|NCT01642485|9886635|FG003|COMPLETED|Period 1, Day 1||4
8832271|NCT01642485|9886636|FG004|COMPLETED|Period 1, Day 1||4
8832272|NCT01642485|9886637|FG005|COMPLETED|Period 1, Day 1||4
8832273|NCT01642485|9886638|FG006|COMPLETED|Period 1, Day 1||4
8832274|NCT01642485|9886639|FG007|COMPLETED|Period 1, Day 1||4
8832275|NCT01642485|9886632|FG000|NOT COMPLETED|Period 1, Day 1||0
8832276|NCT01642485|9886633|FG001|NOT COMPLETED|Period 1, Day 1||0
8832277|NCT01642485|9886634|FG002|NOT COMPLETED|Period 1, Day 1||0
8832278|NCT01642485|9886635|FG003|NOT COMPLETED|Period 1, Day 1||0
8832279|NCT01642485|9886636|FG004|NOT COMPLETED|Period 1, Day 1||0
8832280|NCT01642485|9886637|FG005|NOT COMPLETED|Period 1, Day 1||0
8832281|NCT01642485|9886638|FG006|NOT COMPLETED|Period 1, Day 1||0
8832282|NCT01642485|9886639|FG007|NOT COMPLETED|Period 1, Day 1||0
8832283|NCT01642485|9886632|FG000|STARTED|Period 1, Day 2||4
8832284|NCT01642485|9886633|FG001|STARTED|Period 1, Day 2||4
8832285|NCT01642485|9886634|FG002|STARTED|Period 1, Day 2||4
8832286|NCT01642485|9886635|FG003|STARTED|Period 1, Day 2||4
8832287|NCT01642485|9886636|FG004|STARTED|Period 1, Day 2||4
8832288|NCT01642485|9886637|FG005|STARTED|Period 1, Day 2||4
8832289|NCT01642485|9886638|FG006|STARTED|Period 1, Day 2||4
8832290|NCT01642485|9886639|FG007|STARTED|Period 1, Day 2||4
8832291|NCT01642485|9886632|FG000|COMPLETED|Period 1, Day 2||4
8832292|NCT01642485|9886633|FG001|COMPLETED|Period 1, Day 2||4
8832293|NCT01642485|9886634|FG002|COMPLETED|Period 1, Day 2||4
8832294|NCT01642485|9886635|FG003|COMPLETED|Period 1, Day 2||4
8832295|NCT01642485|9886636|FG004|COMPLETED|Period 1, Day 2||4
8832296|NCT01642485|9886637|FG005|COMPLETED|Period 1, Day 2||4
8832297|NCT01642485|9886638|FG006|COMPLETED|Period 1, Day 2||4
8832298|NCT01642485|9886639|FG007|COMPLETED|Period 1, Day 2||4
8832299|NCT01642485|9886632|FG000|NOT COMPLETED|Period 1, Day 2||0
8832300|NCT01642485|9886633|FG001|NOT COMPLETED|Period 1, Day 2||0
8832301|NCT01642485|9886634|FG002|NOT COMPLETED|Period 1, Day 2||0
8832302|NCT01642485|9886635|FG003|NOT COMPLETED|Period 1, Day 2||0
8832303|NCT01642485|9886636|FG004|NOT COMPLETED|Period 1, Day 2||0
8832304|NCT01642485|9886637|FG005|NOT COMPLETED|Period 1, Day 2||0
8832305|NCT01642485|9886638|FG006|NOT COMPLETED|Period 1, Day 2||0
8832306|NCT01642485|9886639|FG007|NOT COMPLETED|Period 1, Day 2||0
8832307|NCT01642485|9886632|FG000|STARTED|Period 1, Day 3||4
8832308|NCT01642485|9886633|FG001|STARTED|Period 1, Day 3||4
8832309|NCT01642485|9886634|FG002|STARTED|Period 1, Day 3||4
8832310|NCT01642485|9886635|FG003|STARTED|Period 1, Day 3||4
8832311|NCT01642485|9886636|FG004|STARTED|Period 1, Day 3||4
8832312|NCT01642485|9886637|FG005|STARTED|Period 1, Day 3||4
8832313|NCT01642485|9886638|FG006|STARTED|Period 1, Day 3||4
8832314|NCT01642485|9886639|FG007|STARTED|Period 1, Day 3||4
8832315|NCT01642485|9886632|FG000|COMPLETED|Period 1, Day 3||4
8832316|NCT01642485|9886633|FG001|COMPLETED|Period 1, Day 3||4
8832317|NCT01642485|9886634|FG002|COMPLETED|Period 1, Day 3||4
8832318|NCT01642485|9886635|FG003|COMPLETED|Period 1, Day 3||4
8832319|NCT01642485|9886636|FG004|COMPLETED|Period 1, Day 3||4
8832320|NCT01642485|9886637|FG005|COMPLETED|Period 1, Day 3||4
8832321|NCT01642485|9886638|FG006|COMPLETED|Period 1, Day 3||4
8832322|NCT01642485|9886639|FG007|COMPLETED|Period 1, Day 3||4
8832323|NCT01642485|9886632|FG000|NOT COMPLETED|Period 1, Day 3||0
8832324|NCT01642485|9886633|FG001|NOT COMPLETED|Period 1, Day 3||0
8832325|NCT01642485|9886634|FG002|NOT COMPLETED|Period 1, Day 3||0
8832326|NCT01642485|9886635|FG003|NOT COMPLETED|Period 1, Day 3||0
8832327|NCT01642485|9886636|FG004|NOT COMPLETED|Period 1, Day 3||0
8832328|NCT01642485|9886637|FG005|NOT COMPLETED|Period 1, Day 3||0
8832329|NCT01642485|9886638|FG006|NOT COMPLETED|Period 1, Day 3||0
8832330|NCT01642485|9886639|FG007|NOT COMPLETED|Period 1, Day 3||0
8832331|NCT01642485|9886632|FG000|STARTED|Period 2, Day 1||4
8832332|NCT01642485|9886633|FG001|STARTED|Period 2, Day 1||4
8832333|NCT01642485|9886634|FG002|STARTED|Period 2, Day 1||4
8832334|NCT01642485|9886635|FG003|STARTED|Period 2, Day 1||4
8832335|NCT01642485|9886636|FG004|STARTED|Period 2, Day 1||4
8832336|NCT01642485|9886637|FG005|STARTED|Period 2, Day 1||4
8832337|NCT01642485|9886638|FG006|STARTED|Period 2, Day 1||4
8832338|NCT01642485|9886639|FG007|STARTED|Period 2, Day 1||4
8832339|NCT01642485|9886632|FG000|COMPLETED|Period 2, Day 1||4
8832340|NCT01642485|9886633|FG001|COMPLETED|Period 2, Day 1||4
8832341|NCT01642485|9886634|FG002|COMPLETED|Period 2, Day 1||4
8832342|NCT01642485|9886635|FG003|COMPLETED|Period 2, Day 1||4
8832343|NCT01642485|9886636|FG004|COMPLETED|Period 2, Day 1||4
8832344|NCT01642485|9886637|FG005|COMPLETED|Period 2, Day 1||4
8832345|NCT01642485|9886638|FG006|COMPLETED|Period 2, Day 1||4
8832346|NCT01642485|9886639|FG007|COMPLETED|Period 2, Day 1||4
8832347|NCT01642485|9886632|FG000|NOT COMPLETED|Period 2, Day 1||0
8832348|NCT01642485|9886633|FG001|NOT COMPLETED|Period 2, Day 1||0
8832349|NCT01642485|9886634|FG002|NOT COMPLETED|Period 2, Day 1||0
8832350|NCT01642485|9886635|FG003|NOT COMPLETED|Period 2, Day 1||0
8832351|NCT01642485|9886636|FG004|NOT COMPLETED|Period 2, Day 1||0
8832352|NCT01642485|9886637|FG005|NOT COMPLETED|Period 2, Day 1||0
8832353|NCT01642485|9886638|FG006|NOT COMPLETED|Period 2, Day 1||0
8832354|NCT01642485|9886639|FG007|NOT COMPLETED|Period 2, Day 1||0
8832355|NCT01642485|9886632|FG000|STARTED|Period 2, Day 2||4
8832356|NCT01642485|9886633|FG001|STARTED|Period 2, Day 2||4
8832357|NCT01642485|9886634|FG002|STARTED|Period 2, Day 2||4
8832358|NCT01642485|9886635|FG003|STARTED|Period 2, Day 2||4
8832359|NCT01642485|9886636|FG004|STARTED|Period 2, Day 2||4
8832360|NCT01642485|9886637|FG005|STARTED|Period 2, Day 2||4
8832361|NCT01642485|9886638|FG006|STARTED|Period 2, Day 2||4
8832362|NCT01642485|9886639|FG007|STARTED|Period 2, Day 2||4
8832363|NCT01642485|9886632|FG000|COMPLETED|Period 2, Day 2||4
8832364|NCT01642485|9886633|FG001|COMPLETED|Period 2, Day 2||4
8832365|NCT01642485|9886634|FG002|COMPLETED|Period 2, Day 2||4
8832366|NCT01642485|9886635|FG003|COMPLETED|Period 2, Day 2||4
8832367|NCT01642485|9886636|FG004|COMPLETED|Period 2, Day 2||4
8832368|NCT01642485|9886637|FG005|COMPLETED|Period 2, Day 2||4
8832369|NCT01642485|9886638|FG006|COMPLETED|Period 2, Day 2||4
8832370|NCT01642485|9886639|FG007|COMPLETED|Period 2, Day 2||4
8832371|NCT01642485|9886632|FG000|NOT COMPLETED|Period 2, Day 2||0
8832372|NCT01642485|9886633|FG001|NOT COMPLETED|Period 2, Day 2||0
8832373|NCT01642485|9886634|FG002|NOT COMPLETED|Period 2, Day 2||0
8832374|NCT01642485|9886635|FG003|NOT COMPLETED|Period 2, Day 2||0
8832375|NCT01642485|9886636|FG004|NOT COMPLETED|Period 2, Day 2||0
8832376|NCT01642485|9886637|FG005|NOT COMPLETED|Period 2, Day 2||0
8832377|NCT01642485|9886638|FG006|NOT COMPLETED|Period 2, Day 2||0
8832378|NCT01642485|9886639|FG007|NOT COMPLETED|Period 2, Day 2||0
8832379|NCT01642485|9886632|FG000|STARTED|Period 2, Day 3||4
8832380|NCT01642485|9886633|FG001|STARTED|Period 2, Day 3||4
8832381|NCT01642485|9886634|FG002|STARTED|Period 2, Day 3||4
8832382|NCT01642485|9886635|FG003|STARTED|Period 2, Day 3||4
8832383|NCT01642485|9886636|FG004|STARTED|Period 2, Day 3||4
8832384|NCT01642485|9886637|FG005|STARTED|Period 2, Day 3||4
8832385|NCT01642485|9886638|FG006|STARTED|Period 2, Day 3||4
8832386|NCT01642485|9886639|FG007|STARTED|Period 2, Day 3||4
8832387|NCT01642485|9886632|FG000|COMPLETED|Period 2, Day 3||4
8832388|NCT01642485|9886633|FG001|COMPLETED|Period 2, Day 3||4
8832389|NCT01642485|9886634|FG002|COMPLETED|Period 2, Day 3||4
8832390|NCT01642485|9886635|FG003|COMPLETED|Period 2, Day 3||4
8832391|NCT01642485|9886636|FG004|COMPLETED|Period 2, Day 3||4
8832392|NCT01642485|9886637|FG005|COMPLETED|Period 2, Day 3||4
8832393|NCT01642485|9886638|FG006|COMPLETED|Period 2, Day 3||4
8832394|NCT01642485|9886639|FG007|COMPLETED|Period 2, Day 3||4
8832395|NCT01642485|9886632|FG000|NOT COMPLETED|Period 2, Day 3||0
8832396|NCT01642485|9886633|FG001|NOT COMPLETED|Period 2, Day 3||0
8832397|NCT01642485|9886634|FG002|NOT COMPLETED|Period 2, Day 3||0
8832398|NCT01642485|9886635|FG003|NOT COMPLETED|Period 2, Day 3||0
8832399|NCT01642485|9886636|FG004|NOT COMPLETED|Period 2, Day 3||0
8832400|NCT01642485|9886637|FG005|NOT COMPLETED|Period 2, Day 3||0
8832401|NCT01642485|9886638|FG006|NOT COMPLETED|Period 2, Day 3||0
8832402|NCT01642485|9886639|FG007|NOT COMPLETED|Period 2, Day 3||0
8832403|NCT01642589|9886659|FG000|STARTED|Overall Study||200
8832404|NCT01642589|9886660|FG001|STARTED|Overall Study||100
8832405|NCT01642589|9886659|FG000|COMPLETED|Overall Study||199
8832406|NCT01642589|9886660|FG001|COMPLETED|Overall Study||99
8832407|NCT01642589|9886659|FG000|NOT COMPLETED|Overall Study||1
8832408|NCT01642589|9886660|FG001|NOT COMPLETED|Overall Study||1
8832409|NCT01642602|9886666|FG000|STARTED|Overall Study||104
8832410|NCT01642602|9886666|FG000|COMPLETED|Overall Study||102
8832411|NCT01642602|9886666|FG000|NOT COMPLETED|Overall Study||2
8832412|NCT01642615|9886670|FG000|STARTED|Open Label Maintenance Phase||63
8832413|NCT01642615|9886671|FG001|STARTED|Open Label Maintenance Phase||0
8832414|NCT01642615|9886672|FG002|STARTED|Open Label Maintenance Phase||0
8832415|NCT01642615|9886670|FG000|Safety Analysis Set|Open Label Maintenance Phase||62
8832416|NCT01642615|9886671|FG001|Safety Analysis Set|Open Label Maintenance Phase||0
8832417|NCT01642615|9886672|FG002|Safety Analysis Set|Open Label Maintenance Phase||0
8832418|NCT01642615|9886670|FG000|COMPLETED|Open Label Maintenance Phase||58
8832419|NCT01642615|9886671|FG001|COMPLETED|Open Label Maintenance Phase||0
8832420|NCT01642615|9886672|FG002|COMPLETED|Open Label Maintenance Phase||0
8832421|NCT01642615|9886670|FG000|NOT COMPLETED|Open Label Maintenance Phase||5
8832422|NCT01642615|9886671|FG001|NOT COMPLETED|Open Label Maintenance Phase||0
8832423|NCT01642615|9886672|FG002|NOT COMPLETED|Open Label Maintenance Phase||0
8832424|NCT01642615|9886670|FG000|STARTED|Double Blind Maintenance Phase||0
8832425|NCT01642615|9886671|FG001|STARTED|Double Blind Maintenance Phase||25
8832426|NCT01642615|9886672|FG002|STARTED|Double Blind Maintenance Phase||26
8832427|NCT01642615|9886670|FG000|COMPLETED|Double Blind Maintenance Phase||0
8832428|NCT01642615|9886671|FG001|COMPLETED|Double Blind Maintenance Phase||18
8832429|NCT01642615|9886672|FG002|COMPLETED|Double Blind Maintenance Phase||20
8832430|NCT01642615|9886670|FG000|NOT COMPLETED|Double Blind Maintenance Phase||0
8832431|NCT01642615|9886671|FG001|NOT COMPLETED|Double Blind Maintenance Phase||7
8832432|NCT01642615|9886672|FG002|NOT COMPLETED|Double Blind Maintenance Phase||6
8832433|NCT01642914|9886683|FG000|STARTED|Overall Study||173
8832434|NCT01642914|9886684|FG001|STARTED|Overall Study||154
8832435|NCT01642914|9886685|FG002|STARTED|Overall Study||160
8832436|NCT01642914|9886683|FG000|COMPLETED|Overall Study||127
8832437|NCT01642914|9886684|FG001|COMPLETED|Overall Study||122
8832438|NCT01642914|9886685|FG002|COMPLETED|Overall Study||120
8832439|NCT01642914|9886683|FG000|NOT COMPLETED|Overall Study||46
8832440|NCT01642914|9886684|FG001|NOT COMPLETED|Overall Study||32
8832441|NCT01642914|9886685|FG002|NOT COMPLETED|Overall Study||40
8832442|NCT01643044|9886697|FG000|STARTED|Overall Study||24
8832443|NCT01643044|9886698|FG001|STARTED|Overall Study||24
8832444|NCT01643044|9886697|FG000|COMPLETED|Overall Study||20
8832445|NCT01643044|9886698|FG001|COMPLETED|Overall Study||19
8832446|NCT01643044|9886697|FG000|NOT COMPLETED|Overall Study||4
8832447|NCT01643044|9886698|FG001|NOT COMPLETED|Overall Study||5
8832448|NCT01643213|9886706|FG000|STARTED|Overall Study||13
8832449|NCT01643213|9886707|FG001|STARTED|Overall Study||14
8832450|NCT01643213|9886706|FG000|COMPLETED|Overall Study||12
8832451|NCT01643213|9886707|FG001|COMPLETED|Overall Study||14
8832452|NCT01643213|9886706|FG000|NOT COMPLETED|Overall Study||1
8832453|NCT01643213|9886707|FG001|NOT COMPLETED|Overall Study||0
8832454|NCT01643382|9886715|FG000|STARTED|Overall Study||30
8832455|NCT01643382|9886716|FG001|STARTED|Overall Study||30
8832456|NCT01643382|9886715|FG000|COMPLETED|Overall Study||30
8832457|NCT01643382|9886716|FG001|COMPLETED|Overall Study||30
8832458|NCT01643382|9886715|FG000|NOT COMPLETED|Overall Study||0
8832459|NCT01643382|9886716|FG001|NOT COMPLETED|Overall Study||0
8832460|NCT01643408|9886722|FG000|STARTED|Overall Study||30
8832461|NCT01643408|9886722|FG000|COMPLETED|Overall Study||16
8832462|NCT01643408|9886722|FG000|NOT COMPLETED|Overall Study||14
8832463|NCT01643473|9886728|FG000|STARTED|Overall Study||21
8832464|NCT01643473|9886729|FG001|STARTED|Overall Study||21
8832465|NCT01643473|9886728|FG000|COMPLETED|Overall Study||20
8832466|NCT01643473|9886729|FG001|COMPLETED|Overall Study||21
8832467|NCT01643473|9886728|FG000|NOT COMPLETED|Overall Study||1
8832468|NCT01643473|9886729|FG001|NOT COMPLETED|Overall Study||0
8832469|NCT01643616|9886737|FG000|STARTED|Overall Study||125
8832470|NCT01643616|9886738|FG001|STARTED|Overall Study||125
8832471|NCT01643616|9886737|FG000|COMPLETED|Overall Study||125
8832472|NCT01643616|9886738|FG001|COMPLETED|Overall Study||125
8832473|NCT01643616|9886737|FG000|NOT COMPLETED|Overall Study||0
8832474|NCT01643616|9886738|FG001|NOT COMPLETED|Overall Study||0
8832475|NCT01643668|9886744|FG000|STARTED|Overall Study||34
8832476|NCT01643668|9886744|FG000|COMPLETED|Overall Study||33
8832477|NCT01643668|9886744|FG000|NOT COMPLETED|Overall Study||1
8832478|NCT01643707|9886750|FG000|STARTED|Overall Study||858
8832479|NCT01643707|9886751|FG001|STARTED|Overall Study||484
8832480|NCT01643707|9886750|FG000|COMPLETED|Overall Study||823
8832481|NCT01643707|9886751|FG001|COMPLETED|Overall Study||470
8832482|NCT01643707|9886750|FG000|NOT COMPLETED|Overall Study||35
8832483|NCT01643707|9886751|FG001|NOT COMPLETED|Overall Study||14
8832484|NCT01643772|9886764|FG000|STARTED|Overall Study||15
8832485|NCT01643772|9886765|FG001|STARTED|Overall Study||15
8832486|NCT01643772|9886766|FG002|STARTED|Overall Study||15
8832487|NCT01643772|9886767|FG003|STARTED|Overall Study||16
8832488|NCT01643772|9886764|FG000|COMPLETED|Overall Study||15
8832489|NCT01643772|9886765|FG001|COMPLETED|Overall Study||15
8832490|NCT01643772|9886766|FG002|COMPLETED|Overall Study||15
8832491|NCT01643772|9886767|FG003|COMPLETED|Overall Study||14
8832492|NCT01643772|9886764|FG000|NOT COMPLETED|Overall Study||0
8832493|NCT01643772|9886765|FG001|NOT COMPLETED|Overall Study||0
8832494|NCT01643772|9886766|FG002|NOT COMPLETED|Overall Study||0
8832495|NCT01643772|9886767|FG003|NOT COMPLETED|Overall Study||2
8832496|NCT01643798|9886779|FG000|STARTED|Pretreatment 1 and Stimulation||7
8832497|NCT01643798|9886780|FG001|STARTED|Pretreatment 1 and Stimulation||8
8832498|NCT01643798|9886779|FG000|COMPLETED|Pretreatment 1 and Stimulation||6
8832499|NCT01643798|9886780|FG001|COMPLETED|Pretreatment 1 and Stimulation||8
8832500|NCT01643798|9886779|FG000|NOT COMPLETED|Pretreatment 1 and Stimulation||1
8832501|NCT01643798|9886780|FG001|NOT COMPLETED|Pretreatment 1 and Stimulation||0
8832502|NCT01643798|9886779|FG000|STARTED|Pretreatment 2 and Stimulation||6
8832503|NCT01643798|9886780|FG001|STARTED|Pretreatment 2 and Stimulation||8
8832504|NCT01643798|9886779|FG000|COMPLETED|Pretreatment 2 and Stimulation||6
8832505|NCT01643798|9886780|FG001|COMPLETED|Pretreatment 2 and Stimulation||8
8832506|NCT01643798|9886779|FG000|NOT COMPLETED|Pretreatment 2 and Stimulation||0
8832507|NCT01643798|9886780|FG001|NOT COMPLETED|Pretreatment 2 and Stimulation||0
8832508|NCT01643850|9886800|FG000|STARTED|Overall Study||5
8832509|NCT01643850|9886801|FG001|STARTED|Overall Study||2
8832510|NCT01643850|9886802|FG002|STARTED|Overall Study||8
8832511|NCT01643850|9886803|FG003|STARTED|Overall Study||3
8832512|NCT01643850|9886804|FG004|STARTED|Overall Study||3
8832513|NCT01643850|9886805|FG005|STARTED|Overall Study||3
8832514|NCT01643850|9886806|FG006|STARTED|Overall Study||4
8832515|NCT01643850|9886807|FG007|STARTED|Overall Study||4
8832516|NCT01643850|9886808|FG008|STARTED|Overall Study||4
8832517|NCT01643850|9886800|FG000|COMPLETED|Overall Study||5
8832518|NCT01643850|9886801|FG001|COMPLETED|Overall Study||2
8832519|NCT01643850|9886802|FG002|COMPLETED|Overall Study||7
8832520|NCT01643850|9886803|FG003|COMPLETED|Overall Study||3
8832521|NCT01643850|9886804|FG004|COMPLETED|Overall Study||0
8832522|NCT01643850|9886805|FG005|COMPLETED|Overall Study||3
8622649|NCT00489359|9661861|FG001|COMPLETED|Overall Study|Received at least 6 cycles of therapy. Not completed implies participant received <6 cycles.|37
8622650|NCT00489359|9661860|FG000|NOT COMPLETED|Overall Study||7
8622651|NCT00489359|9661861|FG001|NOT COMPLETED|Overall Study||29
8622652|NCT00489411|9661874|FG000|STARTED|Initial Treatment Period (Weeks 1-5)||115
8622653|NCT00489411|9661875|FG001|STARTED|Initial Treatment Period (Weeks 1-5)||116
8832523|NCT01643850|9886806|FG006|COMPLETED|Overall Study||3
8832524|NCT01643850|9886807|FG007|COMPLETED|Overall Study||4
8832525|NCT01643850|9886808|FG008|COMPLETED|Overall Study||3
8832526|NCT01643850|9886800|FG000|NOT COMPLETED|Overall Study||0
8832527|NCT01643850|9886801|FG001|NOT COMPLETED|Overall Study||0
8832528|NCT01643850|9886802|FG002|NOT COMPLETED|Overall Study||1
8832529|NCT01643850|9886803|FG003|NOT COMPLETED|Overall Study||0
8832530|NCT01643850|9886804|FG004|NOT COMPLETED|Overall Study||3
8832531|NCT01643850|9886805|FG005|NOT COMPLETED|Overall Study||0
8832532|NCT01643850|9886806|FG006|NOT COMPLETED|Overall Study||1
8832533|NCT01643850|9886807|FG007|NOT COMPLETED|Overall Study||0
8832534|NCT01643850|9886808|FG008|NOT COMPLETED|Overall Study||1
8832535|NCT01643876|9886874|FG000|STARTED|Overall Study||48
8832536|NCT01643876|9886874|FG000|COMPLETED|Overall Study||48
8832537|NCT01643876|9886874|FG000|NOT COMPLETED|Overall Study||0
8832538|NCT01643902|9886878|FG000|STARTED|Overall Study||20
8832539|NCT01643902|9886878|FG000|COMPLETED|Overall Study||20
8832540|NCT01643902|9886878|FG000|NOT COMPLETED|Overall Study||0
8832541|NCT01643928|9886888|FG000|STARTED|Overall Study||58
8832542|NCT01643928|9886889|FG001|STARTED|Overall Study||32
8832543|NCT01643928|9886890|FG002|STARTED|Overall Study||33
8832544|NCT01643928|9886891|FG003|STARTED|Overall Study||30
8832545|NCT01643928|9886892|FG004|STARTED|Overall Study||30
8832546|NCT01643928|9886888|FG000|COMPLETED|Overall Study||48
8832547|NCT01643928|9886889|FG001|COMPLETED|Overall Study||30
8832548|NCT01643928|9886890|FG002|COMPLETED|Overall Study||30
8832549|NCT01643928|9886891|FG003|COMPLETED|Overall Study||27
8832550|NCT01643928|9886892|FG004|COMPLETED|Overall Study||28
8832551|NCT01643928|9886888|FG000|NOT COMPLETED|Overall Study||10
8832552|NCT01643928|9886889|FG001|NOT COMPLETED|Overall Study||2
8832553|NCT01643928|9886890|FG002|NOT COMPLETED|Overall Study||3
8832554|NCT01643928|9886891|FG003|NOT COMPLETED|Overall Study||3
8832555|NCT01643928|9886892|FG004|NOT COMPLETED|Overall Study||2
8832556|NCT01644058|9886933|FG000|STARTED|Overall Study||18
8832557|NCT01644058|9886933|FG000|COMPLETED|Overall Study||18
8832558|NCT01644058|9886933|FG000|NOT COMPLETED|Overall Study||0
8832559|NCT01644149|9886940|FG000|STARTED|Overall Study||43
8832560|NCT01644149|9886941|FG001|STARTED|Overall Study||40
8832561|NCT01644149|9886940|FG000|COMPLETED|Overall Study|One subject discontinued prior to vaccination. 28 day serum samples not obtained from 3 subjects.|39
8832562|NCT01644149|9886941|FG001|COMPLETED|Overall Study|28 day serum samples were not obtained from one NS subject.|39
8832563|NCT01644149|9886940|FG000|NOT COMPLETED|Overall Study||4
8832564|NCT01644149|9886941|FG001|NOT COMPLETED|Overall Study||1
8832565|NCT01644175|9886950|FG000|STARTED|Overall Study|Randomized|107
8832566|NCT01644175|9886951|FG001|STARTED|Overall Study|Randomized|209
8832567|NCT01644175|9886950|FG000|Treated|Overall Study||107
8832568|NCT01644175|9886951|FG001|Treated|Overall Study||207
8832569|NCT01644175|9886950|FG000|COMPLETED|Overall Study||75
8832570|NCT01644175|9886951|FG001|COMPLETED|Overall Study||156
8832571|NCT01644175|9886950|FG000|NOT COMPLETED|Overall Study||32
8832572|NCT01644175|9886951|FG001|NOT COMPLETED|Overall Study||53
8832573|NCT01644188|9886959|FG000|STARTED|Overall Study|Randomized|479
8832574|NCT01644188|9886960|FG001|STARTED|Overall Study|Randomized|241
8832575|NCT01644188|9886959|FG000|Treated|Overall Study||479
8832576|NCT01644188|9886960|FG001|Treated|Overall Study||241
8832577|NCT01644188|9886959|FG000|COMPLETED|Overall Study||357
8832578|NCT01644188|9886960|FG001|COMPLETED|Overall Study||166
8832579|NCT01644188|9886959|FG000|NOT COMPLETED|Overall Study||122
8832580|NCT01644188|9886960|FG001|NOT COMPLETED|Overall Study||75
8832581|NCT01644240|9886969|FG000|STARTED|Overall Study||6
8832582|NCT01644240|9886970|FG001|STARTED|Overall Study||4
8832583|NCT01644240|9886971|FG002|STARTED|Overall Study||6
8832584|NCT01644240|9886969|FG000|COMPLETED|Overall Study||6
8832585|NCT01644240|9886970|FG001|COMPLETED|Overall Study||4
8832586|NCT01644240|9886971|FG002|COMPLETED|Overall Study||6
8832587|NCT01644240|9886969|FG000|NOT COMPLETED|Overall Study||0
8832588|NCT01644240|9886970|FG001|NOT COMPLETED|Overall Study||0
8832589|NCT01644240|9886971|FG002|NOT COMPLETED|Overall Study||0
8832590|NCT01644292|9886979|FG000|STARTED|Overall Study||2
8832591|NCT01644292|9886979|FG000|COMPLETED|Overall Study||2
8832592|NCT01644292|9886979|FG000|NOT COMPLETED|Overall Study||0
8832593|NCT01644331|9886985|FG000|STARTED|Overall Study||129
8832594|NCT01644331|9886986|FG001|STARTED|Overall Study||128
8832595|NCT01644331|9886985|FG000|COMPLETED|Overall Study||118
8832596|NCT01644331|9886986|FG001|COMPLETED|Overall Study||118
8832597|NCT01644331|9886985|FG000|NOT COMPLETED|Overall Study||11
8832598|NCT01644331|9886986|FG001|NOT COMPLETED|Overall Study||10
8832599|NCT01644396|9886992|FG000|STARTED|Overall Study||50
8832600|NCT01644396|9886992|FG000|COMPLETED|Overall Study||50
8832601|NCT01644396|9886992|FG000|NOT COMPLETED|Overall Study||0
8832602|NCT01644474|9886999|FG000|STARTED|Overall Study|Randomized|51
8832603|NCT01644474|9887000|FG001|STARTED|Overall Study|Randomized|52
8832604|NCT01644474|9886999|FG000|Treated|Overall Study||51
8832605|NCT01644474|9887000|FG001|Treated|Overall Study||52
8832606|NCT01644474|9886999|FG000|COMPLETED|Overall Study||44
8832607|NCT01644474|9887000|FG001|COMPLETED|Overall Study||44
8832608|NCT01644474|9886999|FG000|NOT COMPLETED|Overall Study||7
8832609|NCT01644474|9887000|FG001|NOT COMPLETED|Overall Study||8
8832610|NCT01644500|9887009|FG000|STARTED|Overall Study||244
8832611|NCT01644500|9887010|FG001|STARTED|Overall Study||248
8832612|NCT01644500|9887011|FG002|STARTED|Overall Study||245
8832613|NCT01644500|9887009|FG000|Received at Least One Dose of Study Drug|Overall Study||244
8832614|NCT01644500|9887010|FG001|Received at Least One Dose of Study Drug|Overall Study||248
8832615|NCT01644500|9887011|FG002|Received at Least One Dose of Study Drug|Overall Study||243
8832616|NCT01644500|9887009|FG000|Modified Intent-to-treat Population|Overall Study||239
8832617|NCT01644500|9887010|FG001|Modified Intent-to-treat Population|Overall Study||239
8832618|NCT01644500|9887011|FG002|Modified Intent-to-treat Population|Overall Study||242
8832619|NCT01644500|9887009|FG000|COMPLETED|Overall Study||222
8832620|NCT01644500|9887010|FG001|COMPLETED|Overall Study||224
8832621|NCT01644500|9887011|FG002|COMPLETED|Overall Study||230
8832622|NCT01644500|9887009|FG000|NOT COMPLETED|Overall Study||22
8832623|NCT01644500|9887010|FG001|NOT COMPLETED|Overall Study||24
8832624|NCT01644500|9887011|FG002|NOT COMPLETED|Overall Study||15
8832625|NCT01644565|9887019|FG000|STARTED|Overall Study||5
8832626|NCT01644565|9887020|FG001|STARTED|Overall Study||5
8832627|NCT01644565|9887021|FG002|STARTED|Overall Study||5
8832628|NCT01644565|9887022|FG003|STARTED|Overall Study||5
8832629|NCT01644565|9887023|FG004|STARTED|Overall Study||5
8832630|NCT01644565|9887024|FG005|STARTED|Overall Study||7
8832631|NCT01644565|9887025|FG006|STARTED|Overall Study||7
8832632|NCT01644565|9887026|FG007|STARTED|Overall Study||10
8832633|NCT01644565|9887027|FG008|STARTED|Overall Study||8
8832634|NCT01644565|9887019|FG000|COMPLETED|Overall Study||4
8832635|NCT01644565|9887020|FG001|COMPLETED|Overall Study||5
8832636|NCT01644565|9887021|FG002|COMPLETED|Overall Study||5
8832637|NCT01644565|9887022|FG003|COMPLETED|Overall Study||4
8832638|NCT01644565|9887023|FG004|COMPLETED|Overall Study||4
8832639|NCT01644565|9887024|FG005|COMPLETED|Overall Study||7
8622654|NCT00489411|9661874|FG000|COMPLETED|Initial Treatment Period (Weeks 1-5)||87
8622655|NCT00489411|9661875|FG001|COMPLETED|Initial Treatment Period (Weeks 1-5)||94
8622656|NCT00489411|9661874|FG000|NOT COMPLETED|Initial Treatment Period (Weeks 1-5)||28
8832640|NCT01644565|9887025|FG006|COMPLETED|Overall Study||7
8832641|NCT01644565|9887026|FG007|COMPLETED|Overall Study||8
8832642|NCT01644565|9887027|FG008|COMPLETED|Overall Study||7
8832643|NCT01644565|9887019|FG000|NOT COMPLETED|Overall Study||1
8832644|NCT01644565|9887020|FG001|NOT COMPLETED|Overall Study||0
8832645|NCT01644565|9887021|FG002|NOT COMPLETED|Overall Study||0
8832646|NCT01644565|9887022|FG003|NOT COMPLETED|Overall Study||1
8832647|NCT01644565|9887023|FG004|NOT COMPLETED|Overall Study||1
8832648|NCT01644565|9887024|FG005|NOT COMPLETED|Overall Study||0
8832649|NCT01644565|9887025|FG006|NOT COMPLETED|Overall Study||0
8832650|NCT01644565|9887026|FG007|NOT COMPLETED|Overall Study||2
8832651|NCT01644565|9887027|FG008|NOT COMPLETED|Overall Study||1
8832652|NCT01644617|9887050|FG000|STARTED|Overall Study||42
8832653|NCT01644617|9887051|FG001|STARTED|Overall Study||41
8832654|NCT01644617|9887052|FG002|STARTED|Overall Study||41
8832655|NCT01644617|9887050|FG000|COMPLETED|Overall Study||36
8832656|NCT01644617|9887051|FG001|COMPLETED|Overall Study||36
8832657|NCT01644617|9887052|FG002|COMPLETED|Overall Study||34
8832658|NCT01644617|9887050|FG000|NOT COMPLETED|Overall Study||6
8832659|NCT01644617|9887051|FG001|NOT COMPLETED|Overall Study||5
8832660|NCT01644617|9887052|FG002|NOT COMPLETED|Overall Study||7
8832661|NCT01644643|9887064|FG000|STARTED|Overall Study||15
8832662|NCT01644643|9887065|FG001|STARTED|Overall Study||12
8832663|NCT01644643|9887066|FG002|STARTED|Overall Study||153
8832664|NCT01644643|9887067|FG003|STARTED|Overall Study||153
8832665|NCT01644643|9887064|FG000|COMPLETED|Overall Study||13
8832666|NCT01644643|9887065|FG001|COMPLETED|Overall Study||12
8832667|NCT01644643|9887066|FG002|COMPLETED|Overall Study||148
8622657|NCT00489411|9661875|FG001|NOT COMPLETED|Initial Treatment Period (Weeks 1-5)||22
8622658|NCT00489411|9661874|FG000|STARTED|Washout Period (Weeks 6-7)||87
8622659|NCT00489411|9661875|FG001|STARTED|Washout Period (Weeks 6-7)||94
8622660|NCT00489411|9661874|FG000|COMPLETED|Washout Period (Weeks 6-7)||85
8622661|NCT00489411|9661875|FG001|COMPLETED|Washout Period (Weeks 6-7)||93
8622662|NCT00489411|9661874|FG000|NOT COMPLETED|Washout Period (Weeks 6-7)||2
8622663|NCT00489411|9661875|FG001|NOT COMPLETED|Washout Period (Weeks 6-7)||1
8622664|NCT00489411|9661874|FG000|STARTED|Crossover Treatment Period (Weeks 8-12)||85
8832668|NCT01644643|9887067|FG003|COMPLETED|Overall Study||143
8832669|NCT01644643|9887064|FG000|NOT COMPLETED|Overall Study||2
8832670|NCT01644643|9887065|FG001|NOT COMPLETED|Overall Study||0
8832671|NCT01644643|9887066|FG002|NOT COMPLETED|Overall Study||5
8832672|NCT01644643|9887067|FG003|NOT COMPLETED|Overall Study||10
8832673|NCT01644695|9887083|FG000|STARTED|Overall Study||85
8622665|NCT00489411|9661875|FG001|STARTED|Crossover Treatment Period (Weeks 8-12)||93
8622666|NCT00489411|9661874|FG000|COMPLETED|Crossover Treatment Period (Weeks 8-12)||67
8622667|NCT00489411|9661875|FG001|COMPLETED|Crossover Treatment Period (Weeks 8-12)||74
8622668|NCT00489411|9661874|FG000|NOT COMPLETED|Crossover Treatment Period (Weeks 8-12)||18
8622669|NCT00489411|9661875|FG001|NOT COMPLETED|Crossover Treatment Period (Weeks 8-12)||19
8629466|NCT00530439|9669214|FG001|COMPLETED|Overall Study||154
8629467|NCT00530439|9669213|FG000|NOT COMPLETED|Overall Study||30
8629468|NCT00530439|9669214|FG001|NOT COMPLETED|Overall Study||26
8629469|NCT00530504|9669220|FG000|STARTED|Overall Study||1500
8629470|NCT00530504|9669220|FG000|COMPLETED|Overall Study||1348
8629471|NCT00530504|9669220|FG000|NOT COMPLETED|Overall Study||152
8629472|NCT00530621|9669226|FG000|STARTED|Overall Study||80
8629473|NCT00530621|9669227|FG001|STARTED|Overall Study||80
8832674|NCT01644695|9887083|FG000|COMPLETED|Overall Study||85
8832675|NCT01644695|9887083|FG000|NOT COMPLETED|Overall Study||0
8832676|NCT01644734|9887087|FG000|STARTED|Overall Study|Patients with documentation of treatment.|1282
8832677|NCT01644734|9887087|FG000|COMPLETED|Overall Study||1016
8832678|NCT01644734|9887087|FG000|NOT COMPLETED|Overall Study||266
8832679|NCT01644890|9887093|FG000|STARTED|Overall Study||218
8832680|NCT01644890|9887094|FG001|STARTED|Overall Study||218
8832681|NCT01644890|9887093|FG000|COMPLETED|Overall Study||2
8832682|NCT01644890|9887094|FG001|COMPLETED|Overall Study||3
8832683|NCT01644890|9887093|FG000|NOT COMPLETED|Overall Study||216
8832684|NCT01644890|9887094|FG001|NOT COMPLETED|Overall Study||215
8832685|NCT01645059|9887100|FG000|STARTED|Overall Study||129
8832686|NCT01645059|9887100|FG000|COMPLETED|Overall Study||129
8832687|NCT01645059|9887100|FG000|NOT COMPLETED|Overall Study||0
8832688|NCT01645098|9887111|FG000|STARTED|Overall Study||24
8832689|NCT01645098|9887112|FG001|STARTED|Overall Study||29
8832690|NCT01645098|9887111|FG000|COMPLETED|Overall Study||24
8832691|NCT01645098|9887112|FG001|COMPLETED|Overall Study||29
8832692|NCT01645098|9887111|FG000|NOT COMPLETED|Overall Study||0
8832693|NCT01645098|9887112|FG001|NOT COMPLETED|Overall Study||0
8832694|NCT01645111|9887118|FG000|STARTED|Overall Study||50
8832695|NCT01645111|9887118|FG000|COMPLETED|Overall Study||35
8832696|NCT01645111|9887118|FG000|NOT COMPLETED|Overall Study||15
8832697|NCT01645176|9887122|FG000|STARTED|Overall Study||21
8832698|NCT01645176|9887122|FG000|COMPLETED|Overall Study||16
8832699|NCT01645176|9887122|FG000|NOT COMPLETED|Overall Study||5
8832700|NCT01645280|9887131|FG000|STARTED|Overall Study|16 participants in placebo group early escaped to receive Ustekinmab; included in safety population.|55
8832701|NCT01645280|9887132|FG001|STARTED|Overall Study||54
8832702|NCT01645280|9887133|FG002|STARTED|Overall Study||55
8832703|NCT01645280|9887134|FG003|STARTED|Overall Study||54
8832704|NCT01645280|9887135|FG004|STARTED|Overall Study||55
8832705|NCT01645280|9887131|FG000|COMPLETED|Overall Study||49
8832706|NCT01645280|9887132|FG001|COMPLETED|Overall Study||51
8832707|NCT01645280|9887133|FG002|COMPLETED|Overall Study||49
8832708|NCT01645280|9887134|FG003|COMPLETED|Overall Study||48
8832709|NCT01645280|9887135|FG004|COMPLETED|Overall Study||47
8832710|NCT01645280|9887131|FG000|NOT COMPLETED|Overall Study||6
8832711|NCT01645280|9887132|FG001|NOT COMPLETED|Overall Study||3
8832712|NCT01645280|9887133|FG002|NOT COMPLETED|Overall Study||6
8832713|NCT01645280|9887134|FG003|NOT COMPLETED|Overall Study||6
8832714|NCT01645280|9887135|FG004|NOT COMPLETED|Overall Study||8
8832715|NCT01645306|9887151|FG000|STARTED|Overall Study||51
8832716|NCT01645306|9887152|FG001|STARTED|Overall Study||54
8832717|NCT01645306|9887153|FG002|STARTED|Overall Study||53
8832718|NCT01645306|9887151|FG000|COMPLETED|Overall Study||49
8832719|NCT01645306|9887152|FG001|COMPLETED|Overall Study||50
8832720|NCT01645306|9887153|FG002|COMPLETED|Overall Study||48
8832721|NCT01645306|9887151|FG000|NOT COMPLETED|Overall Study||2
8832722|NCT01645306|9887152|FG001|NOT COMPLETED|Overall Study||4
8832723|NCT01645306|9887153|FG002|NOT COMPLETED|Overall Study||5
8832724|NCT01645735|9887163|FG000|STARTED|Overall Study||32
8832725|NCT01645735|9887164|FG001|STARTED|Overall Study||17
8832726|NCT01645735|9887163|FG000|COMPLETED|Overall Study||28
8832727|NCT01645735|9887164|FG001|COMPLETED|Overall Study||16
8832728|NCT01645735|9887163|FG000|NOT COMPLETED|Overall Study||4
8832729|NCT01645735|9887164|FG001|NOT COMPLETED|Overall Study||1
8832730|NCT01645930|9887171|FG000|STARTED|Overall Study||43
8832731|NCT01645930|9887171|FG000|COMPLETED|Overall Study||0
8832732|NCT01645930|9887171|FG000|NOT COMPLETED|Overall Study||43
8832733|NCT01646021|9887177|FG000|STARTED|Overall Study||139
8832734|NCT01646021|9887178|FG001|STARTED|Overall Study||141
8832735|NCT01646021|9887177|FG000|Treated|Overall Study||139
8832736|NCT01646021|9887178|FG001|Treated|Overall Study||139
8832737|NCT01646021|9887177|FG000|COMPLETED|Overall Study||0
8832738|NCT01646021|9887178|FG001|COMPLETED|Overall Study||0
8832739|NCT01646021|9887177|FG000|NOT COMPLETED|Overall Study||139
8832740|NCT01646021|9887178|FG001|NOT COMPLETED|Overall Study||141
8832741|NCT01646073|9887186|FG000|STARTED|Period A (12 Weeks)||87
8832742|NCT01646073|9887187|FG001|STARTED|Period A (12 Weeks)||338
8832743|NCT01646073|9887186|FG000|COMPLETED|Period A (12 Weeks)||85
8832744|NCT01646073|9887187|FG001|COMPLETED|Period A (12 Weeks)||333
8832745|NCT01646073|9887186|FG000|NOT COMPLETED|Period A (12 Weeks)||2
8832746|NCT01646073|9887187|FG001|NOT COMPLETED|Period A (12 Weeks)||5
8832747|NCT01646073|9887186|FG000|STARTED|Period B (12 Weeks)||85
8832748|NCT01646073|9887187|FG001|STARTED|Period B (12 Weeks)||333
8832749|NCT01646073|9887186|FG000|COMPLETED|Period B (12 Weeks)||84
8832750|NCT01646073|9887187|FG001|COMPLETED|Period B (12 Weeks)||320
8832751|NCT01646073|9887186|FG000|NOT COMPLETED|Period B (12 Weeks)||1
8832752|NCT01646073|9887187|FG001|NOT COMPLETED|Period B (12 Weeks)||13
8832753|NCT01646125|9887198|FG000|STARTED|Overall Study||31
8832754|NCT01646125|9887199|FG001|STARTED|Overall Study||28
8832755|NCT01646125|9887198|FG000|COMPLETED|Overall Study||0
8832756|NCT01646125|9887199|FG001|COMPLETED|Overall Study||0
8832757|NCT01646125|9887198|FG000|NOT COMPLETED|Overall Study||31
8832758|NCT01646125|9887199|FG001|NOT COMPLETED|Overall Study||28
8832759|NCT01646138|9887211|FG000|STARTED|Overall Study||5
8832760|NCT01646138|9887212|FG001|STARTED|Overall Study||4
8832761|NCT01646138|9887213|FG002|STARTED|Overall Study||5
8832762|NCT01646138|9887214|FG003|STARTED|Overall Study||19
8832763|NCT01646138|9887215|FG004|STARTED|Overall Study||15
8832764|NCT01646138|9887211|FG000|COMPLETED|Overall Study||5
8832765|NCT01646138|9887212|FG001|COMPLETED|Overall Study||4
8832766|NCT01646138|9887213|FG002|COMPLETED|Overall Study||5
8832767|NCT01646138|9887214|FG003|COMPLETED|Overall Study||19
8832768|NCT01646138|9887215|FG004|COMPLETED|Overall Study||13
8832769|NCT01646138|9887211|FG000|NOT COMPLETED|Overall Study||0
8832770|NCT01646138|9887212|FG001|NOT COMPLETED|Overall Study||0
8832771|NCT01646138|9887213|FG002|NOT COMPLETED|Overall Study||0
8832772|NCT01646138|9887214|FG003|NOT COMPLETED|Overall Study||0
8832773|NCT01646138|9887215|FG004|NOT COMPLETED|Overall Study||2
8832774|NCT01646151|9887227|FG000|STARTED|Overall Study||2580
8832775|NCT01646151|9887227|FG000|COMPLETED|Overall Study||2410
8832776|NCT01646151|9887227|FG000|NOT COMPLETED|Overall Study||170
8832777|NCT01646177|9887235|FG000|STARTED|Blinded Induction Dosing (Week 0-12)||193
8832778|NCT01646177|9887236|FG001|STARTED|Blinded Induction Dosing (Week 0-12)||382
8832779|NCT01646177|9887237|FG002|STARTED|Blinded Induction Dosing (Week 0-12)||386
8832780|NCT01646177|9887238|FG003|STARTED|Blinded Induction Dosing (Week 0-12)||385
8832781|NCT01646177|9887239|FG004|STARTED|Blinded Induction Dosing (Week 0-12)||0
8832782|NCT01646177|9887240|FG005|STARTED|Blinded Induction Dosing (Week 0-12)||0
8832783|NCT01646177|9887241|FG006|STARTED|Blinded Induction Dosing (Week 0-12)||0
8832784|NCT01646177|9887242|FG007|STARTED|Blinded Induction Dosing (Week 0-12)||0
8832785|NCT01646177|9887243|FG008|STARTED|Blinded Induction Dosing (Week 0-12)||0
8832786|NCT01646177|9887244|FG009|STARTED|Blinded Induction Dosing (Week 0-12)||0
8832787|NCT01646177|9887245|FG010|STARTED|Blinded Induction Dosing (Week 0-12)||0
8832788|NCT01646177|9887246|FG011|STARTED|Blinded Induction Dosing (Week 0-12)||0
8832789|NCT01646177|9887235|FG000|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||193
8832790|NCT01646177|9887236|FG001|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||382
8832791|NCT01646177|9887237|FG002|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||382
8832792|NCT01646177|9887238|FG003|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||384
8832793|NCT01646177|9887239|FG004|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
8832794|NCT01646177|9887240|FG005|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
8832795|NCT01646177|9887241|FG006|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
8832796|NCT01646177|9887242|FG007|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
8832797|NCT01646177|9887243|FG008|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
8622670|NCT00489424|9661884|FG000|STARTED|Overall Study||267
8622671|NCT00489424|9661885|FG001|STARTED|Overall Study||264
8622672|NCT00489424|9661886|FG002|STARTED|Overall Study||262
8622673|NCT00489424|9661884|FG000|COMPLETED|Overall Study||263
8622674|NCT00489424|9661885|FG001|COMPLETED|Overall Study||259
8622675|NCT00489424|9661886|FG002|COMPLETED|Overall Study||257
8622676|NCT00489424|9661884|FG000|NOT COMPLETED|Overall Study||4
8622677|NCT00489424|9661885|FG001|NOT COMPLETED|Overall Study||5
8622678|NCT00489424|9661886|FG002|NOT COMPLETED|Overall Study||5
8832798|NCT01646177|9887244|FG009|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
8832799|NCT01646177|9887245|FG010|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
8832800|NCT01646177|9887246|FG011|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
8832801|NCT01646177|9887235|FG000|COMPLETED|Blinded Induction Dosing (Week 0-12)||183
8832802|NCT01646177|9887236|FG001|COMPLETED|Blinded Induction Dosing (Week 0-12)||369
8622679|NCT00489476|9661898|FG000|STARTED|Overall Study||39
8622680|NCT00489476|9661899|FG001|STARTED|Overall Study||43
8832803|NCT01646177|9887237|FG002|COMPLETED|Blinded Induction Dosing (Week 0-12)||360
8832804|NCT01646177|9887238|FG003|COMPLETED|Blinded Induction Dosing (Week 0-12)||363
8832805|NCT01646177|9887239|FG004|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
8832806|NCT01646177|9887240|FG005|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
8832807|NCT01646177|9887241|FG006|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
8832808|NCT01646177|9887242|FG007|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
8832809|NCT01646177|9887243|FG008|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
8832810|NCT01646177|9887244|FG009|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
8832811|NCT01646177|9887245|FG010|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
8832812|NCT01646177|9887246|FG011|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
8832813|NCT01646177|9887235|FG000|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||10
8832814|NCT01646177|9887236|FG001|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||13
8832815|NCT01646177|9887237|FG002|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||26
8832816|NCT01646177|9887238|FG003|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||22
8832817|NCT01646177|9887239|FG004|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
8832818|NCT01646177|9887240|FG005|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
8832819|NCT01646177|9887241|FG006|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
8832820|NCT01646177|9887242|FG007|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
8832821|NCT01646177|9887243|FG008|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
8832822|NCT01646177|9887244|FG009|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
8832823|NCT01646177|9887245|FG010|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
8832824|NCT01646177|9887246|FG011|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
8832825|NCT01646177|9887235|FG000|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|0
8832826|NCT01646177|9887236|FG001|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|0
8832827|NCT01646177|9887237|FG002|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|0
8832828|NCT01646177|9887238|FG003|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|0
8832829|NCT01646177|9887239|FG004|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|183
8832830|NCT01646177|9887240|FG005|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|369
8832831|NCT01646177|9887241|FG006|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|360
8622681|NCT00489476|9661900|FG002|STARTED|Overall Study||43
8622682|NCT00489476|9661901|FG003|STARTED|Overall Study||43
8622683|NCT00489476|9661898|FG000|COMPLETED|Overall Study||39
8832832|NCT01646177|9887242|FG007|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|362
8832833|NCT01646177|9887243|FG008|STARTED|Long-Term Extension Period (Week 12-264)||0
8832834|NCT01646177|9887244|FG009|STARTED|Long-Term Extension Period (Week 12-264)||0
8832835|NCT01646177|9887245|FG010|STARTED|Long-Term Extension Period (Week 12-264)||0
8832836|NCT01646177|9887246|FG011|STARTED|Long-Term Extension Period (Week 12-264)||0
8832837|NCT01646177|9887235|FG000|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
8832838|NCT01646177|9887236|FG001|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
8832839|NCT01646177|9887237|FG002|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
8832840|NCT01646177|9887238|FG003|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
8832841|NCT01646177|9887239|FG004|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||183
8832842|NCT01646177|9887240|FG005|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||369
8832843|NCT01646177|9887241|FG006|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||360
8832844|NCT01646177|9887242|FG007|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||362
8832845|NCT01646177|9887243|FG008|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
8832846|NCT01646177|9887244|FG009|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
8832847|NCT01646177|9887245|FG010|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
8832848|NCT01646177|9887246|FG011|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
8832849|NCT01646177|9887235|FG000|COMPLETED|Long-Term Extension Period (Week 12-264)||0
8832850|NCT01646177|9887236|FG001|COMPLETED|Long-Term Extension Period (Week 12-264)||0
8832851|NCT01646177|9887237|FG002|COMPLETED|Long-Term Extension Period (Week 12-264)||0
8832852|NCT01646177|9887238|FG003|COMPLETED|Long-Term Extension Period (Week 12-264)||0
8832853|NCT01646177|9887239|FG004|COMPLETED|Long-Term Extension Period (Week 12-264)||135
8832854|NCT01646177|9887240|FG005|COMPLETED|Long-Term Extension Period (Week 12-264)||256
8832855|NCT01646177|9887241|FG006|COMPLETED|Long-Term Extension Period (Week 12-264)||244
8832856|NCT01646177|9887242|FG007|COMPLETED|Long-Term Extension Period (Week 12-264)||255
8832857|NCT01646177|9887243|FG008|COMPLETED|Long-Term Extension Period (Week 12-264)||0
8832858|NCT01646177|9887244|FG009|COMPLETED|Long-Term Extension Period (Week 12-264)||0
8832859|NCT01646177|9887245|FG010|COMPLETED|Long-Term Extension Period (Week 12-264)||0
8832860|NCT01646177|9887246|FG011|COMPLETED|Long-Term Extension Period (Week 12-264)||0
8832861|NCT01646177|9887235|FG000|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
8832862|NCT01646177|9887236|FG001|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
8832863|NCT01646177|9887237|FG002|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
8832864|NCT01646177|9887238|FG003|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
8832865|NCT01646177|9887239|FG004|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||48
8832866|NCT01646177|9887240|FG005|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||113
8832867|NCT01646177|9887241|FG006|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||116
8832868|NCT01646177|9887242|FG007|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||107
8832869|NCT01646177|9887243|FG008|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
8832870|NCT01646177|9887244|FG009|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
8832871|NCT01646177|9887245|FG010|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
8832872|NCT01646177|9887246|FG011|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
8832873|NCT01646177|9887235|FG000|STARTED|Follow-Up Period (Minimum of 12 Weeks)||0
8832874|NCT01646177|9887236|FG001|STARTED|Follow-Up Period (Minimum of 12 Weeks)||0
8832875|NCT01646177|9887237|FG002|STARTED|Follow-Up Period (Minimum of 12 Weeks)||0
8832876|NCT01646177|9887238|FG003|STARTED|Follow-Up Period (Minimum of 12 Weeks)||0
8832877|NCT01646177|9887239|FG004|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0
8832878|NCT01646177|9887240|FG005|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0
8832879|NCT01646177|9887241|FG006|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0
8832880|NCT01646177|9887242|FG007|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0
8832881|NCT01646177|9887243|FG008|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|157
8832882|NCT01646177|9887244|FG009|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|309
8832883|NCT01646177|9887245|FG010|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|305
8832884|NCT01646177|9887246|FG011|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|313
8832885|NCT01646177|9887235|FG000|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
8832886|NCT01646177|9887236|FG001|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
8832887|NCT01646177|9887237|FG002|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
8832888|NCT01646177|9887238|FG003|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
8832889|NCT01646177|9887239|FG004|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
8832890|NCT01646177|9887240|FG005|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
8832891|NCT01646177|9887241|FG006|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
8832892|NCT01646177|9887242|FG007|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
8832893|NCT01646177|9887243|FG008|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||157
8832894|NCT01646177|9887244|FG009|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||309
8832895|NCT01646177|9887245|FG010|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||305
8832896|NCT01646177|9887246|FG011|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||313
8832897|NCT01646177|9887235|FG000|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
8832898|NCT01646177|9887236|FG001|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
8832899|NCT01646177|9887237|FG002|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
8832900|NCT01646177|9887238|FG003|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
8832901|NCT01646177|9887239|FG004|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
8832902|NCT01646177|9887240|FG005|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
8832903|NCT01646177|9887241|FG006|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
8832904|NCT01646177|9887242|FG007|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
8832905|NCT01646177|9887243|FG008|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||126
8832906|NCT01646177|9887244|FG009|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||233
8832907|NCT01646177|9887245|FG010|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||225
8832908|NCT01646177|9887246|FG011|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||230
8832909|NCT01646177|9887235|FG000|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
8832910|NCT01646177|9887236|FG001|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
8832911|NCT01646177|9887237|FG002|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
8832912|NCT01646177|9887238|FG003|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
8832913|NCT01646177|9887239|FG004|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
8832914|NCT01646177|9887240|FG005|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
8832915|NCT01646177|9887241|FG006|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
8832916|NCT01646177|9887242|FG007|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
8832917|NCT01646177|9887243|FG008|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||31
8832918|NCT01646177|9887244|FG009|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||76
8832919|NCT01646177|9887245|FG010|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||80
8832920|NCT01646177|9887246|FG011|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||83
8832921|NCT01646203|9887269|FG000|STARTED|Overall Study||2
8832922|NCT01646203|9887270|FG001|STARTED|Overall Study||5
8832923|NCT01646203|9887271|FG002|STARTED|Overall Study||7
8832924|NCT01646203|9887269|FG000|Received at Least One Dose of Study Drug|Overall Study||2
8832925|NCT01646203|9887270|FG001|Received at Least One Dose of Study Drug|Overall Study||5
8832926|NCT01646203|9887271|FG002|Received at Least One Dose of Study Drug|Overall Study||7
8832927|NCT01646203|9887269|FG000|COMPLETED|Overall Study||0
8832928|NCT01646203|9887270|FG001|COMPLETED|Overall Study||3
8832929|NCT01646203|9887271|FG002|COMPLETED|Overall Study||6
8832930|NCT01646203|9887269|FG000|NOT COMPLETED|Overall Study||2
8832931|NCT01646203|9887270|FG001|NOT COMPLETED|Overall Study||2
8832932|NCT01646203|9887271|FG002|NOT COMPLETED|Overall Study||1
8832933|NCT01646216|9887286|FG000|STARTED|Overall Study||17
8832934|NCT01646216|9887287|FG001|STARTED|Overall Study||17
8832935|NCT01646216|9887286|FG000|COMPLETED|Overall Study||6
8832936|NCT01646216|9887287|FG001|COMPLETED|Overall Study||4
8832937|NCT01646216|9887286|FG000|NOT COMPLETED|Overall Study||11
8832938|NCT01646216|9887287|FG001|NOT COMPLETED|Overall Study||13
8832939|NCT01646255|9887299|FG000|STARTED|Overall Study||172
8832940|NCT01646255|9887300|FG001|STARTED|Overall Study||174
8832941|NCT01646255|9887299|FG000|COMPLETED|Overall Study||151
8832942|NCT01646255|9887300|FG001|COMPLETED|Overall Study||160
8832943|NCT01646255|9887299|FG000|NOT COMPLETED|Overall Study||21
8832944|NCT01646255|9887300|FG001|NOT COMPLETED|Overall Study||14
8832945|NCT01646268|9887309|FG000|STARTED|Overall Study||124
8832946|NCT01646268|9887310|FG001|STARTED|Overall Study||123
8832947|NCT01646268|9887309|FG000|COMPLETED|Overall Study||113
8832948|NCT01646268|9887310|FG001|COMPLETED|Overall Study||107
8944335|NCT02395627|10006164|FG002|NOT COMPLETED|Overall Study||0
8832949|NCT01646268|9887309|FG000|NOT COMPLETED|Overall Study||11
8832950|NCT01646268|9887310|FG001|NOT COMPLETED|Overall Study||16
8832951|NCT01646320|9887318|FG000|STARTED|Short-term Period (Day 1 to Week 24)||160
8832952|NCT01646320|9887319|FG001|STARTED|Short-term Period (Day 1 to Week 24)||160
8832953|NCT01646320|9887318|FG000|COMPLETED|Short-term Period (Day 1 to Week 24)||148
8832954|NCT01646320|9887319|FG001|COMPLETED|Short-term Period (Day 1 to Week 24)||153
8832955|NCT01646320|9887318|FG000|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||12
8832956|NCT01646320|9887319|FG001|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||7
8832957|NCT01646320|9887318|FG000|STARTED|Long-term Period (Weeks 24 to 52)||147
8832958|NCT01646320|9887319|FG001|STARTED|Long-term Period (Weeks 24 to 52)||147
8832959|NCT01646320|9887318|FG000|COMPLETED|Long-term Period (Weeks 24 to 52)||141
8832960|NCT01646320|9887319|FG001|COMPLETED|Long-term Period (Weeks 24 to 52)||140
8832961|NCT01646320|9887318|FG000|NOT COMPLETED|Long-term Period (Weeks 24 to 52)||6
8832962|NCT01646320|9887319|FG001|NOT COMPLETED|Long-term Period (Weeks 24 to 52)||7
8832963|NCT01646346|9887325|FG000|STARTED|Overall Study||46
8832964|NCT01646346|9887325|FG000|COMPLETED|Overall Study||46
8832965|NCT01646346|9887325|FG000|NOT COMPLETED|Overall Study||0
8832966|NCT01646385|9887331|FG000|STARTED|Overall Study||3529
8944336|NCT02395653|10006174|FG000|STARTED|Overall Study||71
8832967|NCT01646385|9887332|FG001|STARTED|Overall Study||2864
8832968|NCT01646385|9887331|FG000|COMPLETED|Overall Study|Completed refers to participants who continued up to last follow-up.|2691
8832969|NCT01646385|9887332|FG001|COMPLETED|Overall Study|Completed refers to participants who continued up to last follow-up.|1993
8832970|NCT01646385|9887331|FG000|NOT COMPLETED|Overall Study||838
8832971|NCT01646385|9887332|FG001|NOT COMPLETED|Overall Study||871
8832972|NCT01646398|9887340|FG000|STARTED|Overall Study||382
8832973|NCT01646398|9887341|FG001|STARTED|Overall Study||382
8832974|NCT01646398|9887340|FG000|COMPLETED|Overall Study||381
8832975|NCT01646398|9887341|FG001|COMPLETED|Overall Study||382
8832976|NCT01646398|9887340|FG000|NOT COMPLETED|Overall Study||1
8832977|NCT01646398|9887341|FG001|NOT COMPLETED|Overall Study||0
8832978|NCT01646645|9887347|FG000|STARTED|Overall Study||58
8832979|NCT01646645|9887347|FG000|COMPLETED|Overall Study||28
8832980|NCT01646645|9887347|FG000|NOT COMPLETED|Overall Study||30
8832981|NCT01646671|9887354|FG000|STARTED|Overall Study||3
8832982|NCT01646671|9887355|FG001|STARTED|Overall Study||11
8832983|NCT01646671|9887356|FG002|STARTED|Overall Study||21
8832984|NCT01646671|9887354|FG000|COMPLETED|Overall Study||3
8832985|NCT01646671|9887355|FG001|COMPLETED|Overall Study||11
8832986|NCT01646671|9887356|FG002|COMPLETED|Overall Study||21
8832987|NCT01646671|9887354|FG000|NOT COMPLETED|Overall Study||0
8832988|NCT01646671|9887355|FG001|NOT COMPLETED|Overall Study||0
8832989|NCT01646671|9887356|FG002|NOT COMPLETED|Overall Study||0
8832990|NCT01646762|9887366|FG000|STARTED|Overall Study||13
8622684|NCT00489476|9661899|FG001|COMPLETED|Overall Study||42
8622685|NCT00489476|9661900|FG002|COMPLETED|Overall Study||43
8622686|NCT00489476|9661901|FG003|COMPLETED|Overall Study||43
8622687|NCT00489476|9661898|FG000|NOT COMPLETED|Overall Study||0
8832991|NCT01646762|9887366|FG000|COMPLETED|Overall Study||13
8832992|NCT01646762|9887366|FG000|NOT COMPLETED|Overall Study||0
8832993|NCT01646827|9887372|FG000|STARTED|Overall Study||18
8832994|NCT01646827|9887373|FG001|STARTED|Overall Study||19
8832995|NCT01646827|9887372|FG000|COMPLETED|Overall Study||16
8832996|NCT01646827|9887373|FG001|COMPLETED|Overall Study||14
8832997|NCT01646827|9887372|FG000|NOT COMPLETED|Overall Study||2
8832998|NCT01646827|9887373|FG001|NOT COMPLETED|Overall Study||5
8832999|NCT01647217|9887381|FG000|STARTED|Overall Study||8
8833000|NCT01647217|9887382|FG001|STARTED|Overall Study||9
8833001|NCT01647217|9887381|FG000|COMPLETED|Overall Study||7
8833002|NCT01647217|9887382|FG001|COMPLETED|Overall Study||8
8833003|NCT01647217|9887381|FG000|NOT COMPLETED|Overall Study||1
8833004|NCT01647217|9887382|FG001|NOT COMPLETED|Overall Study||1
8833005|NCT01647282|9887392|FG000|STARTED|Overall Study||30
8622688|NCT00489476|9661899|FG001|NOT COMPLETED|Overall Study||1
8833006|NCT01647282|9887393|FG001|STARTED|Overall Study||30
8833007|NCT01647282|9887392|FG000|COMPLETED|Overall Study||23
8833008|NCT01647282|9887393|FG001|COMPLETED|Overall Study||25
8833009|NCT01647282|9887392|FG000|NOT COMPLETED|Overall Study||7
8833010|NCT01647282|9887393|FG001|NOT COMPLETED|Overall Study||5
8833011|NCT01647438|9887401|FG000|STARTED|Overall Study||32
8833012|NCT01647438|9887402|FG001|STARTED|Overall Study||31
8833013|NCT01647438|9887401|FG000|COMPLETED|Overall Study||32
8833014|NCT01647438|9887402|FG001|COMPLETED|Overall Study||31
8833015|NCT01647438|9887401|FG000|NOT COMPLETED|Overall Study||0
8833016|NCT01647438|9887402|FG001|NOT COMPLETED|Overall Study||0
8833017|NCT01647464|9887408|FG000|STARTED|Overall Study||10
8833018|NCT01647464|9887408|FG000|COMPLETED|Overall Study||10
8833019|NCT01647464|9887408|FG000|NOT COMPLETED|Overall Study||0
8833020|NCT01647516|9887415|FG000|STARTED|Induction Period (IP)||66
8833021|NCT01647516|9887416|FG001|STARTED|Induction Period (IP)||66
8833022|NCT01647516|9887417|FG002|STARTED|Induction Period (IP)||67
8833023|NCT01647516|9887418|FG003|STARTED|Induction Period (IP)||0
8833024|NCT01647516|9887419|FG004|STARTED|Induction Period (IP)||0
8833025|NCT01647516|9887420|FG005|STARTED|Induction Period (IP)||0
8833026|NCT01647516|9887415|FG000|Received Study Drug|Induction Period (IP)||65
8833027|NCT01647516|9887416|FG001|Received Study Drug|Induction Period (IP)||65
8833028|NCT01647516|9887417|FG002|Received Study Drug|Induction Period (IP)||67
8833029|NCT01647516|9887418|FG003|Received Study Drug|Induction Period (IP)||0
8833030|NCT01647516|9887419|FG004|Received Study Drug|Induction Period (IP)||0
8833031|NCT01647516|9887420|FG005|Received Study Drug|Induction Period (IP)||0
8833032|NCT01647516|9887415|FG000|COMPLETED|Induction Period (IP)||60
8833033|NCT01647516|9887416|FG001|COMPLETED|Induction Period (IP)||63
8833034|NCT01647516|9887417|FG002|COMPLETED|Induction Period (IP)||63
8833035|NCT01647516|9887418|FG003|COMPLETED|Induction Period (IP)||0
8833036|NCT01647516|9887419|FG004|COMPLETED|Induction Period (IP)||0
8833037|NCT01647516|9887420|FG005|COMPLETED|Induction Period (IP)||0
8833038|NCT01647516|9887415|FG000|NOT COMPLETED|Induction Period (IP)||6
8833039|NCT01647516|9887416|FG001|NOT COMPLETED|Induction Period (IP)||3
8833040|NCT01647516|9887417|FG002|NOT COMPLETED|Induction Period (IP)||4
8833041|NCT01647516|9887418|FG003|NOT COMPLETED|Induction Period (IP)||0
8833042|NCT01647516|9887419|FG004|NOT COMPLETED|Induction Period (IP)||0
8833043|NCT01647516|9887420|FG005|NOT COMPLETED|Induction Period (IP)||0
8833044|NCT01647516|9887415|FG000|STARTED|Maintenance Period (MP)|The MP includes participants who were responders at week 8.|25
8622689|NCT00489476|9661900|FG002|NOT COMPLETED|Overall Study||0
8622690|NCT00489476|9661901|FG003|NOT COMPLETED|Overall Study||0
8833045|NCT01647516|9887416|FG001|STARTED|Maintenance Period (MP)|The MP includes participants who were responders at week 8.|36
8833046|NCT01647516|9887417|FG002|STARTED|Maintenance Period (MP)|The MP includes participants who were responders at week 8.|42
8833047|NCT01647516|9887418|FG003|STARTED|Maintenance Period (MP)||0
8833048|NCT01647516|9887419|FG004|STARTED|Maintenance Period (MP)||0
8833049|NCT01647516|9887420|FG005|STARTED|Maintenance Period (MP)||0
8833050|NCT01647516|9887415|FG000|COMPLETED|Maintenance Period (MP)||21
8833051|NCT01647516|9887416|FG001|COMPLETED|Maintenance Period (MP)||30
8833052|NCT01647516|9887417|FG002|COMPLETED|Maintenance Period (MP)||40
8833053|NCT01647516|9887418|FG003|COMPLETED|Maintenance Period (MP)||0
8833054|NCT01647516|9887419|FG004|COMPLETED|Maintenance Period (MP)||0
8833055|NCT01647516|9887420|FG005|COMPLETED|Maintenance Period (MP)||0
8833056|NCT01647516|9887415|FG000|NOT COMPLETED|Maintenance Period (MP)||4
8833057|NCT01647516|9887416|FG001|NOT COMPLETED|Maintenance Period (MP)||6
8833058|NCT01647516|9887417|FG002|NOT COMPLETED|Maintenance Period (MP)||2
8833059|NCT01647516|9887418|FG003|NOT COMPLETED|Maintenance Period (MP)||0
8833060|NCT01647516|9887419|FG004|NOT COMPLETED|Maintenance Period (MP)||0
8833061|NCT01647516|9887420|FG005|NOT COMPLETED|Maintenance Period (MP)||0
8833062|NCT01647516|9887415|FG000|STARTED|Open-Label Period||0
8833063|NCT01647516|9887416|FG001|STARTED|Open-Label Period||0
8833064|NCT01647516|9887417|FG002|STARTED|Open-Label Period||0
8833065|NCT01647516|9887418|FG003|STARTED|Open-Label Period|"The participants were:~non-responders at Week 8,completed the MP or had disease relapse during MP"|55
8833066|NCT01647516|9887419|FG004|STARTED|Open-Label Period|"The participants were:~non-responders at Week 8,completed the MP or had disease relapse during MP"|56
8833067|NCT01647516|9887420|FG005|STARTED|Open-Label Period|"The participants were:~non-responders at Week 8,completed the MP or had disease relapse during MP"|59
8833068|NCT01647516|9887415|FG000|COMPLETED|Open-Label Period||0
8833069|NCT01647516|9887416|FG001|COMPLETED|Open-Label Period||0
8622691|NCT00489489|9661914|FG000|STARTED|Overall Study|randomized|41
8622692|NCT00489489|9661915|FG001|STARTED|Overall Study|randomized|37
8622693|NCT00489489|9661916|FG002|STARTED|Overall Study|randomized|40
8622694|NCT00489489|9661914|FG000|Treated|Overall Study||41
8622695|NCT00489489|9661915|FG001|Treated|Overall Study||36
8622696|NCT00489489|9661916|FG002|Treated|Overall Study|One participant received teriflunomide 7 mg instead of teriflunomide 14 mg|39
8622697|NCT00489489|9661914|FG000|COMPLETED|Overall Study|completed treatment period|38
8622698|NCT00489489|9661915|FG001|COMPLETED|Overall Study|completed treatment period|32
8622699|NCT00489489|9661916|FG002|COMPLETED|Overall Study|completed treatment period|37
8622700|NCT00489489|9661914|FG000|NOT COMPLETED|Overall Study||3
8622701|NCT00489489|9661915|FG001|NOT COMPLETED|Overall Study||5
8622702|NCT00489489|9661916|FG002|NOT COMPLETED|Overall Study||3
8622703|NCT00489541|9661928|FG000|STARTED|12-Month Clinical Follow-up||224
8622704|NCT00489541|9661929|FG001|STARTED|12-Month Clinical Follow-up||125
8622705|NCT00489541|9661928|FG000|COMPLETED|12-Month Clinical Follow-up||215
8622706|NCT00489541|9661929|FG001|COMPLETED|12-Month Clinical Follow-up||120
8622707|NCT00489541|9661928|FG000|NOT COMPLETED|12-Month Clinical Follow-up||9
8833070|NCT01647516|9887417|FG002|COMPLETED|Open-Label Period||0
8833071|NCT01647516|9887418|FG003|COMPLETED|Open-Label Period||6
8833072|NCT01647516|9887419|FG004|COMPLETED|Open-Label Period||5
8833073|NCT01647516|9887420|FG005|COMPLETED|Open-Label Period||3
8833074|NCT01647516|9887415|FG000|NOT COMPLETED|Open-Label Period||0
8833075|NCT01647516|9887416|FG001|NOT COMPLETED|Open-Label Period||0
8833076|NCT01647516|9887417|FG002|NOT COMPLETED|Open-Label Period||0
8833077|NCT01647516|9887418|FG003|NOT COMPLETED|Open-Label Period||49
8833078|NCT01647516|9887419|FG004|NOT COMPLETED|Open-Label Period||51
8833079|NCT01647516|9887420|FG005|NOT COMPLETED|Open-Label Period||56
8833080|NCT01647542|9887438|FG000|STARTED|Overall Study||131
8833081|NCT01647542|9887439|FG001|STARTED|Overall Study||131
8833082|NCT01647542|9887440|FG002|STARTED|Overall Study||131
8833083|NCT01647542|9887438|FG000|COMPLETED|Overall Study||55
8833084|NCT01647542|9887439|FG001|COMPLETED|Overall Study||58
8833085|NCT01647542|9887440|FG002|COMPLETED|Overall Study||59
8833086|NCT01647542|9887438|FG000|NOT COMPLETED|Overall Study||76
8833087|NCT01647542|9887439|FG001|NOT COMPLETED|Overall Study||73
8833088|NCT01647542|9887440|FG002|NOT COMPLETED|Overall Study||72
8833089|NCT01647581|9887450|FG000|STARTED|Overall Study||547
8833090|NCT01647581|9887451|FG001|STARTED|Overall Study||551
8833091|NCT01647581|9887450|FG000|COMPLETED|Overall Study||530
8833092|NCT01647581|9887451|FG001|COMPLETED|Overall Study||520
8833093|NCT01647581|9887450|FG000|NOT COMPLETED|Overall Study||17
8833094|NCT01647581|9887451|FG001|NOT COMPLETED|Overall Study||31
8833095|NCT01647711|9887462|FG000|STARTED|Overall Study||6
8833096|NCT01647711|9887463|FG001|STARTED|Overall Study||3
8833097|NCT01647711|9887464|FG002|STARTED|Overall Study||9
8833098|NCT01647711|9887465|FG003|STARTED|Overall Study||11
8833099|NCT01647711|9887466|FG004|STARTED|Overall Study||6
8833100|NCT01647711|9887462|FG000|COMPLETED|Overall Study||0
8833101|NCT01647711|9887463|FG001|COMPLETED|Overall Study||0
8833102|NCT01647711|9887464|FG002|COMPLETED|Overall Study||0
8833103|NCT01647711|9887465|FG003|COMPLETED|Overall Study||0
8833104|NCT01647711|9887466|FG004|COMPLETED|Overall Study||0
8622708|NCT00489541|9661929|FG001|NOT COMPLETED|12-Month Clinical Follow-up||5
8622709|NCT00489541|9661928|FG000|STARTED|9-Month Angiographic Follow-up||224
8622710|NCT00489541|9661929|FG001|STARTED|9-Month Angiographic Follow-up||125
8833105|NCT01647711|9887462|FG000|NOT COMPLETED|Overall Study||6
8833106|NCT01647711|9887463|FG001|NOT COMPLETED|Overall Study||3
8833107|NCT01647711|9887464|FG002|NOT COMPLETED|Overall Study||9
8833108|NCT01647711|9887465|FG003|NOT COMPLETED|Overall Study||11
8833109|NCT01647711|9887466|FG004|NOT COMPLETED|Overall Study||6
8833110|NCT01647737|9887482|FG000|STARTED|Overall Study||30
8622711|NCT00489541|9661928|FG000|COMPLETED|9-Month Angiographic Follow-up||197
8622712|NCT00489541|9661929|FG001|COMPLETED|9-Month Angiographic Follow-up||108
8622713|NCT00489541|9661928|FG000|NOT COMPLETED|9-Month Angiographic Follow-up||27
8622714|NCT00489541|9661929|FG001|NOT COMPLETED|9-Month Angiographic Follow-up||17
8622715|NCT00489554|9661935|FG000|STARTED|Overall Study||230
8622716|NCT00489554|9661935|FG000|COMPLETED|Overall Study||226
8622717|NCT00489554|9661935|FG000|NOT COMPLETED|Overall Study||4
8622718|NCT00489736|9661941|FG000|STARTED|Overall Study|Randomized and treated patients|249
8622719|NCT00489736|9661942|FG001|STARTED|Overall Study|Randomized and treated patients|255
8622720|NCT00489736|9661941|FG000|COMPLETED|Overall Study|completed study drug period|153
8622721|NCT00489736|9661942|FG001|COMPLETED|Overall Study|completed study drug period|186
8622722|NCT00489736|9661941|FG000|NOT COMPLETED|Overall Study||96
8622723|NCT00489736|9661942|FG001|NOT COMPLETED|Overall Study||69
8622724|NCT00489827|9661950|FG000|STARTED|Overall Study||430
8622725|NCT00489827|9661951|FG001|STARTED|Overall Study||435
8622726|NCT00489827|9661950|FG000|COMPLETED|Overall Study||428
8622727|NCT00489827|9661951|FG001|COMPLETED|Overall Study||433
8622728|NCT00489827|9661950|FG000|NOT COMPLETED|Overall Study||2
8622729|NCT00489827|9661951|FG001|NOT COMPLETED|Overall Study||2
8622730|NCT00489853|9661957|FG000|STARTED|Treatment Period 1||36
8622731|NCT00489853|9661958|FG001|STARTED|Treatment Period 1||37
8622732|NCT00489853|9661959|FG002|STARTED|Treatment Period 1||38
8833111|NCT01647737|9887483|FG001|STARTED|Overall Study||30
8833112|NCT01647737|9887482|FG000|COMPLETED|Overall Study||26
8833113|NCT01647737|9887483|FG001|COMPLETED|Overall Study||25
8833114|NCT01647737|9887482|FG000|NOT COMPLETED|Overall Study||4
8833115|NCT01647737|9887483|FG001|NOT COMPLETED|Overall Study||5
8833116|NCT01647945|9887493|FG000|STARTED|Overall Study||6
8833117|NCT01647945|9887494|FG001|STARTED|Overall Study||6
8833118|NCT01647945|9887495|FG002|STARTED|Overall Study||5
8833119|NCT01647945|9887496|FG003|STARTED|Overall Study||6
8833120|NCT01647945|9887493|FG000|COMPLETED|Overall Study||6
8833121|NCT01647945|9887494|FG001|COMPLETED|Overall Study||6
8833122|NCT01647945|9887495|FG002|COMPLETED|Overall Study||3
8833123|NCT01647945|9887496|FG003|COMPLETED|Overall Study||5
8833124|NCT01647945|9887493|FG000|NOT COMPLETED|Overall Study||0
8833125|NCT01647945|9887494|FG001|NOT COMPLETED|Overall Study||0
8833126|NCT01647945|9887495|FG002|NOT COMPLETED|Overall Study||2
8833127|NCT01647945|9887496|FG003|NOT COMPLETED|Overall Study||1
8833128|NCT01647958|9887508|FG000|STARTED|Initial Study||41
8833129|NCT01647958|9887509|FG001|STARTED|Initial Study||24
8833130|NCT01647958|9887508|FG000|COMPLETED|Initial Study||39
8833131|NCT01647958|9887509|FG001|COMPLETED|Initial Study||21
8833132|NCT01647958|9887508|FG000|NOT COMPLETED|Initial Study||2
8833133|NCT01647958|9887509|FG001|NOT COMPLETED|Initial Study||3
8833134|NCT01647958|9887508|FG000|STARTED|Continuation Phase||39
8833135|NCT01647958|9887509|FG001|STARTED|Continuation Phase||21
8833136|NCT01647958|9887508|FG000|COMPLETED|Continuation Phase|Treatment-arm patients received TIF procedure during Initial Study phase|0
8833137|NCT01647958|9887509|FG001|COMPLETED|Continuation Phase|21 Control patients received TIF crossover procedure following 6-month follow-up visit.|21
8833138|NCT01647958|9887508|FG000|NOT COMPLETED|Continuation Phase||39
8833139|NCT01647958|9887509|FG001|NOT COMPLETED|Continuation Phase||0
8833140|NCT01647958|9887508|FG000|STARTED|Extended Follow-up Phase|Treatment and Control/Crossover patients were combined into 1 cohort for this follow up. 39+21=60|60
8833141|NCT01647958|9887509|FG001|STARTED|Extended Follow-up Phase|Treatment and Control/Crossover patients combined into 1 cohort for this period=60, 0 under Control|0
8833142|NCT01647958|9887508|FG000|COMPLETED|Extended Follow-up Phase|The 8 lost to follow up patients are of the combined Treatment and Control cohort of 52 patients|52
8833143|NCT01647958|9887509|FG001|COMPLETED|Extended Follow-up Phase||0
8833144|NCT01647958|9887508|FG000|NOT COMPLETED|Extended Follow-up Phase||8
8833145|NCT01647958|9887509|FG001|NOT COMPLETED|Extended Follow-up Phase||0
8833146|NCT01648101|9887527|FG000|STARTED|Titration Phase (4 Weeks)||25
8833147|NCT01648101|9887528|FG001|STARTED|Titration Phase (4 Weeks)||26
8833148|NCT01648101|9887529|FG002|STARTED|Titration Phase (4 Weeks)||24
8833149|NCT01648101|9887527|FG000|COMPLETED|Titration Phase (4 Weeks)||23
8833150|NCT01648101|9887528|FG001|COMPLETED|Titration Phase (4 Weeks)||23
8833151|NCT01648101|9887529|FG002|COMPLETED|Titration Phase (4 Weeks)||18
8833152|NCT01648101|9887527|FG000|NOT COMPLETED|Titration Phase (4 Weeks)||2
8833153|NCT01648101|9887528|FG001|NOT COMPLETED|Titration Phase (4 Weeks)||3
8833154|NCT01648101|9887529|FG002|NOT COMPLETED|Titration Phase (4 Weeks)||6
8833155|NCT01648101|9887527|FG000|STARTED|Maintenance Phase (12 Weeks)||23
8833156|NCT01648101|9887528|FG001|STARTED|Maintenance Phase (12 Weeks)||23
8833157|NCT01648101|9887529|FG002|STARTED|Maintenance Phase (12 Weeks)||18
8833158|NCT01648101|9887527|FG000|COMPLETED|Maintenance Phase (12 Weeks)||20
8833159|NCT01648101|9887528|FG001|COMPLETED|Maintenance Phase (12 Weeks)||20
8833160|NCT01648101|9887529|FG002|COMPLETED|Maintenance Phase (12 Weeks)||12
8622733|NCT00489853|9661957|FG000|COMPLETED|Treatment Period 1||36
8622734|NCT00489853|9661958|FG001|COMPLETED|Treatment Period 1||37
8833161|NCT01648101|9887527|FG000|NOT COMPLETED|Maintenance Phase (12 Weeks)||3
8833162|NCT01648101|9887528|FG001|NOT COMPLETED|Maintenance Phase (12 Weeks)||3
8833163|NCT01648101|9887529|FG002|NOT COMPLETED|Maintenance Phase (12 Weeks)||6
8833164|NCT01648101|9887527|FG000|STARTED|Transition Phase (4 Weeks)|After completing the MP, only those par. that chose to enter the OLE study started the TnP|17
8833165|NCT01648101|9887528|FG001|STARTED|Transition Phase (4 Weeks)|After completing the MP, only those par. that chose to enter the OLE study started the TnP|18
8833166|NCT01648101|9887529|FG002|STARTED|Transition Phase (4 Weeks)|After completing the MP, only those par. that chose to enter the OLE study started the TnP|9
8833167|NCT01648101|9887527|FG000|COMPLETED|Transition Phase (4 Weeks)||12
8833168|NCT01648101|9887528|FG001|COMPLETED|Transition Phase (4 Weeks)||13
8833169|NCT01648101|9887529|FG002|COMPLETED|Transition Phase (4 Weeks)||5
8833170|NCT01648101|9887527|FG000|NOT COMPLETED|Transition Phase (4 Weeks)||5
8833171|NCT01648101|9887528|FG001|NOT COMPLETED|Transition Phase (4 Weeks)||5
8833172|NCT01648101|9887529|FG002|NOT COMPLETED|Transition Phase (4 Weeks)||4
8833173|NCT01648101|9887527|FG000|STARTED|Taper/Follow-up Phase (4 Weeks)|Includes only those par. who completed the Titration + MN phase, but opted not to enroll in the OLE|1
8833174|NCT01648101|9887528|FG001|STARTED|Taper/Follow-up Phase (4 Weeks)|Includes only those par. who completed the Titration + MN phase, but opted not to enroll in the OLE|2
8833175|NCT01648101|9887529|FG002|STARTED|Taper/Follow-up Phase (4 Weeks)|Includes only those par. who completed the Titration + MN phase, but opted not to enroll in the OLE|3
8833176|NCT01648101|9887527|FG000|COMPLETED|Taper/Follow-up Phase (4 Weeks)||1
8833177|NCT01648101|9887528|FG001|COMPLETED|Taper/Follow-up Phase (4 Weeks)||1
8833178|NCT01648101|9887529|FG002|COMPLETED|Taper/Follow-up Phase (4 Weeks)||3
8833179|NCT01648101|9887527|FG000|NOT COMPLETED|Taper/Follow-up Phase (4 Weeks)||0
8833180|NCT01648101|9887528|FG001|NOT COMPLETED|Taper/Follow-up Phase (4 Weeks)||1
8833181|NCT01648101|9887529|FG002|NOT COMPLETED|Taper/Follow-up Phase (4 Weeks)||0
8833182|NCT01648140|9887545|FG000|STARTED|Overall Study||41
8833183|NCT01648140|9887546|FG001|STARTED|Overall Study||40
8833184|NCT01648140|9887547|FG002|STARTED|Overall Study||17
8833185|NCT01648140|9887548|FG003|STARTED|Overall Study||13
8833186|NCT01648140|9887545|FG000|COMPLETED|Overall Study||29
8833187|NCT01648140|9887546|FG001|COMPLETED|Overall Study||28
8833188|NCT01648140|9887547|FG002|COMPLETED|Overall Study||9
8833189|NCT01648140|9887548|FG003|COMPLETED|Overall Study||11
8833190|NCT01648140|9887545|FG000|NOT COMPLETED|Overall Study||12
8833191|NCT01648140|9887546|FG001|NOT COMPLETED|Overall Study||12
8833192|NCT01648140|9887547|FG002|NOT COMPLETED|Overall Study||8
8833193|NCT01648140|9887548|FG003|NOT COMPLETED|Overall Study||2
8833194|NCT01648166|9887569|FG000|STARTED|Overall Study||153
8833195|NCT01648166|9887570|FG001|STARTED|Overall Study||367
8833196|NCT01648166|9887569|FG000|COMPLETED|Overall Study||100
8833197|NCT01648166|9887570|FG001|COMPLETED|Overall Study||267
8833198|NCT01648166|9887569|FG000|NOT COMPLETED|Overall Study||53
8833199|NCT01648166|9887570|FG001|NOT COMPLETED|Overall Study||100
8849811|NCT01743469|9905058|FG001|COMPLETED|Follow-up Period - Post-Treatment||5
8849812|NCT01743469|9905059|FG002|COMPLETED|Follow-up Period - Post-Treatment||14
8849813|NCT01743469|9905060|FG003|COMPLETED|Follow-up Period - Post-Treatment||5
8849814|NCT01743469|9905057|FG000|NOT COMPLETED|Follow-up Period - Post-Treatment||45
8849815|NCT01743469|9905058|FG001|NOT COMPLETED|Follow-up Period - Post-Treatment||48
8849816|NCT01743469|9905059|FG002|NOT COMPLETED|Follow-up Period - Post-Treatment||23
8849817|NCT01743469|9905060|FG003|NOT COMPLETED|Follow-up Period - Post-Treatment||16
8849818|NCT01743521|9905074|FG000|STARTED|Overall Study||7
8849819|NCT01743521|9905075|FG001|STARTED|Overall Study||3
8849820|NCT01743521|9905076|FG002|STARTED|Overall Study||2
8849821|NCT01743521|9905077|FG003|STARTED|Overall Study||2
8849822|NCT01743521|9905074|FG000|COMPLETED|Overall Study||7
8849823|NCT01743521|9905075|FG001|COMPLETED|Overall Study||3
8849824|NCT01743521|9905076|FG002|COMPLETED|Overall Study||2
8849825|NCT01743521|9905077|FG003|COMPLETED|Overall Study||2
8849826|NCT01743521|9905074|FG000|NOT COMPLETED|Overall Study||0
8849827|NCT01743521|9905075|FG001|NOT COMPLETED|Overall Study||0
8849828|NCT01743521|9905076|FG002|NOT COMPLETED|Overall Study||0
8849829|NCT01743521|9905077|FG003|NOT COMPLETED|Overall Study||0
8849830|NCT01743560|9905085|FG000|STARTED|Overall Study||52
8849831|NCT01743560|9905085|FG000|Full Analysis Set (FAS)|Overall Study|≥ 1 dose study drug|49
8849832|NCT01743560|9905085|FG000|Safety Analysis Set (SAF)|Overall Study|≥ 1 dose study drug +1 post baseline safety assessment|49
8849833|NCT01743560|9905085|FG000|COMPLETED|Overall Study||9
8849834|NCT01743560|9905085|FG000|NOT COMPLETED|Overall Study||43
8849835|NCT01743677|9905098|FG000|STARTED|First Intervention Period||10
8849836|NCT01743677|9905099|FG001|STARTED|First Intervention Period||10
8849837|NCT01743677|9905100|FG002|STARTED|First Intervention Period||10
8849838|NCT01743677|9905101|FG003|STARTED|First Intervention Period||10
8849839|NCT01743677|9905102|FG004|STARTED|First Intervention Period||10
8849840|NCT01743677|9905103|FG005|STARTED|First Intervention Period||10
8849841|NCT01743677|9905098|FG000|COMPLETED|First Intervention Period||10
8849842|NCT01743677|9905099|FG001|COMPLETED|First Intervention Period||10
8849843|NCT01743677|9905100|FG002|COMPLETED|First Intervention Period||10
8849844|NCT01743677|9905101|FG003|COMPLETED|First Intervention Period||10
8849845|NCT01743677|9905102|FG004|COMPLETED|First Intervention Period||10
8849846|NCT01743677|9905103|FG005|COMPLETED|First Intervention Period||10
8849847|NCT01743677|9905098|FG000|NOT COMPLETED|First Intervention Period||0
8849848|NCT01743677|9905099|FG001|NOT COMPLETED|First Intervention Period||0
8849849|NCT01743677|9905100|FG002|NOT COMPLETED|First Intervention Period||0
8849850|NCT01743677|9905101|FG003|NOT COMPLETED|First Intervention Period||0
8849851|NCT01743677|9905102|FG004|NOT COMPLETED|First Intervention Period||0
8849852|NCT01743677|9905103|FG005|NOT COMPLETED|First Intervention Period||0
8849853|NCT01743677|9905098|FG000|STARTED|Washout Period 1 (at Least 7 Days)||10
8849854|NCT01743677|9905099|FG001|STARTED|Washout Period 1 (at Least 7 Days)||10
8849855|NCT01743677|9905100|FG002|STARTED|Washout Period 1 (at Least 7 Days)||10
8849856|NCT01743677|9905101|FG003|STARTED|Washout Period 1 (at Least 7 Days)||10
8833200|NCT01648283|9887576|FG000|STARTED|Overall Study||78
8833201|NCT01648283|9887576|FG000|COMPLETED|Overall Study||64
8833202|NCT01648283|9887576|FG000|NOT COMPLETED|Overall Study||14
8833203|NCT01648322|9887586|FG000|STARTED|Overall Study||35
8833204|NCT01648322|9887587|FG001|STARTED|Overall Study||67
8833205|NCT01648322|9887588|FG002|STARTED|Overall Study||65
8833206|NCT01648322|9887589|FG003|STARTED|Overall Study||65
8833207|NCT01648322|9887586|FG000|COMPLETED|Overall Study||33
8833208|NCT01648322|9887587|FG001|COMPLETED|Overall Study||62
8833209|NCT01648322|9887588|FG002|COMPLETED|Overall Study||60
8833210|NCT01648322|9887589|FG003|COMPLETED|Overall Study||61
8833211|NCT01648322|9887586|FG000|NOT COMPLETED|Overall Study||2
8833212|NCT01648322|9887587|FG001|NOT COMPLETED|Overall Study||5
8833213|NCT01648322|9887588|FG002|NOT COMPLETED|Overall Study||5
8833214|NCT01648322|9887589|FG003|NOT COMPLETED|Overall Study||4
8833215|NCT01648348|9887618|FG000|STARTED|Overall Study||5
8833216|NCT01648348|9887619|FG001|STARTED|Overall Study||3
8833217|NCT01648348|9887620|FG002|STARTED|Overall Study||4
8833218|NCT01648348|9887621|FG003|STARTED|Overall Study||3
8833219|NCT01648348|9887622|FG004|STARTED|Overall Study||52
8833220|NCT01648348|9887623|FG005|STARTED|Overall Study||49
8833221|NCT01648348|9887618|FG000|COMPLETED|Overall Study||3
8833222|NCT01648348|9887619|FG001|COMPLETED|Overall Study||3
8833223|NCT01648348|9887620|FG002|COMPLETED|Overall Study||3
8833224|NCT01648348|9887621|FG003|COMPLETED|Overall Study||3
8833225|NCT01648348|9887622|FG004|COMPLETED|Overall Study||49
8833226|NCT01648348|9887623|FG005|COMPLETED|Overall Study||43
8833227|NCT01648348|9887618|FG000|NOT COMPLETED|Overall Study||2
8833228|NCT01648348|9887619|FG001|NOT COMPLETED|Overall Study||0
8833229|NCT01648348|9887620|FG002|NOT COMPLETED|Overall Study||1
8833230|NCT01648348|9887621|FG003|NOT COMPLETED|Overall Study||0
8833231|NCT01648348|9887622|FG004|NOT COMPLETED|Overall Study||3
8833232|NCT01648348|9887623|FG005|NOT COMPLETED|Overall Study||6
8833233|NCT01648452|9887636|FG000|STARTED|Overall Study||5
8833234|NCT01648452|9887636|FG000|COMPLETED|Overall Study|One participant was explanted due to an adverse event. Remainder kept implant at study completion.|5
8833235|NCT01648452|9887636|FG000|NOT COMPLETED|Overall Study||0
8833236|NCT01648491|9887642|FG000|STARTED|Overall Study||1
8833237|NCT01648491|9887642|FG000|COMPLETED|Overall Study||1
8833238|NCT01648491|9887642|FG000|NOT COMPLETED|Overall Study||0
8833239|NCT01648530|9887647|FG000|STARTED|Overall Study||16789
8833240|NCT01648530|9887647|FG000|COMPLETED|Overall Study||5915
8833241|NCT01648530|9887647|FG000|NOT COMPLETED|Overall Study||10874
8833242|NCT01648582|9887656|FG000|STARTED|Overall Study||258
8833243|NCT01648582|9887657|FG001|STARTED|Overall Study||257
8833244|NCT01648582|9887658|FG002|STARTED|Overall Study||259
8833245|NCT01648582|9887656|FG000|Received at Least One Dose of Study Drug|Overall Study||258
8833246|NCT01648582|9887657|FG001|Received at Least One Dose of Study Drug|Overall Study||257
8833247|NCT01648582|9887658|FG002|Received at Least One Dose of Study Drug|Overall Study||259
8833248|NCT01648582|9887656|FG000|Modified Intent-to-Treat Population|Overall Study||253
8833249|NCT01648582|9887657|FG001|Modified Intent-to-Treat Population|Overall Study||252
8833250|NCT01648582|9887658|FG002|Modified Intent-to-Treat Population|Overall Study||250
8833251|NCT01648582|9887656|FG000|COMPLETED|Overall Study||226
8833252|NCT01648582|9887657|FG001|COMPLETED|Overall Study||219
8833253|NCT01648582|9887658|FG002|COMPLETED|Overall Study||227
8833254|NCT01648582|9887656|FG000|NOT COMPLETED|Overall Study||32
8833255|NCT01648582|9887657|FG001|NOT COMPLETED|Overall Study||38
8833256|NCT01648582|9887658|FG002|NOT COMPLETED|Overall Study||32
8833257|NCT01648699|9887669|FG000|STARTED|Overall Study||20
8833258|NCT01648699|9887669|FG000|COMPLETED|Overall Study||15
8833259|NCT01648699|9887669|FG000|NOT COMPLETED|Overall Study||5
8833260|NCT01648764|9887696|FG000|STARTED|Overall Study||3
8833261|NCT01648764|9887697|FG001|STARTED|Overall Study||3
8833262|NCT01648764|9887698|FG002|STARTED|Overall Study||3
8833263|NCT01648764|9887699|FG003|STARTED|Overall Study||3
8833264|NCT01648764|9887700|FG004|STARTED|Overall Study||3
8833265|NCT01648764|9887701|FG005|STARTED|Overall Study||5
8833266|NCT01648764|9887702|FG006|STARTED|Overall Study||9
8833267|NCT01648764|9887703|FG007|STARTED|Overall Study||3
8833268|NCT01648764|9887704|FG008|STARTED|Overall Study||3
8833269|NCT01648764|9887705|FG009|STARTED|Overall Study||7
8833270|NCT01648764|9887706|FG010|STARTED|Overall Study||3
8833271|NCT01648764|9887707|FG011|STARTED|Overall Study||9
8833272|NCT01648764|9887708|FG012|STARTED|Overall Study||7
8833273|NCT01648764|9887709|FG013|STARTED|Overall Study||12
8833274|NCT01648764|9887696|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
8833275|NCT01648764|9887697|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
8833276|NCT01648764|9887698|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
8833277|NCT01648764|9887699|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
8833278|NCT01648764|9887700|FG004|Received at Least 1 Dose of Study Drug|Overall Study||3
8833279|NCT01648764|9887701|FG005|Received at Least 1 Dose of Study Drug|Overall Study||5
8833280|NCT01648764|9887702|FG006|Received at Least 1 Dose of Study Drug|Overall Study||9
8833281|NCT01648764|9887703|FG007|Received at Least 1 Dose of Study Drug|Overall Study||3
8833282|NCT01648764|9887704|FG008|Received at Least 1 Dose of Study Drug|Overall Study||3
8833283|NCT01648764|9887705|FG009|Received at Least 1 Dose of Study Drug|Overall Study||7
8833284|NCT01648764|9887706|FG010|Received at Least 1 Dose of Study Drug|Overall Study||3
8833285|NCT01648764|9887707|FG011|Received at Least 1 Dose of Study Drug|Overall Study||9
8833286|NCT01648764|9887708|FG012|Received at Least 1 Dose of Study Drug|Overall Study||7
8833287|NCT01648764|9887709|FG013|Received at Least 1 Dose of Study Drug|Overall Study||12
8833288|NCT01648764|9887696|FG000|COMPLETED|Overall Study||3
8833289|NCT01648764|9887697|FG001|COMPLETED|Overall Study||2
8833290|NCT01648764|9887698|FG002|COMPLETED|Overall Study||3
8833291|NCT01648764|9887699|FG003|COMPLETED|Overall Study||3
8833292|NCT01648764|9887700|FG004|COMPLETED|Overall Study||3
8833293|NCT01648764|9887701|FG005|COMPLETED|Overall Study||3
8833294|NCT01648764|9887702|FG006|COMPLETED|Overall Study||4
8833295|NCT01648764|9887703|FG007|COMPLETED|Overall Study||3
8833296|NCT01648764|9887704|FG008|COMPLETED|Overall Study||3
8833297|NCT01648764|9887705|FG009|COMPLETED|Overall Study||4
8833298|NCT01648764|9887706|FG010|COMPLETED|Overall Study||3
8833299|NCT01648764|9887707|FG011|COMPLETED|Overall Study||4
8833300|NCT01648764|9887708|FG012|COMPLETED|Overall Study||3
8833301|NCT01648764|9887709|FG013|COMPLETED|Overall Study||9
8833302|NCT01648764|9887696|FG000|NOT COMPLETED|Overall Study||0
8833303|NCT01648764|9887697|FG001|NOT COMPLETED|Overall Study||1
8833304|NCT01648764|9887698|FG002|NOT COMPLETED|Overall Study||0
8833305|NCT01648764|9887699|FG003|NOT COMPLETED|Overall Study||0
8833306|NCT01648764|9887700|FG004|NOT COMPLETED|Overall Study||0
8833307|NCT01648764|9887701|FG005|NOT COMPLETED|Overall Study||2
8833308|NCT01648764|9887702|FG006|NOT COMPLETED|Overall Study||5
8833309|NCT01648764|9887703|FG007|NOT COMPLETED|Overall Study||0
8833310|NCT01648764|9887704|FG008|NOT COMPLETED|Overall Study||0
8833311|NCT01648764|9887705|FG009|NOT COMPLETED|Overall Study||3
8833312|NCT01648764|9887706|FG010|NOT COMPLETED|Overall Study||0
8833313|NCT01648764|9887707|FG011|NOT COMPLETED|Overall Study||5
8833314|NCT01648764|9887708|FG012|NOT COMPLETED|Overall Study||4
8833315|NCT01648764|9887709|FG013|NOT COMPLETED|Overall Study||3
8833316|NCT01648790|9887743|FG000|STARTED|Treatment 1||4
8833317|NCT01648790|9887744|FG001|STARTED|Treatment 1||4
8833318|NCT01648790|9887745|FG002|STARTED|Treatment 1||4
8833319|NCT01648790|9887746|FG003|STARTED|Treatment 1||4
8833320|NCT01648790|9887747|FG004|STARTED|Treatment 1||4
8833321|NCT01648790|9887743|FG000|Received at Least 1 Dose of Study Drug|Treatment 1||4
8833322|NCT01648790|9887744|FG001|Received at Least 1 Dose of Study Drug|Treatment 1||4
8833323|NCT01648790|9887745|FG002|Received at Least 1 Dose of Study Drug|Treatment 1||4
8833324|NCT01648790|9887746|FG003|Received at Least 1 Dose of Study Drug|Treatment 1||4
8833325|NCT01648790|9887747|FG004|Received at Least 1 Dose of Study Drug|Treatment 1||4
8833326|NCT01648790|9887743|FG000|COMPLETED|Treatment 1||4
8833327|NCT01648790|9887744|FG001|COMPLETED|Treatment 1||4
8833328|NCT01648790|9887745|FG002|COMPLETED|Treatment 1||4
8833329|NCT01648790|9887746|FG003|COMPLETED|Treatment 1||4
8833330|NCT01648790|9887747|FG004|COMPLETED|Treatment 1||4
8833331|NCT01648790|9887743|FG000|NOT COMPLETED|Treatment 1||0
8833332|NCT01648790|9887744|FG001|NOT COMPLETED|Treatment 1||0
8833333|NCT01648790|9887745|FG002|NOT COMPLETED|Treatment 1||0
8833334|NCT01648790|9887746|FG003|NOT COMPLETED|Treatment 1||0
8833335|NCT01648790|9887747|FG004|NOT COMPLETED|Treatment 1||0
8833336|NCT01648790|9887743|FG000|STARTED|Treatment 2||4
8833337|NCT01648790|9887744|FG001|STARTED|Treatment 2||4
8833338|NCT01648790|9887745|FG002|STARTED|Treatment 2||4
8833339|NCT01648790|9887746|FG003|STARTED|Treatment 2||4
8833340|NCT01648790|9887747|FG004|STARTED|Treatment 2||4
8833341|NCT01648790|9887743|FG000|COMPLETED|Treatment 2||4
8833342|NCT01648790|9887744|FG001|COMPLETED|Treatment 2||4
8833343|NCT01648790|9887745|FG002|COMPLETED|Treatment 2||4
8833344|NCT01648790|9887746|FG003|COMPLETED|Treatment 2||4
8833345|NCT01648790|9887747|FG004|COMPLETED|Treatment 2||4
8833346|NCT01648790|9887743|FG000|NOT COMPLETED|Treatment 2||0
8833347|NCT01648790|9887744|FG001|NOT COMPLETED|Treatment 2||0
8833348|NCT01648790|9887745|FG002|NOT COMPLETED|Treatment 2||0
8833349|NCT01648790|9887746|FG003|NOT COMPLETED|Treatment 2||0
8833350|NCT01648790|9887747|FG004|NOT COMPLETED|Treatment 2||0
8833351|NCT01648790|9887743|FG000|STARTED|Treatment 3||4
8833352|NCT01648790|9887744|FG001|STARTED|Treatment 3||4
8833353|NCT01648790|9887745|FG002|STARTED|Treatment 3||4
8833354|NCT01648790|9887746|FG003|STARTED|Treatment 3|Withdrew consent prior to dosing on this treatment day.|4
8833355|NCT01648790|9887747|FG004|STARTED|Treatment 3||4
8833356|NCT01648790|9887743|FG000|COMPLETED|Treatment 3||4
8833357|NCT01648790|9887744|FG001|COMPLETED|Treatment 3||4
8833358|NCT01648790|9887745|FG002|COMPLETED|Treatment 3||4
8833359|NCT01648790|9887746|FG003|COMPLETED|Treatment 3||3
8833360|NCT01648790|9887747|FG004|COMPLETED|Treatment 3||4
8833361|NCT01648790|9887743|FG000|NOT COMPLETED|Treatment 3||0
8833362|NCT01648790|9887744|FG001|NOT COMPLETED|Treatment 3||0
8833363|NCT01648790|9887745|FG002|NOT COMPLETED|Treatment 3||0
8833364|NCT01648790|9887746|FG003|NOT COMPLETED|Treatment 3||1
8833365|NCT01648790|9887747|FG004|NOT COMPLETED|Treatment 3||0
8833366|NCT01648790|9887743|FG000|STARTED|Treatment 4||4
8833367|NCT01648790|9887744|FG001|STARTED|Treatment 4||4
8833368|NCT01648790|9887745|FG002|STARTED|Treatment 4||4
8833369|NCT01648790|9887746|FG003|STARTED|Treatment 4||3
8833370|NCT01648790|9887747|FG004|STARTED|Treatment 4||4
8833371|NCT01648790|9887743|FG000|COMPLETED|Treatment 4||4
8833372|NCT01648790|9887744|FG001|COMPLETED|Treatment 4||4
8833373|NCT01648790|9887745|FG002|COMPLETED|Treatment 4||4
8833374|NCT01648790|9887746|FG003|COMPLETED|Treatment 4||3
8833375|NCT01648790|9887747|FG004|COMPLETED|Treatment 4||4
8833376|NCT01648790|9887743|FG000|NOT COMPLETED|Treatment 4||0
8833377|NCT01648790|9887744|FG001|NOT COMPLETED|Treatment 4||0
8833378|NCT01648790|9887745|FG002|NOT COMPLETED|Treatment 4||0
8833379|NCT01648790|9887746|FG003|NOT COMPLETED|Treatment 4||0
8833380|NCT01648790|9887747|FG004|NOT COMPLETED|Treatment 4||0
8833381|NCT01648790|9887743|FG000|STARTED|Treatment 5||4
8833382|NCT01648790|9887744|FG001|STARTED|Treatment 5||4
8833383|NCT01648790|9887745|FG002|STARTED|Treatment 5||4
8833384|NCT01648790|9887746|FG003|STARTED|Treatment 5||3
8833385|NCT01648790|9887747|FG004|STARTED|Treatment 5||4
8833386|NCT01648790|9887743|FG000|COMPLETED|Treatment 5||4
8833387|NCT01648790|9887744|FG001|COMPLETED|Treatment 5||4
8833388|NCT01648790|9887745|FG002|COMPLETED|Treatment 5||4
8833389|NCT01648790|9887746|FG003|COMPLETED|Treatment 5||3
8833390|NCT01648790|9887747|FG004|COMPLETED|Treatment 5||4
8833391|NCT01648790|9887743|FG000|NOT COMPLETED|Treatment 5||0
8833392|NCT01648790|9887744|FG001|NOT COMPLETED|Treatment 5||0
8833393|NCT01648790|9887745|FG002|NOT COMPLETED|Treatment 5||0
8622735|NCT00489853|9661959|FG002|COMPLETED|Treatment Period 1||38
8622736|NCT00489853|9661957|FG000|NOT COMPLETED|Treatment Period 1||0
8622737|NCT00489853|9661958|FG001|NOT COMPLETED|Treatment Period 1||0
8833394|NCT01648790|9887746|FG003|NOT COMPLETED|Treatment 5||0
8833395|NCT01648790|9887747|FG004|NOT COMPLETED|Treatment 5||0
8833396|NCT01648920|9887759|FG000|STARTED|Overall Study||50
8833397|NCT01648920|9887759|FG000|COMPLETED|Overall Study||50
8833398|NCT01648920|9887759|FG000|NOT COMPLETED|Overall Study||0
8833399|NCT01648959|9887763|FG000|STARTED|Overall Study||5
8833400|NCT01648959|9887763|FG000|COMPLETED|Overall Study||5
8833401|NCT01648959|9887763|FG000|NOT COMPLETED|Overall Study||0
8833402|NCT01649180|9887767|FG000|STARTED|Overall Study||3
8833403|NCT01649180|9887767|FG000|COMPLETED|Overall Study||3
8833404|NCT01649180|9887767|FG000|NOT COMPLETED|Overall Study||0
8833405|NCT01649232|9887773|FG000|STARTED|Overall Study||30
8833406|NCT01649232|9887774|FG001|STARTED|Overall Study||30
8833407|NCT01649232|9887773|FG000|COMPLETED|Overall Study|technical problems or excessive artifacts, two data sets were excluded from further analysis.|28
8833408|NCT01649232|9887774|FG001|COMPLETED|Overall Study||30
8833409|NCT01649232|9887773|FG000|NOT COMPLETED|Overall Study||2
8833410|NCT01649232|9887774|FG001|NOT COMPLETED|Overall Study||0
8833411|NCT01649271|9887788|FG000|STARTED|Overall Study||6
8833412|NCT01649271|9887789|FG001|STARTED|Overall Study||7
8833413|NCT01649271|9887788|FG000|COMPLETED|Overall Study||0
8833414|NCT01649271|9887789|FG001|COMPLETED|Overall Study||0
8833415|NCT01649271|9887788|FG000|NOT COMPLETED|Overall Study||6
8833416|NCT01649271|9887789|FG001|NOT COMPLETED|Overall Study||7
8833417|NCT01649297|9887801|FG000|STARTED|Overall Study|randomised|219
8833418|NCT01649297|9887802|FG001|STARTED|Overall Study|randomised|218
8833419|NCT01649297|9887803|FG002|STARTED|Overall Study|randomised|219
8833420|NCT01649297|9887804|FG003|STARTED|Overall Study|randomised|220
8833421|NCT01649297|9887805|FG004|STARTED|Overall Study|randomised|107
8833422|NCT01649297|9887801|FG000|COMPLETED|Overall Study||205
8833423|NCT01649297|9887802|FG001|COMPLETED|Overall Study||205
8833424|NCT01649297|9887803|FG002|COMPLETED|Overall Study||202
8833425|NCT01649297|9887804|FG003|COMPLETED|Overall Study||201
8833426|NCT01649297|9887805|FG004|COMPLETED|Overall Study||103
8833427|NCT01649297|9887801|FG000|NOT COMPLETED|Overall Study||14
8833428|NCT01649297|9887802|FG001|NOT COMPLETED|Overall Study||13
8833429|NCT01649297|9887803|FG002|NOT COMPLETED|Overall Study||17
8833430|NCT01649297|9887804|FG003|NOT COMPLETED|Overall Study||19
8833431|NCT01649297|9887805|FG004|NOT COMPLETED|Overall Study||4
8833432|NCT01649362|9887819|FG000|STARTED|Overall Study||47
8833433|NCT01649362|9887820|FG001|STARTED|Overall Study||54
8833434|NCT01649362|9887819|FG000|COMPLETED|Overall Study||46
8833435|NCT01649362|9887820|FG001|COMPLETED|Overall Study||40
8833436|NCT01649362|9887819|FG000|NOT COMPLETED|Overall Study||1
8833437|NCT01649362|9887820|FG001|NOT COMPLETED|Overall Study||14
8833438|NCT01649375|9887829|FG000|STARTED|Up to Week 16||73
8833439|NCT01649375|9887830|FG001|STARTED|Up to Week 16||72
8833440|NCT01649375|9887831|FG002|STARTED|Up to Week 16||74
8833441|NCT01649375|9887832|FG003|STARTED|Up to Week 16||0
8833442|NCT01649375|9887833|FG004|STARTED|Up to Week 16||0
8833443|NCT01649375|9887829|FG000|COMPLETED|Up to Week 16||68
8833444|NCT01649375|9887830|FG001|COMPLETED|Up to Week 16||66
8833445|NCT01649375|9887831|FG002|COMPLETED|Up to Week 16||66
8833446|NCT01649375|9887832|FG003|COMPLETED|Up to Week 16||0
8833447|NCT01649375|9887833|FG004|COMPLETED|Up to Week 16||0
8833448|NCT01649375|9887829|FG000|NOT COMPLETED|Up to Week 16||5
8833449|NCT01649375|9887830|FG001|NOT COMPLETED|Up to Week 16||6
8833450|NCT01649375|9887831|FG002|NOT COMPLETED|Up to Week 16||8
8622738|NCT00489853|9661959|FG002|NOT COMPLETED|Treatment Period 1||0
8833451|NCT01649375|9887832|FG003|NOT COMPLETED|Up to Week 16||0
8833452|NCT01649375|9887833|FG004|NOT COMPLETED|Up to Week 16||0
8833453|NCT01649375|9887829|FG000|STARTED|Week 16 up to Week 260||68
8833454|NCT01649375|9887830|FG001|STARTED|Week 16 up to Week 260||66
8833455|NCT01649375|9887831|FG002|STARTED|Week 16 up to Week 260||0
8833456|NCT01649375|9887832|FG003|STARTED|Week 16 up to Week 260||32
8833457|NCT01649375|9887833|FG004|STARTED|Week 16 up to Week 260||34
8833458|NCT01649375|9887829|FG000|COMPLETED|Week 16 up to Week 260||48
8833459|NCT01649375|9887830|FG001|COMPLETED|Week 16 up to Week 260||53
8833460|NCT01649375|9887831|FG002|COMPLETED|Week 16 up to Week 260||0
8833461|NCT01649375|9887832|FG003|COMPLETED|Week 16 up to Week 260||20
8833462|NCT01649375|9887833|FG004|COMPLETED|Week 16 up to Week 260||29
8833463|NCT01649375|9887829|FG000|NOT COMPLETED|Week 16 up to Week 260||20
8833464|NCT01649375|9887830|FG001|NOT COMPLETED|Week 16 up to Week 260||13
8833465|NCT01649375|9887831|FG002|NOT COMPLETED|Week 16 up to Week 260||0
8833466|NCT01649375|9887832|FG003|NOT COMPLETED|Week 16 up to Week 260||12
8833467|NCT01649375|9887833|FG004|NOT COMPLETED|Week 16 up to Week 260||5
8833468|NCT01649427|9887843|FG000|STARTED|Overall Study||35
8833469|NCT01649427|9887844|FG001|STARTED|Overall Study||38
8833470|NCT01649427|9887843|FG000|COMPLETED|Overall Study||24
8833471|NCT01649427|9887844|FG001|COMPLETED|Overall Study||26
8833472|NCT01649427|9887843|FG000|NOT COMPLETED|Overall Study||11
8833473|NCT01649427|9887844|FG001|NOT COMPLETED|Overall Study||12
8833474|NCT01649557|9887853|FG000|STARTED|Overall Study||179
8833475|NCT01649557|9887854|FG001|STARTED|Overall Study||41
8833476|NCT01649557|9887855|FG002|STARTED|Overall Study||24
8833477|NCT01649557|9887853|FG000|6-week Enrollers|Overall Study||159
8833478|NCT01649557|9887854|FG001|6-week Enrollers|Overall Study||35
8833479|NCT01649557|9887855|FG002|6-week Enrollers|Overall Study||22
8833480|NCT01649557|9887853|FG000|52-week Enrollers|Overall Study||20
8833481|NCT01649557|9887854|FG001|52-week Enrollers|Overall Study||6
8833482|NCT01649557|9887855|FG002|52-week Enrollers|Overall Study||2
8833483|NCT01649557|9887853|FG000|COMPLETED|Overall Study||135
8833484|NCT01649557|9887854|FG001|COMPLETED|Overall Study||27
8833485|NCT01649557|9887855|FG002|COMPLETED|Overall Study||15
8833486|NCT01649557|9887853|FG000|NOT COMPLETED|Overall Study||44
8833487|NCT01649557|9887854|FG001|NOT COMPLETED|Overall Study||14
8833488|NCT01649557|9887855|FG002|NOT COMPLETED|Overall Study||9
8833489|NCT01649596|9887865|FG000|STARTED|Overall Study||46
8833490|NCT01649596|9887866|FG001|STARTED|Overall Study||48
8833491|NCT01649596|9887865|FG000|COMPLETED|Overall Study||46
8833492|NCT01649596|9887866|FG001|COMPLETED|Overall Study||48
8833493|NCT01649596|9887865|FG000|NOT COMPLETED|Overall Study||0
8833494|NCT01649596|9887866|FG001|NOT COMPLETED|Overall Study||0
8833495|NCT01649609|9887874|FG000|STARTED|Overall Study||20
8833496|NCT01649609|9887875|FG001|STARTED|Overall Study||20
8833497|NCT01649609|9887874|FG000|COMPLETED|Overall Study||20
8833498|NCT01649609|9887875|FG001|COMPLETED|Overall Study||20
8833499|NCT01649609|9887874|FG000|NOT COMPLETED|Overall Study||0
8833500|NCT01649609|9887875|FG001|NOT COMPLETED|Overall Study||0
8833501|NCT01649765|9887883|FG000|STARTED|Overall Study||40
8833502|NCT01649765|9887884|FG001|STARTED|Overall Study||53
8833503|NCT01649765|9887883|FG000|COMPLETED|Overall Study||31
8833504|NCT01649765|9887884|FG001|COMPLETED|Overall Study||45
8833505|NCT01649765|9887883|FG000|NOT COMPLETED|Overall Study||9
8833506|NCT01649765|9887884|FG001|NOT COMPLETED|Overall Study||8
8833507|NCT01649791|9887891|FG000|STARTED|Overall Study||8
8833508|NCT01649791|9887891|FG000|COMPLETED|Overall Study||5
8833509|NCT01649791|9887891|FG000|NOT COMPLETED|Overall Study||3
8833510|NCT01649804|9887895|FG000|STARTED|Overall Study||12
8833511|NCT01649804|9887895|FG000|COMPLETED|Overall Study||4
8833512|NCT01649804|9887895|FG000|NOT COMPLETED|Overall Study||8
8833513|NCT01649856|9887901|FG000|STARTED|Overall Study||369
8833514|NCT01649856|9887902|FG001|STARTED|Overall Study||203
8833515|NCT01649856|9887901|FG000|COMPLETED|Overall Study||230
8833516|NCT01649856|9887902|FG001|COMPLETED|Overall Study||125
8833517|NCT01649856|9887901|FG000|NOT COMPLETED|Overall Study||139
8833518|NCT01649856|9887902|FG001|NOT COMPLETED|Overall Study||78
8833519|NCT01649869|9887910|FG000|STARTED|Overall Study||18
8833520|NCT01649869|9887911|FG001|STARTED|Overall Study||17
8833521|NCT01649869|9887910|FG000|COMPLETED|Overall Study||16
8833522|NCT01649869|9887911|FG001|COMPLETED|Overall Study||16
8833523|NCT01649869|9887910|FG000|NOT COMPLETED|Overall Study||2
8833524|NCT01649869|9887911|FG001|NOT COMPLETED|Overall Study||1
8833525|NCT01649947|9887921|FG000|STARTED|Overall Study||12
8833526|NCT01649947|9887922|FG001|STARTED|Overall Study||20
8833527|NCT01649947|9887921|FG000|COMPLETED|Overall Study||0
8833528|NCT01649947|9887922|FG001|COMPLETED|Overall Study||2
8833529|NCT01649947|9887921|FG000|NOT COMPLETED|Overall Study||12
8833530|NCT01649947|9887922|FG001|NOT COMPLETED|Overall Study||18
8833531|NCT01650194|9887929|FG000|STARTED|Overall Study||60
8833532|NCT01650194|9887929|FG000|Treated|Overall Study||60
8833533|NCT01650194|9887929|FG000|COMPLETED|Overall Study||13
8833534|NCT01650194|9887929|FG000|NOT COMPLETED|Overall Study||47
8833535|NCT01650246|9887934|FG000|STARTED|Overall Study||143
8833536|NCT01650246|9887934|FG000|COMPLETED|Overall Study||0
8833537|NCT01650246|9887934|FG000|NOT COMPLETED|Overall Study||143
8833538|NCT01650259|9887940|FG000|STARTED|Overall Study|Started are the registered patients|2513
8833539|NCT01650259|9887941|FG001|STARTED|Overall Study|Started are the registered patients|2363
8833540|NCT01650259|9887940|FG000|COMPLETED|Overall Study||1470
8833541|NCT01650259|9887941|FG001|COMPLETED|Overall Study||2128
8833542|NCT01650259|9887940|FG000|NOT COMPLETED|Overall Study||1043
8833543|NCT01650259|9887941|FG001|NOT COMPLETED|Overall Study||235
8833544|NCT01650298|9887947|FG000|STARTED|Overall Study||16
8833545|NCT01650298|9887948|FG001|STARTED|Overall Study||48
8833546|NCT01650298|9887947|FG000|COMPLETED|Overall Study||11
8833547|NCT01650298|9887948|FG001|COMPLETED|Overall Study||42
8833548|NCT01650298|9887947|FG000|NOT COMPLETED|Overall Study||5
8833549|NCT01650298|9887948|FG001|NOT COMPLETED|Overall Study||6
8833550|NCT01650324|9887959|FG000|STARTED|Overall Study||8
8833551|NCT01650324|9887960|FG001|STARTED|Overall Study||6
8833552|NCT01650324|9887961|FG002|STARTED|Overall Study||6
8833553|NCT01650324|9887962|FG003|STARTED|Overall Study||6
8833554|NCT01650324|9887963|FG004|STARTED|Overall Study||6
8833555|NCT01650324|9887959|FG000|COMPLETED|Overall Study||8
8833556|NCT01650324|9887960|FG001|COMPLETED|Overall Study||6
8833557|NCT01650324|9887961|FG002|COMPLETED|Overall Study||6
8833558|NCT01650324|9887962|FG003|COMPLETED|Overall Study||6
8833559|NCT01650324|9887963|FG004|COMPLETED|Overall Study||6
8833560|NCT01650324|9887959|FG000|NOT COMPLETED|Overall Study||0
8833561|NCT01650324|9887960|FG001|NOT COMPLETED|Overall Study||0
8833562|NCT01650324|9887961|FG002|NOT COMPLETED|Overall Study||0
8833563|NCT01650324|9887962|FG003|NOT COMPLETED|Overall Study||0
8833564|NCT01650324|9887963|FG004|NOT COMPLETED|Overall Study||0
8833565|NCT01650402|9887982|FG000|STARTED|Overall Study||99
8833566|NCT01650402|9887983|FG001|STARTED|Overall Study||100
8833567|NCT01650402|9887982|FG000|COMPLETED|Overall Study||79
8833568|NCT01650402|9887983|FG001|COMPLETED|Overall Study||86
8833569|NCT01650402|9887982|FG000|NOT COMPLETED|Overall Study||20
8833570|NCT01650402|9887983|FG001|NOT COMPLETED|Overall Study||14
8833571|NCT01650519|9887991|FG000|STARTED|Overall Study||20
8833572|NCT01650519|9887992|FG001|STARTED|Overall Study||31
8833573|NCT01650519|9887991|FG000|COMPLETED|Overall Study||19
8833574|NCT01650519|9887992|FG001|COMPLETED|Overall Study||31
8833575|NCT01650519|9887991|FG000|NOT COMPLETED|Overall Study||1
8833576|NCT01650519|9887992|FG001|NOT COMPLETED|Overall Study||0
8833577|NCT01650545|9888000|FG000|STARTED|Overall Study||11
8833578|NCT01650545|9888001|FG001|STARTED|Overall Study||10
8833579|NCT01650545|9888000|FG000|COMPLETED|Overall Study||11
8833580|NCT01650545|9888001|FG001|COMPLETED|Overall Study||10
8833581|NCT01650545|9888000|FG000|NOT COMPLETED|Overall Study||0
8833582|NCT01650545|9888001|FG001|NOT COMPLETED|Overall Study||0
8944337|NCT02395653|10006174|FG000|Received at Least 1 Dose of Study Drug|Overall Study||61
8944338|NCT02395653|10006174|FG000|COMPLETED|Overall Study||59
8944339|NCT02395653|10006174|FG000|NOT COMPLETED|Overall Study||12
8944340|NCT02395692|10006178|FG000|STARTED|Overall Study||19
8944341|NCT02395692|10006179|FG001|STARTED|Overall Study||0
8944342|NCT02395692|10006178|FG000|COMPLETED|Overall Study||19
8944343|NCT02395692|10006179|FG001|COMPLETED|Overall Study||0
8944344|NCT02395692|10006178|FG000|NOT COMPLETED|Overall Study||0
8944345|NCT02395692|10006179|FG001|NOT COMPLETED|Overall Study||0
8944346|NCT02395822|10006186|FG000|STARTED|Overall Study||17
8833583|NCT01650558|9888012|FG000|STARTED|Overall Study||500
8833584|NCT01650558|9888013|FG001|STARTED|Overall Study||500
8833585|NCT01650558|9888014|FG002|STARTED|Overall Study||499
8833586|NCT01650558|9888012|FG000|COMPLETED|Overall Study||417
8833587|NCT01650558|9888013|FG001|COMPLETED|Overall Study||408
8833588|NCT01650558|9888014|FG002|COMPLETED|Overall Study||424
8833589|NCT01650558|9888012|FG000|NOT COMPLETED|Overall Study||83
8833590|NCT01650558|9888013|FG001|NOT COMPLETED|Overall Study||92
8833591|NCT01650558|9888014|FG002|NOT COMPLETED|Overall Study||75
8833592|NCT01650584|9888025|FG000|STARTED|Overall Study|Each participant received one of 2 treatments in each eye.|35
8833593|NCT01650584|9888025|FG000|COMPLETED|Overall Study||35
8833594|NCT01650584|9888025|FG000|NOT COMPLETED|Overall Study||0
8833595|NCT01650636|9888032|FG000|STARTED|Intervention Phase||150
8833596|NCT01650636|9888033|FG001|STARTED|Intervention Phase||150
8833597|NCT01650636|9888032|FG000|COMPLETED|Intervention Phase||150
8833598|NCT01650636|9888033|FG001|COMPLETED|Intervention Phase||150
8833599|NCT01650636|9888032|FG000|NOT COMPLETED|Intervention Phase||0
8833600|NCT01650636|9888033|FG001|NOT COMPLETED|Intervention Phase||0
8833601|NCT01650636|9888032|FG000|STARTED|Washout up to 5 Months||150
8833602|NCT01650636|9888033|FG001|STARTED|Washout up to 5 Months||150
8833603|NCT01650636|9888032|FG000|COMPLETED|Washout up to 5 Months||141
8833604|NCT01650636|9888033|FG001|COMPLETED|Washout up to 5 Months||132
8833605|NCT01650636|9888032|FG000|NOT COMPLETED|Washout up to 5 Months||9
8833606|NCT01650636|9888033|FG001|NOT COMPLETED|Washout up to 5 Months||18
8833607|NCT01650636|9888032|FG000|STARTED|5 Month Visit||141
8833608|NCT01650636|9888033|FG001|STARTED|5 Month Visit||132
8833609|NCT01650636|9888032|FG000|COMPLETED|5 Month Visit||141
8833610|NCT01650636|9888033|FG001|COMPLETED|5 Month Visit||132
8833611|NCT01650636|9888032|FG000|NOT COMPLETED|5 Month Visit||0
8833612|NCT01650636|9888033|FG001|NOT COMPLETED|5 Month Visit||0
8833613|NCT01650636|9888032|FG000|STARTED|Washout up to 9 Months||141
8833614|NCT01650636|9888033|FG001|STARTED|Washout up to 9 Months||132
8833615|NCT01650636|9888032|FG000|COMPLETED|Washout up to 9 Months||135
8833616|NCT01650636|9888033|FG001|COMPLETED|Washout up to 9 Months||129
8833617|NCT01650636|9888032|FG000|NOT COMPLETED|Washout up to 9 Months||6
8833618|NCT01650636|9888033|FG001|NOT COMPLETED|Washout up to 9 Months||3
8833619|NCT01650636|9888032|FG000|STARTED|9 Month Visit||135
8833620|NCT01650636|9888033|FG001|STARTED|9 Month Visit||129
8833621|NCT01650636|9888032|FG000|COMPLETED|9 Month Visit||135
8833622|NCT01650636|9888033|FG001|COMPLETED|9 Month Visit||129
8833623|NCT01650636|9888032|FG000|NOT COMPLETED|9 Month Visit||0
8833624|NCT01650636|9888033|FG001|NOT COMPLETED|9 Month Visit||0
8944347|NCT02395822|10006186|FG000|COMPLETED|Overall Study||15
8944348|NCT02395822|10006186|FG000|NOT COMPLETED|Overall Study||2
8944349|NCT02395978|10006195|FG000|STARTED|Overall Study||6
8833625|NCT01650779|9888039|FG000|STARTED|Overall Study||15
8833626|NCT01650779|9888039|FG000|COMPLETED|Overall Study||14
8833627|NCT01650779|9888039|FG000|NOT COMPLETED|Overall Study||1
8833628|NCT01650805|9888045|FG000|STARTED|Overall Study|Started means patient has been randomized.|155
8833629|NCT01650805|9888046|FG001|STARTED|Overall Study||152
8833630|NCT01650805|9888045|FG000|COMPLETED|Overall Study|Completed means patient initiated and discontinued study treatment.|154
8833631|NCT01650805|9888046|FG001|COMPLETED|Overall Study||152
8833632|NCT01650805|9888045|FG000|NOT COMPLETED|Overall Study||1
8833633|NCT01650805|9888046|FG001|NOT COMPLETED|Overall Study||0
8944350|NCT02395978|10006196|FG001|STARTED|Overall Study||6
8833634|NCT01650831|9888052|FG000|STARTED|Overall Study||113
8833635|NCT01650831|9888052|FG000|COMPLETED|Overall Study||112
8833636|NCT01650831|9888052|FG000|NOT COMPLETED|Overall Study||1
8833637|NCT01650844|9888062|FG000|STARTED|Overall Study||200
8833638|NCT01650844|9888063|FG001|STARTED|Overall Study||200
8833639|NCT01650844|9888062|FG000|COMPLETED|Overall Study||199
8833640|NCT01650844|9888063|FG001|COMPLETED|Overall Study||196
8833641|NCT01650844|9888062|FG000|NOT COMPLETED|Overall Study||1
8833642|NCT01650844|9888063|FG001|NOT COMPLETED|Overall Study||4
8833643|NCT01651000|9888071|FG000|STARTED|Overall Study||72
8833644|NCT01651000|9888072|FG001|STARTED|Overall Study||141
8833645|NCT01651000|9888071|FG000|Entered Extension Study|Overall Study||50
8833646|NCT01651000|9888072|FG001|Entered Extension Study|Overall Study||93
8833647|NCT01651000|9888071|FG000|COMPLETED|Overall Study||62
8833648|NCT01651000|9888072|FG001|COMPLETED|Overall Study||113
8833649|NCT01651000|9888071|FG000|NOT COMPLETED|Overall Study||10
8833650|NCT01651000|9888072|FG001|NOT COMPLETED|Overall Study||28
8833651|NCT01651039|9888078|FG000|STARTED|Overall Study||32
8833652|NCT01651039|9888078|FG000|COMPLETED|Overall Study||2
8833653|NCT01651039|9888078|FG000|NOT COMPLETED|Overall Study||30
8833654|NCT01651052|9888082|FG000|STARTED|Overall Study||133
8833655|NCT01651052|9888082|FG000|Study Valve Group|Overall Study||133
8833656|NCT01651052|9888082|FG000|COMPLETED|Overall Study||107
8833657|NCT01651052|9888082|FG000|NOT COMPLETED|Overall Study||26
8833658|NCT01651078|9888086|FG000|STARTED|Overall Study|Two (2) out of 44 patients were enrolled but did not go on to have the NeuroBlate Procedure.|42
8833659|NCT01651078|9888086|FG000|COMPLETED|Overall Study||16
8833660|NCT01651078|9888086|FG000|NOT COMPLETED|Overall Study||26
8833661|NCT01651104|9888090|FG000|STARTED|Overall Study||63
8833662|NCT01651104|9888090|FG000|COMPLETED|Overall Study||63
8833663|NCT01651104|9888090|FG000|NOT COMPLETED|Overall Study||0
8833664|NCT01651117|9888098|FG000|STARTED|Overall Study||156
8833665|NCT01651117|9888099|FG001|STARTED|Overall Study||205
8833666|NCT01651117|9888100|FG002|STARTED|Overall Study||49
8833667|NCT01651117|9888101|FG003|STARTED|Overall Study||70
8833668|NCT01651117|9888098|FG000|COMPLETED|Overall Study||154
8833669|NCT01651117|9888099|FG001|COMPLETED|Overall Study||202
8833670|NCT01651117|9888100|FG002|COMPLETED|Overall Study||47
8833671|NCT01651117|9888101|FG003|COMPLETED|Overall Study||68
8833672|NCT01651117|9888098|FG000|NOT COMPLETED|Overall Study||2
8833673|NCT01651117|9888099|FG001|NOT COMPLETED|Overall Study||3
8833674|NCT01651117|9888100|FG002|NOT COMPLETED|Overall Study||2
8833675|NCT01651117|9888101|FG003|NOT COMPLETED|Overall Study||2
8833676|NCT01651195|9888118|FG000|STARTED|Overall Study||284
8833677|NCT01651195|9888119|FG001|STARTED|Overall Study||284
8833678|NCT01651195|9888120|FG002|STARTED|Overall Study||204
8833679|NCT01651195|9888121|FG003|STARTED|Overall Study||211
8833680|NCT01651195|9888118|FG000|COMPLETED|Overall Study||63
8833681|NCT01651195|9888119|FG001|COMPLETED|Overall Study||73
8833682|NCT01651195|9888120|FG002|COMPLETED|Overall Study||121
8833683|NCT01651195|9888121|FG003|COMPLETED|Overall Study||103
8833684|NCT01651195|9888118|FG000|NOT COMPLETED|Overall Study||221
8833685|NCT01651195|9888119|FG001|NOT COMPLETED|Overall Study||211
8833686|NCT01651195|9888120|FG002|NOT COMPLETED|Overall Study||83
8833687|NCT01651195|9888121|FG003|NOT COMPLETED|Overall Study||108
8833688|NCT01651208|9888137|FG000|STARTED|Overall Study||227
8833689|NCT01651208|9888138|FG001|STARTED|Overall Study||225
8833690|NCT01651208|9888137|FG000|COMPLETED|Overall Study|14 patients had no pharmacy claims data to analyze primary outcome|213
8833691|NCT01651208|9888138|FG001|COMPLETED|Overall Study|16 subjects had no pharmacy claims data to analyze primary outcome|209
8833692|NCT01651208|9888137|FG000|NOT COMPLETED|Overall Study||14
8833693|NCT01651208|9888138|FG001|NOT COMPLETED|Overall Study||16
8833694|NCT01651260|9888145|FG000|STARTED|Overall Study||65
8833695|NCT01651260|9888145|FG000|COMPLETED|Overall Study||62
8833696|NCT01651260|9888145|FG000|NOT COMPLETED|Overall Study||3
8833697|NCT01651351|9888152|FG000|STARTED|Overall Study||15
8833698|NCT01651351|9888153|FG001|STARTED|Overall Study||15
8833699|NCT01651351|9888152|FG000|COMPLETED|Overall Study||15
8833700|NCT01651351|9888153|FG001|COMPLETED|Overall Study||15
8833701|NCT01651351|9888152|FG000|NOT COMPLETED|Overall Study||0
8833702|NCT01651351|9888153|FG001|NOT COMPLETED|Overall Study||0
8833703|NCT01651442|9888162|FG000|STARTED|Phase I Treatment||104
8833704|NCT01651442|9888163|FG001|STARTED|Phase I Treatment||107
8833705|NCT01651442|9888164|FG002|STARTED|Phase I Treatment||0
8833706|NCT01651442|9888165|FG003|STARTED|Phase I Treatment||0
8833707|NCT01651442|9888166|FG004|STARTED|Phase I Treatment||0
8833708|NCT01651442|9888167|FG005|STARTED|Phase I Treatment||0
8833709|NCT01651442|9888162|FG000|COMPLETED|Phase I Treatment||88
8833710|NCT01651442|9888163|FG001|COMPLETED|Phase I Treatment||80
8833711|NCT01651442|9888164|FG002|COMPLETED|Phase I Treatment||0
8833712|NCT01651442|9888165|FG003|COMPLETED|Phase I Treatment||0
8833713|NCT01651442|9888166|FG004|COMPLETED|Phase I Treatment||0
8833714|NCT01651442|9888167|FG005|COMPLETED|Phase I Treatment||0
8833715|NCT01651442|9888162|FG000|NOT COMPLETED|Phase I Treatment||16
8833716|NCT01651442|9888163|FG001|NOT COMPLETED|Phase I Treatment||27
8833717|NCT01651442|9888164|FG002|NOT COMPLETED|Phase I Treatment||0
8833718|NCT01651442|9888165|FG003|NOT COMPLETED|Phase I Treatment||0
8833719|NCT01651442|9888166|FG004|NOT COMPLETED|Phase I Treatment||0
8833720|NCT01651442|9888167|FG005|NOT COMPLETED|Phase I Treatment||0
8833721|NCT01651442|9888162|FG000|STARTED|Phase II Treatment||0
8833722|NCT01651442|9888163|FG001|STARTED|Phase II Treatment||0
8833723|NCT01651442|9888164|FG002|STARTED|Phase II Treatment||27
8833724|NCT01651442|9888165|FG003|STARTED|Phase II Treatment||27
8833725|NCT01651442|9888166|FG004|STARTED|Phase II Treatment||27
8833726|NCT01651442|9888167|FG005|STARTED|Phase II Treatment||27
8833727|NCT01651442|9888162|FG000|COMPLETED|Phase II Treatment||0
8833728|NCT01651442|9888163|FG001|COMPLETED|Phase II Treatment||0
8833729|NCT01651442|9888164|FG002|COMPLETED|Phase II Treatment||25
8833730|NCT01651442|9888165|FG003|COMPLETED|Phase II Treatment||15
8833731|NCT01651442|9888166|FG004|COMPLETED|Phase II Treatment||21
8833732|NCT01651442|9888167|FG005|COMPLETED|Phase II Treatment||17
8833733|NCT01651442|9888162|FG000|NOT COMPLETED|Phase II Treatment||0
8833734|NCT01651442|9888163|FG001|NOT COMPLETED|Phase II Treatment||0
8833735|NCT01651442|9888164|FG002|NOT COMPLETED|Phase II Treatment||2
8833736|NCT01651442|9888165|FG003|NOT COMPLETED|Phase II Treatment||12
8833737|NCT01651442|9888166|FG004|NOT COMPLETED|Phase II Treatment||6
8833738|NCT01651442|9888167|FG005|NOT COMPLETED|Phase II Treatment||10
8833739|NCT01651780|9888181|FG000|STARTED|Overall Study||405
8833740|NCT01651780|9888182|FG001|STARTED|Overall Study||398
8833741|NCT01651780|9888181|FG000|Intent-To-Treat (ITT) Population|Overall Study||404
8833742|NCT01651780|9888182|FG001|Intent-To-Treat (ITT) Population|Overall Study||398
8833743|NCT01651780|9888181|FG000|Received at Least 1 Dose of Study Drug|Overall Study|All but 1 participant in the bivalirudin group (withdrew consent) comprised the ITT population.|393
8833744|NCT01651780|9888182|FG001|Received at Least 1 Dose of Study Drug|Overall Study||394
8833745|NCT01651780|9888181|FG000|BRAVO 2 Feasibility Cohort|Overall Study|1st 2 participants/site made up the bivalirudin feasibility cohort (BRAVO2) and analyzed separately.|65
8833746|NCT01651780|9888182|FG001|BRAVO 2 Feasibility Cohort|Overall Study|1st 2 participants/site made up the bivalirudin feasibility cohort (BRAVO2) and analyzed separately.|0
8833747|NCT01651780|9888181|FG000|COMPLETED|Overall Study||394
8833748|NCT01651780|9888182|FG001|COMPLETED|Overall Study||388
8833749|NCT01651780|9888181|FG000|NOT COMPLETED|Overall Study||11
8833750|NCT01651780|9888182|FG001|NOT COMPLETED|Overall Study||10
8833751|NCT01651793|9888192|FG000|STARTED|Overall Study||6
8833752|NCT01651793|9888193|FG001|STARTED|Overall Study||6
8833753|NCT01651793|9888194|FG002|STARTED|Overall Study||6
8833754|NCT01651793|9888195|FG003|STARTED|Overall Study||6
8833755|NCT01651793|9888192|FG000|COMPLETED|Overall Study||6
8833756|NCT01651793|9888193|FG001|COMPLETED|Overall Study||6
8833757|NCT01651793|9888194|FG002|COMPLETED|Overall Study||6
8833758|NCT01651793|9888195|FG003|COMPLETED|Overall Study||5
8833759|NCT01651793|9888192|FG000|NOT COMPLETED|Overall Study||0
8833760|NCT01651793|9888193|FG001|NOT COMPLETED|Overall Study||0
8833761|NCT01651793|9888194|FG002|NOT COMPLETED|Overall Study||0
8833762|NCT01651793|9888195|FG003|NOT COMPLETED|Overall Study||1
8833763|NCT01651806|9888214|FG000|STARTED|Overall Study||13
8833764|NCT01651806|9888215|FG001|STARTED|Overall Study||12
8833765|NCT01651806|9888216|FG002|STARTED|Overall Study||25
8833766|NCT01651806|9888217|FG003|STARTED|Overall Study||7
8833767|NCT01651806|9888218|FG004|STARTED|Overall Study||8
8833768|NCT01651806|9888214|FG000|COMPLETED|Overall Study||13
8833769|NCT01651806|9888215|FG001|COMPLETED|Overall Study||12
8833770|NCT01651806|9888216|FG002|COMPLETED|Overall Study||25
8833771|NCT01651806|9888217|FG003|COMPLETED|Overall Study||7
8833772|NCT01651806|9888218|FG004|COMPLETED|Overall Study||8
8833773|NCT01651806|9888214|FG000|NOT COMPLETED|Overall Study||0
8833774|NCT01651806|9888215|FG001|NOT COMPLETED|Overall Study||0
8833775|NCT01651806|9888216|FG002|NOT COMPLETED|Overall Study||0
8833776|NCT01651806|9888217|FG003|NOT COMPLETED|Overall Study||0
8833777|NCT01651806|9888218|FG004|NOT COMPLETED|Overall Study||0
8833778|NCT01651936|9888233|FG000|STARTED|Base Study||30
8833779|NCT01651936|9888234|FG001|STARTED|Base Study||26
8833780|NCT01651936|9888235|FG002|STARTED|Base Study||0
8833781|NCT01651936|9888233|FG000|COMPLETED|Base Study||3
8833782|NCT01651936|9888234|FG001|COMPLETED|Base Study||1
8833783|NCT01651936|9888235|FG002|COMPLETED|Base Study||0
8833784|NCT01651936|9888233|FG000|NOT COMPLETED|Base Study||27
8833785|NCT01651936|9888234|FG001|NOT COMPLETED|Base Study||25
8833786|NCT01651936|9888235|FG002|NOT COMPLETED|Base Study||0
8833787|NCT01651936|9888233|FG000|STARTED|Extension Study||0
8833788|NCT01651936|9888234|FG001|STARTED|Extension Study||0
8833789|NCT01651936|9888235|FG002|STARTED|Extension Study|Includes completers and early escapees from the Base Study|14
8833790|NCT01651936|9888233|FG000|COMPLETED|Extension Study||0
8833791|NCT01651936|9888234|FG001|COMPLETED|Extension Study||0
8833792|NCT01651936|9888235|FG002|COMPLETED|Extension Study||0
8833793|NCT01651936|9888233|FG000|NOT COMPLETED|Extension Study||0
8833794|NCT01651936|9888234|FG001|NOT COMPLETED|Extension Study||0
8833795|NCT01651936|9888235|FG002|NOT COMPLETED|Extension Study||14
8833796|NCT01651949|9888245|FG000|STARTED|Overall Study||1106
8833797|NCT01651949|9888246|FG001|STARTED|Overall Study||1101
8833798|NCT01651949|9888247|FG002|STARTED|Overall Study||313
8833799|NCT01651949|9888245|FG000|Vaccination 1|Overall Study||1103
8833800|NCT01651949|9888246|FG001|Vaccination 1|Overall Study||1099
8833801|NCT01651949|9888247|FG002|Vaccination 1|Overall Study||313
8833802|NCT01651949|9888245|FG000|Vaccination 2|Overall Study||1089
8833803|NCT01651949|9888246|FG001|Vaccination 2|Overall Study||1069
8833804|NCT01651949|9888247|FG002|Vaccination 2|Overall Study||298
8833805|NCT01651949|9888245|FG000|Vaccination 3|Overall Study||1067
8833806|NCT01651949|9888246|FG001|Vaccination 3|Overall Study||1037
8833807|NCT01651949|9888247|FG002|Vaccination 3|Overall Study||291
8833808|NCT01651949|9888245|FG000|COMPLETED|Overall Study||1053
8833809|NCT01651949|9888246|FG001|COMPLETED|Overall Study||1015
8833810|NCT01651949|9888247|FG002|COMPLETED|Overall Study||282
8833811|NCT01651949|9888245|FG000|NOT COMPLETED|Overall Study||53
8833812|NCT01651949|9888246|FG001|NOT COMPLETED|Overall Study||86
8833813|NCT01651949|9888247|FG002|NOT COMPLETED|Overall Study||31
8833814|NCT01652001|9888257|FG000|STARTED|Overall Study||100
8833815|NCT01652001|9888258|FG001|STARTED|Overall Study||85
8833816|NCT01652001|9888257|FG000|COMPLETED|Overall Study||91
8833817|NCT01652001|9888258|FG001|COMPLETED|Overall Study||79
8833818|NCT01652001|9888257|FG000|NOT COMPLETED|Overall Study||9
8833819|NCT01652001|9888258|FG001|NOT COMPLETED|Overall Study||6
8833820|NCT01652040|9888266|FG000|STARTED|Overall Study||13
8833821|NCT01652040|9888267|FG001|STARTED|Overall Study||13
8833822|NCT01652040|9888266|FG000|COMPLETED|Overall Study||11
8833823|NCT01652040|9888267|FG001|COMPLETED|Overall Study||11
8833824|NCT01652040|9888266|FG000|NOT COMPLETED|Overall Study||2
8833825|NCT01652040|9888267|FG001|NOT COMPLETED|Overall Study||2
8833826|NCT01652287|9888276|FG000|STARTED|Overall Study||31
8833827|NCT01652287|9888277|FG001|STARTED|Overall Study||31
8833828|NCT01652287|9888276|FG000|COMPLETED|Overall Study|• Did not receive allocated intervention (withdrew consent) (n=2)|29
8833829|NCT01652287|9888277|FG001|COMPLETED|Overall Study||31
8833830|NCT01652287|9888276|FG000|NOT COMPLETED|Overall Study||2
8833831|NCT01652287|9888277|FG001|NOT COMPLETED|Overall Study||0
8833832|NCT01652469|9888285|FG000|STARTED|Overall Study||38
8833833|NCT01652469|9888286|FG001|STARTED|Overall Study||42
8833834|NCT01652469|9888285|FG000|COMPLETED|Overall Study||37
8833835|NCT01652469|9888286|FG001|COMPLETED|Overall Study||36
8833836|NCT01652469|9888285|FG000|NOT COMPLETED|Overall Study||1
8833837|NCT01652469|9888286|FG001|NOT COMPLETED|Overall Study||6
8833838|NCT01652495|9888294|FG000|STARTED|Overall Study||22
8833839|NCT01652495|9888295|FG001|STARTED|Overall Study||22
8833840|NCT01652495|9888294|FG000|COMPLETED|Overall Study||20
8833841|NCT01652495|9888295|FG001|COMPLETED|Overall Study||20
8833842|NCT01652495|9888294|FG000|NOT COMPLETED|Overall Study||2
8833843|NCT01652495|9888295|FG001|NOT COMPLETED|Overall Study||2
8833844|NCT01652573|9888305|FG000|STARTED|Overall Study||10
8833845|NCT01652573|9888306|FG001|STARTED|Overall Study||11
8833846|NCT01652573|9888305|FG000|COMPLETED|Overall Study||10
8833847|NCT01652573|9888306|FG001|COMPLETED|Overall Study||10
8833848|NCT01652573|9888305|FG000|NOT COMPLETED|Overall Study||0
8833849|NCT01652573|9888306|FG001|NOT COMPLETED|Overall Study||1
8833850|NCT01652664|9888314|FG000|STARTED|Overall Study||77
8833851|NCT01652664|9888315|FG001|STARTED|Overall Study||75
8833852|NCT01652664|9888314|FG000|COMPLETED|Overall Study||71
8833853|NCT01652664|9888315|FG001|COMPLETED|Overall Study||74
8833854|NCT01652664|9888314|FG000|NOT COMPLETED|Overall Study||6
8833855|NCT01652664|9888315|FG001|NOT COMPLETED|Overall Study||1
8833856|NCT01652690|9888324|FG000|STARTED|Overall Study||300
8833857|NCT01652690|9888325|FG001|STARTED|Overall Study||300
8833858|NCT01652690|9888324|FG000|COMPLETED|Overall Study||265
8833859|NCT01652690|9888325|FG001|COMPLETED|Overall Study||279
8833860|NCT01652690|9888324|FG000|NOT COMPLETED|Overall Study||35
8833861|NCT01652690|9888325|FG001|NOT COMPLETED|Overall Study||21
8833862|NCT01652703|9888337|FG000|STARTED|Overall Study||52
8833863|NCT01652703|9888338|FG001|STARTED|Overall Study||51
8833864|NCT01652703|9888339|FG002|STARTED|Overall Study||50
8833865|NCT01652703|9888340|FG003|STARTED|Overall Study||52
8833866|NCT01652703|9888341|FG004|STARTED|Overall Study||52
8833867|NCT01652703|9888342|FG005|STARTED|Overall Study||53
8833868|NCT01652703|9888337|FG000|Received Treatment|Overall Study||52
8833869|NCT01652703|9888338|FG001|Received Treatment|Overall Study||50
8833870|NCT01652703|9888339|FG002|Received Treatment|Overall Study||49
8833871|NCT01652703|9888340|FG003|Received Treatment|Overall Study||52
8833872|NCT01652703|9888341|FG004|Received Treatment|Overall Study||51
8833873|NCT01652703|9888342|FG005|Received Treatment|Overall Study||53
8833874|NCT01652703|9888337|FG000|COMPLETED|Overall Study||52
8833875|NCT01652703|9888338|FG001|COMPLETED|Overall Study||50
8833876|NCT01652703|9888339|FG002|COMPLETED|Overall Study||47
8833877|NCT01652703|9888340|FG003|COMPLETED|Overall Study||50
8833878|NCT01652703|9888341|FG004|COMPLETED|Overall Study||51
8833879|NCT01652703|9888342|FG005|COMPLETED|Overall Study||51
8833880|NCT01652703|9888337|FG000|NOT COMPLETED|Overall Study||0
8833881|NCT01652703|9888338|FG001|NOT COMPLETED|Overall Study||1
8833882|NCT01652703|9888339|FG002|NOT COMPLETED|Overall Study||3
8833883|NCT01652703|9888340|FG003|NOT COMPLETED|Overall Study||2
8833884|NCT01652703|9888341|FG004|NOT COMPLETED|Overall Study||1
8833885|NCT01652703|9888342|FG005|NOT COMPLETED|Overall Study||2
8833886|NCT01652716|9888358|FG000|STARTED|Overall Study||229
8833887|NCT01652716|9888359|FG001|STARTED|Overall Study|Two subjects in the exenatide BID group withdrew from the study before receiving study drug.|148
8833888|NCT01652716|9888358|FG000|Completed 28-week|Overall Study||197
8833889|NCT01652716|9888359|FG001|Completed 28-week|Overall Study||118
8833890|NCT01652716|9888358|FG000|COMPLETED|Overall Study|* completed study|173
8833891|NCT01652716|9888359|FG001|COMPLETED|Overall Study|* completed study|102
8833892|NCT01652716|9888358|FG000|NOT COMPLETED|Overall Study||56
8833893|NCT01652716|9888359|FG001|NOT COMPLETED|Overall Study||46
8833894|NCT01652729|9888368|FG000|STARTED|Overall Study|One subject was enrolled twice at different sites. He was randomized to exenatide at both sites.|182
8833895|NCT01652729|9888369|FG001|STARTED|Overall Study||122
8833896|NCT01652729|9888370|FG002|STARTED|Overall Study||61
8833897|NCT01652729|9888368|FG000|Modified Intent-to-Treat|Overall Study|All randomized subjects who received at least one dose of study drug.|181
8833898|NCT01652729|9888369|FG001|Modified Intent-to-Treat|Overall Study||122
8833899|NCT01652729|9888370|FG002|Modified Intent-to-Treat|Overall Study||61
8833900|NCT01652729|9888368|FG000|Treated|Overall Study|All subjects who received at least one dose of study medication even if not randomized.|181
8833901|NCT01652729|9888369|FG001|Treated|Overall Study||122
8833902|NCT01652729|9888370|FG002|Treated|Overall Study||61
8833903|NCT01652729|9888368|FG000|Evaluable|Overall Study|Subjects who completed study procedures to Week 24 or beyond and had adequate study drug exposure|143
8833904|NCT01652729|9888369|FG001|Evaluable|Overall Study||91
8833905|NCT01652729|9888370|FG002|Evaluable|Overall Study||43
8833906|NCT01652729|9888368|FG000|Meal Test Subjects|Overall Study||60
8833907|NCT01652729|9888369|FG001|Meal Test Subjects|Overall Study||41
8833908|NCT01652729|9888370|FG002|Meal Test Subjects|Overall Study||20
8833909|NCT01652729|9888368|FG000|Meal Test Evaluable|Overall Study|ITT subjects who ate >=75% of meal and did not miss 2-hour postprandial glucose measures at V3 and 8|44
8833910|NCT01652729|9888369|FG001|Meal Test Evaluable|Overall Study||31
8833911|NCT01652729|9888370|FG002|Meal Test Evaluable|Overall Study||15
8833912|NCT01652729|9888368|FG000|COMPLETED|Overall Study|The double-enrolled subject's reasons for withdrawal were LTFU and PV. Only PV is shown below.|155
8833913|NCT01652729|9888369|FG001|COMPLETED|Overall Study||109
8833914|NCT01652729|9888370|FG002|COMPLETED|Overall Study||47
8833915|NCT01652729|9888368|FG000|NOT COMPLETED|Overall Study||27
8833916|NCT01652729|9888369|FG001|NOT COMPLETED|Overall Study||13
8833917|NCT01652729|9888370|FG002|NOT COMPLETED|Overall Study||14
8833918|NCT01652872|9888380|FG000|STARTED|Overall Study||377
8833919|NCT01652872|9888381|FG001|STARTED|Overall Study||379
8833920|NCT01652872|9888380|FG000|Received Investigational Product|Overall Study||377
8833921|NCT01652872|9888381|FG001|Received Investigational Product|Overall Study||377
8833922|NCT01652872|9888380|FG000|COMPLETED|Overall Study||232
8833923|NCT01652872|9888381|FG001|COMPLETED|Overall Study||226
8833924|NCT01652872|9888380|FG000|NOT COMPLETED|Overall Study||145
8833925|NCT01652872|9888381|FG001|NOT COMPLETED|Overall Study||153
8833926|NCT01652885|9888387|FG000|STARTED|Overall Study||23
8833927|NCT01652885|9888387|FG000|COMPLETED|Overall Study||22
8833928|NCT01652885|9888387|FG000|NOT COMPLETED|Overall Study||1
8833929|NCT01652976|9888391|FG000|STARTED|Overall Study||44
8833930|NCT01652976|9888391|FG000|COMPLETED|Overall Study||44
8833931|NCT01652976|9888391|FG000|NOT COMPLETED|Overall Study||0
8833932|NCT01653028|9888400|FG000|STARTED|Overall Study||12
8833933|NCT01653028|9888401|FG001|STARTED|Overall Study||10
8833934|NCT01653028|9888402|FG002|STARTED|Overall Study||11
8833935|NCT01653028|9888403|FG003|STARTED|Overall Study||10
8833936|NCT01653028|9888404|FG004|STARTED|Overall Study||29
8833937|NCT01653028|9888400|FG000|COMPLETED|Overall Study||12
8833938|NCT01653028|9888401|FG001|COMPLETED|Overall Study||10
8833939|NCT01653028|9888402|FG002|COMPLETED|Overall Study||11
8833940|NCT01653028|9888403|FG003|COMPLETED|Overall Study||10
8833941|NCT01653028|9888404|FG004|COMPLETED|Overall Study||29
8833942|NCT01653028|9888400|FG000|NOT COMPLETED|Overall Study||0
8833943|NCT01653028|9888401|FG001|NOT COMPLETED|Overall Study||0
8833944|NCT01653028|9888402|FG002|NOT COMPLETED|Overall Study||0
8833945|NCT01653028|9888403|FG003|NOT COMPLETED|Overall Study||0
8833946|NCT01653028|9888404|FG004|NOT COMPLETED|Overall Study||0
8833947|NCT01653132|9888416|FG000|STARTED|First Intervention||5
8833948|NCT01653132|9888417|FG001|STARTED|First Intervention||5
8833949|NCT01653132|9888416|FG000|COMPLETED|First Intervention|one dropped out: wanted to start anticholinergic drug for tremor that could affect saliva volume|4
8833950|NCT01653132|9888417|FG001|COMPLETED|First Intervention||5
8833951|NCT01653132|9888416|FG000|NOT COMPLETED|First Intervention||1
8833952|NCT01653132|9888417|FG001|NOT COMPLETED|First Intervention||0
8833953|NCT01653132|9888416|FG000|STARTED|Washout 1-2 Months||4
8833954|NCT01653132|9888417|FG001|STARTED|Washout 1-2 Months||5
8833955|NCT01653132|9888416|FG000|COMPLETED|Washout 1-2 Months||4
8833956|NCT01653132|9888417|FG001|COMPLETED|Washout 1-2 Months||5
8833957|NCT01653132|9888416|FG000|NOT COMPLETED|Washout 1-2 Months||0
8833958|NCT01653132|9888417|FG001|NOT COMPLETED|Washout 1-2 Months||0
8833959|NCT01653132|9888416|FG000|STARTED|Second Intervention||4
8833960|NCT01653132|9888417|FG001|STARTED|Second Intervention||5
8833961|NCT01653132|9888416|FG000|COMPLETED|Second Intervention||4
8833962|NCT01653132|9888417|FG001|COMPLETED|Second Intervention||5
8833963|NCT01653132|9888416|FG000|NOT COMPLETED|Second Intervention||0
8833964|NCT01653132|9888417|FG001|NOT COMPLETED|Second Intervention||0
8833965|NCT01653158|9888427|FG000|STARTED|Overall Study||3
8833966|NCT01653158|9888428|FG001|STARTED|Overall Study||3
8833967|NCT01653158|9888429|FG002|STARTED|Overall Study||3
8833968|NCT01653158|9888430|FG003|STARTED|Overall Study||3
8833969|NCT01653158|9888431|FG004|STARTED|Overall Study||3
8833970|NCT01653158|9888432|FG005|STARTED|Overall Study||3
8833971|NCT01653158|9888433|FG006|STARTED|Overall Study||9
8833972|NCT01653158|9888434|FG007|STARTED|Overall Study|Six (6) and 13 participants were enrolled in dose escalation and expansion cohorts, respectively.|19
8833973|NCT01653158|9888427|FG000|COMPLETED|Overall Study||2
8833974|NCT01653158|9888428|FG001|COMPLETED|Overall Study||3
8833975|NCT01653158|9888429|FG002|COMPLETED|Overall Study||3
8833976|NCT01653158|9888430|FG003|COMPLETED|Overall Study||1
8833977|NCT01653158|9888431|FG004|COMPLETED|Overall Study||2
8833978|NCT01653158|9888432|FG005|COMPLETED|Overall Study||2
8833979|NCT01653158|9888433|FG006|COMPLETED|Overall Study||7
8833980|NCT01653158|9888434|FG007|COMPLETED|Overall Study||4
8833981|NCT01653158|9888427|FG000|NOT COMPLETED|Overall Study||1
8833982|NCT01653158|9888428|FG001|NOT COMPLETED|Overall Study||0
8833983|NCT01653158|9888429|FG002|NOT COMPLETED|Overall Study||0
8833984|NCT01653158|9888430|FG003|NOT COMPLETED|Overall Study||2
8833985|NCT01653158|9888431|FG004|NOT COMPLETED|Overall Study||1
8833986|NCT01653158|9888432|FG005|NOT COMPLETED|Overall Study||1
8833987|NCT01653158|9888433|FG006|NOT COMPLETED|Overall Study||2
8833988|NCT01653158|9888434|FG007|NOT COMPLETED|Overall Study||15
8833989|NCT01653210|9888457|FG000|STARTED|Overall Study||15
8833990|NCT01653210|9888457|FG000|COMPLETED|Overall Study||12
8833991|NCT01653210|9888457|FG000|NOT COMPLETED|Overall Study||3
8833992|NCT01653262|9888461|FG000|STARTED|Overall Study||29
8833993|NCT01653262|9888461|FG000|COMPLETED|Overall Study||26
8833994|NCT01653262|9888461|FG000|NOT COMPLETED|Overall Study||3
8833995|NCT01653288|9888467|FG000|STARTED|Overall Study||36
8833996|NCT01653288|9888468|FG001|STARTED|Overall Study||36
8833997|NCT01653288|9888467|FG000|COMPLETED|Overall Study||26
8833998|NCT01653288|9888468|FG001|COMPLETED|Overall Study||35
8833999|NCT01653288|9888467|FG000|NOT COMPLETED|Overall Study||10
8834000|NCT01653288|9888468|FG001|NOT COMPLETED|Overall Study||1
8834001|NCT01653327|9888476|FG000|STARTED|Overall Study||11
8834002|NCT01653327|9888476|FG000|COMPLETED|Overall Study||10
8834003|NCT01653327|9888476|FG000|NOT COMPLETED|Overall Study||1
8834004|NCT01653405|9888484|FG000|STARTED|Overall Study||11794
8834005|NCT01653405|9888485|FG001|STARTED|Overall Study||1248782
8834006|NCT01653405|9888484|FG000|COMPLETED|Overall Study|These patients had enough data to calculate TTR.|8029
8834007|NCT01653405|9888485|FG001|COMPLETED|Overall Study|These patients had enough data to calculate TTR.|179979
8834008|NCT01653405|9888484|FG000|NOT COMPLETED|Overall Study||3765
8834009|NCT01653405|9888485|FG001|NOT COMPLETED|Overall Study||1068803
8834010|NCT01653418|9888491|FG000|STARTED|Overall Study||10
8834011|NCT01653418|9888491|FG000|COMPLETED|Overall Study||10
8834012|NCT01653418|9888491|FG000|NOT COMPLETED|Overall Study||0
8834013|NCT01653509|9888497|FG000|STARTED|Overall Study||12
8834014|NCT01653509|9888498|FG001|STARTED|Overall Study||13
8834015|NCT01653509|9888497|FG000|COMPLETED|Overall Study||12
8834016|NCT01653509|9888498|FG001|COMPLETED|Overall Study||13
8834017|NCT01653509|9888497|FG000|NOT COMPLETED|Overall Study||0
8834018|NCT01653509|9888498|FG001|NOT COMPLETED|Overall Study||0
8834019|NCT01653587|9888508|FG000|STARTED|Overall Study||120
8834020|NCT01653587|9888509|FG001|STARTED|Overall Study||120
8834021|NCT01653587|9888508|FG000|COMPLETED|Overall Study||120
8834022|NCT01653587|9888509|FG001|COMPLETED|Overall Study||120
8834023|NCT01653587|9888508|FG000|NOT COMPLETED|Overall Study||0
8834024|NCT01653587|9888509|FG001|NOT COMPLETED|Overall Study||0
8834025|NCT01653704|9888517|FG000|STARTED|Overall Study||21
8834026|NCT01653704|9888518|FG001|STARTED|Overall Study||21
8834027|NCT01653704|9888517|FG000|COMPLETED|Overall Study||19
8834028|NCT01653704|9888518|FG001|COMPLETED|Overall Study||20
8834029|NCT01653704|9888517|FG000|NOT COMPLETED|Overall Study||2
8834030|NCT01653704|9888518|FG001|NOT COMPLETED|Overall Study||1
8834031|NCT01653743|9888526|FG000|STARTED|Overall Study||54
8834032|NCT01653743|9888527|FG001|STARTED|Overall Study||27
8834033|NCT01653743|9888526|FG000|COMPLETED|Overall Study||50
8834034|NCT01653743|9888527|FG001|COMPLETED|Overall Study||27
8834035|NCT01653743|9888526|FG000|NOT COMPLETED|Overall Study||4
8834036|NCT01653743|9888527|FG001|NOT COMPLETED|Overall Study||0
8834037|NCT01653782|9888536|FG000|STARTED|Overall Study||52
8834038|NCT01653782|9888537|FG001|STARTED|Overall Study||55
8834039|NCT01653782|9888538|FG002|STARTED|Overall Study||52
8834040|NCT01653782|9888536|FG000|COMPLETED|Overall Study||36
8834041|NCT01653782|9888537|FG001|COMPLETED|Overall Study||37
8834042|NCT01653782|9888538|FG002|COMPLETED|Overall Study||46
8834043|NCT01653782|9888536|FG000|NOT COMPLETED|Overall Study||16
8834044|NCT01653782|9888537|FG001|NOT COMPLETED|Overall Study||18
8834045|NCT01653782|9888538|FG002|NOT COMPLETED|Overall Study||6
8834046|NCT01653847|9888548|FG000|STARTED|Overall Study||20
8834047|NCT01653847|9888549|FG001|STARTED|Overall Study||20
8834048|NCT01653847|9888548|FG000|COMPLETED|Overall Study||19
8834049|NCT01653847|9888549|FG001|COMPLETED|Overall Study||20
8834050|NCT01653847|9888548|FG000|NOT COMPLETED|Overall Study||1
8834051|NCT01653847|9888549|FG001|NOT COMPLETED|Overall Study||0
8834052|NCT01653912|9888557|FG000|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||4
8834053|NCT01653912|9888558|FG001|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
8834054|NCT01653912|9888559|FG002|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
8834055|NCT01653912|9888560|FG003|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
8834056|NCT01653912|9888561|FG004|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
8834057|NCT01653912|9888562|FG005|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
8834058|NCT01653912|9888557|FG000|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||4
8834059|NCT01653912|9888558|FG001|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
8834060|NCT01653912|9888559|FG002|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
8834061|NCT01653912|9888560|FG003|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
8834062|NCT01653912|9888561|FG004|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
8834063|NCT01653912|9888562|FG005|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
8834064|NCT01653912|9888557|FG000|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
8834065|NCT01653912|9888558|FG001|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
8834066|NCT01653912|9888559|FG002|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
8834067|NCT01653912|9888560|FG003|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
8834068|NCT01653912|9888561|FG004|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
8834069|NCT01653912|9888562|FG005|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
8834070|NCT01653912|9888557|FG000|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
8834071|NCT01653912|9888558|FG001|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||4
8834072|NCT01653912|9888559|FG002|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
8834073|NCT01653912|9888560|FG003|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
8834074|NCT01653912|9888561|FG004|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
8834075|NCT01653912|9888562|FG005|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
8834076|NCT01653912|9888557|FG000|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
8834077|NCT01653912|9888558|FG001|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||3
8834078|NCT01653912|9888559|FG002|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
8834079|NCT01653912|9888560|FG003|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
8834080|NCT01653912|9888561|FG004|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
8834081|NCT01653912|9888562|FG005|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
8834082|NCT01653912|9888557|FG000|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
8834083|NCT01653912|9888558|FG001|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||1
8834084|NCT01653912|9888559|FG002|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
8834085|NCT01653912|9888560|FG003|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
8834086|NCT01653912|9888561|FG004|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
8834087|NCT01653912|9888562|FG005|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
8834088|NCT01653912|9888557|FG000|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
8834089|NCT01653912|9888558|FG001|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
8834090|NCT01653912|9888559|FG002|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||6
8834091|NCT01653912|9888560|FG003|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
8834092|NCT01653912|9888561|FG004|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
8834093|NCT01653912|9888562|FG005|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
8834094|NCT01653912|9888557|FG000|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
8834095|NCT01653912|9888558|FG001|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
8834096|NCT01653912|9888559|FG002|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||4
8834097|NCT01653912|9888560|FG003|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
8834098|NCT01653912|9888561|FG004|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
8834099|NCT01653912|9888562|FG005|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
8834100|NCT01653912|9888557|FG000|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
8834101|NCT01653912|9888558|FG001|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
8834102|NCT01653912|9888559|FG002|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||2
8834103|NCT01653912|9888560|FG003|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
8834104|NCT01653912|9888561|FG004|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
8834105|NCT01653912|9888562|FG005|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
8834106|NCT01653912|9888557|FG000|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
8834107|NCT01653912|9888558|FG001|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
8834108|NCT01653912|9888559|FG002|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
8834109|NCT01653912|9888560|FG003|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||12
8834110|NCT01653912|9888561|FG004|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
8834111|NCT01653912|9888562|FG005|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
8834112|NCT01653912|9888557|FG000|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
8834113|NCT01653912|9888558|FG001|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
8834114|NCT01653912|9888559|FG002|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
8622739|NCT00489853|9661957|FG000|STARTED|Wash-out Period 1||36
8622740|NCT00489853|9661958|FG001|STARTED|Wash-out Period 1||37
8622741|NCT00489853|9661959|FG002|STARTED|Wash-out Period 1||38
8622742|NCT00489853|9661957|FG000|COMPLETED|Wash-out Period 1||35
8622743|NCT00489853|9661958|FG001|COMPLETED|Wash-out Period 1||34
8622744|NCT00489853|9661959|FG002|COMPLETED|Wash-out Period 1||32
8622745|NCT00489853|9661957|FG000|NOT COMPLETED|Wash-out Period 1||1
8622746|NCT00489853|9661958|FG001|NOT COMPLETED|Wash-out Period 1||3
8622747|NCT00489853|9661959|FG002|NOT COMPLETED|Wash-out Period 1||6
8622748|NCT00489853|9661957|FG000|STARTED|Treatment Period 2||33
8622749|NCT00489853|9661958|FG001|STARTED|Treatment Period 2||35
8622750|NCT00489853|9661959|FG002|STARTED|Treatment Period 2||33
8622751|NCT00489853|9661957|FG000|COMPLETED|Treatment Period 2||33
8622752|NCT00489853|9661958|FG001|COMPLETED|Treatment Period 2||35
8622753|NCT00489853|9661959|FG002|COMPLETED|Treatment Period 2||33
8834115|NCT01653912|9888560|FG003|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||10
8834116|NCT01653912|9888561|FG004|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
8834117|NCT01653912|9888562|FG005|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
8834118|NCT01653912|9888557|FG000|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
8834119|NCT01653912|9888558|FG001|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
8834120|NCT01653912|9888559|FG002|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
8834121|NCT01653912|9888560|FG003|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||2
8834122|NCT01653912|9888561|FG004|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
8834123|NCT01653912|9888562|FG005|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
8834124|NCT01653912|9888557|FG000|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
8834125|NCT01653912|9888558|FG001|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
8834126|NCT01653912|9888559|FG002|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
8834127|NCT01653912|9888560|FG003|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
8622754|NCT00489853|9661957|FG000|NOT COMPLETED|Treatment Period 2||0
8622755|NCT00489853|9661958|FG001|NOT COMPLETED|Treatment Period 2||0
8622756|NCT00489853|9661959|FG002|NOT COMPLETED|Treatment Period 2||0
8622757|NCT00489853|9661957|FG000|STARTED|Wash-out Period 2||33
8622758|NCT00489853|9661958|FG001|STARTED|Wash-out Period 2||35
8622759|NCT00489853|9661959|FG002|STARTED|Wash-out Period 2||33
8622760|NCT00489853|9661957|FG000|COMPLETED|Wash-out Period 2||29
8834128|NCT01653912|9888561|FG004|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||3
8834129|NCT01653912|9888562|FG005|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
8834130|NCT01653912|9888557|FG000|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
8834131|NCT01653912|9888558|FG001|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
8622761|NCT00489853|9661958|FG001|COMPLETED|Wash-out Period 2||32
8622762|NCT00489853|9661959|FG002|COMPLETED|Wash-out Period 2||31
8834132|NCT01653912|9888559|FG002|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
8834133|NCT01653912|9888560|FG003|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
8834134|NCT01653912|9888561|FG004|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||3
8622763|NCT00489853|9661957|FG000|NOT COMPLETED|Wash-out Period 2||4
8622764|NCT00489853|9661958|FG001|NOT COMPLETED|Wash-out Period 2||3
8622765|NCT00489853|9661959|FG002|NOT COMPLETED|Wash-out Period 2||2
8622766|NCT00489853|9661957|FG000|STARTED|Treatment Period 3||29
8622767|NCT00489853|9661958|FG001|STARTED|Treatment Period 3||30
8622768|NCT00489853|9661959|FG002|STARTED|Treatment Period 3||33
8622769|NCT00489853|9661957|FG000|COMPLETED|Treatment Period 3||29
8622770|NCT00489853|9661958|FG001|COMPLETED|Treatment Period 3||29
8622771|NCT00489853|9661959|FG002|COMPLETED|Treatment Period 3||33
8622772|NCT00489853|9661957|FG000|NOT COMPLETED|Treatment Period 3||0
8622773|NCT00489853|9661958|FG001|NOT COMPLETED|Treatment Period 3||1
8622774|NCT00489853|9661959|FG002|NOT COMPLETED|Treatment Period 3||0
8834135|NCT01653912|9888562|FG005|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
8834136|NCT01653912|9888557|FG000|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
8834137|NCT01653912|9888558|FG001|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
8834138|NCT01653912|9888559|FG002|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
8834139|NCT01653912|9888560|FG003|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
8834140|NCT01653912|9888561|FG004|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
8834141|NCT01653912|9888562|FG005|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
8834142|NCT01653912|9888557|FG000|STARTED|Phase 2: GSK2110183 125 mg||0
8834143|NCT01653912|9888558|FG001|STARTED|Phase 2: GSK2110183 125 mg||0
8834144|NCT01653912|9888559|FG002|STARTED|Phase 2: GSK2110183 125 mg||0
8834145|NCT01653912|9888560|FG003|STARTED|Phase 2: GSK2110183 125 mg||0
8834146|NCT01653912|9888561|FG004|STARTED|Phase 2: GSK2110183 125 mg||0
8622775|NCT00489853|9661957|FG000|STARTED|Follow-up Period||29
8622776|NCT00489853|9661958|FG001|STARTED|Follow-up Period||29
8622777|NCT00489853|9661959|FG002|STARTED|Follow-up Period||33
8622778|NCT00489853|9661957|FG000|COMPLETED|Follow-up Period||29
8622779|NCT00489853|9661958|FG001|COMPLETED|Follow-up Period||29
8622780|NCT00489853|9661959|FG002|COMPLETED|Follow-up Period||33
8622781|NCT00489853|9661957|FG000|NOT COMPLETED|Follow-up Period||0
8622782|NCT00489853|9661958|FG001|NOT COMPLETED|Follow-up Period||0
8622783|NCT00489853|9661959|FG002|NOT COMPLETED|Follow-up Period||0
8622784|NCT00489866|9661969|FG000|STARTED|Overall Study||7
8622785|NCT00489866|9661970|FG001|STARTED|Overall Study||7
8622786|NCT00489866|9661969|FG000|COMPLETED|Overall Study||5
8622787|NCT00489866|9661970|FG001|COMPLETED|Overall Study||7
8622788|NCT00489866|9661969|FG000|NOT COMPLETED|Overall Study||2
8622789|NCT00489866|9661970|FG001|NOT COMPLETED|Overall Study||0
8622790|NCT00489918|9661989|FG000|STARTED|Overall Study||33
8834147|NCT01653912|9888562|FG005|STARTED|Phase 2: GSK2110183 125 mg|Per SAP, Cohort B (n=2) data was summarized in phase 2 total column as cohort B had <10 subjects.|30
8834148|NCT01653912|9888557|FG000|COMPLETED|Phase 2: GSK2110183 125 mg||0
8834149|NCT01653912|9888558|FG001|COMPLETED|Phase 2: GSK2110183 125 mg||0
8834150|NCT01653912|9888559|FG002|COMPLETED|Phase 2: GSK2110183 125 mg||0
8834151|NCT01653912|9888560|FG003|COMPLETED|Phase 2: GSK2110183 125 mg||0
8834152|NCT01653912|9888561|FG004|COMPLETED|Phase 2: GSK2110183 125 mg||0
8834153|NCT01653912|9888562|FG005|COMPLETED|Phase 2: GSK2110183 125 mg||22
8834154|NCT01653912|9888557|FG000|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
8834155|NCT01653912|9888558|FG001|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
8834156|NCT01653912|9888559|FG002|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
8834157|NCT01653912|9888560|FG003|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
8834158|NCT01653912|9888561|FG004|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
8834159|NCT01653912|9888562|FG005|NOT COMPLETED|Phase 2: GSK2110183 125 mg||8
8834160|NCT01653964|9888568|FG000|STARTED|Overall Study||82
8622791|NCT00489918|9661990|FG001|STARTED|Overall Study||34
8622792|NCT00489918|9661991|FG002|STARTED|Overall Study||32
8622793|NCT00489918|9661992|FG003|STARTED|Overall Study||33
8622794|NCT00489918|9661993|FG004|STARTED|Overall Study||33
8622795|NCT00489918|9661989|FG000|COMPLETED|Overall Study||31
8622796|NCT00489918|9661990|FG001|COMPLETED|Overall Study||32
8622797|NCT00489918|9661991|FG002|COMPLETED|Overall Study||28
8622798|NCT00489918|9661992|FG003|COMPLETED|Overall Study||32
8834161|NCT01653964|9888568|FG000|COMPLETED|Overall Study||82
8834162|NCT01653964|9888568|FG000|NOT COMPLETED|Overall Study||0
8834163|NCT01654068|9888572|FG000|STARTED|Overall Study||14
8834164|NCT01654068|9888572|FG000|COMPLETED|Overall Study||14
8834165|NCT01654068|9888572|FG000|NOT COMPLETED|Overall Study||0
8622799|NCT00489918|9661993|FG004|COMPLETED|Overall Study||32
8622800|NCT00489918|9661989|FG000|NOT COMPLETED|Overall Study||2
8622801|NCT00489918|9661990|FG001|NOT COMPLETED|Overall Study||2
8622802|NCT00489918|9661991|FG002|NOT COMPLETED|Overall Study||4
8622803|NCT00489918|9661992|FG003|NOT COMPLETED|Overall Study||1
8622804|NCT00489918|9661993|FG004|NOT COMPLETED|Overall Study||1
8622805|NCT00489970|9662008|FG000|STARTED|Persistence Year 1||1069
8622806|NCT00489970|9662009|FG001|STARTED|Persistence Year 1||523
8622807|NCT00489970|9662010|FG002|STARTED|Persistence Year 1||0
8834166|NCT01654107|9888578|FG000|STARTED|Overall Study||28
8622808|NCT00489970|9662008|FG000|COMPLETED|Persistence Year 1||1069
8622809|NCT00489970|9662009|FG001|COMPLETED|Persistence Year 1||523
8622810|NCT00489970|9662010|FG002|COMPLETED|Persistence Year 1||0
8622811|NCT00489970|9662008|FG000|NOT COMPLETED|Persistence Year 1||0
8622812|NCT00489970|9662009|FG001|NOT COMPLETED|Persistence Year 1||0
8622813|NCT00489970|9662010|FG002|NOT COMPLETED|Persistence Year 1||0
8622814|NCT00489970|9662008|FG000|STARTED|Persistence Year 3|Number of subjects who returned at Year 3|1019
8622815|NCT00489970|9662009|FG001|STARTED|Persistence Year 3|Number of subjects who returned at Year 3|486
8622816|NCT00489970|9662010|FG002|STARTED|Persistence Year 3||0
8622817|NCT00489970|9662008|FG000|COMPLETED|Persistence Year 3||1019
8622818|NCT00489970|9662009|FG001|COMPLETED|Persistence Year 3||486
8622819|NCT00489970|9662010|FG002|COMPLETED|Persistence Year 3||0
8622820|NCT00489970|9662008|FG000|NOT COMPLETED|Persistence Year 3||0
8834167|NCT01654107|9888579|FG001|STARTED|Overall Study||30
8834168|NCT01654107|9888578|FG000|COMPLETED|Overall Study||25
8834169|NCT01654107|9888579|FG001|COMPLETED|Overall Study||22
8834170|NCT01654107|9888578|FG000|NOT COMPLETED|Overall Study||3
8834171|NCT01654107|9888579|FG001|NOT COMPLETED|Overall Study||8
8834172|NCT01654224|9888587|FG000|STARTED|Overall Study||95
8834173|NCT01654224|9888588|FG001|STARTED|Overall Study||110
8834174|NCT01654224|9888587|FG000|COMPLETED|Overall Study||89
8834175|NCT01654224|9888588|FG001|COMPLETED|Overall Study||98
8834176|NCT01654224|9888587|FG000|NOT COMPLETED|Overall Study||6
8834177|NCT01654224|9888588|FG001|NOT COMPLETED|Overall Study||12
8834178|NCT01654250|9888596|FG000|STARTED|Overall Study||44
8834179|NCT01654250|9888597|FG001|STARTED|Overall Study||42
8834180|NCT01654250|9888596|FG000|COMPLETED|Overall Study||43
8834181|NCT01654250|9888597|FG001|COMPLETED|Overall Study||42
8834182|NCT01654250|9888596|FG000|NOT COMPLETED|Overall Study||1
8834183|NCT01654250|9888597|FG001|NOT COMPLETED|Overall Study||0
8834184|NCT01654263|9888610|FG000|STARTED|Overall Study||164
8834185|NCT01654263|9888611|FG001|STARTED|Overall Study||147
8834186|NCT01654263|9888612|FG002|STARTED|Overall Study||139
8834187|NCT01654263|9888613|FG003|STARTED|Overall Study||145
8834188|NCT01654263|9888614|FG004|STARTED|Overall Study||140
8834189|NCT01654263|9888615|FG005|STARTED|Overall Study||149
8834190|NCT01654263|9888610|FG000|COMPLETED|Overall Study||164
8834191|NCT01654263|9888611|FG001|COMPLETED|Overall Study||147
8834192|NCT01654263|9888612|FG002|COMPLETED|Overall Study||137
8834193|NCT01654263|9888613|FG003|COMPLETED|Overall Study||144
8834194|NCT01654263|9888614|FG004|COMPLETED|Overall Study||139
8834195|NCT01654263|9888615|FG005|COMPLETED|Overall Study||148
8834196|NCT01654263|9888610|FG000|NOT COMPLETED|Overall Study||0
8834197|NCT01654263|9888611|FG001|NOT COMPLETED|Overall Study||0
8834198|NCT01654263|9888612|FG002|NOT COMPLETED|Overall Study||2
8834199|NCT01654263|9888613|FG003|NOT COMPLETED|Overall Study||1
8834200|NCT01654263|9888614|FG004|NOT COMPLETED|Overall Study||1
8834201|NCT01654263|9888615|FG005|NOT COMPLETED|Overall Study||1
8834202|NCT01654276|9888626|FG000|STARTED|Overall Study||24
8834203|NCT01654276|9888626|FG000|Visit 2 (2 Months)|Overall Study||19
8834204|NCT01654276|9888626|FG000|Visit 3 (4 Months)|Overall Study||18
8834205|NCT01654276|9888626|FG000|Visit 4 (6months)|Overall Study||18
8834206|NCT01654276|9888626|FG000|COMPLETED|Overall Study||18
8834207|NCT01654276|9888626|FG000|NOT COMPLETED|Overall Study||6
8834208|NCT01654289|9888633|FG000|STARTED|Overall Study||138
8834209|NCT01654289|9888634|FG001|STARTED|Overall Study||137
8834210|NCT01654289|9888635|FG002|STARTED|Overall Study||138
8834211|NCT01654289|9888633|FG000|COMPLETED|Overall Study||111
8834212|NCT01654289|9888634|FG001|COMPLETED|Overall Study||109
8834213|NCT01654289|9888635|FG002|COMPLETED|Overall Study||133
8622821|NCT00489970|9662009|FG001|NOT COMPLETED|Persistence Year 3||0
8622822|NCT00489970|9662010|FG002|NOT COMPLETED|Persistence Year 3||0
8834214|NCT01654289|9888633|FG000|NOT COMPLETED|Overall Study||27
8834215|NCT01654289|9888634|FG001|NOT COMPLETED|Overall Study||28
8834216|NCT01654289|9888635|FG002|NOT COMPLETED|Overall Study||5
8834217|NCT01654302|9888645|FG000|STARTED|First Intervention (Day 1)||20
8834218|NCT01654302|9888646|FG001|STARTED|First Intervention (Day 1)||20
8834219|NCT01654302|9888645|FG000|COMPLETED|First Intervention (Day 1)||20
8834220|NCT01654302|9888646|FG001|COMPLETED|First Intervention (Day 1)||20
8834221|NCT01654302|9888645|FG000|NOT COMPLETED|First Intervention (Day 1)||0
8834222|NCT01654302|9888646|FG001|NOT COMPLETED|First Intervention (Day 1)||0
8834223|NCT01654302|9888645|FG000|STARTED|Second Intervention (Day 7)||20
8834224|NCT01654302|9888646|FG001|STARTED|Second Intervention (Day 7)||20
8834225|NCT01654302|9888645|FG000|COMPLETED|Second Intervention (Day 7)||19
8834226|NCT01654302|9888646|FG001|COMPLETED|Second Intervention (Day 7)||19
8834227|NCT01654302|9888645|FG000|NOT COMPLETED|Second Intervention (Day 7)||1
8834228|NCT01654302|9888646|FG001|NOT COMPLETED|Second Intervention (Day 7)||1
8834229|NCT01654380|9888654|FG000|STARTED|Part A, Period 1||4
8834230|NCT01654380|9888655|FG001|STARTED|Part A, Period 1||4
8834231|NCT01654380|9888656|FG002|STARTED|Part A, Period 1||0
8834232|NCT01654380|9888657|FG003|STARTED|Part A, Period 1||0
8834233|NCT01654380|9888654|FG000|Received at Least 1 Dose of Study Drug|Part A, Period 1||4
8834234|NCT01654380|9888655|FG001|Received at Least 1 Dose of Study Drug|Part A, Period 1||4
8834235|NCT01654380|9888656|FG002|Received at Least 1 Dose of Study Drug|Part A, Period 1||0
8834236|NCT01654380|9888657|FG003|Received at Least 1 Dose of Study Drug|Part A, Period 1||0
8834237|NCT01654380|9888654|FG000|COMPLETED|Part A, Period 1||4
8834238|NCT01654380|9888655|FG001|COMPLETED|Part A, Period 1||4
8834239|NCT01654380|9888656|FG002|COMPLETED|Part A, Period 1||0
8834240|NCT01654380|9888657|FG003|COMPLETED|Part A, Period 1||0
8834241|NCT01654380|9888654|FG000|NOT COMPLETED|Part A, Period 1||0
8834242|NCT01654380|9888655|FG001|NOT COMPLETED|Part A, Period 1||0
8834243|NCT01654380|9888656|FG002|NOT COMPLETED|Part A, Period 1||0
8834244|NCT01654380|9888657|FG003|NOT COMPLETED|Part A, Period 1||0
8834245|NCT01654380|9888654|FG000|STARTED|Part A, Washout of at Least 6 Days||4
8834246|NCT01654380|9888655|FG001|STARTED|Part A, Washout of at Least 6 Days||4
8834247|NCT01654380|9888656|FG002|STARTED|Part A, Washout of at Least 6 Days||0
8834248|NCT01654380|9888657|FG003|STARTED|Part A, Washout of at Least 6 Days||0
8834249|NCT01654380|9888654|FG000|COMPLETED|Part A, Washout of at Least 6 Days||4
8834250|NCT01654380|9888655|FG001|COMPLETED|Part A, Washout of at Least 6 Days||4
8834251|NCT01654380|9888656|FG002|COMPLETED|Part A, Washout of at Least 6 Days||0
8834252|NCT01654380|9888657|FG003|COMPLETED|Part A, Washout of at Least 6 Days||0
8834253|NCT01654380|9888654|FG000|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
8834254|NCT01654380|9888655|FG001|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
8834255|NCT01654380|9888656|FG002|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
8834256|NCT01654380|9888657|FG003|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
8834257|NCT01654380|9888654|FG000|STARTED|Part A, Period 2||4
8834258|NCT01654380|9888655|FG001|STARTED|Part A, Period 2||4
8834259|NCT01654380|9888656|FG002|STARTED|Part A, Period 2||0
8834260|NCT01654380|9888657|FG003|STARTED|Part A, Period 2||0
8834261|NCT01654380|9888654|FG000|COMPLETED|Part A, Period 2||4
8834262|NCT01654380|9888655|FG001|COMPLETED|Part A, Period 2||4
8834263|NCT01654380|9888656|FG002|COMPLETED|Part A, Period 2||0
8834264|NCT01654380|9888657|FG003|COMPLETED|Part A, Period 2||0
8834265|NCT01654380|9888654|FG000|NOT COMPLETED|Part A, Period 2||0
8834266|NCT01654380|9888655|FG001|NOT COMPLETED|Part A, Period 2||0
8834267|NCT01654380|9888656|FG002|NOT COMPLETED|Part A, Period 2||0
8834268|NCT01654380|9888657|FG003|NOT COMPLETED|Part A, Period 2||0
8834269|NCT01654380|9888654|FG000|STARTED|Part A, Washout of at Least 6 Days||4
8834270|NCT01654380|9888655|FG001|STARTED|Part A, Washout of at Least 6 Days||4
8834271|NCT01654380|9888656|FG002|STARTED|Part A, Washout of at Least 6 Days||0
8834272|NCT01654380|9888657|FG003|STARTED|Part A, Washout of at Least 6 Days||0
8834273|NCT01654380|9888654|FG000|COMPLETED|Part A, Washout of at Least 6 Days||4
8834274|NCT01654380|9888655|FG001|COMPLETED|Part A, Washout of at Least 6 Days||4
8834275|NCT01654380|9888656|FG002|COMPLETED|Part A, Washout of at Least 6 Days||0
8834276|NCT01654380|9888657|FG003|COMPLETED|Part A, Washout of at Least 6 Days||0
8834277|NCT01654380|9888654|FG000|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
8834278|NCT01654380|9888655|FG001|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
8834279|NCT01654380|9888656|FG002|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
8834280|NCT01654380|9888657|FG003|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
8834281|NCT01654380|9888654|FG000|STARTED|Part A, Period 3||4
8834282|NCT01654380|9888655|FG001|STARTED|Part A, Period 3||4
8834283|NCT01654380|9888656|FG002|STARTED|Part A, Period 3||0
8834284|NCT01654380|9888657|FG003|STARTED|Part A, Period 3||0
8834285|NCT01654380|9888654|FG000|COMPLETED|Part A, Period 3||4
8834286|NCT01654380|9888655|FG001|COMPLETED|Part A, Period 3||4
8834287|NCT01654380|9888656|FG002|COMPLETED|Part A, Period 3||0
8834288|NCT01654380|9888657|FG003|COMPLETED|Part A, Period 3||0
8834289|NCT01654380|9888654|FG000|NOT COMPLETED|Part A, Period 3||0
8834290|NCT01654380|9888655|FG001|NOT COMPLETED|Part A, Period 3||0
8834291|NCT01654380|9888656|FG002|NOT COMPLETED|Part A, Period 3||0
8834292|NCT01654380|9888657|FG003|NOT COMPLETED|Part A, Period 3||0
8834293|NCT01654380|9888654|FG000|STARTED|Part A, Washout of at Least 6 Days||4
8834294|NCT01654380|9888655|FG001|STARTED|Part A, Washout of at Least 6 Days||4
8834295|NCT01654380|9888656|FG002|STARTED|Part A, Washout of at Least 6 Days||0
8834296|NCT01654380|9888657|FG003|STARTED|Part A, Washout of at Least 6 Days||0
8834297|NCT01654380|9888654|FG000|COMPLETED|Part A, Washout of at Least 6 Days||4
8834298|NCT01654380|9888655|FG001|COMPLETED|Part A, Washout of at Least 6 Days||4
8834299|NCT01654380|9888656|FG002|COMPLETED|Part A, Washout of at Least 6 Days||0
8834300|NCT01654380|9888657|FG003|COMPLETED|Part A, Washout of at Least 6 Days||0
8834301|NCT01654380|9888654|FG000|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
8834302|NCT01654380|9888655|FG001|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
8834303|NCT01654380|9888656|FG002|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
8834304|NCT01654380|9888657|FG003|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
8834305|NCT01654380|9888654|FG000|STARTED|Part A, Period 4||4
8834306|NCT01654380|9888655|FG001|STARTED|Part A, Period 4||4
8834307|NCT01654380|9888656|FG002|STARTED|Part A, Period 4||0
8834308|NCT01654380|9888657|FG003|STARTED|Part A, Period 4||0
8834309|NCT01654380|9888654|FG000|COMPLETED|Part A, Period 4||4
8834310|NCT01654380|9888655|FG001|COMPLETED|Part A, Period 4||4
8834311|NCT01654380|9888656|FG002|COMPLETED|Part A, Period 4||0
8834312|NCT01654380|9888657|FG003|COMPLETED|Part A, Period 4||0
8834313|NCT01654380|9888654|FG000|NOT COMPLETED|Part A, Period 4||0
8834314|NCT01654380|9888655|FG001|NOT COMPLETED|Part A, Period 4||0
8834315|NCT01654380|9888656|FG002|NOT COMPLETED|Part A, Period 4||0
8834316|NCT01654380|9888657|FG003|NOT COMPLETED|Part A, Period 4||0
8834317|NCT01654380|9888654|FG000|STARTED|Part B, Period 1|Participants in Part A were not included in Part B.|0
8834318|NCT01654380|9888655|FG001|STARTED|Part B, Period 1|Participants in Part A were not included in Part B.|0
8834319|NCT01654380|9888656|FG002|STARTED|Part B, Period 1|Participants in Part B were not included in Part A.|7
8834320|NCT01654380|9888657|FG003|STARTED|Part B, Period 1|Participants in Part B were not included in Part A.|7
8834321|NCT01654380|9888654|FG000|Received at Least 1 Dose of Study Drug|Part B, Period 1||0
8834322|NCT01654380|9888655|FG001|Received at Least 1 Dose of Study Drug|Part B, Period 1||0
8834323|NCT01654380|9888656|FG002|Received at Least 1 Dose of Study Drug|Part B, Period 1||7
8834324|NCT01654380|9888657|FG003|Received at Least 1 Dose of Study Drug|Part B, Period 1||7
8834325|NCT01654380|9888654|FG000|COMPLETED|Part B, Period 1||0
8834326|NCT01654380|9888655|FG001|COMPLETED|Part B, Period 1||0
8834327|NCT01654380|9888656|FG002|COMPLETED|Part B, Period 1|Participant who did not complete received only 1 dose of LY2605541 74.1 mU/min IV for 8 hours|6
8834328|NCT01654380|9888657|FG003|COMPLETED|Part B, Period 1||7
8834329|NCT01654380|9888654|FG000|NOT COMPLETED|Part B, Period 1||0
8834330|NCT01654380|9888655|FG001|NOT COMPLETED|Part B, Period 1||0
8834331|NCT01654380|9888656|FG002|NOT COMPLETED|Part B, Period 1||1
8834332|NCT01654380|9888657|FG003|NOT COMPLETED|Part B, Period 1||0
8834333|NCT01654380|9888654|FG000|STARTED|Part B, Washout of at Least 6 Days||0
8834334|NCT01654380|9888655|FG001|STARTED|Part B, Washout of at Least 6 Days||0
8834335|NCT01654380|9888656|FG002|STARTED|Part B, Washout of at Least 6 Days||6
8834336|NCT01654380|9888657|FG003|STARTED|Part B, Washout of at Least 6 Days||7
8834337|NCT01654380|9888654|FG000|COMPLETED|Part B, Washout of at Least 6 Days||0
8834338|NCT01654380|9888655|FG001|COMPLETED|Part B, Washout of at Least 6 Days||0
8834339|NCT01654380|9888656|FG002|COMPLETED|Part B, Washout of at Least 6 Days||6
8834340|NCT01654380|9888657|FG003|COMPLETED|Part B, Washout of at Least 6 Days||7
8834341|NCT01654380|9888654|FG000|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
8834342|NCT01654380|9888655|FG001|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
8834343|NCT01654380|9888656|FG002|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
8834344|NCT01654380|9888657|FG003|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
8834345|NCT01654380|9888654|FG000|STARTED|Part B, Period 2||0
8834346|NCT01654380|9888655|FG001|STARTED|Part B, Period 2||0
8834347|NCT01654380|9888656|FG002|STARTED|Part B, Period 2||6
8834348|NCT01654380|9888657|FG003|STARTED|Part B, Period 2||7
8834349|NCT01654380|9888654|FG000|COMPLETED|Part B, Period 2||0
8834350|NCT01654380|9888655|FG001|COMPLETED|Part B, Period 2||0
8834351|NCT01654380|9888656|FG002|COMPLETED|Part B, Period 2||6
8834352|NCT01654380|9888657|FG003|COMPLETED|Part B, Period 2||7
8834353|NCT01654380|9888654|FG000|NOT COMPLETED|Part B, Period 2||0
8834354|NCT01654380|9888655|FG001|NOT COMPLETED|Part B, Period 2||0
8834355|NCT01654380|9888656|FG002|NOT COMPLETED|Part B, Period 2||0
8834356|NCT01654380|9888657|FG003|NOT COMPLETED|Part B, Period 2||0
8834357|NCT01654380|9888654|FG000|STARTED|Part B, Washout of at Least 6 Days||0
8834358|NCT01654380|9888655|FG001|STARTED|Part B, Washout of at Least 6 Days||0
8834359|NCT01654380|9888656|FG002|STARTED|Part B, Washout of at Least 6 Days||6
8834360|NCT01654380|9888657|FG003|STARTED|Part B, Washout of at Least 6 Days||7
8834361|NCT01654380|9888654|FG000|COMPLETED|Part B, Washout of at Least 6 Days||0
8834362|NCT01654380|9888655|FG001|COMPLETED|Part B, Washout of at Least 6 Days||0
8834363|NCT01654380|9888656|FG002|COMPLETED|Part B, Washout of at Least 6 Days||6
8834364|NCT01654380|9888657|FG003|COMPLETED|Part B, Washout of at Least 6 Days||7
8834365|NCT01654380|9888654|FG000|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
8834366|NCT01654380|9888655|FG001|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
8834367|NCT01654380|9888656|FG002|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
8834368|NCT01654380|9888657|FG003|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
8834369|NCT01654380|9888654|FG000|STARTED|Part B, Period 3||0
8834370|NCT01654380|9888655|FG001|STARTED|Part B, Period 3||0
8834371|NCT01654380|9888656|FG002|STARTED|Part B, Period 3||6
8834372|NCT01654380|9888657|FG003|STARTED|Part B, Period 3||7
8834373|NCT01654380|9888654|FG000|COMPLETED|Part B, Period 3||0
8834374|NCT01654380|9888655|FG001|COMPLETED|Part B, Period 3||0
8834375|NCT01654380|9888656|FG002|COMPLETED|Part B, Period 3||6
8834376|NCT01654380|9888657|FG003|COMPLETED|Part B, Period 3||7
8834377|NCT01654380|9888654|FG000|NOT COMPLETED|Part B, Period 3||0
8834378|NCT01654380|9888655|FG001|NOT COMPLETED|Part B, Period 3||0
8834379|NCT01654380|9888656|FG002|NOT COMPLETED|Part B, Period 3||0
8834380|NCT01654380|9888657|FG003|NOT COMPLETED|Part B, Period 3||0
8834381|NCT01654380|9888654|FG000|STARTED|Part B, Washout of at Least 6 Days||0
8834382|NCT01654380|9888655|FG001|STARTED|Part B, Washout of at Least 6 Days||0
8834383|NCT01654380|9888656|FG002|STARTED|Part B, Washout of at Least 6 Days||6
8834384|NCT01654380|9888657|FG003|STARTED|Part B, Washout of at Least 6 Days||7
8622823|NCT00489970|9662008|FG000|STARTED|Persistence Year 5|Number of subjects who returned at Year 5|856
8622824|NCT00489970|9662009|FG001|STARTED|Persistence Year 5|Number of subjects who returned at Year 5|401
8622825|NCT00489970|9662010|FG002|STARTED|Persistence Year 5||0
8622826|NCT00489970|9662008|FG000|COMPLETED|Persistence Year 5||856
8622827|NCT00489970|9662009|FG001|COMPLETED|Persistence Year 5||401
8622828|NCT00489970|9662010|FG002|COMPLETED|Persistence Year 5||0
8622829|NCT00489970|9662008|FG000|NOT COMPLETED|Persistence Year 5||0
8622830|NCT00489970|9662009|FG001|NOT COMPLETED|Persistence Year 5||0
8834385|NCT01654380|9888654|FG000|COMPLETED|Part B, Washout of at Least 6 Days||0
8834386|NCT01654380|9888655|FG001|COMPLETED|Part B, Washout of at Least 6 Days||0
8834387|NCT01654380|9888656|FG002|COMPLETED|Part B, Washout of at Least 6 Days||6
8834388|NCT01654380|9888657|FG003|COMPLETED|Part B, Washout of at Least 6 Days||7
8834389|NCT01654380|9888654|FG000|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
8834390|NCT01654380|9888655|FG001|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
8834391|NCT01654380|9888656|FG002|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
8834392|NCT01654380|9888657|FG003|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
8834393|NCT01654380|9888654|FG000|STARTED|Part B, Period 4||0
8834394|NCT01654380|9888655|FG001|STARTED|Part B, Period 4||0
8834395|NCT01654380|9888656|FG002|STARTED|Part B, Period 4||6
8834396|NCT01654380|9888657|FG003|STARTED|Part B, Period 4||7
8834397|NCT01654380|9888654|FG000|COMPLETED|Part B, Period 4||0
8834398|NCT01654380|9888655|FG001|COMPLETED|Part B, Period 4||0
8834399|NCT01654380|9888656|FG002|COMPLETED|Part B, Period 4||6
8834400|NCT01654380|9888657|FG003|COMPLETED|Part B, Period 4||7
8834401|NCT01654380|9888654|FG000|NOT COMPLETED|Part B, Period 4||0
8834402|NCT01654380|9888655|FG001|NOT COMPLETED|Part B, Period 4||0
8834403|NCT01654380|9888656|FG002|NOT COMPLETED|Part B, Period 4||0
8834404|NCT01654380|9888657|FG003|NOT COMPLETED|Part B, Period 4||0
8834405|NCT01654445|9888676|FG000|STARTED|Overall Study||25
8834406|NCT01654445|9888677|FG001|STARTED|Overall Study||25
8834407|NCT01654445|9888676|FG000|COMPLETED|Overall Study||25
8834408|NCT01654445|9888677|FG001|COMPLETED|Overall Study||25
8834409|NCT01654445|9888676|FG000|NOT COMPLETED|Overall Study||0
8834410|NCT01654445|9888677|FG001|NOT COMPLETED|Overall Study||0
8849857|NCT01743677|9905102|FG004|STARTED|Washout Period 1 (at Least 7 Days)||10
8849858|NCT01743677|9905103|FG005|STARTED|Washout Period 1 (at Least 7 Days)||10
8849859|NCT01743677|9905098|FG000|COMPLETED|Washout Period 1 (at Least 7 Days)||10
8849860|NCT01743677|9905099|FG001|COMPLETED|Washout Period 1 (at Least 7 Days)||10
8849861|NCT01743677|9905100|FG002|COMPLETED|Washout Period 1 (at Least 7 Days)||10
8849862|NCT01743677|9905101|FG003|COMPLETED|Washout Period 1 (at Least 7 Days)||10
8849863|NCT01743677|9905102|FG004|COMPLETED|Washout Period 1 (at Least 7 Days)||10
8849864|NCT01743677|9905103|FG005|COMPLETED|Washout Period 1 (at Least 7 Days)||10
8849865|NCT01743677|9905098|FG000|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0
8849866|NCT01743677|9905099|FG001|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0
8849867|NCT01743677|9905100|FG002|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0
8849868|NCT01743677|9905101|FG003|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0
8849869|NCT01743677|9905102|FG004|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0
8849870|NCT01743677|9905103|FG005|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0
8849871|NCT01743677|9905098|FG000|STARTED|Second Intervention Period||10
8849872|NCT01743677|9905099|FG001|STARTED|Second Intervention Period||10
8849873|NCT01743677|9905100|FG002|STARTED|Second Intervention Period||10
8849874|NCT01743677|9905101|FG003|STARTED|Second Intervention Period||10
8849875|NCT01743677|9905102|FG004|STARTED|Second Intervention Period||10
8849876|NCT01743677|9905103|FG005|STARTED|Second Intervention Period||10
8849877|NCT01743677|9905098|FG000|COMPLETED|Second Intervention Period||10
8849878|NCT01743677|9905099|FG001|COMPLETED|Second Intervention Period||10
8849879|NCT01743677|9905100|FG002|COMPLETED|Second Intervention Period||10
8849880|NCT01743677|9905101|FG003|COMPLETED|Second Intervention Period||10
8849881|NCT01743677|9905102|FG004|COMPLETED|Second Intervention Period||10
8849882|NCT01743677|9905103|FG005|COMPLETED|Second Intervention Period||10
8849883|NCT01743677|9905098|FG000|NOT COMPLETED|Second Intervention Period||0
8849884|NCT01743677|9905099|FG001|NOT COMPLETED|Second Intervention Period||0
8849885|NCT01743677|9905100|FG002|NOT COMPLETED|Second Intervention Period||0
8849886|NCT01743677|9905101|FG003|NOT COMPLETED|Second Intervention Period||0
8849887|NCT01743677|9905102|FG004|NOT COMPLETED|Second Intervention Period||0
8849888|NCT01743677|9905103|FG005|NOT COMPLETED|Second Intervention Period||0
8849889|NCT01743677|9905098|FG000|STARTED|Washout Period 2 (at Least 7 Days)||10
8849890|NCT01743677|9905099|FG001|STARTED|Washout Period 2 (at Least 7 Days)||10
8849891|NCT01743677|9905100|FG002|STARTED|Washout Period 2 (at Least 7 Days)||10
8849892|NCT01743677|9905101|FG003|STARTED|Washout Period 2 (at Least 7 Days)||10
8849893|NCT01743677|9905102|FG004|STARTED|Washout Period 2 (at Least 7 Days)||10
8849894|NCT01743677|9905103|FG005|STARTED|Washout Period 2 (at Least 7 Days)||10
8849895|NCT01743677|9905098|FG000|COMPLETED|Washout Period 2 (at Least 7 Days)||10
8849896|NCT01743677|9905099|FG001|COMPLETED|Washout Period 2 (at Least 7 Days)||10
8849897|NCT01743677|9905100|FG002|COMPLETED|Washout Period 2 (at Least 7 Days)||10
8849898|NCT01743677|9905101|FG003|COMPLETED|Washout Period 2 (at Least 7 Days)||10
8849899|NCT01743677|9905102|FG004|COMPLETED|Washout Period 2 (at Least 7 Days)||10
8849900|NCT01743677|9905103|FG005|COMPLETED|Washout Period 2 (at Least 7 Days)||10
8849901|NCT01743677|9905098|FG000|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0
8849902|NCT01743677|9905099|FG001|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0
8849903|NCT01743677|9905100|FG002|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0
8622831|NCT00489970|9662010|FG002|NOT COMPLETED|Persistence Year 5||0
8622832|NCT00489970|9662008|FG000|STARTED|Persistence Year 9|Number of subjects who returned at Year 9.|309
8622833|NCT00489970|9662009|FG001|STARTED|Persistence Year 9|Number of subjects who returned at Year 9.|138
8622834|NCT00489970|9662010|FG002|STARTED|Persistence Year 9|Number of subjects who received the first dose at Year 9.|362
8622835|NCT00489970|9662008|FG000|COMPLETED|Persistence Year 9||306
8849904|NCT01743677|9905101|FG003|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0
8849905|NCT01743677|9905102|FG004|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0
8849906|NCT01743677|9905103|FG005|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0
8849907|NCT01743677|9905098|FG000|STARTED|Third Intervention Period||10
8622836|NCT00489970|9662009|FG001|COMPLETED|Persistence Year 9||136
8849908|NCT01743677|9905099|FG001|STARTED|Third Intervention Period||10
8849909|NCT01743677|9905100|FG002|STARTED|Third Intervention Period||10
8834411|NCT01654523|9888683|FG000|STARTED|Overall Study||20
8834412|NCT01654523|9888683|FG000|COMPLETED|Overall Study||19
8834413|NCT01654523|9888683|FG000|NOT COMPLETED|Overall Study||1
8834414|NCT01654536|9888689|FG000|STARTED|Overall Study||368
8834415|NCT01654536|9888690|FG001|STARTED|Overall Study||369
8834416|NCT01654536|9888689|FG000|COMPLETED|Overall Study||324
8834417|NCT01654536|9888690|FG001|COMPLETED|Overall Study||331
8834418|NCT01654536|9888689|FG000|NOT COMPLETED|Overall Study||44
8834419|NCT01654536|9888690|FG001|NOT COMPLETED|Overall Study||38
8834420|NCT01654549|9888699|FG000|STARTED|Overall Study||20
8834421|NCT01654549|9888700|FG001|STARTED|Overall Study||20
8834422|NCT01654549|9888699|FG000|COMPLETED|Overall Study||20
8834423|NCT01654549|9888700|FG001|COMPLETED|Overall Study||19
8834424|NCT01654549|9888699|FG000|NOT COMPLETED|Overall Study||0
8834425|NCT01654549|9888700|FG001|NOT COMPLETED|Overall Study||1
8834426|NCT01654601|9888712|FG000|STARTED|1st Administration||14
8834427|NCT01654601|9888713|FG001|STARTED|1st Administration||14
8834428|NCT01654601|9888712|FG000|COMPLETED|1st Administration||12
8834429|NCT01654601|9888713|FG001|COMPLETED|1st Administration||12
8834430|NCT01654601|9888712|FG000|NOT COMPLETED|1st Administration||2
8834431|NCT01654601|9888713|FG001|NOT COMPLETED|1st Administration||2
8834432|NCT01654601|9888712|FG000|STARTED|2nd Administration||12
8834433|NCT01654601|9888713|FG001|STARTED|2nd Administration||12
8834434|NCT01654601|9888712|FG000|COMPLETED|2nd Administration||11
8834435|NCT01654601|9888713|FG001|COMPLETED|2nd Administration||11
8834436|NCT01654601|9888712|FG000|NOT COMPLETED|2nd Administration||1
8834437|NCT01654601|9888713|FG001|NOT COMPLETED|2nd Administration||1
8834438|NCT01654666|9888722|FG000|STARTED|Overall Study||63
8622837|NCT00489970|9662010|FG002|COMPLETED|Persistence Year 9||357
8622838|NCT00489970|9662008|FG000|NOT COMPLETED|Persistence Year 9||3
8622839|NCT00489970|9662009|FG001|NOT COMPLETED|Persistence Year 9||2
8622840|NCT00489970|9662010|FG002|NOT COMPLETED|Persistence Year 9||5
8834439|NCT01654666|9888723|FG001|STARTED|Overall Study||63
8834440|NCT01654666|9888724|FG002|STARTED|Overall Study||63
8834441|NCT01654666|9888722|FG000|Primary Analysis|Overall Study||52
8834442|NCT01654666|9888723|FG001|Primary Analysis|Overall Study||56
8834443|NCT01654666|9888724|FG002|Primary Analysis|Overall Study||54
8834444|NCT01654666|9888722|FG000|COMPLETED|Overall Study||48
8834445|NCT01654666|9888723|FG001|COMPLETED|Overall Study||50
8834446|NCT01654666|9888724|FG002|COMPLETED|Overall Study||49
8834447|NCT01654666|9888722|FG000|NOT COMPLETED|Overall Study||15
8834448|NCT01654666|9888723|FG001|NOT COMPLETED|Overall Study||13
8834449|NCT01654666|9888724|FG002|NOT COMPLETED|Overall Study||14
8834450|NCT01654796|9888735|FG000|STARTED|Overall Study||26
8834451|NCT01654796|9888736|FG001|STARTED|Overall Study||29
8834452|NCT01654796|9888737|FG002|STARTED|Overall Study||29
8834453|NCT01654796|9888735|FG000|COMPLETED|Overall Study||25
8834454|NCT01654796|9888736|FG001|COMPLETED|Overall Study||26
8834455|NCT01654796|9888737|FG002|COMPLETED|Overall Study||28
8834456|NCT01654796|9888735|FG000|NOT COMPLETED|Overall Study||1
8834457|NCT01654796|9888736|FG001|NOT COMPLETED|Overall Study||3
8834458|NCT01654796|9888737|FG002|NOT COMPLETED|Overall Study||1
8834459|NCT01654861|9888746|FG000|STARTED|Overall Study||3
8834460|NCT01654861|9888746|FG000|COMPLETED|Overall Study||3
8834461|NCT01654861|9888746|FG000|NOT COMPLETED|Overall Study||0
8834462|NCT01654887|9888752|FG000|STARTED|Overall Study||103
8834463|NCT01654887|9888753|FG001|STARTED|Overall Study||88
8834464|NCT01654887|9888752|FG000|COMPLETED|Overall Study||103
8834465|NCT01654887|9888753|FG001|COMPLETED|Overall Study||88
8834466|NCT01654887|9888752|FG000|NOT COMPLETED|Overall Study||0
8834467|NCT01654887|9888753|FG001|NOT COMPLETED|Overall Study||0
8834468|NCT01655043|9888760|FG000|STARTED|Overall Study||20
8834469|NCT01655043|9888760|FG000|COMPLETED|Overall Study||20
8834470|NCT01655043|9888760|FG000|NOT COMPLETED|Overall Study||0
8834471|NCT01655069|9888768|FG000|STARTED|Overall Study||61
8834472|NCT01655069|9888769|FG001|STARTED|Overall Study||58
8834473|NCT01655069|9888770|FG002|STARTED|Overall Study||14
8834474|NCT01655069|9888771|FG003|STARTED|Overall Study||15
8834475|NCT01655069|9888768|FG000|Safety Analysis Set (SAF)|Overall Study||61
8834476|NCT01655069|9888769|FG001|Safety Analysis Set (SAF)|Overall Study||57
8834477|NCT01655069|9888770|FG002|Safety Analysis Set (SAF)|Overall Study||14
8834478|NCT01655069|9888771|FG003|Safety Analysis Set (SAF)|Overall Study||15
8834479|NCT01655069|9888768|FG000|Full Analysis Set (FAS)|Overall Study||60
8834480|NCT01655069|9888769|FG001|Full Analysis Set (FAS)|Overall Study||57
8834481|NCT01655069|9888770|FG002|Full Analysis Set (FAS)|Overall Study||14
8834482|NCT01655069|9888771|FG003|Full Analysis Set (FAS)|Overall Study||15
8834483|NCT01655069|9888768|FG000|COMPLETED|Overall Study||53
8834484|NCT01655069|9888769|FG001|COMPLETED|Overall Study||46
8834485|NCT01655069|9888770|FG002|COMPLETED|Overall Study||12
8834486|NCT01655069|9888771|FG003|COMPLETED|Overall Study||11
8834487|NCT01655069|9888768|FG000|NOT COMPLETED|Overall Study||8
8834488|NCT01655069|9888769|FG001|NOT COMPLETED|Overall Study||12
8834489|NCT01655069|9888770|FG002|NOT COMPLETED|Overall Study||2
8834490|NCT01655069|9888771|FG003|NOT COMPLETED|Overall Study||4
8834491|NCT01655329|9888779|FG000|STARTED|Overall Study|The same 10 radiologists are interpreting images in both arms.|10
8834492|NCT01655329|9888779|FG000|COMPLETED|Overall Study||10
8622841|NCT00490009|9662021|FG000|STARTED|Overall Study||9
8834493|NCT01655329|9888779|FG000|NOT COMPLETED|Overall Study||0
8834494|NCT01655381|9888793|FG000|STARTED|Overall Study||15
8834495|NCT01655381|9888793|FG000|COMPLETED|Overall Study||12
8834496|NCT01655381|9888793|FG000|NOT COMPLETED|Overall Study||3
8834497|NCT01655498|9888798|FG000|STARTED|Overall Study||61
8834498|NCT01655498|9888798|FG000|COMPLETED|Overall Study||56
8834499|NCT01655498|9888798|FG000|NOT COMPLETED|Overall Study||5
8834500|NCT01655563|9888807|FG000|STARTED|Overall Study||18
8834501|NCT01655563|9888808|FG001|STARTED|Overall Study||35
8834502|NCT01655563|9888807|FG000|COMPLETED|Overall Study||18
8834503|NCT01655563|9888808|FG001|COMPLETED|Overall Study||35
8834504|NCT01655563|9888807|FG000|NOT COMPLETED|Overall Study||0
8834505|NCT01655563|9888808|FG001|NOT COMPLETED|Overall Study||0
8834506|NCT01655693|9888817|FG000|STARTED|Overall Study||130
8834507|NCT01655693|9888818|FG001|STARTED|Overall Study||133
8834508|NCT01655693|9888819|FG002|STARTED|Overall Study||134
8834509|NCT01655693|9888817|FG000|COMPLETED|Overall Study||4
8834510|NCT01655693|9888818|FG001|COMPLETED|Overall Study||7
8834511|NCT01655693|9888819|FG002|COMPLETED|Overall Study||4
8834512|NCT01655693|9888817|FG000|NOT COMPLETED|Overall Study||126
8834513|NCT01655693|9888818|FG001|NOT COMPLETED|Overall Study||126
8834514|NCT01655693|9888819|FG002|NOT COMPLETED|Overall Study||130
8834515|NCT01655719|9888837|FG000|STARTED|Overall Study||1
8834516|NCT01655719|9888837|FG000|COMPLETED|Overall Study||1
8834517|NCT01655719|9888837|FG000|NOT COMPLETED|Overall Study||0
8834518|NCT01655823|9888846|FG000|STARTED|Overall Study||25
8834519|NCT01655823|9888847|FG001|STARTED|Overall Study||25
8834520|NCT01655823|9888848|FG002|STARTED|Overall Study||24
8834521|NCT01655823|9888849|FG003|STARTED|Overall Study||25
8834522|NCT01655823|9888850|FG004|STARTED|Overall Study||26
8834523|NCT01655823|9888846|FG000|COMPLETED|Overall Study||25
8834524|NCT01655823|9888847|FG001|COMPLETED|Overall Study||23
8834525|NCT01655823|9888848|FG002|COMPLETED|Overall Study||24
8834526|NCT01655823|9888849|FG003|COMPLETED|Overall Study||24
8834527|NCT01655823|9888850|FG004|COMPLETED|Overall Study||25
8834528|NCT01655823|9888846|FG000|NOT COMPLETED|Overall Study||0
8834529|NCT01655823|9888847|FG001|NOT COMPLETED|Overall Study||2
8834530|NCT01655823|9888848|FG002|NOT COMPLETED|Overall Study||0
8834531|NCT01655823|9888849|FG003|NOT COMPLETED|Overall Study||1
8834532|NCT01655823|9888850|FG004|NOT COMPLETED|Overall Study||1
8834533|NCT01655901|9888862|FG000|STARTED|First Intervention (Hour 1)||5
8834534|NCT01655901|9888863|FG001|STARTED|First Intervention (Hour 1)||5
8834535|NCT01655901|9888864|FG002|STARTED|First Intervention (Hour 1)||5
8834536|NCT01655901|9888865|FG003|STARTED|First Intervention (Hour 1)||5
8834537|NCT01655901|9888866|FG004|STARTED|First Intervention (Hour 1)||5
8834538|NCT01655901|9888867|FG005|STARTED|First Intervention (Hour 1)||5
8834539|NCT01655901|9888862|FG000|COMPLETED|First Intervention (Hour 1)||5
8834540|NCT01655901|9888863|FG001|COMPLETED|First Intervention (Hour 1)||5
8834541|NCT01655901|9888864|FG002|COMPLETED|First Intervention (Hour 1)||5
8834542|NCT01655901|9888865|FG003|COMPLETED|First Intervention (Hour 1)||5
8834543|NCT01655901|9888866|FG004|COMPLETED|First Intervention (Hour 1)||5
8834544|NCT01655901|9888867|FG005|COMPLETED|First Intervention (Hour 1)||5
8834545|NCT01655901|9888862|FG000|NOT COMPLETED|First Intervention (Hour 1)||0
8834546|NCT01655901|9888863|FG001|NOT COMPLETED|First Intervention (Hour 1)||0
8834547|NCT01655901|9888864|FG002|NOT COMPLETED|First Intervention (Hour 1)||0
8834548|NCT01655901|9888865|FG003|NOT COMPLETED|First Intervention (Hour 1)||0
8834549|NCT01655901|9888866|FG004|NOT COMPLETED|First Intervention (Hour 1)||0
8834550|NCT01655901|9888867|FG005|NOT COMPLETED|First Intervention (Hour 1)||0
8834551|NCT01655901|9888862|FG000|STARTED|Washout (1 Week)||5
8834552|NCT01655901|9888863|FG001|STARTED|Washout (1 Week)||5
8834553|NCT01655901|9888864|FG002|STARTED|Washout (1 Week)||5
8834554|NCT01655901|9888865|FG003|STARTED|Washout (1 Week)||5
8834555|NCT01655901|9888866|FG004|STARTED|Washout (1 Week)||5
8834556|NCT01655901|9888867|FG005|STARTED|Washout (1 Week)||5
8834557|NCT01655901|9888862|FG000|COMPLETED|Washout (1 Week)||5
8834558|NCT01655901|9888863|FG001|COMPLETED|Washout (1 Week)||5
8834559|NCT01655901|9888864|FG002|COMPLETED|Washout (1 Week)||5
8834560|NCT01655901|9888865|FG003|COMPLETED|Washout (1 Week)||5
8834561|NCT01655901|9888866|FG004|COMPLETED|Washout (1 Week)||5
8834562|NCT01655901|9888867|FG005|COMPLETED|Washout (1 Week)||5
8622842|NCT00490009|9662021|FG000|COMPLETED|Overall Study||9
8622843|NCT00490009|9662021|FG000|NOT COMPLETED|Overall Study||0
8622844|NCT00490022|9662028|FG000|STARTED|Overall Study||16
8622845|NCT00490022|9662029|FG001|STARTED|Overall Study||15
8622846|NCT00490022|9662028|FG000|COMPLETED|Overall Study||15
8622847|NCT00490022|9662029|FG001|COMPLETED|Overall Study||12
8622848|NCT00490022|9662028|FG000|NOT COMPLETED|Overall Study||1
8622849|NCT00490022|9662029|FG001|NOT COMPLETED|Overall Study||3
8622850|NCT00490035|9662039|FG000|STARTED|Overall Study||100
8622851|NCT00490035|9662040|FG001|STARTED|Overall Study||99
8834563|NCT01655901|9888862|FG000|NOT COMPLETED|Washout (1 Week)||0
8834564|NCT01655901|9888863|FG001|NOT COMPLETED|Washout (1 Week)||0
8834565|NCT01655901|9888864|FG002|NOT COMPLETED|Washout (1 Week)||0
8834566|NCT01655901|9888865|FG003|NOT COMPLETED|Washout (1 Week)||0
8622852|NCT00490035|9662041|FG002|STARTED|Overall Study||100
8622853|NCT00490035|9662042|FG003|STARTED|Overall Study||100
8622854|NCT00490035|9662039|FG000|COMPLETED|Overall Study||92
8834567|NCT01655901|9888866|FG004|NOT COMPLETED|Washout (1 Week)||0
8834568|NCT01655901|9888867|FG005|NOT COMPLETED|Washout (1 Week)||0
8834569|NCT01655901|9888862|FG000|STARTED|Second Intervention (Hour 2)||5
8834570|NCT01655901|9888863|FG001|STARTED|Second Intervention (Hour 2)||5
8834571|NCT01655901|9888864|FG002|STARTED|Second Intervention (Hour 2)||5
8834572|NCT01655901|9888865|FG003|STARTED|Second Intervention (Hour 2)||5
8834573|NCT01655901|9888866|FG004|STARTED|Second Intervention (Hour 2)||5
8834574|NCT01655901|9888867|FG005|STARTED|Second Intervention (Hour 2)||5
8834575|NCT01655901|9888862|FG000|COMPLETED|Second Intervention (Hour 2)||5
8834576|NCT01655901|9888863|FG001|COMPLETED|Second Intervention (Hour 2)||5
8834577|NCT01655901|9888864|FG002|COMPLETED|Second Intervention (Hour 2)||5
8834578|NCT01655901|9888865|FG003|COMPLETED|Second Intervention (Hour 2)||5
8834579|NCT01655901|9888866|FG004|COMPLETED|Second Intervention (Hour 2)||5
8834580|NCT01655901|9888867|FG005|COMPLETED|Second Intervention (Hour 2)||5
8834581|NCT01655901|9888862|FG000|NOT COMPLETED|Second Intervention (Hour 2)||0
8834582|NCT01655901|9888863|FG001|NOT COMPLETED|Second Intervention (Hour 2)||0
8834583|NCT01655901|9888864|FG002|NOT COMPLETED|Second Intervention (Hour 2)||0
8834584|NCT01655901|9888865|FG003|NOT COMPLETED|Second Intervention (Hour 2)||0
8834585|NCT01655901|9888866|FG004|NOT COMPLETED|Second Intervention (Hour 2)||0
8834586|NCT01655901|9888867|FG005|NOT COMPLETED|Second Intervention (Hour 2)||0
8834587|NCT01655901|9888862|FG000|STARTED|Washout (1 Week)||5
8834588|NCT01655901|9888863|FG001|STARTED|Washout (1 Week)||5
8834589|NCT01655901|9888864|FG002|STARTED|Washout (1 Week)||5
8834590|NCT01655901|9888865|FG003|STARTED|Washout (1 Week)||5
8834591|NCT01655901|9888866|FG004|STARTED|Washout (1 Week)||5
8834592|NCT01655901|9888867|FG005|STARTED|Washout (1 Week)||5
8834593|NCT01655901|9888862|FG000|COMPLETED|Washout (1 Week)||5
8834594|NCT01655901|9888863|FG001|COMPLETED|Washout (1 Week)||5
8834595|NCT01655901|9888864|FG002|COMPLETED|Washout (1 Week)||5
8834596|NCT01655901|9888865|FG003|COMPLETED|Washout (1 Week)||5
8834597|NCT01655901|9888866|FG004|COMPLETED|Washout (1 Week)||5
8834598|NCT01655901|9888867|FG005|COMPLETED|Washout (1 Week)||5
8834599|NCT01655901|9888862|FG000|NOT COMPLETED|Washout (1 Week)||0
8834600|NCT01655901|9888863|FG001|NOT COMPLETED|Washout (1 Week)||0
8834601|NCT01655901|9888864|FG002|NOT COMPLETED|Washout (1 Week)||0
8834602|NCT01655901|9888865|FG003|NOT COMPLETED|Washout (1 Week)||0
8834603|NCT01655901|9888866|FG004|NOT COMPLETED|Washout (1 Week)||0
8834604|NCT01655901|9888867|FG005|NOT COMPLETED|Washout (1 Week)||0
8834605|NCT01655901|9888862|FG000|STARTED|Third Intervention (Hour 3)||5
8834606|NCT01655901|9888863|FG001|STARTED|Third Intervention (Hour 3)||5
8834607|NCT01655901|9888864|FG002|STARTED|Third Intervention (Hour 3)||5
8834608|NCT01655901|9888865|FG003|STARTED|Third Intervention (Hour 3)||5
8834609|NCT01655901|9888866|FG004|STARTED|Third Intervention (Hour 3)||5
8834610|NCT01655901|9888867|FG005|STARTED|Third Intervention (Hour 3)||5
8834611|NCT01655901|9888862|FG000|COMPLETED|Third Intervention (Hour 3)||4
8834612|NCT01655901|9888863|FG001|COMPLETED|Third Intervention (Hour 3)||4
8834613|NCT01655901|9888864|FG002|COMPLETED|Third Intervention (Hour 3)||4
8834614|NCT01655901|9888865|FG003|COMPLETED|Third Intervention (Hour 3)||5
8834615|NCT01655901|9888866|FG004|COMPLETED|Third Intervention (Hour 3)||4
8834616|NCT01655901|9888867|FG005|COMPLETED|Third Intervention (Hour 3)||5
8834617|NCT01655901|9888862|FG000|NOT COMPLETED|Third Intervention (Hour 3)||1
8834618|NCT01655901|9888863|FG001|NOT COMPLETED|Third Intervention (Hour 3)||1
8834619|NCT01655901|9888864|FG002|NOT COMPLETED|Third Intervention (Hour 3)||1
8834620|NCT01655901|9888865|FG003|NOT COMPLETED|Third Intervention (Hour 3)||0
8834621|NCT01655901|9888866|FG004|NOT COMPLETED|Third Intervention (Hour 3)||1
8834622|NCT01655901|9888867|FG005|NOT COMPLETED|Third Intervention (Hour 3)||0
8834623|NCT01656031|9888876|FG000|STARTED|Overall Study||39
8834624|NCT01656031|9888876|FG000|COMPLETED|Overall Study||39
8834625|NCT01656031|9888876|FG000|NOT COMPLETED|Overall Study||0
8834626|NCT01656161|9888880|FG000|STARTED|Overall Study|Intention to treat analysis set|120
8834627|NCT01656161|9888880|FG000|Received Triptorelin at Day 1|Overall Study|Safety analysis set|120
8834628|NCT01656161|9888880|FG000|Received Triptorelin at Day 169|Overall Study||115
8834629|NCT01656161|9888880|FG000|COMPLETED|Overall Study|Per protocol analysis set|113
8834630|NCT01656161|9888880|FG000|NOT COMPLETED|Overall Study||7
8834631|NCT01656187|9888889|FG000|STARTED|First Intervention (24 Weeks)||20
8834632|NCT01656187|9888890|FG001|STARTED|First Intervention (24 Weeks)||26
8834633|NCT01656187|9888889|FG000|COMPLETED|First Intervention (24 Weeks)||14
8834634|NCT01656187|9888890|FG001|COMPLETED|First Intervention (24 Weeks)||23
8834635|NCT01656187|9888889|FG000|NOT COMPLETED|First Intervention (24 Weeks)||6
8834636|NCT01656187|9888890|FG001|NOT COMPLETED|First Intervention (24 Weeks)||3
8834637|NCT01656187|9888889|FG000|STARTED|Washout (4 Weeks)||14
8834638|NCT01656187|9888890|FG001|STARTED|Washout (4 Weeks)||23
8834639|NCT01656187|9888889|FG000|COMPLETED|Washout (4 Weeks)||14
8834640|NCT01656187|9888890|FG001|COMPLETED|Washout (4 Weeks)||22
8834641|NCT01656187|9888889|FG000|NOT COMPLETED|Washout (4 Weeks)||0
8834642|NCT01656187|9888890|FG001|NOT COMPLETED|Washout (4 Weeks)||1
8834643|NCT01656187|9888889|FG000|STARTED|Second Intervention (24 Weeks)||14
8834644|NCT01656187|9888890|FG001|STARTED|Second Intervention (24 Weeks)||22
8834645|NCT01656187|9888889|FG000|COMPLETED|Second Intervention (24 Weeks)||13
8834646|NCT01656187|9888890|FG001|COMPLETED|Second Intervention (24 Weeks)||19
8834647|NCT01656187|9888889|FG000|NOT COMPLETED|Second Intervention (24 Weeks)||1
8834648|NCT01656187|9888890|FG001|NOT COMPLETED|Second Intervention (24 Weeks)||3
8834649|NCT01656200|9888896|FG000|STARTED|Overall Study||17
8834650|NCT01656200|9888896|FG000|COMPLETED|Overall Study||16
8834651|NCT01656200|9888896|FG000|NOT COMPLETED|Overall Study||1
8834652|NCT01656252|9888900|FG000|STARTED|Phase I||14
8834653|NCT01656252|9888900|FG000|COMPLETED|Phase I||14
8834654|NCT01656252|9888900|FG000|NOT COMPLETED|Phase I||0
8834655|NCT01656252|9888900|FG000|STARTED|Phase II||0
8834656|NCT01656252|9888900|FG000|COMPLETED|Phase II||0
8834657|NCT01656252|9888900|FG000|NOT COMPLETED|Phase II||0
8834658|NCT01656304|9888906|FG000|STARTED|Overall Study||16
8834659|NCT01656304|9888906|FG000|COMPLETED|Overall Study||15
8834660|NCT01656304|9888906|FG000|NOT COMPLETED|Overall Study||1
8834661|NCT01656395|9888916|FG000|STARTED|Overall Study||60
8834662|NCT01656395|9888917|FG001|STARTED|Overall Study||127
8834663|NCT01656395|9888918|FG002|STARTED|Overall Study||142
8834664|NCT01656395|9888919|FG003|STARTED|Overall Study||53
8834665|NCT01656395|9888920|FG004|STARTED|Overall Study||60
8834666|NCT01656395|9888921|FG005|STARTED|Overall Study||134
8834667|NCT01656395|9888922|FG006|STARTED|Overall Study||0
8834668|NCT01656395|9888923|FG007|STARTED|Overall Study||0
8834669|NCT01656395|9888916|FG000|Treated Participants|Overall Study||58
8834670|NCT01656395|9888917|FG001|Treated Participants|Overall Study||126
8834671|NCT01656395|9888918|FG002|Treated Participants|Overall Study||135
8834672|NCT01656395|9888919|FG003|Treated Participants|Overall Study||52
8834673|NCT01656395|9888920|FG004|Treated Participants|Overall Study||60
8834674|NCT01656395|9888921|FG005|Treated Participants|Overall Study||126
8834675|NCT01656395|9888922|FG006|Treated Participants|Overall Study||0
8834676|NCT01656395|9888923|FG007|Treated Participants|Overall Study||0
8834677|NCT01656395|9888916|FG000|COMPLETED|Overall Study||43
8834678|NCT01656395|9888917|FG001|COMPLETED|Overall Study||93
8834679|NCT01656395|9888918|FG002|COMPLETED|Overall Study||106
8834680|NCT01656395|9888919|FG003|COMPLETED|Overall Study||41
8834681|NCT01656395|9888920|FG004|COMPLETED|Overall Study||46
8834682|NCT01656395|9888921|FG005|COMPLETED|Overall Study||94
8834683|NCT01656395|9888922|FG006|COMPLETED|Overall Study||0
8834684|NCT01656395|9888923|FG007|COMPLETED|Overall Study||0
8834685|NCT01656395|9888916|FG000|NOT COMPLETED|Overall Study||17
8834686|NCT01656395|9888917|FG001|NOT COMPLETED|Overall Study||34
8834687|NCT01656395|9888918|FG002|NOT COMPLETED|Overall Study||36
8834688|NCT01656395|9888919|FG003|NOT COMPLETED|Overall Study||12
8834689|NCT01656395|9888920|FG004|NOT COMPLETED|Overall Study||14
8834690|NCT01656395|9888921|FG005|NOT COMPLETED|Overall Study||40
8834691|NCT01656395|9888922|FG006|NOT COMPLETED|Overall Study||0
8834692|NCT01656395|9888923|FG007|NOT COMPLETED|Overall Study||0
8834693|NCT01656408|9888947|FG000|STARTED|Overall Study||8
8834694|NCT01656408|9888948|FG001|STARTED|Overall Study||8
8834695|NCT01656408|9888949|FG002|STARTED|Overall Study||8
8834696|NCT01656408|9888950|FG003|STARTED|Overall Study||7
8834697|NCT01656408|9888951|FG004|STARTED|Overall Study||9
8834698|NCT01656408|9888952|FG005|STARTED|Overall Study||9
8834699|NCT01656408|9888953|FG006|STARTED|Overall Study||10
8834700|NCT01656408|9888954|FG007|STARTED|Overall Study||8
8834701|NCT01656408|9888955|FG008|STARTED|Overall Study||18
8834702|NCT01656408|9888956|FG009|STARTED|Overall Study||18
8834703|NCT01656408|9888947|FG000|COMPLETED|Overall Study||7
8834704|NCT01656408|9888948|FG001|COMPLETED|Overall Study||8
8834705|NCT01656408|9888949|FG002|COMPLETED|Overall Study||6
8834706|NCT01656408|9888950|FG003|COMPLETED|Overall Study||7
8834707|NCT01656408|9888951|FG004|COMPLETED|Overall Study||8
8834708|NCT01656408|9888952|FG005|COMPLETED|Overall Study||7
8834709|NCT01656408|9888953|FG006|COMPLETED|Overall Study||9
8834710|NCT01656408|9888954|FG007|COMPLETED|Overall Study||7
8834711|NCT01656408|9888955|FG008|COMPLETED|Overall Study||16
8834712|NCT01656408|9888956|FG009|COMPLETED|Overall Study||15
8834713|NCT01656408|9888947|FG000|NOT COMPLETED|Overall Study||1
8834714|NCT01656408|9888948|FG001|NOT COMPLETED|Overall Study||0
8834715|NCT01656408|9888949|FG002|NOT COMPLETED|Overall Study||2
8834716|NCT01656408|9888950|FG003|NOT COMPLETED|Overall Study||0
8834717|NCT01656408|9888951|FG004|NOT COMPLETED|Overall Study||1
8834718|NCT01656408|9888952|FG005|NOT COMPLETED|Overall Study||2
8834719|NCT01656408|9888953|FG006|NOT COMPLETED|Overall Study||1
8834720|NCT01656408|9888954|FG007|NOT COMPLETED|Overall Study||1
8834721|NCT01656408|9888955|FG008|NOT COMPLETED|Overall Study||2
8834722|NCT01656408|9888956|FG009|NOT COMPLETED|Overall Study||3
8834723|NCT01656460|9889002|FG000|STARTED|Overall Study||3
8834724|NCT01656460|9889003|FG001|STARTED|Overall Study||3
8834725|NCT01656460|9889004|FG002|STARTED|Overall Study||3
8834726|NCT01656460|9889005|FG003|STARTED|Overall Study||3
8834727|NCT01656460|9889002|FG000|COMPLETED|Overall Study||3
8834728|NCT01656460|9889003|FG001|COMPLETED|Overall Study||3
8834729|NCT01656460|9889004|FG002|COMPLETED|Overall Study||3
8834730|NCT01656460|9889005|FG003|COMPLETED|Overall Study||3
8834731|NCT01656460|9889002|FG000|NOT COMPLETED|Overall Study||0
8834732|NCT01656460|9889003|FG001|NOT COMPLETED|Overall Study||0
8834733|NCT01656460|9889004|FG002|NOT COMPLETED|Overall Study||0
8834734|NCT01656460|9889005|FG003|NOT COMPLETED|Overall Study||0
8834735|NCT01656486|9889015|FG000|STARTED|Overall Study||1
8834736|NCT01656486|9889015|FG000|COMPLETED|Overall Study||1
8834737|NCT01656486|9889015|FG000|NOT COMPLETED|Overall Study||0
8834738|NCT01656629|9889022|FG000|STARTED|Overall Study||21
8834739|NCT01656629|9889023|FG001|STARTED|Overall Study||18
8834740|NCT01656629|9889024|FG002|STARTED|Overall Study||16
8834741|NCT01656629|9889022|FG000|COMPLETED|Overall Study||16
8834742|NCT01656629|9889023|FG001|COMPLETED|Overall Study||16
8834743|NCT01656629|9889024|FG002|COMPLETED|Overall Study||14
8834744|NCT01656629|9889022|FG000|NOT COMPLETED|Overall Study||5
8834745|NCT01656629|9889023|FG001|NOT COMPLETED|Overall Study||2
8834746|NCT01656629|9889024|FG002|NOT COMPLETED|Overall Study||2
8834747|NCT01656733|9889034|FG000|STARTED|Overall Study|4 discontinued after BL visit (lost to follow up)|67
8834748|NCT01656733|9889035|FG001|STARTED|Overall Study|5 discontinued after BL visit ( lost to follow up)|70
8834749|NCT01656733|9889034|FG000|Visit 1 (1 Week After Quit Date)|Overall Study||45
8834750|NCT01656733|9889035|FG001|Visit 1 (1 Week After Quit Date)|Overall Study||42
8834751|NCT01656733|9889034|FG000|Visit 2 (2 Weeks After Quit Date)|Overall Study||32
8834752|NCT01656733|9889035|FG001|Visit 2 (2 Weeks After Quit Date)|Overall Study||44
8834753|NCT01656733|9889034|FG000|Visit 3 (3 Weeks After Quit Date)|Overall Study||33
8834754|NCT01656733|9889035|FG001|Visit 3 (3 Weeks After Quit Date)|Overall Study||34
8834755|NCT01656733|9889034|FG000|Visit 4 (4 Weeks After Quit Date)|Overall Study||32
8834756|NCT01656733|9889035|FG001|Visit 4 (4 Weeks After Quit Date)|Overall Study||30
8834757|NCT01656733|9889034|FG000|Visit 5 (6 Weeks After Quit Date)|Overall Study||37
8834758|NCT01656733|9889035|FG001|Visit 5 (6 Weeks After Quit Date)|Overall Study||36
8834759|NCT01656733|9889034|FG000|Visit 6 ( 32-36 Weeks Gestation)|Overall Study||39
8834760|NCT01656733|9889035|FG001|Visit 6 ( 32-36 Weeks Gestation)|Overall Study||47
8834761|NCT01656733|9889034|FG000|Participants With Perinatal Outcomes|Overall Study||67
8834762|NCT01656733|9889035|FG001|Participants With Perinatal Outcomes|Overall Study||66
8834763|NCT01656733|9889034|FG000|Visit 7 (1 Month Postpartum) Phone Call|Overall Study||47
8834764|NCT01656733|9889035|FG001|Visit 7 (1 Month Postpartum) Phone Call|Overall Study||50
8834765|NCT01656733|9889034|FG000|Visit 8 (6 Months Postpartum)|Overall Study||30
8834766|NCT01656733|9889035|FG001|Visit 8 (6 Months Postpartum)|Overall Study||28
8834767|NCT01656733|9889034|FG000|COMPLETED|Overall Study||67
8834768|NCT01656733|9889035|FG001|COMPLETED|Overall Study||66
8834769|NCT01656733|9889034|FG000|NOT COMPLETED|Overall Study||0
8834770|NCT01656733|9889035|FG001|NOT COMPLETED|Overall Study||4
8834771|NCT01656759|9889043|FG000|STARTED|Overall Study||27
8834772|NCT01656759|9889044|FG001|STARTED|Overall Study||25
8834773|NCT01656759|9889043|FG000|COMPLETED|Overall Study||25
8834774|NCT01656759|9889044|FG001|COMPLETED|Overall Study||22
8834775|NCT01656759|9889043|FG000|NOT COMPLETED|Overall Study||2
8834776|NCT01656759|9889044|FG001|NOT COMPLETED|Overall Study||3
8834777|NCT01656772|9889052|FG000|STARTED|Overall Study||43
8834778|NCT01656772|9889053|FG001|STARTED|Overall Study||77
8834779|NCT01656772|9889052|FG000|COMPLETED|Overall Study||43
8834780|NCT01656772|9889053|FG001|COMPLETED|Overall Study||77
8834781|NCT01656772|9889052|FG000|NOT COMPLETED|Overall Study||0
8834782|NCT01656772|9889053|FG001|NOT COMPLETED|Overall Study||0
8834783|NCT01656850|9889061|FG000|STARTED|First Intervention (3 Months)||20
8834784|NCT01656850|9889062|FG001|STARTED|First Intervention (3 Months)||20
8834785|NCT01656850|9889061|FG000|COMPLETED|First Intervention (3 Months)||17
8834786|NCT01656850|9889062|FG001|COMPLETED|First Intervention (3 Months)||16
8834787|NCT01656850|9889061|FG000|NOT COMPLETED|First Intervention (3 Months)||3
8834788|NCT01656850|9889062|FG001|NOT COMPLETED|First Intervention (3 Months)||4
8834789|NCT01656850|9889061|FG000|STARTED|Washout (2 Weeks)||17
8834790|NCT01656850|9889062|FG001|STARTED|Washout (2 Weeks)||16
8834791|NCT01656850|9889061|FG000|COMPLETED|Washout (2 Weeks)||17
8834792|NCT01656850|9889062|FG001|COMPLETED|Washout (2 Weeks)||16
8834793|NCT01656850|9889061|FG000|NOT COMPLETED|Washout (2 Weeks)||0
8834794|NCT01656850|9889062|FG001|NOT COMPLETED|Washout (2 Weeks)||0
8834795|NCT01656850|9889061|FG000|STARTED|Second Intervention (3 Months)||17
8834796|NCT01656850|9889062|FG001|STARTED|Second Intervention (3 Months)||16
8834797|NCT01656850|9889061|FG000|COMPLETED|Second Intervention (3 Months)||17
8834798|NCT01656850|9889062|FG001|COMPLETED|Second Intervention (3 Months)||16
8834799|NCT01656850|9889061|FG000|NOT COMPLETED|Second Intervention (3 Months)||0
8834800|NCT01656850|9889062|FG001|NOT COMPLETED|Second Intervention (3 Months)||0
8834801|NCT01656889|9889074|FG000|STARTED|Treatment Period, 12 Weeks|Randomized (Met all I/E criteria at completion of run-in)|222
8834802|NCT01656889|9889075|FG001|STARTED|Treatment Period, 12 Weeks|Randomized (Met all I/E criteria at completion of run-in)|225
8834803|NCT01656889|9889074|FG000|COMPLETED|Treatment Period, 12 Weeks|Completed treatment|210
8834804|NCT01656889|9889075|FG001|COMPLETED|Treatment Period, 12 Weeks|Completed treatment|214
8834805|NCT01656889|9889074|FG000|NOT COMPLETED|Treatment Period, 12 Weeks||12
8834806|NCT01656889|9889075|FG001|NOT COMPLETED|Treatment Period, 12 Weeks||11
8834807|NCT01656889|9889074|FG000|STARTED|Post Treatment Follow-Up, 3 Months||210
8834808|NCT01656889|9889075|FG001|STARTED|Post Treatment Follow-Up, 3 Months||213
8834809|NCT01656889|9889074|FG000|COMPLETED|Post Treatment Follow-Up, 3 Months||206
8834810|NCT01656889|9889075|FG001|COMPLETED|Post Treatment Follow-Up, 3 Months||204
8834811|NCT01656889|9889074|FG000|NOT COMPLETED|Post Treatment Follow-Up, 3 Months||4
8834812|NCT01656889|9889075|FG001|NOT COMPLETED|Post Treatment Follow-Up, 3 Months||9
8834813|NCT01656967|9889083|FG000|STARTED|Overall Study||33
8834814|NCT01656967|9889084|FG001|STARTED|Overall Study||33
8834815|NCT01656967|9889083|FG000|SGA Placement|Overall Study||32
8834816|NCT01656967|9889084|FG001|SGA Placement|Overall Study||33
8834817|NCT01656967|9889083|FG000|ETT Insertion|Overall Study||29
8834818|NCT01656967|9889084|FG001|ETT Insertion|Overall Study||31
8834819|NCT01656967|9889083|FG000|COMPLETED|Overall Study||29
8834820|NCT01656967|9889084|FG001|COMPLETED|Overall Study||31
8834821|NCT01656967|9889083|FG000|NOT COMPLETED|Overall Study||4
8834822|NCT01656967|9889084|FG001|NOT COMPLETED|Overall Study||2
8834823|NCT01657019|9889094|FG000|STARTED|Overall Study||604
8834824|NCT01657019|9889094|FG000|COMPLETED|Overall Study||369
8834825|NCT01657019|9889094|FG000|NOT COMPLETED|Overall Study||235
8834826|NCT01657032|9889100|FG000|STARTED|Overall Study||44
8834827|NCT01657032|9889101|FG001|STARTED|Overall Study||44
8834828|NCT01657032|9889100|FG000|COMPLETED|Overall Study||44
8834829|NCT01657032|9889101|FG001|COMPLETED|Overall Study||37
8834830|NCT01657032|9889100|FG000|NOT COMPLETED|Overall Study||0
8834831|NCT01657032|9889101|FG001|NOT COMPLETED|Overall Study||7
8834832|NCT01657162|9889109|FG000|STARTED|Overall Study||558
8834833|NCT01657162|9889110|FG001|STARTED|Overall Study||581
8834834|NCT01657162|9889109|FG000|Study 003 ITT Population|Overall Study|Participants received 80 mcg abaloparatide SC during Study 003.|824
8834835|NCT01657162|9889110|FG001|Study 003 ITT Population|Overall Study|Participants received abaloparatide-matching placebo during Study 003.|821
8834836|NCT01657162|9889109|FG000|Study 003 Modified ITT (mITT) Population|Overall Study|Participants received 80 mcg abaloparatide SC during Study 003.|690
8834837|NCT01657162|9889110|FG001|Study 003 Modified ITT (mITT) Population|Overall Study|Participants received abaloparatide-matching placebo during Study 003.|711
8834838|NCT01657162|9889109|FG000|Completed Study 003|Overall Study|Participants received 80 mcg abaloparatide SC during Study 003.|606
8834839|NCT01657162|9889110|FG001|Completed Study 003|Overall Study|Participants received abaloparatide-matching placebo during Study 003.|637
8834840|NCT01657162|9889109|FG000|Study 005 ITT Population|Overall Study||558
8834841|NCT01657162|9889110|FG001|Study 005 ITT Population|Overall Study||581
8834842|NCT01657162|9889109|FG000|Study 005 Safety Population|Overall Study||553
8834843|NCT01657162|9889110|FG001|Study 005 Safety Population|Overall Study||580
8834844|NCT01657162|9889109|FG000|Study 005 mITT Population|Overall Study||544
8834845|NCT01657162|9889110|FG001|Study 005 mITT Population|Overall Study||568
8834846|NCT01657162|9889109|FG000|COMPLETED|Overall Study||499
8834847|NCT01657162|9889110|FG001|COMPLETED|Overall Study||506
8834848|NCT01657162|9889109|FG000|NOT COMPLETED|Overall Study||59
8834849|NCT01657162|9889110|FG001|NOT COMPLETED|Overall Study||75
8834850|NCT01657253|9889118|FG000|STARTED|Overall Study||93
8834851|NCT01657253|9889119|FG001|STARTED|Overall Study||90
8834852|NCT01657253|9889118|FG000|COMPLETED|Overall Study||76
8834853|NCT01657253|9889119|FG001|COMPLETED|Overall Study||72
8834854|NCT01657253|9889118|FG000|NOT COMPLETED|Overall Study||17
8834855|NCT01657253|9889119|FG001|NOT COMPLETED|Overall Study||18
8834856|NCT01657266|9889127|FG000|STARTED|Overall Study||73
8834857|NCT01657266|9889128|FG001|STARTED|Overall Study||75
8834858|NCT01657266|9889127|FG000|COMPLETED|Overall Study||69
8834859|NCT01657266|9889128|FG001|COMPLETED|Overall Study||70
8834860|NCT01657266|9889127|FG000|NOT COMPLETED|Overall Study||4
8834861|NCT01657266|9889128|FG001|NOT COMPLETED|Overall Study||5
8834862|NCT01657292|9889134|FG000|STARTED|Overall Study||61
8834863|NCT01657292|9889134|FG000|COMPLETED|Overall Study||51
8834864|NCT01657292|9889134|FG000|NOT COMPLETED|Overall Study||10
8834865|NCT01657305|9889141|FG000|STARTED|Overall Study||107
8834866|NCT01657305|9889141|FG000|COMPLETED|Overall Study||82
8834867|NCT01657305|9889141|FG000|NOT COMPLETED|Overall Study||25
8834868|NCT01657344|9889181|FG000|STARTED|Overall Study||421622
8834869|NCT01657344|9889182|FG001|STARTED|Overall Study||409967
8834870|NCT01657344|9889183|FG002|STARTED|Overall Study||196300
8834871|NCT01657344|9889184|FG003|STARTED|Overall Study||376517
8834872|NCT01657344|9889185|FG004|STARTED|Overall Study||157802
8834873|NCT01657344|9889186|FG005|STARTED|Overall Study||316477
8834874|NCT01657344|9889187|FG006|STARTED|Overall Study||140776
8834875|NCT01657344|9889181|FG000|COMPLETED|Overall Study||421622
8834876|NCT01657344|9889182|FG001|COMPLETED|Overall Study||409967
8834877|NCT01657344|9889183|FG002|COMPLETED|Overall Study||196300
8834878|NCT01657344|9889184|FG003|COMPLETED|Overall Study||376517
8834879|NCT01657344|9889185|FG004|COMPLETED|Overall Study||157802
8834880|NCT01657344|9889186|FG005|COMPLETED|Overall Study||316477
8834881|NCT01657344|9889187|FG006|COMPLETED|Overall Study||140776
8834882|NCT01657344|9889181|FG000|NOT COMPLETED|Overall Study||0
8834883|NCT01657344|9889182|FG001|NOT COMPLETED|Overall Study||0
8834884|NCT01657344|9889183|FG002|NOT COMPLETED|Overall Study||0
8834885|NCT01657344|9889184|FG003|NOT COMPLETED|Overall Study||0
8834886|NCT01657344|9889185|FG004|NOT COMPLETED|Overall Study||0
8834887|NCT01657344|9889186|FG005|NOT COMPLETED|Overall Study||0
8834888|NCT01657344|9889187|FG006|NOT COMPLETED|Overall Study||0
8834889|NCT01657370|9889203|FG000|STARTED|Overall Study||33
8834890|NCT01657370|9889204|FG001|STARTED|Overall Study||32
8834891|NCT01657370|9889205|FG002|STARTED|Overall Study||32
8834892|NCT01657370|9889206|FG003|STARTED|Overall Study||33
8834893|NCT01657370|9889207|FG004|STARTED|Overall Study||34
8834894|NCT01657370|9889208|FG005|STARTED|Overall Study||31
8834895|NCT01657370|9889203|FG000|COMPLETED|Overall Study||27
8834896|NCT01657370|9889204|FG001|COMPLETED|Overall Study||28
8834897|NCT01657370|9889205|FG002|COMPLETED|Overall Study||25
8834898|NCT01657370|9889206|FG003|COMPLETED|Overall Study||28
8834899|NCT01657370|9889207|FG004|COMPLETED|Overall Study||27
8834900|NCT01657370|9889208|FG005|COMPLETED|Overall Study||27
8834901|NCT01657370|9889203|FG000|NOT COMPLETED|Overall Study||6
8834902|NCT01657370|9889204|FG001|NOT COMPLETED|Overall Study||4
8834903|NCT01657370|9889205|FG002|NOT COMPLETED|Overall Study||7
8834904|NCT01657370|9889206|FG003|NOT COMPLETED|Overall Study||5
8834905|NCT01657370|9889207|FG004|NOT COMPLETED|Overall Study||7
8834906|NCT01657370|9889208|FG005|NOT COMPLETED|Overall Study||4
8834907|NCT01657461|9889229|FG000|STARTED|Overall Study||98
8834908|NCT01657461|9889230|FG001|STARTED|Overall Study||98
8834909|NCT01657461|9889229|FG000|COMPLETED|Overall Study||88
8834910|NCT01657461|9889230|FG001|COMPLETED|Overall Study||78
8834911|NCT01657461|9889229|FG000|NOT COMPLETED|Overall Study||10
8834912|NCT01657461|9889230|FG001|NOT COMPLETED|Overall Study||20
8834913|NCT01657617|9889236|FG000|STARTED|Overall Study||35
8834914|NCT01657617|9889236|FG000|COMPLETED|Overall Study||35
8834915|NCT01657617|9889236|FG000|NOT COMPLETED|Overall Study||0
8834916|NCT01657760|9889242|FG000|STARTED|Overall Study||5
8834917|NCT01657760|9889243|FG001|STARTED|Overall Study||7
8834918|NCT01657760|9889244|FG002|STARTED|Overall Study||7
8834919|NCT01657760|9889245|FG003|STARTED|Overall Study||7
8834920|NCT01657760|9889242|FG000|COMPLETED|Overall Study||4
8834921|NCT01657760|9889243|FG001|COMPLETED|Overall Study||6
8834922|NCT01657760|9889244|FG002|COMPLETED|Overall Study||6
8834923|NCT01657760|9889245|FG003|COMPLETED|Overall Study||4
8834924|NCT01657760|9889242|FG000|NOT COMPLETED|Overall Study||1
8834925|NCT01657760|9889243|FG001|NOT COMPLETED|Overall Study||1
8834926|NCT01657760|9889244|FG002|NOT COMPLETED|Overall Study||1
8834927|NCT01657760|9889245|FG003|NOT COMPLETED|Overall Study||3
8834928|NCT01657799|9889260|FG000|STARTED|Overall Study||102
8834929|NCT01657799|9889261|FG001|STARTED|Overall Study||103
8834930|NCT01657799|9889262|FG002|STARTED|Overall Study||102
8834931|NCT01657799|9889260|FG000|Received Treatment|Overall Study||101
8834932|NCT01657799|9889261|FG001|Received Treatment|Overall Study||103
8834933|NCT01657799|9889262|FG002|Received Treatment|Overall Study||102
8834934|NCT01657799|9889260|FG000|COMPLETED|Overall Study||0
8834935|NCT01657799|9889261|FG001|COMPLETED|Overall Study||0
8834936|NCT01657799|9889262|FG002|COMPLETED|Overall Study||0
8834937|NCT01657799|9889260|FG000|NOT COMPLETED|Overall Study||102
8834938|NCT01657799|9889261|FG001|NOT COMPLETED|Overall Study||103
8834939|NCT01657799|9889262|FG002|NOT COMPLETED|Overall Study||102
8834940|NCT01657877|9889270|FG000|STARTED|Overall Study||79
8834941|NCT01657877|9889270|FG000|Received 500ppm Fluoride as SMFP+ 0% CSP|Overall Study|Discontinuations: 1 due to other reason in P2 and 1 protocol violation in P4|70
8834942|NCT01657877|9889270|FG000|Received 1500ppm Fluoride as SMFP+5% CSP|Overall Study|Discontinuations:2 withdrawal of consent in period (P) 1; 1 AE in P2;1 protocol violation in P3 & P4|75
8834943|NCT01657877|9889270|FG000|Received 0ppm Fluoride+ 5% CSP|Overall Study|Discontinuations: 1 protocol violation in P1 and P2 each and 1 withdrawal of consent in P1.|71
8834944|NCT01657877|9889270|FG000|Received 0ppm Fluoride+ 0% CSP|Overall Study|Discontinuation: 1 in P4 due to other reasons|69
8834945|NCT01657877|9889270|FG000|Received 1500ppm Fluoride as SMFP+0% CSP|Overall Study|Discontinuations: 1 protocol violation in P1 and 1 withdrawal of consent and AE in P3|71
8834946|NCT01657877|9889270|FG000|COMPLETED|Overall Study||65
8834947|NCT01657877|9889270|FG000|NOT COMPLETED|Overall Study||14
8834948|NCT01657903|9889287|FG000|STARTED|Overall Study||56
8834949|NCT01657903|9889287|FG000|Received Placebo (No NaF/KNO3)Toothpaste|Overall Study|One participant was lost to follow up in study period 1|56
8834950|NCT01657903|9889287|FG000|Received NaF/KNO3 Toothpaste 1|Overall Study|One participant withdrew consent in study period 3|55
8834951|NCT01657903|9889287|FG000|Received NaF/KNO3 Toothpaste 3|Overall Study||54
8834952|NCT01657903|9889287|FG000|Received NaF/KNO3 Toothpaste 2|Overall Study||55
8834953|NCT01657903|9889287|FG000|COMPLETED|Overall Study||54
8834954|NCT01657903|9889287|FG000|NOT COMPLETED|Overall Study||2
8834955|NCT01658020|9889300|FG000|STARTED|Overall Study||175
8834956|NCT01658020|9889301|FG001|STARTED|Overall Study||167
8834957|NCT01658020|9889300|FG000|COMPLETED|Overall Study||167
8834958|NCT01658020|9889301|FG001|COMPLETED|Overall Study||158
8834959|NCT01658020|9889300|FG000|NOT COMPLETED|Overall Study||8
8834960|NCT01658020|9889301|FG001|NOT COMPLETED|Overall Study||9
8834961|NCT01658059|9889308|FG000|STARTED|First Intervention- 2 Days||12
8944351|NCT02395978|10006197|FG002|STARTED|Overall Study||21
8944352|NCT02395978|10006198|FG003|STARTED|Overall Study||19
8944353|NCT02395978|10006199|FG004|STARTED|Overall Study||20
8944354|NCT02395978|10006195|FG000|COMPLETED|Overall Study||6
8944355|NCT02395978|10006196|FG001|COMPLETED|Overall Study||6
8944356|NCT02395978|10006197|FG002|COMPLETED|Overall Study||19
8944357|NCT02395978|10006198|FG003|COMPLETED|Overall Study||14
8944358|NCT02395978|10006199|FG004|COMPLETED|Overall Study||15
8944359|NCT02395978|10006195|FG000|NOT COMPLETED|Overall Study||0
8944360|NCT02395978|10006196|FG001|NOT COMPLETED|Overall Study||0
8944361|NCT02395978|10006197|FG002|NOT COMPLETED|Overall Study||2
8944362|NCT02395978|10006198|FG003|NOT COMPLETED|Overall Study||5
8944363|NCT02395978|10006199|FG004|NOT COMPLETED|Overall Study||5
8944364|NCT02395991|10006212|FG000|STARTED|Overall Study||60
8944365|NCT02395991|10006212|FG000|COMPLETED|Overall Study||59
8944366|NCT02395991|10006212|FG000|NOT COMPLETED|Overall Study||1
8944367|NCT02396147|10006219|FG000|STARTED|Period 1||27
8944368|NCT02396147|10006220|FG001|STARTED|Period 1||27
8944369|NCT02396147|10006219|FG000|COMPLETED|Period 1||27
8944370|NCT02396147|10006220|FG001|COMPLETED|Period 1||27
8944371|NCT02396147|10006219|FG000|NOT COMPLETED|Period 1||0
8944372|NCT02396147|10006220|FG001|NOT COMPLETED|Period 1||0
8944373|NCT02396147|10006219|FG000|STARTED|Period 2||27
8944374|NCT02396147|10006220|FG001|STARTED|Period 2||27
8944375|NCT02396147|10006219|FG000|COMPLETED|Period 2||27
8944376|NCT02396147|10006220|FG001|COMPLETED|Period 2||27
8944377|NCT02396147|10006219|FG000|NOT COMPLETED|Period 2||0
8944378|NCT02396147|10006220|FG001|NOT COMPLETED|Period 2||0
8944379|NCT02396147|10006219|FG000|STARTED|Period 3||27
8944380|NCT02396147|10006220|FG001|STARTED|Period 3||27
8944381|NCT02396147|10006219|FG000|COMPLETED|Period 3||27
8944382|NCT02396147|10006220|FG001|COMPLETED|Period 3||27
8944383|NCT02396147|10006219|FG000|NOT COMPLETED|Period 3||0
8944384|NCT02396147|10006220|FG001|NOT COMPLETED|Period 3||0
8944385|NCT02396160|10006236|FG000|STARTED|Overall Study||75
8944386|NCT02396160|10006237|FG001|STARTED|Overall Study||75
8944387|NCT02396160|10006236|FG000|COMPLETED|Overall Study||69
8944388|NCT02396160|10006237|FG001|COMPLETED|Overall Study||73
8944389|NCT02396160|10006236|FG000|NOT COMPLETED|Overall Study||6
8944390|NCT02396160|10006237|FG001|NOT COMPLETED|Overall Study||2
8944391|NCT02396212|10006243|FG000|STARTED|Overall Study||19
8834962|NCT01658059|9889309|FG001|STARTED|First Intervention- 2 Days||10
8834963|NCT01658059|9889308|FG000|COMPLETED|First Intervention- 2 Days||6
8834964|NCT01658059|9889309|FG001|COMPLETED|First Intervention- 2 Days||5
8834965|NCT01658059|9889308|FG000|NOT COMPLETED|First Intervention- 2 Days||6
8834966|NCT01658059|9889309|FG001|NOT COMPLETED|First Intervention- 2 Days||5
8834967|NCT01658059|9889308|FG000|STARTED|Washout Period- 14 Days||6
8834968|NCT01658059|9889309|FG001|STARTED|Washout Period- 14 Days||5
8834969|NCT01658059|9889308|FG000|COMPLETED|Washout Period- 14 Days||6
8834970|NCT01658059|9889309|FG001|COMPLETED|Washout Period- 14 Days||5
8834971|NCT01658059|9889308|FG000|NOT COMPLETED|Washout Period- 14 Days||0
8834972|NCT01658059|9889309|FG001|NOT COMPLETED|Washout Period- 14 Days||0
8834973|NCT01658059|9889308|FG000|STARTED|Second Intervention- 2 Days||6
8834974|NCT01658059|9889309|FG001|STARTED|Second Intervention- 2 Days||5
8834975|NCT01658059|9889308|FG000|COMPLETED|Second Intervention- 2 Days||6
8834976|NCT01658059|9889309|FG001|COMPLETED|Second Intervention- 2 Days||5
8834977|NCT01658059|9889308|FG000|NOT COMPLETED|Second Intervention- 2 Days||0
8834978|NCT01658059|9889309|FG001|NOT COMPLETED|Second Intervention- 2 Days||0
8834979|NCT01658072|9889317|FG000|STARTED|Overall Study||45
8834980|NCT01658072|9889318|FG001|STARTED|Overall Study||45
8834981|NCT01658072|9889317|FG000|COMPLETED|Overall Study||41
8834982|NCT01658072|9889318|FG001|COMPLETED|Overall Study||43
8834983|NCT01658072|9889317|FG000|NOT COMPLETED|Overall Study||4
8834984|NCT01658072|9889318|FG001|NOT COMPLETED|Overall Study||2
8834985|NCT01658150|9889324|FG000|STARTED|Overall Study||11
8834986|NCT01658150|9889324|FG000|COMPLETED|Overall Study||10
8834987|NCT01658150|9889324|FG000|NOT COMPLETED|Overall Study||1
8834988|NCT01658228|9889331|FG000|STARTED|Overall Study||30
8834989|NCT01658228|9889332|FG001|STARTED|Overall Study||31
8834990|NCT01658228|9889331|FG000|COMPLETED|Overall Study||23
8834991|NCT01658228|9889332|FG001|COMPLETED|Overall Study||23
8834992|NCT01658228|9889331|FG000|NOT COMPLETED|Overall Study||7
8834993|NCT01658228|9889332|FG001|NOT COMPLETED|Overall Study||8
8834994|NCT01658436|9889338|FG000|STARTED|Overall Study||20
8834995|NCT01658436|9889339|FG001|STARTED|Overall Study||11
8834996|NCT01658436|9889338|FG000|COMPLETED|Overall Study||0
8834997|NCT01658436|9889339|FG001|COMPLETED|Overall Study||0
8834998|NCT01658436|9889338|FG000|NOT COMPLETED|Overall Study||20
8834999|NCT01658436|9889339|FG001|NOT COMPLETED|Overall Study||11
8835000|NCT01658514|9889348|FG000|STARTED|Overall Study||14
8835001|NCT01658514|9889349|FG001|STARTED|Overall Study||11
8835002|NCT01658514|9889350|FG002|STARTED|Overall Study||14
8835003|NCT01658514|9889348|FG000|Completed Treatment A|Overall Study||14
8835004|NCT01658514|9889349|FG001|Completed Treatment A|Overall Study||11
8835005|NCT01658514|9889350|FG002|Completed Treatment A|Overall Study||12
8835006|NCT01658514|9889348|FG000|Completed Treatment B|Overall Study||13
8835007|NCT01658514|9889349|FG001|Completed Treatment B|Overall Study||11
8835008|NCT01658514|9889350|FG002|Completed Treatment B|Overall Study||14
8835009|NCT01658514|9889348|FG000|Completed Treatment C|Overall Study||13
8835010|NCT01658514|9889349|FG001|Completed Treatment C|Overall Study||11
8835011|NCT01658514|9889350|FG002|Completed Treatment C|Overall Study||12
8835012|NCT01658514|9889348|FG000|Started - Normal RF Cohort Only|Overall Study||3
8835013|NCT01658514|9889349|FG001|Started - Normal RF Cohort Only|Overall Study||2
8835014|NCT01658514|9889350|FG002|Started - Normal RF Cohort Only|Overall Study||3
8835015|NCT01658514|9889348|FG000|Completed - Normal RF Cohort Only|Overall Study||3
8835016|NCT01658514|9889349|FG001|Completed - Normal RF Cohort Only|Overall Study||2
8835017|NCT01658514|9889350|FG002|Completed - Normal RF Cohort Only|Overall Study||3
8835018|NCT01658514|9889348|FG000|Started - Mild RI Cohort Only|Overall Study||4
8835019|NCT01658514|9889349|FG001|Started - Mild RI Cohort Only|Overall Study||3
8835020|NCT01658514|9889350|FG002|Started - Mild RI Cohort Only|Overall Study||4
8835021|NCT01658514|9889348|FG000|Completed - Mild RI Cohort Only|Overall Study||4
8835022|NCT01658514|9889349|FG001|Completed - Mild RI Cohort Only|Overall Study||3
8835023|NCT01658514|9889350|FG002|Completed - Mild RI Cohort Only|Overall Study||4
8835024|NCT01658514|9889348|FG000|Started - Moderate RI Cohort Only|Overall Study||4
8835025|NCT01658514|9889349|FG001|Started - Moderate RI Cohort Only|Overall Study||4
8835026|NCT01658514|9889350|FG002|Started - Moderate RI Cohort Only|Overall Study||4
8835027|NCT01658514|9889348|FG000|Completed - Moderate RI Cohort Only|Overall Study||3
8835028|NCT01658514|9889349|FG001|Completed - Moderate RI Cohort Only|Overall Study||4
8835029|NCT01658514|9889350|FG002|Completed - Moderate RI Cohort Only|Overall Study||2
8835030|NCT01658514|9889348|FG000|Started - Severe RI Cohort Only|Overall Study||3
8835031|NCT01658514|9889349|FG001|Started - Severe RI Cohort Only|Overall Study||2
8835032|NCT01658514|9889350|FG002|Started - Severe RI Cohort Only|Overall Study||3
8835033|NCT01658514|9889348|FG000|Completed - Severe RI Cohort Only|Overall Study||3
8835034|NCT01658514|9889349|FG001|Completed - Severe RI Cohort Only|Overall Study||2
8835035|NCT01658514|9889350|FG002|Completed - Severe RI Cohort Only|Overall Study||3
8835036|NCT01658514|9889348|FG000|COMPLETED|Overall Study||13
8835037|NCT01658514|9889349|FG001|COMPLETED|Overall Study||11
8835038|NCT01658514|9889350|FG002|COMPLETED|Overall Study||12
8835039|NCT01658514|9889348|FG000|NOT COMPLETED|Overall Study||1
8835040|NCT01658514|9889349|FG001|NOT COMPLETED|Overall Study||0
8835041|NCT01658514|9889350|FG002|NOT COMPLETED|Overall Study||2
8835042|NCT01658579|9889361|FG000|STARTED|Treatment Period A||15
8835043|NCT01658579|9889362|FG001|STARTED|Treatment Period A||15
8835044|NCT01658579|9889363|FG002|STARTED|Treatment Period A||15
8835045|NCT01658579|9889364|FG003|STARTED|Treatment Period A||14
8835046|NCT01658579|9889361|FG000|COMPLETED|Treatment Period A||14
8835047|NCT01658579|9889362|FG001|COMPLETED|Treatment Period A||15
8835048|NCT01658579|9889363|FG002|COMPLETED|Treatment Period A||14
8835049|NCT01658579|9889364|FG003|COMPLETED|Treatment Period A||13
8835050|NCT01658579|9889361|FG000|NOT COMPLETED|Treatment Period A||1
8835051|NCT01658579|9889362|FG001|NOT COMPLETED|Treatment Period A||0
8835052|NCT01658579|9889363|FG002|NOT COMPLETED|Treatment Period A||1
8835053|NCT01658579|9889364|FG003|NOT COMPLETED|Treatment Period A||1
8835054|NCT01658579|9889361|FG000|STARTED|Treatment Period B||14
8835055|NCT01658579|9889362|FG001|STARTED|Treatment Period B||15
8835056|NCT01658579|9889363|FG002|STARTED|Treatment Period B||14
8835057|NCT01658579|9889364|FG003|STARTED|Treatment Period B||13
8835058|NCT01658579|9889361|FG000|COMPLETED|Treatment Period B||14
8835059|NCT01658579|9889362|FG001|COMPLETED|Treatment Period B||15
8835060|NCT01658579|9889363|FG002|COMPLETED|Treatment Period B||14
8835061|NCT01658579|9889364|FG003|COMPLETED|Treatment Period B||12
8835062|NCT01658579|9889361|FG000|NOT COMPLETED|Treatment Period B||0
8835063|NCT01658579|9889362|FG001|NOT COMPLETED|Treatment Period B||0
8835064|NCT01658579|9889363|FG002|NOT COMPLETED|Treatment Period B||0
8835065|NCT01658579|9889364|FG003|NOT COMPLETED|Treatment Period B||1
8835066|NCT01658657|9889372|FG000|STARTED|Overall Study||7
8835067|NCT01658657|9889373|FG001|STARTED|Overall Study||10
8835068|NCT01658657|9889372|FG000|COMPLETED|Overall Study||4
8835069|NCT01658657|9889373|FG001|COMPLETED|Overall Study||7
8835070|NCT01658657|9889372|FG000|NOT COMPLETED|Overall Study||3
8835071|NCT01658657|9889373|FG001|NOT COMPLETED|Overall Study||3
8835072|NCT01658735|9889382|FG000|STARTED|Overall Study||39
8835073|NCT01658735|9889383|FG001|STARTED|Overall Study||36
8835074|NCT01658735|9889384|FG002|STARTED|Overall Study||38
8835075|NCT01658735|9889382|FG000|COMPLETED|Overall Study||34
8835076|NCT01658735|9889383|FG001|COMPLETED|Overall Study||29
8835077|NCT01658735|9889384|FG002|COMPLETED|Overall Study||34
8835078|NCT01658735|9889382|FG000|NOT COMPLETED|Overall Study||5
8835079|NCT01658735|9889383|FG001|NOT COMPLETED|Overall Study||7
8835080|NCT01658735|9889384|FG002|NOT COMPLETED|Overall Study||4
8835081|NCT01658839|9889392|FG000|STARTED|Overall Study||25
8835082|NCT01658839|9889392|FG000|COMPLETED|Overall Study||25
8835083|NCT01658839|9889392|FG000|NOT COMPLETED|Overall Study||0
8835084|NCT01658904|9889399|FG000|STARTED|Overall Study||3
8835085|NCT01658904|9889400|FG001|STARTED|Overall Study||0
8835086|NCT01658904|9889401|FG002|STARTED|Overall Study||0
8835087|NCT01658904|9889399|FG000|COMPLETED|Overall Study||1
8835088|NCT01658904|9889400|FG001|COMPLETED|Overall Study||0
8835089|NCT01658904|9889401|FG002|COMPLETED|Overall Study||0
8835090|NCT01658904|9889399|FG000|NOT COMPLETED|Overall Study||2
8835091|NCT01658904|9889400|FG001|NOT COMPLETED|Overall Study||0
8835092|NCT01658904|9889401|FG002|NOT COMPLETED|Overall Study||0
8835093|NCT01658943|9889414|FG000|STARTED|Overall Study||70
8835094|NCT01658943|9889415|FG001|STARTED|Overall Study||67
8835095|NCT01658943|9889414|FG000|Eligible|Overall Study||63
8835096|NCT01658943|9889415|FG001|Eligible|Overall Study||58
8835097|NCT01658943|9889414|FG000|Eligible and Began Protocol Therapy|Overall Study||62
8835098|NCT01658943|9889415|FG001|Eligible and Began Protocol Therapy|Overall Study||58
8835099|NCT01658943|9889414|FG000|COMPLETED|Overall Study||0
8835100|NCT01658943|9889415|FG001|COMPLETED|Overall Study||0
8835101|NCT01658943|9889414|FG000|NOT COMPLETED|Overall Study||70
8835102|NCT01658943|9889415|FG001|NOT COMPLETED|Overall Study||67
8835103|NCT01658995|9889423|FG000|STARTED|Overall Study||42
8835104|NCT01658995|9889424|FG001|STARTED|Overall Study||40
8835105|NCT01658995|9889423|FG000|COMPLETED|Overall Study||42
8835106|NCT01658995|9889424|FG001|COMPLETED|Overall Study||40
8835107|NCT01658995|9889423|FG000|NOT COMPLETED|Overall Study||0
8835108|NCT01658995|9889424|FG001|NOT COMPLETED|Overall Study||0
8835109|NCT01659021|9889432|FG000|STARTED|Main Study||174
8835110|NCT01659021|9889433|FG001|STARTED|Main Study||87
8835111|NCT01659021|9889432|FG000|Randomized and Treated|Main Study||173
8835112|NCT01659021|9889433|FG001|Randomized and Treated|Main Study||86
8835113|NCT01659021|9889432|FG000|COMPLETED|Main Study||100
8835114|NCT01659021|9889433|FG001|COMPLETED|Main Study||50
8835115|NCT01659021|9889432|FG000|NOT COMPLETED|Main Study||74
8835116|NCT01659021|9889433|FG001|NOT COMPLETED|Main Study||37
8835117|NCT01659021|9889432|FG000|STARTED|Long-Term Follow Up|Participants did not have to complete the main study to enter the Long-Term Follow Up period.|138
8835118|NCT01659021|9889433|FG001|STARTED|Long-Term Follow Up|Participants did not have to complete the main study to enter the Long-Term Follow Up period.|69
8835119|NCT01659021|9889432|FG000|COMPLETED|Long-Term Follow Up||133
8835120|NCT01659021|9889433|FG001|COMPLETED|Long-Term Follow Up||65
8835121|NCT01659021|9889432|FG000|NOT COMPLETED|Long-Term Follow Up||5
8835122|NCT01659021|9889433|FG001|NOT COMPLETED|Long-Term Follow Up||4
8835123|NCT01659125|9889443|FG000|STARTED|Overall Study||26
8835124|NCT01659125|9889443|FG000|Initiated Treatment|Overall Study||24
8835125|NCT01659125|9889443|FG000|Completed the Posttreatment Assessment|Overall Study||17
8835126|NCT01659125|9889443|FG000|Completed 3-month Follow-up|Overall Study||16
8835127|NCT01659125|9889443|FG000|Completed 6-month Follow-up|Overall Study||12
8835128|NCT01659125|9889443|FG000|COMPLETED|Overall Study||12
8835129|NCT01659125|9889443|FG000|NOT COMPLETED|Overall Study||14
8835130|NCT01659255|9889464|FG000|STARTED|Overall Study||3
8835131|NCT01659255|9889465|FG001|STARTED|Overall Study||3
8835132|NCT01659255|9889466|FG002|STARTED|Overall Study||4
8835133|NCT01659255|9889467|FG003|STARTED|Overall Study||3
8835134|NCT01659255|9889468|FG004|STARTED|Overall Study||3
8835135|NCT01659255|9889469|FG005|STARTED|Overall Study||3
8835136|NCT01659255|9889470|FG006|STARTED|Overall Study||3
8835137|NCT01659255|9889471|FG007|STARTED|Overall Study||3
8835138|NCT01659255|9889472|FG008|STARTED|Overall Study||3
8835139|NCT01659255|9889473|FG009|STARTED|Overall Study||3
8835140|NCT01659255|9889474|FG010|STARTED|Overall Study||3
8835141|NCT01659255|9889475|FG011|STARTED|Overall Study||5
8835142|NCT01659255|9889476|FG012|STARTED|Overall Study||8
8835143|NCT01659255|9889477|FG013|STARTED|Overall Study||21
8835144|NCT01659255|9889478|FG014|STARTED|Overall Study||10
8835145|NCT01659255|9889479|FG015|STARTED|Overall Study||9
8835146|NCT01659255|9889480|FG016|STARTED|Overall Study||3
8835147|NCT01659255|9889464|FG000|COMPLETED|Overall Study||1
8835148|NCT01659255|9889465|FG001|COMPLETED|Overall Study||2
8835149|NCT01659255|9889466|FG002|COMPLETED|Overall Study||4
8835150|NCT01659255|9889467|FG003|COMPLETED|Overall Study||3
8835151|NCT01659255|9889468|FG004|COMPLETED|Overall Study||3
8835152|NCT01659255|9889469|FG005|COMPLETED|Overall Study||2
8835153|NCT01659255|9889470|FG006|COMPLETED|Overall Study||1
8835154|NCT01659255|9889471|FG007|COMPLETED|Overall Study||1
8835155|NCT01659255|9889472|FG008|COMPLETED|Overall Study||2
8835156|NCT01659255|9889473|FG009|COMPLETED|Overall Study||0
8835157|NCT01659255|9889474|FG010|COMPLETED|Overall Study||0
8835158|NCT01659255|9889475|FG011|COMPLETED|Overall Study||1
8835159|NCT01659255|9889476|FG012|COMPLETED|Overall Study||0
8835160|NCT01659255|9889477|FG013|COMPLETED|Overall Study||3
8835161|NCT01659255|9889478|FG014|COMPLETED|Overall Study||2
8835162|NCT01659255|9889479|FG015|COMPLETED|Overall Study||4
8835163|NCT01659255|9889480|FG016|COMPLETED|Overall Study||0
8835164|NCT01659255|9889464|FG000|NOT COMPLETED|Overall Study||2
8835165|NCT01659255|9889465|FG001|NOT COMPLETED|Overall Study||1
8835166|NCT01659255|9889466|FG002|NOT COMPLETED|Overall Study||0
8835167|NCT01659255|9889467|FG003|NOT COMPLETED|Overall Study||0
8835168|NCT01659255|9889468|FG004|NOT COMPLETED|Overall Study||0
8835169|NCT01659255|9889469|FG005|NOT COMPLETED|Overall Study||1
8835170|NCT01659255|9889470|FG006|NOT COMPLETED|Overall Study||2
8835171|NCT01659255|9889471|FG007|NOT COMPLETED|Overall Study||2
8835172|NCT01659255|9889472|FG008|NOT COMPLETED|Overall Study||1
8835173|NCT01659255|9889473|FG009|NOT COMPLETED|Overall Study||3
8835174|NCT01659255|9889474|FG010|NOT COMPLETED|Overall Study||3
8835175|NCT01659255|9889475|FG011|NOT COMPLETED|Overall Study||4
8835176|NCT01659255|9889476|FG012|NOT COMPLETED|Overall Study||8
8835177|NCT01659255|9889477|FG013|NOT COMPLETED|Overall Study||18
8835178|NCT01659255|9889478|FG014|NOT COMPLETED|Overall Study||8
8835179|NCT01659255|9889479|FG015|NOT COMPLETED|Overall Study||5
8835180|NCT01659255|9889480|FG016|NOT COMPLETED|Overall Study||3
8835181|NCT01659268|9889520|FG000|STARTED|Overall Study||9
8835182|NCT01659268|9889521|FG001|STARTED|Overall Study||8
8835183|NCT01659268|9889520|FG000|COMPLETED|Overall Study||9
8835184|NCT01659268|9889521|FG001|COMPLETED|Overall Study||8
8835185|NCT01659268|9889520|FG000|NOT COMPLETED|Overall Study||0
8835186|NCT01659268|9889521|FG001|NOT COMPLETED|Overall Study||0
8835187|NCT01659320|9889527|FG000|STARTED|Overall Study||16
8835188|NCT01659320|9889527|FG000|COMPLETED|Overall Study||13
8835189|NCT01659320|9889527|FG000|NOT COMPLETED|Overall Study||3
8835190|NCT01659567|9889531|FG000|STARTED|Overall Study||516
8835191|NCT01659567|9889531|FG000|COMPLETED|Overall Study||393
8835192|NCT01659567|9889531|FG000|NOT COMPLETED|Overall Study||123
8835193|NCT01659736|9889537|FG000|STARTED|Treatment Period||14
8835194|NCT01659736|9889538|FG001|STARTED|Treatment Period||12
8835195|NCT01659736|9889537|FG000|COMPLETED|Treatment Period|n = 10, but data from one completer was excluded from all analyses due to protocol violation.|9
8835196|NCT01659736|9889538|FG001|COMPLETED|Treatment Period||10
8835197|NCT01659736|9889537|FG000|NOT COMPLETED|Treatment Period||5
8835198|NCT01659736|9889538|FG001|NOT COMPLETED|Treatment Period||2
8835199|NCT01659736|9889537|FG000|STARTED|3-month Follow-up||9
8835200|NCT01659736|9889538|FG001|STARTED|3-month Follow-up||10
8835201|NCT01659736|9889537|FG000|COMPLETED|3-month Follow-up||9
8835202|NCT01659736|9889538|FG001|COMPLETED|3-month Follow-up||9
8835203|NCT01659736|9889537|FG000|NOT COMPLETED|3-month Follow-up||0
8835204|NCT01659736|9889538|FG001|NOT COMPLETED|3-month Follow-up||1
8835205|NCT01659853|9889546|FG000|STARTED|Treatment Period 1||35
8835206|NCT01659853|9889547|FG001|STARTED|Treatment Period 1||35
8835207|NCT01659853|9889546|FG000|COMPLETED|Treatment Period 1||35
8835208|NCT01659853|9889547|FG001|COMPLETED|Treatment Period 1||35
8835209|NCT01659853|9889546|FG000|NOT COMPLETED|Treatment Period 1||0
8835210|NCT01659853|9889547|FG001|NOT COMPLETED|Treatment Period 1||0
8835211|NCT01659853|9889546|FG000|STARTED|Washout , 3 to 7 Days||35
8835212|NCT01659853|9889547|FG001|STARTED|Washout , 3 to 7 Days||35
8835213|NCT01659853|9889546|FG000|COMPLETED|Washout , 3 to 7 Days||33
8835214|NCT01659853|9889547|FG001|COMPLETED|Washout , 3 to 7 Days||35
8835215|NCT01659853|9889546|FG000|NOT COMPLETED|Washout , 3 to 7 Days||2
8835216|NCT01659853|9889547|FG001|NOT COMPLETED|Washout , 3 to 7 Days||0
8835217|NCT01659853|9889546|FG000|STARTED|Treatment Period 2||33
8835218|NCT01659853|9889547|FG001|STARTED|Treatment Period 2||35
8835219|NCT01659853|9889546|FG000|COMPLETED|Treatment Period 2||33
8835220|NCT01659853|9889547|FG001|COMPLETED|Treatment Period 2||35
8835221|NCT01659853|9889546|FG000|NOT COMPLETED|Treatment Period 2||0
8835222|NCT01659853|9889547|FG001|NOT COMPLETED|Treatment Period 2||0
8835223|NCT01659866|9889557|FG000|STARTED|Overall Study||430
8835224|NCT01659866|9889558|FG001|STARTED|Overall Study||80
8835225|NCT01659866|9889557|FG000|COMPLETED|Overall Study||430
8835226|NCT01659866|9889558|FG001|COMPLETED|Overall Study||80
8835227|NCT01659866|9889557|FG000|NOT COMPLETED|Overall Study||0
8835228|NCT01659866|9889558|FG001|NOT COMPLETED|Overall Study||0
8835229|NCT01659996|9889567|FG000|STARTED|Overall Study||421
8835230|NCT01659996|9889568|FG001|STARTED|Overall Study||395
8835231|NCT01659996|9889569|FG002|STARTED|Overall Study||472
8835232|NCT01659996|9889567|FG000|COMPLETED|Overall Study||413
8835233|NCT01659996|9889568|FG001|COMPLETED|Overall Study||388
8835234|NCT01659996|9889569|FG002|COMPLETED|Overall Study||461
8835235|NCT01659996|9889567|FG000|NOT COMPLETED|Overall Study||8
8835236|NCT01659996|9889568|FG001|NOT COMPLETED|Overall Study||7
8835237|NCT01659996|9889569|FG002|NOT COMPLETED|Overall Study||11
8835238|NCT01660022|9889585|FG000|STARTED|First Sequence (7 Days)||8
8622855|NCT00490035|9662040|FG001|COMPLETED|Overall Study||93
8622856|NCT00490035|9662041|FG002|COMPLETED|Overall Study||88
8622857|NCT00490035|9662042|FG003|COMPLETED|Overall Study||94
8622858|NCT00490035|9662039|FG000|NOT COMPLETED|Overall Study||8
8835239|NCT01660022|9889586|FG001|STARTED|First Sequence (7 Days)||8
8835240|NCT01660022|9889587|FG002|STARTED|First Sequence (7 Days)||8
8835241|NCT01660022|9889588|FG003|STARTED|First Sequence (7 Days)||8
8835242|NCT01660022|9889589|FG004|STARTED|First Sequence (7 Days)||7
8835243|NCT01660022|9889590|FG005|STARTED|First Sequence (7 Days)||20
8835244|NCT01660022|9889585|FG000|COMPLETED|First Sequence (7 Days)||8
8835245|NCT01660022|9889586|FG001|COMPLETED|First Sequence (7 Days)||7
8835246|NCT01660022|9889587|FG002|COMPLETED|First Sequence (7 Days)||8
8835247|NCT01660022|9889588|FG003|COMPLETED|First Sequence (7 Days)||7
8835248|NCT01660022|9889589|FG004|COMPLETED|First Sequence (7 Days)||6
8835249|NCT01660022|9889590|FG005|COMPLETED|First Sequence (7 Days)||16
8835250|NCT01660022|9889585|FG000|NOT COMPLETED|First Sequence (7 Days)||0
8835251|NCT01660022|9889586|FG001|NOT COMPLETED|First Sequence (7 Days)||1
8835252|NCT01660022|9889587|FG002|NOT COMPLETED|First Sequence (7 Days)||0
8835253|NCT01660022|9889588|FG003|NOT COMPLETED|First Sequence (7 Days)||1
8835254|NCT01660022|9889589|FG004|NOT COMPLETED|First Sequence (7 Days)||1
8835255|NCT01660022|9889590|FG005|NOT COMPLETED|First Sequence (7 Days)||4
8835256|NCT01660022|9889585|FG000|STARTED|Second Sequence (42 Days)||8
8835257|NCT01660022|9889586|FG001|STARTED|Second Sequence (42 Days)||7
8835258|NCT01660022|9889587|FG002|STARTED|Second Sequence (42 Days)||8
8835259|NCT01660022|9889588|FG003|STARTED|Second Sequence (42 Days)||7
8835260|NCT01660022|9889589|FG004|STARTED|Second Sequence (42 Days)||6
8835261|NCT01660022|9889590|FG005|STARTED|Second Sequence (42 Days)||16
8835262|NCT01660022|9889585|FG000|COMPLETED|Second Sequence (42 Days)||8
8835263|NCT01660022|9889586|FG001|COMPLETED|Second Sequence (42 Days)||7
8835264|NCT01660022|9889587|FG002|COMPLETED|Second Sequence (42 Days)||8
8835265|NCT01660022|9889588|FG003|COMPLETED|Second Sequence (42 Days)||7
8835266|NCT01660022|9889589|FG004|COMPLETED|Second Sequence (42 Days)||6
8835267|NCT01660022|9889590|FG005|COMPLETED|Second Sequence (42 Days)||16
8835268|NCT01660022|9889585|FG000|NOT COMPLETED|Second Sequence (42 Days)||0
8835269|NCT01660022|9889586|FG001|NOT COMPLETED|Second Sequence (42 Days)||0
8835270|NCT01660022|9889587|FG002|NOT COMPLETED|Second Sequence (42 Days)||0
8835271|NCT01660022|9889588|FG003|NOT COMPLETED|Second Sequence (42 Days)||0
8835272|NCT01660022|9889589|FG004|NOT COMPLETED|Second Sequence (42 Days)||0
8835273|NCT01660022|9889590|FG005|NOT COMPLETED|Second Sequence (42 Days)||0
8835274|NCT01660191|9889619|FG000|STARTED|Enrollment and Washout||45
8835275|NCT01660191|9889620|FG001|STARTED|Enrollment and Washout||45
8835276|NCT01660191|9889621|FG002|STARTED|Enrollment and Washout||44
8835277|NCT01660191|9889619|FG000|COMPLETED|Enrollment and Washout||45
8835278|NCT01660191|9889620|FG001|COMPLETED|Enrollment and Washout||45
8835279|NCT01660191|9889621|FG002|COMPLETED|Enrollment and Washout||44
8835280|NCT01660191|9889619|FG000|NOT COMPLETED|Enrollment and Washout||0
8835281|NCT01660191|9889620|FG001|NOT COMPLETED|Enrollment and Washout||0
8835282|NCT01660191|9889621|FG002|NOT COMPLETED|Enrollment and Washout||0
8835283|NCT01660191|9889619|FG000|STARTED|Randomization||45
8835284|NCT01660191|9889620|FG001|STARTED|Randomization||45
8835285|NCT01660191|9889621|FG002|STARTED|Randomization||44
8835286|NCT01660191|9889619|FG000|COMPLETED|Randomization||45
8835287|NCT01660191|9889620|FG001|COMPLETED|Randomization||45
8835288|NCT01660191|9889621|FG002|COMPLETED|Randomization||44
8835289|NCT01660191|9889619|FG000|NOT COMPLETED|Randomization||0
8835290|NCT01660191|9889620|FG001|NOT COMPLETED|Randomization||0
8835291|NCT01660191|9889621|FG002|NOT COMPLETED|Randomization||0
8835292|NCT01660191|9889619|FG000|STARTED|End of Treatment||45
8622859|NCT00490035|9662040|FG001|NOT COMPLETED|Overall Study||6
8622860|NCT00490035|9662041|FG002|NOT COMPLETED|Overall Study||12
8622861|NCT00490035|9662042|FG003|NOT COMPLETED|Overall Study||6
8622862|NCT00490061|9662052|FG000|STARTED|Overall Study||17
8835293|NCT01660191|9889620|FG001|STARTED|End of Treatment||45
8835294|NCT01660191|9889621|FG002|STARTED|End of Treatment||44
8835295|NCT01660191|9889619|FG000|COMPLETED|End of Treatment||44
8835296|NCT01660191|9889620|FG001|COMPLETED|End of Treatment||39
8835297|NCT01660191|9889621|FG002|COMPLETED|End of Treatment||43
8835298|NCT01660191|9889619|FG000|NOT COMPLETED|End of Treatment||1
8835299|NCT01660191|9889620|FG001|NOT COMPLETED|End of Treatment||6
8835300|NCT01660191|9889621|FG002|NOT COMPLETED|End of Treatment||1
8835301|NCT01660230|9889641|FG000|STARTED|Overall Study||4
8835302|NCT01660230|9889642|FG001|STARTED|Overall Study||4
8835303|NCT01660230|9889643|FG002|STARTED|Overall Study||4
8835304|NCT01660230|9889644|FG003|STARTED|Overall Study||4
8835305|NCT01660230|9889645|FG004|STARTED|Overall Study||4
8835306|NCT01660230|9889646|FG005|STARTED|Overall Study||2
8835307|NCT01660230|9889647|FG006|STARTED|Overall Study||4
8835308|NCT01660230|9889648|FG007|STARTED|Overall Study||6
8835309|NCT01660230|9889649|FG008|STARTED|Overall Study||6
8835310|NCT01660230|9889650|FG009|STARTED|Overall Study||6
8835311|NCT01660230|9889651|FG010|STARTED|Overall Study||6
8835312|NCT01660230|9889652|FG011|STARTED|Overall Study||14
8835313|NCT01660230|9889641|FG000|COMPLETED|Overall Study||4
8835314|NCT01660230|9889642|FG001|COMPLETED|Overall Study||4
8835315|NCT01660230|9889643|FG002|COMPLETED|Overall Study||4
8835316|NCT01660230|9889644|FG003|COMPLETED|Overall Study||4
8835317|NCT01660230|9889645|FG004|COMPLETED|Overall Study||4
8835318|NCT01660230|9889646|FG005|COMPLETED|Overall Study||2
8835319|NCT01660230|9889647|FG006|COMPLETED|Overall Study||4
8835320|NCT01660230|9889648|FG007|COMPLETED|Overall Study||6
8835321|NCT01660230|9889649|FG008|COMPLETED|Overall Study||6
8835322|NCT01660230|9889650|FG009|COMPLETED|Overall Study||6
8835323|NCT01660230|9889651|FG010|COMPLETED|Overall Study||6
8835324|NCT01660230|9889652|FG011|COMPLETED|Overall Study||14
8835325|NCT01660230|9889641|FG000|NOT COMPLETED|Overall Study||0
8835326|NCT01660230|9889642|FG001|NOT COMPLETED|Overall Study||0
8835327|NCT01660230|9889643|FG002|NOT COMPLETED|Overall Study||0
8835328|NCT01660230|9889644|FG003|NOT COMPLETED|Overall Study||0
8835329|NCT01660230|9889645|FG004|NOT COMPLETED|Overall Study||0
8835330|NCT01660230|9889646|FG005|NOT COMPLETED|Overall Study||0
8835331|NCT01660230|9889647|FG006|NOT COMPLETED|Overall Study||0
8835332|NCT01660230|9889648|FG007|NOT COMPLETED|Overall Study||0
8835333|NCT01660230|9889649|FG008|NOT COMPLETED|Overall Study||0
8835334|NCT01660230|9889650|FG009|NOT COMPLETED|Overall Study||0
8835335|NCT01660230|9889651|FG010|NOT COMPLETED|Overall Study||0
8835336|NCT01660230|9889652|FG011|NOT COMPLETED|Overall Study||0
8835337|NCT01660256|9889682|FG000|STARTED|Overall Study||84
8835338|NCT01660256|9889683|FG001|STARTED|Overall Study||83
8835339|NCT01660256|9889684|FG002|STARTED|Overall Study||42
8835340|NCT01660256|9889682|FG000|COMPLETED|Overall Study||79
8835341|NCT01660256|9889683|FG001|COMPLETED|Overall Study||83
8835342|NCT01660256|9889684|FG002|COMPLETED|Overall Study||38
8835343|NCT01660256|9889682|FG000|NOT COMPLETED|Overall Study||5
8835344|NCT01660256|9889683|FG001|NOT COMPLETED|Overall Study||0
8835345|NCT01660256|9889684|FG002|NOT COMPLETED|Overall Study||4
8835346|NCT01660321|9889692|FG000|STARTED|Overall Study||26
8835347|NCT01660321|9889692|FG000|COMPLETED|Overall Study||26
8835348|NCT01660321|9889692|FG000|NOT COMPLETED|Overall Study||0
8835349|NCT01660334|9889696|FG000|STARTED|Overall Study||13
8835350|NCT01660334|9889696|FG000|COMPLETED|Overall Study||12
8835351|NCT01660334|9889696|FG000|NOT COMPLETED|Overall Study||1
8835352|NCT01660412|9889700|FG000|STARTED|Overall Study||29
8835353|NCT01660412|9889701|FG001|STARTED|Overall Study||31
8835354|NCT01660412|9889700|FG000|Head|Overall Study||1
8835355|NCT01660412|9889701|FG001|Head|Overall Study||4
8835356|NCT01660412|9889700|FG000|Thorax|Overall Study||9
8835357|NCT01660412|9889701|FG001|Thorax|Overall Study||9
8835358|NCT01660412|9889700|FG000|Appendicular Structures|Overall Study||17
8835359|NCT01660412|9889701|FG001|Appendicular Structures|Overall Study||11
8835360|NCT01660412|9889700|FG000|Other|Overall Study||2
8835361|NCT01660412|9889701|FG001|Other|Overall Study||4
8835362|NCT01660412|9889700|FG000|Injection 1|Overall Study||29
8835363|NCT01660412|9889701|FG001|Injection 1|Overall Study||31
8835364|NCT01660412|9889700|FG000|Injection 2|Overall Study||29
8835365|NCT01660412|9889701|FG001|Injection 2|Overall Study||31
8835366|NCT01660412|9889700|FG000|Injection 3|Overall Study||29
8835367|NCT01660412|9889701|FG001|Injection 3|Overall Study||31
8835368|NCT01660412|9889700|FG000|Injection 4|Overall Study||29
8835369|NCT01660412|9889701|FG001|Injection 4|Overall Study||31
8835370|NCT01660412|9889700|FG000|COMPLETED|Overall Study||29
8835371|NCT01660412|9889701|FG001|COMPLETED|Overall Study||28
8835372|NCT01660412|9889700|FG000|NOT COMPLETED|Overall Study||0
8835373|NCT01660412|9889701|FG001|NOT COMPLETED|Overall Study||3
8835374|NCT01660672|9889707|FG000|STARTED|Overall Study||7
8835375|NCT01660672|9889707|FG000|COMPLETED|Overall Study||7
8835376|NCT01660672|9889707|FG000|NOT COMPLETED|Overall Study||0
8835377|NCT01660698|9889714|FG000|STARTED|Overall Study||10
8835378|NCT01660698|9889715|FG001|STARTED|Overall Study||10
8835379|NCT01660698|9889714|FG000|COMPLETED|Overall Study||10
8835380|NCT01660698|9889715|FG001|COMPLETED|Overall Study||10
8835381|NCT01660698|9889714|FG000|NOT COMPLETED|Overall Study||0
8835382|NCT01660698|9889715|FG001|NOT COMPLETED|Overall Study||0
8835383|NCT01660711|9889721|FG000|STARTED|Overall Study||22
8835384|NCT01660711|9889721|FG000|COMPLETED|Overall Study||14
8835385|NCT01660711|9889721|FG000|NOT COMPLETED|Overall Study||8
8835386|NCT01660737|9889725|FG000|STARTED|Overall Study||123
8835387|NCT01660737|9889725|FG000|COMPLETED|Overall Study||123
8835388|NCT01660737|9889725|FG000|NOT COMPLETED|Overall Study||0
8835389|NCT01660763|9889731|FG000|STARTED|Overall Study||315
8835390|NCT01660763|9889732|FG001|STARTED|Overall Study||104
8835391|NCT01660763|9889731|FG000|COMPLETED|Overall Study||215
8835392|NCT01660763|9889732|FG001|COMPLETED|Overall Study||43
8835393|NCT01660763|9889731|FG000|NOT COMPLETED|Overall Study||100
8835394|NCT01660763|9889732|FG001|NOT COMPLETED|Overall Study||61
8835395|NCT01660802|9889740|FG000|STARTED|Overall Study||130
8835396|NCT01660802|9889741|FG001|STARTED|Overall Study||132
8835397|NCT01660802|9889740|FG000|COMPLETED|Overall Study||126
8835398|NCT01660802|9889741|FG001|COMPLETED|Overall Study||121
8835399|NCT01660802|9889740|FG000|NOT COMPLETED|Overall Study||4
8723372|NCT01022762|9770847|FG000|Exposed to Trial Drug|Overall Study|One participant was not exposed to the treatment due to fulfillment of exclusion criteria|217
8723373|NCT01022762|9770848|FG001|Exposed to Trial Drug|Overall Study|Four participants were not exposed to the treatment due to non-compliance or lost to follow-up|218
8723374|NCT01022762|9770847|FG000|COMPLETED|Overall Study||196
8723375|NCT01022762|9770848|FG001|COMPLETED|Overall Study||194
8723376|NCT01022762|9770847|FG000|NOT COMPLETED|Overall Study||22
8723377|NCT01022762|9770848|FG001|NOT COMPLETED|Overall Study||28
8723378|NCT01022853|9770859|FG000|STARTED|Overall Study|entered and treated|3
8723379|NCT01022853|9770860|FG001|STARTED|Overall Study|entered and treated|4
8723380|NCT01022853|9770861|FG002|STARTED|Overall Study|entered and treated|13
8723381|NCT01022853|9770862|FG003|STARTED|Overall Study|entered and treated|8
8723382|NCT01022853|9770863|FG004|STARTED|Overall Study|entered and treated|2
8723383|NCT01022853|9770859|FG000|COMPLETED|Overall Study||0
8723384|NCT01022853|9770860|FG001|COMPLETED|Overall Study||0
8723385|NCT01022853|9770861|FG002|COMPLETED|Overall Study||0
8723386|NCT01022853|9770862|FG003|COMPLETED|Overall Study||0
8723387|NCT01022853|9770863|FG004|COMPLETED|Overall Study||0
8723388|NCT01022853|9770859|FG000|NOT COMPLETED|Overall Study||3
8723389|NCT01022853|9770860|FG001|NOT COMPLETED|Overall Study||4
8723390|NCT01022853|9770861|FG002|NOT COMPLETED|Overall Study||13
8723391|NCT01022853|9770862|FG003|NOT COMPLETED|Overall Study||8
8723392|NCT01022853|9770863|FG004|NOT COMPLETED|Overall Study||2
8723393|NCT01022996|9770878|FG000|STARTED|Overall Study||57
8723394|NCT01022996|9770878|FG000|COMPLETED|Overall Study||0
8723395|NCT01022996|9770878|FG000|NOT COMPLETED|Overall Study||57
8723396|NCT01023022|9770882|FG000|STARTED|Overall Study|Previous No.: 178 subjects incl. 2 pts who withdraw their approval for processing personal data|176
8723397|NCT01023022|9770882|FG000|COMPLETED|Overall Study||162
8723398|NCT01023022|9770882|FG000|NOT COMPLETED|Overall Study||14
8723399|NCT01023035|9770889|FG000|STARTED|Treatment Period||249
8723400|NCT01023035|9770890|FG001|STARTED|Treatment Period||251
8723401|NCT01023035|9770891|FG002|STARTED|Treatment Period||187
8723402|NCT01023035|9770889|FG000|COMPLETED|Treatment Period||177
8723403|NCT01023035|9770890|FG001|COMPLETED|Treatment Period||166
8723404|NCT01023035|9770891|FG002|COMPLETED|Treatment Period||69
8723405|NCT01023035|9770889|FG000|NOT COMPLETED|Treatment Period||72
8723406|NCT01023035|9770890|FG001|NOT COMPLETED|Treatment Period||85
8723407|NCT01023035|9770891|FG002|NOT COMPLETED|Treatment Period||118
8723408|NCT01023035|9770889|FG000|STARTED|Follow-up Period (up to Week 72)||238
8723409|NCT01023035|9770890|FG001|STARTED|Follow-up Period (up to Week 72)||235
8723410|NCT01023035|9770891|FG002|STARTED|Follow-up Period (up to Week 72)||147
8723411|NCT01023035|9770889|FG000|COMPLETED|Follow-up Period (up to Week 72)||210
8723412|NCT01023035|9770890|FG001|COMPLETED|Follow-up Period (up to Week 72)||207
8723413|NCT01023035|9770891|FG002|COMPLETED|Follow-up Period (up to Week 72)||108
8723414|NCT01023035|9770889|FG000|NOT COMPLETED|Follow-up Period (up to Week 72)||28
8723415|NCT01023035|9770890|FG001|NOT COMPLETED|Follow-up Period (up to Week 72)||28
8723416|NCT01023035|9770891|FG002|NOT COMPLETED|Follow-up Period (up to Week 72)||39
8723417|NCT01023061|9770901|FG000|STARTED|Overall Study||24
8723418|NCT01023061|9770901|FG000|COMPLETED|Overall Study||22
8723419|NCT01023061|9770901|FG000|NOT COMPLETED|Overall Study||2
8723420|NCT01023074|9770908|FG000|STARTED|Overall Study||26
8723421|NCT01023074|9770909|FG001|STARTED|Overall Study||13
8723422|NCT01023074|9770910|FG002|STARTED|Overall Study||13
8723423|NCT01023074|9770908|FG000|COMPLETED|Overall Study||26
8723424|NCT01023074|9770909|FG001|COMPLETED|Overall Study||13
8723425|NCT01023074|9770910|FG002|COMPLETED|Overall Study||13
8723426|NCT01023074|9770908|FG000|NOT COMPLETED|Overall Study||0
8723427|NCT01023074|9770909|FG001|NOT COMPLETED|Overall Study||0
8723428|NCT01023074|9770910|FG002|NOT COMPLETED|Overall Study||0
8723429|NCT01023178|9770925|FG000|STARTED|Overall Study||5
8723430|NCT01023178|9770926|FG001|STARTED|Overall Study||8
8723431|NCT01023178|9770927|FG002|STARTED|Overall Study||7
8723432|NCT01023178|9770925|FG000|COMPLETED|Overall Study||3
8723433|NCT01023178|9770926|FG001|COMPLETED|Overall Study||6
8723434|NCT01023178|9770927|FG002|COMPLETED|Overall Study||4
8723435|NCT01023178|9770925|FG000|NOT COMPLETED|Overall Study||2
8723436|NCT01023178|9770926|FG001|NOT COMPLETED|Overall Study||2
8723437|NCT01023178|9770927|FG002|NOT COMPLETED|Overall Study||3
8723438|NCT01023217|9770937|FG000|STARTED|Overall Study||45
8723439|NCT01023217|9770938|FG001|STARTED|Overall Study||45
8723440|NCT01023217|9770937|FG000|COMPLETED|Overall Study||44
8723441|NCT01023217|9770938|FG001|COMPLETED|Overall Study||45
8723442|NCT01023217|9770937|FG000|NOT COMPLETED|Overall Study||1
8723443|NCT01023217|9770938|FG001|NOT COMPLETED|Overall Study||0
8723444|NCT01023256|9770948|FG000|STARTED|Overall Study||25
8723445|NCT01023256|9770949|FG001|STARTED|Overall Study||22
8723446|NCT01023256|9770950|FG002|STARTED|Overall Study||24
8723447|NCT01023256|9770951|FG003|STARTED|Overall Study||27
8723448|NCT01023256|9770948|FG000|COMPLETED|Overall Study||21
8723449|NCT01023256|9770949|FG001|COMPLETED|Overall Study||19
8723450|NCT01023256|9770950|FG002|COMPLETED|Overall Study||23
8723451|NCT01023256|9770951|FG003|COMPLETED|Overall Study||22
8723452|NCT01023256|9770948|FG000|NOT COMPLETED|Overall Study||4
8723453|NCT01023256|9770949|FG001|NOT COMPLETED|Overall Study||3
8723454|NCT01023256|9770950|FG002|NOT COMPLETED|Overall Study||1
8835400|NCT01660802|9889741|FG001|NOT COMPLETED|Overall Study||11
8835401|NCT01660815|9889747|FG000|STARTED|Overall Study||7
8835402|NCT01660815|9889747|FG000|COMPLETED|Overall Study||7
8835403|NCT01660815|9889747|FG000|NOT COMPLETED|Overall Study||0
8835404|NCT01660893|9889755|FG000|STARTED|Overall Study||10
8835405|NCT01660893|9889756|FG001|STARTED|Overall Study||10
8622863|NCT00490061|9662052|FG000|COMPLETED|Overall Study||16
8622864|NCT00490061|9662052|FG000|NOT COMPLETED|Overall Study||1
8835406|NCT01660893|9889757|FG002|STARTED|Overall Study||6
8835407|NCT01660893|9889755|FG000|COMPLETED|Overall Study||10
8835408|NCT01660893|9889756|FG001|COMPLETED|Overall Study||10
8835409|NCT01660893|9889757|FG002|COMPLETED|Overall Study||6
8835410|NCT01660893|9889755|FG000|NOT COMPLETED|Overall Study||0
8835411|NCT01660893|9889756|FG001|NOT COMPLETED|Overall Study||0
8835412|NCT01660893|9889757|FG002|NOT COMPLETED|Overall Study||0
8835413|NCT01660906|9889765|FG000|STARTED|Overall Study||39
8835414|NCT01660906|9889765|FG000|COMPLETED|Overall Study||36
8835415|NCT01660906|9889765|FG000|NOT COMPLETED|Overall Study||3
8835416|NCT01661062|9889769|FG000|STARTED|Overall Study||23
8835417|NCT01661062|9889769|FG000|COMPLETED|Overall Study||18
8835418|NCT01661062|9889769|FG000|NOT COMPLETED|Overall Study||5
8835419|NCT01661088|9889773|FG000|STARTED|FOLFIRINOX||25
8835420|NCT01661088|9889773|FG000|COMPLETED|FOLFIRINOX||21
8835421|NCT01661088|9889773|FG000|NOT COMPLETED|FOLFIRINOX||4
8835422|NCT01661088|9889773|FG000|STARTED|IMRT With FDR Gemcitabine||21
8835423|NCT01661088|9889773|FG000|COMPLETED|IMRT With FDR Gemcitabine||19
8835424|NCT01661088|9889773|FG000|NOT COMPLETED|IMRT With FDR Gemcitabine||2
8835425|NCT01661114|9889777|FG000|STARTED|Overall Study||39
8835426|NCT01661114|9889777|FG000|COMPLETED|Overall Study||39
8835427|NCT01661114|9889777|FG000|NOT COMPLETED|Overall Study||0
8835428|NCT01661140|9889781|FG000|STARTED|Open-Label Period|All participants entered the study in the initial phase for 24 weeks of open label treatment.|427
8835429|NCT01661140|9889782|FG001|STARTED|Open-Label Period||0
8835430|NCT01661140|9889783|FG002|STARTED|Open-Label Period||0
8835431|NCT01661140|9889781|FG000|COMPLETED|Open-Label Period||351
8835432|NCT01661140|9889782|FG001|COMPLETED|Open-Label Period||0
8835433|NCT01661140|9889783|FG002|COMPLETED|Open-Label Period||0
8835434|NCT01661140|9889781|FG000|NOT COMPLETED|Open-Label Period||76
8835435|NCT01661140|9889782|FG001|NOT COMPLETED|Open-Label Period||0
8835436|NCT01661140|9889783|FG002|NOT COMPLETED|Open-Label Period||0
8835437|NCT01661140|9889781|FG000|STARTED|Double-Blind Period|Those with a good/moderate disease response in the initial phase were randomized to the MTX arms.|0
8835438|NCT01661140|9889782|FG001|STARTED|Double-Blind Period|Only those with a good/moderate disease response in the initial phase were randomized.|136
8835439|NCT01661140|9889783|FG002|STARTED|Double-Blind Period|Only those with a good/moderate disease response in the initial phase were randomized.|136
8835440|NCT01661140|9889781|FG000|COMPLETED|Double-Blind Period||0
8835441|NCT01661140|9889782|FG001|COMPLETED|Double-Blind Period||95
8835442|NCT01661140|9889783|FG002|COMPLETED|Double-Blind Period||86
8835443|NCT01661140|9889781|FG000|NOT COMPLETED|Double-Blind Period||0
8835444|NCT01661140|9889782|FG001|NOT COMPLETED|Double-Blind Period||41
8835445|NCT01661140|9889783|FG002|NOT COMPLETED|Double-Blind Period||50
8835446|NCT01661179|9889791|FG000|STARTED|Overall Study||14
8835447|NCT01661179|9889791|FG000|COMPLETED|Overall Study||8
8835448|NCT01661179|9889791|FG000|NOT COMPLETED|Overall Study||6
8835449|NCT01661205|9889795|FG000|STARTED|Overall Study||26
8835450|NCT01661205|9889795|FG000|COMPLETED|Overall Study||24
8835451|NCT01661205|9889795|FG000|NOT COMPLETED|Overall Study||2
8835452|NCT01661270|9889801|FG000|STARTED|Overall Study||109
8835453|NCT01661270|9889802|FG001|STARTED|Overall Study||223
8835454|NCT01661270|9889801|FG000|Adverse Event|Overall Study|Met end of treatment (EOT) criteria.|26
8835455|NCT01661270|9889802|FG001|Adverse Event|Overall Study|Met EOT criteria|47
8835456|NCT01661270|9889801|FG000|Disease Progression|Overall Study|Met EOT criteria|67
8835457|NCT01661270|9889802|FG001|Disease Progression|Overall Study|Met EOT criteria|118
8835458|NCT01661270|9889801|FG000|Physician Decision|Overall Study|Met EOT criteria|1
8835459|NCT01661270|9889802|FG001|Physician Decision|Overall Study|Met EOT criteria|8
8835460|NCT01661270|9889801|FG000|Participant's Request|Overall Study|Met EOT criteria|15
8835461|NCT01661270|9889802|FG001|Participant's Request|Overall Study|Met EOT criteria|48
8835462|NCT01661270|9889801|FG000|Other Reasons|Overall Study||0
8835463|NCT01661270|9889802|FG001|Other Reasons|Overall Study||2
8835464|NCT01661270|9889801|FG000|COMPLETED|Overall Study|Treatment until disease progression/death, toxicity, consent withdrawal or Investigator's decision.|109
8835465|NCT01661270|9889802|FG001|COMPLETED|Overall Study|Treatment until disease progression/death, toxicity, consent withdrawal or Investigator's decision.|223
8835466|NCT01661270|9889801|FG000|NOT COMPLETED|Overall Study||0
8835467|NCT01661270|9889802|FG001|NOT COMPLETED|Overall Study||0
8835468|NCT01661283|9889809|FG000|STARTED|Overall Study|15 patients enrolled in the first stage; 10 patients enrolled in the second stage|25
8835469|NCT01661283|9889809|FG000|COMPLETED|Overall Study||25
8835470|NCT01661283|9889809|FG000|NOT COMPLETED|Overall Study||0
8944392|NCT02396212|10006243|FG000|COMPLETED|Overall Study||16
8944393|NCT02396212|10006243|FG000|NOT COMPLETED|Overall Study||3
8944394|NCT02396251|10006249|FG000|STARTED|Overall Study||36
8944395|NCT02396251|10006250|FG001|STARTED|Overall Study||12
8944396|NCT02396251|10006249|FG000|COMPLETED|Overall Study||23
8944397|NCT02396251|10006250|FG001|COMPLETED|Overall Study||7
8944398|NCT02396251|10006249|FG000|NOT COMPLETED|Overall Study||13
8944399|NCT02396251|10006250|FG001|NOT COMPLETED|Overall Study||5
8944400|NCT02396316|10006257|FG000|STARTED|Overall Study||27
8944401|NCT02396316|10006258|FG001|STARTED|Overall Study||27
8944402|NCT02396316|10006257|FG000|Treated|Overall Study||27
8944403|NCT02396316|10006258|FG001|Treated|Overall Study||27
8944404|NCT02396316|10006257|FG000|Received Sham Injection at Week 1|Overall Study||10
8835471|NCT01661595|9889817|FG000|STARTED|Phase 1: Week 0-4||5
8835472|NCT01661595|9889818|FG001|STARTED|Phase 1: Week 0-4||4
8835473|NCT01661595|9889819|FG002|STARTED|Phase 1: Week 0-4||5
8835474|NCT01661595|9889820|FG003|STARTED|Phase 1: Week 0-4||4
8835475|NCT01661595|9889817|FG000|COMPLETED|Phase 1: Week 0-4||4
8835476|NCT01661595|9889818|FG001|COMPLETED|Phase 1: Week 0-4||4
8835477|NCT01661595|9889819|FG002|COMPLETED|Phase 1: Week 0-4||5
8835478|NCT01661595|9889820|FG003|COMPLETED|Phase 1: Week 0-4||4
8835479|NCT01661595|9889817|FG000|NOT COMPLETED|Phase 1: Week 0-4||1
8835480|NCT01661595|9889818|FG001|NOT COMPLETED|Phase 1: Week 0-4||0
8835481|NCT01661595|9889819|FG002|NOT COMPLETED|Phase 1: Week 0-4||0
8835482|NCT01661595|9889820|FG003|NOT COMPLETED|Phase 1: Week 0-4||0
8835483|NCT01661595|9889817|FG000|STARTED|Phase 2: Week 5-8.||4
8835484|NCT01661595|9889818|FG001|STARTED|Phase 2: Week 5-8.||4
8835485|NCT01661595|9889819|FG002|STARTED|Phase 2: Week 5-8.||5
8835486|NCT01661595|9889820|FG003|STARTED|Phase 2: Week 5-8.||4
8835487|NCT01661595|9889817|FG000|COMPLETED|Phase 2: Week 5-8.||4
8835488|NCT01661595|9889818|FG001|COMPLETED|Phase 2: Week 5-8.||4
8835489|NCT01661595|9889819|FG002|COMPLETED|Phase 2: Week 5-8.||4
8835490|NCT01661595|9889820|FG003|COMPLETED|Phase 2: Week 5-8.||4
8835491|NCT01661595|9889817|FG000|NOT COMPLETED|Phase 2: Week 5-8.||0
8835492|NCT01661595|9889818|FG001|NOT COMPLETED|Phase 2: Week 5-8.||0
8835493|NCT01661595|9889819|FG002|NOT COMPLETED|Phase 2: Week 5-8.||1
8835494|NCT01661595|9889820|FG003|NOT COMPLETED|Phase 2: Week 5-8.||0
8835495|NCT01661621|9889839|FG000|STARTED|Overall Study||116
8835496|NCT01661621|9889840|FG001|STARTED|Overall Study||279
8835497|NCT01661621|9889839|FG000|COMPLETED|Overall Study||116
8835498|NCT01661621|9889840|FG001|COMPLETED|Overall Study||279
8835499|NCT01661621|9889839|FG000|NOT COMPLETED|Overall Study||0
8835500|NCT01661621|9889840|FG001|NOT COMPLETED|Overall Study||0
8849910|NCT01743677|9905101|FG003|STARTED|Third Intervention Period||10
8849911|NCT01743677|9905102|FG004|STARTED|Third Intervention Period||10
8849912|NCT01743677|9905103|FG005|STARTED|Third Intervention Period||10
8849913|NCT01743677|9905098|FG000|COMPLETED|Third Intervention Period||10
8849914|NCT01743677|9905099|FG001|COMPLETED|Third Intervention Period||10
8849915|NCT01743677|9905100|FG002|COMPLETED|Third Intervention Period||10
8849916|NCT01743677|9905101|FG003|COMPLETED|Third Intervention Period||10
8849917|NCT01743677|9905102|FG004|COMPLETED|Third Intervention Period||10
8849918|NCT01743677|9905103|FG005|COMPLETED|Third Intervention Period||10
8849919|NCT01743677|9905098|FG000|NOT COMPLETED|Third Intervention Period||0
8849920|NCT01743677|9905099|FG001|NOT COMPLETED|Third Intervention Period||0
8849921|NCT01743677|9905100|FG002|NOT COMPLETED|Third Intervention Period||0
8849922|NCT01743677|9905101|FG003|NOT COMPLETED|Third Intervention Period||0
8849923|NCT01743677|9905102|FG004|NOT COMPLETED|Third Intervention Period||0
8849924|NCT01743677|9905103|FG005|NOT COMPLETED|Third Intervention Period||0
8849925|NCT01743729|9905115|FG000|STARTED|Overall Study|One participant from placebo arm included in Lifitegrast arm for safety analysis set (N=359).|358
8849926|NCT01743729|9905116|FG001|STARTED|Overall Study|One placebo participant was considered for Lifitegrast arm; Placebo safety analysis set (N= 359).|360
8849927|NCT01743729|9905115|FG000|COMPLETED|Overall Study||321
8849928|NCT01743729|9905116|FG001|COMPLETED|Overall Study||348
8849929|NCT01743729|9905115|FG000|NOT COMPLETED|Overall Study||37
8849930|NCT01743729|9905116|FG001|NOT COMPLETED|Overall Study||12
8849931|NCT01743859|9905122|FG000|STARTED|Overall Study||37
8849932|NCT01743859|9905122|FG000|COMPLETED|Overall Study||28
8849933|NCT01743859|9905122|FG000|NOT COMPLETED|Overall Study||9
8849934|NCT01743963|9905128|FG000|STARTED|Overall Study||21
8849935|NCT01743963|9905129|FG001|STARTED|Overall Study||17
8849936|NCT01743963|9905128|FG000|COMPLETED|Overall Study||21
8849937|NCT01743963|9905129|FG001|COMPLETED|Overall Study||17
8849938|NCT01743963|9905128|FG000|NOT COMPLETED|Overall Study||0
8849939|NCT01743963|9905129|FG001|NOT COMPLETED|Overall Study||0
8849940|NCT01743976|9905137|FG000|STARTED|Overall Study||2
8849941|NCT01743976|9905138|FG001|STARTED|Overall Study||3
8849942|NCT01743976|9905137|FG000|COMPLETED|Overall Study||2
8849943|NCT01743976|9905138|FG001|COMPLETED|Overall Study||3
8849944|NCT01743976|9905137|FG000|NOT COMPLETED|Overall Study||0
8849945|NCT01743976|9905138|FG001|NOT COMPLETED|Overall Study||0
8849946|NCT01743989|9905147|FG000|STARTED|Treatment Phase||120
8849947|NCT01743989|9905148|FG001|STARTED|Treatment Phase||119
8849948|NCT01743989|9905149|FG002|STARTED|Treatment Phase||381
8849949|NCT01743989|9905147|FG000|Participants Who Signed Informed Consent|Treatment Phase||120
8849950|NCT01743989|9905148|FG001|Participants Who Signed Informed Consent|Treatment Phase||118
8849951|NCT01743989|9905149|FG002|Participants Who Signed Informed Consent|Treatment Phase||381
8849952|NCT01743989|9905147|FG000|COMPLETED|Treatment Phase||119
8849953|NCT01743989|9905148|FG001|COMPLETED|Treatment Phase||104
8849954|NCT01743989|9905149|FG002|COMPLETED|Treatment Phase||0
8849955|NCT01743989|9905147|FG000|NOT COMPLETED|Treatment Phase||1
8849956|NCT01743989|9905148|FG001|NOT COMPLETED|Treatment Phase||15
8849957|NCT01743989|9905149|FG002|NOT COMPLETED|Treatment Phase||381
8849958|NCT01743989|9905147|FG000|STARTED|TFR Phase||119
8849959|NCT01743989|9905148|FG001|STARTED|TFR Phase||104
8849960|NCT01743989|9905149|FG002|STARTED|TFR Phase||0
8944405|NCT02396316|10006258|FG001|Received Sham Injection at Week 1|Overall Study||0
8944406|NCT02396316|10006257|FG000|Received AFL Injection at Week 1|Overall Study||0
8622865|NCT00490100|9662056|FG000|STARTED|Overall Study||6
8622866|NCT00490100|9662056|FG000|COMPLETED|Overall Study||3
8622867|NCT00490100|9662056|FG000|NOT COMPLETED|Overall Study||3
8835501|NCT01661686|9889848|FG000|STARTED|Overall Study||49
8835502|NCT01661686|9889849|FG001|STARTED|Overall Study||49
8835503|NCT01661686|9889848|FG000|COMPLETED|Overall Study||47
8835504|NCT01661686|9889849|FG001|COMPLETED|Overall Study||47
8835505|NCT01661686|9889848|FG000|NOT COMPLETED|Overall Study||2
8835506|NCT01661686|9889849|FG001|NOT COMPLETED|Overall Study||2
8835507|NCT01661712|9889857|FG000|STARTED|Overall Study|initial sham stimulation night|18
8835508|NCT01661712|9889858|FG001|STARTED|Overall Study|initial night on transcutaneous electrical stimulation|18
8835509|NCT01661712|9889857|FG000|Washout Period|Overall Study|>Three nights of no stimulation/sham stimulation|18
8835510|NCT01661712|9889858|FG001|Washout Period|Overall Study|>Three nights of no stimulation/sham stimulation|18
8835511|NCT01661712|9889857|FG000|COMPLETED|Overall Study|night on transcutaneous electrical stimulation|18
8835512|NCT01661712|9889858|FG001|COMPLETED|Overall Study|sham stimulation night|18
8835513|NCT01661712|9889857|FG000|NOT COMPLETED|Overall Study||0
8835514|NCT01661712|9889858|FG001|NOT COMPLETED|Overall Study||0
8835515|NCT01661764|9889876|FG000|STARTED|Overall Study||26
8835516|NCT01661764|9889877|FG001|STARTED|Overall Study||25
8835517|NCT01661764|9889878|FG002|STARTED|Overall Study||25
8835518|NCT01661764|9889879|FG003|STARTED|Overall Study||26
8835519|NCT01661764|9889880|FG004|STARTED|Overall Study||19
8835520|NCT01661764|9889881|FG005|STARTED|Overall Study||20
8835521|NCT01661764|9889876|FG000|COMPLETED|Overall Study||24
8835522|NCT01661764|9889877|FG001|COMPLETED|Overall Study||20
8835523|NCT01661764|9889878|FG002|COMPLETED|Overall Study||22
8835524|NCT01661764|9889879|FG003|COMPLETED|Overall Study||24
8835525|NCT01661764|9889880|FG004|COMPLETED|Overall Study||16
8835526|NCT01661764|9889881|FG005|COMPLETED|Overall Study||18
8835527|NCT01661764|9889876|FG000|NOT COMPLETED|Overall Study||2
8835528|NCT01661764|9889877|FG001|NOT COMPLETED|Overall Study||5
8835529|NCT01661764|9889878|FG002|NOT COMPLETED|Overall Study||3
8835530|NCT01661764|9889879|FG003|NOT COMPLETED|Overall Study||2
8835531|NCT01661764|9889880|FG004|NOT COMPLETED|Overall Study||3
8835532|NCT01661764|9889881|FG005|NOT COMPLETED|Overall Study||2
8835533|NCT01661790|9889897|FG000|STARTED|Overall Study||36
8835534|NCT01661790|9889898|FG001|STARTED|Overall Study||36
8835535|NCT01661790|9889897|FG000|COMPLETED|Overall Study||36
8835536|NCT01661790|9889898|FG001|COMPLETED|Overall Study||34
8835537|NCT01661790|9889897|FG000|NOT COMPLETED|Overall Study||0
8835538|NCT01661790|9889898|FG001|NOT COMPLETED|Overall Study||2
8835539|NCT01661881|9889904|FG000|STARTED|Overall Study||23
8835540|NCT01661881|9889904|FG000|COMPLETED|Overall Study||22
8835541|NCT01661881|9889904|FG000|NOT COMPLETED|Overall Study||1
8835542|NCT01661933|9889908|FG000|STARTED|Gluten Micro-challenge|All 12 enrolled completed hookworm inoculation and gluten micro-challenge.|12
8835543|NCT01661933|9889908|FG000|COMPLETED|Gluten Micro-challenge|Two gluten intolerant participants did not proceed to the low-dose challenge.|12
8835544|NCT01661933|9889908|FG000|NOT COMPLETED|Gluten Micro-challenge||0
8835545|NCT01661933|9889908|FG000|STARTED|Low-dose Gluten Challenge|One was symptomatically intolerant to gluten >25 mg. One had active CeD pre- & post-micro-challenge|12
8622868|NCT00490139|9662065|FG000|STARTED|Overall Study||2093
8622869|NCT00490139|9662066|FG001|STARTED|Overall Study||2091
8622870|NCT00490139|9662067|FG002|STARTED|Overall Study||2100
8622871|NCT00490139|9662068|FG003|STARTED|Overall Study||2097
8622872|NCT00490139|9662065|FG000|COMPLETED|Overall Study||1785
8622873|NCT00490139|9662066|FG001|COMPLETED|Overall Study||1816
8835546|NCT01661933|9889908|FG000|COMPLETED|Low-dose Gluten Challenge|Two had challenge interrupted for 1-2 weeks. All completed challenge.|10
8835547|NCT01661933|9889908|FG000|NOT COMPLETED|Low-dose Gluten Challenge||2
8835548|NCT01661933|9889908|FG000|STARTED|High-dose Gluten Challenge|2 of 10 available after post-GC-1g did not enroll for reasons unrelated to gluten.|10
8622874|NCT00490139|9662067|FG002|COMPLETED|Overall Study||1666
8622875|NCT00490139|9662068|FG003|COMPLETED|Overall Study||1790
8622876|NCT00490139|9662065|FG000|NOT COMPLETED|Overall Study||308
8835549|NCT01661933|9889908|FG000|COMPLETED|High-dose Gluten Challenge||8
8835550|NCT01661933|9889908|FG000|NOT COMPLETED|High-dose Gluten Challenge||2
8835551|NCT01661946|9889916|FG000|STARTED|Overall Study||5
8835552|NCT01661946|9889917|FG001|STARTED|Overall Study||5
8835553|NCT01661946|9889916|FG000|COMPLETED|Overall Study||5
8835554|NCT01661946|9889917|FG001|COMPLETED|Overall Study||5
8835555|NCT01661946|9889916|FG000|NOT COMPLETED|Overall Study||0
8835556|NCT01661946|9889917|FG001|NOT COMPLETED|Overall Study||0
8835557|NCT01661972|9889925|FG000|STARTED|Overall Study||13
8835558|NCT01661972|9889926|FG001|STARTED|Overall Study||50
8835559|NCT01661972|9889925|FG000|COMPLETED|Overall Study||11
8835560|NCT01661972|9889926|FG001|COMPLETED|Overall Study||46
8835561|NCT01661972|9889925|FG000|NOT COMPLETED|Overall Study||2
8835562|NCT01661972|9889926|FG001|NOT COMPLETED|Overall Study||4
8835563|NCT01662024|9889934|FG000|STARTED|Overall Study||20
8835564|NCT01662024|9889934|FG000|COMPLETED|Overall Study||15
8835565|NCT01662024|9889934|FG000|NOT COMPLETED|Overall Study||5
8835566|NCT01662063|9889943|FG000|STARTED|Overall Study||44
8622877|NCT00490139|9662066|FG001|NOT COMPLETED|Overall Study||275
8622878|NCT00490139|9662067|FG002|NOT COMPLETED|Overall Study||434
8622879|NCT00490139|9662068|FG003|NOT COMPLETED|Overall Study||307
8835567|NCT01662063|9889944|FG001|STARTED|Overall Study||173
8835568|NCT01662063|9889945|FG002|STARTED|Overall Study||1
8835569|NCT01662063|9889943|FG000|COMPLETED|Overall Study||39
8835570|NCT01662063|9889944|FG001|COMPLETED|Overall Study||144
8835571|NCT01662063|9889945|FG002|COMPLETED|Overall Study||0
8835572|NCT01662063|9889943|FG000|NOT COMPLETED|Overall Study||5
8835573|NCT01662063|9889944|FG001|NOT COMPLETED|Overall Study||29
8835574|NCT01662063|9889945|FG002|NOT COMPLETED|Overall Study||1
8835575|NCT01662115|9889956|FG000|STARTED|Overall Study||2
8835576|NCT01662115|9889957|FG001|STARTED|Overall Study||2
8835577|NCT01662115|9889958|FG002|STARTED|Overall Study||0
8835578|NCT01662115|9889956|FG000|COMPLETED|Overall Study||2
8835579|NCT01662115|9889957|FG001|COMPLETED|Overall Study||2
8835580|NCT01662115|9889958|FG002|COMPLETED|Overall Study||0
8835581|NCT01662115|9889956|FG000|NOT COMPLETED|Overall Study||0
8835582|NCT01662115|9889957|FG001|NOT COMPLETED|Overall Study||0
8835583|NCT01662115|9889958|FG002|NOT COMPLETED|Overall Study||0
8835584|NCT01662297|9889968|FG000|STARTED|Overall Study||0
8835585|NCT01662297|9889969|FG001|STARTED|Overall Study||1
8835586|NCT01662297|9889968|FG000|COMPLETED|Overall Study||0
8835587|NCT01662297|9889969|FG001|COMPLETED|Overall Study||1
8835588|NCT01662297|9889968|FG000|NOT COMPLETED|Overall Study||0
8835589|NCT01662297|9889969|FG001|NOT COMPLETED|Overall Study||0
8835590|NCT01662310|9889975|FG000|STARTED|Run-In or Stabilization Phase||201
8835591|NCT01662310|9889976|FG001|STARTED|Run-In or Stabilization Phase||0
8835592|NCT01662310|9889977|FG002|STARTED|Run-In or Stabilization Phase||0
8835593|NCT01662310|9889978|FG003|STARTED|Run-In or Stabilization Phase||0
8835594|NCT01662310|9889979|FG004|STARTED|Run-In or Stabilization Phase||0
8835595|NCT01662310|9889975|FG000|COMPLETED|Run-In or Stabilization Phase||136
8835596|NCT01662310|9889976|FG001|COMPLETED|Run-In or Stabilization Phase||0
8835597|NCT01662310|9889977|FG002|COMPLETED|Run-In or Stabilization Phase||0
8835598|NCT01662310|9889978|FG003|COMPLETED|Run-In or Stabilization Phase||0
8835599|NCT01662310|9889979|FG004|COMPLETED|Run-In or Stabilization Phase||0
8835600|NCT01662310|9889975|FG000|NOT COMPLETED|Run-In or Stabilization Phase||65
8835601|NCT01662310|9889976|FG001|NOT COMPLETED|Run-In or Stabilization Phase||0
8835602|NCT01662310|9889977|FG002|NOT COMPLETED|Run-In or Stabilization Phase||0
8835603|NCT01662310|9889978|FG003|NOT COMPLETED|Run-In or Stabilization Phase||0
8835604|NCT01662310|9889979|FG004|NOT COMPLETED|Run-In or Stabilization Phase||0
8835605|NCT01662310|9889975|FG000|STARTED|Double-Blind Phase||0
8835606|NCT01662310|9889976|FG001|STARTED|Double-Blind Phase||65
8835607|NCT01662310|9889977|FG002|STARTED|Double-Blind Phase||71
8835608|NCT01662310|9889978|FG003|STARTED|Double-Blind Phase||0
8835609|NCT01662310|9889979|FG004|STARTED|Double-Blind Phase||0
8835610|NCT01662310|9889975|FG000|Treated|Double-Blind Phase||0
8835611|NCT01662310|9889976|FG001|Treated|Double-Blind Phase||64
8835612|NCT01662310|9889977|FG002|Treated|Double-Blind Phase||71
8835613|NCT01662310|9889978|FG003|Treated|Double-Blind Phase||0
8835614|NCT01662310|9889979|FG004|Treated|Double-Blind Phase||0
8835615|NCT01662310|9889975|FG000|COMPLETED|Double-Blind Phase||0
8835616|NCT01662310|9889976|FG001|COMPLETED|Double-Blind Phase||50
8835617|NCT01662310|9889977|FG002|COMPLETED|Double-Blind Phase||66
8835618|NCT01662310|9889978|FG003|COMPLETED|Double-Blind Phase||0
8835619|NCT01662310|9889979|FG004|COMPLETED|Double-Blind Phase||0
8835620|NCT01662310|9889975|FG000|NOT COMPLETED|Double-Blind Phase||0
8835621|NCT01662310|9889976|FG001|NOT COMPLETED|Double-Blind Phase||15
8835622|NCT01662310|9889977|FG002|NOT COMPLETED|Double-Blind Phase||5
8835623|NCT01662310|9889978|FG003|NOT COMPLETED|Double-Blind Phase||0
8835624|NCT01662310|9889979|FG004|NOT COMPLETED|Double-Blind Phase||0
8835625|NCT01662310|9889975|FG000|STARTED|Open-Label Extension Phase||0
8835626|NCT01662310|9889976|FG001|STARTED|Open-Label Extension Phase||0
8835627|NCT01662310|9889977|FG002|STARTED|Open-Label Extension Phase||0
8835628|NCT01662310|9889978|FG003|STARTED|Open-Label Extension Phase||47
8835629|NCT01662310|9889979|FG004|STARTED|Open-Label Extension Phase||59
8835630|NCT01662310|9889975|FG000|COMPLETED|Open-Label Extension Phase||0
8835631|NCT01662310|9889976|FG001|COMPLETED|Open-Label Extension Phase||0
8835632|NCT01662310|9889977|FG002|COMPLETED|Open-Label Extension Phase||0
8835633|NCT01662310|9889978|FG003|COMPLETED|Open-Label Extension Phase||36
8835634|NCT01662310|9889979|FG004|COMPLETED|Open-Label Extension Phase||49
8835635|NCT01662310|9889975|FG000|NOT COMPLETED|Open-Label Extension Phase||0
8835636|NCT01662310|9889976|FG001|NOT COMPLETED|Open-Label Extension Phase||0
8835637|NCT01662310|9889977|FG002|NOT COMPLETED|Open-Label Extension Phase||0
8835638|NCT01662310|9889978|FG003|NOT COMPLETED|Open-Label Extension Phase||11
8835639|NCT01662310|9889979|FG004|NOT COMPLETED|Open-Label Extension Phase||10
8835640|NCT01662336|9889991|FG000|STARTED|Overall Study||173
8835641|NCT01662336|9889991|FG000|Completed Month 6 Visit|Overall Study||142
8835642|NCT01662336|9889991|FG000|Completed Month 12 Visit|Overall Study||109
8835643|NCT01662336|9889991|FG000|COMPLETED|Overall Study||107
8835644|NCT01662336|9889991|FG000|NOT COMPLETED|Overall Study||66
8835645|NCT01662362|9890000|FG000|STARTED|Overall Study||63
8835646|NCT01662362|9890000|FG000|COMPLETED|Overall Study||25
8835647|NCT01662362|9890000|FG000|NOT COMPLETED|Overall Study||38
8835648|NCT01662440|9890009|FG000|STARTED|Overall Study||167
8835649|NCT01662440|9890010|FG001|STARTED|Overall Study||217
8835650|NCT01662440|9890011|FG002|STARTED|Overall Study||221
8835651|NCT01662440|9890012|FG003|STARTED|Overall Study||56
8835652|NCT01662440|9890009|FG000|COMPLETED|Overall Study||158
8835653|NCT01662440|9890010|FG001|COMPLETED|Overall Study||211
8835654|NCT01662440|9890011|FG002|COMPLETED|Overall Study||215
8835655|NCT01662440|9890012|FG003|COMPLETED|Overall Study||52
8835656|NCT01662440|9890009|FG000|NOT COMPLETED|Overall Study||9
8835657|NCT01662440|9890010|FG001|NOT COMPLETED|Overall Study||6
8835658|NCT01662440|9890011|FG002|NOT COMPLETED|Overall Study||6
8835659|NCT01662440|9890012|FG003|NOT COMPLETED|Overall Study||4
8835660|NCT01662492|9890035|FG000|STARTED|Overall Study||45
8835661|NCT01662492|9890036|FG001|STARTED|Overall Study||43
8835662|NCT01662492|9890037|FG002|STARTED|Overall Study||37
8835663|NCT01662492|9890035|FG000|COMPLETED|Overall Study||42
8835664|NCT01662492|9890036|FG001|COMPLETED|Overall Study||42
8835665|NCT01662492|9890037|FG002|COMPLETED|Overall Study||31
8835666|NCT01662492|9890035|FG000|NOT COMPLETED|Overall Study||3
8835667|NCT01662492|9890036|FG001|NOT COMPLETED|Overall Study||1
8835668|NCT01662492|9890037|FG002|NOT COMPLETED|Overall Study||6
8835669|NCT01662505|9890048|FG000|STARTED|Overall Study||7
8835670|NCT01662505|9890049|FG001|STARTED|Overall Study||4
8835671|NCT01662505|9890050|FG002|STARTED|Overall Study||8
8835672|NCT01662505|9890048|FG000|COMPLETED|Overall Study||0
8835673|NCT01662505|9890049|FG001|COMPLETED|Overall Study||0
8835674|NCT01662505|9890050|FG002|COMPLETED|Overall Study||0
8835675|NCT01662505|9890048|FG000|NOT COMPLETED|Overall Study||7
8835676|NCT01662505|9890049|FG001|NOT COMPLETED|Overall Study||4
8835677|NCT01662505|9890050|FG002|NOT COMPLETED|Overall Study||8
8835678|NCT01662531|9890061|FG000|STARTED|Overall Study||27
8835679|NCT01662531|9890061|FG000|COMPLETED|Overall Study||27
8835680|NCT01662531|9890061|FG000|NOT COMPLETED|Overall Study||0
8835681|NCT01662583|9890070|FG000|STARTED|Overall Study||216
8835682|NCT01662583|9890071|FG001|STARTED|Overall Study||225
8835683|NCT01662583|9890072|FG002|STARTED|Overall Study||219
8835684|NCT01662583|9890070|FG000|COMPLETED|Overall Study||216
8835685|NCT01662583|9890071|FG001|COMPLETED|Overall Study||225
8835686|NCT01662583|9890072|FG002|COMPLETED|Overall Study||219
8835687|NCT01662583|9890070|FG000|NOT COMPLETED|Overall Study||0
8835688|NCT01662583|9890071|FG001|NOT COMPLETED|Overall Study||0
8835689|NCT01662583|9890072|FG002|NOT COMPLETED|Overall Study||0
8835690|NCT01662635|9890080|FG000|STARTED|Overall Study||230
8835691|NCT01662635|9890080|FG000|COMPLETED|Overall Study||200
8835692|NCT01662635|9890080|FG000|NOT COMPLETED|Overall Study||30
8835693|NCT01662648|9890088|FG000|STARTED|Overall Study||520
8835694|NCT01662648|9890089|FG001|STARTED|Overall Study||597
8835695|NCT01662648|9890088|FG000|COMPLETED|Overall Study||373
8835696|NCT01662648|9890089|FG001|COMPLETED|Overall Study||419
8835697|NCT01662648|9890088|FG000|NOT COMPLETED|Overall Study||147
8835698|NCT01662648|9890089|FG001|NOT COMPLETED|Overall Study||178
8835699|NCT01662752|9890095|FG000|STARTED|Overall Study||30
8835700|NCT01662752|9890095|FG000|COMPLETED|Overall Study||30
8835701|NCT01662752|9890095|FG000|NOT COMPLETED|Overall Study||0
8835702|NCT01662765|9890101|FG000|STARTED|Overall Study||42
8835703|NCT01662765|9890102|FG001|STARTED|Overall Study||42
8835704|NCT01662765|9890101|FG000|COMPLETED|Overall Study||41
8835705|NCT01662765|9890102|FG001|COMPLETED|Overall Study||40
8835706|NCT01662765|9890101|FG000|NOT COMPLETED|Overall Study||1
8835707|NCT01662765|9890102|FG001|NOT COMPLETED|Overall Study||2
8835708|NCT01662778|9890113|FG000|STARTED|Period 1||6
8835709|NCT01662778|9890114|FG001|STARTED|Period 1||5
8835710|NCT01662778|9890115|FG002|STARTED|Period 1||6
8835711|NCT01662778|9890116|FG003|STARTED|Period 1||4
8835712|NCT01662778|9890113|FG000|COMPLETED|Period 1||6
8835713|NCT01662778|9890114|FG001|COMPLETED|Period 1||5
8835714|NCT01662778|9890115|FG002|COMPLETED|Period 1||6
8835715|NCT01662778|9890116|FG003|COMPLETED|Period 1||4
8835716|NCT01662778|9890113|FG000|NOT COMPLETED|Period 1||0
8835717|NCT01662778|9890114|FG001|NOT COMPLETED|Period 1||0
8835718|NCT01662778|9890115|FG002|NOT COMPLETED|Period 1||0
8835719|NCT01662778|9890116|FG003|NOT COMPLETED|Period 1||0
8835720|NCT01662778|9890113|FG000|STARTED|Period 2||6
8835721|NCT01662778|9890114|FG001|STARTED|Period 2||5
8835722|NCT01662778|9890115|FG002|STARTED|Period 2||6
8835723|NCT01662778|9890116|FG003|STARTED|Period 2||4
8835724|NCT01662778|9890113|FG000|COMPLETED|Period 2||6
8835725|NCT01662778|9890114|FG001|COMPLETED|Period 2||5
8835726|NCT01662778|9890115|FG002|COMPLETED|Period 2||6
8835727|NCT01662778|9890116|FG003|COMPLETED|Period 2||4
8835728|NCT01662778|9890113|FG000|NOT COMPLETED|Period 2||0
8835729|NCT01662778|9890114|FG001|NOT COMPLETED|Period 2||0
8835730|NCT01662778|9890115|FG002|NOT COMPLETED|Period 2||0
8835731|NCT01662778|9890116|FG003|NOT COMPLETED|Period 2||0
8835732|NCT01662778|9890113|FG000|STARTED|Period 3||6
8835733|NCT01662778|9890114|FG001|STARTED|Period 3||5
8835734|NCT01662778|9890115|FG002|STARTED|Period 3||6
8835735|NCT01662778|9890116|FG003|STARTED|Period 3||4
8835736|NCT01662778|9890113|FG000|COMPLETED|Period 3||6
8835737|NCT01662778|9890114|FG001|COMPLETED|Period 3||5
8835738|NCT01662778|9890115|FG002|COMPLETED|Period 3||6
8835739|NCT01662778|9890116|FG003|COMPLETED|Period 3||4
8835740|NCT01662778|9890113|FG000|NOT COMPLETED|Period 3||0
8835741|NCT01662778|9890114|FG001|NOT COMPLETED|Period 3||0
8835742|NCT01662778|9890115|FG002|NOT COMPLETED|Period 3||0
8835743|NCT01662778|9890116|FG003|NOT COMPLETED|Period 3||0
8835744|NCT01662778|9890113|FG000|STARTED|Period 4||6
8835745|NCT01662778|9890114|FG001|STARTED|Period 4||5
8835746|NCT01662778|9890115|FG002|STARTED|Period 4||6
8835747|NCT01662778|9890116|FG003|STARTED|Period 4||4
8835748|NCT01662778|9890113|FG000|COMPLETED|Period 4||6
8835749|NCT01662778|9890114|FG001|COMPLETED|Period 4||5
8835750|NCT01662778|9890115|FG002|COMPLETED|Period 4||6
8835751|NCT01662778|9890116|FG003|COMPLETED|Period 4||4
8835752|NCT01662778|9890113|FG000|NOT COMPLETED|Period 4||0
8835753|NCT01662778|9890114|FG001|NOT COMPLETED|Period 4||0
8835754|NCT01662778|9890115|FG002|NOT COMPLETED|Period 4||0
8835755|NCT01662778|9890116|FG003|NOT COMPLETED|Period 4||0
8835756|NCT01662791|9890132|FG000|STARTED|Part 1 - Observational||8
8835757|NCT01662791|9890133|FG001|STARTED|Part 1 - Observational||41
8835758|NCT01662791|9890132|FG000|COMPLETED|Part 1 - Observational||8
8835759|NCT01662791|9890133|FG001|COMPLETED|Part 1 - Observational||41
8835760|NCT01662791|9890132|FG000|NOT COMPLETED|Part 1 - Observational||0
8835761|NCT01662791|9890133|FG001|NOT COMPLETED|Part 1 - Observational||0
8835762|NCT01662791|9890132|FG000|STARTED|Part 2 - Interventional||8
8835763|NCT01662791|9890133|FG001|STARTED|Part 2 - Interventional|The Control Group did not take part in the second part of the study.|0
8835764|NCT01662791|9890132|FG000|COMPLETED|Part 2 - Interventional||8
8835765|NCT01662791|9890133|FG001|COMPLETED|Part 2 - Interventional||0
8835766|NCT01662791|9890132|FG000|NOT COMPLETED|Part 2 - Interventional||0
8835767|NCT01662791|9890133|FG001|NOT COMPLETED|Part 2 - Interventional||0
8835768|NCT01662856|9890141|FG000|STARTED|Part I + Part II (Overall Study)||168
8835769|NCT01662856|9890142|FG001|STARTED|Part I + Part II (Overall Study)||57
8835770|NCT01662856|9890141|FG000|Completed Study up to Week 6|Part I + Part II (Overall Study)||164
8835771|NCT01662856|9890142|FG001|Completed Study up to Week 6|Part I + Part II (Overall Study)||56
8835772|NCT01662856|9890141|FG000|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6|152
8835773|NCT01662856|9890142|FG001|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6|55
8835774|NCT01662856|9890141|FG000|NOT COMPLETED|Part I + Part II (Overall Study)||16
8835775|NCT01662856|9890142|FG001|NOT COMPLETED|Part I + Part II (Overall Study)||2
8835776|NCT01662856|9890141|FG000|STARTED|Primary Part II||109
8835777|NCT01662856|9890142|FG001|STARTED|Primary Part II||57
8835778|NCT01662856|9890141|FG000|Completed Study up to Week 6|Primary Part II||106
8835779|NCT01662856|9890142|FG001|Completed Study up to Week 6|Primary Part II||56
8835780|NCT01662856|9890141|FG000|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6|99
8835781|NCT01662856|9890142|FG001|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6|55
8835782|NCT01662856|9890141|FG000|NOT COMPLETED|Primary Part II||10
8835783|NCT01662856|9890142|FG001|NOT COMPLETED|Primary Part II||2
8835784|NCT01662882|9890151|FG000|STARTED|Overall Study||15
8835785|NCT01662882|9890152|FG001|STARTED|Overall Study||18
8835786|NCT01662882|9890153|FG002|STARTED|Overall Study||15
8835787|NCT01662882|9890151|FG000|COMPLETED|Overall Study||15
8835788|NCT01662882|9890152|FG001|COMPLETED|Overall Study||18
8835789|NCT01662882|9890153|FG002|COMPLETED|Overall Study||15
8835790|NCT01662882|9890151|FG000|NOT COMPLETED|Overall Study||0
8835791|NCT01662882|9890152|FG001|NOT COMPLETED|Overall Study||0
8835792|NCT01662882|9890153|FG002|NOT COMPLETED|Overall Study||0
8835793|NCT01662895|9890163|FG000|STARTED|Overall Study||21
8835794|NCT01662895|9890164|FG001|STARTED|Overall Study||21
8835795|NCT01662895|9890163|FG000|Initiated Study Drug|Overall Study||21
8835796|NCT01662895|9890164|FG001|Initiated Study Drug|Overall Study||21
8835797|NCT01662895|9890163|FG000|COMPLETED|Overall Study||21
8835798|NCT01662895|9890164|FG001|COMPLETED|Overall Study||20
8835799|NCT01662895|9890163|FG000|NOT COMPLETED|Overall Study||0
8835800|NCT01662895|9890164|FG001|NOT COMPLETED|Overall Study||1
8835801|NCT01662908|9890172|FG000|STARTED|Overall Study||56
8835802|NCT01662908|9890173|FG001|STARTED|Overall Study||28
8835803|NCT01662908|9890172|FG000|COMPLETED|Overall Study||50
8835804|NCT01662908|9890173|FG001|COMPLETED|Overall Study||23
8835805|NCT01662908|9890172|FG000|NOT COMPLETED|Overall Study||6
8835806|NCT01662908|9890173|FG001|NOT COMPLETED|Overall Study||5
8835807|NCT01662960|9890183|FG000|STARTED|End of 4 Week Treatment Period||25
8835808|NCT01662960|9890184|FG001|STARTED|End of 4 Week Treatment Period||23
8835809|NCT01662960|9890185|FG002|STARTED|End of 4 Week Treatment Period||9
8835810|NCT01662960|9890186|FG003|STARTED|End of 4 Week Treatment Period||15
8835811|NCT01662960|9890183|FG000|COMPLETED|End of 4 Week Treatment Period||24
8835812|NCT01662960|9890184|FG001|COMPLETED|End of 4 Week Treatment Period||19
8835813|NCT01662960|9890185|FG002|COMPLETED|End of 4 Week Treatment Period||8
8835814|NCT01662960|9890186|FG003|COMPLETED|End of 4 Week Treatment Period||15
8835815|NCT01662960|9890183|FG000|NOT COMPLETED|End of 4 Week Treatment Period||1
8835816|NCT01662960|9890184|FG001|NOT COMPLETED|End of 4 Week Treatment Period||4
8835817|NCT01662960|9890185|FG002|NOT COMPLETED|End of 4 Week Treatment Period||1
8835818|NCT01662960|9890186|FG003|NOT COMPLETED|End of 4 Week Treatment Period||0
8835819|NCT01662960|9890183|FG000|STARTED|3 Month Follow-up||24
8835820|NCT01662960|9890184|FG001|STARTED|3 Month Follow-up||19
8835821|NCT01662960|9890185|FG002|STARTED|3 Month Follow-up||8
8835822|NCT01662960|9890186|FG003|STARTED|3 Month Follow-up||15
8835823|NCT01662960|9890183|FG000|COMPLETED|3 Month Follow-up||21
8835824|NCT01662960|9890184|FG001|COMPLETED|3 Month Follow-up||16
8835825|NCT01662960|9890185|FG002|COMPLETED|3 Month Follow-up||5
8835826|NCT01662960|9890186|FG003|COMPLETED|3 Month Follow-up||13
8835827|NCT01662960|9890183|FG000|NOT COMPLETED|3 Month Follow-up||3
8835828|NCT01662960|9890184|FG001|NOT COMPLETED|3 Month Follow-up||3
8835829|NCT01662960|9890185|FG002|NOT COMPLETED|3 Month Follow-up||3
8835830|NCT01662960|9890186|FG003|NOT COMPLETED|3 Month Follow-up||2
8835831|NCT01662986|9890198|FG000|STARTED|Overall Study||40
8835832|NCT01662986|9890199|FG001|STARTED|Overall Study||39
8835833|NCT01662986|9890198|FG000|COMPLETED|Overall Study||22
8835834|NCT01662986|9890199|FG001|COMPLETED|Overall Study||26
8835835|NCT01662986|9890198|FG000|NOT COMPLETED|Overall Study||18
8835836|NCT01662986|9890199|FG001|NOT COMPLETED|Overall Study||13
8835837|NCT01662999|9890211|FG000|STARTED|Period 1||7
8835838|NCT01662999|9890212|FG001|STARTED|Period 1||7
8835839|NCT01662999|9890213|FG002|STARTED|Period 1||7
8835840|NCT01662999|9890214|FG003|STARTED|Period 1||7
8835841|NCT01662999|9890215|FG004|STARTED|Period 1||7
8835842|NCT01662999|9890216|FG005|STARTED|Period 1||7
8835843|NCT01662999|9890211|FG000|COMPLETED|Period 1||7
8835844|NCT01662999|9890212|FG001|COMPLETED|Period 1||7
8835845|NCT01662999|9890213|FG002|COMPLETED|Period 1||7
8835846|NCT01662999|9890214|FG003|COMPLETED|Period 1||7
8835847|NCT01662999|9890215|FG004|COMPLETED|Period 1||7
8835848|NCT01662999|9890216|FG005|COMPLETED|Period 1||7
8835849|NCT01662999|9890211|FG000|NOT COMPLETED|Period 1||0
8835850|NCT01662999|9890212|FG001|NOT COMPLETED|Period 1||0
8835851|NCT01662999|9890213|FG002|NOT COMPLETED|Period 1||0
8835852|NCT01662999|9890214|FG003|NOT COMPLETED|Period 1||0
8835853|NCT01662999|9890215|FG004|NOT COMPLETED|Period 1||0
8835854|NCT01662999|9890216|FG005|NOT COMPLETED|Period 1||0
8835855|NCT01662999|9890211|FG000|STARTED|Period 2||7
8835856|NCT01662999|9890212|FG001|STARTED|Period 2||7
8835857|NCT01662999|9890213|FG002|STARTED|Period 2||7
8835858|NCT01662999|9890214|FG003|STARTED|Period 2||7
8835859|NCT01662999|9890215|FG004|STARTED|Period 2||7
8835860|NCT01662999|9890216|FG005|STARTED|Period 2||7
8835861|NCT01662999|9890211|FG000|COMPLETED|Period 2||7
8835862|NCT01662999|9890212|FG001|COMPLETED|Period 2||7
8835863|NCT01662999|9890213|FG002|COMPLETED|Period 2||7
8835864|NCT01662999|9890214|FG003|COMPLETED|Period 2||7
8835865|NCT01662999|9890215|FG004|COMPLETED|Period 2||7
8835866|NCT01662999|9890216|FG005|COMPLETED|Period 2||7
8835867|NCT01662999|9890211|FG000|NOT COMPLETED|Period 2||0
8835868|NCT01662999|9890212|FG001|NOT COMPLETED|Period 2||0
8835869|NCT01662999|9890213|FG002|NOT COMPLETED|Period 2||0
8835870|NCT01662999|9890214|FG003|NOT COMPLETED|Period 2||0
8835871|NCT01662999|9890215|FG004|NOT COMPLETED|Period 2||0
8835872|NCT01662999|9890216|FG005|NOT COMPLETED|Period 2||0
8835873|NCT01662999|9890211|FG000|STARTED|Period 3||7
8835874|NCT01662999|9890212|FG001|STARTED|Period 3||7
8835875|NCT01662999|9890213|FG002|STARTED|Period 3||7
8835876|NCT01662999|9890214|FG003|STARTED|Period 3||7
8835877|NCT01662999|9890215|FG004|STARTED|Period 3||7
8835878|NCT01662999|9890216|FG005|STARTED|Period 3||7
8835879|NCT01662999|9890211|FG000|COMPLETED|Period 3||7
8835880|NCT01662999|9890212|FG001|COMPLETED|Period 3|Participant did not provide 36, 48, or 60 hour samples in this period for Treatment B.|6
8835881|NCT01662999|9890213|FG002|COMPLETED|Period 3||7
8835882|NCT01662999|9890214|FG003|COMPLETED|Period 3||7
8835883|NCT01662999|9890215|FG004|COMPLETED|Period 3||7
8835884|NCT01662999|9890216|FG005|COMPLETED|Period 3||7
8835885|NCT01662999|9890211|FG000|NOT COMPLETED|Period 3||0
8835886|NCT01662999|9890212|FG001|NOT COMPLETED|Period 3||1
8835887|NCT01662999|9890213|FG002|NOT COMPLETED|Period 3||0
8835888|NCT01662999|9890214|FG003|NOT COMPLETED|Period 3||0
8835889|NCT01662999|9890215|FG004|NOT COMPLETED|Period 3||0
8835890|NCT01662999|9890216|FG005|NOT COMPLETED|Period 3||0
8622880|NCT00490256|9662082|FG000|STARTED|Overall Study||7
8622881|NCT00490256|9662083|FG001|STARTED|Overall Study||7
8622882|NCT00490256|9662082|FG000|Intraoperative Portion of the Study|Overall Study|Intraoperative management|7
8835891|NCT01663012|9890246|FG000|STARTED|Overall Study||20
8835892|NCT01663012|9890246|FG000|COMPLETED|Overall Study||20
8835893|NCT01663012|9890246|FG000|NOT COMPLETED|Overall Study||0
8835894|NCT01663103|9890252|FG000|STARTED|Overall Study||21
8835895|NCT01663103|9890253|FG001|STARTED|Overall Study||21
8835896|NCT01663103|9890252|FG000|COMPLETED|Overall Study||18
8835897|NCT01663103|9890253|FG001|COMPLETED|Overall Study||19
8835898|NCT01663103|9890252|FG000|NOT COMPLETED|Overall Study||3
8835899|NCT01663103|9890253|FG001|NOT COMPLETED|Overall Study||2
8835900|NCT01663233|9890265|FG000|STARTED|Overall Study||130
8835901|NCT01663233|9890266|FG001|STARTED|Overall Study||136
8835902|NCT01663233|9890265|FG000|COMPLETED|Overall Study||126
8835903|NCT01663233|9890266|FG001|COMPLETED|Overall Study||129
8835904|NCT01663233|9890265|FG000|NOT COMPLETED|Overall Study||4
8835905|NCT01663233|9890266|FG001|NOT COMPLETED|Overall Study||7
8835906|NCT01663259|9890272|FG000|STARTED|Overall Study||42
8835907|NCT01663259|9890272|FG000|COMPLETED|Overall Study||42
8835908|NCT01663259|9890272|FG000|NOT COMPLETED|Overall Study||0
8835909|NCT01663272|9890276|FG000|STARTED|Overall Study||5
8835910|NCT01663272|9890277|FG001|STARTED|Overall Study||6
8835911|NCT01663272|9890278|FG002|STARTED|Overall Study||1
8622883|NCT00490256|9662083|FG001|Intraoperative Portion of the Study|Overall Study|Intraoperative management|7
8835912|NCT01663272|9890276|FG000|COMPLETED|Overall Study||5
8835913|NCT01663272|9890277|FG001|COMPLETED|Overall Study||6
8835914|NCT01663272|9890278|FG002|COMPLETED|Overall Study||1
8835915|NCT01663272|9890276|FG000|NOT COMPLETED|Overall Study||0
8835916|NCT01663272|9890277|FG001|NOT COMPLETED|Overall Study||0
8835917|NCT01663272|9890278|FG002|NOT COMPLETED|Overall Study||0
8835918|NCT01663363|9890282|FG000|STARTED|Overall Study|334 Eyes were treated among 170 participants|170
8835919|NCT01663363|9890282|FG000|COMPLETED|Overall Study|334 Eyes were treated among 170 participants|170
8835920|NCT01663363|9890282|FG000|NOT COMPLETED|Overall Study||0
8835921|NCT01663402|9890288|FG000|STARTED|Overall Study||9462
8835922|NCT01663402|9890289|FG001|STARTED|Overall Study||9462
8835923|NCT01663402|9890288|FG000|Treated|Overall Study||9443
8835924|NCT01663402|9890289|FG001|Treated|Overall Study||9451
8835925|NCT01663402|9890288|FG000|COMPLETED|Overall Study||7947
8835926|NCT01663402|9890289|FG001|COMPLETED|Overall Study||7378
8835927|NCT01663402|9890288|FG000|NOT COMPLETED|Overall Study||1515
8835928|NCT01663402|9890289|FG001|NOT COMPLETED|Overall Study||2084
8835929|NCT01663506|9890295|FG000|STARTED|Overall Study||23
8835930|NCT01663506|9890295|FG000|COMPLETED|Overall Study||15
8835931|NCT01663506|9890295|FG000|NOT COMPLETED|Overall Study||8
8835932|NCT01663532|9890301|FG000|STARTED|Overall Study||168
8835933|NCT01663532|9890302|FG001|STARTED|Overall Study||172
8835934|NCT01663532|9890301|FG000|COMPLETED|Overall Study||94
8835935|NCT01663532|9890302|FG001|COMPLETED|Overall Study||65
8835936|NCT01663532|9890301|FG000|NOT COMPLETED|Overall Study||74
8835937|NCT01663532|9890302|FG001|NOT COMPLETED|Overall Study||107
8835938|NCT01663623|9890310|FG000|STARTED|Overall Study||52
8835939|NCT01663623|9890311|FG001|STARTED|Overall Study||53
8835940|NCT01663623|9890310|FG000|COMPLETED|Overall Study||40
8835941|NCT01663623|9890311|FG001|COMPLETED|Overall Study||33
8835942|NCT01663623|9890310|FG000|NOT COMPLETED|Overall Study||12
8835943|NCT01663623|9890311|FG001|NOT COMPLETED|Overall Study||20
8835944|NCT01663636|9890319|FG000|STARTED|Infant SMS Reminder Feasibility Study||160
8835945|NCT01663636|9890320|FG001|STARTED|Infant SMS Reminder Feasibility Study||161
8835946|NCT01663636|9890319|FG000|COMPLETED|Infant SMS Reminder Feasibility Study||135
8835947|NCT01663636|9890320|FG001|COMPLETED|Infant SMS Reminder Feasibility Study||130
8835948|NCT01663636|9890319|FG000|NOT COMPLETED|Infant SMS Reminder Feasibility Study||25
8835949|NCT01663636|9890320|FG001|NOT COMPLETED|Infant SMS Reminder Feasibility Study||31
8835950|NCT01663636|9890319|FG000|STARTED|Parent SMS Acceptability Assessment||135
8835951|NCT01663636|9890320|FG001|STARTED|Parent SMS Acceptability Assessment||130
8835952|NCT01663636|9890319|FG000|COMPLETED|Parent SMS Acceptability Assessment||135
8835953|NCT01663636|9890320|FG001|COMPLETED|Parent SMS Acceptability Assessment||130
8835954|NCT01663636|9890319|FG000|NOT COMPLETED|Parent SMS Acceptability Assessment||0
8835955|NCT01663636|9890320|FG001|NOT COMPLETED|Parent SMS Acceptability Assessment||0
8835956|NCT01663714|9890326|FG000|STARTED|Dosimetric and Therapeutic Treatment||30
8835957|NCT01663714|9890326|FG000|COMPLETED|Dosimetric and Therapeutic Treatment||0
8835958|NCT01663714|9890326|FG000|NOT COMPLETED|Dosimetric and Therapeutic Treatment||30
8835959|NCT01663714|9890326|FG000|STARTED|Long-Term Follow-Up|22 of the30 participants withdrawing from Study BEX104514 enrolled in the LTFU study.|22
8835960|NCT01663714|9890326|FG000|COMPLETED|Long-Term Follow-Up||16
8835961|NCT01663714|9890326|FG000|NOT COMPLETED|Long-Term Follow-Up||6
8835962|NCT01663727|9890334|FG000|STARTED|Overall Study||242
8835963|NCT01663727|9890335|FG001|STARTED|Overall Study||239
8835964|NCT01663727|9890334|FG000|COMPLETED|Overall Study||0
8835965|NCT01663727|9890335|FG001|COMPLETED|Overall Study||1
8835966|NCT01663727|9890334|FG000|NOT COMPLETED|Overall Study||242
8835967|NCT01663727|9890335|FG001|NOT COMPLETED|Overall Study||238
8835968|NCT01663740|9890343|FG000|STARTED|Overall Study|Safety Population|38
8835969|NCT01663740|9890344|FG001|STARTED|Overall Study|Safety Population|21
8835970|NCT01663740|9890343|FG000|COMPLETED|Overall Study||22
8835971|NCT01663740|9890344|FG001|COMPLETED|Overall Study||13
8835972|NCT01663740|9890343|FG000|NOT COMPLETED|Overall Study||16
8835973|NCT01663740|9890344|FG001|NOT COMPLETED|Overall Study||8
8835974|NCT01663779|9890352|FG000|STARTED|Overall Study||27
8835975|NCT01663779|9890353|FG001|STARTED|Overall Study||23
8835976|NCT01663779|9890352|FG000|COMPLETED|Overall Study||27
8835977|NCT01663779|9890353|FG001|COMPLETED|Overall Study||23
8835978|NCT01663779|9890352|FG000|NOT COMPLETED|Overall Study||0
8835979|NCT01663779|9890353|FG001|NOT COMPLETED|Overall Study||0
8835980|NCT01663857|9890363|FG000|STARTED|Overall Study||6
8835981|NCT01663857|9890364|FG001|STARTED|Overall Study||2
8835982|NCT01663857|9890365|FG002|STARTED|Overall Study||58
8835983|NCT01663857|9890366|FG003|STARTED|Overall Study||52
8835984|NCT01663857|9890363|FG000|Received at Least One Dose of Study Drug|Overall Study||6
8835985|NCT01663857|9890364|FG001|Received at Least One Dose of Study Drug|Overall Study||2
8835986|NCT01663857|9890365|FG002|Received at Least One Dose of Study Drug|Overall Study||58
8835987|NCT01663857|9890366|FG003|Received at Least One Dose of Study Drug|Overall Study||52
8835988|NCT01663857|9890363|FG000|COMPLETED|Overall Study||6
8835989|NCT01663857|9890364|FG001|COMPLETED|Overall Study||1
8835990|NCT01663857|9890365|FG002|COMPLETED|Overall Study||48
8835991|NCT01663857|9890366|FG003|COMPLETED|Overall Study||48
8835992|NCT01663857|9890363|FG000|NOT COMPLETED|Overall Study||0
8835993|NCT01663857|9890364|FG001|NOT COMPLETED|Overall Study||1
8835994|NCT01663857|9890365|FG002|NOT COMPLETED|Overall Study||10
8835995|NCT01663857|9890366|FG003|NOT COMPLETED|Overall Study||4
8835996|NCT01663896|9890382|FG000|STARTED|Overall Study||418
8835997|NCT01663896|9890382|FG000|COMPLETED|Overall Study||375
8835998|NCT01663896|9890382|FG000|NOT COMPLETED|Overall Study||43
8835999|NCT01663922|9890387|FG000|STARTED|First Intervention (14 Days or 5 Days)||8
8836000|NCT01663922|9890388|FG001|STARTED|First Intervention (14 Days or 5 Days)||9
8836001|NCT01663922|9890387|FG000|COMPLETED|First Intervention (14 Days or 5 Days)||8
8836002|NCT01663922|9890388|FG001|COMPLETED|First Intervention (14 Days or 5 Days)||9
8836003|NCT01663922|9890387|FG000|NOT COMPLETED|First Intervention (14 Days or 5 Days)||0
8836004|NCT01663922|9890388|FG001|NOT COMPLETED|First Intervention (14 Days or 5 Days)||0
8836005|NCT01663922|9890387|FG000|STARTED|Washout (7 Days)||8
8836006|NCT01663922|9890388|FG001|STARTED|Washout (7 Days)||9
8836007|NCT01663922|9890387|FG000|COMPLETED|Washout (7 Days)||8
8836008|NCT01663922|9890388|FG001|COMPLETED|Washout (7 Days)||9
8836009|NCT01663922|9890387|FG000|NOT COMPLETED|Washout (7 Days)||0
8836010|NCT01663922|9890388|FG001|NOT COMPLETED|Washout (7 Days)||0
8836011|NCT01663922|9890387|FG000|STARTED|Second Intervention (14 Days)||8
8836012|NCT01663922|9890388|FG001|STARTED|Second Intervention (14 Days)||9
8836013|NCT01663922|9890387|FG000|COMPLETED|Second Intervention (14 Days)||8
8836014|NCT01663922|9890388|FG001|COMPLETED|Second Intervention (14 Days)||9
8836015|NCT01663922|9890387|FG000|NOT COMPLETED|Second Intervention (14 Days)||0
8836016|NCT01663922|9890388|FG001|NOT COMPLETED|Second Intervention (14 Days)||0
8836017|NCT01663922|9890387|FG000|STARTED|Washout (7 Days)||8
8836018|NCT01663922|9890388|FG001|STARTED|Washout (7 Days)||9
8836019|NCT01663922|9890387|FG000|COMPLETED|Washout (7 Days)||8
8836020|NCT01663922|9890388|FG001|COMPLETED|Washout (7 Days)||9
8836021|NCT01663922|9890387|FG000|NOT COMPLETED|Washout (7 Days)||0
8836022|NCT01663922|9890388|FG001|NOT COMPLETED|Washout (7 Days)||0
8836023|NCT01663922|9890387|FG000|STARTED|Third Intervention (14 Days or 5 Days)||8
8836024|NCT01663922|9890388|FG001|STARTED|Third Intervention (14 Days or 5 Days)||9
8836025|NCT01663922|9890387|FG000|COMPLETED|Third Intervention (14 Days or 5 Days)||8
8836026|NCT01663922|9890388|FG001|COMPLETED|Third Intervention (14 Days or 5 Days)||9
8836027|NCT01663922|9890387|FG000|NOT COMPLETED|Third Intervention (14 Days or 5 Days)||0
8836028|NCT01663922|9890388|FG001|NOT COMPLETED|Third Intervention (14 Days or 5 Days)||0
8836029|NCT01663935|9890393|FG000|STARTED|Overall Study||20
8836030|NCT01663935|9890393|FG000|COMPLETED|Overall Study||20
8836031|NCT01663935|9890393|FG000|NOT COMPLETED|Overall Study||0
8836032|NCT01663987|9890399|FG000|STARTED|Overall Study||39
8836033|NCT01663987|9890400|FG001|STARTED|Overall Study||40
8836034|NCT01663987|9890399|FG000|COMPLETED|Overall Study||26
8836035|NCT01663987|9890400|FG001|COMPLETED|Overall Study||34
8836036|NCT01663987|9890399|FG000|NOT COMPLETED|Overall Study||13
8836037|NCT01663987|9890400|FG001|NOT COMPLETED|Overall Study||6
8836038|NCT01664039|9890408|FG000|STARTED|Overall Study||52
8836039|NCT01664039|9890409|FG001|STARTED|Overall Study||52
8836040|NCT01664039|9890408|FG000|COMPLETED|Overall Study||46
8836041|NCT01664039|9890409|FG001|COMPLETED|Overall Study||43
8836042|NCT01664039|9890408|FG000|NOT COMPLETED|Overall Study||6
8836043|NCT01664039|9890409|FG001|NOT COMPLETED|Overall Study||9
8836044|NCT01664052|9890417|FG000|STARTED|Phase 1|Screening and enrollment|31
8836045|NCT01664052|9890418|FG001|STARTED|Phase 1||0
8836046|NCT01664052|9890417|FG000|Insert Placed in at Least One Tube|Phase 1||25
8836047|NCT01664052|9890418|FG001|Insert Placed in at Least One Tube|Phase 1||0
8836048|NCT01664052|9890417|FG000|HSG 1 Hour Post Placement|Phase 1||24
8836049|NCT01664052|9890418|FG001|HSG 1 Hour Post Placement|Phase 1||0
8836050|NCT01664052|9890417|FG000|Repeat HSG and Hysterectomy at 30 Days|Phase 1||9
8836051|NCT01664052|9890418|FG001|Repeat HSG and Hysterectomy at 30 Days|Phase 1||0
8836052|NCT01664052|9890417|FG000|Repeat HSG and Hysterectomy at 60 Days|Phase 1||8
8836053|NCT01664052|9890418|FG001|Repeat HSG and Hysterectomy at 60 Days|Phase 1||0
8836054|NCT01664052|9890417|FG000|Repeat HSG and Hysterectomy at 90 Days|Phase 1||7
8836055|NCT01664052|9890418|FG001|Repeat HSG and Hysterectomy at 90 Days|Phase 1||0
8836056|NCT01664052|9890417|FG000|COMPLETED|Phase 1||24
8836057|NCT01664052|9890418|FG001|COMPLETED|Phase 1||0
8836058|NCT01664052|9890417|FG000|NOT COMPLETED|Phase 1||7
8836059|NCT01664052|9890418|FG001|NOT COMPLETED|Phase 1||0
8836060|NCT01664052|9890417|FG000|STARTED|Phase 2|Screened and enrolled|0
8836061|NCT01664052|9890418|FG001|STARTED|Phase 2||35
8836062|NCT01664052|9890417|FG000|Insert Placed|Phase 2||0
8836063|NCT01664052|9890418|FG001|Insert Placed|Phase 2||31
8836064|NCT01664052|9890417|FG000|HSG 1 Hour Post Placement|Phase 2||0
8836065|NCT01664052|9890418|FG001|HSG 1 Hour Post Placement|Phase 2||31
8836066|NCT01664052|9890417|FG000|Repeat HSG and Hysterectomy at 30 Days|Phase 2||0
8836067|NCT01664052|9890418|FG001|Repeat HSG and Hysterectomy at 30 Days|Phase 2||10
8836068|NCT01664052|9890417|FG000|Repeat HSG and Hysterectomy at 60 Days|Phase 2||0
8836069|NCT01664052|9890418|FG001|Repeat HSG and Hysterectomy at 60 Days|Phase 2||10
8836070|NCT01664052|9890417|FG000|Repeat HSG and Hysterectomy at 90 Days|Phase 2||0
8836071|NCT01664052|9890418|FG001|Repeat HSG and Hysterectomy at 90 Days|Phase 2||10
8836072|NCT01664052|9890417|FG000|COMPLETED|Phase 2||0
8836073|NCT01664052|9890418|FG001|COMPLETED|Phase 2||31
8836074|NCT01664052|9890417|FG000|NOT COMPLETED|Phase 2||0
8836075|NCT01664052|9890418|FG001|NOT COMPLETED|Phase 2||4
8836076|NCT01664078|9890425|FG000|STARTED|Overall Study||190
8836077|NCT01664078|9890425|FG000|COMPLETED|Overall Study||121
8836078|NCT01664078|9890425|FG000|NOT COMPLETED|Overall Study||69
8836079|NCT01664091|9890475|FG000|STARTED|Overall Study||32
8836080|NCT01664091|9890475|FG000|COMPLETED|Overall Study||26
8836081|NCT01664091|9890475|FG000|NOT COMPLETED|Overall Study||6
8836082|NCT01664104|9890480|FG000|STARTED|Overall Study||136
8836083|NCT01664104|9890480|FG000|COMPLETED|Overall Study||120
8836084|NCT01664104|9890480|FG000|NOT COMPLETED|Overall Study||16
8836085|NCT01664117|9890486|FG000|STARTED|Overall Study||209
8836086|NCT01664117|9890486|FG000|COMPLETED|Overall Study||209
8836087|NCT01664117|9890486|FG000|NOT COMPLETED|Overall Study||0
8836088|NCT01664130|9890493|FG000|STARTED|Overall Study||35
8836089|NCT01664130|9890493|FG000|COMPLETED|Overall Study||33
8836090|NCT01664130|9890493|FG000|NOT COMPLETED|Overall Study||2
8836091|NCT01664247|9890502|FG000|STARTED|Overall Study||174
8836092|NCT01664247|9890503|FG001|STARTED|Overall Study||172
8836093|NCT01664247|9890502|FG000|Exposed|Overall Study|1 subject was randomised in error and withdrew before exposure to the drug|173
8836094|NCT01664247|9890503|FG001|Exposed|Overall Study|Two subjects were randomised in error and withdrew prior to exposure to drug|170
8836095|NCT01664247|9890502|FG000|COMPLETED|Overall Study||160
8836096|NCT01664247|9890503|FG001|COMPLETED|Overall Study||131
8836097|NCT01664247|9890502|FG000|NOT COMPLETED|Overall Study||14
8836098|NCT01664247|9890503|FG001|NOT COMPLETED|Overall Study||41
8836099|NCT01664494|9890509|FG000|STARTED|Overall Study||563
8836100|NCT01664494|9890509|FG000|COMPLETED|Overall Study||370
8836101|NCT01664494|9890509|FG000|NOT COMPLETED|Overall Study||193
8836102|NCT01664533|9890513|FG000|STARTED|Overall Study||57
8836103|NCT01664533|9890513|FG000|COMPLETED|Overall Study||0
8944407|NCT02396316|10006258|FG001|Received AFL Injection at Week 1|Overall Study||22
8944408|NCT02396316|10006257|FG000|Received Active Injection at Week 5|Overall Study||4
8944409|NCT02396316|10006258|FG001|Received Active Injection at Week 5|Overall Study||4
8944410|NCT02396316|10006257|FG000|Received Active Injection at Week 9|Overall Study||2
8944411|NCT02396316|10006258|FG001|Received Active Injection at Week 9|Overall Study||1
8944412|NCT02396316|10006257|FG000|COMPLETED|Overall Study||20
8944413|NCT02396316|10006258|FG001|COMPLETED|Overall Study||22
8944414|NCT02396316|10006257|FG000|NOT COMPLETED|Overall Study||7
8944415|NCT02396316|10006258|FG001|NOT COMPLETED|Overall Study||5
8944416|NCT02396381|10006270|FG000|STARTED|Overall Study||488
8944417|NCT02396381|10006271|FG001|STARTED|Overall Study||496
8944418|NCT02396381|10006270|FG000|Full Analysis Set - As Exposed (FAS-EX)|Overall Study||414
8944419|NCT02396381|10006271|FG001|Full Analysis Set - As Exposed (FAS-EX)|Overall Study||443
8944420|NCT02396381|10006270|FG000|COMPLETED|Overall Study||381
8944421|NCT02396381|10006271|FG001|COMPLETED|Overall Study||422
8944422|NCT02396381|10006270|FG000|NOT COMPLETED|Overall Study||107
8944423|NCT02396381|10006271|FG001|NOT COMPLETED|Overall Study||74
8944424|NCT02396420|10006280|FG000|STARTED|Overall Study||2
8944425|NCT02396420|10006280|FG000|1 Month Post PAE|Overall Study||2
8944426|NCT02396420|10006280|FG000|3 Months Post PAE|Overall Study||2
8944427|NCT02396420|10006280|FG000|6 Months Post PAE|Overall Study||2
8944428|NCT02396420|10006280|FG000|COMPLETED|Overall Study||1
8944429|NCT02396420|10006280|FG000|NOT COMPLETED|Overall Study||1
8944430|NCT02396511|10006285|FG000|STARTED|Overall Study||2
8944431|NCT02396511|10006285|FG000|COMPLETED|Overall Study||2
8944432|NCT02396511|10006285|FG000|NOT COMPLETED|Overall Study||0
8944433|NCT02396537|10006291|FG000|STARTED|Overall Study||40
8944434|NCT02396537|10006292|FG001|STARTED|Overall Study||37
8944435|NCT02396537|10006291|FG000|COMPLETED|Overall Study||40
8944436|NCT02396537|10006292|FG001|COMPLETED|Overall Study||36
8944437|NCT02396537|10006291|FG000|NOT COMPLETED|Overall Study||0
8944438|NCT02396537|10006292|FG001|NOT COMPLETED|Overall Study||1
8944439|NCT02396732|10006300|FG000|STARTED|Overall Study||14
8944440|NCT02396732|10006301|FG001|STARTED|Overall Study||17
8944441|NCT02396732|10006300|FG000|COMPLETED|Overall Study||14
8944442|NCT02396732|10006301|FG001|COMPLETED|Overall Study||17
8944443|NCT02396732|10006300|FG000|NOT COMPLETED|Overall Study||0
8944444|NCT02396732|10006301|FG001|NOT COMPLETED|Overall Study||0
8944445|NCT02396745|10006307|FG000|STARTED|Overall Study||1
8944446|NCT02396745|10006307|FG000|COMPLETED|Overall Study||1
8944447|NCT02396745|10006307|FG000|NOT COMPLETED|Overall Study||0
8944448|NCT02396758|10006315|FG000|STARTED|Overall Study||38
8944449|NCT02396758|10006316|FG001|STARTED|Overall Study||37
8944450|NCT02396758|10006317|FG002|STARTED|Overall Study||38
8944451|NCT02396758|10006318|FG003|STARTED|Overall Study||18
8944452|NCT02396758|10006315|FG000|COMPLETED|Overall Study||26
8944453|NCT02396758|10006316|FG001|COMPLETED|Overall Study||31
8944454|NCT02396758|10006317|FG002|COMPLETED|Overall Study||34
8944455|NCT02396758|10006318|FG003|COMPLETED|Overall Study||13
8944456|NCT02396758|10006315|FG000|NOT COMPLETED|Overall Study||12
8944457|NCT02396758|10006316|FG001|NOT COMPLETED|Overall Study||6
8944458|NCT02396758|10006317|FG002|NOT COMPLETED|Overall Study||4
8944459|NCT02396758|10006318|FG003|NOT COMPLETED|Overall Study||5
8944460|NCT02396849|10006330|FG000|STARTED|Overall Study||29
8944461|NCT02396849|10006331|FG001|STARTED|Overall Study||30
8944462|NCT02396849|10006330|FG000|COMPLETED|Overall Study||27
8836104|NCT01664533|9890513|FG000|NOT COMPLETED|Overall Study||57
8836105|NCT01664559|9890520|FG000|STARTED|Overall Study||34
8836106|NCT01664559|9890521|FG001|STARTED|Overall Study||33
8836107|NCT01664559|9890520|FG000|COMPLETED|Overall Study||34
8836108|NCT01664559|9890521|FG001|COMPLETED|Overall Study||33
8836109|NCT01664559|9890520|FG000|NOT COMPLETED|Overall Study||0
8836110|NCT01664559|9890521|FG001|NOT COMPLETED|Overall Study||0
8836111|NCT01664624|9890531|FG000|STARTED|Overall Study||10
8836112|NCT01664624|9890532|FG001|STARTED|Overall Study||11
8944463|NCT02396849|10006331|FG001|COMPLETED|Overall Study||28
8944464|NCT02396849|10006330|FG000|NOT COMPLETED|Overall Study||2
8944465|NCT02396849|10006331|FG001|NOT COMPLETED|Overall Study||2
8944466|NCT02396953|10006342|FG000|STARTED|Overall Study||9
8944467|NCT02396953|10006343|FG001|STARTED|Overall Study||9
8944468|NCT02396953|10006344|FG002|STARTED|Overall Study||10
8944469|NCT02396953|10006342|FG000|COMPLETED|Overall Study||5
8944470|NCT02396953|10006343|FG001|COMPLETED|Overall Study||6
8944471|NCT02396953|10006344|FG002|COMPLETED|Overall Study||7
8944472|NCT02396953|10006342|FG000|NOT COMPLETED|Overall Study||4
8944473|NCT02396953|10006343|FG001|NOT COMPLETED|Overall Study||3
8944474|NCT02396953|10006344|FG002|NOT COMPLETED|Overall Study||3
8944475|NCT02397057|10006361|FG000|STARTED|Overall Study|"Two Normal Saline participants received Injectafer. The data presented is considered accurate."|105
8944476|NCT02397057|10006362|FG001|STARTED|Overall Study||104
8944477|NCT02397057|10006361|FG000|COMPLETED|Overall Study||94
8944478|NCT02397057|10006362|FG001|COMPLETED|Overall Study||91
8944479|NCT02397057|10006361|FG000|NOT COMPLETED|Overall Study||11
8944480|NCT02397057|10006362|FG001|NOT COMPLETED|Overall Study||13
8836113|NCT01664624|9890533|FG002|STARTED|Overall Study||10
8836114|NCT01664624|9890534|FG003|STARTED|Overall Study||9
8836115|NCT01664624|9890531|FG000|COMPLETED|Overall Study||10
8836116|NCT01664624|9890532|FG001|COMPLETED|Overall Study||10
8836117|NCT01664624|9890533|FG002|COMPLETED|Overall Study||10
8836118|NCT01664624|9890534|FG003|COMPLETED|Overall Study||9
8836119|NCT01664624|9890531|FG000|NOT COMPLETED|Overall Study||0
8836120|NCT01664624|9890532|FG001|NOT COMPLETED|Overall Study||1
8836121|NCT01664624|9890533|FG002|NOT COMPLETED|Overall Study||0
8836122|NCT01664624|9890534|FG003|NOT COMPLETED|Overall Study||0
8836123|NCT01664741|9890547|FG000|STARTED|Overall Study||6
8836124|NCT01664741|9890548|FG001|STARTED|Overall Study||6
8836125|NCT01664741|9890549|FG002|STARTED|Overall Study||13
8836126|NCT01664741|9890547|FG000|COMPLETED|Overall Study||6
8836127|NCT01664741|9890548|FG001|COMPLETED|Overall Study||6
8836128|NCT01664741|9890549|FG002|COMPLETED|Overall Study||13
8836129|NCT01664741|9890547|FG000|NOT COMPLETED|Overall Study||0
8836130|NCT01664741|9890548|FG001|NOT COMPLETED|Overall Study||0
8836131|NCT01664741|9890549|FG002|NOT COMPLETED|Overall Study||0
8836132|NCT01664793|9890558|FG000|STARTED|Overall Study||49039
8836133|NCT01664793|9890559|FG001|STARTED|Overall Study||38626
8836134|NCT01664793|9890558|FG000|COMPLETED|Overall Study||49039
8836135|NCT01664793|9890559|FG001|COMPLETED|Overall Study||38626
8836136|NCT01664793|9890558|FG000|NOT COMPLETED|Overall Study||0
8836137|NCT01664793|9890559|FG001|NOT COMPLETED|Overall Study||0
8836138|NCT01664806|9890569|FG000|STARTED|Overall Study||20
8836139|NCT01664806|9890570|FG001|STARTED|Overall Study||20
8836140|NCT01664806|9890569|FG000|COMPLETED|Overall Study||20
8836141|NCT01664806|9890570|FG001|COMPLETED|Overall Study||20
8836142|NCT01664806|9890569|FG000|NOT COMPLETED|Overall Study||0
8836143|NCT01664806|9890570|FG001|NOT COMPLETED|Overall Study||0
8836144|NCT01664858|9890579|FG000|STARTED|Overall Study||481
8836145|NCT01664858|9890580|FG001|STARTED|Overall Study||481
8836146|NCT01664858|9890581|FG002|STARTED|Overall Study||240
8836147|NCT01664858|9890579|FG000|COMPLETED|Overall Study||467
8836148|NCT01664858|9890580|FG001|COMPLETED|Overall Study||468
8836149|NCT01664858|9890581|FG002|COMPLETED|Overall Study||234
8836150|NCT01664858|9890579|FG000|NOT COMPLETED|Overall Study||14
8836151|NCT01664858|9890580|FG001|NOT COMPLETED|Overall Study||13
8836152|NCT01664858|9890581|FG002|NOT COMPLETED|Overall Study||6
8836153|NCT01664897|9890592|FG000|STARTED|Overall Study||29
8836154|NCT01664897|9890592|FG000|COMPLETED|Overall Study||29
8836155|NCT01664897|9890592|FG000|NOT COMPLETED|Overall Study||0
8836156|NCT01664923|9890598|FG000|STARTED|Period1:Double Blind Phase-29 Months||198
8836157|NCT01664923|9890599|FG001|STARTED|Period1:Double Blind Phase-29 Months||198
8836158|NCT01664923|9890598|FG000|Received Study Treatment|Period1:Double Blind Phase-29 Months||197
8836159|NCT01664923|9890599|FG001|Received Study Treatment|Period1:Double Blind Phase-29 Months||198
8836160|NCT01664923|9890598|FG000|COMPLETED|Period1:Double Blind Phase-29 Months||93
8836161|NCT01664923|9890599|FG001|COMPLETED|Period1:Double Blind Phase-29 Months||38
8836162|NCT01664923|9890598|FG000|NOT COMPLETED|Period1:Double Blind Phase-29 Months||105
8836163|NCT01664923|9890599|FG001|NOT COMPLETED|Period1:Double Blind Phase-29 Months||160
8836164|NCT01664923|9890598|FG000|STARTED|Period 2: Open-label Phase-36 Months||93
8836165|NCT01664923|9890599|FG001|STARTED|Period 2: Open-label Phase-36 Months||38
8836166|NCT01664923|9890598|FG000|Treated|Period 2: Open-label Phase-36 Months||93
8836167|NCT01664923|9890599|FG001|Treated|Period 2: Open-label Phase-36 Months||37
8836168|NCT01664923|9890598|FG000|COMPLETED|Period 2: Open-label Phase-36 Months||52
8836169|NCT01664923|9890599|FG001|COMPLETED|Period 2: Open-label Phase-36 Months||15
8836170|NCT01664923|9890598|FG000|NOT COMPLETED|Period 2: Open-label Phase-36 Months||41
8836171|NCT01664923|9890599|FG001|NOT COMPLETED|Period 2: Open-label Phase-36 Months||23
8836172|NCT01664949|9890611|FG000|STARTED|Overall Study||224
8836173|NCT01664949|9890612|FG001|STARTED|Overall Study||236
8836174|NCT01664949|9890611|FG000|COMPLETED|Overall Study||200
8836175|NCT01664949|9890612|FG001|COMPLETED|Overall Study||211
8836176|NCT01664949|9890611|FG000|NOT COMPLETED|Overall Study||24
8836177|NCT01664949|9890612|FG001|NOT COMPLETED|Overall Study||25
8836178|NCT01664975|9890620|FG000|STARTED|Overall Study||57
8836179|NCT01664975|9890621|FG001|STARTED|Overall Study||54
8836180|NCT01664975|9890620|FG000|COMPLETED|Overall Study||52
8836181|NCT01664975|9890621|FG001|COMPLETED|Overall Study||51
8836182|NCT01664975|9890620|FG000|NOT COMPLETED|Overall Study||5
8836183|NCT01664975|9890621|FG001|NOT COMPLETED|Overall Study||3
8836184|NCT01665040|9890627|FG000|STARTED|Overall Study||40
8836185|NCT01665040|9890627|FG000|COMPLETED|Overall Study||36
8836186|NCT01665040|9890627|FG000|NOT COMPLETED|Overall Study||4
8836187|NCT01665053|9890633|FG000|STARTED|Overall Study||838
8836188|NCT01665053|9890634|FG001|STARTED|Overall Study||846
8836189|NCT01665053|9890633|FG000|Completed 12-Month Clinical F/U|Overall Study||797
8836190|NCT01665053|9890634|FG001|Completed 12-Month Clinical F/U|Overall Study||822
8836191|NCT01665053|9890633|FG000|No 12-Month F/U|Overall Study||32
8836192|NCT01665053|9890634|FG001|No 12-Month F/U|Overall Study||15
8944481|NCT02397096|10006370|FG000|STARTED|Day 1 to Week 24||447
8836193|NCT01665053|9890633|FG000|Death With No 12-month Clinical FU|Overall Study||9
8836194|NCT01665053|9890634|FG001|Death With No 12-month Clinical FU|Overall Study||9
8836195|NCT01665053|9890633|FG000|COMPLETED|Overall Study||806
8836196|NCT01665053|9890634|FG001|COMPLETED|Overall Study||831
8836197|NCT01665053|9890633|FG000|NOT COMPLETED|Overall Study||32
8836198|NCT01665053|9890634|FG001|NOT COMPLETED|Overall Study||15
8944482|NCT02397096|10006371|FG001|STARTED|Day 1 to Week 24||223
8836199|NCT01665092|9890644|FG000|STARTED|Overall Study||75
8836200|NCT01665092|9890645|FG001|STARTED|Overall Study||35
8836201|NCT01665092|9890646|FG002|STARTED|Overall Study||34
8836202|NCT01665092|9890647|FG003|STARTED|Overall Study||106
8836203|NCT01665092|9890644|FG000|COMPLETED|Overall Study||75
8836204|NCT01665092|9890645|FG001|COMPLETED|Overall Study||35
8836205|NCT01665092|9890646|FG002|COMPLETED|Overall Study||32
8836206|NCT01665092|9890647|FG003|COMPLETED|Overall Study||105
8836207|NCT01665092|9890644|FG000|NOT COMPLETED|Overall Study||0
8836208|NCT01665092|9890645|FG001|NOT COMPLETED|Overall Study||0
8836209|NCT01665092|9890646|FG002|NOT COMPLETED|Overall Study||2
8836210|NCT01665092|9890647|FG003|NOT COMPLETED|Overall Study||1
8836211|NCT01665157|9890660|FG000|STARTED|Overall Study||60
8836212|NCT01665157|9890661|FG001|STARTED|Overall Study||60
8836213|NCT01665157|9890662|FG002|STARTED|Overall Study||60
8836214|NCT01665157|9890660|FG000|COMPLETED|Overall Study||60
8836215|NCT01665157|9890661|FG001|COMPLETED|Overall Study||60
8836216|NCT01665157|9890662|FG002|COMPLETED|Overall Study||60
8836217|NCT01665157|9890660|FG000|NOT COMPLETED|Overall Study||0
8836218|NCT01665157|9890661|FG001|NOT COMPLETED|Overall Study||0
8836219|NCT01665157|9890662|FG002|NOT COMPLETED|Overall Study||0
8836220|NCT01665170|9890677|FG000|STARTED|Overall Study|First patient in|30
8836221|NCT01665170|9890678|FG001|STARTED|Overall Study||30
8836222|NCT01665170|9890677|FG000|Bevore TSST|Overall Study||30
8836223|NCT01665170|9890678|FG001|Bevore TSST|Overall Study||30
8836224|NCT01665170|9890677|FG000|During TSST|Overall Study||30
8836225|NCT01665170|9890678|FG001|During TSST|Overall Study||30
8836226|NCT01665170|9890677|FG000|After TSST|Overall Study||30
8836227|NCT01665170|9890678|FG001|After TSST|Overall Study||30
8836228|NCT01665170|9890677|FG000|COMPLETED|Overall Study|Last TSST/ last patient out|30
8836229|NCT01665170|9890678|FG001|COMPLETED|Overall Study||30
8836230|NCT01665170|9890677|FG000|NOT COMPLETED|Overall Study||0
8836231|NCT01665170|9890678|FG001|NOT COMPLETED|Overall Study||0
8836232|NCT01665430|9890686|FG000|STARTED|Overall Study||38
8836233|NCT01665430|9890686|FG000|COMPLETED|Overall Study||29
8836234|NCT01665430|9890686|FG000|NOT COMPLETED|Overall Study||9
8836235|NCT01665508|9890690|FG000|STARTED|Overall Study||12
8836236|NCT01665508|9890690|FG000|COMPLETED|Overall Study||7
8836237|NCT01665508|9890690|FG000|NOT COMPLETED|Overall Study||5
8836238|NCT01665599|9890699|FG000|STARTED|Overall Study||180
8836239|NCT01665599|9890699|FG000|COMPLETED|Overall Study||172
8836240|NCT01665599|9890699|FG000|NOT COMPLETED|Overall Study||8
8836241|NCT01665768|9890703|FG000|STARTED|Overall Study||49
8836242|NCT01665768|9890703|FG000|COMPLETED|Overall Study||26
8836243|NCT01665768|9890703|FG000|NOT COMPLETED|Overall Study||23
8836244|NCT01665807|9890710|FG000|STARTED|Overall Study||411
8836245|NCT01665807|9890711|FG001|STARTED|Overall Study||58
8944483|NCT02397096|10006370|FG000|COMPLETED|Day 1 to Week 24||427
8944484|NCT02397096|10006371|FG001|COMPLETED|Day 1 to Week 24||209
8944485|NCT02397096|10006370|FG000|NOT COMPLETED|Day 1 to Week 24||20
8944486|NCT02397096|10006371|FG001|NOT COMPLETED|Day 1 to Week 24||14
8944487|NCT02397096|10006370|FG000|STARTED|Week 24 to Week 48||427
8622884|NCT00490256|9662082|FG000|COMPLETED|Overall Study||7
8622885|NCT00490256|9662083|FG001|COMPLETED|Overall Study||7
8622886|NCT00490256|9662082|FG000|NOT COMPLETED|Overall Study||0
8622887|NCT00490256|9662083|FG001|NOT COMPLETED|Overall Study||0
8836246|NCT01665807|9890712|FG002|STARTED|Overall Study||402
8944488|NCT02397096|10006371|FG001|STARTED|Week 24 to Week 48||209
8944489|NCT02397096|10006370|FG000|COMPLETED|Week 24 to Week 48||407
8944490|NCT02397096|10006371|FG001|COMPLETED|Week 24 to Week 48||202
8944491|NCT02397096|10006370|FG000|NOT COMPLETED|Week 24 to Week 48||20
8944492|NCT02397096|10006371|FG001|NOT COMPLETED|Week 24 to Week 48||7
8944493|NCT02397096|10006370|FG000|STARTED|Study Extensions|The extension study is optional; not all eligible participants enrolled.|399
8944494|NCT02397096|10006371|FG001|STARTED|Study Extensions|The extension study is optional; not all eligible participants enrolled.|202
8836247|NCT01665807|9890710|FG000|COMPLETED|Overall Study||409
8836248|NCT01665807|9890711|FG001|COMPLETED|Overall Study||58
8836249|NCT01665807|9890712|FG002|COMPLETED|Overall Study||401
8836250|NCT01665807|9890710|FG000|NOT COMPLETED|Overall Study||2
8836251|NCT01665807|9890711|FG001|NOT COMPLETED|Overall Study||0
8836252|NCT01665807|9890712|FG002|NOT COMPLETED|Overall Study||1
8836253|NCT01665872|9890722|FG000|STARTED|Screening||172
8836254|NCT01665872|9890723|FG001|STARTED|Screening||172
8836255|NCT01665872|9890722|FG000|COMPLETED|Screening||172
8836256|NCT01665872|9890723|FG001|COMPLETED|Screening||172
8836257|NCT01665872|9890722|FG000|NOT COMPLETED|Screening||0
8836258|NCT01665872|9890723|FG001|NOT COMPLETED|Screening||0
8836259|NCT01665872|9890722|FG000|STARTED|Treatment||87
8836260|NCT01665872|9890723|FG001|STARTED|Treatment||67
8836261|NCT01665872|9890722|FG000|COMPLETED|Treatment||72
8836262|NCT01665872|9890723|FG001|COMPLETED|Treatment||50
8836263|NCT01665872|9890722|FG000|NOT COMPLETED|Treatment||15
8836264|NCT01665872|9890723|FG001|NOT COMPLETED|Treatment||17
8836265|NCT01665872|9890722|FG000|STARTED|6 Month Follow-up||72
8836266|NCT01665872|9890723|FG001|STARTED|6 Month Follow-up||50
8836267|NCT01665872|9890722|FG000|COMPLETED|6 Month Follow-up||66
8836268|NCT01665872|9890723|FG001|COMPLETED|6 Month Follow-up||49
8836269|NCT01665872|9890722|FG000|NOT COMPLETED|6 Month Follow-up||6
8836270|NCT01665872|9890723|FG001|NOT COMPLETED|6 Month Follow-up||1
8836271|NCT01665872|9890722|FG000|STARTED|12 Month Follow-up||72
8836272|NCT01665872|9890723|FG001|STARTED|12 Month Follow-up||50
8836273|NCT01665872|9890722|FG000|COMPLETED|12 Month Follow-up||58
8836274|NCT01665872|9890723|FG001|COMPLETED|12 Month Follow-up||47
8836275|NCT01665872|9890722|FG000|NOT COMPLETED|12 Month Follow-up||14
8836276|NCT01665872|9890723|FG001|NOT COMPLETED|12 Month Follow-up||3
8836277|NCT01665911|9890729|FG000|STARTED|Overall Study||28
8836278|NCT01665911|9890729|FG000|0 mg Fluoride in 200 ml Milk|Overall Study||22
8836279|NCT01665911|9890729|FG000|1.5 mg Sodium Fluoride in 100 ml Milk|Overall Study||23
8836280|NCT01665911|9890729|FG000|1.5 mg Sodium Fluoride in 200 ml Milk|Overall Study||25
8836281|NCT01665911|9890729|FG000|3.0 mg Sodium Fluoride in 100 ml Milk|Overall Study||22
8836282|NCT01665911|9890729|FG000|3.0 mg Sodium Fluoride in 200 ml Milk|Overall Study||22
8836283|NCT01665911|9890729|FG000|COMPLETED|Overall Study||22
8836284|NCT01665911|9890729|FG000|NOT COMPLETED|Overall Study||6
8836285|NCT01665950|9890737|FG000|STARTED|Overall Study||2
8836286|NCT01665950|9890738|FG001|STARTED|Overall Study||0
8836287|NCT01665950|9890739|FG002|STARTED|Overall Study||2
8836288|NCT01665950|9890737|FG000|COMPLETED|Overall Study||1
8836289|NCT01665950|9890738|FG001|COMPLETED|Overall Study||0
8836290|NCT01665950|9890739|FG002|COMPLETED|Overall Study||1
8836291|NCT01665950|9890737|FG000|NOT COMPLETED|Overall Study||1
8836292|NCT01665950|9890738|FG001|NOT COMPLETED|Overall Study||0
8836293|NCT01665950|9890739|FG002|NOT COMPLETED|Overall Study||1
8836294|NCT01666002|9890749|FG000|STARTED|Overall Study||17
8836295|NCT01666002|9890750|FG001|STARTED|Overall Study||10
8836296|NCT01666002|9890749|FG000|COMPLETED|Overall Study||12
8836297|NCT01666002|9890750|FG001|COMPLETED|Overall Study||10
8836298|NCT01666002|9890749|FG000|NOT COMPLETED|Overall Study||5
8836299|NCT01666002|9890750|FG001|NOT COMPLETED|Overall Study||0
8836300|NCT01666119|9890757|FG000|STARTED|Overall Study||249
8836301|NCT01666119|9890757|FG000|COMPLETED|Overall Study||197
8836302|NCT01666119|9890757|FG000|NOT COMPLETED|Overall Study||52
8836303|NCT01666197|9890763|FG000|STARTED|Overall Study||50
8836304|NCT01666197|9890764|FG001|STARTED|Overall Study||50
8836305|NCT01666197|9890763|FG000|COMPLETED|Overall Study||50
8836306|NCT01666197|9890764|FG001|COMPLETED|Overall Study||50
8836307|NCT01666197|9890763|FG000|NOT COMPLETED|Overall Study||0
8836308|NCT01666197|9890764|FG001|NOT COMPLETED|Overall Study||0
8836309|NCT01666210|9890772|FG000|STARTED|Overall Study||30
8836310|NCT01666210|9890773|FG001|STARTED|Overall Study||30
8836311|NCT01666210|9890772|FG000|COMPLETED|Overall Study||28
8836312|NCT01666210|9890773|FG001|COMPLETED|Overall Study||29
8836313|NCT01666210|9890772|FG000|NOT COMPLETED|Overall Study||2
8836314|NCT01666210|9890773|FG001|NOT COMPLETED|Overall Study||1
8836315|NCT01666314|9890787|FG000|STARTED|Overall Study||33
8836316|NCT01666314|9890788|FG001|STARTED|Overall Study||32
8836317|NCT01666314|9890789|FG002|STARTED|Overall Study||36
8836318|NCT01666314|9890790|FG003|STARTED|Overall Study||36
8836319|NCT01666314|9890787|FG000|COMPLETED|Overall Study||0
8836320|NCT01666314|9890788|FG001|COMPLETED|Overall Study||0
8836321|NCT01666314|9890789|FG002|COMPLETED|Overall Study||0
8836322|NCT01666314|9890790|FG003|COMPLETED|Overall Study||0
8836323|NCT01666314|9890787|FG000|NOT COMPLETED|Overall Study||33
8836324|NCT01666314|9890788|FG001|NOT COMPLETED|Overall Study||32
8836325|NCT01666314|9890789|FG002|NOT COMPLETED|Overall Study||36
8836326|NCT01666314|9890790|FG003|NOT COMPLETED|Overall Study||36
8836327|NCT01666444|9890813|FG000|STARTED|Overall Study||149
8836328|NCT01666444|9890814|FG001|STARTED|Overall Study||148
8836329|NCT01666444|9890813|FG000|COMPLETED|Overall Study||147
8836330|NCT01666444|9890814|FG001|COMPLETED|Overall Study||147
8836331|NCT01666444|9890813|FG000|NOT COMPLETED|Overall Study||2
8836332|NCT01666444|9890814|FG001|NOT COMPLETED|Overall Study||1
8836333|NCT01666652|9890825|FG000|STARTED|Overall Study||20
8836334|NCT01666652|9890826|FG001|STARTED|Overall Study||20
8836335|NCT01666652|9890827|FG002|STARTED|Overall Study||20
8836336|NCT01666652|9890828|FG003|STARTED|Overall Study||20
8836337|NCT01666652|9890829|FG004|STARTED|Overall Study||20
8836338|NCT01666652|9890825|FG000|COMPLETED|Overall Study||18
8836339|NCT01666652|9890826|FG001|COMPLETED|Overall Study||19
8836340|NCT01666652|9890827|FG002|COMPLETED|Overall Study||19
8836341|NCT01666652|9890828|FG003|COMPLETED|Overall Study||16
8836342|NCT01666652|9890829|FG004|COMPLETED|Overall Study||19
8836343|NCT01666652|9890825|FG000|NOT COMPLETED|Overall Study||2
8836344|NCT01666652|9890826|FG001|NOT COMPLETED|Overall Study||1
8836345|NCT01666652|9890827|FG002|NOT COMPLETED|Overall Study||1
8836346|NCT01666652|9890828|FG003|NOT COMPLETED|Overall Study||4
8836347|NCT01666652|9890829|FG004|NOT COMPLETED|Overall Study||1
8836348|NCT01666730|9890841|FG000|STARTED|Overall Study||50
8836349|NCT01666730|9890841|FG000|COMPLETED|Overall Study||0
8836350|NCT01666730|9890841|FG000|NOT COMPLETED|Overall Study||50
8836351|NCT01666782|9890847|FG000|STARTED|Overall Study||54
8836352|NCT01666782|9890848|FG001|STARTED|Overall Study||51
8836353|NCT01666782|9890847|FG000|COMPLETED|Overall Study||50
8836354|NCT01666782|9890848|FG001|COMPLETED|Overall Study||50
8836355|NCT01666782|9890847|FG000|NOT COMPLETED|Overall Study||4
8836356|NCT01666782|9890848|FG001|NOT COMPLETED|Overall Study||1
8836357|NCT01666912|9890856|FG000|STARTED|Overall Study||48
8836358|NCT01666912|9890857|FG001|STARTED|Overall Study||48
8836359|NCT01666912|9890856|FG000|COMPLETED|Overall Study||27
8836360|NCT01666912|9890857|FG001|COMPLETED|Overall Study||37
8836361|NCT01666912|9890856|FG000|NOT COMPLETED|Overall Study||21
8836362|NCT01666912|9890857|FG001|NOT COMPLETED|Overall Study||11
8836363|NCT01666951|9890865|FG000|STARTED|Overall Study||18
8836364|NCT01666951|9890866|FG001|STARTED|Overall Study||18
8836365|NCT01666951|9890865|FG000|COMPLETED|Overall Study||17
8836366|NCT01666951|9890866|FG001|COMPLETED|Overall Study||17
8836367|NCT01666951|9890865|FG000|NOT COMPLETED|Overall Study||1
8836368|NCT01666951|9890866|FG001|NOT COMPLETED|Overall Study||1
8836369|NCT01667029|9890872|FG000|STARTED|Overall Study||4
8836370|NCT01667029|9890873|FG001|STARTED|Overall Study||4
8836371|NCT01667029|9890872|FG000|COMPLETED|Overall Study||3
8836372|NCT01667029|9890873|FG001|COMPLETED|Overall Study||3
8836373|NCT01667029|9890872|FG000|NOT COMPLETED|Overall Study||1
8836374|NCT01667029|9890873|FG001|NOT COMPLETED|Overall Study||1
8836375|NCT01667107|9890881|FG000|STARTED|Overall Study||8
8836376|NCT01667107|9890882|FG001|STARTED|Overall Study||18
8836377|NCT01667107|9890881|FG000|COMPLETED|Overall Study||4
8836378|NCT01667107|9890882|FG001|COMPLETED|Overall Study||11
8836379|NCT01667107|9890881|FG000|NOT COMPLETED|Overall Study||4
8836380|NCT01667107|9890882|FG001|NOT COMPLETED|Overall Study||7
8836381|NCT01667224|9890890|FG000|STARTED|Overall Study||40
8836382|NCT01667224|9890891|FG001|STARTED|Overall Study||40
8836383|NCT01667224|9890890|FG000|COMPLETED|Overall Study||36
8836384|NCT01667224|9890891|FG001|COMPLETED|Overall Study||38
8836385|NCT01667224|9890890|FG000|NOT COMPLETED|Overall Study||4
8836386|NCT01667224|9890891|FG001|NOT COMPLETED|Overall Study||2
8849961|NCT01743989|9905147|FG000|COMPLETED|TFR Phase||37
8849962|NCT01743989|9905148|FG001|COMPLETED|TFR Phase||36
8849963|NCT01743989|9905149|FG002|COMPLETED|TFR Phase||0
8849964|NCT01743989|9905147|FG000|NOT COMPLETED|TFR Phase||82
8849965|NCT01743989|9905148|FG001|NOT COMPLETED|TFR Phase||68
8849966|NCT01743989|9905149|FG002|NOT COMPLETED|TFR Phase||0
8849967|NCT01743989|9905147|FG000|STARTED|Re-treatment Phase||74
8849968|NCT01743989|9905148|FG001|STARTED|Re-treatment Phase||55
8849969|NCT01743989|9905149|FG002|STARTED|Re-treatment Phase||0
8849970|NCT01743989|9905147|FG000|COMPLETED|Re-treatment Phase||58
8849971|NCT01743989|9905148|FG001|COMPLETED|Re-treatment Phase||46
8849972|NCT01743989|9905149|FG002|COMPLETED|Re-treatment Phase||0
8849973|NCT01743989|9905147|FG000|NOT COMPLETED|Re-treatment Phase||16
8849974|NCT01743989|9905148|FG001|NOT COMPLETED|Re-treatment Phase||9
8849975|NCT01743989|9905149|FG002|NOT COMPLETED|Re-treatment Phase||0
8849976|NCT01744197|9905162|FG000|STARTED|Overall Study||32
8849977|NCT01744197|9905163|FG001|STARTED|Overall Study||29
8849978|NCT01744197|9905162|FG000|COMPLETED|Overall Study||28
8849979|NCT01744197|9905163|FG001|COMPLETED|Overall Study||26
8849980|NCT01744197|9905162|FG000|NOT COMPLETED|Overall Study||4
8849981|NCT01744197|9905163|FG001|NOT COMPLETED|Overall Study||3
8849982|NCT01744340|9905171|FG000|STARTED|Overall Study||8
8849983|NCT01744340|9905172|FG001|STARTED|Overall Study||15
8849984|NCT01744340|9905171|FG000|COMPLETED|Overall Study||8
8849985|NCT01744340|9905172|FG001|COMPLETED|Overall Study||15
8849986|NCT01744340|9905171|FG000|NOT COMPLETED|Overall Study||0
8849987|NCT01744340|9905172|FG001|NOT COMPLETED|Overall Study||0
8849988|NCT01744353|9905181|FG000|STARTED|Overall Study||6
8849989|NCT01744353|9905182|FG001|STARTED|Overall Study||26
8849990|NCT01744353|9905183|FG002|STARTED|Overall Study||3
8849991|NCT01744353|9905181|FG000|COMPLETED|Overall Study||6
8849992|NCT01744353|9905182|FG001|COMPLETED|Overall Study||26
8849993|NCT01744353|9905183|FG002|COMPLETED|Overall Study||3
8849994|NCT01744353|9905181|FG000|NOT COMPLETED|Overall Study||0
8849995|NCT01744353|9905182|FG001|NOT COMPLETED|Overall Study||0
8849996|NCT01744353|9905183|FG002|NOT COMPLETED|Overall Study||0
8622888|NCT00490269|9662091|FG000|STARTED|Dronabinol Then Placebo||6
8622889|NCT00490269|9662092|FG001|STARTED|Dronabinol Then Placebo||6
8622890|NCT00490269|9662091|FG000|COMPLETED|Dronabinol Then Placebo||6
8622891|NCT00490269|9662092|FG001|COMPLETED|Dronabinol Then Placebo||6
8622892|NCT00490269|9662091|FG000|NOT COMPLETED|Dronabinol Then Placebo||0
8622893|NCT00490269|9662092|FG001|NOT COMPLETED|Dronabinol Then Placebo||0
8622894|NCT00490269|9662091|FG000|STARTED|Placebo Then Dronabinol||6
8622895|NCT00490269|9662092|FG001|STARTED|Placebo Then Dronabinol||6
8622896|NCT00490269|9662091|FG000|COMPLETED|Placebo Then Dronabinol||6
8622897|NCT00490269|9662092|FG001|COMPLETED|Placebo Then Dronabinol||6
8849997|NCT01744392|9905189|FG000|STARTED|Overall Study||23
8849998|NCT01744392|9905189|FG000|COMPLETED|Overall Study||22
8849999|NCT01744392|9905189|FG000|NOT COMPLETED|Overall Study||1
8850000|NCT01744483|9905197|FG000|STARTED|Overall Study||44
8850001|NCT01744483|9905198|FG001|STARTED|Overall Study||35
8850002|NCT01744483|9905199|FG002|STARTED|Overall Study||38
8850003|NCT01744483|9905197|FG000|COMPLETED|Overall Study||15
8850004|NCT01744483|9905198|FG001|COMPLETED|Overall Study||13
8850005|NCT01744483|9905199|FG002|COMPLETED|Overall Study||10
8850006|NCT01744483|9905197|FG000|NOT COMPLETED|Overall Study||29
8850007|NCT01744483|9905198|FG001|NOT COMPLETED|Overall Study||22
8850008|NCT01744483|9905199|FG002|NOT COMPLETED|Overall Study||28
8850009|NCT01744496|9905209|FG000|STARTED|Titration Period||33
8850010|NCT01744496|9905210|FG001|STARTED|Titration Period||35
8850011|NCT01744496|9905209|FG000|COMPLETED|Titration Period||31
8850012|NCT01744496|9905210|FG001|COMPLETED|Titration Period||33
8850013|NCT01744496|9905209|FG000|NOT COMPLETED|Titration Period||2
8850014|NCT01744496|9905210|FG001|NOT COMPLETED|Titration Period||2
8850015|NCT01744496|9905209|FG000|STARTED|Maintenance Period||31
8850016|NCT01744496|9905210|FG001|STARTED|Maintenance Period||33
8850017|NCT01744496|9905209|FG000|COMPLETED|Maintenance Period||27
8850018|NCT01744496|9905210|FG001|COMPLETED|Maintenance Period||29
8850019|NCT01744496|9905209|FG000|NOT COMPLETED|Maintenance Period||4
8850020|NCT01744496|9905210|FG001|NOT COMPLETED|Maintenance Period||4
8850021|NCT01744574|9905220|FG000|STARTED|Overall Study||57
8836387|NCT01667250|9890901|FG000|STARTED|Run-in (no Treatment)||0
8836388|NCT01667250|9890902|FG001|STARTED|Run-in (no Treatment)||0
8836389|NCT01667250|9890903|FG002|STARTED|Run-in (no Treatment)||73
8836390|NCT01667250|9890901|FG000|COMPLETED|Run-in (no Treatment)||0
8836391|NCT01667250|9890902|FG001|COMPLETED|Run-in (no Treatment)||0
8836392|NCT01667250|9890903|FG002|COMPLETED|Run-in (no Treatment)||59
8836393|NCT01667250|9890901|FG000|NOT COMPLETED|Run-in (no Treatment)||0
8836394|NCT01667250|9890902|FG001|NOT COMPLETED|Run-in (no Treatment)||0
8836395|NCT01667250|9890903|FG002|NOT COMPLETED|Run-in (no Treatment)||14
8836396|NCT01667250|9890901|FG000|STARTED|Randomised Period||30
8836397|NCT01667250|9890902|FG001|STARTED|Randomised Period||29
8836398|NCT01667250|9890903|FG002|STARTED|Randomised Period||0
8836399|NCT01667250|9890901|FG000|COMPLETED|Randomised Period||29
8836400|NCT01667250|9890902|FG001|COMPLETED|Randomised Period||28
8836401|NCT01667250|9890903|FG002|COMPLETED|Randomised Period||0
8836402|NCT01667250|9890901|FG000|NOT COMPLETED|Randomised Period||1
8836403|NCT01667250|9890902|FG001|NOT COMPLETED|Randomised Period||1
8836404|NCT01667250|9890903|FG002|NOT COMPLETED|Randomised Period||0
8836405|NCT01667406|9890920|FG000|STARTED|Overall Study||2
8836406|NCT01667406|9890921|FG001|STARTED|Overall Study||3
8836407|NCT01667406|9890922|FG002|STARTED|Overall Study||24
8836408|NCT01667406|9890923|FG003|STARTED|Overall Study||24
8836409|NCT01667406|9890924|FG004|STARTED|Overall Study||5
8836410|NCT01667406|9890925|FG005|STARTED|Overall Study||20
8836411|NCT01667406|9890926|FG006|STARTED|Overall Study||15
8836412|NCT01667406|9890927|FG007|STARTED|Overall Study||20
8836413|NCT01667406|9890928|FG008|STARTED|Overall Study||31
8836414|NCT01667406|9890929|FG009|STARTED|Overall Study||31
8836415|NCT01667406|9890920|FG000|COMPLETED|Overall Study||2
8836416|NCT01667406|9890921|FG001|COMPLETED|Overall Study||3
8836417|NCT01667406|9890922|FG002|COMPLETED|Overall Study||24
8836418|NCT01667406|9890923|FG003|COMPLETED|Overall Study||24
8836419|NCT01667406|9890924|FG004|COMPLETED|Overall Study||5
8836420|NCT01667406|9890925|FG005|COMPLETED|Overall Study||20
8836421|NCT01667406|9890926|FG006|COMPLETED|Overall Study||15
8836422|NCT01667406|9890927|FG007|COMPLETED|Overall Study||20
8836423|NCT01667406|9890928|FG008|COMPLETED|Overall Study||31
8836424|NCT01667406|9890929|FG009|COMPLETED|Overall Study||31
8836425|NCT01667406|9890920|FG000|NOT COMPLETED|Overall Study||0
8836426|NCT01667406|9890921|FG001|NOT COMPLETED|Overall Study||0
8836427|NCT01667406|9890922|FG002|NOT COMPLETED|Overall Study||0
8836428|NCT01667406|9890923|FG003|NOT COMPLETED|Overall Study||0
8836429|NCT01667406|9890924|FG004|NOT COMPLETED|Overall Study||0
8836430|NCT01667406|9890925|FG005|NOT COMPLETED|Overall Study||0
8836431|NCT01667406|9890926|FG006|NOT COMPLETED|Overall Study||0
8836432|NCT01667406|9890927|FG007|NOT COMPLETED|Overall Study||0
8836433|NCT01667406|9890928|FG008|NOT COMPLETED|Overall Study||0
8836434|NCT01667406|9890929|FG009|NOT COMPLETED|Overall Study||0
8836435|NCT01667419|9890985|FG000|STARTED|Overall Study||157
8836436|NCT01667419|9890986|FG001|STARTED|Overall Study||157
8836437|NCT01667419|9890987|FG002|STARTED|Overall Study||93
8836438|NCT01667419|9890988|FG003|STARTED|Overall Study||91
8836439|NCT01667419|9890985|FG000|COMPLETED|Overall Study||114
8836440|NCT01667419|9890986|FG001|COMPLETED|Overall Study||110
8836441|NCT01667419|9890987|FG002|COMPLETED|Overall Study||57
8836442|NCT01667419|9890988|FG003|COMPLETED|Overall Study||52
8836443|NCT01667419|9890985|FG000|NOT COMPLETED|Overall Study||43
8836444|NCT01667419|9890986|FG001|NOT COMPLETED|Overall Study||47
8836445|NCT01667419|9890987|FG002|NOT COMPLETED|Overall Study||36
8836446|NCT01667419|9890988|FG003|NOT COMPLETED|Overall Study||39
8836447|NCT01667432|9890999|FG000|STARTED|Overall Study||141
8836448|NCT01667432|9890999|FG000|COMPLETED|Overall Study||84
8836449|NCT01667432|9890999|FG000|NOT COMPLETED|Overall Study||57
8836450|NCT01667471|9891003|FG000|STARTED|Overall Study||7
8836451|NCT01667471|9891003|FG000|COMPLETED|Overall Study||7
8836452|NCT01667471|9891003|FG000|NOT COMPLETED|Overall Study||0
8836453|NCT01667536|9891008|FG000|STARTED|Overall Study||105
8836454|NCT01667536|9891008|FG000|COMPLETED|Overall Study|105 subjects comprised the safety popn, defined as all subjects who received an MIP-1404 injection.|105
8836455|NCT01667536|9891008|FG000|NOT COMPLETED|Overall Study||0
8836456|NCT01667549|9891020|FG000|STARTED|Overall Study|20 dyads=20 infants, 20 mothers|20
8836457|NCT01667549|9891021|FG001|STARTED|Overall Study|20 dyads=20 infants, 20 mothers|20
8836458|NCT01667549|9891022|FG002|STARTED|Overall Study|21 dyads=21 infants, 21 mothers|21
8836459|NCT01667549|9891023|FG003|STARTED|Overall Study|20 dyads= 20 infants, 20 mothers|20
8836460|NCT01667549|9891024|FG004|STARTED|Overall Study|16 dyads=16 infants, 16 mothers|16
8836461|NCT01667549|9891020|FG000|COMPLETED|Overall Study|17 dyads=17 infants, 17 mothers|17
8836462|NCT01667549|9891021|FG001|COMPLETED|Overall Study|15 dyads=15 infants, 15 mothers|15
8836463|NCT01667549|9891022|FG002|COMPLETED|Overall Study|14 dyads=14 infants, 14 mothers|14
8836464|NCT01667549|9891023|FG003|COMPLETED|Overall Study|14 dyads= 14 infants, 14 mothers|14
8836465|NCT01667549|9891024|FG004|COMPLETED|Overall Study|15 dyads=15 infants, 15 mothers|15
8836466|NCT01667549|9891020|FG000|NOT COMPLETED|Overall Study||3
8836467|NCT01667549|9891021|FG001|NOT COMPLETED|Overall Study||5
8836468|NCT01667549|9891022|FG002|NOT COMPLETED|Overall Study||7
8836469|NCT01667549|9891023|FG003|NOT COMPLETED|Overall Study||6
8836470|NCT01667549|9891024|FG004|NOT COMPLETED|Overall Study||1
8836471|NCT01667562|9891041|FG000|STARTED|Diagnostic Phase||375
8836472|NCT01667562|9891042|FG001|STARTED|Diagnostic Phase||0
8836473|NCT01667562|9891041|FG000|COMPLETED|Diagnostic Phase||345
8836474|NCT01667562|9891042|FG001|COMPLETED|Diagnostic Phase||0
8836475|NCT01667562|9891041|FG000|NOT COMPLETED|Diagnostic Phase||30
8836476|NCT01667562|9891042|FG001|NOT COMPLETED|Diagnostic Phase||0
8836477|NCT01667562|9891041|FG000|STARTED|Erlotinib Phase||0
8836478|NCT01667562|9891042|FG001|STARTED|Erlotinib Phase||30
8836479|NCT01667562|9891041|FG000|COMPLETED|Erlotinib Phase||0
8836480|NCT01667562|9891042|FG001|COMPLETED|Erlotinib Phase||27
8836481|NCT01667562|9891041|FG000|NOT COMPLETED|Erlotinib Phase||0
8836482|NCT01667562|9891042|FG001|NOT COMPLETED|Erlotinib Phase||3
8836483|NCT01667679|9891049|FG000|STARTED|Treatment Period 1 (<=12 Weeks)||138
8836484|NCT01667679|9891050|FG001|STARTED|Treatment Period 1 (<=12 Weeks)||137
8836485|NCT01667679|9891049|FG000|COMPLETED|Treatment Period 1 (<=12 Weeks)||122
8836486|NCT01667679|9891050|FG001|COMPLETED|Treatment Period 1 (<=12 Weeks)||107
8836487|NCT01667679|9891049|FG000|NOT COMPLETED|Treatment Period 1 (<=12 Weeks)||16
8836488|NCT01667679|9891050|FG001|NOT COMPLETED|Treatment Period 1 (<=12 Weeks)||30
8836489|NCT01667679|9891049|FG000|STARTED|Treatment Period 2 (<=12 Weeks)||122
8836490|NCT01667679|9891050|FG001|STARTED|Treatment Period 2 (<=12 Weeks)||107
8836491|NCT01667679|9891049|FG000|COMPLETED|Treatment Period 2 (<=12 Weeks)||100
8836492|NCT01667679|9891050|FG001|COMPLETED|Treatment Period 2 (<=12 Weeks)||85
8836493|NCT01667679|9891049|FG000|NOT COMPLETED|Treatment Period 2 (<=12 Weeks)||22
8836494|NCT01667679|9891050|FG001|NOT COMPLETED|Treatment Period 2 (<=12 Weeks)||22
8836495|NCT01667731|9891063|FG000|STARTED|Overall Study||26
8836496|NCT01667731|9891064|FG001|STARTED|Overall Study||42
8836497|NCT01667731|9891065|FG002|STARTED|Overall Study||24
8836498|NCT01667731|9891066|FG003|STARTED|Overall Study||17
8836499|NCT01667731|9891067|FG004|STARTED|Overall Study||115
8836500|NCT01667731|9891063|FG000|COMPLETED|Overall Study||21
8836501|NCT01667731|9891064|FG001|COMPLETED|Overall Study||26
8836502|NCT01667731|9891065|FG002|COMPLETED|Overall Study||22
8836503|NCT01667731|9891066|FG003|COMPLETED|Overall Study||15
8836504|NCT01667731|9891067|FG004|COMPLETED|Overall Study||87
8836505|NCT01667731|9891063|FG000|NOT COMPLETED|Overall Study||5
8836506|NCT01667731|9891064|FG001|NOT COMPLETED|Overall Study||16
8836507|NCT01667731|9891065|FG002|NOT COMPLETED|Overall Study||2
8836508|NCT01667731|9891066|FG003|NOT COMPLETED|Overall Study||2
8836509|NCT01667731|9891067|FG004|NOT COMPLETED|Overall Study||28
8836510|NCT01667796|9891082|FG000|STARTED|Overall Study||27
8836511|NCT01667796|9891083|FG001|STARTED|Overall Study||30
8836512|NCT01667796|9891082|FG000|COMPLETED|Overall Study||24
8836513|NCT01667796|9891083|FG001|COMPLETED|Overall Study||29
8836514|NCT01667796|9891082|FG000|NOT COMPLETED|Overall Study||3
8836515|NCT01667796|9891083|FG001|NOT COMPLETED|Overall Study||1
8836516|NCT01667848|9891095|FG000|STARTED|Overall Study||67
8836517|NCT01667848|9891096|FG001|STARTED|Overall Study||81
8836518|NCT01667848|9891095|FG000|COMPLETED|Overall Study||67
8836519|NCT01667848|9891096|FG001|COMPLETED|Overall Study||81
8836520|NCT01667848|9891095|FG000|NOT COMPLETED|Overall Study||0
8836521|NCT01667848|9891096|FG001|NOT COMPLETED|Overall Study||0
8836522|NCT01667900|9891107|FG000|STARTED|Part A, Period 1||1
8836523|NCT01667900|9891108|FG001|STARTED|Part A, Period 1||1
8836524|NCT01667900|9891109|FG002|STARTED|Part A, Period 1||1
8836525|NCT01667900|9891110|FG003|STARTED|Part A, Period 1||1
8836526|NCT01667900|9891111|FG004|STARTED|Part A, Period 1||1
8836527|NCT01667900|9891112|FG005|STARTED|Part A, Period 1||1
8836528|NCT01667900|9891113|FG006|STARTED|Part A, Period 1||1
8836529|NCT01667900|9891114|FG007|STARTED|Part A, Period 1||1
8836530|NCT01667900|9891115|FG008|STARTED|Part A, Period 1||1
8836531|NCT01667900|9891116|FG009|STARTED|Part A, Period 1||1
8836532|NCT01667900|9891117|FG010|STARTED|Part A, Period 1||1
8836533|NCT01667900|9891118|FG011|STARTED|Part A, Period 1||1
8836534|NCT01667900|9891119|FG012|STARTED|Part A, Period 1||1
8836535|NCT01667900|9891120|FG013|STARTED|Part A, Period 1||1
8836536|NCT01667900|9891121|FG014|STARTED|Part A, Period 1||1
8836537|NCT01667900|9891122|FG015|STARTED|Part A, Period 1||1
8836538|NCT01667900|9891123|FG016|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
8836539|NCT01667900|9891124|FG017|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
8836540|NCT01667900|9891125|FG018|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
8836541|NCT01667900|9891126|FG019|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
8836542|NCT01667900|9891107|FG000|COMPLETED|Part A, Period 1||1
8836543|NCT01667900|9891108|FG001|COMPLETED|Part A, Period 1||1
8836544|NCT01667900|9891109|FG002|COMPLETED|Part A, Period 1||1
8836545|NCT01667900|9891110|FG003|COMPLETED|Part A, Period 1||1
8836546|NCT01667900|9891111|FG004|COMPLETED|Part A, Period 1||1
8836547|NCT01667900|9891112|FG005|COMPLETED|Part A, Period 1||1
8836548|NCT01667900|9891113|FG006|COMPLETED|Part A, Period 1||1
8836549|NCT01667900|9891114|FG007|COMPLETED|Part A, Period 1||1
8836550|NCT01667900|9891115|FG008|COMPLETED|Part A, Period 1||1
8836551|NCT01667900|9891116|FG009|COMPLETED|Part A, Period 1||1
8836552|NCT01667900|9891117|FG010|COMPLETED|Part A, Period 1||1
8836553|NCT01667900|9891118|FG011|COMPLETED|Part A, Period 1||1
8836554|NCT01667900|9891119|FG012|COMPLETED|Part A, Period 1||1
8836555|NCT01667900|9891120|FG013|COMPLETED|Part A, Period 1||1
8836556|NCT01667900|9891121|FG014|COMPLETED|Part A, Period 1||1
8836557|NCT01667900|9891122|FG015|COMPLETED|Part A, Period 1||1
8836558|NCT01667900|9891123|FG016|COMPLETED|Part A, Period 1||0
8836559|NCT01667900|9891124|FG017|COMPLETED|Part A, Period 1||0
8836560|NCT01667900|9891125|FG018|COMPLETED|Part A, Period 1||0
8836561|NCT01667900|9891126|FG019|COMPLETED|Part A, Period 1||0
8836562|NCT01667900|9891107|FG000|NOT COMPLETED|Part A, Period 1||0
8836563|NCT01667900|9891108|FG001|NOT COMPLETED|Part A, Period 1||0
8836564|NCT01667900|9891109|FG002|NOT COMPLETED|Part A, Period 1||0
8836565|NCT01667900|9891110|FG003|NOT COMPLETED|Part A, Period 1||0
8836566|NCT01667900|9891111|FG004|NOT COMPLETED|Part A, Period 1||0
8836567|NCT01667900|9891112|FG005|NOT COMPLETED|Part A, Period 1||0
8836568|NCT01667900|9891113|FG006|NOT COMPLETED|Part A, Period 1||0
8836569|NCT01667900|9891114|FG007|NOT COMPLETED|Part A, Period 1||0
8836570|NCT01667900|9891115|FG008|NOT COMPLETED|Part A, Period 1||0
8836571|NCT01667900|9891116|FG009|NOT COMPLETED|Part A, Period 1||0
8836572|NCT01667900|9891117|FG010|NOT COMPLETED|Part A, Period 1||0
8836573|NCT01667900|9891118|FG011|NOT COMPLETED|Part A, Period 1||0
8836574|NCT01667900|9891119|FG012|NOT COMPLETED|Part A, Period 1||0
8836575|NCT01667900|9891120|FG013|NOT COMPLETED|Part A, Period 1||0
8836576|NCT01667900|9891121|FG014|NOT COMPLETED|Part A, Period 1||0
8836577|NCT01667900|9891122|FG015|NOT COMPLETED|Part A, Period 1||0
8836578|NCT01667900|9891123|FG016|NOT COMPLETED|Part A, Period 1||0
8836579|NCT01667900|9891124|FG017|NOT COMPLETED|Part A, Period 1||0
8836580|NCT01667900|9891125|FG018|NOT COMPLETED|Part A, Period 1||0
8836581|NCT01667900|9891126|FG019|NOT COMPLETED|Part A, Period 1||0
8836582|NCT01667900|9891107|FG000|STARTED|Part A, Washout 1||1
8836583|NCT01667900|9891108|FG001|STARTED|Part A, Washout 1||1
8836584|NCT01667900|9891109|FG002|STARTED|Part A, Washout 1||1
8836585|NCT01667900|9891110|FG003|STARTED|Part A, Washout 1||1
8836586|NCT01667900|9891111|FG004|STARTED|Part A, Washout 1||1
8836587|NCT01667900|9891112|FG005|STARTED|Part A, Washout 1||1
8836588|NCT01667900|9891113|FG006|STARTED|Part A, Washout 1||1
8836589|NCT01667900|9891114|FG007|STARTED|Part A, Washout 1||1
8836590|NCT01667900|9891115|FG008|STARTED|Part A, Washout 1||1
8836591|NCT01667900|9891116|FG009|STARTED|Part A, Washout 1||1
8836592|NCT01667900|9891117|FG010|STARTED|Part A, Washout 1||1
8836593|NCT01667900|9891118|FG011|STARTED|Part A, Washout 1||1
8836594|NCT01667900|9891119|FG012|STARTED|Part A, Washout 1||1
8836595|NCT01667900|9891120|FG013|STARTED|Part A, Washout 1||1
8836596|NCT01667900|9891121|FG014|STARTED|Part A, Washout 1||1
8836597|NCT01667900|9891122|FG015|STARTED|Part A, Washout 1||1
8836598|NCT01667900|9891123|FG016|STARTED|Part A, Washout 1||0
8836599|NCT01667900|9891124|FG017|STARTED|Part A, Washout 1||0
8836600|NCT01667900|9891125|FG018|STARTED|Part A, Washout 1||0
8836601|NCT01667900|9891126|FG019|STARTED|Part A, Washout 1||0
8836602|NCT01667900|9891107|FG000|COMPLETED|Part A, Washout 1||1
8836603|NCT01667900|9891108|FG001|COMPLETED|Part A, Washout 1||1
8836604|NCT01667900|9891109|FG002|COMPLETED|Part A, Washout 1||1
8836605|NCT01667900|9891110|FG003|COMPLETED|Part A, Washout 1||1
8836606|NCT01667900|9891111|FG004|COMPLETED|Part A, Washout 1||1
8836607|NCT01667900|9891112|FG005|COMPLETED|Part A, Washout 1||1
8836608|NCT01667900|9891113|FG006|COMPLETED|Part A, Washout 1||1
8836609|NCT01667900|9891114|FG007|COMPLETED|Part A, Washout 1||1
8836610|NCT01667900|9891115|FG008|COMPLETED|Part A, Washout 1||1
8836611|NCT01667900|9891116|FG009|COMPLETED|Part A, Washout 1||1
8836612|NCT01667900|9891117|FG010|COMPLETED|Part A, Washout 1||1
8836613|NCT01667900|9891118|FG011|COMPLETED|Part A, Washout 1||1
8836614|NCT01667900|9891119|FG012|COMPLETED|Part A, Washout 1||1
8836615|NCT01667900|9891120|FG013|COMPLETED|Part A, Washout 1||1
8836616|NCT01667900|9891121|FG014|COMPLETED|Part A, Washout 1||1
8836617|NCT01667900|9891122|FG015|COMPLETED|Part A, Washout 1||1
8836618|NCT01667900|9891123|FG016|COMPLETED|Part A, Washout 1||0
8836619|NCT01667900|9891124|FG017|COMPLETED|Part A, Washout 1||0
8836620|NCT01667900|9891125|FG018|COMPLETED|Part A, Washout 1||0
8836621|NCT01667900|9891126|FG019|COMPLETED|Part A, Washout 1||0
8836622|NCT01667900|9891107|FG000|NOT COMPLETED|Part A, Washout 1||0
8836623|NCT01667900|9891108|FG001|NOT COMPLETED|Part A, Washout 1||0
8836624|NCT01667900|9891109|FG002|NOT COMPLETED|Part A, Washout 1||0
8836625|NCT01667900|9891110|FG003|NOT COMPLETED|Part A, Washout 1||0
8836626|NCT01667900|9891111|FG004|NOT COMPLETED|Part A, Washout 1||0
8836627|NCT01667900|9891112|FG005|NOT COMPLETED|Part A, Washout 1||0
8836628|NCT01667900|9891113|FG006|NOT COMPLETED|Part A, Washout 1||0
8836629|NCT01667900|9891114|FG007|NOT COMPLETED|Part A, Washout 1||0
8836630|NCT01667900|9891115|FG008|NOT COMPLETED|Part A, Washout 1||0
8836631|NCT01667900|9891116|FG009|NOT COMPLETED|Part A, Washout 1||0
8836632|NCT01667900|9891117|FG010|NOT COMPLETED|Part A, Washout 1||0
8836633|NCT01667900|9891118|FG011|NOT COMPLETED|Part A, Washout 1||0
8836634|NCT01667900|9891119|FG012|NOT COMPLETED|Part A, Washout 1||0
8836635|NCT01667900|9891120|FG013|NOT COMPLETED|Part A, Washout 1||0
8836636|NCT01667900|9891121|FG014|NOT COMPLETED|Part A, Washout 1||0
8836637|NCT01667900|9891122|FG015|NOT COMPLETED|Part A, Washout 1||0
8836638|NCT01667900|9891123|FG016|NOT COMPLETED|Part A, Washout 1||0
8836639|NCT01667900|9891124|FG017|NOT COMPLETED|Part A, Washout 1||0
8836640|NCT01667900|9891125|FG018|NOT COMPLETED|Part A, Washout 1||0
8836641|NCT01667900|9891126|FG019|NOT COMPLETED|Part A, Washout 1||0
8836642|NCT01667900|9891107|FG000|STARTED|Part A, Period 2||1
8836643|NCT01667900|9891108|FG001|STARTED|Part A, Period 2||1
8836644|NCT01667900|9891109|FG002|STARTED|Part A, Period 2||1
8836645|NCT01667900|9891110|FG003|STARTED|Part A, Period 2||1
8836646|NCT01667900|9891111|FG004|STARTED|Part A, Period 2||1
8836647|NCT01667900|9891112|FG005|STARTED|Part A, Period 2||1
8836648|NCT01667900|9891113|FG006|STARTED|Part A, Period 2||1
8836649|NCT01667900|9891114|FG007|STARTED|Part A, Period 2||1
8836650|NCT01667900|9891115|FG008|STARTED|Part A, Period 2||1
8836651|NCT01667900|9891116|FG009|STARTED|Part A, Period 2||1
8836652|NCT01667900|9891117|FG010|STARTED|Part A, Period 2||1
8836653|NCT01667900|9891118|FG011|STARTED|Part A, Period 2||1
8622898|NCT00490269|9662091|FG000|NOT COMPLETED|Placebo Then Dronabinol||0
8622899|NCT00490269|9662092|FG001|NOT COMPLETED|Placebo Then Dronabinol||0
8622900|NCT00490282|9662098|FG000|STARTED|Overall Study||25
8622901|NCT00490282|9662098|FG000|COMPLETED|Overall Study||22
8622902|NCT00490282|9662098|FG000|NOT COMPLETED|Overall Study||3
8622903|NCT00490451|9662105|FG000|STARTED|Overall Study||63
8622904|NCT00490451|9662106|FG001|STARTED|Overall Study||38
8622905|NCT00490451|9662105|FG000|COMPLETED|Overall Study||0
8622906|NCT00490451|9662106|FG001|COMPLETED|Overall Study||0
8622907|NCT00490451|9662105|FG000|NOT COMPLETED|Overall Study||63
8622908|NCT00490451|9662106|FG001|NOT COMPLETED|Overall Study||38
8622909|NCT00490477|9662114|FG000|STARTED|Overall Study||8
8622910|NCT00490477|9662115|FG001|STARTED|Overall Study||8
8622911|NCT00490477|9662114|FG000|COMPLETED|Overall Study||8
8622912|NCT00490477|9662115|FG001|COMPLETED|Overall Study||8
8622913|NCT00490477|9662114|FG000|NOT COMPLETED|Overall Study||0
8622914|NCT00490477|9662115|FG001|NOT COMPLETED|Overall Study||0
8622915|NCT00490490|9662121|FG000|STARTED|Completed Assessment for CR||8
8622916|NCT00490490|9662121|FG000|COMPLETED|Completed Assessment for CR||8
8622917|NCT00490490|9662121|FG000|NOT COMPLETED|Completed Assessment for CR||0
8622918|NCT00490490|9662121|FG000|STARTED|Completed Assessment for TTP||8
8622919|NCT00490490|9662121|FG000|COMPLETED|Completed Assessment for TTP||5
8622920|NCT00490490|9662121|FG000|NOT COMPLETED|Completed Assessment for TTP||3
8622921|NCT00490529|9662125|FG000|STARTED|Completed Pre-CpG-MCL Vaccine Procedures||59
8622922|NCT00490529|9662125|FG000|COMPLETED|Completed Pre-CpG-MCL Vaccine Procedures||48
8622923|NCT00490529|9662125|FG000|NOT COMPLETED|Completed Pre-CpG-MCL Vaccine Procedures||11
8622924|NCT00490529|9662125|FG000|STARTED|Treatment With CpG-MCL Vaccine||48
8622925|NCT00490529|9662125|FG000|COMPLETED|Treatment With CpG-MCL Vaccine||47
8622926|NCT00490529|9662125|FG000|NOT COMPLETED|Treatment With CpG-MCL Vaccine||1
8622927|NCT00490542|9662131|FG000|STARTED|Overall Study||38
8622928|NCT00490542|9662132|FG001|STARTED|Overall Study||35
8622929|NCT00490542|9662131|FG000|COMPLETED|Overall Study||31
8836654|NCT01667900|9891119|FG012|STARTED|Part A, Period 2||1
8836655|NCT01667900|9891120|FG013|STARTED|Part A, Period 2||1
8836656|NCT01667900|9891121|FG014|STARTED|Part A, Period 2||1
8836657|NCT01667900|9891122|FG015|STARTED|Part A, Period 2||1
8836658|NCT01667900|9891123|FG016|STARTED|Part A, Period 2||0
8836659|NCT01667900|9891124|FG017|STARTED|Part A, Period 2||0
8836660|NCT01667900|9891125|FG018|STARTED|Part A, Period 2||0
8836661|NCT01667900|9891126|FG019|STARTED|Part A, Period 2||0
8836662|NCT01667900|9891107|FG000|COMPLETED|Part A, Period 2||1
8836663|NCT01667900|9891108|FG001|COMPLETED|Part A, Period 2||1
8836664|NCT01667900|9891109|FG002|COMPLETED|Part A, Period 2||1
8836665|NCT01667900|9891110|FG003|COMPLETED|Part A, Period 2||1
8836666|NCT01667900|9891111|FG004|COMPLETED|Part A, Period 2||1
8836667|NCT01667900|9891112|FG005|COMPLETED|Part A, Period 2||1
8836668|NCT01667900|9891113|FG006|COMPLETED|Part A, Period 2||1
8836669|NCT01667900|9891114|FG007|COMPLETED|Part A, Period 2||1
8836670|NCT01667900|9891115|FG008|COMPLETED|Part A, Period 2||1
8836671|NCT01667900|9891116|FG009|COMPLETED|Part A, Period 2||1
8836672|NCT01667900|9891117|FG010|COMPLETED|Part A, Period 2||1
8836673|NCT01667900|9891118|FG011|COMPLETED|Part A, Period 2||1
8836674|NCT01667900|9891119|FG012|COMPLETED|Part A, Period 2||1
8836675|NCT01667900|9891120|FG013|COMPLETED|Part A, Period 2||1
8836676|NCT01667900|9891121|FG014|COMPLETED|Part A, Period 2||1
8836677|NCT01667900|9891122|FG015|COMPLETED|Part A, Period 2||1
8836678|NCT01667900|9891123|FG016|COMPLETED|Part A, Period 2||0
8836679|NCT01667900|9891124|FG017|COMPLETED|Part A, Period 2||0
8836680|NCT01667900|9891125|FG018|COMPLETED|Part A, Period 2||0
8836681|NCT01667900|9891126|FG019|COMPLETED|Part A, Period 2||0
8836682|NCT01667900|9891107|FG000|NOT COMPLETED|Part A, Period 2||0
8836683|NCT01667900|9891108|FG001|NOT COMPLETED|Part A, Period 2||0
8836684|NCT01667900|9891109|FG002|NOT COMPLETED|Part A, Period 2||0
8836685|NCT01667900|9891110|FG003|NOT COMPLETED|Part A, Period 2||0
8836686|NCT01667900|9891111|FG004|NOT COMPLETED|Part A, Period 2||0
8836687|NCT01667900|9891112|FG005|NOT COMPLETED|Part A, Period 2||0
8836688|NCT01667900|9891113|FG006|NOT COMPLETED|Part A, Period 2||0
8836689|NCT01667900|9891114|FG007|NOT COMPLETED|Part A, Period 2||0
8836690|NCT01667900|9891115|FG008|NOT COMPLETED|Part A, Period 2||0
8836691|NCT01667900|9891116|FG009|NOT COMPLETED|Part A, Period 2||0
8836692|NCT01667900|9891117|FG010|NOT COMPLETED|Part A, Period 2||0
8622930|NCT00490542|9662132|FG001|COMPLETED|Overall Study||31
8622931|NCT00490542|9662131|FG000|NOT COMPLETED|Overall Study||7
8622932|NCT00490542|9662132|FG001|NOT COMPLETED|Overall Study||4
8622933|NCT00490555|9662142|FG000|STARTED|Overall Study||8
8622934|NCT00490555|9662143|FG001|STARTED|Overall Study||8
8622935|NCT00490555|9662144|FG002|STARTED|Overall Study||9
8622936|NCT00490555|9662145|FG003|STARTED|Overall Study||7
8622937|NCT00490555|9662142|FG000|COMPLETED|Overall Study||8
8622938|NCT00490555|9662143|FG001|COMPLETED|Overall Study||8
8622939|NCT00490555|9662144|FG002|COMPLETED|Overall Study||7
8622940|NCT00490555|9662145|FG003|COMPLETED|Overall Study||7
8836693|NCT01667900|9891118|FG011|NOT COMPLETED|Part A, Period 2||0
8836694|NCT01667900|9891119|FG012|NOT COMPLETED|Part A, Period 2||0
8836695|NCT01667900|9891120|FG013|NOT COMPLETED|Part A, Period 2||0
8836696|NCT01667900|9891121|FG014|NOT COMPLETED|Part A, Period 2||0
8836697|NCT01667900|9891122|FG015|NOT COMPLETED|Part A, Period 2||0
8836698|NCT01667900|9891123|FG016|NOT COMPLETED|Part A, Period 2||0
8622941|NCT00490555|9662142|FG000|NOT COMPLETED|Overall Study||0
8622942|NCT00490555|9662143|FG001|NOT COMPLETED|Overall Study||0
8622943|NCT00490555|9662144|FG002|NOT COMPLETED|Overall Study||2
8622944|NCT00490555|9662145|FG003|NOT COMPLETED|Overall Study||0
8836699|NCT01667900|9891124|FG017|NOT COMPLETED|Part A, Period 2||0
8836700|NCT01667900|9891125|FG018|NOT COMPLETED|Part A, Period 2||0
8836701|NCT01667900|9891126|FG019|NOT COMPLETED|Part A, Period 2||0
8836702|NCT01667900|9891107|FG000|STARTED|Part A, Washout 2||1
8836703|NCT01667900|9891108|FG001|STARTED|Part A, Washout 2||1
8836704|NCT01667900|9891109|FG002|STARTED|Part A, Washout 2||1
8836705|NCT01667900|9891110|FG003|STARTED|Part A, Washout 2||1
8836706|NCT01667900|9891111|FG004|STARTED|Part A, Washout 2||1
8836707|NCT01667900|9891112|FG005|STARTED|Part A, Washout 2||1
8836708|NCT01667900|9891113|FG006|STARTED|Part A, Washout 2||1
8836709|NCT01667900|9891114|FG007|STARTED|Part A, Washout 2||1
8836710|NCT01667900|9891115|FG008|STARTED|Part A, Washout 2||1
8836711|NCT01667900|9891116|FG009|STARTED|Part A, Washout 2||1
8836712|NCT01667900|9891117|FG010|STARTED|Part A, Washout 2||1
8836713|NCT01667900|9891118|FG011|STARTED|Part A, Washout 2||1
8836714|NCT01667900|9891119|FG012|STARTED|Part A, Washout 2||1
8836715|NCT01667900|9891120|FG013|STARTED|Part A, Washout 2||1
8836716|NCT01667900|9891121|FG014|STARTED|Part A, Washout 2||1
8836717|NCT01667900|9891122|FG015|STARTED|Part A, Washout 2||1
8836718|NCT01667900|9891123|FG016|STARTED|Part A, Washout 2||0
8836719|NCT01667900|9891124|FG017|STARTED|Part A, Washout 2||0
8836720|NCT01667900|9891125|FG018|STARTED|Part A, Washout 2||0
8836721|NCT01667900|9891126|FG019|STARTED|Part A, Washout 2||0
8836722|NCT01667900|9891107|FG000|COMPLETED|Part A, Washout 2||1
8836723|NCT01667900|9891108|FG001|COMPLETED|Part A, Washout 2||1
8836724|NCT01667900|9891109|FG002|COMPLETED|Part A, Washout 2||1
8836725|NCT01667900|9891110|FG003|COMPLETED|Part A, Washout 2||1
8836726|NCT01667900|9891111|FG004|COMPLETED|Part A, Washout 2||1
8836727|NCT01667900|9891112|FG005|COMPLETED|Part A, Washout 2||1
8836728|NCT01667900|9891113|FG006|COMPLETED|Part A, Washout 2||1
8944495|NCT02397096|10006370|FG000|COMPLETED|Study Extensions|The extension study is ongoing.|0
8944496|NCT02397096|10006371|FG001|COMPLETED|Study Extensions|The extension study is ongoing.|0
8944497|NCT02397096|10006370|FG000|NOT COMPLETED|Study Extensions||399
8944498|NCT02397096|10006371|FG001|NOT COMPLETED|Study Extensions||202
8944499|NCT02397122|10006383|FG000|STARTED|Overall Study||20
8944500|NCT02397122|10006384|FG001|STARTED|Overall Study||20
8944501|NCT02397122|10006383|FG000|COMPLETED|Overall Study||20
8944502|NCT02397122|10006384|FG001|COMPLETED|Overall Study||20
8944503|NCT02397122|10006383|FG000|NOT COMPLETED|Overall Study||0
8944504|NCT02397122|10006384|FG001|NOT COMPLETED|Overall Study||0
8836729|NCT01667900|9891114|FG007|COMPLETED|Part A, Washout 2||1
8836730|NCT01667900|9891115|FG008|COMPLETED|Part A, Washout 2||1
8836731|NCT01667900|9891116|FG009|COMPLETED|Part A, Washout 2||1
8836732|NCT01667900|9891117|FG010|COMPLETED|Part A, Washout 2||1
8836733|NCT01667900|9891118|FG011|COMPLETED|Part A, Washout 2||1
8836734|NCT01667900|9891119|FG012|COMPLETED|Part A, Washout 2||1
8836735|NCT01667900|9891120|FG013|COMPLETED|Part A, Washout 2||1
8836736|NCT01667900|9891121|FG014|COMPLETED|Part A, Washout 2||1
8836737|NCT01667900|9891122|FG015|COMPLETED|Part A, Washout 2||1
8836738|NCT01667900|9891123|FG016|COMPLETED|Part A, Washout 2||0
8836739|NCT01667900|9891124|FG017|COMPLETED|Part A, Washout 2||0
8836740|NCT01667900|9891125|FG018|COMPLETED|Part A, Washout 2||0
8836741|NCT01667900|9891126|FG019|COMPLETED|Part A, Washout 2||0
8836742|NCT01667900|9891107|FG000|NOT COMPLETED|Part A, Washout 2||0
8836743|NCT01667900|9891108|FG001|NOT COMPLETED|Part A, Washout 2||0
8836744|NCT01667900|9891109|FG002|NOT COMPLETED|Part A, Washout 2||0
8836745|NCT01667900|9891110|FG003|NOT COMPLETED|Part A, Washout 2||0
8836746|NCT01667900|9891111|FG004|NOT COMPLETED|Part A, Washout 2||0
8836747|NCT01667900|9891112|FG005|NOT COMPLETED|Part A, Washout 2||0
8836748|NCT01667900|9891113|FG006|NOT COMPLETED|Part A, Washout 2||0
8836749|NCT01667900|9891114|FG007|NOT COMPLETED|Part A, Washout 2||0
8836750|NCT01667900|9891115|FG008|NOT COMPLETED|Part A, Washout 2||0
8836751|NCT01667900|9891116|FG009|NOT COMPLETED|Part A, Washout 2||0
8836752|NCT01667900|9891117|FG010|NOT COMPLETED|Part A, Washout 2||0
8836753|NCT01667900|9891118|FG011|NOT COMPLETED|Part A, Washout 2||0
8836754|NCT01667900|9891119|FG012|NOT COMPLETED|Part A, Washout 2||0
8836755|NCT01667900|9891120|FG013|NOT COMPLETED|Part A, Washout 2||0
8836756|NCT01667900|9891121|FG014|NOT COMPLETED|Part A, Washout 2||0
8836757|NCT01667900|9891122|FG015|NOT COMPLETED|Part A, Washout 2||0
8622945|NCT00490568|9662155|FG000|STARTED|Overall Study||1461
8622946|NCT00490568|9662155|FG000|COMPLETED|Overall Study||97
8622947|NCT00490568|9662155|FG000|NOT COMPLETED|Overall Study||1364
8836758|NCT01667900|9891123|FG016|NOT COMPLETED|Part A, Washout 2||0
8836759|NCT01667900|9891124|FG017|NOT COMPLETED|Part A, Washout 2||0
8836760|NCT01667900|9891125|FG018|NOT COMPLETED|Part A, Washout 2||0
8836761|NCT01667900|9891126|FG019|NOT COMPLETED|Part A, Washout 2||0
8836762|NCT01667900|9891107|FG000|STARTED|Part A, Period 3||1
8836763|NCT01667900|9891108|FG001|STARTED|Part A, Period 3||1
8836764|NCT01667900|9891109|FG002|STARTED|Part A, Period 3||1
8836765|NCT01667900|9891110|FG003|STARTED|Part A, Period 3||1
8836766|NCT01667900|9891111|FG004|STARTED|Part A, Period 3||1
8836767|NCT01667900|9891112|FG005|STARTED|Part A, Period 3||1
8836768|NCT01667900|9891113|FG006|STARTED|Part A, Period 3||1
8836769|NCT01667900|9891114|FG007|STARTED|Part A, Period 3||1
8836770|NCT01667900|9891115|FG008|STARTED|Part A, Period 3||1
8836771|NCT01667900|9891116|FG009|STARTED|Part A, Period 3||1
8836772|NCT01667900|9891117|FG010|STARTED|Part A, Period 3||1
8836773|NCT01667900|9891118|FG011|STARTED|Part A, Period 3||1
8836774|NCT01667900|9891119|FG012|STARTED|Part A, Period 3||1
8836775|NCT01667900|9891120|FG013|STARTED|Part A, Period 3||1
8836776|NCT01667900|9891121|FG014|STARTED|Part A, Period 3||1
8836777|NCT01667900|9891122|FG015|STARTED|Part A, Period 3||1
8836778|NCT01667900|9891123|FG016|STARTED|Part A, Period 3||0
8836779|NCT01667900|9891124|FG017|STARTED|Part A, Period 3||0
8836780|NCT01667900|9891125|FG018|STARTED|Part A, Period 3||0
8836781|NCT01667900|9891126|FG019|STARTED|Part A, Period 3||0
8836782|NCT01667900|9891107|FG000|COMPLETED|Part A, Period 3||1
8836783|NCT01667900|9891108|FG001|COMPLETED|Part A, Period 3||1
8836784|NCT01667900|9891109|FG002|COMPLETED|Part A, Period 3||1
8836785|NCT01667900|9891110|FG003|COMPLETED|Part A, Period 3||1
8836786|NCT01667900|9891111|FG004|COMPLETED|Part A, Period 3||1
8836787|NCT01667900|9891112|FG005|COMPLETED|Part A, Period 3||1
8836788|NCT01667900|9891113|FG006|COMPLETED|Part A, Period 3||1
8836789|NCT01667900|9891114|FG007|COMPLETED|Part A, Period 3||1
8836790|NCT01667900|9891115|FG008|COMPLETED|Part A, Period 3||1
8836791|NCT01667900|9891116|FG009|COMPLETED|Part A, Period 3||1
8836792|NCT01667900|9891117|FG010|COMPLETED|Part A, Period 3||1
8836793|NCT01667900|9891118|FG011|COMPLETED|Part A, Period 3||1
8836794|NCT01667900|9891119|FG012|COMPLETED|Part A, Period 3||1
8836795|NCT01667900|9891120|FG013|COMPLETED|Part A, Period 3||1
8836796|NCT01667900|9891121|FG014|COMPLETED|Part A, Period 3||1
8836797|NCT01667900|9891122|FG015|COMPLETED|Part A, Period 3||1
8836798|NCT01667900|9891123|FG016|COMPLETED|Part A, Period 3||0
8836799|NCT01667900|9891124|FG017|COMPLETED|Part A, Period 3||0
8836800|NCT01667900|9891125|FG018|COMPLETED|Part A, Period 3||0
8836801|NCT01667900|9891126|FG019|COMPLETED|Part A, Period 3||0
8836802|NCT01667900|9891107|FG000|NOT COMPLETED|Part A, Period 3||0
8836803|NCT01667900|9891108|FG001|NOT COMPLETED|Part A, Period 3||0
8836804|NCT01667900|9891109|FG002|NOT COMPLETED|Part A, Period 3||0
8836805|NCT01667900|9891110|FG003|NOT COMPLETED|Part A, Period 3||0
8836806|NCT01667900|9891111|FG004|NOT COMPLETED|Part A, Period 3||0
8836807|NCT01667900|9891112|FG005|NOT COMPLETED|Part A, Period 3||0
8836808|NCT01667900|9891113|FG006|NOT COMPLETED|Part A, Period 3||0
8836809|NCT01667900|9891114|FG007|NOT COMPLETED|Part A, Period 3||0
8836810|NCT01667900|9891115|FG008|NOT COMPLETED|Part A, Period 3||0
8836811|NCT01667900|9891116|FG009|NOT COMPLETED|Part A, Period 3||0
8836812|NCT01667900|9891117|FG010|NOT COMPLETED|Part A, Period 3||0
8836813|NCT01667900|9891118|FG011|NOT COMPLETED|Part A, Period 3||0
8836814|NCT01667900|9891119|FG012|NOT COMPLETED|Part A, Period 3||0
8836815|NCT01667900|9891120|FG013|NOT COMPLETED|Part A, Period 3||0
8836816|NCT01667900|9891121|FG014|NOT COMPLETED|Part A, Period 3||0
8836817|NCT01667900|9891122|FG015|NOT COMPLETED|Part A, Period 3||0
8836818|NCT01667900|9891123|FG016|NOT COMPLETED|Part A, Period 3||0
8836819|NCT01667900|9891124|FG017|NOT COMPLETED|Part A, Period 3||0
8836820|NCT01667900|9891125|FG018|NOT COMPLETED|Part A, Period 3||0
8836821|NCT01667900|9891126|FG019|NOT COMPLETED|Part A, Period 3||0
8836822|NCT01667900|9891107|FG000|STARTED|Part B|Part A participants did not participate in Part B.|0
8836823|NCT01667900|9891108|FG001|STARTED|Part B|Part A participants did not participate in Part B.|0
8836824|NCT01667900|9891109|FG002|STARTED|Part B|Part A participants did not participate in Part B.|0
8836825|NCT01667900|9891110|FG003|STARTED|Part B|Part A participants did not participate in Part B.|0
8836826|NCT01667900|9891111|FG004|STARTED|Part B|Part A participants did not participate in Part B.|0
8836827|NCT01667900|9891112|FG005|STARTED|Part B|Part A participants did not participate in Part B.|0
8836828|NCT01667900|9891113|FG006|STARTED|Part B|Part A participants did not participate in Part B.|0
8836829|NCT01667900|9891114|FG007|STARTED|Part B|Part A participants did not participate in Part B.|0
8836830|NCT01667900|9891115|FG008|STARTED|Part B|Part A participants did not participate in Part B.|0
8836831|NCT01667900|9891116|FG009|STARTED|Part B|Part A participants did not participate in Part B.|0
8836832|NCT01667900|9891117|FG010|STARTED|Part B|Part A participants did not participate in Part B.|0
8836833|NCT01667900|9891118|FG011|STARTED|Part B|Part A participants did not participate in Part B.|0
8836834|NCT01667900|9891119|FG012|STARTED|Part B|Part A participants did not participate in Part B.|0
8836835|NCT01667900|9891120|FG013|STARTED|Part B|Part A participants did not participate in Part B.|0
8836836|NCT01667900|9891121|FG014|STARTED|Part B|Part A participants did not participate in Part B.|0
8836837|NCT01667900|9891122|FG015|STARTED|Part B|Part A participants did not participate in Part B.|0
8836838|NCT01667900|9891123|FG016|STARTED|Part B||11
8836839|NCT01667900|9891124|FG017|STARTED|Part B||11
8836840|NCT01667900|9891125|FG018|STARTED|Part B||10
8836841|NCT01667900|9891126|FG019|STARTED|Part B||10
8836842|NCT01667900|9891107|FG000|COMPLETED|Part B||0
8836843|NCT01667900|9891108|FG001|COMPLETED|Part B||0
8836844|NCT01667900|9891109|FG002|COMPLETED|Part B||0
8836845|NCT01667900|9891110|FG003|COMPLETED|Part B||0
8836846|NCT01667900|9891111|FG004|COMPLETED|Part B||0
8836847|NCT01667900|9891112|FG005|COMPLETED|Part B||0
8836848|NCT01667900|9891113|FG006|COMPLETED|Part B||0
8836849|NCT01667900|9891114|FG007|COMPLETED|Part B||0
8836850|NCT01667900|9891115|FG008|COMPLETED|Part B||0
8836851|NCT01667900|9891116|FG009|COMPLETED|Part B||0
8836852|NCT01667900|9891117|FG010|COMPLETED|Part B||0
8836853|NCT01667900|9891118|FG011|COMPLETED|Part B||0
8836854|NCT01667900|9891119|FG012|COMPLETED|Part B||0
8836855|NCT01667900|9891120|FG013|COMPLETED|Part B||0
8836856|NCT01667900|9891121|FG014|COMPLETED|Part B||0
8836857|NCT01667900|9891122|FG015|COMPLETED|Part B||0
8836858|NCT01667900|9891123|FG016|COMPLETED|Part B||10
8836859|NCT01667900|9891124|FG017|COMPLETED|Part B||11
8836860|NCT01667900|9891125|FG018|COMPLETED|Part B||10
8836861|NCT01667900|9891126|FG019|COMPLETED|Part B||10
8836862|NCT01667900|9891107|FG000|NOT COMPLETED|Part B||0
8836863|NCT01667900|9891108|FG001|NOT COMPLETED|Part B||0
8836864|NCT01667900|9891109|FG002|NOT COMPLETED|Part B||0
8836865|NCT01667900|9891110|FG003|NOT COMPLETED|Part B||0
8836866|NCT01667900|9891111|FG004|NOT COMPLETED|Part B||0
8836867|NCT01667900|9891112|FG005|NOT COMPLETED|Part B||0
8836868|NCT01667900|9891113|FG006|NOT COMPLETED|Part B||0
8836869|NCT01667900|9891114|FG007|NOT COMPLETED|Part B||0
8836870|NCT01667900|9891115|FG008|NOT COMPLETED|Part B||0
8836871|NCT01667900|9891116|FG009|NOT COMPLETED|Part B||0
8836872|NCT01667900|9891117|FG010|NOT COMPLETED|Part B||0
8836873|NCT01667900|9891118|FG011|NOT COMPLETED|Part B||0
8836874|NCT01667900|9891119|FG012|NOT COMPLETED|Part B||0
8836875|NCT01667900|9891120|FG013|NOT COMPLETED|Part B||0
8836876|NCT01667900|9891121|FG014|NOT COMPLETED|Part B||0
8836877|NCT01667900|9891122|FG015|NOT COMPLETED|Part B||0
8836878|NCT01667900|9891123|FG016|NOT COMPLETED|Part B||1
8836879|NCT01667900|9891124|FG017|NOT COMPLETED|Part B||0
8836880|NCT01667900|9891125|FG018|NOT COMPLETED|Part B||0
8836881|NCT01667900|9891126|FG019|NOT COMPLETED|Part B||0
8836882|NCT01667926|9891148|FG000|STARTED|Overall Study||13
8622948|NCT00490646|9662162|FG000|STARTED|Overall Study||25
8622949|NCT00490646|9662163|FG001|STARTED|Overall Study||25
8836883|NCT01667926|9891149|FG001|STARTED|Overall Study||13
8836884|NCT01667926|9891150|FG002|STARTED|Overall Study||11
8836885|NCT01667926|9891148|FG000|COMPLETED|Overall Study||8
8836886|NCT01667926|9891149|FG001|COMPLETED|Overall Study||9
8836887|NCT01667926|9891150|FG002|COMPLETED|Overall Study|Participants in the screen fail group were not randomized in the study.|0
8836888|NCT01667926|9891148|FG000|NOT COMPLETED|Overall Study||5
8836889|NCT01667926|9891149|FG001|NOT COMPLETED|Overall Study||4
8836890|NCT01667926|9891150|FG002|NOT COMPLETED|Overall Study||11
8836891|NCT01667978|9891158|FG000|STARTED|Overall Study||18
8836892|NCT01667978|9891159|FG001|STARTED|Overall Study||17
8836893|NCT01667978|9891158|FG000|COMPLETED|Overall Study||16
8836894|NCT01667978|9891159|FG001|COMPLETED|Overall Study||17
8836895|NCT01667978|9891158|FG000|NOT COMPLETED|Overall Study||2
8836896|NCT01667978|9891159|FG001|NOT COMPLETED|Overall Study||0
8836897|NCT01668004|9891165|FG000|STARTED|Overall Study||101
8836898|NCT01668004|9891165|FG000|Treated|Overall Study||101
8836899|NCT01668004|9891165|FG000|COMPLETED|Overall Study||76
8836900|NCT01668004|9891165|FG000|NOT COMPLETED|Overall Study||25
8836901|NCT01668017|9891176|FG000|STARTED|Overall Study||4
8836902|NCT01668017|9891177|FG001|STARTED|Overall Study||9
8836903|NCT01668017|9891178|FG002|STARTED|Overall Study||6
8836904|NCT01668017|9891179|FG003|STARTED|Overall Study||5
8836905|NCT01668017|9891180|FG004|STARTED|Overall Study||2
8836906|NCT01668017|9891176|FG000|COMPLETED|Overall Study||4
8836907|NCT01668017|9891177|FG001|COMPLETED|Overall Study||9
8836908|NCT01668017|9891178|FG002|COMPLETED|Overall Study||6
8836909|NCT01668017|9891179|FG003|COMPLETED|Overall Study||5
8836910|NCT01668017|9891180|FG004|COMPLETED|Overall Study||2
8836911|NCT01668017|9891176|FG000|NOT COMPLETED|Overall Study||0
8836912|NCT01668017|9891177|FG001|NOT COMPLETED|Overall Study||0
8836913|NCT01668017|9891178|FG002|NOT COMPLETED|Overall Study||0
8836914|NCT01668017|9891179|FG003|NOT COMPLETED|Overall Study||0
8836915|NCT01668017|9891180|FG004|NOT COMPLETED|Overall Study||0
8836916|NCT01668030|9891207|FG000|STARTED|Overall Study||10
8836917|NCT01668030|9891208|FG001|STARTED|Overall Study||10
8836918|NCT01668030|9891207|FG000|COMPLETED|Overall Study||10
8836919|NCT01668030|9891208|FG001|COMPLETED|Overall Study||10
8836920|NCT01668030|9891207|FG000|NOT COMPLETED|Overall Study||0
8836921|NCT01668030|9891208|FG001|NOT COMPLETED|Overall Study||0
8836922|NCT01668173|9891213|FG000|STARTED|Overall Study||7
8836923|NCT01668173|9891213|FG000|COMPLETED|Overall Study||0
8836924|NCT01668173|9891213|FG000|NOT COMPLETED|Overall Study||7
8836925|NCT01668355|9891219|FG000|STARTED|Overall Study||164
8836926|NCT01668355|9891220|FG001|STARTED|Overall Study||167
8836927|NCT01668355|9891219|FG000|COMPLETED|Overall Study||155
8836928|NCT01668355|9891220|FG001|COMPLETED|Overall Study||165
8836929|NCT01668355|9891219|FG000|NOT COMPLETED|Overall Study||9
8836930|NCT01668355|9891220|FG001|NOT COMPLETED|Overall Study||2
8836931|NCT01668537|9891229|FG000|STARTED|Overall Study||327
8836932|NCT01668537|9891230|FG001|STARTED|Overall Study||324
8836933|NCT01668537|9891229|FG000|COMPLETED|Overall Study||305
8836934|NCT01668537|9891230|FG001|COMPLETED|Overall Study||314
8836935|NCT01668537|9891229|FG000|NOT COMPLETED|Overall Study||22
8622950|NCT00490646|9662162|FG000|Treated|Overall Study||24
8836936|NCT01668537|9891230|FG001|NOT COMPLETED|Overall Study||10
8836937|NCT01668589|9891240|FG000|STARTED|Overall Study||600
8836938|NCT01668589|9891241|FG001|STARTED|Overall Study||300
8836939|NCT01668589|9891242|FG002|STARTED|Overall Study||300
8836940|NCT01668589|9891243|FG003|STARTED|Overall Study||301
8836941|NCT01668589|9891240|FG000|Received Denosumab|Overall Study||599
8836942|NCT01668589|9891241|FG001|Received Denosumab|Overall Study||300
8836943|NCT01668589|9891242|FG002|Received Denosumab|Overall Study||300
8836944|NCT01668589|9891243|FG003|Received Denosumab|Overall Study||301
8836945|NCT01668589|9891240|FG000|COMPLETED|Overall Study||461
8836946|NCT01668589|9891241|FG001|COMPLETED|Overall Study||242
8836947|NCT01668589|9891242|FG002|COMPLETED|Overall Study||265
8836948|NCT01668589|9891243|FG003|COMPLETED|Overall Study||266
8836949|NCT01668589|9891240|FG000|NOT COMPLETED|Overall Study||139
8836950|NCT01668589|9891241|FG001|NOT COMPLETED|Overall Study||58
8836951|NCT01668589|9891242|FG002|NOT COMPLETED|Overall Study||35
8836952|NCT01668589|9891243|FG003|NOT COMPLETED|Overall Study||35
8836953|NCT01668602|9891255|FG000|STARTED|Overall Study||2
8836954|NCT01668602|9891256|FG001|STARTED|Overall Study||22
8836955|NCT01668602|9891255|FG000|Cohort 2 - Began FastFES Sessions|Overall Study|This milestone does not apply to Cohort 1.|0
8836956|NCT01668602|9891256|FG001|Cohort 2 - Began FastFES Sessions|Overall Study||20
8836957|NCT01668602|9891255|FG000|Cohort 2 - Completed 3 Sessions of FastFES|Overall Study|This milestone does not apply to Cohort 1.|0
8836958|NCT01668602|9891256|FG001|Cohort 2 - Completed 3 Sessions of FastFES|Overall Study||19
8836959|NCT01668602|9891255|FG000|Cohort 2 - Began Fast Walking Sessions|Overall Study|This milestone does not apply to Cohort 1.|0
8836960|NCT01668602|9891256|FG001|Cohort 2 - Began Fast Walking Sessions|Overall Study||20
8836961|NCT01668602|9891255|FG000|Cohort 2 - Completed 3 Sessions of Fast Walking|Overall Study|This milestone does not apply to Cohort 1.|0
8836962|NCT01668602|9891256|FG001|Cohort 2 - Completed 3 Sessions of Fast Walking|Overall Study||18
8836963|NCT01668602|9891255|FG000|COMPLETED|Overall Study||2
8836964|NCT01668602|9891256|FG001|COMPLETED|Overall Study||18
8836965|NCT01668602|9891255|FG000|NOT COMPLETED|Overall Study||0
8836966|NCT01668602|9891256|FG001|NOT COMPLETED|Overall Study||4
8836967|NCT01668628|9891267|FG000|STARTED|Overall Study|5 subjects had been excluded due to protocol violation and then data of the rest were anlayzed.|349
8836968|NCT01668628|9891268|FG001|STARTED|Overall Study||359
8836969|NCT01668628|9891269|FG002|STARTED|Overall Study|2 subjects had been excluded due to protocol violation and then data of the rest were anlayzed.|367
8836970|NCT01668628|9891267|FG000|COMPLETED|Overall Study||347
8836971|NCT01668628|9891268|FG001|COMPLETED|Overall Study||359
8836972|NCT01668628|9891269|FG002|COMPLETED|Overall Study||367
8836973|NCT01668628|9891267|FG000|NOT COMPLETED|Overall Study||2
8836974|NCT01668628|9891268|FG001|NOT COMPLETED|Overall Study||0
8836975|NCT01668628|9891269|FG002|NOT COMPLETED|Overall Study||0
8836976|NCT01668654|9891281|FG000|STARTED|Overall Study||4
8836977|NCT01668654|9891281|FG000|COMPLETED|Overall Study||0
8836978|NCT01668654|9891281|FG000|NOT COMPLETED|Overall Study||4
8836979|NCT01668667|9891289|FG000|STARTED|Overall Study||126
8836980|NCT01668667|9891290|FG001|STARTED|Overall Study||125
8836981|NCT01668667|9891291|FG002|STARTED|Overall Study||125
8836982|NCT01668667|9891292|FG003|STARTED|Overall Study||125
8836983|NCT01668667|9891289|FG000|COMPLETED|Overall Study||95
8836984|NCT01668667|9891290|FG001|COMPLETED|Overall Study||99
8836985|NCT01668667|9891291|FG002|COMPLETED|Overall Study||94
8836986|NCT01668667|9891292|FG003|COMPLETED|Overall Study||102
8836987|NCT01668667|9891289|FG000|NOT COMPLETED|Overall Study||31
8836988|NCT01668667|9891290|FG001|NOT COMPLETED|Overall Study||26
8944505|NCT02397265|10006394|FG000|STARTED|First Intervention of Three||2
8944506|NCT02397265|10006395|FG001|STARTED|First Intervention of Three||2
8944507|NCT02397265|10006396|FG002|STARTED|First Intervention of Three||2
8944508|NCT02397265|10006394|FG000|COMPLETED|First Intervention of Three||2
8944509|NCT02397265|10006395|FG001|COMPLETED|First Intervention of Three||2
8944510|NCT02397265|10006396|FG002|COMPLETED|First Intervention of Three||2
8944511|NCT02397265|10006394|FG000|NOT COMPLETED|First Intervention of Three||0
8944512|NCT02397265|10006395|FG001|NOT COMPLETED|First Intervention of Three||0
8944513|NCT02397265|10006396|FG002|NOT COMPLETED|First Intervention of Three||0
8944514|NCT02397265|10006394|FG000|STARTED|Second Intervention of Three||2
8944515|NCT02397265|10006395|FG001|STARTED|Second Intervention of Three||2
8944516|NCT02397265|10006396|FG002|STARTED|Second Intervention of Three||2
8944517|NCT02397265|10006394|FG000|COMPLETED|Second Intervention of Three||2
8944518|NCT02397265|10006395|FG001|COMPLETED|Second Intervention of Three||2
8944519|NCT02397265|10006396|FG002|COMPLETED|Second Intervention of Three||2
8944520|NCT02397265|10006394|FG000|NOT COMPLETED|Second Intervention of Three||0
8944521|NCT02397265|10006395|FG001|NOT COMPLETED|Second Intervention of Three||0
8944522|NCT02397265|10006396|FG002|NOT COMPLETED|Second Intervention of Three||0
8944523|NCT02397265|10006394|FG000|STARTED|Third Intervention of Three||2
8944524|NCT02397265|10006395|FG001|STARTED|Third Intervention of Three||2
8944525|NCT02397265|10006396|FG002|STARTED|Third Intervention of Three||2
8944526|NCT02397265|10006394|FG000|COMPLETED|Third Intervention of Three||2
8944527|NCT02397265|10006395|FG001|COMPLETED|Third Intervention of Three||2
8944528|NCT02397265|10006396|FG002|COMPLETED|Third Intervention of Three||2
8944529|NCT02397265|10006394|FG000|NOT COMPLETED|Third Intervention of Three||0
8944530|NCT02397265|10006395|FG001|NOT COMPLETED|Third Intervention of Three||0
8944531|NCT02397265|10006396|FG002|NOT COMPLETED|Third Intervention of Three||0
8944532|NCT02397278|10006406|FG000|STARTED|Overall Study||7
8944533|NCT02397278|10006407|FG001|STARTED|Overall Study||8
8944534|NCT02397278|10006406|FG000|COMPLETED|Overall Study||6
8944535|NCT02397278|10006407|FG001|COMPLETED|Overall Study||5
8944536|NCT02397278|10006406|FG000|NOT COMPLETED|Overall Study||1
8944537|NCT02397278|10006407|FG001|NOT COMPLETED|Overall Study||3
8944538|NCT02397291|10006415|FG000|STARTED|Overall Study||19
8944539|NCT02397291|10006416|FG001|STARTED|Overall Study||5
8944540|NCT02397291|10006415|FG000|COMPLETED|Overall Study||19
8944541|NCT02397291|10006416|FG001|COMPLETED|Overall Study||5
8944542|NCT02397291|10006415|FG000|NOT COMPLETED|Overall Study||0
8944543|NCT02397291|10006416|FG001|NOT COMPLETED|Overall Study||0
8944544|NCT02397408|10006422|FG000|STARTED|Overall Study||18
8944545|NCT02397408|10006422|FG000|Completed Surgery Per Protocol|Overall Study||16
8836989|NCT01668667|9891291|FG002|NOT COMPLETED|Overall Study||31
8836990|NCT01668667|9891292|FG003|NOT COMPLETED|Overall Study||23
8836991|NCT01668797|9891304|FG000|STARTED|Phase A (Conversion Phase)||406
8836992|NCT01668797|9891305|FG001|STARTED|Phase A (Conversion Phase)||0
8836993|NCT01668797|9891306|FG002|STARTED|Phase A (Conversion Phase)||0
8836994|NCT01668797|9891307|FG003|STARTED|Phase A (Conversion Phase)||0
8836995|NCT01668797|9891304|FG000|COMPLETED|Phase A (Conversion Phase)||346
8836996|NCT01668797|9891305|FG001|COMPLETED|Phase A (Conversion Phase)||0
8836997|NCT01668797|9891306|FG002|COMPLETED|Phase A (Conversion Phase)||0
8836998|NCT01668797|9891307|FG003|COMPLETED|Phase A (Conversion Phase)||0
8836999|NCT01668797|9891304|FG000|NOT COMPLETED|Phase A (Conversion Phase)||60
8837000|NCT01668797|9891305|FG001|NOT COMPLETED|Phase A (Conversion Phase)||0
8837001|NCT01668797|9891306|FG002|NOT COMPLETED|Phase A (Conversion Phase)||0
8837002|NCT01668797|9891307|FG003|NOT COMPLETED|Phase A (Conversion Phase)||0
8837003|NCT01668797|9891304|FG000|STARTED|Phase B (Stabilization Phase)||0
8837004|NCT01668797|9891305|FG001|STARTED|Phase B (Stabilization Phase)|N= 464; 346 rolled over from Phase A and 118 entered directly into Phase B|464
8837005|NCT01668797|9891306|FG002|STARTED|Phase B (Stabilization Phase)||0
8837006|NCT01668797|9891307|FG003|STARTED|Phase B (Stabilization Phase)||0
8837007|NCT01668797|9891304|FG000|COMPLETED|Phase B (Stabilization Phase)||0
8837008|NCT01668797|9891305|FG001|COMPLETED|Phase B (Stabilization Phase)||202
8837009|NCT01668797|9891306|FG002|COMPLETED|Phase B (Stabilization Phase)||0
8837010|NCT01668797|9891307|FG003|COMPLETED|Phase B (Stabilization Phase)||0
8837011|NCT01668797|9891304|FG000|NOT COMPLETED|Phase B (Stabilization Phase)||0
8837012|NCT01668797|9891305|FG001|NOT COMPLETED|Phase B (Stabilization Phase)||262
8837013|NCT01668797|9891306|FG002|NOT COMPLETED|Phase B (Stabilization Phase)||0
8837014|NCT01668797|9891307|FG003|NOT COMPLETED|Phase B (Stabilization Phase)||0
8837015|NCT01668797|9891304|FG000|STARTED|Phase C (Double-Blind Maintenance Phase)||0
8837016|NCT01668797|9891305|FG001|STARTED|Phase C (Double-Blind Maintenance Phase)||0
8837017|NCT01668797|9891306|FG002|STARTED|Phase C (Double-Blind Maintenance Phase)|N= 202 rolled over from Phase B|97
8837018|NCT01668797|9891307|FG003|STARTED|Phase C (Double-Blind Maintenance Phase)||105
8837019|NCT01668797|9891304|FG000|COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
8837020|NCT01668797|9891305|FG001|COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
8837021|NCT01668797|9891306|FG002|COMPLETED|Phase C (Double-Blind Maintenance Phase)||14
8837022|NCT01668797|9891307|FG003|COMPLETED|Phase C (Double-Blind Maintenance Phase)||9
8837023|NCT01668797|9891304|FG000|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
8837024|NCT01668797|9891305|FG001|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
8837025|NCT01668797|9891306|FG002|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||83
8837026|NCT01668797|9891307|FG003|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||96
8837027|NCT01668836|9891318|FG000|STARTED|Overall Study||12
8837028|NCT01668836|9891319|FG001|STARTED|Overall Study||12
8837029|NCT01668836|9891320|FG002|STARTED|Overall Study||12
8837030|NCT01668836|9891321|FG003|STARTED|Overall Study||12
8837031|NCT01668836|9891318|FG000|COMPLETED|Overall Study||12
8837032|NCT01668836|9891319|FG001|COMPLETED|Overall Study||12
8837033|NCT01668836|9891320|FG002|COMPLETED|Overall Study||12
8837034|NCT01668836|9891321|FG003|COMPLETED|Overall Study||12
8837035|NCT01668836|9891318|FG000|NOT COMPLETED|Overall Study||0
8837036|NCT01668836|9891319|FG001|NOT COMPLETED|Overall Study||0
8837037|NCT01668836|9891320|FG002|NOT COMPLETED|Overall Study||0
8837038|NCT01668836|9891321|FG003|NOT COMPLETED|Overall Study||0
8622951|NCT00490646|9662163|FG001|Treated|Overall Study||24
8622952|NCT00490646|9662162|FG000|COMPLETED|Overall Study|Completed=Off-treatment (Major reasons: Disease progression=14; study drug toxicity=4)|23
8622953|NCT00490646|9662163|FG001|COMPLETED|Overall Study|Completed=Off-treatment (Major reasons: Disease progression=13; study drug toxicity=1)|23
8622954|NCT00490646|9662162|FG000|NOT COMPLETED|Overall Study||2
8837039|NCT01668966|9891337|FG000|STARTED|Overall Study||23
8837040|NCT01668966|9891337|FG000|Treated|Overall Study||21
8837041|NCT01668966|9891337|FG000|COMPLETED|Overall Study||19
8837042|NCT01668966|9891337|FG000|NOT COMPLETED|Overall Study||4
8837043|NCT01669096|9891341|FG000|STARTED|Overall Study||20
8837044|NCT01669096|9891341|FG000|COMPLETED|Overall Study||20
8837045|NCT01669096|9891341|FG000|NOT COMPLETED|Overall Study||0
8837046|NCT01669122|9891345|FG000|STARTED|Period I|Participants who received Lozenge A=10, Lozenge B=10, Lozenge C=10, Reference Lozenge=10|40
8837047|NCT01669122|9891345|FG000|Safety Population|Period I||39
8837048|NCT01669122|9891345|FG000|COMPLETED|Period I||39
8837049|NCT01669122|9891345|FG000|NOT COMPLETED|Period I||1
8837050|NCT01669122|9891345|FG000|STARTED|Washout Period I||39
8837051|NCT01669122|9891345|FG000|COMPLETED|Washout Period I||39
8837052|NCT01669122|9891345|FG000|NOT COMPLETED|Washout Period I||0
8837053|NCT01669122|9891345|FG000|STARTED|Period II|Participants who received Lozenge A=9, Lozenge B=10, Lozenge C=10, Reference Lozenge=10|39
8837054|NCT01669122|9891345|FG000|COMPLETED|Period II||39
8837055|NCT01669122|9891345|FG000|NOT COMPLETED|Period II||0
8837056|NCT01669122|9891345|FG000|STARTED|Washout Period II||39
8837057|NCT01669122|9891345|FG000|COMPLETED|Washout Period II||37
8837058|NCT01669122|9891345|FG000|NOT COMPLETED|Washout Period II||2
8837059|NCT01669122|9891345|FG000|STARTED|Washout Period III||37
8837060|NCT01669122|9891345|FG000|COMPLETED|Washout Period III||37
8837061|NCT01669122|9891345|FG000|NOT COMPLETED|Washout Period III||0
8837062|NCT01669122|9891345|FG000|STARTED|Period III|Participants who received Lozenge A=10, Lozenge B=8, Lozenge C=10, Reference Lozenge=9|37
8837063|NCT01669122|9891345|FG000|COMPLETED|Period III||37
8944546|NCT02397408|10006422|FG000|COMPLETED|Overall Study||12
8837064|NCT01669122|9891345|FG000|NOT COMPLETED|Period III||0
8837065|NCT01669122|9891345|FG000|STARTED|Period IV|Participants who received Lozenge A=9, Lozenge B=10, Lozenge C=9, Reference Lozenge=9|37
8837066|NCT01669122|9891345|FG000|COMPLETED|Period IV||37
8837067|NCT01669122|9891345|FG000|NOT COMPLETED|Period IV||0
8837068|NCT01669174|9891358|FG000|STARTED|Overall Study||33
8837069|NCT01669174|9891359|FG001|STARTED|Overall Study||34
8837070|NCT01669174|9891358|FG000|COMPLETED|Overall Study||27
8837071|NCT01669174|9891359|FG001|COMPLETED|Overall Study||28
8837072|NCT01669174|9891358|FG000|NOT COMPLETED|Overall Study||6
8837073|NCT01669174|9891359|FG001|NOT COMPLETED|Overall Study||6
8837074|NCT01669343|9891365|FG000|STARTED|Part A: All Patients||121
8837075|NCT01669343|9891365|FG000|COMPLETED|Part A: All Patients||112
8837076|NCT01669343|9891365|FG000|NOT COMPLETED|Part A: All Patients||9
8837077|NCT01669343|9891365|FG000|STARTED|Part B: Patients With BMI>=25||48
8837078|NCT01669343|9891365|FG000|COMPLETED|Part B: Patients With BMI>=25||31
8837079|NCT01669343|9891365|FG000|NOT COMPLETED|Part B: Patients With BMI>=25||17
8837080|NCT01669421|9891372|FG000|STARTED|Phase 1: Standard Dose Therapy||10
8837081|NCT01669421|9891372|FG000|COMPLETED|Phase 1: Standard Dose Therapy||8
8837082|NCT01669421|9891372|FG000|NOT COMPLETED|Phase 1: Standard Dose Therapy||2
8837083|NCT01669421|9891372|FG000|STARTED|Phase 2: Double Dose Therapy||8
8837084|NCT01669421|9891372|FG000|COMPLETED|Phase 2: Double Dose Therapy||8
8837085|NCT01669421|9891372|FG000|NOT COMPLETED|Phase 2: Double Dose Therapy||0
8837086|NCT01669421|9891372|FG000|STARTED|Phase 3: Standard Dose Therapy||8
8837087|NCT01669421|9891372|FG000|COMPLETED|Phase 3: Standard Dose Therapy||8
8837088|NCT01669421|9891372|FG000|NOT COMPLETED|Phase 3: Standard Dose Therapy||0
8837089|NCT01669434|9891388|FG000|STARTED|Overall Study||146
8837090|NCT01669434|9891389|FG001|STARTED|Overall Study||145
8837091|NCT01669434|9891388|FG000|COMPLETED|Overall Study||137
8837092|NCT01669434|9891389|FG001|COMPLETED|Overall Study||138
8944547|NCT02397408|10006422|FG000|NOT COMPLETED|Overall Study||6
8944548|NCT02397447|10006428|FG000|STARTED|Overall Study||12
8944549|NCT02397447|10006429|FG001|STARTED|Overall Study||12
8944550|NCT02397447|10006428|FG000|COMPLETED|Overall Study||10
8944551|NCT02397447|10006429|FG001|COMPLETED|Overall Study||10
8944552|NCT02397447|10006428|FG000|NOT COMPLETED|Overall Study||2
8944553|NCT02397447|10006429|FG001|NOT COMPLETED|Overall Study||2
8944554|NCT02397460|10006443|FG000|STARTED|Treatment Period 1||7
8944555|NCT02397460|10006444|FG001|STARTED|Treatment Period 1||7
8944556|NCT02397460|10006445|FG002|STARTED|Treatment Period 1||6
8944557|NCT02397460|10006446|FG003|STARTED|Treatment Period 1||6
8944558|NCT02397460|10006447|FG004|STARTED|Treatment Period 1||6
8944559|NCT02397460|10006448|FG005|STARTED|Treatment Period 1||6
8944560|NCT02397460|10006449|FG006|STARTED|Treatment Period 1||6
8944561|NCT02397460|10006450|FG007|STARTED|Treatment Period 1||6
8944562|NCT02397460|10006443|FG000|COMPLETED|Treatment Period 1||7
8944563|NCT02397460|10006444|FG001|COMPLETED|Treatment Period 1||7
8944564|NCT02397460|10006445|FG002|COMPLETED|Treatment Period 1||6
8944565|NCT02397460|10006446|FG003|COMPLETED|Treatment Period 1||6
8944566|NCT02397460|10006447|FG004|COMPLETED|Treatment Period 1||6
8944567|NCT02397460|10006448|FG005|COMPLETED|Treatment Period 1||6
8944568|NCT02397460|10006449|FG006|COMPLETED|Treatment Period 1||6
8944569|NCT02397460|10006450|FG007|COMPLETED|Treatment Period 1||6
8944570|NCT02397460|10006443|FG000|NOT COMPLETED|Treatment Period 1||0
8944571|NCT02397460|10006444|FG001|NOT COMPLETED|Treatment Period 1||0
8944572|NCT02397460|10006445|FG002|NOT COMPLETED|Treatment Period 1||0
8944573|NCT02397460|10006446|FG003|NOT COMPLETED|Treatment Period 1||0
8944574|NCT02397460|10006447|FG004|NOT COMPLETED|Treatment Period 1||0
8944575|NCT02397460|10006448|FG005|NOT COMPLETED|Treatment Period 1||0
8944576|NCT02397460|10006449|FG006|NOT COMPLETED|Treatment Period 1||0
8944577|NCT02397460|10006450|FG007|NOT COMPLETED|Treatment Period 1||0
8944578|NCT02397460|10006443|FG000|STARTED|Treatment Period 2||7
8944579|NCT02397460|10006444|FG001|STARTED|Treatment Period 2||7
8944580|NCT02397460|10006445|FG002|STARTED|Treatment Period 2||6
8944581|NCT02397460|10006446|FG003|STARTED|Treatment Period 2||6
8944582|NCT02397460|10006447|FG004|STARTED|Treatment Period 2||6
8944583|NCT02397460|10006448|FG005|STARTED|Treatment Period 2||6
8944584|NCT02397460|10006449|FG006|STARTED|Treatment Period 2||6
8944585|NCT02397460|10006450|FG007|STARTED|Treatment Period 2||6
8944586|NCT02397460|10006443|FG000|COMPLETED|Treatment Period 2||7
8944587|NCT02397460|10006444|FG001|COMPLETED|Treatment Period 2||7
8944588|NCT02397460|10006445|FG002|COMPLETED|Treatment Period 2||6
8944589|NCT02397460|10006446|FG003|COMPLETED|Treatment Period 2||6
8944590|NCT02397460|10006447|FG004|COMPLETED|Treatment Period 2||6
8944591|NCT02397460|10006448|FG005|COMPLETED|Treatment Period 2||6
8944592|NCT02397460|10006449|FG006|COMPLETED|Treatment Period 2||6
8944593|NCT02397460|10006450|FG007|COMPLETED|Treatment Period 2||5
8944594|NCT02397460|10006443|FG000|NOT COMPLETED|Treatment Period 2||0
8944595|NCT02397460|10006444|FG001|NOT COMPLETED|Treatment Period 2||0
8944596|NCT02397460|10006445|FG002|NOT COMPLETED|Treatment Period 2||0
8944597|NCT02397460|10006446|FG003|NOT COMPLETED|Treatment Period 2||0
8944598|NCT02397460|10006447|FG004|NOT COMPLETED|Treatment Period 2||0
8944599|NCT02397460|10006448|FG005|NOT COMPLETED|Treatment Period 2||0
8944600|NCT02397460|10006449|FG006|NOT COMPLETED|Treatment Period 2||0
8837093|NCT01669434|9891388|FG000|NOT COMPLETED|Overall Study||9
8837094|NCT01669434|9891389|FG001|NOT COMPLETED|Overall Study||7
8837095|NCT01669538|9891397|FG000|STARTED|Overall Study||40
8837096|NCT01669538|9891398|FG001|STARTED|Overall Study||42
8837097|NCT01669538|9891397|FG000|COMPLETED|Overall Study||28
8837098|NCT01669538|9891398|FG001|COMPLETED|Overall Study||33
8837099|NCT01669538|9891397|FG000|NOT COMPLETED|Overall Study||12
8837100|NCT01669538|9891398|FG001|NOT COMPLETED|Overall Study||9
8837101|NCT01669577|9891404|FG000|STARTED|Overall Study|calculated ISS<16, no informed consent, not enough data(complete case analysis), were excluded|334
8837102|NCT01669577|9891404|FG000|COMPLETED|Overall Study|complete case analysis (data missing completely at random)|200
8837103|NCT01669577|9891404|FG000|NOT COMPLETED|Overall Study||134
8837104|NCT01669603|9891410|FG000|STARTED|Overall Study||95
8837105|NCT01669603|9891411|FG001|STARTED|Overall Study||95
8837106|NCT01669603|9891410|FG000|COMPLETED|Overall Study||58
8837107|NCT01669603|9891411|FG001|COMPLETED|Overall Study||57
8837108|NCT01669603|9891410|FG000|NOT COMPLETED|Overall Study||37
8837109|NCT01669603|9891411|FG001|NOT COMPLETED|Overall Study||38
8837110|NCT01669629|9891417|FG000|STARTED|Period 1||92
8837111|NCT01669629|9891418|FG001|STARTED|Period 1||91
8837112|NCT01669629|9891417|FG000|COMPLETED|Period 1||91
8837113|NCT01669629|9891418|FG001|COMPLETED|Period 1||89
8837114|NCT01669629|9891417|FG000|NOT COMPLETED|Period 1||1
8837115|NCT01669629|9891418|FG001|NOT COMPLETED|Period 1||2
8837116|NCT01669629|9891417|FG000|STARTED|Period 2||91
8837117|NCT01669629|9891418|FG001|STARTED|Period 2||89
8837118|NCT01669629|9891417|FG000|COMPLETED|Period 2||91
8837119|NCT01669629|9891418|FG001|COMPLETED|Period 2||89
8837120|NCT01669629|9891417|FG000|NOT COMPLETED|Period 2||0
8837121|NCT01669629|9891418|FG001|NOT COMPLETED|Period 2||0
8837122|NCT01669642|9891429|FG000|STARTED|Overall Study||20
8837123|NCT01669642|9891430|FG001|STARTED|Overall Study||20
8837124|NCT01669642|9891431|FG002|STARTED|Overall Study||20
8837125|NCT01669642|9891432|FG003|STARTED|Overall Study||21
8837126|NCT01669642|9891433|FG004|STARTED|Overall Study||20
8837127|NCT01669642|9891434|FG005|STARTED|Overall Study||10
8837128|NCT01669642|9891429|FG000|COMPLETED|Overall Study||20
8837129|NCT01669642|9891430|FG001|COMPLETED|Overall Study||20
8837130|NCT01669642|9891431|FG002|COMPLETED|Overall Study||20
8837131|NCT01669642|9891432|FG003|COMPLETED|Overall Study||20
8837132|NCT01669642|9891433|FG004|COMPLETED|Overall Study||20
8837133|NCT01669642|9891434|FG005|COMPLETED|Overall Study||0
8837134|NCT01669642|9891429|FG000|NOT COMPLETED|Overall Study||0
8837135|NCT01669642|9891430|FG001|NOT COMPLETED|Overall Study||0
8837136|NCT01669642|9891431|FG002|NOT COMPLETED|Overall Study||0
8837137|NCT01669642|9891432|FG003|NOT COMPLETED|Overall Study||1
8837138|NCT01669642|9891433|FG004|NOT COMPLETED|Overall Study||0
8837139|NCT01669642|9891434|FG005|NOT COMPLETED|Overall Study||10
8837140|NCT01669720|9891453|FG000|STARTED|Overall Study||7
8837141|NCT01669720|9891454|FG001|STARTED|Overall Study||3
8837142|NCT01669720|9891453|FG000|COMPLETED|Overall Study||7
8837143|NCT01669720|9891454|FG001|COMPLETED|Overall Study||3
8837144|NCT01669720|9891453|FG000|NOT COMPLETED|Overall Study||0
8837145|NCT01669720|9891454|FG001|NOT COMPLETED|Overall Study||0
8837146|NCT01669785|9891463|FG000|STARTED|Overall Study||45
8837147|NCT01669785|9891464|FG001|STARTED|Overall Study||48
8837148|NCT01669785|9891465|FG002|STARTED|Overall Study||46
8837149|NCT01669785|9891463|FG000|COMPLETED|Overall Study||45
8837150|NCT01669785|9891464|FG001|COMPLETED|Overall Study||48
8837151|NCT01669785|9891465|FG002|COMPLETED|Overall Study||46
8837152|NCT01669785|9891463|FG000|NOT COMPLETED|Overall Study||0
8837153|NCT01669785|9891464|FG001|NOT COMPLETED|Overall Study||0
8837154|NCT01669785|9891465|FG002|NOT COMPLETED|Overall Study||0
8837155|NCT01669798|9891474|FG000|STARTED|Overall Study||32
8837156|NCT01669798|9891474|FG000|COMPLETED|Overall Study||27
8837157|NCT01669798|9891474|FG000|NOT COMPLETED|Overall Study||5
8622955|NCT00490646|9662163|FG001|NOT COMPLETED|Overall Study||2
8622956|NCT00490698|9662169|FG000|STARTED|Overall Study||11
8622957|NCT00490698|9662169|FG000|COMPLETED|Overall Study||1
8837158|NCT01669811|9891480|FG000|STARTED|Overall Study||145
8837159|NCT01669811|9891481|FG001|STARTED|Overall Study||142
8837160|NCT01669811|9891480|FG000|COMPLETED|Overall Study||142
8837161|NCT01669811|9891481|FG001|COMPLETED|Overall Study||131
8837162|NCT01669811|9891480|FG000|NOT COMPLETED|Overall Study||3
8837163|NCT01669811|9891481|FG001|NOT COMPLETED|Overall Study||11
8837164|NCT01669863|9891487|FG000|STARTED|Overall Study||6
8837165|NCT01669863|9891487|FG000|COMPLETED|Overall Study||6
8837166|NCT01669863|9891487|FG000|NOT COMPLETED|Overall Study||0
8837167|NCT01669902|9891492|FG000|STARTED|Overall Study||107
8837168|NCT01669902|9891492|FG000|COMPLETED|Overall Study||78
8837169|NCT01669902|9891492|FG000|NOT COMPLETED|Overall Study||29
8837170|NCT01669928|9891498|FG000|STARTED|First Intervention||51
8837171|NCT01669928|9891499|FG001|STARTED|First Intervention||52
8837172|NCT01669928|9891498|FG000|COMPLETED|First Intervention||48
8837173|NCT01669928|9891499|FG001|COMPLETED|First Intervention||47
8837174|NCT01669928|9891498|FG000|NOT COMPLETED|First Intervention||3
8837175|NCT01669928|9891499|FG001|NOT COMPLETED|First Intervention||5
8837176|NCT01669928|9891498|FG000|STARTED|Second Intervention||48
8837177|NCT01669928|9891499|FG001|STARTED|Second Intervention||47
8837178|NCT01669928|9891498|FG000|COMPLETED|Second Intervention||48
8837179|NCT01669928|9891499|FG001|COMPLETED|Second Intervention||47
8837180|NCT01669928|9891498|FG000|NOT COMPLETED|Second Intervention||0
8837181|NCT01669928|9891499|FG001|NOT COMPLETED|Second Intervention||0
8622958|NCT00490698|9662169|FG000|NOT COMPLETED|Overall Study||10
8622959|NCT00490724|9662176|FG000|STARTED|Period I||21
8837182|NCT01670019|9891509|FG000|STARTED|Overall Study||23
8837183|NCT01670019|9891510|FG001|STARTED|Overall Study||23
8837184|NCT01670019|9891509|FG000|COMPLETED|Overall Study||14
8837185|NCT01670019|9891510|FG001|COMPLETED|Overall Study||23
8837186|NCT01670019|9891509|FG000|NOT COMPLETED|Overall Study||9
8837187|NCT01670019|9891510|FG001|NOT COMPLETED|Overall Study||0
8837188|NCT01670045|9891516|FG000|STARTED|Overall Study||43
8837189|NCT01670045|9891516|FG000|COMPLETED|Overall Study||27
8837190|NCT01670045|9891516|FG000|NOT COMPLETED|Overall Study||16
8837191|NCT01670097|9891522|FG000|STARTED|Overall Study||20
8837192|NCT01670097|9891523|FG001|STARTED|Overall Study||21
8837193|NCT01670097|9891522|FG000|Completed Week 1 Intervention|Overall Study||18
8837194|NCT01670097|9891523|FG001|Completed Week 1 Intervention|Overall Study||17
8837195|NCT01670097|9891522|FG000|Completed Week 2 Intervention|Overall Study||13
8837196|NCT01670097|9891523|FG001|Completed Week 2 Intervention|Overall Study||15
8837197|NCT01670097|9891522|FG000|COMPLETED|Overall Study||18
8837198|NCT01670097|9891523|FG001|COMPLETED|Overall Study||17
8837199|NCT01670097|9891522|FG000|NOT COMPLETED|Overall Study||2
8837200|NCT01670097|9891523|FG001|NOT COMPLETED|Overall Study||4
8837201|NCT01670110|9891531|FG000|STARTED|Overall Study||33
8837202|NCT01670110|9891532|FG001|STARTED|Overall Study||15
8837203|NCT01670110|9891531|FG000|COMPLETED|Overall Study||29
8837204|NCT01670110|9891532|FG001|COMPLETED|Overall Study||12
8837205|NCT01670110|9891531|FG000|NOT COMPLETED|Overall Study||4
8837206|NCT01670110|9891532|FG001|NOT COMPLETED|Overall Study||3
8837207|NCT01670188|9891540|FG000|STARTED|Overall Study||38
8837208|NCT01670188|9891541|FG001|STARTED|Overall Study||40
8837209|NCT01670188|9891540|FG000|COMPLETED|Overall Study||38
8837210|NCT01670188|9891541|FG001|COMPLETED|Overall Study||39
8837211|NCT01670188|9891540|FG000|NOT COMPLETED|Overall Study||0
8837212|NCT01670188|9891541|FG001|NOT COMPLETED|Overall Study||1
8837213|NCT01670201|9891547|FG000|STARTED|Overall Study||8
8837214|NCT01670201|9891547|FG000|COMPLETED|Overall Study||8
8837215|NCT01670201|9891547|FG000|NOT COMPLETED|Overall Study||0
8837216|NCT01670279|9891554|FG000|STARTED|Overall Study||6
8837217|NCT01670279|9891555|FG001|STARTED|Overall Study||7
8837218|NCT01670279|9891556|FG002|STARTED|Overall Study||0
8837219|NCT01670279|9891557|FG003|STARTED|Overall Study||5
8837220|NCT01670279|9891554|FG000|COMPLETED|Overall Study||6
8837221|NCT01670279|9891555|FG001|COMPLETED|Overall Study||5
8837222|NCT01670279|9891556|FG002|COMPLETED|Overall Study||0
8837223|NCT01670279|9891557|FG003|COMPLETED|Overall Study||4
8837224|NCT01670279|9891554|FG000|NOT COMPLETED|Overall Study||0
8837225|NCT01670279|9891555|FG001|NOT COMPLETED|Overall Study||2
8837226|NCT01670279|9891556|FG002|NOT COMPLETED|Overall Study||0
8837227|NCT01670279|9891557|FG003|NOT COMPLETED|Overall Study||1
8837228|NCT01670292|9891565|FG000|STARTED|Overall Study||82
8837229|NCT01670292|9891565|FG000|COMPLETED|Overall Study||68
8837230|NCT01670292|9891565|FG000|NOT COMPLETED|Overall Study||14
8837231|NCT01670487|9891579|FG000|STARTED|Overall Study||150
8837232|NCT01670487|9891580|FG001|STARTED|Overall Study||150
8837233|NCT01670487|9891579|FG000|COMPLETED|Overall Study||150
8837234|NCT01670487|9891580|FG001|COMPLETED|Overall Study||150
8837235|NCT01670487|9891579|FG000|NOT COMPLETED|Overall Study||0
8837236|NCT01670487|9891580|FG001|NOT COMPLETED|Overall Study||0
8837237|NCT01670526|9891588|FG000|STARTED|Overall Study||49
8837238|NCT01670526|9891589|FG001|STARTED|Overall Study||45
8837239|NCT01670526|9891588|FG000|COMPLETED|Overall Study||37
8837240|NCT01670526|9891589|FG001|COMPLETED|Overall Study||39
8837241|NCT01670526|9891588|FG000|NOT COMPLETED|Overall Study||12
8837242|NCT01670526|9891589|FG001|NOT COMPLETED|Overall Study||6
8837243|NCT01670721|9891595|FG000|STARTED|Overall Study||175
8837244|NCT01670721|9891595|FG000|COMPLETED|Overall Study|81 participants with DP and 41 with adverse events were considered as completed.|122
8837245|NCT01670721|9891595|FG000|NOT COMPLETED|Overall Study||53
8837246|NCT01670760|9891599|FG000|STARTED|Overall Study||20
8837247|NCT01670760|9891599|FG000|COMPLETED|Overall Study||20
8837248|NCT01670760|9891599|FG000|NOT COMPLETED|Overall Study||0
8837249|NCT01670825|9891605|FG000|STARTED|Overall Study||42
8837250|NCT01670825|9891606|FG001|STARTED|Overall Study||39
8837251|NCT01670825|9891605|FG000|COMPLETED|Overall Study||42
8837252|NCT01670825|9891606|FG001|COMPLETED|Overall Study||39
8837253|NCT01670825|9891605|FG000|NOT COMPLETED|Overall Study||0
8837254|NCT01670825|9891606|FG001|NOT COMPLETED|Overall Study||0
8837255|NCT01671007|9891623|FG000|STARTED|Overall Study||2089
8837256|NCT01671007|9891624|FG001|STARTED|Overall Study||2834
8837257|NCT01671007|9891625|FG002|STARTED|Overall Study||2033
8837258|NCT01671007|9891626|FG003|STARTED|Overall Study||2214
8837259|NCT01671007|9891627|FG004|STARTED|Overall Study||180
8837260|NCT01671007|9891628|FG005|STARTED|Overall Study||513
8837261|NCT01671007|9891629|FG006|STARTED|Overall Study||80
8837262|NCT01671007|9891630|FG007|STARTED|Overall Study||526
8837263|NCT01671007|9891631|FG008|STARTED|Overall Study||2
8837264|NCT01671007|9891623|FG000|All Eligible|Overall Study||2066
8837265|NCT01671007|9891624|FG001|All Eligible|Overall Study||2758
8837266|NCT01671007|9891625|FG002|All Eligible|Overall Study||2008
8837267|NCT01671007|9891626|FG003|All Eligible|Overall Study||2197
8837268|NCT01671007|9891627|FG004|All Eligible|Overall Study||180
8837269|NCT01671007|9891628|FG005|All Eligible|Overall Study||507
8837270|NCT01671007|9891629|FG006|All Eligible|Overall Study||79
8837271|NCT01671007|9891630|FG007|All Eligible|Overall Study||507
8837272|NCT01671007|9891631|FG008|All Eligible|Overall Study||2
8837273|NCT01671007|9891623|FG000|COMPLETED|Overall Study||1768
8837274|NCT01671007|9891624|FG001|COMPLETED|Overall Study||2183
8837275|NCT01671007|9891625|FG002|COMPLETED|Overall Study||1667
8837276|NCT01671007|9891626|FG003|COMPLETED|Overall Study||1846
8837277|NCT01671007|9891627|FG004|COMPLETED|Overall Study||155
8837278|NCT01671007|9891628|FG005|COMPLETED|Overall Study||401
8837279|NCT01671007|9891629|FG006|COMPLETED|Overall Study||59
8837280|NCT01671007|9891630|FG007|COMPLETED|Overall Study||394
8837281|NCT01671007|9891631|FG008|COMPLETED|Overall Study||2
8837282|NCT01671007|9891623|FG000|NOT COMPLETED|Overall Study||321
8837283|NCT01671007|9891624|FG001|NOT COMPLETED|Overall Study||651
8837284|NCT01671007|9891625|FG002|NOT COMPLETED|Overall Study||366
8837285|NCT01671007|9891626|FG003|NOT COMPLETED|Overall Study||368
8837286|NCT01671007|9891627|FG004|NOT COMPLETED|Overall Study||25
8837287|NCT01671007|9891628|FG005|NOT COMPLETED|Overall Study||112
8837288|NCT01671007|9891629|FG006|NOT COMPLETED|Overall Study||21
8837289|NCT01671007|9891630|FG007|NOT COMPLETED|Overall Study||132
8837290|NCT01671007|9891631|FG008|NOT COMPLETED|Overall Study||0
8837291|NCT01671059|9891642|FG000|STARTED|Overall Study||80
8837292|NCT01671059|9891642|FG000|COMPLETED|Overall Study||75
8837293|NCT01671059|9891642|FG000|NOT COMPLETED|Overall Study||5
8837294|NCT01671085|9891649|FG000|STARTED|Overall Study|1 participant who dropped out was replaced.|11
8837295|NCT01671085|9891650|FG001|STARTED|Overall Study||2
8837296|NCT01671085|9891649|FG000|Received at Least 1 Dose of Study Drug|Overall Study||11
8837297|NCT01671085|9891650|FG001|Received at Least 1 Dose of Study Drug|Overall Study||2
8837298|NCT01671085|9891649|FG000|COMPLETED|Overall Study||10
8837299|NCT01671085|9891650|FG001|COMPLETED|Overall Study||2
8837300|NCT01671085|9891649|FG000|NOT COMPLETED|Overall Study||1
8837301|NCT01671085|9891650|FG001|NOT COMPLETED|Overall Study||0
8837302|NCT01671111|9891657|FG000|STARTED|Overall Study||30
8837303|NCT01671111|9891657|FG000|COMPLETED|Overall Study||0
8837304|NCT01671111|9891657|FG000|NOT COMPLETED|Overall Study||30
8837305|NCT01671176|9891661|FG000|STARTED|Overall Study||30
8837306|NCT01671176|9891661|FG000|COMPLETED|Overall Study||30
8837307|NCT01671176|9891661|FG000|NOT COMPLETED|Overall Study||0
8837308|NCT01671280|9891665|FG000|STARTED|Overall Study|The number is enrollment.|403
8837309|NCT01671280|9891665|FG000|COMPLETED|Overall Study||401
8837310|NCT01671280|9891665|FG000|NOT COMPLETED|Overall Study||2
8837311|NCT01671293|9891671|FG000|STARTED|Overall Study||36
8837312|NCT01671293|9891672|FG001|STARTED|Overall Study||34
8837313|NCT01671293|9891671|FG000|COMPLETED|Overall Study||33
8837314|NCT01671293|9891672|FG001|COMPLETED|Overall Study||32
8837315|NCT01671293|9891671|FG000|NOT COMPLETED|Overall Study||3
8837316|NCT01671293|9891672|FG001|NOT COMPLETED|Overall Study||2
8837317|NCT01671319|9891678|FG000|STARTED|Overall Study||42
8837318|NCT01671319|9891678|FG000|COMPLETED|Overall Study||41
8837319|NCT01671319|9891678|FG000|NOT COMPLETED|Overall Study||1
8837320|NCT01671332|9891684|FG000|STARTED|Overall Study||40
8837321|NCT01671332|9891685|FG001|STARTED|Overall Study||40
8837322|NCT01671332|9891684|FG000|Crossed Over to Docetaxel Plus Suramin|Overall Study||0
8837323|NCT01671332|9891685|FG001|Crossed Over to Docetaxel Plus Suramin|Overall Study|Participants with disease progression on Docetaxel Arm were allowed to crossover to Suramin.|13
8837324|NCT01671332|9891684|FG000|COMPLETED|Overall Study||39
8837325|NCT01671332|9891685|FG001|COMPLETED|Overall Study||39
8837326|NCT01671332|9891684|FG000|NOT COMPLETED|Overall Study||1
8837327|NCT01671332|9891685|FG001|NOT COMPLETED|Overall Study||1
8837328|NCT01671345|9891693|FG000|STARTED|Overall Study||77
8837329|NCT01671345|9891694|FG001|STARTED|Overall Study||92
8837330|NCT01671345|9891693|FG000|COMPLETED|Overall Study||64
8837331|NCT01671345|9891694|FG001|COMPLETED|Overall Study||83
8837332|NCT01671345|9891693|FG000|NOT COMPLETED|Overall Study||13
8837333|NCT01671345|9891694|FG001|NOT COMPLETED|Overall Study||9
8837334|NCT01671423|9891705|FG000|STARTED|Overall Study||20
8837335|NCT01671423|9891706|FG001|STARTED|Overall Study||20
8837336|NCT01671423|9891705|FG000|COMPLETED|Overall Study||14
8837337|NCT01671423|9891706|FG001|COMPLETED|Overall Study||9
8837338|NCT01671423|9891705|FG000|NOT COMPLETED|Overall Study||6
8837339|NCT01671423|9891706|FG001|NOT COMPLETED|Overall Study||11
8837340|NCT01671488|9891712|FG000|STARTED|Overall Study||11
8837341|NCT01671488|9891712|FG000|COMPLETED|Overall Study||10
8837342|NCT01671488|9891712|FG000|NOT COMPLETED|Overall Study||1
8837343|NCT01671605|9891718|FG000|STARTED|Overall Study||72
8837344|NCT01671605|9891719|FG001|STARTED|Overall Study||31
8837345|NCT01671605|9891718|FG000|COMPLETED|Overall Study||72
8837346|NCT01671605|9891719|FG001|COMPLETED|Overall Study||31
8837347|NCT01671605|9891718|FG000|NOT COMPLETED|Overall Study||0
8837348|NCT01671605|9891719|FG001|NOT COMPLETED|Overall Study||0
8837349|NCT01671748|9891727|FG000|STARTED|4 Week run-in Phase||47
8837350|NCT01671748|9891728|FG001|STARTED|4 Week run-in Phase||0
8837351|NCT01671748|9891727|FG000|COMPLETED|4 Week run-in Phase||36
8837352|NCT01671748|9891728|FG001|COMPLETED|4 Week run-in Phase||0
8837353|NCT01671748|9891727|FG000|NOT COMPLETED|4 Week run-in Phase||11
8837354|NCT01671748|9891728|FG001|NOT COMPLETED|4 Week run-in Phase||0
8837355|NCT01671748|9891727|FG000|STARTED|12 Week Treatment Phase||19
8837356|NCT01671748|9891728|FG001|STARTED|12 Week Treatment Phase||17
8837357|NCT01671748|9891727|FG000|COMPLETED|12 Week Treatment Phase||19
8837358|NCT01671748|9891728|FG001|COMPLETED|12 Week Treatment Phase||17
8837359|NCT01671748|9891727|FG000|NOT COMPLETED|12 Week Treatment Phase||0
8837360|NCT01671748|9891728|FG001|NOT COMPLETED|12 Week Treatment Phase||0
8837361|NCT01671839|9891734|FG000|STARTED|Overall Study||55
8837362|NCT01671839|9891734|FG000|3-year Follow-up|Overall Study||45
8837363|NCT01671839|9891734|FG000|5-year Follow-up|Overall Study||37
8837364|NCT01671839|9891734|FG000|COMPLETED|Overall Study||37
8837365|NCT01671839|9891734|FG000|NOT COMPLETED|Overall Study||18
8837366|NCT01672294|9891745|FG000|STARTED|Overall Study||71
8837367|NCT01672294|9891746|FG001|STARTED|Overall Study||71
8837368|NCT01672294|9891747|FG002|STARTED|Overall Study||72
8837369|NCT01672294|9891748|FG003|STARTED|Overall Study||72
8837370|NCT01672294|9891745|FG000|COMPLETED|Overall Study||65
8837371|NCT01672294|9891746|FG001|COMPLETED|Overall Study||50
8837372|NCT01672294|9891747|FG002|COMPLETED|Overall Study||61
8837373|NCT01672294|9891748|FG003|COMPLETED|Overall Study||59
8837374|NCT01672294|9891745|FG000|NOT COMPLETED|Overall Study||6
8837375|NCT01672294|9891746|FG001|NOT COMPLETED|Overall Study||21
8837376|NCT01672294|9891747|FG002|NOT COMPLETED|Overall Study||11
8837377|NCT01672294|9891748|FG003|NOT COMPLETED|Overall Study||13
8837378|NCT01672658|9891760|FG000|STARTED|Overall Study||16
8837379|NCT01672658|9891761|FG001|STARTED|Overall Study||15
8837380|NCT01672658|9891760|FG000|COMPLETED|Overall Study||16
8837381|NCT01672658|9891761|FG001|COMPLETED|Overall Study||14
8837382|NCT01672658|9891760|FG000|NOT COMPLETED|Overall Study||0
8837383|NCT01672658|9891761|FG001|NOT COMPLETED|Overall Study||1
8837384|NCT01672710|9891769|FG000|STARTED|Controlled Comparison 5 Week Follow-up||22
8837385|NCT01672710|9891770|FG001|STARTED|Controlled Comparison 5 Week Follow-up||10
8837386|NCT01672710|9891769|FG000|COMPLETED|Controlled Comparison 5 Week Follow-up|sauna intervention group repeat all assessments 7 days after complete the regimen|22
8837387|NCT01672710|9891770|FG001|COMPLETED|Controlled Comparison 5 Week Follow-up|waitlist group repeat baseline assessments after 4 week time period then begin sauna|10
8837388|NCT01672710|9891769|FG000|NOT COMPLETED|Controlled Comparison 5 Week Follow-up||0
8837389|NCT01672710|9891770|FG001|NOT COMPLETED|Controlled Comparison 5 Week Follow-up||0
8837390|NCT01672710|9891769|FG000|STARTED|Waitlist Assessed After Sauna Regimen|immediate start group no further assessments until 3 month follow up|22
8837391|NCT01672710|9891770|FG001|STARTED|Waitlist Assessed After Sauna Regimen|waitlisted group receive the 4 week intervention and complete 7 day assessments|10
8837392|NCT01672710|9891769|FG000|COMPLETED|Waitlist Assessed After Sauna Regimen|non applicable, cannot compare the immediate start and waitlist in this period|22
8837393|NCT01672710|9891770|FG001|COMPLETED|Waitlist Assessed After Sauna Regimen||9
8837394|NCT01672710|9891769|FG000|NOT COMPLETED|Waitlist Assessed After Sauna Regimen||0
8837395|NCT01672710|9891770|FG001|NOT COMPLETED|Waitlist Assessed After Sauna Regimen||1
8837396|NCT01672710|9891769|FG000|STARTED|3 Month Follow up||22
8837397|NCT01672710|9891770|FG001|STARTED|3 Month Follow up||9
8837398|NCT01672710|9891769|FG000|COMPLETED|3 Month Follow up||16
8837399|NCT01672710|9891770|FG001|COMPLETED|3 Month Follow up||5
8837400|NCT01672710|9891769|FG000|NOT COMPLETED|3 Month Follow up||6
8837401|NCT01672710|9891770|FG001|NOT COMPLETED|3 Month Follow up||4
8837402|NCT01672723|9891776|FG000|STARTED|First Intervention||19
8837403|NCT01672723|9891777|FG001|STARTED|First Intervention||15
8837404|NCT01672723|9891776|FG000|COMPLETED|First Intervention||16
8837405|NCT01672723|9891777|FG001|COMPLETED|First Intervention||15
8837406|NCT01672723|9891776|FG000|NOT COMPLETED|First Intervention||3
8837407|NCT01672723|9891777|FG001|NOT COMPLETED|First Intervention||0
8837408|NCT01672723|9891776|FG000|STARTED|Washout Period of 10 Days||16
8837409|NCT01672723|9891777|FG001|STARTED|Washout Period of 10 Days||15
8837410|NCT01672723|9891776|FG000|COMPLETED|Washout Period of 10 Days||16
8837411|NCT01672723|9891777|FG001|COMPLETED|Washout Period of 10 Days||15
8837412|NCT01672723|9891776|FG000|NOT COMPLETED|Washout Period of 10 Days||0
8837413|NCT01672723|9891777|FG001|NOT COMPLETED|Washout Period of 10 Days||0
8837414|NCT01672723|9891776|FG000|STARTED|Second Intervention||16
8837415|NCT01672723|9891777|FG001|STARTED|Second Intervention||15
8837416|NCT01672723|9891776|FG000|COMPLETED|Second Intervention||16
8837417|NCT01672723|9891777|FG001|COMPLETED|Second Intervention||15
8837418|NCT01672723|9891776|FG000|NOT COMPLETED|Second Intervention||0
8837419|NCT01672723|9891777|FG001|NOT COMPLETED|Second Intervention||0
8837420|NCT01672736|9891783|FG000|STARTED|Overall Study|Phase I study part stopped early due to manufacturer's decision to stop further drug development.|19
8837421|NCT01672736|9891783|FG000|COMPLETED|Overall Study|3 patients taken off study due to non-availability of further study (Linsitinib) drug supply.|16
8837422|NCT01672736|9891783|FG000|NOT COMPLETED|Overall Study||3
8837423|NCT01672788|9891787|FG000|STARTED|Treatment Period 1 (3 Days)||9
8837424|NCT01672788|9891788|FG001|STARTED|Treatment Period 1 (3 Days)||9
8837425|NCT01672788|9891789|FG002|STARTED|Treatment Period 1 (3 Days)||9
8837426|NCT01672788|9891790|FG003|STARTED|Treatment Period 1 (3 Days)||9
8837427|NCT01672788|9891787|FG000|COMPLETED|Treatment Period 1 (3 Days)||9
8837428|NCT01672788|9891788|FG001|COMPLETED|Treatment Period 1 (3 Days)||9
8837429|NCT01672788|9891789|FG002|COMPLETED|Treatment Period 1 (3 Days)||9
8837430|NCT01672788|9891790|FG003|COMPLETED|Treatment Period 1 (3 Days)||9
8837431|NCT01672788|9891787|FG000|NOT COMPLETED|Treatment Period 1 (3 Days)||0
8837432|NCT01672788|9891788|FG001|NOT COMPLETED|Treatment Period 1 (3 Days)||0
8837433|NCT01672788|9891789|FG002|NOT COMPLETED|Treatment Period 1 (3 Days)||0
8837434|NCT01672788|9891790|FG003|NOT COMPLETED|Treatment Period 1 (3 Days)||0
8837435|NCT01672788|9891787|FG000|STARTED|Washout Period 1 (7 Days)||9
8837436|NCT01672788|9891788|FG001|STARTED|Washout Period 1 (7 Days)||9
8837437|NCT01672788|9891789|FG002|STARTED|Washout Period 1 (7 Days)||9
8837438|NCT01672788|9891790|FG003|STARTED|Washout Period 1 (7 Days)||9
8837439|NCT01672788|9891787|FG000|COMPLETED|Washout Period 1 (7 Days)||9
8837440|NCT01672788|9891788|FG001|COMPLETED|Washout Period 1 (7 Days)||9
8837441|NCT01672788|9891789|FG002|COMPLETED|Washout Period 1 (7 Days)||9
8837442|NCT01672788|9891790|FG003|COMPLETED|Washout Period 1 (7 Days)||9
8837443|NCT01672788|9891787|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
8837444|NCT01672788|9891788|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
8837445|NCT01672788|9891789|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
8837446|NCT01672788|9891790|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
8837447|NCT01672788|9891787|FG000|STARTED|Treatment Period 2 (3 Days)||9
8837448|NCT01672788|9891788|FG001|STARTED|Treatment Period 2 (3 Days)||9
8837449|NCT01672788|9891789|FG002|STARTED|Treatment Period 2 (3 Days)||9
8837450|NCT01672788|9891790|FG003|STARTED|Treatment Period 2 (3 Days)||9
8837451|NCT01672788|9891787|FG000|COMPLETED|Treatment Period 2 (3 Days)||9
8837452|NCT01672788|9891788|FG001|COMPLETED|Treatment Period 2 (3 Days)||9
8837453|NCT01672788|9891789|FG002|COMPLETED|Treatment Period 2 (3 Days)||9
8837454|NCT01672788|9891790|FG003|COMPLETED|Treatment Period 2 (3 Days)||9
8837455|NCT01672788|9891787|FG000|NOT COMPLETED|Treatment Period 2 (3 Days)||0
8837456|NCT01672788|9891788|FG001|NOT COMPLETED|Treatment Period 2 (3 Days)||0
8837457|NCT01672788|9891789|FG002|NOT COMPLETED|Treatment Period 2 (3 Days)||0
8837458|NCT01672788|9891790|FG003|NOT COMPLETED|Treatment Period 2 (3 Days)||0
8837459|NCT01672788|9891787|FG000|STARTED|Washout Period 2 (7 Days)||9
8837460|NCT01672788|9891788|FG001|STARTED|Washout Period 2 (7 Days)||9
8837461|NCT01672788|9891789|FG002|STARTED|Washout Period 2 (7 Days)||9
8837462|NCT01672788|9891790|FG003|STARTED|Washout Period 2 (7 Days)||9
8837463|NCT01672788|9891787|FG000|COMPLETED|Washout Period 2 (7 Days)||9
8837464|NCT01672788|9891788|FG001|COMPLETED|Washout Period 2 (7 Days)||9
8837465|NCT01672788|9891789|FG002|COMPLETED|Washout Period 2 (7 Days)||9
8837466|NCT01672788|9891790|FG003|COMPLETED|Washout Period 2 (7 Days)||8
8837467|NCT01672788|9891787|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
8837468|NCT01672788|9891788|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
8837469|NCT01672788|9891789|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
8837470|NCT01672788|9891790|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||1
8837471|NCT01672788|9891787|FG000|STARTED|Treatment Period 3 (3 Days)||9
8837472|NCT01672788|9891788|FG001|STARTED|Treatment Period 3 (3 Days)||9
8837473|NCT01672788|9891789|FG002|STARTED|Treatment Period 3 (3 Days)||9
8837474|NCT01672788|9891790|FG003|STARTED|Treatment Period 3 (3 Days)||8
8837475|NCT01672788|9891787|FG000|COMPLETED|Treatment Period 3 (3 Days)||9
8837476|NCT01672788|9891788|FG001|COMPLETED|Treatment Period 3 (3 Days)||9
8837477|NCT01672788|9891789|FG002|COMPLETED|Treatment Period 3 (3 Days)||9
8837478|NCT01672788|9891790|FG003|COMPLETED|Treatment Period 3 (3 Days)||8
8837479|NCT01672788|9891787|FG000|NOT COMPLETED|Treatment Period 3 (3 Days)||0
8837480|NCT01672788|9891788|FG001|NOT COMPLETED|Treatment Period 3 (3 Days)||0
8837481|NCT01672788|9891789|FG002|NOT COMPLETED|Treatment Period 3 (3 Days)||0
8837482|NCT01672788|9891790|FG003|NOT COMPLETED|Treatment Period 3 (3 Days)||0
8837483|NCT01672788|9891787|FG000|STARTED|Washout Period 3 (7 Days)||9
8837484|NCT01672788|9891788|FG001|STARTED|Washout Period 3 (7 Days)||9
8837485|NCT01672788|9891789|FG002|STARTED|Washout Period 3 (7 Days)||9
8837486|NCT01672788|9891790|FG003|STARTED|Washout Period 3 (7 Days)||8
8837487|NCT01672788|9891787|FG000|COMPLETED|Washout Period 3 (7 Days)||9
8837488|NCT01672788|9891788|FG001|COMPLETED|Washout Period 3 (7 Days)||9
8837489|NCT01672788|9891789|FG002|COMPLETED|Washout Period 3 (7 Days)||9
8837490|NCT01672788|9891790|FG003|COMPLETED|Washout Period 3 (7 Days)||8
8837491|NCT01672788|9891787|FG000|NOT COMPLETED|Washout Period 3 (7 Days)||0
8837492|NCT01672788|9891788|FG001|NOT COMPLETED|Washout Period 3 (7 Days)||0
8837493|NCT01672788|9891789|FG002|NOT COMPLETED|Washout Period 3 (7 Days)||0
8837494|NCT01672788|9891790|FG003|NOT COMPLETED|Washout Period 3 (7 Days)||0
8837495|NCT01672788|9891787|FG000|STARTED|Treatment Period 4 (3 Days)||9
8837496|NCT01672788|9891788|FG001|STARTED|Treatment Period 4 (3 Days)||9
8837497|NCT01672788|9891789|FG002|STARTED|Treatment Period 4 (3 Days)||9
8837498|NCT01672788|9891790|FG003|STARTED|Treatment Period 4 (3 Days)||8
8837499|NCT01672788|9891787|FG000|COMPLETED|Treatment Period 4 (3 Days)||9
8837500|NCT01672788|9891788|FG001|COMPLETED|Treatment Period 4 (3 Days)||9
8837501|NCT01672788|9891789|FG002|COMPLETED|Treatment Period 4 (3 Days)||9
8837502|NCT01672788|9891790|FG003|COMPLETED|Treatment Period 4 (3 Days)||8
8837503|NCT01672788|9891787|FG000|NOT COMPLETED|Treatment Period 4 (3 Days)||0
8837504|NCT01672788|9891788|FG001|NOT COMPLETED|Treatment Period 4 (3 Days)||0
8837505|NCT01672788|9891789|FG002|NOT COMPLETED|Treatment Period 4 (3 Days)||0
8837506|NCT01672788|9891790|FG003|NOT COMPLETED|Treatment Period 4 (3 Days)||0
8837507|NCT01672801|9891802|FG000|STARTED|Overall Study||9
8837508|NCT01672801|9891803|FG001|STARTED|Overall Study||9
8837509|NCT01672801|9891802|FG000|COMPLETED|Overall Study||9
8837510|NCT01672801|9891803|FG001|COMPLETED|Overall Study||8
8837511|NCT01672801|9891802|FG000|NOT COMPLETED|Overall Study||0
8837512|NCT01672801|9891803|FG001|NOT COMPLETED|Overall Study||1
8837513|NCT01672827|9891809|FG000|STARTED|Overall Study||276
8837514|NCT01672827|9891809|FG000|COMPLETED|Overall Study||276
8837515|NCT01672827|9891809|FG000|NOT COMPLETED|Overall Study||0
8837516|NCT01672853|9891818|FG000|STARTED|Overall Study||79
8837517|NCT01672853|9891819|FG001|STARTED|Overall Study||77
8837518|NCT01672853|9891820|FG002|STARTED|Overall Study||79
8837519|NCT01672853|9891818|FG000|COMPLETED|Overall Study||69
8837520|NCT01672853|9891819|FG001|COMPLETED|Overall Study||60
8837521|NCT01672853|9891820|FG002|COMPLETED|Overall Study||65
8837522|NCT01672853|9891818|FG000|NOT COMPLETED|Overall Study||10
8837523|NCT01672853|9891819|FG001|NOT COMPLETED|Overall Study||17
8837524|NCT01672853|9891820|FG002|NOT COMPLETED|Overall Study||14
8837525|NCT01672866|9891831|FG000|STARTED|Blinded Phase (up to 240 Weeks)||74
8837526|NCT01672866|9891832|FG001|STARTED|Blinded Phase (up to 240 Weeks)||74
8837527|NCT01672866|9891833|FG002|STARTED|Blinded Phase (up to 240 Weeks)||74
8837528|NCT01672866|9891831|FG000|COMPLETED|Blinded Phase (up to 240 Weeks)||0
8837529|NCT01672866|9891832|FG001|COMPLETED|Blinded Phase (up to 240 Weeks)||0
8837530|NCT01672866|9891833|FG002|COMPLETED|Blinded Phase (up to 240 Weeks)||0
8837531|NCT01672866|9891831|FG000|NOT COMPLETED|Blinded Phase (up to 240 Weeks)||74
8837532|NCT01672866|9891832|FG001|NOT COMPLETED|Blinded Phase (up to 240 Weeks)||74
8837533|NCT01672866|9891833|FG002|NOT COMPLETED|Blinded Phase (up to 240 Weeks)||74
8837534|NCT01672866|9891831|FG000|STARTED|Open-Label Phase (up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|11
8837535|NCT01672866|9891832|FG001|STARTED|Open-Label Phase (up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|15
8837536|NCT01672866|9891833|FG002|STARTED|Open-Label Phase (up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|16
8837537|NCT01672866|9891831|FG000|COMPLETED|Open-Label Phase (up to 240 Weeks)||0
8556548|NCT03767634|9588305|FG000|STARTED|Overall Study||62145
8556549|NCT03767634|9588306|FG001|STARTED|Overall Study|8,146 neonates were included in the matched propensity score analysis|19080
8556550|NCT03767634|9588307|FG002|STARTED|Overall Study|8,146 neonates were included in the matched propensity score analysis|16282
8556551|NCT03767634|9588305|FG000|COMPLETED|Overall Study||62145
8556552|NCT03767634|9588306|FG001|COMPLETED|Overall Study|8,146 neonates were included in the matched propensity score analysis|19080
8556553|NCT03767634|9588307|FG002|COMPLETED|Overall Study|8,146 neonates were included in the matched propensity score analysis|16282
8837538|NCT01672866|9891832|FG001|COMPLETED|Open-Label Phase (up to 240 Weeks)||0
8837539|NCT01672866|9891833|FG002|COMPLETED|Open-Label Phase (up to 240 Weeks)||0
8837540|NCT01672866|9891831|FG000|NOT COMPLETED|Open-Label Phase (up to 240 Weeks)||11
8556554|NCT03767634|9588305|FG000|NOT COMPLETED|Overall Study||0
8556555|NCT03767634|9588306|FG001|NOT COMPLETED|Overall Study||0
8556556|NCT03767634|9588307|FG002|NOT COMPLETED|Overall Study||0
8556557|NCT03446573|9588318|FG000|STARTED|Overall Study||369
8556558|NCT03446573|9588319|FG001|STARTED|Overall Study||372
8556559|NCT03446573|9588318|FG000|COMPLETED|Overall Study||0
8556560|NCT03446573|9588319|FG001|COMPLETED|Overall Study||0
8556561|NCT03446573|9588318|FG000|NOT COMPLETED|Overall Study||369
8556562|NCT03446573|9588319|FG001|NOT COMPLETED|Overall Study||372
8556563|NCT03388138|9588330|FG000|STARTED|Overall Study||94
8622960|NCT00490724|9662177|FG001|STARTED|Period I||20
8622961|NCT00490724|9662178|FG002|STARTED|Period I||20
8837541|NCT01672866|9891832|FG001|NOT COMPLETED|Open-Label Phase (up to 240 Weeks)||15
8837542|NCT01672866|9891833|FG002|NOT COMPLETED|Open-Label Phase (up to 240 Weeks)||16
8837543|NCT01672879|9891846|FG000|STARTED|Blinded Phase (Up to 240 Weeks)||87
8837544|NCT01672879|9891847|FG001|STARTED|Blinded Phase (Up to 240 Weeks)||86
8837545|NCT01672879|9891848|FG002|STARTED|Blinded Phase (Up to 240 Weeks)||86
8837546|NCT01672879|9891846|FG000|COMPLETED|Blinded Phase (Up to 240 Weeks)||0
8837547|NCT01672879|9891847|FG001|COMPLETED|Blinded Phase (Up to 240 Weeks)||0
8837548|NCT01672879|9891848|FG002|COMPLETED|Blinded Phase (Up to 240 Weeks)||0
8837549|NCT01672879|9891846|FG000|NOT COMPLETED|Blinded Phase (Up to 240 Weeks)||87
8837550|NCT01672879|9891847|FG001|NOT COMPLETED|Blinded Phase (Up to 240 Weeks)||86
8837551|NCT01672879|9891848|FG002|NOT COMPLETED|Blinded Phase (Up to 240 Weeks)||86
8837552|NCT01672879|9891846|FG000|STARTED|Open-Label Phase (Up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|15
8837553|NCT01672879|9891847|FG001|STARTED|Open-Label Phase (Up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|17
8837554|NCT01672879|9891848|FG002|STARTED|Open-Label Phase (Up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|8
8837555|NCT01672879|9891846|FG000|COMPLETED|Open-Label Phase (Up to 240 Weeks)||0
8837556|NCT01672879|9891847|FG001|COMPLETED|Open-Label Phase (Up to 240 Weeks)||0
8837557|NCT01672879|9891848|FG002|COMPLETED|Open-Label Phase (Up to 240 Weeks)||0
8837558|NCT01672879|9891846|FG000|NOT COMPLETED|Open-Label Phase (Up to 240 Weeks)||15
8837559|NCT01672879|9891847|FG001|NOT COMPLETED|Open-Label Phase (Up to 240 Weeks)||17
8837560|NCT01672879|9891848|FG002|NOT COMPLETED|Open-Label Phase (Up to 240 Weeks)||8
8837561|NCT01672892|9891859|FG000|STARTED|Overall Study||137
8622962|NCT00490724|9662176|FG000|COMPLETED|Period I||21
8837562|NCT01672892|9891860|FG001|STARTED|Overall Study||152
8837563|NCT01672892|9891859|FG000|Eligible Population|Overall Study||130
8837564|NCT01672892|9891860|FG001|Eligible Population|Overall Study||149
8837565|NCT01672892|9891859|FG000|Adverse Event Population|Overall Study||125
8837566|NCT01672892|9891860|FG001|Adverse Event Population|Overall Study||144
8837567|NCT01672892|9891859|FG000|COMPLETED|Overall Study||130
8837568|NCT01672892|9891860|FG001|COMPLETED|Overall Study||149
8837569|NCT01672892|9891859|FG000|NOT COMPLETED|Overall Study||7
8837570|NCT01672892|9891860|FG001|NOT COMPLETED|Overall Study||3
8837571|NCT01672957|9891869|FG000|STARTED|Overall Study||128
8837572|NCT01672957|9891869|FG000|Intent-to-treat (ITT) Population|Overall Study|All enrolled participants who had no major protocol violation.|123
8837573|NCT01672957|9891869|FG000|COMPLETED|Overall Study||73
8837574|NCT01672957|9891869|FG000|NOT COMPLETED|Overall Study||55
8944601|NCT02397460|10006450|FG007|NOT COMPLETED|Treatment Period 2||1
8944602|NCT02397460|10006443|FG000|STARTED|Treatment Period 3||7
8944603|NCT02397460|10006444|FG001|STARTED|Treatment Period 3||7
8622963|NCT00490724|9662177|FG001|COMPLETED|Period I||20
8622964|NCT00490724|9662178|FG002|COMPLETED|Period I||19
8622965|NCT00490724|9662176|FG000|NOT COMPLETED|Period I||0
8837575|NCT01672970|9891873|FG000|STARTED|Overall Study||291
8837576|NCT01672970|9891873|FG000|Treated|Overall Study||290
8837577|NCT01672970|9891873|FG000|COMPLETED|Overall Study||244
8837578|NCT01672970|9891873|FG000|NOT COMPLETED|Overall Study||47
8837579|NCT01672983|9891883|FG000|STARTED|Overall Study||18
8837580|NCT01672983|9891884|FG001|STARTED|Overall Study||18
8837581|NCT01672983|9891885|FG002|STARTED|Overall Study||19
8837582|NCT01672983|9891886|FG003|STARTED|Overall Study||18
8837583|NCT01672983|9891887|FG004|STARTED|Overall Study||19
8837584|NCT01672983|9891888|FG005|STARTED|Overall Study||18
8837585|NCT01672983|9891883|FG000|Completed Study Drug|Overall Study||18
8837586|NCT01672983|9891884|FG001|Completed Study Drug|Overall Study||17
8837587|NCT01672983|9891885|FG002|Completed Study Drug|Overall Study||18
8837588|NCT01672983|9891886|FG003|Completed Study Drug|Overall Study||18
8837589|NCT01672983|9891887|FG004|Completed Study Drug|Overall Study||12
8837590|NCT01672983|9891888|FG005|Completed Study Drug|Overall Study||17
8837591|NCT01672983|9891883|FG000|COMPLETED|Overall Study||18
8837592|NCT01672983|9891884|FG001|COMPLETED|Overall Study||18
8837593|NCT01672983|9891885|FG002|COMPLETED|Overall Study||19
8837594|NCT01672983|9891886|FG003|COMPLETED|Overall Study||18
8837595|NCT01672983|9891887|FG004|COMPLETED|Overall Study||19
8837596|NCT01672983|9891888|FG005|COMPLETED|Overall Study||18
8837597|NCT01672983|9891883|FG000|NOT COMPLETED|Overall Study||0
8837598|NCT01672983|9891884|FG001|NOT COMPLETED|Overall Study||0
8837599|NCT01672983|9891885|FG002|NOT COMPLETED|Overall Study||0
8837600|NCT01672983|9891886|FG003|NOT COMPLETED|Overall Study||0
8837601|NCT01672983|9891887|FG004|NOT COMPLETED|Overall Study||0
8837602|NCT01672983|9891888|FG005|NOT COMPLETED|Overall Study||0
8837603|NCT01672996|9891917|FG000|STARTED|Overall Study||30
8837604|NCT01672996|9891918|FG001|STARTED|Overall Study||30
8837605|NCT01672996|9891919|FG002|STARTED|Overall Study||6
8837606|NCT01672996|9891917|FG000|COMPLETED|Overall Study||30
8837607|NCT01672996|9891918|FG001|COMPLETED|Overall Study||30
8837608|NCT01672996|9891919|FG002|COMPLETED|Overall Study||6
8837609|NCT01672996|9891917|FG000|NOT COMPLETED|Overall Study||0
8837610|NCT01672996|9891918|FG001|NOT COMPLETED|Overall Study||0
8837611|NCT01672996|9891919|FG002|NOT COMPLETED|Overall Study||0
8837612|NCT01673009|9891935|FG000|STARTED|Overall Study||36
8837613|NCT01673009|9891935|FG000|COMPLETED|Overall Study||23
8837614|NCT01673009|9891935|FG000|NOT COMPLETED|Overall Study||13
8837615|NCT01673022|9891939|FG000|STARTED|Overall Study||430
8837616|NCT01673022|9891939|FG000|COMPLETED|Overall Study||422
8837617|NCT01673022|9891939|FG000|NOT COMPLETED|Overall Study||8
8837618|NCT01673113|9891945|FG000|STARTED|Overall Study||11
8837619|NCT01673113|9891946|FG001|STARTED|Overall Study||11
8837620|NCT01673113|9891945|FG000|COMPLETED|Overall Study||11
8837621|NCT01673113|9891946|FG001|COMPLETED|Overall Study||11
8837622|NCT01673113|9891945|FG000|NOT COMPLETED|Overall Study||0
8837623|NCT01673113|9891946|FG001|NOT COMPLETED|Overall Study||0
8837624|NCT01673126|9891955|FG000|STARTED|Overall Study|First stimulation (20 minutes) Washout (2 days) Second stimulation (20 minutes)|36
8837625|NCT01673126|9891956|FG001|STARTED|Overall Study|First stimulation (20 minutes) Washout (2days) Second stimulation (20 minutes)|26
8837626|NCT01673126|9891955|FG000|COMPLETED|Overall Study||32
8837627|NCT01673126|9891956|FG001|COMPLETED|Overall Study||23
8837628|NCT01673126|9891955|FG000|NOT COMPLETED|Overall Study||4
8837629|NCT01673126|9891956|FG001|NOT COMPLETED|Overall Study||3
8837630|NCT01673178|9891967|FG000|STARTED|Overall Study||22
8837631|NCT01673178|9891968|FG001|STARTED|Overall Study||21
8837632|NCT01673178|9891969|FG002|STARTED|Overall Study||21
8837633|NCT01673178|9891970|FG003|STARTED|Overall Study||22
8837634|NCT01673178|9891971|FG004|STARTED|Overall Study||21
8837635|NCT01673178|9891967|FG000|COMPLETED|Overall Study||19
8837636|NCT01673178|9891968|FG001|COMPLETED|Overall Study||19
8837637|NCT01673178|9891969|FG002|COMPLETED|Overall Study||18
8837638|NCT01673178|9891970|FG003|COMPLETED|Overall Study||14
8837639|NCT01673178|9891971|FG004|COMPLETED|Overall Study||19
8837640|NCT01673178|9891967|FG000|NOT COMPLETED|Overall Study||3
8837641|NCT01673178|9891968|FG001|NOT COMPLETED|Overall Study||2
8837642|NCT01673178|9891969|FG002|NOT COMPLETED|Overall Study||3
8837643|NCT01673178|9891970|FG003|NOT COMPLETED|Overall Study||8
8837644|NCT01673178|9891971|FG004|NOT COMPLETED|Overall Study||2
8837645|NCT01673191|9891989|FG000|STARTED|Overall Study||26
8837646|NCT01673191|9891990|FG001|STARTED|Overall Study||11
8837647|NCT01673191|9891989|FG000|COMPLETED|Overall Study||26
8837648|NCT01673191|9891990|FG001|COMPLETED|Overall Study||11
8837649|NCT01673191|9891989|FG000|NOT COMPLETED|Overall Study||0
8837650|NCT01673191|9891990|FG001|NOT COMPLETED|Overall Study||0
8837651|NCT01673256|9891996|FG000|STARTED|Overall Study||90
8837652|NCT01673256|9891996|FG000|COMPLETED|Overall Study||90
8837653|NCT01673256|9891996|FG000|NOT COMPLETED|Overall Study||0
8837654|NCT01673282|9892002|FG000|STARTED|Overall Study||153
8837655|NCT01673282|9892003|FG001|STARTED|Overall Study||158
8837656|NCT01673282|9892002|FG000|COMPLETED|Overall Study||120
8837657|NCT01673282|9892003|FG001|COMPLETED|Overall Study||132
8837658|NCT01673282|9892002|FG000|NOT COMPLETED|Overall Study||33
8837659|NCT01673282|9892003|FG001|NOT COMPLETED|Overall Study||26
8837660|NCT01673347|9892009|FG000|STARTED|Overall Study||24
8837661|NCT01673347|9892009|FG000|COMPLETED|Overall Study||17
8837662|NCT01673347|9892009|FG000|NOT COMPLETED|Overall Study||7
8850022|NCT01744574|9905221|FG001|STARTED|Overall Study||56
8850023|NCT01744574|9905222|FG002|STARTED|Overall Study||52
8850024|NCT01744574|9905223|FG003|STARTED|Overall Study||51
8837663|NCT01673373|9892013|FG000|STARTED|Overall Study||68
8837664|NCT01673373|9892013|FG000|COMPLETED|Overall Study|Completed primary endpoint follow up.|66
8837665|NCT01673373|9892013|FG000|NOT COMPLETED|Overall Study||2
8837666|NCT01673386|9892017|FG000|STARTED|Overall Study||27
8837667|NCT01673386|9892018|FG001|STARTED|Overall Study||31
8837668|NCT01673386|9892017|FG000|COMPLETED|Overall Study|Of 2 subjects, 1 subject discontinued tivozanib early, completed planned treatment with sunitinib.|2
8837669|NCT01673386|9892018|FG001|COMPLETED|Overall Study|Of 4 subjects, 3 subjects discontinued sunitinib early, completed planned treatment with tivozanib.|4
8837670|NCT01673386|9892017|FG000|NOT COMPLETED|Overall Study||25
8837671|NCT01673386|9892018|FG001|NOT COMPLETED|Overall Study||27
8837672|NCT01673490|9892024|FG000|STARTED|Overall Study||59
8837673|NCT01673490|9892024|FG000|COMPLETED|Overall Study||52
8837674|NCT01673490|9892024|FG000|NOT COMPLETED|Overall Study||7
8837675|NCT01673568|9892030|FG000|STARTED|Overall Study||28
8837676|NCT01673568|9892031|FG001|STARTED|Overall Study||28
8837677|NCT01673568|9892030|FG000|COMPLETED|Overall Study||28
8837678|NCT01673568|9892031|FG001|COMPLETED|Overall Study||28
8837679|NCT01673568|9892030|FG000|NOT COMPLETED|Overall Study||0
8837680|NCT01673568|9892031|FG001|NOT COMPLETED|Overall Study||0
8837681|NCT01673594|9892039|FG000|STARTED|Overall Study||18
8837682|NCT01673594|9892040|FG001|STARTED|Overall Study||19
8837683|NCT01673594|9892039|FG000|COMPLETED|Overall Study||12
8837684|NCT01673594|9892040|FG001|COMPLETED|Overall Study||13
8837685|NCT01673594|9892039|FG000|NOT COMPLETED|Overall Study||6
8837686|NCT01673594|9892040|FG001|NOT COMPLETED|Overall Study||6
8837687|NCT01673646|9892049|FG000|STARTED|Overall Study||11
8837688|NCT01673646|9892050|FG001|STARTED|Overall Study||11
8837689|NCT01673646|9892051|FG002|STARTED|Overall Study||11
8837690|NCT01673646|9892049|FG000|Entered/Treated in Core Phase|Overall Study||11
8837691|NCT01673646|9892050|FG001|Entered/Treated in Core Phase|Overall Study||11
8837692|NCT01673646|9892051|FG002|Entered/Treated in Core Phase|Overall Study||11
8837693|NCT01673646|9892049|FG000|Completed Core Phase|Overall Study||9
8837694|NCT01673646|9892050|FG001|Completed Core Phase|Overall Study||10
8837695|NCT01673646|9892051|FG002|Completed Core Phase|Overall Study||10
8837696|NCT01673646|9892049|FG000|Entered Ext. Phase|Overall Study||7
8837697|NCT01673646|9892050|FG001|Entered Ext. Phase|Overall Study||9
8837698|NCT01673646|9892051|FG002|Entered Ext. Phase|Overall Study||9
8837699|NCT01673646|9892049|FG000|Did Not Enter Ext. Phase|Overall Study||2
8837700|NCT01673646|9892050|FG001|Did Not Enter Ext. Phase|Overall Study||1
8837701|NCT01673646|9892051|FG002|Did Not Enter Ext. Phase|Overall Study||1
8837702|NCT01673646|9892049|FG000|Treated Beyond 24 Months|Overall Study||7
8837703|NCT01673646|9892050|FG001|Treated Beyond 24 Months|Overall Study||8
8837704|NCT01673646|9892051|FG002|Treated Beyond 24 Months|Overall Study||8
8837705|NCT01673646|9892049|FG000|Discontinued Beyond 24 Months|Overall Study||0
8837706|NCT01673646|9892050|FG001|Discontinued Beyond 24 Months|Overall Study||4
8837707|NCT01673646|9892051|FG002|Discontinued Beyond 24 Months|Overall Study||1
8837708|NCT01673646|9892049|FG000|COMPLETED|Overall Study||7
8837709|NCT01673646|9892050|FG001|COMPLETED|Overall Study||4
8622966|NCT00490724|9662177|FG001|NOT COMPLETED|Period I||0
8622967|NCT00490724|9662178|FG002|NOT COMPLETED|Period I||1
8622968|NCT00490724|9662176|FG000|STARTED|Period II||21
8622969|NCT00490724|9662177|FG001|STARTED|Period II||20
8622970|NCT00490724|9662178|FG002|STARTED|Period II||19
8622971|NCT00490724|9662176|FG000|COMPLETED|Period II||18
8622972|NCT00490724|9662177|FG001|COMPLETED|Period II||19
8622973|NCT00490724|9662178|FG002|COMPLETED|Period II||16
8622974|NCT00490724|9662176|FG000|NOT COMPLETED|Period II||3
8622975|NCT00490724|9662177|FG001|NOT COMPLETED|Period II||1
8622976|NCT00490724|9662178|FG002|NOT COMPLETED|Period II||3
8622977|NCT00490802|9662188|FG000|STARTED|Overall Study||10
8622978|NCT00490802|9662189|FG001|STARTED|Overall Study||9
8622979|NCT00490802|9662188|FG000|COMPLETED|Overall Study||9
8622980|NCT00490802|9662189|FG001|COMPLETED|Overall Study||7
8622981|NCT00490802|9662188|FG000|NOT COMPLETED|Overall Study||1
8622982|NCT00490802|9662189|FG001|NOT COMPLETED|Overall Study||2
8622983|NCT00490815|9662198|FG000|STARTED|Overall Study||20
8622984|NCT00490815|9662199|FG001|STARTED|Overall Study||17
8622985|NCT00490815|9662198|FG000|COMPLETED|Overall Study||12
8622986|NCT00490815|9662199|FG001|COMPLETED|Overall Study||8
8622987|NCT00490815|9662198|FG000|NOT COMPLETED|Overall Study||8
8622988|NCT00490815|9662199|FG001|NOT COMPLETED|Overall Study||9
8837710|NCT01673646|9892051|FG002|COMPLETED|Overall Study||7
8837711|NCT01673646|9892049|FG000|NOT COMPLETED|Overall Study||4
8837712|NCT01673646|9892050|FG001|NOT COMPLETED|Overall Study||7
8837713|NCT01673646|9892051|FG002|NOT COMPLETED|Overall Study||4
8837714|NCT01673698|9892065|FG000|STARTED|Overall Study||187
8837715|NCT01673698|9892066|FG001|STARTED|Overall Study||139
8837716|NCT01673698|9892065|FG000|COMPLETED|Overall Study||136
8837717|NCT01673698|9892066|FG001|COMPLETED|Overall Study||126
8837718|NCT01673698|9892065|FG000|NOT COMPLETED|Overall Study||51
8622989|NCT00490841|9662205|FG000|STARTED|Overall Study||202
8622990|NCT00490841|9662205|FG000|COMPLETED|Overall Study||189
8622991|NCT00490841|9662205|FG000|NOT COMPLETED|Overall Study||13
8622992|NCT00490919|9662212|FG000|STARTED|Open-label Run-in Period||1024
8622993|NCT00490919|9662213|FG001|STARTED|Open-label Run-in Period||0
8622994|NCT00490919|9662214|FG002|STARTED|Open-label Run-in Period||0
8622995|NCT00490919|9662212|FG000|COMPLETED|Open-label Run-in Period|Completed run-in and randomized; however 2 had no safety data after randomization visit (N = 539)|541
8622996|NCT00490919|9662213|FG001|COMPLETED|Open-label Run-in Period||0
8837719|NCT01673698|9892066|FG001|NOT COMPLETED|Overall Study||13
8837720|NCT01673802|9892073|FG000|STARTED|Gadoxetate Standard Dose 0.025 mmol/kg||8
8837721|NCT01673802|9892073|FG000|COMPLETED|Gadoxetate Standard Dose 0.025 mmol/kg||8
8837722|NCT01673802|9892073|FG000|NOT COMPLETED|Gadoxetate Standard Dose 0.025 mmol/kg||0
8837723|NCT01673802|9892073|FG000|STARTED|Gadoxetate Double Dose 0.050 mmol/kg||10
8837724|NCT01673802|9892073|FG000|COMPLETED|Gadoxetate Double Dose 0.050 mmol/kg||10
8837725|NCT01673802|9892073|FG000|NOT COMPLETED|Gadoxetate Double Dose 0.050 mmol/kg||0
8837726|NCT01673828|9892079|FG000|STARTED|Overall Study||7
8837727|NCT01673828|9892080|FG001|STARTED|Overall Study||6
8837728|NCT01673828|9892079|FG000|COMPLETED|Overall Study||7
8837729|NCT01673828|9892080|FG001|COMPLETED|Overall Study||6
8837730|NCT01673828|9892079|FG000|NOT COMPLETED|Overall Study||0
8837731|NCT01673828|9892080|FG001|NOT COMPLETED|Overall Study||0
8837732|NCT01673854|9892086|FG000|STARTED|Vem 1 Phase (Vemurafenib, 960 mg)||46
8837733|NCT01673854|9892086|FG000|COMPLETED|Vem 1 Phase (Vemurafenib, 960 mg)||46
8837734|NCT01673854|9892086|FG000|NOT COMPLETED|Vem 1 Phase (Vemurafenib, 960 mg)||0
8837735|NCT01673854|9892086|FG000|STARTED|Ipilimumab Phase (Ipilimumab, 10 mg/kg)||46
8837736|NCT01673854|9892086|FG000|COMPLETED|Ipilimumab Phase (Ipilimumab, 10 mg/kg)||19
8837737|NCT01673854|9892086|FG000|NOT COMPLETED|Ipilimumab Phase (Ipilimumab, 10 mg/kg)||27
8837738|NCT01673854|9892086|FG000|STARTED|Vem 2 Phase (Vemurafenib Retreatment)||19
8837739|NCT01673854|9892086|FG000|COMPLETED|Vem 2 Phase (Vemurafenib Retreatment)||0
8837740|NCT01673854|9892086|FG000|NOT COMPLETED|Vem 2 Phase (Vemurafenib Retreatment)||19
8837741|NCT01673893|9892092|FG000|STARTED|Overall Study||59
8837742|NCT01673893|9892092|FG000|COMPLETED|Overall Study||59
8837743|NCT01673893|9892092|FG000|NOT COMPLETED|Overall Study||0
8837744|NCT01673919|9892098|FG000|STARTED|Overall Study||7
8837745|NCT01673919|9892098|FG000|COMPLETED|Overall Study||7
8837746|NCT01673919|9892098|FG000|NOT COMPLETED|Overall Study||0
8837747|NCT01673984|9892104|FG000|STARTED|Overall Study||14
8837748|NCT01673984|9892105|FG001|STARTED|Overall Study||7
8837749|NCT01673984|9892104|FG000|COMPLETED|Overall Study||4
8837750|NCT01673984|9892105|FG001|COMPLETED|Overall Study||1
8837751|NCT01673984|9892104|FG000|NOT COMPLETED|Overall Study||10
8837752|NCT01673984|9892105|FG001|NOT COMPLETED|Overall Study||6
8837753|NCT01674010|9892111|FG000|STARTED|Open Treatment Phase 1||309
8837754|NCT01674010|9892112|FG001|STARTED|Open Treatment Phase 1||0
8837755|NCT01674010|9892113|FG002|STARTED|Open Treatment Phase 1||0
8837756|NCT01674010|9892111|FG000|COMPLETED|Open Treatment Phase 1||129
8837757|NCT01674010|9892112|FG001|COMPLETED|Open Treatment Phase 1||0
8837758|NCT01674010|9892113|FG002|COMPLETED|Open Treatment Phase 1||0
8837759|NCT01674010|9892111|FG000|NOT COMPLETED|Open Treatment Phase 1||180
8837760|NCT01674010|9892112|FG001|NOT COMPLETED|Open Treatment Phase 1||0
8837761|NCT01674010|9892113|FG002|NOT COMPLETED|Open Treatment Phase 1||0
8622997|NCT00490919|9662214|FG002|COMPLETED|Open-label Run-in Period||0
8622998|NCT00490919|9662212|FG000|NOT COMPLETED|Open-label Run-in Period||483
8837762|NCT01674010|9892111|FG000|STARTED|Randomization Phase 2||0
8837763|NCT01674010|9892112|FG001|STARTED|Randomization Phase 2||65
8837764|NCT01674010|9892113|FG002|STARTED|Randomization Phase 2||64
8837765|NCT01674010|9892111|FG000|COMPLETED|Randomization Phase 2||0
8837766|NCT01674010|9892112|FG001|COMPLETED|Randomization Phase 2||3
8837767|NCT01674010|9892113|FG002|COMPLETED|Randomization Phase 2||3
8837768|NCT01674010|9892111|FG000|NOT COMPLETED|Randomization Phase 2||0
8837769|NCT01674010|9892112|FG001|NOT COMPLETED|Randomization Phase 2||62
8837770|NCT01674010|9892113|FG002|NOT COMPLETED|Randomization Phase 2||61
8837771|NCT01674062|9892123|FG000|STARTED|Overall Study||66
8837772|NCT01674062|9892124|FG001|STARTED|Overall Study||29
8837773|NCT01674062|9892123|FG000|COMPLETED|Overall Study||0
8837774|NCT01674062|9892124|FG001|COMPLETED|Overall Study||0
8837775|NCT01674062|9892123|FG000|NOT COMPLETED|Overall Study||66
8837776|NCT01674062|9892124|FG001|NOT COMPLETED|Overall Study||29
8837777|NCT01674478|9892132|FG000|STARTED|Overall Study||9
8837778|NCT01674478|9892133|FG001|STARTED|Overall Study||9
8837779|NCT01674478|9892132|FG000|COMPLETED|Overall Study||9
8837780|NCT01674478|9892133|FG001|COMPLETED|Overall Study||9
8837781|NCT01674478|9892132|FG000|NOT COMPLETED|Overall Study||0
8837782|NCT01674478|9892133|FG001|NOT COMPLETED|Overall Study||0
8837783|NCT01674569|9892139|FG000|STARTED|Overall Study||3
8837784|NCT01674569|9892140|FG001|STARTED|Overall Study||8
8837785|NCT01674569|9892141|FG002|STARTED|Overall Study||4
8837786|NCT01674569|9892142|FG003|STARTED|Overall Study||10
8837787|NCT01674569|9892143|FG004|STARTED|Overall Study||7
8837788|NCT01674569|9892144|FG005|STARTED|Overall Study||3
8837789|NCT01674569|9892139|FG000|COMPLETED|Overall Study||3
8837790|NCT01674569|9892140|FG001|COMPLETED|Overall Study||5
8837791|NCT01674569|9892141|FG002|COMPLETED|Overall Study||2
8837792|NCT01674569|9892142|FG003|COMPLETED|Overall Study||9
8837793|NCT01674569|9892143|FG004|COMPLETED|Overall Study||5
8837794|NCT01674569|9892144|FG005|COMPLETED|Overall Study||1
8837795|NCT01674569|9892139|FG000|NOT COMPLETED|Overall Study||0
8837796|NCT01674569|9892140|FG001|NOT COMPLETED|Overall Study||3
8837797|NCT01674569|9892141|FG002|NOT COMPLETED|Overall Study||2
8837798|NCT01674569|9892142|FG003|NOT COMPLETED|Overall Study||1
8837799|NCT01674569|9892143|FG004|NOT COMPLETED|Overall Study||2
8837800|NCT01674569|9892144|FG005|NOT COMPLETED|Overall Study||2
8837801|NCT01674621|9892153|FG000|STARTED|Overall Study||50
8837802|NCT01674621|9892154|FG001|STARTED|Overall Study||51
8622999|NCT00490919|9662213|FG001|NOT COMPLETED|Open-label Run-in Period||0
8837803|NCT01674621|9892155|FG002|STARTED|Overall Study||48
8837804|NCT01674621|9892156|FG003|STARTED|Overall Study||51
8837805|NCT01674621|9892157|FG004|STARTED|Overall Study||50
8837806|NCT01674621|9892153|FG000|Modified Intent-to-Treat Population|Overall Study||47
8837807|NCT01674621|9892154|FG001|Modified Intent-to-Treat Population|Overall Study||46
8837808|NCT01674621|9892155|FG002|Modified Intent-to-Treat Population|Overall Study||43
8837809|NCT01674621|9892156|FG003|Modified Intent-to-Treat Population|Overall Study||49
8837810|NCT01674621|9892157|FG004|Modified Intent-to-Treat Population|Overall Study||46
8837811|NCT01674621|9892153|FG000|Safety Population|Overall Study||50
8837812|NCT01674621|9892154|FG001|Safety Population|Overall Study||51
8837813|NCT01674621|9892155|FG002|Safety Population|Overall Study||47
8837814|NCT01674621|9892156|FG003|Safety Population|Overall Study||51
8837815|NCT01674621|9892157|FG004|Safety Population|Overall Study||50
8837816|NCT01674621|9892153|FG000|COMPLETED|Overall Study||45
8837817|NCT01674621|9892154|FG001|COMPLETED|Overall Study||43
8837818|NCT01674621|9892155|FG002|COMPLETED|Overall Study||41
8837819|NCT01674621|9892156|FG003|COMPLETED|Overall Study||45
8837820|NCT01674621|9892157|FG004|COMPLETED|Overall Study||44
8837821|NCT01674621|9892153|FG000|NOT COMPLETED|Overall Study||5
8837822|NCT01674621|9892154|FG001|NOT COMPLETED|Overall Study||8
8837823|NCT01674621|9892155|FG002|NOT COMPLETED|Overall Study||7
8837824|NCT01674621|9892156|FG003|NOT COMPLETED|Overall Study||6
8837825|NCT01674621|9892157|FG004|NOT COMPLETED|Overall Study||6
8837826|NCT01674634|9892170|FG000|STARTED|Overall Study||715
8837827|NCT01674634|9892170|FG000|COMPLETED|Overall Study||709
8837828|NCT01674634|9892170|FG000|NOT COMPLETED|Overall Study||6
8837829|NCT01674647|9892180|FG000|STARTED|Treatment Period||1002
8837830|NCT01674647|9892181|FG001|STARTED|Treatment Period||502
8837831|NCT01674647|9892180|FG000|Subjects Received Treatment|Treatment Period||988
8837832|NCT01674647|9892181|FG001|Subjects Received Treatment|Treatment Period||499
8837833|NCT01674647|9892180|FG000|COMPLETED|Treatment Period||846
8837834|NCT01674647|9892181|FG001|COMPLETED|Treatment Period||400
8837835|NCT01674647|9892180|FG000|NOT COMPLETED|Treatment Period||156
8837836|NCT01674647|9892181|FG001|NOT COMPLETED|Treatment Period||102
8837837|NCT01674647|9892180|FG000|STARTED|30-day Safety Follow-up Period||982
8837838|NCT01674647|9892181|FG001|STARTED|30-day Safety Follow-up Period||487
8837839|NCT01674647|9892180|FG000|COMPLETED|30-day Safety Follow-up Period||924
8837840|NCT01674647|9892181|FG001|COMPLETED|30-day Safety Follow-up Period||446
8837841|NCT01674647|9892180|FG000|NOT COMPLETED|30-day Safety Follow-up Period||58
8837842|NCT01674647|9892181|FG001|NOT COMPLETED|30-day Safety Follow-up Period||41
8837843|NCT01674712|9892192|FG000|STARTED|Overall Study||114
8837844|NCT01674712|9892193|FG001|STARTED|Overall Study||117
8837845|NCT01674712|9892194|FG002|STARTED|Overall Study||115
8837846|NCT01674712|9892195|FG003|STARTED|Overall Study||116
8837847|NCT01674712|9892196|FG004|STARTED|Overall Study||113
8837848|NCT01674712|9892192|FG000|Full Analysis Subject Sample|Overall Study||109
8837849|NCT01674712|9892193|FG001|Full Analysis Subject Sample|Overall Study||114
8837850|NCT01674712|9892194|FG002|Full Analysis Subject Sample|Overall Study||110
8837851|NCT01674712|9892195|FG003|Full Analysis Subject Sample|Overall Study||112
8837852|NCT01674712|9892196|FG004|Full Analysis Subject Sample|Overall Study||111
8837853|NCT01674712|9892192|FG000|Safety Subject Sample|Overall Study||111
8837854|NCT01674712|9892193|FG001|Safety Subject Sample|Overall Study||117
8837855|NCT01674712|9892194|FG002|Safety Subject Sample|Overall Study||113
8837856|NCT01674712|9892195|FG003|Safety Subject Sample|Overall Study||115
8837857|NCT01674712|9892196|FG004|Safety Subject Sample|Overall Study||112
8837858|NCT01674712|9892192|FG000|COMPLETED|Overall Study||104
8837859|NCT01674712|9892193|FG001|COMPLETED|Overall Study||108
8837860|NCT01674712|9892194|FG002|COMPLETED|Overall Study||106
8837861|NCT01674712|9892195|FG003|COMPLETED|Overall Study||108
8837862|NCT01674712|9892196|FG004|COMPLETED|Overall Study||102
8837863|NCT01674712|9892192|FG000|NOT COMPLETED|Overall Study||10
8837864|NCT01674712|9892193|FG001|NOT COMPLETED|Overall Study||9
8837865|NCT01674712|9892194|FG002|NOT COMPLETED|Overall Study||9
8837866|NCT01674712|9892195|FG003|NOT COMPLETED|Overall Study||8
8837867|NCT01674712|9892196|FG004|NOT COMPLETED|Overall Study||11
8837868|NCT01674725|9892210|FG000|STARTED|Overall Study||92
8837869|NCT01674725|9892211|FG001|STARTED|Overall Study||95
8837870|NCT01674725|9892210|FG000|COMPLETED|Overall Study||89
8837871|NCT01674725|9892211|FG001|COMPLETED|Overall Study||94
8837872|NCT01674725|9892210|FG000|NOT COMPLETED|Overall Study||3
8837873|NCT01674725|9892211|FG001|NOT COMPLETED|Overall Study||1
8837874|NCT01675050|9892219|FG000|STARTED|Period One Treatment||2
8837875|NCT01675050|9892220|FG001|STARTED|Period One Treatment||2
8837876|NCT01675050|9892219|FG000|COMPLETED|Period One Treatment||1
8837877|NCT01675050|9892220|FG001|COMPLETED|Period One Treatment||2
8837878|NCT01675050|9892219|FG000|NOT COMPLETED|Period One Treatment||1
8837879|NCT01675050|9892220|FG001|NOT COMPLETED|Period One Treatment||0
8837880|NCT01675050|9892219|FG000|STARTED|Wash Out Period||1
8837881|NCT01675050|9892220|FG001|STARTED|Wash Out Period||2
8837882|NCT01675050|9892219|FG000|COMPLETED|Wash Out Period||1
8837883|NCT01675050|9892220|FG001|COMPLETED|Wash Out Period||2
8837884|NCT01675050|9892219|FG000|NOT COMPLETED|Wash Out Period||0
8837885|NCT01675050|9892220|FG001|NOT COMPLETED|Wash Out Period||0
8837886|NCT01675050|9892219|FG000|STARTED|Second Period Treatment||1
8837887|NCT01675050|9892220|FG001|STARTED|Second Period Treatment||2
8837888|NCT01675050|9892219|FG000|COMPLETED|Second Period Treatment||1
8837889|NCT01675050|9892220|FG001|COMPLETED|Second Period Treatment||2
8837890|NCT01675050|9892219|FG000|NOT COMPLETED|Second Period Treatment||0
8837891|NCT01675050|9892220|FG001|NOT COMPLETED|Second Period Treatment||0
8837892|NCT01675063|9892226|FG000|STARTED|Overall Study||77
8837893|NCT01675063|9892226|FG000|COMPLETED|Overall Study||77
8837894|NCT01675063|9892226|FG000|NOT COMPLETED|Overall Study||0
8837895|NCT01675128|9892233|FG000|STARTED|Overall Study||4
8837896|NCT01675128|9892234|FG001|STARTED|Overall Study||10
8837897|NCT01675128|9892235|FG002|STARTED|Overall Study||10
8837898|NCT01675128|9892233|FG000|COMPLETED|Overall Study||2
8837899|NCT01675128|9892234|FG001|COMPLETED|Overall Study||8
8837900|NCT01675128|9892235|FG002|COMPLETED|Overall Study||9
8837901|NCT01675128|9892233|FG000|NOT COMPLETED|Overall Study||2
8837902|NCT01675128|9892234|FG001|NOT COMPLETED|Overall Study||2
8837903|NCT01675128|9892235|FG002|NOT COMPLETED|Overall Study||1
8837904|NCT01675141|9892250|FG000|STARTED|Overall Study||11
8837905|NCT01675141|9892250|FG000|COMPLETED|Overall Study||0
8837906|NCT01675141|9892250|FG000|NOT COMPLETED|Overall Study||11
8837907|NCT01675154|9892258|FG000|STARTED|First Intervention Period (4 Weeks)||2
8837908|NCT01675154|9892259|FG001|STARTED|First Intervention Period (4 Weeks)||1
8837909|NCT01675154|9892260|FG002|STARTED|First Intervention Period (4 Weeks)||1
8837910|NCT01675154|9892261|FG003|STARTED|First Intervention Period (4 Weeks)||1
8837911|NCT01675154|9892258|FG000|COMPLETED|First Intervention Period (4 Weeks)||2
8837912|NCT01675154|9892259|FG001|COMPLETED|First Intervention Period (4 Weeks)||1
8837913|NCT01675154|9892260|FG002|COMPLETED|First Intervention Period (4 Weeks)||1
8837914|NCT01675154|9892261|FG003|COMPLETED|First Intervention Period (4 Weeks)||1
8837915|NCT01675154|9892258|FG000|NOT COMPLETED|First Intervention Period (4 Weeks)||0
8837916|NCT01675154|9892259|FG001|NOT COMPLETED|First Intervention Period (4 Weeks)||0
8837917|NCT01675154|9892260|FG002|NOT COMPLETED|First Intervention Period (4 Weeks)||0
8837918|NCT01675154|9892261|FG003|NOT COMPLETED|First Intervention Period (4 Weeks)||0
8837919|NCT01675154|9892258|FG000|STARTED|First Washout Period (1 Week)|Subjects were enrolled Regimen 1|2
8837920|NCT01675154|9892259|FG001|STARTED|First Washout Period (1 Week)||1
8837921|NCT01675154|9892260|FG002|STARTED|First Washout Period (1 Week)||1
8837922|NCT01675154|9892261|FG003|STARTED|First Washout Period (1 Week)||1
8837923|NCT01675154|9892258|FG000|COMPLETED|First Washout Period (1 Week)||2
8837924|NCT01675154|9892259|FG001|COMPLETED|First Washout Period (1 Week)||1
8837925|NCT01675154|9892260|FG002|COMPLETED|First Washout Period (1 Week)||1
8837926|NCT01675154|9892261|FG003|COMPLETED|First Washout Period (1 Week)||1
8837927|NCT01675154|9892258|FG000|NOT COMPLETED|First Washout Period (1 Week)||0
8837928|NCT01675154|9892259|FG001|NOT COMPLETED|First Washout Period (1 Week)||0
8837929|NCT01675154|9892260|FG002|NOT COMPLETED|First Washout Period (1 Week)||0
8837930|NCT01675154|9892261|FG003|NOT COMPLETED|First Washout Period (1 Week)||0
8837931|NCT01675154|9892258|FG000|STARTED|Second Intervention Period (4 Weeks)||1
8837932|NCT01675154|9892259|FG001|STARTED|Second Intervention Period (4 Weeks)|Subjects were enrolled in Regimen 2|1
8837933|NCT01675154|9892260|FG002|STARTED|Second Intervention Period (4 Weeks)||1
8837934|NCT01675154|9892261|FG003|STARTED|Second Intervention Period (4 Weeks)||2
8837935|NCT01675154|9892258|FG000|COMPLETED|Second Intervention Period (4 Weeks)||0
8837936|NCT01675154|9892259|FG001|COMPLETED|Second Intervention Period (4 Weeks)||1
8837937|NCT01675154|9892260|FG002|COMPLETED|Second Intervention Period (4 Weeks)||1
8837938|NCT01675154|9892261|FG003|COMPLETED|Second Intervention Period (4 Weeks)||1
8837939|NCT01675154|9892258|FG000|NOT COMPLETED|Second Intervention Period (4 Weeks)||1
8837940|NCT01675154|9892259|FG001|NOT COMPLETED|Second Intervention Period (4 Weeks)||0
8837941|NCT01675154|9892260|FG002|NOT COMPLETED|Second Intervention Period (4 Weeks)||0
8837942|NCT01675154|9892261|FG003|NOT COMPLETED|Second Intervention Period (4 Weeks)||1
8837943|NCT01675154|9892258|FG000|STARTED|Second Washout Period (1 Week)||1
8837944|NCT01675154|9892259|FG001|STARTED|Second Washout Period (1 Week)||1
8837945|NCT01675154|9892260|FG002|STARTED|Second Washout Period (1 Week)||1
8837946|NCT01675154|9892261|FG003|STARTED|Second Washout Period (1 Week)||2
8837947|NCT01675154|9892258|FG000|COMPLETED|Second Washout Period (1 Week)||1
8837948|NCT01675154|9892259|FG001|COMPLETED|Second Washout Period (1 Week)||1
8837949|NCT01675154|9892260|FG002|COMPLETED|Second Washout Period (1 Week)||1
8837950|NCT01675154|9892261|FG003|COMPLETED|Second Washout Period (1 Week)||2
8837951|NCT01675154|9892258|FG000|NOT COMPLETED|Second Washout Period (1 Week)||0
8837952|NCT01675154|9892259|FG001|NOT COMPLETED|Second Washout Period (1 Week)||0
8837953|NCT01675154|9892260|FG002|NOT COMPLETED|Second Washout Period (1 Week)||0
8837954|NCT01675154|9892261|FG003|NOT COMPLETED|Second Washout Period (1 Week)||0
8837955|NCT01675154|9892258|FG000|STARTED|Third Intervention Period (4 Weeks)||1
8837956|NCT01675154|9892259|FG001|STARTED|Third Intervention Period (4 Weeks)||1
8837957|NCT01675154|9892260|FG002|STARTED|Third Intervention Period (4 Weeks)||1
8837958|NCT01675154|9892261|FG003|STARTED|Third Intervention Period (4 Weeks)||0
8837959|NCT01675154|9892258|FG000|COMPLETED|Third Intervention Period (4 Weeks)||1
8837960|NCT01675154|9892259|FG001|COMPLETED|Third Intervention Period (4 Weeks)||0
8837961|NCT01675154|9892260|FG002|COMPLETED|Third Intervention Period (4 Weeks)||1
8837962|NCT01675154|9892261|FG003|COMPLETED|Third Intervention Period (4 Weeks)||0
8837963|NCT01675154|9892258|FG000|NOT COMPLETED|Third Intervention Period (4 Weeks)||0
8837964|NCT01675154|9892259|FG001|NOT COMPLETED|Third Intervention Period (4 Weeks)||1
8850025|NCT01744574|9905220|FG000|COMPLETED|Overall Study||33
8623000|NCT00490919|9662214|FG002|NOT COMPLETED|Open-label Run-in Period||0
8623001|NCT00490919|9662212|FG000|STARTED|Double-blind Phase||0
8629668|NCT00531050|9669386|FG005|STARTED|Part 2: Period 2||4
8837965|NCT01675154|9892260|FG002|NOT COMPLETED|Third Intervention Period (4 Weeks)||0
8837966|NCT01675154|9892261|FG003|NOT COMPLETED|Third Intervention Period (4 Weeks)||0
8837967|NCT01675154|9892258|FG000|STARTED|Third Washout Period (1 Week)||1
8837968|NCT01675154|9892259|FG001|STARTED|Third Washout Period (1 Week)||0
8837969|NCT01675154|9892260|FG002|STARTED|Third Washout Period (1 Week)||1
8837970|NCT01675154|9892261|FG003|STARTED|Third Washout Period (1 Week)||0
8837971|NCT01675154|9892258|FG000|COMPLETED|Third Washout Period (1 Week)||1
8837972|NCT01675154|9892259|FG001|COMPLETED|Third Washout Period (1 Week)||0
8837973|NCT01675154|9892260|FG002|COMPLETED|Third Washout Period (1 Week)||1
8837974|NCT01675154|9892261|FG003|COMPLETED|Third Washout Period (1 Week)||0
8837975|NCT01675154|9892258|FG000|NOT COMPLETED|Third Washout Period (1 Week)||0
8837976|NCT01675154|9892259|FG001|NOT COMPLETED|Third Washout Period (1 Week)||0
8837977|NCT01675154|9892260|FG002|NOT COMPLETED|Third Washout Period (1 Week)||0
8837978|NCT01675154|9892261|FG003|NOT COMPLETED|Third Washout Period (1 Week)||0
8837979|NCT01675154|9892258|FG000|STARTED|Fourth Intervention Period (4 Weeks)||1
8837980|NCT01675154|9892259|FG001|STARTED|Fourth Intervention Period (4 Weeks)||0
8837981|NCT01675154|9892260|FG002|STARTED|Fourth Intervention Period (4 Weeks)||1
8837982|NCT01675154|9892261|FG003|STARTED|Fourth Intervention Period (4 Weeks)||0
8837983|NCT01675154|9892258|FG000|COMPLETED|Fourth Intervention Period (4 Weeks)||1
8837984|NCT01675154|9892259|FG001|COMPLETED|Fourth Intervention Period (4 Weeks)||0
8837985|NCT01675154|9892260|FG002|COMPLETED|Fourth Intervention Period (4 Weeks)||1
8837986|NCT01675154|9892261|FG003|COMPLETED|Fourth Intervention Period (4 Weeks)||0
8837987|NCT01675154|9892258|FG000|NOT COMPLETED|Fourth Intervention Period (4 Weeks)||0
8837988|NCT01675154|9892259|FG001|NOT COMPLETED|Fourth Intervention Period (4 Weeks)||0
8837989|NCT01675154|9892260|FG002|NOT COMPLETED|Fourth Intervention Period (4 Weeks)||0
8837990|NCT01675154|9892261|FG003|NOT COMPLETED|Fourth Intervention Period (4 Weeks)||0
8837991|NCT01675167|9892285|FG000|STARTED|Open-label Titration Phase||815
8837992|NCT01675167|9892286|FG001|STARTED|Open-label Titration Phase||0
8837993|NCT01675167|9892287|FG002|STARTED|Open-label Titration Phase||0
8837994|NCT01675167|9892285|FG000|COMPLETED|Open-label Titration Phase||511
8837995|NCT01675167|9892286|FG001|COMPLETED|Open-label Titration Phase||0
8837996|NCT01675167|9892287|FG002|COMPLETED|Open-label Titration Phase||0
8837997|NCT01675167|9892285|FG000|NOT COMPLETED|Open-label Titration Phase||304
8837998|NCT01675167|9892286|FG001|NOT COMPLETED|Open-label Titration Phase||0
8837999|NCT01675167|9892287|FG002|NOT COMPLETED|Open-label Titration Phase||0
8838000|NCT01675167|9892285|FG000|STARTED|Double-blind Treatment Phase|All subjects completing OL titration in the previous period were randomized to a DB treatment.|0
8838001|NCT01675167|9892286|FG001|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|254
8838002|NCT01675167|9892287|FG002|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|257
8838003|NCT01675167|9892285|FG000|COMPLETED|Double-blind Treatment Phase||0
8838004|NCT01675167|9892286|FG001|COMPLETED|Double-blind Treatment Phase||206
8838005|NCT01675167|9892287|FG002|COMPLETED|Double-blind Treatment Phase||147
8838006|NCT01675167|9892285|FG000|NOT COMPLETED|Double-blind Treatment Phase||0
8838007|NCT01675167|9892286|FG001|NOT COMPLETED|Double-blind Treatment Phase||48
8838008|NCT01675167|9892287|FG002|NOT COMPLETED|Double-blind Treatment Phase||110
8838009|NCT01675297|9892297|FG000|STARTED|Overall Study||806
8838010|NCT01675297|9892298|FG001|STARTED|Overall Study||247
8838011|NCT01675297|9892297|FG000|COMPLETED|Overall Study||642
8838012|NCT01675297|9892298|FG001|COMPLETED|Overall Study||199
8838013|NCT01675297|9892297|FG000|NOT COMPLETED|Overall Study||164
8838014|NCT01675297|9892298|FG001|NOT COMPLETED|Overall Study||48
8838015|NCT01675427|9892304|FG000|STARTED|Overall Study||4766
8838016|NCT01675427|9892304|FG000|COMPLETED|Overall Study||4732
8838017|NCT01675427|9892304|FG000|NOT COMPLETED|Overall Study||34
8838018|NCT01675453|9892340|FG000|STARTED|Overall Study||20
8838019|NCT01675453|9892341|FG001|STARTED|Overall Study||20
8838020|NCT01675453|9892340|FG000|COMPLETED|Overall Study||20
8838021|NCT01675453|9892341|FG001|COMPLETED|Overall Study||20
8838022|NCT01675453|9892340|FG000|NOT COMPLETED|Overall Study||0
8838023|NCT01675453|9892341|FG001|NOT COMPLETED|Overall Study||0
8838024|NCT01675492|9892347|FG000|STARTED|Overall Study||84
8838025|NCT01675492|9892347|FG000|COMPLETED|Overall Study||42
8838026|NCT01675492|9892347|FG000|NOT COMPLETED|Overall Study||42
8838027|NCT01675531|9892352|FG000|STARTED|Overall Study||66
8838028|NCT01675531|9892352|FG000|COMPLETED|Overall Study||41
8838029|NCT01675531|9892352|FG000|NOT COMPLETED|Overall Study||25
8838030|NCT01675544|9892357|FG000|STARTED|Overall Study||46
8838031|NCT01675544|9892357|FG000|COMPLETED|Overall Study||44
8838032|NCT01675544|9892357|FG000|NOT COMPLETED|Overall Study||2
8838033|NCT01675596|9892361|FG000|STARTED|Overall Study|One patient did not receive the study device.|199
8838034|NCT01675596|9892361|FG000|COMPLETED|Overall Study||191
8838035|NCT01675596|9892361|FG000|NOT COMPLETED|Overall Study||8
8838036|NCT01675622|9892367|FG000|STARTED|Overall Study||122
8838037|NCT01675622|9892368|FG001|STARTED|Overall Study||120
8838038|NCT01675622|9892367|FG000|COMPLETED|Overall Study||96
8838039|NCT01675622|9892368|FG001|COMPLETED|Overall Study||96
8838040|NCT01675622|9892367|FG000|NOT COMPLETED|Overall Study||26
8838041|NCT01675622|9892368|FG001|NOT COMPLETED|Overall Study||24
8838042|NCT01675635|9892376|FG000|STARTED|Overall Study||117
8838043|NCT01675635|9892377|FG001|STARTED|Overall Study||117
8838044|NCT01675635|9892376|FG000|COMPLETED|Overall Study||117
8838045|NCT01675635|9892377|FG001|COMPLETED|Overall Study||117
8838046|NCT01675635|9892376|FG000|NOT COMPLETED|Overall Study||0
8838047|NCT01675635|9892377|FG001|NOT COMPLETED|Overall Study||0
8838048|NCT01675661|9892390|FG000|STARTED|Overall Study||153
8838049|NCT01675661|9892391|FG001|STARTED|Overall Study||149
8838050|NCT01675661|9892390|FG000|COMPLETED|Overall Study||113
8838051|NCT01675661|9892391|FG001|COMPLETED|Overall Study||103
8838052|NCT01675661|9892390|FG000|NOT COMPLETED|Overall Study||40
8838053|NCT01675661|9892391|FG001|NOT COMPLETED|Overall Study||46
8838054|NCT01675765|9892399|FG000|STARTED|Overall Study||38
8838055|NCT01675765|9892400|FG001|STARTED|Overall Study||22
8838056|NCT01675765|9892399|FG000|COMPLETED|Overall Study||27
8838057|NCT01675765|9892400|FG001|COMPLETED|Overall Study||14
8838058|NCT01675765|9892399|FG000|NOT COMPLETED|Overall Study||11
8838059|NCT01675765|9892400|FG001|NOT COMPLETED|Overall Study||8
8838060|NCT01675778|9892406|FG000|STARTED|Overall Study||174
8838061|NCT01675778|9892406|FG000|COMPLETED|Overall Study||174
8838062|NCT01675778|9892406|FG000|NOT COMPLETED|Overall Study||0
8838063|NCT01675830|9892411|FG000|STARTED|Overall Study||10
8838064|NCT01675830|9892411|FG000|COMPLETED|Overall Study||10
8838065|NCT01675830|9892411|FG000|NOT COMPLETED|Overall Study||0
8838066|NCT01675882|9892419|FG000|STARTED|Overall Study||53
8838067|NCT01675882|9892420|FG001|STARTED|Overall Study||56
8838068|NCT01675882|9892421|FG002|STARTED|Overall Study||56
8838069|NCT01675882|9892422|FG003|STARTED|Overall Study||56
8838070|NCT01675882|9892419|FG000|COMPLETED|Overall Study||51
8838071|NCT01675882|9892420|FG001|COMPLETED|Overall Study||49
8838072|NCT01675882|9892421|FG002|COMPLETED|Overall Study||53
8838073|NCT01675882|9892422|FG003|COMPLETED|Overall Study||54
8838074|NCT01675882|9892419|FG000|NOT COMPLETED|Overall Study||2
8838075|NCT01675882|9892420|FG001|NOT COMPLETED|Overall Study||7
8838076|NCT01675882|9892421|FG002|NOT COMPLETED|Overall Study||3
8838077|NCT01675882|9892422|FG003|NOT COMPLETED|Overall Study||2
8838078|NCT01676012|9892432|FG000|STARTED|Overall Study||32
8838079|NCT01676012|9892432|FG000|COMPLETED|Overall Study||29
8838080|NCT01676012|9892432|FG000|NOT COMPLETED|Overall Study||3
8838081|NCT01676116|9892438|FG000|STARTED|Overall Study||292
8838082|NCT01676116|9892439|FG001|STARTED|Overall Study||146
8838083|NCT01676116|9892438|FG000|COMPLETED|Overall Study||276
8838084|NCT01676116|9892439|FG001|COMPLETED|Overall Study||117
8838085|NCT01676116|9892438|FG000|NOT COMPLETED|Overall Study||16
8838086|NCT01676116|9892439|FG001|NOT COMPLETED|Overall Study||29
8838087|NCT01676220|9892447|FG000|STARTED|Overall Study||439
8838088|NCT01676220|9892448|FG001|STARTED|Overall Study||439
8838089|NCT01676220|9892447|FG000|Treated|Overall Study||435
8838090|NCT01676220|9892448|FG001|Treated|Overall Study||438
8838091|NCT01676220|9892447|FG000|Modified Intent-To-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|432
8838092|NCT01676220|9892448|FG001|Modified Intent-To-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|430
8838093|NCT01676220|9892447|FG000|COMPLETED|Overall Study||337
8838094|NCT01676220|9892448|FG001|COMPLETED|Overall Study||314
8838095|NCT01676220|9892447|FG000|NOT COMPLETED|Overall Study||102
8838096|NCT01676220|9892448|FG001|NOT COMPLETED|Overall Study||125
8838097|NCT01676298|9892464|FG000|STARTED|Overall Study||1
8838098|NCT01676298|9892465|FG001|STARTED|Overall Study||1
8838099|NCT01676298|9892466|FG002|STARTED|Overall Study||1
8944604|NCT02397460|10006445|FG002|STARTED|Treatment Period 3||6
8944605|NCT02397460|10006446|FG003|STARTED|Treatment Period 3||6
8944606|NCT02397460|10006447|FG004|STARTED|Treatment Period 3||6
8944607|NCT02397460|10006448|FG005|STARTED|Treatment Period 3||6
8944608|NCT02397460|10006449|FG006|STARTED|Treatment Period 3||6
8944609|NCT02397460|10006450|FG007|STARTED|Treatment Period 3||5
8944610|NCT02397460|10006443|FG000|COMPLETED|Treatment Period 3||7
8944611|NCT02397460|10006444|FG001|COMPLETED|Treatment Period 3||7
8944612|NCT02397460|10006445|FG002|COMPLETED|Treatment Period 3||6
8944613|NCT02397460|10006446|FG003|COMPLETED|Treatment Period 3||6
8944614|NCT02397460|10006447|FG004|COMPLETED|Treatment Period 3||6
8944615|NCT02397460|10006448|FG005|COMPLETED|Treatment Period 3||6
8944616|NCT02397460|10006449|FG006|COMPLETED|Treatment Period 3||6
8944617|NCT02397460|10006450|FG007|COMPLETED|Treatment Period 3||5
8944618|NCT02397460|10006443|FG000|NOT COMPLETED|Treatment Period 3||0
8944619|NCT02397460|10006444|FG001|NOT COMPLETED|Treatment Period 3||0
8944620|NCT02397460|10006445|FG002|NOT COMPLETED|Treatment Period 3||0
8944621|NCT02397460|10006446|FG003|NOT COMPLETED|Treatment Period 3||0
8944622|NCT02397460|10006447|FG004|NOT COMPLETED|Treatment Period 3||0
8944623|NCT02397460|10006448|FG005|NOT COMPLETED|Treatment Period 3||0
8944624|NCT02397460|10006449|FG006|NOT COMPLETED|Treatment Period 3||0
8944625|NCT02397460|10006450|FG007|NOT COMPLETED|Treatment Period 3||0
8944626|NCT02397460|10006443|FG000|STARTED|Treatment Period 4||7
8944627|NCT02397460|10006444|FG001|STARTED|Treatment Period 4||7
8944628|NCT02397460|10006445|FG002|STARTED|Treatment Period 4||6
8944629|NCT02397460|10006446|FG003|STARTED|Treatment Period 4||6
8944630|NCT02397460|10006447|FG004|STARTED|Treatment Period 4||6
8944631|NCT02397460|10006448|FG005|STARTED|Treatment Period 4||6
8944632|NCT02397460|10006449|FG006|STARTED|Treatment Period 4||6
8944633|NCT02397460|10006450|FG007|STARTED|Treatment Period 4||5
8838100|NCT01676298|9892467|FG003|STARTED|Overall Study||1
8838101|NCT01676298|9892468|FG004|STARTED|Overall Study||1
8838102|NCT01676298|9892469|FG005|STARTED|Overall Study||1
8838103|NCT01676298|9892470|FG006|STARTED|Overall Study||1
8838104|NCT01676298|9892471|FG007|STARTED|Overall Study||1
8838105|NCT01676298|9892464|FG000|All Genotypes Confirmed With Reference|Overall Study||1
8838106|NCT01676298|9892465|FG001|All Genotypes Confirmed With Reference|Overall Study||1
8838107|NCT01676298|9892466|FG002|All Genotypes Confirmed With Reference|Overall Study||1
8838108|NCT01676298|9892467|FG003|All Genotypes Confirmed With Reference|Overall Study||1
8838109|NCT01676298|9892468|FG004|All Genotypes Confirmed With Reference|Overall Study||1
8838110|NCT01676298|9892469|FG005|All Genotypes Confirmed With Reference|Overall Study||1
8838111|NCT01676298|9892470|FG006|All Genotypes Confirmed With Reference|Overall Study||1
8838112|NCT01676298|9892471|FG007|All Genotypes Confirmed With Reference|Overall Study||1
8838113|NCT01676298|9892464|FG000|Participated in All Tests|Overall Study||1
8838114|NCT01676298|9892465|FG001|Participated in All Tests|Overall Study||1
8838115|NCT01676298|9892466|FG002|Participated in All Tests|Overall Study||1
8838116|NCT01676298|9892467|FG003|Participated in All Tests|Overall Study||1
8838117|NCT01676298|9892468|FG004|Participated in All Tests|Overall Study||1
8838118|NCT01676298|9892469|FG005|Participated in All Tests|Overall Study||1
8838119|NCT01676298|9892470|FG006|Participated in All Tests|Overall Study||1
8838120|NCT01676298|9892471|FG007|Participated in All Tests|Overall Study||1
8838121|NCT01676298|9892464|FG000|COMPLETED|Overall Study||1
8838122|NCT01676298|9892465|FG001|COMPLETED|Overall Study||1
8838123|NCT01676298|9892466|FG002|COMPLETED|Overall Study||1
8838124|NCT01676298|9892467|FG003|COMPLETED|Overall Study||1
8838125|NCT01676298|9892468|FG004|COMPLETED|Overall Study||1
8838126|NCT01676298|9892469|FG005|COMPLETED|Overall Study||1
8838127|NCT01676298|9892470|FG006|COMPLETED|Overall Study||1
8838128|NCT01676298|9892471|FG007|COMPLETED|Overall Study||1
8838129|NCT01676298|9892464|FG000|NOT COMPLETED|Overall Study||0
8838130|NCT01676298|9892465|FG001|NOT COMPLETED|Overall Study||0
8838131|NCT01676298|9892466|FG002|NOT COMPLETED|Overall Study||0
8838132|NCT01676298|9892467|FG003|NOT COMPLETED|Overall Study||0
8838133|NCT01676298|9892468|FG004|NOT COMPLETED|Overall Study||0
8838134|NCT01676298|9892469|FG005|NOT COMPLETED|Overall Study||0
8838135|NCT01676298|9892470|FG006|NOT COMPLETED|Overall Study||0
8838136|NCT01676298|9892471|FG007|NOT COMPLETED|Overall Study||0
8838137|NCT01676311|9892491|FG000|STARTED|Overall Study||7
8838138|NCT01676311|9892492|FG001|STARTED|Overall Study||7
8838139|NCT01676311|9892491|FG000|COMPLETED|Overall Study||7
8838140|NCT01676311|9892492|FG001|COMPLETED|Overall Study||5
8838141|NCT01676311|9892491|FG000|NOT COMPLETED|Overall Study||0
8838142|NCT01676311|9892492|FG001|NOT COMPLETED|Overall Study||2
8838143|NCT01676415|9892500|FG000|STARTED|Overall Study||4
8838144|NCT01676415|9892501|FG001|STARTED|Overall Study||5
8838145|NCT01676415|9892500|FG000|COMPLETED|Overall Study||4
8838146|NCT01676415|9892501|FG001|COMPLETED|Overall Study||5
8838147|NCT01676415|9892500|FG000|NOT COMPLETED|Overall Study||0
8838148|NCT01676415|9892501|FG001|NOT COMPLETED|Overall Study||0
8838149|NCT01676532|9892507|FG000|STARTED|Overall Study||127
8838150|NCT01676532|9892507|FG000|COMPLETED|Overall Study||127
8838151|NCT01676532|9892507|FG000|NOT COMPLETED|Overall Study||0
8838152|NCT01676714|9892516|FG000|STARTED|Overall Study||10
8838153|NCT01676714|9892516|FG000|COMPLETED|Overall Study||10
8838154|NCT01676714|9892516|FG000|NOT COMPLETED|Overall Study||0
8838155|NCT01676727|9892521|FG000|STARTED|Overall Study||100
8838156|NCT01676727|9892521|FG000|Implanted|Overall Study||92
8838157|NCT01676727|9892521|FG000|COMPLETED|Overall Study||68
8838158|NCT01676727|9892521|FG000|NOT COMPLETED|Overall Study||32
8838159|NCT01676831|9892528|FG000|STARTED|Overall Study||8
8838160|NCT01676831|9892529|FG001|STARTED|Overall Study||5
8838161|NCT01676831|9892528|FG000|COMPLETED|Overall Study||8
8838162|NCT01676831|9892529|FG001|COMPLETED|Overall Study||4
8838163|NCT01676831|9892528|FG000|NOT COMPLETED|Overall Study||0
8838164|NCT01676831|9892529|FG001|NOT COMPLETED|Overall Study||1
8838165|NCT01676896|9892538|FG000|STARTED|Overall Study||96
8838166|NCT01676896|9892539|FG001|STARTED|Overall Study||96
8838167|NCT01676896|9892540|FG002|STARTED|Overall Study||100
8838168|NCT01676896|9892538|FG000|COMPLETED|Overall Study||84
8838169|NCT01676896|9892539|FG001|COMPLETED|Overall Study||89
8838170|NCT01676896|9892540|FG002|COMPLETED|Overall Study||81
8838171|NCT01676896|9892538|FG000|NOT COMPLETED|Overall Study||12
8838172|NCT01676896|9892539|FG001|NOT COMPLETED|Overall Study||7
8838173|NCT01676896|9892540|FG002|NOT COMPLETED|Overall Study||19
8838174|NCT01676909|9892550|FG000|STARTED|Overall Study||124
8838175|NCT01676909|9892551|FG001|STARTED|Overall Study||118
8838176|NCT01676909|9892550|FG000|Post-Treatment Assessment|Overall Study|19 not completed (3 withdrawn, 15 timed out, 1 declined)|105
8838177|NCT01676909|9892551|FG001|Post-Treatment Assessment|Overall Study|11 not completed (5 withdrawn, 6 timed out)|107
8838178|NCT01676909|9892550|FG000|COMPLETED|Overall Study|18 not completed (3 withdrawn, 15 timed out)|106
8838179|NCT01676909|9892551|FG001|COMPLETED|Overall Study|14 not completed (5 withdrawn, 9 timed out|104
8838180|NCT01676909|9892550|FG000|NOT COMPLETED|Overall Study||18
8838181|NCT01676909|9892551|FG001|NOT COMPLETED|Overall Study||14
8838182|NCT01677182|9892562|FG000|STARTED|Overall Study||184
8838183|NCT01677182|9892563|FG001|STARTED|Overall Study||169
8838184|NCT01677182|9892564|FG002|STARTED|Overall Study||182
8838185|NCT01677182|9892562|FG000|COMPLETED|Overall Study||150
8838186|NCT01677182|9892563|FG001|COMPLETED|Overall Study||141
8838187|NCT01677182|9892564|FG002|COMPLETED|Overall Study||143
8838188|NCT01677182|9892562|FG000|NOT COMPLETED|Overall Study||34
8838189|NCT01677182|9892563|FG001|NOT COMPLETED|Overall Study||28
8838190|NCT01677182|9892564|FG002|NOT COMPLETED|Overall Study||39
8838191|NCT01677195|9892575|FG000|STARTED|Overall Study||71
8838192|NCT01677195|9892576|FG001|STARTED|Overall Study||83
8838193|NCT01677195|9892577|FG002|STARTED|Overall Study||80
8838194|NCT01677195|9892575|FG000|COMPLETED|Overall Study||42
8838195|NCT01677195|9892576|FG001|COMPLETED|Overall Study||51
8838196|NCT01677195|9892577|FG002|COMPLETED|Overall Study||50
8838197|NCT01677195|9892575|FG000|NOT COMPLETED|Overall Study||29
8838198|NCT01677195|9892576|FG001|NOT COMPLETED|Overall Study||32
8838199|NCT01677195|9892577|FG002|NOT COMPLETED|Overall Study||30
8838200|NCT01677286|9892585|FG000|STARTED|Overall Study||25
8838201|NCT01677286|9892585|FG000|COMPLETED|Overall Study||14
8838202|NCT01677286|9892585|FG000|NOT COMPLETED|Overall Study||11
8838203|NCT01677299|9892595|FG000|STARTED|Overall Study||6
8838204|NCT01677299|9892596|FG001|STARTED|Overall Study||6
8838205|NCT01677299|9892597|FG002|STARTED|Overall Study||6
8838206|NCT01677299|9892598|FG003|STARTED|Overall Study||6
8838207|NCT01677299|9892595|FG000|COMPLETED|Overall Study||6
8838208|NCT01677299|9892596|FG001|COMPLETED|Overall Study||3
8838209|NCT01677299|9892597|FG002|COMPLETED|Overall Study||5
8838210|NCT01677299|9892598|FG003|COMPLETED|Overall Study||5
8838211|NCT01677299|9892595|FG000|NOT COMPLETED|Overall Study||0
8838212|NCT01677299|9892596|FG001|NOT COMPLETED|Overall Study||3
8838213|NCT01677299|9892597|FG002|NOT COMPLETED|Overall Study||1
8838214|NCT01677299|9892598|FG003|NOT COMPLETED|Overall Study||1
8838215|NCT01677312|9892614|FG000|STARTED|Overall Study||36
8838216|NCT01677312|9892615|FG001|STARTED|Overall Study||36
8838217|NCT01677312|9892614|FG000|COMPLETED|Overall Study||36
8838218|NCT01677312|9892615|FG001|COMPLETED|Overall Study||36
8838219|NCT01677312|9892614|FG000|NOT COMPLETED|Overall Study||0
8838220|NCT01677312|9892615|FG001|NOT COMPLETED|Overall Study||0
8838221|NCT01677377|9892624|FG000|STARTED|Overall Study||15
8838222|NCT01677377|9892625|FG001|STARTED|Overall Study||15
8838223|NCT01677377|9892626|FG002|STARTED|Overall Study||15
8838224|NCT01677377|9892624|FG000|COMPLETED|Overall Study||14
8838225|NCT01677377|9892625|FG001|COMPLETED|Overall Study||14
8838226|NCT01677377|9892626|FG002|COMPLETED|Overall Study||9
8838227|NCT01677377|9892624|FG000|NOT COMPLETED|Overall Study||1
8838228|NCT01677377|9892625|FG001|NOT COMPLETED|Overall Study||1
8838229|NCT01677377|9892626|FG002|NOT COMPLETED|Overall Study||6
8838230|NCT01677507|9892634|FG000|STARTED|Initial Assignment||63
8838231|NCT01677507|9892635|FG001|STARTED|Initial Assignment||58
8838232|NCT01677507|9892634|FG000|COMPLETED|Initial Assignment||63
8838233|NCT01677507|9892635|FG001|COMPLETED|Initial Assignment||56
8838234|NCT01677507|9892634|FG000|NOT COMPLETED|Initial Assignment||0
8838235|NCT01677507|9892635|FG001|NOT COMPLETED|Initial Assignment||2
8838236|NCT01677507|9892634|FG000|STARTED|Second Assigment||63
8838237|NCT01677507|9892635|FG001|STARTED|Second Assigment||56
8838238|NCT01677507|9892634|FG000|COMPLETED|Second Assigment||60
8838239|NCT01677507|9892635|FG001|COMPLETED|Second Assigment||51
8838240|NCT01677507|9892634|FG000|NOT COMPLETED|Second Assigment||3
8838241|NCT01677507|9892635|FG001|NOT COMPLETED|Second Assigment||5
8838242|NCT01677624|9892643|FG000|STARTED|Overall Study||28
8838243|NCT01677624|9892643|FG000|COMPLETED|Overall Study||27
8838244|NCT01677624|9892643|FG000|NOT COMPLETED|Overall Study||1
8838245|NCT01677741|9892655|FG000|STARTED|Overall Study||3
8838246|NCT01677741|9892656|FG001|STARTED|Overall Study||10
8838247|NCT01677741|9892657|FG002|STARTED|Overall Study||8
8838248|NCT01677741|9892658|FG003|STARTED|Overall Study||6
8838249|NCT01677741|9892659|FG004|STARTED|Overall Study||17
8838250|NCT01677741|9892660|FG005|STARTED|Overall Study||28
8838251|NCT01677741|9892661|FG006|STARTED|Overall Study||11
8838252|NCT01677741|9892662|FG007|STARTED|Overall Study||2
8838253|NCT01677741|9892655|FG000|DLT Evaluable Population|Overall Study||3
8838254|NCT01677741|9892656|FG001|DLT Evaluable Population|Overall Study||10
8838255|NCT01677741|9892657|FG002|DLT Evaluable Population|Overall Study||8
8838256|NCT01677741|9892658|FG003|DLT Evaluable Population|Overall Study||6
8838257|NCT01677741|9892659|FG004|DLT Evaluable Population|Overall Study||0
8838258|NCT01677741|9892660|FG005|DLT Evaluable Population|Overall Study||0
8623002|NCT00490919|9662213|FG001|STARTED|Double-blind Phase|1 subject had no safety data in DB phase; therefore is excluded from randomized safety population.|256
8623003|NCT00490919|9662214|FG002|STARTED|Double-blind Phase|1 subject had no safety data in DB phase; therefore is excluded from randomized safety population.|283
8838259|NCT01677741|9892661|FG006|DLT Evaluable Population|Overall Study||0
8838260|NCT01677741|9892662|FG007|DLT Evaluable Population|Overall Study||0
8838261|NCT01677741|9892655|FG000|PK Population|Overall Study||3
8838262|NCT01677741|9892656|FG001|PK Population|Overall Study||10
8838263|NCT01677741|9892657|FG002|PK Population|Overall Study||8
8838264|NCT01677741|9892658|FG003|PK Population|Overall Study||6
8838265|NCT01677741|9892659|FG004|PK Population|Overall Study||17
8838266|NCT01677741|9892660|FG005|PK Population|Overall Study||28
8838267|NCT01677741|9892661|FG006|PK Population|Overall Study||11
8838268|NCT01677741|9892662|FG007|PK Population|Overall Study||2
8838269|NCT01677741|9892655|FG000|COMPLETED|Overall Study||0
8838270|NCT01677741|9892656|FG001|COMPLETED|Overall Study||0
8838271|NCT01677741|9892657|FG002|COMPLETED|Overall Study||0
8838272|NCT01677741|9892658|FG003|COMPLETED|Overall Study||0
8838273|NCT01677741|9892659|FG004|COMPLETED|Overall Study||0
8838274|NCT01677741|9892660|FG005|COMPLETED|Overall Study||0
8838275|NCT01677741|9892661|FG006|COMPLETED|Overall Study||0
8838276|NCT01677741|9892662|FG007|COMPLETED|Overall Study||0
8838277|NCT01677741|9892655|FG000|NOT COMPLETED|Overall Study||3
8838278|NCT01677741|9892656|FG001|NOT COMPLETED|Overall Study||10
8838279|NCT01677741|9892657|FG002|NOT COMPLETED|Overall Study||8
8838280|NCT01677741|9892658|FG003|NOT COMPLETED|Overall Study||6
8838281|NCT01677741|9892659|FG004|NOT COMPLETED|Overall Study||17
8838282|NCT01677741|9892660|FG005|NOT COMPLETED|Overall Study||28
8838283|NCT01677741|9892661|FG006|NOT COMPLETED|Overall Study||11
8838284|NCT01677741|9892662|FG007|NOT COMPLETED|Overall Study||2
8838285|NCT01677767|9892696|FG000|STARTED|Overall Study||124
8838286|NCT01677767|9892696|FG000|COMPLETED|Overall Study||102
8838287|NCT01677767|9892696|FG000|NOT COMPLETED|Overall Study||22
8838288|NCT01677858|9892707|FG000|STARTED|Overall Study||3
8838289|NCT01677858|9892708|FG001|STARTED|Overall Study||3
8838290|NCT01677858|9892709|FG002|STARTED|Overall Study||15
8838291|NCT01677858|9892710|FG003|STARTED|Overall Study||6
8838292|NCT01677858|9892711|FG004|STARTED|Overall Study||89
8838293|NCT01677858|9892707|FG000|COMPLETED|Overall Study|Completed indicates participants ongoing in study|0
8838294|NCT01677858|9892708|FG001|COMPLETED|Overall Study|Completed indicates participants ongoing in study|1
8838295|NCT01677858|9892709|FG002|COMPLETED|Overall Study|Completed indicates participants ongoing in study|1
8838296|NCT01677858|9892710|FG003|COMPLETED|Overall Study|Completed indicates participants ongoing in study|0
8838297|NCT01677858|9892711|FG004|COMPLETED|Overall Study|Completed indicates participants ongoing in study|4
8838298|NCT01677858|9892707|FG000|NOT COMPLETED|Overall Study||3
8838299|NCT01677858|9892708|FG001|NOT COMPLETED|Overall Study||2
8838300|NCT01677858|9892709|FG002|NOT COMPLETED|Overall Study||14
8838301|NCT01677858|9892710|FG003|NOT COMPLETED|Overall Study||6
8838302|NCT01677858|9892711|FG004|NOT COMPLETED|Overall Study||85
8838303|NCT01677910|9892731|FG000|STARTED|Double-Blind Treatment Period||45
8838304|NCT01677910|9892732|FG001|STARTED|Double-Blind Treatment Period||45
8838305|NCT01677910|9892733|FG002|STARTED|Double-Blind Treatment Period||45
8838306|NCT01677910|9892734|FG003|STARTED|Double-Blind Treatment Period||0
8838307|NCT01677910|9892731|FG000|COMPLETED|Double-Blind Treatment Period||38
8838308|NCT01677910|9892732|FG001|COMPLETED|Double-Blind Treatment Period||42
8838309|NCT01677910|9892733|FG002|COMPLETED|Double-Blind Treatment Period||38
8838310|NCT01677910|9892734|FG003|COMPLETED|Double-Blind Treatment Period||0
8838311|NCT01677910|9892731|FG000|NOT COMPLETED|Double-Blind Treatment Period||7
8623004|NCT00490919|9662212|FG000|COMPLETED|Double-blind Phase||0
8623005|NCT00490919|9662213|FG001|COMPLETED|Double-blind Phase||170
8838312|NCT01677910|9892732|FG001|NOT COMPLETED|Double-Blind Treatment Period||3
8838313|NCT01677910|9892733|FG002|NOT COMPLETED|Double-Blind Treatment Period||7
8838314|NCT01677910|9892734|FG003|NOT COMPLETED|Double-Blind Treatment Period||0
8838315|NCT01677910|9892731|FG000|STARTED|Open-Label Extension Period (OLE)||0
8838316|NCT01677910|9892732|FG001|STARTED|Open-Label Extension Period (OLE)||0
8838317|NCT01677910|9892733|FG002|STARTED|Open-Label Extension Period (OLE)||0
8838318|NCT01677910|9892734|FG003|STARTED|Open-Label Extension Period (OLE)||115
8838319|NCT01677910|9892731|FG000|COMPLETED|Open-Label Extension Period (OLE)||0
8838320|NCT01677910|9892732|FG001|COMPLETED|Open-Label Extension Period (OLE)||0
8838321|NCT01677910|9892733|FG002|COMPLETED|Open-Label Extension Period (OLE)||0
8838322|NCT01677910|9892734|FG003|COMPLETED|Open-Label Extension Period (OLE)||79
8838323|NCT01677910|9892731|FG000|NOT COMPLETED|Open-Label Extension Period (OLE)||0
8838324|NCT01677910|9892732|FG001|NOT COMPLETED|Open-Label Extension Period (OLE)||0
8838325|NCT01677910|9892733|FG002|NOT COMPLETED|Open-Label Extension Period (OLE)||0
8838326|NCT01677910|9892734|FG003|NOT COMPLETED|Open-Label Extension Period (OLE)||36
8838327|NCT01677936|9892746|FG000|STARTED|Overall Study|31 randomized to raisins; 4 excluded due to lack of post-baseline evaluation; 27 = full dataset|31
8838328|NCT01677936|9892747|FG001|STARTED|Overall Study|20 randomized to snacks; 1 excluded due to lack of post-baseline evaluation; 19 = full dataset|20
8838329|NCT01677936|9892746|FG000|COMPLETED|Overall Study|Full analysis dataset completers|22
8838330|NCT01677936|9892747|FG001|COMPLETED|Overall Study|Full analysis dataset completers|15
8838331|NCT01677936|9892746|FG000|NOT COMPLETED|Overall Study||9
8838332|NCT01677936|9892747|FG001|NOT COMPLETED|Overall Study||5
8838333|NCT01677988|9892753|FG000|STARTED|Overall Study||3
8838334|NCT01677988|9892753|FG000|COMPLETED|Overall Study||1
8838335|NCT01677988|9892753|FG000|NOT COMPLETED|Overall Study||2
8838336|NCT01678131|9892761|FG000|STARTED|Overall Study||10
8838337|NCT01678131|9892762|FG001|STARTED|Overall Study||10
8838338|NCT01678131|9892763|FG002|STARTED|Overall Study||11
8838339|NCT01678131|9892761|FG000|COMPLETED|Overall Study||10
8838340|NCT01678131|9892762|FG001|COMPLETED|Overall Study||9
8838341|NCT01678131|9892763|FG002|COMPLETED|Overall Study||9
8838342|NCT01678131|9892761|FG000|NOT COMPLETED|Overall Study||0
8838343|NCT01678131|9892762|FG001|NOT COMPLETED|Overall Study||1
8838344|NCT01678131|9892763|FG002|NOT COMPLETED|Overall Study||2
8838345|NCT01678144|9892771|FG000|STARTED|Stage 1: MAR Classic||7
8838346|NCT01678144|9892771|FG000|COMPLETED|Stage 1: MAR Classic||6
8838347|NCT01678144|9892771|FG000|NOT COMPLETED|Stage 1: MAR Classic||1
8838348|NCT01678144|9892771|FG000|STARTED|Stage 2: MAR Regular and MAR Expanded||5
8838349|NCT01678144|9892771|FG000|COMPLETED|Stage 2: MAR Regular and MAR Expanded||5
8838350|NCT01678144|9892771|FG000|NOT COMPLETED|Stage 2: MAR Regular and MAR Expanded||0
8838351|NCT01678196|9892777|FG000|STARTED|Overall Study||34
8838352|NCT01678196|9892778|FG001|STARTED|Overall Study||32
8838353|NCT01678196|9892777|FG000|COMPLETED|Overall Study|Primary outcome data was from the electronic medical record and was available for all participants.|34
8850026|NCT01744574|9905221|FG001|COMPLETED|Overall Study||31
8623006|NCT00490919|9662214|FG002|COMPLETED|Double-blind Phase||199
8838354|NCT01678196|9892778|FG001|COMPLETED|Overall Study|Primary outcome data was from the electronic medical record and was available for all participants.|32
8838355|NCT01678196|9892777|FG000|NOT COMPLETED|Overall Study||0
8838356|NCT01678196|9892778|FG001|NOT COMPLETED|Overall Study||0
8838357|NCT01678209|9892787|FG000|STARTED|Overall Study||47
8838358|NCT01678209|9892788|FG001|STARTED|Overall Study||40
8838359|NCT01678209|9892789|FG002|STARTED|Overall Study||40
8838360|NCT01678209|9892787|FG000|COMPLETED|Overall Study||30
8838361|NCT01678209|9892788|FG001|COMPLETED|Overall Study||22
8838362|NCT01678209|9892789|FG002|COMPLETED|Overall Study||22
8838363|NCT01678209|9892787|FG000|NOT COMPLETED|Overall Study||17
8838364|NCT01678209|9892788|FG001|NOT COMPLETED|Overall Study||18
8838365|NCT01678209|9892789|FG002|NOT COMPLETED|Overall Study||18
8838366|NCT01678313|9892799|FG000|STARTED|Completed the 3-month Therapy||70
8838367|NCT01678313|9892800|FG001|STARTED|Completed the 3-month Therapy||70
8838368|NCT01678313|9892799|FG000|COMPLETED|Completed the 3-month Therapy||64
8838369|NCT01678313|9892800|FG001|COMPLETED|Completed the 3-month Therapy||58
8838370|NCT01678313|9892799|FG000|NOT COMPLETED|Completed the 3-month Therapy||6
8838371|NCT01678313|9892800|FG001|NOT COMPLETED|Completed the 3-month Therapy||12
8838372|NCT01678313|9892799|FG000|STARTED|PSA >4 ng/dL at 3 Months||64
8838373|NCT01678313|9892800|FG001|STARTED|PSA >4 ng/dL at 3 Months||58
8838374|NCT01678313|9892799|FG000|COMPLETED|PSA >4 ng/dL at 3 Months||56
8623007|NCT00490919|9662212|FG000|NOT COMPLETED|Double-blind Phase||0
8623008|NCT00490919|9662213|FG001|NOT COMPLETED|Double-blind Phase||86
8623009|NCT00490919|9662214|FG002|NOT COMPLETED|Double-blind Phase||84
8623010|NCT00490945|9662226|FG000|STARTED|Overall Study||8
8838375|NCT01678313|9892800|FG001|COMPLETED|PSA >4 ng/dL at 3 Months||49
8838376|NCT01678313|9892799|FG000|NOT COMPLETED|PSA >4 ng/dL at 3 Months||8
8838377|NCT01678313|9892800|FG001|NOT COMPLETED|PSA >4 ng/dL at 3 Months||9
8838378|NCT01678313|9892799|FG000|STARTED|Prostate Biopsy at 3 Months||56
8838379|NCT01678313|9892800|FG001|STARTED|Prostate Biopsy at 3 Months||49
8838380|NCT01678313|9892799|FG000|COMPLETED|Prostate Biopsy at 3 Months||45
8838381|NCT01678313|9892800|FG001|COMPLETED|Prostate Biopsy at 3 Months||37
8838382|NCT01678313|9892799|FG000|NOT COMPLETED|Prostate Biopsy at 3 Months||11
8838383|NCT01678313|9892800|FG001|NOT COMPLETED|Prostate Biopsy at 3 Months||12
8838384|NCT01678443|9892806|FG000|STARTED|Overall Study||2
8838385|NCT01678443|9892806|FG000|COMPLETED|Overall Study||2
8838386|NCT01678443|9892806|FG000|NOT COMPLETED|Overall Study||0
8838387|NCT01678560|9892812|FG000|STARTED|Overall Study||26
8838388|NCT01678560|9892813|FG001|STARTED|Overall Study||26
8838389|NCT01678560|9892812|FG000|COMPLETED|Overall Study||22
8838390|NCT01678560|9892813|FG001|COMPLETED|Overall Study||20
8838391|NCT01678560|9892812|FG000|NOT COMPLETED|Overall Study||4
8838392|NCT01678560|9892813|FG001|NOT COMPLETED|Overall Study||6
8838393|NCT01678794|9892825|FG000|STARTED|Overall Study||16
8838394|NCT01678794|9892826|FG001|STARTED|Overall Study||17
8838395|NCT01678794|9892825|FG000|COMPLETED|Overall Study||16
8838396|NCT01678794|9892826|FG001|COMPLETED|Overall Study||17
8838397|NCT01678794|9892825|FG000|NOT COMPLETED|Overall Study||0
8838398|NCT01678794|9892826|FG001|NOT COMPLETED|Overall Study||0
8838399|NCT01678807|9892835|FG000|STARTED|Overall Study||65
8838400|NCT01678807|9892836|FG001|STARTED|Overall Study||65
8838401|NCT01678807|9892837|FG002|STARTED|Overall Study||65
8838402|NCT01678807|9892835|FG000|COMPLETED|Overall Study||61
8838403|NCT01678807|9892836|FG001|COMPLETED|Overall Study||60
8838404|NCT01678807|9892837|FG002|COMPLETED|Overall Study||65
8838405|NCT01678807|9892835|FG000|NOT COMPLETED|Overall Study||4
8838406|NCT01678807|9892836|FG001|NOT COMPLETED|Overall Study||5
8838407|NCT01678807|9892837|FG002|NOT COMPLETED|Overall Study||0
8838408|NCT01678820|9892848|FG000|STARTED|Overall Study||100
8838409|NCT01678820|9892849|FG001|STARTED|Overall Study||99
8838410|NCT01678820|9892850|FG002|STARTED|Overall Study||100
8838411|NCT01678820|9892848|FG000|Treated With Double-blind Study Drug|Overall Study||100
8838412|NCT01678820|9892849|FG001|Treated With Double-blind Study Drug|Overall Study||97
8838413|NCT01678820|9892850|FG002|Treated With Double-blind Study Drug|Overall Study||98
8838414|NCT01678820|9892848|FG000|COMPLETED|Overall Study||38
8838415|NCT01678820|9892849|FG001|COMPLETED|Overall Study||36
8838416|NCT01678820|9892850|FG002|COMPLETED|Overall Study||43
8838417|NCT01678820|9892848|FG000|NOT COMPLETED|Overall Study||62
8838418|NCT01678820|9892849|FG001|NOT COMPLETED|Overall Study||63
8838419|NCT01678820|9892850|FG002|NOT COMPLETED|Overall Study||57
8838420|NCT01678846|9892861|FG000|STARTED|Overall Study|Whole school implementation. Started and completed shows number of students in the end-line survey.|1921
8838421|NCT01678846|9892862|FG001|STARTED|Overall Study||1899
8838422|NCT01678846|9892861|FG000|COMPLETED|Overall Study||1921
8838423|NCT01678846|9892862|FG001|COMPLETED|Overall Study||1899
8838424|NCT01678846|9892861|FG000|NOT COMPLETED|Overall Study||0
8838425|NCT01678846|9892862|FG001|NOT COMPLETED|Overall Study||0
8838426|NCT01678885|9892870|FG000|STARTED|Phase I; 2 Wks Duration, Both Sub-study||22
8838427|NCT01678885|9892871|FG001|STARTED|Phase I; 2 Wks Duration, Both Sub-study||18
8838428|NCT01678885|9892872|FG002|STARTED|Phase I; 2 Wks Duration, Both Sub-study||23
8838429|NCT01678885|9892873|FG003|STARTED|Phase I; 2 Wks Duration, Both Sub-study||24
8838430|NCT01678885|9892874|FG004|STARTED|Phase I; 2 Wks Duration, Both Sub-study||0
8623011|NCT00490945|9662227|FG001|STARTED|Overall Study||9
8623012|NCT00490945|9662228|FG002|STARTED|Overall Study||8
8838431|NCT01678885|9892870|FG000|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||22
8838432|NCT01678885|9892871|FG001|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||15
8838433|NCT01678885|9892872|FG002|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||22
8838434|NCT01678885|9892873|FG003|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||21
8838435|NCT01678885|9892874|FG004|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||0
8838436|NCT01678885|9892870|FG000|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||0
8838437|NCT01678885|9892871|FG001|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||3
8838438|NCT01678885|9892872|FG002|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||1
8838439|NCT01678885|9892873|FG003|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||3
8838440|NCT01678885|9892874|FG004|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||0
8838441|NCT01678885|9892870|FG000|STARTED|Phase II; 8 Week Low Calorie Diet||0
8838442|NCT01678885|9892871|FG001|STARTED|Phase II; 8 Week Low Calorie Diet||0
8838443|NCT01678885|9892872|FG002|STARTED|Phase II; 8 Week Low Calorie Diet||0
8838444|NCT01678885|9892873|FG003|STARTED|Phase II; 8 Week Low Calorie Diet||0
8838445|NCT01678885|9892874|FG004|STARTED|Phase II; 8 Week Low Calorie Diet||87
8838446|NCT01678885|9892870|FG000|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
8838447|NCT01678885|9892871|FG001|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
8838448|NCT01678885|9892872|FG002|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
8838449|NCT01678885|9892873|FG003|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
8838450|NCT01678885|9892874|FG004|COMPLETED|Phase II; 8 Week Low Calorie Diet||70
8838451|NCT01678885|9892870|FG000|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
8838452|NCT01678885|9892871|FG001|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
8838453|NCT01678885|9892872|FG002|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
8838454|NCT01678885|9892873|FG003|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
8838455|NCT01678885|9892874|FG004|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||17
8838456|NCT01678898|9892885|FG000|STARTED|PB-102-F01||6
8838457|NCT01678898|9892886|FG001|STARTED|PB-102-F01||8
8838458|NCT01678898|9892887|FG002|STARTED|PB-102-F01||4
8838459|NCT01678898|9892885|FG000|COMPLETED|PB-102-F01||6
8838460|NCT01678898|9892886|FG001|COMPLETED|PB-102-F01||6
8838461|NCT01678898|9892887|FG002|COMPLETED|PB-102-F01||4
8838462|NCT01678898|9892885|FG000|NOT COMPLETED|PB-102-F01||0
8838463|NCT01678898|9892886|FG001|NOT COMPLETED|PB-102-F01||2
8838464|NCT01678898|9892887|FG002|NOT COMPLETED|PB-102-F01||0
8838465|NCT01678898|9892885|FG000|STARTED|PB-102-F02||6
8838466|NCT01678898|9892886|FG001|STARTED|PB-102-F02||6
8838467|NCT01678898|9892887|FG002|STARTED|PB-102-F02||4
8838468|NCT01678898|9892885|FG000|COMPLETED|PB-102-F02||6
8838469|NCT01678898|9892886|FG001|COMPLETED|PB-102-F02||6
8838470|NCT01678898|9892887|FG002|COMPLETED|PB-102-F02||4
8838471|NCT01678898|9892885|FG000|NOT COMPLETED|PB-102-F02||0
8838472|NCT01678898|9892886|FG001|NOT COMPLETED|PB-102-F02||0
8838473|NCT01678898|9892887|FG002|NOT COMPLETED|PB-102-F02||0
8838474|NCT01678911|9892904|FG000|STARTED|First Intervention||4
8838475|NCT01678911|9892905|FG001|STARTED|First Intervention||1
8838476|NCT01678911|9892904|FG000|Cross Over|First Intervention||4
8838477|NCT01678911|9892905|FG001|Cross Over|First Intervention||1
8838478|NCT01678911|9892904|FG000|COMPLETED|First Intervention||4
8838479|NCT01678911|9892905|FG001|COMPLETED|First Intervention||1
8838480|NCT01678911|9892904|FG000|NOT COMPLETED|First Intervention||0
8838481|NCT01678911|9892905|FG001|NOT COMPLETED|First Intervention||0
8838482|NCT01678911|9892904|FG000|STARTED|Second Intervention||4
8838483|NCT01678911|9892905|FG001|STARTED|Second Intervention||1
8838484|NCT01678911|9892904|FG000|COMPLETED|Second Intervention||2
8838485|NCT01678911|9892905|FG001|COMPLETED|Second Intervention||1
8838486|NCT01678911|9892904|FG000|NOT COMPLETED|Second Intervention||2
8838487|NCT01678911|9892905|FG001|NOT COMPLETED|Second Intervention||0
8838488|NCT01678924|9892915|FG000|STARTED|Overall Study||64
8838489|NCT01678924|9892916|FG001|STARTED|Overall Study||63
8838490|NCT01678924|9892917|FG002|STARTED|Overall Study||30
8838491|NCT01678924|9892918|FG003|STARTED|Overall Study||123
8838492|NCT01678924|9892915|FG000|COMPLETED|Overall Study||54
8838493|NCT01678924|9892916|FG001|COMPLETED|Overall Study||51
8838494|NCT01678924|9892917|FG002|COMPLETED|Overall Study||28
8838495|NCT01678924|9892918|FG003|COMPLETED|Overall Study||105
8838496|NCT01678924|9892915|FG000|NOT COMPLETED|Overall Study||10
8838497|NCT01678924|9892916|FG001|NOT COMPLETED|Overall Study||12
8838498|NCT01678924|9892917|FG002|NOT COMPLETED|Overall Study||2
8838499|NCT01678924|9892918|FG003|NOT COMPLETED|Overall Study||18
8838500|NCT01678976|9892931|FG000|STARTED|First Period||6
8838501|NCT01678976|9892932|FG001|STARTED|First Period||7
8838502|NCT01678976|9892931|FG000|COMPLETED|First Period||6
8838503|NCT01678976|9892932|FG001|COMPLETED|First Period||6
8838504|NCT01678976|9892931|FG000|NOT COMPLETED|First Period||0
8838505|NCT01678976|9892932|FG001|NOT COMPLETED|First Period||1
8838506|NCT01678976|9892931|FG000|STARTED|Second Period||6
8838507|NCT01678976|9892932|FG001|STARTED|Second Period||6
8838508|NCT01678976|9892931|FG000|COMPLETED|Second Period||6
8838509|NCT01678976|9892932|FG001|COMPLETED|Second Period||6
8838510|NCT01678976|9892931|FG000|NOT COMPLETED|Second Period||0
8838511|NCT01678976|9892932|FG001|NOT COMPLETED|Second Period||0
8838512|NCT01679002|9892944|FG000|STARTED|Overall Study||4
8838513|NCT01679002|9892945|FG001|STARTED|Overall Study||4
8838514|NCT01679002|9892946|FG002|STARTED|Overall Study||4
8838515|NCT01679002|9892944|FG000|BIA 2-093 900 mg Once-daily Period|Overall Study||4
8838516|NCT01679002|9892945|FG001|BIA 2-093 900 mg Once-daily Period|Overall Study||3
8838517|NCT01679002|9892946|FG002|BIA 2-093 900 mg Once-daily Period|Overall Study||4
8838518|NCT01679002|9892944|FG000|BIA 2-093 450 mg Twice-daily Period|Overall Study||4
8838519|NCT01679002|9892945|FG001|BIA 2-093 450 mg Twice-daily Period|Overall Study||4
8838520|NCT01679002|9892946|FG002|BIA 2-093 450 mg Twice-daily Period|Overall Study||4
8838521|NCT01679002|9892944|FG000|Oxcarbazepine 450 mg Twice-daily Period|Overall Study||3
8838522|NCT01679002|9892945|FG001|Oxcarbazepine 450 mg Twice-daily Period|Overall Study||4
8838523|NCT01679002|9892946|FG002|Oxcarbazepine 450 mg Twice-daily Period|Overall Study||4
8838524|NCT01679002|9892944|FG000|COMPLETED|Overall Study||3
8838525|NCT01679002|9892945|FG001|COMPLETED|Overall Study||3
8838526|NCT01679002|9892946|FG002|COMPLETED|Overall Study||4
8838527|NCT01679002|9892944|FG000|NOT COMPLETED|Overall Study||1
8838528|NCT01679002|9892945|FG001|NOT COMPLETED|Overall Study||1
8838529|NCT01679002|9892946|FG002|NOT COMPLETED|Overall Study||0
8838530|NCT01679028|9892960|FG000|STARTED|Overall Study||2
8838531|NCT01679028|9892961|FG001|STARTED|Overall Study||4
8838532|NCT01679028|9892962|FG002|STARTED|Overall Study||2
8838533|NCT01679028|9892963|FG003|STARTED|Overall Study||4
8838534|NCT01679028|9892964|FG004|STARTED|Overall Study||2
8838535|NCT01679028|9892965|FG005|STARTED|Overall Study||6
8838536|NCT01679028|9892960|FG000|COMPLETED|Overall Study||2
8838537|NCT01679028|9892961|FG001|COMPLETED|Overall Study||4
8838538|NCT01679028|9892962|FG002|COMPLETED|Overall Study||2
8623013|NCT00490945|9662229|FG003|STARTED|Overall Study||7
8623014|NCT00490945|9662230|FG004|STARTED|Overall Study||7
8623015|NCT00490945|9662226|FG000|COMPLETED|Overall Study||8
8623016|NCT00490945|9662227|FG001|COMPLETED|Overall Study||8
8623017|NCT00490945|9662228|FG002|COMPLETED|Overall Study||8
8623018|NCT00490945|9662229|FG003|COMPLETED|Overall Study||7
8623019|NCT00490945|9662230|FG004|COMPLETED|Overall Study||7
8623020|NCT00490945|9662226|FG000|NOT COMPLETED|Overall Study||0
8623021|NCT00490945|9662227|FG001|NOT COMPLETED|Overall Study||1
8623022|NCT00490945|9662228|FG002|NOT COMPLETED|Overall Study||0
8623023|NCT00490945|9662229|FG003|NOT COMPLETED|Overall Study||0
8623024|NCT00490945|9662230|FG004|NOT COMPLETED|Overall Study||0
8623025|NCT00490971|9662250|FG000|STARTED|Acute/Continuation|617 participants were assigned to paliperidone, out of which 614 took the study medication.|614
8623026|NCT00490971|9662251|FG001|STARTED|Acute/Continuation|149 participants were assigned to paliperidone, out of which 148 took the study medication.|148
8623027|NCT00490971|9662252|FG002|STARTED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
8623028|NCT00490971|9662253|FG003|STARTED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
8623029|NCT00490971|9662254|FG004|STARTED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
8623030|NCT00490971|9662250|FG000|COMPLETED|Acute/Continuation||308
8623031|NCT00490971|9662251|FG001|COMPLETED|Acute/Continuation||86
8623032|NCT00490971|9662252|FG002|COMPLETED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
8623033|NCT00490971|9662253|FG003|COMPLETED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
8623034|NCT00490971|9662254|FG004|COMPLETED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
8623035|NCT00490971|9662250|FG000|NOT COMPLETED|Acute/Continuation||306
8623036|NCT00490971|9662251|FG001|NOT COMPLETED|Acute/Continuation||62
8623037|NCT00490971|9662252|FG002|NOT COMPLETED|Acute/Continuation||0
8623038|NCT00490971|9662253|FG003|NOT COMPLETED|Acute/Continuation||0
8623039|NCT00490971|9662254|FG004|NOT COMPLETED|Acute/Continuation||0
8623040|NCT00490971|9662250|FG000|STARTED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
8623041|NCT00490971|9662251|FG001|STARTED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
8623042|NCT00490971|9662252|FG002|STARTED|Maintenance|148 participants were assigned to pali/placebo, out of which 147 took the study medication.|147
8623043|NCT00490971|9662253|FG003|STARTED|Maintenance|152 participants were assigned to pali/pali, out of which 149 took the study medication.|149
8623044|NCT00490971|9662254|FG004|STARTED|Maintenance||83
8623045|NCT00490971|9662250|FG000|COMPLETED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
8623046|NCT00490971|9662251|FG001|COMPLETED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
8623047|NCT00490971|9662252|FG002|COMPLETED|Maintenance||96
8623048|NCT00490971|9662253|FG003|COMPLETED|Maintenance||96
8623049|NCT00490971|9662254|FG004|COMPLETED|Maintenance||44
8623050|NCT00490971|9662250|FG000|NOT COMPLETED|Maintenance||0
8623051|NCT00490971|9662251|FG001|NOT COMPLETED|Maintenance||0
8623052|NCT00490971|9662252|FG002|NOT COMPLETED|Maintenance||51
8623053|NCT00490971|9662253|FG003|NOT COMPLETED|Maintenance||53
8623054|NCT00490971|9662254|FG004|NOT COMPLETED|Maintenance||39
8623055|NCT00491075|9662266|FG000|STARTED|Overall Study||16
8623056|NCT00491075|9662266|FG000|COMPLETED|Overall Study||14
8838539|NCT01679028|9892963|FG003|COMPLETED|Overall Study||4
8838540|NCT01679028|9892964|FG004|COMPLETED|Overall Study||2
8838541|NCT01679028|9892965|FG005|COMPLETED|Overall Study||6
8838542|NCT01679028|9892960|FG000|NOT COMPLETED|Overall Study||0
8838543|NCT01679028|9892961|FG001|NOT COMPLETED|Overall Study||0
8838544|NCT01679028|9892962|FG002|NOT COMPLETED|Overall Study||0
8838545|NCT01679028|9892963|FG003|NOT COMPLETED|Overall Study||0
8838546|NCT01679028|9892964|FG004|NOT COMPLETED|Overall Study||0
8838547|NCT01679028|9892965|FG005|NOT COMPLETED|Overall Study||0
8838548|NCT01679197|9892979|FG000|STARTED|Overall Study||23
8838549|NCT01679197|9892979|FG000|COMPLETED|Overall Study||19
8838550|NCT01679197|9892979|FG000|NOT COMPLETED|Overall Study||4
8838551|NCT01679236|9892991|FG000|STARTED|Overall Study||30
8838552|NCT01679236|9892992|FG001|STARTED|Overall Study||25
8838553|NCT01679236|9892991|FG000|COMPLETED|Overall Study||15
8838554|NCT01679236|9892992|FG001|COMPLETED|Overall Study||10
8838555|NCT01679236|9892991|FG000|NOT COMPLETED|Overall Study||15
8838556|NCT01679236|9892992|FG001|NOT COMPLETED|Overall Study||15
8838557|NCT01679301|9892998|FG000|STARTED|Screening Period||11
8838558|NCT01679301|9892999|FG001|STARTED|Screening Period||0
8838559|NCT01679301|9893000|FG002|STARTED|Screening Period||0
8838560|NCT01679301|9892998|FG000|COMPLETED|Screening Period||8
8838561|NCT01679301|9892999|FG001|COMPLETED|Screening Period||0
8838562|NCT01679301|9893000|FG002|COMPLETED|Screening Period||0
8838563|NCT01679301|9892998|FG000|NOT COMPLETED|Screening Period||3
8838564|NCT01679301|9892999|FG001|NOT COMPLETED|Screening Period||0
8838565|NCT01679301|9893000|FG002|NOT COMPLETED|Screening Period||0
8838566|NCT01679301|9892998|FG000|STARTED|Study Period||0
8838567|NCT01679301|9892999|FG001|STARTED|Study Period||4
8838568|NCT01679301|9893000|FG002|STARTED|Study Period||4
8838569|NCT01679301|9892998|FG000|COMPLETED|Study Period||0
8838570|NCT01679301|9892999|FG001|COMPLETED|Study Period||4
8838571|NCT01679301|9893000|FG002|COMPLETED|Study Period||4
8838572|NCT01679301|9892998|FG000|NOT COMPLETED|Study Period||0
8838573|NCT01679301|9892999|FG001|NOT COMPLETED|Study Period||0
8838574|NCT01679301|9893000|FG002|NOT COMPLETED|Study Period||0
8838575|NCT01679314|9893008|FG000|STARTED|Overall Study||26
8838576|NCT01679314|9893009|FG001|STARTED|Overall Study||28
8838577|NCT01679314|9893008|FG000|COMPLETED|Overall Study||24
8838578|NCT01679314|9893009|FG001|COMPLETED|Overall Study||28
8838579|NCT01679314|9893008|FG000|NOT COMPLETED|Overall Study||2
8838580|NCT01679314|9893009|FG001|NOT COMPLETED|Overall Study||0
8838581|NCT01679405|9893021|FG000|STARTED|Overall Study||3
8838582|NCT01679405|9893022|FG001|STARTED|Overall Study||6
8838583|NCT01679405|9893021|FG000|COMPLETED|Overall Study||1
8838584|NCT01679405|9893022|FG001|COMPLETED|Overall Study||1
8838585|NCT01679405|9893021|FG000|NOT COMPLETED|Overall Study||2
8838586|NCT01679405|9893022|FG001|NOT COMPLETED|Overall Study||5
8838587|NCT01679600|9893030|FG000|STARTED|Overall Study||7
8838588|NCT01679600|9893031|FG001|STARTED|Overall Study||7
8838589|NCT01679600|9893030|FG000|COMPLETED|Overall Study||7
8838590|NCT01679600|9893031|FG001|COMPLETED|Overall Study||7
8838591|NCT01679600|9893030|FG000|NOT COMPLETED|Overall Study||0
8838592|NCT01679600|9893031|FG001|NOT COMPLETED|Overall Study||0
8838593|NCT01679613|9893037|FG000|STARTED|Overall Study||4
8838594|NCT01679613|9893038|FG001|STARTED|Overall Study||4
8838595|NCT01679613|9893039|FG002|STARTED|Overall Study||13
8838596|NCT01679613|9893040|FG003|STARTED|Overall Study||13
8838597|NCT01679613|9893037|FG000|Received Nintedanib (Pilot)|Overall Study||4
8838598|NCT01679613|9893038|FG001|Received Nintedanib (Pilot)|Overall Study||3
8838599|NCT01679613|9893039|FG002|Received Nintedanib (Pilot)|Overall Study||0
8838600|NCT01679613|9893040|FG003|Received Nintedanib (Pilot)|Overall Study||0
8838601|NCT01679613|9893037|FG000|Received Nintedanib+Ketoconazole (Pilot)|Overall Study||4
8838602|NCT01679613|9893038|FG001|Received Nintedanib+Ketoconazole (Pilot)|Overall Study|One subject received only ketoconazole not nintedanib|4
8838603|NCT01679613|9893039|FG002|Received Nintedanib+Ketoconazole (Pilot)|Overall Study||0
8838604|NCT01679613|9893040|FG003|Received Nintedanib+Ketoconazole (Pilot)|Overall Study||0
8838605|NCT01679613|9893037|FG000|Received Nintedanib (Main)|Overall Study||0
8838606|NCT01679613|9893038|FG001|Received Nintedanib (Main)|Overall Study||0
8838607|NCT01679613|9893039|FG002|Received Nintedanib (Main)|Overall Study||13
8838608|NCT01679613|9893040|FG003|Received Nintedanib (Main)|Overall Study||11
8838609|NCT01679613|9893037|FG000|Received Nintedanib+Ketoconazole (Main)|Overall Study||0
8838610|NCT01679613|9893038|FG001|Received Nintedanib+Ketoconazole (Main)|Overall Study||0
8838611|NCT01679613|9893039|FG002|Received Nintedanib+Ketoconazole (Main)|Overall Study|Two subjects received only ketoconazole not nintedanib|13
8838612|NCT01679613|9893040|FG003|Received Nintedanib+Ketoconazole (Main)|Overall Study|Two subjects received only ketoconazole not nintedanib|13
8838613|NCT01679613|9893037|FG000|COMPLETED|Overall Study||4
8838614|NCT01679613|9893038|FG001|COMPLETED|Overall Study||3
8838615|NCT01679613|9893039|FG002|COMPLETED|Overall Study||11
8838616|NCT01679613|9893040|FG003|COMPLETED|Overall Study||11
8838617|NCT01679613|9893037|FG000|NOT COMPLETED|Overall Study||0
8838618|NCT01679613|9893038|FG001|NOT COMPLETED|Overall Study||1
8838619|NCT01679613|9893039|FG002|NOT COMPLETED|Overall Study||2
8838620|NCT01679613|9893040|FG003|NOT COMPLETED|Overall Study||2
8838621|NCT01680016|9893049|FG000|STARTED|Overall Study||121
8838622|NCT01680016|9893050|FG001|STARTED|Overall Study||122
8838623|NCT01680016|9893051|FG002|STARTED|Overall Study||201
8838624|NCT01680016|9893052|FG003|STARTED|Overall Study||200
8838625|NCT01680016|9893049|FG000|COMPLETED|Overall Study||115
8838626|NCT01680016|9893050|FG001|COMPLETED|Overall Study||114
8838627|NCT01680016|9893051|FG002|COMPLETED|Overall Study||196
8838628|NCT01680016|9893052|FG003|COMPLETED|Overall Study||195
8838629|NCT01680016|9893049|FG000|NOT COMPLETED|Overall Study||6
8838630|NCT01680016|9893050|FG001|NOT COMPLETED|Overall Study||8
8838631|NCT01680016|9893051|FG002|NOT COMPLETED|Overall Study||5
8838632|NCT01680016|9893052|FG003|NOT COMPLETED|Overall Study||5
8838633|NCT01680159|9893078|FG000|STARTED|Screening Period||46
8838634|NCT01680159|9893078|FG000|COMPLETED|Screening Period||39
8838635|NCT01680159|9893078|FG000|NOT COMPLETED|Screening Period||7
8838636|NCT01680159|9893078|FG000|STARTED|Increased Dose Period||51
8838637|NCT01680159|9893078|FG000|COMPLETED|Increased Dose Period||43
8838638|NCT01680159|9893078|FG000|NOT COMPLETED|Increased Dose Period||8
8838639|NCT01680172|9893100|FG000|STARTED|Overall Study||3
8838640|NCT01680172|9893101|FG001|STARTED|Overall Study||2
8838641|NCT01680172|9893100|FG000|COMPLETED|Overall Study||3
8838642|NCT01680172|9893101|FG001|COMPLETED|Overall Study||2
8838643|NCT01680172|9893100|FG000|NOT COMPLETED|Overall Study||0
8838644|NCT01680172|9893101|FG001|NOT COMPLETED|Overall Study||0
8838645|NCT01680328|9893107|FG000|STARTED|Overall Study||82
8838646|NCT01680328|9893107|FG000|Subjects Missing Injections|Overall Study|One missed the [1600 μL, 450 μL/s; thighs]; one missed the [400 μL, 300 μL/s; abdomen]|2
8838647|NCT01680328|9893107|FG000|COMPLETED|Overall Study||80
8838648|NCT01680328|9893107|FG000|NOT COMPLETED|Overall Study||2
8838649|NCT01680341|9893144|FG000|STARTED|Overall Study||136
8838650|NCT01680341|9893145|FG001|STARTED|Overall Study||136
8838651|NCT01680341|9893144|FG000|Exposed|Overall Study|One (1) subject withdrew consent prior to exposure to trial product.|135
8838652|NCT01680341|9893145|FG001|Exposed|Overall Study|Two (2) subjects withdrew consent prior to exposure to trial product.|134
8838653|NCT01680341|9893144|FG000|COMPLETED|Overall Study||115
8838654|NCT01680341|9893145|FG001|COMPLETED|Overall Study||119
8838655|NCT01680341|9893144|FG000|NOT COMPLETED|Overall Study||21
8838656|NCT01680341|9893145|FG001|NOT COMPLETED|Overall Study||17
8838657|NCT01680458|9893151|FG000|STARTED|Overall Study||30
8838658|NCT01680458|9893151|FG000|COMPLETED|Overall Study||27
8838659|NCT01680458|9893151|FG000|NOT COMPLETED|Overall Study||3
8838660|NCT01680497|9893155|FG000|STARTED|Overall Study||70
8838661|NCT01680497|9893155|FG000|COMPLETED|Overall Study||68
8838662|NCT01680497|9893155|FG000|NOT COMPLETED|Overall Study||2
8850027|NCT01744574|9905222|FG002|COMPLETED|Overall Study||32
8850028|NCT01744574|9905223|FG003|COMPLETED|Overall Study||40
8850029|NCT01744574|9905220|FG000|NOT COMPLETED|Overall Study||24
8850030|NCT01744574|9905221|FG001|NOT COMPLETED|Overall Study||25
8850031|NCT01744574|9905222|FG002|NOT COMPLETED|Overall Study||20
8850032|NCT01744574|9905223|FG003|NOT COMPLETED|Overall Study||11
8850033|NCT01744665|9905233|FG000|STARTED|Monitoring Phase||59
8850034|NCT01744665|9905233|FG000|COMPLETED|Monitoring Phase||41
8850035|NCT01744665|9905233|FG000|NOT COMPLETED|Monitoring Phase||18
8850036|NCT01744665|9905233|FG000|STARTED|Consolidation Phase||41
8850037|NCT01744665|9905233|FG000|COMPLETED|Consolidation Phase||22
8850038|NCT01744665|9905233|FG000|NOT COMPLETED|Consolidation Phase||19
8850039|NCT01744665|9905233|FG000|STARTED|Treatment Free Remission Phase||32
8850040|NCT01744665|9905233|FG000|COMPLETED|Treatment Free Remission Phase||32
8850041|NCT01744665|9905233|FG000|NOT COMPLETED|Treatment Free Remission Phase||0
8850042|NCT01744665|9905233|FG000|STARTED|Re-initiation Phase||17
8850043|NCT01744665|9905233|FG000|COMPLETED|Re-initiation Phase||4
8850044|NCT01744665|9905233|FG000|NOT COMPLETED|Re-initiation Phase||13
8850045|NCT01744691|9905240|FG000|STARTED|Overall Study|Participants who received study treatment|144
8850046|NCT01744691|9905240|FG000|COMPLETED|Overall Study|Participants who were on study treatment at the time of the primary analysis|101
8850047|NCT01744691|9905240|FG000|NOT COMPLETED|Overall Study||43
8850048|NCT01744704|9905256|FG000|STARTED|Overall Study||3
8850049|NCT01744704|9905257|FG001|STARTED|Overall Study||3
8850050|NCT01744704|9905258|FG002|STARTED|Overall Study||3
8850051|NCT01744704|9905259|FG003|STARTED|Overall Study||6
8850052|NCT01744704|9905260|FG004|STARTED|Overall Study||6
8850053|NCT01744704|9905261|FG005|STARTED|Overall Study||7
8850054|NCT01744704|9905262|FG006|STARTED|Overall Study||6
8850055|NCT01744704|9905263|FG007|STARTED|Overall Study||9
8850056|NCT01744704|9905264|FG008|STARTED|Overall Study||3
8850057|NCT01744704|9905265|FG009|STARTED|Overall Study||9
8850058|NCT01744704|9905266|FG010|STARTED|Overall Study||9
8850059|NCT01744704|9905267|FG011|STARTED|Overall Study||10
8850060|NCT01744704|9905256|FG000|COMPLETED|Overall Study||3
8850061|NCT01744704|9905257|FG001|COMPLETED|Overall Study||3
8850062|NCT01744704|9905258|FG002|COMPLETED|Overall Study||3
8850063|NCT01744704|9905259|FG003|COMPLETED|Overall Study||6
8850064|NCT01744704|9905260|FG004|COMPLETED|Overall Study||6
8850065|NCT01744704|9905261|FG005|COMPLETED|Overall Study||7
8850066|NCT01744704|9905262|FG006|COMPLETED|Overall Study||6
8850067|NCT01744704|9905263|FG007|COMPLETED|Overall Study||9
8850068|NCT01744704|9905264|FG008|COMPLETED|Overall Study||3
8850069|NCT01744704|9905265|FG009|COMPLETED|Overall Study||9
8850070|NCT01744704|9905266|FG010|COMPLETED|Overall Study||9
8850071|NCT01744704|9905267|FG011|COMPLETED|Overall Study||10
8850072|NCT01744704|9905256|FG000|NOT COMPLETED|Overall Study||0
8850073|NCT01744704|9905257|FG001|NOT COMPLETED|Overall Study||0
8850074|NCT01744704|9905258|FG002|NOT COMPLETED|Overall Study||0
8850075|NCT01744704|9905259|FG003|NOT COMPLETED|Overall Study||0
8850076|NCT01744704|9905260|FG004|NOT COMPLETED|Overall Study||0
8850077|NCT01744704|9905261|FG005|NOT COMPLETED|Overall Study||0
8850078|NCT01744704|9905262|FG006|NOT COMPLETED|Overall Study||0
8850079|NCT01744704|9905263|FG007|NOT COMPLETED|Overall Study||0
8850080|NCT01744704|9905264|FG008|NOT COMPLETED|Overall Study||0
8850081|NCT01744704|9905265|FG009|NOT COMPLETED|Overall Study||0
8850082|NCT01744704|9905266|FG010|NOT COMPLETED|Overall Study||0
8850083|NCT01744704|9905267|FG011|NOT COMPLETED|Overall Study||0
8850084|NCT01744730|9905299|FG000|STARTED|Overall Study||4
8850085|NCT01744730|9905300|FG001|STARTED|Overall Study||3
8850086|NCT01744730|9905301|FG002|STARTED|Overall Study||4
8850087|NCT01744730|9905302|FG003|STARTED|Overall Study||11
8850088|NCT01744730|9905303|FG004|STARTED|Overall Study|Please note this study (NCT01431326) is ongoing and data only represents a subset of this study.|178
8850089|NCT01744730|9905299|FG000|COMPLETED|Overall Study||4
8850090|NCT01744730|9905300|FG001|COMPLETED|Overall Study||3
8850091|NCT01744730|9905301|FG002|COMPLETED|Overall Study||4
8838663|NCT01680549|9893161|FG000|STARTED|Overall Study||25
8838664|NCT01680549|9893162|FG001|STARTED|Overall Study||25
8838665|NCT01680549|9893161|FG000|COMPLETED|Overall Study||20
8838666|NCT01680549|9893162|FG001|COMPLETED|Overall Study||17
8838667|NCT01680549|9893161|FG000|NOT COMPLETED|Overall Study||5
8838668|NCT01680549|9893162|FG001|NOT COMPLETED|Overall Study||8
8850092|NCT01744730|9905302|FG003|COMPLETED|Overall Study||11
8850093|NCT01744730|9905303|FG004|COMPLETED|Overall Study|Please note this study (NCT01431326) is ongoing and data only represents a subset of this study.|178
8850094|NCT01744730|9905299|FG000|NOT COMPLETED|Overall Study||0
8850095|NCT01744730|9905300|FG001|NOT COMPLETED|Overall Study||0
8850096|NCT01744730|9905301|FG002|NOT COMPLETED|Overall Study||0
8850097|NCT01744730|9905302|FG003|NOT COMPLETED|Overall Study||0
8850098|NCT01744730|9905303|FG004|NOT COMPLETED|Overall Study||0
8850099|NCT01744782|9905316|FG000|STARTED|Overall Study||17
8850100|NCT01744782|9905316|FG000|COMPLETED|Overall Study||16
8850101|NCT01744782|9905316|FG000|NOT COMPLETED|Overall Study||1
8850102|NCT01744821|9905324|FG000|STARTED|Overall Study||1
8850103|NCT01744821|9905325|FG001|STARTED|Overall Study||3
8850104|NCT01744821|9905326|FG002|STARTED|Overall Study||2
8850105|NCT01744821|9905327|FG003|STARTED|Overall Study||1
8850106|NCT01744821|9905324|FG000|COMPLETED|Overall Study||1
8850107|NCT01744821|9905325|FG001|COMPLETED|Overall Study||3
8850108|NCT01744821|9905326|FG002|COMPLETED|Overall Study||2
8850109|NCT01744821|9905327|FG003|COMPLETED|Overall Study||1
8850110|NCT01744821|9905324|FG000|NOT COMPLETED|Overall Study||0
8850111|NCT01744821|9905325|FG001|NOT COMPLETED|Overall Study||0
8850112|NCT01744821|9905326|FG002|NOT COMPLETED|Overall Study||0
8850113|NCT01744821|9905327|FG003|NOT COMPLETED|Overall Study||0
8850430|NCT01746420|9905637|FG001|COMPLETED|Overall Study||18
8850431|NCT01746420|9905638|FG002|COMPLETED|Overall Study||17
8850432|NCT01746420|9905639|FG003|COMPLETED|Overall Study||20
8850433|NCT01746420|9905640|FG004|COMPLETED|Overall Study||20
8850434|NCT01746420|9905636|FG000|NOT COMPLETED|Overall Study||3
8850435|NCT01746420|9905637|FG001|NOT COMPLETED|Overall Study||2
8850436|NCT01746420|9905638|FG002|NOT COMPLETED|Overall Study||3
8850437|NCT01746420|9905639|FG003|NOT COMPLETED|Overall Study||0
8850438|NCT01746420|9905640|FG004|NOT COMPLETED|Overall Study||0
8850439|NCT01746511|9905655|FG000|STARTED|Overall Study||40
8850440|NCT01746511|9905656|FG001|STARTED|Overall Study||39
8850441|NCT01746511|9905655|FG000|COMPLETED|Overall Study||40
8850442|NCT01746511|9905656|FG001|COMPLETED|Overall Study||39
8850443|NCT01746511|9905655|FG000|NOT COMPLETED|Overall Study||0
8850444|NCT01746511|9905656|FG001|NOT COMPLETED|Overall Study||0
8850445|NCT01746732|9905662|FG000|STARTED|Lead-In Period||23
8850446|NCT01746732|9905663|FG001|STARTED|Lead-In Period||0
8850447|NCT01746732|9905664|FG002|STARTED|Lead-In Period||0
8850448|NCT01746732|9905662|FG000|Participants Received at Least 1 Dose|Lead-In Period||22
8850449|NCT01746732|9905663|FG001|Participants Received at Least 1 Dose|Lead-In Period||0
8850450|NCT01746732|9905664|FG002|Participants Received at Least 1 Dose|Lead-In Period||0
8850451|NCT01746732|9905662|FG000|COMPLETED|Lead-In Period||22
8850452|NCT01746732|9905663|FG001|COMPLETED|Lead-In Period||0
8850453|NCT01746732|9905664|FG002|COMPLETED|Lead-In Period||0
8850454|NCT01746732|9905662|FG000|NOT COMPLETED|Lead-In Period||1
8850455|NCT01746732|9905663|FG001|NOT COMPLETED|Lead-In Period||0
8850456|NCT01746732|9905664|FG002|NOT COMPLETED|Lead-In Period||0
8850457|NCT01746732|9905662|FG000|STARTED|Period 1||0
8850458|NCT01746732|9905663|FG001|STARTED|Period 1||11
8850459|NCT01746732|9905664|FG002|STARTED|Period 1||11
8850460|NCT01746732|9905662|FG000|COMPLETED|Period 1||0
8850461|NCT01746732|9905663|FG001|COMPLETED|Period 1||10
8850462|NCT01746732|9905664|FG002|COMPLETED|Period 1||11
8850463|NCT01746732|9905662|FG000|NOT COMPLETED|Period 1||0
8850464|NCT01746732|9905663|FG001|NOT COMPLETED|Period 1||1
8850465|NCT01746732|9905664|FG002|NOT COMPLETED|Period 1||0
8850466|NCT01746732|9905662|FG000|STARTED|Period 2||0
8850467|NCT01746732|9905663|FG001|STARTED|Period 2||10
8850468|NCT01746732|9905664|FG002|STARTED|Period 2||11
8850469|NCT01746732|9905662|FG000|COMPLETED|Period 2||0
8850470|NCT01746732|9905663|FG001|COMPLETED|Period 2||10
8850471|NCT01746732|9905664|FG002|COMPLETED|Period 2||7
8850472|NCT01746732|9905662|FG000|NOT COMPLETED|Period 2||0
8850473|NCT01746732|9905663|FG001|NOT COMPLETED|Period 2||0
8850474|NCT01746732|9905664|FG002|NOT COMPLETED|Period 2||4
8850475|NCT01746745|9905672|FG000|STARTED|Overall Study||6
8850476|NCT01746745|9905672|FG000|Received Study Drug|Overall Study||6
8850477|NCT01746745|9905672|FG000|COMPLETED|Overall Study||6
8850478|NCT01746745|9905672|FG000|NOT COMPLETED|Overall Study||0
8623057|NCT00491075|9662266|FG000|NOT COMPLETED|Overall Study||2
8623058|NCT00491179|9662272|FG000|STARTED|Overall Study||25
8623059|NCT00491179|9662273|FG001|STARTED|Overall Study||10
8623060|NCT00491179|9662272|FG000|COMPLETED|Overall Study||18
8623061|NCT00491179|9662273|FG001|COMPLETED|Overall Study||8
8850479|NCT01746784|9905681|FG000|STARTED|Overall Study||19
8850480|NCT01746784|9905682|FG001|STARTED|Overall Study||10
8850481|NCT01746784|9905683|FG002|STARTED|Overall Study||9
8850482|NCT01746784|9905684|FG003|STARTED|Overall Study||9
8850483|NCT01746784|9905685|FG004|STARTED|Overall Study||19
8850484|NCT01746784|9905681|FG000|Enrolled|Overall Study||19
8850485|NCT01746784|9905682|FG001|Enrolled|Overall Study||10
8850486|NCT01746784|9905683|FG002|Enrolled|Overall Study||9
8850487|NCT01746784|9905684|FG003|Enrolled|Overall Study||9
8850488|NCT01746784|9905685|FG004|Enrolled|Overall Study||19
8838669|NCT01680640|9893176|FG000|STARTED|Overall Study||55
8838670|NCT01680640|9893177|FG001|STARTED|Overall Study||49
8838671|NCT01680640|9893176|FG000|COMPLETED|Overall Study||45
8838672|NCT01680640|9893177|FG001|COMPLETED|Overall Study||44
8838673|NCT01680640|9893176|FG000|NOT COMPLETED|Overall Study||10
8838674|NCT01680640|9893177|FG001|NOT COMPLETED|Overall Study||5
8838675|NCT01680653|9893183|FG000|STARTED|Overall Study||57
8838676|NCT01680653|9893183|FG000|COMPLETED|Overall Study||57
8838677|NCT01680653|9893183|FG000|NOT COMPLETED|Overall Study||0
8838678|NCT01680666|9893195|FG000|STARTED|Overall Study||84
8838679|NCT01680666|9893196|FG001|STARTED|Overall Study||66
8838680|NCT01680666|9893195|FG000|COMPLETED|Overall Study||84
8838681|NCT01680666|9893196|FG001|COMPLETED|Overall Study||66
8838682|NCT01680666|9893195|FG000|NOT COMPLETED|Overall Study||0
8838683|NCT01680666|9893196|FG001|NOT COMPLETED|Overall Study||0
8838684|NCT01680783|9893205|FG000|STARTED|Overall Study||39
8838685|NCT01680783|9893206|FG001|STARTED|Overall Study||44
8838686|NCT01680783|9893205|FG000|COMPLETED|Overall Study||39
8838687|NCT01680783|9893206|FG001|COMPLETED|Overall Study||44
8838688|NCT01680783|9893205|FG000|NOT COMPLETED|Overall Study||0
8838689|NCT01680783|9893206|FG001|NOT COMPLETED|Overall Study||0
8838690|NCT01680835|9893212|FG000|STARTED|Overall Study||108
8838691|NCT01680835|9893212|FG000|COMPLETED|Overall Study||83
8838692|NCT01680835|9893212|FG000|NOT COMPLETED|Overall Study||25
8838693|NCT01680848|9893216|FG000|STARTED|Overall Study||282
8838694|NCT01680848|9893216|FG000|COMPLETED|Overall Study||189
8838695|NCT01680848|9893216|FG000|NOT COMPLETED|Overall Study||93
8838696|NCT01680861|9893222|FG000|STARTED|Early Post-transplant Period|One patient didn't produce sufficient urine during first 24hr post-transplant (ineligible).|16
8838697|NCT01680861|9893223|FG001|STARTED|Early Post-transplant Period|One patient developed immediate DGF (delayed graft function) and was therefore ineligible.|16
8838698|NCT01680861|9893222|FG000|COMPLETED|Early Post-transplant Period||15
8838699|NCT01680861|9893223|FG001|COMPLETED|Early Post-transplant Period||15
8838700|NCT01680861|9893222|FG000|NOT COMPLETED|Early Post-transplant Period||1
8838701|NCT01680861|9893223|FG001|NOT COMPLETED|Early Post-transplant Period||1
8838702|NCT01680861|9893222|FG000|STARTED|First 12 Months Post-transplant||15
8838703|NCT01680861|9893223|FG001|STARTED|First 12 Months Post-transplant||15
8838704|NCT01680861|9893222|FG000|COMPLETED|First 12 Months Post-transplant||15
8838705|NCT01680861|9893223|FG001|COMPLETED|First 12 Months Post-transplant||15
8838706|NCT01680861|9893222|FG000|NOT COMPLETED|First 12 Months Post-transplant||0
8838707|NCT01680861|9893223|FG001|NOT COMPLETED|First 12 Months Post-transplant||0
8838708|NCT01680887|9893233|FG000|STARTED|Overall Study||80
8838709|NCT01680887|9893234|FG001|STARTED|Overall Study||76
8838710|NCT01680887|9893233|FG000|COMPLETED|Overall Study||51
8838711|NCT01680887|9893234|FG001|COMPLETED|Overall Study||52
8838712|NCT01680887|9893233|FG000|NOT COMPLETED|Overall Study||29
8838713|NCT01680887|9893234|FG001|NOT COMPLETED|Overall Study||24
8838714|NCT01680900|9893242|FG000|STARTED|Overall Study||24
8838715|NCT01680900|9893243|FG001|STARTED|Overall Study||12
8838716|NCT01680900|9893242|FG000|COMPLETED|Overall Study||20
8838717|NCT01680900|9893243|FG001|COMPLETED|Overall Study||11
8838718|NCT01680900|9893242|FG000|NOT COMPLETED|Overall Study||4
8838719|NCT01680900|9893243|FG001|NOT COMPLETED|Overall Study||1
8838720|NCT01680991|9893252|FG000|STARTED|Overall Study||12
8838721|NCT01680991|9893253|FG001|STARTED|Overall Study||23
8838722|NCT01680991|9893254|FG002|STARTED|Overall Study||13
8838723|NCT01680991|9893252|FG000|COMPLETED|Overall Study||4
8838724|NCT01680991|9893253|FG001|COMPLETED|Overall Study||4
8838725|NCT01680991|9893254|FG002|COMPLETED|Overall Study||9
8838726|NCT01680991|9893252|FG000|NOT COMPLETED|Overall Study||8
8838727|NCT01680991|9893253|FG001|NOT COMPLETED|Overall Study||19
8838728|NCT01680991|9893254|FG002|NOT COMPLETED|Overall Study||4
8838729|NCT01681004|9893266|FG000|STARTED|Primary Endpoint: 6 Months||102
8838730|NCT01681004|9893267|FG001|STARTED|Primary Endpoint: 6 Months||46
8838731|NCT01681004|9893266|FG000|Crossover to Surgical Treatment|Primary Endpoint: 6 Months||0
8838732|NCT01681004|9893267|FG001|Crossover to Surgical Treatment|Primary Endpoint: 6 Months|Crossover to surgical treatment allowed per study protocol after the 6-month visit was complete.|39
8838733|NCT01681004|9893266|FG000|COMPLETED|Primary Endpoint: 6 Months||101
8838734|NCT01681004|9893267|FG001|COMPLETED|Primary Endpoint: 6 Months||44
8838735|NCT01681004|9893266|FG000|NOT COMPLETED|Primary Endpoint: 6 Months||1
8838736|NCT01681004|9893267|FG001|NOT COMPLETED|Primary Endpoint: 6 Months||2
8838737|NCT01681004|9893266|FG000|STARTED|Study Completion||101
8838738|NCT01681004|9893267|FG001|STARTED|Study Completion||44
8838739|NCT01681004|9893266|FG000|COMPLETED|Study Completion||89
8838740|NCT01681004|9893267|FG001|COMPLETED|Study Completion||36
8838741|NCT01681004|9893266|FG000|NOT COMPLETED|Study Completion||12
8838742|NCT01681004|9893267|FG001|NOT COMPLETED|Study Completion||8
8838743|NCT01681030|9893280|FG000|STARTED|Overall Study||13
8838744|NCT01681030|9893281|FG001|STARTED|Overall Study||18
8838745|NCT01681030|9893282|FG002|STARTED|Overall Study||11
8838746|NCT01681030|9893280|FG000|COMPLETED|Overall Study||13
8838747|NCT01681030|9893281|FG001|COMPLETED|Overall Study||18
8838748|NCT01681030|9893282|FG002|COMPLETED|Overall Study||11
8838749|NCT01681030|9893280|FG000|NOT COMPLETED|Overall Study||0
8838750|NCT01681030|9893281|FG001|NOT COMPLETED|Overall Study||0
8838751|NCT01681030|9893282|FG002|NOT COMPLETED|Overall Study||0
8838752|NCT01681069|9893292|FG000|STARTED|Overall Study||60
8838753|NCT01681069|9893293|FG001|STARTED|Overall Study||60
8838754|NCT01681069|9893292|FG000|Full Analysis Set (FAS)|Overall Study||57
8838755|NCT01681069|9893293|FG001|Full Analysis Set (FAS)|Overall Study||60
8838756|NCT01681069|9893292|FG000|COMPLETED|Overall Study|Valid Case Analysis Set (VAS)|55
8838757|NCT01681069|9893293|FG001|COMPLETED|Overall Study|Valid Case Analysis Set (VAS)|53
8838758|NCT01681069|9893292|FG000|NOT COMPLETED|Overall Study||5
8838759|NCT01681069|9893293|FG001|NOT COMPLETED|Overall Study||7
8838760|NCT01681095|9893301|FG000|STARTED|Overall Study||55
8838761|NCT01681095|9893302|FG001|STARTED|Overall Study||55
8838762|NCT01681095|9893301|FG000|COMPLETED|Overall Study||55
8838763|NCT01681095|9893302|FG001|COMPLETED|Overall Study||55
8838764|NCT01681095|9893301|FG000|NOT COMPLETED|Overall Study||0
8838765|NCT01681095|9893302|FG001|NOT COMPLETED|Overall Study||0
8838766|NCT01681121|9893310|FG000|STARTED|Overall Study||44
8838767|NCT01681121|9893311|FG001|STARTED|Overall Study||49
8838768|NCT01681121|9893310|FG000|COMPLETED|Overall Study||36
8838769|NCT01681121|9893311|FG001|COMPLETED|Overall Study||38
8838770|NCT01681121|9893310|FG000|NOT COMPLETED|Overall Study||8
8838771|NCT01681121|9893311|FG001|NOT COMPLETED|Overall Study||11
8838772|NCT01681186|9893327|FG000|STARTED|First Intervention||4
8838773|NCT01681186|9893328|FG001|STARTED|First Intervention||2
8838774|NCT01681186|9893329|FG002|STARTED|First Intervention||2
8838775|NCT01681186|9893330|FG003|STARTED|First Intervention||3
8838776|NCT01681186|9893331|FG004|STARTED|First Intervention||3
8838777|NCT01681186|9893332|FG005|STARTED|First Intervention||2
8838778|NCT01681186|9893333|FG006|STARTED|First Intervention||7
8838779|NCT01681186|9893334|FG007|STARTED|First Intervention||7
8838780|NCT01681186|9893327|FG000|COMPLETED|First Intervention||4
8838781|NCT01681186|9893328|FG001|COMPLETED|First Intervention||2
8838782|NCT01681186|9893329|FG002|COMPLETED|First Intervention||2
8838783|NCT01681186|9893330|FG003|COMPLETED|First Intervention||3
8838784|NCT01681186|9893331|FG004|COMPLETED|First Intervention||3
8838785|NCT01681186|9893332|FG005|COMPLETED|First Intervention||2
8838786|NCT01681186|9893333|FG006|COMPLETED|First Intervention||7
8838787|NCT01681186|9893334|FG007|COMPLETED|First Intervention||7
8838788|NCT01681186|9893327|FG000|NOT COMPLETED|First Intervention||0
8838789|NCT01681186|9893328|FG001|NOT COMPLETED|First Intervention||0
8838790|NCT01681186|9893329|FG002|NOT COMPLETED|First Intervention||0
8838791|NCT01681186|9893330|FG003|NOT COMPLETED|First Intervention||0
8838792|NCT01681186|9893331|FG004|NOT COMPLETED|First Intervention||0
8838793|NCT01681186|9893332|FG005|NOT COMPLETED|First Intervention||0
8838794|NCT01681186|9893333|FG006|NOT COMPLETED|First Intervention||0
8838795|NCT01681186|9893334|FG007|NOT COMPLETED|First Intervention||0
8838796|NCT01681186|9893327|FG000|STARTED|Washout Period From First Intervention||4
8838797|NCT01681186|9893328|FG001|STARTED|Washout Period From First Intervention||2
8838798|NCT01681186|9893329|FG002|STARTED|Washout Period From First Intervention||2
8838799|NCT01681186|9893330|FG003|STARTED|Washout Period From First Intervention||3
8838800|NCT01681186|9893331|FG004|STARTED|Washout Period From First Intervention||3
8838801|NCT01681186|9893332|FG005|STARTED|Washout Period From First Intervention||2
8838802|NCT01681186|9893333|FG006|STARTED|Washout Period From First Intervention||7
8838803|NCT01681186|9893334|FG007|STARTED|Washout Period From First Intervention||7
8838804|NCT01681186|9893327|FG000|COMPLETED|Washout Period From First Intervention||4
8838805|NCT01681186|9893328|FG001|COMPLETED|Washout Period From First Intervention||2
8838806|NCT01681186|9893329|FG002|COMPLETED|Washout Period From First Intervention||2
8838807|NCT01681186|9893330|FG003|COMPLETED|Washout Period From First Intervention||3
8838808|NCT01681186|9893331|FG004|COMPLETED|Washout Period From First Intervention||3
8838809|NCT01681186|9893332|FG005|COMPLETED|Washout Period From First Intervention||2
8838810|NCT01681186|9893333|FG006|COMPLETED|Washout Period From First Intervention||7
8838811|NCT01681186|9893334|FG007|COMPLETED|Washout Period From First Intervention||7
8838812|NCT01681186|9893327|FG000|NOT COMPLETED|Washout Period From First Intervention||0
8838813|NCT01681186|9893328|FG001|NOT COMPLETED|Washout Period From First Intervention||0
8838814|NCT01681186|9893329|FG002|NOT COMPLETED|Washout Period From First Intervention||0
8838815|NCT01681186|9893330|FG003|NOT COMPLETED|Washout Period From First Intervention||0
8838816|NCT01681186|9893331|FG004|NOT COMPLETED|Washout Period From First Intervention||0
8838817|NCT01681186|9893332|FG005|NOT COMPLETED|Washout Period From First Intervention||0
8838818|NCT01681186|9893333|FG006|NOT COMPLETED|Washout Period From First Intervention||0
8838819|NCT01681186|9893334|FG007|NOT COMPLETED|Washout Period From First Intervention||0
8838820|NCT01681186|9893327|FG000|STARTED|Second Intervention||4
8838821|NCT01681186|9893328|FG001|STARTED|Second Intervention||2
8838822|NCT01681186|9893329|FG002|STARTED|Second Intervention||2
8838823|NCT01681186|9893330|FG003|STARTED|Second Intervention||3
8838824|NCT01681186|9893331|FG004|STARTED|Second Intervention||3
8838825|NCT01681186|9893332|FG005|STARTED|Second Intervention||2
8838826|NCT01681186|9893333|FG006|STARTED|Second Intervention||7
8838827|NCT01681186|9893334|FG007|STARTED|Second Intervention||7
8838828|NCT01681186|9893327|FG000|COMPLETED|Second Intervention||4
8838829|NCT01681186|9893328|FG001|COMPLETED|Second Intervention||2
8838830|NCT01681186|9893329|FG002|COMPLETED|Second Intervention||2
8838831|NCT01681186|9893330|FG003|COMPLETED|Second Intervention||3
8838832|NCT01681186|9893331|FG004|COMPLETED|Second Intervention||3
8838833|NCT01681186|9893332|FG005|COMPLETED|Second Intervention||2
8838834|NCT01681186|9893333|FG006|COMPLETED|Second Intervention||7
8838835|NCT01681186|9893334|FG007|COMPLETED|Second Intervention||7
8838836|NCT01681186|9893327|FG000|NOT COMPLETED|Second Intervention||0
8838837|NCT01681186|9893328|FG001|NOT COMPLETED|Second Intervention||0
8838838|NCT01681186|9893329|FG002|NOT COMPLETED|Second Intervention||0
8838839|NCT01681186|9893330|FG003|NOT COMPLETED|Second Intervention||0
8838840|NCT01681186|9893331|FG004|NOT COMPLETED|Second Intervention||0
8838841|NCT01681186|9893332|FG005|NOT COMPLETED|Second Intervention||0
8838842|NCT01681186|9893333|FG006|NOT COMPLETED|Second Intervention||0
8838843|NCT01681186|9893334|FG007|NOT COMPLETED|Second Intervention||0
8838844|NCT01681186|9893327|FG000|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
8838845|NCT01681186|9893328|FG001|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
8838846|NCT01681186|9893329|FG002|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
8838847|NCT01681186|9893330|FG003|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
8838848|NCT01681186|9893331|FG004|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
8838849|NCT01681186|9893332|FG005|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
8838850|NCT01681186|9893333|FG006|STARTED|Washout Period From Second Intervention||7
8838851|NCT01681186|9893334|FG007|STARTED|Washout Period From Second Intervention||7
8838852|NCT01681186|9893327|FG000|COMPLETED|Washout Period From Second Intervention||0
8838853|NCT01681186|9893328|FG001|COMPLETED|Washout Period From Second Intervention||0
8838854|NCT01681186|9893329|FG002|COMPLETED|Washout Period From Second Intervention||0
8838855|NCT01681186|9893330|FG003|COMPLETED|Washout Period From Second Intervention||0
8838856|NCT01681186|9893331|FG004|COMPLETED|Washout Period From Second Intervention||0
8838857|NCT01681186|9893332|FG005|COMPLETED|Washout Period From Second Intervention||0
8838858|NCT01681186|9893333|FG006|COMPLETED|Washout Period From Second Intervention||6
8838859|NCT01681186|9893334|FG007|COMPLETED|Washout Period From Second Intervention||6
8838860|NCT01681186|9893327|FG000|NOT COMPLETED|Washout Period From Second Intervention||0
8838861|NCT01681186|9893328|FG001|NOT COMPLETED|Washout Period From Second Intervention||0
8838862|NCT01681186|9893329|FG002|NOT COMPLETED|Washout Period From Second Intervention||0
8838863|NCT01681186|9893330|FG003|NOT COMPLETED|Washout Period From Second Intervention||0
8838864|NCT01681186|9893331|FG004|NOT COMPLETED|Washout Period From Second Intervention||0
8838865|NCT01681186|9893332|FG005|NOT COMPLETED|Washout Period From Second Intervention||0
8838866|NCT01681186|9893333|FG006|NOT COMPLETED|Washout Period From Second Intervention||1
8838867|NCT01681186|9893334|FG007|NOT COMPLETED|Washout Period From Second Intervention||1
8838868|NCT01681186|9893327|FG000|STARTED|Third Intervention||0
8838869|NCT01681186|9893328|FG001|STARTED|Third Intervention||0
8838870|NCT01681186|9893329|FG002|STARTED|Third Intervention||0
8838871|NCT01681186|9893330|FG003|STARTED|Third Intervention||0
8838872|NCT01681186|9893331|FG004|STARTED|Third Intervention||0
8838873|NCT01681186|9893332|FG005|STARTED|Third Intervention||0
8838874|NCT01681186|9893333|FG006|STARTED|Third Intervention||6
8838875|NCT01681186|9893334|FG007|STARTED|Third Intervention||6
8838876|NCT01681186|9893327|FG000|COMPLETED|Third Intervention||0
8838877|NCT01681186|9893328|FG001|COMPLETED|Third Intervention||0
8838878|NCT01681186|9893329|FG002|COMPLETED|Third Intervention||0
8838879|NCT01681186|9893330|FG003|COMPLETED|Third Intervention||0
8838880|NCT01681186|9893331|FG004|COMPLETED|Third Intervention||0
8838881|NCT01681186|9893332|FG005|COMPLETED|Third Intervention||0
8838882|NCT01681186|9893333|FG006|COMPLETED|Third Intervention||6
8838883|NCT01681186|9893334|FG007|COMPLETED|Third Intervention||6
8838884|NCT01681186|9893327|FG000|NOT COMPLETED|Third Intervention||0
8838885|NCT01681186|9893328|FG001|NOT COMPLETED|Third Intervention||0
8838886|NCT01681186|9893329|FG002|NOT COMPLETED|Third Intervention||0
8838887|NCT01681186|9893330|FG003|NOT COMPLETED|Third Intervention||0
8838888|NCT01681186|9893331|FG004|NOT COMPLETED|Third Intervention||0
8838889|NCT01681186|9893332|FG005|NOT COMPLETED|Third Intervention||0
8838890|NCT01681186|9893333|FG006|NOT COMPLETED|Third Intervention||0
8838891|NCT01681186|9893334|FG007|NOT COMPLETED|Third Intervention||0
8838892|NCT01681186|9893327|FG000|STARTED|Washout Period From Third Intervention||0
8838893|NCT01681186|9893328|FG001|STARTED|Washout Period From Third Intervention||0
8838894|NCT01681186|9893329|FG002|STARTED|Washout Period From Third Intervention||0
8838895|NCT01681186|9893330|FG003|STARTED|Washout Period From Third Intervention||0
8838896|NCT01681186|9893331|FG004|STARTED|Washout Period From Third Intervention||0
8838897|NCT01681186|9893332|FG005|STARTED|Washout Period From Third Intervention||0
8838898|NCT01681186|9893333|FG006|STARTED|Washout Period From Third Intervention||6
8838899|NCT01681186|9893334|FG007|STARTED|Washout Period From Third Intervention||6
8838900|NCT01681186|9893327|FG000|COMPLETED|Washout Period From Third Intervention||0
8838901|NCT01681186|9893328|FG001|COMPLETED|Washout Period From Third Intervention||0
8838902|NCT01681186|9893329|FG002|COMPLETED|Washout Period From Third Intervention||0
8838903|NCT01681186|9893330|FG003|COMPLETED|Washout Period From Third Intervention||0
8838904|NCT01681186|9893331|FG004|COMPLETED|Washout Period From Third Intervention||0
8838905|NCT01681186|9893332|FG005|COMPLETED|Washout Period From Third Intervention||0
8838906|NCT01681186|9893333|FG006|COMPLETED|Washout Period From Third Intervention||5
8838907|NCT01681186|9893334|FG007|COMPLETED|Washout Period From Third Intervention||6
8838908|NCT01681186|9893327|FG000|NOT COMPLETED|Washout Period From Third Intervention||0
8838909|NCT01681186|9893328|FG001|NOT COMPLETED|Washout Period From Third Intervention||0
8838910|NCT01681186|9893329|FG002|NOT COMPLETED|Washout Period From Third Intervention||0
8838911|NCT01681186|9893330|FG003|NOT COMPLETED|Washout Period From Third Intervention||0
8838912|NCT01681186|9893331|FG004|NOT COMPLETED|Washout Period From Third Intervention||0
8838913|NCT01681186|9893332|FG005|NOT COMPLETED|Washout Period From Third Intervention||0
8838914|NCT01681186|9893333|FG006|NOT COMPLETED|Washout Period From Third Intervention||1
8838915|NCT01681186|9893334|FG007|NOT COMPLETED|Washout Period From Third Intervention||0
8838916|NCT01681186|9893327|FG000|STARTED|Fourth Intervention||0
8838917|NCT01681186|9893328|FG001|STARTED|Fourth Intervention||0
8838918|NCT01681186|9893329|FG002|STARTED|Fourth Intervention||0
8838919|NCT01681186|9893330|FG003|STARTED|Fourth Intervention||0
8838920|NCT01681186|9893331|FG004|STARTED|Fourth Intervention||0
8838921|NCT01681186|9893332|FG005|STARTED|Fourth Intervention||0
8838922|NCT01681186|9893333|FG006|STARTED|Fourth Intervention||5
8838923|NCT01681186|9893334|FG007|STARTED|Fourth Intervention||6
8838924|NCT01681186|9893327|FG000|COMPLETED|Fourth Intervention||0
8838925|NCT01681186|9893328|FG001|COMPLETED|Fourth Intervention||0
8838926|NCT01681186|9893329|FG002|COMPLETED|Fourth Intervention||0
8838927|NCT01681186|9893330|FG003|COMPLETED|Fourth Intervention||0
8838928|NCT01681186|9893331|FG004|COMPLETED|Fourth Intervention||0
8838929|NCT01681186|9893332|FG005|COMPLETED|Fourth Intervention||0
8838930|NCT01681186|9893333|FG006|COMPLETED|Fourth Intervention||5
8838931|NCT01681186|9893334|FG007|COMPLETED|Fourth Intervention||5
8838932|NCT01681186|9893327|FG000|NOT COMPLETED|Fourth Intervention||0
8838933|NCT01681186|9893328|FG001|NOT COMPLETED|Fourth Intervention||0
8838934|NCT01681186|9893329|FG002|NOT COMPLETED|Fourth Intervention||0
8838935|NCT01681186|9893330|FG003|NOT COMPLETED|Fourth Intervention||0
8838936|NCT01681186|9893331|FG004|NOT COMPLETED|Fourth Intervention||0
8838937|NCT01681186|9893332|FG005|NOT COMPLETED|Fourth Intervention||0
8838938|NCT01681186|9893333|FG006|NOT COMPLETED|Fourth Intervention||0
8838939|NCT01681186|9893334|FG007|NOT COMPLETED|Fourth Intervention||1
8838940|NCT01681212|9893364|FG000|STARTED|Overall Study|Enrolled|21
8838941|NCT01681212|9893364|FG000|Received Treatment|Overall Study||15
8838942|NCT01681212|9893364|FG000|COMPLETED|Overall Study|Completed=patients who received treatment; not completed=patients who did not receive treatment|15
8838943|NCT01681212|9893364|FG000|NOT COMPLETED|Overall Study||6
8838944|NCT01681277|9893373|FG000|STARTED|Overall Study||12
8838945|NCT01681277|9893374|FG001|STARTED|Overall Study||9
8838946|NCT01681277|9893375|FG002|STARTED|Overall Study||9
8838947|NCT01681277|9893376|FG003|STARTED|Overall Study||9
8838948|NCT01681277|9893377|FG004|STARTED|Overall Study||9
8838949|NCT01681277|9893373|FG000|COMPLETED|Overall Study||11
8838950|NCT01681277|9893374|FG001|COMPLETED|Overall Study||9
8838951|NCT01681277|9893375|FG002|COMPLETED|Overall Study||9
8838952|NCT01681277|9893376|FG003|COMPLETED|Overall Study||9
8838953|NCT01681277|9893377|FG004|COMPLETED|Overall Study||9
8838954|NCT01681277|9893373|FG000|NOT COMPLETED|Overall Study||1
8838955|NCT01681277|9893374|FG001|NOT COMPLETED|Overall Study||0
8838956|NCT01681277|9893375|FG002|NOT COMPLETED|Overall Study||0
8838957|NCT01681277|9893376|FG003|NOT COMPLETED|Overall Study||0
8944634|NCT02397460|10006443|FG000|COMPLETED|Treatment Period 4||7
8944635|NCT02397460|10006444|FG001|COMPLETED|Treatment Period 4||6
8944636|NCT02397460|10006445|FG002|COMPLETED|Treatment Period 4||6
8944637|NCT02397460|10006446|FG003|COMPLETED|Treatment Period 4||6
8944638|NCT02397460|10006447|FG004|COMPLETED|Treatment Period 4||5
8944639|NCT02397460|10006448|FG005|COMPLETED|Treatment Period 4||6
8944640|NCT02397460|10006449|FG006|COMPLETED|Treatment Period 4||6
8944641|NCT02397460|10006450|FG007|COMPLETED|Treatment Period 4||5
8944642|NCT02397460|10006443|FG000|NOT COMPLETED|Treatment Period 4||0
8944643|NCT02397460|10006444|FG001|NOT COMPLETED|Treatment Period 4||1
8944644|NCT02397460|10006445|FG002|NOT COMPLETED|Treatment Period 4||0
8944645|NCT02397460|10006446|FG003|NOT COMPLETED|Treatment Period 4||0
8944646|NCT02397460|10006447|FG004|NOT COMPLETED|Treatment Period 4||1
8944647|NCT02397460|10006448|FG005|NOT COMPLETED|Treatment Period 4||0
8944648|NCT02397460|10006449|FG006|NOT COMPLETED|Treatment Period 4||0
8944649|NCT02397460|10006450|FG007|NOT COMPLETED|Treatment Period 4||0
8944650|NCT02397473|10006526|FG000|STARTED|Treatment Phase||57
8944651|NCT02397473|10006527|FG001|STARTED|Treatment Phase||52
8944652|NCT02397473|10006526|FG000|Received at Least One Dose of Study Drug|Treatment Phase||57
8623062|NCT00491179|9662272|FG000|NOT COMPLETED|Overall Study||7
8623063|NCT00491179|9662273|FG001|NOT COMPLETED|Overall Study||2
8623064|NCT00491244|9662281|FG000|STARTED|Overall Study||189
8623065|NCT00491244|9662282|FG001|STARTED|Overall Study||188
8623066|NCT00491244|9662281|FG000|COMPLETED|Overall Study||162
8623067|NCT00491244|9662282|FG001|COMPLETED|Overall Study||168
8623068|NCT00491244|9662281|FG000|NOT COMPLETED|Overall Study||27
8623069|NCT00491244|9662282|FG001|NOT COMPLETED|Overall Study||20
8623070|NCT00491322|9662290|FG000|STARTED|Overall Study||41
8838958|NCT01681277|9893377|FG004|NOT COMPLETED|Overall Study||0
8838959|NCT01681368|9893393|FG000|STARTED|Overall Study||11
8838960|NCT01681368|9893393|FG000|COMPLETED|Overall Study||9
8838961|NCT01681368|9893393|FG000|NOT COMPLETED|Overall Study||2
8838962|NCT01681433|9893399|FG000|STARTED|Overall Study||36
8838963|NCT01681433|9893400|FG001|STARTED|Overall Study||36
8838964|NCT01681433|9893399|FG000|COMPLETED|Overall Study||4
8838965|NCT01681433|9893400|FG001|COMPLETED|Overall Study||3
8838966|NCT01681433|9893399|FG000|NOT COMPLETED|Overall Study||32
8838967|NCT01681433|9893400|FG001|NOT COMPLETED|Overall Study||33
8838968|NCT01681472|9893410|FG000|STARTED|Overall Study||8
8838969|NCT01681472|9893411|FG001|STARTED|Overall Study||8
8838970|NCT01681472|9893412|FG002|STARTED|Overall Study||8
8838971|NCT01681472|9893413|FG003|STARTED|Overall Study||8
8838972|NCT01681472|9893410|FG000|COMPLETED|Overall Study||8
8838973|NCT01681472|9893411|FG001|COMPLETED|Overall Study||7
8838974|NCT01681472|9893412|FG002|COMPLETED|Overall Study||8
8838975|NCT01681472|9893413|FG003|COMPLETED|Overall Study||8
8838976|NCT01681472|9893410|FG000|NOT COMPLETED|Overall Study||0
8838977|NCT01681472|9893411|FG001|NOT COMPLETED|Overall Study||1
8838978|NCT01681472|9893412|FG002|NOT COMPLETED|Overall Study||0
8838979|NCT01681472|9893413|FG003|NOT COMPLETED|Overall Study||0
8838980|NCT01681511|9893434|FG000|STARTED|Overall Study|All randomized subjects in the Lubri-Sil arm.|46
8838981|NCT01681511|9893435|FG001|STARTED|Overall Study|All randomized subjects in the TIC arm.|49
8838982|NCT01681511|9893434|FG000|Intent to Treat (ITT) Population|Overall Study|Any subject receiving the Lubri-Sil treatment after randomization.|45
8838983|NCT01681511|9893435|FG001|Intent to Treat (ITT) Population|Overall Study|Any subject receiving the TIC treatment after randomization.|46
8838984|NCT01681511|9893434|FG000|Evaluable Population|Overall Study|Subjects w/ positive urine culture results also removed from the Lubri-Sil arm of this population.|16
8838985|NCT01681511|9893435|FG001|Evaluable Population|Overall Study|Subjects w/ positive urine culture results also removed from the TIC arm of this population.|14
8838986|NCT01681511|9893434|FG000|COMPLETED|Overall Study||28
8838987|NCT01681511|9893435|FG001|COMPLETED|Overall Study||35
8838988|NCT01681511|9893434|FG000|NOT COMPLETED|Overall Study||18
8838989|NCT01681511|9893435|FG001|NOT COMPLETED|Overall Study||14
8838990|NCT01681576|9893443|FG000|STARTED|Period 1||36
8838991|NCT01681576|9893444|FG001|STARTED|Period 1||36
8838992|NCT01681576|9893443|FG000|COMPLETED|Period 1||34
8838993|NCT01681576|9893444|FG001|COMPLETED|Period 1||36
8838994|NCT01681576|9893443|FG000|NOT COMPLETED|Period 1||2
8838995|NCT01681576|9893444|FG001|NOT COMPLETED|Period 1||0
8838996|NCT01681576|9893443|FG000|STARTED|Period 2|Period 2: Valsartan 320mg|34
8838997|NCT01681576|9893444|FG001|STARTED|Period 2|Period 2: LCZ696 400mg|36
8838998|NCT01681576|9893443|FG000|COMPLETED|Period 2||30
8838999|NCT01681576|9893444|FG001|COMPLETED|Period 2||35
8839000|NCT01681576|9893443|FG000|NOT COMPLETED|Period 2||4
8839001|NCT01681576|9893444|FG001|NOT COMPLETED|Period 2||1
8839002|NCT01681628|9893454|FG000|STARTED|Time 1 (Entry) to Time 2 One Week Later.||128
8839003|NCT01681628|9893455|FG001|STARTED|Time 1 (Entry) to Time 2 One Week Later.||128
8839004|NCT01681628|9893454|FG000|COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||114
8839005|NCT01681628|9893455|FG001|COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||122
8839006|NCT01681628|9893454|FG000|NOT COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||14
8839007|NCT01681628|9893455|FG001|NOT COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||6
8839008|NCT01681628|9893454|FG000|STARTED|Time 2 to Time 3 (One Week Later).|Only wait list group studied in this period.|0
8839009|NCT01681628|9893455|FG001|STARTED|Time 2 to Time 3 (One Week Later).||122
8839010|NCT01681628|9893454|FG000|COMPLETED|Time 2 to Time 3 (One Week Later).|Only wait list group studied in this period.|0
8839011|NCT01681628|9893455|FG001|COMPLETED|Time 2 to Time 3 (One Week Later).||107
8839012|NCT01681628|9893454|FG000|NOT COMPLETED|Time 2 to Time 3 (One Week Later).||0
8839013|NCT01681628|9893455|FG001|NOT COMPLETED|Time 2 to Time 3 (One Week Later).||15
8839014|NCT01681628|9893454|FG000|STARTED|19 Months Follow-up||114
8839015|NCT01681628|9893455|FG001|STARTED|19 Months Follow-up||107
8839016|NCT01681628|9893454|FG000|COMPLETED|19 Months Follow-up||52
8839017|NCT01681628|9893455|FG001|COMPLETED|19 Months Follow-up||64
8839018|NCT01681628|9893454|FG000|NOT COMPLETED|19 Months Follow-up||62
8839019|NCT01681628|9893455|FG001|NOT COMPLETED|19 Months Follow-up||43
8839020|NCT01681771|9893466|FG000|STARTED|Overall Study||25
8839021|NCT01681771|9893467|FG001|STARTED|Overall Study||25
8839022|NCT01681771|9893466|FG000|COMPLETED|Overall Study||21
8839023|NCT01681771|9893467|FG001|COMPLETED|Overall Study||23
8839024|NCT01681771|9893466|FG000|NOT COMPLETED|Overall Study||4
8839025|NCT01681771|9893467|FG001|NOT COMPLETED|Overall Study||2
8839026|NCT01681810|9893473|FG000|STARTED|Overall Study||20
8839027|NCT01681810|9893473|FG000|COMPLETED|Overall Study||20
8839028|NCT01681810|9893473|FG000|NOT COMPLETED|Overall Study||0
8839029|NCT01681836|9893477|FG000|STARTED|First Intervention||6
8839030|NCT01681836|9893478|FG001|STARTED|First Intervention||5
8839031|NCT01681836|9893477|FG000|COMPLETED|First Intervention||6
8839032|NCT01681836|9893478|FG001|COMPLETED|First Intervention||5
8839033|NCT01681836|9893477|FG000|NOT COMPLETED|First Intervention||0
8839034|NCT01681836|9893478|FG001|NOT COMPLETED|First Intervention||0
8839035|NCT01681836|9893477|FG000|STARTED|Washout Period of 3-7 Days||6
8839036|NCT01681836|9893478|FG001|STARTED|Washout Period of 3-7 Days||5
8839037|NCT01681836|9893477|FG000|COMPLETED|Washout Period of 3-7 Days||6
8839038|NCT01681836|9893478|FG001|COMPLETED|Washout Period of 3-7 Days||5
8839039|NCT01681836|9893477|FG000|NOT COMPLETED|Washout Period of 3-7 Days||0
8839040|NCT01681836|9893478|FG001|NOT COMPLETED|Washout Period of 3-7 Days||0
8839041|NCT01681836|9893477|FG000|STARTED|Second Intervention||6
8839042|NCT01681836|9893478|FG001|STARTED|Second Intervention||5
8839043|NCT01681836|9893477|FG000|COMPLETED|Second Intervention||6
8839044|NCT01681836|9893478|FG001|COMPLETED|Second Intervention||4
8839045|NCT01681836|9893477|FG000|NOT COMPLETED|Second Intervention||0
8839046|NCT01681836|9893478|FG001|NOT COMPLETED|Second Intervention||1
8839047|NCT01681849|9893487|FG000|STARTED|Overall Study||15
8839048|NCT01681849|9893488|FG001|STARTED|Overall Study||13
8839049|NCT01681849|9893489|FG002|STARTED|Overall Study||56
8839050|NCT01681849|9893487|FG000|COMPLETED|Overall Study||7
8839051|NCT01681849|9893488|FG001|COMPLETED|Overall Study||6
8839052|NCT01681849|9893489|FG002|COMPLETED|Overall Study||17
8839053|NCT01681849|9893487|FG000|NOT COMPLETED|Overall Study||8
8839054|NCT01681849|9893488|FG001|NOT COMPLETED|Overall Study||7
8839055|NCT01681849|9893489|FG002|NOT COMPLETED|Overall Study||39
8839056|NCT01681992|9893499|FG000|STARTED|Overall Study||1493
8839057|NCT01681992|9893500|FG001|STARTED|Overall Study||1497
8839058|NCT01681992|9893501|FG002|STARTED|Overall Study||1526
8839059|NCT01681992|9893499|FG000|COMPLETED|Overall Study||1427
8839060|NCT01681992|9893500|FG001|COMPLETED|Overall Study||1427
8839061|NCT01681992|9893501|FG002|COMPLETED|Overall Study||1443
8839062|NCT01681992|9893499|FG000|NOT COMPLETED|Overall Study||66
8839063|NCT01681992|9893500|FG001|NOT COMPLETED|Overall Study||70
8839064|NCT01681992|9893501|FG002|NOT COMPLETED|Overall Study||83
8839065|NCT01682031|9893511|FG000|STARTED|Overall Study||8
8839066|NCT01682031|9893512|FG001|STARTED|Overall Study||10
8839067|NCT01682031|9893511|FG000|COMPLETED|Overall Study||7
8839068|NCT01682031|9893512|FG001|COMPLETED|Overall Study||5
8839069|NCT01682031|9893511|FG000|NOT COMPLETED|Overall Study||1
8839070|NCT01682031|9893512|FG001|NOT COMPLETED|Overall Study||5
8839071|NCT01682044|9893518|FG000|STARTED|Overall Study||20
8839072|NCT01682044|9893518|FG000|COMPLETED|Overall Study||16
8839073|NCT01682044|9893518|FG000|NOT COMPLETED|Overall Study||4
8839074|NCT01682083|9893524|FG000|STARTED|Overall Study||438
8839075|NCT01682083|9893525|FG001|STARTED|Overall Study||432
8839076|NCT01682083|9893524|FG000|COMPLETED|Overall Study|Ongoing patients at the time of data cut-off. 3 patients were untreated|331
8623071|NCT00491322|9662291|FG001|STARTED|Overall Study||51
8623072|NCT00491322|9662290|FG000|COMPLETED|Overall Study||40
8623073|NCT00491322|9662291|FG001|COMPLETED|Overall Study||50
8839077|NCT01682083|9893525|FG001|COMPLETED|Overall Study|Ongoing patients at the time of data cut-off.|277
8839078|NCT01682083|9893524|FG000|NOT COMPLETED|Overall Study||107
8839079|NCT01682083|9893525|FG001|NOT COMPLETED|Overall Study||155
8839080|NCT01682135|9893534|FG000|STARTED|Overall Study||6
8839081|NCT01682135|9893535|FG001|STARTED|Overall Study||10
8839082|NCT01682135|9893536|FG002|STARTED|Overall Study||12
8839083|NCT01682135|9893534|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
8839084|NCT01682135|9893535|FG001|Received at Least 1 Dose of Study Drug|Overall Study||10
8839085|NCT01682135|9893536|FG002|Received at Least 1 Dose of Study Drug|Overall Study||12
8839086|NCT01682135|9893534|FG000|COMPLETED|Overall Study||6
8839087|NCT01682135|9893535|FG001|COMPLETED|Overall Study||10
8839088|NCT01682135|9893536|FG002|COMPLETED|Overall Study||12
8839089|NCT01682135|9893534|FG000|NOT COMPLETED|Overall Study||0
8839090|NCT01682135|9893535|FG001|NOT COMPLETED|Overall Study||0
8839091|NCT01682135|9893536|FG002|NOT COMPLETED|Overall Study||0
8839092|NCT01682148|9893548|FG000|STARTED|Overall Study||44
8839093|NCT01682148|9893549|FG001|STARTED|Overall Study||44
8839094|NCT01682148|9893548|FG000|COMPLETED|Overall Study||40
8839095|NCT01682148|9893549|FG001|COMPLETED|Overall Study||41
8839096|NCT01682148|9893548|FG000|NOT COMPLETED|Overall Study||4
8839097|NCT01682148|9893549|FG001|NOT COMPLETED|Overall Study||3
8839098|NCT01682213|9893560|FG000|STARTED|Overall Study||23
8839099|NCT01682213|9893560|FG000|COMPLETED|Overall Study||21
8839100|NCT01682213|9893560|FG000|NOT COMPLETED|Overall Study||2
8839101|NCT01682460|9893565|FG000|STARTED|Overall Study||15
8839102|NCT01682460|9893565|FG000|COMPLETED|Overall Study||11
8839103|NCT01682460|9893565|FG000|NOT COMPLETED|Overall Study||4
8839104|NCT01682512|9893572|FG000|STARTED|Overall Study||116
8839105|NCT01682512|9893573|FG001|STARTED|Overall Study||111
8839106|NCT01682512|9893574|FG002|STARTED|Overall Study||66
8839107|NCT01682512|9893572|FG000|Randomized in Part-I|Overall Study||66
8839108|NCT01682512|9893573|FG001|Randomized in Part-I|Overall Study||65
8839109|NCT01682512|9893574|FG002|Randomized in Part-I|Overall Study||66
8839110|NCT01682512|9893572|FG000|Randomized in Part-II|Overall Study||50
8839111|NCT01682512|9893573|FG001|Randomized in Part-II|Overall Study||46
8839112|NCT01682512|9893574|FG002|Randomized in Part-II|Overall Study||0
8839113|NCT01682512|9893572|FG000|COMPLETED|Overall Study||44
8839114|NCT01682512|9893573|FG001|COMPLETED|Overall Study||40
8839115|NCT01682512|9893574|FG002|COMPLETED|Overall Study||48
8839116|NCT01682512|9893572|FG000|NOT COMPLETED|Overall Study||72
8839117|NCT01682512|9893573|FG001|NOT COMPLETED|Overall Study||71
8839118|NCT01682512|9893574|FG002|NOT COMPLETED|Overall Study||18
8839119|NCT01682538|9893582|FG000|STARTED|Overall Study||12
8839120|NCT01682538|9893582|FG000|COMPLETED|Overall Study||12
8839121|NCT01682538|9893582|FG000|NOT COMPLETED|Overall Study||0
8839122|NCT01682603|9893597|FG000|STARTED|Overall Study||37
8839123|NCT01682603|9893597|FG000|COMPLETED|Overall Study||34
8839124|NCT01682603|9893597|FG000|NOT COMPLETED|Overall Study||3
8839125|NCT01682642|9893605|FG000|STARTED|Overall Study||61
8839126|NCT01682642|9893606|FG001|STARTED|Overall Study||59
8839127|NCT01682642|9893605|FG000|COMPLETED|Overall Study||61
8839128|NCT01682642|9893606|FG001|COMPLETED|Overall Study||58
8839129|NCT01682642|9893605|FG000|NOT COMPLETED|Overall Study||0
8839130|NCT01682642|9893606|FG001|NOT COMPLETED|Overall Study||1
8839131|NCT01682681|9893618|FG000|STARTED|Overall Study||1234
8839132|NCT01682681|9893618|FG000|Treated|Overall Study|2 Participants were not compliant with eligibility criteria|1232
8839133|NCT01682681|9893618|FG000|COMPLETED|Overall Study||902
8839134|NCT01682681|9893618|FG000|NOT COMPLETED|Overall Study||332
8839135|NCT01682720|9893626|FG000|STARTED|Overall Study||85
8839136|NCT01682720|9893627|FG001|STARTED|Overall Study||74
8839137|NCT01682720|9893628|FG002|STARTED|Overall Study||12
8839138|NCT01682720|9893629|FG003|STARTED|Overall Study||250
8839139|NCT01682720|9893626|FG000|Included in Full Analysis Set|Overall Study||0
8839140|NCT01682720|9893627|FG001|Included in Full Analysis Set|Overall Study||73
8839141|NCT01682720|9893628|FG002|Included in Full Analysis Set|Overall Study||11
8839142|NCT01682720|9893629|FG003|Included in Full Analysis Set|Overall Study||250
8839143|NCT01682720|9893626|FG000|COMPLETED|Overall Study||0
8839144|NCT01682720|9893627|FG001|COMPLETED|Overall Study||69
8839145|NCT01682720|9893628|FG002|COMPLETED|Overall Study||5
8839146|NCT01682720|9893629|FG003|COMPLETED|Overall Study||211
8839147|NCT01682720|9893626|FG000|NOT COMPLETED|Overall Study||85
8839148|NCT01682720|9893627|FG001|NOT COMPLETED|Overall Study||5
8839149|NCT01682720|9893628|FG002|NOT COMPLETED|Overall Study||7
8839150|NCT01682720|9893629|FG003|NOT COMPLETED|Overall Study||39
8839151|NCT01682759|9893641|FG000|STARTED|Overall Study||376
8839152|NCT01682759|9893642|FG001|STARTED|Overall Study||375
8839153|NCT01682759|9893641|FG000|Treated|Overall Study||375
8839154|NCT01682759|9893642|FG001|Treated|Overall Study||375
8839155|NCT01682759|9893641|FG000|COMPLETED|Overall Study||307
8839156|NCT01682759|9893642|FG001|COMPLETED|Overall Study||305
8839157|NCT01682759|9893641|FG000|NOT COMPLETED|Overall Study||69
8839158|NCT01682759|9893642|FG001|NOT COMPLETED|Overall Study||70
8839159|NCT01682811|9893655|FG000|STARTED|Part 1 Levulan Injection||1
8839160|NCT01682811|9893656|FG001|STARTED|Part 1 Levulan Injection||0
8839161|NCT01682811|9893657|FG002|STARTED|Part 1 Levulan Injection||0
8839162|NCT01682811|9893658|FG003|STARTED|Part 1 Levulan Injection||0
8839163|NCT01682811|9893659|FG004|STARTED|Part 1 Levulan Injection||0
8839164|NCT01682811|9893660|FG005|STARTED|Part 1 Levulan Injection||0
8839165|NCT01682811|9893661|FG006|STARTED|Part 1 Levulan Injection||0
8839166|NCT01682811|9893655|FG000|Control|Part 1 Levulan Injection||1
8839167|NCT01682811|9893656|FG001|Control|Part 1 Levulan Injection||0
8839168|NCT01682811|9893657|FG002|Control|Part 1 Levulan Injection||0
8839169|NCT01682811|9893658|FG003|Control|Part 1 Levulan Injection||0
8623074|NCT00491322|9662290|FG000|NOT COMPLETED|Overall Study||1
8623075|NCT00491322|9662291|FG001|NOT COMPLETED|Overall Study||1
8623076|NCT00491374|9662299|FG000|STARTED|Overall Study||0
8623077|NCT00491374|9662300|FG001|STARTED|Overall Study||0
8839170|NCT01682811|9893659|FG004|Control|Part 1 Levulan Injection||0
8839171|NCT01682811|9893660|FG005|Control|Part 1 Levulan Injection||0
8839172|NCT01682811|9893661|FG006|Control|Part 1 Levulan Injection||0
8839173|NCT01682811|9893655|FG000|Treated 3 Hours|Part 1 Levulan Injection||1
8839174|NCT01682811|9893656|FG001|Treated 3 Hours|Part 1 Levulan Injection||0
8839175|NCT01682811|9893657|FG002|Treated 3 Hours|Part 1 Levulan Injection||0
8839176|NCT01682811|9893658|FG003|Treated 3 Hours|Part 1 Levulan Injection||0
8839177|NCT01682811|9893659|FG004|Treated 3 Hours|Part 1 Levulan Injection||0
8839178|NCT01682811|9893660|FG005|Treated 3 Hours|Part 1 Levulan Injection||0
8839179|NCT01682811|9893661|FG006|Treated 3 Hours|Part 1 Levulan Injection||0
8839180|NCT01682811|9893655|FG000|Treated 24 Hours|Part 1 Levulan Injection||1
8839181|NCT01682811|9893656|FG001|Treated 24 Hours|Part 1 Levulan Injection||0
8839182|NCT01682811|9893657|FG002|Treated 24 Hours|Part 1 Levulan Injection||0
8839183|NCT01682811|9893658|FG003|Treated 24 Hours|Part 1 Levulan Injection||0
8839184|NCT01682811|9893659|FG004|Treated 24 Hours|Part 1 Levulan Injection||0
8839185|NCT01682811|9893660|FG005|Treated 24 Hours|Part 1 Levulan Injection||0
8839186|NCT01682811|9893661|FG006|Treated 24 Hours|Part 1 Levulan Injection||0
8839187|NCT01682811|9893655|FG000|COMPLETED|Part 1 Levulan Injection||1
8839188|NCT01682811|9893656|FG001|COMPLETED|Part 1 Levulan Injection||0
8839189|NCT01682811|9893657|FG002|COMPLETED|Part 1 Levulan Injection||0
8839190|NCT01682811|9893658|FG003|COMPLETED|Part 1 Levulan Injection||0
8839191|NCT01682811|9893659|FG004|COMPLETED|Part 1 Levulan Injection||0
8839192|NCT01682811|9893660|FG005|COMPLETED|Part 1 Levulan Injection||0
8839193|NCT01682811|9893661|FG006|COMPLETED|Part 1 Levulan Injection||0
8839194|NCT01682811|9893655|FG000|NOT COMPLETED|Part 1 Levulan Injection||0
8839195|NCT01682811|9893656|FG001|NOT COMPLETED|Part 1 Levulan Injection||0
8839196|NCT01682811|9893657|FG002|NOT COMPLETED|Part 1 Levulan Injection||0
8839197|NCT01682811|9893658|FG003|NOT COMPLETED|Part 1 Levulan Injection||0
8839198|NCT01682811|9893659|FG004|NOT COMPLETED|Part 1 Levulan Injection||0
8839199|NCT01682811|9893660|FG005|NOT COMPLETED|Part 1 Levulan Injection||0
8839200|NCT01682811|9893661|FG006|NOT COMPLETED|Part 1 Levulan Injection||0
8839201|NCT01682811|9893655|FG000|STARTED|Part 1 Levulan Painting||0
8839202|NCT01682811|9893656|FG001|STARTED|Part 1 Levulan Painting||1
8839203|NCT01682811|9893657|FG002|STARTED|Part 1 Levulan Painting||0
8839204|NCT01682811|9893658|FG003|STARTED|Part 1 Levulan Painting||0
8839205|NCT01682811|9893659|FG004|STARTED|Part 1 Levulan Painting||0
8839206|NCT01682811|9893660|FG005|STARTED|Part 1 Levulan Painting||0
8839207|NCT01682811|9893661|FG006|STARTED|Part 1 Levulan Painting||0
8839208|NCT01682811|9893655|FG000|Control|Part 1 Levulan Painting||0
8839209|NCT01682811|9893656|FG001|Control|Part 1 Levulan Painting||1
8839210|NCT01682811|9893657|FG002|Control|Part 1 Levulan Painting||0
8839211|NCT01682811|9893658|FG003|Control|Part 1 Levulan Painting||0
8839212|NCT01682811|9893659|FG004|Control|Part 1 Levulan Painting||0
8839213|NCT01682811|9893660|FG005|Control|Part 1 Levulan Painting||0
8839214|NCT01682811|9893661|FG006|Control|Part 1 Levulan Painting||0
8839215|NCT01682811|9893655|FG000|Treated 3 Hours|Part 1 Levulan Painting||0
8839216|NCT01682811|9893656|FG001|Treated 3 Hours|Part 1 Levulan Painting||1
8839217|NCT01682811|9893657|FG002|Treated 3 Hours|Part 1 Levulan Painting||0
8623078|NCT00491374|9662299|FG000|COMPLETED|Overall Study||0
8839218|NCT01682811|9893658|FG003|Treated 3 Hours|Part 1 Levulan Painting||0
8839219|NCT01682811|9893659|FG004|Treated 3 Hours|Part 1 Levulan Painting||0
8839220|NCT01682811|9893660|FG005|Treated 3 Hours|Part 1 Levulan Painting||0
8839221|NCT01682811|9893661|FG006|Treated 3 Hours|Part 1 Levulan Painting||0
8839222|NCT01682811|9893655|FG000|Treated 24 Hours|Part 1 Levulan Painting||0
8839223|NCT01682811|9893656|FG001|Treated 24 Hours|Part 1 Levulan Painting||1
8839224|NCT01682811|9893657|FG002|Treated 24 Hours|Part 1 Levulan Painting||0
8839225|NCT01682811|9893658|FG003|Treated 24 Hours|Part 1 Levulan Painting||0
8839226|NCT01682811|9893659|FG004|Treated 24 Hours|Part 1 Levulan Painting||0
8839227|NCT01682811|9893660|FG005|Treated 24 Hours|Part 1 Levulan Painting||0
8839228|NCT01682811|9893661|FG006|Treated 24 Hours|Part 1 Levulan Painting||0
8839229|NCT01682811|9893655|FG000|COMPLETED|Part 1 Levulan Painting||0
8839230|NCT01682811|9893656|FG001|COMPLETED|Part 1 Levulan Painting||1
8839231|NCT01682811|9893657|FG002|COMPLETED|Part 1 Levulan Painting||0
8839232|NCT01682811|9893658|FG003|COMPLETED|Part 1 Levulan Painting||0
8839233|NCT01682811|9893659|FG004|COMPLETED|Part 1 Levulan Painting||0
8839234|NCT01682811|9893660|FG005|COMPLETED|Part 1 Levulan Painting||0
8839235|NCT01682811|9893661|FG006|COMPLETED|Part 1 Levulan Painting||0
8839236|NCT01682811|9893655|FG000|NOT COMPLETED|Part 1 Levulan Painting||0
8839237|NCT01682811|9893656|FG001|NOT COMPLETED|Part 1 Levulan Painting||0
8839238|NCT01682811|9893657|FG002|NOT COMPLETED|Part 1 Levulan Painting||0
8839239|NCT01682811|9893658|FG003|NOT COMPLETED|Part 1 Levulan Painting||0
8839240|NCT01682811|9893659|FG004|NOT COMPLETED|Part 1 Levulan Painting||0
8839241|NCT01682811|9893660|FG005|NOT COMPLETED|Part 1 Levulan Painting||0
8839242|NCT01682811|9893661|FG006|NOT COMPLETED|Part 1 Levulan Painting||0
8839243|NCT01682811|9893655|FG000|STARTED|Part 1 Levulan Painted Twice||0
8839244|NCT01682811|9893656|FG001|STARTED|Part 1 Levulan Painted Twice||0
8839245|NCT01682811|9893657|FG002|STARTED|Part 1 Levulan Painted Twice||2
8839246|NCT01682811|9893658|FG003|STARTED|Part 1 Levulan Painted Twice||0
8839247|NCT01682811|9893659|FG004|STARTED|Part 1 Levulan Painted Twice||0
8839248|NCT01682811|9893660|FG005|STARTED|Part 1 Levulan Painted Twice||0
8839249|NCT01682811|9893661|FG006|STARTED|Part 1 Levulan Painted Twice||0
8839250|NCT01682811|9893655|FG000|Control|Part 1 Levulan Painted Twice||0
8839251|NCT01682811|9893656|FG001|Control|Part 1 Levulan Painted Twice||0
8839252|NCT01682811|9893657|FG002|Control|Part 1 Levulan Painted Twice||2
8839253|NCT01682811|9893658|FG003|Control|Part 1 Levulan Painted Twice||0
8839254|NCT01682811|9893659|FG004|Control|Part 1 Levulan Painted Twice||0
8839255|NCT01682811|9893660|FG005|Control|Part 1 Levulan Painted Twice||0
8839256|NCT01682811|9893661|FG006|Control|Part 1 Levulan Painted Twice||0
8839257|NCT01682811|9893655|FG000|Treated 24 Hours|Part 1 Levulan Painted Twice||0
8839258|NCT01682811|9893656|FG001|Treated 24 Hours|Part 1 Levulan Painted Twice||0
8839259|NCT01682811|9893657|FG002|Treated 24 Hours|Part 1 Levulan Painted Twice||2
8839260|NCT01682811|9893658|FG003|Treated 24 Hours|Part 1 Levulan Painted Twice||0
8839261|NCT01682811|9893659|FG004|Treated 24 Hours|Part 1 Levulan Painted Twice||0
8839262|NCT01682811|9893660|FG005|Treated 24 Hours|Part 1 Levulan Painted Twice||0
8839263|NCT01682811|9893661|FG006|Treated 24 Hours|Part 1 Levulan Painted Twice||0
8839264|NCT01682811|9893655|FG000|COMPLETED|Part 1 Levulan Painted Twice||0
8839265|NCT01682811|9893656|FG001|COMPLETED|Part 1 Levulan Painted Twice||0
8839266|NCT01682811|9893657|FG002|COMPLETED|Part 1 Levulan Painted Twice||2
8839267|NCT01682811|9893658|FG003|COMPLETED|Part 1 Levulan Painted Twice||0
8839268|NCT01682811|9893659|FG004|COMPLETED|Part 1 Levulan Painted Twice||0
8839269|NCT01682811|9893660|FG005|COMPLETED|Part 1 Levulan Painted Twice||0
8839270|NCT01682811|9893661|FG006|COMPLETED|Part 1 Levulan Painted Twice||0
8839271|NCT01682811|9893655|FG000|NOT COMPLETED|Part 1 Levulan Painted Twice||0
8839272|NCT01682811|9893656|FG001|NOT COMPLETED|Part 1 Levulan Painted Twice||0
8839273|NCT01682811|9893657|FG002|NOT COMPLETED|Part 1 Levulan Painted Twice||0
8839274|NCT01682811|9893658|FG003|NOT COMPLETED|Part 1 Levulan Painted Twice||0
8839275|NCT01682811|9893659|FG004|NOT COMPLETED|Part 1 Levulan Painted Twice||0
8839276|NCT01682811|9893660|FG005|NOT COMPLETED|Part 1 Levulan Painted Twice||0
8839277|NCT01682811|9893661|FG006|NOT COMPLETED|Part 1 Levulan Painted Twice||0
8839278|NCT01682811|9893655|FG000|STARTED|Part 1 Levulan Paint Twice Microneedling||0
8839279|NCT01682811|9893656|FG001|STARTED|Part 1 Levulan Paint Twice Microneedling||0
8839280|NCT01682811|9893657|FG002|STARTED|Part 1 Levulan Paint Twice Microneedling||0
8839281|NCT01682811|9893658|FG003|STARTED|Part 1 Levulan Paint Twice Microneedling||2
8839282|NCT01682811|9893659|FG004|STARTED|Part 1 Levulan Paint Twice Microneedling||0
8839283|NCT01682811|9893660|FG005|STARTED|Part 1 Levulan Paint Twice Microneedling||0
8839284|NCT01682811|9893661|FG006|STARTED|Part 1 Levulan Paint Twice Microneedling||0
8839285|NCT01682811|9893655|FG000|Control|Part 1 Levulan Paint Twice Microneedling||0
8839286|NCT01682811|9893656|FG001|Control|Part 1 Levulan Paint Twice Microneedling||0
8839287|NCT01682811|9893657|FG002|Control|Part 1 Levulan Paint Twice Microneedling||0
8839288|NCT01682811|9893658|FG003|Control|Part 1 Levulan Paint Twice Microneedling||2
8839289|NCT01682811|9893659|FG004|Control|Part 1 Levulan Paint Twice Microneedling||0
8839290|NCT01682811|9893660|FG005|Control|Part 1 Levulan Paint Twice Microneedling||0
8839291|NCT01682811|9893661|FG006|Control|Part 1 Levulan Paint Twice Microneedling||0
8839292|NCT01682811|9893655|FG000|Treated 24 Hours|Part 1 Levulan Paint Twice Microneedling||0
8839293|NCT01682811|9893656|FG001|Treated 24 Hours|Part 1 Levulan Paint Twice Microneedling||0
8839294|NCT01682811|9893657|FG002|Treated 24 Hours|Part 1 Levulan Paint Twice Microneedling||0
8839295|NCT01682811|9893658|FG003|Treated 24 Hours|Part 1 Levulan Paint Twice Microneedling||2
8839296|NCT01682811|9893659|FG004|Treated 24 Hours|Part 1 Levulan Paint Twice Microneedling||0
8839297|NCT01682811|9893660|FG005|Treated 24 Hours|Part 1 Levulan Paint Twice Microneedling||0
8839298|NCT01682811|9893661|FG006|Treated 24 Hours|Part 1 Levulan Paint Twice Microneedling||0
8839299|NCT01682811|9893655|FG000|COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
8839300|NCT01682811|9893656|FG001|COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
8839301|NCT01682811|9893657|FG002|COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
8839302|NCT01682811|9893658|FG003|COMPLETED|Part 1 Levulan Paint Twice Microneedling||2
8839303|NCT01682811|9893659|FG004|COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
8839304|NCT01682811|9893660|FG005|COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
8839305|NCT01682811|9893661|FG006|COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
8839306|NCT01682811|9893655|FG000|NOT COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
8839307|NCT01682811|9893656|FG001|NOT COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
8839308|NCT01682811|9893657|FG002|NOT COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
8839309|NCT01682811|9893658|FG003|NOT COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
8839310|NCT01682811|9893659|FG004|NOT COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
8839311|NCT01682811|9893660|FG005|NOT COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
8839312|NCT01682811|9893661|FG006|NOT COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
8839313|NCT01682811|9893655|FG000|STARTED|Part 2 Dose Level 1||0
8839314|NCT01682811|9893656|FG001|STARTED|Part 2 Dose Level 1||0
8839315|NCT01682811|9893657|FG002|STARTED|Part 2 Dose Level 1||0
8839316|NCT01682811|9893658|FG003|STARTED|Part 2 Dose Level 1||0
8839317|NCT01682811|9893659|FG004|STARTED|Part 2 Dose Level 1||11
8839318|NCT01682811|9893660|FG005|STARTED|Part 2 Dose Level 1||0
8839319|NCT01682811|9893661|FG006|STARTED|Part 2 Dose Level 1||0
8839320|NCT01682811|9893655|FG000|Control|Part 2 Dose Level 1||0
8839321|NCT01682811|9893656|FG001|Control|Part 2 Dose Level 1||0
8839322|NCT01682811|9893657|FG002|Control|Part 2 Dose Level 1||0
8839323|NCT01682811|9893658|FG003|Control|Part 2 Dose Level 1||0
8839324|NCT01682811|9893659|FG004|Control|Part 2 Dose Level 1||10
8839325|NCT01682811|9893660|FG005|Control|Part 2 Dose Level 1||0
8839326|NCT01682811|9893661|FG006|Control|Part 2 Dose Level 1||0
8839327|NCT01682811|9893655|FG000|Treated|Part 2 Dose Level 1||0
8839328|NCT01682811|9893656|FG001|Treated|Part 2 Dose Level 1||0
8839329|NCT01682811|9893657|FG002|Treated|Part 2 Dose Level 1||0
8839330|NCT01682811|9893658|FG003|Treated|Part 2 Dose Level 1||0
8839331|NCT01682811|9893659|FG004|Treated|Part 2 Dose Level 1||10
8839332|NCT01682811|9893660|FG005|Treated|Part 2 Dose Level 1||0
8839333|NCT01682811|9893661|FG006|Treated|Part 2 Dose Level 1||0
8839334|NCT01682811|9893655|FG000|COMPLETED|Part 2 Dose Level 1||0
8839335|NCT01682811|9893656|FG001|COMPLETED|Part 2 Dose Level 1||0
8839336|NCT01682811|9893657|FG002|COMPLETED|Part 2 Dose Level 1||0
8839337|NCT01682811|9893658|FG003|COMPLETED|Part 2 Dose Level 1||0
8839338|NCT01682811|9893659|FG004|COMPLETED|Part 2 Dose Level 1||0
8839339|NCT01682811|9893660|FG005|COMPLETED|Part 2 Dose Level 1||0
8839340|NCT01682811|9893661|FG006|COMPLETED|Part 2 Dose Level 1||0
8839341|NCT01682811|9893655|FG000|NOT COMPLETED|Part 2 Dose Level 1||0
8839342|NCT01682811|9893656|FG001|NOT COMPLETED|Part 2 Dose Level 1||0
8839343|NCT01682811|9893657|FG002|NOT COMPLETED|Part 2 Dose Level 1||0
8839344|NCT01682811|9893658|FG003|NOT COMPLETED|Part 2 Dose Level 1||0
8839345|NCT01682811|9893659|FG004|NOT COMPLETED|Part 2 Dose Level 1||11
8839346|NCT01682811|9893660|FG005|NOT COMPLETED|Part 2 Dose Level 1||0
8839347|NCT01682811|9893661|FG006|NOT COMPLETED|Part 2 Dose Level 1||0
8839348|NCT01682811|9893655|FG000|STARTED|Part 2 Dose Level 2||0
8839349|NCT01682811|9893656|FG001|STARTED|Part 2 Dose Level 2||0
8839350|NCT01682811|9893657|FG002|STARTED|Part 2 Dose Level 2||0
8839351|NCT01682811|9893658|FG003|STARTED|Part 2 Dose Level 2||0
8839352|NCT01682811|9893659|FG004|STARTED|Part 2 Dose Level 2||0
8839353|NCT01682811|9893660|FG005|STARTED|Part 2 Dose Level 2||3
8839354|NCT01682811|9893661|FG006|STARTED|Part 2 Dose Level 2||0
8839355|NCT01682811|9893655|FG000|Control|Part 2 Dose Level 2||0
8839356|NCT01682811|9893656|FG001|Control|Part 2 Dose Level 2||0
8839357|NCT01682811|9893657|FG002|Control|Part 2 Dose Level 2||0
8839358|NCT01682811|9893658|FG003|Control|Part 2 Dose Level 2||0
8839359|NCT01682811|9893659|FG004|Control|Part 2 Dose Level 2||0
8839360|NCT01682811|9893660|FG005|Control|Part 2 Dose Level 2||3
8839361|NCT01682811|9893661|FG006|Control|Part 2 Dose Level 2||0
8839362|NCT01682811|9893655|FG000|Treated|Part 2 Dose Level 2||0
8839363|NCT01682811|9893656|FG001|Treated|Part 2 Dose Level 2||0
8839364|NCT01682811|9893657|FG002|Treated|Part 2 Dose Level 2||0
8839365|NCT01682811|9893658|FG003|Treated|Part 2 Dose Level 2||0
8839366|NCT01682811|9893659|FG004|Treated|Part 2 Dose Level 2||0
8839367|NCT01682811|9893660|FG005|Treated|Part 2 Dose Level 2||3
8839368|NCT01682811|9893661|FG006|Treated|Part 2 Dose Level 2||0
8839369|NCT01682811|9893655|FG000|COMPLETED|Part 2 Dose Level 2||0
8839370|NCT01682811|9893656|FG001|COMPLETED|Part 2 Dose Level 2||0
8839371|NCT01682811|9893657|FG002|COMPLETED|Part 2 Dose Level 2||0
8839372|NCT01682811|9893658|FG003|COMPLETED|Part 2 Dose Level 2||0
8839373|NCT01682811|9893659|FG004|COMPLETED|Part 2 Dose Level 2||0
8839374|NCT01682811|9893660|FG005|COMPLETED|Part 2 Dose Level 2||0
8839375|NCT01682811|9893661|FG006|COMPLETED|Part 2 Dose Level 2||0
8839376|NCT01682811|9893655|FG000|NOT COMPLETED|Part 2 Dose Level 2||0
8839377|NCT01682811|9893656|FG001|NOT COMPLETED|Part 2 Dose Level 2||0
8839378|NCT01682811|9893657|FG002|NOT COMPLETED|Part 2 Dose Level 2||0
8839379|NCT01682811|9893658|FG003|NOT COMPLETED|Part 2 Dose Level 2||0
8839380|NCT01682811|9893659|FG004|NOT COMPLETED|Part 2 Dose Level 2||0
8839381|NCT01682811|9893660|FG005|NOT COMPLETED|Part 2 Dose Level 2||3
8839382|NCT01682811|9893661|FG006|NOT COMPLETED|Part 2 Dose Level 2||0
8839383|NCT01682811|9893655|FG000|STARTED|Part 2 Dose Level 3||0
8839384|NCT01682811|9893656|FG001|STARTED|Part 2 Dose Level 3||0
8839385|NCT01682811|9893657|FG002|STARTED|Part 2 Dose Level 3||0
8839386|NCT01682811|9893658|FG003|STARTED|Part 2 Dose Level 3||0
8839387|NCT01682811|9893659|FG004|STARTED|Part 2 Dose Level 3||0
8839388|NCT01682811|9893660|FG005|STARTED|Part 2 Dose Level 3||0
8839389|NCT01682811|9893661|FG006|STARTED|Part 2 Dose Level 3||0
8839390|NCT01682811|9893655|FG000|Control|Part 2 Dose Level 3||0
8839391|NCT01682811|9893656|FG001|Control|Part 2 Dose Level 3||0
8839392|NCT01682811|9893657|FG002|Control|Part 2 Dose Level 3||0
8839393|NCT01682811|9893658|FG003|Control|Part 2 Dose Level 3||0
8839394|NCT01682811|9893659|FG004|Control|Part 2 Dose Level 3||0
8839395|NCT01682811|9893660|FG005|Control|Part 2 Dose Level 3||0
8839396|NCT01682811|9893661|FG006|Control|Part 2 Dose Level 3||0
8839397|NCT01682811|9893655|FG000|Treated|Part 2 Dose Level 3||0
8839398|NCT01682811|9893656|FG001|Treated|Part 2 Dose Level 3||0
8839399|NCT01682811|9893657|FG002|Treated|Part 2 Dose Level 3||0
8839400|NCT01682811|9893658|FG003|Treated|Part 2 Dose Level 3||0
8839401|NCT01682811|9893659|FG004|Treated|Part 2 Dose Level 3||0
8839402|NCT01682811|9893660|FG005|Treated|Part 2 Dose Level 3||0
8839403|NCT01682811|9893661|FG006|Treated|Part 2 Dose Level 3||0
8839404|NCT01682811|9893655|FG000|COMPLETED|Part 2 Dose Level 3||0
8623079|NCT00491374|9662300|FG001|COMPLETED|Overall Study||0
8623080|NCT00491374|9662299|FG000|NOT COMPLETED|Overall Study||0
8623081|NCT00491374|9662300|FG001|NOT COMPLETED|Overall Study||0
8623082|NCT00491491|9662308|FG000|STARTED|Overall Study||22
8623083|NCT00491491|9662309|FG001|STARTED|Overall Study||21
8623084|NCT00491491|9662308|FG000|COMPLETED|Overall Study||22
8623085|NCT00491491|9662309|FG001|COMPLETED|Overall Study||21
8623086|NCT00491491|9662308|FG000|NOT COMPLETED|Overall Study||0
8623087|NCT00491491|9662309|FG001|NOT COMPLETED|Overall Study||0
8623088|NCT00491530|9662318|FG000|STARTED|Overall Study||174
8623089|NCT00491530|9662319|FG001|STARTED|Overall Study||50
8623090|NCT00491530|9662320|FG002|STARTED|Overall Study||86
8623091|NCT00491530|9662318|FG000|COMPLETED|Overall Study||162
8623092|NCT00491530|9662319|FG001|COMPLETED|Overall Study||44
8623093|NCT00491530|9662320|FG002|COMPLETED|Overall Study||81
8623094|NCT00491530|9662318|FG000|NOT COMPLETED|Overall Study||12
8623095|NCT00491530|9662319|FG001|NOT COMPLETED|Overall Study||6
8623096|NCT00491530|9662320|FG002|NOT COMPLETED|Overall Study||5
8839405|NCT01682811|9893656|FG001|COMPLETED|Part 2 Dose Level 3||0
8839406|NCT01682811|9893657|FG002|COMPLETED|Part 2 Dose Level 3||0
8839407|NCT01682811|9893658|FG003|COMPLETED|Part 2 Dose Level 3||0
8839408|NCT01682811|9893659|FG004|COMPLETED|Part 2 Dose Level 3||0
8839409|NCT01682811|9893660|FG005|COMPLETED|Part 2 Dose Level 3||0
8839410|NCT01682811|9893661|FG006|COMPLETED|Part 2 Dose Level 3||0
8839411|NCT01682811|9893655|FG000|NOT COMPLETED|Part 2 Dose Level 3||0
8839412|NCT01682811|9893656|FG001|NOT COMPLETED|Part 2 Dose Level 3||0
8839413|NCT01682811|9893657|FG002|NOT COMPLETED|Part 2 Dose Level 3||0
8839414|NCT01682811|9893658|FG003|NOT COMPLETED|Part 2 Dose Level 3||0
8839415|NCT01682811|9893659|FG004|NOT COMPLETED|Part 2 Dose Level 3||0
8839416|NCT01682811|9893660|FG005|NOT COMPLETED|Part 2 Dose Level 3||0
8839417|NCT01682811|9893661|FG006|NOT COMPLETED|Part 2 Dose Level 3||0
8839418|NCT01682837|9893680|FG000|STARTED|Baseline||35
8839419|NCT01682837|9893680|FG000|COMPLETED|Baseline||30
8839420|NCT01682837|9893680|FG000|NOT COMPLETED|Baseline||5
8839421|NCT01682837|9893680|FG000|STARTED|First Intervention (4 Weeks)||30
8839422|NCT01682837|9893680|FG000|Received KMgCit|First Intervention (4 Weeks)||8
8839423|NCT01682837|9893680|FG000|Received KCit|First Intervention (4 Weeks)||8
8839424|NCT01682837|9893680|FG000|Received KCl|First Intervention (4 Weeks)||7
8839425|NCT01682837|9893680|FG000|Received Placebo|First Intervention (4 Weeks)||7
8839426|NCT01682837|9893680|FG000|COMPLETED|First Intervention (4 Weeks)||30
8839427|NCT01682837|9893680|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0
8839428|NCT01682837|9893680|FG000|STARTED|Second Intervention (4 Weeks)||30
8839429|NCT01682837|9893680|FG000|Received KMgCit|Second Intervention (4 Weeks)||7
8839430|NCT01682837|9893680|FG000|Received KCit|Second Intervention (4 Weeks)||6
8839431|NCT01682837|9893680|FG000|Received KCl|Second Intervention (4 Weeks)||8
8839432|NCT01682837|9893680|FG000|Received Placebo|Second Intervention (4 Weeks)||9
8839433|NCT01682837|9893680|FG000|COMPLETED|Second Intervention (4 Weeks)||30
8839434|NCT01682837|9893680|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0
8839435|NCT01682837|9893680|FG000|STARTED|Third Intervention (4 Weeks)||30
8839436|NCT01682837|9893680|FG000|Received KMgCit|Third Intervention (4 Weeks)||9
8839437|NCT01682837|9893680|FG000|Received KCit|Third Intervention (4 Weeks)||7
8839438|NCT01682837|9893680|FG000|Received KCl|Third Intervention (4 Weeks)||7
8839439|NCT01682837|9893680|FG000|Received Placebo|Third Intervention (4 Weeks)||7
8839440|NCT01682837|9893680|FG000|COMPLETED|Third Intervention (4 Weeks)||30
8839441|NCT01682837|9893680|FG000|NOT COMPLETED|Third Intervention (4 Weeks)||0
8623097|NCT00491556|9662330|FG000|STARTED|Entry-Week (WK) 48: EXP/Standard Care||75
8623098|NCT00491556|9662331|FG001|STARTED|Entry-Week (WK) 48: EXP/Standard Care||27
8623099|NCT00491556|9662330|FG000|Wk 24 VL Suppressed (EXP)/WK 24 (STAND)|Entry-Week (WK) 48: EXP/Standard Care||53
8623100|NCT00491556|9662331|FG001|Wk 24 VL Suppressed (EXP)/WK 24 (STAND)|Entry-Week (WK) 48: EXP/Standard Care||27
8839442|NCT01682837|9893680|FG000|STARTED|Fourth Intervention (4 Weeks)||30
8839443|NCT01682837|9893680|FG000|Received KMgCit|Fourth Intervention (4 Weeks)||6
8839444|NCT01682837|9893680|FG000|Received KCit|Fourth Intervention (4 Weeks)||9
8839445|NCT01682837|9893680|FG000|Received KCl|Fourth Intervention (4 Weeks)||8
8839446|NCT01682837|9893680|FG000|Received Placebo|Fourth Intervention (4 Weeks)||7
8839447|NCT01682837|9893680|FG000|COMPLETED|Fourth Intervention (4 Weeks)||30
8839448|NCT01682837|9893680|FG000|NOT COMPLETED|Fourth Intervention (4 Weeks)||0
8839449|NCT01682863|9893693|FG000|STARTED|Overall Study||204
8839450|NCT01682863|9893694|FG001|STARTED|Overall Study||204
8839451|NCT01682863|9893695|FG002|STARTED|Overall Study||207
8839452|NCT01682863|9893693|FG000|Safety Set|Overall Study||204
8839453|NCT01682863|9893694|FG001|Safety Set|Overall Study||204
8839454|NCT01682863|9893695|FG002|Safety Set|Overall Study||206
8839455|NCT01682863|9893693|FG000|Full Analysis Set (FAS)|Overall Study|included all randomized patients who received at least one dose of study medication|204
8839456|NCT01682863|9893694|FG001|Full Analysis Set (FAS)|Overall Study||204
8839457|NCT01682863|9893695|FG002|Full Analysis Set (FAS)|Overall Study||206
8839458|NCT01682863|9893693|FG000|Randomized Set|Overall Study||204
8839459|NCT01682863|9893694|FG001|Randomized Set|Overall Study||204
8839460|NCT01682863|9893695|FG002|Randomized Set|Overall Study|1 randomized patient was not treated; experienced an AE prior to receiving any study drug|207
8839461|NCT01682863|9893693|FG000|COMPLETED|Overall Study||177
8839462|NCT01682863|9893694|FG001|COMPLETED|Overall Study||187
8839463|NCT01682863|9893695|FG002|COMPLETED|Overall Study||183
8839464|NCT01682863|9893693|FG000|NOT COMPLETED|Overall Study||27
8839465|NCT01682863|9893694|FG001|NOT COMPLETED|Overall Study||17
8839466|NCT01682863|9893695|FG002|NOT COMPLETED|Overall Study||24
8839467|NCT01682876|9893707|FG000|STARTED|Overall Study||176
8839468|NCT01682876|9893708|FG001|STARTED|Overall Study||183
8839469|NCT01682876|9893709|FG002|STARTED|Overall Study||180
8839470|NCT01682876|9893710|FG003|STARTED|Overall Study||176
8839471|NCT01682876|9893707|FG000|COMPLETED|Overall Study||155
8839472|NCT01682876|9893708|FG001|COMPLETED|Overall Study||163
8839473|NCT01682876|9893709|FG002|COMPLETED|Overall Study||169
8839474|NCT01682876|9893710|FG003|COMPLETED|Overall Study||157
8839475|NCT01682876|9893707|FG000|NOT COMPLETED|Overall Study||21
8839476|NCT01682876|9893708|FG001|NOT COMPLETED|Overall Study||20
8839477|NCT01682876|9893709|FG002|NOT COMPLETED|Overall Study||11
8839478|NCT01682876|9893710|FG003|NOT COMPLETED|Overall Study||19
8839479|NCT01682954|9893725|FG000|STARTED|Overall Study||40
8839480|NCT01682954|9893726|FG001|STARTED|Overall Study||38
8839481|NCT01682954|9893725|FG000|COMPLETED|Overall Study||35
8839482|NCT01682954|9893726|FG001|COMPLETED|Overall Study||33
8839483|NCT01682954|9893725|FG000|NOT COMPLETED|Overall Study||5
8839484|NCT01682954|9893726|FG001|NOT COMPLETED|Overall Study||5
8839485|NCT01683019|9893735|FG000|STARTED|Overall Study||18
8839486|NCT01683019|9893736|FG001|STARTED|Overall Study||15
8839487|NCT01683019|9893737|FG002|STARTED|Overall Study||19
8839488|NCT01683019|9893735|FG000|COMPLETED|Overall Study||16
8839489|NCT01683019|9893736|FG001|COMPLETED|Overall Study||14
8839490|NCT01683019|9893737|FG002|COMPLETED|Overall Study||15
8839491|NCT01683019|9893735|FG000|NOT COMPLETED|Overall Study||2
8839492|NCT01683019|9893736|FG001|NOT COMPLETED|Overall Study||1
8839493|NCT01683019|9893737|FG002|NOT COMPLETED|Overall Study||4
8839494|NCT01683058|9893745|FG000|STARTED|Overall Study||74
8839495|NCT01683058|9893745|FG000|COMPLETED|Overall Study||45
8839496|NCT01683058|9893745|FG000|NOT COMPLETED|Overall Study||29
8839497|NCT01683071|9893756|FG000|STARTED|Part 1||25
8839498|NCT01683071|9893757|FG001|STARTED|Part 1||26
8839499|NCT01683071|9893758|FG002|STARTED|Part 1||25
8839500|NCT01683071|9893759|FG003|STARTED|Part 1||25
8839501|NCT01683071|9893760|FG004|STARTED|Part 1||0
8839502|NCT01683071|9893761|FG005|STARTED|Part 1||0
8839503|NCT01683071|9893756|FG000|COMPLETED|Part 1||21
8839504|NCT01683071|9893757|FG001|COMPLETED|Part 1||22
8839505|NCT01683071|9893758|FG002|COMPLETED|Part 1||22
8839506|NCT01683071|9893759|FG003|COMPLETED|Part 1||20
8839507|NCT01683071|9893760|FG004|COMPLETED|Part 1||0
8839508|NCT01683071|9893761|FG005|COMPLETED|Part 1||0
8839509|NCT01683071|9893756|FG000|NOT COMPLETED|Part 1||4
8839510|NCT01683071|9893757|FG001|NOT COMPLETED|Part 1||4
8839511|NCT01683071|9893758|FG002|NOT COMPLETED|Part 1||3
8839512|NCT01683071|9893759|FG003|NOT COMPLETED|Part 1||5
8839513|NCT01683071|9893760|FG004|NOT COMPLETED|Part 1||0
8839514|NCT01683071|9893761|FG005|NOT COMPLETED|Part 1||0
8839515|NCT01683071|9893756|FG000|STARTED|Part 2||0
8839516|NCT01683071|9893757|FG001|STARTED|Part 2||0
8839517|NCT01683071|9893758|FG002|STARTED|Part 2||0
8839518|NCT01683071|9893759|FG003|STARTED|Part 2||0
8839519|NCT01683071|9893760|FG004|STARTED|Part 2||99
8839520|NCT01683071|9893761|FG005|STARTED|Part 2||97
8839521|NCT01683071|9893756|FG000|COMPLETED|Part 2||0
8839522|NCT01683071|9893757|FG001|COMPLETED|Part 2||0
8839523|NCT01683071|9893758|FG002|COMPLETED|Part 2||0
8839524|NCT01683071|9893759|FG003|COMPLETED|Part 2||0
8839525|NCT01683071|9893760|FG004|COMPLETED|Part 2||82
8839526|NCT01683071|9893761|FG005|COMPLETED|Part 2||82
8839527|NCT01683071|9893756|FG000|NOT COMPLETED|Part 2||0
8839528|NCT01683071|9893757|FG001|NOT COMPLETED|Part 2||0
8839529|NCT01683071|9893758|FG002|NOT COMPLETED|Part 2||0
8839530|NCT01683071|9893759|FG003|NOT COMPLETED|Part 2||0
8839531|NCT01683071|9893760|FG004|NOT COMPLETED|Part 2||17
8839532|NCT01683071|9893761|FG005|NOT COMPLETED|Part 2||15
8839533|NCT01683266|9893783|FG000|STARTED|Overall Study||274
8839534|NCT01683266|9893784|FG001|STARTED|Overall Study||275
8839535|NCT01683266|9893783|FG000|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|273
8839536|NCT01683266|9893784|FG001|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|273
8839537|NCT01683266|9893783|FG000|COMPLETED|Overall Study||219
8839538|NCT01683266|9893784|FG001|COMPLETED|Overall Study||225
8839539|NCT01683266|9893783|FG000|NOT COMPLETED|Overall Study||55
8839540|NCT01683266|9893784|FG001|NOT COMPLETED|Overall Study||50
8839541|NCT01683331|9893792|FG000|STARTED|Overall Study||18
8839542|NCT01683331|9893793|FG001|STARTED|Overall Study||18
8839543|NCT01683331|9893792|FG000|Began Dosage|Overall Study||18
8839544|NCT01683331|9893793|FG001|Began Dosage|Overall Study||18
8839545|NCT01683331|9893792|FG000|12 Months|Overall Study||18
8839546|NCT01683331|9893793|FG001|12 Months|Overall Study||18
8839547|NCT01683331|9893792|FG000|24 Months|Overall Study||18
8839548|NCT01683331|9893793|FG001|24 Months|Overall Study||18
8839549|NCT01683331|9893792|FG000|COMPLETED|Overall Study||18
8839550|NCT01683331|9893793|FG001|COMPLETED|Overall Study||18
8839551|NCT01683331|9893792|FG000|NOT COMPLETED|Overall Study||0
8839552|NCT01683331|9893793|FG001|NOT COMPLETED|Overall Study||0
8839553|NCT01683383|9893801|FG000|STARTED|Overall Study||50
8839554|NCT01683383|9893802|FG001|STARTED|Overall Study||51
8839555|NCT01683383|9893801|FG000|Transported and Treated|Overall Study||49
8839556|NCT01683383|9893802|FG001|Transported and Treated|Overall Study||51
8839557|NCT01683383|9893801|FG000|COMPLETED|Overall Study||49
8839558|NCT01683383|9893802|FG001|COMPLETED|Overall Study||51
8839559|NCT01683383|9893801|FG000|NOT COMPLETED|Overall Study||1
8839560|NCT01683383|9893802|FG001|NOT COMPLETED|Overall Study||0
8839561|NCT01683409|9893813|FG000|STARTED|Treatment Period (Weeks 1-24)||27
8839562|NCT01683409|9893814|FG001|STARTED|Treatment Period (Weeks 1-24)||25
8839563|NCT01683409|9893815|FG002|STARTED|Treatment Period (Weeks 1-24)||27
8839564|NCT01683409|9893816|FG003|STARTED|Treatment Period (Weeks 1-24)||26
8839565|NCT01683409|9893817|FG004|STARTED|Treatment Period (Weeks 1-24)||25
8839566|NCT01683409|9893813|FG000|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||27
8839567|NCT01683409|9893814|FG001|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||25
8839568|NCT01683409|9893815|FG002|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||26
8839569|NCT01683409|9893816|FG003|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||26
8839570|NCT01683409|9893817|FG004|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||25
8839571|NCT01683409|9893813|FG000|COMPLETED|Treatment Period (Weeks 1-24)||27
8839572|NCT01683409|9893814|FG001|COMPLETED|Treatment Period (Weeks 1-24)||21
8839573|NCT01683409|9893815|FG002|COMPLETED|Treatment Period (Weeks 1-24)||26
8839574|NCT01683409|9893816|FG003|COMPLETED|Treatment Period (Weeks 1-24)||24
8839575|NCT01683409|9893817|FG004|COMPLETED|Treatment Period (Weeks 1-24)||23
8839576|NCT01683409|9893813|FG000|NOT COMPLETED|Treatment Period (Weeks 1-24)||0
8839577|NCT01683409|9893814|FG001|NOT COMPLETED|Treatment Period (Weeks 1-24)||4
8839578|NCT01683409|9893815|FG002|NOT COMPLETED|Treatment Period (Weeks 1-24)||1
8839579|NCT01683409|9893816|FG003|NOT COMPLETED|Treatment Period (Weeks 1-24)||2
8839580|NCT01683409|9893817|FG004|NOT COMPLETED|Treatment Period (Weeks 1-24)||2
8839581|NCT01683409|9893813|FG000|STARTED|Washout Period 1 (Weeks 25-28)||27
8839582|NCT01683409|9893814|FG001|STARTED|Washout Period 1 (Weeks 25-28)||21
8839583|NCT01683409|9893815|FG002|STARTED|Washout Period 1 (Weeks 25-28)||26
8839584|NCT01683409|9893816|FG003|STARTED|Washout Period 1 (Weeks 25-28)||24
8839585|NCT01683409|9893817|FG004|STARTED|Washout Period 1 (Weeks 25-28)||23
8839586|NCT01683409|9893813|FG000|COMPLETED|Washout Period 1 (Weeks 25-28)||24
8839587|NCT01683409|9893814|FG001|COMPLETED|Washout Period 1 (Weeks 25-28)||17
8839588|NCT01683409|9893815|FG002|COMPLETED|Washout Period 1 (Weeks 25-28)||25
8839589|NCT01683409|9893816|FG003|COMPLETED|Washout Period 1 (Weeks 25-28)||22
8839590|NCT01683409|9893817|FG004|COMPLETED|Washout Period 1 (Weeks 25-28)||20
8839591|NCT01683409|9893813|FG000|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||3
8839592|NCT01683409|9893814|FG001|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||4
8839593|NCT01683409|9893815|FG002|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||1
8839594|NCT01683409|9893816|FG003|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||2
8839595|NCT01683409|9893817|FG004|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||3
8839596|NCT01683409|9893813|FG000|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 18 participants.|6
8839597|NCT01683409|9893814|FG001|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 11 participants.|6
8839598|NCT01683409|9893815|FG002|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 17 participants.|8
8839599|NCT01683409|9893816|FG003|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 16 participants.|6
8839600|NCT01683409|9893817|FG004|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 8 participants.|12
8839601|NCT01683409|9893813|FG000|COMPLETED|Washout Period 2 (Weeks 29-32)||6
8839602|NCT01683409|9893814|FG001|COMPLETED|Washout Period 2 (Weeks 29-32)||6
8839603|NCT01683409|9893815|FG002|COMPLETED|Washout Period 2 (Weeks 29-32)||7
8839604|NCT01683409|9893816|FG003|COMPLETED|Washout Period 2 (Weeks 29-32)||6
8839605|NCT01683409|9893817|FG004|COMPLETED|Washout Period 2 (Weeks 29-32)||9
8839606|NCT01683409|9893813|FG000|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||0
8839607|NCT01683409|9893814|FG001|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||0
8839608|NCT01683409|9893815|FG002|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||1
8839609|NCT01683409|9893816|FG003|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||0
8839610|NCT01683409|9893817|FG004|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||3
8839611|NCT01683422|9893843|FG000|STARTED|Overall Study||9
8839612|NCT01683422|9893843|FG000|COMPLETED|Overall Study||9
8839613|NCT01683422|9893843|FG000|NOT COMPLETED|Overall Study||0
8839614|NCT01683526|9893849|FG000|STARTED|Overall Study||60
8839615|NCT01683526|9893850|FG001|STARTED|Overall Study||57
8839616|NCT01683526|9893849|FG000|COMPLETED|Overall Study||60
8839617|NCT01683526|9893850|FG001|COMPLETED|Overall Study||57
8839618|NCT01683526|9893849|FG000|NOT COMPLETED|Overall Study||0
8839619|NCT01683526|9893850|FG001|NOT COMPLETED|Overall Study||0
8839620|NCT01683565|9893858|FG000|STARTED|Overall Study||15
8839621|NCT01683565|9893859|FG001|STARTED|Overall Study||16
8839622|NCT01683565|9893858|FG000|COMPLETED|Overall Study||12
8839623|NCT01683565|9893859|FG001|COMPLETED|Overall Study||15
8839624|NCT01683565|9893858|FG000|NOT COMPLETED|Overall Study||3
8839625|NCT01683565|9893859|FG001|NOT COMPLETED|Overall Study||1
8839626|NCT01683604|9893867|FG000|STARTED|Overall Study||37
8839627|NCT01683604|9893867|FG000|COMPLETED|Overall Study||32
8839628|NCT01683604|9893867|FG000|NOT COMPLETED|Overall Study||5
8839629|NCT01683630|9893878|FG000|STARTED|Overall Study||1404
8839630|NCT01683630|9893879|FG001|STARTED|Overall Study||445
8839631|NCT01683630|9893878|FG000|COMPLETED|Overall Study||1404
8839632|NCT01683630|9893879|FG001|COMPLETED|Overall Study||445
8839633|NCT01683630|9893878|FG000|NOT COMPLETED|Overall Study||0
8839634|NCT01683630|9893879|FG001|NOT COMPLETED|Overall Study||0
8839635|NCT01683812|9893885|FG000|STARTED|Overall Study||23
8839636|NCT01683812|9893885|FG000|COMPLETED|Overall Study||23
8839637|NCT01683812|9893885|FG000|NOT COMPLETED|Overall Study||0
8839638|NCT01683838|9893891|FG000|STARTED|Overall Study||104
8839639|NCT01683838|9893892|FG001|STARTED|Overall Study||100
8839640|NCT01683838|9893891|FG000|Intent to Treat (ITT) Population|Overall Study||103
8839641|NCT01683838|9893892|FG001|Intent to Treat (ITT) Population|Overall Study||100
8839642|NCT01683838|9893891|FG000|Safety Population|Overall Study||103
8839643|NCT01683838|9893892|FG001|Safety Population|Overall Study||100
8839644|NCT01683838|9893891|FG000|Efficacy Population|Overall Study||89
8839645|NCT01683838|9893892|FG001|Efficacy Population|Overall Study||93
8839646|NCT01683838|9893891|FG000|COMPLETED|Overall Study||78
8839647|NCT01683838|9893892|FG001|COMPLETED|Overall Study||88
8839648|NCT01683838|9893891|FG000|NOT COMPLETED|Overall Study||26
8839649|NCT01683838|9893892|FG001|NOT COMPLETED|Overall Study||12
8839650|NCT01683994|9893903|FG000|STARTED|Overall Study||4
8839651|NCT01683994|9893904|FG001|STARTED|Overall Study||8
8839652|NCT01683994|9893905|FG002|STARTED|Overall Study||7
8839653|NCT01683994|9893906|FG003|STARTED|Overall Study||13
8839654|NCT01683994|9893907|FG004|STARTED|Overall Study||13
8839655|NCT01683994|9893903|FG000|# of Patients Who Received Treatment|Overall Study||4
8839656|NCT01683994|9893904|FG001|# of Patients Who Received Treatment|Overall Study||8
8839657|NCT01683994|9893905|FG002|# of Patients Who Received Treatment|Overall Study||7
8839658|NCT01683994|9893906|FG003|# of Patients Who Received Treatment|Overall Study||12
8839659|NCT01683994|9893907|FG004|# of Patients Who Received Treatment|Overall Study||13
8839660|NCT01683994|9893903|FG000|COMPLETED|Overall Study||3
8839661|NCT01683994|9893904|FG001|COMPLETED|Overall Study||8
8839662|NCT01683994|9893905|FG002|COMPLETED|Overall Study||7
8839663|NCT01683994|9893906|FG003|COMPLETED|Overall Study||10
8839664|NCT01683994|9893907|FG004|COMPLETED|Overall Study||12
8839665|NCT01683994|9893903|FG000|NOT COMPLETED|Overall Study||1
8839666|NCT01683994|9893904|FG001|NOT COMPLETED|Overall Study||0
8839667|NCT01683994|9893905|FG002|NOT COMPLETED|Overall Study||0
8839668|NCT01683994|9893906|FG003|NOT COMPLETED|Overall Study||3
8839669|NCT01683994|9893907|FG004|NOT COMPLETED|Overall Study||1
8839670|NCT01684007|9893927|FG000|STARTED|Overall Study||53
8839671|NCT01684007|9893928|FG001|STARTED|Overall Study||50
8839672|NCT01684007|9893927|FG000|COMPLETED|Overall Study||53
8839673|NCT01684007|9893928|FG001|COMPLETED|Overall Study||50
8839674|NCT01684007|9893927|FG000|NOT COMPLETED|Overall Study||0
8839675|NCT01684007|9893928|FG001|NOT COMPLETED|Overall Study||0
8839676|NCT01684020|9893936|FG000|STARTED|Overall Study||5
8839677|NCT01684020|9893937|FG001|STARTED|Overall Study||5
8839678|NCT01684020|9893936|FG000|COMPLETED|Overall Study||4
8839679|NCT01684020|9893937|FG001|COMPLETED|Overall Study||5
8839680|NCT01684020|9893936|FG000|NOT COMPLETED|Overall Study||1
8839681|NCT01684020|9893937|FG001|NOT COMPLETED|Overall Study||0
8839682|NCT01684033|9893943|FG000|STARTED|Period 1, First 30 Days||99
8839683|NCT01684033|9893944|FG001|STARTED|Period 1, First 30 Days||99
8839684|NCT01684033|9893943|FG000|COMPLETED|Period 1, First 30 Days||95
8839685|NCT01684033|9893944|FG001|COMPLETED|Period 1, First 30 Days||98
8839686|NCT01684033|9893943|FG000|NOT COMPLETED|Period 1, First 30 Days||4
8623101|NCT00491556|9662330|FG000|COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||49
8623102|NCT00491556|9662331|FG001|COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||27
8623103|NCT00491556|9662330|FG000|NOT COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||26
8623104|NCT00491556|9662331|FG001|NOT COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||0
8623105|NCT00491556|9662330|FG000|STARTED|Wk 48-152: EXP (On De-Int)/Standard Care||49
8839687|NCT01684033|9893944|FG001|NOT COMPLETED|Period 1, First 30 Days||1
8839688|NCT01684033|9893943|FG000|STARTED|Period 2, Second 30 Days||95
8839689|NCT01684033|9893944|FG001|STARTED|Period 2, Second 30 Days||98
8839690|NCT01684033|9893943|FG000|COMPLETED|Period 2, Second 30 Days||94
8839691|NCT01684033|9893944|FG001|COMPLETED|Period 2, Second 30 Days||98
8839692|NCT01684033|9893943|FG000|NOT COMPLETED|Period 2, Second 30 Days||1
8839693|NCT01684033|9893944|FG001|NOT COMPLETED|Period 2, Second 30 Days||0
8839694|NCT01684046|9893950|FG000|STARTED|Period 1, First 30 Days||97
8839695|NCT01684046|9893951|FG001|STARTED|Period 1, First 30 Days||95
8839696|NCT01684046|9893950|FG000|COMPLETED|Period 1, First 30 Days||97
8839697|NCT01684046|9893951|FG001|COMPLETED|Period 1, First 30 Days||93
8839698|NCT01684046|9893950|FG000|NOT COMPLETED|Period 1, First 30 Days||0
8839699|NCT01684046|9893951|FG001|NOT COMPLETED|Period 1, First 30 Days||2
8839700|NCT01684046|9893950|FG000|STARTED|Period 2, Second 30 Days||97
8839701|NCT01684046|9893951|FG001|STARTED|Period 2, Second 30 Days||93
8839702|NCT01684046|9893950|FG000|COMPLETED|Period 2, Second 30 Days||97
8839703|NCT01684046|9893951|FG001|COMPLETED|Period 2, Second 30 Days||93
8839704|NCT01684046|9893950|FG000|NOT COMPLETED|Period 2, Second 30 Days||0
8839705|NCT01684046|9893951|FG001|NOT COMPLETED|Period 2, Second 30 Days||0
8839706|NCT01684202|9893961|FG000|STARTED|Dose-escalation Period||15
8839707|NCT01684202|9893962|FG001|STARTED|Dose-escalation Period||8
8839708|NCT01684202|9893963|FG002|STARTED|Dose-escalation Period||9
8839709|NCT01684202|9893964|FG003|STARTED|Dose-escalation Period||11
8839710|NCT01684202|9893961|FG000|COMPLETED|Dose-escalation Period||14
8839711|NCT01684202|9893962|FG001|COMPLETED|Dose-escalation Period||7
8839712|NCT01684202|9893963|FG002|COMPLETED|Dose-escalation Period||9
8839713|NCT01684202|9893964|FG003|COMPLETED|Dose-escalation Period||11
8839714|NCT01684202|9893961|FG000|NOT COMPLETED|Dose-escalation Period||1
8839715|NCT01684202|9893962|FG001|NOT COMPLETED|Dose-escalation Period||1
8839716|NCT01684202|9893963|FG002|NOT COMPLETED|Dose-escalation Period||0
8839717|NCT01684202|9893964|FG003|NOT COMPLETED|Dose-escalation Period||0
8839718|NCT01684202|9893961|FG000|STARTED|Maintenance Period||14
8839719|NCT01684202|9893962|FG001|STARTED|Maintenance Period||7
8839720|NCT01684202|9893963|FG002|STARTED|Maintenance Period||9
8839721|NCT01684202|9893964|FG003|STARTED|Maintenance Period||11
8839722|NCT01684202|9893961|FG000|COMPLETED|Maintenance Period||13
8839723|NCT01684202|9893962|FG001|COMPLETED|Maintenance Period||4
8839724|NCT01684202|9893963|FG002|COMPLETED|Maintenance Period||8
8839725|NCT01684202|9893964|FG003|COMPLETED|Maintenance Period||10
8839726|NCT01684202|9893961|FG000|NOT COMPLETED|Maintenance Period||1
8839727|NCT01684202|9893962|FG001|NOT COMPLETED|Maintenance Period||3
8839728|NCT01684202|9893963|FG002|NOT COMPLETED|Maintenance Period||1
8839729|NCT01684202|9893964|FG003|NOT COMPLETED|Maintenance Period||1
8839730|NCT01684215|9893978|FG000|STARTED|Phase 1, Part 1||6
8839731|NCT01684215|9893979|FG001|STARTED|Phase 1, Part 1||6
8839732|NCT01684215|9893980|FG002|STARTED|Phase 1, Part 1||0
8839733|NCT01684215|9893981|FG003|STARTED|Phase 1, Part 1||0
8839734|NCT01684215|9893978|FG000|Treated|Phase 1, Part 1||6
8839735|NCT01684215|9893979|FG001|Treated|Phase 1, Part 1||6
8839736|NCT01684215|9893980|FG002|Treated|Phase 1, Part 1||0
8839737|NCT01684215|9893981|FG003|Treated|Phase 1, Part 1||0
8839738|NCT01684215|9893978|FG000|COMPLETED|Phase 1, Part 1||0
8839739|NCT01684215|9893979|FG001|COMPLETED|Phase 1, Part 1||0
8839740|NCT01684215|9893980|FG002|COMPLETED|Phase 1, Part 1||0
8839741|NCT01684215|9893981|FG003|COMPLETED|Phase 1, Part 1||0
8839742|NCT01684215|9893978|FG000|NOT COMPLETED|Phase 1, Part 1||6
8839743|NCT01684215|9893979|FG001|NOT COMPLETED|Phase 1, Part 1||6
8839744|NCT01684215|9893980|FG002|NOT COMPLETED|Phase 1, Part 1||0
8839745|NCT01684215|9893981|FG003|NOT COMPLETED|Phase 1, Part 1||0
8839746|NCT01684215|9893978|FG000|STARTED|Phase 1, Part 2||0
8839747|NCT01684215|9893979|FG001|STARTED|Phase 1, Part 2||0
8839748|NCT01684215|9893980|FG002|STARTED|Phase 1, Part 2|Eligible participants who consented for Phase 1 Part 2.|6
8839749|NCT01684215|9893981|FG003|STARTED|Phase 1, Part 2||0
8839750|NCT01684215|9893978|FG000|COMPLETED|Phase 1, Part 2||0
8839751|NCT01684215|9893979|FG001|COMPLETED|Phase 1, Part 2||0
8839752|NCT01684215|9893980|FG002|COMPLETED|Phase 1, Part 2||0
8839753|NCT01684215|9893981|FG003|COMPLETED|Phase 1, Part 2||0
8839754|NCT01684215|9893978|FG000|NOT COMPLETED|Phase 1, Part 2||0
8839755|NCT01684215|9893979|FG001|NOT COMPLETED|Phase 1, Part 2||0
8839756|NCT01684215|9893980|FG002|NOT COMPLETED|Phase 1, Part 2||6
8839757|NCT01684215|9893981|FG003|NOT COMPLETED|Phase 1, Part 2||0
8839758|NCT01684215|9893978|FG000|STARTED|Phase 2||0
8839759|NCT01684215|9893979|FG001|STARTED|Phase 2||0
8839760|NCT01684215|9893980|FG002|STARTED|Phase 2||0
8839761|NCT01684215|9893981|FG003|STARTED|Phase 2|Eligible participants who consented for Phase 2.|43
8839762|NCT01684215|9893978|FG000|Treated|Phase 2||0
8839763|NCT01684215|9893979|FG001|Treated|Phase 2||0
8839764|NCT01684215|9893980|FG002|Treated|Phase 2||0
8839765|NCT01684215|9893981|FG003|Treated|Phase 2||42
8839766|NCT01684215|9893978|FG000|COMPLETED|Phase 2||0
8839767|NCT01684215|9893979|FG001|COMPLETED|Phase 2||0
8839768|NCT01684215|9893980|FG002|COMPLETED|Phase 2||0
8839769|NCT01684215|9893981|FG003|COMPLETED|Phase 2||0
8839770|NCT01684215|9893978|FG000|NOT COMPLETED|Phase 2||0
8839771|NCT01684215|9893979|FG001|NOT COMPLETED|Phase 2||0
8839772|NCT01684215|9893980|FG002|NOT COMPLETED|Phase 2||0
8839773|NCT01684215|9893981|FG003|NOT COMPLETED|Phase 2||43
8839774|NCT01684410|9893997|FG000|STARTED|Overall Study||10
8839775|NCT01684410|9893998|FG001|STARTED|Overall Study||10
8839776|NCT01684410|9893999|FG002|STARTED|Overall Study||10
8839777|NCT01684410|9893997|FG000|COMPLETED|Overall Study||10
8839778|NCT01684410|9893998|FG001|COMPLETED|Overall Study||10
8839779|NCT01684410|9893999|FG002|COMPLETED|Overall Study||10
8839780|NCT01684410|9893997|FG000|NOT COMPLETED|Overall Study||0
8839781|NCT01684410|9893998|FG001|NOT COMPLETED|Overall Study||0
8839782|NCT01684410|9893999|FG002|NOT COMPLETED|Overall Study||0
8839783|NCT01684423|9894012|FG000|STARTED|Overall Study||11
8839784|NCT01684423|9894013|FG001|STARTED|Overall Study||13
8839785|NCT01684423|9894014|FG002|STARTED|Overall Study||13
8839786|NCT01684423|9894015|FG003|STARTED|Overall Study||19
8839787|NCT01684423|9894016|FG004|STARTED|Overall Study||7
8839788|NCT01684423|9894012|FG000|COMPLETED|Overall Study||11
8839789|NCT01684423|9894013|FG001|COMPLETED|Overall Study||13
8839790|NCT01684423|9894014|FG002|COMPLETED|Overall Study||12
8839791|NCT01684423|9894015|FG003|COMPLETED|Overall Study||19
8839792|NCT01684423|9894016|FG004|COMPLETED|Overall Study||7
8839793|NCT01684423|9894012|FG000|NOT COMPLETED|Overall Study||0
8839794|NCT01684423|9894013|FG001|NOT COMPLETED|Overall Study||0
8839795|NCT01684423|9894014|FG002|NOT COMPLETED|Overall Study||1
8839796|NCT01684423|9894015|FG003|NOT COMPLETED|Overall Study||0
8839797|NCT01684423|9894016|FG004|NOT COMPLETED|Overall Study||0
8839798|NCT01684436|9894030|FG000|STARTED|Overall Study||30
8839799|NCT01684436|9894030|FG000|COMPLETED|Overall Study||29
8839800|NCT01684436|9894030|FG000|NOT COMPLETED|Overall Study||1
8839801|NCT01684566|9894036|FG000|STARTED|Overall Study||60
8839802|NCT01684566|9894037|FG001|STARTED|Overall Study||56
8839803|NCT01684566|9894036|FG000|Treated (ITT)|Overall Study||57
8839804|NCT01684566|9894037|FG001|Treated (ITT)|Overall Study||52
8839805|NCT01684566|9894036|FG000|COMPLETED|Overall Study||44
8839806|NCT01684566|9894037|FG001|COMPLETED|Overall Study||49
8839807|NCT01684566|9894036|FG000|NOT COMPLETED|Overall Study||16
8839808|NCT01684566|9894037|FG001|NOT COMPLETED|Overall Study||7
8839809|NCT01684592|9894045|FG000|STARTED|Overall Study||64
8839810|NCT01684592|9894046|FG001|STARTED|Overall Study||64
8839811|NCT01684592|9894045|FG000|COMPLETED|Overall Study||38
8839812|NCT01684592|9894046|FG001|COMPLETED|Overall Study||40
8839813|NCT01684592|9894045|FG000|NOT COMPLETED|Overall Study||26
8839814|NCT01684592|9894046|FG001|NOT COMPLETED|Overall Study||24
8839815|NCT01684722|9894056|FG000|STARTED|Overall Study||333
8839816|NCT01684722|9894057|FG001|STARTED|Overall Study||289
8623106|NCT00491556|9662331|FG001|STARTED|Wk 48-152: EXP (On De-Int)/Standard Care||27
8839817|NCT01684722|9894058|FG002|STARTED|Overall Study||320
8839818|NCT01684722|9894059|FG003|STARTED|Overall Study||370
8839819|NCT01684722|9894056|FG000|COMPLETED|Overall Study||236
8839820|NCT01684722|9894057|FG001|COMPLETED|Overall Study||212
8839821|NCT01684722|9894058|FG002|COMPLETED|Overall Study||226
8839822|NCT01684722|9894059|FG003|COMPLETED|Overall Study||260
8839823|NCT01684722|9894056|FG000|NOT COMPLETED|Overall Study||97
8839824|NCT01684722|9894057|FG001|NOT COMPLETED|Overall Study||77
8839825|NCT01684722|9894058|FG002|NOT COMPLETED|Overall Study||94
8839826|NCT01684722|9894059|FG003|NOT COMPLETED|Overall Study||110
8839827|NCT01684748|9894083|FG000|STARTED|First Intervention - 8 Weeks||10
8839828|NCT01684748|9894084|FG001|STARTED|First Intervention - 8 Weeks||10
8839829|NCT01684748|9894083|FG000|COMPLETED|First Intervention - 8 Weeks||8
8839830|NCT01684748|9894084|FG001|COMPLETED|First Intervention - 8 Weeks||8
8839831|NCT01684748|9894083|FG000|NOT COMPLETED|First Intervention - 8 Weeks||2
8839832|NCT01684748|9894084|FG001|NOT COMPLETED|First Intervention - 8 Weeks||2
8839833|NCT01684748|9894083|FG000|STARTED|Second Intervention - 8 Weeks||8
8839834|NCT01684748|9894084|FG001|STARTED|Second Intervention - 8 Weeks||8
8839835|NCT01684748|9894083|FG000|COMPLETED|Second Intervention - 8 Weeks||8
8839836|NCT01684748|9894084|FG001|COMPLETED|Second Intervention - 8 Weeks||8
8839837|NCT01684748|9894083|FG000|NOT COMPLETED|Second Intervention - 8 Weeks||0
8839838|NCT01684748|9894084|FG001|NOT COMPLETED|Second Intervention - 8 Weeks||0
8839839|NCT01684839|9894090|FG000|STARTED|Overall Study||9
8839840|NCT01684839|9894090|FG000|COMPLETED|Overall Study||9
8839841|NCT01684839|9894090|FG000|NOT COMPLETED|Overall Study||0
8839842|NCT01684878|9894098|FG000|STARTED|Part 1: Safety Run in Phase||22
8839843|NCT01684878|9894099|FG001|STARTED|Part 1: Safety Run in Phase||28
8839844|NCT01684878|9894100|FG002|STARTED|Part 1: Safety Run in Phase||0
8839845|NCT01684878|9894101|FG003|STARTED|Part 1: Safety Run in Phase||0
8839846|NCT01684878|9894098|FG000|COMPLETED|Part 1: Safety Run in Phase||6
8839847|NCT01684878|9894099|FG001|COMPLETED|Part 1: Safety Run in Phase||5
8839848|NCT01684878|9894100|FG002|COMPLETED|Part 1: Safety Run in Phase||0
8839849|NCT01684878|9894101|FG003|COMPLETED|Part 1: Safety Run in Phase||0
8839850|NCT01684878|9894098|FG000|NOT COMPLETED|Part 1: Safety Run in Phase||16
8839851|NCT01684878|9894099|FG001|NOT COMPLETED|Part 1: Safety Run in Phase||23
8839852|NCT01684878|9894100|FG002|NOT COMPLETED|Part 1: Safety Run in Phase||0
8839853|NCT01684878|9894101|FG003|NOT COMPLETED|Part 1: Safety Run in Phase||0
8839854|NCT01684878|9894098|FG000|STARTED|Part 2: Randomized Phase||0
8839855|NCT01684878|9894099|FG001|STARTED|Part 2: Randomized Phase||0
8839856|NCT01684878|9894100|FG002|STARTED|Part 2: Randomized Phase||78
8839857|NCT01684878|9894101|FG003|STARTED|Part 2: Randomized Phase||78
8839858|NCT01684878|9894098|FG000|Participants Randomized But Not Treated|Part 2: Randomized Phase||0
8839859|NCT01684878|9894099|FG001|Participants Randomized But Not Treated|Part 2: Randomized Phase||0
8839860|NCT01684878|9894100|FG002|Participants Randomized But Not Treated|Part 2: Randomized Phase||1
8839861|NCT01684878|9894101|FG003|Participants Randomized But Not Treated|Part 2: Randomized Phase||2
8839862|NCT01684878|9894098|FG000|Participants Mis-randomized|Part 2: Randomized Phase||0
8839863|NCT01684878|9894099|FG001|Participants Mis-randomized|Part 2: Randomized Phase||0
8839864|NCT01684878|9894100|FG002|Participants Mis-randomized|Part 2: Randomized Phase||2
8839865|NCT01684878|9894101|FG003|Participants Mis-randomized|Part 2: Randomized Phase||0
8839866|NCT01684878|9894098|FG000|COMPLETED|Part 2: Randomized Phase||0
8839867|NCT01684878|9894099|FG001|COMPLETED|Part 2: Randomized Phase||0
8839868|NCT01684878|9894100|FG002|COMPLETED|Part 2: Randomized Phase||0
8839869|NCT01684878|9894101|FG003|COMPLETED|Part 2: Randomized Phase||0
8839870|NCT01684878|9894098|FG000|NOT COMPLETED|Part 2: Randomized Phase||0
8839871|NCT01684878|9894099|FG001|NOT COMPLETED|Part 2: Randomized Phase||0
8839872|NCT01684878|9894100|FG002|NOT COMPLETED|Part 2: Randomized Phase||78
8839873|NCT01684878|9894101|FG003|NOT COMPLETED|Part 2: Randomized Phase||78
8839874|NCT01684917|9894115|FG000|STARTED|Overall Study||11
8839875|NCT01684917|9894116|FG001|STARTED|Overall Study||7
8839876|NCT01684917|9894117|FG002|STARTED|Overall Study||13
8839877|NCT01684917|9894118|FG003|STARTED|Overall Study||5
8839878|NCT01684917|9894115|FG000|COMPLETED|Overall Study||11
8839879|NCT01684917|9894116|FG001|COMPLETED|Overall Study||7
8839880|NCT01684917|9894117|FG002|COMPLETED|Overall Study||13
8839881|NCT01684917|9894118|FG003|COMPLETED|Overall Study||5
8839882|NCT01684917|9894115|FG000|NOT COMPLETED|Overall Study||0
8839883|NCT01684917|9894116|FG001|NOT COMPLETED|Overall Study||0
8839884|NCT01684917|9894117|FG002|NOT COMPLETED|Overall Study||0
8839885|NCT01684917|9894118|FG003|NOT COMPLETED|Overall Study||0
8839886|NCT01684930|9894130|FG000|STARTED|Overall Study||12
8839887|NCT01684930|9894131|FG001|STARTED|Overall Study||14
8839888|NCT01684930|9894130|FG000|COMPLETED|Overall Study||9
8839889|NCT01684930|9894131|FG001|COMPLETED|Overall Study||13
8839890|NCT01684930|9894130|FG000|NOT COMPLETED|Overall Study||3
8839891|NCT01684930|9894131|FG001|NOT COMPLETED|Overall Study||1
8839892|NCT01684943|9894140|FG000|STARTED|Overall Study||29
8839893|NCT01684943|9894141|FG001|STARTED|Overall Study||3
8839894|NCT01684943|9894142|FG002|STARTED|Overall Study||1
8839895|NCT01684943|9894140|FG000|COMPLETED|Overall Study||20
8839896|NCT01684943|9894141|FG001|COMPLETED|Overall Study||2
8839897|NCT01684943|9894142|FG002|COMPLETED|Overall Study||0
8839898|NCT01684943|9894140|FG000|NOT COMPLETED|Overall Study||9
8839899|NCT01684943|9894141|FG001|NOT COMPLETED|Overall Study||1
8839900|NCT01684943|9894142|FG002|NOT COMPLETED|Overall Study||1
8839901|NCT01685021|9894155|FG000|STARTED|Overall Study||22
8839902|NCT01685021|9894155|FG000|COMPLETED|Overall Study|Last patient last visit date. Study was Terminated prematurely.|6
8839903|NCT01685021|9894155|FG000|NOT COMPLETED|Overall Study||16
8839904|NCT01685047|9894159|FG000|STARTED|Overall Study|481 subjects signed the consent. 1 subject was withdrawn prior to the baseline visit.|481
8839905|NCT01685047|9894159|FG000|COMPLETED|Overall Study||396
8839906|NCT01685047|9894159|FG000|NOT COMPLETED|Overall Study||85
8839907|NCT01685060|9894163|FG000|STARTED|Overall Study||140
8839908|NCT01685060|9894163|FG000|Entered Post-treatment Efficacy f/u|Overall Study||7
8839909|NCT01685060|9894163|FG000|Entered Survival Follow up|Overall Study||98
8839910|NCT01685060|9894163|FG000|Discontinued From Study|Overall Study||35
8839911|NCT01685060|9894163|FG000|COMPLETED|Overall Study||0
8839912|NCT01685060|9894163|FG000|NOT COMPLETED|Overall Study||140
8839913|NCT01685073|9894169|FG000|STARTED|Overall Study|Randomized|62
8839914|NCT01685073|9894170|FG001|STARTED|Overall Study|Randomized|65
8839915|NCT01685073|9894169|FG000|COMPLETED|Overall Study|Retained in treatment through 12 weeks|32
8839916|NCT01685073|9894170|FG001|COMPLETED|Overall Study|Retained in treatment through 12 weeks|33
8839917|NCT01685073|9894169|FG000|NOT COMPLETED|Overall Study||30
8839918|NCT01685073|9894170|FG001|NOT COMPLETED|Overall Study||32
8839919|NCT01685138|9894176|FG000|STARTED|Overall Study||124
8839920|NCT01685138|9894176|FG000|Discontinued From Treatment Phase|Overall Study||124
8839921|NCT01685138|9894176|FG000|Entered Post-treatment Efficacy f/up|Overall Study||10
8839922|NCT01685138|9894176|FG000|Entered Survival Follow-up|Overall Study||63
8839923|NCT01685138|9894176|FG000|Discontinued From Study|Overall Study||51
8839924|NCT01685138|9894176|FG000|COMPLETED|Overall Study||32
8839925|NCT01685138|9894176|FG000|NOT COMPLETED|Overall Study||92
8839926|NCT01685203|9894187|FG000|STARTED|Overall Study||44
8839927|NCT01685203|9894188|FG001|STARTED|Overall Study||42
8839928|NCT01685203|9894189|FG002|STARTED|Overall Study||40
8839929|NCT01685203|9894190|FG003|STARTED|Overall Study||42
8839930|NCT01685203|9894191|FG004|STARTED|Overall Study||49
8839931|NCT01685203|9894192|FG005|STARTED|Overall Study||47
8839932|NCT01685203|9894193|FG006|STARTED|Overall Study||52
8839933|NCT01685203|9894187|FG000|Completed Study Drug|Overall Study||42
8839934|NCT01685203|9894188|FG001|Completed Study Drug|Overall Study||40
8839935|NCT01685203|9894189|FG002|Completed Study Drug|Overall Study||39
8839936|NCT01685203|9894190|FG003|Completed Study Drug|Overall Study||42
8839937|NCT01685203|9894191|FG004|Completed Study Drug|Overall Study||49
8839938|NCT01685203|9894192|FG005|Completed Study Drug|Overall Study||43
8839939|NCT01685203|9894193|FG006|Completed Study Drug|Overall Study||52
8839940|NCT01685203|9894187|FG000|COMPLETED|Overall Study||40
8839941|NCT01685203|9894188|FG001|COMPLETED|Overall Study||39
8839942|NCT01685203|9894189|FG002|COMPLETED|Overall Study||40
8839943|NCT01685203|9894190|FG003|COMPLETED|Overall Study||41
8839944|NCT01685203|9894191|FG004|COMPLETED|Overall Study||49
8839945|NCT01685203|9894192|FG005|COMPLETED|Overall Study||44
8839946|NCT01685203|9894193|FG006|COMPLETED|Overall Study||52
8839947|NCT01685203|9894187|FG000|NOT COMPLETED|Overall Study||4
8839948|NCT01685203|9894188|FG001|NOT COMPLETED|Overall Study||3
8839949|NCT01685203|9894189|FG002|NOT COMPLETED|Overall Study||0
8839950|NCT01685203|9894190|FG003|NOT COMPLETED|Overall Study||1
8839951|NCT01685203|9894191|FG004|NOT COMPLETED|Overall Study||0
8839952|NCT01685203|9894192|FG005|NOT COMPLETED|Overall Study||3
8839953|NCT01685203|9894193|FG006|NOT COMPLETED|Overall Study||0
8839954|NCT01685216|9894209|FG000|STARTED|Overall Study||7
8839955|NCT01685216|9894209|FG000|COMPLETED|Overall Study||6
8839956|NCT01685216|9894209|FG000|NOT COMPLETED|Overall Study||1
8839957|NCT01685229|9894215|FG000|STARTED|Overall Study||146
8839958|NCT01685229|9894216|FG001|STARTED|Overall Study||52
8839959|NCT01685229|9894215|FG000|COMPLETED|Overall Study||120
8839960|NCT01685229|9894216|FG001|COMPLETED|Overall Study||36
8839961|NCT01685229|9894215|FG000|NOT COMPLETED|Overall Study||26
8839962|NCT01685229|9894216|FG001|NOT COMPLETED|Overall Study||16
8839963|NCT01685242|9894227|FG000|STARTED|Overall Study||50
8839964|NCT01685242|9894228|FG001|STARTED|Overall Study||50
8839965|NCT01685242|9894227|FG000|COMPLETED|Overall Study||49
8839966|NCT01685242|9894228|FG001|COMPLETED|Overall Study||47
8839967|NCT01685242|9894227|FG000|NOT COMPLETED|Overall Study||1
8839968|NCT01685242|9894228|FG001|NOT COMPLETED|Overall Study||3
8839969|NCT01685320|9894236|FG000|STARTED|Overall Study||15
8839970|NCT01685320|9894237|FG001|STARTED|Overall Study||15
8839971|NCT01685320|9894236|FG000|COMPLETED|Overall Study||15
8839972|NCT01685320|9894237|FG001|COMPLETED|Overall Study||15
8839973|NCT01685320|9894236|FG000|NOT COMPLETED|Overall Study||0
8839974|NCT01685320|9894237|FG001|NOT COMPLETED|Overall Study||0
8839975|NCT01685372|9894245|FG000|STARTED|Timepoint 1 (T1): Vaccine,1st Blood Draw||7
8839976|NCT01685372|9894246|FG001|STARTED|Timepoint 1 (T1): Vaccine,1st Blood Draw||9
8839977|NCT01685372|9894245|FG000|COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||7
8839978|NCT01685372|9894246|FG001|COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||9
8839979|NCT01685372|9894245|FG000|NOT COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||0
8839980|NCT01685372|9894246|FG001|NOT COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||0
8839981|NCT01685372|9894245|FG000|STARTED|Timepoint 2 (T2): 2nd Blood Draw||7
8839982|NCT01685372|9894246|FG001|STARTED|Timepoint 2 (T2): 2nd Blood Draw||9
8839983|NCT01685372|9894245|FG000|COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||7
8839984|NCT01685372|9894246|FG001|COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||9
8839985|NCT01685372|9894245|FG000|NOT COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||0
8839986|NCT01685372|9894246|FG001|NOT COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||0
8839987|NCT01685372|9894245|FG000|STARTED|Timepoint 3 (T3): 3rd Blood Draw||7
8839988|NCT01685372|9894246|FG001|STARTED|Timepoint 3 (T3): 3rd Blood Draw||9
8839989|NCT01685372|9894245|FG000|COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||4
8839990|NCT01685372|9894246|FG001|COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||5
8556564|NCT03388138|9588331|FG001|STARTED|Overall Study||47
8556565|NCT03388138|9588330|FG000|COMPLETED|Overall Study||93
8556566|NCT03388138|9588331|FG001|COMPLETED|Overall Study||47
8556567|NCT03388138|9588330|FG000|NOT COMPLETED|Overall Study||1
8556568|NCT03388138|9588331|FG001|NOT COMPLETED|Overall Study||0
8556569|NCT03067610|9588337|FG000|STARTED|Overall Study||72
8556570|NCT03067610|9588337|FG000|COMPLETED|Overall Study||72
8556571|NCT03067610|9588337|FG000|NOT COMPLETED|Overall Study||0
8556572|NCT03027609|9588347|FG000|STARTED|Overall Study|Safety and ITT population|79
8556573|NCT03027609|9588348|FG001|STARTED|Overall Study|Safety and ITT population|79
8839991|NCT01685372|9894245|FG000|NOT COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||3
8839992|NCT01685372|9894246|FG001|NOT COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||4
8839993|NCT01685411|9894252|FG000|STARTED|Overall Study||5
8839994|NCT01685411|9894252|FG000|COMPLETED|Overall Study||5
8839995|NCT01685411|9894252|FG000|NOT COMPLETED|Overall Study||0
8839996|NCT01685437|9894256|FG000|STARTED|Overall Study||189
8839997|NCT01685437|9894256|FG000|COMPLETED|Overall Study||158
8839998|NCT01685437|9894256|FG000|NOT COMPLETED|Overall Study||31
8839999|NCT01685463|9894262|FG000|STARTED|Overall Study||10
8840000|NCT01685463|9894263|FG001|STARTED|Overall Study||8
8840001|NCT01685463|9894262|FG000|COMPLETED|Overall Study||10
8840002|NCT01685463|9894263|FG001|COMPLETED|Overall Study||8
8840003|NCT01685463|9894262|FG000|NOT COMPLETED|Overall Study||0
8840004|NCT01685463|9894263|FG001|NOT COMPLETED|Overall Study||0
8840005|NCT01685567|9894269|FG000|STARTED|Overall Study||219
8840006|NCT01685567|9894269|FG000|COMPLETED|Overall Study||219
8840007|NCT01685567|9894269|FG000|NOT COMPLETED|Overall Study||0
8840008|NCT01685684|9894275|FG000|STARTED|Titration Phase||740
8840009|NCT01685684|9894276|FG001|STARTED|Titration Phase||0
8840010|NCT01685684|9894277|FG002|STARTED|Titration Phase||0
8840011|NCT01685684|9894275|FG000|COMPLETED|Titration Phase||389
8840012|NCT01685684|9894276|FG001|COMPLETED|Titration Phase||0
8840013|NCT01685684|9894277|FG002|COMPLETED|Titration Phase||0
8840014|NCT01685684|9894275|FG000|NOT COMPLETED|Titration Phase||351
8840015|NCT01685684|9894276|FG001|NOT COMPLETED|Titration Phase||0
8840016|NCT01685684|9894277|FG002|NOT COMPLETED|Titration Phase||0
8840017|NCT01685684|9894275|FG000|STARTED|Double-blind Maintenance Phase||0
8840018|NCT01685684|9894276|FG001|STARTED|Double-blind Maintenance Phase||193
8840019|NCT01685684|9894277|FG002|STARTED|Double-blind Maintenance Phase||196
8840020|NCT01685684|9894275|FG000|COMPLETED|Double-blind Maintenance Phase||0
8840021|NCT01685684|9894276|FG001|COMPLETED|Double-blind Maintenance Phase||122
8840022|NCT01685684|9894277|FG002|COMPLETED|Double-blind Maintenance Phase||100
8840023|NCT01685684|9894275|FG000|NOT COMPLETED|Double-blind Maintenance Phase||0
8840024|NCT01685684|9894276|FG001|NOT COMPLETED|Double-blind Maintenance Phase||71
8840025|NCT01685684|9894277|FG002|NOT COMPLETED|Double-blind Maintenance Phase||96
8840026|NCT01685697|9894287|FG000|STARTED|Overall Study||31
8840027|NCT01685697|9894288|FG001|STARTED|Overall Study||31
8840028|NCT01685697|9894287|FG000|COMPLETED|Overall Study||28
8840029|NCT01685697|9894288|FG001|COMPLETED|Overall Study||28
8840030|NCT01685697|9894287|FG000|NOT COMPLETED|Overall Study||3
8840031|NCT01685697|9894288|FG001|NOT COMPLETED|Overall Study||3
8840032|NCT01685801|9894298|FG000|STARTED|Cycle 1 Period 1 (2 Weeks)||5
8840033|NCT01685801|9894299|FG001|STARTED|Cycle 1 Period 1 (2 Weeks)||6
8840034|NCT01685801|9894300|FG002|STARTED|Cycle 1 Period 1 (2 Weeks)||7
8840035|NCT01685801|9894301|FG003|STARTED|Cycle 1 Period 1 (2 Weeks)||6
8840036|NCT01685801|9894298|FG000|COMPLETED|Cycle 1 Period 1 (2 Weeks)||5
8840037|NCT01685801|9894299|FG001|COMPLETED|Cycle 1 Period 1 (2 Weeks)||6
8840038|NCT01685801|9894300|FG002|COMPLETED|Cycle 1 Period 1 (2 Weeks)||7
8840039|NCT01685801|9894301|FG003|COMPLETED|Cycle 1 Period 1 (2 Weeks)||6
8840040|NCT01685801|9894298|FG000|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
8840041|NCT01685801|9894299|FG001|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
8840042|NCT01685801|9894300|FG002|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
8840043|NCT01685801|9894301|FG003|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
8840044|NCT01685801|9894298|FG000|STARTED|Cycle 1 Period 2 (2 Weeks)||5
8840045|NCT01685801|9894299|FG001|STARTED|Cycle 1 Period 2 (2 Weeks)||6
8840046|NCT01685801|9894300|FG002|STARTED|Cycle 1 Period 2 (2 Weeks)||7
8840047|NCT01685801|9894301|FG003|STARTED|Cycle 1 Period 2 (2 Weeks)||6
8840048|NCT01685801|9894298|FG000|COMPLETED|Cycle 1 Period 2 (2 Weeks)||5
8840049|NCT01685801|9894299|FG001|COMPLETED|Cycle 1 Period 2 (2 Weeks)||6
8840050|NCT01685801|9894300|FG002|COMPLETED|Cycle 1 Period 2 (2 Weeks)||7
8840051|NCT01685801|9894301|FG003|COMPLETED|Cycle 1 Period 2 (2 Weeks)||5
8840052|NCT01685801|9894298|FG000|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||0
8840053|NCT01685801|9894299|FG001|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||0
8840054|NCT01685801|9894300|FG002|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||0
8840055|NCT01685801|9894301|FG003|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||1
8840056|NCT01685801|9894298|FG000|STARTED|Washout Period 1 (4 Weeks)||5
8840057|NCT01685801|9894299|FG001|STARTED|Washout Period 1 (4 Weeks)||6
8840058|NCT01685801|9894300|FG002|STARTED|Washout Period 1 (4 Weeks)||7
8840059|NCT01685801|9894301|FG003|STARTED|Washout Period 1 (4 Weeks)||5
8840060|NCT01685801|9894298|FG000|COMPLETED|Washout Period 1 (4 Weeks)||5
8840061|NCT01685801|9894299|FG001|COMPLETED|Washout Period 1 (4 Weeks)||6
8840062|NCT01685801|9894300|FG002|COMPLETED|Washout Period 1 (4 Weeks)||7
8840063|NCT01685801|9894301|FG003|COMPLETED|Washout Period 1 (4 Weeks)||5
8840064|NCT01685801|9894298|FG000|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
8840065|NCT01685801|9894299|FG001|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
8840066|NCT01685801|9894300|FG002|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
8840067|NCT01685801|9894301|FG003|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
8840068|NCT01685801|9894298|FG000|STARTED|Cycle 2 Period 1 (2 Weeks)||5
8840069|NCT01685801|9894299|FG001|STARTED|Cycle 2 Period 1 (2 Weeks)||6
8840070|NCT01685801|9894300|FG002|STARTED|Cycle 2 Period 1 (2 Weeks)||7
8840071|NCT01685801|9894301|FG003|STARTED|Cycle 2 Period 1 (2 Weeks)||5
8840072|NCT01685801|9894298|FG000|COMPLETED|Cycle 2 Period 1 (2 Weeks)||5
8840073|NCT01685801|9894299|FG001|COMPLETED|Cycle 2 Period 1 (2 Weeks)||6
8840074|NCT01685801|9894300|FG002|COMPLETED|Cycle 2 Period 1 (2 Weeks)||7
8840075|NCT01685801|9894301|FG003|COMPLETED|Cycle 2 Period 1 (2 Weeks)||5
8840076|NCT01685801|9894298|FG000|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
8840077|NCT01685801|9894299|FG001|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
8840078|NCT01685801|9894300|FG002|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
8840079|NCT01685801|9894301|FG003|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
8840080|NCT01685801|9894298|FG000|STARTED|Cycle 2 Period 2 (2 Weeks)||5
8840081|NCT01685801|9894299|FG001|STARTED|Cycle 2 Period 2 (2 Weeks)||6
8840082|NCT01685801|9894300|FG002|STARTED|Cycle 2 Period 2 (2 Weeks)||7
8840083|NCT01685801|9894301|FG003|STARTED|Cycle 2 Period 2 (2 Weeks)||5
8840084|NCT01685801|9894298|FG000|COMPLETED|Cycle 2 Period 2 (2 Weeks)||5
8840085|NCT01685801|9894299|FG001|COMPLETED|Cycle 2 Period 2 (2 Weeks)||5
8840086|NCT01685801|9894300|FG002|COMPLETED|Cycle 2 Period 2 (2 Weeks)||7
8840087|NCT01685801|9894301|FG003|COMPLETED|Cycle 2 Period 2 (2 Weeks)||4
8840088|NCT01685801|9894298|FG000|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||0
8840089|NCT01685801|9894299|FG001|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||1
8840090|NCT01685801|9894300|FG002|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||0
8840091|NCT01685801|9894301|FG003|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||1
8840092|NCT01685801|9894298|FG000|STARTED|Washout Period 2 (4 Weeks)||5
8840093|NCT01685801|9894299|FG001|STARTED|Washout Period 2 (4 Weeks)||5
8840094|NCT01685801|9894300|FG002|STARTED|Washout Period 2 (4 Weeks)||7
8840095|NCT01685801|9894301|FG003|STARTED|Washout Period 2 (4 Weeks)||4
8840096|NCT01685801|9894298|FG000|COMPLETED|Washout Period 2 (4 Weeks)||5
8840097|NCT01685801|9894299|FG001|COMPLETED|Washout Period 2 (4 Weeks)||5
8840098|NCT01685801|9894300|FG002|COMPLETED|Washout Period 2 (4 Weeks)||7
8840099|NCT01685801|9894301|FG003|COMPLETED|Washout Period 2 (4 Weeks)||4
8840100|NCT01685801|9894298|FG000|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
8840101|NCT01685801|9894299|FG001|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
8840102|NCT01685801|9894300|FG002|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
8840103|NCT01685801|9894301|FG003|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
8840104|NCT01685801|9894298|FG000|STARTED|Open-label Period (8 Weeks)||5
8840105|NCT01685801|9894299|FG001|STARTED|Open-label Period (8 Weeks)||5
8840106|NCT01685801|9894300|FG002|STARTED|Open-label Period (8 Weeks)||7
8840107|NCT01685801|9894301|FG003|STARTED|Open-label Period (8 Weeks)||4
8840108|NCT01685801|9894298|FG000|COMPLETED|Open-label Period (8 Weeks)||5
8840109|NCT01685801|9894299|FG001|COMPLETED|Open-label Period (8 Weeks)||5
8840110|NCT01685801|9894300|FG002|COMPLETED|Open-label Period (8 Weeks)||7
8840111|NCT01685801|9894301|FG003|COMPLETED|Open-label Period (8 Weeks)||4
8840112|NCT01685801|9894298|FG000|NOT COMPLETED|Open-label Period (8 Weeks)||0
8840113|NCT01685801|9894299|FG001|NOT COMPLETED|Open-label Period (8 Weeks)||0
8840114|NCT01685801|9894300|FG002|NOT COMPLETED|Open-label Period (8 Weeks)||0
8840115|NCT01685801|9894301|FG003|NOT COMPLETED|Open-label Period (8 Weeks)||0
8850114|NCT01744860|9905337|FG000|STARTED|Overall Study||420
8850115|NCT01744860|9905337|FG000|COMPLETED|Overall Study||420
8850116|NCT01744860|9905337|FG000|NOT COMPLETED|Overall Study||0
8850117|NCT01744977|9905351|FG000|STARTED|Overall Study||120
8850118|NCT01744977|9905352|FG001|STARTED|Overall Study||120
8850119|NCT01744977|9905351|FG000|6 Month Completed|Overall Study||113
8850120|NCT01744977|9905352|FG001|6 Month Completed|Overall Study||115
8850121|NCT01744977|9905351|FG000|COMPLETED|Overall Study||109
8850122|NCT01744977|9905352|FG001|COMPLETED|Overall Study||115
8850123|NCT01744977|9905351|FG000|NOT COMPLETED|Overall Study||11
8850124|NCT01744977|9905352|FG001|NOT COMPLETED|Overall Study||5
8850125|NCT01745055|9905358|FG000|STARTED|Overall Study||12
8850126|NCT01745055|9905358|FG000|COMPLETED|Overall Study||12
8944653|NCT02397473|10006527|FG001|Received at Least One Dose of Study Drug|Treatment Phase||49
8944654|NCT02397473|10006526|FG000|COMPLETED|Treatment Phase||45
8944655|NCT02397473|10006527|FG001|COMPLETED|Treatment Phase||45
8944656|NCT02397473|10006526|FG000|NOT COMPLETED|Treatment Phase||12
8944657|NCT02397473|10006527|FG001|NOT COMPLETED|Treatment Phase||7
8944658|NCT02397473|10006526|FG000|STARTED|Post Treatment Follow-up Phase|Participants who discontinued treatment period had an option to enter post treatment phase.|50
8944659|NCT02397473|10006527|FG001|STARTED|Post Treatment Follow-up Phase||47
8944660|NCT02397473|10006526|FG000|COMPLETED|Post Treatment Follow-up Phase||47
8944661|NCT02397473|10006527|FG001|COMPLETED|Post Treatment Follow-up Phase||45
8944662|NCT02397473|10006526|FG000|NOT COMPLETED|Post Treatment Follow-up Phase||3
8944663|NCT02397473|10006527|FG001|NOT COMPLETED|Post Treatment Follow-up Phase||2
8944664|NCT02397564|10006536|FG000|STARTED|Overall Study||20
8944665|NCT02397564|10006536|FG000|COMPLETED|Overall Study||16
8944666|NCT02397564|10006536|FG000|NOT COMPLETED|Overall Study||4
8944667|NCT02397655|10006541|FG000|STARTED|Overall Study||12012
8944668|NCT02397655|10006541|FG000|COMPLETED|Overall Study||10711
8944669|NCT02397655|10006541|FG000|NOT COMPLETED|Overall Study||1301
8944670|NCT02397694|10006547|FG000|STARTED|Double-Blinded Phase||65
8944671|NCT02397694|10006548|FG001|STARTED|Double-Blinded Phase||33
8944672|NCT02397694|10006547|FG000|COMPLETED|Double-Blinded Phase||62
8944673|NCT02397694|10006548|FG001|COMPLETED|Double-Blinded Phase||30
8944674|NCT02397694|10006547|FG000|NOT COMPLETED|Double-Blinded Phase||3
8944675|NCT02397694|10006548|FG001|NOT COMPLETED|Double-Blinded Phase||3
8944676|NCT02397694|10006547|FG000|STARTED|Open Label Extension Phase||62
8944677|NCT02397694|10006548|FG001|STARTED|Open Label Extension Phase||30
8944678|NCT02397694|10006547|FG000|COMPLETED|Open Label Extension Phase||54
8944679|NCT02397694|10006548|FG001|COMPLETED|Open Label Extension Phase||29
8944680|NCT02397694|10006547|FG000|NOT COMPLETED|Open Label Extension Phase||8
8944681|NCT02397694|10006548|FG001|NOT COMPLETED|Open Label Extension Phase||1
8944682|NCT02397707|10006561|FG000|STARTED|Overall Study||14
8944683|NCT02397707|10006562|FG001|STARTED|Overall Study||10
8944684|NCT02397707|10006563|FG002|STARTED|Overall Study||9
8944685|NCT02397707|10006561|FG000|COMPLETED|Overall Study||14
8944686|NCT02397707|10006562|FG001|COMPLETED|Overall Study||10
8944687|NCT02397707|10006563|FG002|COMPLETED|Overall Study||9
8944688|NCT02397707|10006561|FG000|NOT COMPLETED|Overall Study||0
8944689|NCT02397707|10006562|FG001|NOT COMPLETED|Overall Study||0
8944690|NCT02397707|10006563|FG002|NOT COMPLETED|Overall Study||0
8944691|NCT02397785|10006574|FG000|STARTED|Overall Study||24
8944692|NCT02397785|10006575|FG001|STARTED|Overall Study||34
8944693|NCT02397785|10006574|FG000|COMPLETED|Overall Study||22
8944694|NCT02397785|10006575|FG001|COMPLETED|Overall Study||25
8944695|NCT02397785|10006574|FG000|NOT COMPLETED|Overall Study||2
8944696|NCT02397785|10006575|FG001|NOT COMPLETED|Overall Study||9
8944697|NCT02397837|10006583|FG000|STARTED|Overall Study||33
8944698|NCT02397837|10006584|FG001|STARTED|Overall Study||30
8944699|NCT02397837|10006583|FG000|COMPLETED|Overall Study||26
8944700|NCT02397837|10006584|FG001|COMPLETED|Overall Study||24
8850127|NCT01745055|9905358|FG000|NOT COMPLETED|Overall Study||0
8850128|NCT01745094|9905371|FG000|STARTED|Overall Study||35
8850129|NCT01745094|9905372|FG001|STARTED|Overall Study||37
8850130|NCT01745094|9905373|FG002|STARTED|Overall Study||58
8850131|NCT01745094|9905374|FG003|STARTED|Overall Study||93
8850132|NCT01745094|9905371|FG000|COMPLETED|Overall Study||30
8944701|NCT02397837|10006583|FG000|NOT COMPLETED|Overall Study||7
8944702|NCT02397837|10006584|FG001|NOT COMPLETED|Overall Study||6
8944703|NCT02397889|10006592|FG000|STARTED|Overall Study||15
8944704|NCT02397889|10006593|FG001|STARTED|Overall Study||15
8944705|NCT02397889|10006592|FG000|COMPLETED|Overall Study||14
8944706|NCT02397889|10006593|FG001|COMPLETED|Overall Study||15
8944707|NCT02397889|10006592|FG000|NOT COMPLETED|Overall Study||1
8944708|NCT02397889|10006593|FG001|NOT COMPLETED|Overall Study||0
8948746|NCT02432274|10011221|FG004|Underwent Run-in Period|Overall Study||0
8948747|NCT02432274|10011222|FG005|Underwent Run-in Period|Overall Study||0
8948748|NCT02432274|10011223|FG006|Underwent Run-in Period|Overall Study||0
8948749|NCT02432274|10011224|FG007|Underwent Run-in Period|Overall Study||0
8948750|NCT02432274|10011217|FG000|Treated (Safety Population)|Overall Study|2 participants assigned to lenvatinib17mg/m^2 actually received 11mg/m^2 (dose capped at 24 mg/day).|5
8948751|NCT02432274|10011218|FG001|Treated (Safety Population)|Overall Study|2 participants assigned to lenvatinib17mg/m^2 actually received 14mg/m^2 (dose capped at 24 mg/day).|11
8948752|NCT02432274|10011219|FG002|Treated (Safety Population)|Overall Study||7
8840116|NCT01685840|9894320|FG000|STARTED|Overall Study||448
8840117|NCT01685840|9894321|FG001|STARTED|Overall Study||446
8840118|NCT01685840|9894320|FG000|COMPLETED|Overall Study||119
8840119|NCT01685840|9894321|FG001|COMPLETED|Overall Study||114
8840120|NCT01685840|9894320|FG000|NOT COMPLETED|Overall Study||329
8840121|NCT01685840|9894321|FG001|NOT COMPLETED|Overall Study||332
8840122|NCT01685983|9894329|FG000|STARTED|Overall Study||82
8840123|NCT01685983|9894329|FG000|COMPLETED|Overall Study||0
8840124|NCT01685983|9894329|FG000|NOT COMPLETED|Overall Study||82
8840125|NCT01685996|9894335|FG000|STARTED|Overall Study||34
8840126|NCT01685996|9894336|FG001|STARTED|Overall Study||40
8840127|NCT01685996|9894335|FG000|COMPLETED|Overall Study||18
8840128|NCT01685996|9894336|FG001|COMPLETED|Overall Study||27
8840129|NCT01685996|9894335|FG000|NOT COMPLETED|Overall Study||16
8840130|NCT01685996|9894336|FG001|NOT COMPLETED|Overall Study||13
8840131|NCT01686152|9894345|FG000|STARTED|Overall Study||252
8840132|NCT01686152|9894346|FG001|STARTED|Overall Study||253
8840133|NCT01686152|9894347|FG002|STARTED|Overall Study||84
8840134|NCT01686152|9894345|FG000|COMPLETED|Overall Study||211
8840135|NCT01686152|9894346|FG001|COMPLETED|Overall Study||218
8840136|NCT01686152|9894347|FG002|COMPLETED|Overall Study||75
8840137|NCT01686152|9894345|FG000|NOT COMPLETED|Overall Study||41
8840138|NCT01686152|9894346|FG001|NOT COMPLETED|Overall Study||35
8840139|NCT01686152|9894347|FG002|NOT COMPLETED|Overall Study||9
8840140|NCT01686165|9894355|FG000|STARTED|Overall Study||5
8840141|NCT01686165|9894355|FG000|COMPLETED|Overall Study||5
8840142|NCT01686165|9894355|FG000|NOT COMPLETED|Overall Study||0
8840143|NCT01686373|9894361|FG000|STARTED|Overall Study||34
8840144|NCT01686373|9894362|FG001|STARTED|Overall Study||40
8840145|NCT01686373|9894361|FG000|Received 15 Treatment Sessions|Overall Study||33
8840146|NCT01686373|9894362|FG001|Received 15 Treatment Sessions|Overall Study||39
8840147|NCT01686373|9894361|FG000|COMPLETED|Overall Study||31
8840148|NCT01686373|9894362|FG001|COMPLETED|Overall Study||38
8840149|NCT01686373|9894361|FG000|NOT COMPLETED|Overall Study||3
8840150|NCT01686373|9894362|FG001|NOT COMPLETED|Overall Study||2
8840151|NCT01686438|9894371|FG000|STARTED|Overall Study||15
8840152|NCT01686438|9894372|FG001|STARTED|Overall Study||35
8840153|NCT01686438|9894373|FG002|STARTED|Overall Study||37
8840154|NCT01686438|9894371|FG000|2-Week Follow Up|Overall Study||12
8840155|NCT01686438|9894372|FG001|2-Week Follow Up|Overall Study||31
8840156|NCT01686438|9894373|FG002|2-Week Follow Up|Overall Study||27
8840157|NCT01686438|9894371|FG000|3-Month Follow Up|Overall Study||7
8840158|NCT01686438|9894372|FG001|3-Month Follow Up|Overall Study||21
8840159|NCT01686438|9894373|FG002|3-Month Follow Up|Overall Study||17
8840160|NCT01686438|9894371|FG000|6-Month Follow Up|Overall Study||7
8840161|NCT01686438|9894372|FG001|6-Month Follow Up|Overall Study||26
8840162|NCT01686438|9894373|FG002|6-Month Follow Up|Overall Study||24
8840163|NCT01686438|9894371|FG000|COMPLETED|Overall Study||7
8840164|NCT01686438|9894372|FG001|COMPLETED|Overall Study||26
8840165|NCT01686438|9894373|FG002|COMPLETED|Overall Study||24
8840166|NCT01686438|9894371|FG000|NOT COMPLETED|Overall Study||8
8840167|NCT01686438|9894372|FG001|NOT COMPLETED|Overall Study||9
8840168|NCT01686438|9894373|FG002|NOT COMPLETED|Overall Study||13
8840169|NCT01686451|9894385|FG000|STARTED|Overall Study||33
8840170|NCT01686451|9894386|FG001|STARTED|Overall Study||27
8840171|NCT01686451|9894385|FG000|COMPLETED|Overall Study||33
8840172|NCT01686451|9894386|FG001|COMPLETED|Overall Study||27
8840173|NCT01686451|9894385|FG000|NOT COMPLETED|Overall Study||0
8840174|NCT01686451|9894386|FG001|NOT COMPLETED|Overall Study||0
8840175|NCT01686503|9894398|FG000|STARTED|Overall Study||66
8840176|NCT01686503|9894399|FG001|STARTED|Overall Study||66
8840177|NCT01686503|9894400|FG002|STARTED|Overall Study||66
8840178|NCT01686503|9894401|FG003|STARTED|Overall Study||33
8840179|NCT01686503|9894398|FG000|COMPLETED|Overall Study||65
8840180|NCT01686503|9894399|FG001|COMPLETED|Overall Study||63
8840181|NCT01686503|9894400|FG002|COMPLETED|Overall Study||64
8840182|NCT01686503|9894401|FG003|COMPLETED|Overall Study||32
8840183|NCT01686503|9894398|FG000|NOT COMPLETED|Overall Study||1
8840184|NCT01686503|9894399|FG001|NOT COMPLETED|Overall Study||3
8840185|NCT01686503|9894400|FG002|NOT COMPLETED|Overall Study||2
8840186|NCT01686503|9894401|FG003|NOT COMPLETED|Overall Study||1
8840187|NCT01686568|9894413|FG000|STARTED|Main Study||16
8840188|NCT01686568|9894414|FG001|STARTED|Main Study||15
8840189|NCT01686568|9894413|FG000|COMPLETED|Main Study||14
8840190|NCT01686568|9894414|FG001|COMPLETED|Main Study||11
8840191|NCT01686568|9894413|FG000|NOT COMPLETED|Main Study||2
8840192|NCT01686568|9894414|FG001|NOT COMPLETED|Main Study||4
8840193|NCT01686568|9894413|FG000|STARTED|Sub-Study||14
8840194|NCT01686568|9894414|FG001|STARTED|Sub-Study||11
8840195|NCT01686568|9894413|FG000|COMPLETED|Sub-Study||12
8840196|NCT01686568|9894414|FG001|COMPLETED|Sub-Study||9
8840197|NCT01686568|9894413|FG000|NOT COMPLETED|Sub-Study||2
8840198|NCT01686568|9894414|FG001|NOT COMPLETED|Sub-Study||2
8840199|NCT01686581|9894420|FG000|STARTED|Overall Study||641
8840200|NCT01686581|9894420|FG000|Safety Analysis Set; Received Study Drug|Overall Study||633
8840201|NCT01686581|9894420|FG000|Completed 24 Months|Overall Study||128
8840202|NCT01686581|9894420|FG000|COMPLETED|Overall Study||464
8840203|NCT01686581|9894420|FG000|NOT COMPLETED|Overall Study||177
8840204|NCT01686633|9894427|FG000|STARTED|Overall Study||347
8840205|NCT01686633|9894428|FG001|STARTED|Overall Study||346
8840206|NCT01686633|9894429|FG002|STARTED|Overall Study||346
8840207|NCT01686633|9894427|FG000|COMPLETED|Overall Study||296
8840208|NCT01686633|9894428|FG001|COMPLETED|Overall Study||314
8840209|NCT01686633|9894429|FG002|COMPLETED|Overall Study||321
8840210|NCT01686633|9894427|FG000|NOT COMPLETED|Overall Study||51
8840211|NCT01686633|9894428|FG001|NOT COMPLETED|Overall Study||32
8840212|NCT01686633|9894429|FG002|NOT COMPLETED|Overall Study||25
8840213|NCT01686646|9894441|FG000|STARTED|Overall Study||45
8840214|NCT01686646|9894442|FG001|STARTED|Overall Study||45
8840215|NCT01686646|9894443|FG002|STARTED|Overall Study||75
8840216|NCT01686646|9894444|FG003|STARTED|Overall Study||75
8840217|NCT01686646|9894441|FG000|Intent to Treat Population|Overall Study||45
8840218|NCT01686646|9894442|FG001|Intent to Treat Population|Overall Study||45
8840219|NCT01686646|9894443|FG002|Intent to Treat Population|Overall Study||75
8840220|NCT01686646|9894444|FG003|Intent to Treat Population|Overall Study||75
8840221|NCT01686646|9894441|FG000|Safety Population|Overall Study|One subject randomized to Paracetamol+Caffeine (500/65) group but received 1000/130 combination.|46
8840222|NCT01686646|9894442|FG001|Safety Population|Overall Study||45
8840223|NCT01686646|9894443|FG002|Safety Population|Overall Study||74
8840224|NCT01686646|9894444|FG003|Safety Population|Overall Study||75
8840225|NCT01686646|9894441|FG000|COMPLETED|Overall Study||45
8840226|NCT01686646|9894442|FG001|COMPLETED|Overall Study||45
8840227|NCT01686646|9894443|FG002|COMPLETED|Overall Study||75
8840228|NCT01686646|9894444|FG003|COMPLETED|Overall Study||75
8840229|NCT01686646|9894441|FG000|NOT COMPLETED|Overall Study||0
8840230|NCT01686646|9894442|FG001|NOT COMPLETED|Overall Study||0
8840231|NCT01686646|9894443|FG002|NOT COMPLETED|Overall Study||0
8840232|NCT01686646|9894444|FG003|NOT COMPLETED|Overall Study||0
8840233|NCT01686750|9894456|FG000|STARTED|Overall Study||11001
8840234|NCT01686750|9894457|FG001|STARTED|Overall Study||10725
8840235|NCT01686750|9894456|FG000|COMPLETED|Overall Study||11001
8840236|NCT01686750|9894457|FG001|COMPLETED|Overall Study||10725
8840237|NCT01686750|9894456|FG000|NOT COMPLETED|Overall Study||0
8840238|NCT01686750|9894457|FG001|NOT COMPLETED|Overall Study||0
8840239|NCT01686828|9894469|FG000|STARTED|Overall Study||13
8840240|NCT01686828|9894470|FG001|STARTED|Overall Study||14
8840241|NCT01686828|9894471|FG002|STARTED|Overall Study||13
8840242|NCT01686828|9894472|FG003|STARTED|Overall Study||13
8840243|NCT01686828|9894469|FG000|COMPLETED|Overall Study||12
8840244|NCT01686828|9894470|FG001|COMPLETED|Overall Study||13
8840245|NCT01686828|9894471|FG002|COMPLETED|Overall Study||12
8840246|NCT01686828|9894472|FG003|COMPLETED|Overall Study||13
8840247|NCT01686828|9894469|FG000|NOT COMPLETED|Overall Study||1
8840248|NCT01686828|9894470|FG001|NOT COMPLETED|Overall Study||1
8840249|NCT01686828|9894471|FG002|NOT COMPLETED|Overall Study||1
8840250|NCT01686828|9894472|FG003|NOT COMPLETED|Overall Study||0
8840251|NCT01686932|9894488|FG000|STARTED|Period 1||25
8840252|NCT01686932|9894489|FG001|STARTED|Period 1||26
8840253|NCT01686932|9894488|FG000|COMPLETED|Period 1||24
8840254|NCT01686932|9894489|FG001|COMPLETED|Period 1||25
8840255|NCT01686932|9894488|FG000|NOT COMPLETED|Period 1||1
8840256|NCT01686932|9894489|FG001|NOT COMPLETED|Period 1||1
8840257|NCT01686932|9894488|FG000|STARTED|Period 2||24
8840258|NCT01686932|9894489|FG001|STARTED|Period 2||25
8840259|NCT01686932|9894488|FG000|COMPLETED|Period 2||24
8840260|NCT01686932|9894489|FG001|COMPLETED|Period 2||25
8840261|NCT01686932|9894488|FG000|NOT COMPLETED|Period 2||0
8840262|NCT01686932|9894489|FG001|NOT COMPLETED|Period 2||0
8840263|NCT01686958|9894495|FG000|STARTED|Overall Study||30
8840264|NCT01686958|9894495|FG000|COMPLETED|Overall Study|No. of patients who completed ALL assessments at 12 months post treatment; 1 pt only had PSA test.|29
8840265|NCT01686958|9894495|FG000|NOT COMPLETED|Overall Study||1
8840266|NCT01687036|9894500|FG000|STARTED|Overall Study||10
8840267|NCT01687036|9894500|FG000|COMPLETED|Overall Study||10
8840268|NCT01687036|9894500|FG000|NOT COMPLETED|Overall Study||0
8840269|NCT01687088|9894506|FG000|STARTED|Overall Study||50
8840270|NCT01687088|9894507|FG001|STARTED|Overall Study||50
8840271|NCT01687088|9894506|FG000|COMPLETED|Overall Study||50
8840272|NCT01687088|9894507|FG001|COMPLETED|Overall Study||50
8840273|NCT01687088|9894506|FG000|NOT COMPLETED|Overall Study||0
8840274|NCT01687088|9894507|FG001|NOT COMPLETED|Overall Study||0
8840275|NCT01687101|9894513|FG000|STARTED|Overall Study||32
8840276|NCT01687101|9894513|FG000|COMPLETED|Overall Study||25
8840277|NCT01687101|9894513|FG000|NOT COMPLETED|Overall Study||7
8840278|NCT01687114|9894517|FG000|STARTED|Overall Study||5
8840279|NCT01687114|9894517|FG000|COMPLETED|Overall Study||5
8840280|NCT01687114|9894517|FG000|NOT COMPLETED|Overall Study||0
8840281|NCT01687166|9894525|FG000|STARTED|Overall Study||167
8840282|NCT01687166|9894526|FG001|STARTED|Overall Study||172
8840283|NCT01687166|9894527|FG002|STARTED|Overall Study||56
8840284|NCT01687166|9894528|FG003|STARTED|Overall Study||3
8840285|NCT01687166|9894525|FG000|COMPLETED|Overall Study||139
8840286|NCT01687166|9894526|FG001|COMPLETED|Overall Study||145
8840287|NCT01687166|9894527|FG002|COMPLETED|Overall Study||42
8840288|NCT01687166|9894528|FG003|COMPLETED|Overall Study||1
8840289|NCT01687166|9894525|FG000|NOT COMPLETED|Overall Study||28
8840290|NCT01687166|9894526|FG001|NOT COMPLETED|Overall Study||27
8840291|NCT01687166|9894527|FG002|NOT COMPLETED|Overall Study||14
8840292|NCT01687166|9894528|FG003|NOT COMPLETED|Overall Study||2
8840293|NCT01687179|9894536|FG000|STARTED|Overall Study||3
8840294|NCT01687179|9894537|FG001|STARTED|Overall Study||10
8840295|NCT01687179|9894536|FG000|COMPLETED|Overall Study||2
8840296|NCT01687179|9894537|FG001|COMPLETED|Overall Study||6
8840297|NCT01687179|9894536|FG000|NOT COMPLETED|Overall Study||1
8840298|NCT01687179|9894537|FG001|NOT COMPLETED|Overall Study||4
8840299|NCT01687218|9894549|FG000|STARTED|Overall Study||33
8840300|NCT01687218|9894550|FG001|STARTED|Overall Study||32
8840301|NCT01687218|9894551|FG002|STARTED|Overall Study||31
8840302|NCT01687218|9894552|FG003|STARTED|Overall Study||34
8840303|NCT01687218|9894553|FG004|STARTED|Overall Study||33
8840304|NCT01687218|9894554|FG005|STARTED|Overall Study||32
8840305|NCT01687218|9894549|FG000|COMPLETED|Overall Study||30
8840306|NCT01687218|9894550|FG001|COMPLETED|Overall Study||29
8840307|NCT01687218|9894551|FG002|COMPLETED|Overall Study||30
8840308|NCT01687218|9894552|FG003|COMPLETED|Overall Study||32
8840309|NCT01687218|9894553|FG004|COMPLETED|Overall Study||32
8840310|NCT01687218|9894554|FG005|COMPLETED|Overall Study||32
8840311|NCT01687218|9894549|FG000|NOT COMPLETED|Overall Study||3
8840312|NCT01687218|9894550|FG001|NOT COMPLETED|Overall Study||3
8840313|NCT01687218|9894551|FG002|NOT COMPLETED|Overall Study||1
8840314|NCT01687218|9894552|FG003|NOT COMPLETED|Overall Study||2
8840315|NCT01687218|9894553|FG004|NOT COMPLETED|Overall Study||1
8840316|NCT01687218|9894554|FG005|NOT COMPLETED|Overall Study||0
8840317|NCT01687244|9894564|FG000|STARTED|Overall Study||21
8840318|NCT01687244|9894565|FG001|STARTED|Overall Study||19
8840319|NCT01687244|9894564|FG000|COMPLETED|Overall Study||21
8840320|NCT01687244|9894565|FG001|COMPLETED|Overall Study||19
8840321|NCT01687244|9894564|FG000|NOT COMPLETED|Overall Study||0
8840322|NCT01687244|9894565|FG001|NOT COMPLETED|Overall Study||0
8840323|NCT01687257|9894581|FG000|STARTED|Overall Study||25
8840324|NCT01687257|9894582|FG001|STARTED|Overall Study||4
8840325|NCT01687257|9894583|FG002|STARTED|Overall Study||21
8840326|NCT01687257|9894581|FG000|COMPLETED|Overall Study||17
8840327|NCT01687257|9894582|FG001|COMPLETED|Overall Study||0
8840328|NCT01687257|9894583|FG002|COMPLETED|Overall Study||15
8840329|NCT01687257|9894581|FG000|NOT COMPLETED|Overall Study||8
8840330|NCT01687257|9894582|FG001|NOT COMPLETED|Overall Study||4
8840331|NCT01687257|9894583|FG002|NOT COMPLETED|Overall Study||6
8840332|NCT01687270|9894597|FG000|STARTED|Overall Study||40
8840333|NCT01687270|9894597|FG000|COMPLETED|Overall Study||28
8840334|NCT01687270|9894597|FG000|NOT COMPLETED|Overall Study||12
8840335|NCT01687283|9894603|FG000|STARTED|Overall Study||158
8840336|NCT01687283|9894604|FG001|STARTED|Overall Study||157
8840337|NCT01687283|9894603|FG000|COMPLETED|Overall Study||123
8840338|NCT01687283|9894604|FG001|COMPLETED|Overall Study||130
8840339|NCT01687283|9894603|FG000|NOT COMPLETED|Overall Study||35
8840340|NCT01687283|9894604|FG001|NOT COMPLETED|Overall Study||27
8840341|NCT01687296|9894612|FG000|STARTED|Overall Study||123
8840342|NCT01687296|9894613|FG001|STARTED|Overall Study||128
8840343|NCT01687296|9894612|FG000|COMPLETED|Overall Study||116
8840344|NCT01687296|9894613|FG001|COMPLETED|Overall Study||123
8840345|NCT01687296|9894612|FG000|NOT COMPLETED|Overall Study||7
8840346|NCT01687296|9894613|FG001|NOT COMPLETED|Overall Study||5
8840347|NCT01687387|9894622|FG000|STARTED|Overall Study||51
8840348|NCT01687387|9894623|FG001|STARTED|Overall Study||50
8840349|NCT01687387|9894624|FG002|STARTED|Overall Study||51
8840350|NCT01687387|9894622|FG000|COMPLETED|Overall Study||10
8840351|NCT01687387|9894623|FG001|COMPLETED|Overall Study||12
8840352|NCT01687387|9894624|FG002|COMPLETED|Overall Study||13
8840353|NCT01687387|9894622|FG000|NOT COMPLETED|Overall Study||41
8840354|NCT01687387|9894623|FG001|NOT COMPLETED|Overall Study||38
8840355|NCT01687387|9894624|FG002|NOT COMPLETED|Overall Study||38
8840356|NCT01687400|9894632|FG000|STARTED|Overall Study||114
8840357|NCT01687400|9894632|FG000|COMPLETED|Overall Study||114
8840358|NCT01687400|9894632|FG000|NOT COMPLETED|Overall Study||0
8840359|NCT01687413|9894643|FG000|STARTED|Overall Study||27
8840360|NCT01687413|9894644|FG001|STARTED|Overall Study||15
8840361|NCT01687413|9894643|FG000|COMPLETED|Overall Study||26
8840362|NCT01687413|9894644|FG001|COMPLETED|Overall Study||11
8840363|NCT01687413|9894643|FG000|NOT COMPLETED|Overall Study||1
8840364|NCT01687413|9894644|FG001|NOT COMPLETED|Overall Study||4
8840365|NCT01687478|9894670|FG000|STARTED|Overall Study||88
8840366|NCT01687478|9894671|FG001|STARTED|Overall Study||88
8840367|NCT01687478|9894670|FG000|Safety Analysis Set|Overall Study||88
8840368|NCT01687478|9894671|FG001|Safety Analysis Set|Overall Study||87
8840369|NCT01687478|9894670|FG000|COMPLETED|Overall Study||56
8840370|NCT01687478|9894671|FG001|COMPLETED|Overall Study||49
8840371|NCT01687478|9894670|FG000|NOT COMPLETED|Overall Study||32
8840372|NCT01687478|9894671|FG001|NOT COMPLETED|Overall Study||39
8840373|NCT01687595|9894679|FG000|STARTED|Overall Study||70
8840374|NCT01687595|9894680|FG001|STARTED|Overall Study||10
8840375|NCT01687595|9894679|FG000|Received at Least 1 Dose of Study Drug|Overall Study||70
8840376|NCT01687595|9894680|FG001|Received at Least 1 Dose of Study Drug|Overall Study||10
8840377|NCT01687595|9894679|FG000|COMPLETED|Overall Study||0
8840378|NCT01687595|9894680|FG001|COMPLETED|Overall Study||0
8840379|NCT01687595|9894679|FG000|NOT COMPLETED|Overall Study||70
8840380|NCT01687595|9894680|FG001|NOT COMPLETED|Overall Study||10
8840381|NCT01687673|9894686|FG000|STARTED|Overall Study||29
8840382|NCT01687673|9894686|FG000|COMPLETED|Overall Study||28
8840383|NCT01687673|9894686|FG000|NOT COMPLETED|Overall Study||1
8840384|NCT01687712|9894692|FG000|STARTED|Cycle 1||549
8840385|NCT01687712|9894693|FG001|STARTED|Cycle 1||551
8840386|NCT01687712|9894692|FG000|Received hCG|Cycle 1||516
8840387|NCT01687712|9894693|FG001|Received hCG|Cycle 1||520
8840388|NCT01687712|9894692|FG000|Oocyte/Ovum Pick Up|Cycle 1||513
8840389|NCT01687712|9894693|FG001|Oocyte/Ovum Pick Up|Cycle 1||517
8840390|NCT01687712|9894692|FG000|Fertilization Performed|Cycle 1||508
8840391|NCT01687712|9894693|FG001|Fertilization Performed|Cycle 1||512
8840392|NCT01687712|9894692|FG000|Embryo Transfer|Cycle 1||466
8840393|NCT01687712|9894693|FG001|Embryo Transfer|Cycle 1||483
8840394|NCT01687712|9894692|FG000|Biochemical Pregnancy|Cycle 1||163
8840395|NCT01687712|9894693|FG001|Biochemical Pregnancy|Cycle 1||203
8840396|NCT01687712|9894692|FG000|Clinical Pregnancy|Cycle 1||114
8840397|NCT01687712|9894693|FG001|Clinical Pregnancy|Cycle 1||138
8840398|NCT01687712|9894692|FG000|COMPLETED|Cycle 1||101
8840399|NCT01687712|9894693|FG001|COMPLETED|Cycle 1||122
8840400|NCT01687712|9894692|FG000|NOT COMPLETED|Cycle 1||448
8840401|NCT01687712|9894693|FG001|NOT COMPLETED|Cycle 1||429
8840402|NCT01687712|9894692|FG000|STARTED|Cycle 2||109
8840403|NCT01687712|9894693|FG001|STARTED|Cycle 2||120
8840404|NCT01687712|9894692|FG000|Received hCG|Cycle 2||107
8840405|NCT01687712|9894693|FG001|Received hCG|Cycle 2||119
8840406|NCT01687712|9894692|FG000|Oocyte/Ovum Pick Up|Cycle 2||107
8840407|NCT01687712|9894693|FG001|Oocyte/Ovum Pick Up|Cycle 2||119
8840408|NCT01687712|9894692|FG000|Fertilization Performed|Cycle 2||106
8840409|NCT01687712|9894693|FG001|Fertilization Performed|Cycle 2||119
8840410|NCT01687712|9894692|FG000|Embryo Transfer|Cycle 2||101
8840411|NCT01687712|9894693|FG001|Embryo Transfer|Cycle 2||117
8840412|NCT01687712|9894692|FG000|Biochemical Pregnancy|Cycle 2||35
8840413|NCT01687712|9894693|FG001|Biochemical Pregnancy|Cycle 2||43
8840414|NCT01687712|9894692|FG000|Clinical Pregnancy|Cycle 2||17
8840415|NCT01687712|9894693|FG001|Clinical Pregnancy|Cycle 2||26
8840416|NCT01687712|9894692|FG000|COMPLETED|Cycle 2||16
8840417|NCT01687712|9894693|FG001|COMPLETED|Cycle 2||25
8840418|NCT01687712|9894692|FG000|NOT COMPLETED|Cycle 2||93
8840419|NCT01687712|9894693|FG001|NOT COMPLETED|Cycle 2||95
8840420|NCT01687712|9894692|FG000|STARTED|Cycle 3||28
8840421|NCT01687712|9894693|FG001|STARTED|Cycle 3||24
8840422|NCT01687712|9894692|FG000|Received hCG|Cycle 3||27
8840423|NCT01687712|9894693|FG001|Received hCG|Cycle 3||24
8840424|NCT01687712|9894692|FG000|Ooctye/Ovum Pick-Up|Cycle 3||27
8840425|NCT01687712|9894693|FG001|Ooctye/Ovum Pick-Up|Cycle 3||24
8840426|NCT01687712|9894692|FG000|Fertilization Performed|Cycle 3||27
8840427|NCT01687712|9894693|FG001|Fertilization Performed|Cycle 3||24
8840428|NCT01687712|9894692|FG000|Embryo Transfer|Cycle 3||26
8840429|NCT01687712|9894693|FG001|Embryo Transfer|Cycle 3||24
8840430|NCT01687712|9894692|FG000|Biochemically Pregnant|Cycle 3||7
8840431|NCT01687712|9894693|FG001|Biochemically Pregnant|Cycle 3||2
8840432|NCT01687712|9894692|FG000|Clinical Pregnancy|Cycle 3||5
8840433|NCT01687712|9894693|FG001|Clinical Pregnancy|Cycle 3||0
8840434|NCT01687712|9894692|FG000|COMPLETED|Cycle 3||4
8840435|NCT01687712|9894693|FG001|COMPLETED|Cycle 3||0
8840436|NCT01687712|9894692|FG000|NOT COMPLETED|Cycle 3||24
8840437|NCT01687712|9894693|FG001|NOT COMPLETED|Cycle 3||24
8840438|NCT01687790|9894703|FG000|STARTED|Overall Study||60
8840439|NCT01687790|9894703|FG000|COMPLETED|Overall Study||60
8840440|NCT01687790|9894703|FG000|NOT COMPLETED|Overall Study||0
8840441|NCT01687972|9894710|FG000|STARTED|Overall Study||44
8840442|NCT01687972|9894711|FG001|STARTED|Overall Study||44
8840443|NCT01687972|9894710|FG000|COMPLETED|Overall Study||44
8840444|NCT01687972|9894711|FG001|COMPLETED|Overall Study||44
8840445|NCT01687972|9894710|FG000|NOT COMPLETED|Overall Study||0
8840446|NCT01687972|9894711|FG001|NOT COMPLETED|Overall Study||0
8840447|NCT01687998|9894719|FG000|STARTED|Overall Study||6038
8840448|NCT01687998|9894720|FG001|STARTED|Overall Study||6054
8840449|NCT01687998|9894719|FG000|Received at Least One Dose of Study Drug|Overall Study||6036
8840450|NCT01687998|9894720|FG001|Received at Least One Dose of Study Drug|Overall Study||6052
8840451|NCT01687998|9894719|FG000|COMPLETED|Overall Study||5926
8840452|NCT01687998|9894720|FG001|COMPLETED|Overall Study||5934
8840453|NCT01687998|9894719|FG000|NOT COMPLETED|Overall Study||112
8840454|NCT01687998|9894720|FG001|NOT COMPLETED|Overall Study||120
8840455|NCT01688037|9894729|FG000|STARTED|Double-Blind Period (Week 0 to 6)||54
8840456|NCT01688037|9894730|FG001|STARTED|Double-Blind Period (Week 0 to 6)||28
8840457|NCT01688037|9894731|FG002|STARTED|Double-Blind Period (Week 0 to 6)||27
8840458|NCT01688037|9894729|FG000|COMPLETED|Double-Blind Period (Week 0 to 6)||47
8840459|NCT01688037|9894730|FG001|COMPLETED|Double-Blind Period (Week 0 to 6)||25
8840460|NCT01688037|9894731|FG002|COMPLETED|Double-Blind Period (Week 0 to 6)||21
8840461|NCT01688037|9894729|FG000|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||7
8840462|NCT01688037|9894730|FG001|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||3
8840463|NCT01688037|9894731|FG002|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||6
8840464|NCT01688037|9894729|FG000|STARTED|Open-Label Period (Week 6 to 12)||47
8840465|NCT01688037|9894730|FG001|STARTED|Open-Label Period (Week 6 to 12)||25
8840466|NCT01688037|9894731|FG002|STARTED|Open-Label Period (Week 6 to 12)||21
8840467|NCT01688037|9894729|FG000|COMPLETED|Open-Label Period (Week 6 to 12)||42
8840468|NCT01688037|9894730|FG001|COMPLETED|Open-Label Period (Week 6 to 12)||22
8840469|NCT01688037|9894731|FG002|COMPLETED|Open-Label Period (Week 6 to 12)||17
8623107|NCT00491556|9662330|FG000|COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||25
8623108|NCT00491556|9662331|FG001|COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||22
8623109|NCT00491556|9662330|FG000|NOT COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||24
8623110|NCT00491556|9662331|FG001|NOT COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||5
8840470|NCT01688037|9894729|FG000|NOT COMPLETED|Open-Label Period (Week 6 to 12)||5
8840471|NCT01688037|9894730|FG001|NOT COMPLETED|Open-Label Period (Week 6 to 12)||3
8840472|NCT01688037|9894731|FG002|NOT COMPLETED|Open-Label Period (Week 6 to 12)||4
8840473|NCT01688037|9894729|FG000|STARTED|Follow-up Period (Week 12 to 16)||42
8840474|NCT01688037|9894730|FG001|STARTED|Follow-up Period (Week 12 to 16)||22
8840475|NCT01688037|9894731|FG002|STARTED|Follow-up Period (Week 12 to 16)||17
8840476|NCT01688037|9894729|FG000|COMPLETED|Follow-up Period (Week 12 to 16)||42
8840477|NCT01688037|9894730|FG001|COMPLETED|Follow-up Period (Week 12 to 16)||21
8840478|NCT01688037|9894731|FG002|COMPLETED|Follow-up Period (Week 12 to 16)||17
8840479|NCT01688037|9894729|FG000|NOT COMPLETED|Follow-up Period (Week 12 to 16)||0
8840480|NCT01688037|9894730|FG001|NOT COMPLETED|Follow-up Period (Week 12 to 16)||1
8840481|NCT01688037|9894731|FG002|NOT COMPLETED|Follow-up Period (Week 12 to 16)||0
8840482|NCT01688050|9894743|FG000|STARTED|Overall Study||50
8840483|NCT01688050|9894743|FG000|5-Year|Overall Study|Patients eligible for Follow-up at 5 year|22
8840484|NCT01688050|9894743|FG000|COMPLETED|Overall Study||19
8840485|NCT01688050|9894743|FG000|NOT COMPLETED|Overall Study||31
8840486|NCT01688102|9894749|FG000|STARTED|Overall Study||60
8840487|NCT01688102|9894750|FG001|STARTED|Overall Study||58
8840488|NCT01688102|9894749|FG000|COMPLETED|Overall Study||44
8840489|NCT01688102|9894750|FG001|COMPLETED|Overall Study||40
8840490|NCT01688102|9894749|FG000|NOT COMPLETED|Overall Study||16
8840491|NCT01688102|9894750|FG001|NOT COMPLETED|Overall Study||18
8840492|NCT01688141|9894758|FG000|STARTED|Overall Study||11706
8840493|NCT01688141|9894759|FG001|STARTED|Overall Study||11651
8840494|NCT01688141|9894758|FG000|COMPLETED|Overall Study||11706
8840495|NCT01688141|9894759|FG001|COMPLETED|Overall Study||11651
8840496|NCT01688141|9894758|FG000|NOT COMPLETED|Overall Study||0
8840497|NCT01688141|9894759|FG001|NOT COMPLETED|Overall Study||0
8840498|NCT01688310|9894767|FG000|STARTED|Overall Study||100
8840499|NCT01688310|9894768|FG001|STARTED|Overall Study||100
8840500|NCT01688310|9894767|FG000|COMPLETED|Overall Study||100
8840501|NCT01688310|9894768|FG001|COMPLETED|Overall Study||100
8840502|NCT01688310|9894767|FG000|NOT COMPLETED|Overall Study||0
8840503|NCT01688310|9894768|FG001|NOT COMPLETED|Overall Study||0
8840504|NCT01688336|9894776|FG000|STARTED|Overall Study||9
8840505|NCT01688336|9894776|FG000|COMPLETED|Overall Study||9
8840506|NCT01688336|9894776|FG000|NOT COMPLETED|Overall Study||0
8840507|NCT01688466|9894783|FG000|STARTED|Overall Study||17
8840508|NCT01688466|9894784|FG001|STARTED|Overall Study||17
8840509|NCT01688466|9894783|FG000|COMPLETED|Overall Study||15
8840510|NCT01688466|9894784|FG001|COMPLETED|Overall Study||10
8840511|NCT01688466|9894783|FG000|NOT COMPLETED|Overall Study||2
8840512|NCT01688466|9894784|FG001|NOT COMPLETED|Overall Study||7
8840513|NCT01688596|9894792|FG000|STARTED|Overall Study||67
8840514|NCT01688596|9894793|FG001|STARTED|Overall Study||68
8840515|NCT01688596|9894792|FG000|COMPLETED|Overall Study||59
8840516|NCT01688596|9894793|FG001|COMPLETED|Overall Study||59
8840517|NCT01688596|9894792|FG000|NOT COMPLETED|Overall Study||8
8840518|NCT01688596|9894793|FG001|NOT COMPLETED|Overall Study||9
8840519|NCT01688609|9894799|FG000|STARTED|Overall Study||18
8840520|NCT01688609|9894799|FG000|COMPLETED|Overall Study||18
8840521|NCT01688609|9894799|FG000|NOT COMPLETED|Overall Study||0
8840522|NCT01688635|9894803|FG000|STARTED|Period 1||45
8840523|NCT01688635|9894804|FG001|STARTED|Period 1||46
8840524|NCT01688635|9894803|FG000|Received at Least 1 Dose of Study Drug|Period 1||45
8840525|NCT01688635|9894804|FG001|Received at Least 1 Dose of Study Drug|Period 1||46
8840526|NCT01688635|9894803|FG000|COMPLETED|Period 1||45
8840527|NCT01688635|9894804|FG001|COMPLETED|Period 1||46
8840528|NCT01688635|9894803|FG000|NOT COMPLETED|Period 1||0
8840529|NCT01688635|9894804|FG001|NOT COMPLETED|Period 1||0
8840530|NCT01688635|9894803|FG000|STARTED|Washout 1||45
8840531|NCT01688635|9894804|FG001|STARTED|Washout 1||46
8840532|NCT01688635|9894803|FG000|COMPLETED|Washout 1||44
8840533|NCT01688635|9894804|FG001|COMPLETED|Washout 1||44
8840534|NCT01688635|9894803|FG000|NOT COMPLETED|Washout 1||1
8840535|NCT01688635|9894804|FG001|NOT COMPLETED|Washout 1||2
8840536|NCT01688635|9894803|FG000|STARTED|Period 2||44
8840537|NCT01688635|9894804|FG001|STARTED|Period 2||44
8840538|NCT01688635|9894803|FG000|COMPLETED|Period 2||44
8840539|NCT01688635|9894804|FG001|COMPLETED|Period 2||44
8840540|NCT01688635|9894803|FG000|NOT COMPLETED|Period 2||0
8840541|NCT01688635|9894804|FG001|NOT COMPLETED|Period 2||0
8840542|NCT01688635|9894803|FG000|STARTED|Washout 2||44
8840543|NCT01688635|9894804|FG001|STARTED|Washout 2||44
8840544|NCT01688635|9894803|FG000|COMPLETED|Washout 2||41
8840545|NCT01688635|9894804|FG001|COMPLETED|Washout 2||42
8840546|NCT01688635|9894803|FG000|NOT COMPLETED|Washout 2||3
8840547|NCT01688635|9894804|FG001|NOT COMPLETED|Washout 2||2
8840548|NCT01688635|9894803|FG000|STARTED|Period 3||41
8840549|NCT01688635|9894804|FG001|STARTED|Period 3||42
8840550|NCT01688635|9894803|FG000|COMPLETED|Period 3||41
8840551|NCT01688635|9894804|FG001|COMPLETED|Period 3||42
8840552|NCT01688635|9894803|FG000|NOT COMPLETED|Period 3||0
8840553|NCT01688635|9894804|FG001|NOT COMPLETED|Period 3||0
8840554|NCT01688635|9894803|FG000|STARTED|Washout 3||41
8840555|NCT01688635|9894804|FG001|STARTED|Washout 3||42
8840556|NCT01688635|9894803|FG000|COMPLETED|Washout 3||40
8840557|NCT01688635|9894804|FG001|COMPLETED|Washout 3||42
8840558|NCT01688635|9894803|FG000|NOT COMPLETED|Washout 3||1
8840559|NCT01688635|9894804|FG001|NOT COMPLETED|Washout 3||0
8840560|NCT01688635|9894803|FG000|STARTED|Period 4||40
8840561|NCT01688635|9894804|FG001|STARTED|Period 4||42
8840562|NCT01688635|9894803|FG000|COMPLETED|Period 4||40
8840563|NCT01688635|9894804|FG001|COMPLETED|Period 4||42
8840564|NCT01688635|9894803|FG000|NOT COMPLETED|Period 4||0
8840565|NCT01688635|9894804|FG001|NOT COMPLETED|Period 4||0
8840566|NCT01688726|9894813|FG000|STARTED|Overall Study||46
8840567|NCT01688726|9894814|FG001|STARTED|Overall Study||45
8840568|NCT01688726|9894813|FG000|COMPLETED|Overall Study||45
8840569|NCT01688726|9894814|FG001|COMPLETED|Overall Study||44
8840570|NCT01688726|9894813|FG000|NOT COMPLETED|Overall Study||1
8840571|NCT01688726|9894814|FG001|NOT COMPLETED|Overall Study||1
8840572|NCT01688739|9894834|FG000|STARTED|Overall Study||13
8840573|NCT01688739|9894835|FG001|STARTED|Overall Study||3
8840574|NCT01688739|9894836|FG002|STARTED|Overall Study||3
8840575|NCT01688739|9894837|FG003|STARTED|Overall Study||6
8840576|NCT01688739|9894838|FG004|STARTED|Overall Study||6
8840577|NCT01688739|9894839|FG005|STARTED|Overall Study||6
8840578|NCT01688739|9894840|FG006|STARTED|Overall Study||6
8840579|NCT01688739|9894841|FG007|STARTED|Overall Study||6
8840580|NCT01688739|9894842|FG008|STARTED|Overall Study||6
8840581|NCT01688739|9894843|FG009|STARTED|Overall Study||6
8840582|NCT01688739|9894834|FG000|Received Study Drug|Overall Study||12
8840583|NCT01688739|9894835|FG001|Received Study Drug|Overall Study||3
8840584|NCT01688739|9894836|FG002|Received Study Drug|Overall Study||3
8840585|NCT01688739|9894837|FG003|Received Study Drug|Overall Study||6
8840586|NCT01688739|9894838|FG004|Received Study Drug|Overall Study||6
8840587|NCT01688739|9894839|FG005|Received Study Drug|Overall Study||6
8840588|NCT01688739|9894840|FG006|Received Study Drug|Overall Study||6
8840589|NCT01688739|9894841|FG007|Received Study Drug|Overall Study||6
8840590|NCT01688739|9894842|FG008|Received Study Drug|Overall Study||6
8840591|NCT01688739|9894843|FG009|Received Study Drug|Overall Study||6
8840592|NCT01688739|9894834|FG000|COMPLETED|Overall Study||12
8840593|NCT01688739|9894835|FG001|COMPLETED|Overall Study||3
8840594|NCT01688739|9894836|FG002|COMPLETED|Overall Study||3
8840595|NCT01688739|9894837|FG003|COMPLETED|Overall Study||6
8840596|NCT01688739|9894838|FG004|COMPLETED|Overall Study||6
8840597|NCT01688739|9894839|FG005|COMPLETED|Overall Study||6
8840598|NCT01688739|9894840|FG006|COMPLETED|Overall Study||6
8840599|NCT01688739|9894841|FG007|COMPLETED|Overall Study||6
8840600|NCT01688739|9894842|FG008|COMPLETED|Overall Study||6
8840601|NCT01688739|9894843|FG009|COMPLETED|Overall Study||6
8840602|NCT01688739|9894834|FG000|NOT COMPLETED|Overall Study||1
8840603|NCT01688739|9894835|FG001|NOT COMPLETED|Overall Study||0
8840604|NCT01688739|9894836|FG002|NOT COMPLETED|Overall Study||0
8840605|NCT01688739|9894837|FG003|NOT COMPLETED|Overall Study||0
8840606|NCT01688739|9894838|FG004|NOT COMPLETED|Overall Study||0
8840607|NCT01688739|9894839|FG005|NOT COMPLETED|Overall Study||0
8840608|NCT01688739|9894840|FG006|NOT COMPLETED|Overall Study||0
8840609|NCT01688739|9894841|FG007|NOT COMPLETED|Overall Study||0
8840610|NCT01688739|9894842|FG008|NOT COMPLETED|Overall Study||0
8840611|NCT01688739|9894843|FG009|NOT COMPLETED|Overall Study||0
8840612|NCT01688830|9894894|FG000|STARTED|Overall Study||21
8840613|NCT01688830|9894895|FG001|STARTED|Overall Study||6
8840614|NCT01688830|9894896|FG002|STARTED|Overall Study||6
8840615|NCT01688830|9894897|FG003|STARTED|Overall Study||6
8840616|NCT01688830|9894898|FG004|STARTED|Overall Study||5
8840617|NCT01688830|9894899|FG005|STARTED|Overall Study||6
8840618|NCT01688830|9894900|FG006|STARTED|Overall Study||12
8840619|NCT01688830|9894901|FG007|STARTED|Overall Study||6
8840620|NCT01688830|9894902|FG008|STARTED|Overall Study||6
8840621|NCT01688830|9894903|FG009|STARTED|Overall Study||6
8840622|NCT01688830|9894904|FG010|STARTED|Overall Study||6
8840623|NCT01688830|9894905|FG011|STARTED|Overall Study||6
8840624|NCT01688830|9894906|FG012|STARTED|Overall Study||6
8840625|NCT01688830|9894907|FG013|STARTED|Overall Study||6
8840626|NCT01688830|9894908|FG014|STARTED|Overall Study||6
8840627|NCT01688830|9894909|FG015|STARTED|Overall Study||9
8840628|NCT01688830|9894910|FG016|STARTED|Overall Study||9
8840629|NCT01688830|9894911|FG017|STARTED|Overall Study||9
8840630|NCT01688830|9894912|FG018|STARTED|Overall Study||8
8840631|NCT01688830|9894913|FG019|STARTED|Overall Study||3
8840632|NCT01688830|9894914|FG020|STARTED|Overall Study||9
8840633|NCT01688830|9894894|FG000|COMPLETED|Overall Study||21
8840634|NCT01688830|9894895|FG001|COMPLETED|Overall Study||6
8840635|NCT01688830|9894896|FG002|COMPLETED|Overall Study||6
8840636|NCT01688830|9894897|FG003|COMPLETED|Overall Study||6
8840637|NCT01688830|9894898|FG004|COMPLETED|Overall Study||5
8840638|NCT01688830|9894899|FG005|COMPLETED|Overall Study||6
8840639|NCT01688830|9894900|FG006|COMPLETED|Overall Study||12
8840640|NCT01688830|9894901|FG007|COMPLETED|Overall Study||6
8840641|NCT01688830|9894902|FG008|COMPLETED|Overall Study||6
8840642|NCT01688830|9894903|FG009|COMPLETED|Overall Study||6
8840643|NCT01688830|9894904|FG010|COMPLETED|Overall Study||5
8840644|NCT01688830|9894905|FG011|COMPLETED|Overall Study||6
8840645|NCT01688830|9894906|FG012|COMPLETED|Overall Study||6
8840646|NCT01688830|9894907|FG013|COMPLETED|Overall Study||6
8840647|NCT01688830|9894908|FG014|COMPLETED|Overall Study||6
8840648|NCT01688830|9894909|FG015|COMPLETED|Overall Study||9
8840649|NCT01688830|9894910|FG016|COMPLETED|Overall Study||9
8840650|NCT01688830|9894911|FG017|COMPLETED|Overall Study||9
8840651|NCT01688830|9894912|FG018|COMPLETED|Overall Study||8
8840652|NCT01688830|9894913|FG019|COMPLETED|Overall Study||3
8840653|NCT01688830|9894914|FG020|COMPLETED|Overall Study||9
8840654|NCT01688830|9894894|FG000|NOT COMPLETED|Overall Study||0
8840655|NCT01688830|9894895|FG001|NOT COMPLETED|Overall Study||0
8840656|NCT01688830|9894896|FG002|NOT COMPLETED|Overall Study||0
8840657|NCT01688830|9894897|FG003|NOT COMPLETED|Overall Study||0
8840658|NCT01688830|9894898|FG004|NOT COMPLETED|Overall Study||0
8840659|NCT01688830|9894899|FG005|NOT COMPLETED|Overall Study||0
8840660|NCT01688830|9894900|FG006|NOT COMPLETED|Overall Study||0
8840661|NCT01688830|9894901|FG007|NOT COMPLETED|Overall Study||0
8840662|NCT01688830|9894902|FG008|NOT COMPLETED|Overall Study||0
8840663|NCT01688830|9894903|FG009|NOT COMPLETED|Overall Study||0
8623111|NCT00491608|9662337|FG000|STARTED|Overall Study|Participants who received treatment|209
8840664|NCT01688830|9894904|FG010|NOT COMPLETED|Overall Study||1
8840665|NCT01688830|9894905|FG011|NOT COMPLETED|Overall Study||0
8840666|NCT01688830|9894906|FG012|NOT COMPLETED|Overall Study||0
8840667|NCT01688830|9894907|FG013|NOT COMPLETED|Overall Study||0
8840668|NCT01688830|9894908|FG014|NOT COMPLETED|Overall Study||0
8840669|NCT01688830|9894909|FG015|NOT COMPLETED|Overall Study||0
8840670|NCT01688830|9894910|FG016|NOT COMPLETED|Overall Study||0
8840671|NCT01688830|9894911|FG017|NOT COMPLETED|Overall Study||0
8840672|NCT01688830|9894912|FG018|NOT COMPLETED|Overall Study||0
8840673|NCT01688830|9894913|FG019|NOT COMPLETED|Overall Study||0
8840674|NCT01688830|9894914|FG020|NOT COMPLETED|Overall Study||0
8840675|NCT01688843|9894998|FG000|STARTED|Overall Study||1060
8840676|NCT01688843|9894998|FG000|COMPLETED|Overall Study||1060
8840677|NCT01688843|9894998|FG000|NOT COMPLETED|Overall Study||0
8840678|NCT01688856|9895007|FG000|STARTED|Overall Study||28
8840679|NCT01688856|9895008|FG001|STARTED|Overall Study||28
8840680|NCT01688856|9895009|FG002|STARTED|Overall Study||11
8840681|NCT01688856|9895007|FG000|COMPLETED|Overall Study||21
8840682|NCT01688856|9895008|FG001|COMPLETED|Overall Study||24
8840683|NCT01688856|9895009|FG002|COMPLETED|Overall Study||8
8840684|NCT01688856|9895007|FG000|NOT COMPLETED|Overall Study||7
8840685|NCT01688856|9895008|FG001|NOT COMPLETED|Overall Study||4
8840686|NCT01688856|9895009|FG002|NOT COMPLETED|Overall Study||3
8840687|NCT01688882|9895019|FG000|STARTED|Overall Study||13
8840688|NCT01688882|9895020|FG001|STARTED|Overall Study|4 patients who completed 12 weeks of placebo changed to open-label QGE031 treatment.|7
8840689|NCT01688882|9895019|FG000|Safety Follow-up|Overall Study||11
8840690|NCT01688882|9895020|FG001|Safety Follow-up|Overall Study||5
8840691|NCT01688882|9895019|FG000|COMPLETED|Overall Study||10
8840692|NCT01688882|9895020|FG001|COMPLETED|Overall Study|The one patient that discontinued was already switched to open-label QGE031 treatment.|6
8840693|NCT01688882|9895019|FG000|NOT COMPLETED|Overall Study||3
8840694|NCT01688882|9895020|FG001|NOT COMPLETED|Overall Study||1
8840695|NCT01688895|9895030|FG000|STARTED|Overall Study||150
8840696|NCT01688895|9895030|FG000|COMPLETED|Overall Study||150
8840697|NCT01688895|9895030|FG000|NOT COMPLETED|Overall Study||0
8840698|NCT01688921|9895036|FG000|STARTED|Overall Study||627
8840699|NCT01688921|9895037|FG001|STARTED|Overall Study||623
8840700|NCT01688921|9895036|FG000|COMPLETED|Overall Study||611
8840701|NCT01688921|9895037|FG001|COMPLETED|Overall Study||608
8840702|NCT01688921|9895036|FG000|NOT COMPLETED|Overall Study||16
8840703|NCT01688921|9895037|FG001|NOT COMPLETED|Overall Study||15
8840704|NCT01688973|9895046|FG000|STARTED|Overall Study||27
8840705|NCT01688973|9895047|FG001|STARTED|Overall Study||28
8840706|NCT01688973|9895046|FG000|Eligible/Evaluable Patients|Overall Study||25
8840707|NCT01688973|9895047|FG001|Eligible/Evaluable Patients|Overall Study||25
8840708|NCT01688973|9895046|FG000|COMPLETED|Overall Study||25
8840709|NCT01688973|9895047|FG001|COMPLETED|Overall Study||25
8840710|NCT01688973|9895046|FG000|NOT COMPLETED|Overall Study||2
8840711|NCT01688973|9895047|FG001|NOT COMPLETED|Overall Study||3
8840712|NCT01688999|9895057|FG000|STARTED|Overall Study||50
8840713|NCT01688999|9895058|FG001|STARTED|Overall Study||6
8840714|NCT01688999|9895059|FG002|STARTED|Overall Study||13
8840715|NCT01688999|9895057|FG000|COMPLETED|Overall Study||42
8840716|NCT01688999|9895058|FG001|COMPLETED|Overall Study||5
8840717|NCT01688999|9895059|FG002|COMPLETED|Overall Study||10
8840718|NCT01688999|9895057|FG000|NOT COMPLETED|Overall Study||8
8840719|NCT01688999|9895058|FG001|NOT COMPLETED|Overall Study||1
8840720|NCT01688999|9895059|FG002|NOT COMPLETED|Overall Study||3
8840721|NCT01689155|9895066|FG000|STARTED|Overall Study||116
8840722|NCT01689155|9895066|FG000|COMPLETED|Overall Study||116
8840723|NCT01689155|9895066|FG000|NOT COMPLETED|Overall Study||0
8840724|NCT01689207|9895082|FG000|STARTED|Overall Study|Subjects randomised|4
8840725|NCT01689207|9895083|FG001|STARTED|Overall Study|Subjects randomised|8
8840726|NCT01689207|9895084|FG002|STARTED|Overall Study|Subjects randomised|16
8840727|NCT01689207|9895085|FG003|STARTED|Overall Study|Subjects randomised|8
8840728|NCT01689207|9895086|FG004|STARTED|Overall Study|Subjects randomised|4
8840729|NCT01689207|9895087|FG005|STARTED|Overall Study|Subjects randomised|8
8840730|NCT01689207|9895088|FG006|STARTED|Overall Study|Subjects randomised|10
8840731|NCT01689207|9895089|FG007|STARTED|Overall Study|Subjects randomised|10
8840732|NCT01689207|9895090|FG008|STARTED|Overall Study|Subjects randomised|6
8840733|NCT01689207|9895091|FG009|STARTED|Overall Study|Subjects randomised|10
8840734|NCT01689207|9895092|FG010|STARTED|Overall Study|Subjects randomised|8
8840735|NCT01689207|9895082|FG000|COMPLETED|Overall Study|Subjects completed study|4
8840736|NCT01689207|9895083|FG001|COMPLETED|Overall Study|Subjects completed study|7
8840737|NCT01689207|9895084|FG002|COMPLETED|Overall Study|Subjects completed study|16
8840738|NCT01689207|9895085|FG003|COMPLETED|Overall Study|Subjects completed study|8
8840739|NCT01689207|9895086|FG004|COMPLETED|Overall Study|Subjects completed study|2
8840740|NCT01689207|9895087|FG005|COMPLETED|Overall Study|Subjects completed study|7
8840741|NCT01689207|9895088|FG006|COMPLETED|Overall Study|Subjects completed study|10
8840742|NCT01689207|9895089|FG007|COMPLETED|Overall Study|Subjects completed study|10
8840743|NCT01689207|9895090|FG008|COMPLETED|Overall Study|Subjects completed study|5
8840744|NCT01689207|9895091|FG009|COMPLETED|Overall Study|Subjects completed study|10
8840745|NCT01689207|9895092|FG010|COMPLETED|Overall Study|Subjects completed study|8
8840746|NCT01689207|9895082|FG000|NOT COMPLETED|Overall Study||0
8840747|NCT01689207|9895083|FG001|NOT COMPLETED|Overall Study||1
8840748|NCT01689207|9895084|FG002|NOT COMPLETED|Overall Study||0
8840749|NCT01689207|9895085|FG003|NOT COMPLETED|Overall Study||0
8840750|NCT01689207|9895086|FG004|NOT COMPLETED|Overall Study||2
8840751|NCT01689207|9895087|FG005|NOT COMPLETED|Overall Study||1
8840752|NCT01689207|9895088|FG006|NOT COMPLETED|Overall Study||0
8840753|NCT01689207|9895089|FG007|NOT COMPLETED|Overall Study||0
8840754|NCT01689207|9895090|FG008|NOT COMPLETED|Overall Study||1
8840755|NCT01689207|9895091|FG009|NOT COMPLETED|Overall Study||0
8840756|NCT01689207|9895092|FG010|NOT COMPLETED|Overall Study||0
8840757|NCT01689324|9895122|FG000|STARTED|Overall Study||43
8840758|NCT01689324|9895122|FG000|COMPLETED|Overall Study||43
8840759|NCT01689324|9895122|FG000|NOT COMPLETED|Overall Study||0
8840760|NCT01689337|9895126|FG000|STARTED|Overall Study||1
8840761|NCT01689337|9895126|FG000|COMPLETED|Overall Study||0
8840762|NCT01689337|9895126|FG000|NOT COMPLETED|Overall Study||1
8840763|NCT01689350|9895134|FG000|STARTED|Overall Study||47
8840764|NCT01689350|9895135|FG001|STARTED|Overall Study||45
8840765|NCT01689350|9895134|FG000|COMPLETED|Overall Study||47
8840766|NCT01689350|9895135|FG001|COMPLETED|Overall Study||45
8840767|NCT01689350|9895134|FG000|NOT COMPLETED|Overall Study||0
8840768|NCT01689350|9895135|FG001|NOT COMPLETED|Overall Study||0
8840769|NCT01689363|9895141|FG000|STARTED|Overall Study||32
8840770|NCT01689363|9895142|FG001|STARTED|Overall Study||32
8840771|NCT01689363|9895143|FG002|STARTED|Overall Study||32
8840772|NCT01689363|9895144|FG003|STARTED|Overall Study||31
8840773|NCT01689363|9895145|FG004|STARTED|Overall Study||31
8840774|NCT01689363|9895146|FG005|STARTED|Overall Study||31
8840775|NCT01689363|9895147|FG006|STARTED|Overall Study||32
8840776|NCT01689363|9895148|FG007|STARTED|Overall Study||32
8840777|NCT01689363|9895141|FG000|COMPLETED|Overall Study||32
8840778|NCT01689363|9895142|FG001|COMPLETED|Overall Study||31
8840779|NCT01689363|9895143|FG002|COMPLETED|Overall Study||32
8840780|NCT01689363|9895144|FG003|COMPLETED|Overall Study||31
8840781|NCT01689363|9895145|FG004|COMPLETED|Overall Study||31
8840782|NCT01689363|9895146|FG005|COMPLETED|Overall Study||31
8840783|NCT01689363|9895147|FG006|COMPLETED|Overall Study||32
8840784|NCT01689363|9895148|FG007|COMPLETED|Overall Study||32
8840785|NCT01689363|9895141|FG000|NOT COMPLETED|Overall Study||0
8840786|NCT01689363|9895142|FG001|NOT COMPLETED|Overall Study||1
8840787|NCT01689363|9895143|FG002|NOT COMPLETED|Overall Study||0
8840788|NCT01689363|9895144|FG003|NOT COMPLETED|Overall Study||0
8840789|NCT01689363|9895145|FG004|NOT COMPLETED|Overall Study||0
8840790|NCT01689363|9895146|FG005|NOT COMPLETED|Overall Study||0
8840791|NCT01689363|9895147|FG006|NOT COMPLETED|Overall Study||0
8840792|NCT01689363|9895148|FG007|NOT COMPLETED|Overall Study||0
8840793|NCT01689441|9895161|FG000|STARTED|Overall Study||36
8840794|NCT01689441|9895162|FG001|STARTED|Overall Study||31
8840795|NCT01689441|9895161|FG000|COMPLETED|Overall Study||36
8840796|NCT01689441|9895162|FG001|COMPLETED|Overall Study||31
8840797|NCT01689441|9895161|FG000|NOT COMPLETED|Overall Study||0
8840798|NCT01689441|9895162|FG001|NOT COMPLETED|Overall Study||0
8840799|NCT01689532|9895170|FG000|STARTED|Overall Study||61
8840800|NCT01689532|9895171|FG001|STARTED|Overall Study||61
8840801|NCT01689532|9895170|FG000|COMPLETED|Overall Study||47
8840802|NCT01689532|9895171|FG001|COMPLETED|Overall Study||52
8840803|NCT01689532|9895170|FG000|NOT COMPLETED|Overall Study||14
8840804|NCT01689532|9895171|FG001|NOT COMPLETED|Overall Study||9
8840805|NCT01689649|9895177|FG000|STARTED|Overall Study||139
8840806|NCT01689649|9895177|FG000|COMPLETED|Overall Study||117
8840807|NCT01689649|9895177|FG000|NOT COMPLETED|Overall Study||22
8840808|NCT01689701|9895183|FG000|STARTED|Overall Study||27
8840809|NCT01689701|9895184|FG001|STARTED|Overall Study||27
8840810|NCT01689701|9895183|FG000|COMPLETED|Overall Study||22
8840811|NCT01689701|9895184|FG001|COMPLETED|Overall Study||21
8840812|NCT01689701|9895183|FG000|NOT COMPLETED|Overall Study||5
8840813|NCT01689701|9895184|FG001|NOT COMPLETED|Overall Study||6
8840814|NCT01689779|9895192|FG000|STARTED|Overall Study||28
8840815|NCT01689779|9895193|FG001|STARTED|Overall Study||32
8840816|NCT01689779|9895192|FG000|COMPLETED|Overall Study||28
8840817|NCT01689779|9895193|FG001|COMPLETED|Overall Study||32
8840818|NCT01689779|9895192|FG000|NOT COMPLETED|Overall Study||0
8840819|NCT01689779|9895193|FG001|NOT COMPLETED|Overall Study||0
8840820|NCT01689857|9895201|FG000|STARTED|Overall Study||20
8840821|NCT01689857|9895202|FG001|STARTED|Overall Study||20
8840822|NCT01689857|9895201|FG000|COMPLETED|Overall Study||15
8840823|NCT01689857|9895202|FG001|COMPLETED|Overall Study||18
8840824|NCT01689857|9895201|FG000|NOT COMPLETED|Overall Study||5
8840825|NCT01689857|9895202|FG001|NOT COMPLETED|Overall Study||2
8840826|NCT01690000|9895210|FG000|STARTED|Overall Study||40
8840827|NCT01690000|9895211|FG001|STARTED|Overall Study||41
8840828|NCT01690000|9895210|FG000|COMPLETED|Overall Study||37
8840829|NCT01690000|9895211|FG001|COMPLETED|Overall Study||35
8840830|NCT01690000|9895210|FG000|NOT COMPLETED|Overall Study||3
8840831|NCT01690000|9895211|FG001|NOT COMPLETED|Overall Study||6
8840832|NCT01690052|9895217|FG000|STARTED|FIRST INTERVENTION: 4 WEEKS||7
8840833|NCT01690052|9895218|FG001|STARTED|FIRST INTERVENTION: 4 WEEKS||8
8840834|NCT01690052|9895217|FG000|COMPLETED|FIRST INTERVENTION: 4 WEEKS||6
8840835|NCT01690052|9895218|FG001|COMPLETED|FIRST INTERVENTION: 4 WEEKS||6
8840836|NCT01690052|9895217|FG000|NOT COMPLETED|FIRST INTERVENTION: 4 WEEKS||1
8840837|NCT01690052|9895218|FG001|NOT COMPLETED|FIRST INTERVENTION: 4 WEEKS||2
8840838|NCT01690052|9895217|FG000|STARTED|Washout Period of 1 Week||6
8840839|NCT01690052|9895218|FG001|STARTED|Washout Period of 1 Week||6
8840840|NCT01690052|9895217|FG000|COMPLETED|Washout Period of 1 Week||6
8840841|NCT01690052|9895218|FG001|COMPLETED|Washout Period of 1 Week||6
8840842|NCT01690052|9895217|FG000|NOT COMPLETED|Washout Period of 1 Week||0
8840843|NCT01690052|9895218|FG001|NOT COMPLETED|Washout Period of 1 Week||0
8840844|NCT01690052|9895217|FG000|STARTED|SECOND INTERVENTION: 4 WEEKS||6
8840845|NCT01690052|9895218|FG001|STARTED|SECOND INTERVENTION: 4 WEEKS||6
8840846|NCT01690052|9895217|FG000|COMPLETED|SECOND INTERVENTION: 4 WEEKS||6
8840847|NCT01690052|9895218|FG001|COMPLETED|SECOND INTERVENTION: 4 WEEKS||6
8840848|NCT01690052|9895217|FG000|NOT COMPLETED|SECOND INTERVENTION: 4 WEEKS||0
8840849|NCT01690052|9895218|FG001|NOT COMPLETED|SECOND INTERVENTION: 4 WEEKS||0
8840850|NCT01690117|9895226|FG000|STARTED|Overall Study||47
8840851|NCT01690117|9895227|FG001|STARTED|Overall Study||45
8840852|NCT01690117|9895226|FG000|Post-Measurement|Overall Study||41
8840853|NCT01690117|9895227|FG001|Post-Measurement|Overall Study||40
8840854|NCT01690117|9895226|FG000|COMPLETED|Overall Study||31
8840855|NCT01690117|9895227|FG001|COMPLETED|Overall Study||31
8840856|NCT01690117|9895226|FG000|NOT COMPLETED|Overall Study||16
8840857|NCT01690117|9895227|FG001|NOT COMPLETED|Overall Study||14
8840858|NCT01690130|9895237|FG000|STARTED|Overall Study||10
8840859|NCT01690130|9895238|FG001|STARTED|Overall Study||9
8840860|NCT01690130|9895237|FG000|COMPLETED|Overall Study||9
8840861|NCT01690130|9895238|FG001|COMPLETED|Overall Study||9
9065983|NCT04126343|10126460|FG002|Completed Placebo Period|Overall Study||9
9065984|NCT04126343|10126461|FG003|Completed Placebo Period|Overall Study||9
9065985|NCT04126343|10126462|FG004|Completed Placebo Period|Overall Study||7
9065986|NCT04126343|10126463|FG005|Completed Placebo Period|Overall Study||9
9065987|NCT04126343|10126458|FG000|Completed Moxifloxacin Period|Overall Study||8
9065988|NCT04126343|10126459|FG001|Completed Moxifloxacin Period|Overall Study||9
9065989|NCT04126343|10126460|FG002|Completed Moxifloxacin Period|Overall Study||7
9065990|NCT04126343|10126461|FG003|Completed Moxifloxacin Period|Overall Study||9
9065991|NCT04126343|10126462|FG004|Completed Moxifloxacin Period|Overall Study||9
9065992|NCT04126343|10126463|FG005|Completed Moxifloxacin Period|Overall Study||9
9065993|NCT04126343|10126458|FG000|COMPLETED|Overall Study||6
9065994|NCT04126343|10126459|FG001|COMPLETED|Overall Study||5
9065995|NCT04126343|10126460|FG002|COMPLETED|Overall Study||6
9065996|NCT04126343|10126461|FG003|COMPLETED|Overall Study||5
9065997|NCT04126343|10126462|FG004|COMPLETED|Overall Study||6
9065998|NCT04126343|10126463|FG005|COMPLETED|Overall Study||5
9065999|NCT04126343|10126458|FG000|NOT COMPLETED|Overall Study||3
9066000|NCT04126343|10126459|FG001|NOT COMPLETED|Overall Study||4
9066001|NCT04126343|10126460|FG002|NOT COMPLETED|Overall Study||3
9066002|NCT04126343|10126461|FG003|NOT COMPLETED|Overall Study||4
9066003|NCT04126343|10126462|FG004|NOT COMPLETED|Overall Study||3
9066004|NCT04126343|10126463|FG005|NOT COMPLETED|Overall Study||4
9066005|NCT04126187|10126478|FG000|STARTED|Overall Study||30
9066006|NCT04126187|10126478|FG000|COMPLETED|Overall Study||30
9066007|NCT04126187|10126478|FG000|NOT COMPLETED|Overall Study||0
9066008|NCT04124952|10126482|FG000|STARTED|Overall Study||30
9066009|NCT04124952|10126482|FG000|COMPLETED|Overall Study||29
9066010|NCT04124952|10126482|FG000|NOT COMPLETED|Overall Study||1
9066011|NCT04123665|10126488|FG000|STARTED|Overall Study||50
8840862|NCT01690130|9895237|FG000|NOT COMPLETED|Overall Study||1
8840863|NCT01690130|9895238|FG001|NOT COMPLETED|Overall Study||0
8840864|NCT01690143|9895244|FG000|STARTED|Overall Study||45
8840865|NCT01690143|9895244|FG000|COMPLETED|Overall Study||44
8840866|NCT01690143|9895244|FG000|NOT COMPLETED|Overall Study||1
8840867|NCT01690273|9895252|FG000|STARTED|Overall Study||18
8840868|NCT01690273|9895253|FG001|STARTED|Overall Study||17
8840869|NCT01690273|9895254|FG002|STARTED|Overall Study||20
8840870|NCT01690273|9895252|FG000|COMPLETED|Overall Study||18
8840871|NCT01690273|9895253|FG001|COMPLETED|Overall Study||17
8840872|NCT01690273|9895254|FG002|COMPLETED|Overall Study||20
8840873|NCT01690273|9895252|FG000|NOT COMPLETED|Overall Study||0
8840874|NCT01690273|9895253|FG001|NOT COMPLETED|Overall Study||0
8840875|NCT01690273|9895254|FG002|NOT COMPLETED|Overall Study||0
8840876|NCT01690520|9895268|FG000|STARTED|Overall Study||78
8840877|NCT01690520|9895269|FG001|STARTED|Overall Study||82
8840878|NCT01690520|9895268|FG000|Modified Intent to Treat (mITT)|Overall Study||78
8840879|NCT01690520|9895269|FG001|Modified Intent to Treat (mITT)|Overall Study||80
8840880|NCT01690520|9895268|FG000|COMPLETED|Overall Study||27
8840881|NCT01690520|9895269|FG001|COMPLETED|Overall Study||35
8840882|NCT01690520|9895268|FG000|NOT COMPLETED|Overall Study||51
8840883|NCT01690520|9895269|FG001|NOT COMPLETED|Overall Study||47
8840884|NCT01690546|9895275|FG000|STARTED|Overall Study||35
8840885|NCT01690546|9895275|FG000|Extended Release Injectable NTX|Overall Study||27
8840886|NCT01690546|9895275|FG000|COMPLETED|Overall Study||26
8840887|NCT01690546|9895275|FG000|NOT COMPLETED|Overall Study||9
8840888|NCT01690663|9895283|FG000|STARTED|Overall Study||23
8840889|NCT01690663|9895284|FG001|STARTED|Overall Study||20
8840890|NCT01690663|9895285|FG002|STARTED|Overall Study||22
9066012|NCT04123665|10126489|FG001|STARTED|Overall Study||48
8840891|NCT01690663|9895286|FG003|STARTED|Overall Study||24
8840892|NCT01690663|9895283|FG000|COMPLETED|Overall Study||20
8840893|NCT01690663|9895284|FG001|COMPLETED|Overall Study||17
8840894|NCT01690663|9895285|FG002|COMPLETED|Overall Study||19
8840895|NCT01690663|9895286|FG003|COMPLETED|Overall Study||20
8840896|NCT01690663|9895283|FG000|NOT COMPLETED|Overall Study||3
8840897|NCT01690663|9895284|FG001|NOT COMPLETED|Overall Study||3
9066013|NCT04123665|10126488|FG000|COMPLETED|Overall Study||42
8840898|NCT01690663|9895285|FG002|NOT COMPLETED|Overall Study||3
8840899|NCT01690663|9895286|FG003|NOT COMPLETED|Overall Study||4
8840900|NCT01690923|9895296|FG000|STARTED|Overall Study||10
8840901|NCT01690923|9895297|FG001|STARTED|Overall Study|1 participant was withdrawn and excluded due to poor fit with the pillows mask|11
8840902|NCT01690923|9895296|FG000|COMPLETED|Overall Study||10
8840903|NCT01690923|9895297|FG001|COMPLETED|Overall Study||10
8840904|NCT01690923|9895296|FG000|NOT COMPLETED|Overall Study||0
8840905|NCT01690923|9895297|FG001|NOT COMPLETED|Overall Study||1
8840906|NCT01690988|9895304|FG000|STARTED|Overall Study||227
8840907|NCT01690988|9895305|FG001|STARTED|Overall Study||222
8840908|NCT01690988|9895306|FG002|STARTED|Overall Study||223
8840909|NCT01690988|9895304|FG000|COMPLETED|Overall Study||221
8840910|NCT01690988|9895305|FG001|COMPLETED|Overall Study||217
8840911|NCT01690988|9895306|FG002|COMPLETED|Overall Study||216
8840912|NCT01690988|9895304|FG000|NOT COMPLETED|Overall Study||6
8840913|NCT01690988|9895305|FG001|NOT COMPLETED|Overall Study||5
8840914|NCT01690988|9895306|FG002|NOT COMPLETED|Overall Study||7
8840915|NCT01691014|9895321|FG000|STARTED|Overall Study||8
8840916|NCT01691014|9895322|FG001|STARTED|Overall Study||26
8840917|NCT01691014|9895323|FG002|STARTED|Overall Study||36
8840918|NCT01691014|9895324|FG003|STARTED|Overall Study||9
8840919|NCT01691014|9895321|FG000|COMPLETED|Overall Study||5
8840920|NCT01691014|9895322|FG001|COMPLETED|Overall Study||11
8840921|NCT01691014|9895323|FG002|COMPLETED|Overall Study||25
8840922|NCT01691014|9895324|FG003|COMPLETED|Overall Study||4
8840923|NCT01691014|9895321|FG000|NOT COMPLETED|Overall Study||3
8840924|NCT01691014|9895322|FG001|NOT COMPLETED|Overall Study||15
8840925|NCT01691014|9895323|FG002|NOT COMPLETED|Overall Study||11
8840926|NCT01691014|9895324|FG003|NOT COMPLETED|Overall Study||5
8840927|NCT01691027|9895334|FG000|STARTED|Scotoma Awareness|Four subjects started scotoma awareness training module|4
8840928|NCT01691027|9895334|FG000|COMPLETED|Scotoma Awareness|Four subjects were able to complete scotoma awareness training module|4
8840929|NCT01691027|9895334|FG000|NOT COMPLETED|Scotoma Awareness||0
8840930|NCT01691027|9895334|FG000|STARTED|Line and Circle Tracing Training|Four subjects started line and circle tracing training module|4
8840931|NCT01691027|9895334|FG000|COMPLETED|Line and Circle Tracing Training|Four subjects were able to complete line and circle tracing training module.|4
8840932|NCT01691027|9895334|FG000|NOT COMPLETED|Line and Circle Tracing Training||0
8840933|NCT01691027|9895334|FG000|STARTED|Video Games Training|Four subjects started video game training module|4
8840934|NCT01691027|9895334|FG000|COMPLETED|Video Games Training|Four subjects were able to complete video games training module|4
8840935|NCT01691027|9895334|FG000|NOT COMPLETED|Video Games Training||0
8840936|NCT01691092|9895339|FG000|STARTED|Overall Study||79
8840937|NCT01691092|9895339|FG000|COMPLETED|Overall Study||38
8840938|NCT01691092|9895339|FG000|NOT COMPLETED|Overall Study||41
8840939|NCT01691105|9895345|FG000|STARTED|Baseline||477
8840940|NCT01691105|9895346|FG001|STARTED|Baseline||567
8840941|NCT01691105|9895345|FG000|COMPLETED|Baseline||477
8840942|NCT01691105|9895346|FG001|COMPLETED|Baseline||567
8840943|NCT01691105|9895345|FG000|NOT COMPLETED|Baseline||0
8840944|NCT01691105|9895346|FG001|NOT COMPLETED|Baseline||0
8840945|NCT01691105|9895345|FG000|STARTED|1 Month Follow-up||477
8840946|NCT01691105|9895346|FG001|STARTED|1 Month Follow-up||567
8840947|NCT01691105|9895345|FG000|COMPLETED|1 Month Follow-up||434
8840948|NCT01691105|9895346|FG001|COMPLETED|1 Month Follow-up||526
8840949|NCT01691105|9895345|FG000|NOT COMPLETED|1 Month Follow-up||43
8840950|NCT01691105|9895346|FG001|NOT COMPLETED|1 Month Follow-up||41
8840951|NCT01691105|9895345|FG000|STARTED|6 Month Follow-up||477
8840952|NCT01691105|9895346|FG001|STARTED|6 Month Follow-up||567
8840953|NCT01691105|9895345|FG000|COMPLETED|6 Month Follow-up||425
8840954|NCT01691105|9895346|FG001|COMPLETED|6 Month Follow-up||496
8840955|NCT01691105|9895345|FG000|NOT COMPLETED|6 Month Follow-up||52
8840956|NCT01691105|9895346|FG001|NOT COMPLETED|6 Month Follow-up||71
8840957|NCT01691105|9895345|FG000|STARTED|12 Month Follow-up||477
8840958|NCT01691105|9895346|FG001|STARTED|12 Month Follow-up||567
8840959|NCT01691105|9895345|FG000|COMPLETED|12 Month Follow-up||405
8840960|NCT01691105|9895346|FG001|COMPLETED|12 Month Follow-up||466
8840961|NCT01691105|9895345|FG000|NOT COMPLETED|12 Month Follow-up||72
8840962|NCT01691105|9895346|FG001|NOT COMPLETED|12 Month Follow-up||101
8840963|NCT01691105|9895345|FG000|STARTED|12 Month Biochemical Verification||477
8840964|NCT01691105|9895346|FG001|STARTED|12 Month Biochemical Verification||567
8840965|NCT01691105|9895345|FG000|COMPLETED|12 Month Biochemical Verification||53
8840966|NCT01691105|9895346|FG001|COMPLETED|12 Month Biochemical Verification||65
8840967|NCT01691105|9895345|FG000|NOT COMPLETED|12 Month Biochemical Verification||424
8840968|NCT01691105|9895346|FG001|NOT COMPLETED|12 Month Biochemical Verification||502
8840969|NCT01691248|9895354|FG000|STARTED|Overall Study|Randomized|305
8840970|NCT01691248|9895355|FG001|STARTED|Overall Study|Randomized|306
8840971|NCT01691248|9895354|FG000|Treated|Overall Study|Received at least 1 dose of study drug|301
8840972|NCT01691248|9895355|FG001|Treated|Overall Study|Received at least 1 dose of study drug|299
8840973|NCT01691248|9895354|FG000|Safety Analysis Set|Overall Study|A participant randomized to Fidaxomicin, received placebo instead.|300
8840974|NCT01691248|9895355|FG001|Safety Analysis Set|Overall Study|A participant randomized to Fidaxomicin, received placebo instead.|300
8840975|NCT01691248|9895354|FG000|COMPLETED|Overall Study||194
8840976|NCT01691248|9895355|FG001|COMPLETED|Overall Study||192
8840977|NCT01691248|9895354|FG000|NOT COMPLETED|Overall Study||111
8840978|NCT01691248|9895355|FG001|NOT COMPLETED|Overall Study||114
8840979|NCT01691313|9895365|FG000|STARTED|Overall Study||22
8840980|NCT01691313|9895366|FG001|STARTED|Overall Study||32
8840981|NCT01691313|9895367|FG002|STARTED|Overall Study||25
8840982|NCT01691313|9895368|FG003|STARTED|Overall Study||25
8840983|NCT01691313|9895365|FG000|COMPLETED|Overall Study||22
8840984|NCT01691313|9895366|FG001|COMPLETED|Overall Study||32
8840985|NCT01691313|9895367|FG002|COMPLETED|Overall Study||25
8840986|NCT01691313|9895368|FG003|COMPLETED|Overall Study||25
8840987|NCT01691313|9895365|FG000|NOT COMPLETED|Overall Study||0
8840988|NCT01691313|9895366|FG001|NOT COMPLETED|Overall Study||0
8840989|NCT01691313|9895367|FG002|NOT COMPLETED|Overall Study||0
8840990|NCT01691313|9895368|FG003|NOT COMPLETED|Overall Study||0
8840991|NCT01691326|9895380|FG000|STARTED|Overall Study||30
8840992|NCT01691326|9895381|FG001|STARTED|Overall Study||30
8840993|NCT01691326|9895380|FG000|COMPLETED|Overall Study||30
8840994|NCT01691326|9895381|FG001|COMPLETED|Overall Study||30
8840995|NCT01691326|9895380|FG000|NOT COMPLETED|Overall Study||0
8840996|NCT01691326|9895381|FG001|NOT COMPLETED|Overall Study||0
8840997|NCT01691339|9895393|FG000|STARTED|Overall Study||50
8840998|NCT01691339|9895394|FG001|STARTED|Overall Study||50
8840999|NCT01691339|9895395|FG002|STARTED|Overall Study||51
8841000|NCT01691339|9895396|FG003|STARTED|Overall Study||49
8841001|NCT01691339|9895393|FG000|COMPLETED|Overall Study||50
8841002|NCT01691339|9895394|FG001|COMPLETED|Overall Study||50
8841003|NCT01691339|9895395|FG002|COMPLETED|Overall Study||51
8841004|NCT01691339|9895396|FG003|COMPLETED|Overall Study||49
8841005|NCT01691339|9895393|FG000|NOT COMPLETED|Overall Study||0
8841006|NCT01691339|9895394|FG001|NOT COMPLETED|Overall Study||0
8841007|NCT01691339|9895395|FG002|NOT COMPLETED|Overall Study||0
8841008|NCT01691339|9895396|FG003|NOT COMPLETED|Overall Study||0
8841009|NCT01691378|9895408|FG000|STARTED|Overall Study||22
8841010|NCT01691378|9895409|FG001|STARTED|Overall Study||22
8841011|NCT01691378|9895408|FG000|COMPLETED|Overall Study||15
8841012|NCT01691378|9895409|FG001|COMPLETED|Overall Study||20
8841013|NCT01691378|9895408|FG000|NOT COMPLETED|Overall Study||7
8841014|NCT01691378|9895409|FG001|NOT COMPLETED|Overall Study||2
8944709|NCT02397915|10006599|FG000|STARTED|Period 1||150
8944710|NCT02397915|10006600|FG001|STARTED|Period 1||150
8944711|NCT02397915|10006601|FG002|STARTED|Period 1||0
8944712|NCT02397915|10006602|FG003|STARTED|Period 1||0
8944713|NCT02397915|10006599|FG000|COMPLETED|Period 1||149
8944714|NCT02397915|10006600|FG001|COMPLETED|Period 1||149
8944715|NCT02397915|10006601|FG002|COMPLETED|Period 1||0
8944716|NCT02397915|10006602|FG003|COMPLETED|Period 1||0
8944717|NCT02397915|10006599|FG000|NOT COMPLETED|Period 1||1
8944718|NCT02397915|10006600|FG001|NOT COMPLETED|Period 1||1
8944719|NCT02397915|10006601|FG002|NOT COMPLETED|Period 1||0
8944720|NCT02397915|10006602|FG003|NOT COMPLETED|Period 1||0
8944721|NCT02397915|10006599|FG000|STARTED|Period 2||0
8944722|NCT02397915|10006600|FG001|STARTED|Period 2||0
8944723|NCT02397915|10006601|FG002|STARTED|Period 2||149
8944724|NCT02397915|10006602|FG003|STARTED|Period 2||149
8944725|NCT02397915|10006599|FG000|COMPLETED|Period 2||0
8944726|NCT02397915|10006600|FG001|COMPLETED|Period 2||0
8944727|NCT02397915|10006601|FG002|COMPLETED|Period 2||149
8944728|NCT02397915|10006602|FG003|COMPLETED|Period 2||149
8944729|NCT02397915|10006599|FG000|NOT COMPLETED|Period 2||0
8944730|NCT02397915|10006600|FG001|NOT COMPLETED|Period 2||0
8944731|NCT02397915|10006601|FG002|NOT COMPLETED|Period 2||0
8944732|NCT02397915|10006602|FG003|NOT COMPLETED|Period 2||0
8944733|NCT02397954|10006610|FG000|STARTED|Overall Study||4
8944734|NCT02397954|10006610|FG000|COMPLETED|Overall Study||4
8944735|NCT02397954|10006610|FG000|NOT COMPLETED|Overall Study||0
8944736|NCT02398188|10006616|FG000|STARTED|Overall Study||398
8944737|NCT02398188|10006617|FG001|STARTED|Overall Study||395
8944738|NCT02398188|10006616|FG000|COMPLETED|Overall Study||371
8944739|NCT02398188|10006617|FG001|COMPLETED|Overall Study||361
8944740|NCT02398188|10006616|FG000|NOT COMPLETED|Overall Study||27
8944741|NCT02398188|10006617|FG001|NOT COMPLETED|Overall Study||34
8944742|NCT02398227|10006625|FG000|STARTED|Overall Study||83
8944743|NCT02398227|10006626|FG001|STARTED|Overall Study||89
8944744|NCT02398227|10006625|FG000|COMPLETED|Overall Study||56
8944745|NCT02398227|10006626|FG001|COMPLETED|Overall Study||71
8944746|NCT02398227|10006625|FG000|NOT COMPLETED|Overall Study||27
8944747|NCT02398227|10006626|FG001|NOT COMPLETED|Overall Study||18
8944748|NCT02398409|10006634|FG000|STARTED|Overall Study||69
8944749|NCT02398409|10006635|FG001|STARTED|Overall Study||68
8944750|NCT02398409|10006634|FG000|COMPLETED|Overall Study||67
8944751|NCT02398409|10006635|FG001|COMPLETED|Overall Study||63
8944752|NCT02398409|10006634|FG000|NOT COMPLETED|Overall Study||2
8944753|NCT02398409|10006635|FG001|NOT COMPLETED|Overall Study||5
8944754|NCT02399085|10006641|FG000|STARTED|Overall Study||81
8944755|NCT02399085|10006641|FG000|COMPLETED|Overall Study|30 patients completed the combination treatment on both study drugs (12 cycles).|30
8841015|NCT01691430|9895417|FG000|STARTED|Overall Study||92
8841016|NCT01691430|9895418|FG001|STARTED|Overall Study||93
8841017|NCT01691430|9895417|FG000|Received Medication|Overall Study||92
8841018|NCT01691430|9895418|FG001|Received Medication|Overall Study||93
8944756|NCT02399085|10006641|FG000|NOT COMPLETED|Overall Study||51
8944757|NCT02399163|10006645|FG000|STARTED|Overall Study||62
8944758|NCT02399163|10006645|FG000|COMPLETED|Overall Study||53
8944759|NCT02399163|10006645|FG000|NOT COMPLETED|Overall Study||9
8944760|NCT02399228|10006657|FG000|STARTED|Overall Study||13
8841019|NCT01691430|9895417|FG000|COMPLETED|Overall Study||70
8841020|NCT01691430|9895418|FG001|COMPLETED|Overall Study||73
8944761|NCT02399228|10006657|FG000|COMPLETED|Overall Study||7
8841021|NCT01691430|9895417|FG000|NOT COMPLETED|Overall Study||22
8841022|NCT01691430|9895418|FG001|NOT COMPLETED|Overall Study||20
8841023|NCT01691482|9895424|FG000|STARTED|Treatment Period 1||28
8841024|NCT01691482|9895425|FG001|STARTED|Treatment Period 1||28
8841025|NCT01691482|9895424|FG000|COMPLETED|Treatment Period 1||28
8841026|NCT01691482|9895425|FG001|COMPLETED|Treatment Period 1||28
8841027|NCT01691482|9895424|FG000|NOT COMPLETED|Treatment Period 1||0
8841028|NCT01691482|9895425|FG001|NOT COMPLETED|Treatment Period 1||0
8841029|NCT01691482|9895424|FG000|STARTED|Treatment Period 2||28
8841030|NCT01691482|9895425|FG001|STARTED|Treatment Period 2||28
8841031|NCT01691482|9895424|FG000|COMPLETED|Treatment Period 2||27
8841032|NCT01691482|9895425|FG001|COMPLETED|Treatment Period 2||26
8841033|NCT01691482|9895424|FG000|NOT COMPLETED|Treatment Period 2||1
8841034|NCT01691482|9895425|FG001|NOT COMPLETED|Treatment Period 2||2
8841035|NCT01691508|9895434|FG000|STARTED|Overall Study||66
8841036|NCT01691508|9895435|FG001|STARTED|Overall Study||69
8841037|NCT01691508|9895434|FG000|COMPLETED|Overall Study||62
8841038|NCT01691508|9895435|FG001|COMPLETED|Overall Study||66
8841039|NCT01691508|9895434|FG000|NOT COMPLETED|Overall Study||4
8841040|NCT01691508|9895435|FG001|NOT COMPLETED|Overall Study||3
8841041|NCT01691521|9895444|FG000|STARTED|Overall Study||191
8841042|NCT01691521|9895445|FG001|STARTED|Overall Study||191
8841043|NCT01691521|9895446|FG002|STARTED|Overall Study||194
8841044|NCT01691521|9895444|FG000|COMPLETED|Overall Study||179
8841045|NCT01691521|9895445|FG001|COMPLETED|Overall Study||175
8841046|NCT01691521|9895446|FG002|COMPLETED|Overall Study||185
8841047|NCT01691521|9895444|FG000|NOT COMPLETED|Overall Study||12
8841048|NCT01691521|9895445|FG001|NOT COMPLETED|Overall Study||16
8841049|NCT01691521|9895446|FG002|NOT COMPLETED|Overall Study||9
8841050|NCT01691534|9895462|FG000|STARTED|Overall Study||15
8841051|NCT01691534|9895463|FG001|STARTED|Overall Study||15
8841052|NCT01691534|9895464|FG002|STARTED|Overall Study||15
8841053|NCT01691534|9895465|FG003|STARTED|Overall Study||15
8841054|NCT01691534|9895466|FG004|STARTED|Overall Study||15
8841055|NCT01691534|9895467|FG005|STARTED|Overall Study||15
8841056|NCT01691534|9895468|FG006|STARTED|Overall Study||15
8841057|NCT01691534|9895462|FG000|COMPLETED|Overall Study||15
8841058|NCT01691534|9895463|FG001|COMPLETED|Overall Study||14
8841059|NCT01691534|9895464|FG002|COMPLETED|Overall Study||14
8841060|NCT01691534|9895465|FG003|COMPLETED|Overall Study||14
8841061|NCT01691534|9895466|FG004|COMPLETED|Overall Study||15
8841062|NCT01691534|9895467|FG005|COMPLETED|Overall Study||14
8841063|NCT01691534|9895468|FG006|COMPLETED|Overall Study||14
8841064|NCT01691534|9895462|FG000|NOT COMPLETED|Overall Study||0
8841065|NCT01691534|9895463|FG001|NOT COMPLETED|Overall Study||1
8841066|NCT01691534|9895464|FG002|NOT COMPLETED|Overall Study||1
8841067|NCT01691534|9895465|FG003|NOT COMPLETED|Overall Study||1
8841068|NCT01691534|9895466|FG004|NOT COMPLETED|Overall Study||0
8841069|NCT01691534|9895467|FG005|NOT COMPLETED|Overall Study||1
8841070|NCT01691534|9895468|FG006|NOT COMPLETED|Overall Study||1
8841071|NCT01691560|9895489|FG000|STARTED|Overall Study||34
8841072|NCT01691560|9895490|FG001|STARTED|Overall Study||33
8841073|NCT01691560|9895491|FG002|STARTED|Overall Study||34
8841074|NCT01691560|9895492|FG003|STARTED|Overall Study||33
8841075|NCT01691560|9895489|FG000|COMPLETED|Overall Study||34
8841076|NCT01691560|9895490|FG001|COMPLETED|Overall Study||33
8841077|NCT01691560|9895491|FG002|COMPLETED|Overall Study||34
8841078|NCT01691560|9895492|FG003|COMPLETED|Overall Study||33
8841079|NCT01691560|9895489|FG000|NOT COMPLETED|Overall Study||0
8841080|NCT01691560|9895490|FG001|NOT COMPLETED|Overall Study||0
8841081|NCT01691560|9895491|FG002|NOT COMPLETED|Overall Study||0
8841082|NCT01691560|9895492|FG003|NOT COMPLETED|Overall Study||0
8841083|NCT01691612|9895502|FG000|STARTED|Overall Study||14
8841084|NCT01691612|9895502|FG000|First Visit (Allergen Challenge)|Overall Study||8
8841085|NCT01691612|9895502|FG000|Second Visit (Bronchoscopy)|Overall Study||7
8841086|NCT01691612|9895502|FG000|COMPLETED|Overall Study||7
8841087|NCT01691612|9895502|FG000|NOT COMPLETED|Overall Study||7
8841088|NCT01691690|9895508|FG000|STARTED|Overall Study||125
8841089|NCT01691690|9895509|FG001|STARTED|Overall Study||125
8841090|NCT01691690|9895508|FG000|COMPLETED|Overall Study||118
8841091|NCT01691690|9895509|FG001|COMPLETED|Overall Study||121
8841092|NCT01691690|9895508|FG000|NOT COMPLETED|Overall Study||7
8841093|NCT01691690|9895509|FG001|NOT COMPLETED|Overall Study||4
8623112|NCT00491608|9662337|FG000|COMPLETED|Overall Study||206
8623113|NCT00491608|9662337|FG000|NOT COMPLETED|Overall Study||3
8623114|NCT00491751|9662344|FG000|STARTED|Overall Study||22
8841094|NCT01691768|9895520|FG000|STARTED|Overall Study||189
8841095|NCT01691768|9895521|FG001|STARTED|Overall Study||183
8623115|NCT00491751|9662345|FG001|STARTED|Overall Study||44
8841096|NCT01691768|9895520|FG000|COMPLETED|Overall Study||174
8841097|NCT01691768|9895521|FG001|COMPLETED|Overall Study||167
8841098|NCT01691768|9895520|FG000|NOT COMPLETED|Overall Study||15
8841099|NCT01691768|9895521|FG001|NOT COMPLETED|Overall Study||16
8850133|NCT01745094|9905372|FG001|COMPLETED|Overall Study||37
8850134|NCT01745094|9905373|FG002|COMPLETED|Overall Study||46
8850135|NCT01745094|9905374|FG003|COMPLETED|Overall Study||90
8850136|NCT01745094|9905371|FG000|NOT COMPLETED|Overall Study||5
8850137|NCT01745094|9905372|FG001|NOT COMPLETED|Overall Study||0
8850138|NCT01745094|9905373|FG002|NOT COMPLETED|Overall Study||12
8850139|NCT01745094|9905374|FG003|NOT COMPLETED|Overall Study||3
8850140|NCT01745120|9905389|FG000|STARTED|Overall Study||11
8850141|NCT01745120|9905390|FG001|STARTED|Overall Study||8
8841100|NCT01691781|9895530|FG000|STARTED|Overall Study||19
8841101|NCT01691781|9895531|FG001|STARTED|Overall Study||22
8841102|NCT01691781|9895530|FG000|COMPLETED|Overall Study||12
8841103|NCT01691781|9895531|FG001|COMPLETED|Overall Study||15
8841104|NCT01691781|9895530|FG000|NOT COMPLETED|Overall Study||7
8841105|NCT01691781|9895531|FG001|NOT COMPLETED|Overall Study||7
8841106|NCT01691794|9895540|FG000|STARTED|Overall Study||3
8841107|NCT01691794|9895541|FG001|STARTED|Overall Study||33
8841108|NCT01691794|9895542|FG002|STARTED|Overall Study||23
8841109|NCT01691794|9895540|FG000|COMPLETED|Overall Study|Completed baseline to End of Study|2
8841110|NCT01691794|9895541|FG001|COMPLETED|Overall Study|Completed baseline to End of Study|15
8841111|NCT01691794|9895542|FG002|COMPLETED|Overall Study|Completed baseline to End of Study|13
8841112|NCT01691794|9895540|FG000|NOT COMPLETED|Overall Study||1
8841113|NCT01691794|9895541|FG001|NOT COMPLETED|Overall Study||18
8841114|NCT01691794|9895542|FG002|NOT COMPLETED|Overall Study||10
8841115|NCT01691820|9895552|FG000|STARTED|Overall Study||210
8841116|NCT01691820|9895553|FG001|STARTED|Overall Study||152
8841117|NCT01691820|9895552|FG000|COMPLETED|Overall Study||184
8841118|NCT01691820|9895553|FG001|COMPLETED|Overall Study||115
8841119|NCT01691820|9895552|FG000|NOT COMPLETED|Overall Study||26
8841120|NCT01691820|9895553|FG001|NOT COMPLETED|Overall Study||37
8841121|NCT01691833|9895566|FG000|STARTED|Overall Study||50
8841122|NCT01691833|9895567|FG001|STARTED|Overall Study||50
8841123|NCT01691833|9895568|FG002|STARTED|Overall Study||13
8841124|NCT01691833|9895566|FG000|COMPLETED|Overall Study||49
8841125|NCT01691833|9895567|FG001|COMPLETED|Overall Study||49
8841126|NCT01691833|9895568|FG002|COMPLETED|Overall Study||13
8841127|NCT01691833|9895566|FG000|NOT COMPLETED|Overall Study||1
8841128|NCT01691833|9895567|FG001|NOT COMPLETED|Overall Study||1
8841129|NCT01691833|9895568|FG002|NOT COMPLETED|Overall Study||0
8841130|NCT01691859|9895576|FG000|STARTED|Overall Study||347
8841131|NCT01691859|9895576|FG000|COMPLETED|Overall Study||0
8841132|NCT01691859|9895576|FG000|NOT COMPLETED|Overall Study||347
8841133|NCT01691885|9895580|FG000|STARTED|Treatment Period 1(7-14 Days)||22
8841134|NCT01691885|9895581|FG001|STARTED|Treatment Period 1(7-14 Days)||23
8841135|NCT01691885|9895580|FG000|COMPLETED|Treatment Period 1(7-14 Days)||21
8841136|NCT01691885|9895581|FG001|COMPLETED|Treatment Period 1(7-14 Days)||22
8841137|NCT01691885|9895580|FG000|NOT COMPLETED|Treatment Period 1(7-14 Days)||1
8841138|NCT01691885|9895581|FG001|NOT COMPLETED|Treatment Period 1(7-14 Days)||1
8841139|NCT01691885|9895580|FG000|STARTED|Washout Period (7-9 Days)||21
8841140|NCT01691885|9895581|FG001|STARTED|Washout Period (7-9 Days)||22
8841141|NCT01691885|9895580|FG000|COMPLETED|Washout Period (7-9 Days)||21
8841142|NCT01691885|9895581|FG001|COMPLETED|Washout Period (7-9 Days)||21
8841143|NCT01691885|9895580|FG000|NOT COMPLETED|Washout Period (7-9 Days)||0
8841144|NCT01691885|9895581|FG001|NOT COMPLETED|Washout Period (7-9 Days)||1
8841145|NCT01691885|9895580|FG000|STARTED|Treatment Period 2 (7-14 Days)||21
8841146|NCT01691885|9895581|FG001|STARTED|Treatment Period 2 (7-14 Days)||21
8841147|NCT01691885|9895580|FG000|COMPLETED|Treatment Period 2 (7-14 Days)||21
8841148|NCT01691885|9895581|FG001|COMPLETED|Treatment Period 2 (7-14 Days)||21
8841149|NCT01691885|9895580|FG000|NOT COMPLETED|Treatment Period 2 (7-14 Days)||0
8841150|NCT01691885|9895581|FG001|NOT COMPLETED|Treatment Period 2 (7-14 Days)||0
8841151|NCT01691898|9895593|FG000|STARTED|Overall Study||63
8841152|NCT01691898|9895594|FG001|STARTED|Overall Study||59
8841153|NCT01691898|9895595|FG002|STARTED|Overall Study||20
8841154|NCT01691898|9895596|FG003|STARTED|Overall Study||9
8841155|NCT01691898|9895597|FG004|STARTED|Overall Study||40
8841156|NCT01691898|9895598|FG005|STARTED|Overall Study||40
8841157|NCT01691898|9895593|FG000|COMPLETED|Overall Study||16
8841158|NCT01691898|9895594|FG001|COMPLETED|Overall Study||15
8841159|NCT01691898|9895595|FG002|COMPLETED|Overall Study||11
8841160|NCT01691898|9895596|FG003|COMPLETED|Overall Study||4
8841161|NCT01691898|9895597|FG004|COMPLETED|Overall Study||26
8841162|NCT01691898|9895598|FG005|COMPLETED|Overall Study||5
8841163|NCT01691898|9895593|FG000|NOT COMPLETED|Overall Study||47
8841164|NCT01691898|9895594|FG001|NOT COMPLETED|Overall Study||44
8841165|NCT01691898|9895595|FG002|NOT COMPLETED|Overall Study||9
8841166|NCT01691898|9895596|FG003|NOT COMPLETED|Overall Study||5
8841167|NCT01691898|9895597|FG004|NOT COMPLETED|Overall Study||14
8841168|NCT01691898|9895598|FG005|NOT COMPLETED|Overall Study||35
8841169|NCT01691950|9895632|FG000|STARTED|Overall Study||20
8841170|NCT01691950|9895633|FG001|STARTED|Overall Study||10
8841171|NCT01691950|9895632|FG000|COMPLETED|Overall Study||10
8841172|NCT01691950|9895633|FG001|COMPLETED|Overall Study||10
8841173|NCT01691950|9895632|FG000|NOT COMPLETED|Overall Study||10
8841174|NCT01691950|9895633|FG001|NOT COMPLETED|Overall Study||0
8841175|NCT01692119|9895641|FG000|STARTED|Overall Study||130
8841176|NCT01692119|9895642|FG001|STARTED|Overall Study||128
8841177|NCT01692119|9895641|FG000|COMPLETED|Overall Study||110
8841178|NCT01692119|9895642|FG001|COMPLETED|Overall Study||127
8841179|NCT01692119|9895641|FG000|NOT COMPLETED|Overall Study||20
8841180|NCT01692119|9895642|FG001|NOT COMPLETED|Overall Study||1
8841181|NCT01692197|9895648|FG000|STARTED|Overall Study||43
8841182|NCT01692197|9895648|FG000|COMPLETED|Overall Study||40
8841183|NCT01692197|9895648|FG000|NOT COMPLETED|Overall Study||3
8841184|NCT01692275|9895659|FG000|STARTED|Overall Study||375
8841185|NCT01692275|9895660|FG001|STARTED|Overall Study||375
8841186|NCT01692275|9895659|FG000|COMPLETED|Overall Study||309
8841187|NCT01692275|9895660|FG001|COMPLETED|Overall Study||316
8841188|NCT01692275|9895659|FG000|NOT COMPLETED|Overall Study||66
8841189|NCT01692275|9895660|FG001|NOT COMPLETED|Overall Study||59
8841190|NCT01692301|9895680|FG000|STARTED|Overall Study|"Started indicates patients in randomized, full analysis and safety set"|229
8841191|NCT01692301|9895681|FG001|STARTED|Overall Study||225
8841192|NCT01692301|9895680|FG000|COMPLETED|Overall Study||184
8841193|NCT01692301|9895681|FG001|COMPLETED|Overall Study||183
8841194|NCT01692301|9895680|FG000|NOT COMPLETED|Overall Study||45
8841195|NCT01692301|9895681|FG001|NOT COMPLETED|Overall Study||42
8841196|NCT01692340|9895690|FG000|STARTED|Overall Study||8
8841197|NCT01692340|9895691|FG001|STARTED|Overall Study||4
8841198|NCT01692340|9895692|FG002|STARTED|Overall Study||0
8841199|NCT01692340|9895690|FG000|COMPLETED|Overall Study||8
8841200|NCT01692340|9895691|FG001|COMPLETED|Overall Study||4
8841201|NCT01692340|9895692|FG002|COMPLETED|Overall Study||0
8841202|NCT01692340|9895690|FG000|NOT COMPLETED|Overall Study||0
8841203|NCT01692340|9895691|FG001|NOT COMPLETED|Overall Study||0
8841204|NCT01692340|9895692|FG002|NOT COMPLETED|Overall Study||0
8841205|NCT01692496|9895701|FG000|STARTED|Overall Study||52
8841206|NCT01692496|9895701|FG000|3 Weeks Pazopanib (Per Protocol PP)|Overall Study||50
8841207|NCT01692496|9895701|FG000|COMPLETED|Overall Study||52
8841208|NCT01692496|9895701|FG000|NOT COMPLETED|Overall Study||0
8841209|NCT01692626|9895705|FG000|STARTED|Overall Study||6
8841210|NCT01692626|9895706|FG001|STARTED|Overall Study||7
8841211|NCT01692626|9895705|FG000|COMPLETED|Overall Study||2
8841212|NCT01692626|9895706|FG001|COMPLETED|Overall Study||1
8841213|NCT01692626|9895705|FG000|NOT COMPLETED|Overall Study||4
8841214|NCT01692626|9895706|FG001|NOT COMPLETED|Overall Study||6
8841215|NCT01692730|9895713|FG000|STARTED|Overall Study||723
8841216|NCT01692730|9895714|FG001|STARTED|Overall Study||729
8841217|NCT01692730|9895713|FG000|COMPLETED|Overall Study||498
8841218|NCT01692730|9895714|FG001|COMPLETED|Overall Study||502
8623116|NCT00491751|9662346|FG002|STARTED|Overall Study||42
8623117|NCT00491751|9662344|FG000|COMPLETED|Overall Study||22
8623118|NCT00491751|9662345|FG001|COMPLETED|Overall Study||44
8623119|NCT00491751|9662346|FG002|COMPLETED|Overall Study||42
8623120|NCT00491751|9662344|FG000|NOT COMPLETED|Overall Study||0
8623121|NCT00491751|9662345|FG001|NOT COMPLETED|Overall Study||0
8623122|NCT00491751|9662346|FG002|NOT COMPLETED|Overall Study||0
8623123|NCT00491764|9662362|FG000|STARTED|Overall Study||37
8623124|NCT00491764|9662363|FG001|STARTED|Overall Study||37
8623125|NCT00491764|9662364|FG002|STARTED|Overall Study||36
8623126|NCT00491764|9662365|FG003|STARTED|Overall Study||36
8623127|NCT00491764|9662366|FG004|STARTED|Overall Study||36
8623128|NCT00491764|9662367|FG005|STARTED|Overall Study||36
8623129|NCT00491764|9662362|FG000|COMPLETED|Overall Study||32
8623130|NCT00491764|9662363|FG001|COMPLETED|Overall Study||30
8623131|NCT00491764|9662364|FG002|COMPLETED|Overall Study||28
8623132|NCT00491764|9662365|FG003|COMPLETED|Overall Study||28
8623133|NCT00491764|9662366|FG004|COMPLETED|Overall Study||33
8841219|NCT01692730|9895713|FG000|NOT COMPLETED|Overall Study||225
8841220|NCT01692730|9895714|FG001|NOT COMPLETED|Overall Study||227
8841221|NCT01692743|9895723|FG000|STARTED|Overall Study||117
8841222|NCT01692743|9895724|FG001|STARTED|Overall Study||116
8841223|NCT01692743|9895725|FG002|STARTED|Overall Study||115
8841224|NCT01692743|9895723|FG000|COMPLETED|Overall Study||90
8841225|NCT01692743|9895724|FG001|COMPLETED|Overall Study||81
8841226|NCT01692743|9895725|FG002|COMPLETED|Overall Study||88
8841227|NCT01692743|9895723|FG000|NOT COMPLETED|Overall Study||27
8841228|NCT01692743|9895724|FG001|NOT COMPLETED|Overall Study||35
8841229|NCT01692743|9895725|FG002|NOT COMPLETED|Overall Study||27
8841230|NCT01692756|9895737|FG000|STARTED|Overall Study||12
8841231|NCT01692756|9895738|FG001|STARTED|Overall Study||12
8841232|NCT01692756|9895739|FG002|STARTED|Overall Study||13
8841233|NCT01692756|9895740|FG003|STARTED|Overall Study||12
8841234|NCT01692756|9895737|FG000|COMPLETED|Overall Study||11
8841235|NCT01692756|9895738|FG001|COMPLETED|Overall Study||11
8841236|NCT01692756|9895739|FG002|COMPLETED|Overall Study||11
8841237|NCT01692756|9895740|FG003|COMPLETED|Overall Study||12
8841238|NCT01692756|9895737|FG000|NOT COMPLETED|Overall Study||1
8841239|NCT01692756|9895738|FG001|NOT COMPLETED|Overall Study||1
8841240|NCT01692756|9895739|FG002|NOT COMPLETED|Overall Study||2
8841241|NCT01692756|9895740|FG003|NOT COMPLETED|Overall Study||0
8841242|NCT01692782|9895753|FG000|STARTED|Overall Study||116
8841243|NCT01692782|9895754|FG001|STARTED|Overall Study||115
8841244|NCT01692782|9895755|FG002|STARTED|Overall Study||110
8841245|NCT01692782|9895753|FG000|COMPLETED|Overall Study||96
8841246|NCT01692782|9895754|FG001|COMPLETED|Overall Study||59
8841247|NCT01692782|9895755|FG002|COMPLETED|Overall Study||100
8623134|NCT00491764|9662367|FG005|COMPLETED|Overall Study||27
8623135|NCT00491764|9662362|FG000|NOT COMPLETED|Overall Study||5
8841248|NCT01692782|9895753|FG000|NOT COMPLETED|Overall Study||20
8841249|NCT01692782|9895754|FG001|NOT COMPLETED|Overall Study||56
8841250|NCT01692782|9895755|FG002|NOT COMPLETED|Overall Study||10
8841251|NCT01692938|9895765|FG000|STARTED|Overall Study||16
8841252|NCT01692938|9895766|FG001|STARTED|Overall Study||16
8841253|NCT01692938|9895765|FG000|COMPLETED|Overall Study||12
8841254|NCT01692938|9895766|FG001|COMPLETED|Overall Study||12
8841255|NCT01692938|9895765|FG000|NOT COMPLETED|Overall Study||4
8841256|NCT01692938|9895766|FG001|NOT COMPLETED|Overall Study||4
8841257|NCT01692951|9895776|FG000|STARTED|Overall Study||37
8623136|NCT00491764|9662363|FG001|NOT COMPLETED|Overall Study||7
8623137|NCT00491764|9662364|FG002|NOT COMPLETED|Overall Study||8
8841258|NCT01692951|9895777|FG001|STARTED|Overall Study||111
8841259|NCT01692951|9895778|FG002|STARTED|Overall Study||18
8841260|NCT01692951|9895779|FG003|STARTED|Overall Study||54
8841261|NCT01692951|9895776|FG000|COMPLETED|Overall Study||37
8841262|NCT01692951|9895777|FG001|COMPLETED|Overall Study||111
8841263|NCT01692951|9895778|FG002|COMPLETED|Overall Study||18
8841264|NCT01692951|9895779|FG003|COMPLETED|Overall Study||54
8841265|NCT01692951|9895776|FG000|NOT COMPLETED|Overall Study||0
8841266|NCT01692951|9895777|FG001|NOT COMPLETED|Overall Study||0
8841267|NCT01692951|9895778|FG002|NOT COMPLETED|Overall Study||0
8841268|NCT01692951|9895779|FG003|NOT COMPLETED|Overall Study||0
8841269|NCT01692964|9895789|FG000|STARTED|Overall Study||237
8841270|NCT01692964|9895789|FG000|COMPLETED|Overall Study||237
8841271|NCT01692964|9895789|FG000|NOT COMPLETED|Overall Study||0
8841272|NCT01693029|9895796|FG000|STARTED|Overall Study||217
8841273|NCT01693029|9895797|FG001|STARTED|Overall Study||218
8841274|NCT01693029|9895796|FG000|COMPLETED|Overall Study||173
8841275|NCT01693029|9895797|FG001|COMPLETED|Overall Study||161
8841276|NCT01693029|9895796|FG000|NOT COMPLETED|Overall Study||44
8841277|NCT01693029|9895797|FG001|NOT COMPLETED|Overall Study||57
8841278|NCT01693068|9895805|FG000|STARTED|Randomization Period||64
8841279|NCT01693068|9895806|FG001|STARTED|Randomization Period||130
8623138|NCT00491764|9662365|FG003|NOT COMPLETED|Overall Study||8
8623139|NCT00491764|9662366|FG004|NOT COMPLETED|Overall Study||3
8623140|NCT00491764|9662367|FG005|NOT COMPLETED|Overall Study||9
8623141|NCT00491829|9662384|FG000|STARTED|Overall Study||311
8623142|NCT00491829|9662385|FG001|STARTED|Overall Study||316
8623143|NCT00491829|9662386|FG002|STARTED|Overall Study||318
8623144|NCT00491829|9662384|FG000|COMPLETED|Overall Study||216
8623145|NCT00491829|9662385|FG001|COMPLETED|Overall Study||202
8623146|NCT00491829|9662386|FG002|COMPLETED|Overall Study||243
8841280|NCT01693068|9895807|FG002|STARTED|Randomization Period||0
8841281|NCT01693068|9895805|FG000|Treated|Randomization Period||61
8841282|NCT01693068|9895806|FG001|Treated|Randomization Period||130
8841283|NCT01693068|9895807|FG002|Treated|Randomization Period||0
8841284|NCT01693068|9895805|FG000|COMPLETED|Randomization Period||62
8841285|NCT01693068|9895806|FG001|COMPLETED|Randomization Period||125
8841286|NCT01693068|9895807|FG002|COMPLETED|Randomization Period||0
8841287|NCT01693068|9895805|FG000|NOT COMPLETED|Randomization Period||2
8841288|NCT01693068|9895806|FG001|NOT COMPLETED|Randomization Period||5
8841289|NCT01693068|9895807|FG002|NOT COMPLETED|Randomization Period||0
8841290|NCT01693068|9895805|FG000|STARTED|Cross-over (Dacarbazine To Pimasertib)||0
8841291|NCT01693068|9895806|FG001|STARTED|Cross-over (Dacarbazine To Pimasertib)||0
8841292|NCT01693068|9895807|FG002|STARTED|Cross-over (Dacarbazine To Pimasertib)||41
8841293|NCT01693068|9895805|FG000|Treated|Cross-over (Dacarbazine To Pimasertib)||0
8841294|NCT01693068|9895806|FG001|Treated|Cross-over (Dacarbazine To Pimasertib)||0
8841295|NCT01693068|9895807|FG002|Treated|Cross-over (Dacarbazine To Pimasertib)||41
8841296|NCT01693068|9895805|FG000|COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0
8841297|NCT01693068|9895806|FG001|COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0
8841298|NCT01693068|9895807|FG002|COMPLETED|Cross-over (Dacarbazine To Pimasertib)||40
8841299|NCT01693068|9895805|FG000|NOT COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0
8841300|NCT01693068|9895806|FG001|NOT COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0
8841301|NCT01693068|9895807|FG002|NOT COMPLETED|Cross-over (Dacarbazine To Pimasertib)||1
8841302|NCT01693120|9895815|FG000|STARTED|Enrollment|70 subjects exited the study after consent, but prior to undergoing a study ablation procedure.|199
8841303|NCT01693120|9895815|FG000|COMPLETED|Enrollment|129 of the 199 enrolled subjects underwent a Phased RF study procedure|129
8841304|NCT01693120|9895815|FG000|NOT COMPLETED|Enrollment||70
8841305|NCT01693120|9895815|FG000|STARTED|Phased RF Study Procedure and Follow-up||129
8841306|NCT01693120|9895815|FG000|COMPLETED|Phased RF Study Procedure and Follow-up|112 of the 129 subjects with a Phased RF procedure completed the 6-month follow-up visit|112
8841307|NCT01693120|9895815|FG000|NOT COMPLETED|Phased RF Study Procedure and Follow-up||17
8841308|NCT01693185|9895821|FG000|STARTED|Overall Study||27
8841309|NCT01693185|9895822|FG001|STARTED|Overall Study||33
8841310|NCT01693185|9895821|FG000|COMPLETED|Overall Study||27
8841311|NCT01693185|9895822|FG001|COMPLETED|Overall Study||27
8841312|NCT01693185|9895821|FG000|NOT COMPLETED|Overall Study||0
8841313|NCT01693185|9895822|FG001|NOT COMPLETED|Overall Study||6
8841314|NCT01693250|9895830|FG000|STARTED|Overall Study|3 months post baseline assessment|23
8841315|NCT01693250|9895831|FG001|STARTED|Overall Study|three month post baseline assessment|17
8841316|NCT01693250|9895830|FG000|COMPLETED|Overall Study|21 teens completed 6 months post baseline assessment|21
8841317|NCT01693250|9895831|FG001|COMPLETED|Overall Study|15 teens completed 6 months post baseline assessment|15
8841318|NCT01693250|9895830|FG000|NOT COMPLETED|Overall Study||2
8841319|NCT01693250|9895831|FG001|NOT COMPLETED|Overall Study||2
8841320|NCT01693523|9895842|FG000|STARTED|Overall Study||23
8841321|NCT01693523|9895843|FG001|STARTED|Overall Study||21
8841322|NCT01693523|9895844|FG002|STARTED|Overall Study||35
8841323|NCT01693523|9895842|FG000|COMPLETED|Overall Study||18
8841324|NCT01693523|9895843|FG001|COMPLETED|Overall Study||13
8841325|NCT01693523|9895844|FG002|COMPLETED|Overall Study||27
8623147|NCT00491829|9662384|FG000|NOT COMPLETED|Overall Study||95
8841326|NCT01693523|9895842|FG000|NOT COMPLETED|Overall Study||5
8841327|NCT01693523|9895843|FG001|NOT COMPLETED|Overall Study||8
8841328|NCT01693523|9895844|FG002|NOT COMPLETED|Overall Study||8
8841329|NCT01693562|9895874|FG000|STARTED|Escalation Phase||4
8841330|NCT01693562|9895875|FG001|STARTED|Escalation Phase||4
8623148|NCT00491829|9662385|FG001|NOT COMPLETED|Overall Study||114
8623149|NCT00491829|9662386|FG002|NOT COMPLETED|Overall Study||75
8841331|NCT01693562|9895876|FG002|STARTED|Escalation Phase||3
8841332|NCT01693562|9895877|FG003|STARTED|Escalation Phase||3
8841333|NCT01693562|9895878|FG004|STARTED|Escalation Phase||6
8841334|NCT01693562|9895879|FG005|STARTED|Escalation Phase||7
8841335|NCT01693562|9895880|FG006|STARTED|Escalation Phase||0
8841336|NCT01693562|9895881|FG007|STARTED|Escalation Phase||0
8841337|NCT01693562|9895882|FG008|STARTED|Escalation Phase||0
8841338|NCT01693562|9895883|FG009|STARTED|Escalation Phase||0
8841339|NCT01693562|9895884|FG010|STARTED|Escalation Phase||0
8841340|NCT01693562|9895885|FG011|STARTED|Escalation Phase||0
8841341|NCT01693562|9895886|FG012|STARTED|Escalation Phase||0
8841342|NCT01693562|9895887|FG013|STARTED|Escalation Phase||0
8841343|NCT01693562|9895888|FG014|STARTED|Escalation Phase||0
8841344|NCT01693562|9895889|FG015|STARTED|Escalation Phase||0
8841345|NCT01693562|9895890|FG016|STARTED|Escalation Phase||0
8841346|NCT01693562|9895891|FG017|STARTED|Escalation Phase||0
8841347|NCT01693562|9895892|FG018|STARTED|Escalation Phase||0
8841348|NCT01693562|9895893|FG019|STARTED|Escalation Phase||0
8841349|NCT01693562|9895894|FG020|STARTED|Escalation Phase||0
8841350|NCT01693562|9895895|FG021|STARTED|Escalation Phase||0
8841351|NCT01693562|9895896|FG022|STARTED|Escalation Phase||0
8841352|NCT01693562|9895874|FG000|COMPLETED|Escalation Phase||0
8841353|NCT01693562|9895875|FG001|COMPLETED|Escalation Phase||0
8841354|NCT01693562|9895876|FG002|COMPLETED|Escalation Phase||0
8841355|NCT01693562|9895877|FG003|COMPLETED|Escalation Phase||0
8841356|NCT01693562|9895878|FG004|COMPLETED|Escalation Phase||0
8841357|NCT01693562|9895879|FG005|COMPLETED|Escalation Phase||0
8841358|NCT01693562|9895880|FG006|COMPLETED|Escalation Phase||0
8841359|NCT01693562|9895881|FG007|COMPLETED|Escalation Phase||0
8841360|NCT01693562|9895882|FG008|COMPLETED|Escalation Phase||0
8841361|NCT01693562|9895883|FG009|COMPLETED|Escalation Phase||0
8841362|NCT01693562|9895884|FG010|COMPLETED|Escalation Phase||0
8841363|NCT01693562|9895885|FG011|COMPLETED|Escalation Phase||0
8841364|NCT01693562|9895886|FG012|COMPLETED|Escalation Phase||0
8841365|NCT01693562|9895887|FG013|COMPLETED|Escalation Phase||0
8841366|NCT01693562|9895888|FG014|COMPLETED|Escalation Phase||0
8841367|NCT01693562|9895889|FG015|COMPLETED|Escalation Phase||0
8841368|NCT01693562|9895890|FG016|COMPLETED|Escalation Phase||0
8841369|NCT01693562|9895891|FG017|COMPLETED|Escalation Phase||0
8841370|NCT01693562|9895892|FG018|COMPLETED|Escalation Phase||0
8841371|NCT01693562|9895893|FG019|COMPLETED|Escalation Phase||0
8841372|NCT01693562|9895894|FG020|COMPLETED|Escalation Phase||0
8841373|NCT01693562|9895895|FG021|COMPLETED|Escalation Phase||0
8841374|NCT01693562|9895896|FG022|COMPLETED|Escalation Phase||0
8841375|NCT01693562|9895874|FG000|NOT COMPLETED|Escalation Phase||4
8841376|NCT01693562|9895875|FG001|NOT COMPLETED|Escalation Phase||4
8841377|NCT01693562|9895876|FG002|NOT COMPLETED|Escalation Phase||3
8841378|NCT01693562|9895877|FG003|NOT COMPLETED|Escalation Phase||3
8841379|NCT01693562|9895878|FG004|NOT COMPLETED|Escalation Phase||6
8841380|NCT01693562|9895879|FG005|NOT COMPLETED|Escalation Phase||7
8841381|NCT01693562|9895880|FG006|NOT COMPLETED|Escalation Phase||0
8841382|NCT01693562|9895881|FG007|NOT COMPLETED|Escalation Phase||0
8841383|NCT01693562|9895882|FG008|NOT COMPLETED|Escalation Phase||0
8841384|NCT01693562|9895883|FG009|NOT COMPLETED|Escalation Phase||0
8841385|NCT01693562|9895884|FG010|NOT COMPLETED|Escalation Phase||0
8944762|NCT02399228|10006657|FG000|NOT COMPLETED|Overall Study||6
8944763|NCT02399254|10006661|FG000|STARTED|Overall Study||21
8944764|NCT02399254|10006661|FG000|COMPLETED|Overall Study||19
8556574|NCT03027609|9588347|FG000|COMPLETED|Overall Study|Safety and ITT population|49
8556575|NCT03027609|9588348|FG001|COMPLETED|Overall Study|Safety and ITT population|62
8556576|NCT03027609|9588347|FG000|NOT COMPLETED|Overall Study||30
8556577|NCT03027609|9588348|FG001|NOT COMPLETED|Overall Study||17
8556578|NCT02993107|9588364|FG000|STARTED|Overall Study||113
8556579|NCT02993107|9588365|FG001|STARTED|Overall Study||120
8556580|NCT02993107|9588366|FG002|STARTED|Overall Study||50
8556581|NCT02993107|9588367|FG003|STARTED|Overall Study||35
8556582|NCT02993107|9588368|FG004|STARTED|Overall Study||34
8556583|NCT02993107|9588369|FG005|STARTED|Overall Study||36
8556584|NCT02993107|9588364|FG000|Adverse Event|Overall Study||12
8556585|NCT02993107|9588365|FG001|Adverse Event|Overall Study||4
8556586|NCT02993107|9588366|FG002|Adverse Event|Overall Study||1
8556587|NCT02993107|9588367|FG003|Adverse Event|Overall Study||1
8556588|NCT02993107|9588368|FG004|Adverse Event|Overall Study||3
8556589|NCT02993107|9588369|FG005|Adverse Event|Overall Study||5
8556590|NCT02993107|9588364|FG000|Physician Decision|Overall Study||1
8556591|NCT02993107|9588365|FG001|Physician Decision|Overall Study||0
8841386|NCT01693562|9895885|FG011|NOT COMPLETED|Escalation Phase||0
8841387|NCT01693562|9895886|FG012|NOT COMPLETED|Escalation Phase||0
8841388|NCT01693562|9895887|FG013|NOT COMPLETED|Escalation Phase||0
8556592|NCT02993107|9588366|FG002|Physician Decision|Overall Study||1
8556593|NCT02993107|9588367|FG003|Physician Decision|Overall Study||0
8841389|NCT01693562|9895888|FG014|NOT COMPLETED|Escalation Phase||0
8841390|NCT01693562|9895889|FG015|NOT COMPLETED|Escalation Phase||0
8841391|NCT01693562|9895890|FG016|NOT COMPLETED|Escalation Phase||0
8841392|NCT01693562|9895891|FG017|NOT COMPLETED|Escalation Phase||0
8556594|NCT02993107|9588368|FG004|Physician Decision|Overall Study||0
8556595|NCT02993107|9588369|FG005|Physician Decision|Overall Study||0
8841393|NCT01693562|9895892|FG018|NOT COMPLETED|Escalation Phase||0
8944765|NCT02399254|10006661|FG000|NOT COMPLETED|Overall Study||2
8841394|NCT01693562|9895893|FG019|NOT COMPLETED|Escalation Phase||0
8623150|NCT00491894|9662394|FG000|STARTED|Overall Study||137
8623151|NCT00491894|9662394|FG000|COMPLETED|Overall Study||103
8623152|NCT00491894|9662394|FG000|NOT COMPLETED|Overall Study||34
8623153|NCT00492024|9662400|FG000|STARTED|Treatment||251
8623154|NCT00492024|9662401|FG001|STARTED|Treatment||123
8623155|NCT00492024|9662400|FG000|COMPLETED|Treatment||222
8623156|NCT00492024|9662401|FG001|COMPLETED|Treatment||101
8623157|NCT00492024|9662400|FG000|NOT COMPLETED|Treatment||29
8623158|NCT00492024|9662401|FG001|NOT COMPLETED|Treatment||22
8623159|NCT00492024|9662400|FG000|STARTED|Follow up||222
8623160|NCT00492024|9662401|FG001|STARTED|Follow up||101
8623161|NCT00492024|9662400|FG000|COMPLETED|Follow up||221
8623162|NCT00492024|9662401|FG001|COMPLETED|Follow up||99
8623163|NCT00492024|9662400|FG000|NOT COMPLETED|Follow up||1
8841395|NCT01693562|9895894|FG020|NOT COMPLETED|Escalation Phase||0
8841396|NCT01693562|9895895|FG021|NOT COMPLETED|Escalation Phase||0
8841397|NCT01693562|9895896|FG022|NOT COMPLETED|Escalation Phase||0
8841398|NCT01693562|9895874|FG000|STARTED|Exploration Phase||0
8841399|NCT01693562|9895875|FG001|STARTED|Exploration Phase||0
8841400|NCT01693562|9895876|FG002|STARTED|Exploration Phase||0
8841401|NCT01693562|9895877|FG003|STARTED|Exploration Phase||0
8841402|NCT01693562|9895878|FG004|STARTED|Exploration Phase||0
8841403|NCT01693562|9895879|FG005|STARTED|Exploration Phase||0
8841404|NCT01693562|9895880|FG006|STARTED|Exploration Phase||21
8556596|NCT02993107|9588364|FG000|Withdrawal by Subject|Overall Study||32
8556597|NCT02993107|9588365|FG001|Withdrawal by Subject|Overall Study||7
8556598|NCT02993107|9588366|FG002|Withdrawal by Subject|Overall Study||7
8556599|NCT02993107|9588367|FG003|Withdrawal by Subject|Overall Study||3
8556600|NCT02993107|9588368|FG004|Withdrawal by Subject|Overall Study||6
8556601|NCT02993107|9588369|FG005|Withdrawal by Subject|Overall Study||2
8556602|NCT02993107|9588364|FG000|Lost to Follow-up|Overall Study||0
8556603|NCT02993107|9588365|FG001|Lost to Follow-up|Overall Study||1
8556604|NCT02993107|9588366|FG002|Lost to Follow-up|Overall Study||0
8556605|NCT02993107|9588367|FG003|Lost to Follow-up|Overall Study||0
8556606|NCT02993107|9588368|FG004|Lost to Follow-up|Overall Study||0
8623164|NCT00492024|9662401|FG001|NOT COMPLETED|Follow up||2
8841405|NCT01693562|9895881|FG007|STARTED|Exploration Phase||0
8841406|NCT01693562|9895882|FG008|STARTED|Exploration Phase||0
8841407|NCT01693562|9895883|FG009|STARTED|Exploration Phase||0
8841408|NCT01693562|9895884|FG010|STARTED|Exploration Phase||0
8841409|NCT01693562|9895885|FG011|STARTED|Exploration Phase||0
8841410|NCT01693562|9895886|FG012|STARTED|Exploration Phase||0
8841411|NCT01693562|9895887|FG013|STARTED|Exploration Phase||0
8841412|NCT01693562|9895888|FG014|STARTED|Exploration Phase||0
8841413|NCT01693562|9895889|FG015|STARTED|Exploration Phase||0
8841414|NCT01693562|9895890|FG016|STARTED|Exploration Phase||0
8841415|NCT01693562|9895891|FG017|STARTED|Exploration Phase||0
8841416|NCT01693562|9895892|FG018|STARTED|Exploration Phase||0
8841417|NCT01693562|9895893|FG019|STARTED|Exploration Phase||0
8841418|NCT01693562|9895894|FG020|STARTED|Exploration Phase||0
8841419|NCT01693562|9895895|FG021|STARTED|Exploration Phase||0
8841420|NCT01693562|9895896|FG022|STARTED|Exploration Phase||0
8841421|NCT01693562|9895874|FG000|COMPLETED|Exploration Phase||0
8841422|NCT01693562|9895875|FG001|COMPLETED|Exploration Phase||0
8841423|NCT01693562|9895876|FG002|COMPLETED|Exploration Phase||0
8841424|NCT01693562|9895877|FG003|COMPLETED|Exploration Phase||0
8841425|NCT01693562|9895878|FG004|COMPLETED|Exploration Phase||0
8841426|NCT01693562|9895879|FG005|COMPLETED|Exploration Phase||0
8841427|NCT01693562|9895880|FG006|COMPLETED|Exploration Phase||0
8841428|NCT01693562|9895881|FG007|COMPLETED|Exploration Phase||0
8841429|NCT01693562|9895882|FG008|COMPLETED|Exploration Phase||0
8841430|NCT01693562|9895883|FG009|COMPLETED|Exploration Phase||0
8841431|NCT01693562|9895884|FG010|COMPLETED|Exploration Phase||0
8841432|NCT01693562|9895885|FG011|COMPLETED|Exploration Phase||0
8841433|NCT01693562|9895886|FG012|COMPLETED|Exploration Phase||0
8841434|NCT01693562|9895887|FG013|COMPLETED|Exploration Phase||0
8841435|NCT01693562|9895888|FG014|COMPLETED|Exploration Phase||0
8841436|NCT01693562|9895889|FG015|COMPLETED|Exploration Phase||0
8841437|NCT01693562|9895890|FG016|COMPLETED|Exploration Phase||0
8841438|NCT01693562|9895891|FG017|COMPLETED|Exploration Phase||0
8841439|NCT01693562|9895892|FG018|COMPLETED|Exploration Phase||0
8841440|NCT01693562|9895893|FG019|COMPLETED|Exploration Phase||0
8841441|NCT01693562|9895894|FG020|COMPLETED|Exploration Phase||0
8623165|NCT00492063|9662411|FG000|STARTED|Overall Study||652
8623166|NCT00492063|9662412|FG001|STARTED|Overall Study||648
8623167|NCT00492063|9662413|FG002|STARTED|Overall Study||678
8623168|NCT00492063|9662414|FG003|STARTED|Overall Study||676
8623169|NCT00492063|9662411|FG000|COMPLETED|Overall Study||642
8623170|NCT00492063|9662412|FG001|COMPLETED|Overall Study||634
8556607|NCT02993107|9588369|FG005|Lost to Follow-up|Overall Study||1
8623171|NCT00492063|9662413|FG002|COMPLETED|Overall Study||667
8623172|NCT00492063|9662414|FG003|COMPLETED|Overall Study||666
8623173|NCT00492063|9662411|FG000|NOT COMPLETED|Overall Study||10
8623174|NCT00492063|9662412|FG001|NOT COMPLETED|Overall Study||14
8623175|NCT00492063|9662413|FG002|NOT COMPLETED|Overall Study||11
8841442|NCT01693562|9895895|FG021|COMPLETED|Exploration Phase||0
8841443|NCT01693562|9895896|FG022|COMPLETED|Exploration Phase||0
8623176|NCT00492063|9662414|FG003|NOT COMPLETED|Overall Study||10
8841444|NCT01693562|9895874|FG000|NOT COMPLETED|Exploration Phase||0
8841445|NCT01693562|9895875|FG001|NOT COMPLETED|Exploration Phase||0
8841446|NCT01693562|9895876|FG002|NOT COMPLETED|Exploration Phase||0
8841447|NCT01693562|9895877|FG003|NOT COMPLETED|Exploration Phase||0
8841448|NCT01693562|9895878|FG004|NOT COMPLETED|Exploration Phase||0
8841449|NCT01693562|9895879|FG005|NOT COMPLETED|Exploration Phase||0
8841450|NCT01693562|9895880|FG006|NOT COMPLETED|Exploration Phase||21
8841451|NCT01693562|9895881|FG007|NOT COMPLETED|Exploration Phase||0
8841452|NCT01693562|9895882|FG008|NOT COMPLETED|Exploration Phase||0
8841453|NCT01693562|9895883|FG009|NOT COMPLETED|Exploration Phase||0
8841454|NCT01693562|9895884|FG010|NOT COMPLETED|Exploration Phase||0
8841455|NCT01693562|9895885|FG011|NOT COMPLETED|Exploration Phase||0
8841456|NCT01693562|9895886|FG012|NOT COMPLETED|Exploration Phase||0
8841457|NCT01693562|9895887|FG013|NOT COMPLETED|Exploration Phase||0
8841458|NCT01693562|9895888|FG014|NOT COMPLETED|Exploration Phase||0
8841459|NCT01693562|9895889|FG015|NOT COMPLETED|Exploration Phase||0
8841460|NCT01693562|9895890|FG016|NOT COMPLETED|Exploration Phase||0
8841461|NCT01693562|9895891|FG017|NOT COMPLETED|Exploration Phase||0
8841462|NCT01693562|9895892|FG018|NOT COMPLETED|Exploration Phase||0
8841463|NCT01693562|9895893|FG019|NOT COMPLETED|Exploration Phase||0
8841464|NCT01693562|9895894|FG020|NOT COMPLETED|Exploration Phase||0
8841465|NCT01693562|9895895|FG021|NOT COMPLETED|Exploration Phase||0
8841466|NCT01693562|9895896|FG022|NOT COMPLETED|Exploration Phase||0
8841467|NCT01693562|9895874|FG000|STARTED|Expansion Phase||0
8841468|NCT01693562|9895875|FG001|STARTED|Expansion Phase||0
8841469|NCT01693562|9895876|FG002|STARTED|Expansion Phase||0
8841470|NCT01693562|9895877|FG003|STARTED|Expansion Phase||0
8841471|NCT01693562|9895878|FG004|STARTED|Expansion Phase||0
8841472|NCT01693562|9895879|FG005|STARTED|Expansion Phase||0
8841473|NCT01693562|9895880|FG006|STARTED|Expansion Phase||0
8841474|NCT01693562|9895881|FG007|STARTED|Expansion Phase||62
8841475|NCT01693562|9895882|FG008|STARTED|Expansion Phase||22
8841476|NCT01693562|9895883|FG009|STARTED|Expansion Phase|2 eligible NSCLC participants from dose-escalation were added to the dose expansion summaries.|304
8841477|NCT01693562|9895884|FG010|STARTED|Expansion Phase||40
8841478|NCT01693562|9895885|FG011|STARTED|Expansion Phase||21
8841479|NCT01693562|9895886|FG012|STARTED|Expansion Phase||24
8841480|NCT01693562|9895887|FG013|STARTED|Expansion Phase||51
8841481|NCT01693562|9895888|FG014|STARTED|Expansion Phase||40
8841482|NCT01693562|9895889|FG015|STARTED|Expansion Phase||31
8841483|NCT01693562|9895890|FG016|STARTED|Expansion Phase||201
8841484|NCT01693562|9895891|FG017|STARTED|Expansion Phase||20
8841485|NCT01693562|9895892|FG018|STARTED|Expansion Phase||47
8841486|NCT01693562|9895893|FG019|STARTED|Expansion Phase||20
8841487|NCT01693562|9895894|FG020|STARTED|Expansion Phase||21
8841488|NCT01693562|9895895|FG021|STARTED|Expansion Phase||62
8841489|NCT01693562|9895896|FG022|STARTED|Expansion Phase||10
8841490|NCT01693562|9895874|FG000|COMPLETED|Expansion Phase||0
8841491|NCT01693562|9895875|FG001|COMPLETED|Expansion Phase||0
8841492|NCT01693562|9895876|FG002|COMPLETED|Expansion Phase||0
8841493|NCT01693562|9895877|FG003|COMPLETED|Expansion Phase||0
8841494|NCT01693562|9895878|FG004|COMPLETED|Expansion Phase||0
8841495|NCT01693562|9895879|FG005|COMPLETED|Expansion Phase||0
8841496|NCT01693562|9895880|FG006|COMPLETED|Expansion Phase||0
8841497|NCT01693562|9895881|FG007|COMPLETED|Expansion Phase||0
8841498|NCT01693562|9895882|FG008|COMPLETED|Expansion Phase||0
8841499|NCT01693562|9895883|FG009|COMPLETED|Expansion Phase||4
8841500|NCT01693562|9895884|FG010|COMPLETED|Expansion Phase||0
8841501|NCT01693562|9895885|FG011|COMPLETED|Expansion Phase||0
8841502|NCT01693562|9895886|FG012|COMPLETED|Expansion Phase||1
8841503|NCT01693562|9895887|FG013|COMPLETED|Expansion Phase||0
8841504|NCT01693562|9895888|FG014|COMPLETED|Expansion Phase||0
8841505|NCT01693562|9895889|FG015|COMPLETED|Expansion Phase||0
8841506|NCT01693562|9895890|FG016|COMPLETED|Expansion Phase||4
8841507|NCT01693562|9895891|FG017|COMPLETED|Expansion Phase||0
8841508|NCT01693562|9895892|FG018|COMPLETED|Expansion Phase||0
8841509|NCT01693562|9895893|FG019|COMPLETED|Expansion Phase||0
8841510|NCT01693562|9895894|FG020|COMPLETED|Expansion Phase||0
8841511|NCT01693562|9895895|FG021|COMPLETED|Expansion Phase||0
8841512|NCT01693562|9895896|FG022|COMPLETED|Expansion Phase||0
8841513|NCT01693562|9895874|FG000|NOT COMPLETED|Expansion Phase||0
8841514|NCT01693562|9895875|FG001|NOT COMPLETED|Expansion Phase||0
8841515|NCT01693562|9895876|FG002|NOT COMPLETED|Expansion Phase||0
8841516|NCT01693562|9895877|FG003|NOT COMPLETED|Expansion Phase||0
8623177|NCT00492089|9662426|FG000|STARTED|First Intervention (6 Weeks)||5
8623178|NCT00492089|9662427|FG001|STARTED|First Intervention (6 Weeks)||6
8623179|NCT00492089|9662426|FG000|COMPLETED|First Intervention (6 Weeks)||5
8623180|NCT00492089|9662427|FG001|COMPLETED|First Intervention (6 Weeks)||6
8623181|NCT00492089|9662426|FG000|NOT COMPLETED|First Intervention (6 Weeks)||0
8841517|NCT01693562|9895878|FG004|NOT COMPLETED|Expansion Phase||0
8841518|NCT01693562|9895879|FG005|NOT COMPLETED|Expansion Phase||0
8841519|NCT01693562|9895880|FG006|NOT COMPLETED|Expansion Phase||0
8841520|NCT01693562|9895881|FG007|NOT COMPLETED|Expansion Phase||62
8841521|NCT01693562|9895882|FG008|NOT COMPLETED|Expansion Phase||22
8841522|NCT01693562|9895883|FG009|NOT COMPLETED|Expansion Phase||300
8841523|NCT01693562|9895884|FG010|NOT COMPLETED|Expansion Phase||40
8623182|NCT00492089|9662427|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0
8623183|NCT00492089|9662426|FG000|STARTED|Second Intervention (6 Weeks)||5
8841524|NCT01693562|9895885|FG011|NOT COMPLETED|Expansion Phase||21
8841525|NCT01693562|9895886|FG012|NOT COMPLETED|Expansion Phase||23
8841526|NCT01693562|9895887|FG013|NOT COMPLETED|Expansion Phase||51
8841527|NCT01693562|9895888|FG014|NOT COMPLETED|Expansion Phase||40
8841528|NCT01693562|9895889|FG015|NOT COMPLETED|Expansion Phase||31
8841529|NCT01693562|9895890|FG016|NOT COMPLETED|Expansion Phase||197
8841530|NCT01693562|9895891|FG017|NOT COMPLETED|Expansion Phase||20
8841531|NCT01693562|9895892|FG018|NOT COMPLETED|Expansion Phase||47
8841532|NCT01693562|9895893|FG019|NOT COMPLETED|Expansion Phase||20
8841533|NCT01693562|9895894|FG020|NOT COMPLETED|Expansion Phase||21
8841534|NCT01693562|9895895|FG021|NOT COMPLETED|Expansion Phase||62
8841535|NCT01693562|9895896|FG022|NOT COMPLETED|Expansion Phase||10
8841536|NCT01693614|9895982|FG000|STARTED|Overall Study||26
8841537|NCT01693614|9895983|FG001|STARTED|Overall Study||22
8841538|NCT01693614|9895984|FG002|STARTED|Overall Study||24
8841539|NCT01693614|9895982|FG000|COMPLETED|Overall Study||0
8841540|NCT01693614|9895983|FG001|COMPLETED|Overall Study||0
8841541|NCT01693614|9895984|FG002|COMPLETED|Overall Study||0
8841542|NCT01693614|9895982|FG000|NOT COMPLETED|Overall Study||26
8841543|NCT01693614|9895983|FG001|NOT COMPLETED|Overall Study||22
8841544|NCT01693614|9895984|FG002|NOT COMPLETED|Overall Study||24
8841545|NCT01693900|9895995|FG000|STARTED|Overall Study||25
8841546|NCT01693900|9895996|FG001|STARTED|Overall Study||25
8841547|NCT01693900|9895995|FG000|COMPLETED|Overall Study||25
8841548|NCT01693900|9895996|FG001|COMPLETED|Overall Study||25
8841549|NCT01693900|9895995|FG000|NOT COMPLETED|Overall Study||0
8841550|NCT01693900|9895996|FG001|NOT COMPLETED|Overall Study||0
8841551|NCT01694108|9896004|FG000|STARTED|Overall Study||2129
8841552|NCT01694108|9896005|FG001|STARTED|Overall Study||2133
8841553|NCT01694108|9896004|FG000|COMPLETED|Overall Study|100% follow-up|2129
8841554|NCT01694108|9896005|FG001|COMPLETED|Overall Study|100% follow-up|2133
8841555|NCT01694108|9896004|FG000|NOT COMPLETED|Overall Study||0
8841556|NCT01694108|9896005|FG001|NOT COMPLETED|Overall Study||0
8841557|NCT01694121|9896020|FG000|STARTED|Overall Study||228
8841558|NCT01694121|9896021|FG001|STARTED|Overall Study||227
8841559|NCT01694121|9896020|FG000|COMPLETED|Overall Study||227
8841560|NCT01694121|9896021|FG001|COMPLETED|Overall Study||227
8841561|NCT01694121|9896020|FG000|NOT COMPLETED|Overall Study||1
8841562|NCT01694121|9896021|FG001|NOT COMPLETED|Overall Study||0
8841563|NCT01694186|9896029|FG000|STARTED|Overall Study|Two investigators each site Investigator 1 unmasked treating and investigator 2 masked follow up.|42
8841564|NCT01694186|9896030|FG001|STARTED|Overall Study|Two investigators each site Investigator 1 unmasked treating and investigator 2 masked follow up.|87
8841565|NCT01694186|9896029|FG000|COMPLETED|Overall Study|Two investigators each site Investigator 1 unmasked treating and investigator 2 masked follow up.|36
8841566|NCT01694186|9896030|FG001|COMPLETED|Overall Study|Two investigators each site Investigator 1 unmasked treating and investigator 2 masked follow up.|80
8841567|NCT01694186|9896029|FG000|NOT COMPLETED|Overall Study||6
8841568|NCT01694186|9896030|FG001|NOT COMPLETED|Overall Study||7
8841569|NCT01694199|9896038|FG000|STARTED|Overall Study||71
8841570|NCT01694199|9896039|FG001|STARTED|Overall Study||68
8841571|NCT01694199|9896038|FG000|COMPLETED|Overall Study||71
8841572|NCT01694199|9896039|FG001|COMPLETED|Overall Study||68
8841573|NCT01694199|9896038|FG000|NOT COMPLETED|Overall Study||0
8841574|NCT01694199|9896039|FG001|NOT COMPLETED|Overall Study||0
8841575|NCT01694420|9896045|FG000|STARTED|Overall Study||33
8841576|NCT01694420|9896045|FG000|COMPLETED|Overall Study||30
8841577|NCT01694420|9896045|FG000|NOT COMPLETED|Overall Study||3
8841578|NCT01694433|9896051|FG000|STARTED|Overall Study||33
8841579|NCT01694433|9896052|FG001|STARTED|Overall Study||33
8841580|NCT01694433|9896051|FG000|Baseline Visit|Overall Study||33
8841581|NCT01694433|9896052|FG001|Baseline Visit|Overall Study||32
8841582|NCT01694433|9896051|FG000|COMPLETED|Overall Study||22
8841583|NCT01694433|9896052|FG001|COMPLETED|Overall Study||29
8841584|NCT01694433|9896051|FG000|NOT COMPLETED|Overall Study||11
8841585|NCT01694433|9896052|FG001|NOT COMPLETED|Overall Study||4
8841586|NCT01694485|9896063|FG000|STARTED|Overall Study||117
8841587|NCT01694485|9896064|FG001|STARTED|Overall Study||22
8841588|NCT01694485|9896065|FG002|STARTED|Overall Study||40
8841589|NCT01694485|9896066|FG003|STARTED|Overall Study||100
8841590|NCT01694485|9896067|FG004|STARTED|Overall Study||80
8841591|NCT01694485|9896063|FG000|Received Treatment|Overall Study||116
8841592|NCT01694485|9896064|FG001|Received Treatment|Overall Study||21
8841593|NCT01694485|9896065|FG002|Received Treatment|Overall Study||40
8841594|NCT01694485|9896066|FG003|Received Treatment|Overall Study||98
8841595|NCT01694485|9896067|FG004|Received Treatment|Overall Study||79
8841596|NCT01694485|9896063|FG000|Completed Week 8 Assessment|Overall Study||106
8841597|NCT01694485|9896064|FG001|Completed Week 8 Assessment|Overall Study||18
8841598|NCT01694485|9896065|FG002|Completed Week 8 Assessment|Overall Study||38
8841599|NCT01694485|9896066|FG003|Completed Week 8 Assessment|Overall Study||94
8841600|NCT01694485|9896067|FG004|Completed Week 8 Assessment|Overall Study||76
8841601|NCT01694485|9896063|FG000|Entered Open-label Period|Overall Study||100
8841602|NCT01694485|9896064|FG001|Entered Open-label Period|Overall Study||19
8841603|NCT01694485|9896065|FG002|Entered Open-label Period|Overall Study||36
8841604|NCT01694485|9896066|FG003|Entered Open-label Period|Overall Study||88
8841605|NCT01694485|9896067|FG004|Entered Open-label Period|Overall Study||68
8841606|NCT01694485|9896063|FG000|COMPLETED|Overall Study||84
8841607|NCT01694485|9896064|FG001|COMPLETED|Overall Study||15
8841608|NCT01694485|9896065|FG002|COMPLETED|Overall Study||27
8841609|NCT01694485|9896066|FG003|COMPLETED|Overall Study||62
8841610|NCT01694485|9896067|FG004|COMPLETED|Overall Study||55
8841611|NCT01694485|9896063|FG000|NOT COMPLETED|Overall Study||33
8841612|NCT01694485|9896064|FG001|NOT COMPLETED|Overall Study||7
8841613|NCT01694485|9896065|FG002|NOT COMPLETED|Overall Study||13
8841614|NCT01694485|9896066|FG003|NOT COMPLETED|Overall Study||38
8841615|NCT01694485|9896067|FG004|NOT COMPLETED|Overall Study||25
8841616|NCT01694563|9896084|FG000|STARTED|Overall Study||365
8841617|NCT01694563|9896084|FG000|COMPLETED|Overall Study||278
8841618|NCT01694563|9896084|FG000|NOT COMPLETED|Overall Study||87
8841619|NCT01694641|9896093|FG000|STARTED|Overall Study||80
8841620|NCT01694641|9896094|FG001|STARTED|Overall Study||81
8841621|NCT01694641|9896093|FG000|COMPLETED|Overall Study||68
8841622|NCT01694641|9896094|FG001|COMPLETED|Overall Study||71
8841623|NCT01694641|9896093|FG000|NOT COMPLETED|Overall Study||12
8841624|NCT01694641|9896094|FG001|NOT COMPLETED|Overall Study||10
8841625|NCT01694667|9896103|FG000|STARTED|Overall Study||29
8841626|NCT01694667|9896104|FG001|STARTED|Overall Study||28
8841627|NCT01694667|9896103|FG000|COMPLETED|Overall Study||29
8841628|NCT01694667|9896104|FG001|COMPLETED|Overall Study||28
8841629|NCT01694667|9896103|FG000|NOT COMPLETED|Overall Study||0
8841630|NCT01694667|9896104|FG001|NOT COMPLETED|Overall Study||0
8841631|NCT01694706|9896110|FG000|STARTED|Overall Study||5
8841632|NCT01694706|9896111|FG001|STARTED|Overall Study||5
8841633|NCT01694706|9896112|FG002|STARTED|Overall Study||5
8841634|NCT01694706|9896110|FG000|Received Faldaprevir|Overall Study||5
8841635|NCT01694706|9896111|FG001|Received Faldaprevir|Overall Study||5
8841636|NCT01694706|9896112|FG002|Received Faldaprevir|Overall Study||5
8841637|NCT01694706|9896110|FG000|Received Faldaprevir +OMP|Overall Study||5
8841638|NCT01694706|9896111|FG001|Received Faldaprevir +OMP|Overall Study||5
8841639|NCT01694706|9896112|FG002|Received Faldaprevir +OMP|Overall Study||5
8841640|NCT01694706|9896110|FG000|Received Faldaprevir Fed|Overall Study||4
8841641|NCT01694706|9896111|FG001|Received Faldaprevir Fed|Overall Study||5
8841642|NCT01694706|9896112|FG002|Received Faldaprevir Fed|Overall Study||5
8841643|NCT01694706|9896110|FG000|COMPLETED|Overall Study||4
8841644|NCT01694706|9896111|FG001|COMPLETED|Overall Study||4
8841645|NCT01694706|9896112|FG002|COMPLETED|Overall Study||5
8841646|NCT01694706|9896110|FG000|NOT COMPLETED|Overall Study||1
8841647|NCT01694706|9896111|FG001|NOT COMPLETED|Overall Study||1
8841648|NCT01694706|9896112|FG002|NOT COMPLETED|Overall Study||0
8841649|NCT01694771|9896123|FG000|STARTED|Overall Study||567
8841650|NCT01694771|9896124|FG001|STARTED|Overall Study||565
8841651|NCT01694771|9896123|FG000|COMPLETED|Overall Study||527
8841652|NCT01694771|9896124|FG001|COMPLETED|Overall Study||525
8841653|NCT01694771|9896123|FG000|NOT COMPLETED|Overall Study||40
8841654|NCT01694771|9896124|FG001|NOT COMPLETED|Overall Study||40
8841655|NCT01694966|9896133|FG000|STARTED|Overall Study||504
8841656|NCT01694966|9896134|FG001|STARTED|Overall Study||247
8841657|NCT01694966|9896135|FG002|STARTED|Overall Study||498
8623184|NCT00492089|9662427|FG001|STARTED|Second Intervention (6 Weeks)||6
8623185|NCT00492089|9662426|FG000|COMPLETED|Second Intervention (6 Weeks)||5
8623186|NCT00492089|9662427|FG001|COMPLETED|Second Intervention (6 Weeks)||6
8623187|NCT00492089|9662426|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
8623188|NCT00492089|9662427|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0
8841658|NCT01694966|9896133|FG000|COMPLETED|Overall Study||470
8841659|NCT01694966|9896134|FG001|COMPLETED|Overall Study||232
8841660|NCT01694966|9896135|FG002|COMPLETED|Overall Study||464
8841661|NCT01694966|9896133|FG000|NOT COMPLETED|Overall Study||34
8841662|NCT01694966|9896134|FG001|NOT COMPLETED|Overall Study||15
8841663|NCT01694966|9896135|FG002|NOT COMPLETED|Overall Study||34
8841664|NCT01695044|9896145|FG000|STARTED|Overall Study||119
8841665|NCT01695044|9896145|FG000|COMPLETED|Overall Study||17
8841666|NCT01695044|9896145|FG000|NOT COMPLETED|Overall Study||102
8841667|NCT01695135|9896155|FG000|STARTED|Double-blind Treatment Phase||71
8841668|NCT01695135|9896156|FG001|STARTED|Double-blind Treatment Phase||143
8841669|NCT01695135|9896157|FG002|STARTED|Double-blind Treatment Phase||0
8841670|NCT01695135|9896158|FG003|STARTED|Double-blind Treatment Phase||0
8841671|NCT01695135|9896155|FG000|COMPLETED|Double-blind Treatment Phase||0
8841672|NCT01695135|9896156|FG001|COMPLETED|Double-blind Treatment Phase||4
8841673|NCT01695135|9896157|FG002|COMPLETED|Double-blind Treatment Phase||0
8841674|NCT01695135|9896158|FG003|COMPLETED|Double-blind Treatment Phase||0
8841675|NCT01695135|9896155|FG000|NOT COMPLETED|Double-blind Treatment Phase||71
8841676|NCT01695135|9896156|FG001|NOT COMPLETED|Double-blind Treatment Phase||139
8841677|NCT01695135|9896157|FG002|NOT COMPLETED|Double-blind Treatment Phase||0
8841678|NCT01695135|9896158|FG003|NOT COMPLETED|Double-blind Treatment Phase||0
8841679|NCT01695135|9896155|FG000|STARTED|Open Label Extension Treatment Phase||0
8841680|NCT01695135|9896156|FG001|STARTED|Open Label Extension Treatment Phase||0
8841681|NCT01695135|9896157|FG002|STARTED|Open Label Extension Treatment Phase||49
8841682|NCT01695135|9896158|FG003|STARTED|Open Label Extension Treatment Phase||80
8841683|NCT01695135|9896155|FG000|COMPLETED|Open Label Extension Treatment Phase||0
8841684|NCT01695135|9896156|FG001|COMPLETED|Open Label Extension Treatment Phase||0
8623189|NCT00492115|9662435|FG000|STARTED|Overall Study||19
8841685|NCT01695135|9896157|FG002|COMPLETED|Open Label Extension Treatment Phase||9
8841686|NCT01695135|9896158|FG003|COMPLETED|Open Label Extension Treatment Phase||10
8841687|NCT01695135|9896155|FG000|NOT COMPLETED|Open Label Extension Treatment Phase||0
8841688|NCT01695135|9896156|FG001|NOT COMPLETED|Open Label Extension Treatment Phase||0
8841689|NCT01695135|9896157|FG002|NOT COMPLETED|Open Label Extension Treatment Phase||40
8841690|NCT01695135|9896158|FG003|NOT COMPLETED|Open Label Extension Treatment Phase||70
8841691|NCT01695239|9896170|FG000|STARTED|Double-Blind (DB) Treatment Period||106
8841692|NCT01695239|9896171|FG001|STARTED|Double-Blind (DB) Treatment Period||101
8623190|NCT00492115|9662436|FG001|STARTED|Overall Study||19
8623191|NCT00492115|9662435|FG000|COMPLETED|Overall Study|3 dropped due to anxiety or not being able to tolerate CPAP|16
8841693|NCT01695239|9896172|FG002|STARTED|Double-Blind (DB) Treatment Period||107
8841694|NCT01695239|9896173|FG003|STARTED|Double-Blind (DB) Treatment Period||103
8841695|NCT01695239|9896174|FG004|STARTED|Double-Blind (DB) Treatment Period||0
8841696|NCT01695239|9896175|FG005|STARTED|Double-Blind (DB) Treatment Period||0
8841697|NCT01695239|9896176|FG006|STARTED|Double-Blind (DB) Treatment Period||0
8841698|NCT01695239|9896177|FG007|STARTED|Double-Blind (DB) Treatment Period||0
8841699|NCT01695239|9896178|FG008|STARTED|Double-Blind (DB) Treatment Period||0
8841700|NCT01695239|9896179|FG009|STARTED|Double-Blind (DB) Treatment Period||0
8841701|NCT01695239|9896180|FG010|STARTED|Double-Blind (DB) Treatment Period||0
8841702|NCT01695239|9896181|FG011|STARTED|Double-Blind (DB) Treatment Period||0
8841703|NCT01695239|9896182|FG012|STARTED|Double-Blind (DB) Treatment Period||0
8841704|NCT01695239|9896183|FG013|STARTED|Double-Blind (DB) Treatment Period||0
8841705|NCT01695239|9896170|FG000|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||106
8841706|NCT01695239|9896171|FG001|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||101
8841707|NCT01695239|9896172|FG002|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||107
8841708|NCT01695239|9896173|FG003|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||102
8841709|NCT01695239|9896174|FG004|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
8841710|NCT01695239|9896175|FG005|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
8841711|NCT01695239|9896176|FG006|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
8841712|NCT01695239|9896177|FG007|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
8841713|NCT01695239|9896178|FG008|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
8556608|NCT02993107|9588364|FG000|Sponsor Decision|Overall Study||4
8556609|NCT02993107|9588365|FG001|Sponsor Decision|Overall Study||0
8556610|NCT02993107|9588366|FG002|Sponsor Decision|Overall Study||1
8556611|NCT02993107|9588367|FG003|Sponsor Decision|Overall Study||1
8556612|NCT02993107|9588368|FG004|Sponsor Decision|Overall Study||0
8556613|NCT02993107|9588369|FG005|Sponsor Decision|Overall Study||4
8556614|NCT02993107|9588364|FG000|Protocol Deviation|Overall Study||0
8556615|NCT02993107|9588365|FG001|Protocol Deviation|Overall Study||0
8556616|NCT02993107|9588366|FG002|Protocol Deviation|Overall Study||0
8556617|NCT02993107|9588367|FG003|Protocol Deviation|Overall Study||0
8556618|NCT02993107|9588368|FG004|Protocol Deviation|Overall Study||1
8556619|NCT02993107|9588369|FG005|Protocol Deviation|Overall Study||0
8841714|NCT01695239|9896179|FG009|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
8841715|NCT01695239|9896180|FG010|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
8841716|NCT01695239|9896181|FG011|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
8841717|NCT01695239|9896182|FG012|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
8841718|NCT01695239|9896183|FG013|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
8556620|NCT02993107|9588364|FG000|Other Reasons|Overall Study||2
8556621|NCT02993107|9588365|FG001|Other Reasons|Overall Study||1
8556622|NCT02993107|9588366|FG002|Other Reasons|Overall Study||1
8556623|NCT02993107|9588367|FG003|Other Reasons|Overall Study||1
8556624|NCT02993107|9588368|FG004|Other Reasons|Overall Study||2
8556625|NCT02993107|9588369|FG005|Other Reasons|Overall Study||3
8556626|NCT02993107|9588364|FG000|COMPLETED|Overall Study||62
8556627|NCT02993107|9588365|FG001|COMPLETED|Overall Study||107
8556628|NCT02993107|9588366|FG002|COMPLETED|Overall Study||39
8723455|NCT01023256|9770951|FG003|NOT COMPLETED|Overall Study||5
8723456|NCT01023269|9770964|FG000|STARTED|Overall Study||3
8723457|NCT01023269|9770965|FG001|STARTED|Overall Study||2
8723458|NCT01023269|9770964|FG000|COMPLETED|Overall Study||1
8723459|NCT01023269|9770965|FG001|COMPLETED|Overall Study||2
8723460|NCT01023269|9770964|FG000|NOT COMPLETED|Overall Study||2
8723461|NCT01023269|9770965|FG001|NOT COMPLETED|Overall Study||0
8723462|NCT01023308|9770971|FG000|STARTED|Overall Study||387
8723463|NCT01023308|9770972|FG001|STARTED|Overall Study||381
8723464|NCT01023308|9770971|FG000|COMPLETED|Overall Study|completed all planned cycles of study treatment as per protocol|102
8723465|NCT01023308|9770972|FG001|COMPLETED|Overall Study|completed all planned cycles of study treatment as per protocol|102
8723466|NCT01023308|9770971|FG000|NOT COMPLETED|Overall Study||285
8723467|NCT01023308|9770972|FG001|NOT COMPLETED|Overall Study||279
8723468|NCT01023477|9770980|FG000|STARTED|Overall Study||7
8723469|NCT01023477|9770981|FG001|STARTED|Overall Study||5
8723470|NCT01023477|9770980|FG000|COMPLETED|Overall Study||7
8723471|NCT01023477|9770981|FG001|COMPLETED|Overall Study||5
8723472|NCT01023477|9770980|FG000|NOT COMPLETED|Overall Study||0
8723473|NCT01023477|9770981|FG001|NOT COMPLETED|Overall Study||0
8723474|NCT01023516|9770989|FG000|STARTED|Overall Study||313
8723475|NCT01023516|9770990|FG001|STARTED|Overall Study||302
8723476|NCT01023516|9770989|FG000|COMPLETED|Overall Study||289
8723477|NCT01023516|9770990|FG001|COMPLETED|Overall Study||284
8723478|NCT01023516|9770989|FG000|NOT COMPLETED|Overall Study||24
8723479|NCT01023516|9770990|FG001|NOT COMPLETED|Overall Study||18
8723480|NCT01023568|9770999|FG000|STARTED|Overall Study||45
8723481|NCT01023568|9771000|FG001|STARTED|Overall Study||44
8723482|NCT01023568|9771001|FG002|STARTED|Overall Study||45
8556629|NCT02993107|9588367|FG003|COMPLETED|Overall Study||29
8556630|NCT02993107|9588368|FG004|COMPLETED|Overall Study||22
8556631|NCT02993107|9588369|FG005|COMPLETED|Overall Study||21
8723483|NCT01023568|9770999|FG000|COMPLETED|Overall Study||45
8723484|NCT01023568|9771000|FG001|COMPLETED|Overall Study||44
8841719|NCT01695239|9896170|FG000|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||27
8841720|NCT01695239|9896171|FG001|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||9
8841721|NCT01695239|9896172|FG002|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||11
8841722|NCT01695239|9896173|FG003|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||10
8556632|NCT02993107|9588364|FG000|NOT COMPLETED|Overall Study||51
8556633|NCT02993107|9588365|FG001|NOT COMPLETED|Overall Study||13
8556634|NCT02993107|9588366|FG002|NOT COMPLETED|Overall Study||11
8841723|NCT01695239|9896174|FG004|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
8841724|NCT01695239|9896175|FG005|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
8841725|NCT01695239|9896176|FG006|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
8841726|NCT01695239|9896177|FG007|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
8841727|NCT01695239|9896178|FG008|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
8841728|NCT01695239|9896179|FG009|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
8841729|NCT01695239|9896180|FG010|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
8841730|NCT01695239|9896181|FG011|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
8841731|NCT01695239|9896182|FG012|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
8841732|NCT01695239|9896183|FG013|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
8841733|NCT01695239|9896170|FG000|COMPLETED|Double-Blind (DB) Treatment Period||91
8841734|NCT01695239|9896171|FG001|COMPLETED|Double-Blind (DB) Treatment Period||97
8841735|NCT01695239|9896172|FG002|COMPLETED|Double-Blind (DB) Treatment Period||97
8841736|NCT01695239|9896173|FG003|COMPLETED|Double-Blind (DB) Treatment Period||96
8841737|NCT01695239|9896174|FG004|COMPLETED|Double-Blind (DB) Treatment Period||0
8841738|NCT01695239|9896175|FG005|COMPLETED|Double-Blind (DB) Treatment Period||0
8841739|NCT01695239|9896176|FG006|COMPLETED|Double-Blind (DB) Treatment Period||0
8841740|NCT01695239|9896177|FG007|COMPLETED|Double-Blind (DB) Treatment Period||0
8841741|NCT01695239|9896178|FG008|COMPLETED|Double-Blind (DB) Treatment Period||0
8841742|NCT01695239|9896179|FG009|COMPLETED|Double-Blind (DB) Treatment Period||0
8841743|NCT01695239|9896180|FG010|COMPLETED|Double-Blind (DB) Treatment Period||0
8841744|NCT01695239|9896181|FG011|COMPLETED|Double-Blind (DB) Treatment Period||0
8841745|NCT01695239|9896182|FG012|COMPLETED|Double-Blind (DB) Treatment Period||0
8841746|NCT01695239|9896183|FG013|COMPLETED|Double-Blind (DB) Treatment Period||0
8841747|NCT01695239|9896170|FG000|NOT COMPLETED|Double-Blind (DB) Treatment Period||15
8841748|NCT01695239|9896171|FG001|NOT COMPLETED|Double-Blind (DB) Treatment Period||4
8841749|NCT01695239|9896172|FG002|NOT COMPLETED|Double-Blind (DB) Treatment Period||10
8841750|NCT01695239|9896173|FG003|NOT COMPLETED|Double-Blind (DB) Treatment Period||7
8841751|NCT01695239|9896174|FG004|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
8841752|NCT01695239|9896175|FG005|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
8841753|NCT01695239|9896176|FG006|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
8841754|NCT01695239|9896177|FG007|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
8841755|NCT01695239|9896178|FG008|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
8841756|NCT01695239|9896179|FG009|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
8841757|NCT01695239|9896180|FG010|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
8841758|NCT01695239|9896181|FG011|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
8944766|NCT02399345|10006666|FG000|STARTED|Overall Study||10
8556635|NCT02993107|9588367|FG003|NOT COMPLETED|Overall Study||6
8556636|NCT02993107|9588368|FG004|NOT COMPLETED|Overall Study||12
8623192|NCT00492115|9662436|FG001|COMPLETED|Overall Study|4 dropped due to not being able to tolerate CPAP|15
8623193|NCT00492115|9662435|FG000|NOT COMPLETED|Overall Study||3
8556637|NCT02993107|9588369|FG005|NOT COMPLETED|Overall Study||15
8556638|NCT02981082|9588397|FG000|STARTED|Overall Study||4
8556639|NCT02981082|9588398|FG001|STARTED|Overall Study||2
8556640|NCT02981082|9588397|FG000|COMPLETED|Overall Study||1
8556641|NCT02981082|9588398|FG001|COMPLETED|Overall Study||1
8556642|NCT02981082|9588397|FG000|NOT COMPLETED|Overall Study||3
8623194|NCT00492115|9662436|FG001|NOT COMPLETED|Overall Study||4
8623195|NCT00492206|9662442|FG000|STARTED|Overall Study||40
8623196|NCT00492206|9662442|FG000|COMPLETED|Overall Study||40
8623197|NCT00492206|9662442|FG000|NOT COMPLETED|Overall Study||0
8623198|NCT00492232|9662450|FG000|STARTED|Placebo Run-in||0
8623199|NCT00492232|9662451|FG001|STARTED|Placebo Run-in|All subjects received placebo in the placebo run-in period.|205
8623200|NCT00492232|9662450|FG000|COMPLETED|Placebo Run-in||0
8623201|NCT00492232|9662451|FG001|COMPLETED|Placebo Run-in|These subjects successfully completed the placebo run-in period and were randomized to the DBTP.|135
8623202|NCT00492232|9662450|FG000|NOT COMPLETED|Placebo Run-in||0
8623203|NCT00492232|9662451|FG001|NOT COMPLETED|Placebo Run-in||70
8623204|NCT00492232|9662450|FG000|STARTED|Double-Blind Treatment||65
8623205|NCT00492232|9662451|FG001|STARTED|Double-Blind Treatment||70
8623206|NCT00492232|9662450|FG000|COMPLETED|Double-Blind Treatment||47
8623207|NCT00492232|9662451|FG001|COMPLETED|Double-Blind Treatment||45
8623208|NCT00492232|9662450|FG000|NOT COMPLETED|Double-Blind Treatment||18
8623209|NCT00492232|9662451|FG001|NOT COMPLETED|Double-Blind Treatment||25
8623210|NCT00492232|9662450|FG000|STARTED|Open-Label Treatment|In the previous DBTP, 45 and 44 subjects were randomized to ramelteon and placebo, respectively.|89
8623211|NCT00492232|9662451|FG001|STARTED|Open-Label Treatment|All subjects received ramelteon in the OLTP.|0
8841759|NCT01695239|9896182|FG012|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
8841760|NCT01695239|9896183|FG013|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
8841761|NCT01695239|9896170|FG000|STARTED|IR Participants (Week 16 Up To Week 24)|Only inadequate responders were included.|0
8841762|NCT01695239|9896171|FG001|STARTED|IR Participants (Week 16 Up To Week 24)|Only inadequate responders were included.|0
8841763|NCT01695239|9896172|FG002|STARTED|IR Participants (Week 16 Up To Week 24)|Only inadequate responders were included.|0
8841764|NCT01695239|9896173|FG003|STARTED|IR Participants (Week 16 Up To Week 24)|Only inadequate responders were included.|0
8841765|NCT01695239|9896174|FG004|STARTED|IR Participants (Week 16 Up To Week 24)|IR from placebo who re-randomized to ixeQ4W and IR from ixeQ4W.|24
8841766|NCT01695239|9896175|FG005|STARTED|IR Participants (Week 16 Up To Week 24)|IR from placebo who re-randomized to ixeQ2W and IR from ixeQ2W.|24
8841767|NCT01695239|9896176|FG006|STARTED|IR Participants (Week 16 Up To Week 24)|Adalimumab Q2W (IR) who re-randomized to IxeQ2W or IxeQ4W and PBO for ixe and adalimumab.|9
8841768|NCT01695239|9896177|FG007|STARTED|IR Participants (Week 16 Up To Week 24)||0
8841769|NCT01695239|9896178|FG008|STARTED|IR Participants (Week 16 Up To Week 24)||0
8841770|NCT01695239|9896179|FG009|STARTED|IR Participants (Week 16 Up To Week 24)||0
8841771|NCT01695239|9896180|FG010|STARTED|IR Participants (Week 16 Up To Week 24)||0
8841772|NCT01695239|9896181|FG011|STARTED|IR Participants (Week 16 Up To Week 24)||0
8841773|NCT01695239|9896182|FG012|STARTED|IR Participants (Week 16 Up To Week 24)||0
8841774|NCT01695239|9896183|FG013|STARTED|IR Participants (Week 16 Up To Week 24)||0
8841775|NCT01695239|9896170|FG000|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8841776|NCT01695239|9896171|FG001|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8841777|NCT01695239|9896172|FG002|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8841778|NCT01695239|9896173|FG003|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8841779|NCT01695239|9896174|FG004|COMPLETED|IR Participants (Week 16 Up To Week 24)||24
8841780|NCT01695239|9896175|FG005|COMPLETED|IR Participants (Week 16 Up To Week 24)||24
8841781|NCT01695239|9896176|FG006|COMPLETED|IR Participants (Week 16 Up To Week 24)||9
8841782|NCT01695239|9896177|FG007|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8841783|NCT01695239|9896178|FG008|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8841784|NCT01695239|9896179|FG009|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8841785|NCT01695239|9896180|FG010|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8841786|NCT01695239|9896181|FG011|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8841787|NCT01695239|9896182|FG012|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8841788|NCT01695239|9896183|FG013|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8841789|NCT01695239|9896170|FG000|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8841790|NCT01695239|9896171|FG001|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8841791|NCT01695239|9896172|FG002|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8841792|NCT01695239|9896173|FG003|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8841793|NCT01695239|9896174|FG004|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8841794|NCT01695239|9896175|FG005|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8841795|NCT01695239|9896176|FG006|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8841796|NCT01695239|9896177|FG007|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8841797|NCT01695239|9896178|FG008|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8841798|NCT01695239|9896179|FG009|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8841799|NCT01695239|9896180|FG010|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8841800|NCT01695239|9896181|FG011|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8841801|NCT01695239|9896182|FG012|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8841802|NCT01695239|9896183|FG013|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8841803|NCT01695239|9896170|FG000|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
8841804|NCT01695239|9896171|FG001|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
8841805|NCT01695239|9896172|FG002|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
8841806|NCT01695239|9896173|FG003|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
8841807|NCT01695239|9896174|FG004|STARTED|Placebo Washout (Week 24 Up To Week 32)|Only included PBO washout participants.|0
8841808|NCT01695239|9896175|FG005|STARTED|Placebo Washout (Week 24 Up To Week 32)|Only included PBO washout participants.|0
8841809|NCT01695239|9896176|FG006|STARTED|Placebo Washout (Week 24 Up To Week 32)|Only included PBO washout participants.|0
8841810|NCT01695239|9896177|FG007|STARTED|Placebo Washout (Week 24 Up To Week 32)|Adalimumab Q2W responders who re-randomized to IxeQ2W or IxeQ4W and PBO for ixe and adalimumab.|88
8841811|NCT01695239|9896178|FG008|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
8841812|NCT01695239|9896179|FG009|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
8841813|NCT01695239|9896180|FG010|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
8841814|NCT01695239|9896181|FG011|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
8841815|NCT01695239|9896182|FG012|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
8841816|NCT01695239|9896183|FG013|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
8841817|NCT01695239|9896170|FG000|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8841818|NCT01695239|9896171|FG001|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8841819|NCT01695239|9896172|FG002|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8841820|NCT01695239|9896173|FG003|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8841821|NCT01695239|9896174|FG004|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8841822|NCT01695239|9896175|FG005|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8841823|NCT01695239|9896176|FG006|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8841824|NCT01695239|9896177|FG007|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||77
8841825|NCT01695239|9896178|FG008|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8841826|NCT01695239|9896179|FG009|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8841827|NCT01695239|9896180|FG010|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8841828|NCT01695239|9896181|FG011|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8841829|NCT01695239|9896182|FG012|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8841830|NCT01695239|9896183|FG013|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8841831|NCT01695239|9896170|FG000|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8841832|NCT01695239|9896171|FG001|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8841833|NCT01695239|9896172|FG002|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8841834|NCT01695239|9896173|FG003|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8841835|NCT01695239|9896174|FG004|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8841836|NCT01695239|9896175|FG005|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8841837|NCT01695239|9896176|FG006|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8841838|NCT01695239|9896177|FG007|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||11
8841839|NCT01695239|9896178|FG008|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8841840|NCT01695239|9896179|FG009|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8841841|NCT01695239|9896180|FG010|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8841842|NCT01695239|9896181|FG011|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8841843|NCT01695239|9896182|FG012|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8841844|NCT01695239|9896183|FG013|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8841845|NCT01695239|9896170|FG000|STARTED|Extension Long-Term Extension Periods||0
8841846|NCT01695239|9896171|FG001|STARTED|Extension Long-Term Extension Periods||0
8556643|NCT02981082|9588398|FG001|NOT COMPLETED|Overall Study||1
8556644|NCT02924129|9588406|FG000|STARTED|Overall Study||67
8556645|NCT02924129|9588407|FG001|STARTED|Overall Study||67
8556646|NCT02924129|9588406|FG000|COMPLETED|Overall Study||62
8556647|NCT02924129|9588407|FG001|COMPLETED|Overall Study||63
8556648|NCT02924129|9588406|FG000|NOT COMPLETED|Overall Study||5
8556649|NCT02924129|9588407|FG001|NOT COMPLETED|Overall Study||4
8556650|NCT02831673|9588415|FG000|STARTED|Overall Study||356
8556651|NCT02831673|9588416|FG001|STARTED|Overall Study||358
8556652|NCT02831673|9588415|FG000|COMPLETED|Overall Study||0
8556653|NCT02831673|9588416|FG001|COMPLETED|Overall Study||0
8841847|NCT01695239|9896172|FG002|STARTED|Extension Long-Term Extension Periods||0
8841848|NCT01695239|9896173|FG003|STARTED|Extension Long-Term Extension Periods||0
8841849|NCT01695239|9896174|FG004|STARTED|Extension Long-Term Extension Periods||0
8841850|NCT01695239|9896175|FG005|STARTED|Extension Long-Term Extension Periods||0
8841851|NCT01695239|9896176|FG006|STARTED|Extension Long-Term Extension Periods||0
8841852|NCT01695239|9896177|FG007|STARTED|Extension Long-Term Extension Periods|Only included combined extension participants.|0
8841853|NCT01695239|9896178|FG008|STARTED|Extension Long-Term Extension Periods|IxeQ4W who re-randomized to ixeQ4W.|187
8841854|NCT01695239|9896179|FG009|STARTED|Extension Long-Term Extension Periods|IxeQ2W who re-randomized to ixeQ2W.|183
8841855|NCT01695239|9896180|FG010|STARTED|Extension Long-Term Extension Periods||0
8841856|NCT01695239|9896181|FG011|STARTED|Extension Long-Term Extension Periods||0
8841857|NCT01695239|9896182|FG012|STARTED|Extension Long-Term Extension Periods||0
8841858|NCT01695239|9896183|FG013|STARTED|Extension Long-Term Extension Periods||0
8841859|NCT01695239|9896170|FG000|COMPLETED|Extension Long-Term Extension Periods||0
8841860|NCT01695239|9896171|FG001|COMPLETED|Extension Long-Term Extension Periods||0
8841861|NCT01695239|9896172|FG002|COMPLETED|Extension Long-Term Extension Periods||0
8841862|NCT01695239|9896173|FG003|COMPLETED|Extension Long-Term Extension Periods||0
8841863|NCT01695239|9896174|FG004|COMPLETED|Extension Long-Term Extension Periods||0
8841864|NCT01695239|9896175|FG005|COMPLETED|Extension Long-Term Extension Periods||0
8841865|NCT01695239|9896176|FG006|COMPLETED|Extension Long-Term Extension Periods||0
8841866|NCT01695239|9896177|FG007|COMPLETED|Extension Long-Term Extension Periods||0
8841867|NCT01695239|9896178|FG008|COMPLETED|Extension Long-Term Extension Periods||121
8841868|NCT01695239|9896179|FG009|COMPLETED|Extension Long-Term Extension Periods||122
8841869|NCT01695239|9896180|FG010|COMPLETED|Extension Long-Term Extension Periods||0
8841870|NCT01695239|9896181|FG011|COMPLETED|Extension Long-Term Extension Periods||0
8841871|NCT01695239|9896182|FG012|COMPLETED|Extension Long-Term Extension Periods||0
8841872|NCT01695239|9896183|FG013|COMPLETED|Extension Long-Term Extension Periods||0
8841873|NCT01695239|9896170|FG000|NOT COMPLETED|Extension Long-Term Extension Periods||0
8841874|NCT01695239|9896171|FG001|NOT COMPLETED|Extension Long-Term Extension Periods||0
8841875|NCT01695239|9896172|FG002|NOT COMPLETED|Extension Long-Term Extension Periods||0
8841876|NCT01695239|9896173|FG003|NOT COMPLETED|Extension Long-Term Extension Periods||0
8841877|NCT01695239|9896174|FG004|NOT COMPLETED|Extension Long-Term Extension Periods||0
8841878|NCT01695239|9896175|FG005|NOT COMPLETED|Extension Long-Term Extension Periods||0
8841879|NCT01695239|9896176|FG006|NOT COMPLETED|Extension Long-Term Extension Periods||0
8841880|NCT01695239|9896177|FG007|NOT COMPLETED|Extension Long-Term Extension Periods||0
8841881|NCT01695239|9896178|FG008|NOT COMPLETED|Extension Long-Term Extension Periods||66
8841882|NCT01695239|9896179|FG009|NOT COMPLETED|Extension Long-Term Extension Periods||61
8944767|NCT02399345|10006666|FG000|COMPLETED|Overall Study||10
8944768|NCT02399345|10006666|FG000|NOT COMPLETED|Overall Study||0
8944769|NCT02399475|10006672|FG000|STARTED|Overall Study||7
8944770|NCT02399475|10006673|FG001|STARTED|Overall Study||7
8944771|NCT02399475|10006672|FG000|COMPLETED|Overall Study||6
8944772|NCT02399475|10006673|FG001|COMPLETED|Overall Study||7
8944773|NCT02399475|10006672|FG000|NOT COMPLETED|Overall Study||1
8556654|NCT02831673|9588415|FG000|NOT COMPLETED|Overall Study||356
8556655|NCT02831673|9588416|FG001|NOT COMPLETED|Overall Study||358
8841883|NCT01695239|9896180|FG010|NOT COMPLETED|Extension Long-Term Extension Periods||0
8841884|NCT01695239|9896181|FG011|NOT COMPLETED|Extension Long-Term Extension Periods||0
8841885|NCT01695239|9896182|FG012|NOT COMPLETED|Extension Long-Term Extension Periods||0
8841886|NCT01695239|9896183|FG013|NOT COMPLETED|Extension Long-Term Extension Periods||0
8841887|NCT01695239|9896170|FG000|STARTED|Post-Treatment Follow-Up Period||0
8841888|NCT01695239|9896171|FG001|STARTED|Post-Treatment Follow-Up Period||0
8841889|NCT01695239|9896172|FG002|STARTED|Post-Treatment Follow-Up Period||0
8841890|NCT01695239|9896173|FG003|STARTED|Post-Treatment Follow-Up Period||0
8841891|NCT01695239|9896174|FG004|STARTED|Post-Treatment Follow-Up Period||0
8556656|NCT02741700|9588424|FG000|STARTED|Overall Study||152
8556657|NCT02741700|9588425|FG001|STARTED|Overall Study||154
8556658|NCT02741700|9588424|FG000|COMPLETED|Overall Study||126
8556659|NCT02741700|9588425|FG001|COMPLETED|Overall Study||135
8841892|NCT01695239|9896175|FG005|STARTED|Post-Treatment Follow-Up Period||0
8841893|NCT01695239|9896176|FG006|STARTED|Post-Treatment Follow-Up Period||0
8841894|NCT01695239|9896177|FG007|STARTED|Post-Treatment Follow-Up Period||0
8556660|NCT02741700|9588424|FG000|NOT COMPLETED|Overall Study||26
8556661|NCT02741700|9588425|FG001|NOT COMPLETED|Overall Study||19
8556662|NCT02635776|9588433|FG000|STARTED|Overall Study||416
8556663|NCT02635776|9588434|FG001|STARTED|Overall Study||139
8556664|NCT02635776|9588433|FG000|COMPLETED|Overall Study||314
8556665|NCT02635776|9588434|FG001|COMPLETED|Overall Study||128
8556666|NCT02635776|9588433|FG000|NOT COMPLETED|Overall Study||102
8556667|NCT02635776|9588434|FG001|NOT COMPLETED|Overall Study||11
8841895|NCT01695239|9896178|FG008|STARTED|Post-Treatment Follow-Up Period|Only included post-treatment follow-up participants.|0
8841896|NCT01695239|9896179|FG009|STARTED|Post-Treatment Follow-Up Period|Only included post-treatment follow-up participants.|0
8841897|NCT01695239|9896180|FG010|STARTED|Post-Treatment Follow-Up Period|Participants who discontinued early and received PBO.|20
8841898|NCT01695239|9896181|FG011|STARTED|Post-Treatment Follow-Up Period|Participants who discontinued early and received adalimumab.|1
8841899|NCT01695239|9896182|FG012|STARTED|Post-Treatment Follow-Up Period|IxeQ4W participants who entered post-treatment follow-up.|165
8841900|NCT01695239|9896183|FG013|STARTED|Post-Treatment Follow-Up Period|IxeQ2W participants who entered post-treatment follow-up.|171
8556668|NCT02609724|9588445|FG000|STARTED|Overall Study||65
8556669|NCT02609724|9588446|FG001|STARTED|Overall Study||64
8556670|NCT02609724|9588447|FG002|STARTED|Overall Study||65
8556671|NCT02609724|9588445|FG000|Post Intensive Treatment Phase (= Primary Endpoint)|Overall Study||63
8556672|NCT02609724|9588446|FG001|Post Intensive Treatment Phase (= Primary Endpoint)|Overall Study||63
8556673|NCT02609724|9588447|FG002|Post Intensive Treatment Phase (= Primary Endpoint)|Overall Study||64
8556674|NCT02609724|9588445|FG000|COMPLETED|Overall Study|post follow-up phase|60
8556675|NCT02609724|9588446|FG001|COMPLETED|Overall Study|post follow-up phase|61
8556676|NCT02609724|9588447|FG002|COMPLETED|Overall Study|post follow-up phase|61
8556677|NCT02609724|9588445|FG000|NOT COMPLETED|Overall Study||5
8556678|NCT02609724|9588446|FG001|NOT COMPLETED|Overall Study||3
8556679|NCT02609724|9588447|FG002|NOT COMPLETED|Overall Study||4
8568711|NCT00092547|9600913|FG002|COMPLETED|Long-term Follow-up (Month 96 Visit)||267
8568712|NCT00092547|9600911|FG000|NOT COMPLETED|Long-term Follow-up (Month 96 Visit)||0
8568713|NCT00092547|9600912|FG001|NOT COMPLETED|Long-term Follow-up (Month 96 Visit)||0
8568714|NCT00092547|9600913|FG002|NOT COMPLETED|Long-term Follow-up (Month 96 Visit)||0
8568715|NCT00092547|9600911|FG000|STARTED|Long-term Follow-up (Month 126 Visit)||454
8568716|NCT00092547|9600912|FG001|STARTED|Long-term Follow-up (Month 126 Visit)||0
8568717|NCT00092547|9600913|FG002|STARTED|Long-term Follow-up (Month 126 Visit)||211
8568718|NCT00092547|9600911|FG000|COMPLETED|Long-term Follow-up (Month 126 Visit)||454
8568719|NCT00092547|9600912|FG001|COMPLETED|Long-term Follow-up (Month 126 Visit)||0
8623212|NCT00492232|9662450|FG000|COMPLETED|Open-Label Treatment||88
8623213|NCT00492232|9662451|FG001|COMPLETED|Open-Label Treatment||0
8623214|NCT00492232|9662450|FG000|NOT COMPLETED|Open-Label Treatment||1
8841901|NCT01695239|9896170|FG000|COMPLETED|Post-Treatment Follow-Up Period||0
8841902|NCT01695239|9896171|FG001|COMPLETED|Post-Treatment Follow-Up Period||0
8841903|NCT01695239|9896172|FG002|COMPLETED|Post-Treatment Follow-Up Period||0
8841904|NCT01695239|9896173|FG003|COMPLETED|Post-Treatment Follow-Up Period||0
8841905|NCT01695239|9896174|FG004|COMPLETED|Post-Treatment Follow-Up Period||0
8841906|NCT01695239|9896175|FG005|COMPLETED|Post-Treatment Follow-Up Period||0
8841907|NCT01695239|9896176|FG006|COMPLETED|Post-Treatment Follow-Up Period||0
8841908|NCT01695239|9896177|FG007|COMPLETED|Post-Treatment Follow-Up Period||0
8841909|NCT01695239|9896178|FG008|COMPLETED|Post-Treatment Follow-Up Period||0
8841910|NCT01695239|9896179|FG009|COMPLETED|Post-Treatment Follow-Up Period||0
8841911|NCT01695239|9896180|FG010|COMPLETED|Post-Treatment Follow-Up Period||20
8841912|NCT01695239|9896181|FG011|COMPLETED|Post-Treatment Follow-Up Period||0
8841913|NCT01695239|9896182|FG012|COMPLETED|Post-Treatment Follow-Up Period||156
8841914|NCT01695239|9896183|FG013|COMPLETED|Post-Treatment Follow-Up Period||166
8841915|NCT01695239|9896170|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||0
8841916|NCT01695239|9896171|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||0
8841917|NCT01695239|9896172|FG002|NOT COMPLETED|Post-Treatment Follow-Up Period||0
8841918|NCT01695239|9896173|FG003|NOT COMPLETED|Post-Treatment Follow-Up Period||0
8841919|NCT01695239|9896174|FG004|NOT COMPLETED|Post-Treatment Follow-Up Period||0
8841920|NCT01695239|9896175|FG005|NOT COMPLETED|Post-Treatment Follow-Up Period||0
8944774|NCT02399475|10006673|FG001|NOT COMPLETED|Overall Study||0
8944775|NCT02399917|10006682|FG000|STARTED|Overall Study||6
8569410|NCT00096993|9601649|FG000|NOT COMPLETED|Overall Study||65
8841921|NCT01695239|9896176|FG006|NOT COMPLETED|Post-Treatment Follow-Up Period||0
8841922|NCT01695239|9896177|FG007|NOT COMPLETED|Post-Treatment Follow-Up Period||0
8841923|NCT01695239|9896178|FG008|NOT COMPLETED|Post-Treatment Follow-Up Period||0
8841924|NCT01695239|9896179|FG009|NOT COMPLETED|Post-Treatment Follow-Up Period||0
8841925|NCT01695239|9896180|FG010|NOT COMPLETED|Post-Treatment Follow-Up Period||0
8841926|NCT01695239|9896181|FG011|NOT COMPLETED|Post-Treatment Follow-Up Period||1
8841927|NCT01695239|9896182|FG012|NOT COMPLETED|Post-Treatment Follow-Up Period||9
8841928|NCT01695239|9896183|FG013|NOT COMPLETED|Post-Treatment Follow-Up Period||5
8841929|NCT01695291|9896207|FG000|STARTED|Overall Study||10
8841930|NCT01695291|9896208|FG001|STARTED|Overall Study||21
8841931|NCT01695291|9896207|FG000|COMPLETED|Overall Study||8
8841932|NCT01695291|9896208|FG001|COMPLETED|Overall Study||14
8841933|NCT01695291|9896207|FG000|NOT COMPLETED|Overall Study||2
8841934|NCT01695291|9896208|FG001|NOT COMPLETED|Overall Study||7
8841935|NCT01695304|9896216|FG000|STARTED|Overall Study||120
8841936|NCT01695304|9896217|FG001|STARTED|Overall Study||120
8841937|NCT01695304|9896216|FG000|COMPLETED|Overall Study|2 deaths & 1 drop out in the intervention group, contributed some information over the 26 weeks|120
8841938|NCT01695304|9896217|FG001|COMPLETED|Overall Study|3 deaths & 2 drop out in the intervention group, contributed some information over the 26 weeks|120
8841939|NCT01695304|9896216|FG000|NOT COMPLETED|Overall Study||0
8841940|NCT01695304|9896217|FG001|NOT COMPLETED|Overall Study||0
8841941|NCT01695330|9896225|FG000|STARTED|Overall Study||52
8841942|NCT01695330|9896226|FG001|STARTED|Overall Study||0
8841943|NCT01695330|9896225|FG000|COMPLETED|Overall Study||5
8841944|NCT01695330|9896226|FG001|COMPLETED|Overall Study||0
8841945|NCT01695330|9896225|FG000|NOT COMPLETED|Overall Study||47
8841946|NCT01695330|9896226|FG001|NOT COMPLETED|Overall Study||0
8841947|NCT01695369|9896230|FG000|STARTED|Overall Study||61
8841948|NCT01695369|9896230|FG000|COMPLETED|Overall Study||61
8841949|NCT01695369|9896230|FG000|NOT COMPLETED|Overall Study||0
8841950|NCT01695473|9896236|FG000|STARTED|Overall Study||11
8841951|NCT01695473|9896236|FG000|COMPLETED|Overall Study||11
8841952|NCT01695473|9896236|FG000|NOT COMPLETED|Overall Study||0
8841953|NCT01695668|9896243|FG000|STARTED|Overall Study||38
8841954|NCT01695668|9896244|FG001|STARTED|Overall Study||37
8841955|NCT01695668|9896243|FG000|COMPLETED|Overall Study||23
8841956|NCT01695668|9896244|FG001|COMPLETED|Overall Study||20
8841957|NCT01695668|9896243|FG000|NOT COMPLETED|Overall Study||15
8841958|NCT01695668|9896244|FG001|NOT COMPLETED|Overall Study||17
8841959|NCT01695746|9896250|FG000|STARTED|Overall Study||108
8841960|NCT01695746|9896250|FG000|COMPLETED|Overall Study||96
8841961|NCT01695746|9896250|FG000|NOT COMPLETED|Overall Study||12
8841962|NCT01695772|9896255|FG000|STARTED|Overall Study||50
8841963|NCT01695772|9896255|FG000|COMPLETED|Overall Study||12
8841964|NCT01695772|9896255|FG000|NOT COMPLETED|Overall Study||38
8841965|NCT01695954|9896261|FG000|STARTED|Overall Study||18
8841966|NCT01695954|9896262|FG001|STARTED|Overall Study||16
8841967|NCT01695954|9896261|FG000|COMPLETED|Overall Study||14
8841968|NCT01695954|9896262|FG001|COMPLETED|Overall Study||14
8841969|NCT01695954|9896261|FG000|NOT COMPLETED|Overall Study||4
8841970|NCT01695954|9896262|FG001|NOT COMPLETED|Overall Study||2
8841971|NCT01695993|9896273|FG000|STARTED|Overall Study||81
8841972|NCT01695993|9896274|FG001|STARTED|Overall Study||80
8841973|NCT01695993|9896275|FG002|STARTED|Overall Study||81
8841974|NCT01695993|9896273|FG000|COMPLETED|Overall Study||76
8841975|NCT01695993|9896274|FG001|COMPLETED|Overall Study||75
8841976|NCT01695993|9896275|FG002|COMPLETED|Overall Study||75
8841977|NCT01695993|9896273|FG000|NOT COMPLETED|Overall Study||5
8841978|NCT01695993|9896274|FG001|NOT COMPLETED|Overall Study||5
8841979|NCT01695993|9896275|FG002|NOT COMPLETED|Overall Study||6
8841980|NCT01696032|9896287|FG000|STARTED|Overall Study||14
8841981|NCT01696032|9896288|FG001|STARTED|Overall Study||6
8841982|NCT01696032|9896289|FG002|STARTED|Overall Study||51
8841983|NCT01696032|9896290|FG003|STARTED|Overall Study||49
8841984|NCT01696032|9896287|FG000|COMPLETED|Overall Study||0
8841985|NCT01696032|9896288|FG001|COMPLETED|Overall Study||0
8841986|NCT01696032|9896289|FG002|COMPLETED|Overall Study||0
8841987|NCT01696032|9896290|FG003|COMPLETED|Overall Study||27
8841988|NCT01696032|9896287|FG000|NOT COMPLETED|Overall Study||14
8556680|NCT02359994|9588457|FG000|STARTED|Overall Population Study||161
8556681|NCT02359994|9588458|FG001|STARTED|Overall Population Study||163
8556682|NCT02359994|9588457|FG000|Treated|Overall Population Study||160
8556683|NCT02359994|9588458|FG001|Treated|Overall Population Study||162
8841989|NCT01696032|9896288|FG001|NOT COMPLETED|Overall Study||6
8841990|NCT01696032|9896289|FG002|NOT COMPLETED|Overall Study||51
8841991|NCT01696032|9896290|FG003|NOT COMPLETED|Overall Study||22
8556684|NCT02359994|9588457|FG000|COMPLETED|Overall Population Study||156
8556685|NCT02359994|9588458|FG001|COMPLETED|Overall Population Study||155
8841992|NCT01696045|9896306|FG000|STARTED|Overall Study||4
8841993|NCT01696045|9896307|FG001|STARTED|Overall Study||8
8841994|NCT01696045|9896306|FG000|COMPLETED|Overall Study||1
8841995|NCT01696045|9896307|FG001|COMPLETED|Overall Study||1
8841996|NCT01696045|9896306|FG000|NOT COMPLETED|Overall Study||3
8841997|NCT01696045|9896307|FG001|NOT COMPLETED|Overall Study||7
8841998|NCT01696058|9896315|FG000|STARTED|Overall Study||566
8841999|NCT01696058|9896316|FG001|STARTED|Overall Study||569
8842000|NCT01696058|9896315|FG000|COMPLETED|Overall Study||523
8842001|NCT01696058|9896316|FG001|COMPLETED|Overall Study||538
8842002|NCT01696058|9896315|FG000|NOT COMPLETED|Overall Study||43
8842003|NCT01696058|9896316|FG001|NOT COMPLETED|Overall Study||31
8842004|NCT01696071|9896322|FG000|STARTED|Treatment Period 1: 4 Weeks||51
8842005|NCT01696071|9896323|FG001|STARTED|Treatment Period 1: 4 Weeks||47
8842006|NCT01696071|9896322|FG000|COMPLETED|Treatment Period 1: 4 Weeks||51
8842007|NCT01696071|9896323|FG001|COMPLETED|Treatment Period 1: 4 Weeks||47
8842008|NCT01696071|9896322|FG000|NOT COMPLETED|Treatment Period 1: 4 Weeks||0
8842009|NCT01696071|9896323|FG001|NOT COMPLETED|Treatment Period 1: 4 Weeks||0
8842010|NCT01696071|9896322|FG000|STARTED|Treatment Period 2: 4 Weeks||51
8842011|NCT01696071|9896323|FG001|STARTED|Treatment Period 2: 4 Weeks||47
8842012|NCT01696071|9896322|FG000|COMPLETED|Treatment Period 2: 4 Weeks||50
8842013|NCT01696071|9896323|FG001|COMPLETED|Treatment Period 2: 4 Weeks||47
8842014|NCT01696071|9896322|FG000|NOT COMPLETED|Treatment Period 2: 4 Weeks||1
8842015|NCT01696071|9896323|FG001|NOT COMPLETED|Treatment Period 2: 4 Weeks||0
8842016|NCT01696084|9896332|FG000|STARTED|Overall Study||153
8842017|NCT01696084|9896333|FG001|STARTED|Overall Study||156
8556686|NCT02359994|9588457|FG000|NOT COMPLETED|Overall Population Study||5
8556687|NCT02359994|9588458|FG001|NOT COMPLETED|Overall Population Study||8
8556688|NCT02359994|9588457|FG000|STARTED|Extended Oncology 24-Month Survival|Oncology subjects in the PerClot group who completed either the 6 week or 3 month visit in the Overall Population Study.|85
8556689|NCT02359994|9588458|FG001|STARTED|Extended Oncology 24-Month Survival|Oncology subjects in the Arista group who completed either the 6 week or 3 month visit in the Overall Population Study.|93
8556690|NCT02359994|9588457|FG000|COMPLETED|Extended Oncology 24-Month Survival||65
8556691|NCT02359994|9588458|FG001|COMPLETED|Extended Oncology 24-Month Survival||72
8556692|NCT02359994|9588457|FG000|NOT COMPLETED|Extended Oncology 24-Month Survival||20
8556693|NCT02359994|9588458|FG001|NOT COMPLETED|Extended Oncology 24-Month Survival||21
8556694|NCT02336230|9588464|FG000|STARTED|Overall Study||55
8556695|NCT02336230|9588464|FG000|Full Analysis Set (FAS)|Overall Study||55
8556696|NCT02336230|9588464|FG000|Safety Analysis Population|Overall Study||54
8556697|NCT02336230|9588464|FG000|COMPLETED|Overall Study||42
8842018|NCT01696084|9896332|FG000|COMPLETED|Overall Study||22
8842019|NCT01696084|9896333|FG001|COMPLETED|Overall Study||10
8842020|NCT01696084|9896332|FG000|NOT COMPLETED|Overall Study||131
8842021|NCT01696084|9896333|FG001|NOT COMPLETED|Overall Study||146
8842022|NCT01696188|9896341|FG000|STARTED|Overall Study||41
8842023|NCT01696188|9896342|FG001|STARTED|Overall Study||43
8842024|NCT01696188|9896341|FG000|COMPLETED|Overall Study||40
8842025|NCT01696188|9896342|FG001|COMPLETED|Overall Study||42
8842026|NCT01696188|9896341|FG000|NOT COMPLETED|Overall Study||1
8842027|NCT01696188|9896342|FG001|NOT COMPLETED|Overall Study||1
8842028|NCT01696214|9896352|FG000|STARTED|Overall Study||5
8842029|NCT01696214|9896353|FG001|STARTED|Overall Study||5
8842030|NCT01696214|9896354|FG002|STARTED|Overall Study||5
8842031|NCT01696214|9896355|FG003|STARTED|Overall Study||5
8842032|NCT01696214|9896352|FG000|COMPLETED|Overall Study||4
8842033|NCT01696214|9896353|FG001|COMPLETED|Overall Study||5
8842034|NCT01696214|9896354|FG002|COMPLETED|Overall Study||5
8842035|NCT01696214|9896355|FG003|COMPLETED|Overall Study||5
8842036|NCT01696214|9896352|FG000|NOT COMPLETED|Overall Study||1
8842037|NCT01696214|9896353|FG001|NOT COMPLETED|Overall Study||0
8842038|NCT01696214|9896354|FG002|NOT COMPLETED|Overall Study||0
8842039|NCT01696214|9896355|FG003|NOT COMPLETED|Overall Study||0
8842040|NCT01696279|9896373|FG000|STARTED|Part 1: Single Dose Lanthanum Carbonate||20
8842041|NCT01696279|9896374|FG001|STARTED|Part 1: Single Dose Lanthanum Carbonate||0
8842042|NCT01696279|9896375|FG002|STARTED|Part 1: Single Dose Lanthanum Carbonate||0
8842043|NCT01696279|9896376|FG003|STARTED|Part 1: Single Dose Lanthanum Carbonate||0
8842044|NCT01696279|9896373|FG000|Safety Analysis Set 1|Part 1: Single Dose Lanthanum Carbonate||20
8842045|NCT01696279|9896374|FG001|Safety Analysis Set 1|Part 1: Single Dose Lanthanum Carbonate||0
8842046|NCT01696279|9896375|FG002|Safety Analysis Set 1|Part 1: Single Dose Lanthanum Carbonate||0
8842047|NCT01696279|9896376|FG003|Safety Analysis Set 1|Part 1: Single Dose Lanthanum Carbonate||0
8842048|NCT01696279|9896373|FG000|Entered Part 2a|Part 1: Single Dose Lanthanum Carbonate||19
8842049|NCT01696279|9896374|FG001|Entered Part 2a|Part 1: Single Dose Lanthanum Carbonate||0
8842050|NCT01696279|9896375|FG002|Entered Part 2a|Part 1: Single Dose Lanthanum Carbonate||0
8842051|NCT01696279|9896376|FG003|Entered Part 2a|Part 1: Single Dose Lanthanum Carbonate||0
8842052|NCT01696279|9896373|FG000|COMPLETED|Part 1: Single Dose Lanthanum Carbonate||19
8842053|NCT01696279|9896374|FG001|COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
8842054|NCT01696279|9896375|FG002|COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
8842055|NCT01696279|9896376|FG003|COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
8842056|NCT01696279|9896373|FG000|NOT COMPLETED|Part 1: Single Dose Lanthanum Carbonate||1
8842057|NCT01696279|9896374|FG001|NOT COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
8842058|NCT01696279|9896375|FG002|NOT COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
8842059|NCT01696279|9896376|FG003|NOT COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
8842060|NCT01696279|9896373|FG000|STARTED|Part 2a: Calcium Carbonate + Lanthanum||0
8842061|NCT01696279|9896374|FG001|STARTED|Part 2a: Calcium Carbonate + Lanthanum|19 participants enrolled from Part 1 and 34 new participants enrolled in Part 2a|53
8842062|NCT01696279|9896375|FG002|STARTED|Part 2a: Calcium Carbonate + Lanthanum||0
8842063|NCT01696279|9896376|FG003|STARTED|Part 2a: Calcium Carbonate + Lanthanum||0
8842064|NCT01696279|9896373|FG000|Safety Completer Set|Part 2a: Calcium Carbonate + Lanthanum||0
8842065|NCT01696279|9896374|FG001|Safety Completer Set|Part 2a: Calcium Carbonate + Lanthanum||37
8842066|NCT01696279|9896375|FG002|Safety Completer Set|Part 2a: Calcium Carbonate + Lanthanum||0
8842067|NCT01696279|9896376|FG003|Safety Completer Set|Part 2a: Calcium Carbonate + Lanthanum||0
8842068|NCT01696279|9896373|FG000|Full Analysis Set|Part 2a: Calcium Carbonate + Lanthanum||0
8842069|NCT01696279|9896374|FG001|Full Analysis Set|Part 2a: Calcium Carbonate + Lanthanum||53
8842070|NCT01696279|9896375|FG002|Full Analysis Set|Part 2a: Calcium Carbonate + Lanthanum||0
8842071|NCT01696279|9896376|FG003|Full Analysis Set|Part 2a: Calcium Carbonate + Lanthanum||0
8842072|NCT01696279|9896373|FG000|Per-protocol Set 1|Part 2a: Calcium Carbonate + Lanthanum||0
8842073|NCT01696279|9896374|FG001|Per-protocol Set 1|Part 2a: Calcium Carbonate + Lanthanum||17
8842074|NCT01696279|9896375|FG002|Per-protocol Set 1|Part 2a: Calcium Carbonate + Lanthanum||0
8842075|NCT01696279|9896376|FG003|Per-protocol Set 1|Part 2a: Calcium Carbonate + Lanthanum||0
8842076|NCT01696279|9896373|FG000|Per-protocol Set 2|Part 2a: Calcium Carbonate + Lanthanum||0
8842077|NCT01696279|9896374|FG001|Per-protocol Set 2|Part 2a: Calcium Carbonate + Lanthanum||25
8842078|NCT01696279|9896375|FG002|Per-protocol Set 2|Part 2a: Calcium Carbonate + Lanthanum||0
8842079|NCT01696279|9896376|FG003|Per-protocol Set 2|Part 2a: Calcium Carbonate + Lanthanum||0
8842080|NCT01696279|9896373|FG000|Entered Part 3|Part 2a: Calcium Carbonate + Lanthanum||0
8842081|NCT01696279|9896374|FG001|Entered Part 3|Part 2a: Calcium Carbonate + Lanthanum||34
8842082|NCT01696279|9896375|FG002|Entered Part 3|Part 2a: Calcium Carbonate + Lanthanum||0
8842083|NCT01696279|9896376|FG003|Entered Part 3|Part 2a: Calcium Carbonate + Lanthanum||0
8842084|NCT01696279|9896373|FG000|COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
8842085|NCT01696279|9896374|FG001|COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||34
8842086|NCT01696279|9896375|FG002|COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
8842087|NCT01696279|9896376|FG003|COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
8842088|NCT01696279|9896373|FG000|NOT COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
8842089|NCT01696279|9896374|FG001|NOT COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||19
8842090|NCT01696279|9896375|FG002|NOT COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
8842091|NCT01696279|9896376|FG003|NOT COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
8842092|NCT01696279|9896373|FG000|STARTED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
8842093|NCT01696279|9896374|FG001|STARTED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
8842094|NCT01696279|9896375|FG002|STARTED|Part 2b: Lanthanum Carbonate (8 Weeks)|9 new participants were enrolled in Part 2b|9
8842095|NCT01696279|9896376|FG003|STARTED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
8842096|NCT01696279|9896373|FG000|Safety Completer Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
8842097|NCT01696279|9896374|FG001|Safety Completer Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
8842098|NCT01696279|9896375|FG002|Safety Completer Set|Part 2b: Lanthanum Carbonate (8 Weeks)||9
8842099|NCT01696279|9896376|FG003|Safety Completer Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
8842100|NCT01696279|9896373|FG000|Full Analysis Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
8842101|NCT01696279|9896374|FG001|Full Analysis Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
8842102|NCT01696279|9896375|FG002|Full Analysis Set|Part 2b: Lanthanum Carbonate (8 Weeks)||9
8842103|NCT01696279|9896376|FG003|Full Analysis Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
8842104|NCT01696279|9896373|FG000|Per-protocol Set 1|Part 2b: Lanthanum Carbonate (8 Weeks)||0
8842105|NCT01696279|9896374|FG001|Per-protocol Set 1|Part 2b: Lanthanum Carbonate (8 Weeks)||0
8842106|NCT01696279|9896375|FG002|Per-protocol Set 1|Part 2b: Lanthanum Carbonate (8 Weeks)||0
8842107|NCT01696279|9896376|FG003|Per-protocol Set 1|Part 2b: Lanthanum Carbonate (8 Weeks)||0
8842108|NCT01696279|9896373|FG000|Per-protocol Set 2|Part 2b: Lanthanum Carbonate (8 Weeks)||0
8842109|NCT01696279|9896374|FG001|Per-protocol Set 2|Part 2b: Lanthanum Carbonate (8 Weeks)||0
8842110|NCT01696279|9896375|FG002|Per-protocol Set 2|Part 2b: Lanthanum Carbonate (8 Weeks)||9
8842111|NCT01696279|9896376|FG003|Per-protocol Set 2|Part 2b: Lanthanum Carbonate (8 Weeks)||0
8842112|NCT01696279|9896373|FG000|COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
8842113|NCT01696279|9896374|FG001|COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
8842114|NCT01696279|9896375|FG002|COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||8
8842115|NCT01696279|9896376|FG003|COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
8842116|NCT01696279|9896373|FG000|NOT COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
8842117|NCT01696279|9896374|FG001|NOT COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
8842118|NCT01696279|9896375|FG002|NOT COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||1
8842119|NCT01696279|9896376|FG003|NOT COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
8842120|NCT01696279|9896373|FG000|STARTED|Part 3: Lanthanum Carbonate (6 Months)||0
8842121|NCT01696279|9896374|FG001|STARTED|Part 3: Lanthanum Carbonate (6 Months)||0
8842122|NCT01696279|9896375|FG002|STARTED|Part 3: Lanthanum Carbonate (6 Months)||0
8842123|NCT01696279|9896376|FG003|STARTED|Part 3: Lanthanum Carbonate (6 Months)|34 participants from Part 2a and 8 participants from Part 2b continued to Part 3|42
8842124|NCT01696279|9896373|FG000|COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
8842125|NCT01696279|9896374|FG001|COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
8842126|NCT01696279|9896375|FG002|COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
8842127|NCT01696279|9896376|FG003|COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||34
8842128|NCT01696279|9896373|FG000|NOT COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
8842129|NCT01696279|9896374|FG001|NOT COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
8842130|NCT01696279|9896375|FG002|NOT COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
8842131|NCT01696279|9896376|FG003|NOT COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||8
8842132|NCT01696357|9896387|FG000|STARTED|Overall Study||42
8842133|NCT01696357|9896388|FG001|STARTED|Overall Study||42
8842134|NCT01696357|9896387|FG000|COMPLETED|Overall Study||40
8842135|NCT01696357|9896388|FG001|COMPLETED|Overall Study||41
8842136|NCT01696357|9896387|FG000|NOT COMPLETED|Overall Study||2
8842137|NCT01696357|9896388|FG001|NOT COMPLETED|Overall Study||1
8842138|NCT01696396|9896398|FG000|STARTED|Overall Study||100
8842139|NCT01696396|9896399|FG001|STARTED|Overall Study||27
8842140|NCT01696396|9896400|FG002|STARTED|Overall Study||85
8842141|NCT01696396|9896401|FG003|STARTED|Overall Study||42
8842142|NCT01696396|9896398|FG000|Received Study Drug|Overall Study||98
8842143|NCT01696396|9896399|FG001|Received Study Drug|Overall Study||26
8842144|NCT01696396|9896400|FG002|Received Study Drug|Overall Study||84
8842145|NCT01696396|9896401|FG003|Received Study Drug|Overall Study||41
8842146|NCT01696396|9896398|FG000|Entered Open-label Period|Overall Study||84
8842147|NCT01696396|9896399|FG001|Entered Open-label Period|Overall Study||21
8842148|NCT01696396|9896400|FG002|Entered Open-label Period|Overall Study||75
8842149|NCT01696396|9896401|FG003|Entered Open-label Period|Overall Study||37
8842150|NCT01696396|9896398|FG000|COMPLETED|Overall Study||69
8842151|NCT01696396|9896399|FG001|COMPLETED|Overall Study||20
8842152|NCT01696396|9896400|FG002|COMPLETED|Overall Study||59
8842153|NCT01696396|9896401|FG003|COMPLETED|Overall Study||28
8842154|NCT01696396|9896398|FG000|NOT COMPLETED|Overall Study||31
8842155|NCT01696396|9896399|FG001|NOT COMPLETED|Overall Study||7
8842156|NCT01696396|9896400|FG002|NOT COMPLETED|Overall Study||26
8842157|NCT01696396|9896401|FG003|NOT COMPLETED|Overall Study||14
8842158|NCT01696643|9896417|FG000|STARTED|Overall Study||703
8842159|NCT01696643|9896418|FG001|STARTED|Overall Study||704
8842160|NCT01696643|9896417|FG000|Received at Least 1 Dose of Study Drug|Overall Study||701
8842161|NCT01696643|9896418|FG001|Received at Least 1 Dose of Study Drug|Overall Study|2 participants randomized to placebo took CB-5945. Their results are included in the CB-5945 group.|702
8842162|NCT01696643|9896417|FG000|COMPLETED|Overall Study||174
8842163|NCT01696643|9896418|FG001|COMPLETED|Overall Study||169
8842164|NCT01696643|9896417|FG000|NOT COMPLETED|Overall Study||529
8842165|NCT01696643|9896418|FG001|NOT COMPLETED|Overall Study||535
8842166|NCT01696695|9896424|FG000|STARTED|Overall Study||882
8842167|NCT01696695|9896424|FG000|COMPLETED|Overall Study||0
8842168|NCT01696695|9896424|FG000|NOT COMPLETED|Overall Study||882
8842169|NCT01696760|9896430|FG000|STARTED|Overall Study||9
8842170|NCT01696760|9896431|FG001|STARTED|Overall Study||3
8842171|NCT01696760|9896430|FG000|COMPLETED|Overall Study||9
8842172|NCT01696760|9896431|FG001|COMPLETED|Overall Study||3
8842173|NCT01696760|9896430|FG000|NOT COMPLETED|Overall Study||0
8842174|NCT01696760|9896431|FG001|NOT COMPLETED|Overall Study||0
8842175|NCT01696773|9896439|FG000|STARTED|Days 1-13, Washout||6
8842176|NCT01696773|9896440|FG001|STARTED|Days 1-13, Washout||6
8842177|NCT01696773|9896439|FG000|COMPLETED|Days 1-13, Washout||6
8842178|NCT01696773|9896440|FG001|COMPLETED|Days 1-13, Washout||6
8842179|NCT01696773|9896439|FG000|NOT COMPLETED|Days 1-13, Washout||0
8842180|NCT01696773|9896440|FG001|NOT COMPLETED|Days 1-13, Washout||0
8842181|NCT01696773|9896439|FG000|STARTED|Day 14, First Intervention||6
8842182|NCT01696773|9896440|FG001|STARTED|Day 14, First Intervention||6
8842183|NCT01696773|9896439|FG000|COMPLETED|Day 14, First Intervention||6
8842184|NCT01696773|9896440|FG001|COMPLETED|Day 14, First Intervention||6
8842185|NCT01696773|9896439|FG000|NOT COMPLETED|Day 14, First Intervention||0
8842186|NCT01696773|9896440|FG001|NOT COMPLETED|Day 14, First Intervention||0
8842187|NCT01696773|9896439|FG000|STARTED|Days 15-27, Washout||6
8842188|NCT01696773|9896440|FG001|STARTED|Days 15-27, Washout||6
8842189|NCT01696773|9896439|FG000|COMPLETED|Days 15-27, Washout||5
8842190|NCT01696773|9896440|FG001|COMPLETED|Days 15-27, Washout||6
8842191|NCT01696773|9896439|FG000|NOT COMPLETED|Days 15-27, Washout||1
8842192|NCT01696773|9896440|FG001|NOT COMPLETED|Days 15-27, Washout||0
8842193|NCT01696773|9896439|FG000|STARTED|Day 28, Second Intervention||5
8842194|NCT01696773|9896440|FG001|STARTED|Day 28, Second Intervention||6
8842195|NCT01696773|9896439|FG000|COMPLETED|Day 28, Second Intervention||5
8842196|NCT01696773|9896440|FG001|COMPLETED|Day 28, Second Intervention||6
8842197|NCT01696773|9896439|FG000|NOT COMPLETED|Day 28, Second Intervention||0
8842198|NCT01696773|9896440|FG001|NOT COMPLETED|Day 28, Second Intervention||0
8842199|NCT01696877|9896448|FG000|STARTED|Overall Study||15
8842200|NCT01696877|9896449|FG001|STARTED|Overall Study||14
8842201|NCT01696877|9896448|FG000|COMPLETED|Overall Study||15
8842202|NCT01696877|9896449|FG001|COMPLETED|Overall Study||13
8842203|NCT01696877|9896448|FG000|NOT COMPLETED|Overall Study||0
8842204|NCT01696877|9896449|FG001|NOT COMPLETED|Overall Study||1
8842205|NCT01696929|9896457|FG000|STARTED|Overall Study||6
8842206|NCT01696929|9896457|FG000|COMPLETED|Overall Study||5
8842207|NCT01696929|9896457|FG000|NOT COMPLETED|Overall Study||1
8842208|NCT01696942|9896463|FG000|STARTED|Overall Study||5
8842209|NCT01696942|9896464|FG001|STARTED|Overall Study||5
8842210|NCT01696942|9896463|FG000|COMPLETED|Overall Study||3
8842211|NCT01696942|9896464|FG001|COMPLETED|Overall Study||2
8842212|NCT01696942|9896463|FG000|NOT COMPLETED|Overall Study||2
8842213|NCT01696942|9896464|FG001|NOT COMPLETED|Overall Study||3
8842214|NCT01696955|9896472|FG000|STARTED|Main Study||42
8842215|NCT01696955|9896473|FG001|STARTED|Main Study||39
8842216|NCT01696955|9896472|FG000|COMPLETED|Main Study||40
8842217|NCT01696955|9896473|FG001|COMPLETED|Main Study||38
8842218|NCT01696955|9896472|FG000|NOT COMPLETED|Main Study||2
8842219|NCT01696955|9896473|FG001|NOT COMPLETED|Main Study||1
8842220|NCT01696955|9896472|FG000|STARTED|Failure on Cetuximab-Received Tivantinib||0
8842221|NCT01696955|9896473|FG001|STARTED|Failure on Cetuximab-Received Tivantinib||15
8842222|NCT01696955|9896472|FG000|COMPLETED|Failure on Cetuximab-Received Tivantinib||0
8842223|NCT01696955|9896473|FG001|COMPLETED|Failure on Cetuximab-Received Tivantinib|23 patients did not cross over|15
8842224|NCT01696955|9896472|FG000|NOT COMPLETED|Failure on Cetuximab-Received Tivantinib||0
8842225|NCT01696955|9896473|FG001|NOT COMPLETED|Failure on Cetuximab-Received Tivantinib||0
8842226|NCT01696968|9896488|FG000|STARTED|Overall Study||77456
8842227|NCT01696968|9896489|FG001|STARTED|Overall Study||77445
8842228|NCT01696968|9896488|FG000|COMPLETED|Overall Study||76255
8842229|NCT01696968|9896489|FG001|COMPLETED|Overall Study||70633
8842230|NCT01696968|9896488|FG000|NOT COMPLETED|Overall Study||1201
8842231|NCT01696968|9896489|FG001|NOT COMPLETED|Overall Study||6812
8842232|NCT01696981|9896498|FG000|STARTED|Overall Study||77455
8842233|NCT01696981|9896499|FG001|STARTED|Overall Study||77445
8842234|NCT01696981|9896498|FG000|COMPLETED|Overall Study||76254
8842235|NCT01696981|9896499|FG001|COMPLETED|Overall Study||67071
8842236|NCT01696981|9896498|FG000|NOT COMPLETED|Overall Study||1201
8842237|NCT01696981|9896499|FG001|NOT COMPLETED|Overall Study||10374
8842238|NCT01696994|9896507|FG000|STARTED|Overall Study||39111
8842239|NCT01696994|9896508|FG001|STARTED|Overall Study||39105
8842240|NCT01696994|9896507|FG000|COMPLETED|Overall Study||33919
8842241|NCT01696994|9896508|FG001|COMPLETED|Overall Study||30668
8842242|NCT01696994|9896507|FG000|NOT COMPLETED|Overall Study||5192
8842243|NCT01696994|9896508|FG001|NOT COMPLETED|Overall Study||8437
8842244|NCT01697319|9896516|FG000|STARTED|Primary Phase|One subject enrolled but did not receive a single dose of study drug|16
8842245|NCT01697319|9896516|FG000|COMPLETED|Primary Phase||15
8842246|NCT01697319|9896516|FG000|NOT COMPLETED|Primary Phase||1
8842247|NCT01697319|9896516|FG000|STARTED|Extension Phase||15
8842248|NCT01697319|9896516|FG000|COMPLETED|Extension Phase||0
8842249|NCT01697319|9896516|FG000|NOT COMPLETED|Extension Phase||15
8842250|NCT01697345|9896520|FG000|STARTED|Overall Study||13
8842251|NCT01697345|9896520|FG000|COMPLETED|Overall Study|One patient withdrew due to symptoms of recurrent Gardnerella vaginalis.|12
8842252|NCT01697345|9896520|FG000|NOT COMPLETED|Overall Study||1
8842253|NCT01697358|9896541|FG000|STARTED|Period I: Randomization to 6 Months||110
8842254|NCT01697358|9896542|FG001|STARTED|Period I: Randomization to 6 Months||108
8842255|NCT01697358|9896541|FG000|COMPLETED|Period I: Randomization to 6 Months||97
8842256|NCT01697358|9896542|FG001|COMPLETED|Period I: Randomization to 6 Months||107
8842257|NCT01697358|9896541|FG000|NOT COMPLETED|Period I: Randomization to 6 Months||13
8842258|NCT01697358|9896542|FG001|NOT COMPLETED|Period I: Randomization to 6 Months||1
8842259|NCT01697358|9896541|FG000|STARTED|Period II: 6-24M Long-term Follow-up||97
8623215|NCT00492232|9662451|FG001|NOT COMPLETED|Open-Label Treatment||0
8623216|NCT00492284|9662461|FG000|STARTED|Overall Study||39
8623217|NCT00492284|9662462|FG001|STARTED|Overall Study||39
8623218|NCT00492284|9662463|FG002|STARTED|Overall Study||43
8623219|NCT00492284|9662464|FG003|STARTED|Overall Study||41
8623220|NCT00492284|9662461|FG000|COMPLETED|Overall Study||38
8623221|NCT00492284|9662462|FG001|COMPLETED|Overall Study||35
8623222|NCT00492284|9662463|FG002|COMPLETED|Overall Study||37
8623223|NCT00492284|9662464|FG003|COMPLETED|Overall Study||31
8623224|NCT00492284|9662461|FG000|NOT COMPLETED|Overall Study||1
8623225|NCT00492284|9662462|FG001|NOT COMPLETED|Overall Study||4
8623226|NCT00492284|9662463|FG002|NOT COMPLETED|Overall Study||6
8842260|NCT01697358|9896542|FG001|STARTED|Period II: 6-24M Long-term Follow-up||107
9066014|NCT04123665|10126489|FG001|COMPLETED|Overall Study||48
9066015|NCT04123665|10126488|FG000|NOT COMPLETED|Overall Study||8
9066016|NCT04123665|10126489|FG001|NOT COMPLETED|Overall Study||0
9066017|NCT04122534|10126495|FG000|STARTED|Overall Study||48
9066018|NCT04122534|10126495|FG000|COMPLETED|Overall Study||44
9066019|NCT04122534|10126495|FG000|NOT COMPLETED|Overall Study||4
9066020|NCT04121078|10126501|FG000|STARTED|Study Period 1 (1 Day)||6
9066021|NCT04121078|10126502|FG001|STARTED|Study Period 1 (1 Day)||6
9066022|NCT04121078|10126501|FG000|COMPLETED|Study Period 1 (1 Day)||6
9066023|NCT04121078|10126502|FG001|COMPLETED|Study Period 1 (1 Day)||6
9066024|NCT04121078|10126501|FG000|NOT COMPLETED|Study Period 1 (1 Day)||0
9066025|NCT04121078|10126502|FG001|NOT COMPLETED|Study Period 1 (1 Day)||0
9066026|NCT04121078|10126501|FG000|STARTED|Washout Period (at Least 7 Days)||6
9066027|NCT04121078|10126502|FG001|STARTED|Washout Period (at Least 7 Days)||6
9066028|NCT04121078|10126501|FG000|COMPLETED|Washout Period (at Least 7 Days)||6
9066029|NCT04121078|10126502|FG001|COMPLETED|Washout Period (at Least 7 Days)||6
9066030|NCT04121078|10126501|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0
9066031|NCT04121078|10126502|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0
9066032|NCT04121078|10126501|FG000|STARTED|Study Period 2 (1 Day)||6
9066033|NCT04121078|10126502|FG001|STARTED|Study Period 2 (1 Day)||6
8842261|NCT01697358|9896541|FG000|COMPLETED|Period II: 6-24M Long-term Follow-up||48
8842262|NCT01697358|9896542|FG001|COMPLETED|Period II: 6-24M Long-term Follow-up||52
8842263|NCT01697358|9896541|FG000|NOT COMPLETED|Period II: 6-24M Long-term Follow-up||49
8842264|NCT01697358|9896542|FG001|NOT COMPLETED|Period II: 6-24M Long-term Follow-up||55
8842265|NCT01697449|9896548|FG000|STARTED|Overall Study||191
8842266|NCT01697449|9896548|FG000|COMPLETED|Overall Study||101
8842267|NCT01697449|9896548|FG000|NOT COMPLETED|Overall Study||90
8842268|NCT01697462|9896555|FG000|STARTED|Overall Study||258
8623227|NCT00492284|9662464|FG003|NOT COMPLETED|Overall Study||10
8842269|NCT01697462|9896555|FG000|COMPLETED|Overall Study||181
8842270|NCT01697462|9896555|FG000|NOT COMPLETED|Overall Study||77
8842271|NCT01697501|9896559|FG000|STARTED|Overall Study||88
8842272|NCT01697501|9896559|FG000|COMPLETED|Overall Study||86
8842273|NCT01697501|9896559|FG000|NOT COMPLETED|Overall Study||2
8623228|NCT00492297|9662474|FG000|STARTED|Treatment||83
8623229|NCT00492297|9662474|FG000|First Stage of Simon Optimal Design|Treatment|32 subjects of 83 subjects enrolled were treated in first stage.|32
8629474|NCT00530621|9669226|FG000|Received at Least 1 Dose of Study Drug|Overall Study||79
8842274|NCT01697579|9896577|FG000|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|74
8842275|NCT01697579|9896578|FG001|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|43
8842276|NCT01697579|9896579|FG002|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|44
8842277|NCT01697579|9896580|FG003|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|41
8842278|NCT01697579|9896581|FG004|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|38
8842279|NCT01697579|9896582|FG005|STARTED|Base Study-Cycle 1|Enrollment in Cycles 2-6 was optional.|0
8842280|NCT01697579|9896583|FG006|STARTED|Base Study-Cycle 1|Enrollment in Cycles 2-6 was optional.|0
8842281|NCT01697579|9896577|FG000|COMPLETED|Base Study-Cycle 1||72
8842282|NCT01697579|9896578|FG001|COMPLETED|Base Study-Cycle 1||42
8842283|NCT01697579|9896579|FG002|COMPLETED|Base Study-Cycle 1||43
8842284|NCT01697579|9896580|FG003|COMPLETED|Base Study-Cycle 1||40
8842285|NCT01697579|9896581|FG004|COMPLETED|Base Study-Cycle 1||35
8842286|NCT01697579|9896582|FG005|COMPLETED|Base Study-Cycle 1||0
8842287|NCT01697579|9896583|FG006|COMPLETED|Base Study-Cycle 1||0
8842288|NCT01697579|9896577|FG000|NOT COMPLETED|Base Study-Cycle 1||2
8842289|NCT01697579|9896578|FG001|NOT COMPLETED|Base Study-Cycle 1||1
8842290|NCT01697579|9896579|FG002|NOT COMPLETED|Base Study-Cycle 1||1
8842291|NCT01697579|9896580|FG003|NOT COMPLETED|Base Study-Cycle 1||1
8842292|NCT01697579|9896581|FG004|NOT COMPLETED|Base Study-Cycle 1||3
8842293|NCT01697579|9896582|FG005|NOT COMPLETED|Base Study-Cycle 1||0
8842294|NCT01697579|9896583|FG006|NOT COMPLETED|Base Study-Cycle 1||0
8842295|NCT01697579|9896577|FG000|STARTED|Optional Extension-Cycles 2-6|47 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 5 mg/kg|0
8842296|NCT01697579|9896578|FG001|STARTED|Optional Extension-Cycles 2-6|33 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 3 mg/kg|0
8842297|NCT01697579|9896579|FG002|STARTED|Optional Extension-Cycles 2-6|25 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 3 mg/kg|0
8842298|NCT01697579|9896580|FG003|STARTED|Optional Extension-Cycles 2-6|27 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 3 mg/kg|0
8842299|NCT01697579|9896581|FG004|STARTED|Optional Extension-Cycles 2-6|21 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 3 mg/kg|0
8842300|NCT01697579|9896582|FG005|STARTED|Optional Extension-Cycles 2-6|Enrollment in Cycles 2-6 was optional.|47
8842301|NCT01697579|9896583|FG006|STARTED|Optional Extension-Cycles 2-6|Enrollment in Cycles 2-6 was optional.|106
8842302|NCT01697579|9896577|FG000|COMPLETED|Optional Extension-Cycles 2-6||0
8842303|NCT01697579|9896578|FG001|COMPLETED|Optional Extension-Cycles 2-6||0
8842304|NCT01697579|9896579|FG002|COMPLETED|Optional Extension-Cycles 2-6||0
8842305|NCT01697579|9896580|FG003|COMPLETED|Optional Extension-Cycles 2-6||0
8842306|NCT01697579|9896581|FG004|COMPLETED|Optional Extension-Cycles 2-6||0
8842307|NCT01697579|9896582|FG005|COMPLETED|Optional Extension-Cycles 2-6||12
8842308|NCT01697579|9896583|FG006|COMPLETED|Optional Extension-Cycles 2-6||37
8842309|NCT01697579|9896577|FG000|NOT COMPLETED|Optional Extension-Cycles 2-6||0
8842310|NCT01697579|9896578|FG001|NOT COMPLETED|Optional Extension-Cycles 2-6||0
8842311|NCT01697579|9896579|FG002|NOT COMPLETED|Optional Extension-Cycles 2-6||0
8842312|NCT01697579|9896580|FG003|NOT COMPLETED|Optional Extension-Cycles 2-6||0
8842313|NCT01697579|9896581|FG004|NOT COMPLETED|Optional Extension-Cycles 2-6||0
8842314|NCT01697579|9896582|FG005|NOT COMPLETED|Optional Extension-Cycles 2-6||35
8842315|NCT01697579|9896583|FG006|NOT COMPLETED|Optional Extension-Cycles 2-6||69
8842316|NCT01697592|9896621|FG000|STARTED|Phase A (Up to 24 Weeks)||126
8842317|NCT01697592|9896622|FG001|STARTED|Phase A (Up to 24 Weeks)||65
8842318|NCT01697592|9896623|FG002|STARTED|Phase A (Up to 24 Weeks)||66
8842319|NCT01697592|9896624|FG003|STARTED|Phase A (Up to 24 Weeks)||65
8842320|NCT01697592|9896625|FG004|STARTED|Phase A (Up to 24 Weeks)||67
8842321|NCT01697592|9896626|FG005|STARTED|Phase A (Up to 24 Weeks)||63
8842322|NCT01697592|9896627|FG006|STARTED|Phase A (Up to 24 Weeks)||34
8842323|NCT01697592|9896628|FG007|STARTED|Phase A (Up to 24 Weeks)||33
8842324|NCT01697592|9896629|FG008|STARTED|Phase A (Up to 24 Weeks)||34
8842325|NCT01697592|9896630|FG009|STARTED|Phase A (Up to 24 Weeks)||32
8842326|NCT01697592|9896621|FG000|COMPLETED|Phase A (Up to 24 Weeks)||123
8842327|NCT01697592|9896622|FG001|COMPLETED|Phase A (Up to 24 Weeks)||62
8842328|NCT01697592|9896623|FG002|COMPLETED|Phase A (Up to 24 Weeks)||65
8842329|NCT01697592|9896624|FG003|COMPLETED|Phase A (Up to 24 Weeks)||63
8842330|NCT01697592|9896625|FG004|COMPLETED|Phase A (Up to 24 Weeks)||67
8842331|NCT01697592|9896626|FG005|COMPLETED|Phase A (Up to 24 Weeks)||62
8842332|NCT01697592|9896627|FG006|COMPLETED|Phase A (Up to 24 Weeks)||32
8842333|NCT01697592|9896628|FG007|COMPLETED|Phase A (Up to 24 Weeks)||33
8842334|NCT01697592|9896629|FG008|COMPLETED|Phase A (Up to 24 Weeks)||34
8842335|NCT01697592|9896630|FG009|COMPLETED|Phase A (Up to 24 Weeks)||30
8842336|NCT01697592|9896621|FG000|NOT COMPLETED|Phase A (Up to 24 Weeks)||3
8842337|NCT01697592|9896622|FG001|NOT COMPLETED|Phase A (Up to 24 Weeks)||3
8842338|NCT01697592|9896623|FG002|NOT COMPLETED|Phase A (Up to 24 Weeks)||1
8842339|NCT01697592|9896624|FG003|NOT COMPLETED|Phase A (Up to 24 Weeks)||2
8842340|NCT01697592|9896625|FG004|NOT COMPLETED|Phase A (Up to 24 Weeks)||0
8842341|NCT01697592|9896626|FG005|NOT COMPLETED|Phase A (Up to 24 Weeks)||1
8842342|NCT01697592|9896627|FG006|NOT COMPLETED|Phase A (Up to 24 Weeks)||2
8842343|NCT01697592|9896628|FG007|NOT COMPLETED|Phase A (Up to 24 Weeks)||0
8623230|NCT00492297|9662474|FG000|Second Stage of Simon Optimal Design|Treatment|Recruitment continued into the second stage. 51 of 83 subjects were treated in the second stage.|51
8623231|NCT00492297|9662474|FG000|COMPLETED|Treatment||78
8842344|NCT01697592|9896629|FG008|NOT COMPLETED|Phase A (Up to 24 Weeks)||0
8842345|NCT01697592|9896630|FG009|NOT COMPLETED|Phase A (Up to 24 Weeks)||2
8842346|NCT01697592|9896621|FG000|STARTED|Phase B (Week 25 to Week 52)||123
8842347|NCT01697592|9896622|FG001|STARTED|Phase B (Week 25 to Week 52)||62
8842348|NCT01697592|9896623|FG002|STARTED|Phase B (Week 25 to Week 52)||65
8842349|NCT01697592|9896624|FG003|STARTED|Phase B (Week 25 to Week 52)||63
8842350|NCT01697592|9896625|FG004|STARTED|Phase B (Week 25 to Week 52)||67
8842351|NCT01697592|9896626|FG005|STARTED|Phase B (Week 25 to Week 52)||62
8842352|NCT01697592|9896627|FG006|STARTED|Phase B (Week 25 to Week 52)||32
8842353|NCT01697592|9896628|FG007|STARTED|Phase B (Week 25 to Week 52)||33
8842354|NCT01697592|9896629|FG008|STARTED|Phase B (Week 25 to Week 52)||34
8842355|NCT01697592|9896630|FG009|STARTED|Phase B (Week 25 to Week 52)||30
8842356|NCT01697592|9896621|FG000|COMPLETED|Phase B (Week 25 to Week 52)||118
8842357|NCT01697592|9896622|FG001|COMPLETED|Phase B (Week 25 to Week 52)||61
8842358|NCT01697592|9896623|FG002|COMPLETED|Phase B (Week 25 to Week 52)||64
8842359|NCT01697592|9896624|FG003|COMPLETED|Phase B (Week 25 to Week 52)||60
8842360|NCT01697592|9896625|FG004|COMPLETED|Phase B (Week 25 to Week 52)||67
8842361|NCT01697592|9896626|FG005|COMPLETED|Phase B (Week 25 to Week 52)||60
8842362|NCT01697592|9896627|FG006|COMPLETED|Phase B (Week 25 to Week 52)||31
8842363|NCT01697592|9896628|FG007|COMPLETED|Phase B (Week 25 to Week 52)||32
8842364|NCT01697592|9896629|FG008|COMPLETED|Phase B (Week 25 to Week 52)||32
8842365|NCT01697592|9896630|FG009|COMPLETED|Phase B (Week 25 to Week 52)||30
8842366|NCT01697592|9896621|FG000|NOT COMPLETED|Phase B (Week 25 to Week 52)||5
8842367|NCT01697592|9896622|FG001|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
8842368|NCT01697592|9896623|FG002|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
8842369|NCT01697592|9896624|FG003|NOT COMPLETED|Phase B (Week 25 to Week 52)||3
8842370|NCT01697592|9896625|FG004|NOT COMPLETED|Phase B (Week 25 to Week 52)||0
8842371|NCT01697592|9896626|FG005|NOT COMPLETED|Phase B (Week 25 to Week 52)||2
8842372|NCT01697592|9896627|FG006|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
8842373|NCT01697592|9896628|FG007|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
8842374|NCT01697592|9896629|FG008|NOT COMPLETED|Phase B (Week 25 to Week 52)||2
8842375|NCT01697592|9896630|FG009|NOT COMPLETED|Phase B (Week 25 to Week 52)||0
8842376|NCT01697696|9896668|FG000|STARTED|Overall Study||254
8842377|NCT01697696|9896669|FG001|STARTED|Overall Study||257
8842378|NCT01697696|9896668|FG000|Safety Set|Overall Study||251
8842379|NCT01697696|9896669|FG001|Safety Set|Overall Study|Safety set included a patient that was treated, but not randomized|256
8842380|NCT01697696|9896668|FG000|Full Analysis Set (FAS)|Overall Study||251
8842381|NCT01697696|9896669|FG001|Full Analysis Set (FAS)|Overall Study||255
8842382|NCT01697696|9896668|FG000|COMPLETED|Overall Study||207
8842383|NCT01697696|9896669|FG001|COMPLETED|Overall Study||210
8842384|NCT01697696|9896668|FG000|NOT COMPLETED|Overall Study||47
8842385|NCT01697696|9896669|FG001|NOT COMPLETED|Overall Study||47
8842386|NCT01697709|9896677|FG000|STARTED|Overall Study||64
8842387|NCT01697709|9896678|FG001|STARTED|Overall Study||66
8842388|NCT01697709|9896677|FG000|COMPLETED|Overall Study||34
8842389|NCT01697709|9896678|FG001|COMPLETED|Overall Study||38
8842390|NCT01697709|9896677|FG000|NOT COMPLETED|Overall Study||30
8842391|NCT01697709|9896678|FG001|NOT COMPLETED|Overall Study||28
8842392|NCT01697748|9896686|FG000|STARTED|Overall Study||329
8842393|NCT01697748|9896687|FG001|STARTED|Overall Study||328
8842394|NCT01697748|9896686|FG000|COMPLETED|Overall Study||271
8842395|NCT01697748|9896687|FG001|COMPLETED|Overall Study||260
8842396|NCT01697748|9896686|FG000|NOT COMPLETED|Overall Study||58
8842397|NCT01697748|9896687|FG001|NOT COMPLETED|Overall Study||68
8842398|NCT01697956|9896695|FG000|STARTED|Overall Study|enrolled and randomized|67
8842399|NCT01697956|9896696|FG001|STARTED|Overall Study|enrolled and randomized|32
8842400|NCT01697956|9896695|FG000|Per Protocol Population|Overall Study||66
8842401|NCT01697956|9896696|FG001|Per Protocol Population|Overall Study||31
8842402|NCT01697956|9896695|FG000|COMPLETED|Overall Study||66
8842403|NCT01697956|9896696|FG001|COMPLETED|Overall Study||31
8842404|NCT01697956|9896695|FG000|NOT COMPLETED|Overall Study||1
8842405|NCT01697956|9896696|FG001|NOT COMPLETED|Overall Study||1
8842406|NCT01697969|9896708|FG000|STARTED|Overall Study||13
8842407|NCT01697969|9896708|FG000|COMPLETED|Overall Study||10
8842408|NCT01697969|9896708|FG000|NOT COMPLETED|Overall Study||3
8842409|NCT01698008|9896715|FG000|STARTED|Overall Study||3
8842410|NCT01698008|9896716|FG001|STARTED|Overall Study||2
8842411|NCT01698008|9896715|FG000|COMPLETED|Overall Study||2
8842412|NCT01698008|9896716|FG001|COMPLETED|Overall Study||0
8842413|NCT01698008|9896715|FG000|NOT COMPLETED|Overall Study||1
8842414|NCT01698008|9896716|FG001|NOT COMPLETED|Overall Study||2
8842415|NCT01698268|9896724|FG000|STARTED|Overall Study||25
8842416|NCT01698268|9896725|FG001|STARTED|Overall Study||25
8842417|NCT01698268|9896724|FG000|COMPLETED|Overall Study||23
8842418|NCT01698268|9896725|FG001|COMPLETED|Overall Study||24
8842419|NCT01698268|9896724|FG000|NOT COMPLETED|Overall Study||2
8842420|NCT01698268|9896725|FG001|NOT COMPLETED|Overall Study||1
8842421|NCT01698320|9896733|FG000|STARTED|Run-In Period (Week -1 to Day 0)||364
8842422|NCT01698320|9896734|FG001|STARTED|Run-In Period (Week -1 to Day 0)||0
8842423|NCT01698320|9896735|FG002|STARTED|Run-In Period (Week -1 to Day 0)||0
8842424|NCT01698320|9896733|FG000|COMPLETED|Run-In Period (Week -1 to Day 0)||337
8842425|NCT01698320|9896734|FG001|COMPLETED|Run-In Period (Week -1 to Day 0)||0
8842426|NCT01698320|9896735|FG002|COMPLETED|Run-In Period (Week -1 to Day 0)||0
8842427|NCT01698320|9896733|FG000|NOT COMPLETED|Run-In Period (Week -1 to Day 0)||27
8842428|NCT01698320|9896734|FG001|NOT COMPLETED|Run-In Period (Week -1 to Day 0)||0
8842429|NCT01698320|9896735|FG002|NOT COMPLETED|Run-In Period (Week -1 to Day 0)||0
8842430|NCT01698320|9896733|FG000|STARTED|12-Week Double-Blind Period||0
8842431|NCT01698320|9896734|FG001|STARTED|12-Week Double-Blind Period||169
8842432|NCT01698320|9896735|FG002|STARTED|12-Week Double-Blind Period||168
8842433|NCT01698320|9896733|FG000|Safety Population|12-Week Double-Blind Period||0
8842434|NCT01698320|9896734|FG001|Safety Population|12-Week Double-Blind Period|One participant took both placebo and albuterol so is counted in both treatment groups for safety.|170
8842435|NCT01698320|9896735|FG002|Safety Population|12-Week Double-Blind Period||168
8842436|NCT01698320|9896733|FG000|COMPLETED|12-Week Double-Blind Period||0
8842437|NCT01698320|9896734|FG001|COMPLETED|12-Week Double-Blind Period||165
8842438|NCT01698320|9896735|FG002|COMPLETED|12-Week Double-Blind Period||156
8842439|NCT01698320|9896733|FG000|NOT COMPLETED|12-Week Double-Blind Period||0
8842440|NCT01698320|9896734|FG001|NOT COMPLETED|12-Week Double-Blind Period||4
8842441|NCT01698320|9896735|FG002|NOT COMPLETED|12-Week Double-Blind Period||12
8842442|NCT01698320|9896733|FG000|STARTED|40-Week Open-Label Period||0
8842443|NCT01698320|9896734|FG001|STARTED|40-Week Open-Label Period||165
8842444|NCT01698320|9896735|FG002|STARTED|40-Week Open-Label Period||156
8842445|NCT01698320|9896733|FG000|COMPLETED|40-Week Open-Label Period||0
8842446|NCT01698320|9896734|FG001|COMPLETED|40-Week Open-Label Period||146
8842447|NCT01698320|9896735|FG002|COMPLETED|40-Week Open-Label Period||146
8842448|NCT01698320|9896733|FG000|NOT COMPLETED|40-Week Open-Label Period||0
8842449|NCT01698320|9896734|FG001|NOT COMPLETED|40-Week Open-Label Period||19
8842450|NCT01698320|9896735|FG002|NOT COMPLETED|40-Week Open-Label Period||10
8842451|NCT01698333|9896743|FG000|STARTED|Overall Study||25
8842452|NCT01698333|9896743|FG000|COMPLETED|Overall Study||25
8842453|NCT01698333|9896743|FG000|NOT COMPLETED|Overall Study||0
8842454|NCT01698463|9896747|FG000|STARTED|Overall Study||11
8842455|NCT01698463|9896747|FG000|COMPLETED|Overall Study||11
8842456|NCT01698463|9896747|FG000|NOT COMPLETED|Overall Study||0
8842457|NCT01698502|9896753|FG000|STARTED|Overall Study||11
8842458|NCT01698502|9896754|FG001|STARTED|Overall Study||10
8842459|NCT01698502|9896753|FG000|COMPLETED|Overall Study||11
8842460|NCT01698502|9896754|FG001|COMPLETED|Overall Study||10
8842461|NCT01698502|9896753|FG000|NOT COMPLETED|Overall Study||0
8842462|NCT01698502|9896754|FG001|NOT COMPLETED|Overall Study||0
8842463|NCT01698528|9896762|FG000|STARTED|Overall Study||20
8842464|NCT01698528|9896763|FG001|STARTED|Overall Study||20
8842465|NCT01698528|9896762|FG000|COMPLETED|Overall Study||19
8842466|NCT01698528|9896763|FG001|COMPLETED|Overall Study||16
8842467|NCT01698528|9896762|FG000|NOT COMPLETED|Overall Study||1
8842468|NCT01698528|9896763|FG001|NOT COMPLETED|Overall Study||4
8842469|NCT01698554|9896773|FG000|STARTED|Overall Study||153
8842470|NCT01698554|9896774|FG001|STARTED|Overall Study||157
8842471|NCT01698554|9896775|FG002|STARTED|Overall Study||75
8842472|NCT01698554|9896776|FG003|STARTED|Overall Study||79
8842473|NCT01698554|9896773|FG000|COMPLETED|Overall Study||147
8842474|NCT01698554|9896774|FG001|COMPLETED|Overall Study||147
8842475|NCT01698554|9896775|FG002|COMPLETED|Overall Study||73
8842476|NCT01698554|9896776|FG003|COMPLETED|Overall Study||77
8842477|NCT01698554|9896773|FG000|NOT COMPLETED|Overall Study||6
8842478|NCT01698554|9896774|FG001|NOT COMPLETED|Overall Study||10
8842479|NCT01698554|9896775|FG002|NOT COMPLETED|Overall Study||2
8842480|NCT01698554|9896776|FG003|NOT COMPLETED|Overall Study||2
8842481|NCT01698684|9896789|FG000|STARTED|Overall Study||145
8842482|NCT01698684|9896790|FG001|STARTED|Overall Study||147
8842483|NCT01698684|9896791|FG002|STARTED|Overall Study||148
8842484|NCT01698684|9896789|FG000|ITT Population|Overall Study||136
8842485|NCT01698684|9896790|FG001|ITT Population|Overall Study||139
8842486|NCT01698684|9896791|FG002|ITT Population|Overall Study||139
8842487|NCT01698684|9896789|FG000|Safety Population|Overall Study||143
8842488|NCT01698684|9896790|FG001|Safety Population|Overall Study||146
8842489|NCT01698684|9896791|FG002|Safety Population|Overall Study||146
8842490|NCT01698684|9896789|FG000|COMPLETED|Overall Study||116
8842491|NCT01698684|9896790|FG001|COMPLETED|Overall Study||124
8842492|NCT01698684|9896791|FG002|COMPLETED|Overall Study||127
8842493|NCT01698684|9896789|FG000|NOT COMPLETED|Overall Study||29
8842494|NCT01698684|9896790|FG001|NOT COMPLETED|Overall Study||23
8842495|NCT01698684|9896791|FG002|NOT COMPLETED|Overall Study||21
8850142|NCT01745120|9905389|FG000|COMPLETED|Overall Study||10
8850143|NCT01745120|9905390|FG001|COMPLETED|Overall Study||8
8850144|NCT01745120|9905389|FG000|NOT COMPLETED|Overall Study||1
8850145|NCT01745120|9905390|FG001|NOT COMPLETED|Overall Study||0
8850146|NCT01745133|9905402|FG000|STARTED|Overall Study||19
8850147|NCT01745133|9905403|FG001|STARTED|Overall Study||20
8850148|NCT01745133|9905404|FG002|STARTED|Overall Study||19
8850149|NCT01745133|9905402|FG000|COMPLETED|Overall Study||13
8850150|NCT01745133|9905403|FG001|COMPLETED|Overall Study||16
8850151|NCT01745133|9905404|FG002|COMPLETED|Overall Study||15
8850152|NCT01745133|9905402|FG000|NOT COMPLETED|Overall Study||6
8850153|NCT01745133|9905403|FG001|NOT COMPLETED|Overall Study||4
8850154|NCT01745133|9905404|FG002|NOT COMPLETED|Overall Study||4
8850155|NCT01745146|9905414|FG000|STARTED|Overall Study||30
8850156|NCT01745146|9905415|FG001|STARTED|Overall Study||60
8850157|NCT01745146|9905414|FG000|Allocation to Intervention|Overall Study||30
8850158|NCT01745146|9905415|FG001|Allocation to Intervention|Overall Study||60
8850159|NCT01745146|9905414|FG000|Primary Outcome Assessment|Overall Study||27
8850160|NCT01745146|9905415|FG001|Primary Outcome Assessment|Overall Study||57
8850161|NCT01745146|9905414|FG000|Analysis|Overall Study||27
8842496|NCT01698710|9896799|FG000|STARTED|Overall Study||5
8842497|NCT01698710|9896799|FG000|COMPLETED|Overall Study||5
8842498|NCT01698710|9896799|FG000|NOT COMPLETED|Overall Study||0
8842499|NCT01698775|9896805|FG000|STARTED|Phase A||107
8842500|NCT01698775|9896806|FG001|STARTED|Phase A||106
8842501|NCT01698775|9896805|FG000|COMPLETED|Phase A||98
8842502|NCT01698775|9896806|FG001|COMPLETED|Phase A||97
8842503|NCT01698775|9896805|FG000|NOT COMPLETED|Phase A||9
8842504|NCT01698775|9896806|FG001|NOT COMPLETED|Phase A||9
8842505|NCT01698775|9896805|FG000|STARTED|Phase B||98
8623232|NCT00492297|9662474|FG000|NOT COMPLETED|Treatment||5
8623233|NCT00492297|9662474|FG000|STARTED|Active Follow-up 30(+4) Days Duration|AFU is 30(+4) days duration for subjects withdrawn from sorafenib due to PD.|78
8623234|NCT00492297|9662474|FG000|COMPLETED|Active Follow-up 30(+4) Days Duration||59
8623235|NCT00492297|9662474|FG000|NOT COMPLETED|Active Follow-up 30(+4) Days Duration||19
8623236|NCT00492297|9662474|FG000|STARTED|Survival Only Follow-up||59
8623237|NCT00492297|9662474|FG000|COMPLETED|Survival Only Follow-up||0
8623238|NCT00492297|9662474|FG000|NOT COMPLETED|Survival Only Follow-up||59
8842506|NCT01698775|9896806|FG001|STARTED|Phase B||97
8842507|NCT01698775|9896805|FG000|COMPLETED|Phase B||84
8842508|NCT01698775|9896806|FG001|COMPLETED|Phase B||86
8842509|NCT01698775|9896805|FG000|NOT COMPLETED|Phase B||14
8842510|NCT01698775|9896806|FG001|NOT COMPLETED|Phase B||11
8842511|NCT01698801|9896816|FG000|STARTED|Treatment Phase||26
8842512|NCT01698801|9896816|FG000|COMPLETED|Treatment Phase|Completed includes participants who continued to receive study medication and treatment is ongoing.|15
8842513|NCT01698801|9896816|FG000|NOT COMPLETED|Treatment Phase||11
8842514|NCT01698801|9896816|FG000|STARTED|Follow Up Phase|11 participants did not complete the study and moved into the follow up phase lasting up to 5 years.|11
8842515|NCT01698801|9896816|FG000|COMPLETED|Follow Up Phase|Completed includes participants who remain in follow-up for up to 5 years from start of treatment|6
8842516|NCT01698801|9896816|FG000|NOT COMPLETED|Follow Up Phase||5
8842517|NCT01698814|9896823|FG000|STARTED|Overall Study||331
8842518|NCT01698814|9896824|FG001|STARTED|Overall Study||169
8842519|NCT01698814|9896823|FG000|COMPLETED|Overall Study||329
8842520|NCT01698814|9896824|FG001|COMPLETED|Overall Study||166
8842521|NCT01698814|9896823|FG000|NOT COMPLETED|Overall Study||2
8842522|NCT01698814|9896824|FG001|NOT COMPLETED|Overall Study||3
8842523|NCT01698879|9896833|FG000|STARTED|Overall Study||6
8842524|NCT01698879|9896834|FG001|STARTED|Overall Study||20
8842525|NCT01698879|9896835|FG002|STARTED|Overall Study||20
8842526|NCT01698879|9896833|FG000|COMPLETED|Overall Study||5
8842527|NCT01698879|9896834|FG001|COMPLETED|Overall Study||20
8842528|NCT01698879|9896835|FG002|COMPLETED|Overall Study||20
8842529|NCT01698879|9896833|FG000|NOT COMPLETED|Overall Study||1
8842530|NCT01698879|9896834|FG001|NOT COMPLETED|Overall Study||0
8842531|NCT01698879|9896835|FG002|NOT COMPLETED|Overall Study||0
8842532|NCT01699022|9896849|FG000|STARTED|Overall Study||17
8842533|NCT01699022|9896849|FG000|COMPLETED|Overall Study||14
8842534|NCT01699022|9896849|FG000|NOT COMPLETED|Overall Study||3
8842535|NCT01699087|9896854|FG000|STARTED|Overall Study||176
8842536|NCT01699087|9896854|FG000|Treated|Overall Study||161
8842537|NCT01699087|9896854|FG000|COMPLETED|Overall Study||152
8842538|NCT01699087|9896854|FG000|NOT COMPLETED|Overall Study||24
8842539|NCT01699178|9896861|FG000|STARTED|Overall Study||88
8842540|NCT01699178|9896862|FG001|STARTED|Overall Study||94
8842541|NCT01699178|9896861|FG000|COMPLETED|Overall Study||69
8842542|NCT01699178|9896862|FG001|COMPLETED|Overall Study||62
8842543|NCT01699178|9896861|FG000|NOT COMPLETED|Overall Study||19
8842544|NCT01699178|9896862|FG001|NOT COMPLETED|Overall Study||32
8842545|NCT01699373|9896870|FG000|STARTED|Overall Study||85
8842546|NCT01699373|9896871|FG001|STARTED|Overall Study||85
8842547|NCT01699373|9896870|FG000|COMPLETED|Overall Study||85
8842548|NCT01699373|9896871|FG001|COMPLETED|Overall Study||85
8842549|NCT01699373|9896870|FG000|NOT COMPLETED|Overall Study||0
8842550|NCT01699373|9896871|FG001|NOT COMPLETED|Overall Study||0
8842551|NCT01699503|9896879|FG000|STARTED|Overall Study||2008
8842552|NCT01699503|9896880|FG001|STARTED|Overall Study||1997
8842553|NCT01699503|9896879|FG000|Baseline|Overall Study||1723
8842554|NCT01699503|9896880|FG001|Baseline|Overall Study||1693
8842555|NCT01699503|9896879|FG000|1 Month Follow-up|Overall Study||998
8842556|NCT01699503|9896880|FG001|1 Month Follow-up|Overall Study||1022
8842557|NCT01699503|9896879|FG000|6 Month Follow-up|Overall Study||903
8842558|NCT01699503|9896880|FG001|6 Month Follow-up|Overall Study||893
8842559|NCT01699503|9896879|FG000|COMPLETED|Overall Study||1008
8842560|NCT01699503|9896880|FG001|COMPLETED|Overall Study||992
8842561|NCT01699503|9896879|FG000|NOT COMPLETED|Overall Study||1000
8842562|NCT01699503|9896880|FG001|NOT COMPLETED|Overall Study||1005
8842563|NCT01699542|9896888|FG000|STARTED|Overall Study||9
8842564|NCT01699542|9896889|FG001|STARTED|Overall Study||9
8842565|NCT01699542|9896888|FG000|COMPLETED|Overall Study||9
8842566|NCT01699542|9896889|FG001|COMPLETED|Overall Study||9
8842567|NCT01699542|9896888|FG000|NOT COMPLETED|Overall Study||0
8842568|NCT01699542|9896889|FG001|NOT COMPLETED|Overall Study||0
8842569|NCT01699607|9896897|FG000|STARTED|Overall Study||6
8842570|NCT01699607|9896898|FG001|STARTED|Overall Study||4
8623239|NCT00492336|9662480|FG000|STARTED|Overall Study||28
8842571|NCT01699607|9896897|FG000|COMPLETED|Overall Study||6
8842572|NCT01699607|9896898|FG001|COMPLETED|Overall Study||4
8842573|NCT01699607|9896897|FG000|NOT COMPLETED|Overall Study||0
8842574|NCT01699607|9896898|FG001|NOT COMPLETED|Overall Study||0
8842575|NCT01699685|9896905|FG000|STARTED|Period 1||39
8842576|NCT01699685|9896906|FG001|STARTED|Period 1||39
8842577|NCT01699685|9896905|FG000|Safety Population|Period 1||39
8842578|NCT01699685|9896906|FG001|Safety Population|Period 1||38
8842579|NCT01699685|9896905|FG000|Full Analysis Population (FAS)|Period 1||38
8842580|NCT01699685|9896906|FG001|Full Analysis Population (FAS)|Period 1||38
8842581|NCT01699685|9896905|FG000|COMPLETED|Period 1||36
8842582|NCT01699685|9896906|FG001|COMPLETED|Period 1||36
8842583|NCT01699685|9896905|FG000|NOT COMPLETED|Period 1||3
8842584|NCT01699685|9896906|FG001|NOT COMPLETED|Period 1||3
8842585|NCT01699685|9896905|FG000|STARTED|Period 2||36
8842586|NCT01699685|9896906|FG001|STARTED|Period 2||36
8842587|NCT01699685|9896905|FG000|COMPLETED|Period 2||35
8842588|NCT01699685|9896906|FG001|COMPLETED|Period 2||36
8842589|NCT01699685|9896905|FG000|NOT COMPLETED|Period 2||1
8842590|NCT01699685|9896906|FG001|NOT COMPLETED|Period 2||0
8842591|NCT01699698|9896914|FG000|STARTED|Overall Study||44
8842592|NCT01699698|9896915|FG001|STARTED|Overall Study||61
8842593|NCT01699698|9896914|FG000|COMPLETED|Overall Study||42
8842594|NCT01699698|9896915|FG001|COMPLETED|Overall Study||56
8842595|NCT01699698|9896914|FG000|NOT COMPLETED|Overall Study||2
8842596|NCT01699698|9896915|FG001|NOT COMPLETED|Overall Study||5
8842597|NCT01699750|9896924|FG000|STARTED|Overall Study||34
8842598|NCT01699750|9896925|FG001|STARTED|Overall Study||36
8842599|NCT01699750|9896924|FG000|COMPLETED|Overall Study||34
8842600|NCT01699750|9896925|FG001|COMPLETED|Overall Study||33
8842601|NCT01699750|9896924|FG000|NOT COMPLETED|Overall Study||0
8842602|NCT01699750|9896925|FG001|NOT COMPLETED|Overall Study||3
8842603|NCT01699763|9896935|FG000|STARTED|Overall Study||112
8842604|NCT01699763|9896935|FG000|COMPLETED|Overall Study||112
8842605|NCT01699763|9896935|FG000|NOT COMPLETED|Overall Study||0
8842606|NCT01699789|9896941|FG000|STARTED|Overall Study|606 eligible clients enrolled and contacted by telephone for baseline or follow-up survey in RS arm|606
8842607|NCT01699789|9896942|FG001|STARTED|Overall Study|640 eligible clients enrolled and contacted by telephone for baseline or follow-up survey in CEP arm|640
8842608|NCT01699789|9896941|FG000|Baseline|Overall Study||492
8842609|NCT01699789|9896942|FG001|Baseline|Overall Study||489
8842610|NCT01699789|9896941|FG000|6-Month Follow-Up|Overall Study||380
8842611|NCT01699789|9896942|FG001|6-Month Follow-Up|Overall Study||379
8842612|NCT01699789|9896941|FG000|12-Month Follow-Up|Overall Study||364
8842613|NCT01699789|9896942|FG001|12-Month Follow-Up|Overall Study||369
8842614|NCT01699789|9896941|FG000|3-Year Follow-up|Overall Study||293
8842615|NCT01699789|9896942|FG001|3-Year Follow-up|Overall Study||307
8842616|NCT01699789|9896941|FG000|4-Year Follow-up|Overall Study||143
8842617|NCT01699789|9896942|FG001|4-Year Follow-up|Overall Study||140
8842618|NCT01699789|9896941|FG000|COMPLETED|Overall Study|Clients in 44 programs with completed at least 1 data point at baseline, 6, or 12 mo FUP analyzed|504
8842619|NCT01699789|9896942|FG001|COMPLETED|Overall Study|Clients in 46 programs with completed at least 1 data point at baseline, 6, or 12 mo FUP analyzed|514
8842620|NCT01699789|9896941|FG000|NOT COMPLETED|Overall Study||102
8842621|NCT01699789|9896942|FG001|NOT COMPLETED|Overall Study||126
8842622|NCT01699815|9896952|FG000|STARTED|Overall Study||62
8842623|NCT01699815|9896953|FG001|STARTED|Overall Study||64
8842624|NCT01699815|9896952|FG000|COMPLETED|Overall Study||57
8842625|NCT01699815|9896953|FG001|COMPLETED|Overall Study||56
8842626|NCT01699815|9896952|FG000|NOT COMPLETED|Overall Study||5
8842627|NCT01699815|9896953|FG001|NOT COMPLETED|Overall Study||8
8842628|NCT01699867|9896959|FG000|STARTED|Overall Study||50
8842629|NCT01699867|9896959|FG000|COMPLETED|Overall Study||47
8842630|NCT01699867|9896959|FG000|NOT COMPLETED|Overall Study||3
8842631|NCT01700036|9896963|FG000|STARTED|Overall Study||40
8842632|NCT01700036|9896963|FG000|COMPLETED|Overall Study||40
8842633|NCT01700036|9896963|FG000|NOT COMPLETED|Overall Study||0
8842634|NCT01700049|9896967|FG000|STARTED|Overall Study||28
8842635|NCT01700049|9896967|FG000|COMPLETED|Overall Study||27
8842636|NCT01700049|9896967|FG000|NOT COMPLETED|Overall Study||1
8842637|NCT01700140|9896975|FG000|STARTED|Overall Study||61
8842638|NCT01700140|9896976|FG001|STARTED|Overall Study||66
8842639|NCT01700140|9896977|FG002|STARTED|Overall Study||62
8842640|NCT01700140|9896975|FG000|COMPLETED|Overall Study||55
8842641|NCT01700140|9896976|FG001|COMPLETED|Overall Study||57
8842642|NCT01700140|9896977|FG002|COMPLETED|Overall Study||61
8842643|NCT01700140|9896975|FG000|NOT COMPLETED|Overall Study||6
8842644|NCT01700140|9896976|FG001|NOT COMPLETED|Overall Study||9
8842645|NCT01700140|9896977|FG002|NOT COMPLETED|Overall Study||1
8842646|NCT01700179|9896988|FG000|STARTED|Overall Study||8
8842647|NCT01700179|9896988|FG000|COMPLETED|Overall Study||6
8842648|NCT01700179|9896988|FG000|NOT COMPLETED|Overall Study||2
8842649|NCT01700192|9896994|FG000|STARTED|Overall Study||741
8842650|NCT01700192|9896995|FG001|STARTED|Overall Study||741
8842651|NCT01700192|9896994|FG000|Treated|Overall Study||740
8842652|NCT01700192|9896995|FG001|Treated|Overall Study||741
8842653|NCT01700192|9896994|FG000|All Participants as Treated (APaT)|Overall Study|Three participants randomized to receive placebo were given MK-8237 12 DU.|743
8842654|NCT01700192|9896995|FG001|All Participants as Treated (APaT)|Overall Study|Three participants randomized to receive placebo were given MK-8237 12 DU.|738
8842655|NCT01700192|9896994|FG000|COMPLETED|Overall Study||561
8842656|NCT01700192|9896995|FG001|COMPLETED|Overall Study||613
8842657|NCT01700192|9896994|FG000|NOT COMPLETED|Overall Study||180
8842658|NCT01700192|9896995|FG001|NOT COMPLETED|Overall Study||128
8842659|NCT01700205|9897003|FG000|STARTED|Overall Study|Mother-Infant Dyads|59
8842660|NCT01700205|9897004|FG001|STARTED|Overall Study|Mother-Infant Dyads|54
8842661|NCT01700205|9897003|FG000|COMPLETED|Overall Study|Mother-Infant Dyads|44
8842662|NCT01700205|9897004|FG001|COMPLETED|Overall Study|Mother-Infant Dyads|39
8842663|NCT01700205|9897003|FG000|NOT COMPLETED|Overall Study||15
8842664|NCT01700205|9897004|FG001|NOT COMPLETED|Overall Study||15
8842665|NCT01700335|9897010|FG000|STARTED|Overall Study||3
8842666|NCT01700335|9897011|FG001|STARTED|Overall Study||6
8842667|NCT01700335|9897010|FG000|COMPLETED|Overall Study||2
8842668|NCT01700335|9897011|FG001|COMPLETED|Overall Study||2
8842669|NCT01700335|9897010|FG000|NOT COMPLETED|Overall Study||1
8842670|NCT01700335|9897011|FG001|NOT COMPLETED|Overall Study||4
8842671|NCT01700387|9897020|FG000|STARTED|Overall Study||10
8842672|NCT01700387|9897021|FG001|STARTED|Overall Study||10
8842673|NCT01700387|9897020|FG000|COMPLETED|Overall Study||6
8842674|NCT01700387|9897021|FG001|COMPLETED|Overall Study||6
8842675|NCT01700387|9897020|FG000|NOT COMPLETED|Overall Study||4
8842676|NCT01700387|9897021|FG001|NOT COMPLETED|Overall Study||4
8842677|NCT01700517|9897034|FG000|STARTED|Overall Study||40
8842678|NCT01700517|9897035|FG001|STARTED|Overall Study||40
8842679|NCT01700517|9897036|FG002|STARTED|Overall Study||40
8842680|NCT01700517|9897034|FG000|COMPLETED|Overall Study||40
8842681|NCT01700517|9897035|FG001|COMPLETED|Overall Study||40
8842682|NCT01700517|9897036|FG002|COMPLETED|Overall Study||40
8842683|NCT01700517|9897034|FG000|NOT COMPLETED|Overall Study||0
8842684|NCT01700517|9897035|FG001|NOT COMPLETED|Overall Study||0
8842685|NCT01700517|9897036|FG002|NOT COMPLETED|Overall Study||0
8842686|NCT01700530|9897047|FG000|STARTED|Overall Study||9
8842687|NCT01700530|9897048|FG001|STARTED|Overall Study||21
8842688|NCT01700530|9897049|FG002|STARTED|Overall Study||20
8842689|NCT01700530|9897047|FG000|COMPLETED|Overall Study||9
8842690|NCT01700530|9897048|FG001|COMPLETED|Overall Study||18
8842691|NCT01700530|9897049|FG002|COMPLETED|Overall Study||19
8842692|NCT01700530|9897047|FG000|NOT COMPLETED|Overall Study||0
8842693|NCT01700530|9897048|FG001|NOT COMPLETED|Overall Study||3
8842694|NCT01700530|9897049|FG002|NOT COMPLETED|Overall Study||1
8842695|NCT01700621|9897059|FG000|STARTED|Received Study Vaccines||240
8842696|NCT01700621|9897060|FG001|STARTED|Received Study Vaccines||240
8842697|NCT01700621|9897059|FG000|COMPLETED|Received Study Vaccines||240
8842698|NCT01700621|9897060|FG001|COMPLETED|Received Study Vaccines||240
8842699|NCT01700621|9897059|FG000|NOT COMPLETED|Received Study Vaccines||0
8842700|NCT01700621|9897060|FG001|NOT COMPLETED|Received Study Vaccines||0
8842701|NCT01700621|9897059|FG000|STARTED|Analyzed for Immunogenicity||240
8842702|NCT01700621|9897060|FG001|STARTED|Analyzed for Immunogenicity||240
8842703|NCT01700621|9897059|FG000|COMPLETED|Analyzed for Immunogenicity||227
8842704|NCT01700621|9897060|FG001|COMPLETED|Analyzed for Immunogenicity||233
8842705|NCT01700621|9897059|FG000|NOT COMPLETED|Analyzed for Immunogenicity||13
8842706|NCT01700621|9897060|FG001|NOT COMPLETED|Analyzed for Immunogenicity||7
8842707|NCT01700673|9897070|FG000|STARTED|Overall Study||1
8842708|NCT01700673|9897071|FG001|STARTED|Overall Study||23
8842709|NCT01700673|9897072|FG002|STARTED|Overall Study||1
8842710|NCT01700673|9897070|FG000|COMPLETED|Overall Study||1
8842711|NCT01700673|9897071|FG001|COMPLETED|Overall Study||17
8842712|NCT01700673|9897072|FG002|COMPLETED|Overall Study||1
8842713|NCT01700673|9897070|FG000|NOT COMPLETED|Overall Study||0
8842714|NCT01700673|9897071|FG001|NOT COMPLETED|Overall Study||6
8842715|NCT01700673|9897072|FG002|NOT COMPLETED|Overall Study||0
8842716|NCT01700725|9897084|FG000|STARTED|Overall Study||14
8842717|NCT01700725|9897085|FG001|STARTED|Overall Study||14
8842718|NCT01700725|9897086|FG002|STARTED|Overall Study||12
8944776|NCT02399917|10006683|FG001|STARTED|Overall Study||6
8944777|NCT02399917|10006684|FG002|STARTED|Overall Study||24
8944778|NCT02399917|10006682|FG000|COMPLETED|Overall Study||6
8944779|NCT02399917|10006683|FG001|COMPLETED|Overall Study||6
8944780|NCT02399917|10006684|FG002|COMPLETED|Overall Study||24
8944781|NCT02399917|10006682|FG000|NOT COMPLETED|Overall Study||0
8944782|NCT02399917|10006683|FG001|NOT COMPLETED|Overall Study||0
8944783|NCT02399917|10006684|FG002|NOT COMPLETED|Overall Study||0
8944784|NCT02400073|10006693|FG000|STARTED|Overall Study||122
8944785|NCT02400073|10006693|FG000|COMPLETED|Overall Study||111
8944786|NCT02400073|10006693|FG000|NOT COMPLETED|Overall Study||11
8944787|NCT02400307|10006699|FG000|STARTED|Overall Study||11
8944788|NCT02400307|10006700|FG001|STARTED|Overall Study||8
8944789|NCT02400307|10006699|FG000|COMPLETED|Overall Study||10
8944790|NCT02400307|10006700|FG001|COMPLETED|Overall Study||8
8623240|NCT00492336|9662481|FG001|STARTED|Overall Study||29
8623241|NCT00492336|9662480|FG000|COMPLETED|Overall Study||26
8842719|NCT01700725|9897084|FG000|COMPLETED|Overall Study||14
8842720|NCT01700725|9897085|FG001|COMPLETED|Overall Study||14
8842721|NCT01700725|9897086|FG002|COMPLETED|Overall Study||12
8944791|NCT02400307|10006699|FG000|NOT COMPLETED|Overall Study||1
8944792|NCT02400307|10006700|FG001|NOT COMPLETED|Overall Study||0
8944793|NCT02400333|10006710|FG000|STARTED|Overall Study||9
8944794|NCT02400333|10006711|FG001|STARTED|Overall Study||9
8944795|NCT02400333|10006712|FG002|STARTED|Overall Study||9
8944796|NCT02400333|10006713|FG003|STARTED|Overall Study||9
8623242|NCT00492336|9662481|FG001|COMPLETED|Overall Study||23
8842722|NCT01700725|9897084|FG000|NOT COMPLETED|Overall Study||0
8842723|NCT01700725|9897085|FG001|NOT COMPLETED|Overall Study||0
8842724|NCT01700725|9897086|FG002|NOT COMPLETED|Overall Study||0
8842725|NCT01700816|9897096|FG000|STARTED|Overall Study||21
8842726|NCT01700816|9897097|FG001|STARTED|Overall Study||19
8842727|NCT01700816|9897096|FG000|COMPLETED|Overall Study||21
8842728|NCT01700816|9897097|FG001|COMPLETED|Overall Study||19
8842729|NCT01700816|9897096|FG000|NOT COMPLETED|Overall Study||0
8842730|NCT01700816|9897097|FG001|NOT COMPLETED|Overall Study||0
8842731|NCT01700829|9897105|FG000|STARTED|Overall Study||41
8842732|NCT01700829|9897106|FG001|STARTED|Overall Study||41
8842733|NCT01700829|9897105|FG000|COMPLETED|Overall Study||40
8842734|NCT01700829|9897106|FG001|COMPLETED|Overall Study||40
8842735|NCT01700829|9897105|FG000|NOT COMPLETED|Overall Study||1
8842736|NCT01700829|9897106|FG001|NOT COMPLETED|Overall Study||1
8842737|NCT01700907|9897114|FG000|STARTED|Overall Study||10
8842738|NCT01700907|9897115|FG001|STARTED|Overall Study||10
8842739|NCT01700907|9897114|FG000|COMPLETED|Overall Study||10
8842740|NCT01700907|9897115|FG001|COMPLETED|Overall Study||10
8842741|NCT01700907|9897114|FG000|NOT COMPLETED|Overall Study||0
8842742|NCT01700907|9897115|FG001|NOT COMPLETED|Overall Study||0
8623243|NCT00492336|9662480|FG000|NOT COMPLETED|Overall Study||2
8623244|NCT00492336|9662481|FG001|NOT COMPLETED|Overall Study||6
8623245|NCT00492401|9662487|FG000|STARTED|Overall Study||55
8842743|NCT01700959|9897127|FG000|STARTED|Overall Study||89
8842744|NCT01700959|9897128|FG001|STARTED|Overall Study||88
8842745|NCT01700959|9897129|FG002|STARTED|Overall Study||105
8842746|NCT01700959|9897130|FG003|STARTED|Overall Study||105
8842747|NCT01700959|9897131|FG004|STARTED|Overall Study||96
8842748|NCT01700959|9897132|FG005|STARTED|Overall Study||97
8842749|NCT01700959|9897127|FG000|COMPLETED|Overall Study||62
8842750|NCT01700959|9897128|FG001|COMPLETED|Overall Study||64
8842751|NCT01700959|9897129|FG002|COMPLETED|Overall Study||65
8842752|NCT01700959|9897130|FG003|COMPLETED|Overall Study||70
8842753|NCT01700959|9897131|FG004|COMPLETED|Overall Study||69
8842754|NCT01700959|9897132|FG005|COMPLETED|Overall Study||72
8842755|NCT01700959|9897127|FG000|NOT COMPLETED|Overall Study||27
8842756|NCT01700959|9897128|FG001|NOT COMPLETED|Overall Study||24
8842757|NCT01700959|9897129|FG002|NOT COMPLETED|Overall Study||40
8842758|NCT01700959|9897130|FG003|NOT COMPLETED|Overall Study||35
8842759|NCT01700959|9897131|FG004|NOT COMPLETED|Overall Study||27
8842760|NCT01700959|9897132|FG005|NOT COMPLETED|Overall Study||25
8842761|NCT01700985|9897150|FG000|STARTED|Overall Study||23
8842762|NCT01700985|9897151|FG001|STARTED|Overall Study||21
8842763|NCT01700985|9897150|FG000|COMPLETED|Overall Study||23
8842764|NCT01700985|9897151|FG001|COMPLETED|Overall Study||20
8842765|NCT01700985|9897150|FG000|NOT COMPLETED|Overall Study||0
8842766|NCT01700985|9897151|FG001|NOT COMPLETED|Overall Study||1
8842767|NCT01701011|9897160|FG000|STARTED|Overall Study||127
8842768|NCT01701011|9897161|FG001|STARTED|Overall Study||126
8842769|NCT01701011|9897162|FG002|STARTED|Overall Study||124
8842770|NCT01701011|9897160|FG000|COMPLETED|Overall Study||92
8842771|NCT01701011|9897161|FG001|COMPLETED|Overall Study||102
8842772|NCT01701011|9897162|FG002|COMPLETED|Overall Study||90
8842773|NCT01701011|9897160|FG000|NOT COMPLETED|Overall Study||35
8842774|NCT01701011|9897161|FG001|NOT COMPLETED|Overall Study||24
8842775|NCT01701011|9897162|FG002|NOT COMPLETED|Overall Study||34
8842776|NCT01701024|9897173|FG000|STARTED|Overall Study||253
8842777|NCT01701024|9897174|FG001|STARTED|Overall Study||245
8842778|NCT01701024|9897173|FG000|COMPLETED|Overall Study||243
8842779|NCT01701024|9897174|FG001|COMPLETED|Overall Study||236
8842780|NCT01701024|9897173|FG000|NOT COMPLETED|Overall Study||10
8842781|NCT01701024|9897174|FG001|NOT COMPLETED|Overall Study||9
8842782|NCT01701037|9897180|FG000|STARTED|Overall Study||13
8842783|NCT01701037|9897180|FG000|COMPLETED|Overall Study||13
8842784|NCT01701037|9897180|FG000|NOT COMPLETED|Overall Study||0
8842785|NCT01701063|9897188|FG000|STARTED|Overall Study||13
8842786|NCT01701063|9897189|FG001|STARTED|Overall Study||19
8842787|NCT01701063|9897190|FG002|STARTED|Overall Study||10
8842788|NCT01701063|9897188|FG000|COMPLETED|Overall Study||13
8842789|NCT01701063|9897189|FG001|COMPLETED|Overall Study||18
8842790|NCT01701063|9897190|FG002|COMPLETED|Overall Study||8
8842791|NCT01701063|9897188|FG000|NOT COMPLETED|Overall Study||0
8842792|NCT01701063|9897189|FG001|NOT COMPLETED|Overall Study||1
8842793|NCT01701063|9897190|FG002|NOT COMPLETED|Overall Study||2
8842794|NCT01701102|9897203|FG000|STARTED|Overall Study||22
8842795|NCT01701102|9897204|FG001|STARTED|Overall Study||6
8623246|NCT00492401|9662487|FG000|COMPLETED|Overall Study||55
8623247|NCT00492401|9662487|FG000|NOT COMPLETED|Overall Study||0
8842796|NCT01701102|9897205|FG002|STARTED|Overall Study||10
8842797|NCT01701102|9897206|FG003|STARTED|Overall Study||18
8842798|NCT01701102|9897203|FG000|COMPLETED|Overall Study||22
8842799|NCT01701102|9897204|FG001|COMPLETED|Overall Study||6
8842800|NCT01701102|9897205|FG002|COMPLETED|Overall Study||10
8842801|NCT01701102|9897206|FG003|COMPLETED|Overall Study||18
8842802|NCT01701102|9897203|FG000|NOT COMPLETED|Overall Study||0
8842803|NCT01701102|9897204|FG001|NOT COMPLETED|Overall Study||0
8842804|NCT01701102|9897205|FG002|NOT COMPLETED|Overall Study||0
8842805|NCT01701102|9897206|FG003|NOT COMPLETED|Overall Study||0
8623248|NCT00492531|9662495|FG000|STARTED|Overall Study||37
8842806|NCT01701115|9897218|FG000|STARTED|Overall Study||77
8842807|NCT01701115|9897219|FG001|STARTED|Overall Study||77
8842808|NCT01701115|9897218|FG000|COMPLETED|Overall Study||75
8842809|NCT01701115|9897219|FG001|COMPLETED|Overall Study||77
8842810|NCT01701115|9897218|FG000|NOT COMPLETED|Overall Study||2
8842811|NCT01701115|9897219|FG001|NOT COMPLETED|Overall Study||0
8842812|NCT01701193|9897229|FG000|STARTED|Overall Study||18
8842813|NCT01701193|9897230|FG001|STARTED|Overall Study||19
8842814|NCT01701193|9897231|FG002|STARTED|Overall Study||5
8842815|NCT01701193|9897232|FG003|STARTED|Overall Study||5
8842816|NCT01701193|9897229|FG000|COMPLETED|Overall Study||15
8842817|NCT01701193|9897230|FG001|COMPLETED|Overall Study||17
8842818|NCT01701193|9897231|FG002|COMPLETED|Overall Study||4
8842819|NCT01701193|9897232|FG003|COMPLETED|Overall Study||3
8842820|NCT01701193|9897229|FG000|NOT COMPLETED|Overall Study||3
8842821|NCT01701193|9897230|FG001|NOT COMPLETED|Overall Study||2
8842822|NCT01701193|9897231|FG002|NOT COMPLETED|Overall Study||1
8842823|NCT01701193|9897232|FG003|NOT COMPLETED|Overall Study||2
8842824|NCT01701245|9897247|FG000|STARTED|Overall Study||49
8842825|NCT01701245|9897248|FG001|STARTED|Overall Study||48
8842826|NCT01701245|9897247|FG000|FAS Unmatched Data|Overall Study|1 patient protocol violation|48
8842827|NCT01701245|9897248|FG001|FAS Unmatched Data|Overall Study|3 patients protocol violation|45
8842828|NCT01701245|9897247|FG000|FAS Matched Data|Overall Study||42
8842829|NCT01701245|9897248|FG001|FAS Matched Data|Overall Study||32
8842830|NCT01701245|9897247|FG000|COMPLETED|Overall Study||37
8842831|NCT01701245|9897248|FG001|COMPLETED|Overall Study||33
8842832|NCT01701245|9897247|FG000|NOT COMPLETED|Overall Study||12
8842833|NCT01701245|9897248|FG001|NOT COMPLETED|Overall Study||15
8842834|NCT01701258|9897258|FG000|STARTED|Assessment and Scheduling||153
8842835|NCT01701258|9897259|FG001|STARTED|Assessment and Scheduling||0
8842836|NCT01701258|9897260|FG002|STARTED|Assessment and Scheduling||0
8842837|NCT01701258|9897261|FG003|STARTED|Assessment and Scheduling||0
8842838|NCT01701258|9897262|FG004|STARTED|Assessment and Scheduling||0
8842839|NCT01701258|9897263|FG005|STARTED|Assessment and Scheduling||0
8842840|NCT01701258|9897264|FG006|STARTED|Assessment and Scheduling||0
8842841|NCT01701258|9897265|FG007|STARTED|Assessment and Scheduling||0
8842842|NCT01701258|9897266|FG008|STARTED|Assessment and Scheduling||0
8842843|NCT01701258|9897267|FG009|STARTED|Assessment and Scheduling||0
8842844|NCT01701258|9897268|FG010|STARTED|Assessment and Scheduling||0
8842845|NCT01701258|9897269|FG011|STARTED|Assessment and Scheduling||0
8842846|NCT01701258|9897270|FG012|STARTED|Assessment and Scheduling||0
8842847|NCT01701258|9897258|FG000|Eligible After Screening Visit|Assessment and Scheduling||96
8842848|NCT01701258|9897259|FG001|Eligible After Screening Visit|Assessment and Scheduling||0
8842849|NCT01701258|9897260|FG002|Eligible After Screening Visit|Assessment and Scheduling||0
8842850|NCT01701258|9897261|FG003|Eligible After Screening Visit|Assessment and Scheduling||0
8842851|NCT01701258|9897262|FG004|Eligible After Screening Visit|Assessment and Scheduling||0
8842852|NCT01701258|9897263|FG005|Eligible After Screening Visit|Assessment and Scheduling||0
8842853|NCT01701258|9897264|FG006|Eligible After Screening Visit|Assessment and Scheduling||0
8842854|NCT01701258|9897265|FG007|Eligible After Screening Visit|Assessment and Scheduling||0
8842855|NCT01701258|9897266|FG008|Eligible After Screening Visit|Assessment and Scheduling||0
8842856|NCT01701258|9897267|FG009|Eligible After Screening Visit|Assessment and Scheduling||0
8842857|NCT01701258|9897268|FG010|Eligible After Screening Visit|Assessment and Scheduling||0
8842858|NCT01701258|9897269|FG011|Eligible After Screening Visit|Assessment and Scheduling||0
8623249|NCT00492531|9662496|FG001|STARTED|Overall Study||37
8623250|NCT00492531|9662495|FG000|COMPLETED|Overall Study|Of 15 subjects who completed study, 13 were enrolled in Open label.|15
8623251|NCT00492531|9662496|FG001|COMPLETED|Overall Study|Of 14 subjects who completed study, 13 were enrolled in Open label.|14
8623252|NCT00492531|9662495|FG000|NOT COMPLETED|Overall Study||22
8623253|NCT00492531|9662496|FG001|NOT COMPLETED|Overall Study||23
8623254|NCT00492544|9662502|FG000|STARTED|Overall Study||100
8623255|NCT00492544|9662502|FG000|COMPLETED|Overall Study||100
8623256|NCT00492544|9662502|FG000|NOT COMPLETED|Overall Study||0
8623257|NCT00492557|9662508|FG000|STARTED|Overall Study||580
8623258|NCT00492557|9662509|FG001|STARTED|Overall Study||580
8623259|NCT00492557|9662508|FG000|Vaccinated Dose 1|Overall Study||577
8623260|NCT00492557|9662509|FG001|Vaccinated Dose 1|Overall Study||575
8623261|NCT00492557|9662508|FG000|Vaccinated Dose 2|Overall Study||560
8623262|NCT00492557|9662509|FG001|Vaccinated Dose 2|Overall Study||558
8623263|NCT00492557|9662508|FG000|COMPLETED|Overall Study||556
8623264|NCT00492557|9662509|FG001|COMPLETED|Overall Study||557
8623265|NCT00492557|9662508|FG000|NOT COMPLETED|Overall Study||24
8623266|NCT00492557|9662509|FG001|NOT COMPLETED|Overall Study||23
8623267|NCT00492583|9662520|FG000|STARTED|Overall Study||95
8623268|NCT00492583|9662521|FG001|STARTED|Overall Study||87
8623269|NCT00492583|9662520|FG000|COMPLETED|Overall Study||95
8623270|NCT00492583|9662521|FG001|COMPLETED|Overall Study||87
8623271|NCT00492583|9662520|FG000|NOT COMPLETED|Overall Study||0
8623272|NCT00492583|9662521|FG001|NOT COMPLETED|Overall Study||0
8623273|NCT00492622|9662527|FG000|STARTED|Overall Study|all subjects received the immediate release formulation|12
8623274|NCT00492622|9662527|FG000|COMPLETED|Overall Study||12
8623275|NCT00492622|9662527|FG000|NOT COMPLETED|Overall Study||0
8623276|NCT00492648|9662537|FG000|STARTED|Month 30 (109671 Study)||4
8623277|NCT00492648|9662538|FG001|STARTED|Month 30 (109671 Study)||30
8623278|NCT00492648|9662537|FG000|COMPLETED|Month 30 (109671 Study)||4
8623279|NCT00492648|9662538|FG001|COMPLETED|Month 30 (109671 Study)||29
8623280|NCT00492648|9662537|FG000|NOT COMPLETED|Month 30 (109671 Study)||0
8623281|NCT00492648|9662538|FG001|NOT COMPLETED|Month 30 (109671 Study)||1
8623282|NCT00492648|9662537|FG000|STARTED|Month 42 (109674 Study)||3
8623283|NCT00492648|9662538|FG001|STARTED|Month 42 (109674 Study)||20
8623284|NCT00492648|9662537|FG000|COMPLETED|Month 42 (109674 Study)||3
8623285|NCT00492648|9662538|FG001|COMPLETED|Month 42 (109674 Study)||20
8623286|NCT00492648|9662537|FG000|NOT COMPLETED|Month 42 (109674 Study)||0
8842859|NCT01701258|9897270|FG012|Eligible After Screening Visit|Assessment and Scheduling||0
8842860|NCT01701258|9897258|FG000|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||68
8623287|NCT00492648|9662538|FG001|NOT COMPLETED|Month 42 (109674 Study)||0
8623288|NCT00492726|9662546|FG000|STARTED|Overall Study||410
8623289|NCT00492726|9662547|FG001|STARTED|Overall Study||394
8623290|NCT00492726|9662546|FG000|End of Treatment (EOT, Day 5 to 14)|Overall Study||387
8623291|NCT00492726|9662547|FG001|End of Treatment (EOT, Day 5 to 14)|Overall Study||377
8623292|NCT00492726|9662546|FG000|End of Study|Overall Study||360
8623293|NCT00492726|9662547|FG001|End of Study|Overall Study||358
8623294|NCT00492726|9662546|FG000|COMPLETED|Overall Study||360
8842861|NCT01701258|9897259|FG001|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
8842862|NCT01701258|9897260|FG002|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
8842863|NCT01701258|9897261|FG003|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
8842864|NCT01701258|9897262|FG004|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
8842865|NCT01701258|9897263|FG005|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
8842866|NCT01701258|9897264|FG006|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
8842867|NCT01701258|9897265|FG007|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
8842868|NCT01701258|9897266|FG008|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
8842869|NCT01701258|9897267|FG009|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
8842870|NCT01701258|9897268|FG010|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
8842871|NCT01701258|9897269|FG011|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
8842872|NCT01701258|9897270|FG012|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
8842873|NCT01701258|9897258|FG000|Returned for PET (Session 3)|Assessment and Scheduling||73
8842874|NCT01701258|9897259|FG001|Returned for PET (Session 3)|Assessment and Scheduling||0
8842875|NCT01701258|9897260|FG002|Returned for PET (Session 3)|Assessment and Scheduling||0
8842876|NCT01701258|9897261|FG003|Returned for PET (Session 3)|Assessment and Scheduling||0
8842877|NCT01701258|9897262|FG004|Returned for PET (Session 3)|Assessment and Scheduling||0
8842878|NCT01701258|9897263|FG005|Returned for PET (Session 3)|Assessment and Scheduling||0
8842879|NCT01701258|9897264|FG006|Returned for PET (Session 3)|Assessment and Scheduling||0
8842880|NCT01701258|9897265|FG007|Returned for PET (Session 3)|Assessment and Scheduling||0
8842881|NCT01701258|9897266|FG008|Returned for PET (Session 3)|Assessment and Scheduling||0
8842882|NCT01701258|9897267|FG009|Returned for PET (Session 3)|Assessment and Scheduling||0
8842883|NCT01701258|9897268|FG010|Returned for PET (Session 3)|Assessment and Scheduling||0
8842884|NCT01701258|9897269|FG011|Returned for PET (Session 3)|Assessment and Scheduling||0
8842885|NCT01701258|9897270|FG012|Returned for PET (Session 3)|Assessment and Scheduling||0
8842886|NCT01701258|9897258|FG000|Returned for EEG (Session 4)|Assessment and Scheduling||66
8842887|NCT01701258|9897259|FG001|Returned for EEG (Session 4)|Assessment and Scheduling||0
8842888|NCT01701258|9897260|FG002|Returned for EEG (Session 4)|Assessment and Scheduling||0
8842889|NCT01701258|9897261|FG003|Returned for EEG (Session 4)|Assessment and Scheduling||0
8842890|NCT01701258|9897262|FG004|Returned for EEG (Session 4)|Assessment and Scheduling||0
8842891|NCT01701258|9897263|FG005|Returned for EEG (Session 4)|Assessment and Scheduling||0
8842892|NCT01701258|9897264|FG006|Returned for EEG (Session 4)|Assessment and Scheduling||0
8842893|NCT01701258|9897265|FG007|Returned for EEG (Session 4)|Assessment and Scheduling||0
8842894|NCT01701258|9897266|FG008|Returned for EEG (Session 4)|Assessment and Scheduling||0
8842895|NCT01701258|9897267|FG009|Returned for EEG (Session 4)|Assessment and Scheduling||0
8842896|NCT01701258|9897268|FG010|Returned for EEG (Session 4)|Assessment and Scheduling||0
8944797|NCT02400333|10006710|FG000|COMPLETED|Overall Study||8
8944798|NCT02400333|10006711|FG001|COMPLETED|Overall Study||8
8944799|NCT02400333|10006712|FG002|COMPLETED|Overall Study||7
8944800|NCT02400333|10006713|FG003|COMPLETED|Overall Study||7
8944801|NCT02400333|10006710|FG000|NOT COMPLETED|Overall Study||1
8944802|NCT02400333|10006711|FG001|NOT COMPLETED|Overall Study||1
8944803|NCT02400333|10006712|FG002|NOT COMPLETED|Overall Study||2
8944804|NCT02400333|10006713|FG003|NOT COMPLETED|Overall Study||2
8944805|NCT02400346|10006724|FG000|STARTED|Overall Study||132
8944806|NCT02400346|10006724|FG000|COMPLETED|Overall Study||88
8944807|NCT02400346|10006724|FG000|NOT COMPLETED|Overall Study||44
8944808|NCT02400437|10006728|FG000|STARTED|Overall Study||26
8944809|NCT02400437|10006728|FG000|COMPLETED|Overall Study||26
8944810|NCT02400437|10006728|FG000|NOT COMPLETED|Overall Study||0
8944811|NCT02400463|10006734|FG000|STARTED|Overall Study||6
8944812|NCT02400463|10006734|FG000|COMPLETED|Overall Study||6
8944813|NCT02400463|10006734|FG000|NOT COMPLETED|Overall Study||0
8944814|NCT02400580|10006740|FG000|STARTED|Overall Study||91
8944815|NCT02400580|10006741|FG001|STARTED|Overall Study||92
8944816|NCT02400580|10006740|FG000|COMPLETED|Overall Study||89
8944817|NCT02400580|10006741|FG001|COMPLETED|Overall Study||91
8944818|NCT02400580|10006740|FG000|NOT COMPLETED|Overall Study||2
8944819|NCT02400580|10006741|FG001|NOT COMPLETED|Overall Study||1
8944820|NCT02400710|10006749|FG000|STARTED|Overall Study||10
8944821|NCT02400710|10006750|FG001|STARTED|Overall Study||10
8944822|NCT02400710|10006749|FG000|COMPLETED|Overall Study||10
8944823|NCT02400710|10006750|FG001|COMPLETED|Overall Study||10
8944824|NCT02400710|10006749|FG000|NOT COMPLETED|Overall Study||0
8944825|NCT02400710|10006750|FG001|NOT COMPLETED|Overall Study||0
8944826|NCT02400749|10006758|FG000|STARTED|Week 0 -16||50
8944827|NCT02400749|10006759|FG001|STARTED|Week 0 -16||50
8944828|NCT02400749|10006758|FG000|COMPLETED|Week 0 -16||39
8623295|NCT00492726|9662547|FG001|COMPLETED|Overall Study||358
8623296|NCT00492726|9662546|FG000|NOT COMPLETED|Overall Study||50
8623297|NCT00492726|9662547|FG001|NOT COMPLETED|Overall Study||36
8623298|NCT00492752|9662555|FG000|STARTED|Double Blind Treatment||134
8944829|NCT02400749|10006759|FG001|COMPLETED|Week 0 -16||44
8944830|NCT02400749|10006758|FG000|NOT COMPLETED|Week 0 -16||11
8944831|NCT02400749|10006759|FG001|NOT COMPLETED|Week 0 -16||6
8944832|NCT02400749|10006758|FG000|STARTED|Week 17 - 32||39
8944833|NCT02400749|10006759|FG001|STARTED|Week 17 - 32||44
8944834|NCT02400749|10006758|FG000|COMPLETED|Week 17 - 32||34
8944835|NCT02400749|10006759|FG001|COMPLETED|Week 17 - 32||41
8944836|NCT02400749|10006758|FG000|NOT COMPLETED|Week 17 - 32||5
8944837|NCT02400749|10006759|FG001|NOT COMPLETED|Week 17 - 32||3
8944838|NCT02400905|10006765|FG000|STARTED|Overall Study||271
8944839|NCT02400905|10006765|FG000|30-Days Follow-up|Overall Study||268
8944840|NCT02400905|10006765|FG000|12-Months Follow-up|Overall Study||256
8944841|NCT02400905|10006765|FG000|24-Months Follow-up|Overall Study||225
8944842|NCT02400905|10006765|FG000|36 Months-Follow-up|Overall Study||208
8944843|NCT02400905|10006765|FG000|COMPLETED|Overall Study||208
8944844|NCT02400905|10006765|FG000|NOT COMPLETED|Overall Study||63
8944845|NCT02400996|10006770|FG000|STARTED|Overall Study||40
8944846|NCT02400996|10006770|FG000|COMPLETED|Overall Study||40
8944847|NCT02400996|10006770|FG000|NOT COMPLETED|Overall Study||0
8944848|NCT02401022|10006776|FG000|STARTED|Overall Study||104
8944849|NCT02401022|10006777|FG001|STARTED|Overall Study||110
8944850|NCT02401022|10006776|FG000|COMPLETED|Overall Study||89
8944851|NCT02401022|10006777|FG001|COMPLETED|Overall Study||90
8944852|NCT02401022|10006776|FG000|NOT COMPLETED|Overall Study||15
8944853|NCT02401022|10006777|FG001|NOT COMPLETED|Overall Study||20
8944854|NCT02401048|10006785|FG000|STARTED|Overall Study||27
8944855|NCT02401048|10006786|FG001|STARTED|Overall Study||34
8944856|NCT02401048|10006785|FG000|COMPLETED|Overall Study||5
8944857|NCT02401048|10006786|FG001|COMPLETED|Overall Study||4
8944858|NCT02401048|10006785|FG000|NOT COMPLETED|Overall Study||22
8944859|NCT02401048|10006786|FG001|NOT COMPLETED|Overall Study||30
8944860|NCT02401230|10006800|FG000|STARTED|Overall Study||26
8944861|NCT02401230|10006801|FG001|STARTED|Overall Study||25
8944862|NCT02401230|10006802|FG002|STARTED|Overall Study||25
8944863|NCT02401230|10006800|FG000|COMPLETED|Overall Study||20
8944864|NCT02401230|10006801|FG001|COMPLETED|Overall Study||19
8944865|NCT02401230|10006802|FG002|COMPLETED|Overall Study||21
8944866|NCT02401230|10006800|FG000|NOT COMPLETED|Overall Study||6
8944867|NCT02401230|10006801|FG001|NOT COMPLETED|Overall Study||6
8944868|NCT02401230|10006802|FG002|NOT COMPLETED|Overall Study||4
8944869|NCT02401256|10006814|FG000|STARTED|Overall Study||70
8944870|NCT02401256|10006814|FG000|Finished Phase 1|Overall Study||64
8944871|NCT02401256|10006814|FG000|Finished Phase 2|Overall Study||58
8944872|NCT02401256|10006814|FG000|Finished Phase 3|Overall Study||53
8944873|NCT02401256|10006814|FG000|Analysed|Overall Study|Volunteers that completed at least until Phase 2 inpatient visit (Volunteers with Efavirenz PK data)|61
8944874|NCT02401256|10006814|FG000|COMPLETED|Overall Study||53
8944875|NCT02401256|10006814|FG000|NOT COMPLETED|Overall Study||17
8944876|NCT02401412|10006822|FG000|STARTED|Overall Study||89
8944877|NCT02401412|10006823|FG001|STARTED|Overall Study||81
8944878|NCT02401412|10006822|FG000|Received Study Device|Overall Study||89
8944879|NCT02401412|10006823|FG001|Received Study Device|Overall Study||80
8944880|NCT02401412|10006822|FG000|COMPLETED|Overall Study||59
8944881|NCT02401412|10006823|FG001|COMPLETED|Overall Study||49
8944882|NCT02401412|10006822|FG000|NOT COMPLETED|Overall Study||30
8944883|NCT02401412|10006823|FG001|NOT COMPLETED|Overall Study||32
8944884|NCT02401464|10006833|FG000|STARTED|Intervention Period 1 (6 Days)||13
8944885|NCT02401464|10006834|FG001|STARTED|Intervention Period 1 (6 Days)||13
8944886|NCT02401464|10006835|FG002|STARTED|Intervention Period 1 (6 Days)||13
8944887|NCT02401464|10006836|FG003|STARTED|Intervention Period 1 (6 Days)||13
8944888|NCT02401464|10006833|FG000|COMPLETED|Intervention Period 1 (6 Days)||13
8944889|NCT02401464|10006834|FG001|COMPLETED|Intervention Period 1 (6 Days)||13
8944890|NCT02401464|10006835|FG002|COMPLETED|Intervention Period 1 (6 Days)||13
8944891|NCT02401464|10006836|FG003|COMPLETED|Intervention Period 1 (6 Days)||13
8944892|NCT02401464|10006833|FG000|NOT COMPLETED|Intervention Period 1 (6 Days)||0
8944893|NCT02401464|10006834|FG001|NOT COMPLETED|Intervention Period 1 (6 Days)||0
8944894|NCT02401464|10006835|FG002|NOT COMPLETED|Intervention Period 1 (6 Days)||0
8944895|NCT02401464|10006836|FG003|NOT COMPLETED|Intervention Period 1 (6 Days)||0
8944896|NCT02401464|10006833|FG000|STARTED|Washout Period (At Least 6 Days)||13
8944897|NCT02401464|10006834|FG001|STARTED|Washout Period (At Least 6 Days)||13
8944898|NCT02401464|10006835|FG002|STARTED|Washout Period (At Least 6 Days)||13
8944899|NCT02401464|10006836|FG003|STARTED|Washout Period (At Least 6 Days)||13
8944900|NCT02401464|10006833|FG000|COMPLETED|Washout Period (At Least 6 Days)||13
8944901|NCT02401464|10006834|FG001|COMPLETED|Washout Period (At Least 6 Days)||13
8944902|NCT02401464|10006835|FG002|COMPLETED|Washout Period (At Least 6 Days)||13
8944903|NCT02401464|10006836|FG003|COMPLETED|Washout Period (At Least 6 Days)||13
8944904|NCT02401464|10006833|FG000|NOT COMPLETED|Washout Period (At Least 6 Days)||0
8944905|NCT02401464|10006834|FG001|NOT COMPLETED|Washout Period (At Least 6 Days)||0
8944906|NCT02401464|10006835|FG002|NOT COMPLETED|Washout Period (At Least 6 Days)||0
8944907|NCT02401464|10006836|FG003|NOT COMPLETED|Washout Period (At Least 6 Days)||0
8944908|NCT02401464|10006833|FG000|STARTED|Intervention Period 2 (6 Days)||13
8944909|NCT02401464|10006834|FG001|STARTED|Intervention Period 2 (6 Days)||13
8944910|NCT02401464|10006835|FG002|STARTED|Intervention Period 2 (6 Days)||13
8944911|NCT02401464|10006836|FG003|STARTED|Intervention Period 2 (6 Days)||13
8944912|NCT02401464|10006833|FG000|COMPLETED|Intervention Period 2 (6 Days)||13
8944913|NCT02401464|10006834|FG001|COMPLETED|Intervention Period 2 (6 Days)||13
8944914|NCT02401464|10006835|FG002|COMPLETED|Intervention Period 2 (6 Days)||13
8944915|NCT02401464|10006836|FG003|COMPLETED|Intervention Period 2 (6 Days)||13
8944916|NCT02401464|10006833|FG000|NOT COMPLETED|Intervention Period 2 (6 Days)||0
8944917|NCT02401464|10006834|FG001|NOT COMPLETED|Intervention Period 2 (6 Days)||0
8944918|NCT02401464|10006835|FG002|NOT COMPLETED|Intervention Period 2 (6 Days)||0
8944919|NCT02401464|10006836|FG003|NOT COMPLETED|Intervention Period 2 (6 Days)||0
8944920|NCT02401529|10006850|FG000|STARTED|Overall Study||59
8944921|NCT02401529|10006851|FG001|STARTED|Overall Study||57
8944922|NCT02401529|10006850|FG000|COMPLETED|Overall Study||50
8944923|NCT02401529|10006851|FG001|COMPLETED|Overall Study||50
8944924|NCT02401529|10006850|FG000|NOT COMPLETED|Overall Study||9
8944925|NCT02401529|10006851|FG001|NOT COMPLETED|Overall Study||7
8944926|NCT02401542|10006861|FG000|STARTED|Overall Study||41
8944927|NCT02401542|10006862|FG001|STARTED|Overall Study||30
8944928|NCT02401542|10006863|FG002|STARTED|Overall Study||0
8944929|NCT02401542|10006861|FG000|COMPLETED|Overall Study||40
8944930|NCT02401542|10006862|FG001|COMPLETED|Overall Study||30
8944931|NCT02401542|10006863|FG002|COMPLETED|Overall Study||0
8944932|NCT02401542|10006861|FG000|NOT COMPLETED|Overall Study||1
8944933|NCT02401542|10006862|FG001|NOT COMPLETED|Overall Study||0
8944934|NCT02401542|10006863|FG002|NOT COMPLETED|Overall Study||0
8944935|NCT02401555|10006876|FG000|STARTED|Overall Study||87
8944936|NCT02401555|10006877|FG001|STARTED|Overall Study||212
8944937|NCT02401555|10006878|FG002|STARTED|Overall Study||120
8944938|NCT02401555|10006876|FG000|COMPLETED|Overall Study||87
8944939|NCT02401555|10006877|FG001|COMPLETED|Overall Study||212
8944940|NCT02401555|10006878|FG002|COMPLETED|Overall Study||120
8944941|NCT02401555|10006876|FG000|NOT COMPLETED|Overall Study||0
8944942|NCT02401555|10006877|FG001|NOT COMPLETED|Overall Study||0
8944943|NCT02401555|10006878|FG002|NOT COMPLETED|Overall Study||0
8944944|NCT02401672|10006888|FG000|STARTED|Overall Study||22
8944945|NCT02401672|10006889|FG001|STARTED|Overall Study||20
8944946|NCT02401672|10006888|FG000|COMPLETED|Overall Study||21
8944947|NCT02401672|10006889|FG001|COMPLETED|Overall Study||17
8944948|NCT02401672|10006888|FG000|NOT COMPLETED|Overall Study||1
8944949|NCT02401672|10006889|FG001|NOT COMPLETED|Overall Study||3
8944950|NCT02401867|10006895|FG000|STARTED|Enrolled||150
8944951|NCT02401867|10006895|FG000|COMPLETED|Enrolled||150
8944952|NCT02401867|10006895|FG000|NOT COMPLETED|Enrolled||0
8944953|NCT02401867|10006895|FG000|STARTED|Specimen Collection||150
8944954|NCT02401867|10006895|FG000|COMPLETED|Specimen Collection|Completed both vaginal self-swab and provider-collected cervical swab|140
8944955|NCT02401867|10006895|FG000|NOT COMPLETED|Specimen Collection||10
8944956|NCT02401867|10006895|FG000|STARTED|Analysis||140
8944957|NCT02401867|10006895|FG000|COMPLETED|Analysis|Comparative analysis of vaginal HPV DNA results and cervical HPV DNA results|131
8944958|NCT02401867|10006895|FG000|NOT COMPLETED|Analysis||9
8944959|NCT02402062|10006900|FG000|STARTED|Overall Study||17
8944960|NCT02402062|10006900|FG000|COMPLETED|Overall Study||17
8944961|NCT02402062|10006900|FG000|NOT COMPLETED|Overall Study||0
8944962|NCT02402127|10006910|FG000|STARTED|First Wear Period (1 Day)||4
8944963|NCT02402127|10006911|FG001|STARTED|First Wear Period (1 Day)||4
8944964|NCT02402127|10006912|FG002|STARTED|First Wear Period (1 Day)||4
8944965|NCT02402127|10006913|FG003|STARTED|First Wear Period (1 Day)||4
8944966|NCT02402127|10006914|FG004|STARTED|First Wear Period (1 Day)||4
8944967|NCT02402127|10006915|FG005|STARTED|First Wear Period (1 Day)||4
8944968|NCT02402127|10006910|FG000|Randomized and Treated|First Wear Period (1 Day)||4
8944969|NCT02402127|10006911|FG001|Randomized and Treated|First Wear Period (1 Day)||4
8944970|NCT02402127|10006912|FG002|Randomized and Treated|First Wear Period (1 Day)||4
8944971|NCT02402127|10006913|FG003|Randomized and Treated|First Wear Period (1 Day)||4
8944972|NCT02402127|10006914|FG004|Randomized and Treated|First Wear Period (1 Day)||4
8944973|NCT02402127|10006915|FG005|Randomized and Treated|First Wear Period (1 Day)||4
8944974|NCT02402127|10006910|FG000|COMPLETED|First Wear Period (1 Day)||4
8944975|NCT02402127|10006911|FG001|COMPLETED|First Wear Period (1 Day)||4
8944976|NCT02402127|10006912|FG002|COMPLETED|First Wear Period (1 Day)||4
8944977|NCT02402127|10006913|FG003|COMPLETED|First Wear Period (1 Day)||4
8944978|NCT02402127|10006914|FG004|COMPLETED|First Wear Period (1 Day)||4
8944979|NCT02402127|10006915|FG005|COMPLETED|First Wear Period (1 Day)||4
8944980|NCT02402127|10006910|FG000|NOT COMPLETED|First Wear Period (1 Day)||0
8944981|NCT02402127|10006911|FG001|NOT COMPLETED|First Wear Period (1 Day)||0
8944982|NCT02402127|10006912|FG002|NOT COMPLETED|First Wear Period (1 Day)||0
8944983|NCT02402127|10006913|FG003|NOT COMPLETED|First Wear Period (1 Day)||0
8944984|NCT02402127|10006914|FG004|NOT COMPLETED|First Wear Period (1 Day)||0
8944985|NCT02402127|10006915|FG005|NOT COMPLETED|First Wear Period (1 Day)||0
8944986|NCT02402127|10006910|FG000|STARTED|Second Wear Period (1 Day)||4
8944987|NCT02402127|10006911|FG001|STARTED|Second Wear Period (1 Day)||4
8944988|NCT02402127|10006912|FG002|STARTED|Second Wear Period (1 Day)||4
8944989|NCT02402127|10006913|FG003|STARTED|Second Wear Period (1 Day)||4
8944990|NCT02402127|10006914|FG004|STARTED|Second Wear Period (1 Day)||4
8944991|NCT02402127|10006915|FG005|STARTED|Second Wear Period (1 Day)||4
8944992|NCT02402127|10006910|FG000|COMPLETED|Second Wear Period (1 Day)||4
8944993|NCT02402127|10006911|FG001|COMPLETED|Second Wear Period (1 Day)||4
8944994|NCT02402127|10006912|FG002|COMPLETED|Second Wear Period (1 Day)||4
8944995|NCT02402127|10006913|FG003|COMPLETED|Second Wear Period (1 Day)||4
8944996|NCT02402127|10006914|FG004|COMPLETED|Second Wear Period (1 Day)||4
8944997|NCT02402127|10006915|FG005|COMPLETED|Second Wear Period (1 Day)||4
8944998|NCT02402127|10006910|FG000|NOT COMPLETED|Second Wear Period (1 Day)||0
8944999|NCT02402127|10006911|FG001|NOT COMPLETED|Second Wear Period (1 Day)||0
8945000|NCT02402127|10006912|FG002|NOT COMPLETED|Second Wear Period (1 Day)||0
8945001|NCT02402127|10006913|FG003|NOT COMPLETED|Second Wear Period (1 Day)||0
8945002|NCT02402127|10006914|FG004|NOT COMPLETED|Second Wear Period (1 Day)||0
8945003|NCT02402127|10006915|FG005|NOT COMPLETED|Second Wear Period (1 Day)||0
8945004|NCT02402127|10006910|FG000|STARTED|Third Wear Period (1 Day)||4
8945005|NCT02402127|10006911|FG001|STARTED|Third Wear Period (1 Day)||4
8945006|NCT02402127|10006912|FG002|STARTED|Third Wear Period (1 Day)||4
8945007|NCT02402127|10006913|FG003|STARTED|Third Wear Period (1 Day)||4
8945008|NCT02402127|10006914|FG004|STARTED|Third Wear Period (1 Day)||4
8945009|NCT02402127|10006915|FG005|STARTED|Third Wear Period (1 Day)||4
8945010|NCT02402127|10006910|FG000|COMPLETED|Third Wear Period (1 Day)||4
8945011|NCT02402127|10006911|FG001|COMPLETED|Third Wear Period (1 Day)||4
8945012|NCT02402127|10006912|FG002|COMPLETED|Third Wear Period (1 Day)||4
8945013|NCT02402127|10006913|FG003|COMPLETED|Third Wear Period (1 Day)||4
8945014|NCT02402127|10006914|FG004|COMPLETED|Third Wear Period (1 Day)||4
8945015|NCT02402127|10006915|FG005|COMPLETED|Third Wear Period (1 Day)||4
8945016|NCT02402127|10006910|FG000|NOT COMPLETED|Third Wear Period (1 Day)||0
8723485|NCT01023568|9771001|FG002|COMPLETED|Overall Study||45
8723486|NCT01023568|9770999|FG000|NOT COMPLETED|Overall Study||0
8723487|NCT01023568|9771000|FG001|NOT COMPLETED|Overall Study||0
8723488|NCT01023568|9771001|FG002|NOT COMPLETED|Overall Study||0
8723489|NCT01023581|9771016|FG000|STARTED|Overall Study||109
8945017|NCT02402127|10006911|FG001|NOT COMPLETED|Third Wear Period (1 Day)||0
8945018|NCT02402127|10006912|FG002|NOT COMPLETED|Third Wear Period (1 Day)||0
8945019|NCT02402127|10006913|FG003|NOT COMPLETED|Third Wear Period (1 Day)||0
8945020|NCT02402127|10006914|FG004|NOT COMPLETED|Third Wear Period (1 Day)||0
8945021|NCT02402127|10006915|FG005|NOT COMPLETED|Third Wear Period (1 Day)||0
8945022|NCT02402153|10006926|FG000|STARTED|Overall Study||18
8945023|NCT02402153|10006926|FG000|COMPLETED|Overall Study||18
8945024|NCT02402153|10006926|FG000|NOT COMPLETED|Overall Study||0
8945025|NCT02402166|10006930|FG000|STARTED|Overall Study||24
8945026|NCT02402166|10006930|FG000|COMPLETED|Overall Study||19
8945027|NCT02402166|10006930|FG000|NOT COMPLETED|Overall Study||5
8945028|NCT02402218|10006951|FG000|STARTED|Overall Study||36
8945029|NCT02402218|10006952|FG001|STARTED|Overall Study||54
8945030|NCT02402218|10006953|FG002|STARTED|Overall Study||54
8945031|NCT02402218|10006951|FG000|Initiated Treatment With LDV/SOF|Overall Study||24
8945032|NCT02402218|10006952|FG001|Initiated Treatment With LDV/SOF|Overall Study||45
8945033|NCT02402218|10006953|FG002|Initiated Treatment With LDV/SOF|Overall Study||41
8945034|NCT02402218|10006951|FG000|Completed Treatment With LDV/SOF|Overall Study||23
8945035|NCT02402218|10006952|FG001|Completed Treatment With LDV/SOF|Overall Study||42
8945036|NCT02402218|10006953|FG002|Completed Treatment With LDV/SOF|Overall Study||39
8945037|NCT02402218|10006951|FG000|Achieved Sustained Virologic Response|Overall Study||22
8945038|NCT02402218|10006952|FG001|Achieved Sustained Virologic Response|Overall Study||41
8945039|NCT02402218|10006953|FG002|Achieved Sustained Virologic Response|Overall Study||37
8945040|NCT02402218|10006951|FG000|COMPLETED|Overall Study||22
8945041|NCT02402218|10006952|FG001|COMPLETED|Overall Study||41
8945042|NCT02402218|10006953|FG002|COMPLETED|Overall Study||37
8945043|NCT02402218|10006951|FG000|NOT COMPLETED|Overall Study||14
8945044|NCT02402218|10006952|FG001|NOT COMPLETED|Overall Study||13
8945045|NCT02402218|10006953|FG002|NOT COMPLETED|Overall Study||17
8945046|NCT02402296|10006963|FG000|STARTED|Overall Study||15
8945047|NCT02402296|10006964|FG001|STARTED|Overall Study||15
8945048|NCT02402296|10006963|FG000|COMPLETED|Overall Study||15
8945049|NCT02402296|10006964|FG001|COMPLETED|Overall Study||15
8945050|NCT02402296|10006963|FG000|NOT COMPLETED|Overall Study||0
8945051|NCT02402296|10006964|FG001|NOT COMPLETED|Overall Study||0
8945052|NCT02402322|10006973|FG000|STARTED|Pretreatment||27
8945053|NCT02402322|10006974|FG001|STARTED|Pretreatment||25
8945054|NCT02402322|10006975|FG002|STARTED|Pretreatment||25
8945055|NCT02402322|10006973|FG000|Posttreatment Measures|Pretreatment||24
8945056|NCT02402322|10006974|FG001|Posttreatment Measures|Pretreatment||24
8945057|NCT02402322|10006975|FG002|Posttreatment Measures|Pretreatment||24
8945058|NCT02402322|10006973|FG000|COMPLETED|Pretreatment||24
8945059|NCT02402322|10006974|FG001|COMPLETED|Pretreatment||24
8945060|NCT02402322|10006975|FG002|COMPLETED|Pretreatment||24
8945061|NCT02402322|10006973|FG000|NOT COMPLETED|Pretreatment||3
8945062|NCT02402322|10006974|FG001|NOT COMPLETED|Pretreatment||1
8945063|NCT02402322|10006975|FG002|NOT COMPLETED|Pretreatment||1
8945064|NCT02402322|10006973|FG000|STARTED|Follow-up||24
8945065|NCT02402322|10006974|FG001|STARTED|Follow-up||24
8945066|NCT02402322|10006975|FG002|STARTED|Follow-up|These individuals were not evaluated at this follow-up as they started an alternative treatment.|24
8945067|NCT02402322|10006973|FG000|COMPLETED|Follow-up||18
8945068|NCT02402322|10006974|FG001|COMPLETED|Follow-up||21
8945069|NCT02402322|10006975|FG002|COMPLETED|Follow-up||0
8945070|NCT02402322|10006973|FG000|NOT COMPLETED|Follow-up||6
8945071|NCT02402322|10006974|FG001|NOT COMPLETED|Follow-up||3
8945072|NCT02402322|10006975|FG002|NOT COMPLETED|Follow-up||24
8945073|NCT02402452|10006985|FG000|STARTED|Overall Study||10
8945074|NCT02402452|10006986|FG001|STARTED|Overall Study||10
9066034|NCT04121078|10126501|FG000|COMPLETED|Study Period 2 (1 Day)||6
8945075|NCT02402452|10006985|FG000|COMPLETED|Overall Study||10
8945076|NCT02402452|10006986|FG001|COMPLETED|Overall Study||10
8945077|NCT02402452|10006985|FG000|NOT COMPLETED|Overall Study||0
8945078|NCT02402452|10006986|FG001|NOT COMPLETED|Overall Study||0
8945079|NCT02402764|10006992|FG000|STARTED|Overall Study||10
9066035|NCT04121078|10126502|FG001|COMPLETED|Study Period 2 (1 Day)||6
8945080|NCT02402764|10006992|FG000|COMPLETED|Overall Study||10
8945081|NCT02402764|10006992|FG000|NOT COMPLETED|Overall Study||0
8945082|NCT02402881|10006998|FG000|STARTED|Pre-Intervention Study Period||2222
8945083|NCT02402881|10006999|FG001|STARTED|Pre-Intervention Study Period||5657
8945084|NCT02402881|10006998|FG000|COMPLETED|Pre-Intervention Study Period||2222
8945085|NCT02402881|10006999|FG001|COMPLETED|Pre-Intervention Study Period||5657
8945086|NCT02402881|10006998|FG000|NOT COMPLETED|Pre-Intervention Study Period||0
8945087|NCT02402881|10006999|FG001|NOT COMPLETED|Pre-Intervention Study Period||0
8945088|NCT02402881|10006998|FG000|STARTED|Post-Intervention Study Period||3111
8945089|NCT02402881|10006999|FG001|STARTED|Post-Intervention Study Period||8662
8945090|NCT02402881|10006998|FG000|COMPLETED|Post-Intervention Study Period||3111
8945091|NCT02402881|10006999|FG001|COMPLETED|Post-Intervention Study Period||8662
8945092|NCT02402881|10006998|FG000|NOT COMPLETED|Post-Intervention Study Period||0
8945093|NCT02402881|10006999|FG001|NOT COMPLETED|Post-Intervention Study Period||0
8945094|NCT02402907|10007007|FG000|STARTED|Overall Study||682
8945095|NCT02402907|10007008|FG001|STARTED|Overall Study||674
8623299|NCT00492752|9662556|FG001|STARTED|Double Blind Treatment||16
8623300|NCT00492752|9662557|FG002|STARTED|Double Blind Treatment||70
8623301|NCT00492752|9662558|FG003|STARTED|Double Blind Treatment||6
8945096|NCT02402907|10007007|FG000|COMPLETED|Overall Study||662
8945097|NCT02402907|10007008|FG001|COMPLETED|Overall Study||647
8945098|NCT02402907|10007007|FG000|NOT COMPLETED|Overall Study||20
8945099|NCT02402907|10007008|FG001|NOT COMPLETED|Overall Study||27
8945100|NCT02402933|10007014|FG000|STARTED|Overall Study||26
8945101|NCT02402933|10007014|FG000|Received at Least One Dose of Study Drug|Overall Study||22
8945102|NCT02402933|10007014|FG000|COMPLETED|Overall Study||12
8945103|NCT02402933|10007014|FG000|NOT COMPLETED|Overall Study||14
8945104|NCT02403180|10007020|FG000|STARTED|Pre-Treatment Period||36
8945105|NCT02403180|10007021|FG001|STARTED|Pre-Treatment Period||34
8945106|NCT02403180|10007020|FG000|COMPLETED|Pre-Treatment Period||36
8945107|NCT02403180|10007021|FG001|COMPLETED|Pre-Treatment Period||33
8945108|NCT02403180|10007020|FG000|NOT COMPLETED|Pre-Treatment Period||0
8945109|NCT02403180|10007021|FG001|NOT COMPLETED|Pre-Treatment Period||1
8945110|NCT02403180|10007020|FG000|STARTED|Period 1 (5 Days)||36
8945111|NCT02403180|10007021|FG001|STARTED|Period 1 (5 Days)||33
8945112|NCT02403180|10007020|FG000|Randomized|Period 1 (5 Days)||36
8945113|NCT02403180|10007021|FG001|Randomized|Period 1 (5 Days)||33
8945114|NCT02403180|10007020|FG000|COMPLETED|Period 1 (5 Days)||36
8945115|NCT02403180|10007021|FG001|COMPLETED|Period 1 (5 Days)||33
8945116|NCT02403180|10007020|FG000|NOT COMPLETED|Period 1 (5 Days)||0
8945117|NCT02403180|10007021|FG001|NOT COMPLETED|Period 1 (5 Days)||0
8945118|NCT02403180|10007020|FG000|STARTED|Period 2 (5 Days)||36
8945119|NCT02403180|10007021|FG001|STARTED|Period 2 (5 Days)||33
8945120|NCT02403180|10007020|FG000|COMPLETED|Period 2 (5 Days)||36
8945121|NCT02403180|10007021|FG001|COMPLETED|Period 2 (5 Days)||32
8945122|NCT02403180|10007020|FG000|NOT COMPLETED|Period 2 (5 Days)||0
8945123|NCT02403180|10007021|FG001|NOT COMPLETED|Period 2 (5 Days)||1
8945124|NCT02403206|10007029|FG000|STARTED|Overall Study||194
8945125|NCT02403206|10007030|FG001|STARTED|Overall Study||196
8945126|NCT02403206|10007029|FG000|Treated Prior to Randomization|Overall Study||0
8945127|NCT02403206|10007030|FG001|Treated Prior to Randomization|Overall Study||1
8945128|NCT02403206|10007029|FG000|Randomized and Treated|Overall Study||188
8945129|NCT02403206|10007030|FG001|Randomized and Treated|Overall Study||190
8945130|NCT02403206|10007029|FG000|COMPLETED|Overall Study||183
8945131|NCT02403206|10007030|FG001|COMPLETED|Overall Study||186
8945132|NCT02403206|10007029|FG000|NOT COMPLETED|Overall Study||11
8945133|NCT02403206|10007030|FG001|NOT COMPLETED|Overall Study||10
8945134|NCT02403271|10007037|FG000|STARTED|Period 1|All Phase 1b participants went on to participate in Phase 2.|7
8945135|NCT02403271|10007038|FG001|STARTED|Period 1||0
8945136|NCT02403271|10007037|FG000|COMPLETED|Period 1||6
8945137|NCT02403271|10007038|FG001|COMPLETED|Period 1||0
8945138|NCT02403271|10007037|FG000|NOT COMPLETED|Period 1||1
8945139|NCT02403271|10007038|FG001|NOT COMPLETED|Period 1||0
8945140|NCT02403271|10007037|FG000|STARTED|Period 2||0
8945141|NCT02403271|10007038|FG001|STARTED|Period 2|Phase 2 includes all subjects who participated in Phase 1b.|124
8945142|NCT02403271|10007037|FG000|COMPLETED|Period 2||0
8945143|NCT02403271|10007038|FG001|COMPLETED|Period 2||0
8945144|NCT02403271|10007037|FG000|NOT COMPLETED|Period 2||0
8945145|NCT02403271|10007038|FG001|NOT COMPLETED|Period 2||124
8945146|NCT02403479|10007046|FG000|STARTED|Overall Study||10
8945147|NCT02403479|10007047|FG001|STARTED|Overall Study||12
8945148|NCT02403479|10007046|FG000|COMPLETED|Overall Study||8
8945149|NCT02403479|10007047|FG001|COMPLETED|Overall Study||12
8945150|NCT02403479|10007046|FG000|NOT COMPLETED|Overall Study||2
8945151|NCT02403479|10007047|FG001|NOT COMPLETED|Overall Study||0
8623302|NCT00492752|9662555|FG000|Received Treatment|Double Blind Treatment|Safety Population. 1 participant never received treatment due to an Adverse Event.|133
8623303|NCT00492752|9662556|FG001|Received Treatment|Double Blind Treatment|Safety Population|16
8629669|NCT00531050|9669381|FG000|COMPLETED|Part 2: Period 2||3
8945152|NCT02403622|10007055|FG000|STARTED|Overall Study||15
8945153|NCT02403622|10007055|FG000|COMPLETED|Overall Study||13
8945154|NCT02403622|10007055|FG000|NOT COMPLETED|Overall Study||2
8945155|NCT02403635|10007059|FG000|STARTED|Overall Study||27
8945156|NCT02403635|10007059|FG000|Screening (28 Days)|Overall Study||27
8945157|NCT02403635|10007059|FG000|Received the First Dose|Overall Study||18
8945158|NCT02403635|10007059|FG000|COMPLETED|Overall Study||18
8945159|NCT02403635|10007059|FG000|NOT COMPLETED|Overall Study||9
8945160|NCT02403674|10007081|FG000|STARTED|Overall Study||368
8945161|NCT02403674|10007082|FG001|STARTED|Overall Study||366
8945162|NCT02403674|10007081|FG000|Treated|Overall Study||364
8945163|NCT02403674|10007082|FG001|Treated|Overall Study||364
8945164|NCT02403674|10007081|FG000|COMPLETED|Overall Study||313
8945165|NCT02403674|10007082|FG001|COMPLETED|Overall Study||303
8945166|NCT02403674|10007081|FG000|NOT COMPLETED|Overall Study||55
8945167|NCT02403674|10007082|FG001|NOT COMPLETED|Overall Study||63
8945168|NCT02403778|10007090|FG000|STARTED|Overall Study||6
8945169|NCT02403778|10007091|FG001|STARTED|Overall Study||4
8945170|NCT02403778|10007090|FG000|COMPLETED|Overall Study||6
8945171|NCT02403778|10007091|FG001|COMPLETED|Overall Study||4
8945172|NCT02403778|10007090|FG000|NOT COMPLETED|Overall Study||0
8945173|NCT02403778|10007091|FG001|NOT COMPLETED|Overall Study||0
8945174|NCT02403817|10007099|FG000|STARTED|Overall Study||28
8945175|NCT02403817|10007100|FG001|STARTED|Overall Study||2
8945176|NCT02403817|10007099|FG000|COMPLETED|Overall Study||23
8945177|NCT02403817|10007100|FG001|COMPLETED|Overall Study||2
8945178|NCT02403817|10007099|FG000|NOT COMPLETED|Overall Study||5
8945179|NCT02403817|10007100|FG001|NOT COMPLETED|Overall Study||0
8945180|NCT02403830|10007106|FG000|STARTED|Visit 1||15
8945181|NCT02403830|10007107|FG001|STARTED|Visit 1||15
8945182|NCT02403830|10007106|FG000|COMPLETED|Visit 1||15
8945183|NCT02403830|10007107|FG001|COMPLETED|Visit 1||15
8945184|NCT02403830|10007106|FG000|NOT COMPLETED|Visit 1||0
8945185|NCT02403830|10007107|FG001|NOT COMPLETED|Visit 1||0
8945186|NCT02403830|10007106|FG000|STARTED|Visit 2|One subject completed visit 1 and then withdrew from the study for an adverse event (nausea).|14
8945187|NCT02403830|10007107|FG001|STARTED|Visit 2||15
8945188|NCT02403830|10007106|FG000|COMPLETED|Visit 2||14
8945189|NCT02403830|10007107|FG001|COMPLETED|Visit 2||15
8945190|NCT02403830|10007106|FG000|NOT COMPLETED|Visit 2||0
8945191|NCT02403830|10007107|FG001|NOT COMPLETED|Visit 2||0
8945192|NCT02403895|10007113|FG000|STARTED|Overall Study||11
8945193|NCT02403895|10007113|FG000|COMPLETED|Overall Study||11
8945194|NCT02403895|10007113|FG000|NOT COMPLETED|Overall Study||0
8945195|NCT02403986|10007119|FG000|STARTED|Overall Study||26
8945196|NCT02403986|10007120|FG001|STARTED|Overall Study||27
8945197|NCT02403986|10007119|FG000|COMPLETED|Overall Study||21
8945198|NCT02403986|10007120|FG001|COMPLETED|Overall Study||23
8945199|NCT02403986|10007119|FG000|NOT COMPLETED|Overall Study||5
8945200|NCT02403986|10007120|FG001|NOT COMPLETED|Overall Study||4
8945201|NCT02403999|10007129|FG000|STARTED|Overall Study||10
8945202|NCT02403999|10007130|FG001|STARTED|Overall Study||10
8945203|NCT02403999|10007131|FG002|STARTED|Overall Study||11
8945204|NCT02403999|10007129|FG000|COMPLETED|Overall Study||10
8945205|NCT02403999|10007130|FG001|COMPLETED|Overall Study||10
8945206|NCT02403999|10007131|FG002|COMPLETED|Overall Study||11
8945207|NCT02403999|10007129|FG000|NOT COMPLETED|Overall Study||0
8945208|NCT02403999|10007130|FG001|NOT COMPLETED|Overall Study||0
8945209|NCT02403999|10007131|FG002|NOT COMPLETED|Overall Study||0
8945210|NCT02404025|10007139|FG000|STARTED|Overall Study||10
8945211|NCT02404025|10007139|FG000|COMPLETED|Overall Study||6
8945212|NCT02404025|10007139|FG000|NOT COMPLETED|Overall Study||4
8945213|NCT02404103|10007145|FG000|STARTED|Overall Study||14
8945214|NCT02404103|10007146|FG001|STARTED|Overall Study||12
8945215|NCT02404103|10007145|FG000|COMPLETED|Overall Study||10
8945216|NCT02404103|10007146|FG001|COMPLETED|Overall Study||9
8945217|NCT02404103|10007145|FG000|NOT COMPLETED|Overall Study||4
8945218|NCT02404103|10007146|FG001|NOT COMPLETED|Overall Study||3
8945219|NCT02404168|10007162|FG000|STARTED|Overall Study||4
8945220|NCT02404168|10007162|FG000|COMPLETED|Overall Study||4
8623304|NCT00492752|9662557|FG002|Received Treatment|Double Blind Treatment|Safety Population. 1 participant never received treatment due to protocol violation.|69
8623305|NCT00492752|9662558|FG003|Received Treatment|Double Blind Treatment|Safety Population|6
8623306|NCT00492752|9662555|FG000|COMPLETED|Double Blind Treatment||120
8623307|NCT00492752|9662556|FG001|COMPLETED|Double Blind Treatment||16
8623308|NCT00492752|9662557|FG002|COMPLETED|Double Blind Treatment||67
8945221|NCT02404168|10007162|FG000|NOT COMPLETED|Overall Study||0
8945222|NCT02404220|10007172|FG000|STARTED|Overall Study||5
8945223|NCT02404220|10007173|FG001|STARTED|Overall Study||8
8945224|NCT02404220|10007174|FG002|STARTED|Overall Study||7
8945225|NCT02404220|10007175|FG003|STARTED|Overall Study||10
8945226|NCT02404220|10007172|FG000|COMPLETED|Overall Study||0
8945227|NCT02404220|10007173|FG001|COMPLETED|Overall Study||0
8945228|NCT02404220|10007174|FG002|COMPLETED|Overall Study||0
8945229|NCT02404220|10007175|FG003|COMPLETED|Overall Study||0
8945230|NCT02404220|10007172|FG000|NOT COMPLETED|Overall Study||5
8945231|NCT02404220|10007173|FG001|NOT COMPLETED|Overall Study||8
8945232|NCT02404220|10007174|FG002|NOT COMPLETED|Overall Study||7
8945233|NCT02404220|10007175|FG003|NOT COMPLETED|Overall Study||10
8945234|NCT02404285|10007187|FG000|STARTED|Overall Study||33
8945235|NCT02404285|10007188|FG001|STARTED|Overall Study||35
8945236|NCT02404285|10007187|FG000|COMPLETED|Overall Study||31
8945237|NCT02404285|10007188|FG001|COMPLETED|Overall Study||33
8945238|NCT02404285|10007187|FG000|NOT COMPLETED|Overall Study||2
8945239|NCT02404285|10007188|FG001|NOT COMPLETED|Overall Study||2
8945240|NCT02404311|10007205|FG000|STARTED|Part A: Month 0-18||210
8945241|NCT02404311|10007206|FG001|STARTED|Part A: Month 0-18||42
8945242|NCT02404311|10007207|FG002|STARTED|Part A: Month 0-18||0
8945243|NCT02404311|10007208|FG003|STARTED|Part A: Month 0-18||0
8945244|NCT02404311|10007209|FG004|STARTED|Part A: Month 0-18||0
8945245|NCT02404311|10007205|FG000|Per Protocol|Part A: Month 0-18||185
8945246|NCT02404311|10007206|FG001|Per Protocol|Part A: Month 0-18||37
8945247|NCT02404311|10007207|FG002|Per Protocol|Part A: Month 0-18||0
9066036|NCT04121078|10126501|FG000|NOT COMPLETED|Study Period 2 (1 Day)||0
9066037|NCT04121078|10126502|FG001|NOT COMPLETED|Study Period 2 (1 Day)||0
9066038|NCT04117607|10126511|FG000|STARTED|Overall Study||3
9066039|NCT04117607|10126512|FG001|STARTED|Overall Study||7
8556698|NCT02336230|9588464|FG000|NOT COMPLETED|Overall Study||13
8556699|NCT02032823|9588470|FG000|STARTED|Overall Study||921
9066040|NCT04117607|10126513|FG002|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
9066041|NCT04117607|10126514|FG003|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
9066042|NCT04117607|10126515|FG004|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
9066043|NCT04117607|10126516|FG005|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
9066044|NCT04117607|10126517|FG006|STARTED|Overall Study||4
9066045|NCT04117607|10126518|FG007|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
9066046|NCT04117607|10126519|FG008|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
9066047|NCT04117607|10126520|FG009|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
9066048|NCT04117607|10126521|FG010|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
9066049|NCT04117607|10126522|FG011|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
9066050|NCT04117607|10126523|FG012|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
9066051|NCT04117607|10126524|FG013|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
9066052|NCT04117607|10126511|FG000|Received Study Product|Overall Study||3
9066053|NCT04117607|10126512|FG001|Received Study Product|Overall Study||6
9066054|NCT04117607|10126513|FG002|Received Study Product|Overall Study||0
9066055|NCT04117607|10126514|FG003|Received Study Product|Overall Study||0
9066056|NCT04117607|10126515|FG004|Received Study Product|Overall Study||0
9066057|NCT04117607|10126516|FG005|Received Study Product|Overall Study||0
9066058|NCT04117607|10126517|FG006|Received Study Product|Overall Study||3
9066059|NCT04117607|10126518|FG007|Received Study Product|Overall Study||0
9066060|NCT04117607|10126519|FG008|Received Study Product|Overall Study||0
9066061|NCT04117607|10126520|FG009|Received Study Product|Overall Study||0
9066062|NCT04117607|10126521|FG010|Received Study Product|Overall Study||0
9066063|NCT04117607|10126522|FG011|Received Study Product|Overall Study||0
9066064|NCT04117607|10126523|FG012|Received Study Product|Overall Study||0
9066065|NCT04117607|10126524|FG013|Received Study Product|Overall Study||0
9066066|NCT04117607|10126511|FG000|Completed All PK Blood Draws|Overall Study||0
9066067|NCT04117607|10126512|FG001|Completed All PK Blood Draws|Overall Study||6
9066068|NCT04117607|10126513|FG002|Completed All PK Blood Draws|Overall Study||0
9066069|NCT04117607|10126514|FG003|Completed All PK Blood Draws|Overall Study||0
9066070|NCT04117607|10126515|FG004|Completed All PK Blood Draws|Overall Study||0
9066071|NCT04117607|10126516|FG005|Completed All PK Blood Draws|Overall Study||0
9066072|NCT04117607|10126517|FG006|Completed All PK Blood Draws|Overall Study||1
9066073|NCT04117607|10126518|FG007|Completed All PK Blood Draws|Overall Study||0
9066074|NCT04117607|10126519|FG008|Completed All PK Blood Draws|Overall Study||0
9066075|NCT04117607|10126520|FG009|Completed All PK Blood Draws|Overall Study||0
9066076|NCT04117607|10126521|FG010|Completed All PK Blood Draws|Overall Study||0
9066077|NCT04117607|10126522|FG011|Completed All PK Blood Draws|Overall Study||0
9066078|NCT04117607|10126523|FG012|Completed All PK Blood Draws|Overall Study||0
9066079|NCT04117607|10126524|FG013|Completed All PK Blood Draws|Overall Study||0
9066080|NCT04117607|10126511|FG000|COMPLETED|Overall Study||3
9066081|NCT04117607|10126512|FG001|COMPLETED|Overall Study||6
9066082|NCT04117607|10126513|FG002|COMPLETED|Overall Study||0
9066083|NCT04117607|10126514|FG003|COMPLETED|Overall Study||0
9066084|NCT04117607|10126515|FG004|COMPLETED|Overall Study||0
9066085|NCT04117607|10126516|FG005|COMPLETED|Overall Study||0
9066086|NCT04117607|10126517|FG006|COMPLETED|Overall Study||3
9066087|NCT04117607|10126518|FG007|COMPLETED|Overall Study||0
9066088|NCT04117607|10126519|FG008|COMPLETED|Overall Study||0
9066089|NCT04117607|10126520|FG009|COMPLETED|Overall Study||0
9066090|NCT04117607|10126521|FG010|COMPLETED|Overall Study||0
9066091|NCT04117607|10126522|FG011|COMPLETED|Overall Study||0
9066092|NCT04117607|10126523|FG012|COMPLETED|Overall Study||0
9066093|NCT04117607|10126524|FG013|COMPLETED|Overall Study||0
9066094|NCT04117607|10126511|FG000|NOT COMPLETED|Overall Study||0
9066095|NCT04117607|10126512|FG001|NOT COMPLETED|Overall Study||1
9066096|NCT04117607|10126513|FG002|NOT COMPLETED|Overall Study||0
9066097|NCT04117607|10126514|FG003|NOT COMPLETED|Overall Study||0
9066098|NCT04117607|10126515|FG004|NOT COMPLETED|Overall Study||0
9066099|NCT04117607|10126516|FG005|NOT COMPLETED|Overall Study||0
9066100|NCT04117607|10126517|FG006|NOT COMPLETED|Overall Study||1
9066101|NCT04117607|10126518|FG007|NOT COMPLETED|Overall Study||0
9066102|NCT04117607|10126519|FG008|NOT COMPLETED|Overall Study||0
9066103|NCT04117607|10126520|FG009|NOT COMPLETED|Overall Study||0
9066104|NCT04117607|10126521|FG010|NOT COMPLETED|Overall Study||0
8556700|NCT02032823|9588471|FG001|STARTED|Overall Study||915
8945248|NCT02404311|10007208|FG003|Per Protocol|Part A: Month 0-18||0
8945249|NCT02404311|10007209|FG004|Per Protocol|Part A: Month 0-18||0
8945250|NCT02404311|10007205|FG000|Month 6.5 Immunogenicity Timepoint|Part A: Month 0-18||194
8623309|NCT00492752|9662558|FG003|COMPLETED|Double Blind Treatment||6
8623310|NCT00492752|9662555|FG000|NOT COMPLETED|Double Blind Treatment||14
8623311|NCT00492752|9662556|FG001|NOT COMPLETED|Double Blind Treatment||0
8623312|NCT00492752|9662557|FG002|NOT COMPLETED|Double Blind Treatment||3
8945251|NCT02404311|10007206|FG001|Month 6.5 Immunogenicity Timepoint|Part A: Month 0-18||37
8945252|NCT02404311|10007207|FG002|Month 6.5 Immunogenicity Timepoint|Part A: Month 0-18||0
8945253|NCT02404311|10007208|FG003|Month 6.5 Immunogenicity Timepoint|Part A: Month 0-18||0
8945254|NCT02404311|10007209|FG004|Month 6.5 Immunogenicity Timepoint|Part A: Month 0-18||0
8945255|NCT02404311|10007205|FG000|Month 12.5 Immunogenicity Timepoint|Part A: Month 0-18||186
8945256|NCT02404311|10007206|FG001|Month 12.5 Immunogenicity Timepoint|Part A: Month 0-18||33
8945257|NCT02404311|10007207|FG002|Month 12.5 Immunogenicity Timepoint|Part A: Month 0-18||0
8945258|NCT02404311|10007208|FG003|Month 12.5 Immunogenicity Timepoint|Part A: Month 0-18||0
8945259|NCT02404311|10007209|FG004|Month 12.5 Immunogenicity Timepoint|Part A: Month 0-18||0
8945260|NCT02404311|10007205|FG000|COMPLETED|Part A: Month 0-18||184
8945261|NCT02404311|10007206|FG001|COMPLETED|Part A: Month 0-18||36
8945262|NCT02404311|10007207|FG002|COMPLETED|Part A: Month 0-18||0
8945263|NCT02404311|10007208|FG003|COMPLETED|Part A: Month 0-18||0
8945264|NCT02404311|10007209|FG004|COMPLETED|Part A: Month 0-18||0
8945265|NCT02404311|10007205|FG000|NOT COMPLETED|Part A: Month 0-18||26
8945266|NCT02404311|10007206|FG001|NOT COMPLETED|Part A: Month 0-18||6
8945267|NCT02404311|10007207|FG002|NOT COMPLETED|Part A: Month 0-18||0
8945268|NCT02404311|10007208|FG003|NOT COMPLETED|Part A: Month 0-18||0
8945269|NCT02404311|10007209|FG004|NOT COMPLETED|Part A: Month 0-18||0
8945270|NCT02404311|10007205|FG000|STARTED|Part B: Month 30-36||0
8945271|NCT02404311|10007206|FG001|STARTED|Part B: Month 30-36||0
8945272|NCT02404311|10007207|FG002|STARTED|Part B: Month 30-36||32
8945273|NCT02404311|10007208|FG003|STARTED|Part B: Month 30-36||31
8945274|NCT02404311|10007209|FG004|STARTED|Part B: Month 30-36||7
8945275|NCT02404311|10007205|FG000|Month 30.5 Immunogenicity Timepoint|Part B: Month 30-36||0
8945276|NCT02404311|10007206|FG001|Month 30.5 Immunogenicity Timepoint|Part B: Month 30-36||0
8945277|NCT02404311|10007207|FG002|Month 30.5 Immunogenicity Timepoint|Part B: Month 30-36||28
8945278|NCT02404311|10007208|FG003|Month 30.5 Immunogenicity Timepoint|Part B: Month 30-36||30
8945279|NCT02404311|10007209|FG004|Month 30.5 Immunogenicity Timepoint|Part B: Month 30-36||6
8945280|NCT02404311|10007205|FG000|COMPLETED|Part B: Month 30-36||0
8945281|NCT02404311|10007206|FG001|COMPLETED|Part B: Month 30-36||0
8945282|NCT02404311|10007207|FG002|COMPLETED|Part B: Month 30-36||32
8945283|NCT02404311|10007208|FG003|COMPLETED|Part B: Month 30-36||31
8945284|NCT02404311|10007209|FG004|COMPLETED|Part B: Month 30-36||7
8945285|NCT02404311|10007205|FG000|NOT COMPLETED|Part B: Month 30-36||0
8945286|NCT02404311|10007206|FG001|NOT COMPLETED|Part B: Month 30-36||0
8945287|NCT02404311|10007207|FG002|NOT COMPLETED|Part B: Month 30-36||0
8945288|NCT02404311|10007208|FG003|NOT COMPLETED|Part B: Month 30-36||0
8945289|NCT02404311|10007209|FG004|NOT COMPLETED|Part B: Month 30-36||0
8945290|NCT02404350|10007225|FG000|STARTED|Overall Study||222
8945291|NCT02404350|10007226|FG001|STARTED|Overall Study||220
8945292|NCT02404350|10007227|FG002|STARTED|Overall Study||222
8945293|NCT02404350|10007228|FG003|STARTED|Overall Study||332
8945294|NCT02404350|10007225|FG000|COMPLETED|Overall Study||207
8945295|NCT02404350|10007226|FG001|COMPLETED|Overall Study||214
8945296|NCT02404350|10007227|FG002|COMPLETED|Overall Study||216
8945297|NCT02404350|10007228|FG003|COMPLETED|Overall Study||295
8945298|NCT02404350|10007225|FG000|NOT COMPLETED|Overall Study||15
8945299|NCT02404350|10007226|FG001|NOT COMPLETED|Overall Study||6
8945300|NCT02404350|10007227|FG002|NOT COMPLETED|Overall Study||6
8945301|NCT02404350|10007228|FG003|NOT COMPLETED|Overall Study||37
8945302|NCT02404389|10007244|FG000|STARTED|Overall Study||20
8945303|NCT02404389|10007245|FG001|STARTED|Overall Study||20
8945304|NCT02404389|10007246|FG002|STARTED|Overall Study||11
8945305|NCT02404389|10007247|FG003|STARTED|Overall Study||10
8945306|NCT02404389|10007248|FG004|STARTED|Overall Study||21
8945307|NCT02404389|10007244|FG000|COMPLETED|Overall Study||18
8945308|NCT02404389|10007245|FG001|COMPLETED|Overall Study||20
8945309|NCT02404389|10007246|FG002|COMPLETED|Overall Study||10
8945310|NCT02404389|10007247|FG003|COMPLETED|Overall Study||9
8945311|NCT02404389|10007248|FG004|COMPLETED|Overall Study||18
8945312|NCT02404389|10007244|FG000|NOT COMPLETED|Overall Study||2
8945313|NCT02404389|10007245|FG001|NOT COMPLETED|Overall Study||0
8945314|NCT02404389|10007246|FG002|NOT COMPLETED|Overall Study||1
8945315|NCT02404389|10007247|FG003|NOT COMPLETED|Overall Study||1
8945316|NCT02404389|10007248|FG004|NOT COMPLETED|Overall Study||3
8945317|NCT02404441|10007272|FG000|STARTED|Phase 1 Part||16
8945318|NCT02404441|10007273|FG001|STARTED|Phase 1 Part||15
8945319|NCT02404441|10007274|FG002|STARTED|Phase 1 Part||11
8945320|NCT02404441|10007275|FG003|STARTED|Phase 1 Part||6
8945321|NCT02404441|10007276|FG004|STARTED|Phase 1 Part||10
8945322|NCT02404441|10007277|FG005|STARTED|Phase 1 Part||0
8945323|NCT02404441|10007278|FG006|STARTED|Phase 1 Part||0
8945324|NCT02404441|10007279|FG007|STARTED|Phase 1 Part||0
8945325|NCT02404441|10007280|FG008|STARTED|Phase 1 Part||0
8945326|NCT02404441|10007281|FG009|STARTED|Phase 1 Part||0
8945327|NCT02404441|10007272|FG000|COMPLETED|Phase 1 Part||0
8945328|NCT02404441|10007273|FG001|COMPLETED|Phase 1 Part||0
8945329|NCT02404441|10007274|FG002|COMPLETED|Phase 1 Part||0
8945330|NCT02404441|10007275|FG003|COMPLETED|Phase 1 Part||0
8945331|NCT02404441|10007276|FG004|COMPLETED|Phase 1 Part||0
8945332|NCT02404441|10007277|FG005|COMPLETED|Phase 1 Part||0
8945333|NCT02404441|10007278|FG006|COMPLETED|Phase 1 Part||0
8945334|NCT02404441|10007279|FG007|COMPLETED|Phase 1 Part||0
8945335|NCT02404441|10007280|FG008|COMPLETED|Phase 1 Part||0
8945336|NCT02404441|10007281|FG009|COMPLETED|Phase 1 Part||0
8945337|NCT02404441|10007272|FG000|NOT COMPLETED|Phase 1 Part||16
8945338|NCT02404441|10007273|FG001|NOT COMPLETED|Phase 1 Part||15
8945339|NCT02404441|10007274|FG002|NOT COMPLETED|Phase 1 Part||11
8945340|NCT02404441|10007275|FG003|NOT COMPLETED|Phase 1 Part||6
8945341|NCT02404441|10007276|FG004|NOT COMPLETED|Phase 1 Part||10
8945342|NCT02404441|10007277|FG005|NOT COMPLETED|Phase 1 Part||0
8945343|NCT02404441|10007278|FG006|NOT COMPLETED|Phase 1 Part||0
8945344|NCT02404441|10007279|FG007|NOT COMPLETED|Phase 1 Part||0
8945345|NCT02404441|10007280|FG008|NOT COMPLETED|Phase 1 Part||0
8945346|NCT02404441|10007281|FG009|NOT COMPLETED|Phase 1 Part||0
8945347|NCT02404441|10007272|FG000|STARTED|Phase 2 Part||0
8945348|NCT02404441|10007273|FG001|STARTED|Phase 2 Part||0
8945349|NCT02404441|10007274|FG002|STARTED|Phase 2 Part||0
8945350|NCT02404441|10007275|FG003|STARTED|Phase 2 Part||0
8945351|NCT02404441|10007276|FG004|STARTED|Phase 2 Part||0
8945352|NCT02404441|10007277|FG005|STARTED|Phase 2 Part||59
8945353|NCT02404441|10007278|FG006|STARTED|Phase 2 Part||61
8945354|NCT02404441|10007279|FG007|STARTED|Phase 2 Part||40
8945355|NCT02404441|10007280|FG008|STARTED|Phase 2 Part||59
8945356|NCT02404441|10007281|FG009|STARTED|Phase 2 Part||42
8945357|NCT02404441|10007272|FG000|Entered Post-treatment Follow-up|Phase 2 Part||0
8945358|NCT02404441|10007273|FG001|Entered Post-treatment Follow-up|Phase 2 Part||0
8945359|NCT02404441|10007274|FG002|Entered Post-treatment Follow-up|Phase 2 Part||0
8945360|NCT02404441|10007275|FG003|Entered Post-treatment Follow-up|Phase 2 Part||0
8945361|NCT02404441|10007276|FG004|Entered Post-treatment Follow-up|Phase 2 Part||0
8945362|NCT02404441|10007277|FG005|Entered Post-treatment Follow-up|Phase 2 Part||2
8945363|NCT02404441|10007278|FG006|Entered Post-treatment Follow-up|Phase 2 Part||6
8945364|NCT02404441|10007279|FG007|Entered Post-treatment Follow-up|Phase 2 Part||1
8945365|NCT02404441|10007280|FG008|Entered Post-treatment Follow-up|Phase 2 Part||6
8945366|NCT02404441|10007281|FG009|Entered Post-treatment Follow-up|Phase 2 Part||1
8945367|NCT02404441|10007272|FG000|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||0
8945368|NCT02404441|10007273|FG001|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||0
8945369|NCT02404441|10007274|FG002|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||0
8945370|NCT02404441|10007275|FG003|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||0
8945371|NCT02404441|10007276|FG004|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||0
8945372|NCT02404441|10007277|FG005|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||2
8945373|NCT02404441|10007278|FG006|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||6
8945374|NCT02404441|10007279|FG007|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||1
8945375|NCT02404441|10007280|FG008|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||6
8945376|NCT02404441|10007281|FG009|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||1
8945377|NCT02404441|10007272|FG000|Entered Survival Follow-up|Phase 2 Part||0
8945378|NCT02404441|10007273|FG001|Entered Survival Follow-up|Phase 2 Part||0
8945379|NCT02404441|10007274|FG002|Entered Survival Follow-up|Phase 2 Part||0
8945380|NCT02404441|10007275|FG003|Entered Survival Follow-up|Phase 2 Part||0
8945381|NCT02404441|10007276|FG004|Entered Survival Follow-up|Phase 2 Part||0
8945382|NCT02404441|10007277|FG005|Entered Survival Follow-up|Phase 2 Part||38
8945383|NCT02404441|10007278|FG006|Entered Survival Follow-up|Phase 2 Part||34
8945384|NCT02404441|10007279|FG007|Entered Survival Follow-up|Phase 2 Part||26
8945385|NCT02404441|10007280|FG008|Entered Survival Follow-up|Phase 2 Part||35
8945386|NCT02404441|10007281|FG009|Entered Survival Follow-up|Phase 2 Part||25
8945387|NCT02404441|10007272|FG000|COMPLETED|Phase 2 Part||0
8945388|NCT02404441|10007273|FG001|COMPLETED|Phase 2 Part||0
8945389|NCT02404441|10007274|FG002|COMPLETED|Phase 2 Part||0
8945390|NCT02404441|10007275|FG003|COMPLETED|Phase 2 Part||0
8945391|NCT02404441|10007276|FG004|COMPLETED|Phase 2 Part||0
8945392|NCT02404441|10007277|FG005|COMPLETED|Phase 2 Part||0
8945393|NCT02404441|10007278|FG006|COMPLETED|Phase 2 Part||0
8945394|NCT02404441|10007279|FG007|COMPLETED|Phase 2 Part||0
8945395|NCT02404441|10007280|FG008|COMPLETED|Phase 2 Part||0
8945396|NCT02404441|10007281|FG009|COMPLETED|Phase 2 Part||0
8945397|NCT02404441|10007272|FG000|NOT COMPLETED|Phase 2 Part||0
8945398|NCT02404441|10007273|FG001|NOT COMPLETED|Phase 2 Part||0
8945399|NCT02404441|10007274|FG002|NOT COMPLETED|Phase 2 Part||0
8945400|NCT02404441|10007275|FG003|NOT COMPLETED|Phase 2 Part||0
8945401|NCT02404441|10007276|FG004|NOT COMPLETED|Phase 2 Part||0
8945402|NCT02404441|10007277|FG005|NOT COMPLETED|Phase 2 Part||59
8945403|NCT02404441|10007278|FG006|NOT COMPLETED|Phase 2 Part||61
8945404|NCT02404441|10007279|FG007|NOT COMPLETED|Phase 2 Part||40
8945405|NCT02404441|10007280|FG008|NOT COMPLETED|Phase 2 Part||59
8945406|NCT02404441|10007281|FG009|NOT COMPLETED|Phase 2 Part||42
8945407|NCT02404493|10007327|FG000|STARTED|Overall Study||17
8945408|NCT02404493|10007328|FG001|STARTED|Overall Study||6
8945409|NCT02404493|10007327|FG000|COMPLETED|Overall Study||16
8945410|NCT02404493|10007328|FG001|COMPLETED|Overall Study||5
8945411|NCT02404493|10007327|FG000|NOT COMPLETED|Overall Study||1
8945412|NCT02404493|10007328|FG001|NOT COMPLETED|Overall Study||1
8945413|NCT02404532|10007334|FG000|STARTED|Overall Study||29
8945414|NCT02404532|10007334|FG000|COMPLETED|Overall Study||29
8945415|NCT02404532|10007334|FG000|NOT COMPLETED|Overall Study||0
8945416|NCT02404610|10007345|FG000|STARTED|Overall Study||54
8945417|NCT02404610|10007346|FG001|STARTED|Overall Study||53
8945418|NCT02404610|10007345|FG000|COMPLETED|Overall Study||54
8945419|NCT02404610|10007346|FG001|COMPLETED|Overall Study||53
8945420|NCT02404610|10007345|FG000|NOT COMPLETED|Overall Study||0
8945421|NCT02404610|10007346|FG001|NOT COMPLETED|Overall Study||0
8945422|NCT02404649|10007354|FG000|STARTED|Overall Study||17
8945423|NCT02404649|10007355|FG001|STARTED|Overall Study||16
8945424|NCT02404649|10007354|FG000|COMPLETED|Overall Study||16
8945425|NCT02404649|10007355|FG001|COMPLETED|Overall Study||14
8945426|NCT02404649|10007354|FG000|NOT COMPLETED|Overall Study||1
8945427|NCT02404649|10007355|FG001|NOT COMPLETED|Overall Study||2
8945428|NCT02404792|10007363|FG000|STARTED|Overall Study||32
8945429|NCT02404792|10007364|FG001|STARTED|Overall Study||37
8945430|NCT02404792|10007363|FG000|COMPLETED|Overall Study||27
8945431|NCT02404792|10007364|FG001|COMPLETED|Overall Study||29
8945432|NCT02404792|10007363|FG000|NOT COMPLETED|Overall Study||5
8945433|NCT02404792|10007364|FG001|NOT COMPLETED|Overall Study||8
8945434|NCT02404805|10007378|FG000|STARTED|Overall Study||5
8945435|NCT02404805|10007379|FG001|STARTED|Overall Study||3
8945436|NCT02404805|10007380|FG002|STARTED|Overall Study||5
8945437|NCT02404805|10007381|FG003|STARTED|Overall Study||5
8945438|NCT02404805|10007382|FG004|STARTED|Overall Study||3
8945439|NCT02404805|10007383|FG005|STARTED|Overall Study||4
8945440|NCT02404805|10007378|FG000|COMPLETED|Overall Study||4
8945441|NCT02404805|10007379|FG001|COMPLETED|Overall Study||3
8945442|NCT02404805|10007380|FG002|COMPLETED|Overall Study||5
8945443|NCT02404805|10007381|FG003|COMPLETED|Overall Study||5
8945444|NCT02404805|10007382|FG004|COMPLETED|Overall Study||3
8945445|NCT02404805|10007383|FG005|COMPLETED|Overall Study||4
8945446|NCT02404805|10007378|FG000|NOT COMPLETED|Overall Study||1
8945447|NCT02404805|10007379|FG001|NOT COMPLETED|Overall Study||0
8945448|NCT02404805|10007380|FG002|NOT COMPLETED|Overall Study||0
8945449|NCT02404805|10007381|FG003|NOT COMPLETED|Overall Study||0
8945450|NCT02404805|10007382|FG004|NOT COMPLETED|Overall Study||0
8945451|NCT02404805|10007383|FG005|NOT COMPLETED|Overall Study||0
8623313|NCT00492752|9662558|FG003|NOT COMPLETED|Double Blind Treatment||0
8623314|NCT00492752|9662555|FG000|STARTED|Follow-up and/or Open Label Sorafenib||120
8623315|NCT00492752|9662556|FG001|STARTED|Follow-up and/or Open Label Sorafenib||16
8623316|NCT00492752|9662557|FG002|STARTED|Follow-up and/or Open Label Sorafenib||67
8945452|NCT02405091|10007395|FG000|STARTED|Overall Study||49
8945453|NCT02405091|10007396|FG001|STARTED|Overall Study||107
8945454|NCT02405091|10007397|FG002|STARTED|Overall Study||11
8945455|NCT02405091|10007395|FG000|COMPLETED|Overall Study||20
8945456|NCT02405091|10007396|FG001|COMPLETED|Overall Study||74
8945457|NCT02405091|10007397|FG002|COMPLETED|Overall Study||9
8945458|NCT02405091|10007395|FG000|NOT COMPLETED|Overall Study||29
8945459|NCT02405091|10007396|FG001|NOT COMPLETED|Overall Study||33
8945460|NCT02405091|10007397|FG002|NOT COMPLETED|Overall Study||2
8945461|NCT02405195|10007408|FG000|STARTED|Overall Study||18
8945462|NCT02405195|10007408|FG000|COMPLETED|Overall Study||18
8945463|NCT02405195|10007408|FG000|NOT COMPLETED|Overall Study||0
8945464|NCT02405325|10007414|FG000|STARTED|Overall Study||267
8945465|NCT02405325|10007415|FG001|STARTED|Overall Study||209
8945466|NCT02405325|10007414|FG000|COMPLETED|Overall Study||203
8945467|NCT02405325|10007415|FG001|COMPLETED|Overall Study||175
8945468|NCT02405325|10007414|FG000|NOT COMPLETED|Overall Study||64
8945469|NCT02405325|10007415|FG001|NOT COMPLETED|Overall Study||34
8945470|NCT02405390|10007423|FG000|STARTED|Overall Study||46
8945471|NCT02405390|10007424|FG001|STARTED|Overall Study||46
8945472|NCT02405390|10007423|FG000|COMPLETED|Overall Study||46
8945473|NCT02405390|10007424|FG001|COMPLETED|Overall Study||46
8945474|NCT02405390|10007423|FG000|NOT COMPLETED|Overall Study||0
8945475|NCT02405390|10007424|FG001|NOT COMPLETED|Overall Study||0
8945476|NCT02405429|10007430|FG000|STARTED|Overall Study||49
8945477|NCT02405429|10007430|FG000|COMPLETED|Overall Study||49
8945478|NCT02405429|10007430|FG000|NOT COMPLETED|Overall Study||0
8945479|NCT02405442|10007438|FG000|STARTED|Double-Blind Phase (up to Week 8)||53
8945480|NCT02405442|10007439|FG001|STARTED|Double-Blind Phase (up to Week 8)||53
8945481|NCT02405442|10007440|FG002|STARTED|Double-Blind Phase (up to Week 8)||53
8945482|NCT02405442|10007441|FG003|STARTED|Double-Blind Phase (up to Week 8)||28
8945483|NCT02405442|10007438|FG000|COMPLETED|Double-Blind Phase (up to Week 8)||52
8945484|NCT02405442|10007439|FG001|COMPLETED|Double-Blind Phase (up to Week 8)||48
8945485|NCT02405442|10007440|FG002|COMPLETED|Double-Blind Phase (up to Week 8)||47
8945486|NCT02405442|10007441|FG003|COMPLETED|Double-Blind Phase (up to Week 8)||27
8945487|NCT02405442|10007438|FG000|NOT COMPLETED|Double-Blind Phase (up to Week 8)||1
8945488|NCT02405442|10007439|FG001|NOT COMPLETED|Double-Blind Phase (up to Week 8)||5
8945489|NCT02405442|10007440|FG002|NOT COMPLETED|Double-Blind Phase (up to Week 8)||6
8945490|NCT02405442|10007441|FG003|NOT COMPLETED|Double-Blind Phase (up to Week 8)||1
8623317|NCT00492752|9662558|FG003|STARTED|Follow-up and/or Open Label Sorafenib||6
8945491|NCT02405442|10007438|FG000|STARTED|Open-Label Phase (up to Week 52)||52
8945492|NCT02405442|10007439|FG001|STARTED|Open-Label Phase (up to Week 52)||48
8945493|NCT02405442|10007440|FG002|STARTED|Open-Label Phase (up to Week 52)||47
8945494|NCT02405442|10007441|FG003|STARTED|Open-Label Phase (up to Week 52)|1 participant completed Double-Blind Phase, but did not continue in Open-Label Phase.|26
8945495|NCT02405442|10007438|FG000|COMPLETED|Open-Label Phase (up to Week 52)||4
8945496|NCT02405442|10007439|FG001|COMPLETED|Open-Label Phase (up to Week 52)||3
8945497|NCT02405442|10007440|FG002|COMPLETED|Open-Label Phase (up to Week 52)||2
8945498|NCT02405442|10007441|FG003|COMPLETED|Open-Label Phase (up to Week 52)||2
8945499|NCT02405442|10007438|FG000|NOT COMPLETED|Open-Label Phase (up to Week 52)||48
8945500|NCT02405442|10007439|FG001|NOT COMPLETED|Open-Label Phase (up to Week 52)||45
8945501|NCT02405442|10007440|FG002|NOT COMPLETED|Open-Label Phase (up to Week 52)||45
8945502|NCT02405442|10007441|FG003|NOT COMPLETED|Open-Label Phase (up to Week 52)||24
8945503|NCT02405442|10007438|FG000|STARTED|Extended Treatment Phase(up to Week 208)|1 participant completed Open-Label Phase, but did not continue in Extended Treatment Phase.|3
8945504|NCT02405442|10007439|FG001|STARTED|Extended Treatment Phase(up to Week 208)|1 participant completed Open-Label Phase, but did not continue in Extended Treatment Phase.|2
8945505|NCT02405442|10007440|FG002|STARTED|Extended Treatment Phase(up to Week 208)||2
8945506|NCT02405442|10007441|FG003|STARTED|Extended Treatment Phase(up to Week 208)||2
8945507|NCT02405442|10007438|FG000|COMPLETED|Extended Treatment Phase(up to Week 208)||0
8945508|NCT02405442|10007439|FG001|COMPLETED|Extended Treatment Phase(up to Week 208)||0
8945509|NCT02405442|10007440|FG002|COMPLETED|Extended Treatment Phase(up to Week 208)||0
8945510|NCT02405442|10007441|FG003|COMPLETED|Extended Treatment Phase(up to Week 208)||0
8945511|NCT02405442|10007438|FG000|NOT COMPLETED|Extended Treatment Phase(up to Week 208)||3
8945512|NCT02405442|10007439|FG001|NOT COMPLETED|Extended Treatment Phase(up to Week 208)||2
8945513|NCT02405442|10007440|FG002|NOT COMPLETED|Extended Treatment Phase(up to Week 208)||2
8945514|NCT02405442|10007441|FG003|NOT COMPLETED|Extended Treatment Phase(up to Week 208)||2
8945515|NCT02405780|10007459|FG000|STARTED|Period I||216
8945516|NCT02405780|10007460|FG001|STARTED|Period I||108
8945517|NCT02405780|10007461|FG002|STARTED|Period I||108
8945518|NCT02405780|10007462|FG003|STARTED|Period I||213
8945519|NCT02405780|10007459|FG000|COMPLETED|Period I||189
8945520|NCT02405780|10007460|FG001|COMPLETED|Period I||100
8945521|NCT02405780|10007461|FG002|COMPLETED|Period I||93
8945522|NCT02405780|10007462|FG003|COMPLETED|Period I||190
8945523|NCT02405780|10007459|FG000|NOT COMPLETED|Period I||27
8945524|NCT02405780|10007460|FG001|NOT COMPLETED|Period I||8
8945525|NCT02405780|10007461|FG002|NOT COMPLETED|Period I||15
8945526|NCT02405780|10007462|FG003|NOT COMPLETED|Period I||23
8945527|NCT02405780|10007459|FG000|STARTED|Period II||189
8945528|NCT02405780|10007460|FG001|STARTED|Period II||100
8945529|NCT02405780|10007461|FG002|STARTED|Period II||93
8945530|NCT02405780|10007462|FG003|STARTED|Period II||190
8945531|NCT02405780|10007459|FG000|COMPLETED|Period II||174
8945532|NCT02405780|10007460|FG001|COMPLETED|Period II||88
8945533|NCT02405780|10007461|FG002|COMPLETED|Period II||81
8945534|NCT02405780|10007462|FG003|COMPLETED|Period II||172
8945535|NCT02405780|10007459|FG000|NOT COMPLETED|Period II||15
8945536|NCT02405780|10007460|FG001|NOT COMPLETED|Period II||12
8945537|NCT02405780|10007461|FG002|NOT COMPLETED|Period II||12
8945538|NCT02405780|10007462|FG003|NOT COMPLETED|Period II||18
8945539|NCT02405962|10007489|FG000|STARTED|Overall Study||84
8945540|NCT02405962|10007490|FG001|STARTED|Overall Study||84
8945541|NCT02405962|10007489|FG000|Post-intervention|Overall Study||80
8945542|NCT02405962|10007490|FG001|Post-intervention|Overall Study||81
8945543|NCT02405962|10007489|FG000|3 Months After the Intervention|Overall Study||80
8945544|NCT02405962|10007490|FG001|3 Months After the Intervention|Overall Study||79
8945545|NCT02405962|10007489|FG000|COMPLETED|Overall Study||83
8945546|NCT02405962|10007490|FG001|COMPLETED|Overall Study||79
8945547|NCT02405962|10007489|FG000|NOT COMPLETED|Overall Study||1
8945548|NCT02405962|10007490|FG001|NOT COMPLETED|Overall Study||5
8945549|NCT02406027|10007499|FG000|STARTED|Double-blind Treatment Phase (Period 1)||35
8945550|NCT02406027|10007500|FG001|STARTED|Double-blind Treatment Phase (Period 1)||29
8945551|NCT02406027|10007501|FG002|STARTED|Double-blind Treatment Phase (Period 1)||26
8945552|NCT02406027|10007502|FG003|STARTED|Double-blind Treatment Phase (Period 1)||0
8945553|NCT02406027|10007503|FG004|STARTED|Double-blind Treatment Phase (Period 1)||0
8945554|NCT02406027|10007504|FG005|STARTED|Double-blind Treatment Phase (Period 1)||0
8945555|NCT02406027|10007505|FG006|STARTED|Double-blind Treatment Phase (Period 1)||0
8945556|NCT02406027|10007499|FG000|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||6
8945557|NCT02406027|10007500|FG001|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||8
8945558|NCT02406027|10007501|FG002|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||6
8945559|NCT02406027|10007502|FG003|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||0
8945560|NCT02406027|10007503|FG004|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||0
8945561|NCT02406027|10007504|FG005|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||0
8945562|NCT02406027|10007505|FG006|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||0
8945563|NCT02406027|10007499|FG000|Prodromal|Double-blind Treatment Phase (Period 1)||29
8945564|NCT02406027|10007500|FG001|Prodromal|Double-blind Treatment Phase (Period 1)||21
8945565|NCT02406027|10007501|FG002|Prodromal|Double-blind Treatment Phase (Period 1)||20
8945566|NCT02406027|10007502|FG003|Prodromal|Double-blind Treatment Phase (Period 1)||0
8945567|NCT02406027|10007503|FG004|Prodromal|Double-blind Treatment Phase (Period 1)||0
8945568|NCT02406027|10007504|FG005|Prodromal|Double-blind Treatment Phase (Period 1)||0
8723490|NCT01023581|9771017|FG001|STARTED|Overall Study||112
8723491|NCT01023581|9771018|FG002|STARTED|Overall Study||113
8723492|NCT01023581|9771019|FG003|STARTED|Overall Study||114
8723493|NCT01023581|9771020|FG004|STARTED|Overall Study||111
8723494|NCT01023581|9771021|FG005|STARTED|Overall Study||111
8723495|NCT01023581|9771022|FG006|STARTED|Overall Study||114
8723496|NCT01023581|9771016|FG000|Received Study Treatment|Overall Study||106
8945569|NCT02406027|10007505|FG006|Prodromal|Double-blind Treatment Phase (Period 1)||0
8945570|NCT02406027|10007499|FG000|COMPLETED|Double-blind Treatment Phase (Period 1)||29
8945571|NCT02406027|10007500|FG001|COMPLETED|Double-blind Treatment Phase (Period 1)||26
8945572|NCT02406027|10007501|FG002|COMPLETED|Double-blind Treatment Phase (Period 1)||22
8945573|NCT02406027|10007502|FG003|COMPLETED|Double-blind Treatment Phase (Period 1)||0
8945574|NCT02406027|10007503|FG004|COMPLETED|Double-blind Treatment Phase (Period 1)||0
8945575|NCT02406027|10007504|FG005|COMPLETED|Double-blind Treatment Phase (Period 1)||0
8945576|NCT02406027|10007505|FG006|COMPLETED|Double-blind Treatment Phase (Period 1)||0
8945577|NCT02406027|10007499|FG000|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||6
8945578|NCT02406027|10007500|FG001|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||3
8945579|NCT02406027|10007501|FG002|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||4
8945580|NCT02406027|10007502|FG003|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||0
8945581|NCT02406027|10007503|FG004|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||0
8945582|NCT02406027|10007504|FG005|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||0
8945583|NCT02406027|10007505|FG006|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||0
8842897|NCT01701258|9897269|FG011|Returned for EEG (Session 4)|Assessment and Scheduling||0
8842898|NCT01701258|9897270|FG012|Returned for EEG (Session 4)|Assessment and Scheduling||0
8842899|NCT01701258|9897258|FG000|COMPLETED|Assessment and Scheduling||70
8842900|NCT01701258|9897259|FG001|COMPLETED|Assessment and Scheduling||0
8842901|NCT01701258|9897260|FG002|COMPLETED|Assessment and Scheduling||0
8842902|NCT01701258|9897261|FG003|COMPLETED|Assessment and Scheduling||0
8945584|NCT02406027|10007499|FG000|STARTED|Open-label Phase (Period 2)||0
8945585|NCT02406027|10007500|FG001|STARTED|Open-label Phase (Period 2)||0
8945586|NCT02406027|10007501|FG002|STARTED|Open-label Phase (Period 2)||0
8945587|NCT02406027|10007502|FG003|STARTED|Open-label Phase (Period 2)||15
8945588|NCT02406027|10007503|FG004|STARTED|Open-label Phase (Period 2)||14
8945589|NCT02406027|10007504|FG005|STARTED|Open-label Phase (Period 2)||26
8945590|NCT02406027|10007505|FG006|STARTED|Open-label Phase (Period 2)||22
8945591|NCT02406027|10007499|FG000|COMPLETED|Open-label Phase (Period 2)||0
8945592|NCT02406027|10007500|FG001|COMPLETED|Open-label Phase (Period 2)||0
8945593|NCT02406027|10007501|FG002|COMPLETED|Open-label Phase (Period 2)||0
8945594|NCT02406027|10007502|FG003|COMPLETED|Open-label Phase (Period 2)||0
8945595|NCT02406027|10007503|FG004|COMPLETED|Open-label Phase (Period 2)||0
8945596|NCT02406027|10007504|FG005|COMPLETED|Open-label Phase (Period 2)||0
8945597|NCT02406027|10007505|FG006|COMPLETED|Open-label Phase (Period 2)||0
8945598|NCT02406027|10007499|FG000|NOT COMPLETED|Open-label Phase (Period 2)||0
8945599|NCT02406027|10007500|FG001|NOT COMPLETED|Open-label Phase (Period 2)||0
8945600|NCT02406027|10007501|FG002|NOT COMPLETED|Open-label Phase (Period 2)||0
8945601|NCT02406027|10007502|FG003|NOT COMPLETED|Open-label Phase (Period 2)||15
8945602|NCT02406027|10007503|FG004|NOT COMPLETED|Open-label Phase (Period 2)||14
8945603|NCT02406027|10007504|FG005|NOT COMPLETED|Open-label Phase (Period 2)||26
8945604|NCT02406027|10007505|FG006|NOT COMPLETED|Open-label Phase (Period 2)||22
8945605|NCT02406248|10007521|FG000|STARTED|Overall Study||108
8945606|NCT02406248|10007521|FG000|COMPLETED|Overall Study||99
8945607|NCT02406248|10007521|FG000|NOT COMPLETED|Overall Study||9
8945608|NCT02406261|10007527|FG000|STARTED|Period 1||50
8945609|NCT02406261|10007528|FG001|STARTED|Period 1||32
8945610|NCT02406261|10007527|FG000|Received at Least One Dose of Study Drug|Period 1||50
8945611|NCT02406261|10007528|FG001|Received at Least One Dose of Study Drug|Period 1||32
8945612|NCT02406261|10007527|FG000|COMPLETED|Period 1||47
8945613|NCT02406261|10007528|FG001|COMPLETED|Period 1||32
8945614|NCT02406261|10007527|FG000|NOT COMPLETED|Period 1||3
8945615|NCT02406261|10007528|FG001|NOT COMPLETED|Period 1||0
8945616|NCT02406261|10007527|FG000|STARTED|Period 2|Cohort A participated in Period 1 only|0
8945617|NCT02406261|10007528|FG001|STARTED|Period 2||32
8945618|NCT02406261|10007527|FG000|COMPLETED|Period 2||0
8945619|NCT02406261|10007528|FG001|COMPLETED|Period 2||29
8945620|NCT02406261|10007527|FG000|NOT COMPLETED|Period 2||0
8945621|NCT02406261|10007528|FG001|NOT COMPLETED|Period 2||3
8945622|NCT02406443|10007537|FG000|STARTED|Overall Study||18
8945623|NCT02406443|10007538|FG001|STARTED|Overall Study||18
8945624|NCT02406443|10007537|FG000|COMPLETED|Overall Study||16
8945625|NCT02406443|10007538|FG001|COMPLETED|Overall Study||16
8945626|NCT02406443|10007537|FG000|NOT COMPLETED|Overall Study||2
8945627|NCT02406443|10007538|FG001|NOT COMPLETED|Overall Study||2
8945628|NCT02406495|10007544|FG000|STARTED|Overall Study||40
8945629|NCT02406495|10007544|FG000|COMPLETED|Overall Study||40
8945630|NCT02406495|10007544|FG000|NOT COMPLETED|Overall Study||0
8945631|NCT02406573|10007557|FG000|STARTED|Overall Study||30
8945632|NCT02406573|10007557|FG000|COMPLETED|Overall Study||30
8945633|NCT02406573|10007557|FG000|NOT COMPLETED|Overall Study||0
8945634|NCT02406586|10007564|FG000|STARTED|Overall Study||12
8945635|NCT02406586|10007565|FG001|STARTED|Overall Study||12
8945636|NCT02406586|10007566|FG002|STARTED|Overall Study||12
8945637|NCT02406586|10007564|FG000|COMPLETED|Overall Study||11
8945638|NCT02406586|10007565|FG001|COMPLETED|Overall Study||8
8842903|NCT01701258|9897262|FG004|COMPLETED|Assessment and Scheduling||0
8842904|NCT01701258|9897263|FG005|COMPLETED|Assessment and Scheduling||0
8842905|NCT01701258|9897264|FG006|COMPLETED|Assessment and Scheduling||0
8842906|NCT01701258|9897265|FG007|COMPLETED|Assessment and Scheduling||0
8842907|NCT01701258|9897266|FG008|COMPLETED|Assessment and Scheduling||0
8842908|NCT01701258|9897267|FG009|COMPLETED|Assessment and Scheduling||0
8842909|NCT01701258|9897268|FG010|COMPLETED|Assessment and Scheduling||0
8945639|NCT02406586|10007566|FG002|COMPLETED|Overall Study||10
8945640|NCT02406586|10007564|FG000|NOT COMPLETED|Overall Study||1
8945641|NCT02406586|10007565|FG001|NOT COMPLETED|Overall Study||4
8945642|NCT02406586|10007566|FG002|NOT COMPLETED|Overall Study||2
8945643|NCT02406612|10007579|FG000|STARTED|Overall Study||26
8945644|NCT02406612|10007580|FG001|STARTED|Overall Study||21
8945645|NCT02406612|10007579|FG000|COMPLETED|Overall Study||22
8945646|NCT02406612|10007580|FG001|COMPLETED|Overall Study||17
8945647|NCT02406612|10007579|FG000|NOT COMPLETED|Overall Study||4
8945648|NCT02406612|10007580|FG001|NOT COMPLETED|Overall Study||4
8945649|NCT02406651|10007586|FG000|STARTED|Overall Study||30
8945650|NCT02406651|10007586|FG000|COMPLETED|Overall Study||27
8945651|NCT02406651|10007586|FG000|NOT COMPLETED|Overall Study||3
8945652|NCT02406677|10007593|FG000|STARTED|Overall Study||6436
8945653|NCT02406677|10007594|FG001|STARTED|Overall Study||4565
8945654|NCT02406677|10007593|FG000|COMPLETED|Overall Study||6135
8945655|NCT02406677|10007594|FG001|COMPLETED|Overall Study||3967
8945656|NCT02406677|10007593|FG000|NOT COMPLETED|Overall Study||301
8945657|NCT02406677|10007594|FG001|NOT COMPLETED|Overall Study||598
8945658|NCT02406742|10007607|FG000|STARTED|Overall Study||14
8945659|NCT02406742|10007608|FG001|STARTED|Overall Study||16
8945660|NCT02406742|10007609|FG002|STARTED|Overall Study||16
8945661|NCT02406742|10007607|FG000|Dose Escalation 1|Overall Study||3
8945662|NCT02406742|10007608|FG001|Dose Escalation 1|Overall Study||0
8945663|NCT02406742|10007609|FG002|Dose Escalation 1|Overall Study||0
8945664|NCT02406742|10007607|FG000|Dose Escalation 2|Overall Study||9
8945665|NCT02406742|10007608|FG001|Dose Escalation 2|Overall Study||5
8945666|NCT02406742|10007609|FG002|Dose Escalation 2|Overall Study||3
8945667|NCT02406742|10007607|FG000|Dose Escalation 3|Overall Study||2
8945668|NCT02406742|10007608|FG001|Dose Escalation 3|Overall Study||3
8945669|NCT02406742|10007609|FG002|Dose Escalation 3|Overall Study||3
8945670|NCT02406742|10007607|FG000|Dose Escalation 4|Overall Study||0
8945671|NCT02406742|10007608|FG001|Dose Escalation 4|Overall Study||3
8945672|NCT02406742|10007609|FG002|Dose Escalation 4|Overall Study||3
8945673|NCT02406742|10007607|FG000|Dose Escalation 5|Overall Study||0
8945674|NCT02406742|10007608|FG001|Dose Escalation 5|Overall Study||5
8945675|NCT02406742|10007609|FG002|Dose Escalation 5|Overall Study||5
8945676|NCT02406742|10007607|FG000|COMPLETED|Overall Study||0
8945677|NCT02406742|10007608|FG001|COMPLETED|Overall Study||0
8945678|NCT02406742|10007609|FG002|COMPLETED|Overall Study||0
8945679|NCT02406742|10007607|FG000|NOT COMPLETED|Overall Study||14
8945680|NCT02406742|10007608|FG001|NOT COMPLETED|Overall Study||16
8945681|NCT02406742|10007609|FG002|NOT COMPLETED|Overall Study||16
8945682|NCT02406859|10007620|FG000|STARTED|Part 1 - Manometric Parameters||15
8945683|NCT02406859|10007621|FG001|STARTED|Part 1 - Manometric Parameters||14
8945684|NCT02406859|10007622|FG002|STARTED|Part 1 - Manometric Parameters||21
8945685|NCT02406859|10007620|FG000|COMPLETED|Part 1 - Manometric Parameters||12
8945686|NCT02406859|10007621|FG001|COMPLETED|Part 1 - Manometric Parameters||13
8945687|NCT02406859|10007622|FG002|COMPLETED|Part 1 - Manometric Parameters||17
8945688|NCT02406859|10007620|FG000|NOT COMPLETED|Part 1 - Manometric Parameters||3
8945689|NCT02406859|10007621|FG001|NOT COMPLETED|Part 1 - Manometric Parameters||1
8945690|NCT02406859|10007622|FG002|NOT COMPLETED|Part 1 - Manometric Parameters||4
8945691|NCT02406859|10007620|FG000|STARTED|Part 2 - Biofeedback Training||12
8945692|NCT02406859|10007621|FG001|STARTED|Part 2 - Biofeedback Training||13
8945693|NCT02406859|10007622|FG002|STARTED|Part 2 - Biofeedback Training||17
8945694|NCT02406859|10007620|FG000|COMPLETED|Part 2 - Biofeedback Training||12
8945695|NCT02406859|10007621|FG001|COMPLETED|Part 2 - Biofeedback Training||13
8945696|NCT02406859|10007622|FG002|COMPLETED|Part 2 - Biofeedback Training||17
8945697|NCT02406859|10007620|FG000|NOT COMPLETED|Part 2 - Biofeedback Training||0
8945698|NCT02406859|10007621|FG001|NOT COMPLETED|Part 2 - Biofeedback Training||0
8945699|NCT02406859|10007622|FG002|NOT COMPLETED|Part 2 - Biofeedback Training||0
8945700|NCT02406885|10007641|FG000|STARTED|Overall Study||17
8945701|NCT02406885|10007642|FG001|STARTED|Overall Study||16
8945702|NCT02406885|10007641|FG000|COMPLETED|Overall Study||14
8945703|NCT02406885|10007642|FG001|COMPLETED|Overall Study||14
8945704|NCT02406885|10007641|FG000|NOT COMPLETED|Overall Study||3
8945705|NCT02406885|10007642|FG001|NOT COMPLETED|Overall Study||2
8945706|NCT02406937|10007651|FG000|STARTED|Overall Study||60
8945707|NCT02406937|10007652|FG001|STARTED|Overall Study||60
8945708|NCT02406937|10007653|FG002|STARTED|Overall Study||60
8945709|NCT02406937|10007651|FG000|COMPLETED|Overall Study||59
8945710|NCT02406937|10007652|FG001|COMPLETED|Overall Study||59
8945711|NCT02406937|10007653|FG002|COMPLETED|Overall Study||58
8945712|NCT02406937|10007651|FG000|NOT COMPLETED|Overall Study||1
8945713|NCT02406937|10007652|FG001|NOT COMPLETED|Overall Study||1
8945714|NCT02406937|10007653|FG002|NOT COMPLETED|Overall Study||2
8945715|NCT02407041|10007664|FG000|STARTED|Overall Study||5
8945716|NCT02407041|10007664|FG000|COMPLETED|Overall Study||5
8945717|NCT02407041|10007664|FG000|NOT COMPLETED|Overall Study||0
8945718|NCT02407054|10007671|FG000|STARTED|Overall Study||13
8945719|NCT02407054|10007672|FG001|STARTED|Overall Study||65
8945720|NCT02407054|10007673|FG002|STARTED|Overall Study||64
8945721|NCT02407054|10007671|FG000|Received at Least One Dose of Study Drug|Overall Study||13
8945722|NCT02407054|10007672|FG001|Received at Least One Dose of Study Drug|Overall Study||65
8945723|NCT02407054|10007673|FG002|Received at Least One Dose of Study Drug|Overall Study||64
8945724|NCT02407054|10007671|FG000|COMPLETED|Overall Study||6
8945725|NCT02407054|10007672|FG001|COMPLETED|Overall Study||47
8945726|NCT02407054|10007673|FG002|COMPLETED|Overall Study||57
8945727|NCT02407054|10007671|FG000|NOT COMPLETED|Overall Study||7
8945728|NCT02407054|10007672|FG001|NOT COMPLETED|Overall Study||18
8945729|NCT02407054|10007673|FG002|NOT COMPLETED|Overall Study||7
8945730|NCT02407132|10007684|FG000|STARTED|Immediate Post-intervention||110
8945731|NCT02407132|10007685|FG001|STARTED|Immediate Post-intervention||111
8945732|NCT02407132|10007684|FG000|COMPLETED|Immediate Post-intervention||107
8945733|NCT02407132|10007685|FG001|COMPLETED|Immediate Post-intervention||101
8945734|NCT02407132|10007684|FG000|NOT COMPLETED|Immediate Post-intervention||3
8945735|NCT02407132|10007685|FG001|NOT COMPLETED|Immediate Post-intervention||10
8945736|NCT02407132|10007684|FG000|STARTED|6 Months Post-intervention||107
8945737|NCT02407132|10007685|FG001|STARTED|6 Months Post-intervention||101
8945738|NCT02407132|10007684|FG000|COMPLETED|6 Months Post-intervention||96
8945739|NCT02407132|10007685|FG001|COMPLETED|6 Months Post-intervention||92
8945740|NCT02407132|10007684|FG000|NOT COMPLETED|6 Months Post-intervention||11
8945741|NCT02407132|10007685|FG001|NOT COMPLETED|6 Months Post-intervention||9
8945742|NCT02407132|10007684|FG000|STARTED|12 Months Post-intervention||96
8945743|NCT02407132|10007685|FG001|STARTED|12 Months Post-intervention||92
8945744|NCT02407132|10007684|FG000|COMPLETED|12 Months Post-intervention||83
8945745|NCT02407132|10007685|FG001|COMPLETED|12 Months Post-intervention||90
8945746|NCT02407132|10007684|FG000|NOT COMPLETED|12 Months Post-intervention||13
8945747|NCT02407132|10007685|FG001|NOT COMPLETED|12 Months Post-intervention||2
8945748|NCT02407223|10007694|FG000|STARTED|Overall Study||116
8945749|NCT02407223|10007695|FG001|STARTED|Overall Study||118
8945750|NCT02407223|10007696|FG002|STARTED|Overall Study||122
8945751|NCT02407223|10007694|FG000|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|22
8945752|NCT02407223|10007695|FG001|Early Escape at Week 16|Overall Study||0
8945753|NCT02407223|10007696|FG002|Early Escape at Week 16|Overall Study||0
8945754|NCT02407223|10007694|FG000|Cross Over at Week 24|Overall Study|Study discontinuation/completion reported under randomization group|60
8945755|NCT02407223|10007695|FG001|Cross Over at Week 24|Overall Study||0
8945756|NCT02407223|10007696|FG002|Cross Over at Week 24|Overall Study||0
8945757|NCT02407223|10007694|FG000|Qualified Re-randomization at Week 52|Overall Study||0
8945758|NCT02407223|10007695|FG001|Qualified Re-randomization at Week 52|Overall Study||3
8945759|NCT02407223|10007696|FG002|Qualified Re-randomization at Week 52|Overall Study||2
8945760|NCT02407223|10007694|FG000|COMPLETED|Overall Study||0
8945761|NCT02407223|10007695|FG001|COMPLETED|Overall Study||0
8945762|NCT02407223|10007696|FG002|COMPLETED|Overall Study||0
8945763|NCT02407223|10007694|FG000|NOT COMPLETED|Overall Study||116
8945764|NCT02407223|10007695|FG001|NOT COMPLETED|Overall Study||118
8945765|NCT02407223|10007696|FG002|NOT COMPLETED|Overall Study||122
8948753|NCT02432274|10011220|FG003|Treated (Safety Population)|Overall Study||1
8948754|NCT02432274|10011221|FG004|Treated (Safety Population)|Overall Study||31
8948755|NCT02432274|10011222|FG005|Treated (Safety Population)|Overall Study|4 participants assigned to lenvatinib14mg/m^2 actually received 11mg/m^2 (dose capped at 24 mg/day).|11
8948756|NCT02432274|10011223|FG006|Treated (Safety Population)|Overall Study||11
8948757|NCT02432274|10011224|FG007|Treated (Safety Population)|Overall Study||20
8948758|NCT02432274|10011217|FG000|COMPLETED|Overall Study||0
8948759|NCT02432274|10011218|FG001|COMPLETED|Overall Study||0
8948760|NCT02432274|10011219|FG002|COMPLETED|Overall Study||0
8948761|NCT02432274|10011220|FG003|COMPLETED|Overall Study||0
8948762|NCT02432274|10011221|FG004|COMPLETED|Overall Study||0
8948763|NCT02432274|10011222|FG005|COMPLETED|Overall Study||0
8948764|NCT02432274|10011223|FG006|COMPLETED|Overall Study||0
8948765|NCT02432274|10011224|FG007|COMPLETED|Overall Study||0
8948766|NCT02432274|10011217|FG000|NOT COMPLETED|Overall Study||3
8948767|NCT02432274|10011218|FG001|NOT COMPLETED|Overall Study||9
8948768|NCT02432274|10011219|FG002|NOT COMPLETED|Overall Study||11
8948769|NCT02432274|10011220|FG003|NOT COMPLETED|Overall Study||1
8948770|NCT02432274|10011221|FG004|NOT COMPLETED|Overall Study||31
8623318|NCT00492752|9662555|FG000|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||120
8623319|NCT00492752|9662556|FG001|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||0
8623320|NCT00492752|9662557|FG002|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||67
8623321|NCT00492752|9662558|FG003|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||0
8623322|NCT00492752|9662555|FG000|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||0
8623323|NCT00492752|9662556|FG001|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||16
8623324|NCT00492752|9662557|FG002|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||0
8623325|NCT00492752|9662558|FG003|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||6
8623326|NCT00492752|9662555|FG000|COMPLETED|Follow-up and/or Open Label Sorafenib|1 participant completed all assessments, 33 were followed up until the end of this trial|34
8623327|NCT00492752|9662556|FG001|COMPLETED|Follow-up and/or Open Label Sorafenib||0
8948771|NCT02432274|10011222|FG005|NOT COMPLETED|Overall Study||7
8948772|NCT02432274|10011223|FG006|NOT COMPLETED|Overall Study||15
8948773|NCT02432274|10011224|FG007|NOT COMPLETED|Overall Study||20
8948774|NCT02432287|10011256|FG000|STARTED|First Intervention||8
8948775|NCT02432287|10011257|FG001|STARTED|First Intervention||8
8948776|NCT02432287|10011256|FG000|COMPLETED|First Intervention||8
8948777|NCT02432287|10011257|FG001|COMPLETED|First Intervention||7
8948778|NCT02432287|10011256|FG000|NOT COMPLETED|First Intervention||0
8948779|NCT02432287|10011257|FG001|NOT COMPLETED|First Intervention||1
8948780|NCT02432287|10011256|FG000|STARTED|Washout Period||7
8948781|NCT02432287|10011257|FG001|STARTED|Washout Period||7
8945766|NCT02407249|10007706|FG000|STARTED|Overall Study||73
8945767|NCT02407249|10007706|FG000|Treated|Overall Study||60
8945768|NCT02407249|10007706|FG000|COMPLETED|Overall Study||47
8945769|NCT02407249|10007706|FG000|NOT COMPLETED|Overall Study||26
8945770|NCT02407457|10007712|FG000|STARTED|Baseline||235
8945771|NCT02407457|10007713|FG001|STARTED|Baseline||220
8945772|NCT02407457|10007712|FG000|COMPLETED|Baseline||235
8945773|NCT02407457|10007713|FG001|COMPLETED|Baseline||220
8945774|NCT02407457|10007712|FG000|NOT COMPLETED|Baseline||0
8945775|NCT02407457|10007713|FG001|NOT COMPLETED|Baseline||0
8945776|NCT02407457|10007712|FG000|STARTED|1 Month||235
8945777|NCT02407457|10007713|FG001|STARTED|1 Month||220
8945778|NCT02407457|10007712|FG000|COMPLETED|1 Month||229
8945779|NCT02407457|10007713|FG001|COMPLETED|1 Month||213
8945780|NCT02407457|10007712|FG000|NOT COMPLETED|1 Month||6
8945781|NCT02407457|10007713|FG001|NOT COMPLETED|1 Month||7
8945782|NCT02407457|10007712|FG000|STARTED|6-Month||231
8945783|NCT02407457|10007713|FG001|STARTED|6-Month||219
8945784|NCT02407457|10007712|FG000|COMPLETED|6-Month||211
8945785|NCT02407457|10007713|FG001|COMPLETED|6-Month||194
8945786|NCT02407457|10007712|FG000|NOT COMPLETED|6-Month||20
8945787|NCT02407457|10007713|FG001|NOT COMPLETED|6-Month||25
8945788|NCT02407457|10007712|FG000|STARTED|1 Year||227
8945789|NCT02407457|10007713|FG001|STARTED|1 Year||208
8945790|NCT02407457|10007712|FG000|COMPLETED|1 Year||194
8945791|NCT02407457|10007713|FG001|COMPLETED|1 Year||180
8945792|NCT02407457|10007712|FG000|NOT COMPLETED|1 Year||33
8945793|NCT02407457|10007713|FG001|NOT COMPLETED|1 Year||28
8945794|NCT02407457|10007712|FG000|STARTED|2-year||218
8945795|NCT02407457|10007713|FG001|STARTED|2-year||194
8945796|NCT02407457|10007712|FG000|COMPLETED|2-year||184
8945797|NCT02407457|10007713|FG001|COMPLETED|2-year||159
8945798|NCT02407457|10007712|FG000|NOT COMPLETED|2-year||34
8945799|NCT02407457|10007713|FG001|NOT COMPLETED|2-year||35
8945800|NCT02407457|10007712|FG000|STARTED|3-year||198
8945801|NCT02407457|10007713|FG001|STARTED|3-year||175
8945802|NCT02407457|10007712|FG000|COMPLETED|3-year||156
8945803|NCT02407457|10007713|FG001|COMPLETED|3-year||137
8945804|NCT02407457|10007712|FG000|NOT COMPLETED|3-year||42
8945805|NCT02407457|10007713|FG001|NOT COMPLETED|3-year||38
8945806|NCT02407457|10007712|FG000|STARTED|4-year||181
8945807|NCT02407457|10007713|FG001|STARTED|4-year||156
8945808|NCT02407457|10007712|FG000|COMPLETED|4-year||100
8945809|NCT02407457|10007713|FG001|COMPLETED|4-year||95
8945810|NCT02407457|10007712|FG000|NOT COMPLETED|4-year||81
8945811|NCT02407457|10007713|FG001|NOT COMPLETED|4-year||61
8945812|NCT02407457|10007712|FG000|STARTED|5-year||123
8945813|NCT02407457|10007713|FG001|STARTED|5-year||113
8945814|NCT02407457|10007712|FG000|COMPLETED|5-year|Due to the time frame of the study - subjects have not passed 5-year.|31
8945815|NCT02407457|10007713|FG001|COMPLETED|5-year||36
8945816|NCT02407457|10007712|FG000|NOT COMPLETED|5-year||92
8945817|NCT02407457|10007713|FG001|NOT COMPLETED|5-year||77
8945818|NCT02407704|10007723|FG000|STARTED|Overall Study||2
8945819|NCT02407704|10007724|FG001|STARTED|Overall Study||3
8945820|NCT02407704|10007725|FG002|STARTED|Overall Study||5
8945821|NCT02407704|10007726|FG003|STARTED|Overall Study||5
8945822|NCT02407704|10007723|FG000|COMPLETED|Overall Study||2
8945823|NCT02407704|10007724|FG001|COMPLETED|Overall Study||3
8945824|NCT02407704|10007725|FG002|COMPLETED|Overall Study||4
8945825|NCT02407704|10007726|FG003|COMPLETED|Overall Study||2
8945826|NCT02407704|10007723|FG000|NOT COMPLETED|Overall Study||0
8945827|NCT02407704|10007724|FG001|NOT COMPLETED|Overall Study||0
8945828|NCT02407704|10007725|FG002|NOT COMPLETED|Overall Study||1
8945829|NCT02407704|10007726|FG003|NOT COMPLETED|Overall Study||3
8945830|NCT02407756|10007744|FG000|STARTED|Overall Study||20
8945831|NCT02407756|10007745|FG001|STARTED|Overall Study||18
8945832|NCT02407756|10007746|FG002|STARTED|Overall Study||20
8945833|NCT02407756|10007747|FG003|STARTED|Overall Study||19
8945834|NCT02407756|10007744|FG000|Treated|Overall Study||20
8945835|NCT02407756|10007745|FG001|Treated|Overall Study||18
8945836|NCT02407756|10007746|FG002|Treated|Overall Study||20
8945837|NCT02407756|10007747|FG003|Treated|Overall Study||19
8945838|NCT02407756|10007744|FG000|COMPLETED|Overall Study||20
8945839|NCT02407756|10007745|FG001|COMPLETED|Overall Study||18
8945840|NCT02407756|10007746|FG002|COMPLETED|Overall Study||20
8945841|NCT02407756|10007747|FG003|COMPLETED|Overall Study||19
8945842|NCT02407756|10007744|FG000|NOT COMPLETED|Overall Study||0
8945843|NCT02407756|10007745|FG001|NOT COMPLETED|Overall Study||0
8945844|NCT02407756|10007746|FG002|NOT COMPLETED|Overall Study||0
8945845|NCT02407756|10007747|FG003|NOT COMPLETED|Overall Study||0
8945846|NCT02407990|10007765|FG000|STARTED|Overall Study||3
8945847|NCT02407990|10007766|FG001|STARTED|Overall Study||26
8945848|NCT02407990|10007767|FG002|STARTED|Overall Study||26
8945849|NCT02407990|10007768|FG003|STARTED|Overall Study||7
8945850|NCT02407990|10007769|FG004|STARTED|Overall Study||21
8945851|NCT02407990|10007770|FG005|STARTED|Overall Study||20
8945852|NCT02407990|10007771|FG006|STARTED|Overall Study||13
8945853|NCT02407990|10007772|FG007|STARTED|Overall Study||335
8945854|NCT02407990|10007765|FG000|COMPLETED|Overall Study||0
8945855|NCT02407990|10007766|FG001|COMPLETED|Overall Study||0
8945856|NCT02407990|10007767|FG002|COMPLETED|Overall Study||0
8945857|NCT02407990|10007768|FG003|COMPLETED|Overall Study||0
8945858|NCT02407990|10007769|FG004|COMPLETED|Overall Study||0
8945859|NCT02407990|10007770|FG005|COMPLETED|Overall Study||0
8945860|NCT02407990|10007771|FG006|COMPLETED|Overall Study||0
8945861|NCT02407990|10007772|FG007|COMPLETED|Overall Study||0
8945862|NCT02407990|10007765|FG000|NOT COMPLETED|Overall Study||3
8945863|NCT02407990|10007766|FG001|NOT COMPLETED|Overall Study||26
8945864|NCT02407990|10007767|FG002|NOT COMPLETED|Overall Study||26
8945865|NCT02407990|10007768|FG003|NOT COMPLETED|Overall Study||7
8945866|NCT02407990|10007769|FG004|NOT COMPLETED|Overall Study||21
8945867|NCT02407990|10007770|FG005|NOT COMPLETED|Overall Study||20
8945868|NCT02407990|10007771|FG006|NOT COMPLETED|Overall Study||13
8945869|NCT02407990|10007772|FG007|NOT COMPLETED|Overall Study||335
8945870|NCT02408016|10007799|FG000|STARTED|Overall Study||6
8945871|NCT02408016|10007800|FG001|STARTED|Overall Study||4
8945872|NCT02408016|10007801|FG002|STARTED|Overall Study||0
8945873|NCT02408016|10007799|FG000|COMPLETED|Overall Study||0
8945874|NCT02408016|10007800|FG001|COMPLETED|Overall Study||1
8945875|NCT02408016|10007801|FG002|COMPLETED|Overall Study||0
8945876|NCT02408016|10007799|FG000|NOT COMPLETED|Overall Study||6
8945877|NCT02408016|10007800|FG001|NOT COMPLETED|Overall Study||3
8945878|NCT02408016|10007801|FG002|NOT COMPLETED|Overall Study||0
8945879|NCT02408120|10007811|FG000|STARTED|Overall Study||112
8945880|NCT02408120|10007812|FG001|STARTED|Overall Study||112
8945881|NCT02408120|10007811|FG000|COMPLETED|Overall Study||108
8945882|NCT02408120|10007812|FG001|COMPLETED|Overall Study||107
8945883|NCT02408120|10007811|FG000|NOT COMPLETED|Overall Study||4
8945884|NCT02408120|10007812|FG001|NOT COMPLETED|Overall Study||5
8945885|NCT02408198|10007820|FG000|STARTED|Overall Study||13
8945886|NCT02408198|10007821|FG001|STARTED|Overall Study||5
8945887|NCT02408198|10007820|FG000|COMPLETED|Overall Study||10
8945888|NCT02408198|10007821|FG001|COMPLETED|Overall Study||5
8945889|NCT02408198|10007820|FG000|NOT COMPLETED|Overall Study||3
8945890|NCT02408198|10007821|FG001|NOT COMPLETED|Overall Study||0
8945891|NCT02408263|10007827|FG000|STARTED|Overall Study||25
8945892|NCT02408263|10007828|FG001|STARTED|Overall Study||25
8945893|NCT02408263|10007827|FG000|COMPLETED|Overall Study||25
8945894|NCT02408263|10007828|FG001|COMPLETED|Overall Study||25
8945895|NCT02408263|10007827|FG000|NOT COMPLETED|Overall Study||0
8945896|NCT02408263|10007828|FG001|NOT COMPLETED|Overall Study||0
8945897|NCT02408445|10007835|FG000|STARTED|Overall Study||10
8945898|NCT02408445|10007836|FG001|STARTED|Overall Study||10
8945899|NCT02408445|10007835|FG000|COMPLETED|Overall Study||10
8945900|NCT02408445|10007836|FG001|COMPLETED|Overall Study||10
8945901|NCT02408445|10007835|FG000|NOT COMPLETED|Overall Study||0
8945902|NCT02408445|10007836|FG001|NOT COMPLETED|Overall Study||0
8945903|NCT02408484|10007841|FG000|STARTED|Overall Study||15
8945904|NCT02408484|10007841|FG000|SAF Population|Overall Study||14
8945905|NCT02408484|10007841|FG000|FAS Population|Overall Study||14
8945906|NCT02408484|10007841|FG000|PK Population|Overall Study||13
8945907|NCT02408484|10007841|FG000|firstBLEED Population|Overall Study||8
8945908|NCT02408484|10007841|FG000|BLEED Population|Overall Study||8
8945909|NCT02408484|10007841|FG000|SURG Population|Overall Study||3
8945910|NCT02408484|10007841|FG000|COMPLETED|Overall Study||11
8945911|NCT02408484|10007841|FG000|NOT COMPLETED|Overall Study||4
8945912|NCT02408523|10007863|FG000|STARTED|Overall Study||121
8945913|NCT02408523|10007864|FG001|STARTED|Overall Study||121
8945914|NCT02408523|10007863|FG000|Completed Treatment Period|Overall Study||110
8945915|NCT02408523|10007864|FG001|Completed Treatment Period|Overall Study||103
8945916|NCT02408523|10007863|FG000|Enrolled Transition Period|Overall Study||108
8945917|NCT02408523|10007864|FG001|Enrolled Transition Period|Overall Study||101
8945918|NCT02408523|10007863|FG000|Enrolled Taper Period|Overall Study||7
8945919|NCT02408523|10007864|FG001|Enrolled Taper Period|Overall Study||9
8945920|NCT02408523|10007863|FG000|Enrolled Safety Folllow-up Period|Overall Study||10
8945921|NCT02408523|10007864|FG001|Enrolled Safety Folllow-up Period|Overall Study||11
8945922|NCT02408523|10007863|FG000|COMPLETED|Overall Study||110
8945923|NCT02408523|10007864|FG001|COMPLETED|Overall Study||103
8945924|NCT02408523|10007863|FG000|NOT COMPLETED|Overall Study||11
8945925|NCT02408523|10007864|FG001|NOT COMPLETED|Overall Study||18
8945926|NCT02408692|10007881|FG000|STARTED|Overall Study||5
8945927|NCT02408692|10007882|FG001|STARTED|Overall Study||5
8945928|NCT02408692|10007883|FG002|STARTED|Overall Study||5
8945929|NCT02408692|10007881|FG000|COMPLETED|Overall Study||5
8945930|NCT02408692|10007882|FG001|COMPLETED|Overall Study||5
8945931|NCT02408692|10007883|FG002|COMPLETED|Overall Study||5
8945932|NCT02408692|10007881|FG000|NOT COMPLETED|Overall Study||0
8945933|NCT02408692|10007882|FG001|NOT COMPLETED|Overall Study||0
8945934|NCT02408692|10007883|FG002|NOT COMPLETED|Overall Study||0
8945935|NCT02408796|10007891|FG000|STARTED|Overall Study||39
8945936|NCT02408796|10007891|FG000|COMPLETED|Overall Study||39
8945937|NCT02408796|10007891|FG000|NOT COMPLETED|Overall Study||0
8945938|NCT02408965|10007897|FG000|STARTED|Overall Study||140
8945939|NCT02408965|10007898|FG001|STARTED|Overall Study||144
8945940|NCT02408965|10007897|FG000|COMPLETED|Overall Study||140
8945941|NCT02408965|10007898|FG001|COMPLETED|Overall Study||144
8945942|NCT02408965|10007897|FG000|NOT COMPLETED|Overall Study||0
8945943|NCT02408965|10007898|FG001|NOT COMPLETED|Overall Study||0
8945944|NCT02409277|10007907|FG000|STARTED|Overall Study||267
8945945|NCT02409277|10007908|FG001|STARTED|Overall Study||60
8945946|NCT02409277|10007909|FG002|STARTED|Overall Study||599
8945947|NCT02409277|10007907|FG000|3 Months Follow-up|Overall Study||178
8945948|NCT02409277|10007908|FG001|3 Months Follow-up|Overall Study||40
8945949|NCT02409277|10007909|FG002|3 Months Follow-up|Overall Study||599
8945950|NCT02409277|10007907|FG000|6 Months Follow-up|Overall Study||182
8945951|NCT02409277|10007908|FG001|6 Months Follow-up|Overall Study||42
8945952|NCT02409277|10007909|FG002|6 Months Follow-up|Overall Study||599
8945953|NCT02409277|10007907|FG000|12 Months Follow-up|Overall Study||167
8945954|NCT02409277|10007908|FG001|12 Months Follow-up|Overall Study||43
8945955|NCT02409277|10007909|FG002|12 Months Follow-up|Overall Study||599
8945956|NCT02409277|10007907|FG000|COMPLETED|Overall Study||167
8945957|NCT02409277|10007908|FG001|COMPLETED|Overall Study||43
8945958|NCT02409277|10007909|FG002|COMPLETED|Overall Study||599
8945959|NCT02409277|10007907|FG000|NOT COMPLETED|Overall Study||100
8945960|NCT02409277|10007908|FG001|NOT COMPLETED|Overall Study||17
8945961|NCT02409277|10007909|FG002|NOT COMPLETED|Overall Study||0
8945962|NCT02409329|10007937|FG000|STARTED|Overall Study||127
8945963|NCT02409329|10007938|FG001|STARTED|Overall Study||126
8945964|NCT02409329|10007939|FG002|STARTED|Overall Study||253
8945965|NCT02409329|10007937|FG000|COMPLETED|Overall Study||122
8945966|NCT02409329|10007938|FG001|COMPLETED|Overall Study||120
8945967|NCT02409329|10007939|FG002|COMPLETED|Overall Study||244
8945968|NCT02409329|10007937|FG000|NOT COMPLETED|Overall Study||5
8945969|NCT02409329|10007938|FG001|NOT COMPLETED|Overall Study||6
8945970|NCT02409329|10007939|FG002|NOT COMPLETED|Overall Study||9
8945971|NCT02409459|10007950|FG000|STARTED|Overall Study||41
8945972|NCT02409459|10007951|FG001|STARTED|Overall Study||40
8945973|NCT02409459|10007950|FG000|COMPLETED|Overall Study||40
8945974|NCT02409459|10007951|FG001|COMPLETED|Overall Study||39
8945975|NCT02409459|10007950|FG000|NOT COMPLETED|Overall Study||1
8945976|NCT02409459|10007951|FG001|NOT COMPLETED|Overall Study||1
8945977|NCT02409667|10007957|FG000|STARTED|Treatment Period 1, Baseline to Week 24||1647
8945978|NCT02409667|10007958|FG001|STARTED|Treatment Period 1, Baseline to Week 24||0
8945979|NCT02409667|10007959|FG002|STARTED|Treatment Period 1, Baseline to Week 24||0
8945980|NCT02409667|10007960|FG003|STARTED|Treatment Period 1, Baseline to Week 24||0
8945981|NCT02409667|10007961|FG004|STARTED|Treatment Period 1, Baseline to Week 24||0
8945982|NCT02409667|10007957|FG000|COMPLETED|Treatment Period 1, Baseline to Week 24||1526
8945983|NCT02409667|10007958|FG001|COMPLETED|Treatment Period 1, Baseline to Week 24||0
8945984|NCT02409667|10007959|FG002|COMPLETED|Treatment Period 1, Baseline to Week 24||0
8945985|NCT02409667|10007960|FG003|COMPLETED|Treatment Period 1, Baseline to Week 24||0
8945986|NCT02409667|10007961|FG004|COMPLETED|Treatment Period 1, Baseline to Week 24||0
8945987|NCT02409667|10007957|FG000|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||121
8945988|NCT02409667|10007958|FG001|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||0
8945989|NCT02409667|10007959|FG002|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||0
8945990|NCT02409667|10007960|FG003|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||0
8945991|NCT02409667|10007961|FG004|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||0
8945992|NCT02409667|10007957|FG000|STARTED|Treatment Period 2, Week 24 to Week 52)||0
8945993|NCT02409667|10007958|FG001|STARTED|Treatment Period 2, Week 24 to Week 52)||644
8945994|NCT02409667|10007959|FG002|STARTED|Treatment Period 2, Week 24 to Week 52)||662
8945995|NCT02409667|10007960|FG003|STARTED|Treatment Period 2, Week 24 to Week 52)||114
8945996|NCT02409667|10007961|FG004|STARTED|Treatment Period 2, Week 24 to Week 52)||93
8945997|NCT02409667|10007957|FG000|COMPLETED|Treatment Period 2, Week 24 to Week 52)||0
8945998|NCT02409667|10007958|FG001|COMPLETED|Treatment Period 2, Week 24 to Week 52)||621
8945999|NCT02409667|10007959|FG002|COMPLETED|Treatment Period 2, Week 24 to Week 52)||641
8946000|NCT02409667|10007960|FG003|COMPLETED|Treatment Period 2, Week 24 to Week 52)||106
8946001|NCT02409667|10007961|FG004|COMPLETED|Treatment Period 2, Week 24 to Week 52)||90
8946002|NCT02409667|10007957|FG000|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||0
8946003|NCT02409667|10007958|FG001|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||23
8946004|NCT02409667|10007959|FG002|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||21
8946005|NCT02409667|10007960|FG003|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||8
8946006|NCT02409667|10007961|FG004|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||3
8946007|NCT02409680|10007974|FG000|STARTED|Overall Study||5990
8946008|NCT02409680|10007975|FG001|STARTED|Overall Study||5986
8946009|NCT02409680|10007974|FG000|Treated|Overall Study||5943
8946010|NCT02409680|10007975|FG001|Treated|Overall Study||5936
8946011|NCT02409680|10007974|FG000|Included in mITT Analysis|Overall Study||5787
8946012|NCT02409680|10007975|FG001|Included in mITT Analysis|Overall Study||5771
8946013|NCT02409680|10007974|FG000|COMPLETED|Overall Study||5975
8946014|NCT02409680|10007975|FG001|COMPLETED|Overall Study||5956
8946015|NCT02409680|10007974|FG000|NOT COMPLETED|Overall Study||15
8946016|NCT02409680|10007975|FG001|NOT COMPLETED|Overall Study||30
8946017|NCT02409719|10007983|FG000|STARTED|Overall Study||31
8946018|NCT02409719|10007984|FG001|STARTED|Overall Study||45
8946019|NCT02409719|10007983|FG000|2 Weeks|Overall Study||28
8946020|NCT02409719|10007984|FG001|2 Weeks|Overall Study||42
8946021|NCT02409719|10007983|FG000|4 Weeks|Overall Study||28
8946022|NCT02409719|10007984|FG001|4 Weeks|Overall Study||42
8946023|NCT02409719|10007983|FG000|6 Weeks|Overall Study||28
8946024|NCT02409719|10007984|FG001|6 Weeks|Overall Study||42
8946025|NCT02409719|10007983|FG000|3 Months|Overall Study||28
8946026|NCT02409719|10007984|FG001|3 Months|Overall Study||42
8946027|NCT02409719|10007983|FG000|6 Months|Overall Study||28
8946028|NCT02409719|10007984|FG001|6 Months|Overall Study||42
8946029|NCT02409719|10007983|FG000|12 Months|Overall Study||28
8946030|NCT02409719|10007984|FG001|12 Months|Overall Study||42
8946031|NCT02409719|10007983|FG000|COMPLETED|Overall Study||28
8946032|NCT02409719|10007984|FG001|COMPLETED|Overall Study||42
8946033|NCT02409719|10007983|FG000|NOT COMPLETED|Overall Study||3
8946034|NCT02409719|10007984|FG001|NOT COMPLETED|Overall Study||3
8946035|NCT02409732|10007990|FG000|STARTED|Overall Study|First patient consented on 4/23/15|20
8946036|NCT02409732|10007990|FG000|COMPLETED|Overall Study||14
8946037|NCT02409732|10007990|FG000|NOT COMPLETED|Overall Study||6
8946038|NCT02409784|10007995|FG000|STARTED|Overall Study||10
8946039|NCT02409784|10007995|FG000|COMPLETED|Overall Study||10
8946040|NCT02409784|10007995|FG000|NOT COMPLETED|Overall Study||0
8946041|NCT02409914|10008000|FG000|STARTED|Overall Study||7
8946042|NCT02409914|10008000|FG000|COMPLETED|Overall Study||7
8946043|NCT02409914|10008000|FG000|NOT COMPLETED|Overall Study||0
8946044|NCT02409927|10008004|FG000|STARTED|Overall Study||10
8946045|NCT02409927|10008004|FG000|COMPLETED|Overall Study||10
8946046|NCT02409927|10008004|FG000|NOT COMPLETED|Overall Study||0
8946047|NCT02410018|10008010|FG000|STARTED|Overall Study||2
8946048|NCT02410018|10008011|FG001|STARTED|Overall Study||1
8946049|NCT02410018|10008010|FG000|COMPLETED|Overall Study||2
8946050|NCT02410018|10008011|FG001|COMPLETED|Overall Study||1
8946051|NCT02410018|10008010|FG000|NOT COMPLETED|Overall Study||0
8946052|NCT02410018|10008011|FG001|NOT COMPLETED|Overall Study||0
8946053|NCT02410161|10008019|FG000|STARTED|Overall Study||10
8946054|NCT02410161|10008020|FG001|STARTED|Overall Study||10
8946055|NCT02410161|10008019|FG000|COMPLETED|Overall Study||10
8946056|NCT02410161|10008020|FG001|COMPLETED|Overall Study||10
8946057|NCT02410161|10008019|FG000|NOT COMPLETED|Overall Study||0
8946058|NCT02410161|10008020|FG001|NOT COMPLETED|Overall Study||0
8946059|NCT02410200|10008026|FG000|STARTED|Overall Study||22
8946060|NCT02410200|10008026|FG000|COMPLETED|Overall Study||20
8946061|NCT02410200|10008026|FG000|NOT COMPLETED|Overall Study||2
8946062|NCT02410213|10008030|FG000|STARTED|Overall Study||16
8946063|NCT02410213|10008031|FG001|STARTED|Overall Study||19
8946064|NCT02410213|10008030|FG000|COMPLETED|Overall Study||16
8946065|NCT02410213|10008031|FG001|COMPLETED|Overall Study||19
8946066|NCT02410213|10008030|FG000|NOT COMPLETED|Overall Study||0
8946067|NCT02410213|10008031|FG001|NOT COMPLETED|Overall Study||0
8946068|NCT02410252|10008037|FG000|STARTED|Overall Study||25
8946069|NCT02410252|10008037|FG000|COMPLETED|Overall Study||19
8946070|NCT02410252|10008037|FG000|NOT COMPLETED|Overall Study||6
8946071|NCT02410278|10008045|FG000|STARTED|Run-in Period||102
8946072|NCT02410278|10008046|FG001|STARTED|Run-in Period||0
8946073|NCT02410278|10008047|FG002|STARTED|Run-in Period||0
8946074|NCT02410278|10008045|FG000|Received at Least 1 Dose of DMF|Run-in Period||98
8946075|NCT02410278|10008046|FG001|Received at Least 1 Dose of DMF|Run-in Period||0
8946076|NCT02410278|10008047|FG002|Received at Least 1 Dose of DMF|Run-in Period||0
8946077|NCT02410278|10008045|FG000|COMPLETED|Run-in Period||64
8946078|NCT02410278|10008046|FG001|COMPLETED|Run-in Period||0
8946079|NCT02410278|10008047|FG002|COMPLETED|Run-in Period||0
8946080|NCT02410278|10008045|FG000|NOT COMPLETED|Run-in Period||38
8946081|NCT02410278|10008046|FG001|NOT COMPLETED|Run-in Period||0
8946082|NCT02410278|10008047|FG002|NOT COMPLETED|Run-in Period||0
8946083|NCT02410278|10008045|FG000|STARTED|Study Treatment Period||0
8946084|NCT02410278|10008046|FG001|STARTED|Study Treatment Period||31
8946085|NCT02410278|10008047|FG002|STARTED|Study Treatment Period||33
8946086|NCT02410278|10008045|FG000|Modified Intent-to Treat(mITT)Population|Study Treatment Period||0
8946087|NCT02410278|10008046|FG001|Modified Intent-to Treat(mITT)Population|Study Treatment Period||30
8946088|NCT02410278|10008047|FG002|Modified Intent-to Treat(mITT)Population|Study Treatment Period||33
8946089|NCT02410278|10008045|FG000|Completed Randomized Study Treatment|Study Treatment Period||0
8946090|NCT02410278|10008046|FG001|Completed Randomized Study Treatment|Study Treatment Period||20
8946091|NCT02410278|10008047|FG002|Completed Randomized Study Treatment|Study Treatment Period||29
8946092|NCT02410278|10008045|FG000|COMPLETED|Study Treatment Period||0
8946093|NCT02410278|10008046|FG001|COMPLETED|Study Treatment Period||20
8946094|NCT02410278|10008047|FG002|COMPLETED|Study Treatment Period||29
8946095|NCT02410278|10008045|FG000|NOT COMPLETED|Study Treatment Period||0
8946096|NCT02410278|10008046|FG001|NOT COMPLETED|Study Treatment Period||11
8946097|NCT02410278|10008047|FG002|NOT COMPLETED|Study Treatment Period||4
8946098|NCT02410291|10008056|FG000|STARTED|Overall Study||29
8946099|NCT02410291|10008057|FG001|STARTED|Overall Study||29
8946100|NCT02410291|10008056|FG000|COMPLETED|Overall Study||29
8946101|NCT02410291|10008057|FG001|COMPLETED|Overall Study||29
8946102|NCT02410291|10008056|FG000|NOT COMPLETED|Overall Study||0
8946103|NCT02410291|10008057|FG001|NOT COMPLETED|Overall Study||0
8946104|NCT02410382|10008065|FG000|STARTED|Overall Study||0
8946105|NCT02410382|10008066|FG001|STARTED|Overall Study||0
8946106|NCT02410382|10008065|FG000|COMPLETED|Overall Study|Study was terminated by IRB - attempts made to obtain info were unsuccessful.|0
8946107|NCT02410382|10008066|FG001|COMPLETED|Overall Study||0
8946108|NCT02410382|10008065|FG000|NOT COMPLETED|Overall Study||0
8946109|NCT02410382|10008066|FG001|NOT COMPLETED|Overall Study||0
8946110|NCT02410629|10008074|FG000|STARTED|Overall Study||8
8946111|NCT02410629|10008075|FG001|STARTED|Overall Study||9
8946112|NCT02410629|10008074|FG000|COMPLETED|Overall Study|5 subjects from the music glove group were crossed over to conventional hand exercise group.|5
8946113|NCT02410629|10008075|FG001|COMPLETED|Overall Study|6 subjects from the conventional hand exercise group were crossed over to music glove group.|6
8946114|NCT02410629|10008074|FG000|NOT COMPLETED|Overall Study||3
8946115|NCT02410629|10008075|FG001|NOT COMPLETED|Overall Study||3
8946116|NCT02410707|10008081|FG000|STARTED|Overall Study||43
8946117|NCT02410707|10008081|FG000|COMPLETED|Overall Study||43
8946118|NCT02410707|10008081|FG000|NOT COMPLETED|Overall Study||0
8946119|NCT02410772|10008090|FG000|STARTED|Overall Study||829
8946120|NCT02410772|10008091|FG001|STARTED|Overall Study||838
8946121|NCT02410772|10008092|FG002|STARTED|Overall Study||849
8946122|NCT02410772|10008090|FG000|Microbiologically Eligible Analysis Population|Overall Study||768
8946123|NCT02410772|10008091|FG001|Microbiologically Eligible Analysis Population|Overall Study||784
8946124|NCT02410772|10008092|FG002|Microbiologically Eligible Analysis Population|Overall Study||791
8946125|NCT02410772|10008090|FG000|Assessable Population|Overall Study||726
8946126|NCT02410772|10008091|FG001|Assessable Population|Overall Study||752
8946127|NCT02410772|10008092|FG002|Assessable Population|Overall Study||756
8946128|NCT02410772|10008090|FG000|COMPLETED|Overall Study||726
8946129|NCT02410772|10008091|FG001|COMPLETED|Overall Study||752
8946130|NCT02410772|10008092|FG002|COMPLETED|Overall Study||756
8946131|NCT02410772|10008090|FG000|NOT COMPLETED|Overall Study||103
8946132|NCT02410772|10008091|FG001|NOT COMPLETED|Overall Study||86
8946133|NCT02410772|10008092|FG002|NOT COMPLETED|Overall Study||93
8946134|NCT02410798|10008100|FG000|STARTED|Overall Study||12
8946135|NCT02410798|10008100|FG000|COMPLETED|Overall Study||12
8946136|NCT02410798|10008100|FG000|NOT COMPLETED|Overall Study||0
8946137|NCT02410811|10008109|FG000|STARTED|Overall Study||5
8946138|NCT02410811|10008110|FG001|STARTED|Overall Study||10
8946139|NCT02410811|10008111|FG002|STARTED|Overall Study||11
8946140|NCT02410811|10008112|FG003|STARTED|Overall Study||7
8946141|NCT02410811|10008109|FG000|COMPLETED|Overall Study||5
8946142|NCT02410811|10008110|FG001|COMPLETED|Overall Study||10
8946143|NCT02410811|10008111|FG002|COMPLETED|Overall Study||10
8946144|NCT02410811|10008112|FG003|COMPLETED|Overall Study||7
8946145|NCT02410811|10008109|FG000|NOT COMPLETED|Overall Study||0
8946146|NCT02410811|10008110|FG001|NOT COMPLETED|Overall Study||0
8946147|NCT02410811|10008111|FG002|NOT COMPLETED|Overall Study||1
8946148|NCT02410811|10008112|FG003|NOT COMPLETED|Overall Study||0
8946149|NCT02410824|10008122|FG000|STARTED|First Intervention (One Week)||22
8946150|NCT02410824|10008123|FG001|STARTED|First Intervention (One Week)||23
8946151|NCT02410824|10008122|FG000|COMPLETED|First Intervention (One Week)||22
8946152|NCT02410824|10008123|FG001|COMPLETED|First Intervention (One Week)||22
8946153|NCT02410824|10008122|FG000|NOT COMPLETED|First Intervention (One Week)||0
8946154|NCT02410824|10008123|FG001|NOT COMPLETED|First Intervention (One Week)||1
8946155|NCT02410824|10008122|FG000|STARTED|Second Intervention (One Week)||22
8946156|NCT02410824|10008123|FG001|STARTED|Second Intervention (One Week)||22
8946157|NCT02410824|10008122|FG000|COMPLETED|Second Intervention (One Week)||22
8946158|NCT02410824|10008123|FG001|COMPLETED|Second Intervention (One Week)||22
8946159|NCT02410824|10008122|FG000|NOT COMPLETED|Second Intervention (One Week)||0
8946160|NCT02410824|10008123|FG001|NOT COMPLETED|Second Intervention (One Week)||0
8946161|NCT02410837|10008130|FG000|STARTED|Overall Study||1388
8946162|NCT02410837|10008130|FG000|Procedure|Overall Study||1388
8946163|NCT02410837|10008130|FG000|1-Month|Overall Study||1374
8946164|NCT02410837|10008130|FG000|12-Month|Overall Study||1121
8946165|NCT02410837|10008130|FG000|24-Month|Overall Study||900
8946166|NCT02410837|10008130|FG000|COMPLETED|Overall Study||900
8946167|NCT02410837|10008130|FG000|NOT COMPLETED|Overall Study||488
8946168|NCT02410967|10008136|FG000|STARTED|Treatment Phase (4 Weeks)||27
8946169|NCT02410967|10008137|FG001|STARTED|Treatment Phase (4 Weeks)||26
8946170|NCT02410967|10008136|FG000|COMPLETED|Treatment Phase (4 Weeks)||26
8946171|NCT02410967|10008137|FG001|COMPLETED|Treatment Phase (4 Weeks)||22
8946172|NCT02410967|10008136|FG000|NOT COMPLETED|Treatment Phase (4 Weeks)||1
8946173|NCT02410967|10008137|FG001|NOT COMPLETED|Treatment Phase (4 Weeks)||4
8946174|NCT02410967|10008136|FG000|STARTED|Follow-up Phase (8 Weeks)||26
8946175|NCT02410967|10008137|FG001|STARTED|Follow-up Phase (8 Weeks)||22
8946176|NCT02410967|10008136|FG000|COMPLETED|Follow-up Phase (8 Weeks)||22
8946177|NCT02410967|10008137|FG001|COMPLETED|Follow-up Phase (8 Weeks)||16
8946178|NCT02410967|10008136|FG000|NOT COMPLETED|Follow-up Phase (8 Weeks)||4
8946179|NCT02410967|10008137|FG001|NOT COMPLETED|Follow-up Phase (8 Weeks)||6
8946180|NCT02411084|10008145|FG000|STARTED|Overall Study||18
8946181|NCT02411084|10008146|FG001|STARTED|Overall Study||18
8946182|NCT02411084|10008145|FG000|COMPLETED|Overall Study||5
8946183|NCT02411084|10008146|FG001|COMPLETED|Overall Study||5
8946184|NCT02411084|10008145|FG000|NOT COMPLETED|Overall Study||13
8946185|NCT02411084|10008146|FG001|NOT COMPLETED|Overall Study||13
8946186|NCT02411110|10008154|FG000|STARTED|Treatment Period 1||65
8946187|NCT02411110|10008155|FG001|STARTED|Treatment Period 1||66
8946188|NCT02411110|10008154|FG000|COMPLETED|Treatment Period 1||56
8946189|NCT02411110|10008155|FG001|COMPLETED|Treatment Period 1||59
8946190|NCT02411110|10008154|FG000|NOT COMPLETED|Treatment Period 1||9
8946191|NCT02411110|10008155|FG001|NOT COMPLETED|Treatment Period 1||7
8946192|NCT02411110|10008154|FG000|STARTED|Treatment Period 2|Period 2 was optional.|50
8946193|NCT02411110|10008155|FG001|STARTED|Treatment Period 2|Period 2 was optional.|48
8946194|NCT02411110|10008154|FG000|COMPLETED|Treatment Period 2||49
8946195|NCT02411110|10008155|FG001|COMPLETED|Treatment Period 2||44
8946196|NCT02411110|10008154|FG000|NOT COMPLETED|Treatment Period 2||1
8946197|NCT02411110|10008155|FG001|NOT COMPLETED|Treatment Period 2||4
8946198|NCT02411201|10008163|FG000|STARTED|Overall Study||51
8946199|NCT02411201|10008163|FG000|COMPLETED|Overall Study||45
8946200|NCT02411201|10008163|FG000|NOT COMPLETED|Overall Study||6
8946201|NCT02411292|10008169|FG000|STARTED|Overall Study||110
8946202|NCT02411292|10008169|FG000|COMPLETED|Overall Study||89
8946203|NCT02411292|10008169|FG000|NOT COMPLETED|Overall Study||21
8946204|NCT02411396|10008175|FG000|STARTED|Overall Study||483
8946205|NCT02411396|10008175|FG000|COMPLETED|Overall Study||442
8946206|NCT02411396|10008175|FG000|NOT COMPLETED|Overall Study||41
8946207|NCT02411461|10008187|FG000|STARTED|Overall Study||16
8946208|NCT02411461|10008188|FG001|STARTED|Overall Study||8
8946209|NCT02411461|10008189|FG002|STARTED|Overall Study||15
8946210|NCT02411461|10008187|FG000|COMPLETED|Overall Study||16
8946211|NCT02411461|10008188|FG001|COMPLETED|Overall Study||8
8946212|NCT02411461|10008189|FG002|COMPLETED|Overall Study||15
8946213|NCT02411461|10008187|FG000|NOT COMPLETED|Overall Study||0
8623328|NCT00492752|9662557|FG002|COMPLETED|Follow-up and/or Open Label Sorafenib|20 participants were followed up until the end of this trial|20
8623329|NCT00492752|9662558|FG003|COMPLETED|Follow-up and/or Open Label Sorafenib||0
8623330|NCT00492752|9662555|FG000|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||86
8946214|NCT02411461|10008188|FG001|NOT COMPLETED|Overall Study||0
8946215|NCT02411461|10008189|FG002|NOT COMPLETED|Overall Study||0
8946216|NCT02411539|10008199|FG000|STARTED|Overall Study||20
8946217|NCT02411539|10008200|FG001|STARTED|Overall Study||20
8946218|NCT02411539|10008199|FG000|COMPLETED|Overall Study||18
8946219|NCT02411539|10008200|FG001|COMPLETED|Overall Study||19
8946220|NCT02411539|10008199|FG000|NOT COMPLETED|Overall Study||2
8946221|NCT02411539|10008200|FG001|NOT COMPLETED|Overall Study||1
8946222|NCT02411565|10008211|FG000|STARTED|Overall Study||1
8946223|NCT02411565|10008212|FG001|STARTED|Overall Study||2
8946224|NCT02411565|10008211|FG000|COMPLETED|Overall Study||1
8946225|NCT02411565|10008212|FG001|COMPLETED|Overall Study||2
8946226|NCT02411565|10008211|FG000|NOT COMPLETED|Overall Study||0
8946227|NCT02411565|10008212|FG001|NOT COMPLETED|Overall Study||0
8946228|NCT02411578|10008220|FG000|STARTED|Crossover Trial Phase||8
8946229|NCT02411578|10008221|FG001|STARTED|Crossover Trial Phase||12
8946230|NCT02411578|10008220|FG000|COMPLETED|Crossover Trial Phase||8
8946231|NCT02411578|10008221|FG001|COMPLETED|Crossover Trial Phase||11
8946232|NCT02411578|10008220|FG000|NOT COMPLETED|Crossover Trial Phase||0
8946233|NCT02411578|10008221|FG001|NOT COMPLETED|Crossover Trial Phase||1
8946234|NCT02411578|10008220|FG000|STARTED|Extension Phase||8
8946235|NCT02411578|10008221|FG001|STARTED|Extension Phase|2 Crossover Trial participants could not continue due to study syringes expiration|9
8946236|NCT02411578|10008220|FG000|COMPLETED|Extension Phase||8
8946237|NCT02411578|10008221|FG001|COMPLETED|Extension Phase||9
8946238|NCT02411578|10008220|FG000|NOT COMPLETED|Extension Phase||0
8946239|NCT02411578|10008221|FG001|NOT COMPLETED|Extension Phase||0
8946240|NCT02411591|10008232|FG000|STARTED|Overall Study||3
8946241|NCT02411591|10008233|FG001|STARTED|Overall Study||57
8946242|NCT02411591|10008234|FG002|STARTED|Overall Study||6
8946243|NCT02411591|10008232|FG000|Part A|Overall Study||3
8946244|NCT02411591|10008233|FG001|Part A|Overall Study||6
8946245|NCT02411591|10008234|FG002|Part A|Overall Study||6
8946246|NCT02411591|10008232|FG000|Expansion Cohort Part B|Overall Study||0
8946247|NCT02411591|10008233|FG001|Expansion Cohort Part B|Overall Study||51
8946248|NCT02411591|10008234|FG002|Expansion Cohort Part B|Overall Study||0
8946249|NCT02411591|10008232|FG000|Progressive Disease|Overall Study||3
8946250|NCT02411591|10008233|FG001|Progressive Disease|Overall Study||42
8946251|NCT02411591|10008234|FG002|Progressive Disease|Overall Study||3
8946252|NCT02411591|10008232|FG000|Death|Overall Study||0
8946253|NCT02411591|10008233|FG001|Death|Overall Study||2
8946254|NCT02411591|10008234|FG002|Death|Overall Study||0
8946255|NCT02411591|10008232|FG000|COMPLETED|Overall Study||3
8946256|NCT02411591|10008233|FG001|COMPLETED|Overall Study||47
8946257|NCT02411591|10008234|FG002|COMPLETED|Overall Study||3
8946258|NCT02411591|10008232|FG000|NOT COMPLETED|Overall Study||0
8946259|NCT02411591|10008233|FG001|NOT COMPLETED|Overall Study||10
8946260|NCT02411591|10008234|FG002|NOT COMPLETED|Overall Study||3
8946261|NCT02411747|10008252|FG000|STARTED|Overall Study||16
8946262|NCT02411747|10008253|FG001|STARTED|Overall Study||16
8946263|NCT02411747|10008252|FG000|Simulation Training Completed|Overall Study||16
8946264|NCT02411747|10008253|FG001|Simulation Training Completed|Overall Study||16
8946265|NCT02411747|10008252|FG000|COMPLETED|Overall Study||13
8946266|NCT02411747|10008253|FG001|COMPLETED|Overall Study||12
8946267|NCT02411747|10008252|FG000|NOT COMPLETED|Overall Study||3
8946268|NCT02411747|10008253|FG001|NOT COMPLETED|Overall Study||4
8946269|NCT02411916|10008261|FG000|STARTED|Overall Study||73
8946270|NCT02411916|10008262|FG001|STARTED|Overall Study||70
8946271|NCT02411916|10008261|FG000|COMPLETED|Overall Study||73
8946272|NCT02411916|10008262|FG001|COMPLETED|Overall Study||70
8946273|NCT02411916|10008261|FG000|NOT COMPLETED|Overall Study||0
8946274|NCT02411916|10008262|FG001|NOT COMPLETED|Overall Study||0
8946275|NCT02411929|10008268|FG000|STARTED|Period 1||8
8946276|NCT02411929|10008268|FG000|COMPLETED|Period 1||8
8946277|NCT02411929|10008268|FG000|NOT COMPLETED|Period 1||0
8946278|NCT02411929|10008268|FG000|STARTED|Washout Period||8
8946279|NCT02411929|10008268|FG000|COMPLETED|Washout Period||8
8946280|NCT02411929|10008268|FG000|NOT COMPLETED|Washout Period||0
8946281|NCT02411929|10008268|FG000|STARTED|Period 2||8
8946282|NCT02411929|10008268|FG000|COMPLETED|Period 2||8
8946283|NCT02411929|10008268|FG000|NOT COMPLETED|Period 2||0
8946284|NCT02412098|10008280|FG000|STARTED|Overall Study||14
8946285|NCT02412098|10008281|FG001|STARTED|Overall Study||14
8623331|NCT00492752|9662556|FG001|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||16
8629670|NCT00531050|9669382|FG001|COMPLETED|Part 2: Period 2||4
8946286|NCT02412098|10008282|FG002|STARTED|Overall Study||21
8946287|NCT02412098|10008280|FG000|COMPLETED|Overall Study||14
8946288|NCT02412098|10008281|FG001|COMPLETED|Overall Study||14
8946289|NCT02412098|10008282|FG002|COMPLETED|Overall Study||21
8946290|NCT02412098|10008280|FG000|NOT COMPLETED|Overall Study||0
8946291|NCT02412098|10008281|FG001|NOT COMPLETED|Overall Study||0
8946292|NCT02412098|10008282|FG002|NOT COMPLETED|Overall Study||0
8946293|NCT02412111|10008296|FG000|STARTED|Ivacaftor Run-in Period (4 Weeks)||156
8946294|NCT02412111|10008297|FG001|STARTED|Ivacaftor Run-in Period (4 Weeks)||0
8946295|NCT02412111|10008298|FG002|STARTED|Ivacaftor Run-in Period (4 Weeks)||0
8946296|NCT02412111|10008296|FG000|COMPLETED|Ivacaftor Run-in Period (4 Weeks)||153
8946297|NCT02412111|10008297|FG001|COMPLETED|Ivacaftor Run-in Period (4 Weeks)||0
8946298|NCT02412111|10008298|FG002|COMPLETED|Ivacaftor Run-in Period (4 Weeks)||0
8946299|NCT02412111|10008296|FG000|NOT COMPLETED|Ivacaftor Run-in Period (4 Weeks)||3
8946300|NCT02412111|10008297|FG001|NOT COMPLETED|Ivacaftor Run-in Period (4 Weeks)||0
8946301|NCT02412111|10008298|FG002|NOT COMPLETED|Ivacaftor Run-in Period (4 Weeks)||0
8946302|NCT02412111|10008296|FG000|STARTED|Active Comparator Period (8 Weeks)||0
8946303|NCT02412111|10008297|FG001|STARTED|Active Comparator Period (8 Weeks)||76
8946304|NCT02412111|10008298|FG002|STARTED|Active Comparator Period (8 Weeks)||75
8946305|NCT02412111|10008296|FG000|Full Analysis Set|Active Comparator Period (8 Weeks)||0
8946306|NCT02412111|10008297|FG001|Full Analysis Set|Active Comparator Period (8 Weeks)||76
8946307|NCT02412111|10008298|FG002|Full Analysis Set|Active Comparator Period (8 Weeks)||74
8946308|NCT02412111|10008296|FG000|COMPLETED|Active Comparator Period (8 Weeks)||0
8946309|NCT02412111|10008297|FG001|COMPLETED|Active Comparator Period (8 Weeks)||75
8946310|NCT02412111|10008298|FG002|COMPLETED|Active Comparator Period (8 Weeks)||69
8623332|NCT00492752|9662557|FG002|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||47
8623333|NCT00492752|9662558|FG003|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||6
8623334|NCT00492856|9662565|FG000|STARTED|Induction||105
8623335|NCT00492856|9662566|FG001|STARTED|Induction||0
8623336|NCT00492856|9662567|FG002|STARTED|Induction||0
8946311|NCT02412111|10008296|FG000|NOT COMPLETED|Active Comparator Period (8 Weeks)||0
8946312|NCT02412111|10008297|FG001|NOT COMPLETED|Active Comparator Period (8 Weeks)||1
8946313|NCT02412111|10008298|FG002|NOT COMPLETED|Active Comparator Period (8 Weeks)||6
8946314|NCT02412228|10008308|FG000|STARTED|Overall Study||12
8946315|NCT02412228|10008308|FG000|COMPLETED|Overall Study||12
8946316|NCT02412228|10008308|FG000|NOT COMPLETED|Overall Study||0
8946317|NCT02412306|10008317|FG000|STARTED|Overall Study||5
8946318|NCT02412306|10008318|FG001|STARTED|Overall Study||9
8946319|NCT02412306|10008319|FG002|STARTED|Overall Study||21
8946320|NCT02412306|10008320|FG003|STARTED|Overall Study||14
8946321|NCT02412306|10008321|FG004|STARTED|Overall Study||17
8946322|NCT02412306|10008317|FG000|COMPLETED|Overall Study||0
8946323|NCT02412306|10008318|FG001|COMPLETED|Overall Study||1
8946324|NCT02412306|10008319|FG002|COMPLETED|Overall Study||5
8946325|NCT02412306|10008320|FG003|COMPLETED|Overall Study||14
8946326|NCT02412306|10008321|FG004|COMPLETED|Overall Study||15
8946327|NCT02412306|10008317|FG000|NOT COMPLETED|Overall Study||5
8946328|NCT02412306|10008318|FG001|NOT COMPLETED|Overall Study||8
8946329|NCT02412306|10008319|FG002|NOT COMPLETED|Overall Study||16
8946330|NCT02412306|10008320|FG003|NOT COMPLETED|Overall Study||0
8946331|NCT02412306|10008321|FG004|NOT COMPLETED|Overall Study||2
8946332|NCT02412371|10008348|FG000|STARTED|Overall Study||7
8946333|NCT02412371|10008349|FG001|STARTED|Overall Study||9
8946334|NCT02412371|10008350|FG002|STARTED|Overall Study||7
8946335|NCT02412371|10008351|FG003|STARTED|Overall Study||8
8946336|NCT02412371|10008352|FG004|STARTED|Overall Study||12
8946337|NCT02412371|10008353|FG005|STARTED|Overall Study||5
8946338|NCT02412371|10008348|FG000|COMPLETED|Overall Study||0
8946339|NCT02412371|10008349|FG001|COMPLETED|Overall Study||0
8946340|NCT02412371|10008350|FG002|COMPLETED|Overall Study||0
8946341|NCT02412371|10008351|FG003|COMPLETED|Overall Study||0
8946342|NCT02412371|10008352|FG004|COMPLETED|Overall Study||0
8946343|NCT02412371|10008353|FG005|COMPLETED|Overall Study||0
8946344|NCT02412371|10008348|FG000|NOT COMPLETED|Overall Study||7
8946345|NCT02412371|10008349|FG001|NOT COMPLETED|Overall Study||9
8946346|NCT02412371|10008350|FG002|NOT COMPLETED|Overall Study||7
8946347|NCT02412371|10008351|FG003|NOT COMPLETED|Overall Study||8
8946348|NCT02412371|10008352|FG004|NOT COMPLETED|Overall Study||12
8946349|NCT02412371|10008353|FG005|NOT COMPLETED|Overall Study||5
8946350|NCT02412436|10008368|FG000|STARTED|Overall Study||62
8946351|NCT02412436|10008368|FG000|COMPLETED|Overall Study||44
8946352|NCT02412436|10008368|FG000|NOT COMPLETED|Overall Study||18
8946353|NCT02412488|10008372|FG000|STARTED|Overall Study||192
8946354|NCT02412488|10008372|FG000|Reveal LINQ Implanted|Overall Study||191
8946355|NCT02412488|10008372|FG000|COMPLETED|Overall Study||174
8946356|NCT02412488|10008372|FG000|NOT COMPLETED|Overall Study||18
8946357|NCT02412501|10008376|FG000|STARTED|Overall Study||101
8946358|NCT02412501|10008376|FG000|COMPLETED|Overall Study||101
8946359|NCT02412501|10008376|FG000|NOT COMPLETED|Overall Study||0
8946360|NCT02412631|10008383|FG000|STARTED|Overall Study||44
8623337|NCT00492856|9662568|FG003|STARTED|Induction||0
8623338|NCT00492856|9662565|FG000|COMPLETED|Induction||99
8623339|NCT00492856|9662566|FG001|COMPLETED|Induction||0
8946361|NCT02412631|10008384|FG001|STARTED|Overall Study||40
8946362|NCT02412631|10008383|FG000|COMPLETED|Overall Study||18
8946363|NCT02412631|10008384|FG001|COMPLETED|Overall Study||16
8946364|NCT02412631|10008383|FG000|NOT COMPLETED|Overall Study||26
8946365|NCT02412631|10008384|FG001|NOT COMPLETED|Overall Study||24
8946366|NCT02412644|10008392|FG000|STARTED|Overall Study||21
8946367|NCT02412644|10008393|FG001|STARTED|Overall Study||8
8946368|NCT02412644|10008392|FG000|COMPLETED|Overall Study||6
8623340|NCT00492856|9662567|FG002|COMPLETED|Induction||0
8946369|NCT02412644|10008393|FG001|COMPLETED|Overall Study||4
8946370|NCT02412644|10008392|FG000|NOT COMPLETED|Overall Study||15
8946371|NCT02412644|10008393|FG001|NOT COMPLETED|Overall Study||4
8946372|NCT02412657|10008406|FG000|STARTED|Overall Study||25
8946373|NCT02412657|10008407|FG001|STARTED|Overall Study||25
8946374|NCT02412657|10008408|FG002|STARTED|Overall Study||25
8946375|NCT02412657|10008406|FG000|COMPLETED|Overall Study||24
8946376|NCT02412657|10008407|FG001|COMPLETED|Overall Study||23
8946377|NCT02412657|10008408|FG002|COMPLETED|Overall Study||22
8946378|NCT02412657|10008406|FG000|NOT COMPLETED|Overall Study||1
8946379|NCT02412657|10008407|FG001|NOT COMPLETED|Overall Study||2
8946380|NCT02412657|10008408|FG002|NOT COMPLETED|Overall Study||3
8946381|NCT02412722|10008422|FG000|STARTED|Overall Study||11
8946382|NCT02412722|10008423|FG001|STARTED|Overall Study||8
8946383|NCT02412722|10008424|FG002|STARTED|Overall Study||7
8946384|NCT02412722|10008425|FG003|STARTED|Overall Study||15
8946385|NCT02412722|10008426|FG004|STARTED|Overall Study||7
8946386|NCT02412722|10008427|FG005|STARTED|Overall Study||13
8946387|NCT02412722|10008422|FG000|Safety Population|Overall Study||11
8946388|NCT02412722|10008423|FG001|Safety Population|Overall Study||6
8946389|NCT02412722|10008424|FG002|Safety Population|Overall Study||7
8946390|NCT02412722|10008425|FG003|Safety Population|Overall Study||15
8946391|NCT02412722|10008426|FG004|Safety Population|Overall Study||7
8946392|NCT02412722|10008427|FG005|Safety Population|Overall Study||13
8946393|NCT02412722|10008422|FG000|COMPLETED|Overall Study||0
9066105|NCT04117607|10126522|FG011|NOT COMPLETED|Overall Study||0
9066106|NCT04117607|10126523|FG012|NOT COMPLETED|Overall Study||0
9066107|NCT04117607|10126524|FG013|NOT COMPLETED|Overall Study||0
9066108|NCT04116684|10126542|FG000|STARTED|Overall Study||3
9066109|NCT04116684|10126543|FG001|STARTED|Overall Study||1
9066110|NCT04116684|10126542|FG000|COMPLETED|Overall Study||1
9066111|NCT04116684|10126543|FG001|COMPLETED|Overall Study||1
9066112|NCT04116684|10126542|FG000|NOT COMPLETED|Overall Study||2
9066113|NCT04116684|10126543|FG001|NOT COMPLETED|Overall Study||0
9066114|NCT04096365|10126549|FG000|STARTED|Overall Study||12
9066115|NCT04096365|10126549|FG000|COMPLETED|Overall Study||11
9066116|NCT04096365|10126549|FG000|NOT COMPLETED|Overall Study||1
9066117|NCT04080297|10126555|FG000|STARTED|Overall Study||10
9066118|NCT04080297|10126556|FG001|STARTED|Overall Study||11
9066119|NCT04080297|10126555|FG000|COMPLETED|Overall Study||8
9066120|NCT04080297|10126556|FG001|COMPLETED|Overall Study||8
9066121|NCT04080297|10126555|FG000|NOT COMPLETED|Overall Study||2
9066122|NCT04080297|10126556|FG001|NOT COMPLETED|Overall Study||3
9066123|NCT04115358|10126565|FG000|STARTED|Overall Study||34
9066124|NCT04115358|10126566|FG001|STARTED|Overall Study||33
9066125|NCT04115358|10126567|FG002|STARTED|Overall Study||34
9066126|NCT04115358|10126565|FG000|COMPLETED|Overall Study|34 participants 48 teeth for clinical assessment, 28 participants 35 teeth for radiographic assessment.|34
9066127|NCT04115358|10126566|FG001|COMPLETED|Overall Study|33 participants 40 teeth for clinical assessment, 26 participants 32 teeth for radiographic assessment.|33
9066128|NCT04115358|10126567|FG002|COMPLETED|Overall Study|34 participants 38 teeth for clinical assessment, 26 participants 31 teeth for radiographic assessment.|33
9066129|NCT04115358|10126565|FG000|NOT COMPLETED|Overall Study||0
9066130|NCT04115358|10126566|FG001|NOT COMPLETED|Overall Study||0
9066131|NCT04115358|10126567|FG002|NOT COMPLETED|Overall Study||1
9066132|NCT04114058|10126578|FG000|STARTED|Overall Study||20
9066133|NCT04114058|10126579|FG001|STARTED|Overall Study||17
9066134|NCT04114058|10126578|FG000|COMPLETED|Overall Study||20
9066135|NCT04114058|10126579|FG001|COMPLETED|Overall Study||17
9066136|NCT04114058|10126578|FG000|NOT COMPLETED|Overall Study||0
9066137|NCT04114058|10126579|FG001|NOT COMPLETED|Overall Study||0
9066138|NCT04113785|10126585|FG000|STARTED|Overall Study||21
9066139|NCT04113785|10126585|FG000|COMPLETED|Overall Study||21
9066140|NCT04113785|10126585|FG000|NOT COMPLETED|Overall Study||0
9066141|NCT04113694|10126591|FG000|STARTED|Overall Study||259
9066142|NCT04113694|10126591|FG000|COMPLETED|Overall Study||248
9066143|NCT04113694|10126591|FG000|NOT COMPLETED|Overall Study||11
9066144|NCT04112160|10126600|FG000|STARTED|Overall Study||63
9066145|NCT04112160|10126601|FG001|STARTED|Overall Study||62
9066146|NCT04112160|10126600|FG000|COMPLETED|Overall Study||62
9066147|NCT04112160|10126601|FG001|COMPLETED|Overall Study||62
9066148|NCT04112160|10126600|FG000|NOT COMPLETED|Overall Study||1
9066149|NCT04112160|10126601|FG001|NOT COMPLETED|Overall Study||0
9066150|NCT04112069|10126607|FG000|STARTED|Overall Study||10
9066151|NCT04112069|10126608|FG001|STARTED|Overall Study||10
9066152|NCT04112069|10126607|FG000|COMPLETED|Overall Study||10
9066153|NCT04112069|10126608|FG001|COMPLETED|Overall Study||10
9066154|NCT04112069|10126607|FG000|NOT COMPLETED|Overall Study||0
9066155|NCT04112069|10126608|FG001|NOT COMPLETED|Overall Study||0
9066156|NCT04109703|10126616|FG000|STARTED|Overall Study||49
9066157|NCT04109703|10126617|FG001|STARTED|Overall Study||51
9066158|NCT04109703|10126616|FG000|COMPLETED|Overall Study||49
9066159|NCT04109703|10126617|FG001|COMPLETED|Overall Study||51
9066160|NCT04109703|10126616|FG000|NOT COMPLETED|Overall Study||0
8946394|NCT02412722|10008423|FG001|COMPLETED|Overall Study||0
8946395|NCT02412722|10008424|FG002|COMPLETED|Overall Study||0
8946396|NCT02412722|10008425|FG003|COMPLETED|Overall Study||0
8946397|NCT02412722|10008426|FG004|COMPLETED|Overall Study||0
9066161|NCT04109703|10126617|FG001|NOT COMPLETED|Overall Study||0
9066162|NCT04109443|10126627|FG000|STARTED|Overall Study||77
9066163|NCT04109443|10126628|FG001|STARTED|Overall Study||77
9066164|NCT04109443|10126627|FG000|COMPLETED|Overall Study||67
8946398|NCT02412722|10008427|FG005|COMPLETED|Overall Study||0
8946399|NCT02412722|10008422|FG000|NOT COMPLETED|Overall Study||11
8946400|NCT02412722|10008423|FG001|NOT COMPLETED|Overall Study||8
8946401|NCT02412722|10008424|FG002|NOT COMPLETED|Overall Study||7
8946402|NCT02412722|10008425|FG003|NOT COMPLETED|Overall Study||15
9066165|NCT04109443|10126628|FG001|COMPLETED|Overall Study||65
9066166|NCT04109443|10126627|FG000|NOT COMPLETED|Overall Study||10
8946403|NCT02412722|10008426|FG004|NOT COMPLETED|Overall Study||7
8946404|NCT02412722|10008427|FG005|NOT COMPLETED|Overall Study||13
8946405|NCT02412761|10008461|FG000|STARTED|First Intervention (2 Weeks)||5
8946406|NCT02412761|10008462|FG001|STARTED|First Intervention (2 Weeks)||6
8946407|NCT02412761|10008463|FG002|STARTED|First Intervention (2 Weeks)||5
8946408|NCT02412761|10008464|FG003|STARTED|First Intervention (2 Weeks)||8
8946409|NCT02412761|10008465|FG004|STARTED|First Intervention (2 Weeks)||4
8946410|NCT02412761|10008466|FG005|STARTED|First Intervention (2 Weeks)||7
8946411|NCT02412761|10008461|FG000|COMPLETED|First Intervention (2 Weeks)||5
8946412|NCT02412761|10008462|FG001|COMPLETED|First Intervention (2 Weeks)||5
8946413|NCT02412761|10008463|FG002|COMPLETED|First Intervention (2 Weeks)||4
8946414|NCT02412761|10008464|FG003|COMPLETED|First Intervention (2 Weeks)||8
8946415|NCT02412761|10008465|FG004|COMPLETED|First Intervention (2 Weeks)||4
8946416|NCT02412761|10008466|FG005|COMPLETED|First Intervention (2 Weeks)||6
8946417|NCT02412761|10008461|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0
8946418|NCT02412761|10008462|FG001|NOT COMPLETED|First Intervention (2 Weeks)||1
8946419|NCT02412761|10008463|FG002|NOT COMPLETED|First Intervention (2 Weeks)||1
8946420|NCT02412761|10008464|FG003|NOT COMPLETED|First Intervention (2 Weeks)||0
8623341|NCT00492856|9662568|FG003|COMPLETED|Induction||0
8842910|NCT01701258|9897269|FG011|COMPLETED|Assessment and Scheduling||0
8946421|NCT02412761|10008465|FG004|NOT COMPLETED|First Intervention (2 Weeks)||0
8946422|NCT02412761|10008466|FG005|NOT COMPLETED|First Intervention (2 Weeks)||1
8946423|NCT02412761|10008461|FG000|STARTED|Second Intervention (2 Weeks)||5
8946424|NCT02412761|10008462|FG001|STARTED|Second Intervention (2 Weeks)||5
8946425|NCT02412761|10008463|FG002|STARTED|Second Intervention (2 Weeks)||4
8946426|NCT02412761|10008464|FG003|STARTED|Second Intervention (2 Weeks)||8
8946427|NCT02412761|10008465|FG004|STARTED|Second Intervention (2 Weeks)||4
8946428|NCT02412761|10008466|FG005|STARTED|Second Intervention (2 Weeks)||6
8946429|NCT02412761|10008461|FG000|COMPLETED|Second Intervention (2 Weeks)||5
8946430|NCT02412761|10008462|FG001|COMPLETED|Second Intervention (2 Weeks)||5
8946431|NCT02412761|10008463|FG002|COMPLETED|Second Intervention (2 Weeks)||4
8946432|NCT02412761|10008464|FG003|COMPLETED|Second Intervention (2 Weeks)||8
8946433|NCT02412761|10008465|FG004|COMPLETED|Second Intervention (2 Weeks)||4
8946434|NCT02412761|10008466|FG005|COMPLETED|Second Intervention (2 Weeks)||6
8946435|NCT02412761|10008461|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0
8946436|NCT02412761|10008462|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0
8946437|NCT02412761|10008463|FG002|NOT COMPLETED|Second Intervention (2 Weeks)||0
8946438|NCT02412761|10008464|FG003|NOT COMPLETED|Second Intervention (2 Weeks)||0
8842911|NCT01701258|9897270|FG012|COMPLETED|Assessment and Scheduling||0
8842912|NCT01701258|9897258|FG000|NOT COMPLETED|Assessment and Scheduling||83
8842913|NCT01701258|9897259|FG001|NOT COMPLETED|Assessment and Scheduling||0
8842914|NCT01701258|9897260|FG002|NOT COMPLETED|Assessment and Scheduling||0
8946439|NCT02412761|10008465|FG004|NOT COMPLETED|Second Intervention (2 Weeks)||0
8946440|NCT02412761|10008466|FG005|NOT COMPLETED|Second Intervention (2 Weeks)||0
8946441|NCT02412761|10008461|FG000|STARTED|Third Intervention (2 Weeks)||5
8946442|NCT02412761|10008462|FG001|STARTED|Third Intervention (2 Weeks)||5
8946443|NCT02412761|10008463|FG002|STARTED|Third Intervention (2 Weeks)||4
8946444|NCT02412761|10008464|FG003|STARTED|Third Intervention (2 Weeks)||8
8946445|NCT02412761|10008465|FG004|STARTED|Third Intervention (2 Weeks)||4
8946446|NCT02412761|10008466|FG005|STARTED|Third Intervention (2 Weeks)||6
8946447|NCT02412761|10008461|FG000|COMPLETED|Third Intervention (2 Weeks)||5
8946448|NCT02412761|10008462|FG001|COMPLETED|Third Intervention (2 Weeks)||5
8946449|NCT02412761|10008463|FG002|COMPLETED|Third Intervention (2 Weeks)||4
8946450|NCT02412761|10008464|FG003|COMPLETED|Third Intervention (2 Weeks)||8
8946451|NCT02412761|10008465|FG004|COMPLETED|Third Intervention (2 Weeks)||4
8946452|NCT02412761|10008466|FG005|COMPLETED|Third Intervention (2 Weeks)||6
8946453|NCT02412761|10008461|FG000|NOT COMPLETED|Third Intervention (2 Weeks)||0
8946454|NCT02412761|10008462|FG001|NOT COMPLETED|Third Intervention (2 Weeks)||0
8842915|NCT01701258|9897261|FG003|NOT COMPLETED|Assessment and Scheduling||0
8842916|NCT01701258|9897262|FG004|NOT COMPLETED|Assessment and Scheduling||0
8842917|NCT01701258|9897263|FG005|NOT COMPLETED|Assessment and Scheduling||0
8842918|NCT01701258|9897264|FG006|NOT COMPLETED|Assessment and Scheduling||0
8842919|NCT01701258|9897265|FG007|NOT COMPLETED|Assessment and Scheduling||0
8842920|NCT01701258|9897266|FG008|NOT COMPLETED|Assessment and Scheduling||0
8842921|NCT01701258|9897267|FG009|NOT COMPLETED|Assessment and Scheduling||0
8842922|NCT01701258|9897268|FG010|NOT COMPLETED|Assessment and Scheduling||0
8842923|NCT01701258|9897269|FG011|NOT COMPLETED|Assessment and Scheduling||0
8842924|NCT01701258|9897270|FG012|NOT COMPLETED|Assessment and Scheduling||0
8842925|NCT01701258|9897258|FG000|STARTED|Drug+fMRI (Session 2)||0
8842926|NCT01701258|9897259|FG001|STARTED|Drug+fMRI (Session 2)||0
8842927|NCT01701258|9897260|FG002|STARTED|Drug+fMRI (Session 2)||11
8842928|NCT01701258|9897261|FG003|STARTED|Drug+fMRI (Session 2)||11
8842929|NCT01701258|9897262|FG004|STARTED|Drug+fMRI (Session 2)||0
8842930|NCT01701258|9897263|FG005|STARTED|Drug+fMRI (Session 2)||9
8842931|NCT01701258|9897264|FG006|STARTED|Drug+fMRI (Session 2)||8
8842932|NCT01701258|9897265|FG007|STARTED|Drug+fMRI (Session 2)||0
8842933|NCT01701258|9897266|FG008|STARTED|Drug+fMRI (Session 2)||6
8842934|NCT01701258|9897267|FG009|STARTED|Drug+fMRI (Session 2)||6
8842935|NCT01701258|9897268|FG010|STARTED|Drug+fMRI (Session 2)||0
8842936|NCT01701258|9897269|FG011|STARTED|Drug+fMRI (Session 2)||10
8842937|NCT01701258|9897270|FG012|STARTED|Drug+fMRI (Session 2)||7
8946455|NCT02412761|10008463|FG002|NOT COMPLETED|Third Intervention (2 Weeks)||0
8946456|NCT02412761|10008464|FG003|NOT COMPLETED|Third Intervention (2 Weeks)||0
8946457|NCT02412761|10008465|FG004|NOT COMPLETED|Third Intervention (2 Weeks)||0
8946458|NCT02412761|10008466|FG005|NOT COMPLETED|Third Intervention (2 Weeks)||0
8946459|NCT02412852|10008478|FG000|STARTED|Overall Study||4
8946460|NCT02412852|10008479|FG001|STARTED|Overall Study||8
8946461|NCT02412852|10008480|FG002|STARTED|Overall Study||5
8946462|NCT02412852|10008481|FG003|STARTED|Overall Study||9
8946463|NCT02412852|10008478|FG000|COMPLETED|Overall Study||4
8946464|NCT02412852|10008479|FG001|COMPLETED|Overall Study||7
8946465|NCT02412852|10008480|FG002|COMPLETED|Overall Study||5
8946466|NCT02412852|10008481|FG003|COMPLETED|Overall Study||8
8946467|NCT02412852|10008478|FG000|NOT COMPLETED|Overall Study||0
8946468|NCT02412852|10008479|FG001|NOT COMPLETED|Overall Study||1
8946469|NCT02412852|10008480|FG002|NOT COMPLETED|Overall Study||0
8946470|NCT02412852|10008481|FG003|NOT COMPLETED|Overall Study||1
8946471|NCT02412878|10008491|FG000|STARTED|Overall Study||238
8946472|NCT02412878|10008492|FG001|STARTED|Overall Study||240
8946473|NCT02412878|10008491|FG000|Received Carfilzomib|Overall Study||235
8946474|NCT02412878|10008492|FG001|Received Carfilzomib|Overall Study||238
8946475|NCT02412878|10008491|FG000|COMPLETED|Overall Study||217
8946476|NCT02412878|10008492|FG001|COMPLETED|Overall Study||227
8946477|NCT02412878|10008491|FG000|NOT COMPLETED|Overall Study||21
8946478|NCT02412878|10008492|FG001|NOT COMPLETED|Overall Study||13
8946479|NCT02412956|10008500|FG000|STARTED|Overall Study||44
8946480|NCT02412956|10008501|FG001|STARTED|Overall Study||47
8946481|NCT02412956|10008502|FG002|STARTED|Overall Study||8
8946482|NCT02412956|10008500|FG000|COMPLETED|Overall Study||35
8946483|NCT02412956|10008501|FG001|COMPLETED|Overall Study||30
8946484|NCT02412956|10008502|FG002|COMPLETED|Overall Study||8
8946485|NCT02412956|10008500|FG000|NOT COMPLETED|Overall Study||9
8946486|NCT02412956|10008501|FG001|NOT COMPLETED|Overall Study||17
8946487|NCT02412956|10008502|FG002|NOT COMPLETED|Overall Study||0
8946488|NCT02412982|10008510|FG000|STARTED|Primary Endpoint||51
8946489|NCT02412982|10008511|FG001|STARTED|Primary Endpoint||52
8946490|NCT02412982|10008510|FG000|COMPLETED|Primary Endpoint||47
8946491|NCT02412982|10008511|FG001|COMPLETED|Primary Endpoint||49
8946492|NCT02412982|10008510|FG000|NOT COMPLETED|Primary Endpoint||4
8946493|NCT02412982|10008511|FG001|NOT COMPLETED|Primary Endpoint||3
8946494|NCT02412982|10008510|FG000|STARTED|Intervention Group: Randomization|Control group patients did not undergo randomization (see study protocol section)|0
8946495|NCT02412982|10008511|FG001|STARTED|Intervention Group: Randomization|52 patients in the intervention group underwent 1:1 randomization to the two intervention study arms: 26 patients in 40 mg every 12 hours with escalation to 50 mg every 12 hours and 26 patients in 30 mg every 8 hours.|52
8946496|NCT02412982|10008510|FG000|COMPLETED|Intervention Group: Randomization||0
8946497|NCT02412982|10008511|FG001|COMPLETED|Intervention Group: Randomization||51
8946498|NCT02412982|10008510|FG000|NOT COMPLETED|Intervention Group: Randomization||0
8946499|NCT02412982|10008511|FG001|NOT COMPLETED|Intervention Group: Randomization||1
8946500|NCT02413008|10008519|FG000|STARTED|Overall Study||50
8946501|NCT02413008|10008520|FG001|STARTED|Overall Study||11
8946502|NCT02413008|10008519|FG000|COMPLETED|Overall Study||43
8946503|NCT02413008|10008520|FG001|COMPLETED|Overall Study||9
8946504|NCT02413008|10008519|FG000|NOT COMPLETED|Overall Study||7
8946505|NCT02413008|10008520|FG001|NOT COMPLETED|Overall Study||2
8946506|NCT02413034|10008531|FG000|STARTED|Overall Study||14
8946507|NCT02413034|10008532|FG001|STARTED|Overall Study||14
8946508|NCT02413034|10008531|FG000|COMPLETED|Overall Study||14
8946509|NCT02413034|10008532|FG001|COMPLETED|Overall Study||14
8946510|NCT02413034|10008531|FG000|NOT COMPLETED|Overall Study||0
8946511|NCT02413034|10008532|FG001|NOT COMPLETED|Overall Study||0
8946512|NCT02413151|10008540|FG000|STARTED|Overall Study||32
8946513|NCT02413151|10008541|FG001|STARTED|Overall Study||30
8946514|NCT02413151|10008540|FG000|COMPLETED|Overall Study||22
8946515|NCT02413151|10008541|FG001|COMPLETED|Overall Study||28
8946516|NCT02413151|10008540|FG000|NOT COMPLETED|Overall Study||10
8946517|NCT02413151|10008541|FG001|NOT COMPLETED|Overall Study||2
8946518|NCT02413190|10008548|FG000|STARTED|Overall Study||94
8946519|NCT02413190|10008548|FG000|COMPLETED|Overall Study||94
8946520|NCT02413190|10008548|FG000|NOT COMPLETED|Overall Study||0
8946521|NCT02413203|10008554|FG000|STARTED|Overall Study||10
8946522|NCT02413203|10008555|FG001|STARTED|Overall Study||10
8946523|NCT02413203|10008554|FG000|COMPLETED|Overall Study||10
8946524|NCT02413203|10008555|FG001|COMPLETED|Overall Study||10
8946525|NCT02413203|10008554|FG000|NOT COMPLETED|Overall Study||0
8946526|NCT02413203|10008555|FG001|NOT COMPLETED|Overall Study||0
8946527|NCT02413229|10008569|FG000|STARTED|Overall Study||25
8946528|NCT02413229|10008570|FG001|STARTED|Overall Study||12
8946529|NCT02413229|10008571|FG002|STARTED|Overall Study||26
8946530|NCT02413229|10008572|FG003|STARTED|Overall Study||12
8946531|NCT02413229|10008573|FG004|STARTED|Overall Study||24
8946532|NCT02413229|10008574|FG005|STARTED|Overall Study||12
8946533|NCT02413229|10008575|FG006|STARTED|Overall Study||25
8946534|NCT02413229|10008576|FG007|STARTED|Overall Study||15
8946535|NCT02413229|10008569|FG000|COMPLETED|Overall Study||24
8946536|NCT02413229|10008570|FG001|COMPLETED|Overall Study||11
8946537|NCT02413229|10008571|FG002|COMPLETED|Overall Study||25
8946538|NCT02413229|10008572|FG003|COMPLETED|Overall Study||11
8946539|NCT02413229|10008573|FG004|COMPLETED|Overall Study||21
8946540|NCT02413229|10008574|FG005|COMPLETED|Overall Study||12
8946541|NCT02413229|10008575|FG006|COMPLETED|Overall Study||25
8946542|NCT02413229|10008576|FG007|COMPLETED|Overall Study||11
8946543|NCT02413229|10008569|FG000|NOT COMPLETED|Overall Study||1
8946544|NCT02413229|10008570|FG001|NOT COMPLETED|Overall Study||1
8946545|NCT02413229|10008571|FG002|NOT COMPLETED|Overall Study||1
8946546|NCT02413229|10008572|FG003|NOT COMPLETED|Overall Study||1
8946547|NCT02413229|10008573|FG004|NOT COMPLETED|Overall Study||3
8946548|NCT02413229|10008574|FG005|NOT COMPLETED|Overall Study||0
8946549|NCT02413229|10008575|FG006|NOT COMPLETED|Overall Study||0
8946550|NCT02413229|10008576|FG007|NOT COMPLETED|Overall Study||4
8946551|NCT02413255|10008611|FG000|STARTED|Overall Study||18
8946552|NCT02413255|10008612|FG001|STARTED|Overall Study||6
8946553|NCT02413255|10008613|FG002|STARTED|Overall Study||6
8946554|NCT02413255|10008614|FG003|STARTED|Overall Study||6
8946555|NCT02413255|10008615|FG004|STARTED|Overall Study||6
8946556|NCT02413255|10008616|FG005|STARTED|Overall Study||6
8946557|NCT02413255|10008617|FG006|STARTED|Overall Study||6
8946558|NCT02413255|10008618|FG007|STARTED|Overall Study||6
8946559|NCT02413255|10008619|FG008|STARTED|Overall Study||6
8946560|NCT02413255|10008620|FG009|STARTED|Overall Study||6
8946561|NCT02413255|10008621|FG010|STARTED|Overall Study||12
8946562|NCT02413255|10008622|FG011|STARTED|Overall Study||6
8946563|NCT02413255|10008623|FG012|STARTED|Overall Study||6
8946564|NCT02413255|10008624|FG013|STARTED|Overall Study||6
8946565|NCT02413255|10008625|FG014|STARTED|Overall Study||6
8946566|NCT02413255|10008626|FG015|STARTED|Overall Study||6
8946567|NCT02413255|10008627|FG016|STARTED|Overall Study||6
8946568|NCT02413255|10008611|FG000|COMPLETED|Overall Study||18
8946569|NCT02413255|10008612|FG001|COMPLETED|Overall Study||6
8946570|NCT02413255|10008613|FG002|COMPLETED|Overall Study||6
8946571|NCT02413255|10008614|FG003|COMPLETED|Overall Study||6
8946572|NCT02413255|10008615|FG004|COMPLETED|Overall Study||6
8946573|NCT02413255|10008616|FG005|COMPLETED|Overall Study||6
8946574|NCT02413255|10008617|FG006|COMPLETED|Overall Study||6
8946575|NCT02413255|10008618|FG007|COMPLETED|Overall Study||6
8946576|NCT02413255|10008619|FG008|COMPLETED|Overall Study||6
8946577|NCT02413255|10008620|FG009|COMPLETED|Overall Study||6
8946578|NCT02413255|10008621|FG010|COMPLETED|Overall Study||12
8946579|NCT02413255|10008622|FG011|COMPLETED|Overall Study||6
8946580|NCT02413255|10008623|FG012|COMPLETED|Overall Study||6
8946581|NCT02413255|10008624|FG013|COMPLETED|Overall Study||6
8946582|NCT02413255|10008625|FG014|COMPLETED|Overall Study||5
8946583|NCT02413255|10008626|FG015|COMPLETED|Overall Study||6
8946584|NCT02413255|10008627|FG016|COMPLETED|Overall Study||6
8946585|NCT02413255|10008611|FG000|NOT COMPLETED|Overall Study||0
8946586|NCT02413255|10008612|FG001|NOT COMPLETED|Overall Study||0
8946587|NCT02413255|10008613|FG002|NOT COMPLETED|Overall Study||0
8623342|NCT00492856|9662565|FG000|NOT COMPLETED|Induction||6
8623343|NCT00492856|9662566|FG001|NOT COMPLETED|Induction||0
8623344|NCT00492856|9662567|FG002|NOT COMPLETED|Induction||0
8623345|NCT00492856|9662568|FG003|NOT COMPLETED|Induction||0
8623346|NCT00492856|9662565|FG000|STARTED|Consolidation|Patients in CR (CRm), CRi, or PR after induction, register for consolidation and are eligible.|92
8623347|NCT00492856|9662566|FG001|STARTED|Consolidation||0
8946588|NCT02413255|10008614|FG003|NOT COMPLETED|Overall Study||0
8946589|NCT02413255|10008615|FG004|NOT COMPLETED|Overall Study||0
8946590|NCT02413255|10008616|FG005|NOT COMPLETED|Overall Study||0
8623348|NCT00492856|9662567|FG002|STARTED|Consolidation||0
8623349|NCT00492856|9662568|FG003|STARTED|Consolidation||0
8623350|NCT00492856|9662565|FG000|COMPLETED|Consolidation||83
8623351|NCT00492856|9662566|FG001|COMPLETED|Consolidation||0
8623352|NCT00492856|9662567|FG002|COMPLETED|Consolidation||0
8623353|NCT00492856|9662568|FG003|COMPLETED|Consolidation||0
8623354|NCT00492856|9662565|FG000|NOT COMPLETED|Consolidation||9
8623355|NCT00492856|9662566|FG001|NOT COMPLETED|Consolidation||0
8623356|NCT00492856|9662567|FG002|NOT COMPLETED|Consolidation||0
8623357|NCT00492856|9662568|FG003|NOT COMPLETED|Consolidation||0
8623358|NCT00492856|9662565|FG000|STARTED|Post-consolidation|Patients who achieve CRm, are randomized to the treatment arm, and are eligible.|0
8623359|NCT00492856|9662566|FG001|STARTED|Post-consolidation||41
8946591|NCT02413255|10008617|FG006|NOT COMPLETED|Overall Study||0
8946592|NCT02413255|10008618|FG007|NOT COMPLETED|Overall Study||0
8946593|NCT02413255|10008619|FG008|NOT COMPLETED|Overall Study||0
8946594|NCT02413255|10008620|FG009|NOT COMPLETED|Overall Study||0
8946595|NCT02413255|10008621|FG010|NOT COMPLETED|Overall Study||0
8946596|NCT02413255|10008622|FG011|NOT COMPLETED|Overall Study||0
8946597|NCT02413255|10008623|FG012|NOT COMPLETED|Overall Study||0
8946598|NCT02413255|10008624|FG013|NOT COMPLETED|Overall Study||0
8946599|NCT02413255|10008625|FG014|NOT COMPLETED|Overall Study||1
8623360|NCT00492856|9662567|FG002|STARTED|Post-consolidation||27
8623361|NCT00492856|9662568|FG003|STARTED|Post-consolidation||1
8623362|NCT00492856|9662565|FG000|COMPLETED|Post-consolidation||0
8623363|NCT00492856|9662566|FG001|COMPLETED|Post-consolidation||29
8623364|NCT00492856|9662567|FG002|COMPLETED|Post-consolidation||0
8623365|NCT00492856|9662568|FG003|COMPLETED|Post-consolidation||0
8946600|NCT02413255|10008626|FG015|NOT COMPLETED|Overall Study||0
8946601|NCT02413255|10008627|FG016|NOT COMPLETED|Overall Study||0
8946602|NCT02413294|10008678|FG000|STARTED|Overall Study||12
8946603|NCT02413294|10008678|FG000|COMPLETED|Overall Study||11
8946604|NCT02413294|10008678|FG000|NOT COMPLETED|Overall Study||1
8946605|NCT02413320|10008684|FG000|STARTED|Overall Study||49
8946606|NCT02413320|10008685|FG001|STARTED|Overall Study||52
8946607|NCT02413320|10008684|FG000|COMPLETED|Overall Study||48
8946608|NCT02413320|10008685|FG001|COMPLETED|Overall Study||52
8946609|NCT02413320|10008684|FG000|NOT COMPLETED|Overall Study||1
8946610|NCT02413320|10008685|FG001|NOT COMPLETED|Overall Study||0
8946611|NCT02413333|10008695|FG000|STARTED|Period 1||66
8946612|NCT02413333|10008696|FG001|STARTED|Period 1||66
8946613|NCT02413333|10008695|FG000|Randomized and Treated|Period 1||66
8946614|NCT02413333|10008696|FG001|Randomized and Treated|Period 1||66
8946615|NCT02413333|10008695|FG000|COMPLETED|Period 1||65
8946616|NCT02413333|10008696|FG001|COMPLETED|Period 1||65
8946617|NCT02413333|10008695|FG000|NOT COMPLETED|Period 1||1
8946618|NCT02413333|10008696|FG001|NOT COMPLETED|Period 1||1
8946619|NCT02413333|10008695|FG000|STARTED|Period 2||65
8946620|NCT02413333|10008696|FG001|STARTED|Period 2||65
8946621|NCT02413333|10008695|FG000|COMPLETED|Period 2||64
8946622|NCT02413333|10008696|FG001|COMPLETED|Period 2||65
8946623|NCT02413333|10008695|FG000|NOT COMPLETED|Period 2||1
8946624|NCT02413333|10008696|FG001|NOT COMPLETED|Period 2||0
8946625|NCT02413346|10008704|FG000|STARTED|Overall Study||236
8946626|NCT02413346|10008705|FG001|STARTED|Overall Study||247
8946627|NCT02413346|10008704|FG000|COMPLETED|Overall Study||177
8946628|NCT02413346|10008705|FG001|COMPLETED|Overall Study||177
8946629|NCT02413346|10008704|FG000|NOT COMPLETED|Overall Study||59
8946630|NCT02413346|10008705|FG001|NOT COMPLETED|Overall Study||70
8946631|NCT02413372|10008714|FG000|STARTED|Treatment||25
8946632|NCT02413372|10008715|FG001|STARTED|Treatment||24
8946633|NCT02413372|10008716|FG002|STARTED|Treatment||26
8946634|NCT02413372|10008714|FG000|COMPLETED|Treatment||24
8946635|NCT02413372|10008715|FG001|COMPLETED|Treatment||22
8946636|NCT02413372|10008716|FG002|COMPLETED|Treatment||25
8946637|NCT02413372|10008714|FG000|NOT COMPLETED|Treatment||1
8946638|NCT02413372|10008715|FG001|NOT COMPLETED|Treatment||2
8946639|NCT02413372|10008716|FG002|NOT COMPLETED|Treatment||1
8946640|NCT02413372|10008714|FG000|STARTED|Follow-up||22
8946641|NCT02413372|10008715|FG001|STARTED|Follow-up||21
8946642|NCT02413372|10008716|FG002|STARTED|Follow-up||25
8946643|NCT02413372|10008714|FG000|COMPLETED|Follow-up||20
8946644|NCT02413372|10008715|FG001|COMPLETED|Follow-up||20
8946645|NCT02413372|10008716|FG002|COMPLETED|Follow-up||23
8946646|NCT02413372|10008714|FG000|NOT COMPLETED|Follow-up||2
8946647|NCT02413372|10008715|FG001|NOT COMPLETED|Follow-up||1
8946648|NCT02413372|10008716|FG002|NOT COMPLETED|Follow-up||2
8946649|NCT02413398|10008726|FG000|STARTED|Overall Study||160
8946650|NCT02413398|10008727|FG001|STARTED|Overall Study||161
8946651|NCT02413398|10008726|FG000|COMPLETED|Overall Study||156
8946652|NCT02413398|10008727|FG001|COMPLETED|Overall Study||154
8946653|NCT02413398|10008726|FG000|NOT COMPLETED|Overall Study||4
8946654|NCT02413398|10008727|FG001|NOT COMPLETED|Overall Study||7
8946655|NCT02413463|10008735|FG000|STARTED|Overall Study||30
8946656|NCT02413463|10008736|FG001|STARTED|Overall Study||30
8946657|NCT02413463|10008735|FG000|COMPLETED|Overall Study||25
8946658|NCT02413463|10008736|FG001|COMPLETED|Overall Study||28
8946659|NCT02413463|10008735|FG000|NOT COMPLETED|Overall Study||5
8946660|NCT02413463|10008736|FG001|NOT COMPLETED|Overall Study||2
8946661|NCT02413489|10008745|FG000|STARTED|Overall Study||15
8946662|NCT02413489|10008746|FG001|STARTED|Overall Study||16
8946663|NCT02413489|10008747|FG002|STARTED|Overall Study||5
8946664|NCT02413489|10008745|FG000|COMPLETED|Overall Study||0
8946665|NCT02413489|10008746|FG001|COMPLETED|Overall Study||0
8946666|NCT02413489|10008747|FG002|COMPLETED|Overall Study||0
8946667|NCT02413489|10008745|FG000|NOT COMPLETED|Overall Study||15
8946668|NCT02413489|10008746|FG001|NOT COMPLETED|Overall Study||16
8946669|NCT02413489|10008747|FG002|NOT COMPLETED|Overall Study||5
8946670|NCT02413580|10008755|FG000|STARTED|Overall Study||49
8946671|NCT02413580|10008755|FG000|COMPLETED|Overall Study||46
8946672|NCT02413580|10008755|FG000|NOT COMPLETED|Overall Study||3
8946673|NCT02413593|10008759|FG000|STARTED|Overall Study||111
8946674|NCT02413593|10008759|FG000|COMPLETED|Overall Study||107
8946675|NCT02413593|10008759|FG000|NOT COMPLETED|Overall Study||4
8946676|NCT02413684|10008763|FG000|STARTED|Overall Study||53
8946677|NCT02413684|10008763|FG000|COMPLETED|Overall Study||40
8946678|NCT02413684|10008763|FG000|NOT COMPLETED|Overall Study||13
8946679|NCT02413879|10008767|FG000|STARTED|Overall Study||86
8946680|NCT02413879|10008767|FG000|COMPLETED|Overall Study||86
8946681|NCT02413879|10008767|FG000|NOT COMPLETED|Overall Study||0
8946682|NCT02413918|10008771|FG000|STARTED|Overall Study||41
8946683|NCT02413918|10008771|FG000|COMPLETED|Overall Study||16
8946684|NCT02413918|10008771|FG000|NOT COMPLETED|Overall Study||25
8946685|NCT02413996|10008780|FG000|STARTED|Overall Study||44
8946686|NCT02413996|10008781|FG001|STARTED|Overall Study||41
8946687|NCT02413996|10008780|FG000|COMPLETED|Overall Study||35
8946688|NCT02413996|10008781|FG001|COMPLETED|Overall Study||39
8946689|NCT02413996|10008780|FG000|NOT COMPLETED|Overall Study||9
8946690|NCT02413996|10008781|FG001|NOT COMPLETED|Overall Study||2
8946691|NCT02414204|10008789|FG000|STARTED|Overall Study||2
8946692|NCT02414204|10008790|FG001|STARTED|Overall Study||2
8946693|NCT02414204|10008789|FG000|COMPLETED|Overall Study||2
8946694|NCT02414204|10008790|FG001|COMPLETED|Overall Study||2
8946695|NCT02414204|10008789|FG000|NOT COMPLETED|Overall Study||0
8946696|NCT02414204|10008790|FG001|NOT COMPLETED|Overall Study||0
8946697|NCT02414243|10008798|FG000|STARTED|Overall Study||19
8946698|NCT02414243|10008799|FG001|STARTED|Overall Study||21
8946699|NCT02414243|10008798|FG000|Moved to the Other Group|Overall Study||17
8946700|NCT02414243|10008799|FG001|Moved to the Other Group|Overall Study||20
8946701|NCT02414243|10008798|FG000|Entered Open Challenge at Home|Overall Study||17
8946702|NCT02414243|10008799|FG001|Entered Open Challenge at Home|Overall Study||20
8946703|NCT02414243|10008798|FG000|COMPLETED|Overall Study||13
8946704|NCT02414243|10008799|FG001|COMPLETED|Overall Study||17
8946705|NCT02414243|10008798|FG000|NOT COMPLETED|Overall Study||6
8946706|NCT02414243|10008799|FG001|NOT COMPLETED|Overall Study||4
8946707|NCT02414633|10008806|FG000|STARTED|Overall Study||148
8946708|NCT02414633|10008806|FG000|COMPLETED|Overall Study||148
8946709|NCT02414633|10008806|FG000|NOT COMPLETED|Overall Study||0
8946710|NCT02414828|10008814|FG000|STARTED|Overall Study||11
8946711|NCT02414828|10008815|FG001|STARTED|Overall Study||10
8946712|NCT02414828|10008816|FG002|STARTED|Overall Study||20
8946713|NCT02414828|10008817|FG003|STARTED|Overall Study||31
8946714|NCT02414828|10008814|FG000|COMPLETED|Overall Study||11
8946715|NCT02414828|10008815|FG001|COMPLETED|Overall Study||9
8946716|NCT02414828|10008816|FG002|COMPLETED|Overall Study||19
8946717|NCT02414828|10008817|FG003|COMPLETED|Overall Study||29
8946718|NCT02414828|10008814|FG000|NOT COMPLETED|Overall Study||0
8946719|NCT02414828|10008815|FG001|NOT COMPLETED|Overall Study||1
8946720|NCT02414828|10008816|FG002|NOT COMPLETED|Overall Study||1
8946721|NCT02414828|10008817|FG003|NOT COMPLETED|Overall Study||2
8946722|NCT02414841|10008830|FG000|STARTED|Overall Study||405
8946723|NCT02414841|10008831|FG001|STARTED|Overall Study||208
8946724|NCT02414841|10008830|FG000|COMPLETED|Overall Study||349
8946725|NCT02414841|10008831|FG001|COMPLETED|Overall Study||175
8946726|NCT02414841|10008830|FG000|NOT COMPLETED|Overall Study||56
8946727|NCT02414841|10008831|FG001|NOT COMPLETED|Overall Study||33
8946728|NCT02414854|10008843|FG000|STARTED|Overall Study||317
8946729|NCT02414854|10008844|FG001|STARTED|Overall Study||631
8946730|NCT02414854|10008845|FG002|STARTED|Overall Study||321
8946731|NCT02414854|10008846|FG003|STARTED|Overall Study||633
8946732|NCT02414854|10008843|FG000|Treated|Overall Study|2 got other treatment (1 each dupilumab 200+300) than assigned + were allocated to those in AE table|315
8946733|NCT02414854|10008844|FG001|Treated|Overall Study||629
8946734|NCT02414854|10008845|FG002|Treated|Overall Study||321
8946735|NCT02414854|10008846|FG003|Treated|Overall Study|1 got other treatment (dupilumab 200) than assigned + was allocated to that in AE table|632
8946736|NCT02414854|10008843|FG000|COMPLETED|Overall Study||295
8946737|NCT02414854|10008844|FG001|COMPLETED|Overall Study||586
8946738|NCT02414854|10008845|FG002|COMPLETED|Overall Study||301
8946739|NCT02414854|10008846|FG003|COMPLETED|Overall Study||582
8946740|NCT02414854|10008843|FG000|NOT COMPLETED|Overall Study||22
8946741|NCT02414854|10008844|FG001|NOT COMPLETED|Overall Study||45
8946742|NCT02414854|10008845|FG002|NOT COMPLETED|Overall Study||20
8946743|NCT02414854|10008846|FG003|NOT COMPLETED|Overall Study||51
8946744|NCT02414932|10008858|FG000|STARTED|Overall Study||3
8946745|NCT02414932|10008859|FG001|STARTED|Overall Study||3
8946746|NCT02414932|10008858|FG000|COMPLETED|Overall Study||0
8946747|NCT02414932|10008859|FG001|COMPLETED|Overall Study||0
8946748|NCT02414932|10008858|FG000|NOT COMPLETED|Overall Study||3
8946749|NCT02414932|10008859|FG001|NOT COMPLETED|Overall Study||3
8946750|NCT02414958|10008868|FG000|STARTED|Overall Study||243
8946751|NCT02414958|10008869|FG001|STARTED|Overall Study||243
8946752|NCT02414958|10008870|FG002|STARTED|Overall Study||244
8946753|NCT02414958|10008868|FG000|COMPLETED|Overall Study||211
8946754|NCT02414958|10008869|FG001|COMPLETED|Overall Study||223
8946755|NCT02414958|10008870|FG002|COMPLETED|Overall Study||230
8946756|NCT02414958|10008868|FG000|NOT COMPLETED|Overall Study||32
8946757|NCT02414958|10008869|FG001|NOT COMPLETED|Overall Study||20
8946758|NCT02414958|10008870|FG002|NOT COMPLETED|Overall Study||14
8948782|NCT02432287|10011256|FG000|COMPLETED|Washout Period||7
8948783|NCT02432287|10011257|FG001|COMPLETED|Washout Period||7
8948784|NCT02432287|10011256|FG000|NOT COMPLETED|Washout Period||0
8948785|NCT02432287|10011257|FG001|NOT COMPLETED|Washout Period||0
8948786|NCT02432287|10011256|FG000|STARTED|Second Intervention||7
8948787|NCT02432287|10011257|FG001|STARTED|Second Intervention||7
8948788|NCT02432287|10011256|FG000|COMPLETED|Second Intervention||7
8948789|NCT02432287|10011257|FG001|COMPLETED|Second Intervention||7
8948790|NCT02432287|10011256|FG000|NOT COMPLETED|Second Intervention||0
8948791|NCT02432287|10011257|FG001|NOT COMPLETED|Second Intervention||0
8948792|NCT02432300|10011265|FG000|STARTED|Overall Study||17
8948793|NCT02432300|10011265|FG000|COMPLETED|Overall Study||13
8948794|NCT02432300|10011265|FG000|NOT COMPLETED|Overall Study||4
8948795|NCT02432456|10011271|FG000|STARTED|Overall Study||75
8948796|NCT02432456|10011272|FG001|STARTED|Overall Study||75
8948797|NCT02432456|10011271|FG000|COMPLETED|Overall Study||75
8948798|NCT02432456|10011272|FG001|COMPLETED|Overall Study||75
8948799|NCT02432456|10011271|FG000|NOT COMPLETED|Overall Study||0
8948800|NCT02432456|10011272|FG001|NOT COMPLETED|Overall Study||0
8948801|NCT02432703|10011280|FG000|STARTED|Overall Study||75
8948802|NCT02432703|10011281|FG001|STARTED|Overall Study||74
8948803|NCT02432703|10011280|FG000|COMPLETED|Overall Study||53
8948804|NCT02432703|10011281|FG001|COMPLETED|Overall Study||56
8948805|NCT02432703|10011280|FG000|NOT COMPLETED|Overall Study||22
8948806|NCT02432703|10011281|FG001|NOT COMPLETED|Overall Study||18
8948807|NCT02432716|10011287|FG000|STARTED|Overall Study||6
8948808|NCT02432716|10011288|FG001|STARTED|Overall Study||6
8948809|NCT02432716|10011287|FG000|COMPLETED|Overall Study||6
8948810|NCT02432716|10011288|FG001|COMPLETED|Overall Study||6
8948811|NCT02432716|10011287|FG000|NOT COMPLETED|Overall Study||0
8948812|NCT02432716|10011288|FG001|NOT COMPLETED|Overall Study||0
8948813|NCT02432729|10011296|FG000|STARTED|Month 3 Visit||720
8948814|NCT02432729|10011296|FG000|COMPLETED|Month 3 Visit||718
8948815|NCT02432729|10011296|FG000|NOT COMPLETED|Month 3 Visit||2
8948816|NCT02432729|10011296|FG000|STARTED|Month 6 Visit||718
8948817|NCT02432729|10011296|FG000|COMPLETED|Month 6 Visit||632
8948818|NCT02432729|10011296|FG000|NOT COMPLETED|Month 6 Visit||86
8946759|NCT02415127|10008880|FG000|STARTED|Overall Study||47
8946760|NCT02415127|10008881|FG001|STARTED|Overall Study||45
8946761|NCT02415127|10008880|FG000|COMPLETED|Overall Study||46
8946762|NCT02415127|10008881|FG001|COMPLETED|Overall Study||45
8946763|NCT02415127|10008880|FG000|NOT COMPLETED|Overall Study||1
8946764|NCT02415127|10008881|FG001|NOT COMPLETED|Overall Study||0
8946765|NCT02415244|10008889|FG000|STARTED|Overall Study||50
8946766|NCT02415244|10008890|FG001|STARTED|Overall Study||25
8946767|NCT02415244|10008889|FG000|COMPLETED|Overall Study||50
8946768|NCT02415244|10008890|FG001|COMPLETED|Overall Study||25
8946769|NCT02415244|10008889|FG000|NOT COMPLETED|Overall Study||0
8946770|NCT02415244|10008890|FG001|NOT COMPLETED|Overall Study||0
8946771|NCT02415400|10008900|FG000|STARTED|Overall Study||1153
8946772|NCT02415400|10008901|FG001|STARTED|Overall Study||1153
8946773|NCT02415400|10008902|FG002|STARTED|Overall Study||1154
8946774|NCT02415400|10008903|FG003|STARTED|Overall Study||1154
8946775|NCT02415400|10008900|FG000|COMPLETED|Overall Study||1087
8946776|NCT02415400|10008901|FG001|COMPLETED|Overall Study||1091
8946777|NCT02415400|10008902|FG002|COMPLETED|Overall Study||1069
8946778|NCT02415400|10008903|FG003|COMPLETED|Overall Study||1071
8623366|NCT00492856|9662565|FG000|NOT COMPLETED|Post-consolidation||0
8623367|NCT00492856|9662566|FG001|NOT COMPLETED|Post-consolidation||12
8623368|NCT00492856|9662567|FG002|NOT COMPLETED|Post-consolidation||27
8623369|NCT00492856|9662568|FG003|NOT COMPLETED|Post-consolidation||1
8623370|NCT00492921|9662580|FG000|STARTED|Overall Study||5
8623371|NCT00492921|9662581|FG001|STARTED|Overall Study||4
8623372|NCT00492921|9662582|FG002|STARTED|Overall Study||3
8623373|NCT00492921|9662580|FG000|COMPLETED|Overall Study||4
8623374|NCT00492921|9662581|FG001|COMPLETED|Overall Study||4
8946779|NCT02415400|10008900|FG000|NOT COMPLETED|Overall Study||66
8946780|NCT02415400|10008901|FG001|NOT COMPLETED|Overall Study||62
8946781|NCT02415400|10008902|FG002|NOT COMPLETED|Overall Study||85
8946782|NCT02415400|10008903|FG003|NOT COMPLETED|Overall Study||83
8946783|NCT02415439|10008930|FG000|STARTED|Overall Study||6
8946784|NCT02415439|10008931|FG001|STARTED|Overall Study||6
8946785|NCT02415439|10008932|FG002|STARTED|Overall Study||6
8946786|NCT02415439|10008933|FG003|STARTED|Overall Study||6
8946787|NCT02415439|10008934|FG004|STARTED|Overall Study||6
8946788|NCT02415439|10008935|FG005|STARTED|Overall Study||6
8946789|NCT02415439|10008936|FG006|STARTED|Overall Study||6
8946790|NCT02415439|10008937|FG007|STARTED|Overall Study||12
8946791|NCT02415439|10008938|FG008|STARTED|Overall Study||6
8946792|NCT02415439|10008939|FG009|STARTED|Overall Study||6
8946793|NCT02415439|10008940|FG010|STARTED|Overall Study||6
8946794|NCT02415439|10008941|FG011|STARTED|Overall Study||6
8946795|NCT02415439|10008942|FG012|STARTED|Overall Study||8
8946796|NCT02415439|10008930|FG000|COMPLETED|Overall Study||6
8946797|NCT02415439|10008931|FG001|COMPLETED|Overall Study||6
8946798|NCT02415439|10008932|FG002|COMPLETED|Overall Study||6
8946799|NCT02415439|10008933|FG003|COMPLETED|Overall Study||6
8946800|NCT02415439|10008934|FG004|COMPLETED|Overall Study||6
8946801|NCT02415439|10008935|FG005|COMPLETED|Overall Study||6
8946802|NCT02415439|10008936|FG006|COMPLETED|Overall Study||6
8946803|NCT02415439|10008937|FG007|COMPLETED|Overall Study||12
8946804|NCT02415439|10008938|FG008|COMPLETED|Overall Study||5
8946805|NCT02415439|10008939|FG009|COMPLETED|Overall Study||6
8946806|NCT02415439|10008940|FG010|COMPLETED|Overall Study||6
8946807|NCT02415439|10008941|FG011|COMPLETED|Overall Study||6
8946808|NCT02415439|10008942|FG012|COMPLETED|Overall Study||8
8946809|NCT02415439|10008930|FG000|NOT COMPLETED|Overall Study||0
8946810|NCT02415439|10008931|FG001|NOT COMPLETED|Overall Study||0
8946811|NCT02415439|10008932|FG002|NOT COMPLETED|Overall Study||0
8946812|NCT02415439|10008933|FG003|NOT COMPLETED|Overall Study||0
8946813|NCT02415439|10008934|FG004|NOT COMPLETED|Overall Study||0
8623375|NCT00492921|9662582|FG002|COMPLETED|Overall Study||2
8623376|NCT00492921|9662580|FG000|NOT COMPLETED|Overall Study||1
8623377|NCT00492921|9662581|FG001|NOT COMPLETED|Overall Study||0
8946814|NCT02415439|10008935|FG005|NOT COMPLETED|Overall Study||0
8946815|NCT02415439|10008936|FG006|NOT COMPLETED|Overall Study||0
8946816|NCT02415439|10008937|FG007|NOT COMPLETED|Overall Study||0
8946817|NCT02415439|10008938|FG008|NOT COMPLETED|Overall Study||1
8946818|NCT02415439|10008939|FG009|NOT COMPLETED|Overall Study||0
8946819|NCT02415439|10008940|FG010|NOT COMPLETED|Overall Study||0
8946820|NCT02415439|10008941|FG011|NOT COMPLETED|Overall Study||0
8946821|NCT02415439|10008942|FG012|NOT COMPLETED|Overall Study||0
8946822|NCT02415595|10008976|FG000|STARTED|Overall Study||50
8946823|NCT02415595|10008977|FG001|STARTED|Overall Study||52
8946824|NCT02415595|10008978|FG002|STARTED|Overall Study||51
8946825|NCT02415595|10008979|FG003|STARTED|Overall Study||53
8946826|NCT02415595|10008976|FG000|COMPLETED|Overall Study||0
8946827|NCT02415595|10008977|FG001|COMPLETED|Overall Study||0
8946828|NCT02415595|10008978|FG002|COMPLETED|Overall Study||0
8946829|NCT02415595|10008979|FG003|COMPLETED|Overall Study||0
8946830|NCT02415595|10008976|FG000|NOT COMPLETED|Overall Study||50
8946831|NCT02415595|10008977|FG001|NOT COMPLETED|Overall Study||52
8946832|NCT02415595|10008978|FG002|NOT COMPLETED|Overall Study||51
8946833|NCT02415595|10008979|FG003|NOT COMPLETED|Overall Study||53
8946834|NCT02415608|10008992|FG000|STARTED|Overall Study||3
8946835|NCT02415608|10008993|FG001|STARTED|Overall Study||1
8946836|NCT02415608|10008992|FG000|COMPLETED|Overall Study||3
8946837|NCT02415608|10008993|FG001|COMPLETED|Overall Study||1
8946838|NCT02415608|10008992|FG000|NOT COMPLETED|Overall Study||0
8946839|NCT02415608|10008993|FG001|NOT COMPLETED|Overall Study||0
8946840|NCT02415842|10009012|FG000|STARTED|Overall Study||29
8946841|NCT02415842|10009013|FG001|STARTED|Overall Study||29
8946842|NCT02415842|10009014|FG002|STARTED|Overall Study||29
8946843|NCT02415842|10009015|FG003|STARTED|Overall Study||27
8946844|NCT02415842|10009016|FG004|STARTED|Overall Study||30
8556701|NCT02032823|9588470|FG000|COMPLETED|Overall Study||0
8556702|NCT02032823|9588471|FG001|COMPLETED|Overall Study||0
8556703|NCT02032823|9588470|FG000|NOT COMPLETED|Overall Study||921
8556704|NCT02032823|9588471|FG001|NOT COMPLETED|Overall Study||915
8556705|NCT01557751|9588477|FG000|STARTED|Overall Study||156
8556706|NCT01557751|9588477|FG000|COMPLETED|Overall Study||153
8946845|NCT02415842|10009017|FG005|STARTED|Overall Study||30
8946846|NCT02415842|10009018|FG006|STARTED|Overall Study||30
8946847|NCT02415842|10009019|FG007|STARTED|Overall Study||26
8946848|NCT02415842|10009020|FG008|STARTED|Overall Study||29
8946849|NCT02415842|10009021|FG009|STARTED|Overall Study||53
8946850|NCT02415842|10009022|FG010|STARTED|Overall Study||49
8946851|NCT02415842|10009023|FG011|STARTED|Overall Study||33
8946852|NCT02415842|10009024|FG012|STARTED|Overall Study||20
8946853|NCT02415842|10009012|FG000|COMPLETED|Overall Study||29
8946854|NCT02415842|10009013|FG001|COMPLETED|Overall Study||29
8946855|NCT02415842|10009014|FG002|COMPLETED|Overall Study||29
8946856|NCT02415842|10009015|FG003|COMPLETED|Overall Study||27
8946857|NCT02415842|10009016|FG004|COMPLETED|Overall Study||30
8946858|NCT02415842|10009017|FG005|COMPLETED|Overall Study||30
8946859|NCT02415842|10009018|FG006|COMPLETED|Overall Study||30
8946860|NCT02415842|10009019|FG007|COMPLETED|Overall Study||26
8946861|NCT02415842|10009020|FG008|COMPLETED|Overall Study||29
8946862|NCT02415842|10009021|FG009|COMPLETED|Overall Study||53
8946863|NCT02415842|10009022|FG010|COMPLETED|Overall Study||49
8946864|NCT02415842|10009023|FG011|COMPLETED|Overall Study||33
8946865|NCT02415842|10009024|FG012|COMPLETED|Overall Study||20
8623378|NCT00492921|9662582|FG002|NOT COMPLETED|Overall Study||1
8946866|NCT02415842|10009012|FG000|NOT COMPLETED|Overall Study||0
8946867|NCT02415842|10009013|FG001|NOT COMPLETED|Overall Study||0
8946868|NCT02415842|10009014|FG002|NOT COMPLETED|Overall Study||0
8946869|NCT02415842|10009015|FG003|NOT COMPLETED|Overall Study||0
8946870|NCT02415842|10009016|FG004|NOT COMPLETED|Overall Study||0
8946871|NCT02415842|10009017|FG005|NOT COMPLETED|Overall Study||0
8946872|NCT02415842|10009018|FG006|NOT COMPLETED|Overall Study||0
8946873|NCT02415842|10009019|FG007|NOT COMPLETED|Overall Study||0
8946874|NCT02415842|10009020|FG008|NOT COMPLETED|Overall Study||0
8946875|NCT02415842|10009021|FG009|NOT COMPLETED|Overall Study||0
8946876|NCT02415842|10009022|FG010|NOT COMPLETED|Overall Study||0
8946877|NCT02415842|10009023|FG011|NOT COMPLETED|Overall Study||0
8946878|NCT02415842|10009024|FG012|NOT COMPLETED|Overall Study||0
8946879|NCT02415855|10009071|FG000|STARTED|Overall Study||37
8946880|NCT02415855|10009072|FG001|STARTED|Overall Study||64
8946881|NCT02415855|10009071|FG000|COMPLETED|Overall Study||34
8946882|NCT02415855|10009072|FG001|COMPLETED|Overall Study||62
8946883|NCT02415855|10009071|FG000|NOT COMPLETED|Overall Study||3
8946884|NCT02415855|10009072|FG001|NOT COMPLETED|Overall Study||2
8946885|NCT02415959|10009083|FG000|STARTED|Overall Study||14
8946886|NCT02415959|10009084|FG001|STARTED|Overall Study||14
8946887|NCT02415959|10009085|FG002|STARTED|Overall Study||14
8946888|NCT02415959|10009086|FG003|STARTED|Overall Study||14
8946889|NCT02415959|10009087|FG004|STARTED|Overall Study||14
8946890|NCT02415959|10009083|FG000|COMPLETED|Overall Study||14
8946891|NCT02415959|10009084|FG001|COMPLETED|Overall Study||13
8946892|NCT02415959|10009085|FG002|COMPLETED|Overall Study||14
8946893|NCT02415959|10009086|FG003|COMPLETED|Overall Study||13
8946894|NCT02415959|10009087|FG004|COMPLETED|Overall Study||14
8946895|NCT02415959|10009083|FG000|NOT COMPLETED|Overall Study||0
8946896|NCT02415959|10009084|FG001|NOT COMPLETED|Overall Study||1
8946897|NCT02415959|10009085|FG002|NOT COMPLETED|Overall Study||0
8946898|NCT02415959|10009086|FG003|NOT COMPLETED|Overall Study||1
8946899|NCT02415959|10009087|FG004|NOT COMPLETED|Overall Study||0
8946900|NCT02415998|10009099|FG000|STARTED|Overall Study||25
8946901|NCT02415998|10009099|FG000|COMPLETED|Overall Study||20
8946902|NCT02415998|10009099|FG000|NOT COMPLETED|Overall Study||5
8946903|NCT02416102|10009106|FG000|STARTED|Overall Study||16
8946904|NCT02416102|10009107|FG001|STARTED|Overall Study||15
8946905|NCT02416102|10009108|FG002|STARTED|Overall Study||0
8946906|NCT02416102|10009106|FG000|COMPLETED|Overall Study||7
8946907|NCT02416102|10009107|FG001|COMPLETED|Overall Study||7
8946908|NCT02416102|10009108|FG002|COMPLETED|Overall Study||0
8946909|NCT02416102|10009106|FG000|NOT COMPLETED|Overall Study||9
8946910|NCT02416102|10009107|FG001|NOT COMPLETED|Overall Study||8
8946911|NCT02416102|10009108|FG002|NOT COMPLETED|Overall Study||0
8556707|NCT01557751|9588477|FG000|NOT COMPLETED|Overall Study||3
8556708|NCT01363401|9588483|FG000|STARTED|Overall Study|"Including 8 subjects of Phase 1 safety assessment. (Called Modified ITT in this clinical trials)"|41
8946912|NCT02416180|10009116|FG000|STARTED|Overall Study||111
8946913|NCT02416180|10009116|FG000|COMPLETED|Overall Study||110
8946914|NCT02416180|10009116|FG000|NOT COMPLETED|Overall Study||1
8946915|NCT02416193|10009122|FG000|STARTED|Overall Study||15
8946916|NCT02416193|10009123|FG001|STARTED|Overall Study||15
8946917|NCT02416193|10009122|FG000|COMPLETED|Overall Study||15
8946918|NCT02416193|10009123|FG001|COMPLETED|Overall Study||15
8946919|NCT02416193|10009122|FG000|NOT COMPLETED|Overall Study||0
8946920|NCT02416193|10009123|FG001|NOT COMPLETED|Overall Study||0
8946921|NCT02416453|10009140|FG000|STARTED|Overall Study||10
8946922|NCT02416453|10009141|FG001|STARTED|Overall Study||10
8946923|NCT02416453|10009142|FG002|STARTED|Overall Study||10
8946924|NCT02416453|10009143|FG003|STARTED|Overall Study||112
8946925|NCT02416453|10009144|FG004|STARTED|Overall Study||13
8946926|NCT02416453|10009145|FG005|STARTED|Overall Study||114
8946927|NCT02416453|10009146|FG006|STARTED|Overall Study||13
8946928|NCT02416453|10009147|FG007|STARTED|Overall Study||106
8946929|NCT02416453|10009148|FG008|STARTED|Overall Study||18
8946930|NCT02416453|10009149|FG009|STARTED|Overall Study||13
8946931|NCT02416453|10009150|FG010|STARTED|Overall Study||2
8946932|NCT02416453|10009140|FG000|COMPLETED|Overall Study||7
8946933|NCT02416453|10009141|FG001|COMPLETED|Overall Study||7
8946934|NCT02416453|10009142|FG002|COMPLETED|Overall Study||9
8946935|NCT02416453|10009143|FG003|COMPLETED|Overall Study||97
8946936|NCT02416453|10009144|FG004|COMPLETED|Overall Study||12
8946937|NCT02416453|10009145|FG005|COMPLETED|Overall Study||98
8946938|NCT02416453|10009146|FG006|COMPLETED|Overall Study||11
8946939|NCT02416453|10009147|FG007|COMPLETED|Overall Study||94
8946940|NCT02416453|10009148|FG008|COMPLETED|Overall Study||13
8946941|NCT02416453|10009149|FG009|COMPLETED|Overall Study||13
8946942|NCT02416453|10009150|FG010|COMPLETED|Overall Study||2
8946943|NCT02416453|10009140|FG000|NOT COMPLETED|Overall Study||3
8946944|NCT02416453|10009141|FG001|NOT COMPLETED|Overall Study||3
8946945|NCT02416453|10009142|FG002|NOT COMPLETED|Overall Study||1
8946946|NCT02416453|10009143|FG003|NOT COMPLETED|Overall Study||15
8946947|NCT02416453|10009144|FG004|NOT COMPLETED|Overall Study||1
8946948|NCT02416453|10009145|FG005|NOT COMPLETED|Overall Study||16
8946949|NCT02416453|10009146|FG006|NOT COMPLETED|Overall Study||2
8946950|NCT02416453|10009147|FG007|NOT COMPLETED|Overall Study||12
8946951|NCT02416453|10009148|FG008|NOT COMPLETED|Overall Study||5
8946952|NCT02416453|10009149|FG009|NOT COMPLETED|Overall Study||0
8946953|NCT02416453|10009150|FG010|NOT COMPLETED|Overall Study||0
8946954|NCT02416622|10009183|FG000|STARTED|Overall Study||6
8946955|NCT02416622|10009184|FG001|STARTED|Overall Study||8
8946956|NCT02416622|10009185|FG002|STARTED|Overall Study||13
8946957|NCT02416622|10009183|FG000|Completed Month 12|Overall Study||6
8946958|NCT02416622|10009184|FG001|Completed Month 12|Overall Study||8
8946959|NCT02416622|10009185|FG002|Completed Month 12|Overall Study||13
8946960|NCT02416622|10009183|FG000|Started Long-Term Follow-Up|Overall Study||6
8946961|NCT02416622|10009184|FG001|Started Long-Term Follow-Up|Overall Study||8
8946962|NCT02416622|10009185|FG002|Started Long-Term Follow-Up|Overall Study||13
8946963|NCT02416622|10009183|FG000|COMPLETED|Overall Study||0
8946964|NCT02416622|10009184|FG001|COMPLETED|Overall Study||0
8946965|NCT02416622|10009185|FG002|COMPLETED|Overall Study||0
8946966|NCT02416622|10009183|FG000|NOT COMPLETED|Overall Study||6
8946967|NCT02416622|10009184|FG001|NOT COMPLETED|Overall Study||8
8946968|NCT02416622|10009185|FG002|NOT COMPLETED|Overall Study||13
8946969|NCT02416713|10009197|FG000|STARTED|Overall Study||8
8946970|NCT02416713|10009198|FG001|STARTED|Overall Study||9
8946971|NCT02416713|10009199|FG002|STARTED|Overall Study||8
8946972|NCT02416713|10009200|FG003|STARTED|Overall Study||10
8946973|NCT02416713|10009197|FG000|COMPLETED|Overall Study||8
8946974|NCT02416713|10009198|FG001|COMPLETED|Overall Study||9
8946975|NCT02416713|10009199|FG002|COMPLETED|Overall Study||8
8946976|NCT02416713|10009200|FG003|COMPLETED|Overall Study||10
8946977|NCT02416713|10009197|FG000|NOT COMPLETED|Overall Study||0
8946978|NCT02416713|10009198|FG001|NOT COMPLETED|Overall Study||0
8946979|NCT02416713|10009199|FG002|NOT COMPLETED|Overall Study||0
8946980|NCT02416713|10009200|FG003|NOT COMPLETED|Overall Study||0
8946981|NCT02416791|10009213|FG000|STARTED|6 Weeks||3
8946982|NCT02416791|10009214|FG001|STARTED|6 Weeks||3
8946983|NCT02416791|10009215|FG002|STARTED|6 Weeks||3
8946984|NCT02416791|10009213|FG000|COMPLETED|6 Weeks||3
8946985|NCT02416791|10009214|FG001|COMPLETED|6 Weeks||3
8946986|NCT02416791|10009215|FG002|COMPLETED|6 Weeks||3
8946987|NCT02416791|10009213|FG000|NOT COMPLETED|6 Weeks||0
8946988|NCT02416791|10009214|FG001|NOT COMPLETED|6 Weeks||0
8946989|NCT02416791|10009215|FG002|NOT COMPLETED|6 Weeks||0
8946990|NCT02416791|10009213|FG000|STARTED|6 Months||3
8946991|NCT02416791|10009214|FG001|STARTED|6 Months||3
8946992|NCT02416791|10009215|FG002|STARTED|6 Months||3
8946993|NCT02416791|10009213|FG000|COMPLETED|6 Months||3
8946994|NCT02416791|10009214|FG001|COMPLETED|6 Months||3
8946995|NCT02416791|10009215|FG002|COMPLETED|6 Months||2
8946996|NCT02416791|10009213|FG000|NOT COMPLETED|6 Months||0
8946997|NCT02416791|10009214|FG001|NOT COMPLETED|6 Months||0
8946998|NCT02416791|10009215|FG002|NOT COMPLETED|6 Months||1
8946999|NCT02416908|10009226|FG000|STARTED|Dose Escalation Phase||6
8947000|NCT02416908|10009227|FG001|STARTED|Dose Escalation Phase||0
8947001|NCT02416908|10009228|FG002|STARTED|Dose Escalation Phase||34
8947002|NCT02416908|10009229|FG003|STARTED|Dose Escalation Phase||0
8947003|NCT02416908|10009226|FG000|COMPLETED|Dose Escalation Phase||6
8947004|NCT02416908|10009227|FG001|COMPLETED|Dose Escalation Phase||0
8947005|NCT02416908|10009228|FG002|COMPLETED|Dose Escalation Phase||30
8947006|NCT02416908|10009229|FG003|COMPLETED|Dose Escalation Phase||0
8947007|NCT02416908|10009226|FG000|NOT COMPLETED|Dose Escalation Phase||0
8947008|NCT02416908|10009227|FG001|NOT COMPLETED|Dose Escalation Phase||0
8947009|NCT02416908|10009228|FG002|NOT COMPLETED|Dose Escalation Phase||4
8947010|NCT02416908|10009229|FG003|NOT COMPLETED|Dose Escalation Phase||0
8947011|NCT02416908|10009226|FG000|STARTED|Maintenance Phase||0
8947012|NCT02416908|10009227|FG001|STARTED|Maintenance Phase||0
8947013|NCT02416908|10009228|FG002|STARTED|Maintenance Phase||0
8947014|NCT02416908|10009229|FG003|STARTED|Maintenance Phase||2
8947015|NCT02416908|10009226|FG000|COMPLETED|Maintenance Phase||0
8947016|NCT02416908|10009227|FG001|COMPLETED|Maintenance Phase||0
8947017|NCT02416908|10009228|FG002|COMPLETED|Maintenance Phase||0
8947018|NCT02416908|10009229|FG003|COMPLETED|Maintenance Phase||2
8947019|NCT02416908|10009226|FG000|NOT COMPLETED|Maintenance Phase||0
8947020|NCT02416908|10009227|FG001|NOT COMPLETED|Maintenance Phase||0
8947021|NCT02416908|10009228|FG002|NOT COMPLETED|Maintenance Phase||0
8947022|NCT02416908|10009229|FG003|NOT COMPLETED|Maintenance Phase||0
8947023|NCT02416934|10009238|FG000|STARTED|Overall Study||36
8947024|NCT02416934|10009239|FG001|STARTED|Overall Study||38
8947025|NCT02416934|10009238|FG000|Double Blind (0-52 Weeks)|Overall Study||36
8947026|NCT02416934|10009239|FG001|Double Blind (0-52 Weeks)|Overall Study||38
8947027|NCT02416934|10009238|FG000|Last Participant Completed 1 yr|Overall Study||33
8947028|NCT02416934|10009239|FG001|Last Participant Completed 1 yr|Overall Study||31
8947029|NCT02416934|10009238|FG000|COMPLETED|Overall Study||33
8947030|NCT02416934|10009239|FG001|COMPLETED|Overall Study||31
8947031|NCT02416934|10009238|FG000|NOT COMPLETED|Overall Study||3
8947032|NCT02416934|10009239|FG001|NOT COMPLETED|Overall Study||7
8947033|NCT02416973|10009254|FG000|STARTED|Overall Study||14
8947034|NCT02416973|10009255|FG001|STARTED|Overall Study||13
8947035|NCT02416973|10009256|FG002|STARTED|Overall Study||14
8947036|NCT02416973|10009254|FG000|COMPLETED|Overall Study||13
8947037|NCT02416973|10009255|FG001|COMPLETED|Overall Study||10
8947038|NCT02416973|10009256|FG002|COMPLETED|Overall Study||13
8947039|NCT02416973|10009254|FG000|NOT COMPLETED|Overall Study||1
8947040|NCT02416973|10009255|FG001|NOT COMPLETED|Overall Study||3
8947041|NCT02416973|10009256|FG002|NOT COMPLETED|Overall Study||1
8947042|NCT02417064|10009267|FG000|STARTED|Double-blind Induction Phase (4 Weeks)||117
8947043|NCT02417064|10009268|FG001|STARTED|Double-blind Induction Phase (4 Weeks)||116
8947044|NCT02417064|10009269|FG002|STARTED|Double-blind Induction Phase (4 Weeks)||113
8947045|NCT02417064|10009267|FG000|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||115
8947046|NCT02417064|10009268|FG001|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||114
8947047|NCT02417064|10009269|FG002|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||113
8947048|NCT02417064|10009267|FG000|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||115
8947049|NCT02417064|10009268|FG001|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||116
8947050|NCT02417064|10009269|FG002|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||113
8947051|NCT02417064|10009267|FG000|COMPLETED|Double-blind Induction Phase (4 Weeks)||111
8947052|NCT02417064|10009268|FG001|COMPLETED|Double-blind Induction Phase (4 Weeks)||97
8947053|NCT02417064|10009269|FG002|COMPLETED|Double-blind Induction Phase (4 Weeks)||107
8947054|NCT02417064|10009267|FG000|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||6
8947055|NCT02417064|10009268|FG001|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||19
8947056|NCT02417064|10009269|FG002|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||6
8947057|NCT02417064|10009267|FG000|STARTED|Follow-up Phase (24 Weeks)||47
8947058|NCT02417064|10009268|FG001|STARTED|Follow-up Phase (24 Weeks)||52
8947059|NCT02417064|10009269|FG002|STARTED|Follow-up Phase (24 Weeks)||69
8947060|NCT02417064|10009267|FG000|COMPLETED|Follow-up Phase (24 Weeks)||8
8947061|NCT02417064|10009268|FG001|COMPLETED|Follow-up Phase (24 Weeks)||10
8947062|NCT02417064|10009269|FG002|COMPLETED|Follow-up Phase (24 Weeks)||18
8947063|NCT02417064|10009267|FG000|NOT COMPLETED|Follow-up Phase (24 Weeks)||39
8947064|NCT02417064|10009268|FG001|NOT COMPLETED|Follow-up Phase (24 Weeks)||42
8947065|NCT02417064|10009269|FG002|NOT COMPLETED|Follow-up Phase (24 Weeks)||51
8947066|NCT02417129|10009280|FG000|STARTED|Overall Study||2
8947067|NCT02417129|10009281|FG001|STARTED|Overall Study||0
8947068|NCT02417129|10009280|FG000|COMPLETED|Overall Study||2
8947069|NCT02417129|10009281|FG001|COMPLETED|Overall Study||0
8947070|NCT02417129|10009280|FG000|NOT COMPLETED|Overall Study||0
8947071|NCT02417129|10009281|FG001|NOT COMPLETED|Overall Study||0
8947072|NCT02417233|10009290|FG000|STARTED|Overall Study||169
8947073|NCT02417233|10009291|FG001|STARTED|Overall Study||289
8947074|NCT02417233|10009292|FG002|STARTED|Overall Study||298
8947075|NCT02417233|10009290|FG000|COMPLETED|Overall Study||133
8947076|NCT02417233|10009291|FG001|COMPLETED|Overall Study||238
8947077|NCT02417233|10009292|FG002|COMPLETED|Overall Study||239
8947078|NCT02417233|10009290|FG000|NOT COMPLETED|Overall Study||36
8947079|NCT02417233|10009291|FG001|NOT COMPLETED|Overall Study||51
8947080|NCT02417233|10009292|FG002|NOT COMPLETED|Overall Study||59
8947081|NCT02417246|10009303|FG000|STARTED|Phase 1 Brand Name Metoprolol ER||24
8947082|NCT02417246|10009304|FG001|STARTED|Phase 1 Brand Name Metoprolol ER||24
8947083|NCT02417246|10009303|FG000|COMPLETED|Phase 1 Brand Name Metoprolol ER||20
8947084|NCT02417246|10009304|FG001|COMPLETED|Phase 1 Brand Name Metoprolol ER||20
8947085|NCT02417246|10009303|FG000|NOT COMPLETED|Phase 1 Brand Name Metoprolol ER||4
8947086|NCT02417246|10009304|FG001|NOT COMPLETED|Phase 1 Brand Name Metoprolol ER||4
8947087|NCT02417246|10009303|FG000|STARTED|Phase 2 1st Generic Administered||20
8947088|NCT02417246|10009304|FG001|STARTED|Phase 2 1st Generic Administered||20
8947089|NCT02417246|10009303|FG000|COMPLETED|Phase 2 1st Generic Administered||19
8947090|NCT02417246|10009304|FG001|COMPLETED|Phase 2 1st Generic Administered||20
8947091|NCT02417246|10009303|FG000|NOT COMPLETED|Phase 2 1st Generic Administered||1
8947092|NCT02417246|10009304|FG001|NOT COMPLETED|Phase 2 1st Generic Administered||0
8947093|NCT02417246|10009303|FG000|STARTED|Phase 3 Brand Name Metoprolol ER #2||19
8947094|NCT02417246|10009304|FG001|STARTED|Phase 3 Brand Name Metoprolol ER #2||20
8947095|NCT02417246|10009303|FG000|COMPLETED|Phase 3 Brand Name Metoprolol ER #2||18
8947096|NCT02417246|10009304|FG001|COMPLETED|Phase 3 Brand Name Metoprolol ER #2||20
8947097|NCT02417246|10009303|FG000|NOT COMPLETED|Phase 3 Brand Name Metoprolol ER #2||1
8948819|NCT02432729|10011296|FG000|STARTED|Month 12 Visit||632
8947098|NCT02417246|10009304|FG001|NOT COMPLETED|Phase 3 Brand Name Metoprolol ER #2||0
8947099|NCT02417246|10009303|FG000|STARTED|Phase 4 2nd Generic Administered||18
8947100|NCT02417246|10009304|FG001|STARTED|Phase 4 2nd Generic Administered||20
8947101|NCT02417246|10009303|FG000|COMPLETED|Phase 4 2nd Generic Administered||18
8947102|NCT02417246|10009304|FG001|COMPLETED|Phase 4 2nd Generic Administered||20
8947103|NCT02417246|10009303|FG000|NOT COMPLETED|Phase 4 2nd Generic Administered||0
8947104|NCT02417246|10009304|FG001|NOT COMPLETED|Phase 4 2nd Generic Administered||0
8947105|NCT02417376|10009314|FG000|STARTED|Overall Study||35
8947106|NCT02417376|10009315|FG001|STARTED|Overall Study||35
8947107|NCT02417376|10009314|FG000|COMPLETED|Overall Study||30
8947108|NCT02417376|10009315|FG001|COMPLETED|Overall Study||25
8947109|NCT02417376|10009314|FG000|NOT COMPLETED|Overall Study||5
8947110|NCT02417376|10009315|FG001|NOT COMPLETED|Overall Study||10
8947111|NCT02417441|10009323|FG000|STARTED|Overall Study||645
8947112|NCT02417441|10009324|FG001|STARTED|Overall Study||325
8947113|NCT02417441|10009323|FG000|COMPLETED|Overall Study||593
8947114|NCT02417441|10009324|FG001|COMPLETED|Overall Study||306
8947115|NCT02417441|10009323|FG000|NOT COMPLETED|Overall Study||52
8947116|NCT02417441|10009324|FG001|NOT COMPLETED|Overall Study||19
8947117|NCT02417532|10009331|FG000|STARTED|Overall Study||56
8947118|NCT02417532|10009331|FG000|COMPLETED|Overall Study||56
8947119|NCT02417532|10009331|FG000|NOT COMPLETED|Overall Study||0
8947120|NCT02417753|10009337|FG000|STARTED|Overall Study||1
8947121|NCT02417753|10009337|FG000|COMPLETED|Overall Study||0
8947122|NCT02417753|10009337|FG000|NOT COMPLETED|Overall Study||1
8947123|NCT02417831|10009341|FG000|STARTED|Period 1: Treatment Period 1 + Washout||17
8947124|NCT02417831|10009342|FG001|STARTED|Period 1: Treatment Period 1 + Washout||17
8947125|NCT02417831|10009341|FG000|COMPLETED|Period 1: Treatment Period 1 + Washout||17
8947126|NCT02417831|10009342|FG001|COMPLETED|Period 1: Treatment Period 1 + Washout||17
8947127|NCT02417831|10009341|FG000|NOT COMPLETED|Period 1: Treatment Period 1 + Washout||0
8947128|NCT02417831|10009342|FG001|NOT COMPLETED|Period 1: Treatment Period 1 + Washout||0
8947129|NCT02417831|10009341|FG000|STARTED|Period 2: Treatment Period 2 + Washout||17
8947130|NCT02417831|10009342|FG001|STARTED|Period 2: Treatment Period 2 + Washout||17
8947131|NCT02417831|10009341|FG000|COMPLETED|Period 2: Treatment Period 2 + Washout||17
8947132|NCT02417831|10009342|FG001|COMPLETED|Period 2: Treatment Period 2 + Washout||17
8947133|NCT02417831|10009341|FG000|NOT COMPLETED|Period 2: Treatment Period 2 + Washout||0
8947134|NCT02417831|10009342|FG001|NOT COMPLETED|Period 2: Treatment Period 2 + Washout||0
8947135|NCT02417844|10009348|FG000|STARTED|Overall Study||17
8947136|NCT02417844|10009349|FG001|STARTED|Overall Study||17
8947137|NCT02417844|10009348|FG000|COMPLETED|Overall Study||17
8947138|NCT02417844|10009349|FG001|COMPLETED|Overall Study||17
8947139|NCT02417844|10009348|FG000|NOT COMPLETED|Overall Study||0
8947140|NCT02417844|10009349|FG001|NOT COMPLETED|Overall Study||0
8947141|NCT02417935|10009357|FG000|STARTED|Treatment Period||151
8947142|NCT02417935|10009358|FG001|STARTED|Treatment Period||153
8947143|NCT02417935|10009357|FG000|Received at Least One Dose of Study Drug|Treatment Period||151
8947144|NCT02417935|10009358|FG001|Received at Least One Dose of Study Drug|Treatment Period||152
8947145|NCT02417935|10009357|FG000|COMPLETED|Treatment Period||130
8947146|NCT02417935|10009358|FG001|COMPLETED|Treatment Period||137
8947147|NCT02417935|10009357|FG000|NOT COMPLETED|Treatment Period||21
8947148|NCT02417935|10009358|FG001|NOT COMPLETED|Treatment Period||16
8947149|NCT02417935|10009357|FG000|STARTED|Tapering Period|Participants who discontinued treatment period had an option to enter the taper period|134
8947150|NCT02417935|10009358|FG001|STARTED|Tapering Period|Participants who discontinued treatment period had an option to enter the taper period|142
8947151|NCT02417935|10009357|FG000|COMPLETED|Tapering Period||134
8947152|NCT02417935|10009358|FG001|COMPLETED|Tapering Period||142
8947153|NCT02417935|10009357|FG000|NOT COMPLETED|Tapering Period||0
8947154|NCT02417935|10009358|FG001|NOT COMPLETED|Tapering Period||0
8947155|NCT02417961|10009364|FG000|STARTED|Overall Study||116
8947156|NCT02417961|10009364|FG000|COMPLETED|Overall Study||112
8947157|NCT02417961|10009364|FG000|NOT COMPLETED|Overall Study||4
8947158|NCT02418000|10009373|FG000|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||7
8947159|NCT02418000|10009374|FG001|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||0
8947160|NCT02418000|10009375|FG002|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||0
8947161|NCT02418000|10009376|FG003|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||0
8947162|NCT02418000|10009377|FG004|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||0
8947163|NCT02418000|10009373|FG000|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
8947164|NCT02418000|10009374|FG001|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
8947165|NCT02418000|10009375|FG002|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
8947166|NCT02418000|10009376|FG003|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
8947167|NCT02418000|10009377|FG004|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
8947168|NCT02418000|10009373|FG000|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||7
8947169|NCT02418000|10009374|FG001|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
8947170|NCT02418000|10009375|FG002|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
8947171|NCT02418000|10009376|FG003|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
8947172|NCT02418000|10009377|FG004|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
8947173|NCT02418000|10009373|FG000|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||0
8947174|NCT02418000|10009374|FG001|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||10
8947175|NCT02418000|10009375|FG002|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||0
8947176|NCT02418000|10009376|FG003|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||0
8947177|NCT02418000|10009377|FG004|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||0
8947178|NCT02418000|10009373|FG000|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
8947179|NCT02418000|10009374|FG001|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
8947180|NCT02418000|10009375|FG002|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
8947181|NCT02418000|10009376|FG003|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
8947182|NCT02418000|10009377|FG004|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
8947183|NCT02418000|10009373|FG000|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
8947184|NCT02418000|10009374|FG001|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||10
8947185|NCT02418000|10009375|FG002|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
8947186|NCT02418000|10009376|FG003|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
8947187|NCT02418000|10009377|FG004|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
8947188|NCT02418000|10009373|FG000|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||0
8947189|NCT02418000|10009374|FG001|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||0
8947190|NCT02418000|10009375|FG002|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||3
8947191|NCT02418000|10009376|FG003|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||0
8947192|NCT02418000|10009377|FG004|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||0
8947193|NCT02418000|10009373|FG000|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
8947194|NCT02418000|10009374|FG001|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
8947195|NCT02418000|10009375|FG002|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
8947196|NCT02418000|10009376|FG003|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
8947197|NCT02418000|10009377|FG004|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
8947198|NCT02418000|10009373|FG000|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
8947199|NCT02418000|10009374|FG001|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
8947200|NCT02418000|10009375|FG002|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||3
8947201|NCT02418000|10009376|FG003|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
8947202|NCT02418000|10009377|FG004|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
8947203|NCT02418000|10009373|FG000|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||0
8947204|NCT02418000|10009374|FG001|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||0
8947205|NCT02418000|10009375|FG002|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||0
8947206|NCT02418000|10009376|FG003|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||3
8947207|NCT02418000|10009377|FG004|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||0
8947208|NCT02418000|10009373|FG000|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
8947209|NCT02418000|10009374|FG001|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
8623379|NCT00492973|9662592|FG000|STARTED|Overall Study||37
8623380|NCT00492973|9662593|FG001|STARTED|Overall Study||39
8623381|NCT00492973|9662592|FG000|COMPLETED|Overall Study||37
8623382|NCT00492973|9662593|FG001|COMPLETED|Overall Study|One patient died of complications related to deep joint sepsis in the early postoperative period.|38
8623383|NCT00492973|9662592|FG000|NOT COMPLETED|Overall Study||0
8947210|NCT02418000|10009375|FG002|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
8947211|NCT02418000|10009376|FG003|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
8947212|NCT02418000|10009377|FG004|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
8947213|NCT02418000|10009373|FG000|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
8947214|NCT02418000|10009374|FG001|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
8947215|NCT02418000|10009375|FG002|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
8947216|NCT02418000|10009376|FG003|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||3
8947217|NCT02418000|10009377|FG004|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
8947218|NCT02418000|10009373|FG000|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||0
8947219|NCT02418000|10009374|FG001|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||0
8947220|NCT02418000|10009375|FG002|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||0
8947221|NCT02418000|10009376|FG003|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||0
8947222|NCT02418000|10009377|FG004|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||4
8947223|NCT02418000|10009373|FG000|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
8947224|NCT02418000|10009374|FG001|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
8947225|NCT02418000|10009375|FG002|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
8947226|NCT02418000|10009376|FG003|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
8947227|NCT02418000|10009377|FG004|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
8947228|NCT02418000|10009373|FG000|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
8947229|NCT02418000|10009374|FG001|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
8947230|NCT02418000|10009375|FG002|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
8947231|NCT02418000|10009376|FG003|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
8947232|NCT02418000|10009377|FG004|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||4
8947233|NCT02418026|10009403|FG000|STARTED|Overall Study||44
8947234|NCT02418026|10009404|FG001|STARTED|Overall Study||35
8947235|NCT02418026|10009403|FG000|COMPLETED|Overall Study||44
8947236|NCT02418026|10009404|FG001|COMPLETED|Overall Study||35
8947237|NCT02418026|10009403|FG000|NOT COMPLETED|Overall Study||0
8947238|NCT02418026|10009404|FG001|NOT COMPLETED|Overall Study||0
8947239|NCT02418156|10009410|FG000|STARTED|Overall Study||38
8947240|NCT02418156|10009410|FG000|COMPLETED|Overall Study||21
8947241|NCT02418156|10009410|FG000|NOT COMPLETED|Overall Study||17
8947242|NCT02418182|10009416|FG000|STARTED|Overall Study||49
8947243|NCT02418182|10009417|FG001|STARTED|Overall Study||50
8947244|NCT02418182|10009416|FG000|COMPLETED|Overall Study||31
8623384|NCT00492973|9662593|FG001|NOT COMPLETED|Overall Study||1
8623385|NCT00493012|9662601|FG000|STARTED|Overall Study||100
8623386|NCT00493012|9662602|FG001|STARTED|Overall Study||100
8947245|NCT02418182|10009417|FG001|COMPLETED|Overall Study||33
8947246|NCT02418182|10009416|FG000|NOT COMPLETED|Overall Study||18
8947247|NCT02418182|10009417|FG001|NOT COMPLETED|Overall Study||17
8947248|NCT02418234|10009423|FG000|STARTED|Overall Study||314
8947249|NCT02418234|10009423|FG000|COMPLETED|Overall Study||314
8947250|NCT02418234|10009423|FG000|NOT COMPLETED|Overall Study||0
8947251|NCT02418312|10009433|FG000|STARTED|Overall Study||114
8947252|NCT02418312|10009434|FG001|STARTED|Overall Study||114
8947253|NCT02418312|10009433|FG000|COMPLETED|Overall Study||114
8947254|NCT02418312|10009434|FG001|COMPLETED|Overall Study||114
8947255|NCT02418312|10009433|FG000|NOT COMPLETED|Overall Study||0
8947256|NCT02418312|10009434|FG001|NOT COMPLETED|Overall Study||0
8947257|NCT02418455|10009440|FG000|STARTED|48-Week Treatment Period||8
8947258|NCT02418455|10009440|FG000|Emergency IND (eIND)|48-Week Treatment Period||1
8947259|NCT02418455|10009440|FG000|COMPLETED|48-Week Treatment Period||7
8947260|NCT02418455|10009440|FG000|NOT COMPLETED|48-Week Treatment Period||1
8947261|NCT02418455|10009440|FG000|STARTED|Continuation Period||7
8947262|NCT02418455|10009440|FG000|COMPLETED|Continuation Period||0
8947263|NCT02418455|10009440|FG000|NOT COMPLETED|Continuation Period||7
8947264|NCT02418468|10009448|FG000|STARTED|Overall Study||13
9066167|NCT04109443|10126628|FG001|NOT COMPLETED|Overall Study||12
9066168|NCT04107493|10126637|FG000|STARTED|First Intervention (1 Hour)||16
9066169|NCT04107493|10126638|FG001|STARTED|First Intervention (1 Hour)||17
9066170|NCT04107493|10126637|FG000|COMPLETED|First Intervention (1 Hour)||16
9066171|NCT04107493|10126638|FG001|COMPLETED|First Intervention (1 Hour)||17
9066172|NCT04107493|10126637|FG000|NOT COMPLETED|First Intervention (1 Hour)||0
9066173|NCT04107493|10126638|FG001|NOT COMPLETED|First Intervention (1 Hour)||0
9066174|NCT04107493|10126637|FG000|STARTED|Washout (One Hour)||16
9066175|NCT04107493|10126638|FG001|STARTED|Washout (One Hour)||17
9066176|NCT04107493|10126637|FG000|COMPLETED|Washout (One Hour)||16
9066177|NCT04107493|10126638|FG001|COMPLETED|Washout (One Hour)||17
9066178|NCT04107493|10126637|FG000|NOT COMPLETED|Washout (One Hour)||0
9066179|NCT04107493|10126638|FG001|NOT COMPLETED|Washout (One Hour)||0
9066180|NCT04107493|10126637|FG000|STARTED|Second Intervention||16
9066181|NCT04107493|10126638|FG001|STARTED|Second Intervention||17
9066182|NCT04107493|10126637|FG000|COMPLETED|Second Intervention||16
9066183|NCT04107493|10126638|FG001|COMPLETED|Second Intervention||17
9066184|NCT04107493|10126637|FG000|NOT COMPLETED|Second Intervention||0
9066185|NCT04107493|10126638|FG001|NOT COMPLETED|Second Intervention||0
9066186|NCT04106817|10126647|FG000|STARTED|Overall Study||12
9066187|NCT04106817|10126648|FG001|STARTED|Overall Study||11
9066188|NCT04106817|10126649|FG002|STARTED|Overall Study||12
9066189|NCT04106817|10126647|FG000|COMPLETED|Overall Study||11
9066190|NCT04106817|10126648|FG001|COMPLETED|Overall Study||11
9066191|NCT04106817|10126649|FG002|COMPLETED|Overall Study||12
9066192|NCT04106817|10126647|FG000|NOT COMPLETED|Overall Study||1
9066193|NCT04106817|10126648|FG001|NOT COMPLETED|Overall Study||0
9066194|NCT04106817|10126649|FG002|NOT COMPLETED|Overall Study||0
9066195|NCT04105972|10126659|FG000|STARTED|Overall Study||88
9066196|NCT04105972|10126660|FG001|STARTED|Overall Study||87
9066197|NCT04105972|10126659|FG000|COMPLETED|Overall Study||86
8623387|NCT00493012|9662601|FG000|COMPLETED|Overall Study||82
8623388|NCT00493012|9662602|FG001|COMPLETED|Overall Study||83
8623389|NCT00493012|9662601|FG000|NOT COMPLETED|Overall Study||18
8623390|NCT00493012|9662602|FG001|NOT COMPLETED|Overall Study||17
8623391|NCT00493038|9662610|FG000|STARTED|Treatment||147
9066198|NCT04105972|10126660|FG001|COMPLETED|Overall Study||86
9066199|NCT04105972|10126659|FG000|NOT COMPLETED|Overall Study||2
9066200|NCT04105972|10126660|FG001|NOT COMPLETED|Overall Study||1
9066201|NCT04105218|10126668|FG000|STARTED|Overall Study||6
9066202|NCT04105218|10126669|FG001|STARTED|Overall Study||6
9066203|NCT04105218|10126668|FG000|Completed First Condition|Overall Study||0
9066204|NCT04105218|10126669|FG001|Completed First Condition|Overall Study||1
9066205|NCT04105218|10126668|FG000|Completed Second Condition|Overall Study||0
9066206|NCT04105218|10126669|FG001|Completed Second Condition|Overall Study||0
9066207|NCT04105218|10126668|FG000|COMPLETED|Overall Study||0
9066208|NCT04105218|10126669|FG001|COMPLETED|Overall Study||0
9066209|NCT04105218|10126668|FG000|NOT COMPLETED|Overall Study||6
9066210|NCT04105218|10126669|FG001|NOT COMPLETED|Overall Study||6
9066211|NCT04102956|10126677|FG000|STARTED|Overall Study||42
9066212|NCT04102956|10126678|FG001|STARTED|Overall Study||38
9066213|NCT04102956|10126677|FG000|COMPLETED|Overall Study||42
9066214|NCT04102956|10126678|FG001|COMPLETED|Overall Study||38
8623392|NCT00493038|9662611|FG001|STARTED|Treatment||146
8623393|NCT00493038|9662610|FG000|Randomization|Treatment||147
8623394|NCT00493038|9662611|FG001|Randomization|Treatment||146
8623395|NCT00493038|9662610|FG000|Treated With Study Medication|Treatment||145
8623396|NCT00493038|9662611|FG001|Treated With Study Medication|Treatment||142
8623397|NCT00493038|9662610|FG000|Test-of-Cure Visit|Treatment||123
9066215|NCT04102956|10126677|FG000|NOT COMPLETED|Overall Study||0
9066216|NCT04102956|10126678|FG001|NOT COMPLETED|Overall Study||0
9066217|NCT04102540|10126684|FG000|STARTED|Overall Study||32
9066218|NCT04102540|10126684|FG000|COMPLETED|Overall Study||24
9066219|NCT04102540|10126684|FG000|NOT COMPLETED|Overall Study||8
9066220|NCT04102345|10126690|FG000|STARTED|Overall Study||26
8623398|NCT00493038|9662611|FG001|Test-of-Cure Visit|Treatment||126
8947265|NCT02418468|10009449|FG001|STARTED|Overall Study||11
8947266|NCT02418468|10009448|FG000|COMPLETED|Overall Study||11
8947267|NCT02418468|10009449|FG001|COMPLETED|Overall Study||10
8947268|NCT02418468|10009448|FG000|NOT COMPLETED|Overall Study||2
9066221|NCT04102345|10126691|FG001|STARTED|Overall Study||32
9066222|NCT04102345|10126690|FG000|COMPLETED|Overall Study||25
9066223|NCT04102345|10126691|FG001|COMPLETED|Overall Study||32
9066224|NCT04102345|10126690|FG000|NOT COMPLETED|Overall Study||1
9066225|NCT04102345|10126691|FG001|NOT COMPLETED|Overall Study||0
9066226|NCT04092907|10126699|FG000|STARTED|Overall Study||50
8947269|NCT02418468|10009449|FG001|NOT COMPLETED|Overall Study||1
8947270|NCT02418546|10009458|FG000|STARTED|Overall Study||26
8947271|NCT02418546|10009459|FG001|STARTED|Overall Study||26
8947272|NCT02418546|10009460|FG002|STARTED|Overall Study||26
8947273|NCT02418546|10009458|FG000|COMPLETED|Overall Study||19
8947274|NCT02418546|10009459|FG001|COMPLETED|Overall Study||20
8947275|NCT02418546|10009460|FG002|COMPLETED|Overall Study||23
8947276|NCT02418546|10009458|FG000|NOT COMPLETED|Overall Study||7
8947277|NCT02418546|10009459|FG001|NOT COMPLETED|Overall Study||6
8947278|NCT02418546|10009460|FG002|NOT COMPLETED|Overall Study||3
8947279|NCT02418585|10009470|FG000|STARTED|Double Blind (DB) Phase (4 Weeks)||116
8947280|NCT02418585|10009471|FG001|STARTED|Double Blind (DB) Phase (4 Weeks)||111
8947281|NCT02418585|10009470|FG000|Safety Analysis Set|Double Blind (DB) Phase (4 Weeks)||115
8947282|NCT02418585|10009471|FG001|Safety Analysis Set|Double Blind (DB) Phase (4 Weeks)||109
8947283|NCT02418585|10009470|FG000|Full Analysis Set|Double Blind (DB) Phase (4 Weeks)||114
8947284|NCT02418585|10009471|FG001|Full Analysis Set|Double Blind (DB) Phase (4 Weeks)||109
8947285|NCT02418585|10009470|FG000|COMPLETED|Double Blind (DB) Phase (4 Weeks)||98
8947286|NCT02418585|10009471|FG001|COMPLETED|Double Blind (DB) Phase (4 Weeks)||99
8947287|NCT02418585|10009470|FG000|NOT COMPLETED|Double Blind (DB) Phase (4 Weeks)||18
8947288|NCT02418585|10009471|FG001|NOT COMPLETED|Double Blind (DB) Phase (4 Weeks)||12
8947289|NCT02418585|10009470|FG000|STARTED|Follow-up Phase (24 Weeks)||34
8947290|NCT02418585|10009471|FG001|STARTED|Follow-up Phase (24 Weeks)||52
8947291|NCT02418585|10009470|FG000|COMPLETED|Follow-up Phase (24 Weeks)||16
8947292|NCT02418585|10009471|FG001|COMPLETED|Follow-up Phase (24 Weeks)||27
8947293|NCT02418585|10009470|FG000|NOT COMPLETED|Follow-up Phase (24 Weeks)||18
8947294|NCT02418585|10009471|FG001|NOT COMPLETED|Follow-up Phase (24 Weeks)||25
8947295|NCT02418676|10009482|FG000|STARTED|Overall Study||5
8947296|NCT02418676|10009483|FG001|STARTED|Overall Study||5
8947297|NCT02418676|10009484|FG002|STARTED|Overall Study||5
8947298|NCT02418676|10009482|FG000|COMPLETED|Overall Study||5
8947299|NCT02418676|10009483|FG001|COMPLETED|Overall Study||5
8947300|NCT02418676|10009484|FG002|COMPLETED|Overall Study||5
8947301|NCT02418676|10009482|FG000|NOT COMPLETED|Overall Study||0
8947302|NCT02418676|10009483|FG001|NOT COMPLETED|Overall Study||0
8947303|NCT02418676|10009484|FG002|NOT COMPLETED|Overall Study||0
8947304|NCT02418754|10009495|FG000|STARTED|Period 1 (Day 1 to Week 12)||103
8947305|NCT02418754|10009496|FG001|STARTED|Period 1 (Day 1 to Week 12)||200
8947306|NCT02418754|10009497|FG002|STARTED|Period 1 (Day 1 to Week 12)||202
8947307|NCT02418754|10009498|FG003|STARTED|Period 1 (Day 1 to Week 12)||0
8947308|NCT02418754|10009499|FG004|STARTED|Period 1 (Day 1 to Week 12)||0
8947309|NCT02418754|10009495|FG000|COMPLETED|Period 1 (Day 1 to Week 12)||101
8947310|NCT02418754|10009496|FG001|COMPLETED|Period 1 (Day 1 to Week 12)||196
8947311|NCT02418754|10009497|FG002|COMPLETED|Period 1 (Day 1 to Week 12)||200
8947312|NCT02418754|10009498|FG003|COMPLETED|Period 1 (Day 1 to Week 12)||0
8947313|NCT02418754|10009499|FG004|COMPLETED|Period 1 (Day 1 to Week 12)||0
8947314|NCT02418754|10009495|FG000|NOT COMPLETED|Period 1 (Day 1 to Week 12)||2
8947315|NCT02418754|10009496|FG001|NOT COMPLETED|Period 1 (Day 1 to Week 12)||4
8947316|NCT02418754|10009497|FG002|NOT COMPLETED|Period 1 (Day 1 to Week 12)||2
8947317|NCT02418754|10009498|FG003|NOT COMPLETED|Period 1 (Day 1 to Week 12)||0
8947318|NCT02418754|10009499|FG004|NOT COMPLETED|Period 1 (Day 1 to Week 12)||0
8947319|NCT02418754|10009495|FG000|STARTED|Period 2 (Day 1 to Week 52/End of Study)||103
8947320|NCT02418754|10009496|FG001|STARTED|Period 2 (Day 1 to Week 52/End of Study)||106
8947321|NCT02418754|10009497|FG002|STARTED|Period 2 (Day 1 to Week 52/End of Study)||108
8947322|NCT02418754|10009498|FG003|STARTED|Period 2 (Day 1 to Week 52/End of Study)||94
8947323|NCT02418754|10009499|FG004|STARTED|Period 2 (Day 1 to Week 52/End of Study)||94
8947324|NCT02418754|10009495|FG000|COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||70
8947325|NCT02418754|10009496|FG001|COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||64
8947326|NCT02418754|10009497|FG002|COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||71
8947327|NCT02418754|10009498|FG003|COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||67
8947328|NCT02418754|10009499|FG004|COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||67
8947329|NCT02418754|10009495|FG000|NOT COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||33
8947330|NCT02418754|10009496|FG001|NOT COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||42
8947331|NCT02418754|10009497|FG002|NOT COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||37
8947332|NCT02418754|10009498|FG003|NOT COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||27
8947333|NCT02418754|10009499|FG004|NOT COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||27
8947334|NCT02418819|10009513|FG000|STARTED|Overall Study||22
8947335|NCT02418819|10009514|FG001|STARTED|Overall Study||16
8947336|NCT02418819|10009515|FG002|STARTED|Overall Study||33
8947337|NCT02418819|10009516|FG003|STARTED|Overall Study||29
8947338|NCT02418819|10009513|FG000|COMPLETED|Overall Study||21
8947339|NCT02418819|10009514|FG001|COMPLETED|Overall Study||16
8623399|NCT00493038|9662610|FG000|COMPLETED|Treatment||123
8623400|NCT00493038|9662611|FG001|COMPLETED|Treatment||126
8623401|NCT00493038|9662610|FG000|NOT COMPLETED|Treatment||24
8623402|NCT00493038|9662611|FG001|NOT COMPLETED|Treatment||20
8623403|NCT00493038|9662610|FG000|STARTED|Follow-up||123
8947340|NCT02418819|10009515|FG002|COMPLETED|Overall Study||29
8947341|NCT02418819|10009516|FG003|COMPLETED|Overall Study||28
8947342|NCT02418819|10009513|FG000|NOT COMPLETED|Overall Study||1
8947343|NCT02418819|10009514|FG001|NOT COMPLETED|Overall Study||0
8947344|NCT02418819|10009515|FG002|NOT COMPLETED|Overall Study||4
8947345|NCT02418819|10009516|FG003|NOT COMPLETED|Overall Study||1
8623404|NCT00493038|9662611|FG001|STARTED|Follow-up||126
8623405|NCT00493038|9662610|FG000|COMPLETED|Follow-up||122
8623406|NCT00493038|9662611|FG001|COMPLETED|Follow-up||126
8623407|NCT00493038|9662610|FG000|NOT COMPLETED|Follow-up||1
8623408|NCT00493038|9662611|FG001|NOT COMPLETED|Follow-up||0
8623409|NCT00493064|9662617|FG000|STARTED|Overall Study||63
8623410|NCT00493064|9662617|FG000|COMPLETED|Overall Study||52
8623411|NCT00493064|9662617|FG000|NOT COMPLETED|Overall Study||11
8623412|NCT00493181|9662621|FG000|STARTED|Overall Study||8
8623413|NCT00493181|9662621|FG000|COMPLETED|Overall Study||8
8623414|NCT00493181|9662621|FG000|NOT COMPLETED|Overall Study||0
8623415|NCT00493220|9662631|FG000|STARTED|First Intervention||5
8623416|NCT00493220|9662632|FG001|STARTED|First Intervention||5
8623417|NCT00493220|9662633|FG002|STARTED|First Intervention||5
8623418|NCT00493220|9662634|FG003|STARTED|First Intervention||5
8623419|NCT00493220|9662635|FG004|STARTED|First Intervention||5
8623420|NCT00493220|9662636|FG005|STARTED|First Intervention||5
8623421|NCT00493220|9662631|FG000|COMPLETED|First Intervention||5
8623422|NCT00493220|9662632|FG001|COMPLETED|First Intervention||5
8623423|NCT00493220|9662633|FG002|COMPLETED|First Intervention||5
8623424|NCT00493220|9662634|FG003|COMPLETED|First Intervention||5
8623425|NCT00493220|9662635|FG004|COMPLETED|First Intervention||5
8623426|NCT00493220|9662636|FG005|COMPLETED|First Intervention||5
8623427|NCT00493220|9662631|FG000|NOT COMPLETED|First Intervention||0
8623428|NCT00493220|9662632|FG001|NOT COMPLETED|First Intervention||0
8623429|NCT00493220|9662633|FG002|NOT COMPLETED|First Intervention||0
8623430|NCT00493220|9662634|FG003|NOT COMPLETED|First Intervention||0
8623431|NCT00493220|9662635|FG004|NOT COMPLETED|First Intervention||0
8623432|NCT00493220|9662636|FG005|NOT COMPLETED|First Intervention||0
8623433|NCT00493220|9662631|FG000|STARTED|First 7-Day Washout & Safety Follow-up||5
8623434|NCT00493220|9662632|FG001|STARTED|First 7-Day Washout & Safety Follow-up||5
8623435|NCT00493220|9662633|FG002|STARTED|First 7-Day Washout & Safety Follow-up||5
8623436|NCT00493220|9662634|FG003|STARTED|First 7-Day Washout & Safety Follow-up||5
8623437|NCT00493220|9662635|FG004|STARTED|First 7-Day Washout & Safety Follow-up||5
8623438|NCT00493220|9662636|FG005|STARTED|First 7-Day Washout & Safety Follow-up||5
8623439|NCT00493220|9662631|FG000|COMPLETED|First 7-Day Washout & Safety Follow-up||5
8623440|NCT00493220|9662632|FG001|COMPLETED|First 7-Day Washout & Safety Follow-up||5
8623441|NCT00493220|9662633|FG002|COMPLETED|First 7-Day Washout & Safety Follow-up||5
8623442|NCT00493220|9662634|FG003|COMPLETED|First 7-Day Washout & Safety Follow-up||5
8623443|NCT00493220|9662635|FG004|COMPLETED|First 7-Day Washout & Safety Follow-up||5
8623444|NCT00493220|9662636|FG005|COMPLETED|First 7-Day Washout & Safety Follow-up||5
8623445|NCT00493220|9662631|FG000|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
8623446|NCT00493220|9662632|FG001|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
8623447|NCT00493220|9662633|FG002|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
8623448|NCT00493220|9662634|FG003|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
8623449|NCT00493220|9662635|FG004|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
8623450|NCT00493220|9662636|FG005|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
8623451|NCT00493220|9662631|FG000|STARTED|Second Intervention||5
8623452|NCT00493220|9662632|FG001|STARTED|Second Intervention||5
8623453|NCT00493220|9662633|FG002|STARTED|Second Intervention||5
8623454|NCT00493220|9662634|FG003|STARTED|Second Intervention||5
8623455|NCT00493220|9662635|FG004|STARTED|Second Intervention||5
8623456|NCT00493220|9662636|FG005|STARTED|Second Intervention||5
8623457|NCT00493220|9662631|FG000|COMPLETED|Second Intervention||5
8623458|NCT00493220|9662632|FG001|COMPLETED|Second Intervention||5
8623459|NCT00493220|9662633|FG002|COMPLETED|Second Intervention||5
8623460|NCT00493220|9662634|FG003|COMPLETED|Second Intervention||5
8623461|NCT00493220|9662635|FG004|COMPLETED|Second Intervention||5
8623462|NCT00493220|9662636|FG005|COMPLETED|Second Intervention||5
8623463|NCT00493220|9662631|FG000|NOT COMPLETED|Second Intervention||0
8623464|NCT00493220|9662632|FG001|NOT COMPLETED|Second Intervention||0
8623465|NCT00493220|9662633|FG002|NOT COMPLETED|Second Intervention||0
8623466|NCT00493220|9662634|FG003|NOT COMPLETED|Second Intervention||0
8623467|NCT00493220|9662635|FG004|NOT COMPLETED|Second Intervention||0
8623468|NCT00493220|9662636|FG005|NOT COMPLETED|Second Intervention||0
8623469|NCT00493220|9662631|FG000|STARTED|Second 7-Day Washout & Safety Follow-up||5
8623470|NCT00493220|9662632|FG001|STARTED|Second 7-Day Washout & Safety Follow-up||5
8623471|NCT00493220|9662633|FG002|STARTED|Second 7-Day Washout & Safety Follow-up||5
8623472|NCT00493220|9662634|FG003|STARTED|Second 7-Day Washout & Safety Follow-up||5
8623473|NCT00493220|9662635|FG004|STARTED|Second 7-Day Washout & Safety Follow-up||5
8623474|NCT00493220|9662636|FG005|STARTED|Second 7-Day Washout & Safety Follow-up||5
8623475|NCT00493220|9662631|FG000|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
8623476|NCT00493220|9662632|FG001|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
8623477|NCT00493220|9662633|FG002|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
8623478|NCT00493220|9662634|FG003|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
8623479|NCT00493220|9662635|FG004|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
8623480|NCT00493220|9662636|FG005|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
8623481|NCT00493220|9662631|FG000|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
8623482|NCT00493220|9662632|FG001|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
8623483|NCT00493220|9662633|FG002|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
8623484|NCT00493220|9662634|FG003|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
8623485|NCT00493220|9662635|FG004|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
8623486|NCT00493220|9662636|FG005|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
8623487|NCT00493220|9662631|FG000|STARTED|Third Intervention||5
8623488|NCT00493220|9662632|FG001|STARTED|Third Intervention||5
8623489|NCT00493220|9662633|FG002|STARTED|Third Intervention||5
8623490|NCT00493220|9662634|FG003|STARTED|Third Intervention||5
8623491|NCT00493220|9662635|FG004|STARTED|Third Intervention||5
8623492|NCT00493220|9662636|FG005|STARTED|Third Intervention||5
8623493|NCT00493220|9662631|FG000|COMPLETED|Third Intervention||4
8623494|NCT00493220|9662632|FG001|COMPLETED|Third Intervention||5
8623495|NCT00493220|9662633|FG002|COMPLETED|Third Intervention||5
8623496|NCT00493220|9662634|FG003|COMPLETED|Third Intervention||5
8623497|NCT00493220|9662635|FG004|COMPLETED|Third Intervention||5
8623498|NCT00493220|9662636|FG005|COMPLETED|Third Intervention||5
8623499|NCT00493220|9662631|FG000|NOT COMPLETED|Third Intervention||1
8623500|NCT00493220|9662632|FG001|NOT COMPLETED|Third Intervention||0
8842938|NCT01701258|9897258|FG000|Received Drug Challenge|Drug+fMRI (Session 2)||0
8842939|NCT01701258|9897259|FG001|Received Drug Challenge|Drug+fMRI (Session 2)||0
8842940|NCT01701258|9897260|FG002|Received Drug Challenge|Drug+fMRI (Session 2)||11
8842941|NCT01701258|9897261|FG003|Received Drug Challenge|Drug+fMRI (Session 2)||11
8842942|NCT01701258|9897262|FG004|Received Drug Challenge|Drug+fMRI (Session 2)||0
8842943|NCT01701258|9897263|FG005|Received Drug Challenge|Drug+fMRI (Session 2)||9
8842944|NCT01701258|9897264|FG006|Received Drug Challenge|Drug+fMRI (Session 2)||8
8842945|NCT01701258|9897265|FG007|Received Drug Challenge|Drug+fMRI (Session 2)||0
8842946|NCT01701258|9897266|FG008|Received Drug Challenge|Drug+fMRI (Session 2)||6
8623501|NCT00493220|9662633|FG002|NOT COMPLETED|Third Intervention||0
8623502|NCT00493220|9662634|FG003|NOT COMPLETED|Third Intervention||0
8947346|NCT02418845|10009528|FG000|STARTED|Overall Study||125
8947347|NCT02418845|10009529|FG001|STARTED|Overall Study||64
8947348|NCT02418845|10009528|FG000|COMPLETED|Overall Study||109
8947349|NCT02418845|10009529|FG001|COMPLETED|Overall Study||52
8947350|NCT02418845|10009528|FG000|NOT COMPLETED|Overall Study||16
8947351|NCT02418845|10009529|FG001|NOT COMPLETED|Overall Study||12
8947352|NCT02418910|10009535|FG000|STARTED|Overall Study||50
8947353|NCT02418910|10009535|FG000|COMPLETED|Overall Study||43
8947354|NCT02418910|10009535|FG000|NOT COMPLETED|Overall Study||7
8947355|NCT02418949|10009543|FG000|STARTED|Overall Study||23
8947356|NCT02418949|10009544|FG001|STARTED|Overall Study||22
8947357|NCT02418949|10009545|FG002|STARTED|Overall Study||26
8947358|NCT02418949|10009546|FG003|STARTED|Overall Study||25
8947359|NCT02418949|10009543|FG000|COMPLETED|Overall Study||20
8947360|NCT02418949|10009544|FG001|COMPLETED|Overall Study||21
8947361|NCT02418949|10009545|FG002|COMPLETED|Overall Study||23
8947362|NCT02418949|10009546|FG003|COMPLETED|Overall Study||24
8947363|NCT02418949|10009543|FG000|NOT COMPLETED|Overall Study||3
8947364|NCT02418949|10009544|FG001|NOT COMPLETED|Overall Study||1
8947365|NCT02418949|10009545|FG002|NOT COMPLETED|Overall Study||3
8947366|NCT02418949|10009546|FG003|NOT COMPLETED|Overall Study||1
8947367|NCT02419001|10009558|FG000|STARTED|Period 1- Ceftriaxone Without SYN-004||6
8947368|NCT02419001|10009559|FG001|STARTED|Period 1- Ceftriaxone Without SYN-004||5
8947369|NCT02419001|10009558|FG000|COMPLETED|Period 1- Ceftriaxone Without SYN-004|The Adverse Event (AE) was with ceftriaxone, not with Investigational Product (IP)|5
8947370|NCT02419001|10009559|FG001|COMPLETED|Period 1- Ceftriaxone Without SYN-004||5
8947371|NCT02419001|10009558|FG000|NOT COMPLETED|Period 1- Ceftriaxone Without SYN-004||1
8947372|NCT02419001|10009559|FG001|NOT COMPLETED|Period 1- Ceftriaxone Without SYN-004||0
8947373|NCT02419001|10009558|FG000|STARTED|Period 2- Ceftriaxone With SYN-004||5
8947374|NCT02419001|10009559|FG001|STARTED|Period 2- Ceftriaxone With SYN-004||5
8947375|NCT02419001|10009558|FG000|COMPLETED|Period 2- Ceftriaxone With SYN-004||5
8947376|NCT02419001|10009559|FG001|COMPLETED|Period 2- Ceftriaxone With SYN-004||5
8947377|NCT02419001|10009558|FG000|NOT COMPLETED|Period 2- Ceftriaxone With SYN-004||0
8947378|NCT02419001|10009559|FG001|NOT COMPLETED|Period 2- Ceftriaxone With SYN-004||0
8947379|NCT02419313|10009565|FG000|STARTED|First Intervention||18
8947380|NCT02419313|10009566|FG001|STARTED|First Intervention||15
8947381|NCT02419313|10009565|FG000|COMPLETED|First Intervention||16
8947382|NCT02419313|10009566|FG001|COMPLETED|First Intervention||15
8947383|NCT02419313|10009565|FG000|NOT COMPLETED|First Intervention||2
8947384|NCT02419313|10009566|FG001|NOT COMPLETED|First Intervention||0
8947385|NCT02419313|10009565|FG000|STARTED|Second Intervention||16
8947386|NCT02419313|10009566|FG001|STARTED|Second Intervention||15
8947387|NCT02419313|10009565|FG000|COMPLETED|Second Intervention||15
8623503|NCT00493220|9662635|FG004|NOT COMPLETED|Third Intervention||0
8623504|NCT00493220|9662636|FG005|NOT COMPLETED|Third Intervention||0
8623505|NCT00493220|9662631|FG000|STARTED|Final 7-Day Safety Follow-up||4
8623506|NCT00493220|9662632|FG001|STARTED|Final 7-Day Safety Follow-up||5
8623507|NCT00493220|9662633|FG002|STARTED|Final 7-Day Safety Follow-up||5
8623508|NCT00493220|9662634|FG003|STARTED|Final 7-Day Safety Follow-up||5
8623509|NCT00493220|9662635|FG004|STARTED|Final 7-Day Safety Follow-up||5
8623510|NCT00493220|9662636|FG005|STARTED|Final 7-Day Safety Follow-up||5
8947388|NCT02419313|10009566|FG001|COMPLETED|Second Intervention||15
8947389|NCT02419313|10009565|FG000|NOT COMPLETED|Second Intervention||1
8947390|NCT02419313|10009566|FG001|NOT COMPLETED|Second Intervention||0
8947391|NCT02419469|10009572|FG000|STARTED|Overall Study||1
8947392|NCT02419469|10009572|FG000|COMPLETED|Overall Study||0
8623511|NCT00493220|9662631|FG000|COMPLETED|Final 7-Day Safety Follow-up||4
8947393|NCT02419469|10009572|FG000|NOT COMPLETED|Overall Study||1
8947394|NCT02419508|10009578|FG000|STARTED|Overall Study||96
8947395|NCT02419508|10009579|FG001|STARTED|Overall Study||92
8947396|NCT02419508|10009578|FG000|Full Analysis Set|Overall Study||95
8947397|NCT02419508|10009579|FG001|Full Analysis Set|Overall Study||92
8947398|NCT02419508|10009578|FG000|Safety Analysis Set|Overall Study||95
8947399|NCT02419508|10009579|FG001|Safety Analysis Set|Overall Study||92
8947400|NCT02419508|10009578|FG000|COMPLETED|Overall Study||86
8556709|NCT01363401|9588484|FG001|STARTED|Overall Study||31
8556710|NCT01363401|9588483|FG000|COMPLETED|Overall Study||39
8556711|NCT01363401|9588484|FG001|COMPLETED|Overall Study||27
8556712|NCT01363401|9588483|FG000|NOT COMPLETED|Overall Study||2
8556713|NCT01363401|9588484|FG001|NOT COMPLETED|Overall Study||4
8947401|NCT02419508|10009579|FG001|COMPLETED|Overall Study||88
8947402|NCT02419508|10009578|FG000|NOT COMPLETED|Overall Study||10
8947403|NCT02419508|10009579|FG001|NOT COMPLETED|Overall Study||4
8947404|NCT02419521|10009585|FG000|STARTED|Overall Study||75
8947405|NCT02419521|10009585|FG000|COMPLETED|Overall Study||74
8947406|NCT02419521|10009585|FG000|NOT COMPLETED|Overall Study||1
8947407|NCT02419547|10009589|FG000|STARTED|Overall Study||11
8947408|NCT02419547|10009589|FG000|COMPLETED|Overall Study||11
8947409|NCT02419547|10009589|FG000|NOT COMPLETED|Overall Study||0
8947410|NCT02419573|10009595|FG000|STARTED|Overall Study||1499
8947411|NCT02419573|10009596|FG001|STARTED|Overall Study||1505
8947412|NCT02419573|10009595|FG000|COMPLETED|Overall Study||1495
8947413|NCT02419573|10009596|FG001|COMPLETED|Overall Study||1505
8947414|NCT02419573|10009595|FG000|NOT COMPLETED|Overall Study||4
8947415|NCT02419573|10009596|FG001|NOT COMPLETED|Overall Study||0
8947416|NCT02419612|10009604|FG000|STARTED|Short-term Treatment Period||227
8947417|NCT02419612|10009605|FG001|STARTED|Short-term Treatment Period||217
8947418|NCT02419612|10009604|FG000|Recevied Treatment|Short-term Treatment Period||227
8947419|NCT02419612|10009605|FG001|Recevied Treatment|Short-term Treatment Period||216
8947420|NCT02419612|10009604|FG000|COMPLETED|Short-term Treatment Period||210
8947421|NCT02419612|10009605|FG001|COMPLETED|Short-term Treatment Period||194
8947422|NCT02419612|10009604|FG000|NOT COMPLETED|Short-term Treatment Period||17
8947423|NCT02419612|10009605|FG001|NOT COMPLETED|Short-term Treatment Period||23
8947424|NCT02419612|10009604|FG000|STARTED|Long-term Treatment Period|Not all subjects who completed the previous period were eligible to enter the long-term period.|196
8947425|NCT02419612|10009605|FG001|STARTED|Long-term Treatment Period|Not all subjects who completed the previous period were eligible to enter the long-term period.|186
8947426|NCT02419612|10009604|FG000|Received Treatment|Long-term Treatment Period||196
8947427|NCT02419612|10009605|FG001|Received Treatment|Long-term Treatment Period||183
8947428|NCT02419612|10009604|FG000|COMPLETED|Long-term Treatment Period||174
8947429|NCT02419612|10009605|FG001|COMPLETED|Long-term Treatment Period||164
8947430|NCT02419612|10009604|FG000|NOT COMPLETED|Long-term Treatment Period||22
8947431|NCT02419612|10009605|FG001|NOT COMPLETED|Long-term Treatment Period||22
8947432|NCT02419690|10009613|FG000|STARTED|Overall Study||122
8947433|NCT02419690|10009614|FG001|STARTED|Overall Study||122
8947434|NCT02419690|10009613|FG000|COMPLETED|Overall Study||122
8947435|NCT02419690|10009614|FG001|COMPLETED|Overall Study||122
8947436|NCT02419690|10009613|FG000|NOT COMPLETED|Overall Study||0
8947437|NCT02419690|10009614|FG001|NOT COMPLETED|Overall Study||0
8947438|NCT02419755|10009622|FG000|STARTED|Overall Study||6
8947439|NCT02419755|10009623|FG001|STARTED|Overall Study||6
8947440|NCT02419755|10009622|FG000|COMPLETED|Overall Study||3
8947441|NCT02419755|10009623|FG001|COMPLETED|Overall Study||2
8947442|NCT02419755|10009622|FG000|NOT COMPLETED|Overall Study||3
8947443|NCT02419755|10009623|FG001|NOT COMPLETED|Overall Study||4
8947444|NCT02419807|10009629|FG000|STARTED|Overall Study||102
8947445|NCT02419807|10009629|FG000|COMPLETED|Overall Study||92
8947446|NCT02419807|10009629|FG000|NOT COMPLETED|Overall Study||10
8947447|NCT02419924|10009633|FG000|STARTED|Overall Study||12
8947448|NCT02419924|10009633|FG000|COMPLETED|Overall Study||12
8947449|NCT02419924|10009633|FG000|NOT COMPLETED|Overall Study||0
8947450|NCT02419937|10009639|FG000|STARTED|Overall Study||12
8947451|NCT02419937|10009640|FG001|STARTED|Overall Study||16
8947452|NCT02419937|10009639|FG000|COMPLETED|Overall Study||11
8947453|NCT02419937|10009640|FG001|COMPLETED|Overall Study||16
8947454|NCT02419937|10009639|FG000|NOT COMPLETED|Overall Study||1
8947455|NCT02419937|10009640|FG001|NOT COMPLETED|Overall Study||0
8947456|NCT02420015|10009648|FG000|STARTED|Overall Study||21
8947457|NCT02420015|10009649|FG001|STARTED|Overall Study||13
8947458|NCT02420015|10009648|FG000|COMPLETED|Overall Study||21
8947459|NCT02420015|10009649|FG001|COMPLETED|Overall Study||13
8947460|NCT02420015|10009648|FG000|NOT COMPLETED|Overall Study||0
8947461|NCT02420015|10009649|FG001|NOT COMPLETED|Overall Study||0
8947462|NCT02420041|10009657|FG000|STARTED|Overall Study||14
8947463|NCT02420041|10009658|FG001|STARTED|Overall Study||14
8947464|NCT02420041|10009657|FG000|COMPLETED|Overall Study||14
8556714|NCT00961064|9588490|FG000|STARTED|Overall Study||30
8556715|NCT00961064|9588490|FG000|COMPLETED|Overall Study||30
8556716|NCT00961064|9588490|FG000|NOT COMPLETED|Overall Study||0
8556717|NCT00378482|9588494|FG000|STARTED|Overall Study||37
8556718|NCT00378482|9588494|FG000|COMPLETED|Overall Study||6
8556719|NCT00378482|9588494|FG000|NOT COMPLETED|Overall Study||31
8556720|NCT03825393|9588500|FG000|STARTED|Overall Study||100
8556721|NCT03825393|9588501|FG001|STARTED|Overall Study||100
8947465|NCT02420041|10009658|FG001|COMPLETED|Overall Study||14
8947466|NCT02420041|10009657|FG000|NOT COMPLETED|Overall Study||0
8947467|NCT02420041|10009658|FG001|NOT COMPLETED|Overall Study||0
8947468|NCT02420093|10009666|FG000|STARTED|Overall Study||9
8947469|NCT02420093|10009667|FG001|STARTED|Overall Study||8
8947470|NCT02420093|10009666|FG000|COMPLETED|Overall Study||8
8947471|NCT02420093|10009667|FG001|COMPLETED|Overall Study||7
8947472|NCT02420093|10009666|FG000|NOT COMPLETED|Overall Study||1
8947473|NCT02420093|10009667|FG001|NOT COMPLETED|Overall Study||1
8947474|NCT02420210|10009673|FG000|STARTED|Overall Study||2
8947475|NCT02420210|10009673|FG000|COMPLETED|Overall Study||2
8947476|NCT02420210|10009673|FG000|NOT COMPLETED|Overall Study||0
8947477|NCT02420223|10009679|FG000|STARTED|Overall Study||12
8947478|NCT02420223|10009680|FG001|STARTED|Overall Study||13
8947479|NCT02420223|10009679|FG000|COMPLETED|Overall Study||11
8947480|NCT02420223|10009680|FG001|COMPLETED|Overall Study||11
8947481|NCT02420223|10009679|FG000|NOT COMPLETED|Overall Study||1
8947482|NCT02420223|10009680|FG001|NOT COMPLETED|Overall Study||2
8947483|NCT02420262|10009688|FG000|STARTED|Overall Study||252
8947484|NCT02420262|10009689|FG001|STARTED|Overall Study||254
8947485|NCT02420262|10009688|FG000|Exposed|Overall Study||252
8947486|NCT02420262|10009689|FG001|Exposed|Overall Study|One subject withdrew consent before exposure to trial product due to personal reasons.|253
8947487|NCT02420262|10009688|FG000|COMPLETED|Overall Study||250
8947488|NCT02420262|10009689|FG001|COMPLETED|Overall Study||249
8947489|NCT02420262|10009688|FG000|NOT COMPLETED|Overall Study||2
8947490|NCT02420262|10009689|FG001|NOT COMPLETED|Overall Study||5
8947491|NCT02420327|10009695|FG000|STARTED|Overall Study||43
8947492|NCT02420327|10009695|FG000|COMPLETED|Overall Study||27
8947493|NCT02420327|10009695|FG000|NOT COMPLETED|Overall Study||16
8947494|NCT02420353|10009707|FG000|STARTED|Overall Study||10
8947495|NCT02420353|10009708|FG001|STARTED|Overall Study||10
8947496|NCT02420353|10009707|FG000|Allocation to Intervention|Overall Study||10
8947497|NCT02420353|10009708|FG001|Allocation to Intervention|Overall Study||10
8947498|NCT02420353|10009707|FG000|COMPLETED|Overall Study||10
8947499|NCT02420353|10009708|FG001|COMPLETED|Overall Study||9
8947500|NCT02420353|10009707|FG000|NOT COMPLETED|Overall Study||0
8947501|NCT02420353|10009708|FG001|NOT COMPLETED|Overall Study||1
8947502|NCT02420379|10009716|FG000|STARTED|Overall Study||26
8947503|NCT02420379|10009717|FG001|STARTED|Overall Study||7
8947504|NCT02420379|10009716|FG000|COMPLETED|Overall Study||25
8947505|NCT02420379|10009717|FG001|COMPLETED|Overall Study||3
8947506|NCT02420379|10009716|FG000|NOT COMPLETED|Overall Study||1
8947507|NCT02420379|10009717|FG001|NOT COMPLETED|Overall Study||4
8947508|NCT02420639|10009723|FG000|STARTED|Overall Study|Study obtained 12 patients|12
8947509|NCT02420639|10009723|FG000|COMPLETED|Overall Study|Total of 12 patients enrolled|12
8947510|NCT02420639|10009723|FG000|NOT COMPLETED|Overall Study||0
8947511|NCT02420691|10009727|FG000|STARTED|Overall Study||20
8947512|NCT02420691|10009727|FG000|COMPLETED|Overall Study||14
8947513|NCT02420691|10009727|FG000|NOT COMPLETED|Overall Study||6
8947514|NCT02420873|10009734|FG000|STARTED|Overall Study||9
8947515|NCT02420873|10009735|FG001|STARTED|Overall Study||0
8947516|NCT02420873|10009736|FG002|STARTED|Overall Study||0
8947517|NCT02420873|10009734|FG000|COMPLETED|Overall Study||9
8947518|NCT02420873|10009735|FG001|COMPLETED|Overall Study||0
8947519|NCT02420873|10009736|FG002|COMPLETED|Overall Study||0
8947520|NCT02420873|10009734|FG000|NOT COMPLETED|Overall Study||0
8947521|NCT02420873|10009735|FG001|NOT COMPLETED|Overall Study||0
8947522|NCT02420873|10009736|FG002|NOT COMPLETED|Overall Study||0
8947523|NCT02420951|10009746|FG000|STARTED|Overall Study||25
8947524|NCT02420951|10009747|FG001|STARTED|Overall Study||25
8947525|NCT02420951|10009746|FG000|COMPLETED|Overall Study||25
8947526|NCT02420951|10009747|FG001|COMPLETED|Overall Study||25
8947527|NCT02420951|10009746|FG000|NOT COMPLETED|Overall Study||0
8947528|NCT02420951|10009747|FG001|NOT COMPLETED|Overall Study||0
8947529|NCT02421055|10009755|FG000|STARTED|Overall Study||34
8947530|NCT02421055|10009756|FG001|STARTED|Overall Study||50
8947531|NCT02421055|10009757|FG002|STARTED|Overall Study||74
8947532|NCT02421055|10009755|FG000|Pre-operative Serum Sample (Minimum)|Overall Study||34
8947533|NCT02421055|10009756|FG001|Pre-operative Serum Sample (Minimum)|Overall Study||50
8947534|NCT02421055|10009757|FG002|Pre-operative Serum Sample (Minimum)|Overall Study||74
8947535|NCT02421055|10009755|FG000|Pre-operative Complete Sample Set|Overall Study||23
8947536|NCT02421055|10009756|FG001|Pre-operative Complete Sample Set|Overall Study||22
8947537|NCT02421055|10009757|FG002|Pre-operative Complete Sample Set|Overall Study||36
8947538|NCT02421055|10009755|FG000|Post-operative Serum Sample (Minimum)|Overall Study||0
8947539|NCT02421055|10009756|FG001|Post-operative Serum Sample (Minimum)|Overall Study||23
8947540|NCT02421055|10009757|FG002|Post-operative Serum Sample (Minimum)|Overall Study||26
8947541|NCT02421055|10009755|FG000|Post-operative Complete Sample Set|Overall Study||0
8947542|NCT02421055|10009756|FG001|Post-operative Complete Sample Set|Overall Study||13
8947543|NCT02421055|10009757|FG002|Post-operative Complete Sample Set|Overall Study||14
8947544|NCT02421055|10009755|FG000|COMPLETED|Overall Study||0
8947545|NCT02421055|10009756|FG001|COMPLETED|Overall Study||50
8947546|NCT02421055|10009757|FG002|COMPLETED|Overall Study||74
8947547|NCT02421055|10009755|FG000|NOT COMPLETED|Overall Study||34
8947548|NCT02421055|10009756|FG001|NOT COMPLETED|Overall Study||0
8947549|NCT02421055|10009757|FG002|NOT COMPLETED|Overall Study||0
8947550|NCT02421094|10009768|FG000|STARTED|Overall Study||15
8947551|NCT02421094|10009769|FG001|STARTED|Overall Study||15
8947552|NCT02421094|10009768|FG000|COMPLETED|Overall Study||15
8947553|NCT02421094|10009769|FG001|COMPLETED|Overall Study||15
8947554|NCT02421094|10009768|FG000|NOT COMPLETED|Overall Study||0
8947555|NCT02421094|10009769|FG001|NOT COMPLETED|Overall Study||0
8947556|NCT02421120|10009775|FG000|STARTED|Overall Study||21
8947557|NCT02421120|10009775|FG000|COMPLETED|Overall Study||20
8947558|NCT02421120|10009775|FG000|NOT COMPLETED|Overall Study||1
8947559|NCT02421146|10009783|FG000|STARTED|Overall Study||2
8947560|NCT02421146|10009784|FG001|STARTED|Overall Study||4
8947561|NCT02421146|10009785|FG002|STARTED|Overall Study||3
8947562|NCT02421146|10009786|FG003|STARTED|Overall Study||3
8947563|NCT02421146|10009783|FG000|COMPLETED|Overall Study||2
8947564|NCT02421146|10009784|FG001|COMPLETED|Overall Study||4
8947565|NCT02421146|10009785|FG002|COMPLETED|Overall Study||3
8947566|NCT02421146|10009786|FG003|COMPLETED|Overall Study||3
8947567|NCT02421146|10009783|FG000|NOT COMPLETED|Overall Study||0
8947568|NCT02421146|10009784|FG001|NOT COMPLETED|Overall Study||0
8947569|NCT02421146|10009785|FG002|NOT COMPLETED|Overall Study||0
8947570|NCT02421146|10009786|FG003|NOT COMPLETED|Overall Study||0
8947571|NCT02421172|10009798|FG000|STARTED|Period 1||33
8947572|NCT02421172|10009799|FG001|STARTED|Period 1||33
8947573|NCT02421172|10009800|FG002|STARTED|Period 1||0
8947574|NCT02421172|10009801|FG003|STARTED|Period 1||0
8947575|NCT02421172|10009802|FG004|STARTED|Period 1||0
8947576|NCT02421172|10009798|FG000|PD Analysis Set Period 1|Period 1||31
8947577|NCT02421172|10009799|FG001|PD Analysis Set Period 1|Period 1||33
8947578|NCT02421172|10009800|FG002|PD Analysis Set Period 1|Period 1||0
8947579|NCT02421172|10009801|FG003|PD Analysis Set Period 1|Period 1||0
8947580|NCT02421172|10009802|FG004|PD Analysis Set Period 1|Period 1||0
8947581|NCT02421172|10009798|FG000|PK Analysis Set Period 1|Period 1||33
8947582|NCT02421172|10009799|FG001|PK Analysis Set Period 1|Period 1||0
8947583|NCT02421172|10009800|FG002|PK Analysis Set Period 1|Period 1||0
8947584|NCT02421172|10009801|FG003|PK Analysis Set Period 1|Period 1||0
8947585|NCT02421172|10009802|FG004|PK Analysis Set Period 1|Period 1||0
8947586|NCT02421172|10009798|FG000|COMPLETED|Period 1||29
8947587|NCT02421172|10009799|FG001|COMPLETED|Period 1||31
8947588|NCT02421172|10009800|FG002|COMPLETED|Period 1||0
8947589|NCT02421172|10009801|FG003|COMPLETED|Period 1||0
8947590|NCT02421172|10009802|FG004|COMPLETED|Period 1||0
8947591|NCT02421172|10009798|FG000|NOT COMPLETED|Period 1||4
8947592|NCT02421172|10009799|FG001|NOT COMPLETED|Period 1||2
8947593|NCT02421172|10009800|FG002|NOT COMPLETED|Period 1||0
8947594|NCT02421172|10009801|FG003|NOT COMPLETED|Period 1||0
8947595|NCT02421172|10009802|FG004|NOT COMPLETED|Period 1||0
8947596|NCT02421172|10009798|FG000|STARTED|Period 2||0
8947597|NCT02421172|10009799|FG001|STARTED|Period 2||0
8947598|NCT02421172|10009800|FG002|STARTED|Period 2||29
8947599|NCT02421172|10009801|FG003|STARTED|Period 2||16
8947600|NCT02421172|10009802|FG004|STARTED|Period 2||15
8947601|NCT02421172|10009798|FG000|COMPLETED|Period 2||0
8947602|NCT02421172|10009799|FG001|COMPLETED|Period 2||0
8947603|NCT02421172|10009800|FG002|COMPLETED|Period 2||22
8947604|NCT02421172|10009801|FG003|COMPLETED|Period 2||13
8947605|NCT02421172|10009802|FG004|COMPLETED|Period 2||14
8947606|NCT02421172|10009798|FG000|NOT COMPLETED|Period 2||0
8947607|NCT02421172|10009799|FG001|NOT COMPLETED|Period 2||0
8947608|NCT02421172|10009800|FG002|NOT COMPLETED|Period 2||7
8947609|NCT02421172|10009801|FG003|NOT COMPLETED|Period 2||3
8947610|NCT02421172|10009802|FG004|NOT COMPLETED|Period 2||1
8947611|NCT02421211|10009815|FG000|STARTED|Overall Study||20
8947612|NCT02421211|10009816|FG001|STARTED|Overall Study||20
8947613|NCT02421211|10009815|FG000|COMPLETED|Overall Study||20
8947614|NCT02421211|10009816|FG001|COMPLETED|Overall Study||20
8947615|NCT02421211|10009815|FG000|NOT COMPLETED|Overall Study||0
8947616|NCT02421211|10009816|FG001|NOT COMPLETED|Overall Study||0
8947617|NCT02421224|10009835|FG000|STARTED|Overall Study||444
8947618|NCT02421224|10009836|FG001|STARTED|Overall Study||397
8947619|NCT02421224|10009837|FG002|STARTED|Overall Study||508
8947620|NCT02421224|10009838|FG003|STARTED|Overall Study||482
8947621|NCT02421224|10009839|FG004|STARTED|Overall Study||495
8947622|NCT02421224|10009840|FG005|STARTED|Overall Study||515
8947623|NCT02421224|10009841|FG006|STARTED|Overall Study||489
8947624|NCT02421224|10009842|FG007|STARTED|Overall Study||364
8947625|NCT02421224|10009843|FG008|STARTED|Overall Study||496
8947626|NCT02421224|10009835|FG000|COMPLETED|Overall Study||442
8947627|NCT02421224|10009836|FG001|COMPLETED|Overall Study||394
8947628|NCT02421224|10009837|FG002|COMPLETED|Overall Study||507
8947629|NCT02421224|10009838|FG003|COMPLETED|Overall Study||479
8947630|NCT02421224|10009839|FG004|COMPLETED|Overall Study||491
8947631|NCT02421224|10009840|FG005|COMPLETED|Overall Study||513
8947632|NCT02421224|10009841|FG006|COMPLETED|Overall Study||489
8947633|NCT02421224|10009842|FG007|COMPLETED|Overall Study||362
8947634|NCT02421224|10009843|FG008|COMPLETED|Overall Study||495
8947635|NCT02421224|10009835|FG000|NOT COMPLETED|Overall Study||2
8947636|NCT02421224|10009836|FG001|NOT COMPLETED|Overall Study||3
8947637|NCT02421224|10009837|FG002|NOT COMPLETED|Overall Study||1
8947638|NCT02421224|10009838|FG003|NOT COMPLETED|Overall Study||3
8947639|NCT02421224|10009839|FG004|NOT COMPLETED|Overall Study||4
8947640|NCT02421224|10009840|FG005|NOT COMPLETED|Overall Study||2
8947641|NCT02421224|10009841|FG006|NOT COMPLETED|Overall Study||0
8947642|NCT02421224|10009842|FG007|NOT COMPLETED|Overall Study||2
8947643|NCT02421224|10009843|FG008|NOT COMPLETED|Overall Study||1
8947644|NCT02421354|10009863|FG000|STARTED|Overall Study||8
8947645|NCT02421354|10009863|FG000|COMPLETED|Overall Study||8
8947646|NCT02421354|10009863|FG000|NOT COMPLETED|Overall Study||0
8947647|NCT02421419|10009870|FG000|STARTED|Overall Study||6
8947648|NCT02421419|10009871|FG001|STARTED|Overall Study||11
8947649|NCT02421419|10009872|FG002|STARTED|Overall Study||9
8947650|NCT02421419|10009870|FG000|COMPLETED|Overall Study||6
8947651|NCT02421419|10009871|FG001|COMPLETED|Overall Study||11
8947652|NCT02421419|10009872|FG002|COMPLETED|Overall Study||8
8947653|NCT02421419|10009870|FG000|NOT COMPLETED|Overall Study||0
8947654|NCT02421419|10009871|FG001|NOT COMPLETED|Overall Study||0
8947655|NCT02421419|10009872|FG002|NOT COMPLETED|Overall Study||1
8947656|NCT02421510|10009883|FG000|STARTED|Overall Study||258
8947657|NCT02421510|10009884|FG001|STARTED|Overall Study||261
8947658|NCT02421510|10009885|FG002|STARTED|Overall Study||263
8947659|NCT02421510|10009883|FG000|Completed the 24 Week Treatment Period|Overall Study||236
8947660|NCT02421510|10009884|FG001|Completed the 24 Week Treatment Period|Overall Study||239
8947661|NCT02421510|10009885|FG002|Completed the 24 Week Treatment Period|Overall Study||240
8947662|NCT02421510|10009883|FG000|COMPLETED|Overall Study||225
8947663|NCT02421510|10009884|FG001|COMPLETED|Overall Study||226
8947664|NCT02421510|10009885|FG002|COMPLETED|Overall Study||227
8947665|NCT02421510|10009883|FG000|NOT COMPLETED|Overall Study||33
8947666|NCT02421510|10009884|FG001|NOT COMPLETED|Overall Study||35
8947667|NCT02421510|10009885|FG002|NOT COMPLETED|Overall Study||36
8947668|NCT02421588|10009895|FG000|STARTED|Overall Study||221
8947669|NCT02421588|10009896|FG001|STARTED|Overall Study||221
8947670|NCT02421588|10009895|FG000|COMPLETED|Overall Study||0
8947671|NCT02421588|10009896|FG001|COMPLETED|Overall Study||0
8947672|NCT02421588|10009895|FG000|NOT COMPLETED|Overall Study||221
8947673|NCT02421588|10009896|FG001|NOT COMPLETED|Overall Study||221
8947674|NCT02421601|10009902|FG000|STARTED|Overall Study||991
8947675|NCT02421601|10009902|FG000|COMPLETED|Overall Study||909
8947676|NCT02421601|10009902|FG000|NOT COMPLETED|Overall Study||82
8947677|NCT02421666|10009908|FG000|STARTED|Overall Study Baseline||272
8947678|NCT02421666|10009909|FG001|STARTED|Overall Study Baseline||260
8947679|NCT02421666|10009908|FG000|COMPLETED|Overall Study Baseline||272
8947680|NCT02421666|10009909|FG001|COMPLETED|Overall Study Baseline||260
8947681|NCT02421666|10009908|FG000|NOT COMPLETED|Overall Study Baseline||0
8947682|NCT02421666|10009909|FG001|NOT COMPLETED|Overall Study Baseline||0
8947683|NCT02421666|10009908|FG000|STARTED|6-month Follow-up||272
8947684|NCT02421666|10009909|FG001|STARTED|6-month Follow-up||260
8947685|NCT02421666|10009908|FG000|COMPLETED|6-month Follow-up||259
8947686|NCT02421666|10009909|FG001|COMPLETED|6-month Follow-up||247
8947687|NCT02421666|10009908|FG000|NOT COMPLETED|6-month Follow-up||13
8947688|NCT02421666|10009909|FG001|NOT COMPLETED|6-month Follow-up||13
8947689|NCT02421666|10009908|FG000|STARTED|12-month Follow-up||259
8947690|NCT02421666|10009909|FG001|STARTED|12-month Follow-up||247
8947691|NCT02421666|10009908|FG000|COMPLETED|12-month Follow-up||248
8947692|NCT02421666|10009909|FG001|COMPLETED|12-month Follow-up||231
8947693|NCT02421666|10009908|FG000|NOT COMPLETED|12-month Follow-up||11
8947694|NCT02421666|10009909|FG001|NOT COMPLETED|12-month Follow-up||16
8947695|NCT02421757|10009917|FG000|STARTED|Overall Study||11
8947696|NCT02421757|10009918|FG001|STARTED|Overall Study||9
8947697|NCT02421757|10009917|FG000|COMPLETED|Overall Study||11
8947698|NCT02421757|10009918|FG001|COMPLETED|Overall Study||9
8947699|NCT02421757|10009917|FG000|NOT COMPLETED|Overall Study||0
8947700|NCT02421757|10009918|FG001|NOT COMPLETED|Overall Study||0
8947701|NCT02421887|10009926|FG000|STARTED|Overall Study||85
8947702|NCT02421887|10009927|FG001|STARTED|Overall Study||86
8947703|NCT02421887|10009926|FG000|COMPLETED|Overall Study||68
8947704|NCT02421887|10009927|FG001|COMPLETED|Overall Study||77
8947705|NCT02421887|10009926|FG000|NOT COMPLETED|Overall Study||17
8947706|NCT02421887|10009927|FG001|NOT COMPLETED|Overall Study||9
8947707|NCT02421952|10009933|FG000|STARTED|Overall Study||208
8947708|NCT02421952|10009933|FG000|Excluded From PACU and Post-Analysis|Overall Study||16
8947709|NCT02421952|10009933|FG000|Included in PACU Analysis|Overall Study||192
8947710|NCT02421952|10009933|FG000|COMPLETED|Overall Study||99
8947711|NCT02421952|10009933|FG000|NOT COMPLETED|Overall Study||109
8947712|NCT02422186|10009942|FG000|STARTED|Double-blind Induction Phase (4 Weeks)||72
8947713|NCT02422186|10009943|FG001|STARTED|Double-blind Induction Phase (4 Weeks)||66
8947714|NCT02422186|10009942|FG000|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||72
8947715|NCT02422186|10009943|FG001|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||65
8947716|NCT02422186|10009942|FG000|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||72
8947717|NCT02422186|10009943|FG001|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||65
8947718|NCT02422186|10009942|FG000|COMPLETED|Double-blind Induction Phase (4 Weeks)||62
8947719|NCT02422186|10009943|FG001|COMPLETED|Double-blind Induction Phase (4 Weeks)||60
8947720|NCT02422186|10009942|FG000|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||10
8947721|NCT02422186|10009943|FG001|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||6
8947722|NCT02422186|10009942|FG000|STARTED|Follow-up Phase (2 Weeks)||12
8947723|NCT02422186|10009943|FG001|STARTED|Follow-up Phase (2 Weeks)||3
8947724|NCT02422186|10009942|FG000|COMPLETED|Follow-up Phase (2 Weeks)||8
8947725|NCT02422186|10009943|FG001|COMPLETED|Follow-up Phase (2 Weeks)||3
8947726|NCT02422186|10009942|FG000|NOT COMPLETED|Follow-up Phase (2 Weeks)||4
8947727|NCT02422186|10009943|FG001|NOT COMPLETED|Follow-up Phase (2 Weeks)||0
8947728|NCT02422264|10009953|FG000|STARTED|Overall Study||296
8947729|NCT02422264|10009954|FG001|STARTED|Overall Study||305
8947730|NCT02422264|10009953|FG000|COMPLETED|Overall Study||291
8947731|NCT02422264|10009954|FG001|COMPLETED|Overall Study||301
8947732|NCT02422264|10009953|FG000|NOT COMPLETED|Overall Study||5
8947733|NCT02422264|10009954|FG001|NOT COMPLETED|Overall Study||4
8947734|NCT02422290|10009960|FG000|STARTED|Overall Study||5
8947735|NCT02422290|10009960|FG000|COMPLETED|Overall Study||5
8947736|NCT02422290|10009960|FG000|NOT COMPLETED|Overall Study||0
8947737|NCT02422511|10009972|FG000|STARTED|Overall Study||255
8947738|NCT02422511|10009973|FG001|STARTED|Overall Study||128
8947739|NCT02422511|10009974|FG002|STARTED|Overall Study||257
8947740|NCT02422511|10009975|FG003|STARTED|Overall Study||129
8947741|NCT02422511|10009976|FG004|STARTED|Overall Study||66
8947742|NCT02422511|10009977|FG005|STARTED|Overall Study||33
8947743|NCT02422511|10009978|FG006|STARTED|Overall Study||68
8947744|NCT02422511|10009979|FG007|STARTED|Overall Study||34
8947745|NCT02422511|10009972|FG000|Received Disclosure|Overall Study||158
8947746|NCT02422511|10009973|FG001|Received Disclosure|Overall Study|Newborns did not receive disclosure|79
8947747|NCT02422511|10009974|FG002|Received Disclosure|Overall Study||194
8947748|NCT02422511|10009975|FG003|Received Disclosure|Overall Study||97
8947749|NCT02422511|10009976|FG004|Received Disclosure|Overall Study||43
8947750|NCT02422511|10009977|FG005|Received Disclosure|Overall Study||21
8947751|NCT02422511|10009978|FG006|Received Disclosure|Overall Study||38
8947752|NCT02422511|10009979|FG007|Received Disclosure|Overall Study||19
8947753|NCT02422511|10009972|FG000|COMPLETED|Overall Study||143
8947754|NCT02422511|10009973|FG001|COMPLETED|Overall Study|Newborns did not complete survey|0
8947755|NCT02422511|10009974|FG002|COMPLETED|Overall Study||168
8947756|NCT02422511|10009975|FG003|COMPLETED|Overall Study|Newborns did not complete survey|0
8947757|NCT02422511|10009976|FG004|COMPLETED|Overall Study||39
8947758|NCT02422511|10009977|FG005|COMPLETED|Overall Study|Newborns did not complete survey|0
8947759|NCT02422511|10009978|FG006|COMPLETED|Overall Study||38
8947760|NCT02422511|10009979|FG007|COMPLETED|Overall Study|Newborns did not complete survey|0
8947761|NCT02422511|10009972|FG000|NOT COMPLETED|Overall Study||112
8947762|NCT02422511|10009973|FG001|NOT COMPLETED|Overall Study||128
8947763|NCT02422511|10009974|FG002|NOT COMPLETED|Overall Study||89
8947764|NCT02422511|10009975|FG003|NOT COMPLETED|Overall Study||129
8947765|NCT02422511|10009976|FG004|NOT COMPLETED|Overall Study||27
8947766|NCT02422511|10009977|FG005|NOT COMPLETED|Overall Study||33
8947767|NCT02422511|10009978|FG006|NOT COMPLETED|Overall Study||30
8947768|NCT02422511|10009979|FG007|NOT COMPLETED|Overall Study||34
8947769|NCT02422940|10009999|FG000|STARTED|Overall Study||152
8947770|NCT02422940|10010000|FG001|STARTED|Overall Study||142
8947771|NCT02422940|10009999|FG000|COMPLETED|Overall Study||31
8947772|NCT02422940|10010000|FG001|COMPLETED|Overall Study||21
8947773|NCT02422940|10009999|FG000|NOT COMPLETED|Overall Study||121
8947774|NCT02422940|10010000|FG001|NOT COMPLETED|Overall Study||121
8947775|NCT02423109|10010006|FG000|STARTED|Lens 1||19
8947776|NCT02423109|10010007|FG001|STARTED|Lens 1||14
8947777|NCT02423109|10010006|FG000|COMPLETED|Lens 1||18
8947778|NCT02423109|10010007|FG001|COMPLETED|Lens 1||14
8947779|NCT02423109|10010006|FG000|NOT COMPLETED|Lens 1||1
8947780|NCT02423109|10010007|FG001|NOT COMPLETED|Lens 1||0
8947781|NCT02423109|10010006|FG000|STARTED|Lens 2||18
8947782|NCT02423109|10010007|FG001|STARTED|Lens 2||14
8947783|NCT02423109|10010006|FG000|COMPLETED|Lens 2||18
8947784|NCT02423109|10010007|FG001|COMPLETED|Lens 2||14
8947785|NCT02423109|10010006|FG000|NOT COMPLETED|Lens 2||0
8947786|NCT02423109|10010007|FG001|NOT COMPLETED|Lens 2||0
8947787|NCT02423122|10010017|FG000|STARTED|Overall Study||9
8947788|NCT02423122|10010018|FG001|STARTED|Overall Study||7
8947789|NCT02423122|10010017|FG000|COMPLETED|Overall Study||9
8947790|NCT02423122|10010018|FG001|COMPLETED|Overall Study||7
8947791|NCT02423122|10010017|FG000|NOT COMPLETED|Overall Study||0
8842947|NCT01701258|9897267|FG009|Received Drug Challenge|Drug+fMRI (Session 2)||6
8842948|NCT01701258|9897268|FG010|Received Drug Challenge|Drug+fMRI (Session 2)||0
8842949|NCT01701258|9897269|FG011|Received Drug Challenge|Drug+fMRI (Session 2)||10
8842950|NCT01701258|9897270|FG012|Received Drug Challenge|Drug+fMRI (Session 2)||7
8842951|NCT01701258|9897258|FG000|COMPLETED|Drug+fMRI (Session 2)||0
8842952|NCT01701258|9897259|FG001|COMPLETED|Drug+fMRI (Session 2)||0
8842953|NCT01701258|9897260|FG002|COMPLETED|Drug+fMRI (Session 2)||11
8842954|NCT01701258|9897261|FG003|COMPLETED|Drug+fMRI (Session 2)||11
8842955|NCT01701258|9897262|FG004|COMPLETED|Drug+fMRI (Session 2)||0
8947792|NCT02423122|10010018|FG001|NOT COMPLETED|Overall Study||0
8947793|NCT02423200|10010026|FG000|STARTED|Overall Study||8
8947794|NCT02423200|10010027|FG001|STARTED|Overall Study||1
8947795|NCT02423200|10010026|FG000|COMPLETED|Overall Study||7
8947796|NCT02423200|10010027|FG001|COMPLETED|Overall Study||1
8947797|NCT02423200|10010026|FG000|NOT COMPLETED|Overall Study||1
8947798|NCT02423200|10010027|FG001|NOT COMPLETED|Overall Study||0
8947799|NCT02423291|10010034|FG000|STARTED|Overall Study|Patients enrolled|15
8947800|NCT02423291|10010034|FG000|COMPLETED|Overall Study|Patients that have completed therapy|0
8947801|NCT02423291|10010034|FG000|NOT COMPLETED|Overall Study||15
8947802|NCT02423317|10010040|FG000|STARTED|Overall Study||30
8947803|NCT02423317|10010041|FG001|STARTED|Overall Study||30
8947804|NCT02423317|10010040|FG000|COMPLETED|Overall Study||30
8947805|NCT02423317|10010041|FG001|COMPLETED|Overall Study||30
8947806|NCT02423317|10010040|FG000|NOT COMPLETED|Overall Study||0
8947807|NCT02423317|10010041|FG001|NOT COMPLETED|Overall Study||0
8948820|NCT02432729|10011296|FG000|COMPLETED|Month 12 Visit||436
8948821|NCT02432729|10011296|FG000|NOT COMPLETED|Month 12 Visit||196
8948822|NCT02432742|10011301|FG000|STARTED|Overall Study||100
8948823|NCT02432742|10011301|FG000|COMPLETED|Overall Study||95
8948824|NCT02432742|10011301|FG000|NOT COMPLETED|Overall Study||5
8948828|NCT02433080|10011309|FG001|8 Weeks|Overall Study||24
8842956|NCT01701258|9897263|FG005|COMPLETED|Drug+fMRI (Session 2)||9
8948829|NCT02433080|10011308|FG000|COMPLETED|Overall Study||25
8948830|NCT02433080|10011309|FG001|COMPLETED|Overall Study||24
8948831|NCT02433080|10011308|FG000|NOT COMPLETED|Overall Study||1
8948832|NCT02433080|10011309|FG001|NOT COMPLETED|Overall Study||4
8948833|NCT02433288|10011318|FG000|STARTED|Overall Study||443
8947808|NCT02423343|10010053|FG000|STARTED|Overall Study||3
8947809|NCT02423343|10010054|FG001|STARTED|Overall Study||5
8947810|NCT02423343|10010055|FG002|STARTED|Overall Study||3
8947811|NCT02423343|10010056|FG003|STARTED|Overall Study||4
8947812|NCT02423343|10010057|FG004|STARTED|Overall Study||25
8947813|NCT02423343|10010058|FG005|STARTED|Overall Study||1
8947814|NCT02423343|10010053|FG000|Received at Least One Dose of Study Drug|Overall Study||3
8947815|NCT02423343|10010054|FG001|Received at Least One Dose of Study Drug|Overall Study||5
8947816|NCT02423343|10010055|FG002|Received at Least One Dose of Study Drug|Overall Study||3
8947817|NCT02423343|10010056|FG003|Received at Least One Dose of Study Drug|Overall Study||4
8947818|NCT02423343|10010057|FG004|Received at Least One Dose of Study Drug|Overall Study||25
8947819|NCT02423343|10010058|FG005|Received at Least One Dose of Study Drug|Overall Study||1
8947820|NCT02423343|10010053|FG000|COMPLETED|Overall Study||3
8947821|NCT02423343|10010054|FG001|COMPLETED|Overall Study||4
8947822|NCT02423343|10010055|FG002|COMPLETED|Overall Study||3
8947823|NCT02423343|10010056|FG003|COMPLETED|Overall Study||4
8947824|NCT02423343|10010057|FG004|COMPLETED|Overall Study||20
8947825|NCT02423343|10010058|FG005|COMPLETED|Overall Study||1
8947826|NCT02423343|10010053|FG000|NOT COMPLETED|Overall Study||0
8947827|NCT02423343|10010054|FG001|NOT COMPLETED|Overall Study||1
8947828|NCT02423343|10010055|FG002|NOT COMPLETED|Overall Study||0
8947829|NCT02423343|10010056|FG003|NOT COMPLETED|Overall Study||0
8947830|NCT02423343|10010057|FG004|NOT COMPLETED|Overall Study||5
8947831|NCT02423343|10010058|FG005|NOT COMPLETED|Overall Study||0
8947832|NCT02423408|10010088|FG000|STARTED|Overall Study||83
8947833|NCT02423408|10010089|FG001|STARTED|Overall Study||82
8947834|NCT02423408|10010088|FG000|COMPLETED|Overall Study||82
8947835|NCT02423408|10010089|FG001|COMPLETED|Overall Study||80
8947836|NCT02423408|10010088|FG000|NOT COMPLETED|Overall Study||1
8947837|NCT02423408|10010089|FG001|NOT COMPLETED|Overall Study||2
8623512|NCT00493220|9662632|FG001|COMPLETED|Final 7-Day Safety Follow-up||5
8623513|NCT00493220|9662633|FG002|COMPLETED|Final 7-Day Safety Follow-up||5
8623514|NCT00493220|9662634|FG003|COMPLETED|Final 7-Day Safety Follow-up||5
8623515|NCT00493220|9662635|FG004|COMPLETED|Final 7-Day Safety Follow-up||5
8623516|NCT00493220|9662636|FG005|COMPLETED|Final 7-Day Safety Follow-up||5
8623517|NCT00493220|9662631|FG000|NOT COMPLETED|Final 7-Day Safety Follow-up||0
8947838|NCT02423447|10010095|FG000|STARTED|Overall Study||13
8947839|NCT02423447|10010096|FG001|STARTED|Overall Study||12
8947840|NCT02423447|10010095|FG000|COMPLETED|Overall Study||13
8947841|NCT02423447|10010096|FG001|COMPLETED|Overall Study||12
8947842|NCT02423447|10010095|FG000|NOT COMPLETED|Overall Study||0
8947843|NCT02423447|10010096|FG001|NOT COMPLETED|Overall Study||0
8947844|NCT02423577|10010107|FG000|STARTED|Overall Study||53
8623518|NCT00493220|9662632|FG001|NOT COMPLETED|Final 7-Day Safety Follow-up||0
8623519|NCT00493220|9662633|FG002|NOT COMPLETED|Final 7-Day Safety Follow-up||0
8623520|NCT00493220|9662634|FG003|NOT COMPLETED|Final 7-Day Safety Follow-up||0
8623521|NCT00493220|9662635|FG004|NOT COMPLETED|Final 7-Day Safety Follow-up||0
8623522|NCT00493220|9662636|FG005|NOT COMPLETED|Final 7-Day Safety Follow-up||0
8623523|NCT00493246|9662654|FG000|STARTED|Overall Study||2
8623524|NCT00493246|9662655|FG001|STARTED|Overall Study||1
8623525|NCT00493246|9662656|FG002|STARTED|Overall Study||12
8623526|NCT00493246|9662657|FG003|STARTED|Overall Study||13
8623527|NCT00493246|9662658|FG004|STARTED|Overall Study|All subjects who were randomized.Excludes 1 subject who was randomized in error.|9
8623528|NCT00493246|9662659|FG005|STARTED|Overall Study|All subjects who were randomized.|16
8623529|NCT00493246|9662660|FG006|STARTED|Overall Study|All subjects who were randomized.|12
8623530|NCT00493246|9662661|FG007|STARTED|Overall Study|All subjects who were randomized.|10
8623531|NCT00493246|9662654|FG000|COMPLETED|Overall Study|Completed study 30 days after the last dose|2
8623532|NCT00493246|9662655|FG001|COMPLETED|Overall Study|Completed study 30 days after the last dose|1
8623533|NCT00493246|9662656|FG002|COMPLETED|Overall Study|Completed study 30 days after the last dose|12
8623534|NCT00493246|9662657|FG003|COMPLETED|Overall Study|Completed study 30 days after the last dose|13
8623535|NCT00493246|9662658|FG004|COMPLETED|Overall Study|Completed study 30 days after the last dose|8
8623536|NCT00493246|9662659|FG005|COMPLETED|Overall Study|Completed study 30 days after the last dose|15
8623537|NCT00493246|9662660|FG006|COMPLETED|Overall Study|Completed study 30 days after the last dose|11
8623538|NCT00493246|9662661|FG007|COMPLETED|Overall Study|Completed study 30 days after the last dose|10
8623539|NCT00493246|9662654|FG000|NOT COMPLETED|Overall Study||0
8623540|NCT00493246|9662655|FG001|NOT COMPLETED|Overall Study||0
8623541|NCT00493246|9662656|FG002|NOT COMPLETED|Overall Study||0
8623542|NCT00493246|9662657|FG003|NOT COMPLETED|Overall Study||0
8623543|NCT00493246|9662658|FG004|NOT COMPLETED|Overall Study||1
8623544|NCT00493246|9662659|FG005|NOT COMPLETED|Overall Study||1
8623545|NCT00493246|9662660|FG006|NOT COMPLETED|Overall Study||1
8623546|NCT00493246|9662661|FG007|NOT COMPLETED|Overall Study||0
8623547|NCT00493285|9662685|FG000|STARTED|Overall Study||13
8623548|NCT00493285|9662686|FG001|STARTED|Overall Study||6
8623549|NCT00493285|9662687|FG002|STARTED|Overall Study||9
8623550|NCT00493285|9662688|FG003|STARTED|Overall Study||6
8623551|NCT00493285|9662689|FG004|STARTED|Overall Study||10
8947845|NCT02423577|10010108|FG001|STARTED|Overall Study||26
8947846|NCT02423577|10010107|FG000|COMPLETED|Overall Study||53
8947847|NCT02423577|10010108|FG001|COMPLETED|Overall Study||26
8947848|NCT02423577|10010107|FG000|NOT COMPLETED|Overall Study||0
8947849|NCT02423577|10010108|FG001|NOT COMPLETED|Overall Study||0
8947850|NCT02423798|10010114|FG000|STARTED|Overall Study||24
8623552|NCT00493285|9662690|FG005|STARTED|Overall Study||5
8623553|NCT00493285|9662685|FG000|COMPLETED|Overall Study||13
8623554|NCT00493285|9662686|FG001|COMPLETED|Overall Study||6
8623555|NCT00493285|9662687|FG002|COMPLETED|Overall Study||9
8623556|NCT00493285|9662688|FG003|COMPLETED|Overall Study||6
8623557|NCT00493285|9662689|FG004|COMPLETED|Overall Study||9
8623558|NCT00493285|9662690|FG005|COMPLETED|Overall Study||5
8623559|NCT00493285|9662685|FG000|NOT COMPLETED|Overall Study||0
8623560|NCT00493285|9662686|FG001|NOT COMPLETED|Overall Study||0
8623561|NCT00493285|9662687|FG002|NOT COMPLETED|Overall Study||0
8623562|NCT00493285|9662688|FG003|NOT COMPLETED|Overall Study||0
8623563|NCT00493285|9662689|FG004|NOT COMPLETED|Overall Study||1
8623564|NCT00493285|9662690|FG005|NOT COMPLETED|Overall Study||0
8623565|NCT00493311|9662706|FG000|STARTED|Overall Study||29
8623566|NCT00493311|9662707|FG001|STARTED|Overall Study||31
8623567|NCT00493311|9662706|FG000|COMPLETED|Overall Study||27
8623568|NCT00493311|9662707|FG001|COMPLETED|Overall Study||29
8623569|NCT00493311|9662706|FG000|NOT COMPLETED|Overall Study||2
8623570|NCT00493311|9662707|FG001|NOT COMPLETED|Overall Study||2
8623571|NCT00493454|9662713|FG000|STARTED|Overall Study||6
8623572|NCT00493454|9662713|FG000|COMPLETED|Overall Study||5
8623573|NCT00493454|9662713|FG000|NOT COMPLETED|Overall Study||1
8623574|NCT00493467|9662717|FG000|STARTED|Overall Study||31
8623575|NCT00493467|9662717|FG000|COMPLETED|Overall Study||30
8623576|NCT00493467|9662717|FG000|NOT COMPLETED|Overall Study||1
8623577|NCT00493636|9662723|FG000|STARTED|Overall Study||81
8623578|NCT00493636|9662724|FG001|STARTED|Overall Study||79
8623579|NCT00493636|9662723|FG000|COMPLETED|Overall Study||79
8623580|NCT00493636|9662724|FG001|COMPLETED|Overall Study||77
8623581|NCT00493636|9662723|FG000|NOT COMPLETED|Overall Study||2
8623582|NCT00493636|9662724|FG001|NOT COMPLETED|Overall Study||2
8623583|NCT00493649|9662730|FG000|STARTED|Overall Study||493
8623584|NCT00493649|9662730|FG000|COMPLETED|Overall Study||411
8623585|NCT00493649|9662730|FG000|NOT COMPLETED|Overall Study||82
8623586|NCT00493779|9662737|FG000|STARTED|Overall Study|Number of subjects who had discontinued clopidogrel treatment and entered follow-up phase|98
8623587|NCT00493779|9662737|FG000|COMPLETED|Overall Study|Completed follow-up phase|97
8623588|NCT00493779|9662737|FG000|NOT COMPLETED|Overall Study||1
8623589|NCT00493805|9662742|FG000|STARTED|Overall Study||17
8623590|NCT00493805|9662743|FG001|STARTED|Overall Study||42
8623591|NCT00493805|9662742|FG000|COMPLETED|Overall Study||17
8623592|NCT00493805|9662743|FG001|COMPLETED|Overall Study||42
8623593|NCT00493805|9662742|FG000|NOT COMPLETED|Overall Study||0
8623594|NCT00493805|9662743|FG001|NOT COMPLETED|Overall Study||0
8623595|NCT00493974|9662751|FG000|STARTED|Overall Study||60
8623596|NCT00493974|9662752|FG001|STARTED|Overall Study||59
8623597|NCT00493974|9662751|FG000|COMPLETED|Overall Study||47
8623598|NCT00493974|9662752|FG001|COMPLETED|Overall Study||45
8623599|NCT00493974|9662751|FG000|NOT COMPLETED|Overall Study||13
8623600|NCT00493974|9662752|FG001|NOT COMPLETED|Overall Study||14
8623601|NCT00494013|9662760|FG000|STARTED|Overall Study||223
8623602|NCT00494013|9662761|FG001|STARTED|Overall Study||219
8623603|NCT00494013|9662760|FG000|Full Analysis Set (Intent to Treat)|Overall Study||219
8623604|NCT00494013|9662761|FG001|Full Analysis Set (Intent to Treat)|Overall Study||210
8623605|NCT00494013|9662760|FG000|COMPLETED|Overall Study||193
8623606|NCT00494013|9662761|FG001|COMPLETED|Overall Study||183
8623607|NCT00494013|9662760|FG000|NOT COMPLETED|Overall Study||30
8623608|NCT00494013|9662761|FG001|NOT COMPLETED|Overall Study||36
8623609|NCT00494026|9662767|FG000|STARTED|Overall Study||4
8623610|NCT00494026|9662767|FG000|COMPLETED|Overall Study|2 patients did receive the full study treatment prior to the study being terminated.|0
8623611|NCT00494026|9662767|FG000|NOT COMPLETED|Overall Study||4
8623612|NCT00494091|9662773|FG000|STARTED|Overall Study||6
8623613|NCT00494091|9662774|FG001|STARTED|Overall Study||76
8623614|NCT00494091|9662773|FG000|COMPLETED|Overall Study||0
8623615|NCT00494091|9662774|FG001|COMPLETED|Overall Study||0
8623616|NCT00494091|9662773|FG000|NOT COMPLETED|Overall Study||6
8623617|NCT00494091|9662774|FG001|NOT COMPLETED|Overall Study||76
8623618|NCT00494143|9662781|FG000|STARTED|Overall Study||1
8623619|NCT00494143|9662782|FG001|STARTED|Overall Study||2
8623620|NCT00494143|9662783|FG002|STARTED|Overall Study||3
8623621|NCT00494143|9662784|FG003|STARTED|Overall Study||0
8623622|NCT00494143|9662785|FG004|STARTED|Overall Study||1
8623623|NCT00494143|9662786|FG005|STARTED|Overall Study||0
8623624|NCT00494143|9662781|FG000|COMPLETED|Overall Study||1
8623625|NCT00494143|9662782|FG001|COMPLETED|Overall Study||2
8623626|NCT00494143|9662783|FG002|COMPLETED|Overall Study||3
8623627|NCT00494143|9662784|FG003|COMPLETED|Overall Study||0
8623628|NCT00494143|9662785|FG004|COMPLETED|Overall Study||1
8623629|NCT00494143|9662786|FG005|COMPLETED|Overall Study||0
8623630|NCT00494143|9662781|FG000|NOT COMPLETED|Overall Study||0
8623631|NCT00494143|9662782|FG001|NOT COMPLETED|Overall Study||0
8623632|NCT00494143|9662783|FG002|NOT COMPLETED|Overall Study||0
8623633|NCT00494143|9662784|FG003|NOT COMPLETED|Overall Study||0
8623634|NCT00494143|9662785|FG004|NOT COMPLETED|Overall Study||0
8623635|NCT00494143|9662786|FG005|NOT COMPLETED|Overall Study||0
8623636|NCT00494221|9662801|FG000|STARTED|Overall Study||58
8623637|NCT00494221|9662802|FG001|STARTED|Overall Study||56
8623638|NCT00494221|9662803|FG002|STARTED|Overall Study||58
8623639|NCT00494221|9662801|FG000|COMPLETED|Overall Study||42
8623640|NCT00494221|9662802|FG001|COMPLETED|Overall Study||45
8623641|NCT00494221|9662803|FG002|COMPLETED|Overall Study||44
8623642|NCT00494221|9662801|FG000|NOT COMPLETED|Overall Study||16
8623643|NCT00494221|9662802|FG001|NOT COMPLETED|Overall Study||11
8623644|NCT00494221|9662803|FG002|NOT COMPLETED|Overall Study||14
8623645|NCT00494299|9662813|FG000|STARTED|Overall Study||229
8623646|NCT00494299|9662814|FG001|STARTED|Overall Study||229
8623647|NCT00494299|9662813|FG000|Received Treatment|Overall Study||229
8623648|NCT00494299|9662814|FG001|Received Treatment|Overall Study||227
8623649|NCT00494299|9662813|FG000|COMPLETED|Overall Study||0
8623650|NCT00494299|9662814|FG001|COMPLETED|Overall Study||0
8623651|NCT00494299|9662813|FG000|NOT COMPLETED|Overall Study||229
8623652|NCT00494299|9662814|FG001|NOT COMPLETED|Overall Study||229
8623653|NCT00494442|9662822|FG000|STARTED|Overall Study|Patients received treatment|24
8623654|NCT00494442|9662823|FG001|STARTED|Overall Study|Patients received treatment|33
8623655|NCT00494442|9662822|FG000|COMPLETED|Overall Study|Patients completed the full study schedule (168 days treatment)|7
8623656|NCT00494442|9662823|FG001|COMPLETED|Overall Study|Patients completed the full study schedule (168 days treatment)|17
8623657|NCT00494442|9662822|FG000|NOT COMPLETED|Overall Study||17
8623658|NCT00494442|9662823|FG001|NOT COMPLETED|Overall Study||16
8623659|NCT00494481|9662831|FG000|STARTED|Overall Study|randomised patients|35
8623660|NCT00494481|9662832|FG001|STARTED|Overall Study|randomised patients|29
8623661|NCT00494481|9662831|FG000|COMPLETED|Overall Study|ongoing study treatment at data cut-off|6
8623662|NCT00494481|9662832|FG001|COMPLETED|Overall Study|ongoing study treatment at data cut-off|5
8623663|NCT00494481|9662831|FG000|NOT COMPLETED|Overall Study||29
8623664|NCT00494481|9662832|FG001|NOT COMPLETED|Overall Study||24
8623665|NCT00494494|9662840|FG000|STARTED|Overall Study||40
8623666|NCT00494494|9662841|FG001|STARTED|Overall Study||39
8623667|NCT00494494|9662840|FG000|COMPLETED|Overall Study||40
8623668|NCT00494494|9662841|FG001|COMPLETED|Overall Study||39
8623669|NCT00494494|9662840|FG000|NOT COMPLETED|Overall Study||0
8623670|NCT00494494|9662841|FG001|NOT COMPLETED|Overall Study||0
8623671|NCT00494507|9662851|FG000|STARTED|Double-Blind Phase||12
8623672|NCT00494507|9662852|FG001|STARTED|Double-Blind Phase||9
8623673|NCT00494507|9662853|FG002|STARTED|Double-Blind Phase||24
8623674|NCT00494507|9662854|FG003|STARTED|Double-Blind Phase||20
8623675|NCT00494507|9662851|FG000|Reached Endpoint of Acute Worsening|Double-Blind Phase||0
8623676|NCT00494507|9662852|FG001|Reached Endpoint of Acute Worsening|Double-Blind Phase||2
8623677|NCT00494507|9662853|FG002|Reached Endpoint of Acute Worsening|Double-Blind Phase||0
8623678|NCT00494507|9662854|FG003|Reached Endpoint of Acute Worsening|Double-Blind Phase||5
8623679|NCT00494507|9662851|FG000|COMPLETED|Double-Blind Phase||9
8623680|NCT00494507|9662852|FG001|COMPLETED|Double-Blind Phase||9
8623681|NCT00494507|9662853|FG002|COMPLETED|Double-Blind Phase||22
8623682|NCT00494507|9662854|FG003|COMPLETED|Double-Blind Phase||19
8623683|NCT00494507|9662851|FG000|NOT COMPLETED|Double-Blind Phase||3
8623684|NCT00494507|9662852|FG001|NOT COMPLETED|Double-Blind Phase||0
8623685|NCT00494507|9662853|FG002|NOT COMPLETED|Double-Blind Phase||2
8623686|NCT00494507|9662854|FG003|NOT COMPLETED|Double-Blind Phase||1
8623687|NCT00494507|9662851|FG000|STARTED|Open-Label Phase||9
8623688|NCT00494507|9662852|FG001|STARTED|Open-Label Phase|1 subject randomized to Acetazolamide in this phase is not included-drug arm was removed from trial.|8
8623689|NCT00494507|9662853|FG002|STARTED|Open-Label Phase||22
8623690|NCT00494507|9662854|FG003|STARTED|Open-Label Phase||19
8623691|NCT00494507|9662851|FG000|COMPLETED|Open-Label Phase||9
8623692|NCT00494507|9662852|FG001|COMPLETED|Open-Label Phase||7
8623693|NCT00494507|9662853|FG002|COMPLETED|Open-Label Phase||17
8623694|NCT00494507|9662854|FG003|COMPLETED|Open-Label Phase||14
8623695|NCT00494507|9662851|FG000|NOT COMPLETED|Open-Label Phase||0
8623696|NCT00494507|9662852|FG001|NOT COMPLETED|Open-Label Phase||1
8623697|NCT00494507|9662853|FG002|NOT COMPLETED|Open-Label Phase||5
8623698|NCT00494507|9662854|FG003|NOT COMPLETED|Open-Label Phase||5
8623699|NCT00494585|9662874|FG000|STARTED|Overall Study||22
8623700|NCT00494585|9662874|FG000|COMPLETED|Overall Study||22
8623701|NCT00494585|9662874|FG000|NOT COMPLETED|Overall Study||0
8623702|NCT00494676|9662878|FG000|STARTED|Allocation||37
8623703|NCT00494676|9662879|FG001|STARTED|Allocation||36
8623704|NCT00494676|9662878|FG000|COMPLETED|Allocation||35
8623705|NCT00494676|9662879|FG001|COMPLETED|Allocation||32
8623706|NCT00494676|9662878|FG000|NOT COMPLETED|Allocation||2
8623707|NCT00494676|9662879|FG001|NOT COMPLETED|Allocation||4
8623708|NCT00494676|9662878|FG000|STARTED|First Intervention||35
8623709|NCT00494676|9662879|FG001|STARTED|First Intervention||32
8623710|NCT00494676|9662878|FG000|COMPLETED|First Intervention||34
8623711|NCT00494676|9662879|FG001|COMPLETED|First Intervention||29
8623712|NCT00494676|9662878|FG000|NOT COMPLETED|First Intervention||1
8623713|NCT00494676|9662879|FG001|NOT COMPLETED|First Intervention||3
8623714|NCT00494676|9662878|FG000|STARTED|Second Intervention||34
8623715|NCT00494676|9662879|FG001|STARTED|Second Intervention||29
8623716|NCT00494676|9662878|FG000|COMPLETED|Second Intervention||33
8623717|NCT00494676|9662879|FG001|COMPLETED|Second Intervention||28
8623718|NCT00494676|9662878|FG000|NOT COMPLETED|Second Intervention||1
8623719|NCT00494676|9662879|FG001|NOT COMPLETED|Second Intervention||1
8623720|NCT00494780|9662887|FG000|STARTED|Overall Study||29
8623721|NCT00494780|9662888|FG001|STARTED|Overall Study||30
8623722|NCT00494780|9662887|FG000|COMPLETED|Overall Study||18
8623723|NCT00494780|9662888|FG001|COMPLETED|Overall Study||17
8623724|NCT00494780|9662887|FG000|NOT COMPLETED|Overall Study||11
8623725|NCT00494780|9662888|FG001|NOT COMPLETED|Overall Study||13
8623726|NCT00494806|9662898|FG000|STARTED|Overall Study||34
8623727|NCT00494806|9662899|FG001|STARTED|Overall Study||32
8623728|NCT00494806|9662898|FG000|COMPLETED|Overall Study||34
8623729|NCT00494806|9662899|FG001|COMPLETED|Overall Study||32
8623730|NCT00494806|9662898|FG000|NOT COMPLETED|Overall Study||0
8623731|NCT00494806|9662899|FG001|NOT COMPLETED|Overall Study||0
8623732|NCT00494871|9662907|FG000|STARTED|Double-blind (DB) Treatment Period||640
8623733|NCT00494871|9662908|FG001|STARTED|Double-blind (DB) Treatment Period||640
8623734|NCT00494871|9662907|FG000|Started Treatment|Double-blind (DB) Treatment Period|Safety population|639
8623735|NCT00494871|9662908|FG001|Started Treatment|Double-blind (DB) Treatment Period|Safety population|639
8623736|NCT00494871|9662907|FG000|COMPLETED|Double-blind (DB) Treatment Period||480
8623737|NCT00494871|9662908|FG001|COMPLETED|Double-blind (DB) Treatment Period||468
8623738|NCT00494871|9662907|FG000|NOT COMPLETED|Double-blind (DB) Treatment Period||160
8623739|NCT00494871|9662908|FG001|NOT COMPLETED|Double-blind (DB) Treatment Period||172
8623740|NCT00494871|9662907|FG000|STARTED|Follow-up (FU) Period|All treated participants were to enter FU period, whether or not they completed the DB period|639
8623741|NCT00494871|9662908|FG001|STARTED|Follow-up (FU) Period|All treated participants were to enter FU period, whether or not they completed the DB period|639
8623742|NCT00494871|9662907|FG000|Entered FU and Valid for Safety|Follow-up (FU) Period|Safety population|628
8623743|NCT00494871|9662908|FG001|Entered FU and Valid for Safety|Follow-up (FU) Period|Safety population|630
8623744|NCT00494871|9662907|FG000|COMPLETED|Follow-up (FU) Period||610
8623745|NCT00494871|9662908|FG001|COMPLETED|Follow-up (FU) Period||616
8623746|NCT00494871|9662907|FG000|NOT COMPLETED|Follow-up (FU) Period||29
8623747|NCT00494871|9662908|FG001|NOT COMPLETED|Follow-up (FU) Period||23
8629475|NCT00530621|9669227|FG001|Received at Least 1 Dose of Study Drug|Overall Study||80
8629476|NCT00530621|9669226|FG000|COMPLETED|Overall Study||0
8629477|NCT00530621|9669227|FG001|COMPLETED|Overall Study||0
8629478|NCT00530621|9669226|FG000|NOT COMPLETED|Overall Study||80
8629479|NCT00530621|9669227|FG001|NOT COMPLETED|Overall Study||80
8629480|NCT00530634|9669237|FG000|STARTED|Overall Study||3
8629481|NCT00530634|9669237|FG000|COMPLETED|Overall Study||3
8629482|NCT00530634|9669237|FG000|NOT COMPLETED|Overall Study||0
8629483|NCT00530712|9669241|FG000|STARTED|Enrollment|Total Enrolled Subjects|287
8629484|NCT00530712|9669241|FG000|COMPLETED|Enrollment|Subjects Available at Discharge|287
8629485|NCT00530712|9669241|FG000|NOT COMPLETED|Enrollment||0
8629486|NCT00530712|9669241|FG000|STARTED|30 Day Follow-up Visit|Subjects Expected for 30-Day Visit|287
8629487|NCT00530712|9669241|FG000|COMPLETED|30 Day Follow-up Visit|Subjects that Completed 30-Day Follow-up Visit|280
8629488|NCT00530712|9669241|FG000|NOT COMPLETED|30 Day Follow-up Visit||7
8629489|NCT00530712|9669241|FG000|STARTED|6 Month Follow-up Visit|Subjects Expected for 6-Month Visit|287
8629490|NCT00530712|9669241|FG000|COMPLETED|6 Month Follow-up Visit|Subjects that Completed 6-Month Follow-up Visit|275
8629491|NCT00530712|9669241|FG000|NOT COMPLETED|6 Month Follow-up Visit||12
8629492|NCT00530712|9669241|FG000|STARTED|12 Month Follow-up Visit|Subjects Expected for 12 Month Visit|287
8629493|NCT00530712|9669241|FG000|COMPLETED|12 Month Follow-up Visit|Subjects that Completed 12-Month Follow-up Visit|263
8629494|NCT00530712|9669241|FG000|NOT COMPLETED|12 Month Follow-up Visit||24
8629495|NCT00530764|9669250|FG000|STARTED|Overall Study||90
8629496|NCT00530764|9669251|FG001|STARTED|Overall Study||88
8629497|NCT00530764|9669252|FG002|STARTED|Overall Study||91
8629498|NCT00530764|9669253|FG003|STARTED|Overall Study||91
8629499|NCT00530764|9669250|FG000|COMPLETED|Overall Study||59
8629500|NCT00530764|9669251|FG001|COMPLETED|Overall Study||67
8629501|NCT00530764|9669252|FG002|COMPLETED|Overall Study||71
8629502|NCT00530764|9669253|FG003|COMPLETED|Overall Study||66
8947851|NCT02423798|10010114|FG000|COMPLETED|Overall Study||21
8947852|NCT02423798|10010114|FG000|NOT COMPLETED|Overall Study||3
8947853|NCT02423980|10010119|FG000|STARTED|Overall Study||7
8947854|NCT02423980|10010119|FG000|COMPLETED|Overall Study||7
8947855|NCT02423980|10010119|FG000|NOT COMPLETED|Overall Study||0
8947856|NCT02423993|10010129|FG000|STARTED|Overall Study||19
8947857|NCT02423993|10010130|FG001|STARTED|Overall Study||16
8947858|NCT02423993|10010131|FG002|STARTED|Overall Study||23
8947859|NCT02423993|10010132|FG003|STARTED|Overall Study||19
8947860|NCT02423993|10010129|FG000|COMPLETED|Overall Study||19
8947861|NCT02423993|10010130|FG001|COMPLETED|Overall Study||16
8947862|NCT02423993|10010131|FG002|COMPLETED|Overall Study||23
8947863|NCT02423993|10010132|FG003|COMPLETED|Overall Study||19
8947864|NCT02423993|10010129|FG000|NOT COMPLETED|Overall Study||0
8947865|NCT02423993|10010130|FG001|NOT COMPLETED|Overall Study||0
8947866|NCT02423993|10010131|FG002|NOT COMPLETED|Overall Study||0
8947867|NCT02423993|10010132|FG003|NOT COMPLETED|Overall Study||0
8947868|NCT02424097|10010144|FG000|STARTED|Overall Study||20
8947869|NCT02424097|10010145|FG001|STARTED|Overall Study||20
8947870|NCT02424097|10010144|FG000|COMPLETED|Overall Study||19
8947871|NCT02424097|10010145|FG001|COMPLETED|Overall Study||18
8947872|NCT02424097|10010144|FG000|NOT COMPLETED|Overall Study||1
8947873|NCT02424097|10010145|FG001|NOT COMPLETED|Overall Study||2
8947874|NCT02424149|10010153|FG000|STARTED|Overall Study||54
8947875|NCT02424149|10010154|FG001|STARTED|Overall Study||53
8947876|NCT02424149|10010153|FG000|COMPLETED|Overall Study||52
8947877|NCT02424149|10010154|FG001|COMPLETED|Overall Study||52
8947878|NCT02424149|10010153|FG000|NOT COMPLETED|Overall Study||2
8947879|NCT02424149|10010154|FG001|NOT COMPLETED|Overall Study||1
8947880|NCT02424175|10010160|FG000|STARTED|Overall Study||10
8947881|NCT02424175|10010160|FG000|COMPLETED|Overall Study||10
8947882|NCT02424175|10010160|FG000|NOT COMPLETED|Overall Study||0
8947883|NCT02424253|10010166|FG000|STARTED|Overall Study||65
8947884|NCT02424253|10010167|FG001|STARTED|Overall Study||33
8947885|NCT02424253|10010166|FG000|COMPLETED|Overall Study||54
8947886|NCT02424253|10010167|FG001|COMPLETED|Overall Study||24
8947887|NCT02424253|10010166|FG000|NOT COMPLETED|Overall Study||11
8947888|NCT02424253|10010167|FG001|NOT COMPLETED|Overall Study||9
8947889|NCT02424344|10010175|FG000|STARTED|Overall Study||134
8947890|NCT02424344|10010176|FG001|STARTED|Overall Study||133
8947891|NCT02424344|10010175|FG000|COMPLETED|Overall Study||127
8947892|NCT02424344|10010176|FG001|COMPLETED|Overall Study||123
8947893|NCT02424344|10010175|FG000|NOT COMPLETED|Overall Study||7
8947894|NCT02424344|10010176|FG001|NOT COMPLETED|Overall Study||10
8947895|NCT02424357|10010184|FG000|STARTED|Overall Study||35
8947896|NCT02424357|10010185|FG001|STARTED|Overall Study||30
8947897|NCT02424357|10010184|FG000|COMPLETED|Overall Study||35
8947898|NCT02424357|10010185|FG001|COMPLETED|Overall Study||30
8947899|NCT02424357|10010184|FG000|NOT COMPLETED|Overall Study||0
8947900|NCT02424357|10010185|FG001|NOT COMPLETED|Overall Study||0
8947901|NCT02424383|10010193|FG000|STARTED|Overall Study||1005
8947902|NCT02424383|10010193|FG000|Per-Protocol Population|Overall Study||966
8947903|NCT02424383|10010193|FG000|COMPLETED|Overall Study||629
8947904|NCT02424383|10010193|FG000|NOT COMPLETED|Overall Study||376
8947905|NCT02424526|10010199|FG000|STARTED|Overall Study||9
8947906|NCT02424526|10010200|FG001|STARTED|Overall Study||10
8947907|NCT02424526|10010199|FG000|COMPLETED|Overall Study||9
8947908|NCT02424526|10010200|FG001|COMPLETED|Overall Study||10
8947909|NCT02424526|10010199|FG000|NOT COMPLETED|Overall Study||0
8947910|NCT02424526|10010200|FG001|NOT COMPLETED|Overall Study||0
8947911|NCT02424539|10010211|FG000|STARTED|Overall Study||120
8947912|NCT02424539|10010212|FG001|STARTED|Overall Study||119
8947913|NCT02424539|10010213|FG002|STARTED|Overall Study||119
8947914|NCT02424539|10010211|FG000|COMPLETED|Overall Study||106
8947915|NCT02424539|10010212|FG001|COMPLETED|Overall Study||111
8947916|NCT02424539|10010213|FG002|COMPLETED|Overall Study||111
8947917|NCT02424539|10010211|FG000|NOT COMPLETED|Overall Study||14
8947918|NCT02424539|10010212|FG001|NOT COMPLETED|Overall Study||8
8947919|NCT02424539|10010213|FG002|NOT COMPLETED|Overall Study||8
8947920|NCT02424578|10010223|FG000|STARTED|Overall Study||15
8947921|NCT02424578|10010224|FG001|STARTED|Overall Study||15
8947922|NCT02424578|10010223|FG000|COMPLETED|Overall Study||15
8947923|NCT02424578|10010224|FG001|COMPLETED|Overall Study||14
8947924|NCT02424578|10010223|FG000|NOT COMPLETED|Overall Study||0
8947925|NCT02424578|10010224|FG001|NOT COMPLETED|Overall Study||1
8947926|NCT02424591|10010232|FG000|STARTED|Overall Study||22
8947927|NCT02424591|10010233|FG001|STARTED|Overall Study||23
8947928|NCT02424591|10010232|FG000|COMPLETED|Overall Study||20
8947929|NCT02424591|10010233|FG001|COMPLETED|Overall Study||20
8947930|NCT02424591|10010232|FG000|NOT COMPLETED|Overall Study||2
8947931|NCT02424591|10010233|FG001|NOT COMPLETED|Overall Study||3
8947932|NCT02424630|10010241|FG000|STARTED|Overall Study||25
8947933|NCT02424630|10010242|FG001|STARTED|Overall Study||27
8947934|NCT02424630|10010241|FG000|COMPLETED|Overall Study||24
8947935|NCT02424630|10010242|FG001|COMPLETED|Overall Study||24
8947936|NCT02424630|10010241|FG000|NOT COMPLETED|Overall Study||1
8947937|NCT02424630|10010242|FG001|NOT COMPLETED|Overall Study||3
8947938|NCT02424734|10010251|FG000|STARTED|Overall Study||4
8947939|NCT02424734|10010252|FG001|STARTED|Overall Study||5
8947940|NCT02424734|10010253|FG002|STARTED|Overall Study||2
8947941|NCT02424734|10010251|FG000|Treated|Overall Study||4
8947942|NCT02424734|10010252|FG001|Treated|Overall Study||5
8947943|NCT02424734|10010253|FG002|Treated|Overall Study||2
8947944|NCT02424734|10010251|FG000|COMPLETED|Overall Study||2
8947945|NCT02424734|10010252|FG001|COMPLETED|Overall Study||3
8947946|NCT02424734|10010253|FG002|COMPLETED|Overall Study||2
8947947|NCT02424734|10010251|FG000|NOT COMPLETED|Overall Study||2
8947948|NCT02424734|10010252|FG001|NOT COMPLETED|Overall Study||2
8947949|NCT02424734|10010253|FG002|NOT COMPLETED|Overall Study||0
8947950|NCT02424799|10010268|FG000|STARTED|Part A (Up to Day 11)||9
8947951|NCT02424799|10010269|FG001|STARTED|Part A (Up to Day 11)||8
8947952|NCT02424799|10010270|FG002|STARTED|Part A (Up to Day 11)||0
8947953|NCT02424799|10010271|FG003|STARTED|Part A (Up to Day 11)||0
8947954|NCT02424799|10010272|FG004|STARTED|Part A (Up to Day 11)||0
8947955|NCT02424799|10010273|FG005|STARTED|Part A (Up to Day 11)||0
8947956|NCT02424799|10010268|FG000|COMPLETED|Part A (Up to Day 11)||9
8947957|NCT02424799|10010269|FG001|COMPLETED|Part A (Up to Day 11)||8
8947958|NCT02424799|10010270|FG002|COMPLETED|Part A (Up to Day 11)||0
8947959|NCT02424799|10010271|FG003|COMPLETED|Part A (Up to Day 11)||0
8947960|NCT02424799|10010272|FG004|COMPLETED|Part A (Up to Day 11)||0
8947961|NCT02424799|10010273|FG005|COMPLETED|Part A (Up to Day 11)||0
8947962|NCT02424799|10010268|FG000|NOT COMPLETED|Part A (Up to Day 11)||0
8947963|NCT02424799|10010269|FG001|NOT COMPLETED|Part A (Up to Day 11)||0
8947964|NCT02424799|10010270|FG002|NOT COMPLETED|Part A (Up to Day 11)||0
8947965|NCT02424799|10010271|FG003|NOT COMPLETED|Part A (Up to Day 11)||0
8947966|NCT02424799|10010272|FG004|NOT COMPLETED|Part A (Up to Day 11)||0
8947967|NCT02424799|10010273|FG005|NOT COMPLETED|Part A (Up to Day 11)||0
8947968|NCT02424799|10010268|FG000|STARTED|Part B (Up to Day 19)||0
8947969|NCT02424799|10010269|FG001|STARTED|Part B (Up to Day 19)||0
8947970|NCT02424799|10010270|FG002|STARTED|Part B (Up to Day 19)||3
8947971|NCT02424799|10010271|FG003|STARTED|Part B (Up to Day 19)||9
8947972|NCT02424799|10010272|FG004|STARTED|Part B (Up to Day 19)||0
8947973|NCT02424799|10010273|FG005|STARTED|Part B (Up to Day 19)||0
8947974|NCT02424799|10010268|FG000|COMPLETED|Part B (Up to Day 19)||0
8947975|NCT02424799|10010269|FG001|COMPLETED|Part B (Up to Day 19)||0
8947976|NCT02424799|10010270|FG002|COMPLETED|Part B (Up to Day 19)||3
8947977|NCT02424799|10010271|FG003|COMPLETED|Part B (Up to Day 19)||9
8947978|NCT02424799|10010272|FG004|COMPLETED|Part B (Up to Day 19)||0
8947979|NCT02424799|10010273|FG005|COMPLETED|Part B (Up to Day 19)||0
8947980|NCT02424799|10010268|FG000|NOT COMPLETED|Part B (Up to Day 19)||0
8947981|NCT02424799|10010269|FG001|NOT COMPLETED|Part B (Up to Day 19)||0
8947982|NCT02424799|10010270|FG002|NOT COMPLETED|Part B (Up to Day 19)||0
8947983|NCT02424799|10010271|FG003|NOT COMPLETED|Part B (Up to Day 19)||0
8947984|NCT02424799|10010272|FG004|NOT COMPLETED|Part B (Up to Day 19)||0
8947985|NCT02424799|10010273|FG005|NOT COMPLETED|Part B (Up to Day 19)||0
8947986|NCT02424799|10010268|FG000|STARTED|Part C (Up to Day 23)||0
8947987|NCT02424799|10010269|FG001|STARTED|Part C (Up to Day 23)||0
8947988|NCT02424799|10010270|FG002|STARTED|Part C (Up to Day 23)||0
8947989|NCT02424799|10010271|FG003|STARTED|Part C (Up to Day 23)||0
8947990|NCT02424799|10010272|FG004|STARTED|Part C (Up to Day 23)||1
8947991|NCT02424799|10010273|FG005|STARTED|Part C (Up to Day 23)||4
8947992|NCT02424799|10010268|FG000|COMPLETED|Part C (Up to Day 23)||0
8947993|NCT02424799|10010269|FG001|COMPLETED|Part C (Up to Day 23)||0
8947994|NCT02424799|10010270|FG002|COMPLETED|Part C (Up to Day 23)||0
8947995|NCT02424799|10010271|FG003|COMPLETED|Part C (Up to Day 23)||0
8947996|NCT02424799|10010272|FG004|COMPLETED|Part C (Up to Day 23)||1
8947997|NCT02424799|10010273|FG005|COMPLETED|Part C (Up to Day 23)||4
8947998|NCT02424799|10010268|FG000|NOT COMPLETED|Part C (Up to Day 23)||0
8947999|NCT02424799|10010269|FG001|NOT COMPLETED|Part C (Up to Day 23)||0
8948000|NCT02424799|10010270|FG002|NOT COMPLETED|Part C (Up to Day 23)||0
8948001|NCT02424799|10010271|FG003|NOT COMPLETED|Part C (Up to Day 23)||0
8948002|NCT02424799|10010272|FG004|NOT COMPLETED|Part C (Up to Day 23)||0
8948003|NCT02424799|10010273|FG005|NOT COMPLETED|Part C (Up to Day 23)||0
8948004|NCT02424968|10010305|FG000|STARTED|Overall Study||18
8948005|NCT02424968|10010305|FG000|COMPLETED|Overall Study||18
8948006|NCT02424968|10010305|FG000|NOT COMPLETED|Overall Study||0
8948007|NCT02425098|10010311|FG000|STARTED|Overall Study||176
8948008|NCT02425098|10010312|FG001|STARTED|Overall Study||175
8948009|NCT02425098|10010311|FG000|COMPLETED|Overall Study||163
8948010|NCT02425098|10010312|FG001|COMPLETED|Overall Study||159
8948011|NCT02425098|10010311|FG000|NOT COMPLETED|Overall Study||13
8948012|NCT02425098|10010312|FG001|NOT COMPLETED|Overall Study||16
8948013|NCT02425111|10010318|FG000|STARTED|Part A: Treatment Period||101
8948014|NCT02425111|10010318|FG000|COMPLETED|Part A: Treatment Period||78
8948015|NCT02425111|10010318|FG000|NOT COMPLETED|Part A: Treatment Period||23
8948016|NCT02425111|10010318|FG000|STARTED|Part B: Treatment Extension Period||56
8948017|NCT02425111|10010318|FG000|COMPLETED|Part B: Treatment Extension Period||46
8948018|NCT02425111|10010318|FG000|NOT COMPLETED|Part B: Treatment Extension Period||10
8948019|NCT02425449|10010328|FG000|STARTED|Overall Study||0
8948020|NCT02425449|10010329|FG001|STARTED|Overall Study||4
8948021|NCT02425449|10010330|FG002|STARTED|Overall Study||5
8948022|NCT02425449|10010331|FG003|STARTED|Overall Study||5
8948023|NCT02425449|10010332|FG004|STARTED|Overall Study||5
8948024|NCT02425449|10010328|FG000|COMPLETED|Overall Study||0
8948025|NCT02425449|10010329|FG001|COMPLETED|Overall Study||4
8948026|NCT02425449|10010330|FG002|COMPLETED|Overall Study||5
8948027|NCT02425449|10010331|FG003|COMPLETED|Overall Study||5
8948028|NCT02425449|10010332|FG004|COMPLETED|Overall Study||5
8948029|NCT02425449|10010328|FG000|NOT COMPLETED|Overall Study||0
8948030|NCT02425449|10010329|FG001|NOT COMPLETED|Overall Study||0
8948031|NCT02425449|10010330|FG002|NOT COMPLETED|Overall Study||0
8948032|NCT02425449|10010331|FG003|NOT COMPLETED|Overall Study||0
8948033|NCT02425449|10010332|FG004|NOT COMPLETED|Overall Study||0
8948034|NCT02425891|10010346|FG000|STARTED|Overall Study||451
8948035|NCT02425891|10010347|FG001|STARTED|Overall Study||451
8948036|NCT02425891|10010346|FG000|COMPLETED|Overall Study||0
8948037|NCT02425891|10010347|FG001|COMPLETED|Overall Study||0
8948038|NCT02425891|10010346|FG000|NOT COMPLETED|Overall Study||451
8948039|NCT02425891|10010347|FG001|NOT COMPLETED|Overall Study||451
8948040|NCT02425956|10010354|FG000|STARTED|Overall Study||21
8948041|NCT02425956|10010354|FG000|COMPLETED|Overall Study||21
8948042|NCT02425956|10010354|FG000|NOT COMPLETED|Overall Study||0
8948043|NCT02426086|10010360|FG000|STARTED|Overall Study||48
8948044|NCT02426086|10010361|FG001|STARTED|Overall Study||59
8948045|NCT02426086|10010360|FG000|Treated|Overall Study||48
8948046|NCT02426086|10010361|FG001|Treated|Overall Study||59
8948047|NCT02426086|10010360|FG000|COMPLETED|Overall Study||0
8948048|NCT02426086|10010361|FG001|COMPLETED|Overall Study||0
8948049|NCT02426086|10010360|FG000|NOT COMPLETED|Overall Study||48
8948050|NCT02426086|10010361|FG001|NOT COMPLETED|Overall Study||59
8948051|NCT02426138|10010374|FG000|STARTED|First Intervention (12 Weeks)||21
8948052|NCT02426138|10010375|FG001|STARTED|First Intervention (12 Weeks)||23
8948053|NCT02426138|10010374|FG000|COMPLETED|First Intervention (12 Weeks)||20
8948054|NCT02426138|10010375|FG001|COMPLETED|First Intervention (12 Weeks)||22
8948055|NCT02426138|10010374|FG000|NOT COMPLETED|First Intervention (12 Weeks)||1
8948056|NCT02426138|10010375|FG001|NOT COMPLETED|First Intervention (12 Weeks)||1
8948057|NCT02426138|10010374|FG000|STARTED|Second Intervention (12 Weeks)||20
8948058|NCT02426138|10010375|FG001|STARTED|Second Intervention (12 Weeks)||22
8948059|NCT02426138|10010374|FG000|COMPLETED|Second Intervention (12 Weeks)||20
8948060|NCT02426138|10010375|FG001|COMPLETED|Second Intervention (12 Weeks)||22
8948061|NCT02426138|10010374|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||0
8948062|NCT02426138|10010375|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||0
8948063|NCT02426138|10010374|FG000|STARTED|Intent to Treat Population Milestone||20
8948064|NCT02426138|10010375|FG001|STARTED|Intent to Treat Population Milestone||22
8948065|NCT02426138|10010374|FG000|COMPLETED|Intent to Treat Population Milestone||20
8948066|NCT02426138|10010375|FG001|COMPLETED|Intent to Treat Population Milestone||22
8948067|NCT02426138|10010374|FG000|NOT COMPLETED|Intent to Treat Population Milestone||0
8948068|NCT02426138|10010375|FG001|NOT COMPLETED|Intent to Treat Population Milestone||0
8948069|NCT02426476|10010385|FG000|STARTED|Overall Study||57
8948070|NCT02426476|10010386|FG001|STARTED|Overall Study||56
8948071|NCT02426476|10010385|FG000|COMPLETED|Overall Study||38
8948072|NCT02426476|10010386|FG001|COMPLETED|Overall Study||39
8948073|NCT02426476|10010385|FG000|NOT COMPLETED|Overall Study||19
8948074|NCT02426476|10010386|FG001|NOT COMPLETED|Overall Study||17
8948075|NCT02426541|10010396|FG000|STARTED|Overall Study||16
8948076|NCT02426541|10010397|FG001|STARTED|Overall Study||16
8948077|NCT02426541|10010396|FG000|COMPLETED|Overall Study||15
8948078|NCT02426541|10010397|FG001|COMPLETED|Overall Study||16
8948079|NCT02426541|10010396|FG000|NOT COMPLETED|Overall Study||1
8948080|NCT02426541|10010397|FG001|NOT COMPLETED|Overall Study||0
8948081|NCT02426580|10010405|FG000|STARTED|Overall Study|April 2015|70
8948082|NCT02426580|10010406|FG001|STARTED|Overall Study|January 2014|70
8948083|NCT02426580|10010405|FG000|COMPLETED|Overall Study|the last patient enrolled in this group in April 2017|59
8948084|NCT02426580|10010406|FG001|COMPLETED|Overall Study|the last patient in this group enrolled in April 2017|54
8948085|NCT02426580|10010405|FG000|NOT COMPLETED|Overall Study||11
8948086|NCT02426580|10010406|FG001|NOT COMPLETED|Overall Study||16
8948087|NCT02426658|10010412|FG000|STARTED|Overall Study||16
8948088|NCT02426658|10010412|FG000|COMPLETED|Overall Study||13
8948089|NCT02426658|10010412|FG000|NOT COMPLETED|Overall Study||3
8948090|NCT02426749|10010418|FG000|STARTED|Overall Study||12
8948091|NCT02426749|10010419|FG001|STARTED|Overall Study||10
8948092|NCT02426749|10010418|FG000|COMPLETED|Overall Study||9
8948093|NCT02426749|10010419|FG001|COMPLETED|Overall Study||9
8948094|NCT02426749|10010418|FG000|NOT COMPLETED|Overall Study||3
8948095|NCT02426749|10010419|FG001|NOT COMPLETED|Overall Study||1
8948096|NCT02426918|10010430|FG000|STARTED|Overall Study||110
8948097|NCT02426918|10010431|FG001|STARTED|Overall Study||109
8948098|NCT02426918|10010432|FG002|STARTED|Overall Study||111
8948099|NCT02426918|10010430|FG000|Safety Population|Overall Study||110
8948100|NCT02426918|10010431|FG001|Safety Population|Overall Study||107
8948101|NCT02426918|10010432|FG002|Safety Population|Overall Study||107
8948102|NCT02426918|10010430|FG000|COMPLETED|Overall Study||93
9066227|NCT04092907|10126700|FG001|STARTED|Overall Study||50
9066228|NCT04092907|10126699|FG000|COMPLETED|Overall Study||48
9066229|NCT04092907|10126700|FG001|COMPLETED|Overall Study||50
9066230|NCT04092907|10126699|FG000|NOT COMPLETED|Overall Study||2
9066231|NCT04092907|10126700|FG001|NOT COMPLETED|Overall Study||0
9066232|NCT04089982|10126708|FG000|STARTED|Overall Study||6
9066233|NCT04089982|10126709|FG001|STARTED|Overall Study||5
9066234|NCT04089982|10126708|FG000|COMPLETED|Overall Study||6
9066235|NCT04089982|10126709|FG001|COMPLETED|Overall Study||5
9066236|NCT04089982|10126708|FG000|NOT COMPLETED|Overall Study||0
9066237|NCT04089982|10126709|FG001|NOT COMPLETED|Overall Study||0
9066238|NCT04086433|10126717|FG000|STARTED|Overall Study||17
9066239|NCT04086433|10126718|FG001|STARTED|Overall Study||18
9066240|NCT04086433|10126717|FG000|COMPLETED|Overall Study||17
9066241|NCT04086433|10126718|FG001|COMPLETED|Overall Study||18
9066242|NCT04086433|10126717|FG000|NOT COMPLETED|Overall Study||0
9066243|NCT04086433|10126718|FG001|NOT COMPLETED|Overall Study||0
9066244|NCT04086407|10126724|FG000|STARTED|Overall Study||8
9066245|NCT04086407|10126724|FG000|COMPLETED|Overall Study||8
9066246|NCT04086407|10126724|FG000|NOT COMPLETED|Overall Study||0
9066247|NCT04099277|10126731|FG000|STARTED|Overall Study||2
9066248|NCT04099277|10126731|FG000|Received at Least 1 Dose of Study Drug|Overall Study||2
9066249|NCT04099277|10126731|FG000|COMPLETED|Overall Study||0
9066250|NCT04099277|10126731|FG000|NOT COMPLETED|Overall Study||2
9066251|NCT04098809|10126737|FG000|STARTED|Overall Study||27
9066252|NCT04098809|10126738|FG001|STARTED|Overall Study||25
8723497|NCT01023581|9771017|FG001|Received Study Treatment|Overall Study||112
8723498|NCT01023581|9771018|FG002|Received Study Treatment|Overall Study||110
8723499|NCT01023581|9771019|FG003|Received Study Treatment|Overall Study||109
8723500|NCT01023581|9771020|FG004|Received Study Treatment|Overall Study||111
8723501|NCT01023581|9771021|FG005|Received Study Treatment|Overall Study||106
8723502|NCT01023581|9771022|FG006|Received Study Treatment|Overall Study||114
8723503|NCT01023581|9771016|FG000|COMPLETED|Overall Study|The number of completed patients represents those who completed study drug.|74
8723504|NCT01023581|9771017|FG001|COMPLETED|Overall Study||89
8723505|NCT01023581|9771018|FG002|COMPLETED|Overall Study||71
8723506|NCT01023581|9771019|FG003|COMPLETED|Overall Study||94
8723507|NCT01023581|9771020|FG004|COMPLETED|Overall Study||95
8723508|NCT01023581|9771021|FG005|COMPLETED|Overall Study||92
8948103|NCT02426918|10010431|FG001|COMPLETED|Overall Study||90
8948104|NCT02426918|10010432|FG002|COMPLETED|Overall Study||97
8948105|NCT02426918|10010430|FG000|NOT COMPLETED|Overall Study||17
9066253|NCT04098809|10126737|FG000|COMPLETED|Overall Study||24
9066254|NCT04098809|10126738|FG001|COMPLETED|Overall Study||21
9066255|NCT04098809|10126737|FG000|NOT COMPLETED|Overall Study||3
9066256|NCT04098809|10126738|FG001|NOT COMPLETED|Overall Study||4
9066257|NCT04098575|10126747|FG000|STARTED|Overall Study||505
9066258|NCT04098575|10126748|FG001|STARTED|Overall Study||2961
8948106|NCT02426918|10010431|FG001|NOT COMPLETED|Overall Study||19
9066259|NCT04098575|10126749|FG002|STARTED|Overall Study||6105
9066260|NCT04098575|10126747|FG000|COMPLETED|Overall Study||505
9066261|NCT04098575|10126748|FG001|COMPLETED|Overall Study||2961
9066262|NCT04098575|10126749|FG002|COMPLETED|Overall Study||6105
9066263|NCT04098575|10126747|FG000|NOT COMPLETED|Overall Study||0
9066264|NCT04098575|10126748|FG001|NOT COMPLETED|Overall Study||0
9066265|NCT04098575|10126749|FG002|NOT COMPLETED|Overall Study||0
9066266|NCT04098458|10126757|FG000|STARTED|Overall Study||18
9066267|NCT04098458|10126757|FG000|COMPLETED|Overall Study||14
9066268|NCT04098458|10126757|FG000|NOT COMPLETED|Overall Study||4
9066269|NCT04095286|10126762|FG000|STARTED|Period 1 (4 Days) + Washout (7days)||4
9066270|NCT04095286|10126763|FG001|STARTED|Period 1 (4 Days) + Washout (7days)||5
9066271|NCT04095286|10126764|FG002|STARTED|Period 1 (4 Days) + Washout (7days)||5
9066272|NCT04095286|10126765|FG003|STARTED|Period 1 (4 Days) + Washout (7days)||5
9066273|NCT04095286|10126766|FG004|STARTED|Period 1 (4 Days) + Washout (7days)||5
9066274|NCT04095286|10126767|FG005|STARTED|Period 1 (4 Days) + Washout (7days)||5
9066275|NCT04095286|10126762|FG000|COMPLETED|Period 1 (4 Days) + Washout (7days)||3
9066276|NCT04095286|10126763|FG001|COMPLETED|Period 1 (4 Days) + Washout (7days)||4
9066277|NCT04095286|10126764|FG002|COMPLETED|Period 1 (4 Days) + Washout (7days)||4
9066278|NCT04095286|10126765|FG003|COMPLETED|Period 1 (4 Days) + Washout (7days)||5
9066279|NCT04095286|10126766|FG004|COMPLETED|Period 1 (4 Days) + Washout (7days)||5
9066280|NCT04095286|10126767|FG005|COMPLETED|Period 1 (4 Days) + Washout (7days)||5
9066281|NCT04095286|10126762|FG000|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||1
9066282|NCT04095286|10126763|FG001|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||1
9066283|NCT04095286|10126764|FG002|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||1
9066284|NCT04095286|10126765|FG003|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||0
9066285|NCT04095286|10126766|FG004|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||0
9066286|NCT04095286|10126767|FG005|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||0
9066287|NCT04095286|10126762|FG000|STARTED|Period 2 (4 Days) + Washout (7days)||3
9066288|NCT04095286|10126763|FG001|STARTED|Period 2 (4 Days) + Washout (7days)||4
9066289|NCT04095286|10126764|FG002|STARTED|Period 2 (4 Days) + Washout (7days)||4
9066290|NCT04095286|10126765|FG003|STARTED|Period 2 (4 Days) + Washout (7days)||5
9066291|NCT04095286|10126766|FG004|STARTED|Period 2 (4 Days) + Washout (7days)||5
9066292|NCT04095286|10126767|FG005|STARTED|Period 2 (4 Days) + Washout (7days)||5
9066293|NCT04095286|10126762|FG000|COMPLETED|Period 2 (4 Days) + Washout (7days)||3
9066294|NCT04095286|10126763|FG001|COMPLETED|Period 2 (4 Days) + Washout (7days)||4
9066295|NCT04095286|10126764|FG002|COMPLETED|Period 2 (4 Days) + Washout (7days)||2
9066296|NCT04095286|10126765|FG003|COMPLETED|Period 2 (4 Days) + Washout (7days)||5
9066297|NCT04095286|10126766|FG004|COMPLETED|Period 2 (4 Days) + Washout (7days)||4
9066298|NCT04095286|10126767|FG005|COMPLETED|Period 2 (4 Days) + Washout (7days)||5
9066299|NCT04095286|10126762|FG000|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||0
9066300|NCT04095286|10126763|FG001|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||0
9066301|NCT04095286|10126764|FG002|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||2
9066302|NCT04095286|10126765|FG003|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||0
9066303|NCT04095286|10126766|FG004|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||1
9066304|NCT04095286|10126767|FG005|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||0
9066305|NCT04095286|10126762|FG000|STARTED|Period 3 (4 Days) + Follow up (14 Days)||3
9066306|NCT04095286|10126763|FG001|STARTED|Period 3 (4 Days) + Follow up (14 Days)||4
9066307|NCT04095286|10126764|FG002|STARTED|Period 3 (4 Days) + Follow up (14 Days)||2
9066308|NCT04095286|10126765|FG003|STARTED|Period 3 (4 Days) + Follow up (14 Days)||5
9066309|NCT04095286|10126766|FG004|STARTED|Period 3 (4 Days) + Follow up (14 Days)||4
9066310|NCT04095286|10126767|FG005|STARTED|Period 3 (4 Days) + Follow up (14 Days)||5
9066311|NCT04095286|10126762|FG000|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||3
9066312|NCT04095286|10126763|FG001|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||4
9066313|NCT04095286|10126764|FG002|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||2
9066314|NCT04095286|10126765|FG003|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||5
9066315|NCT04095286|10126766|FG004|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||4
9066316|NCT04095286|10126767|FG005|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||5
9066317|NCT04095286|10126762|FG000|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0
9066318|NCT04095286|10126763|FG001|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0
9066319|NCT04095286|10126764|FG002|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0
9066320|NCT04095286|10126765|FG003|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0
9066321|NCT04095286|10126766|FG004|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0
9066322|NCT04095286|10126767|FG005|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0
9066323|NCT04094883|10126775|FG000|STARTED|Overall Study||11
9066324|NCT04094883|10126775|FG000|COMPLETED|Overall Study||10
9066325|NCT04094883|10126775|FG000|NOT COMPLETED|Overall Study||1
9066326|NCT04091659|10126781|FG000|STARTED|Overall Study||40
9066327|NCT04091659|10126782|FG001|STARTED|Overall Study||58
9066328|NCT04091659|10126781|FG000|COMPLETED|Overall Study||37
9066329|NCT04091659|10126782|FG001|COMPLETED|Overall Study||57
9066330|NCT04091659|10126781|FG000|NOT COMPLETED|Overall Study||3
9066331|NCT04091659|10126782|FG001|NOT COMPLETED|Overall Study||1
9066332|NCT04091061|10126792|FG000|STARTED|Overall Study||6
9066333|NCT04091061|10126793|FG001|STARTED|Overall Study||6
9066334|NCT04091061|10126794|FG002|STARTED|Overall Study||6
9066335|NCT04091061|10126795|FG003|STARTED|Overall Study||6
9066336|NCT04091061|10126792|FG000|COMPLETED|Overall Study||6
9066337|NCT04091061|10126793|FG001|COMPLETED|Overall Study||6
9066338|NCT04091061|10126794|FG002|COMPLETED|Overall Study||6
9066339|NCT04091061|10126795|FG003|COMPLETED|Overall Study||6
9066340|NCT04091061|10126792|FG000|NOT COMPLETED|Overall Study||0
9066341|NCT04091061|10126793|FG001|NOT COMPLETED|Overall Study||0
9066342|NCT04091061|10126794|FG002|NOT COMPLETED|Overall Study||0
9066343|NCT04091061|10126795|FG003|NOT COMPLETED|Overall Study||0
9066344|NCT04090242|10126807|FG000|STARTED|Overall Study||28
9066345|NCT04090242|10126808|FG001|STARTED|Overall Study||30
9066346|NCT04090242|10126807|FG000|COMPLETED|Overall Study||27
9066347|NCT04090242|10126808|FG001|COMPLETED|Overall Study||30
9066348|NCT04090242|10126807|FG000|NOT COMPLETED|Overall Study||1
9066349|NCT04090242|10126808|FG001|NOT COMPLETED|Overall Study||0
9066350|NCT04089761|10126815|FG000|STARTED|"Run In Phase"||60
9066351|NCT04089761|10126815|FG000|COMPLETED|"Run In Phase"||45
9066352|NCT04089761|10126815|FG000|NOT COMPLETED|"Run In Phase"||15
9066353|NCT04089761|10126815|FG000|STARTED|"Treatment Phase"||45
9066354|NCT04089761|10126815|FG000|COMPLETED|"Treatment Phase"||39
9066355|NCT04089761|10126815|FG000|NOT COMPLETED|"Treatment Phase"||6
9066356|NCT04089761|10126815|FG000|STARTED|"Follow Up Phase (Optional)"|"Due to the COVID-19 pandemic, Only 27 participants were able to continue to the folllow Up phase"|27
9066357|NCT04089761|10126815|FG000|COMPLETED|"Follow Up Phase (Optional)"||27
9066358|NCT04089761|10126815|FG000|NOT COMPLETED|"Follow Up Phase (Optional)"||0
9066359|NCT04079803|10126822|FG000|STARTED|Overall Study||22
9066360|NCT04079803|10126823|FG001|STARTED|Overall Study||21
9066361|NCT04079803|10126824|FG002|STARTED|Overall Study||21
9066362|NCT04079803|10126822|FG000|COMPLETED|Overall Study||22
9066363|NCT04079803|10126823|FG001|COMPLETED|Overall Study||21
9066364|NCT04079803|10126824|FG002|COMPLETED|Overall Study||20
9066365|NCT04079803|10126822|FG000|NOT COMPLETED|Overall Study||0
9066366|NCT04079803|10126823|FG001|NOT COMPLETED|Overall Study||0
9066367|NCT04079803|10126824|FG002|NOT COMPLETED|Overall Study||1
9066368|NCT04086576|10126848|FG000|STARTED|Overall Study||10
9066369|NCT04086576|10126849|FG001|STARTED|Overall Study||10
9066370|NCT04086576|10126848|FG000|COMPLETED|Overall Study||10
9066371|NCT04086576|10126849|FG001|COMPLETED|Overall Study||10
9066372|NCT04086576|10126848|FG000|NOT COMPLETED|Overall Study||0
9066373|NCT04086576|10126849|FG001|NOT COMPLETED|Overall Study||0
9066374|NCT04086641|10126867|FG000|STARTED|Foot 1 (Two Week Utilization)||2
9066375|NCT04086641|10126868|FG001|STARTED|Foot 1 (Two Week Utilization)||3
9066376|NCT04086641|10126867|FG000|COMPLETED|Foot 1 (Two Week Utilization)||1
9066377|NCT04086641|10126868|FG001|COMPLETED|Foot 1 (Two Week Utilization)||1
9066378|NCT04086641|10126867|FG000|NOT COMPLETED|Foot 1 (Two Week Utilization)||1
9066379|NCT04086641|10126868|FG001|NOT COMPLETED|Foot 1 (Two Week Utilization)||2
9066380|NCT04086641|10126867|FG000|STARTED|Foot 2 (Two Week Utilization)||1
9066381|NCT04086641|10126868|FG001|STARTED|Foot 2 (Two Week Utilization)||1
9066382|NCT04086641|10126867|FG000|COMPLETED|Foot 2 (Two Week Utilization)||1
9066383|NCT04086641|10126868|FG001|COMPLETED|Foot 2 (Two Week Utilization)||1
9066384|NCT04086641|10126867|FG000|NOT COMPLETED|Foot 2 (Two Week Utilization)||0
9066385|NCT04086641|10126868|FG001|NOT COMPLETED|Foot 2 (Two Week Utilization)||0
9066386|NCT04080882|10126876|FG000|STARTED|Overall Study||20
9066387|NCT04080882|10126877|FG001|STARTED|Overall Study||60
9066388|NCT04080882|10126876|FG000|COMPLETED|Overall Study||18
9066389|NCT04080882|10126877|FG001|COMPLETED|Overall Study||58
9066390|NCT04080882|10126876|FG000|NOT COMPLETED|Overall Study||2
9066391|NCT04080882|10126877|FG001|NOT COMPLETED|Overall Study||2
9066392|NCT04085289|10126886|FG000|STARTED|Overall Study||6
9066393|NCT04085289|10126887|FG001|STARTED|Overall Study||12
9066394|NCT04085289|10126888|FG002|STARTED|Overall Study||12
9066395|NCT04085289|10126886|FG000|Received at Least One Dose of Study Drug|Overall Study||6
9066396|NCT04085289|10126887|FG001|Received at Least One Dose of Study Drug|Overall Study||12
9066397|NCT04085289|10126888|FG002|Received at Least One Dose of Study Drug|Overall Study||12
9066398|NCT04085289|10126886|FG000|COMPLETED|Overall Study||6
9066399|NCT04085289|10126887|FG001|COMPLETED|Overall Study||12
9066400|NCT04085289|10126888|FG002|COMPLETED|Overall Study||11
9066401|NCT04085289|10126886|FG000|NOT COMPLETED|Overall Study||0
9066402|NCT04085289|10126887|FG001|NOT COMPLETED|Overall Study||0
9066403|NCT04085289|10126888|FG002|NOT COMPLETED|Overall Study||1
9066404|NCT04084015|10126895|FG000|STARTED|Overall Study||2
9066405|NCT04084015|10126895|FG000|COMPLETED|Overall Study||2
9066406|NCT04084015|10126895|FG000|NOT COMPLETED|Overall Study||0
9066407|NCT04082663|10126899|FG000|STARTED|Overall Study||20
9066408|NCT04082663|10126899|FG000|COMPLETED|Overall Study||13
9066409|NCT04082663|10126899|FG000|NOT COMPLETED|Overall Study||7
9066410|NCT04084028|10126907|FG000|STARTED|Overall Study||18
9066411|NCT04084028|10126908|FG001|STARTED|Overall Study||16
9066412|NCT04084028|10126909|FG002|STARTED|Overall Study||9
9066413|NCT04084028|10126910|FG003|STARTED|Overall Study||10
9066414|NCT04084028|10126907|FG000|COMPLETED|Overall Study||18
9066415|NCT04084028|10126908|FG001|COMPLETED|Overall Study||16
9066416|NCT04084028|10126909|FG002|COMPLETED|Overall Study||9
9066417|NCT04084028|10126910|FG003|COMPLETED|Overall Study||10
9066418|NCT04084028|10126907|FG000|NOT COMPLETED|Overall Study||0
9066419|NCT04084028|10126908|FG001|NOT COMPLETED|Overall Study||0
9066420|NCT04084028|10126909|FG002|NOT COMPLETED|Overall Study||0
9066421|NCT04084028|10126910|FG003|NOT COMPLETED|Overall Study||0
9066422|NCT04082819|10126925|FG000|STARTED|Overall Study||37
9066423|NCT04082819|10126926|FG001|STARTED|Overall Study||54
9066424|NCT04082819|10126927|FG002|STARTED|Overall Study||3
9066425|NCT04082819|10126925|FG000|COMPLETED|Overall Study||37
9066426|NCT04082819|10126926|FG001|COMPLETED|Overall Study||54
9066427|NCT04082819|10126927|FG002|COMPLETED|Overall Study||3
9066428|NCT04082819|10126925|FG000|NOT COMPLETED|Overall Study||0
9066429|NCT04082819|10126926|FG001|NOT COMPLETED|Overall Study||0
9066430|NCT04082819|10126927|FG002|NOT COMPLETED|Overall Study||0
9066431|NCT04081961|10126941|FG000|STARTED|Overall Study||9
9066432|NCT04081961|10126942|FG001|STARTED|Overall Study||9
9066433|NCT04081961|10126943|FG002|STARTED|Overall Study||9
9066434|NCT04081961|10126941|FG000|COMPLETED|Overall Study||9
9066435|NCT04081961|10126942|FG001|COMPLETED|Overall Study||9
9066436|NCT04081961|10126943|FG002|COMPLETED|Overall Study||9
9066437|NCT04081961|10126941|FG000|NOT COMPLETED|Overall Study||0
9066438|NCT04081961|10126942|FG001|NOT COMPLETED|Overall Study||0
9066439|NCT04081961|10126943|FG002|NOT COMPLETED|Overall Study||0
9066440|NCT04081610|10126953|FG000|STARTED|Overall Study||16
9066441|NCT04081610|10126954|FG001|STARTED|Overall Study||18
9066442|NCT04081610|10126953|FG000|COMPLETED|Overall Study||16
9066443|NCT04081610|10126954|FG001|COMPLETED|Overall Study||18
9066444|NCT04081610|10126953|FG000|NOT COMPLETED|Overall Study||0
9066445|NCT04081610|10126954|FG001|NOT COMPLETED|Overall Study||0
9066446|NCT04081324|10126964|FG000|STARTED|Overall Study||6
9066447|NCT04081324|10126965|FG001|STARTED|Overall Study||10
9066448|NCT04081324|10126966|FG002|STARTED|Overall Study||10
9066449|NCT04081324|10126967|FG003|STARTED|Overall Study||10
9066450|NCT04081324|10126964|FG000|Received At Least One Dose of Study Drug|Overall Study||6
9066451|NCT04081324|10126965|FG001|Received At Least One Dose of Study Drug|Overall Study||10
9066452|NCT04081324|10126966|FG002|Received At Least One Dose of Study Drug|Overall Study||10
9066453|NCT04081324|10126967|FG003|Received At Least One Dose of Study Drug|Overall Study||10
9066454|NCT04081324|10126964|FG000|COMPLETED|Overall Study||6
9066455|NCT04081324|10126965|FG001|COMPLETED|Overall Study||10
9066456|NCT04081324|10126966|FG002|COMPLETED|Overall Study||10
9066457|NCT04081324|10126967|FG003|COMPLETED|Overall Study||10
9066458|NCT04081324|10126964|FG000|NOT COMPLETED|Overall Study||0
9066459|NCT04081324|10126965|FG001|NOT COMPLETED|Overall Study||0
9066460|NCT04081324|10126966|FG002|NOT COMPLETED|Overall Study||0
9066461|NCT04081324|10126967|FG003|NOT COMPLETED|Overall Study||0
9066462|NCT04079790|10126980|FG000|STARTED|Part 1, Period 1(Day 1 to Day 4)||14
9066463|NCT04079790|10126981|FG001|STARTED|Part 1, Period 1(Day 1 to Day 4)||2
9066464|NCT04079790|10126982|FG002|STARTED|Part 1, Period 1(Day 1 to Day 4)||0
9066465|NCT04079790|10126983|FG003|STARTED|Part 1, Period 1(Day 1 to Day 4)||0
9066466|NCT04079790|10126980|FG000|COMPLETED|Part 1, Period 1(Day 1 to Day 4)||13
9066467|NCT04079790|10126981|FG001|COMPLETED|Part 1, Period 1(Day 1 to Day 4)||2
9066468|NCT04079790|10126982|FG002|COMPLETED|Part 1, Period 1(Day 1 to Day 4)||0
9066469|NCT04079790|10126983|FG003|COMPLETED|Part 1, Period 1(Day 1 to Day 4)||0
9066470|NCT04079790|10126980|FG000|NOT COMPLETED|Part 1, Period 1(Day 1 to Day 4)||1
9066471|NCT04079790|10126981|FG001|NOT COMPLETED|Part 1, Period 1(Day 1 to Day 4)||0
9066472|NCT04079790|10126982|FG002|NOT COMPLETED|Part 1, Period 1(Day 1 to Day 4)||0
9066473|NCT04079790|10126983|FG003|NOT COMPLETED|Part 1, Period 1(Day 1 to Day 4)||0
9066474|NCT04079790|10126980|FG000|STARTED|Part 1, Period 2 (Day 5 to Day 8)||13
9066475|NCT04079790|10126981|FG001|STARTED|Part 1, Period 2 (Day 5 to Day 8)||2
9066476|NCT04079790|10126982|FG002|STARTED|Part 1, Period 2 (Day 5 to Day 8)||0
9066477|NCT04079790|10126983|FG003|STARTED|Part 1, Period 2 (Day 5 to Day 8)||0
9066478|NCT04079790|10126980|FG000|COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||13
9066479|NCT04079790|10126981|FG001|COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||2
9066480|NCT04079790|10126982|FG002|COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0
9066481|NCT04079790|10126983|FG003|COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0
9066482|NCT04079790|10126980|FG000|NOT COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0
9066483|NCT04079790|10126981|FG001|NOT COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0
9066484|NCT04079790|10126982|FG002|NOT COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0
9066485|NCT04079790|10126983|FG003|NOT COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0
9066486|NCT04079790|10126980|FG000|STARTED|Part 1, Period 3 (Day 9 to Day 11)||13
9066487|NCT04079790|10126981|FG001|STARTED|Part 1, Period 3 (Day 9 to Day 11)||2
9066488|NCT04079790|10126982|FG002|STARTED|Part 1, Period 3 (Day 9 to Day 11)||0
9066489|NCT04079790|10126983|FG003|STARTED|Part 1, Period 3 (Day 9 to Day 11)||0
9066490|NCT04079790|10126980|FG000|COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||13
9066491|NCT04079790|10126981|FG001|COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||2
9066492|NCT04079790|10126982|FG002|COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0
9066493|NCT04079790|10126983|FG003|COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0
9066494|NCT04079790|10126980|FG000|NOT COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0
9066495|NCT04079790|10126981|FG001|NOT COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0
9066496|NCT04079790|10126982|FG002|NOT COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0
9066497|NCT04079790|10126983|FG003|NOT COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0
9066498|NCT04079790|10126980|FG000|STARTED|Part 2, Period 1 (Day 1 to Day 3)||0
9066499|NCT04079790|10126981|FG001|STARTED|Part 2, Period 1 (Day 1 to Day 3)||0
9066500|NCT04079790|10126982|FG002|STARTED|Part 2, Period 1 (Day 1 to Day 3)||15
9066501|NCT04079790|10126983|FG003|STARTED|Part 2, Period 1 (Day 1 to Day 3)||3
8623748|NCT00494975|9662918|FG000|STARTED|Overall Study||10
8623749|NCT00494975|9662919|FG001|STARTED|Overall Study||11
8623750|NCT00494975|9662918|FG000|COMPLETED|Overall Study||8
8623751|NCT00494975|9662919|FG001|COMPLETED|Overall Study||10
9066502|NCT04079790|10126980|FG000|COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||0
9066503|NCT04079790|10126981|FG001|COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||0
9066504|NCT04079790|10126982|FG002|COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||12
8623752|NCT00494975|9662918|FG000|NOT COMPLETED|Overall Study||2
9066505|NCT04079790|10126983|FG003|COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||3
9066506|NCT04079790|10126980|FG000|NOT COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||0
9066507|NCT04079790|10126981|FG001|NOT COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||0
9066508|NCT04079790|10126982|FG002|NOT COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||3
9066509|NCT04079790|10126983|FG003|NOT COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||0
9066510|NCT04079790|10126980|FG000|STARTED|Part 2, Period 2 (Day 1 to Day 3)||0
9066511|NCT04079790|10126981|FG001|STARTED|Part 2, Period 2 (Day 1 to Day 3)||0
9066512|NCT04079790|10126982|FG002|STARTED|Part 2, Period 2 (Day 1 to Day 3)||12
9066513|NCT04079790|10126983|FG003|STARTED|Part 2, Period 2 (Day 1 to Day 3)||3
9066514|NCT04079790|10126980|FG000|COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0
9066515|NCT04079790|10126981|FG001|COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0
9066516|NCT04079790|10126982|FG002|COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||12
9066517|NCT04079790|10126983|FG003|COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||3
9066518|NCT04079790|10126980|FG000|NOT COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0
9066519|NCT04079790|10126981|FG001|NOT COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0
9066520|NCT04079790|10126982|FG002|NOT COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0
9066521|NCT04079790|10126983|FG003|NOT COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0
9066522|NCT04079127|10127009|FG000|STARTED|Overall Study|hips (in 141 patients)|150
9066523|NCT04079127|10127009|FG000|COMPLETED|Overall Study|89 hips have completed the study, and all 10 year data of 81 were available for analysis.|89
9066524|NCT04079127|10127009|FG000|NOT COMPLETED|Overall Study||61
9066525|NCT04076787|10127016|FG000|STARTED|Overall Study||318
9066526|NCT04076787|10127017|FG001|STARTED|Overall Study||1031
9066527|NCT04076787|10127018|FG002|STARTED|Overall Study||420
9066528|NCT04076787|10127016|FG000|COMPLETED|Overall Study||318
9066529|NCT04076787|10127017|FG001|COMPLETED|Overall Study||1031
9066530|NCT04076787|10127018|FG002|COMPLETED|Overall Study||420
9066531|NCT04076787|10127016|FG000|NOT COMPLETED|Overall Study||0
9066532|NCT04076787|10127017|FG001|NOT COMPLETED|Overall Study||0
9066533|NCT04076787|10127018|FG002|NOT COMPLETED|Overall Study||0
9066534|NCT04075812|10127026|FG000|STARTED|Overall Study||2
9066535|NCT04075812|10127026|FG000|COMPLETED|Overall Study||2
9066536|NCT04075812|10127026|FG000|NOT COMPLETED|Overall Study||0
9066537|NCT04075409|10127033|FG000|STARTED|Overall Study||13
9066538|NCT04075409|10127034|FG001|STARTED|Overall Study||13
9066539|NCT04075409|10127035|FG002|STARTED|Overall Study||13
9066540|NCT04075409|10127033|FG000|COMPLETED|Overall Study||13
9066541|NCT04075409|10127034|FG001|COMPLETED|Overall Study||13
9066542|NCT04075409|10127035|FG002|COMPLETED|Overall Study||13
9066543|NCT04075409|10127033|FG000|NOT COMPLETED|Overall Study||0
9066544|NCT04075409|10127034|FG001|NOT COMPLETED|Overall Study||0
9066545|NCT04075409|10127035|FG002|NOT COMPLETED|Overall Study||0
9066546|NCT04074941|10127056|FG000|STARTED|Overall Study||11
9066547|NCT04074941|10127057|FG001|STARTED|Overall Study||9
9066548|NCT04074941|10127056|FG000|COMPLETED|Overall Study||11
9066549|NCT04074941|10127057|FG001|COMPLETED|Overall Study||9
9066550|NCT04074941|10127056|FG000|NOT COMPLETED|Overall Study||0
9066551|NCT04074941|10127057|FG001|NOT COMPLETED|Overall Study||0
9066552|NCT04073823|10127065|FG000|STARTED|Overall Study||1
9066553|NCT04073823|10127066|FG001|STARTED|Overall Study||1
9066554|NCT04073823|10127065|FG000|COMPLETED|Overall Study||1
9066555|NCT04073823|10127066|FG001|COMPLETED|Overall Study||1
9066556|NCT04073823|10127065|FG000|NOT COMPLETED|Overall Study||0
9066557|NCT04073823|10127066|FG001|NOT COMPLETED|Overall Study||0
9066558|NCT04073407|10127074|FG000|STARTED|Part 1||6
9066559|NCT04073407|10127075|FG001|STARTED|Part 1||3
9066560|NCT04073407|10127074|FG000|COMPLETED|Part 1||1
9066561|NCT04073407|10127075|FG001|COMPLETED|Part 1||2
9066562|NCT04073407|10127074|FG000|NOT COMPLETED|Part 1||5
9066563|NCT04073407|10127075|FG001|NOT COMPLETED|Part 1||1
9066564|NCT04073407|10127074|FG000|STARTED|Part 2|Following Part 1, all subjects (including those randomly assigned to the placebo arm in Part 1) were given the option to continue in Part 2 to receive the study food product twice daily for an additional 12 weeks. If the subject chose to not take part in Part 2, the subject underwent a safety follow-up visit approximately 2 weeks after Week13 (Visit 6).|0
9066565|NCT04073407|10127075|FG001|STARTED|Part 2|Following Part 1, all subjects (including those randomly assigned to the placebo arm in Part 1) were given the option to continue in Part 2 to receive the study food product twice daily for an additional 12 weeks. If the subject chose to not take part in Part 2, the subject underwent a safety follow-up visit approximately 2 weeks after Week13 (Visit 6).|1
9066566|NCT04073407|10127074|FG000|COMPLETED|Part 2||0
9066567|NCT04073407|10127075|FG001|COMPLETED|Part 2||0
9066568|NCT04073407|10127074|FG000|NOT COMPLETED|Part 2||0
9066569|NCT04073407|10127075|FG001|NOT COMPLETED|Part 2||1
9066570|NCT04073368|10127085|FG000|STARTED|Overall Study||32
9066571|NCT04073368|10127086|FG001|STARTED|Overall Study||26
9066572|NCT04073368|10127087|FG002|STARTED|Overall Study||29
9066573|NCT04073368|10127088|FG003|STARTED|Overall Study||15
9066574|NCT04073368|10127085|FG000|COMPLETED|Overall Study||20
9066575|NCT04073368|10127086|FG001|COMPLETED|Overall Study||18
8842957|NCT01701258|9897264|FG006|COMPLETED|Drug+fMRI (Session 2)||8
8842958|NCT01701258|9897265|FG007|COMPLETED|Drug+fMRI (Session 2)||0
8842959|NCT01701258|9897266|FG008|COMPLETED|Drug+fMRI (Session 2)||6
8842960|NCT01701258|9897267|FG009|COMPLETED|Drug+fMRI (Session 2)||6
8842961|NCT01701258|9897268|FG010|COMPLETED|Drug+fMRI (Session 2)||0
8842962|NCT01701258|9897269|FG011|COMPLETED|Drug+fMRI (Session 2)||10
9066576|NCT04073368|10127087|FG002|COMPLETED|Overall Study||26
8842963|NCT01701258|9897270|FG012|COMPLETED|Drug+fMRI (Session 2)||7
8842964|NCT01701258|9897258|FG000|NOT COMPLETED|Drug+fMRI (Session 2)||0
9066577|NCT04073368|10127088|FG003|COMPLETED|Overall Study||13
9066578|NCT04073368|10127085|FG000|NOT COMPLETED|Overall Study||12
9066579|NCT04073368|10127086|FG001|NOT COMPLETED|Overall Study||8
9066580|NCT04073368|10127087|FG002|NOT COMPLETED|Overall Study||3
9066581|NCT04073368|10127088|FG003|NOT COMPLETED|Overall Study||2
9066582|NCT04073186|10127098|FG000|STARTED|First Wearing Cycle||86
9066583|NCT04073186|10127098|FG000|COMPLETED|First Wearing Cycle||80
9066584|NCT04073186|10127098|FG000|NOT COMPLETED|First Wearing Cycle||6
9066585|NCT04073186|10127098|FG000|STARTED|Second Wearing Cycle||80
9066586|NCT04073186|10127098|FG000|COMPLETED|Second Wearing Cycle||79
9066587|NCT04073186|10127098|FG000|NOT COMPLETED|Second Wearing Cycle||1
9066588|NCT04072237|10127103|FG000|STARTED|Stage I: MarzAA 18 µg/kg IV||11
9066589|NCT04072237|10127103|FG000|COMPLETED|Stage I: MarzAA 18 µg/kg IV||10
9066590|NCT04072237|10127103|FG000|NOT COMPLETED|Stage I: MarzAA 18 µg/kg IV||1
9066591|NCT04072237|10127103|FG000|STARTED|Stage 2: MarzAA 30 µg/kg SC||8
9066592|NCT04072237|10127103|FG000|COMPLETED|Stage 2: MarzAA 30 µg/kg SC||8
9066593|NCT04072237|10127103|FG000|NOT COMPLETED|Stage 2: MarzAA 30 µg/kg SC||0
9066594|NCT04072237|10127103|FG000|STARTED|Stage 3: MarzAA 45 µg/kg SC||8
9066595|NCT04072237|10127103|FG000|COMPLETED|Stage 3: MarzAA 45 µg/kg SC||8
9066596|NCT04072237|10127103|FG000|NOT COMPLETED|Stage 3: MarzAA 45 µg/kg SC||0
9066597|NCT04072237|10127103|FG000|STARTED|Stage 4: MarzAA 60 µg/kg SC||8
9066598|NCT04072237|10127103|FG000|COMPLETED|Stage 4: MarzAA 60 µg/kg SC||8
9066599|NCT04072237|10127103|FG000|NOT COMPLETED|Stage 4: MarzAA 60 µg/kg SC||0
9066600|NCT04072237|10127103|FG000|STARTED|Stage 5: MarzAA 2 x 30 ug/kg SC||8
9066601|NCT04072237|10127103|FG000|COMPLETED|Stage 5: MarzAA 2 x 30 ug/kg SC||8
9066602|NCT04072237|10127103|FG000|NOT COMPLETED|Stage 5: MarzAA 2 x 30 ug/kg SC||0
9066603|NCT04072237|10127103|FG000|STARTED|Stage 6: MarzAA 90 µg/kg SC||8
9066604|NCT04072237|10127103|FG000|COMPLETED|Stage 6: MarzAA 90 µg/kg SC||8
9066605|NCT04072237|10127103|FG000|NOT COMPLETED|Stage 6: MarzAA 90 µg/kg SC||0
9066606|NCT04072237|10127103|FG000|STARTED|Stage 7: MarzAA 120 µg/kg SC||8
9066607|NCT04072237|10127103|FG000|COMPLETED|Stage 7: MarzAA 120 µg/kg SC||8
9066608|NCT04072237|10127103|FG000|NOT COMPLETED|Stage 7: MarzAA 120 µg/kg SC||0
9066609|NCT04072237|10127103|FG000|STARTED|Stage 8: MarzAA 2 x 60 µg/kg Q3H SC||8
9066610|NCT04072237|10127103|FG000|COMPLETED|Stage 8: MarzAA 2 x 60 µg/kg Q3H SC||8
9066611|NCT04072237|10127103|FG000|NOT COMPLETED|Stage 8: MarzAA 2 x 60 µg/kg Q3H SC||0
9066612|NCT04072237|10127103|FG000|STARTED|Stage 9: MarzAA 3 x 60 µg/kg Q3H SC||8
9066613|NCT04072237|10127103|FG000|COMPLETED|Stage 9: MarzAA 3 x 60 µg/kg Q3H SC||8
9066614|NCT04072237|10127103|FG000|NOT COMPLETED|Stage 9: MarzAA 3 x 60 µg/kg Q3H SC||0
9066615|NCT04063371|10127133|FG000|STARTED|Overall Study||100
9066616|NCT04063371|10127134|FG001|STARTED|Overall Study||100
9066617|NCT04063371|10127135|FG002|STARTED|Overall Study||100
9066618|NCT04063371|10127133|FG000|COMPLETED|Overall Study||100
9066619|NCT04063371|10127134|FG001|COMPLETED|Overall Study||100
9066620|NCT04063371|10127135|FG002|COMPLETED|Overall Study||100
9066621|NCT04063371|10127133|FG000|NOT COMPLETED|Overall Study||0
9066622|NCT04063371|10127134|FG001|NOT COMPLETED|Overall Study||0
9066623|NCT04063371|10127135|FG002|NOT COMPLETED|Overall Study||0
9066624|NCT04042324|10127145|FG000|STARTED|UFH and Triferic Admixture (Day 1)||12
9066625|NCT04042324|10127146|FG001|STARTED|UFH and Triferic Admixture (Day 1)||0
9066626|NCT04042324|10127147|FG002|STARTED|UFH and Triferic Admixture (Day 1)||0
9066627|NCT04042324|10127145|FG000|COMPLETED|UFH and Triferic Admixture (Day 1)||12
9066628|NCT04042324|10127146|FG001|COMPLETED|UFH and Triferic Admixture (Day 1)||0
9066629|NCT04042324|10127147|FG002|COMPLETED|UFH and Triferic Admixture (Day 1)||0
9066630|NCT04042324|10127145|FG000|NOT COMPLETED|UFH and Triferic Admixture (Day 1)||0
9066631|NCT04042324|10127146|FG001|NOT COMPLETED|UFH and Triferic Admixture (Day 1)||0
9066632|NCT04042324|10127147|FG002|NOT COMPLETED|UFH and Triferic Admixture (Day 1)||0
9066633|NCT04042324|10127145|FG000|STARTED|Triferic Post-dialyzer (Day 3)||0
9066634|NCT04042324|10127146|FG001|STARTED|Triferic Post-dialyzer (Day 3)||12
9066635|NCT04042324|10127147|FG002|STARTED|Triferic Post-dialyzer (Day 3)||0
9066636|NCT04042324|10127145|FG000|COMPLETED|Triferic Post-dialyzer (Day 3)||0
9066637|NCT04042324|10127146|FG001|COMPLETED|Triferic Post-dialyzer (Day 3)||12
9066638|NCT04042324|10127147|FG002|COMPLETED|Triferic Post-dialyzer (Day 3)||0
9066639|NCT04042324|10127145|FG000|NOT COMPLETED|Triferic Post-dialyzer (Day 3)||0
9066640|NCT04042324|10127146|FG001|NOT COMPLETED|Triferic Post-dialyzer (Day 3)||0
9066641|NCT04042324|10127147|FG002|NOT COMPLETED|Triferic Post-dialyzer (Day 3)||0
9066642|NCT04042324|10127145|FG000|STARTED|Triferic Pre-dialyzer (Day 5)||0
9066643|NCT04042324|10127146|FG001|STARTED|Triferic Pre-dialyzer (Day 5)||0
9066644|NCT04042324|10127147|FG002|STARTED|Triferic Pre-dialyzer (Day 5)||12
9066645|NCT04042324|10127145|FG000|COMPLETED|Triferic Pre-dialyzer (Day 5)||0
9066646|NCT04042324|10127146|FG001|COMPLETED|Triferic Pre-dialyzer (Day 5)||0
9066647|NCT04042324|10127147|FG002|COMPLETED|Triferic Pre-dialyzer (Day 5)||12
9066648|NCT04042324|10127145|FG000|NOT COMPLETED|Triferic Pre-dialyzer (Day 5)||0
9066649|NCT04042324|10127146|FG001|NOT COMPLETED|Triferic Pre-dialyzer (Day 5)||0
9066650|NCT04042324|10127147|FG002|NOT COMPLETED|Triferic Pre-dialyzer (Day 5)||0
9066651|NCT04071392|10127159|FG000|STARTED|Overall Study||12
9066652|NCT04071392|10127160|FG001|STARTED|Overall Study||12
9066653|NCT04071392|10127159|FG000|COMPLETED|Overall Study||10
9066654|NCT04071392|10127160|FG001|COMPLETED|Overall Study||10
9066655|NCT04071392|10127159|FG000|NOT COMPLETED|Overall Study||2
9066656|NCT04071392|10127160|FG001|NOT COMPLETED|Overall Study||2
9066657|NCT04071301|10127166|FG000|STARTED|Overall Study||15
9066658|NCT04071301|10127166|FG000|COMPLETED|Overall Study||8
9066659|NCT04071301|10127166|FG000|NOT COMPLETED|Overall Study||7
9066660|NCT04071158|10127175|FG000|STARTED|Overall Study||143
9066661|NCT04071158|10127176|FG001|STARTED|Overall Study||143
9066662|NCT04071158|10127177|FG002|STARTED|Overall Study||143
9066663|NCT04071158|10127178|FG003|STARTED|Overall Study||143
9066664|NCT04071158|10127179|FG004|STARTED|Overall Study||141
9066665|NCT04071158|10127175|FG000|Treated|Overall Study||141
9066666|NCT04071158|10127176|FG001|Treated|Overall Study||141
9066667|NCT04071158|10127177|FG002|Treated|Overall Study||143
9066668|NCT04071158|10127178|FG003|Treated|Overall Study||143
9066669|NCT04071158|10127179|FG004|Treated|Overall Study||141
9066670|NCT04071158|10127175|FG000|Safety Population|Overall Study||141
9066671|NCT04071158|10127176|FG001|Safety Population|Overall Study||141
9066672|NCT04071158|10127177|FG002|Safety Population|Overall Study|1 participant randomized to this arm received RSV vaccine 240 mcg with aluminum hydroxide withTdap|142
9066673|NCT04071158|10127178|FG003|Safety Population|Overall Study|1 participant of this arm actually received RSV vaccine 240 mcg with aluminum hydroxide with Tdap|144
9066674|NCT04071158|10127179|FG004|Safety Population|Overall Study||141
9066675|NCT04071158|10127175|FG000|COMPLETED|Overall Study||140
9066676|NCT04071158|10127176|FG001|COMPLETED|Overall Study||139
9066677|NCT04071158|10127177|FG002|COMPLETED|Overall Study||140
9066678|NCT04071158|10127178|FG003|COMPLETED|Overall Study||140
9066679|NCT04071158|10127179|FG004|COMPLETED|Overall Study||136
9066680|NCT04071158|10127175|FG000|NOT COMPLETED|Overall Study||3
9066681|NCT04071158|10127176|FG001|NOT COMPLETED|Overall Study||4
9066682|NCT04071158|10127177|FG002|NOT COMPLETED|Overall Study||3
9066683|NCT04071158|10127178|FG003|NOT COMPLETED|Overall Study||3
9066684|NCT04071158|10127179|FG004|NOT COMPLETED|Overall Study||5
9066685|NCT04070287|10127202|FG000|STARTED|Overall Study||114
9066686|NCT04070287|10127203|FG001|STARTED|Overall Study||86
9066687|NCT04070287|10127204|FG002|STARTED|Overall Study||81
9066688|NCT04070287|10127205|FG003|STARTED|Overall Study||11
9066689|NCT04070287|10127206|FG004|STARTED|Overall Study||96
9066690|NCT04070287|10127202|FG000|COMPLETED|Overall Study||103
9066691|NCT04070287|10127203|FG001|COMPLETED|Overall Study||44
9066692|NCT04070287|10127204|FG002|COMPLETED|Overall Study||75
9066693|NCT04070287|10127205|FG003|COMPLETED|Overall Study||7
9066694|NCT04070287|10127206|FG004|COMPLETED|Overall Study||95
9066695|NCT04070287|10127202|FG000|NOT COMPLETED|Overall Study||11
9066696|NCT04070287|10127203|FG001|NOT COMPLETED|Overall Study||42
9066697|NCT04070287|10127204|FG002|NOT COMPLETED|Overall Study||6
9066698|NCT04070287|10127205|FG003|NOT COMPLETED|Overall Study||4
9066699|NCT04070287|10127206|FG004|NOT COMPLETED|Overall Study||1
8623753|NCT00494975|9662919|FG001|NOT COMPLETED|Overall Study||1
8623754|NCT00495040|9662925|FG000|STARTED|Overall Study||38
8623755|NCT00495040|9662925|FG000|COMPLETED|Overall Study||35
8623756|NCT00495040|9662925|FG000|NOT COMPLETED|Overall Study||3
8623757|NCT00495079|9662929|FG000|STARTED|Overall Study||65
8623758|NCT00495079|9662929|FG000|COMPLETED|Overall Study||65
8623759|NCT00495079|9662929|FG000|NOT COMPLETED|Overall Study||0
8623760|NCT00495157|9662939|FG000|STARTED|Overall Study||113
9066700|NCT04069715|10127220|FG000|STARTED|Overall Study||47
9066701|NCT04069715|10127221|FG001|STARTED|Overall Study||48
9066702|NCT04069715|10127220|FG000|COMPLETED|Overall Study||42
9066703|NCT04069715|10127221|FG001|COMPLETED|Overall Study||43
9066704|NCT04069715|10127220|FG000|NOT COMPLETED|Overall Study||5
9066705|NCT04069715|10127221|FG001|NOT COMPLETED|Overall Study||5
9066706|NCT04050722|10127229|FG000|STARTED|Overall Study||65
9066707|NCT04050722|10127230|FG001|STARTED|Overall Study||65
9066708|NCT04050722|10127229|FG000|COMPLETED|Overall Study||64
9066709|NCT04050722|10127230|FG001|COMPLETED|Overall Study||65
9066710|NCT04050722|10127229|FG000|NOT COMPLETED|Overall Study||1
9066711|NCT04050722|10127230|FG001|NOT COMPLETED|Overall Study||0
9066712|NCT04069221|10127238|FG000|STARTED|Overall Study||8
9066713|NCT04069221|10127239|FG001|STARTED|Overall Study||6
9066714|NCT04069221|10127240|FG002|STARTED|Overall Study||6
9066715|NCT04069221|10127241|FG003|STARTED|Overall Study||6
9066716|NCT04069221|10127238|FG000|COMPLETED|Overall Study||8
9066717|NCT04069221|10127239|FG001|COMPLETED|Overall Study||6
9066718|NCT04069221|10127240|FG002|COMPLETED|Overall Study||6
9066719|NCT04069221|10127241|FG003|COMPLETED|Overall Study||6
9066720|NCT04069221|10127238|FG000|NOT COMPLETED|Overall Study||0
9066721|NCT04069221|10127239|FG001|NOT COMPLETED|Overall Study||0
9066722|NCT04069221|10127240|FG002|NOT COMPLETED|Overall Study||0
9066723|NCT04069221|10127241|FG003|NOT COMPLETED|Overall Study||0
9066724|NCT04067141|10127251|FG000|STARTED|First Intervention||35
9066725|NCT04067141|10127252|FG001|STARTED|First Intervention||35
9066726|NCT04067141|10127251|FG000|COMPLETED|First Intervention||35
9066727|NCT04067141|10127252|FG001|COMPLETED|First Intervention||34
9066728|NCT04067141|10127251|FG000|NOT COMPLETED|First Intervention||0
9066729|NCT04067141|10127252|FG001|NOT COMPLETED|First Intervention||1
9066730|NCT04067141|10127251|FG000|STARTED|Second Intervention|Unacceptable lens fit at dispense. One withdrawal by subject.|34
9066731|NCT04067141|10127252|FG001|STARTED|Second Intervention|Unacceptable lens fit at dispense. One withdrawal by subject|33
9066732|NCT04067141|10127251|FG000|COMPLETED|Second Intervention||34
9066733|NCT04067141|10127252|FG001|COMPLETED|Second Intervention||31
9066734|NCT04067141|10127251|FG000|NOT COMPLETED|Second Intervention||0
9066735|NCT04067141|10127252|FG001|NOT COMPLETED|Second Intervention||2
9066736|NCT04049578|10127258|FG000|STARTED|Overall Study||2
9066737|NCT04049578|10127258|FG000|COMPLETED|Overall Study||1
9066738|NCT04049578|10127258|FG000|NOT COMPLETED|Overall Study||1
9066739|NCT04067401|10127264|FG000|STARTED|Overall Study||748
9066740|NCT04067401|10127265|FG001|STARTED|Overall Study||737
9066741|NCT04067401|10127264|FG000|Baseline Survey Completion|Overall Study||746
9066742|NCT04067401|10127265|FG001|Baseline Survey Completion|Overall Study||735
9066743|NCT04067401|10127264|FG000|1 Month Survey Completion|Overall Study||697
9066744|NCT04067401|10127265|FG001|1 Month Survey Completion|Overall Study||694
9066745|NCT04067401|10127264|FG000|6 Month Survey Completion|Overall Study||629
9066746|NCT04067401|10127265|FG001|6 Month Survey Completion|Overall Study||618
9066747|NCT04067401|10127264|FG000|COMPLETED|Overall Study||740
9066748|NCT04067401|10127265|FG001|COMPLETED|Overall Study||737
9066749|NCT04067401|10127264|FG000|NOT COMPLETED|Overall Study||8
9066750|NCT04067401|10127265|FG001|NOT COMPLETED|Overall Study||0
9066751|NCT04067050|10127273|FG000|STARTED|One Month||32
9066752|NCT04067050|10127274|FG001|STARTED|One Month||29
9066753|NCT04067050|10127273|FG000|COMPLETED|One Month||28
9066754|NCT04067050|10127274|FG001|COMPLETED|One Month||29
9066755|NCT04067050|10127273|FG000|NOT COMPLETED|One Month||4
9066756|NCT04067050|10127274|FG001|NOT COMPLETED|One Month||0
9066757|NCT04067050|10127273|FG000|STARTED|Two Month|6 subjects discontinued after 1 month visit. 22 Subjects continued the study.|22
9066758|NCT04067050|10127274|FG001|STARTED|Two Month||29
9066759|NCT04067050|10127273|FG000|COMPLETED|Two Month||20
9066760|NCT04067050|10127274|FG001|COMPLETED|Two Month||29
9066761|NCT04067050|10127273|FG000|NOT COMPLETED|Two Month||2
9066762|NCT04067050|10127274|FG001|NOT COMPLETED|Two Month||0
9066763|NCT04066647|10127280|FG000|STARTED|Overall Study||7
9066764|NCT04066647|10127280|FG000|COMPLETED|Overall Study||7
9066765|NCT04066647|10127280|FG000|NOT COMPLETED|Overall Study||0
9066766|NCT04066426|10127288|FG000|STARTED|Overall Study||50
9066767|NCT04066426|10127289|FG001|STARTED|Overall Study||50
9066768|NCT04066426|10127290|FG002|STARTED|Overall Study||50
8842965|NCT01701258|9897259|FG001|NOT COMPLETED|Drug+fMRI (Session 2)||0
8842966|NCT01701258|9897260|FG002|NOT COMPLETED|Drug+fMRI (Session 2)||0
8842967|NCT01701258|9897261|FG003|NOT COMPLETED|Drug+fMRI (Session 2)||0
9066769|NCT04066426|10127291|FG003|STARTED|Overall Study||50
9066770|NCT04066426|10127288|FG000|COMPLETED|Overall Study||40
9066771|NCT04066426|10127289|FG001|COMPLETED|Overall Study||40
9066772|NCT04066426|10127290|FG002|COMPLETED|Overall Study||42
9066773|NCT04066426|10127291|FG003|COMPLETED|Overall Study||47
9066774|NCT04066426|10127288|FG000|NOT COMPLETED|Overall Study||10
9066775|NCT04066426|10127289|FG001|NOT COMPLETED|Overall Study||10
9066776|NCT04066426|10127290|FG002|NOT COMPLETED|Overall Study||8
9066777|NCT04066426|10127291|FG003|NOT COMPLETED|Overall Study||3
9066778|NCT04061694|10127303|FG000|STARTED|Overall Study||21
9066779|NCT04061694|10127304|FG001|STARTED|Overall Study||25
9066780|NCT04061694|10127303|FG000|COMPLETED|Overall Study||19
9066781|NCT04061694|10127304|FG001|COMPLETED|Overall Study||25
9066782|NCT04061694|10127303|FG000|NOT COMPLETED|Overall Study||2
9066783|NCT04061694|10127304|FG001|NOT COMPLETED|Overall Study||0
9066784|NCT04060654|10127310|FG000|STARTED|Overall Study||17
9066785|NCT04060654|10127310|FG000|COMPLETED|Overall Study||11
9066786|NCT04060654|10127310|FG000|NOT COMPLETED|Overall Study||6
9066787|NCT04059250|10127314|FG000|STARTED|Overall Study||25
9066788|NCT04059250|10127315|FG001|STARTED|Overall Study||25
9066789|NCT04059250|10127314|FG000|COMPLETED|Overall Study||25
9066790|NCT04059250|10127315|FG001|COMPLETED|Overall Study||25
9066791|NCT04059250|10127314|FG000|NOT COMPLETED|Overall Study||0
9066792|NCT04059250|10127315|FG001|NOT COMPLETED|Overall Study||0
9066793|NCT04058353|10127323|FG000|STARTED|Overall Study||126
9066794|NCT04058353|10127324|FG001|STARTED|Overall Study||132
9066795|NCT04058353|10127323|FG000|COMPLETED|Overall Study||122
9066796|NCT04058353|10127324|FG001|COMPLETED|Overall Study||131
9066797|NCT04058353|10127323|FG000|NOT COMPLETED|Overall Study||4
9066798|NCT04058353|10127324|FG001|NOT COMPLETED|Overall Study||1
9066799|NCT04057248|10127331|FG000|STARTED|Overall Study||14
9066800|NCT04057248|10127331|FG000|COMPLETED|Overall Study||12
9066801|NCT04057248|10127331|FG000|NOT COMPLETED|Overall Study||2
9066802|NCT04055519|10127335|FG000|STARTED|First Wear Period (30 Days)||16
9066803|NCT04055519|10127336|FG001|STARTED|First Wear Period (30 Days)||20
9066804|NCT04055519|10127335|FG000|COMPLETED|First Wear Period (30 Days)||16
9066805|NCT04055519|10127336|FG001|COMPLETED|First Wear Period (30 Days)||20
9066806|NCT04055519|10127335|FG000|NOT COMPLETED|First Wear Period (30 Days)||0
9066807|NCT04055519|10127336|FG001|NOT COMPLETED|First Wear Period (30 Days)||0
9066808|NCT04055519|10127335|FG000|STARTED|Second Wear Period (30 Days)||16
9066809|NCT04055519|10127336|FG001|STARTED|Second Wear Period (30 Days)||20
9066810|NCT04055519|10127335|FG000|COMPLETED|Second Wear Period (30 Days)||16
9066811|NCT04055519|10127336|FG001|COMPLETED|Second Wear Period (30 Days)||20
9066812|NCT04055519|10127335|FG000|NOT COMPLETED|Second Wear Period (30 Days)||0
9066813|NCT04055519|10127336|FG001|NOT COMPLETED|Second Wear Period (30 Days)||0
9066814|NCT04055675|10127347|FG000|STARTED|Overall Study||96
9066815|NCT04055675|10127348|FG001|STARTED|Overall Study||104
9066816|NCT04055675|10127347|FG000|COMPLETED|Overall Study||96
9066817|NCT04055675|10127348|FG001|COMPLETED|Overall Study||104
9066818|NCT04055675|10127347|FG000|NOT COMPLETED|Overall Study||0
9066819|NCT04055675|10127348|FG001|NOT COMPLETED|Overall Study||0
9066820|NCT04054765|10127356|FG000|STARTED|Baseline||155
9066821|NCT04054765|10127357|FG001|STARTED|Baseline||132
9066822|NCT04054765|10127356|FG000|COMPLETED|Baseline||150
9066823|NCT04054765|10127357|FG001|COMPLETED|Baseline||129
9066824|NCT04054765|10127356|FG000|NOT COMPLETED|Baseline||5
9066825|NCT04054765|10127357|FG001|NOT COMPLETED|Baseline||3
9066826|NCT04054765|10127356|FG000|STARTED|Post-Gameplay / 1-week Follow up||150
9066827|NCT04054765|10127357|FG001|STARTED|Post-Gameplay / 1-week Follow up||129
9066828|NCT04054765|10127356|FG000|COMPLETED|Post-Gameplay / 1-week Follow up||142
9066829|NCT04054765|10127357|FG001|COMPLETED|Post-Gameplay / 1-week Follow up||126
9066830|NCT04054765|10127356|FG000|NOT COMPLETED|Post-Gameplay / 1-week Follow up||8
9066831|NCT04054765|10127357|FG001|NOT COMPLETED|Post-Gameplay / 1-week Follow up||3
9066832|NCT04054765|10127356|FG000|STARTED|3-month Follow up||142
9066833|NCT04054765|10127357|FG001|STARTED|3-month Follow up||126
9066834|NCT04054765|10127356|FG000|COMPLETED|3-month Follow up||142
9066835|NCT04054765|10127357|FG001|COMPLETED|3-month Follow up||123
9066836|NCT04054765|10127356|FG000|NOT COMPLETED|3-month Follow up||0
9066837|NCT04054765|10127357|FG001|NOT COMPLETED|3-month Follow up||3
9066838|NCT04054765|10127356|FG000|STARTED|6-month Follow up||142
9066839|NCT04054765|10127357|FG001|STARTED|6-month Follow up||123
9066840|NCT04054765|10127356|FG000|COMPLETED|6-month Follow up||110
9066841|NCT04054765|10127357|FG001|COMPLETED|6-month Follow up||91
9066842|NCT04054765|10127356|FG000|NOT COMPLETED|6-month Follow up||32
9066843|NCT04054765|10127357|FG001|NOT COMPLETED|6-month Follow up||32
9066844|NCT04054011|10127363|FG000|STARTED|Overall Study||15
9066845|NCT04054011|10127363|FG000|COMPLETED|Overall Study||12
9066846|NCT04054011|10127363|FG000|NOT COMPLETED|Overall Study||3
9066847|NCT04059094|10127374|FG000|STARTED|Overall Study||18
9066848|NCT04059094|10127375|FG001|STARTED|Overall Study||6
9066849|NCT04059094|10127376|FG002|STARTED|Overall Study||5
9066850|NCT04059094|10127377|FG003|STARTED|Overall Study||5
9066851|NCT04059094|10127378|FG004|STARTED|Overall Study||18
9066852|NCT04059094|10127374|FG000|COMPLETED|Overall Study||18
9066853|NCT04059094|10127375|FG001|COMPLETED|Overall Study||4
9066854|NCT04059094|10127376|FG002|COMPLETED|Overall Study||5
9066855|NCT04059094|10127377|FG003|COMPLETED|Overall Study||5
9066856|NCT04059094|10127378|FG004|COMPLETED|Overall Study||17
9066857|NCT04059094|10127374|FG000|NOT COMPLETED|Overall Study||0
8623761|NCT00495157|9662940|FG001|STARTED|Overall Study||115
8623762|NCT00495157|9662941|FG002|STARTED|Overall Study||114
9066858|NCT04059094|10127375|FG001|NOT COMPLETED|Overall Study||2
9066859|NCT04059094|10127376|FG002|NOT COMPLETED|Overall Study||0
9066860|NCT04059094|10127377|FG003|NOT COMPLETED|Overall Study||0
9066861|NCT04059094|10127378|FG004|NOT COMPLETED|Overall Study||1
9066862|NCT04051684|10127396|FG000|STARTED|Overall Study||12
9066863|NCT04051684|10127397|FG001|STARTED|Overall Study||11
9066864|NCT04051684|10127396|FG000|COMPLETED|Overall Study||12
9066865|NCT04051684|10127397|FG001|COMPLETED|Overall Study||11
9066866|NCT04051684|10127396|FG000|NOT COMPLETED|Overall Study||0
9066867|NCT04051684|10127397|FG001|NOT COMPLETED|Overall Study||0
9066868|NCT04046341|10127403|FG000|STARTED|Overall Study||15
9066869|NCT04046341|10127403|FG000|COMPLETED|Overall Study||12
9066870|NCT04046341|10127403|FG000|NOT COMPLETED|Overall Study||3
9066871|NCT04045964|10127409|FG000|STARTED|Overall Study||16
9066872|NCT04045964|10127410|FG001|STARTED|Overall Study||16
9066873|NCT04045964|10127409|FG000|Intervention Visit(s)|Overall Study||15
8623763|NCT00495157|9662939|FG000|COMPLETED|Overall Study||97
9066874|NCT04045964|10127410|FG001|Intervention Visit(s)|Overall Study||16
9066875|NCT04045964|10127409|FG000|Follow up Visit 1|Overall Study||15
9066876|NCT04045964|10127410|FG001|Follow up Visit 1|Overall Study||15
9066877|NCT04045964|10127409|FG000|Follow up Visit 2|Overall Study||15
9066878|NCT04045964|10127410|FG001|Follow up Visit 2|Overall Study||15
9066879|NCT04045964|10127409|FG000|COMPLETED|Overall Study||15
9066880|NCT04045964|10127410|FG001|COMPLETED|Overall Study||15
9066881|NCT04045964|10127409|FG000|NOT COMPLETED|Overall Study||1
9066882|NCT04045964|10127410|FG001|NOT COMPLETED|Overall Study||1
9066883|NCT04043416|10127418|FG000|STARTED|Campaign 1||14
9066884|NCT04043416|10127419|FG001|STARTED|Campaign 1||14
9066885|NCT04043416|10127418|FG000|COMPLETED|Campaign 1||14
9066886|NCT04043416|10127419|FG001|COMPLETED|Campaign 1||14
9066887|NCT04043416|10127418|FG000|NOT COMPLETED|Campaign 1||0
9066888|NCT04043416|10127419|FG001|NOT COMPLETED|Campaign 1||0
9066889|NCT04043416|10127418|FG000|STARTED|Washout||14
9066890|NCT04043416|10127419|FG001|STARTED|Washout||14
9066891|NCT04043416|10127418|FG000|COMPLETED|Washout||14
9066892|NCT04043416|10127419|FG001|COMPLETED|Washout||13
9066893|NCT04043416|10127418|FG000|NOT COMPLETED|Washout||0
9066894|NCT04043416|10127419|FG001|NOT COMPLETED|Washout||1
9066895|NCT04043416|10127418|FG000|STARTED|Campaign 2||14
9066896|NCT04043416|10127419|FG001|STARTED|Campaign 2||13
9066897|NCT04043416|10127418|FG000|COMPLETED|Campaign 2||14
9066898|NCT04043416|10127419|FG001|COMPLETED|Campaign 2||13
9066899|NCT04043416|10127418|FG000|NOT COMPLETED|Campaign 2||0
9066900|NCT04043416|10127419|FG001|NOT COMPLETED|Campaign 2||0
9066901|NCT04057768|10127428|FG000|STARTED|Overall Study||10
9066902|NCT04057768|10127428|FG000|COMPLETED|Overall Study||10
9066903|NCT04057768|10127428|FG000|NOT COMPLETED|Overall Study||0
9066904|NCT04052542|10127444|FG000|STARTED|Overall Study||116
9066905|NCT04052542|10127445|FG001|STARTED|Overall Study||28
9066906|NCT04052542|10127446|FG002|STARTED|Overall Study||146
9066907|NCT04052542|10127447|FG003|STARTED|Overall Study||188
9066908|NCT04052542|10127448|FG004|STARTED|Overall Study||24
9066909|NCT04052542|10127449|FG005|STARTED|Overall Study||183
9066910|NCT04052542|10127450|FG006|STARTED|Overall Study||275
9066911|NCT04052542|10127451|FG007|STARTED|Overall Study||27
9066912|NCT04052542|10127452|FG008|STARTED|Overall Study||276
9066913|NCT04052542|10127453|FG009|STARTED|Overall Study||22
9066914|NCT04052542|10127454|FG010|STARTED|Overall Study||31
9066915|NCT04052542|10127455|FG011|STARTED|Overall Study||12
9066916|NCT04052542|10127444|FG000|COMPLETED|Overall Study||116
9066917|NCT04052542|10127445|FG001|COMPLETED|Overall Study||28
9066918|NCT04052542|10127446|FG002|COMPLETED|Overall Study||146
9066919|NCT04052542|10127447|FG003|COMPLETED|Overall Study||188
9066920|NCT04052542|10127448|FG004|COMPLETED|Overall Study||24
9066921|NCT04052542|10127449|FG005|COMPLETED|Overall Study||183
9066922|NCT04052542|10127450|FG006|COMPLETED|Overall Study||275
9066923|NCT04052542|10127451|FG007|COMPLETED|Overall Study||27
9066924|NCT04052542|10127452|FG008|COMPLETED|Overall Study||276
9066925|NCT04052542|10127453|FG009|COMPLETED|Overall Study||22
9066926|NCT04052542|10127454|FG010|COMPLETED|Overall Study||31
9066927|NCT04052542|10127455|FG011|COMPLETED|Overall Study||12
9066928|NCT04052542|10127444|FG000|NOT COMPLETED|Overall Study||0
9066929|NCT04052542|10127445|FG001|NOT COMPLETED|Overall Study||0
9066930|NCT04052542|10127446|FG002|NOT COMPLETED|Overall Study||0
9066931|NCT04052542|10127447|FG003|NOT COMPLETED|Overall Study||0
9066932|NCT04052542|10127448|FG004|NOT COMPLETED|Overall Study||0
9066933|NCT04052542|10127449|FG005|NOT COMPLETED|Overall Study||0
9066934|NCT04052542|10127450|FG006|NOT COMPLETED|Overall Study||0
9066935|NCT04052542|10127451|FG007|NOT COMPLETED|Overall Study||0
9066936|NCT04052542|10127452|FG008|NOT COMPLETED|Overall Study||0
9066937|NCT04052542|10127453|FG009|NOT COMPLETED|Overall Study||0
9066938|NCT04052542|10127454|FG010|NOT COMPLETED|Overall Study||0
9066939|NCT04052542|10127455|FG011|NOT COMPLETED|Overall Study||0
9066940|NCT04054193|10127481|FG000|STARTED|Cycle 1||103
9066941|NCT04054193|10127481|FG000|Treated (≥1 Dose)|Cycle 1||100
9066942|NCT04054193|10127481|FG000|COMPLETED|Cycle 1||98
9066943|NCT04054193|10127481|FG000|NOT COMPLETED|Cycle 1||5
9066944|NCT04054193|10127481|FG000|STARTED|Cycles 2-3|Participation in Cycles 2-3 was optional after completing Cycle 1.|69
9066945|NCT04054193|10127481|FG000|COMPLETED|Cycles 2-3||48
9066946|NCT04054193|10127481|FG000|NOT COMPLETED|Cycles 2-3||21
9066947|NCT04050618|10127488|FG000|STARTED|First Intervention||58
9066948|NCT04050618|10127489|FG001|STARTED|First Intervention||56
9066949|NCT04050618|10127488|FG000|COMPLETED|First Intervention||56
9066950|NCT04050618|10127489|FG001|COMPLETED|First Intervention||56
9066951|NCT04050618|10127488|FG000|NOT COMPLETED|First Intervention||2
9066952|NCT04050618|10127489|FG001|NOT COMPLETED|First Intervention||0
9066953|NCT04050618|10127488|FG000|STARTED|Second Intervention||56
9066954|NCT04050618|10127489|FG001|STARTED|Second Intervention||56
9066955|NCT04050618|10127488|FG000|COMPLETED|Second Intervention||55
9066956|NCT04050618|10127489|FG001|COMPLETED|Second Intervention||56
9066957|NCT04050618|10127488|FG000|NOT COMPLETED|Second Intervention||1
9066958|NCT04050618|10127489|FG001|NOT COMPLETED|Second Intervention||0
9066959|NCT04053465|10127502|FG000|STARTED|Overall Study||22
9066960|NCT04053465|10127503|FG001|STARTED|Overall Study||12
9066961|NCT04053465|10127502|FG000|COMPLETED|Overall Study||18
9066962|NCT04053465|10127503|FG001|COMPLETED|Overall Study||8
9066963|NCT04053465|10127502|FG000|NOT COMPLETED|Overall Study||4
9066964|NCT04053465|10127503|FG001|NOT COMPLETED|Overall Study||4
9066965|NCT04053270|10127511|FG000|STARTED|Overall Study||49
9066966|NCT04053270|10127512|FG001|STARTED|Overall Study||51
9066967|NCT04053270|10127511|FG000|COMPLETED|Overall Study||47
9066968|NCT04053270|10127512|FG001|COMPLETED|Overall Study||46
9066969|NCT04053270|10127511|FG000|NOT COMPLETED|Overall Study||2
9066970|NCT04053270|10127512|FG001|NOT COMPLETED|Overall Study||5
9066971|NCT04049552|10127522|FG000|STARTED|Overall Study||4
9066972|NCT04049552|10127522|FG000|COMPLETED|Overall Study||3
9066973|NCT04049552|10127522|FG000|NOT COMPLETED|Overall Study||1
9066974|NCT04053023|10127530|FG000|STARTED|Part A: Period 1 (Day 1 to Day 19)||19
9066975|NCT04053023|10127531|FG001|STARTED|Part A: Period 1 (Day 1 to Day 19)||0
9066976|NCT04053023|10127530|FG000|COMPLETED|Part A: Period 1 (Day 1 to Day 19)||19
9066977|NCT04053023|10127531|FG001|COMPLETED|Part A: Period 1 (Day 1 to Day 19)||0
9066978|NCT04053023|10127530|FG000|NOT COMPLETED|Part A: Period 1 (Day 1 to Day 19)||0
9066979|NCT04053023|10127531|FG001|NOT COMPLETED|Part A: Period 1 (Day 1 to Day 19)||0
9066980|NCT04053023|10127530|FG000|STARTED|Part A: Period 2 (Day 20 to Day 38)||19
9066981|NCT04053023|10127531|FG001|STARTED|Part A: Period 2 (Day 20 to Day 38)||0
9066982|NCT04053023|10127530|FG000|COMPLETED|Part A: Period 2 (Day 20 to Day 38)||18
9066983|NCT04053023|10127531|FG001|COMPLETED|Part A: Period 2 (Day 20 to Day 38)||0
9066984|NCT04053023|10127530|FG000|NOT COMPLETED|Part A: Period 2 (Day 20 to Day 38)||1
9066985|NCT04053023|10127531|FG001|NOT COMPLETED|Part A: Period 2 (Day 20 to Day 38)||0
9066986|NCT04053023|10127530|FG000|STARTED|Part B: Period 1 (Day 1 to Day 19)||0
9066987|NCT04053023|10127531|FG001|STARTED|Part B: Period 1 (Day 1 to Day 19)||0
9066988|NCT04053023|10127530|FG000|COMPLETED|Part B: Period 1 (Day 1 to Day 19)||0
9066989|NCT04053023|10127531|FG001|COMPLETED|Part B: Period 1 (Day 1 to Day 19)||0
9066990|NCT04053023|10127530|FG000|NOT COMPLETED|Part B: Period 1 (Day 1 to Day 19)||0
9066991|NCT04053023|10127531|FG001|NOT COMPLETED|Part B: Period 1 (Day 1 to Day 19)||0
9066992|NCT04053023|10127530|FG000|STARTED|Part B: Period 2 (Day 20 to Day 38)||0
9066993|NCT04053023|10127531|FG001|STARTED|Part B: Period 2 (Day 20 to Day 38)||0
9066994|NCT04053023|10127530|FG000|COMPLETED|Part B: Period 2 (Day 20 to Day 38)||0
9066995|NCT04053023|10127531|FG001|COMPLETED|Part B: Period 2 (Day 20 to Day 38)||0
9066996|NCT04053023|10127530|FG000|NOT COMPLETED|Part B: Period 2 (Day 20 to Day 38)||0
9066997|NCT04053023|10127531|FG001|NOT COMPLETED|Part B: Period 2 (Day 20 to Day 38)||0
9066998|NCT04051710|10127544|FG000|STARTED|Overall Study||620
9066999|NCT04051710|10127545|FG001|STARTED|Overall Study||620
9067000|NCT04051710|10127546|FG002|STARTED|Overall Study||310
9067001|NCT04051710|10127544|FG000|COMPLETED|Overall Study||616
9067002|NCT04051710|10127545|FG001|COMPLETED|Overall Study||612
9067003|NCT04051710|10127546|FG002|COMPLETED|Overall Study||306
9067004|NCT04051710|10127544|FG000|NOT COMPLETED|Overall Study||4
9067005|NCT04051710|10127545|FG001|NOT COMPLETED|Overall Study||8
9067006|NCT04051710|10127546|FG002|NOT COMPLETED|Overall Study||4
9067007|NCT04050865|10127556|FG000|STARTED|Overall Study||48
9067008|NCT04050865|10127557|FG001|STARTED|Overall Study||48
9067009|NCT04050865|10127556|FG000|COMPLETED|Overall Study||44
9067010|NCT04050865|10127557|FG001|COMPLETED|Overall Study||43
9067011|NCT04050865|10127556|FG000|NOT COMPLETED|Overall Study||4
9067012|NCT04050865|10127557|FG001|NOT COMPLETED|Overall Study||5
9067013|NCT04050605|10127563|FG000|STARTED|Overall Study||40
8842968|NCT01701258|9897262|FG004|NOT COMPLETED|Drug+fMRI (Session 2)||0
8842969|NCT01701258|9897263|FG005|NOT COMPLETED|Drug+fMRI (Session 2)||0
9067014|NCT04050605|10127563|FG000|COMPLETED|Overall Study||40
9067015|NCT04050605|10127563|FG000|NOT COMPLETED|Overall Study||0
9067016|NCT04050371|10127575|FG000|STARTED|Overall Study||24
9067017|NCT04050371|10127576|FG001|STARTED|Overall Study||24
9067018|NCT04050371|10127575|FG000|COMPLETED|Overall Study||23
9067019|NCT04050371|10127576|FG001|COMPLETED|Overall Study||24
9067020|NCT04050371|10127575|FG000|NOT COMPLETED|Overall Study||1
9067021|NCT04050371|10127576|FG001|NOT COMPLETED|Overall Study||0
9067022|NCT04048460|10127582|FG000|STARTED|Overall Study||10
9067023|NCT04048460|10127582|FG000|COMPLETED|Overall Study||10
9067024|NCT04048460|10127582|FG000|NOT COMPLETED|Overall Study||0
9067025|NCT04048681|10127586|FG000|STARTED|Overall Study||1
9067026|NCT04048681|10127587|FG001|STARTED|Overall Study||1
9067027|NCT04048681|10127588|FG002|STARTED|Overall Study||1
9067028|NCT04048681|10127589|FG003|STARTED|Overall Study||1
9067029|NCT04048681|10127590|FG004|STARTED|Overall Study||1
9067030|NCT04048681|10127586|FG000|COMPLETED|Overall Study||1
9067031|NCT04048681|10127587|FG001|COMPLETED|Overall Study||1
9067032|NCT04048681|10127588|FG002|COMPLETED|Overall Study||1
9067033|NCT04048681|10127589|FG003|COMPLETED|Overall Study||0
9067034|NCT04048681|10127590|FG004|COMPLETED|Overall Study||1
9067035|NCT04048681|10127586|FG000|NOT COMPLETED|Overall Study||0
9067036|NCT04048681|10127587|FG001|NOT COMPLETED|Overall Study||0
9067037|NCT04048681|10127588|FG002|NOT COMPLETED|Overall Study||0
9067038|NCT04048681|10127589|FG003|NOT COMPLETED|Overall Study||1
9067039|NCT04048681|10127590|FG004|NOT COMPLETED|Overall Study||0
9067040|NCT04046250|10127600|FG000|STARTED|Overall Study||11
9067041|NCT04046250|10127601|FG001|STARTED|Overall Study||11
9067042|NCT04046250|10127600|FG000|COMPLETED|Overall Study|Four Methotrexate + TK-112690 Treatments|8
9067043|NCT04046250|10127601|FG001|COMPLETED|Overall Study|Four Methotrexate + TK-12260 Placebo Treatments|7
9067044|NCT04046250|10127600|FG000|NOT COMPLETED|Overall Study||3
9067045|NCT04046250|10127601|FG001|NOT COMPLETED|Overall Study||4
8842970|NCT01701258|9897264|FG006|NOT COMPLETED|Drug+fMRI (Session 2)||0
9067046|NCT04047342|10127609|FG000|STARTED|Overall Study||409
9067047|NCT04047342|10127610|FG001|STARTED|Overall Study||415
9067048|NCT04047342|10127609|FG000|COMPLETED|Overall Study||409
9067049|NCT04047342|10127610|FG001|COMPLETED|Overall Study||415
9067050|NCT04047342|10127609|FG000|NOT COMPLETED|Overall Study||0
9067051|NCT04047342|10127610|FG001|NOT COMPLETED|Overall Study||0
9067052|NCT04044352|10127616|FG000|STARTED|Overall Study||76
9067053|NCT04044352|10127616|FG000|COMPLETED|Overall Study||65
9067054|NCT04044352|10127616|FG000|NOT COMPLETED|Overall Study||11
9067055|NCT04043728|10127624|FG000|STARTED|Overall Study||6
9067056|NCT04043728|10127625|FG001|STARTED|Overall Study||6
9067057|NCT04043728|10127626|FG002|STARTED|Overall Study||6
9067058|NCT04043728|10127624|FG000|COMPLETED|Overall Study||5
9067059|NCT04043728|10127625|FG001|COMPLETED|Overall Study||4
9067060|NCT04043728|10127626|FG002|COMPLETED|Overall Study||6
9067061|NCT04043728|10127624|FG000|NOT COMPLETED|Overall Study||1
9067062|NCT04043728|10127625|FG001|NOT COMPLETED|Overall Study||2
9067063|NCT04043728|10127626|FG002|NOT COMPLETED|Overall Study||0
9067064|NCT04041453|10127638|FG000|STARTED|Overall Study||38
9067065|NCT04041453|10127639|FG001|STARTED|Overall Study||57
9067066|NCT04041453|10127640|FG002|STARTED|Overall Study||23
9067067|NCT04041453|10127641|FG003|STARTED|Overall Study||58
9067068|NCT04041453|10127638|FG000|Safety Population|Overall Study||38
9067069|NCT04041453|10127639|FG001|Safety Population|Overall Study||56
9067070|NCT04041453|10127640|FG002|Safety Population|Overall Study||23
9067071|NCT04041453|10127641|FG003|Safety Population|Overall Study||58
9067072|NCT04041453|10127638|FG000|COMPLETED|Overall Study||24
9067073|NCT04041453|10127639|FG001|COMPLETED|Overall Study||35
9067074|NCT04041453|10127640|FG002|COMPLETED|Overall Study||18
9067075|NCT04041453|10127641|FG003|COMPLETED|Overall Study||40
9067076|NCT04041453|10127638|FG000|NOT COMPLETED|Overall Study||14
9067077|NCT04041453|10127639|FG001|NOT COMPLETED|Overall Study||22
9067078|NCT04041453|10127640|FG002|NOT COMPLETED|Overall Study||5
9067079|NCT04041453|10127641|FG003|NOT COMPLETED|Overall Study||18
9067080|NCT04041414|10127655|FG000|STARTED|Overall Study||27
9067081|NCT04041414|10127656|FG001|STARTED|Overall Study||20
9067082|NCT04041414|10127655|FG000|COMPLETED|Overall Study||26
9067083|NCT04041414|10127656|FG001|COMPLETED|Overall Study||18
9067084|NCT04041414|10127655|FG000|NOT COMPLETED|Overall Study||1
9067085|NCT04041414|10127656|FG001|NOT COMPLETED|Overall Study||2
9067086|NCT04041219|10127665|FG000|STARTED|Overall Study||10
9067087|NCT04041219|10127665|FG000|COMPLETED|Overall Study||10
9067088|NCT04041219|10127665|FG000|NOT COMPLETED|Overall Study||0
9067089|NCT04041700|10127669|FG000|STARTED|Overall Study||29
9067090|NCT04041700|10127669|FG000|COMPLETED|Overall Study||27
9067091|NCT04041700|10127669|FG000|NOT COMPLETED|Overall Study||2
9067092|NCT04040933|10127673|FG000|STARTED|Overall Study||36
9067093|NCT04040933|10127673|FG000|Treated|Overall Study||36
9067094|NCT04040933|10127673|FG000|COMPLETED|Overall Study||33
9067095|NCT04040933|10127673|FG000|NOT COMPLETED|Overall Study||3
9067096|NCT04039867|10127684|FG000|STARTED|Overall Study||17
9067097|NCT04039867|10127684|FG000|COMPLETED|Overall Study||17
9067098|NCT04039867|10127684|FG000|NOT COMPLETED|Overall Study||0
9067099|NCT04039412|10127691|FG000|STARTED|Overall Study||110
9067100|NCT04039412|10127692|FG001|STARTED|Overall Study||110
9067101|NCT04039412|10127693|FG002|STARTED|Overall Study||110
9067102|NCT04039412|10127691|FG000|COMPLETED|Overall Study||109
9067103|NCT04039412|10127692|FG001|COMPLETED|Overall Study||107
9067104|NCT04039412|10127693|FG002|COMPLETED|Overall Study||108
9067105|NCT04039412|10127691|FG000|NOT COMPLETED|Overall Study||1
9067106|NCT04039412|10127692|FG001|NOT COMPLETED|Overall Study||3
9067107|NCT04039412|10127693|FG002|NOT COMPLETED|Overall Study||2
9067108|NCT04035161|10127704|FG000|STARTED|Overall Study||1121
9067109|NCT04035161|10127704|FG000|Treated With Investigational Product|Overall Study||609
9067110|NCT04035161|10127704|FG000|Treated With Reference Standard|Overall Study||419
9067111|NCT04035161|10127704|FG000|Treated With Active Control|Overall Study||609
9067112|NCT04035161|10127704|FG000|Treated With Negative Control|Overall Study||605
9067113|NCT04035161|10127704|FG000|COMPLETED|Overall Study||1121
9067114|NCT04035161|10127704|FG000|NOT COMPLETED|Overall Study||0
9067115|NCT04029519|10127714|FG000|STARTED|Overall Study||84
9067116|NCT04029519|10127714|FG000|COMPLETED|Overall Study||79
9067117|NCT04029519|10127714|FG000|NOT COMPLETED|Overall Study||5
9067118|NCT04039919|10127723|FG000|STARTED|Treatment Period 1||7
9067119|NCT04039919|10127724|FG001|STARTED|Treatment Period 1||6
9067120|NCT04039919|10127725|FG002|STARTED|Treatment Period 1||5
9067121|NCT04039919|10127726|FG003|STARTED|Treatment Period 1||6
9067122|NCT04039919|10127727|FG004|STARTED|Treatment Period 1||16
9067123|NCT04039919|10127723|FG000|COMPLETED|Treatment Period 1||6
9067124|NCT04039919|10127724|FG001|COMPLETED|Treatment Period 1||6
9067125|NCT04039919|10127725|FG002|COMPLETED|Treatment Period 1||5
9067126|NCT04039919|10127726|FG003|COMPLETED|Treatment Period 1||6
9067127|NCT04039919|10127727|FG004|COMPLETED|Treatment Period 1||0
9067128|NCT04039919|10127723|FG000|NOT COMPLETED|Treatment Period 1||1
9067129|NCT04039919|10127724|FG001|NOT COMPLETED|Treatment Period 1||0
9067130|NCT04039919|10127725|FG002|NOT COMPLETED|Treatment Period 1||0
9067131|NCT04039919|10127726|FG003|NOT COMPLETED|Treatment Period 1||0
9067132|NCT04039919|10127727|FG004|NOT COMPLETED|Treatment Period 1||16
9067133|NCT04039919|10127723|FG000|STARTED|Treatment Period 2||6
9067134|NCT04039919|10127724|FG001|STARTED|Treatment Period 2||6
9067135|NCT04039919|10127725|FG002|STARTED|Treatment Period 2||5
9067136|NCT04039919|10127726|FG003|STARTED|Treatment Period 2||6
9067137|NCT04039919|10127727|FG004|STARTED|Treatment Period 2||0
9067138|NCT04039919|10127723|FG000|COMPLETED|Treatment Period 2||6
9067139|NCT04039919|10127724|FG001|COMPLETED|Treatment Period 2||6
9067140|NCT04039919|10127725|FG002|COMPLETED|Treatment Period 2||5
9067141|NCT04039919|10127726|FG003|COMPLETED|Treatment Period 2||6
9067142|NCT04039919|10127727|FG004|COMPLETED|Treatment Period 2||0
9067143|NCT04039919|10127723|FG000|NOT COMPLETED|Treatment Period 2||0
9067144|NCT04039919|10127724|FG001|NOT COMPLETED|Treatment Period 2||0
9067145|NCT04039919|10127725|FG002|NOT COMPLETED|Treatment Period 2||0
9067146|NCT04039919|10127726|FG003|NOT COMPLETED|Treatment Period 2||0
9067147|NCT04039919|10127727|FG004|NOT COMPLETED|Treatment Period 2||0
9067148|NCT04039919|10127723|FG000|STARTED|Treatment Period 3||6
9067149|NCT04039919|10127724|FG001|STARTED|Treatment Period 3||6
9067150|NCT04039919|10127725|FG002|STARTED|Treatment Period 3||5
9067151|NCT04039919|10127726|FG003|STARTED|Treatment Period 3||6
9067152|NCT04039919|10127727|FG004|STARTED|Treatment Period 3||0
9067153|NCT04039919|10127723|FG000|COMPLETED|Treatment Period 3||6
9067154|NCT04039919|10127724|FG001|COMPLETED|Treatment Period 3||6
9067155|NCT04039919|10127725|FG002|COMPLETED|Treatment Period 3||5
9067156|NCT04039919|10127726|FG003|COMPLETED|Treatment Period 3||6
9067157|NCT04039919|10127727|FG004|COMPLETED|Treatment Period 3||0
9067158|NCT04039919|10127723|FG000|NOT COMPLETED|Treatment Period 3||0
9067159|NCT04039919|10127724|FG001|NOT COMPLETED|Treatment Period 3||0
9067160|NCT04039919|10127725|FG002|NOT COMPLETED|Treatment Period 3||0
9067161|NCT04039919|10127726|FG003|NOT COMPLETED|Treatment Period 3||0
9067162|NCT04039919|10127727|FG004|NOT COMPLETED|Treatment Period 3||0
9067163|NCT04039919|10127723|FG000|STARTED|Treatment Period 4||6
9067164|NCT04039919|10127724|FG001|STARTED|Treatment Period 4||6
9067165|NCT04039919|10127725|FG002|STARTED|Treatment Period 4||5
9067166|NCT04039919|10127726|FG003|STARTED|Treatment Period 4||6
9067167|NCT04039919|10127727|FG004|STARTED|Treatment Period 4||0
9067168|NCT04039919|10127723|FG000|COMPLETED|Treatment Period 4||6
9067169|NCT04039919|10127724|FG001|COMPLETED|Treatment Period 4||6
9067170|NCT04039919|10127725|FG002|COMPLETED|Treatment Period 4||5
9067171|NCT04039919|10127726|FG003|COMPLETED|Treatment Period 4||6
9067172|NCT04039919|10127727|FG004|COMPLETED|Treatment Period 4||0
9067173|NCT04039919|10127723|FG000|NOT COMPLETED|Treatment Period 4||0
9067174|NCT04039919|10127724|FG001|NOT COMPLETED|Treatment Period 4||0
9067175|NCT04039919|10127725|FG002|NOT COMPLETED|Treatment Period 4||0
9067176|NCT04039919|10127726|FG003|NOT COMPLETED|Treatment Period 4||0
9067177|NCT04039919|10127727|FG004|NOT COMPLETED|Treatment Period 4||0
9067178|NCT04039919|10127723|FG000|STARTED|Treatment Period 5||6
9067179|NCT04039919|10127724|FG001|STARTED|Treatment Period 5||6
9067180|NCT04039919|10127725|FG002|STARTED|Treatment Period 5||5
9067181|NCT04039919|10127726|FG003|STARTED|Treatment Period 5||6
9067182|NCT04039919|10127727|FG004|STARTED|Treatment Period 5||0
9067183|NCT04039919|10127723|FG000|COMPLETED|Treatment Period 5||5
9067184|NCT04039919|10127724|FG001|COMPLETED|Treatment Period 5||6
9067185|NCT04039919|10127725|FG002|COMPLETED|Treatment Period 5||5
9067186|NCT04039919|10127726|FG003|COMPLETED|Treatment Period 5||6
8623764|NCT00495157|9662940|FG001|COMPLETED|Overall Study||92
8623765|NCT00495157|9662941|FG002|COMPLETED|Overall Study||101
8623766|NCT00495157|9662939|FG000|NOT COMPLETED|Overall Study||16
9067187|NCT04039919|10127727|FG004|COMPLETED|Treatment Period 5||0
9067188|NCT04039919|10127723|FG000|NOT COMPLETED|Treatment Period 5||1
9067189|NCT04039919|10127724|FG001|NOT COMPLETED|Treatment Period 5||0
9067190|NCT04039919|10127725|FG002|NOT COMPLETED|Treatment Period 5||0
9067191|NCT04039919|10127726|FG003|NOT COMPLETED|Treatment Period 5||0
9067192|NCT04039919|10127727|FG004|NOT COMPLETED|Treatment Period 5||0
9067193|NCT04039919|10127723|FG000|STARTED|Treatment Period 6||5
9067194|NCT04039919|10127724|FG001|STARTED|Treatment Period 6||6
9067195|NCT04039919|10127725|FG002|STARTED|Treatment Period 6||5
9067196|NCT04039919|10127726|FG003|STARTED|Treatment Period 6||6
9067197|NCT04039919|10127727|FG004|STARTED|Treatment Period 6||0
9067198|NCT04039919|10127723|FG000|COMPLETED|Treatment Period 6||5
9067199|NCT04039919|10127724|FG001|COMPLETED|Treatment Period 6||6
9067200|NCT04039919|10127725|FG002|COMPLETED|Treatment Period 6||5
9067201|NCT04039919|10127726|FG003|COMPLETED|Treatment Period 6||6
9067202|NCT04039919|10127727|FG004|COMPLETED|Treatment Period 6||0
9067203|NCT04039919|10127723|FG000|NOT COMPLETED|Treatment Period 6||0
9067204|NCT04039919|10127724|FG001|NOT COMPLETED|Treatment Period 6||0
9067205|NCT04039919|10127725|FG002|NOT COMPLETED|Treatment Period 6||0
9067206|NCT04039919|10127726|FG003|NOT COMPLETED|Treatment Period 6||0
9067207|NCT04039919|10127727|FG004|NOT COMPLETED|Treatment Period 6||0
9067208|NCT04037969|10127763|FG000|STARTED|Overall Study||10
9067209|NCT04037969|10127764|FG001|STARTED|Overall Study||10
9067210|NCT04037969|10127763|FG000|COMPLETED|Overall Study||10
8623767|NCT00495157|9662940|FG001|NOT COMPLETED|Overall Study||23
9067211|NCT04037969|10127764|FG001|COMPLETED|Overall Study||10
9067212|NCT04037969|10127763|FG000|NOT COMPLETED|Overall Study||0
9067213|NCT04037969|10127764|FG001|NOT COMPLETED|Overall Study||0
9067214|NCT04037865|10127769|FG000|STARTED|Overall Study||8
9067215|NCT04037865|10127769|FG000|COMPLETED|Overall Study||8
9067216|NCT04037865|10127769|FG000|NOT COMPLETED|Overall Study||0
9067217|NCT04037748|10127776|FG000|STARTED|Treatment Period 1||36
9067218|NCT04037748|10127777|FG001|STARTED|Treatment Period 1||36
9067219|NCT04037748|10127776|FG000|COMPLETED|Treatment Period 1||28
9067220|NCT04037748|10127777|FG001|COMPLETED|Treatment Period 1||30
9067221|NCT04037748|10127776|FG000|NOT COMPLETED|Treatment Period 1||8
9067222|NCT04037748|10127777|FG001|NOT COMPLETED|Treatment Period 1||6
9067223|NCT04037748|10127776|FG000|STARTED|Treatment Period 2||28
9067224|NCT04037748|10127777|FG001|STARTED|Treatment Period 2||30
9067225|NCT04037748|10127776|FG000|COMPLETED|Treatment Period 2||26
9067226|NCT04037748|10127777|FG001|COMPLETED|Treatment Period 2||29
9067227|NCT04037748|10127776|FG000|NOT COMPLETED|Treatment Period 2||2
9067228|NCT04037748|10127777|FG001|NOT COMPLETED|Treatment Period 2||1
9067229|NCT04036838|10127783|FG000|STARTED|Overall Study||415
9067230|NCT04036838|10127783|FG000|COMPLETED|Overall Study||324
9067231|NCT04036838|10127783|FG000|NOT COMPLETED|Overall Study||91
9067232|NCT04034121|10127787|FG000|STARTED|European Cohort|The European Cohort enrolled 30 patients|30
9067233|NCT04034121|10127787|FG000|COMPLETED|European Cohort||30
9067234|NCT04034121|10127787|FG000|NOT COMPLETED|European Cohort||0
9067235|NCT04034121|10127787|FG000|STARTED|Brazil Cohort|The Brazil Cohort enrolled 20 patients|20
9067236|NCT04034121|10127787|FG000|COMPLETED|Brazil Cohort||20
9067237|NCT04034121|10127787|FG000|NOT COMPLETED|Brazil Cohort||0
9067238|NCT04027686|10127794|FG000|STARTED|Overall Study||17
9067239|NCT04027686|10127795|FG001|STARTED|Overall Study||6
9067240|NCT04027686|10127794|FG000|COMPLETED|Overall Study||15
9067241|NCT04027686|10127795|FG001|COMPLETED|Overall Study||5
9067242|NCT04027686|10127794|FG000|NOT COMPLETED|Overall Study||2
9067243|NCT04027686|10127795|FG001|NOT COMPLETED|Overall Study||1
9067244|NCT04022694|10127807|FG000|STARTED|Overall Study||167
9067245|NCT04022694|10127808|FG001|STARTED|Overall Study||145
9067246|NCT04022694|10127809|FG002|STARTED|Overall Study|This was a cross-sectional study, so participants at baseline -- were not the same as exposure.|143
9067247|NCT04022694|10127810|FG003|STARTED|Overall Study|This was a cross-sectional study, so participants at baseline -- were not the same as exposure.|173
9067248|NCT04022694|10127807|FG000|COMPLETED|Overall Study||167
9067249|NCT04022694|10127808|FG001|COMPLETED|Overall Study||145
9067250|NCT04022694|10127809|FG002|COMPLETED|Overall Study||143
9067251|NCT04022694|10127810|FG003|COMPLETED|Overall Study||173
9067252|NCT04022694|10127807|FG000|NOT COMPLETED|Overall Study||0
9067253|NCT04022694|10127808|FG001|NOT COMPLETED|Overall Study||0
9067254|NCT04022694|10127809|FG002|NOT COMPLETED|Overall Study||0
9067255|NCT04022694|10127810|FG003|NOT COMPLETED|Overall Study||0
9067256|NCT04036110|10127825|FG000|STARTED|Overall Study||12
9067257|NCT04036110|10127826|FG001|STARTED|Overall Study||12
9067258|NCT04036110|10127827|FG002|STARTED|Overall Study||12
9067259|NCT04036110|10127825|FG000|COMPLETED|Overall Study||5
9067260|NCT04036110|10127826|FG001|COMPLETED|Overall Study||5
9067261|NCT04036110|10127827|FG002|COMPLETED|Overall Study||10
9067262|NCT04036110|10127825|FG000|NOT COMPLETED|Overall Study||7
9067263|NCT04036110|10127826|FG001|NOT COMPLETED|Overall Study||7
9067264|NCT04036110|10127827|FG002|NOT COMPLETED|Overall Study||2
9067265|NCT04035694|10127837|FG000|STARTED|Overall Study||374
9067266|NCT04035694|10127838|FG001|STARTED|Overall Study||216
9067267|NCT04035694|10127837|FG000|COMPLETED|Overall Study||374
9067268|NCT04035694|10127838|FG001|COMPLETED|Overall Study||216
9067269|NCT04035694|10127837|FG000|NOT COMPLETED|Overall Study||0
9067270|NCT04035694|10127838|FG001|NOT COMPLETED|Overall Study||0
9067271|NCT04035577|10127844|FG000|STARTED|Overall Study|One participant withdrew after signing the consent but before initiating any study activities.|21
9067272|NCT04035577|10127844|FG000|COMPLETED|Overall Study||19
9067273|NCT04035577|10127844|FG000|NOT COMPLETED|Overall Study||2
9067274|NCT04035564|10127852|FG000|STARTED|Overall Study||27
9067275|NCT04035564|10127853|FG001|STARTED|Overall Study||25
9067276|NCT04035564|10127852|FG000|COMPLETED|Overall Study||23
9067277|NCT04035564|10127853|FG001|COMPLETED|Overall Study||19
9067278|NCT04035564|10127852|FG000|NOT COMPLETED|Overall Study||4
9067279|NCT04035564|10127853|FG001|NOT COMPLETED|Overall Study||6
9067280|NCT04032977|10127861|FG000|STARTED|Overall Study||80
9067281|NCT04032977|10127862|FG001|STARTED|Overall Study||78
9067282|NCT04032977|10127861|FG000|COMPLETED|Overall Study||71
9067283|NCT04032977|10127862|FG001|COMPLETED|Overall Study||70
9067284|NCT04032977|10127861|FG000|NOT COMPLETED|Overall Study||9
9067285|NCT04032977|10127862|FG001|NOT COMPLETED|Overall Study||8
9067286|NCT04032652|10127870|FG000|STARTED|Overall Study||1
9067287|NCT04032652|10127871|FG001|STARTED|Overall Study||1
9067288|NCT04032652|10127870|FG000|COMPLETED|Overall Study||0
9067289|NCT04032652|10127871|FG001|COMPLETED|Overall Study||0
9067290|NCT04032652|10127870|FG000|NOT COMPLETED|Overall Study||1
9067291|NCT04032652|10127871|FG001|NOT COMPLETED|Overall Study||1
9067292|NCT04024501|10127877|FG000|STARTED|Overall Study||25
9067293|NCT04024501|10127877|FG000|COMPLETED|Overall Study||25
9067294|NCT04024501|10127877|FG000|NOT COMPLETED|Overall Study||0
9067295|NCT04032613|10127891|FG000|STARTED|Overall Study||21
9067296|NCT04032613|10127892|FG001|STARTED|Overall Study||25
9067297|NCT04032613|10127891|FG000|COMPLETED|Overall Study||16
9067298|NCT04032613|10127892|FG001|COMPLETED|Overall Study||23
9067299|NCT04032613|10127891|FG000|NOT COMPLETED|Overall Study||5
9067300|NCT04032613|10127892|FG001|NOT COMPLETED|Overall Study||2
9067301|NCT04032171|10127900|FG000|STARTED|Overall Study||1
9067302|NCT04032171|10127901|FG001|STARTED|Overall Study||0
9067303|NCT04032171|10127900|FG000|COMPLETED|Overall Study||0
9067304|NCT04032171|10127901|FG001|COMPLETED|Overall Study||0
9067305|NCT04032171|10127900|FG000|NOT COMPLETED|Overall Study||1
9067306|NCT04032171|10127901|FG001|NOT COMPLETED|Overall Study||0
9067307|NCT04032158|10127909|FG000|STARTED|Overall Study||2
9067308|NCT04032158|10127910|FG001|STARTED|Overall Study||1
9067309|NCT04032158|10127909|FG000|COMPLETED|Overall Study||0
9067310|NCT04032158|10127910|FG001|COMPLETED|Overall Study||0
9067311|NCT04032158|10127909|FG000|NOT COMPLETED|Overall Study||2
9067312|NCT04032158|10127910|FG001|NOT COMPLETED|Overall Study||1
9067313|NCT04031404|10127916|FG000|STARTED|Baseline||10
9067314|NCT04031404|10127917|FG001|STARTED|Baseline||13
9067315|NCT04031404|10127916|FG000|COMPLETED|Baseline||8
9067316|NCT04031404|10127917|FG001|COMPLETED|Baseline||8
9067317|NCT04031404|10127916|FG000|NOT COMPLETED|Baseline||2
9067318|NCT04031404|10127917|FG001|NOT COMPLETED|Baseline||5
9067319|NCT04031404|10127916|FG000|STARTED|Pre-randomization||8
9067320|NCT04031404|10127917|FG001|STARTED|Pre-randomization||8
9067321|NCT04031404|10127916|FG000|COMPLETED|Pre-randomization||6
9067322|NCT04031404|10127917|FG001|COMPLETED|Pre-randomization||5
9067323|NCT04031404|10127916|FG000|NOT COMPLETED|Pre-randomization||2
9067324|NCT04031404|10127917|FG001|NOT COMPLETED|Pre-randomization||3
9067325|NCT04031404|10127916|FG000|STARTED|First Drink Visit||6
9067326|NCT04031404|10127917|FG001|STARTED|First Drink Visit||5
9067327|NCT04031404|10127916|FG000|COMPLETED|First Drink Visit||6
9067328|NCT04031404|10127917|FG001|COMPLETED|First Drink Visit||5
9067329|NCT04031404|10127916|FG000|NOT COMPLETED|First Drink Visit||0
9067330|NCT04031404|10127917|FG001|NOT COMPLETED|First Drink Visit||0
9067331|NCT04031404|10127916|FG000|STARTED|Washout (5 Day Min)||6
9067332|NCT04031404|10127917|FG001|STARTED|Washout (5 Day Min)||5
9067333|NCT04031404|10127916|FG000|COMPLETED|Washout (5 Day Min)||5
9067334|NCT04031404|10127917|FG001|COMPLETED|Washout (5 Day Min)||5
9067335|NCT04031404|10127916|FG000|NOT COMPLETED|Washout (5 Day Min)||1
9067336|NCT04031404|10127917|FG001|NOT COMPLETED|Washout (5 Day Min)||0
9067337|NCT04031404|10127916|FG000|STARTED|Second Drink Visit||5
9067338|NCT04031404|10127917|FG001|STARTED|Second Drink Visit||5
9067339|NCT04031404|10127916|FG000|COMPLETED|Second Drink Visit||5
9067340|NCT04031404|10127917|FG001|COMPLETED|Second Drink Visit||5
9067341|NCT04031404|10127916|FG000|NOT COMPLETED|Second Drink Visit||0
9067342|NCT04031404|10127917|FG001|NOT COMPLETED|Second Drink Visit||0
9067343|NCT04031885|10127933|FG000|STARTED|Overall Study||1
9067344|NCT04031885|10127934|FG001|STARTED|Overall Study||3
9067345|NCT04031885|10127933|FG000|Received Any Quantity of Study Treatment|Overall Study||1
9067346|NCT04031885|10127934|FG001|Received Any Quantity of Study Treatment|Overall Study||1
9067347|NCT04031885|10127933|FG000|COMPLETED|Overall Study||1
9067348|NCT04031885|10127934|FG001|COMPLETED|Overall Study||3
9067349|NCT04031885|10127933|FG000|NOT COMPLETED|Overall Study||0
9067350|NCT04031885|10127934|FG001|NOT COMPLETED|Overall Study||0
9067351|NCT04018924|10127940|FG000|STARTED|Overall Study|The total number of participants is 90 and the patient is control of themselves.|90
9067352|NCT04018924|10127940|FG000|Standard Of Care Intervention|Overall Study||90
9067353|NCT04018924|10127940|FG000|EmoLED Intervention|Overall Study||90
9067354|NCT04018924|10127940|FG000|COMPLETED|Overall Study||84
9067355|NCT04018924|10127940|FG000|NOT COMPLETED|Overall Study||6
9067356|NCT04015440|10127946|FG000|STARTED|Overall Study||117
9067357|NCT04015440|10127947|FG001|STARTED|Overall Study||112
9067358|NCT04015440|10127946|FG000|COMPLETED|Overall Study||109
9067359|NCT04015440|10127947|FG001|COMPLETED|Overall Study||108
9067360|NCT04015440|10127946|FG000|NOT COMPLETED|Overall Study||8
9067361|NCT04015440|10127947|FG001|NOT COMPLETED|Overall Study||4
9067362|NCT04030104|10127953|FG000|STARTED|Overall Study||480
9067363|NCT04030104|10127953|FG000|COMPLETED|Overall Study||480
9067364|NCT04030104|10127953|FG000|NOT COMPLETED|Overall Study||0
9067365|NCT04029961|10127962|FG000|STARTED|Overall Study||13
9067366|NCT04029961|10127963|FG001|STARTED|Overall Study||13
9067367|NCT04029961|10127962|FG000|COMPLETED|Overall Study||12
9067368|NCT04029961|10127963|FG001|COMPLETED|Overall Study||12
9067369|NCT04029961|10127962|FG000|NOT COMPLETED|Overall Study||1
9067370|NCT04029961|10127963|FG001|NOT COMPLETED|Overall Study||1
9067371|NCT04025684|10127973|FG000|STARTED|Overall Study||20
9067372|NCT04025684|10127974|FG001|STARTED|Overall Study||19
9067373|NCT04025684|10127975|FG002|STARTED|Overall Study||20
9067374|NCT04025684|10127976|FG003|STARTED|Overall Study||21
9067375|NCT04025684|10127973|FG000|COMPLETED|Overall Study||18
9067376|NCT04025684|10127974|FG001|COMPLETED|Overall Study||15
9067377|NCT04025684|10127975|FG002|COMPLETED|Overall Study||20
9067378|NCT04025684|10127976|FG003|COMPLETED|Overall Study||20
9067379|NCT04025684|10127973|FG000|NOT COMPLETED|Overall Study||2
9067380|NCT04025684|10127974|FG001|NOT COMPLETED|Overall Study||4
9067381|NCT04025684|10127975|FG002|NOT COMPLETED|Overall Study||0
9067382|NCT04025684|10127976|FG003|NOT COMPLETED|Overall Study||1
9067383|NCT04019054|10127988|FG000|STARTED|Overall Study||11
9067384|NCT04019054|10127989|FG001|STARTED|Overall Study||11
9067385|NCT04019054|10127988|FG000|COMPLETED|Overall Study||8
9067386|NCT04019054|10127989|FG001|COMPLETED|Overall Study||9
9067387|NCT04019054|10127988|FG000|NOT COMPLETED|Overall Study||3
9067388|NCT04019054|10127989|FG001|NOT COMPLETED|Overall Study||2
9067389|NCT04029545|10127998|FG000|STARTED|Overall Study||2
9067390|NCT04029545|10127999|FG001|STARTED|Overall Study||1
9067391|NCT04029545|10128000|FG002|STARTED|Overall Study||2
9067392|NCT04029545|10127998|FG000|COMPLETED|Overall Study||2
9067393|NCT04029545|10127999|FG001|COMPLETED|Overall Study||1
9067394|NCT04029545|10128000|FG002|COMPLETED|Overall Study||2
9067395|NCT04029545|10127998|FG000|NOT COMPLETED|Overall Study||0
9067396|NCT04029545|10127999|FG001|NOT COMPLETED|Overall Study||0
9067397|NCT04029545|10128000|FG002|NOT COMPLETED|Overall Study||0
9067398|NCT04029584|10128008|FG000|STARTED|Uninduced Study 1st Intervention (1 Day)||4
9067399|NCT04029584|10128009|FG001|STARTED|Uninduced Study 1st Intervention (1 Day)||6
9067400|NCT04029584|10128008|FG000|COMPLETED|Uninduced Study 1st Intervention (1 Day)||4
9067401|NCT04029584|10128009|FG001|COMPLETED|Uninduced Study 1st Intervention (1 Day)||6
9067402|NCT04029584|10128008|FG000|NOT COMPLETED|Uninduced Study 1st Intervention (1 Day)||0
9067403|NCT04029584|10128009|FG001|NOT COMPLETED|Uninduced Study 1st Intervention (1 Day)||0
9067404|NCT04029584|10128008|FG000|STARTED|Uninduced Washout (1 Day)||4
9067405|NCT04029584|10128009|FG001|STARTED|Uninduced Washout (1 Day)||6
9067406|NCT04029584|10128008|FG000|COMPLETED|Uninduced Washout (1 Day)||4
9067407|NCT04029584|10128009|FG001|COMPLETED|Uninduced Washout (1 Day)||6
9067408|NCT04029584|10128008|FG000|NOT COMPLETED|Uninduced Washout (1 Day)||0
9067409|NCT04029584|10128009|FG001|NOT COMPLETED|Uninduced Washout (1 Day)||0
9067410|NCT04029584|10128008|FG000|STARTED|Uninduced Study 2nd Intervention (1 Day)||4
9067411|NCT04029584|10128009|FG001|STARTED|Uninduced Study 2nd Intervention (1 Day)||6
9067412|NCT04029584|10128008|FG000|COMPLETED|Uninduced Study 2nd Intervention (1 Day)||4
9067413|NCT04029584|10128009|FG001|COMPLETED|Uninduced Study 2nd Intervention (1 Day)||6
9067414|NCT04029584|10128008|FG000|NOT COMPLETED|Uninduced Study 2nd Intervention (1 Day)||0
9067415|NCT04029584|10128009|FG001|NOT COMPLETED|Uninduced Study 2nd Intervention (1 Day)||0
9067416|NCT04029584|10128008|FG000|STARTED|Washout Between (>1 Week)||4
9067417|NCT04029584|10128009|FG001|STARTED|Washout Between (>1 Week)||6
9067418|NCT04029584|10128008|FG000|COMPLETED|Washout Between (>1 Week)||4
9067419|NCT04029584|10128009|FG001|COMPLETED|Washout Between (>1 Week)||6
9067420|NCT04029584|10128008|FG000|NOT COMPLETED|Washout Between (>1 Week)||0
9067421|NCT04029584|10128009|FG001|NOT COMPLETED|Washout Between (>1 Week)||0
9067422|NCT04029584|10128008|FG000|STARTED|Induced Study 1st Intervention (1 Day)||2
9067423|NCT04029584|10128009|FG001|STARTED|Induced Study 1st Intervention (1 Day)||8
9067424|NCT04029584|10128008|FG000|COMPLETED|Induced Study 1st Intervention (1 Day)||2
9067425|NCT04029584|10128009|FG001|COMPLETED|Induced Study 1st Intervention (1 Day)||8
9067426|NCT04029584|10128008|FG000|NOT COMPLETED|Induced Study 1st Intervention (1 Day)||0
9067427|NCT04029584|10128009|FG001|NOT COMPLETED|Induced Study 1st Intervention (1 Day)||0
9067428|NCT04029584|10128008|FG000|STARTED|Induced Washout (1 Day)||2
9067429|NCT04029584|10128009|FG001|STARTED|Induced Washout (1 Day)||8
9067430|NCT04029584|10128008|FG000|COMPLETED|Induced Washout (1 Day)||2
9067431|NCT04029584|10128009|FG001|COMPLETED|Induced Washout (1 Day)||8
9067432|NCT04029584|10128008|FG000|NOT COMPLETED|Induced Washout (1 Day)||0
9067433|NCT04029584|10128009|FG001|NOT COMPLETED|Induced Washout (1 Day)||0
9067434|NCT04029584|10128008|FG000|STARTED|Induced Study 2nd Intervention (1 Day)||2
9067435|NCT04029584|10128009|FG001|STARTED|Induced Study 2nd Intervention (1 Day)||8
9067436|NCT04029584|10128008|FG000|COMPLETED|Induced Study 2nd Intervention (1 Day)||2
9067437|NCT04029584|10128009|FG001|COMPLETED|Induced Study 2nd Intervention (1 Day)||8
9067438|NCT04029584|10128008|FG000|NOT COMPLETED|Induced Study 2nd Intervention (1 Day)||0
9067439|NCT04029584|10128009|FG001|NOT COMPLETED|Induced Study 2nd Intervention (1 Day)||0
9067440|NCT04029311|10128021|FG000|STARTED|Overall Study||15
9067441|NCT04029311|10128022|FG001|STARTED|Overall Study||13
9067442|NCT04029311|10128021|FG000|COMPLETED|Overall Study||12
9067443|NCT04029311|10128022|FG001|COMPLETED|Overall Study||13
9067444|NCT04029311|10128021|FG000|NOT COMPLETED|Overall Study||3
9067445|NCT04029311|10128022|FG001|NOT COMPLETED|Overall Study||0
9067446|NCT04028960|10128030|FG000|STARTED|Overall Study||2
9067447|NCT04028960|10128031|FG001|STARTED|Overall Study||2
9067448|NCT04028960|10128030|FG000|COMPLETED|Overall Study||2
9067449|NCT04028960|10128031|FG001|COMPLETED|Overall Study||2
9067450|NCT04028960|10128030|FG000|NOT COMPLETED|Overall Study||0
9067451|NCT04028960|10128031|FG001|NOT COMPLETED|Overall Study||0
9067452|NCT04026399|10128039|FG000|STARTED|Overall Study||6
9067453|NCT04026399|10128040|FG001|STARTED|Overall Study||6
9067454|NCT04026399|10128039|FG000|COMPLETED|Overall Study||1
9067455|NCT04026399|10128040|FG001|COMPLETED|Overall Study||3
9067456|NCT04026399|10128039|FG000|NOT COMPLETED|Overall Study||5
9067457|NCT04026399|10128040|FG001|NOT COMPLETED|Overall Study||3
9067458|NCT04023578|10128046|FG000|STARTED|Overall Study||15
9067459|NCT04023578|10128046|FG000|COMPLETED|Overall Study||13
9067460|NCT04023578|10128046|FG000|NOT COMPLETED|Overall Study||2
9067461|NCT04023695|10128053|FG000|STARTED|Overall Study||57
9067462|NCT04023695|10128054|FG001|STARTED|Overall Study||53
9067463|NCT04023695|10128053|FG000|COMPLETED|Overall Study||57
9067464|NCT04023695|10128054|FG001|COMPLETED|Overall Study||53
9067465|NCT04023695|10128053|FG000|NOT COMPLETED|Overall Study||0
9067466|NCT04023695|10128054|FG001|NOT COMPLETED|Overall Study||0
9067467|NCT04018664|10128068|FG000|STARTED|Overall Study||14
9067468|NCT04018664|10128069|FG001|STARTED|Overall Study||6
9067469|NCT04018664|10128070|FG002|STARTED|Overall Study||6
9067470|NCT04018664|10128071|FG003|STARTED|Overall Study||6
9067471|NCT04018664|10128072|FG004|STARTED|Overall Study||6
9067472|NCT04018664|10128073|FG005|STARTED|Overall Study||6
9067473|NCT04018664|10128074|FG006|STARTED|Overall Study||6
9067474|NCT04018664|10128075|FG007|STARTED|Overall Study||6
9067475|NCT04018664|10128068|FG000|COMPLETED|Overall Study||14
9067476|NCT04018664|10128069|FG001|COMPLETED|Overall Study||6
9067477|NCT04018664|10128070|FG002|COMPLETED|Overall Study||6
9067478|NCT04018664|10128071|FG003|COMPLETED|Overall Study||6
9067479|NCT04018664|10128072|FG004|COMPLETED|Overall Study||6
9067480|NCT04018664|10128073|FG005|COMPLETED|Overall Study||6
9067481|NCT04018664|10128074|FG006|COMPLETED|Overall Study||6
9067482|NCT04018664|10128075|FG007|COMPLETED|Overall Study||6
9067483|NCT04018664|10128068|FG000|NOT COMPLETED|Overall Study||0
9067484|NCT04018664|10128069|FG001|NOT COMPLETED|Overall Study||0
9067485|NCT04018664|10128070|FG002|NOT COMPLETED|Overall Study||0
9067486|NCT04018664|10128071|FG003|NOT COMPLETED|Overall Study||0
9067487|NCT04018664|10128072|FG004|NOT COMPLETED|Overall Study||0
9067488|NCT04018664|10128073|FG005|NOT COMPLETED|Overall Study||0
9067489|NCT04018664|10128074|FG006|NOT COMPLETED|Overall Study||0
9067490|NCT04018664|10128075|FG007|NOT COMPLETED|Overall Study||0
9067491|NCT04016259|10128095|FG000|STARTED|Overall Study||15
9067492|NCT04016259|10128096|FG001|STARTED|Overall Study||15
9067493|NCT04016259|10128095|FG000|COMPLETED|Overall Study||15
9067494|NCT04016259|10128096|FG001|COMPLETED|Overall Study||15
9067495|NCT04016259|10128095|FG000|NOT COMPLETED|Overall Study||0
9067496|NCT04016259|10128096|FG001|NOT COMPLETED|Overall Study||0
9067497|NCT04016077|10128104|FG000|STARTED|Overall Study||10
9067498|NCT04016077|10128105|FG001|STARTED|Overall Study||8
9067499|NCT04016077|10128104|FG000|COMPLETED|Overall Study||10
9067500|NCT04016077|10128105|FG001|COMPLETED|Overall Study||8
9067501|NCT04016077|10128104|FG000|NOT COMPLETED|Overall Study||0
9067502|NCT04016077|10128105|FG001|NOT COMPLETED|Overall Study||0
9067503|NCT04027803|10128113|FG000|STARTED|Overall Study||39
9067504|NCT04027803|10128114|FG001|STARTED|Overall Study||39
9067505|NCT04027803|10128113|FG000|COMPLETED|Overall Study||39
9067506|NCT04027803|10128114|FG001|COMPLETED|Overall Study||39
9067507|NCT04027803|10128113|FG000|NOT COMPLETED|Overall Study||0
9067508|NCT04027803|10128114|FG001|NOT COMPLETED|Overall Study||0
9067509|NCT04016311|10128122|FG000|STARTED|Overall Study||18
9067510|NCT04016311|10128123|FG001|STARTED|Overall Study||20
9067511|NCT04016311|10128122|FG000|COMPLETED|Overall Study||17
9067512|NCT04016311|10128123|FG001|COMPLETED|Overall Study||20
9067513|NCT04016311|10128122|FG000|NOT COMPLETED|Overall Study||1
9067514|NCT04016311|10128123|FG001|NOT COMPLETED|Overall Study||0
9067515|NCT04027439|10128137|FG000|STARTED|Part A (R, PC, PG) Single Dose||6
9067516|NCT04027439|10128138|FG001|STARTED|Part A (R, PC, PG) Single Dose||6
9067517|NCT04027439|10128139|FG002|STARTED|Part A (R, PC, PG) Single Dose||7
9067518|NCT04027439|10128140|FG003|STARTED|Part A (R, PC, PG) Single Dose||6
9067519|NCT04027439|10128141|FG004|STARTED|Part A (R, PC, PG) Single Dose||6
9067520|NCT04027439|10128142|FG005|STARTED|Part A (R, PC, PG) Single Dose||6
9067521|NCT04027439|10128143|FG006|STARTED|Part A (R, PC, PG) Single Dose||0
9067522|NCT04027439|10128144|FG007|STARTED|Part A (R, PC, PG) Single Dose||0
9067523|NCT04027439|10128145|FG008|STARTED|Part A (R, PC, PG) Single Dose||0
9067524|NCT04027439|10128146|FG009|STARTED|Part A (R, PC, PG) Single Dose||0
9067525|NCT04027439|10128147|FG010|STARTED|Part A (R, PC, PG) Single Dose||0
9067526|NCT04027439|10128148|FG011|STARTED|Part A (R, PC, PG) Single Dose||0
9067527|NCT04027439|10128149|FG012|STARTED|Part A (R, PC, PG) Single Dose||0
9067528|NCT04027439|10128150|FG013|STARTED|Part A (R, PC, PG) Single Dose||0
9067529|NCT04027439|10128151|FG014|STARTED|Part A (R, PC, PG) Single Dose||0
9067530|NCT04027439|10128152|FG015|STARTED|Part A (R, PC, PG) Single Dose||0
9067531|NCT04027439|10128137|FG000|COMPLETED|Part A (R, PC, PG) Single Dose||6
9067532|NCT04027439|10128138|FG001|COMPLETED|Part A (R, PC, PG) Single Dose||6
9067533|NCT04027439|10128139|FG002|COMPLETED|Part A (R, PC, PG) Single Dose||7
9067534|NCT04027439|10128140|FG003|COMPLETED|Part A (R, PC, PG) Single Dose||6
9067535|NCT04027439|10128141|FG004|COMPLETED|Part A (R, PC, PG) Single Dose||6
9067536|NCT04027439|10128142|FG005|COMPLETED|Part A (R, PC, PG) Single Dose||6
9067537|NCT04027439|10128143|FG006|COMPLETED|Part A (R, PC, PG) Single Dose||0
9067538|NCT04027439|10128144|FG007|COMPLETED|Part A (R, PC, PG) Single Dose||0
9067539|NCT04027439|10128145|FG008|COMPLETED|Part A (R, PC, PG) Single Dose||0
8623768|NCT00495157|9662941|FG002|NOT COMPLETED|Overall Study||13
8623769|NCT00495170|9662949|FG000|STARTED|Overall Study||84
8623770|NCT00495170|9662949|FG000|COMPLETED|Overall Study||64
8623771|NCT00495170|9662949|FG000|NOT COMPLETED|Overall Study||20
8623772|NCT00495391|9662955|FG000|STARTED|Overall Study||42
8623773|NCT00495391|9662956|FG001|STARTED|Overall Study||22
8623774|NCT00495391|9662955|FG000|From Baseline to Week 8|Overall Study||31
9067540|NCT04027439|10128146|FG009|COMPLETED|Part A (R, PC, PG) Single Dose||0
9067541|NCT04027439|10128147|FG010|COMPLETED|Part A (R, PC, PG) Single Dose||0
9067542|NCT04027439|10128148|FG011|COMPLETED|Part A (R, PC, PG) Single Dose||0
9067543|NCT04027439|10128149|FG012|COMPLETED|Part A (R, PC, PG) Single Dose||0
9067544|NCT04027439|10128150|FG013|COMPLETED|Part A (R, PC, PG) Single Dose||0
9067545|NCT04027439|10128151|FG014|COMPLETED|Part A (R, PC, PG) Single Dose||0
9067546|NCT04027439|10128152|FG015|COMPLETED|Part A (R, PC, PG) Single Dose||0
9067547|NCT04027439|10128137|FG000|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
9067548|NCT04027439|10128138|FG001|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
9067549|NCT04027439|10128139|FG002|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
9067550|NCT04027439|10128140|FG003|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
9067551|NCT04027439|10128141|FG004|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
9067552|NCT04027439|10128142|FG005|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
9067553|NCT04027439|10128143|FG006|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
9067554|NCT04027439|10128144|FG007|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
9067555|NCT04027439|10128145|FG008|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
9067556|NCT04027439|10128146|FG009|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
9067557|NCT04027439|10128147|FG010|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
9067558|NCT04027439|10128148|FG011|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
9067559|NCT04027439|10128149|FG012|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
9067560|NCT04027439|10128150|FG013|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
9067561|NCT04027439|10128151|FG014|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
8623775|NCT00495391|9662956|FG001|From Baseline to Week 8|Overall Study||20
8623776|NCT00495391|9662955|FG000|From Baseline to Week 16|Overall Study||24
8623777|NCT00495391|9662956|FG001|From Baseline to Week 16|Overall Study||11
9067562|NCT04027439|10128152|FG015|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
9067563|NCT04027439|10128137|FG000|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||0
9067564|NCT04027439|10128138|FG001|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||0
9067565|NCT04027439|10128139|FG002|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||0
9067566|NCT04027439|10128140|FG003|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||0
9067567|NCT04027439|10128141|FG004|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||0
9067568|NCT04027439|10128142|FG005|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||0
9067569|NCT04027439|10128143|FG006|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||4
9067570|NCT04027439|10128144|FG007|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||3
9067571|NCT04027439|10128145|FG008|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||4
9067572|NCT04027439|10128146|FG009|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||3
9067573|NCT04027439|10128147|FG010|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||4
9067574|NCT04027439|10128148|FG011|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||3
9067575|NCT04027439|10128149|FG012|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||3
9067576|NCT04027439|10128150|FG013|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||4
9067577|NCT04027439|10128151|FG014|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||4
9067578|NCT04027439|10128152|FG015|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||3
9067579|NCT04027439|10128137|FG000|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
9067580|NCT04027439|10128138|FG001|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
9067581|NCT04027439|10128139|FG002|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
9067582|NCT04027439|10128140|FG003|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
9067583|NCT04027439|10128141|FG004|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
9067584|NCT04027439|10128142|FG005|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
8623778|NCT00495391|9662955|FG000|From Baseline to End of Treatment|Overall Study||6
8623779|NCT00495391|9662956|FG001|From Baseline to End of Treatment|Overall Study||1
8623780|NCT00495391|9662955|FG000|From Baseline to End of Follow up|Overall Study||6
8623781|NCT00495391|9662956|FG001|From Baseline to End of Follow up|Overall Study||1
8623782|NCT00495391|9662955|FG000|COMPLETED|Overall Study||6
8623783|NCT00495391|9662956|FG001|COMPLETED|Overall Study||1
9067585|NCT04027439|10128143|FG006|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||4
9067586|NCT04027439|10128144|FG007|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day|1 patient discontinued in part b/period 2 and another in part b/period 3.|1
9067587|NCT04027439|10128145|FG008|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||4
9067588|NCT04027439|10128146|FG009|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||3
9067589|NCT04027439|10128147|FG010|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||4
9067590|NCT04027439|10128148|FG011|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||3
9067591|NCT04027439|10128149|FG012|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||3
9067592|NCT04027439|10128150|FG013|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||4
9067593|NCT04027439|10128151|FG014|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||4
9067594|NCT04027439|10128152|FG015|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||3
9067595|NCT04027439|10128137|FG000|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
9067596|NCT04027439|10128138|FG001|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
9067597|NCT04027439|10128139|FG002|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
9067598|NCT04027439|10128140|FG003|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
9067599|NCT04027439|10128141|FG004|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
9067600|NCT04027439|10128142|FG005|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
9067601|NCT04027439|10128143|FG006|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
9067602|NCT04027439|10128144|FG007|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||2
9067603|NCT04027439|10128145|FG008|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
9067604|NCT04027439|10128146|FG009|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
9067605|NCT04027439|10128147|FG010|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
9067606|NCT04027439|10128148|FG011|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
9067607|NCT04027439|10128149|FG012|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
9067608|NCT04027439|10128150|FG013|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
9067609|NCT04027439|10128151|FG014|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
9067610|NCT04027439|10128152|FG015|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
9067611|NCT04027218|10128182|FG000|STARTED|Overall Study||10
9067612|NCT04027218|10128183|FG001|STARTED|Overall Study||11
9067613|NCT04027218|10128184|FG002|STARTED|Overall Study||9
9067614|NCT04027218|10128185|FG003|STARTED|Overall Study||11
9067615|NCT04027218|10128186|FG004|STARTED|Overall Study||10
9067616|NCT04027218|10128187|FG005|STARTED|Overall Study||11
9067617|NCT04027218|10128182|FG000|COMPLETED|Overall Study||10
9067618|NCT04027218|10128183|FG001|COMPLETED|Overall Study||8
9067619|NCT04027218|10128184|FG002|COMPLETED|Overall Study||9
9067620|NCT04027218|10128185|FG003|COMPLETED|Overall Study||11
9067621|NCT04027218|10128186|FG004|COMPLETED|Overall Study||10
9067622|NCT04027218|10128187|FG005|COMPLETED|Overall Study||11
9067623|NCT04027218|10128182|FG000|NOT COMPLETED|Overall Study||0
9067624|NCT04027218|10128183|FG001|NOT COMPLETED|Overall Study||3
9067625|NCT04027218|10128184|FG002|NOT COMPLETED|Overall Study||0
9067626|NCT04027218|10128185|FG003|NOT COMPLETED|Overall Study||0
9067627|NCT04027218|10128186|FG004|NOT COMPLETED|Overall Study||0
9067628|NCT04027218|10128187|FG005|NOT COMPLETED|Overall Study||0
9067629|NCT04026750|10128199|FG000|STARTED|Overall Study||3
9067630|NCT04026750|10128200|FG001|STARTED|Overall Study||2
9067631|NCT04026750|10128199|FG000|COMPLETED|Overall Study||3
9067632|NCT04026750|10128200|FG001|COMPLETED|Overall Study||2
9067633|NCT04026750|10128199|FG000|NOT COMPLETED|Overall Study||0
9067634|NCT04026750|10128200|FG001|NOT COMPLETED|Overall Study||0
9067635|NCT04026308|10128209|FG000|STARTED|Overall Study||14
9067636|NCT04026308|10128210|FG001|STARTED|Overall Study||16
9067637|NCT04026308|10128209|FG000|COMPLETED|Overall Study||14
9067638|NCT04026308|10128210|FG001|COMPLETED|Overall Study||16
9067639|NCT04026308|10128209|FG000|NOT COMPLETED|Overall Study||0
9067640|NCT04026308|10128210|FG001|NOT COMPLETED|Overall Study||0
9067641|NCT04023682|10128216|FG000|STARTED|Overall Study||31
9067642|NCT04023682|10128216|FG000|COMPLETED|Overall Study||25
9067643|NCT04023682|10128216|FG000|NOT COMPLETED|Overall Study||6
9067644|NCT04021771|10128226|FG000|STARTED|Overall Study||55
9067645|NCT04021771|10128227|FG001|STARTED|Overall Study||54
9067646|NCT04021771|10128226|FG000|COMPLETED|Overall Study||55
9067647|NCT04021771|10128227|FG001|COMPLETED|Overall Study||54
9067648|NCT04021771|10128226|FG000|NOT COMPLETED|Overall Study||0
9067649|NCT04021771|10128227|FG001|NOT COMPLETED|Overall Study||0
9067650|NCT04019626|10128238|FG000|STARTED|Overall Study||42
9067651|NCT04019626|10128239|FG001|STARTED|Overall Study||42
9067652|NCT04019626|10128240|FG002|STARTED|Overall Study||45
9067653|NCT04019626|10128241|FG003|STARTED|Overall Study||46
9067654|NCT04019626|10128242|FG004|STARTED|Overall Study||44
9067655|NCT04019626|10128243|FG005|STARTED|Overall Study||21
9067656|NCT04019626|10128238|FG000|COMPLETED|Overall Study||36
9067657|NCT04019626|10128239|FG001|COMPLETED|Overall Study||32
9067658|NCT04019626|10128240|FG002|COMPLETED|Overall Study||37
9067659|NCT04019626|10128241|FG003|COMPLETED|Overall Study||39
9067660|NCT04019626|10128242|FG004|COMPLETED|Overall Study||38
9067661|NCT04019626|10128243|FG005|COMPLETED|Overall Study||20
9067662|NCT04019626|10128238|FG000|NOT COMPLETED|Overall Study||6
9067663|NCT04019626|10128239|FG001|NOT COMPLETED|Overall Study||10
9067664|NCT04019626|10128240|FG002|NOT COMPLETED|Overall Study||8
9067665|NCT04019626|10128241|FG003|NOT COMPLETED|Overall Study||7
9067666|NCT04019626|10128242|FG004|NOT COMPLETED|Overall Study||6
9067667|NCT04019626|10128243|FG005|NOT COMPLETED|Overall Study||1
9067668|NCT04023994|10128263|FG000|STARTED|Overall Study||10
9067669|NCT04023994|10128264|FG001|STARTED|Overall Study||4
9067670|NCT04023994|10128265|FG002|STARTED|Overall Study||4
9067671|NCT04023994|10128266|FG003|STARTED|Overall Study||6
9067672|NCT04023994|10128267|FG004|STARTED|Overall Study||6
9067673|NCT04023994|10128268|FG005|STARTED|Overall Study||6
9067674|NCT04023994|10128263|FG000|COMPLETED|Overall Study||10
9067675|NCT04023994|10128264|FG001|COMPLETED|Overall Study||3
9067676|NCT04023994|10128265|FG002|COMPLETED|Overall Study||2
9067677|NCT04023994|10128266|FG003|COMPLETED|Overall Study||5
9067678|NCT04023994|10128267|FG004|COMPLETED|Overall Study||6
9067679|NCT04023994|10128268|FG005|COMPLETED|Overall Study||6
9067680|NCT04023994|10128263|FG000|NOT COMPLETED|Overall Study||0
9067681|NCT04023994|10128264|FG001|NOT COMPLETED|Overall Study||1
9067682|NCT04023994|10128265|FG002|NOT COMPLETED|Overall Study||2
9067683|NCT04023994|10128266|FG003|NOT COMPLETED|Overall Study||1
9067684|NCT04023994|10128267|FG004|NOT COMPLETED|Overall Study||0
9067685|NCT04023994|10128268|FG005|NOT COMPLETED|Overall Study||0
9067686|NCT04022668|10128290|FG000|STARTED|Overall Study||1000
9067687|NCT04022668|10128291|FG001|STARTED|Overall Study||1000
9067688|NCT04022668|10128292|FG002|STARTED|Overall Study||1000
9067689|NCT04022668|10128290|FG000|COMPLETED|Overall Study||986
9067690|NCT04022668|10128291|FG001|COMPLETED|Overall Study||973
9067691|NCT04022668|10128292|FG002|COMPLETED|Overall Study||1000
9067692|NCT04022668|10128290|FG000|NOT COMPLETED|Overall Study||14
9067693|NCT04022668|10128291|FG001|NOT COMPLETED|Overall Study||27
9067694|NCT04022668|10128292|FG002|NOT COMPLETED|Overall Study||0
9067695|NCT04020822|10128300|FG000|STARTED|Overall Study||19
9067696|NCT04020822|10128300|FG000|COMPLETED|Overall Study||19
9067697|NCT04020822|10128300|FG000|NOT COMPLETED|Overall Study||0
9067698|NCT04019990|10128304|FG000|STARTED|Overall Study||13
9067699|NCT04019990|10128305|FG001|STARTED|Overall Study||15
9067700|NCT04019990|10128304|FG000|COMPLETED|Overall Study||12
9067701|NCT04019990|10128305|FG001|COMPLETED|Overall Study||12
9067702|NCT04019990|10128304|FG000|NOT COMPLETED|Overall Study||1
9067703|NCT04019990|10128305|FG001|NOT COMPLETED|Overall Study||3
9067704|NCT04017611|10128311|FG000|STARTED|Overall Study||13
9067705|NCT04017611|10128311|FG000|COMPLETED|Overall Study||12
9067706|NCT04017611|10128311|FG000|NOT COMPLETED|Overall Study||1
9067707|NCT04015232|10128317|FG000|STARTED|Overall Study||100
9067708|NCT04015232|10128318|FG001|STARTED|Overall Study||100
9067709|NCT04015232|10128317|FG000|COMPLETED|Overall Study||89
9067710|NCT04015232|10128318|FG001|COMPLETED|Overall Study||93
9067711|NCT04015232|10128317|FG000|NOT COMPLETED|Overall Study||11
9067712|NCT04015232|10128318|FG001|NOT COMPLETED|Overall Study||7
9067713|NCT04016623|10128328|FG000|STARTED|Pair 1 Test / Control Dispense||10
9067714|NCT04016623|10128328|FG000|COMPLETED|Pair 1 Test / Control Dispense||10
9067715|NCT04016623|10128328|FG000|NOT COMPLETED|Pair 1 Test / Control Dispense||0
9067716|NCT04016623|10128328|FG000|STARTED|Pair 1 Test /Control Follow up||10
9067717|NCT04016623|10128328|FG000|COMPLETED|Pair 1 Test /Control Follow up||10
9067718|NCT04016623|10128328|FG000|NOT COMPLETED|Pair 1 Test /Control Follow up||0
9067719|NCT04016623|10128328|FG000|STARTED|Pair 2 Test / Control Dispense||10
9067720|NCT04016623|10128328|FG000|COMPLETED|Pair 2 Test / Control Dispense||10
9067721|NCT04016623|10128328|FG000|NOT COMPLETED|Pair 2 Test / Control Dispense||0
9067722|NCT04016623|10128328|FG000|STARTED|Pair 2 Test /Control Follow up||10
9067723|NCT04016623|10128328|FG000|COMPLETED|Pair 2 Test /Control Follow up||10
9067724|NCT04016623|10128328|FG000|NOT COMPLETED|Pair 2 Test /Control Follow up||0
9067725|NCT04016623|10128328|FG000|STARTED|Pair 3 Test / Control Dispense||10
9067726|NCT04016623|10128328|FG000|COMPLETED|Pair 3 Test / Control Dispense||10
9067727|NCT04016623|10128328|FG000|NOT COMPLETED|Pair 3 Test / Control Dispense||0
9067728|NCT04016623|10128328|FG000|STARTED|Pair 3 Test /Control Follow up||10
9067729|NCT04016623|10128328|FG000|COMPLETED|Pair 3 Test /Control Follow up||10
9067730|NCT04016623|10128328|FG000|NOT COMPLETED|Pair 3 Test /Control Follow up||0
9067731|NCT04016623|10128328|FG000|STARTED|Pair 4 Test / Control Dispense||10
9067732|NCT04016623|10128328|FG000|COMPLETED|Pair 4 Test / Control Dispense||10
9067733|NCT04016623|10128328|FG000|NOT COMPLETED|Pair 4 Test / Control Dispense||0
9067734|NCT04016623|10128328|FG000|STARTED|Pair 4 Test /Control Follow up||10
9067735|NCT04016623|10128328|FG000|COMPLETED|Pair 4 Test /Control Follow up||10
9067736|NCT04016623|10128328|FG000|NOT COMPLETED|Pair 4 Test /Control Follow up||0
9067737|NCT04013737|10128350|FG000|STARTED|Overall Study||18
9067738|NCT04013737|10128351|FG001|STARTED|Overall Study||15
9067739|NCT04013737|10128350|FG000|COMPLETED|Overall Study|12 participants declined to participate in the study|18
9067740|NCT04013737|10128351|FG001|COMPLETED|Overall Study||15
9067741|NCT04013737|10128350|FG000|NOT COMPLETED|Overall Study||0
9067742|NCT04013737|10128351|FG001|NOT COMPLETED|Overall Study||0
9067743|NCT04014062|10128358|FG000|STARTED|Period I: Dosing||71
9067744|NCT04014062|10128359|FG001|STARTED|Period I: Dosing||71
9067745|NCT04014062|10128358|FG000|COMPLETED|Period I: Dosing|Period I: Dosing, includes a washout period of 42 days before starting Period II: Crossover Dosing|64
9067746|NCT04014062|10128359|FG001|COMPLETED|Period I: Dosing|Period I: Dosing, includes a washout period of 42 days before starting Period II: Crossover Dosing|65
9067747|NCT04014062|10128358|FG000|NOT COMPLETED|Period I: Dosing||7
9067748|NCT04014062|10128359|FG001|NOT COMPLETED|Period I: Dosing||6
9067749|NCT04014062|10128358|FG000|STARTED|Period II: Crossover Dosing||64
9067750|NCT04014062|10128359|FG001|STARTED|Period II: Crossover Dosing||65
9067751|NCT04014062|10128358|FG000|COMPLETED|Period II: Crossover Dosing||64
9067752|NCT04014062|10128359|FG001|COMPLETED|Period II: Crossover Dosing||65
9067753|NCT04014062|10128358|FG000|NOT COMPLETED|Period II: Crossover Dosing||0
9067754|NCT04014062|10128359|FG001|NOT COMPLETED|Period II: Crossover Dosing||0
9067755|NCT04013789|10128370|FG000|STARTED|First Wear Period (1 Week)||33
9067756|NCT04013789|10128371|FG001|STARTED|First Wear Period (1 Week)||34
9067757|NCT04013789|10128370|FG000|COMPLETED|First Wear Period (1 Week)||33
9067758|NCT04013789|10128371|FG001|COMPLETED|First Wear Period (1 Week)||34
9067759|NCT04013789|10128370|FG000|NOT COMPLETED|First Wear Period (1 Week)||0
9067760|NCT04013789|10128371|FG001|NOT COMPLETED|First Wear Period (1 Week)||0
9067761|NCT04013789|10128370|FG000|STARTED|Second Wear Period (1 Week)|One subject withdrew from the study between the first wear period and the second wear period.|32
9067762|NCT04013789|10128371|FG001|STARTED|Second Wear Period (1 Week)||34
9067763|NCT04013789|10128370|FG000|COMPLETED|Second Wear Period (1 Week)||32
9067764|NCT04013789|10128371|FG001|COMPLETED|Second Wear Period (1 Week)||34
9067765|NCT04013789|10128370|FG000|NOT COMPLETED|Second Wear Period (1 Week)||0
9067766|NCT04013789|10128371|FG001|NOT COMPLETED|Second Wear Period (1 Week)||0
9067767|NCT04012970|10128381|FG000|STARTED|Intervention Session, 30 Minutes||26
9067768|NCT04012970|10128382|FG001|STARTED|Intervention Session, 30 Minutes||14
9067769|NCT04012970|10128381|FG000|COMPLETED|Intervention Session, 30 Minutes||26
9067770|NCT04012970|10128382|FG001|COMPLETED|Intervention Session, 30 Minutes||14
9067771|NCT04012970|10128381|FG000|NOT COMPLETED|Intervention Session, 30 Minutes||0
9067772|NCT04012970|10128382|FG001|NOT COMPLETED|Intervention Session, 30 Minutes||0
9067773|NCT04012970|10128381|FG000|STARTED|Control Session, 30 Minutes||26
9067774|NCT04012970|10128382|FG001|STARTED|Control Session, 30 Minutes||14
9067775|NCT04012970|10128381|FG000|COMPLETED|Control Session, 30 Minutes||26
9067776|NCT04012970|10128382|FG001|COMPLETED|Control Session, 30 Minutes||14
9067777|NCT04012970|10128381|FG000|NOT COMPLETED|Control Session, 30 Minutes||0
9067778|NCT04012970|10128382|FG001|NOT COMPLETED|Control Session, 30 Minutes||0
9067779|NCT04013191|10128396|FG000|STARTED|Overall Study||10
9067780|NCT04013191|10128397|FG001|STARTED|Overall Study||18
9067781|NCT04013191|10128396|FG000|Completed Period 1A (Single Dose)|Overall Study||10
9067782|NCT04013191|10128397|FG001|Completed Period 1A (Single Dose)|Overall Study||18
9067783|NCT04013191|10128396|FG000|Completed Period 1B (Multiple Dose)|Overall Study||9
9067784|NCT04013191|10128397|FG001|Completed Period 1B (Multiple Dose)|Overall Study||18
9067785|NCT04013191|10128396|FG000|COMPLETED|Overall Study||9
9067786|NCT04013191|10128397|FG001|COMPLETED|Overall Study||18
9067787|NCT04013191|10128396|FG000|NOT COMPLETED|Overall Study||1
9067788|NCT04013191|10128397|FG001|NOT COMPLETED|Overall Study||0
9067789|NCT04011631|10128407|FG000|STARTED|Overall Study||100
9067790|NCT04011631|10128407|FG000|COMPLETED|Overall Study||100
9067791|NCT04011631|10128407|FG000|NOT COMPLETED|Overall Study||0
9067792|NCT04011735|10128414|FG000|STARTED|Overall Study||133
9067793|NCT04011735|10128415|FG001|STARTED|Overall Study||71
9067794|NCT04011735|10128416|FG002|STARTED|Overall Study||56
9067795|NCT04011735|10128414|FG000|COMPLETED|Overall Study||132
9067796|NCT04011735|10128415|FG001|COMPLETED|Overall Study||70
9067797|NCT04011735|10128416|FG002|COMPLETED|Overall Study||55
9067798|NCT04011735|10128414|FG000|NOT COMPLETED|Overall Study||1
9067799|NCT04011735|10128415|FG001|NOT COMPLETED|Overall Study||1
9067800|NCT04011735|10128416|FG002|NOT COMPLETED|Overall Study||1
9067801|NCT04009577|10128430|FG000|STARTED|Core Study||7
9067802|NCT04009577|10128431|FG001|STARTED|Core Study||3
9067803|NCT04009577|10128432|FG002|STARTED|Core Study||21
9067804|NCT04009577|10128433|FG003|STARTED|Core Study||22
9067805|NCT04009577|10128430|FG000|LEM5|Core Study||7
9067806|NCT04009577|10128431|FG001|LEM5|Core Study||3
9067807|NCT04009577|10128432|FG002|LEM5|Core Study||21
9067808|NCT04009577|10128433|FG003|LEM5|Core Study||5
9067809|NCT04009577|10128430|FG000|LEM10|Core Study||3
9067810|NCT04009577|10128431|FG001|LEM10|Core Study||2
9067811|NCT04009577|10128432|FG002|LEM10|Core Study||10
9067812|NCT04009577|10128433|FG003|LEM10|Core Study||22
9067813|NCT04009577|10128430|FG000|COMPLETED|Core Study||6
9067814|NCT04009577|10128431|FG001|COMPLETED|Core Study||3
9067815|NCT04009577|10128432|FG002|COMPLETED|Core Study||17
9067816|NCT04009577|10128433|FG003|COMPLETED|Core Study||17
9067817|NCT04009577|10128430|FG000|NOT COMPLETED|Core Study||1
9067818|NCT04009577|10128431|FG001|NOT COMPLETED|Core Study||0
9067819|NCT04009577|10128432|FG002|NOT COMPLETED|Core Study||4
8623784|NCT00495391|9662955|FG000|NOT COMPLETED|Overall Study||36
8623785|NCT00495391|9662956|FG001|NOT COMPLETED|Overall Study||21
8623786|NCT00495469|9662969|FG000|STARTED|Overall Study||36
8623787|NCT00495469|9662970|FG001|STARTED|Overall Study||37
8623788|NCT00495469|9662971|FG002|STARTED|Overall Study||34
8623789|NCT00495469|9662972|FG003|STARTED|Overall Study||36
8623790|NCT00495469|9662973|FG004|STARTED|Overall Study||36
9067820|NCT04009577|10128433|FG003|NOT COMPLETED|Core Study||5
9067821|NCT04009577|10128430|FG000|STARTED|Extension Phase||6
9067822|NCT04009577|10128431|FG001|STARTED|Extension Phase||3
9067823|NCT04009577|10128432|FG002|STARTED|Extension Phase||17
9067824|NCT04009577|10128433|FG003|STARTED|Extension Phase||17
9067825|NCT04009577|10128430|FG000|Treated|Extension Phase||6
9067826|NCT04009577|10128431|FG001|Treated|Extension Phase||3
8623791|NCT00495469|9662974|FG005|STARTED|Overall Study||36
8623792|NCT00495469|9662975|FG006|STARTED|Overall Study||35
8623793|NCT00495469|9662969|FG000|COMPLETED|Overall Study||30
8623794|NCT00495469|9662970|FG001|COMPLETED|Overall Study||30
8623795|NCT00495469|9662971|FG002|COMPLETED|Overall Study||27
8623796|NCT00495469|9662972|FG003|COMPLETED|Overall Study||32
8623797|NCT00495469|9662973|FG004|COMPLETED|Overall Study||31
8623798|NCT00495469|9662974|FG005|COMPLETED|Overall Study||31
8723509|NCT01023581|9771022|FG006|COMPLETED|Overall Study||94
8723510|NCT01023581|9771016|FG000|NOT COMPLETED|Overall Study||35
8723511|NCT01023581|9771017|FG001|NOT COMPLETED|Overall Study||23
8723512|NCT01023581|9771018|FG002|NOT COMPLETED|Overall Study||42
8723513|NCT01023581|9771019|FG003|NOT COMPLETED|Overall Study||20
8723514|NCT01023581|9771020|FG004|NOT COMPLETED|Overall Study||16
8723515|NCT01023581|9771021|FG005|NOT COMPLETED|Overall Study||19
8723516|NCT01023581|9771022|FG006|NOT COMPLETED|Overall Study||20
8723517|NCT01023659|9771041|FG000|STARTED|Overall Study||258
8723518|NCT01023659|9771042|FG001|STARTED|Overall Study||365
8723519|NCT01023659|9771043|FG002|STARTED|Overall Study||264
8723520|NCT01023659|9771041|FG000|COMPLETED|Overall Study||185
8723521|NCT01023659|9771042|FG001|COMPLETED|Overall Study||137
8723522|NCT01023659|9771043|FG002|COMPLETED|Overall Study||165
8723523|NCT01023659|9771041|FG000|NOT COMPLETED|Overall Study||73
8723524|NCT01023659|9771042|FG001|NOT COMPLETED|Overall Study||228
9067827|NCT04009577|10128432|FG002|Treated|Extension Phase||15
9067828|NCT04009577|10128433|FG003|Treated|Extension Phase||17
9067829|NCT04009577|10128430|FG000|LEM5|Extension Phase||6
9067830|NCT04009577|10128431|FG001|LEM5|Extension Phase||3
9067831|NCT04009577|10128432|FG002|LEM5|Extension Phase||15
8623799|NCT00495469|9662975|FG006|COMPLETED|Overall Study||30
8623800|NCT00495469|9662969|FG000|NOT COMPLETED|Overall Study||6
8623801|NCT00495469|9662970|FG001|NOT COMPLETED|Overall Study||7
8623802|NCT00495469|9662971|FG002|NOT COMPLETED|Overall Study||7
8623803|NCT00495469|9662972|FG003|NOT COMPLETED|Overall Study||4
8623804|NCT00495469|9662973|FG004|NOT COMPLETED|Overall Study||5
8723525|NCT01023659|9771043|FG002|NOT COMPLETED|Overall Study||99
8723526|NCT01023672|9771052|FG000|STARTED|Overall Study||20
8723527|NCT01023672|9771052|FG000|COMPLETED|Overall Study||17
8723528|NCT01023672|9771052|FG000|NOT COMPLETED|Overall Study||3
9067832|NCT04009577|10128433|FG003|LEM5|Extension Phase||8
9067833|NCT04009577|10128430|FG000|LEM10|Extension Phase||5
9067834|NCT04009577|10128431|FG001|LEM10|Extension Phase||3
9067835|NCT04009577|10128432|FG002|LEM10|Extension Phase||12
8723529|NCT01023711|9771056|FG000|STARTED|Overall Study||107
9067836|NCT04009577|10128433|FG003|LEM10|Extension Phase||17
9067837|NCT04009577|10128430|FG000|COMPLETED|Extension Phase||6
9067838|NCT04009577|10128431|FG001|COMPLETED|Extension Phase||3
9067839|NCT04009577|10128432|FG002|COMPLETED|Extension Phase||13
9067840|NCT04009577|10128433|FG003|COMPLETED|Extension Phase||16
9067841|NCT04009577|10128430|FG000|NOT COMPLETED|Extension Phase||0
9067842|NCT04009577|10128431|FG001|NOT COMPLETED|Extension Phase||0
9067843|NCT04009577|10128432|FG002|NOT COMPLETED|Extension Phase||4
9067844|NCT04009577|10128433|FG003|NOT COMPLETED|Extension Phase||1
9067845|NCT04007159|10128459|FG000|STARTED|Induction Phase||280
9067846|NCT04007159|10128459|FG000|COMPLETED|Induction Phase||258
9067847|NCT04007159|10128459|FG000|NOT COMPLETED|Induction Phase||22
9067848|NCT04007159|10128459|FG000|STARTED|Rest Phase||258
9067849|NCT04007159|10128459|FG000|COMPLETED|Rest Phase||258
9067850|NCT04007159|10128459|FG000|NOT COMPLETED|Rest Phase||0
9067851|NCT04007159|10128459|FG000|STARTED|Challenge Phase||258
9067852|NCT04007159|10128459|FG000|COMPLETED|Challenge Phase||255
9067853|NCT04007159|10128459|FG000|NOT COMPLETED|Challenge Phase||3
9067854|NCT04007107|10128470|FG000|STARTED|Treatment Period 1 (Day 1)||26
9067855|NCT04007107|10128471|FG001|STARTED|Treatment Period 1 (Day 1)||26
9067856|NCT04007107|10128472|FG002|STARTED|Treatment Period 1 (Day 1)||25
9067857|NCT04007107|10128473|FG003|STARTED|Treatment Period 1 (Day 1)||26
9067858|NCT04007107|10128470|FG000|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26
9067859|NCT04007107|10128471|FG001|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26
9067860|NCT04007107|10128472|FG002|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||25
9067861|NCT04007107|10128473|FG003|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26
9067862|NCT04007107|10128470|FG000|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26
9067863|NCT04007107|10128471|FG001|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26
9067864|NCT04007107|10128472|FG002|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||25
9067865|NCT04007107|10128473|FG003|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26
9067866|NCT04007107|10128470|FG000|Per Protocol (PP) Set|Treatment Period 1 (Day 1)||26
9067867|NCT04007107|10128471|FG001|Per Protocol (PP) Set|Treatment Period 1 (Day 1)||25
9067868|NCT04007107|10128472|FG002|Per Protocol (PP) Set|Treatment Period 1 (Day 1)||25
9067869|NCT04007107|10128473|FG003|Per Protocol (PP) Set|Treatment Period 1 (Day 1)||26
9067870|NCT04007107|10128470|FG000|COMPLETED|Treatment Period 1 (Day 1)||26
9067871|NCT04007107|10128471|FG001|COMPLETED|Treatment Period 1 (Day 1)||26
9067872|NCT04007107|10128472|FG002|COMPLETED|Treatment Period 1 (Day 1)||25
9067873|NCT04007107|10128473|FG003|COMPLETED|Treatment Period 1 (Day 1)||26
9067874|NCT04007107|10128470|FG000|NOT COMPLETED|Treatment Period 1 (Day 1)||0
9067875|NCT04007107|10128471|FG001|NOT COMPLETED|Treatment Period 1 (Day 1)||0
9067876|NCT04007107|10128472|FG002|NOT COMPLETED|Treatment Period 1 (Day 1)||0
9067877|NCT04007107|10128473|FG003|NOT COMPLETED|Treatment Period 1 (Day 1)||0
9067878|NCT04007107|10128470|FG000|STARTED|Treatment Period 2 (Day 1)||26
9067879|NCT04007107|10128471|FG001|STARTED|Treatment Period 2 (Day 1)||26
9067880|NCT04007107|10128472|FG002|STARTED|Treatment Period 2 (Day 1)||25
9067881|NCT04007107|10128473|FG003|STARTED|Treatment Period 2 (Day 1)||26
9067882|NCT04007107|10128470|FG000|COMPLETED|Treatment Period 2 (Day 1)||26
9067883|NCT04007107|10128471|FG001|COMPLETED|Treatment Period 2 (Day 1)||25
9067884|NCT04007107|10128472|FG002|COMPLETED|Treatment Period 2 (Day 1)||25
9067885|NCT04007107|10128473|FG003|COMPLETED|Treatment Period 2 (Day 1)||26
9067886|NCT04007107|10128470|FG000|NOT COMPLETED|Treatment Period 2 (Day 1)||0
9067887|NCT04007107|10128471|FG001|NOT COMPLETED|Treatment Period 2 (Day 1)||1
9067888|NCT04007107|10128472|FG002|NOT COMPLETED|Treatment Period 2 (Day 1)||0
9067889|NCT04007107|10128473|FG003|NOT COMPLETED|Treatment Period 2 (Day 1)||0
9067890|NCT04006795|10128478|FG000|STARTED|Induction Phase||37
9067891|NCT04006795|10128478|FG000|COMPLETED|Induction Phase||37
9067892|NCT04006795|10128478|FG000|NOT COMPLETED|Induction Phase||0
9067893|NCT04006795|10128478|FG000|STARTED|Rest Phase||37
9067894|NCT04006795|10128478|FG000|COMPLETED|Rest Phase||37
9067895|NCT04006795|10128478|FG000|NOT COMPLETED|Rest Phase||0
9067896|NCT04006795|10128478|FG000|STARTED|Challenge Phase||37
9067897|NCT04006795|10128478|FG000|COMPLETED|Challenge Phase||37
9067898|NCT04006795|10128478|FG000|NOT COMPLETED|Challenge Phase||0
9067899|NCT04005885|10128489|FG000|STARTED|First Intervention||26
9067900|NCT04005885|10128490|FG001|STARTED|First Intervention||29
9067901|NCT04005885|10128489|FG000|COMPLETED|First Intervention||25
9067902|NCT04005885|10128490|FG001|COMPLETED|First Intervention||28
9067903|NCT04005885|10128489|FG000|NOT COMPLETED|First Intervention||1
9067904|NCT04005885|10128490|FG001|NOT COMPLETED|First Intervention||1
9067905|NCT04005885|10128489|FG000|STARTED|Second Intervention||25
9067906|NCT04005885|10128490|FG001|STARTED|Second Intervention||28
9067907|NCT04005885|10128489|FG000|COMPLETED|Second Intervention||25
9067908|NCT04005885|10128490|FG001|COMPLETED|Second Intervention||26
9067909|NCT04005885|10128489|FG000|NOT COMPLETED|Second Intervention||0
9067910|NCT04005885|10128490|FG001|NOT COMPLETED|Second Intervention||2
9067911|NCT04005885|10128489|FG000|STARTED|Third Intervention||25
9067912|NCT04005885|10128490|FG001|STARTED|Third Intervention||26
9067913|NCT04005885|10128489|FG000|COMPLETED|Third Intervention||25
9067914|NCT04005885|10128490|FG001|COMPLETED|Third Intervention||26
9067915|NCT04005885|10128489|FG000|NOT COMPLETED|Third Intervention||0
9067916|NCT04005885|10128490|FG001|NOT COMPLETED|Third Intervention||0
9067917|NCT04000815|10128504|FG000|STARTED|Overall Study||29
9067918|NCT04000815|10128505|FG001|STARTED|Overall Study||20
9067919|NCT04000815|10128506|FG002|STARTED|Overall Study||22
9067920|NCT04000815|10128504|FG000|COMPLETED|Overall Study||15
9067921|NCT04000815|10128505|FG001|COMPLETED|Overall Study||15
9067922|NCT04000815|10128506|FG002|COMPLETED|Overall Study||15
9067923|NCT04000815|10128504|FG000|NOT COMPLETED|Overall Study||14
9067924|NCT04000815|10128505|FG001|NOT COMPLETED|Overall Study||5
9067925|NCT04000815|10128506|FG002|NOT COMPLETED|Overall Study||7
9067926|NCT03999944|10128514|FG000|STARTED|First Sleep Night||26
9067927|NCT03999944|10128515|FG001|STARTED|First Sleep Night||26
9067928|NCT03999944|10128514|FG000|COMPLETED|First Sleep Night||22
9067929|NCT03999944|10128515|FG001|COMPLETED|First Sleep Night||24
9067930|NCT03999944|10128514|FG000|NOT COMPLETED|First Sleep Night||4
9067931|NCT03999944|10128515|FG001|NOT COMPLETED|First Sleep Night||2
9067932|NCT03999944|10128514|FG000|STARTED|Second Sleep Night||22
9067933|NCT03999944|10128515|FG001|STARTED|Second Sleep Night||24
9067934|NCT03999944|10128514|FG000|COMPLETED|Second Sleep Night||22
9067935|NCT03999944|10128515|FG001|COMPLETED|Second Sleep Night||20
9067936|NCT03999944|10128514|FG000|NOT COMPLETED|Second Sleep Night||0
9067937|NCT03999944|10128515|FG001|NOT COMPLETED|Second Sleep Night||4
9067938|NCT03995680|10128524|FG000|STARTED|Overall Study||199
9067939|NCT03995680|10128525|FG001|STARTED|Overall Study||198
9067940|NCT03995680|10128524|FG000|COMPLETED|Overall Study||197
9067941|NCT03995680|10128525|FG001|COMPLETED|Overall Study||196
9067942|NCT03995680|10128524|FG000|NOT COMPLETED|Overall Study||2
9067943|NCT03995680|10128525|FG001|NOT COMPLETED|Overall Study||2
9067944|NCT04006366|10128531|FG000|STARTED|Overall Study||6
9067945|NCT04006366|10128531|FG000|COMPLETED|Overall Study||5
9067946|NCT04006366|10128531|FG000|NOT COMPLETED|Overall Study||1
9067947|NCT04006145|10128537|FG000|STARTED|Overall Study||23
9067948|NCT04006145|10128538|FG001|STARTED|Overall Study||24
9067949|NCT04006145|10128537|FG000|Received Treatment|Overall Study||23
9067950|NCT04006145|10128538|FG001|Received Treatment|Overall Study||24
9067951|NCT04006145|10128537|FG000|COMPLETED|Overall Study||22
9067952|NCT04006145|10128538|FG001|COMPLETED|Overall Study||21
9067953|NCT04006145|10128537|FG000|NOT COMPLETED|Overall Study||1
9067954|NCT04006145|10128538|FG001|NOT COMPLETED|Overall Study||3
9067955|NCT04005755|10128544|FG000|STARTED|Overall Study||232
9067956|NCT04005755|10128544|FG000|COMPLETED|Overall Study||215
9067957|NCT04005755|10128544|FG000|NOT COMPLETED|Overall Study||17
9067958|NCT04005586|10128548|FG000|STARTED|Overall Study||25
9067959|NCT04005586|10128548|FG000|COMPLETED|Overall Study||25
9067960|NCT04005586|10128548|FG000|NOT COMPLETED|Overall Study||0
9067961|NCT04005404|10128555|FG000|STARTED|Overall Study||43
9067962|NCT04005404|10128556|FG001|STARTED|Overall Study||34
9067963|NCT04005404|10128557|FG002|STARTED|Overall Study||3
9067964|NCT04005404|10128555|FG000|COMPLETED|Overall Study||42
9067965|NCT04005404|10128556|FG001|COMPLETED|Overall Study||33
9067966|NCT04005404|10128557|FG002|COMPLETED|Overall Study||3
9067967|NCT04005404|10128555|FG000|NOT COMPLETED|Overall Study||1
9067968|NCT04005404|10128556|FG001|NOT COMPLETED|Overall Study||1
9067969|NCT04005404|10128557|FG002|NOT COMPLETED|Overall Study||0
9067970|NCT03993288|10128567|FG000|STARTED|Overall Study||133
9067971|NCT03993288|10128568|FG001|STARTED|Overall Study||134
9067972|NCT03993288|10128567|FG000|Intention-to-treat (ITT) Population|Overall Study||123
9067973|NCT03993288|10128568|FG001|Intention-to-treat (ITT) Population|Overall Study||129
9067974|NCT03993288|10128567|FG000|Safety Analysis Set|Overall Study||133
9067975|NCT03993288|10128568|FG001|Safety Analysis Set|Overall Study||134
9067976|NCT03993288|10128567|FG000|COMPLETED|Overall Study||123
9067977|NCT03993288|10128568|FG001|COMPLETED|Overall Study||129
9067978|NCT03993288|10128567|FG000|NOT COMPLETED|Overall Study||10
9067979|NCT03993288|10128568|FG001|NOT COMPLETED|Overall Study||5
9067980|NCT03990298|10128574|FG000|STARTED|Overall Study||16
9067981|NCT03990298|10128574|FG000|COMPLETED|Overall Study||16
9067982|NCT03990298|10128574|FG000|NOT COMPLETED|Overall Study||0
9067983|NCT03988647|10128578|FG000|STARTED|Overall Study||1
9067984|NCT03988647|10128578|FG000|COMPLETED|Overall Study||1
9067985|NCT03988647|10128578|FG000|NOT COMPLETED|Overall Study||0
9067986|NCT03979872|10128586|FG000|STARTED|Overall Study||22
9067987|NCT03979872|10128587|FG001|STARTED|Overall Study||23
9067988|NCT03979872|10128588|FG002|STARTED|Overall Study||24
9067989|NCT03979872|10128589|FG003|STARTED|Overall Study||23
9067990|NCT03979872|10128586|FG000|COMPLETED|Overall Study||19
9067991|NCT03979872|10128587|FG001|COMPLETED|Overall Study||15
9067992|NCT03979872|10128588|FG002|COMPLETED|Overall Study||18
9067993|NCT03979872|10128589|FG003|COMPLETED|Overall Study||19
9067994|NCT03979872|10128586|FG000|NOT COMPLETED|Overall Study||3
9067995|NCT03979872|10128587|FG001|NOT COMPLETED|Overall Study||8
9067996|NCT03979872|10128588|FG002|NOT COMPLETED|Overall Study||6
9067997|NCT03979872|10128589|FG003|NOT COMPLETED|Overall Study||4
9067998|NCT03978832|10128599|FG000|STARTED|Overall Study|69 participants signed the ICF and entered screening; 25 met eligibility criteria and were enrolled.|69
9067999|NCT03978832|10128599|FG000|Stabilization Period|Overall Study||25
9068000|NCT03978832|10128599|FG000|Treatment Period|Overall Study||23
9068001|NCT03978832|10128599|FG000|COMPLETED|Overall Study||15
9068002|NCT03978832|10128599|FG000|NOT COMPLETED|Overall Study||54
9068003|NCT04005391|10128605|FG000|STARTED|Overall Study|10/23/18|108
9068004|NCT04005391|10128606|FG001|STARTED|Overall Study|10/23/18|100
9068005|NCT04005391|10128605|FG000|COMPLETED|Overall Study||101
9068006|NCT04005391|10128606|FG001|COMPLETED|Overall Study||100
9068007|NCT04005391|10128605|FG000|NOT COMPLETED|Overall Study||7
9068008|NCT04005391|10128606|FG001|NOT COMPLETED|Overall Study||0
9068009|NCT04004481|10128616|FG000|STARTED|Overall Study||50
9068010|NCT04004481|10128616|FG000|COMPLETED|Overall Study||47
9068011|NCT04004481|10128616|FG000|NOT COMPLETED|Overall Study||3
9068012|NCT04004260|10128640|FG000|STARTED|Overall Study||79
9068013|NCT04004260|10128641|FG001|STARTED|Overall Study||79
9068014|NCT04004260|10128640|FG000|COMPLETED|Overall Study||37
9068015|NCT04004260|10128641|FG001|COMPLETED|Overall Study||47
9068016|NCT04004260|10128640|FG000|NOT COMPLETED|Overall Study||42
9068017|NCT04004260|10128641|FG001|NOT COMPLETED|Overall Study||32
9068018|NCT03997851|10128647|FG000|STARTED|Overall Study||17
9068019|NCT03997851|10128647|FG000|COMPLETED|Overall Study||17
9068020|NCT03997851|10128647|FG000|NOT COMPLETED|Overall Study||0
9068021|NCT03991715|10128657|FG000|STARTED|Overall Study||5
9068022|NCT03991715|10128657|FG000|COMPLETED|Overall Study||5
9068023|NCT03991715|10128657|FG000|NOT COMPLETED|Overall Study||0
9068024|NCT03990415|10128664|FG000|STARTED|Overall Study||19
9068025|NCT03990415|10128665|FG001|STARTED|Overall Study||19
9068026|NCT03990415|10128666|FG002|STARTED|Overall Study||14
9068027|NCT03990415|10128664|FG000|COMPLETED|Overall Study||15
9068028|NCT03990415|10128665|FG001|COMPLETED|Overall Study||17
9068029|NCT03990415|10128666|FG002|COMPLETED|Overall Study||14
9068030|NCT03990415|10128664|FG000|NOT COMPLETED|Overall Study||4
9068031|NCT03990415|10128665|FG001|NOT COMPLETED|Overall Study||2
9068032|NCT03990415|10128666|FG002|NOT COMPLETED|Overall Study||0
9068033|NCT04002960|10128674|FG000|STARTED|Overall Study||23
9068034|NCT04002960|10128674|FG000|COMPLETED|Overall Study||21
9068035|NCT04002960|10128674|FG000|NOT COMPLETED|Overall Study||2
9068036|NCT04002973|10128678|FG000|STARTED|Overall Study||11
9068037|NCT04002973|10128678|FG000|COMPLETED|Overall Study||11
9068038|NCT04002973|10128678|FG000|NOT COMPLETED|Overall Study||0
9068039|NCT04002648|10128684|FG000|STARTED|Overall Study||104
9068040|NCT04002648|10128685|FG001|STARTED|Overall Study||104
9068041|NCT04002648|10128684|FG000|COMPLETED|Overall Study||102
9068042|NCT04002648|10128685|FG001|COMPLETED|Overall Study||104
9068043|NCT04002648|10128684|FG000|NOT COMPLETED|Overall Study||2
9068044|NCT04002648|10128685|FG001|NOT COMPLETED|Overall Study||0
9068045|NCT03993210|10128693|FG000|STARTED|Overall Study||1
9068046|NCT03993210|10128694|FG001|STARTED|Overall Study||0
9068047|NCT03993210|10128693|FG000|COMPLETED|Overall Study||1
9068048|NCT03993210|10128694|FG001|COMPLETED|Overall Study||0
9068049|NCT03993210|10128693|FG000|NOT COMPLETED|Overall Study||0
9068050|NCT03993210|10128694|FG001|NOT COMPLETED|Overall Study||0
9068051|NCT03992014|10128704|FG000|STARTED|Treatment Period 1 (8 Days)||6
9068052|NCT03992014|10128704|FG000|COMPLETED|Treatment Period 1 (8 Days)||6
9068053|NCT03992014|10128704|FG000|NOT COMPLETED|Treatment Period 1 (8 Days)||0
9068054|NCT03992014|10128704|FG000|STARTED|Washout Period (7 Days)||6
9068055|NCT03992014|10128704|FG000|COMPLETED|Washout Period (7 Days)||6
9068056|NCT03992014|10128704|FG000|NOT COMPLETED|Washout Period (7 Days)||0
9068057|NCT03992014|10128704|FG000|STARTED|Treatment Period 2 (8 Days)||6
9068058|NCT03992014|10128704|FG000|COMPLETED|Treatment Period 2 (8 Days)||6
9068059|NCT03992014|10128704|FG000|NOT COMPLETED|Treatment Period 2 (8 Days)||0
9068060|NCT03990649|10128714|FG000|STARTED|Part A: DB Treatment Period (15 Weeks)||9
9068061|NCT03990649|10128715|FG001|STARTED|Part A: DB Treatment Period (15 Weeks)||15
9068062|NCT03990649|10128716|FG002|STARTED|Part A: DB Treatment Period (15 Weeks)||0
9068063|NCT03990649|10128714|FG000|COMPLETED|Part A: DB Treatment Period (15 Weeks)||6
9068064|NCT03990649|10128715|FG001|COMPLETED|Part A: DB Treatment Period (15 Weeks)||12
9068065|NCT03990649|10128716|FG002|COMPLETED|Part A: DB Treatment Period (15 Weeks)||0
9068066|NCT03990649|10128714|FG000|NOT COMPLETED|Part A: DB Treatment Period (15 Weeks)||3
9068067|NCT03990649|10128715|FG001|NOT COMPLETED|Part A: DB Treatment Period (15 Weeks)||3
9068068|NCT03990649|10128716|FG002|NOT COMPLETED|Part A: DB Treatment Period (15 Weeks)||0
9068069|NCT03990649|10128714|FG000|STARTED|Part B: OL Extension Period (14 Weeks)||0
9068070|NCT03990649|10128715|FG001|STARTED|Part B: OL Extension Period (14 Weeks)||0
9068071|NCT03990649|10128716|FG002|STARTED|Part B: OL Extension Period (14 Weeks)||18
9068072|NCT03990649|10128714|FG000|COMPLETED|Part B: OL Extension Period (14 Weeks)||0
9068073|NCT03990649|10128715|FG001|COMPLETED|Part B: OL Extension Period (14 Weeks)||0
9068074|NCT03990649|10128716|FG002|COMPLETED|Part B: OL Extension Period (14 Weeks)||14
9068075|NCT03990649|10128714|FG000|NOT COMPLETED|Part B: OL Extension Period (14 Weeks)||0
9068076|NCT03990649|10128715|FG001|NOT COMPLETED|Part B: OL Extension Period (14 Weeks)||0
9068077|NCT03990649|10128716|FG002|NOT COMPLETED|Part B: OL Extension Period (14 Weeks)||4
9068078|NCT04002791|10128725|FG000|STARTED|Overall Study||127
9068079|NCT04002791|10128726|FG001|STARTED|Overall Study||126
9068080|NCT04002791|10128725|FG000|COMPLETED|Overall Study||127
9068081|NCT04002791|10128726|FG001|COMPLETED|Overall Study||126
9068082|NCT04002791|10128725|FG000|NOT COMPLETED|Overall Study||0
9068083|NCT04002791|10128726|FG001|NOT COMPLETED|Overall Study||0
9068084|NCT04000581|10128734|FG000|STARTED|Overall Study||5
9068085|NCT04000581|10128735|FG001|STARTED|Overall Study||12
9068086|NCT04000581|10128734|FG000|COMPLETED|Overall Study||5
9068087|NCT04000581|10128735|FG001|COMPLETED|Overall Study||11
9068088|NCT04000581|10128734|FG000|NOT COMPLETED|Overall Study||0
9068089|NCT04000581|10128735|FG001|NOT COMPLETED|Overall Study||1
9068090|NCT03996694|10128741|FG000|STARTED|First Intervention (1 Day)||3
9068091|NCT03996694|10128742|FG001|STARTED|First Intervention (1 Day)||3
9068092|NCT03996694|10128743|FG002|STARTED|First Intervention (1 Day)||4
9068093|NCT03996694|10128744|FG003|STARTED|First Intervention (1 Day)||3
9068094|NCT03996694|10128745|FG004|STARTED|First Intervention (1 Day)||3
9068095|NCT03996694|10128746|FG005|STARTED|First Intervention (1 Day)||3
9068096|NCT03996694|10128741|FG000|COMPLETED|First Intervention (1 Day)||3
9068097|NCT03996694|10128742|FG001|COMPLETED|First Intervention (1 Day)||3
9068098|NCT03996694|10128743|FG002|COMPLETED|First Intervention (1 Day)||4
9068099|NCT03996694|10128744|FG003|COMPLETED|First Intervention (1 Day)||3
9068100|NCT03996694|10128745|FG004|COMPLETED|First Intervention (1 Day)||3
9068101|NCT03996694|10128746|FG005|COMPLETED|First Intervention (1 Day)||3
9068102|NCT03996694|10128741|FG000|NOT COMPLETED|First Intervention (1 Day)||0
9068103|NCT03996694|10128742|FG001|NOT COMPLETED|First Intervention (1 Day)||0
9068104|NCT03996694|10128743|FG002|NOT COMPLETED|First Intervention (1 Day)||0
9068105|NCT03996694|10128744|FG003|NOT COMPLETED|First Intervention (1 Day)||0
9068106|NCT03996694|10128745|FG004|NOT COMPLETED|First Intervention (1 Day)||0
9068107|NCT03996694|10128746|FG005|NOT COMPLETED|First Intervention (1 Day)||0
9068108|NCT03996694|10128741|FG000|STARTED|First Washout (7 Days)||3
9068109|NCT03996694|10128742|FG001|STARTED|First Washout (7 Days)||3
9068110|NCT03996694|10128743|FG002|STARTED|First Washout (7 Days)||4
9068111|NCT03996694|10128744|FG003|STARTED|First Washout (7 Days)||3
9068112|NCT03996694|10128745|FG004|STARTED|First Washout (7 Days)||3
9068113|NCT03996694|10128746|FG005|STARTED|First Washout (7 Days)||3
9068114|NCT03996694|10128741|FG000|COMPLETED|First Washout (7 Days)||3
9068115|NCT03996694|10128742|FG001|COMPLETED|First Washout (7 Days)||2
9068116|NCT03996694|10128743|FG002|COMPLETED|First Washout (7 Days)||2
9068117|NCT03996694|10128744|FG003|COMPLETED|First Washout (7 Days)||3
9068118|NCT03996694|10128745|FG004|COMPLETED|First Washout (7 Days)||3
9068119|NCT03996694|10128746|FG005|COMPLETED|First Washout (7 Days)||3
9068120|NCT03996694|10128741|FG000|NOT COMPLETED|First Washout (7 Days)||0
9068121|NCT03996694|10128742|FG001|NOT COMPLETED|First Washout (7 Days)||1
9068122|NCT03996694|10128743|FG002|NOT COMPLETED|First Washout (7 Days)||2
9068123|NCT03996694|10128744|FG003|NOT COMPLETED|First Washout (7 Days)||0
9068124|NCT03996694|10128745|FG004|NOT COMPLETED|First Washout (7 Days)||0
9068125|NCT03996694|10128746|FG005|NOT COMPLETED|First Washout (7 Days)||0
9068126|NCT03996694|10128741|FG000|STARTED|Second Intervention (1 Day)||3
9068127|NCT03996694|10128742|FG001|STARTED|Second Intervention (1 Day)||2
9068128|NCT03996694|10128743|FG002|STARTED|Second Intervention (1 Day)||2
9068129|NCT03996694|10128744|FG003|STARTED|Second Intervention (1 Day)||3
9068130|NCT03996694|10128745|FG004|STARTED|Second Intervention (1 Day)||3
9068131|NCT03996694|10128746|FG005|STARTED|Second Intervention (1 Day)||3
9068132|NCT03996694|10128741|FG000|COMPLETED|Second Intervention (1 Day)||3
9068133|NCT03996694|10128742|FG001|COMPLETED|Second Intervention (1 Day)||2
9068134|NCT03996694|10128743|FG002|COMPLETED|Second Intervention (1 Day)||2
9068135|NCT03996694|10128744|FG003|COMPLETED|Second Intervention (1 Day)||3
9068136|NCT03996694|10128745|FG004|COMPLETED|Second Intervention (1 Day)||3
9068137|NCT03996694|10128746|FG005|COMPLETED|Second Intervention (1 Day)||3
9068138|NCT03996694|10128741|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
9068139|NCT03996694|10128742|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
9068140|NCT03996694|10128743|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
9068141|NCT03996694|10128744|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
9068142|NCT03996694|10128745|FG004|NOT COMPLETED|Second Intervention (1 Day)||0
9068143|NCT03996694|10128746|FG005|NOT COMPLETED|Second Intervention (1 Day)||0
9068144|NCT03996694|10128741|FG000|STARTED|Second Washout (7 Days)||3
9068145|NCT03996694|10128742|FG001|STARTED|Second Washout (7 Days)||2
9068146|NCT03996694|10128743|FG002|STARTED|Second Washout (7 Days)||2
9068147|NCT03996694|10128744|FG003|STARTED|Second Washout (7 Days)||3
9068148|NCT03996694|10128745|FG004|STARTED|Second Washout (7 Days)||3
9068149|NCT03996694|10128746|FG005|STARTED|Second Washout (7 Days)||3
9068150|NCT03996694|10128741|FG000|COMPLETED|Second Washout (7 Days)||3
9068151|NCT03996694|10128742|FG001|COMPLETED|Second Washout (7 Days)||2
9068152|NCT03996694|10128743|FG002|COMPLETED|Second Washout (7 Days)||2
9068153|NCT03996694|10128744|FG003|COMPLETED|Second Washout (7 Days)||3
9068154|NCT03996694|10128745|FG004|COMPLETED|Second Washout (7 Days)||3
9068155|NCT03996694|10128746|FG005|COMPLETED|Second Washout (7 Days)||3
9068156|NCT03996694|10128741|FG000|NOT COMPLETED|Second Washout (7 Days)||0
9068157|NCT03996694|10128742|FG001|NOT COMPLETED|Second Washout (7 Days)||0
9068158|NCT03996694|10128743|FG002|NOT COMPLETED|Second Washout (7 Days)||0
9068159|NCT03996694|10128744|FG003|NOT COMPLETED|Second Washout (7 Days)||0
9068160|NCT03996694|10128745|FG004|NOT COMPLETED|Second Washout (7 Days)||0
9068161|NCT03996694|10128746|FG005|NOT COMPLETED|Second Washout (7 Days)||0
9068162|NCT03996694|10128741|FG000|STARTED|Third Intervention (1 Day)||3
9068163|NCT03996694|10128742|FG001|STARTED|Third Intervention (1 Day)||2
9068164|NCT03996694|10128743|FG002|STARTED|Third Intervention (1 Day)||2
9068165|NCT03996694|10128744|FG003|STARTED|Third Intervention (1 Day)||3
9068166|NCT03996694|10128745|FG004|STARTED|Third Intervention (1 Day)||3
9068167|NCT03996694|10128746|FG005|STARTED|Third Intervention (1 Day)||3
9068168|NCT03996694|10128741|FG000|COMPLETED|Third Intervention (1 Day)||3
9068169|NCT03996694|10128742|FG001|COMPLETED|Third Intervention (1 Day)||2
9068170|NCT03996694|10128743|FG002|COMPLETED|Third Intervention (1 Day)||2
9068171|NCT03996694|10128744|FG003|COMPLETED|Third Intervention (1 Day)||3
9068172|NCT03996694|10128745|FG004|COMPLETED|Third Intervention (1 Day)||3
9068173|NCT03996694|10128746|FG005|COMPLETED|Third Intervention (1 Day)||3
9068174|NCT03996694|10128741|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
9068175|NCT03996694|10128742|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
9068176|NCT03996694|10128743|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
9068177|NCT03996694|10128744|FG003|NOT COMPLETED|Third Intervention (1 Day)||0
9068178|NCT03996694|10128745|FG004|NOT COMPLETED|Third Intervention (1 Day)||0
9068179|NCT03996694|10128746|FG005|NOT COMPLETED|Third Intervention (1 Day)||0
9068180|NCT03996694|10128741|FG000|STARTED|Third Washout (7 Days)||3
9068181|NCT03996694|10128742|FG001|STARTED|Third Washout (7 Days)||2
9068182|NCT03996694|10128743|FG002|STARTED|Third Washout (7 Days)||2
9068183|NCT03996694|10128744|FG003|STARTED|Third Washout (7 Days)||3
9068184|NCT03996694|10128745|FG004|STARTED|Third Washout (7 Days)||3
9068185|NCT03996694|10128746|FG005|STARTED|Third Washout (7 Days)||3
9068186|NCT03996694|10128741|FG000|COMPLETED|Third Washout (7 Days)||3
9068187|NCT03996694|10128742|FG001|COMPLETED|Third Washout (7 Days)||2
9068188|NCT03996694|10128743|FG002|COMPLETED|Third Washout (7 Days)||2
9068189|NCT03996694|10128744|FG003|COMPLETED|Third Washout (7 Days)||3
9068190|NCT03996694|10128745|FG004|COMPLETED|Third Washout (7 Days)||2
9068191|NCT03996694|10128746|FG005|COMPLETED|Third Washout (7 Days)||3
9068192|NCT03996694|10128741|FG000|NOT COMPLETED|Third Washout (7 Days)||0
9068193|NCT03996694|10128742|FG001|NOT COMPLETED|Third Washout (7 Days)||0
9068194|NCT03996694|10128743|FG002|NOT COMPLETED|Third Washout (7 Days)||0
9068195|NCT03996694|10128744|FG003|NOT COMPLETED|Third Washout (7 Days)||0
9068196|NCT03996694|10128745|FG004|NOT COMPLETED|Third Washout (7 Days)||1
9068197|NCT03996694|10128746|FG005|NOT COMPLETED|Third Washout (7 Days)||0
9068198|NCT03996694|10128741|FG000|STARTED|Fourth Intervention (1 Day)||3
9068199|NCT03996694|10128742|FG001|STARTED|Fourth Intervention (1 Day)||2
9068200|NCT03996694|10128743|FG002|STARTED|Fourth Intervention (1 Day)||2
9068201|NCT03996694|10128744|FG003|STARTED|Fourth Intervention (1 Day)||3
9068202|NCT03996694|10128745|FG004|STARTED|Fourth Intervention (1 Day)||2
9068203|NCT03996694|10128746|FG005|STARTED|Fourth Intervention (1 Day)||3
9068204|NCT03996694|10128741|FG000|COMPLETED|Fourth Intervention (1 Day)||3
9068205|NCT03996694|10128742|FG001|COMPLETED|Fourth Intervention (1 Day)||2
9068206|NCT03996694|10128743|FG002|COMPLETED|Fourth Intervention (1 Day)||2
9068207|NCT03996694|10128744|FG003|COMPLETED|Fourth Intervention (1 Day)||3
9068208|NCT03996694|10128745|FG004|COMPLETED|Fourth Intervention (1 Day)||2
9068209|NCT03996694|10128746|FG005|COMPLETED|Fourth Intervention (1 Day)||3
9068210|NCT03996694|10128741|FG000|NOT COMPLETED|Fourth Intervention (1 Day)||0
9068211|NCT03996694|10128742|FG001|NOT COMPLETED|Fourth Intervention (1 Day)||0
9068212|NCT03996694|10128743|FG002|NOT COMPLETED|Fourth Intervention (1 Day)||0
9068213|NCT03996694|10128744|FG003|NOT COMPLETED|Fourth Intervention (1 Day)||0
9068214|NCT03996694|10128745|FG004|NOT COMPLETED|Fourth Intervention (1 Day)||0
9068215|NCT03996694|10128746|FG005|NOT COMPLETED|Fourth Intervention (1 Day)||0
9068216|NCT03996694|10128741|FG000|STARTED|Fourth Washout (7 Days)||3
9068217|NCT03996694|10128742|FG001|STARTED|Fourth Washout (7 Days)||2
9068218|NCT03996694|10128743|FG002|STARTED|Fourth Washout (7 Days)||2
9068219|NCT03996694|10128744|FG003|STARTED|Fourth Washout (7 Days)||3
9068220|NCT03996694|10128745|FG004|STARTED|Fourth Washout (7 Days)||2
9068221|NCT03996694|10128746|FG005|STARTED|Fourth Washout (7 Days)||3
9068222|NCT03996694|10128741|FG000|COMPLETED|Fourth Washout (7 Days)||3
9068223|NCT03996694|10128742|FG001|COMPLETED|Fourth Washout (7 Days)||2
9068224|NCT03996694|10128743|FG002|COMPLETED|Fourth Washout (7 Days)||2
9068225|NCT03996694|10128744|FG003|COMPLETED|Fourth Washout (7 Days)||3
9068226|NCT03996694|10128745|FG004|COMPLETED|Fourth Washout (7 Days)||2
9068227|NCT03996694|10128746|FG005|COMPLETED|Fourth Washout (7 Days)||3
9068228|NCT03996694|10128741|FG000|NOT COMPLETED|Fourth Washout (7 Days)||0
9068229|NCT03996694|10128742|FG001|NOT COMPLETED|Fourth Washout (7 Days)||0
9068230|NCT03996694|10128743|FG002|NOT COMPLETED|Fourth Washout (7 Days)||0
9068231|NCT03996694|10128744|FG003|NOT COMPLETED|Fourth Washout (7 Days)||0
9068232|NCT03996694|10128745|FG004|NOT COMPLETED|Fourth Washout (7 Days)||0
9068233|NCT03996694|10128746|FG005|NOT COMPLETED|Fourth Washout (7 Days)||0
9068234|NCT03996694|10128741|FG000|STARTED|Fifth Intervention (1 Day)||3
9068235|NCT03996694|10128742|FG001|STARTED|Fifth Intervention (1 Day)||2
9068236|NCT03996694|10128743|FG002|STARTED|Fifth Intervention (1 Day)||2
9068237|NCT03996694|10128744|FG003|STARTED|Fifth Intervention (1 Day)||3
9068238|NCT03996694|10128745|FG004|STARTED|Fifth Intervention (1 Day)||2
9068239|NCT03996694|10128746|FG005|STARTED|Fifth Intervention (1 Day)||3
9068240|NCT03996694|10128741|FG000|COMPLETED|Fifth Intervention (1 Day)||3
9068241|NCT03996694|10128742|FG001|COMPLETED|Fifth Intervention (1 Day)||2
9068242|NCT03996694|10128743|FG002|COMPLETED|Fifth Intervention (1 Day)||2
9068243|NCT03996694|10128744|FG003|COMPLETED|Fifth Intervention (1 Day)||3
9068244|NCT03996694|10128745|FG004|COMPLETED|Fifth Intervention (1 Day)||2
9068245|NCT03996694|10128746|FG005|COMPLETED|Fifth Intervention (1 Day)||3
9068246|NCT03996694|10128741|FG000|NOT COMPLETED|Fifth Intervention (1 Day)||0
9068247|NCT03996694|10128742|FG001|NOT COMPLETED|Fifth Intervention (1 Day)||0
9068248|NCT03996694|10128743|FG002|NOT COMPLETED|Fifth Intervention (1 Day)||0
9068249|NCT03996694|10128744|FG003|NOT COMPLETED|Fifth Intervention (1 Day)||0
9068250|NCT03996694|10128745|FG004|NOT COMPLETED|Fifth Intervention (1 Day)||0
9068251|NCT03996694|10128746|FG005|NOT COMPLETED|Fifth Intervention (1 Day)||0
9068252|NCT03996694|10128741|FG000|STARTED|Fifth Washout (7 Days)||3
9068253|NCT03996694|10128742|FG001|STARTED|Fifth Washout (7 Days)||2
9068254|NCT03996694|10128743|FG002|STARTED|Fifth Washout (7 Days)||2
9068255|NCT03996694|10128744|FG003|STARTED|Fifth Washout (7 Days)||3
9068256|NCT03996694|10128745|FG004|STARTED|Fifth Washout (7 Days)||2
9068257|NCT03996694|10128746|FG005|STARTED|Fifth Washout (7 Days)||3
9068258|NCT03996694|10128741|FG000|COMPLETED|Fifth Washout (7 Days)||3
9068259|NCT03996694|10128742|FG001|COMPLETED|Fifth Washout (7 Days)||2
9068260|NCT03996694|10128743|FG002|COMPLETED|Fifth Washout (7 Days)||2
9068261|NCT03996694|10128744|FG003|COMPLETED|Fifth Washout (7 Days)||3
9068262|NCT03996694|10128745|FG004|COMPLETED|Fifth Washout (7 Days)||2
9068263|NCT03996694|10128746|FG005|COMPLETED|Fifth Washout (7 Days)||3
9068264|NCT03996694|10128741|FG000|NOT COMPLETED|Fifth Washout (7 Days)||0
9068265|NCT03996694|10128742|FG001|NOT COMPLETED|Fifth Washout (7 Days)||0
9068266|NCT03996694|10128743|FG002|NOT COMPLETED|Fifth Washout (7 Days)||0
9068267|NCT03996694|10128744|FG003|NOT COMPLETED|Fifth Washout (7 Days)||0
9068268|NCT03996694|10128745|FG004|NOT COMPLETED|Fifth Washout (7 Days)||0
9068269|NCT03996694|10128746|FG005|NOT COMPLETED|Fifth Washout (7 Days)||0
9068270|NCT03996694|10128741|FG000|STARTED|Sixth Intervention (1 Day)||3
9068271|NCT03996694|10128742|FG001|STARTED|Sixth Intervention (1 Day)||2
9068272|NCT03996694|10128743|FG002|STARTED|Sixth Intervention (1 Day)||2
9068273|NCT03996694|10128744|FG003|STARTED|Sixth Intervention (1 Day)||3
9068274|NCT03996694|10128745|FG004|STARTED|Sixth Intervention (1 Day)||2
9068275|NCT03996694|10128746|FG005|STARTED|Sixth Intervention (1 Day)||3
9068276|NCT03996694|10128741|FG000|COMPLETED|Sixth Intervention (1 Day)||3
9068277|NCT03996694|10128742|FG001|COMPLETED|Sixth Intervention (1 Day)||2
9068278|NCT03996694|10128743|FG002|COMPLETED|Sixth Intervention (1 Day)||2
9068279|NCT03996694|10128744|FG003|COMPLETED|Sixth Intervention (1 Day)||3
9068280|NCT03996694|10128745|FG004|COMPLETED|Sixth Intervention (1 Day)||2
9068281|NCT03996694|10128746|FG005|COMPLETED|Sixth Intervention (1 Day)||3
9068282|NCT03996694|10128741|FG000|NOT COMPLETED|Sixth Intervention (1 Day)||0
9068283|NCT03996694|10128742|FG001|NOT COMPLETED|Sixth Intervention (1 Day)||0
9068284|NCT03996694|10128743|FG002|NOT COMPLETED|Sixth Intervention (1 Day)||0
9068285|NCT03996694|10128744|FG003|NOT COMPLETED|Sixth Intervention (1 Day)||0
9068286|NCT03996694|10128745|FG004|NOT COMPLETED|Sixth Intervention (1 Day)||0
9068287|NCT03996694|10128746|FG005|NOT COMPLETED|Sixth Intervention (1 Day)||0
9068288|NCT03988907|10128762|FG000|STARTED|Overall Study||8
9068289|NCT03988907|10128763|FG001|STARTED|Overall Study||27
9068290|NCT03988907|10128762|FG000|COMPLETED|Overall Study||8
9068291|NCT03988907|10128763|FG001|COMPLETED|Overall Study||26
9068292|NCT03988907|10128762|FG000|NOT COMPLETED|Overall Study||0
9068293|NCT03988907|10128763|FG001|NOT COMPLETED|Overall Study||1
9068294|NCT03988088|10128777|FG000|STARTED|Single-Dose Pharmacokinetic Study||11
9068295|NCT03988088|10128778|FG001|STARTED|Single-Dose Pharmacokinetic Study||7
9068296|NCT03988088|10128779|FG002|STARTED|Single-Dose Pharmacokinetic Study||0
9068297|NCT03988088|10128780|FG003|STARTED|Single-Dose Pharmacokinetic Study||0
9068298|NCT03988088|10128777|FG000|COMPLETED|Single-Dose Pharmacokinetic Study||11
9068299|NCT03988088|10128778|FG001|COMPLETED|Single-Dose Pharmacokinetic Study||6
9068300|NCT03988088|10128779|FG002|COMPLETED|Single-Dose Pharmacokinetic Study||0
9068301|NCT03988088|10128780|FG003|COMPLETED|Single-Dose Pharmacokinetic Study||0
9068302|NCT03988088|10128777|FG000|NOT COMPLETED|Single-Dose Pharmacokinetic Study||0
9068303|NCT03988088|10128778|FG001|NOT COMPLETED|Single-Dose Pharmacokinetic Study||1
9068304|NCT03988088|10128779|FG002|NOT COMPLETED|Single-Dose Pharmacokinetic Study||0
9068305|NCT03988088|10128780|FG003|NOT COMPLETED|Single-Dose Pharmacokinetic Study||0
9068306|NCT03988088|10128777|FG000|STARTED|Open-Label Addendum||0
9068307|NCT03988088|10128778|FG001|STARTED|Open-Label Addendum||0
9068308|NCT03988088|10128779|FG002|STARTED|Open-Label Addendum|The US participants had the option to enter this optional 3-month open-label extension addendum.|2
9068309|NCT03988088|10128780|FG003|STARTED|Open-Label Addendum|The US participants had the option to enter this optional 3-month open-label extension addendum.|2
9068310|NCT03988088|10128777|FG000|COMPLETED|Open-Label Addendum||0
9068311|NCT03988088|10128778|FG001|COMPLETED|Open-Label Addendum||0
9068312|NCT03988088|10128779|FG002|COMPLETED|Open-Label Addendum||1
9068313|NCT03988088|10128780|FG003|COMPLETED|Open-Label Addendum||2
9068314|NCT03988088|10128777|FG000|NOT COMPLETED|Open-Label Addendum||0
9068315|NCT03988088|10128778|FG001|NOT COMPLETED|Open-Label Addendum||0
9068316|NCT03988088|10128779|FG002|NOT COMPLETED|Open-Label Addendum||1
9068317|NCT03988088|10128780|FG003|NOT COMPLETED|Open-Label Addendum||0
9068318|NCT03980522|10128793|FG000|STARTED|Treatment Period||13
9068319|NCT03980522|10128794|FG001|STARTED|Treatment Period||3
9068320|NCT03980522|10128795|FG002|STARTED|Treatment Period||6
9068321|NCT03980522|10128796|FG003|STARTED|Treatment Period||1
9068322|NCT03980522|10128797|FG004|STARTED|Treatment Period||3
8623805|NCT00495469|9662974|FG005|NOT COMPLETED|Overall Study||5
8623806|NCT00495469|9662975|FG006|NOT COMPLETED|Overall Study||5
8623807|NCT00495495|9662998|FG000|STARTED|Overall Study||394
9068323|NCT03980522|10128793|FG000|COMPLETED|Treatment Period||12
9068324|NCT03980522|10128794|FG001|COMPLETED|Treatment Period||3
9068325|NCT03980522|10128795|FG002|COMPLETED|Treatment Period||6
9068326|NCT03980522|10128796|FG003|COMPLETED|Treatment Period||1
9068327|NCT03980522|10128797|FG004|COMPLETED|Treatment Period||3
9068328|NCT03980522|10128793|FG000|NOT COMPLETED|Treatment Period||1
9068329|NCT03980522|10128794|FG001|NOT COMPLETED|Treatment Period||0
9068330|NCT03980522|10128795|FG002|NOT COMPLETED|Treatment Period||0
9068331|NCT03980522|10128796|FG003|NOT COMPLETED|Treatment Period||0
9068332|NCT03980522|10128797|FG004|NOT COMPLETED|Treatment Period||0
9068333|NCT03980522|10128793|FG000|STARTED|Extension Period||12
9068334|NCT03980522|10128794|FG001|STARTED|Extension Period||3
8623808|NCT00495495|9662998|FG000|COMPLETED|Overall Study||295
8623809|NCT00495495|9662998|FG000|NOT COMPLETED|Overall Study||99
9068335|NCT03980522|10128795|FG002|STARTED|Extension Period|1 participant did not sign the optional Extension Period consent form.|5
9068336|NCT03980522|10128796|FG003|STARTED|Extension Period||1
9068337|NCT03980522|10128797|FG004|STARTED|Extension Period||3
9068338|NCT03980522|10128793|FG000|COMPLETED|Extension Period||12
9068339|NCT03980522|10128794|FG001|COMPLETED|Extension Period||3
9068340|NCT03980522|10128795|FG002|COMPLETED|Extension Period||5
9068341|NCT03980522|10128796|FG003|COMPLETED|Extension Period||1
9068342|NCT03980522|10128797|FG004|COMPLETED|Extension Period||3
8623810|NCT00495521|9663005|FG000|STARTED|Overall Study||1
9068343|NCT03980522|10128793|FG000|NOT COMPLETED|Extension Period||0
9068344|NCT03980522|10128794|FG001|NOT COMPLETED|Extension Period||0
9068345|NCT03980522|10128795|FG002|NOT COMPLETED|Extension Period||0
9068346|NCT03980522|10128796|FG003|NOT COMPLETED|Extension Period||0
9068347|NCT03980522|10128797|FG004|NOT COMPLETED|Extension Period||0
9068348|NCT03999684|10128809|FG000|STARTED|Overall Study||18
9068349|NCT03999684|10128809|FG000|COMPLETED|Overall Study||18
9068350|NCT03999684|10128809|FG000|NOT COMPLETED|Overall Study||0
9068351|NCT03995784|10128813|FG000|STARTED|Overall Study||6
9068352|NCT03995784|10128813|FG000|COMPLETED|Overall Study||5
9068353|NCT03995784|10128813|FG000|NOT COMPLETED|Overall Study||1
9068354|NCT03993392|10128824|FG000|STARTED|Overall Study||26
9068355|NCT03993392|10128824|FG000|Treated With SUBLOCADE|Overall Study||24
9068356|NCT03993392|10128824|FG000|COMPLETED|Overall Study||20
9068357|NCT03993392|10128824|FG000|NOT COMPLETED|Overall Study||6
9068358|NCT03989427|10128831|FG000|STARTED|First Intervention (2 Weeks)||15
9068359|NCT03989427|10128832|FG001|STARTED|First Intervention (2 Weeks)||15
9068360|NCT03989427|10128831|FG000|COMPLETED|First Intervention (2 Weeks)||15
9068361|NCT03989427|10128832|FG001|COMPLETED|First Intervention (2 Weeks)||15
9068362|NCT03989427|10128831|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0
9068363|NCT03989427|10128832|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0
9068364|NCT03989427|10128831|FG000|STARTED|Washout (1 Week)||15
9068365|NCT03989427|10128832|FG001|STARTED|Washout (1 Week)||15
9068366|NCT03989427|10128831|FG000|COMPLETED|Washout (1 Week)||15
9068367|NCT03989427|10128832|FG001|COMPLETED|Washout (1 Week)||15
9068368|NCT03989427|10128831|FG000|NOT COMPLETED|Washout (1 Week)||0
9068369|NCT03989427|10128832|FG001|NOT COMPLETED|Washout (1 Week)||0
9068370|NCT03989427|10128831|FG000|STARTED|Second Intervention (2 Weeks)||15
9068371|NCT03989427|10128832|FG001|STARTED|Second Intervention (2 Weeks)||15
9068372|NCT03989427|10128831|FG000|COMPLETED|Second Intervention (2 Weeks)||15
9068373|NCT03989427|10128832|FG001|COMPLETED|Second Intervention (2 Weeks)||15
9068374|NCT03989427|10128831|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0
9068375|NCT03989427|10128832|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0
9068376|NCT03981822|10128847|FG000|STARTED|Overall Study||5
9068377|NCT03981822|10128848|FG001|STARTED|Overall Study||5
9068378|NCT03981822|10128849|FG002|STARTED|Overall Study||5
9068379|NCT03981822|10128850|FG003|STARTED|Overall Study||3
9068380|NCT03981822|10128851|FG004|STARTED|Overall Study||25
9068381|NCT03981822|10128852|FG005|STARTED|Overall Study||23
9068382|NCT03981822|10128853|FG006|STARTED|Overall Study||22
9068383|NCT03981822|10128854|FG007|STARTED|Overall Study||17
9068384|NCT03981822|10128847|FG000|COMPLETED|Overall Study||5
9068385|NCT03981822|10128848|FG001|COMPLETED|Overall Study||3
9068386|NCT03981822|10128849|FG002|COMPLETED|Overall Study||4
9068387|NCT03981822|10128850|FG003|COMPLETED|Overall Study||3
9068388|NCT03981822|10128851|FG004|COMPLETED|Overall Study||17
9068389|NCT03981822|10128852|FG005|COMPLETED|Overall Study||17
9068390|NCT03981822|10128853|FG006|COMPLETED|Overall Study||16
9068391|NCT03981822|10128854|FG007|COMPLETED|Overall Study||12
9068392|NCT03981822|10128847|FG000|NOT COMPLETED|Overall Study||0
9068393|NCT03981822|10128848|FG001|NOT COMPLETED|Overall Study||2
9068394|NCT03981822|10128849|FG002|NOT COMPLETED|Overall Study||1
9068395|NCT03981822|10128850|FG003|NOT COMPLETED|Overall Study||0
9068396|NCT03981822|10128851|FG004|NOT COMPLETED|Overall Study||8
9068397|NCT03981822|10128852|FG005|NOT COMPLETED|Overall Study||6
9068398|NCT03981822|10128853|FG006|NOT COMPLETED|Overall Study||6
9068399|NCT03981822|10128854|FG007|NOT COMPLETED|Overall Study||5
9068400|NCT03992482|10128868|FG000|STARTED|Overall Study||13
9068401|NCT03992482|10128869|FG001|STARTED|Overall Study||14
9068402|NCT03992482|10128868|FG000|COMPLETED|Overall Study||13
9068403|NCT03992482|10128869|FG001|COMPLETED|Overall Study||14
9068404|NCT03992482|10128868|FG000|NOT COMPLETED|Overall Study||0
9068405|NCT03992482|10128869|FG001|NOT COMPLETED|Overall Study||0
9068406|NCT03993119|10128879|FG000|STARTED|Overall Study||192
9068407|NCT03993119|10128880|FG001|STARTED|Overall Study||76
9068408|NCT03993119|10128881|FG002|STARTED|Overall Study||166
9068409|NCT03993119|10128882|FG003|STARTED|Overall Study||66
9068410|NCT03993119|10128879|FG000|COMPLETED|Overall Study||192
9068411|NCT03993119|10128880|FG001|COMPLETED|Overall Study||76
9068412|NCT03993119|10128881|FG002|COMPLETED|Overall Study||166
9068413|NCT03993119|10128882|FG003|COMPLETED|Overall Study||66
9068414|NCT03993119|10128879|FG000|NOT COMPLETED|Overall Study||0
9068415|NCT03993119|10128880|FG001|NOT COMPLETED|Overall Study||0
9068416|NCT03993119|10128881|FG002|NOT COMPLETED|Overall Study||0
9068417|NCT03993119|10128882|FG003|NOT COMPLETED|Overall Study||0
9068418|NCT03991494|10128907|FG000|STARTED|Overall Study||4
9068419|NCT03991494|10128907|FG000|COMPLETED|Overall Study||0
9068420|NCT03991494|10128907|FG000|NOT COMPLETED|Overall Study||4
9068421|NCT03989570|10128916|FG000|STARTED|Overall Study||31
9068422|NCT03989570|10128917|FG001|STARTED|Overall Study||31
9068423|NCT03989570|10128918|FG002|STARTED|Overall Study||31
9068424|NCT03989570|10128916|FG000|COMPLETED|Overall Study||31
9068425|NCT03989570|10128917|FG001|COMPLETED|Overall Study||31
9068426|NCT03989570|10128918|FG002|COMPLETED|Overall Study||31
9068427|NCT03989570|10128916|FG000|NOT COMPLETED|Overall Study||0
9068428|NCT03989570|10128917|FG001|NOT COMPLETED|Overall Study||0
9068429|NCT03989570|10128918|FG002|NOT COMPLETED|Overall Study||0
9068430|NCT03988803|10128926|FG000|STARTED|Screening||16
9068431|NCT03988803|10128926|FG000|COMPLETED|Screening||16
9068432|NCT03988803|10128926|FG000|NOT COMPLETED|Screening||0
9068433|NCT03988803|10128926|FG000|STARTED|Period 1||16
9068434|NCT03988803|10128926|FG000|COMPLETED|Period 1||16
9068435|NCT03988803|10128926|FG000|NOT COMPLETED|Period 1||0
9068436|NCT03988803|10128926|FG000|STARTED|Period 2||16
9068437|NCT03988803|10128926|FG000|Treated|Period 2||15
9068438|NCT03988803|10128926|FG000|Started Days 1 - 7: Multiple Doses of 5 mg Memantine qd|Period 2||15
9068439|NCT03988803|10128926|FG000|Started Days 8 - 14: Multiple Doses of 10 mg Memantine qd|Period 2||14
9068440|NCT03988803|10128926|FG000|Started Days 15 - 21: Multiple Doses of 15 mg Memantine qd|Period 2||13
9068441|NCT03988803|10128926|FG000|Started Days 22 - 35: Multiple Doses of 20 mg Memantine qd|Period 2||13
9068442|NCT03988803|10128926|FG000|COMPLETED|Period 2||13
9068443|NCT03988803|10128926|FG000|NOT COMPLETED|Period 2||3
9068444|NCT03988803|10128926|FG000|STARTED|Period 3||13
9068445|NCT03988803|10128926|FG000|COMPLETED|Period 3||13
9068446|NCT03988803|10128926|FG000|NOT COMPLETED|Period 3||0
9068447|NCT03987932|10128937|FG000|STARTED|Overall Study||4
9068448|NCT03987932|10128938|FG001|STARTED|Overall Study||3
9068449|NCT03987932|10128939|FG002|STARTED|Overall Study||4
9068450|NCT03987932|10128937|FG000|1 Month|Overall Study||4
9068451|NCT03987932|10128938|FG001|1 Month|Overall Study||2
9068452|NCT03987932|10128939|FG002|1 Month|Overall Study||3
9068453|NCT03987932|10128937|FG000|3 Months|Overall Study||4
9068454|NCT03987932|10128938|FG001|3 Months|Overall Study||2
9068455|NCT03987932|10128939|FG002|3 Months|Overall Study||3
9068456|NCT03987932|10128937|FG000|6 Months|Overall Study||2
9068457|NCT03987932|10128938|FG001|6 Months|Overall Study||2
9068458|NCT03987932|10128939|FG002|6 Months|Overall Study||2
9068459|NCT03987932|10128937|FG000|COMPLETED|Overall Study||2
9068460|NCT03987932|10128938|FG001|COMPLETED|Overall Study||2
9068461|NCT03987932|10128939|FG002|COMPLETED|Overall Study||2
9068462|NCT03987932|10128937|FG000|NOT COMPLETED|Overall Study||2
9068463|NCT03987932|10128938|FG001|NOT COMPLETED|Overall Study||1
9068464|NCT03987932|10128939|FG002|NOT COMPLETED|Overall Study||2
9068465|NCT03987191|10128949|FG000|STARTED|Overall Study||17
9068466|NCT03987191|10128950|FG001|STARTED|Overall Study||15
9068467|NCT03987191|10128949|FG000|Data Collected|Overall Study||17
9068468|NCT03987191|10128950|FG001|Data Collected|Overall Study||13
9068469|NCT03987191|10128949|FG000|COMPLETED|Overall Study||17
9068470|NCT03987191|10128950|FG001|COMPLETED|Overall Study||13
9068471|NCT03987191|10128949|FG000|NOT COMPLETED|Overall Study||0
9068472|NCT03987191|10128950|FG001|NOT COMPLETED|Overall Study||2
9068473|NCT03988842|10128956|FG000|STARTED|Overall Study||4
9068474|NCT03988842|10128956|FG000|COMPLETED|Overall Study||3
9068475|NCT03988842|10128956|FG000|NOT COMPLETED|Overall Study||1
9068476|NCT03981861|10128961|FG000|STARTED|Overall Study||12
9068477|NCT03981861|10128961|FG000|COMPLETED|Overall Study||9
9068478|NCT03981861|10128961|FG000|NOT COMPLETED|Overall Study||3
9068479|NCT03974334|10128965|FG000|STARTED|Overall Study||25
9068480|NCT03974334|10128965|FG000|COMPLETED|Overall Study||24
9068481|NCT03974334|10128965|FG000|NOT COMPLETED|Overall Study||1
9068482|NCT03988426|10128969|FG000|STARTED|Overall Study||25
9068483|NCT03988426|10128969|FG000|COMPLETED|Overall Study||24
9068484|NCT03988426|10128969|FG000|NOT COMPLETED|Overall Study||1
9068485|NCT03988374|10128978|FG000|STARTED|Overall Study||104
9068486|NCT03988374|10128979|FG001|STARTED|Overall Study||107
9068487|NCT03988374|10128980|FG002|STARTED|Overall Study||108
9068488|NCT03988374|10128978|FG000|COMPLETED|Overall Study||103
9068489|NCT03988374|10128979|FG001|COMPLETED|Overall Study||105
9068490|NCT03988374|10128980|FG002|COMPLETED|Overall Study||107
9068491|NCT03988374|10128978|FG000|NOT COMPLETED|Overall Study||1
9068492|NCT03988374|10128979|FG001|NOT COMPLETED|Overall Study||2
9068493|NCT03988374|10128980|FG002|NOT COMPLETED|Overall Study||1
9068494|NCT03987074|10128993|FG000|STARTED|Overall Study||21
9068495|NCT03987074|10128994|FG001|STARTED|Overall Study||22
9068496|NCT03987074|10128995|FG002|STARTED|Overall Study||22
9068497|NCT03987074|10128996|FG003|STARTED|Overall Study||22
9068498|NCT03987074|10128997|FG004|STARTED|Overall Study||21
9068499|NCT03987074|10128993|FG000|COMPLETED|Overall Study||18
9068500|NCT03987074|10128994|FG001|COMPLETED|Overall Study||20
9068501|NCT03987074|10128995|FG002|COMPLETED|Overall Study||21
9068502|NCT03987074|10128996|FG003|COMPLETED|Overall Study||18
9068503|NCT03987074|10128997|FG004|COMPLETED|Overall Study||19
9068504|NCT03987074|10128993|FG000|NOT COMPLETED|Overall Study||3
9068505|NCT03987074|10128994|FG001|NOT COMPLETED|Overall Study||2
9068506|NCT03987074|10128995|FG002|NOT COMPLETED|Overall Study||1
9068507|NCT03987074|10128996|FG003|NOT COMPLETED|Overall Study||4
9068508|NCT03987074|10128997|FG004|NOT COMPLETED|Overall Study||2
9068509|NCT03977935|10129011|FG000|STARTED|Overall Study||40
9068510|NCT03977935|10129012|FG001|STARTED|Overall Study||40
9068511|NCT03977935|10129011|FG000|COMPLETED|Overall Study||40
9068512|NCT03977935|10129012|FG001|COMPLETED|Overall Study||40
9068513|NCT03977935|10129011|FG000|NOT COMPLETED|Overall Study||0
9068514|NCT03977935|10129012|FG001|NOT COMPLETED|Overall Study||0
9068515|NCT03988049|10129020|FG000|STARTED|Overall Study||22
9068516|NCT03988049|10129021|FG001|STARTED|Overall Study||22
9068517|NCT03988049|10129020|FG000|COMPLETED|Overall Study||22
9068518|NCT03988049|10129021|FG001|COMPLETED|Overall Study||22
9068519|NCT03988049|10129020|FG000|NOT COMPLETED|Overall Study||0
9068520|NCT03988049|10129021|FG001|NOT COMPLETED|Overall Study||0
9068521|NCT03979820|10129031|FG000|STARTED|Overall Study||13
9068522|NCT03979820|10129032|FG001|STARTED|Overall Study||14
9068523|NCT03979820|10129033|FG002|STARTED|Overall Study||16
9068524|NCT03979820|10129034|FG003|STARTED|Overall Study||10
9068525|NCT03979820|10129031|FG000|COMPLETED|Overall Study||7
9068526|NCT03979820|10129032|FG001|COMPLETED|Overall Study||14
9068527|NCT03979820|10129033|FG002|COMPLETED|Overall Study||15
9068528|NCT03979820|10129034|FG003|COMPLETED|Overall Study||0
9068529|NCT03979820|10129031|FG000|NOT COMPLETED|Overall Study||6
9068530|NCT03979820|10129032|FG001|NOT COMPLETED|Overall Study||0
9068531|NCT03979820|10129033|FG002|NOT COMPLETED|Overall Study||1
9068532|NCT03979820|10129034|FG003|NOT COMPLETED|Overall Study||10
9068533|NCT03972137|10129048|FG000|STARTED|Overall Study||10
9068534|NCT03972137|10129048|FG000|Enrolled|Overall Study||10
9068535|NCT03972137|10129048|FG000|Treatment Completed|Overall Study||6
9068536|NCT03972137|10129048|FG000|Follow-up Completed|Overall Study||4
9068537|NCT03972137|10129048|FG000|COMPLETED|Overall Study||4
8842971|NCT01701258|9897265|FG007|NOT COMPLETED|Drug+fMRI (Session 2)||0
8842972|NCT01701258|9897266|FG008|NOT COMPLETED|Drug+fMRI (Session 2)||0
8842973|NCT01701258|9897267|FG009|NOT COMPLETED|Drug+fMRI (Session 2)||0
9068538|NCT03972137|10129048|FG000|NOT COMPLETED|Overall Study||6
9068539|NCT03970395|10129066|FG000|STARTED|Overall Study||48
9068540|NCT03970395|10129067|FG001|STARTED|Overall Study||48
9068541|NCT03970395|10129066|FG000|COMPLETED|Overall Study||41
9068542|NCT03970395|10129067|FG001|COMPLETED|Overall Study||36
9068543|NCT03970395|10129066|FG000|NOT COMPLETED|Overall Study||7
9068544|NCT03970395|10129067|FG001|NOT COMPLETED|Overall Study||12
9068545|NCT03987620|10129079|FG000|STARTED|Overall Study||303
9068546|NCT03987620|10129080|FG001|STARTED|Overall Study||152
9068547|NCT03987620|10129079|FG000|Withdrawn Before Treatment|Overall Study||5
9068548|NCT03987620|10129080|FG001|Withdrawn Before Treatment|Overall Study||1
9068549|NCT03987620|10129079|FG000|Withdrawn Before TOC|Overall Study||48
9068550|NCT03987620|10129080|FG001|Withdrawn Before TOC|Overall Study||45
9068551|NCT03987620|10129079|FG000|Completed the TOC Visit|Overall Study||250
9068552|NCT03987620|10129080|FG001|Completed the TOC Visit|Overall Study||106
9068553|NCT03987620|10129079|FG000|Withdrawn At or After the TOC Visit|Overall Study||4
9068554|NCT03987620|10129080|FG001|Withdrawn At or After the TOC Visit|Overall Study||4
9068555|NCT03987620|10129079|FG000|COMPLETED|Overall Study||246
9068556|NCT03987620|10129080|FG001|COMPLETED|Overall Study||102
9068557|NCT03987620|10129079|FG000|NOT COMPLETED|Overall Study||57
9068558|NCT03987620|10129080|FG001|NOT COMPLETED|Overall Study||50
9068559|NCT03983317|10129086|FG000|STARTED|Overall Study||25
9068560|NCT03983317|10129086|FG000|COMPLETED|Overall Study||20
9068561|NCT03983317|10129086|FG000|NOT COMPLETED|Overall Study||5
9068562|NCT03985657|10129090|FG000|STARTED|Intervention 1 (One Night)||20
9068563|NCT03985657|10129091|FG001|STARTED|Intervention 1 (One Night)||11
9068564|NCT03985657|10129090|FG000|COMPLETED|Intervention 1 (One Night)||20
9068565|NCT03985657|10129091|FG001|COMPLETED|Intervention 1 (One Night)||10
9068566|NCT03985657|10129090|FG000|NOT COMPLETED|Intervention 1 (One Night)||0
9068567|NCT03985657|10129091|FG001|NOT COMPLETED|Intervention 1 (One Night)||1
9068568|NCT03985657|10129090|FG000|STARTED|Washout (Up to 1 Week)||20
9068569|NCT03985657|10129091|FG001|STARTED|Washout (Up to 1 Week)||10
9068570|NCT03985657|10129090|FG000|COMPLETED|Washout (Up to 1 Week)||20
9068571|NCT03985657|10129091|FG001|COMPLETED|Washout (Up to 1 Week)||10
9068572|NCT03985657|10129090|FG000|NOT COMPLETED|Washout (Up to 1 Week)||0
9068573|NCT03985657|10129091|FG001|NOT COMPLETED|Washout (Up to 1 Week)||0
9068574|NCT03985657|10129090|FG000|STARTED|Intervention 2 (One Night)||20
9068575|NCT03985657|10129091|FG001|STARTED|Intervention 2 (One Night)||10
9068576|NCT03985657|10129090|FG000|COMPLETED|Intervention 2 (One Night)||20
9068577|NCT03985657|10129091|FG001|COMPLETED|Intervention 2 (One Night)||10
9068578|NCT03985657|10129090|FG000|NOT COMPLETED|Intervention 2 (One Night)||0
9068579|NCT03985657|10129091|FG001|NOT COMPLETED|Intervention 2 (One Night)||0
9068580|NCT03981939|10129100|FG000|STARTED|Overall Study||549
9068581|NCT03981939|10129101|FG001|STARTED|Overall Study||1902
9068582|NCT03981939|10129102|FG002|STARTED|Overall Study||581
9068583|NCT03981939|10129100|FG000|COMPLETED|Overall Study||549
9068584|NCT03981939|10129101|FG001|COMPLETED|Overall Study||1902
9068585|NCT03981939|10129102|FG002|COMPLETED|Overall Study||581
9068586|NCT03981939|10129100|FG000|NOT COMPLETED|Overall Study||0
9068587|NCT03981939|10129101|FG001|NOT COMPLETED|Overall Study||0
9068588|NCT03981939|10129102|FG002|NOT COMPLETED|Overall Study||0
9068589|NCT03973905|10129115|FG000|STARTED|Overall Study||107
9068590|NCT03973905|10129116|FG001|STARTED|Overall Study||183
9068591|NCT03973905|10129115|FG000|COMPLETED|Overall Study||107
9068592|NCT03973905|10129116|FG001|COMPLETED|Overall Study||183
9068593|NCT03973905|10129115|FG000|NOT COMPLETED|Overall Study||0
9068594|NCT03973905|10129116|FG001|NOT COMPLETED|Overall Study||0
9068595|NCT03984838|10129122|FG000|STARTED|Overall Study||16
9068596|NCT03984838|10129122|FG000|COMPLETED|Overall Study||16
9068597|NCT03984838|10129122|FG000|NOT COMPLETED|Overall Study||0
9068598|NCT03983941|10129128|FG000|STARTED|Overall Study||2
9068599|NCT03983941|10129129|FG001|STARTED|Overall Study||5
8842974|NCT01701258|9897268|FG010|NOT COMPLETED|Drug+fMRI (Session 2)||0
9068600|NCT03983941|10129128|FG000|COMPLETED|Overall Study||2
9068601|NCT03983941|10129129|FG001|COMPLETED|Overall Study||5
9068602|NCT03983941|10129128|FG000|NOT COMPLETED|Overall Study||0
9068603|NCT03983941|10129129|FG001|NOT COMPLETED|Overall Study||0
9068604|NCT03976752|10129137|FG000|STARTED|Overall Study||4
9068605|NCT03976752|10129138|FG001|STARTED|Overall Study||37
9068606|NCT03976752|10129137|FG000|Started Study Arm A|Overall Study||0
9068607|NCT03976752|10129138|FG001|Started Study Arm A|Overall Study||14
9068608|NCT03976752|10129137|FG000|Completed Study Arm A|Overall Study||0
9068609|NCT03976752|10129138|FG001|Completed Study Arm A|Overall Study||8
9068610|NCT03976752|10129137|FG000|Started Study Arm B|Overall Study||0
9068611|NCT03976752|10129138|FG001|Started Study Arm B|Overall Study||8
9068612|NCT03976752|10129137|FG000|Completed Study Arm B|Overall Study||0
9068613|NCT03976752|10129138|FG001|Completed Study Arm B|Overall Study||8
9068614|NCT03976752|10129137|FG000|Started Study Arm C|Overall Study||0
9068615|NCT03976752|10129138|FG001|Started Study Arm C|Overall Study||11
9068616|NCT03976752|10129137|FG000|Completed Study Arm C|Overall Study||0
9068617|NCT03976752|10129138|FG001|Completed Study Arm C|Overall Study||8
9068618|NCT03976752|10129137|FG000|Started Study Arm D|Overall Study||0
9068619|NCT03976752|10129138|FG001|Started Study Arm D|Overall Study||6
9068620|NCT03976752|10129137|FG000|Completed Study Arm D|Overall Study||0
9068621|NCT03976752|10129138|FG001|Completed Study Arm D|Overall Study||4
9068622|NCT03976752|10129137|FG000|COMPLETED|Overall Study||3
9068623|NCT03976752|10129138|FG001|COMPLETED|Overall Study||28
9068624|NCT03976752|10129137|FG000|NOT COMPLETED|Overall Study||1
9068625|NCT03976752|10129138|FG001|NOT COMPLETED|Overall Study||9
9068626|NCT03984825|10129149|FG000|STARTED|Run-in Period (Day -3 to -1)||23
9068627|NCT03984825|10129149|FG000|COMPLETED|Run-in Period (Day -3 to -1)||23
9068628|NCT03984825|10129149|FG000|NOT COMPLETED|Run-in Period (Day -3 to -1)||0
9068629|NCT03984825|10129149|FG000|STARTED|Treatment Period 1 (Day 1 to 10)||23
9068630|NCT03984825|10129149|FG000|COMPLETED|Treatment Period 1 (Day 1 to 10)||21
9068631|NCT03984825|10129149|FG000|NOT COMPLETED|Treatment Period 1 (Day 1 to 10)||2
9068632|NCT03984825|10129149|FG000|STARTED|Treatment Period 2 (Day 11 to 21)||21
9068633|NCT03984825|10129149|FG000|COMPLETED|Treatment Period 2 (Day 11 to 21)||17
9068634|NCT03984825|10129149|FG000|NOT COMPLETED|Treatment Period 2 (Day 11 to 21)||4
9068635|NCT03971721|10129158|FG000|STARTED|Overall Study||3
9068636|NCT03971721|10129158|FG000|COMPLETED|Overall Study||3
9068637|NCT03971721|10129158|FG000|NOT COMPLETED|Overall Study||0
9068638|NCT03982433|10129162|FG000|STARTED|Overall Study||8
9068639|NCT03982433|10129162|FG000|COMPLETED|Overall Study||7
9068640|NCT03982433|10129162|FG000|NOT COMPLETED|Overall Study||1
9068641|NCT03979677|10129166|FG000|STARTED|Overall Study|Participants enrolled|41
9068642|NCT03979677|10129166|FG000|COMPLETED|Overall Study|participants completed|28
9068643|NCT03979677|10129166|FG000|NOT COMPLETED|Overall Study||13
9068644|NCT03976466|10129172|FG000|STARTED|Overall Study||44
9068645|NCT03976466|10129173|FG001|STARTED|Overall Study||43
9068646|NCT03976466|10129172|FG000|COMPLETED|Overall Study||43
9068647|NCT03976466|10129173|FG001|COMPLETED|Overall Study||40
9068648|NCT03976466|10129172|FG000|NOT COMPLETED|Overall Study||1
9068649|NCT03976466|10129173|FG001|NOT COMPLETED|Overall Study||3
9068650|NCT03979638|10129183|FG000|STARTED|Period 1||33
9068651|NCT03979638|10129184|FG001|STARTED|Period 1||35
9068652|NCT03979638|10129183|FG000|COMPLETED|Period 1||26
9068653|NCT03979638|10129184|FG001|COMPLETED|Period 1||28
9068654|NCT03979638|10129183|FG000|NOT COMPLETED|Period 1||7
9068655|NCT03979638|10129184|FG001|NOT COMPLETED|Period 1||7
9068656|NCT03979638|10129183|FG000|STARTED|Period 2||26
9068657|NCT03979638|10129184|FG001|STARTED|Period 2||28
9068658|NCT03979638|10129183|FG000|COMPLETED|Period 2||25
9068659|NCT03979638|10129184|FG001|COMPLETED|Period 2||27
9068660|NCT03979638|10129183|FG000|NOT COMPLETED|Period 2||1
9068661|NCT03979638|10129184|FG001|NOT COMPLETED|Period 2||1
9068662|NCT03979274|10129199|FG000|STARTED|Treatment Period 1||22
9068663|NCT03979274|10129200|FG001|STARTED|Treatment Period 1||22
9068664|NCT03979274|10129199|FG000|COMPLETED|Treatment Period 1||22
9068665|NCT03979274|10129200|FG001|COMPLETED|Treatment Period 1||22
9068666|NCT03979274|10129199|FG000|NOT COMPLETED|Treatment Period 1||0
9068667|NCT03979274|10129200|FG001|NOT COMPLETED|Treatment Period 1||0
9068668|NCT03979274|10129199|FG000|STARTED|Treatment Period 2||22
9068669|NCT03979274|10129200|FG001|STARTED|Treatment Period 2||22
9068670|NCT03979274|10129199|FG000|COMPLETED|Treatment Period 2||22
9068671|NCT03979274|10129200|FG001|COMPLETED|Treatment Period 2||21
9068672|NCT03979274|10129199|FG000|NOT COMPLETED|Treatment Period 2||0
9068673|NCT03979274|10129200|FG001|NOT COMPLETED|Treatment Period 2||1
9068674|NCT03979066|10129208|FG000|STARTED|Overall Study||0
9068675|NCT03979066|10129209|FG001|STARTED|Overall Study||0
9068676|NCT03979066|10129208|FG000|COMPLETED|Overall Study||0
9068677|NCT03979066|10129209|FG001|COMPLETED|Overall Study||0
9068678|NCT03979066|10129208|FG000|NOT COMPLETED|Overall Study||0
9068679|NCT03979066|10129209|FG001|NOT COMPLETED|Overall Study||0
9068680|NCT03977727|10129217|FG000|STARTED|First Treatment||20
8623811|NCT00495521|9663006|FG001|STARTED|Overall Study||1
8623812|NCT00495521|9663005|FG000|COMPLETED|Overall Study||1
8623813|NCT00495521|9663006|FG001|COMPLETED|Overall Study||0
8623814|NCT00495521|9663005|FG000|NOT COMPLETED|Overall Study||0
8623815|NCT00495521|9663006|FG001|NOT COMPLETED|Overall Study||1
9068681|NCT03977727|10129218|FG001|STARTED|First Treatment||20
9068682|NCT03977727|10129217|FG000|Received Treatment|First Treatment||20
9068683|NCT03977727|10129218|FG001|Received Treatment|First Treatment||20
9068684|NCT03977727|10129217|FG000|COMPLETED|First Treatment||20
9068685|NCT03977727|10129218|FG001|COMPLETED|First Treatment||20
9068686|NCT03977727|10129217|FG000|NOT COMPLETED|First Treatment||0
9068687|NCT03977727|10129218|FG001|NOT COMPLETED|First Treatment||0
9068688|NCT03977727|10129217|FG000|STARTED|Second Treatment||20
9068689|NCT03977727|10129218|FG001|STARTED|Second Treatment||20
9068690|NCT03977727|10129217|FG000|COMPLETED|Second Treatment||20
9068691|NCT03977727|10129218|FG001|COMPLETED|Second Treatment||17
9068692|NCT03977727|10129217|FG000|NOT COMPLETED|Second Treatment||0
8623816|NCT00495586|9663014|FG000|STARTED|Overall Study||156
9068693|NCT03977727|10129218|FG001|NOT COMPLETED|Second Treatment||3
9068694|NCT03977155|10129227|FG000|STARTED|Overall Study||43
9068695|NCT03977155|10129228|FG001|STARTED|Overall Study||48
9068696|NCT03977155|10129229|FG002|STARTED|Overall Study||42
9068697|NCT03977155|10129227|FG000|COMPLETED|Overall Study||38
9068698|NCT03977155|10129228|FG001|COMPLETED|Overall Study||46
9068699|NCT03977155|10129229|FG002|COMPLETED|Overall Study||40
9068700|NCT03977155|10129227|FG000|NOT COMPLETED|Overall Study||5
9068701|NCT03977155|10129228|FG001|NOT COMPLETED|Overall Study||2
9068702|NCT03977155|10129229|FG002|NOT COMPLETED|Overall Study||2
9068703|NCT03974802|10129239|FG000|STARTED|Overall Study||41
9068704|NCT03974802|10129239|FG000|COMPLETED|Overall Study||41
9068705|NCT03974802|10129239|FG000|NOT COMPLETED|Overall Study||0
9068706|NCT03970733|10129251|FG000|STARTED|Overall Study||97
9068707|NCT03970733|10129252|FG001|STARTED|Overall Study||98
9068708|NCT03970733|10129253|FG002|STARTED|Overall Study||51
9068709|NCT03970733|10129251|FG000|COMPLETED|Overall Study||93
9068710|NCT03970733|10129252|FG001|COMPLETED|Overall Study||92
9068711|NCT03970733|10129253|FG002|COMPLETED|Overall Study||49
9068712|NCT03970733|10129251|FG000|NOT COMPLETED|Overall Study||4
9068713|NCT03970733|10129252|FG001|NOT COMPLETED|Overall Study||6
9068714|NCT03970733|10129253|FG002|NOT COMPLETED|Overall Study||2
9068715|NCT03968978|10129263|FG000|STARTED|Overall Study||111
9068716|NCT03968978|10129264|FG001|STARTED|Overall Study||105
9068717|NCT03968978|10129263|FG000|COMPLETED|Overall Study||110
9068718|NCT03968978|10129264|FG001|COMPLETED|Overall Study||105
9068719|NCT03968978|10129263|FG000|NOT COMPLETED|Overall Study||1
9068720|NCT03968978|10129264|FG001|NOT COMPLETED|Overall Study||0
9068721|NCT03968848|10129272|FG000|STARTED|Overall Study||8
9068722|NCT03968848|10129273|FG001|STARTED|Overall Study||8
9068723|NCT03968848|10129272|FG000|COMPLETED|Overall Study||8
9068724|NCT03968848|10129273|FG001|COMPLETED|Overall Study||8
9068725|NCT03968848|10129272|FG000|NOT COMPLETED|Overall Study||0
9068726|NCT03968848|10129273|FG001|NOT COMPLETED|Overall Study||0
9068727|NCT03967444|10129281|FG000|STARTED|Overall Study||19
9068728|NCT03967444|10129282|FG001|STARTED|Overall Study||40
9068729|NCT03967444|10129281|FG000|COMPLETED|Overall Study||18
9068730|NCT03967444|10129282|FG001|COMPLETED|Overall Study||38
9068731|NCT03967444|10129281|FG000|NOT COMPLETED|Overall Study||1
8623817|NCT00495586|9663015|FG001|STARTED|Overall Study||162
8623818|NCT00495586|9663014|FG000|COMPLETED|Overall Study||152
8623819|NCT00495586|9663015|FG001|COMPLETED|Overall Study||158
8623820|NCT00495586|9663014|FG000|NOT COMPLETED|Overall Study||4
8623821|NCT00495586|9663015|FG001|NOT COMPLETED|Overall Study||4
8623822|NCT00495612|9663025|FG000|STARTED|Overall Study||36
8623823|NCT00495612|9663026|FG001|STARTED|Overall Study||33
8623824|NCT00495612|9663025|FG000|COMPLETED|Overall Study||32
8623825|NCT00495612|9663026|FG001|COMPLETED|Overall Study||33
8623826|NCT00495612|9663025|FG000|NOT COMPLETED|Overall Study||4
8623827|NCT00495612|9663026|FG001|NOT COMPLETED|Overall Study||0
8623828|NCT00495625|9663032|FG000|STARTED|Overall Study||33
8623829|NCT00495625|9663032|FG000|COMPLETED|Overall Study||23
8623830|NCT00495625|9663032|FG000|NOT COMPLETED|Overall Study||10
8623831|NCT00495677|9663043|FG000|STARTED|Stage 1 (25 Days)||2
8623832|NCT00495677|9663044|FG001|STARTED|Stage 1 (25 Days)||6
8623833|NCT00495677|9663045|FG002|STARTED|Stage 1 (25 Days)||6
8623834|NCT00495677|9663046|FG003|STARTED|Stage 1 (25 Days)||6
8623835|NCT00495677|9663047|FG004|STARTED|Stage 1 (25 Days)||0
8623836|NCT00495677|9663048|FG005|STARTED|Stage 1 (25 Days)||0
8623837|NCT00495677|9663049|FG006|STARTED|Stage 1 (25 Days)||0
8623838|NCT00495677|9663043|FG000|COMPLETED|Stage 1 (25 Days)||2
8623839|NCT00495677|9663044|FG001|COMPLETED|Stage 1 (25 Days)||6
8623840|NCT00495677|9663045|FG002|COMPLETED|Stage 1 (25 Days)||5
8623841|NCT00495677|9663046|FG003|COMPLETED|Stage 1 (25 Days)||6
8623842|NCT00495677|9663047|FG004|COMPLETED|Stage 1 (25 Days)||0
8623843|NCT00495677|9663048|FG005|COMPLETED|Stage 1 (25 Days)||0
8623844|NCT00495677|9663049|FG006|COMPLETED|Stage 1 (25 Days)||0
8623845|NCT00495677|9663043|FG000|NOT COMPLETED|Stage 1 (25 Days)||0
8623846|NCT00495677|9663044|FG001|NOT COMPLETED|Stage 1 (25 Days)||0
8623847|NCT00495677|9663045|FG002|NOT COMPLETED|Stage 1 (25 Days)||1
8623848|NCT00495677|9663046|FG003|NOT COMPLETED|Stage 1 (25 Days)||0
8623849|NCT00495677|9663047|FG004|NOT COMPLETED|Stage 1 (25 Days)||0
8623850|NCT00495677|9663048|FG005|NOT COMPLETED|Stage 1 (25 Days)||0
8623851|NCT00495677|9663049|FG006|NOT COMPLETED|Stage 1 (25 Days)||0
8623852|NCT00495677|9663043|FG000|STARTED|Stage 2 (25 Days)||0
8623853|NCT00495677|9663044|FG001|STARTED|Stage 2 (25 Days)||0
8623854|NCT00495677|9663045|FG002|STARTED|Stage 2 (25 Days)||0
8623855|NCT00495677|9663046|FG003|STARTED|Stage 2 (25 Days)||0
8623856|NCT00495677|9663047|FG004|STARTED|Stage 2 (25 Days)||8
8623857|NCT00495677|9663048|FG005|STARTED|Stage 2 (25 Days)||8
8623858|NCT00495677|9663049|FG006|STARTED|Stage 2 (25 Days)||7
8623859|NCT00495677|9663043|FG000|COMPLETED|Stage 2 (25 Days)||0
8623860|NCT00495677|9663044|FG001|COMPLETED|Stage 2 (25 Days)||0
8623861|NCT00495677|9663045|FG002|COMPLETED|Stage 2 (25 Days)||0
9068732|NCT03967444|10129282|FG001|NOT COMPLETED|Overall Study||2
9068733|NCT03966924|10129288|FG000|STARTED|Overall Study||2
9068734|NCT03966924|10129288|FG000|COMPLETED|Overall Study||2
9068735|NCT03966924|10129288|FG000|NOT COMPLETED|Overall Study||0
9068736|NCT03966911|10129294|FG000|STARTED|Overall Study||169
9068737|NCT03966911|10129295|FG001|STARTED|Overall Study||142
9068738|NCT03966911|10129294|FG000|COMPLETED|Overall Study||160
9068739|NCT03966911|10129295|FG001|COMPLETED|Overall Study||126
9068740|NCT03966911|10129294|FG000|NOT COMPLETED|Overall Study||9
8623862|NCT00495677|9663046|FG003|COMPLETED|Stage 2 (25 Days)||0
8623863|NCT00495677|9663047|FG004|COMPLETED|Stage 2 (25 Days)||8
8623864|NCT00495677|9663048|FG005|COMPLETED|Stage 2 (25 Days)||8
8623865|NCT00495677|9663049|FG006|COMPLETED|Stage 2 (25 Days)||7
8623866|NCT00495677|9663043|FG000|NOT COMPLETED|Stage 2 (25 Days)||0
8623867|NCT00495677|9663044|FG001|NOT COMPLETED|Stage 2 (25 Days)||0
8623868|NCT00495677|9663045|FG002|NOT COMPLETED|Stage 2 (25 Days)||0
9068741|NCT03966911|10129295|FG001|NOT COMPLETED|Overall Study||16
9068742|NCT03966365|10129305|FG000|STARTED|Overall Study||12
9068743|NCT03966365|10129306|FG001|STARTED|Overall Study||12
9068744|NCT03966365|10129305|FG000|COMPLETED|Overall Study||11
9068745|NCT03966365|10129306|FG001|COMPLETED|Overall Study||12
9068746|NCT03966365|10129305|FG000|NOT COMPLETED|Overall Study||1
9068747|NCT03966365|10129306|FG001|NOT COMPLETED|Overall Study||0
9068748|NCT03965403|10129312|FG000|STARTED|Overall Study||7
9068749|NCT03965403|10129312|FG000|COMPLETED|Overall Study||6
9068750|NCT03965403|10129312|FG000|NOT COMPLETED|Overall Study||1
9068751|NCT03965754|10129320|FG000|STARTED|Overall Study||1422
9068752|NCT03965754|10129321|FG001|STARTED|Overall Study||1425
9068753|NCT03965754|10129322|FG002|STARTED|Overall Study||1425
9068754|NCT03965754|10129323|FG003|STARTED|Overall Study||1425
9068755|NCT03965754|10129320|FG000|COMPLETED|Overall Study||1422
9068756|NCT03965754|10129321|FG001|COMPLETED|Overall Study||1425
9068757|NCT03965754|10129322|FG002|COMPLETED|Overall Study||1425
9068758|NCT03965754|10129323|FG003|COMPLETED|Overall Study||1425
9068759|NCT03965754|10129320|FG000|NOT COMPLETED|Overall Study||0
9068760|NCT03965754|10129321|FG001|NOT COMPLETED|Overall Study||0
9068761|NCT03965754|10129322|FG002|NOT COMPLETED|Overall Study||0
9068762|NCT03965754|10129323|FG003|NOT COMPLETED|Overall Study||0
9068763|NCT03965533|10129340|FG000|STARTED|Part A (112 Days)||2
9068764|NCT03965533|10129341|FG001|STARTED|Part A (112 Days)||6
9068765|NCT03965533|10129342|FG002|STARTED|Part A (112 Days)||2
9068766|NCT03965533|10129343|FG003|STARTED|Part A (112 Days)||6
9068767|NCT03965533|10129344|FG004|STARTED|Part A (112 Days)||0
9068768|NCT03965533|10129345|FG005|STARTED|Part A (112 Days)||0
9068769|NCT03965533|10129346|FG006|STARTED|Part A (112 Days)||0
9068770|NCT03965533|10129340|FG000|COMPLETED|Part A (112 Days)||2
9068771|NCT03965533|10129341|FG001|COMPLETED|Part A (112 Days)||6
9068772|NCT03965533|10129342|FG002|COMPLETED|Part A (112 Days)||2
9068773|NCT03965533|10129343|FG003|COMPLETED|Part A (112 Days)||6
9068774|NCT03965533|10129344|FG004|COMPLETED|Part A (112 Days)||0
9068775|NCT03965533|10129345|FG005|COMPLETED|Part A (112 Days)||0
9068776|NCT03965533|10129346|FG006|COMPLETED|Part A (112 Days)||0
9068777|NCT03965533|10129340|FG000|NOT COMPLETED|Part A (112 Days)||0
9068778|NCT03965533|10129341|FG001|NOT COMPLETED|Part A (112 Days)||0
9068779|NCT03965533|10129342|FG002|NOT COMPLETED|Part A (112 Days)||0
9068780|NCT03965533|10129343|FG003|NOT COMPLETED|Part A (112 Days)||0
9068781|NCT03965533|10129344|FG004|NOT COMPLETED|Part A (112 Days)||0
9068782|NCT03965533|10129345|FG005|NOT COMPLETED|Part A (112 Days)||0
9068783|NCT03965533|10129346|FG006|NOT COMPLETED|Part A (112 Days)||0
9068784|NCT03965533|10129340|FG000|STARTED|Part B (112 Days)||0
9068785|NCT03965533|10129341|FG001|STARTED|Part B (112 Days)||0
9068786|NCT03965533|10129342|FG002|STARTED|Part B (112 Days)||0
9068787|NCT03965533|10129343|FG003|STARTED|Part B (112 Days)||0
9068788|NCT03965533|10129344|FG004|STARTED|Part B (112 Days)||4
9068789|NCT03965533|10129345|FG005|STARTED|Part B (112 Days)||8
9068790|NCT03965533|10129346|FG006|STARTED|Part B (112 Days)||8
9068791|NCT03965533|10129340|FG000|COMPLETED|Part B (112 Days)||0
9068792|NCT03965533|10129341|FG001|COMPLETED|Part B (112 Days)||0
9068793|NCT03965533|10129342|FG002|COMPLETED|Part B (112 Days)||0
9068794|NCT03965533|10129343|FG003|COMPLETED|Part B (112 Days)||0
9068795|NCT03965533|10129344|FG004|COMPLETED|Part B (112 Days)||4
9068796|NCT03965533|10129345|FG005|COMPLETED|Part B (112 Days)||8
9068797|NCT03965533|10129346|FG006|COMPLETED|Part B (112 Days)||8
9068798|NCT03965533|10129340|FG000|NOT COMPLETED|Part B (112 Days)||0
9068799|NCT03965533|10129341|FG001|NOT COMPLETED|Part B (112 Days)||0
9068800|NCT03965533|10129342|FG002|NOT COMPLETED|Part B (112 Days)||0
9068801|NCT03965533|10129343|FG003|NOT COMPLETED|Part B (112 Days)||0
9068802|NCT03965533|10129344|FG004|NOT COMPLETED|Part B (112 Days)||0
9068803|NCT03965533|10129345|FG005|NOT COMPLETED|Part B (112 Days)||0
9068804|NCT03965533|10129346|FG006|NOT COMPLETED|Part B (112 Days)||0
9068805|NCT03965351|10129369|FG000|STARTED|First Intervention (4 Weeks)||3
9068806|NCT03965351|10129370|FG001|STARTED|First Intervention (4 Weeks)||5
9068807|NCT03965351|10129369|FG000|COMPLETED|First Intervention (4 Weeks)||3
9068808|NCT03965351|10129370|FG001|COMPLETED|First Intervention (4 Weeks)||4
9068809|NCT03965351|10129369|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0
9068810|NCT03965351|10129370|FG001|NOT COMPLETED|First Intervention (4 Weeks)||1
9068811|NCT03965351|10129369|FG000|STARTED|Wash Out Period (4 Weeks)||3
9068812|NCT03965351|10129370|FG001|STARTED|Wash Out Period (4 Weeks)||4
9068813|NCT03965351|10129369|FG000|COMPLETED|Wash Out Period (4 Weeks)||3
8623869|NCT00495677|9663046|FG003|NOT COMPLETED|Stage 2 (25 Days)||0
8623870|NCT00495677|9663047|FG004|NOT COMPLETED|Stage 2 (25 Days)||0
9068814|NCT03965351|10129370|FG001|COMPLETED|Wash Out Period (4 Weeks)||4
9068815|NCT03965351|10129369|FG000|NOT COMPLETED|Wash Out Period (4 Weeks)||0
9068816|NCT03965351|10129370|FG001|NOT COMPLETED|Wash Out Period (4 Weeks)||0
9068817|NCT03965351|10129369|FG000|STARTED|Second Intervention (4 Weeks)||3
9068818|NCT03965351|10129370|FG001|STARTED|Second Intervention (4 Weeks)||4
9068819|NCT03965351|10129369|FG000|COMPLETED|Second Intervention (4 Weeks)||3
9068820|NCT03965351|10129370|FG001|COMPLETED|Second Intervention (4 Weeks)||3
9068821|NCT03965351|10129369|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0
9068822|NCT03965351|10129370|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||1
9068823|NCT03964220|10129378|FG000|STARTED|Overall Study||2619
9068824|NCT03964220|10129379|FG001|STARTED|Overall Study||5238
9068825|NCT03964220|10129378|FG000|COMPLETED|Overall Study||2619
9068826|NCT03964220|10129379|FG001|COMPLETED|Overall Study||5238
9068827|NCT03964220|10129378|FG000|NOT COMPLETED|Overall Study||0
9068828|NCT03964220|10129379|FG001|NOT COMPLETED|Overall Study||0
9068829|NCT03958955|10129385|FG000|STARTED|Overall Study||27
9068830|NCT03958955|10129385|FG000|Lesions Treated With Delgocitinib Cream|Overall Study||27
9068831|NCT03958955|10129385|FG000|Lesions Treated With Delgocitinib Cream Vehicle|Overall Study||27
9068832|NCT03958955|10129385|FG000|COMPLETED|Overall Study||26
9068833|NCT03958955|10129385|FG000|NOT COMPLETED|Overall Study||1
9068834|NCT03965052|10129393|FG000|STARTED|Overall Study||12
9068835|NCT03965052|10129394|FG001|STARTED|Overall Study||12
9068836|NCT03965052|10129393|FG000|COMPLETED|Overall Study||11
9068837|NCT03965052|10129394|FG001|COMPLETED|Overall Study||12
9068838|NCT03965052|10129393|FG000|NOT COMPLETED|Overall Study||1
9068839|NCT03965052|10129394|FG001|NOT COMPLETED|Overall Study||0
9068840|NCT03965039|10129404|FG000|STARTED|Overall Study||30
9068841|NCT03965039|10129405|FG001|STARTED|Overall Study||30
9068842|NCT03965039|10129406|FG002|STARTED|Overall Study||30
9068843|NCT03965039|10129407|FG003|STARTED|Overall Study||30
9068844|NCT03965039|10129404|FG000|COMPLETED|Overall Study||30
9068845|NCT03965039|10129405|FG001|COMPLETED|Overall Study||29
9068846|NCT03965039|10129406|FG002|COMPLETED|Overall Study||30
9068847|NCT03965039|10129407|FG003|COMPLETED|Overall Study||29
9068848|NCT03965039|10129404|FG000|NOT COMPLETED|Overall Study||0
9068849|NCT03965039|10129405|FG001|NOT COMPLETED|Overall Study||1
9068850|NCT03965039|10129406|FG002|NOT COMPLETED|Overall Study||0
9068851|NCT03965039|10129407|FG003|NOT COMPLETED|Overall Study||1
9068852|NCT03963401|10129423|FG000|STARTED|Initial Period (Day 1 - Week 16)||60
9068853|NCT03963401|10129424|FG001|STARTED|Initial Period (Day 1 - Week 16)||61
9068854|NCT03963401|10129425|FG002|STARTED|Initial Period (Day 1 - Week 16)||16
9068855|NCT03963401|10129426|FG003|STARTED|Initial Period (Day 1 - Week 16)||15
9068856|NCT03963401|10129427|FG004|STARTED|Initial Period (Day 1 - Week 16)||34
9068857|NCT03963401|10129428|FG005|STARTED|Initial Period (Day 1 - Week 16)||33
9068858|NCT03963401|10129423|FG000|Treated|Initial Period (Day 1 - Week 16)||60
9068859|NCT03963401|10129424|FG001|Treated|Initial Period (Day 1 - Week 16)||60
9068860|NCT03963401|10129425|FG002|Treated|Initial Period (Day 1 - Week 16)||16
9068861|NCT03963401|10129426|FG003|Treated|Initial Period (Day 1 - Week 16)||15
9068862|NCT03963401|10129427|FG004|Treated|Initial Period (Day 1 - Week 16)||34
9068863|NCT03963401|10129428|FG005|Treated|Initial Period (Day 1 - Week 16)||33
9068864|NCT03963401|10129423|FG000|COMPLETED|Initial Period (Day 1 - Week 16)||57
9068865|NCT03963401|10129424|FG001|COMPLETED|Initial Period (Day 1 - Week 16)||57
9068866|NCT03963401|10129425|FG002|COMPLETED|Initial Period (Day 1 - Week 16)||14
9068867|NCT03963401|10129426|FG003|COMPLETED|Initial Period (Day 1 - Week 16)||13
9068868|NCT03963401|10129427|FG004|COMPLETED|Initial Period (Day 1 - Week 16)||31
9068869|NCT03963401|10129428|FG005|COMPLETED|Initial Period (Day 1 - Week 16)||31
9068870|NCT03963401|10129423|FG000|NOT COMPLETED|Initial Period (Day 1 - Week 16)||3
9068871|NCT03963401|10129424|FG001|NOT COMPLETED|Initial Period (Day 1 - Week 16)||4
9068872|NCT03963401|10129425|FG002|NOT COMPLETED|Initial Period (Day 1 - Week 16)||2
9068873|NCT03963401|10129426|FG003|NOT COMPLETED|Initial Period (Day 1 - Week 16)||2
9068874|NCT03963401|10129427|FG004|NOT COMPLETED|Initial Period (Day 1 - Week 16)||3
9068875|NCT03963401|10129428|FG005|NOT COMPLETED|Initial Period (Day 1 - Week 16)||2
9068876|NCT03963401|10129423|FG000|STARTED|Extension Period (Week 17 - Week 52)||57
9068877|NCT03963401|10129424|FG001|STARTED|Extension Period (Week 17 - Week 52)||57
9068878|NCT03963401|10129425|FG002|STARTED|Extension Period (Week 17 - Week 52)||14
9068879|NCT03963401|10129426|FG003|STARTED|Extension Period (Week 17 - Week 52)||13
9068880|NCT03963401|10129427|FG004|STARTED|Extension Period (Week 17 - Week 52)||31
9068881|NCT03963401|10129428|FG005|STARTED|Extension Period (Week 17 - Week 52)||31
9068882|NCT03963401|10129423|FG000|COMPLETED|Extension Period (Week 17 - Week 52)||43
9068883|NCT03963401|10129424|FG001|COMPLETED|Extension Period (Week 17 - Week 52)||52
9068884|NCT03963401|10129425|FG002|COMPLETED|Extension Period (Week 17 - Week 52)||10
9068885|NCT03963401|10129426|FG003|COMPLETED|Extension Period (Week 17 - Week 52)||12
9068886|NCT03963401|10129427|FG004|COMPLETED|Extension Period (Week 17 - Week 52)||25
9068887|NCT03963401|10129428|FG005|COMPLETED|Extension Period (Week 17 - Week 52)||26
9068888|NCT03963401|10129423|FG000|NOT COMPLETED|Extension Period (Week 17 - Week 52)||14
9068889|NCT03963401|10129424|FG001|NOT COMPLETED|Extension Period (Week 17 - Week 52)||5
9068890|NCT03963401|10129425|FG002|NOT COMPLETED|Extension Period (Week 17 - Week 52)||4
9068891|NCT03963401|10129426|FG003|NOT COMPLETED|Extension Period (Week 17 - Week 52)||1
9068892|NCT03963401|10129427|FG004|NOT COMPLETED|Extension Period (Week 17 - Week 52)||6
9068893|NCT03963401|10129428|FG005|NOT COMPLETED|Extension Period (Week 17 - Week 52)||5
9068894|NCT03962634|10129448|FG000|STARTED|Overall Study||1
9068895|NCT03962634|10129449|FG001|STARTED|Overall Study||2
9068896|NCT03962634|10129448|FG000|COMPLETED|Overall Study||1
9068897|NCT03962634|10129449|FG001|COMPLETED|Overall Study||2
9068898|NCT03962634|10129448|FG000|NOT COMPLETED|Overall Study||0
9068899|NCT03962634|10129449|FG001|NOT COMPLETED|Overall Study||0
9068900|NCT03962790|10129455|FG000|STARTED|Period 1||48
9068901|NCT03962790|10129456|FG001|STARTED|Period 1||46
9068902|NCT03962790|10129455|FG000|COMPLETED|Period 1||45
9068903|NCT03962790|10129456|FG001|COMPLETED|Period 1||44
9068904|NCT03962790|10129455|FG000|NOT COMPLETED|Period 1||3
9068905|NCT03962790|10129456|FG001|NOT COMPLETED|Period 1||2
9068906|NCT03962790|10129455|FG000|STARTED|Period 2||45
9068907|NCT03962790|10129456|FG001|STARTED|Period 2||44
9068908|NCT03962790|10129455|FG000|COMPLETED|Period 2||45
9068909|NCT03962790|10129456|FG001|COMPLETED|Period 2||44
9068910|NCT03962790|10129455|FG000|NOT COMPLETED|Period 2||0
9068911|NCT03962790|10129456|FG001|NOT COMPLETED|Period 2||0
9068912|NCT03956225|10129464|FG000|STARTED|Overall Study||119
9068913|NCT03956225|10129465|FG001|STARTED|Overall Study||117
9068914|NCT03956225|10129464|FG000|COMPLETED|Overall Study||114
9068915|NCT03956225|10129465|FG001|COMPLETED|Overall Study||113
9068916|NCT03956225|10129464|FG000|NOT COMPLETED|Overall Study||5
9068917|NCT03956225|10129465|FG001|NOT COMPLETED|Overall Study||4
9068918|NCT03951610|10129474|FG000|STARTED|First Intervention||27
9068919|NCT03951610|10129475|FG001|STARTED|First Intervention||25
9068920|NCT03951610|10129474|FG000|COMPLETED|First Intervention||27
9068921|NCT03951610|10129475|FG001|COMPLETED|First Intervention||25
9068922|NCT03951610|10129474|FG000|NOT COMPLETED|First Intervention||0
9068923|NCT03951610|10129475|FG001|NOT COMPLETED|First Intervention||0
9068924|NCT03951610|10129474|FG000|STARTED|Second Intervention||27
9068925|NCT03951610|10129475|FG001|STARTED|Second Intervention||25
9068926|NCT03951610|10129474|FG000|COMPLETED|Second Intervention||27
9068927|NCT03951610|10129475|FG001|COMPLETED|Second Intervention||25
9068928|NCT03951610|10129474|FG000|NOT COMPLETED|Second Intervention||0
9068929|NCT03951610|10129475|FG001|NOT COMPLETED|Second Intervention||0
9068930|NCT03958149|10129483|FG000|STARTED|Overall Study||20
9068931|NCT03958149|10129484|FG001|STARTED|Overall Study||18
9068932|NCT03958149|10129483|FG000|COMPLETED|Overall Study||20
9068933|NCT03958149|10129484|FG001|COMPLETED|Overall Study||17
9068934|NCT03958149|10129483|FG000|NOT COMPLETED|Overall Study||0
9068935|NCT03958149|10129484|FG001|NOT COMPLETED|Overall Study||1
9068936|NCT03953183|10129496|FG000|STARTED|Overall Study||30
9068937|NCT03953183|10129497|FG001|STARTED|Overall Study||30
9068938|NCT03953183|10129496|FG000|COMPLETED|Overall Study||30
9068939|NCT03953183|10129497|FG001|COMPLETED|Overall Study||28
9068940|NCT03953183|10129496|FG000|NOT COMPLETED|Overall Study||0
9068941|NCT03953183|10129497|FG001|NOT COMPLETED|Overall Study||2
9068942|NCT03949335|10129505|FG000|STARTED|Overall Study||135
9068943|NCT03949335|10129506|FG001|STARTED|Overall Study||137
9068944|NCT03949335|10129505|FG000|COMPLETED|Overall Study||132
9068945|NCT03949335|10129506|FG001|COMPLETED|Overall Study||131
9068946|NCT03949335|10129505|FG000|NOT COMPLETED|Overall Study||3
9068947|NCT03949335|10129506|FG001|NOT COMPLETED|Overall Study||6
9068948|NCT03962738|10129518|FG000|STARTED|Overall Study||258
9068949|NCT03962738|10129519|FG001|STARTED|Overall Study||109
9068950|NCT03962738|10129520|FG002|STARTED|Overall Study||261
9068951|NCT03962738|10129521|FG003|STARTED|Overall Study||218
9068952|NCT03962738|10129518|FG000|Received At Least One Dose of Study Drug|Overall Study||214
9068953|NCT03962738|10129519|FG001|Received At Least One Dose of Study Drug|Overall Study||87
9068954|NCT03962738|10129520|FG002|Received At Least One Dose of Study Drug|Overall Study||208
9068955|NCT03962738|10129521|FG003|Received At Least One Dose of Study Drug|Overall Study||182
9068956|NCT03962738|10129518|FG000|COMPLETED|Overall Study||251
9068957|NCT03962738|10129519|FG001|COMPLETED|Overall Study||109
9068958|NCT03962738|10129520|FG002|COMPLETED|Overall Study||259
9068959|NCT03962738|10129521|FG003|COMPLETED|Overall Study||217
9068960|NCT03962738|10129518|FG000|NOT COMPLETED|Overall Study||7
9068961|NCT03962738|10129519|FG001|NOT COMPLETED|Overall Study||0
9068962|NCT03962738|10129520|FG002|NOT COMPLETED|Overall Study||2
9068963|NCT03962738|10129521|FG003|NOT COMPLETED|Overall Study||1
9068964|NCT03962101|10129539|FG000|STARTED|Overall Study||45
9068965|NCT03962101|10129539|FG000|COMPLETED|Overall Study||41
9068966|NCT03962101|10129539|FG000|NOT COMPLETED|Overall Study||4
9068967|NCT03959137|10129544|FG000|STARTED|Overall Study||215
9068968|NCT03959137|10129544|FG000|COMPLETED|Overall Study||209
9068969|NCT03959137|10129544|FG000|NOT COMPLETED|Overall Study||6
9068970|NCT03946124|10129548|FG000|STARTED|Overall Study||74
9068971|NCT03946124|10129548|FG000|COMPLETED|Overall Study||55
9068972|NCT03946124|10129548|FG000|NOT COMPLETED|Overall Study||19
9068973|NCT03961308|10129554|FG000|STARTED|Overall Study||102
9068974|NCT03961308|10129555|FG001|STARTED|Overall Study||102
9068975|NCT03961308|10129554|FG000|COMPLETED|Overall Study||100
9068976|NCT03961308|10129555|FG001|COMPLETED|Overall Study||100
9068977|NCT03961308|10129554|FG000|NOT COMPLETED|Overall Study||2
9068978|NCT03961308|10129555|FG001|NOT COMPLETED|Overall Study||2
9068979|NCT03961295|10129563|FG000|STARTED|Overall Study||12
9068980|NCT03961295|10129564|FG001|STARTED|Overall Study||12
9068981|NCT03961295|10129563|FG000|COMPLETED|Overall Study||12
9068982|NCT03961295|10129564|FG001|COMPLETED|Overall Study||12
9068983|NCT03961295|10129563|FG000|NOT COMPLETED|Overall Study||0
9068984|NCT03961295|10129564|FG001|NOT COMPLETED|Overall Study||0
9068985|NCT03960957|10129572|FG000|STARTED|Overall Study||224
9068986|NCT03960957|10129573|FG001|STARTED|Overall Study||77
9068987|NCT03960957|10129572|FG000|COMPLETED|Overall Study||216
9068988|NCT03960957|10129573|FG001|COMPLETED|Overall Study||71
9068989|NCT03960957|10129572|FG000|NOT COMPLETED|Overall Study||8
9068990|NCT03960957|10129573|FG001|NOT COMPLETED|Overall Study||6
9068991|NCT03956862|10129581|FG000|STARTED|Overall Study||50
9068992|NCT03956862|10129582|FG001|STARTED|Overall Study||47
9068993|NCT03956862|10129581|FG000|COMPLETED|Overall Study||48
9068994|NCT03956862|10129582|FG001|COMPLETED|Overall Study||45
9068995|NCT03956862|10129581|FG000|NOT COMPLETED|Overall Study||2
9068996|NCT03956862|10129582|FG001|NOT COMPLETED|Overall Study||2
9068997|NCT03954444|10129591|FG000|STARTED|Overall Study||379
9068998|NCT03954444|10129592|FG001|STARTED|Overall Study||382
9068999|NCT03954444|10129593|FG002|STARTED|Overall Study||344
9069000|NCT03954444|10129591|FG000|COMPLETED|Overall Study||366
9069001|NCT03954444|10129592|FG001|COMPLETED|Overall Study||366
9069002|NCT03954444|10129593|FG002|COMPLETED|Overall Study||327
9069003|NCT03954444|10129591|FG000|NOT COMPLETED|Overall Study||13
9069004|NCT03954444|10129592|FG001|NOT COMPLETED|Overall Study||16
9069005|NCT03954444|10129593|FG002|NOT COMPLETED|Overall Study||17
9069006|NCT03953820|10129601|FG000|STARTED|Two-Sequence, Two-Way Crossover||15
9069007|NCT03953820|10129602|FG001|STARTED|Two-Sequence, Two-Way Crossover||16
9069008|NCT03953820|10129603|FG002|STARTED|Two-Sequence, Two-Way Crossover||0
9069009|NCT03953820|10129601|FG000|COMPLETED|Two-Sequence, Two-Way Crossover||13
9069010|NCT03953820|10129602|FG001|COMPLETED|Two-Sequence, Two-Way Crossover||16
9069011|NCT03953820|10129603|FG002|COMPLETED|Two-Sequence, Two-Way Crossover||0
9069012|NCT03953820|10129601|FG000|NOT COMPLETED|Two-Sequence, Two-Way Crossover||2
9069013|NCT03953820|10129602|FG001|NOT COMPLETED|Two-Sequence, Two-Way Crossover||0
9069014|NCT03953820|10129603|FG002|NOT COMPLETED|Two-Sequence, Two-Way Crossover||0
9069015|NCT03953820|10129601|FG000|STARTED|DBF Following High-Fat Meal|This arm did not continue in Period 2.|0
9069016|NCT03953820|10129602|FG001|STARTED|DBF Following High-Fat Meal|This arm did not continue in Period 2.|0
9069017|NCT03953820|10129603|FG002|STARTED|DBF Following High-Fat Meal|Participants in Period 2 completed 1 of the 2 arms in Period 1 and volunteered to continue.|10
9069018|NCT03953820|10129601|FG000|COMPLETED|DBF Following High-Fat Meal||0
9069019|NCT03953820|10129602|FG001|COMPLETED|DBF Following High-Fat Meal||0
9069020|NCT03953820|10129603|FG002|COMPLETED|DBF Following High-Fat Meal||10
9069021|NCT03953820|10129601|FG000|NOT COMPLETED|DBF Following High-Fat Meal||0
9069022|NCT03953820|10129602|FG001|NOT COMPLETED|DBF Following High-Fat Meal||0
9069023|NCT03953820|10129603|FG002|NOT COMPLETED|DBF Following High-Fat Meal||0
9069024|NCT03951766|10129616|FG000|STARTED|Treatment Phase||100
9069025|NCT03951766|10129616|FG000|COMPLETED|Treatment Phase||99
9069026|NCT03951766|10129616|FG000|NOT COMPLETED|Treatment Phase||1
9069027|NCT03951766|10129616|FG000|STARTED|Follow-up Phase||99
9069028|NCT03951766|10129616|FG000|COMPLETED|Follow-up Phase||89
9069029|NCT03951766|10129616|FG000|NOT COMPLETED|Follow-up Phase||10
9069030|NCT03961100|10129626|FG000|STARTED|Part 1||5
9069031|NCT03961100|10129627|FG001|STARTED|Part 1||5
9069032|NCT03961100|10129628|FG002|STARTED|Part 1||5
9069033|NCT03961100|10129629|FG003|STARTED|Part 1||0
9069034|NCT03961100|10129630|FG004|STARTED|Part 1||0
9069035|NCT03961100|10129626|FG000|COMPLETED|Part 1||5
9069036|NCT03961100|10129627|FG001|COMPLETED|Part 1||5
9069037|NCT03961100|10129628|FG002|COMPLETED|Part 1||5
9069038|NCT03961100|10129629|FG003|COMPLETED|Part 1||0
9069039|NCT03961100|10129630|FG004|COMPLETED|Part 1||0
9069040|NCT03961100|10129626|FG000|NOT COMPLETED|Part 1||0
9069041|NCT03961100|10129627|FG001|NOT COMPLETED|Part 1||0
9069042|NCT03961100|10129628|FG002|NOT COMPLETED|Part 1||0
9069043|NCT03961100|10129629|FG003|NOT COMPLETED|Part 1||0
9069044|NCT03961100|10129630|FG004|NOT COMPLETED|Part 1||0
9069045|NCT03961100|10129626|FG000|STARTED|Part 2||0
9069046|NCT03961100|10129627|FG001|STARTED|Part 2||0
9069047|NCT03961100|10129628|FG002|STARTED|Part 2||0
9069048|NCT03961100|10129629|FG003|STARTED|Part 2||8
9069049|NCT03961100|10129630|FG004|STARTED|Part 2||8
9069050|NCT03961100|10129626|FG000|COMPLETED|Part 2||0
9069051|NCT03961100|10129627|FG001|COMPLETED|Part 2||0
9069052|NCT03961100|10129628|FG002|COMPLETED|Part 2||0
9069053|NCT03961100|10129629|FG003|COMPLETED|Part 2||8
9069054|NCT03961100|10129630|FG004|COMPLETED|Part 2||8
9069055|NCT03961100|10129626|FG000|NOT COMPLETED|Part 2||0
9069056|NCT03961100|10129627|FG001|NOT COMPLETED|Part 2||0
9069057|NCT03961100|10129628|FG002|NOT COMPLETED|Part 2||0
9069058|NCT03961100|10129629|FG003|NOT COMPLETED|Part 2||0
9069059|NCT03961100|10129630|FG004|NOT COMPLETED|Part 2||0
9069060|NCT03950856|10129646|FG000|STARTED|Overall Study||702
9069061|NCT03950856|10129647|FG001|STARTED|Overall Study||704
9069062|NCT03950856|10129648|FG002|STARTED|Overall Study||701
9069063|NCT03950856|10129649|FG003|STARTED|Overall Study||233
9069064|NCT03950856|10129646|FG000|Vaccinated|Overall Study||698
9069065|NCT03950856|10129647|FG001|Vaccinated|Overall Study||704
9069066|NCT03950856|10129648|FG002|Vaccinated|Overall Study||700
9069067|NCT03950856|10129649|FG003|Vaccinated|Overall Study||231
9069068|NCT03950856|10129646|FG000|COMPLETED|Overall Study||683
9069069|NCT03950856|10129647|FG001|COMPLETED|Overall Study||689
9069070|NCT03950856|10129648|FG002|COMPLETED|Overall Study||683
9069071|NCT03950856|10129649|FG003|COMPLETED|Overall Study||227
9069072|NCT03950856|10129646|FG000|NOT COMPLETED|Overall Study||19
9069073|NCT03950856|10129647|FG001|NOT COMPLETED|Overall Study||15
9069074|NCT03950856|10129648|FG002|NOT COMPLETED|Overall Study||18
9069075|NCT03950856|10129649|FG003|NOT COMPLETED|Overall Study||6
9069076|NCT03947983|10129663|FG000|STARTED|Overall Study||19
9069077|NCT03947983|10129664|FG001|STARTED|Overall Study||19
9069078|NCT03947983|10129663|FG000|12 Weeks|Overall Study||15
9069079|NCT03947983|10129664|FG001|12 Weeks|Overall Study||17
9069080|NCT03947983|10129663|FG000|COMPLETED|Overall Study||14
9069081|NCT03947983|10129664|FG001|COMPLETED|Overall Study||13
9069082|NCT03947983|10129663|FG000|NOT COMPLETED|Overall Study||5
9069083|NCT03947983|10129664|FG001|NOT COMPLETED|Overall Study||6
9069084|NCT03960658|10129670|FG000|STARTED|Overall Study||12
9069085|NCT03960658|10129670|FG000|COMPLETED|Overall Study||10
9069086|NCT03960658|10129670|FG000|NOT COMPLETED|Overall Study||2
9069087|NCT03959332|10129676|FG000|STARTED|Overall Study||16
9069088|NCT03959332|10129677|FG001|STARTED|Overall Study||16
9069089|NCT03959332|10129676|FG000|COMPLETED|Overall Study||16
9069090|NCT03959332|10129677|FG001|COMPLETED|Overall Study||16
9069091|NCT03959332|10129676|FG000|NOT COMPLETED|Overall Study||0
9069092|NCT03959332|10129677|FG001|NOT COMPLETED|Overall Study||0
9069093|NCT03959189|10129685|FG000|STARTED|Overall Study||7
9069094|NCT03959189|10129686|FG001|STARTED|Overall Study||5
9069095|NCT03959189|10129685|FG000|COMPLETED|Overall Study||7
9069096|NCT03959189|10129686|FG001|COMPLETED|Overall Study||5
9069097|NCT03959189|10129685|FG000|NOT COMPLETED|Overall Study||0
9069098|NCT03959189|10129686|FG001|NOT COMPLETED|Overall Study||0
9069099|NCT03956550|10129702|FG000|STARTED|Overall Study||88
9069100|NCT03956550|10129703|FG001|STARTED|Overall Study||86
9069101|NCT03956550|10129704|FG002|STARTED|Overall Study||85
9069102|NCT03956550|10129702|FG000|COMPLETED|Overall Study||18
9069103|NCT03956550|10129703|FG001|COMPLETED|Overall Study||14
9069104|NCT03956550|10129704|FG002|COMPLETED|Overall Study||15
9069105|NCT03956550|10129702|FG000|NOT COMPLETED|Overall Study||70
9069106|NCT03956550|10129703|FG001|NOT COMPLETED|Overall Study||72
9069107|NCT03956550|10129704|FG002|NOT COMPLETED|Overall Study||70
9069108|NCT03954158|10129716|FG000|STARTED|Overall Study||20
9069109|NCT03954158|10129717|FG001|STARTED|Overall Study||21
9069110|NCT03954158|10129718|FG002|STARTED|Overall Study||20
9069111|NCT03954158|10129719|FG003|STARTED|Overall Study||20
9069112|NCT03954158|10129716|FG000|COMPLETED|Overall Study||20
9069113|NCT03954158|10129717|FG001|COMPLETED|Overall Study||21
9069114|NCT03954158|10129718|FG002|COMPLETED|Overall Study||20
9069115|NCT03954158|10129719|FG003|COMPLETED|Overall Study||20
9069116|NCT03954158|10129716|FG000|NOT COMPLETED|Overall Study||0
9069117|NCT03954158|10129717|FG001|NOT COMPLETED|Overall Study||0
9069118|NCT03954158|10129718|FG002|NOT COMPLETED|Overall Study||0
9069119|NCT03954158|10129719|FG003|NOT COMPLETED|Overall Study||0
9069120|NCT03958656|10129756|FG000|STARTED|Overall Study||3
9069121|NCT03958656|10129757|FG001|STARTED|Overall Study||4
9069122|NCT03958656|10129758|FG002|STARTED|Overall Study||5
9069123|NCT03958656|10129759|FG003|STARTED|Overall Study||1
9069124|NCT03958656|10129756|FG000|COMPLETED|Overall Study||3
9069125|NCT03958656|10129757|FG001|COMPLETED|Overall Study||3
9069126|NCT03958656|10129758|FG002|COMPLETED|Overall Study||3
9069127|NCT03958656|10129759|FG003|COMPLETED|Overall Study||1
9069128|NCT03958656|10129756|FG000|NOT COMPLETED|Overall Study||0
9069129|NCT03958656|10129757|FG001|NOT COMPLETED|Overall Study||1
9069130|NCT03958656|10129758|FG002|NOT COMPLETED|Overall Study||2
9069131|NCT03958656|10129759|FG003|NOT COMPLETED|Overall Study||0
9069132|NCT03955133|10129769|FG000|STARTED|Overall Study|participants recruited from 3 care homes|19
9069133|NCT03955133|10129769|FG000|COMPLETED|Overall Study|End of study funding|19
9069134|NCT03955133|10129769|FG000|NOT COMPLETED|Overall Study||0
9069135|NCT03954626|10129774|FG000|STARTED|Overall Study||14
9069136|NCT03954626|10129774|FG000|COMPLETED|Overall Study||14
9069137|NCT03954626|10129774|FG000|NOT COMPLETED|Overall Study||0
9069138|NCT03951805|10129782|FG000|STARTED|Overall Study||51
9069139|NCT03951805|10129783|FG001|STARTED|Overall Study||51
9069140|NCT03951805|10129784|FG002|STARTED|Overall Study||52
9069141|NCT03951805|10129785|FG003|STARTED|Overall Study||51
9069142|NCT03951805|10129782|FG000|Full Analysis Set (FAS)|Overall Study||51
9069143|NCT03951805|10129783|FG001|Full Analysis Set (FAS)|Overall Study||51
9069144|NCT03951805|10129784|FG002|Full Analysis Set (FAS)|Overall Study||52
9069145|NCT03951805|10129785|FG003|Full Analysis Set (FAS)|Overall Study||51
9069146|NCT03951805|10129782|FG000|Safety Analysis Set (SAS)|Overall Study||51
9069147|NCT03951805|10129783|FG001|Safety Analysis Set (SAS)|Overall Study||51
9069148|NCT03951805|10129784|FG002|Safety Analysis Set (SAS)|Overall Study||52
9069149|NCT03951805|10129785|FG003|Safety Analysis Set (SAS)|Overall Study||51
9069150|NCT03951805|10129782|FG000|COMPLETED|Overall Study||50
9069151|NCT03951805|10129783|FG001|COMPLETED|Overall Study||51
9069152|NCT03951805|10129784|FG002|COMPLETED|Overall Study||52
9069153|NCT03951805|10129785|FG003|COMPLETED|Overall Study||51
9069154|NCT03951805|10129782|FG000|NOT COMPLETED|Overall Study||1
9069155|NCT03951805|10129783|FG001|NOT COMPLETED|Overall Study||0
9069156|NCT03951805|10129784|FG002|NOT COMPLETED|Overall Study||0
9069157|NCT03951805|10129785|FG003|NOT COMPLETED|Overall Study||0
9069158|NCT03944785|10129798|FG000|STARTED|2 Month Study Completion||2
9069159|NCT03944785|10129799|FG001|STARTED|2 Month Study Completion||34
9069160|NCT03944785|10129800|FG002|STARTED|2 Month Study Completion||128
9069161|NCT03944785|10129798|FG000|COMPLETED|2 Month Study Completion||2
9069162|NCT03944785|10129799|FG001|COMPLETED|2 Month Study Completion||30
9069163|NCT03944785|10129800|FG002|COMPLETED|2 Month Study Completion||123
9069164|NCT03944785|10129798|FG000|NOT COMPLETED|2 Month Study Completion||0
9069165|NCT03944785|10129799|FG001|NOT COMPLETED|2 Month Study Completion||4
9069166|NCT03944785|10129800|FG002|NOT COMPLETED|2 Month Study Completion||5
9069167|NCT03944785|10129798|FG000|STARTED|4 Month Study Optional Extension||1
9069168|NCT03944785|10129799|FG001|STARTED|4 Month Study Optional Extension||10
9069169|NCT03944785|10129800|FG002|STARTED|4 Month Study Optional Extension||64
9069170|NCT03944785|10129798|FG000|COMPLETED|4 Month Study Optional Extension||0
9069171|NCT03944785|10129799|FG001|COMPLETED|4 Month Study Optional Extension||8
9069172|NCT03944785|10129800|FG002|COMPLETED|4 Month Study Optional Extension||41
9069173|NCT03944785|10129798|FG000|NOT COMPLETED|4 Month Study Optional Extension||1
9069174|NCT03944785|10129799|FG001|NOT COMPLETED|4 Month Study Optional Extension||2
9069175|NCT03944785|10129800|FG002|NOT COMPLETED|4 Month Study Optional Extension||23
9069176|NCT03950622|10129810|FG000|STARTED|Overall Study||604
9069177|NCT03950622|10129811|FG001|STARTED|Overall Study||601
9069178|NCT03950622|10129810|FG000|Vaccinated|Overall Study||602
9069179|NCT03950622|10129811|FG001|Vaccinated|Overall Study||600
9069180|NCT03950622|10129810|FG000|COMPLETED|Overall Study||596
9069181|NCT03950622|10129811|FG001|COMPLETED|Overall Study||594
9069182|NCT03950622|10129810|FG000|NOT COMPLETED|Overall Study||8
9069183|NCT03950622|10129811|FG001|NOT COMPLETED|Overall Study||7
9069184|NCT03949621|10129819|FG000|STARTED|Overall Study||12
9069185|NCT03949621|10129820|FG001|STARTED|Overall Study||12
9069186|NCT03949621|10129819|FG000|COMPLETED|Overall Study||12
9069187|NCT03949621|10129820|FG001|COMPLETED|Overall Study||12
9069188|NCT03949621|10129819|FG000|NOT COMPLETED|Overall Study||0
9069189|NCT03949621|10129820|FG001|NOT COMPLETED|Overall Study||0
9069190|NCT03949244|10129829|FG000|STARTED|Overall Study||12
9069191|NCT03949244|10129830|FG001|STARTED|Overall Study||21
9069192|NCT03949244|10129831|FG002|STARTED|Overall Study||14
9069193|NCT03949244|10129829|FG000|COMPLETED|Overall Study||12
9069194|NCT03949244|10129830|FG001|COMPLETED|Overall Study||21
9069195|NCT03949244|10129831|FG002|COMPLETED|Overall Study||14
8623871|NCT00495677|9663048|FG005|NOT COMPLETED|Stage 2 (25 Days)||0
8623872|NCT00495677|9663049|FG006|NOT COMPLETED|Stage 2 (25 Days)||0
8623873|NCT00495755|9663065|FG000|STARTED|Overall Study||13
8623874|NCT00495755|9663065|FG000|COMPLETED|Overall Study||10
8623875|NCT00495755|9663065|FG000|NOT COMPLETED|Overall Study||3
9069196|NCT03949244|10129829|FG000|NOT COMPLETED|Overall Study||0
9069197|NCT03949244|10129830|FG001|NOT COMPLETED|Overall Study||0
9069198|NCT03949244|10129831|FG002|NOT COMPLETED|Overall Study||0
9069199|NCT03948581|10129841|FG000|STARTED|Overall Study||51
9069200|NCT03948581|10129842|FG001|STARTED|Overall Study||51
9069201|NCT03948581|10129841|FG000|COMPLETED|Overall Study||51
9069202|NCT03948581|10129842|FG001|COMPLETED|Overall Study||50
9069203|NCT03948581|10129841|FG000|NOT COMPLETED|Overall Study||0
9069204|NCT03948581|10129842|FG001|NOT COMPLETED|Overall Study||1
9069205|NCT03948386|10129851|FG000|STARTED|Overall Study||52
9069206|NCT03948386|10129852|FG001|STARTED|Overall Study||54
9069207|NCT03948386|10129853|FG002|STARTED|Overall Study||53
9069208|NCT03948386|10129851|FG000|COMPLETED|Overall Study||51
9069209|NCT03948386|10129852|FG001|COMPLETED|Overall Study||53
9069210|NCT03948386|10129853|FG002|COMPLETED|Overall Study||50
9069211|NCT03948386|10129851|FG000|NOT COMPLETED|Overall Study||1
9069212|NCT03948386|10129852|FG001|NOT COMPLETED|Overall Study||1
9069213|NCT03948386|10129853|FG002|NOT COMPLETED|Overall Study||3
9069214|NCT03948334|10129863|FG000|STARTED|Overall Study||60
9069215|NCT03948334|10129864|FG001|STARTED|Overall Study||63
9069216|NCT03948334|10129863|FG000|COMPLETED|Overall Study||0
9069217|NCT03948334|10129864|FG001|COMPLETED|Overall Study||0
9069218|NCT03948334|10129863|FG000|NOT COMPLETED|Overall Study||60
9069219|NCT03948334|10129864|FG001|NOT COMPLETED|Overall Study||63
9069220|NCT03946059|10129880|FG000|STARTED|Overall Study||13
9069221|NCT03946059|10129881|FG001|STARTED|Overall Study||12
9069222|NCT03946059|10129880|FG000|COMPLETED|Overall Study||13
9069223|NCT03946059|10129881|FG001|COMPLETED|Overall Study||11
9069224|NCT03946059|10129880|FG000|NOT COMPLETED|Overall Study||0
9069225|NCT03946059|10129881|FG001|NOT COMPLETED|Overall Study||1
9069226|NCT03944707|10129891|FG000|STARTED|Overall Study||47
9069227|NCT03944707|10129892|FG001|STARTED|Overall Study||29
9069228|NCT03944707|10129891|FG000|PK Analysis Set|Overall Study||33
9069229|NCT03944707|10129892|FG001|PK Analysis Set|Overall Study||0
9069230|NCT03944707|10129891|FG000|PD Analysis Set|Overall Study||47
9069231|NCT03944707|10129892|FG001|PD Analysis Set|Overall Study||29
9069232|NCT03944707|10129891|FG000|COMPLETED|Overall Study||35
9069233|NCT03944707|10129892|FG001|COMPLETED|Overall Study||19
9069234|NCT03944707|10129891|FG000|NOT COMPLETED|Overall Study||12
9069235|NCT03944707|10129892|FG001|NOT COMPLETED|Overall Study||10
8623876|NCT00495794|9663072|FG000|STARTED|Overall Study||2319
9069236|NCT03944668|10129898|FG000|STARTED|Overall Study|Enrolled in Study|17
9069237|NCT03944668|10129898|FG000|Able to Use Patient Data|Overall Study|3 Patient's Data Unusable|14
9069238|NCT03944668|10129898|FG000|Participated in Intervention|Overall Study|Started Cardiac Rehabilitation|10
9069239|NCT03944668|10129898|FG000|COMPLETED|Overall Study|Completed 75% of Comprehensive Cardiac Rehabilitation Sessions|8
9069240|NCT03944668|10129898|FG000|NOT COMPLETED|Overall Study||9
9069241|NCT03943160|10129903|FG000|STARTED|Overall Study||50
9069242|NCT03943160|10129903|FG000|COMPLETED|Overall Study||50
9069243|NCT03943160|10129903|FG000|NOT COMPLETED|Overall Study||0
9069244|NCT03943095|10129909|FG000|STARTED|Overall Study||52
9069245|NCT03943095|10129910|FG001|STARTED|Overall Study||52
9069246|NCT03943095|10129909|FG000|COMPLETED|Overall Study||51
9069247|NCT03943095|10129910|FG001|COMPLETED|Overall Study||51
9069248|NCT03943095|10129909|FG000|NOT COMPLETED|Overall Study||1
9069249|NCT03943095|10129910|FG001|NOT COMPLETED|Overall Study||1
9069250|NCT03943290|10129926|FG000|STARTED|Overall Study||7
9069251|NCT03943290|10129927|FG001|STARTED|Overall Study||1
9069252|NCT03943290|10129928|FG002|STARTED|Overall Study||13
9069253|NCT03943290|10129929|FG003|STARTED|Overall Study||6
9069254|NCT03943290|10129930|FG004|STARTED|Overall Study||7
9069255|NCT03943290|10129931|FG005|STARTED|Overall Study||6
9069256|NCT03943290|10129932|FG006|STARTED|Overall Study||6
9069257|NCT03943290|10129933|FG007|STARTED|Overall Study||8
9069258|NCT03943290|10129934|FG008|STARTED|Overall Study||8
9069259|NCT03943290|10129926|FG000|COMPLETED|Overall Study||0
9069260|NCT03943290|10129927|FG001|COMPLETED|Overall Study||0
8623877|NCT00495794|9663073|FG001|STARTED|Overall Study||2303
9069261|NCT03943290|10129928|FG002|COMPLETED|Overall Study||0
9069262|NCT03943290|10129929|FG003|COMPLETED|Overall Study||0
9069263|NCT03943290|10129930|FG004|COMPLETED|Overall Study||0
9069264|NCT03943290|10129931|FG005|COMPLETED|Overall Study||0
9069265|NCT03943290|10129932|FG006|COMPLETED|Overall Study||0
9069266|NCT03943290|10129933|FG007|COMPLETED|Overall Study||0
9069267|NCT03943290|10129934|FG008|COMPLETED|Overall Study||0
9069268|NCT03943290|10129926|FG000|NOT COMPLETED|Overall Study||7
9069269|NCT03943290|10129927|FG001|NOT COMPLETED|Overall Study||1
9069270|NCT03943290|10129928|FG002|NOT COMPLETED|Overall Study||13
9069271|NCT03943290|10129929|FG003|NOT COMPLETED|Overall Study||6
9069272|NCT03943290|10129930|FG004|NOT COMPLETED|Overall Study||7
9069273|NCT03943290|10129931|FG005|NOT COMPLETED|Overall Study||6
9069274|NCT03943290|10129932|FG006|NOT COMPLETED|Overall Study||6
9069275|NCT03943290|10129933|FG007|NOT COMPLETED|Overall Study||8
9069276|NCT03943290|10129934|FG008|NOT COMPLETED|Overall Study||8
9069277|NCT03942042|10129969|FG000|STARTED|Induction Dosing Period (12 Weeks)||7
9069278|NCT03942042|10129970|FG001|STARTED|Induction Dosing Period (12 Weeks)||5
9069279|NCT03942042|10129969|FG000|Received at Least One Dose of Study Drug|Induction Dosing Period (12 Weeks)||7
9069280|NCT03942042|10129970|FG001|Received at Least One Dose of Study Drug|Induction Dosing Period (12 Weeks)||5
9069281|NCT03942042|10129969|FG000|Participants With GIS=1 at Week 12|Induction Dosing Period (12 Weeks)||4
9069282|NCT03942042|10129970|FG001|Participants With GIS=1 at Week 12|Induction Dosing Period (12 Weeks)||0
9069283|NCT03942042|10129969|FG000|Participants Who Completed Week 12 With GIS >= 2|Induction Dosing Period (12 Weeks)||2
9069284|NCT03942042|10129970|FG001|Participants Who Completed Week 12 With GIS >= 2|Induction Dosing Period (12 Weeks)||4
9069285|NCT03942042|10129969|FG000|COMPLETED|Induction Dosing Period (12 Weeks)||6
9069286|NCT03942042|10129970|FG001|COMPLETED|Induction Dosing Period (12 Weeks)||4
9069287|NCT03942042|10129969|FG000|NOT COMPLETED|Induction Dosing Period (12 Weeks)||1
9069288|NCT03942042|10129970|FG001|NOT COMPLETED|Induction Dosing Period (12 Weeks)||1
9069289|NCT03942042|10129969|FG000|STARTED|Maintenance Dosing Period (8 Weeks)|Only participants with GIS ≥2 at Week 12 and based on investigators' discretion continued to maintenance dosing period.|2
9069290|NCT03942042|10129970|FG001|STARTED|Maintenance Dosing Period (8 Weeks)||4
9069291|NCT03942042|10129969|FG000|COMPLETED|Maintenance Dosing Period (8 Weeks)||2
9069292|NCT03942042|10129970|FG001|COMPLETED|Maintenance Dosing Period (8 Weeks)||4
9069293|NCT03942042|10129969|FG000|NOT COMPLETED|Maintenance Dosing Period (8 Weeks)||0
9069294|NCT03942042|10129970|FG001|NOT COMPLETED|Maintenance Dosing Period (8 Weeks)||0
9069295|NCT03938337|10129982|FG000|STARTED|Overall Study||1
9069296|NCT03938337|10129983|FG001|STARTED|Overall Study||0
9069297|NCT03938337|10129982|FG000|COMPLETED|Overall Study||1
9069298|NCT03938337|10129983|FG001|COMPLETED|Overall Study||0
9069299|NCT03938337|10129982|FG000|NOT COMPLETED|Overall Study||0
9069300|NCT03938337|10129983|FG001|NOT COMPLETED|Overall Study||0
9069301|NCT03923530|10129989|FG000|STARTED|Overall Study||12
9069302|NCT03923530|10129989|FG000|COMPLETED|Overall Study||8
9069303|NCT03923530|10129989|FG000|NOT COMPLETED|Overall Study||4
9069304|NCT03914417|10129993|FG000|STARTED|Overall Study||21
9069305|NCT03914417|10129993|FG000|COMPLETED|Overall Study||19
9069306|NCT03914417|10129993|FG000|NOT COMPLETED|Overall Study||2
9069307|NCT03913377|10129999|FG000|STARTED|Period 1||21
9069308|NCT03913377|10130000|FG001|STARTED|Period 1||22
9069309|NCT03913377|10130001|FG002|STARTED|Period 1||22
9069310|NCT03913377|10129999|FG000|COMPLETED|Period 1||21
9069311|NCT03913377|10130000|FG001|COMPLETED|Period 1||21
9069312|NCT03913377|10130001|FG002|COMPLETED|Period 1||21
9069313|NCT03913377|10129999|FG000|NOT COMPLETED|Period 1||0
9069314|NCT03913377|10130000|FG001|NOT COMPLETED|Period 1||1
9069315|NCT03913377|10130001|FG002|NOT COMPLETED|Period 1||1
9069316|NCT03913377|10129999|FG000|STARTED|Period 2||0
9069317|NCT03913377|10130000|FG001|STARTED|Period 2||21
9069318|NCT03913377|10130001|FG002|STARTED|Period 2||21
9069319|NCT03913377|10129999|FG000|COMPLETED|Period 2||0
9069320|NCT03913377|10130000|FG001|COMPLETED|Period 2||21
9069321|NCT03913377|10130001|FG002|COMPLETED|Period 2||21
9069322|NCT03913377|10129999|FG000|NOT COMPLETED|Period 2||0
9069323|NCT03913377|10130000|FG001|NOT COMPLETED|Period 2||0
9069324|NCT03913377|10130001|FG002|NOT COMPLETED|Period 2||0
9069325|NCT03937791|10130008|FG000|STARTED|Overall Study||1
9069326|NCT03937791|10130008|FG000|COMPLETED|Overall Study||1
9069327|NCT03937791|10130008|FG000|NOT COMPLETED|Overall Study||0
9069328|NCT03937778|10130012|FG000|STARTED|Overall Study||7
9069329|NCT03937778|10130012|FG000|COMPLETED|Overall Study||5
9069330|NCT03937778|10130012|FG000|NOT COMPLETED|Overall Study||2
9069331|NCT03937479|10130021|FG000|STARTED|Overall Study||83
9069332|NCT03937479|10130022|FG001|STARTED|Overall Study||85
9069333|NCT03937479|10130023|FG002|STARTED|Overall Study||82
9069334|NCT03937479|10130024|FG003|STARTED|Overall Study||82
9069335|NCT03937479|10130025|FG004|STARTED|Overall Study||84
9069336|NCT03937479|10130021|FG000|Received Treatment|Overall Study||83
9069337|NCT03937479|10130022|FG001|Received Treatment|Overall Study||83
9069338|NCT03937479|10130023|FG002|Received Treatment|Overall Study||81
9069339|NCT03937479|10130024|FG003|Received Treatment|Overall Study||82
9069340|NCT03937479|10130025|FG004|Received Treatment|Overall Study||84
9069341|NCT03937479|10130021|FG000|COMPLETED|Overall Study||73
9069342|NCT03937479|10130022|FG001|COMPLETED|Overall Study||70
9069343|NCT03937479|10130023|FG002|COMPLETED|Overall Study||75
9069344|NCT03937479|10130024|FG003|COMPLETED|Overall Study||76
9069345|NCT03937479|10130025|FG004|COMPLETED|Overall Study||79
9069346|NCT03937479|10130021|FG000|NOT COMPLETED|Overall Study||10
9069347|NCT03937479|10130022|FG001|NOT COMPLETED|Overall Study||15
9069348|NCT03937479|10130023|FG002|NOT COMPLETED|Overall Study||7
9069349|NCT03937479|10130024|FG003|NOT COMPLETED|Overall Study||6
9069350|NCT03937479|10130025|FG004|NOT COMPLETED|Overall Study||5
9069351|NCT03936387|10130037|FG000|STARTED|Overall Study||10
9069352|NCT03936387|10130037|FG000|COMPLETED|Overall Study||10
9069353|NCT03936387|10130037|FG000|NOT COMPLETED|Overall Study||0
9069354|NCT03935399|10130043|FG000|STARTED|First Study Day||5
9069355|NCT03935399|10130044|FG001|STARTED|First Study Day||5
9069356|NCT03935399|10130043|FG000|COMPLETED|First Study Day||5
9069357|NCT03935399|10130044|FG001|COMPLETED|First Study Day||5
9069358|NCT03935399|10130043|FG000|NOT COMPLETED|First Study Day||0
9069359|NCT03935399|10130044|FG001|NOT COMPLETED|First Study Day||0
9069360|NCT03935399|10130043|FG000|STARTED|Second Study Day||5
9069361|NCT03935399|10130044|FG001|STARTED|Second Study Day||5
9069362|NCT03935399|10130043|FG000|COMPLETED|Second Study Day||5
9069363|NCT03935399|10130044|FG001|COMPLETED|Second Study Day||5
9069364|NCT03935399|10130043|FG000|NOT COMPLETED|Second Study Day||0
9069365|NCT03935399|10130044|FG001|NOT COMPLETED|Second Study Day||0
9069366|NCT03936608|10130052|FG000|STARTED|Overall Study||2
9069367|NCT03936608|10130053|FG001|STARTED|Overall Study||2
9069368|NCT03936608|10130052|FG000|COMPLETED|Overall Study||0
9069369|NCT03936608|10130053|FG001|COMPLETED|Overall Study||0
9069370|NCT03936608|10130052|FG000|NOT COMPLETED|Overall Study||2
9069371|NCT03936608|10130053|FG001|NOT COMPLETED|Overall Study||2
9069372|NCT03936244|10130061|FG000|STARTED|Overall Study||57
9069373|NCT03936244|10130062|FG001|STARTED|Overall Study||43
9069374|NCT03936244|10130061|FG000|COMPLETED|Overall Study||45
9069375|NCT03936244|10130062|FG001|COMPLETED|Overall Study||39
9069376|NCT03936244|10130061|FG000|NOT COMPLETED|Overall Study||12
9069377|NCT03936244|10130062|FG001|NOT COMPLETED|Overall Study||4
9069378|NCT03935126|10130069|FG000|STARTED|Overall Study||3
8623878|NCT00495794|9663072|FG000|COMPLETED|Overall Study||1797
8623879|NCT00495794|9663073|FG001|COMPLETED|Overall Study||2303
9069379|NCT03935126|10130069|FG000|COMPLETED|Overall Study||0
9069380|NCT03935126|10130069|FG000|NOT COMPLETED|Overall Study||3
9069381|NCT03928327|10130075|FG000|STARTED|Period 1||12
9069382|NCT03928327|10130076|FG001|STARTED|Period 1||12
9069383|NCT03928327|10130075|FG000|COMPLETED|Period 1||12
9069384|NCT03928327|10130076|FG001|COMPLETED|Period 1||12
9069385|NCT03928327|10130075|FG000|NOT COMPLETED|Period 1||0
9069386|NCT03928327|10130076|FG001|NOT COMPLETED|Period 1||0
9069387|NCT03928327|10130075|FG000|STARTED|Washout Period||12
9069388|NCT03928327|10130076|FG001|STARTED|Washout Period||12
9069389|NCT03928327|10130075|FG000|COMPLETED|Washout Period||12
9069390|NCT03928327|10130076|FG001|COMPLETED|Washout Period||12
9069391|NCT03928327|10130075|FG000|NOT COMPLETED|Washout Period||0
9069392|NCT03928327|10130076|FG001|NOT COMPLETED|Washout Period||0
9069393|NCT03928327|10130075|FG000|STARTED|Period 2||12
9069394|NCT03928327|10130076|FG001|STARTED|Period 2||12
9069395|NCT03928327|10130075|FG000|COMPLETED|Period 2||12
9069396|NCT03928327|10130076|FG001|COMPLETED|Period 2||12
9069397|NCT03928327|10130075|FG000|NOT COMPLETED|Period 2||0
9069398|NCT03928327|10130076|FG001|NOT COMPLETED|Period 2||0
9069399|NCT03933462|10130088|FG000|STARTED|Overall Study||10
9069400|NCT03933462|10130089|FG001|STARTED|Overall Study||10
9069401|NCT03933462|10130088|FG000|Crossover|Overall Study||8
9069402|NCT03933462|10130089|FG001|Crossover|Overall Study||10
9069403|NCT03933462|10130088|FG000|COMPLETED|Overall Study||8
9069404|NCT03933462|10130089|FG001|COMPLETED|Overall Study||10
9069405|NCT03933462|10130088|FG000|NOT COMPLETED|Overall Study||2
9069406|NCT03933462|10130089|FG001|NOT COMPLETED|Overall Study||0
9069407|NCT03933774|10130097|FG000|STARTED|Overall Study||12
9069408|NCT03933774|10130098|FG001|STARTED|Overall Study||13
9069409|NCT03933774|10130097|FG000|COMPLETED|Overall Study||10
9069410|NCT03933774|10130098|FG001|COMPLETED|Overall Study||11
9069411|NCT03933774|10130097|FG000|NOT COMPLETED|Overall Study||2
9069412|NCT03933774|10130098|FG001|NOT COMPLETED|Overall Study||2
9069413|NCT03931330|10130104|FG000|STARTED|Overall Study||8
9069414|NCT03931330|10130104|FG000|4 Weeks of Neuromodulation|Overall Study|at 4 weeks of neuromodulation|7
9069415|NCT03931330|10130104|FG000|COMPLETED|Overall Study||7
9069416|NCT03931330|10130104|FG000|NOT COMPLETED|Overall Study||1
9069417|NCT03918811|10130111|FG000|STARTED|Overall Study||367
9069418|NCT03918811|10130112|FG001|STARTED|Overall Study||358
9069419|NCT03918811|10130111|FG000|COMPLETED|Overall Study||363
9069420|NCT03918811|10130112|FG001|COMPLETED|Overall Study||345
9069421|NCT03918811|10130111|FG000|NOT COMPLETED|Overall Study||4
9069422|NCT03918811|10130112|FG001|NOT COMPLETED|Overall Study||13
9069423|NCT03933618|10130124|FG000|STARTED|Baseline||4
9069424|NCT03933618|10130125|FG001|STARTED|Baseline||4
9069425|NCT03933618|10130126|FG002|STARTED|Baseline||4
9069426|NCT03933618|10130127|FG003|STARTED|Baseline||4
9069427|NCT03933618|10130128|FG004|STARTED|Baseline||4
9069428|NCT03933618|10130129|FG005|STARTED|Baseline||4
9069429|NCT03933618|10130124|FG000|COMPLETED|Baseline||4
9069430|NCT03933618|10130125|FG001|COMPLETED|Baseline||4
9069431|NCT03933618|10130126|FG002|COMPLETED|Baseline||4
9069432|NCT03933618|10130127|FG003|COMPLETED|Baseline||4
9069433|NCT03933618|10130128|FG004|COMPLETED|Baseline||4
9069434|NCT03933618|10130129|FG005|COMPLETED|Baseline||4
9069435|NCT03933618|10130124|FG000|NOT COMPLETED|Baseline||0
9069436|NCT03933618|10130125|FG001|NOT COMPLETED|Baseline||0
9069437|NCT03933618|10130126|FG002|NOT COMPLETED|Baseline||0
9069438|NCT03933618|10130127|FG003|NOT COMPLETED|Baseline||0
9069439|NCT03933618|10130128|FG004|NOT COMPLETED|Baseline||0
9069440|NCT03933618|10130129|FG005|NOT COMPLETED|Baseline||0
9069441|NCT03933618|10130124|FG000|STARTED|Baseline to Week 8||4
9069442|NCT03933618|10130125|FG001|STARTED|Baseline to Week 8||4
9069443|NCT03933618|10130126|FG002|STARTED|Baseline to Week 8||4
9069444|NCT03933618|10130127|FG003|STARTED|Baseline to Week 8||4
9069445|NCT03933618|10130128|FG004|STARTED|Baseline to Week 8||4
9069446|NCT03933618|10130129|FG005|STARTED|Baseline to Week 8||4
9069447|NCT03933618|10130124|FG000|COMPLETED|Baseline to Week 8||4
9069448|NCT03933618|10130125|FG001|COMPLETED|Baseline to Week 8||4
9069449|NCT03933618|10130126|FG002|COMPLETED|Baseline to Week 8||4
9069450|NCT03933618|10130127|FG003|COMPLETED|Baseline to Week 8||4
9069451|NCT03933618|10130128|FG004|COMPLETED|Baseline to Week 8||4
9069452|NCT03933618|10130129|FG005|COMPLETED|Baseline to Week 8||4
9069453|NCT03933618|10130124|FG000|NOT COMPLETED|Baseline to Week 8||0
9069454|NCT03933618|10130125|FG001|NOT COMPLETED|Baseline to Week 8||0
9069455|NCT03933618|10130126|FG002|NOT COMPLETED|Baseline to Week 8||0
9069456|NCT03933618|10130127|FG003|NOT COMPLETED|Baseline to Week 8||0
9069457|NCT03933618|10130128|FG004|NOT COMPLETED|Baseline to Week 8||0
9069458|NCT03933618|10130129|FG005|NOT COMPLETED|Baseline to Week 8||0
9069459|NCT03933618|10130124|FG000|STARTED|Week 8 to Week 16||4
9069460|NCT03933618|10130125|FG001|STARTED|Week 8 to Week 16||4
9069461|NCT03933618|10130126|FG002|STARTED|Week 8 to Week 16||4
9069462|NCT03933618|10130127|FG003|STARTED|Week 8 to Week 16||4
9069463|NCT03933618|10130128|FG004|STARTED|Week 8 to Week 16||4
9069464|NCT03933618|10130129|FG005|STARTED|Week 8 to Week 16||4
9069465|NCT03933618|10130124|FG000|COMPLETED|Week 8 to Week 16||4
9069466|NCT03933618|10130125|FG001|COMPLETED|Week 8 to Week 16||4
9069467|NCT03933618|10130126|FG002|COMPLETED|Week 8 to Week 16||4
9069468|NCT03933618|10130127|FG003|COMPLETED|Week 8 to Week 16||4
9069469|NCT03933618|10130128|FG004|COMPLETED|Week 8 to Week 16||4
9069470|NCT03933618|10130129|FG005|COMPLETED|Week 8 to Week 16||4
9069471|NCT03933618|10130124|FG000|NOT COMPLETED|Week 8 to Week 16||0
9069472|NCT03933618|10130125|FG001|NOT COMPLETED|Week 8 to Week 16||0
9069473|NCT03933618|10130126|FG002|NOT COMPLETED|Week 8 to Week 16||0
9069474|NCT03933618|10130127|FG003|NOT COMPLETED|Week 8 to Week 16||0
9069475|NCT03933618|10130128|FG004|NOT COMPLETED|Week 8 to Week 16||0
9069476|NCT03933618|10130129|FG005|NOT COMPLETED|Week 8 to Week 16||0
9069477|NCT03933618|10130124|FG000|STARTED|Week 16 to Week 24||4
9069478|NCT03933618|10130125|FG001|STARTED|Week 16 to Week 24||4
9069479|NCT03933618|10130126|FG002|STARTED|Week 16 to Week 24||4
9069480|NCT03933618|10130127|FG003|STARTED|Week 16 to Week 24||4
9069481|NCT03933618|10130128|FG004|STARTED|Week 16 to Week 24||4
9069482|NCT03933618|10130129|FG005|STARTED|Week 16 to Week 24||4
9069483|NCT03933618|10130124|FG000|COMPLETED|Week 16 to Week 24||4
9069484|NCT03933618|10130125|FG001|COMPLETED|Week 16 to Week 24||4
9069485|NCT03933618|10130126|FG002|COMPLETED|Week 16 to Week 24||4
9069486|NCT03933618|10130127|FG003|COMPLETED|Week 16 to Week 24||4
9069487|NCT03933618|10130128|FG004|COMPLETED|Week 16 to Week 24||4
9069488|NCT03933618|10130129|FG005|COMPLETED|Week 16 to Week 24||4
9069489|NCT03933618|10130124|FG000|NOT COMPLETED|Week 16 to Week 24||0
9069490|NCT03933618|10130125|FG001|NOT COMPLETED|Week 16 to Week 24||0
9069491|NCT03933618|10130126|FG002|NOT COMPLETED|Week 16 to Week 24||0
9069492|NCT03933618|10130127|FG003|NOT COMPLETED|Week 16 to Week 24||0
9069493|NCT03933618|10130128|FG004|NOT COMPLETED|Week 16 to Week 24||0
9069494|NCT03933618|10130129|FG005|NOT COMPLETED|Week 16 to Week 24||0
9069495|NCT03931785|10130147|FG000|STARTED|Overall Study||97
9069496|NCT03931785|10130148|FG001|STARTED|Overall Study||97
9069497|NCT03931785|10130149|FG002|STARTED|Overall Study||97
9069498|NCT03931785|10130150|FG003|STARTED|Overall Study||97
9069499|NCT03931785|10130147|FG000|COMPLETED|Overall Study||92
9069500|NCT03931785|10130148|FG001|COMPLETED|Overall Study||90
9069501|NCT03931785|10130149|FG002|COMPLETED|Overall Study||84
9069502|NCT03931785|10130150|FG003|COMPLETED|Overall Study||86
9069503|NCT03931785|10130147|FG000|NOT COMPLETED|Overall Study||5
9069504|NCT03931785|10130148|FG001|NOT COMPLETED|Overall Study||7
9069505|NCT03931785|10130149|FG002|NOT COMPLETED|Overall Study||13
9069506|NCT03931785|10130150|FG003|NOT COMPLETED|Overall Study||11
9069507|NCT03930641|10130160|FG000|STARTED|Overall Study||34
9069508|NCT03930641|10130160|FG000|COMPLETED|Overall Study||34
9069509|NCT03930641|10130160|FG000|NOT COMPLETED|Overall Study||0
9069510|NCT03927846|10130166|FG000|STARTED|Overall Study||30
9069511|NCT03927846|10130167|FG001|STARTED|Overall Study||30
9069512|NCT03927846|10130166|FG000|COMPLETED|Overall Study||20
9069513|NCT03927846|10130167|FG001|COMPLETED|Overall Study||19
9069514|NCT03927846|10130166|FG000|NOT COMPLETED|Overall Study||10
9069515|NCT03927846|10130167|FG001|NOT COMPLETED|Overall Study||11
9069516|NCT03927105|10130173|FG000|STARTED|Overall Study||4
9069517|NCT03927105|10130173|FG000|Began Treatment|Overall Study||3
9069518|NCT03927105|10130173|FG000|Follow-up|Overall Study||3
9069519|NCT03927105|10130173|FG000|COMPLETED|Overall Study||0
9069520|NCT03927105|10130173|FG000|NOT COMPLETED|Overall Study||4
9069521|NCT03923933|10130179|FG000|STARTED|Overall Study||17
9069522|NCT03923933|10130180|FG001|STARTED|Overall Study||17
9069523|NCT03923933|10130179|FG000|COMPLETED|Overall Study||16
9069524|NCT03923933|10130180|FG001|COMPLETED|Overall Study||16
9069525|NCT03923933|10130179|FG000|NOT COMPLETED|Overall Study||1
9069526|NCT03923933|10130180|FG001|NOT COMPLETED|Overall Study||1
9069527|NCT03909295|10130186|FG000|STARTED|Overall Study||52
9069528|NCT03909295|10130186|FG000|Safety Set (SAF)|Overall Study||52
9069529|NCT03909295|10130186|FG000|COMPLETED|Overall Study||0
9069530|NCT03909295|10130186|FG000|NOT COMPLETED|Overall Study||52
9069531|NCT03908970|10130192|FG000|STARTED|Overall Study||182
9069532|NCT03908970|10130193|FG001|STARTED|Overall Study||182
9069533|NCT03908970|10130192|FG000|COMPLETED|Overall Study||165
9069534|NCT03908970|10130193|FG001|COMPLETED|Overall Study||135
9069535|NCT03908970|10130192|FG000|NOT COMPLETED|Overall Study||17
9069536|NCT03908970|10130193|FG001|NOT COMPLETED|Overall Study||47
9069537|NCT03897179|10130199|FG000|STARTED|Overall Study||27
9069538|NCT03897179|10130199|FG000|COMPLETED|Overall Study||26
9069539|NCT03897179|10130199|FG000|NOT COMPLETED|Overall Study||1
9069540|NCT03930264|10130205|FG000|STARTED|Overall Study||15
9069541|NCT03930264|10130206|FG001|STARTED|Overall Study||15
9069542|NCT03930264|10130205|FG000|COMPLETED|Overall Study||15
8842975|NCT01701258|9897269|FG011|NOT COMPLETED|Drug+fMRI (Session 2)||0
8842976|NCT01701258|9897270|FG012|NOT COMPLETED|Drug+fMRI (Session 2)||0
8842977|NCT01701258|9897258|FG000|STARTED|PET (Session 3)||0
8842978|NCT01701258|9897259|FG001|STARTED|PET (Session 3)||20
9069543|NCT03930264|10130206|FG001|COMPLETED|Overall Study||14
9069544|NCT03930264|10130205|FG000|NOT COMPLETED|Overall Study||0
9069545|NCT03930264|10130206|FG001|NOT COMPLETED|Overall Study||1
9069546|NCT03929367|10130212|FG000|STARTED|Overall Study||11
9069547|NCT03929367|10130212|FG000|COMPLETED|Overall Study||11
9069548|NCT03929367|10130212|FG000|NOT COMPLETED|Overall Study||0
9069549|NCT03928522|10130221|FG000|STARTED|Overall Study||12
9069550|NCT03928522|10130222|FG001|STARTED|Overall Study||12
9069551|NCT03928522|10130223|FG002|STARTED|Overall Study||12
9069552|NCT03928522|10130224|FG003|STARTED|Overall Study||12
9069553|NCT03928522|10130225|FG004|STARTED|Overall Study||12
9069554|NCT03928522|10130221|FG000|COMPLETED|Overall Study||12
9069555|NCT03928522|10130222|FG001|COMPLETED|Overall Study||12
9069556|NCT03928522|10130223|FG002|COMPLETED|Overall Study||12
9069557|NCT03928522|10130224|FG003|COMPLETED|Overall Study||12
9069558|NCT03928522|10130225|FG004|COMPLETED|Overall Study||12
9069559|NCT03928522|10130221|FG000|NOT COMPLETED|Overall Study||0
9069560|NCT03928522|10130222|FG001|NOT COMPLETED|Overall Study||0
9069561|NCT03928522|10130223|FG002|NOT COMPLETED|Overall Study||0
9069562|NCT03928522|10130224|FG003|NOT COMPLETED|Overall Study||0
9069563|NCT03928522|10130225|FG004|NOT COMPLETED|Overall Study||0
9069564|NCT03910439|10130237|FG000|STARTED|Overall Study||4
9069565|NCT03910439|10130237|FG000|COMPLETED|Overall Study||4
9069566|NCT03910439|10130237|FG000|NOT COMPLETED|Overall Study||0
9069567|NCT03907241|10130248|FG000|STARTED|Overall Study||27
9069568|NCT03907241|10130248|FG000|COMPLETED|Overall Study||23
9069569|NCT03907241|10130248|FG000|NOT COMPLETED|Overall Study||4
9069570|NCT03927950|10130263|FG000|STARTED|Overall Study||135
9069571|NCT03927950|10130263|FG000|COMPLETED|Overall Study||126
9069572|NCT03927950|10130263|FG000|NOT COMPLETED|Overall Study||9
9069573|NCT03927781|10130268|FG000|STARTED|Overall Study||10
9069574|NCT03927781|10130268|FG000|COMPLETED|Overall Study||10
9069575|NCT03927781|10130268|FG000|NOT COMPLETED|Overall Study||0
9069576|NCT03927209|10130274|FG000|STARTED|Overall Study||5
9069577|NCT03927209|10130275|FG001|STARTED|Overall Study||5
9069578|NCT03927209|10130274|FG000|COMPLETED|Overall Study||5
9069579|NCT03927209|10130275|FG001|COMPLETED|Overall Study||5
9069580|NCT03927209|10130274|FG000|NOT COMPLETED|Overall Study||0
9069581|NCT03927209|10130275|FG001|NOT COMPLETED|Overall Study||0
9069582|NCT03920670|10130285|FG000|STARTED|Overall Study||60
9069583|NCT03920670|10130286|FG001|STARTED|Overall Study||60
9069584|NCT03920670|10130285|FG000|COMPLETED|Overall Study||57
9069585|NCT03920670|10130286|FG001|COMPLETED|Overall Study||58
9069586|NCT03920670|10130285|FG000|NOT COMPLETED|Overall Study||3
9069587|NCT03920670|10130286|FG001|NOT COMPLETED|Overall Study||2
8948107|NCT02426918|10010432|FG002|NOT COMPLETED|Overall Study||14
9069588|NCT03919422|10130294|FG000|STARTED|Overall Study||40
9069589|NCT03919422|10130295|FG001|STARTED|Overall Study||40
9069590|NCT03919422|10130294|FG000|COMPLETED|Overall Study||40
9069591|NCT03919422|10130295|FG001|COMPLETED|Overall Study||40
8623880|NCT00495794|9663072|FG000|NOT COMPLETED|Overall Study||522
8623881|NCT00495794|9663073|FG001|NOT COMPLETED|Overall Study||0
9069592|NCT03919422|10130294|FG000|NOT COMPLETED|Overall Study||0
9069593|NCT03919422|10130295|FG001|NOT COMPLETED|Overall Study||0
9069594|NCT03907579|10130301|FG000|STARTED|Overall Study||100
9069595|NCT03907579|10130301|FG000|COMPLETED|Overall Study||100
9069596|NCT03907579|10130301|FG000|NOT COMPLETED|Overall Study||0
9069597|NCT03898063|10130307|FG000|STARTED|Overall Study||74
9069598|NCT03898063|10130308|FG001|STARTED|Overall Study||74
9069599|NCT03898063|10130307|FG000|COMPLETED|Overall Study||64
9069600|NCT03898063|10130308|FG001|COMPLETED|Overall Study||66
9069601|NCT03898063|10130307|FG000|NOT COMPLETED|Overall Study||10
9069602|NCT03898063|10130308|FG001|NOT COMPLETED|Overall Study||8
9069603|NCT03895307|10130318|FG000|STARTED|Overall Study||21
9069604|NCT03895307|10130319|FG001|STARTED|Overall Study||20
9069605|NCT03895307|10130320|FG002|STARTED|Overall Study||22
9069606|NCT03895307|10130321|FG003|STARTED|Overall Study||21
9069607|NCT03895307|10130318|FG000|COMPLETED|Overall Study||19
9069608|NCT03895307|10130319|FG001|COMPLETED|Overall Study||20
9069609|NCT03895307|10130320|FG002|COMPLETED|Overall Study||20
9069610|NCT03895307|10130321|FG003|COMPLETED|Overall Study||21
9069611|NCT03895307|10130318|FG000|NOT COMPLETED|Overall Study||2
9069612|NCT03895307|10130319|FG001|NOT COMPLETED|Overall Study||0
9069613|NCT03895307|10130320|FG002|NOT COMPLETED|Overall Study||2
9069614|NCT03895307|10130321|FG003|NOT COMPLETED|Overall Study||0
9069615|NCT03926208|10130333|FG000|STARTED|Overall Study||119
9069616|NCT03926208|10130334|FG001|STARTED|Overall Study||123
9069617|NCT03926208|10130333|FG000|COMPLETED|Overall Study||119
9069618|NCT03926208|10130334|FG001|COMPLETED|Overall Study||123
9069619|NCT03926208|10130333|FG000|NOT COMPLETED|Overall Study||0
9069620|NCT03926208|10130334|FG001|NOT COMPLETED|Overall Study||0
9069621|NCT03926065|10130340|FG000|STARTED|Study Week 1||11
9069622|NCT03926065|10130341|FG001|STARTED|Study Week 1||9
9069623|NCT03926065|10130342|FG002|STARTED|Study Week 1||14
9069624|NCT03926065|10130343|FG003|STARTED|Study Week 1||18
8842979|NCT01701258|9897260|FG002|STARTED|PET (Session 3)||0
8842980|NCT01701258|9897261|FG003|STARTED|PET (Session 3)||0
8842981|NCT01701258|9897262|FG004|STARTED|PET (Session 3)||16
8842982|NCT01701258|9897263|FG005|STARTED|PET (Session 3)||0
9069625|NCT03926065|10130344|FG004|STARTED|Study Week 1||15
9069626|NCT03926065|10130340|FG000|COMPLETED|Study Week 1||11
9069627|NCT03926065|10130341|FG001|COMPLETED|Study Week 1||9
9069628|NCT03926065|10130342|FG002|COMPLETED|Study Week 1||14
9069629|NCT03926065|10130343|FG003|COMPLETED|Study Week 1||18
9069630|NCT03926065|10130344|FG004|COMPLETED|Study Week 1||15
9069631|NCT03926065|10130340|FG000|NOT COMPLETED|Study Week 1||0
9069632|NCT03926065|10130341|FG001|NOT COMPLETED|Study Week 1||0
9069633|NCT03926065|10130342|FG002|NOT COMPLETED|Study Week 1||0
9069634|NCT03926065|10130343|FG003|NOT COMPLETED|Study Week 1||0
9069635|NCT03926065|10130344|FG004|NOT COMPLETED|Study Week 1||0
9069636|NCT03926065|10130340|FG000|STARTED|Study Week 2||11
9069637|NCT03926065|10130341|FG001|STARTED|Study Week 2||9
9069638|NCT03926065|10130342|FG002|STARTED|Study Week 2||14
9069639|NCT03926065|10130343|FG003|STARTED|Study Week 2||18
9069640|NCT03926065|10130344|FG004|STARTED|Study Week 2||15
9069641|NCT03926065|10130340|FG000|COMPLETED|Study Week 2||11
9069642|NCT03926065|10130341|FG001|COMPLETED|Study Week 2||9
9069643|NCT03926065|10130342|FG002|COMPLETED|Study Week 2||14
9069644|NCT03926065|10130343|FG003|COMPLETED|Study Week 2||18
9069645|NCT03926065|10130344|FG004|COMPLETED|Study Week 2||15
9069646|NCT03926065|10130340|FG000|NOT COMPLETED|Study Week 2||0
9069647|NCT03926065|10130341|FG001|NOT COMPLETED|Study Week 2||0
9069648|NCT03926065|10130342|FG002|NOT COMPLETED|Study Week 2||0
9069649|NCT03926065|10130343|FG003|NOT COMPLETED|Study Week 2||0
9069650|NCT03926065|10130344|FG004|NOT COMPLETED|Study Week 2||0
9069651|NCT03926065|10130340|FG000|STARTED|Study Week 3||11
9069652|NCT03926065|10130341|FG001|STARTED|Study Week 3||9
9069653|NCT03926065|10130342|FG002|STARTED|Study Week 3||14
9069654|NCT03926065|10130343|FG003|STARTED|Study Week 3||18
9069655|NCT03926065|10130344|FG004|STARTED|Study Week 3||15
9069656|NCT03926065|10130340|FG000|COMPLETED|Study Week 3||11
9069657|NCT03926065|10130341|FG001|COMPLETED|Study Week 3||9
9069658|NCT03926065|10130342|FG002|COMPLETED|Study Week 3||14
9069659|NCT03926065|10130343|FG003|COMPLETED|Study Week 3||18
9069660|NCT03926065|10130344|FG004|COMPLETED|Study Week 3||15
9069661|NCT03926065|10130340|FG000|NOT COMPLETED|Study Week 3||0
9069662|NCT03926065|10130341|FG001|NOT COMPLETED|Study Week 3||0
9069663|NCT03926065|10130342|FG002|NOT COMPLETED|Study Week 3||0
9069664|NCT03926065|10130343|FG003|NOT COMPLETED|Study Week 3||0
9069665|NCT03926065|10130344|FG004|NOT COMPLETED|Study Week 3||0
9069666|NCT03926065|10130340|FG000|STARTED|Study Week 4||11
9069667|NCT03926065|10130341|FG001|STARTED|Study Week 4||9
9069668|NCT03926065|10130342|FG002|STARTED|Study Week 4||14
9069669|NCT03926065|10130343|FG003|STARTED|Study Week 4||18
9069670|NCT03926065|10130344|FG004|STARTED|Study Week 4||15
9069671|NCT03926065|10130340|FG000|COMPLETED|Study Week 4||11
9069672|NCT03926065|10130341|FG001|COMPLETED|Study Week 4||9
9069673|NCT03926065|10130342|FG002|COMPLETED|Study Week 4||14
9069674|NCT03926065|10130343|FG003|COMPLETED|Study Week 4||18
9069675|NCT03926065|10130344|FG004|COMPLETED|Study Week 4||15
9069676|NCT03926065|10130340|FG000|NOT COMPLETED|Study Week 4||0
9069677|NCT03926065|10130341|FG001|NOT COMPLETED|Study Week 4||0
9069678|NCT03926065|10130342|FG002|NOT COMPLETED|Study Week 4||0
9069679|NCT03926065|10130343|FG003|NOT COMPLETED|Study Week 4||0
9069680|NCT03926065|10130344|FG004|NOT COMPLETED|Study Week 4||0
9069681|NCT03909100|10130354|FG000|STARTED|Overall Study||120
9069682|NCT03909100|10130354|FG000|Safety Population|Overall Study||112
9069683|NCT03909100|10130354|FG000|Received Treatment in Session 2|Overall Study||107
9069684|NCT03909100|10130354|FG000|Evaluable Population|Overall Study||106
9069685|NCT03909100|10130354|FG000|COMPLETED|Overall Study||105
9069686|NCT03909100|10130354|FG000|NOT COMPLETED|Overall Study||15
9069687|NCT03905642|10130361|FG000|STARTED|Overall Study||49
9069688|NCT03905642|10130361|FG000|COMPLETED|Overall Study||41
9069689|NCT03905642|10130361|FG000|NOT COMPLETED|Overall Study||8
9069690|NCT03892889|10130365|FG000|STARTED|Overall Study||277
9069691|NCT03892889|10130365|FG000|COMPLETED|Overall Study||73
9069692|NCT03892889|10130365|FG000|NOT COMPLETED|Overall Study||204
9069693|NCT03921723|10130369|FG000|STARTED|Period 1 (4 Days)||22
9069694|NCT03921723|10130369|FG000|COMPLETED|Period 1 (4 Days)||22
9069695|NCT03921723|10130369|FG000|NOT COMPLETED|Period 1 (4 Days)||0
9069696|NCT03921723|10130369|FG000|STARTED|Period 2 (4 Days)||22
9069697|NCT03921723|10130369|FG000|COMPLETED|Period 2 (4 Days)||19
9069698|NCT03921723|10130369|FG000|NOT COMPLETED|Period 2 (4 Days)||3
9069699|NCT03921723|10130369|FG000|STARTED|Period 3 (4 Days)||19
9069700|NCT03921723|10130369|FG000|COMPLETED|Period 3 (4 Days)||18
9069701|NCT03921723|10130369|FG000|NOT COMPLETED|Period 3 (4 Days)||1
9069702|NCT03921190|10130379|FG000|STARTED|Overall Study||56
9069703|NCT03921190|10130380|FG001|STARTED|Overall Study||64
9069704|NCT03921190|10130379|FG000|COMPLETED|Overall Study||56
9069705|NCT03921190|10130380|FG001|COMPLETED|Overall Study||64
9069706|NCT03921190|10130379|FG000|NOT COMPLETED|Overall Study||0
9069707|NCT03921190|10130380|FG001|NOT COMPLETED|Overall Study||0
9069708|NCT03920865|10130391|FG000|STARTED|Overall Study||8
9069709|NCT03920865|10130392|FG001|STARTED|Overall Study||8
9069710|NCT03920865|10130393|FG002|STARTED|Overall Study||10
9069711|NCT03920865|10130391|FG000|COMPLETED|Overall Study||8
9069712|NCT03920865|10130392|FG001|COMPLETED|Overall Study||8
9069713|NCT03920865|10130393|FG002|COMPLETED|Overall Study||10
9069714|NCT03920865|10130391|FG000|NOT COMPLETED|Overall Study||0
9069715|NCT03920865|10130392|FG001|NOT COMPLETED|Overall Study||0
9069716|NCT03920865|10130393|FG002|NOT COMPLETED|Overall Study||0
9069717|NCT03918239|10130413|FG000|STARTED|Overall Study||94
9069718|NCT03918239|10130414|FG001|STARTED|Overall Study||96
9069719|NCT03918239|10130413|FG000|COMPLETED|Overall Study||84
9069720|NCT03918239|10130414|FG001|COMPLETED|Overall Study||89
9069721|NCT03918239|10130413|FG000|NOT COMPLETED|Overall Study||10
9069722|NCT03918239|10130414|FG001|NOT COMPLETED|Overall Study||7
9069723|NCT03917823|10130422|FG000|STARTED|Overall Study||2
9069724|NCT03917823|10130423|FG001|STARTED|Overall Study||2
9069725|NCT03917823|10130422|FG000|COMPLETED|Overall Study||1
9069726|NCT03917823|10130423|FG001|COMPLETED|Overall Study||0
9069727|NCT03917823|10130422|FG000|NOT COMPLETED|Overall Study||1
9069728|NCT03917823|10130423|FG001|NOT COMPLETED|Overall Study||2
9069729|NCT03911752|10130432|FG000|STARTED|Overall Study||8
9069730|NCT03911752|10130433|FG001|STARTED|Overall Study||2
9069731|NCT03911752|10130434|FG002|STARTED|Overall Study||2
9069732|NCT03911752|10130432|FG000|COMPLETED|Overall Study||8
9069733|NCT03911752|10130433|FG001|COMPLETED|Overall Study||2
9069734|NCT03911752|10130434|FG002|COMPLETED|Overall Study||2
9069735|NCT03911752|10130432|FG000|NOT COMPLETED|Overall Study||0
9069736|NCT03911752|10130433|FG001|NOT COMPLETED|Overall Study||0
9069737|NCT03911752|10130434|FG002|NOT COMPLETED|Overall Study||0
9069738|NCT03902613|10130444|FG000|STARTED|Overall Study||1
9069739|NCT03902613|10130444|FG000|COMPLETED|Overall Study||0
9069740|NCT03902613|10130444|FG000|NOT COMPLETED|Overall Study||1
9069741|NCT03902574|10130451|FG000|STARTED|Overall Study||7
9069742|NCT03902574|10130452|FG001|STARTED|Overall Study||7
9069743|NCT03902574|10130453|FG002|STARTED|Overall Study||7
9069744|NCT03902574|10130451|FG000|COMPLETED|Overall Study||7
9069745|NCT03902574|10130452|FG001|COMPLETED|Overall Study||7
9069746|NCT03902574|10130453|FG002|COMPLETED|Overall Study||6
9069747|NCT03902574|10130451|FG000|NOT COMPLETED|Overall Study||0
9069748|NCT03902574|10130452|FG001|NOT COMPLETED|Overall Study||0
9069749|NCT03902574|10130453|FG002|NOT COMPLETED|Overall Study||1
9069750|NCT03914950|10130461|FG000|STARTED|Overall Study||174
9069751|NCT03914950|10130461|FG000|COMPLETED|Overall Study||120
9069752|NCT03914950|10130461|FG000|NOT COMPLETED|Overall Study||54
9069753|NCT03911843|10130473|FG000|STARTED|Overall Study||26
9069754|NCT03911843|10130474|FG001|STARTED|Overall Study||38
9069755|NCT03911843|10130473|FG000|COMPLETED|Overall Study||22
9069756|NCT03911843|10130474|FG001|COMPLETED|Overall Study||37
9069757|NCT03911843|10130473|FG000|NOT COMPLETED|Overall Study||4
9069758|NCT03911843|10130474|FG001|NOT COMPLETED|Overall Study||1
9069759|NCT03896633|10130482|FG000|STARTED|Overall Study||321
9069760|NCT03896633|10130483|FG001|STARTED|Overall Study||316
9069761|NCT03896633|10130482|FG000|COMPLETED|Overall Study||312
9069762|NCT03896633|10130483|FG001|COMPLETED|Overall Study||306
9069763|NCT03896633|10130482|FG000|NOT COMPLETED|Overall Study||9
9069764|NCT03896633|10130483|FG001|NOT COMPLETED|Overall Study||10
9069765|NCT03894813|10130491|FG000|STARTED|Overall Study||63
9069766|NCT03894813|10130492|FG001|STARTED|Overall Study||63
9069767|NCT03894813|10130491|FG000|COMPLETED|Overall Study||52
9069768|NCT03894813|10130492|FG001|COMPLETED|Overall Study||47
9069769|NCT03894813|10130491|FG000|NOT COMPLETED|Overall Study||11
9069770|NCT03894813|10130492|FG001|NOT COMPLETED|Overall Study||16
9069771|NCT03911960|10130500|FG000|STARTED|Overall Study||9
9069772|NCT03911960|10130501|FG001|STARTED|Overall Study||5
9069773|NCT03911960|10130500|FG000|COMPLETED|Overall Study||4
9069774|NCT03911960|10130501|FG001|COMPLETED|Overall Study||2
9069775|NCT03911960|10130500|FG000|NOT COMPLETED|Overall Study||5
9069776|NCT03911960|10130501|FG001|NOT COMPLETED|Overall Study||3
9069777|NCT03907072|10130511|FG000|STARTED|Overall Study||2
9069778|NCT03907072|10130512|FG001|STARTED|Overall Study||2
9069779|NCT03907072|10130513|FG002|STARTED|Overall Study||2
9069780|NCT03907072|10130511|FG000|COMPLETED|Overall Study||0
9069781|NCT03907072|10130512|FG001|COMPLETED|Overall Study||0
9069782|NCT03907072|10130513|FG002|COMPLETED|Overall Study||0
9069783|NCT03907072|10130511|FG000|NOT COMPLETED|Overall Study||2
9069784|NCT03907072|10130512|FG001|NOT COMPLETED|Overall Study||2
9069785|NCT03907072|10130513|FG002|NOT COMPLETED|Overall Study||2
9069786|NCT03906448|10130523|FG000|STARTED|Overall Study||1
9069787|NCT03906448|10130524|FG001|STARTED|Overall Study||0
9069788|NCT03906448|10130523|FG000|COMPLETED|Overall Study||1
9069789|NCT03906448|10130524|FG001|COMPLETED|Overall Study||0
9069790|NCT03906448|10130523|FG000|NOT COMPLETED|Overall Study||0
9069791|NCT03906448|10130524|FG001|NOT COMPLETED|Overall Study||0
9069792|NCT03911401|10130533|FG000|STARTED|Overall Study||83
9069793|NCT03911401|10130534|FG001|STARTED|Overall Study||85
9069794|NCT03911401|10130535|FG002|STARTED|Overall Study||83
9069795|NCT03911401|10130533|FG000|COMPLETED|Overall Study||76
9069796|NCT03911401|10130534|FG001|COMPLETED|Overall Study||76
9069797|NCT03911401|10130535|FG002|COMPLETED|Overall Study||58
9069798|NCT03911401|10130533|FG000|NOT COMPLETED|Overall Study||7
9069799|NCT03911401|10130534|FG001|NOT COMPLETED|Overall Study||9
9069800|NCT03911401|10130535|FG002|NOT COMPLETED|Overall Study||25
9069801|NCT03909763|10130543|FG000|STARTED|Overall Study||55
9069802|NCT03909763|10130543|FG000|COMPLETED|Overall Study||45
8623882|NCT00495820|9663081|FG000|STARTED|Overall Study||30
8623883|NCT00495820|9663082|FG001|STARTED|Overall Study||30
8623884|NCT00495820|9663081|FG000|COMPLETED|Overall Study||29
8623885|NCT00495820|9663082|FG001|COMPLETED|Overall Study||29
8623886|NCT00495820|9663081|FG000|NOT COMPLETED|Overall Study||1
9069803|NCT03909763|10130543|FG000|NOT COMPLETED|Overall Study||10
9069804|NCT03909009|10130549|FG000|STARTED|Overall Study||10
9069805|NCT03909009|10130550|FG001|STARTED|Overall Study||10
9069806|NCT03909009|10130549|FG000|COMPLETED|Overall Study||10
9069807|NCT03909009|10130550|FG001|COMPLETED|Overall Study||10
9069808|NCT03909009|10130549|FG000|NOT COMPLETED|Overall Study||0
9069809|NCT03909009|10130550|FG001|NOT COMPLETED|Overall Study||0
9069810|NCT03906968|10130556|FG000|STARTED|Overall Study||40
9069811|NCT03906968|10130556|FG000|COMPLETED|Overall Study||40
9069812|NCT03906968|10130556|FG000|NOT COMPLETED|Overall Study||0
9069813|NCT03904420|10130562|FG000|STARTED|Overall Study||2
9069814|NCT03904420|10130563|FG001|STARTED|Overall Study||2
9069815|NCT03904420|10130562|FG000|COMPLETED|Overall Study||0
9069816|NCT03904420|10130563|FG001|COMPLETED|Overall Study||0
9069817|NCT03904420|10130562|FG000|NOT COMPLETED|Overall Study||2
9069818|NCT03904420|10130563|FG001|NOT COMPLETED|Overall Study||2
9069819|NCT03903822|10130577|FG000|STARTED|Treatment Phase (6 Weeks)||37
9069820|NCT03903822|10130578|FG001|STARTED|Treatment Phase (6 Weeks)||37
9069821|NCT03903822|10130579|FG002|STARTED|Treatment Phase (6 Weeks)||36
9069822|NCT03903822|10130580|FG003|STARTED|Treatment Phase (6 Weeks)||37
9069823|NCT03903822|10130581|FG004|STARTED|Treatment Phase (6 Weeks)||36
9069824|NCT03903822|10130582|FG005|STARTED|Treatment Phase (6 Weeks)||36
9069825|NCT03903822|10130583|FG006|STARTED|Treatment Phase (6 Weeks)||36
8623887|NCT00495820|9663082|FG001|NOT COMPLETED|Overall Study||1
8623888|NCT00496015|9663093|FG000|STARTED|Overall Study||178
9069826|NCT03903822|10130584|FG007|STARTED|Treatment Phase (6 Weeks)||37
9069827|NCT03903822|10130577|FG000|COMPLETED|Treatment Phase (6 Weeks)||28
9069828|NCT03903822|10130578|FG001|COMPLETED|Treatment Phase (6 Weeks)||27
9069829|NCT03903822|10130579|FG002|COMPLETED|Treatment Phase (6 Weeks)||33
9069830|NCT03903822|10130580|FG003|COMPLETED|Treatment Phase (6 Weeks)||32
9069831|NCT03903822|10130581|FG004|COMPLETED|Treatment Phase (6 Weeks)||31
9069832|NCT03903822|10130582|FG005|COMPLETED|Treatment Phase (6 Weeks)||25
9069833|NCT03903822|10130583|FG006|COMPLETED|Treatment Phase (6 Weeks)||31
9069834|NCT03903822|10130584|FG007|COMPLETED|Treatment Phase (6 Weeks)||33
9069835|NCT03903822|10130577|FG000|NOT COMPLETED|Treatment Phase (6 Weeks)||9
9069836|NCT03903822|10130578|FG001|NOT COMPLETED|Treatment Phase (6 Weeks)||10
8623889|NCT00496015|9663094|FG001|STARTED|Overall Study||27
9069837|NCT03903822|10130579|FG002|NOT COMPLETED|Treatment Phase (6 Weeks)||3
9069838|NCT03903822|10130580|FG003|NOT COMPLETED|Treatment Phase (6 Weeks)||5
9069839|NCT03903822|10130581|FG004|NOT COMPLETED|Treatment Phase (6 Weeks)||5
9069840|NCT03903822|10130582|FG005|NOT COMPLETED|Treatment Phase (6 Weeks)||11
9069841|NCT03903822|10130583|FG006|NOT COMPLETED|Treatment Phase (6 Weeks)||5
9069842|NCT03903822|10130584|FG007|NOT COMPLETED|Treatment Phase (6 Weeks)||4
9069843|NCT03903822|10130577|FG000|STARTED|Follow up Phase (4 Weeks)|Participants not completing treatment phase could also start this phase.|37
9069844|NCT03903822|10130578|FG001|STARTED|Follow up Phase (4 Weeks)|Participants not completing treatment phase could also start this phase.|37
9069845|NCT03903822|10130579|FG002|STARTED|Follow up Phase (4 Weeks)|Participants not completing treatment phase could also start this phase.|36
9069846|NCT03903822|10130580|FG003|STARTED|Follow up Phase (4 Weeks)|Participants not completing treatment phase could also start this phase.|37
9069847|NCT03903822|10130581|FG004|STARTED|Follow up Phase (4 Weeks)|Participants not completing treatment phase could also start this phase.|36
9069848|NCT03903822|10130582|FG005|STARTED|Follow up Phase (4 Weeks)|Participants not completing treatment phase could also start this phase.|36
9069849|NCT03903822|10130583|FG006|STARTED|Follow up Phase (4 Weeks)|Participants not completing treatment phase could also start this phase.|36
9069850|NCT03903822|10130584|FG007|STARTED|Follow up Phase (4 Weeks)|Participants not completing treatment phase could also start this phase.|37
9069851|NCT03903822|10130577|FG000|COMPLETED|Follow up Phase (4 Weeks)||29
9069852|NCT03903822|10130578|FG001|COMPLETED|Follow up Phase (4 Weeks)||29
9069853|NCT03903822|10130579|FG002|COMPLETED|Follow up Phase (4 Weeks)||32
9069854|NCT03903822|10130580|FG003|COMPLETED|Follow up Phase (4 Weeks)||33
9069855|NCT03903822|10130581|FG004|COMPLETED|Follow up Phase (4 Weeks)||32
9069856|NCT03903822|10130582|FG005|COMPLETED|Follow up Phase (4 Weeks)||28
9069857|NCT03903822|10130583|FG006|COMPLETED|Follow up Phase (4 Weeks)||31
9069858|NCT03903822|10130584|FG007|COMPLETED|Follow up Phase (4 Weeks)||31
9069859|NCT03903822|10130577|FG000|NOT COMPLETED|Follow up Phase (4 Weeks)||8
9069860|NCT03903822|10130578|FG001|NOT COMPLETED|Follow up Phase (4 Weeks)||8
9069861|NCT03903822|10130579|FG002|NOT COMPLETED|Follow up Phase (4 Weeks)||4
9069862|NCT03903822|10130580|FG003|NOT COMPLETED|Follow up Phase (4 Weeks)||4
9069863|NCT03903822|10130581|FG004|NOT COMPLETED|Follow up Phase (4 Weeks)||4
9069864|NCT03903822|10130582|FG005|NOT COMPLETED|Follow up Phase (4 Weeks)||8
9069865|NCT03903822|10130583|FG006|NOT COMPLETED|Follow up Phase (4 Weeks)||5
9069866|NCT03903822|10130584|FG007|NOT COMPLETED|Follow up Phase (4 Weeks)||6
9069867|NCT03905096|10130604|FG000|STARTED|Period 1 for Trial Part 1 and 2||18
9069868|NCT03905096|10130605|FG001|STARTED|Period 1 for Trial Part 1 and 2||14
9069869|NCT03905096|10130604|FG000|COMPLETED|Period 1 for Trial Part 1 and 2||18
9069870|NCT03905096|10130605|FG001|COMPLETED|Period 1 for Trial Part 1 and 2||14
9069871|NCT03905096|10130604|FG000|NOT COMPLETED|Period 1 for Trial Part 1 and 2||0
9069872|NCT03905096|10130605|FG001|NOT COMPLETED|Period 1 for Trial Part 1 and 2||0
9069873|NCT03905096|10130604|FG000|STARTED|Period 2 for Trial Part 1 and 2||18
9069874|NCT03905096|10130605|FG001|STARTED|Period 2 for Trial Part 1 and 2||14
9069875|NCT03905096|10130604|FG000|COMPLETED|Period 2 for Trial Part 1 and 2||17
9069876|NCT03905096|10130605|FG001|COMPLETED|Period 2 for Trial Part 1 and 2||14
9069877|NCT03905096|10130604|FG000|NOT COMPLETED|Period 2 for Trial Part 1 and 2||1
9069878|NCT03905096|10130605|FG001|NOT COMPLETED|Period 2 for Trial Part 1 and 2||0
9069879|NCT03899064|10130618|FG000|STARTED|Overall Study||58
9069880|NCT03899064|10130618|FG000|MC2-01 Cream, Irradiation|Overall Study||58
9069881|NCT03899064|10130618|FG000|MC2-01 Cream, No Irradiation|Overall Study||58
9069882|NCT03899064|10130618|FG000|MC2-01 Vehicle, Irradiation|Overall Study||58
9069883|NCT03899064|10130618|FG000|MC2-01 Vehicle, no Irradiation|Overall Study||58
9069884|NCT03899064|10130618|FG000|Control, Irradiation|Overall Study||58
9069885|NCT03899064|10130618|FG000|COMPLETED|Overall Study||51
9069886|NCT03899064|10130618|FG000|NOT COMPLETED|Overall Study||7
9069887|NCT03894969|10130627|FG000|STARTED|Overall Study||134
9069888|NCT03894969|10130628|FG001|STARTED|Overall Study||134
9069889|NCT03894969|10130629|FG002|STARTED|Overall Study||122
9069890|NCT03894969|10130630|FG003|STARTED|Overall Study||135
9069891|NCT03894969|10130631|FG004|STARTED|Overall Study||16
9069892|NCT03894969|10130627|FG000|COMPLETED|Overall Study||132
9069893|NCT03894969|10130628|FG001|COMPLETED|Overall Study||131
9069894|NCT03894969|10130629|FG002|COMPLETED|Overall Study||120
9069895|NCT03894969|10130630|FG003|COMPLETED|Overall Study||129
9069896|NCT03894969|10130631|FG004|COMPLETED|Overall Study||2
9069897|NCT03894969|10130627|FG000|NOT COMPLETED|Overall Study||2
9069898|NCT03894969|10130628|FG001|NOT COMPLETED|Overall Study||3
9069899|NCT03894969|10130629|FG002|NOT COMPLETED|Overall Study||2
9069900|NCT03894969|10130630|FG003|NOT COMPLETED|Overall Study||6
9069901|NCT03894969|10130631|FG004|NOT COMPLETED|Overall Study||14
9069902|NCT03903159|10130644|FG000|STARTED|Overall Study||15
9069903|NCT03903159|10130644|FG000|COMPLETED|Overall Study||10
9069904|NCT03903159|10130644|FG000|NOT COMPLETED|Overall Study||5
9069905|NCT03902392|10130650|FG000|STARTED|Overall Study||25
9069906|NCT03902392|10130651|FG001|STARTED|Overall Study||25
9069907|NCT03902392|10130650|FG000|COMPLETED|Overall Study||18
9069908|NCT03902392|10130651|FG001|COMPLETED|Overall Study||18
9069909|NCT03902392|10130650|FG000|NOT COMPLETED|Overall Study||7
9069910|NCT03902392|10130651|FG001|NOT COMPLETED|Overall Study||7
9069911|NCT03901105|10130657|FG000|STARTED|Overall Study||205
9069912|NCT03901105|10130657|FG000|COMPLETED|Overall Study||205
9069913|NCT03901105|10130657|FG000|NOT COMPLETED|Overall Study||0
9069914|NCT03895853|10130669|FG000|STARTED|Overall Study||0
9069915|NCT03895853|10130670|FG001|STARTED|Overall Study||2
9069916|NCT03895853|10130669|FG000|COMPLETED|Overall Study||0
9069917|NCT03895853|10130670|FG001|COMPLETED|Overall Study||2
9069918|NCT03895853|10130669|FG000|NOT COMPLETED|Overall Study||0
9069919|NCT03895853|10130670|FG001|NOT COMPLETED|Overall Study||0
9069920|NCT03901313|10130676|FG000|STARTED|Overall Study||4
9069921|NCT03901313|10130677|FG001|STARTED|Overall Study||4
9069922|NCT03901313|10130678|FG002|STARTED|Overall Study||4
9069923|NCT03901313|10130679|FG003|STARTED|Overall Study||4
9069924|NCT03901313|10130680|FG004|STARTED|Overall Study||4
9069925|NCT03901313|10130681|FG005|STARTED|Overall Study||4
9069926|NCT03901313|10130676|FG000|COMPLETED|Overall Study||4
9069927|NCT03901313|10130677|FG001|COMPLETED|Overall Study||4
9069928|NCT03901313|10130678|FG002|COMPLETED|Overall Study||4
9069929|NCT03901313|10130679|FG003|COMPLETED|Overall Study||4
9069930|NCT03901313|10130680|FG004|COMPLETED|Overall Study||4
9069931|NCT03901313|10130681|FG005|COMPLETED|Overall Study||4
9069932|NCT03901313|10130676|FG000|NOT COMPLETED|Overall Study||0
9069933|NCT03901313|10130677|FG001|NOT COMPLETED|Overall Study||0
9069934|NCT03901313|10130678|FG002|NOT COMPLETED|Overall Study||0
9069935|NCT03901313|10130679|FG003|NOT COMPLETED|Overall Study||0
9069936|NCT03901313|10130680|FG004|NOT COMPLETED|Overall Study||0
9069937|NCT03901313|10130681|FG005|NOT COMPLETED|Overall Study||0
9069938|NCT03901092|10130689|FG000|STARTED|Overall Study||83
9069939|NCT03901092|10130690|FG001|STARTED|Overall Study||159
9069940|NCT03901092|10130689|FG000|COMPLETED|Overall Study||83
9069941|NCT03901092|10130690|FG001|COMPLETED|Overall Study||159
9069942|NCT03901092|10130689|FG000|NOT COMPLETED|Overall Study||0
9069943|NCT03901092|10130690|FG001|NOT COMPLETED|Overall Study||0
9069944|NCT03900728|10130707|FG000|STARTED|Overall Study||40
9069945|NCT03900728|10130708|FG001|STARTED|Overall Study||57
9069946|NCT03900728|10130709|FG002|STARTED|Overall Study||39
9069947|NCT03900728|10130707|FG000|COMPLETED|Overall Study||40
9069948|NCT03900728|10130708|FG001|COMPLETED|Overall Study||57
9069949|NCT03900728|10130709|FG002|COMPLETED|Overall Study||35
9069950|NCT03900728|10130707|FG000|NOT COMPLETED|Overall Study||0
9069951|NCT03900728|10130708|FG001|NOT COMPLETED|Overall Study||0
9069952|NCT03900728|10130709|FG002|NOT COMPLETED|Overall Study||4
9069953|NCT03900299|10130719|FG000|STARTED|Overall Study||56
9069954|NCT03900299|10130720|FG001|STARTED|Overall Study||58
9069955|NCT03900299|10130719|FG000|COMPLETED|Overall Study||56
9069956|NCT03900299|10130720|FG001|COMPLETED|Overall Study||58
9069957|NCT03900299|10130719|FG000|NOT COMPLETED|Overall Study||0
9069958|NCT03900299|10130720|FG001|NOT COMPLETED|Overall Study||0
9069959|NCT03898349|10130729|FG000|STARTED|Overall Study||125
9069960|NCT03898349|10130730|FG001|STARTED|Overall Study||625
9069961|NCT03898349|10130729|FG000|COMPLETED|Overall Study||15
9069962|NCT03898349|10130730|FG001|COMPLETED|Overall Study||15
9069963|NCT03898349|10130729|FG000|NOT COMPLETED|Overall Study||110
9069964|NCT03898349|10130730|FG001|NOT COMPLETED|Overall Study||610
9069965|NCT03897634|10130736|FG000|STARTED|Overall Study||22
9069966|NCT03897634|10130736|FG000|COMPLETED|Overall Study||22
9069967|NCT03897634|10130736|FG000|NOT COMPLETED|Overall Study||0
9069968|NCT03895372|10130748|FG000|STARTED|Investigational Treatment Period||23
9069969|NCT03895372|10130749|FG001|STARTED|Investigational Treatment Period||22
9069970|NCT03895372|10130750|FG002|STARTED|Investigational Treatment Period||11
9069971|NCT03895372|10130751|FG003|STARTED|Investigational Treatment Period||11
9069972|NCT03895372|10130752|FG004|STARTED|Investigational Treatment Period||12
9069973|NCT03895372|10130753|FG005|STARTED|Investigational Treatment Period||11
9069974|NCT03895372|10130754|FG006|STARTED|Investigational Treatment Period||45
9069975|NCT03895372|10130755|FG007|STARTED|Investigational Treatment Period||43
9069976|NCT03895372|10130748|FG000|COMPLETED|Investigational Treatment Period||19
9069977|NCT03895372|10130749|FG001|COMPLETED|Investigational Treatment Period||19
9069978|NCT03895372|10130750|FG002|COMPLETED|Investigational Treatment Period||10
9069979|NCT03895372|10130751|FG003|COMPLETED|Investigational Treatment Period||9
9069980|NCT03895372|10130752|FG004|COMPLETED|Investigational Treatment Period||12
9069981|NCT03895372|10130753|FG005|COMPLETED|Investigational Treatment Period||9
9069982|NCT03895372|10130754|FG006|COMPLETED|Investigational Treatment Period||37
9069983|NCT03895372|10130755|FG007|COMPLETED|Investigational Treatment Period||38
9069984|NCT03895372|10130748|FG000|NOT COMPLETED|Investigational Treatment Period||4
9069985|NCT03895372|10130749|FG001|NOT COMPLETED|Investigational Treatment Period||3
9069986|NCT03895372|10130750|FG002|NOT COMPLETED|Investigational Treatment Period||1
9069987|NCT03895372|10130751|FG003|NOT COMPLETED|Investigational Treatment Period||2
9069988|NCT03895372|10130752|FG004|NOT COMPLETED|Investigational Treatment Period||0
9069989|NCT03895372|10130753|FG005|NOT COMPLETED|Investigational Treatment Period||2
9069990|NCT03895372|10130754|FG006|NOT COMPLETED|Investigational Treatment Period||8
9069991|NCT03895372|10130755|FG007|NOT COMPLETED|Investigational Treatment Period||5
9069992|NCT03895372|10130748|FG000|STARTED|Extension Treatment Period||19
9069993|NCT03895372|10130749|FG001|STARTED|Extension Treatment Period||19
9069994|NCT03895372|10130750|FG002|STARTED|Extension Treatment Period||10
9069995|NCT03895372|10130751|FG003|STARTED|Extension Treatment Period||9
9069996|NCT03895372|10130752|FG004|STARTED|Extension Treatment Period||12
9069997|NCT03895372|10130753|FG005|STARTED|Extension Treatment Period||9
9069998|NCT03895372|10130754|FG006|STARTED|Extension Treatment Period||37
9069999|NCT03895372|10130755|FG007|STARTED|Extension Treatment Period||38
9070000|NCT03895372|10130748|FG000|COMPLETED|Extension Treatment Period||16
9070001|NCT03895372|10130749|FG001|COMPLETED|Extension Treatment Period||14
9070002|NCT03895372|10130750|FG002|COMPLETED|Extension Treatment Period||10
9070003|NCT03895372|10130751|FG003|COMPLETED|Extension Treatment Period||8
9070004|NCT03895372|10130752|FG004|COMPLETED|Extension Treatment Period||9
9070005|NCT03895372|10130753|FG005|COMPLETED|Extension Treatment Period||8
9070006|NCT03895372|10130754|FG006|COMPLETED|Extension Treatment Period||33
9070007|NCT03895372|10130755|FG007|COMPLETED|Extension Treatment Period||32
9070008|NCT03895372|10130748|FG000|NOT COMPLETED|Extension Treatment Period||3
9070009|NCT03895372|10130749|FG001|NOT COMPLETED|Extension Treatment Period||5
9070010|NCT03895372|10130750|FG002|NOT COMPLETED|Extension Treatment Period||0
9070011|NCT03895372|10130751|FG003|NOT COMPLETED|Extension Treatment Period||1
9070012|NCT03895372|10130752|FG004|NOT COMPLETED|Extension Treatment Period||3
9070013|NCT03895372|10130753|FG005|NOT COMPLETED|Extension Treatment Period||1
9070014|NCT03895372|10130754|FG006|NOT COMPLETED|Extension Treatment Period||4
9070015|NCT03895372|10130755|FG007|NOT COMPLETED|Extension Treatment Period||6
9070016|NCT03896022|10130781|FG000|STARTED|Overall Study||74
9070017|NCT03896022|10130782|FG001|STARTED|Overall Study||51
9070018|NCT03896022|10130783|FG002|STARTED|Overall Study||52
9070019|NCT03896022|10130781|FG000|COMPLETED|Overall Study||70
9070020|NCT03896022|10130782|FG001|COMPLETED|Overall Study||51
9070021|NCT03896022|10130783|FG002|COMPLETED|Overall Study||52
9070022|NCT03896022|10130781|FG000|NOT COMPLETED|Overall Study||4
9070023|NCT03896022|10130782|FG001|NOT COMPLETED|Overall Study||0
9070024|NCT03896022|10130783|FG002|NOT COMPLETED|Overall Study||0
9070025|NCT03891862|10130795|FG000|STARTED|Open-label Period||135
9070026|NCT03891862|10130796|FG001|STARTED|Open-label Period||0
9070027|NCT03891862|10130797|FG002|STARTED|Open-label Period||0
9070028|NCT03891862|10130795|FG000|Safety Analysis Set|Open-label Period||132
9070029|NCT03891862|10130796|FG001|Safety Analysis Set|Open-label Period||0
9070030|NCT03891862|10130797|FG002|Safety Analysis Set|Open-label Period||0
9070031|NCT03891862|10130795|FG000|COMPLETED|Open-label Period||119
9070032|NCT03891862|10130796|FG001|COMPLETED|Open-label Period||0
9070033|NCT03891862|10130797|FG002|COMPLETED|Open-label Period||0
9070034|NCT03891862|10130795|FG000|NOT COMPLETED|Open-label Period||16
9070035|NCT03891862|10130796|FG001|NOT COMPLETED|Open-label Period||0
9070036|NCT03891862|10130797|FG002|NOT COMPLETED|Open-label Period||0
9070037|NCT03891862|10130795|FG000|STARTED|Placebo-controlled Period and Follow-up||0
9070038|NCT03891862|10130796|FG001|STARTED|Placebo-controlled Period and Follow-up||59
9070039|NCT03891862|10130797|FG002|STARTED|Placebo-controlled Period and Follow-up||59
9070040|NCT03891862|10130795|FG000|Persistence of Effect Analysis Set|Placebo-controlled Period and Follow-up||0
9070041|NCT03891862|10130796|FG001|Persistence of Effect Analysis Set|Placebo-controlled Period and Follow-up||58
9070042|NCT03891862|10130797|FG002|Persistence of Effect Analysis Set|Placebo-controlled Period and Follow-up||59
9070043|NCT03891862|10130795|FG000|Completed Placebo-controlled Period|Placebo-controlled Period and Follow-up||0
9070044|NCT03891862|10130796|FG001|Completed Placebo-controlled Period|Placebo-controlled Period and Follow-up||53
9070045|NCT03891862|10130797|FG002|Completed Placebo-controlled Period|Placebo-controlled Period and Follow-up||56
9070046|NCT03891862|10130795|FG000|COMPLETED|Placebo-controlled Period and Follow-up||0
9070047|NCT03891862|10130796|FG001|COMPLETED|Placebo-controlled Period and Follow-up||53
9070048|NCT03891862|10130797|FG002|COMPLETED|Placebo-controlled Period and Follow-up||55
9070049|NCT03891862|10130795|FG000|NOT COMPLETED|Placebo-controlled Period and Follow-up||0
9070050|NCT03891862|10130796|FG001|NOT COMPLETED|Placebo-controlled Period and Follow-up||6
9070051|NCT03891862|10130797|FG002|NOT COMPLETED|Placebo-controlled Period and Follow-up||4
9070052|NCT03894449|10130809|FG000|STARTED|Overall Study||15
9070053|NCT03894449|10130810|FG001|STARTED|Overall Study||15
9070054|NCT03894449|10130811|FG002|STARTED|Overall Study||15
9070055|NCT03894449|10130812|FG003|STARTED|Overall Study||15
9070056|NCT03894449|10130813|FG004|STARTED|Overall Study||15
9070057|NCT03894449|10130809|FG000|COMPLETED|Overall Study||15
9070058|NCT03894449|10130810|FG001|COMPLETED|Overall Study||15
9070059|NCT03894449|10130811|FG002|COMPLETED|Overall Study||15
9070060|NCT03894449|10130812|FG003|COMPLETED|Overall Study||15
9070061|NCT03894449|10130813|FG004|COMPLETED|Overall Study||15
9070062|NCT03894449|10130809|FG000|NOT COMPLETED|Overall Study||0
9070063|NCT03894449|10130810|FG001|NOT COMPLETED|Overall Study||0
9070064|NCT03894449|10130811|FG002|NOT COMPLETED|Overall Study||0
9070065|NCT03894449|10130812|FG003|NOT COMPLETED|Overall Study||0
9070066|NCT03894449|10130813|FG004|NOT COMPLETED|Overall Study||0
9070067|NCT03892564|10130825|FG000|STARTED|Overall Study||35
9070068|NCT03892564|10130825|FG000|MC2-01 Cream + Irridiation|Overall Study||35
9070069|NCT03892564|10130825|FG000|MC2-01 Cream + Non-irridiation|Overall Study||35
9070070|NCT03892564|10130825|FG000|MC2-01 Vehicle + Irridiation|Overall Study||35
9070071|NCT03892564|10130825|FG000|MC2-01 Vehicle + Non-irridiation|Overall Study||35
9070072|NCT03892564|10130825|FG000|Control Site|Overall Study||35
9070073|NCT03892564|10130825|FG000|COMPLETED|Overall Study||33
9070074|NCT03892564|10130825|FG000|NOT COMPLETED|Overall Study||2
9070075|NCT03892707|10130832|FG000|STARTED|Overall Study||250
9070076|NCT03892707|10130833|FG001|STARTED|Overall Study||250
9070077|NCT03892707|10130832|FG000|Started Study Treatment at Baseline|Overall Study||244
9070078|NCT03892707|10130833|FG001|Started Study Treatment at Baseline|Overall Study||250
9070079|NCT03892707|10130832|FG000|COMPLETED|Overall Study||244
9070080|NCT03892707|10130833|FG001|COMPLETED|Overall Study||244
9070081|NCT03892707|10130832|FG000|NOT COMPLETED|Overall Study||6
9070082|NCT03892707|10130833|FG001|NOT COMPLETED|Overall Study||6
9070083|NCT03892460|10130842|FG000|STARTED|Overall Study||30
9070084|NCT03892460|10130843|FG001|STARTED|Overall Study||24
9070085|NCT03892460|10130842|FG000|Randomization|Overall Study||25
9070086|NCT03892460|10130843|FG001|Randomization|Overall Study||20
9070087|NCT03892460|10130842|FG000|COMPLETED|Overall Study||18
9070088|NCT03892460|10130843|FG001|COMPLETED|Overall Study||19
9070089|NCT03892460|10130842|FG000|NOT COMPLETED|Overall Study||12
9070090|NCT03892460|10130843|FG001|NOT COMPLETED|Overall Study||5
9070091|NCT03891641|10130852|FG000|STARTED|Overall Study||10
9070092|NCT03891641|10130853|FG001|STARTED|Overall Study||7
9070093|NCT03891641|10130852|FG000|COMPLETED|Overall Study||8
9070094|NCT03891641|10130853|FG001|COMPLETED|Overall Study||5
9070095|NCT03891641|10130852|FG000|NOT COMPLETED|Overall Study||2
9070096|NCT03891641|10130853|FG001|NOT COMPLETED|Overall Study||2
9070097|NCT03889704|10130859|FG000|STARTED|Overall Study||2
9070098|NCT03889704|10130859|FG000|COMPLETED|Overall Study||1
9070099|NCT03889704|10130859|FG000|NOT COMPLETED|Overall Study||1
9070100|NCT03889444|10130863|FG000|STARTED|Overall Study||141
9070101|NCT03889444|10130863|FG000|COMPLETED|Overall Study||141
9070102|NCT03889444|10130863|FG000|NOT COMPLETED|Overall Study||0
9070103|NCT03888755|10130867|FG000|STARTED|Overall Study||8
9070104|NCT03888755|10130867|FG000|COMPLETED|Overall Study||8
9070105|NCT03888755|10130867|FG000|NOT COMPLETED|Overall Study||0
9070106|NCT03888391|10130873|FG000|STARTED|Overall Study||18
9070107|NCT03888391|10130873|FG000|COMPLETED|Overall Study||3
9070108|NCT03888391|10130873|FG000|NOT COMPLETED|Overall Study||15
9070109|NCT03888482|10130879|FG000|STARTED|First Wear Period (8 -1/+2 Days)||76
9070110|NCT03888482|10130880|FG001|STARTED|First Wear Period (8 -1/+2 Days)||75
9070111|NCT03888482|10130879|FG000|COMPLETED|First Wear Period (8 -1/+2 Days)||76
9070112|NCT03888482|10130880|FG001|COMPLETED|First Wear Period (8 -1/+2 Days)||75
9070113|NCT03888482|10130879|FG000|NOT COMPLETED|First Wear Period (8 -1/+2 Days)||0
9070114|NCT03888482|10130880|FG001|NOT COMPLETED|First Wear Period (8 -1/+2 Days)||0
9070115|NCT03888482|10130879|FG000|STARTED|Second Wear (8 -1/+2 Days)|2 subjects were discontinued between Treatment 1 and Treatment 2.|74
9070116|NCT03888482|10130880|FG001|STARTED|Second Wear (8 -1/+2 Days)||75
9070117|NCT03888482|10130879|FG000|COMPLETED|Second Wear (8 -1/+2 Days)||73
9070118|NCT03888482|10130880|FG001|COMPLETED|Second Wear (8 -1/+2 Days)||74
9070119|NCT03888482|10130879|FG000|NOT COMPLETED|Second Wear (8 -1/+2 Days)||1
9070120|NCT03888482|10130880|FG001|NOT COMPLETED|Second Wear (8 -1/+2 Days)||1
9070121|NCT03888274|10130888|FG000|STARTED|Overall Study||30
9070122|NCT03888274|10130888|FG000|COMPLETED|Overall Study||30
9070123|NCT03888274|10130888|FG000|NOT COMPLETED|Overall Study||0
9070124|NCT03888365|10130894|FG000|STARTED|Cohort A Peak Level/Cohort B Period 1||20
9070125|NCT03888365|10130895|FG001|STARTED|Cohort A Peak Level/Cohort B Period 1||23
9070126|NCT03888365|10130894|FG000|Safety Population|Cohort A Peak Level/Cohort B Period 1||20
9070127|NCT03888365|10130895|FG001|Safety Population|Cohort A Peak Level/Cohort B Period 1||23
9070128|NCT03888365|10130894|FG000|COMPLETED|Cohort A Peak Level/Cohort B Period 1||20
9070129|NCT03888365|10130895|FG001|COMPLETED|Cohort A Peak Level/Cohort B Period 1||23
9070130|NCT03888365|10130894|FG000|NOT COMPLETED|Cohort A Peak Level/Cohort B Period 1||0
9070131|NCT03888365|10130895|FG001|NOT COMPLETED|Cohort A Peak Level/Cohort B Period 1||0
9070132|NCT03888365|10130894|FG000|STARTED|Rest - At Least 1 h||20
9070133|NCT03888365|10130895|FG001|STARTED|Rest - At Least 1 h||23
9070134|NCT03888365|10130894|FG000|COMPLETED|Rest - At Least 1 h||20
9070135|NCT03888365|10130895|FG001|COMPLETED|Rest - At Least 1 h||23
9070136|NCT03888365|10130894|FG000|NOT COMPLETED|Rest - At Least 1 h||0
9070137|NCT03888365|10130895|FG001|NOT COMPLETED|Rest - At Least 1 h||0
9070138|NCT03888365|10130894|FG000|STARTED|Cohort A Trough Level/Cohort B Period 2||20
9070139|NCT03888365|10130895|FG001|STARTED|Cohort A Trough Level/Cohort B Period 2||23
9070140|NCT03888365|10130894|FG000|COMPLETED|Cohort A Trough Level/Cohort B Period 2||20
9070141|NCT03888365|10130895|FG001|COMPLETED|Cohort A Trough Level/Cohort B Period 2||23
9070142|NCT03888365|10130894|FG000|NOT COMPLETED|Cohort A Trough Level/Cohort B Period 2||0
9070143|NCT03888365|10130895|FG001|NOT COMPLETED|Cohort A Trough Level/Cohort B Period 2||0
9070144|NCT03888469|10130904|FG000|STARTED|First Wear Period (8 -1/+2 Days)||46
9070145|NCT03888469|10130905|FG001|STARTED|First Wear Period (8 -1/+2 Days)||46
9070146|NCT03888469|10130904|FG000|COMPLETED|First Wear Period (8 -1/+2 Days)||46
9070147|NCT03888469|10130905|FG001|COMPLETED|First Wear Period (8 -1/+2 Days)||46
9070148|NCT03888469|10130904|FG000|NOT COMPLETED|First Wear Period (8 -1/+2 Days)||0
9070149|NCT03888469|10130905|FG001|NOT COMPLETED|First Wear Period (8 -1/+2 Days)||0
9070150|NCT03888469|10130904|FG000|STARTED|Second Wear Period (8 -1/+2 Days)||46
9070151|NCT03888469|10130905|FG001|STARTED|Second Wear Period (8 -1/+2 Days)||46
9070152|NCT03888469|10130904|FG000|COMPLETED|Second Wear Period (8 -1/+2 Days)||46
9070153|NCT03888469|10130905|FG001|COMPLETED|Second Wear Period (8 -1/+2 Days)||46
9070154|NCT03888469|10130904|FG000|NOT COMPLETED|Second Wear Period (8 -1/+2 Days)||0
9070155|NCT03888469|10130905|FG001|NOT COMPLETED|Second Wear Period (8 -1/+2 Days)||0
9070156|NCT03887442|10130915|FG000|STARTED|Overall Study||9
9070157|NCT03887442|10130916|FG001|STARTED|Overall Study||8
9070158|NCT03887442|10130915|FG000|COMPLETED|Overall Study||8
9070159|NCT03887442|10130916|FG001|COMPLETED|Overall Study||8
9070160|NCT03887442|10130915|FG000|NOT COMPLETED|Overall Study||1
9070161|NCT03887442|10130916|FG001|NOT COMPLETED|Overall Study||0
9070162|NCT03887286|10130924|FG000|STARTED|Overall Study||47
9070163|NCT03887286|10130924|FG000|COMPLETED|Overall Study||47
9070164|NCT03887286|10130924|FG000|NOT COMPLETED|Overall Study||0
9070165|NCT03881007|10130931|FG000|STARTED|First 3 Months||172
9070166|NCT03881007|10130932|FG001|STARTED|First 3 Months||171
9070167|NCT03881007|10130931|FG000|COMPLETED|First 3 Months||121
9070168|NCT03881007|10130932|FG001|COMPLETED|First 3 Months||119
9070169|NCT03881007|10130931|FG000|NOT COMPLETED|First 3 Months||51
9070170|NCT03881007|10130932|FG001|NOT COMPLETED|First 3 Months||52
9070171|NCT03881007|10130931|FG000|STARTED|Last 3 Months||121
9070172|NCT03881007|10130932|FG001|STARTED|Last 3 Months||119
9070173|NCT03881007|10130931|FG000|COMPLETED|Last 3 Months||77
9070174|NCT03881007|10130932|FG001|COMPLETED|Last 3 Months||74
9070175|NCT03881007|10130931|FG000|NOT COMPLETED|Last 3 Months||44
9070176|NCT03881007|10130932|FG001|NOT COMPLETED|Last 3 Months||45
9070177|NCT03878602|10130940|FG000|STARTED|Overall Study||75
9070178|NCT03878602|10130941|FG001|STARTED|Overall Study||67
9070179|NCT03878602|10130940|FG000|COMPLETED|Overall Study||66
9070180|NCT03878602|10130941|FG001|COMPLETED|Overall Study||66
9070181|NCT03878602|10130940|FG000|NOT COMPLETED|Overall Study||9
9070182|NCT03878602|10130941|FG001|NOT COMPLETED|Overall Study||1
9070183|NCT03875118|10130951|FG000|STARTED|Overall Study||34
9070184|NCT03875118|10130952|FG001|STARTED|Overall Study||34
9070185|NCT03875118|10130951|FG000|COMPLETED|Overall Study||30
9070186|NCT03875118|10130952|FG001|COMPLETED|Overall Study||30
9070187|NCT03875118|10130951|FG000|NOT COMPLETED|Overall Study||4
9070188|NCT03875118|10130952|FG001|NOT COMPLETED|Overall Study||4
9070189|NCT03873987|10130960|FG000|STARTED|Overall Study||52
9070190|NCT03873987|10130961|FG001|STARTED|Overall Study||50
9070191|NCT03873987|10130960|FG000|COMPLETED|Overall Study||50
9070192|NCT03873987|10130961|FG001|COMPLETED|Overall Study||49
9070193|NCT03873987|10130960|FG000|NOT COMPLETED|Overall Study||2
9070194|NCT03873987|10130961|FG001|NOT COMPLETED|Overall Study||1
9070195|NCT03870893|10130970|FG000|STARTED|Overall Study||23
9070196|NCT03870893|10130971|FG001|STARTED|Overall Study||24
9070197|NCT03870893|10130970|FG000|COMPLETED|Overall Study||23
9070198|NCT03870893|10130971|FG001|COMPLETED|Overall Study||23
9070199|NCT03870893|10130970|FG000|NOT COMPLETED|Overall Study||0
9070200|NCT03870893|10130971|FG001|NOT COMPLETED|Overall Study||1
9070201|NCT03887299|10130980|FG000|STARTED|Overall Study||77
9070202|NCT03887299|10130981|FG001|STARTED|Overall Study||77
9070203|NCT03887299|10130980|FG000|COMPLETED|Overall Study||77
9070204|NCT03887299|10130981|FG001|COMPLETED|Overall Study||77
9070205|NCT03887299|10130980|FG000|NOT COMPLETED|Overall Study||0
9070206|NCT03887299|10130981|FG001|NOT COMPLETED|Overall Study||0
9070207|NCT03878758|10130987|FG000|STARTED|Overall Study||158
9070208|NCT03878758|10130987|FG000|COMPLETED|Overall Study||154
9070209|NCT03878758|10130987|FG000|NOT COMPLETED|Overall Study||4
9070210|NCT03849300|10131004|FG000|STARTED|Overall Study||42
9070211|NCT03849300|10131005|FG001|STARTED|Overall Study||42
9070212|NCT03849300|10131006|FG002|STARTED|Overall Study||32
9070213|NCT03849300|10131007|FG003|STARTED|Overall Study||31
9070214|NCT03849300|10131004|FG000|COMPLETED|Overall Study||37
9070215|NCT03849300|10131005|FG001|COMPLETED|Overall Study||35
9070216|NCT03849300|10131006|FG002|COMPLETED|Overall Study||28
9070217|NCT03849300|10131007|FG003|COMPLETED|Overall Study||25
9070218|NCT03849300|10131004|FG000|NOT COMPLETED|Overall Study||5
9070219|NCT03849300|10131005|FG001|NOT COMPLETED|Overall Study||7
9070220|NCT03849300|10131006|FG002|NOT COMPLETED|Overall Study||4
9070221|NCT03849300|10131007|FG003|NOT COMPLETED|Overall Study||6
9070222|NCT03887429|10131023|FG000|STARTED|Overall Study||8
9070223|NCT03887429|10131024|FG001|STARTED|Overall Study||9
9070224|NCT03887429|10131025|FG002|STARTED|Overall Study||9
9070225|NCT03887429|10131026|FG003|STARTED|Overall Study||8
9070226|NCT03887429|10131023|FG000|Completed First Intervention (5 Days)|Overall Study||7
9070227|NCT03887429|10131024|FG001|Completed First Intervention (5 Days)|Overall Study||8
9070228|NCT03887429|10131025|FG002|Completed First Intervention (5 Days)|Overall Study||7
9070229|NCT03887429|10131026|FG003|Completed First Intervention (5 Days)|Overall Study||7
9070230|NCT03887429|10131023|FG000|Completed Washout (9 Days)|Overall Study||7
9070231|NCT03887429|10131024|FG001|Completed Washout (9 Days)|Overall Study||8
9070232|NCT03887429|10131025|FG002|Completed Washout (9 Days)|Overall Study||7
9070233|NCT03887429|10131026|FG003|Completed Washout (9 Days)|Overall Study||7
9070234|NCT03887429|10131023|FG000|Completed Second Intervention (5 Days)|Overall Study||7
9070235|NCT03887429|10131024|FG001|Completed Second Intervention (5 Days)|Overall Study||8
9070236|NCT03887429|10131025|FG002|Completed Second Intervention (5 Days)|Overall Study||7
9070237|NCT03887429|10131026|FG003|Completed Second Intervention (5 Days)|Overall Study||7
9070238|NCT03887429|10131023|FG000|COMPLETED|Overall Study||7
9070239|NCT03887429|10131024|FG001|COMPLETED|Overall Study||8
9070240|NCT03887429|10131025|FG002|COMPLETED|Overall Study||7
9070241|NCT03887429|10131026|FG003|COMPLETED|Overall Study||7
9070242|NCT03887429|10131023|FG000|NOT COMPLETED|Overall Study||1
9070243|NCT03887429|10131024|FG001|NOT COMPLETED|Overall Study||1
9070244|NCT03887429|10131025|FG002|NOT COMPLETED|Overall Study||2
9070245|NCT03887429|10131026|FG003|NOT COMPLETED|Overall Study||1
9070246|NCT03886701|10131041|FG000|STARTED|Period 1: Study Days 1-4||11
9070247|NCT03886701|10131041|FG000|COMPLETED|Period 1: Study Days 1-4||11
9070248|NCT03886701|10131041|FG000|NOT COMPLETED|Period 1: Study Days 1-4||0
9070249|NCT03886701|10131041|FG000|STARTED|Period 2: Study Days 7-21||11
9070250|NCT03886701|10131041|FG000|COMPLETED|Period 2: Study Days 7-21||11
9070251|NCT03886701|10131041|FG000|NOT COMPLETED|Period 2: Study Days 7-21||0
9070252|NCT03883113|10131049|FG000|STARTED|Overall Study||87
9070253|NCT03883113|10131050|FG001|STARTED|Overall Study||58
9070254|NCT03883113|10131049|FG000|COMPLETED|Overall Study||71
9070255|NCT03883113|10131050|FG001|COMPLETED|Overall Study||46
9070256|NCT03883113|10131049|FG000|NOT COMPLETED|Overall Study||16
9070257|NCT03883113|10131050|FG001|NOT COMPLETED|Overall Study||12
9070258|NCT03880227|10131072|FG000|STARTED|First Visit||20
9070259|NCT03880227|10131073|FG001|STARTED|First Visit||21
9070260|NCT03880227|10131074|FG002|STARTED|First Visit||22
9070261|NCT03880227|10131075|FG003|STARTED|First Visit||18
9070262|NCT03880227|10131072|FG000|COMPLETED|First Visit||19
9070263|NCT03880227|10131073|FG001|COMPLETED|First Visit||21
9070264|NCT03880227|10131074|FG002|COMPLETED|First Visit||22
9070265|NCT03880227|10131075|FG003|COMPLETED|First Visit||18
9070266|NCT03880227|10131072|FG000|NOT COMPLETED|First Visit||1
9070267|NCT03880227|10131073|FG001|NOT COMPLETED|First Visit||0
9070268|NCT03880227|10131074|FG002|NOT COMPLETED|First Visit||0
9070269|NCT03880227|10131075|FG003|NOT COMPLETED|First Visit||0
9070270|NCT03880227|10131072|FG000|STARTED|1 Week Washout/ Delay||19
9070271|NCT03880227|10131073|FG001|STARTED|1 Week Washout/ Delay||21
9070272|NCT03880227|10131074|FG002|STARTED|1 Week Washout/ Delay||22
9070273|NCT03880227|10131075|FG003|STARTED|1 Week Washout/ Delay||18
9070274|NCT03880227|10131072|FG000|COMPLETED|1 Week Washout/ Delay||19
9070275|NCT03880227|10131073|FG001|COMPLETED|1 Week Washout/ Delay||20
9070276|NCT03880227|10131074|FG002|COMPLETED|1 Week Washout/ Delay||19
9070277|NCT03880227|10131075|FG003|COMPLETED|1 Week Washout/ Delay||18
9070278|NCT03880227|10131072|FG000|NOT COMPLETED|1 Week Washout/ Delay||0
9070279|NCT03880227|10131073|FG001|NOT COMPLETED|1 Week Washout/ Delay||1
9070280|NCT03880227|10131074|FG002|NOT COMPLETED|1 Week Washout/ Delay||3
9070281|NCT03880227|10131075|FG003|NOT COMPLETED|1 Week Washout/ Delay||0
9070282|NCT03880227|10131072|FG000|STARTED|Second Visit||19
9070283|NCT03880227|10131073|FG001|STARTED|Second Visit||20
9070284|NCT03880227|10131074|FG002|STARTED|Second Visit||19
9070285|NCT03880227|10131075|FG003|STARTED|Second Visit||18
9070286|NCT03880227|10131072|FG000|COMPLETED|Second Visit||19
9070287|NCT03880227|10131073|FG001|COMPLETED|Second Visit||20
9070288|NCT03880227|10131074|FG002|COMPLETED|Second Visit||19
9070289|NCT03880227|10131075|FG003|COMPLETED|Second Visit||18
9070290|NCT03880227|10131072|FG000|NOT COMPLETED|Second Visit||0
9070291|NCT03880227|10131073|FG001|NOT COMPLETED|Second Visit||0
9070292|NCT03880227|10131074|FG002|NOT COMPLETED|Second Visit||0
9070293|NCT03880227|10131075|FG003|NOT COMPLETED|Second Visit||0
9070294|NCT03876743|10131089|FG000|STARTED|Overall Study||54
9070295|NCT03876743|10131090|FG001|STARTED|Overall Study||51
9070296|NCT03876743|10131091|FG002|STARTED|Overall Study||46
9070297|NCT03876743|10131092|FG003|STARTED|Overall Study||50
9070298|NCT03876743|10131089|FG000|COMPLETED|Overall Study||48
9070299|NCT03876743|10131090|FG001|COMPLETED|Overall Study||47
9070300|NCT03876743|10131091|FG002|COMPLETED|Overall Study||42
9070301|NCT03876743|10131092|FG003|COMPLETED|Overall Study||43
9070302|NCT03876743|10131089|FG000|NOT COMPLETED|Overall Study||6
9070303|NCT03876743|10131090|FG001|NOT COMPLETED|Overall Study||4
9070304|NCT03876743|10131091|FG002|NOT COMPLETED|Overall Study||4
9070305|NCT03876743|10131092|FG003|NOT COMPLETED|Overall Study||7
9070306|NCT03885934|10131112|FG000|STARTED|Overall Study||64
9070307|NCT03885934|10131113|FG001|STARTED|Overall Study||64
9070308|NCT03885934|10131114|FG002|STARTED|Overall Study||62
9070309|NCT03885934|10131115|FG003|STARTED|Overall Study||64
9070310|NCT03885934|10131116|FG004|STARTED|Overall Study||177
9070311|NCT03885934|10131117|FG005|STARTED|Overall Study||175
9070312|NCT03885934|10131112|FG000|PCV Dose 1|Overall Study||64
9070313|NCT03885934|10131113|FG001|PCV Dose 1|Overall Study||64
9070314|NCT03885934|10131114|FG002|PCV Dose 1|Overall Study||62
9070315|NCT03885934|10131115|FG003|PCV Dose 1|Overall Study||64
9070316|NCT03885934|10131116|FG004|PCV Dose 1|Overall Study||177
9070317|NCT03885934|10131117|FG005|PCV Dose 1|Overall Study||175
9070318|NCT03885934|10131112|FG000|PCV Dose 2|Overall Study||63
9070319|NCT03885934|10131113|FG001|PCV Dose 2|Overall Study||64
9070320|NCT03885934|10131114|FG002|PCV Dose 2|Overall Study||62
9070321|NCT03885934|10131115|FG003|PCV Dose 2|Overall Study||64
9070322|NCT03885934|10131116|FG004|PCV Dose 2|Overall Study||0
9070323|NCT03885934|10131117|FG005|PCV Dose 2|Overall Study||0
9070324|NCT03885934|10131112|FG000|PCV Dose 3|Overall Study||63
9070325|NCT03885934|10131113|FG001|PCV Dose 3|Overall Study||64
9070326|NCT03885934|10131114|FG002|PCV Dose 3|Overall Study||0
9070327|NCT03885934|10131115|FG003|PCV Dose 3|Overall Study||0
9070328|NCT03885934|10131116|FG004|PCV Dose 3|Overall Study||0
9070329|NCT03885934|10131117|FG005|PCV Dose 3|Overall Study||0
9070330|NCT03885934|10131112|FG000|COMPLETED|Overall Study||63
9070331|NCT03885934|10131113|FG001|COMPLETED|Overall Study||64
9070332|NCT03885934|10131114|FG002|COMPLETED|Overall Study||62
9070333|NCT03885934|10131115|FG003|COMPLETED|Overall Study||64
9070334|NCT03885934|10131116|FG004|COMPLETED|Overall Study||177
9070335|NCT03885934|10131117|FG005|COMPLETED|Overall Study||175
9070336|NCT03885934|10131112|FG000|NOT COMPLETED|Overall Study||1
9070337|NCT03885934|10131113|FG001|NOT COMPLETED|Overall Study||0
9070338|NCT03885934|10131114|FG002|NOT COMPLETED|Overall Study||0
9070339|NCT03885934|10131115|FG003|NOT COMPLETED|Overall Study||0
9070340|NCT03885934|10131116|FG004|NOT COMPLETED|Overall Study||0
9070341|NCT03885934|10131117|FG005|NOT COMPLETED|Overall Study||0
9070342|NCT03885726|10131131|FG000|STARTED|Overall Study||32
9070343|NCT03885726|10131131|FG000|COMPLETED|Overall Study||28
9070344|NCT03885726|10131131|FG000|NOT COMPLETED|Overall Study||4
9070345|NCT03885154|10131143|FG000|STARTED|Overall Study||12
9070346|NCT03885154|10131144|FG001|STARTED|Overall Study||10
9070347|NCT03885154|10131145|FG002|STARTED|Overall Study||0
9070348|NCT03885154|10131146|FG003|STARTED|Overall Study||2
9070349|NCT03885154|10131143|FG000|COMPLETED|Overall Study||12
9070350|NCT03885154|10131144|FG001|COMPLETED|Overall Study||10
9070351|NCT03885154|10131145|FG002|COMPLETED|Overall Study||0
9070352|NCT03885154|10131146|FG003|COMPLETED|Overall Study||2
9070353|NCT03885154|10131143|FG000|NOT COMPLETED|Overall Study||0
9070354|NCT03885154|10131144|FG001|NOT COMPLETED|Overall Study||0
9070355|NCT03885154|10131145|FG002|NOT COMPLETED|Overall Study||0
9070356|NCT03885154|10131146|FG003|NOT COMPLETED|Overall Study||0
9070357|NCT03883386|10131156|FG000|STARTED|First Assignment||2
9070358|NCT03883386|10131157|FG001|STARTED|First Assignment||1
9070359|NCT03883386|10131156|FG000|Surveys Begun|First Assignment||1
9070360|NCT03883386|10131157|FG001|Surveys Begun|First Assignment||1
9070361|NCT03883386|10131156|FG000|COMPLETED|First Assignment||0
9070362|NCT03883386|10131157|FG001|COMPLETED|First Assignment||0
9070363|NCT03883386|10131156|FG000|NOT COMPLETED|First Assignment||2
9070364|NCT03883386|10131157|FG001|NOT COMPLETED|First Assignment||1
9070365|NCT03883386|10131156|FG000|STARTED|Washout and Second Assignment||0
9070366|NCT03883386|10131157|FG001|STARTED|Washout and Second Assignment||0
9070367|NCT03883386|10131156|FG000|COMPLETED|Washout and Second Assignment||0
9070368|NCT03883386|10131157|FG001|COMPLETED|Washout and Second Assignment||0
9070369|NCT03883386|10131156|FG000|NOT COMPLETED|Washout and Second Assignment||0
9070370|NCT03883386|10131157|FG001|NOT COMPLETED|Washout and Second Assignment||0
9070371|NCT03882528|10131163|FG000|STARTED|Overall Study||12
9070372|NCT03882528|10131163|FG000|COMPLETED|Overall Study||12
9070373|NCT03882528|10131163|FG000|NOT COMPLETED|Overall Study||0
9070374|NCT03882801|10131169|FG000|STARTED|Period 1||12
9070375|NCT03882801|10131170|FG001|STARTED|Period 1||12
9070376|NCT03882801|10131169|FG000|Treated|Period 1|1 participant did not receive any dose of study drug|11
9070377|NCT03882801|10131170|FG001|Treated|Period 1||12
9070378|NCT03882801|10131169|FG000|COMPLETED|Period 1||10
9070379|NCT03882801|10131170|FG001|COMPLETED|Period 1||10
9070380|NCT03882801|10131169|FG000|NOT COMPLETED|Period 1||2
9070381|NCT03882801|10131170|FG001|NOT COMPLETED|Period 1||2
9070382|NCT03882801|10131169|FG000|STARTED|Washout Period||10
9070383|NCT03882801|10131170|FG001|STARTED|Washout Period||10
9070384|NCT03882801|10131169|FG000|COMPLETED|Washout Period||10
9070385|NCT03882801|10131170|FG001|COMPLETED|Washout Period||9
9070386|NCT03882801|10131169|FG000|NOT COMPLETED|Washout Period||0
9070387|NCT03882801|10131170|FG001|NOT COMPLETED|Washout Period||1
9070388|NCT03882801|10131169|FG000|STARTED|Period 2||10
9070389|NCT03882801|10131170|FG001|STARTED|Period 2||9
9070390|NCT03882801|10131169|FG000|COMPLETED|Period 2||10
9070391|NCT03882801|10131170|FG001|COMPLETED|Period 2||8
9070392|NCT03882801|10131169|FG000|NOT COMPLETED|Period 2||0
9070393|NCT03882801|10131170|FG001|NOT COMPLETED|Period 2||1
9070394|NCT03882424|10131181|FG000|STARTED|Overall Study||38
9070395|NCT03882424|10131182|FG001|STARTED|Overall Study||38
9070396|NCT03882424|10131183|FG002|STARTED|Overall Study||38
9070397|NCT03882424|10131181|FG000|COMPLETED|Overall Study||34
9070398|NCT03882424|10131182|FG001|COMPLETED|Overall Study||38
9070399|NCT03882424|10131183|FG002|COMPLETED|Overall Study||38
9070400|NCT03882424|10131181|FG000|NOT COMPLETED|Overall Study||4
9070401|NCT03882424|10131182|FG001|NOT COMPLETED|Overall Study||0
9070402|NCT03882424|10131183|FG002|NOT COMPLETED|Overall Study||0
9070403|NCT03881163|10131191|FG000|STARTED|Overall Study||24
9070404|NCT03881163|10131191|FG000|COMPLETED|Overall Study||24
9070405|NCT03881163|10131191|FG000|NOT COMPLETED|Overall Study||0
9070406|NCT03881670|10131199|FG000|STARTED|Overall Study||12
9070407|NCT03881670|10131200|FG001|STARTED|Overall Study||12
9070408|NCT03881670|10131199|FG000|Completed First Intervention|Overall Study||12
9070409|NCT03881670|10131200|FG001|Completed First Intervention|Overall Study||12
9070410|NCT03881670|10131199|FG000|Completed Second Intervetion|Overall Study||12
9070411|NCT03881670|10131200|FG001|Completed Second Intervetion|Overall Study||12
9070412|NCT03881670|10131199|FG000|COMPLETED|Overall Study||12
9070413|NCT03881670|10131200|FG001|COMPLETED|Overall Study||12
9070414|NCT03881670|10131199|FG000|NOT COMPLETED|Overall Study||0
9070415|NCT03881670|10131200|FG001|NOT COMPLETED|Overall Study||0
9070416|NCT03880266|10131216|FG000|STARTED|Overall Study||12
9070417|NCT03880266|10131217|FG001|STARTED|Overall Study||6
9070418|NCT03880266|10131218|FG002|STARTED|Overall Study||12
9070419|NCT03880266|10131219|FG003|STARTED|Overall Study||4
9070420|NCT03880266|10131220|FG004|STARTED|Overall Study||12
9070421|NCT03880266|10131221|FG005|STARTED|Overall Study||6
9070422|NCT03880266|10131222|FG006|STARTED|Overall Study||13
9070423|NCT03880266|10131223|FG007|STARTED|Overall Study||7
9070424|NCT03880266|10131216|FG000|COMPLETED|Overall Study||12
9070425|NCT03880266|10131217|FG001|COMPLETED|Overall Study||5
9070426|NCT03880266|10131218|FG002|COMPLETED|Overall Study||11
9070427|NCT03880266|10131219|FG003|COMPLETED|Overall Study||4
9070428|NCT03880266|10131220|FG004|COMPLETED|Overall Study||12
9070429|NCT03880266|10131221|FG005|COMPLETED|Overall Study||6
9070430|NCT03880266|10131222|FG006|COMPLETED|Overall Study||13
9070431|NCT03880266|10131223|FG007|COMPLETED|Overall Study||7
9070432|NCT03880266|10131216|FG000|NOT COMPLETED|Overall Study||0
9070433|NCT03880266|10131217|FG001|NOT COMPLETED|Overall Study||1
9070434|NCT03880266|10131218|FG002|NOT COMPLETED|Overall Study||1
9070435|NCT03880266|10131219|FG003|NOT COMPLETED|Overall Study||0
9070436|NCT03880266|10131220|FG004|NOT COMPLETED|Overall Study||0
9070437|NCT03880266|10131221|FG005|NOT COMPLETED|Overall Study||0
9070438|NCT03880266|10131222|FG006|NOT COMPLETED|Overall Study||0
9070439|NCT03880266|10131223|FG007|NOT COMPLETED|Overall Study||0
9070440|NCT03856320|10131243|FG000|STARTED|Overall Study||20
9070441|NCT03856320|10131244|FG001|STARTED|Overall Study||22
9070442|NCT03856320|10131243|FG000|COMPLETED|Overall Study||20
9070443|NCT03856320|10131244|FG001|COMPLETED|Overall Study||20
9070444|NCT03856320|10131243|FG000|NOT COMPLETED|Overall Study||0
8623890|NCT00496015|9663095|FG002|STARTED|Overall Study||172
8623891|NCT00496015|9663096|FG003|STARTED|Overall Study||37
8623892|NCT00496015|9663097|FG004|STARTED|Overall Study||336
9070445|NCT03856320|10131244|FG001|NOT COMPLETED|Overall Study||2
9070446|NCT03848871|10131250|FG000|STARTED|Overall Study||20
9070447|NCT03848871|10131250|FG000|COMPLETED|Overall Study||20
9070448|NCT03848871|10131250|FG000|NOT COMPLETED|Overall Study||0
9070449|NCT03880474|10131256|FG000|STARTED|Overall Study||1077
9070450|NCT03880474|10131257|FG001|STARTED|Overall Study||1075
9070451|NCT03880474|10131256|FG000|COMPLETED|Overall Study||1054
9070452|NCT03880474|10131257|FG001|COMPLETED|Overall Study||1055
9070453|NCT03880474|10131256|FG000|NOT COMPLETED|Overall Study||23
9070454|NCT03880474|10131257|FG001|NOT COMPLETED|Overall Study||20
9070455|NCT03878160|10131266|FG000|STARTED|Overall Study||7
9070456|NCT03878160|10131267|FG001|STARTED|Overall Study||9
9070457|NCT03878160|10131268|FG002|STARTED|Overall Study||11
9070458|NCT03878160|10131266|FG000|COMPLETED|Overall Study||5
9070459|NCT03878160|10131267|FG001|COMPLETED|Overall Study||8
9070460|NCT03878160|10131268|FG002|COMPLETED|Overall Study||10
9070461|NCT03878160|10131266|FG000|NOT COMPLETED|Overall Study||2
9070462|NCT03878160|10131267|FG001|NOT COMPLETED|Overall Study||1
9070463|NCT03878160|10131268|FG002|NOT COMPLETED|Overall Study||1
9070464|NCT03864627|10131278|FG000|STARTED|Overall Study||11
9070465|NCT03864627|10131279|FG001|STARTED|Overall Study||22
9070466|NCT03864627|10131278|FG000|COMPLETED|Overall Study||7
9070467|NCT03864627|10131279|FG001|COMPLETED|Overall Study||10
9070468|NCT03864627|10131278|FG000|NOT COMPLETED|Overall Study||4
9070469|NCT03864627|10131279|FG001|NOT COMPLETED|Overall Study||12
9070470|NCT03861000|10131288|FG000|STARTED|Overall Study||2
9070471|NCT03861000|10131289|FG001|STARTED|Overall Study||1
9070472|NCT03861000|10131288|FG000|COMPLETED|Overall Study||2
9070473|NCT03861000|10131289|FG001|COMPLETED|Overall Study||1
9070474|NCT03861000|10131288|FG000|NOT COMPLETED|Overall Study||0
9070475|NCT03861000|10131289|FG001|NOT COMPLETED|Overall Study||0
9070476|NCT03848403|10131294|FG000|STARTED|Period 1 (Day 1)||24
9070477|NCT03848403|10131295|FG001|STARTED|Period 1 (Day 1)||24
9070478|NCT03848403|10131296|FG002|STARTED|Period 1 (Day 1)||22
9070479|NCT03848403|10131294|FG000|Received Intervention|Period 1 (Day 1)||24
9070480|NCT03848403|10131295|FG001|Received Intervention|Period 1 (Day 1)||24
9070481|NCT03848403|10131296|FG002|Received Intervention|Period 1 (Day 1)||22
9070482|NCT03848403|10131294|FG000|COMPLETED|Period 1 (Day 1)||24
9070483|NCT03848403|10131295|FG001|COMPLETED|Period 1 (Day 1)||24
9070484|NCT03848403|10131296|FG002|COMPLETED|Period 1 (Day 1)||22
9070485|NCT03848403|10131294|FG000|NOT COMPLETED|Period 1 (Day 1)||0
9070486|NCT03848403|10131295|FG001|NOT COMPLETED|Period 1 (Day 1)||0
9070487|NCT03848403|10131296|FG002|NOT COMPLETED|Period 1 (Day 1)||0
9070488|NCT03848403|10131294|FG000|STARTED|Period 2 (Day 8)||24
9070489|NCT03848403|10131295|FG001|STARTED|Period 2 (Day 8)||24
9070490|NCT03848403|10131296|FG002|STARTED|Period 2 (Day 8)||22
9070491|NCT03848403|10131294|FG000|Received at Least One Dose of Study Drug|Period 2 (Day 8)||24
9070492|NCT03848403|10131295|FG001|Received at Least One Dose of Study Drug|Period 2 (Day 8)||24
9070493|NCT03848403|10131296|FG002|Received at Least One Dose of Study Drug|Period 2 (Day 8)||22
9070494|NCT03848403|10131294|FG000|COMPLETED|Period 2 (Day 8)||15
9070495|NCT03848403|10131295|FG001|COMPLETED|Period 2 (Day 8)||15
9070496|NCT03848403|10131296|FG002|COMPLETED|Period 2 (Day 8)||15
9070497|NCT03848403|10131294|FG000|NOT COMPLETED|Period 2 (Day 8)||9
9070498|NCT03848403|10131295|FG001|NOT COMPLETED|Period 2 (Day 8)||9
9070499|NCT03848403|10131296|FG002|NOT COMPLETED|Period 2 (Day 8)||7
9070500|NCT03848403|10131294|FG000|STARTED|Period 3 (Day 15)||15
9070501|NCT03848403|10131295|FG001|STARTED|Period 3 (Day 15)||15
9070502|NCT03848403|10131296|FG002|STARTED|Period 3 (Day 15)||15
9070503|NCT03848403|10131294|FG000|COMPLETED|Period 3 (Day 15)||15
9070504|NCT03848403|10131295|FG001|COMPLETED|Period 3 (Day 15)||15
9070505|NCT03848403|10131296|FG002|COMPLETED|Period 3 (Day 15)||15
9070506|NCT03848403|10131294|FG000|NOT COMPLETED|Period 3 (Day 15)||0
9070507|NCT03848403|10131295|FG001|NOT COMPLETED|Period 3 (Day 15)||0
9070508|NCT03848403|10131296|FG002|NOT COMPLETED|Period 3 (Day 15)||0
9070509|NCT03847233|10131304|FG000|STARTED|Index Procedure||31
9070510|NCT03847233|10131304|FG000|COMPLETED|Index Procedure||31
9070511|NCT03847233|10131304|FG000|NOT COMPLETED|Index Procedure||0
9070512|NCT03847233|10131304|FG000|STARTED|6 Month After Index Procedure||31
9070513|NCT03847233|10131304|FG000|COMPLETED|6 Month After Index Procedure||30
9070514|NCT03847233|10131304|FG000|NOT COMPLETED|6 Month After Index Procedure||1
9070515|NCT03879603|10131315|FG000|STARTED|Overall Study||5
8623893|NCT00496015|9663093|FG000|COMPLETED|Overall Study||177
8623894|NCT00496015|9663094|FG001|COMPLETED|Overall Study||27
9070516|NCT03879603|10131316|FG001|STARTED|Overall Study||5
9070517|NCT03879603|10131317|FG002|STARTED|Overall Study||5
9070518|NCT03879603|10131318|FG003|STARTED|Overall Study||5
9070519|NCT03879603|10131319|FG004|STARTED|Overall Study||5
9070520|NCT03879603|10131320|FG005|STARTED|Overall Study||5
9070521|NCT03879603|10131315|FG000|Received First Product Administration|Overall Study||5
9070522|NCT03879603|10131316|FG001|Received First Product Administration|Overall Study||5
9070523|NCT03879603|10131317|FG002|Received First Product Administration|Overall Study||5
9070524|NCT03879603|10131318|FG003|Received First Product Administration|Overall Study||5
9070525|NCT03879603|10131319|FG004|Received First Product Administration|Overall Study||5
9070526|NCT03879603|10131320|FG005|Received First Product Administration|Overall Study||5
9070527|NCT03879603|10131315|FG000|Received All Product Administrations|Overall Study|Second administration not completed due to a grade 3 neutropenia not related to study product.|4
9070528|NCT03879603|10131316|FG001|Received All Product Administrations|Overall Study||5
9070529|NCT03879603|10131317|FG002|Received All Product Administrations|Overall Study||5
9070530|NCT03879603|10131318|FG003|Received All Product Administrations|Overall Study||5
9070531|NCT03879603|10131319|FG004|Received All Product Administrations|Overall Study||5
9070532|NCT03879603|10131320|FG005|Received All Product Administrations|Overall Study||5
9070533|NCT03879603|10131315|FG000|COMPLETED|Overall Study||5
9070534|NCT03879603|10131316|FG001|COMPLETED|Overall Study||5
9070535|NCT03879603|10131317|FG002|COMPLETED|Overall Study||5
9070536|NCT03879603|10131318|FG003|COMPLETED|Overall Study||5
9070537|NCT03879603|10131319|FG004|COMPLETED|Overall Study||5
9070538|NCT03879603|10131320|FG005|COMPLETED|Overall Study||5
9070539|NCT03879603|10131315|FG000|NOT COMPLETED|Overall Study||0
9070540|NCT03879603|10131316|FG001|NOT COMPLETED|Overall Study||0
9070541|NCT03879603|10131317|FG002|NOT COMPLETED|Overall Study||0
9070542|NCT03879603|10131318|FG003|NOT COMPLETED|Overall Study||0
9070543|NCT03879603|10131319|FG004|NOT COMPLETED|Overall Study||0
9070544|NCT03879603|10131320|FG005|NOT COMPLETED|Overall Study||0
9070545|NCT03878745|10131336|FG000|STARTED|Overall Study||55
9070546|NCT03878745|10131336|FG000|COMPLETED|Overall Study||55
9070547|NCT03878745|10131336|FG000|NOT COMPLETED|Overall Study||0
9070548|NCT03848221|10131351|FG000|STARTED|Overall Study||25
9070549|NCT03848221|10131352|FG001|STARTED|Overall Study||24
9070550|NCT03848221|10131353|FG002|STARTED|Overall Study||24
8623895|NCT00496015|9663095|FG002|COMPLETED|Overall Study||172
8623896|NCT00496015|9663096|FG003|COMPLETED|Overall Study||36
8623897|NCT00496015|9663097|FG004|COMPLETED|Overall Study||336
8623898|NCT00496015|9663093|FG000|NOT COMPLETED|Overall Study||1
8623899|NCT00496015|9663094|FG001|NOT COMPLETED|Overall Study||0
8623900|NCT00496015|9663095|FG002|NOT COMPLETED|Overall Study||0
8623901|NCT00496015|9663096|FG003|NOT COMPLETED|Overall Study||1
8623902|NCT00496015|9663097|FG004|NOT COMPLETED|Overall Study||0
8623903|NCT00496054|9663117|FG000|STARTED|Overall Study||110
8623904|NCT00496054|9663117|FG000|COMPLETED|Overall Study||102
8623905|NCT00496054|9663117|FG000|NOT COMPLETED|Overall Study||8
8623906|NCT00496080|9663121|FG000|STARTED|Overall Study||87
9070551|NCT03848221|10131351|FG000|COMPLETED|Overall Study||25
9070552|NCT03848221|10131352|FG001|COMPLETED|Overall Study||24
9070553|NCT03848221|10131353|FG002|COMPLETED|Overall Study||24
9070554|NCT03848221|10131351|FG000|NOT COMPLETED|Overall Study||0
9070555|NCT03848221|10131352|FG001|NOT COMPLETED|Overall Study||0
9070556|NCT03848221|10131353|FG002|NOT COMPLETED|Overall Study||0
9070557|NCT03878108|10131363|FG000|STARTED|Overall Study||11
9070558|NCT03878108|10131364|FG001|STARTED|Overall Study||10
9070559|NCT03878108|10131363|FG000|Completed First Phase|Overall Study||10
9070560|NCT03878108|10131364|FG001|Completed First Phase|Overall Study||10
8623907|NCT00496080|9663121|FG000|COMPLETED|Overall Study||60
8623908|NCT00496080|9663121|FG000|NOT COMPLETED|Overall Study||27
8623909|NCT00496197|9663126|FG000|STARTED|Overall Study||282
8623910|NCT00496197|9663126|FG000|COMPLETED|Overall Study||160
8623911|NCT00496197|9663126|FG000|NOT COMPLETED|Overall Study||122
8623912|NCT00496262|9663130|FG000|STARTED|Overall Study||15
8623913|NCT00496262|9663130|FG000|COMPLETED|Overall Study||15
8623914|NCT00496262|9663130|FG000|NOT COMPLETED|Overall Study||0
8623915|NCT00496340|9663136|FG000|STARTED|Overall Study||42
8623916|NCT00496340|9663136|FG000|COMPLETED|Overall Study||42
8623917|NCT00496340|9663136|FG000|NOT COMPLETED|Overall Study||0
8623918|NCT00496366|9663140|FG000|STARTED|Overall Study||11
8623919|NCT00496366|9663140|FG000|COMPLETED|Overall Study||10
8623920|NCT00496366|9663140|FG000|NOT COMPLETED|Overall Study||1
8623921|NCT00496379|9663144|FG000|STARTED|Overall Study||15
8623922|NCT00496379|9663144|FG000|COMPLETED|Overall Study||15
8623923|NCT00496379|9663144|FG000|NOT COMPLETED|Overall Study||0
8623924|NCT00496470|9663150|FG000|STARTED|Overall Study||329
8623925|NCT00496470|9663151|FG001|STARTED|Overall Study||331
8623926|NCT00496470|9663150|FG000|Received Study Medication|Overall Study||329
8623927|NCT00496470|9663151|FG001|Received Study Medication|Overall Study||330
8623928|NCT00496470|9663150|FG000|COMPLETED|Overall Study||303
8623929|NCT00496470|9663151|FG001|COMPLETED|Overall Study||302
8623930|NCT00496470|9663150|FG000|NOT COMPLETED|Overall Study||26
8623931|NCT00496470|9663151|FG001|NOT COMPLETED|Overall Study||29
8623932|NCT00496483|9663157|FG000|STARTED|Overall Study||60
8623933|NCT00496483|9663157|FG000|Dosed|Overall Study||51
8623934|NCT00496483|9663157|FG000|COMPLETED|Overall Study||48
8623935|NCT00496483|9663157|FG000|NOT COMPLETED|Overall Study||12
8623936|NCT00496587|9663164|FG000|STARTED|Overall Study||34
8623937|NCT00496587|9663164|FG000|COMPLETED|Overall Study||3
8623938|NCT00496587|9663164|FG000|NOT COMPLETED|Overall Study||31
8623939|NCT00496626|9663170|FG000|STARTED|Overall Study||302
9070561|NCT03878108|10131363|FG000|COMPLETED|Overall Study||10
9070562|NCT03878108|10131364|FG001|COMPLETED|Overall Study||10
9070563|NCT03878108|10131363|FG000|NOT COMPLETED|Overall Study||1
9070564|NCT03878108|10131364|FG001|NOT COMPLETED|Overall Study||0
8623940|NCT00496626|9663171|FG001|STARTED|Overall Study||298
9070565|NCT03877432|10131370|FG000|STARTED|Overall Study||10
8623941|NCT00496626|9663170|FG000|COMPLETED|Overall Study||296
8623942|NCT00496626|9663171|FG001|COMPLETED|Overall Study||292
8623943|NCT00496626|9663170|FG000|NOT COMPLETED|Overall Study||6
9070566|NCT03877432|10131370|FG000|COMPLETED|Overall Study||10
9070567|NCT03877432|10131370|FG000|NOT COMPLETED|Overall Study||0
8623944|NCT00496626|9663171|FG001|NOT COMPLETED|Overall Study||6
8623945|NCT00496769|9663183|FG000|STARTED|Double Blind|Randomized|2807
8623946|NCT00496769|9663184|FG001|STARTED|Double Blind|Randomized|2791
8623947|NCT00496769|9663185|FG002|STARTED|Double Blind||0
8623948|NCT00496769|9663183|FG000|Received Treatment|Double Blind||2798
8623949|NCT00496769|9663184|FG001|Received Treatment|Double Blind||2708
8623950|NCT00496769|9663185|FG002|Received Treatment|Double Blind||0
8623951|NCT00496769|9663183|FG000|COMPLETED|Double Blind||2249
8623952|NCT00496769|9663184|FG001|COMPLETED|Double Blind||2142
8623953|NCT00496769|9663185|FG002|COMPLETED|Double Blind||0
8623954|NCT00496769|9663183|FG000|NOT COMPLETED|Double Blind||558
8623955|NCT00496769|9663184|FG001|NOT COMPLETED|Double Blind||649
8623956|NCT00496769|9663185|FG002|NOT COMPLETED|Double Blind||0
8623957|NCT00496769|9663183|FG000|STARTED|Open Label||0
8623958|NCT00496769|9663184|FG001|STARTED|Open Label||0
8623959|NCT00496769|9663185|FG002|STARTED|Open Label||3275
8623960|NCT00496769|9663183|FG000|COMPLETED|Open Label||0
8623961|NCT00496769|9663184|FG001|COMPLETED|Open Label||0
8623962|NCT00496769|9663185|FG002|COMPLETED|Open Label||2264
8623963|NCT00496769|9663183|FG000|NOT COMPLETED|Open Label||0
8623964|NCT00496769|9663184|FG001|NOT COMPLETED|Open Label||0
8623965|NCT00496769|9663185|FG002|NOT COMPLETED|Open Label||1011
8623966|NCT00496808|9663194|FG000|STARTED|Overall Study||69
8623967|NCT00496808|9663194|FG000|COMPLETED|Overall Study||69
8623968|NCT00496808|9663194|FG000|NOT COMPLETED|Overall Study||0
8623969|NCT00496860|9663201|FG000|STARTED|Overall Study||4
8623970|NCT00496860|9663202|FG001|STARTED|Overall Study||16
8623971|NCT00496860|9663203|FG002|STARTED|Overall Study||6
8623972|NCT00496860|9663201|FG000|COMPLETED|Overall Study||3
8623973|NCT00496860|9663202|FG001|COMPLETED|Overall Study||15
8623974|NCT00496860|9663203|FG002|COMPLETED|Overall Study||6
8623975|NCT00496860|9663201|FG000|NOT COMPLETED|Overall Study||1
8623976|NCT00496860|9663202|FG001|NOT COMPLETED|Overall Study||1
8623977|NCT00496860|9663203|FG002|NOT COMPLETED|Overall Study||0
8623978|NCT00496873|9663211|FG000|STARTED|Overall Study||85
8623979|NCT00496873|9663211|FG000|COMPLETED|Overall Study||78
8623980|NCT00496873|9663211|FG000|NOT COMPLETED|Overall Study||7
8623981|NCT00496964|9663217|FG000|STARTED|Overall Study||1
8623982|NCT00496964|9663218|FG001|STARTED|Overall Study||4
8623983|NCT00496964|9663217|FG000|COMPLETED|Overall Study||1
8623984|NCT00496964|9663218|FG001|COMPLETED|Overall Study||3
8623985|NCT00496964|9663217|FG000|NOT COMPLETED|Overall Study||0
8623986|NCT00496964|9663218|FG001|NOT COMPLETED|Overall Study||1
8623987|NCT00497055|9663228|FG000|STARTED|Overall Study||45
9070568|NCT03877237|10131380|FG000|STARTED|Overall Study||156
9070569|NCT03877237|10131381|FG001|STARTED|Overall Study||157
9070570|NCT03877237|10131380|FG000|Treated|Overall Study||156
9070571|NCT03877237|10131381|FG001|Treated|Overall Study||157
9070572|NCT03877237|10131380|FG000|COMPLETED|Overall Study||151
9070573|NCT03877237|10131381|FG001|COMPLETED|Overall Study||151
9070574|NCT03877237|10131380|FG000|NOT COMPLETED|Overall Study||5
9070575|NCT03877237|10131381|FG001|NOT COMPLETED|Overall Study||6
9070576|NCT03866434|10131387|FG000|STARTED|Overall Study||20
9070577|NCT03866434|10131387|FG000|COMPLETED|Overall Study||20
9070578|NCT03866434|10131387|FG000|NOT COMPLETED|Overall Study||0
9070579|NCT03863210|10131393|FG000|STARTED|Overall Study|March 1st, 2014.|104
9070580|NCT03863210|10131393|FG000|COMPLETED|Overall Study|September 1st, 2014.|102
9070581|NCT03863210|10131393|FG000|NOT COMPLETED|Overall Study||2
9070582|NCT03859323|10131410|FG000|STARTED|Overall Study||5
9070583|NCT03859323|10131411|FG001|STARTED|Overall Study||5
9070584|NCT03859323|10131412|FG002|STARTED|Overall Study||5
8623988|NCT00497055|9663229|FG001|STARTED|Overall Study||45
8623989|NCT00497055|9663228|FG000|COMPLETED|Overall Study||35
8623990|NCT00497055|9663229|FG001|COMPLETED|Overall Study||40
8623991|NCT00497055|9663228|FG000|NOT COMPLETED|Overall Study||10
9070585|NCT03859323|10131413|FG003|STARTED|Overall Study||5
9070586|NCT03859323|10131414|FG004|STARTED|Overall Study||5
9070587|NCT03859323|10131415|FG005|STARTED|Overall Study||5
9070588|NCT03859323|10131416|FG006|STARTED|Overall Study||12
9070589|NCT03859323|10131417|FG007|STARTED|Overall Study||10
9070590|NCT03859323|10131418|FG008|STARTED|Overall Study||10
9070591|NCT03859323|10131419|FG009|STARTED|Overall Study||10
9070592|NCT03859323|10131420|FG010|STARTED|Overall Study||10
9070593|NCT03859323|10131421|FG011|STARTED|Overall Study||12
9070594|NCT03859323|10131422|FG012|STARTED|Overall Study||10
8623992|NCT00497055|9663229|FG001|NOT COMPLETED|Overall Study||5
8623993|NCT00497081|9663237|FG000|STARTED|Overall Study||30
8623994|NCT00497081|9663238|FG001|STARTED|Overall Study||30
8623995|NCT00497081|9663237|FG000|COMPLETED|Overall Study||28
8623996|NCT00497081|9663238|FG001|COMPLETED|Overall Study||28
8623997|NCT00497081|9663237|FG000|NOT COMPLETED|Overall Study||2
8623998|NCT00497081|9663238|FG001|NOT COMPLETED|Overall Study||2
8623999|NCT00497146|9663246|FG000|STARTED|Treatment Period||115
8624000|NCT00497146|9663247|FG001|STARTED|Treatment Period||112
8624001|NCT00497146|9663246|FG000|COMPLETED|Treatment Period||88
8624002|NCT00497146|9663247|FG001|COMPLETED|Treatment Period||91
8624003|NCT00497146|9663246|FG000|NOT COMPLETED|Treatment Period||27
8624004|NCT00497146|9663247|FG001|NOT COMPLETED|Treatment Period||21
8624005|NCT00497146|9663246|FG000|STARTED|Long-term Follow-up Period||65
8624006|NCT00497146|9663247|FG001|STARTED|Long-term Follow-up Period||72
9070595|NCT03859323|10131410|FG000|COMPLETED|Overall Study||5
9070596|NCT03859323|10131411|FG001|COMPLETED|Overall Study||5
9070597|NCT03859323|10131412|FG002|COMPLETED|Overall Study||4
9070598|NCT03859323|10131413|FG003|COMPLETED|Overall Study||5
9070599|NCT03859323|10131414|FG004|COMPLETED|Overall Study||5
9070600|NCT03859323|10131415|FG005|COMPLETED|Overall Study||4
9070601|NCT03859323|10131416|FG006|COMPLETED|Overall Study||11
9070602|NCT03859323|10131417|FG007|COMPLETED|Overall Study||10
9070603|NCT03859323|10131418|FG008|COMPLETED|Overall Study||10
9070604|NCT03859323|10131419|FG009|COMPLETED|Overall Study||8
9070605|NCT03859323|10131420|FG010|COMPLETED|Overall Study||9
9070606|NCT03859323|10131421|FG011|COMPLETED|Overall Study||10
9070607|NCT03859323|10131422|FG012|COMPLETED|Overall Study||9
9070608|NCT03859323|10131410|FG000|NOT COMPLETED|Overall Study||0
9070609|NCT03859323|10131411|FG001|NOT COMPLETED|Overall Study||0
9070610|NCT03859323|10131412|FG002|NOT COMPLETED|Overall Study||1
9070611|NCT03859323|10131413|FG003|NOT COMPLETED|Overall Study||0
9070612|NCT03859323|10131414|FG004|NOT COMPLETED|Overall Study||0
9070613|NCT03859323|10131415|FG005|NOT COMPLETED|Overall Study||1
9070614|NCT03859323|10131416|FG006|NOT COMPLETED|Overall Study||1
9070615|NCT03859323|10131417|FG007|NOT COMPLETED|Overall Study||0
9070616|NCT03859323|10131418|FG008|NOT COMPLETED|Overall Study||0
9070617|NCT03859323|10131419|FG009|NOT COMPLETED|Overall Study||2
9070618|NCT03859323|10131420|FG010|NOT COMPLETED|Overall Study||1
9070619|NCT03859323|10131421|FG011|NOT COMPLETED|Overall Study||2
9070620|NCT03859323|10131422|FG012|NOT COMPLETED|Overall Study||1
9070621|NCT03867838|10131461|FG000|STARTED|Overall Study||6
9070622|NCT03867838|10131461|FG000|COMPLETED|Overall Study||6
9070623|NCT03867838|10131461|FG000|NOT COMPLETED|Overall Study||0
9070624|NCT03855059|10131467|FG000|STARTED|Overall Study||25
9070625|NCT03855059|10131468|FG001|STARTED|Overall Study||25
9070626|NCT03855059|10131467|FG000|COMPLETED|Overall Study||23
9070627|NCT03855059|10131468|FG001|COMPLETED|Overall Study||25
9070628|NCT03855059|10131467|FG000|NOT COMPLETED|Overall Study||2
9070629|NCT03855059|10131468|FG001|NOT COMPLETED|Overall Study||0
9070630|NCT03852537|10131476|FG000|STARTED|Overall Study||23
9070631|NCT03852537|10131477|FG001|STARTED|Overall Study||21
9070632|NCT03852537|10131476|FG000|COMPLETED|Overall Study||23
9070633|NCT03852537|10131477|FG001|COMPLETED|Overall Study||21
9070634|NCT03852537|10131476|FG000|NOT COMPLETED|Overall Study||0
9070635|NCT03852537|10131477|FG001|NOT COMPLETED|Overall Study||0
9070636|NCT03875859|10131483|FG000|STARTED|Overall Study||4
9070637|NCT03875859|10131483|FG000|COMPLETED|Overall Study||4
9070638|NCT03875859|10131483|FG000|NOT COMPLETED|Overall Study||0
9070639|NCT03875508|10131487|FG000|STARTED|Overall Study||108
9070640|NCT03875508|10131487|FG000|COMPLETED|Overall Study||96
9070641|NCT03875508|10131487|FG000|NOT COMPLETED|Overall Study||12
9070642|NCT03869333|10131495|FG000|STARTED|Overall Study||14
9070643|NCT03869333|10131496|FG001|STARTED|Overall Study||16
9070644|NCT03869333|10131497|FG002|STARTED|Overall Study||16
9070645|NCT03869333|10131498|FG003|STARTED|Overall Study||12
9070646|NCT03869333|10131495|FG000|Received First Dose|Overall Study||14
9070647|NCT03869333|10131496|FG001|Received First Dose|Overall Study||16
9070648|NCT03869333|10131497|FG002|Received First Dose|Overall Study||16
9070649|NCT03869333|10131498|FG003|Received First Dose|Overall Study||12
9070650|NCT03869333|10131495|FG000|Received Second Dose|Overall Study||13
9070651|NCT03869333|10131496|FG001|Received Second Dose|Overall Study||15
9070652|NCT03869333|10131497|FG002|Received Second Dose|Overall Study||16
8624007|NCT00497146|9663246|FG000|COMPLETED|Long-term Follow-up Period||50
8624008|NCT00497146|9663247|FG001|COMPLETED|Long-term Follow-up Period||66
8624009|NCT00497146|9663246|FG000|NOT COMPLETED|Long-term Follow-up Period||15
8624010|NCT00497146|9663247|FG001|NOT COMPLETED|Long-term Follow-up Period||6
9070653|NCT03869333|10131498|FG003|Received Second Dose|Overall Study||12
9070654|NCT03869333|10131495|FG000|Received Third Dose|Overall Study||13
9070655|NCT03869333|10131496|FG001|Received Third Dose|Overall Study||15
9070656|NCT03869333|10131497|FG002|Received Third Dose|Overall Study||16
9070657|NCT03869333|10131498|FG003|Received Third Dose|Overall Study||11
9070658|NCT03869333|10131495|FG000|COMPLETED|Overall Study||12
9070659|NCT03869333|10131496|FG001|COMPLETED|Overall Study||15
9070660|NCT03869333|10131497|FG002|COMPLETED|Overall Study||16
9070661|NCT03869333|10131498|FG003|COMPLETED|Overall Study||12
9070662|NCT03869333|10131495|FG000|NOT COMPLETED|Overall Study||2
9070663|NCT03869333|10131496|FG001|NOT COMPLETED|Overall Study||1
9070664|NCT03869333|10131497|FG002|NOT COMPLETED|Overall Study||0
9070665|NCT03869333|10131498|FG003|NOT COMPLETED|Overall Study||0
9070666|NCT03864900|10131510|FG000|STARTED|Overall Study||36
9070667|NCT03864900|10131511|FG001|STARTED|Overall Study||36
9070668|NCT03864900|10131510|FG000|COMPLETED|Overall Study||33
9070669|NCT03864900|10131511|FG001|COMPLETED|Overall Study||30
9070670|NCT03864900|10131510|FG000|NOT COMPLETED|Overall Study||3
9070671|NCT03864900|10131511|FG001|NOT COMPLETED|Overall Study||6
9070672|NCT03863795|10131521|FG000|STARTED|Overall Study||306
9070673|NCT03863795|10131522|FG001|STARTED|Overall Study||269
9070674|NCT03863795|10131523|FG002|STARTED|Overall Study||244
9070675|NCT03863795|10131524|FG003|STARTED|Overall Study||281
9070676|NCT03863795|10131521|FG000|COMPLETED|Overall Study||306
9070677|NCT03863795|10131522|FG001|COMPLETED|Overall Study||269
9070678|NCT03863795|10131523|FG002|COMPLETED|Overall Study||244
8624011|NCT00497198|9663257|FG000|STARTED|Overall Study||92
8624012|NCT00497198|9663258|FG001|STARTED|Overall Study||91
9070679|NCT03863795|10131524|FG003|COMPLETED|Overall Study||281
9070680|NCT03863795|10131521|FG000|NOT COMPLETED|Overall Study||0
9070681|NCT03863795|10131522|FG001|NOT COMPLETED|Overall Study||0
9070682|NCT03863795|10131523|FG002|NOT COMPLETED|Overall Study||0
9070683|NCT03863795|10131524|FG003|NOT COMPLETED|Overall Study||0
9070684|NCT03875482|10131536|FG000|STARTED|Overall Study||105
9070685|NCT03875482|10131537|FG001|STARTED|Overall Study||52
9070686|NCT03875482|10131536|FG000|COMPLETED|Overall Study||92
9070687|NCT03875482|10131537|FG001|COMPLETED|Overall Study||32
9070688|NCT03875482|10131536|FG000|NOT COMPLETED|Overall Study||13
9070689|NCT03875482|10131537|FG001|NOT COMPLETED|Overall Study||20
9070690|NCT03874377|10131543|FG000|STARTED|Overall Study||11
9070691|NCT03874377|10131543|FG000|COMPLETED|Overall Study||8
9070692|NCT03874377|10131543|FG000|NOT COMPLETED|Overall Study||3
9070693|NCT03863496|10131547|FG000|STARTED|Overall Study||71
9070694|NCT03863496|10131547|FG000|COMPLETED|Overall Study||71
9070695|NCT03863496|10131547|FG000|NOT COMPLETED|Overall Study||0
9070696|NCT03874013|10131555|FG000|STARTED|Overall Study||22
9070697|NCT03874013|10131556|FG001|STARTED|Overall Study||22
9070698|NCT03874013|10131555|FG000|COMPLETED|Overall Study||22
9070699|NCT03874013|10131556|FG001|COMPLETED|Overall Study||21
9070700|NCT03874013|10131555|FG000|NOT COMPLETED|Overall Study||0
9070701|NCT03874013|10131556|FG001|NOT COMPLETED|Overall Study||1
9070702|NCT03873116|10131565|FG000|STARTED|Overall Study||6
9070703|NCT03873116|10131566|FG001|STARTED|Overall Study||7
9070704|NCT03873116|10131567|FG002|STARTED|Overall Study||6
9070705|NCT03873116|10131565|FG000|COMPLETED|Overall Study||6
9070706|NCT03873116|10131566|FG001|COMPLETED|Overall Study||7
9070707|NCT03873116|10131567|FG002|COMPLETED|Overall Study||5
9070708|NCT03873116|10131565|FG000|NOT COMPLETED|Overall Study||0
9070709|NCT03873116|10131566|FG001|NOT COMPLETED|Overall Study||0
9070710|NCT03873116|10131567|FG002|NOT COMPLETED|Overall Study||1
9070711|NCT03872843|10131577|FG000|STARTED|Overall Study||12
9070712|NCT03872843|10131578|FG001|STARTED|Overall Study||10
9070713|NCT03872843|10131577|FG000|COMPLETED|Overall Study||7
9070714|NCT03872843|10131578|FG001|COMPLETED|Overall Study||3
9070715|NCT03872843|10131577|FG000|NOT COMPLETED|Overall Study||5
9070716|NCT03872843|10131578|FG001|NOT COMPLETED|Overall Study||7
9070717|NCT03870997|10131590|FG000|STARTED|Overall Study||15702
9070718|NCT03870997|10131591|FG001|STARTED|Overall Study||15702
9070719|NCT03870997|10131592|FG002|STARTED|Overall Study||15756
9070720|NCT03870997|10131593|FG003|STARTED|Overall Study||15757
9070721|NCT03870997|10131594|FG004|STARTED|Overall Study||15702
9070722|NCT03870997|10131595|FG005|STARTED|Overall Study||15702
9070723|NCT03870997|10131590|FG000|COMPLETED|Overall Study||5158
9070724|NCT03870997|10131591|FG001|COMPLETED|Overall Study||5271
9070725|NCT03870997|10131592|FG002|COMPLETED|Overall Study||4778
9070726|NCT03870997|10131593|FG003|COMPLETED|Overall Study||4810
9070727|NCT03870997|10131594|FG004|COMPLETED|Overall Study||5114
9070728|NCT03870997|10131595|FG005|COMPLETED|Overall Study||5171
9070729|NCT03870997|10131590|FG000|NOT COMPLETED|Overall Study||10544
9070730|NCT03870997|10131591|FG001|NOT COMPLETED|Overall Study||10431
9070731|NCT03870997|10131592|FG002|NOT COMPLETED|Overall Study||10978
9070732|NCT03870997|10131593|FG003|NOT COMPLETED|Overall Study||10947
9070733|NCT03870997|10131594|FG004|NOT COMPLETED|Overall Study||10588
9070734|NCT03870997|10131595|FG005|NOT COMPLETED|Overall Study||10531
9070735|NCT03869684|10131607|FG000|STARTED|Overall Study||3
9070736|NCT03869684|10131608|FG001|STARTED|Overall Study||5
9070737|NCT03869684|10131609|FG002|STARTED|Overall Study||5
9070738|NCT03869684|10131607|FG000|COMPLETED|Overall Study||1
9070739|NCT03869684|10131608|FG001|COMPLETED|Overall Study||2
9070740|NCT03869684|10131609|FG002|COMPLETED|Overall Study||2
9070741|NCT03869684|10131607|FG000|NOT COMPLETED|Overall Study||2
9070742|NCT03869684|10131608|FG001|NOT COMPLETED|Overall Study||3
9070743|NCT03869684|10131609|FG002|NOT COMPLETED|Overall Study||3
9070744|NCT03861338|10131617|FG000|STARTED|Overall Study||10
9070745|NCT03861338|10131617|FG000|COMPLETED|Overall Study||8
9070746|NCT03861338|10131617|FG000|NOT COMPLETED|Overall Study||2
8624013|NCT00497198|9663257|FG000|COMPLETED|Overall Study||87
8624014|NCT00497198|9663258|FG001|COMPLETED|Overall Study||86
8624015|NCT00497198|9663257|FG000|NOT COMPLETED|Overall Study||5
8624016|NCT00497198|9663258|FG001|NOT COMPLETED|Overall Study||5
8624017|NCT00497289|9663266|FG000|STARTED|Overall Study||24
9070747|NCT03858335|10131623|FG000|STARTED|Overall Study||16
9070748|NCT03858335|10131624|FG001|STARTED|Overall Study||16
9070749|NCT03858335|10131623|FG000|COMPLETED|Overall Study||12
9070750|NCT03858335|10131624|FG001|COMPLETED|Overall Study||12
9070751|NCT03858335|10131623|FG000|NOT COMPLETED|Overall Study||4
9070752|NCT03858335|10131624|FG001|NOT COMPLETED|Overall Study||4
9070753|NCT03857243|10131632|FG000|STARTED|Overall Study||1
9070754|NCT03857243|10131633|FG001|STARTED|Overall Study||1
9070755|NCT03857243|10131632|FG000|COMPLETED|Overall Study||1
9070756|NCT03857243|10131633|FG001|COMPLETED|Overall Study||1
9070757|NCT03857243|10131632|FG000|NOT COMPLETED|Overall Study||0
9070758|NCT03857243|10131633|FG001|NOT COMPLETED|Overall Study||0
9070759|NCT03851744|10131641|FG000|STARTED|Overall Study||4
9070760|NCT03851744|10131642|FG001|STARTED|Overall Study||6
9070761|NCT03851744|10131641|FG000|COMPLETED|Overall Study||4
9070762|NCT03851744|10131642|FG001|COMPLETED|Overall Study||4
9070763|NCT03851744|10131641|FG000|NOT COMPLETED|Overall Study||0
8556722|NCT03825393|9588500|FG000|COMPLETED|Overall Study||100
8556723|NCT03825393|9588501|FG001|COMPLETED|Overall Study||100
8556724|NCT03825393|9588500|FG000|NOT COMPLETED|Overall Study||0
8556725|NCT03825393|9588501|FG001|NOT COMPLETED|Overall Study||0
8568720|NCT00092547|9600913|FG002|COMPLETED|Long-term Follow-up (Month 126 Visit)||211
8568721|NCT00092547|9600911|FG000|NOT COMPLETED|Long-term Follow-up (Month 126 Visit)||0
9070764|NCT03851744|10131642|FG001|NOT COMPLETED|Overall Study||2
9070765|NCT03849937|10131648|FG000|STARTED|Overall Study||147
9070766|NCT03849937|10131649|FG001|STARTED|Overall Study||72
9070767|NCT03849937|10131648|FG000|COMPLETED|Overall Study||94
9070768|NCT03849937|10131649|FG001|COMPLETED|Overall Study||35
9070769|NCT03849937|10131648|FG000|NOT COMPLETED|Overall Study||53
9070770|NCT03849937|10131649|FG001|NOT COMPLETED|Overall Study||37
9070771|NCT03848416|10131663|FG000|STARTED|Overall Study||33
9070772|NCT03848416|10131664|FG001|STARTED|Overall Study||33
9070773|NCT03848416|10131665|FG002|STARTED|Overall Study||33
9070774|NCT03848416|10131663|FG000|Received at Least One Dose of Study Drug|Overall Study||33
9070775|NCT03848416|10131664|FG001|Received at Least One Dose of Study Drug|Overall Study||33
9070776|NCT03848416|10131665|FG002|Received at Least One Dose of Study Drug|Overall Study||33
9070777|NCT03848416|10131663|FG000|COMPLETED|Overall Study||32
9070778|NCT03848416|10131664|FG001|COMPLETED|Overall Study||33
9070779|NCT03848416|10131665|FG002|COMPLETED|Overall Study||32
9070780|NCT03848416|10131663|FG000|NOT COMPLETED|Overall Study||1
9070781|NCT03848416|10131664|FG001|NOT COMPLETED|Overall Study||0
9070782|NCT03848416|10131665|FG002|NOT COMPLETED|Overall Study||1
9070783|NCT03847987|10131675|FG000|STARTED|Overall Study||16
9070784|NCT03847987|10131676|FG001|STARTED|Overall Study||8
9070785|NCT03847987|10131675|FG000|COMPLETED|Overall Study||13
9070786|NCT03847987|10131676|FG001|COMPLETED|Overall Study||8
9070787|NCT03847987|10131675|FG000|NOT COMPLETED|Overall Study||3
9070788|NCT03847987|10131676|FG001|NOT COMPLETED|Overall Study||0
9070789|NCT03854253|10131695|FG000|STARTED|Overall Study||50
9070790|NCT03854253|10131696|FG001|STARTED|Overall Study||50
9070791|NCT03854253|10131695|FG000|COMPLETED|Overall Study||49
9070792|NCT03854253|10131696|FG001|COMPLETED|Overall Study||50
9070793|NCT03854253|10131695|FG000|NOT COMPLETED|Overall Study||1
9070794|NCT03854253|10131696|FG001|NOT COMPLETED|Overall Study||0
9070795|NCT03870737|10131702|FG000|STARTED|Overall Study||22
9070796|NCT03870737|10131702|FG000|COMPLETED|Overall Study||20
9070797|NCT03870737|10131702|FG000|NOT COMPLETED|Overall Study||2
9070798|NCT03860181|10131710|FG000|STARTED|Overall Study||21
9070799|NCT03860181|10131711|FG001|STARTED|Overall Study||22
9070800|NCT03860181|10131712|FG002|STARTED|Overall Study||25
9070801|NCT03860181|10131713|FG003|STARTED|Overall Study||21
9070802|NCT03860181|10131710|FG000|COMPLETED|Overall Study||21
9070803|NCT03860181|10131711|FG001|COMPLETED|Overall Study||22
9070804|NCT03860181|10131712|FG002|COMPLETED|Overall Study||25
9070805|NCT03860181|10131713|FG003|COMPLETED|Overall Study||21
9070806|NCT03860181|10131710|FG000|NOT COMPLETED|Overall Study||0
9070807|NCT03860181|10131711|FG001|NOT COMPLETED|Overall Study||0
9070808|NCT03860181|10131712|FG002|NOT COMPLETED|Overall Study||0
9070809|NCT03860181|10131713|FG003|NOT COMPLETED|Overall Study||0
9070810|NCT03856944|10131734|FG000|STARTED|Overall Study||29
9070811|NCT03856944|10131734|FG000|COMPLETED|Overall Study||29
9070812|NCT03856944|10131734|FG000|NOT COMPLETED|Overall Study||0
9070813|NCT03853551|10131738|FG000|STARTED|Overall Study||60
9070814|NCT03853551|10131738|FG000|COMPLETED|Overall Study||51
9070815|NCT03853551|10131738|FG000|NOT COMPLETED|Overall Study||9
9070816|NCT03870555|10131745|FG000|STARTED|Period 1 (2 Days)||2
9070817|NCT03870555|10131746|FG001|STARTED|Period 1 (2 Days)||2
9070818|NCT03870555|10131747|FG002|STARTED|Period 1 (2 Days)||2
9070819|NCT03870555|10131745|FG000|COMPLETED|Period 1 (2 Days)||2
9070820|NCT03870555|10131746|FG001|COMPLETED|Period 1 (2 Days)||2
9070821|NCT03870555|10131747|FG002|COMPLETED|Period 1 (2 Days)||2
9070822|NCT03870555|10131745|FG000|NOT COMPLETED|Period 1 (2 Days)||0
9070823|NCT03870555|10131746|FG001|NOT COMPLETED|Period 1 (2 Days)||0
9070824|NCT03870555|10131747|FG002|NOT COMPLETED|Period 1 (2 Days)||0
9070825|NCT03870555|10131745|FG000|STARTED|Washout Period (at Least 16 Days)||2
9070826|NCT03870555|10131746|FG001|STARTED|Washout Period (at Least 16 Days)||2
9070827|NCT03870555|10131747|FG002|STARTED|Washout Period (at Least 16 Days)||2
9070828|NCT03870555|10131745|FG000|COMPLETED|Washout Period (at Least 16 Days)||2
9070829|NCT03870555|10131746|FG001|COMPLETED|Washout Period (at Least 16 Days)||2
9070830|NCT03870555|10131747|FG002|COMPLETED|Washout Period (at Least 16 Days)||2
9070831|NCT03870555|10131745|FG000|NOT COMPLETED|Washout Period (at Least 16 Days)||0
9070832|NCT03870555|10131746|FG001|NOT COMPLETED|Washout Period (at Least 16 Days)||0
9070833|NCT03870555|10131747|FG002|NOT COMPLETED|Washout Period (at Least 16 Days)||0
9070834|NCT03870555|10131745|FG000|STARTED|Period 2 (2 Days)||2
9070835|NCT03870555|10131746|FG001|STARTED|Period 2 (2 Days)||2
9070836|NCT03870555|10131747|FG002|STARTED|Period 2 (2 Days)||2
9070837|NCT03870555|10131745|FG000|COMPLETED|Period 2 (2 Days)||2
9070838|NCT03870555|10131746|FG001|COMPLETED|Period 2 (2 Days)||2
9070839|NCT03870555|10131747|FG002|COMPLETED|Period 2 (2 Days)||2
9070840|NCT03870555|10131745|FG000|NOT COMPLETED|Period 2 (2 Days)||0
9070841|NCT03870555|10131746|FG001|NOT COMPLETED|Period 2 (2 Days)||0
9070842|NCT03870555|10131747|FG002|NOT COMPLETED|Period 2 (2 Days)||0
9070843|NCT03870555|10131745|FG000|STARTED|Washout Period (at Least 16 Days)||2
9070844|NCT03870555|10131746|FG001|STARTED|Washout Period (at Least 16 Days)||2
9070845|NCT03870555|10131747|FG002|STARTED|Washout Period (at Least 16 Days)||2
9070846|NCT03870555|10131745|FG000|COMPLETED|Washout Period (at Least 16 Days)||2
9070847|NCT03870555|10131746|FG001|COMPLETED|Washout Period (at Least 16 Days)||2
9070848|NCT03870555|10131747|FG002|COMPLETED|Washout Period (at Least 16 Days)||2
9070849|NCT03870555|10131745|FG000|NOT COMPLETED|Washout Period (at Least 16 Days)||0
9070850|NCT03870555|10131746|FG001|NOT COMPLETED|Washout Period (at Least 16 Days)||0
9070851|NCT03870555|10131747|FG002|NOT COMPLETED|Washout Period (at Least 16 Days)||0
9070852|NCT03870555|10131745|FG000|STARTED|Period 3 (2 Days)||2
9070853|NCT03870555|10131746|FG001|STARTED|Period 3 (2 Days)||2
9070854|NCT03870555|10131747|FG002|STARTED|Period 3 (2 Days)||2
9070855|NCT03870555|10131745|FG000|COMPLETED|Period 3 (2 Days)||1
9070856|NCT03870555|10131746|FG001|COMPLETED|Period 3 (2 Days)||2
9070857|NCT03870555|10131747|FG002|COMPLETED|Period 3 (2 Days)||2
9070858|NCT03870555|10131745|FG000|NOT COMPLETED|Period 3 (2 Days)||1
9070859|NCT03870555|10131746|FG001|NOT COMPLETED|Period 3 (2 Days)||0
9070860|NCT03870555|10131747|FG002|NOT COMPLETED|Period 3 (2 Days)||0
9070861|NCT03861845|10131761|FG000|STARTED|Overall Study||6
9070862|NCT03861845|10131762|FG001|STARTED|Overall Study||5
9070863|NCT03861845|10131763|FG002|STARTED|Overall Study||4
9070864|NCT03861845|10131761|FG000|COMPLETED|Overall Study||6
9070865|NCT03861845|10131762|FG001|COMPLETED|Overall Study||5
9070866|NCT03861845|10131763|FG002|COMPLETED|Overall Study||4
9070867|NCT03861845|10131761|FG000|NOT COMPLETED|Overall Study||0
9070868|NCT03861845|10131762|FG001|NOT COMPLETED|Overall Study||0
9070869|NCT03861845|10131763|FG002|NOT COMPLETED|Overall Study||0
9070870|NCT03851094|10131773|FG000|STARTED|Overall Study||111
9070871|NCT03851094|10131774|FG001|STARTED|Overall Study||55
9070872|NCT03851094|10131773|FG000|COMPLETED|Overall Study||111
9070873|NCT03851094|10131774|FG001|COMPLETED|Overall Study||51
9070874|NCT03851094|10131773|FG000|NOT COMPLETED|Overall Study||0
9070875|NCT03851094|10131774|FG001|NOT COMPLETED|Overall Study||4
9070876|NCT03869450|10131785|FG000|STARTED|Overall Study||31
9070877|NCT03869450|10131786|FG001|STARTED|Overall Study||25
9070878|NCT03869450|10131787|FG002|STARTED|Overall Study||34
9070879|NCT03869450|10131785|FG000|COMPLETED|Overall Study||30
9070880|NCT03869450|10131786|FG001|COMPLETED|Overall Study||23
9070881|NCT03869450|10131787|FG002|COMPLETED|Overall Study||34
9070882|NCT03869450|10131785|FG000|NOT COMPLETED|Overall Study||1
9070883|NCT03869450|10131786|FG001|NOT COMPLETED|Overall Study||2
9070884|NCT03869450|10131787|FG002|NOT COMPLETED|Overall Study||0
9070885|NCT03868631|10131797|FG000|STARTED|Baseline to Week 6||30
9070886|NCT03868631|10131798|FG001|STARTED|Baseline to Week 6||31
9070887|NCT03868631|10131797|FG000|COMPLETED|Baseline to Week 6||26
9070888|NCT03868631|10131798|FG001|COMPLETED|Baseline to Week 6||27
9070889|NCT03868631|10131797|FG000|NOT COMPLETED|Baseline to Week 6||4
9070890|NCT03868631|10131798|FG001|NOT COMPLETED|Baseline to Week 6||4
9070891|NCT03868631|10131797|FG000|STARTED|Week 6 to Week 12 (Study Completion)||26
9070892|NCT03868631|10131798|FG001|STARTED|Week 6 to Week 12 (Study Completion)||27
9070893|NCT03868631|10131797|FG000|COMPLETED|Week 6 to Week 12 (Study Completion)||22
9070894|NCT03868631|10131798|FG001|COMPLETED|Week 6 to Week 12 (Study Completion)||26
9070895|NCT03868631|10131797|FG000|NOT COMPLETED|Week 6 to Week 12 (Study Completion)||4
9070896|NCT03868631|10131798|FG001|NOT COMPLETED|Week 6 to Week 12 (Study Completion)||1
9070897|NCT03865953|10131806|FG000|STARTED|First Intervention (4 Weeks)||25
9070898|NCT03865953|10131807|FG001|STARTED|First Intervention (4 Weeks)||28
9070899|NCT03865953|10131806|FG000|COMPLETED|First Intervention (4 Weeks)||23
9070900|NCT03865953|10131807|FG001|COMPLETED|First Intervention (4 Weeks)||27
9070901|NCT03865953|10131806|FG000|NOT COMPLETED|First Intervention (4 Weeks)||2
9070902|NCT03865953|10131807|FG001|NOT COMPLETED|First Intervention (4 Weeks)||1
9070903|NCT03865953|10131806|FG000|STARTED|Washout/Baseline Period (3 Weeks)||23
9070904|NCT03865953|10131807|FG001|STARTED|Washout/Baseline Period (3 Weeks)||27
9070905|NCT03865953|10131806|FG000|COMPLETED|Washout/Baseline Period (3 Weeks)||23
9070906|NCT03865953|10131807|FG001|COMPLETED|Washout/Baseline Period (3 Weeks)||27
9070907|NCT03865953|10131806|FG000|NOT COMPLETED|Washout/Baseline Period (3 Weeks)||0
9070908|NCT03865953|10131807|FG001|NOT COMPLETED|Washout/Baseline Period (3 Weeks)||0
9070909|NCT03865953|10131806|FG000|STARTED|Second Intervention (4 Weeks)||23
9070910|NCT03865953|10131807|FG001|STARTED|Second Intervention (4 Weeks)||27
9070911|NCT03865953|10131806|FG000|COMPLETED|Second Intervention (4 Weeks)||23
9070912|NCT03865953|10131807|FG001|COMPLETED|Second Intervention (4 Weeks)||25
9070913|NCT03865953|10131806|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0
9070914|NCT03865953|10131807|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||2
9070915|NCT03865381|10131813|FG000|STARTED|Overall Study||60
9070916|NCT03865381|10131813|FG000|COMPLETED|Overall Study||55
9070917|NCT03865381|10131813|FG000|NOT COMPLETED|Overall Study||5
9070918|NCT03865446|10131819|FG000|STARTED|Overall Study||8
9070919|NCT03865446|10131820|FG001|STARTED|Overall Study||8
9070920|NCT03865446|10131819|FG000|COMPLETED|Overall Study||8
9070921|NCT03865446|10131820|FG001|COMPLETED|Overall Study||8
9070922|NCT03865446|10131819|FG000|NOT COMPLETED|Overall Study||0
8624018|NCT00497289|9663267|FG001|STARTED|Overall Study||24
8624019|NCT00497289|9663266|FG000|COMPLETED|Overall Study||19
8624020|NCT00497289|9663267|FG001|COMPLETED|Overall Study||18
8624021|NCT00497289|9663266|FG000|NOT COMPLETED|Overall Study||5
8624022|NCT00497289|9663267|FG001|NOT COMPLETED|Overall Study||6
9070923|NCT03865446|10131820|FG001|NOT COMPLETED|Overall Study||0
9070924|NCT03862027|10131826|FG000|STARTED|Overall Study||1
9070925|NCT03862027|10131826|FG000|COMPLETED|Overall Study||1
9070926|NCT03862027|10131826|FG000|NOT COMPLETED|Overall Study||0
9070927|NCT03859960|10131832|FG000|STARTED|Overall Study||14
9070928|NCT03859960|10131833|FG001|STARTED|Overall Study||19
9070929|NCT03859960|10131832|FG000|COMPLETED|Overall Study||14
9070930|NCT03859960|10131833|FG001|COMPLETED|Overall Study||19
9070931|NCT03859960|10131832|FG000|NOT COMPLETED|Overall Study||0
9070932|NCT03859960|10131833|FG001|NOT COMPLETED|Overall Study||0
9070933|NCT03868059|10131841|FG000|STARTED|Overall Study||138
9070934|NCT03868059|10131841|FG000|COMPLETED|Overall Study||126
9070935|NCT03868059|10131841|FG000|NOT COMPLETED|Overall Study||12
9070936|NCT03868254|10131847|FG000|STARTED|Overall Study||98
9070937|NCT03868254|10131848|FG001|STARTED|Overall Study||76
9070938|NCT03868254|10131847|FG000|COMPLETED|Overall Study||98
9070939|NCT03868254|10131848|FG001|COMPLETED|Overall Study||76
9070940|NCT03868254|10131847|FG000|NOT COMPLETED|Overall Study||0
9070941|NCT03868254|10131848|FG001|NOT COMPLETED|Overall Study||0
9070942|NCT03865407|10131856|FG000|STARTED|Overall Study||10
9070943|NCT03865407|10131857|FG001|STARTED|Overall Study||7
9070944|NCT03865407|10131856|FG000|COMPLETED|Overall Study||7
9070945|NCT03865407|10131857|FG001|COMPLETED|Overall Study||7
9070946|NCT03865407|10131856|FG000|NOT COMPLETED|Overall Study||3
9070947|NCT03865407|10131857|FG001|NOT COMPLETED|Overall Study||0
9070948|NCT03857230|10131865|FG000|STARTED|Period 1 (Primapur-Gonal-F)||12
9070949|NCT03857230|10131866|FG001|STARTED|Period 1 (Primapur-Gonal-F)||12
9070950|NCT03857230|10131865|FG000|COMPLETED|Period 1 (Primapur-Gonal-F)||12
9070951|NCT03857230|10131866|FG001|COMPLETED|Period 1 (Primapur-Gonal-F)||12
9070952|NCT03857230|10131865|FG000|NOT COMPLETED|Period 1 (Primapur-Gonal-F)||0
9070953|NCT03857230|10131866|FG001|NOT COMPLETED|Period 1 (Primapur-Gonal-F)||0
9070954|NCT03857230|10131865|FG000|STARTED|Period 2 (Gonal-F-Primapur)||12
9070955|NCT03857230|10131866|FG001|STARTED|Period 2 (Gonal-F-Primapur)||12
9070956|NCT03857230|10131865|FG000|COMPLETED|Period 2 (Gonal-F-Primapur)||12
9070957|NCT03857230|10131866|FG001|COMPLETED|Period 2 (Gonal-F-Primapur)||12
9070958|NCT03857230|10131865|FG000|NOT COMPLETED|Period 2 (Gonal-F-Primapur)||0
9070959|NCT03857230|10131866|FG001|NOT COMPLETED|Period 2 (Gonal-F-Primapur)||0
9070960|NCT03865329|10131872|FG000|STARTED|Overall Study||9
9070961|NCT03865329|10131872|FG000|COMPLETED|Overall Study||9
9070962|NCT03865329|10131872|FG000|NOT COMPLETED|Overall Study||0
9070963|NCT03864653|10131876|FG000|STARTED|Overall Study||39
9070964|NCT03864653|10131876|FG000|COMPLETED|Overall Study||38
9070965|NCT03864653|10131876|FG000|NOT COMPLETED|Overall Study||1
9070966|NCT03862482|10131883|FG000|STARTED|Overall Study|Eight participants (forty implant units) were randomly allocated to Configuration 1 by study coordinator. Each participant was also randomly assigned one of the three implant units (B or SW or SC) on a rotating basis to one of five sites between mental foramen. As a result, an equal number of each implant unit type was placed at each the five sites|8
9070967|NCT03862482|10131884|FG001|STARTED|Overall Study|Eight participants (forty implant units) were randomly allocated to Configuration 2 by study coordinator. Each participant was also randomly assigned one of the three implant units (B or SW or SC) on a rotating basis to one of five sites between mental foramen. As a result, an equal number of each implant unit type was placed at each the five sites|8
9070968|NCT03862482|10131885|FG002|STARTED|Overall Study|Six participants (thirty implant units) were randomly allocated to Configuration 3 by study coordinator. Each participant was also randomly assigned one of the three implant units (B or SW or SC) on a rotating basis to one of five sites between mental foramen. As a result, an equal number of each implant unit type was placed at each the five sites|6
9070969|NCT03862482|10131883|FG000|COMPLETED|Overall Study|Sixteen B, 16 SW, and eight SC implant units were placed on a rotating basis at the five sites for a total of 40 implant units. Of these, one implant unit (SW) had fractured and was subsequently excluded from all future analyses|8
9070970|NCT03862482|10131884|FG001|COMPLETED|Overall Study|Eight B, 16 SW, and 16 SC implant units were placed on a rotating basis at the five sites for a total of 40 implant units. Of these, two implant units (one B, one SW) were removed from all future analyses due to technical issues with radiographs|8
8556726|NCT03813719|9588509|FG000|STARTED|Overall Study||250
8556727|NCT03813719|9588509|FG000|COMPLETED|Overall Study||250
8556728|NCT03813719|9588509|FG000|NOT COMPLETED|Overall Study||0
8568722|NCT00092547|9600912|FG001|NOT COMPLETED|Long-term Follow-up (Month 126 Visit)||0
8568723|NCT00092547|9600913|FG002|NOT COMPLETED|Long-term Follow-up (Month 126 Visit)||0
8568724|NCT00093015|9600926|FG000|STARTED|Overall Study||2026
8568725|NCT00093015|9600927|FG001|STARTED|Overall Study||2012
8568726|NCT00093015|9600926|FG000|Received Study Medication|Overall Study||2019
8568727|NCT00093015|9600927|FG001|Received Study Medication|Overall Study||2004
8568728|NCT00093015|9600926|FG000|COMPLETED|Overall Study||1361
8624023|NCT00497770|9663279|FG000|STARTED|Overall Study||304
9070971|NCT03862482|10131885|FG002|COMPLETED|Overall Study|Twelve B, six SW, and 12 SC implant units were placed on a rotating basis at the five sites for a total of 30 implant units|6
9070972|NCT03862482|10131883|FG000|NOT COMPLETED|Overall Study||0
9070973|NCT03862482|10131884|FG001|NOT COMPLETED|Overall Study||0
9070974|NCT03862482|10131885|FG002|NOT COMPLETED|Overall Study||0
9070975|NCT03853213|10131893|FG000|STARTED|Overall Study||11
9070976|NCT03853213|10131894|FG001|STARTED|Overall Study||9
9070977|NCT03853213|10131893|FG000|COMPLETED|Overall Study||10
9070978|NCT03853213|10131894|FG001|COMPLETED|Overall Study||7
9070979|NCT03853213|10131893|FG000|NOT COMPLETED|Overall Study||1
9070980|NCT03853213|10131894|FG001|NOT COMPLETED|Overall Study||2
9070981|NCT03847610|10131900|FG000|STARTED|Overall Study||11
9070982|NCT03847610|10131900|FG000|COMPLETED|Overall Study||10
9070983|NCT03847610|10131900|FG000|NOT COMPLETED|Overall Study||1
9070984|NCT03850093|10131907|FG000|STARTED|Overall Study||22
9070985|NCT03850093|10131908|FG001|STARTED|Overall Study||22
9070986|NCT03850093|10131909|FG002|STARTED|Overall Study||19
9070987|NCT03850093|10131907|FG000|COMPLETED|Overall Study||21
9070988|NCT03850093|10131908|FG001|COMPLETED|Overall Study||22
9070989|NCT03850093|10131909|FG002|COMPLETED|Overall Study||17
9070990|NCT03850093|10131907|FG000|NOT COMPLETED|Overall Study||1
9070991|NCT03850093|10131908|FG001|NOT COMPLETED|Overall Study||0
9070992|NCT03850093|10131909|FG002|NOT COMPLETED|Overall Study||2
9070993|NCT03848208|10131927|FG000|STARTED|Overall Study||18
9070994|NCT03848208|10131928|FG001|STARTED|Overall Study||6
9070995|NCT03848208|10131929|FG002|STARTED|Overall Study||6
9070996|NCT03848208|10131930|FG003|STARTED|Overall Study||6
9070997|NCT03848208|10131931|FG004|STARTED|Overall Study||6
9070998|NCT03848208|10131932|FG005|STARTED|Overall Study||6
9070999|NCT03848208|10131933|FG006|STARTED|Overall Study||6
9071000|NCT03848208|10131934|FG007|STARTED|Overall Study||6
9071001|NCT03848208|10131935|FG008|STARTED|Overall Study||6
9071002|NCT03848208|10131936|FG009|STARTED|Overall Study||6
9071003|NCT03848208|10131927|FG000|COMPLETED|Overall Study||18
9071004|NCT03848208|10131928|FG001|COMPLETED|Overall Study||6
9071005|NCT03848208|10131929|FG002|COMPLETED|Overall Study||6
9071006|NCT03848208|10131930|FG003|COMPLETED|Overall Study||6
9071007|NCT03848208|10131931|FG004|COMPLETED|Overall Study||6
9071008|NCT03848208|10131932|FG005|COMPLETED|Overall Study||6
9071009|NCT03848208|10131933|FG006|COMPLETED|Overall Study||6
9071010|NCT03848208|10131934|FG007|COMPLETED|Overall Study||6
9071011|NCT03848208|10131935|FG008|COMPLETED|Overall Study||6
9071012|NCT03848208|10131936|FG009|COMPLETED|Overall Study||6
9071013|NCT03848208|10131927|FG000|NOT COMPLETED|Overall Study||0
9071014|NCT03848208|10131928|FG001|NOT COMPLETED|Overall Study||0
9071015|NCT03848208|10131929|FG002|NOT COMPLETED|Overall Study||0
9071016|NCT03848208|10131930|FG003|NOT COMPLETED|Overall Study||0
9071017|NCT03848208|10131931|FG004|NOT COMPLETED|Overall Study||0
9071018|NCT03848208|10131932|FG005|NOT COMPLETED|Overall Study||0
9071019|NCT03848208|10131933|FG006|NOT COMPLETED|Overall Study||0
9071020|NCT03848208|10131934|FG007|NOT COMPLETED|Overall Study||0
9071021|NCT03848208|10131935|FG008|NOT COMPLETED|Overall Study||0
9071022|NCT03848208|10131936|FG009|NOT COMPLETED|Overall Study||0
9071023|NCT03847389|10131970|FG000|STARTED|Overall Study||8
9071024|NCT03847389|10131971|FG001|STARTED|Overall Study|Start of Cohort 2 can only happen if less than or equal to 40% of subjects in Cohort 1 had HPA axis suppression.|0
9071025|NCT03847389|10131972|FG002|STARTED|Overall Study|Start of Cohort 3 can only happen if less than or equal to 40% of subjects in Cohort 2 had HPA axis suppression.|0
9071026|NCT03847389|10131970|FG000|COMPLETED|Overall Study||8
9071027|NCT03847389|10131971|FG001|COMPLETED|Overall Study||0
9071028|NCT03847389|10131972|FG002|COMPLETED|Overall Study||0
9071029|NCT03847389|10131970|FG000|NOT COMPLETED|Overall Study||0
9071030|NCT03847389|10131971|FG001|NOT COMPLETED|Overall Study||0
9071031|NCT03847389|10131972|FG002|NOT COMPLETED|Overall Study||0
9071032|NCT03862040|10131983|FG000|STARTED|Overall Study||7
9071033|NCT03862040|10131983|FG000|COMPLETED|Overall Study||7
9071034|NCT03862040|10131983|FG000|NOT COMPLETED|Overall Study||0
9071035|NCT03861936|10131990|FG000|STARTED|Overall Study||48
9071036|NCT03861936|10131991|FG001|STARTED|Overall Study||53
9071037|NCT03861936|10131992|FG002|STARTED|Overall Study||49
9071038|NCT03861936|10131990|FG000|COMPLETED|Overall Study||34
9071039|NCT03861936|10131991|FG001|COMPLETED|Overall Study||43
9071040|NCT03861936|10131992|FG002|COMPLETED|Overall Study||39
9071041|NCT03861936|10131990|FG000|NOT COMPLETED|Overall Study||14
9071042|NCT03861936|10131991|FG001|NOT COMPLETED|Overall Study||10
9071043|NCT03861936|10131992|FG002|NOT COMPLETED|Overall Study||10
9071044|NCT03859739|10132004|FG000|STARTED|Overall Study||5
8842983|NCT01701258|9897264|FG006|STARTED|PET (Session 3)||0
8842984|NCT01701258|9897265|FG007|STARTED|PET (Session 3)||19
8842985|NCT01701258|9897266|FG008|STARTED|PET (Session 3)||0
8842986|NCT01701258|9897267|FG009|STARTED|PET (Session 3)||0
9071045|NCT03859739|10132005|FG001|STARTED|Overall Study||6
9071046|NCT03859739|10132006|FG002|STARTED|Overall Study||6
9071047|NCT03859739|10132007|FG003|STARTED|Overall Study||4
9071048|NCT03859739|10132004|FG000|COMPLETED|Overall Study||5
9071049|NCT03859739|10132005|FG001|COMPLETED|Overall Study||6
9071050|NCT03859739|10132006|FG002|COMPLETED|Overall Study||6
9071051|NCT03859739|10132007|FG003|COMPLETED|Overall Study||4
9071052|NCT03859739|10132004|FG000|NOT COMPLETED|Overall Study||0
9071053|NCT03859739|10132005|FG001|NOT COMPLETED|Overall Study||0
8842987|NCT01701258|9897268|FG010|STARTED|PET (Session 3)||18
8842988|NCT01701258|9897269|FG011|STARTED|PET (Session 3)||0
8842989|NCT01701258|9897270|FG012|STARTED|PET (Session 3)||0
9071054|NCT03859739|10132006|FG002|NOT COMPLETED|Overall Study||0
9071055|NCT03859739|10132007|FG003|NOT COMPLETED|Overall Study||0
9071056|NCT03857750|10132019|FG000|STARTED|Overall Study||16
9071057|NCT03857750|10132020|FG001|STARTED|Overall Study||16
9071058|NCT03857750|10132019|FG000|COMPLETED|Overall Study||16
9071059|NCT03857750|10132020|FG001|COMPLETED|Overall Study||16
9071060|NCT03857750|10132019|FG000|NOT COMPLETED|Overall Study||0
9071061|NCT03857750|10132020|FG001|NOT COMPLETED|Overall Study||0
9071062|NCT03856255|10132026|FG000|STARTED|Overall Study||23
9071063|NCT03856255|10132026|FG000|COMPLETED|Overall Study||23
9071064|NCT03856255|10132026|FG000|NOT COMPLETED|Overall Study||0
9071065|NCT03850509|10132032|FG000|STARTED|Overall Study||2
9071066|NCT03850509|10132033|FG001|STARTED|Overall Study||1
9071067|NCT03850509|10132032|FG000|COMPLETED|Overall Study||0
9071068|NCT03850509|10132033|FG001|COMPLETED|Overall Study||0
9071069|NCT03850509|10132032|FG000|NOT COMPLETED|Overall Study||2
9071070|NCT03850509|10132033|FG001|NOT COMPLETED|Overall Study||1
9071071|NCT03860753|10132041|FG000|STARTED|Overall Study||4
9071072|NCT03860753|10132042|FG001|STARTED|Overall Study||0
9071073|NCT03860753|10132041|FG000|COMPLETED|Overall Study||4
9071074|NCT03860753|10132042|FG001|COMPLETED|Overall Study||0
9071075|NCT03860753|10132041|FG000|NOT COMPLETED|Overall Study||0
9071076|NCT03860753|10132042|FG001|NOT COMPLETED|Overall Study||0
9071077|NCT03848455|10132051|FG000|STARTED|Overall Study||90
9071078|NCT03848455|10132052|FG001|STARTED|Overall Study||125
9071079|NCT03848455|10132053|FG002|STARTED|Overall Study||23
9071080|NCT03848455|10132051|FG000|COMPLETED|Overall Study||90
9071081|NCT03848455|10132052|FG001|COMPLETED|Overall Study||125
9071082|NCT03848455|10132053|FG002|COMPLETED|Overall Study||23
9071083|NCT03848455|10132051|FG000|NOT COMPLETED|Overall Study||0
9071084|NCT03848455|10132052|FG001|NOT COMPLETED|Overall Study||0
9071085|NCT03848455|10132053|FG002|NOT COMPLETED|Overall Study||0
9071086|NCT03858894|10132064|FG000|STARTED|Overall Study||48
9071087|NCT03858894|10132065|FG001|STARTED|Overall Study||50
9071088|NCT03858894|10132064|FG000|COMPLETED|Overall Study||44
9071089|NCT03858894|10132065|FG001|COMPLETED|Overall Study||50
9071090|NCT03858894|10132064|FG000|NOT COMPLETED|Overall Study||4
9071091|NCT03858894|10132065|FG001|NOT COMPLETED|Overall Study||0
9071092|NCT03856164|10132073|FG000|STARTED|Overall Study||55
9071093|NCT03856164|10132074|FG001|STARTED|Overall Study||55
9071094|NCT03856164|10132073|FG000|COMPLETED|Overall Study||55
9071095|NCT03856164|10132074|FG001|COMPLETED|Overall Study||55
9071096|NCT03856164|10132073|FG000|NOT COMPLETED|Overall Study||0
9071097|NCT03856164|10132074|FG001|NOT COMPLETED|Overall Study||0
9071098|NCT03850275|10132088|FG000|STARTED|Overall Study||5
9071099|NCT03850275|10132089|FG001|STARTED|Overall Study||5
9071100|NCT03850275|10132090|FG002|STARTED|Overall Study||5
9071101|NCT03850275|10132091|FG003|STARTED|Overall Study||5
9071102|NCT03850275|10132092|FG004|STARTED|Overall Study||5
9071103|NCT03850275|10132093|FG005|STARTED|Overall Study||5
9071104|NCT03850275|10132088|FG000|COMPLETED|Overall Study||5
9071105|NCT03850275|10132089|FG001|COMPLETED|Overall Study||5
9071106|NCT03850275|10132090|FG002|COMPLETED|Overall Study||5
9071107|NCT03850275|10132091|FG003|COMPLETED|Overall Study||5
9071108|NCT03850275|10132092|FG004|COMPLETED|Overall Study||5
9071109|NCT03850275|10132093|FG005|COMPLETED|Overall Study||5
9071110|NCT03850275|10132088|FG000|NOT COMPLETED|Overall Study||0
9071111|NCT03850275|10132089|FG001|NOT COMPLETED|Overall Study||0
9071112|NCT03850275|10132090|FG002|NOT COMPLETED|Overall Study||0
9071113|NCT03850275|10132091|FG003|NOT COMPLETED|Overall Study||0
9071114|NCT03850275|10132092|FG004|NOT COMPLETED|Overall Study||0
9071115|NCT03850275|10132093|FG005|NOT COMPLETED|Overall Study||0
9071116|NCT03851016|10132118|FG000|STARTED|First Intervention (3 Weeks)||12
9071117|NCT03851016|10132119|FG001|STARTED|First Intervention (3 Weeks)||12
9071118|NCT03851016|10132118|FG000|COMPLETED|First Intervention (3 Weeks)||11
9071119|NCT03851016|10132119|FG001|COMPLETED|First Intervention (3 Weeks)||10
9071120|NCT03851016|10132118|FG000|NOT COMPLETED|First Intervention (3 Weeks)||1
9071121|NCT03851016|10132119|FG001|NOT COMPLETED|First Intervention (3 Weeks)||2
9071122|NCT03851016|10132118|FG000|STARTED|Washout (1 Week)||11
9071123|NCT03851016|10132119|FG001|STARTED|Washout (1 Week)||10
9071124|NCT03851016|10132118|FG000|COMPLETED|Washout (1 Week)||11
9071125|NCT03851016|10132119|FG001|COMPLETED|Washout (1 Week)||10
9071126|NCT03851016|10132118|FG000|NOT COMPLETED|Washout (1 Week)||0
9071127|NCT03851016|10132119|FG001|NOT COMPLETED|Washout (1 Week)||0
9071128|NCT03851016|10132118|FG000|STARTED|Second Intervention (3 Weeks)||11
9071129|NCT03851016|10132119|FG001|STARTED|Second Intervention (3 Weeks)||10
9071130|NCT03851016|10132118|FG000|COMPLETED|Second Intervention (3 Weeks)||11
9071131|NCT03851016|10132119|FG001|COMPLETED|Second Intervention (3 Weeks)||10
9071132|NCT03851016|10132118|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0
9071133|NCT03851016|10132119|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
9071134|NCT03850496|10132128|FG000|STARTED|Overall Study||26
9071135|NCT03850496|10132129|FG001|STARTED|Overall Study||25
9071136|NCT03850496|10132130|FG002|STARTED|Overall Study||25
9071137|NCT03850496|10132128|FG000|COMPLETED|Overall Study||25
9071138|NCT03850496|10132129|FG001|COMPLETED|Overall Study||24
9071139|NCT03850496|10132130|FG002|COMPLETED|Overall Study||21
9071140|NCT03850496|10132128|FG000|NOT COMPLETED|Overall Study||1
9071141|NCT03850496|10132129|FG001|NOT COMPLETED|Overall Study||1
9071142|NCT03850496|10132130|FG002|NOT COMPLETED|Overall Study||4
9071143|NCT03848949|10132140|FG000|STARTED|Overall Study||54
9071144|NCT03848949|10132141|FG001|STARTED|Overall Study||53
9071145|NCT03848949|10132140|FG000|COMPLETED|Overall Study||49
9071146|NCT03848949|10132141|FG001|COMPLETED|Overall Study||46
9071147|NCT03848949|10132140|FG000|NOT COMPLETED|Overall Study||5
9071148|NCT03848949|10132141|FG001|NOT COMPLETED|Overall Study||7
9071149|NCT03849690|10132147|FG000|STARTED|Period 1 (3 Days)||12
9071150|NCT03849690|10132147|FG000|COMPLETED|Period 1 (3 Days)||12
9071151|NCT03849690|10132147|FG000|NOT COMPLETED|Period 1 (3 Days)||0
9071152|NCT03849690|10132147|FG000|STARTED|Washout Period (at Least 4 Days)||12
9071153|NCT03849690|10132147|FG000|COMPLETED|Washout Period (at Least 4 Days)||12
9071154|NCT03849690|10132147|FG000|NOT COMPLETED|Washout Period (at Least 4 Days)||0
9071155|NCT03849690|10132147|FG000|STARTED|Period 2 (6 Days)||12
9071156|NCT03849690|10132147|FG000|COMPLETED|Period 2 (6 Days)||12
9071157|NCT03849690|10132147|FG000|NOT COMPLETED|Period 2 (6 Days)||0
8624024|NCT00497770|9663280|FG001|STARTED|Overall Study||65
8624025|NCT00497770|9663281|FG002|STARTED|Overall Study||37
8624026|NCT00497770|9663282|FG003|STARTED|Overall Study||28
8624027|NCT00497770|9663279|FG000|COMPLETED|Overall Study||304
8624028|NCT00497770|9663280|FG001|COMPLETED|Overall Study||65
8624029|NCT00497770|9663281|FG002|COMPLETED|Overall Study||37
8624030|NCT00497770|9663282|FG003|COMPLETED|Overall Study||28
8624031|NCT00497770|9663279|FG000|NOT COMPLETED|Overall Study||0
8624032|NCT00497770|9663280|FG001|NOT COMPLETED|Overall Study||0
8624033|NCT00497770|9663281|FG002|NOT COMPLETED|Overall Study||0
8624034|NCT00497770|9663282|FG003|NOT COMPLETED|Overall Study||0
8624035|NCT00497796|9663295|FG000|STARTED|Overall Study||147
8624036|NCT00497796|9663296|FG001|STARTED|Overall Study||160
8842990|NCT01701258|9897258|FG000|COMPLETED|PET (Session 3)||0
8842991|NCT01701258|9897259|FG001|COMPLETED|PET (Session 3)||20
8624037|NCT00497796|9663295|FG000|COMPLETED|Overall Study||62
8624038|NCT00497796|9663296|FG001|COMPLETED|Overall Study||101
8624039|NCT00497796|9663295|FG000|NOT COMPLETED|Overall Study||85
8624040|NCT00497796|9663296|FG001|NOT COMPLETED|Overall Study||59
9071158|NCT03845933|10132158|FG000|STARTED|Overall Study||131
9071159|NCT03845933|10132159|FG001|STARTED|Overall Study||131
9071160|NCT03845933|10132158|FG000|COMPLETED|Overall Study||131
9071161|NCT03845933|10132159|FG001|COMPLETED|Overall Study||131
9071162|NCT03845933|10132158|FG000|NOT COMPLETED|Overall Study||0
9071163|NCT03845933|10132159|FG001|NOT COMPLETED|Overall Study||0
9071164|NCT03844945|10132169|FG000|STARTED|Overall Study||55
9071165|NCT03844945|10132170|FG001|STARTED|Overall Study||54
9071166|NCT03844945|10132171|FG002|STARTED|Overall Study||51
9071167|NCT03844945|10132172|FG003|STARTED|Overall Study||55
9071168|NCT03844945|10132169|FG000|COMPLETED|Overall Study||54
9071169|NCT03844945|10132170|FG001|COMPLETED|Overall Study||53
9071170|NCT03844945|10132171|FG002|COMPLETED|Overall Study||46
9071171|NCT03844945|10132172|FG003|COMPLETED|Overall Study||54
9071172|NCT03844945|10132169|FG000|NOT COMPLETED|Overall Study||1
9071173|NCT03844945|10132170|FG001|NOT COMPLETED|Overall Study||1
9071174|NCT03844945|10132171|FG002|NOT COMPLETED|Overall Study||5
9071175|NCT03844945|10132172|FG003|NOT COMPLETED|Overall Study||1
9071176|NCT03844321|10132184|FG000|STARTED|Overall Study||2220
9071177|NCT03844321|10132185|FG001|STARTED|Overall Study||2192
9071178|NCT03844321|10132184|FG000|COMPLETED|Overall Study||579
9071179|NCT03844321|10132185|FG001|COMPLETED|Overall Study||533
9071180|NCT03844321|10132184|FG000|NOT COMPLETED|Overall Study||1641
9071181|NCT03844321|10132185|FG001|NOT COMPLETED|Overall Study||1659
9071182|NCT03843632|10132195|FG000|STARTED|Overall Study||50
9071183|NCT03843632|10132196|FG001|STARTED|Overall Study||30
9071184|NCT03843632|10132197|FG002|STARTED|Overall Study||33
9071185|NCT03843632|10132198|FG003|STARTED|Overall Study||37
9071186|NCT03843632|10132195|FG000|Vaccination 1|Overall Study||50
9071187|NCT03843632|10132196|FG001|Vaccination 1|Overall Study||30
9071188|NCT03843632|10132197|FG002|Vaccination 1|Overall Study||33
9071189|NCT03843632|10132198|FG003|Vaccination 1|Overall Study||37
9071190|NCT03843632|10132195|FG000|Vaccination 2|Overall Study||49
9071191|NCT03843632|10132196|FG001|Vaccination 2|Overall Study||30
9071192|NCT03843632|10132197|FG002|Vaccination 2|Overall Study||0
9071193|NCT03843632|10132198|FG003|Vaccination 2|Overall Study||0
9071194|NCT03843632|10132195|FG000|COMPLETED|Overall Study||49
9071195|NCT03843632|10132196|FG001|COMPLETED|Overall Study||30
9071196|NCT03843632|10132197|FG002|COMPLETED|Overall Study||33
9071197|NCT03843632|10132198|FG003|COMPLETED|Overall Study||37
9071198|NCT03843632|10132195|FG000|NOT COMPLETED|Overall Study||1
9071199|NCT03843632|10132196|FG001|NOT COMPLETED|Overall Study||0
9071200|NCT03843632|10132197|FG002|NOT COMPLETED|Overall Study||0
9071201|NCT03843632|10132198|FG003|NOT COMPLETED|Overall Study||0
9071202|NCT03840811|10132211|FG000|STARTED|Overall Study||9
9071203|NCT03840811|10132212|FG001|STARTED|Overall Study||6
9071204|NCT03840811|10132213|FG002|STARTED|Overall Study||12
9071205|NCT03840811|10132211|FG000|COMPLETED|Overall Study||9
9071206|NCT03840811|10132212|FG001|COMPLETED|Overall Study||6
9071207|NCT03840811|10132213|FG002|COMPLETED|Overall Study||11
9071208|NCT03840811|10132211|FG000|NOT COMPLETED|Overall Study||0
9071209|NCT03840811|10132212|FG001|NOT COMPLETED|Overall Study||0
9071210|NCT03840811|10132213|FG002|NOT COMPLETED|Overall Study||1
9071211|NCT03837028|10132225|FG000|STARTED|Overall Study||35
9071212|NCT03837028|10132226|FG001|STARTED|Overall Study||34
9071213|NCT03837028|10132227|FG002|STARTED|Overall Study||33
9071214|NCT03837028|10132228|FG003|STARTED|Overall Study||25
9071215|NCT03837028|10132225|FG000|COMPLETED|Overall Study||19
9071216|NCT03837028|10132226|FG001|COMPLETED|Overall Study||23
9071217|NCT03837028|10132227|FG002|COMPLETED|Overall Study||20
9071218|NCT03837028|10132228|FG003|COMPLETED|Overall Study||18
9071219|NCT03837028|10132225|FG000|NOT COMPLETED|Overall Study||16
9071220|NCT03837028|10132226|FG001|NOT COMPLETED|Overall Study||11
9071221|NCT03837028|10132227|FG002|NOT COMPLETED|Overall Study||13
9071222|NCT03837028|10132228|FG003|NOT COMPLETED|Overall Study||7
9071223|NCT03825939|10132241|FG000|STARTED|Overall Study||18
9071224|NCT03825939|10132242|FG001|STARTED|Overall Study||20
9071225|NCT03825939|10132243|FG002|STARTED|Overall Study||14
9071226|NCT03825939|10132241|FG000|COMPLETED|Overall Study||18
9071227|NCT03825939|10132242|FG001|COMPLETED|Overall Study||20
9071228|NCT03825939|10132243|FG002|COMPLETED|Overall Study||14
9071229|NCT03825939|10132241|FG000|NOT COMPLETED|Overall Study||0
9071230|NCT03825939|10132242|FG001|NOT COMPLETED|Overall Study||0
9071231|NCT03825939|10132243|FG002|NOT COMPLETED|Overall Study||0
9071232|NCT03817775|10132253|FG000|STARTED|Overall Study||22
9071233|NCT03817775|10132254|FG001|STARTED|Overall Study||54
9071234|NCT03817775|10132253|FG000|COMPLETED|Overall Study||22
9071235|NCT03817775|10132254|FG001|COMPLETED|Overall Study||54
9071236|NCT03817775|10132253|FG000|NOT COMPLETED|Overall Study||0
9071237|NCT03817775|10132254|FG001|NOT COMPLETED|Overall Study||0
9071238|NCT03843372|10132262|FG000|STARTED|Overall Study||14
9071239|NCT03843372|10132263|FG001|STARTED|Overall Study||18
9071240|NCT03843372|10132262|FG000|COMPLETED|Overall Study||12
9071241|NCT03843372|10132263|FG001|COMPLETED|Overall Study||16
9071242|NCT03843372|10132262|FG000|NOT COMPLETED|Overall Study||2
9071243|NCT03843372|10132263|FG001|NOT COMPLETED|Overall Study||2
9071244|NCT03841331|10132271|FG000|STARTED|Overall Study||117
9071245|NCT03841331|10132272|FG001|STARTED|Overall Study||116
9071246|NCT03841331|10132271|FG000|COMPLETED|Overall Study||108
9071247|NCT03841331|10132272|FG001|COMPLETED|Overall Study||106
9071248|NCT03841331|10132271|FG000|NOT COMPLETED|Overall Study||9
9071249|NCT03841331|10132272|FG001|NOT COMPLETED|Overall Study||10
9071250|NCT03840278|10132278|FG000|STARTED|Overall Study||5
9071251|NCT03840278|10132279|FG001|STARTED|Overall Study||5
9071252|NCT03840278|10132278|FG000|COMPLETED|Overall Study||5
9071253|NCT03840278|10132279|FG001|COMPLETED|Overall Study||5
9071254|NCT03840278|10132278|FG000|NOT COMPLETED|Overall Study||0
9071255|NCT03840278|10132279|FG001|NOT COMPLETED|Overall Study||0
9071256|NCT03840135|10132287|FG000|STARTED|Overall Study||86
9071257|NCT03840135|10132288|FG001|STARTED|Overall Study||86
9071258|NCT03840135|10132287|FG000|COMPLETED|Overall Study||79
9071259|NCT03840135|10132288|FG001|COMPLETED|Overall Study||85
9071260|NCT03840135|10132287|FG000|NOT COMPLETED|Overall Study||7
9071261|NCT03840135|10132288|FG001|NOT COMPLETED|Overall Study||1
9071262|NCT03839641|10132300|FG000|STARTED|Overall Study||5
9071263|NCT03839641|10132301|FG001|STARTED|Overall Study||5
9071264|NCT03839641|10132300|FG000|COMPLETED|Overall Study||4
9071265|NCT03839641|10132301|FG001|COMPLETED|Overall Study||4
9071266|NCT03839641|10132300|FG000|NOT COMPLETED|Overall Study||1
9071267|NCT03839641|10132301|FG001|NOT COMPLETED|Overall Study||1
9071268|NCT03839212|10132309|FG000|STARTED|Overall Study||18
9071269|NCT03839212|10132309|FG000|COMPLETED|Overall Study||14
9071270|NCT03839212|10132309|FG000|NOT COMPLETED|Overall Study||4
9071271|NCT03839355|10132315|FG000|STARTED|Overall Study||18
9071272|NCT03839355|10132316|FG001|STARTED|Overall Study||16
9071273|NCT03839355|10132315|FG000|COMPLETED|Overall Study||17
9071274|NCT03839355|10132316|FG001|COMPLETED|Overall Study||16
9071275|NCT03839355|10132315|FG000|NOT COMPLETED|Overall Study||1
9071276|NCT03839355|10132316|FG001|NOT COMPLETED|Overall Study||0
9071277|NCT03838874|10132324|FG000|STARTED|Overall Study||80
9071278|NCT03838874|10132325|FG001|STARTED|Overall Study||74
9071279|NCT03838874|10132324|FG000|COMPLETED|Overall Study||80
9071280|NCT03838874|10132325|FG001|COMPLETED|Overall Study||74
9071281|NCT03838874|10132324|FG000|NOT COMPLETED|Overall Study||0
9071282|NCT03838874|10132325|FG001|NOT COMPLETED|Overall Study||0
9071283|NCT03838731|10132333|FG000|STARTED|Overall Study||27
9071284|NCT03838731|10132334|FG001|STARTED|Overall Study||29
9071285|NCT03838731|10132333|FG000|COMPLETED|Overall Study||26
9071286|NCT03838731|10132334|FG001|COMPLETED|Overall Study||28
9071287|NCT03838731|10132333|FG000|NOT COMPLETED|Overall Study||1
9071288|NCT03838731|10132334|FG001|NOT COMPLETED|Overall Study||1
9071289|NCT03838198|10132342|FG000|STARTED|Phase 1: Safety Plan (SP) vs. SP w/Texts|Because it was a SMART trial, no participants were allocated to receive booster calls until Phase 2.|0
9071290|NCT03838198|10132343|FG001|STARTED|Phase 1: Safety Plan (SP) vs. SP w/Texts||40
9071291|NCT03838198|10132344|FG002|STARTED|Phase 1: Safety Plan (SP) vs. SP w/Texts|Because it was a SMART trial, no participants were allocated to receive booster calls until Phase 2.|0
9071292|NCT03838198|10132345|FG003|STARTED|Phase 1: Safety Plan (SP) vs. SP w/Texts||40
9071293|NCT03838198|10132342|FG000|COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||0
9071294|NCT03838198|10132343|FG001|COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||40
9071295|NCT03838198|10132344|FG002|COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||0
9071296|NCT03838198|10132345|FG003|COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||40
9071297|NCT03838198|10132342|FG000|NOT COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||0
9071298|NCT03838198|10132343|FG001|NOT COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||0
9071299|NCT03838198|10132344|FG002|NOT COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||0
9071300|NCT03838198|10132345|FG003|NOT COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||0
9071301|NCT03838198|10132342|FG000|STARTED|Phase 2: Added Booster Call or Not|These participants continued with Phase 1 intervention (Safety plan and text) with added booster call.|18
9071302|NCT03838198|10132343|FG001|STARTED|Phase 2: Added Booster Call or Not|These participants continued with Phase 1 intervention (Safety plan and text) with no added booster call.|22
9071303|NCT03838198|10132344|FG002|STARTED|Phase 2: Added Booster Call or Not|These participants continued with Phase 1 intervention (Safety plan only) with added booster call.|18
9071304|NCT03838198|10132345|FG003|STARTED|Phase 2: Added Booster Call or Not|These participants continued with Phase 1 intervention (Safety plan only) with no added booster call in Phase 2|22
9071305|NCT03838198|10132342|FG000|COMPLETED|Phase 2: Added Booster Call or Not|All 18 completed the safety plan; but only 14 had both parent and adolescent completing the call; 1 had parent only; 1 had adolescent only; 2 were unable to be reached.|18
9071306|NCT03838198|10132343|FG001|COMPLETED|Phase 2: Added Booster Call or Not||0
9071307|NCT03838198|10132344|FG002|COMPLETED|Phase 2: Added Booster Call or Not|Of the 17 who completed the safety plan, only 15 had both parent and adolescent completing the call; 1 had parent only; 1 was unable to be reached.|17
9071308|NCT03838198|10132345|FG003|COMPLETED|Phase 2: Added Booster Call or Not||0
9071309|NCT03838198|10132342|FG000|NOT COMPLETED|Phase 2: Added Booster Call or Not||0
9071310|NCT03838198|10132343|FG001|NOT COMPLETED|Phase 2: Added Booster Call or Not||22
9071311|NCT03838198|10132344|FG002|NOT COMPLETED|Phase 2: Added Booster Call or Not||1
9071312|NCT03838198|10132345|FG003|NOT COMPLETED|Phase 2: Added Booster Call or Not||22
9071313|NCT03838198|10132342|FG000|STARTED|1 Month Follow up Period||18
9071314|NCT03838198|10132343|FG001|STARTED|1 Month Follow up Period|All participants from Phase 1 and 2 were followed unless they withdrew.|22
9071315|NCT03838198|10132344|FG002|STARTED|1 Month Follow up Period||17
9071316|NCT03838198|10132345|FG003|STARTED|1 Month Follow up Period|All participants from Phase 1 and 2 were followed unless they withdrew.|22
9071317|NCT03838198|10132342|FG000|Adolescent Surveys Completed|1 Month Follow up Period||16
9071318|NCT03838198|10132343|FG001|Adolescent Surveys Completed|1 Month Follow up Period||22
9071319|NCT03838198|10132344|FG002|Adolescent Surveys Completed|1 Month Follow up Period||16
9071320|NCT03838198|10132345|FG003|Adolescent Surveys Completed|1 Month Follow up Period||22
9071321|NCT03838198|10132342|FG000|COMPLETED|1 Month Follow up Period||16
9071322|NCT03838198|10132343|FG001|COMPLETED|1 Month Follow up Period||22
9071323|NCT03838198|10132344|FG002|COMPLETED|1 Month Follow up Period||16
9071324|NCT03838198|10132345|FG003|COMPLETED|1 Month Follow up Period||21
9071325|NCT03838198|10132342|FG000|NOT COMPLETED|1 Month Follow up Period||2
9071326|NCT03838198|10132343|FG001|NOT COMPLETED|1 Month Follow up Period||0
9071327|NCT03838198|10132344|FG002|NOT COMPLETED|1 Month Follow up Period||1
9071328|NCT03838198|10132345|FG003|NOT COMPLETED|1 Month Follow up Period||1
9071329|NCT03838198|10132342|FG000|STARTED|3 Month Follow up Period||18
9071330|NCT03838198|10132343|FG001|STARTED|3 Month Follow up Period||22
9071331|NCT03838198|10132344|FG002|STARTED|3 Month Follow up Period||17
9071332|NCT03838198|10132345|FG003|STARTED|3 Month Follow up Period||22
9071333|NCT03838198|10132342|FG000|Adolescent Survey Completed|3 Month Follow up Period||16
9071334|NCT03838198|10132343|FG001|Adolescent Survey Completed|3 Month Follow up Period||21
9071335|NCT03838198|10132344|FG002|Adolescent Survey Completed|3 Month Follow up Period||15
9071336|NCT03838198|10132345|FG003|Adolescent Survey Completed|3 Month Follow up Period||21
9071337|NCT03838198|10132342|FG000|COMPLETED|3 Month Follow up Period||15
9071338|NCT03838198|10132343|FG001|COMPLETED|3 Month Follow up Period||19
9071339|NCT03838198|10132344|FG002|COMPLETED|3 Month Follow up Period||14
9071340|NCT03838198|10132345|FG003|COMPLETED|3 Month Follow up Period||18
9071341|NCT03838198|10132342|FG000|NOT COMPLETED|3 Month Follow up Period||3
9071342|NCT03838198|10132343|FG001|NOT COMPLETED|3 Month Follow up Period||3
9071343|NCT03838198|10132344|FG002|NOT COMPLETED|3 Month Follow up Period||3
9071344|NCT03838198|10132345|FG003|NOT COMPLETED|3 Month Follow up Period||4
9071345|NCT03831451|10132358|FG000|STARTED|Overall Study||74
9071346|NCT03831451|10132359|FG001|STARTED|Overall Study||55
9071347|NCT03831451|10132358|FG000|COMPLETED|Overall Study||74
9071348|NCT03831451|10132359|FG001|COMPLETED|Overall Study||55
9071349|NCT03831451|10132358|FG000|NOT COMPLETED|Overall Study||0
9071350|NCT03831451|10132359|FG001|NOT COMPLETED|Overall Study||0
9071351|NCT03822078|10132371|FG000|STARTED|Overall Study||12
9071352|NCT03822078|10132372|FG001|STARTED|Overall Study||6
9071353|NCT03822078|10132373|FG002|STARTED|Overall Study||6
9071354|NCT03822078|10132374|FG003|STARTED|Overall Study||8
9071355|NCT03822078|10132375|FG004|STARTED|Overall Study||7
9071356|NCT03822078|10132376|FG005|STARTED|Overall Study||6
9071357|NCT03822078|10132371|FG000|Received Study Drug|Overall Study||10
9071358|NCT03822078|10132372|FG001|Received Study Drug|Overall Study||6
9071359|NCT03822078|10132373|FG002|Received Study Drug|Overall Study||6
9071360|NCT03822078|10132374|FG003|Received Study Drug|Overall Study||6
9071361|NCT03822078|10132375|FG004|Received Study Drug|Overall Study||6
9071362|NCT03822078|10132376|FG005|Received Study Drug|Overall Study||6
9071363|NCT03822078|10132371|FG000|COMPLETED|Overall Study||10
9071364|NCT03822078|10132372|FG001|COMPLETED|Overall Study||6
9071365|NCT03822078|10132373|FG002|COMPLETED|Overall Study||6
9071366|NCT03822078|10132374|FG003|COMPLETED|Overall Study||6
9071367|NCT03822078|10132375|FG004|COMPLETED|Overall Study||6
9071368|NCT03822078|10132376|FG005|COMPLETED|Overall Study||6
9071369|NCT03822078|10132371|FG000|NOT COMPLETED|Overall Study||2
9071370|NCT03822078|10132372|FG001|NOT COMPLETED|Overall Study||0
9071371|NCT03822078|10132373|FG002|NOT COMPLETED|Overall Study||0
9071372|NCT03822078|10132374|FG003|NOT COMPLETED|Overall Study||2
9071373|NCT03822078|10132375|FG004|NOT COMPLETED|Overall Study||1
9071374|NCT03822078|10132376|FG005|NOT COMPLETED|Overall Study||0
9071375|NCT03815240|10132396|FG000|STARTED|Intervention no Dressing||2
9071376|NCT03815240|10132397|FG001|STARTED|Intervention no Dressing||1
9071377|NCT03815240|10132398|FG002|STARTED|Intervention no Dressing||1
9071378|NCT03815240|10132399|FG003|STARTED|Intervention no Dressing||2
9071379|NCT03815240|10132400|FG004|STARTED|Intervention no Dressing||1
9071380|NCT03815240|10132401|FG005|STARTED|Intervention no Dressing||2
9071381|NCT03815240|10132402|FG006|STARTED|Intervention no Dressing||1
9071382|NCT03815240|10132403|FG007|STARTED|Intervention no Dressing||1
9071383|NCT03815240|10132404|FG008|STARTED|Intervention no Dressing||1
9071384|NCT03815240|10132396|FG000|COMPLETED|Intervention no Dressing||2
9071385|NCT03815240|10132397|FG001|COMPLETED|Intervention no Dressing||1
9071386|NCT03815240|10132398|FG002|COMPLETED|Intervention no Dressing||1
9071387|NCT03815240|10132399|FG003|COMPLETED|Intervention no Dressing||2
9071388|NCT03815240|10132400|FG004|COMPLETED|Intervention no Dressing||1
9071389|NCT03815240|10132401|FG005|COMPLETED|Intervention no Dressing||2
9071390|NCT03815240|10132402|FG006|COMPLETED|Intervention no Dressing||1
9071391|NCT03815240|10132403|FG007|COMPLETED|Intervention no Dressing||1
9071392|NCT03815240|10132404|FG008|COMPLETED|Intervention no Dressing||1
9071393|NCT03815240|10132396|FG000|NOT COMPLETED|Intervention no Dressing||0
9071394|NCT03815240|10132397|FG001|NOT COMPLETED|Intervention no Dressing||0
9071395|NCT03815240|10132398|FG002|NOT COMPLETED|Intervention no Dressing||0
9071396|NCT03815240|10132399|FG003|NOT COMPLETED|Intervention no Dressing||0
9071397|NCT03815240|10132400|FG004|NOT COMPLETED|Intervention no Dressing||0
9071398|NCT03815240|10132401|FG005|NOT COMPLETED|Intervention no Dressing||0
9071399|NCT03815240|10132402|FG006|NOT COMPLETED|Intervention no Dressing||0
9071400|NCT03815240|10132403|FG007|NOT COMPLETED|Intervention no Dressing||0
9071401|NCT03815240|10132404|FG008|NOT COMPLETED|Intervention no Dressing||0
9071402|NCT03815240|10132396|FG000|STARTED|Intervention Mepilex Dressing||2
8842992|NCT01701258|9897260|FG002|COMPLETED|PET (Session 3)||0
9071403|NCT03815240|10132397|FG001|STARTED|Intervention Mepilex Dressing||1
8842993|NCT01701258|9897261|FG003|COMPLETED|PET (Session 3)||0
9071404|NCT03815240|10132398|FG002|STARTED|Intervention Mepilex Dressing||1
9071405|NCT03815240|10132399|FG003|STARTED|Intervention Mepilex Dressing||2
9071406|NCT03815240|10132400|FG004|STARTED|Intervention Mepilex Dressing||1
9071407|NCT03815240|10132401|FG005|STARTED|Intervention Mepilex Dressing||2
9071408|NCT03815240|10132402|FG006|STARTED|Intervention Mepilex Dressing||1
9071409|NCT03815240|10132403|FG007|STARTED|Intervention Mepilex Dressing||1
9071410|NCT03815240|10132404|FG008|STARTED|Intervention Mepilex Dressing||1
9071411|NCT03815240|10132396|FG000|COMPLETED|Intervention Mepilex Dressing||2
9071412|NCT03815240|10132397|FG001|COMPLETED|Intervention Mepilex Dressing||1
9071413|NCT03815240|10132398|FG002|COMPLETED|Intervention Mepilex Dressing||1
9071414|NCT03815240|10132399|FG003|COMPLETED|Intervention Mepilex Dressing||2
9071415|NCT03815240|10132400|FG004|COMPLETED|Intervention Mepilex Dressing||1
9071416|NCT03815240|10132401|FG005|COMPLETED|Intervention Mepilex Dressing||2
9071417|NCT03815240|10132402|FG006|COMPLETED|Intervention Mepilex Dressing||1
9071418|NCT03815240|10132403|FG007|COMPLETED|Intervention Mepilex Dressing||1
9071419|NCT03815240|10132404|FG008|COMPLETED|Intervention Mepilex Dressing||1
9071420|NCT03815240|10132396|FG000|NOT COMPLETED|Intervention Mepilex Dressing||0
9071421|NCT03815240|10132397|FG001|NOT COMPLETED|Intervention Mepilex Dressing||0
9071422|NCT03815240|10132398|FG002|NOT COMPLETED|Intervention Mepilex Dressing||0
9071423|NCT03815240|10132399|FG003|NOT COMPLETED|Intervention Mepilex Dressing||0
9071424|NCT03815240|10132400|FG004|NOT COMPLETED|Intervention Mepilex Dressing||0
9071425|NCT03815240|10132401|FG005|NOT COMPLETED|Intervention Mepilex Dressing||0
9071426|NCT03815240|10132402|FG006|NOT COMPLETED|Intervention Mepilex Dressing||0
9071427|NCT03815240|10132403|FG007|NOT COMPLETED|Intervention Mepilex Dressing||0
9071428|NCT03815240|10132404|FG008|NOT COMPLETED|Intervention Mepilex Dressing||0
9071429|NCT03815240|10132396|FG000|STARTED|Intervention Allevyn Dressing||2
9071430|NCT03815240|10132397|FG001|STARTED|Intervention Allevyn Dressing||1
9071431|NCT03815240|10132398|FG002|STARTED|Intervention Allevyn Dressing||1
9071432|NCT03815240|10132399|FG003|STARTED|Intervention Allevyn Dressing||2
9071433|NCT03815240|10132400|FG004|STARTED|Intervention Allevyn Dressing||1
9071434|NCT03815240|10132401|FG005|STARTED|Intervention Allevyn Dressing||2
9071435|NCT03815240|10132402|FG006|STARTED|Intervention Allevyn Dressing||1
9071436|NCT03815240|10132403|FG007|STARTED|Intervention Allevyn Dressing||1
9071437|NCT03815240|10132404|FG008|STARTED|Intervention Allevyn Dressing||1
9071438|NCT03815240|10132396|FG000|COMPLETED|Intervention Allevyn Dressing||2
9071439|NCT03815240|10132397|FG001|COMPLETED|Intervention Allevyn Dressing||1
9071440|NCT03815240|10132398|FG002|COMPLETED|Intervention Allevyn Dressing||1
9071441|NCT03815240|10132399|FG003|COMPLETED|Intervention Allevyn Dressing||2
9071442|NCT03815240|10132400|FG004|COMPLETED|Intervention Allevyn Dressing||1
9071443|NCT03815240|10132401|FG005|COMPLETED|Intervention Allevyn Dressing||2
9071444|NCT03815240|10132402|FG006|COMPLETED|Intervention Allevyn Dressing||1
9071445|NCT03815240|10132403|FG007|COMPLETED|Intervention Allevyn Dressing||1
9071446|NCT03815240|10132404|FG008|COMPLETED|Intervention Allevyn Dressing||1
9071447|NCT03815240|10132396|FG000|NOT COMPLETED|Intervention Allevyn Dressing||0
9071448|NCT03815240|10132397|FG001|NOT COMPLETED|Intervention Allevyn Dressing||0
9071449|NCT03815240|10132398|FG002|NOT COMPLETED|Intervention Allevyn Dressing||0
9071450|NCT03815240|10132399|FG003|NOT COMPLETED|Intervention Allevyn Dressing||0
9071451|NCT03815240|10132400|FG004|NOT COMPLETED|Intervention Allevyn Dressing||0
9071452|NCT03815240|10132401|FG005|NOT COMPLETED|Intervention Allevyn Dressing||0
9071453|NCT03815240|10132402|FG006|NOT COMPLETED|Intervention Allevyn Dressing||0
9071454|NCT03815240|10132403|FG007|NOT COMPLETED|Intervention Allevyn Dressing||0
9071455|NCT03815240|10132404|FG008|NOT COMPLETED|Intervention Allevyn Dressing||0
9071456|NCT03815240|10132396|FG000|STARTED|Intervention Optifoam Dressing||2
9071457|NCT03815240|10132397|FG001|STARTED|Intervention Optifoam Dressing||1
9071458|NCT03815240|10132398|FG002|STARTED|Intervention Optifoam Dressing||1
9071459|NCT03815240|10132399|FG003|STARTED|Intervention Optifoam Dressing||2
9071460|NCT03815240|10132400|FG004|STARTED|Intervention Optifoam Dressing||1
9071461|NCT03815240|10132401|FG005|STARTED|Intervention Optifoam Dressing||2
9071462|NCT03815240|10132402|FG006|STARTED|Intervention Optifoam Dressing||1
9071463|NCT03815240|10132403|FG007|STARTED|Intervention Optifoam Dressing||1
9071464|NCT03815240|10132404|FG008|STARTED|Intervention Optifoam Dressing||1
9071465|NCT03815240|10132396|FG000|COMPLETED|Intervention Optifoam Dressing||2
9071466|NCT03815240|10132397|FG001|COMPLETED|Intervention Optifoam Dressing||1
9071467|NCT03815240|10132398|FG002|COMPLETED|Intervention Optifoam Dressing||1
9071468|NCT03815240|10132399|FG003|COMPLETED|Intervention Optifoam Dressing||2
9071469|NCT03815240|10132400|FG004|COMPLETED|Intervention Optifoam Dressing||1
9071470|NCT03815240|10132401|FG005|COMPLETED|Intervention Optifoam Dressing||2
9071471|NCT03815240|10132402|FG006|COMPLETED|Intervention Optifoam Dressing||1
9071472|NCT03815240|10132403|FG007|COMPLETED|Intervention Optifoam Dressing||1
9071473|NCT03815240|10132404|FG008|COMPLETED|Intervention Optifoam Dressing||1
9071474|NCT03815240|10132396|FG000|NOT COMPLETED|Intervention Optifoam Dressing||0
9071475|NCT03815240|10132397|FG001|NOT COMPLETED|Intervention Optifoam Dressing||0
9071476|NCT03815240|10132398|FG002|NOT COMPLETED|Intervention Optifoam Dressing||0
9071477|NCT03815240|10132399|FG003|NOT COMPLETED|Intervention Optifoam Dressing||0
9071478|NCT03815240|10132400|FG004|NOT COMPLETED|Intervention Optifoam Dressing||0
9071479|NCT03815240|10132401|FG005|NOT COMPLETED|Intervention Optifoam Dressing||0
9071480|NCT03815240|10132402|FG006|NOT COMPLETED|Intervention Optifoam Dressing||0
9071481|NCT03815240|10132403|FG007|NOT COMPLETED|Intervention Optifoam Dressing||0
9071482|NCT03815240|10132404|FG008|NOT COMPLETED|Intervention Optifoam Dressing||0
9071483|NCT03836859|10132422|FG000|STARTED|Overall Study||20
9071484|NCT03836859|10132423|FG001|STARTED|Overall Study||10
9071485|NCT03836859|10132422|FG000|COMPLETED|Overall Study||20
9071486|NCT03836859|10132423|FG001|COMPLETED|Overall Study||10
9071487|NCT03836859|10132422|FG000|NOT COMPLETED|Overall Study||0
9071488|NCT03836859|10132423|FG001|NOT COMPLETED|Overall Study||0
9071489|NCT03835078|10132429|FG000|STARTED|Overall Study||39
9071490|NCT03835078|10132429|FG000|COMPLETED|Overall Study||39
9071491|NCT03835078|10132429|FG000|NOT COMPLETED|Overall Study||0
9071492|NCT03834025|10132442|FG000|STARTED|Sent Recruitment Letter (Phase 1)||4150
9071493|NCT03834025|10132443|FG001|STARTED|Sent Recruitment Letter (Phase 1)||3871
9071494|NCT03834025|10132444|FG002|STARTED|Sent Recruitment Letter (Phase 1)||4121
9071495|NCT03834025|10132445|FG003|STARTED|Sent Recruitment Letter (Phase 1)||3693
9071496|NCT03834025|10132446|FG004|STARTED|Sent Recruitment Letter (Phase 1)||0
9071497|NCT03834025|10132447|FG005|STARTED|Sent Recruitment Letter (Phase 1)||0
9071498|NCT03834025|10132448|FG006|STARTED|Sent Recruitment Letter (Phase 1)||0
9071499|NCT03834025|10132442|FG000|Sent Letter|Sent Recruitment Letter (Phase 1)||4150
9071500|NCT03834025|10132443|FG001|Sent Letter|Sent Recruitment Letter (Phase 1)||3871
9071501|NCT03834025|10132444|FG002|Sent Letter|Sent Recruitment Letter (Phase 1)||4121
9071502|NCT03834025|10132445|FG003|Sent Letter|Sent Recruitment Letter (Phase 1)||3693
9071503|NCT03834025|10132446|FG004|Sent Letter|Sent Recruitment Letter (Phase 1)||0
9071504|NCT03834025|10132447|FG005|Sent Letter|Sent Recruitment Letter (Phase 1)||0
9071505|NCT03834025|10132448|FG006|Sent Letter|Sent Recruitment Letter (Phase 1)||0
9071506|NCT03834025|10132442|FG000|Responded to Letter|Sent Recruitment Letter (Phase 1)||36
9071507|NCT03834025|10132443|FG001|Responded to Letter|Sent Recruitment Letter (Phase 1)||36
9071508|NCT03834025|10132444|FG002|Responded to Letter|Sent Recruitment Letter (Phase 1)||44
9071509|NCT03834025|10132445|FG003|Responded to Letter|Sent Recruitment Letter (Phase 1)||44
9071510|NCT03834025|10132446|FG004|Responded to Letter|Sent Recruitment Letter (Phase 1)||0
9071511|NCT03834025|10132447|FG005|Responded to Letter|Sent Recruitment Letter (Phase 1)||0
9071512|NCT03834025|10132448|FG006|Responded to Letter|Sent Recruitment Letter (Phase 1)||0
9071513|NCT03834025|10132442|FG000|COMPLETED|Sent Recruitment Letter (Phase 1)||36
9071514|NCT03834025|10132443|FG001|COMPLETED|Sent Recruitment Letter (Phase 1)||36
9071515|NCT03834025|10132444|FG002|COMPLETED|Sent Recruitment Letter (Phase 1)||44
9071516|NCT03834025|10132445|FG003|COMPLETED|Sent Recruitment Letter (Phase 1)||44
9071517|NCT03834025|10132446|FG004|COMPLETED|Sent Recruitment Letter (Phase 1)||0
9071518|NCT03834025|10132447|FG005|COMPLETED|Sent Recruitment Letter (Phase 1)||0
9071519|NCT03834025|10132448|FG006|COMPLETED|Sent Recruitment Letter (Phase 1)||0
9071520|NCT03834025|10132442|FG000|NOT COMPLETED|Sent Recruitment Letter (Phase 1)||4114
9071521|NCT03834025|10132443|FG001|NOT COMPLETED|Sent Recruitment Letter (Phase 1)||3835
9071522|NCT03834025|10132444|FG002|NOT COMPLETED|Sent Recruitment Letter (Phase 1)||4077
9071523|NCT03834025|10132445|FG003|NOT COMPLETED|Sent Recruitment Letter (Phase 1)||3649
9071524|NCT03834025|10132446|FG004|NOT COMPLETED|Sent Recruitment Letter (Phase 1)||0
9071525|NCT03834025|10132447|FG005|NOT COMPLETED|Sent Recruitment Letter (Phase 1)||0
9071526|NCT03834025|10132448|FG006|NOT COMPLETED|Sent Recruitment Letter (Phase 1)||0
9071527|NCT03834025|10132442|FG000|STARTED|Randomized to Payment Condition(Phase 2)||0
9071528|NCT03834025|10132443|FG001|STARTED|Randomized to Payment Condition(Phase 2)||0
9071529|NCT03834025|10132444|FG002|STARTED|Randomized to Payment Condition(Phase 2)||0
9071530|NCT03834025|10132445|FG003|STARTED|Randomized to Payment Condition(Phase 2)||0
9071531|NCT03834025|10132446|FG004|STARTED|Randomized to Payment Condition(Phase 2)||24
9071532|NCT03834025|10132447|FG005|STARTED|Randomized to Payment Condition(Phase 2)||21
9071533|NCT03834025|10132448|FG006|STARTED|Randomized to Payment Condition(Phase 2)||28
9071534|NCT03834025|10132442|FG000|COMPLETED|Randomized to Payment Condition(Phase 2)||0
9071535|NCT03834025|10132443|FG001|COMPLETED|Randomized to Payment Condition(Phase 2)||0
9071536|NCT03834025|10132444|FG002|COMPLETED|Randomized to Payment Condition(Phase 2)||0
9071537|NCT03834025|10132445|FG003|COMPLETED|Randomized to Payment Condition(Phase 2)||0
9071538|NCT03834025|10132446|FG004|COMPLETED|Randomized to Payment Condition(Phase 2)||24
9071539|NCT03834025|10132447|FG005|COMPLETED|Randomized to Payment Condition(Phase 2)||21
9071540|NCT03834025|10132448|FG006|COMPLETED|Randomized to Payment Condition(Phase 2)||27
9071541|NCT03834025|10132442|FG000|NOT COMPLETED|Randomized to Payment Condition(Phase 2)||0
9071542|NCT03834025|10132443|FG001|NOT COMPLETED|Randomized to Payment Condition(Phase 2)||0
9071543|NCT03834025|10132444|FG002|NOT COMPLETED|Randomized to Payment Condition(Phase 2)||0
9071544|NCT03834025|10132445|FG003|NOT COMPLETED|Randomized to Payment Condition(Phase 2)||0
9071545|NCT03834025|10132446|FG004|NOT COMPLETED|Randomized to Payment Condition(Phase 2)||0
9071546|NCT03834025|10132447|FG005|NOT COMPLETED|Randomized to Payment Condition(Phase 2)||0
9071547|NCT03834025|10132448|FG006|NOT COMPLETED|Randomized to Payment Condition(Phase 2)||1
9071548|NCT03836677|10132464|FG000|STARTED|Period 1||13
9071549|NCT03836677|10132465|FG001|STARTED|Period 1||10
9071550|NCT03836677|10132464|FG000|COMPLETED|Period 1||13
9071551|NCT03836677|10132465|FG001|COMPLETED|Period 1||9
9071552|NCT03836677|10132464|FG000|NOT COMPLETED|Period 1||0
9071553|NCT03836677|10132465|FG001|NOT COMPLETED|Period 1||1
9071554|NCT03836677|10132464|FG000|STARTED|Washout||13
9071555|NCT03836677|10132465|FG001|STARTED|Washout||9
9071556|NCT03836677|10132464|FG000|COMPLETED|Washout||13
9071557|NCT03836677|10132465|FG001|COMPLETED|Washout||9
9071558|NCT03836677|10132464|FG000|NOT COMPLETED|Washout||0
9071559|NCT03836677|10132465|FG001|NOT COMPLETED|Washout||0
9071560|NCT03836677|10132464|FG000|STARTED|Period 2||13
9071561|NCT03836677|10132465|FG001|STARTED|Period 2||9
9071562|NCT03836677|10132464|FG000|COMPLETED|Period 2||12
9071563|NCT03836677|10132465|FG001|COMPLETED|Period 2||9
9071564|NCT03836677|10132464|FG000|NOT COMPLETED|Period 2||1
9071565|NCT03836677|10132465|FG001|NOT COMPLETED|Period 2||0
9071566|NCT03836989|10132473|FG000|STARTED|Overall Study||4
9071567|NCT03836989|10132474|FG001|STARTED|Overall Study||0
9071568|NCT03836989|10132473|FG000|Subjects > 60 Years Old With Complete Paralysis|Overall Study||1
9071569|NCT03836989|10132474|FG001|Subjects > 60 Years Old With Complete Paralysis|Overall Study||0
9071570|NCT03836989|10132473|FG000|Subjects > 60 Years Old With Incomplete Paralysis|Overall Study||1
9071571|NCT03836989|10132474|FG001|Subjects > 60 Years Old With Incomplete Paralysis|Overall Study||0
9071572|NCT03836989|10132473|FG000|Subject < 60 Years Old + Complete Paralysis < 15 Days Duration|Overall Study||1
9071573|NCT03836989|10132474|FG001|Subject < 60 Years Old + Complete Paralysis < 15 Days Duration|Overall Study||0
9071574|NCT03836989|10132473|FG000|Subjects < 60 Years Old + Complete Paralysis > 15 Days|Overall Study||1
9071575|NCT03836989|10132474|FG001|Subjects < 60 Years Old + Complete Paralysis > 15 Days|Overall Study||0
9071576|NCT03836989|10132473|FG000|COMPLETED|Overall Study||4
9071577|NCT03836989|10132474|FG001|COMPLETED|Overall Study||0
9071578|NCT03836989|10132473|FG000|NOT COMPLETED|Overall Study||0
9071579|NCT03836989|10132474|FG001|NOT COMPLETED|Overall Study||0
9071580|NCT03827564|10132485|FG000|STARTED|Overall Study||9
9071581|NCT03827564|10132486|FG001|STARTED|Overall Study||5
9071582|NCT03827564|10132485|FG000|COMPLETED|Overall Study||8
9071583|NCT03827564|10132486|FG001|COMPLETED|Overall Study||5
9071584|NCT03827564|10132485|FG000|NOT COMPLETED|Overall Study||1
9071585|NCT03827564|10132486|FG001|NOT COMPLETED|Overall Study||0
9071586|NCT03824236|10132495|FG000|STARTED|Overall Study||25
9071587|NCT03824236|10132496|FG001|STARTED|Overall Study||24
9071588|NCT03824236|10132497|FG002|STARTED|Overall Study||12
9071589|NCT03824236|10132495|FG000|COMPLETED|Overall Study||25
9071590|NCT03824236|10132496|FG001|COMPLETED|Overall Study||24
9071591|NCT03824236|10132497|FG002|COMPLETED|Overall Study||11
9071592|NCT03824236|10132495|FG000|NOT COMPLETED|Overall Study||0
9071593|NCT03824236|10132496|FG001|NOT COMPLETED|Overall Study||0
9071594|NCT03824236|10132497|FG002|NOT COMPLETED|Overall Study||1
9071595|NCT03811951|10132507|FG000|STARTED|First Intervention (1 Day)||2
9071596|NCT03811951|10132508|FG001|STARTED|First Intervention (1 Day)||2
9071597|NCT03811951|10132507|FG000|COMPLETED|First Intervention (1 Day)||2
9071598|NCT03811951|10132508|FG001|COMPLETED|First Intervention (1 Day)||2
9071599|NCT03811951|10132507|FG000|NOT COMPLETED|First Intervention (1 Day)||0
9071600|NCT03811951|10132508|FG001|NOT COMPLETED|First Intervention (1 Day)||0
9071601|NCT03811951|10132507|FG000|STARTED|Washout (1 Week)||2
9071602|NCT03811951|10132508|FG001|STARTED|Washout (1 Week)||2
9071603|NCT03811951|10132507|FG000|COMPLETED|Washout (1 Week)||2
9071604|NCT03811951|10132508|FG001|COMPLETED|Washout (1 Week)||2
9071605|NCT03811951|10132507|FG000|NOT COMPLETED|Washout (1 Week)||0
9071606|NCT03811951|10132508|FG001|NOT COMPLETED|Washout (1 Week)||0
9071607|NCT03811951|10132507|FG000|STARTED|Second Intervention (1 Day)||2
9071608|NCT03811951|10132508|FG001|STARTED|Second Intervention (1 Day)||2
9071609|NCT03811951|10132507|FG000|COMPLETED|Second Intervention (1 Day)||2
9071610|NCT03811951|10132508|FG001|COMPLETED|Second Intervention (1 Day)||2
9071611|NCT03811951|10132507|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
9071612|NCT03811951|10132508|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
9071613|NCT03810235|10132518|FG000|STARTED|Overall Study||32
9071614|NCT03810235|10132519|FG001|STARTED|Overall Study||31
9071615|NCT03810235|10132518|FG000|Participant Data Analyzed|Overall Study||30
9071616|NCT03810235|10132519|FG001|Participant Data Analyzed|Overall Study||31
9071617|NCT03810235|10132518|FG000|COMPLETED|Overall Study||30
9071618|NCT03810235|10132519|FG001|COMPLETED|Overall Study||31
9071619|NCT03810235|10132518|FG000|NOT COMPLETED|Overall Study||2
9071620|NCT03810235|10132519|FG001|NOT COMPLETED|Overall Study||0
9071621|NCT03806556|10132528|FG000|STARTED|Overall Study||6
9071622|NCT03806556|10132529|FG001|STARTED|Overall Study||5
9071623|NCT03806556|10132528|FG000|COMPLETED|Overall Study||6
9071624|NCT03806556|10132529|FG001|COMPLETED|Overall Study||5
9071625|NCT03806556|10132528|FG000|NOT COMPLETED|Overall Study||0
9071626|NCT03806556|10132529|FG001|NOT COMPLETED|Overall Study||0
9071627|NCT03836664|10132538|FG000|STARTED|Overall Study||14
8624041|NCT00497874|9663304|FG000|STARTED|Overall Study||443
8624042|NCT00497874|9663305|FG001|STARTED|Overall Study||459
8624043|NCT00497874|9663304|FG000|COMPLETED|Overall Study||296
8624044|NCT00497874|9663305|FG001|COMPLETED|Overall Study||343
8624045|NCT00497874|9663304|FG000|NOT COMPLETED|Overall Study||147
8624046|NCT00497874|9663305|FG001|NOT COMPLETED|Overall Study||116
8624047|NCT00498173|9663315|FG000|STARTED|Phase 1-Blinded Randomization (8 Weeks)||29
8624048|NCT00498173|9663316|FG001|STARTED|Phase 1-Blinded Randomization (8 Weeks)||31
8624049|NCT00498173|9663317|FG002|STARTED|Phase 1-Blinded Randomization (8 Weeks)||0
8624050|NCT00498173|9663315|FG000|COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||27
8624051|NCT00498173|9663316|FG001|COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||30
9071628|NCT03836664|10132539|FG001|STARTED|Overall Study||11
9071629|NCT03836664|10132538|FG000|COMPLETED|Overall Study||11
8624052|NCT00498173|9663317|FG002|COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||0
9071630|NCT03836664|10132539|FG001|COMPLETED|Overall Study||8
9071631|NCT03836664|10132538|FG000|NOT COMPLETED|Overall Study||3
9071632|NCT03836664|10132539|FG001|NOT COMPLETED|Overall Study||3
9071633|NCT03832738|10132552|FG000|STARTED|Overall Study||51
9071634|NCT03832738|10132553|FG001|STARTED|Overall Study||50
9071635|NCT03832738|10132554|FG002|STARTED|Overall Study||51
9071636|NCT03832738|10132552|FG000|COMPLETED|Overall Study||43
9071637|NCT03832738|10132553|FG001|COMPLETED|Overall Study||38
9071638|NCT03832738|10132554|FG002|COMPLETED|Overall Study||32
9071639|NCT03832738|10132552|FG000|NOT COMPLETED|Overall Study||8
9071640|NCT03832738|10132553|FG001|NOT COMPLETED|Overall Study||12
9071641|NCT03832738|10132554|FG002|NOT COMPLETED|Overall Study||19
9071642|NCT03823391|10132564|FG000|STARTED|Period 1: Week 1 to Week 12||17
9071643|NCT03823391|10132565|FG001|STARTED|Period 1: Week 1 to Week 12||31
9071644|NCT03823391|10132564|FG000|COMPLETED|Period 1: Week 1 to Week 12||17
9071645|NCT03823391|10132565|FG001|COMPLETED|Period 1: Week 1 to Week 12||31
9071646|NCT03823391|10132564|FG000|NOT COMPLETED|Period 1: Week 1 to Week 12||0
9071647|NCT03823391|10132565|FG001|NOT COMPLETED|Period 1: Week 1 to Week 12||0
9071648|NCT03823391|10132564|FG000|STARTED|Period 2: Weeks 12 to Week 24||17
9071649|NCT03823391|10132565|FG001|STARTED|Period 2: Weeks 12 to Week 24||31
9071650|NCT03823391|10132564|FG000|COMPLETED|Period 2: Weeks 12 to Week 24||15
9071651|NCT03823391|10132565|FG001|COMPLETED|Period 2: Weeks 12 to Week 24||30
9071652|NCT03823391|10132564|FG000|NOT COMPLETED|Period 2: Weeks 12 to Week 24||2
9071653|NCT03823391|10132565|FG001|NOT COMPLETED|Period 2: Weeks 12 to Week 24||1
9071654|NCT03820258|10132573|FG000|STARTED|Overall Study||21
9071655|NCT03820258|10132573|FG000|COMPLETED|Overall Study||21
9071656|NCT03820258|10132573|FG000|NOT COMPLETED|Overall Study||0
9071657|NCT03819491|10132579|FG000|STARTED|Before Randomization||24
9071658|NCT03819491|10132580|FG001|STARTED|Before Randomization||0
9071659|NCT03819491|10132579|FG000|COMPLETED|Before Randomization||24
9071660|NCT03819491|10132580|FG001|COMPLETED|Before Randomization||0
9071661|NCT03819491|10132579|FG000|NOT COMPLETED|Before Randomization||0
9071662|NCT03819491|10132580|FG001|NOT COMPLETED|Before Randomization||0
9071663|NCT03819491|10132579|FG000|STARTED|After Randomization||12
9071664|NCT03819491|10132580|FG001|STARTED|After Randomization||12
9071665|NCT03819491|10132579|FG000|COMPLETED|After Randomization||12
9071666|NCT03819491|10132580|FG001|COMPLETED|After Randomization||12
9071667|NCT03819491|10132579|FG000|NOT COMPLETED|After Randomization||0
9071668|NCT03819491|10132580|FG001|NOT COMPLETED|After Randomization||0
9071669|NCT03808298|10132587|FG000|STARTED|Overall Study||57
9071670|NCT03808298|10132587|FG000|COMPLETED|Overall Study||49
9071671|NCT03808298|10132587|FG000|NOT COMPLETED|Overall Study||8
9071672|NCT03836729|10132616|FG000|STARTED|Treatment Period 1 (Up to Day 14)||16
9071673|NCT03836729|10132616|FG000|COMPLETED|Treatment Period 1 (Up to Day 14)||16
9071674|NCT03836729|10132616|FG000|NOT COMPLETED|Treatment Period 1 (Up to Day 14)||0
9071675|NCT03836729|10132616|FG000|STARTED|Treatment Period 2 (Up to Day 7)||16
9071676|NCT03836729|10132616|FG000|COMPLETED|Treatment Period 2 (Up to Day 7)||15
9071677|NCT03836729|10132616|FG000|NOT COMPLETED|Treatment Period 2 (Up to Day 7)||1
9071678|NCT03835975|10132629|FG000|STARTED|Overall Study||253
9071679|NCT03835975|10132630|FG001|STARTED|Overall Study||122
9071680|NCT03835975|10132631|FG002|STARTED|Overall Study||248
9071681|NCT03835975|10132632|FG003|STARTED|Overall Study||127
9071682|NCT03835975|10132633|FG004|STARTED|Overall Study||125
9071683|NCT03835975|10132629|FG000|Vaccinated|Overall Study||253
9071684|NCT03835975|10132630|FG001|Vaccinated|Overall Study||122
9071685|NCT03835975|10132631|FG002|Vaccinated|Overall Study||246
9071686|NCT03835975|10132632|FG003|Vaccinated|Overall Study||127
9071687|NCT03835975|10132633|FG004|Vaccinated|Overall Study||125
9071688|NCT03835975|10132629|FG000|Safety Population|Overall Study||253
9071689|NCT03835975|10132630|FG001|Safety Population|Overall Study||122
9071690|NCT03835975|10132631|FG002|Safety Population|Overall Study||246
9071691|NCT03835975|10132632|FG003|Safety Population|Overall Study||127
9071692|NCT03835975|10132633|FG004|Safety Population|Overall Study||125
9071693|NCT03835975|10132629|FG000|Evaluable Immunogenicity Population (for 20vPnC Cohorts)|Overall Study||247
9071694|NCT03835975|10132630|FG001|Evaluable Immunogenicity Population (for 20vPnC Cohorts)|Overall Study||0
9071695|NCT03835975|10132631|FG002|Evaluable Immunogenicity Population (for 20vPnC Cohorts)|Overall Study||243
9071696|NCT03835975|10132632|FG003|Evaluable Immunogenicity Population (for 20vPnC Cohorts)|Overall Study||0
9071697|NCT03835975|10132633|FG004|Evaluable Immunogenicity Population (for 20vPnC Cohorts)|Overall Study||121
9071698|NCT03835975|10132629|FG000|COMPLETED|Overall Study||250
9071699|NCT03835975|10132630|FG001|COMPLETED|Overall Study||119
9071700|NCT03835975|10132631|FG002|COMPLETED|Overall Study||245
9071701|NCT03835975|10132632|FG003|COMPLETED|Overall Study||126
9071702|NCT03835975|10132633|FG004|COMPLETED|Overall Study||125
9071703|NCT03835975|10132629|FG000|NOT COMPLETED|Overall Study||3
9071704|NCT03835975|10132630|FG001|NOT COMPLETED|Overall Study||3
9071705|NCT03835975|10132631|FG002|NOT COMPLETED|Overall Study||3
9071706|NCT03835975|10132632|FG003|NOT COMPLETED|Overall Study||1
9071707|NCT03835975|10132633|FG004|NOT COMPLETED|Overall Study||0
8624053|NCT00498173|9663315|FG000|NOT COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||2
8624054|NCT00498173|9663316|FG001|NOT COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||1
9071708|NCT03821259|10132647|FG000|STARTED|Overall Study||88
9071709|NCT03821259|10132647|FG000|COMPLETED|Overall Study||88
9071710|NCT03821259|10132647|FG000|NOT COMPLETED|Overall Study||0
9071711|NCT03803085|10132653|FG000|STARTED|Overall Study||30
9071712|NCT03803085|10132654|FG001|STARTED|Overall Study||30
9071713|NCT03803085|10132653|FG000|COMPLETED|Overall Study||28
9071714|NCT03803085|10132654|FG001|COMPLETED|Overall Study||28
9071715|NCT03803085|10132653|FG000|NOT COMPLETED|Overall Study||2
9071716|NCT03803085|10132654|FG001|NOT COMPLETED|Overall Study||2
9071717|NCT03801473|10132663|FG000|STARTED|Overall Study||21
9071718|NCT03801473|10132664|FG001|STARTED|Overall Study||21
8624055|NCT00498173|9663317|FG002|NOT COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||0
9071719|NCT03801473|10132663|FG000|COMPLETED|Overall Study||18
9071720|NCT03801473|10132664|FG001|COMPLETED|Overall Study||19
9071721|NCT03801473|10132663|FG000|NOT COMPLETED|Overall Study||3
9071722|NCT03801473|10132664|FG001|NOT COMPLETED|Overall Study||2
9071723|NCT03834168|10132672|FG000|STARTED|Overall Study||19
9071724|NCT03834168|10132673|FG001|STARTED|Overall Study||23
9071725|NCT03834168|10132672|FG000|Total Participant Screened for the Purpose of Eligibility|Overall Study||22
9071726|NCT03834168|10132673|FG001|Total Participant Screened for the Purpose of Eligibility|Overall Study||30
9071727|NCT03834168|10132672|FG000|Ineligible Participants|Overall Study||3
9071728|NCT03834168|10132673|FG001|Ineligible Participants|Overall Study||7
9071729|NCT03834168|10132672|FG000|Unable to Complete the Protocol|Overall Study||0
9071730|NCT03834168|10132673|FG001|Unable to Complete the Protocol|Overall Study||1
9071731|NCT03834168|10132672|FG000|Study Dropouts|Overall Study||1
9071732|NCT03834168|10132673|FG001|Study Dropouts|Overall Study||0
9071733|NCT03834168|10132672|FG000|Participants Received 5 Days of Standardized Meals|Overall Study||19
9071734|NCT03834168|10132673|FG001|Participants Received 5 Days of Standardized Meals|Overall Study||23
9071735|NCT03834168|10132672|FG000|Participants Returned for the 24-h Inpatient Protocol|Overall Study||18
9071736|NCT03834168|10132673|FG001|Participants Returned for the 24-h Inpatient Protocol|Overall Study||23
9071737|NCT03834168|10132672|FG000|COMPLETED|Overall Study||18
9071738|NCT03834168|10132673|FG001|COMPLETED|Overall Study||22
9071739|NCT03834168|10132672|FG000|NOT COMPLETED|Overall Study||1
9071740|NCT03834168|10132673|FG001|NOT COMPLETED|Overall Study||1
9071741|NCT03828149|10132681|FG000|STARTED|First Intervention (Single Dose)||9
9071742|NCT03828149|10132682|FG001|STARTED|First Intervention (Single Dose)||8
9071743|NCT03828149|10132681|FG000|COMPLETED|First Intervention (Single Dose)||9
9071744|NCT03828149|10132682|FG001|COMPLETED|First Intervention (Single Dose)||8
9071745|NCT03828149|10132681|FG000|NOT COMPLETED|First Intervention (Single Dose)||0
9071746|NCT03828149|10132682|FG001|NOT COMPLETED|First Intervention (Single Dose)||0
9071747|NCT03828149|10132681|FG000|STARTED|Washout (6 Days)||9
9071748|NCT03828149|10132682|FG001|STARTED|Washout (6 Days)||8
9071749|NCT03828149|10132681|FG000|COMPLETED|Washout (6 Days)||9
9071750|NCT03828149|10132682|FG001|COMPLETED|Washout (6 Days)||8
9071751|NCT03828149|10132681|FG000|NOT COMPLETED|Washout (6 Days)||0
9071752|NCT03828149|10132682|FG001|NOT COMPLETED|Washout (6 Days)||0
9071753|NCT03828149|10132681|FG000|STARTED|Second Intervention (Single Dose)||9
9071754|NCT03828149|10132682|FG001|STARTED|Second Intervention (Single Dose)||8
9071755|NCT03828149|10132681|FG000|COMPLETED|Second Intervention (Single Dose)||9
9071756|NCT03828149|10132682|FG001|COMPLETED|Second Intervention (Single Dose)||8
9071757|NCT03828149|10132681|FG000|NOT COMPLETED|Second Intervention (Single Dose)||0
9071758|NCT03828149|10132682|FG001|NOT COMPLETED|Second Intervention (Single Dose)||0
9071759|NCT03835221|10132688|FG000|STARTED|Methafilcon A||43
9071760|NCT03835221|10132688|FG000|COMPLETED|Methafilcon A||42
9071761|NCT03835221|10132688|FG000|NOT COMPLETED|Methafilcon A||1
9071762|NCT03835221|10132688|FG000|STARTED|Fanfilcon A||42
9071763|NCT03835221|10132688|FG000|COMPLETED|Fanfilcon A||42
9071764|NCT03835221|10132688|FG000|NOT COMPLETED|Fanfilcon A||0
9071765|NCT03819634|10132694|FG000|STARTED|Overall Study||24
9071766|NCT03819634|10132694|FG000|COMPLETED|Overall Study||22
9071767|NCT03819634|10132694|FG000|NOT COMPLETED|Overall Study||2
9071768|NCT03812679|10132698|FG000|STARTED|Overall Study||22
9071769|NCT03812679|10132698|FG000|COMPLETED|Overall Study||14
9071770|NCT03812679|10132698|FG000|NOT COMPLETED|Overall Study||8
9071771|NCT03809052|10132713|FG000|STARTED|Overall Study||6
9071772|NCT03809052|10132714|FG001|STARTED|Overall Study||6
9071773|NCT03809052|10132715|FG002|STARTED|Overall Study||6
9071774|NCT03809052|10132716|FG003|STARTED|Overall Study||6
9071775|NCT03809052|10132717|FG004|STARTED|Overall Study||6
9071776|NCT03809052|10132718|FG005|STARTED|Overall Study||6
9071777|NCT03809052|10132719|FG006|STARTED|Overall Study||6
9071778|NCT03809052|10132720|FG007|STARTED|Overall Study||14
9071779|NCT03809052|10132721|FG008|STARTED|Overall Study||8
9071780|NCT03809052|10132722|FG009|STARTED|Overall Study||8
9071781|NCT03809052|10132723|FG010|STARTED|Overall Study||6
9071782|NCT03809052|10132713|FG000|COMPLETED|Overall Study||6
9071783|NCT03809052|10132714|FG001|COMPLETED|Overall Study||6
9071784|NCT03809052|10132715|FG002|COMPLETED|Overall Study||6
9071785|NCT03809052|10132716|FG003|COMPLETED|Overall Study||6
9071786|NCT03809052|10132717|FG004|COMPLETED|Overall Study||6
9071787|NCT03809052|10132718|FG005|COMPLETED|Overall Study||6
9071788|NCT03809052|10132719|FG006|COMPLETED|Overall Study||6
9071789|NCT03809052|10132720|FG007|COMPLETED|Overall Study||14
9071790|NCT03809052|10132721|FG008|COMPLETED|Overall Study||8
9071791|NCT03809052|10132722|FG009|COMPLETED|Overall Study||8
9071792|NCT03809052|10132723|FG010|COMPLETED|Overall Study||6
9071793|NCT03809052|10132713|FG000|NOT COMPLETED|Overall Study||0
9071794|NCT03809052|10132714|FG001|NOT COMPLETED|Overall Study||0
9071795|NCT03809052|10132715|FG002|NOT COMPLETED|Overall Study||0
9071796|NCT03809052|10132716|FG003|NOT COMPLETED|Overall Study||0
9071797|NCT03809052|10132717|FG004|NOT COMPLETED|Overall Study||0
9071798|NCT03809052|10132718|FG005|NOT COMPLETED|Overall Study||0
9071799|NCT03809052|10132719|FG006|NOT COMPLETED|Overall Study||0
9071800|NCT03809052|10132720|FG007|NOT COMPLETED|Overall Study||0
9071801|NCT03809052|10132721|FG008|NOT COMPLETED|Overall Study||0
9071802|NCT03809052|10132722|FG009|NOT COMPLETED|Overall Study||0
9071803|NCT03809052|10132723|FG010|NOT COMPLETED|Overall Study||0
9071804|NCT03801148|10132753|FG000|STARTED|Period 1 (2 Days)||31
9071805|NCT03801148|10132754|FG001|STARTED|Period 1 (2 Days)||31
9071806|NCT03801148|10132755|FG002|STARTED|Period 1 (2 Days)||30
9071807|NCT03801148|10132756|FG003|STARTED|Period 1 (2 Days)||30
9071808|NCT03801148|10132753|FG000|COMPLETED|Period 1 (2 Days)||30
9071809|NCT03801148|10132754|FG001|COMPLETED|Period 1 (2 Days)||30
9071810|NCT03801148|10132755|FG002|COMPLETED|Period 1 (2 Days)||30
9071811|NCT03801148|10132756|FG003|COMPLETED|Period 1 (2 Days)||30
9071812|NCT03801148|10132753|FG000|NOT COMPLETED|Period 1 (2 Days)||1
9071813|NCT03801148|10132754|FG001|NOT COMPLETED|Period 1 (2 Days)||1
9071814|NCT03801148|10132755|FG002|NOT COMPLETED|Period 1 (2 Days)||0
9071815|NCT03801148|10132756|FG003|NOT COMPLETED|Period 1 (2 Days)||0
9071816|NCT03801148|10132753|FG000|STARTED|Washout Period (at Least 5 Days)||30
9071817|NCT03801148|10132754|FG001|STARTED|Washout Period (at Least 5 Days)||30
9071818|NCT03801148|10132755|FG002|STARTED|Washout Period (at Least 5 Days)||30
9071819|NCT03801148|10132756|FG003|STARTED|Washout Period (at Least 5 Days)||30
9071820|NCT03801148|10132753|FG000|COMPLETED|Washout Period (at Least 5 Days)||30
9071821|NCT03801148|10132754|FG001|COMPLETED|Washout Period (at Least 5 Days)||30
9071822|NCT03801148|10132755|FG002|COMPLETED|Washout Period (at Least 5 Days)||29
9071823|NCT03801148|10132756|FG003|COMPLETED|Washout Period (at Least 5 Days)||29
9071824|NCT03801148|10132753|FG000|NOT COMPLETED|Washout Period (at Least 5 Days)||0
9071825|NCT03801148|10132754|FG001|NOT COMPLETED|Washout Period (at Least 5 Days)||0
9071826|NCT03801148|10132755|FG002|NOT COMPLETED|Washout Period (at Least 5 Days)||1
9071827|NCT03801148|10132756|FG003|NOT COMPLETED|Washout Period (at Least 5 Days)||1
9071828|NCT03801148|10132753|FG000|STARTED|Period 2 (2 Days)||30
9071829|NCT03801148|10132754|FG001|STARTED|Period 2 (2 Days)||30
9071830|NCT03801148|10132755|FG002|STARTED|Period 2 (2 Days)||29
9071831|NCT03801148|10132756|FG003|STARTED|Period 2 (2 Days)||29
9071832|NCT03801148|10132753|FG000|COMPLETED|Period 2 (2 Days)||30
9071833|NCT03801148|10132754|FG001|COMPLETED|Period 2 (2 Days)||30
9071834|NCT03801148|10132755|FG002|COMPLETED|Period 2 (2 Days)||29
9071835|NCT03801148|10132756|FG003|COMPLETED|Period 2 (2 Days)||29
9071836|NCT03801148|10132753|FG000|NOT COMPLETED|Period 2 (2 Days)||0
9071837|NCT03801148|10132754|FG001|NOT COMPLETED|Period 2 (2 Days)||0
9071838|NCT03801148|10132755|FG002|NOT COMPLETED|Period 2 (2 Days)||0
9071839|NCT03801148|10132756|FG003|NOT COMPLETED|Period 2 (2 Days)||0
9071840|NCT03801148|10132753|FG000|STARTED|Follow-Up (12 Days)||30
9071841|NCT03801148|10132754|FG001|STARTED|Follow-Up (12 Days)||30
9071842|NCT03801148|10132755|FG002|STARTED|Follow-Up (12 Days)||29
9071843|NCT03801148|10132756|FG003|STARTED|Follow-Up (12 Days)||29
9071844|NCT03801148|10132753|FG000|COMPLETED|Follow-Up (12 Days)||30
9071845|NCT03801148|10132754|FG001|COMPLETED|Follow-Up (12 Days)||29
9071846|NCT03801148|10132755|FG002|COMPLETED|Follow-Up (12 Days)||28
9071847|NCT03801148|10132756|FG003|COMPLETED|Follow-Up (12 Days)||29
9071848|NCT03801148|10132753|FG000|NOT COMPLETED|Follow-Up (12 Days)||0
9071849|NCT03801148|10132754|FG001|NOT COMPLETED|Follow-Up (12 Days)||1
9071850|NCT03801148|10132755|FG002|NOT COMPLETED|Follow-Up (12 Days)||1
9071851|NCT03801148|10132756|FG003|NOT COMPLETED|Follow-Up (12 Days)||0
9071852|NCT03832907|10132766|FG000|STARTED|Overall Study||101
9071853|NCT03832907|10132766|FG000|COMPLETED|Overall Study||91
9071854|NCT03832907|10132766|FG000|NOT COMPLETED|Overall Study||10
9071855|NCT03832322|10132772|FG000|STARTED|Overall Study||89
9071856|NCT03832322|10132773|FG001|STARTED|Overall Study||87
9071857|NCT03832322|10132772|FG000|COMPLETED|Overall Study||86
9071858|NCT03832322|10132773|FG001|COMPLETED|Overall Study||86
9071859|NCT03832322|10132772|FG000|NOT COMPLETED|Overall Study||3
9071860|NCT03832322|10132773|FG001|NOT COMPLETED|Overall Study||1
9071861|NCT03832387|10132783|FG000|STARTED|Overall Study||38
9071862|NCT03832387|10132784|FG001|STARTED|Overall Study||39
9071863|NCT03832387|10132783|FG000|COMPLETED|Overall Study||33
9071864|NCT03832387|10132784|FG001|COMPLETED|Overall Study||32
9071865|NCT03832387|10132783|FG000|NOT COMPLETED|Overall Study||5
9071866|NCT03832387|10132784|FG001|NOT COMPLETED|Overall Study||7
9071867|NCT03831971|10132790|FG000|STARTED|Overall Study||12
9071868|NCT03831971|10132790|FG000|COMPLETED|Overall Study||12
9071869|NCT03831971|10132790|FG000|NOT COMPLETED|Overall Study||0
9071870|NCT03831854|10132796|FG000|STARTED|Overall Study||23
9071871|NCT03831854|10132797|FG001|STARTED|Overall Study||23
9071872|NCT03831854|10132796|FG000|COMPLETED|Overall Study||23
9071873|NCT03831854|10132797|FG001|COMPLETED|Overall Study||23
9071874|NCT03831854|10132796|FG000|NOT COMPLETED|Overall Study||0
9071875|NCT03831854|10132797|FG001|NOT COMPLETED|Overall Study||0
9071876|NCT03807739|10132807|FG000|STARTED|Overall Study||9
9071877|NCT03807739|10132808|FG001|STARTED|Overall Study||10
9071878|NCT03807739|10132809|FG002|STARTED|Overall Study||9
9071879|NCT03807739|10132810|FG003|STARTED|Overall Study||10
9071880|NCT03807739|10132807|FG000|COMPLETED|Overall Study||7
9071881|NCT03807739|10132808|FG001|COMPLETED|Overall Study||10
9071882|NCT03807739|10132809|FG002|COMPLETED|Overall Study||9
9071883|NCT03807739|10132810|FG003|COMPLETED|Overall Study||10
9071884|NCT03807739|10132807|FG000|NOT COMPLETED|Overall Study||2
9071885|NCT03807739|10132808|FG001|NOT COMPLETED|Overall Study||0
9071886|NCT03807739|10132809|FG002|NOT COMPLETED|Overall Study||0
9071887|NCT03807739|10132810|FG003|NOT COMPLETED|Overall Study||0
9071888|NCT03831282|10132820|FG000|STARTED|Overall Study||12
9071889|NCT03831282|10132820|FG000|COMPLETED|Overall Study||11
9071890|NCT03831282|10132820|FG000|NOT COMPLETED|Overall Study||1
9071891|NCT03824912|10132827|FG000|STARTED|Overall Study||332
9071892|NCT03824912|10132828|FG001|STARTED|Overall Study||335
9071893|NCT03824912|10132829|FG002|STARTED|Overall Study||164
9071894|NCT03824912|10132827|FG000|COMPLETED|Overall Study||192
9071895|NCT03824912|10132828|FG001|COMPLETED|Overall Study||201
9071896|NCT03824912|10132829|FG002|COMPLETED|Overall Study||96
9071897|NCT03824912|10132827|FG000|NOT COMPLETED|Overall Study||140
9071898|NCT03824912|10132828|FG001|NOT COMPLETED|Overall Study||134
9071899|NCT03824912|10132829|FG002|NOT COMPLETED|Overall Study||68
9071900|NCT03822884|10132843|FG000|STARTED|Overall Study||4
9071901|NCT03822884|10132844|FG001|STARTED|Overall Study||4
9071902|NCT03822884|10132845|FG002|STARTED|Overall Study||4
9071903|NCT03822884|10132846|FG003|STARTED|Overall Study||4
9071904|NCT03822884|10132847|FG004|STARTED|Overall Study||4
9071905|NCT03822884|10132848|FG005|STARTED|Overall Study||4
9071906|NCT03822884|10132843|FG000|COMPLETED|Overall Study||4
9071907|NCT03822884|10132844|FG001|COMPLETED|Overall Study||4
9071908|NCT03822884|10132845|FG002|COMPLETED|Overall Study||4
9071909|NCT03822884|10132846|FG003|COMPLETED|Overall Study||4
9071910|NCT03822884|10132847|FG004|COMPLETED|Overall Study||3
9071911|NCT03822884|10132848|FG005|COMPLETED|Overall Study||4
9071912|NCT03822884|10132843|FG000|NOT COMPLETED|Overall Study||0
9071913|NCT03822884|10132844|FG001|NOT COMPLETED|Overall Study||0
9071914|NCT03822884|10132845|FG002|NOT COMPLETED|Overall Study||0
9071915|NCT03822884|10132846|FG003|NOT COMPLETED|Overall Study||0
9071916|NCT03822884|10132847|FG004|NOT COMPLETED|Overall Study||1
9071917|NCT03822884|10132848|FG005|NOT COMPLETED|Overall Study||0
9071918|NCT03816709|10132856|FG000|STARTED|Overall Study||25
9071919|NCT03816709|10132856|FG000|COMPLETED|Overall Study||25
9071920|NCT03816709|10132856|FG000|NOT COMPLETED|Overall Study||0
9071921|NCT03810014|10132864|FG000|STARTED|Overall Study||215
9071922|NCT03810014|10132865|FG001|STARTED|Overall Study||204
9071923|NCT03810014|10132866|FG002|STARTED|Overall Study||210
9071924|NCT03810014|10132867|FG003|STARTED|Overall Study||213
9071925|NCT03810014|10132864|FG000|COMPLETED|Overall Study||213
9071926|NCT03810014|10132865|FG001|COMPLETED|Overall Study||202
9071927|NCT03810014|10132866|FG002|COMPLETED|Overall Study||210
9071928|NCT03810014|10132867|FG003|COMPLETED|Overall Study||211
9071929|NCT03810014|10132864|FG000|NOT COMPLETED|Overall Study||2
9071930|NCT03810014|10132865|FG001|NOT COMPLETED|Overall Study||2
9071931|NCT03810014|10132866|FG002|NOT COMPLETED|Overall Study||0
9071932|NCT03810014|10132867|FG003|NOT COMPLETED|Overall Study||2
9071933|NCT03806270|10132880|FG000|STARTED|Overall Study||15
9071934|NCT03806270|10132881|FG001|STARTED|Overall Study||15
9071935|NCT03806270|10132882|FG002|STARTED|Overall Study||15
9071936|NCT03806270|10132880|FG000|COMPLETED|Overall Study||15
9071937|NCT03806270|10132881|FG001|COMPLETED|Overall Study||15
9071938|NCT03806270|10132882|FG002|COMPLETED|Overall Study||15
9071939|NCT03806270|10132880|FG000|NOT COMPLETED|Overall Study||0
9071940|NCT03806270|10132881|FG001|NOT COMPLETED|Overall Study||0
9071941|NCT03806270|10132882|FG002|NOT COMPLETED|Overall Study||0
9071942|NCT03830892|10132892|FG000|STARTED|Overall Study||25
9071943|NCT03830892|10132893|FG001|STARTED|Overall Study||23
9071944|NCT03830892|10132892|FG000|15 Watts, 10 mg Nicotine|Overall Study||19
9071945|NCT03830892|10132893|FG001|15 Watts, 10 mg Nicotine|Overall Study||17
9071946|NCT03830892|10132892|FG000|15 Watts, 30 mg Nicotine|Overall Study||19
9071947|NCT03830892|10132893|FG001|15 Watts, 30 mg Nicotine|Overall Study||17
9071948|NCT03830892|10132892|FG000|30 Watts, 10 mg Nicotine|Overall Study||19
9071949|NCT03830892|10132893|FG001|30 Watts, 10 mg Nicotine|Overall Study||17
9071950|NCT03830892|10132892|FG000|30 Watts, 30 mg Nicotine|Overall Study||19
9071951|NCT03830892|10132893|FG001|30 Watts, 30 mg Nicotine|Overall Study||17
9071952|NCT03830892|10132892|FG000|Own Brand|Overall Study||19
9071953|NCT03830892|10132893|FG001|Own Brand|Overall Study||17
9071954|NCT03830892|10132892|FG000|COMPLETED|Overall Study||19
9071955|NCT03830892|10132893|FG001|COMPLETED|Overall Study||17
9071956|NCT03830892|10132892|FG000|NOT COMPLETED|Overall Study||6
9071957|NCT03830892|10132893|FG001|NOT COMPLETED|Overall Study||6
9071958|NCT03830307|10132899|FG000|STARTED|Overall Study||5
9071959|NCT03830307|10132899|FG000|COMPLETED|Overall Study||5
9071960|NCT03830307|10132899|FG000|NOT COMPLETED|Overall Study||0
9071961|NCT03825042|10132905|FG000|STARTED|Overall Study||40
9071962|NCT03825042|10132906|FG001|STARTED|Overall Study||40
9071963|NCT03825042|10132905|FG000|COMPLETED|Overall Study||38
9071964|NCT03825042|10132906|FG001|COMPLETED|Overall Study||40
9071965|NCT03825042|10132905|FG000|NOT COMPLETED|Overall Study||2
9071966|NCT03825042|10132906|FG001|NOT COMPLETED|Overall Study||0
9071967|NCT03823378|10132918|FG000|STARTED|Overall Study||28
9071968|NCT03823378|10132919|FG001|STARTED|Overall Study||16
9071969|NCT03823378|10132920|FG002|STARTED|Overall Study||12
9071970|NCT03823378|10132921|FG003|STARTED|Overall Study||12
9071971|NCT03823378|10132922|FG004|STARTED|Overall Study||20
9071972|NCT03823378|10132923|FG005|STARTED|Overall Study||9
9071973|NCT03823378|10132918|FG000|COMPLETED|Overall Study||7
9071974|NCT03823378|10132919|FG001|COMPLETED|Overall Study||0
9071975|NCT03823378|10132920|FG002|COMPLETED|Overall Study||2
9071976|NCT03823378|10132921|FG003|COMPLETED|Overall Study||2
9071977|NCT03823378|10132922|FG004|COMPLETED|Overall Study||2
9071978|NCT03823378|10132923|FG005|COMPLETED|Overall Study||1
9071979|NCT03823378|10132918|FG000|NOT COMPLETED|Overall Study||21
9071980|NCT03823378|10132919|FG001|NOT COMPLETED|Overall Study||16
9071981|NCT03823378|10132920|FG002|NOT COMPLETED|Overall Study||10
9071982|NCT03823378|10132921|FG003|NOT COMPLETED|Overall Study||10
9071983|NCT03823378|10132922|FG004|NOT COMPLETED|Overall Study||18
9071984|NCT03823378|10132923|FG005|NOT COMPLETED|Overall Study||8
9071985|NCT03831191|10132941|FG000|STARTED|Induction Period (16 Weeks)||33
9071986|NCT03831191|10132942|FG001|STARTED|Induction Period (16 Weeks)||35
9071987|NCT03831191|10132943|FG002|STARTED|Induction Period (16 Weeks)||34
9071988|NCT03831191|10132944|FG003|STARTED|Induction Period (16 Weeks)||34
9071989|NCT03831191|10132945|FG004|STARTED|Induction Period (16 Weeks)||0
9071990|NCT03831191|10132946|FG005|STARTED|Induction Period (16 Weeks)||0
9071991|NCT03831191|10132947|FG006|STARTED|Induction Period (16 Weeks)||0
9071992|NCT03831191|10132948|FG007|STARTED|Induction Period (16 Weeks)||0
9071993|NCT03831191|10132949|FG008|STARTED|Induction Period (16 Weeks)||0
9071994|NCT03831191|10132950|FG009|STARTED|Induction Period (16 Weeks)||0
9071995|NCT03831191|10132951|FG010|STARTED|Induction Period (16 Weeks)||0
9071996|NCT03831191|10132952|FG011|STARTED|Induction Period (16 Weeks)||0
9071997|NCT03831191|10132953|FG012|STARTED|Induction Period (16 Weeks)||0
9071998|NCT03831191|10132954|FG013|STARTED|Induction Period (16 Weeks)||0
9071999|NCT03831191|10132955|FG014|STARTED|Induction Period (16 Weeks)||0
9072000|NCT03831191|10132941|FG000|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||33
9072001|NCT03831191|10132942|FG001|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||35
9072002|NCT03831191|10132943|FG002|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||34
9072003|NCT03831191|10132944|FG003|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||33
9072004|NCT03831191|10132945|FG004|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
9072005|NCT03831191|10132946|FG005|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
9072006|NCT03831191|10132947|FG006|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
9072007|NCT03831191|10132948|FG007|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
9072008|NCT03831191|10132949|FG008|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
9072009|NCT03831191|10132950|FG009|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
9072010|NCT03831191|10132951|FG010|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
9072011|NCT03831191|10132952|FG011|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
9072012|NCT03831191|10132953|FG012|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
9072013|NCT03831191|10132954|FG013|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
9072014|NCT03831191|10132955|FG014|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
9072015|NCT03831191|10132941|FG000|COMPLETED|Induction Period (16 Weeks)||10
8624056|NCT00498173|9663315|FG000|STARTED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
8624057|NCT00498173|9663316|FG001|STARTED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
8624058|NCT00498173|9663317|FG002|STARTED|Phase 2-Atomoxetine Open Label (8 Weeks)||26
8624059|NCT00498173|9663315|FG000|COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
8624060|NCT00498173|9663316|FG001|COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
8624061|NCT00498173|9663317|FG002|COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||26
8624062|NCT00498173|9663315|FG000|NOT COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
8624063|NCT00498173|9663316|FG001|NOT COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
8624064|NCT00498173|9663317|FG002|NOT COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
8624065|NCT00498186|9663325|FG000|STARTED|Overall Study||295
9072016|NCT03831191|10132942|FG001|COMPLETED|Induction Period (16 Weeks)||14
9072017|NCT03831191|10132943|FG002|COMPLETED|Induction Period (16 Weeks)||13
9072018|NCT03831191|10132944|FG003|COMPLETED|Induction Period (16 Weeks)||11
9072019|NCT03831191|10132945|FG004|COMPLETED|Induction Period (16 Weeks)||0
9072020|NCT03831191|10132946|FG005|COMPLETED|Induction Period (16 Weeks)||0
9072021|NCT03831191|10132947|FG006|COMPLETED|Induction Period (16 Weeks)||0
9072022|NCT03831191|10132948|FG007|COMPLETED|Induction Period (16 Weeks)||0
9072023|NCT03831191|10132949|FG008|COMPLETED|Induction Period (16 Weeks)||0
9072024|NCT03831191|10132950|FG009|COMPLETED|Induction Period (16 Weeks)||0
8624066|NCT00498186|9663325|FG000|COMPLETED|Overall Study||122
8624067|NCT00498186|9663325|FG000|NOT COMPLETED|Overall Study||173
9072025|NCT03831191|10132951|FG010|COMPLETED|Induction Period (16 Weeks)||0
9072026|NCT03831191|10132952|FG011|COMPLETED|Induction Period (16 Weeks)||0
9072027|NCT03831191|10132953|FG012|COMPLETED|Induction Period (16 Weeks)||0
9072028|NCT03831191|10132954|FG013|COMPLETED|Induction Period (16 Weeks)||0
9072029|NCT03831191|10132955|FG014|COMPLETED|Induction Period (16 Weeks)||0
9072030|NCT03831191|10132941|FG000|NOT COMPLETED|Induction Period (16 Weeks)||23
9072031|NCT03831191|10132942|FG001|NOT COMPLETED|Induction Period (16 Weeks)||21
9072032|NCT03831191|10132943|FG002|NOT COMPLETED|Induction Period (16 Weeks)||21
9072033|NCT03831191|10132944|FG003|NOT COMPLETED|Induction Period (16 Weeks)||23
9072034|NCT03831191|10132945|FG004|NOT COMPLETED|Induction Period (16 Weeks)||0
9072035|NCT03831191|10132946|FG005|NOT COMPLETED|Induction Period (16 Weeks)||0
9072036|NCT03831191|10132947|FG006|NOT COMPLETED|Induction Period (16 Weeks)||0
9072037|NCT03831191|10132948|FG007|NOT COMPLETED|Induction Period (16 Weeks)||0
9072038|NCT03831191|10132949|FG008|NOT COMPLETED|Induction Period (16 Weeks)||0
9072039|NCT03831191|10132950|FG009|NOT COMPLETED|Induction Period (16 Weeks)||0
9072040|NCT03831191|10132951|FG010|NOT COMPLETED|Induction Period (16 Weeks)||0
9072041|NCT03831191|10132952|FG011|NOT COMPLETED|Induction Period (16 Weeks)||0
9072042|NCT03831191|10132953|FG012|NOT COMPLETED|Induction Period (16 Weeks)||0
9072043|NCT03831191|10132954|FG013|NOT COMPLETED|Induction Period (16 Weeks)||0
9072044|NCT03831191|10132955|FG014|NOT COMPLETED|Induction Period (16 Weeks)||0
9072045|NCT03831191|10132941|FG000|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during induction period.|0
9072046|NCT03831191|10132942|FG001|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during induction period.|0
9072047|NCT03831191|10132943|FG002|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during induction period.|0
9072048|NCT03831191|10132944|FG003|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during induction period.|0
9072049|NCT03831191|10132945|FG004|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|4
9072050|NCT03831191|10132946|FG005|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|5
9072051|NCT03831191|10132947|FG006|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|2
9072052|NCT03831191|10132948|FG007|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|4
9072053|NCT03831191|10132949|FG008|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|8
9072054|NCT03831191|10132950|FG009|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|1
9072055|NCT03831191|10132951|FG010|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|4
9072056|NCT03831191|10132952|FG011|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|8
9072057|NCT03831191|10132953|FG012|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|1
9072058|NCT03831191|10132954|FG013|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|1
9072059|NCT03831191|10132955|FG014|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|9
9072060|NCT03831191|10132941|FG000|COMPLETED|Maintenance Period (36 Weeks)||0
9072061|NCT03831191|10132942|FG001|COMPLETED|Maintenance Period (36 Weeks)||0
9072062|NCT03831191|10132943|FG002|COMPLETED|Maintenance Period (36 Weeks)||0
9072063|NCT03831191|10132944|FG003|COMPLETED|Maintenance Period (36 Weeks)||0
9072064|NCT03831191|10132945|FG004|COMPLETED|Maintenance Period (36 Weeks)||0
9072065|NCT03831191|10132946|FG005|COMPLETED|Maintenance Period (36 Weeks)||0
9072066|NCT03831191|10132947|FG006|COMPLETED|Maintenance Period (36 Weeks)||0
9072067|NCT03831191|10132948|FG007|COMPLETED|Maintenance Period (36 Weeks)||0
8624068|NCT00498355|9663329|FG000|STARTED|Overall Study||7
8624069|NCT00498355|9663329|FG000|COMPLETED|Overall Study||6
8624070|NCT00498355|9663329|FG000|NOT COMPLETED|Overall Study||1
8624071|NCT00498368|9663336|FG000|STARTED|Overall Study||17
8624072|NCT00498368|9663337|FG001|STARTED|Overall Study||17
8624073|NCT00498368|9663336|FG000|COMPLETED|Overall Study||14
8624074|NCT00498368|9663337|FG001|COMPLETED|Overall Study||15
8624075|NCT00498368|9663336|FG000|NOT COMPLETED|Overall Study||3
8624076|NCT00498368|9663337|FG001|NOT COMPLETED|Overall Study||2
9072068|NCT03831191|10132949|FG008|COMPLETED|Maintenance Period (36 Weeks)||0
9072069|NCT03831191|10132950|FG009|COMPLETED|Maintenance Period (36 Weeks)||0
9072070|NCT03831191|10132951|FG010|COMPLETED|Maintenance Period (36 Weeks)||0
9072071|NCT03831191|10132952|FG011|COMPLETED|Maintenance Period (36 Weeks)||1
9072072|NCT03831191|10132953|FG012|COMPLETED|Maintenance Period (36 Weeks)||0
9072073|NCT03831191|10132954|FG013|COMPLETED|Maintenance Period (36 Weeks)||0
9072074|NCT03831191|10132955|FG014|COMPLETED|Maintenance Period (36 Weeks)||0
9072075|NCT03831191|10132941|FG000|NOT COMPLETED|Maintenance Period (36 Weeks)||0
9072076|NCT03831191|10132942|FG001|NOT COMPLETED|Maintenance Period (36 Weeks)||0
9072077|NCT03831191|10132943|FG002|NOT COMPLETED|Maintenance Period (36 Weeks)||0
9072078|NCT03831191|10132944|FG003|NOT COMPLETED|Maintenance Period (36 Weeks)||0
9072079|NCT03831191|10132945|FG004|NOT COMPLETED|Maintenance Period (36 Weeks)||4
9072080|NCT03831191|10132946|FG005|NOT COMPLETED|Maintenance Period (36 Weeks)||5
9072081|NCT03831191|10132947|FG006|NOT COMPLETED|Maintenance Period (36 Weeks)||2
9072082|NCT03831191|10132948|FG007|NOT COMPLETED|Maintenance Period (36 Weeks)||4
9072083|NCT03831191|10132949|FG008|NOT COMPLETED|Maintenance Period (36 Weeks)||8
9072084|NCT03831191|10132950|FG009|NOT COMPLETED|Maintenance Period (36 Weeks)||1
9072085|NCT03831191|10132951|FG010|NOT COMPLETED|Maintenance Period (36 Weeks)||4
8624077|NCT00498433|9663346|FG000|STARTED|Part 1, Period 1:Placebo Run-in(2 Weeks)||10
8624078|NCT00498433|9663347|FG001|STARTED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
9072086|NCT03831191|10132952|FG011|NOT COMPLETED|Maintenance Period (36 Weeks)||7
9072087|NCT03831191|10132953|FG012|NOT COMPLETED|Maintenance Period (36 Weeks)||1
9072088|NCT03831191|10132954|FG013|NOT COMPLETED|Maintenance Period (36 Weeks)||1
9072089|NCT03831191|10132955|FG014|NOT COMPLETED|Maintenance Period (36 Weeks)||9
9072090|NCT03831191|10132941|FG000|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
9072091|NCT03831191|10132942|FG001|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
9072092|NCT03831191|10132943|FG002|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
9072093|NCT03831191|10132944|FG003|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
9072094|NCT03831191|10132945|FG004|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
9072095|NCT03831191|10132946|FG005|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
9072096|NCT03831191|10132947|FG006|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
9072097|NCT03831191|10132948|FG007|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
9072098|NCT03831191|10132949|FG008|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
9072099|NCT03831191|10132950|FG009|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
9072100|NCT03831191|10132951|FG010|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
9072101|NCT03831191|10132952|FG011|STARTED|Post-Treatment Follow-Up Period(8 Weeks)|No participant entered the post follow-up period.|0
9072102|NCT03831191|10132953|FG012|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
9072103|NCT03831191|10132954|FG013|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
9072104|NCT03831191|10132955|FG014|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
9072105|NCT03831191|10132941|FG000|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
9072106|NCT03831191|10132942|FG001|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
9072107|NCT03831191|10132943|FG002|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
9072108|NCT03831191|10132944|FG003|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
9072109|NCT03831191|10132945|FG004|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
9072110|NCT03831191|10132946|FG005|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
9072111|NCT03831191|10132947|FG006|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
9072112|NCT03831191|10132948|FG007|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
9072113|NCT03831191|10132949|FG008|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
9072114|NCT03831191|10132950|FG009|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
9072115|NCT03831191|10132951|FG010|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
9072116|NCT03831191|10132952|FG011|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
9072117|NCT03831191|10132953|FG012|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
9072118|NCT03831191|10132954|FG013|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
9072119|NCT03831191|10132955|FG014|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
9072120|NCT03831191|10132941|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
9072121|NCT03831191|10132942|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
9072122|NCT03831191|10132943|FG002|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
9072123|NCT03831191|10132944|FG003|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
9072124|NCT03831191|10132945|FG004|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
9072125|NCT03831191|10132946|FG005|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
9072126|NCT03831191|10132947|FG006|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
9072127|NCT03831191|10132948|FG007|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
9072128|NCT03831191|10132949|FG008|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
9072129|NCT03831191|10132950|FG009|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
9072130|NCT03831191|10132951|FG010|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
9072131|NCT03831191|10132952|FG011|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
9072132|NCT03831191|10132953|FG012|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
9072133|NCT03831191|10132954|FG013|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
9072134|NCT03831191|10132955|FG014|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
9072135|NCT03830281|10132990|FG000|STARTED|Lead-in Period (2 Weeks)||471
9072136|NCT03830281|10132991|FG001|STARTED|Lead-in Period (2 Weeks)||0
9072137|NCT03830281|10132990|FG000|COMPLETED|Lead-in Period (2 Weeks)||432
9072138|NCT03830281|10132991|FG001|COMPLETED|Lead-in Period (2 Weeks)||0
9072139|NCT03830281|10132990|FG000|NOT COMPLETED|Lead-in Period (2 Weeks)||39
9072140|NCT03830281|10132991|FG001|NOT COMPLETED|Lead-in Period (2 Weeks)||0
9072141|NCT03830281|10132990|FG000|STARTED|Treatment Period (16 Weeks)|Pts who completed lead-in period randomized to Humalog or Ultra-Rapid Lispro in treatment period.|217
9072142|NCT03830281|10132991|FG001|STARTED|Treatment Period (16 Weeks)|Pts who completed lead-in period randomized to Humalog or Ultra-Rapid Lispro in treatment period.|215
9072143|NCT03830281|10132990|FG000|COMPLETED|Treatment Period (16 Weeks)||205
9072144|NCT03830281|10132991|FG001|COMPLETED|Treatment Period (16 Weeks)||198
9072145|NCT03830281|10132990|FG000|NOT COMPLETED|Treatment Period (16 Weeks)||12
9072146|NCT03830281|10132991|FG001|NOT COMPLETED|Treatment Period (16 Weeks)||17
9072147|NCT03828734|10132998|FG000|STARTED|Baseline||32
9072148|NCT03828734|10132999|FG001|STARTED|Baseline||26
9072149|NCT03828734|10132998|FG000|COMPLETED|Baseline||32
9072150|NCT03828734|10132999|FG001|COMPLETED|Baseline||26
9072151|NCT03828734|10132998|FG000|NOT COMPLETED|Baseline||0
9072152|NCT03828734|10132999|FG001|NOT COMPLETED|Baseline||0
9072153|NCT03828734|10132998|FG000|STARTED|Pre-Randomization (1 Week)||32
9072154|NCT03828734|10132999|FG001|STARTED|Pre-Randomization (1 Week)||26
9072155|NCT03828734|10132998|FG000|COMPLETED|Pre-Randomization (1 Week)||29
9072156|NCT03828734|10132999|FG001|COMPLETED|Pre-Randomization (1 Week)||25
9072157|NCT03828734|10132998|FG000|NOT COMPLETED|Pre-Randomization (1 Week)||3
9072158|NCT03828734|10132999|FG001|NOT COMPLETED|Pre-Randomization (1 Week)||1
9072159|NCT03828734|10132998|FG000|STARTED|First Intervention||29
9072160|NCT03828734|10132999|FG001|STARTED|First Intervention||25
9072161|NCT03828734|10132998|FG000|COMPLETED|First Intervention||25
9072162|NCT03828734|10132999|FG001|COMPLETED|First Intervention||25
9072163|NCT03828734|10132998|FG000|NOT COMPLETED|First Intervention||4
9072164|NCT03828734|10132999|FG001|NOT COMPLETED|First Intervention||0
9072165|NCT03828734|10132998|FG000|STARTED|First Washout (1 Week)||25
9072166|NCT03828734|10132999|FG001|STARTED|First Washout (1 Week)||25
9072167|NCT03828734|10132998|FG000|COMPLETED|First Washout (1 Week)||25
9072168|NCT03828734|10132999|FG001|COMPLETED|First Washout (1 Week)||24
9072169|NCT03828734|10132998|FG000|NOT COMPLETED|First Washout (1 Week)||0
9072170|NCT03828734|10132999|FG001|NOT COMPLETED|First Washout (1 Week)||1
9072171|NCT03828734|10132998|FG000|STARTED|Second Intervention||25
9072172|NCT03828734|10132999|FG001|STARTED|Second Intervention||24
9072173|NCT03828734|10132998|FG000|COMPLETED|Second Intervention||25
9072174|NCT03828734|10132999|FG001|COMPLETED|Second Intervention||24
9072175|NCT03828734|10132998|FG000|NOT COMPLETED|Second Intervention||0
9072176|NCT03828734|10132999|FG001|NOT COMPLETED|Second Intervention||0
9072177|NCT03827395|10133007|FG000|STARTED|Overall Study||20
9072178|NCT03827395|10133008|FG001|STARTED|Overall Study||5
9072179|NCT03827395|10133007|FG000|COMPLETED|Overall Study||17
9072180|NCT03827395|10133008|FG001|COMPLETED|Overall Study||3
9072181|NCT03827395|10133007|FG000|NOT COMPLETED|Overall Study||3
9072182|NCT03827395|10133008|FG001|NOT COMPLETED|Overall Study||2
9072183|NCT03819218|10133014|FG000|STARTED|Overall Study||7
9072184|NCT03819218|10133014|FG000|COMPLETED|Overall Study||6
9072185|NCT03819218|10133014|FG000|NOT COMPLETED|Overall Study||1
9072186|NCT03818815|10133020|FG000|STARTED|Overall Study||56
9072187|NCT03818815|10133021|FG001|STARTED|Overall Study||47
9072188|NCT03818815|10133020|FG000|COMPLETED|Overall Study||48
9072189|NCT03818815|10133021|FG001|COMPLETED|Overall Study||42
9072190|NCT03818815|10133020|FG000|NOT COMPLETED|Overall Study||8
9072191|NCT03818815|10133021|FG001|NOT COMPLETED|Overall Study||5
9072192|NCT03828487|10133027|FG000|STARTED|Overall Study||8
9072193|NCT03828487|10133027|FG000|COMPLETED|Overall Study||7
9072194|NCT03828487|10133027|FG000|NOT COMPLETED|Overall Study||1
9072195|NCT03828617|10133035|FG000|STARTED|Overall Study||489
9072196|NCT03828617|10133036|FG001|STARTED|Overall Study||490
9072197|NCT03828617|10133037|FG002|STARTED|Overall Study||486
9072198|NCT03828617|10133038|FG003|STARTED|Overall Study||245
9072199|NCT03828617|10133035|FG000|Vaccinated|Overall Study||488
9072200|NCT03828617|10133036|FG001|Vaccinated|Overall Study||489
9072201|NCT03828617|10133037|FG002|Vaccinated|Overall Study||486
9072202|NCT03828617|10133038|FG003|Vaccinated|Overall Study||245
9072203|NCT03828617|10133035|FG000|Safety Population|Overall Study||488
9072204|NCT03828617|10133036|FG001|Safety Population|Overall Study||489
9072205|NCT03828617|10133037|FG002|Safety Population|Overall Study||486
9072206|NCT03828617|10133038|FG003|Safety Population|Overall Study||245
9072207|NCT03828617|10133035|FG000|Evaluable Immunogenicity Population(EIP)|Overall Study||463
9072208|NCT03828617|10133036|FG001|Evaluable Immunogenicity Population(EIP)|Overall Study||473
9072209|NCT03828617|10133037|FG002|Evaluable Immunogenicity Population(EIP)|Overall Study||456
9072210|NCT03828617|10133038|FG003|Evaluable Immunogenicity Population(EIP)|Overall Study||232
9072211|NCT03828617|10133035|FG000|COMPLETED|Overall Study||465
9072212|NCT03828617|10133036|FG001|COMPLETED|Overall Study||475
9072213|NCT03828617|10133037|FG002|COMPLETED|Overall Study||460
9072214|NCT03828617|10133038|FG003|COMPLETED|Overall Study||235
9072215|NCT03828617|10133035|FG000|NOT COMPLETED|Overall Study||24
9072216|NCT03828617|10133036|FG001|NOT COMPLETED|Overall Study||15
9072217|NCT03828617|10133037|FG002|NOT COMPLETED|Overall Study||26
9072218|NCT03828617|10133038|FG003|NOT COMPLETED|Overall Study||10
9072219|NCT03828539|10133049|FG000|STARTED|Overall Study||389
9072220|NCT03828539|10133050|FG001|STARTED|Overall Study||388
9072221|NCT03828539|10133049|FG000|Full Analysis Set (FAS)|Overall Study||388
9072222|NCT03828539|10133050|FG001|Full Analysis Set (FAS)|Overall Study||388
9072223|NCT03828539|10133049|FG000|Safety Analysis Set (SAF)|Overall Study||388
9072224|NCT03828539|10133050|FG001|Safety Analysis Set (SAF)|Overall Study||388
9072225|NCT03828539|10133049|FG000|COMPLETED|Overall Study||373
9072226|NCT03828539|10133050|FG001|COMPLETED|Overall Study||366
9072227|NCT03828539|10133049|FG000|NOT COMPLETED|Overall Study||16
9072228|NCT03828539|10133050|FG001|NOT COMPLETED|Overall Study||22
9072229|NCT03824704|10133056|FG000|STARTED|Overall Study||1
9072230|NCT03824704|10133056|FG000|COMPLETED|Overall Study||0
9072231|NCT03824704|10133056|FG000|NOT COMPLETED|Overall Study||1
9072232|NCT03823937|10133062|FG000|STARTED|Overall Study||30
9072233|NCT03823937|10133063|FG001|STARTED|Overall Study||20
9072234|NCT03823937|10133062|FG000|COMPLETED|Overall Study||30
9072235|NCT03823937|10133063|FG001|COMPLETED|Overall Study||20
9072236|NCT03823937|10133062|FG000|NOT COMPLETED|Overall Study||0
9072237|NCT03823937|10133063|FG001|NOT COMPLETED|Overall Study||0
9072238|NCT03817879|10133071|FG000|STARTED|Overall Study||35
9072239|NCT03817879|10133072|FG001|STARTED|Overall Study||35
9072240|NCT03817879|10133071|FG000|COMPLETED|Overall Study||30
9072241|NCT03817879|10133072|FG001|COMPLETED|Overall Study||22
9072242|NCT03817879|10133071|FG000|NOT COMPLETED|Overall Study||5
9072243|NCT03817879|10133072|FG001|NOT COMPLETED|Overall Study||13
9072244|NCT03811834|10133078|FG000|STARTED|Period 1 ( 7 Days)||7
9072245|NCT03811834|10133078|FG000|COMPLETED|Period 1 ( 7 Days)||6
9072246|NCT03811834|10133078|FG000|NOT COMPLETED|Period 1 ( 7 Days)||1
9072247|NCT03811834|10133078|FG000|STARTED|Washout Period (9 Days)||6
9072248|NCT03811834|10133078|FG000|COMPLETED|Washout Period (9 Days)||6
9072249|NCT03811834|10133078|FG000|NOT COMPLETED|Washout Period (9 Days)||0
9072250|NCT03811834|10133078|FG000|STARTED|Period 2 (10 Days)||6
9072251|NCT03811834|10133078|FG000|COMPLETED|Period 2 (10 Days)||6
9072252|NCT03811834|10133078|FG000|NOT COMPLETED|Period 2 (10 Days)||0
9072253|NCT03806127|10133093|FG000|STARTED|Overall Study||111
9072254|NCT03806127|10133094|FG001|STARTED|Overall Study||111
9072255|NCT03806127|10133093|FG000|COMPLETED|Overall Study||90
9072256|NCT03806127|10133094|FG001|COMPLETED|Overall Study||99
9072257|NCT03806127|10133093|FG000|NOT COMPLETED|Overall Study||21
9072258|NCT03806127|10133094|FG001|NOT COMPLETED|Overall Study||12
9072259|NCT03827473|10133102|FG000|STARTED|Overall Study||1
9072260|NCT03827473|10133103|FG001|STARTED|Overall Study||0
9072261|NCT03827473|10133102|FG000|COMPLETED|Overall Study||0
9072262|NCT03827473|10133103|FG001|COMPLETED|Overall Study||0
9072263|NCT03827473|10133102|FG000|NOT COMPLETED|Overall Study||1
9072264|NCT03827473|10133103|FG001|NOT COMPLETED|Overall Study||0
9072265|NCT03826914|10133111|FG000|STARTED|Overall Study||35
9072266|NCT03826914|10133112|FG001|STARTED|Overall Study||34
9072267|NCT03826914|10133111|FG000|COMPLETED|Overall Study||34
9072268|NCT03826914|10133112|FG001|COMPLETED|Overall Study||33
9072269|NCT03826914|10133111|FG000|NOT COMPLETED|Overall Study||1
9072270|NCT03826914|10133112|FG001|NOT COMPLETED|Overall Study||1
9072271|NCT03812328|10133123|FG000|STARTED|Overall Study||55
9072272|NCT03812328|10133124|FG001|STARTED|Overall Study||63
9072273|NCT03812328|10133125|FG002|STARTED|Overall Study||89
9072274|NCT03812328|10133123|FG000|Modified Intent-to-Treat (mITT) Population|Overall Study||48
9072275|NCT03812328|10133124|FG001|Modified Intent-to-Treat (mITT) Population|Overall Study||61
9072276|NCT03812328|10133125|FG002|Modified Intent-to-Treat (mITT) Population|Overall Study||84
9072277|NCT03812328|10133123|FG000|Safety Population|Overall Study||55
9072278|NCT03812328|10133124|FG001|Safety Population|Overall Study||63
9072279|NCT03812328|10133125|FG002|Safety Population|Overall Study||88
9072280|NCT03812328|10133123|FG000|COMPLETED|Overall Study||55
9072281|NCT03812328|10133124|FG001|COMPLETED|Overall Study||60
9072282|NCT03812328|10133125|FG002|COMPLETED|Overall Study||88
9072283|NCT03812328|10133123|FG000|NOT COMPLETED|Overall Study||0
9072284|NCT03812328|10133124|FG001|NOT COMPLETED|Overall Study||3
9072285|NCT03812328|10133125|FG002|NOT COMPLETED|Overall Study||1
9072286|NCT03808688|10133135|FG000|STARTED|Overall Study||99
9072287|NCT03808688|10133136|FG001|STARTED|Overall Study||161
9072288|NCT03808688|10133135|FG000|COMPLETED|Overall Study||81
9072289|NCT03808688|10133136|FG001|COMPLETED|Overall Study||138
9072290|NCT03808688|10133135|FG000|NOT COMPLETED|Overall Study||18
9072291|NCT03808688|10133136|FG001|NOT COMPLETED|Overall Study||23
9072292|NCT03811093|10133146|FG000|STARTED|Overall Study||20
9072293|NCT03811093|10133147|FG001|STARTED|Overall Study||19
9072294|NCT03811093|10133146|FG000|COMPLETED|Overall Study||18
9072295|NCT03811093|10133147|FG001|COMPLETED|Overall Study||15
9072296|NCT03811093|10133146|FG000|NOT COMPLETED|Overall Study||2
9072297|NCT03811093|10133147|FG001|NOT COMPLETED|Overall Study||4
9072298|NCT03822182|10133159|FG000|STARTED|Overall Study||26
9072299|NCT03822182|10133160|FG001|STARTED|Overall Study||25
9072300|NCT03822182|10133161|FG002|STARTED|Overall Study||27
9072301|NCT03822182|10133159|FG000|COMPLETED|Overall Study||26
9072302|NCT03822182|10133160|FG001|COMPLETED|Overall Study||24
9072303|NCT03822182|10133161|FG002|COMPLETED|Overall Study||26
9072304|NCT03822182|10133159|FG000|NOT COMPLETED|Overall Study||0
9072305|NCT03822182|10133160|FG001|NOT COMPLETED|Overall Study||1
9072306|NCT03822182|10133161|FG002|NOT COMPLETED|Overall Study||1
9072307|NCT03822416|10133172|FG000|STARTED|Overall Study||19
9072308|NCT03822416|10133173|FG001|STARTED|Overall Study||19
9072309|NCT03822416|10133172|FG000|COMPLETED|Overall Study||18
9072310|NCT03822416|10133173|FG001|COMPLETED|Overall Study||18
9072311|NCT03822416|10133172|FG000|NOT COMPLETED|Overall Study||1
9072312|NCT03822416|10133173|FG001|NOT COMPLETED|Overall Study||1
9072313|NCT03809104|10133179|FG000|STARTED|Overall Study||43
9072314|NCT03809104|10133179|FG000|COMPLETED|Overall Study||40
9072315|NCT03809104|10133179|FG000|NOT COMPLETED|Overall Study||3
9072316|NCT03807089|10133185|FG000|STARTED|Overall Study||101
9072317|NCT03807089|10133186|FG001|STARTED|Overall Study||93
9072318|NCT03807089|10133185|FG000|COMPLETED|Overall Study||101
9072319|NCT03807089|10133186|FG001|COMPLETED|Overall Study||93
9072320|NCT03807089|10133185|FG000|NOT COMPLETED|Overall Study||0
9072321|NCT03807089|10133186|FG001|NOT COMPLETED|Overall Study||0
9072322|NCT03806231|10133194|FG000|STARTED|Overall Study||4
9072323|NCT03806231|10133195|FG001|STARTED|Overall Study||4
9072324|NCT03806231|10133194|FG000|COMPLETED|Overall Study||2
9072325|NCT03806231|10133195|FG001|COMPLETED|Overall Study||4
9072326|NCT03806231|10133194|FG000|NOT COMPLETED|Overall Study||2
9072327|NCT03806231|10133195|FG001|NOT COMPLETED|Overall Study||0
9072328|NCT03804710|10133203|FG000|STARTED|Overall Study||75
9072329|NCT03804710|10133204|FG001|STARTED|Overall Study||74
9072330|NCT03804710|10133203|FG000|COMPLETED|Overall Study||73
9072331|NCT03804710|10133204|FG001|COMPLETED|Overall Study||69
9072332|NCT03804710|10133203|FG000|NOT COMPLETED|Overall Study||2
9072333|NCT03804710|10133204|FG001|NOT COMPLETED|Overall Study||5
9072334|NCT03822377|10133216|FG000|STARTED|Overall Study||65
9072335|NCT03822377|10133217|FG001|STARTED|Overall Study||65
9072336|NCT03822377|10133216|FG000|COMPLETED|Overall Study||65
9072337|NCT03822377|10133217|FG001|COMPLETED|Overall Study||65
9072338|NCT03822377|10133216|FG000|NOT COMPLETED|Overall Study||0
9072339|NCT03822377|10133217|FG001|NOT COMPLETED|Overall Study||0
9072340|NCT03820388|10133228|FG000|STARTED|Overall Study||25
9072341|NCT03820388|10133229|FG001|STARTED|Overall Study||25
9072342|NCT03820388|10133230|FG002|STARTED|Overall Study||25
9072343|NCT03820388|10133228|FG000|COMPLETED|Overall Study||25
9072344|NCT03820388|10133229|FG001|COMPLETED|Overall Study||25
9072345|NCT03820388|10133230|FG002|COMPLETED|Overall Study||25
9072346|NCT03820388|10133228|FG000|NOT COMPLETED|Overall Study||0
9072347|NCT03820388|10133229|FG001|NOT COMPLETED|Overall Study||0
9072348|NCT03820388|10133230|FG002|NOT COMPLETED|Overall Study||0
9072349|NCT03816696|10133238|FG000|STARTED|Period 1 (Up to Day 5)||16
9072350|NCT03816696|10133238|FG000|COMPLETED|Period 1 (Up to Day 5)||16
9072351|NCT03816696|10133238|FG000|NOT COMPLETED|Period 1 (Up to Day 5)||0
9072352|NCT03816696|10133238|FG000|STARTED|Wash Out Period (Days 6 to 9)||16
9072353|NCT03816696|10133238|FG000|COMPLETED|Wash Out Period (Days 6 to 9)||16
9072354|NCT03816696|10133238|FG000|NOT COMPLETED|Wash Out Period (Days 6 to 9)||0
9072355|NCT03816696|10133238|FG000|STARTED|Period 2 (Up to Day 7)||16
9072356|NCT03816696|10133238|FG000|COMPLETED|Period 2 (Up to Day 7)||16
9072357|NCT03816696|10133238|FG000|NOT COMPLETED|Period 2 (Up to Day 7)||0
9072358|NCT03816696|10133238|FG000|STARTED|Period 3 (Up to Day 11)||16
9072359|NCT03816696|10133238|FG000|COMPLETED|Period 3 (Up to Day 11)||16
9072360|NCT03816696|10133238|FG000|NOT COMPLETED|Period 3 (Up to Day 11)||0
9072361|NCT03821064|10133248|FG000|STARTED|Overall Study||11
9072362|NCT03821064|10133248|FG000|COMPLETED|Overall Study||10
9072363|NCT03821064|10133248|FG000|NOT COMPLETED|Overall Study||1
9072364|NCT03820544|10133254|FG000|STARTED|Overall Study||2
9072365|NCT03820544|10133255|FG001|STARTED|Overall Study||2
9072366|NCT03820544|10133254|FG000|COMPLETED|Overall Study||2
9072367|NCT03820544|10133255|FG001|COMPLETED|Overall Study||2
9072368|NCT03820544|10133254|FG000|NOT COMPLETED|Overall Study||0
9072369|NCT03820544|10133255|FG001|NOT COMPLETED|Overall Study||0
9072370|NCT03820024|10133263|FG000|STARTED|Overall Study||19
9072371|NCT03820024|10133264|FG001|STARTED|Overall Study||20
9072372|NCT03820024|10133263|FG000|COMPLETED|Overall Study||18
9072373|NCT03820024|10133264|FG001|COMPLETED|Overall Study||18
9072374|NCT03820024|10133263|FG000|NOT COMPLETED|Overall Study||1
9072375|NCT03820024|10133264|FG001|NOT COMPLETED|Overall Study||2
9072376|NCT03807544|10133270|FG000|STARTED|Overall Study||17
9072377|NCT03807544|10133270|FG000|COMPLETED|Overall Study||17
9072378|NCT03807544|10133270|FG000|NOT COMPLETED|Overall Study||0
9072379|NCT03809182|10133277|FG000|STARTED|Overall Study||20
9072380|NCT03809182|10133278|FG001|STARTED|Overall Study||20
9072381|NCT03809182|10133277|FG000|COMPLETED|Overall Study||20
9072382|NCT03809182|10133278|FG001|COMPLETED|Overall Study||20
9072383|NCT03809182|10133277|FG000|NOT COMPLETED|Overall Study||0
9072384|NCT03809182|10133278|FG001|NOT COMPLETED|Overall Study||0
8624079|NCT00498433|9663348|FG002|STARTED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
8624080|NCT00498433|9663346|FG000|COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||10
8624081|NCT00498433|9663347|FG001|COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
8624082|NCT00498433|9663348|FG002|COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
8624083|NCT00498433|9663346|FG000|NOT COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
8624084|NCT00498433|9663347|FG001|NOT COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
9072385|NCT03816761|10133289|FG000|STARTED|First Treatment Period (7 Days)||4
9072386|NCT03816761|10133290|FG001|STARTED|First Treatment Period (7 Days)||4
9072387|NCT03816761|10133291|FG002|STARTED|First Treatment Period (7 Days)||4
9072388|NCT03816761|10133292|FG003|STARTED|First Treatment Period (7 Days)||4
9072389|NCT03816761|10133293|FG004|STARTED|First Treatment Period (7 Days)||4
9072390|NCT03816761|10133294|FG005|STARTED|First Treatment Period (7 Days)||4
9072391|NCT03816761|10133289|FG000|COMPLETED|First Treatment Period (7 Days)||4
9072392|NCT03816761|10133290|FG001|COMPLETED|First Treatment Period (7 Days)||4
9072393|NCT03816761|10133291|FG002|COMPLETED|First Treatment Period (7 Days)||4
9072394|NCT03816761|10133292|FG003|COMPLETED|First Treatment Period (7 Days)||4
9072395|NCT03816761|10133293|FG004|COMPLETED|First Treatment Period (7 Days)||4
9072396|NCT03816761|10133294|FG005|COMPLETED|First Treatment Period (7 Days)||3
9072397|NCT03816761|10133289|FG000|NOT COMPLETED|First Treatment Period (7 Days)||0
9072398|NCT03816761|10133290|FG001|NOT COMPLETED|First Treatment Period (7 Days)||0
9072399|NCT03816761|10133291|FG002|NOT COMPLETED|First Treatment Period (7 Days)||0
9072400|NCT03816761|10133292|FG003|NOT COMPLETED|First Treatment Period (7 Days)||0
9072401|NCT03816761|10133293|FG004|NOT COMPLETED|First Treatment Period (7 Days)||0
9072402|NCT03816761|10133294|FG005|NOT COMPLETED|First Treatment Period (7 Days)||1
9072403|NCT03816761|10133289|FG000|STARTED|Second Treatment Period (7 Days)||4
9072404|NCT03816761|10133290|FG001|STARTED|Second Treatment Period (7 Days)||4
9072405|NCT03816761|10133291|FG002|STARTED|Second Treatment Period (7 Days)||4
9072406|NCT03816761|10133292|FG003|STARTED|Second Treatment Period (7 Days)||4
9072407|NCT03816761|10133293|FG004|STARTED|Second Treatment Period (7 Days)||4
9072408|NCT03816761|10133294|FG005|STARTED|Second Treatment Period (7 Days)||3
9072409|NCT03816761|10133289|FG000|COMPLETED|Second Treatment Period (7 Days)||4
9072410|NCT03816761|10133290|FG001|COMPLETED|Second Treatment Period (7 Days)||4
9072411|NCT03816761|10133291|FG002|COMPLETED|Second Treatment Period (7 Days)||4
9072412|NCT03816761|10133292|FG003|COMPLETED|Second Treatment Period (7 Days)||3
9072413|NCT03816761|10133293|FG004|COMPLETED|Second Treatment Period (7 Days)||4
9072414|NCT03816761|10133294|FG005|COMPLETED|Second Treatment Period (7 Days)||3
9072415|NCT03816761|10133289|FG000|NOT COMPLETED|Second Treatment Period (7 Days)||0
9072416|NCT03816761|10133290|FG001|NOT COMPLETED|Second Treatment Period (7 Days)||0
9072417|NCT03816761|10133291|FG002|NOT COMPLETED|Second Treatment Period (7 Days)||0
9072418|NCT03816761|10133292|FG003|NOT COMPLETED|Second Treatment Period (7 Days)||1
9072419|NCT03816761|10133293|FG004|NOT COMPLETED|Second Treatment Period (7 Days)||0
9072420|NCT03816761|10133294|FG005|NOT COMPLETED|Second Treatment Period (7 Days)||0
9072421|NCT03801044|10133316|FG000|STARTED|Overall Study||21
9072422|NCT03801044|10133316|FG000|COMPLETED|Overall Study||21
9072423|NCT03801044|10133316|FG000|NOT COMPLETED|Overall Study||0
9072424|NCT03805672|10133326|FG000|STARTED|Overall Study||2
9072425|NCT03805672|10133327|FG001|STARTED|Overall Study||2
9072426|NCT03805672|10133326|FG000|COMPLETED|Overall Study||2
9072427|NCT03805672|10133327|FG001|COMPLETED|Overall Study||2
9072428|NCT03805672|10133326|FG000|NOT COMPLETED|Overall Study||0
9072429|NCT03805672|10133327|FG001|NOT COMPLETED|Overall Study||0
9072430|NCT03808493|10133337|FG000|STARTED|Overall Study||12
9072431|NCT03808493|10133338|FG001|STARTED|Overall Study||12
9072432|NCT03808493|10133339|FG002|STARTED|Overall Study||12
9072433|NCT03808493|10133340|FG003|STARTED|Overall Study||12
9072434|NCT03808493|10133337|FG000|COMPLETED|Overall Study||12
9072435|NCT03808493|10133338|FG001|COMPLETED|Overall Study||12
9072436|NCT03808493|10133339|FG002|COMPLETED|Overall Study||12
9072437|NCT03808493|10133340|FG003|COMPLETED|Overall Study||12
9072438|NCT03808493|10133337|FG000|NOT COMPLETED|Overall Study||0
9072439|NCT03808493|10133338|FG001|NOT COMPLETED|Overall Study||0
9072440|NCT03808493|10133339|FG002|NOT COMPLETED|Overall Study||0
9072441|NCT03808493|10133340|FG003|NOT COMPLETED|Overall Study||0
9072442|NCT03815292|10133352|FG000|STARTED|Overall Study||135
9072443|NCT03815292|10133353|FG001|STARTED|Overall Study||140
9072444|NCT03815292|10133352|FG000|COMPLETED|Overall Study||135
9072445|NCT03815292|10133353|FG001|COMPLETED|Overall Study||140
9072446|NCT03815292|10133352|FG000|NOT COMPLETED|Overall Study||0
9072447|NCT03815292|10133353|FG001|NOT COMPLETED|Overall Study||0
9072448|NCT03812510|10133359|FG000|STARTED|Overall Study||426
9072449|NCT03812510|10133359|FG000|COMPLETED|Overall Study||274
9072450|NCT03812510|10133359|FG000|NOT COMPLETED|Overall Study||152
9072451|NCT03802994|10133369|FG000|STARTED|Overall Study||9
9072452|NCT03802994|10133370|FG001|STARTED|Overall Study||12
9072453|NCT03802994|10133371|FG002|STARTED|Overall Study||15
9072454|NCT03802994|10133372|FG003|STARTED|Overall Study||11
9072455|NCT03802994|10133373|FG004|STARTED|Overall Study||10
9072456|NCT03802994|10133369|FG000|COMPLETED|Overall Study||9
9072457|NCT03802994|10133370|FG001|COMPLETED|Overall Study||10
9072458|NCT03802994|10133371|FG002|COMPLETED|Overall Study||12
9072459|NCT03802994|10133372|FG003|COMPLETED|Overall Study||9
9072460|NCT03802994|10133373|FG004|COMPLETED|Overall Study||8
9072461|NCT03802994|10133369|FG000|NOT COMPLETED|Overall Study||0
9072462|NCT03802994|10133370|FG001|NOT COMPLETED|Overall Study||2
9072463|NCT03802994|10133371|FG002|NOT COMPLETED|Overall Study||3
9072464|NCT03802994|10133372|FG003|NOT COMPLETED|Overall Study||2
9072465|NCT03802994|10133373|FG004|NOT COMPLETED|Overall Study||2
9072466|NCT03810183|10133398|FG000|STARTED|Overall Study||6
9072467|NCT03810183|10133399|FG001|STARTED|Overall Study||3
9072468|NCT03810183|10133398|FG000|COMPLETED|Overall Study||4
9072469|NCT03810183|10133399|FG001|COMPLETED|Overall Study||2
9072470|NCT03810183|10133398|FG000|NOT COMPLETED|Overall Study||2
9072471|NCT03810183|10133399|FG001|NOT COMPLETED|Overall Study||1
9072472|NCT03809910|10133406|FG000|STARTED|Period 1 (Visit 2)||20
9072473|NCT03809910|10133407|FG001|STARTED|Period 1 (Visit 2)||19
9072474|NCT03809910|10133406|FG000|COMPLETED|Period 1 (Visit 2)||20
9072475|NCT03809910|10133407|FG001|COMPLETED|Period 1 (Visit 2)||19
9072476|NCT03809910|10133406|FG000|NOT COMPLETED|Period 1 (Visit 2)||0
9072477|NCT03809910|10133407|FG001|NOT COMPLETED|Period 1 (Visit 2)||0
9072478|NCT03809910|10133406|FG000|STARTED|Washout Period 1 (3 Days)||20
9072479|NCT03809910|10133407|FG001|STARTED|Washout Period 1 (3 Days)||19
9072480|NCT03809910|10133406|FG000|COMPLETED|Washout Period 1 (3 Days)||20
9072481|NCT03809910|10133407|FG001|COMPLETED|Washout Period 1 (3 Days)||19
9072482|NCT03809910|10133406|FG000|NOT COMPLETED|Washout Period 1 (3 Days)||0
9072483|NCT03809910|10133407|FG001|NOT COMPLETED|Washout Period 1 (3 Days)||0
9072484|NCT03809910|10133406|FG000|STARTED|Period 2 (Visit 3)||20
9072485|NCT03809910|10133407|FG001|STARTED|Period 2 (Visit 3)||19
9072486|NCT03809910|10133406|FG000|COMPLETED|Period 2 (Visit 3)||20
9072487|NCT03809910|10133407|FG001|COMPLETED|Period 2 (Visit 3)||19
9072488|NCT03809910|10133406|FG000|NOT COMPLETED|Period 2 (Visit 3)||0
9072489|NCT03809910|10133407|FG001|NOT COMPLETED|Period 2 (Visit 3)||0
9072490|NCT03809910|10133406|FG000|STARTED|Washout Period 2 (3 Days)||20
9072491|NCT03809910|10133407|FG001|STARTED|Washout Period 2 (3 Days)||19
9072492|NCT03809910|10133406|FG000|COMPLETED|Washout Period 2 (3 Days)||20
9072493|NCT03809910|10133407|FG001|COMPLETED|Washout Period 2 (3 Days)||19
9072494|NCT03809910|10133406|FG000|NOT COMPLETED|Washout Period 2 (3 Days)||0
9072495|NCT03809910|10133407|FG001|NOT COMPLETED|Washout Period 2 (3 Days)||0
9072496|NCT03809910|10133406|FG000|STARTED|Period 3 (Visit 4)||20
9072497|NCT03809910|10133407|FG001|STARTED|Period 3 (Visit 4)||19
9072498|NCT03809910|10133406|FG000|COMPLETED|Period 3 (Visit 4)||20
9072499|NCT03809910|10133407|FG001|COMPLETED|Period 3 (Visit 4)||19
9072500|NCT03809910|10133406|FG000|NOT COMPLETED|Period 3 (Visit 4)||0
9072501|NCT03809910|10133407|FG001|NOT COMPLETED|Period 3 (Visit 4)||0
9072502|NCT03806790|10133419|FG000|STARTED|Overall Study||87
9072503|NCT03806790|10133420|FG001|STARTED|Overall Study||95
9072504|NCT03806790|10133419|FG000|COMPLETED|Overall Study||87
9072505|NCT03806790|10133420|FG001|COMPLETED|Overall Study||95
9072506|NCT03806790|10133419|FG000|NOT COMPLETED|Overall Study||0
9072507|NCT03806790|10133420|FG001|NOT COMPLETED|Overall Study||0
9072508|NCT03807245|10133429|FG000|STARTED|Overall Study||24
9072509|NCT03807245|10133430|FG001|STARTED|Overall Study||24
9072510|NCT03807245|10133431|FG002|STARTED|Overall Study||12
9072511|NCT03807245|10133429|FG000|COMPLETED|Overall Study||23
9072512|NCT03807245|10133430|FG001|COMPLETED|Overall Study||24
9072513|NCT03807245|10133431|FG002|COMPLETED|Overall Study||12
9072514|NCT03807245|10133429|FG000|NOT COMPLETED|Overall Study||1
9072515|NCT03807245|10133430|FG001|NOT COMPLETED|Overall Study||0
9072516|NCT03807245|10133431|FG002|NOT COMPLETED|Overall Study||0
9072517|NCT03805971|10133439|FG000|STARTED|Overall Study||65
9072518|NCT03805971|10133439|FG000|COMPLETED|Overall Study||62
9072519|NCT03805971|10133439|FG000|NOT COMPLETED|Overall Study||3
9072520|NCT03802916|10133446|FG000|STARTED|Overall Study||15
9072521|NCT03802916|10133447|FG001|STARTED|Overall Study||15
9072522|NCT03802916|10133446|FG000|COMPLETED|Overall Study||15
9072523|NCT03802916|10133447|FG001|COMPLETED|Overall Study||13
9072524|NCT03802916|10133446|FG000|NOT COMPLETED|Overall Study||0
9072525|NCT03802916|10133447|FG001|NOT COMPLETED|Overall Study||2
9072526|NCT03809039|10133464|FG000|STARTED|Part 1|11 subjects (2 subjects in each of Part 1 MT-6345 1 mg, 5 mg, 20 mg, 60 mg, 240 mg, and 1 subject in Part 1 MT-6345 120 mg) received a matching placebo per their respective dose. The subjects are unique subjects, and were not counted more than once across any arms except for Part 2 Placebo.|11
9072527|NCT03809039|10133465|FG001|STARTED|Part 1|The subjects are unique subjects, and were not counted more than once across any arms.|6
9072528|NCT03809039|10133466|FG002|STARTED|Part 1|The subjects are unique subjects, and were not counted more than once across any arms.|6
9072529|NCT03809039|10133467|FG003|STARTED|Part 1|The subjects are unique subjects, and were not counted more than once across any arms except for Part 2 MT-6345 20mg.|6
9072530|NCT03809039|10133468|FG004|STARTED|Part 1|The subjects are unique subjects, and were not counted more than once across any arms.|6
9072531|NCT03809039|10133469|FG005|STARTED|Part 1|The subjects are unique subjects, and were not counted more than once across any arms.|4
9072532|NCT03809039|10133470|FG006|STARTED|Part 1|The subjects are unique subjects, and were not counted more than once across any arms.|5
9072533|NCT03809039|10133471|FG007|STARTED|Part 1||0
9072534|NCT03809039|10133472|FG008|STARTED|Part 1||0
9072535|NCT03809039|10133464|FG000|COMPLETED|Part 1||10
9072536|NCT03809039|10133465|FG001|COMPLETED|Part 1||6
9072537|NCT03809039|10133466|FG002|COMPLETED|Part 1||6
9072538|NCT03809039|10133467|FG003|COMPLETED|Part 1||5
9072539|NCT03809039|10133468|FG004|COMPLETED|Part 1||6
9072540|NCT03809039|10133469|FG005|COMPLETED|Part 1||4
9072541|NCT03809039|10133470|FG006|COMPLETED|Part 1||5
9072542|NCT03809039|10133471|FG007|COMPLETED|Part 1||0
9072543|NCT03809039|10133472|FG008|COMPLETED|Part 1||0
9072544|NCT03809039|10133464|FG000|NOT COMPLETED|Part 1||1
9072545|NCT03809039|10133465|FG001|NOT COMPLETED|Part 1||0
9072546|NCT03809039|10133466|FG002|NOT COMPLETED|Part 1||0
9072547|NCT03809039|10133467|FG003|NOT COMPLETED|Part 1||1
9072548|NCT03809039|10133468|FG004|NOT COMPLETED|Part 1||0
9072549|NCT03809039|10133469|FG005|NOT COMPLETED|Part 1||0
9072550|NCT03809039|10133470|FG006|NOT COMPLETED|Part 1||0
9072551|NCT03809039|10133471|FG007|NOT COMPLETED|Part 1||0
9072552|NCT03809039|10133472|FG008|NOT COMPLETED|Part 1||0
9072553|NCT03809039|10133464|FG000|STARTED|Part 2|2 subjects who received a matching placebo per Part 1 MT-6345 20mg were selected to return for Part 2. Out of 2 subjects, only 1 subject received the placebo, and another subject withdrew the consent after Part 1. Therefore, this 1 subject is not a unique subject and was not counted again in the total number of exposed subjects.|1
9072554|NCT03809039|10133465|FG001|STARTED|Part 2||0
9072555|NCT03809039|10133466|FG002|STARTED|Part 2||0
9072556|NCT03809039|10133467|FG003|STARTED|Part 2|6 subjects in Part 1 MT-6345 20mg were selected to return for Part 2. Out of 6 subjects, only 5 subjects received MT-6345, and 1 subject withdrew the consent after Part 1. Therefore, these 5 subjects are not a unique subject and were not counted again in the total number of exposed subjects.|5
9072557|NCT03809039|10133468|FG004|STARTED|Part 2||0
9072558|NCT03809039|10133469|FG005|STARTED|Part 2||0
9072559|NCT03809039|10133470|FG006|STARTED|Part 2||0
9072560|NCT03809039|10133471|FG007|STARTED|Part 2||0
9072561|NCT03809039|10133472|FG008|STARTED|Part 2||0
9072562|NCT03809039|10133464|FG000|COMPLETED|Part 2||1
9072563|NCT03809039|10133465|FG001|COMPLETED|Part 2||0
9072564|NCT03809039|10133466|FG002|COMPLETED|Part 2||0
9072565|NCT03809039|10133467|FG003|COMPLETED|Part 2||5
9072566|NCT03809039|10133468|FG004|COMPLETED|Part 2||0
9072567|NCT03809039|10133469|FG005|COMPLETED|Part 2||0
9072568|NCT03809039|10133470|FG006|COMPLETED|Part 2||0
9072569|NCT03809039|10133471|FG007|COMPLETED|Part 2||0
9072570|NCT03809039|10133472|FG008|COMPLETED|Part 2||0
9072571|NCT03809039|10133464|FG000|NOT COMPLETED|Part 2||0
9072572|NCT03809039|10133465|FG001|NOT COMPLETED|Part 2||0
9072573|NCT03809039|10133466|FG002|NOT COMPLETED|Part 2||0
9072574|NCT03809039|10133467|FG003|NOT COMPLETED|Part 2||0
9072575|NCT03809039|10133468|FG004|NOT COMPLETED|Part 2||0
9072576|NCT03809039|10133469|FG005|NOT COMPLETED|Part 2||0
9072577|NCT03809039|10133470|FG006|NOT COMPLETED|Part 2||0
9072578|NCT03809039|10133471|FG007|NOT COMPLETED|Part 2||0
9072579|NCT03809039|10133472|FG008|NOT COMPLETED|Part 2||0
9072580|NCT03809039|10133464|FG000|STARTED|Part 3||0
9072581|NCT03809039|10133465|FG001|STARTED|Part 3||0
9072582|NCT03809039|10133466|FG002|STARTED|Part 3||0
9072583|NCT03809039|10133467|FG003|STARTED|Part 3||0
9072584|NCT03809039|10133468|FG004|STARTED|Part 3||0
9072585|NCT03809039|10133469|FG005|STARTED|Part 3||0
9072586|NCT03809039|10133470|FG006|STARTED|Part 3||0
9072587|NCT03809039|10133471|FG007|STARTED|Part 3|The subjects are unique subjects, and were not counted more than once across any arms.|2
9072588|NCT03809039|10133472|FG008|STARTED|Part 3|The subjects are unique subjects, and were not counted more than once across any arms.|6
9072589|NCT03809039|10133464|FG000|COMPLETED|Part 3||0
9072590|NCT03809039|10133465|FG001|COMPLETED|Part 3||0
9072591|NCT03809039|10133466|FG002|COMPLETED|Part 3||0
9072592|NCT03809039|10133467|FG003|COMPLETED|Part 3||0
9072593|NCT03809039|10133468|FG004|COMPLETED|Part 3||0
9072594|NCT03809039|10133469|FG005|COMPLETED|Part 3||0
9072595|NCT03809039|10133470|FG006|COMPLETED|Part 3||0
9072596|NCT03809039|10133471|FG007|COMPLETED|Part 3||0
9072597|NCT03809039|10133472|FG008|COMPLETED|Part 3||0
9072598|NCT03809039|10133464|FG000|NOT COMPLETED|Part 3||0
9072599|NCT03809039|10133465|FG001|NOT COMPLETED|Part 3||0
9072600|NCT03809039|10133466|FG002|NOT COMPLETED|Part 3||0
9072601|NCT03809039|10133467|FG003|NOT COMPLETED|Part 3||0
9072602|NCT03809039|10133468|FG004|NOT COMPLETED|Part 3||0
9072603|NCT03809039|10133469|FG005|NOT COMPLETED|Part 3||0
8624085|NCT00498433|9663348|FG002|NOT COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
8624086|NCT00498433|9663346|FG000|STARTED|Part 1, Period 2: Aliskiren (4 Weeks)||0
8624087|NCT00498433|9663347|FG001|STARTED|Part 1, Period 2: Aliskiren (4 Weeks)||10
8624088|NCT00498433|9663348|FG002|STARTED|Part 1, Period 2: Aliskiren (4 Weeks)||0
8624089|NCT00498433|9663346|FG000|COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
8624090|NCT00498433|9663347|FG001|COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||10
8624091|NCT00498433|9663348|FG002|COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
8624092|NCT00498433|9663346|FG000|NOT COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
8624093|NCT00498433|9663347|FG001|NOT COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
8624094|NCT00498433|9663348|FG002|NOT COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
8624095|NCT00498433|9663346|FG000|STARTED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
8624096|NCT00498433|9663347|FG001|STARTED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
8624097|NCT00498433|9663348|FG002|STARTED|Part 1, Period 3: Amlodipine (4-8 Weeks)||10
8624098|NCT00498433|9663346|FG000|COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
8624099|NCT00498433|9663347|FG001|COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
8624100|NCT00498433|9663348|FG002|COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||10
8624101|NCT00498433|9663346|FG000|NOT COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
8624102|NCT00498433|9663347|FG001|NOT COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
8624103|NCT00498433|9663348|FG002|NOT COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
8624104|NCT00498433|9663346|FG000|STARTED|Part 2: Placebo Run-in (2 Weeks)||36
8842994|NCT01701258|9897262|FG004|COMPLETED|PET (Session 3)||16
8842995|NCT01701258|9897263|FG005|COMPLETED|PET (Session 3)||0
8842996|NCT01701258|9897264|FG006|COMPLETED|PET (Session 3)||0
8842997|NCT01701258|9897265|FG007|COMPLETED|PET (Session 3)||19
9072604|NCT03809039|10133470|FG006|NOT COMPLETED|Part 3||0
9072605|NCT03809039|10133471|FG007|NOT COMPLETED|Part 3||2
9072606|NCT03809039|10133472|FG008|NOT COMPLETED|Part 3||6
9072607|NCT03807700|10133507|FG000|STARTED|Overall Study||60
9072608|NCT03807700|10133508|FG001|STARTED|Overall Study||59
9072609|NCT03807700|10133507|FG000|COMPLETED|Overall Study||58
9072610|NCT03807700|10133508|FG001|COMPLETED|Overall Study||58
9072611|NCT03807700|10133507|FG000|NOT COMPLETED|Overall Study||2
9072612|NCT03807700|10133508|FG001|NOT COMPLETED|Overall Study||1
9072613|NCT03804918|10133515|FG000|STARTED|Overall Study||17
9072614|NCT03804918|10133515|FG000|COMPLETED|Overall Study||16
9072615|NCT03804918|10133515|FG000|NOT COMPLETED|Overall Study||1
9072616|NCT03805386|10133521|FG000|STARTED|Overall Study||32
9072617|NCT03805386|10133522|FG001|STARTED|Overall Study||33
9072618|NCT03805386|10133521|FG000|COMPLETED|Overall Study||32
9072619|NCT03805386|10133522|FG001|COMPLETED|Overall Study||33
9072620|NCT03805386|10133521|FG000|NOT COMPLETED|Overall Study||0
9072621|NCT03805386|10133522|FG001|NOT COMPLETED|Overall Study||0
9072622|NCT03803475|10133531|FG000|STARTED|Overall Study||485
9072623|NCT03803475|10133531|FG000|COMPLETED|Overall Study||484
9072624|NCT03803475|10133531|FG000|NOT COMPLETED|Overall Study||1
9072625|NCT03802227|10133537|FG000|STARTED|Overall Study||4
9072626|NCT03802227|10133538|FG001|STARTED|Overall Study||4
9072627|NCT03802227|10133537|FG000|COMPLETED|Overall Study||4
9072628|NCT03802227|10133538|FG001|COMPLETED|Overall Study||4
9072629|NCT03802227|10133537|FG000|NOT COMPLETED|Overall Study||0
8842998|NCT01701258|9897266|FG008|COMPLETED|PET (Session 3)||0
8842999|NCT01701258|9897267|FG009|COMPLETED|PET (Session 3)||0
8843000|NCT01701258|9897268|FG010|COMPLETED|PET (Session 3)||18
8843001|NCT01701258|9897269|FG011|COMPLETED|PET (Session 3)||0
8843002|NCT01701258|9897270|FG012|COMPLETED|PET (Session 3)||0
8843003|NCT01701258|9897258|FG000|NOT COMPLETED|PET (Session 3)||0
8843004|NCT01701258|9897259|FG001|NOT COMPLETED|PET (Session 3)||0
9072630|NCT03802227|10133538|FG001|NOT COMPLETED|Overall Study||0
9072631|NCT03802864|10133548|FG000|STARTED|Overall Study||25
9072632|NCT03802864|10133549|FG001|STARTED|Overall Study||25
9072633|NCT03802864|10133548|FG000|COMPLETED|Overall Study||25
9072634|NCT03802864|10133549|FG001|COMPLETED|Overall Study||25
9072635|NCT03802864|10133548|FG000|NOT COMPLETED|Overall Study||0
9072636|NCT03802864|10133549|FG001|NOT COMPLETED|Overall Study||0
9072637|NCT03801265|10133557|FG000|STARTED|Overall Study||23
9072638|NCT03801265|10133558|FG001|STARTED|Overall Study||23
9072639|NCT03801265|10133557|FG000|COMPLETED|Overall Study||23
9072640|NCT03801265|10133558|FG001|COMPLETED|Overall Study||23
9072641|NCT03801265|10133557|FG000|NOT COMPLETED|Overall Study||0
9072642|NCT03801265|10133558|FG001|NOT COMPLETED|Overall Study||0
9072643|NCT03802344|10133567|FG000|STARTED|Overall Study||213
9072644|NCT03802344|10133568|FG001|STARTED|Overall Study||209
9072645|NCT03802344|10133569|FG002|STARTED|Overall Study||68
9072646|NCT03802344|10133567|FG000|COMPLETED|Overall Study||205
9072647|NCT03802344|10133568|FG001|COMPLETED|Overall Study||203
9072648|NCT03802344|10133569|FG002|COMPLETED|Overall Study||55
9072649|NCT03802344|10133567|FG000|NOT COMPLETED|Overall Study||8
9072650|NCT03802344|10133568|FG001|NOT COMPLETED|Overall Study||6
9072651|NCT03802344|10133569|FG002|NOT COMPLETED|Overall Study||13
9072652|NCT03801928|10133584|FG000|STARTED|Overall Study||18
9072653|NCT03801928|10133585|FG001|STARTED|Overall Study||21
9072654|NCT03801928|10133586|FG002|STARTED|Overall Study||9
9072655|NCT03801928|10133587|FG003|STARTED|Overall Study||21
9072656|NCT03801928|10133588|FG004|STARTED|Overall Study||36
9072657|NCT03801928|10133589|FG005|STARTED|Overall Study||10
9072658|NCT03801928|10133584|FG000|COMPLETED|Overall Study||12
9072659|NCT03801928|10133585|FG001|COMPLETED|Overall Study||18
9072660|NCT03801928|10133586|FG002|COMPLETED|Overall Study||4
9072661|NCT03801928|10133587|FG003|COMPLETED|Overall Study||13
9072662|NCT03801928|10133588|FG004|COMPLETED|Overall Study||32
9072663|NCT03801928|10133589|FG005|COMPLETED|Overall Study||5
9072664|NCT03801928|10133584|FG000|NOT COMPLETED|Overall Study||6
9072665|NCT03801928|10133585|FG001|NOT COMPLETED|Overall Study||3
9072666|NCT03801928|10133586|FG002|NOT COMPLETED|Overall Study||5
8624105|NCT00498433|9663347|FG001|STARTED|Part 2: Placebo Run-in (2 Weeks)|For part 2, this arm belongs to randomized, double blind period.|0
8624106|NCT00498433|9663348|FG002|STARTED|Part 2: Placebo Run-in (2 Weeks)|For part 2, this arm belongs to randomized, double blind period.|0
8624107|NCT00498433|9663346|FG000|COMPLETED|Part 2: Placebo Run-in (2 Weeks)||16
8624108|NCT00498433|9663347|FG001|COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
8843005|NCT01701258|9897260|FG002|NOT COMPLETED|PET (Session 3)||0
8843006|NCT01701258|9897261|FG003|NOT COMPLETED|PET (Session 3)||0
8843007|NCT01701258|9897262|FG004|NOT COMPLETED|PET (Session 3)||0
8843008|NCT01701258|9897263|FG005|NOT COMPLETED|PET (Session 3)||0
8843009|NCT01701258|9897264|FG006|NOT COMPLETED|PET (Session 3)||0
8843010|NCT01701258|9897265|FG007|NOT COMPLETED|PET (Session 3)||0
8843011|NCT01701258|9897266|FG008|NOT COMPLETED|PET (Session 3)||0
8843012|NCT01701258|9897267|FG009|NOT COMPLETED|PET (Session 3)||0
8843013|NCT01701258|9897268|FG010|NOT COMPLETED|PET (Session 3)||0
8843014|NCT01701258|9897269|FG011|NOT COMPLETED|PET (Session 3)||0
8843015|NCT01701258|9897270|FG012|NOT COMPLETED|PET (Session 3)||0
8843016|NCT01701258|9897258|FG000|STARTED|EEG (Session 4)||0
8843017|NCT01701258|9897259|FG001|STARTED|EEG (Session 4)||19
8843018|NCT01701258|9897260|FG002|STARTED|EEG (Session 4)||0
8843019|NCT01701258|9897261|FG003|STARTED|EEG (Session 4)||0
8843020|NCT01701258|9897262|FG004|STARTED|EEG (Session 4)||14
8843021|NCT01701258|9897263|FG005|STARTED|EEG (Session 4)||0
8843022|NCT01701258|9897264|FG006|STARTED|EEG (Session 4)||0
8843023|NCT01701258|9897265|FG007|STARTED|EEG (Session 4)||16
8843024|NCT01701258|9897266|FG008|STARTED|EEG (Session 4)||0
8843025|NCT01701258|9897267|FG009|STARTED|EEG (Session 4)||0
8843026|NCT01701258|9897268|FG010|STARTED|EEG (Session 4)||17
8843027|NCT01701258|9897269|FG011|STARTED|EEG (Session 4)||0
8843028|NCT01701258|9897270|FG012|STARTED|EEG (Session 4)||0
8843029|NCT01701258|9897258|FG000|COMPLETED|EEG (Session 4)||0
8843030|NCT01701258|9897259|FG001|COMPLETED|EEG (Session 4)||19
8843031|NCT01701258|9897260|FG002|COMPLETED|EEG (Session 4)||0
8843032|NCT01701258|9897261|FG003|COMPLETED|EEG (Session 4)||0
8843033|NCT01701258|9897262|FG004|COMPLETED|EEG (Session 4)||14
8843034|NCT01701258|9897263|FG005|COMPLETED|EEG (Session 4)||0
8843035|NCT01701258|9897264|FG006|COMPLETED|EEG (Session 4)||0
8843036|NCT01701258|9897265|FG007|COMPLETED|EEG (Session 4)||16
8843037|NCT01701258|9897266|FG008|COMPLETED|EEG (Session 4)||0
8843038|NCT01701258|9897267|FG009|COMPLETED|EEG (Session 4)||0
8843039|NCT01701258|9897268|FG010|COMPLETED|EEG (Session 4)||17
8843040|NCT01701258|9897269|FG011|COMPLETED|EEG (Session 4)||0
8843041|NCT01701258|9897270|FG012|COMPLETED|EEG (Session 4)||0
8843042|NCT01701258|9897258|FG000|NOT COMPLETED|EEG (Session 4)||0
8843043|NCT01701258|9897259|FG001|NOT COMPLETED|EEG (Session 4)||0
8843044|NCT01701258|9897260|FG002|NOT COMPLETED|EEG (Session 4)||0
8843045|NCT01701258|9897261|FG003|NOT COMPLETED|EEG (Session 4)||0
8843046|NCT01701258|9897262|FG004|NOT COMPLETED|EEG (Session 4)||0
8843047|NCT01701258|9897263|FG005|NOT COMPLETED|EEG (Session 4)||0
8843048|NCT01701258|9897264|FG006|NOT COMPLETED|EEG (Session 4)||0
8843049|NCT01701258|9897265|FG007|NOT COMPLETED|EEG (Session 4)||0
8843050|NCT01701258|9897266|FG008|NOT COMPLETED|EEG (Session 4)||0
8843051|NCT01701258|9897267|FG009|NOT COMPLETED|EEG (Session 4)||0
8843052|NCT01701258|9897268|FG010|NOT COMPLETED|EEG (Session 4)||0
8843053|NCT01701258|9897269|FG011|NOT COMPLETED|EEG (Session 4)||0
8843054|NCT01701258|9897270|FG012|NOT COMPLETED|EEG (Session 4)||0
8843055|NCT01701271|9897298|FG000|STARTED|Overall Study||20
8843056|NCT01701271|9897298|FG000|COMPLETED|Overall Study||20
9072667|NCT03801928|10133587|FG003|NOT COMPLETED|Overall Study||8
9072668|NCT03801928|10133588|FG004|NOT COMPLETED|Overall Study||4
9072669|NCT03801928|10133589|FG005|NOT COMPLETED|Overall Study||5
9072670|NCT03800173|10133611|FG000|STARTED|Overall Study||8
9072671|NCT03800173|10133612|FG001|STARTED|Overall Study||6
9072672|NCT03800173|10133613|FG002|STARTED|Overall Study||6
9072673|NCT03800173|10133614|FG003|STARTED|Overall Study||6
9072674|NCT03800173|10133615|FG004|STARTED|Overall Study||6
8843057|NCT01701271|9897298|FG000|NOT COMPLETED|Overall Study||0
8843058|NCT01701362|9897305|FG000|STARTED|Overall Study||275
8843059|NCT01701362|9897306|FG001|STARTED|Overall Study||267
9072675|NCT03800173|10133611|FG000|Safety Population|Overall Study||8
9072676|NCT03800173|10133612|FG001|Safety Population|Overall Study||6
9072677|NCT03800173|10133613|FG002|Safety Population|Overall Study||6
9072678|NCT03800173|10133614|FG003|Safety Population|Overall Study||6
9072679|NCT03800173|10133615|FG004|Safety Population|Overall Study||6
9072680|NCT03800173|10133611|FG000|PK Population|Overall Study||0
9072681|NCT03800173|10133612|FG001|PK Population|Overall Study||6
9072682|NCT03800173|10133613|FG002|PK Population|Overall Study||6
9072683|NCT03800173|10133614|FG003|PK Population|Overall Study||6
9072684|NCT03800173|10133615|FG004|PK Population|Overall Study||6
9072685|NCT03800173|10133611|FG000|COMPLETED|Overall Study||8
9072686|NCT03800173|10133612|FG001|COMPLETED|Overall Study||6
9072687|NCT03800173|10133613|FG002|COMPLETED|Overall Study||6
9072688|NCT03800173|10133614|FG003|COMPLETED|Overall Study||6
9072689|NCT03800173|10133615|FG004|COMPLETED|Overall Study||5
9072690|NCT03800173|10133611|FG000|NOT COMPLETED|Overall Study||0
9072691|NCT03800173|10133612|FG001|NOT COMPLETED|Overall Study||0
9072692|NCT03800173|10133613|FG002|NOT COMPLETED|Overall Study||0
9072693|NCT03800173|10133614|FG003|NOT COMPLETED|Overall Study||0
9072694|NCT03800173|10133615|FG004|NOT COMPLETED|Overall Study||1
9072695|NCT03799783|10133631|FG000|STARTED|Overall Study||19
9072696|NCT03799783|10133631|FG000|COMPLETED|Overall Study||19
9072697|NCT03799783|10133631|FG000|NOT COMPLETED|Overall Study||0
9072698|NCT03800030|10133635|FG000|STARTED|Baseline||4
9072699|NCT03800030|10133636|FG001|STARTED|Baseline||4
9072700|NCT03800030|10133637|FG002|STARTED|Baseline||4
9072701|NCT03800030|10133638|FG003|STARTED|Baseline||6
9072702|NCT03800030|10133639|FG004|STARTED|Baseline||4
9072703|NCT03800030|10133640|FG005|STARTED|Baseline||4
9072704|NCT03800030|10133635|FG000|COMPLETED|Baseline||4
9072705|NCT03800030|10133636|FG001|COMPLETED|Baseline||4
9072706|NCT03800030|10133637|FG002|COMPLETED|Baseline||4
9072707|NCT03800030|10133638|FG003|COMPLETED|Baseline||6
9072708|NCT03800030|10133639|FG004|COMPLETED|Baseline||4
8843060|NCT01701362|9897305|FG000|TREATED|Overall Study||274
8843061|NCT01701362|9897306|FG001|TREATED|Overall Study||265
8843062|NCT01701362|9897305|FG000|COMPLETED|Overall Study||233
8843063|NCT01701362|9897306|FG001|COMPLETED|Overall Study||211
8843064|NCT01701362|9897305|FG000|NOT COMPLETED|Overall Study||42
8843065|NCT01701362|9897306|FG001|NOT COMPLETED|Overall Study||56
8843066|NCT01701375|9897312|FG000|STARTED|Overall Study||2
8843067|NCT01701375|9897312|FG000|COMPLETED|Overall Study||2
8843068|NCT01701375|9897312|FG000|NOT COMPLETED|Overall Study||0
8843069|NCT01701401|9897320|FG000|STARTED|Overall Study||217
8843070|NCT01701401|9897321|FG001|STARTED|Overall Study||218
8843071|NCT01701401|9897322|FG002|STARTED|Overall Study||217
8843072|NCT01701401|9897323|FG003|STARTED|Overall Study||218
8843073|NCT01701401|9897320|FG000|COMPLETED|Overall Study||207
8843074|NCT01701401|9897321|FG001|COMPLETED|Overall Study||209
8843075|NCT01701401|9897322|FG002|COMPLETED|Overall Study||212
8843076|NCT01701401|9897323|FG003|COMPLETED|Overall Study||212
8843077|NCT01701401|9897320|FG000|NOT COMPLETED|Overall Study||10
8843078|NCT01701401|9897321|FG001|NOT COMPLETED|Overall Study||9
8843079|NCT01701401|9897322|FG002|NOT COMPLETED|Overall Study||5
8843080|NCT01701401|9897323|FG003|NOT COMPLETED|Overall Study||6
8843081|NCT01701414|9897335|FG000|STARTED|Overall Study||19
8843082|NCT01701414|9897336|FG001|STARTED|Overall Study||19
8843083|NCT01701414|9897335|FG000|COMPLETED|Overall Study||18
8843084|NCT01701414|9897336|FG001|COMPLETED|Overall Study||18
8843085|NCT01701414|9897335|FG000|NOT COMPLETED|Overall Study||1
8843086|NCT01701414|9897336|FG001|NOT COMPLETED|Overall Study||1
8843087|NCT01701505|9897348|FG000|STARTED|Overall Study||8
8843088|NCT01701505|9897349|FG001|STARTED|Overall Study||8
8843089|NCT01701505|9897350|FG002|STARTED|Overall Study||8
8843090|NCT01701505|9897351|FG003|STARTED|Overall Study||8
8843091|NCT01701505|9897352|FG004|STARTED|Overall Study||8
8843092|NCT01701505|9897353|FG005|STARTED|Overall Study||8
8843093|NCT01701505|9897348|FG000|COMPLETED|Overall Study||8
8843094|NCT01701505|9897349|FG001|COMPLETED|Overall Study||8
8843095|NCT01701505|9897350|FG002|COMPLETED|Overall Study||8
8843096|NCT01701505|9897351|FG003|COMPLETED|Overall Study||8
8843097|NCT01701505|9897352|FG004|COMPLETED|Overall Study||8
8843098|NCT01701505|9897353|FG005|COMPLETED|Overall Study||8
8843099|NCT01701505|9897348|FG000|NOT COMPLETED|Overall Study||0
8843100|NCT01701505|9897349|FG001|NOT COMPLETED|Overall Study||0
8843101|NCT01701505|9897350|FG002|NOT COMPLETED|Overall Study||0
8843102|NCT01701505|9897351|FG003|NOT COMPLETED|Overall Study||0
8843103|NCT01701505|9897352|FG004|NOT COMPLETED|Overall Study||0
8843104|NCT01701505|9897353|FG005|NOT COMPLETED|Overall Study||0
9072709|NCT03800030|10133640|FG005|COMPLETED|Baseline||4
9072710|NCT03800030|10133635|FG000|NOT COMPLETED|Baseline||0
9072711|NCT03800030|10133636|FG001|NOT COMPLETED|Baseline||0
9072712|NCT03800030|10133637|FG002|NOT COMPLETED|Baseline||0
9072713|NCT03800030|10133638|FG003|NOT COMPLETED|Baseline||0
9072714|NCT03800030|10133639|FG004|NOT COMPLETED|Baseline||0
8843105|NCT01701973|9897370|FG000|STARTED|Aim 1: First Intervention (1 Day)||23
8843106|NCT01701973|9897371|FG001|STARTED|Aim 1: First Intervention (1 Day)||21
8843107|NCT01701973|9897372|FG002|STARTED|Aim 1: First Intervention (1 Day)||0
8843108|NCT01701973|9897373|FG003|STARTED|Aim 1: First Intervention (1 Day)||0
8843109|NCT01701973|9897374|FG004|STARTED|Aim 1: First Intervention (1 Day)||0
8843110|NCT01701973|9897375|FG005|STARTED|Aim 1: First Intervention (1 Day)||0
8843111|NCT01701973|9897376|FG006|STARTED|Aim 1: First Intervention (1 Day)||0
8843112|NCT01701973|9897377|FG007|STARTED|Aim 1: First Intervention (1 Day)||0
8843113|NCT01701973|9897370|FG000|COMPLETED|Aim 1: First Intervention (1 Day)||23
9072715|NCT03800030|10133640|FG005|NOT COMPLETED|Baseline||0
9072716|NCT03800030|10133635|FG000|STARTED|Pre-Randomization Period (1 Week)||4
9072717|NCT03800030|10133636|FG001|STARTED|Pre-Randomization Period (1 Week)||4
9072718|NCT03800030|10133637|FG002|STARTED|Pre-Randomization Period (1 Week)||4
9072719|NCT03800030|10133638|FG003|STARTED|Pre-Randomization Period (1 Week)||6
9072720|NCT03800030|10133639|FG004|STARTED|Pre-Randomization Period (1 Week)||4
9072721|NCT03800030|10133640|FG005|STARTED|Pre-Randomization Period (1 Week)||4
9072722|NCT03800030|10133635|FG000|COMPLETED|Pre-Randomization Period (1 Week)||4
9072723|NCT03800030|10133636|FG001|COMPLETED|Pre-Randomization Period (1 Week)||4
9072724|NCT03800030|10133637|FG002|COMPLETED|Pre-Randomization Period (1 Week)||4
9072725|NCT03800030|10133638|FG003|COMPLETED|Pre-Randomization Period (1 Week)||6
9072726|NCT03800030|10133639|FG004|COMPLETED|Pre-Randomization Period (1 Week)||4
9072727|NCT03800030|10133640|FG005|COMPLETED|Pre-Randomization Period (1 Week)||4
9072728|NCT03800030|10133635|FG000|NOT COMPLETED|Pre-Randomization Period (1 Week)||0
9072729|NCT03800030|10133636|FG001|NOT COMPLETED|Pre-Randomization Period (1 Week)||0
9072730|NCT03800030|10133637|FG002|NOT COMPLETED|Pre-Randomization Period (1 Week)||0
9072731|NCT03800030|10133638|FG003|NOT COMPLETED|Pre-Randomization Period (1 Week)||0
9072732|NCT03800030|10133639|FG004|NOT COMPLETED|Pre-Randomization Period (1 Week)||0
9072733|NCT03800030|10133640|FG005|NOT COMPLETED|Pre-Randomization Period (1 Week)||0
9072734|NCT03800030|10133635|FG000|STARTED|First Intervention||4
9072735|NCT03800030|10133636|FG001|STARTED|First Intervention||4
9072736|NCT03800030|10133637|FG002|STARTED|First Intervention||4
9072737|NCT03800030|10133638|FG003|STARTED|First Intervention||6
9072738|NCT03800030|10133639|FG004|STARTED|First Intervention||4
9072739|NCT03800030|10133640|FG005|STARTED|First Intervention||4
9072740|NCT03800030|10133635|FG000|COMPLETED|First Intervention||4
9072741|NCT03800030|10133636|FG001|COMPLETED|First Intervention||4
9072742|NCT03800030|10133637|FG002|COMPLETED|First Intervention||4
9072743|NCT03800030|10133638|FG003|COMPLETED|First Intervention||6
9072744|NCT03800030|10133639|FG004|COMPLETED|First Intervention||4
9072745|NCT03800030|10133640|FG005|COMPLETED|First Intervention||4
9072746|NCT03800030|10133635|FG000|NOT COMPLETED|First Intervention||0
9072747|NCT03800030|10133636|FG001|NOT COMPLETED|First Intervention||0
9072748|NCT03800030|10133637|FG002|NOT COMPLETED|First Intervention||0
9072749|NCT03800030|10133638|FG003|NOT COMPLETED|First Intervention||0
9072750|NCT03800030|10133639|FG004|NOT COMPLETED|First Intervention||0
9072751|NCT03800030|10133640|FG005|NOT COMPLETED|First Intervention||0
9072752|NCT03800030|10133635|FG000|STARTED|First Washout (1 Week)||4
9072753|NCT03800030|10133636|FG001|STARTED|First Washout (1 Week)||4
9072754|NCT03800030|10133637|FG002|STARTED|First Washout (1 Week)||4
9072755|NCT03800030|10133638|FG003|STARTED|First Washout (1 Week)||6
9072756|NCT03800030|10133639|FG004|STARTED|First Washout (1 Week)||4
9072757|NCT03800030|10133640|FG005|STARTED|First Washout (1 Week)||4
9072758|NCT03800030|10133635|FG000|COMPLETED|First Washout (1 Week)||4
9072759|NCT03800030|10133636|FG001|COMPLETED|First Washout (1 Week)||4
9072760|NCT03800030|10133637|FG002|COMPLETED|First Washout (1 Week)||4
9072761|NCT03800030|10133638|FG003|COMPLETED|First Washout (1 Week)||6
9072762|NCT03800030|10133639|FG004|COMPLETED|First Washout (1 Week)||4
9072763|NCT03800030|10133640|FG005|COMPLETED|First Washout (1 Week)||4
9072764|NCT03800030|10133635|FG000|NOT COMPLETED|First Washout (1 Week)||0
9072765|NCT03800030|10133636|FG001|NOT COMPLETED|First Washout (1 Week)||0
9072766|NCT03800030|10133637|FG002|NOT COMPLETED|First Washout (1 Week)||0
9072767|NCT03800030|10133638|FG003|NOT COMPLETED|First Washout (1 Week)||0
9072768|NCT03800030|10133639|FG004|NOT COMPLETED|First Washout (1 Week)||0
9072769|NCT03800030|10133640|FG005|NOT COMPLETED|First Washout (1 Week)||0
9072770|NCT03800030|10133635|FG000|STARTED|Second Intervention||4
9072771|NCT03800030|10133636|FG001|STARTED|Second Intervention||4
9072772|NCT03800030|10133637|FG002|STARTED|Second Intervention||4
9072773|NCT03800030|10133638|FG003|STARTED|Second Intervention||6
9072774|NCT03800030|10133639|FG004|STARTED|Second Intervention||4
9072775|NCT03800030|10133640|FG005|STARTED|Second Intervention||4
9072776|NCT03800030|10133635|FG000|COMPLETED|Second Intervention||4
9072777|NCT03800030|10133636|FG001|COMPLETED|Second Intervention||4
9072778|NCT03800030|10133637|FG002|COMPLETED|Second Intervention||4
9072779|NCT03800030|10133638|FG003|COMPLETED|Second Intervention||5
9072780|NCT03800030|10133639|FG004|COMPLETED|Second Intervention||4
9072781|NCT03800030|10133640|FG005|COMPLETED|Second Intervention||4
9072782|NCT03800030|10133635|FG000|NOT COMPLETED|Second Intervention||0
9072783|NCT03800030|10133636|FG001|NOT COMPLETED|Second Intervention||0
9072784|NCT03800030|10133637|FG002|NOT COMPLETED|Second Intervention||0
9072785|NCT03800030|10133638|FG003|NOT COMPLETED|Second Intervention||1
9072786|NCT03800030|10133639|FG004|NOT COMPLETED|Second Intervention||0
9072787|NCT03800030|10133640|FG005|NOT COMPLETED|Second Intervention||0
9072788|NCT03800030|10133635|FG000|STARTED|Second Washout (1 Week)||4
9072789|NCT03800030|10133636|FG001|STARTED|Second Washout (1 Week)||4
9072790|NCT03800030|10133637|FG002|STARTED|Second Washout (1 Week)||4
9072791|NCT03800030|10133638|FG003|STARTED|Second Washout (1 Week)||5
9072792|NCT03800030|10133639|FG004|STARTED|Second Washout (1 Week)||4
9072793|NCT03800030|10133640|FG005|STARTED|Second Washout (1 Week)||4
9072794|NCT03800030|10133635|FG000|COMPLETED|Second Washout (1 Week)||4
9072795|NCT03800030|10133636|FG001|COMPLETED|Second Washout (1 Week)||4
9072796|NCT03800030|10133637|FG002|COMPLETED|Second Washout (1 Week)||4
9072797|NCT03800030|10133638|FG003|COMPLETED|Second Washout (1 Week)||4
9072798|NCT03800030|10133639|FG004|COMPLETED|Second Washout (1 Week)||4
9072799|NCT03800030|10133640|FG005|COMPLETED|Second Washout (1 Week)||4
9072800|NCT03800030|10133635|FG000|NOT COMPLETED|Second Washout (1 Week)||0
9072801|NCT03800030|10133636|FG001|NOT COMPLETED|Second Washout (1 Week)||0
9072802|NCT03800030|10133637|FG002|NOT COMPLETED|Second Washout (1 Week)||0
9072803|NCT03800030|10133638|FG003|NOT COMPLETED|Second Washout (1 Week)||1
9072804|NCT03800030|10133639|FG004|NOT COMPLETED|Second Washout (1 Week)||0
9072805|NCT03800030|10133640|FG005|NOT COMPLETED|Second Washout (1 Week)||0
9072806|NCT03800030|10133635|FG000|STARTED|Third Intervention||4
9072807|NCT03800030|10133636|FG001|STARTED|Third Intervention||4
9072808|NCT03800030|10133637|FG002|STARTED|Third Intervention||4
9072809|NCT03800030|10133638|FG003|STARTED|Third Intervention||4
9072810|NCT03800030|10133639|FG004|STARTED|Third Intervention||4
9072811|NCT03800030|10133640|FG005|STARTED|Third Intervention||4
9072812|NCT03800030|10133635|FG000|COMPLETED|Third Intervention||4
9072813|NCT03800030|10133636|FG001|COMPLETED|Third Intervention||4
9072814|NCT03800030|10133637|FG002|COMPLETED|Third Intervention||4
9072815|NCT03800030|10133638|FG003|COMPLETED|Third Intervention||4
9072816|NCT03800030|10133639|FG004|COMPLETED|Third Intervention||4
9072817|NCT03800030|10133640|FG005|COMPLETED|Third Intervention||4
9072818|NCT03800030|10133635|FG000|NOT COMPLETED|Third Intervention||0
9072819|NCT03800030|10133636|FG001|NOT COMPLETED|Third Intervention||0
9072820|NCT03800030|10133637|FG002|NOT COMPLETED|Third Intervention||0
9072821|NCT03800030|10133638|FG003|NOT COMPLETED|Third Intervention||0
9072822|NCT03800030|10133639|FG004|NOT COMPLETED|Third Intervention||0
9072823|NCT03800030|10133640|FG005|NOT COMPLETED|Third Intervention||0
9072824|NCT03799211|10133650|FG000|STARTED|Overall Study||36
9072825|NCT03799211|10133651|FG001|STARTED|Overall Study||40
9072826|NCT03799211|10133650|FG000|COMPLETED|Overall Study||32
9072827|NCT03799211|10133651|FG001|COMPLETED|Overall Study||27
9072828|NCT03799211|10133650|FG000|NOT COMPLETED|Overall Study||4
9072829|NCT03799211|10133651|FG001|NOT COMPLETED|Overall Study||13
8843114|NCT01701973|9897371|FG001|COMPLETED|Aim 1: First Intervention (1 Day)||20
8843115|NCT01701973|9897372|FG002|COMPLETED|Aim 1: First Intervention (1 Day)||0
8843116|NCT01701973|9897373|FG003|COMPLETED|Aim 1: First Intervention (1 Day)||0
8843117|NCT01701973|9897374|FG004|COMPLETED|Aim 1: First Intervention (1 Day)||0
8843118|NCT01701973|9897375|FG005|COMPLETED|Aim 1: First Intervention (1 Day)||0
8843119|NCT01701973|9897376|FG006|COMPLETED|Aim 1: First Intervention (1 Day)||0
8843120|NCT01701973|9897377|FG007|COMPLETED|Aim 1: First Intervention (1 Day)||0
8843121|NCT01701973|9897370|FG000|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
8843122|NCT01701973|9897371|FG001|NOT COMPLETED|Aim 1: First Intervention (1 Day)||1
8843123|NCT01701973|9897372|FG002|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
8843124|NCT01701973|9897373|FG003|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
8843125|NCT01701973|9897374|FG004|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
8843126|NCT01701973|9897375|FG005|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
8843127|NCT01701973|9897376|FG006|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
8843128|NCT01701973|9897377|FG007|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
8843129|NCT01701973|9897370|FG000|STARTED|Aim 1: Second Intervention (1 Day)|1 subject was lost to follow-up in between Periods 1 and 2.|22
8843130|NCT01701973|9897371|FG001|STARTED|Aim 1: Second Intervention (1 Day)|3 subjects were lost to follow-up in between Periods 1 and 2.|17
8843131|NCT01701973|9897372|FG002|STARTED|Aim 1: Second Intervention (1 Day)||0
8843132|NCT01701973|9897373|FG003|STARTED|Aim 1: Second Intervention (1 Day)||0
8843133|NCT01701973|9897374|FG004|STARTED|Aim 1: Second Intervention (1 Day)||0
8843134|NCT01701973|9897375|FG005|STARTED|Aim 1: Second Intervention (1 Day)||0
8843135|NCT01701973|9897376|FG006|STARTED|Aim 1: Second Intervention (1 Day)||0
8843136|NCT01701973|9897377|FG007|STARTED|Aim 1: Second Intervention (1 Day)||0
8843137|NCT01701973|9897370|FG000|COMPLETED|Aim 1: Second Intervention (1 Day)||22
8843138|NCT01701973|9897371|FG001|COMPLETED|Aim 1: Second Intervention (1 Day)||17
8843139|NCT01701973|9897372|FG002|COMPLETED|Aim 1: Second Intervention (1 Day)||0
8843140|NCT01701973|9897373|FG003|COMPLETED|Aim 1: Second Intervention (1 Day)||0
8843141|NCT01701973|9897374|FG004|COMPLETED|Aim 1: Second Intervention (1 Day)||0
8843142|NCT01701973|9897375|FG005|COMPLETED|Aim 1: Second Intervention (1 Day)||0
8843143|NCT01701973|9897376|FG006|COMPLETED|Aim 1: Second Intervention (1 Day)||0
8843144|NCT01701973|9897377|FG007|COMPLETED|Aim 1: Second Intervention (1 Day)||0
8843145|NCT01701973|9897370|FG000|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
8843146|NCT01701973|9897371|FG001|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
8843147|NCT01701973|9897372|FG002|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
8843148|NCT01701973|9897373|FG003|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
8843149|NCT01701973|9897374|FG004|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
8843150|NCT01701973|9897375|FG005|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
8843151|NCT01701973|9897376|FG006|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
8843152|NCT01701973|9897377|FG007|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
8843153|NCT01701973|9897370|FG000|STARTED|Aim 2: First Intervention (1 Day)||0
8843154|NCT01701973|9897371|FG001|STARTED|Aim 2: First Intervention (1 Day)||0
8843155|NCT01701973|9897372|FG002|STARTED|Aim 2: First Intervention (1 Day)||5
8843156|NCT01701973|9897373|FG003|STARTED|Aim 2: First Intervention (1 Day)||4
9072830|NCT03798717|10133665|FG000|STARTED|Overall Study||4
9072831|NCT03798717|10133666|FG001|STARTED|Overall Study||3
9072832|NCT03798717|10133667|FG002|STARTED|Overall Study||3
9072833|NCT03798717|10133668|FG003|STARTED|Overall Study||4
8843157|NCT01701973|9897374|FG004|STARTED|Aim 2: First Intervention (1 Day)||2
9072834|NCT03798717|10133669|FG004|STARTED|Overall Study||3
9072835|NCT03798717|10133670|FG005|STARTED|Overall Study||3
9072836|NCT03798717|10133665|FG000|COMPLETED|Overall Study||2
9072837|NCT03798717|10133666|FG001|COMPLETED|Overall Study||2
9072838|NCT03798717|10133667|FG002|COMPLETED|Overall Study||2
9072839|NCT03798717|10133668|FG003|COMPLETED|Overall Study||2
9072840|NCT03798717|10133669|FG004|COMPLETED|Overall Study||2
9072841|NCT03798717|10133670|FG005|COMPLETED|Overall Study||2
9072842|NCT03798717|10133665|FG000|NOT COMPLETED|Overall Study||2
9072843|NCT03798717|10133666|FG001|NOT COMPLETED|Overall Study||1
9072844|NCT03798717|10133667|FG002|NOT COMPLETED|Overall Study||1
9072845|NCT03798717|10133668|FG003|NOT COMPLETED|Overall Study||2
9072846|NCT03798717|10133669|FG004|NOT COMPLETED|Overall Study||1
9072847|NCT03798717|10133670|FG005|NOT COMPLETED|Overall Study||1
9072848|NCT03798483|10133679|FG000|STARTED|Overall Study||15
9072849|NCT03798483|10133679|FG000|Returned All Follow-up Outcome Data|Overall Study||11
9072850|NCT03798483|10133679|FG000|COMPLETED|Overall Study||13
9072851|NCT03798483|10133679|FG000|NOT COMPLETED|Overall Study||2
9072852|NCT03798366|10133689|FG000|STARTED|Overall Study||21
9072853|NCT03798366|10133690|FG001|STARTED|Overall Study||12
9072854|NCT03798366|10133689|FG000|COMPLETED|Overall Study||21
9072855|NCT03798366|10133690|FG001|COMPLETED|Overall Study||11
9072856|NCT03798366|10133689|FG000|NOT COMPLETED|Overall Study||0
9072857|NCT03798366|10133690|FG001|NOT COMPLETED|Overall Study||1
9072858|NCT03799952|10133698|FG000|STARTED|Overall Study||31
9072859|NCT03799952|10133699|FG001|STARTED|Overall Study||31
9072860|NCT03799952|10133698|FG000|COMPLETED|Overall Study||30
9072861|NCT03799952|10133699|FG001|COMPLETED|Overall Study||29
9072862|NCT03799952|10133698|FG000|NOT COMPLETED|Overall Study||1
9072863|NCT03799952|10133699|FG001|NOT COMPLETED|Overall Study||2
9072864|NCT03797872|10133707|FG000|STARTED|Overall Study||1
9072865|NCT03797872|10133708|FG001|STARTED|Overall Study||0
9072866|NCT03797872|10133707|FG000|COMPLETED|Overall Study||0
9072867|NCT03797872|10133708|FG001|COMPLETED|Overall Study||0
9072868|NCT03797872|10133707|FG000|NOT COMPLETED|Overall Study||1
9072869|NCT03797872|10133708|FG001|NOT COMPLETED|Overall Study||0
9072870|NCT03799614|10133716|FG000|STARTED|Overall Study||15
9072871|NCT03799614|10133717|FG001|STARTED|Overall Study||15
9072872|NCT03799614|10133716|FG000|COMPLETED|Overall Study||15
9072873|NCT03799614|10133717|FG001|COMPLETED|Overall Study||15
9072874|NCT03799614|10133716|FG000|NOT COMPLETED|Overall Study||0
9072875|NCT03799614|10133717|FG001|NOT COMPLETED|Overall Study||0
9072876|NCT03799484|10133726|FG000|STARTED|Overall Study||14
9072877|NCT03799484|10133726|FG000|COMPLETED|Overall Study||14
9072878|NCT03799484|10133726|FG000|NOT COMPLETED|Overall Study||0
9072879|NCT03796728|10133733|FG000|STARTED|Overall Study||60
9072880|NCT03796728|10133733|FG000|COMPLETED|Overall Study||36
9072881|NCT03796728|10133733|FG000|NOT COMPLETED|Overall Study||24
9072882|NCT03797144|10133739|FG000|STARTED|Enrollment||16
8843158|NCT01701973|9897375|FG005|STARTED|Aim 2: First Intervention (1 Day)||3
8843159|NCT01701973|9897376|FG006|STARTED|Aim 2: First Intervention (1 Day)||5
8843160|NCT01701973|9897377|FG007|STARTED|Aim 2: First Intervention (1 Day)||4
8843161|NCT01701973|9897370|FG000|COMPLETED|Aim 2: First Intervention (1 Day)||0
8843162|NCT01701973|9897371|FG001|COMPLETED|Aim 2: First Intervention (1 Day)||0
8843163|NCT01701973|9897372|FG002|COMPLETED|Aim 2: First Intervention (1 Day)||5
8843164|NCT01701973|9897373|FG003|COMPLETED|Aim 2: First Intervention (1 Day)||4
8843165|NCT01701973|9897374|FG004|COMPLETED|Aim 2: First Intervention (1 Day)||2
8843166|NCT01701973|9897375|FG005|COMPLETED|Aim 2: First Intervention (1 Day)||3
8843167|NCT01701973|9897376|FG006|COMPLETED|Aim 2: First Intervention (1 Day)||5
8843168|NCT01701973|9897377|FG007|COMPLETED|Aim 2: First Intervention (1 Day)||4
8843169|NCT01701973|9897370|FG000|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
8843170|NCT01701973|9897371|FG001|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
8843171|NCT01701973|9897372|FG002|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
8843172|NCT01701973|9897373|FG003|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
8843173|NCT01701973|9897374|FG004|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
8843174|NCT01701973|9897375|FG005|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
8843175|NCT01701973|9897376|FG006|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
8843176|NCT01701973|9897377|FG007|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
8843177|NCT01701973|9897370|FG000|STARTED|Aim 2: Second Intervention (1 Day)||0
8843178|NCT01701973|9897371|FG001|STARTED|Aim 2: Second Intervention (1 Day)||0
8843179|NCT01701973|9897372|FG002|STARTED|Aim 2: Second Intervention (1 Day)||5
8843180|NCT01701973|9897373|FG003|STARTED|Aim 2: Second Intervention (1 Day)||4
8843181|NCT01701973|9897374|FG004|STARTED|Aim 2: Second Intervention (1 Day)||2
8843182|NCT01701973|9897375|FG005|STARTED|Aim 2: Second Intervention (1 Day)||3
8843183|NCT01701973|9897376|FG006|STARTED|Aim 2: Second Intervention (1 Day)||5
8843184|NCT01701973|9897377|FG007|STARTED|Aim 2: Second Intervention (1 Day)|1 subject was lost to follow-up in between Periods 3 and 4.|3
8843185|NCT01701973|9897370|FG000|COMPLETED|Aim 2: Second Intervention (1 Day)||0
8843186|NCT01701973|9897371|FG001|COMPLETED|Aim 2: Second Intervention (1 Day)||0
8843187|NCT01701973|9897372|FG002|COMPLETED|Aim 2: Second Intervention (1 Day)||5
8843188|NCT01701973|9897373|FG003|COMPLETED|Aim 2: Second Intervention (1 Day)||4
9072883|NCT03797144|10133740|FG001|STARTED|Enrollment||11
9072884|NCT03797144|10133739|FG000|COMPLETED|Enrollment||12
9072885|NCT03797144|10133740|FG001|COMPLETED|Enrollment||10
9072886|NCT03797144|10133739|FG000|NOT COMPLETED|Enrollment||4
9072887|NCT03797144|10133740|FG001|NOT COMPLETED|Enrollment||1
9072888|NCT03797144|10133739|FG000|STARTED|Surgery||12
9072889|NCT03797144|10133740|FG001|STARTED|Surgery||10
9072890|NCT03797144|10133739|FG000|COMPLETED|Surgery||11
9072891|NCT03797144|10133740|FG001|COMPLETED|Surgery||10
9072892|NCT03797144|10133739|FG000|NOT COMPLETED|Surgery||1
9072893|NCT03797144|10133740|FG001|NOT COMPLETED|Surgery||0
9072894|NCT03797144|10133739|FG000|STARTED|3 Month||11
9072895|NCT03797144|10133740|FG001|STARTED|3 Month||10
9072896|NCT03797144|10133739|FG000|COMPLETED|3 Month||9
9072897|NCT03797144|10133740|FG001|COMPLETED|3 Month||10
9072898|NCT03797144|10133739|FG000|NOT COMPLETED|3 Month||2
9072899|NCT03797144|10133740|FG001|NOT COMPLETED|3 Month||0
9072900|NCT03797144|10133739|FG000|STARTED|12 Month||9
9072901|NCT03797144|10133740|FG001|STARTED|12 Month||10
9072902|NCT03797144|10133739|FG000|COMPLETED|12 Month||1
9072903|NCT03797144|10133740|FG001|COMPLETED|12 Month||1
9072904|NCT03797144|10133739|FG000|NOT COMPLETED|12 Month||8
9072905|NCT03797144|10133740|FG001|NOT COMPLETED|12 Month||9
9072906|NCT03797144|10133739|FG000|STARTED|24 Month||1
9072907|NCT03797144|10133740|FG001|STARTED|24 Month||1
9072908|NCT03797144|10133739|FG000|COMPLETED|24 Month||0
9072909|NCT03797144|10133740|FG001|COMPLETED|24 Month||0
9072910|NCT03797144|10133739|FG000|NOT COMPLETED|24 Month||1
9072911|NCT03797144|10133740|FG001|NOT COMPLETED|24 Month||1
9072912|NCT03782571|10133747|FG000|STARTED|Period 1||6
9072913|NCT03782571|10133748|FG001|STARTED|Period 1||6
9072914|NCT03782571|10133749|FG002|STARTED|Period 1||6
9072915|NCT03782571|10133750|FG003|STARTED|Period 1||7
9072916|NCT03782571|10133747|FG000|COMPLETED|Period 1||5
9072917|NCT03782571|10133748|FG001|COMPLETED|Period 1||6
9072918|NCT03782571|10133749|FG002|COMPLETED|Period 1||6
9072919|NCT03782571|10133750|FG003|COMPLETED|Period 1||7
9072920|NCT03782571|10133747|FG000|NOT COMPLETED|Period 1||1
9072921|NCT03782571|10133748|FG001|NOT COMPLETED|Period 1||0
9072922|NCT03782571|10133749|FG002|NOT COMPLETED|Period 1||0
9072923|NCT03782571|10133750|FG003|NOT COMPLETED|Period 1||0
9072924|NCT03782571|10133747|FG000|STARTED|Period 2||5
9072925|NCT03782571|10133748|FG001|STARTED|Period 2||6
9072926|NCT03782571|10133749|FG002|STARTED|Period 2||6
9072927|NCT03782571|10133750|FG003|STARTED|Period 2||7
9072928|NCT03782571|10133747|FG000|COMPLETED|Period 2||5
9072929|NCT03782571|10133748|FG001|COMPLETED|Period 2||6
9072930|NCT03782571|10133749|FG002|COMPLETED|Period 2||6
9072931|NCT03782571|10133750|FG003|COMPLETED|Period 2||7
9072932|NCT03782571|10133747|FG000|NOT COMPLETED|Period 2||0
9072933|NCT03782571|10133748|FG001|NOT COMPLETED|Period 2||0
9072934|NCT03782571|10133749|FG002|NOT COMPLETED|Period 2||0
9072935|NCT03782571|10133750|FG003|NOT COMPLETED|Period 2||0
9072936|NCT03782571|10133747|FG000|STARTED|Period 3||5
9072937|NCT03782571|10133748|FG001|STARTED|Period 3||6
9072938|NCT03782571|10133749|FG002|STARTED|Period 3||6
9072939|NCT03782571|10133750|FG003|STARTED|Period 3||7
9072940|NCT03782571|10133747|FG000|COMPLETED|Period 3||3
9072941|NCT03782571|10133748|FG001|COMPLETED|Period 3||6
9072942|NCT03782571|10133749|FG002|COMPLETED|Period 3||6
9072943|NCT03782571|10133750|FG003|COMPLETED|Period 3||7
9072944|NCT03782571|10133747|FG000|NOT COMPLETED|Period 3||2
9072945|NCT03782571|10133748|FG001|NOT COMPLETED|Period 3||0
9072946|NCT03782571|10133749|FG002|NOT COMPLETED|Period 3||0
9072947|NCT03782571|10133750|FG003|NOT COMPLETED|Period 3||0
9072948|NCT03782571|10133747|FG000|STARTED|Period 4||3
9072949|NCT03782571|10133748|FG001|STARTED|Period 4||6
8624109|NCT00498433|9663348|FG002|COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
9072950|NCT03782571|10133749|FG002|STARTED|Period 4||6
9072951|NCT03782571|10133750|FG003|STARTED|Period 4||7
9072952|NCT03782571|10133747|FG000|COMPLETED|Period 4||3
9072953|NCT03782571|10133748|FG001|COMPLETED|Period 4||6
9072954|NCT03782571|10133749|FG002|COMPLETED|Period 4||6
9072955|NCT03782571|10133750|FG003|COMPLETED|Period 4||7
9072956|NCT03782571|10133747|FG000|NOT COMPLETED|Period 4||0
9072957|NCT03782571|10133748|FG001|NOT COMPLETED|Period 4||0
9072958|NCT03782571|10133749|FG002|NOT COMPLETED|Period 4||0
9072959|NCT03782571|10133750|FG003|NOT COMPLETED|Period 4||0
9072960|NCT03796260|10133764|FG000|STARTED|Period 1||7
9072961|NCT03796260|10133765|FG001|STARTED|Period 1||7
9072962|NCT03796260|10133764|FG000|COMPLETED|Period 1||7
9072963|NCT03796260|10133765|FG001|COMPLETED|Period 1||7
9072964|NCT03796260|10133764|FG000|NOT COMPLETED|Period 1||0
9072965|NCT03796260|10133765|FG001|NOT COMPLETED|Period 1||0
9072966|NCT03796260|10133764|FG000|STARTED|Period 2||7
8629503|NCT00530764|9669250|FG000|NOT COMPLETED|Overall Study||31
9072967|NCT03796260|10133765|FG001|STARTED|Period 2||7
9072968|NCT03796260|10133764|FG000|COMPLETED|Period 2||7
9072969|NCT03796260|10133765|FG001|COMPLETED|Period 2||7
9072970|NCT03796260|10133764|FG000|NOT COMPLETED|Period 2||0
9072971|NCT03796260|10133765|FG001|NOT COMPLETED|Period 2||0
9072972|NCT03796039|10133773|FG000|STARTED|Overall Study||50
9072973|NCT03796039|10133774|FG001|STARTED|Overall Study||47
9072974|NCT03796039|10133773|FG000|COMPLETED|Overall Study||41
9072975|NCT03796039|10133774|FG001|COMPLETED|Overall Study||42
9072976|NCT03796039|10133773|FG000|NOT COMPLETED|Overall Study||9
9072977|NCT03796039|10133774|FG001|NOT COMPLETED|Overall Study||5
9072978|NCT03783780|10133780|FG000|STARTED|Overall Study||21
9072979|NCT03783780|10133780|FG000|COMPLETED|Overall Study||20
9072980|NCT03783780|10133780|FG000|NOT COMPLETED|Overall Study||1
9072981|NCT03780959|10133788|FG000|STARTED|Part 1||69
9072982|NCT03780959|10133789|FG001|STARTED|Part 1||0
9072983|NCT03780959|10133790|FG002|STARTED|Part 1||0
9072984|NCT03780959|10133788|FG000|COMPLETED|Part 1||64
9072985|NCT03780959|10133789|FG001|COMPLETED|Part 1||0
9072986|NCT03780959|10133790|FG002|COMPLETED|Part 1||0
9072987|NCT03780959|10133788|FG000|NOT COMPLETED|Part 1||5
9072988|NCT03780959|10133789|FG001|NOT COMPLETED|Part 1||0
9072989|NCT03780959|10133790|FG002|NOT COMPLETED|Part 1||0
9072990|NCT03780959|10133788|FG000|STARTED|Part 2||0
9072991|NCT03780959|10133789|FG001|STARTED|Part 2||26
9072992|NCT03780959|10133790|FG002|STARTED|Part 2||25
9072993|NCT03780959|10133788|FG000|COMPLETED|Part 2||0
9072994|NCT03780959|10133789|FG001|COMPLETED|Part 2||7
9072995|NCT03780959|10133790|FG002|COMPLETED|Part 2||19
9072996|NCT03780959|10133788|FG000|NOT COMPLETED|Part 2||0
9072997|NCT03780959|10133789|FG001|NOT COMPLETED|Part 2||19
9072998|NCT03780959|10133790|FG002|NOT COMPLETED|Part 2||6
9072999|NCT03796182|10133800|FG000|STARTED|Period 1||6
9073000|NCT03796182|10133801|FG001|STARTED|Period 1||6
9073001|NCT03796182|10133800|FG000|COMPLETED|Period 1||6
9073002|NCT03796182|10133801|FG001|COMPLETED|Period 1||6
9073003|NCT03796182|10133800|FG000|NOT COMPLETED|Period 1||0
9073004|NCT03796182|10133801|FG001|NOT COMPLETED|Period 1||0
9073005|NCT03796182|10133800|FG000|STARTED|Washout Period||6
9073006|NCT03796182|10133801|FG001|STARTED|Washout Period||6
9073007|NCT03796182|10133800|FG000|COMPLETED|Washout Period||6
9073008|NCT03796182|10133801|FG001|COMPLETED|Washout Period||6
9073009|NCT03796182|10133800|FG000|NOT COMPLETED|Washout Period||0
9073010|NCT03796182|10133801|FG001|NOT COMPLETED|Washout Period||0
9073011|NCT03796182|10133800|FG000|STARTED|Period 2||6
9073012|NCT03796182|10133801|FG001|STARTED|Period 2||6
9073013|NCT03796182|10133800|FG000|COMPLETED|Period 2||6
9073014|NCT03796182|10133801|FG001|COMPLETED|Period 2||6
9073015|NCT03796182|10133800|FG000|NOT COMPLETED|Period 2||0
9073016|NCT03796182|10133801|FG001|NOT COMPLETED|Period 2||0
9073017|NCT03796013|10133809|FG000|STARTED|Period 1||14
9073018|NCT03796013|10133810|FG001|STARTED|Period 1||14
9073019|NCT03796013|10133809|FG000|COMPLETED|Period 1||14
9073020|NCT03796013|10133810|FG001|COMPLETED|Period 1||14
9073021|NCT03796013|10133809|FG000|NOT COMPLETED|Period 1||0
9073022|NCT03796013|10133810|FG001|NOT COMPLETED|Period 1||0
9073023|NCT03796013|10133809|FG000|STARTED|Period 2||14
9073024|NCT03796013|10133810|FG001|STARTED|Period 2||14
9073025|NCT03796013|10133809|FG000|COMPLETED|Period 2||14
8843189|NCT01701973|9897374|FG004|COMPLETED|Aim 2: Second Intervention (1 Day)||2
8843190|NCT01701973|9897375|FG005|COMPLETED|Aim 2: Second Intervention (1 Day)||3
8843191|NCT01701973|9897376|FG006|COMPLETED|Aim 2: Second Intervention (1 Day)||5
8843192|NCT01701973|9897377|FG007|COMPLETED|Aim 2: Second Intervention (1 Day)||3
8843193|NCT01701973|9897370|FG000|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
8843194|NCT01701973|9897371|FG001|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
8843195|NCT01701973|9897372|FG002|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
8843196|NCT01701973|9897373|FG003|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
8843197|NCT01701973|9897374|FG004|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
8843198|NCT01701973|9897375|FG005|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
8843199|NCT01701973|9897376|FG006|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
8843200|NCT01701973|9897377|FG007|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
8843201|NCT01701999|9897419|FG000|STARTED|Overall Study||8
8843202|NCT01701999|9897420|FG001|STARTED|Overall Study||37
8843203|NCT01701999|9897419|FG000|COMPLETED|Overall Study||8
8843204|NCT01701999|9897420|FG001|COMPLETED|Overall Study||37
8843205|NCT01701999|9897419|FG000|NOT COMPLETED|Overall Study||0
8843206|NCT01701999|9897420|FG001|NOT COMPLETED|Overall Study||0
8843207|NCT01702025|9897430|FG000|STARTED|Overall Study||11
8843208|NCT01702025|9897431|FG001|STARTED|Overall Study||10
8843209|NCT01702025|9897432|FG002|STARTED|Overall Study||10
8843210|NCT01702025|9897433|FG003|STARTED|Overall Study||10
8843211|NCT01702025|9897430|FG000|COMPLETED|Overall Study||9
8843212|NCT01702025|9897431|FG001|COMPLETED|Overall Study||9
8843213|NCT01702025|9897432|FG002|COMPLETED|Overall Study||9
8843214|NCT01702025|9897433|FG003|COMPLETED|Overall Study||10
8843215|NCT01702025|9897430|FG000|NOT COMPLETED|Overall Study||2
8843216|NCT01702025|9897431|FG001|NOT COMPLETED|Overall Study||1
8843217|NCT01702025|9897432|FG002|NOT COMPLETED|Overall Study||1
8843218|NCT01702025|9897433|FG003|NOT COMPLETED|Overall Study||0
8843219|NCT01702233|9897450|FG000|STARTED|Overall Study||72
8843220|NCT01702233|9897451|FG001|STARTED|Overall Study||67
8843221|NCT01702233|9897452|FG002|STARTED|Overall Study||36
8843222|NCT01702233|9897450|FG000|Full Analysis Set (ITT)|Overall Study||66
8843223|NCT01702233|9897451|FG001|Full Analysis Set (ITT)|Overall Study||63
8843224|NCT01702233|9897452|FG002|Full Analysis Set (ITT)|Overall Study||31
8843225|NCT01702233|9897450|FG000|Per Protocol Set|Overall Study||58
8843226|NCT01702233|9897451|FG001|Per Protocol Set|Overall Study||58
9073026|NCT03796013|10133810|FG001|COMPLETED|Period 2||14
9073027|NCT03796013|10133809|FG000|NOT COMPLETED|Period 2||0
9073028|NCT03796013|10133810|FG001|NOT COMPLETED|Period 2||0
9073029|NCT03795753|10133818|FG000|STARTED|Overall Study||23
9073030|NCT03795753|10133819|FG001|STARTED|Overall Study||13
9073031|NCT03795753|10133818|FG000|COMPLETED|Overall Study||23
9073032|NCT03795753|10133819|FG001|COMPLETED|Overall Study||13
9073033|NCT03795753|10133818|FG000|NOT COMPLETED|Overall Study||0
9073034|NCT03795753|10133819|FG001|NOT COMPLETED|Overall Study||0
9073035|NCT03792477|10133830|FG000|STARTED|Overall Study||6
9073036|NCT03792477|10133831|FG001|STARTED|Overall Study||6
9073037|NCT03792477|10133832|FG002|STARTED|Overall Study||21
9073038|NCT03792477|10133833|FG003|STARTED|Overall Study||21
9073039|NCT03792477|10133834|FG004|STARTED|Overall Study||20
9073040|NCT03792477|10133830|FG000|COMPLETED|Overall Study||6
9073041|NCT03792477|10133831|FG001|COMPLETED|Overall Study||6
9073042|NCT03792477|10133832|FG002|COMPLETED|Overall Study||19
9073043|NCT03792477|10133833|FG003|COMPLETED|Overall Study||20
9073044|NCT03792477|10133834|FG004|COMPLETED|Overall Study||19
9073045|NCT03792477|10133830|FG000|NOT COMPLETED|Overall Study||0
9073046|NCT03792477|10133831|FG001|NOT COMPLETED|Overall Study||0
9073047|NCT03792477|10133832|FG002|NOT COMPLETED|Overall Study||2
9073048|NCT03792477|10133833|FG003|NOT COMPLETED|Overall Study||1
9073049|NCT03792477|10133834|FG004|NOT COMPLETED|Overall Study||1
9073050|NCT03783962|10133842|FG000|STARTED|Overall Study||28
9073051|NCT03783962|10133843|FG001|STARTED|Overall Study||28
9073052|NCT03783962|10133842|FG000|COMPLETED|Overall Study||25
9073053|NCT03783962|10133843|FG001|COMPLETED|Overall Study||21
9073054|NCT03783962|10133842|FG000|NOT COMPLETED|Overall Study||3
9073055|NCT03783962|10133843|FG001|NOT COMPLETED|Overall Study||7
9073056|NCT03782272|10133851|FG000|STARTED|Overall Study||6
9073057|NCT03782272|10133852|FG001|STARTED|Overall Study||6
9073058|NCT03782272|10133851|FG000|COMPLETED|Overall Study||6
9073059|NCT03782272|10133852|FG001|COMPLETED|Overall Study||6
9073060|NCT03782272|10133851|FG000|NOT COMPLETED|Overall Study||0
9073061|NCT03782272|10133852|FG001|NOT COMPLETED|Overall Study||0
9073062|NCT03779724|10133861|FG000|STARTED|Overall Study||25
9073063|NCT03779724|10133862|FG001|STARTED|Overall Study||25
9073064|NCT03779724|10133861|FG000|COMPLETED|Overall Study||19
9073065|NCT03779724|10133862|FG001|COMPLETED|Overall Study||21
9073066|NCT03779724|10133861|FG000|NOT COMPLETED|Overall Study||6
9073067|NCT03779724|10133862|FG001|NOT COMPLETED|Overall Study||4
9073068|NCT03775915|10133872|FG000|STARTED|Overall Study||12
9073069|NCT03775915|10133873|FG001|STARTED|Overall Study||12
9073070|NCT03775915|10133872|FG000|COMPLETED|Overall Study||12
9073071|NCT03775915|10133873|FG001|COMPLETED|Overall Study||12
9073072|NCT03775915|10133872|FG000|NOT COMPLETED|Overall Study||0
9073073|NCT03775915|10133873|FG001|NOT COMPLETED|Overall Study||0
9073074|NCT03794752|10133879|FG000|STARTED|Overall Study||8
9073075|NCT03794752|10133879|FG000|COMPLETED|Overall Study||8
9073076|NCT03794752|10133879|FG000|NOT COMPLETED|Overall Study||0
9073077|NCT03793751|10133889|FG000|STARTED|Overall Study||60
9073078|NCT03793751|10133890|FG001|STARTED|Overall Study||60
9073079|NCT03793751|10133889|FG000|COMPLETED|Overall Study||60
9073080|NCT03793751|10133890|FG001|COMPLETED|Overall Study||60
9073081|NCT03793751|10133889|FG000|NOT COMPLETED|Overall Study||0
9073082|NCT03793751|10133890|FG001|NOT COMPLETED|Overall Study||0
9073083|NCT03793556|10133898|FG000|STARTED|Overall Study||35
9073084|NCT03793556|10133899|FG001|STARTED|Overall Study||36
9073085|NCT03793556|10133898|FG000|COMPLETED|Overall Study||22
9073086|NCT03793556|10133899|FG001|COMPLETED|Overall Study||34
8843227|NCT01702233|9897452|FG002|Per Protocol Set|Overall Study||27
8843228|NCT01702233|9897450|FG000|COMPLETED|Overall Study||66
8843229|NCT01702233|9897451|FG001|COMPLETED|Overall Study|One of these Patient completed the Trial but had no valid outcome measure after enrolment|64
8843230|NCT01702233|9897452|FG002|COMPLETED|Overall Study||31
8843231|NCT01702233|9897450|FG000|NOT COMPLETED|Overall Study||6
8843232|NCT01702233|9897451|FG001|NOT COMPLETED|Overall Study||3
8843233|NCT01702233|9897452|FG002|NOT COMPLETED|Overall Study||5
8843234|NCT01702246|9897461|FG000|STARTED|Overall Study||24
8843235|NCT01702246|9897461|FG000|COMPLETED|Overall Study||19
8843236|NCT01702246|9897461|FG000|NOT COMPLETED|Overall Study||5
8843237|NCT01702259|9897470|FG000|STARTED|Overall Study||34
8843238|NCT01702259|9897471|FG001|STARTED|Overall Study||34
8843239|NCT01702259|9897470|FG000|COMPLETED|Overall Study||34
8843240|NCT01702259|9897471|FG001|COMPLETED|Overall Study||34
8843241|NCT01702259|9897470|FG000|NOT COMPLETED|Overall Study||0
8843242|NCT01702259|9897471|FG001|NOT COMPLETED|Overall Study||0
8843243|NCT01702298|9897477|FG000|STARTED|Overall Study||42
8843244|NCT01702298|9897477|FG000|COMPLETED|Overall Study||41
8843245|NCT01702298|9897477|FG000|NOT COMPLETED|Overall Study||1
8843246|NCT01702311|9897483|FG000|STARTED|Overall Study||122
8843247|NCT01702311|9897484|FG001|STARTED|Overall Study||113
8843248|NCT01702311|9897483|FG000|COMPLETED|Overall Study||106
8843249|NCT01702311|9897484|FG001|COMPLETED|Overall Study||100
8843250|NCT01702311|9897483|FG000|NOT COMPLETED|Overall Study||16
8843251|NCT01702311|9897484|FG001|NOT COMPLETED|Overall Study||13
8843252|NCT01702363|9897493|FG000|STARTED|Overall Study||131
8843253|NCT01702363|9897493|FG000|COMPLETED|Overall Study||111
9073087|NCT03793556|10133898|FG000|NOT COMPLETED|Overall Study||13
9073088|NCT03793556|10133899|FG001|NOT COMPLETED|Overall Study||2
9073089|NCT03785548|10133910|FG000|STARTED|Overall Study||73
9073090|NCT03785548|10133911|FG001|STARTED|Overall Study||74
9073091|NCT03785548|10133910|FG000|COMPLETED|Overall Study||71
9073092|NCT03785548|10133911|FG001|COMPLETED|Overall Study||74
8843254|NCT01702363|9897493|FG000|NOT COMPLETED|Overall Study||20
8843255|NCT01702428|9897502|FG000|STARTED|Overall Study||1239
8843256|NCT01702428|9897503|FG001|STARTED|Overall Study||1232
9073093|NCT03785548|10133910|FG000|NOT COMPLETED|Overall Study||2
9073094|NCT03785548|10133911|FG001|NOT COMPLETED|Overall Study||0
9073095|NCT03782701|10133917|FG000|STARTED|Overall Study||43
8843257|NCT01702428|9897504|FG002|STARTED|Overall Study||1243
8843258|NCT01702428|9897505|FG003|STARTED|Overall Study||1289
8843259|NCT01702428|9897502|FG000|COMPLETED|Overall Study||1175
8843260|NCT01702428|9897503|FG001|COMPLETED|Overall Study||1162
9073096|NCT03782701|10133917|FG000|Lumify|Overall Study||43
9073097|NCT03782701|10133917|FG000|Saline Solution|Overall Study||43
9073098|NCT03782701|10133917|FG000|COMPLETED|Overall Study||43
9073099|NCT03782701|10133917|FG000|NOT COMPLETED|Overall Study||0
9073100|NCT03773133|10133923|FG000|STARTED|Overall Study||8
9073101|NCT03773133|10133923|FG000|Received the Screening IIP|Overall Study||8
9073102|NCT03773133|10133923|FG000|Received the Therapeutic IRPP|Overall Study||0
9073103|NCT03773133|10133923|FG000|COMPLETED|Overall Study||0
9073104|NCT03773133|10133923|FG000|NOT COMPLETED|Overall Study||8
9073105|NCT03792672|10133928|FG000|STARTED|Treatment Period 1 (1 Day)||4
9073106|NCT03792672|10133929|FG001|STARTED|Treatment Period 1 (1 Day)||4
9073107|NCT03792672|10133930|FG002|STARTED|Treatment Period 1 (1 Day)||4
9073108|NCT03792672|10133931|FG003|STARTED|Treatment Period 1 (1 Day)||4
9073109|NCT03792672|10133932|FG004|STARTED|Treatment Period 1 (1 Day)||4
9073110|NCT03792672|10133933|FG005|STARTED|Treatment Period 1 (1 Day)||4
9073111|NCT03792672|10133928|FG000|COMPLETED|Treatment Period 1 (1 Day)||4
9073112|NCT03792672|10133929|FG001|COMPLETED|Treatment Period 1 (1 Day)||4
9073113|NCT03792672|10133930|FG002|COMPLETED|Treatment Period 1 (1 Day)||4
9073114|NCT03792672|10133931|FG003|COMPLETED|Treatment Period 1 (1 Day)||4
9073115|NCT03792672|10133932|FG004|COMPLETED|Treatment Period 1 (1 Day)||4
9073116|NCT03792672|10133933|FG005|COMPLETED|Treatment Period 1 (1 Day)||4
9073117|NCT03792672|10133928|FG000|NOT COMPLETED|Treatment Period 1 (1 Day)||0
9073118|NCT03792672|10133929|FG001|NOT COMPLETED|Treatment Period 1 (1 Day)||0
9073119|NCT03792672|10133930|FG002|NOT COMPLETED|Treatment Period 1 (1 Day)||0
9073120|NCT03792672|10133931|FG003|NOT COMPLETED|Treatment Period 1 (1 Day)||0
9073121|NCT03792672|10133932|FG004|NOT COMPLETED|Treatment Period 1 (1 Day)||0
9073122|NCT03792672|10133933|FG005|NOT COMPLETED|Treatment Period 1 (1 Day)||0
9073123|NCT03792672|10133928|FG000|STARTED|Washout Period 1 (10 Days)||4
9073124|NCT03792672|10133929|FG001|STARTED|Washout Period 1 (10 Days)||4
9073125|NCT03792672|10133930|FG002|STARTED|Washout Period 1 (10 Days)||4
9073126|NCT03792672|10133931|FG003|STARTED|Washout Period 1 (10 Days)||4
9073127|NCT03792672|10133932|FG004|STARTED|Washout Period 1 (10 Days)||4
9073128|NCT03792672|10133933|FG005|STARTED|Washout Period 1 (10 Days)||4
9073129|NCT03792672|10133928|FG000|COMPLETED|Washout Period 1 (10 Days)||4
9073130|NCT03792672|10133929|FG001|COMPLETED|Washout Period 1 (10 Days)||4
9073131|NCT03792672|10133930|FG002|COMPLETED|Washout Period 1 (10 Days)||4
9073132|NCT03792672|10133931|FG003|COMPLETED|Washout Period 1 (10 Days)||4
9073133|NCT03792672|10133932|FG004|COMPLETED|Washout Period 1 (10 Days)||4
9073134|NCT03792672|10133933|FG005|COMPLETED|Washout Period 1 (10 Days)||4
9073135|NCT03792672|10133928|FG000|NOT COMPLETED|Washout Period 1 (10 Days)||0
9073136|NCT03792672|10133929|FG001|NOT COMPLETED|Washout Period 1 (10 Days)||0
9073137|NCT03792672|10133930|FG002|NOT COMPLETED|Washout Period 1 (10 Days)||0
9073138|NCT03792672|10133931|FG003|NOT COMPLETED|Washout Period 1 (10 Days)||0
9073139|NCT03792672|10133932|FG004|NOT COMPLETED|Washout Period 1 (10 Days)||0
9073140|NCT03792672|10133933|FG005|NOT COMPLETED|Washout Period 1 (10 Days)||0
9073141|NCT03792672|10133928|FG000|STARTED|Treatment Period 2 (1 Day)||4
9073142|NCT03792672|10133929|FG001|STARTED|Treatment Period 2 (1 Day)||4
9073143|NCT03792672|10133930|FG002|STARTED|Treatment Period 2 (1 Day)||4
9073144|NCT03792672|10133931|FG003|STARTED|Treatment Period 2 (1 Day)||4
9073145|NCT03792672|10133932|FG004|STARTED|Treatment Period 2 (1 Day)||4
9073146|NCT03792672|10133933|FG005|STARTED|Treatment Period 2 (1 Day)||4
9073147|NCT03792672|10133928|FG000|COMPLETED|Treatment Period 2 (1 Day)||4
9073148|NCT03792672|10133929|FG001|COMPLETED|Treatment Period 2 (1 Day)||4
9073149|NCT03792672|10133930|FG002|COMPLETED|Treatment Period 2 (1 Day)||4
8843261|NCT01702428|9897504|FG002|COMPLETED|Overall Study||1190
8843262|NCT01702428|9897505|FG003|COMPLETED|Overall Study||1232
8843263|NCT01702428|9897502|FG000|NOT COMPLETED|Overall Study||64
8843264|NCT01702428|9897503|FG001|NOT COMPLETED|Overall Study||70
8843265|NCT01702428|9897504|FG002|NOT COMPLETED|Overall Study||53
8843266|NCT01702428|9897505|FG003|NOT COMPLETED|Overall Study||57
8843267|NCT01702454|9897524|FG000|STARTED|Overall Study||241
8843268|NCT01702454|9897525|FG001|STARTED|Overall Study||229
8843269|NCT01702454|9897524|FG000|COMPLETED|Overall Study||238
8843270|NCT01702454|9897525|FG001|COMPLETED|Overall Study||221
8843271|NCT01702454|9897524|FG000|NOT COMPLETED|Overall Study||3
8843272|NCT01702454|9897525|FG001|NOT COMPLETED|Overall Study||8
8843273|NCT01702519|9897536|FG000|STARTED|Period 1||20
8843274|NCT01702519|9897537|FG001|STARTED|Period 1||20
8843275|NCT01702519|9897536|FG000|COMPLETED|Period 1||20
8843276|NCT01702519|9897537|FG001|COMPLETED|Period 1||20
8843277|NCT01702519|9897536|FG000|NOT COMPLETED|Period 1||0
8843278|NCT01702519|9897537|FG001|NOT COMPLETED|Period 1||0
8843279|NCT01702519|9897536|FG000|STARTED|Washout Period||20
8843280|NCT01702519|9897537|FG001|STARTED|Washout Period||20
8843281|NCT01702519|9897536|FG000|COMPLETED|Washout Period||19
8843282|NCT01702519|9897537|FG001|COMPLETED|Washout Period||18
8843283|NCT01702519|9897536|FG000|NOT COMPLETED|Washout Period||1
8843284|NCT01702519|9897537|FG001|NOT COMPLETED|Washout Period||2
8843285|NCT01702519|9897536|FG000|STARTED|Period 2||19
8843286|NCT01702519|9897537|FG001|STARTED|Period 2||18
8843287|NCT01702519|9897536|FG000|COMPLETED|Period 2||19
8843288|NCT01702519|9897537|FG001|COMPLETED|Period 2||18
9073150|NCT03792672|10133931|FG003|COMPLETED|Treatment Period 2 (1 Day)||4
8843289|NCT01702519|9897536|FG000|NOT COMPLETED|Period 2||0
8843290|NCT01702519|9897537|FG001|NOT COMPLETED|Period 2||0
8843291|NCT01702532|9897549|FG000|STARTED|Overall Study||161
8843292|NCT01702532|9897550|FG001|STARTED|Overall Study||161
8843293|NCT01702532|9897549|FG000|Safety Population|Overall Study||161
8843294|NCT01702532|9897550|FG001|Safety Population|Overall Study|One subject randomized but did not receive the study treatment.|160
8843295|NCT01702532|9897549|FG000|COMPLETED|Overall Study||161
9073151|NCT03792672|10133932|FG004|COMPLETED|Treatment Period 2 (1 Day)||4
9073152|NCT03792672|10133933|FG005|COMPLETED|Treatment Period 2 (1 Day)||4
9073153|NCT03792672|10133928|FG000|NOT COMPLETED|Treatment Period 2 (1 Day)||0
9073154|NCT03792672|10133929|FG001|NOT COMPLETED|Treatment Period 2 (1 Day)||0
9073155|NCT03792672|10133930|FG002|NOT COMPLETED|Treatment Period 2 (1 Day)||0
9073156|NCT03792672|10133931|FG003|NOT COMPLETED|Treatment Period 2 (1 Day)||0
9073157|NCT03792672|10133932|FG004|NOT COMPLETED|Treatment Period 2 (1 Day)||0
9073158|NCT03792672|10133933|FG005|NOT COMPLETED|Treatment Period 2 (1 Day)||0
9073159|NCT03792672|10133928|FG000|STARTED|Washout Period 2 (10 Days)||4
9073160|NCT03792672|10133929|FG001|STARTED|Washout Period 2 (10 Days)||4
9073161|NCT03792672|10133930|FG002|STARTED|Washout Period 2 (10 Days)||4
9073162|NCT03792672|10133931|FG003|STARTED|Washout Period 2 (10 Days)||4
9073163|NCT03792672|10133932|FG004|STARTED|Washout Period 2 (10 Days)||4
9073164|NCT03792672|10133933|FG005|STARTED|Washout Period 2 (10 Days)||4
9073165|NCT03792672|10133928|FG000|COMPLETED|Washout Period 2 (10 Days)||4
9073166|NCT03792672|10133929|FG001|COMPLETED|Washout Period 2 (10 Days)||4
9073167|NCT03792672|10133930|FG002|COMPLETED|Washout Period 2 (10 Days)||4
9073168|NCT03792672|10133931|FG003|COMPLETED|Washout Period 2 (10 Days)||4
9073169|NCT03792672|10133932|FG004|COMPLETED|Washout Period 2 (10 Days)||4
9073170|NCT03792672|10133933|FG005|COMPLETED|Washout Period 2 (10 Days)||4
9073171|NCT03792672|10133928|FG000|NOT COMPLETED|Washout Period 2 (10 Days)||0
9073172|NCT03792672|10133929|FG001|NOT COMPLETED|Washout Period 2 (10 Days)||0
9073173|NCT03792672|10133930|FG002|NOT COMPLETED|Washout Period 2 (10 Days)||0
9073174|NCT03792672|10133931|FG003|NOT COMPLETED|Washout Period 2 (10 Days)||0
9073175|NCT03792672|10133932|FG004|NOT COMPLETED|Washout Period 2 (10 Days)||0
9073176|NCT03792672|10133933|FG005|NOT COMPLETED|Washout Period 2 (10 Days)||0
9073177|NCT03792672|10133928|FG000|STARTED|Treatment Period 3 (1 Day)||4
9073178|NCT03792672|10133929|FG001|STARTED|Treatment Period 3 (1 Day)||4
9073179|NCT03792672|10133930|FG002|STARTED|Treatment Period 3 (1 Day)||4
9073180|NCT03792672|10133931|FG003|STARTED|Treatment Period 3 (1 Day)||4
9073181|NCT03792672|10133932|FG004|STARTED|Treatment Period 3 (1 Day)||4
9073182|NCT03792672|10133933|FG005|STARTED|Treatment Period 3 (1 Day)||4
9073183|NCT03792672|10133928|FG000|COMPLETED|Treatment Period 3 (1 Day)||4
9073184|NCT03792672|10133929|FG001|COMPLETED|Treatment Period 3 (1 Day)||4
9073185|NCT03792672|10133930|FG002|COMPLETED|Treatment Period 3 (1 Day)||4
9073186|NCT03792672|10133931|FG003|COMPLETED|Treatment Period 3 (1 Day)||4
9073187|NCT03792672|10133932|FG004|COMPLETED|Treatment Period 3 (1 Day)||4
9073188|NCT03792672|10133933|FG005|COMPLETED|Treatment Period 3 (1 Day)||4
9073189|NCT03792672|10133928|FG000|NOT COMPLETED|Treatment Period 3 (1 Day)||0
9073190|NCT03792672|10133929|FG001|NOT COMPLETED|Treatment Period 3 (1 Day)||0
9073191|NCT03792672|10133930|FG002|NOT COMPLETED|Treatment Period 3 (1 Day)||0
9073192|NCT03792672|10133931|FG003|NOT COMPLETED|Treatment Period 3 (1 Day)||0
9073193|NCT03792672|10133932|FG004|NOT COMPLETED|Treatment Period 3 (1 Day)||0
9073194|NCT03792672|10133933|FG005|NOT COMPLETED|Treatment Period 3 (1 Day)||0
9073195|NCT03792672|10133928|FG000|STARTED|Washout Period 3 (10 Days)||4
9073196|NCT03792672|10133929|FG001|STARTED|Washout Period 3 (10 Days)||4
9073197|NCT03792672|10133930|FG002|STARTED|Washout Period 3 (10 Days)||4
9073198|NCT03792672|10133931|FG003|STARTED|Washout Period 3 (10 Days)||4
9073199|NCT03792672|10133932|FG004|STARTED|Washout Period 3 (10 Days)||4
9073200|NCT03792672|10133933|FG005|STARTED|Washout Period 3 (10 Days)||4
9073201|NCT03792672|10133928|FG000|COMPLETED|Washout Period 3 (10 Days)||3
9073202|NCT03792672|10133929|FG001|COMPLETED|Washout Period 3 (10 Days)||4
9073203|NCT03792672|10133930|FG002|COMPLETED|Washout Period 3 (10 Days)||3
9073204|NCT03792672|10133931|FG003|COMPLETED|Washout Period 3 (10 Days)||2
9073205|NCT03792672|10133932|FG004|COMPLETED|Washout Period 3 (10 Days)||4
9073206|NCT03792672|10133933|FG005|COMPLETED|Washout Period 3 (10 Days)||4
9073207|NCT03792672|10133928|FG000|NOT COMPLETED|Washout Period 3 (10 Days)||1
9073208|NCT03792672|10133929|FG001|NOT COMPLETED|Washout Period 3 (10 Days)||0
9073209|NCT03792672|10133930|FG002|NOT COMPLETED|Washout Period 3 (10 Days)||1
9073210|NCT03792672|10133931|FG003|NOT COMPLETED|Washout Period 3 (10 Days)||2
9073211|NCT03792672|10133932|FG004|NOT COMPLETED|Washout Period 3 (10 Days)||0
9073212|NCT03792672|10133933|FG005|NOT COMPLETED|Washout Period 3 (10 Days)||0
9073213|NCT03792672|10133928|FG000|STARTED|Treatment Period 4 (2 Days)||3
9073214|NCT03792672|10133929|FG001|STARTED|Treatment Period 4 (2 Days)||4
9073215|NCT03792672|10133930|FG002|STARTED|Treatment Period 4 (2 Days)||3
9073216|NCT03792672|10133931|FG003|STARTED|Treatment Period 4 (2 Days)||2
9073217|NCT03792672|10133932|FG004|STARTED|Treatment Period 4 (2 Days)||4
9073218|NCT03792672|10133933|FG005|STARTED|Treatment Period 4 (2 Days)||4
9073219|NCT03792672|10133928|FG000|COMPLETED|Treatment Period 4 (2 Days)||2
9073220|NCT03792672|10133929|FG001|COMPLETED|Treatment Period 4 (2 Days)||4
9073221|NCT03792672|10133930|FG002|COMPLETED|Treatment Period 4 (2 Days)||3
9073222|NCT03792672|10133931|FG003|COMPLETED|Treatment Period 4 (2 Days)||2
9073223|NCT03792672|10133932|FG004|COMPLETED|Treatment Period 4 (2 Days)||4
9073224|NCT03792672|10133933|FG005|COMPLETED|Treatment Period 4 (2 Days)||4
9073225|NCT03792672|10133928|FG000|NOT COMPLETED|Treatment Period 4 (2 Days)||1
9073226|NCT03792672|10133929|FG001|NOT COMPLETED|Treatment Period 4 (2 Days)||0
9073227|NCT03792672|10133930|FG002|NOT COMPLETED|Treatment Period 4 (2 Days)||0
9073228|NCT03792672|10133931|FG003|NOT COMPLETED|Treatment Period 4 (2 Days)||0
9073229|NCT03792672|10133932|FG004|NOT COMPLETED|Treatment Period 4 (2 Days)||0
9073230|NCT03792672|10133933|FG005|NOT COMPLETED|Treatment Period 4 (2 Days)||0
9073231|NCT03786744|10133945|FG000|STARTED|Overall Study||10
9073232|NCT03786744|10133946|FG001|STARTED|Overall Study||10
9073233|NCT03786744|10133945|FG000|COMPLETED|Overall Study||10
9073234|NCT03786744|10133946|FG001|COMPLETED|Overall Study||10
9073235|NCT03786744|10133945|FG000|NOT COMPLETED|Overall Study||0
9073236|NCT03786744|10133946|FG001|NOT COMPLETED|Overall Study||0
9073237|NCT03782181|10133955|FG000|STARTED|Overall Study||20
9073238|NCT03782181|10133956|FG001|STARTED|Overall Study||20
9073239|NCT03782181|10133955|FG000|COMPLETED|Overall Study||20
9073240|NCT03782181|10133956|FG001|COMPLETED|Overall Study||20
9073241|NCT03782181|10133955|FG000|NOT COMPLETED|Overall Study||0
9073242|NCT03782181|10133956|FG001|NOT COMPLETED|Overall Study||0
9073243|NCT03792191|10133965|FG000|STARTED|Overall Study||140
9073244|NCT03792191|10133966|FG001|STARTED|Overall Study||140
9073245|NCT03792191|10133965|FG000|COMPLETED|Overall Study||140
9073246|NCT03792191|10133966|FG001|COMPLETED|Overall Study||140
9073247|NCT03792191|10133965|FG000|NOT COMPLETED|Overall Study||0
9073248|NCT03792191|10133966|FG001|NOT COMPLETED|Overall Study||0
9073249|NCT03791489|10133972|FG000|STARTED|30 Days||30
9073250|NCT03791489|10133972|FG000|COMPLETED|30 Days||30
9073251|NCT03791489|10133972|FG000|NOT COMPLETED|30 Days||0
9073252|NCT03791489|10133972|FG000|STARTED|90 Days (Primary Endpoint)||30
9073253|NCT03791489|10133972|FG000|COMPLETED|90 Days (Primary Endpoint)||30
9073254|NCT03791489|10133972|FG000|NOT COMPLETED|90 Days (Primary Endpoint)||0
9073255|NCT03790865|10133979|FG000|STARTED|Overall Study||52
9073256|NCT03790865|10133980|FG001|STARTED|Overall Study||52
9073257|NCT03790865|10133981|FG002|STARTED|Overall Study||54
9073258|NCT03790865|10133979|FG000|COMPLETED|Overall Study||52
9073259|NCT03790865|10133980|FG001|COMPLETED|Overall Study||50
9073260|NCT03790865|10133981|FG002|COMPLETED|Overall Study||54
9073261|NCT03790865|10133979|FG000|NOT COMPLETED|Overall Study||0
9073262|NCT03790865|10133980|FG001|NOT COMPLETED|Overall Study||2
9073263|NCT03790865|10133981|FG002|NOT COMPLETED|Overall Study||0
9073264|NCT03784300|10133995|FG000|STARTED|Overall Study||6
9073265|NCT03784300|10133996|FG001|STARTED|Overall Study||2
9073266|NCT03784300|10133997|FG002|STARTED|Overall Study||6
9073267|NCT03784300|10133998|FG003|STARTED|Overall Study||2
9073268|NCT03784300|10133999|FG004|STARTED|Overall Study||6
8624110|NCT00498433|9663346|FG000|NOT COMPLETED|Part 2: Placebo Run-in (2 Weeks)||20
8624111|NCT00498433|9663347|FG001|NOT COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
9073269|NCT03784300|10134000|FG005|STARTED|Overall Study||2
9073270|NCT03784300|10133995|FG000|COMPLETED|Overall Study||6
9073271|NCT03784300|10133996|FG001|COMPLETED|Overall Study||2
9073272|NCT03784300|10133997|FG002|COMPLETED|Overall Study||6
9073273|NCT03784300|10133998|FG003|COMPLETED|Overall Study||2
9073274|NCT03784300|10133999|FG004|COMPLETED|Overall Study||6
9073275|NCT03784300|10134000|FG005|COMPLETED|Overall Study||2
9073276|NCT03784300|10133995|FG000|NOT COMPLETED|Overall Study||0
9073277|NCT03784300|10133996|FG001|NOT COMPLETED|Overall Study||0
9073278|NCT03784300|10133997|FG002|NOT COMPLETED|Overall Study||0
9073279|NCT03784300|10133998|FG003|NOT COMPLETED|Overall Study||0
9073280|NCT03784300|10133999|FG004|NOT COMPLETED|Overall Study||0
9073281|NCT03784300|10134000|FG005|NOT COMPLETED|Overall Study||0
9073282|NCT03790878|10134017|FG000|STARTED|Overall Study||26
9073283|NCT03790878|10134018|FG001|STARTED|Overall Study||27
9073284|NCT03790878|10134019|FG002|STARTED|Overall Study||27
9073285|NCT03790878|10134017|FG000|COMPLETED|Overall Study||26
9073286|NCT03790878|10134018|FG001|COMPLETED|Overall Study||27
9073287|NCT03790878|10134019|FG002|COMPLETED|Overall Study||27
9073288|NCT03790878|10134017|FG000|NOT COMPLETED|Overall Study||0
9073289|NCT03790878|10134018|FG001|NOT COMPLETED|Overall Study||0
9073290|NCT03790878|10134019|FG002|NOT COMPLETED|Overall Study||0
9073291|NCT03789474|10134029|FG000|STARTED|Overall Study||30
9073292|NCT03789474|10134030|FG001|STARTED|Overall Study||30
9073293|NCT03789474|10134029|FG000|COMPLETED|Overall Study||30
9073294|NCT03789474|10134030|FG001|COMPLETED|Overall Study||30
9073295|NCT03789474|10134029|FG000|NOT COMPLETED|Overall Study||0
9073296|NCT03789474|10134030|FG001|NOT COMPLETED|Overall Study||0
9073297|NCT03789175|10134036|FG000|STARTED|Week 0 to Week 12 of NR||1
9073298|NCT03789175|10134036|FG000|COMPLETED|Week 0 to Week 12 of NR||1
9073299|NCT03789175|10134036|FG000|NOT COMPLETED|Week 0 to Week 12 of NR||0
9073300|NCT03789175|10134036|FG000|STARTED|Week 12 to Week 24 of NR||1
9073301|NCT03789175|10134036|FG000|COMPLETED|Week 12 to Week 24 of NR|Participant did not meet primary endpoint and completed study at week 24|1
9073302|NCT03789175|10134036|FG000|NOT COMPLETED|Week 12 to Week 24 of NR||0
9073303|NCT03787615|10134042|FG000|STARTED|Overall Study||31
9073304|NCT03787615|10134042|FG000|COMPLETED|Overall Study||27
8624112|NCT00498433|9663348|FG002|NOT COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
9073305|NCT03787615|10134042|FG000|NOT COMPLETED|Overall Study||4
9073306|NCT03786718|10134047|FG000|STARTED|Overall Study||67
9073307|NCT03786718|10134047|FG000|COMPLETED|Overall Study||60
8624113|NCT00498433|9663346|FG000|STARTED|Part 2: Double Blind (12 Weeks)||0
9073308|NCT03786718|10134047|FG000|NOT COMPLETED|Overall Study||7
9073309|NCT03784963|10134056|FG000|STARTED|Overall Study||12
9073310|NCT03784963|10134057|FG001|STARTED|Overall Study||10
9073311|NCT03784963|10134058|FG002|STARTED|Overall Study||1
9073312|NCT03784963|10134059|FG003|STARTED|Overall Study||0
9073313|NCT03784963|10134056|FG000|COMPLETED|Overall Study||0
9073314|NCT03784963|10134057|FG001|COMPLETED|Overall Study||0
9073315|NCT03784963|10134058|FG002|COMPLETED|Overall Study||0
9073316|NCT03784963|10134059|FG003|COMPLETED|Overall Study||0
9073317|NCT03784963|10134056|FG000|NOT COMPLETED|Overall Study||12
9073318|NCT03784963|10134057|FG001|NOT COMPLETED|Overall Study||10
9073319|NCT03784963|10134058|FG002|NOT COMPLETED|Overall Study||1
9073320|NCT03784963|10134059|FG003|NOT COMPLETED|Overall Study||0
9073321|NCT03771274|10134069|FG000|STARTED|Overall Study||39
9073322|NCT03771274|10134069|FG000|COMPLETED|Overall Study||39
9073323|NCT03771274|10134069|FG000|NOT COMPLETED|Overall Study||0
9073324|NCT03787472|10134073|FG000|STARTED|Period 1||23
9073325|NCT03787472|10134074|FG001|STARTED|Period 1||22
9073326|NCT03787472|10134073|FG000|COMPLETED|Period 1||23
9073327|NCT03787472|10134074|FG001|COMPLETED|Period 1||22
9073328|NCT03787472|10134073|FG000|NOT COMPLETED|Period 1||0
9073329|NCT03787472|10134074|FG001|NOT COMPLETED|Period 1||0
9073330|NCT03787472|10134073|FG000|STARTED|Period 2||23
9073331|NCT03787472|10134074|FG001|STARTED|Period 2||22
9073332|NCT03787472|10134073|FG000|COMPLETED|Period 2||23
9073333|NCT03787472|10134074|FG001|COMPLETED|Period 2||22
9073334|NCT03787472|10134073|FG000|NOT COMPLETED|Period 2||0
9073335|NCT03787472|10134074|FG001|NOT COMPLETED|Period 2||0
9073336|NCT03787212|10134080|FG000|STARTED|Period 1||2
9073337|NCT03787212|10134081|FG001|STARTED|Period 1||2
9073338|NCT03787212|10134080|FG000|COMPLETED|Period 1||2
9073339|NCT03787212|10134081|FG001|COMPLETED|Period 1||2
9073340|NCT03787212|10134080|FG000|NOT COMPLETED|Period 1||0
9073341|NCT03787212|10134081|FG001|NOT COMPLETED|Period 1||0
9073342|NCT03787212|10134080|FG000|STARTED|Period 1||2
9073343|NCT03787212|10134081|FG001|STARTED|Period 1||2
9073344|NCT03787212|10134080|FG000|COMPLETED|Period 1||0
9073345|NCT03787212|10134081|FG001|COMPLETED|Period 1||0
9073346|NCT03787212|10134080|FG000|NOT COMPLETED|Period 1||2
9073347|NCT03787212|10134081|FG001|NOT COMPLETED|Period 1||2
9073348|NCT03784001|10134090|FG000|STARTED|Overall Study||46
9073349|NCT03784001|10134091|FG001|STARTED|Overall Study||38
9073350|NCT03784001|10134092|FG002|STARTED|Overall Study||41
9073351|NCT03784001|10134090|FG000|COMPLETED|Overall Study||44
9073352|NCT03784001|10134091|FG001|COMPLETED|Overall Study||38
9073353|NCT03784001|10134092|FG002|COMPLETED|Overall Study||40
9073354|NCT03784001|10134090|FG000|NOT COMPLETED|Overall Study||2
9073355|NCT03784001|10134091|FG001|NOT COMPLETED|Overall Study||0
9073356|NCT03784001|10134092|FG002|NOT COMPLETED|Overall Study||1
9073357|NCT03783702|10134102|FG000|STARTED|Overall Study||56
9073358|NCT03783702|10134103|FG001|STARTED|Overall Study||62
9073359|NCT03783702|10134102|FG000|COMPLETED|Overall Study||49
9073360|NCT03783702|10134103|FG001|COMPLETED|Overall Study||51
9073361|NCT03783702|10134102|FG000|NOT COMPLETED|Overall Study||7
9073362|NCT03783702|10134103|FG001|NOT COMPLETED|Overall Study||11
9073363|NCT03781479|10134112|FG000|STARTED|Overall Study||6
9073364|NCT03781479|10134113|FG001|STARTED|Overall Study||6
9073365|NCT03781479|10134114|FG002|STARTED|Overall Study||1
9073366|NCT03781479|10134112|FG000|COMPLETED|Overall Study||6
9073367|NCT03781479|10134113|FG001|COMPLETED|Overall Study||6
9073368|NCT03781479|10134114|FG002|COMPLETED|Overall Study||0
9073369|NCT03781479|10134112|FG000|NOT COMPLETED|Overall Study||0
9073370|NCT03781479|10134113|FG001|NOT COMPLETED|Overall Study||0
9073371|NCT03781479|10134114|FG002|NOT COMPLETED|Overall Study||1
9073372|NCT03781037|10134120|FG000|STARTED|Overall Study||18
9073373|NCT03781037|10134120|FG000|COMPLETED|Overall Study||18
8843296|NCT01702532|9897550|FG001|COMPLETED|Overall Study||160
8843297|NCT01702532|9897549|FG000|NOT COMPLETED|Overall Study||0
8843298|NCT01702532|9897550|FG001|NOT COMPLETED|Overall Study||1
8843299|NCT01702558|9897562|FG000|STARTED|Overall Study||7
8843300|NCT01702558|9897563|FG001|STARTED|Overall Study||5
8843301|NCT01702558|9897564|FG002|STARTED|Overall Study||6
8843302|NCT01702558|9897565|FG003|STARTED|Overall Study||81
8843303|NCT01702558|9897566|FG004|STARTED|Overall Study||80
8843304|NCT01702558|9897562|FG000|COMPLETED|Overall Study||3
8843305|NCT01702558|9897563|FG001|COMPLETED|Overall Study||1
8843306|NCT01702558|9897564|FG002|COMPLETED|Overall Study||1
8843307|NCT01702558|9897565|FG003|COMPLETED|Overall Study||34
8843308|NCT01702558|9897566|FG004|COMPLETED|Overall Study||38
8843309|NCT01702558|9897562|FG000|NOT COMPLETED|Overall Study||4
8843310|NCT01702558|9897563|FG001|NOT COMPLETED|Overall Study||4
8843311|NCT01702558|9897564|FG002|NOT COMPLETED|Overall Study||5
8843312|NCT01702558|9897565|FG003|NOT COMPLETED|Overall Study||47
8843313|NCT01702558|9897566|FG004|NOT COMPLETED|Overall Study||42
8843314|NCT01702844|9897579|FG000|STARTED|Overall Study||42
8843315|NCT01702844|9897579|FG000|Disease Progression|Overall Study||23
8843316|NCT01702844|9897579|FG000|COMPLETED|Overall Study||23
8843317|NCT01702844|9897579|FG000|NOT COMPLETED|Overall Study||19
8843318|NCT01702961|9897583|FG000|STARTED|Overall Study||75
9073374|NCT03781037|10134120|FG000|NOT COMPLETED|Overall Study||0
9073375|NCT03784079|10134132|FG000|STARTED|Part 1: Up to Day 24||6
9073376|NCT03784079|10134133|FG001|STARTED|Part 1: Up to Day 24||6
9073377|NCT03784079|10134134|FG002|STARTED|Part 1: Up to Day 24||2
8843319|NCT01702961|9897583|FG000|COMPLETED|Overall Study||28
8843320|NCT01702961|9897583|FG000|NOT COMPLETED|Overall Study||47
8843321|NCT01702987|9897589|FG000|STARTED|Overall Study||10
8843322|NCT01702987|9897590|FG001|STARTED|Overall Study||12
9073378|NCT03784079|10134135|FG003|STARTED|Part 1: Up to Day 24||0
9073379|NCT03784079|10134136|FG004|STARTED|Part 1: Up to Day 24||0
9073380|NCT03784079|10134137|FG005|STARTED|Part 1: Up to Day 24||0
9073381|NCT03784079|10134138|FG006|STARTED|Part 1: Up to Day 24||0
9073382|NCT03784079|10134132|FG000|COMPLETED|Part 1: Up to Day 24||6
9073383|NCT03784079|10134133|FG001|COMPLETED|Part 1: Up to Day 24||6
9073384|NCT03784079|10134134|FG002|COMPLETED|Part 1: Up to Day 24||2
9073385|NCT03784079|10134135|FG003|COMPLETED|Part 1: Up to Day 24||0
9073386|NCT03784079|10134136|FG004|COMPLETED|Part 1: Up to Day 24||0
9073387|NCT03784079|10134137|FG005|COMPLETED|Part 1: Up to Day 24||0
9073388|NCT03784079|10134138|FG006|COMPLETED|Part 1: Up to Day 24||0
9073389|NCT03784079|10134132|FG000|NOT COMPLETED|Part 1: Up to Day 24||0
9073390|NCT03784079|10134133|FG001|NOT COMPLETED|Part 1: Up to Day 24||0
9073391|NCT03784079|10134134|FG002|NOT COMPLETED|Part 1: Up to Day 24||0
9073392|NCT03784079|10134135|FG003|NOT COMPLETED|Part 1: Up to Day 24||0
9073393|NCT03784079|10134136|FG004|NOT COMPLETED|Part 1: Up to Day 24||0
9073394|NCT03784079|10134137|FG005|NOT COMPLETED|Part 1: Up to Day 24||0
9073395|NCT03784079|10134138|FG006|NOT COMPLETED|Part 1: Up to Day 24||0
9073396|NCT03784079|10134132|FG000|STARTED|Part 2: Up to Day 12||0
9073397|NCT03784079|10134133|FG001|STARTED|Part 2: Up to Day 12||0
9073398|NCT03784079|10134134|FG002|STARTED|Part 2: Up to Day 12||0
9073399|NCT03784079|10134135|FG003|STARTED|Part 2: Up to Day 12||6
9073400|NCT03784079|10134136|FG004|STARTED|Part 2: Up to Day 12||6
9073401|NCT03784079|10134137|FG005|STARTED|Part 2: Up to Day 12||6
9073402|NCT03784079|10134138|FG006|STARTED|Part 2: Up to Day 12||2
9073403|NCT03784079|10134132|FG000|COMPLETED|Part 2: Up to Day 12||0
9073404|NCT03784079|10134133|FG001|COMPLETED|Part 2: Up to Day 12||0
9073405|NCT03784079|10134134|FG002|COMPLETED|Part 2: Up to Day 12||0
9073406|NCT03784079|10134135|FG003|COMPLETED|Part 2: Up to Day 12||6
9073407|NCT03784079|10134136|FG004|COMPLETED|Part 2: Up to Day 12||6
9073408|NCT03784079|10134137|FG005|COMPLETED|Part 2: Up to Day 12||6
9073409|NCT03784079|10134138|FG006|COMPLETED|Part 2: Up to Day 12||2
9073410|NCT03784079|10134132|FG000|NOT COMPLETED|Part 2: Up to Day 12||0
8843323|NCT01702987|9897589|FG000|COMPLETED|Overall Study||9
8843324|NCT01702987|9897590|FG001|COMPLETED|Overall Study||12
8843325|NCT01702987|9897589|FG000|NOT COMPLETED|Overall Study||1
8843326|NCT01702987|9897590|FG001|NOT COMPLETED|Overall Study||0
8843327|NCT01703000|9897596|FG000|STARTED|Overall Study||100
8843328|NCT01703000|9897596|FG000|COMPLETED|Overall Study||99
8843329|NCT01703000|9897596|FG000|NOT COMPLETED|Overall Study||1
8843330|NCT01703039|9897602|FG000|STARTED|Overall Study||9
8843331|NCT01703039|9897603|FG001|STARTED|Overall Study||12
8843332|NCT01703039|9897602|FG000|COMPLETED|Overall Study||6
8843333|NCT01703039|9897603|FG001|COMPLETED|Overall Study||7
8843334|NCT01703039|9897602|FG000|NOT COMPLETED|Overall Study||3
8843335|NCT01703039|9897603|FG001|NOT COMPLETED|Overall Study||5
8843336|NCT01703065|9897613|FG000|STARTED|Overall Study||9
8843337|NCT01703065|9897614|FG001|STARTED|Overall Study||0
8843338|NCT01703065|9897613|FG000|COMPLETED|Overall Study||8
8843339|NCT01703065|9897614|FG001|COMPLETED|Overall Study||0
8843340|NCT01703065|9897613|FG000|NOT COMPLETED|Overall Study||1
8843341|NCT01703065|9897614|FG001|NOT COMPLETED|Overall Study||0
8843342|NCT01703091|9897623|FG000|STARTED|Overall Study||98
8843343|NCT01703091|9897624|FG001|STARTED|Overall Study||99
8843344|NCT01703091|9897623|FG000|Received at Least One Dose of Study Drug|Overall Study||94
8843345|NCT01703091|9897624|FG001|Received at Least One Dose of Study Drug|Overall Study||98
8843346|NCT01703091|9897623|FG000|COMPLETED|Overall Study||89
8843347|NCT01703091|9897624|FG001|COMPLETED|Overall Study||95
8843348|NCT01703091|9897623|FG000|NOT COMPLETED|Overall Study||9
8843349|NCT01703091|9897624|FG001|NOT COMPLETED|Overall Study||4
8843350|NCT01703117|9897632|FG000|STARTED|Overall Study||26
8843351|NCT01703117|9897633|FG001|STARTED|Overall Study||24
8843352|NCT01703117|9897632|FG000|COMPLETED|Overall Study||22
8843353|NCT01703117|9897633|FG001|COMPLETED|Overall Study||20
8843354|NCT01703117|9897632|FG000|NOT COMPLETED|Overall Study||4
8843355|NCT01703117|9897633|FG001|NOT COMPLETED|Overall Study||4
8843356|NCT01703169|9897641|FG000|STARTED|Overall Study||13
8843357|NCT01703169|9897641|FG000|COMPLETED|Overall Study||13
8843358|NCT01703169|9897641|FG000|NOT COMPLETED|Overall Study||0
8843359|NCT01703208|9897647|FG000|STARTED|Overall Study||2100
8843360|NCT01703208|9897648|FG001|STARTED|Overall Study||2102
8843361|NCT01703208|9897647|FG000|Treated|Overall Study||2092
8843362|NCT01703208|9897648|FG001|Treated|Overall Study||2100
8843363|NCT01703208|9897647|FG000|COMPLETED|Overall Study||0
8843364|NCT01703208|9897648|FG001|COMPLETED|Overall Study||0
8843365|NCT01703208|9897647|FG000|NOT COMPLETED|Overall Study||2100
8843366|NCT01703208|9897648|FG001|NOT COMPLETED|Overall Study||2102
8843367|NCT01703221|9897657|FG000|STARTED|Phase A (Up to 24 Weeks)||166
8843368|NCT01703221|9897658|FG001|STARTED|Phase A (Up to 24 Weeks)||165
8843369|NCT01703221|9897659|FG002|STARTED|Phase A (Up to 24 Weeks)||83
8843370|NCT01703221|9897657|FG000|COMPLETED|Phase A (Up to 24 Weeks)||159
8843371|NCT01703221|9897658|FG001|COMPLETED|Phase A (Up to 24 Weeks)||161
8843372|NCT01703221|9897659|FG002|COMPLETED|Phase A (Up to 24 Weeks)||80
8843373|NCT01703221|9897657|FG000|NOT COMPLETED|Phase A (Up to 24 Weeks)||7
9073411|NCT03784079|10134133|FG001|NOT COMPLETED|Part 2: Up to Day 12||0
9073412|NCT03784079|10134134|FG002|NOT COMPLETED|Part 2: Up to Day 12||0
9073413|NCT03784079|10134135|FG003|NOT COMPLETED|Part 2: Up to Day 12||0
8843374|NCT01703221|9897658|FG001|NOT COMPLETED|Phase A (Up to 24 Weeks)||4
8843375|NCT01703221|9897659|FG002|NOT COMPLETED|Phase A (Up to 24 Weeks)||3
8843376|NCT01703221|9897657|FG000|STARTED|Phase B - (Week 25 to 52)||159
8843377|NCT01703221|9897658|FG001|STARTED|Phase B - (Week 25 to 52)||161
8843378|NCT01703221|9897659|FG002|STARTED|Phase B - (Week 25 to 52)||80
8843379|NCT01703221|9897657|FG000|COMPLETED|Phase B - (Week 25 to 52)||143
8843380|NCT01703221|9897658|FG001|COMPLETED|Phase B - (Week 25 to 52)||147
8843381|NCT01703221|9897659|FG002|COMPLETED|Phase B - (Week 25 to 52)||75
8843382|NCT01703221|9897657|FG000|NOT COMPLETED|Phase B - (Week 25 to 52)||16
9073414|NCT03784079|10134136|FG004|NOT COMPLETED|Part 2: Up to Day 12||0
9073415|NCT03784079|10134137|FG005|NOT COMPLETED|Part 2: Up to Day 12||0
9073416|NCT03784079|10134138|FG006|NOT COMPLETED|Part 2: Up to Day 12||0
9073417|NCT03783039|10134161|FG000|STARTED|Overall Study||119
9073418|NCT03783039|10134162|FG001|STARTED|Overall Study||115
9073419|NCT03783039|10134161|FG000|COMPLETED|Overall Study||117
9073420|NCT03783039|10134162|FG001|COMPLETED|Overall Study||114
9073421|NCT03783039|10134161|FG000|NOT COMPLETED|Overall Study||2
9073422|NCT03783039|10134162|FG001|NOT COMPLETED|Overall Study||1
9073423|NCT03783130|10134172|FG000|STARTED|Overall Study||3
9073424|NCT03783130|10134173|FG001|STARTED|Overall Study||3
9073425|NCT03783130|10134174|FG002|STARTED|Overall Study||5
9073426|NCT03783130|10134175|FG003|STARTED|Overall Study||5
9073427|NCT03783130|10134172|FG000|Received All Product Administrations|Overall Study||3
9073428|NCT03783130|10134173|FG001|Received All Product Administrations|Overall Study||3
9073429|NCT03783130|10134174|FG002|Received All Product Administrations|Overall Study||5
9073430|NCT03783130|10134175|FG003|Received All Product Administrations|Overall Study||5
9073431|NCT03783130|10134172|FG000|COMPLETED|Overall Study||3
9073432|NCT03783130|10134173|FG001|COMPLETED|Overall Study||3
9073433|NCT03783130|10134174|FG002|COMPLETED|Overall Study||5
9073434|NCT03783130|10134175|FG003|COMPLETED|Overall Study||5
9073435|NCT03783130|10134172|FG000|NOT COMPLETED|Overall Study||0
9073436|NCT03783130|10134173|FG001|NOT COMPLETED|Overall Study||0
9073437|NCT03783130|10134174|FG002|NOT COMPLETED|Overall Study||0
9073438|NCT03783130|10134175|FG003|NOT COMPLETED|Overall Study||0
9073439|NCT03776175|10134190|FG000|STARTED|Treatment Period (42 Days)||14
9073440|NCT03776175|10134191|FG001|STARTED|Treatment Period (42 Days)||29
9073441|NCT03776175|10134192|FG002|STARTED|Treatment Period (42 Days)||28
9073442|NCT03776175|10134193|FG003|STARTED|Treatment Period (42 Days)||28
9073443|NCT03776175|10134190|FG000|Treated|Treatment Period (42 Days)||14
9073444|NCT03776175|10134191|FG001|Treated|Treatment Period (42 Days)||29
9073445|NCT03776175|10134192|FG002|Treated|Treatment Period (42 Days)||28
9073446|NCT03776175|10134193|FG003|Treated|Treatment Period (42 Days)||28
9073447|NCT03776175|10134190|FG000|COMPLETED|Treatment Period (42 Days)||13
8843383|NCT01703221|9897658|FG001|NOT COMPLETED|Phase B - (Week 25 to 52)||14
8843384|NCT01703221|9897659|FG002|NOT COMPLETED|Phase B - (Week 25 to 52)||5
8843385|NCT01703260|9897676|FG000|STARTED|Overall Study||7
8843386|NCT01703260|9897677|FG001|STARTED|Overall Study||7
8843387|NCT01703260|9897678|FG002|STARTED|Overall Study||6
8843388|NCT01703260|9897676|FG000|COMPLETED|Overall Study||4
8843389|NCT01703260|9897677|FG001|COMPLETED|Overall Study||3
8843390|NCT01703260|9897678|FG002|COMPLETED|Overall Study||3
8843391|NCT01703260|9897676|FG000|NOT COMPLETED|Overall Study||3
8843392|NCT01703260|9897677|FG001|NOT COMPLETED|Overall Study||4
8843393|NCT01703260|9897678|FG002|NOT COMPLETED|Overall Study||3
8843394|NCT01703286|9897686|FG000|STARTED|Period 1 Including Washout||7
8843395|NCT01703286|9897687|FG001|STARTED|Period 1 Including Washout||7
8843396|NCT01703286|9897688|FG002|STARTED|Period 1 Including Washout||7
8843397|NCT01703286|9897689|FG003|STARTED|Period 1 Including Washout||7
8843398|NCT01703286|9897690|FG004|STARTED|Period 1 Including Washout||7
8843399|NCT01703286|9897691|FG005|STARTED|Period 1 Including Washout||7
8843400|NCT01703286|9897686|FG000|COMPLETED|Period 1 Including Washout||7
8843401|NCT01703286|9897687|FG001|COMPLETED|Period 1 Including Washout||7
8843402|NCT01703286|9897688|FG002|COMPLETED|Period 1 Including Washout||7
8843403|NCT01703286|9897689|FG003|COMPLETED|Period 1 Including Washout||6
8843404|NCT01703286|9897690|FG004|COMPLETED|Period 1 Including Washout||7
8843405|NCT01703286|9897691|FG005|COMPLETED|Period 1 Including Washout||6
8843406|NCT01703286|9897686|FG000|NOT COMPLETED|Period 1 Including Washout||0
8843407|NCT01703286|9897687|FG001|NOT COMPLETED|Period 1 Including Washout||0
8843408|NCT01703286|9897688|FG002|NOT COMPLETED|Period 1 Including Washout||0
8843409|NCT01703286|9897689|FG003|NOT COMPLETED|Period 1 Including Washout||1
8843410|NCT01703286|9897690|FG004|NOT COMPLETED|Period 1 Including Washout||0
8843411|NCT01703286|9897691|FG005|NOT COMPLETED|Period 1 Including Washout||1
8843412|NCT01703286|9897686|FG000|STARTED|Period 2 Including Washout||7
8843413|NCT01703286|9897687|FG001|STARTED|Period 2 Including Washout||7
8843414|NCT01703286|9897688|FG002|STARTED|Period 2 Including Washout||7
8843415|NCT01703286|9897689|FG003|STARTED|Period 2 Including Washout||6
8843416|NCT01703286|9897690|FG004|STARTED|Period 2 Including Washout||7
9073448|NCT03776175|10134191|FG001|COMPLETED|Treatment Period (42 Days)||22
9073449|NCT03776175|10134192|FG002|COMPLETED|Treatment Period (42 Days)||24
9073450|NCT03776175|10134193|FG003|COMPLETED|Treatment Period (42 Days)||26
9073451|NCT03776175|10134190|FG000|NOT COMPLETED|Treatment Period (42 Days)||1
9073452|NCT03776175|10134191|FG001|NOT COMPLETED|Treatment Period (42 Days)||7
9073453|NCT03776175|10134192|FG002|NOT COMPLETED|Treatment Period (42 Days)||4
8843417|NCT01703286|9897691|FG005|STARTED|Period 2 Including Washout||6
8843418|NCT01703286|9897686|FG000|COMPLETED|Period 2 Including Washout||7
9073454|NCT03776175|10134193|FG003|NOT COMPLETED|Treatment Period (42 Days)||2
9073455|NCT03776175|10134190|FG000|STARTED|Follow-Up Period (35 Days)||13
8843419|NCT01703286|9897687|FG001|COMPLETED|Period 2 Including Washout||7
9073456|NCT03776175|10134191|FG001|STARTED|Follow-Up Period (35 Days)||22
8843420|NCT01703286|9897688|FG002|COMPLETED|Period 2 Including Washout||7
8843421|NCT01703286|9897689|FG003|COMPLETED|Period 2 Including Washout||5
9073457|NCT03776175|10134192|FG002|STARTED|Follow-Up Period (35 Days)||24
9073458|NCT03776175|10134193|FG003|STARTED|Follow-Up Period (35 Days)||26
9073459|NCT03776175|10134190|FG000|COMPLETED|Follow-Up Period (35 Days)||13
9073460|NCT03776175|10134191|FG001|COMPLETED|Follow-Up Period (35 Days)||22
9073461|NCT03776175|10134192|FG002|COMPLETED|Follow-Up Period (35 Days)||24
9073462|NCT03776175|10134193|FG003|COMPLETED|Follow-Up Period (35 Days)||24
9073463|NCT03776175|10134190|FG000|NOT COMPLETED|Follow-Up Period (35 Days)||0
9073464|NCT03776175|10134191|FG001|NOT COMPLETED|Follow-Up Period (35 Days)||0
9073465|NCT03776175|10134192|FG002|NOT COMPLETED|Follow-Up Period (35 Days)||0
9073466|NCT03776175|10134193|FG003|NOT COMPLETED|Follow-Up Period (35 Days)||2
9073467|NCT03771963|10134203|FG000|STARTED|Overall Study||200
9073468|NCT03771963|10134203|FG000|COMPLETED|Overall Study||168
9073469|NCT03771963|10134203|FG000|NOT COMPLETED|Overall Study||32
9073470|NCT03771352|10134207|FG000|STARTED|Overall Study||55
9073471|NCT03771352|10134207|FG000|COMPLETED|Overall Study|The fellow eye of one subject was not implanted per the discretion of the investigator.|51
9073472|NCT03771352|10134207|FG000|NOT COMPLETED|Overall Study||4
9073473|NCT03773796|10134211|FG000|STARTED|Overall Study||22
8624114|NCT00498433|9663347|FG001|STARTED|Part 2: Double Blind (12 Weeks)||8
9073474|NCT03773796|10134211|FG000|COMPLETED|Overall Study||19
9073475|NCT03773796|10134211|FG000|NOT COMPLETED|Overall Study||3
9073476|NCT03782233|10134217|FG000|STARTED|Overall Study||50
9073477|NCT03782233|10134218|FG001|STARTED|Overall Study||33
9073478|NCT03782233|10134217|FG000|COMPLETED|Overall Study||46
9073479|NCT03782233|10134218|FG001|COMPLETED|Overall Study||31
9073480|NCT03782233|10134217|FG000|NOT COMPLETED|Overall Study||4
9073481|NCT03782233|10134218|FG001|NOT COMPLETED|Overall Study||2
9073482|NCT03781375|10134228|FG000|STARTED|Double-blind Phase||12
9073483|NCT03781375|10134229|FG001|STARTED|Double-blind Phase||13
8843422|NCT01703286|9897690|FG004|COMPLETED|Period 2 Including Washout||7
8843423|NCT01703286|9897691|FG005|COMPLETED|Period 2 Including Washout||6
8843424|NCT01703286|9897686|FG000|NOT COMPLETED|Period 2 Including Washout||0
8843425|NCT01703286|9897687|FG001|NOT COMPLETED|Period 2 Including Washout||0
8843426|NCT01703286|9897688|FG002|NOT COMPLETED|Period 2 Including Washout||0
8843427|NCT01703286|9897689|FG003|NOT COMPLETED|Period 2 Including Washout||1
8843428|NCT01703286|9897690|FG004|NOT COMPLETED|Period 2 Including Washout||0
8843429|NCT01703286|9897691|FG005|NOT COMPLETED|Period 2 Including Washout||0
8843430|NCT01703286|9897686|FG000|STARTED|Period 3 Including Washout||7
8843431|NCT01703286|9897687|FG001|STARTED|Period 3 Including Washout||7
8843432|NCT01703286|9897688|FG002|STARTED|Period 3 Including Washout||7
8843433|NCT01703286|9897689|FG003|STARTED|Period 3 Including Washout||5
8843434|NCT01703286|9897690|FG004|STARTED|Period 3 Including Washout||7
8843435|NCT01703286|9897691|FG005|STARTED|Period 3 Including Washout||6
8843436|NCT01703286|9897686|FG000|COMPLETED|Period 3 Including Washout||7
8843437|NCT01703286|9897687|FG001|COMPLETED|Period 3 Including Washout||7
8843438|NCT01703286|9897688|FG002|COMPLETED|Period 3 Including Washout||7
8843439|NCT01703286|9897689|FG003|COMPLETED|Period 3 Including Washout||5
8843440|NCT01703286|9897690|FG004|COMPLETED|Period 3 Including Washout||7
8843441|NCT01703286|9897691|FG005|COMPLETED|Period 3 Including Washout||6
8843442|NCT01703286|9897686|FG000|NOT COMPLETED|Period 3 Including Washout||0
8843443|NCT01703286|9897687|FG001|NOT COMPLETED|Period 3 Including Washout||0
8843444|NCT01703286|9897688|FG002|NOT COMPLETED|Period 3 Including Washout||0
8843445|NCT01703286|9897689|FG003|NOT COMPLETED|Period 3 Including Washout||0
8843446|NCT01703286|9897690|FG004|NOT COMPLETED|Period 3 Including Washout||0
8843447|NCT01703286|9897691|FG005|NOT COMPLETED|Period 3 Including Washout||0
8843448|NCT01703507|9897704|FG000|STARTED|Overall Study||6
8843449|NCT01703507|9897705|FG001|STARTED|Overall Study||11
8843450|NCT01703507|9897704|FG000|COMPLETED|Overall Study||5
8843451|NCT01703507|9897705|FG001|COMPLETED|Overall Study||11
8843452|NCT01703507|9897704|FG000|NOT COMPLETED|Overall Study||1
8843453|NCT01703507|9897705|FG001|NOT COMPLETED|Overall Study||0
8843454|NCT01703598|9897711|FG000|STARTED|Overall Study||69
8843455|NCT01703598|9897711|FG000|COMPLETED|Overall Study||69
8843456|NCT01703598|9897711|FG000|NOT COMPLETED|Overall Study||0
8843457|NCT01703663|9897715|FG000|STARTED|First Treatment Period||20
8843458|NCT01703663|9897716|FG001|STARTED|First Treatment Period||20
8843459|NCT01703663|9897715|FG000|COMPLETED|First Treatment Period||20
8843460|NCT01703663|9897716|FG001|COMPLETED|First Treatment Period||20
8843461|NCT01703663|9897715|FG000|NOT COMPLETED|First Treatment Period||0
8843462|NCT01703663|9897716|FG001|NOT COMPLETED|First Treatment Period||0
8843463|NCT01703663|9897715|FG000|STARTED|Second Treatment Period||11
8843464|NCT01703663|9897716|FG001|STARTED|Second Treatment Period||8
9073484|NCT03781375|10134228|FG000|Received Study Drug|Double-blind Phase||12
9073485|NCT03781375|10134229|FG001|Received Study Drug|Double-blind Phase||13
8843465|NCT01703663|9897715|FG000|COMPLETED|Second Treatment Period||11
8843466|NCT01703663|9897716|FG001|COMPLETED|Second Treatment Period||8
8843467|NCT01703663|9897715|FG000|NOT COMPLETED|Second Treatment Period||0
8843468|NCT01703663|9897716|FG001|NOT COMPLETED|Second Treatment Period||0
8843469|NCT01703702|9897724|FG000|STARTED|Overall Study||308
8843470|NCT01703702|9897725|FG001|STARTED|Overall Study||310
8843471|NCT01703702|9897724|FG000|COMPLETED|Overall Study||272
8843472|NCT01703702|9897725|FG001|COMPLETED|Overall Study||288
8843473|NCT01703702|9897724|FG000|NOT COMPLETED|Overall Study||36
8843474|NCT01703702|9897725|FG001|NOT COMPLETED|Overall Study||22
8843475|NCT01703741|9897736|FG000|STARTED|Overall Study||145
8850162|NCT01745146|9905415|FG001|Analysis|Overall Study||57
8850163|NCT01745146|9905414|FG000|COMPLETED|Overall Study||27
8624115|NCT00498433|9663348|FG002|STARTED|Part 2: Double Blind (12 Weeks)||8
9073486|NCT03781375|10134228|FG000|COMPLETED|Double-blind Phase||5
9073487|NCT03781375|10134229|FG001|COMPLETED|Double-blind Phase||7
9073488|NCT03781375|10134228|FG000|NOT COMPLETED|Double-blind Phase||7
9073489|NCT03781375|10134229|FG001|NOT COMPLETED|Double-blind Phase||6
9073490|NCT03781375|10134228|FG000|STARTED|Open-label Phase||11
9073491|NCT03781375|10134229|FG001|STARTED|Open-label Phase||9
9073492|NCT03781375|10134228|FG000|Received Study Drug|Open-label Phase||10
9073493|NCT03781375|10134229|FG001|Received Study Drug|Open-label Phase||9
9073494|NCT03781375|10134228|FG000|COMPLETED|Open-label Phase||8
9073495|NCT03781375|10134229|FG001|COMPLETED|Open-label Phase||6
9073496|NCT03781375|10134228|FG000|NOT COMPLETED|Open-label Phase||3
9073497|NCT03781375|10134229|FG001|NOT COMPLETED|Open-label Phase||3
9073498|NCT03781336|10134238|FG000|STARTED|Overall Study||45
9073499|NCT03781336|10134239|FG001|STARTED|Overall Study||37
9073500|NCT03781336|10134238|FG000|COMPLETED|Overall Study|All participants were included in the analysis (Intent to treat)|43
9073501|NCT03781336|10134239|FG001|COMPLETED|Overall Study|All participants were included in the analysis (Intent to treat)|35
9073502|NCT03781336|10134238|FG000|NOT COMPLETED|Overall Study||2
9073503|NCT03781336|10134239|FG001|NOT COMPLETED|Overall Study||2
9073504|NCT03780400|10134245|FG000|STARTED|Overall Study||60
9073505|NCT03780400|10134245|FG000|COMPLETED|Overall Study||53
9073506|NCT03780400|10134245|FG000|NOT COMPLETED|Overall Study||7
9073507|NCT03779997|10134251|FG000|STARTED|Overall Study||39
9073508|NCT03779997|10134252|FG001|STARTED|Overall Study||39
9073509|NCT03779997|10134251|FG000|Completed at Least One Visit|Overall Study||39
9073510|NCT03779997|10134252|FG001|Completed at Least One Visit|Overall Study||39
9073511|NCT03779997|10134251|FG000|COMPLETED|Overall Study||39
9073512|NCT03779997|10134252|FG001|COMPLETED|Overall Study||39
9073513|NCT03779997|10134251|FG000|NOT COMPLETED|Overall Study||0
9073514|NCT03779997|10134252|FG001|NOT COMPLETED|Overall Study||0
9073515|NCT03779503|10134258|FG000|STARTED|First Intervention||28
9073516|NCT03779503|10134259|FG001|STARTED|First Intervention||27
9073517|NCT03779503|10134258|FG000|COMPLETED|First Intervention||27
8843476|NCT01703741|9897736|FG000|Per Protocol (PP) Population|Overall Study|Subjects having 24 hr pharmacokinetic (PK) data for testosterone, with no major protocol violations.|106
8843477|NCT01703741|9897736|FG000|COMPLETED|Overall Study||127
8843478|NCT01703741|9897736|FG000|NOT COMPLETED|Overall Study||18
8843479|NCT01703819|9897742|FG000|STARTED|Overall Study||34
8843480|NCT01703819|9897743|FG001|STARTED|Overall Study||32
8843481|NCT01703819|9897742|FG000|COMPLETED|Overall Study||34
8843482|NCT01703819|9897743|FG001|COMPLETED|Overall Study||30
8843483|NCT01703819|9897742|FG000|NOT COMPLETED|Overall Study||0
8843484|NCT01703819|9897743|FG001|NOT COMPLETED|Overall Study||2
8843485|NCT01703832|9897751|FG000|STARTED|Overall Study||33
8843486|NCT01703832|9897752|FG001|STARTED|Overall Study||32
8843487|NCT01703832|9897751|FG000|COMPLETED|Overall Study||32
8843488|NCT01703832|9897752|FG001|COMPLETED|Overall Study||32
8843489|NCT01703832|9897751|FG000|NOT COMPLETED|Overall Study||1
8843490|NCT01703832|9897752|FG001|NOT COMPLETED|Overall Study||0
8843491|NCT01703845|9897760|FG000|STARTED|Overall Study|started are actually the randomized|16
8843492|NCT01703845|9897761|FG001|STARTED|Overall Study|started are actually the randomized|16
8843493|NCT01703845|9897760|FG000|COMPLETED|Overall Study||13
8843494|NCT01703845|9897761|FG001|COMPLETED|Overall Study||16
8843495|NCT01703845|9897760|FG000|NOT COMPLETED|Overall Study||3
8843496|NCT01703845|9897761|FG001|NOT COMPLETED|Overall Study||0
8843497|NCT01703858|9897772|FG000|STARTED|Overall Study||5
8843498|NCT01703858|9897773|FG001|STARTED|Overall Study||5
8843499|NCT01703858|9897774|FG002|STARTED|Overall Study||5
8843500|NCT01703858|9897772|FG000|COMPLETED|Overall Study||5
8843501|NCT01703858|9897773|FG001|COMPLETED|Overall Study||4
8843502|NCT01703858|9897774|FG002|COMPLETED|Overall Study||5
8843503|NCT01703858|9897772|FG000|NOT COMPLETED|Overall Study||0
8843504|NCT01703858|9897773|FG001|NOT COMPLETED|Overall Study||1
8843505|NCT01703858|9897774|FG002|NOT COMPLETED|Overall Study||0
8843506|NCT01703988|9897791|FG000|STARTED|Overall Study||8
8843507|NCT01703988|9897792|FG001|STARTED|Overall Study||8
8843508|NCT01703988|9897793|FG002|STARTED|Overall Study||9
8843509|NCT01703988|9897794|FG003|STARTED|Overall Study||9
8843510|NCT01703988|9897791|FG000|COMPLETED|Overall Study||8
8843511|NCT01703988|9897792|FG001|COMPLETED|Overall Study||8
8843512|NCT01703988|9897793|FG002|COMPLETED|Overall Study||9
8843513|NCT01703988|9897794|FG003|COMPLETED|Overall Study||8
8843514|NCT01703988|9897791|FG000|NOT COMPLETED|Overall Study||0
8843515|NCT01703988|9897792|FG001|NOT COMPLETED|Overall Study||0
8843516|NCT01703988|9897793|FG002|NOT COMPLETED|Overall Study||0
8843517|NCT01703988|9897794|FG003|NOT COMPLETED|Overall Study||1
9073518|NCT03779503|10134259|FG001|COMPLETED|First Intervention||26
9073519|NCT03779503|10134258|FG000|NOT COMPLETED|First Intervention||1
9073520|NCT03779503|10134259|FG001|NOT COMPLETED|First Intervention||1
9073521|NCT03779503|10134258|FG000|STARTED|Second Intervention||27
9073522|NCT03779503|10134259|FG001|STARTED|Second Intervention||26
9073523|NCT03779503|10134258|FG000|COMPLETED|Second Intervention||27
9073524|NCT03779503|10134259|FG001|COMPLETED|Second Intervention||26
9073525|NCT03779503|10134258|FG000|NOT COMPLETED|Second Intervention||0
9073526|NCT03779503|10134259|FG001|NOT COMPLETED|Second Intervention||0
8843518|NCT01704079|9897807|FG000|STARTED|Overall Study||72
8843519|NCT01704079|9897808|FG001|STARTED|Overall Study||144
8843520|NCT01704079|9897807|FG000|Entered Extension Study|Overall Study||53
8843521|NCT01704079|9897808|FG001|Entered Extension Study|Overall Study||102
8843522|NCT01704079|9897807|FG000|COMPLETED|Overall Study||58
9073527|NCT03780010|10134267|FG000|STARTED|Overall Study||3
9073528|NCT03780010|10134268|FG001|STARTED|Overall Study||12
9073529|NCT03780010|10134267|FG000|COMPLETED|Overall Study||3
9073530|NCT03780010|10134268|FG001|COMPLETED|Overall Study||12
9073531|NCT03780010|10134267|FG000|NOT COMPLETED|Overall Study||0
9073532|NCT03780010|10134268|FG001|NOT COMPLETED|Overall Study||0
9073533|NCT03778190|10134285|FG000|STARTED|Overall Study||10
9073534|NCT03778190|10134285|FG000|COMPLETED|Overall Study||10
9073535|NCT03778190|10134285|FG000|NOT COMPLETED|Overall Study||0
9073536|NCT03777059|10134293|FG000|STARTED|DB Treatment Period (Up to Week 12)||223
9073537|NCT03777059|10134294|FG001|STARTED|DB Treatment Period (Up to Week 12)||222
9073538|NCT03777059|10134295|FG002|STARTED|DB Treatment Period (Up to Week 12)||230
9073539|NCT03777059|10134296|FG003|STARTED|DB Treatment Period (Up to Week 12)||235
9073540|NCT03777059|10134293|FG000|Treated: Safety Population|DB Treatment Period (Up to Week 12)||222
9073541|NCT03777059|10134294|FG001|Treated: Safety Population|DB Treatment Period (Up to Week 12)||221
9073542|NCT03777059|10134295|FG002|Treated: Safety Population|DB Treatment Period (Up to Week 12)||228
9073543|NCT03777059|10134296|FG003|Treated: Safety Population|DB Treatment Period (Up to Week 12)||231
9073544|NCT03777059|10134293|FG000|COMPLETED|DB Treatment Period (Up to Week 12)||201
9073545|NCT03777059|10134294|FG001|COMPLETED|DB Treatment Period (Up to Week 12)||193
9073546|NCT03777059|10134295|FG002|COMPLETED|DB Treatment Period (Up to Week 12)||207
9073547|NCT03777059|10134296|FG003|COMPLETED|DB Treatment Period (Up to Week 12)||204
9073548|NCT03777059|10134293|FG000|NOT COMPLETED|DB Treatment Period (Up to Week 12)||22
9073549|NCT03777059|10134294|FG001|NOT COMPLETED|DB Treatment Period (Up to Week 12)||29
9073550|NCT03777059|10134295|FG002|NOT COMPLETED|DB Treatment Period (Up to Week 12)||23
9073551|NCT03777059|10134296|FG003|NOT COMPLETED|DB Treatment Period (Up to Week 12)||31
9073552|NCT03777059|10134293|FG000|STARTED|Follow-Up Period (Weeks 12 to 16)||46
9073553|NCT03777059|10134294|FG001|STARTED|Follow-Up Period (Weeks 12 to 16)||54
9073554|NCT03777059|10134295|FG002|STARTED|Follow-Up Period (Weeks 12 to 16)||38
9073555|NCT03777059|10134296|FG003|STARTED|Follow-Up Period (Weeks 12 to 16)||45
9073556|NCT03777059|10134293|FG000|COMPLETED|Follow-Up Period (Weeks 12 to 16)||41
9073557|NCT03777059|10134294|FG001|COMPLETED|Follow-Up Period (Weeks 12 to 16)||49
9073558|NCT03777059|10134295|FG002|COMPLETED|Follow-Up Period (Weeks 12 to 16)||32
9073559|NCT03777059|10134296|FG003|COMPLETED|Follow-Up Period (Weeks 12 to 16)||36
8843523|NCT01704079|9897808|FG001|COMPLETED|Overall Study||121
8843524|NCT01704079|9897807|FG000|NOT COMPLETED|Overall Study||14
8843525|NCT01704079|9897808|FG001|NOT COMPLETED|Overall Study||23
8843526|NCT01704196|9897816|FG000|STARTED|Overall Study||90
8843527|NCT01704196|9897817|FG001|STARTED|Overall Study||89
8843528|NCT01704196|9897816|FG000|COMPLETED|Overall Study||71
8843529|NCT01704196|9897817|FG001|COMPLETED|Overall Study||65
8843530|NCT01704196|9897816|FG000|NOT COMPLETED|Overall Study||19
8843531|NCT01704196|9897817|FG001|NOT COMPLETED|Overall Study||24
8843532|NCT01704261|9897825|FG000|STARTED|Overall Study||154
8843533|NCT01704261|9897826|FG001|STARTED|Overall Study||153
8843534|NCT01704261|9897825|FG000|COMPLETED|Overall Study||141
8843535|NCT01704261|9897826|FG001|COMPLETED|Overall Study||138
8843536|NCT01704261|9897825|FG000|NOT COMPLETED|Overall Study||13
8843537|NCT01704261|9897826|FG001|NOT COMPLETED|Overall Study||15
8843538|NCT01704287|9897835|FG000|STARTED|Initial Treatment Period||180
8843539|NCT01704287|9897836|FG001|STARTED|Initial Treatment Period||181
8843540|NCT01704287|9897837|FG002|STARTED|Initial Treatment Period||179
8843541|NCT01704287|9897838|FG003|STARTED|Initial Treatment Period||0
8843542|NCT01704287|9897839|FG004|STARTED|Initial Treatment Period||0
8843543|NCT01704287|9897835|FG000|Treated|Initial Treatment Period||178
8843544|NCT01704287|9897836|FG001|Treated|Initial Treatment Period||179
8843545|NCT01704287|9897837|FG002|Treated|Initial Treatment Period||171
8843546|NCT01704287|9897838|FG003|Treated|Initial Treatment Period||0
8843547|NCT01704287|9897839|FG004|Treated|Initial Treatment Period||0
8843548|NCT01704287|9897835|FG000|COMPLETED|Initial Treatment Period||33
8843549|NCT01704287|9897836|FG001|COMPLETED|Initial Treatment Period||47
8843550|NCT01704287|9897837|FG002|COMPLETED|Initial Treatment Period||6
8843551|NCT01704287|9897838|FG003|COMPLETED|Initial Treatment Period||0
8843552|NCT01704287|9897839|FG004|COMPLETED|Initial Treatment Period||0
8843553|NCT01704287|9897835|FG000|NOT COMPLETED|Initial Treatment Period||147
8843554|NCT01704287|9897836|FG001|NOT COMPLETED|Initial Treatment Period||134
8843555|NCT01704287|9897837|FG002|NOT COMPLETED|Initial Treatment Period||173
8843556|NCT01704287|9897838|FG003|NOT COMPLETED|Initial Treatment Period||0
8843557|NCT01704287|9897839|FG004|NOT COMPLETED|Initial Treatment Period||0
8843558|NCT01704287|9897835|FG000|STARTED|Switch to Pembrolizumab Treatment Period||0
8843559|NCT01704287|9897836|FG001|STARTED|Switch to Pembrolizumab Treatment Period||0
8843560|NCT01704287|9897837|FG002|STARTED|Switch to Pembrolizumab Treatment Period||0
8843561|NCT01704287|9897838|FG003|STARTED|Switch to Pembrolizumab Treatment Period||53
8843562|NCT01704287|9897839|FG004|STARTED|Switch to Pembrolizumab Treatment Period||45
8843563|NCT01704287|9897835|FG000|COMPLETED|Switch to Pembrolizumab Treatment Period||0
8843564|NCT01704287|9897836|FG001|COMPLETED|Switch to Pembrolizumab Treatment Period||0
8843565|NCT01704287|9897837|FG002|COMPLETED|Switch to Pembrolizumab Treatment Period||0
8843566|NCT01704287|9897838|FG003|COMPLETED|Switch to Pembrolizumab Treatment Period||15
8843567|NCT01704287|9897839|FG004|COMPLETED|Switch to Pembrolizumab Treatment Period||7
9073560|NCT03777059|10134293|FG000|NOT COMPLETED|Follow-Up Period (Weeks 12 to 16)||5
8843568|NCT01704287|9897835|FG000|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||0
8843569|NCT01704287|9897836|FG001|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||0
9073561|NCT03777059|10134294|FG001|NOT COMPLETED|Follow-Up Period (Weeks 12 to 16)||5
9073562|NCT03777059|10134295|FG002|NOT COMPLETED|Follow-Up Period (Weeks 12 to 16)||6
9073563|NCT03777059|10134296|FG003|NOT COMPLETED|Follow-Up Period (Weeks 12 to 16)||9
9073564|NCT03772522|10134308|FG000|STARTED|Pre-intervention||12
9073565|NCT03772522|10134309|FG001|STARTED|Pre-intervention||15
9073566|NCT03772522|10134308|FG000|COMPLETED|Pre-intervention||9
9073567|NCT03772522|10134309|FG001|COMPLETED|Pre-intervention||11
9073568|NCT03772522|10134308|FG000|NOT COMPLETED|Pre-intervention||3
9073569|NCT03772522|10134309|FG001|NOT COMPLETED|Pre-intervention||4
9073570|NCT03772522|10134308|FG000|STARTED|Intervention||9
9073571|NCT03772522|10134309|FG001|STARTED|Intervention||11
9073572|NCT03772522|10134308|FG000|COMPLETED|Intervention||8
9073573|NCT03772522|10134309|FG001|COMPLETED|Intervention||11
9073574|NCT03772522|10134308|FG000|NOT COMPLETED|Intervention||1
9073575|NCT03772522|10134309|FG001|NOT COMPLETED|Intervention||0
9073576|NCT03772522|10134308|FG000|STARTED|Post-intervention Follow-up||8
8843570|NCT01704287|9897837|FG002|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||0
8843571|NCT01704287|9897838|FG003|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||38
8843572|NCT01704287|9897839|FG004|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||38
8843573|NCT01704456|9897860|FG000|STARTED|Overall Study||67
8843574|NCT01704456|9897861|FG001|STARTED|Overall Study||63
8843575|NCT01704456|9897860|FG000|COMPLETED|Overall Study||59
8843576|NCT01704456|9897861|FG001|COMPLETED|Overall Study||49
8843577|NCT01704456|9897860|FG000|NOT COMPLETED|Overall Study||8
8843578|NCT01704456|9897861|FG001|NOT COMPLETED|Overall Study||14
8843579|NCT01704495|9897871|FG000|STARTED|Subjects Randomized||162
8843580|NCT01704495|9897872|FG001|STARTED|Subjects Randomized||156
8843581|NCT01704495|9897873|FG002|STARTED|Subjects Randomized||160
8843582|NCT01704495|9897874|FG003|STARTED|Subjects Randomized||162
8843583|NCT01704495|9897871|FG000|COMPLETED|Subjects Randomized||140
8843584|NCT01704495|9897872|FG001|COMPLETED|Subjects Randomized||141
8843585|NCT01704495|9897873|FG002|COMPLETED|Subjects Randomized||144
8843586|NCT01704495|9897874|FG003|COMPLETED|Subjects Randomized||145
8843587|NCT01704495|9897871|FG000|NOT COMPLETED|Subjects Randomized||22
8843588|NCT01704495|9897872|FG001|NOT COMPLETED|Subjects Randomized||15
8843589|NCT01704495|9897873|FG002|NOT COMPLETED|Subjects Randomized||16
8843590|NCT01704495|9897874|FG003|NOT COMPLETED|Subjects Randomized||17
8843591|NCT01704495|9897871|FG000|STARTED|Optional Safety Extension|46 subjects did not enter safety extension|116
8843592|NCT01704495|9897872|FG001|STARTED|Optional Safety Extension|35 subjects did not enter safety extension|121
8843593|NCT01704495|9897873|FG002|STARTED|Optional Safety Extension|46 subjects did not enter safety extension|114
8843594|NCT01704495|9897874|FG003|STARTED|Optional Safety Extension|46 subjects did not enter safety extension|116
8843595|NCT01704495|9897871|FG000|COMPLETED|Optional Safety Extension||87
8843596|NCT01704495|9897872|FG001|COMPLETED|Optional Safety Extension||88
8843597|NCT01704495|9897873|FG002|COMPLETED|Optional Safety Extension||83
8843598|NCT01704495|9897874|FG003|COMPLETED|Optional Safety Extension||85
8843599|NCT01704495|9897871|FG000|NOT COMPLETED|Optional Safety Extension||29
8843600|NCT01704495|9897872|FG001|NOT COMPLETED|Optional Safety Extension||33
8843601|NCT01704495|9897873|FG002|NOT COMPLETED|Optional Safety Extension||31
8843602|NCT01704495|9897874|FG003|NOT COMPLETED|Optional Safety Extension||31
8843603|NCT01704521|9897886|FG000|STARTED|Overall Study||3
8843604|NCT01704521|9897887|FG001|STARTED|Overall Study||2
8843605|NCT01704521|9897886|FG000|COMPLETED|Overall Study||3
8843606|NCT01704521|9897887|FG001|COMPLETED|Overall Study||2
8843607|NCT01704521|9897886|FG000|NOT COMPLETED|Overall Study||0
8843608|NCT01704521|9897887|FG001|NOT COMPLETED|Overall Study||0
8843609|NCT01704599|9897893|FG000|STARTED|Overall Study|Study was started January 22, 2010|8
8843610|NCT01704599|9897893|FG000|COMPLETED|Overall Study|11 screened 8 entered study 1 terminated.|7
8843611|NCT01704599|9897893|FG000|NOT COMPLETED|Overall Study||1
8843612|NCT01704651|9897922|FG000|STARTED|Overall Study||71
8843613|NCT01704651|9897923|FG001|STARTED|Overall Study||75
8843614|NCT01704651|9897922|FG000|COMPLETED|Overall Study||66
8843615|NCT01704651|9897923|FG001|COMPLETED|Overall Study||68
8843616|NCT01704651|9897922|FG000|NOT COMPLETED|Overall Study||5
8843617|NCT01704651|9897923|FG001|NOT COMPLETED|Overall Study||7
8843618|NCT01704755|9897931|FG000|STARTED|Overall Study||208
8843619|NCT01704755|9897932|FG001|STARTED|Overall Study||172
8843620|NCT01704755|9897931|FG000|Completed Study Drug|Overall Study||204
8843621|NCT01704755|9897932|FG001|Completed Study Drug|Overall Study||163
8843622|NCT01704755|9897931|FG000|COMPLETED|Overall Study||196
8843623|NCT01704755|9897932|FG001|COMPLETED|Overall Study||165
8843624|NCT01704755|9897931|FG000|NOT COMPLETED|Overall Study||12
8843625|NCT01704755|9897932|FG001|NOT COMPLETED|Overall Study||7
8843626|NCT01704781|9897943|FG000|STARTED|Overall Study||3
8843627|NCT01704781|9897944|FG001|STARTED|Overall Study||3
8843628|NCT01704781|9897945|FG002|STARTED|Overall Study||6
8843629|NCT01704781|9897946|FG003|STARTED|Overall Study||12
8843630|NCT01704781|9897947|FG004|STARTED|Overall Study||12
8843631|NCT01704781|9897943|FG000|COMPLETED|Overall Study||3
8843632|NCT01704781|9897944|FG001|COMPLETED|Overall Study||3
8843633|NCT01704781|9897945|FG002|COMPLETED|Overall Study||6
8843634|NCT01704781|9897946|FG003|COMPLETED|Overall Study||12
8843635|NCT01704781|9897947|FG004|COMPLETED|Overall Study||12
8843636|NCT01704781|9897943|FG000|NOT COMPLETED|Overall Study||0
9073577|NCT03772522|10134309|FG001|STARTED|Post-intervention Follow-up||11
9073578|NCT03772522|10134308|FG000|COMPLETED|Post-intervention Follow-up||7
9073579|NCT03772522|10134309|FG001|COMPLETED|Post-intervention Follow-up||11
9073580|NCT03772522|10134308|FG000|NOT COMPLETED|Post-intervention Follow-up||1
9073581|NCT03772522|10134309|FG001|NOT COMPLETED|Post-intervention Follow-up||0
9073582|NCT03772327|10134321|FG000|STARTED|Overall Study||30
9073583|NCT03772327|10134322|FG001|STARTED|Overall Study||33
9073584|NCT03772327|10134321|FG000|Week 0 Visit|Overall Study|2 participants were lost to follow up after randomization prior to any study interventions.|28
9073585|NCT03772327|10134322|FG001|Week 0 Visit|Overall Study||33
9073586|NCT03772327|10134321|FG000|COMPLETED|Overall Study||25
9073587|NCT03772327|10134322|FG001|COMPLETED|Overall Study||26
9073588|NCT03772327|10134321|FG000|NOT COMPLETED|Overall Study||5
9073589|NCT03772327|10134322|FG001|NOT COMPLETED|Overall Study||7
9073590|NCT03777865|10134328|FG000|STARTED|Overall Study||100
9073591|NCT03777865|10134328|FG000|COMPLETED|Overall Study||100
9073592|NCT03777865|10134328|FG000|NOT COMPLETED|Overall Study||0
9073593|NCT03774576|10134332|FG000|STARTED|Period 1||14
9073594|NCT03774576|10134332|FG000|COMPLETED|Period 1||14
9073595|NCT03774576|10134332|FG000|NOT COMPLETED|Period 1||0
9073596|NCT03774576|10134332|FG000|STARTED|Period 2||14
9073597|NCT03774576|10134332|FG000|COMPLETED|Period 2||13
9073598|NCT03774576|10134332|FG000|NOT COMPLETED|Period 2||1
9073599|NCT03776539|10134345|FG000|STARTED|Overall Study||6
9073600|NCT03776539|10134346|FG001|STARTED|Overall Study||6
9073601|NCT03776539|10134347|FG002|STARTED|Overall Study||6
9073602|NCT03776539|10134348|FG003|STARTED|Overall Study||6
9073603|NCT03776539|10134345|FG000|COMPLETED|Overall Study||6
9073604|NCT03776539|10134346|FG001|COMPLETED|Overall Study||6
9073605|NCT03776539|10134347|FG002|COMPLETED|Overall Study||6
9073606|NCT03776539|10134348|FG003|COMPLETED|Overall Study||6
9073607|NCT03776539|10134345|FG000|NOT COMPLETED|Overall Study||0
9073608|NCT03776539|10134346|FG001|NOT COMPLETED|Overall Study||0
9073609|NCT03776539|10134347|FG002|NOT COMPLETED|Overall Study||0
9073610|NCT03776539|10134348|FG003|NOT COMPLETED|Overall Study||0
9073611|NCT03772041|10134360|FG000|STARTED|Overall Study||149
9073612|NCT03772041|10134361|FG001|STARTED|Overall Study||145
9073613|NCT03772041|10134360|FG000|COMPLETED|Overall Study||135
8556729|NCT03798756|9588515|FG000|STARTED|Overall Study||9274
8556730|NCT03798756|9588515|FG000|COMPLETED|Overall Study||9274
8556731|NCT03798756|9588515|FG000|NOT COMPLETED|Overall Study||0
8843637|NCT01704781|9897944|FG001|NOT COMPLETED|Overall Study||0
8843638|NCT01704781|9897945|FG002|NOT COMPLETED|Overall Study||0
8843639|NCT01704781|9897946|FG003|NOT COMPLETED|Overall Study||0
8843640|NCT01704781|9897947|FG004|NOT COMPLETED|Overall Study||0
8850164|NCT01745146|9905415|FG001|COMPLETED|Overall Study||57
8850165|NCT01745146|9905414|FG000|NOT COMPLETED|Overall Study||3
8850166|NCT01745146|9905415|FG001|NOT COMPLETED|Overall Study||3
8850167|NCT01745211|9905422|FG000|STARTED|Overall Study||45
8850168|NCT01745211|9905422|FG000|COMPLETED|Overall Study||27
8850169|NCT01745211|9905422|FG000|NOT COMPLETED|Overall Study||18
8850170|NCT01745367|9905428|FG000|STARTED|Overall Study||8
8850171|NCT01745367|9905429|FG001|STARTED|Overall Study||22
8850172|NCT01745367|9905428|FG000|Treated|Overall Study||8
8850173|NCT01745367|9905429|FG001|Treated|Overall Study||21
8850174|NCT01745367|9905428|FG000|COMPLETED|Overall Study||0
8850175|NCT01745367|9905429|FG001|COMPLETED|Overall Study||0
8850176|NCT01745367|9905428|FG000|NOT COMPLETED|Overall Study||8
8850177|NCT01745367|9905429|FG001|NOT COMPLETED|Overall Study||22
8850178|NCT01745380|9905437|FG000|STARTED|Overall Study||100
8850179|NCT01745380|9905438|FG001|STARTED|Overall Study||50
8850180|NCT01745380|9905437|FG000|COMPLETED|Overall Study||99
8850181|NCT01745380|9905438|FG001|COMPLETED|Overall Study||49
8850182|NCT01745380|9905437|FG000|NOT COMPLETED|Overall Study||1
8850183|NCT01745380|9905438|FG001|NOT COMPLETED|Overall Study||1
8850184|NCT01745393|9905446|FG000|STARTED|Treatment to End-of-treatment Assessment||163
9073614|NCT03772041|10134361|FG001|COMPLETED|Overall Study||135
9073615|NCT03772041|10134360|FG000|NOT COMPLETED|Overall Study||14
9073616|NCT03772041|10134361|FG001|NOT COMPLETED|Overall Study||10
9073617|NCT03775681|10134367|FG000|STARTED|Overall Study||33
9073618|NCT03775681|10134367|FG000|COMPLETED|Overall Study||30
9073619|NCT03775681|10134367|FG000|NOT COMPLETED|Overall Study||3
9073620|NCT03774823|10134373|FG000|STARTED|Overall Study||5
8850185|NCT01745393|9905447|FG001|STARTED|Treatment to End-of-treatment Assessment||164
8850186|NCT01745393|9905446|FG000|Received Treatment|Treatment to End-of-treatment Assessment|Behavioral counseling = TSE-reduction and cessation counseling via telephone|147
8850187|NCT01745393|9905447|FG001|Received Treatment|Treatment to End-of-treatment Assessment|Attention control = nutrition education via telephone|144
8850188|NCT01745393|9905446|FG000|COMPLETED|Treatment to End-of-treatment Assessment||142
9073621|NCT03774823|10134374|FG001|STARTED|Overall Study||5
9073622|NCT03774823|10134373|FG000|COMPLETED|Overall Study||4
9073623|NCT03774823|10134374|FG001|COMPLETED|Overall Study||4
9073624|NCT03774823|10134373|FG000|NOT COMPLETED|Overall Study||1
9073625|NCT03774823|10134374|FG001|NOT COMPLETED|Overall Study||1
9073626|NCT03774745|10134382|FG000|STARTED|Overall Study||6
9073627|NCT03774745|10134383|FG001|STARTED|Overall Study||6
9073628|NCT03774745|10134382|FG000|Follow-Up 1|Overall Study||5
9073629|NCT03774745|10134383|FG001|Follow-Up 1|Overall Study||6
9073630|NCT03774745|10134382|FG000|Follow-up 2|Overall Study||4
9073631|NCT03774745|10134383|FG001|Follow-up 2|Overall Study||2
9073632|NCT03774745|10134382|FG000|COMPLETED|Overall Study||4
9073633|NCT03774745|10134383|FG001|COMPLETED|Overall Study||2
9073634|NCT03774745|10134382|FG000|NOT COMPLETED|Overall Study||2
9073635|NCT03774745|10134383|FG001|NOT COMPLETED|Overall Study||4
8556732|NCT03790917|9588520|FG000|STARTED|Overall Study||201
9073636|NCT03774433|10134389|FG000|STARTED|Overall Study||114
9073637|NCT03774433|10134389|FG000|COMPLETED|Overall Study|Participants who completed at least 12 EMAs for inclusion in data analysis|100
9073638|NCT03774433|10134389|FG000|NOT COMPLETED|Overall Study||14
9073639|NCT03771560|10134393|FG000|STARTED|Overall Study||18
9073640|NCT03771560|10134393|FG000|COMPLETED|Overall Study||12
9073641|NCT03771560|10134393|FG000|NOT COMPLETED|Overall Study||6
9073642|NCT03770091|10134400|FG000|STARTED|Overall Study||15
8843641|NCT01704846|9897963|FG000|STARTED|Treatment Period 1||30
8843642|NCT01704846|9897964|FG001|STARTED|Treatment Period 1||30
8843643|NCT01704846|9897963|FG000|COMPLETED|Treatment Period 1||30
8843644|NCT01704846|9897964|FG001|COMPLETED|Treatment Period 1||30
8843645|NCT01704846|9897963|FG000|NOT COMPLETED|Treatment Period 1||0
8843646|NCT01704846|9897964|FG001|NOT COMPLETED|Treatment Period 1||0
8843647|NCT01704846|9897963|FG000|STARTED|Treatment Period 2||30
8843648|NCT01704846|9897964|FG001|STARTED|Treatment Period 2||30
8843649|NCT01704846|9897963|FG000|COMPLETED|Treatment Period 2||30
8843650|NCT01704846|9897964|FG001|COMPLETED|Treatment Period 2||29
8843651|NCT01704846|9897963|FG000|NOT COMPLETED|Treatment Period 2||0
8843652|NCT01704846|9897964|FG001|NOT COMPLETED|Treatment Period 2||1
8843653|NCT01704846|9897963|FG000|STARTED|Treatment Period 3||30
8843654|NCT01704846|9897964|FG001|STARTED|Treatment Period 3||29
8843655|NCT01704846|9897963|FG000|COMPLETED|Treatment Period 3||30
8843656|NCT01704846|9897964|FG001|COMPLETED|Treatment Period 3||29
8843657|NCT01704846|9897963|FG000|NOT COMPLETED|Treatment Period 3||0
8843658|NCT01704846|9897964|FG001|NOT COMPLETED|Treatment Period 3||0
8843659|NCT01704846|9897963|FG000|STARTED|Treatment Period 4||30
8843660|NCT01704846|9897964|FG001|STARTED|Treatment Period 4||29
8843661|NCT01704846|9897963|FG000|COMPLETED|Treatment Period 4||30
8843662|NCT01704846|9897964|FG001|COMPLETED|Treatment Period 4||29
8843663|NCT01704846|9897963|FG000|NOT COMPLETED|Treatment Period 4||0
8843664|NCT01704846|9897964|FG001|NOT COMPLETED|Treatment Period 4||0
8843665|NCT01704976|9897972|FG000|STARTED|Overall Study||14
8843666|NCT01704976|9897973|FG001|STARTED|Overall Study||13
8843667|NCT01704976|9897972|FG000|COMPLETED|Overall Study|One participant completed < 11 SR-WBV sessions and was excluded from the statistical analysis|13
8843668|NCT01704976|9897973|FG001|COMPLETED|Overall Study|2 participants completed < 11 SR-WBV sessions, they were excluded from statistical analysis|11
8843669|NCT01704976|9897972|FG000|NOT COMPLETED|Overall Study||1
8843670|NCT01704976|9897973|FG001|NOT COMPLETED|Overall Study||2
8843671|NCT01705080|9897982|FG000|STARTED|Overall Study||147
8843672|NCT01705080|9897983|FG001|STARTED|Overall Study||101
8843673|NCT01705080|9897984|FG002|STARTED|Overall Study||28
8843674|NCT01705080|9897982|FG000|Renal Artery Ablation Procedure|Overall Study||147
8843675|NCT01705080|9897983|FG001|Renal Artery Ablation Procedure|Overall Study||101
8843676|NCT01705080|9897984|FG002|Renal Artery Ablation Procedure|Overall Study||28
8843677|NCT01705080|9897982|FG000|Discharge Following Renal Artery Ablation Procedure|Overall Study||147
8843678|NCT01705080|9897983|FG001|Discharge Following Renal Artery Ablation Procedure|Overall Study|Reason Not Completed: Withdrawal by Subject=1|100
8843679|NCT01705080|9897984|FG002|Discharge Following Renal Artery Ablation Procedure|Overall Study||28
8843680|NCT01705080|9897982|FG000|COMPLETED|Overall Study||72
8843681|NCT01705080|9897983|FG001|COMPLETED|Overall Study||49
8843682|NCT01705080|9897984|FG002|COMPLETED|Overall Study||12
8843683|NCT01705080|9897982|FG000|NOT COMPLETED|Overall Study||75
8843684|NCT01705080|9897983|FG001|NOT COMPLETED|Overall Study||52
8843685|NCT01705080|9897984|FG002|NOT COMPLETED|Overall Study||16
8843686|NCT01705145|9897992|FG000|STARTED|Part A||9
8843687|NCT01705145|9897992|FG000|COMPLETED|Part A||9
8843688|NCT01705145|9897992|FG000|NOT COMPLETED|Part A||0
8843689|NCT01705145|9897992|FG000|STARTED|Part B|Eight participants from Part A continued in Part B of the study.|34
8843690|NCT01705145|9897992|FG000|COMPLETED|Part B||33
8843691|NCT01705145|9897992|FG000|NOT COMPLETED|Part B||1
8843692|NCT01705236|9898008|FG000|STARTED|Overall Study||87
8843693|NCT01705236|9898008|FG000|COMPLETED|Overall Study||60
8843694|NCT01705236|9898008|FG000|NOT COMPLETED|Overall Study||27
8843695|NCT01705288|9898014|FG000|STARTED|Overall Study||52
8843696|NCT01705288|9898015|FG001|STARTED|Overall Study||51
8843697|NCT01705288|9898014|FG000|COMPLETED|Overall Study||52
8843698|NCT01705288|9898015|FG001|COMPLETED|Overall Study||51
8843699|NCT01705288|9898014|FG000|NOT COMPLETED|Overall Study||0
8843700|NCT01705288|9898015|FG001|NOT COMPLETED|Overall Study||0
8843701|NCT01705496|9898021|FG000|STARTED|Overall Study||23
8843702|NCT01705496|9898021|FG000|COMPLETED|Overall Study||19
8843703|NCT01705496|9898021|FG000|NOT COMPLETED|Overall Study||4
8843704|NCT01705509|9898025|FG000|STARTED|Inclusion CPET||14
8843705|NCT01705509|9898025|FG000|COMPLETED|Inclusion CPET||7
8843706|NCT01705509|9898025|FG000|NOT COMPLETED|Inclusion CPET||7
8843707|NCT01705509|9898025|FG000|STARTED|CPET w/ Ranexa||7
8843708|NCT01705509|9898025|FG000|COMPLETED|CPET w/ Ranexa||5
8843709|NCT01705509|9898025|FG000|NOT COMPLETED|CPET w/ Ranexa||2
9073643|NCT03770091|10134401|FG001|STARTED|Overall Study||13
8843710|NCT01705574|9898031|FG000|STARTED|Double-Blind Phase||293
8843711|NCT01705574|9898032|FG001|STARTED|Double-Blind Phase||290
8843712|NCT01705574|9898033|FG002|STARTED|Double-Blind Phase||0
8843713|NCT01705574|9898034|FG003|STARTED|Double-Blind Phase||0
8843714|NCT01705574|9898031|FG000|COMPLETED|Double-Blind Phase||260
8843715|NCT01705574|9898032|FG001|COMPLETED|Double-Blind Phase||249
8843716|NCT01705574|9898033|FG002|COMPLETED|Double-Blind Phase||0
9073644|NCT03770091|10134402|FG002|STARTED|Overall Study||12
9073645|NCT03770091|10134400|FG000|COMPLETED|Overall Study||15
9073646|NCT03770091|10134401|FG001|COMPLETED|Overall Study||13
9073647|NCT03770091|10134402|FG002|COMPLETED|Overall Study||12
9073648|NCT03770091|10134400|FG000|NOT COMPLETED|Overall Study||0
9073649|NCT03770091|10134401|FG001|NOT COMPLETED|Overall Study||0
9073650|NCT03770091|10134402|FG002|NOT COMPLETED|Overall Study||0
9073651|NCT03769896|10134412|FG000|STARTED|Open-label Phase||47
9073652|NCT03769896|10134413|FG001|STARTED|Open-label Phase||0
9073653|NCT03769896|10134412|FG000|COMPLETED|Open-label Phase||38
9073654|NCT03769896|10134413|FG001|COMPLETED|Open-label Phase||0
9073655|NCT03769896|10134412|FG000|NOT COMPLETED|Open-label Phase||9
9073656|NCT03769896|10134413|FG001|NOT COMPLETED|Open-label Phase||0
9073657|NCT03769896|10134412|FG000|STARTED|Double-blind Treatment Phase||19
9073658|NCT03769896|10134413|FG001|STARTED|Double-blind Treatment Phase||19
9073659|NCT03769896|10134412|FG000|COMPLETED|Double-blind Treatment Phase||19
9073660|NCT03769896|10134413|FG001|COMPLETED|Double-blind Treatment Phase||19
9073661|NCT03769896|10134412|FG000|NOT COMPLETED|Double-blind Treatment Phase||0
9073662|NCT03769896|10134413|FG001|NOT COMPLETED|Double-blind Treatment Phase||0
9073663|NCT03769649|10134420|FG000|STARTED|Overall Study||15
9073664|NCT03769649|10134420|FG000|COMPLETED|Overall Study||11
9073665|NCT03769649|10134420|FG000|NOT COMPLETED|Overall Study||4
9073666|NCT03769207|10134424|FG000|STARTED|Overall Study||17
9073667|NCT03769207|10134424|FG000|Attended First Study Visit|Overall Study||11
9073668|NCT03769207|10134424|FG000|ECG Patch Shipped|Overall Study||11
9073669|NCT03769207|10134424|FG000|ECG Patch Returned and Readable|Overall Study||9
9073670|NCT03769207|10134424|FG000|Attended Second Study Visit|Overall Study||6
9073671|NCT03769207|10134424|FG000|COMPLETED|Overall Study||6
9073672|NCT03769207|10134424|FG000|NOT COMPLETED|Overall Study||11
9073673|NCT03768856|10134428|FG000|STARTED|Overall Study||5
9073674|NCT03768856|10134428|FG000|COMPLETED|Overall Study||5
9073675|NCT03768856|10134428|FG000|NOT COMPLETED|Overall Study||0
9073676|NCT03768726|10134434|FG000|STARTED|Treatment Phase||10
9073677|NCT03768726|10134435|FG001|STARTED|Treatment Phase||13
9073678|NCT03768726|10134434|FG000|COMPLETED|Treatment Phase||2
8843717|NCT01705574|9898034|FG003|COMPLETED|Double-Blind Phase||0
8843718|NCT01705574|9898031|FG000|NOT COMPLETED|Double-Blind Phase||33
8843719|NCT01705574|9898032|FG001|NOT COMPLETED|Double-Blind Phase||41
8843720|NCT01705574|9898033|FG002|NOT COMPLETED|Double-Blind Phase||0
8843721|NCT01705574|9898034|FG003|NOT COMPLETED|Double-Blind Phase||0
8843722|NCT01705574|9898031|FG000|STARTED|Open-Label Extension Phase||246
8843723|NCT01705574|9898032|FG001|STARTED|Open-Label Extension Phase|Participants either entered the OL GEN arm or OL ATV+RTV+TVD arm.|0
8843724|NCT01705574|9898033|FG002|STARTED|Open-Label Extension Phase|159 participants entered from the DB ATV+RTV+TVD arm.|159
8843725|NCT01705574|9898034|FG003|STARTED|Open-Label Extension Phase|53 participants entered from the DB ATV+ RTV + TVD arm.|53
8843726|NCT01705574|9898031|FG000|COMPLETED|Open-Label Extension Phase||231
8843727|NCT01705574|9898032|FG001|COMPLETED|Open-Label Extension Phase||0
8843728|NCT01705574|9898033|FG002|COMPLETED|Open-Label Extension Phase||148
8843729|NCT01705574|9898034|FG003|COMPLETED|Open-Label Extension Phase||48
8843730|NCT01705574|9898031|FG000|NOT COMPLETED|Open-Label Extension Phase||15
8843731|NCT01705574|9898032|FG001|NOT COMPLETED|Open-Label Extension Phase||0
8843732|NCT01705574|9898033|FG002|NOT COMPLETED|Open-Label Extension Phase||11
8843733|NCT01705574|9898034|FG003|NOT COMPLETED|Open-Label Extension Phase||5
8843734|NCT01705587|9898052|FG000|STARTED|Overall Study||7
8843735|NCT01705587|9898053|FG001|STARTED|Overall Study||6
8843736|NCT01705587|9898052|FG000|COMPLETED|Overall Study||7
8843737|NCT01705587|9898053|FG001|COMPLETED|Overall Study||5
8843738|NCT01705587|9898052|FG000|NOT COMPLETED|Overall Study||0
8843739|NCT01705587|9898053|FG001|NOT COMPLETED|Overall Study||1
8843740|NCT01705652|9898061|FG000|STARTED|Overall Study||9
8843741|NCT01705652|9898062|FG001|STARTED|Overall Study||12
8843742|NCT01705652|9898061|FG000|COMPLETED|Overall Study||6
8843743|NCT01705652|9898062|FG001|COMPLETED|Overall Study||9
8843744|NCT01705652|9898061|FG000|NOT COMPLETED|Overall Study||3
8843745|NCT01705652|9898062|FG001|NOT COMPLETED|Overall Study||3
8843746|NCT01705691|9898070|FG000|STARTED|Overall Study||19
8843747|NCT01705691|9898071|FG001|STARTED|Overall Study||30
8843748|NCT01705691|9898070|FG000|COMPLETED|Overall Study||16
8843749|NCT01705691|9898071|FG001|COMPLETED|Overall Study||24
8843750|NCT01705691|9898070|FG000|NOT COMPLETED|Overall Study||3
8843751|NCT01705691|9898071|FG001|NOT COMPLETED|Overall Study||6
8843752|NCT01705717|9898079|FG000|STARTED|Overall Study||37
8843753|NCT01705717|9898080|FG001|STARTED|Overall Study||12
8843754|NCT01705717|9898079|FG000|COMPLETED|Overall Study||35
8843755|NCT01705717|9898080|FG001|COMPLETED|Overall Study||7
8843756|NCT01705717|9898079|FG000|NOT COMPLETED|Overall Study||2
8843757|NCT01705717|9898080|FG001|NOT COMPLETED|Overall Study||5
8843758|NCT01705730|9898085|FG000|STARTED|Overall Study|Participants who received study drug|68
8843759|NCT01705730|9898085|FG000|COMPLETED|Overall Study||59
8843760|NCT01705730|9898085|FG000|NOT COMPLETED|Overall Study||9
9073679|NCT03768726|10134435|FG001|COMPLETED|Treatment Phase||10
9073680|NCT03768726|10134434|FG000|NOT COMPLETED|Treatment Phase||8
9073681|NCT03768726|10134435|FG001|NOT COMPLETED|Treatment Phase||3
9073682|NCT03768726|10134434|FG000|STARTED|Follow-Up|Participants were followed up after completion or discontinuation of treatment.|8
9073683|NCT03768726|10134435|FG001|STARTED|Follow-Up|Participants were followed up after completion or discontinuation of treatment.|12
9073684|NCT03768726|10134434|FG000|Received Treatment|Follow-Up||8
9073685|NCT03768726|10134435|FG001|Received Treatment|Follow-Up||12
8843761|NCT01705964|9898091|FG000|STARTED|Overall Study||25
9073686|NCT03768726|10134434|FG000|COMPLETED|Follow-Up||2
9073687|NCT03768726|10134435|FG001|COMPLETED|Follow-Up||9
9073688|NCT03768726|10134434|FG000|NOT COMPLETED|Follow-Up||6
9073689|NCT03768726|10134435|FG001|NOT COMPLETED|Follow-Up||3
9073690|NCT03768206|10134443|FG000|STARTED|Overall Study||24
9073691|NCT03768206|10134444|FG001|STARTED|Overall Study||21
9073692|NCT03768206|10134443|FG000|COMPLETED|Overall Study||22
9073693|NCT03768206|10134444|FG001|COMPLETED|Overall Study||19
9073694|NCT03768206|10134443|FG000|NOT COMPLETED|Overall Study||2
9073695|NCT03768206|10134444|FG001|NOT COMPLETED|Overall Study||2
9073696|NCT03767894|10134451|FG000|STARTED|Overall Study||12
9073697|NCT03767894|10134451|FG000|COMPLETED|Overall Study||11
9073698|NCT03767894|10134451|FG000|NOT COMPLETED|Overall Study||1
9073699|NCT03767738|10134457|FG000|STARTED|Overall Study||35
9073700|NCT03767738|10134458|FG001|STARTED|Overall Study||30
9073701|NCT03767738|10134457|FG000|COMPLETED|Overall Study||35
9073702|NCT03767738|10134458|FG001|COMPLETED|Overall Study||30
9073703|NCT03767738|10134457|FG000|NOT COMPLETED|Overall Study||0
9073704|NCT03767738|10134458|FG001|NOT COMPLETED|Overall Study||0
9073705|NCT03767153|10134466|FG000|STARTED|Overall Study||14
9073706|NCT03767153|10134467|FG001|STARTED|Overall Study||11
9073707|NCT03767153|10134466|FG000|COMPLETED|Overall Study||14
9073708|NCT03767153|10134467|FG001|COMPLETED|Overall Study||11
9073709|NCT03767153|10134466|FG000|NOT COMPLETED|Overall Study||0
9073710|NCT03767153|10134467|FG001|NOT COMPLETED|Overall Study||0
9073711|NCT03767062|10134475|FG000|STARTED|Overall Study||45
9073712|NCT03767062|10134476|FG001|STARTED|Overall Study||45
9073713|NCT03767062|10134475|FG000|COMPLETED|Overall Study||37
9073714|NCT03767062|10134476|FG001|COMPLETED|Overall Study||41
9073715|NCT03767062|10134475|FG000|NOT COMPLETED|Overall Study||8
9073716|NCT03767062|10134476|FG001|NOT COMPLETED|Overall Study||4
9073717|NCT03766646|10134484|FG000|STARTED|Overall Study||19
9073718|NCT03766646|10134485|FG001|STARTED|Overall Study||15
8843762|NCT01705964|9898092|FG001|STARTED|Overall Study||24
8843763|NCT01705964|9898091|FG000|COMPLETED|Overall Study||25
8843764|NCT01705964|9898092|FG001|COMPLETED|Overall Study||24
8843765|NCT01705964|9898091|FG000|NOT COMPLETED|Overall Study||0
8843766|NCT01705964|9898092|FG001|NOT COMPLETED|Overall Study||0
8843767|NCT01706003|9898100|FG000|STARTED|Overall Study||23
8843768|NCT01706003|9898101|FG001|STARTED|Overall Study||22
8843769|NCT01706003|9898100|FG000|COMPLETED|Overall Study||12
8843770|NCT01706003|9898101|FG001|COMPLETED|Overall Study||18
8843771|NCT01706003|9898100|FG000|NOT COMPLETED|Overall Study||11
8843772|NCT01706003|9898101|FG001|NOT COMPLETED|Overall Study||4
8843773|NCT01706081|9898109|FG000|STARTED|Overall Study||40
8843774|NCT01706081|9898110|FG001|STARTED|Overall Study||42
8843775|NCT01706081|9898109|FG000|COMPLETED|Overall Study||40
8843776|NCT01706081|9898110|FG001|COMPLETED|Overall Study||42
8843777|NCT01706081|9898109|FG000|NOT COMPLETED|Overall Study||0
8843778|NCT01706081|9898110|FG001|NOT COMPLETED|Overall Study||0
8843779|NCT01706146|9898116|FG000|STARTED|Overall Study||59
8843780|NCT01706146|9898116|FG000|COMPLETED|Overall Study|1 pt developed permanent AF; 1 pt needed dual antiplatelet therapy; 3 possible TIA; 1 withdraw|53
8843781|NCT01706146|9898116|FG000|NOT COMPLETED|Overall Study||6
8843782|NCT01706159|9898122|FG000|STARTED|Overall Study||14
8843783|NCT01706159|9898123|FG001|STARTED|Overall Study||6
8843784|NCT01706159|9898122|FG000|Exposed|Overall Study|One subject was not exposed to rFXIII.|13
8843785|NCT01706159|9898123|FG001|Exposed|Overall Study|One subject was not exposed to placebo.|5
8843786|NCT01706159|9898122|FG000|Completers (With Baron Score at Week 8)|Overall Study||6
8843787|NCT01706159|9898123|FG001|Completers (With Baron Score at Week 8)|Overall Study||3
8843788|NCT01706159|9898122|FG000|COMPLETED|Overall Study||6
8843789|NCT01706159|9898123|FG001|COMPLETED|Overall Study||4
8843790|NCT01706159|9898122|FG000|NOT COMPLETED|Overall Study||8
8843791|NCT01706159|9898123|FG001|NOT COMPLETED|Overall Study||2
8843792|NCT01706198|9898131|FG000|STARTED|Overall Study||2119
8843793|NCT01706198|9898132|FG001|STARTED|Overall Study||2114
8843794|NCT01706198|9898131|FG000|COMPLETED|Overall Study||1946
8843795|NCT01706198|9898132|FG001|COMPLETED|Overall Study||1920
8843796|NCT01706198|9898131|FG000|NOT COMPLETED|Overall Study||173
8843797|NCT01706198|9898132|FG001|NOT COMPLETED|Overall Study||194
8843798|NCT01706250|9898138|FG000|STARTED|Overall Study||20
8843799|NCT01706250|9898138|FG000|COMPLETED|Overall Study||18
8843800|NCT01706250|9898138|FG000|NOT COMPLETED|Overall Study||2
8843801|NCT01706263|9898147|FG000|STARTED|Overall Study||28
8843802|NCT01706263|9898147|FG000|COMPLETED|Overall Study||28
8843803|NCT01706263|9898147|FG000|NOT COMPLETED|Overall Study||0
8843804|NCT01706328|9898154|FG000|STARTED|2-week Run-in Period||993
8843805|NCT01706328|9898155|FG001|STARTED|2-week Run-in Period||0
8843806|NCT01706328|9898156|FG002|STARTED|2-week Run-in Period||0
8843807|NCT01706328|9898154|FG000|COMPLETED|2-week Run-in Period||828
9073719|NCT03766646|10134484|FG000|COMPLETED|Overall Study||18
9073720|NCT03766646|10134485|FG001|COMPLETED|Overall Study||12
9073721|NCT03766646|10134484|FG000|NOT COMPLETED|Overall Study||1
9073722|NCT03766646|10134485|FG001|NOT COMPLETED|Overall Study||3
9073723|NCT03766373|10134493|FG000|STARTED|Overall Study||12
8843808|NCT01706328|9898155|FG001|COMPLETED|2-week Run-in Period||0
8843809|NCT01706328|9898156|FG002|COMPLETED|2-week Run-in Period||0
9073724|NCT03766373|10134494|FG001|STARTED|Overall Study||12
9073725|NCT03766373|10134493|FG000|COMPLETED|Overall Study||12
9073726|NCT03766373|10134494|FG001|COMPLETED|Overall Study||12
9073727|NCT03766373|10134493|FG000|NOT COMPLETED|Overall Study||0
9073728|NCT03766373|10134494|FG001|NOT COMPLETED|Overall Study||0
9073729|NCT03766165|10134502|FG000|STARTED|Overall Study||19
9073730|NCT03766165|10134503|FG001|STARTED|Overall Study||19
9073731|NCT03766165|10134502|FG000|COMPLETED|Overall Study||19
9073732|NCT03766165|10134503|FG001|COMPLETED|Overall Study||19
9073733|NCT03766165|10134502|FG000|NOT COMPLETED|Overall Study||0
9073734|NCT03766165|10134503|FG001|NOT COMPLETED|Overall Study||0
9073735|NCT03765996|10134512|FG000|STARTED|Overall Study||18
9073736|NCT03765996|10134513|FG001|STARTED|Overall Study||18
9073737|NCT03765996|10134512|FG000|COMPLETED|Overall Study||14
9073738|NCT03765996|10134513|FG001|COMPLETED|Overall Study||18
9073739|NCT03765996|10134512|FG000|NOT COMPLETED|Overall Study||4
9073740|NCT03765996|10134513|FG001|NOT COMPLETED|Overall Study||0
9073741|NCT03765762|10134521|FG000|STARTED|Overall Study||18
9073742|NCT03765762|10134522|FG001|STARTED|Overall Study||8
9073743|NCT03765762|10134521|FG000|COMPLETED|Overall Study||18
9073744|NCT03765762|10134522|FG001|COMPLETED|Overall Study||8
9073745|NCT03765762|10134521|FG000|NOT COMPLETED|Overall Study||0
9073746|NCT03765762|10134522|FG001|NOT COMPLETED|Overall Study||0
9073747|NCT03765502|10134531|FG000|STARTED|Simulation 1||20
9073748|NCT03765502|10134532|FG001|STARTED|Simulation 1||13
9073749|NCT03765502|10134533|FG002|STARTED|Simulation 1||33
8843810|NCT01706328|9898154|FG000|NOT COMPLETED|2-week Run-in Period||165
8843811|NCT01706328|9898155|FG001|NOT COMPLETED|2-week Run-in Period||0
8843812|NCT01706328|9898156|FG002|NOT COMPLETED|2-week Run-in Period||0
8843813|NCT01706328|9898154|FG000|STARTED|12-week Double-blind Treatment Period||0
8843814|NCT01706328|9898155|FG001|STARTED|12-week Double-blind Treatment Period||412
8843815|NCT01706328|9898156|FG002|STARTED|12-week Double-blind Treatment Period||416
8843816|NCT01706328|9898154|FG000|COMPLETED|12-week Double-blind Treatment Period||0
8843817|NCT01706328|9898155|FG001|COMPLETED|12-week Double-blind Treatment Period||366
8843818|NCT01706328|9898156|FG002|COMPLETED|12-week Double-blind Treatment Period||371
8843819|NCT01706328|9898154|FG000|NOT COMPLETED|12-week Double-blind Treatment Period||0
8843820|NCT01706328|9898155|FG001|NOT COMPLETED|12-week Double-blind Treatment Period||46
8843821|NCT01706328|9898156|FG002|NOT COMPLETED|12-week Double-blind Treatment Period||45
8843822|NCT01706458|9898164|FG000|STARTED|Overall Study||9
8843823|NCT01706458|9898165|FG001|STARTED|Overall Study||9
8843824|NCT01706458|9898164|FG000|COMPLETED|Overall Study||6
8843825|NCT01706458|9898165|FG001|COMPLETED|Overall Study||5
8843826|NCT01706458|9898164|FG000|NOT COMPLETED|Overall Study||3
8843827|NCT01706458|9898165|FG001|NOT COMPLETED|Overall Study||4
8843828|NCT01706497|9898171|FG000|STARTED|Overall Study||177
8843829|NCT01706497|9898171|FG000|COMPLETED|Overall Study||177
8843830|NCT01706497|9898171|FG000|NOT COMPLETED|Overall Study||0
8843831|NCT01706536|9898180|FG000|STARTED|Overall Study||57
8843832|NCT01706536|9898181|FG001|STARTED|Overall Study||55
8843833|NCT01706536|9898182|FG002|STARTED|Overall Study||54
8843834|NCT01706536|9898183|FG003|STARTED|Overall Study||57
8843835|NCT01706536|9898184|FG004|STARTED|Overall Study||59
8843836|NCT01706536|9898180|FG000|COMPLETED|Overall Study||53
8843837|NCT01706536|9898181|FG001|COMPLETED|Overall Study||51
8843838|NCT01706536|9898182|FG002|COMPLETED|Overall Study||49
8843839|NCT01706536|9898183|FG003|COMPLETED|Overall Study||53
8843840|NCT01706536|9898184|FG004|COMPLETED|Overall Study||57
8843841|NCT01706536|9898180|FG000|NOT COMPLETED|Overall Study||4
8843842|NCT01706536|9898181|FG001|NOT COMPLETED|Overall Study||4
8843843|NCT01706536|9898182|FG002|NOT COMPLETED|Overall Study||5
8843844|NCT01706536|9898183|FG003|NOT COMPLETED|Overall Study||4
8843845|NCT01706536|9898184|FG004|NOT COMPLETED|Overall Study||2
8843846|NCT01706549|9898197|FG000|STARTED|Overall Study||16
8843847|NCT01706549|9898197|FG000|COMPLETED|Overall Study||16
8843848|NCT01706549|9898197|FG000|NOT COMPLETED|Overall Study||0
8843849|NCT01706575|9898201|FG000|STARTED|Overall Study||76
8843850|NCT01706575|9898201|FG000|Treated|Overall Study||70
8843851|NCT01706575|9898201|FG000|COMPLETED|Overall Study||64
8843852|NCT01706575|9898201|FG000|NOT COMPLETED|Overall Study||12
8843853|NCT01706588|9898210|FG000|STARTED|Overall Study||15
8843854|NCT01706588|9898211|FG001|STARTED|Overall Study||15
8843855|NCT01706588|9898212|FG002|STARTED|Overall Study||15
8843856|NCT01706588|9898213|FG003|STARTED|Overall Study||14
8843857|NCT01706588|9898214|FG004|STARTED|Overall Study||16
8843858|NCT01706588|9898210|FG000|COMPLETED|Overall Study||15
8843859|NCT01706588|9898211|FG001|COMPLETED|Overall Study||15
8843860|NCT01706588|9898212|FG002|COMPLETED|Overall Study||15
8843861|NCT01706588|9898213|FG003|COMPLETED|Overall Study||14
8843862|NCT01706588|9898214|FG004|COMPLETED|Overall Study||16
8843863|NCT01706588|9898210|FG000|NOT COMPLETED|Overall Study||0
8843864|NCT01706588|9898211|FG001|NOT COMPLETED|Overall Study||0
8843865|NCT01706588|9898212|FG002|NOT COMPLETED|Overall Study||0
8843866|NCT01706588|9898213|FG003|NOT COMPLETED|Overall Study||0
8843867|NCT01706588|9898214|FG004|NOT COMPLETED|Overall Study||0
8843868|NCT01706666|9898229|FG000|STARTED|Overall Study||1
8843869|NCT01706666|9898230|FG001|STARTED|Overall Study||1
9073750|NCT03765502|10134534|FG003|STARTED|Simulation 1||16
9073751|NCT03765502|10134535|FG004|STARTED|Simulation 1||17
8843870|NCT01706666|9898231|FG002|STARTED|Overall Study||1
8843871|NCT01706666|9898229|FG000|COMPLETED|Overall Study||1
8843872|NCT01706666|9898230|FG001|COMPLETED|Overall Study||1
8843873|NCT01706666|9898231|FG002|COMPLETED|Overall Study||1
8843874|NCT01706666|9898229|FG000|NOT COMPLETED|Overall Study||0
8843875|NCT01706666|9898230|FG001|NOT COMPLETED|Overall Study||0
9073752|NCT03765502|10134531|FG000|COMPLETED|Simulation 1||20
9073753|NCT03765502|10134532|FG001|COMPLETED|Simulation 1||13
9073754|NCT03765502|10134533|FG002|COMPLETED|Simulation 1||33
9073755|NCT03765502|10134534|FG003|COMPLETED|Simulation 1||16
9073756|NCT03765502|10134535|FG004|COMPLETED|Simulation 1||17
9073757|NCT03765502|10134531|FG000|NOT COMPLETED|Simulation 1||0
9073758|NCT03765502|10134532|FG001|NOT COMPLETED|Simulation 1||0
9073759|NCT03765502|10134533|FG002|NOT COMPLETED|Simulation 1||0
9073760|NCT03765502|10134534|FG003|NOT COMPLETED|Simulation 1||0
9073761|NCT03765502|10134535|FG004|NOT COMPLETED|Simulation 1||0
9073762|NCT03765502|10134531|FG000|STARTED|Simulation 2||20
9073763|NCT03765502|10134532|FG001|STARTED|Simulation 2|Participant completed Period 1 GEK simulation but did not return for the Period 2 NG simulation.|12
8843876|NCT01706666|9898231|FG002|NOT COMPLETED|Overall Study||0
8843877|NCT01706770|9898241|FG000|STARTED|Overall Study||33
8843878|NCT01706770|9898242|FG001|STARTED|Overall Study||17
8843879|NCT01706770|9898241|FG000|COMPLETED|Overall Study||31
8843880|NCT01706770|9898242|FG001|COMPLETED|Overall Study||17
8843881|NCT01706770|9898241|FG000|NOT COMPLETED|Overall Study||2
8843882|NCT01706770|9898242|FG001|NOT COMPLETED|Overall Study||0
8843883|NCT01706822|9898248|FG000|STARTED|Overall Study||8
8843884|NCT01706822|9898248|FG000|COMPLETED|Overall Study||8
8843885|NCT01706822|9898248|FG000|NOT COMPLETED|Overall Study||0
8843886|NCT01706926|9898256|FG000|STARTED|Overall Study||81
8843887|NCT01706926|9898257|FG001|STARTED|Overall Study||81
8843888|NCT01706926|9898258|FG002|STARTED|Overall Study||85
8843889|NCT01706926|9898259|FG003|STARTED|Overall Study||79
8843890|NCT01706926|9898256|FG000|COMPLETED|Overall Study||75
8843891|NCT01706926|9898257|FG001|COMPLETED|Overall Study||77
8843892|NCT01706926|9898258|FG002|COMPLETED|Overall Study||79
8843893|NCT01706926|9898259|FG003|COMPLETED|Overall Study||74
8843894|NCT01706926|9898256|FG000|NOT COMPLETED|Overall Study||6
8843895|NCT01706926|9898257|FG001|NOT COMPLETED|Overall Study||4
8843896|NCT01706926|9898258|FG002|NOT COMPLETED|Overall Study||6
8843897|NCT01706926|9898259|FG003|NOT COMPLETED|Overall Study||5
8843898|NCT01706952|9898272|FG000|STARTED|Overall Study||45
8843899|NCT01706952|9898272|FG000|COMPLETED|Overall Study||37
8843900|NCT01706952|9898272|FG000|NOT COMPLETED|Overall Study||8
8843901|NCT01706965|9898280|FG000|STARTED|Overall Study||14
8843902|NCT01706965|9898281|FG001|STARTED|Overall Study||13
8843903|NCT01706965|9898280|FG000|COMPLETED|Overall Study||13
8843904|NCT01706965|9898281|FG001|COMPLETED|Overall Study||12
8843905|NCT01706965|9898280|FG000|NOT COMPLETED|Overall Study||1
8843906|NCT01706965|9898281|FG001|NOT COMPLETED|Overall Study||1
8843907|NCT01706978|9898289|FG000|STARTED|Overall Study||47
8843908|NCT01706978|9898290|FG001|STARTED|Overall Study||41
8843909|NCT01706978|9898289|FG000|COMPLETED|Overall Study||38
8843910|NCT01706978|9898290|FG001|COMPLETED|Overall Study||35
8843911|NCT01706978|9898289|FG000|NOT COMPLETED|Overall Study||9
8843912|NCT01706978|9898290|FG001|NOT COMPLETED|Overall Study||6
8843913|NCT01707004|9898296|FG000|STARTED|Overall Study||20
8843914|NCT01707004|9898296|FG000|COMPLETED|Overall Study|3 participants were not eligible to proceed to Bone Marrow Transplant due to significant infections.|17
8843915|NCT01707004|9898296|FG000|NOT COMPLETED|Overall Study||3
8843916|NCT01707030|9898303|FG000|STARTED|Overall Study||67
8843917|NCT01707030|9898304|FG001|STARTED|Overall Study||71
8843918|NCT01707030|9898303|FG000|COMPLETED|Overall Study||56
8843919|NCT01707030|9898304|FG001|COMPLETED|Overall Study||54
8843920|NCT01707030|9898303|FG000|NOT COMPLETED|Overall Study||11
8843921|NCT01707030|9898304|FG001|NOT COMPLETED|Overall Study||17
8843922|NCT01707043|9898316|FG000|STARTED|Overall Study||10
8843923|NCT01707043|9898317|FG001|STARTED|Overall Study||10
8843924|NCT01707043|9898316|FG000|COMPLETED|Overall Study||10
8843925|NCT01707043|9898317|FG001|COMPLETED|Overall Study||10
8843926|NCT01707043|9898316|FG000|NOT COMPLETED|Overall Study||0
8843927|NCT01707043|9898317|FG001|NOT COMPLETED|Overall Study||0
8843928|NCT01707095|9898325|FG000|STARTED|Overall Study||42
8843929|NCT01707095|9898326|FG001|STARTED|Overall Study||42
8843930|NCT01707095|9898325|FG000|COMPLETED|Overall Study||42
8843931|NCT01707095|9898326|FG001|COMPLETED|Overall Study||42
8843932|NCT01707095|9898325|FG000|NOT COMPLETED|Overall Study||0
8843933|NCT01707095|9898326|FG001|NOT COMPLETED|Overall Study||0
8843934|NCT01707108|9898332|FG000|STARTED|Overall Study||60
8843935|NCT01707108|9898332|FG000|1 Year|Overall Study||60
8843936|NCT01707108|9898332|FG000|COMPLETED|Overall Study||60
8843937|NCT01707108|9898332|FG000|NOT COMPLETED|Overall Study||0
8843938|NCT01707147|9898337|FG000|STARTED|Overall Study||3219
8843939|NCT01707147|9898337|FG000|COMPLETED|Overall Study||3119
8843940|NCT01707147|9898337|FG000|NOT COMPLETED|Overall Study||100
8843941|NCT01707225|9898341|FG000|STARTED|Overall Study||10
8843942|NCT01707225|9898341|FG000|COMPLETED|Overall Study||10
8843943|NCT01707225|9898341|FG000|NOT COMPLETED|Overall Study||0
8843944|NCT01707238|9898347|FG000|STARTED|Overall Study||48
8843945|NCT01707238|9898348|FG001|STARTED|Overall Study||52
8843946|NCT01707238|9898347|FG000|COMPLETED|Overall Study||48
8843947|NCT01707238|9898348|FG001|COMPLETED|Overall Study||52
8843948|NCT01707238|9898347|FG000|NOT COMPLETED|Overall Study||0
8843949|NCT01707238|9898348|FG001|NOT COMPLETED|Overall Study||0
8843950|NCT01707290|9898357|FG000|STARTED|Overall Study||121
9073764|NCT03765502|10134533|FG002|STARTED|Simulation 2|PWD completed Period 1 GEK simulation but did not return for the Period 2 NG simulation.|32
8843951|NCT01707290|9898358|FG001|STARTED|Overall Study||4
8843952|NCT01707290|9898357|FG000|COMPLETED|Overall Study||35
8843953|NCT01707290|9898358|FG001|COMPLETED|Overall Study||3
8843954|NCT01707290|9898357|FG000|NOT COMPLETED|Overall Study||86
9073765|NCT03765502|10134534|FG003|STARTED|Simulation 2||16
9073766|NCT03765502|10134535|FG004|STARTED|Simulation 2||17
9073767|NCT03765502|10134531|FG000|COMPLETED|Simulation 2||20
9073768|NCT03765502|10134532|FG001|COMPLETED|Simulation 2||12
9073769|NCT03765502|10134533|FG002|COMPLETED|Simulation 2||32
9073770|NCT03765502|10134534|FG003|COMPLETED|Simulation 2||16
9073771|NCT03765502|10134535|FG004|COMPLETED|Simulation 2||17
9073772|NCT03765502|10134531|FG000|NOT COMPLETED|Simulation 2||0
9073773|NCT03765502|10134532|FG001|NOT COMPLETED|Simulation 2||0
9073774|NCT03765502|10134533|FG002|NOT COMPLETED|Simulation 2||0
9073775|NCT03765502|10134534|FG003|NOT COMPLETED|Simulation 2||0
9073776|NCT03765502|10134535|FG004|NOT COMPLETED|Simulation 2||0
9073777|NCT03765164|10134557|FG000|STARTED|Pre-intervention||78
9073778|NCT03765164|10134558|FG001|STARTED|Pre-intervention||78
9073779|NCT03765164|10134557|FG000|COMPLETED|Pre-intervention||73
9073780|NCT03765164|10134558|FG001|COMPLETED|Pre-intervention||72
9073781|NCT03765164|10134557|FG000|NOT COMPLETED|Pre-intervention||5
9073782|NCT03765164|10134558|FG001|NOT COMPLETED|Pre-intervention||6
9073783|NCT03765164|10134557|FG000|STARTED|Post-intervention||73
9073784|NCT03765164|10134558|FG001|STARTED|Post-intervention||72
8843955|NCT01707290|9898358|FG001|NOT COMPLETED|Overall Study||1
8843956|NCT01707368|9898367|FG000|STARTED|Overall Study||561
8843957|NCT01707368|9898367|FG000|COMPLETED|Overall Study||393
8843958|NCT01707368|9898367|FG000|NOT COMPLETED|Overall Study||168
8843959|NCT01707381|9898371|FG000|STARTED|Period 1||12
8843960|NCT01707381|9898372|FG001|STARTED|Period 1||13
8843961|NCT01707381|9898371|FG000|COMPLETED|Period 1||10
8843962|NCT01707381|9898372|FG001|COMPLETED|Period 1||11
8843963|NCT01707381|9898371|FG000|NOT COMPLETED|Period 1||2
8843964|NCT01707381|9898372|FG001|NOT COMPLETED|Period 1||2
8843965|NCT01707381|9898371|FG000|STARTED|Period 2||10
8843966|NCT01707381|9898372|FG001|STARTED|Period 2||11
8843967|NCT01707381|9898371|FG000|COMPLETED|Period 2||10
8843968|NCT01707381|9898372|FG001|COMPLETED|Period 2||11
8843969|NCT01707381|9898371|FG000|NOT COMPLETED|Period 2||0
8843970|NCT01707381|9898372|FG001|NOT COMPLETED|Period 2||0
8843971|NCT01707420|9898380|FG000|STARTED|Overall Study||18
8843972|NCT01707420|9898381|FG001|STARTED|Overall Study||18
8843973|NCT01707420|9898380|FG000|COMPLETED|Overall Study||18
8843974|NCT01707420|9898381|FG001|COMPLETED|Overall Study||18
8843975|NCT01707420|9898380|FG000|NOT COMPLETED|Overall Study||0
8843976|NCT01707420|9898381|FG001|NOT COMPLETED|Overall Study||0
8843977|NCT01707472|9898392|FG000|STARTED|Overall Study||4
8843978|NCT01707472|9898393|FG001|STARTED|Overall Study||6
8843979|NCT01707472|9898394|FG002|STARTED|Overall Study||8
8843980|NCT01707472|9898392|FG000|COMPLETED|Overall Study||4
8843981|NCT01707472|9898393|FG001|COMPLETED|Overall Study||6
8843982|NCT01707472|9898394|FG002|COMPLETED|Overall Study||8
8843983|NCT01707472|9898392|FG000|NOT COMPLETED|Overall Study||0
8843984|NCT01707472|9898393|FG001|NOT COMPLETED|Overall Study||0
8843985|NCT01707472|9898394|FG002|NOT COMPLETED|Overall Study||0
8843986|NCT01707654|9898402|FG000|STARTED|Overall Study||9
8843987|NCT01707654|9898402|FG000|COMPLETED|Overall Study||9
8843988|NCT01707654|9898402|FG000|NOT COMPLETED|Overall Study||0
8843989|NCT01707667|9898408|FG000|STARTED|Period 1||7
8843990|NCT01707667|9898409|FG001|STARTED|Period 1||6
8843991|NCT01707667|9898408|FG000|COMPLETED|Period 1||6
8843992|NCT01707667|9898409|FG001|COMPLETED|Period 1||6
8843993|NCT01707667|9898408|FG000|NOT COMPLETED|Period 1||1
8843994|NCT01707667|9898409|FG001|NOT COMPLETED|Period 1||0
8843995|NCT01707667|9898408|FG000|STARTED|Period 2||6
8843996|NCT01707667|9898409|FG001|STARTED|Period 2||6
8843997|NCT01707667|9898408|FG000|COMPLETED|Period 2||6
8843998|NCT01707667|9898409|FG001|COMPLETED|Period 2||6
8843999|NCT01707667|9898408|FG000|NOT COMPLETED|Period 2||0
8844000|NCT01707667|9898409|FG001|NOT COMPLETED|Period 2||0
8844001|NCT01707693|9898417|FG000|STARTED|Overall Study Allocation||59
8844002|NCT01707693|9898418|FG001|STARTED|Overall Study Allocation||62
8844003|NCT01707693|9898417|FG000|COMPLETED|Overall Study Allocation||46
8844004|NCT01707693|9898418|FG001|COMPLETED|Overall Study Allocation||54
8844005|NCT01707693|9898417|FG000|NOT COMPLETED|Overall Study Allocation||13
8844006|NCT01707693|9898418|FG001|NOT COMPLETED|Overall Study Allocation||8
8844007|NCT01707693|9898417|FG000|STARTED|Time 3 Measures @ 6 Mth||46
8844008|NCT01707693|9898418|FG001|STARTED|Time 3 Measures @ 6 Mth||54
8844009|NCT01707693|9898417|FG000|COMPLETED|Time 3 Measures @ 6 Mth||46
8844010|NCT01707693|9898418|FG001|COMPLETED|Time 3 Measures @ 6 Mth||49
8844011|NCT01707693|9898417|FG000|NOT COMPLETED|Time 3 Measures @ 6 Mth||0
8844012|NCT01707693|9898418|FG001|NOT COMPLETED|Time 3 Measures @ 6 Mth||5
8844013|NCT01707992|9898428|FG000|STARTED|Placebo-Controlled Phase (24 Months)||740
8844014|NCT01707992|9898429|FG001|STARTED|Placebo-Controlled Phase (24 Months)||727
8844015|NCT01707992|9898430|FG002|STARTED|Placebo-Controlled Phase (24 Months)||732
8844016|NCT01707992|9898431|FG003|STARTED|Placebo-Controlled Phase (24 Months)||0
8844017|NCT01707992|9898432|FG004|STARTED|Placebo-Controlled Phase (24 Months)||0
8844018|NCT01707992|9898433|FG005|STARTED|Placebo-Controlled Phase (24 Months)||0
8844019|NCT01707992|9898428|FG000|COMPLETED|Placebo-Controlled Phase (24 Months)||596
9073785|NCT03765164|10134557|FG000|COMPLETED|Post-intervention||0
9073786|NCT03765164|10134558|FG001|COMPLETED|Post-intervention||0
8844020|NCT01707992|9898429|FG001|COMPLETED|Placebo-Controlled Phase (24 Months)||623
8844021|NCT01707992|9898430|FG002|COMPLETED|Placebo-Controlled Phase (24 Months)||532
8844022|NCT01707992|9898431|FG003|COMPLETED|Placebo-Controlled Phase (24 Months)||0
9073787|NCT03765164|10134557|FG000|NOT COMPLETED|Post-intervention||73
9073788|NCT03765164|10134558|FG001|NOT COMPLETED|Post-intervention||72
9073789|NCT03765138|10134564|FG000|STARTED|Overall Study||1
9073790|NCT03765138|10134564|FG000|COMPLETED|Overall Study||0
8844023|NCT01707992|9898432|FG004|COMPLETED|Placebo-Controlled Phase (24 Months)||0
8844024|NCT01707992|9898433|FG005|COMPLETED|Placebo-Controlled Phase (24 Months)||0
8844025|NCT01707992|9898428|FG000|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||144
8844026|NCT01707992|9898429|FG001|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||104
8844027|NCT01707992|9898430|FG002|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||200
8844028|NCT01707992|9898431|FG003|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||0
8844029|NCT01707992|9898432|FG004|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||0
8844030|NCT01707992|9898433|FG005|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||0
8844031|NCT01707992|9898428|FG000|STARTED|Active Treatment Phase (24 Months)||0
8844032|NCT01707992|9898429|FG001|STARTED|Active Treatment Phase (24 Months)||0
8844033|NCT01707992|9898430|FG002|STARTED|Active Treatment Phase (24 Months)||0
8844034|NCT01707992|9898431|FG003|STARTED|Active Treatment Phase (24 Months)||891
8844035|NCT01707992|9898432|FG004|STARTED|Active Treatment Phase (24 Months)||504
8844036|NCT01707992|9898433|FG005|STARTED|Active Treatment Phase (24 Months)||215
8844037|NCT01707992|9898428|FG000|COMPLETED|Active Treatment Phase (24 Months)||0
8844038|NCT01707992|9898429|FG001|COMPLETED|Active Treatment Phase (24 Months)||0
8844039|NCT01707992|9898430|FG002|COMPLETED|Active Treatment Phase (24 Months)||0
8844040|NCT01707992|9898431|FG003|COMPLETED|Active Treatment Phase (24 Months)||7
8844041|NCT01707992|9898432|FG004|COMPLETED|Active Treatment Phase (24 Months)||10
8844042|NCT01707992|9898433|FG005|COMPLETED|Active Treatment Phase (24 Months)||0
8844043|NCT01707992|9898428|FG000|NOT COMPLETED|Active Treatment Phase (24 Months)||0
8844044|NCT01707992|9898429|FG001|NOT COMPLETED|Active Treatment Phase (24 Months)||0
8844045|NCT01707992|9898430|FG002|NOT COMPLETED|Active Treatment Phase (24 Months)||0
8844046|NCT01707992|9898431|FG003|NOT COMPLETED|Active Treatment Phase (24 Months)||884
8844047|NCT01707992|9898432|FG004|NOT COMPLETED|Active Treatment Phase (24 Months)||494
8844048|NCT01707992|9898433|FG005|NOT COMPLETED|Active Treatment Phase (24 Months)||215
8844049|NCT01708122|9898450|FG000|STARTED|Overall Study||27
8844050|NCT01708122|9898451|FG001|STARTED|Overall Study||26
8844051|NCT01708122|9898450|FG000|COMPLETED|Overall Study||27
8844052|NCT01708122|9898451|FG001|COMPLETED|Overall Study||26
8844053|NCT01708122|9898450|FG000|NOT COMPLETED|Overall Study||0
8844054|NCT01708122|9898451|FG001|NOT COMPLETED|Overall Study||0
8844055|NCT01708161|9898463|FG000|STARTED|Overall Study||4
8844056|NCT01708161|9898464|FG001|STARTED|Overall Study||10
8844057|NCT01708161|9898465|FG002|STARTED|Overall Study||10
8844058|NCT01708161|9898466|FG003|STARTED|Overall Study||16
8844059|NCT01708161|9898467|FG004|STARTED|Overall Study||6
8844060|NCT01708161|9898468|FG005|STARTED|Overall Study||1
8844061|NCT01708161|9898463|FG000|COMPLETED|Overall Study||0
8844062|NCT01708161|9898464|FG001|COMPLETED|Overall Study||0
8844063|NCT01708161|9898465|FG002|COMPLETED|Overall Study||0
8844064|NCT01708161|9898466|FG003|COMPLETED|Overall Study||0
8844065|NCT01708161|9898467|FG004|COMPLETED|Overall Study||0
8844066|NCT01708161|9898468|FG005|COMPLETED|Overall Study||0
8844067|NCT01708161|9898463|FG000|NOT COMPLETED|Overall Study||4
8844068|NCT01708161|9898464|FG001|NOT COMPLETED|Overall Study||10
8844069|NCT01708161|9898465|FG002|NOT COMPLETED|Overall Study||10
8844070|NCT01708161|9898466|FG003|NOT COMPLETED|Overall Study||16
8844071|NCT01708161|9898467|FG004|NOT COMPLETED|Overall Study||6
8844072|NCT01708161|9898468|FG005|NOT COMPLETED|Overall Study||1
8844073|NCT01708174|9898485|FG000|STARTED|Treatment Period||2
8844074|NCT01708174|9898486|FG001|STARTED|Treatment Period||16
8844075|NCT01708174|9898487|FG002|STARTED|Treatment Period||4
8844076|NCT01708174|9898485|FG000|Pharmacokinetic Analysis Set|Treatment Period||2
8844077|NCT01708174|9898486|FG001|Pharmacokinetic Analysis Set|Treatment Period||13
8844078|NCT01708174|9898487|FG002|Pharmacokinetic Analysis Set|Treatment Period||0
8844079|NCT01708174|9898485|FG000|COMPLETED|Treatment Period||1
8844080|NCT01708174|9898486|FG001|COMPLETED|Treatment Period||14
8844081|NCT01708174|9898487|FG002|COMPLETED|Treatment Period||3
8844082|NCT01708174|9898485|FG000|NOT COMPLETED|Treatment Period||1
8844083|NCT01708174|9898486|FG001|NOT COMPLETED|Treatment Period||2
8844084|NCT01708174|9898487|FG002|NOT COMPLETED|Treatment Period||1
8844085|NCT01708174|9898485|FG000|STARTED|Survival Follow-up||1
8844086|NCT01708174|9898486|FG001|STARTED|Survival Follow-up||10
8844087|NCT01708174|9898487|FG002|STARTED|Survival Follow-up||0
8844088|NCT01708174|9898485|FG000|COMPLETED|Survival Follow-up||1
8844089|NCT01708174|9898486|FG001|COMPLETED|Survival Follow-up||10
8844090|NCT01708174|9898487|FG002|COMPLETED|Survival Follow-up||0
8844091|NCT01708174|9898485|FG000|NOT COMPLETED|Survival Follow-up||0
8844092|NCT01708174|9898486|FG001|NOT COMPLETED|Survival Follow-up||0
8844093|NCT01708174|9898487|FG002|NOT COMPLETED|Survival Follow-up||0
8844094|NCT01708187|9898498|FG000|STARTED|Overall Study||1
8844095|NCT01708187|9898499|FG001|STARTED|Overall Study||1
8844096|NCT01708187|9898498|FG000|COMPLETED|Overall Study||1
8844097|NCT01708187|9898499|FG001|COMPLETED|Overall Study||0
8844098|NCT01708187|9898498|FG000|NOT COMPLETED|Overall Study||0
8844099|NCT01708187|9898499|FG001|NOT COMPLETED|Overall Study||1
8844100|NCT01708213|9898505|FG000|STARTED|Overall Study||72
8844101|NCT01708213|9898505|FG000|COMPLETED|Overall Study||71
8844102|NCT01708213|9898505|FG000|NOT COMPLETED|Overall Study||1
9073791|NCT03765138|10134564|FG000|NOT COMPLETED|Overall Study||1
9073792|NCT03764449|10134571|FG000|STARTED|Overall Study||8
9073793|NCT03764449|10134572|FG001|STARTED|Overall Study||8
9073794|NCT03764449|10134571|FG000|COMPLETED|Overall Study||8
9073795|NCT03764449|10134572|FG001|COMPLETED|Overall Study||8
9073796|NCT03764449|10134571|FG000|NOT COMPLETED|Overall Study||0
9073797|NCT03764449|10134572|FG001|NOT COMPLETED|Overall Study||0
9073798|NCT03763929|10134587|FG000|STARTED|Overall Study||2
9073799|NCT03763929|10134588|FG001|STARTED|Overall Study||4
9073800|NCT03763929|10134587|FG000|COMPLETED|Overall Study||2
9073801|NCT03763929|10134588|FG001|COMPLETED|Overall Study||4
9073802|NCT03763929|10134587|FG000|NOT COMPLETED|Overall Study||0
9073803|NCT03763929|10134588|FG001|NOT COMPLETED|Overall Study||0
9073804|NCT03763747|10134594|FG000|STARTED|Overall Study||200
9073805|NCT03763747|10134594|FG000|COMPLETED|Overall Study||200
9073806|NCT03763747|10134594|FG000|NOT COMPLETED|Overall Study||0
9073807|NCT03763175|10134601|FG000|STARTED|Overall Study||20
9073808|NCT03763175|10134602|FG001|STARTED|Overall Study||19
9073809|NCT03763175|10134603|FG002|STARTED|Overall Study||20
9073810|NCT03763175|10134601|FG000|COMPLETED|Overall Study||19
8844103|NCT01708278|9898515|FG000|STARTED|Overall Study||1
8844104|NCT01708278|9898516|FG001|STARTED|Overall Study||2
8844105|NCT01708278|9898517|FG002|STARTED|Overall Study||2
8844106|NCT01708278|9898518|FG003|STARTED|Overall Study||2
8844107|NCT01708278|9898519|FG004|STARTED|Overall Study||1
8844108|NCT01708278|9898520|FG005|STARTED|Overall Study||1
8844109|NCT01708278|9898515|FG000|COMPLETED|Overall Study||1
8844110|NCT01708278|9898516|FG001|COMPLETED|Overall Study||2
8844111|NCT01708278|9898517|FG002|COMPLETED|Overall Study||2
8844112|NCT01708278|9898518|FG003|COMPLETED|Overall Study||2
8844113|NCT01708278|9898519|FG004|COMPLETED|Overall Study||1
8844114|NCT01708278|9898520|FG005|COMPLETED|Overall Study||1
8844115|NCT01708278|9898515|FG000|NOT COMPLETED|Overall Study||0
8844116|NCT01708278|9898516|FG001|NOT COMPLETED|Overall Study||0
8844117|NCT01708278|9898517|FG002|NOT COMPLETED|Overall Study||0
8844118|NCT01708278|9898518|FG003|NOT COMPLETED|Overall Study||0
8844119|NCT01708278|9898519|FG004|NOT COMPLETED|Overall Study||0
8844120|NCT01708278|9898520|FG005|NOT COMPLETED|Overall Study||0
8844121|NCT01708291|9898536|FG000|STARTED|Overall Study||21
8844122|NCT01708291|9898537|FG001|STARTED|Overall Study||21
8844123|NCT01708291|9898536|FG000|COMPLETED|Overall Study||19
8844124|NCT01708291|9898537|FG001|COMPLETED|Overall Study||20
8844125|NCT01708291|9898536|FG000|NOT COMPLETED|Overall Study||2
8844126|NCT01708291|9898537|FG001|NOT COMPLETED|Overall Study||1
8844127|NCT01708317|9898543|FG000|STARTED|2010 Control Period|# of ED patients eligible for ACASI, had it been available, in control period|3929
8844128|NCT01708317|9898543|FG000|COMPLETED|2010 Control Period||3929
8844129|NCT01708317|9898543|FG000|NOT COMPLETED|2010 Control Period||0
8844130|NCT01708317|9898543|FG000|STARTED|Initial Education Period|# of ED patients eligible for ACASI, had it been available, in initial education period|982
8844131|NCT01708317|9898543|FG000|COMPLETED|Initial Education Period||982
8844132|NCT01708317|9898543|FG000|NOT COMPLETED|Initial Education Period||0
8844133|NCT01708317|9898543|FG000|STARTED|ACASI + Education Period|# of ED patients eligible for ACASI in the period the ACASI was actually available.|2601
8844134|NCT01708317|9898543|FG000|COMPLETED|ACASI + Education Period||2601
8844135|NCT01708317|9898543|FG000|NOT COMPLETED|ACASI + Education Period||0
8844136|NCT01708317|9898543|FG000|STARTED|Final Education Period|# of ED patients eligible for ACASI, had it been available, in final education period|909
8844137|NCT01708317|9898543|FG000|COMPLETED|Final Education Period||909
8844138|NCT01708317|9898543|FG000|NOT COMPLETED|Final Education Period||0
8844139|NCT01708525|9898550|FG000|STARTED|Overall Study||2
8844140|NCT01708525|9898550|FG000|COMPLETED|Overall Study||2
8844141|NCT01708525|9898550|FG000|NOT COMPLETED|Overall Study||0
8844142|NCT01708590|9898558|FG000|STARTED|Induction Phase||222
8844143|NCT01708590|9898559|FG001|STARTED|Induction Phase||219
8844144|NCT01708590|9898560|FG002|STARTED|Induction Phase||220
8844145|NCT01708590|9898561|FG003|STARTED|Induction Phase||0
8844146|NCT01708590|9898562|FG004|STARTED|Induction Phase||0
8844147|NCT01708590|9898563|FG005|STARTED|Induction Phase||0
8844148|NCT01708590|9898564|FG006|STARTED|Induction Phase||0
8844149|NCT01708590|9898558|FG000|COMPLETED|Induction Phase||212
8844150|NCT01708590|9898559|FG001|COMPLETED|Induction Phase||212
8844151|NCT01708590|9898560|FG002|COMPLETED|Induction Phase||209
8844152|NCT01708590|9898561|FG003|COMPLETED|Induction Phase||0
8844153|NCT01708590|9898562|FG004|COMPLETED|Induction Phase||0
8844154|NCT01708590|9898563|FG005|COMPLETED|Induction Phase||0
8844155|NCT01708590|9898564|FG006|COMPLETED|Induction Phase||0
8844156|NCT01708590|9898558|FG000|NOT COMPLETED|Induction Phase||10
8844157|NCT01708590|9898559|FG001|NOT COMPLETED|Induction Phase||7
8844158|NCT01708590|9898560|FG002|NOT COMPLETED|Induction Phase||11
8844159|NCT01708590|9898561|FG003|NOT COMPLETED|Induction Phase||0
8844160|NCT01708590|9898562|FG004|NOT COMPLETED|Induction Phase||0
8844161|NCT01708590|9898563|FG005|NOT COMPLETED|Induction Phase||0
8844162|NCT01708590|9898564|FG006|NOT COMPLETED|Induction Phase||0
8844163|NCT01708590|9898558|FG000|STARTED|Withdrawal Phase||0
8844164|NCT01708590|9898559|FG001|STARTED|Withdrawal Phase||0
8844165|NCT01708590|9898560|FG002|STARTED|Withdrawal Phase||0
8844166|NCT01708590|9898561|FG003|STARTED|Withdrawal Phase||59
8844167|NCT01708590|9898562|FG004|STARTED|Withdrawal Phase||57
8844168|NCT01708590|9898563|FG005|STARTED|Withdrawal Phase||84
8844169|NCT01708590|9898564|FG006|STARTED|Withdrawal Phase||83
8844170|NCT01708590|9898558|FG000|COMPLETED|Withdrawal Phase||0
9073811|NCT03763175|10134602|FG001|COMPLETED|Overall Study||17
9073812|NCT03763175|10134603|FG002|COMPLETED|Overall Study||19
9073813|NCT03763175|10134601|FG000|NOT COMPLETED|Overall Study||1
9073814|NCT03763175|10134602|FG001|NOT COMPLETED|Overall Study||2
9073815|NCT03763175|10134603|FG002|NOT COMPLETED|Overall Study||1
9073816|NCT03763058|10134611|FG000|STARTED|Overall Study||20
9073817|NCT03763058|10134611|FG000|COMPLETED|Overall Study||18
9073818|NCT03763058|10134611|FG000|NOT COMPLETED|Overall Study||2
9073819|NCT03762993|10134617|FG000|STARTED|Overall Study||21
9073820|NCT03762993|10134618|FG001|STARTED|Overall Study||10
9073821|NCT03762993|10134617|FG000|COMPLETED|Overall Study||21
9073822|NCT03762993|10134618|FG001|COMPLETED|Overall Study||10
9073823|NCT03762993|10134617|FG000|NOT COMPLETED|Overall Study||0
9073824|NCT03762993|10134618|FG001|NOT COMPLETED|Overall Study||0
9073825|NCT03762681|10134632|FG000|STARTED|Part 1||8
9073826|NCT03762681|10134633|FG001|STARTED|Part 1||8
9073827|NCT03762681|10134634|FG002|STARTED|Part 1||8
9073828|NCT03762681|10134635|FG003|STARTED|Part 1||8
9073829|NCT03762681|10134636|FG004|STARTED|Part 1||8
9073830|NCT03762681|10134637|FG005|STARTED|Part 1||0
9073831|NCT03762681|10134638|FG006|STARTED|Part 1||0
9073832|NCT03762681|10134639|FG007|STARTED|Part 1||0
9073833|NCT03762681|10134632|FG000|COMPLETED|Part 1||8
8844171|NCT01708590|9898559|FG001|COMPLETED|Withdrawal Phase||0
8844172|NCT01708590|9898560|FG002|COMPLETED|Withdrawal Phase||0
8844173|NCT01708590|9898561|FG003|COMPLETED|Withdrawal Phase||6
8844174|NCT01708590|9898562|FG004|COMPLETED|Withdrawal Phase||45
8844175|NCT01708590|9898563|FG005|COMPLETED|Withdrawal Phase||2
8844176|NCT01708590|9898564|FG006|COMPLETED|Withdrawal Phase||74
8844177|NCT01708590|9898558|FG000|NOT COMPLETED|Withdrawal Phase||0
8844178|NCT01708590|9898559|FG001|NOT COMPLETED|Withdrawal Phase||0
8844179|NCT01708590|9898560|FG002|NOT COMPLETED|Withdrawal Phase||0
8844180|NCT01708590|9898561|FG003|NOT COMPLETED|Withdrawal Phase||53
8844181|NCT01708590|9898562|FG004|NOT COMPLETED|Withdrawal Phase||12
8844182|NCT01708590|9898563|FG005|NOT COMPLETED|Withdrawal Phase||82
8844183|NCT01708590|9898564|FG006|NOT COMPLETED|Withdrawal Phase||9
8844184|NCT01708603|9898581|FG000|STARTED|Overall Study||612
8844185|NCT01708603|9898582|FG001|STARTED|Overall Study||610
8844186|NCT01708603|9898583|FG002|STARTED|Overall Study||300
8844187|NCT01708603|9898584|FG003|STARTED|Overall Study||309
8844188|NCT01708603|9898581|FG000|COMPLETED|Overall Study||597
8844189|NCT01708603|9898582|FG001|COMPLETED|Overall Study||588
8844190|NCT01708603|9898583|FG002|COMPLETED|Overall Study||291
8844191|NCT01708603|9898584|FG003|COMPLETED|Overall Study||300
8844192|NCT01708603|9898581|FG000|NOT COMPLETED|Overall Study||15
8844193|NCT01708603|9898582|FG001|NOT COMPLETED|Overall Study||22
8844194|NCT01708603|9898583|FG002|NOT COMPLETED|Overall Study||9
8844195|NCT01708603|9898584|FG003|NOT COMPLETED|Overall Study||9
8844196|NCT01708629|9898603|FG000|STARTED|Overall Study||624
8844197|NCT01708629|9898604|FG001|STARTED|Overall Study||629
8844198|NCT01708629|9898605|FG002|STARTED|Overall Study||313
8844199|NCT01708629|9898606|FG003|STARTED|Overall Study||315
8844200|NCT01708629|9898603|FG000|COMPLETED|Overall Study||608
8844201|NCT01708629|9898604|FG001|COMPLETED|Overall Study||604
8844202|NCT01708629|9898605|FG002|COMPLETED|Overall Study||303
8844203|NCT01708629|9898606|FG003|COMPLETED|Overall Study||301
8844204|NCT01708629|9898603|FG000|NOT COMPLETED|Overall Study||16
8844205|NCT01708629|9898604|FG001|NOT COMPLETED|Overall Study||25
8844206|NCT01708629|9898605|FG002|NOT COMPLETED|Overall Study||10
8844207|NCT01708629|9898606|FG003|NOT COMPLETED|Overall Study||14
8844208|NCT01708902|9898623|FG000|STARTED|Overall Study||147
8844209|NCT01708902|9898624|FG001|STARTED|Overall Study||145
8844210|NCT01708902|9898625|FG002|STARTED|Overall Study||144
8844211|NCT01708902|9898626|FG003|STARTED|Overall Study||147
8844212|NCT01708902|9898627|FG004|STARTED|Overall Study||147
8844213|NCT01708902|9898628|FG005|STARTED|Overall Study||71
8844214|NCT01708902|9898629|FG006|STARTED|Overall Study||72
8844215|NCT01708902|9898623|FG000|COMPLETED|Overall Study||130
8844216|NCT01708902|9898624|FG001|COMPLETED|Overall Study||137
8844217|NCT01708902|9898625|FG002|COMPLETED|Overall Study||127
8844218|NCT01708902|9898626|FG003|COMPLETED|Overall Study||137
8844219|NCT01708902|9898627|FG004|COMPLETED|Overall Study||131
8844220|NCT01708902|9898628|FG005|COMPLETED|Overall Study||64
8844221|NCT01708902|9898629|FG006|COMPLETED|Overall Study||65
8844222|NCT01708902|9898623|FG000|NOT COMPLETED|Overall Study||17
8844223|NCT01708902|9898624|FG001|NOT COMPLETED|Overall Study||8
8844224|NCT01708902|9898625|FG002|NOT COMPLETED|Overall Study||17
8844225|NCT01708902|9898626|FG003|NOT COMPLETED|Overall Study||10
8844226|NCT01708902|9898627|FG004|NOT COMPLETED|Overall Study||16
8844227|NCT01708902|9898628|FG005|NOT COMPLETED|Overall Study||7
9073834|NCT03762681|10134633|FG001|COMPLETED|Part 1||8
8844228|NCT01708902|9898629|FG006|NOT COMPLETED|Overall Study||7
8844229|NCT01708915|9898652|FG000|STARTED|Overall Study||204
8844230|NCT01708915|9898653|FG001|STARTED|Overall Study||201
8844231|NCT01708915|9898654|FG002|STARTED|Overall Study||198
8844232|NCT01708915|9898655|FG003|STARTED|Overall Study||202
8844233|NCT01708915|9898652|FG000|COMPLETED|Overall Study||118
8844234|NCT01708915|9898653|FG001|COMPLETED|Overall Study||139
8844235|NCT01708915|9898654|FG002|COMPLETED|Overall Study||152
8844236|NCT01708915|9898655|FG003|COMPLETED|Overall Study||169
8844237|NCT01708915|9898652|FG000|NOT COMPLETED|Overall Study||86
8844238|NCT01708915|9898653|FG001|NOT COMPLETED|Overall Study||62
8844239|NCT01708915|9898654|FG002|NOT COMPLETED|Overall Study||46
8844240|NCT01708915|9898655|FG003|NOT COMPLETED|Overall Study||33
9073835|NCT03762681|10134634|FG002|COMPLETED|Part 1||8
9073836|NCT03762681|10134635|FG003|COMPLETED|Part 1||7
9073837|NCT03762681|10134636|FG004|COMPLETED|Part 1||8
9073838|NCT03762681|10134637|FG005|COMPLETED|Part 1||0
9073839|NCT03762681|10134638|FG006|COMPLETED|Part 1||0
9073840|NCT03762681|10134639|FG007|COMPLETED|Part 1||0
9073841|NCT03762681|10134632|FG000|NOT COMPLETED|Part 1||0
9073842|NCT03762681|10134633|FG001|NOT COMPLETED|Part 1||0
9073843|NCT03762681|10134634|FG002|NOT COMPLETED|Part 1||0
9073844|NCT03762681|10134635|FG003|NOT COMPLETED|Part 1||1
9073845|NCT03762681|10134636|FG004|NOT COMPLETED|Part 1||0
9073846|NCT03762681|10134637|FG005|NOT COMPLETED|Part 1||0
8844241|NCT01708967|9898667|FG000|STARTED|Overall Study||50
8844242|NCT01708967|9898668|FG001|STARTED|Overall Study||50
8844243|NCT01708967|9898667|FG000|COMPLETED|Overall Study||50
8844244|NCT01708967|9898668|FG001|COMPLETED|Overall Study||43
8844245|NCT01708967|9898667|FG000|NOT COMPLETED|Overall Study||0
8844246|NCT01708967|9898668|FG001|NOT COMPLETED|Overall Study||7
8844247|NCT01709032|9898674|FG000|STARTED|Overall Study||9
8844248|NCT01709032|9898674|FG000|COMPLETED|Overall Study||6
8844249|NCT01709032|9898674|FG000|NOT COMPLETED|Overall Study||3
8844250|NCT01709084|9898681|FG000|STARTED|Overall Study||213
8844251|NCT01709084|9898682|FG001|STARTED|Overall Study||213
8844252|NCT01709084|9898681|FG000|Treated|Overall Study||213
8844253|NCT01709084|9898682|FG001|Treated|Overall Study||211
8844254|NCT01709084|9898681|FG000|COMPLETED|Overall Study||197
8844255|NCT01709084|9898682|FG001|COMPLETED|Overall Study||198
8844256|NCT01709084|9898681|FG000|NOT COMPLETED|Overall Study||16
8844257|NCT01709084|9898682|FG001|NOT COMPLETED|Overall Study||15
8844258|NCT01709110|9898690|FG000|STARTED|Overall Study||683
8844259|NCT01709110|9898691|FG001|STARTED|Overall Study||683
8844260|NCT01709110|9898690|FG000|Received at Least One Dose of Study Drug|Overall Study||680
8844261|NCT01709110|9898691|FG001|Received at Least One Dose of Study Drug|Overall Study||680
8844262|NCT01709110|9898690|FG000|COMPLETED|Overall Study||498
8844263|NCT01709110|9898691|FG001|COMPLETED|Overall Study||515
8844264|NCT01709110|9898690|FG000|NOT COMPLETED|Overall Study||185
8844265|NCT01709110|9898691|FG001|NOT COMPLETED|Overall Study||168
8844266|NCT01709149|9898700|FG000|STARTED|Open-label Lead-in Phase||711
8844267|NCT01709149|9898701|FG001|STARTED|Open-label Lead-in Phase||0
8844268|NCT01709149|9898702|FG002|STARTED|Open-label Lead-in Phase||0
8844269|NCT01709149|9898700|FG000|COMPLETED|Open-label Lead-in Phase||596
8844270|NCT01709149|9898701|FG001|COMPLETED|Open-label Lead-in Phase||0
8844271|NCT01709149|9898702|FG002|COMPLETED|Open-label Lead-in Phase||0
8844272|NCT01709149|9898700|FG000|NOT COMPLETED|Open-label Lead-in Phase||115
8844273|NCT01709149|9898701|FG001|NOT COMPLETED|Open-label Lead-in Phase||0
8844274|NCT01709149|9898702|FG002|NOT COMPLETED|Open-label Lead-in Phase||0
8844275|NCT01709149|9898700|FG000|STARTED|Double-blind, Placebo-controlled Phase||0
8844276|NCT01709149|9898701|FG001|STARTED|Double-blind, Placebo-controlled Phase||295
8844277|NCT01709149|9898702|FG002|STARTED|Double-blind, Placebo-controlled Phase||301
8844278|NCT01709149|9898700|FG000|COMPLETED|Double-blind, Placebo-controlled Phase||0
8844279|NCT01709149|9898701|FG001|COMPLETED|Double-blind, Placebo-controlled Phase||269
8844280|NCT01709149|9898702|FG002|COMPLETED|Double-blind, Placebo-controlled Phase||204
8844281|NCT01709149|9898700|FG000|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
8844282|NCT01709149|9898701|FG001|NOT COMPLETED|Double-blind, Placebo-controlled Phase||26
8844283|NCT01709149|9898702|FG002|NOT COMPLETED|Double-blind, Placebo-controlled Phase||97
8844284|NCT01709162|9898711|FG000|STARTED|Overall Study|Randomized|18
8844285|NCT01709162|9898712|FG001|STARTED|Overall Study|Randomized|5
8844286|NCT01709162|9898711|FG000|Received Treatment|Overall Study||18
8844287|NCT01709162|9898712|FG001|Received Treatment|Overall Study||4
8844288|NCT01709162|9898711|FG000|Still Receiving Treatment|Overall Study||0
8844289|NCT01709162|9898712|FG001|Still Receiving Treatment|Overall Study||0
8844290|NCT01709162|9898711|FG000|COMPLETED|Overall Study|Completed treatment as per protocol|12
8844291|NCT01709162|9898712|FG001|COMPLETED|Overall Study|Completed treatment as per protocol|0
8844292|NCT01709162|9898711|FG000|NOT COMPLETED|Overall Study||6
8844293|NCT01709162|9898712|FG001|NOT COMPLETED|Overall Study||5
8844294|NCT01709227|9898720|FG000|STARTED|Overall Study||32
8844295|NCT01709227|9898721|FG001|STARTED|Overall Study||41
8844296|NCT01709227|9898720|FG000|COMPLETED|Overall Study||31
8844297|NCT01709227|9898721|FG001|COMPLETED|Overall Study||32
8844298|NCT01709227|9898720|FG000|NOT COMPLETED|Overall Study||1
8844299|NCT01709227|9898721|FG001|NOT COMPLETED|Overall Study||9
8844300|NCT01709305|9898728|FG000|STARTED|Phase 1||5570
8844301|NCT01709305|9898729|FG001|STARTED|Phase 1||0
8844302|NCT01709305|9898730|FG002|STARTED|Phase 1||0
8844303|NCT01709305|9898731|FG003|STARTED|Phase 1||0
8844304|NCT01709305|9898732|FG004|STARTED|Phase 1||0
8844305|NCT01709305|9898728|FG000|COMPLETED|Phase 1||4933
8844306|NCT01709305|9898729|FG001|COMPLETED|Phase 1||0
8844307|NCT01709305|9898730|FG002|COMPLETED|Phase 1||0
8844308|NCT01709305|9898731|FG003|COMPLETED|Phase 1||0
8844309|NCT01709305|9898732|FG004|COMPLETED|Phase 1||0
8844310|NCT01709305|9898728|FG000|NOT COMPLETED|Phase 1||637
8844311|NCT01709305|9898729|FG001|NOT COMPLETED|Phase 1||0
8844312|NCT01709305|9898730|FG002|NOT COMPLETED|Phase 1||0
8844313|NCT01709305|9898731|FG003|NOT COMPLETED|Phase 1||0
8844314|NCT01709305|9898732|FG004|NOT COMPLETED|Phase 1||0
8844315|NCT01709305|9898728|FG000|STARTED|Phase 2||0
8844316|NCT01709305|9898729|FG001|STARTED|Phase 2||552
8844317|NCT01709305|9898730|FG002|STARTED|Phase 2||550
8844318|NCT01709305|9898731|FG003|STARTED|Phase 2||556
8844319|NCT01709305|9898732|FG004|STARTED|Phase 2||554
8844320|NCT01709305|9898728|FG000|COMPLETED|Phase 2||0
8844321|NCT01709305|9898729|FG001|COMPLETED|Phase 2||500
9073847|NCT03762681|10134638|FG006|NOT COMPLETED|Part 1||0
9073848|NCT03762681|10134639|FG007|NOT COMPLETED|Part 1||0
8844322|NCT01709305|9898730|FG002|COMPLETED|Phase 2||505
8844323|NCT01709305|9898731|FG003|COMPLETED|Phase 2||508
8844324|NCT01709305|9898732|FG004|COMPLETED|Phase 2||507
8844325|NCT01709305|9898728|FG000|NOT COMPLETED|Phase 2||0
8844326|NCT01709305|9898729|FG001|NOT COMPLETED|Phase 2||52
8844327|NCT01709305|9898730|FG002|NOT COMPLETED|Phase 2||45
8844328|NCT01709305|9898731|FG003|NOT COMPLETED|Phase 2||48
8844329|NCT01709305|9898732|FG004|NOT COMPLETED|Phase 2||47
8844330|NCT01709383|9898749|FG000|STARTED|Overall Study||24
8844331|NCT01709383|9898750|FG001|STARTED|Overall Study||14
8844332|NCT01709383|9898749|FG000|Completed Treatment|Overall Study||24
8844333|NCT01709383|9898750|FG001|Completed Treatment|Overall Study||14
8844334|NCT01709383|9898749|FG000|Completed Follow-ups|Overall Study||23
8844335|NCT01709383|9898750|FG001|Completed Follow-ups|Overall Study||14
8844336|NCT01709383|9898749|FG000|Included in Analysis|Overall Study||22
8844337|NCT01709383|9898750|FG001|Included in Analysis|Overall Study||13
8844338|NCT01709383|9898749|FG000|COMPLETED|Overall Study||23
8844339|NCT01709383|9898750|FG001|COMPLETED|Overall Study||14
8844340|NCT01709383|9898749|FG000|NOT COMPLETED|Overall Study||1
8844341|NCT01709383|9898750|FG001|NOT COMPLETED|Overall Study||0
8844342|NCT01709409|9898760|FG000|STARTED|Overall Study||43
8844343|NCT01709409|9898761|FG001|STARTED|Overall Study||45
8844344|NCT01709409|9898760|FG000|COMPLETED|Overall Study||42
8844345|NCT01709409|9898761|FG001|COMPLETED|Overall Study||45
8844346|NCT01709409|9898760|FG000|NOT COMPLETED|Overall Study||1
8844347|NCT01709409|9898761|FG001|NOT COMPLETED|Overall Study||0
8844348|NCT01709422|9898769|FG000|STARTED|Overall Study||70
8844349|NCT01709422|9898770|FG001|STARTED|Overall Study||70
8844350|NCT01709422|9898769|FG000|COMPLETED|Overall Study||70
8844351|NCT01709422|9898770|FG001|COMPLETED|Overall Study||70
8844352|NCT01709422|9898769|FG000|NOT COMPLETED|Overall Study||0
8844353|NCT01709422|9898770|FG001|NOT COMPLETED|Overall Study||0
9073849|NCT03762681|10134632|FG000|STARTED|Part 2a||0
9073850|NCT03762681|10134633|FG001|STARTED|Part 2a||0
9073851|NCT03762681|10134634|FG002|STARTED|Part 2a||0
8844354|NCT01709474|9898780|FG000|STARTED|Overall Study||3
8844355|NCT01709474|9898781|FG001|STARTED|Overall Study||4
8844356|NCT01709474|9898780|FG000|COMPLETED|Overall Study||3
8844357|NCT01709474|9898781|FG001|COMPLETED|Overall Study||4
8844358|NCT01709474|9898780|FG000|NOT COMPLETED|Overall Study||0
8844359|NCT01709474|9898781|FG001|NOT COMPLETED|Overall Study||0
8844360|NCT01709500|9898789|FG000|STARTED|Overall Study||167
8844361|NCT01709500|9898790|FG001|STARTED|Overall Study||82
8844362|NCT01709500|9898789|FG000|Treated|Overall Study||167
8844363|NCT01709500|9898790|FG001|Treated|Overall Study||81
8844364|NCT01709500|9898789|FG000|COMPLETED|Overall Study||0
8844365|NCT01709500|9898790|FG001|COMPLETED|Overall Study||0
8844366|NCT01709500|9898789|FG000|NOT COMPLETED|Overall Study||167
8844367|NCT01709500|9898790|FG001|NOT COMPLETED|Overall Study||82
8844368|NCT01709513|9898799|FG000|STARTED|Overall Study||63
8844369|NCT01709513|9898800|FG001|STARTED|Overall Study||125
8844370|NCT01709513|9898801|FG002|STARTED|Overall Study||126
8844371|NCT01709513|9898799|FG000|Treated|Overall Study||63
8844372|NCT01709513|9898800|FG001|Treated|Overall Study||124
8844373|NCT01709513|9898801|FG002|Treated|Overall Study||126
8844374|NCT01709513|9898799|FG000|COMPLETED|Overall Study||42
8844375|NCT01709513|9898800|FG001|COMPLETED|Overall Study||82
8844376|NCT01709513|9898801|FG002|COMPLETED|Overall Study||96
8844377|NCT01709513|9898799|FG000|NOT COMPLETED|Overall Study||21
8844378|NCT01709513|9898800|FG001|NOT COMPLETED|Overall Study||43
8844379|NCT01709513|9898801|FG002|NOT COMPLETED|Overall Study||30
8624116|NCT00498433|9663346|FG000|COMPLETED|Part 2: Double Blind (12 Weeks)||0
8624117|NCT00498433|9663347|FG001|COMPLETED|Part 2: Double Blind (12 Weeks)||8
8624118|NCT00498433|9663348|FG002|COMPLETED|Part 2: Double Blind (12 Weeks)||8
8624119|NCT00498433|9663346|FG000|NOT COMPLETED|Part 2: Double Blind (12 Weeks)||0
8624120|NCT00498433|9663347|FG001|NOT COMPLETED|Part 2: Double Blind (12 Weeks)||0
8624121|NCT00498433|9663348|FG002|NOT COMPLETED|Part 2: Double Blind (12 Weeks)||0
8624122|NCT00498485|9663367|FG000|STARTED|Overall Study||7
8624123|NCT00498485|9663368|FG001|STARTED|Overall Study||10
8624124|NCT00498485|9663367|FG000|COMPLETED|Overall Study||6
8624125|NCT00498485|9663368|FG001|COMPLETED|Overall Study||5
8624126|NCT00498485|9663367|FG000|NOT COMPLETED|Overall Study||1
8624127|NCT00498485|9663368|FG001|NOT COMPLETED|Overall Study||5
8844380|NCT01709578|9898815|FG000|STARTED|Overall Study||181
8844381|NCT01709578|9898816|FG001|STARTED|Overall Study||181
8844382|NCT01709578|9898817|FG002|STARTED|Overall Study||184
8844383|NCT01709578|9898815|FG000|COMPLETED|Overall Study||101
8844384|NCT01709578|9898816|FG001|COMPLETED|Overall Study||125
8844385|NCT01709578|9898817|FG002|COMPLETED|Overall Study||133
8844386|NCT01709578|9898815|FG000|NOT COMPLETED|Overall Study||80
8844387|NCT01709578|9898816|FG001|NOT COMPLETED|Overall Study||56
8844388|NCT01709578|9898817|FG002|NOT COMPLETED|Overall Study||51
8844389|NCT01709695|9898827|FG000|STARTED|Overall Study||13
8844390|NCT01709695|9898828|FG001|STARTED|Overall Study||14
8844391|NCT01709695|9898827|FG000|COMPLETED|Overall Study||12
8624128|NCT00498550|9663378|FG000|STARTED|Overall Study||15
8844392|NCT01709695|9898828|FG001|COMPLETED|Overall Study||13
8844393|NCT01709695|9898827|FG000|NOT COMPLETED|Overall Study||1
9073852|NCT03762681|10134635|FG003|STARTED|Part 2a||0
8624129|NCT00498550|9663379|FG001|STARTED|Overall Study||16
8624130|NCT00498550|9663378|FG000|COMPLETED|Overall Study|13 of 15 received clozapine all 12 visits, two discontinued clozapine early but remained in study.|15
9073853|NCT03762681|10134636|FG004|STARTED|Part 2a||0
9073854|NCT03762681|10134637|FG005|STARTED|Part 2a||2
9073855|NCT03762681|10134638|FG006|STARTED|Part 2a||8
9073856|NCT03762681|10134639|FG007|STARTED|Part 2a||5
9073857|NCT03762681|10134632|FG000|COMPLETED|Part 2a||0
9073858|NCT03762681|10134633|FG001|COMPLETED|Part 2a||0
9073859|NCT03762681|10134634|FG002|COMPLETED|Part 2a||0
9073860|NCT03762681|10134635|FG003|COMPLETED|Part 2a||0
9073861|NCT03762681|10134636|FG004|COMPLETED|Part 2a||0
9073862|NCT03762681|10134637|FG005|COMPLETED|Part 2a||2
9073863|NCT03762681|10134638|FG006|COMPLETED|Part 2a||8
9073864|NCT03762681|10134639|FG007|COMPLETED|Part 2a||4
9073865|NCT03762681|10134632|FG000|NOT COMPLETED|Part 2a||0
9073866|NCT03762681|10134633|FG001|NOT COMPLETED|Part 2a||0
9073867|NCT03762681|10134634|FG002|NOT COMPLETED|Part 2a||0
9073868|NCT03762681|10134635|FG003|NOT COMPLETED|Part 2a||0
9073869|NCT03762681|10134636|FG004|NOT COMPLETED|Part 2a||0
9073870|NCT03762681|10134637|FG005|NOT COMPLETED|Part 2a||0
9073871|NCT03762681|10134638|FG006|NOT COMPLETED|Part 2a||0
9073872|NCT03762681|10134639|FG007|NOT COMPLETED|Part 2a||1
9073873|NCT03762668|10134668|FG000|STARTED|Period 1, First Week of Wear||30
9073874|NCT03762668|10134669|FG001|STARTED|Period 1, First Week of Wear||30
9073875|NCT03762668|10134668|FG000|COMPLETED|Period 1, First Week of Wear||30
9073876|NCT03762668|10134669|FG001|COMPLETED|Period 1, First Week of Wear||29
9073877|NCT03762668|10134668|FG000|NOT COMPLETED|Period 1, First Week of Wear||0
9073878|NCT03762668|10134669|FG001|NOT COMPLETED|Period 1, First Week of Wear||1
9073879|NCT03762668|10134668|FG000|STARTED|Period 2, Second Week of Wear||30
9073880|NCT03762668|10134669|FG001|STARTED|Period 2, Second Week of Wear||29
9073881|NCT03762668|10134668|FG000|COMPLETED|Period 2, Second Week of Wear||30
8844394|NCT01709695|9898828|FG001|NOT COMPLETED|Overall Study||1
8844395|NCT01709708|9898836|FG000|STARTED|Overall Study||27
8844396|NCT01709708|9898837|FG001|STARTED|Overall Study||14
8844397|NCT01709708|9898836|FG000|COMPLETED|Overall Study||26
8844398|NCT01709708|9898837|FG001|COMPLETED|Overall Study||12
8844399|NCT01709708|9898836|FG000|NOT COMPLETED|Overall Study||1
8844400|NCT01709708|9898837|FG001|NOT COMPLETED|Overall Study||2
8844401|NCT01709721|9898847|FG000|STARTED|Open Label Phase||41
8844402|NCT01709721|9898848|FG001|STARTED|Open Label Phase||40
8844403|NCT01709721|9898849|FG002|STARTED|Open Label Phase||72
8844404|NCT01709721|9898847|FG000|COMPLETED|Open Label Phase||41
8844405|NCT01709721|9898848|FG001|COMPLETED|Open Label Phase||40
8844406|NCT01709721|9898849|FG002|COMPLETED|Open Label Phase||0
8844407|NCT01709721|9898847|FG000|NOT COMPLETED|Open Label Phase||0
8844408|NCT01709721|9898848|FG001|NOT COMPLETED|Open Label Phase||0
8844409|NCT01709721|9898849|FG002|NOT COMPLETED|Open Label Phase||72
8844410|NCT01709721|9898847|FG000|STARTED|Randomized Phase||41
8844411|NCT01709721|9898848|FG001|STARTED|Randomized Phase||40
8844412|NCT01709721|9898849|FG002|STARTED|Randomized Phase||0
8844413|NCT01709721|9898847|FG000|COMPLETED|Randomized Phase||38
8844414|NCT01709721|9898848|FG001|COMPLETED|Randomized Phase||34
8844415|NCT01709721|9898849|FG002|COMPLETED|Randomized Phase||0
8844416|NCT01709721|9898847|FG000|NOT COMPLETED|Randomized Phase||3
8844417|NCT01709721|9898848|FG001|NOT COMPLETED|Randomized Phase||6
8844418|NCT01709721|9898849|FG002|NOT COMPLETED|Randomized Phase||0
8844419|NCT01709747|9898857|FG000|STARTED|Overall Study||364
8844420|NCT01709747|9898857|FG000|COMPLETED|Overall Study||287
8844421|NCT01709747|9898857|FG000|NOT COMPLETED|Overall Study||77
8844422|NCT01709786|9898862|FG000|STARTED|Overall Study||88
8844423|NCT01709786|9898862|FG000|COMPLETED|Overall Study||88
8844424|NCT01709786|9898862|FG000|NOT COMPLETED|Overall Study||0
8844425|NCT01709799|9898871|FG000|STARTED|Overall Study||25
8844426|NCT01709799|9898872|FG001|STARTED|Overall Study||21
8844427|NCT01709799|9898873|FG002|STARTED|Overall Study||18
8844428|NCT01709799|9898871|FG000|COMPLETED|Overall Study||22
8844429|NCT01709799|9898872|FG001|COMPLETED|Overall Study||18
8844430|NCT01709799|9898873|FG002|COMPLETED|Overall Study||15
8844431|NCT01709799|9898871|FG000|NOT COMPLETED|Overall Study||3
8844432|NCT01709799|9898872|FG001|NOT COMPLETED|Overall Study||3
8844433|NCT01709799|9898873|FG002|NOT COMPLETED|Overall Study||3
8844434|NCT01709838|9898881|FG000|STARTED|Overall Study||134
8844435|NCT01709838|9898881|FG000|COMPLETED|Overall Study||67
8844436|NCT01709838|9898881|FG000|NOT COMPLETED|Overall Study||67
8844437|NCT01709864|9898889|FG000|STARTED|Overall Study||222
8844438|NCT01709864|9898890|FG001|STARTED|Overall Study||219
8844439|NCT01709864|9898889|FG000|Full Analysis Set (FAS)|Overall Study|FAS included all randomized patients who received at least one dose of trial drug.|222
8844440|NCT01709864|9898890|FG001|Full Analysis Set (FAS)|Overall Study|FAS included all randomized patients who received at least one dose of trial drug.|216
8844441|NCT01709864|9898889|FG000|Per Protocol Set (PPS)|Overall Study|PPS included all patients in the FAS who did not have any major protocol deviations.|204
8844442|NCT01709864|9898890|FG001|Per Protocol Set (PPS)|Overall Study|PPS included all patients in the FAS who did not have any major protocol deviations.|201
8844443|NCT01709864|9898889|FG000|COMPLETED|Overall Study||215
8844444|NCT01709864|9898890|FG001|COMPLETED|Overall Study||208
8844445|NCT01709864|9898889|FG000|NOT COMPLETED|Overall Study||7
8844446|NCT01709864|9898890|FG001|NOT COMPLETED|Overall Study||11
8844447|NCT01709903|9898898|FG000|STARTED|Overall Study|Randomized set|372
8844448|NCT01709903|9898899|FG001|STARTED|Overall Study|Randomized set|372
8844449|NCT01709903|9898898|FG000|COMPLETED|Overall Study||343
9073882|NCT03762668|10134669|FG001|COMPLETED|Period 2, Second Week of Wear||29
9073883|NCT03762668|10134668|FG000|NOT COMPLETED|Period 2, Second Week of Wear||0
9073884|NCT03762668|10134669|FG001|NOT COMPLETED|Period 2, Second Week of Wear||0
9073885|NCT03762616|10134675|FG000|STARTED|Overall Study||120
9073886|NCT03762616|10134675|FG000|COMPLETED|Overall Study||118
9073887|NCT03762616|10134675|FG000|NOT COMPLETED|Overall Study||2
9073888|NCT03762213|10134683|FG000|STARTED|Overall Study||16
9073889|NCT03762213|10134684|FG001|STARTED|Overall Study||14
9073890|NCT03762213|10134683|FG000|COMPLETED|Overall Study||16
9073891|NCT03762213|10134684|FG001|COMPLETED|Overall Study||14
9073892|NCT03762213|10134683|FG000|NOT COMPLETED|Overall Study||0
9073893|NCT03762213|10134684|FG001|NOT COMPLETED|Overall Study||0
9073894|NCT03762200|10134690|FG000|STARTED|Overall Study||103
9073895|NCT03762200|10134690|FG000|COMPLETED|Overall Study||101
9073896|NCT03762200|10134690|FG000|NOT COMPLETED|Overall Study||2
9073897|NCT03761368|10134696|FG000|STARTED|Overall Study||50
9073898|NCT03761368|10134697|FG001|STARTED|Overall Study||51
9073899|NCT03761368|10134696|FG000|COMPLETED|Overall Study||50
9073900|NCT03761368|10134697|FG001|COMPLETED|Overall Study||51
9073901|NCT03761368|10134696|FG000|NOT COMPLETED|Overall Study||0
9073902|NCT03761368|10134697|FG001|NOT COMPLETED|Overall Study||0
9073903|NCT03761147|10134705|FG000|STARTED|Overall Study||32
9073904|NCT03761147|10134706|FG001|STARTED|Overall Study||32
9073905|NCT03761147|10134705|FG000|COMPLETED|Overall Study||25
9073906|NCT03761147|10134706|FG001|COMPLETED|Overall Study||28
9073907|NCT03761147|10134705|FG000|NOT COMPLETED|Overall Study||7
9073908|NCT03761147|10134706|FG001|NOT COMPLETED|Overall Study||4
9073909|NCT03760913|10134731|FG000|STARTED|Overall Study||17
9073910|NCT03760913|10134732|FG001|STARTED|Overall Study||3
9073911|NCT03760913|10134733|FG002|STARTED|Overall Study||6
9073912|NCT03760913|10134734|FG003|STARTED|Overall Study||3
9073913|NCT03760913|10134735|FG004|STARTED|Overall Study||6
9073914|NCT03760913|10134736|FG005|STARTED|Overall Study||3
9073915|NCT03760913|10134737|FG006|STARTED|Overall Study||6
9073916|NCT03760913|10134738|FG007|STARTED|Overall Study||3
9073917|NCT03760913|10134739|FG008|STARTED|Overall Study||3
9073918|NCT03760913|10134740|FG009|STARTED|Overall Study||6
9073919|NCT03760913|10134741|FG010|STARTED|Overall Study||6
9073920|NCT03760913|10134742|FG011|STARTED|Overall Study||6
9073921|NCT03760913|10134743|FG012|STARTED|Overall Study||12
9073922|NCT03760913|10134744|FG013|STARTED|Overall Study||6
9073923|NCT03760913|10134745|FG014|STARTED|Overall Study||6
9073924|NCT03760913|10134746|FG015|STARTED|Overall Study||6
9073925|NCT03760913|10134747|FG016|STARTED|Overall Study||6
9073926|NCT03760913|10134748|FG017|STARTED|Overall Study||6
9073927|NCT03760913|10134749|FG018|STARTED|Overall Study||6
9073928|NCT03760913|10134731|FG000|COMPLETED|Overall Study||17
9073929|NCT03760913|10134732|FG001|COMPLETED|Overall Study||3
9073930|NCT03760913|10134733|FG002|COMPLETED|Overall Study||6
9073931|NCT03760913|10134734|FG003|COMPLETED|Overall Study||3
9073932|NCT03760913|10134735|FG004|COMPLETED|Overall Study||6
9073933|NCT03760913|10134736|FG005|COMPLETED|Overall Study||3
9073934|NCT03760913|10134737|FG006|COMPLETED|Overall Study||6
8624131|NCT00498550|9663379|FG001|COMPLETED|Overall Study||15
8624132|NCT00498550|9663378|FG000|NOT COMPLETED|Overall Study||0
8624133|NCT00498550|9663379|FG001|NOT COMPLETED|Overall Study||1
9073935|NCT03760913|10134738|FG007|COMPLETED|Overall Study||3
9073936|NCT03760913|10134739|FG008|COMPLETED|Overall Study||3
9073937|NCT03760913|10134740|FG009|COMPLETED|Overall Study||6
9073938|NCT03760913|10134741|FG010|COMPLETED|Overall Study||6
9073939|NCT03760913|10134742|FG011|COMPLETED|Overall Study||6
9073940|NCT03760913|10134743|FG012|COMPLETED|Overall Study||12
9073941|NCT03760913|10134744|FG013|COMPLETED|Overall Study||6
9073942|NCT03760913|10134745|FG014|COMPLETED|Overall Study||6
9073943|NCT03760913|10134746|FG015|COMPLETED|Overall Study||6
9073944|NCT03760913|10134747|FG016|COMPLETED|Overall Study||6
9073945|NCT03760913|10134748|FG017|COMPLETED|Overall Study||6
9073946|NCT03760913|10134749|FG018|COMPLETED|Overall Study||6
9073947|NCT03760913|10134731|FG000|NOT COMPLETED|Overall Study||0
9073948|NCT03760913|10134732|FG001|NOT COMPLETED|Overall Study||0
9073949|NCT03760913|10134733|FG002|NOT COMPLETED|Overall Study||0
9073950|NCT03760913|10134734|FG003|NOT COMPLETED|Overall Study||0
9073951|NCT03760913|10134735|FG004|NOT COMPLETED|Overall Study||0
9073952|NCT03760913|10134736|FG005|NOT COMPLETED|Overall Study||0
9073953|NCT03760913|10134737|FG006|NOT COMPLETED|Overall Study||0
9073954|NCT03760913|10134738|FG007|NOT COMPLETED|Overall Study||0
9073955|NCT03760913|10134739|FG008|NOT COMPLETED|Overall Study||0
9073956|NCT03760913|10134740|FG009|NOT COMPLETED|Overall Study||0
9073957|NCT03760913|10134741|FG010|NOT COMPLETED|Overall Study||0
9073958|NCT03760913|10134742|FG011|NOT COMPLETED|Overall Study||0
9073959|NCT03760913|10134743|FG012|NOT COMPLETED|Overall Study||0
9073960|NCT03760913|10134744|FG013|NOT COMPLETED|Overall Study||0
9073961|NCT03760913|10134745|FG014|NOT COMPLETED|Overall Study||0
9073962|NCT03760913|10134746|FG015|NOT COMPLETED|Overall Study||0
9073963|NCT03760913|10134747|FG016|NOT COMPLETED|Overall Study||0
9073964|NCT03760913|10134748|FG017|NOT COMPLETED|Overall Study||0
9073965|NCT03760913|10134749|FG018|NOT COMPLETED|Overall Study||0
9073966|NCT03760796|10134802|FG000|STARTED|Overall Study||200
8624134|NCT00498602|9663392|FG000|STARTED|Overall Study||36
9073967|NCT03760796|10134803|FG001|STARTED|Overall Study||864
9073968|NCT03760796|10134802|FG000|COMPLETED|Overall Study||200
9073969|NCT03760796|10134803|FG001|COMPLETED|Overall Study||864
9073970|NCT03760796|10134802|FG000|NOT COMPLETED|Overall Study||0
9073971|NCT03760796|10134803|FG001|NOT COMPLETED|Overall Study||0
9073972|NCT03760640|10134811|FG000|STARTED|Period 1||20
9073973|NCT03760640|10134812|FG001|STARTED|Period 1||22
9073974|NCT03760640|10134811|FG000|Received at Least 1 Dose of Study Drug|Period 1||20
9073975|NCT03760640|10134812|FG001|Received at Least 1 Dose of Study Drug|Period 1||22
9073976|NCT03760640|10134811|FG000|COMPLETED|Period 1||20
9073977|NCT03760640|10134812|FG001|COMPLETED|Period 1||22
9073978|NCT03760640|10134811|FG000|NOT COMPLETED|Period 1||0
9073979|NCT03760640|10134812|FG001|NOT COMPLETED|Period 1||0
9073980|NCT03760640|10134811|FG000|STARTED|Period 2||20
8624135|NCT00498602|9663393|FG001|STARTED|Overall Study||61
8844450|NCT01709903|9898899|FG001|COMPLETED|Overall Study||333
8844451|NCT01709903|9898898|FG000|NOT COMPLETED|Overall Study||29
8844452|NCT01709903|9898899|FG001|NOT COMPLETED|Overall Study||39
8844453|NCT01710020|9898905|FG000|STARTED|Period 1||12
8844454|NCT01710020|9898905|FG000|COMPLETED|Period 1||11
8844455|NCT01710020|9898905|FG000|NOT COMPLETED|Period 1||1
8844456|NCT01710020|9898905|FG000|STARTED|Washout Period (at Least 14 Days)||11
8844457|NCT01710020|9898905|FG000|COMPLETED|Washout Period (at Least 14 Days)||11
8844458|NCT01710020|9898905|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8844459|NCT01710020|9898905|FG000|STARTED|Period 2||11
8844460|NCT01710020|9898905|FG000|COMPLETED|Period 2||11
8844461|NCT01710020|9898905|FG000|NOT COMPLETED|Period 2||0
8844462|NCT01710033|9898915|FG000|STARTED|Stage 1||6
8844463|NCT01710033|9898916|FG001|STARTED|Stage 1||6
8844464|NCT01710033|9898917|FG002|STARTED|Stage 1||6
8844465|NCT01710033|9898918|FG003|STARTED|Stage 1||6
8844466|NCT01710033|9898919|FG004|STARTED|Stage 1||0
8844467|NCT01710033|9898915|FG000|COMPLETED|Stage 1||6
8844468|NCT01710033|9898916|FG001|COMPLETED|Stage 1||6
8844469|NCT01710033|9898917|FG002|COMPLETED|Stage 1||6
8844470|NCT01710033|9898918|FG003|COMPLETED|Stage 1||6
8844471|NCT01710033|9898919|FG004|COMPLETED|Stage 1||0
8844472|NCT01710033|9898915|FG000|NOT COMPLETED|Stage 1||0
8844473|NCT01710033|9898916|FG001|NOT COMPLETED|Stage 1||0
8844474|NCT01710033|9898917|FG002|NOT COMPLETED|Stage 1||0
8844475|NCT01710033|9898918|FG003|NOT COMPLETED|Stage 1||0
8844476|NCT01710033|9898919|FG004|NOT COMPLETED|Stage 1||0
8844477|NCT01710033|9898915|FG000|STARTED|Stage 2||0
8844478|NCT01710033|9898916|FG001|STARTED|Stage 2||0
8844479|NCT01710033|9898917|FG002|STARTED|Stage 2||0
8844480|NCT01710033|9898918|FG003|STARTED|Stage 2||0
8844481|NCT01710033|9898919|FG004|STARTED|Stage 2||4
8844482|NCT01710033|9898915|FG000|COMPLETED|Stage 2||0
8844483|NCT01710033|9898916|FG001|COMPLETED|Stage 2||0
8844484|NCT01710033|9898917|FG002|COMPLETED|Stage 2||0
8844485|NCT01710033|9898918|FG003|COMPLETED|Stage 2||0
8844486|NCT01710033|9898919|FG004|COMPLETED|Stage 2||3
8844487|NCT01710033|9898915|FG000|NOT COMPLETED|Stage 2||0
8844488|NCT01710033|9898916|FG001|NOT COMPLETED|Stage 2||0
8844489|NCT01710033|9898917|FG002|NOT COMPLETED|Stage 2||0
8844490|NCT01710033|9898918|FG003|NOT COMPLETED|Stage 2||0
8844491|NCT01710033|9898919|FG004|NOT COMPLETED|Stage 2||1
8844492|NCT01710046|9898934|FG000|STARTED|Overall Study||9
8844493|NCT01710046|9898935|FG001|STARTED|Overall Study||3
8844494|NCT01710046|9898934|FG000|COMPLETED|Overall Study||8
8844495|NCT01710046|9898935|FG001|COMPLETED|Overall Study||3
8844496|NCT01710046|9898934|FG000|NOT COMPLETED|Overall Study||1
8844497|NCT01710046|9898935|FG001|NOT COMPLETED|Overall Study||0
8844498|NCT01710137|9898943|FG000|STARTED|Overall Study||89
8844499|NCT01710137|9898944|FG001|STARTED|Overall Study||90
8844500|NCT01710137|9898943|FG000|COMPLETED|Overall Study||65
8844501|NCT01710137|9898944|FG001|COMPLETED|Overall Study||76
8844502|NCT01710137|9898943|FG000|NOT COMPLETED|Overall Study||24
8844503|NCT01710137|9898944|FG001|NOT COMPLETED|Overall Study||14
8844504|NCT01710254|9898950|FG000|STARTED|Overall Study||30
8844505|NCT01710254|9898950|FG000|COMPLETED|Overall Study||30
8844506|NCT01710254|9898950|FG000|NOT COMPLETED|Overall Study||0
8844507|NCT01710306|9898956|FG000|STARTED|Overall Study||86
8844508|NCT01710306|9898957|FG001|STARTED|Overall Study||85
8844509|NCT01710306|9898956|FG000|COMPLETED|Overall Study||68
8844510|NCT01710306|9898957|FG001|COMPLETED|Overall Study||55
8844511|NCT01710306|9898956|FG000|NOT COMPLETED|Overall Study||18
8844512|NCT01710306|9898957|FG001|NOT COMPLETED|Overall Study||30
8844513|NCT01710332|9898966|FG000|STARTED|Overall Study||6
8844514|NCT01710332|9898967|FG001|STARTED|Overall Study||6
8844515|NCT01710332|9898966|FG000|COMPLETED|Overall Study||6
8844516|NCT01710332|9898967|FG001|COMPLETED|Overall Study||6
8844517|NCT01710332|9898966|FG000|NOT COMPLETED|Overall Study||0
8844518|NCT01710332|9898967|FG001|NOT COMPLETED|Overall Study||0
8844519|NCT01710345|9898976|FG000|STARTED|Overall Study|41 patients were randomized to sufentanil 20 mcg, one patient not dosed due to damaged medication.|40
8844520|NCT01710345|9898977|FG001|STARTED|Overall Study||40
8844521|NCT01710345|9898978|FG002|STARTED|Overall Study||20
8844522|NCT01710345|9898976|FG000|COMPLETED|Overall Study||37
8844523|NCT01710345|9898977|FG001|COMPLETED|Overall Study||35
8844524|NCT01710345|9898978|FG002|COMPLETED|Overall Study||19
8624136|NCT00498602|9663394|FG002|STARTED|Overall Study||40
8844525|NCT01710345|9898976|FG000|NOT COMPLETED|Overall Study||3
8844526|NCT01710345|9898977|FG001|NOT COMPLETED|Overall Study||5
8844527|NCT01710345|9898978|FG002|NOT COMPLETED|Overall Study||1
8844528|NCT01710358|9898989|FG000|STARTED|Treatment Period Part A (Weeks 0 to 24)||489
8844529|NCT01710358|9898990|FG001|STARTED|Treatment Period Part A (Weeks 0 to 24)||488
8844530|NCT01710358|9898991|FG002|STARTED|Treatment Period Part A (Weeks 0 to 24)||330
8844531|NCT01710358|9898989|FG000|Received at Least 1 Dose of Study Drug|Treatment Period Part A (Weeks 0 to 24)||488
8844532|NCT01710358|9898990|FG001|Received at Least 1 Dose of Study Drug|Treatment Period Part A (Weeks 0 to 24)||487
9073981|NCT03760640|10134812|FG001|STARTED|Period 2||22
8624137|NCT00498602|9663395|FG003|STARTED|Overall Study||35
9073982|NCT03760640|10134811|FG000|COMPLETED|Period 2||20
9073983|NCT03760640|10134812|FG001|COMPLETED|Period 2||22
9073984|NCT03760640|10134811|FG000|NOT COMPLETED|Period 2||0
9073985|NCT03760640|10134812|FG001|NOT COMPLETED|Period 2||0
9073986|NCT03760510|10134820|FG000|STARTED|Overall Study||250
8844533|NCT01710358|9898991|FG002|Received at Least 1 Dose of Study Drug|Treatment Period Part A (Weeks 0 to 24)||330
8844534|NCT01710358|9898989|FG000|Rescued|Treatment Period Part A (Weeks 0 to 24)||128
8844535|NCT01710358|9898990|FG001|Rescued|Treatment Period Part A (Weeks 0 to 24)||35
8844536|NCT01710358|9898991|FG002|Rescued|Treatment Period Part A (Weeks 0 to 24)||40
8844537|NCT01710358|9898989|FG000|COMPLETED|Treatment Period Part A (Weeks 0 to 24)|Includes all participants rescued during Part A.|438
8844538|NCT01710358|9898990|FG001|COMPLETED|Treatment Period Part A (Weeks 0 to 24)|Includes all participants rescued during Part A.|459
8844539|NCT01710358|9898991|FG002|COMPLETED|Treatment Period Part A (Weeks 0 to 24)|Includes all participants rescued during Part A.|307
8844540|NCT01710358|9898989|FG000|NOT COMPLETED|Treatment Period Part A (Weeks 0 to 24)||51
8844541|NCT01710358|9898990|FG001|NOT COMPLETED|Treatment Period Part A (Weeks 0 to 24)||29
8844542|NCT01710358|9898991|FG002|NOT COMPLETED|Treatment Period Part A (Weeks 0 to 24)||23
8844543|NCT01710358|9898989|FG000|STARTED|Treatment Period Part B (Weeks 24 to 52)|Excludes participants rescued during Part A.|310
8844544|NCT01710358|9898990|FG001|STARTED|Treatment Period Part B (Weeks 24 to 52)|Excludes participants rescued during Part A.|424
8844545|NCT01710358|9898991|FG002|STARTED|Treatment Period Part B (Weeks 24 to 52)|Excludes participants rescued during Part A.|267
8844546|NCT01710358|9898989|FG000|Received at Least 1 Dose of Study Drug|Treatment Period Part B (Weeks 24 to 52)|Participants originally randomized to placebo received baricitinib during Part B.|306
8844547|NCT01710358|9898990|FG001|Received at Least 1 Dose of Study Drug|Treatment Period Part B (Weeks 24 to 52)||424
8844548|NCT01710358|9898991|FG002|Received at Least 1 Dose of Study Drug|Treatment Period Part B (Weeks 24 to 52)||267
8844549|NCT01710358|9898989|FG000|Rescued|Treatment Period Part B (Weeks 24 to 52)||5
8844550|NCT01710358|9898990|FG001|Rescued|Treatment Period Part B (Weeks 24 to 52)||8
8844551|NCT01710358|9898991|FG002|Rescued|Treatment Period Part B (Weeks 24 to 52)||11
8844552|NCT01710358|9898989|FG000|COMPLETED|Treatment Period Part B (Weeks 24 to 52)|Includes all participants rescued during Part B.|294
8844553|NCT01710358|9898990|FG001|COMPLETED|Treatment Period Part B (Weeks 24 to 52)|Includes all participants rescued during Part B.|402
8844554|NCT01710358|9898991|FG002|COMPLETED|Treatment Period Part B (Weeks 24 to 52)|Includes all participants rescued during Part B.|252
8844555|NCT01710358|9898989|FG000|NOT COMPLETED|Treatment Period Part B (Weeks 24 to 52)||16
8844556|NCT01710358|9898990|FG001|NOT COMPLETED|Treatment Period Part B (Weeks 24 to 52)||22
8844557|NCT01710358|9898991|FG002|NOT COMPLETED|Treatment Period Part B (Weeks 24 to 52)||15
8844558|NCT01710358|9898989|FG000|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
8844559|NCT01710358|9898990|FG001|STARTED|Rescue Period|Baricitinib 4 mg administered PO QD through Week 52. Participants continued background MTX therapy.|227
8844560|NCT01710358|9898991|FG002|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
8844561|NCT01710358|9898989|FG000|COMPLETED|Rescue Period||0
8844562|NCT01710358|9898990|FG001|COMPLETED|Rescue Period||196
8844563|NCT01710358|9898991|FG002|COMPLETED|Rescue Period||0
8844564|NCT01710358|9898989|FG000|NOT COMPLETED|Rescue Period||0
8844565|NCT01710358|9898990|FG001|NOT COMPLETED|Rescue Period||31
8844566|NCT01710358|9898991|FG002|NOT COMPLETED|Rescue Period||0
8844567|NCT01710358|9898989|FG000|STARTED|Follow-up Period|Participants from treatment who entered the post-treatment follow-up period.|33
8844568|NCT01710358|9898990|FG001|STARTED|Follow-up Period|Rescued participants who entered post-treatment follow-up are included in Baricitinib 4mg follow up.|76
8844569|NCT01710358|9898991|FG002|STARTED|Follow-up Period|Participants from treatment who entered the post-treatment follow-up period.|20
8844570|NCT01710358|9898989|FG000|COMPLETED|Follow-up Period||33
8844571|NCT01710358|9898990|FG001|COMPLETED|Follow-up Period||76
8844572|NCT01710358|9898991|FG002|COMPLETED|Follow-up Period||20
8844573|NCT01710358|9898989|FG000|NOT COMPLETED|Follow-up Period||0
8844574|NCT01710358|9898990|FG001|NOT COMPLETED|Follow-up Period||0
8844575|NCT01710358|9898991|FG002|NOT COMPLETED|Follow-up Period||0
8850189|NCT01745393|9905447|FG001|COMPLETED|Treatment to End-of-treatment Assessment||156
8850190|NCT01745393|9905446|FG000|NOT COMPLETED|Treatment to End-of-treatment Assessment||21
8850191|NCT01745393|9905447|FG001|NOT COMPLETED|Treatment to End-of-treatment Assessment||8
8850192|NCT01745393|9905446|FG000|STARTED|12-month Follow-up||142
8850193|NCT01745393|9905447|FG001|STARTED|12-month Follow-up||156
8850194|NCT01745393|9905446|FG000|COMPLETED|12-month Follow-up||136
8850195|NCT01745393|9905447|FG001|COMPLETED|12-month Follow-up||151
8850196|NCT01745393|9905446|FG000|NOT COMPLETED|12-month Follow-up||6
8850197|NCT01745393|9905447|FG001|NOT COMPLETED|12-month Follow-up||5
8850198|NCT01745627|9905453|FG000|STARTED|Overall Study||42
8850199|NCT01745627|9905453|FG000|COMPLETED|Overall Study||20
8850200|NCT01745627|9905453|FG000|NOT COMPLETED|Overall Study||22
8850201|NCT01745822|9905459|FG000|STARTED|Overall Study|168 mothers and 163 infants|331
8850202|NCT01745822|9905460|FG001|STARTED|Overall Study|163 mothers and 160 infants|323
8850203|NCT01745822|9905459|FG000|COMPLETED|Overall Study||331
8850204|NCT01745822|9905460|FG001|COMPLETED|Overall Study||323
8850205|NCT01745822|9905459|FG000|NOT COMPLETED|Overall Study||0
8850206|NCT01745822|9905460|FG001|NOT COMPLETED|Overall Study||0
8850207|NCT01745848|9905466|FG000|STARTED|Overall Study||26
9073987|NCT03760510|10134821|FG001|STARTED|Overall Study||250
9073988|NCT03760510|10134820|FG000|COMPLETED|Overall Study||145
9073989|NCT03760510|10134821|FG001|COMPLETED|Overall Study||153
9073990|NCT03760510|10134820|FG000|NOT COMPLETED|Overall Study||105
9073991|NCT03760510|10134821|FG001|NOT COMPLETED|Overall Study||97
9073992|NCT03760250|10134827|FG000|STARTED|Overall Study||6
9073993|NCT03760250|10134827|FG000|COMPLETED|Overall Study||4
9073994|NCT03760250|10134827|FG000|NOT COMPLETED|Overall Study||2
8624138|NCT00498602|9663396|FG004|STARTED|Overall Study||12
9073995|NCT03759600|10134831|FG000|STARTED|Overall Study||20
9073996|NCT03759600|10134831|FG000|COMPLETED|Overall Study||0
9073997|NCT03759600|10134831|FG000|NOT COMPLETED|Overall Study||20
9073998|NCT03759340|10134835|FG000|STARTED|Overall Study||56
9073999|NCT03759340|10134835|FG000|COMPLETED|Overall Study||0
9074000|NCT03759340|10134835|FG000|NOT COMPLETED|Overall Study||56
9074001|NCT03758716|10134839|FG000|STARTED|Overall Study||12
9074002|NCT03758716|10134839|FG000|COMPLETED|Overall Study||12
9074003|NCT03758716|10134839|FG000|NOT COMPLETED|Overall Study||0
9074004|NCT03758365|10134843|FG000|STARTED|Overall Study||36
9074005|NCT03758365|10134843|FG000|MC2-01 Cream|Overall Study||36
9074006|NCT03758365|10134843|FG000|Clobetasol Propionate 0.05% Lotion|Overall Study||36
9074007|NCT03758365|10134843|FG000|Betamethasone Dipropionate 0.05% Cream|Overall Study||36
9074008|NCT03758365|10134843|FG000|Triamcinolone Acetonide 0,1% Cream|Overall Study||36
9074009|NCT03758365|10134843|FG000|Hydrocortisone Butyrate 0.1% Cream|Overall Study||36
9074010|NCT03758365|10134843|FG000|Desonide 0.05% Cream|Overall Study||36
9074011|NCT03758365|10134843|FG000|Vehicle Cream|Overall Study||36
9074012|NCT03758365|10134843|FG000|COMPLETED|Overall Study||36
9074013|NCT03758365|10134843|FG000|NOT COMPLETED|Overall Study||0
9074014|NCT03758157|10134854|FG000|STARTED|Overall Study||110
9074015|NCT03758157|10134854|FG000|COMPLETED|Overall Study||110
9074016|NCT03758157|10134854|FG000|NOT COMPLETED|Overall Study||0
9074017|NCT03757988|10134858|FG000|STARTED|Overall Study||17
9074018|NCT03757988|10134858|FG000|COMPLETED|Overall Study||16
9074019|NCT03757988|10134858|FG000|NOT COMPLETED|Overall Study||1
9074020|NCT03757312|10134865|FG000|STARTED|Overall Study||5
9074021|NCT03757312|10134866|FG001|STARTED|Overall Study||9
9074022|NCT03757312|10134865|FG000|COMPLETED|Overall Study||5
9074023|NCT03757312|10134866|FG001|COMPLETED|Overall Study||9
9074024|NCT03757312|10134865|FG000|NOT COMPLETED|Overall Study||0
9074025|NCT03757312|10134866|FG001|NOT COMPLETED|Overall Study||0
9074026|NCT03757234|10134879|FG000|STARTED|Overall Study||75
9074027|NCT03757234|10134880|FG001|STARTED|Overall Study||18
9074028|NCT03757234|10134881|FG002|STARTED|Overall Study||17
9074029|NCT03757234|10134882|FG003|STARTED|Overall Study||17
9074030|NCT03757234|10134883|FG004|STARTED|Overall Study||74
9074031|NCT03757234|10134879|FG000|Completed PTE Visit|Overall Study||72
9074032|NCT03757234|10134880|FG001|Completed PTE Visit|Overall Study||16
9074033|NCT03757234|10134881|FG002|Completed PTE Visit|Overall Study||17
9074034|NCT03757234|10134882|FG003|Completed PTE Visit|Overall Study||16
9074035|NCT03757234|10134883|FG004|Completed PTE Visit|Overall Study||71
9074036|NCT03757234|10134879|FG000|COMPLETED|Overall Study||72
9074037|NCT03757234|10134880|FG001|COMPLETED|Overall Study||16
9074038|NCT03757234|10134881|FG002|COMPLETED|Overall Study||17
9074039|NCT03757234|10134882|FG003|COMPLETED|Overall Study||16
9074040|NCT03757234|10134883|FG004|COMPLETED|Overall Study||70
9074041|NCT03757234|10134879|FG000|NOT COMPLETED|Overall Study||3
9074042|NCT03757234|10134880|FG001|NOT COMPLETED|Overall Study||2
9074043|NCT03757234|10134881|FG002|NOT COMPLETED|Overall Study||0
9074044|NCT03757234|10134882|FG003|NOT COMPLETED|Overall Study||1
9074045|NCT03757234|10134883|FG004|NOT COMPLETED|Overall Study||4
9074046|NCT03757039|10134899|FG000|STARTED|Overall Study||32
9074047|NCT03757039|10134900|FG001|STARTED|Overall Study||9
9074048|NCT03757039|10134899|FG000|AOHG MF|Overall Study||11
9074049|NCT03757039|10134900|FG001|AOHG MF|Overall Study||0
9074050|NCT03757039|10134899|FG000|DT1 MF|Overall Study||11
9074051|NCT03757039|10134900|FG001|DT1 MF|Overall Study||0
9074052|NCT03757039|10134899|FG000|DACP MF|Overall Study||10
9074053|NCT03757039|10134900|FG001|DACP MF|Overall Study||0
9074054|NCT03757039|10134899|FG000|COMPLETED|Overall Study||32
9074055|NCT03757039|10134900|FG001|COMPLETED|Overall Study||9
9074056|NCT03757039|10134899|FG000|NOT COMPLETED|Overall Study||0
9074057|NCT03757039|10134900|FG001|NOT COMPLETED|Overall Study||0
9074058|NCT03756883|10134911|FG000|STARTED|Overall Study||485
9074059|NCT03756883|10134912|FG001|STARTED|Overall Study||413
9074060|NCT03756883|10134913|FG002|STARTED|Overall Study||101
9074061|NCT03756883|10134911|FG000|COMPLETED|Overall Study||472
9074062|NCT03756883|10134912|FG001|COMPLETED|Overall Study||402
9074063|NCT03756883|10134913|FG002|COMPLETED|Overall Study||94
9074064|NCT03756883|10134911|FG000|NOT COMPLETED|Overall Study||13
9074065|NCT03756883|10134912|FG001|NOT COMPLETED|Overall Study||11
9074066|NCT03756883|10134913|FG002|NOT COMPLETED|Overall Study||7
9074067|NCT03756506|10134923|FG000|STARTED|Overall Study||7
9074068|NCT03756506|10134924|FG001|STARTED|Overall Study||6
9074069|NCT03756506|10134923|FG000|COMPLETED|Overall Study||6
9074070|NCT03756506|10134924|FG001|COMPLETED|Overall Study||6
9074071|NCT03756506|10134923|FG000|NOT COMPLETED|Overall Study||1
9074072|NCT03756506|10134924|FG001|NOT COMPLETED|Overall Study||0
9074073|NCT03756285|10134932|FG000|STARTED|Overall Study||27
9074074|NCT03756285|10134933|FG001|STARTED|Overall Study||14
9074075|NCT03756285|10134932|FG000|COMPLETED|Overall Study||24
9074076|NCT03756285|10134933|FG001|COMPLETED|Overall Study||9
9074077|NCT03756285|10134932|FG000|NOT COMPLETED|Overall Study||3
9074078|NCT03756285|10134933|FG001|NOT COMPLETED|Overall Study||5
9074079|NCT03756129|10134946|FG000|STARTED|Overall Study||11
9074080|NCT03756129|10134947|FG001|STARTED|Overall Study||10
9074081|NCT03756129|10134948|FG002|STARTED|Overall Study||10
9074082|NCT03756129|10134949|FG003|STARTED|Overall Study|1 participant in this group was randomized but not treated, and is not included in this data set.|9
9074083|NCT03756129|10134950|FG004|STARTED|Overall Study|1 participant in this group was randomized but not treated, and is not included in this data set.|10
9074084|NCT03756129|10134951|FG005|STARTED|Overall Study||20
9074085|NCT03756129|10134946|FG000|COMPLETED|Overall Study||8
9074086|NCT03756129|10134947|FG001|COMPLETED|Overall Study||8
9074087|NCT03756129|10134948|FG002|COMPLETED|Overall Study||7
9074088|NCT03756129|10134949|FG003|COMPLETED|Overall Study||6
9074089|NCT03756129|10134950|FG004|COMPLETED|Overall Study||9
9074090|NCT03756129|10134951|FG005|COMPLETED|Overall Study||15
9074091|NCT03756129|10134946|FG000|NOT COMPLETED|Overall Study||3
9074092|NCT03756129|10134947|FG001|NOT COMPLETED|Overall Study||2
9074093|NCT03756129|10134948|FG002|NOT COMPLETED|Overall Study||3
9074094|NCT03756129|10134949|FG003|NOT COMPLETED|Overall Study||3
9074095|NCT03756129|10134950|FG004|NOT COMPLETED|Overall Study||1
9074096|NCT03756129|10134951|FG005|NOT COMPLETED|Overall Study||5
9074097|NCT03756038|10134975|FG000|STARTED|Overall Study||1
9074098|NCT03756038|10134976|FG001|STARTED|Overall Study||0
9074099|NCT03756038|10134975|FG000|COMPLETED|Overall Study||1
9074100|NCT03756038|10134976|FG001|COMPLETED|Overall Study||0
9074101|NCT03756038|10134975|FG000|NOT COMPLETED|Overall Study||0
9074102|NCT03756038|10134976|FG001|NOT COMPLETED|Overall Study||0
9074103|NCT03756012|10134982|FG000|STARTED|Overall Study||15
9074104|NCT03756012|10134982|FG000|COMPLETED|Overall Study||15
9074105|NCT03756012|10134982|FG000|NOT COMPLETED|Overall Study||0
8844576|NCT01710501|9899015|FG000|STARTED|Overall Study||29
8844577|NCT01710501|9899016|FG001|STARTED|Overall Study||28
8844578|NCT01710501|9899017|FG002|STARTED|Overall Study||30
8844579|NCT01710501|9899015|FG000|COMPLETED|Overall Study||27
8844580|NCT01710501|9899016|FG001|COMPLETED|Overall Study||28
8844581|NCT01710501|9899017|FG002|COMPLETED|Overall Study||30
8844582|NCT01710501|9899015|FG000|NOT COMPLETED|Overall Study||2
8844583|NCT01710501|9899016|FG001|NOT COMPLETED|Overall Study||0
8844584|NCT01710501|9899017|FG002|NOT COMPLETED|Overall Study||0
8844585|NCT01710514|9899027|FG000|STARTED|Overall Study||54
8844586|NCT01710514|9899028|FG001|STARTED|Overall Study||54
8844587|NCT01710514|9899027|FG000|Intent-To-Treat (ITT) Analysis Set|Overall Study|All randomised subjects were included in the Intent-To-Treat (ITT) analysis set.|54
8850208|NCT01745848|9905466|FG000|COMPLETED|Overall Study||20
9074106|NCT03755882|10134987|FG000|STARTED|Period 1||23
9074107|NCT03755882|10134988|FG001|STARTED|Period 1||22
9074108|NCT03755882|10134987|FG000|COMPLETED|Period 1||19
9074109|NCT03755882|10134988|FG001|COMPLETED|Period 1||22
9074110|NCT03755882|10134987|FG000|NOT COMPLETED|Period 1||4
9074111|NCT03755882|10134988|FG001|NOT COMPLETED|Period 1||0
9074112|NCT03755882|10134987|FG000|STARTED|Period 2||19
9074113|NCT03755882|10134988|FG001|STARTED|Period 2||22
9074114|NCT03755882|10134987|FG000|COMPLETED|Period 2||19
9074115|NCT03755882|10134988|FG001|COMPLETED|Period 2||22
9074116|NCT03755882|10134987|FG000|NOT COMPLETED|Period 2||0
9074117|NCT03755882|10134988|FG001|NOT COMPLETED|Period 2||0
9074118|NCT03755661|10134996|FG000|STARTED|Overall Study||12
9074119|NCT03755661|10134997|FG001|STARTED|Overall Study||12
9074120|NCT03755661|10134996|FG000|COMPLETED|Overall Study||11
9074121|NCT03755661|10134997|FG001|COMPLETED|Overall Study||12
9074122|NCT03755661|10134996|FG000|NOT COMPLETED|Overall Study||1
9074123|NCT03755661|10134997|FG001|NOT COMPLETED|Overall Study||0
9074124|NCT03754582|10135003|FG000|STARTED|Pretreatment Phase||21
9074125|NCT03754582|10135004|FG001|STARTED|Pretreatment Phase||0
9074126|NCT03754582|10135005|FG002|STARTED|Pretreatment Phase||0
9074127|NCT03754582|10135003|FG000|COMPLETED|Pretreatment Phase||21
9074128|NCT03754582|10135004|FG001|COMPLETED|Pretreatment Phase||0
9074129|NCT03754582|10135005|FG002|COMPLETED|Pretreatment Phase||0
9074130|NCT03754582|10135003|FG000|NOT COMPLETED|Pretreatment Phase||0
9074131|NCT03754582|10135004|FG001|NOT COMPLETED|Pretreatment Phase||0
9074132|NCT03754582|10135005|FG002|NOT COMPLETED|Pretreatment Phase||0
9074133|NCT03754582|10135003|FG000|STARTED|Treatment Phase||0
9074134|NCT03754582|10135004|FG001|STARTED|Treatment Phase||21
9074135|NCT03754582|10135005|FG002|STARTED|Treatment Phase||0
9074136|NCT03754582|10135003|FG000|COMPLETED|Treatment Phase||0
9074137|NCT03754582|10135004|FG001|COMPLETED|Treatment Phase||20
9074138|NCT03754582|10135005|FG002|COMPLETED|Treatment Phase||0
9074139|NCT03754582|10135003|FG000|NOT COMPLETED|Treatment Phase||0
9074140|NCT03754582|10135004|FG001|NOT COMPLETED|Treatment Phase||1
9074141|NCT03754582|10135005|FG002|NOT COMPLETED|Treatment Phase||0
9074142|NCT03754582|10135003|FG000|STARTED|Follow-up Phase||0
9074143|NCT03754582|10135004|FG001|STARTED|Follow-up Phase||0
9074144|NCT03754582|10135005|FG002|STARTED|Follow-up Phase|1 participant who discontinued in Treatment Phase was assessed at Follow-up Visit.|21
9074145|NCT03754582|10135003|FG000|COMPLETED|Follow-up Phase||0
9074146|NCT03754582|10135004|FG001|COMPLETED|Follow-up Phase||0
9074147|NCT03754582|10135005|FG002|COMPLETED|Follow-up Phase||20
9074148|NCT03754582|10135003|FG000|NOT COMPLETED|Follow-up Phase||0
9074149|NCT03754582|10135004|FG001|NOT COMPLETED|Follow-up Phase||0
9074150|NCT03754582|10135005|FG002|NOT COMPLETED|Follow-up Phase||1
9074151|NCT03754556|10135021|FG000|STARTED|Overall Study||326658
9074152|NCT03754556|10135021|FG000|COMPLETED|Overall Study||326658
9074153|NCT03754556|10135021|FG000|NOT COMPLETED|Overall Study||0
9074154|NCT03753113|10135027|FG000|STARTED|Overall Study||12
9074155|NCT03753113|10135028|FG001|STARTED|Overall Study||12
9074156|NCT03753113|10135027|FG000|COMPLETED|Overall Study||12
9074157|NCT03753113|10135028|FG001|COMPLETED|Overall Study||12
9074158|NCT03753113|10135027|FG000|NOT COMPLETED|Overall Study||0
9074159|NCT03753113|10135028|FG001|NOT COMPLETED|Overall Study||0
9074160|NCT03752567|10135034|FG000|STARTED|Overall Study||40
9074161|NCT03752567|10135034|FG000|COMPLETED|Overall Study||40
9074162|NCT03752567|10135034|FG000|NOT COMPLETED|Overall Study||0
9074163|NCT03752528|10135038|FG000|STARTED|Part A||53
9074164|NCT03752528|10135038|FG000|COMPLETED|Part A||51
9074165|NCT03752528|10135038|FG000|NOT COMPLETED|Part A||2
9074166|NCT03752528|10135038|FG000|STARTED|Part B||24
9074167|NCT03752528|10135038|FG000|COMPLETED|Part B||20
9074168|NCT03752528|10135038|FG000|NOT COMPLETED|Part B||4
9074169|NCT03752151|10135045|FG000|STARTED|Overall Study||77
9074170|NCT03752151|10135045|FG000|COMPLETED|Overall Study||75
9074171|NCT03752151|10135045|FG000|NOT COMPLETED|Overall Study||2
9074172|NCT03751657|10135052|FG000|STARTED|Overall Study||125
9074173|NCT03751657|10135053|FG001|STARTED|Overall Study||122
9074174|NCT03751657|10135052|FG000|COMPLETED|Overall Study||122
9074175|NCT03751657|10135053|FG001|COMPLETED|Overall Study||119
9074176|NCT03751657|10135052|FG000|NOT COMPLETED|Overall Study||3
9074177|NCT03751657|10135053|FG001|NOT COMPLETED|Overall Study||3
9074178|NCT03751280|10135061|FG000|STARTED|Overall Study||56
9074179|NCT03751280|10135062|FG001|STARTED|Overall Study||56
9074180|NCT03751280|10135061|FG000|Full Analysis Set (FAS)|Overall Study||54
9074181|NCT03751280|10135062|FG001|Full Analysis Set (FAS)|Overall Study||55
9074182|NCT03751280|10135061|FG000|Safety Set (SAF)|Overall Study||55
9074183|NCT03751280|10135062|FG001|Safety Set (SAF)|Overall Study||55
9074184|NCT03751280|10135061|FG000|COMPLETED|Overall Study||48
9074185|NCT03751280|10135062|FG001|COMPLETED|Overall Study||44
9074186|NCT03751280|10135061|FG000|NOT COMPLETED|Overall Study||8
9074187|NCT03751280|10135062|FG001|NOT COMPLETED|Overall Study||12
9074188|NCT03751020|10135072|FG000|STARTED|Overall Study||36
9074189|NCT03751020|10135073|FG001|STARTED|Overall Study||36
9074190|NCT03751020|10135074|FG002|STARTED|Overall Study||36
9074191|NCT03751020|10135072|FG000|Post Intervention|Overall Study||33
9074192|NCT03751020|10135073|FG001|Post Intervention|Overall Study||33
9074193|NCT03751020|10135074|FG002|Post Intervention|Overall Study||30
9074194|NCT03751020|10135072|FG000|3 Month Follow Up|Overall Study||27
9074195|NCT03751020|10135073|FG001|3 Month Follow Up|Overall Study||32
9074196|NCT03751020|10135074|FG002|3 Month Follow Up|Overall Study||26
9074197|NCT03751020|10135072|FG000|COMPLETED|Overall Study||27
9074198|NCT03751020|10135073|FG001|COMPLETED|Overall Study||32
9074199|NCT03751020|10135074|FG002|COMPLETED|Overall Study||26
9074200|NCT03751020|10135072|FG000|NOT COMPLETED|Overall Study||9
9074201|NCT03751020|10135073|FG001|NOT COMPLETED|Overall Study||4
9074202|NCT03751020|10135074|FG002|NOT COMPLETED|Overall Study||10
9074203|NCT03750955|10135084|FG000|STARTED|Hygiene Phase of 2 Weeks|No intervention during the hygiene phase.|16
9074204|NCT03750955|10135085|FG001|STARTED|Hygiene Phase of 2 Weeks|No intervention during the hygiene phase.|16
9074205|NCT03750955|10135084|FG000|COMPLETED|Hygiene Phase of 2 Weeks||13
9074206|NCT03750955|10135085|FG001|COMPLETED|Hygiene Phase of 2 Weeks||13
9074207|NCT03750955|10135084|FG000|NOT COMPLETED|Hygiene Phase of 2 Weeks||3
9074208|NCT03750955|10135085|FG001|NOT COMPLETED|Hygiene Phase of 2 Weeks||3
9074209|NCT03750955|10135084|FG000|STARTED|Gingivitis Induction Phase of 2 Weeks||13
9074210|NCT03750955|10135085|FG001|STARTED|Gingivitis Induction Phase of 2 Weeks||13
9074211|NCT03750955|10135084|FG000|COMPLETED|Gingivitis Induction Phase of 2 Weeks|6 participants randomized to L maxillary sextant SIBO; 7 randomized to R maxillary sextant SIBO.|13
9074212|NCT03750955|10135085|FG001|COMPLETED|Gingivitis Induction Phase of 2 Weeks|6 randomized to R max. sextant oral hygiene maintenance (OHM); 7 randomized to L max. sextant OHM.|13
9074213|NCT03750955|10135084|FG000|NOT COMPLETED|Gingivitis Induction Phase of 2 Weeks||0
9074214|NCT03750955|10135085|FG001|NOT COMPLETED|Gingivitis Induction Phase of 2 Weeks||0
9074215|NCT03750955|10135084|FG000|STARTED|Resolution Phase of 2 Weeks|No stent in use; oral hygiene resumed.|13
9074216|NCT03750955|10135085|FG001|STARTED|Resolution Phase of 2 Weeks|Oral hygiene maintenance continued.|13
9074217|NCT03750955|10135084|FG000|COMPLETED|Resolution Phase of 2 Weeks||13
9074218|NCT03750955|10135085|FG001|COMPLETED|Resolution Phase of 2 Weeks||13
9074219|NCT03750955|10135084|FG000|NOT COMPLETED|Resolution Phase of 2 Weeks||0
9074220|NCT03750955|10135085|FG001|NOT COMPLETED|Resolution Phase of 2 Weeks||0
9074221|NCT03750695|10135093|FG000|STARTED|Overall Study||8
9074222|NCT03750695|10135094|FG001|STARTED|Overall Study||8
9074223|NCT03750695|10135093|FG000|COMPLETED|Overall Study||8
9074224|NCT03750695|10135094|FG001|COMPLETED|Overall Study||7
9074225|NCT03750695|10135093|FG000|NOT COMPLETED|Overall Study||0
9074226|NCT03750695|10135094|FG001|NOT COMPLETED|Overall Study||1
9074227|NCT03748992|10135105|FG000|STARTED|Overall Study||10
9074228|NCT03748992|10135105|FG000|COMPLETED|Overall Study||10
9074229|NCT03748992|10135105|FG000|NOT COMPLETED|Overall Study||0
9074230|NCT03748979|10135120|FG000|STARTED|Overall Study||6
9074231|NCT03748979|10135121|FG001|STARTED|Overall Study||6
9074232|NCT03748979|10135122|FG002|STARTED|Overall Study||6
9074233|NCT03748979|10135123|FG003|STARTED|Overall Study||6
9074234|NCT03748979|10135124|FG004|STARTED|Overall Study||4
9074235|NCT03748979|10135125|FG005|STARTED|Overall Study||4
9074236|NCT03748979|10135126|FG006|STARTED|Overall Study||5
9074237|NCT03748979|10135127|FG007|STARTED|Overall Study||5
9074238|NCT03748979|10135128|FG008|STARTED|Overall Study||4
9074239|NCT03748979|10135129|FG009|STARTED|Overall Study||5
9074240|NCT03748979|10135130|FG010|STARTED|Overall Study||6
9074241|NCT03748979|10135120|FG000|COMPLETED|Overall Study||6
9074242|NCT03748979|10135121|FG001|COMPLETED|Overall Study||6
9074243|NCT03748979|10135122|FG002|COMPLETED|Overall Study||6
9074244|NCT03748979|10135123|FG003|COMPLETED|Overall Study||6
9074245|NCT03748979|10135124|FG004|COMPLETED|Overall Study||4
9074246|NCT03748979|10135125|FG005|COMPLETED|Overall Study||4
9074247|NCT03748979|10135126|FG006|COMPLETED|Overall Study||5
9074248|NCT03748979|10135127|FG007|COMPLETED|Overall Study||5
9074249|NCT03748979|10135128|FG008|COMPLETED|Overall Study||4
9074250|NCT03748979|10135129|FG009|COMPLETED|Overall Study||5
9074251|NCT03748979|10135130|FG010|COMPLETED|Overall Study||6
9074252|NCT03748979|10135120|FG000|NOT COMPLETED|Overall Study||0
9074253|NCT03748979|10135121|FG001|NOT COMPLETED|Overall Study||0
9074254|NCT03748979|10135122|FG002|NOT COMPLETED|Overall Study||0
9074255|NCT03748979|10135123|FG003|NOT COMPLETED|Overall Study||0
9074256|NCT03748979|10135124|FG004|NOT COMPLETED|Overall Study||0
9074257|NCT03748979|10135125|FG005|NOT COMPLETED|Overall Study||0
9074258|NCT03748979|10135126|FG006|NOT COMPLETED|Overall Study||0
9074259|NCT03748979|10135127|FG007|NOT COMPLETED|Overall Study||0
9074260|NCT03748979|10135128|FG008|NOT COMPLETED|Overall Study||0
9074261|NCT03748979|10135129|FG009|NOT COMPLETED|Overall Study||0
9074262|NCT03748979|10135130|FG010|NOT COMPLETED|Overall Study||0
9074263|NCT03748758|10135170|FG000|STARTED|Overall Study||12
9074264|NCT03748758|10135171|FG001|STARTED|Overall Study||12
9074265|NCT03748758|10135172|FG002|STARTED|Overall Study||6
9074266|NCT03748758|10135170|FG000|COMPLETED|Overall Study||12
9074267|NCT03748758|10135171|FG001|COMPLETED|Overall Study||12
9074268|NCT03748758|10135172|FG002|COMPLETED|Overall Study||5
9074269|NCT03748758|10135170|FG000|NOT COMPLETED|Overall Study||0
9074270|NCT03748758|10135171|FG001|NOT COMPLETED|Overall Study||0
9074271|NCT03748758|10135172|FG002|NOT COMPLETED|Overall Study||1
9074272|NCT03748706|10135202|FG000|STARTED|Overall Study||13
9074273|NCT03748706|10135202|FG000|COMPLETED|Overall Study||12
9074274|NCT03748706|10135202|FG000|NOT COMPLETED|Overall Study||1
9074275|NCT03748264|10135209|FG000|STARTED|Overall Study||21
9074276|NCT03748264|10135210|FG001|STARTED|Overall Study||21
9074277|NCT03748264|10135211|FG002|STARTED|Overall Study||20
9074278|NCT03748264|10135209|FG000|COMPLETED|Overall Study||21
9074279|NCT03748264|10135210|FG001|COMPLETED|Overall Study||21
9074280|NCT03748264|10135211|FG002|COMPLETED|Overall Study||20
9074281|NCT03748264|10135209|FG000|NOT COMPLETED|Overall Study||0
9074282|NCT03748264|10135210|FG001|NOT COMPLETED|Overall Study||0
9074283|NCT03748264|10135211|FG002|NOT COMPLETED|Overall Study||0
9074284|NCT03747497|10135221|FG000|STARTED|Overall Study||131
9074285|NCT03747497|10135222|FG001|STARTED|Overall Study||65
9074286|NCT03747497|10135221|FG000|COMPLETED|Overall Study||106
9074287|NCT03747497|10135222|FG001|COMPLETED|Overall Study||55
9074288|NCT03747497|10135221|FG000|NOT COMPLETED|Overall Study||25
9074289|NCT03747497|10135222|FG001|NOT COMPLETED|Overall Study||10
9074290|NCT03746405|10135230|FG000|STARTED|Overall Study||10
9074291|NCT03746405|10135231|FG001|STARTED|Overall Study||8
9074292|NCT03746405|10135230|FG000|COMPLETED|Overall Study||7
9074293|NCT03746405|10135231|FG001|COMPLETED|Overall Study||6
9074294|NCT03746405|10135230|FG000|NOT COMPLETED|Overall Study||3
9074295|NCT03746405|10135231|FG001|NOT COMPLETED|Overall Study||2
9074296|NCT03745937|10135241|FG000|STARTED|Overall Study||2
9074297|NCT03745937|10135242|FG001|STARTED|Overall Study||6
9074298|NCT03745937|10135243|FG002|STARTED|Overall Study||3
9074299|NCT03745937|10135244|FG003|STARTED|Overall Study||9
9074300|NCT03745937|10135241|FG000|COMPLETED|Overall Study||2
9074301|NCT03745937|10135242|FG001|COMPLETED|Overall Study||5
9074302|NCT03745937|10135243|FG002|COMPLETED|Overall Study||3
9074303|NCT03745937|10135244|FG003|COMPLETED|Overall Study||7
9074304|NCT03745937|10135241|FG000|NOT COMPLETED|Overall Study||0
9074305|NCT03745937|10135242|FG001|NOT COMPLETED|Overall Study||1
9074306|NCT03745937|10135243|FG002|NOT COMPLETED|Overall Study||0
9074307|NCT03745937|10135244|FG003|NOT COMPLETED|Overall Study||2
9074308|NCT03745222|10135258|FG000|STARTED|Overall Study||0
9074309|NCT03745222|10135259|FG001|STARTED|Overall Study||1
9074310|NCT03745222|10135260|FG002|STARTED|Overall Study||0
9074311|NCT03745222|10135258|FG000|COMPLETED|Overall Study||0
9074312|NCT03745222|10135259|FG001|COMPLETED|Overall Study||0
9074313|NCT03745222|10135260|FG002|COMPLETED|Overall Study||0
9074314|NCT03745222|10135258|FG000|NOT COMPLETED|Overall Study||0
9074315|NCT03745222|10135259|FG001|NOT COMPLETED|Overall Study||1
9074316|NCT03745222|10135260|FG002|NOT COMPLETED|Overall Study||0
9074317|NCT03745092|10135270|FG000|STARTED|Overall Study||26
9074318|NCT03745092|10135271|FG001|STARTED|Overall Study||23
9074319|NCT03745092|10135270|FG000|COMPLETED|Overall Study||26
9074320|NCT03745092|10135271|FG001|COMPLETED|Overall Study||23
9074321|NCT03745092|10135270|FG000|NOT COMPLETED|Overall Study||0
9074322|NCT03745092|10135271|FG001|NOT COMPLETED|Overall Study||0
9074323|NCT03744780|10135277|FG000|STARTED|Overall Study||32
9074324|NCT03744780|10135277|FG000|COMPLETED|Overall Study||32
9074325|NCT03744780|10135277|FG000|NOT COMPLETED|Overall Study||0
9074326|NCT03743311|10135284|FG000|STARTED|Overall Study||311
9074327|NCT03743311|10135285|FG001|STARTED|Overall Study||298
9074328|NCT03743311|10135286|FG002|STARTED|Overall Study||423
9074329|NCT03743311|10135284|FG000|COMPLETED|Overall Study||311
9074330|NCT03743311|10135285|FG001|COMPLETED|Overall Study||298
9074331|NCT03743311|10135286|FG002|COMPLETED|Overall Study||423
9074332|NCT03743311|10135284|FG000|NOT COMPLETED|Overall Study||0
9074333|NCT03743311|10135285|FG001|NOT COMPLETED|Overall Study||0
9074334|NCT03743311|10135286|FG002|NOT COMPLETED|Overall Study||0
9074335|NCT03743038|10135295|FG000|STARTED|Overall Study||12
9074336|NCT03743038|10135295|FG000|Test Article A|Overall Study||12
9074337|NCT03743038|10135295|FG000|Test Article B|Overall Study||12
9074338|NCT03743038|10135295|FG000|COMPLETED|Overall Study||11
9074339|NCT03743038|10135295|FG000|NOT COMPLETED|Overall Study||1
9074340|NCT03742973|10135303|FG000|STARTED|Overall Study||0
9074341|NCT03742973|10135304|FG001|STARTED|Overall Study||0
9074342|NCT03742973|10135303|FG000|COMPLETED|Overall Study||0
9074343|NCT03742973|10135304|FG001|COMPLETED|Overall Study||0
9074344|NCT03742973|10135303|FG000|NOT COMPLETED|Overall Study||0
9074345|NCT03742973|10135304|FG001|NOT COMPLETED|Overall Study||0
9074346|NCT03742440|10135310|FG000|STARTED|Overall Study||40
9074347|NCT03742440|10135310|FG000|COMPLETED|Overall Study||40
9074348|NCT03742440|10135310|FG000|NOT COMPLETED|Overall Study||0
9074349|NCT03742427|10135314|FG000|STARTED|Overall Study||50
9074350|NCT03742427|10135314|FG000|COMPLETED|Overall Study||50
9074351|NCT03742427|10135314|FG000|NOT COMPLETED|Overall Study||0
9074352|NCT03742271|10135318|FG000|STARTED|Overall Study||127
9074353|NCT03742271|10135318|FG000|COMPLETED|Overall Study||115
9074354|NCT03742271|10135318|FG000|NOT COMPLETED|Overall Study||12
9074355|NCT03742154|10135324|FG000|STARTED|Overall Study||50
9074356|NCT03742154|10135325|FG001|STARTED|Overall Study||49
9074357|NCT03742154|10135324|FG000|COMPLETED|Overall Study||50
9074358|NCT03742154|10135325|FG001|COMPLETED|Overall Study||49
9074359|NCT03742154|10135324|FG000|NOT COMPLETED|Overall Study||0
9074360|NCT03742154|10135325|FG001|NOT COMPLETED|Overall Study||0
9074361|NCT03741725|10135334|FG000|STARTED|Overall Study||101
9074362|NCT03741725|10135335|FG001|STARTED|Overall Study||100
9074363|NCT03741725|10135336|FG002|STARTED|Overall Study||100
9074364|NCT03741725|10135334|FG000|COMPLETED|Overall Study||101
9074365|NCT03741725|10135335|FG001|COMPLETED|Overall Study||100
9074366|NCT03741725|10135336|FG002|COMPLETED|Overall Study||100
9074367|NCT03741725|10135334|FG000|NOT COMPLETED|Overall Study||0
9074368|NCT03741725|10135335|FG001|NOT COMPLETED|Overall Study||0
9074369|NCT03741725|10135336|FG002|NOT COMPLETED|Overall Study||0
9074370|NCT03741088|10135347|FG000|STARTED|Overall Study||8
9074371|NCT03741088|10135347|FG000|COMPLETED|Overall Study||5
9074372|NCT03741088|10135347|FG000|NOT COMPLETED|Overall Study||3
9074373|NCT03741062|10135353|FG000|STARTED|Overall Study||5
9074374|NCT03741062|10135354|FG001|STARTED|Overall Study||6
9074375|NCT03741062|10135353|FG000|COMPLETED|Overall Study||4
9074376|NCT03741062|10135354|FG001|COMPLETED|Overall Study||6
9074377|NCT03741062|10135353|FG000|NOT COMPLETED|Overall Study||1
9074378|NCT03741062|10135354|FG001|NOT COMPLETED|Overall Study||0
9074379|NCT03740659|10135363|FG000|STARTED|Overall Study||42
9074380|NCT03740659|10135364|FG001|STARTED|Overall Study||42
9074381|NCT03740659|10135365|FG002|STARTED|Overall Study||41
9074382|NCT03740659|10135363|FG000|COMPLETED|Overall Study||42
9074383|NCT03740659|10135364|FG001|COMPLETED|Overall Study||42
9074384|NCT03740659|10135365|FG002|COMPLETED|Overall Study||41
9074385|NCT03740659|10135363|FG000|NOT COMPLETED|Overall Study||0
9074386|NCT03740659|10135364|FG001|NOT COMPLETED|Overall Study||0
9074387|NCT03740659|10135365|FG002|NOT COMPLETED|Overall Study||0
9074388|NCT03740152|10135373|FG000|STARTED|Overall Study||10
9074389|NCT03740152|10135373|FG000|COMPLETED|Overall Study||10
9074390|NCT03740152|10135373|FG000|NOT COMPLETED|Overall Study||0
9074391|NCT03739866|10135385|FG000|STARTED|Overall Study||6
9074392|NCT03739866|10135386|FG001|STARTED|Overall Study||6
9074393|NCT03739866|10135387|FG002|STARTED|Overall Study||7
9074394|NCT03739866|10135388|FG003|STARTED|Overall Study||6
9074395|NCT03739866|10135389|FG004|STARTED|Overall Study||6
9074396|NCT03739866|10135390|FG005|STARTED|Overall Study||10
9074397|NCT03739866|10135391|FG006|STARTED|Overall Study||7
9074398|NCT03739866|10135392|FG007|STARTED|Overall Study||5
9074399|NCT03739866|10135385|FG000|COMPLETED|Overall Study||6
9074400|NCT03739866|10135386|FG001|COMPLETED|Overall Study||6
9074401|NCT03739866|10135387|FG002|COMPLETED|Overall Study||6
9074402|NCT03739866|10135388|FG003|COMPLETED|Overall Study||5
9074403|NCT03739866|10135389|FG004|COMPLETED|Overall Study||5
9074404|NCT03739866|10135390|FG005|COMPLETED|Overall Study||10
9074405|NCT03739866|10135391|FG006|COMPLETED|Overall Study||7
9074406|NCT03739866|10135392|FG007|COMPLETED|Overall Study||5
9074407|NCT03739866|10135385|FG000|NOT COMPLETED|Overall Study||0
9074408|NCT03739866|10135386|FG001|NOT COMPLETED|Overall Study||0
9074409|NCT03739866|10135387|FG002|NOT COMPLETED|Overall Study||1
9074410|NCT03739866|10135388|FG003|NOT COMPLETED|Overall Study||1
9074411|NCT03739866|10135389|FG004|NOT COMPLETED|Overall Study||1
9074412|NCT03739866|10135390|FG005|NOT COMPLETED|Overall Study||0
9074413|NCT03739866|10135391|FG006|NOT COMPLETED|Overall Study||0
9074414|NCT03739866|10135392|FG007|NOT COMPLETED|Overall Study||0
9074415|NCT03739684|10135414|FG000|STARTED|Overall Study||208
9074416|NCT03739684|10135414|FG000|COMPLETED|Overall Study||195
9074417|NCT03739684|10135414|FG000|NOT COMPLETED|Overall Study||13
9074418|NCT03739528|10135420|FG000|STARTED|Overall Study||403
9074419|NCT03739528|10135421|FG001|STARTED|Overall Study||405
9074420|NCT03739528|10135420|FG000|Received at Least One Treatment|Overall Study||395
9074421|NCT03739528|10135421|FG001|Received at Least One Treatment|Overall Study||393
9074422|NCT03739528|10135420|FG000|COMPLETED|Overall Study||388
9074423|NCT03739528|10135421|FG001|COMPLETED|Overall Study||388
9074424|NCT03739528|10135420|FG000|NOT COMPLETED|Overall Study||15
9074425|NCT03739528|10135421|FG001|NOT COMPLETED|Overall Study||17
9074426|NCT03739242|10135432|FG000|STARTED|Overall Study||44
9074427|NCT03739242|10135433|FG001|STARTED|Overall Study||44
9074428|NCT03739242|10135432|FG000|COMPLETED|Overall Study||43
9074429|NCT03739242|10135433|FG001|COMPLETED|Overall Study||42
9074430|NCT03739242|10135432|FG000|NOT COMPLETED|Overall Study||1
9074431|NCT03739242|10135433|FG001|NOT COMPLETED|Overall Study||2
9074432|NCT03738865|10135441|FG000|STARTED|Overall Study||66
9074433|NCT03738865|10135442|FG001|STARTED|Overall Study||66
9074434|NCT03738865|10135441|FG000|COMPLETED|Overall Study||61
9074435|NCT03738865|10135442|FG001|COMPLETED|Overall Study||62
9074436|NCT03738865|10135441|FG000|NOT COMPLETED|Overall Study||5
9074437|NCT03738865|10135442|FG001|NOT COMPLETED|Overall Study||4
8624139|NCT00498602|9663397|FG005|STARTED|Overall Study||44
9074438|NCT03738826|10135450|FG000|STARTED|Overall Study||130
9074439|NCT03738826|10135451|FG001|STARTED|Overall Study||5
9074440|NCT03738826|10135450|FG000|COMPLETED|Overall Study||130
9074441|NCT03738826|10135451|FG001|COMPLETED|Overall Study||5
9074442|NCT03738826|10135450|FG000|NOT COMPLETED|Overall Study||0
9074443|NCT03738826|10135451|FG001|NOT COMPLETED|Overall Study||0
9074444|NCT03738475|10135459|FG000|STARTED|Overall Study||16
9074445|NCT03738475|10135460|FG001|STARTED|Overall Study||18
9074446|NCT03738475|10135459|FG000|COMPLETED|Overall Study||15
9074447|NCT03738475|10135460|FG001|COMPLETED|Overall Study||18
9074448|NCT03738475|10135459|FG000|NOT COMPLETED|Overall Study||1
9074449|NCT03738475|10135460|FG001|NOT COMPLETED|Overall Study||0
9074450|NCT03738241|10135476|FG000|STARTED|Overall Study||38
9074451|NCT03738241|10135477|FG001|STARTED|Overall Study||40
9074452|NCT03738241|10135478|FG002|STARTED|Overall Study||24
9074453|NCT03738241|10135479|FG003|STARTED|Overall Study||18
9074454|NCT03738241|10135480|FG004|STARTED|Overall Study||40
9074455|NCT03738241|10135481|FG005|STARTED|Overall Study||44
9074456|NCT03738241|10135482|FG006|STARTED|Overall Study||20
9074457|NCT03738241|10135483|FG007|STARTED|Overall Study||16
9074458|NCT03738241|10135484|FG008|STARTED|Overall Study||29
9074459|NCT03738241|10135485|FG009|STARTED|Overall Study||35
9074460|NCT03738241|10135476|FG000|COMPLETED|Overall Study||37
8624140|NCT00498602|9663398|FG006|STARTED|Overall Study||17
9074461|NCT03738241|10135477|FG001|COMPLETED|Overall Study||40
9074462|NCT03738241|10135478|FG002|COMPLETED|Overall Study||24
9074463|NCT03738241|10135479|FG003|COMPLETED|Overall Study||18
9074464|NCT03738241|10135480|FG004|COMPLETED|Overall Study||40
9074465|NCT03738241|10135481|FG005|COMPLETED|Overall Study||44
9074466|NCT03738241|10135482|FG006|COMPLETED|Overall Study||20
9074467|NCT03738241|10135483|FG007|COMPLETED|Overall Study||16
9074468|NCT03738241|10135484|FG008|COMPLETED|Overall Study||28
9074469|NCT03738241|10135485|FG009|COMPLETED|Overall Study||34
9074470|NCT03738241|10135476|FG000|NOT COMPLETED|Overall Study||1
9074471|NCT03738241|10135477|FG001|NOT COMPLETED|Overall Study||0
9074472|NCT03738241|10135478|FG002|NOT COMPLETED|Overall Study||0
9074473|NCT03738241|10135479|FG003|NOT COMPLETED|Overall Study||0
9074474|NCT03738241|10135480|FG004|NOT COMPLETED|Overall Study||0
9074475|NCT03738241|10135481|FG005|NOT COMPLETED|Overall Study||0
9074476|NCT03738241|10135482|FG006|NOT COMPLETED|Overall Study||0
9074477|NCT03738241|10135483|FG007|NOT COMPLETED|Overall Study||0
9074478|NCT03738241|10135484|FG008|NOT COMPLETED|Overall Study||1
9074479|NCT03738241|10135485|FG009|NOT COMPLETED|Overall Study||1
9074480|NCT03738163|10135507|FG000|STARTED|Overall Study||121
9074481|NCT03738163|10135507|FG000|COMPLETED|Overall Study||114
9074482|NCT03738163|10135507|FG000|NOT COMPLETED|Overall Study||7
9074483|NCT03738020|10135511|FG000|STARTED|Overall Study||58
9074484|NCT03738020|10135511|FG000|COMPLETED|Overall Study||57
9074485|NCT03738020|10135511|FG000|NOT COMPLETED|Overall Study||1
9074486|NCT03736928|10135523|FG000|STARTED|Overall Study||80
9074487|NCT03736928|10135524|FG001|STARTED|Overall Study||80
9074488|NCT03736928|10135525|FG002|STARTED|Overall Study||80
9074489|NCT03736928|10135526|FG003|STARTED|Overall Study||81
9074490|NCT03736928|10135527|FG004|STARTED|Overall Study||78
9074491|NCT03736928|10135523|FG000|COMPLETED|Overall Study||73
9074492|NCT03736928|10135524|FG001|COMPLETED|Overall Study||78
9074493|NCT03736928|10135525|FG002|COMPLETED|Overall Study||75
8624141|NCT00498602|9663392|FG000|Treated|Overall Study||36
8624142|NCT00498602|9663393|FG001|Treated|Overall Study|One participant discontinued due to an AE, with an outcome of death.|60
8624143|NCT00498602|9663394|FG002|Treated|Overall Study||40
8624144|NCT00498602|9663395|FG003|Treated|Overall Study||35
9074494|NCT03736928|10135526|FG003|COMPLETED|Overall Study||76
9074495|NCT03736928|10135527|FG004|COMPLETED|Overall Study||67
9074496|NCT03736928|10135523|FG000|NOT COMPLETED|Overall Study||7
9074497|NCT03736928|10135524|FG001|NOT COMPLETED|Overall Study||2
9074498|NCT03736928|10135525|FG002|NOT COMPLETED|Overall Study||5
9074499|NCT03736928|10135526|FG003|NOT COMPLETED|Overall Study||5
9074500|NCT03736928|10135527|FG004|NOT COMPLETED|Overall Study||11
9074501|NCT03736785|10135542|FG000|STARTED|Overall Study||135
9074502|NCT03736785|10135543|FG001|STARTED|Overall Study||132
9074503|NCT03736785|10135544|FG002|STARTED|Overall Study||132
9074504|NCT03736785|10135542|FG000|COMPLETED|Overall Study||118
9074505|NCT03736785|10135543|FG001|COMPLETED|Overall Study||115
9074506|NCT03736785|10135544|FG002|COMPLETED|Overall Study||118
9074507|NCT03736785|10135542|FG000|NOT COMPLETED|Overall Study||17
9074508|NCT03736785|10135543|FG001|NOT COMPLETED|Overall Study||17
9074509|NCT03736785|10135544|FG002|NOT COMPLETED|Overall Study||14
9074510|NCT03736031|10135555|FG000|STARTED|Overall Study||56
9074511|NCT03736031|10135556|FG001|STARTED|Overall Study||46
9074512|NCT03736031|10135555|FG000|COMPLETED|Overall Study||24
9074513|NCT03736031|10135556|FG001|COMPLETED|Overall Study||40
9074514|NCT03736031|10135555|FG000|NOT COMPLETED|Overall Study||32
9074515|NCT03736031|10135556|FG001|NOT COMPLETED|Overall Study||6
9074516|NCT03735862|10135562|FG000|STARTED|Overall Study||73
9074517|NCT03735862|10135562|FG000|COMPLETED|Overall Study||73
9074518|NCT03735862|10135562|FG000|NOT COMPLETED|Overall Study||0
9074519|NCT03734991|10135568|FG000|STARTED|Overall Study||249
9074520|NCT03734991|10135569|FG001|STARTED|Overall Study||127
9074521|NCT03734991|10135568|FG000|Withdrawn Before Treatment|Overall Study||2
9074522|NCT03734991|10135569|FG001|Withdrawn Before Treatment|Overall Study||3
9074523|NCT03734991|10135568|FG000|Withdrawn Before TOC|Overall Study||59
9074524|NCT03734991|10135569|FG001|Withdrawn Before TOC|Overall Study||41
9074525|NCT03734991|10135568|FG000|Completed the TOC Visit|Overall Study||188
9074526|NCT03734991|10135569|FG001|Completed the TOC Visit|Overall Study||83
9074527|NCT03734991|10135568|FG000|Withdrawn At or After the TOC Visit|Overall Study||5
9074528|NCT03734991|10135569|FG001|Withdrawn At or After the TOC Visit|Overall Study||3
9074529|NCT03734991|10135568|FG000|COMPLETED|Overall Study||183
9074530|NCT03734991|10135569|FG001|COMPLETED|Overall Study||80
9074531|NCT03734991|10135568|FG000|NOT COMPLETED|Overall Study||66
9074532|NCT03734991|10135569|FG001|NOT COMPLETED|Overall Study||47
9074533|NCT03734822|10135575|FG000|STARTED|Overall Study||47
9074534|NCT03734822|10135575|FG000|COMPLETED|Overall Study||47
9074535|NCT03734822|10135575|FG000|NOT COMPLETED|Overall Study||0
9074536|NCT03734601|10135579|FG000|STARTED|Overall Study||22
9074537|NCT03734601|10135579|FG000|COMPLETED|Overall Study||22
9074538|NCT03734601|10135579|FG000|NOT COMPLETED|Overall Study||0
9074539|NCT03733899|10135583|FG000|STARTED|Period 1||3
9074540|NCT03733899|10135584|FG001|STARTED|Period 1||3
9074541|NCT03733899|10135585|FG002|STARTED|Period 1||3
9074542|NCT03733899|10135586|FG003|STARTED|Period 1||4
9074543|NCT03733899|10135587|FG004|STARTED|Period 1||4
9074544|NCT03733899|10135588|FG005|STARTED|Period 1||3
9074545|NCT03733899|10135583|FG000|COMPLETED|Period 1||3
9074546|NCT03733899|10135584|FG001|COMPLETED|Period 1||3
9074547|NCT03733899|10135585|FG002|COMPLETED|Period 1||3
9074548|NCT03733899|10135586|FG003|COMPLETED|Period 1||4
9074549|NCT03733899|10135587|FG004|COMPLETED|Period 1||4
8624145|NCT00498602|9663396|FG004|Treated|Overall Study||12
9074550|NCT03733899|10135588|FG005|COMPLETED|Period 1||2
9074551|NCT03733899|10135583|FG000|NOT COMPLETED|Period 1||0
9074552|NCT03733899|10135584|FG001|NOT COMPLETED|Period 1||0
9074553|NCT03733899|10135585|FG002|NOT COMPLETED|Period 1||0
9074554|NCT03733899|10135586|FG003|NOT COMPLETED|Period 1||0
9074555|NCT03733899|10135587|FG004|NOT COMPLETED|Period 1||0
9074556|NCT03733899|10135588|FG005|NOT COMPLETED|Period 1||1
9074557|NCT03733899|10135583|FG000|STARTED|Period 2||3
9074558|NCT03733899|10135584|FG001|STARTED|Period 2||3
9074559|NCT03733899|10135585|FG002|STARTED|Period 2||3
9074560|NCT03733899|10135586|FG003|STARTED|Period 2||4
9074561|NCT03733899|10135587|FG004|STARTED|Period 2||4
9074562|NCT03733899|10135588|FG005|STARTED|Period 2||2
9074563|NCT03733899|10135583|FG000|COMPLETED|Period 2||3
9074564|NCT03733899|10135584|FG001|COMPLETED|Period 2||2
9074565|NCT03733899|10135585|FG002|COMPLETED|Period 2||3
9074566|NCT03733899|10135586|FG003|COMPLETED|Period 2||4
9074567|NCT03733899|10135587|FG004|COMPLETED|Period 2||4
9074568|NCT03733899|10135588|FG005|COMPLETED|Period 2||2
9074569|NCT03733899|10135583|FG000|NOT COMPLETED|Period 2||0
9074570|NCT03733899|10135584|FG001|NOT COMPLETED|Period 2||1
9074571|NCT03733899|10135585|FG002|NOT COMPLETED|Period 2||0
9074572|NCT03733899|10135586|FG003|NOT COMPLETED|Period 2||0
9074573|NCT03733899|10135587|FG004|NOT COMPLETED|Period 2||0
9074574|NCT03733899|10135588|FG005|NOT COMPLETED|Period 2||0
9074575|NCT03733899|10135583|FG000|STARTED|Period 3||3
9074576|NCT03733899|10135584|FG001|STARTED|Period 3||2
9074577|NCT03733899|10135585|FG002|STARTED|Period 3||3
9074578|NCT03733899|10135586|FG003|STARTED|Period 3||4
9074579|NCT03733899|10135587|FG004|STARTED|Period 3||4
9074580|NCT03733899|10135588|FG005|STARTED|Period 3||2
9074581|NCT03733899|10135583|FG000|COMPLETED|Period 3||2
9074582|NCT03733899|10135584|FG001|COMPLETED|Period 3||2
9074583|NCT03733899|10135585|FG002|COMPLETED|Period 3||3
9074584|NCT03733899|10135586|FG003|COMPLETED|Period 3||4
9074585|NCT03733899|10135587|FG004|COMPLETED|Period 3||4
9074586|NCT03733899|10135588|FG005|COMPLETED|Period 3||2
9074587|NCT03733899|10135583|FG000|NOT COMPLETED|Period 3||1
9074588|NCT03733899|10135584|FG001|NOT COMPLETED|Period 3||0
9074589|NCT03733899|10135585|FG002|NOT COMPLETED|Period 3||0
9074590|NCT03733899|10135586|FG003|NOT COMPLETED|Period 3||0
9074591|NCT03733899|10135587|FG004|NOT COMPLETED|Period 3||0
9074592|NCT03733899|10135588|FG005|NOT COMPLETED|Period 3||0
9074593|NCT03733483|10135601|FG000|STARTED|Overall Study||12
9074594|NCT03733483|10135601|FG000|COMPLETED|Overall Study||12
9074595|NCT03733483|10135601|FG000|NOT COMPLETED|Overall Study||0
9074596|NCT03733470|10135607|FG000|STARTED|Overall Study||8
9074597|NCT03733470|10135608|FG001|STARTED|Overall Study||11
9074598|NCT03733470|10135607|FG000|COMPLETED|Overall Study||7
9074599|NCT03733470|10135608|FG001|COMPLETED|Overall Study||10
9074600|NCT03733470|10135607|FG000|NOT COMPLETED|Overall Study||1
9074601|NCT03733470|10135608|FG001|NOT COMPLETED|Overall Study||1
9074602|NCT03733301|10135617|FG000|STARTED|Overall Study||109
9074603|NCT03733301|10135618|FG001|STARTED|Overall Study||109
9074604|NCT03733301|10135619|FG002|STARTED|Overall Study||111
9074605|NCT03733301|10135617|FG000|Received One Dose of Study Drug|Overall Study||108
9074606|NCT03733301|10135618|FG001|Received One Dose of Study Drug|Overall Study||109
9074607|NCT03733301|10135619|FG002|Received One Dose of Study Drug|Overall Study||111
9074608|NCT03733301|10135617|FG000|COMPLETED|Overall Study||102
9074609|NCT03733301|10135618|FG001|COMPLETED|Overall Study||100
9074610|NCT03733301|10135619|FG002|COMPLETED|Overall Study||107
9074611|NCT03733301|10135617|FG000|NOT COMPLETED|Overall Study||7
9074612|NCT03733301|10135618|FG001|NOT COMPLETED|Overall Study||9
9074613|NCT03733301|10135619|FG002|NOT COMPLETED|Overall Study||4
9074614|NCT03732638|10135630|FG000|STARTED|Overall Study||370
9074615|NCT03732638|10135631|FG001|STARTED|Overall Study||371
9074616|NCT03732638|10135630|FG000|COMPLETED|Overall Study||316
9074617|NCT03732638|10135631|FG001|COMPLETED|Overall Study||310
9074618|NCT03732638|10135630|FG000|NOT COMPLETED|Overall Study||54
9074619|NCT03732638|10135631|FG001|NOT COMPLETED|Overall Study||61
9074620|NCT03732248|10135640|FG000|STARTED|Overall Study||11
9074621|NCT03732248|10135641|FG001|STARTED|Overall Study||10
9074622|NCT03732248|10135640|FG000|COMPLETED|Overall Study||10
9074623|NCT03732248|10135641|FG001|COMPLETED|Overall Study||10
9074624|NCT03732248|10135640|FG000|NOT COMPLETED|Overall Study||1
9074625|NCT03732248|10135641|FG001|NOT COMPLETED|Overall Study||0
9074626|NCT03731182|10135649|FG000|STARTED|Overall Study||70
9074627|NCT03731182|10135650|FG001|STARTED|Overall Study||34
9074628|NCT03731182|10135649|FG000|V114 or Prevnar 13™ Vaccination (Day 1)|Overall Study||69
9074629|NCT03731182|10135650|FG001|V114 or Prevnar 13™ Vaccination (Day 1)|Overall Study||34
9074630|NCT03731182|10135649|FG000|COMPLETED|Overall Study||65
9074631|NCT03731182|10135650|FG001|COMPLETED|Overall Study||34
9074632|NCT03731182|10135649|FG000|NOT COMPLETED|Overall Study||5
9074633|NCT03731182|10135650|FG001|NOT COMPLETED|Overall Study||0
9074634|NCT03730961|10135659|FG000|STARTED|Overall Study||12
9074635|NCT03730961|10135660|FG001|STARTED|Overall Study||11
9074636|NCT03730961|10135659|FG000|Period 1 Completion|Overall Study||12
9074637|NCT03730961|10135660|FG001|Period 1 Completion|Overall Study||11
9074638|NCT03730961|10135659|FG000|Period 2 Completion|Overall Study|1 participant did not complete Period 2 due to hypotension but remained in the study|11
9074639|NCT03730961|10135660|FG001|Period 2 Completion|Overall Study|1 participant discontinued study due to AE|10
9074640|NCT03730961|10135659|FG000|COMPLETED|Overall Study||12
9074641|NCT03730961|10135660|FG001|COMPLETED|Overall Study||10
9074642|NCT03730961|10135659|FG000|NOT COMPLETED|Overall Study||0
9074643|NCT03730961|10135660|FG001|NOT COMPLETED|Overall Study||1
9074644|NCT03730116|10135666|FG000|STARTED|Inclusion|Planned to include 1920 pts, included 1909|1909
9074645|NCT03730116|10135666|FG000|FVFP|Inclusion||1909
9074646|NCT03730116|10135666|FG000|COMPLETED|Inclusion||1909
9074647|NCT03730116|10135666|FG000|NOT COMPLETED|Inclusion||0
9074648|NCT03730116|10135666|FG000|STARTED|1 Month After Inclusion||1909
9074649|NCT03730116|10135666|FG000|1 Month After Inclusion|1 Month After Inclusion||1909
9074650|NCT03730116|10135666|FG000|COMPLETED|1 Month After Inclusion||1909
9074651|NCT03730116|10135666|FG000|NOT COMPLETED|1 Month After Inclusion||0
9074652|NCT03730116|10135666|FG000|STARTED|3 Month After Inclusion||1909
9074653|NCT03730116|10135666|FG000|3 Month After Inclusion|3 Month After Inclusion||1909
9074654|NCT03730116|10135666|FG000|COMPLETED|3 Month After Inclusion||1892
9074655|NCT03730116|10135666|FG000|NOT COMPLETED|3 Month After Inclusion||17
9074656|NCT03730103|10135676|FG000|STARTED|Overall Study||61
9074657|NCT03730103|10135677|FG001|STARTED|Overall Study||52
9074658|NCT03730103|10135676|FG000|COMPLETED|Overall Study||61
9074659|NCT03730103|10135677|FG001|COMPLETED|Overall Study||47
9074660|NCT03730103|10135676|FG000|NOT COMPLETED|Overall Study||0
9074661|NCT03730103|10135677|FG001|NOT COMPLETED|Overall Study||5
9074662|NCT03729960|10135683|FG000|STARTED|Overall Study||20
9074663|NCT03729960|10135683|FG000|COMPLETED|Overall Study||20
9074664|NCT03729960|10135683|FG000|NOT COMPLETED|Overall Study||0
9074665|NCT03729024|10135688|FG000|STARTED|Overall Study||21
9074666|NCT03729024|10135688|FG000|COMPLETED|Overall Study||21
9074667|NCT03729024|10135688|FG000|NOT COMPLETED|Overall Study||0
9074668|NCT03728790|10135694|FG000|STARTED|Overall Study||112
9074669|NCT03728790|10135695|FG001|STARTED|Overall Study||101
9074670|NCT03728790|10135694|FG000|COMPLETED|Overall Study||112
9074671|NCT03728790|10135695|FG001|COMPLETED|Overall Study||101
9074672|NCT03728790|10135694|FG000|NOT COMPLETED|Overall Study||0
9074673|NCT03728790|10135695|FG001|NOT COMPLETED|Overall Study||0
9074674|NCT03728348|10135701|FG000|STARTED|Overall Study||983
9074675|NCT03728348|10135701|FG000|Did Not Complete Study Procedures|Overall Study||107
9074676|NCT03728348|10135701|FG000|Multi-target DNA Test Excluded|Overall Study||15
9074677|NCT03728348|10135701|FG000|Colonoscopy Excluded|Overall Study||19
9074678|NCT03728348|10135701|FG000|COMPLETED|Overall Study||842
9074679|NCT03728348|10135701|FG000|NOT COMPLETED|Overall Study||141
9074680|NCT03728140|10135707|FG000|STARTED|Overall Study|embryo transfer with self-spent culture medium|160
9074681|NCT03728140|10135708|FG001|STARTED|Overall Study|embryo transfer with new culture medium|175
9074682|NCT03728140|10135707|FG000|COMPLETED|Overall Study||150
9074683|NCT03728140|10135708|FG001|COMPLETED|Overall Study||168
9074684|NCT03728140|10135707|FG000|NOT COMPLETED|Overall Study||10
9074685|NCT03728140|10135708|FG001|NOT COMPLETED|Overall Study||7
9074686|NCT03727854|10135716|FG000|STARTED|Overall Study||20
9074687|NCT03727854|10135717|FG001|STARTED|Overall Study||20
9074688|NCT03727854|10135716|FG000|COMPLETED|Overall Study||20
9074689|NCT03727854|10135717|FG001|COMPLETED|Overall Study||20
9074690|NCT03727854|10135716|FG000|NOT COMPLETED|Overall Study||0
9074691|NCT03727854|10135717|FG001|NOT COMPLETED|Overall Study||0
9074692|NCT03727425|10135723|FG000|STARTED|Overall Study||55
9074693|NCT03727425|10135723|FG000|COMPLETED|Overall Study||55
9074694|NCT03727425|10135723|FG000|NOT COMPLETED|Overall Study||0
9074695|NCT03727347|10135727|FG000|STARTED|Overall Study||50
9074696|NCT03727347|10135727|FG000|2-week Evaluation|Overall Study||50
9074697|NCT03727347|10135727|FG000|4-week Evaluation|Overall Study||50
9074698|NCT03727347|10135727|FG000|12-week Primary Endpoint Evaluation|Overall Study||50
9074699|NCT03727347|10135727|FG000|26-week Evaluation|Overall Study||48
9074700|NCT03727347|10135727|FG000|52-week Evaluation|Overall Study||47
9074701|NCT03727347|10135727|FG000|COMPLETED|Overall Study||47
9074702|NCT03727347|10135727|FG000|NOT COMPLETED|Overall Study||3
9074703|NCT03726996|10135740|FG000|STARTED|Overall Study||4
9074704|NCT03726996|10135740|FG000|COMPLETED|Overall Study||0
9074705|NCT03726996|10135740|FG000|NOT COMPLETED|Overall Study||4
9074706|NCT03726164|10135746|FG000|STARTED|Overall Study||310
9074707|NCT03726164|10135747|FG001|STARTED|Overall Study||316
9074708|NCT03726164|10135746|FG000|COMPLETED|Overall Study||99
9074709|NCT03726164|10135747|FG001|COMPLETED|Overall Study||119
9074710|NCT03726164|10135746|FG000|NOT COMPLETED|Overall Study||211
8624146|NCT00498602|9663397|FG005|Treated|Overall Study||44
8624147|NCT00498602|9663398|FG006|Treated|Overall Study||17
8844588|NCT01710514|9899028|FG001|Intent-To-Treat (ITT) Analysis Set|Overall Study|All randomised subjects were included in the ITT analysis set.|54
9074711|NCT03726164|10135747|FG001|NOT COMPLETED|Overall Study||197
9074712|NCT03725852|10135755|FG000|STARTED|Overall Study||45
9074713|NCT03725852|10135756|FG001|STARTED|Overall Study||23
8844589|NCT01710514|9899027|FG000|Full Analysis Set (FAS)|Overall Study|All randomised and exposed subjects with at least one completed primary efficacy assessment.|46
8844590|NCT01710514|9899028|FG001|Full Analysis Set (FAS)|Overall Study|All randomised and exposed subjects with at least one completed primary efficacy assessment.|48
8850209|NCT01745848|9905466|FG000|NOT COMPLETED|Overall Study||6
9074714|NCT03725852|10135755|FG000|COMPLETED|Overall Study||41
9074715|NCT03725852|10135756|FG001|COMPLETED|Overall Study||23
9074716|NCT03725852|10135755|FG000|NOT COMPLETED|Overall Study||4
9074717|NCT03725852|10135756|FG001|NOT COMPLETED|Overall Study||0
9074718|NCT03725722|10135767|FG000|STARTED|Overall Study||49
9074719|NCT03725722|10135768|FG001|STARTED|Overall Study||50
9074720|NCT03725722|10135769|FG002|STARTED|Overall Study||50
9074721|NCT03725722|10135770|FG003|STARTED|Overall Study||52
9074722|NCT03725722|10135771|FG004|STARTED|Overall Study||50
9074723|NCT03725722|10135767|FG000|COMPLETED|Overall Study||38
9074724|NCT03725722|10135768|FG001|COMPLETED|Overall Study||44
9074725|NCT03725722|10135769|FG002|COMPLETED|Overall Study||44
9074726|NCT03725722|10135770|FG003|COMPLETED|Overall Study||46
9074727|NCT03725722|10135771|FG004|COMPLETED|Overall Study||36
9074728|NCT03725722|10135767|FG000|NOT COMPLETED|Overall Study||11
8624148|NCT00498602|9663392|FG000|COMPLETED|Overall Study||26
8844591|NCT01710514|9899027|FG000|FAS With Embryo Transfer (ET)|Overall Study|Data on pregnancy was reported for the subjects with embryo transfer.|43
8844592|NCT01710514|9899028|FG001|FAS With Embryo Transfer (ET)|Overall Study|Data on pregnancy was reported for the subjects with embryo transfer.|47
8844593|NCT01710514|9899027|FG000|Safety Analysis Set|Overall Study|All subjects received at least one dose of Investigational Medicinal Product (IMP).|54
8844594|NCT01710514|9899028|FG001|Safety Analysis Set|Overall Study|All subjects received at least one dose of IMP.|54
8844595|NCT01710514|9899027|FG000|COMPLETED|Overall Study||47
8844596|NCT01710514|9899028|FG001|COMPLETED|Overall Study||47
8844597|NCT01710514|9899027|FG000|NOT COMPLETED|Overall Study||7
8844598|NCT01710514|9899028|FG001|NOT COMPLETED|Overall Study||7
8844599|NCT01710527|9899037|FG000|STARTED|Period 1: Intervention Period 1||16
8844600|NCT01710527|9899038|FG001|STARTED|Period 1: Intervention Period 1||16
8844601|NCT01710527|9899037|FG000|COMPLETED|Period 1: Intervention Period 1||16
8844602|NCT01710527|9899038|FG001|COMPLETED|Period 1: Intervention Period 1||16
8948108|NCT02427100|10010442|FG000|STARTED|Overall Study||15
8948109|NCT02427100|10010443|FG001|STARTED|Overall Study||17
8948110|NCT02427100|10010442|FG000|COMPLETED|Overall Study||15
9074729|NCT03725722|10135768|FG001|NOT COMPLETED|Overall Study||6
9074730|NCT03725722|10135769|FG002|NOT COMPLETED|Overall Study||6
9074731|NCT03725722|10135770|FG003|NOT COMPLETED|Overall Study||6
9074732|NCT03725722|10135771|FG004|NOT COMPLETED|Overall Study||14
9074733|NCT03725098|10135785|FG000|STARTED|Overall Study||53
9074734|NCT03725098|10135786|FG001|STARTED|Overall Study||52
9074735|NCT03725098|10135785|FG000|COMPLETED|Overall Study||53
9074736|NCT03725098|10135786|FG001|COMPLETED|Overall Study||52
9074737|NCT03725098|10135785|FG000|NOT COMPLETED|Overall Study||0
9074738|NCT03725098|10135786|FG001|NOT COMPLETED|Overall Study||0
9074739|NCT03725085|10135792|FG000|STARTED|Overall Study||552
9074740|NCT03725085|10135792|FG000|COMPLETED|Overall Study||550
9074741|NCT03725085|10135792|FG000|NOT COMPLETED|Overall Study||2
9074742|NCT03725033|10135799|FG000|STARTED|Overall Study||105
8624149|NCT00498602|9663393|FG001|COMPLETED|Overall Study||51
8624150|NCT00498602|9663394|FG002|COMPLETED|Overall Study||32
9074743|NCT03725033|10135800|FG001|STARTED|Overall Study||97
9074744|NCT03725033|10135799|FG000|COMPLETED|Overall Study||105
9074745|NCT03725033|10135800|FG001|COMPLETED|Overall Study||97
9074746|NCT03725033|10135799|FG000|NOT COMPLETED|Overall Study||0
9074747|NCT03725033|10135800|FG001|NOT COMPLETED|Overall Study||0
9074748|NCT03724981|10135808|FG000|STARTED|First Device||156
9074749|NCT03724981|10135809|FG001|STARTED|First Device||156
9074750|NCT03724981|10135808|FG000|COMPLETED|First Device||155
9074751|NCT03724981|10135809|FG001|COMPLETED|First Device||155
9074752|NCT03724981|10135808|FG000|NOT COMPLETED|First Device||1
9074753|NCT03724981|10135809|FG001|NOT COMPLETED|First Device||1
9074754|NCT03724981|10135808|FG000|STARTED|Second Device||155
9074755|NCT03724981|10135809|FG001|STARTED|Second Device||155
9074756|NCT03724981|10135808|FG000|COMPLETED|Second Device||155
9074757|NCT03724981|10135809|FG001|COMPLETED|Second Device||155
9074758|NCT03724981|10135808|FG000|NOT COMPLETED|Second Device||0
9074759|NCT03724981|10135809|FG001|NOT COMPLETED|Second Device||0
9074760|NCT03724968|10135819|FG000|STARTED|Overall Study||0
9074761|NCT03724968|10135820|FG001|STARTED|Overall Study||2
9074762|NCT03724968|10135819|FG000|COMPLETED|Overall Study||0
9074763|NCT03724968|10135820|FG001|COMPLETED|Overall Study||0
9074764|NCT03724968|10135819|FG000|NOT COMPLETED|Overall Study||0
9074765|NCT03724968|10135820|FG001|NOT COMPLETED|Overall Study||2
9074766|NCT03724877|10135828|FG000|STARTED|Overall Study||6921
9074767|NCT03724877|10135829|FG001|STARTED|Overall Study||1932
9074768|NCT03724877|10135828|FG000|COMPLETED|Overall Study||6921
9074769|NCT03724877|10135829|FG001|COMPLETED|Overall Study||1932
9074770|NCT03724877|10135828|FG000|NOT COMPLETED|Overall Study||0
9074771|NCT03724877|10135829|FG001|NOT COMPLETED|Overall Study||0
9074772|NCT03724253|10135840|FG000|STARTED|Overall Study||5
9074773|NCT03724253|10135841|FG001|STARTED|Overall Study||5
9074774|NCT03724253|10135842|FG002|STARTED|Overall Study||5
9074775|NCT03724253|10135843|FG003|STARTED|Overall Study||3
9074776|NCT03724253|10135844|FG004|STARTED|Overall Study||1
9074777|NCT03724253|10135840|FG000|COMPLETED|Overall Study||5
9074778|NCT03724253|10135841|FG001|COMPLETED|Overall Study||5
9074779|NCT03724253|10135842|FG002|COMPLETED|Overall Study||5
9074780|NCT03724253|10135843|FG003|COMPLETED|Overall Study||3
9074781|NCT03724253|10135844|FG004|COMPLETED|Overall Study||1
8624151|NCT00498602|9663395|FG003|COMPLETED|Overall Study||30
9074782|NCT03724253|10135840|FG000|NOT COMPLETED|Overall Study||0
9074783|NCT03724253|10135841|FG001|NOT COMPLETED|Overall Study||0
9074784|NCT03724253|10135842|FG002|NOT COMPLETED|Overall Study||0
9074785|NCT03724253|10135843|FG003|NOT COMPLETED|Overall Study||0
9074786|NCT03724253|10135844|FG004|NOT COMPLETED|Overall Study||0
9074787|NCT03723980|10135858|FG000|STARTED|Overall Study||40
9074788|NCT03723980|10135859|FG001|STARTED|Overall Study||40
9074789|NCT03723980|10135858|FG000|COMPLETED|Overall Study||33
9074790|NCT03723980|10135859|FG001|COMPLETED|Overall Study||35
9074791|NCT03723980|10135858|FG000|NOT COMPLETED|Overall Study||7
9074792|NCT03723980|10135859|FG001|NOT COMPLETED|Overall Study||5
9074793|NCT03723603|10135871|FG000|STARTED|Overall Study||8
9074794|NCT03723603|10135871|FG000|COMPLETED|Overall Study||5
9074795|NCT03723603|10135871|FG000|NOT COMPLETED|Overall Study||3
9074796|NCT03723447|10135877|FG000|STARTED|Overall Study||50
9074797|NCT03723447|10135878|FG001|STARTED|Overall Study||51
9074798|NCT03723447|10135877|FG000|COMPLETED|Overall Study||50
9074799|NCT03723447|10135878|FG001|COMPLETED|Overall Study||51
9074800|NCT03723447|10135877|FG000|NOT COMPLETED|Overall Study||0
9074801|NCT03723447|10135878|FG001|NOT COMPLETED|Overall Study||0
9074802|NCT03723070|10135884|FG000|STARTED|Overall Study||88
9074803|NCT03723070|10135884|FG000|COMPLETED|Overall Study||79
9074804|NCT03723070|10135884|FG000|NOT COMPLETED|Overall Study||9
9074805|NCT03720210|10135888|FG000|STARTED|Overall Study||1
9074806|NCT03720210|10135888|FG000|COMPLETED|Overall Study||0
9074807|NCT03720210|10135888|FG000|NOT COMPLETED|Overall Study||1
9074808|NCT03718455|10135892|FG000|STARTED|Overall Study||1
9074809|NCT03718455|10135892|FG000|COMPLETED|Overall Study||1
9074810|NCT03718455|10135892|FG000|NOT COMPLETED|Overall Study||0
9074811|NCT03718143|10135896|FG000|STARTED|Overall Study||3
9074812|NCT03718143|10135897|FG001|STARTED|Overall Study||2
9074813|NCT03718143|10135898|FG002|STARTED|Overall Study||1
9074814|NCT03718143|10135896|FG000|COMPLETED|Overall Study||0
9074815|NCT03718143|10135897|FG001|COMPLETED|Overall Study||0
9074816|NCT03718143|10135898|FG002|COMPLETED|Overall Study||0
9074817|NCT03718143|10135896|FG000|NOT COMPLETED|Overall Study||3
9074818|NCT03718143|10135897|FG001|NOT COMPLETED|Overall Study||2
9074819|NCT03718143|10135898|FG002|NOT COMPLETED|Overall Study||1
9074820|NCT03709576|10135906|FG000|STARTED|Overall Study||3
9074821|NCT03709576|10135906|FG000|COMPLETED|Overall Study||2
9074822|NCT03709576|10135906|FG000|NOT COMPLETED|Overall Study||1
9074823|NCT03704636|10135911|FG000|STARTED|Overall Study||23
9074824|NCT03704636|10135911|FG000|COMPLETED|Overall Study||20
9074825|NCT03704636|10135911|FG000|NOT COMPLETED|Overall Study||3
9074826|NCT03703791|10135917|FG000|STARTED|Overall Study||0
9074827|NCT03703791|10135918|FG001|STARTED|Overall Study||1
9074828|NCT03703791|10135917|FG000|COMPLETED|Overall Study||0
9074829|NCT03703791|10135918|FG001|COMPLETED|Overall Study||0
9074830|NCT03703791|10135917|FG000|NOT COMPLETED|Overall Study||0
9074831|NCT03703791|10135918|FG001|NOT COMPLETED|Overall Study||1
9074832|NCT03701295|10135924|FG000|STARTED|Overall Study||1
9074833|NCT03701295|10135924|FG000|COMPLETED|Overall Study||1
9074834|NCT03701295|10135924|FG000|NOT COMPLETED|Overall Study||0
9074835|NCT03697551|10135928|FG000|STARTED|Overall Study||4
9074836|NCT03697551|10135928|FG000|COMPLETED|Overall Study||4
9074837|NCT03697551|10135928|FG000|NOT COMPLETED|Overall Study||0
9074838|NCT03694821|10135935|FG000|STARTED|Overall Study||4
9074839|NCT03694821|10135936|FG001|STARTED|Overall Study||8
9074840|NCT03694821|10135937|FG002|STARTED|Overall Study||6
9074841|NCT03694821|10135935|FG000|COMPLETED|Overall Study||0
9074842|NCT03694821|10135936|FG001|COMPLETED|Overall Study||0
9074843|NCT03694821|10135937|FG002|COMPLETED|Overall Study||2
9074844|NCT03694821|10135935|FG000|NOT COMPLETED|Overall Study||4
9074845|NCT03694821|10135936|FG001|NOT COMPLETED|Overall Study||8
9074846|NCT03694821|10135937|FG002|NOT COMPLETED|Overall Study||4
9074847|NCT03686969|10135947|FG000|STARTED|Overall Study||1
9074848|NCT03686969|10135948|FG001|STARTED|Overall Study||0
9074849|NCT03686969|10135947|FG000|COMPLETED|Overall Study||0
9074850|NCT03686969|10135948|FG001|COMPLETED|Overall Study||0
9074851|NCT03686969|10135947|FG000|NOT COMPLETED|Overall Study||1
9074852|NCT03686969|10135948|FG001|NOT COMPLETED|Overall Study||0
9074853|NCT03682367|10135956|FG000|STARTED|Overall Study||4
9074854|NCT03682367|10135957|FG001|STARTED|Overall Study||4
9074855|NCT03682367|10135956|FG000|COMPLETED|Overall Study|Withdrawn due to non-compliance|2
9074856|NCT03682367|10135957|FG001|COMPLETED|Overall Study|Patients withdrawn due to confounding neuropathic pain or exited early from study.|0
9074857|NCT03682367|10135956|FG000|NOT COMPLETED|Overall Study||2
9074858|NCT03682367|10135957|FG001|NOT COMPLETED|Overall Study||4
9074859|NCT03680911|10135965|FG000|STARTED|Visit 1 (Baseline)||3
9074860|NCT03680911|10135966|FG001|STARTED|Visit 1 (Baseline)||4
9074861|NCT03680911|10135965|FG000|COMPLETED|Visit 1 (Baseline)||3
9074862|NCT03680911|10135966|FG001|COMPLETED|Visit 1 (Baseline)||4
9074863|NCT03680911|10135965|FG000|NOT COMPLETED|Visit 1 (Baseline)||0
9074864|NCT03680911|10135966|FG001|NOT COMPLETED|Visit 1 (Baseline)||0
9074865|NCT03680911|10135965|FG000|STARTED|At Home Treatment||3
9074866|NCT03680911|10135966|FG001|STARTED|At Home Treatment||4
9074867|NCT03680911|10135965|FG000|COMPLETED|At Home Treatment||0
9074868|NCT03680911|10135966|FG001|COMPLETED|At Home Treatment||1
9074869|NCT03680911|10135965|FG000|NOT COMPLETED|At Home Treatment||3
9074870|NCT03680911|10135966|FG001|NOT COMPLETED|At Home Treatment||3
9074871|NCT03680911|10135965|FG000|STARTED|Visit 2 (1 Month Follow up)||0
9074872|NCT03680911|10135966|FG001|STARTED|Visit 2 (1 Month Follow up)||1
9074873|NCT03680911|10135965|FG000|COMPLETED|Visit 2 (1 Month Follow up)||0
9074874|NCT03680911|10135966|FG001|COMPLETED|Visit 2 (1 Month Follow up)||1
9074875|NCT03680911|10135965|FG000|NOT COMPLETED|Visit 2 (1 Month Follow up)||0
9074876|NCT03680911|10135966|FG001|NOT COMPLETED|Visit 2 (1 Month Follow up)||0
9074877|NCT03680911|10135965|FG000|STARTED|Visit 3 (4 Month Follow up)||0
9074878|NCT03680911|10135966|FG001|STARTED|Visit 3 (4 Month Follow up)||1
9074879|NCT03680911|10135965|FG000|COMPLETED|Visit 3 (4 Month Follow up)||0
9074880|NCT03680911|10135966|FG001|COMPLETED|Visit 3 (4 Month Follow up)||0
9074881|NCT03680911|10135965|FG000|NOT COMPLETED|Visit 3 (4 Month Follow up)||0
9074882|NCT03680911|10135966|FG001|NOT COMPLETED|Visit 3 (4 Month Follow up)||1
9074883|NCT03656692|10135972|FG000|STARTED|Overall Study||5
9074884|NCT03656692|10135972|FG000|COMPLETED|Overall Study||2
9074885|NCT03656692|10135972|FG000|NOT COMPLETED|Overall Study||3
9074886|NCT03648983|10135976|FG000|STARTED|Overall Study||95
9074887|NCT03648983|10135976|FG000|COMPLETED|Overall Study||0
9074888|NCT03648983|10135976|FG000|NOT COMPLETED|Overall Study||95
9074889|NCT03643159|10135983|FG000|STARTED|Overall Study||2
9074890|NCT03643159|10135983|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||2
9074891|NCT03643159|10135983|FG000|COMPLETED|Overall Study||0
9074892|NCT03643159|10135983|FG000|NOT COMPLETED|Overall Study||2
9074893|NCT03632655|10135990|FG000|STARTED|Overall Study||22
9074894|NCT03632655|10135991|FG001|STARTED|Overall Study||16
9074895|NCT03632655|10135990|FG000|COMPLETED|Overall Study||0
9074896|NCT03632655|10135991|FG001|COMPLETED|Overall Study||0
9074897|NCT03632655|10135990|FG000|NOT COMPLETED|Overall Study||22
9074898|NCT03632655|10135991|FG001|NOT COMPLETED|Overall Study||16
9074899|NCT03630120|10136001|FG000|STARTED|Overall Study||2
9074900|NCT03630120|10136002|FG001|STARTED|Overall Study||2
9074901|NCT03630120|10136003|FG002|STARTED|Overall Study||1
9074902|NCT03630120|10136004|FG003|STARTED|Overall Study||1
9074903|NCT03630120|10136001|FG000|COMPLETED|Overall Study||2
9074904|NCT03630120|10136002|FG001|COMPLETED|Overall Study||1
9074905|NCT03630120|10136003|FG002|COMPLETED|Overall Study||0
9074906|NCT03630120|10136004|FG003|COMPLETED|Overall Study||0
9074907|NCT03630120|10136001|FG000|NOT COMPLETED|Overall Study||0
9074908|NCT03630120|10136002|FG001|NOT COMPLETED|Overall Study||1
9074909|NCT03630120|10136003|FG002|NOT COMPLETED|Overall Study||1
9074910|NCT03630120|10136004|FG003|NOT COMPLETED|Overall Study||1
9074911|NCT03621657|10136017|FG000|STARTED|Overall Study||0
9074912|NCT03621657|10136018|FG001|STARTED|Overall Study||0
9074913|NCT03621657|10136019|FG002|STARTED|Overall Study||1
9074914|NCT03621657|10136017|FG000|COMPLETED|Overall Study||0
9074915|NCT03621657|10136018|FG001|COMPLETED|Overall Study||0
9074916|NCT03621657|10136019|FG002|COMPLETED|Overall Study||1
9074917|NCT03621657|10136017|FG000|NOT COMPLETED|Overall Study||0
9074918|NCT03621657|10136018|FG001|NOT COMPLETED|Overall Study||0
9074919|NCT03621657|10136019|FG002|NOT COMPLETED|Overall Study||0
9074920|NCT03615144|10136031|FG000|STARTED|Overall Study||1
9074921|NCT03615144|10136032|FG001|STARTED|Overall Study||0
9074922|NCT03615144|10136031|FG000|COMPLETED|Overall Study||0
9074923|NCT03615144|10136032|FG001|COMPLETED|Overall Study||0
9074924|NCT03615144|10136031|FG000|NOT COMPLETED|Overall Study||1
9074925|NCT03615144|10136032|FG001|NOT COMPLETED|Overall Study||0
9074926|NCT03605303|10136038|FG000|STARTED|Period 1||2
9074927|NCT03605303|10136039|FG001|STARTED|Period 1||1
9074928|NCT03605303|10136038|FG000|COMPLETED|Period 1||0
9074929|NCT03605303|10136039|FG001|COMPLETED|Period 1||0
9074930|NCT03605303|10136038|FG000|NOT COMPLETED|Period 1||2
9074931|NCT03605303|10136039|FG001|NOT COMPLETED|Period 1||1
9074932|NCT03605303|10136038|FG000|STARTED|Period 2||0
9074933|NCT03605303|10136039|FG001|STARTED|Period 2||0
9074934|NCT03605303|10136038|FG000|COMPLETED|Period 2||0
9074935|NCT03605303|10136039|FG001|COMPLETED|Period 2||0
9074936|NCT03605303|10136038|FG000|NOT COMPLETED|Period 2||0
9074937|NCT03605303|10136039|FG001|NOT COMPLETED|Period 2||0
9074938|NCT03600740|10136045|FG000|STARTED|Overall Study||1
9074939|NCT03600740|10136045|FG000|COMPLETED|Overall Study||0
9074940|NCT03600740|10136045|FG000|NOT COMPLETED|Overall Study||1
9074941|NCT03598140|10136051|FG000|STARTED|Overall Study||10
9074942|NCT03598140|10136052|FG001|STARTED|Overall Study||11
9074943|NCT03598140|10136051|FG000|COMPLETED|Overall Study||9
9074944|NCT03598140|10136052|FG001|COMPLETED|Overall Study||11
9074945|NCT03598140|10136051|FG000|NOT COMPLETED|Overall Study||1
9074946|NCT03598140|10136052|FG001|NOT COMPLETED|Overall Study||0
9074947|NCT03598036|10136060|FG000|STARTED|Overall Study||5
9074948|NCT03598036|10136061|FG001|STARTED|Overall Study|Trial ended prematurely before any patients were enrolled into Cohort 2|0
9074949|NCT03598036|10136060|FG000|Week 1: 7.9 mg Twice Daily|Overall Study||5
9074950|NCT03598036|10136061|FG001|Week 1: 7.9 mg Twice Daily|Overall Study||0
9074951|NCT03598036|10136060|FG000|Week 2: 15.9 mg Twice Daily|Overall Study||5
9074952|NCT03598036|10136061|FG001|Week 2: 15.9 mg Twice Daily|Overall Study||0
9074953|NCT03598036|10136060|FG000|Weeks 3 - 24: 23.7 mg Twice Daily|Overall Study|1 subject withdrew at Week 12|5
9074954|NCT03598036|10136061|FG001|Weeks 3 - 24: 23.7 mg Twice Daily|Overall Study||0
9074955|NCT03598036|10136060|FG000|COMPLETED|Overall Study||4
9074956|NCT03598036|10136061|FG001|COMPLETED|Overall Study||0
9074957|NCT03598036|10136060|FG000|NOT COMPLETED|Overall Study||1
9074958|NCT03598036|10136061|FG001|NOT COMPLETED|Overall Study||0
9074959|NCT03591458|10136071|FG000|STARTED|Overall Study||1
9074960|NCT03591458|10136072|FG001|STARTED|Overall Study||1
9074961|NCT03591458|10136071|FG000|COMPLETED|Overall Study||1
9074962|NCT03591458|10136072|FG001|COMPLETED|Overall Study||1
9074963|NCT03591458|10136071|FG000|NOT COMPLETED|Overall Study||0
9074964|NCT03591458|10136072|FG001|NOT COMPLETED|Overall Study||0
9074965|NCT03590743|10136080|FG000|STARTED|Overall Study||2
9074966|NCT03590743|10136081|FG001|STARTED|Overall Study||3
9074967|NCT03590743|10136080|FG000|COMPLETED|Overall Study||2
9074968|NCT03590743|10136081|FG001|COMPLETED|Overall Study||2
9074969|NCT03590743|10136080|FG000|NOT COMPLETED|Overall Study||0
9074970|NCT03590743|10136081|FG001|NOT COMPLETED|Overall Study||1
9074971|NCT03580382|10136089|FG000|STARTED|Overall Study||0
9074972|NCT03580382|10136090|FG001|STARTED|Overall Study||3
9074973|NCT03580382|10136089|FG000|COMPLETED|Overall Study||0
9074974|NCT03580382|10136090|FG001|COMPLETED|Overall Study||0
9074975|NCT03580382|10136089|FG000|NOT COMPLETED|Overall Study||0
9074976|NCT03580382|10136090|FG001|NOT COMPLETED|Overall Study||3
9074977|NCT03571646|10136097|FG000|STARTED|Overall Study||3
9074978|NCT03571646|10136098|FG001|STARTED|Overall Study||3
9074979|NCT03571646|10136097|FG000|COMPLETED|Overall Study||1
9074980|NCT03571646|10136098|FG001|COMPLETED|Overall Study||2
9074981|NCT03571646|10136097|FG000|NOT COMPLETED|Overall Study||2
9074982|NCT03571646|10136098|FG001|NOT COMPLETED|Overall Study||1
9074983|NCT03565328|10136104|FG000|STARTED|Overall Study||1
9074984|NCT03565328|10136104|FG000|COMPLETED|Overall Study||1
9074985|NCT03565328|10136104|FG000|NOT COMPLETED|Overall Study||0
9074986|NCT03544242|10136111|FG000|STARTED|Overall Study||1
9074987|NCT03544242|10136112|FG001|STARTED|Overall Study||1
9074988|NCT03544242|10136113|FG002|STARTED|Overall Study||2
9074989|NCT03544242|10136111|FG000|COMPLETED|Overall Study||1
9074990|NCT03544242|10136112|FG001|COMPLETED|Overall Study||1
9074991|NCT03544242|10136113|FG002|COMPLETED|Overall Study||2
9074992|NCT03544242|10136111|FG000|NOT COMPLETED|Overall Study||0
9074993|NCT03544242|10136112|FG001|NOT COMPLETED|Overall Study||0
9074994|NCT03544242|10136113|FG002|NOT COMPLETED|Overall Study||0
9074995|NCT03543358|10136121|FG000|STARTED|Overall Study||3
9074996|NCT03543358|10136122|FG001|STARTED|Overall Study||0
9074997|NCT03543358|10136121|FG000|Received Treatment or Retreatment|Overall Study||0
9074998|NCT03543358|10136122|FG001|Received Treatment or Retreatment|Overall Study||0
9074999|NCT03543358|10136121|FG000|COMPLETED|Overall Study||0
9075000|NCT03543358|10136122|FG001|COMPLETED|Overall Study||0
9075001|NCT03543358|10136121|FG000|NOT COMPLETED|Overall Study||3
9075002|NCT03543358|10136122|FG001|NOT COMPLETED|Overall Study||0
9075003|NCT03538015|10136129|FG000|STARTED|Overall Study||0
9075004|NCT03538015|10136130|FG001|STARTED|Overall Study||0
9075005|NCT03538015|10136131|FG002|STARTED|Overall Study||1
9075006|NCT03538015|10136129|FG000|COMPLETED|Overall Study||0
9075007|NCT03538015|10136130|FG001|COMPLETED|Overall Study||0
9075008|NCT03538015|10136131|FG002|COMPLETED|Overall Study||0
9075009|NCT03538015|10136129|FG000|NOT COMPLETED|Overall Study||0
9075010|NCT03538015|10136130|FG001|NOT COMPLETED|Overall Study||0
9075011|NCT03538015|10136131|FG002|NOT COMPLETED|Overall Study||1
9075012|NCT03534362|10136141|FG000|STARTED|Overall Study||0
9075013|NCT03534362|10136142|FG001|STARTED|Overall Study||1
9075014|NCT03534362|10136141|FG000|COMPLETED|Overall Study||0
9075015|NCT03534362|10136142|FG001|COMPLETED|Overall Study||1
9075016|NCT03534362|10136141|FG000|NOT COMPLETED|Overall Study||0
9075017|NCT03534362|10136142|FG001|NOT COMPLETED|Overall Study||0
9075018|NCT03509207|10136150|FG000|STARTED|Overall Study||3
9075019|NCT03509207|10136150|FG000|COMPLETED|Overall Study||1
9075020|NCT03509207|10136150|FG000|NOT COMPLETED|Overall Study||2
9075021|NCT03505372|10136154|FG000|STARTED|Overall Study||5
9075022|NCT03505372|10136154|FG000|COMPLETED|Overall Study||5
9075023|NCT03505372|10136154|FG000|NOT COMPLETED|Overall Study||0
9075024|NCT03500406|10136160|FG000|STARTED|Overall Study||4
9075025|NCT03500406|10136161|FG001|STARTED|Overall Study||20
9075026|NCT03500406|10136160|FG000|COMPLETED|Overall Study||4
9075027|NCT03500406|10136161|FG001|COMPLETED|Overall Study||20
9075028|NCT03500406|10136160|FG000|NOT COMPLETED|Overall Study||0
9075029|NCT03500406|10136161|FG001|NOT COMPLETED|Overall Study||0
9075030|NCT03500341|10136167|FG000|STARTED|Overall Study||16
9075031|NCT03500341|10136167|FG000|COMPLETED|Overall Study||14
9075032|NCT03500341|10136167|FG000|NOT COMPLETED|Overall Study||2
9075033|NCT03500159|10136173|FG000|STARTED|Overall Study||2
9075034|NCT03500159|10136174|FG001|STARTED|Overall Study||1
9075035|NCT03500159|10136173|FG000|COMPLETED|Overall Study||0
9075036|NCT03500159|10136174|FG001|COMPLETED|Overall Study||0
9075037|NCT03500159|10136173|FG000|NOT COMPLETED|Overall Study||2
9075038|NCT03500159|10136174|FG001|NOT COMPLETED|Overall Study||1
9075039|NCT03490916|10136182|FG000|STARTED|Overall Study||0
9075040|NCT03490916|10136183|FG001|STARTED|Overall Study||0
9075041|NCT03490916|10136182|FG000|COMPLETED|Overall Study||0
9075042|NCT03490916|10136183|FG001|COMPLETED|Overall Study||0
9075043|NCT03490916|10136182|FG000|NOT COMPLETED|Overall Study||0
9075044|NCT03490916|10136183|FG001|NOT COMPLETED|Overall Study||0
9075045|NCT03483051|10136191|FG000|STARTED|First Treatment, Pre Crossover||2
9075046|NCT03483051|10136192|FG001|STARTED|First Treatment, Pre Crossover||1
9075047|NCT03483051|10136191|FG000|COMPLETED|First Treatment, Pre Crossover||2
9075048|NCT03483051|10136192|FG001|COMPLETED|First Treatment, Pre Crossover||1
9075049|NCT03483051|10136191|FG000|NOT COMPLETED|First Treatment, Pre Crossover||0
9075050|NCT03483051|10136192|FG001|NOT COMPLETED|First Treatment, Pre Crossover||0
9075051|NCT03483051|10136191|FG000|STARTED|Second Treatment, After Crossover||2
9075052|NCT03483051|10136192|FG001|STARTED|Second Treatment, After Crossover||1
9075053|NCT03483051|10136191|FG000|COMPLETED|Second Treatment, After Crossover||2
9075054|NCT03483051|10136192|FG001|COMPLETED|Second Treatment, After Crossover||1
9075055|NCT03483051|10136191|FG000|NOT COMPLETED|Second Treatment, After Crossover||0
9075056|NCT03483051|10136192|FG001|NOT COMPLETED|Second Treatment, After Crossover||0
9075057|NCT03477903|10136200|FG000|STARTED|Overall Study||1
9075058|NCT03477903|10136200|FG000|COMPLETED|Overall Study||0
9075059|NCT03477903|10136200|FG000|NOT COMPLETED|Overall Study||1
9075060|NCT03469258|10136204|FG000|STARTED|Overall Study||4
9075061|NCT03469258|10136204|FG000|COMPLETED|Overall Study||0
9075062|NCT03469258|10136204|FG000|NOT COMPLETED|Overall Study||4
9075063|NCT03466658|10136208|FG000|STARTED|Overall Study||17
9075064|NCT03466658|10136208|FG000|COMPLETED|Overall Study||14
9075065|NCT03466658|10136208|FG000|NOT COMPLETED|Overall Study||3
9075066|NCT03465891|10136216|FG000|STARTED|Overall Study||1
9075067|NCT03465891|10136217|FG001|STARTED|Overall Study||1
9075068|NCT03465891|10136216|FG000|COMPLETED|Overall Study||0
9075069|NCT03465891|10136217|FG001|COMPLETED|Overall Study||0
9075070|NCT03465891|10136216|FG000|NOT COMPLETED|Overall Study||1
9075071|NCT03465891|10136217|FG001|NOT COMPLETED|Overall Study||1
9075072|NCT03465735|10136225|FG000|STARTED|Overall Study||8
9075073|NCT03465735|10136226|FG001|STARTED|Overall Study||7
9075074|NCT03465735|10136225|FG000|COMPLETED|Overall Study||7
9075075|NCT03465735|10136226|FG001|COMPLETED|Overall Study||5
9075076|NCT03465735|10136225|FG000|NOT COMPLETED|Overall Study||1
9075077|NCT03465735|10136226|FG001|NOT COMPLETED|Overall Study||2
9075078|NCT03461705|10136232|FG000|STARTED|Overall Study||5
9075079|NCT03461705|10136232|FG000|COMPLETED|Overall Study||5
9075080|NCT03461705|10136232|FG000|NOT COMPLETED|Overall Study||0
9075081|NCT03457818|10136238|FG000|STARTED|Overall Study||4
9075082|NCT03457818|10136239|FG001|STARTED|Overall Study||4
9075083|NCT03457818|10136238|FG000|COMPLETED|Overall Study|Study terminated|0
9075084|NCT03457818|10136239|FG001|COMPLETED|Overall Study|study terminated|0
9075085|NCT03457818|10136238|FG000|NOT COMPLETED|Overall Study||4
9075086|NCT03457818|10136239|FG001|NOT COMPLETED|Overall Study||4
9075087|NCT03455556|10136245|FG000|STARTED|Overall Study||1
9075088|NCT03455556|10136245|FG000|COMPLETED|Overall Study||1
9075089|NCT03455556|10136245|FG000|NOT COMPLETED|Overall Study||0
9075090|NCT03447639|10136251|FG000|STARTED|Overall Study|No patients were randomized to the Povidone-Iodine irrigation arm|0
9075091|NCT03447639|10136252|FG001|STARTED|Overall Study|3 patients were randomized to the Standard of Care arm.|3
9075092|NCT03447639|10136251|FG000|COMPLETED|Overall Study|No patients were randomized to the Povidone-Iodine irrigation arm|0
9075093|NCT03447639|10136252|FG001|COMPLETED|Overall Study|2 patients were withdrawn because their catheters had to be re-inserted.|1
9075094|NCT03447639|10136251|FG000|NOT COMPLETED|Overall Study||0
9075095|NCT03447639|10136252|FG001|NOT COMPLETED|Overall Study||2
9075096|NCT03429712|10136258|FG000|STARTED|Overall Study||19
9075097|NCT03429712|10136258|FG000|COMPLETED|Overall Study||10
9075098|NCT03429712|10136258|FG000|NOT COMPLETED|Overall Study||9
9075099|NCT03426137|10136265|FG000|STARTED|Overall Study||0
9075100|NCT03426137|10136266|FG001|STARTED|Overall Study||0
9075101|NCT03426137|10136267|FG002|STARTED|Overall Study||0
9075102|NCT03426137|10136265|FG000|COMPLETED|Overall Study||0
9075103|NCT03426137|10136266|FG001|COMPLETED|Overall Study||0
9075104|NCT03426137|10136267|FG002|COMPLETED|Overall Study||0
9075105|NCT03426137|10136265|FG000|NOT COMPLETED|Overall Study||0
9075106|NCT03426137|10136266|FG001|NOT COMPLETED|Overall Study||0
9075107|NCT03426137|10136267|FG002|NOT COMPLETED|Overall Study||0
9075108|NCT03425799|10136277|FG000|STARTED|Overall Study|Study terminated due to low recruitment|0
9075109|NCT03425799|10136278|FG001|STARTED|Overall Study|Study terminated due to low recruitment|0
9075110|NCT03425799|10136277|FG000|COMPLETED|Overall Study|Study terminated due to low recruitment|0
9075111|NCT03425799|10136278|FG001|COMPLETED|Overall Study|Study terminated due to low recruitment|0
9075112|NCT03425799|10136277|FG000|NOT COMPLETED|Overall Study||0
9075113|NCT03425799|10136278|FG001|NOT COMPLETED|Overall Study||0
9075114|NCT03423654|10136286|FG000|STARTED|Overall Study||3
9075115|NCT03423654|10136287|FG001|STARTED|Overall Study||3
9075116|NCT03423654|10136286|FG000|COMPLETED|Overall Study||3
9075117|NCT03423654|10136287|FG001|COMPLETED|Overall Study||3
9075118|NCT03423654|10136286|FG000|NOT COMPLETED|Overall Study||0
9075119|NCT03423654|10136287|FG001|NOT COMPLETED|Overall Study||0
9075120|NCT03387059|10136295|FG000|STARTED|Overall Study||5
9075121|NCT03387059|10136296|FG001|STARTED|Overall Study||4
9075122|NCT03387059|10136295|FG000|COMPLETED|Overall Study||0
9075123|NCT03387059|10136296|FG001|COMPLETED|Overall Study||0
9075124|NCT03387059|10136295|FG000|NOT COMPLETED|Overall Study||5
9075125|NCT03387059|10136296|FG001|NOT COMPLETED|Overall Study||4
9075126|NCT03382925|10136304|FG000|STARTED|Overall Study||10
9075127|NCT03382925|10136305|FG001|STARTED|Overall Study||6
9075128|NCT03382925|10136304|FG000|COMPLETED|Overall Study||10
9075129|NCT03382925|10136305|FG001|COMPLETED|Overall Study||6
9075130|NCT03382925|10136304|FG000|NOT COMPLETED|Overall Study||0
9075131|NCT03382925|10136305|FG001|NOT COMPLETED|Overall Study||0
9075132|NCT03379233|10136313|FG000|STARTED|Overall Study||1
9075133|NCT03379233|10136314|FG001|STARTED|Overall Study||6
9075134|NCT03379233|10136313|FG000|COMPLETED|Overall Study||0
9075135|NCT03379233|10136314|FG001|COMPLETED|Overall Study||0
9075136|NCT03379233|10136313|FG000|NOT COMPLETED|Overall Study||1
9075137|NCT03379233|10136314|FG001|NOT COMPLETED|Overall Study||6
9075138|NCT03370536|10136320|FG000|STARTED|Overall Study||1
9075139|NCT03370536|10136320|FG000|COMPLETED|Overall Study||0
9075140|NCT03370536|10136320|FG000|NOT COMPLETED|Overall Study||1
9075141|NCT03363633|10136324|FG000|STARTED|Overall Study||12
9075142|NCT03363633|10136324|FG000|COMPLETED|Overall Study|See note in Pre-Assignment Details|0
9075143|NCT03363633|10136324|FG000|NOT COMPLETED|Overall Study||12
9075144|NCT03361228|10136330|FG000|STARTED|Overall Study||4
9075145|NCT03361228|10136331|FG001|STARTED|Overall Study||1
9075146|NCT03361228|10136330|FG000|COMPLETED|Overall Study||0
9075147|NCT03361228|10136331|FG001|COMPLETED|Overall Study||0
9075148|NCT03361228|10136330|FG000|NOT COMPLETED|Overall Study||4
9075149|NCT03361228|10136331|FG001|NOT COMPLETED|Overall Study||1
9075150|NCT03360903|10136339|FG000|STARTED|First Intervention||4
9075151|NCT03360903|10136340|FG001|STARTED|First Intervention||4
9075152|NCT03360903|10136339|FG000|COMPLETED|First Intervention||4
9075153|NCT03360903|10136340|FG001|COMPLETED|First Intervention||4
9075154|NCT03360903|10136339|FG000|NOT COMPLETED|First Intervention||0
9075155|NCT03360903|10136340|FG001|NOT COMPLETED|First Intervention||0
9075156|NCT03360903|10136339|FG000|STARTED|Washout (2 Weeks)||4
9075157|NCT03360903|10136340|FG001|STARTED|Washout (2 Weeks)||4
9075158|NCT03360903|10136339|FG000|COMPLETED|Washout (2 Weeks)||4
9075159|NCT03360903|10136340|FG001|COMPLETED|Washout (2 Weeks)||4
9075160|NCT03360903|10136339|FG000|NOT COMPLETED|Washout (2 Weeks)||0
9075161|NCT03360903|10136340|FG001|NOT COMPLETED|Washout (2 Weeks)||0
9075162|NCT03360903|10136339|FG000|STARTED|Second Intervention||4
9075163|NCT03360903|10136340|FG001|STARTED|Second Intervention||4
9075164|NCT03360903|10136339|FG000|COMPLETED|Second Intervention||4
9075165|NCT03360903|10136340|FG001|COMPLETED|Second Intervention||4
9075166|NCT03360903|10136339|FG000|NOT COMPLETED|Second Intervention||0
9075167|NCT03360903|10136340|FG001|NOT COMPLETED|Second Intervention||0
9075168|NCT03359174|10136346|FG000|STARTED|Overall Study||2
9075169|NCT03359174|10136346|FG000|COMPLETED|Overall Study||1
9075170|NCT03359174|10136346|FG000|NOT COMPLETED|Overall Study||1
9075171|NCT03352882|10136350|FG000|STARTED|Overall Study||1
9075172|NCT03352882|10136350|FG000|COMPLETED|Overall Study||1
9075173|NCT03352882|10136350|FG000|NOT COMPLETED|Overall Study||0
9075174|NCT03348904|10136357|FG000|STARTED|Overall Study||0
9075175|NCT03348904|10136358|FG001|STARTED|Overall Study||2
9075176|NCT03348904|10136359|FG002|STARTED|Overall Study||0
9075177|NCT03348904|10136357|FG000|COMPLETED|Overall Study||0
9075178|NCT03348904|10136358|FG001|COMPLETED|Overall Study||1
9075179|NCT03348904|10136359|FG002|COMPLETED|Overall Study||0
9075180|NCT03348904|10136357|FG000|NOT COMPLETED|Overall Study||0
9075181|NCT03348904|10136358|FG001|NOT COMPLETED|Overall Study||1
9075182|NCT03348904|10136359|FG002|NOT COMPLETED|Overall Study||0
9075183|NCT03345901|10136367|FG000|STARTED|Overall Study||18
9075184|NCT03345901|10136367|FG000|COMPLETED|Overall Study||0
9075185|NCT03345901|10136367|FG000|NOT COMPLETED|Overall Study||18
9075186|NCT03344562|10136374|FG000|STARTED|Overall Study||10
9075187|NCT03344562|10136375|FG001|STARTED|Overall Study||9
9075188|NCT03344562|10136374|FG000|COMPLETED|Overall Study||8
9075189|NCT03344562|10136375|FG001|COMPLETED|Overall Study||9
9075190|NCT03344562|10136374|FG000|NOT COMPLETED|Overall Study||2
9075191|NCT03344562|10136375|FG001|NOT COMPLETED|Overall Study||0
9075192|NCT03342638|10136383|FG000|STARTED|Overall Study||34
9075193|NCT03342638|10136384|FG001|STARTED|Overall Study||32
9075194|NCT03342638|10136383|FG000|COMPLETED|Overall Study||33
9075195|NCT03342638|10136384|FG001|COMPLETED|Overall Study||31
9075196|NCT03342638|10136383|FG000|NOT COMPLETED|Overall Study||1
9075197|NCT03342638|10136384|FG001|NOT COMPLETED|Overall Study||1
9075198|NCT03342157|10136392|FG000|STARTED|Overall Study||1
9075199|NCT03342157|10136393|FG001|STARTED|Overall Study||1
9075200|NCT03342157|10136392|FG000|COMPLETED|Overall Study||1
9075201|NCT03342157|10136393|FG001|COMPLETED|Overall Study||1
9075202|NCT03342157|10136392|FG000|NOT COMPLETED|Overall Study||0
9075203|NCT03342157|10136393|FG001|NOT COMPLETED|Overall Study||0
9075204|NCT03339401|10136401|FG000|STARTED|Overall Study||20
9075205|NCT03339401|10136402|FG001|STARTED|Overall Study||9
9075206|NCT03339401|10136401|FG000|COMPLETED|Overall Study||11
9075207|NCT03339401|10136402|FG001|COMPLETED|Overall Study||5
9075208|NCT03339401|10136401|FG000|NOT COMPLETED|Overall Study||9
9075209|NCT03339401|10136402|FG001|NOT COMPLETED|Overall Study||4
9075210|NCT03339245|10136410|FG000|STARTED|Overall Study||6
9075211|NCT03339245|10136411|FG001|STARTED|Overall Study||7
9075212|NCT03339245|10136410|FG000|COMPLETED|Overall Study|"1 withdrawn due to elevated glucose during pre-intervention testing~1 withdrawn for personal reason"|4
9075213|NCT03339245|10136411|FG001|COMPLETED|Overall Study|1 withdrawn due to elevated glucose on baseline testing|6
9075214|NCT03339245|10136410|FG000|NOT COMPLETED|Overall Study||2
9075215|NCT03339245|10136411|FG001|NOT COMPLETED|Overall Study||1
9075216|NCT03333746|10136417|FG000|STARTED|Overall Study||1
9075217|NCT03333746|10136417|FG000|COMPLETED|Overall Study||0
9075218|NCT03333746|10136417|FG000|NOT COMPLETED|Overall Study||1
9075219|NCT03329404|10136423|FG000|STARTED|Overall Study||4
9075220|NCT03329404|10136424|FG001|STARTED|Overall Study||5
9075221|NCT03329404|10136423|FG000|COMPLETED|Overall Study||3
9075222|NCT03329404|10136424|FG001|COMPLETED|Overall Study||1
9075223|NCT03329404|10136423|FG000|NOT COMPLETED|Overall Study||1
9075224|NCT03329404|10136424|FG001|NOT COMPLETED|Overall Study||4
9075225|NCT03326869|10136432|FG000|STARTED|Overall Study||1
9075226|NCT03326869|10136433|FG001|STARTED|Overall Study||1
9075227|NCT03326869|10136432|FG000|COMPLETED|Overall Study||0
9075228|NCT03326869|10136433|FG001|COMPLETED|Overall Study||0
9075229|NCT03326869|10136432|FG000|NOT COMPLETED|Overall Study||1
9075230|NCT03326869|10136433|FG001|NOT COMPLETED|Overall Study||1
9075231|NCT03325114|10136439|FG000|STARTED|Overall Study||1
9075232|NCT03325114|10136439|FG000|COMPLETED|Overall Study||0
9075233|NCT03325114|10136439|FG000|NOT COMPLETED|Overall Study||1
9075234|NCT03319407|10136443|FG000|STARTED|Overall Study||21
9075235|NCT03319407|10136443|FG000|COMPLETED|Overall Study||0
9075236|NCT03319407|10136443|FG000|NOT COMPLETED|Overall Study||21
9075237|NCT03316105|10136449|FG000|STARTED|Overall Study||9
9075238|NCT03316105|10136450|FG001|STARTED|Overall Study||7
9075239|NCT03316105|10136449|FG000|COMPLETED|Overall Study||9
9075240|NCT03316105|10136450|FG001|COMPLETED|Overall Study||7
9075241|NCT03316105|10136449|FG000|NOT COMPLETED|Overall Study||0
9075242|NCT03316105|10136450|FG001|NOT COMPLETED|Overall Study||0
9075243|NCT03305055|10136458|FG000|STARTED|Overall Study||2
9075244|NCT03305055|10136459|FG001|STARTED|Overall Study||2
9075245|NCT03305055|10136458|FG000|COMPLETED|Overall Study||1
9075246|NCT03305055|10136459|FG001|COMPLETED|Overall Study||0
9075247|NCT03305055|10136458|FG000|NOT COMPLETED|Overall Study||1
9075248|NCT03305055|10136459|FG001|NOT COMPLETED|Overall Study||2
9075249|NCT03303469|10136465|FG000|STARTED|Overall Study||3
9075250|NCT03303469|10136465|FG000|COMPLETED|Overall Study||1
9075251|NCT03303469|10136465|FG000|NOT COMPLETED|Overall Study||2
9075252|NCT03302247|10136469|FG000|STARTED|Overall Study||3
9075253|NCT03302247|10136469|FG000|COMPLETED|Overall Study||0
9075254|NCT03302247|10136469|FG000|NOT COMPLETED|Overall Study||3
9075255|NCT03300024|10136475|FG000|STARTED|Overall Study||4
9075256|NCT03300024|10136476|FG001|STARTED|Overall Study||6
9075257|NCT03300024|10136475|FG000|COMPLETED|Overall Study||0
9075258|NCT03300024|10136476|FG001|COMPLETED|Overall Study||0
9075259|NCT03300024|10136475|FG000|NOT COMPLETED|Overall Study||4
9075260|NCT03300024|10136476|FG001|NOT COMPLETED|Overall Study||6
9075261|NCT03283709|10136486|FG000|STARTED|Overall Study||0
9075262|NCT03283709|10136487|FG001|STARTED|Overall Study||1
9075263|NCT03283709|10136486|FG000|COMPLETED|Overall Study||0
9075264|NCT03283709|10136487|FG001|COMPLETED|Overall Study||0
9075265|NCT03283709|10136486|FG000|NOT COMPLETED|Overall Study||0
9075266|NCT03283709|10136487|FG001|NOT COMPLETED|Overall Study||1
9075267|NCT03277183|10136495|FG000|STARTED|Overall Study||3
9075268|NCT03277183|10136496|FG001|STARTED|Overall Study||2
9075269|NCT03277183|10136495|FG000|COMPLETED|Overall Study||0
9075270|NCT03277183|10136496|FG001|COMPLETED|Overall Study||0
9075271|NCT03277183|10136495|FG000|NOT COMPLETED|Overall Study||3
9075272|NCT03277183|10136496|FG001|NOT COMPLETED|Overall Study||2
9075273|NCT03269968|10136504|FG000|STARTED|Overall Study||0
9075274|NCT03269968|10136505|FG001|STARTED|Overall Study||0
9075275|NCT03269968|10136504|FG000|COMPLETED|Overall Study||0
9075276|NCT03269968|10136505|FG001|COMPLETED|Overall Study||0
9075277|NCT03269968|10136504|FG000|NOT COMPLETED|Overall Study||0
9075278|NCT03269968|10136505|FG001|NOT COMPLETED|Overall Study||0
9075279|NCT03248141|10136513|FG000|STARTED|Overall Study||11
9075280|NCT03248141|10136514|FG001|STARTED|Overall Study|No enrollment occurred in this arm prior to study termination.|0
9075281|NCT03248141|10136513|FG000|COMPLETED|Overall Study|Participants who were present in the study till termination were considered as completed.|11
9075282|NCT03248141|10136514|FG001|COMPLETED|Overall Study||0
9075283|NCT03248141|10136513|FG000|NOT COMPLETED|Overall Study||0
9075284|NCT03248141|10136514|FG001|NOT COMPLETED|Overall Study||0
9075285|NCT03263806|10136522|FG000|STARTED|Overall Study||6
9075286|NCT03263806|10136523|FG001|STARTED|Overall Study||7
9075287|NCT03263806|10136522|FG000|COMPLETED|Overall Study|Study Terminated due to lack of enrollment|0
9075288|NCT03263806|10136523|FG001|COMPLETED|Overall Study|Study Terminated due to lack of enrollment|0
9075289|NCT03263806|10136522|FG000|NOT COMPLETED|Overall Study||6
9075290|NCT03263806|10136523|FG001|NOT COMPLETED|Overall Study||7
9075291|NCT03261531|10136529|FG000|STARTED|Overall Study||7
9075292|NCT03261531|10136529|FG000|COMPLETED|Overall Study||3
9075293|NCT03261531|10136529|FG000|NOT COMPLETED|Overall Study||4
9075294|NCT03251326|10136533|FG000|STARTED|Overall Study||0
9075295|NCT03251326|10136534|FG001|STARTED|Overall Study||0
9075296|NCT03251326|10136535|FG002|STARTED|Overall Study||0
9075297|NCT03251326|10136536|FG003|STARTED|Overall Study||0
9075298|NCT03251326|10136533|FG000|COMPLETED|Overall Study||0
9075299|NCT03251326|10136534|FG001|COMPLETED|Overall Study||0
9075300|NCT03251326|10136535|FG002|COMPLETED|Overall Study||0
9075301|NCT03251326|10136536|FG003|COMPLETED|Overall Study||0
9075302|NCT03251326|10136533|FG000|NOT COMPLETED|Overall Study||0
9075303|NCT03251326|10136534|FG001|NOT COMPLETED|Overall Study||0
9075304|NCT03251326|10136535|FG002|NOT COMPLETED|Overall Study||0
9075305|NCT03251326|10136536|FG003|NOT COMPLETED|Overall Study||0
9075306|NCT03219372|10136548|FG000|STARTED|Overall Study||1
9075307|NCT03219372|10136549|FG001|STARTED|Overall Study||0
9075308|NCT03219372|10136548|FG000|COMPLETED|Overall Study||0
9075309|NCT03219372|10136549|FG001|COMPLETED|Overall Study||0
9075310|NCT03219372|10136548|FG000|NOT COMPLETED|Overall Study||1
9075311|NCT03219372|10136549|FG001|NOT COMPLETED|Overall Study||0
9075312|NCT03217175|10136555|FG000|STARTED|Overall Study||4
9075313|NCT03217175|10136556|FG001|STARTED|Overall Study||1
9075314|NCT03217175|10136555|FG000|COMPLETED|Overall Study||0
9075315|NCT03217175|10136556|FG001|COMPLETED|Overall Study||0
9075316|NCT03217175|10136555|FG000|NOT COMPLETED|Overall Study||4
9075317|NCT03217175|10136556|FG001|NOT COMPLETED|Overall Study||1
9075318|NCT03231397|10136566|FG000|STARTED|Overall Study||0
9075319|NCT03231397|10136567|FG001|STARTED|Overall Study||1
9075320|NCT03231397|10136568|FG002|STARTED|Overall Study||1
9075321|NCT03231397|10136569|FG003|STARTED|Overall Study||0
9075322|NCT03231397|10136566|FG000|COMPLETED|Overall Study||0
9075323|NCT03231397|10136567|FG001|COMPLETED|Overall Study||1
9075324|NCT03231397|10136568|FG002|COMPLETED|Overall Study||1
9075325|NCT03231397|10136569|FG003|COMPLETED|Overall Study||0
9075326|NCT03231397|10136566|FG000|NOT COMPLETED|Overall Study||0
9075327|NCT03231397|10136567|FG001|NOT COMPLETED|Overall Study||0
9075328|NCT03231397|10136568|FG002|NOT COMPLETED|Overall Study||0
9075329|NCT03231397|10136569|FG003|NOT COMPLETED|Overall Study||0
9075330|NCT03232892|10136579|FG000|STARTED|Overall Study||1
9075331|NCT03232892|10136579|FG000|COMPLETED|Overall Study||1
9075332|NCT03232892|10136579|FG000|NOT COMPLETED|Overall Study||0
9075333|NCT03223662|10136583|FG000|STARTED|Overall Study||2
9075334|NCT03223662|10136583|FG000|COMPLETED|Overall Study||0
9075335|NCT03223662|10136583|FG000|NOT COMPLETED|Overall Study||2
9075336|NCT03212144|10136589|FG000|STARTED|First Sequence (4 Weeks)||2
9075337|NCT03212144|10136590|FG001|STARTED|First Sequence (4 Weeks)||1
9075338|NCT03212144|10136589|FG000|COMPLETED|First Sequence (4 Weeks)||1
9075339|NCT03212144|10136590|FG001|COMPLETED|First Sequence (4 Weeks)||1
9075340|NCT03212144|10136589|FG000|NOT COMPLETED|First Sequence (4 Weeks)||1
9075341|NCT03212144|10136590|FG001|NOT COMPLETED|First Sequence (4 Weeks)||0
9075342|NCT03212144|10136589|FG000|STARTED|Washout (4 Weeks)||1
9075343|NCT03212144|10136590|FG001|STARTED|Washout (4 Weeks)||1
9075344|NCT03212144|10136589|FG000|COMPLETED|Washout (4 Weeks)||1
9075345|NCT03212144|10136590|FG001|COMPLETED|Washout (4 Weeks)||1
9075346|NCT03212144|10136589|FG000|NOT COMPLETED|Washout (4 Weeks)||0
9075347|NCT03212144|10136590|FG001|NOT COMPLETED|Washout (4 Weeks)||0
9075348|NCT03212144|10136589|FG000|STARTED|Second Sequence (4 Weeks)||1
9075349|NCT03212144|10136590|FG001|STARTED|Second Sequence (4 Weeks)||1
9075350|NCT03212144|10136589|FG000|COMPLETED|Second Sequence (4 Weeks)||0
9075351|NCT03212144|10136590|FG001|COMPLETED|Second Sequence (4 Weeks)||0
9075352|NCT03212144|10136589|FG000|NOT COMPLETED|Second Sequence (4 Weeks)||1
9075353|NCT03212144|10136590|FG001|NOT COMPLETED|Second Sequence (4 Weeks)||1
9075354|NCT03218163|10136596|FG000|STARTED|Overall Study||0
9075355|NCT03218163|10136596|FG000|COMPLETED|Overall Study||0
9075356|NCT03218163|10136596|FG000|NOT COMPLETED|Overall Study||0
9075357|NCT03172520|10136600|FG000|STARTED|Overall Study||10
9075358|NCT03172520|10136600|FG000|COMPLETED|Overall Study||0
9075359|NCT03172520|10136600|FG000|NOT COMPLETED|Overall Study||10
9075360|NCT03204539|10136606|FG000|STARTED|Overall Study||0
9075361|NCT03204539|10136607|FG001|STARTED|Overall Study||1
9075362|NCT03204539|10136606|FG000|COMPLETED|Overall Study||0
9075363|NCT03204539|10136607|FG001|COMPLETED|Overall Study||0
9075364|NCT03204539|10136606|FG000|NOT COMPLETED|Overall Study||0
9075365|NCT03204539|10136607|FG001|NOT COMPLETED|Overall Study||1
9075366|NCT03206216|10136615|FG000|STARTED|Overall Study||0
9075367|NCT03206216|10136616|FG001|STARTED|Overall Study||1
9075368|NCT03206216|10136615|FG000|COMPLETED|Overall Study||0
9075369|NCT03206216|10136616|FG001|COMPLETED|Overall Study||0
9075370|NCT03206216|10136615|FG000|NOT COMPLETED|Overall Study||0
9075371|NCT03206216|10136616|FG001|NOT COMPLETED|Overall Study||1
9075372|NCT03195660|10136622|FG000|STARTED|Overall Study||2
9075373|NCT03195660|10136622|FG000|COMPLETED|Overall Study||0
9075374|NCT03195660|10136622|FG000|NOT COMPLETED|Overall Study||2
9075375|NCT03195465|10136626|FG000|STARTED|Overall Study||0
9075376|NCT03195465|10136626|FG000|COMPLETED|Overall Study||0
9075377|NCT03195465|10136626|FG000|NOT COMPLETED|Overall Study||0
9075378|NCT03166618|10136632|FG000|STARTED|Overall Study||0
9075379|NCT03166618|10136633|FG001|STARTED|Overall Study||1
9075380|NCT03166618|10136632|FG000|COMPLETED|Overall Study||0
9075381|NCT03166618|10136633|FG001|COMPLETED|Overall Study||0
9075382|NCT03166618|10136632|FG000|NOT COMPLETED|Overall Study||0
9075383|NCT03166618|10136633|FG001|NOT COMPLETED|Overall Study||1
9075384|NCT03169530|10136641|FG000|STARTED|Overall Study||15
9075385|NCT03169530|10136642|FG001|STARTED|Overall Study||17
9075386|NCT03169530|10136641|FG000|COMPLETED|Overall Study||0
9075387|NCT03169530|10136642|FG001|COMPLETED|Overall Study||0
9075388|NCT03169530|10136641|FG000|NOT COMPLETED|Overall Study||15
9075389|NCT03169530|10136642|FG001|NOT COMPLETED|Overall Study||17
9075390|NCT03189433|10136650|FG000|STARTED|Overall Study||2
9075391|NCT03189433|10136651|FG001|STARTED|Overall Study||0
9075392|NCT03189433|10136650|FG000|COMPLETED|Overall Study||0
9075393|NCT03189433|10136651|FG001|COMPLETED|Overall Study||0
9075394|NCT03189433|10136650|FG000|NOT COMPLETED|Overall Study||2
9075395|NCT03189433|10136651|FG001|NOT COMPLETED|Overall Study||0
9075396|NCT03151226|10136657|FG000|STARTED|Overall Study||3
9075397|NCT03151226|10136657|FG000|COMPLETED|Overall Study||0
9075398|NCT03151226|10136657|FG000|NOT COMPLETED|Overall Study||3
9075399|NCT03165747|10136663|FG000|STARTED|Overall Study||0
9075400|NCT03165747|10136664|FG001|STARTED|Overall Study||0
9075401|NCT03165747|10136663|FG000|COMPLETED|Overall Study||0
9075402|NCT03165747|10136664|FG001|COMPLETED|Overall Study||0
9075403|NCT03165747|10136663|FG000|NOT COMPLETED|Overall Study||0
9075404|NCT03165747|10136664|FG001|NOT COMPLETED|Overall Study||0
9075405|NCT03168906|10136672|FG000|STARTED|Overall Study||6
9075406|NCT03168906|10136673|FG001|STARTED|Overall Study||6
9075407|NCT03168906|10136672|FG000|COMPLETED|Overall Study|Study discontinued due to futile nature of drug|0
9075408|NCT03168906|10136673|FG001|COMPLETED|Overall Study|Study discontinued due to futile nature of drug|0
9075409|NCT03168906|10136672|FG000|NOT COMPLETED|Overall Study||6
9075410|NCT03168906|10136673|FG001|NOT COMPLETED|Overall Study||6
9075411|NCT03178201|10136680|FG000|STARTED|Overall Study||5
9075412|NCT03178201|10136680|FG000|COMPLETED|Overall Study||0
9075413|NCT03178201|10136680|FG000|NOT COMPLETED|Overall Study||5
9075414|NCT03172026|10136686|FG000|STARTED|Overall Study||2
9075415|NCT03172026|10136687|FG001|STARTED|Overall Study||0
9075416|NCT03172026|10136686|FG000|8 Week Assessment|Overall Study||0
9075417|NCT03172026|10136687|FG001|8 Week Assessment|Overall Study||0
9075418|NCT03172026|10136686|FG000|6 Month Assessment|Overall Study||0
9075419|NCT03172026|10136687|FG001|6 Month Assessment|Overall Study||0
9075420|NCT03172026|10136686|FG000|COMPLETED|Overall Study||0
9075421|NCT03172026|10136687|FG001|COMPLETED|Overall Study||0
9075422|NCT03172026|10136686|FG000|NOT COMPLETED|Overall Study||2
9075423|NCT03172026|10136687|FG001|NOT COMPLETED|Overall Study||0
9075424|NCT03152526|10136696|FG000|STARTED|Overall Study|No participants were enrolled on this arm.|0
9075425|NCT03152526|10136697|FG001|STARTED|Overall Study|One participant was enrolled on this arm.|1
9075426|NCT03152526|10136696|FG000|COMPLETED|Overall Study|No participants were enrolled on this arm.|0
9075427|NCT03152526|10136697|FG001|COMPLETED|Overall Study|The one participant enrolled on this arm withdrew from the study early.|0
9075428|NCT03152526|10136696|FG000|NOT COMPLETED|Overall Study||0
9075429|NCT03152526|10136697|FG001|NOT COMPLETED|Overall Study||1
9075430|NCT03161964|10136705|FG000|STARTED|Overall Study||1
9075431|NCT03161964|10136706|FG001|STARTED|Overall Study||1
9075432|NCT03161964|10136705|FG000|COMPLETED|Overall Study||1
9075433|NCT03161964|10136706|FG001|COMPLETED|Overall Study||0
9075434|NCT03161964|10136705|FG000|NOT COMPLETED|Overall Study||0
9075435|NCT03161964|10136706|FG001|NOT COMPLETED|Overall Study||1
9075436|NCT03150160|10136714|FG000|STARTED|Overall Study||0
9075437|NCT03150160|10136715|FG001|STARTED|Overall Study||1
9075438|NCT03150160|10136714|FG000|COMPLETED|Overall Study||0
9075439|NCT03150160|10136715|FG001|COMPLETED|Overall Study||1
9075440|NCT03150160|10136714|FG000|NOT COMPLETED|Overall Study||0
9075441|NCT03150160|10136715|FG001|NOT COMPLETED|Overall Study||0
9075442|NCT03137225|10136723|FG000|STARTED|First 4 Hour Measurement Period||1
9075443|NCT03137225|10136724|FG001|STARTED|First 4 Hour Measurement Period||0
9075444|NCT03137225|10136723|FG000|COMPLETED|First 4 Hour Measurement Period||1
9075445|NCT03137225|10136724|FG001|COMPLETED|First 4 Hour Measurement Period||0
9075446|NCT03137225|10136723|FG000|NOT COMPLETED|First 4 Hour Measurement Period||0
9075447|NCT03137225|10136724|FG001|NOT COMPLETED|First 4 Hour Measurement Period||0
9075448|NCT03137225|10136723|FG000|STARTED|Second 4 Hour Measurement Period||1
9075449|NCT03137225|10136724|FG001|STARTED|Second 4 Hour Measurement Period||0
9075450|NCT03137225|10136723|FG000|COMPLETED|Second 4 Hour Measurement Period||1
9075451|NCT03137225|10136724|FG001|COMPLETED|Second 4 Hour Measurement Period||0
9075452|NCT03137225|10136723|FG000|NOT COMPLETED|Second 4 Hour Measurement Period||0
9075453|NCT03137225|10136724|FG001|NOT COMPLETED|Second 4 Hour Measurement Period||0
9075454|NCT03123393|10136732|FG000|STARTED|Overall Study||24
9075455|NCT03123393|10136733|FG001|STARTED|Overall Study||25
9075456|NCT03123393|10136732|FG000|COMPLETED|Overall Study||3
9075457|NCT03123393|10136733|FG001|COMPLETED|Overall Study||2
9075458|NCT03123393|10136732|FG000|NOT COMPLETED|Overall Study||21
9075459|NCT03123393|10136733|FG001|NOT COMPLETED|Overall Study||23
9075460|NCT03123328|10136739|FG000|STARTED|Overall Study||380
9075461|NCT03123328|10136739|FG000|COMPLETED|Overall Study||351
9075462|NCT03123328|10136739|FG000|NOT COMPLETED|Overall Study||29
9075463|NCT03119662|10136745|FG000|STARTED|Overall Study||2
9075464|NCT03119662|10136746|FG001|STARTED|Overall Study||2
9075465|NCT03119662|10136745|FG000|COMPLETED|Overall Study||2
9075466|NCT03119662|10136746|FG001|COMPLETED|Overall Study||1
9075467|NCT03119662|10136745|FG000|NOT COMPLETED|Overall Study||0
9075468|NCT03119662|10136746|FG001|NOT COMPLETED|Overall Study||1
9075469|NCT03109418|10136754|FG000|STARTED|Overall Study||2
9075470|NCT03109418|10136755|FG001|STARTED|Overall Study||4
9075471|NCT03109418|10136754|FG000|COMPLETED|Overall Study||2
9075472|NCT03109418|10136755|FG001|COMPLETED|Overall Study||3
9075473|NCT03109418|10136754|FG000|NOT COMPLETED|Overall Study||0
9075474|NCT03109418|10136755|FG001|NOT COMPLETED|Overall Study||1
9075475|NCT03120676|10136761|FG000|STARTED|Overall Study||3
9075476|NCT03120676|10136761|FG000|COMPLETED|Overall Study||2
9075477|NCT03120676|10136761|FG000|NOT COMPLETED|Overall Study||1
8624152|NCT00498602|9663396|FG004|COMPLETED|Overall Study||8
8624153|NCT00498602|9663397|FG005|COMPLETED|Overall Study||31
9075478|NCT03109873|10136767|FG000|STARTED|Overall Study||5
9075479|NCT03109873|10136768|FG001|STARTED|Overall Study||4
9075480|NCT03109873|10136767|FG000|COMPLETED|Overall Study||5
8624154|NCT00498602|9663398|FG006|COMPLETED|Overall Study||15
8624155|NCT00498602|9663392|FG000|NOT COMPLETED|Overall Study||10
8624156|NCT00498602|9663393|FG001|NOT COMPLETED|Overall Study||10
8624157|NCT00498602|9663394|FG002|NOT COMPLETED|Overall Study||8
8624158|NCT00498602|9663395|FG003|NOT COMPLETED|Overall Study||5
8624159|NCT00498602|9663396|FG004|NOT COMPLETED|Overall Study||4
9075481|NCT03109873|10136768|FG001|COMPLETED|Overall Study||4
9075482|NCT03109873|10136767|FG000|NOT COMPLETED|Overall Study||0
9075483|NCT03109873|10136768|FG001|NOT COMPLETED|Overall Study||0
9075484|NCT03100617|10136774|FG000|STARTED|Overall Study||6
9075485|NCT03100617|10136774|FG000|COMPLETED|Overall Study||6
9075486|NCT03100617|10136774|FG000|NOT COMPLETED|Overall Study||0
9075487|NCT03115853|10136778|FG000|STARTED|Overall Study||31
9075488|NCT03115853|10136778|FG000|COMPLETED|Overall Study||31
9075489|NCT03115853|10136778|FG000|NOT COMPLETED|Overall Study||0
9075490|NCT03113071|10136786|FG000|STARTED|Overall Study||1
9075491|NCT03113071|10136787|FG001|STARTED|Overall Study||0
9075492|NCT03113071|10136786|FG000|COMPLETED|Overall Study||0
9075493|NCT03113071|10136787|FG001|COMPLETED|Overall Study||0
9075494|NCT03113071|10136786|FG000|NOT COMPLETED|Overall Study||1
9075495|NCT03113071|10136787|FG001|NOT COMPLETED|Overall Study||0
9075496|NCT03110900|10136795|FG000|STARTED|Overall Study||1
9075497|NCT03110900|10136796|FG001|STARTED|Overall Study||1
9075498|NCT03110900|10136795|FG000|COMPLETED|Overall Study||0
9075499|NCT03110900|10136796|FG001|COMPLETED|Overall Study||0
9075500|NCT03110900|10136795|FG000|NOT COMPLETED|Overall Study||1
9075501|NCT03110900|10136796|FG001|NOT COMPLETED|Overall Study||1
9075502|NCT03078868|10136802|FG000|STARTED|Overall Study||3
9075503|NCT03078868|10136802|FG000|COMPLETED|Overall Study||0
9075504|NCT03078868|10136802|FG000|NOT COMPLETED|Overall Study||3
9075505|NCT03078270|10136808|FG000|STARTED|Overall Study||4
9075506|NCT03078270|10136809|FG001|STARTED|Overall Study||0
9075507|NCT03078270|10136808|FG000|COMPLETED|Overall Study||0
9075508|NCT03078270|10136809|FG001|COMPLETED|Overall Study||0
9075509|NCT03078270|10136808|FG000|NOT COMPLETED|Overall Study||4
9075510|NCT03078270|10136809|FG001|NOT COMPLETED|Overall Study||0
9075511|NCT03065933|10136815|FG000|STARTED|Overall Study||5
9075512|NCT03065933|10136815|FG000|COMPLETED|Overall Study||0
9075513|NCT03065933|10136815|FG000|NOT COMPLETED|Overall Study||5
9075514|NCT03070002|10136819|FG000|STARTED|3 Cycles of Treatment||1
9075515|NCT03070002|10136819|FG000|COMPLETED|3 Cycles of Treatment||1
9075516|NCT03070002|10136819|FG000|NOT COMPLETED|3 Cycles of Treatment||0
9075517|NCT03070002|10136819|FG000|STARTED|Follow up for 2 Years||1
9075518|NCT03070002|10136819|FG000|COMPLETED|Follow up for 2 Years||0
9075519|NCT03070002|10136819|FG000|NOT COMPLETED|Follow up for 2 Years||1
9075520|NCT03058705|10136823|FG000|STARTED|Overall Study||10
9075521|NCT03058705|10136823|FG000|COMPLETED|Overall Study||6
9075522|NCT03058705|10136823|FG000|NOT COMPLETED|Overall Study||4
9075523|NCT03061279|10136829|FG000|STARTED|Overall Study||0
9075524|NCT03061279|10136830|FG001|STARTED|Overall Study||1
9075525|NCT03061279|10136829|FG000|COMPLETED|Overall Study||0
9075526|NCT03061279|10136830|FG001|COMPLETED|Overall Study||0
9075527|NCT03061279|10136829|FG000|NOT COMPLETED|Overall Study||0
9075528|NCT03061279|10136830|FG001|NOT COMPLETED|Overall Study||1
9075529|NCT03040323|10136838|FG000|STARTED|Overall Study|No information available regarding how many participants Started and Completed the study in each arm|0
9075530|NCT03040323|10136839|FG001|STARTED|Overall Study|No information available regarding how many participants Started and Completed the study in each arm|0
9075531|NCT03040323|10136838|FG000|COMPLETED|Overall Study||0
9075532|NCT03040323|10136839|FG001|COMPLETED|Overall Study||0
9075533|NCT03040323|10136838|FG000|NOT COMPLETED|Overall Study||0
9075534|NCT03040323|10136839|FG001|NOT COMPLETED|Overall Study||0
9075535|NCT03053518|10136845|FG000|STARTED|Overall Study||22
9075536|NCT03053518|10136845|FG000|COMPLETED|Overall Study||12
9075537|NCT03053518|10136845|FG000|NOT COMPLETED|Overall Study||10
9075538|NCT03050398|10136849|FG000|STARTED|Overall Study||8
9075539|NCT03050398|10136849|FG000|COMPLETED|Overall Study||0
9075540|NCT03050398|10136849|FG000|NOT COMPLETED|Overall Study||8
9075541|NCT03042780|10136853|FG000|STARTED|Overall Study||2
9075542|NCT03042780|10136853|FG000|COMPLETED|Overall Study||2
9075543|NCT03042780|10136853|FG000|NOT COMPLETED|Overall Study||0
9075544|NCT03053960|10136857|FG000|STARTED|Overall Study||8
9075545|NCT03053960|10136857|FG000|COMPLETED|Overall Study||8
9075546|NCT03053960|10136857|FG000|NOT COMPLETED|Overall Study||0
9075547|NCT03036735|10136861|FG000|STARTED|Overall Study||10
9075548|NCT03036735|10136861|FG000|COMPLETED|Overall Study||0
9075549|NCT03036735|10136861|FG000|NOT COMPLETED|Overall Study||10
9075550|NCT03029832|10136867|FG000|STARTED|Overall Study||4
9075551|NCT03029832|10136868|FG001|STARTED|Overall Study||1
9075552|NCT03029832|10136867|FG000|COMPLETED|Overall Study||0
9075553|NCT03029832|10136868|FG001|COMPLETED|Overall Study||0
9075554|NCT03029832|10136867|FG000|NOT COMPLETED|Overall Study||4
9075555|NCT03029832|10136868|FG001|NOT COMPLETED|Overall Study||1
8624160|NCT00498602|9663397|FG005|NOT COMPLETED|Overall Study||13
9075556|NCT03020446|10136874|FG000|STARTED|Overall Study||3
9075557|NCT03020446|10136874|FG000|COMPLETED|Overall Study||0
9075558|NCT03020446|10136874|FG000|NOT COMPLETED|Overall Study||3
9075559|NCT03031340|10136880|FG000|STARTED|Overall Study||2
9075560|NCT03031340|10136881|FG001|STARTED|Overall Study||1
9075561|NCT03031340|10136880|FG000|COMPLETED|Overall Study||0
9075562|NCT03031340|10136881|FG001|COMPLETED|Overall Study||0
9075563|NCT03031340|10136880|FG000|NOT COMPLETED|Overall Study||2
9075564|NCT03031340|10136881|FG001|NOT COMPLETED|Overall Study||1
9075565|NCT03017040|10136887|FG000|STARTED|Overall Study|Participants enroll one wrist into each group,thus, one participant flows into both groups.|1
9075566|NCT03017040|10136888|FG001|STARTED|Overall Study|Participants enroll one wrist into each group,thus, one participant flows into both groups.|1
9075567|NCT03017040|10136887|FG000|COMPLETED|Overall Study||0
9075568|NCT03017040|10136888|FG001|COMPLETED|Overall Study||0
9075569|NCT03017040|10136887|FG000|NOT COMPLETED|Overall Study||1
9075570|NCT03017040|10136888|FG001|NOT COMPLETED|Overall Study||1
9075571|NCT03007719|10136896|FG000|STARTED|Overall Study||0
9075572|NCT03007719|10136897|FG001|STARTED|Overall Study||4
9075573|NCT03007719|10136896|FG000|COMPLETED|Overall Study||0
9075574|NCT03007719|10136897|FG001|COMPLETED|Overall Study||4
9075575|NCT03007719|10136896|FG000|NOT COMPLETED|Overall Study||0
9075576|NCT03007719|10136897|FG001|NOT COMPLETED|Overall Study||0
9075577|NCT03010423|10136903|FG000|STARTED|Overall Study||8
9075578|NCT03010423|10136903|FG000|COMPLETED|Overall Study||0
9075579|NCT03010423|10136903|FG000|NOT COMPLETED|Overall Study||8
9075580|NCT02985801|10136909|FG000|STARTED|Overall Study||8
9075581|NCT02985801|10136910|FG001|STARTED|Overall Study||8
9075582|NCT02985801|10136909|FG000|COMPLETED|Overall Study||8
9075583|NCT02985801|10136910|FG001|COMPLETED|Overall Study||8
9075584|NCT02985801|10136909|FG000|NOT COMPLETED|Overall Study||0
9075585|NCT02985801|10136910|FG001|NOT COMPLETED|Overall Study||0
9075586|NCT02991430|10136919|FG000|STARTED|Treatment Period 1||14
9075587|NCT02991430|10136920|FG001|STARTED|Treatment Period 1||15
9075588|NCT02991430|10136921|FG002|STARTED|Treatment Period 1||16
9075589|NCT02991430|10136919|FG000|COMPLETED|Treatment Period 1||13
9075590|NCT02991430|10136920|FG001|COMPLETED|Treatment Period 1||11
9075591|NCT02991430|10136921|FG002|COMPLETED|Treatment Period 1||14
9075592|NCT02991430|10136919|FG000|NOT COMPLETED|Treatment Period 1||1
9075593|NCT02991430|10136920|FG001|NOT COMPLETED|Treatment Period 1||4
9075594|NCT02991430|10136921|FG002|NOT COMPLETED|Treatment Period 1||2
9075595|NCT02991430|10136919|FG000|STARTED|Treatment Period 2||13
9075596|NCT02991430|10136920|FG001|STARTED|Treatment Period 2||11
9075597|NCT02991430|10136921|FG002|STARTED|Treatment Period 2||14
9075598|NCT02991430|10136919|FG000|COMPLETED|Treatment Period 2||7
9075599|NCT02991430|10136920|FG001|COMPLETED|Treatment Period 2||8
9075600|NCT02991430|10136921|FG002|COMPLETED|Treatment Period 2||10
9075601|NCT02991430|10136919|FG000|NOT COMPLETED|Treatment Period 2||6
9075602|NCT02991430|10136920|FG001|NOT COMPLETED|Treatment Period 2||3
9075603|NCT02991430|10136921|FG002|NOT COMPLETED|Treatment Period 2||4
9075604|NCT02991430|10136919|FG000|STARTED|Post-treatment Observation Period||7
9075605|NCT02991430|10136920|FG001|STARTED|Post-treatment Observation Period||8
9075606|NCT02991430|10136921|FG002|STARTED|Post-treatment Observation Period||10
8624161|NCT00498602|9663398|FG006|NOT COMPLETED|Overall Study||2
8624162|NCT00498615|9663414|FG000|STARTED|Fasudil 80mg||2
9075607|NCT02991430|10136919|FG000|COMPLETED|Post-treatment Observation Period||4
9075608|NCT02991430|10136920|FG001|COMPLETED|Post-treatment Observation Period||2
9075609|NCT02991430|10136921|FG002|COMPLETED|Post-treatment Observation Period||5
9075610|NCT02991430|10136919|FG000|NOT COMPLETED|Post-treatment Observation Period||3
9075611|NCT02991430|10136920|FG001|NOT COMPLETED|Post-treatment Observation Period||6
9075612|NCT02991430|10136921|FG002|NOT COMPLETED|Post-treatment Observation Period||5
9075613|NCT02995967|10136931|FG000|STARTED|Overall Study||1
9075614|NCT02995967|10136932|FG001|STARTED|Overall Study||2
9075615|NCT02995967|10136931|FG000|COMPLETED|Overall Study||1
9075616|NCT02995967|10136932|FG001|COMPLETED|Overall Study||2
9075617|NCT02995967|10136931|FG000|NOT COMPLETED|Overall Study||0
9075618|NCT02995967|10136932|FG001|NOT COMPLETED|Overall Study||0
9075619|NCT02994251|10136939|FG000|STARTED|Overall Study||0
9075620|NCT02994251|10136939|FG000|COMPLETED|Overall Study||0
9075621|NCT02994251|10136939|FG000|NOT COMPLETED|Overall Study||0
9075622|NCT02978885|10136945|FG000|STARTED|Overall Study||0
9075623|NCT02978885|10136946|FG001|STARTED|Overall Study||1
9075624|NCT02978885|10136945|FG000|COMPLETED|Overall Study||0
9075625|NCT02978885|10136946|FG001|COMPLETED|Overall Study||1
9075626|NCT02978885|10136945|FG000|NOT COMPLETED|Overall Study||0
9075627|NCT02978885|10136946|FG001|NOT COMPLETED|Overall Study||0
9075628|NCT02978833|10136954|FG000|STARTED|Overall Study||1
9075629|NCT02978833|10136955|FG001|STARTED|Overall Study||1
8556733|NCT03790917|9588520|FG000|COMPLETED|Overall Study||200
8556734|NCT03790917|9588520|FG000|NOT COMPLETED|Overall Study||1
8556735|NCT03790306|9588525|FG000|STARTED|Overall Study||207
8556736|NCT03790306|9588525|FG000|COMPLETED|Overall Study||207
8556737|NCT03790306|9588525|FG000|NOT COMPLETED|Overall Study||0
8568729|NCT00093015|9600927|FG001|COMPLETED|Overall Study||1348
8568730|NCT00093015|9600926|FG000|NOT COMPLETED|Overall Study||665
8568731|NCT00093015|9600927|FG001|NOT COMPLETED|Overall Study||664
8568732|NCT00093041|9600939|FG000|STARTED|Overall Study||4
8568733|NCT00093041|9600940|FG001|STARTED|Overall Study||4
8568734|NCT00093041|9600941|FG002|STARTED|Overall Study||5
9075630|NCT02978833|10136954|FG000|COMPLETED|Overall Study||0
9075631|NCT02978833|10136955|FG001|COMPLETED|Overall Study||0
9075632|NCT02978833|10136954|FG000|NOT COMPLETED|Overall Study||1
9075633|NCT02978833|10136955|FG001|NOT COMPLETED|Overall Study||1
8568735|NCT00093041|9600942|FG003|STARTED|Overall Study||4
8568736|NCT00093041|9600943|FG004|STARTED|Overall Study||4
9075634|NCT02971839|10136967|FG000|STARTED|Overall Study||2
9075635|NCT02971839|10136968|FG001|STARTED|Overall Study||2
9075636|NCT02971839|10136969|FG002|STARTED|Overall Study||2
9075637|NCT02971839|10136970|FG003|STARTED|Overall Study||2
9075638|NCT02971839|10136971|FG004|STARTED|Overall Study||3
9075639|NCT02971839|10136967|FG000|COMPLETED|Overall Study||2
9075640|NCT02971839|10136968|FG001|COMPLETED|Overall Study||2
9075641|NCT02971839|10136969|FG002|COMPLETED|Overall Study||2
9075642|NCT02971839|10136970|FG003|COMPLETED|Overall Study||2
9075643|NCT02971839|10136971|FG004|COMPLETED|Overall Study||3
9075644|NCT02971839|10136967|FG000|NOT COMPLETED|Overall Study||0
9075645|NCT02971839|10136968|FG001|NOT COMPLETED|Overall Study||0
9075646|NCT02971839|10136969|FG002|NOT COMPLETED|Overall Study||0
9075647|NCT02971839|10136970|FG003|NOT COMPLETED|Overall Study||0
9075648|NCT02971839|10136971|FG004|NOT COMPLETED|Overall Study||0
9075649|NCT02985840|10136985|FG000|STARTED|Overall Study||64
9075650|NCT02985840|10136986|FG001|STARTED|Overall Study||63
9075651|NCT02985840|10136985|FG000|COMPLETED|Overall Study||64
9075652|NCT02985840|10136986|FG001|COMPLETED|Overall Study||63
9075653|NCT02985840|10136985|FG000|NOT COMPLETED|Overall Study||0
9075654|NCT02985840|10136986|FG001|NOT COMPLETED|Overall Study||0
9075655|NCT02966223|10136992|FG000|STARTED|Overall Study||20
9075656|NCT02966223|10136992|FG000|COMPLETED|Overall Study||5
9075657|NCT02966223|10136992|FG000|NOT COMPLETED|Overall Study||15
9075658|NCT02965846|10136999|FG000|STARTED|Overall Study||5
9075659|NCT02965846|10137000|FG001|STARTED|Overall Study||5
9075660|NCT02965846|10137001|FG002|STARTED|Overall Study||33
9075661|NCT02965846|10136999|FG000|COMPLETED|Overall Study||0
9075662|NCT02965846|10137000|FG001|COMPLETED|Overall Study||0
9075663|NCT02965846|10137001|FG002|COMPLETED|Overall Study||0
9075664|NCT02965846|10136999|FG000|NOT COMPLETED|Overall Study||5
9075665|NCT02965846|10137000|FG001|NOT COMPLETED|Overall Study||5
9075666|NCT02965846|10137001|FG002|NOT COMPLETED|Overall Study||33
9075667|NCT02974803|10137007|FG000|STARTED|Overall Study||6
9075668|NCT02974803|10137007|FG000|COMPLETED|Overall Study||6
9075669|NCT02974803|10137007|FG000|NOT COMPLETED|Overall Study||0
9075670|NCT02974686|10137013|FG000|STARTED|Overall Study||0
9075671|NCT02974686|10137014|FG001|STARTED|Overall Study||0
9075672|NCT02974686|10137013|FG000|COMPLETED|Overall Study||0
9075673|NCT02974686|10137014|FG001|COMPLETED|Overall Study||0
9075674|NCT02974686|10137013|FG000|NOT COMPLETED|Overall Study||0
9075675|NCT02974686|10137014|FG001|NOT COMPLETED|Overall Study||0
9075676|NCT02956005|10137022|FG000|STARTED|Overall Study||18
9075677|NCT02956005|10137022|FG000|COMPLETED|Overall Study||2
9075678|NCT02956005|10137022|FG000|NOT COMPLETED|Overall Study||16
9075679|NCT02966184|10137028|FG000|STARTED|Overall Study||0
9075680|NCT02966184|10137029|FG001|STARTED|Overall Study||8
9075681|NCT02966184|10137028|FG000|COMPLETED|Overall Study||0
9075682|NCT02966184|10137029|FG001|COMPLETED|Overall Study||0
9075683|NCT02966184|10137028|FG000|NOT COMPLETED|Overall Study||0
9075684|NCT02966184|10137029|FG001|NOT COMPLETED|Overall Study||8
9075685|NCT02940223|10137037|FG000|STARTED|Overall Study||2
9075686|NCT02940223|10137038|FG001|STARTED|Overall Study||0
9075687|NCT02940223|10137037|FG000|COMPLETED|Overall Study||0
9075688|NCT02940223|10137038|FG001|COMPLETED|Overall Study||0
9075689|NCT02940223|10137037|FG000|NOT COMPLETED|Overall Study||2
9075690|NCT02940223|10137038|FG001|NOT COMPLETED|Overall Study||0
9075691|NCT02954159|10137046|FG000|STARTED|Overall Study||2
9075692|NCT02954159|10137047|FG001|STARTED|Overall Study||2
9075693|NCT02954159|10137046|FG000|COMPLETED|Overall Study||1
9075694|NCT02954159|10137047|FG001|COMPLETED|Overall Study||1
9075695|NCT02954159|10137046|FG000|NOT COMPLETED|Overall Study||1
9075696|NCT02954159|10137047|FG001|NOT COMPLETED|Overall Study||1
9075697|NCT02954952|10137056|FG000|STARTED|Overall Study||36
9075698|NCT02954952|10137057|FG001|STARTED|Overall Study||5
9075699|NCT02954952|10137058|FG002|STARTED|Overall Study||3
9075700|NCT02954952|10137056|FG000|COMPLETED|Overall Study||35
9075701|NCT02954952|10137057|FG001|COMPLETED|Overall Study||4
9075702|NCT02954952|10137058|FG002|COMPLETED|Overall Study||3
9075703|NCT02954952|10137056|FG000|NOT COMPLETED|Overall Study||1
9075704|NCT02954952|10137057|FG001|NOT COMPLETED|Overall Study||1
9075705|NCT02954952|10137058|FG002|NOT COMPLETED|Overall Study||0
9075706|NCT02950896|10137066|FG000|STARTED|Overall Study||4
9075707|NCT02950896|10137066|FG000|COMPLETED|Overall Study||4
9075708|NCT02950896|10137066|FG000|NOT COMPLETED|Overall Study||0
9075709|NCT02947022|10137070|FG000|STARTED|Overall Study||1
9075710|NCT02947022|10137070|FG000|COMPLETED|Overall Study||0
9075711|NCT02947022|10137070|FG000|NOT COMPLETED|Overall Study||1
9075712|NCT02936999|10137077|FG000|STARTED|Overall Study||8
9075713|NCT02936999|10137077|FG000|COMPLETED|Overall Study||8
9075714|NCT02936999|10137077|FG000|NOT COMPLETED|Overall Study||0
9075715|NCT02950480|10137085|FG000|STARTED|Overall Study||2
9075716|NCT02950480|10137086|FG001|STARTED|Overall Study||2
9075717|NCT02950480|10137085|FG000|COMPLETED|Overall Study||1
9075718|NCT02950480|10137086|FG001|COMPLETED|Overall Study||2
9075719|NCT02950480|10137085|FG000|NOT COMPLETED|Overall Study||1
9075720|NCT02950480|10137086|FG001|NOT COMPLETED|Overall Study||0
9075721|NCT02949947|10137094|FG000|STARTED|Overall Study||1
9075722|NCT02949947|10137095|FG001|STARTED|Overall Study||2
9075723|NCT02949947|10137094|FG000|COMPLETED|Overall Study||0
9075724|NCT02949947|10137095|FG001|COMPLETED|Overall Study||1
9075725|NCT02949947|10137094|FG000|NOT COMPLETED|Overall Study||1
9075726|NCT02949947|10137095|FG001|NOT COMPLETED|Overall Study||1
9075727|NCT02947100|10137101|FG000|STARTED|Overall Study||4
9075728|NCT02947100|10137101|FG000|COMPLETED|Overall Study||0
9075729|NCT02947100|10137101|FG000|NOT COMPLETED|Overall Study||4
9075730|NCT02936206|10137107|FG000|STARTED|Overall Study||0
9075731|NCT02936206|10137108|FG001|STARTED|Overall Study||2
9075732|NCT02936206|10137107|FG000|COMPLETED|Overall Study||0
9075733|NCT02936206|10137108|FG001|COMPLETED|Overall Study||2
9075734|NCT02936206|10137107|FG000|NOT COMPLETED|Overall Study||0
9075735|NCT02936206|10137108|FG001|NOT COMPLETED|Overall Study||0
9075736|NCT02934932|10137114|FG000|STARTED|Overall Study||9
9075737|NCT02934932|10137114|FG000|COMPLETED|Overall Study||6
9075738|NCT02934932|10137114|FG000|NOT COMPLETED|Overall Study||3
9075739|NCT02908516|10137122|FG000|STARTED|Overall Study||3
9075740|NCT02908516|10137123|FG001|STARTED|Overall Study||3
9075741|NCT02908516|10137122|FG000|COMPLETED|Overall Study||0
9075742|NCT02908516|10137123|FG001|COMPLETED|Overall Study||0
9075743|NCT02908516|10137122|FG000|NOT COMPLETED|Overall Study||3
9075744|NCT02908516|10137123|FG001|NOT COMPLETED|Overall Study||3
9075745|NCT02923830|10137131|FG000|STARTED|Overall Study||13
9075746|NCT02923830|10137132|FG001|STARTED|Overall Study||15
9075747|NCT02923830|10137131|FG000|COMPLETED|Overall Study|Study terminated|0
9075748|NCT02923830|10137132|FG001|COMPLETED|Overall Study|Study terminated|0
9075749|NCT02923830|10137131|FG000|NOT COMPLETED|Overall Study||13
9075750|NCT02923830|10137132|FG001|NOT COMPLETED|Overall Study||15
9075751|NCT02920450|10137138|FG000|STARTED|Overall Study||3
9075752|NCT02920450|10137139|FG001|STARTED|Overall Study||0
9075753|NCT02920450|10137140|FG002|STARTED|Overall Study||0
9075754|NCT02920450|10137141|FG003|STARTED|Overall Study||0
9075755|NCT02920450|10137138|FG000|COMPLETED|Overall Study||1
9075756|NCT02920450|10137139|FG001|COMPLETED|Overall Study||0
9075757|NCT02920450|10137140|FG002|COMPLETED|Overall Study||0
9075758|NCT02920450|10137141|FG003|COMPLETED|Overall Study||0
9075759|NCT02920450|10137138|FG000|NOT COMPLETED|Overall Study||2
9075760|NCT02920450|10137139|FG001|NOT COMPLETED|Overall Study||0
9075761|NCT02920450|10137140|FG002|NOT COMPLETED|Overall Study||0
9075762|NCT02920450|10137141|FG003|NOT COMPLETED|Overall Study||0
9075763|NCT02920177|10137150|FG000|STARTED|Overall Study||2
9075764|NCT02920177|10137151|FG001|STARTED|Overall Study||2
9075765|NCT02920177|10137150|FG000|COMPLETED|Overall Study||0
9075766|NCT02920177|10137151|FG001|COMPLETED|Overall Study||0
9075767|NCT02920177|10137150|FG000|NOT COMPLETED|Overall Study||2
9075768|NCT02920177|10137151|FG001|NOT COMPLETED|Overall Study||2
9075769|NCT02926638|10137159|FG000|STARTED|Overall Study||4
9075770|NCT02926638|10137160|FG001|STARTED|Overall Study||5
9075771|NCT02926638|10137159|FG000|Eligible|Overall Study||3
9075772|NCT02926638|10137160|FG001|Eligible|Overall Study||5
9075773|NCT02926638|10137159|FG000|COMPLETED|Overall Study||0
9075774|NCT02926638|10137160|FG001|COMPLETED|Overall Study||0
9075775|NCT02926638|10137159|FG000|NOT COMPLETED|Overall Study||4
9075776|NCT02926638|10137160|FG001|NOT COMPLETED|Overall Study||5
9075777|NCT02920242|10137169|FG000|STARTED|Overall Study||13
9075778|NCT02920242|10137170|FG001|STARTED|Overall Study||11
9075779|NCT02920242|10137171|FG002|STARTED|Overall Study||4
9075780|NCT02920242|10137169|FG000|Safety Set|Overall Study||12
9075781|NCT02920242|10137170|FG001|Safety Set|Overall Study||11
9075782|NCT02920242|10137171|FG002|Safety Set|Overall Study||4
9075783|NCT02920242|10137169|FG000|COMPLETED|Overall Study||11
9075784|NCT02920242|10137170|FG001|COMPLETED|Overall Study||11
9075785|NCT02920242|10137171|FG002|COMPLETED|Overall Study||3
9075786|NCT02920242|10137169|FG000|NOT COMPLETED|Overall Study||2
9075787|NCT02920242|10137170|FG001|NOT COMPLETED|Overall Study||0
9075788|NCT02920242|10137171|FG002|NOT COMPLETED|Overall Study||1
9075789|NCT02900781|10137181|FG000|STARTED|Overall Study||4
9075790|NCT02900781|10137182|FG001|STARTED|Overall Study||5
9075791|NCT02900781|10137181|FG000|COMPLETED|Overall Study||0
9075792|NCT02900781|10137182|FG001|COMPLETED|Overall Study||0
9075793|NCT02900781|10137181|FG000|NOT COMPLETED|Overall Study||4
9075794|NCT02900781|10137182|FG001|NOT COMPLETED|Overall Study||5
9075795|NCT02892500|10137190|FG000|STARTED|Overall Study||0
9075796|NCT02892500|10137191|FG001|STARTED|Overall Study||0
9075797|NCT02892500|10137190|FG000|COMPLETED|Overall Study||0
9075798|NCT02892500|10137191|FG001|COMPLETED|Overall Study||0
9075799|NCT02892500|10137190|FG000|NOT COMPLETED|Overall Study||0
9075800|NCT02892500|10137191|FG001|NOT COMPLETED|Overall Study||0
9075801|NCT02904356|10137197|FG000|STARTED|Overall Study||2
9075802|NCT02904356|10137197|FG000|COMPLETED|Overall Study||2
9075803|NCT02904356|10137197|FG000|NOT COMPLETED|Overall Study||0
9075804|NCT02899728|10137203|FG000|STARTED|Overall Study|0|5
9075805|NCT02899728|10137204|FG001|STARTED|Overall Study||3
9075806|NCT02899728|10137203|FG000|COMPLETED|Overall Study||4
9075807|NCT02899728|10137204|FG001|COMPLETED|Overall Study||2
9075808|NCT02899728|10137203|FG000|NOT COMPLETED|Overall Study||1
9075809|NCT02899728|10137204|FG001|NOT COMPLETED|Overall Study||1
9075810|NCT02875067|10137210|FG000|STARTED|Overall Study||6
9075811|NCT02875067|10137210|FG000|COMPLETED|Overall Study||0
9075812|NCT02875067|10137210|FG000|NOT COMPLETED|Overall Study||6
9075813|NCT02877732|10137216|FG000|STARTED|Overall Study||6
9075814|NCT02877732|10137217|FG001|STARTED|Overall Study||6
9075815|NCT02877732|10137216|FG000|COMPLETED|Overall Study||0
9075816|NCT02877732|10137217|FG001|COMPLETED|Overall Study||0
9075817|NCT02877732|10137216|FG000|NOT COMPLETED|Overall Study||6
9075818|NCT02877732|10137217|FG001|NOT COMPLETED|Overall Study||6
9075819|NCT02860169|10137225|FG000|STARTED|Part A||46
9075820|NCT02860169|10137225|FG000|Healthy Participants|Part A||46
9075821|NCT02860169|10137225|FG000|Participants With Cold and Flu|Part A||0
9075822|NCT02860169|10137225|FG000|COMPLETED|Part A||35
9075823|NCT02860169|10137225|FG000|NOT COMPLETED|Part A||11
8844603|NCT01710527|9899037|FG000|NOT COMPLETED|Period 1: Intervention Period 1||0
8844604|NCT01710527|9899038|FG001|NOT COMPLETED|Period 1: Intervention Period 1||0
8844605|NCT01710527|9899037|FG000|STARTED|Period 2: Washout Period (7 Days)||16
8844606|NCT01710527|9899038|FG001|STARTED|Period 2: Washout Period (7 Days)||16
8844607|NCT01710527|9899037|FG000|COMPLETED|Period 2: Washout Period (7 Days)||16
8844608|NCT01710527|9899038|FG001|COMPLETED|Period 2: Washout Period (7 Days)||15
8844609|NCT01710527|9899037|FG000|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
8844610|NCT01710527|9899038|FG001|NOT COMPLETED|Period 2: Washout Period (7 Days)||1
8844611|NCT01710527|9899037|FG000|STARTED|Period 3: Intervention Period 2||16
8844612|NCT01710527|9899038|FG001|STARTED|Period 3: Intervention Period 2||15
8844613|NCT01710527|9899037|FG000|COMPLETED|Period 3: Intervention Period 2||16
9075824|NCT02860169|10137225|FG000|STARTED|Part B||20
9075825|NCT02860169|10137225|FG000|Healthy Participants|Part B||10
9075826|NCT02860169|10137225|FG000|Participants With Cold and Flu|Part B||10
9075827|NCT02860169|10137225|FG000|COMPLETED|Part B||9
9075828|NCT02860169|10137225|FG000|NOT COMPLETED|Part B||11
9075829|NCT02860169|10137225|FG000|STARTED|Part C||48
9075830|NCT02860169|10137225|FG000|Healthy Participants|Part C||6
9075831|NCT02860169|10137225|FG000|Participants With Cold and Flu|Part C||42
9075832|NCT02860169|10137225|FG000|COMPLETED|Part C||47
9075833|NCT02860169|10137225|FG000|NOT COMPLETED|Part C||1
9075834|NCT02865395|10137234|FG000|STARTED|Overall Study||6
9075835|NCT02865395|10137235|FG001|STARTED|Overall Study||10
9075836|NCT02865395|10137236|FG002|STARTED|Overall Study||7
9075837|NCT02865395|10137234|FG000|COMPLETED|Overall Study|Data Not Collected|0
9075838|NCT02865395|10137235|FG001|COMPLETED|Overall Study|Data Not Collected|0
9075839|NCT02865395|10137236|FG002|COMPLETED|Overall Study|Data Not Collected|0
9075840|NCT02865395|10137234|FG000|NOT COMPLETED|Overall Study||6
9075841|NCT02865395|10137235|FG001|NOT COMPLETED|Overall Study||10
9075842|NCT02865395|10137236|FG002|NOT COMPLETED|Overall Study||7
9075843|NCT02868892|10137244|FG000|STARTED|Overall Study||6
9075844|NCT02868892|10137244|FG000|COMPLETED|Overall Study||0
9075845|NCT02868892|10137244|FG000|NOT COMPLETED|Overall Study||6
9075846|NCT02865083|10137250|FG000|STARTED|Overall Study||3
9075847|NCT02865083|10137251|FG001|STARTED|Overall Study||1
9075848|NCT02865083|10137250|FG000|COMPLETED|Overall Study||0
9075849|NCT02865083|10137251|FG001|COMPLETED|Overall Study||0
9075850|NCT02865083|10137250|FG000|NOT COMPLETED|Overall Study||3
9075851|NCT02865083|10137251|FG001|NOT COMPLETED|Overall Study||1
9075852|NCT02865122|10137260|FG000|STARTED|Overall Study||1
9075853|NCT02865122|10137261|FG001|STARTED|Overall Study||1
9075854|NCT02865122|10137262|FG002|STARTED|Overall Study||0
9075855|NCT02865122|10137260|FG000|COMPLETED|Overall Study||0
9075856|NCT02865122|10137261|FG001|COMPLETED|Overall Study||1
9075857|NCT02865122|10137262|FG002|COMPLETED|Overall Study||0
9075858|NCT02865122|10137260|FG000|NOT COMPLETED|Overall Study||1
9075859|NCT02865122|10137261|FG001|NOT COMPLETED|Overall Study||0
9075860|NCT02865122|10137262|FG002|NOT COMPLETED|Overall Study||0
9075861|NCT02865915|10137272|FG000|STARTED|Overall Study||25
9075862|NCT02865915|10137273|FG001|STARTED|Overall Study||30
9075863|NCT02865915|10137272|FG000|COMPLETED|Overall Study|Study terminated prior to completion by any subject|0
9075864|NCT02865915|10137273|FG001|COMPLETED|Overall Study|Study terminated prior to completion by any subject|0
9075865|NCT02865915|10137272|FG000|NOT COMPLETED|Overall Study||25
9075866|NCT02865915|10137273|FG001|NOT COMPLETED|Overall Study||30
9075867|NCT02855411|10137279|FG000|STARTED|Overall Study||35
9075868|NCT02855411|10137279|FG000|Assigned to Study Treatment|Overall Study||0
9075869|NCT02855411|10137279|FG000|COMPLETED|Overall Study||0
9075870|NCT02855411|10137279|FG000|NOT COMPLETED|Overall Study||35
9075871|NCT02828124|10137287|FG000|STARTED|Overall Study||1
9075872|NCT02828124|10137288|FG001|STARTED|Overall Study||2
9075873|NCT02828124|10137289|FG002|STARTED|Overall Study||1
9075874|NCT02828124|10137290|FG003|STARTED|Overall Study||6
9075875|NCT02828124|10137287|FG000|COMPLETED|Overall Study||0
9075876|NCT02828124|10137288|FG001|COMPLETED|Overall Study||0
9075877|NCT02828124|10137289|FG002|COMPLETED|Overall Study||0
9075878|NCT02828124|10137290|FG003|COMPLETED|Overall Study||0
9075879|NCT02828124|10137287|FG000|NOT COMPLETED|Overall Study||1
9075880|NCT02828124|10137288|FG001|NOT COMPLETED|Overall Study||2
9075881|NCT02828124|10137289|FG002|NOT COMPLETED|Overall Study||1
9075882|NCT02828124|10137290|FG003|NOT COMPLETED|Overall Study||6
9075883|NCT02826551|10137302|FG000|STARTED|Overall Study||11
9075884|NCT02826551|10137303|FG001|STARTED|Overall Study||12
9075885|NCT02826551|10137302|FG000|COMPLETED|Overall Study||11
9075886|NCT02826551|10137303|FG001|COMPLETED|Overall Study||12
9075887|NCT02826551|10137302|FG000|NOT COMPLETED|Overall Study||0
9075888|NCT02826551|10137303|FG001|NOT COMPLETED|Overall Study||0
9075889|NCT02825043|10137309|FG000|STARTED|Overall Study||6
9075890|NCT02825043|10137309|FG000|COMPLETED|Overall Study||2
9075891|NCT02825043|10137309|FG000|NOT COMPLETED|Overall Study||4
9075892|NCT02819804|10137313|FG000|STARTED|Complete Cycle 1 (28 Days)||1
9075893|NCT02819804|10137313|FG000|COMPLETED|Complete Cycle 1 (28 Days)||0
9075894|NCT02819804|10137313|FG000|NOT COMPLETED|Complete Cycle 1 (28 Days)||1
9075895|NCT02819804|10137313|FG000|STARTED|Start Cycle 2 and Beyond||0
9075896|NCT02819804|10137313|FG000|COMPLETED|Start Cycle 2 and Beyond||0
9075897|NCT02819804|10137313|FG000|NOT COMPLETED|Start Cycle 2 and Beyond||0
9075898|NCT02819804|10137313|FG000|STARTED|Follow-up for 1 Year||1
9075899|NCT02819804|10137313|FG000|COMPLETED|Follow-up for 1 Year||1
9075900|NCT02819804|10137313|FG000|NOT COMPLETED|Follow-up for 1 Year||0
9075901|NCT02809118|10137320|FG000|STARTED|Overall Study||18
9075902|NCT02809118|10137321|FG001|STARTED|Overall Study||19
9075903|NCT02809118|10137322|FG002|STARTED|Overall Study||19
9075904|NCT02809118|10137320|FG000|COMPLETED|Overall Study||18
9075905|NCT02809118|10137321|FG001|COMPLETED|Overall Study||18
9075906|NCT02809118|10137322|FG002|COMPLETED|Overall Study||18
9075907|NCT02809118|10137320|FG000|NOT COMPLETED|Overall Study||0
9075908|NCT02809118|10137321|FG001|NOT COMPLETED|Overall Study||1
9075909|NCT02809118|10137322|FG002|NOT COMPLETED|Overall Study||1
9075910|NCT02818946|10137330|FG000|STARTED|Overall Study||30
9075911|NCT02818946|10137330|FG000|COMPLETED|Overall Study||30
9075912|NCT02818946|10137330|FG000|NOT COMPLETED|Overall Study||0
9075913|NCT02819908|10137336|FG000|STARTED|Overall Study||12
9075914|NCT02819908|10137337|FG001|STARTED|Overall Study||13
9075915|NCT02819908|10137336|FG000|COMPLETED|Overall Study||12
9075916|NCT02819908|10137337|FG001|COMPLETED|Overall Study||13
9075917|NCT02819908|10137336|FG000|NOT COMPLETED|Overall Study||0
9075918|NCT02819908|10137337|FG001|NOT COMPLETED|Overall Study||0
9075919|NCT02808390|10137348|FG000|STARTED|Overall Study||4
9075920|NCT02808390|10137349|FG001|STARTED|Overall Study||8
9075921|NCT02808390|10137350|FG002|STARTED|Overall Study||7
9075922|NCT02808390|10137348|FG000|COMPLETED|Overall Study||2
9075923|NCT02808390|10137349|FG001|COMPLETED|Overall Study||2
9075924|NCT02808390|10137350|FG002|COMPLETED|Overall Study||4
9075925|NCT02808390|10137348|FG000|NOT COMPLETED|Overall Study||2
9075926|NCT02808390|10137349|FG001|NOT COMPLETED|Overall Study||6
9075927|NCT02808390|10137350|FG002|NOT COMPLETED|Overall Study||3
9075928|NCT02806960|10137358|FG000|STARTED|Period 1||3
9075929|NCT02806960|10137359|FG001|STARTED|Period 1||3
9075930|NCT02806960|10137360|FG002|STARTED|Period 1||3
9075931|NCT02806960|10137361|FG003|STARTED|Period 1||3
9075932|NCT02806960|10137358|FG000|COMPLETED|Period 1||0
9075933|NCT02806960|10137359|FG001|COMPLETED|Period 1||0
9075934|NCT02806960|10137360|FG002|COMPLETED|Period 1||0
9075935|NCT02806960|10137361|FG003|COMPLETED|Period 1||0
9075936|NCT02806960|10137358|FG000|NOT COMPLETED|Period 1||3
9075937|NCT02806960|10137359|FG001|NOT COMPLETED|Period 1||3
9075938|NCT02806960|10137360|FG002|NOT COMPLETED|Period 1||3
9075939|NCT02806960|10137361|FG003|NOT COMPLETED|Period 1||3
9075940|NCT02806960|10137358|FG000|STARTED|Period 2||0
9075941|NCT02806960|10137359|FG001|STARTED|Period 2||0
9075942|NCT02806960|10137360|FG002|STARTED|Period 2||0
9075943|NCT02806960|10137361|FG003|STARTED|Period 2||0
9075944|NCT02806960|10137358|FG000|COMPLETED|Period 2||0
9075945|NCT02806960|10137359|FG001|COMPLETED|Period 2||0
9075946|NCT02806960|10137360|FG002|COMPLETED|Period 2||0
9075947|NCT02806960|10137361|FG003|COMPLETED|Period 2||0
9075948|NCT02806960|10137358|FG000|NOT COMPLETED|Period 2||0
9075949|NCT02806960|10137359|FG001|NOT COMPLETED|Period 2||0
9075950|NCT02806960|10137360|FG002|NOT COMPLETED|Period 2||0
9075951|NCT02806960|10137361|FG003|NOT COMPLETED|Period 2||0
9075952|NCT02806960|10137358|FG000|STARTED|Period 3||0
9075953|NCT02806960|10137359|FG001|STARTED|Period 3||0
9075954|NCT02806960|10137360|FG002|STARTED|Period 3||0
9075955|NCT02806960|10137361|FG003|STARTED|Period 3||0
9075956|NCT02806960|10137358|FG000|COMPLETED|Period 3||0
9075957|NCT02806960|10137359|FG001|COMPLETED|Period 3||0
9075958|NCT02806960|10137360|FG002|COMPLETED|Period 3||0
9075959|NCT02806960|10137361|FG003|COMPLETED|Period 3||0
9075960|NCT02806960|10137358|FG000|NOT COMPLETED|Period 3||0
9075961|NCT02806960|10137359|FG001|NOT COMPLETED|Period 3||0
9075962|NCT02806960|10137360|FG002|NOT COMPLETED|Period 3||0
9075963|NCT02806960|10137361|FG003|NOT COMPLETED|Period 3||0
9075964|NCT02806960|10137358|FG000|STARTED|Period 4||0
9075965|NCT02806960|10137359|FG001|STARTED|Period 4||0
9075966|NCT02806960|10137360|FG002|STARTED|Period 4||0
9075967|NCT02806960|10137361|FG003|STARTED|Period 4||0
9075968|NCT02806960|10137358|FG000|COMPLETED|Period 4||0
8624163|NCT00498615|9663415|FG001|STARTED|Fasudil 80mg||4
8624164|NCT00498615|9663416|FG002|STARTED|Fasudil 80mg||3
8624165|NCT00498615|9663417|FG003|STARTED|Fasudil 80mg||2
9075969|NCT02806960|10137359|FG001|COMPLETED|Period 4||0
9075970|NCT02806960|10137360|FG002|COMPLETED|Period 4||0
9075971|NCT02806960|10137361|FG003|COMPLETED|Period 4||0
9075972|NCT02806960|10137358|FG000|NOT COMPLETED|Period 4||0
9075973|NCT02806960|10137359|FG001|NOT COMPLETED|Period 4||0
9075974|NCT02806960|10137360|FG002|NOT COMPLETED|Period 4||0
9075975|NCT02806960|10137361|FG003|NOT COMPLETED|Period 4||0
9075976|NCT02815397|10137371|FG000|STARTED|Overall Study||2
9075977|NCT02815397|10137371|FG000|COMPLETED|Overall Study||0
9075978|NCT02815397|10137371|FG000|NOT COMPLETED|Overall Study||2
9075979|NCT02802592|10137375|FG000|STARTED|Overall Study||4
9075980|NCT02802592|10137375|FG000|COMPLETED|Overall Study||0
9075981|NCT02802592|10137375|FG000|NOT COMPLETED|Overall Study||4
9075982|NCT02774148|10137382|FG000|STARTED|Overall Study||0
9075983|NCT02774148|10137383|FG001|STARTED|Overall Study||0
8624166|NCT00498615|9663418|FG004|STARTED|Fasudil 80mg||3
8624167|NCT00498615|9663419|FG005|STARTED|Fasudil 80mg||3
8624168|NCT00498615|9663414|FG000|COMPLETED|Fasudil 80mg||2
9075984|NCT02774148|10137382|FG000|COMPLETED|Overall Study||0
9075985|NCT02774148|10137383|FG001|COMPLETED|Overall Study||0
9075986|NCT02774148|10137382|FG000|NOT COMPLETED|Overall Study||0
9075987|NCT02774148|10137383|FG001|NOT COMPLETED|Overall Study||0
9075988|NCT02773576|10137391|FG000|STARTED|Overall Study||0
9075989|NCT02773576|10137392|FG001|STARTED|Overall Study||0
9075990|NCT02773576|10137391|FG000|COMPLETED|Overall Study||0
9075991|NCT02773576|10137392|FG001|COMPLETED|Overall Study||0
9075992|NCT02773576|10137391|FG000|NOT COMPLETED|Overall Study||0
9075993|NCT02773576|10137392|FG001|NOT COMPLETED|Overall Study||0
9075994|NCT02730793|10137400|FG000|STARTED|Overall Study||2
9075995|NCT02730793|10137401|FG001|STARTED|Overall Study||3
9075996|NCT02730793|10137400|FG000|COMPLETED|Overall Study||2
9075997|NCT02730793|10137401|FG001|COMPLETED|Overall Study||1
9075998|NCT02730793|10137400|FG000|NOT COMPLETED|Overall Study||0
9075999|NCT02730793|10137401|FG001|NOT COMPLETED|Overall Study||2
9076000|NCT02744352|10137409|FG000|STARTED|Overall Study||4
9076001|NCT02744352|10137410|FG001|STARTED|Overall Study||4
9076002|NCT02744352|10137409|FG000|COMPLETED|Overall Study||4
9076003|NCT02744352|10137410|FG001|COMPLETED|Overall Study||4
9076004|NCT02744352|10137409|FG000|NOT COMPLETED|Overall Study||0
9076005|NCT02744352|10137410|FG001|NOT COMPLETED|Overall Study||0
9076006|NCT02760602|10137418|FG000|STARTED|Overall Study||13
9076007|NCT02760602|10137419|FG001|STARTED|Overall Study||13
9076008|NCT02760602|10137418|FG000|COMPLETED|Overall Study||0
9076009|NCT02760602|10137419|FG001|COMPLETED|Overall Study||0
9076010|NCT02760602|10137418|FG000|NOT COMPLETED|Overall Study||13
9076011|NCT02760602|10137419|FG001|NOT COMPLETED|Overall Study||13
9076012|NCT02757521|10137427|FG000|STARTED|Overall Study||1
9076013|NCT02757521|10137428|FG001|STARTED|Overall Study||0
9076014|NCT02757521|10137427|FG000|COMPLETED|Overall Study||0
9076015|NCT02757521|10137428|FG001|COMPLETED|Overall Study||0
9076016|NCT02757521|10137427|FG000|NOT COMPLETED|Overall Study||1
9076017|NCT02757521|10137428|FG001|NOT COMPLETED|Overall Study||0
9076018|NCT02758132|10137436|FG000|STARTED|Overall Study||0
9076019|NCT02758132|10137437|FG001|STARTED|Overall Study||1
9076020|NCT02758132|10137436|FG000|COMPLETED|Overall Study||0
9076021|NCT02758132|10137437|FG001|COMPLETED|Overall Study||0
9076022|NCT02758132|10137436|FG000|NOT COMPLETED|Overall Study||0
9076023|NCT02758132|10137437|FG001|NOT COMPLETED|Overall Study||1
9076024|NCT02757547|10137443|FG000|STARTED|Overall Study||2
9076025|NCT02757547|10137443|FG000|COMPLETED|Overall Study||2
9076026|NCT02757547|10137443|FG000|NOT COMPLETED|Overall Study||0
9076027|NCT02757053|10137450|FG000|STARTED|Overall Study||3
9076028|NCT02757053|10137451|FG001|STARTED|Overall Study||5
9076029|NCT02757053|10137450|FG000|COMPLETED|Overall Study||0
9076030|NCT02757053|10137451|FG001|COMPLETED|Overall Study||0
9076031|NCT02757053|10137450|FG000|NOT COMPLETED|Overall Study||3
9076032|NCT02757053|10137451|FG001|NOT COMPLETED|Overall Study||5
9076033|NCT02734940|10137459|FG000|STARTED|Overall Study||0
9076034|NCT02734940|10137460|FG001|STARTED|Overall Study||0
9076035|NCT02734940|10137459|FG000|COMPLETED|Overall Study||0
9076036|NCT02734940|10137460|FG001|COMPLETED|Overall Study||0
9076037|NCT02734940|10137459|FG000|NOT COMPLETED|Overall Study||0
9076038|NCT02734940|10137460|FG001|NOT COMPLETED|Overall Study||0
9076039|NCT02749617|10137466|FG000|STARTED|Overall Study||2
9076040|NCT02749617|10137466|FG000|COMPLETED|Overall Study||2
9076041|NCT02749617|10137466|FG000|NOT COMPLETED|Overall Study||0
9076042|NCT02749227|10137470|FG000|STARTED|Overall Study||4
9076043|NCT02749227|10137470|FG000|COMPLETED|Overall Study||4
9076044|NCT02749227|10137470|FG000|NOT COMPLETED|Overall Study||0
9076045|NCT02745210|10137476|FG000|STARTED|Overall Study||0
9076046|NCT02745210|10137477|FG001|STARTED|Overall Study||9
9076047|NCT02745210|10137476|FG000|COMPLETED|Overall Study||0
9076048|NCT02745210|10137477|FG001|COMPLETED|Overall Study||9
9076049|NCT02745210|10137476|FG000|NOT COMPLETED|Overall Study||0
9076050|NCT02745210|10137477|FG001|NOT COMPLETED|Overall Study||0
8624169|NCT00498615|9663415|FG001|COMPLETED|Fasudil 80mg||4
8624170|NCT00498615|9663416|FG002|COMPLETED|Fasudil 80mg||3
8624171|NCT00498615|9663417|FG003|COMPLETED|Fasudil 80mg||2
8624172|NCT00498615|9663418|FG004|COMPLETED|Fasudil 80mg||3
8624173|NCT00498615|9663419|FG005|COMPLETED|Fasudil 80mg||3
8624174|NCT00498615|9663414|FG000|NOT COMPLETED|Fasudil 80mg||0
9076051|NCT02725671|10137481|FG000|STARTED|Overall Study||2
9076052|NCT02725671|10137481|FG000|COMPLETED|Overall Study||1
9076053|NCT02725671|10137481|FG000|NOT COMPLETED|Overall Study||1
9076054|NCT02746263|10137489|FG000|STARTED|Overall Study||0
9076055|NCT02746263|10137490|FG001|STARTED|Overall Study||1
9076056|NCT02746263|10137489|FG000|Per Protocol Analysis Set|Overall Study||0
9076057|NCT02746263|10137490|FG001|Per Protocol Analysis Set|Overall Study||0
9076058|NCT02746263|10137489|FG000|COMPLETED|Overall Study||0
9076059|NCT02746263|10137490|FG001|COMPLETED|Overall Study||1
9076060|NCT02746263|10137489|FG000|NOT COMPLETED|Overall Study||0
9076061|NCT02746263|10137490|FG001|NOT COMPLETED|Overall Study||0
9076062|NCT02721277|10137496|FG000|STARTED|Overall Study||2
9076063|NCT02721277|10137496|FG000|COMPLETED|Overall Study||2
9076064|NCT02721277|10137496|FG000|NOT COMPLETED|Overall Study||0
9076065|NCT02732327|10137502|FG000|STARTED|Overall Study||0
8624175|NCT00498615|9663415|FG001|NOT COMPLETED|Fasudil 80mg||0
9076066|NCT02732327|10137503|FG001|STARTED|Overall Study||2
9076067|NCT02732327|10137502|FG000|COMPLETED|Overall Study||0
9076068|NCT02732327|10137503|FG001|COMPLETED|Overall Study||1
9076069|NCT02732327|10137502|FG000|NOT COMPLETED|Overall Study||0
9076070|NCT02732327|10137503|FG001|NOT COMPLETED|Overall Study||1
9076071|NCT02726399|10137509|FG000|STARTED|Overall Study||7
9076072|NCT02726399|10137509|FG000|COMPLETED|Overall Study||0
9076073|NCT02726399|10137509|FG000|NOT COMPLETED|Overall Study||7
9076074|NCT02720510|10137515|FG000|STARTED|Overall Study||3
9076075|NCT02720510|10137516|FG001|STARTED|Overall Study||3
9076076|NCT02720510|10137515|FG000|COMPLETED|Overall Study||0
9076077|NCT02720510|10137516|FG001|COMPLETED|Overall Study||0
9076078|NCT02720510|10137515|FG000|NOT COMPLETED|Overall Study||3
9076079|NCT02720510|10137516|FG001|NOT COMPLETED|Overall Study||3
9076080|NCT02715765|10137525|FG000|STARTED|Overall Study||3
9076081|NCT02715765|10137526|FG001|STARTED|Overall Study||0
9076082|NCT02715765|10137527|FG002|STARTED|Overall Study||0
9076083|NCT02715765|10137525|FG000|COMPLETED|Overall Study||0
9076084|NCT02715765|10137526|FG001|COMPLETED|Overall Study||0
9076085|NCT02715765|10137527|FG002|COMPLETED|Overall Study||0
9076086|NCT02715765|10137525|FG000|NOT COMPLETED|Overall Study||3
9076087|NCT02715765|10137526|FG001|NOT COMPLETED|Overall Study||0
9076088|NCT02715765|10137527|FG002|NOT COMPLETED|Overall Study||0
9076089|NCT02717949|10137537|FG000|STARTED|Overall Study||0
9076090|NCT02717949|10137538|FG001|STARTED|Overall Study||0
9076091|NCT02717949|10137537|FG000|COMPLETED|Overall Study||0
9076092|NCT02717949|10137538|FG001|COMPLETED|Overall Study||0
9076093|NCT02717949|10137537|FG000|NOT COMPLETED|Overall Study||0
9076094|NCT02717949|10137538|FG001|NOT COMPLETED|Overall Study||0
9076095|NCT02717130|10137546|FG000|STARTED|Overall Study|Of the nine enrolled subjects, eight received study drug.|8
9076096|NCT02717130|10137546|FG000|COMPLETED|Overall Study||1
9076097|NCT02717130|10137546|FG000|NOT COMPLETED|Overall Study||7
8624176|NCT00498615|9663416|FG002|NOT COMPLETED|Fasudil 80mg||0
8624177|NCT00498615|9663417|FG003|NOT COMPLETED|Fasudil 80mg||0
8624178|NCT00498615|9663418|FG004|NOT COMPLETED|Fasudil 80mg||0
8624179|NCT00498615|9663419|FG005|NOT COMPLETED|Fasudil 80mg||0
8624180|NCT00498615|9663414|FG000|STARTED|Fasudil 40mg||2
8624181|NCT00498615|9663415|FG001|STARTED|Fasudil 40mg||4
8624182|NCT00498615|9663416|FG002|STARTED|Fasudil 40mg||3
8624183|NCT00498615|9663417|FG003|STARTED|Fasudil 40mg||2
8624184|NCT00498615|9663418|FG004|STARTED|Fasudil 40mg||3
8624185|NCT00498615|9663419|FG005|STARTED|Fasudil 40mg||3
8624186|NCT00498615|9663414|FG000|COMPLETED|Fasudil 40mg||2
8624187|NCT00498615|9663415|FG001|COMPLETED|Fasudil 40mg||4
8624188|NCT00498615|9663416|FG002|COMPLETED|Fasudil 40mg||3
8624189|NCT00498615|9663417|FG003|COMPLETED|Fasudil 40mg||2
8624190|NCT00498615|9663418|FG004|COMPLETED|Fasudil 40mg||3
8624191|NCT00498615|9663419|FG005|COMPLETED|Fasudil 40mg||3
9076098|NCT02685202|10137550|FG000|STARTED|Overall Study||9
9076099|NCT02685202|10137550|FG000|COMPLETED|Overall Study||0
9076100|NCT02685202|10137550|FG000|NOT COMPLETED|Overall Study||9
9076101|NCT02709083|10137554|FG000|STARTED|Overall Study||7
9076102|NCT02709083|10137554|FG000|COMPLETED|Overall Study||0
9076103|NCT02709083|10137554|FG000|NOT COMPLETED|Overall Study||7
9076104|NCT02693171|10137558|FG000|STARTED|Overall Study|At study termination, 13 subjects had enrolled, 12 subjects received at least 1 dose of study drug.|12
9076105|NCT02693171|10137558|FG000|COMPLETED|Overall Study||3
9076106|NCT02693171|10137558|FG000|NOT COMPLETED|Overall Study||9
9076107|NCT02696226|10137566|FG000|STARTED|Overall Study||1
9076108|NCT02696226|10137567|FG001|STARTED|Overall Study||0
9076109|NCT02696226|10137568|FG002|STARTED|Overall Study||2
9076110|NCT02696226|10137569|FG003|STARTED|Overall Study||0
9076111|NCT02696226|10137566|FG000|COMPLETED|Overall Study||0
9076112|NCT02696226|10137567|FG001|COMPLETED|Overall Study||0
9076113|NCT02696226|10137568|FG002|COMPLETED|Overall Study||0
9076114|NCT02696226|10137569|FG003|COMPLETED|Overall Study||0
9076115|NCT02696226|10137566|FG000|NOT COMPLETED|Overall Study||1
9076116|NCT02696226|10137567|FG001|NOT COMPLETED|Overall Study||0
9076117|NCT02696226|10137568|FG002|NOT COMPLETED|Overall Study||2
9076118|NCT02696226|10137569|FG003|NOT COMPLETED|Overall Study||0
9076119|NCT02693743|10137581|FG000|STARTED|Overall Study||1
9076120|NCT02693743|10137582|FG001|STARTED|Overall Study||0
9076121|NCT02693743|10137581|FG000|COMPLETED|Overall Study||0
9076122|NCT02693743|10137582|FG001|COMPLETED|Overall Study||0
9076123|NCT02693743|10137581|FG000|NOT COMPLETED|Overall Study||1
9076124|NCT02693743|10137582|FG001|NOT COMPLETED|Overall Study||0
9076125|NCT02706691|10137588|FG000|STARTED|Overall Study||1
9076126|NCT02706691|10137588|FG000|COMPLETED|Overall Study||0
9076127|NCT02706691|10137588|FG000|NOT COMPLETED|Overall Study||1
9076128|NCT02708849|10137595|FG000|STARTED|Overall Study||2
9076129|NCT02708849|10137596|FG001|STARTED|Overall Study||1
8624192|NCT00498615|9663414|FG000|NOT COMPLETED|Fasudil 40mg||0
8624193|NCT00498615|9663415|FG001|NOT COMPLETED|Fasudil 40mg||0
8624194|NCT00498615|9663416|FG002|NOT COMPLETED|Fasudil 40mg||0
8624195|NCT00498615|9663417|FG003|NOT COMPLETED|Fasudil 40mg||0
8624196|NCT00498615|9663418|FG004|NOT COMPLETED|Fasudil 40mg||0
9076130|NCT02708849|10137595|FG000|COMPLETED|Overall Study||1
9076131|NCT02708849|10137596|FG001|COMPLETED|Overall Study||1
9076132|NCT02708849|10137595|FG000|NOT COMPLETED|Overall Study||1
9076133|NCT02708849|10137596|FG001|NOT COMPLETED|Overall Study||0
9076134|NCT02693717|10137602|FG000|STARTED|Overall Study||7
9076135|NCT02693717|10137602|FG000|COMPLETED|Overall Study||7
9076136|NCT02693717|10137602|FG000|NOT COMPLETED|Overall Study||0
9076137|NCT02694757|10137606|FG000|STARTED|Overall Study||3
9076138|NCT02694757|10137606|FG000|COMPLETED|Overall Study||0
9076139|NCT02694757|10137606|FG000|NOT COMPLETED|Overall Study||3
9076140|NCT02693002|10137612|FG000|STARTED|Overall Study||2
9076141|NCT02693002|10137613|FG001|STARTED|Overall Study||2
9076142|NCT02693002|10137612|FG000|COMPLETED|Overall Study||1
9076143|NCT02693002|10137613|FG001|COMPLETED|Overall Study||2
9076144|NCT02693002|10137612|FG000|NOT COMPLETED|Overall Study||1
9076145|NCT02693002|10137613|FG001|NOT COMPLETED|Overall Study||0
9076146|NCT02689518|10137619|FG000|STARTED|Overall Study||49
9076147|NCT02689518|10137619|FG000|COMPLETED|Overall Study||46
9076148|NCT02689518|10137619|FG000|NOT COMPLETED|Overall Study||3
9076149|NCT02687165|10137623|FG000|STARTED|Overall Study||0
9076150|NCT02687165|10137624|FG001|STARTED|Overall Study||0
9076151|NCT02687165|10137623|FG000|COMPLETED|Overall Study||0
9076152|NCT02687165|10137624|FG001|COMPLETED|Overall Study||0
9076153|NCT02687165|10137623|FG000|NOT COMPLETED|Overall Study||0
9076154|NCT02687165|10137624|FG001|NOT COMPLETED|Overall Study||0
9076155|NCT02679560|10137632|FG000|STARTED|Overall Study||1
9076156|NCT02679560|10137633|FG001|STARTED|Overall Study||2
9076157|NCT02679560|10137632|FG000|COMPLETED|Overall Study||1
9076158|NCT02679560|10137633|FG001|COMPLETED|Overall Study||2
9076159|NCT02679560|10137632|FG000|NOT COMPLETED|Overall Study||0
9076160|NCT02679560|10137633|FG001|NOT COMPLETED|Overall Study||0
9076161|NCT02679066|10137641|FG000|STARTED|Overall Study||100
9076162|NCT02679066|10137642|FG001|STARTED|Overall Study||100
9076163|NCT02679066|10137641|FG000|COMPLETED|Overall Study||100
8624197|NCT00498615|9663419|FG005|NOT COMPLETED|Fasudil 40mg||0
8624198|NCT00498615|9663414|FG000|STARTED|Placebo||2
9076164|NCT02679066|10137642|FG001|COMPLETED|Overall Study||100
9076165|NCT02679066|10137641|FG000|NOT COMPLETED|Overall Study||0
9076166|NCT02679066|10137642|FG001|NOT COMPLETED|Overall Study||0
9076167|NCT02673684|10137650|FG000|STARTED|Overall Study||9
9076168|NCT02673684|10137651|FG001|STARTED|Overall Study||8
9076169|NCT02673684|10137650|FG000|COMPLETED|Overall Study||0
9076170|NCT02673684|10137651|FG001|COMPLETED|Overall Study||0
9076171|NCT02673684|10137650|FG000|NOT COMPLETED|Overall Study||9
9076172|NCT02673684|10137651|FG001|NOT COMPLETED|Overall Study||8
9076173|NCT02674204|10137661|FG000|STARTED|Overall Study||1
9076174|NCT02674204|10137662|FG001|STARTED|Overall Study||1
9076175|NCT02674204|10137661|FG000|COMPLETED|Overall Study||0
9076176|NCT02674204|10137662|FG001|COMPLETED|Overall Study||1
9076177|NCT02674204|10137661|FG000|NOT COMPLETED|Overall Study||1
9076178|NCT02674204|10137662|FG001|NOT COMPLETED|Overall Study||0
9076179|NCT02665221|10137670|FG000|STARTED|Overall Study||15
9076180|NCT02665221|10137671|FG001|STARTED|Overall Study||15
9076181|NCT02665221|10137670|FG000|COMPLETED|Overall Study||0
9076182|NCT02665221|10137671|FG001|COMPLETED|Overall Study||0
9076183|NCT02665221|10137670|FG000|NOT COMPLETED|Overall Study||15
9076184|NCT02665221|10137671|FG001|NOT COMPLETED|Overall Study||15
9076185|NCT02672033|10137677|FG000|STARTED|Overall Study||2
9076186|NCT02672033|10137677|FG000|COMPLETED|Overall Study||2
9076187|NCT02672033|10137677|FG000|NOT COMPLETED|Overall Study||0
9076188|NCT02671461|10137684|FG000|STARTED|Treatment||3
9076189|NCT02671461|10137685|FG001|STARTED|Treatment||5
9076190|NCT02671461|10137686|FG002|STARTED|Treatment||7
9076191|NCT02671461|10137684|FG000|COMPLETED|Treatment||1
9076192|NCT02671461|10137685|FG001|COMPLETED|Treatment||2
9076193|NCT02671461|10137686|FG002|COMPLETED|Treatment||2
9076194|NCT02671461|10137684|FG000|NOT COMPLETED|Treatment||2
9076195|NCT02671461|10137685|FG001|NOT COMPLETED|Treatment||3
9076196|NCT02671461|10137686|FG002|NOT COMPLETED|Treatment||5
9076197|NCT02671461|10137684|FG000|STARTED|Follow-up||2
9076198|NCT02671461|10137685|FG001|STARTED|Follow-up||5
9076199|NCT02671461|10137686|FG002|STARTED|Follow-up||7
9076200|NCT02671461|10137684|FG000|COMPLETED|Follow-up||1
9076201|NCT02671461|10137685|FG001|COMPLETED|Follow-up||4
9076202|NCT02671461|10137686|FG002|COMPLETED|Follow-up||6
9076203|NCT02671461|10137684|FG000|NOT COMPLETED|Follow-up||1
9076204|NCT02671461|10137685|FG001|NOT COMPLETED|Follow-up||1
9076205|NCT02671461|10137686|FG002|NOT COMPLETED|Follow-up||1
9076206|NCT02671136|10137696|FG000|STARTED|Overall Study||3
9076207|NCT02671136|10137697|FG001|STARTED|Overall Study||0
9076208|NCT02671136|10137696|FG000|COMPLETED|Overall Study||3
9076209|NCT02671136|10137697|FG001|COMPLETED|Overall Study||0
9076210|NCT02671136|10137696|FG000|NOT COMPLETED|Overall Study||0
9076211|NCT02671136|10137697|FG001|NOT COMPLETED|Overall Study||0
9076212|NCT02663752|10137703|FG000|STARTED|Overall Study||1
9076213|NCT02663752|10137703|FG000|COMPLETED|Overall Study||1
9076214|NCT02663752|10137703|FG000|NOT COMPLETED|Overall Study||0
9076215|NCT02658357|10137709|FG000|STARTED|Overall Study||0
9076216|NCT02658357|10137710|FG001|STARTED|Overall Study||0
9076217|NCT02658357|10137709|FG000|COMPLETED|Overall Study||0
9076218|NCT02658357|10137710|FG001|COMPLETED|Overall Study||0
9076219|NCT02658357|10137709|FG000|NOT COMPLETED|Overall Study||0
9076220|NCT02658357|10137710|FG001|NOT COMPLETED|Overall Study||0
9076221|NCT02665988|10137718|FG000|STARTED|Overall Study||2
9076222|NCT02665988|10137719|FG001|STARTED|Overall Study||2
9076223|NCT02665988|10137718|FG000|COMPLETED|Overall Study||2
9076224|NCT02665988|10137719|FG001|COMPLETED|Overall Study||2
9076225|NCT02665988|10137718|FG000|NOT COMPLETED|Overall Study||0
9076226|NCT02665988|10137719|FG001|NOT COMPLETED|Overall Study||0
9076227|NCT02660528|10137725|FG000|STARTED|Overall Study||0
9076228|NCT02660528|10137725|FG000|COMPLETED|Overall Study||0
9076229|NCT02660528|10137725|FG000|NOT COMPLETED|Overall Study||0
9076230|NCT02658877|10137731|FG000|STARTED|Overall Study||3
9076231|NCT02658877|10137732|FG001|STARTED|Overall Study||0
9076232|NCT02658877|10137731|FG000|COMPLETED|Overall Study||3
9076233|NCT02658877|10137732|FG001|COMPLETED|Overall Study||0
9076234|NCT02658877|10137731|FG000|NOT COMPLETED|Overall Study||0
9076235|NCT02658877|10137732|FG001|NOT COMPLETED|Overall Study||0
9076236|NCT02654782|10137740|FG000|STARTED|Overall Study||5
9076237|NCT02654782|10137741|FG001|STARTED|Overall Study||5
9076238|NCT02654782|10137740|FG000|COMPLETED|Overall Study||5
9076239|NCT02654782|10137741|FG001|COMPLETED|Overall Study||5
9076240|NCT02654782|10137740|FG000|NOT COMPLETED|Overall Study||0
9076241|NCT02654782|10137741|FG001|NOT COMPLETED|Overall Study||0
9076242|NCT02656199|10137747|FG000|STARTED|Overall Study|0 analyzed.PI left the institution.Effort to contact PI unsuccessful.No study data available|0
9076243|NCT02656199|10137747|FG000|COMPLETED|Overall Study|0 analyzed.PI left the institution.Effort to contact PI unsuccessful.No study data available|0
9076244|NCT02656199|10137747|FG000|NOT COMPLETED|Overall Study||0
9076245|NCT02654639|10137751|FG000|STARTED|Overall Study||4
9076246|NCT02654639|10137751|FG000|COMPLETED|Overall Study||4
9076247|NCT02654639|10137751|FG000|NOT COMPLETED|Overall Study||0
9076248|NCT02653495|10137757|FG000|STARTED|Overall Study||15
9076249|NCT02653495|10137758|FG001|STARTED|Overall Study||2
9076250|NCT02653495|10137757|FG000|COMPLETED|Overall Study||3
9076251|NCT02653495|10137758|FG001|COMPLETED|Overall Study||2
9076252|NCT02653495|10137757|FG000|NOT COMPLETED|Overall Study||12
9076253|NCT02653495|10137758|FG001|NOT COMPLETED|Overall Study||0
9076254|NCT02640573|10137764|FG000|STARTED|Overall Study||1
9076255|NCT02640573|10137764|FG000|COMPLETED|Overall Study||0
9076256|NCT02640573|10137764|FG000|NOT COMPLETED|Overall Study||1
9076257|NCT02639390|10137770|FG000|STARTED|Overall Study||0
9076258|NCT02639390|10137771|FG001|STARTED|Overall Study||5
9076259|NCT02639390|10137770|FG000|COMPLETED|Overall Study||0
9076260|NCT02639390|10137771|FG001|COMPLETED|Overall Study||3
9076261|NCT02639390|10137770|FG000|NOT COMPLETED|Overall Study||0
9076262|NCT02639390|10137771|FG001|NOT COMPLETED|Overall Study||2
9076263|NCT02634606|10137777|FG000|STARTED|Overall Study||13
9076264|NCT02634606|10137777|FG000|COMPLETED|Overall Study||0
9076265|NCT02634606|10137777|FG000|NOT COMPLETED|Overall Study||13
9076266|NCT02634827|10137785|FG000|STARTED|Overall Study||1
9076267|NCT02634827|10137785|FG000|COMPLETED|Overall Study||1
9076268|NCT02634827|10137785|FG000|NOT COMPLETED|Overall Study||0
9076269|NCT02636283|10137791|FG000|STARTED|Overall Study||3
9076270|NCT02636283|10137792|FG001|STARTED|Overall Study||3
9076271|NCT02636283|10137791|FG000|COMPLETED|Overall Study||1
9076272|NCT02636283|10137792|FG001|COMPLETED|Overall Study||0
9076273|NCT02636283|10137791|FG000|NOT COMPLETED|Overall Study||2
9076274|NCT02636283|10137792|FG001|NOT COMPLETED|Overall Study||3
9076275|NCT02638129|10137800|FG000|STARTED|Overall Study||28
9076276|NCT02638129|10137801|FG001|STARTED|Overall Study||30
9076277|NCT02638129|10137800|FG000|COMPLETED|Overall Study||0
9076278|NCT02638129|10137801|FG001|COMPLETED|Overall Study||0
9076279|NCT02638129|10137800|FG000|NOT COMPLETED|Overall Study||28
9076280|NCT02638129|10137801|FG001|NOT COMPLETED|Overall Study||30
9076281|NCT02615990|10137809|FG000|STARTED|Overall Study||1
9076282|NCT02615990|10137810|FG001|STARTED|Overall Study||1
9076283|NCT02615990|10137809|FG000|COMPLETED|Overall Study||0
9076284|NCT02615990|10137810|FG001|COMPLETED|Overall Study||0
9076285|NCT02615990|10137809|FG000|NOT COMPLETED|Overall Study||1
9076286|NCT02615990|10137810|FG001|NOT COMPLETED|Overall Study||1
9076287|NCT02640677|10137816|FG000|STARTED|Overall Study||2
9076288|NCT02640677|10137816|FG000|COMPLETED|Overall Study||0
9076289|NCT02640677|10137816|FG000|NOT COMPLETED|Overall Study||2
9076290|NCT02633540|10137820|FG000|STARTED|Overall Study||2
9076291|NCT02633540|10137820|FG000|COMPLETED|Overall Study||2
9076292|NCT02633540|10137820|FG000|NOT COMPLETED|Overall Study||0
9076293|NCT02623959|10137826|FG000|STARTED|Overall Study||0
9076294|NCT02623959|10137827|FG001|STARTED|Overall Study||1
9076295|NCT02623959|10137826|FG000|COMPLETED|Overall Study||0
9076296|NCT02623959|10137827|FG001|COMPLETED|Overall Study|due to progression|0
9076297|NCT02623959|10137826|FG000|NOT COMPLETED|Overall Study||0
9076298|NCT02623959|10137827|FG001|NOT COMPLETED|Overall Study||1
9076299|NCT02631148|10137837|FG000|STARTED|Overall Study||12
9076300|NCT02631148|10137838|FG001|STARTED|Overall Study||0
9076301|NCT02631148|10137837|FG000|COMPLETED|Overall Study||2
9076302|NCT02631148|10137838|FG001|COMPLETED|Overall Study||0
9076303|NCT02631148|10137837|FG000|NOT COMPLETED|Overall Study||10
9076304|NCT02631148|10137838|FG001|NOT COMPLETED|Overall Study||0
9076305|NCT02630472|10137846|FG000|STARTED|Overall Study||10
9076306|NCT02630472|10137847|FG001|STARTED|Overall Study||0
9076307|NCT02630472|10137846|FG000|COMPLETED|Overall Study||0
9076308|NCT02630472|10137847|FG001|COMPLETED|Overall Study||0
8624199|NCT00498615|9663415|FG001|STARTED|Placebo||4
8624200|NCT00498615|9663416|FG002|STARTED|Placebo||3
8624201|NCT00498615|9663417|FG003|STARTED|Placebo||2
8624202|NCT00498615|9663418|FG004|STARTED|Placebo||3
8624203|NCT00498615|9663419|FG005|STARTED|Placebo||3
9076309|NCT02630472|10137846|FG000|NOT COMPLETED|Overall Study||10
9076310|NCT02630472|10137847|FG001|NOT COMPLETED|Overall Study||0
9076311|NCT02626520|10137856|FG000|STARTED|Overall Study||1
9076312|NCT02626520|10137857|FG001|STARTED|Overall Study||10
9076313|NCT02626520|10137856|FG000|COMPLETED|Overall Study||0
9076314|NCT02626520|10137857|FG001|COMPLETED|Overall Study||0
9076315|NCT02626520|10137856|FG000|NOT COMPLETED|Overall Study||1
9076316|NCT02626520|10137857|FG001|NOT COMPLETED|Overall Study||10
9076317|NCT02614898|10137865|FG000|STARTED|Overall Study||15
9076318|NCT02614898|10137866|FG001|STARTED|Overall Study||52
9076319|NCT02614898|10137865|FG000|Safety Population|Overall Study||15
9076320|NCT02614898|10137866|FG001|Safety Population|Overall Study||52
9076321|NCT02614898|10137865|FG000|COMPLETED|Overall Study||0
9076322|NCT02614898|10137866|FG001|COMPLETED|Overall Study||1
9076323|NCT02614898|10137865|FG000|NOT COMPLETED|Overall Study||15
9076324|NCT02614898|10137866|FG001|NOT COMPLETED|Overall Study||51
9076325|NCT02622828|10137873|FG000|STARTED|Overall Study||4
9076326|NCT02622828|10137873|FG000|COMPLETED|Overall Study||1
9076327|NCT02622828|10137873|FG000|NOT COMPLETED|Overall Study||3
9076328|NCT02624739|10137879|FG000|STARTED|Overall Study||0
9076329|NCT02624739|10137880|FG001|STARTED|Overall Study||0
9076330|NCT02624739|10137879|FG000|COMPLETED|Overall Study||0
9076331|NCT02624739|10137880|FG001|COMPLETED|Overall Study||0
9076332|NCT02624739|10137879|FG000|NOT COMPLETED|Overall Study||0
9076333|NCT02624739|10137880|FG001|NOT COMPLETED|Overall Study||0
9076334|NCT02608905|10137888|FG000|STARTED|Overall Study||7
9076335|NCT02608905|10137889|FG001|STARTED|Overall Study||10
9076336|NCT02608905|10137888|FG000|COMPLETED|Overall Study||5
9076337|NCT02608905|10137889|FG001|COMPLETED|Overall Study||10
9076338|NCT02608905|10137888|FG000|NOT COMPLETED|Overall Study||2
9076339|NCT02608905|10137889|FG001|NOT COMPLETED|Overall Study||0
9076340|NCT02619812|10137899|FG000|STARTED|Overall Study||0
9076341|NCT02619812|10137900|FG001|STARTED|Overall Study||0
9076342|NCT02619812|10137901|FG002|STARTED|Overall Study||1
9076343|NCT02619812|10137902|FG003|STARTED|Overall Study||2
9076344|NCT02619812|10137899|FG000|COMPLETED|Overall Study||0
9076345|NCT02619812|10137900|FG001|COMPLETED|Overall Study||0
8624204|NCT00498615|9663414|FG000|COMPLETED|Placebo||2
9076346|NCT02619812|10137901|FG002|COMPLETED|Overall Study||0
9076347|NCT02619812|10137902|FG003|COMPLETED|Overall Study||0
9076348|NCT02619812|10137899|FG000|NOT COMPLETED|Overall Study||0
9076349|NCT02619812|10137900|FG001|NOT COMPLETED|Overall Study||0
9076350|NCT02619812|10137901|FG002|NOT COMPLETED|Overall Study||1
9076351|NCT02619812|10137902|FG003|NOT COMPLETED|Overall Study||2
8624205|NCT00498615|9663415|FG001|COMPLETED|Placebo||4
9076352|NCT02612285|10137912|FG000|STARTED|Overall Study||1
9076353|NCT02612285|10137912|FG000|COMPLETED|Overall Study|Subject did not complete Cycle 1; no data points recorded|0
9076354|NCT02612285|10137912|FG000|NOT COMPLETED|Overall Study||1
9076355|NCT02614586|10137916|FG000|STARTED|Overall Study||11
9076356|NCT02614586|10137916|FG000|COMPLETED|Overall Study||11
9076357|NCT02614586|10137916|FG000|NOT COMPLETED|Overall Study||0
9076358|NCT02606279|10137922|FG000|STARTED|Overall Study||0
9076359|NCT02606279|10137923|FG001|STARTED|Overall Study||1
9076360|NCT02606279|10137922|FG000|COMPLETED|Overall Study||0
9076361|NCT02606279|10137923|FG001|COMPLETED|Overall Study||0
9076362|NCT02606279|10137922|FG000|NOT COMPLETED|Overall Study||0
9076363|NCT02606279|10137923|FG001|NOT COMPLETED|Overall Study||1
9076364|NCT02605824|10137931|FG000|STARTED|Overall Study||1
9076365|NCT02605824|10137932|FG001|STARTED|Overall Study||0
9076366|NCT02605824|10137931|FG000|COMPLETED|Overall Study||0
9076367|NCT02605824|10137932|FG001|COMPLETED|Overall Study||0
9076368|NCT02605824|10137931|FG000|NOT COMPLETED|Overall Study||1
9076369|NCT02605824|10137932|FG001|NOT COMPLETED|Overall Study||0
9076370|NCT02598622|10137940|FG000|STARTED|Overall Study||8
9076371|NCT02598622|10137941|FG001|STARTED|Overall Study|Study terminated prior to randomization phase. No enrollment in this arm.|0
9076372|NCT02598622|10137940|FG000|COMPLETED|Overall Study||2
9076373|NCT02598622|10137941|FG001|COMPLETED|Overall Study||0
9076374|NCT02598622|10137940|FG000|NOT COMPLETED|Overall Study||6
9076375|NCT02598622|10137941|FG001|NOT COMPLETED|Overall Study||0
9076376|NCT02589145|10137950|FG000|STARTED|Overall Study||4
9076377|NCT02589145|10137951|FG001|STARTED|Overall Study||2
9076378|NCT02589145|10137952|FG002|STARTED|Overall Study||2
9076379|NCT02589145|10137950|FG000|COMPLETED|Overall Study||4
9076380|NCT02589145|10137951|FG001|COMPLETED|Overall Study||2
9076381|NCT02589145|10137952|FG002|COMPLETED|Overall Study||2
9076382|NCT02589145|10137950|FG000|NOT COMPLETED|Overall Study||0
9076383|NCT02589145|10137951|FG001|NOT COMPLETED|Overall Study||0
9076384|NCT02589145|10137952|FG002|NOT COMPLETED|Overall Study||0
9076385|NCT02582749|10137962|FG000|STARTED|Overall Study||5
9076386|NCT02582749|10137963|FG001|STARTED|Overall Study||11
9076387|NCT02582749|10137962|FG000|COMPLETED|Overall Study||0
9076388|NCT02582749|10137963|FG001|COMPLETED|Overall Study||0
9076389|NCT02582749|10137962|FG000|NOT COMPLETED|Overall Study||5
9076390|NCT02582749|10137963|FG001|NOT COMPLETED|Overall Study||11
9076391|NCT02590068|10137971|FG000|STARTED|Overall Study||0
9076392|NCT02590068|10137972|FG001|STARTED|Overall Study||14
9076393|NCT02590068|10137971|FG000|COMPLETED|Overall Study||0
9076394|NCT02590068|10137972|FG001|COMPLETED|Overall Study||14
9076395|NCT02590068|10137971|FG000|NOT COMPLETED|Overall Study||0
9076396|NCT02590068|10137972|FG001|NOT COMPLETED|Overall Study||0
9076397|NCT02593682|10137980|FG000|STARTED|Overall Study||0
9076398|NCT02593682|10137981|FG001|STARTED|Overall Study||0
9076399|NCT02593682|10137980|FG000|COMPLETED|Overall Study||0
9076400|NCT02593682|10137981|FG001|COMPLETED|Overall Study||0
9076401|NCT02593682|10137980|FG000|NOT COMPLETED|Overall Study||0
9076402|NCT02593682|10137981|FG001|NOT COMPLETED|Overall Study||0
9076403|NCT02587650|10137987|FG000|STARTED|Overall Study||0
9076404|NCT02587650|10137988|FG001|STARTED|Overall Study||0
9076405|NCT02587650|10137989|FG002|STARTED|Overall Study||1
9076406|NCT02587650|10137990|FG003|STARTED|Overall Study||0
9076407|NCT02587650|10137987|FG000|COMPLETED|Overall Study||0
9076408|NCT02587650|10137988|FG001|COMPLETED|Overall Study||0
9076409|NCT02587650|10137989|FG002|COMPLETED|Overall Study||1
9076410|NCT02587650|10137990|FG003|COMPLETED|Overall Study||0
9076411|NCT02587650|10137987|FG000|NOT COMPLETED|Overall Study||0
9076412|NCT02587650|10137988|FG001|NOT COMPLETED|Overall Study||0
9076413|NCT02587650|10137989|FG002|NOT COMPLETED|Overall Study||0
9076414|NCT02587650|10137990|FG003|NOT COMPLETED|Overall Study||0
9076415|NCT02569957|10137996|FG000|STARTED|Overall Study||0
9076416|NCT02569957|10137997|FG001|STARTED|Overall Study||1
9076417|NCT02569957|10137996|FG000|COMPLETED|Overall Study||0
9076418|NCT02569957|10137997|FG001|COMPLETED|Overall Study||0
9076419|NCT02569957|10137996|FG000|NOT COMPLETED|Overall Study||0
9076420|NCT02569957|10137997|FG001|NOT COMPLETED|Overall Study||1
9076421|NCT02568007|10138006|FG000|STARTED|Overall Study||2
9076422|NCT02568007|10138007|FG001|STARTED|Overall Study||2
9076423|NCT02568007|10138008|FG002|STARTED|Overall Study||0
9076424|NCT02568007|10138006|FG000|COMPLETED|Overall Study||2
9076425|NCT02568007|10138007|FG001|COMPLETED|Overall Study||2
9076426|NCT02568007|10138008|FG002|COMPLETED|Overall Study||0
9076427|NCT02568007|10138006|FG000|NOT COMPLETED|Overall Study||0
9076428|NCT02568007|10138007|FG001|NOT COMPLETED|Overall Study||0
9076429|NCT02568007|10138008|FG002|NOT COMPLETED|Overall Study||0
9076430|NCT02575365|10138016|FG000|STARTED|Overall Study||4
9076431|NCT02575365|10138016|FG000|COMPLETED|Overall Study||0
9076432|NCT02575365|10138016|FG000|NOT COMPLETED|Overall Study||4
9076433|NCT02549755|10138020|FG000|STARTED|Overall Study||1
9076434|NCT02549755|10138020|FG000|COMPLETED|Overall Study||0
9076435|NCT02549755|10138020|FG000|NOT COMPLETED|Overall Study||1
9076436|NCT02547129|10138026|FG000|STARTED|Overall Study||2
9076437|NCT02547129|10138027|FG001|STARTED|Overall Study||2
9076438|NCT02547129|10138026|FG000|COMPLETED|Overall Study||1
9076439|NCT02547129|10138027|FG001|COMPLETED|Overall Study||2
9076440|NCT02547129|10138026|FG000|NOT COMPLETED|Overall Study||1
9076441|NCT02547129|10138027|FG001|NOT COMPLETED|Overall Study||0
9076442|NCT02528097|10138035|FG000|STARTED|Overall Study||1
9076443|NCT02528097|10138036|FG001|STARTED|Overall Study||1
9076444|NCT02528097|10138035|FG000|COMPLETED|Overall Study||1
9076445|NCT02528097|10138036|FG001|COMPLETED|Overall Study||1
9076446|NCT02528097|10138035|FG000|NOT COMPLETED|Overall Study||0
9076447|NCT02528097|10138036|FG001|NOT COMPLETED|Overall Study||0
9076448|NCT02549716|10138044|FG000|STARTED|Overall Study||1
9076449|NCT02549716|10138045|FG001|STARTED|Overall Study||2
9076450|NCT02549716|10138044|FG000|COMPLETED|Overall Study||1
9076451|NCT02549716|10138045|FG001|COMPLETED|Overall Study||2
9076452|NCT02549716|10138044|FG000|NOT COMPLETED|Overall Study||0
9076453|NCT02549716|10138045|FG001|NOT COMPLETED|Overall Study||0
9076454|NCT02540434|10138053|FG000|STARTED|Overall Study||1
9076455|NCT02540434|10138054|FG001|STARTED|Overall Study||1
9076456|NCT02540434|10138053|FG000|COMPLETED|Overall Study||1
9076457|NCT02540434|10138054|FG001|COMPLETED|Overall Study||1
9076458|NCT02540434|10138053|FG000|NOT COMPLETED|Overall Study||0
9076459|NCT02540434|10138054|FG001|NOT COMPLETED|Overall Study||0
9076460|NCT02531308|10138062|FG000|STARTED|Overall Study||5
9076461|NCT02531308|10138062|FG000|COMPLETED|Overall Study||2
9076462|NCT02531308|10138062|FG000|NOT COMPLETED|Overall Study||3
9076463|NCT02533531|10138066|FG000|STARTED|Overall Study||1
9076464|NCT02533531|10138066|FG000|COMPLETED|Overall Study||0
9076465|NCT02533531|10138066|FG000|NOT COMPLETED|Overall Study||1
9076466|NCT02534038|10138072|FG000|STARTED|Period 1 (6 Weeks)||1
9076467|NCT02534038|10138073|FG001|STARTED|Period 1 (6 Weeks)||0
9076468|NCT02534038|10138072|FG000|COMPLETED|Period 1 (6 Weeks)||1
9076469|NCT02534038|10138073|FG001|COMPLETED|Period 1 (6 Weeks)||0
9076470|NCT02534038|10138072|FG000|NOT COMPLETED|Period 1 (6 Weeks)||0
9076471|NCT02534038|10138073|FG001|NOT COMPLETED|Period 1 (6 Weeks)||0
9076472|NCT02534038|10138072|FG000|STARTED|Period 2 (6 Weeks)||1
9076473|NCT02534038|10138073|FG001|STARTED|Period 2 (6 Weeks)||0
9076474|NCT02534038|10138072|FG000|COMPLETED|Period 2 (6 Weeks)||1
9076475|NCT02534038|10138073|FG001|COMPLETED|Period 2 (6 Weeks)||0
9076476|NCT02534038|10138072|FG000|NOT COMPLETED|Period 2 (6 Weeks)||0
9076477|NCT02534038|10138073|FG001|NOT COMPLETED|Period 2 (6 Weeks)||0
9076478|NCT02520726|10138082|FG000|STARTED|Overall Study||3
9076479|NCT02520726|10138083|FG001|STARTED|Overall Study||2
9076480|NCT02520726|10138082|FG000|COMPLETED|Overall Study||0
9076481|NCT02520726|10138083|FG001|COMPLETED|Overall Study||0
9076482|NCT02520726|10138082|FG000|NOT COMPLETED|Overall Study||3
9076483|NCT02520726|10138083|FG001|NOT COMPLETED|Overall Study||2
9076484|NCT02520297|10138089|FG000|STARTED|Overall Study||1
9076485|NCT02520297|10138089|FG000|COMPLETED|Overall Study||1
9076486|NCT02520297|10138089|FG000|NOT COMPLETED|Overall Study||0
9076487|NCT02519712|10138093|FG000|STARTED|Overall Study||4
9076488|NCT02519712|10138093|FG000|COMPLETED|Overall Study||0
9076489|NCT02519712|10138093|FG000|NOT COMPLETED|Overall Study||4
9076490|NCT02518750|10138097|FG000|STARTED|Overall Study||3
9076491|NCT02518750|10138097|FG000|COMPLETED|Overall Study||1
9076492|NCT02518750|10138097|FG000|NOT COMPLETED|Overall Study||2
9076493|NCT02516228|10138101|FG000|STARTED|Overall Study||6
9076494|NCT02516228|10138101|FG000|COMPLETED|Overall Study||3
9076495|NCT02516228|10138101|FG000|NOT COMPLETED|Overall Study||3
9076496|NCT02515851|10138107|FG000|STARTED|Overall Study||15
9076497|NCT02515851|10138108|FG001|STARTED|Overall Study||15
9076498|NCT02515851|10138107|FG000|COMPLETED|Overall Study||15
9076499|NCT02515851|10138108|FG001|COMPLETED|Overall Study||15
9076500|NCT02515851|10138107|FG000|NOT COMPLETED|Overall Study||0
9076501|NCT02515851|10138108|FG001|NOT COMPLETED|Overall Study||0
9076502|NCT02506985|10138116|FG000|STARTED|Overall Study||4
9076503|NCT02506985|10138117|FG001|STARTED|Overall Study||6
8624206|NCT00498615|9663416|FG002|COMPLETED|Placebo||3
8624207|NCT00498615|9663417|FG003|COMPLETED|Placebo||2
9076504|NCT02506985|10138116|FG000|COMPLETED|Overall Study||4
9076505|NCT02506985|10138117|FG001|COMPLETED|Overall Study||6
9076506|NCT02506985|10138116|FG000|NOT COMPLETED|Overall Study||0
9076507|NCT02506985|10138117|FG001|NOT COMPLETED|Overall Study||0
9076508|NCT02514252|10138123|FG000|STARTED|Overall Study||6
9076509|NCT02514252|10138123|FG000|COMPLETED|Overall Study||6
9076510|NCT02514252|10138123|FG000|NOT COMPLETED|Overall Study||0
9076511|NCT02501759|10138127|FG000|STARTED|Overall Study||2
9076512|NCT02501759|10138127|FG000|COMPLETED|Overall Study||1
9076513|NCT02501759|10138127|FG000|NOT COMPLETED|Overall Study||1
9076514|NCT02487277|10138133|FG000|STARTED|Overall Study||3
9076515|NCT02487277|10138134|FG001|STARTED|Overall Study||0
9076516|NCT02487277|10138133|FG000|COMPLETED|Overall Study||3
9076517|NCT02487277|10138134|FG001|COMPLETED|Overall Study||0
9076518|NCT02487277|10138133|FG000|NOT COMPLETED|Overall Study||0
9076519|NCT02487277|10138134|FG001|NOT COMPLETED|Overall Study||0
9076520|NCT02506101|10138141|FG000|STARTED|Overall Study||2
9076521|NCT02506101|10138142|FG001|STARTED|Overall Study||0
9076522|NCT02506101|10138141|FG000|COMPLETED|Overall Study||0
9076523|NCT02506101|10138142|FG001|COMPLETED|Overall Study||0
9076524|NCT02506101|10138141|FG000|NOT COMPLETED|Overall Study||2
9076525|NCT02506101|10138142|FG001|NOT COMPLETED|Overall Study||0
9076526|NCT02499887|10138150|FG000|STARTED|Overall Study||3
9076527|NCT02499887|10138151|FG001|STARTED|Overall Study||3
9076528|NCT02499887|10138150|FG000|COMPLETED|Overall Study||3
8624208|NCT00498615|9663418|FG004|COMPLETED|Placebo||3
8624209|NCT00498615|9663419|FG005|COMPLETED|Placebo||3
8624210|NCT00498615|9663414|FG000|NOT COMPLETED|Placebo||0
8624211|NCT00498615|9663415|FG001|NOT COMPLETED|Placebo||0
9076529|NCT02499887|10138151|FG001|COMPLETED|Overall Study||3
9076530|NCT02499887|10138150|FG000|NOT COMPLETED|Overall Study||0
9076531|NCT02499887|10138151|FG001|NOT COMPLETED|Overall Study||0
9076532|NCT02504099|10138157|FG000|STARTED|Overall Study||3
9076533|NCT02504099|10138157|FG000|COMPLETED|Overall Study||3
9076534|NCT02504099|10138157|FG000|NOT COMPLETED|Overall Study||0
9076535|NCT02500901|10138161|FG000|STARTED|Overall Study||2
9076536|NCT02500901|10138161|FG000|COMPLETED|Overall Study||0
9076537|NCT02500901|10138161|FG000|NOT COMPLETED|Overall Study||2
9076538|NCT02483533|10138167|FG000|STARTED|Overall Study||50
9076539|NCT02483533|10138168|FG001|STARTED|Overall Study||50
9076540|NCT02483533|10138167|FG000|COMPLETED|Overall Study||0
9076541|NCT02483533|10138168|FG001|COMPLETED|Overall Study||0
9076542|NCT02483533|10138167|FG000|NOT COMPLETED|Overall Study||50
9076543|NCT02483533|10138168|FG001|NOT COMPLETED|Overall Study||50
9076544|NCT02496039|10138174|FG000|STARTED|Overall Study||5
9076545|NCT02496039|10138174|FG000|COMPLETED|Overall Study||1
9076546|NCT02496039|10138174|FG000|NOT COMPLETED|Overall Study||4
9076547|NCT02492295|10138178|FG000|STARTED|Overall Study||0
9076548|NCT02492295|10138178|FG000|COMPLETED|Overall Study||0
9076549|NCT02492295|10138178|FG000|NOT COMPLETED|Overall Study||0
9076550|NCT02494206|10138183|FG000|STARTED|Overall Study||9
9076551|NCT02494206|10138183|FG000|COMPLETED|Overall Study||7
9076552|NCT02494206|10138183|FG000|NOT COMPLETED|Overall Study||2
9076553|NCT02473445|10138187|FG000|STARTED|Overall Study||22
9076554|NCT02473445|10138187|FG000|COMPLETED|Overall Study||0
9076555|NCT02473445|10138187|FG000|NOT COMPLETED|Overall Study||22
9076556|NCT02491411|10138191|FG000|STARTED|Overall Study||4
9076557|NCT02491411|10138191|FG000|COMPLETED|Overall Study||0
9076558|NCT02491411|10138191|FG000|NOT COMPLETED|Overall Study||4
9076559|NCT02476994|10138197|FG000|STARTED|Overall Study||1
9076560|NCT02476994|10138198|FG001|STARTED|Overall Study||0
9076561|NCT02476994|10138197|FG000|COMPLETED|Overall Study||0
9076562|NCT02476994|10138198|FG001|COMPLETED|Overall Study||0
9076563|NCT02476994|10138197|FG000|NOT COMPLETED|Overall Study||1
9076564|NCT02476994|10138198|FG001|NOT COMPLETED|Overall Study||0
9076565|NCT02473523|10138204|FG000|STARTED|Overall Study||2
9076566|NCT02473523|10138204|FG000|COMPLETED|Overall Study||0
9076567|NCT02473523|10138204|FG000|NOT COMPLETED|Overall Study||2
9076568|NCT02468583|10138210|FG000|STARTED|Overall Study||3
9076569|NCT02468583|10138211|FG001|STARTED|Overall Study||3
9076570|NCT02468583|10138210|FG000|COMPLETED|Overall Study||3
9076571|NCT02468583|10138211|FG001|COMPLETED|Overall Study||3
9076572|NCT02468583|10138210|FG000|NOT COMPLETED|Overall Study||0
9076573|NCT02468583|10138211|FG001|NOT COMPLETED|Overall Study||0
9076574|NCT02450591|10138217|FG000|STARTED|Overall Study||4
9076575|NCT02450591|10138217|FG000|COMPLETED|Overall Study||4
9076576|NCT02450591|10138217|FG000|NOT COMPLETED|Overall Study||0
9076577|NCT02472639|10138223|FG000|STARTED|Overall Study||4
9076578|NCT02472639|10138224|FG001|STARTED|Overall Study||3
9076579|NCT02472639|10138223|FG000|COMPLETED|Overall Study||0
9076580|NCT02472639|10138224|FG001|COMPLETED|Overall Study||0
9076581|NCT02472639|10138223|FG000|NOT COMPLETED|Overall Study||4
9076582|NCT02472639|10138224|FG001|NOT COMPLETED|Overall Study||3
9076583|NCT02469415|10138230|FG000|STARTED|Overall Study||3
9076584|NCT02469415|10138230|FG000|COMPLETED|Overall Study||0
9076585|NCT02469415|10138230|FG000|NOT COMPLETED|Overall Study||3
9076586|NCT02461550|10138234|FG000|STARTED|Overall Study||2
9076587|NCT02461550|10138234|FG000|COMPLETED|Overall Study||2
9076588|NCT02461550|10138234|FG000|NOT COMPLETED|Overall Study||0
9076589|NCT02461355|10138238|FG000|STARTED|Overall Study||2
9076590|NCT02461355|10138238|FG000|COMPLETED|Overall Study||2
9076591|NCT02461355|10138238|FG000|NOT COMPLETED|Overall Study||0
9076592|NCT02452359|10138242|FG000|STARTED|Overall Study||54
9076593|NCT02452359|10138242|FG000|COMPLETED|Overall Study||33
9076594|NCT02452359|10138242|FG000|NOT COMPLETED|Overall Study||21
9076595|NCT02434146|10138246|FG000|STARTED|Overall Study||3
9076596|NCT02434146|10138246|FG000|COMPLETED|Overall Study||3
9076597|NCT02434146|10138246|FG000|NOT COMPLETED|Overall Study||0
9076598|NCT02452398|10138250|FG000|STARTED|Overall Study|Study was halted prematurely. No results analysis completed.|79
9076599|NCT02452398|10138250|FG000|COMPLETED|Overall Study|Study was halted prematurely. No results analysis completed.|38
9076600|NCT02452398|10138250|FG000|NOT COMPLETED|Overall Study||41
9076601|NCT02447887|10138254|FG000|STARTED|Overall Study||3
9076602|NCT02447887|10138254|FG000|COMPLETED|Overall Study||0
9076603|NCT02447887|10138254|FG000|NOT COMPLETED|Overall Study||3
9076604|NCT02431494|10138261|FG000|STARTED|Overall Study|The results cannot be evaluated because the sample size was so small. He had trouble recruiting|0
9076605|NCT02431494|10138262|FG001|STARTED|Overall Study|The results cannot be evaluated because the sample size was so small. He had trouble recruiting|0
9076606|NCT02431494|10138263|FG002|STARTED|Overall Study|The results cannot be evaluated because the sample size was so small. He had trouble recruiting|0
9076607|NCT02431494|10138261|FG000|COMPLETED|Overall Study||0
9076608|NCT02431494|10138262|FG001|COMPLETED|Overall Study||0
9076609|NCT02431494|10138263|FG002|COMPLETED|Overall Study||0
9076610|NCT02431494|10138261|FG000|NOT COMPLETED|Overall Study||0
9076611|NCT02431494|10138262|FG001|NOT COMPLETED|Overall Study||0
9076612|NCT02431494|10138263|FG002|NOT COMPLETED|Overall Study||0
9076613|NCT02439970|10138275|FG000|STARTED|Overall Study||2
9076614|NCT02439970|10138276|FG001|STARTED|Overall Study||3
9076615|NCT02439970|10138275|FG000|COMPLETED|Overall Study||0
9076616|NCT02439970|10138276|FG001|COMPLETED|Overall Study||0
9076617|NCT02439970|10138275|FG000|NOT COMPLETED|Overall Study||2
9076618|NCT02439970|10138276|FG001|NOT COMPLETED|Overall Study||3
9076619|NCT02439957|10138284|FG000|STARTED|Overall Study||3
9076620|NCT02439957|10138285|FG001|STARTED|Overall Study||3
9076621|NCT02439957|10138284|FG000|Blinded Treatment Period|Overall Study||1
9076622|NCT02439957|10138285|FG001|Blinded Treatment Period|Overall Study||2
9076623|NCT02439957|10138284|FG000|COMPLETED|Overall Study||0
9076624|NCT02439957|10138285|FG001|COMPLETED|Overall Study||0
9076625|NCT02439957|10138284|FG000|NOT COMPLETED|Overall Study||3
9076626|NCT02439957|10138285|FG001|NOT COMPLETED|Overall Study||3
9076627|NCT02441036|10138296|FG000|STARTED|Overall Study||3
9076628|NCT02441036|10138297|FG001|STARTED|Overall Study||5
9076629|NCT02441036|10138298|FG002|STARTED|Overall Study||3
9076630|NCT02441036|10138299|FG003|STARTED|Overall Study||4
9076631|NCT02441036|10138300|FG004|STARTED|Overall Study||1
9076632|NCT02441036|10138296|FG000|Treated|Overall Study||3
9076633|NCT02441036|10138297|FG001|Treated|Overall Study||5
9076634|NCT02441036|10138298|FG002|Treated|Overall Study||3
9076635|NCT02441036|10138299|FG003|Treated|Overall Study||4
9076636|NCT02441036|10138300|FG004|Treated|Overall Study||1
9076637|NCT02441036|10138296|FG000|Tissue Resected|Overall Study||3
9076638|NCT02441036|10138297|FG001|Tissue Resected|Overall Study||4
9076639|NCT02441036|10138298|FG002|Tissue Resected|Overall Study||3
9076640|NCT02441036|10138299|FG003|Tissue Resected|Overall Study||3
9076641|NCT02441036|10138300|FG004|Tissue Resected|Overall Study||1
9076642|NCT02441036|10138296|FG000|COMPLETED|Overall Study||3
9076643|NCT02441036|10138297|FG001|COMPLETED|Overall Study||4
9076644|NCT02441036|10138298|FG002|COMPLETED|Overall Study||3
9076645|NCT02441036|10138299|FG003|COMPLETED|Overall Study||3
9076646|NCT02441036|10138300|FG004|COMPLETED|Overall Study||1
9076647|NCT02441036|10138296|FG000|NOT COMPLETED|Overall Study||0
9076648|NCT02441036|10138297|FG001|NOT COMPLETED|Overall Study||1
9076649|NCT02441036|10138298|FG002|NOT COMPLETED|Overall Study||0
9076650|NCT02441036|10138299|FG003|NOT COMPLETED|Overall Study||1
9076651|NCT02441036|10138300|FG004|NOT COMPLETED|Overall Study||0
9076652|NCT02436265|10138315|FG000|STARTED|Overall Study||3
9076653|NCT02436265|10138316|FG001|STARTED|Overall Study||4
9076654|NCT02436265|10138315|FG000|COMPLETED|Overall Study||3
9076655|NCT02436265|10138316|FG001|COMPLETED|Overall Study||4
9076656|NCT02436265|10138315|FG000|NOT COMPLETED|Overall Study||0
9076657|NCT02436265|10138316|FG001|NOT COMPLETED|Overall Study||0
9076658|NCT02429583|10138324|FG000|STARTED|Overall Study||1
9076659|NCT02429583|10138325|FG001|STARTED|Overall Study||23
9076660|NCT02429583|10138324|FG000|COMPLETED|Overall Study||1
9076661|NCT02429583|10138325|FG001|COMPLETED|Overall Study||3
9076662|NCT02429583|10138324|FG000|NOT COMPLETED|Overall Study||0
9076663|NCT02429583|10138325|FG001|NOT COMPLETED|Overall Study||20
9076664|NCT02417870|10138331|FG000|STARTED|Overall Study||2
8624212|NCT00498615|9663416|FG002|NOT COMPLETED|Placebo||0
8624213|NCT00498615|9663417|FG003|NOT COMPLETED|Placebo||0
8624214|NCT00498615|9663418|FG004|NOT COMPLETED|Placebo||0
9076665|NCT02417870|10138331|FG000|COMPLETED|Overall Study||0
9076666|NCT02417870|10138331|FG000|NOT COMPLETED|Overall Study||2
9076667|NCT02430532|10138337|FG000|STARTED|Overall Study||30
9076668|NCT02430532|10138338|FG001|STARTED|Overall Study||28
8624215|NCT00498615|9663419|FG005|NOT COMPLETED|Placebo||0
8624216|NCT00498628|9663435|FG000|STARTED|Overall Study||105
8624217|NCT00498628|9663436|FG001|STARTED|Overall Study||113
8624218|NCT00498628|9663435|FG000|COMPLETED|Overall Study||90
8624219|NCT00498628|9663436|FG001|COMPLETED|Overall Study||92
9076669|NCT02430532|10138337|FG000|COMPLETED|Overall Study||0
9076670|NCT02430532|10138338|FG001|COMPLETED|Overall Study||0
9076671|NCT02430532|10138337|FG000|NOT COMPLETED|Overall Study||30
9076672|NCT02430532|10138338|FG001|NOT COMPLETED|Overall Study||28
9076673|NCT02428231|10138348|FG000|STARTED|Overall Study||30
9076674|NCT02428231|10138349|FG001|STARTED|Overall Study||32
9076675|NCT02428231|10138348|FG000|COMPLETED|Overall Study||17
8624220|NCT00498628|9663435|FG000|NOT COMPLETED|Overall Study||15
8624221|NCT00498628|9663436|FG001|NOT COMPLETED|Overall Study||21
8624222|NCT00498706|9663446|FG000|STARTED|Overall Study||163
8624223|NCT00498706|9663447|FG001|STARTED|Overall Study||162
8624224|NCT00498706|9663446|FG000|Post Treatment Week 18|Overall Study||163
9076676|NCT02428231|10138349|FG001|COMPLETED|Overall Study||15
9076677|NCT02428231|10138348|FG000|NOT COMPLETED|Overall Study||13
9076678|NCT02428231|10138349|FG001|NOT COMPLETED|Overall Study||17
9076679|NCT02424565|10138355|FG000|STARTED|Period 1 (D0)||8
9076680|NCT02424565|10138356|FG001|STARTED|Period 1 (D0)||7
8624225|NCT00498706|9663447|FG001|Post Treatment Week 18|Overall Study||162
8624226|NCT00498706|9663446|FG000|COMPLETED|Overall Study||163
8624227|NCT00498706|9663447|FG001|COMPLETED|Overall Study||162
8624228|NCT00498706|9663446|FG000|NOT COMPLETED|Overall Study||0
8624229|NCT00498706|9663447|FG001|NOT COMPLETED|Overall Study||0
8624230|NCT00498797|9663457|FG000|STARTED|Overall Study|randomised patients|43
8624231|NCT00498797|9663458|FG001|STARTED|Overall Study|randomised patients|43
8624232|NCT00498797|9663457|FG000|COMPLETED|Overall Study|ongoing study treatment at data cut-off|5
8624233|NCT00498797|9663458|FG001|COMPLETED|Overall Study|ongoing study treatment at data cut-off|14
8624234|NCT00498797|9663457|FG000|NOT COMPLETED|Overall Study||38
8624235|NCT00498797|9663458|FG001|NOT COMPLETED|Overall Study||29
8624236|NCT00498927|9663464|FG000|STARTED|Overall Study||47
8624237|NCT00498927|9663464|FG000|COMPLETED|Overall Study||47
8624238|NCT00498927|9663464|FG000|NOT COMPLETED|Overall Study||0
8624239|NCT00498940|9663470|FG000|STARTED|Overall Study||30
8624240|NCT00498940|9663471|FG001|STARTED|Overall Study||31
9076681|NCT02424565|10138355|FG000|COMPLETED|Period 1 (D0)||8
9076682|NCT02424565|10138356|FG001|COMPLETED|Period 1 (D0)||6
9076683|NCT02424565|10138355|FG000|NOT COMPLETED|Period 1 (D0)||0
9076684|NCT02424565|10138356|FG001|NOT COMPLETED|Period 1 (D0)||1
9076685|NCT02424565|10138355|FG000|STARTED|Washout Period||8
9076686|NCT02424565|10138356|FG001|STARTED|Washout Period||6
9076687|NCT02424565|10138355|FG000|COMPLETED|Washout Period||8
9076688|NCT02424565|10138356|FG001|COMPLETED|Washout Period||6
9076689|NCT02424565|10138355|FG000|NOT COMPLETED|Washout Period||0
9076690|NCT02424565|10138356|FG001|NOT COMPLETED|Washout Period||0
9076691|NCT02424565|10138355|FG000|STARTED|Period 2 (D3)||8
9076692|NCT02424565|10138356|FG001|STARTED|Period 2 (D3)||6
9076693|NCT02424565|10138355|FG000|COMPLETED|Period 2 (D3)||8
9076694|NCT02424565|10138356|FG001|COMPLETED|Period 2 (D3)||6
9076695|NCT02424565|10138355|FG000|NOT COMPLETED|Period 2 (D3)||0
9076696|NCT02424565|10138356|FG001|NOT COMPLETED|Period 2 (D3)||0
9076697|NCT02413047|10138362|FG000|STARTED|Overall Study||3
9076698|NCT02413047|10138362|FG000|Participants on Infliximab|Overall Study||2
9076699|NCT02413047|10138362|FG000|Participants on Adalimumab|Overall Study||1
9076700|NCT02413047|10138362|FG000|COMPLETED|Overall Study||3
9076701|NCT02413047|10138362|FG000|NOT COMPLETED|Overall Study||0
9076702|NCT02414698|10138368|FG000|STARTED|Overall Study||3
9076703|NCT02414698|10138369|FG001|STARTED|Overall Study||1
9076704|NCT02414698|10138368|FG000|COMPLETED|Overall Study||3
9076705|NCT02414698|10138369|FG001|COMPLETED|Overall Study||1
9076706|NCT02414698|10138368|FG000|NOT COMPLETED|Overall Study||0
9076707|NCT02414698|10138369|FG001|NOT COMPLETED|Overall Study||0
9076708|NCT02422303|10138377|FG000|STARTED|Overall Study||6
9076709|NCT02422303|10138378|FG001|STARTED|Overall Study||6
9076710|NCT02422303|10138377|FG000|COMPLETED|Overall Study||5
9076711|NCT02422303|10138378|FG001|COMPLETED|Overall Study||5
9076712|NCT02422303|10138377|FG000|NOT COMPLETED|Overall Study||1
9076713|NCT02422303|10138378|FG001|NOT COMPLETED|Overall Study||1
9076714|NCT02415166|10138388|FG000|STARTED|Overall Study||6
9076715|NCT02415166|10138389|FG001|STARTED|Overall Study||0
9076716|NCT02415166|10138390|FG002|STARTED|Overall Study||0
9076717|NCT02415166|10138391|FG003|STARTED|Overall Study||0
9076718|NCT02415166|10138388|FG000|COMPLETED|Overall Study||6
9076719|NCT02415166|10138389|FG001|COMPLETED|Overall Study||0
9076720|NCT02415166|10138390|FG002|COMPLETED|Overall Study||0
9076721|NCT02415166|10138391|FG003|COMPLETED|Overall Study||0
9076722|NCT02415166|10138388|FG000|NOT COMPLETED|Overall Study||0
9076723|NCT02415166|10138389|FG001|NOT COMPLETED|Overall Study||0
9076724|NCT02415166|10138390|FG002|NOT COMPLETED|Overall Study||0
9076725|NCT02415166|10138391|FG003|NOT COMPLETED|Overall Study||0
9076726|NCT02414152|10138401|FG000|STARTED|Overall Study||2
9076727|NCT02414152|10138401|FG000|COMPLETED|Overall Study|Both subjects completed 56 days of anakinra but did not complete all visits in observational period|0
9076728|NCT02414152|10138401|FG000|NOT COMPLETED|Overall Study||2
9076729|NCT02410551|10138405|FG000|STARTED|Overall Study||4
9076730|NCT02410551|10138405|FG000|COMPLETED|Overall Study||0
9076731|NCT02410551|10138405|FG000|NOT COMPLETED|Overall Study||4
9076732|NCT02411643|10138410|FG000|STARTED|Overall Study||2
9076733|NCT02411643|10138410|FG000|COMPLETED|Overall Study||2
9076734|NCT02411643|10138410|FG000|NOT COMPLETED|Overall Study||0
9076735|NCT02410954|10138416|FG000|STARTED|Overall Study||14
9076736|NCT02410954|10138417|FG001|STARTED|Overall Study||0
9076737|NCT02410954|10138416|FG000|COMPLETED|Overall Study||0
9076738|NCT02410954|10138417|FG001|COMPLETED|Overall Study||0
9076739|NCT02410954|10138416|FG000|NOT COMPLETED|Overall Study||14
9076740|NCT02410954|10138417|FG001|NOT COMPLETED|Overall Study||0
9076741|NCT02410577|10138423|FG000|STARTED|Overall Study||2
9076742|NCT02410577|10138423|FG000|COMPLETED|Overall Study||2
9076743|NCT02410577|10138423|FG000|NOT COMPLETED|Overall Study||0
9076744|NCT02409355|10138429|FG000|STARTED|Overall Study||4
9076745|NCT02409355|10138430|FG001|STARTED|Overall Study||4
8624241|NCT00498940|9663470|FG000|COMPLETED|Overall Study||30
9076746|NCT02409355|10138429|FG000|COMPLETED|Overall Study||0
9076747|NCT02409355|10138430|FG001|COMPLETED|Overall Study||0
9076748|NCT02409355|10138429|FG000|NOT COMPLETED|Overall Study||4
9076749|NCT02409355|10138430|FG001|NOT COMPLETED|Overall Study||4
9076750|NCT02403154|10138440|FG000|STARTED|Overall Study||2
9076751|NCT02403154|10138441|FG001|STARTED|Overall Study||0
9076752|NCT02403154|10138442|FG002|STARTED|Overall Study||1
9076753|NCT02403154|10138443|FG003|STARTED|Overall Study||1
8624242|NCT00498940|9663471|FG001|COMPLETED|Overall Study||31
9076754|NCT02403154|10138440|FG000|COMPLETED|Overall Study||0
9076755|NCT02403154|10138441|FG001|COMPLETED|Overall Study||0
9076756|NCT02403154|10138442|FG002|COMPLETED|Overall Study||0
9076757|NCT02403154|10138443|FG003|COMPLETED|Overall Study||0
9076758|NCT02403154|10138440|FG000|NOT COMPLETED|Overall Study||2
9076759|NCT02403154|10138441|FG001|NOT COMPLETED|Overall Study||0
9076760|NCT02403154|10138442|FG002|NOT COMPLETED|Overall Study||1
9076761|NCT02403154|10138443|FG003|NOT COMPLETED|Overall Study||1
9076762|NCT02404545|10138455|FG000|STARTED|Overall Study||6
9076763|NCT02404545|10138456|FG001|STARTED|Overall Study||6
9076764|NCT02404545|10138455|FG000|COMPLETED|Overall Study||0
9076765|NCT02404545|10138456|FG001|COMPLETED|Overall Study||0
9076766|NCT02404545|10138455|FG000|NOT COMPLETED|Overall Study||6
9076767|NCT02404545|10138456|FG001|NOT COMPLETED|Overall Study||6
9076768|NCT02392377|10138465|FG000|STARTED|Overall Study||0
9076769|NCT02392377|10138466|FG001|STARTED|Overall Study||1
9076770|NCT02392377|10138465|FG000|COMPLETED|Overall Study||0
9076771|NCT02392377|10138466|FG001|COMPLETED|Overall Study||0
9076772|NCT02392377|10138465|FG000|NOT COMPLETED|Overall Study||0
9076773|NCT02392377|10138466|FG001|NOT COMPLETED|Overall Study||1
9076774|NCT02399111|10138478|FG000|STARTED|Overall Study||4
8624243|NCT00498940|9663470|FG000|NOT COMPLETED|Overall Study||0
8624244|NCT00498940|9663471|FG001|NOT COMPLETED|Overall Study||0
8624245|NCT00499031|9663477|FG000|STARTED|Overall Study|Total number participants enrolled on study|38
8624246|NCT00499031|9663477|FG000|COMPLETED|Overall Study|Total number participants that are eligible and evaluable.|35
8624247|NCT00499031|9663477|FG000|NOT COMPLETED|Overall Study||3
8624248|NCT00499083|9663481|FG000|STARTED|Overall Study||17
9076775|NCT02399111|10138479|FG001|STARTED|Overall Study||1
9076776|NCT02399111|10138480|FG002|STARTED|Overall Study||4
9076777|NCT02399111|10138481|FG003|STARTED|Overall Study||0
9076778|NCT02399111|10138478|FG000|COMPLETED|Overall Study||4
9076779|NCT02399111|10138479|FG001|COMPLETED|Overall Study||1
9076780|NCT02399111|10138480|FG002|COMPLETED|Overall Study||4
9076781|NCT02399111|10138481|FG003|COMPLETED|Overall Study||0
9076782|NCT02399111|10138478|FG000|NOT COMPLETED|Overall Study||0
9076783|NCT02399111|10138479|FG001|NOT COMPLETED|Overall Study||0
9076784|NCT02399111|10138480|FG002|NOT COMPLETED|Overall Study||0
9076785|NCT02399111|10138481|FG003|NOT COMPLETED|Overall Study||0
9076786|NCT02402036|10138493|FG000|STARTED|Overall Study||10
9076787|NCT02402036|10138493|FG000|COMPLETED|Overall Study||10
9076788|NCT02402036|10138493|FG000|NOT COMPLETED|Overall Study||0
9076789|NCT02394665|10138500|FG000|STARTED|Overall Study||1
9076790|NCT02394665|10138501|FG001|STARTED|Overall Study||0
9076791|NCT02394665|10138502|FG002|STARTED|Overall Study||0
9076792|NCT02394665|10138500|FG000|COMPLETED|Overall Study||0
9076793|NCT02394665|10138501|FG001|COMPLETED|Overall Study||0
9076794|NCT02394665|10138502|FG002|COMPLETED|Overall Study||0
9076795|NCT02394665|10138500|FG000|NOT COMPLETED|Overall Study||1
9076796|NCT02394665|10138501|FG001|NOT COMPLETED|Overall Study||0
9076797|NCT02394665|10138502|FG002|NOT COMPLETED|Overall Study||0
9076798|NCT02389712|10138512|FG000|STARTED|Overall Study||1
9076799|NCT02389712|10138513|FG001|STARTED|Overall Study||1
9076800|NCT02389712|10138512|FG000|COMPLETED|Overall Study||1
9076801|NCT02389712|10138513|FG001|COMPLETED|Overall Study||1
9076802|NCT02389712|10138512|FG000|NOT COMPLETED|Overall Study||0
9076803|NCT02389712|10138513|FG001|NOT COMPLETED|Overall Study||0
9076804|NCT02390362|10138521|FG000|STARTED|Overall Study|1 subject enrolled in this arm. completed 2 doses of Rituximab.|1
9076805|NCT02390362|10138522|FG001|STARTED|Overall Study||2
9076806|NCT02390362|10138521|FG000|COMPLETED|Overall Study||1
9076807|NCT02390362|10138522|FG001|COMPLETED|Overall Study||1
9076808|NCT02390362|10138521|FG000|NOT COMPLETED|Overall Study||0
9076809|NCT02390362|10138522|FG001|NOT COMPLETED|Overall Study||1
9076810|NCT02388776|10138528|FG000|STARTED|Overall Study||2
9076811|NCT02388776|10138528|FG000|COMPLETED|Overall Study||0
9076812|NCT02388776|10138528|FG000|NOT COMPLETED|Overall Study||2
9076813|NCT02383433|10138533|FG000|STARTED|Overall Study||2
9076814|NCT02383433|10138533|FG000|COMPLETED|Overall Study||0
9076815|NCT02383433|10138533|FG000|NOT COMPLETED|Overall Study||2
9076816|NCT02382588|10138539|FG000|STARTED|Overall Study||4
9076817|NCT02382588|10138540|FG001|STARTED|Overall Study||4
9076818|NCT02382588|10138539|FG000|COMPLETED|Overall Study||4
9076819|NCT02382588|10138540|FG001|COMPLETED|Overall Study||4
9076820|NCT02382588|10138539|FG000|NOT COMPLETED|Overall Study||0
9076821|NCT02382588|10138540|FG001|NOT COMPLETED|Overall Study||0
9076822|NCT02381626|10138549|FG000|STARTED|Overall Study||17
9076823|NCT02381626|10138550|FG001|STARTED|Overall Study||16
9076824|NCT02381626|10138551|FG002|STARTED|Overall Study||6
9076825|NCT02381626|10138549|FG000|COMPLETED|Overall Study||17
9076826|NCT02381626|10138550|FG001|COMPLETED|Overall Study||16
9076827|NCT02381626|10138551|FG002|COMPLETED|Overall Study||6
9076828|NCT02381626|10138549|FG000|NOT COMPLETED|Overall Study||0
9076829|NCT02381626|10138550|FG001|NOT COMPLETED|Overall Study||0
9076830|NCT02381626|10138551|FG002|NOT COMPLETED|Overall Study||0
9076831|NCT02379390|10138561|FG000|STARTED|Overall Study||4
9076832|NCT02379390|10138562|FG001|STARTED|Overall Study||4
9076833|NCT02379390|10138561|FG000|COMPLETED|Overall Study||2
9076834|NCT02379390|10138562|FG001|COMPLETED|Overall Study||2
9076835|NCT02379390|10138561|FG000|NOT COMPLETED|Overall Study||2
9076836|NCT02379390|10138562|FG001|NOT COMPLETED|Overall Study||2
9076837|NCT02373865|10138573|FG000|STARTED|Overall Study||2
9076838|NCT02373865|10138574|FG001|STARTED|Overall Study||2
9076839|NCT02373865|10138573|FG000|COMPLETED|Overall Study||2
9076840|NCT02373865|10138574|FG001|COMPLETED|Overall Study||2
9076841|NCT02373865|10138573|FG000|NOT COMPLETED|Overall Study||0
9076842|NCT02373865|10138574|FG001|NOT COMPLETED|Overall Study||0
9076843|NCT02365688|10138580|FG000|STARTED|Overall Study|All subjects received a bolus of 500cc before first incision|18
9076844|NCT02365688|10138580|FG000|COMPLETED|Overall Study|All subjects consented to an change in standard infusion volume pre-incision|18
9076845|NCT02365688|10138580|FG000|NOT COMPLETED|Overall Study||0
9076846|NCT02361580|10138586|FG000|STARTED|Overall Study||6
9076847|NCT02361580|10138587|FG001|STARTED|Overall Study||3
9076848|NCT02361580|10138586|FG000|COMPLETED|Overall Study||0
9076849|NCT02361580|10138587|FG001|COMPLETED|Overall Study||0
9076850|NCT02361580|10138586|FG000|NOT COMPLETED|Overall Study||6
9076851|NCT02361580|10138587|FG001|NOT COMPLETED|Overall Study||3
9076852|NCT02369744|10138595|FG000|STARTED|Overall Study||0
9076853|NCT02369744|10138596|FG001|STARTED|Overall Study||0
9076854|NCT02369744|10138595|FG000|COMPLETED|Overall Study||0
9076855|NCT02369744|10138596|FG001|COMPLETED|Overall Study||0
9076856|NCT02369744|10138595|FG000|NOT COMPLETED|Overall Study||0
9076857|NCT02369744|10138596|FG001|NOT COMPLETED|Overall Study||0
9076858|NCT02379585|10138604|FG000|STARTED|Overall Study||3
9076859|NCT02379585|10138605|FG001|STARTED|Overall Study||5
9076860|NCT02379585|10138604|FG000|COMPLETED|Overall Study||0
9076861|NCT02379585|10138605|FG001|COMPLETED|Overall Study||0
9076862|NCT02379585|10138604|FG000|NOT COMPLETED|Overall Study||3
9076863|NCT02379585|10138605|FG001|NOT COMPLETED|Overall Study||5
9076864|NCT02370888|10138618|FG000|STARTED|Overall Study||9
9076865|NCT02370888|10138618|FG000|Proceed to Treatment|Overall Study||3
9076866|NCT02370888|10138618|FG000|COMPLETED|Overall Study||1
9076867|NCT02370888|10138618|FG000|NOT COMPLETED|Overall Study||8
9076868|NCT02367170|10138628|FG000|STARTED|Overall Study||1
9076869|NCT02367170|10138629|FG001|STARTED|Overall Study||0
9076870|NCT02367170|10138628|FG000|COMPLETED|Overall Study||1
9076871|NCT02367170|10138629|FG001|COMPLETED|Overall Study||0
9076872|NCT02367170|10138628|FG000|NOT COMPLETED|Overall Study||0
9076873|NCT02367170|10138629|FG001|NOT COMPLETED|Overall Study||0
9076874|NCT02376933|10138635|FG000|STARTED|Overall Study||10
9076875|NCT02376933|10138635|FG000|COMPLETED|Overall Study||8
9076876|NCT02376933|10138635|FG000|NOT COMPLETED|Overall Study||2
9076877|NCT02365233|10138642|FG000|STARTED|Overall Study||1
9076878|NCT02365233|10138643|FG001|STARTED|Overall Study||2
9076879|NCT02365233|10138644|FG002|STARTED|Overall Study||2
9076880|NCT02365233|10138642|FG000|COMPLETED|Overall Study||0
9076881|NCT02365233|10138643|FG001|COMPLETED|Overall Study||0
9076882|NCT02365233|10138644|FG002|COMPLETED|Overall Study||0
9076883|NCT02365233|10138642|FG000|NOT COMPLETED|Overall Study||1
9076884|NCT02365233|10138643|FG001|NOT COMPLETED|Overall Study||2
9076885|NCT02365233|10138644|FG002|NOT COMPLETED|Overall Study||2
9076886|NCT02347943|10138655|FG000|STARTED|Overall Study||140
9076887|NCT02347943|10138656|FG001|STARTED|Overall Study||67
9076888|NCT02347943|10138657|FG002|STARTED|Overall Study||45
9076889|NCT02347943|10138655|FG000|COMPLETED|Overall Study||0
9076890|NCT02347943|10138656|FG001|COMPLETED|Overall Study||0
9076891|NCT02347943|10138657|FG002|COMPLETED|Overall Study||0
9076892|NCT02347943|10138655|FG000|NOT COMPLETED|Overall Study||140
9076893|NCT02347943|10138656|FG001|NOT COMPLETED|Overall Study||67
9076894|NCT02347943|10138657|FG002|NOT COMPLETED|Overall Study||45
9076895|NCT02365207|10138665|FG000|STARTED|Overall Study||6
9076896|NCT02365207|10138665|FG000|COMPLETED|Overall Study||4
9076897|NCT02365207|10138665|FG000|NOT COMPLETED|Overall Study||2
9076898|NCT02360111|10138669|FG000|STARTED|Overall Study||3
9076899|NCT02360111|10138669|FG000|COMPLETED|Overall Study||1
9076900|NCT02360111|10138669|FG000|NOT COMPLETED|Overall Study||2
9076901|NCT02353468|10138673|FG000|STARTED|Overall Study||3
9076902|NCT02353468|10138673|FG000|COMPLETED|Overall Study||0
9076903|NCT02353468|10138673|FG000|NOT COMPLETED|Overall Study||3
9076904|NCT02360059|10138679|FG000|STARTED|Overall Study||1
9076905|NCT02360059|10138680|FG001|STARTED|Overall Study||0
9076906|NCT02360059|10138679|FG000|COMPLETED|Overall Study||1
9076907|NCT02360059|10138680|FG001|COMPLETED|Overall Study||0
9076908|NCT02360059|10138679|FG000|NOT COMPLETED|Overall Study||0
9076909|NCT02360059|10138680|FG001|NOT COMPLETED|Overall Study||0
9076910|NCT02350777|10138688|FG000|STARTED|Overall Study||2
9076911|NCT02350777|10138689|FG001|STARTED|Overall Study||2
9076912|NCT02350777|10138688|FG000|COMPLETED|Overall Study||2
9076913|NCT02350777|10138689|FG001|COMPLETED|Overall Study||2
9076914|NCT02350777|10138688|FG000|NOT COMPLETED|Overall Study||0
9076915|NCT02350777|10138689|FG001|NOT COMPLETED|Overall Study||0
9076916|NCT02345460|10138695|FG000|STARTED|Overall Study||1
9076917|NCT02345460|10138695|FG000|COMPLETED|Overall Study||1
9076918|NCT02345460|10138695|FG000|NOT COMPLETED|Overall Study||0
9076919|NCT02346877|10138701|FG000|STARTED|Overall Study||19
9076920|NCT02346877|10138702|FG001|STARTED|Overall Study||0
9076921|NCT02346877|10138701|FG000|COMPLETED|Overall Study||0
9076922|NCT02346877|10138702|FG001|COMPLETED|Overall Study||0
9076923|NCT02346877|10138701|FG000|NOT COMPLETED|Overall Study||19
9076924|NCT02346877|10138702|FG001|NOT COMPLETED|Overall Study||0
9076925|NCT02351063|10138708|FG000|STARTED|Overall Study||1
9076926|NCT02351063|10138708|FG000|COMPLETED|Overall Study|Study terminated. No study data collected.|1
9076927|NCT02351063|10138708|FG000|NOT COMPLETED|Overall Study||0
9076928|NCT02345772|10138712|FG000|STARTED|Overall Study||4
9076929|NCT02345772|10138712|FG000|COMPLETED|Overall Study||0
9076930|NCT02345772|10138712|FG000|NOT COMPLETED|Overall Study||4
9076931|NCT02340728|10138718|FG000|STARTED|Overall Study||13
9076932|NCT02340728|10138719|FG001|STARTED|Overall Study||11
9076933|NCT02340728|10138718|FG000|COMPLETED|Overall Study||13
9076934|NCT02340728|10138719|FG001|COMPLETED|Overall Study||11
9076935|NCT02340728|10138718|FG000|NOT COMPLETED|Overall Study||0
9076936|NCT02340728|10138719|FG001|NOT COMPLETED|Overall Study||0
9076937|NCT02353572|10138725|FG000|STARTED|Overall Study||3
9076938|NCT02353572|10138725|FG000|COMPLETED|Overall Study||0
9076939|NCT02353572|10138725|FG000|NOT COMPLETED|Overall Study||3
9076940|NCT02345369|10138731|FG000|STARTED|Overall Study||0
9076941|NCT02345369|10138732|FG001|STARTED|Overall Study||0
9076942|NCT02345369|10138731|FG000|COMPLETED|Overall Study||0
8624249|NCT00499083|9663481|FG000|Participants at UNMC|Overall Study||3
8624250|NCT00499083|9663481|FG000|Participants at Moffitt Cancer Center|Overall Study||14
8624251|NCT00499083|9663481|FG000|COMPLETED|Overall Study||14
9076943|NCT02345369|10138732|FG001|COMPLETED|Overall Study||0
9076944|NCT02345369|10138731|FG000|NOT COMPLETED|Overall Study||0
9076945|NCT02345369|10138732|FG001|NOT COMPLETED|Overall Study||0
9076946|NCT02343263|10138741|FG000|STARTED|Overall Study|Study closed due for administrative reasons|5
9076947|NCT02343263|10138742|FG001|STARTED|Overall Study||3
9076948|NCT02343263|10138743|FG002|STARTED|Overall Study||1
9076949|NCT02343263|10138741|FG000|COMPLETED|Overall Study|Study closed due for administrative reasons|0
9076950|NCT02343263|10138742|FG001|COMPLETED|Overall Study||0
9076951|NCT02343263|10138743|FG002|COMPLETED|Overall Study||0
9076952|NCT02343263|10138741|FG000|NOT COMPLETED|Overall Study||5
9076953|NCT02343263|10138742|FG001|NOT COMPLETED|Overall Study||3
9076954|NCT02343263|10138743|FG002|NOT COMPLETED|Overall Study||1
9076955|NCT02343159|10138758|FG000|STARTED|Overall Study||27
9076956|NCT02343159|10138759|FG001|STARTED|Overall Study||27
9076957|NCT02343159|10138760|FG002|STARTED|Overall Study||30
9076958|NCT02343159|10138758|FG000|COMPLETED|Overall Study||1
9076959|NCT02343159|10138759|FG001|COMPLETED|Overall Study||1
9076960|NCT02343159|10138760|FG002|COMPLETED|Overall Study||0
9076961|NCT02343159|10138758|FG000|NOT COMPLETED|Overall Study||26
9076962|NCT02343159|10138759|FG001|NOT COMPLETED|Overall Study||26
9076963|NCT02343159|10138760|FG002|NOT COMPLETED|Overall Study||30
9076964|NCT02341495|10138769|FG000|STARTED|Overall Study||4
9076965|NCT02341495|10138769|FG000|COMPLETED|Overall Study||4
9076966|NCT02341495|10138769|FG000|NOT COMPLETED|Overall Study||0
9076967|NCT02336425|10138777|FG000|STARTED|Overall Study||2
9076968|NCT02336425|10138778|FG001|STARTED|Overall Study||2
9076969|NCT02336425|10138779|FG002|STARTED|Overall Study||3
9076970|NCT02336425|10138780|FG003|STARTED|Overall Study||3
9076971|NCT02336425|10138777|FG000|COMPLETED|Overall Study||0
9076972|NCT02336425|10138778|FG001|COMPLETED|Overall Study||0
9076973|NCT02336425|10138779|FG002|COMPLETED|Overall Study||0
9076974|NCT02336425|10138780|FG003|COMPLETED|Overall Study||0
9076975|NCT02336425|10138777|FG000|NOT COMPLETED|Overall Study||2
9076976|NCT02336425|10138778|FG001|NOT COMPLETED|Overall Study||2
9076977|NCT02336425|10138779|FG002|NOT COMPLETED|Overall Study||3
9076978|NCT02336425|10138780|FG003|NOT COMPLETED|Overall Study||3
9076979|NCT02336763|10138790|FG000|STARTED|Overall Study||2
9076980|NCT02336763|10138790|FG000|COMPLETED|Overall Study||2
9076981|NCT02336763|10138790|FG000|NOT COMPLETED|Overall Study||0
9076982|NCT02320825|10138796|FG000|STARTED|Overall Study||8
9076983|NCT02320825|10138797|FG001|STARTED|Overall Study||8
9076984|NCT02320825|10138796|FG000|COMPLETED|Overall Study||8
9076985|NCT02320825|10138797|FG001|COMPLETED|Overall Study||8
9076986|NCT02320825|10138796|FG000|NOT COMPLETED|Overall Study||0
9076987|NCT02320825|10138797|FG001|NOT COMPLETED|Overall Study||0
9076988|NCT02319005|10138805|FG000|STARTED|Overall Study||140
9076989|NCT02319005|10138806|FG001|STARTED|Overall Study||66
9076990|NCT02319005|10138805|FG000|COMPLETED|Overall Study||92
8624252|NCT00499083|9663481|FG000|NOT COMPLETED|Overall Study||3
9076991|NCT02319005|10138806|FG001|COMPLETED|Overall Study||51
9076992|NCT02319005|10138805|FG000|NOT COMPLETED|Overall Study||48
9076993|NCT02319005|10138806|FG001|NOT COMPLETED|Overall Study||15
9076994|NCT02318901|10138815|FG000|STARTED|Overall Study||5
9076995|NCT02318901|10138816|FG001|STARTED|Overall Study||1
9076996|NCT02318901|10138817|FG002|STARTED|Overall Study||10
9076997|NCT02318901|10138815|FG000|COMPLETED|Overall Study||0
9076998|NCT02318901|10138816|FG001|COMPLETED|Overall Study||0
9076999|NCT02318901|10138817|FG002|COMPLETED|Overall Study||0
9077000|NCT02318901|10138815|FG000|NOT COMPLETED|Overall Study||5
9077001|NCT02318901|10138816|FG001|NOT COMPLETED|Overall Study||1
9077002|NCT02318901|10138817|FG002|NOT COMPLETED|Overall Study||10
9077003|NCT02317276|10138825|FG000|STARTED|Overall Study||11
9077004|NCT02317276|10138825|FG000|COMPLETED|Overall Study||5
9077005|NCT02317276|10138825|FG000|NOT COMPLETED|Overall Study||6
8624253|NCT00499096|9663487|FG000|STARTED|Overall Study||58
8624254|NCT00499096|9663488|FG001|STARTED|Overall Study||60
9077006|NCT02307188|10138829|FG000|STARTED|Overall Study||5
9077007|NCT02307188|10138829|FG000|COMPLETED|Overall Study|Four of 5 patients did not meet required criteria to complete the study after they were enrolled.|1
9077008|NCT02307188|10138829|FG000|NOT COMPLETED|Overall Study||4
9077009|NCT02308475|10138833|FG000|STARTED|Overall Study||2
9077010|NCT02308475|10138833|FG000|COMPLETED|Overall Study||2
9077011|NCT02308475|10138833|FG000|NOT COMPLETED|Overall Study||0
9077012|NCT02308735|10138841|FG000|STARTED|Overall Study||2
9077013|NCT02308735|10138842|FG001|STARTED|Overall Study||0
9077014|NCT02308735|10138843|FG002|STARTED|Overall Study||0
9077015|NCT02308735|10138844|FG003|STARTED|Overall Study||2
9077016|NCT02308735|10138841|FG000|COMPLETED|Overall Study||0
9077017|NCT02308735|10138842|FG001|COMPLETED|Overall Study||0
9077018|NCT02308735|10138843|FG002|COMPLETED|Overall Study||0
9077019|NCT02308735|10138844|FG003|COMPLETED|Overall Study||0
9077020|NCT02308735|10138841|FG000|NOT COMPLETED|Overall Study||2
9077021|NCT02308735|10138842|FG001|NOT COMPLETED|Overall Study||0
9077022|NCT02308735|10138843|FG002|NOT COMPLETED|Overall Study||0
9077023|NCT02308735|10138844|FG003|NOT COMPLETED|Overall Study||2
9077024|NCT02299206|10138854|FG000|STARTED|Overall Study||4
9077025|NCT02299206|10138854|FG000|COMPLETED|Overall Study||2
9077026|NCT02299206|10138854|FG000|NOT COMPLETED|Overall Study||2
9077027|NCT02302859|10138860|FG000|STARTED|Overall Study||2
9077028|NCT02302859|10138861|FG001|STARTED|Overall Study||6
9077029|NCT02302859|10138860|FG000|COMPLETED|Overall Study||1
9077030|NCT02302859|10138861|FG001|COMPLETED|Overall Study||4
9077031|NCT02302859|10138860|FG000|NOT COMPLETED|Overall Study||1
9077032|NCT02302859|10138861|FG001|NOT COMPLETED|Overall Study||2
9077033|NCT02299934|10138867|FG000|STARTED|Overall Study||13
9077034|NCT02299934|10138867|FG000|COMPLETED|Overall Study||0
9077035|NCT02299934|10138867|FG000|NOT COMPLETED|Overall Study||13
9077036|NCT02297230|10138875|FG000|STARTED|Overall Study||11
9077037|NCT02297230|10138876|FG001|STARTED|Overall Study||11
9077038|NCT02297230|10138877|FG002|STARTED|Overall Study||11
9077039|NCT02297230|10138878|FG003|STARTED|Overall Study||11
9077040|NCT02297230|10138875|FG000|COMPLETED|Overall Study||11
9077041|NCT02297230|10138876|FG001|COMPLETED|Overall Study||11
9077042|NCT02297230|10138877|FG002|COMPLETED|Overall Study||11
9077043|NCT02297230|10138878|FG003|COMPLETED|Overall Study||11
9077044|NCT02297230|10138875|FG000|NOT COMPLETED|Overall Study||0
9077045|NCT02297230|10138876|FG001|NOT COMPLETED|Overall Study||0
9077046|NCT02297230|10138877|FG002|NOT COMPLETED|Overall Study||0
9077047|NCT02297230|10138878|FG003|NOT COMPLETED|Overall Study||0
9077048|NCT02294981|10138894|FG000|STARTED|Overall Study||4
9077049|NCT02294981|10138894|FG000|COMPLETED|Overall Study||3
9077050|NCT02294981|10138894|FG000|NOT COMPLETED|Overall Study||1
9077051|NCT02284906|10138901|FG000|STARTED|Overall Study||3
9077052|NCT02284906|10138902|FG001|STARTED|Overall Study||18
9077053|NCT02284906|10138903|FG002|STARTED|Overall Study||19
9077054|NCT02284906|10138901|FG000|COMPLETED|Overall Study||0
9077055|NCT02284906|10138902|FG001|COMPLETED|Overall Study||0
9077056|NCT02284906|10138903|FG002|COMPLETED|Overall Study||0
9077057|NCT02284906|10138901|FG000|NOT COMPLETED|Overall Study||3
9077058|NCT02284906|10138902|FG001|NOT COMPLETED|Overall Study||18
9077059|NCT02284906|10138903|FG002|NOT COMPLETED|Overall Study||19
9077060|NCT02287025|10138913|FG000|STARTED|Overall Study||12
9077061|NCT02287025|10138914|FG001|STARTED|Overall Study||11
9077062|NCT02287025|10138913|FG000|COMPLETED|Overall Study||2
9077063|NCT02287025|10138914|FG001|COMPLETED|Overall Study||2
9077064|NCT02287025|10138913|FG000|NOT COMPLETED|Overall Study||10
9077065|NCT02287025|10138914|FG001|NOT COMPLETED|Overall Study||9
9077066|NCT02282332|10138918|FG000|STARTED|Overall Study|The PI has left the institution and no results data is available. Efforts were made to contact the PI/study team members, as well as to review data on shared drives, IRB historical records and published resources, but were unsuccessful. No study data are available|0
9077067|NCT02282332|10138918|FG000|COMPLETED|Overall Study|The PI has left the institution and no results data is available. Efforts were made to contact the PI/study team members, as well as to review data on shared drives, IRB historical records and published resources, but were unsuccessful. No study data are available|0
9077068|NCT02282332|10138918|FG000|NOT COMPLETED|Overall Study||0
9077069|NCT02287636|10138922|FG000|STARTED|Overall Study||13
9077070|NCT02287636|10138922|FG000|COMPLETED|Overall Study||13
9077071|NCT02287636|10138922|FG000|NOT COMPLETED|Overall Study||0
9077072|NCT02276560|10138929|FG000|STARTED|Overall Study||1
9077073|NCT02276560|10138930|FG001|STARTED|Overall Study||0
9077074|NCT02276560|10138931|FG002|STARTED|Overall Study||0
9077075|NCT02276560|10138929|FG000|COMPLETED|Overall Study||0
9077076|NCT02276560|10138930|FG001|COMPLETED|Overall Study||0
9077077|NCT02276560|10138931|FG002|COMPLETED|Overall Study||0
9077078|NCT02276560|10138929|FG000|NOT COMPLETED|Overall Study||1
9077079|NCT02276560|10138930|FG001|NOT COMPLETED|Overall Study||0
9077080|NCT02276560|10138931|FG002|NOT COMPLETED|Overall Study||0
9077081|NCT02280252|10138939|FG000|STARTED|Overall Study||0
9077082|NCT02280252|10138939|FG000|COMPLETED|Overall Study||0
9077083|NCT02280252|10138939|FG000|NOT COMPLETED|Overall Study||0
9077084|NCT02284373|10138946|FG000|STARTED|Overall Study||5
9077085|NCT02284373|10138947|FG001|STARTED|Overall Study||5
9077086|NCT02284373|10138948|FG002|STARTED|Overall Study||29
9077087|NCT02284373|10138946|FG000|COMPLETED|Overall Study||5
9077088|NCT02284373|10138947|FG001|COMPLETED|Overall Study||2
9077089|NCT02284373|10138948|FG002|COMPLETED|Overall Study||29
9077090|NCT02284373|10138946|FG000|NOT COMPLETED|Overall Study||0
9077091|NCT02284373|10138947|FG001|NOT COMPLETED|Overall Study||3
9077092|NCT02284373|10138948|FG002|NOT COMPLETED|Overall Study||0
9077093|NCT02285270|10138956|FG000|STARTED|Overall Study||10
9077094|NCT02285270|10138956|FG000|COMPLETED|Overall Study||5
9077095|NCT02285270|10138956|FG000|NOT COMPLETED|Overall Study||5
9077096|NCT02275481|10138962|FG000|STARTED|Overall Study||32
9077097|NCT02275481|10138963|FG001|STARTED|Overall Study||34
9077098|NCT02275481|10138962|FG000|COMPLETED|Overall Study||23
9077099|NCT02275481|10138963|FG001|COMPLETED|Overall Study||31
9077100|NCT02275481|10138962|FG000|NOT COMPLETED|Overall Study||9
9077101|NCT02275481|10138963|FG001|NOT COMPLETED|Overall Study||3
9077102|NCT02266914|10138969|FG000|STARTED|Overall Study||9
9077103|NCT02266914|10138969|FG000|COMPLETED|Overall Study||0
9077104|NCT02266914|10138969|FG000|NOT COMPLETED|Overall Study||9
9077105|NCT02273752|10138973|FG000|STARTED|Overall Study||2
9077106|NCT02273752|10138973|FG000|COMPLETED|Overall Study||0
9077107|NCT02273752|10138973|FG000|NOT COMPLETED|Overall Study||2
9077108|NCT02270684|10138979|FG000|STARTED|Overall Study||1
9077109|NCT02270684|10138980|FG001|STARTED|Overall Study||3
9077110|NCT02270684|10138979|FG000|COMPLETED|Overall Study||0
9077111|NCT02270684|10138980|FG001|COMPLETED|Overall Study||0
9077112|NCT02270684|10138979|FG000|NOT COMPLETED|Overall Study||1
9077113|NCT02270684|10138980|FG001|NOT COMPLETED|Overall Study||3
9077114|NCT02262000|10138988|FG000|STARTED|Overall Study||3
9077115|NCT02262000|10138989|FG001|STARTED|Overall Study||0
9077116|NCT02262000|10138988|FG000|COMPLETED|Overall Study||3
9077117|NCT02262000|10138989|FG001|COMPLETED|Overall Study||0
9077118|NCT02262000|10138988|FG000|NOT COMPLETED|Overall Study||0
9077119|NCT02262000|10138989|FG001|NOT COMPLETED|Overall Study||0
9077120|NCT02271594|10138997|FG000|STARTED|Overall Study||19
9077121|NCT02271594|10138998|FG001|STARTED|Overall Study||12
9077122|NCT02271594|10138997|FG000|COMPLETED|Overall Study|Study closed down|0
9077123|NCT02271594|10138998|FG001|COMPLETED|Overall Study|Study closed down|0
9077124|NCT02271594|10138997|FG000|NOT COMPLETED|Overall Study||19
9077125|NCT02271594|10138998|FG001|NOT COMPLETED|Overall Study||12
9077126|NCT02263365|10139008|FG000|STARTED|Overall Study||22
9077127|NCT02263365|10139009|FG001|STARTED|Overall Study||18
9077128|NCT02263365|10139008|FG000|COMPLETED|Overall Study||0
9077129|NCT02263365|10139009|FG001|COMPLETED|Overall Study||0
9077130|NCT02263365|10139008|FG000|NOT COMPLETED|Overall Study||22
9077131|NCT02263365|10139009|FG001|NOT COMPLETED|Overall Study||18
9077132|NCT02266797|10139018|FG000|STARTED|Overall Study||1
9077133|NCT02266797|10139019|FG001|STARTED|Overall Study||3
9077134|NCT02266797|10139018|FG000|COMPLETED|Overall Study||1
9077135|NCT02266797|10139019|FG001|COMPLETED|Overall Study||2
9077136|NCT02266797|10139018|FG000|NOT COMPLETED|Overall Study||0
9077137|NCT02266797|10139019|FG001|NOT COMPLETED|Overall Study||1
9077138|NCT02249377|10139027|FG000|STARTED|Overall Study||25
9077139|NCT02249377|10139028|FG001|STARTED|Overall Study||25
9077140|NCT02249377|10139027|FG000|COMPLETED|Overall Study||0
9077141|NCT02249377|10139028|FG001|COMPLETED|Overall Study||1
9077142|NCT02249377|10139027|FG000|NOT COMPLETED|Overall Study||25
9077143|NCT02249377|10139028|FG001|NOT COMPLETED|Overall Study||24
9077144|NCT02253394|10139034|FG000|STARTED|Overall Study||0
9077145|NCT02253394|10139035|FG001|STARTED|Overall Study|Ambrisentan 5 or 10 mg QD + placebo (90 d) first, then washout (21 d), then +Spiro 50 mg QD (90 d).|2
9077146|NCT02253394|10139034|FG000|COMPLETED|Overall Study||0
9077147|NCT02253394|10139035|FG001|COMPLETED|Overall Study||2
9077148|NCT02253394|10139034|FG000|NOT COMPLETED|Overall Study||0
9077149|NCT02253394|10139035|FG001|NOT COMPLETED|Overall Study||0
9077150|NCT02241551|10139043|FG000|STARTED|Overall Study||1
9077151|NCT02241551|10139044|FG001|STARTED|Overall Study||0
9077152|NCT02241551|10139043|FG000|COMPLETED|Overall Study||0
9077153|NCT02241551|10139044|FG001|COMPLETED|Overall Study||0
9077154|NCT02241551|10139043|FG000|NOT COMPLETED|Overall Study||1
9077155|NCT02241551|10139044|FG001|NOT COMPLETED|Overall Study||0
9077156|NCT02246114|10139054|FG000|STARTED|Overall Study||1
9077157|NCT02246114|10139055|FG001|STARTED|Overall Study||0
9077158|NCT02246114|10139054|FG000|COMPLETED|Overall Study||0
9077159|NCT02246114|10139055|FG001|COMPLETED|Overall Study||0
9077160|NCT02246114|10139054|FG000|NOT COMPLETED|Overall Study||1
9077161|NCT02246114|10139055|FG001|NOT COMPLETED|Overall Study||0
9077162|NCT02232880|10139061|FG000|STARTED|Overall Study||1
9077163|NCT02232880|10139061|FG000|COMPLETED|Overall Study||0
9077164|NCT02232880|10139061|FG000|NOT COMPLETED|Overall Study||1
9077165|NCT02248740|10139067|FG000|STARTED|Overall Study||18
9077166|NCT02248740|10139068|FG001|STARTED|Overall Study||18
9077167|NCT02248740|10139067|FG000|COMPLETED|Overall Study||0
9077168|NCT02248740|10139068|FG001|COMPLETED|Overall Study||0
9077169|NCT02248740|10139067|FG000|NOT COMPLETED|Overall Study||18
9077170|NCT02248740|10139068|FG001|NOT COMPLETED|Overall Study||18
9077171|NCT02239627|10139076|FG000|STARTED|Overall Study||0
9077172|NCT02239627|10139077|FG001|STARTED|Overall Study||0
9077173|NCT02239627|10139076|FG000|COMPLETED|Overall Study||0
9077174|NCT02239627|10139077|FG001|COMPLETED|Overall Study||0
9077175|NCT02239627|10139076|FG000|NOT COMPLETED|Overall Study||0
9077176|NCT02239627|10139077|FG001|NOT COMPLETED|Overall Study||0
9077177|NCT02244944|10139083|FG000|STARTED|Overall Study||2
9077178|NCT02244944|10139083|FG000|COMPLETED|Overall Study||0
9077179|NCT02244944|10139083|FG000|NOT COMPLETED|Overall Study||2
9077180|NCT02241187|10139087|FG000|STARTED|Overall Study||2
9077181|NCT02241187|10139087|FG000|COMPLETED|Overall Study||0
9077182|NCT02241187|10139087|FG000|NOT COMPLETED|Overall Study||2
9077183|NCT02239926|10139093|FG000|STARTED|Overall Study||0
9077184|NCT02239926|10139094|FG001|STARTED|Overall Study||2
9077185|NCT02239926|10139093|FG000|COMPLETED|Overall Study||0
9077186|NCT02239926|10139094|FG001|COMPLETED|Overall Study||1
9077187|NCT02239926|10139093|FG000|NOT COMPLETED|Overall Study||0
9077188|NCT02239926|10139094|FG001|NOT COMPLETED|Overall Study||1
9077189|NCT02231892|10139103|FG000|STARTED|Overall Study||17
9077190|NCT02231892|10139104|FG001|STARTED|Overall Study||17
9077191|NCT02231892|10139105|FG002|STARTED|Overall Study||70
9077192|NCT02231892|10139103|FG000|Sham|Overall Study||8
9077193|NCT02231892|10139104|FG001|Sham|Overall Study||5
9077194|NCT02231892|10139105|FG002|Sham|Overall Study||26
9077195|NCT02231892|10139103|FG000|100% MT|Overall Study||7
9077196|NCT02231892|10139104|FG001|100% MT|Overall Study||6
9077197|NCT02231892|10139105|FG002|100% MT|Overall Study||25
9077198|NCT02231892|10139103|FG000|110% MT|Overall Study||7
9077199|NCT02231892|10139104|FG001|110% MT|Overall Study||5
9077200|NCT02231892|10139105|FG002|110% MT|Overall Study||27
9077201|NCT02231892|10139103|FG000|COMPLETED|Overall Study||6
9077202|NCT02231892|10139104|FG001|COMPLETED|Overall Study|3 participants completed this phase and Hi Frequency MRI phase, but are only counted in Hi Freq MRI.|5
9077203|NCT02231892|10139105|FG002|COMPLETED|Overall Study|3 participants completed this phase and Hi Frequency Beh phase, but are only counted in Hi Freq MRI.|25
9077204|NCT02231892|10139103|FG000|NOT COMPLETED|Overall Study||11
9077205|NCT02231892|10139104|FG001|NOT COMPLETED|Overall Study||12
9077206|NCT02231892|10139105|FG002|NOT COMPLETED|Overall Study||45
9077207|NCT02241343|10139119|FG000|STARTED|Overall Study||1
9077208|NCT02241343|10139119|FG000|COMPLETED|Overall Study||0
9077209|NCT02241343|10139119|FG000|NOT COMPLETED|Overall Study||1
8624255|NCT00499096|9663487|FG000|COMPLETED|Overall Study||35
8624256|NCT00499096|9663488|FG001|COMPLETED|Overall Study||40
8624257|NCT00499096|9663487|FG000|NOT COMPLETED|Overall Study||23
8624258|NCT00499096|9663488|FG001|NOT COMPLETED|Overall Study||20
8624259|NCT00499109|9663498|FG000|STARTED|Overall Study||183
8624260|NCT00499109|9663499|FG001|STARTED|Overall Study||92
8624261|NCT00499109|9663498|FG000|COMPLETED|Overall Study||165
8624262|NCT00499109|9663499|FG001|COMPLETED|Overall Study||85
8624263|NCT00499109|9663498|FG000|NOT COMPLETED|Overall Study||18
8624264|NCT00499109|9663499|FG001|NOT COMPLETED|Overall Study||7
8624265|NCT00499122|9663508|FG000|STARTED|Overall Study||41
8624266|NCT00499122|9663508|FG000|COMPLETED|Overall Study||39
8624267|NCT00499122|9663508|FG000|NOT COMPLETED|Overall Study||2
9077210|NCT02242578|10139126|FG000|STARTED|Overall Study||0
9077211|NCT02242578|10139127|FG001|STARTED|Overall Study||0
9077212|NCT02242578|10139126|FG000|COMPLETED|Overall Study||0
9077213|NCT02242578|10139127|FG001|COMPLETED|Overall Study||0
9077214|NCT02242578|10139126|FG000|NOT COMPLETED|Overall Study||0
9077215|NCT02242578|10139127|FG001|NOT COMPLETED|Overall Study||0
9077216|NCT02234011|10139133|FG000|STARTED|Overall Study||0
9077217|NCT02234011|10139133|FG000|COMPLETED|Overall Study||0
9077218|NCT02234011|10139133|FG000|NOT COMPLETED|Overall Study||0
9077219|NCT02236546|10139137|FG000|STARTED|Overall Study||3
9077220|NCT02236546|10139137|FG000|COMPLETED|Overall Study||3
9077221|NCT02236546|10139137|FG000|NOT COMPLETED|Overall Study||0
9077222|NCT02234687|10139144|FG000|STARTED|Overall Study|Study Terminated. No outcome measures were analyzed|6
9077223|NCT02234687|10139145|FG001|STARTED|Overall Study||4
9077224|NCT02234687|10139146|FG002|STARTED|Overall Study||4
9077225|NCT02234687|10139144|FG000|COMPLETED|Overall Study|Study Terminated. No outcome measures were analyzed|0
9077226|NCT02234687|10139145|FG001|COMPLETED|Overall Study||0
9077227|NCT02234687|10139146|FG002|COMPLETED|Overall Study||0
9077228|NCT02234687|10139144|FG000|NOT COMPLETED|Overall Study||6
9077229|NCT02234687|10139145|FG001|NOT COMPLETED|Overall Study||4
9077230|NCT02234687|10139146|FG002|NOT COMPLETED|Overall Study||4
9077231|NCT02224599|10139154|FG000|STARTED|Overall Study||3
9077232|NCT02224599|10139154|FG000|COMPLETED|Overall Study||1
9077233|NCT02224599|10139154|FG000|NOT COMPLETED|Overall Study||2
9077234|NCT02201472|10139158|FG000|STARTED|Overall Study||2
9077235|NCT02201472|10139158|FG000|COMPLETED|Overall Study||0
9077236|NCT02201472|10139158|FG000|NOT COMPLETED|Overall Study||2
9077237|NCT02202044|10139162|FG000|STARTED|Overall Study||0
9077238|NCT02202044|10139162|FG000|COMPLETED|Overall Study||0
9077239|NCT02202044|10139162|FG000|NOT COMPLETED|Overall Study||0
9077240|NCT02192775|10139166|FG000|STARTED|Overall Study||2
9077241|NCT02192775|10139166|FG000|COMPLETED|Overall Study||0
9077242|NCT02192775|10139166|FG000|NOT COMPLETED|Overall Study||2
9077243|NCT02200328|10139172|FG000|STARTED|Overall Study||43
9077244|NCT02200328|10139173|FG001|STARTED|Overall Study||33
9077245|NCT02200328|10139172|FG000|COMPLETED|Overall Study||0
9077246|NCT02200328|10139173|FG001|COMPLETED|Overall Study||0
9077247|NCT02200328|10139172|FG000|NOT COMPLETED|Overall Study||43
9077248|NCT02200328|10139173|FG001|NOT COMPLETED|Overall Study||33
9077249|NCT02200042|10139181|FG000|STARTED|Overall Study||0
9077250|NCT02200042|10139182|FG001|STARTED|Overall Study||1
9077251|NCT02200042|10139181|FG000|COMPLETED|Overall Study||0
9077252|NCT02200042|10139182|FG001|COMPLETED|Overall Study||0
9077253|NCT02200042|10139181|FG000|NOT COMPLETED|Overall Study||0
9077254|NCT02200042|10139182|FG001|NOT COMPLETED|Overall Study||1
9077255|NCT02181790|10139190|FG000|STARTED|Overall Study||2
9077256|NCT02181790|10139191|FG001|STARTED|Overall Study||0
9077257|NCT02181790|10139190|FG000|COMPLETED|Overall Study||0
9077258|NCT02181790|10139191|FG001|COMPLETED|Overall Study||0
9077259|NCT02181790|10139190|FG000|NOT COMPLETED|Overall Study||2
9077260|NCT02181790|10139191|FG001|NOT COMPLETED|Overall Study||0
9077261|NCT02198833|10139201|FG000|STARTED|Overall Study|Unable to clear urine of bacteria for all but one patient therefore catheter not placed|1
9077262|NCT02198833|10139202|FG001|STARTED|Overall Study|Unable to clear urine of bacteria for all but one patient therefore catheter not placed.|1
9077263|NCT02198833|10139201|FG000|COMPLETED|Overall Study||1
9077264|NCT02198833|10139202|FG001|COMPLETED|Overall Study||1
9077265|NCT02198833|10139201|FG000|NOT COMPLETED|Overall Study||0
9077266|NCT02198833|10139202|FG001|NOT COMPLETED|Overall Study||0
9077267|NCT02175628|10139210|FG000|STARTED|Overall Study||6
9077268|NCT02175628|10139211|FG001|STARTED|Overall Study||17
9077269|NCT02175628|10139210|FG000|COMPLETED|Overall Study||6
9077270|NCT02175628|10139211|FG001|COMPLETED|Overall Study||17
9077271|NCT02175628|10139210|FG000|NOT COMPLETED|Overall Study||0
9077272|NCT02175628|10139211|FG001|NOT COMPLETED|Overall Study||0
9077273|NCT02177266|10139219|FG000|STARTED|Overall Study||1
9077274|NCT02177266|10139220|FG001|STARTED|Overall Study||1
9077275|NCT02177266|10139219|FG000|COMPLETED|Overall Study||0
9077276|NCT02177266|10139220|FG001|COMPLETED|Overall Study||0
9077277|NCT02177266|10139219|FG000|NOT COMPLETED|Overall Study||1
9077278|NCT02177266|10139220|FG001|NOT COMPLETED|Overall Study||1
9077279|NCT02184520|10139228|FG000|STARTED|Overall Study||0
9077280|NCT02184520|10139229|FG001|STARTED|Overall Study||0
9077281|NCT02184520|10139228|FG000|COMPLETED|Overall Study||0
9077282|NCT02184520|10139229|FG001|COMPLETED|Overall Study||0
9077283|NCT02184520|10139228|FG000|NOT COMPLETED|Overall Study||0
9077284|NCT02184520|10139229|FG001|NOT COMPLETED|Overall Study||0
9077285|NCT02170298|10139237|FG000|STARTED|Overall Study||1
9077286|NCT02170298|10139238|FG001|STARTED|Overall Study||5
9077287|NCT02170298|10139237|FG000|COMPLETED|Overall Study||0
9077288|NCT02170298|10139238|FG001|COMPLETED|Overall Study||4
9077289|NCT02170298|10139237|FG000|NOT COMPLETED|Overall Study||1
9077290|NCT02170298|10139238|FG001|NOT COMPLETED|Overall Study||1
9077291|NCT02177773|10139244|FG000|STARTED|Overall Study||300
9077292|NCT02177773|10139244|FG000|COMPLETED|Overall Study||300
9077293|NCT02177773|10139244|FG000|NOT COMPLETED|Overall Study||0
9077294|NCT02162979|10139250|FG000|STARTED|Overall Study||0
9077295|NCT02162979|10139251|FG001|STARTED|Overall Study||0
9077296|NCT02162979|10139250|FG000|COMPLETED|Overall Study||0
9077297|NCT02162979|10139251|FG001|COMPLETED|Overall Study||0
9077298|NCT02162979|10139250|FG000|NOT COMPLETED|Overall Study||0
9077299|NCT02162979|10139251|FG001|NOT COMPLETED|Overall Study||0
9077300|NCT02169830|10139260|FG000|STARTED|Diet Intervention (4 Weeks)||0
9077301|NCT02169830|10139261|FG001|STARTED|Diet Intervention (4 Weeks)||0
9077302|NCT02169830|10139262|FG002|STARTED|Diet Intervention (4 Weeks)||33
9077303|NCT02169830|10139260|FG000|COMPLETED|Diet Intervention (4 Weeks)||0
9077304|NCT02169830|10139261|FG001|COMPLETED|Diet Intervention (4 Weeks)||0
9077305|NCT02169830|10139262|FG002|COMPLETED|Diet Intervention (4 Weeks)||32
9077306|NCT02169830|10139260|FG000|NOT COMPLETED|Diet Intervention (4 Weeks)||0
9077307|NCT02169830|10139261|FG001|NOT COMPLETED|Diet Intervention (4 Weeks)||0
9077308|NCT02169830|10139262|FG002|NOT COMPLETED|Diet Intervention (4 Weeks)||1
9077309|NCT02169830|10139260|FG000|STARTED|Second Intervention (8 Weeks)||12
9077310|NCT02169830|10139261|FG001|STARTED|Second Intervention (8 Weeks)||5
9077311|NCT02169830|10139262|FG002|STARTED|Second Intervention (8 Weeks)||0
9077312|NCT02169830|10139260|FG000|COMPLETED|Second Intervention (8 Weeks)||9
9077313|NCT02169830|10139261|FG001|COMPLETED|Second Intervention (8 Weeks)||0
9077314|NCT02169830|10139262|FG002|COMPLETED|Second Intervention (8 Weeks)||0
9077315|NCT02169830|10139260|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||3
9077316|NCT02169830|10139261|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||5
9077317|NCT02169830|10139262|FG002|NOT COMPLETED|Second Intervention (8 Weeks)||0
9077318|NCT02169830|10139260|FG000|STARTED|Third Intervention (8 Weeks)||0
9077319|NCT02169830|10139261|FG001|STARTED|Third Intervention (8 Weeks)|These four subjects were randomized to Diet first Topiramate second, and Nortriptyline third. No subjects from this group were weaned and moved to Nortriptyline.|4
9077320|NCT02169830|10139262|FG002|STARTED|Third Intervention (8 Weeks)||0
9077321|NCT02169830|10139260|FG000|COMPLETED|Third Intervention (8 Weeks)||0
9077322|NCT02169830|10139261|FG001|COMPLETED|Third Intervention (8 Weeks)||2
9077323|NCT02169830|10139262|FG002|COMPLETED|Third Intervention (8 Weeks)||0
9077324|NCT02169830|10139260|FG000|NOT COMPLETED|Third Intervention (8 Weeks)||0
9077325|NCT02169830|10139261|FG001|NOT COMPLETED|Third Intervention (8 Weeks)||2
9077326|NCT02169830|10139262|FG002|NOT COMPLETED|Third Intervention (8 Weeks)||0
9077327|NCT02163187|10139272|FG000|STARTED|Overall Study||4
9077328|NCT02163187|10139273|FG001|STARTED|Overall Study||0
9077329|NCT02163187|10139272|FG000|Treatment|Overall Study||2
9077330|NCT02163187|10139273|FG001|Treatment|Overall Study||0
9077331|NCT02163187|10139272|FG000|COMPLETED|Overall Study||2
9077332|NCT02163187|10139273|FG001|COMPLETED|Overall Study||0
9077333|NCT02163187|10139272|FG000|NOT COMPLETED|Overall Study||2
9077334|NCT02163187|10139273|FG001|NOT COMPLETED|Overall Study||0
9077335|NCT02161016|10139279|FG000|STARTED|Overall Study||1
9077336|NCT02161016|10139279|FG000|COMPLETED|Overall Study||0
9077337|NCT02161016|10139279|FG000|NOT COMPLETED|Overall Study||1
9077338|NCT02159040|10139283|FG000|STARTED|Overall Study||1
9077339|NCT02159040|10139283|FG000|COMPLETED|Overall Study||0
9077340|NCT02159040|10139283|FG000|NOT COMPLETED|Overall Study||1
9077341|NCT02168270|10139287|FG000|STARTED|Overall Study||4
9077342|NCT02168270|10139287|FG000|COMPLETED|Overall Study||0
9077343|NCT02168270|10139287|FG000|NOT COMPLETED|Overall Study||4
9077344|NCT02157116|10139291|FG000|STARTED|Overall Study|signed consent form|13
9077345|NCT02157116|10139291|FG000|COMPLETED|Overall Study||4
9077346|NCT02157116|10139291|FG000|NOT COMPLETED|Overall Study||9
9077347|NCT02154087|10139295|FG000|STARTED|Overall Study||1
9077348|NCT02154087|10139295|FG000|COMPLETED|Overall Study||0
9077349|NCT02154087|10139295|FG000|NOT COMPLETED|Overall Study||1
9077350|NCT02152670|10139299|FG000|STARTED|Overall Study||1
9077351|NCT02152670|10139299|FG000|COMPLETED|Overall Study||1
9077352|NCT02152670|10139299|FG000|NOT COMPLETED|Overall Study||0
9077353|NCT02152566|10139303|FG000|STARTED|Overall Study||6
9077354|NCT02152566|10139303|FG000|COMPLETED|Overall Study||3
9077355|NCT02152566|10139303|FG000|NOT COMPLETED|Overall Study||3
9077356|NCT02137096|10139307|FG000|STARTED|Overall Study||1
9077357|NCT02137096|10139307|FG000|COMPLETED|Overall Study||1
9077358|NCT02137096|10139307|FG000|NOT COMPLETED|Overall Study||0
9077359|NCT02147834|10139313|FG000|STARTED|Overall Study||3
9077360|NCT02147834|10139314|FG001|STARTED|Overall Study||2
9077361|NCT02147834|10139313|FG000|COMPLETED|Overall Study||3
9077362|NCT02147834|10139314|FG001|COMPLETED|Overall Study||2
8624268|NCT00499174|9663515|FG000|STARTED|Overall Study||78
8624269|NCT00499174|9663516|FG001|STARTED|Overall Study||102
8624270|NCT00499174|9663515|FG000|COMPLETED|Overall Study||0
8624271|NCT00499174|9663516|FG001|COMPLETED|Overall Study||93
8624272|NCT00499174|9663515|FG000|NOT COMPLETED|Overall Study||78
8624273|NCT00499174|9663516|FG001|NOT COMPLETED|Overall Study||9
9077363|NCT02147834|10139313|FG000|NOT COMPLETED|Overall Study||0
9077364|NCT02147834|10139314|FG001|NOT COMPLETED|Overall Study||0
9077365|NCT02145390|10139320|FG000|STARTED|Overall Study||1
9077366|NCT02145390|10139320|FG000|COMPLETED|Overall Study||0
9077367|NCT02145390|10139320|FG000|NOT COMPLETED|Overall Study||1
9077368|NCT02132884|10139326|FG000|STARTED|Overall Study||0
9077369|NCT02132884|10139327|FG001|STARTED|Overall Study||0
9077370|NCT02132884|10139326|FG000|COMPLETED|Overall Study||0
9077371|NCT02132884|10139327|FG001|COMPLETED|Overall Study||0
9077372|NCT02132884|10139326|FG000|NOT COMPLETED|Overall Study||0
8624274|NCT00499252|9663524|FG000|STARTED|Overall Study||51
9077373|NCT02132884|10139327|FG001|NOT COMPLETED|Overall Study||0
9077374|NCT02144155|10139333|FG000|STARTED|Overall Study||14
9077375|NCT02144155|10139333|FG000|COMPLETED|Overall Study||14
9077376|NCT02144155|10139333|FG000|NOT COMPLETED|Overall Study||0
9077377|NCT02140788|10139337|FG000|STARTED|Overall Study||0
9077378|NCT02140788|10139338|FG001|STARTED|Overall Study||0
9077379|NCT02140788|10139339|FG002|STARTED|Overall Study||0
9077380|NCT02140788|10139340|FG003|STARTED|Overall Study||0
9077381|NCT02140788|10139337|FG000|COMPLETED|Overall Study||0
9077382|NCT02140788|10139338|FG001|COMPLETED|Overall Study||0
9077383|NCT02140788|10139339|FG002|COMPLETED|Overall Study||0
9077384|NCT02140788|10139340|FG003|COMPLETED|Overall Study||0
9077385|NCT02140788|10139337|FG000|NOT COMPLETED|Overall Study||0
9077386|NCT02140788|10139338|FG001|NOT COMPLETED|Overall Study||0
9077387|NCT02140788|10139339|FG002|NOT COMPLETED|Overall Study||0
9077388|NCT02140788|10139340|FG003|NOT COMPLETED|Overall Study||0
9077389|NCT02150863|10139353|FG000|STARTED|Overall Study||0
9077390|NCT02150863|10139354|FG001|STARTED|Overall Study||1
9077391|NCT02150863|10139355|FG002|STARTED|Overall Study||0
9077392|NCT02150863|10139353|FG000|COMPLETED|Overall Study||0
8624275|NCT00499252|9663524|FG000|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|39
8624276|NCT00499252|9663524|FG000|NOT COMPLETED|Overall Study||12
8624277|NCT00499343|9663534|FG000|STARTED|Overall Study||41
8624278|NCT00499343|9663535|FG001|STARTED|Overall Study||43
8624279|NCT00499343|9663534|FG000|COMPLETED|Overall Study||41
8624280|NCT00499343|9663535|FG001|COMPLETED|Overall Study||43
9077393|NCT02150863|10139354|FG001|COMPLETED|Overall Study||0
9077394|NCT02150863|10139355|FG002|COMPLETED|Overall Study||0
9077395|NCT02150863|10139353|FG000|NOT COMPLETED|Overall Study||0
9077396|NCT02150863|10139354|FG001|NOT COMPLETED|Overall Study||1
9077397|NCT02150863|10139355|FG002|NOT COMPLETED|Overall Study||0
9077398|NCT02145169|10139363|FG000|STARTED|Overall Study||0
8624281|NCT00499343|9663534|FG000|NOT COMPLETED|Overall Study||0
8624282|NCT00499343|9663535|FG001|NOT COMPLETED|Overall Study||0
8624283|NCT00499369|9663546|FG000|STARTED|Overall Study||16
8624284|NCT00499369|9663547|FG001|STARTED|Overall Study||18
8624285|NCT00499369|9663548|FG002|STARTED|Overall Study||17
8624286|NCT00499369|9663549|FG003|STARTED|Overall Study||9
8624287|NCT00499369|9663550|FG004|STARTED|Overall Study||12
8624288|NCT00499369|9663546|FG000|Eligible|Overall Study||14
9077399|NCT02145169|10139363|FG000|COMPLETED|Overall Study||0
9077400|NCT02145169|10139363|FG000|NOT COMPLETED|Overall Study||0
9077401|NCT02130622|10139369|FG000|STARTED|Overall Study||2
9077402|NCT02130622|10139370|FG001|STARTED|Overall Study||1
9077403|NCT02130622|10139369|FG000|COMPLETED|Overall Study||2
9077404|NCT02130622|10139370|FG001|COMPLETED|Overall Study||1
9077405|NCT02130622|10139369|FG000|NOT COMPLETED|Overall Study||0
9077406|NCT02130622|10139370|FG001|NOT COMPLETED|Overall Study||0
9077407|NCT02133534|10139376|FG000|STARTED|Overall Study||1
9077408|NCT02133534|10139376|FG000|COMPLETED|Overall Study||1
9077409|NCT02133534|10139376|FG000|NOT COMPLETED|Overall Study||0
9077410|NCT02134912|10139382|FG000|STARTED|Overall Study||0
9077411|NCT02134912|10139383|FG001|STARTED|Overall Study||0
9077412|NCT02134912|10139382|FG000|COMPLETED|Overall Study||0
9077413|NCT02134912|10139383|FG001|COMPLETED|Overall Study||0
9077414|NCT02134912|10139382|FG000|NOT COMPLETED|Overall Study||0
9077415|NCT02134912|10139383|FG001|NOT COMPLETED|Overall Study||0
9077416|NCT02131155|10139391|FG000|STARTED|Overall Study|Started are treated patients.|25
9077417|NCT02131155|10139392|FG001|STARTED|Overall Study|Started are treated patients.|11
9077418|NCT02131155|10139391|FG000|COMPLETED|Overall Study|Completed are patients who completed study procedures as protocol requires.|0
9077419|NCT02131155|10139392|FG001|COMPLETED|Overall Study|Completed are patients who completed study procedures as protocol requires.|0
9077420|NCT02131155|10139391|FG000|NOT COMPLETED|Overall Study||25
9077421|NCT02131155|10139392|FG001|NOT COMPLETED|Overall Study||11
9077422|NCT02117050|10139398|FG000|STARTED|Overall Study||1
9077423|NCT02117050|10139398|FG000|COMPLETED|Overall Study||0
9077424|NCT02117050|10139398|FG000|NOT COMPLETED|Overall Study||1
9077425|NCT02110069|10139405|FG000|STARTED|Overall Study||2
9077426|NCT02110069|10139406|FG001|STARTED|Overall Study||2
9077427|NCT02110069|10139405|FG000|COMPLETED|Overall Study|subject was switched to sirolimus at maintenance course 7 for failure on Vincristine|0
9077428|NCT02110069|10139406|FG001|COMPLETED|Overall Study|1 subject was takend off protocol treatment at 10 months of maintenance for disease response.|2
9077429|NCT02110069|10139405|FG000|NOT COMPLETED|Overall Study||2
9077430|NCT02110069|10139406|FG001|NOT COMPLETED|Overall Study||0
9077431|NCT02110277|10139412|FG000|STARTED|Overall Study||2
9077432|NCT02110277|10139412|FG000|COMPLETED|Overall Study||0
9077433|NCT02110277|10139412|FG000|NOT COMPLETED|Overall Study||2
9077434|NCT02109809|10139416|FG000|STARTED|Overall Study||4
9077435|NCT02109809|10139416|FG000|COMPLETED|Overall Study||1
9077436|NCT02109809|10139416|FG000|NOT COMPLETED|Overall Study||3
9077437|NCT02105116|10139420|FG000|STARTED|Overall Study||6
9077438|NCT02105116|10139420|FG000|COMPLETED|Overall Study||0
9077439|NCT02105116|10139420|FG000|NOT COMPLETED|Overall Study||6
9077440|NCT02099318|10139426|FG000|STARTED|Overall Study||20
9077441|NCT02099318|10139427|FG001|STARTED|Overall Study||20
9077442|NCT02099318|10139426|FG000|COMPLETED|Overall Study||20
9077443|NCT02099318|10139427|FG001|COMPLETED|Overall Study||20
8624289|NCT00499369|9663547|FG001|Eligible|Overall Study||16
8624290|NCT00499369|9663548|FG002|Eligible|Overall Study||16
8624291|NCT00499369|9663549|FG003|Eligible|Overall Study||8
8624292|NCT00499369|9663550|FG004|Eligible|Overall Study||12
9077444|NCT02099318|10139426|FG000|NOT COMPLETED|Overall Study||0
9077445|NCT02099318|10139427|FG001|NOT COMPLETED|Overall Study||0
9077446|NCT02099344|10139437|FG000|STARTED|Overall Study||1
9077447|NCT02099344|10139438|FG001|STARTED|Overall Study||0
9077448|NCT02099344|10139437|FG000|COMPLETED|Overall Study||0
9077449|NCT02099344|10139438|FG001|COMPLETED|Overall Study||0
9077450|NCT02099344|10139437|FG000|NOT COMPLETED|Overall Study||1
9077451|NCT02099344|10139438|FG001|NOT COMPLETED|Overall Study||0
9077452|NCT02094352|10139448|FG000|STARTED|Overall Study||2
9077453|NCT02094352|10139449|FG001|STARTED|Overall Study||1
8624293|NCT00499369|9663546|FG000|COMPLETED|Overall Study||0
8624294|NCT00499369|9663547|FG001|COMPLETED|Overall Study||0
8624295|NCT00499369|9663548|FG002|COMPLETED|Overall Study||0
8624296|NCT00499369|9663549|FG003|COMPLETED|Overall Study||0
8624297|NCT00499369|9663550|FG004|COMPLETED|Overall Study||0
8624298|NCT00499369|9663546|FG000|NOT COMPLETED|Overall Study||16
9077454|NCT02094352|10139448|FG000|COMPLETED|Overall Study||2
9077455|NCT02094352|10139449|FG001|COMPLETED|Overall Study||1
9077456|NCT02094352|10139448|FG000|NOT COMPLETED|Overall Study||0
9077457|NCT02094352|10139449|FG001|NOT COMPLETED|Overall Study||0
9077458|NCT02096042|10139455|FG000|STARTED|Overall Study||1
9077459|NCT02096042|10139456|FG001|STARTED|Overall Study||0
9077460|NCT02096042|10139457|FG002|STARTED|Overall Study||0
9077461|NCT02096042|10139455|FG000|COMPLETED|Overall Study||0
9077462|NCT02096042|10139456|FG001|COMPLETED|Overall Study||0
9077463|NCT02096042|10139457|FG002|COMPLETED|Overall Study||0
9077464|NCT02096042|10139455|FG000|NOT COMPLETED|Overall Study||1
9077465|NCT02096042|10139456|FG001|NOT COMPLETED|Overall Study||0
8624299|NCT00499369|9663547|FG001|NOT COMPLETED|Overall Study||18
8624300|NCT00499369|9663548|FG002|NOT COMPLETED|Overall Study||17
8624301|NCT00499369|9663549|FG003|NOT COMPLETED|Overall Study||9
8624302|NCT00499369|9663550|FG004|NOT COMPLETED|Overall Study||12
9077466|NCT02096042|10139457|FG002|NOT COMPLETED|Overall Study||0
9077467|NCT02088957|10139464|FG000|STARTED|Overall Study||1
9077468|NCT02088957|10139465|FG001|STARTED|Overall Study||0
9077469|NCT02088957|10139464|FG000|COMPLETED|Overall Study||0
9077470|NCT02088957|10139465|FG001|COMPLETED|Overall Study||0
9077471|NCT02088957|10139464|FG000|NOT COMPLETED|Overall Study||1
9077472|NCT02088957|10139465|FG001|NOT COMPLETED|Overall Study||0
9077473|NCT02093689|10139474|FG000|STARTED|Overall Study||18
9077474|NCT02093689|10139475|FG001|STARTED|Overall Study||0
9077475|NCT02093689|10139476|FG002|STARTED|Overall Study||0
9077476|NCT02093689|10139474|FG000|COMPLETED|Overall Study||14
9077477|NCT02093689|10139475|FG001|COMPLETED|Overall Study||0
9077478|NCT02093689|10139476|FG002|COMPLETED|Overall Study||0
9077479|NCT02093689|10139474|FG000|NOT COMPLETED|Overall Study||4
9077480|NCT02093689|10139475|FG001|NOT COMPLETED|Overall Study||0
9077481|NCT02093689|10139476|FG002|NOT COMPLETED|Overall Study||0
9077482|NCT02091752|10139482|FG000|STARTED|Overall Study||3
9077483|NCT02091752|10139482|FG000|COMPLETED|Overall Study||0
9077484|NCT02091752|10139482|FG000|NOT COMPLETED|Overall Study||3
9077485|NCT02068547|10139488|FG000|STARTED|Overall Study||4
9077486|NCT02068547|10139489|FG001|STARTED|Overall Study||4
9077487|NCT02068547|10139488|FG000|COMPLETED|Overall Study||0
9077488|NCT02068547|10139489|FG001|COMPLETED|Overall Study||1
9077489|NCT02068547|10139488|FG000|NOT COMPLETED|Overall Study||4
9077490|NCT02068547|10139489|FG001|NOT COMPLETED|Overall Study||3
9077491|NCT02075411|10139499|FG000|STARTED|Overall Study||0
9077492|NCT02075411|10139500|FG001|STARTED|Overall Study||0
9077493|NCT02075411|10139501|FG002|STARTED|Overall Study||0
9077494|NCT02075411|10139502|FG003|STARTED|Overall Study||1
9077495|NCT02075411|10139499|FG000|COMPLETED|Overall Study||0
9077496|NCT02075411|10139500|FG001|COMPLETED|Overall Study||0
9077497|NCT02075411|10139501|FG002|COMPLETED|Overall Study||0
9077498|NCT02075411|10139502|FG003|COMPLETED|Overall Study||1
9077499|NCT02075411|10139499|FG000|NOT COMPLETED|Overall Study||0
9077500|NCT02075411|10139500|FG001|NOT COMPLETED|Overall Study||0
9077501|NCT02075411|10139501|FG002|NOT COMPLETED|Overall Study||0
9077502|NCT02075411|10139502|FG003|NOT COMPLETED|Overall Study||0
9077503|NCT02074904|10139514|FG000|STARTED|Overall Study||1
9077504|NCT02074904|10139515|FG001|STARTED|Overall Study||0
9077505|NCT02074904|10139514|FG000|COMPLETED|Overall Study||1
9077506|NCT02074904|10139515|FG001|COMPLETED|Overall Study||0
9077507|NCT02074904|10139514|FG000|NOT COMPLETED|Overall Study||0
9077508|NCT02074904|10139515|FG001|NOT COMPLETED|Overall Study||0
9077509|NCT02084147|10139521|FG000|STARTED|Overall Study||72
9077510|NCT02084147|10139521|FG000|COMPLETED|Overall Study||72
9077511|NCT02084147|10139521|FG000|NOT COMPLETED|Overall Study||0
9077512|NCT02081183|10139527|FG000|STARTED|Overall Study||5
9077513|NCT02081183|10139528|FG001|STARTED|Overall Study||6
9077514|NCT02081183|10139527|FG000|COMPLETED|Overall Study||1
9077515|NCT02081183|10139528|FG001|COMPLETED|Overall Study||2
9077516|NCT02081183|10139527|FG000|NOT COMPLETED|Overall Study||4
9077517|NCT02081183|10139528|FG001|NOT COMPLETED|Overall Study||4
9077518|NCT02067611|10139534|FG000|STARTED|Overall Study||72
9077519|NCT02067611|10139535|FG001|STARTED|Overall Study||72
9077520|NCT02067611|10139536|FG002|STARTED|Overall Study||72
9077521|NCT02067611|10139534|FG000|COMPLETED|Overall Study||66
9077522|NCT02067611|10139535|FG001|COMPLETED|Overall Study||66
9077523|NCT02067611|10139536|FG002|COMPLETED|Overall Study||68
9077524|NCT02067611|10139534|FG000|NOT COMPLETED|Overall Study||6
9077525|NCT02067611|10139535|FG001|NOT COMPLETED|Overall Study||6
9077526|NCT02067611|10139536|FG002|NOT COMPLETED|Overall Study||4
9077527|NCT02067104|10139548|FG000|STARTED|Overall Study||4
8624303|NCT00499408|9663562|FG000|STARTED|Overall Study||26
8629504|NCT00530764|9669251|FG001|NOT COMPLETED|Overall Study||21
9077528|NCT02067104|10139549|FG001|STARTED|Overall Study||5
9077529|NCT02067104|10139548|FG000|COMPLETED|Overall Study||0
9077530|NCT02067104|10139549|FG001|COMPLETED|Overall Study||0
9077531|NCT02067104|10139548|FG000|NOT COMPLETED|Overall Study||4
9077532|NCT02067104|10139549|FG001|NOT COMPLETED|Overall Study||5
9077533|NCT02075021|10139555|FG000|STARTED|Overall Study||3
9077534|NCT02075021|10139555|FG000|COMPLETED|Overall Study||3
9077535|NCT02075021|10139555|FG000|NOT COMPLETED|Overall Study||0
9077536|NCT02057874|10139559|FG000|STARTED|Overall Study||2
9077537|NCT02057874|10139559|FG000|COMPLETED|Overall Study||1
9077538|NCT02057874|10139559|FG000|NOT COMPLETED|Overall Study||1
9077539|NCT02057237|10139564|FG000|STARTED|Overall Study||1
9077540|NCT02057237|10139564|FG000|COMPLETED|Overall Study||1
9077541|NCT02057237|10139564|FG000|NOT COMPLETED|Overall Study||0
9077542|NCT02047747|10139569|FG000|STARTED|Overall Study||4
9077543|NCT02047747|10139569|FG000|COMPLETED|Overall Study||1
9077544|NCT02047747|10139569|FG000|NOT COMPLETED|Overall Study||3
9077545|NCT02058537|10139573|FG000|STARTED|Overall Study||3
9077546|NCT02058537|10139573|FG000|COMPLETED|Overall Study||2
9077547|NCT02058537|10139573|FG000|NOT COMPLETED|Overall Study||1
9077548|NCT02057276|10139579|FG000|STARTED|Overall Study||0
9077549|NCT02057276|10139580|FG001|STARTED|Overall Study||0
9077550|NCT02057276|10139579|FG000|COMPLETED|Overall Study||0
9077551|NCT02057276|10139580|FG001|COMPLETED|Overall Study||0
9077552|NCT02057276|10139579|FG000|NOT COMPLETED|Overall Study||0
9077553|NCT02057276|10139580|FG001|NOT COMPLETED|Overall Study||0
9077554|NCT02038153|10139586|FG000|STARTED|Overall Study||3
9077555|NCT02038153|10139586|FG000|COMPLETED|Overall Study||2
9077556|NCT02038153|10139586|FG000|NOT COMPLETED|Overall Study||1
9077557|NCT02054910|10139592|FG000|STARTED|Overall Study||4
9077558|NCT02054910|10139593|FG001|STARTED|Overall Study||1
9077559|NCT02054910|10139592|FG000|COMPLETED|Overall Study||0
9077560|NCT02054910|10139593|FG001|COMPLETED|Overall Study||0
9077561|NCT02054910|10139592|FG000|NOT COMPLETED|Overall Study||4
9077562|NCT02054910|10139593|FG001|NOT COMPLETED|Overall Study||1
9077563|NCT02044302|10139603|FG000|STARTED|Overall Study||2
9077564|NCT02044302|10139604|FG001|STARTED|Overall Study||0
9077565|NCT02044302|10139603|FG000|COMPLETED|Overall Study||0
9077566|NCT02044302|10139604|FG001|COMPLETED|Overall Study||0
9077567|NCT02044302|10139603|FG000|NOT COMPLETED|Overall Study||2
9077568|NCT02044302|10139604|FG001|NOT COMPLETED|Overall Study||0
9077569|NCT02046226|10139608|FG000|STARTED|Overall Study||7
9077570|NCT02046226|10139608|FG000|COMPLETED|Overall Study||0
9077571|NCT02046226|10139608|FG000|NOT COMPLETED|Overall Study||7
9077572|NCT02044848|10139615|FG000|STARTED|Overall Study||2
9077573|NCT02044848|10139616|FG001|STARTED|Overall Study||3
9077574|NCT02044848|10139615|FG000|COMPLETED|Overall Study||0
9077575|NCT02044848|10139616|FG001|COMPLETED|Overall Study||0
9077576|NCT02044848|10139615|FG000|NOT COMPLETED|Overall Study||2
9077577|NCT02044848|10139616|FG001|NOT COMPLETED|Overall Study||3
9077578|NCT02042950|10139622|FG000|STARTED|Overall Study||4
9077579|NCT02042950|10139622|FG000|COMPLETED|Overall Study||0
9077580|NCT02042950|10139622|FG000|NOT COMPLETED|Overall Study||4
9077581|NCT02048904|10139626|FG000|STARTED|Overall Study||142
9077582|NCT02048904|10139626|FG000|COMPLETED|Overall Study||65
9077583|NCT02048904|10139626|FG000|NOT COMPLETED|Overall Study||77
9077584|NCT02044822|10139630|FG000|STARTED|Overall Study||102
9077585|NCT02044822|10139630|FG000|COMPLETED|Overall Study|Completed = reached primary efficacy endpoint of progressive disease or death.|9
9077586|NCT02044822|10139630|FG000|NOT COMPLETED|Overall Study||93
9077587|NCT02042924|10139634|FG000|STARTED|Overall Study||2
9077588|NCT02042924|10139634|FG000|COMPLETED|Overall Study||1
9077589|NCT02042924|10139634|FG000|NOT COMPLETED|Overall Study||1
9077590|NCT02043860|10139638|FG000|STARTED|Overall Study||2
9077591|NCT02043860|10139638|FG000|COMPLETED|Overall Study||2
9077592|NCT02043860|10139638|FG000|NOT COMPLETED|Overall Study||0
9077593|NCT02017522|10139642|FG000|STARTED|Overall Study||3
9077594|NCT02017522|10139642|FG000|Scan|Overall Study||2
9077595|NCT02017522|10139642|FG000|COMPLETED|Overall Study||2
9077596|NCT02017522|10139642|FG000|NOT COMPLETED|Overall Study||1
9077597|NCT02030015|10139647|FG000|STARTED|Overall Study||16
9077598|NCT02030015|10139647|FG000|COMPLETED|Overall Study||0
9077599|NCT02030015|10139647|FG000|NOT COMPLETED|Overall Study||16
9077600|NCT02015663|10139653|FG000|STARTED|Overall Study||16
9077601|NCT02015663|10139654|FG001|STARTED|Overall Study||16
9077602|NCT02015663|10139653|FG000|COMPLETED|Overall Study||1
9077603|NCT02015663|10139654|FG001|COMPLETED|Overall Study||4
9077604|NCT02015663|10139653|FG000|NOT COMPLETED|Overall Study||15
9077605|NCT02015663|10139654|FG001|NOT COMPLETED|Overall Study||12
9077606|NCT02029846|10139663|FG000|STARTED|Overall Study||1
9077607|NCT02029846|10139664|FG001|STARTED|Overall Study||1
9077608|NCT02029846|10139663|FG000|COMPLETED|Overall Study||0
9077609|NCT02029846|10139664|FG001|COMPLETED|Overall Study||0
9077610|NCT02029846|10139663|FG000|NOT COMPLETED|Overall Study||1
9077611|NCT02029846|10139664|FG001|NOT COMPLETED|Overall Study||1
9077612|NCT02027272|10139672|FG000|STARTED|Overall Study||0
9077613|NCT02027272|10139673|FG001|STARTED|Overall Study||1
9077614|NCT02027272|10139672|FG000|COMPLETED|Overall Study||0
9077615|NCT02027272|10139673|FG001|COMPLETED|Overall Study||0
9077616|NCT02027272|10139672|FG000|NOT COMPLETED|Overall Study||0
9077617|NCT02027272|10139673|FG001|NOT COMPLETED|Overall Study||1
9077618|NCT02012608|10139681|FG000|STARTED|Overall Study||7
9077619|NCT02012608|10139682|FG001|STARTED|Overall Study||7
9077620|NCT02012608|10139681|FG000|COMPLETED|Overall Study||4
9077621|NCT02012608|10139682|FG001|COMPLETED|Overall Study||7
9077622|NCT02012608|10139681|FG000|NOT COMPLETED|Overall Study||3
9077623|NCT02012608|10139682|FG001|NOT COMPLETED|Overall Study||0
9077624|NCT02017379|10139691|FG000|STARTED|Overall Study||0
9077625|NCT02017379|10139692|FG001|STARTED|Overall Study||0
9077626|NCT02017379|10139693|FG002|STARTED|Overall Study||0
9077627|NCT02017379|10139691|FG000|COMPLETED|Overall Study||0
9077628|NCT02017379|10139692|FG001|COMPLETED|Overall Study||0
9077629|NCT02017379|10139693|FG002|COMPLETED|Overall Study||0
9077630|NCT02017379|10139691|FG000|NOT COMPLETED|Overall Study||0
9077631|NCT02017379|10139692|FG001|NOT COMPLETED|Overall Study||0
9077632|NCT02017379|10139693|FG002|NOT COMPLETED|Overall Study||0
9077633|NCT02011542|10139701|FG000|STARTED|Overall Study||30
9077634|NCT02011542|10139701|FG000|COMPLETED|Overall Study||29
9077635|NCT02011542|10139701|FG000|NOT COMPLETED|Overall Study||1
9077636|NCT02008370|10139705|FG000|STARTED|Overall Study||7
9077637|NCT02008370|10139705|FG000|COMPLETED|Overall Study||0
9077638|NCT02008370|10139705|FG000|NOT COMPLETED|Overall Study||7
9077639|NCT02009982|10139711|FG000|STARTED|Overall Study||1
9077640|NCT02009982|10139712|FG001|STARTED|Overall Study||2
9077641|NCT02009982|10139711|FG000|COMPLETED|Overall Study||1
9077642|NCT02009982|10139712|FG001|COMPLETED|Overall Study||2
9077643|NCT02009982|10139711|FG000|NOT COMPLETED|Overall Study||0
9077644|NCT02009982|10139712|FG001|NOT COMPLETED|Overall Study||0
9077645|NCT02013414|10139718|FG000|STARTED|Overall Study||9
9077646|NCT02013414|10139718|FG000|COMPLETED|Overall Study||9
9077647|NCT02013414|10139718|FG000|NOT COMPLETED|Overall Study||0
9077648|NCT02005445|10139726|FG000|STARTED|Overall Study||2
9077649|NCT02005445|10139727|FG001|STARTED|Overall Study||2
9077650|NCT02005445|10139726|FG000|COMPLETED|Overall Study||2
9077651|NCT02005445|10139727|FG001|COMPLETED|Overall Study||1
9077652|NCT02005445|10139726|FG000|NOT COMPLETED|Overall Study||0
9077653|NCT02005445|10139727|FG001|NOT COMPLETED|Overall Study||1
9077654|NCT02020837|10139733|FG000|STARTED|Overall Study||2
9077655|NCT02020837|10139733|FG000|COMPLETED|Overall Study||2
9077656|NCT02020837|10139733|FG000|NOT COMPLETED|Overall Study||0
9077657|NCT02015910|10139739|FG000|STARTED|Overall Study||0
9077658|NCT02015910|10139740|FG001|STARTED|Overall Study||1
9077659|NCT02015910|10139739|FG000|COMPLETED|Overall Study||0
9077660|NCT02015910|10139740|FG001|COMPLETED|Overall Study||1
9077661|NCT02015910|10139739|FG000|NOT COMPLETED|Overall Study||0
9077662|NCT02015910|10139740|FG001|NOT COMPLETED|Overall Study||0
9077663|NCT02006927|10139746|FG000|STARTED|Overall Study||3
9077664|NCT02006927|10139746|FG000|COMPLETED|Overall Study||0
9077665|NCT02006927|10139746|FG000|NOT COMPLETED|Overall Study||3
9077666|NCT01996982|10139750|FG000|STARTED|Overall Study||7
9077667|NCT01996982|10139750|FG000|COMPLETED|Overall Study||0
9077668|NCT01996982|10139750|FG000|NOT COMPLETED|Overall Study||7
9077669|NCT02006407|10139754|FG000|STARTED|Overall Study||5
9077670|NCT02006407|10139754|FG000|COMPLETED|Overall Study||5
9077671|NCT02006407|10139754|FG000|NOT COMPLETED|Overall Study||0
9077672|NCT01986751|10139760|FG000|STARTED|Overall Study||10
9077673|NCT01986751|10139761|FG001|STARTED|Overall Study||4
9077674|NCT01986751|10139760|FG000|COMPLETED|Overall Study||0
9077675|NCT01986751|10139761|FG001|COMPLETED|Overall Study||2
9077676|NCT01986751|10139760|FG000|NOT COMPLETED|Overall Study||10
9077677|NCT01986751|10139761|FG001|NOT COMPLETED|Overall Study||2
9077678|NCT01996410|10139779|FG000|STARTED|Overall Study||3
9077679|NCT01996410|10139780|FG001|STARTED|Overall Study||3
9077680|NCT01996410|10139781|FG002|STARTED|Overall Study||0
9077681|NCT01996410|10139782|FG003|STARTED|Overall Study||0
9077682|NCT01996410|10139783|FG004|STARTED|Overall Study||2
9077683|NCT01996410|10139784|FG005|STARTED|Overall Study||2
9077684|NCT01996410|10139785|FG006|STARTED|Overall Study||0
9077685|NCT01996410|10139786|FG007|STARTED|Overall Study||0
9077686|NCT01996410|10139779|FG000|COMPLETED|Overall Study||3
9077687|NCT01996410|10139780|FG001|COMPLETED|Overall Study||3
9077688|NCT01996410|10139781|FG002|COMPLETED|Overall Study||0
9077689|NCT01996410|10139782|FG003|COMPLETED|Overall Study||0
9077690|NCT01996410|10139783|FG004|COMPLETED|Overall Study||2
9077691|NCT01996410|10139784|FG005|COMPLETED|Overall Study||2
9077692|NCT01996410|10139785|FG006|COMPLETED|Overall Study||0
9077693|NCT01996410|10139786|FG007|COMPLETED|Overall Study||0
9077694|NCT01996410|10139779|FG000|NOT COMPLETED|Overall Study||0
9077695|NCT01996410|10139780|FG001|NOT COMPLETED|Overall Study||0
9077696|NCT01996410|10139781|FG002|NOT COMPLETED|Overall Study||0
9077697|NCT01996410|10139782|FG003|NOT COMPLETED|Overall Study||0
9077698|NCT01996410|10139783|FG004|NOT COMPLETED|Overall Study||0
9077699|NCT01996410|10139784|FG005|NOT COMPLETED|Overall Study||0
9077700|NCT01996410|10139785|FG006|NOT COMPLETED|Overall Study||0
9077701|NCT01996410|10139786|FG007|NOT COMPLETED|Overall Study||0
9077702|NCT01996852|10139801|FG000|STARTED|Overall Study||0
9077703|NCT01996852|10139802|FG001|STARTED|Overall Study||0
9077704|NCT01996852|10139803|FG002|STARTED|Overall Study||0
9077705|NCT01996852|10139801|FG000|COMPLETED|Overall Study||0
9077706|NCT01996852|10139802|FG001|COMPLETED|Overall Study||0
9077707|NCT01996852|10139803|FG002|COMPLETED|Overall Study||0
9077708|NCT01996852|10139801|FG000|NOT COMPLETED|Overall Study||0
9077709|NCT01996852|10139802|FG001|NOT COMPLETED|Overall Study||0
9077710|NCT01996852|10139803|FG002|NOT COMPLETED|Overall Study||0
9077711|NCT01997567|10139813|FG000|STARTED|Overall Study||0
9077712|NCT01997567|10139814|FG001|STARTED|Overall Study||0
9077713|NCT01997567|10139813|FG000|COMPLETED|Overall Study||0
9077714|NCT01997567|10139814|FG001|COMPLETED|Overall Study||0
9077715|NCT01997567|10139813|FG000|NOT COMPLETED|Overall Study||0
9077716|NCT01997567|10139814|FG001|NOT COMPLETED|Overall Study||0
9077717|NCT01977729|10139820|FG000|STARTED|Overall Study||1
9077718|NCT01977729|10139820|FG000|COMPLETED|Overall Study||0
9077719|NCT01977729|10139820|FG000|NOT COMPLETED|Overall Study||1
9077720|NCT01973062|10139826|FG000|STARTED|Overall Study||1
9077721|NCT01973062|10139826|FG000|COMPLETED|Overall Study||1
9077722|NCT01973062|10139826|FG000|NOT COMPLETED|Overall Study||0
9077723|NCT01982253|10139833|FG000|STARTED|Overall Study||2
9077724|NCT01982253|10139834|FG001|STARTED|Overall Study||4
9077725|NCT01982253|10139835|FG002|STARTED|Overall Study||4
9077726|NCT01982253|10139833|FG000|COMPLETED|Overall Study||0
9077727|NCT01982253|10139834|FG001|COMPLETED|Overall Study||0
9077728|NCT01982253|10139835|FG002|COMPLETED|Overall Study||0
9077729|NCT01982253|10139833|FG000|NOT COMPLETED|Overall Study||2
9077730|NCT01982253|10139834|FG001|NOT COMPLETED|Overall Study||4
9077731|NCT01982253|10139835|FG002|NOT COMPLETED|Overall Study||4
9077732|NCT01984268|10139843|FG000|STARTED|Overall Study||15
9077733|NCT01984268|10139843|FG000|COMPLETED|Overall Study||0
9077734|NCT01984268|10139843|FG000|NOT COMPLETED|Overall Study||15
9077735|NCT01974284|10139847|FG000|STARTED|Overall Study||7
9077736|NCT01974284|10139847|FG000|COMPLETED|Overall Study||0
9077737|NCT01974284|10139847|FG000|NOT COMPLETED|Overall Study||7
9077738|NCT01971853|10139853|FG000|STARTED|Overall Study||0
9077739|NCT01971853|10139854|FG001|STARTED|Overall Study||0
9077740|NCT01971853|10139853|FG000|COMPLETED|Overall Study||0
9077741|NCT01971853|10139854|FG001|COMPLETED|Overall Study||0
9077742|NCT01971853|10139853|FG000|NOT COMPLETED|Overall Study||0
9077743|NCT01971853|10139854|FG001|NOT COMPLETED|Overall Study||0
9077744|NCT01980875|10139863|FG000|STARTED|Overall Study||8
9077745|NCT01980875|10139864|FG001|STARTED|Overall Study||25
9077746|NCT01980875|10139865|FG002|STARTED|Overall Study||24
9077747|NCT01980875|10139863|FG000|COMPLETED|Overall Study||0
9077748|NCT01980875|10139864|FG001|COMPLETED|Overall Study||0
9077749|NCT01980875|10139865|FG002|COMPLETED|Overall Study||0
9077750|NCT01980875|10139863|FG000|NOT COMPLETED|Overall Study||8
9077751|NCT01980875|10139864|FG001|NOT COMPLETED|Overall Study||25
9077752|NCT01980875|10139865|FG002|NOT COMPLETED|Overall Study||24
9077753|NCT01982383|10139875|FG000|STARTED|Overall Study||2
9077754|NCT01982383|10139876|FG001|STARTED|Overall Study||0
9077755|NCT01982383|10139875|FG000|COMPLETED|Overall Study||2
9077756|NCT01982383|10139876|FG001|COMPLETED|Overall Study||0
9077757|NCT01982383|10139875|FG000|NOT COMPLETED|Overall Study||0
9077758|NCT01982383|10139876|FG001|NOT COMPLETED|Overall Study||0
9077759|NCT01980342|10139882|FG000|STARTED|Overall Study||1
9077760|NCT01980342|10139882|FG000|COMPLETED|Overall Study||0
9077761|NCT01980342|10139882|FG000|NOT COMPLETED|Overall Study||1
9077762|NCT01978535|10139888|FG000|STARTED|Overall Study||1
9077763|NCT01978535|10139889|FG001|STARTED|Overall Study||2
9077764|NCT01978535|10139888|FG000|COMPLETED|Overall Study||1
9077765|NCT01978535|10139889|FG001|COMPLETED|Overall Study||2
9077766|NCT01978535|10139888|FG000|NOT COMPLETED|Overall Study||0
9077767|NCT01978535|10139889|FG001|NOT COMPLETED|Overall Study||0
9077768|NCT01974635|10139895|FG000|STARTED|Overall Study||2
9077769|NCT01974635|10139895|FG000|COMPLETED|Overall Study||2
9077770|NCT01974635|10139895|FG000|NOT COMPLETED|Overall Study||0
9077771|NCT01975467|10139902|FG000|STARTED|Overall Study|Study terminated before enrollment|0
9077772|NCT01975467|10139903|FG001|STARTED|Overall Study|Study terminated before enrollment|0
9077773|NCT01975467|10139902|FG000|COMPLETED|Overall Study||0
9077774|NCT01975467|10139903|FG001|COMPLETED|Overall Study||0
9077775|NCT01975467|10139902|FG000|NOT COMPLETED|Overall Study||0
9077776|NCT01975467|10139903|FG001|NOT COMPLETED|Overall Study||0
9077777|NCT01970462|10139911|FG000|STARTED|Overall Study||1
9077778|NCT01970462|10139912|FG001|STARTED|Overall Study||4
9077779|NCT01970462|10139911|FG000|COMPLETED|Overall Study||1
9077780|NCT01970462|10139912|FG001|COMPLETED|Overall Study||2
9077781|NCT01970462|10139911|FG000|NOT COMPLETED|Overall Study||0
9077782|NCT01970462|10139912|FG001|NOT COMPLETED|Overall Study||2
9077783|NCT01969565|10139918|FG000|STARTED|Overall Study||1
9077784|NCT01969565|10139918|FG000|COMPLETED|Overall Study||0
9077785|NCT01969565|10139918|FG000|NOT COMPLETED|Overall Study||1
9077786|NCT01968226|10139923|FG000|STARTED|Overall Study||3
9077787|NCT01968226|10139923|FG000|COMPLETED|Overall Study||1
9077788|NCT01968226|10139923|FG000|NOT COMPLETED|Overall Study||2
9077789|NCT01965782|10139927|FG000|STARTED|Overall Study||0
9077790|NCT01965782|10139927|FG000|COMPLETED|Overall Study||0
9077791|NCT01965782|10139927|FG000|NOT COMPLETED|Overall Study||0
9077792|NCT01962675|10139933|FG000|STARTED|Overall Study||7
9077793|NCT01962675|10139934|FG001|STARTED|Overall Study||7
9077794|NCT01962675|10139933|FG000|COMPLETED|Overall Study||7
9077795|NCT01962675|10139934|FG001|COMPLETED|Overall Study||7
9077796|NCT01962675|10139933|FG000|NOT COMPLETED|Overall Study||0
9077797|NCT01962675|10139934|FG001|NOT COMPLETED|Overall Study||0
9077798|NCT01962974|10139942|FG000|STARTED|Overall Study||7
9077799|NCT01962974|10139942|FG000|COMPLETED|Overall Study||0
9077800|NCT01962974|10139942|FG000|NOT COMPLETED|Overall Study||7
9077801|NCT01954160|10139948|FG000|STARTED|Overall Study||5
9077802|NCT01954160|10139949|FG001|STARTED|Overall Study|Not started|0
9077803|NCT01954160|10139948|FG000|COMPLETED|Overall Study|Only 4 subjects completed the first early denervation. No subjects completed the late denervation.|0
9077804|NCT01954160|10139949|FG001|COMPLETED|Overall Study||0
9077805|NCT01954160|10139948|FG000|NOT COMPLETED|Overall Study||5
9077806|NCT01954160|10139949|FG001|NOT COMPLETED|Overall Study||0
9077807|NCT01951378|10139959|FG000|STARTED|Overall Study||23
9077808|NCT01951378|10139960|FG001|STARTED|Overall Study||17
9077809|NCT01951378|10139959|FG000|COMPLETED|Overall Study||0
9077810|NCT01951378|10139960|FG001|COMPLETED|Overall Study||0
9077811|NCT01951378|10139959|FG000|NOT COMPLETED|Overall Study||23
9077812|NCT01951378|10139960|FG001|NOT COMPLETED|Overall Study||17
8624304|NCT00499408|9663562|FG000|COMPLETED|Overall Study|Three patients did not have adequate testing to be evaluable for a response.|26
8624305|NCT00499408|9663562|FG000|NOT COMPLETED|Overall Study||0
8624306|NCT00499447|9663566|FG000|STARTED|Overall Study||13
8624307|NCT00499447|9663566|FG000|COMPLETED|Overall Study||13
9077813|NCT01941615|10139966|FG000|STARTED|Run in Treatment: Microgynon®||16
9077814|NCT01941615|10139966|FG000|COMPLETED|Run in Treatment: Microgynon®||16
9077815|NCT01941615|10139966|FG000|NOT COMPLETED|Run in Treatment: Microgynon®||0
9077816|NCT01941615|10139966|FG000|STARTED|Reference Treatment: Microgynon®||0
9077817|NCT01941615|10139966|FG000|COMPLETED|Reference Treatment: Microgynon®||0
8624308|NCT00499447|9663566|FG000|NOT COMPLETED|Overall Study||0
9077818|NCT01941615|10139966|FG000|NOT COMPLETED|Reference Treatment: Microgynon®||0
9077819|NCT01941615|10139966|FG000|STARTED|Microgynon® Plus Deleobuvir+Faldaprevir||0
9077820|NCT01941615|10139966|FG000|COMPLETED|Microgynon® Plus Deleobuvir+Faldaprevir||0
8624309|NCT00499460|9663572|FG000|STARTED|Intervention 1 (30 Days)||8
9077821|NCT01941615|10139966|FG000|NOT COMPLETED|Microgynon® Plus Deleobuvir+Faldaprevir||0
9077822|NCT01946542|10139972|FG000|STARTED|Testing Visit 1||1
9077823|NCT01946542|10139973|FG001|STARTED|Testing Visit 1||1
9077824|NCT01946542|10139972|FG000|COMPLETED|Testing Visit 1||1
9077825|NCT01946542|10139973|FG001|COMPLETED|Testing Visit 1||1
9077826|NCT01946542|10139972|FG000|NOT COMPLETED|Testing Visit 1||0
9077827|NCT01946542|10139973|FG001|NOT COMPLETED|Testing Visit 1||0
9077828|NCT01946542|10139972|FG000|STARTED|Testing Visit 2||1
9077829|NCT01946542|10139973|FG001|STARTED|Testing Visit 2||1
9077830|NCT01946542|10139972|FG000|COMPLETED|Testing Visit 2||1
9077831|NCT01946542|10139973|FG001|COMPLETED|Testing Visit 2||1
9077832|NCT01946542|10139972|FG000|NOT COMPLETED|Testing Visit 2||0
9077833|NCT01946542|10139973|FG001|NOT COMPLETED|Testing Visit 2||0
9077834|NCT01937507|10139979|FG000|STARTED|Overall Study||2
9077835|NCT01937507|10139979|FG000|COMPLETED|Overall Study||0
9077836|NCT01937507|10139979|FG000|NOT COMPLETED|Overall Study||2
9077837|NCT01944059|10139983|FG000|STARTED|Overall Study||31
9077838|NCT01944059|10139983|FG000|COMPLETED|Overall Study||24
9077839|NCT01944059|10139983|FG000|NOT COMPLETED|Overall Study||7
9077840|NCT01935947|10139991|FG000|STARTED|Overall Study||4
9077841|NCT01935947|10139992|FG001|STARTED|Overall Study||4
9077842|NCT01935947|10139993|FG002|STARTED|Overall Study||2
9077843|NCT01935947|10139991|FG000|Epigenetic Therapy|Overall Study||4
9077844|NCT01935947|10139992|FG001|Epigenetic Therapy|Overall Study||4
9077845|NCT01935947|10139993|FG002|Epigenetic Therapy|Overall Study||0
9077846|NCT01935947|10139991|FG000|Cytotoxic Therapy|Overall Study||3
9077847|NCT01935947|10139992|FG001|Cytotoxic Therapy|Overall Study||3
9077848|NCT01935947|10139993|FG002|Cytotoxic Therapy|Overall Study||2
9077849|NCT01935947|10139991|FG000|COMPLETED|Overall Study||1
9077850|NCT01935947|10139992|FG001|COMPLETED|Overall Study||0
9077851|NCT01935947|10139993|FG002|COMPLETED|Overall Study||0
9077852|NCT01935947|10139991|FG000|NOT COMPLETED|Overall Study||3
9077853|NCT01935947|10139992|FG001|NOT COMPLETED|Overall Study||4
9077854|NCT01935947|10139993|FG002|NOT COMPLETED|Overall Study||2
9077855|NCT01939223|10140006|FG000|STARTED|Overall Study||14
9077856|NCT01939223|10140007|FG001|STARTED|Overall Study||11
9077857|NCT01939223|10140006|FG000|Participants Received Treatment|Overall Study||14
9077858|NCT01939223|10140007|FG001|Participants Received Treatment|Overall Study||11
9077859|NCT01939223|10140006|FG000|COMPLETED|Overall Study||1
9077860|NCT01939223|10140007|FG001|COMPLETED|Overall Study||0
9077861|NCT01939223|10140006|FG000|NOT COMPLETED|Overall Study||13
9077862|NCT01939223|10140007|FG001|NOT COMPLETED|Overall Study||11
9077863|NCT01938716|10140013|FG000|STARTED|Overall Study||12
9077864|NCT01938716|10140013|FG000|COMPLETED|Overall Study||8
9077865|NCT01938716|10140013|FG000|NOT COMPLETED|Overall Study||4
9077866|NCT01936974|10140019|FG000|STARTED|Overall Study||2
9077867|NCT01936974|10140020|FG001|STARTED|Overall Study||5
9077868|NCT01936974|10140019|FG000|COMPLETED|Overall Study||0
9077869|NCT01936974|10140020|FG001|COMPLETED|Overall Study||0
9077870|NCT01936974|10140019|FG000|NOT COMPLETED|Overall Study||2
9077871|NCT01936974|10140020|FG001|NOT COMPLETED|Overall Study||5
9077872|NCT01938833|10140026|FG000|STARTED|Overall Study||9
9077873|NCT01938833|10140026|FG000|COMPLETED|Overall Study||9
9077874|NCT01938833|10140026|FG000|NOT COMPLETED|Overall Study||0
9077875|NCT01934647|10140033|FG000|STARTED|Overall Study||2
9077876|NCT01934647|10140034|FG001|STARTED|Overall Study||2
9077877|NCT01934647|10140035|FG002|STARTED|Overall Study||3
9077878|NCT01934647|10140033|FG000|COMPLETED|Overall Study||2
9077879|NCT01934647|10140034|FG001|COMPLETED|Overall Study||2
9077880|NCT01934647|10140035|FG002|COMPLETED|Overall Study||3
9077881|NCT01934647|10140033|FG000|NOT COMPLETED|Overall Study||0
9077882|NCT01934647|10140034|FG001|NOT COMPLETED|Overall Study||0
9077883|NCT01934647|10140035|FG002|NOT COMPLETED|Overall Study||0
9077884|NCT01934504|10140047|FG000|STARTED|Overall Study||6
9077885|NCT01934504|10140048|FG001|STARTED|Overall Study||3
9077886|NCT01934504|10140049|FG002|STARTED|Overall Study||16
9077887|NCT01934504|10140050|FG003|STARTED|Overall Study||8
9077888|NCT01934504|10140047|FG000|COMPLETED|Overall Study||5
9077889|NCT01934504|10140048|FG001|COMPLETED|Overall Study||3
9077890|NCT01934504|10140049|FG002|COMPLETED|Overall Study||11
9077891|NCT01934504|10140050|FG003|COMPLETED|Overall Study||1
9077892|NCT01934504|10140047|FG000|NOT COMPLETED|Overall Study||1
9077893|NCT01934504|10140048|FG001|NOT COMPLETED|Overall Study||0
9077894|NCT01934504|10140049|FG002|NOT COMPLETED|Overall Study||5
9077895|NCT01934504|10140050|FG003|NOT COMPLETED|Overall Study||7
9077896|NCT01928082|10140060|FG000|STARTED|Overall Study||1
9077897|NCT01928082|10140060|FG000|COMPLETED|Overall Study||0
9077898|NCT01928082|10140060|FG000|NOT COMPLETED|Overall Study||1
9077899|NCT01928615|10140064|FG000|STARTED|Overall Study||2
9077900|NCT01928615|10140064|FG000|COMPLETED|Overall Study||0
9077901|NCT01928615|10140064|FG000|NOT COMPLETED|Overall Study||2
9077902|NCT01911793|10140071|FG000|STARTED|Overall Study||1
9077903|NCT01911793|10140072|FG001|STARTED|Overall Study||5
9077904|NCT01911793|10140071|FG000|COMPLETED|Overall Study||0
9077905|NCT01911793|10140072|FG001|COMPLETED|Overall Study||0
9077906|NCT01911793|10140071|FG000|NOT COMPLETED|Overall Study||1
9077907|NCT01911793|10140072|FG001|NOT COMPLETED|Overall Study||5
9077908|NCT01912404|10140080|FG000|STARTED|Overall Study||3
9077909|NCT01912404|10140081|FG001|STARTED|Overall Study||2
9077910|NCT01912404|10140080|FG000|COMPLETED|Overall Study||2
9077911|NCT01912404|10140081|FG001|COMPLETED|Overall Study||2
9077912|NCT01912404|10140080|FG000|NOT COMPLETED|Overall Study||1
9077913|NCT01912404|10140081|FG001|NOT COMPLETED|Overall Study||0
9077914|NCT01910389|10140089|FG000|STARTED|Overall Study||15
9077915|NCT01910389|10140090|FG001|STARTED|Overall Study||8
9077916|NCT01910389|10140089|FG000|COMPLETED|Overall Study||0
9077917|NCT01910389|10140090|FG001|COMPLETED|Overall Study||0
9077918|NCT01910389|10140089|FG000|NOT COMPLETED|Overall Study||15
9077919|NCT01910389|10140090|FG001|NOT COMPLETED|Overall Study||8
9077920|NCT01921114|10140098|FG000|STARTED|Overall Study||0
9077921|NCT01921114|10140099|FG001|STARTED|Overall Study||0
9077922|NCT01921114|10140098|FG000|COMPLETED|Overall Study||0
9077923|NCT01921114|10140099|FG001|COMPLETED|Overall Study||0
9077924|NCT01921114|10140098|FG000|NOT COMPLETED|Overall Study||0
9077925|NCT01921114|10140099|FG001|NOT COMPLETED|Overall Study||0
9077926|NCT01916590|10140107|FG000|STARTED|Overall Study||4
9077927|NCT01916590|10140108|FG001|STARTED|Overall Study||3
9077928|NCT01916590|10140107|FG000|COMPLETED|Overall Study||4
9077929|NCT01916590|10140108|FG001|COMPLETED|Overall Study||3
9077930|NCT01916590|10140107|FG000|NOT COMPLETED|Overall Study||0
9077931|NCT01916590|10140108|FG001|NOT COMPLETED|Overall Study||0
9077932|NCT01913327|10140116|FG000|STARTED|Overall Study||1
9077933|NCT01913327|10140117|FG001|STARTED|Overall Study||2
9077934|NCT01913327|10140116|FG000|COMPLETED|Overall Study||1
9077935|NCT01913327|10140117|FG001|COMPLETED|Overall Study||1
9077936|NCT01913327|10140116|FG000|NOT COMPLETED|Overall Study||0
9077937|NCT01913327|10140117|FG001|NOT COMPLETED|Overall Study||1
9077938|NCT01902888|10140123|FG000|STARTED|Overall Study||3
9077939|NCT01902888|10140123|FG000|COMPLETED|Overall Study||0
9077940|NCT01902888|10140123|FG000|NOT COMPLETED|Overall Study||3
9077941|NCT01901224|10140127|FG000|STARTED|Overall Study||2
9077942|NCT01901224|10140127|FG000|COMPLETED|Overall Study||0
9077943|NCT01901224|10140127|FG000|NOT COMPLETED|Overall Study||2
9077944|NCT01910441|10140133|FG000|STARTED|Overall Study||48
9077945|NCT01910441|10140134|FG001|STARTED|Overall Study||47
9077946|NCT01910441|10140133|FG000|COMPLETED|Overall Study||41
9077947|NCT01910441|10140134|FG001|COMPLETED|Overall Study||37
9077948|NCT01910441|10140133|FG000|NOT COMPLETED|Overall Study||7
9077949|NCT01910441|10140134|FG001|NOT COMPLETED|Overall Study||10
9077950|NCT01902966|10140140|FG000|STARTED|Overall Study||5
9077951|NCT01902966|10140140|FG000|COMPLETED|Overall Study||2
9077952|NCT01902966|10140140|FG000|NOT COMPLETED|Overall Study||3
9077953|NCT01901679|10140146|FG000|STARTED|Overall Study||5
9077954|NCT01901679|10140147|FG001|STARTED|Overall Study||5
9077955|NCT01901679|10140146|FG000|COMPLETED|Overall Study||5
9077956|NCT01901679|10140147|FG001|COMPLETED|Overall Study||5
9077957|NCT01901679|10140146|FG000|NOT COMPLETED|Overall Study||0
9077958|NCT01901679|10140147|FG001|NOT COMPLETED|Overall Study||0
9077959|NCT01900730|10140155|FG000|STARTED|Overall Study||3
9077960|NCT01900730|10140156|FG001|STARTED|Overall Study||0
9077961|NCT01900730|10140155|FG000|COMPLETED|Overall Study||1
9077962|NCT01900730|10140156|FG001|COMPLETED|Overall Study||0
9077963|NCT01900730|10140155|FG000|NOT COMPLETED|Overall Study||2
9077964|NCT01900730|10140156|FG001|NOT COMPLETED|Overall Study||0
9077965|NCT01877564|10140164|FG000|STARTED|Overall Study||6
9077966|NCT01877564|10140165|FG001|STARTED|Overall Study||4
9077967|NCT01877564|10140164|FG000|COMPLETED|Overall Study||6
9077968|NCT01877564|10140165|FG001|COMPLETED|Overall Study||4
9077969|NCT01877564|10140164|FG000|NOT COMPLETED|Overall Study||0
9077970|NCT01877564|10140165|FG001|NOT COMPLETED|Overall Study||0
9077971|NCT01890694|10140173|FG000|STARTED|Overall Study||1
9077972|NCT01890694|10140174|FG001|STARTED|Overall Study||1
9077973|NCT01890694|10140173|FG000|COMPLETED|Overall Study||0
9077974|NCT01890694|10140174|FG001|COMPLETED|Overall Study||0
9077975|NCT01890694|10140173|FG000|NOT COMPLETED|Overall Study||1
9077976|NCT01890694|10140174|FG001|NOT COMPLETED|Overall Study||1
9077977|NCT01900626|10140184|FG000|STARTED|Overall Study||1
9077978|NCT01900626|10140185|FG001|STARTED|Overall Study||1
9077979|NCT01900626|10140184|FG000|COMPLETED|Overall Study||0
9077980|NCT01900626|10140185|FG001|COMPLETED|Overall Study||0
9077981|NCT01900626|10140184|FG000|NOT COMPLETED|Overall Study||1
9077982|NCT01900626|10140185|FG001|NOT COMPLETED|Overall Study||1
9077983|NCT01890577|10140193|FG000|STARTED|Overall Study||28
9077984|NCT01890577|10140193|FG000|COMPLETED|Overall Study||0
9077985|NCT01890577|10140193|FG000|NOT COMPLETED|Overall Study||28
9077986|NCT01895959|10140197|FG000|STARTED|Overall Study||12
9077987|NCT01895959|10140197|FG000|COMPLETED|Overall Study||10
9077988|NCT01895959|10140197|FG000|NOT COMPLETED|Overall Study||2
9077989|NCT01889420|10140201|FG000|STARTED|Overall Study||1
9077990|NCT01889420|10140201|FG000|COMPLETED|Overall Study||1
9077991|NCT01889420|10140201|FG000|NOT COMPLETED|Overall Study||0
9077992|NCT01884077|10140207|FG000|STARTED|Overall Study||8
9077993|NCT01884077|10140208|FG001|STARTED|Overall Study||11
9077994|NCT01884077|10140207|FG000|COMPLETED|Overall Study||0
9077995|NCT01884077|10140208|FG001|COMPLETED|Overall Study||1
9077996|NCT01884077|10140207|FG000|NOT COMPLETED|Overall Study||8
9077997|NCT01884077|10140208|FG001|NOT COMPLETED|Overall Study||10
9077998|NCT01881984|10140214|FG000|STARTED|Overall Study||4
9077999|NCT01881984|10140214|FG000|COMPLETED|Overall Study||4
9078000|NCT01881984|10140214|FG000|NOT COMPLETED|Overall Study||0
9078001|NCT01893359|10140221|FG000|STARTED|Overall Study||0
9078002|NCT01893359|10140222|FG001|STARTED|Overall Study||2
9078003|NCT01893359|10140223|FG002|STARTED|Overall Study||0
9078004|NCT01893359|10140221|FG000|COMPLETED|Overall Study||0
9078005|NCT01893359|10140222|FG001|COMPLETED|Overall Study||2
9078006|NCT01893359|10140223|FG002|COMPLETED|Overall Study||0
9078007|NCT01893359|10140221|FG000|NOT COMPLETED|Overall Study||0
9078008|NCT01893359|10140222|FG001|NOT COMPLETED|Overall Study||0
9078009|NCT01893359|10140223|FG002|NOT COMPLETED|Overall Study||0
9078010|NCT01883908|10140233|FG000|STARTED|Overall Study||3
9078011|NCT01883908|10140234|FG001|STARTED|Overall Study||1
9078012|NCT01883908|10140233|FG000|COMPLETED|Overall Study||3
9078013|NCT01883908|10140234|FG001|COMPLETED|Overall Study||1
9078014|NCT01883908|10140233|FG000|NOT COMPLETED|Overall Study||0
9078015|NCT01883908|10140234|FG001|NOT COMPLETED|Overall Study||0
9078016|NCT01887288|10140240|FG000|STARTED|Overall Study||16
9078017|NCT01887288|10140240|FG000|COMPLETED|Overall Study||0
9078018|NCT01887288|10140240|FG000|NOT COMPLETED|Overall Study||16
9078019|NCT01881932|10140247|FG000|STARTED|Overall Study||2
9078020|NCT01881932|10140248|FG001|STARTED|Overall Study||4
9078021|NCT01881932|10140249|FG002|STARTED|Overall Study||13
9078022|NCT01881932|10140247|FG000|COMPLETED|Overall Study||2
9078023|NCT01881932|10140248|FG001|COMPLETED|Overall Study||4
9078024|NCT01881932|10140249|FG002|COMPLETED|Overall Study||13
9078025|NCT01881932|10140247|FG000|NOT COMPLETED|Overall Study||0
9078026|NCT01881932|10140248|FG001|NOT COMPLETED|Overall Study||0
9078027|NCT01881932|10140249|FG002|NOT COMPLETED|Overall Study||0
9078028|NCT01878786|10140260|FG000|STARTED|Overall Study||9
9078029|NCT01878786|10140261|FG001|STARTED|Overall Study||9
9078030|NCT01878786|10140262|FG002|STARTED|Overall Study||7
9078031|NCT01878786|10140260|FG000|COMPLETED|Overall Study|Study closed prematurely|0
9078032|NCT01878786|10140261|FG001|COMPLETED|Overall Study|Study closed prematurely|0
9078033|NCT01878786|10140262|FG002|COMPLETED|Overall Study|Study closed prematurely; 1 patient was a screen fail|0
9078034|NCT01878786|10140260|FG000|NOT COMPLETED|Overall Study||9
9078035|NCT01878786|10140261|FG001|NOT COMPLETED|Overall Study||9
9078036|NCT01878786|10140262|FG002|NOT COMPLETED|Overall Study||7
9078037|NCT01877343|10140273|FG000|STARTED|Overall Study||2
9078038|NCT01877343|10140274|FG001|STARTED|Overall Study||3
9078039|NCT01877343|10140275|FG002|STARTED|Overall Study||0
9078040|NCT01877343|10140276|FG003|STARTED|Overall Study||0
9078041|NCT01877343|10140277|FG004|STARTED|Overall Study||0
9078042|NCT01877343|10140278|FG005|STARTED|Overall Study||5
9078043|NCT01877343|10140279|FG006|STARTED|Overall Study||0
9078044|NCT01877343|10140273|FG000|COMPLETED|Overall Study||2
9078045|NCT01877343|10140274|FG001|COMPLETED|Overall Study||3
9078046|NCT01877343|10140275|FG002|COMPLETED|Overall Study||0
9078047|NCT01877343|10140276|FG003|COMPLETED|Overall Study||0
9078048|NCT01877343|10140277|FG004|COMPLETED|Overall Study||0
9078049|NCT01877343|10140278|FG005|COMPLETED|Overall Study||5
9078050|NCT01877343|10140279|FG006|COMPLETED|Overall Study||0
9078051|NCT01877343|10140273|FG000|NOT COMPLETED|Overall Study||0
9078052|NCT01877343|10140274|FG001|NOT COMPLETED|Overall Study||0
9078053|NCT01877343|10140275|FG002|NOT COMPLETED|Overall Study||0
9078054|NCT01877343|10140276|FG003|NOT COMPLETED|Overall Study||0
9078055|NCT01877343|10140277|FG004|NOT COMPLETED|Overall Study||0
9078056|NCT01877343|10140278|FG005|NOT COMPLETED|Overall Study||0
9078057|NCT01877343|10140279|FG006|NOT COMPLETED|Overall Study||0
9078058|NCT01861717|10140283|FG000|STARTED|Overall Study||4
9078059|NCT01861717|10140283|FG000|COMPLETED|Overall Study||2
9078060|NCT01861717|10140283|FG000|NOT COMPLETED|Overall Study||2
9078061|NCT01866709|10140290|FG000|STARTED|Overall Study||15
9078062|NCT01866709|10140291|FG001|STARTED|Overall Study||17
9078063|NCT01866709|10140290|FG000|COMPLETED|Overall Study||14
9078064|NCT01866709|10140291|FG001|COMPLETED|Overall Study||17
9078065|NCT01866709|10140290|FG000|NOT COMPLETED|Overall Study||1
9078066|NCT01866709|10140291|FG001|NOT COMPLETED|Overall Study||0
9078067|NCT01860040|10140299|FG000|STARTED|Overall Study|did not meet recruitment goal|1
9078068|NCT01860040|10140300|FG001|STARTED|Overall Study|did not meet recruitment goal|0
9078069|NCT01860040|10140299|FG000|COMPLETED|Overall Study|did not meet recruitment goal|0
9078070|NCT01860040|10140300|FG001|COMPLETED|Overall Study|did not meet recruitment goal|0
9078071|NCT01860040|10140299|FG000|NOT COMPLETED|Overall Study||1
9078072|NCT01860040|10140300|FG001|NOT COMPLETED|Overall Study||0
9078073|NCT01869478|10140307|FG000|STARTED|Overall Study||0
9078074|NCT01869478|10140308|FG001|STARTED|Overall Study||1
9078075|NCT01869478|10140307|FG000|COMPLETED|Overall Study||0
9078076|NCT01869478|10140308|FG001|COMPLETED|Overall Study||1
9078077|NCT01869478|10140307|FG000|NOT COMPLETED|Overall Study||0
9078078|NCT01869478|10140308|FG001|NOT COMPLETED|Overall Study||0
9078079|NCT01851174|10140314|FG000|STARTED|Overall Study||15
9078080|NCT01851174|10140314|FG000|COMPLETED|Overall Study||15
9078081|NCT01851174|10140314|FG000|NOT COMPLETED|Overall Study||0
9078082|NCT01846182|10140321|FG000|STARTED|Overall Study|Unclear due to assignment records.|0
9078083|NCT01846182|10140322|FG001|STARTED|Overall Study|Unclear due to assignment records.|0
9078084|NCT01846182|10140323|FG002|STARTED|Overall Study|Unclear due to assignment records.|0
9078085|NCT01846182|10140321|FG000|COMPLETED|Overall Study|The data on completion subjects is corrupted and not reliable for interpretation.|0
9078086|NCT01846182|10140322|FG001|COMPLETED|Overall Study|The data on completion subjects is corrupted and not reliable for interpretation.|0
9078087|NCT01846182|10140323|FG002|COMPLETED|Overall Study|The data on completion subjects is corrupted and not reliable for interpretation.|0
9078088|NCT01846182|10140321|FG000|NOT COMPLETED|Overall Study||0
9078089|NCT01846182|10140322|FG001|NOT COMPLETED|Overall Study||0
9078090|NCT01846182|10140323|FG002|NOT COMPLETED|Overall Study||0
9078091|NCT01844206|10140335|FG000|STARTED|Overall Study||2
9078092|NCT01844206|10140336|FG001|STARTED|Overall Study||3
9078093|NCT01844206|10140335|FG000|COMPLETED|Overall Study||2
9078094|NCT01844206|10140336|FG001|COMPLETED|Overall Study|One patient requested that epidural catheter be removed during the first post-operative day.|2
9078095|NCT01844206|10140335|FG000|NOT COMPLETED|Overall Study||0
9078096|NCT01844206|10140336|FG001|NOT COMPLETED|Overall Study||1
9078097|NCT01856322|10140345|FG000|STARTED|Overall Study||0
9078098|NCT01856322|10140346|FG001|STARTED|Overall Study||0
9078099|NCT01856322|10140347|FG002|STARTED|Overall Study||3
9078100|NCT01856322|10140345|FG000|COMPLETED|Overall Study||0
9078101|NCT01856322|10140346|FG001|COMPLETED|Overall Study||0
9078102|NCT01856322|10140347|FG002|COMPLETED|Overall Study||0
9078103|NCT01856322|10140345|FG000|NOT COMPLETED|Overall Study||0
9078104|NCT01856322|10140346|FG001|NOT COMPLETED|Overall Study||0
9078105|NCT01856322|10140347|FG002|NOT COMPLETED|Overall Study||3
9078106|NCT01853176|10140356|FG000|STARTED|Overall Study||4
9078107|NCT01853176|10140357|FG001|STARTED|Overall Study||0
9078108|NCT01853176|10140356|FG000|COMPLETED|Overall Study||0
9078109|NCT01853176|10140357|FG001|COMPLETED|Overall Study||0
9078110|NCT01853176|10140356|FG000|NOT COMPLETED|Overall Study||4
9078111|NCT01853176|10140357|FG001|NOT COMPLETED|Overall Study||0
9078112|NCT01857271|10140363|FG000|STARTED|Overall Study||3
9078113|NCT01857271|10140363|FG000|COMPLETED|Overall Study||2
9078114|NCT01857271|10140363|FG000|NOT COMPLETED|Overall Study||1
9078115|NCT01856361|10140369|FG000|STARTED|Overall Study||1
9078116|NCT01856361|10140370|FG001|STARTED|Overall Study||1
9078117|NCT01856361|10140369|FG000|COMPLETED|Overall Study||1
9078118|NCT01856361|10140370|FG001|COMPLETED|Overall Study||1
9078119|NCT01856361|10140369|FG000|NOT COMPLETED|Overall Study||0
9078120|NCT01856361|10140370|FG001|NOT COMPLETED|Overall Study||0
9078121|NCT01853982|10140378|FG000|STARTED|Overall Study||2
9078122|NCT01853982|10140379|FG001|STARTED|Overall Study||2
9078123|NCT01853982|10140378|FG000|Received at Least 1 Dose of Study Drug|Overall Study||2
9078124|NCT01853982|10140379|FG001|Received at Least 1 Dose of Study Drug|Overall Study||2
9078125|NCT01853982|10140378|FG000|COMPLETED|Overall Study||0
9078126|NCT01853982|10140379|FG001|COMPLETED|Overall Study||1
9078127|NCT01853982|10140378|FG000|NOT COMPLETED|Overall Study||2
9078128|NCT01853982|10140379|FG001|NOT COMPLETED|Overall Study||1
8844614|NCT01710527|9899038|FG001|COMPLETED|Period 3: Intervention Period 2||15
8844615|NCT01710527|9899037|FG000|NOT COMPLETED|Period 3: Intervention Period 2||0
8844616|NCT01710527|9899038|FG001|NOT COMPLETED|Period 3: Intervention Period 2||0
8844617|NCT01710657|9899047|FG000|STARTED|Overall Study||184
8844618|NCT01710657|9899048|FG001|STARTED|Overall Study||183
8844619|NCT01710657|9899049|FG002|STARTED|Overall Study||180
8844620|NCT01710657|9899047|FG000|Titration Period (4 Weeks)|Overall Study||184
8844621|NCT01710657|9899048|FG001|Titration Period (4 Weeks)|Overall Study||183
8624310|NCT00499460|9663573|FG001|STARTED|Intervention 1 (30 Days)||7
8624311|NCT00499460|9663572|FG000|COMPLETED|Intervention 1 (30 Days)||6
8624312|NCT00499460|9663573|FG001|COMPLETED|Intervention 1 (30 Days)||7
8624313|NCT00499460|9663572|FG000|NOT COMPLETED|Intervention 1 (30 Days)||2
8624314|NCT00499460|9663573|FG001|NOT COMPLETED|Intervention 1 (30 Days)||0
8624315|NCT00499460|9663572|FG000|STARTED|Intervention 2 (30 Days)||6
8844622|NCT01710657|9899049|FG002|Titration Period (4 Weeks)|Overall Study||180
8844623|NCT01710657|9899047|FG000|Maintenance Period (12 Weeks)|Overall Study||176
8844624|NCT01710657|9899048|FG001|Maintenance Period (12 Weeks)|Overall Study||175
8844625|NCT01710657|9899049|FG002|Maintenance Period (12 Weeks)|Overall Study||168
8844626|NCT01710657|9899047|FG000|COMPLETED|Overall Study||166
8844627|NCT01710657|9899048|FG001|COMPLETED|Overall Study||171
8844628|NCT01710657|9899049|FG002|COMPLETED|Overall Study||148
9078129|NCT01841931|10140385|FG000|STARTED|Overall Study||4
9078130|NCT01841931|10140385|FG000|COMPLETED|Overall Study|As the PI left the institution the study was terminated|0
9078131|NCT01841931|10140385|FG000|NOT COMPLETED|Overall Study||4
9078132|NCT01836809|10140393|FG000|STARTED|Overall Study||0
9078133|NCT01836809|10140394|FG001|STARTED|Overall Study||0
9078134|NCT01836809|10140395|FG002|STARTED|Overall Study||0
8624316|NCT00499460|9663573|FG001|STARTED|Intervention 2 (30 Days)||7
8624317|NCT00499460|9663572|FG000|COMPLETED|Intervention 2 (30 Days)||6
8844629|NCT01710657|9899047|FG000|NOT COMPLETED|Overall Study||18
8844630|NCT01710657|9899048|FG001|NOT COMPLETED|Overall Study||12
9078135|NCT01836809|10140396|FG003|STARTED|Overall Study||2
9078136|NCT01836809|10140393|FG000|COMPLETED|Overall Study||0
9078137|NCT01836809|10140394|FG001|COMPLETED|Overall Study||0
9078138|NCT01836809|10140395|FG002|COMPLETED|Overall Study||0
9078139|NCT01836809|10140396|FG003|COMPLETED|Overall Study||0
9078140|NCT01836809|10140393|FG000|NOT COMPLETED|Overall Study||0
9078141|NCT01836809|10140394|FG001|NOT COMPLETED|Overall Study||0
9078142|NCT01836809|10140395|FG002|NOT COMPLETED|Overall Study||0
9078143|NCT01836809|10140396|FG003|NOT COMPLETED|Overall Study||2
9078144|NCT01831596|10140410|FG000|STARTED|Overall Study||59
8624318|NCT00499460|9663573|FG001|COMPLETED|Intervention 2 (30 Days)||6
8624319|NCT00499460|9663572|FG000|NOT COMPLETED|Intervention 2 (30 Days)||0
8844631|NCT01710657|9899049|FG002|NOT COMPLETED|Overall Study||32
8844632|NCT01710709|9899057|FG000|STARTED|Overall Study||464
9078145|NCT01831596|10140410|FG000|COMPLETED|Overall Study||51
9078146|NCT01831596|10140410|FG000|NOT COMPLETED|Overall Study||8
9078147|NCT01834144|10140416|FG000|STARTED|Overall Study||1
9078148|NCT01834144|10140417|FG001|STARTED|Overall Study||3
9078149|NCT01834144|10140416|FG000|COMPLETED|Overall Study||1
9078150|NCT01834144|10140417|FG001|COMPLETED|Overall Study||2
9078151|NCT01834144|10140416|FG000|NOT COMPLETED|Overall Study||0
9078152|NCT01834144|10140417|FG001|NOT COMPLETED|Overall Study||1
9078153|NCT01821963|10140423|FG000|STARTED|Overall Study||1
9078154|NCT01821963|10140423|FG000|COMPLETED|Overall Study||0
9078155|NCT01821963|10140423|FG000|NOT COMPLETED|Overall Study||1
9078156|NCT01821898|10140429|FG000|STARTED|Overall Study||2
9078157|NCT01821898|10140430|FG001|STARTED|Overall Study||1
9078158|NCT01821898|10140429|FG000|COMPLETED|Overall Study||0
9078159|NCT01821898|10140430|FG001|COMPLETED|Overall Study||0
9078160|NCT01821898|10140429|FG000|NOT COMPLETED|Overall Study||2
9078161|NCT01821898|10140430|FG001|NOT COMPLETED|Overall Study||1
9078162|NCT01814722|10140440|FG000|STARTED|Overall Study||36
9078163|NCT01814722|10140441|FG001|STARTED|Overall Study||21
9078164|NCT01814722|10140442|FG002|STARTED|Overall Study||6
9078165|NCT01814722|10140440|FG000|COMPLETED|Overall Study||36
9078166|NCT01814722|10140441|FG001|COMPLETED|Overall Study||21
9078167|NCT01814722|10140442|FG002|COMPLETED|Overall Study||6
9078168|NCT01814722|10140440|FG000|NOT COMPLETED|Overall Study||0
9078169|NCT01814722|10140441|FG001|NOT COMPLETED|Overall Study||0
9078170|NCT01814722|10140442|FG002|NOT COMPLETED|Overall Study||0
9078171|NCT01830790|10140452|FG000|STARTED|Overall Study||0
9078172|NCT01830790|10140453|FG001|STARTED|Overall Study||10
9078173|NCT01830790|10140452|FG000|COMPLETED|Overall Study||0
9078174|NCT01830790|10140453|FG001|COMPLETED|Overall Study||10
9078175|NCT01830790|10140452|FG000|NOT COMPLETED|Overall Study||0
9078176|NCT01830790|10140453|FG001|NOT COMPLETED|Overall Study||0
9078177|NCT01829477|10140461|FG000|STARTED|Overall Study||17
9078178|NCT01829477|10140462|FG001|STARTED|Overall Study||16
9078179|NCT01829477|10140461|FG000|COMPLETED|Overall Study||1
9078180|NCT01829477|10140462|FG001|COMPLETED|Overall Study||1
9078181|NCT01829477|10140461|FG000|NOT COMPLETED|Overall Study||16
9078182|NCT01829477|10140462|FG001|NOT COMPLETED|Overall Study||15
9078183|NCT01803711|10140470|FG000|STARTED|Overall Study||2
9078184|NCT01803711|10140471|FG001|STARTED|Overall Study||3
9078185|NCT01803711|10140470|FG000|COMPLETED|Overall Study||1
9078186|NCT01803711|10140471|FG001|COMPLETED|Overall Study||2
9078187|NCT01803711|10140470|FG000|NOT COMPLETED|Overall Study||1
9078188|NCT01803711|10140471|FG001|NOT COMPLETED|Overall Study||1
9078189|NCT01821859|10140479|FG000|STARTED|Overall Study||5
9078190|NCT01821859|10140479|FG000|COMPLETED|Overall Study||0
9078191|NCT01821859|10140479|FG000|NOT COMPLETED|Overall Study||5
9078192|NCT01808950|10140486|FG000|STARTED|Overall Study||1
9078193|NCT01808950|10140487|FG001|STARTED|Overall Study||3
9078194|NCT01808950|10140488|FG002|STARTED|Overall Study||0
9078195|NCT01808950|10140486|FG000|COMPLETED|Overall Study||1
9078196|NCT01808950|10140487|FG001|COMPLETED|Overall Study||3
9078197|NCT01808950|10140488|FG002|COMPLETED|Overall Study||0
9078198|NCT01808950|10140486|FG000|NOT COMPLETED|Overall Study||0
9078199|NCT01808950|10140487|FG001|NOT COMPLETED|Overall Study||0
9078200|NCT01808950|10140488|FG002|NOT COMPLETED|Overall Study||0
9078201|NCT01806051|10140499|FG000|STARTED|Overall Study||6
9078202|NCT01806051|10140499|FG000|COMPLETED|Overall Study||0
9078203|NCT01806051|10140499|FG000|NOT COMPLETED|Overall Study||6
9078204|NCT01808794|10140507|FG000|STARTED|Overall Study||0
9078205|NCT01808794|10140508|FG001|STARTED|Overall Study||0
9078206|NCT01808794|10140507|FG000|COMPLETED|Overall Study||0
9078207|NCT01808794|10140508|FG001|COMPLETED|Overall Study||0
9078208|NCT01808794|10140507|FG000|NOT COMPLETED|Overall Study||0
9078209|NCT01808794|10140508|FG001|NOT COMPLETED|Overall Study||0
9078210|NCT01809899|10140516|FG000|STARTED|Overall Study||8
9078211|NCT01809899|10140517|FG001|STARTED|Overall Study||4
9078212|NCT01809899|10140516|FG000|COMPLETED|Overall Study||8
9078213|NCT01809899|10140517|FG001|COMPLETED|Overall Study||4
9078214|NCT01809899|10140516|FG000|NOT COMPLETED|Overall Study||0
9078215|NCT01809899|10140517|FG001|NOT COMPLETED|Overall Study||0
9078216|NCT01810302|10140526|FG000|STARTED|Overall Study||1
9078217|NCT01810302|10140527|FG001|STARTED|Overall Study||1
9078218|NCT01810302|10140526|FG000|COMPLETED|Overall Study||0
9078219|NCT01810302|10140527|FG001|COMPLETED|Overall Study||0
9078220|NCT01810302|10140526|FG000|NOT COMPLETED|Overall Study||1
9078221|NCT01810302|10140527|FG001|NOT COMPLETED|Overall Study||1
8844633|NCT01710709|9899057|FG000|COMPLETED|Overall Study||291
8844634|NCT01710709|9899057|FG000|NOT COMPLETED|Overall Study||173
8844635|NCT01710787|9899065|FG000|STARTED|Overall Study||44
8844636|NCT01710787|9899066|FG001|STARTED|Overall Study||44
8844637|NCT01710787|9899067|FG002|STARTED|Overall Study||22
8844638|NCT01710787|9899065|FG000|COMPLETED|Overall Study||44
8844639|NCT01710787|9899066|FG001|COMPLETED|Overall Study||44
9078222|NCT01806961|10140533|FG000|STARTED|Overall Study||16
9078223|NCT01806961|10140533|FG000|COMPLETED|Overall Study||0
9078224|NCT01806961|10140533|FG000|NOT COMPLETED|Overall Study||16
9078225|NCT01804166|10140537|FG000|STARTED|Overall Study||1
9078226|NCT01804166|10140537|FG000|COMPLETED|Overall Study||1
9078227|NCT01804166|10140537|FG000|NOT COMPLETED|Overall Study||0
9078228|NCT01783015|10140543|FG000|STARTED|Blinded Treatment||11
9078229|NCT01783015|10140544|FG001|STARTED|Blinded Treatment||5
9078230|NCT01783015|10140545|FG002|STARTED|Blinded Treatment||0
9078231|NCT01783015|10140543|FG000|Treated|Blinded Treatment||11
9078232|NCT01783015|10140544|FG001|Treated|Blinded Treatment||5
9078233|NCT01783015|10140545|FG002|Treated|Blinded Treatment||0
9078234|NCT01783015|10140543|FG000|COMPLETED|Blinded Treatment||9
9078235|NCT01783015|10140544|FG001|COMPLETED|Blinded Treatment||2
9078236|NCT01783015|10140545|FG002|COMPLETED|Blinded Treatment||0
9078237|NCT01783015|10140543|FG000|NOT COMPLETED|Blinded Treatment||2
9078238|NCT01783015|10140544|FG001|NOT COMPLETED|Blinded Treatment||3
9078239|NCT01783015|10140545|FG002|NOT COMPLETED|Blinded Treatment||0
9078240|NCT01783015|10140543|FG000|STARTED|Open Label Treatment||0
9078241|NCT01783015|10140544|FG001|STARTED|Open Label Treatment||0
9078242|NCT01783015|10140545|FG002|STARTED|Open Label Treatment||11
9078243|NCT01783015|10140543|FG000|COMPLETED|Open Label Treatment||0
9078244|NCT01783015|10140544|FG001|COMPLETED|Open Label Treatment||0
9078245|NCT01783015|10140545|FG002|COMPLETED|Open Label Treatment||5
9078246|NCT01783015|10140543|FG000|NOT COMPLETED|Open Label Treatment||0
9078247|NCT01783015|10140544|FG001|NOT COMPLETED|Open Label Treatment||0
9078248|NCT01783015|10140545|FG002|NOT COMPLETED|Open Label Treatment||6
9078249|NCT01800162|10140556|FG000|STARTED|Overall Study|1 subject was randomized to uterine evacuation on 6/26/2013.|1
9078250|NCT01800162|10140557|FG001|STARTED|Overall Study||0
9078251|NCT01800162|10140558|FG002|STARTED|Overall Study|1 subject randomized to expectant management on 11/1/2013.|1
9078252|NCT01800162|10140556|FG000|COMPLETED|Overall Study||1
9078253|NCT01800162|10140557|FG001|COMPLETED|Overall Study||0
9078254|NCT01800162|10140558|FG002|COMPLETED|Overall Study||1
9078255|NCT01800162|10140556|FG000|NOT COMPLETED|Overall Study||0
9078256|NCT01800162|10140557|FG001|NOT COMPLETED|Overall Study||0
9078257|NCT01800162|10140558|FG002|NOT COMPLETED|Overall Study||0
9078258|NCT01794936|10140566|FG000|STARTED|Overall Study||9
9078259|NCT01794936|10140566|FG000|COMPLETED|Overall Study||9
9078260|NCT01794936|10140566|FG000|NOT COMPLETED|Overall Study||0
9078261|NCT01797380|10140572|FG000|STARTED|Overall Study|Terminated due to lack of enrollment|3
9078262|NCT01797380|10140573|FG001|STARTED|Overall Study||2
9078263|NCT01797380|10140572|FG000|COMPLETED|Overall Study|Terminated due to lack of enrollment|0
9078264|NCT01797380|10140573|FG001|COMPLETED|Overall Study||0
9078265|NCT01797380|10140572|FG000|NOT COMPLETED|Overall Study||3
9078266|NCT01797380|10140573|FG001|NOT COMPLETED|Overall Study||2
9078267|NCT01781026|10140579|FG000|STARTED|Overall Study||2
9078268|NCT01781026|10140579|FG000|COMPLETED|Overall Study||0
9078269|NCT01781026|10140579|FG000|NOT COMPLETED|Overall Study||2
9078270|NCT01788475|10140586|FG000|STARTED|Overall Study||3
9078271|NCT01788475|10140587|FG001|STARTED|Overall Study||0
9078272|NCT01788475|10140588|FG002|STARTED|Overall Study||0
9078273|NCT01788475|10140586|FG000|COMPLETED|Overall Study||0
9078274|NCT01788475|10140587|FG001|COMPLETED|Overall Study||0
9078275|NCT01788475|10140588|FG002|COMPLETED|Overall Study||0
9078276|NCT01788475|10140586|FG000|NOT COMPLETED|Overall Study||3
9078277|NCT01788475|10140587|FG001|NOT COMPLETED|Overall Study||0
9078278|NCT01788475|10140588|FG002|NOT COMPLETED|Overall Study||0
9078279|NCT01784991|10140598|FG000|STARTED|Overall Study||0
9078280|NCT01784991|10140599|FG001|STARTED|Overall Study||0
9078281|NCT01784991|10140598|FG000|COMPLETED|Overall Study||0
9078282|NCT01784991|10140599|FG001|COMPLETED|Overall Study||0
9078283|NCT01784991|10140598|FG000|NOT COMPLETED|Overall Study||0
9078284|NCT01784991|10140599|FG001|NOT COMPLETED|Overall Study||0
9078285|NCT01777854|10140605|FG000|STARTED|Overall Study||3
9078286|NCT01777854|10140606|FG001|STARTED|Overall Study||3
9078287|NCT01777854|10140605|FG000|COMPLETED|Overall Study||0
9078288|NCT01777854|10140606|FG001|COMPLETED|Overall Study||0
9078289|NCT01777854|10140605|FG000|NOT COMPLETED|Overall Study||3
9078290|NCT01777854|10140606|FG001|NOT COMPLETED|Overall Study||3
9078291|NCT01760993|10140610|FG000|STARTED|Overall Study||0
9078292|NCT01760993|10140610|FG000|COMPLETED|Overall Study||0
9078293|NCT01760993|10140610|FG000|NOT COMPLETED|Overall Study||0
9078294|NCT01772719|10140614|FG000|STARTED|Overall Study||7
9078295|NCT01772719|10140614|FG000|COMPLETED|Overall Study||0
9078296|NCT01772719|10140614|FG000|NOT COMPLETED|Overall Study||7
9078297|NCT01764997|10140626|FG000|STARTED|Run-in Period||776
9078298|NCT01764997|10140627|FG001|STARTED|Run-in Period||0
9078299|NCT01764997|10140628|FG002|STARTED|Run-in Period||0
9078300|NCT01764997|10140629|FG003|STARTED|Run-in Period||0
9078301|NCT01764997|10140630|FG004|STARTED|Run-in Period||0
9078302|NCT01764997|10140626|FG000|COMPLETED|Run-in Period|43 participants proceeded to randomized treatment and 322 proceeded to open-label sub-study.|738
9078303|NCT01764997|10140627|FG001|COMPLETED|Run-in Period||0
9078304|NCT01764997|10140628|FG002|COMPLETED|Run-in Period||0
9078305|NCT01764997|10140629|FG003|COMPLETED|Run-in Period||0
9078306|NCT01764997|10140630|FG004|COMPLETED|Run-in Period||0
9078307|NCT01764997|10140626|FG000|NOT COMPLETED|Run-in Period||38
9078308|NCT01764997|10140627|FG001|NOT COMPLETED|Run-in Period||0
9078309|NCT01764997|10140628|FG002|NOT COMPLETED|Run-in Period||0
9078310|NCT01764997|10140629|FG003|NOT COMPLETED|Run-in Period||0
8624320|NCT00499460|9663573|FG001|NOT COMPLETED|Intervention 2 (30 Days)||1
8624321|NCT00499473|9663591|FG000|STARTED|Overall Study||27
8624322|NCT00499473|9663592|FG001|STARTED|Overall Study||4
8624323|NCT00499473|9663591|FG000|COMPLETED|Overall Study|Patients evaluable|21
8624324|NCT00499473|9663592|FG001|COMPLETED|Overall Study||4
9078311|NCT01764997|10140630|FG004|NOT COMPLETED|Run-in Period||0
9078312|NCT01764997|10140626|FG000|STARTED|Study Drug Treatment Period||0
8624325|NCT00499473|9663591|FG000|NOT COMPLETED|Overall Study||6
8624326|NCT00499473|9663592|FG001|NOT COMPLETED|Overall Study||0
9078313|NCT01764997|10140627|FG001|STARTED|Study Drug Treatment Period||17
9078314|NCT01764997|10140628|FG002|STARTED|Study Drug Treatment Period||13
9078315|NCT01764997|10140629|FG003|STARTED|Study Drug Treatment Period||13
9078316|NCT01764997|10140630|FG004|STARTED|Study Drug Treatment Period||322
9078317|NCT01764997|10140626|FG000|COMPLETED|Study Drug Treatment Period||0
9078318|NCT01764997|10140627|FG001|COMPLETED|Study Drug Treatment Period||16
9078319|NCT01764997|10140628|FG002|COMPLETED|Study Drug Treatment Period||13
9078320|NCT01764997|10140629|FG003|COMPLETED|Study Drug Treatment Period||13
9078321|NCT01764997|10140630|FG004|COMPLETED|Study Drug Treatment Period||286
9078322|NCT01764997|10140626|FG000|NOT COMPLETED|Study Drug Treatment Period||0
9078323|NCT01764997|10140627|FG001|NOT COMPLETED|Study Drug Treatment Period||1
9078324|NCT01764997|10140628|FG002|NOT COMPLETED|Study Drug Treatment Period||0
9078325|NCT01764997|10140629|FG003|NOT COMPLETED|Study Drug Treatment Period||0
9078326|NCT01764997|10140630|FG004|NOT COMPLETED|Study Drug Treatment Period||36
9078327|NCT01760941|10140640|FG000|STARTED|Overall Study||1
9078328|NCT01760941|10140640|FG000|COMPLETED|Overall Study||1
9078329|NCT01760941|10140640|FG000|NOT COMPLETED|Overall Study||0
9078330|NCT01769443|10140646|FG000|STARTED|Overall Study||1
9078331|NCT01769443|10140647|FG001|STARTED|Overall Study||1
9078332|NCT01769443|10140646|FG000|COMPLETED|Overall Study||0
9078333|NCT01769443|10140647|FG001|COMPLETED|Overall Study||1
9078334|NCT01769443|10140646|FG000|NOT COMPLETED|Overall Study||1
9078335|NCT01769443|10140647|FG001|NOT COMPLETED|Overall Study||0
9078336|NCT01760889|10140657|FG000|STARTED|Overall Study||0
9078337|NCT01760889|10140658|FG001|STARTED|Overall Study||0
9078338|NCT01760889|10140659|FG002|STARTED|Overall Study||0
9078339|NCT01760889|10140657|FG000|COMPLETED|Overall Study||0
9078340|NCT01760889|10140658|FG001|COMPLETED|Overall Study||0
9078341|NCT01760889|10140659|FG002|COMPLETED|Overall Study||0
9078342|NCT01760889|10140657|FG000|NOT COMPLETED|Overall Study||0
9078343|NCT01760889|10140658|FG001|NOT COMPLETED|Overall Study||0
9078344|NCT01760889|10140659|FG002|NOT COMPLETED|Overall Study||0
9078345|NCT01749826|10140669|FG000|STARTED|Overall Study||20
9078346|NCT01749826|10140670|FG001|STARTED|Overall Study||0
9078347|NCT01749826|10140669|FG000|COMPLETED|Overall Study||0
9078348|NCT01749826|10140670|FG001|COMPLETED|Overall Study||0
9078349|NCT01749826|10140669|FG000|NOT COMPLETED|Overall Study||20
9078350|NCT01749826|10140670|FG001|NOT COMPLETED|Overall Study||0
9078351|NCT01756586|10140678|FG000|STARTED|Overall Study||2
9078352|NCT01756586|10140679|FG001|STARTED|Overall Study||2
9078353|NCT01756586|10140678|FG000|COMPLETED|Overall Study||0
9078354|NCT01756586|10140679|FG001|COMPLETED|Overall Study||0
9078355|NCT01756586|10140678|FG000|NOT COMPLETED|Overall Study||2
9078356|NCT01756586|10140679|FG001|NOT COMPLETED|Overall Study||2
9078357|NCT01754987|10140687|FG000|STARTED|Overall Study||5
9078358|NCT01754987|10140688|FG001|STARTED|Overall Study||0
9078359|NCT01754987|10140687|FG000|COMPLETED|Overall Study||5
9078360|NCT01754987|10140688|FG001|COMPLETED|Overall Study||0
9078361|NCT01754987|10140687|FG000|NOT COMPLETED|Overall Study||0
9078362|NCT01754987|10140688|FG001|NOT COMPLETED|Overall Study||0
9078363|NCT01756560|10140696|FG000|STARTED|Overall Study||2
9078364|NCT01756560|10140697|FG001|STARTED|Overall Study||0
9078365|NCT01756560|10140696|FG000|COMPLETED|Overall Study||0
9078366|NCT01756560|10140697|FG001|COMPLETED|Overall Study||0
9078367|NCT01756560|10140696|FG000|NOT COMPLETED|Overall Study||2
9078368|NCT01756560|10140697|FG001|NOT COMPLETED|Overall Study||0
9078369|NCT01756573|10140706|FG000|STARTED|Overall Study||3
9078370|NCT01756573|10140707|FG001|STARTED|Overall Study||1
9078371|NCT01756573|10140708|FG002|STARTED|Overall Study||1
9078372|NCT01756573|10140706|FG000|COMPLETED|Overall Study||3
9078373|NCT01756573|10140707|FG001|COMPLETED|Overall Study||1
9078374|NCT01756573|10140708|FG002|COMPLETED|Overall Study||1
9078375|NCT01756573|10140706|FG000|NOT COMPLETED|Overall Study||0
9078376|NCT01756573|10140707|FG001|NOT COMPLETED|Overall Study||0
9078377|NCT01756573|10140708|FG002|NOT COMPLETED|Overall Study||0
9078378|NCT01745913|10140718|FG000|STARTED|Overall Study||1
9078379|NCT01745913|10140719|FG001|STARTED|Overall Study||1
9078380|NCT01745913|10140718|FG000|COMPLETED|Overall Study||0
9078381|NCT01745913|10140719|FG001|COMPLETED|Overall Study||0
9078382|NCT01745913|10140718|FG000|NOT COMPLETED|Overall Study||1
9078383|NCT01745913|10140719|FG001|NOT COMPLETED|Overall Study||1
9078384|NCT01752023|10140731|FG000|STARTED|Overall Study||2
9078385|NCT01752023|10140732|FG001|STARTED|Overall Study||1
9078386|NCT01752023|10140731|FG000|COMPLETED|Overall Study||0
9078387|NCT01752023|10140732|FG001|COMPLETED|Overall Study||0
9078388|NCT01752023|10140731|FG000|NOT COMPLETED|Overall Study||2
9078389|NCT01752023|10140732|FG001|NOT COMPLETED|Overall Study||1
9078390|NCT01740154|10140742|FG000|STARTED|Overall Study||13
9078391|NCT01740154|10140742|FG000|COMPLETED|Overall Study||12
9078392|NCT01740154|10140742|FG000|NOT COMPLETED|Overall Study||1
9078393|NCT01748890|10140746|FG000|STARTED|Overall Study||4
9078394|NCT01748890|10140746|FG000|COMPLETED|Overall Study|Insufficient recruitment for analysis|0
9078395|NCT01748890|10140746|FG000|NOT COMPLETED|Overall Study||4
9078396|NCT01748162|10140752|FG000|STARTED|Overall Study||5
9078397|NCT01748162|10140753|FG001|STARTED|Overall Study||5
9078398|NCT01748162|10140752|FG000|Started 6 Month Initial Treatment Plan|Overall Study||2
9078399|NCT01748162|10140753|FG001|Started 6 Month Initial Treatment Plan|Overall Study||2
9078400|NCT01748162|10140752|FG000|Completed 6 Month Initial Treatment|Overall Study||0
9078401|NCT01748162|10140753|FG001|Completed 6 Month Initial Treatment|Overall Study||0
9078402|NCT01748162|10140752|FG000|Started 6 Month Followup|Overall Study|No participants in either arm had additional croup episodes in the first 6 months; study terminated.|0
9078403|NCT01748162|10140753|FG001|Started 6 Month Followup|Overall Study|No participants in either arm had additional croup episodes in the first 6 months; study terminated.|0
9078404|NCT01748162|10140752|FG000|COMPLETED|Overall Study||0
9078405|NCT01748162|10140753|FG001|COMPLETED|Overall Study||0
9078406|NCT01748162|10140752|FG000|NOT COMPLETED|Overall Study||5
9078407|NCT01748162|10140753|FG001|NOT COMPLETED|Overall Study||5
9078408|NCT01738698|10140763|FG000|STARTED|Overall Study||0
9078409|NCT01738698|10140764|FG001|STARTED|Overall Study||0
9078410|NCT01738698|10140765|FG002|STARTED|Overall Study||0
9078411|NCT01738698|10140766|FG003|STARTED|Overall Study||0
9078412|NCT01738698|10140763|FG000|COMPLETED|Overall Study||0
9078413|NCT01738698|10140764|FG001|COMPLETED|Overall Study||0
9078414|NCT01738698|10140765|FG002|COMPLETED|Overall Study||0
9078415|NCT01738698|10140766|FG003|COMPLETED|Overall Study||0
9078416|NCT01738698|10140763|FG000|NOT COMPLETED|Overall Study||0
9078417|NCT01738698|10140764|FG001|NOT COMPLETED|Overall Study||0
9078418|NCT01738698|10140765|FG002|NOT COMPLETED|Overall Study||0
9078419|NCT01738698|10140766|FG003|NOT COMPLETED|Overall Study||0
9078420|NCT01732926|10140778|FG000|STARTED|Overall Study||320
9078421|NCT01732926|10140779|FG001|STARTED|Overall Study||155
9078422|NCT01732926|10140778|FG000|COMPLETED|Overall Study||53
9078423|NCT01732926|10140779|FG001|COMPLETED|Overall Study||45
9078424|NCT01732926|10140778|FG000|NOT COMPLETED|Overall Study||267
9078425|NCT01732926|10140779|FG001|NOT COMPLETED|Overall Study||110
9078426|NCT01727167|10140787|FG000|STARTED|Overall Study||1
9078427|NCT01727167|10140788|FG001|STARTED|Overall Study||0
9078428|NCT01727167|10140787|FG000|COMPLETED|Overall Study||1
9078429|NCT01727167|10140788|FG001|COMPLETED|Overall Study||0
9078430|NCT01727167|10140787|FG000|NOT COMPLETED|Overall Study||0
9078431|NCT01727167|10140788|FG001|NOT COMPLETED|Overall Study||0
9078432|NCT01732913|10140796|FG000|STARTED|Overall Study||198
9078433|NCT01732913|10140797|FG001|STARTED|Overall Study||97
9078434|NCT01732913|10140796|FG000|COMPLETED|Overall Study||42
9078435|NCT01732913|10140797|FG001|COMPLETED|Overall Study||28
9078436|NCT01732913|10140796|FG000|NOT COMPLETED|Overall Study||156
9078437|NCT01732913|10140797|FG001|NOT COMPLETED|Overall Study||69
9078438|NCT01732211|10140803|FG000|STARTED|Overall Study||1
9078439|NCT01732211|10140803|FG000|COMPLETED|Overall Study||1
9078440|NCT01732211|10140803|FG000|NOT COMPLETED|Overall Study||0
9078441|NCT01716052|10140809|FG000|STARTED|Overall Study||1
9078442|NCT01716052|10140810|FG001|STARTED|Overall Study||1
9078443|NCT01716052|10140809|FG000|COMPLETED|Overall Study||0
9078444|NCT01716052|10140810|FG001|COMPLETED|Overall Study||0
9078445|NCT01716052|10140809|FG000|NOT COMPLETED|Overall Study||1
9078446|NCT01716052|10140810|FG001|NOT COMPLETED|Overall Study||1
9078447|NCT01718444|10140818|FG000|STARTED|Overall Study||0
9078448|NCT01718444|10140819|FG001|STARTED|Overall Study||0
9078449|NCT01718444|10140818|FG000|COMPLETED|Overall Study||0
9078450|NCT01718444|10140819|FG001|COMPLETED|Overall Study||0
9078451|NCT01718444|10140818|FG000|NOT COMPLETED|Overall Study||0
9078452|NCT01718444|10140819|FG001|NOT COMPLETED|Overall Study||0
9078453|NCT01712854|10140825|FG000|STARTED|Overall Study||9
9078454|NCT01712854|10140825|FG000|COMPLETED|Overall Study||8
9078455|NCT01712854|10140825|FG000|NOT COMPLETED|Overall Study||1
9078456|NCT01717482|10140831|FG000|STARTED|Overall Study||4
9078457|NCT01717482|10140832|FG001|STARTED|Overall Study||2
9078458|NCT01717482|10140831|FG000|COMPLETED|Overall Study||0
9078459|NCT01717482|10140832|FG001|COMPLETED|Overall Study||2
9078460|NCT01717482|10140831|FG000|NOT COMPLETED|Overall Study||4
9078461|NCT01717482|10140832|FG001|NOT COMPLETED|Overall Study||0
9078462|NCT01702896|10140839|FG000|STARTED|Overall Study||8
9078463|NCT01702896|10140839|FG000|COMPLETED|Overall Study||0
9078464|NCT01702896|10140839|FG000|NOT COMPLETED|Overall Study||8
9078465|NCT01709136|10140845|FG000|STARTED|Overall Study||3
9078466|NCT01709136|10140845|FG000|COMPLETED|Overall Study||3
9078467|NCT01709136|10140845|FG000|NOT COMPLETED|Overall Study||0
9078468|NCT01708057|10140852|FG000|STARTED|Overall Study||1
9078469|NCT01708057|10140853|FG001|STARTED|Overall Study||1
9078470|NCT01708057|10140854|FG002|STARTED|Overall Study||1
9078471|NCT01708057|10140852|FG000|COMPLETED|Overall Study||0
9078472|NCT01708057|10140853|FG001|COMPLETED|Overall Study||0
9078473|NCT01708057|10140854|FG002|COMPLETED|Overall Study||0
9078474|NCT01708057|10140852|FG000|NOT COMPLETED|Overall Study||1
9078475|NCT01708057|10140853|FG001|NOT COMPLETED|Overall Study||1
9078476|NCT01708057|10140854|FG002|NOT COMPLETED|Overall Study||1
9078477|NCT01697332|10140868|FG000|STARTED|Overall Study||1
9078478|NCT01697332|10140868|FG000|COMPLETED|Overall Study||1
9078479|NCT01697332|10140868|FG000|NOT COMPLETED|Overall Study||0
9078480|NCT01693367|10140874|FG000|STARTED|Overall Study||2
9078481|NCT01693367|10140875|FG001|STARTED|Overall Study||3
9078482|NCT01693367|10140874|FG000|COMPLETED|Overall Study||1
9078483|NCT01693367|10140875|FG001|COMPLETED|Overall Study||1
9078484|NCT01693367|10140874|FG000|NOT COMPLETED|Overall Study||1
9078485|NCT01693367|10140875|FG001|NOT COMPLETED|Overall Study||2
9078486|NCT01705106|10140881|FG000|STARTED|Overall Study||21
9078487|NCT01705106|10140881|FG000|COMPLETED|Overall Study||21
9078488|NCT01705106|10140881|FG000|NOT COMPLETED|Overall Study||0
9078489|NCT01702909|10140885|FG000|STARTED|Overall Study||7
9078490|NCT01702909|10140885|FG000|COMPLETED|Overall Study||7
9078491|NCT01702909|10140885|FG000|NOT COMPLETED|Overall Study||0
9078492|NCT01701622|10140889|FG000|STARTED|Overall Study||1
9078493|NCT01701622|10140889|FG000|COMPLETED|Overall Study||1
9078494|NCT01701622|10140889|FG000|NOT COMPLETED|Overall Study||0
9078495|NCT01697800|10140896|FG000|STARTED|Overall Study||15
9078496|NCT01697800|10140897|FG001|STARTED|Overall Study||25
9078497|NCT01697800|10140896|FG000|COMPLETED|Overall Study||15
9078498|NCT01697800|10140897|FG001|COMPLETED|Overall Study||24
9078499|NCT01697800|10140896|FG000|NOT COMPLETED|Overall Study||0
9078500|NCT01697800|10140897|FG001|NOT COMPLETED|Overall Study||1
9078501|NCT01700348|10140903|FG000|STARTED|Overall Study||116
9078502|NCT01700348|10140903|FG000|COMPLETED|Overall Study||93
9078503|NCT01700348|10140903|FG000|NOT COMPLETED|Overall Study||23
9078504|NCT01693484|10140909|FG000|STARTED|Overall Study||13
9078505|NCT01693484|10140909|FG000|COMPLETED|Overall Study|Study closed by PI|0
9078506|NCT01693484|10140909|FG000|NOT COMPLETED|Overall Study||13
9078507|NCT01693653|10140915|FG000|STARTED|Overall Study||1
9078508|NCT01693653|10140916|FG001|STARTED|Overall Study||0
9078509|NCT01693653|10140915|FG000|COMPLETED|Overall Study||1
9078510|NCT01693653|10140916|FG001|COMPLETED|Overall Study||0
9078511|NCT01693653|10140915|FG000|NOT COMPLETED|Overall Study||0
9078512|NCT01693653|10140916|FG001|NOT COMPLETED|Overall Study||0
9078513|NCT01692691|10140922|FG000|STARTED|Overall Study||1
9078514|NCT01692691|10140922|FG000|COMPLETED|Overall Study||1
9078515|NCT01692691|10140922|FG000|NOT COMPLETED|Overall Study||0
9078516|NCT01691079|10140930|FG000|STARTED|Overall Study||0
9078517|NCT01691079|10140931|FG001|STARTED|Overall Study||0
9078518|NCT01691079|10140930|FG000|COMPLETED|Overall Study||0
9078519|NCT01691079|10140931|FG001|COMPLETED|Overall Study||0
9078520|NCT01691079|10140930|FG000|NOT COMPLETED|Overall Study||0
9078521|NCT01691079|10140931|FG001|NOT COMPLETED|Overall Study||0
9078522|NCT01690910|10140939|FG000|STARTED|Overall Study|The study was never completed due to feasibility issues.|0
9078523|NCT01690910|10140940|FG001|STARTED|Overall Study||0
9078524|NCT01690910|10140939|FG000|COMPLETED|Overall Study||0
9078525|NCT01690910|10140940|FG001|COMPLETED|Overall Study||0
9078526|NCT01690910|10140939|FG000|NOT COMPLETED|Overall Study||0
9078527|NCT01690910|10140940|FG001|NOT COMPLETED|Overall Study||0
9078528|NCT01689974|10140948|FG000|STARTED|Overall Study||5
9078529|NCT01689974|10140949|FG001|STARTED|Overall Study||5
9078530|NCT01689974|10140948|FG000|COMPLETED|Overall Study||0
9078531|NCT01689974|10140949|FG001|COMPLETED|Overall Study||0
9078532|NCT01689974|10140948|FG000|NOT COMPLETED|Overall Study||5
9078533|NCT01689974|10140949|FG001|NOT COMPLETED|Overall Study||5
9078534|NCT01676961|10140955|FG000|STARTED|Overall Study||5
9078535|NCT01676961|10140955|FG000|COMPLETED|Overall Study||0
9078536|NCT01676961|10140955|FG000|NOT COMPLETED|Overall Study||5
9078537|NCT01681589|10140962|FG000|STARTED|Overall Study||0
9078538|NCT01681589|10140963|FG001|STARTED|Overall Study||0
9078539|NCT01681589|10140964|FG002|STARTED|Overall Study||0
9078540|NCT01681589|10140962|FG000|COMPLETED|Overall Study||0
9078541|NCT01681589|10140963|FG001|COMPLETED|Overall Study||0
9078542|NCT01681589|10140964|FG002|COMPLETED|Overall Study||0
9078543|NCT01681589|10140962|FG000|NOT COMPLETED|Overall Study||0
9078544|NCT01681589|10140963|FG001|NOT COMPLETED|Overall Study||0
9078545|NCT01681589|10140964|FG002|NOT COMPLETED|Overall Study||0
9078546|NCT01681745|10140972|FG000|STARTED|Overall Study||0
9078547|NCT01681745|10140972|FG000|COMPLETED|Overall Study||0
9078548|NCT01681745|10140972|FG000|NOT COMPLETED|Overall Study||0
9078549|NCT01682928|10140978|FG000|STARTED|Overall Study|2 subjects in this Arm|2
9078550|NCT01682928|10140979|FG001|STARTED|Overall Study|2 subjects in this Arm|2
9078551|NCT01682928|10140978|FG000|COMPLETED|Overall Study||2
9078552|NCT01682928|10140979|FG001|COMPLETED|Overall Study||2
9078553|NCT01682928|10140978|FG000|NOT COMPLETED|Overall Study||0
9078554|NCT01682928|10140979|FG001|NOT COMPLETED|Overall Study||0
9078555|NCT01668940|10140991|FG000|STARTED|Overall Study||17
9078556|NCT01668940|10140992|FG001|STARTED|Overall Study||14
9078557|NCT01668940|10140993|FG002|STARTED|Overall Study||9
9078558|NCT01668940|10140994|FG003|STARTED|Overall Study||14
9078559|NCT01668940|10140991|FG000|COMPLETED|Overall Study|Data collection was completed, but data analysis did not occur due to study closure.|17
9078560|NCT01668940|10140992|FG001|COMPLETED|Overall Study|Data collection was completed, but data analysis did not occur due to study closure.|14
9078561|NCT01668940|10140993|FG002|COMPLETED|Overall Study|Data collection was completed, but data analysis did not occur due to study closure.|9
9078562|NCT01668940|10140994|FG003|COMPLETED|Overall Study|Data collection was completed, but data analysis did not occur due to study closure.|14
9078563|NCT01668940|10140991|FG000|NOT COMPLETED|Overall Study||0
9078564|NCT01668940|10140992|FG001|NOT COMPLETED|Overall Study||0
9078565|NCT01668940|10140993|FG002|NOT COMPLETED|Overall Study||0
9078566|NCT01668940|10140994|FG003|NOT COMPLETED|Overall Study||0
9078567|NCT01663285|10141004|FG000|STARTED|Overall Study||1
9078568|NCT01663285|10141004|FG000|COMPLETED|Overall Study||1
9078569|NCT01663285|10141004|FG000|NOT COMPLETED|Overall Study||0
9078570|NCT01683864|10141011|FG000|STARTED|Overall Study||0
9078571|NCT01683864|10141012|FG001|STARTED|Overall Study||0
9078572|NCT01683864|10141013|FG002|STARTED|Overall Study||0
9078573|NCT01683864|10141011|FG000|COMPLETED|Overall Study||0
9078574|NCT01683864|10141012|FG001|COMPLETED|Overall Study||0
9078575|NCT01683864|10141013|FG002|COMPLETED|Overall Study||0
9078576|NCT01683864|10141011|FG000|NOT COMPLETED|Overall Study||0
9078577|NCT01683864|10141012|FG001|NOT COMPLETED|Overall Study||0
9078578|NCT01683864|10141013|FG002|NOT COMPLETED|Overall Study||0
9078579|NCT01675011|10141023|FG000|STARTED|Overall Study||3
9078580|NCT01675011|10141024|FG001|STARTED|Overall Study||1
9078581|NCT01675011|10141023|FG000|COMPLETED|Overall Study||0
9078582|NCT01675011|10141024|FG001|COMPLETED|Overall Study||0
9078583|NCT01675011|10141023|FG000|NOT COMPLETED|Overall Study||3
9078584|NCT01675011|10141024|FG001|NOT COMPLETED|Overall Study||1
9078585|NCT01673425|10141030|FG000|STARTED|Overall Study||5
9078586|NCT01673425|10141030|FG000|COMPLETED|Overall Study||4
9078587|NCT01673425|10141030|FG000|NOT COMPLETED|Overall Study||1
9078588|NCT01673061|10141036|FG000|STARTED|Overall Study||0
9078589|NCT01673061|10141037|FG001|STARTED|Overall Study||0
9078590|NCT01673061|10141036|FG000|COMPLETED|Overall Study||0
9078591|NCT01673061|10141037|FG001|COMPLETED|Overall Study||0
9078592|NCT01673061|10141036|FG000|NOT COMPLETED|Overall Study||0
9078593|NCT01673061|10141037|FG001|NOT COMPLETED|Overall Study||0
9078594|NCT01675960|10141045|FG000|STARTED|Overall Study||2
9078595|NCT01675960|10141046|FG001|STARTED|Overall Study||0
9078596|NCT01675960|10141045|FG000|COMPLETED|Overall Study||2
9078597|NCT01675960|10141046|FG001|COMPLETED|Overall Study||0
9078598|NCT01675960|10141045|FG000|NOT COMPLETED|Overall Study||0
9078599|NCT01675960|10141046|FG001|NOT COMPLETED|Overall Study||0
9078600|NCT01668147|10141052|FG000|STARTED|Overall Study||13
9078601|NCT01668147|10141052|FG000|COMPLETED|Overall Study||7
9078602|NCT01668147|10141052|FG000|NOT COMPLETED|Overall Study||6
9078603|NCT01676701|10141062|FG000|STARTED|Overall Study||4
9078604|NCT01676701|10141063|FG001|STARTED|Overall Study||4
9078605|NCT01676701|10141062|FG000|Received at Least 1 Dose of Study Drug|Overall Study||4
9078606|NCT01676701|10141063|FG001|Received at Least 1 Dose of Study Drug|Overall Study||4
9078607|NCT01676701|10141062|FG000|Completed Post-Treatment Follow-Up|Overall Study||4
9078608|NCT01676701|10141063|FG001|Completed Post-Treatment Follow-Up|Overall Study||4
9078609|NCT01676701|10141062|FG000|COMPLETED|Overall Study||0
9078610|NCT01676701|10141063|FG001|COMPLETED|Overall Study||0
9078611|NCT01676701|10141062|FG000|NOT COMPLETED|Overall Study||4
9078612|NCT01676701|10141063|FG001|NOT COMPLETED|Overall Study||4
9078613|NCT01669148|10141071|FG000|STARTED|Overall Study||496
9078614|NCT01669148|10141071|FG000|COMPLETED|Overall Study||426
9078615|NCT01669148|10141071|FG000|NOT COMPLETED|Overall Study||70
9078616|NCT01662102|10141078|FG000|STARTED|Overall Study||1
9078617|NCT01662102|10141079|FG001|STARTED|Overall Study||0
9078618|NCT01662102|10141078|FG000|COMPLETED|Overall Study||0
9078619|NCT01662102|10141079|FG001|COMPLETED|Overall Study||0
9078620|NCT01662102|10141078|FG000|NOT COMPLETED|Overall Study||1
9078621|NCT01662102|10141079|FG001|NOT COMPLETED|Overall Study||0
9078622|NCT01659554|10141086|FG000|STARTED|Overall Study|4 subjects enrolled; 4 subjects treated and 4 did not complete protocol schema|4
9078623|NCT01659554|10141086|FG000|COMPLETED|Overall Study||0
9078624|NCT01659554|10141086|FG000|NOT COMPLETED|Overall Study||4
9078625|NCT01658813|10141090|FG000|STARTED|Overall Study||18
9078626|NCT01658813|10141090|FG000|Eligible|Overall Study||18
9078627|NCT01658813|10141090|FG000|Treated|Overall Study||18
9078628|NCT01658813|10141090|FG000|COMPLETED|Overall Study||15
9078629|NCT01658813|10141090|FG000|NOT COMPLETED|Overall Study||3
9078630|NCT01648296|10141100|FG000|STARTED|Overall Study||11
9078631|NCT01648296|10141101|FG001|STARTED|Overall Study||17
9078632|NCT01648296|10141100|FG000|COMPLETED|Overall Study||11
9078633|NCT01648296|10141101|FG001|COMPLETED|Overall Study||17
9078634|NCT01648296|10141100|FG000|NOT COMPLETED|Overall Study||0
9078635|NCT01648296|10141101|FG001|NOT COMPLETED|Overall Study||0
9078636|NCT01649505|10141111|FG000|STARTED|Overall Study||1
9078637|NCT01649505|10141112|FG001|STARTED|Overall Study||1
9078638|NCT01649505|10141111|FG000|COMPLETED|Overall Study||0
9078639|NCT01649505|10141112|FG001|COMPLETED|Overall Study||0
9078640|NCT01649505|10141111|FG000|NOT COMPLETED|Overall Study||1
9078641|NCT01649505|10141112|FG001|NOT COMPLETED|Overall Study||1
9078642|NCT01642732|10141118|FG000|STARTED|Overall Study||1
9078643|NCT01642732|10141118|FG000|COMPLETED|Overall Study||0
9078644|NCT01642732|10141118|FG000|NOT COMPLETED|Overall Study||1
9078645|NCT01645709|10141124|FG000|STARTED|Overall Study|Study was terminated; not made unblind|0
9078646|NCT01645709|10141125|FG001|STARTED|Overall Study|Study was terminated; not made unblind|0
9078647|NCT01645709|10141124|FG000|COMPLETED|Overall Study|Study was terminated; not made unblind|0
9078648|NCT01645709|10141125|FG001|COMPLETED|Overall Study|Study was terminated; not made unblind|0
9078649|NCT01645709|10141124|FG000|NOT COMPLETED|Overall Study||0
9078650|NCT01645709|10141125|FG001|NOT COMPLETED|Overall Study||0
9078651|NCT01648270|10141131|FG000|STARTED|Intravenous Buprenorphine||25
9078652|NCT01648270|10141131|FG000|COMPLETED|Intravenous Buprenorphine||13
9078653|NCT01648270|10141131|FG000|NOT COMPLETED|Intravenous Buprenorphine||12
9078654|NCT01648270|10141131|FG000|STARTED|Sublingual Buprenorphine||13
9078655|NCT01648270|10141131|FG000|COMPLETED|Sublingual Buprenorphine||13
9078656|NCT01648270|10141131|FG000|NOT COMPLETED|Sublingual Buprenorphine||0
9078657|NCT01648270|10141131|FG000|STARTED|Cyclosporine Plus IV Buprenorphine||13
9078658|NCT01648270|10141131|FG000|COMPLETED|Cyclosporine Plus IV Buprenorphine||13
9078659|NCT01648270|10141131|FG000|NOT COMPLETED|Cyclosporine Plus IV Buprenorphine||0
9078660|NCT01648270|10141131|FG000|STARTED|Cyclosporine + Sublingual Buprenorphine||13
9078661|NCT01648270|10141131|FG000|COMPLETED|Cyclosporine + Sublingual Buprenorphine||13
9078662|NCT01648270|10141131|FG000|NOT COMPLETED|Cyclosporine + Sublingual Buprenorphine||0
9078663|NCT01643525|10141141|FG000|STARTED|Overall Study||29
9078664|NCT01643525|10141141|FG000|COMPLETED|Overall Study||29
9078665|NCT01643525|10141141|FG000|NOT COMPLETED|Overall Study||0
9078666|NCT01641601|10141147|FG000|STARTED|Overall Study||3
9078667|NCT01641601|10141148|FG001|STARTED|Overall Study||5
9078668|NCT01641601|10141147|FG000|COMPLETED|Overall Study|Study discontinued prior to data collection.|0
9078669|NCT01641601|10141148|FG001|COMPLETED|Overall Study|Study discontinued prior to data collection.|0
9078670|NCT01641601|10141147|FG000|NOT COMPLETED|Overall Study||3
9078671|NCT01641601|10141148|FG001|NOT COMPLETED|Overall Study||5
9078672|NCT01633814|10141154|FG000|STARTED|Overall Study||4
9078673|NCT01633814|10141154|FG000|COMPLETED|Overall Study||4
9078674|NCT01633814|10141154|FG000|NOT COMPLETED|Overall Study||0
9078675|NCT01636466|10141160|FG000|STARTED|Overall Study||1
9078676|NCT01636466|10141161|FG001|STARTED|Overall Study||0
9078677|NCT01636466|10141160|FG000|COMPLETED|Overall Study||0
9078678|NCT01636466|10141161|FG001|COMPLETED|Overall Study||0
9078679|NCT01636466|10141160|FG000|NOT COMPLETED|Overall Study||1
9078680|NCT01636466|10141161|FG001|NOT COMPLETED|Overall Study||0
9078681|NCT01629329|10141169|FG000|STARTED|Overall Study||0
9078682|NCT01629329|10141170|FG001|STARTED|Overall Study||0
9078683|NCT01629329|10141169|FG000|COMPLETED|Overall Study||0
9078684|NCT01629329|10141170|FG001|COMPLETED|Overall Study||0
9078685|NCT01629329|10141169|FG000|NOT COMPLETED|Overall Study||0
9078686|NCT01629329|10141170|FG001|NOT COMPLETED|Overall Study||0
9078687|NCT01627899|10141176|FG000|STARTED|Overall Study||5
9078688|NCT01627899|10141176|FG000|COMPLETED|Overall Study||0
9078689|NCT01627899|10141176|FG000|NOT COMPLETED|Overall Study||5
9078690|NCT01632020|10141182|FG000|STARTED|Overall Study||4
9078691|NCT01632020|10141183|FG001|STARTED|Overall Study||3
9078692|NCT01632020|10141182|FG000|COMPLETED|Overall Study||2
9078693|NCT01632020|10141183|FG001|COMPLETED|Overall Study||3
9078694|NCT01632020|10141182|FG000|NOT COMPLETED|Overall Study||2
9078695|NCT01632020|10141183|FG001|NOT COMPLETED|Overall Study||0
9078696|NCT01602471|10141189|FG000|STARTED|Overall Study||4
9078697|NCT01602471|10141189|FG000|COMPLETED|Overall Study||4
9078698|NCT01602471|10141189|FG000|NOT COMPLETED|Overall Study||0
9078699|NCT01619800|10141195|FG000|STARTED|Overall Study||2
9078700|NCT01619800|10141196|FG001|STARTED|Overall Study||0
9078701|NCT01619800|10141195|FG000|COMPLETED|Overall Study||0
9078702|NCT01619800|10141196|FG001|COMPLETED|Overall Study||0
9078703|NCT01619800|10141195|FG000|NOT COMPLETED|Overall Study||2
9078704|NCT01619800|10141196|FG001|NOT COMPLETED|Overall Study||0
9078705|NCT01608906|10141202|FG000|STARTED|Overall Study||152
9078706|NCT01608906|10141202|FG000|COMPLETED|Overall Study||113
9078707|NCT01608906|10141202|FG000|NOT COMPLETED|Overall Study||39
9078708|NCT01621737|10141207|FG000|STARTED|Overall Study||0
9078709|NCT01621737|10141207|FG000|COMPLETED|Overall Study||0
9078710|NCT01621737|10141207|FG000|NOT COMPLETED|Overall Study||0
9078711|NCT01614067|10141213|FG000|STARTED|Overall Study||15
9078712|NCT01614067|10141214|FG001|STARTED|Overall Study||15
9078713|NCT01614067|10141213|FG000|COMPLETED|Overall Study||0
9078714|NCT01614067|10141214|FG001|COMPLETED|Overall Study||0
9078715|NCT01614067|10141213|FG000|NOT COMPLETED|Overall Study||15
9078716|NCT01614067|10141214|FG001|NOT COMPLETED|Overall Study||15
9078717|NCT01607320|10141220|FG000|STARTED|Overall Study|The study was randomized between the two treatments and was never unblinded,therefore unknown.|0
9078718|NCT01607320|10141221|FG001|STARTED|Overall Study|The study was randomized between the two treatments and was never unblinded,therefore unknown.|0
9078719|NCT01607320|10141220|FG000|COMPLETED|Overall Study|The study was randomized between the 2 treatments and was never unblinded,so unknown.|0
9078720|NCT01607320|10141221|FG001|COMPLETED|Overall Study|The study was randomized between the two treatments and was never unblinded,therefore unknown.|0
9078721|NCT01607320|10141220|FG000|NOT COMPLETED|Overall Study||0
9078722|NCT01607320|10141221|FG001|NOT COMPLETED|Overall Study||0
9078723|NCT01605019|10141227|FG000|STARTED|Overall Study||4
9078724|NCT01605019|10141228|FG001|STARTED|Overall Study||0
9078725|NCT01605019|10141227|FG000|COMPLETED|Overall Study||1
9078726|NCT01605019|10141228|FG001|COMPLETED|Overall Study||0
9078727|NCT01605019|10141227|FG000|NOT COMPLETED|Overall Study||3
9078728|NCT01605019|10141228|FG001|NOT COMPLETED|Overall Study||0
9078729|NCT01609231|10141236|FG000|STARTED|Overall Study||6
9078730|NCT01609231|10141237|FG001|STARTED|Overall Study||5
9078731|NCT01609231|10141236|FG000|COMPLETED|Overall Study||3
9078732|NCT01609231|10141237|FG001|COMPLETED|Overall Study||2
9078733|NCT01609231|10141236|FG000|NOT COMPLETED|Overall Study||3
9078734|NCT01609231|10141237|FG001|NOT COMPLETED|Overall Study||3
9078735|NCT01602198|10141245|FG000|STARTED|Overall Study||0
9078736|NCT01602198|10141246|FG001|STARTED|Overall Study||1
9078737|NCT01602198|10141245|FG000|COMPLETED|Overall Study||0
9078738|NCT01602198|10141246|FG001|COMPLETED|Overall Study||1
9078739|NCT01602198|10141245|FG000|NOT COMPLETED|Overall Study||0
9078740|NCT01602198|10141246|FG001|NOT COMPLETED|Overall Study||0
9078741|NCT01606150|10141254|FG000|STARTED|Overall Study||0
9078742|NCT01606150|10141255|FG001|STARTED|Overall Study||0
9078743|NCT01606150|10141254|FG000|COMPLETED|Overall Study|Enrollment was only for two months in 2012 due to technical and enrollment problems|0
9078744|NCT01606150|10141255|FG001|COMPLETED|Overall Study|Enrollment was only for two months in 2012 due to technical and enrollment problems|0
9078745|NCT01606150|10141254|FG000|NOT COMPLETED|Overall Study||0
9078746|NCT01606150|10141255|FG001|NOT COMPLETED|Overall Study||0
9078747|NCT01603043|10141263|FG000|STARTED|Overall Study||7
9078748|NCT01603043|10141264|FG001|STARTED|Overall Study||3
9078749|NCT01603043|10141263|FG000|COMPLETED|Overall Study||0
9078750|NCT01603043|10141264|FG001|COMPLETED|Overall Study||0
9078751|NCT01603043|10141263|FG000|NOT COMPLETED|Overall Study||7
9078752|NCT01603043|10141264|FG001|NOT COMPLETED|Overall Study||3
9078753|NCT01605370|10141272|FG000|STARTED|Overall Study||1
9078754|NCT01605370|10141273|FG001|STARTED|Overall Study||0
9078755|NCT01605370|10141272|FG000|COMPLETED|Overall Study||0
9078756|NCT01605370|10141273|FG001|COMPLETED|Overall Study||0
9078757|NCT01605370|10141272|FG000|NOT COMPLETED|Overall Study||1
9078758|NCT01605370|10141273|FG001|NOT COMPLETED|Overall Study||0
9078759|NCT01605617|10141281|FG000|STARTED|First Intervention||2
9078760|NCT01605617|10141282|FG001|STARTED|First Intervention||2
9078761|NCT01605617|10141281|FG000|COMPLETED|First Intervention||2
9078762|NCT01605617|10141282|FG001|COMPLETED|First Intervention||1
9078763|NCT01605617|10141281|FG000|NOT COMPLETED|First Intervention||0
9078764|NCT01605617|10141282|FG001|NOT COMPLETED|First Intervention||1
9078765|NCT01605617|10141281|FG000|STARTED|Washout Period of 4 Weeks||2
9078766|NCT01605617|10141282|FG001|STARTED|Washout Period of 4 Weeks||1
9078767|NCT01605617|10141281|FG000|COMPLETED|Washout Period of 4 Weeks||0
9078768|NCT01605617|10141282|FG001|COMPLETED|Washout Period of 4 Weeks||0
9078769|NCT01605617|10141281|FG000|NOT COMPLETED|Washout Period of 4 Weeks||2
9078770|NCT01605617|10141282|FG001|NOT COMPLETED|Washout Period of 4 Weeks||1
9078771|NCT01605617|10141281|FG000|STARTED|Second Intervention||0
9078772|NCT01605617|10141282|FG001|STARTED|Second Intervention||0
9078773|NCT01605617|10141281|FG000|COMPLETED|Second Intervention||0
9078774|NCT01605617|10141282|FG001|COMPLETED|Second Intervention||0
9078775|NCT01605617|10141281|FG000|NOT COMPLETED|Second Intervention||0
9078776|NCT01605617|10141282|FG001|NOT COMPLETED|Second Intervention||0
9078777|NCT01606709|10141292|FG000|STARTED|Overall Study||4
9078778|NCT01606709|10141293|FG001|STARTED|Overall Study||3
9078779|NCT01606709|10141292|FG000|COMPLETED|Overall Study||4
9078780|NCT01606709|10141293|FG001|COMPLETED|Overall Study||3
9078781|NCT01606709|10141292|FG000|NOT COMPLETED|Overall Study||0
9078782|NCT01606709|10141293|FG001|NOT COMPLETED|Overall Study||0
9078783|NCT01603121|10141299|FG000|STARTED|First Intervention, 10 Hours||1
9078784|NCT01603121|10141300|FG001|STARTED|First Intervention, 10 Hours||0
9078785|NCT01603121|10141299|FG000|COMPLETED|First Intervention, 10 Hours||1
9078786|NCT01603121|10141300|FG001|COMPLETED|First Intervention, 10 Hours||0
9078787|NCT01603121|10141299|FG000|NOT COMPLETED|First Intervention, 10 Hours||0
9078788|NCT01603121|10141300|FG001|NOT COMPLETED|First Intervention, 10 Hours||0
9078789|NCT01603121|10141299|FG000|STARTED|Second Intervention, 10 Hours||1
9078790|NCT01603121|10141300|FG001|STARTED|Second Intervention, 10 Hours||0
9078791|NCT01603121|10141299|FG000|COMPLETED|Second Intervention, 10 Hours||0
9078792|NCT01603121|10141300|FG001|COMPLETED|Second Intervention, 10 Hours||0
9078793|NCT01603121|10141299|FG000|NOT COMPLETED|Second Intervention, 10 Hours||1
9078794|NCT01603121|10141300|FG001|NOT COMPLETED|Second Intervention, 10 Hours||0
9078795|NCT01602016|10141306|FG000|STARTED|Overall Study||0
9078796|NCT01602016|10141306|FG000|COMPLETED|Overall Study||0
9078797|NCT01602016|10141306|FG000|NOT COMPLETED|Overall Study||0
9078798|NCT01603394|10141313|FG000|STARTED|Overall Study||9
9078799|NCT01603394|10141313|FG000|COMPLETED|Overall Study||8
9078800|NCT01603394|10141313|FG000|NOT COMPLETED|Overall Study||1
9078801|NCT01592383|10141317|FG000|STARTED|Overall Study||2
9078802|NCT01592383|10141317|FG000|COMPLETED|Overall Study||1
9078803|NCT01592383|10141317|FG000|NOT COMPLETED|Overall Study||1
9078804|NCT01598025|10141324|FG000|STARTED|Overall Study||0
9078805|NCT01598025|10141325|FG001|STARTED|Overall Study||3
9078806|NCT01598025|10141324|FG000|COMPLETED|Overall Study||0
9078807|NCT01598025|10141325|FG001|COMPLETED|Overall Study||0
9078808|NCT01598025|10141324|FG000|NOT COMPLETED|Overall Study||0
9078809|NCT01598025|10141325|FG001|NOT COMPLETED|Overall Study||3
9078810|NCT01587963|10141332|FG000|STARTED|Overall Study||7
9078811|NCT01587963|10141333|FG001|STARTED|Overall Study||4
9078812|NCT01587963|10141332|FG000|COMPLETED|Overall Study||6
9078813|NCT01587963|10141333|FG001|COMPLETED|Overall Study||4
9078814|NCT01587963|10141332|FG000|NOT COMPLETED|Overall Study||1
9078815|NCT01587963|10141333|FG001|NOT COMPLETED|Overall Study||0
9078816|NCT01591096|10141339|FG000|STARTED|Overall Study||1
9078817|NCT01591096|10141339|FG000|COMPLETED|Overall Study||0
9078818|NCT01591096|10141339|FG000|NOT COMPLETED|Overall Study||1
9078819|NCT01591954|10141343|FG000|STARTED|Overall Study||1
9078820|NCT01591954|10141343|FG000|COMPLETED|Overall Study||1
9078821|NCT01591954|10141343|FG000|NOT COMPLETED|Overall Study||0
9078822|NCT01589926|10141349|FG000|STARTED|Overall Study||0
9078823|NCT01589926|10141350|FG001|STARTED|Overall Study||0
9078824|NCT01589926|10141349|FG000|COMPLETED|Overall Study||0
9078825|NCT01589926|10141350|FG001|COMPLETED|Overall Study||0
9078826|NCT01589926|10141349|FG000|NOT COMPLETED|Overall Study||0
9078827|NCT01589926|10141350|FG001|NOT COMPLETED|Overall Study||0
9078828|NCT01576575|10141356|FG000|STARTED|Buprenorphine Control||21
9078829|NCT01576575|10141356|FG000|COMPLETED|Buprenorphine Control||18
9078830|NCT01576575|10141356|FG000|NOT COMPLETED|Buprenorphine Control||3
9078831|NCT01576575|10141356|FG000|STARTED|Buprenorphine + Rifampin||18
9078832|NCT01576575|10141356|FG000|COMPLETED|Buprenorphine + Rifampin||15
9078833|NCT01576575|10141356|FG000|NOT COMPLETED|Buprenorphine + Rifampin||3
9078834|NCT01576575|10141356|FG000|STARTED|Buprenorphine + Grapefruit||15
9078835|NCT01576575|10141356|FG000|COMPLETED|Buprenorphine + Grapefruit||14
9078836|NCT01576575|10141356|FG000|NOT COMPLETED|Buprenorphine + Grapefruit||1
9078837|NCT01576575|10141356|FG000|STARTED|Buprenorphine + Ketoconazole||14
9078838|NCT01576575|10141356|FG000|COMPLETED|Buprenorphine + Ketoconazole||14
9078839|NCT01576575|10141356|FG000|NOT COMPLETED|Buprenorphine + Ketoconazole||0
9078840|NCT01590394|10141366|FG000|STARTED|Overall Study||3
9078841|NCT01590394|10141366|FG000|COMPLETED|Overall Study||3
9078842|NCT01590394|10141366|FG000|NOT COMPLETED|Overall Study||0
9078843|NCT01577628|10141372|FG000|STARTED|Overall Study||0
9078844|NCT01577628|10141373|FG001|STARTED|Overall Study||0
9078845|NCT01577628|10141374|FG002|STARTED|Overall Study||2
9078846|NCT01577628|10141372|FG000|COMPLETED|Overall Study||0
9078847|NCT01577628|10141373|FG001|COMPLETED|Overall Study||0
9078848|NCT01577628|10141374|FG002|COMPLETED|Overall Study||0
9078849|NCT01577628|10141372|FG000|NOT COMPLETED|Overall Study||0
9078850|NCT01577628|10141373|FG001|NOT COMPLETED|Overall Study||0
9078851|NCT01577628|10141374|FG002|NOT COMPLETED|Overall Study||2
9078852|NCT01582100|10141380|FG000|STARTED|Overall Study||2
9078853|NCT01582100|10141380|FG000|COMPLETED|Overall Study||0
9078854|NCT01582100|10141380|FG000|NOT COMPLETED|Overall Study||2
9078855|NCT01583647|10141384|FG000|STARTED|Overall Study||10
9078856|NCT01583647|10141385|FG001|STARTED|Overall Study|Study terminated prior to Panel B being conducted.|0
9078857|NCT01583647|10141384|FG000|COMPLETED|Overall Study||10
9078858|NCT01583647|10141385|FG001|COMPLETED|Overall Study||0
9078859|NCT01583647|10141384|FG000|NOT COMPLETED|Overall Study||0
9078860|NCT01583647|10141385|FG001|NOT COMPLETED|Overall Study||0
9078861|NCT01575028|10141393|FG000|STARTED|Overall Study||2
9078862|NCT01575028|10141394|FG001|STARTED|Overall Study||1
9078863|NCT01575028|10141393|FG000|COMPLETED|Overall Study||2
9078864|NCT01575028|10141394|FG001|COMPLETED|Overall Study||0
9078865|NCT01575028|10141393|FG000|NOT COMPLETED|Overall Study||0
9078866|NCT01575028|10141394|FG001|NOT COMPLETED|Overall Study||1
9078867|NCT01578785|10141402|FG000|STARTED|Overall Study||59
9078868|NCT01578785|10141403|FG001|STARTED|Overall Study||119
9078869|NCT01578785|10141402|FG000|COMPLETED|Overall Study||0
9078870|NCT01578785|10141403|FG001|COMPLETED|Overall Study||0
9078871|NCT01578785|10141402|FG000|NOT COMPLETED|Overall Study||59
9078872|NCT01578785|10141403|FG001|NOT COMPLETED|Overall Study||119
9078873|NCT01576549|10141409|FG000|STARTED|Overall Study||2
9078874|NCT01576549|10141409|FG000|Received at Least 1 Dose of Study Drug|Overall Study||2
9078875|NCT01576549|10141409|FG000|Completed Post-Treatment Follow-Up|Overall Study|Each participant discontinued dosing and completed the Post-Treatment Follow-Up Period.|2
9078876|NCT01576549|10141409|FG000|COMPLETED|Overall Study||0
9078877|NCT01576549|10141409|FG000|NOT COMPLETED|Overall Study||2
9078878|NCT01570634|10141414|FG000|STARTED|Overall Study||2
9078879|NCT01570634|10141414|FG000|COMPLETED|Overall Study||2
9078880|NCT01570634|10141414|FG000|NOT COMPLETED|Overall Study||0
9078881|NCT01566370|10141420|FG000|STARTED|Overall Study||2
9078882|NCT01566370|10141421|FG001|STARTED|Overall Study||1
9078883|NCT01566370|10141420|FG000|COMPLETED|Overall Study||0
9078884|NCT01566370|10141421|FG001|COMPLETED|Overall Study||0
9078885|NCT01566370|10141420|FG000|NOT COMPLETED|Overall Study||2
9078886|NCT01566370|10141421|FG001|NOT COMPLETED|Overall Study||1
9078887|NCT01561989|10141429|FG000|STARTED|Overall Study||5
9078888|NCT01561989|10141430|FG001|STARTED|Overall Study||6
9078889|NCT01561989|10141429|FG000|COMPLETED|Overall Study||0
9078890|NCT01561989|10141430|FG001|COMPLETED|Overall Study||0
9078891|NCT01561989|10141429|FG000|NOT COMPLETED|Overall Study||5
9078892|NCT01561989|10141430|FG001|NOT COMPLETED|Overall Study||6
9078893|NCT01564732|10141438|FG000|STARTED|Overall Study||6
9078894|NCT01564732|10141439|FG001|STARTED|Overall Study||5
9078895|NCT01564732|10141438|FG000|COMPLETED|Overall Study||0
9078896|NCT01564732|10141439|FG001|COMPLETED|Overall Study||0
9078897|NCT01564732|10141438|FG000|NOT COMPLETED|Overall Study||6
9078898|NCT01564732|10141439|FG001|NOT COMPLETED|Overall Study||5
9078899|NCT01560507|10141448|FG000|STARTED|Overall Study||5
9078900|NCT01560507|10141449|FG001|STARTED|Overall Study||2
9078901|NCT01560507|10141450|FG002|STARTED|Overall Study||2
9078902|NCT01560507|10141448|FG000|COMPLETED|Overall Study||1
9078903|NCT01560507|10141449|FG001|COMPLETED|Overall Study||0
9078904|NCT01560507|10141450|FG002|COMPLETED|Overall Study||0
9078905|NCT01560507|10141448|FG000|NOT COMPLETED|Overall Study||4
9078906|NCT01560507|10141449|FG001|NOT COMPLETED|Overall Study||2
9078907|NCT01560507|10141450|FG002|NOT COMPLETED|Overall Study||2
9078908|NCT01557881|10141461|FG000|STARTED|Overall Study||98
9078909|NCT01557881|10141461|FG000|COMPLETED|Overall Study||98
9078910|NCT01557881|10141461|FG000|NOT COMPLETED|Overall Study||0
9078911|NCT01555489|10141465|FG000|STARTED|Overall Study||11
9078912|NCT01555489|10141465|FG000|COMPLETED|Overall Study||11
9078913|NCT01555489|10141465|FG000|NOT COMPLETED|Overall Study||0
8624327|NCT00499486|9663598|FG000|STARTED|Overall Study||47
8624328|NCT00499486|9663598|FG000|COMPLETED|Overall Study||31
8624329|NCT00499486|9663598|FG000|NOT COMPLETED|Overall Study||16
9078914|NCT01549977|10141471|FG000|STARTED|Overall Study||1
9078915|NCT01549977|10141472|FG001|STARTED|Overall Study||0
9078916|NCT01549977|10141471|FG000|COMPLETED|Overall Study||1
9078917|NCT01549977|10141472|FG001|COMPLETED|Overall Study||0
9078918|NCT01549977|10141471|FG000|NOT COMPLETED|Overall Study||0
9078919|NCT01549977|10141472|FG001|NOT COMPLETED|Overall Study||0
9078920|NCT01558492|10141478|FG000|STARTED|Overall Study||3
9078921|NCT01558492|10141478|FG000|COMPLETED|Overall Study||3
9078922|NCT01558492|10141478|FG000|NOT COMPLETED|Overall Study||0
9078923|NCT01550562|10141482|FG000|STARTED|First Intervention, 4 - 5 Days||1
9078924|NCT01550562|10141482|FG000|COMPLETED|First Intervention, 4 - 5 Days||1
9078925|NCT01550562|10141482|FG000|NOT COMPLETED|First Intervention, 4 - 5 Days||0
9078926|NCT01550562|10141482|FG000|STARTED|Second Intervention, 4 - 5 Days||1
9078927|NCT01550562|10141482|FG000|COMPLETED|Second Intervention, 4 - 5 Days||1
9078928|NCT01550562|10141482|FG000|NOT COMPLETED|Second Intervention, 4 - 5 Days||0
9078929|NCT01550562|10141482|FG000|STARTED|Third Intervention, 4 - 5 Days||1
9078930|NCT01550562|10141482|FG000|COMPLETED|Third Intervention, 4 - 5 Days||1
9078931|NCT01550562|10141482|FG000|NOT COMPLETED|Third Intervention, 4 - 5 Days||0
9078932|NCT01561495|10141486|FG000|STARTED|Overall Study||1
9078933|NCT01561495|10141486|FG000|COMPLETED|Overall Study||1
9078934|NCT01561495|10141486|FG000|NOT COMPLETED|Overall Study||0
9078935|NCT01555073|10141494|FG000|STARTED|Overall Study||7
9078936|NCT01555073|10141495|FG001|STARTED|Overall Study||3
9078937|NCT01555073|10141496|FG002|STARTED|Overall Study||7
9078938|NCT01555073|10141497|FG003|STARTED|Overall Study||6
9078939|NCT01555073|10141494|FG000|COMPLETED|Overall Study||6
9078940|NCT01555073|10141495|FG001|COMPLETED|Overall Study||1
9078941|NCT01555073|10141496|FG002|COMPLETED|Overall Study||7
9078942|NCT01555073|10141497|FG003|COMPLETED|Overall Study||1
9078943|NCT01555073|10141494|FG000|NOT COMPLETED|Overall Study||1
9078944|NCT01555073|10141495|FG001|NOT COMPLETED|Overall Study||2
9078945|NCT01555073|10141496|FG002|NOT COMPLETED|Overall Study||0
9078946|NCT01555073|10141497|FG003|NOT COMPLETED|Overall Study||5
9078947|NCT01551082|10141507|FG000|STARTED|Overall Study||12
9078948|NCT01551082|10141507|FG000|COMPLETED|Overall Study||12
9078949|NCT01551082|10141507|FG000|NOT COMPLETED|Overall Study||0
9078950|NCT01556009|10141513|FG000|STARTED|Overall Study||0
9078951|NCT01556009|10141514|FG001|STARTED|Overall Study||0
9078952|NCT01556009|10141513|FG000|COMPLETED|Overall Study||0
9078953|NCT01556009|10141514|FG001|COMPLETED|Overall Study||0
9078954|NCT01556009|10141513|FG000|NOT COMPLETED|Overall Study||0
9078955|NCT01556009|10141514|FG001|NOT COMPLETED|Overall Study||0
9078956|NCT01550510|10141522|FG000|STARTED|Overall Study||4
9078957|NCT01550510|10141523|FG001|STARTED|Overall Study||0
9078958|NCT01550510|10141522|FG000|COMPLETED|Overall Study||4
9078959|NCT01550510|10141523|FG001|COMPLETED|Overall Study||0
9078960|NCT01550510|10141522|FG000|NOT COMPLETED|Overall Study||0
9078961|NCT01550510|10141523|FG001|NOT COMPLETED|Overall Study||0
9078962|NCT01541397|10141532|FG000|STARTED|Overall Study||4
9078963|NCT01541397|10141533|FG001|STARTED|Overall Study||2
9078964|NCT01541397|10141532|FG000|COMPLETED|Overall Study||0
9078965|NCT01541397|10141533|FG001|COMPLETED|Overall Study||0
9078966|NCT01541397|10141532|FG000|NOT COMPLETED|Overall Study||4
9078967|NCT01541397|10141533|FG001|NOT COMPLETED|Overall Study||2
9078968|NCT01546207|10141539|FG000|STARTED|Overall Study||4
9078969|NCT01546207|10141539|FG000|COMPLETED|Overall Study||3
9078970|NCT01546207|10141539|FG000|NOT COMPLETED|Overall Study||1
9078971|NCT01553240|10141543|FG000|STARTED|Overall Study||0
9078972|NCT01553240|10141543|FG000|COMPLETED|Overall Study||0
9078973|NCT01553240|10141543|FG000|NOT COMPLETED|Overall Study||0
9078974|NCT01547728|10141547|FG000|STARTED|Overall Study||42
9078975|NCT01547728|10141547|FG000|COMPLETED|Overall Study||1
9078976|NCT01547728|10141547|FG000|NOT COMPLETED|Overall Study||41
9078977|NCT01548651|10141553|FG000|STARTED|Overall Study||4
9078978|NCT01548651|10141554|FG001|STARTED|Overall Study||4
9078979|NCT01548651|10141553|FG000|COMPLETED|Overall Study||3
9078980|NCT01548651|10141554|FG001|COMPLETED|Overall Study||4
9078981|NCT01548651|10141553|FG000|NOT COMPLETED|Overall Study||1
9078982|NCT01548651|10141554|FG001|NOT COMPLETED|Overall Study||0
9078983|NCT01545648|10141560|FG000|STARTED|Overall Study||4
9078984|NCT01545648|10141560|FG000|6 Months of Treatment|Overall Study||4
9078985|NCT01545648|10141560|FG000|COMPLETED|Overall Study||4
9078986|NCT01545648|10141560|FG000|NOT COMPLETED|Overall Study||0
9078987|NCT01546883|10141564|FG000|STARTED|Overall Study||14
9078988|NCT01546883|10141564|FG000|COMPLETED|Overall Study||2
9078989|NCT01546883|10141564|FG000|NOT COMPLETED|Overall Study||12
9078990|NCT01545518|10141568|FG000|STARTED|Overall Study||20
9078991|NCT01545518|10141568|FG000|COMPLETED|Overall Study||20
9078992|NCT01545518|10141568|FG000|NOT COMPLETED|Overall Study||0
9078993|NCT01536015|10141574|FG000|STARTED|Overall Study||12
9078994|NCT01536015|10141575|FG001|STARTED|Overall Study||13
9078995|NCT01536015|10141574|FG000|COMPLETED|Overall Study||4
9078996|NCT01536015|10141575|FG001|COMPLETED|Overall Study||3
9078997|NCT01536015|10141574|FG000|NOT COMPLETED|Overall Study||8
9078998|NCT01536015|10141575|FG001|NOT COMPLETED|Overall Study||10
9078999|NCT01539590|10141583|FG000|STARTED|Overall Study||3
9079000|NCT01539590|10141584|FG001|STARTED|Overall Study||2
9079001|NCT01539590|10141583|FG000|Complete Study Treatment|Overall Study||1
9079002|NCT01539590|10141584|FG001|Complete Study Treatment|Overall Study||2
9079003|NCT01539590|10141583|FG000|COMPLETED|Overall Study||0
9079004|NCT01539590|10141584|FG001|COMPLETED|Overall Study||2
9079005|NCT01539590|10141583|FG000|NOT COMPLETED|Overall Study||3
9079006|NCT01539590|10141584|FG001|NOT COMPLETED|Overall Study||0
9079007|NCT01539811|10141592|FG000|STARTED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
9079008|NCT01539811|10141593|FG001|STARTED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
9079009|NCT01539811|10141592|FG000|COMPLETED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
9079010|NCT01539811|10141593|FG001|COMPLETED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
9079011|NCT01539811|10141592|FG000|NOT COMPLETED|Overall Study||0
9079012|NCT01539811|10141593|FG001|NOT COMPLETED|Overall Study||0
9079013|NCT01534676|10141601|FG000|STARTED|Overall Study||2
9079014|NCT01534676|10141602|FG001|STARTED|Overall Study||1
9079015|NCT01534676|10141601|FG000|COMPLETED|Overall Study||0
9079016|NCT01534676|10141602|FG001|COMPLETED|Overall Study||0
9079017|NCT01534676|10141601|FG000|NOT COMPLETED|Overall Study||2
9079018|NCT01534676|10141602|FG001|NOT COMPLETED|Overall Study||1
9079019|NCT01533753|10141610|FG000|STARTED|Overall Study||2
9079020|NCT01533753|10141611|FG001|STARTED|Overall Study||3
9079021|NCT01533753|10141610|FG000|COMPLETED|Overall Study||2
9079022|NCT01533753|10141611|FG001|COMPLETED|Overall Study||3
9079023|NCT01533753|10141610|FG000|NOT COMPLETED|Overall Study||0
9079024|NCT01533753|10141611|FG001|NOT COMPLETED|Overall Study||0
9079025|NCT01534143|10141617|FG000|STARTED|Overall Study||1
9079026|NCT01534143|10141617|FG000|COMPLETED|Overall Study||1
9079027|NCT01534143|10141617|FG000|NOT COMPLETED|Overall Study||0
9079028|NCT01530880|10141621|FG000|STARTED|Overall Study||35
9079029|NCT01530880|10141621|FG000|COMPLETED|Overall Study||35
9079030|NCT01530880|10141621|FG000|NOT COMPLETED|Overall Study||0
9079031|NCT01530087|10141626|FG000|STARTED|Overall Study||3
9079032|NCT01530087|10141626|FG000|COMPLETED|Overall Study||1
9079033|NCT01530087|10141626|FG000|NOT COMPLETED|Overall Study||2
9079034|NCT01527942|10141633|FG000|STARTED|Overall Study||16
9079035|NCT01527942|10141634|FG001|STARTED|Overall Study||18
9079036|NCT01527942|10141633|FG000|COMPLETED|Overall Study||16
9079037|NCT01527942|10141634|FG001|COMPLETED|Overall Study||18
9079038|NCT01527942|10141633|FG000|NOT COMPLETED|Overall Study||0
9079039|NCT01527942|10141634|FG001|NOT COMPLETED|Overall Study||0
9079040|NCT01521143|10141644|FG000|STARTED|Overall Study||40
9079041|NCT01521143|10141645|FG001|STARTED|Overall Study||36
9079042|NCT01521143|10141646|FG002|STARTED|Overall Study||8
9079043|NCT01521143|10141647|FG003|STARTED|Overall Study||7
9079044|NCT01521143|10141644|FG000|Received Treatment|Overall Study||20
9079045|NCT01521143|10141645|FG001|Received Treatment|Overall Study||20
9079046|NCT01521143|10141646|FG002|Received Treatment|Overall Study||3
9079047|NCT01521143|10141647|FG003|Received Treatment|Overall Study||4
9079048|NCT01521143|10141644|FG000|COMPLETED|Overall Study||11
9079049|NCT01521143|10141645|FG001|COMPLETED|Overall Study||10
9079050|NCT01521143|10141646|FG002|COMPLETED|Overall Study||0
9079051|NCT01521143|10141647|FG003|COMPLETED|Overall Study||0
9079052|NCT01521143|10141644|FG000|NOT COMPLETED|Overall Study||29
9079053|NCT01521143|10141645|FG001|NOT COMPLETED|Overall Study||26
9079054|NCT01521143|10141646|FG002|NOT COMPLETED|Overall Study||8
9079055|NCT01521143|10141647|FG003|NOT COMPLETED|Overall Study||7
9079056|NCT01532635|10141657|FG000|STARTED|Overall Study||4
9079057|NCT01532635|10141657|FG000|COMPLETED|Overall Study||4
9079058|NCT01532635|10141657|FG000|NOT COMPLETED|Overall Study||0
9079059|NCT01531387|10141663|FG000|STARTED|Overall Study||11
9079060|NCT01531387|10141664|FG001|STARTED|Overall Study||11
9079061|NCT01531387|10141663|FG000|COMPLETED|Overall Study||0
9079062|NCT01531387|10141664|FG001|COMPLETED|Overall Study||0
9079063|NCT01531387|10141663|FG000|NOT COMPLETED|Overall Study||11
9079064|NCT01531387|10141664|FG001|NOT COMPLETED|Overall Study||11
9079065|NCT01532362|10141672|FG000|STARTED|Overall Study||1
9079066|NCT01532362|10141673|FG001|STARTED|Overall Study||0
9079067|NCT01532362|10141672|FG000|COMPLETED|Overall Study||1
9079068|NCT01532362|10141673|FG001|COMPLETED|Overall Study||0
9079069|NCT01532362|10141672|FG000|NOT COMPLETED|Overall Study||0
9079070|NCT01532362|10141673|FG001|NOT COMPLETED|Overall Study||0
9079071|NCT01527292|10141683|FG000|STARTED|Overall Study||0
9079072|NCT01527292|10141684|FG001|STARTED|Overall Study||3
9079073|NCT01527292|10141683|FG000|COMPLETED|Overall Study||0
9079074|NCT01527292|10141684|FG001|COMPLETED|Overall Study||0
9079075|NCT01527292|10141683|FG000|NOT COMPLETED|Overall Study||0
9079076|NCT01527292|10141684|FG001|NOT COMPLETED|Overall Study||3
9079077|NCT01525745|10141692|FG000|STARTED|Overall Study||4
9079078|NCT01525745|10141693|FG001|STARTED|Overall Study||2
9079079|NCT01525745|10141692|FG000|COMPLETED|Overall Study||3
9079080|NCT01525745|10141693|FG001|COMPLETED|Overall Study||1
9079081|NCT01525745|10141692|FG000|NOT COMPLETED|Overall Study||1
9079082|NCT01525745|10141693|FG001|NOT COMPLETED|Overall Study||1
9079083|NCT01528696|10141703|FG000|STARTED|Overall Study||18
9079084|NCT01528696|10141704|FG001|STARTED|Overall Study||19
9079085|NCT01528696|10141703|FG000|Hospital Stay (2-5 Days)|Overall Study||18
9079086|NCT01528696|10141704|FG001|Hospital Stay (2-5 Days)|Overall Study||19
9079087|NCT01528696|10141703|FG000|COMPLETED|Overall Study||0
9079088|NCT01528696|10141704|FG001|COMPLETED|Overall Study||0
9079089|NCT01528696|10141703|FG000|NOT COMPLETED|Overall Study||18
9079090|NCT01528696|10141704|FG001|NOT COMPLETED|Overall Study||19
9079091|NCT01526408|10141712|FG000|STARTED|Overall Study|early termination of study and sponsor organization closed|0
9079092|NCT01526408|10141713|FG001|STARTED|Overall Study|early termination of study and sponsor organization closed|0
9079093|NCT01526408|10141712|FG000|COMPLETED|Overall Study|early termination of study and sponsor organization closed|0
9079094|NCT01526408|10141713|FG001|COMPLETED|Overall Study|early termination of study and sponsor organization closed|0
9079095|NCT01526408|10141712|FG000|NOT COMPLETED|Overall Study||0
9079096|NCT01526408|10141713|FG001|NOT COMPLETED|Overall Study||0
9079097|NCT01528293|10141721|FG000|STARTED|Overall Study||1
9079098|NCT01528293|10141722|FG001|STARTED|Overall Study||1
9079099|NCT01528293|10141721|FG000|COMPLETED|Overall Study||0
9079100|NCT01528293|10141722|FG001|COMPLETED|Overall Study||1
9079101|NCT01528293|10141721|FG000|NOT COMPLETED|Overall Study||1
9079102|NCT01528293|10141722|FG001|NOT COMPLETED|Overall Study||0
9079103|NCT01525927|10141730|FG000|STARTED|Overall Study||0
9079104|NCT01525927|10141730|FG000|COMPLETED|Overall Study||0
9079105|NCT01525927|10141730|FG000|NOT COMPLETED|Overall Study||0
9079106|NCT01520714|10141738|FG000|STARTED|Overall Study||0
9079107|NCT01520714|10141739|FG001|STARTED|Overall Study||11
9079108|NCT01520714|10141738|FG000|COMPLETED|Overall Study||0
9079109|NCT01520714|10141739|FG001|COMPLETED|Overall Study||5
9079110|NCT01520714|10141738|FG000|NOT COMPLETED|Overall Study||0
9079111|NCT01520714|10141739|FG001|NOT COMPLETED|Overall Study||6
9079112|NCT01507233|10141747|FG000|STARTED|Overall Study||5
9079113|NCT01507233|10141748|FG001|STARTED|Overall Study||0
9079114|NCT01507233|10141747|FG000|COMPLETED|Overall Study||5
9079115|NCT01507233|10141748|FG001|COMPLETED|Overall Study||0
9079116|NCT01507233|10141747|FG000|NOT COMPLETED|Overall Study||0
9079117|NCT01507233|10141748|FG001|NOT COMPLETED|Overall Study||0
9079118|NCT01516034|10141754|FG000|STARTED|Overall Study||8
9079119|NCT01516034|10141754|FG000|COMPLETED|Overall Study||0
9079120|NCT01516034|10141754|FG000|NOT COMPLETED|Overall Study||8
9079121|NCT01500772|10141758|FG000|STARTED|Overall Study||6
9079122|NCT01500772|10141758|FG000|COMPLETED|Overall Study||0
9079123|NCT01500772|10141758|FG000|NOT COMPLETED|Overall Study||6
9079124|NCT01517763|10141765|FG000|STARTED|Overall Study||0
9079125|NCT01517763|10141766|FG001|STARTED|Overall Study||0
9079126|NCT01517763|10141767|FG002|STARTED|Overall Study||0
9079127|NCT01517763|10141765|FG000|COMPLETED|Overall Study||0
9079128|NCT01517763|10141766|FG001|COMPLETED|Overall Study||0
9079129|NCT01517763|10141767|FG002|COMPLETED|Overall Study||0
9079130|NCT01517763|10141765|FG000|NOT COMPLETED|Overall Study||0
9079131|NCT01517763|10141766|FG001|NOT COMPLETED|Overall Study||0
9079132|NCT01517763|10141767|FG002|NOT COMPLETED|Overall Study||0
9079133|NCT01507584|10141775|FG000|STARTED|Overall Study||0
9079134|NCT01507584|10141775|FG000|COMPLETED|Overall Study||0
9079135|NCT01507584|10141775|FG000|NOT COMPLETED|Overall Study||0
9079136|NCT01510756|10141779|FG000|STARTED|Overall Study||4
9079137|NCT01510756|10141779|FG000|COMPLETED|Overall Study||0
9079138|NCT01510756|10141779|FG000|NOT COMPLETED|Overall Study||4
9079139|NCT01511081|10141785|FG000|STARTED|Overall Study||8
9079140|NCT01511081|10141786|FG001|STARTED|Overall Study||9
9079141|NCT01511081|10141785|FG000|COMPLETED|Overall Study||8
9079142|NCT01511081|10141786|FG001|COMPLETED|Overall Study||9
9079143|NCT01511081|10141785|FG000|NOT COMPLETED|Overall Study||0
9079144|NCT01511081|10141786|FG001|NOT COMPLETED|Overall Study||0
9079145|NCT01500109|10141795|FG000|STARTED|Overall Study||0
9079146|NCT01500109|10141796|FG001|STARTED|Overall Study||0
9079147|NCT01500109|10141797|FG002|STARTED|Overall Study||0
9079148|NCT01500109|10141795|FG000|COMPLETED|Overall Study||0
9079149|NCT01500109|10141796|FG001|COMPLETED|Overall Study||0
9079150|NCT01500109|10141797|FG002|COMPLETED|Overall Study||0
9079151|NCT01500109|10141795|FG000|NOT COMPLETED|Overall Study||0
9079152|NCT01500109|10141796|FG001|NOT COMPLETED|Overall Study||0
9079153|NCT01500109|10141797|FG002|NOT COMPLETED|Overall Study||0
9079154|NCT01509053|10141805|FG000|STARTED|Oral Aripirazole (Phase A)||19
9079155|NCT01509053|10141805|FG000|COMPLETED|Oral Aripirazole (Phase A)||8
9079156|NCT01509053|10141805|FG000|NOT COMPLETED|Oral Aripirazole (Phase A)||11
9079157|NCT01509053|10141805|FG000|STARTED|Aripiprazole IM Depot Treatment Phase(B)|Includes 8 patients from Phase A + 11 patients who entered directly into Phase B.|19
9079158|NCT01509053|10141805|FG000|COMPLETED|Aripiprazole IM Depot Treatment Phase(B)||3
9079159|NCT01509053|10141805|FG000|NOT COMPLETED|Aripiprazole IM Depot Treatment Phase(B)||16
9079160|NCT01509053|10141805|FG000|STARTED|Aripiprazole IM Depot Extension Phase(C)||3
9079161|NCT01509053|10141805|FG000|COMPLETED|Aripiprazole IM Depot Extension Phase(C)||0
9079162|NCT01509053|10141805|FG000|NOT COMPLETED|Aripiprazole IM Depot Extension Phase(C)||3
9079163|NCT01495988|10141817|FG000|STARTED|Vem +/- Bev (Protocol v2.0)||0
9079164|NCT01495988|10141818|FG001|STARTED|Vem +/- Bev (Protocol v2.0)||0
9079165|NCT01495988|10141819|FG002|STARTED|Vem +/- Bev (Protocol v2.0)||5
9079166|NCT01495988|10141820|FG003|STARTED|Vem +/- Bev (Protocol v2.0)||3
9079167|NCT01495988|10141817|FG000|COMPLETED|Vem +/- Bev (Protocol v2.0)||0
9079168|NCT01495988|10141818|FG001|COMPLETED|Vem +/- Bev (Protocol v2.0)||0
9079169|NCT01495988|10141819|FG002|COMPLETED|Vem +/- Bev (Protocol v2.0)||5
9079170|NCT01495988|10141820|FG003|COMPLETED|Vem +/- Bev (Protocol v2.0)||3
9079171|NCT01495988|10141817|FG000|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
9079172|NCT01495988|10141818|FG001|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
9079173|NCT01495988|10141819|FG002|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
9079174|NCT01495988|10141820|FG003|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
9079175|NCT01495988|10141817|FG000|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||0
9079176|NCT01495988|10141818|FG001|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||2
9079177|NCT01495988|10141819|FG002|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||0
9079178|NCT01495988|10141820|FG003|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||0
9079179|NCT01495988|10141817|FG000|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
9079180|NCT01495988|10141818|FG001|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||2
9079181|NCT01495988|10141819|FG002|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
9079182|NCT01495988|10141820|FG003|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
9079183|NCT01495988|10141817|FG000|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
9079184|NCT01495988|10141818|FG001|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
9079185|NCT01495988|10141819|FG002|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
9079186|NCT01495988|10141820|FG003|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
9079187|NCT01498991|10141830|FG000|STARTED|Overall Study||2
9079188|NCT01498991|10141830|FG000|COMPLETED|Overall Study||2
9079189|NCT01498991|10141830|FG000|NOT COMPLETED|Overall Study||0
9079190|NCT01497171|10141836|FG000|STARTED|Overall Study||2
9079191|NCT01497171|10141837|FG001|STARTED|Overall Study||3
9079192|NCT01497171|10141836|FG000|COMPLETED|Overall Study||2
9079193|NCT01497171|10141837|FG001|COMPLETED|Overall Study||3
9079194|NCT01497171|10141836|FG000|NOT COMPLETED|Overall Study||0
9079195|NCT01497171|10141837|FG001|NOT COMPLETED|Overall Study||0
9079196|NCT01483872|10141843|FG000|STARTED|Overall Study||0
9079197|NCT01483872|10141844|FG001|STARTED|Overall Study||1
9079198|NCT01483872|10141843|FG000|COMPLETED|Overall Study||0
9079199|NCT01483872|10141844|FG001|COMPLETED|Overall Study||1
9079200|NCT01483872|10141843|FG000|NOT COMPLETED|Overall Study||0
9079201|NCT01483872|10141844|FG001|NOT COMPLETED|Overall Study||0
9079202|NCT01487499|10141848|FG000|STARTED|Overall Study||4
9079203|NCT01487499|10141848|FG000|COMPLETED|Overall Study||4
9079204|NCT01487499|10141848|FG000|NOT COMPLETED|Overall Study||0
9079205|NCT01478113|10141854|FG000|STARTED|Overall Study||2
9079206|NCT01478113|10141855|FG001|STARTED|Overall Study||2
9079207|NCT01478113|10141854|FG000|COMPLETED|Overall Study||1
9079208|NCT01478113|10141855|FG001|COMPLETED|Overall Study||1
9079209|NCT01478113|10141854|FG000|NOT COMPLETED|Overall Study||1
9079210|NCT01478113|10141855|FG001|NOT COMPLETED|Overall Study||1
9079211|NCT01483209|10141863|FG000|STARTED|Overall Study||2
9079212|NCT01483209|10141863|FG000|COMPLETED|Overall Study||1
9079213|NCT01483209|10141863|FG000|NOT COMPLETED|Overall Study||1
9079214|NCT01484314|10141867|FG000|STARTED|Overall Study||1
9079215|NCT01484314|10141867|FG000|COMPLETED|Overall Study||1
9079216|NCT01484314|10141867|FG000|NOT COMPLETED|Overall Study||0
9079217|NCT01482598|10141873|FG000|STARTED|Overall Study||66
9079218|NCT01482598|10141874|FG001|STARTED|Overall Study||73
9079219|NCT01482598|10141873|FG000|COMPLETED|Overall Study||50
9079220|NCT01482598|10141874|FG001|COMPLETED|Overall Study||51
9079221|NCT01482598|10141873|FG000|NOT COMPLETED|Overall Study||16
9079222|NCT01482598|10141874|FG001|NOT COMPLETED|Overall Study||22
9079223|NCT01479010|10141880|FG000|STARTED|Overall Study||2
9079224|NCT01479010|10141880|FG000|COMPLETED|Overall Study||1
8624330|NCT00499603|9663604|FG000|STARTED|Overall Study||27
8624331|NCT00499603|9663605|FG001|STARTED|Overall Study||23
9079225|NCT01479010|10141880|FG000|NOT COMPLETED|Overall Study||1
9079226|NCT01482325|10141884|FG000|STARTED|Overall Study||31
9079227|NCT01482325|10141884|FG000|COMPLETED|Overall Study||31
9079228|NCT01482325|10141884|FG000|NOT COMPLETED|Overall Study||0
9079229|NCT01477177|10141888|FG000|STARTED|Overall Study||4
9079230|NCT01477177|10141888|FG000|COMPLETED|Overall Study||4
9079231|NCT01477177|10141888|FG000|NOT COMPLETED|Overall Study||0
9079232|NCT01473732|10141894|FG000|STARTED|Overall Study||2
9079233|NCT01473732|10141895|FG001|STARTED|Overall Study||0
9079234|NCT01473732|10141894|FG000|COMPLETED|Overall Study||0
9079235|NCT01473732|10141895|FG001|COMPLETED|Overall Study||0
9079236|NCT01473732|10141894|FG000|NOT COMPLETED|Overall Study||2
9079237|NCT01473732|10141895|FG001|NOT COMPLETED|Overall Study||0
9079238|NCT01472692|10141903|FG000|STARTED|Overall Study||0
9079239|NCT01472692|10141904|FG001|STARTED|Overall Study||0
9079240|NCT01472692|10141903|FG000|COMPLETED|Overall Study||0
9079241|NCT01472692|10141904|FG001|COMPLETED|Overall Study||0
9079242|NCT01472692|10141903|FG000|NOT COMPLETED|Overall Study||0
9079243|NCT01472692|10141904|FG001|NOT COMPLETED|Overall Study||0
9079244|NCT01465230|10141910|FG000|STARTED|Overall Study||2
9079245|NCT01465230|10141910|FG000|COMPLETED|Overall Study||0
8624332|NCT00499603|9663604|FG000|COMPLETED|Overall Study||27
9079246|NCT01465230|10141910|FG000|NOT COMPLETED|Overall Study||2
9079247|NCT01464723|10141914|FG000|STARTED|Overall Study||0
9079248|NCT01464723|10141914|FG000|COMPLETED|Overall Study||0
9079249|NCT01464723|10141914|FG000|NOT COMPLETED|Overall Study||0
9079250|NCT01446250|10141918|FG000|STARTED|Treatment Period 1||5
9079251|NCT01446250|10141919|FG001|STARTED|Treatment Period 1||3
9079252|NCT01446250|10141920|FG002|STARTED|Treatment Period 1||0
9079253|NCT01446250|10141921|FG003|STARTED|Treatment Period 1||0
9079254|NCT01446250|10141918|FG000|COMPLETED|Treatment Period 1||5
9079255|NCT01446250|10141919|FG001|COMPLETED|Treatment Period 1||2
9079256|NCT01446250|10141920|FG002|COMPLETED|Treatment Period 1||0
9079257|NCT01446250|10141921|FG003|COMPLETED|Treatment Period 1||0
9079258|NCT01446250|10141918|FG000|NOT COMPLETED|Treatment Period 1||0
9079259|NCT01446250|10141919|FG001|NOT COMPLETED|Treatment Period 1||1
9079260|NCT01446250|10141920|FG002|NOT COMPLETED|Treatment Period 1||0
8624333|NCT00499603|9663605|FG001|COMPLETED|Overall Study||22
8624334|NCT00499603|9663604|FG000|NOT COMPLETED|Overall Study||0
9079261|NCT01446250|10141921|FG003|NOT COMPLETED|Treatment Period 1||0
9079262|NCT01446250|10141918|FG000|STARTED|Clinical Hold||0
9079263|NCT01446250|10141919|FG001|STARTED|Clinical Hold||2
9079264|NCT01446250|10141920|FG002|STARTED|Clinical Hold||5
9079265|NCT01446250|10141921|FG003|STARTED|Clinical Hold||0
9079266|NCT01446250|10141918|FG000|COMPLETED|Clinical Hold||0
9079267|NCT01446250|10141919|FG001|COMPLETED|Clinical Hold||2
9079268|NCT01446250|10141920|FG002|COMPLETED|Clinical Hold||5
9079269|NCT01446250|10141921|FG003|COMPLETED|Clinical Hold||0
9079270|NCT01446250|10141918|FG000|NOT COMPLETED|Clinical Hold||0
9079271|NCT01446250|10141919|FG001|NOT COMPLETED|Clinical Hold||0
9079272|NCT01446250|10141920|FG002|NOT COMPLETED|Clinical Hold||0
9079273|NCT01446250|10141921|FG003|NOT COMPLETED|Clinical Hold||0
9079274|NCT01446250|10141918|FG000|STARTED|Treatment Period 2||0
9079275|NCT01446250|10141919|FG001|STARTED|Treatment Period 2||7
9079276|NCT01446250|10141920|FG002|STARTED|Treatment Period 2||0
9079277|NCT01446250|10141921|FG003|STARTED|Treatment Period 2||0
9079278|NCT01446250|10141918|FG000|COMPLETED|Treatment Period 2||0
9079279|NCT01446250|10141919|FG001|COMPLETED|Treatment Period 2||6
9079280|NCT01446250|10141920|FG002|COMPLETED|Treatment Period 2||0
9079281|NCT01446250|10141921|FG003|COMPLETED|Treatment Period 2||0
9079282|NCT01446250|10141918|FG000|NOT COMPLETED|Treatment Period 2||0
9079283|NCT01446250|10141919|FG001|NOT COMPLETED|Treatment Period 2||1
9079284|NCT01446250|10141920|FG002|NOT COMPLETED|Treatment Period 2||0
9079285|NCT01446250|10141921|FG003|NOT COMPLETED|Treatment Period 2||0
9079286|NCT01446250|10141918|FG000|STARTED|Follow-up||0
9079287|NCT01446250|10141919|FG001|STARTED|Follow-up||0
9079288|NCT01446250|10141920|FG002|STARTED|Follow-up||0
9079289|NCT01446250|10141921|FG003|STARTED|Follow-up||6
9079290|NCT01446250|10141918|FG000|COMPLETED|Follow-up||0
9079291|NCT01446250|10141919|FG001|COMPLETED|Follow-up||0
9079292|NCT01446250|10141920|FG002|COMPLETED|Follow-up||0
9079293|NCT01446250|10141921|FG003|COMPLETED|Follow-up||0
9079294|NCT01446250|10141918|FG000|NOT COMPLETED|Follow-up||0
9079295|NCT01446250|10141919|FG001|NOT COMPLETED|Follow-up||0
9079296|NCT01446250|10141920|FG002|NOT COMPLETED|Follow-up||0
9079297|NCT01446250|10141921|FG003|NOT COMPLETED|Follow-up||6
9079298|NCT01463293|10141932|FG000|STARTED|Overall Study||74
9079299|NCT01463293|10141933|FG001|STARTED|Overall Study||79
9079300|NCT01463293|10141934|FG002|STARTED|Overall Study||71
9079301|NCT01463293|10141932|FG000|COMPLETED|Overall Study||68
9079302|NCT01463293|10141933|FG001|COMPLETED|Overall Study||63
9079303|NCT01463293|10141934|FG002|COMPLETED|Overall Study||59
9079304|NCT01463293|10141932|FG000|NOT COMPLETED|Overall Study||6
9079305|NCT01463293|10141933|FG001|NOT COMPLETED|Overall Study||16
9079306|NCT01463293|10141934|FG002|NOT COMPLETED|Overall Study||12
9079307|NCT01457053|10141942|FG000|STARTED|Overall Study||2
9079308|NCT01457053|10141943|FG001|STARTED|Overall Study||2
9079309|NCT01457053|10141942|FG000|COMPLETED|Overall Study||1
9079310|NCT01457053|10141943|FG001|COMPLETED|Overall Study||1
9079311|NCT01457053|10141942|FG000|NOT COMPLETED|Overall Study||1
9079312|NCT01457053|10141943|FG001|NOT COMPLETED|Overall Study||1
9079313|NCT01451723|10141951|FG000|STARTED|Overall Study||6
9079314|NCT01451723|10141952|FG001|STARTED|Overall Study||5
9079315|NCT01451723|10141951|FG000|COMPLETED|Overall Study||0
9079316|NCT01451723|10141952|FG001|COMPLETED|Overall Study||0
9079317|NCT01451723|10141951|FG000|NOT COMPLETED|Overall Study||6
9079318|NCT01451723|10141952|FG001|NOT COMPLETED|Overall Study||5
9079319|NCT01452854|10141958|FG000|STARTED|Overall Study||2
9079320|NCT01452854|10141958|FG000|COMPLETED|Overall Study||2
9079321|NCT01452854|10141958|FG000|NOT COMPLETED|Overall Study||0
9079322|NCT01440517|10141962|FG000|STARTED|Overall Study||5
9079323|NCT01440517|10141962|FG000|COMPLETED|Overall Study||4
9079324|NCT01440517|10141962|FG000|NOT COMPLETED|Overall Study||1
9079325|NCT01440595|10141968|FG000|STARTED|Overall Study||1
9079326|NCT01440595|10141969|FG001|STARTED|Overall Study||3
9079327|NCT01440595|10141970|FG002|STARTED|Overall Study||1
9079328|NCT01440595|10141968|FG000|COMPLETED|Overall Study||0
9079329|NCT01440595|10141969|FG001|COMPLETED|Overall Study||0
9079330|NCT01440595|10141970|FG002|COMPLETED|Overall Study||0
9079331|NCT01440595|10141968|FG000|NOT COMPLETED|Overall Study||1
9079332|NCT01440595|10141969|FG001|NOT COMPLETED|Overall Study||3
9079333|NCT01440595|10141970|FG002|NOT COMPLETED|Overall Study||1
9079334|NCT01446796|10141976|FG000|STARTED|Overall Study||3
9079335|NCT01446796|10141977|FG001|STARTED|Overall Study||0
9079336|NCT01446796|10141976|FG000|COMPLETED|Overall Study|"Study terminated early~One subject of three withdrew prior to randomization and did not start"|2
9079337|NCT01446796|10141977|FG001|COMPLETED|Overall Study|Study terminated early|0
9079338|NCT01446796|10141976|FG000|NOT COMPLETED|Overall Study||1
9079339|NCT01446796|10141977|FG001|NOT COMPLETED|Overall Study||0
9079340|NCT01443923|10141987|FG000|STARTED|Overall Study||3
9079341|NCT01443923|10141988|FG001|STARTED|Overall Study||1
9079342|NCT01443923|10141987|FG000|COMPLETED|Overall Study||2
9079343|NCT01443923|10141988|FG001|COMPLETED|Overall Study||1
9079344|NCT01443923|10141987|FG000|NOT COMPLETED|Overall Study||1
9079345|NCT01443923|10141988|FG001|NOT COMPLETED|Overall Study||0
9079346|NCT01439347|10141996|FG000|STARTED|Overall Study||13
9079347|NCT01439347|10141997|FG001|STARTED|Overall Study||13
9079348|NCT01439347|10141996|FG000|COMPLETED|Overall Study||0
9079349|NCT01439347|10141997|FG001|COMPLETED|Overall Study||0
9079350|NCT01439347|10141996|FG000|NOT COMPLETED|Overall Study||13
9079351|NCT01439347|10141997|FG001|NOT COMPLETED|Overall Study||13
9079352|NCT01440452|10142007|FG000|STARTED|Overall Study||6
9079353|NCT01440452|10142008|FG001|STARTED|Overall Study||7
9079354|NCT01440452|10142009|FG002|STARTED|Overall Study||8
9079355|NCT01440452|10142010|FG003|STARTED|Overall Study||4
9079356|NCT01440452|10142007|FG000|COMPLETED|Overall Study||6
9079357|NCT01440452|10142008|FG001|COMPLETED|Overall Study||7
8844640|NCT01710787|9899067|FG002|COMPLETED|Overall Study||22
8844641|NCT01710787|9899065|FG000|NOT COMPLETED|Overall Study||0
8844642|NCT01710787|9899066|FG001|NOT COMPLETED|Overall Study||0
8844643|NCT01710787|9899067|FG002|NOT COMPLETED|Overall Study||0
8844644|NCT01710800|9899075|FG000|STARTED|Overall Study|63 patients consented to be part of the study|63
9079358|NCT01440452|10142009|FG002|COMPLETED|Overall Study||8
9079359|NCT01440452|10142010|FG003|COMPLETED|Overall Study||4
9079360|NCT01440452|10142007|FG000|NOT COMPLETED|Overall Study||0
9079361|NCT01440452|10142008|FG001|NOT COMPLETED|Overall Study||0
9079362|NCT01440452|10142009|FG002|NOT COMPLETED|Overall Study||0
9079363|NCT01440452|10142010|FG003|NOT COMPLETED|Overall Study||0
9079364|NCT01433471|10142022|FG000|STARTED|Overall Study||2
9079365|NCT01433471|10142023|FG001|STARTED|Overall Study||2
9079366|NCT01433471|10142022|FG000|COMPLETED|Overall Study||2
9079367|NCT01433471|10142023|FG001|COMPLETED|Overall Study||1
9079368|NCT01433471|10142022|FG000|NOT COMPLETED|Overall Study||0
9079369|NCT01433471|10142023|FG001|NOT COMPLETED|Overall Study||1
9079370|NCT01436084|10142031|FG000|STARTED|Overall Study||4
9079371|NCT01436084|10142031|FG000|COMPLETED|Overall Study||0
9079372|NCT01436084|10142031|FG000|NOT COMPLETED|Overall Study||4
9079373|NCT01434511|10142035|FG000|STARTED|Overall Study||1
9079374|NCT01434511|10142035|FG000|COMPLETED|Overall Study||1
9079375|NCT01434511|10142035|FG000|NOT COMPLETED|Overall Study||0
9079376|NCT01426555|10142041|FG000|STARTED|Overall Study||35
9079377|NCT01426555|10142042|FG001|STARTED|Overall Study||35
9079378|NCT01426555|10142041|FG000|COMPLETED|Overall Study||17
9079379|NCT01426555|10142042|FG001|COMPLETED|Overall Study||20
9079380|NCT01426555|10142041|FG000|NOT COMPLETED|Overall Study||18
9079381|NCT01426555|10142042|FG001|NOT COMPLETED|Overall Study||15
9079382|NCT01434745|10142052|FG000|STARTED|Overall Study||0
9079383|NCT01434745|10142053|FG001|STARTED|Overall Study||0
9079384|NCT01434745|10142052|FG000|COMPLETED|Overall Study||0
9079385|NCT01434745|10142053|FG001|COMPLETED|Overall Study||0
9079386|NCT01434745|10142052|FG000|NOT COMPLETED|Overall Study||0
9079387|NCT01434745|10142053|FG001|NOT COMPLETED|Overall Study||0
9079388|NCT01415986|10142059|FG000|STARTED|Overall Study||1
9079389|NCT01415986|10142059|FG000|COMPLETED|Overall Study|Study terminated|0
9079390|NCT01415986|10142059|FG000|NOT COMPLETED|Overall Study||1
9079391|NCT01410799|10142064|FG000|STARTED|Overall Study||13
9079392|NCT01410799|10142064|FG000|COMPLETED|Overall Study||0
9079393|NCT01410799|10142064|FG000|NOT COMPLETED|Overall Study||13
9079394|NCT01426113|10142070|FG000|STARTED|Overall Study||3
9079395|NCT01426113|10142071|FG001|STARTED|Overall Study||3
9079396|NCT01426113|10142070|FG000|COMPLETED|Overall Study||2
9079397|NCT01426113|10142071|FG001|COMPLETED|Overall Study||1
9079398|NCT01426113|10142070|FG000|NOT COMPLETED|Overall Study||1
9079399|NCT01426113|10142071|FG001|NOT COMPLETED|Overall Study||2
9079400|NCT01426516|10142079|FG000|STARTED|Overall Study||12
9079401|NCT01426516|10142080|FG001|STARTED|Overall Study||17
9079402|NCT01426516|10142079|FG000|COMPLETED|Overall Study||12
9079403|NCT01426516|10142080|FG001|COMPLETED|Overall Study||17
9079404|NCT01426516|10142079|FG000|NOT COMPLETED|Overall Study||0
9079405|NCT01426516|10142080|FG001|NOT COMPLETED|Overall Study||0
9079406|NCT01420965|10142089|FG000|STARTED|Overall Study||2
9079407|NCT01420965|10142090|FG001|STARTED|Overall Study||2
9079408|NCT01420965|10142091|FG002|STARTED|Overall Study||3
9079409|NCT01420965|10142089|FG000|COMPLETED|Overall Study||1
9079410|NCT01420965|10142090|FG001|COMPLETED|Overall Study||1
9079411|NCT01420965|10142091|FG002|COMPLETED|Overall Study||3
9079412|NCT01420965|10142089|FG000|NOT COMPLETED|Overall Study||1
9079413|NCT01420965|10142090|FG001|NOT COMPLETED|Overall Study||1
9079414|NCT01420965|10142091|FG002|NOT COMPLETED|Overall Study||0
9079415|NCT01417377|10142099|FG000|STARTED|Overall Study||22
9079416|NCT01417377|10142099|FG000|Treated|Overall Study||21
9079417|NCT01417377|10142099|FG000|COMPLETED|Overall Study||9
9079418|NCT01417377|10142099|FG000|NOT COMPLETED|Overall Study||13
9079419|NCT01416272|10142103|FG000|STARTED|Overall Study||12
9079420|NCT01416272|10142103|FG000|COMPLETED|Overall Study||8
9079421|NCT01416272|10142103|FG000|NOT COMPLETED|Overall Study||4
9079422|NCT01414166|10142109|FG000|STARTED|Overall Study||122
9079423|NCT01414166|10142110|FG001|STARTED|Overall Study||122
9079424|NCT01414166|10142109|FG000|Treated|Overall Study||120
9079425|NCT01414166|10142110|FG001|Treated|Overall Study||121
9079426|NCT01414166|10142109|FG000|COMPLETED|Overall Study||31
9079427|NCT01414166|10142110|FG001|COMPLETED|Overall Study||39
9079428|NCT01414166|10142109|FG000|NOT COMPLETED|Overall Study||91
9079429|NCT01414166|10142110|FG001|NOT COMPLETED|Overall Study||83
9079430|NCT01406860|10142118|FG000|STARTED|Overall Study||11
8844645|NCT01710800|9899075|FG000|Received PPI Intervention|Overall Study||44
8844646|NCT01710800|9899075|FG000|Received Placebo Intervention|Overall Study||45
9079431|NCT01406860|10142119|FG001|STARTED|Overall Study||8
9079432|NCT01406860|10142118|FG000|COMPLETED|Overall Study||11
9079433|NCT01406860|10142119|FG001|COMPLETED|Overall Study||8
9079434|NCT01406860|10142118|FG000|NOT COMPLETED|Overall Study||0
9079435|NCT01406860|10142119|FG001|NOT COMPLETED|Overall Study||0
9079436|NCT01401049|10142128|FG000|STARTED|Overall Study|Due to flooding from Hurricane Sandy at our site, all files and pertinent patient data were lost.|0
9079437|NCT01401049|10142129|FG001|STARTED|Overall Study|Due to flooding from Hurricane Sandy at our site, all files and pertinent patient data were lost.|0
9079438|NCT01401049|10142128|FG000|COMPLETED|Overall Study||0
9079439|NCT01401049|10142129|FG001|COMPLETED|Overall Study||0
9079440|NCT01401049|10142128|FG000|NOT COMPLETED|Overall Study||0
9079441|NCT01401049|10142129|FG001|NOT COMPLETED|Overall Study||0
9079442|NCT01409031|10142137|FG000|STARTED|Overall Study||1
9079443|NCT01409031|10142138|FG001|STARTED|Overall Study||2
9079444|NCT01409031|10142137|FG000|COMPLETED|Overall Study||0
9079445|NCT01409031|10142138|FG001|COMPLETED|Overall Study||2
9079446|NCT01409031|10142137|FG000|NOT COMPLETED|Overall Study||1
9079447|NCT01409031|10142138|FG001|NOT COMPLETED|Overall Study||0
9079448|NCT01402531|10142144|FG000|STARTED|Overall Study||0
9079449|NCT01402531|10142144|FG000|COMPLETED|Overall Study||0
9079450|NCT01402531|10142144|FG000|NOT COMPLETED|Overall Study||0
9079451|NCT01394926|10142148|FG000|STARTED|Overall Study||21
9079452|NCT01394926|10142148|FG000|COMPLETED|Overall Study||21
9079453|NCT01394926|10142148|FG000|NOT COMPLETED|Overall Study||0
9079454|NCT01383681|10142157|FG000|STARTED|Overall Study||235
9079455|NCT01383681|10142157|FG000|COMPLETED|Overall Study||189
9079456|NCT01383681|10142157|FG000|NOT COMPLETED|Overall Study||46
9079457|NCT01403194|10142161|FG000|STARTED|Overall Study||11
9079458|NCT01403194|10142161|FG000|COMPLETED|Overall Study||1
9079459|NCT01403194|10142161|FG000|NOT COMPLETED|Overall Study||10
9079460|NCT01397552|10142167|FG000|STARTED|Overall Study||4
9079461|NCT01397552|10142168|FG001|STARTED|Overall Study||4
9079462|NCT01397552|10142167|FG000|COMPLETED|Overall Study||1
9079463|NCT01397552|10142168|FG001|COMPLETED|Overall Study||3
9079464|NCT01397552|10142167|FG000|NOT COMPLETED|Overall Study||3
9079465|NCT01397552|10142168|FG001|NOT COMPLETED|Overall Study||1
9079466|NCT01392170|10142174|FG000|STARTED|Overall Study||2
9079467|NCT01392170|10142174|FG000|COMPLETED|Overall Study||0
9079468|NCT01392170|10142174|FG000|NOT COMPLETED|Overall Study||2
9079469|NCT01389817|10142180|FG000|STARTED|Overall Study||4
9079470|NCT01389817|10142181|FG001|STARTED|Overall Study||0
9079471|NCT01389817|10142180|FG000|COMPLETED|Overall Study||0
9079472|NCT01389817|10142181|FG001|COMPLETED|Overall Study||0
9079473|NCT01389817|10142180|FG000|NOT COMPLETED|Overall Study||4
9079474|NCT01389817|10142181|FG001|NOT COMPLETED|Overall Study||0
9079475|NCT01397695|10142187|FG000|STARTED|Overall Study||0
9079476|NCT01397695|10142187|FG000|COMPLETED|Overall Study||0
9079477|NCT01397695|10142187|FG000|NOT COMPLETED|Overall Study||0
9079478|NCT01390181|10142191|FG000|STARTED|Overall Study||4
9079479|NCT01390181|10142191|FG000|COMPLETED|Overall Study||0
9079480|NCT01390181|10142191|FG000|NOT COMPLETED|Overall Study||4
9079481|NCT01385033|10142197|FG000|STARTED|Part I|These subjects did not participate in Part II or III|6
9079482|NCT01385033|10142198|FG001|STARTED|Part I|These subjects did not participate in Part II or III|14
9079483|NCT01385033|10142199|FG002|STARTED|Part I||0
9079484|NCT01385033|10142200|FG003|STARTED|Part I||0
9079485|NCT01385033|10142201|FG004|STARTED|Part I||0
9079486|NCT01385033|10142202|FG005|STARTED|Part I||0
9079487|NCT01385033|10142197|FG000|COMPLETED|Part I||6
9079488|NCT01385033|10142198|FG001|COMPLETED|Part I||14
9079489|NCT01385033|10142199|FG002|COMPLETED|Part I||0
9079490|NCT01385033|10142200|FG003|COMPLETED|Part I||0
9079491|NCT01385033|10142201|FG004|COMPLETED|Part I||0
9079492|NCT01385033|10142202|FG005|COMPLETED|Part I||0
9079493|NCT01385033|10142197|FG000|NOT COMPLETED|Part I||0
9079494|NCT01385033|10142198|FG001|NOT COMPLETED|Part I||0
9079495|NCT01385033|10142199|FG002|NOT COMPLETED|Part I||0
9079496|NCT01385033|10142200|FG003|NOT COMPLETED|Part I||0
9079497|NCT01385033|10142201|FG004|NOT COMPLETED|Part I||0
9079498|NCT01385033|10142202|FG005|NOT COMPLETED|Part I||0
9079499|NCT01385033|10142197|FG000|STARTED|Part II||0
9079500|NCT01385033|10142198|FG001|STARTED|Part II||0
9079501|NCT01385033|10142199|FG002|STARTED|Part II||0
9079502|NCT01385033|10142200|FG003|STARTED|Part II||0
9079503|NCT01385033|10142201|FG004|STARTED|Part II||0
9079504|NCT01385033|10142202|FG005|STARTED|Part II||0
9079505|NCT01385033|10142197|FG000|COMPLETED|Part II||0
9079506|NCT01385033|10142198|FG001|COMPLETED|Part II||0
9079507|NCT01385033|10142199|FG002|COMPLETED|Part II||0
9079508|NCT01385033|10142200|FG003|COMPLETED|Part II||0
9079509|NCT01385033|10142201|FG004|COMPLETED|Part II||0
9079510|NCT01385033|10142202|FG005|COMPLETED|Part II||0
9079511|NCT01385033|10142197|FG000|NOT COMPLETED|Part II||0
9079512|NCT01385033|10142198|FG001|NOT COMPLETED|Part II||0
8624335|NCT00499603|9663605|FG001|NOT COMPLETED|Overall Study||1
8624336|NCT00499616|9663617|FG000|STARTED|Overall Study||176
9079513|NCT01385033|10142199|FG002|NOT COMPLETED|Part II||0
9079514|NCT01385033|10142200|FG003|NOT COMPLETED|Part II||0
9079515|NCT01385033|10142201|FG004|NOT COMPLETED|Part II||0
9079516|NCT01385033|10142202|FG005|NOT COMPLETED|Part II||0
9079517|NCT01385033|10142197|FG000|STARTED|Part III||0
9079518|NCT01385033|10142198|FG001|STARTED|Part III||0
9079519|NCT01385033|10142199|FG002|STARTED|Part III||0
9079520|NCT01385033|10142200|FG003|STARTED|Part III||0
9079521|NCT01385033|10142201|FG004|STARTED|Part III||0
9079522|NCT01385033|10142202|FG005|STARTED|Part III||0
9079523|NCT01385033|10142197|FG000|COMPLETED|Part III||0
9079524|NCT01385033|10142198|FG001|COMPLETED|Part III||0
9079525|NCT01385033|10142199|FG002|COMPLETED|Part III||0
9079526|NCT01385033|10142200|FG003|COMPLETED|Part III||0
9079527|NCT01385033|10142201|FG004|COMPLETED|Part III||0
9079528|NCT01385033|10142202|FG005|COMPLETED|Part III||0
9079529|NCT01385033|10142197|FG000|NOT COMPLETED|Part III||0
9079530|NCT01385033|10142198|FG001|NOT COMPLETED|Part III||0
9079531|NCT01385033|10142199|FG002|NOT COMPLETED|Part III||0
9079532|NCT01385033|10142200|FG003|NOT COMPLETED|Part III||0
9079533|NCT01385033|10142201|FG004|NOT COMPLETED|Part III||0
9079534|NCT01385033|10142202|FG005|NOT COMPLETED|Part III||0
9079535|NCT01394211|10142209|FG000|STARTED|Overall Study||2
9079536|NCT01394211|10142209|FG000|COMPLETED|Overall Study||0
9079537|NCT01394211|10142209|FG000|NOT COMPLETED|Overall Study||2
9079538|NCT01377441|10142215|FG000|STARTED|Overall Study||0
9079539|NCT01377441|10142216|FG001|STARTED|Overall Study||0
9079540|NCT01377441|10142215|FG000|COMPLETED|Overall Study|All data for this study was lost after Hurricane Sandy.|0
9079541|NCT01377441|10142216|FG001|COMPLETED|Overall Study|All data for this study was lost after Hurricane Sandy.|0
9079542|NCT01377441|10142215|FG000|NOT COMPLETED|Overall Study||0
9079543|NCT01377441|10142216|FG001|NOT COMPLETED|Overall Study||0
9079544|NCT01383447|10142222|FG000|STARTED|Overall Study||2
9079545|NCT01383447|10142222|FG000|COMPLETED|Overall Study||0
9079546|NCT01383447|10142222|FG000|NOT COMPLETED|Overall Study||2
9079547|NCT01372618|10142226|FG000|STARTED|Overall Study||9
9079548|NCT01372618|10142226|FG000|COMPLETED|Overall Study||0
9079549|NCT01372618|10142226|FG000|NOT COMPLETED|Overall Study||9
9079550|NCT01385280|10142230|FG000|STARTED|Overall Study||13
9079551|NCT01385280|10142230|FG000|COMPLETED|Overall Study||13
9079552|NCT01385280|10142230|FG000|NOT COMPLETED|Overall Study||0
9079553|NCT01379274|10142234|FG000|STARTED|Overall Study||2
9079554|NCT01379274|10142234|FG000|COMPLETED|Overall Study||1
9079555|NCT01379274|10142234|FG000|NOT COMPLETED|Overall Study||1
9079556|NCT01379469|10142240|FG000|STARTED|Overall Study||13
9079557|NCT01379469|10142241|FG001|STARTED|Overall Study||7
9079558|NCT01379469|10142240|FG000|COMPLETED|Overall Study||1
8624337|NCT00499616|9663618|FG001|STARTED|Overall Study||142
8624338|NCT00499616|9663619|FG002|STARTED|Overall Study||89
8624339|NCT00499616|9663620|FG003|STARTED|Overall Study||57
8624340|NCT00499616|9663617|FG000|COMPLETED|Overall Study||161
8624341|NCT00499616|9663618|FG001|COMPLETED|Overall Study||114
8624342|NCT00499616|9663619|FG002|COMPLETED|Overall Study||53
8624343|NCT00499616|9663620|FG003|COMPLETED|Overall Study||0
8624344|NCT00499616|9663617|FG000|NOT COMPLETED|Overall Study||15
8624345|NCT00499616|9663618|FG001|NOT COMPLETED|Overall Study||28
8624346|NCT00499616|9663619|FG002|NOT COMPLETED|Overall Study||36
8624347|NCT00499616|9663620|FG003|NOT COMPLETED|Overall Study||57
8624348|NCT00499655|9663635|FG000|STARTED|Overall Study||53
8624349|NCT00499655|9663636|FG001|STARTED|Overall Study||54
8624350|NCT00499655|9663635|FG000|COMPLETED|Overall Study||53
8624351|NCT00499655|9663636|FG001|COMPLETED|Overall Study||54
8624352|NCT00499655|9663635|FG000|NOT COMPLETED|Overall Study||0
8624353|NCT00499655|9663636|FG001|NOT COMPLETED|Overall Study||0
8624354|NCT00499681|9663645|FG000|STARTED|Overall Study||4
8624355|NCT00499681|9663646|FG001|STARTED|Overall Study||2
8624356|NCT00499681|9663645|FG000|COMPLETED|Overall Study||4
8624357|NCT00499681|9663646|FG001|COMPLETED|Overall Study||0
9079559|NCT01379469|10142241|FG001|COMPLETED|Overall Study||3
9079560|NCT01379469|10142240|FG000|NOT COMPLETED|Overall Study||12
9079561|NCT01379469|10142241|FG001|NOT COMPLETED|Overall Study||4
9079562|NCT01369641|10142247|FG000|STARTED|Overall Study||1
9079563|NCT01369641|10142247|FG000|COMPLETED|Overall Study||0
9079564|NCT01369641|10142247|FG000|NOT COMPLETED|Overall Study||1
9079565|NCT01365156|10142253|FG000|STARTED|Overall Study||14
9079566|NCT01365156|10142254|FG001|STARTED|Overall Study||14
9079567|NCT01365156|10142253|FG000|COMPLETED|Overall Study||14
9079568|NCT01365156|10142254|FG001|COMPLETED|Overall Study||14
9079569|NCT01365156|10142253|FG000|NOT COMPLETED|Overall Study||0
9079570|NCT01365156|10142254|FG001|NOT COMPLETED|Overall Study||0
9079571|NCT01359254|10142262|FG000|STARTED|Overall Study||1
9079572|NCT01359254|10142263|FG001|STARTED|Overall Study||0
9079573|NCT01359254|10142262|FG000|COMPLETED|Overall Study||0
9079574|NCT01359254|10142263|FG001|COMPLETED|Overall Study||0
9079575|NCT01359254|10142262|FG000|NOT COMPLETED|Overall Study||1
9079576|NCT01359254|10142263|FG001|NOT COMPLETED|Overall Study||0
9079577|NCT01347632|10142269|FG000|STARTED|Overall Study||35
9079578|NCT01347632|10142269|FG000|COMPLETED|Overall Study||33
9079579|NCT01347632|10142269|FG000|NOT COMPLETED|Overall Study||2
9079580|NCT01356667|10142275|FG000|STARTED|Overall Study||4
9079581|NCT01356667|10142276|FG001|STARTED|Overall Study||6
9079582|NCT01356667|10142275|FG000|COMPLETED|Overall Study||0
9079583|NCT01356667|10142276|FG001|COMPLETED|Overall Study||0
9079584|NCT01356667|10142275|FG000|NOT COMPLETED|Overall Study||4
9079585|NCT01356667|10142276|FG001|NOT COMPLETED|Overall Study||6
9079586|NCT01354951|10142284|FG000|STARTED|Overall Study||3
9079587|NCT01354951|10142284|FG000|COMPLETED|Overall Study||1
9079588|NCT01354951|10142284|FG000|NOT COMPLETED|Overall Study||2
9079589|NCT01350232|10142288|FG000|STARTED|Overall Study||2
9079590|NCT01350232|10142288|FG000|COMPLETED|Overall Study||2
9079591|NCT01350232|10142288|FG000|NOT COMPLETED|Overall Study||0
9079592|NCT01350583|10142292|FG000|STARTED|Overall Study||2
9079593|NCT01350583|10142292|FG000|COMPLETED|Overall Study||2
9079594|NCT01350583|10142292|FG000|NOT COMPLETED|Overall Study||0
9079595|NCT01352416|10142300|FG000|STARTED|Overall Study||4
9079596|NCT01352416|10142301|FG001|STARTED|Overall Study||7
9079597|NCT01352416|10142302|FG002|STARTED|Overall Study||2
9079598|NCT01352416|10142303|FG003|STARTED|Overall Study||2
9079599|NCT01352416|10142300|FG000|COMPLETED|Overall Study||3
9079600|NCT01352416|10142301|FG001|COMPLETED|Overall Study||5
9079601|NCT01352416|10142302|FG002|COMPLETED|Overall Study||0
9079602|NCT01352416|10142303|FG003|COMPLETED|Overall Study||1
9079603|NCT01352416|10142300|FG000|NOT COMPLETED|Overall Study||1
9079604|NCT01352416|10142301|FG001|NOT COMPLETED|Overall Study||2
9079605|NCT01352416|10142302|FG002|NOT COMPLETED|Overall Study||2
8624358|NCT00499681|9663645|FG000|NOT COMPLETED|Overall Study||0
8624359|NCT00499681|9663646|FG001|NOT COMPLETED|Overall Study||2
8624360|NCT00499694|9663652|FG000|STARTED|Overall Study||31
8624361|NCT00499694|9663652|FG000|COMPLETED|Overall Study||30
8624362|NCT00499694|9663652|FG000|NOT COMPLETED|Overall Study||1
9079606|NCT01352416|10142303|FG003|NOT COMPLETED|Overall Study||1
9079607|NCT01350258|10142313|FG000|STARTED|Overall Study||8
9079608|NCT01350258|10142313|FG000|COMPLETED|Overall Study||8
9079609|NCT01350258|10142313|FG000|NOT COMPLETED|Overall Study||0
9079610|NCT01349595|10142319|FG000|STARTED|Overall Study||2
9079611|NCT01349595|10142320|FG001|STARTED|Overall Study||2
8624363|NCT00499746|9663657|FG000|STARTED|Phase 1(6-9 One Day Sessions)||20
9079612|NCT01349595|10142319|FG000|COMPLETED|Overall Study||0
9079613|NCT01349595|10142320|FG001|COMPLETED|Overall Study||0
9079614|NCT01349595|10142319|FG000|NOT COMPLETED|Overall Study||2
9079615|NCT01349595|10142320|FG001|NOT COMPLETED|Overall Study||2
9079616|NCT01337609|10142329|FG000|STARTED|Overall Study||1
9079617|NCT01337609|10142330|FG001|STARTED|Overall Study||2
9079618|NCT01337609|10142331|FG002|STARTED|Overall Study||2
9079619|NCT01337609|10142329|FG000|COMPLETED|Overall Study||0
9079620|NCT01337609|10142330|FG001|COMPLETED|Overall Study||2
9079621|NCT01337609|10142331|FG002|COMPLETED|Overall Study||2
9079622|NCT01337609|10142329|FG000|NOT COMPLETED|Overall Study||1
9079623|NCT01337609|10142330|FG001|NOT COMPLETED|Overall Study||0
9079624|NCT01337609|10142331|FG002|NOT COMPLETED|Overall Study||0
9079625|NCT01347840|10142339|FG000|STARTED|Overall Study|1 subject enrolled but withdrew consent|1
9079626|NCT01347840|10142339|FG000|COMPLETED|Overall Study||0
9079627|NCT01347840|10142339|FG000|NOT COMPLETED|Overall Study||1
9079628|NCT01340573|10142343|FG000|STARTED|Overall Study||3
9079629|NCT01340573|10142343|FG000|COMPLETED|Overall Study||0
9079630|NCT01340573|10142343|FG000|NOT COMPLETED|Overall Study||3
9079631|NCT01335997|10142350|FG000|STARTED|Period I and II||577
9079632|NCT01335997|10142351|FG001|STARTED|Period I and II||562
9079633|NCT01335997|10142350|FG000|COMPLETED|Period I and II||84
9079634|NCT01335997|10142351|FG001|COMPLETED|Period I and II||83
9079635|NCT01335997|10142350|FG000|NOT COMPLETED|Period I and II||493
9079636|NCT01335997|10142351|FG001|NOT COMPLETED|Period I and II||479
9079637|NCT01335997|10142350|FG000|STARTED|Period III||84
9079638|NCT01335997|10142351|FG001|STARTED|Period III||83
9079639|NCT01335997|10142350|FG000|COMPLETED|Period III||6
9079640|NCT01335997|10142351|FG001|COMPLETED|Period III||4
9079641|NCT01335997|10142350|FG000|NOT COMPLETED|Period III||78
8624364|NCT00499746|9663657|FG000|COMPLETED|Phase 1(6-9 One Day Sessions)||8
8624365|NCT00499746|9663657|FG000|NOT COMPLETED|Phase 1(6-9 One Day Sessions)||12
8624366|NCT00499746|9663657|FG000|STARTED|Phase 2 (6-9 One Day Sessions)||8
8624367|NCT00499746|9663657|FG000|COMPLETED|Phase 2 (6-9 One Day Sessions)||8
8624368|NCT00499746|9663657|FG000|NOT COMPLETED|Phase 2 (6-9 One Day Sessions)||0
8624369|NCT00499746|9663657|FG000|STARTED|Phase 3 (9-14 One Day Sessions)||8
8624370|NCT00499746|9663657|FG000|COMPLETED|Phase 3 (9-14 One Day Sessions)||8
9079642|NCT01335997|10142351|FG001|NOT COMPLETED|Period III||79
9079643|NCT01340885|10142362|FG000|STARTED|Overall Study||0
9079644|NCT01340885|10142363|FG001|STARTED|Overall Study||0
9079645|NCT01340885|10142364|FG002|STARTED|Overall Study||0
9079646|NCT01340885|10142362|FG000|COMPLETED|Overall Study||0
9079647|NCT01340885|10142363|FG001|COMPLETED|Overall Study||0
9079648|NCT01340885|10142364|FG002|COMPLETED|Overall Study||0
9079649|NCT01340885|10142362|FG000|NOT COMPLETED|Overall Study||0
9079650|NCT01340885|10142363|FG001|NOT COMPLETED|Overall Study||0
9079651|NCT01340885|10142364|FG002|NOT COMPLETED|Overall Study||0
9079652|NCT01341587|10142374|FG000|STARTED|Overall Study||4
9079653|NCT01341587|10142375|FG001|STARTED|Overall Study||10
9079654|NCT01341587|10142374|FG000|COMPLETED|Overall Study||0
9079655|NCT01341587|10142375|FG001|COMPLETED|Overall Study||0
9079656|NCT01341587|10142374|FG000|NOT COMPLETED|Overall Study||4
9079657|NCT01341587|10142375|FG001|NOT COMPLETED|Overall Study||10
9079658|NCT01326923|10142381|FG000|STARTED|Overall Study||7
9079659|NCT01326923|10142381|FG000|COMPLETED|Overall Study||7
9079660|NCT01326923|10142381|FG000|NOT COMPLETED|Overall Study||0
9079661|NCT01332799|10142387|FG000|STARTED|Overall Study||10
9079662|NCT01332799|10142388|FG001|STARTED|Overall Study||10
9079663|NCT01332799|10142387|FG000|COMPLETED|Overall Study||0
9079664|NCT01332799|10142388|FG001|COMPLETED|Overall Study||0
9079665|NCT01332799|10142387|FG000|NOT COMPLETED|Overall Study||10
9079666|NCT01332799|10142388|FG001|NOT COMPLETED|Overall Study||10
9079667|NCT01329549|10142394|FG000|STARTED|Overall Study||2
9079668|NCT01329549|10142394|FG000|COMPLETED|Overall Study||0
9079669|NCT01329549|10142394|FG000|NOT COMPLETED|Overall Study||2
9079670|NCT01326845|10142400|FG000|STARTED|Overall Study||7
9079671|NCT01326845|10142401|FG001|STARTED|Overall Study||5
9079672|NCT01326845|10142400|FG000|COMPLETED|Overall Study|Study terminated early|0
9079673|NCT01326845|10142401|FG001|COMPLETED|Overall Study|Study terminated early|0
9079674|NCT01326845|10142400|FG000|NOT COMPLETED|Overall Study||7
9079675|NCT01326845|10142401|FG001|NOT COMPLETED|Overall Study||5
9079676|NCT01329341|10142407|FG000|STARTED|Overall Study||60
9079677|NCT01329341|10142407|FG000|COMPLETED|Overall Study||16
9079678|NCT01329341|10142407|FG000|NOT COMPLETED|Overall Study||44
9079679|NCT01319760|10142413|FG000|STARTED|Overall Study|The study experienced a very low enrollment rate. the sponsor decided to stop the study.|0
8629505|NCT00530764|9669252|FG002|NOT COMPLETED|Overall Study||20
9079680|NCT01319760|10142414|FG001|STARTED|Overall Study||5
9079681|NCT01319760|10142413|FG000|COMPLETED|Overall Study|The study experienced a very low enrollment rate. the sponsor decided to stop the study.|0
9079682|NCT01319760|10142414|FG001|COMPLETED|Overall Study||5
9079683|NCT01319760|10142413|FG000|NOT COMPLETED|Overall Study||0
9079684|NCT01319760|10142414|FG001|NOT COMPLETED|Overall Study||0
9079685|NCT01320683|10142420|FG000|STARTED|Overall Study||1
9079686|NCT01320683|10142420|FG000|COMPLETED|Overall Study||0
9079687|NCT01320683|10142420|FG000|NOT COMPLETED|Overall Study||1
9079688|NCT01313273|10142426|FG000|STARTED|Overall Study||2
9079689|NCT01313273|10142427|FG001|STARTED|Overall Study||1
9079690|NCT01313273|10142426|FG000|COMPLETED|Overall Study||0
9079691|NCT01313273|10142427|FG001|COMPLETED|Overall Study||0
9079692|NCT01313273|10142426|FG000|NOT COMPLETED|Overall Study||2
9079693|NCT01313273|10142427|FG001|NOT COMPLETED|Overall Study||1
9079694|NCT01321008|10142433|FG000|STARTED|Overall Study||1
9079695|NCT01321008|10142433|FG000|COMPLETED|Overall Study||0
9079696|NCT01321008|10142433|FG000|NOT COMPLETED|Overall Study||1
9079697|NCT01310803|10142439|FG000|STARTED|Overall Study||1
9079698|NCT01310803|10142440|FG001|STARTED|Overall Study||0
9079699|NCT01310803|10142439|FG000|COMPLETED|Overall Study||0
9079700|NCT01310803|10142440|FG001|COMPLETED|Overall Study||0
9079701|NCT01310803|10142439|FG000|NOT COMPLETED|Overall Study||1
9079702|NCT01310803|10142440|FG001|NOT COMPLETED|Overall Study||0
9079703|NCT01309581|10142448|FG000|STARTED|Overall Study||2
9079704|NCT01309581|10142449|FG001|STARTED|Overall Study||1
9079705|NCT01309581|10142448|FG000|COMPLETED|Overall Study||2
9079706|NCT01309581|10142449|FG001|COMPLETED|Overall Study||1
9079707|NCT01309581|10142448|FG000|NOT COMPLETED|Overall Study||0
9079708|NCT01309581|10142449|FG001|NOT COMPLETED|Overall Study||0
9079709|NCT01315873|10142455|FG000|STARTED|Overall Study||24
9079710|NCT01315873|10142455|FG000|COMPLETED|Overall Study||24
9079711|NCT01315873|10142455|FG000|NOT COMPLETED|Overall Study||0
9079712|NCT01313923|10142459|FG000|STARTED|Overall Study||3
9079713|NCT01313923|10142459|FG000|COMPLETED|Overall Study||0
9079714|NCT01313923|10142459|FG000|NOT COMPLETED|Overall Study||3
9079715|NCT01321697|10142463|FG000|STARTED|Overall Study||7
9079716|NCT01321697|10142463|FG000|COMPLETED|Overall Study||0
9079717|NCT01321697|10142463|FG000|NOT COMPLETED|Overall Study||7
9079718|NCT01312428|10142469|FG000|STARTED|Overall Study||3
9079719|NCT01312428|10142470|FG001|STARTED|Overall Study||4
9079720|NCT01312428|10142469|FG000|COMPLETED|Overall Study||0
9079721|NCT01312428|10142470|FG001|COMPLETED|Overall Study||0
9079722|NCT01312428|10142469|FG000|NOT COMPLETED|Overall Study||3
9079723|NCT01312428|10142470|FG001|NOT COMPLETED|Overall Study||4
9079724|NCT01313416|10142478|FG000|STARTED|Overall Study||2
8624371|NCT00499746|9663657|FG000|NOT COMPLETED|Phase 3 (9-14 One Day Sessions)||0
8624372|NCT00499863|9663673|FG000|STARTED|Overall Study||145
9079725|NCT01313416|10142478|FG000|COMPLETED|Overall Study||2
9079726|NCT01313416|10142478|FG000|NOT COMPLETED|Overall Study||0
9079727|NCT01303003|10142484|FG000|STARTED|Overall Study||0
9079728|NCT01303003|10142485|FG001|STARTED|Overall Study||0
9079729|NCT01303003|10142484|FG000|COMPLETED|Overall Study||0
9079730|NCT01303003|10142485|FG001|COMPLETED|Overall Study||0
9079731|NCT01303003|10142484|FG000|NOT COMPLETED|Overall Study||0
9079732|NCT01303003|10142485|FG001|NOT COMPLETED|Overall Study||0
9079733|NCT01302444|10142493|FG000|STARTED|Overall Study||1
9079734|NCT01302444|10142494|FG001|STARTED|Overall Study||0
9079735|NCT01302444|10142493|FG000|COMPLETED|Overall Study||1
9079736|NCT01302444|10142494|FG001|COMPLETED|Overall Study||0
9079737|NCT01302444|10142493|FG000|NOT COMPLETED|Overall Study||0
9079738|NCT01302444|10142494|FG001|NOT COMPLETED|Overall Study||0
9079739|NCT01301963|10142502|FG000|STARTED|Overall Study||5
9079740|NCT01301963|10142503|FG001|STARTED|Overall Study||4
9079741|NCT01301963|10142502|FG000|COMPLETED|Overall Study||5
9079742|NCT01301963|10142503|FG001|COMPLETED|Overall Study||4
9079743|NCT01301963|10142502|FG000|NOT COMPLETED|Overall Study||0
9079744|NCT01301963|10142503|FG001|NOT COMPLETED|Overall Study||0
9079745|NCT01298921|10142511|FG000|STARTED|Overall Study||0
9079746|NCT01298921|10142512|FG001|STARTED|Overall Study||0
9079747|NCT01298921|10142511|FG000|COMPLETED|Overall Study||0
9079748|NCT01298921|10142512|FG001|COMPLETED|Overall Study||0
9079749|NCT01298921|10142511|FG000|NOT COMPLETED|Overall Study||0
9079750|NCT01298921|10142512|FG001|NOT COMPLETED|Overall Study||0
9079751|NCT01292070|10142520|FG000|STARTED|Overall Study||4
9079752|NCT01292070|10142520|FG000|COMPLETED|Overall Study||4
9079753|NCT01292070|10142520|FG000|NOT COMPLETED|Overall Study||0
9079754|NCT01292265|10142524|FG000|STARTED|Overall Study||3
9079755|NCT01292265|10142524|FG000|COMPLETED|Overall Study||3
9079756|NCT01292265|10142524|FG000|NOT COMPLETED|Overall Study||0
9079757|NCT01290822|10142528|FG000|STARTED|Overall Study||12
9079758|NCT01290822|10142528|FG000|COMPLETED|Overall Study||1
9079759|NCT01290822|10142528|FG000|NOT COMPLETED|Overall Study||11
9079760|NCT01290718|10142532|FG000|STARTED|Overall Study||4
9079761|NCT01290718|10142532|FG000|COMPLETED|Overall Study||0
9079762|NCT01290718|10142532|FG000|NOT COMPLETED|Overall Study||4
9079763|NCT01293123|10142538|FG000|STARTED|Overall Study||1
9079764|NCT01293123|10142539|FG001|STARTED|Overall Study||1
9079765|NCT01293123|10142538|FG000|COMPLETED|Overall Study||1
9079766|NCT01293123|10142539|FG001|COMPLETED|Overall Study||0
8624373|NCT00499863|9663674|FG001|STARTED|Overall Study||72
8624374|NCT00499863|9663673|FG000|COMPLETED|Overall Study||95
9079767|NCT01293123|10142538|FG000|NOT COMPLETED|Overall Study||0
9079768|NCT01293123|10142539|FG001|NOT COMPLETED|Overall Study||1
9079769|NCT01294046|10142545|FG000|STARTED|Overall Study||3
9079770|NCT01294046|10142545|FG000|COMPLETED|Overall Study||0
9079771|NCT01294046|10142545|FG000|NOT COMPLETED|Overall Study||3
9079772|NCT01280643|10142561|FG000|STARTED|Overall Study||0
9079773|NCT01280643|10142562|FG001|STARTED|Overall Study||1
9079774|NCT01280643|10142563|FG002|STARTED|Overall Study||1
9079775|NCT01280643|10142564|FG003|STARTED|Overall Study||1
9079776|NCT01280643|10142565|FG004|STARTED|Overall Study||0
9079777|NCT01280643|10142566|FG005|STARTED|Overall Study||0
9079778|NCT01280643|10142567|FG006|STARTED|Overall Study||0
9079779|NCT01280643|10142568|FG007|STARTED|Overall Study||0
9079780|NCT01280643|10142569|FG008|STARTED|Overall Study||0
9079781|NCT01280643|10142561|FG000|COMPLETED|Overall Study||0
9079782|NCT01280643|10142562|FG001|COMPLETED|Overall Study||0
9079783|NCT01280643|10142563|FG002|COMPLETED|Overall Study||1
9079784|NCT01280643|10142564|FG003|COMPLETED|Overall Study||1
9079785|NCT01280643|10142565|FG004|COMPLETED|Overall Study||0
9079786|NCT01280643|10142566|FG005|COMPLETED|Overall Study||0
9079787|NCT01280643|10142567|FG006|COMPLETED|Overall Study||0
9079788|NCT01280643|10142568|FG007|COMPLETED|Overall Study||0
9079789|NCT01280643|10142569|FG008|COMPLETED|Overall Study||0
9079790|NCT01280643|10142561|FG000|NOT COMPLETED|Overall Study||0
9079791|NCT01280643|10142562|FG001|NOT COMPLETED|Overall Study||1
9079792|NCT01280643|10142563|FG002|NOT COMPLETED|Overall Study||0
9079793|NCT01280643|10142564|FG003|NOT COMPLETED|Overall Study||0
9079794|NCT01280643|10142565|FG004|NOT COMPLETED|Overall Study||0
9079795|NCT01280643|10142566|FG005|NOT COMPLETED|Overall Study||0
9079796|NCT01280643|10142567|FG006|NOT COMPLETED|Overall Study||0
9079797|NCT01280643|10142568|FG007|NOT COMPLETED|Overall Study||0
9079798|NCT01280643|10142569|FG008|NOT COMPLETED|Overall Study||0
9079799|NCT01281124|10142589|FG000|STARTED|Overall Study||1
9079800|NCT01281124|10142589|FG000|COMPLETED|Overall Study||0
9079801|NCT01281124|10142589|FG000|NOT COMPLETED|Overall Study||1
9079802|NCT01272141|10142595|FG000|STARTED|Overall Study||5
9079803|NCT01272141|10142595|FG000|COMPLETED|Overall Study||5
9079804|NCT01272141|10142595|FG000|NOT COMPLETED|Overall Study||0
9079805|NCT01282216|10142601|FG000|STARTED|Overall Study||18
9079806|NCT01282216|10142602|FG001|STARTED|Overall Study||26
9079807|NCT01282216|10142603|FG002|STARTED|Overall Study||52
9079808|NCT01282216|10142604|FG003|STARTED|Overall Study||8
9079809|NCT01282216|10142601|FG000|COMPLETED|Overall Study||18
9079810|NCT01282216|10142602|FG001|COMPLETED|Overall Study||26
9079811|NCT01282216|10142603|FG002|COMPLETED|Overall Study||19
9079812|NCT01282216|10142604|FG003|COMPLETED|Overall Study||0
9079813|NCT01282216|10142601|FG000|NOT COMPLETED|Overall Study||0
9079814|NCT01282216|10142602|FG001|NOT COMPLETED|Overall Study||0
9079815|NCT01282216|10142603|FG002|NOT COMPLETED|Overall Study||33
9079816|NCT01282216|10142604|FG003|NOT COMPLETED|Overall Study||8
9079817|NCT01284491|10142610|FG000|STARTED|Overall Study||13
8948111|NCT02427100|10010443|FG001|COMPLETED|Overall Study||15
8948112|NCT02427100|10010442|FG000|NOT COMPLETED|Overall Study||0
8948113|NCT02427100|10010443|FG001|NOT COMPLETED|Overall Study||2
9079818|NCT01284491|10142610|FG000|COMPLETED|Overall Study||0
9079819|NCT01284491|10142610|FG000|NOT COMPLETED|Overall Study||13
9079820|NCT01284504|10142618|FG000|STARTED|Overall Study||0
9079821|NCT01284504|10142619|FG001|STARTED|Overall Study||0
9079822|NCT01284504|10142618|FG000|COMPLETED|Overall Study||0
9079823|NCT01284504|10142619|FG001|COMPLETED|Overall Study||0
9079824|NCT01284504|10142618|FG000|NOT COMPLETED|Overall Study||0
9079825|NCT01284504|10142619|FG001|NOT COMPLETED|Overall Study||0
9079826|NCT01269034|10142629|FG000|STARTED|Overall Study||1
9079827|NCT01269034|10142630|FG001|STARTED|Overall Study||2
9079828|NCT01269034|10142631|FG002|STARTED|Overall Study||1
9079829|NCT01269034|10142632|FG003|STARTED|Overall Study||9
9079830|NCT01269034|10142629|FG000|COMPLETED|Overall Study||0
9079831|NCT01269034|10142630|FG001|COMPLETED|Overall Study||2
9079832|NCT01269034|10142631|FG002|COMPLETED|Overall Study||1
9079833|NCT01269034|10142632|FG003|COMPLETED|Overall Study||9
9079834|NCT01269034|10142629|FG000|NOT COMPLETED|Overall Study||1
9079835|NCT01269034|10142630|FG001|NOT COMPLETED|Overall Study||0
9079836|NCT01269034|10142631|FG002|NOT COMPLETED|Overall Study||0
9079837|NCT01269034|10142632|FG003|NOT COMPLETED|Overall Study||0
9079838|NCT01274533|10142642|FG000|STARTED|Overall Study||4
9079839|NCT01274533|10142642|FG000|COMPLETED|Overall Study||0
9079840|NCT01274533|10142642|FG000|NOT COMPLETED|Overall Study||4
9079841|NCT01279616|10142646|FG000|STARTED|Overall Study||8
9079842|NCT01279616|10142646|FG000|COMPLETED|Overall Study||1
9079843|NCT01279616|10142646|FG000|NOT COMPLETED|Overall Study||7
9079844|NCT01276054|10142652|FG000|STARTED|Overall Study||2
9079845|NCT01276054|10142653|FG001|STARTED|Overall Study||2
9079846|NCT01276054|10142652|FG000|COMPLETED|Overall Study||0
9079847|NCT01276054|10142653|FG001|COMPLETED|Overall Study||0
9079848|NCT01276054|10142652|FG000|NOT COMPLETED|Overall Study||2
9079849|NCT01276054|10142653|FG001|NOT COMPLETED|Overall Study||2
9079850|NCT01264965|10142659|FG000|STARTED|Overall Study||25
9079851|NCT01264965|10142659|FG000|COMPLETED|Overall Study||15
9079852|NCT01264965|10142659|FG000|NOT COMPLETED|Overall Study||10
9079853|NCT01266824|10142665|FG000|STARTED|Overall Study||2
9079854|NCT01266824|10142666|FG001|STARTED|Overall Study||3
9079855|NCT01266824|10142665|FG000|COMPLETED|Overall Study||0
9079856|NCT01266824|10142666|FG001|COMPLETED|Overall Study||0
9079857|NCT01266824|10142665|FG000|NOT COMPLETED|Overall Study||2
9079858|NCT01266824|10142666|FG001|NOT COMPLETED|Overall Study||3
8948114|NCT02427399|10010454|FG000|STARTED|Overall Study||220
9079859|NCT01264835|10142672|FG000|STARTED|Overall Study||2
9079860|NCT01264835|10142672|FG000|COMPLETED|Overall Study||1
9079861|NCT01264835|10142672|FG000|NOT COMPLETED|Overall Study||1
9079862|NCT01274429|10142676|FG000|STARTED|Overall Study||5
9079863|NCT01274429|10142676|FG000|COMPLETED|Overall Study||0
9079864|NCT01274429|10142676|FG000|NOT COMPLETED|Overall Study||5
9079865|NCT01273064|10142685|FG000|STARTED|Overall Study||23
9079866|NCT01273064|10142686|FG001|STARTED|Overall Study||30
9079867|NCT01273064|10142687|FG002|STARTED|Overall Study||31
9079868|NCT01273064|10142688|FG003|STARTED|Overall Study||20
9079869|NCT01273064|10142689|FG004|STARTED|Overall Study|Began study on the placebo arm, and crossed over to CTS-1027 15 mg at Wk 12 due to lack of response|10
9079870|NCT01273064|10142685|FG000|COMPLETED|Overall Study||0
9079871|NCT01273064|10142686|FG001|COMPLETED|Overall Study||0
9079872|NCT01273064|10142687|FG002|COMPLETED|Overall Study||0
9079873|NCT01273064|10142688|FG003|COMPLETED|Overall Study||0
9079874|NCT01273064|10142689|FG004|COMPLETED|Overall Study||0
9079875|NCT01273064|10142685|FG000|NOT COMPLETED|Overall Study||23
9079876|NCT01273064|10142686|FG001|NOT COMPLETED|Overall Study||30
9079877|NCT01273064|10142687|FG002|NOT COMPLETED|Overall Study||31
9079878|NCT01273064|10142688|FG003|NOT COMPLETED|Overall Study||20
9079879|NCT01273064|10142689|FG004|NOT COMPLETED|Overall Study||10
9079880|NCT01274559|10142703|FG000|STARTED|Overall Study||587
9079881|NCT01274559|10142704|FG001|STARTED|Overall Study||586
9079882|NCT01274559|10142703|FG000|Treated|Overall Study||572
9079883|NCT01274559|10142704|FG001|Treated|Overall Study||572
9079884|NCT01274559|10142703|FG000|COMPLETED|Overall Study||390
9079885|NCT01274559|10142704|FG001|COMPLETED|Overall Study||441
9079886|NCT01274559|10142703|FG000|NOT COMPLETED|Overall Study||197
9079887|NCT01274559|10142704|FG001|NOT COMPLETED|Overall Study||145
9079888|NCT01270581|10142712|FG000|STARTED|Overall Study||4
9079889|NCT01270581|10142713|FG001|STARTED|Overall Study||3
9079890|NCT01270581|10142712|FG000|COMPLETED|Overall Study||3
9079891|NCT01270581|10142713|FG001|COMPLETED|Overall Study||3
9079892|NCT01270581|10142712|FG000|NOT COMPLETED|Overall Study||1
9079893|NCT01270581|10142713|FG001|NOT COMPLETED|Overall Study||0
9079894|NCT01269749|10142721|FG000|STARTED|Overall Study||16
9079895|NCT01269749|10142722|FG001|STARTED|Overall Study||3
9079896|NCT01269749|10142721|FG000|COMPLETED|Overall Study||16
9079897|NCT01269749|10142722|FG001|COMPLETED|Overall Study||3
9079898|NCT01269749|10142721|FG000|NOT COMPLETED|Overall Study||0
8624375|NCT00499863|9663674|FG001|COMPLETED|Overall Study||29
8624376|NCT00499863|9663673|FG000|NOT COMPLETED|Overall Study||50
8624377|NCT00499863|9663674|FG001|NOT COMPLETED|Overall Study||43
8624378|NCT00499889|9663680|FG000|STARTED|Overall Study||42
8624379|NCT00499889|9663680|FG000|COMPLETED|Overall Study||41
9079899|NCT01269749|10142722|FG001|NOT COMPLETED|Overall Study||0
9079900|NCT01270919|10142728|FG000|STARTED|Overall Study|One participant was enrolled but was censored.|0
9079901|NCT01270919|10142728|FG000|COMPLETED|Overall Study||0
9079902|NCT01270919|10142728|FG000|NOT COMPLETED|Overall Study||0
9079903|NCT01262339|10142732|FG000|STARTED|Overall Study||2
9079904|NCT01262339|10142732|FG000|COMPLETED|Overall Study||2
9079905|NCT01262339|10142732|FG000|NOT COMPLETED|Overall Study||0
9079906|NCT01267825|10142738|FG000|STARTED|Overall Study||1
9079907|NCT01267825|10142739|FG001|STARTED|Overall Study||0
9079908|NCT01267825|10142738|FG000|COMPLETED|Overall Study||0
9079909|NCT01267825|10142739|FG001|COMPLETED|Overall Study||0
9079910|NCT01267825|10142738|FG000|NOT COMPLETED|Overall Study||1
9079911|NCT01267825|10142739|FG001|NOT COMPLETED|Overall Study||0
9079912|NCT01259284|10142748|FG000|STARTED|Overall Study||2
9079913|NCT01259284|10142749|FG001|STARTED|Overall Study||0
9079914|NCT01259284|10142750|FG002|STARTED|Overall Study||0
9079915|NCT01259284|10142748|FG000|COMPLETED|Overall Study||0
9079916|NCT01259284|10142749|FG001|COMPLETED|Overall Study||0
9079917|NCT01259284|10142750|FG002|COMPLETED|Overall Study||0
9079918|NCT01259284|10142748|FG000|NOT COMPLETED|Overall Study||2
9079919|NCT01259284|10142749|FG001|NOT COMPLETED|Overall Study||0
9079920|NCT01259284|10142750|FG002|NOT COMPLETED|Overall Study||0
9079921|NCT01249157|10142758|FG000|STARTED|Overall Study||1
9079922|NCT01249157|10142758|FG000|COMPLETED|Overall Study|No data displayed because Outcome Measure has zero total participants analyzed.|0
9079923|NCT01249157|10142758|FG000|NOT COMPLETED|Overall Study||1
9079924|NCT01263028|10142762|FG000|STARTED|Overall Study||6
9079925|NCT01263028|10142762|FG000|COMPLETED|Overall Study||0
9079926|NCT01263028|10142762|FG000|NOT COMPLETED|Overall Study||6
9079927|NCT01256281|10142766|FG000|STARTED|Overall Study||2
9079928|NCT01256281|10142766|FG000|COMPLETED|Overall Study||2
9079929|NCT01256281|10142766|FG000|NOT COMPLETED|Overall Study||0
9079930|NCT01253668|10142770|FG000|STARTED|Overall Study||0
9079931|NCT01253668|10142770|FG000|COMPLETED|Overall Study||0
9079932|NCT01253668|10142770|FG000|NOT COMPLETED|Overall Study||0
9079933|NCT01259024|10142774|FG000|STARTED|Overall Study||1
9079934|NCT01259024|10142774|FG000|COMPLETED|Overall Study||0
9079935|NCT01259024|10142774|FG000|NOT COMPLETED|Overall Study||1
9079936|NCT01251952|10142778|FG000|STARTED|Overall Study||2
9079937|NCT01251952|10142778|FG000|COMPLETED|Overall Study||1
9079938|NCT01251952|10142778|FG000|NOT COMPLETED|Overall Study||1
9079939|NCT01251120|10142784|FG000|STARTED|Overall Study||1
9079940|NCT01251120|10142785|FG001|STARTED|Overall Study||1
9079941|NCT01251120|10142784|FG000|COMPLETED|Overall Study||1
9079942|NCT01251120|10142785|FG001|COMPLETED|Overall Study||0
9079943|NCT01251120|10142784|FG000|NOT COMPLETED|Overall Study||0
9079944|NCT01251120|10142785|FG001|NOT COMPLETED|Overall Study||1
9079945|NCT01248130|10142793|FG000|STARTED|Overall Study||3
9079946|NCT01248130|10142794|FG001|STARTED|Overall Study||4
9079947|NCT01248130|10142793|FG000|COMPLETED|Overall Study||1
9079948|NCT01248130|10142794|FG001|COMPLETED|Overall Study||4
9079949|NCT01248130|10142793|FG000|NOT COMPLETED|Overall Study||2
9079950|NCT01248130|10142794|FG001|NOT COMPLETED|Overall Study||0
9079951|NCT01243892|10142802|FG000|STARTED|Overall Study||15
9079952|NCT01243892|10142803|FG001|STARTED|Overall Study||3
9079953|NCT01243892|10142802|FG000|COMPLETED|Overall Study||13
9079954|NCT01243892|10142803|FG001|COMPLETED|Overall Study||3
9079955|NCT01243892|10142802|FG000|NOT COMPLETED|Overall Study||2
9079956|NCT01243892|10142803|FG001|NOT COMPLETED|Overall Study||0
9079957|NCT01246011|10142812|FG000|STARTED|Overall Study||0
9079958|NCT01246011|10142813|FG001|STARTED|Overall Study||0
9079959|NCT01246011|10142814|FG002|STARTED|Overall Study||9
9079960|NCT01246011|10142812|FG000|COMPLETED|Overall Study||0
9079961|NCT01246011|10142813|FG001|COMPLETED|Overall Study||0
9079962|NCT01246011|10142814|FG002|COMPLETED|Overall Study||5
9079963|NCT01246011|10142812|FG000|NOT COMPLETED|Overall Study||0
9079964|NCT01246011|10142813|FG001|NOT COMPLETED|Overall Study||0
9079965|NCT01246011|10142814|FG002|NOT COMPLETED|Overall Study||4
9079966|NCT01242020|10142825|FG000|STARTED|Overall Study||6
9079967|NCT01242020|10142826|FG001|STARTED|Overall Study||0
9079968|NCT01242020|10142825|FG000|COMPLETED|Overall Study||3
9079969|NCT01242020|10142826|FG001|COMPLETED|Overall Study||0
9079970|NCT01242020|10142825|FG000|NOT COMPLETED|Overall Study||3
9079971|NCT01242020|10142826|FG001|NOT COMPLETED|Overall Study||0
9079972|NCT01244620|10142832|FG000|STARTED|Overall Study||4
9079973|NCT01244620|10142833|FG001|STARTED|Overall Study||4
9079974|NCT01244620|10142834|FG002|STARTED|Overall Study||4
9079975|NCT01244620|10142835|FG003|STARTED|Overall Study||4
9079976|NCT01244620|10142832|FG000|COMPLETED|Overall Study||0
9079977|NCT01244620|10142833|FG001|COMPLETED|Overall Study||0
9079978|NCT01244620|10142834|FG002|COMPLETED|Overall Study||0
9079979|NCT01244620|10142835|FG003|COMPLETED|Overall Study||0
9079980|NCT01244620|10142832|FG000|NOT COMPLETED|Overall Study||4
9079981|NCT01244620|10142833|FG001|NOT COMPLETED|Overall Study||4
9079982|NCT01244620|10142834|FG002|NOT COMPLETED|Overall Study||4
9079983|NCT01244620|10142835|FG003|NOT COMPLETED|Overall Study||4
9079984|NCT01240304|10142845|FG000|STARTED|Overall Study||10
9079985|NCT01240304|10142845|FG000|COMPLETED|Overall Study||0
9079986|NCT01240304|10142845|FG000|NOT COMPLETED|Overall Study||10
9079987|NCT01241279|10142851|FG000|STARTED|Overall Study||4
9079988|NCT01241279|10142852|FG001|STARTED|Overall Study||2
9079989|NCT01241279|10142851|FG000|COMPLETED|Overall Study||4
9079990|NCT01241279|10142852|FG001|COMPLETED|Overall Study||1
9079991|NCT01241279|10142851|FG000|NOT COMPLETED|Overall Study||0
9079992|NCT01241279|10142852|FG001|NOT COMPLETED|Overall Study||1
9079993|NCT01230788|10142858|FG000|STARTED|Overall Study||1
9079994|NCT01230788|10142858|FG000|COMPLETED|Overall Study||0
9079995|NCT01230788|10142858|FG000|NOT COMPLETED|Overall Study||1
9079996|NCT01239680|10142864|FG000|STARTED|Overall Study||3
9079997|NCT01239680|10142865|FG001|STARTED|Overall Study||2
9079998|NCT01239680|10142864|FG000|COMPLETED|Overall Study||1
9079999|NCT01239680|10142865|FG001|COMPLETED|Overall Study||2
9080000|NCT01239680|10142864|FG000|NOT COMPLETED|Overall Study||2
9080001|NCT01239680|10142865|FG001|NOT COMPLETED|Overall Study||0
9080002|NCT01237613|10142871|FG000|STARTED|Overall Study||4
9080003|NCT01237613|10142871|FG000|COMPLETED|Overall Study||4
9080004|NCT01237613|10142871|FG000|NOT COMPLETED|Overall Study||0
9080005|NCT01234103|10142878|FG000|STARTED|Overall Study||542
9080006|NCT01234103|10142879|FG001|STARTED|Overall Study||391
9080007|NCT01234103|10142878|FG000|COMPLETED|Overall Study||542
9080008|NCT01234103|10142879|FG001|COMPLETED|Overall Study||391
9080009|NCT01234103|10142878|FG000|NOT COMPLETED|Overall Study||0
9080010|NCT01234103|10142879|FG001|NOT COMPLETED|Overall Study||0
9080011|NCT01231750|10142887|FG000|STARTED|Overall Study||3
9080012|NCT01231750|10142888|FG001|STARTED|Overall Study||4
9080013|NCT01231750|10142887|FG000|COMPLETED|Overall Study||3
9080014|NCT01231750|10142888|FG001|COMPLETED|Overall Study||4
9080015|NCT01231750|10142887|FG000|NOT COMPLETED|Overall Study||0
9080016|NCT01231750|10142888|FG001|NOT COMPLETED|Overall Study||0
9080017|NCT01230307|10142896|FG000|STARTED|Overall Study||6
9080018|NCT01230307|10142897|FG001|STARTED|Overall Study||6
9080019|NCT01230307|10142896|FG000|COMPLETED|Overall Study||6
9080020|NCT01230307|10142897|FG001|COMPLETED|Overall Study||4
9080021|NCT01230307|10142896|FG000|NOT COMPLETED|Overall Study||0
9080022|NCT01230307|10142897|FG001|NOT COMPLETED|Overall Study||2
9080023|NCT01230489|10142903|FG000|STARTED|Overall Study||13
9080024|NCT01230489|10142903|FG000|COMPLETED|Overall Study||8
9080025|NCT01230489|10142903|FG000|NOT COMPLETED|Overall Study||5
9080026|NCT01222871|10142909|FG000|STARTED|Overall Study||0
9080027|NCT01222871|10142910|FG001|STARTED|Overall Study||0
9080028|NCT01222871|10142909|FG000|COMPLETED|Overall Study||0
9080029|NCT01222871|10142910|FG001|COMPLETED|Overall Study||0
9080030|NCT01222871|10142909|FG000|NOT COMPLETED|Overall Study||0
9080031|NCT01222871|10142910|FG001|NOT COMPLETED|Overall Study||0
9080032|NCT01219673|10142925|FG000|STARTED|Overall Study||0
9080033|NCT01219673|10142926|FG001|STARTED|Overall Study||0
9080034|NCT01219673|10142927|FG002|STARTED|Overall Study||1
9080035|NCT01219673|10142928|FG003|STARTED|Overall Study||0
9080036|NCT01219673|10142929|FG004|STARTED|Overall Study||0
9080037|NCT01219673|10142930|FG005|STARTED|Overall Study||0
9080038|NCT01219673|10142931|FG006|STARTED|Overall Study||0
9080039|NCT01219673|10142932|FG007|STARTED|Overall Study||0
9080040|NCT01219673|10142925|FG000|COMPLETED|Overall Study||0
9080041|NCT01219673|10142926|FG001|COMPLETED|Overall Study||0
9080042|NCT01219673|10142927|FG002|COMPLETED|Overall Study||1
9080043|NCT01219673|10142928|FG003|COMPLETED|Overall Study||0
9080044|NCT01219673|10142929|FG004|COMPLETED|Overall Study||0
9080045|NCT01219673|10142930|FG005|COMPLETED|Overall Study||0
9080046|NCT01219673|10142931|FG006|COMPLETED|Overall Study||0
9080047|NCT01219673|10142932|FG007|COMPLETED|Overall Study||0
9080048|NCT01219673|10142925|FG000|NOT COMPLETED|Overall Study||0
9080049|NCT01219673|10142926|FG001|NOT COMPLETED|Overall Study||0
9080050|NCT01219673|10142927|FG002|NOT COMPLETED|Overall Study||0
9080051|NCT01219673|10142928|FG003|NOT COMPLETED|Overall Study||0
9080052|NCT01219673|10142929|FG004|NOT COMPLETED|Overall Study||0
9080053|NCT01219673|10142930|FG005|NOT COMPLETED|Overall Study||0
9080054|NCT01219673|10142931|FG006|NOT COMPLETED|Overall Study||0
9080055|NCT01219673|10142932|FG007|NOT COMPLETED|Overall Study||0
9080056|NCT01223001|10142952|FG000|STARTED|Overall Study||4
9080057|NCT01223001|10142953|FG001|STARTED|Overall Study||4
9080058|NCT01223001|10142952|FG000|COMPLETED|Overall Study||0
9080059|NCT01223001|10142953|FG001|COMPLETED|Overall Study||0
9080060|NCT01223001|10142952|FG000|NOT COMPLETED|Overall Study||4
9080061|NCT01223001|10142953|FG001|NOT COMPLETED|Overall Study||4
9080062|NCT01217060|10142959|FG000|STARTED|Overall Study||4
9080063|NCT01217060|10142959|FG000|COMPLETED|Overall Study||3
9080064|NCT01217060|10142959|FG000|NOT COMPLETED|Overall Study||1
9080065|NCT01217047|10142967|FG000|STARTED|Overall Study||3
9080066|NCT01217047|10142968|FG001|STARTED|Overall Study||4
9080067|NCT01217047|10142969|FG002|STARTED|Overall Study||3
9080068|NCT01217047|10142967|FG000|COMPLETED|Overall Study||3
9080069|NCT01217047|10142968|FG001|COMPLETED|Overall Study||3
9080070|NCT01217047|10142969|FG002|COMPLETED|Overall Study||3
9080071|NCT01217047|10142967|FG000|NOT COMPLETED|Overall Study||0
9080072|NCT01217047|10142968|FG001|NOT COMPLETED|Overall Study||1
9080073|NCT01217047|10142969|FG002|NOT COMPLETED|Overall Study||0
9080074|NCT01206101|10142980|FG000|STARTED|Overall Study||2
9080075|NCT01206101|10142981|FG001|STARTED|Overall Study||1
9080076|NCT01206101|10142980|FG000|COMPLETED|Overall Study||0
9080077|NCT01206101|10142981|FG001|COMPLETED|Overall Study||0
9080078|NCT01206101|10142980|FG000|NOT COMPLETED|Overall Study||2
9080079|NCT01206101|10142981|FG001|NOT COMPLETED|Overall Study||1
9080080|NCT01216631|10142990|FG000|STARTED|Overall Study||0
9080081|NCT01216631|10142991|FG001|STARTED|Overall Study||0
9080082|NCT01216631|10142992|FG002|STARTED|Overall Study||1
9080083|NCT01216631|10142990|FG000|COMPLETED|Overall Study||0
9080084|NCT01216631|10142991|FG001|COMPLETED|Overall Study||0
9080085|NCT01216631|10142992|FG002|COMPLETED|Overall Study||1
9080086|NCT01216631|10142990|FG000|NOT COMPLETED|Overall Study||0
9080087|NCT01216631|10142991|FG001|NOT COMPLETED|Overall Study||0
9080088|NCT01216631|10142992|FG002|NOT COMPLETED|Overall Study||0
9080089|NCT01211756|10143000|FG000|STARTED|Overall Study||1
9080090|NCT01211756|10143000|FG000|COMPLETED|Overall Study||1
9080091|NCT01211756|10143000|FG000|NOT COMPLETED|Overall Study||0
9080092|NCT01209520|10143004|FG000|STARTED|Overall Study||6
9080093|NCT01209520|10143004|FG000|COMPLETED|Overall Study||3
9080094|NCT01209520|10143004|FG000|NOT COMPLETED|Overall Study||3
8624380|NCT00499889|9663680|FG000|NOT COMPLETED|Overall Study||1
8624381|NCT00499915|9663686|FG000|STARTED|Overall Study||83
8624382|NCT00499915|9663687|FG001|STARTED|Overall Study||82
8624383|NCT00499915|9663686|FG000|COMPLETED|Overall Study||68
8624384|NCT00499915|9663687|FG001|COMPLETED|Overall Study||76
8624385|NCT00499915|9663686|FG000|NOT COMPLETED|Overall Study||15
8624386|NCT00499915|9663687|FG001|NOT COMPLETED|Overall Study||6
8624387|NCT00500110|9663693|FG000|STARTED|Overall Study||39
8624388|NCT00500110|9663693|FG000|COMPLETED|Overall Study||36
8624389|NCT00500110|9663693|FG000|NOT COMPLETED|Overall Study||3
8624390|NCT00500149|9663697|FG000|STARTED|Enrolled (Dose-optimization Phase)||129
8624391|NCT00500149|9663698|FG001|STARTED|Enrolled (Dose-optimization Phase)||0
8624392|NCT00500149|9663697|FG000|COMPLETED|Enrolled (Dose-optimization Phase)||117
8624393|NCT00500149|9663698|FG001|COMPLETED|Enrolled (Dose-optimization Phase)||0
8629506|NCT00530764|9669253|FG003|NOT COMPLETED|Overall Study||25
8844647|NCT01710800|9899075|FG000|COMPLETED|Overall Study|22 drop outs(consented but did not participate, refused 2nd intervention)|41
8844648|NCT01710800|9899075|FG000|NOT COMPLETED|Overall Study||22
9080095|NCT01207726|10143010|FG000|STARTED|Overall Study||7
8624394|NCT00500149|9663697|FG000|NOT COMPLETED|Enrolled (Dose-optimization Phase)||12
8624395|NCT00500149|9663698|FG001|NOT COMPLETED|Enrolled (Dose-optimization Phase)||0
8624396|NCT00500149|9663697|FG000|STARTED|First Intervention (Cross-over Phase)||58
8624397|NCT00500149|9663698|FG001|STARTED|First Intervention (Cross-over Phase)||59
8844649|NCT01710839|9899083|FG000|STARTED|Overall Study||24
8844650|NCT01710839|9899084|FG001|STARTED|Overall Study||6
9080096|NCT01207726|10143011|FG001|STARTED|Overall Study||6
9080097|NCT01207726|10143010|FG000|COMPLETED|Overall Study||7
9080098|NCT01207726|10143011|FG001|COMPLETED|Overall Study||6
9080099|NCT01207726|10143010|FG000|NOT COMPLETED|Overall Study||0
9080100|NCT01207726|10143011|FG001|NOT COMPLETED|Overall Study||0
9080101|NCT01206296|10143021|FG000|STARTED|Overall Study||0
9080102|NCT01206296|10143021|FG000|COMPLETED|Overall Study||0
9080103|NCT01206296|10143021|FG000|NOT COMPLETED|Overall Study||0
9080104|NCT01207102|10143025|FG000|STARTED|Overall Study||10
9080105|NCT01207102|10143025|FG000|COMPLETED|Overall Study||0
9080106|NCT01207102|10143025|FG000|NOT COMPLETED|Overall Study||10
9080107|NCT01213329|10143031|FG000|STARTED|Screening||25
9080108|NCT01213329|10143032|FG001|STARTED|Screening||25
9080109|NCT01213329|10143031|FG000|COMPLETED|Screening||25
9080110|NCT01213329|10143032|FG001|COMPLETED|Screening||25
9080111|NCT01213329|10143031|FG000|NOT COMPLETED|Screening||0
9080112|NCT01213329|10143032|FG001|NOT COMPLETED|Screening||0
9080113|NCT01213329|10143031|FG000|STARTED|Phase 2|No subjects continued into phase 2.This is due to a loss of samples from a processing inconsistency.|0
9080114|NCT01213329|10143032|FG001|STARTED|Phase 2|No subjects continued into phase 2.This is due to a loss of samples from a processing inconsistency.|0
9080115|NCT01213329|10143031|FG000|COMPLETED|Phase 2||0
9080116|NCT01213329|10143032|FG001|COMPLETED|Phase 2||0
9080117|NCT01213329|10143031|FG000|NOT COMPLETED|Phase 2||0
9080118|NCT01213329|10143032|FG001|NOT COMPLETED|Phase 2||0
9080119|NCT01202110|10143038|FG000|STARTED|Overall Study||10
9080120|NCT01202110|10143039|FG001|STARTED|Overall Study||0
9080121|NCT01202110|10143038|FG000|COMPLETED|Overall Study||10
9080122|NCT01202110|10143039|FG001|COMPLETED|Overall Study||0
9080123|NCT01202110|10143038|FG000|NOT COMPLETED|Overall Study||0
9080124|NCT01202110|10143039|FG001|NOT COMPLETED|Overall Study||0
9080125|NCT01206439|10143043|FG000|STARTED|Overall Study||2
9080126|NCT01206439|10143043|FG000|COMPLETED|Overall Study||1
9080127|NCT01206439|10143043|FG000|NOT COMPLETED|Overall Study||1
9080128|NCT01204788|10143049|FG000|STARTED|Overall Study||1
9080129|NCT01204788|10143050|FG001|STARTED|Overall Study||3
9080130|NCT01204788|10143049|FG000|COMPLETED|Overall Study||0
9080131|NCT01204788|10143050|FG001|COMPLETED|Overall Study||0
9080132|NCT01204788|10143049|FG000|NOT COMPLETED|Overall Study||1
9080133|NCT01204788|10143050|FG001|NOT COMPLETED|Overall Study||3
9080134|NCT01200602|10143058|FG000|STARTED|Overall Study||0
9080135|NCT01200602|10143059|FG001|STARTED|Overall Study||0
9080136|NCT01200602|10143058|FG000|COMPLETED|Overall Study||0
9080137|NCT01200602|10143059|FG001|COMPLETED|Overall Study||0
9080138|NCT01200602|10143058|FG000|NOT COMPLETED|Overall Study||0
9080139|NCT01200602|10143059|FG001|NOT COMPLETED|Overall Study||0
9080140|NCT01198548|10143065|FG000|STARTED|Overall Study||10
9080141|NCT01198548|10143065|FG000|COMPLETED|Overall Study||0
9080142|NCT01198548|10143065|FG000|NOT COMPLETED|Overall Study||10
9080143|NCT01194908|10143069|FG000|STARTED|Overall Study||5
9080144|NCT01194908|10143069|FG000|COMPLETED|Overall Study||5
9080145|NCT01194908|10143069|FG000|NOT COMPLETED|Overall Study||0
9080146|NCT01194856|10143075|FG000|STARTED|Overall Study||1
9080147|NCT01194856|10143076|FG001|STARTED|Overall Study||0
9080148|NCT01194856|10143075|FG000|COMPLETED|Overall Study||0
9080149|NCT01194856|10143076|FG001|COMPLETED|Overall Study||0
9080150|NCT01194856|10143075|FG000|NOT COMPLETED|Overall Study||1
9080151|NCT01194856|10143076|FG001|NOT COMPLETED|Overall Study||0
8556738|NCT03727373|9588530|FG000|STARTED|Overall Study||8
8556739|NCT03727373|9588530|FG000|COMPLETED|Overall Study||8
8556740|NCT03727373|9588530|FG000|NOT COMPLETED|Overall Study||0
8556741|NCT05017493|9588536|FG000|STARTED|Overall Study||483
8556742|NCT05017493|9588537|FG001|STARTED|Overall Study||178
8556743|NCT05017493|9588536|FG000|Treatment & Care|Overall Study||483
8556744|NCT05017493|9588537|FG001|Treatment & Care|Overall Study||178
8844651|NCT01710839|9899083|FG000|COMPLETED|Overall Study||23
8844652|NCT01710839|9899084|FG001|COMPLETED|Overall Study||0
9080152|NCT01194427|10143082|FG000|STARTED|Overall Study||2
8556745|NCT05017493|9588536|FG000|Follow up|Overall Study||483
8556746|NCT05017493|9588537|FG001|Follow up|Overall Study||178
8844653|NCT01710839|9899083|FG000|NOT COMPLETED|Overall Study||1
8844654|NCT01710839|9899084|FG001|NOT COMPLETED|Overall Study||6
8844655|NCT01710891|9899092|FG000|STARTED|Overall Study||95
9080153|NCT01194427|10143082|FG000|COMPLETED|Overall Study||2
9080154|NCT01194427|10143082|FG000|NOT COMPLETED|Overall Study||0
9080155|NCT01193556|10143088|FG000|STARTED|Overall Study||26
9080156|NCT01193556|10143089|FG001|STARTED|Overall Study||25
9080157|NCT01193556|10143088|FG000|COMPLETED|Overall Study||0
8556747|NCT05017493|9588536|FG000|Mortality Check|Overall Study||483
8556748|NCT05017493|9588537|FG001|Mortality Check|Overall Study||178
8556749|NCT05017493|9588536|FG000|COMPLETED|Overall Study||361
8556750|NCT05017493|9588537|FG001|COMPLETED|Overall Study||178
9080158|NCT01193556|10143089|FG001|COMPLETED|Overall Study||0
9080159|NCT01193556|10143088|FG000|NOT COMPLETED|Overall Study||26
9080160|NCT01193556|10143089|FG001|NOT COMPLETED|Overall Study||25
9080161|NCT01189435|10143095|FG000|STARTED|Overall Study||2
9080162|NCT01189435|10143095|FG000|COMPLETED|Overall Study||0
9080163|NCT01189435|10143095|FG000|NOT COMPLETED|Overall Study||2
9080164|NCT01193530|10143101|FG000|STARTED|Overall Study||4
9080165|NCT01193530|10143102|FG001|STARTED|Overall Study||8
9080166|NCT01193530|10143101|FG000|COMPLETED|Overall Study||1
9080167|NCT01193530|10143102|FG001|COMPLETED|Overall Study||3
9080168|NCT01193530|10143101|FG000|NOT COMPLETED|Overall Study||3
9080169|NCT01193530|10143102|FG001|NOT COMPLETED|Overall Study||5
9080170|NCT01182610|10143108|FG000|STARTED|Overall Study||1
8624398|NCT00500149|9663697|FG000|COMPLETED|First Intervention (Cross-over Phase)||56
8624399|NCT00500149|9663698|FG001|COMPLETED|First Intervention (Cross-over Phase)||57
8624400|NCT00500149|9663697|FG000|NOT COMPLETED|First Intervention (Cross-over Phase)||2
8624401|NCT00500149|9663698|FG001|NOT COMPLETED|First Intervention (Cross-over Phase)||2
8624402|NCT00500149|9663697|FG000|STARTED|Second Intervention (Cross-over Phase)||56
8624403|NCT00500149|9663698|FG001|STARTED|Second Intervention (Cross-over Phase)||57
8624404|NCT00500149|9663697|FG000|COMPLETED|Second Intervention (Cross-over Phase)||54
8624405|NCT00500149|9663698|FG001|COMPLETED|Second Intervention (Cross-over Phase)||57
8624406|NCT00500149|9663697|FG000|NOT COMPLETED|Second Intervention (Cross-over Phase)||2
8624407|NCT00500149|9663698|FG001|NOT COMPLETED|Second Intervention (Cross-over Phase)||0
9080171|NCT01182610|10143108|FG000|COMPLETED|Overall Study||1
9080172|NCT01182610|10143108|FG000|NOT COMPLETED|Overall Study||0
9080173|NCT01189071|10143114|FG000|STARTED|Overall Study||0
9080174|NCT01189071|10143115|FG001|STARTED|Overall Study||0
9080175|NCT01189071|10143114|FG000|COMPLETED|Overall Study||0
9080176|NCT01189071|10143115|FG001|COMPLETED|Overall Study||0
9080177|NCT01189071|10143114|FG000|NOT COMPLETED|Overall Study||0
9080178|NCT01189071|10143115|FG001|NOT COMPLETED|Overall Study||0
9080179|NCT01183416|10143121|FG000|STARTED|Overall Study||4
9080180|NCT01183416|10143121|FG000|COMPLETED|Overall Study||4
9080181|NCT01183416|10143121|FG000|NOT COMPLETED|Overall Study||0
9080182|NCT01184456|10143127|FG000|STARTED|Overall Study||0
9080183|NCT01184456|10143128|FG001|STARTED|Overall Study||0
9080184|NCT01184456|10143127|FG000|COMPLETED|Overall Study||0
9080185|NCT01184456|10143128|FG001|COMPLETED|Overall Study||0
9080186|NCT01184456|10143127|FG000|NOT COMPLETED|Overall Study||0
9080187|NCT01184456|10143128|FG001|NOT COMPLETED|Overall Study||0
9080188|NCT01183221|10143136|FG000|STARTED|First Dose||15
9080189|NCT01183221|10143137|FG001|STARTED|First Dose||15
9080190|NCT01183221|10143136|FG000|COMPLETED|First Dose||15
9080191|NCT01183221|10143137|FG001|COMPLETED|First Dose||15
9080192|NCT01183221|10143136|FG000|NOT COMPLETED|First Dose||0
9080193|NCT01183221|10143137|FG001|NOT COMPLETED|First Dose||0
9080194|NCT01183221|10143136|FG000|STARTED|3 Weeks Wash Out||15
9080195|NCT01183221|10143137|FG001|STARTED|3 Weeks Wash Out||15
9080196|NCT01183221|10143136|FG000|COMPLETED|3 Weeks Wash Out||14
9080197|NCT01183221|10143137|FG001|COMPLETED|3 Weeks Wash Out||14
9080198|NCT01183221|10143136|FG000|NOT COMPLETED|3 Weeks Wash Out||1
9080199|NCT01183221|10143137|FG001|NOT COMPLETED|3 Weeks Wash Out||1
9080200|NCT01183221|10143136|FG000|STARTED|Second Dose||14
9080201|NCT01183221|10143137|FG001|STARTED|Second Dose||14
9080202|NCT01183221|10143136|FG000|COMPLETED|Second Dose||14
9080203|NCT01183221|10143137|FG001|COMPLETED|Second Dose||14
9080204|NCT01183221|10143136|FG000|NOT COMPLETED|Second Dose||0
9080205|NCT01183221|10143137|FG001|NOT COMPLETED|Second Dose||0
9080206|NCT01189227|10143145|FG000|STARTED|Overall Study||6
9080207|NCT01189227|10143146|FG001|STARTED|Overall Study||3
9080208|NCT01189227|10143145|FG000|COMPLETED|Overall Study||0
9080209|NCT01189227|10143146|FG001|COMPLETED|Overall Study||0
9080210|NCT01189227|10143145|FG000|NOT COMPLETED|Overall Study||6
9080211|NCT01189227|10143146|FG001|NOT COMPLETED|Overall Study||3
9080212|NCT01190306|10143154|FG000|STARTED|Overall Study||61
9080213|NCT01190306|10143155|FG001|STARTED|Overall Study||66
9080214|NCT01190306|10143154|FG000|COMPLETED|Overall Study||61
9080215|NCT01190306|10143155|FG001|COMPLETED|Overall Study||66
8624408|NCT00500240|9663706|FG000|STARTED|Overall Study||25
8624409|NCT00500240|9663707|FG001|STARTED|Overall Study||26
8624410|NCT00500240|9663706|FG000|COMPLETED|Overall Study||25
8624411|NCT00500240|9663707|FG001|COMPLETED|Overall Study||26
8624412|NCT00500240|9663706|FG000|NOT COMPLETED|Overall Study||0
8624413|NCT00500240|9663707|FG001|NOT COMPLETED|Overall Study||0
8624414|NCT00500266|9663715|FG000|STARTED|Overall Study||1053
8624415|NCT00500266|9663715|FG000|Treated|Overall Study||1049
8624416|NCT00500266|9663715|FG000|COMPLETED|Overall Study||1040
8624417|NCT00500266|9663715|FG000|NOT COMPLETED|Overall Study||13
8624418|NCT00500292|9663723|FG000|STARTED|Overall Study|randomised patients|32
8624419|NCT00500292|9663724|FG001|STARTED|Overall Study|randomised patients|35
8624420|NCT00500292|9663725|FG002|STARTED|Overall Study|randomised patients|37
8624421|NCT00500292|9663723|FG000|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 8 March 2008.|7
8624422|NCT00500292|9663724|FG001|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 8 March 2008.|4
8629507|NCT00530777|9669268|FG000|STARTED|Overall Study||74
9080216|NCT01190306|10143154|FG000|NOT COMPLETED|Overall Study||0
9080217|NCT01190306|10143155|FG001|NOT COMPLETED|Overall Study||0
9080218|NCT01179737|10143165|FG000|STARTED|Cohort 1 & Cohort 2||12
9080219|NCT01179737|10143166|FG001|STARTED|Cohort 1 & Cohort 2|One patient was missing the end of study evaluation|3
9080220|NCT01179737|10143167|FG002|STARTED|Cohort 1 & Cohort 2||4
8624423|NCT00500292|9663725|FG002|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 8 March 2008.|10
8624424|NCT00500292|9663723|FG000|NOT COMPLETED|Overall Study||25
8624425|NCT00500292|9663724|FG001|NOT COMPLETED|Overall Study||31
8624426|NCT00500292|9663725|FG002|NOT COMPLETED|Overall Study||27
8624427|NCT00500318|9663735|FG000|STARTED|Overall Study||86
8624428|NCT00500318|9663736|FG001|STARTED|Overall Study||95
8624429|NCT00500318|9663735|FG000|COMPLETED|Overall Study||81
8624430|NCT00500318|9663736|FG001|COMPLETED|Overall Study||78
8624431|NCT00500318|9663735|FG000|NOT COMPLETED|Overall Study||5
8624432|NCT00500318|9663736|FG001|NOT COMPLETED|Overall Study||17
8624433|NCT00500331|9663749|FG000|STARTED|Overall Study||48
8624434|NCT00500331|9663750|FG001|STARTED|Overall Study||47
8624435|NCT00500331|9663751|FG002|STARTED|Overall Study||48
8624436|NCT00500331|9663752|FG003|STARTED|Overall Study||48
8624437|NCT00500331|9663753|FG004|STARTED|Overall Study||48
8624438|NCT00500331|9663754|FG005|STARTED|Overall Study||47
8624439|NCT00500331|9663755|FG006|STARTED|Overall Study||48
8624440|NCT00500331|9663749|FG000|COMPLETED|Overall Study||33
8624441|NCT00500331|9663750|FG001|COMPLETED|Overall Study||42
8624442|NCT00500331|9663751|FG002|COMPLETED|Overall Study||43
8624443|NCT00500331|9663752|FG003|COMPLETED|Overall Study||38
8624444|NCT00500331|9663753|FG004|COMPLETED|Overall Study||44
8624445|NCT00500331|9663754|FG005|COMPLETED|Overall Study||42
8624446|NCT00500331|9663755|FG006|COMPLETED|Overall Study||46
8624447|NCT00500331|9663749|FG000|NOT COMPLETED|Overall Study||15
8624448|NCT00500331|9663750|FG001|NOT COMPLETED|Overall Study||5
8624449|NCT00500331|9663751|FG002|NOT COMPLETED|Overall Study||5
8624450|NCT00500331|9663752|FG003|NOT COMPLETED|Overall Study||10
8624451|NCT00500331|9663753|FG004|NOT COMPLETED|Overall Study||4
8624452|NCT00500331|9663754|FG005|NOT COMPLETED|Overall Study||5
8624453|NCT00500331|9663755|FG006|NOT COMPLETED|Overall Study||2
8624454|NCT00500357|9663772|FG000|STARTED|Overall Study||105
8624455|NCT00500357|9663772|FG000|Received 13vPnC (Vax 3)|Overall Study||105
8624456|NCT00500357|9663772|FG000|Evaluable Immunogenicity Population|Overall Study|Administered Vax 1 and Vax 2 in study 6115A1-500; Vax 3 and at least 1 assay result in 6115A1-3009.|98
8624457|NCT00500357|9663772|FG000|COMPLETED|Overall Study||104
8624458|NCT00500357|9663772|FG000|NOT COMPLETED|Overall Study||1
8624459|NCT00500370|9663789|FG000|STARTED|Overall Study||80
8624460|NCT00500370|9663790|FG001|STARTED|Overall Study||83
8624461|NCT00500370|9663789|FG000|Treatment Start-Baseline (Week 0)|Overall Study||73
8624462|NCT00500370|9663790|FG001|Treatment Start-Baseline (Week 0)|Overall Study||79
8624463|NCT00500370|9663789|FG000|Treatment Complete (Week 24)|Overall Study||48
8624464|NCT00500370|9663790|FG001|Treatment Complete (Week 24)|Overall Study||54
8624465|NCT00500370|9663789|FG000|COMPLETED|Overall Study|COMPLETED = completion of treatment period (Week 24) plus follow-up visit 4 weeks later|47
8624466|NCT00500370|9663790|FG001|COMPLETED|Overall Study|COMPLETED = completion of treatment period (Week 24) plus follow-up visit 4 weeks later|49
8624467|NCT00500370|9663789|FG000|NOT COMPLETED|Overall Study||33
9080221|NCT01179737|10143168|FG003|STARTED|Cohort 1 & Cohort 2||4
9080222|NCT01179737|10143165|FG000|COMPLETED|Cohort 1 & Cohort 2||7
9080223|NCT01179737|10143166|FG001|COMPLETED|Cohort 1 & Cohort 2||1
9080224|NCT01179737|10143167|FG002|COMPLETED|Cohort 1 & Cohort 2||0
9080225|NCT01179737|10143168|FG003|COMPLETED|Cohort 1 & Cohort 2||0
9080226|NCT01179737|10143165|FG000|NOT COMPLETED|Cohort 1 & Cohort 2||5
9080227|NCT01179737|10143166|FG001|NOT COMPLETED|Cohort 1 & Cohort 2||2
9080228|NCT01179737|10143167|FG002|NOT COMPLETED|Cohort 1 & Cohort 2||4
9080229|NCT01179737|10143168|FG003|NOT COMPLETED|Cohort 1 & Cohort 2||4
9080230|NCT01179737|10143165|FG000|STARTED|Cohort 1 & Cohort 2 Expansion|2 participants did not enroll in extension|5
9080231|NCT01179737|10143166|FG001|STARTED|Cohort 1 & Cohort 2 Expansion||1
9080232|NCT01179737|10143167|FG002|STARTED|Cohort 1 & Cohort 2 Expansion||0
9080233|NCT01179737|10143168|FG003|STARTED|Cohort 1 & Cohort 2 Expansion||0
9080234|NCT01179737|10143165|FG000|COMPLETED|Cohort 1 & Cohort 2 Expansion||4
9080235|NCT01179737|10143166|FG001|COMPLETED|Cohort 1 & Cohort 2 Expansion||1
9080236|NCT01179737|10143167|FG002|COMPLETED|Cohort 1 & Cohort 2 Expansion||0
9080237|NCT01179737|10143168|FG003|COMPLETED|Cohort 1 & Cohort 2 Expansion||0
9080238|NCT01179737|10143165|FG000|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||1
9080239|NCT01179737|10143166|FG001|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||0
9080240|NCT01179737|10143167|FG002|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||0
9080241|NCT01179737|10143168|FG003|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||0
9080242|NCT01179737|10143165|FG000|STARTED|Extension|Two patients did not enrol in the extension|3
9080243|NCT01179737|10143166|FG001|STARTED|Extension|One patient did not enrol in the extension|0
9080244|NCT01179737|10143167|FG002|STARTED|Extension||0
9080245|NCT01179737|10143168|FG003|STARTED|Extension||0
9080246|NCT01179737|10143165|FG000|COMPLETED|Extension||0
9080247|NCT01179737|10143166|FG001|COMPLETED|Extension||0
9080248|NCT01179737|10143167|FG002|COMPLETED|Extension||0
9080249|NCT01179737|10143168|FG003|COMPLETED|Extension||0
9080250|NCT01179737|10143165|FG000|NOT COMPLETED|Extension||3
9080251|NCT01179737|10143166|FG001|NOT COMPLETED|Extension||0
9080252|NCT01179737|10143167|FG002|NOT COMPLETED|Extension||0
9080253|NCT01179737|10143168|FG003|NOT COMPLETED|Extension||0
9080254|NCT01183468|10143181|FG000|STARTED|Overall Study||8
9080255|NCT01183468|10143182|FG001|STARTED|Overall Study||9
9080256|NCT01183468|10143183|FG002|STARTED|Overall Study||0
9080257|NCT01183468|10143184|FG003|STARTED|Overall Study||0
9080258|NCT01183468|10143181|FG000|COMPLETED|Overall Study||5
9080259|NCT01183468|10143182|FG001|COMPLETED|Overall Study||7
9080260|NCT01183468|10143183|FG002|COMPLETED|Overall Study||0
9080261|NCT01183468|10143184|FG003|COMPLETED|Overall Study||0
9080262|NCT01183468|10143181|FG000|NOT COMPLETED|Overall Study||3
9080263|NCT01183468|10143182|FG001|NOT COMPLETED|Overall Study||2
9080264|NCT01183468|10143183|FG002|NOT COMPLETED|Overall Study||0
9080265|NCT01183468|10143184|FG003|NOT COMPLETED|Overall Study||0
9080266|NCT01181921|10143192|FG000|STARTED|Overall Study||1
9080267|NCT01181921|10143192|FG000|COMPLETED|Overall Study||0
9080268|NCT01181921|10143192|FG000|NOT COMPLETED|Overall Study||1
9080269|NCT01188798|10143198|FG000|STARTED|Overall Study||2
9080270|NCT01188798|10143199|FG001|STARTED|Overall Study||4
9080271|NCT01188798|10143198|FG000|COMPLETED|Overall Study||0
9080272|NCT01188798|10143199|FG001|COMPLETED|Overall Study||1
9080273|NCT01188798|10143198|FG000|NOT COMPLETED|Overall Study||2
9080274|NCT01188798|10143199|FG001|NOT COMPLETED|Overall Study||3
9080275|NCT01174368|10143206|FG000|STARTED|Overall Study||1
9080276|NCT01174368|10143206|FG000|COMPLETED|Overall Study||0
9080277|NCT01174368|10143206|FG000|NOT COMPLETED|Overall Study||1
9080278|NCT01183897|10143210|FG000|STARTED|Overall Study||31
9080279|NCT01183897|10143210|FG000|COMPLETED|Overall Study||31
9080280|NCT01183897|10143210|FG000|NOT COMPLETED|Overall Study||0
9080281|NCT01183884|10143214|FG000|STARTED|Overall Study||46
9080282|NCT01183884|10143214|FG000|COMPLETED|Overall Study||8
9080283|NCT01183884|10143214|FG000|NOT COMPLETED|Overall Study||38
9080284|NCT01183429|10143218|FG000|STARTED|Overall Study||39
9080285|NCT01183429|10143218|FG000|COMPLETED|Overall Study||39
9080286|NCT01183429|10143218|FG000|NOT COMPLETED|Overall Study||0
9080287|NCT01166178|10143224|FG000|STARTED|Overall Study||21
9080288|NCT01166178|10143225|FG001|STARTED|Overall Study||8
9080289|NCT01166178|10143224|FG000|COMPLETED|Overall Study||0
9080290|NCT01166178|10143225|FG001|COMPLETED|Overall Study||0
9080291|NCT01166178|10143224|FG000|NOT COMPLETED|Overall Study||21
9080292|NCT01166178|10143225|FG001|NOT COMPLETED|Overall Study||8
9080293|NCT01176513|10143231|FG000|STARTED|Overall Study||25
9080294|NCT01176513|10143231|FG000|COMPLETED|Overall Study||22
9080295|NCT01176513|10143231|FG000|NOT COMPLETED|Overall Study||3
9080296|NCT01165450|10143235|FG000|STARTED|Overall Study||2
9080297|NCT01165450|10143235|FG000|COMPLETED|Overall Study||2
9080298|NCT01165450|10143235|FG000|NOT COMPLETED|Overall Study||0
9080299|NCT01179399|10143239|FG000|STARTED|Overall Study||32
9080300|NCT01179399|10143239|FG000|COMPLETED|Overall Study||0
9080301|NCT01179399|10143239|FG000|NOT COMPLETED|Overall Study||32
9080302|NCT01169753|10143245|FG000|STARTED|Overall Study||0
9080303|NCT01169753|10143246|FG001|STARTED|Overall Study||1
9080304|NCT01169753|10143245|FG000|COMPLETED|Overall Study||0
9080305|NCT01169753|10143246|FG001|COMPLETED|Overall Study||0
9080306|NCT01169753|10143245|FG000|NOT COMPLETED|Overall Study||0
9080307|NCT01169753|10143246|FG001|NOT COMPLETED|Overall Study||1
9080308|NCT01171534|10143254|FG000|STARTED|Overall Study|retrospective arm never performed on study|0
9080309|NCT01171534|10143255|FG001|STARTED|Overall Study||7
9080310|NCT01171534|10143254|FG000|COMPLETED|Overall Study||0
9080311|NCT01171534|10143255|FG001|COMPLETED|Overall Study||4
9080312|NCT01171534|10143254|FG000|NOT COMPLETED|Overall Study||0
9080313|NCT01171534|10143255|FG001|NOT COMPLETED|Overall Study||3
9080314|NCT01169610|10143261|FG000|STARTED|Overall Study||1
9080315|NCT01169610|10143261|FG000|COMPLETED|Overall Study||1
9080316|NCT01169610|10143261|FG000|NOT COMPLETED|Overall Study||0
9080317|NCT01163084|10143267|FG000|STARTED|Overall Study||4
9080318|NCT01163084|10143268|FG001|STARTED|Overall Study||5
9080319|NCT01163084|10143267|FG000|COMPLETED|Overall Study||4
9080320|NCT01163084|10143268|FG001|COMPLETED|Overall Study||5
9080321|NCT01163084|10143267|FG000|NOT COMPLETED|Overall Study||0
9080322|NCT01163084|10143268|FG001|NOT COMPLETED|Overall Study||0
9080323|NCT01166724|10143276|FG000|STARTED|Overall Study||7
9080324|NCT01166724|10143277|FG001|STARTED|Overall Study||5
9080325|NCT01166724|10143276|FG000|COMPLETED|Overall Study||0
9080326|NCT01166724|10143277|FG001|COMPLETED|Overall Study||0
9080327|NCT01166724|10143276|FG000|NOT COMPLETED|Overall Study||7
9080328|NCT01166724|10143277|FG001|NOT COMPLETED|Overall Study||5
9080329|NCT01162382|10143283|FG000|STARTED|Overall Study||0
9080330|NCT01162382|10143283|FG000|COMPLETED|Overall Study||0
9080331|NCT01162382|10143283|FG000|NOT COMPLETED|Overall Study||0
9080332|NCT01157533|10143287|FG000|STARTED|Overall Study||1
9080333|NCT01157533|10143287|FG000|COMPLETED|Overall Study||1
9080334|NCT01157533|10143287|FG000|NOT COMPLETED|Overall Study||0
9080335|NCT01162304|10143291|FG000|STARTED|Overall Study||18
9080336|NCT01162304|10143291|FG000|COMPLETED|Overall Study||7
9080337|NCT01162304|10143291|FG000|NOT COMPLETED|Overall Study||11
9080338|NCT01151904|10143297|FG000|STARTED|Overall Study||17
9080339|NCT01151904|10143297|FG000|COMPLETED|Overall Study||17
9080340|NCT01151904|10143297|FG000|NOT COMPLETED|Overall Study||0
9080341|NCT01155518|10143307|FG000|STARTED|Overall Study||1
9080342|NCT01155518|10143308|FG001|STARTED|Overall Study||1
9080343|NCT01155518|10143309|FG002|STARTED|Overall Study||0
9080344|NCT01155518|10143310|FG003|STARTED|Overall Study||0
9080345|NCT01155518|10143311|FG004|STARTED|Overall Study||1
9080346|NCT01155518|10143312|FG005|STARTED|Overall Study||2
9080347|NCT01155518|10143307|FG000|COMPLETED|Overall Study||1
9080348|NCT01155518|10143308|FG001|COMPLETED|Overall Study|never started the study|0
9080349|NCT01155518|10143309|FG002|COMPLETED|Overall Study||0
9080350|NCT01155518|10143310|FG003|COMPLETED|Overall Study||0
9080351|NCT01155518|10143311|FG004|COMPLETED|Overall Study||1
9080352|NCT01155518|10143312|FG005|COMPLETED|Overall Study||2
9080353|NCT01155518|10143307|FG000|NOT COMPLETED|Overall Study||0
9080354|NCT01155518|10143308|FG001|NOT COMPLETED|Overall Study||1
9080355|NCT01155518|10143309|FG002|NOT COMPLETED|Overall Study||0
9080356|NCT01155518|10143310|FG003|NOT COMPLETED|Overall Study||0
9080357|NCT01155518|10143311|FG004|NOT COMPLETED|Overall Study||0
9080358|NCT01155518|10143312|FG005|NOT COMPLETED|Overall Study||0
9080359|NCT01150409|10143328|FG000|STARTED|Overall Study||11
9080360|NCT01150409|10143329|FG001|STARTED|Overall Study||0
9080361|NCT01150409|10143328|FG000|COMPLETED|Overall Study||11
9080362|NCT01150409|10143329|FG001|COMPLETED|Overall Study||0
9080363|NCT01150409|10143328|FG000|NOT COMPLETED|Overall Study||0
9080364|NCT01150409|10143329|FG001|NOT COMPLETED|Overall Study||0
9080365|NCT01151553|10143335|FG000|STARTED|Overall Study||5
9080366|NCT01151553|10143335|FG000|COMPLETED|Overall Study||5
9080367|NCT01151553|10143335|FG000|NOT COMPLETED|Overall Study||0
9080368|NCT01148056|10143339|FG000|STARTED|Overall Study||2
9080369|NCT01148056|10143339|FG000|COMPLETED|Overall Study||2
9080370|NCT01148056|10143339|FG000|NOT COMPLETED|Overall Study||0
9080371|NCT01147393|10143343|FG000|STARTED|Dose Level 1||3
9080372|NCT01147393|10143343|FG000|COMPLETED|Dose Level 1||1
9080373|NCT01147393|10143343|FG000|NOT COMPLETED|Dose Level 1||2
9080374|NCT01147393|10143343|FG000|STARTED|Dose Level -1||1
9080375|NCT01147393|10143343|FG000|COMPLETED|Dose Level -1||0
9080376|NCT01147393|10143343|FG000|NOT COMPLETED|Dose Level -1||1
9080377|NCT01147042|10143350|FG000|STARTED|Overall Study||2
9080378|NCT01147042|10143351|FG001|STARTED|Overall Study||0
9080379|NCT01147042|10143350|FG000|COMPLETED|Overall Study||2
9080380|NCT01147042|10143351|FG001|COMPLETED|Overall Study||0
9080381|NCT01147042|10143350|FG000|NOT COMPLETED|Overall Study||0
9080382|NCT01147042|10143351|FG001|NOT COMPLETED|Overall Study||0
9080383|NCT01147536|10143356|FG000|STARTED|Overall Study||12
9080384|NCT01147536|10143356|FG000|Received at Least 1 Dose of Study Drug|Overall Study||12
9080385|NCT01147536|10143356|FG000|COMPLETED|Overall Study||9
9080386|NCT01147536|10143356|FG000|NOT COMPLETED|Overall Study||3
9080387|NCT01139996|10143362|FG000|STARTED|Overall Study||11
9080388|NCT01139996|10143363|FG001|STARTED|Overall Study||11
9080389|NCT01139996|10143362|FG000|COMPLETED|Overall Study||11
9080390|NCT01139996|10143363|FG001|COMPLETED|Overall Study||11
9080391|NCT01139996|10143362|FG000|NOT COMPLETED|Overall Study||0
9080392|NCT01139996|10143363|FG001|NOT COMPLETED|Overall Study||0
9080393|NCT01133288|10143369|FG000|STARTED|Eligibility Assessment||7
9080394|NCT01133288|10143369|FG000|COMPLETED|Eligibility Assessment||2
9080395|NCT01133288|10143369|FG000|NOT COMPLETED|Eligibility Assessment||5
9080396|NCT01133288|10143369|FG000|STARTED|Intervention Allocation||2
9080397|NCT01133288|10143369|FG000|COMPLETED|Intervention Allocation||0
9080398|NCT01133288|10143369|FG000|NOT COMPLETED|Intervention Allocation||2
8844656|NCT01710891|9899093|FG001|STARTED|Overall Study||103
8844657|NCT01710891|9899092|FG000|COMPLETED|Overall Study||95
9080399|NCT01142128|10143377|FG000|STARTED|Overall Study||8
9080400|NCT01142128|10143377|FG000|Nexium Alone|Overall Study||3
9080401|NCT01142128|10143377|FG000|Placebo to Nexium, Alone|Overall Study||3
9080402|NCT01142128|10143377|FG000|Viokase 16 Plus Nexium|Overall Study||2
9080403|NCT01142128|10143377|FG000|Viokase 16 Plus Placebo to Nexium|Overall Study||0
9080404|NCT01142128|10143377|FG000|COMPLETED|Overall Study||4
9080405|NCT01142128|10143377|FG000|NOT COMPLETED|Overall Study||4
9080406|NCT01131884|10143389|FG000|STARTED|Overall Study||1
9080407|NCT01131884|10143390|FG001|STARTED|Overall Study||0
9080408|NCT01131884|10143389|FG000|COMPLETED|Overall Study||1
9080409|NCT01131884|10143390|FG001|COMPLETED|Overall Study||0
9080410|NCT01131884|10143389|FG000|NOT COMPLETED|Overall Study||0
9080411|NCT01131884|10143390|FG001|NOT COMPLETED|Overall Study||0
9080412|NCT01128114|10143396|FG000|STARTED|Overall Study||32
9080413|NCT01128114|10143396|FG000|COMPLETED|Overall Study||24
9080414|NCT01128114|10143396|FG000|NOT COMPLETED|Overall Study||8
9080415|NCT01126879|10143402|FG000|STARTED|Overall Study||8
9080416|NCT01126879|10143403|FG001|STARTED|Overall Study||4
9080417|NCT01126879|10143402|FG000|Started 3 Months of Genistein/Placebo|Overall Study||8
9080418|NCT01126879|10143403|FG001|Started 3 Months of Genistein/Placebo|Overall Study||4
8844658|NCT01710891|9899093|FG001|COMPLETED|Overall Study||103
9080419|NCT01126879|10143402|FG000|Prostatectomy or Radiation|Overall Study||8
9080420|NCT01126879|10143403|FG001|Prostatectomy or Radiation|Overall Study||4
9080421|NCT01126879|10143402|FG000|Completed 3 Months Genistein/Placebo|Overall Study||4
9080422|NCT01126879|10143403|FG001|Completed 3 Months Genistein/Placebo|Overall Study||2
9080423|NCT01126879|10143402|FG000|COMPLETED|Overall Study||3
9080424|NCT01126879|10143403|FG001|COMPLETED|Overall Study||2
9080425|NCT01126879|10143402|FG000|NOT COMPLETED|Overall Study||5
9080426|NCT01126879|10143403|FG001|NOT COMPLETED|Overall Study||2
9080427|NCT01136811|10143409|FG000|STARTED|Overall Study||11
9080428|NCT01136811|10143409|FG000|COMPLETED|Overall Study||0
9080429|NCT01136811|10143409|FG000|NOT COMPLETED|Overall Study||11
9080430|NCT01139294|10143415|FG000|STARTED|Overall Study||0
9080431|NCT01139294|10143416|FG001|STARTED|Overall Study||0
9080432|NCT01139294|10143415|FG000|COMPLETED|Overall Study||0
9080433|NCT01139294|10143416|FG001|COMPLETED|Overall Study||0
9080434|NCT01139294|10143415|FG000|NOT COMPLETED|Overall Study||0
9080435|NCT01139294|10143416|FG001|NOT COMPLETED|Overall Study||0
9080436|NCT01139125|10143422|FG000|STARTED|Overall Study||3
9080437|NCT01139125|10143422|FG000|COMPLETED|Overall Study||2
9080438|NCT01139125|10143422|FG000|NOT COMPLETED|Overall Study||1
9080439|NCT01136668|10143428|FG000|STARTED|Overall Study||7
9080440|NCT01136668|10143429|FG001|STARTED|Overall Study||6
9080441|NCT01136668|10143428|FG000|COMPLETED|Overall Study||7
9080442|NCT01136668|10143429|FG001|COMPLETED|Overall Study||6
9080443|NCT01136668|10143428|FG000|NOT COMPLETED|Overall Study||0
9080444|NCT01136668|10143429|FG001|NOT COMPLETED|Overall Study||0
9080445|NCT01133639|10143437|FG000|STARTED|Overall Study|18 total subjects were enrolled, study was terminated prematurely and data was not analyzed|0
9080446|NCT01133639|10143438|FG001|STARTED|Overall Study|18 total subjects were enrolled, study was terminated prematurely and data was not analyzed|0
9080447|NCT01133639|10143437|FG000|COMPLETED|Overall Study|18 total subjects were enrolled, study was terminated prematurely and data was not analyzed|0
9080448|NCT01133639|10143438|FG001|COMPLETED|Overall Study|18 total subjects were enrolled,study was terminated prematurely and data was not analyzed|0
9080449|NCT01133639|10143437|FG000|NOT COMPLETED|Overall Study||0
9080450|NCT01133639|10143438|FG001|NOT COMPLETED|Overall Study||0
9080451|NCT01131455|10143446|FG000|STARTED|Overall Study||6
9080452|NCT01131455|10143447|FG001|STARTED|Overall Study||4
9080453|NCT01131455|10143448|FG002|STARTED|Overall Study||0
9080454|NCT01131455|10143446|FG000|COMPLETED|Overall Study||0
9080455|NCT01131455|10143447|FG001|COMPLETED|Overall Study||0
9080456|NCT01131455|10143448|FG002|COMPLETED|Overall Study||0
9080457|NCT01131455|10143446|FG000|NOT COMPLETED|Overall Study||6
9080458|NCT01131455|10143447|FG001|NOT COMPLETED|Overall Study||4
9080459|NCT01131455|10143448|FG002|NOT COMPLETED|Overall Study||0
9080460|NCT01126801|10143458|FG000|STARTED|Overall Study||1
9080461|NCT01126801|10143459|FG001|STARTED|Overall Study||1
9080462|NCT01126801|10143458|FG000|COMPLETED|Overall Study||1
9080463|NCT01126801|10143459|FG001|COMPLETED|Overall Study||1
9080464|NCT01126801|10143458|FG000|NOT COMPLETED|Overall Study||0
9080465|NCT01126801|10143459|FG001|NOT COMPLETED|Overall Study||0
9080466|NCT01123850|10143465|FG000|STARTED|Overall Study||45
9080467|NCT01123850|10143465|FG000|COMPLETED|Overall Study||0
9080468|NCT01123850|10143465|FG000|NOT COMPLETED|Overall Study||45
9080469|NCT01126957|10143469|FG000|STARTED|Overall Study||103
9080470|NCT01126957|10143469|FG000|COMPLETED|Overall Study||103
9080471|NCT01126957|10143469|FG000|NOT COMPLETED|Overall Study||0
9080472|NCT01127503|10143476|FG000|STARTED|Overall Study||1
9080473|NCT01127503|10143477|FG001|STARTED|Overall Study||1
9080474|NCT01127503|10143476|FG000|COMPLETED|Overall Study||1
9080475|NCT01127503|10143477|FG001|COMPLETED|Overall Study||1
9080476|NCT01127503|10143476|FG000|NOT COMPLETED|Overall Study||0
9080477|NCT01127503|10143477|FG001|NOT COMPLETED|Overall Study||0
9080478|NCT01122511|10143485|FG000|STARTED|Overall Study||2
9080479|NCT01122511|10143486|FG001|STARTED|Overall Study||2
9080480|NCT01122511|10143485|FG000|COMPLETED|Overall Study||0
9080481|NCT01122511|10143486|FG001|COMPLETED|Overall Study||0
9080482|NCT01122511|10143485|FG000|NOT COMPLETED|Overall Study||2
9080483|NCT01122511|10143486|FG001|NOT COMPLETED|Overall Study||2
9080484|NCT01118013|10143492|FG000|STARTED|Overall Study||6
9080485|NCT01118013|10143492|FG000|COMPLETED|Overall Study||6
9080486|NCT01118013|10143492|FG000|NOT COMPLETED|Overall Study||0
9080487|NCT01122381|10143498|FG000|STARTED|Overall Study||1
9080488|NCT01122381|10143499|FG001|STARTED|Overall Study||1
9080489|NCT01122381|10143498|FG000|COMPLETED|Overall Study|Subject never took the drug per review of ESX levels after unblinding|1
9080490|NCT01122381|10143499|FG001|COMPLETED|Overall Study||0
9080491|NCT01122381|10143498|FG000|NOT COMPLETED|Overall Study||0
9080492|NCT01122381|10143499|FG001|NOT COMPLETED|Overall Study||1
9080493|NCT01116232|10143505|FG000|STARTED|Overall Study||4
9080494|NCT01116232|10143505|FG000|COMPLETED|Overall Study||0
9080495|NCT01116232|10143505|FG000|NOT COMPLETED|Overall Study||4
9080496|NCT01110174|10143512|FG000|STARTED|Overall Study||8
9080497|NCT01110174|10143512|FG000|COMPLETED|Overall Study||8
9080498|NCT01110174|10143512|FG000|NOT COMPLETED|Overall Study||0
9080499|NCT01115699|10143516|FG000|STARTED|Overall Study||2
9080500|NCT01115699|10143516|FG000|COMPLETED|Overall Study||2
9080501|NCT01115699|10143516|FG000|NOT COMPLETED|Overall Study||0
9080502|NCT01108666|10143520|FG000|STARTED|Overall Study|Despite all possible efforts to contact the PI/study, data per dose-level are not available to be reported|7
9080503|NCT01108666|10143520|FG000|COMPLETED|Overall Study|Despite all possible efforts to contact the PI/study, data per dose-level are not available to be reported|7
9080504|NCT01108666|10143520|FG000|NOT COMPLETED|Overall Study||0
9080505|NCT01115244|10143526|FG000|STARTED|Overall Study||0
9080506|NCT01115244|10143527|FG001|STARTED|Overall Study||0
9080507|NCT01115244|10143526|FG000|COMPLETED|Overall Study||0
9080508|NCT01115244|10143527|FG001|COMPLETED|Overall Study||0
9080509|NCT01115244|10143526|FG000|NOT COMPLETED|Overall Study||0
9080510|NCT01115244|10143527|FG001|NOT COMPLETED|Overall Study||0
9080511|NCT01108523|10143533|FG000|STARTED|Overall Study||7
9080512|NCT01108523|10143533|FG000|COMPLETED|Overall Study||3
9080513|NCT01108523|10143533|FG000|NOT COMPLETED|Overall Study||4
9080514|NCT01107795|10143537|FG000|STARTED|Overall Study||41
9080515|NCT01107795|10143537|FG000|COMPLETED|Overall Study||41
9080516|NCT01107795|10143537|FG000|NOT COMPLETED|Overall Study||0
9080517|NCT01106534|10143541|FG000|STARTED|Overall Study||2997
9080518|NCT01106534|10143541|FG000|COMPLETED|Overall Study||2960
9080519|NCT01106534|10143541|FG000|NOT COMPLETED|Overall Study||37
9080520|NCT01104116|10143546|FG000|STARTED|Overall Study||1
9080521|NCT01104116|10143546|FG000|COMPLETED|Overall Study||1
9080522|NCT01104116|10143546|FG000|NOT COMPLETED|Overall Study||0
9080523|NCT01100658|10143550|FG000|STARTED|Overall Study||1
9080524|NCT01100658|10143550|FG000|COMPLETED|Overall Study||0
9080525|NCT01100658|10143550|FG000|NOT COMPLETED|Overall Study||1
9080526|NCT01103180|10143556|FG000|STARTED|Overall Study||35
9080527|NCT01103180|10143557|FG001|STARTED|Overall Study||35
9080528|NCT01103180|10143556|FG000|COMPLETED|Overall Study||13
9080529|NCT01103180|10143557|FG001|COMPLETED|Overall Study||14
9080530|NCT01103180|10143556|FG000|NOT COMPLETED|Overall Study||22
9080531|NCT01103180|10143557|FG001|NOT COMPLETED|Overall Study||21
9080532|NCT01090141|10143565|FG000|STARTED|Overall Study||0
9080533|NCT01090141|10143566|FG001|STARTED|Overall Study||0
9080534|NCT01090141|10143565|FG000|COMPLETED|Overall Study||0
9080535|NCT01090141|10143566|FG001|COMPLETED|Overall Study||0
9080536|NCT01090141|10143565|FG000|NOT COMPLETED|Overall Study||0
9080537|NCT01090141|10143566|FG001|NOT COMPLETED|Overall Study||0
9080538|NCT01102140|10143574|FG000|STARTED|Overall Study||13
9080539|NCT01102140|10143575|FG001|STARTED|Overall Study||7
9080540|NCT01102140|10143574|FG000|COMPLETED|Overall Study||10
9080541|NCT01102140|10143575|FG001|COMPLETED|Overall Study||5
9080542|NCT01102140|10143574|FG000|NOT COMPLETED|Overall Study||3
9080543|NCT01102140|10143575|FG001|NOT COMPLETED|Overall Study||2
9080544|NCT01095250|10143587|FG000|STARTED|Overall Study||8
9080545|NCT01095250|10143588|FG001|STARTED|Overall Study||10
9080546|NCT01095250|10143589|FG002|STARTED|Overall Study||8
9080547|NCT01095250|10143590|FG003|STARTED|Overall Study||5
9080548|NCT01095250|10143587|FG000|COMPLETED|Overall Study||0
9080549|NCT01095250|10143588|FG001|COMPLETED|Overall Study||0
9080550|NCT01095250|10143589|FG002|COMPLETED|Overall Study||0
9080551|NCT01095250|10143590|FG003|COMPLETED|Overall Study||0
9080552|NCT01095250|10143587|FG000|NOT COMPLETED|Overall Study||8
9080553|NCT01095250|10143588|FG001|NOT COMPLETED|Overall Study||10
9080554|NCT01095250|10143589|FG002|NOT COMPLETED|Overall Study||8
9080555|NCT01095250|10143590|FG003|NOT COMPLETED|Overall Study||5
9080556|NCT01094561|10143600|FG000|STARTED|Overall Study||23
9080557|NCT01094561|10143600|FG000|COMPLETED|Overall Study||17
9080558|NCT01094561|10143600|FG000|NOT COMPLETED|Overall Study||6
9080559|NCT01093846|10143607|FG000|STARTED|Overall Study||19
9080560|NCT01093846|10143608|FG001|STARTED|Overall Study||18
9080561|NCT01093846|10143609|FG002|STARTED|Overall Study||22
9080562|NCT01093846|10143607|FG000|COMPLETED|Overall Study||0
9080563|NCT01093846|10143608|FG001|COMPLETED|Overall Study||0
9080564|NCT01093846|10143609|FG002|COMPLETED|Overall Study||1
9080565|NCT01093846|10143607|FG000|NOT COMPLETED|Overall Study||19
9080566|NCT01093846|10143608|FG001|NOT COMPLETED|Overall Study||18
9080567|NCT01093846|10143609|FG002|NOT COMPLETED|Overall Study||21
9080568|NCT01078844|10143615|FG000|STARTED|Overall Study||4
9080569|NCT01078844|10143615|FG000|COMPLETED|Overall Study||0
9080570|NCT01078844|10143615|FG000|NOT COMPLETED|Overall Study||4
9080571|NCT01081886|10143622|FG000|STARTED|Overall Study||11
9080572|NCT01081886|10143623|FG001|STARTED|Overall Study||13
9080573|NCT01081886|10143622|FG000|COMPLETED|Overall Study||0
9080574|NCT01081886|10143623|FG001|COMPLETED|Overall Study||0
9080575|NCT01081886|10143622|FG000|NOT COMPLETED|Overall Study||11
9080576|NCT01081886|10143623|FG001|NOT COMPLETED|Overall Study||13
9080577|NCT01085643|10143629|FG000|STARTED|Overall Study||4
9080578|NCT01085643|10143629|FG000|COMPLETED|Overall Study||4
9080579|NCT01085643|10143629|FG000|NOT COMPLETED|Overall Study||0
9080580|NCT01083472|10143635|FG000|STARTED|Overall Study||18
9080581|NCT01083472|10143636|FG001|STARTED|Overall Study||19
9080582|NCT01083472|10143635|FG000|COMPLETED|Overall Study||18
9080583|NCT01083472|10143636|FG001|COMPLETED|Overall Study||19
9080584|NCT01083472|10143635|FG000|NOT COMPLETED|Overall Study||0
9080585|NCT01083472|10143636|FG001|NOT COMPLETED|Overall Study||0
9080586|NCT01080768|10143644|FG000|STARTED|Overall Study||14
9080587|NCT01080768|10143645|FG001|STARTED|Overall Study||17
9080588|NCT01080768|10143644|FG000|COMPLETED|Overall Study||12
9080589|NCT01080768|10143645|FG001|COMPLETED|Overall Study||16
9080590|NCT01080768|10143644|FG000|NOT COMPLETED|Overall Study||2
9080591|NCT01080768|10143645|FG001|NOT COMPLETED|Overall Study||1
9080592|NCT01079598|10143651|FG000|STARTED|Overall Study||8
9080593|NCT01079598|10143651|FG000|COMPLETED|Overall Study||8
9080594|NCT01079598|10143651|FG000|NOT COMPLETED|Overall Study||0
9080595|NCT01074502|10143655|FG000|STARTED|Overall Study||3
9080596|NCT01074502|10143655|FG000|COMPLETED|Overall Study||2
9080597|NCT01074502|10143655|FG000|NOT COMPLETED|Overall Study||1
9080598|NCT01074437|10143661|FG000|STARTED|Overall Study||4
9080599|NCT01074437|10143662|FG001|STARTED|Overall Study||5
9080600|NCT01074437|10143661|FG000|COMPLETED|Overall Study||4
9080601|NCT01074437|10143662|FG001|COMPLETED|Overall Study||5
9080602|NCT01074437|10143661|FG000|NOT COMPLETED|Overall Study||0
9080603|NCT01074437|10143662|FG001|NOT COMPLETED|Overall Study||0
9080604|NCT01069861|10143668|FG000|STARTED|Overall Study||4
9080605|NCT01069861|10143668|FG000|COMPLETED|Overall Study||1
9080606|NCT01069861|10143668|FG000|NOT COMPLETED|Overall Study||3
9080607|NCT01072526|10143672|FG000|STARTED|Overall Study|Study started in December 2007 (recruited 6 patients total of 20 anticipated)|6
9080608|NCT01072526|10143673|FG001|STARTED|Overall Study||0
9080609|NCT01072526|10143672|FG000|COMPLETED|Overall Study|Study completed in September 2008(recruited 6 patients total of 20 anticipated)|6
9080610|NCT01072526|10143673|FG001|COMPLETED|Overall Study||0
9080611|NCT01072526|10143672|FG000|NOT COMPLETED|Overall Study||0
9080612|NCT01072526|10143673|FG001|NOT COMPLETED|Overall Study||0
9080613|NCT01071993|10143683|FG000|STARTED|Overall Study||0
9080614|NCT01071993|10143684|FG001|STARTED|Overall Study||0
9080615|NCT01071993|10143683|FG000|COMPLETED|Overall Study||0
9080616|NCT01071993|10143684|FG001|COMPLETED|Overall Study||0
9080617|NCT01071993|10143683|FG000|NOT COMPLETED|Overall Study||0
9080618|NCT01071993|10143684|FG001|NOT COMPLETED|Overall Study||0
9080619|NCT01065051|10143692|FG000|STARTED|Overall Study||1
9080620|NCT01065051|10143693|FG001|STARTED|Overall Study||0
9080621|NCT01065051|10143692|FG000|COMPLETED|Overall Study||1
9080622|NCT01065051|10143693|FG001|COMPLETED|Overall Study||0
9080623|NCT01065051|10143692|FG000|NOT COMPLETED|Overall Study||0
9080624|NCT01065051|10143693|FG001|NOT COMPLETED|Overall Study||0
9080625|NCT01069120|10143701|FG000|STARTED|Overall Study||27
9080626|NCT01069120|10143701|FG000|COMPLETED|Overall Study||0
9080627|NCT01069120|10143701|FG000|NOT COMPLETED|Overall Study||27
9080628|NCT01066637|10143709|FG000|STARTED|Overall Study||16
9080629|NCT01066637|10143710|FG001|STARTED|Overall Study||10
9080630|NCT01066637|10143709|FG000|COMPLETED|Overall Study||16
9080631|NCT01066637|10143710|FG001|COMPLETED|Overall Study||10
9080632|NCT01066637|10143709|FG000|NOT COMPLETED|Overall Study||0
9080633|NCT01066637|10143710|FG001|NOT COMPLETED|Overall Study||0
9080634|NCT01058642|10143720|FG000|STARTED|Treatment Period 1||9
9080635|NCT01058642|10143721|FG001|STARTED|Treatment Period 1||12
9080636|NCT01058642|10143722|FG002|STARTED|Treatment Period 1||11
9080637|NCT01058642|10143723|FG003|STARTED|Treatment Period 1||9
9080638|NCT01058642|10143720|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1||9
9080639|NCT01058642|10143721|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1||12
9080640|NCT01058642|10143722|FG002|Received at Least 1 Dose of Study Drug|Treatment Period 1||11
9080641|NCT01058642|10143723|FG003|Received at Least 1 Dose of Study Drug|Treatment Period 1||9
9080642|NCT01058642|10143720|FG000|COMPLETED|Treatment Period 1||7
9080643|NCT01058642|10143721|FG001|COMPLETED|Treatment Period 1||11
9080644|NCT01058642|10143722|FG002|COMPLETED|Treatment Period 1||9
9080645|NCT01058642|10143723|FG003|COMPLETED|Treatment Period 1||7
9080646|NCT01058642|10143720|FG000|NOT COMPLETED|Treatment Period 1||2
9080647|NCT01058642|10143721|FG001|NOT COMPLETED|Treatment Period 1||1
9080648|NCT01058642|10143722|FG002|NOT COMPLETED|Treatment Period 1||2
9080649|NCT01058642|10143723|FG003|NOT COMPLETED|Treatment Period 1||2
9080650|NCT01058642|10143720|FG000|STARTED|Washout Period||7
9080651|NCT01058642|10143721|FG001|STARTED|Washout Period||11
9080652|NCT01058642|10143722|FG002|STARTED|Washout Period||9
9080653|NCT01058642|10143723|FG003|STARTED|Washout Period||7
9080654|NCT01058642|10143720|FG000|COMPLETED|Washout Period||7
9080655|NCT01058642|10143721|FG001|COMPLETED|Washout Period||11
9080656|NCT01058642|10143722|FG002|COMPLETED|Washout Period||9
9080657|NCT01058642|10143723|FG003|COMPLETED|Washout Period||7
9080658|NCT01058642|10143720|FG000|NOT COMPLETED|Washout Period||0
9080659|NCT01058642|10143721|FG001|NOT COMPLETED|Washout Period||0
9080660|NCT01058642|10143722|FG002|NOT COMPLETED|Washout Period||0
9080661|NCT01058642|10143723|FG003|NOT COMPLETED|Washout Period||0
9080662|NCT01058642|10143720|FG000|STARTED|Treatment Period 2||7
9080663|NCT01058642|10143721|FG001|STARTED|Treatment Period 2||11
9080664|NCT01058642|10143722|FG002|STARTED|Treatment Period 2||9
9080665|NCT01058642|10143723|FG003|STARTED|Treatment Period 2||7
9080666|NCT01058642|10143720|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 2||7
9080667|NCT01058642|10143721|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 2||11
9080668|NCT01058642|10143722|FG002|Received at Least 1 Dose of Study Drug|Treatment Period 2||9
9080669|NCT01058642|10143723|FG003|Received at Least 1 Dose of Study Drug|Treatment Period 2||7
9080670|NCT01058642|10143720|FG000|COMPLETED|Treatment Period 2||7
9080671|NCT01058642|10143721|FG001|COMPLETED|Treatment Period 2||11
9080672|NCT01058642|10143722|FG002|COMPLETED|Treatment Period 2||9
9080673|NCT01058642|10143723|FG003|COMPLETED|Treatment Period 2||7
9080674|NCT01058642|10143720|FG000|NOT COMPLETED|Treatment Period 2||0
9080675|NCT01058642|10143721|FG001|NOT COMPLETED|Treatment Period 2||0
9080676|NCT01058642|10143722|FG002|NOT COMPLETED|Treatment Period 2||0
9080677|NCT01058642|10143723|FG003|NOT COMPLETED|Treatment Period 2||0
8624468|NCT00500370|9663790|FG001|NOT COMPLETED|Overall Study||34
8624469|NCT00500448|9663798|FG000|STARTED|Overall Study||14
8624470|NCT00500448|9663799|FG001|STARTED|Overall Study||16
8624471|NCT00500448|9663798|FG000|COMPLETED|Overall Study||14
8624472|NCT00500448|9663799|FG001|COMPLETED|Overall Study||16
8624473|NCT00500448|9663798|FG000|NOT COMPLETED|Overall Study||0
9080678|NCT01065818|10143731|FG000|STARTED|Overall Study||6
9080679|NCT01065818|10143731|FG000|COMPLETED|Overall Study||4
9080680|NCT01065818|10143731|FG000|NOT COMPLETED|Overall Study||2
9080681|NCT01051921|10143735|FG000|STARTED|Overall Study||67
9080682|NCT01051921|10143735|FG000|COMPLETED|Overall Study||37
9080683|NCT01051921|10143735|FG000|NOT COMPLETED|Overall Study||30
9080684|NCT01048125|10143741|FG000|STARTED|Overall Study||0
9080685|NCT01048125|10143742|FG001|STARTED|Overall Study||0
9080686|NCT01048125|10143741|FG000|COMPLETED|Overall Study||0
9080687|NCT01048125|10143742|FG001|COMPLETED|Overall Study||0
9080688|NCT01048125|10143741|FG000|NOT COMPLETED|Overall Study||0
9080689|NCT01048125|10143742|FG001|NOT COMPLETED|Overall Study||0
9080690|NCT01056315|10143750|FG000|STARTED|Overall Study||27
9080691|NCT01056315|10143751|FG001|STARTED|Overall Study||23
9080692|NCT01056315|10143750|FG000|COMPLETED|Overall Study||13
9080693|NCT01056315|10143751|FG001|COMPLETED|Overall Study||12
9080694|NCT01056315|10143750|FG000|NOT COMPLETED|Overall Study||14
9080695|NCT01056315|10143751|FG001|NOT COMPLETED|Overall Study||11
9080696|NCT01058369|10143757|FG000|STARTED|Overall Study||2
9080697|NCT01058369|10143757|FG000|COMPLETED|Overall Study||0
9080698|NCT01058369|10143757|FG000|NOT COMPLETED|Overall Study||2
9080699|NCT01048723|10143761|FG000|STARTED|Overall Study||2
9080700|NCT01048723|10143761|FG000|COMPLETED|Overall Study||2
9080701|NCT01048723|10143761|FG000|NOT COMPLETED|Overall Study||0
9080702|NCT01053221|10143767|FG000|STARTED|Overall Study||5
9080703|NCT01053221|10143768|FG001|STARTED|Overall Study||9
9080704|NCT01053221|10143767|FG000|COMPLETED|Overall Study||0
9080705|NCT01053221|10143768|FG001|COMPLETED|Overall Study||0
9080706|NCT01053221|10143767|FG000|NOT COMPLETED|Overall Study||5
9080707|NCT01053221|10143768|FG001|NOT COMPLETED|Overall Study||9
9080708|NCT01038752|10143776|FG000|STARTED|Overall Study||8
9080709|NCT01038752|10143777|FG001|STARTED|Overall Study||6
9080710|NCT01038752|10143776|FG000|COMPLETED|Overall Study||3
9080711|NCT01038752|10143777|FG001|COMPLETED|Overall Study||1
9080712|NCT01038752|10143776|FG000|NOT COMPLETED|Overall Study||5
9080713|NCT01038752|10143777|FG001|NOT COMPLETED|Overall Study||5
9080714|NCT01050218|10143783|FG000|STARTED|Overall Study||237
9080715|NCT01050218|10143783|FG000|COMPLETED|Overall Study||142
9080716|NCT01050218|10143783|FG000|NOT COMPLETED|Overall Study||95
9080717|NCT01045694|10143787|FG000|STARTED|Overall Study||8
9080718|NCT01045694|10143787|FG000|COMPLETED|Overall Study||6
9080719|NCT01045694|10143787|FG000|NOT COMPLETED|Overall Study||2
9080720|NCT01035944|10143795|FG000|STARTED|Overall Study||14
9080721|NCT01035944|10143796|FG001|STARTED|Overall Study||14
9080722|NCT01035944|10143797|FG002|STARTED|Overall Study||5
9080723|NCT01035944|10143798|FG003|STARTED|Overall Study||4
9080724|NCT01035944|10143795|FG000|COMPLETED|Overall Study||11
9080725|NCT01035944|10143796|FG001|COMPLETED|Overall Study||13
9080726|NCT01035944|10143797|FG002|COMPLETED|Overall Study||4
9080727|NCT01035944|10143798|FG003|COMPLETED|Overall Study||4
9080728|NCT01035944|10143795|FG000|NOT COMPLETED|Overall Study||3
9080729|NCT01035944|10143796|FG001|NOT COMPLETED|Overall Study||1
9080730|NCT01035944|10143797|FG002|NOT COMPLETED|Overall Study||1
9080731|NCT01035944|10143798|FG003|NOT COMPLETED|Overall Study||0
9080732|NCT01031628|10143812|FG000|STARTED|Overall Study||0
9080733|NCT01031628|10143813|FG001|STARTED|Overall Study||1
9080734|NCT01031628|10143814|FG002|STARTED|Overall Study||3
9080735|NCT01031628|10143815|FG003|STARTED|Overall Study||0
9080736|NCT01031628|10143812|FG000|COMPLETED|Overall Study||0
9080737|NCT01031628|10143813|FG001|COMPLETED|Overall Study||0
9080738|NCT01031628|10143814|FG002|COMPLETED|Overall Study||0
9080739|NCT01031628|10143815|FG003|COMPLETED|Overall Study||0
9080740|NCT01031628|10143812|FG000|NOT COMPLETED|Overall Study||0
9080741|NCT01031628|10143813|FG001|NOT COMPLETED|Overall Study||1
9080742|NCT01031628|10143814|FG002|NOT COMPLETED|Overall Study||3
9080743|NCT01031628|10143815|FG003|NOT COMPLETED|Overall Study||0
9080744|NCT01030757|10143825|FG000|STARTED|Overall Study||2
9080745|NCT01030757|10143825|FG000|COMPLETED|Overall Study||2
9080746|NCT01030757|10143825|FG000|NOT COMPLETED|Overall Study||0
9080747|NCT01035073|10143829|FG000|STARTED|Overall Study||0
9080748|NCT01035073|10143829|FG000|COMPLETED|Overall Study||0
9080749|NCT01035073|10143829|FG000|NOT COMPLETED|Overall Study||0
9080750|NCT01031550|10143835|FG000|STARTED|Overall Study||5
9080751|NCT01031550|10143836|FG001|STARTED|Overall Study||3
9080752|NCT01031550|10143835|FG000|COMPLETED|Overall Study||5
9080753|NCT01031550|10143836|FG001|COMPLETED|Overall Study||3
9080754|NCT01031550|10143835|FG000|NOT COMPLETED|Overall Study||0
9080755|NCT01031550|10143836|FG001|NOT COMPLETED|Overall Study||0
9080756|NCT01030198|10143846|FG000|STARTED|Overall Study|None recruited|0
9080757|NCT01030198|10143847|FG001|STARTED|Overall Study||7
9080758|NCT01030198|10143846|FG000|COMPLETED|Overall Study|None recruited|0
9080759|NCT01030198|10143847|FG001|COMPLETED|Overall Study|Study terminated due to poor results and lack of enrollment|0
9080760|NCT01030198|10143846|FG000|NOT COMPLETED|Overall Study||0
9080761|NCT01030198|10143847|FG001|NOT COMPLETED|Overall Study||7
9080762|NCT01028300|10143853|FG000|STARTED|Overall Study||4
9080763|NCT01028300|10143853|FG000|COMPLETED|Overall Study||0
9080764|NCT01028300|10143853|FG000|NOT COMPLETED|Overall Study||4
9080765|NCT01025271|10143857|FG000|STARTED|Overall Study|unable to meet enrollment no data available. Study terminated early|2
9080766|NCT01025271|10143857|FG000|COMPLETED|Overall Study|unable to meet enrollment no data available. Study terminated early|2
9080767|NCT01025271|10143857|FG000|NOT COMPLETED|Overall Study||0
9080768|NCT01022398|10143864|FG000|STARTED|Overall Study||2
9080769|NCT01022398|10143865|FG001|STARTED|Overall Study||2
9080770|NCT01022398|10143864|FG000|COMPLETED|Overall Study||0
9080771|NCT01022398|10143865|FG001|COMPLETED|Overall Study||0
9080772|NCT01022398|10143864|FG000|NOT COMPLETED|Overall Study||2
9080773|NCT01022398|10143865|FG001|NOT COMPLETED|Overall Study||2
9080774|NCT01019980|10143872|FG000|STARTED|Overall Study|2 patients entered study but did not receive any drug since it was not available in the region.|2
9080775|NCT01019980|10143873|FG001|STARTED|Overall Study||0
9080776|NCT01019980|10143872|FG000|Discontinued|Overall Study||2
9080777|NCT01019980|10143873|FG001|Discontinued|Overall Study||0
9080778|NCT01019980|10143872|FG000|COMPLETED|Overall Study||0
9080779|NCT01019980|10143873|FG001|COMPLETED|Overall Study||0
9080780|NCT01019980|10143872|FG000|NOT COMPLETED|Overall Study||2
9080781|NCT01019980|10143873|FG001|NOT COMPLETED|Overall Study||0
9080782|NCT01025492|10143879|FG000|STARTED|Overall Study||24
9080783|NCT01025492|10143879|FG000|COMPLETED|Overall Study||24
9080784|NCT01025492|10143879|FG000|NOT COMPLETED|Overall Study||0
9080785|NCT01017263|10143883|FG000|STARTED|Overall Study||14
9080786|NCT01017263|10143883|FG000|COMPLETED|Overall Study|A total of 14 participants screened: 2 qualified and received drug the remaining 12 failed screen|2
9080787|NCT01017263|10143883|FG000|NOT COMPLETED|Overall Study||12
9080788|NCT01020903|10143889|FG000|STARTED|Overall Study|Please be advised that the investigator of the study left the institution in 2011.|100
9080789|NCT01020903|10143890|FG001|STARTED|Overall Study|Please be advised that the investigator of the study left the institution in 2011.|100
9080790|NCT01020903|10143889|FG000|COMPLETED|Overall Study|Please be advised that the investigator of the study left the institution in 2011.|100
9080791|NCT01020903|10143890|FG001|COMPLETED|Overall Study|Please be advised that the investigator of the study entitled left the institution in 2011.|100
9080792|NCT01020903|10143889|FG000|NOT COMPLETED|Overall Study||0
9080793|NCT01020903|10143890|FG001|NOT COMPLETED|Overall Study||0
9080794|NCT01023620|10143898|FG000|STARTED|Overall Study||0
9080795|NCT01023620|10143899|FG001|STARTED|Overall Study||0
9080796|NCT01023620|10143898|FG000|COMPLETED|Overall Study||0
9080797|NCT01023620|10143899|FG001|COMPLETED|Overall Study||0
9080798|NCT01023620|10143898|FG000|NOT COMPLETED|Overall Study||0
9080799|NCT01023620|10143899|FG001|NOT COMPLETED|Overall Study||0
9080800|NCT01018810|10143910|FG000|STARTED|Overall Study||4
9080801|NCT01018810|10143911|FG001|STARTED|Overall Study||1
9080802|NCT01018810|10143912|FG002|STARTED|Overall Study||1
9080803|NCT01018810|10143913|FG003|STARTED|Overall Study||1
9080804|NCT01018810|10143914|FG004|STARTED|Overall Study||1
9080805|NCT01018810|10143910|FG000|COMPLETED|Overall Study||2
9080806|NCT01018810|10143911|FG001|COMPLETED|Overall Study||0
9080807|NCT01018810|10143912|FG002|COMPLETED|Overall Study||0
9080808|NCT01018810|10143913|FG003|COMPLETED|Overall Study||0
9080809|NCT01018810|10143914|FG004|COMPLETED|Overall Study||0
9080810|NCT01018810|10143910|FG000|NOT COMPLETED|Overall Study||2
9080811|NCT01018810|10143911|FG001|NOT COMPLETED|Overall Study||1
9080812|NCT01018810|10143912|FG002|NOT COMPLETED|Overall Study||1
9080813|NCT01018810|10143913|FG003|NOT COMPLETED|Overall Study||1
9080814|NCT01018810|10143914|FG004|NOT COMPLETED|Overall Study||1
9080815|NCT01016561|10143926|FG000|STARTED|Overall Study|Despite all possible efforts to contact the PI/study team, no data are available to be reported|0
9080816|NCT01016561|10143926|FG000|COMPLETED|Overall Study|Despite all possible efforts to contact the PI/study team, no data are available to be reported|0
9080817|NCT01016561|10143926|FG000|NOT COMPLETED|Overall Study||0
9080818|NCT01016847|10143932|FG000|STARTED|Overall Study||1
9080819|NCT01016847|10143933|FG001|STARTED|Overall Study||2
9080820|NCT01016847|10143932|FG000|COMPLETED|Overall Study||1
9080821|NCT01016847|10143933|FG001|COMPLETED|Overall Study||2
9080822|NCT01016847|10143932|FG000|NOT COMPLETED|Overall Study||0
9080823|NCT01016847|10143933|FG001|NOT COMPLETED|Overall Study||0
9080824|NCT01014767|10143943|FG000|STARTED|Overall Study||12
9080825|NCT01014767|10143944|FG001|STARTED|Overall Study||1
9080826|NCT01014767|10143945|FG002|STARTED|Overall Study||4
9080827|NCT01014767|10143946|FG003|STARTED|Overall Study||1
9080828|NCT01014767|10143943|FG000|COMPLETED|Overall Study||0
9080829|NCT01014767|10143944|FG001|COMPLETED|Overall Study||0
9080830|NCT01014767|10143945|FG002|COMPLETED|Overall Study||0
9080831|NCT01014767|10143946|FG003|COMPLETED|Overall Study||0
9080832|NCT01014767|10143943|FG000|NOT COMPLETED|Overall Study||12
9080833|NCT01014767|10143944|FG001|NOT COMPLETED|Overall Study||1
9080834|NCT01014767|10143945|FG002|NOT COMPLETED|Overall Study||4
9080835|NCT01014767|10143946|FG003|NOT COMPLETED|Overall Study||1
9080836|NCT01013701|10143956|FG000|STARTED|Overall Study||7
9080837|NCT01013701|10143956|FG000|COMPLETED|Overall Study||0
9080838|NCT01013701|10143956|FG000|NOT COMPLETED|Overall Study||7
9080839|NCT01012414|10143961|FG000|STARTED|Overall Study||10
9080840|NCT01012414|10143961|FG000|COMPLETED|Overall Study|No subjects completed the study.|0
9080841|NCT01012414|10143961|FG000|NOT COMPLETED|Overall Study||10
9080842|NCT01011634|10143969|FG000|STARTED|Overall Study||9
9080843|NCT01011634|10143970|FG001|STARTED|Overall Study||9
9080844|NCT01011634|10143969|FG000|COMPLETED|Overall Study||9
9080845|NCT01011634|10143970|FG001|COMPLETED|Overall Study||8
9080846|NCT01011634|10143969|FG000|NOT COMPLETED|Overall Study||0
9080847|NCT01011634|10143970|FG001|NOT COMPLETED|Overall Study||1
9080848|NCT01009931|10143976|FG000|STARTED|Overall Study||1
9080849|NCT01009931|10143976|FG000|COMPLETED|Overall Study||0
9080850|NCT01009931|10143976|FG000|NOT COMPLETED|Overall Study||1
9080851|NCT01001390|10143980|FG000|STARTED|Overall Study||2
9080852|NCT01001390|10143981|FG001|STARTED|Overall Study||0
9080853|NCT01001390|10143980|FG000|COMPLETED|Overall Study||0
9080854|NCT01001390|10143981|FG001|COMPLETED|Overall Study||0
9080855|NCT01001390|10143980|FG000|NOT COMPLETED|Overall Study||2
9080856|NCT01001390|10143981|FG001|NOT COMPLETED|Overall Study||0
9080857|NCT01006018|10143989|FG000|STARTED|Overall Study||0
9080858|NCT01006018|10143990|FG001|STARTED|Overall Study||0
9080859|NCT01006018|10143991|FG002|STARTED|Overall Study||0
9080860|NCT01006018|10143989|FG000|COMPLETED|Overall Study||0
9080861|NCT01006018|10143990|FG001|COMPLETED|Overall Study||0
9080862|NCT01006018|10143991|FG002|COMPLETED|Overall Study||0
9080863|NCT01006018|10143989|FG000|NOT COMPLETED|Overall Study||0
9080864|NCT01006018|10143990|FG001|NOT COMPLETED|Overall Study||0
9080865|NCT01006018|10143991|FG002|NOT COMPLETED|Overall Study||0
9080866|NCT01004510|10143999|FG000|STARTED|Overall Study||3
9080867|NCT01004510|10143999|FG000|COMPLETED|Overall Study||2
9080868|NCT01004510|10143999|FG000|NOT COMPLETED|Overall Study||1
9080869|NCT01005914|10144003|FG000|STARTED|Overall Study||11
9080870|NCT01005914|10144003|FG000|COMPLETED|Overall Study||1
9080871|NCT01005914|10144003|FG000|NOT COMPLETED|Overall Study||10
9080872|NCT00996333|10144007|FG000|STARTED|Overall Study||46
9080873|NCT00996333|10144007|FG000|COMPLETED|Overall Study||33
9080874|NCT00996333|10144007|FG000|NOT COMPLETED|Overall Study||13
9080875|NCT00998738|10144011|FG000|STARTED|Overall Study||1
9080876|NCT00998738|10144011|FG000|COMPLETED|Overall Study||0
9080877|NCT00998738|10144011|FG000|NOT COMPLETED|Overall Study||1
9080878|NCT00996502|10144015|FG000|STARTED|Overall Study||4
9080879|NCT00996502|10144015|FG000|COMPLETED|Overall Study||4
9080880|NCT00996502|10144015|FG000|NOT COMPLETED|Overall Study||0
9080881|NCT00997386|10144019|FG000|STARTED|Overall Study||16
8624474|NCT00500448|9663799|FG001|NOT COMPLETED|Overall Study||0
8624475|NCT00500539|9663805|FG000|STARTED|Treatment Period (24 Weeks)||155
8624476|NCT00500539|9663805|FG000|COMPLETED|Treatment Period (24 Weeks)||140
9080882|NCT00997386|10144019|FG000|COMPLETED|Overall Study||9
9080883|NCT00997386|10144019|FG000|NOT COMPLETED|Overall Study||7
9080884|NCT00985738|10144025|FG000|STARTED|Overall Study||8
9080885|NCT00985738|10144026|FG001|STARTED|Overall Study||8
9080886|NCT00985738|10144025|FG000|COMPLETED|Overall Study||0
9080887|NCT00985738|10144026|FG001|COMPLETED|Overall Study||0
9080888|NCT00985738|10144025|FG000|NOT COMPLETED|Overall Study||8
9080889|NCT00985738|10144026|FG001|NOT COMPLETED|Overall Study||8
9080890|NCT00986999|10144032|FG000|STARTED|Overall Study||7
9080891|NCT00986999|10144032|FG000|COMPLETED|Overall Study||6
9080892|NCT00986999|10144032|FG000|NOT COMPLETED|Overall Study||1
9080893|NCT00989937|10144036|FG000|STARTED|Overall Study||0
9080894|NCT00989937|10144036|FG000|COMPLETED|Overall Study||0
9080895|NCT00989937|10144036|FG000|NOT COMPLETED|Overall Study||0
9080896|NCT00986947|10144040|FG000|STARTED|Overall Study||20
9080897|NCT00986947|10144040|FG000|COMPLETED|Overall Study||0
9080898|NCT00986947|10144040|FG000|NOT COMPLETED|Overall Study||20
9080899|NCT00982995|10144044|FG000|STARTED|Overall Study||3
9080900|NCT00982995|10144044|FG000|COMPLETED|Overall Study||3
9080901|NCT00982995|10144044|FG000|NOT COMPLETED|Overall Study||0
9080902|NCT00984490|10144048|FG000|STARTED|Overall Study||5
9080903|NCT00984490|10144048|FG000|COMPLETED|Overall Study||5
9080904|NCT00984490|10144048|FG000|NOT COMPLETED|Overall Study||0
9080905|NCT00986310|10144055|FG000|STARTED|Overall Study||0
9080906|NCT00986310|10144056|FG001|STARTED|Overall Study||0
9080907|NCT00986310|10144055|FG000|COMPLETED|Overall Study||0
9080908|NCT00986310|10144056|FG001|COMPLETED|Overall Study||0
9080909|NCT00986310|10144055|FG000|NOT COMPLETED|Overall Study||0
9080910|NCT00986310|10144056|FG001|NOT COMPLETED|Overall Study||0
9080911|NCT00978874|10144062|FG000|STARTED|Overall Study|The study was terminated and no data are available to be reported|0
9080912|NCT00978874|10144062|FG000|COMPLETED|Overall Study|The study was terminated and no data are available to be reported|0
9080913|NCT00978874|10144062|FG000|NOT COMPLETED|Overall Study||0
9080914|NCT00983645|10144068|FG000|STARTED|Overall Study||8
9080915|NCT00983645|10144069|FG001|STARTED|Overall Study||7
9080916|NCT00983645|10144068|FG000|COMPLETED|Overall Study||8
9080917|NCT00983645|10144069|FG001|COMPLETED|Overall Study||7
9080918|NCT00983645|10144068|FG000|NOT COMPLETED|Overall Study||0
9080919|NCT00983645|10144069|FG001|NOT COMPLETED|Overall Study||0
9080920|NCT00979147|10144077|FG000|STARTED|Overall Study||0
9080921|NCT00979147|10144078|FG001|STARTED|Overall Study||0
9080922|NCT00979147|10144077|FG000|COMPLETED|Overall Study||0
9080923|NCT00979147|10144078|FG001|COMPLETED|Overall Study||0
9080924|NCT00979147|10144077|FG000|NOT COMPLETED|Overall Study||0
9080925|NCT00979147|10144078|FG001|NOT COMPLETED|Overall Study||0
9080926|NCT00967447|10144084|FG000|STARTED|Overall Study|there are no collected data in CRF|2
9080927|NCT00967447|10144084|FG000|COMPLETED|Overall Study|there are no collected data in CRF|2
8624477|NCT00500539|9663805|FG000|NOT COMPLETED|Treatment Period (24 Weeks)||15
9080928|NCT00967447|10144084|FG000|NOT COMPLETED|Overall Study||0
9080929|NCT00970606|10144090|FG000|STARTED|Overall Study||4
9080930|NCT00970606|10144091|FG001|STARTED|Overall Study||3
9080931|NCT00970606|10144090|FG000|COMPLETED|Overall Study||4
9080932|NCT00970606|10144091|FG001|COMPLETED|Overall Study||3
9080933|NCT00970606|10144090|FG000|NOT COMPLETED|Overall Study||0
9080934|NCT00970606|10144091|FG001|NOT COMPLETED|Overall Study||0
9080935|NCT00979550|10144099|FG000|STARTED|Overall Study||4
9080936|NCT00979550|10144100|FG001|STARTED|Overall Study||3
9080937|NCT00979550|10144099|FG000|COMPLETED|Overall Study||4
9080938|NCT00979550|10144100|FG001|COMPLETED|Overall Study||3
9080939|NCT00979550|10144099|FG000|NOT COMPLETED|Overall Study||0
9080940|NCT00979550|10144100|FG001|NOT COMPLETED|Overall Study||0
9080941|NCT00966992|10144108|FG000|STARTED|Overall Study||3
9080942|NCT00966992|10144109|FG001|STARTED|Overall Study||0
9080943|NCT00966992|10144108|FG000|COMPLETED|Overall Study||3
9080944|NCT00966992|10144109|FG001|COMPLETED|Overall Study||0
9080945|NCT00966992|10144108|FG000|NOT COMPLETED|Overall Study||0
9080946|NCT00966992|10144109|FG001|NOT COMPLETED|Overall Study||0
9080947|NCT00981370|10144115|FG000|STARTED|Overall Study||0
9080948|NCT00981370|10144115|FG000|COMPLETED|Overall Study||0
9080949|NCT00981370|10144115|FG000|NOT COMPLETED|Overall Study||0
9080950|NCT00975611|10144119|FG000|STARTED|Overall Study||22
9080951|NCT00975611|10144119|FG000|COMPLETED|Overall Study||5
9080952|NCT00975611|10144119|FG000|NOT COMPLETED|Overall Study||17
9080953|NCT00978419|10144125|FG000|STARTED|Overall Study||0
9080954|NCT00978419|10144126|FG001|STARTED|Overall Study||0
9080955|NCT00978419|10144125|FG000|COMPLETED|Overall Study||0
9080956|NCT00978419|10144126|FG001|COMPLETED|Overall Study||0
9080957|NCT00978419|10144125|FG000|NOT COMPLETED|Overall Study||0
9080958|NCT00978419|10144126|FG001|NOT COMPLETED|Overall Study||0
9080959|NCT00973856|10144134|FG000|STARTED|Overall Study||3
9080960|NCT00973856|10144135|FG001|STARTED|Overall Study||2
9080961|NCT00973856|10144134|FG000|COMPLETED|Overall Study||3
9080962|NCT00973856|10144135|FG001|COMPLETED|Overall Study||2
9080963|NCT00973856|10144134|FG000|NOT COMPLETED|Overall Study||0
9080964|NCT00973856|10144135|FG001|NOT COMPLETED|Overall Study||0
9080965|NCT00979810|10144140|FG000|STARTED|Overall Study||11
9080966|NCT00979810|10144140|FG000|COMPLETED|Overall Study||11
9080967|NCT00979810|10144140|FG000|NOT COMPLETED|Overall Study||0
9080968|NCT00974922|10144144|FG000|STARTED|Overall Study||40
9080969|NCT00974922|10144144|FG000|COMPLETED|Overall Study||16
9080970|NCT00974922|10144144|FG000|NOT COMPLETED|Overall Study||24
9080971|NCT00976339|10144150|FG000|STARTED|Overall Study||10
9080972|NCT00976339|10144151|FG001|STARTED|Overall Study||10
9080973|NCT00976339|10144150|FG000|COMPLETED|Overall Study||10
9080974|NCT00976339|10144151|FG001|COMPLETED|Overall Study||10
9080975|NCT00976339|10144150|FG000|NOT COMPLETED|Overall Study||0
9080976|NCT00976339|10144151|FG001|NOT COMPLETED|Overall Study||0
9080977|NCT00965146|10144159|FG000|STARTED|Overall Study||210
9080978|NCT00965146|10144159|FG000|COMPLETED|Overall Study|Study was terminated prior to reaching 15 year endpoint.|0
9080979|NCT00965146|10144159|FG000|NOT COMPLETED|Overall Study||210
9080980|NCT00972023|10144163|FG000|STARTED|Overall Study||1
9080981|NCT00972023|10144163|FG000|COMPLETED|Overall Study||0
9080982|NCT00972023|10144163|FG000|NOT COMPLETED|Overall Study||1
9080983|NCT00970736|10144169|FG000|STARTED|Overall Study||20
9080984|NCT00970736|10144169|FG000|COMPLETED|Overall Study||18
9080985|NCT00970736|10144169|FG000|NOT COMPLETED|Overall Study||2
9080986|NCT00957827|10144175|FG000|STARTED|Overall Study||2
9080987|NCT00957827|10144176|FG001|STARTED|Overall Study||2
9080988|NCT00957827|10144175|FG000|COMPLETED|Overall Study||2
9080989|NCT00957827|10144176|FG001|COMPLETED|Overall Study||2
9080990|NCT00957827|10144175|FG000|NOT COMPLETED|Overall Study||0
9080991|NCT00957827|10144176|FG001|NOT COMPLETED|Overall Study||0
9080992|NCT00953329|10144182|FG000|STARTED|Overall Study||1
9080993|NCT00953329|10144182|FG000|COMPLETED|Overall Study||0
9080994|NCT00953329|10144182|FG000|NOT COMPLETED|Overall Study||1
9080995|NCT00965055|10144186|FG000|STARTED|Overall Study||2
9080996|NCT00965055|10144186|FG000|COMPLETED|Overall Study||2
9080997|NCT00965055|10144186|FG000|NOT COMPLETED|Overall Study||0
9080998|NCT00962429|10144192|FG000|STARTED|Overall Study||0
9080999|NCT00962429|10144193|FG001|STARTED|Overall Study||0
9081000|NCT00962429|10144192|FG000|COMPLETED|Overall Study||0
9081001|NCT00962429|10144193|FG001|COMPLETED|Overall Study||0
9081002|NCT00962429|10144192|FG000|NOT COMPLETED|Overall Study||0
9081003|NCT00962429|10144193|FG001|NOT COMPLETED|Overall Study||0
9081004|NCT00958893|10144199|FG000|STARTED|Overall Study||4
9081005|NCT00958893|10144199|FG000|COMPLETED|Overall Study||0
9081006|NCT00958893|10144199|FG000|NOT COMPLETED|Overall Study||4
9081007|NCT00966654|10144203|FG000|STARTED|Overall Study||12
9081008|NCT00966654|10144203|FG000|COMPLETED|Overall Study||0
9081009|NCT00966654|10144203|FG000|NOT COMPLETED|Overall Study||12
9081010|NCT00960154|10144211|FG000|STARTED|Overall Study||25
9081011|NCT00960154|10144212|FG001|STARTED|Overall Study||25
9081012|NCT00960154|10144211|FG000|COMPLETED|Overall Study||0
9081013|NCT00960154|10144212|FG001|COMPLETED|Overall Study||0
9081014|NCT00960154|10144211|FG000|NOT COMPLETED|Overall Study||25
9081015|NCT00960154|10144212|FG001|NOT COMPLETED|Overall Study||25
9081016|NCT00960752|10144221|FG000|STARTED|Overall Study||13
9081017|NCT00960752|10144222|FG001|STARTED|Overall Study||13
9081018|NCT00960752|10144223|FG002|STARTED|Overall Study||19
9081019|NCT00960752|10144221|FG000|COMPLETED|Overall Study||13
9081020|NCT00960752|10144222|FG001|COMPLETED|Overall Study||13
9081021|NCT00960752|10144223|FG002|COMPLETED|Overall Study||17
9081022|NCT00960752|10144221|FG000|NOT COMPLETED|Overall Study||0
9081023|NCT00960752|10144222|FG001|NOT COMPLETED|Overall Study||0
9081024|NCT00960752|10144223|FG002|NOT COMPLETED|Overall Study||2
9081025|NCT00958347|10144231|FG000|STARTED|Overall Study||226
9081026|NCT00958347|10144231|FG000|COMPLETED|Overall Study|11 revisions total, one was a bilateral participant with the other hip counted as not completed.|0
9081027|NCT00958347|10144231|FG000|NOT COMPLETED|Overall Study||226
9081028|NCT00954187|10144237|FG000|STARTED|Overall Study|No subjects were assigned treatment and no study procedures were performed|0
9081029|NCT00954187|10144238|FG001|STARTED|Overall Study|No subjects were assigned treatment and no study procedures were performed|0
9081030|NCT00954187|10144237|FG000|COMPLETED|Overall Study||0
9081031|NCT00954187|10144238|FG001|COMPLETED|Overall Study||0
9081032|NCT00954187|10144237|FG000|NOT COMPLETED|Overall Study||0
9081033|NCT00954187|10144238|FG001|NOT COMPLETED|Overall Study||0
9081034|NCT00953615|10144244|FG000|STARTED|Overall Study||1
8624478|NCT00500539|9663805|FG000|STARTED|Follow-up Period (16 Weeks)|Participants could discontinue study drug and still enter the follow-up period.|148
8624479|NCT00500539|9663805|FG000|COMPLETED|Follow-up Period (16 Weeks)||136
8624480|NCT00500539|9663805|FG000|NOT COMPLETED|Follow-up Period (16 Weeks)||12
8624481|NCT00500578|9663814|FG000|STARTED|Overall Study||18
8624482|NCT00500578|9663815|FG001|STARTED|Overall Study||32
8624483|NCT00500578|9663814|FG000|COMPLETED|Overall Study|All completed|18
9081035|NCT00953615|10144244|FG000|COMPLETED|Overall Study||0
9081036|NCT00953615|10144244|FG000|NOT COMPLETED|Overall Study||1
9081037|NCT00947284|10144248|FG000|STARTED|Overall Study||0
9081038|NCT00947284|10144249|FG001|STARTED|Overall Study||3
9081039|NCT00947284|10144248|FG000|COMPLETED|Overall Study||0
9081040|NCT00947284|10144249|FG001|COMPLETED|Overall Study||0
9081041|NCT00947284|10144248|FG000|NOT COMPLETED|Overall Study||0
9081042|NCT00947284|10144249|FG001|NOT COMPLETED|Overall Study||3
9081043|NCT00957034|10144256|FG000|STARTED|Overall Study||6
9081044|NCT00957034|10144257|FG001|STARTED|Overall Study||4
9081045|NCT00957034|10144258|FG002|STARTED|Overall Study||7
9081046|NCT00957034|10144256|FG000|COMPLETED|Overall Study||0
9081047|NCT00957034|10144257|FG001|COMPLETED|Overall Study||0
9081048|NCT00957034|10144258|FG002|COMPLETED|Overall Study||1
9081049|NCT00957034|10144256|FG000|NOT COMPLETED|Overall Study||6
9081050|NCT00957034|10144257|FG001|NOT COMPLETED|Overall Study||4
9081051|NCT00957034|10144258|FG002|NOT COMPLETED|Overall Study||6
9081052|NCT00949988|10144266|FG000|STARTED|Overall Study||3
9081053|NCT00949988|10144266|FG000|COMPLETED|Overall Study||0
9081054|NCT00949988|10144266|FG000|NOT COMPLETED|Overall Study||3
9081055|NCT00948194|10144272|FG000|STARTED|Overall Study||6
9081056|NCT00948194|10144273|FG001|STARTED|Overall Study||7
9081057|NCT00948194|10144272|FG000|COMPLETED|Overall Study||5
9081058|NCT00948194|10144273|FG001|COMPLETED|Overall Study||7
9081059|NCT00948194|10144272|FG000|NOT COMPLETED|Overall Study||1
9081060|NCT00948194|10144273|FG001|NOT COMPLETED|Overall Study||0
9081061|NCT00946985|10144279|FG000|STARTED|Stabilization Phase (25 Weeks)||162
9081062|NCT00946985|10144279|FG000|COMPLETED|Stabilization Phase (25 Weeks)||2
9081063|NCT00946985|10144279|FG000|NOT COMPLETED|Stabilization Phase (25 Weeks)||160
9081064|NCT00946985|10144279|FG000|STARTED|Relapse Prevention Phase (24 Months)|Both randomized patients were discontinued when the sponsor terminated the trial early.|2
9081065|NCT00946985|10144279|FG000|COMPLETED|Relapse Prevention Phase (24 Months)||0
9081066|NCT00946985|10144279|FG000|NOT COMPLETED|Relapse Prevention Phase (24 Months)||2
9081067|NCT00950183|10144283|FG000|STARTED|Overall Study||36
9081068|NCT00950183|10144283|FG000|COMPLETED|Overall Study||0
9081069|NCT00950183|10144283|FG000|NOT COMPLETED|Overall Study||36
9081070|NCT00950690|10144287|FG000|STARTED|Overall Study||1349
9081071|NCT00950690|10144287|FG000|COMPLETED|Overall Study||1105
9081072|NCT00950690|10144287|FG000|NOT COMPLETED|Overall Study||244
9081073|NCT00944229|10144291|FG000|STARTED|Overall Study||58
9081074|NCT00944229|10144291|FG000|COMPLETED|Overall Study||33
9081075|NCT00944229|10144291|FG000|NOT COMPLETED|Overall Study||25
9081076|NCT00941928|10144295|FG000|STARTED|Overall Study||2
9081077|NCT00941928|10144295|FG000|COMPLETED|Overall Study||0
9081078|NCT00941928|10144295|FG000|NOT COMPLETED|Overall Study||2
9081079|NCT00949403|10144299|FG000|STARTED|Overall Study||9
9081080|NCT00949403|10144299|FG000|COMPLETED|Overall Study||9
9081081|NCT00949403|10144299|FG000|NOT COMPLETED|Overall Study||0
9081082|NCT00947791|10144305|FG000|STARTED|Overall Study||0
9081083|NCT00947791|10144306|FG001|STARTED|Overall Study||1
9081084|NCT00947791|10144305|FG000|COMPLETED|Overall Study||0
9081085|NCT00947791|10144306|FG001|COMPLETED|Overall Study||1
9081086|NCT00947791|10144305|FG000|NOT COMPLETED|Overall Study||0
9081087|NCT00947791|10144306|FG001|NOT COMPLETED|Overall Study||0
9081088|NCT00947011|10144312|FG000|STARTED|Overall Study||12
9081089|NCT00947011|10144312|FG000|COMPLETED|Overall Study||0
9081090|NCT00947011|10144312|FG000|NOT COMPLETED|Overall Study||12
9081091|NCT00943605|10144320|FG000|STARTED|Overall Study|There were 10 total subjects (5/group) who were retrospectively unenrolled for deviations.|30
9081092|NCT00943605|10144321|FG001|STARTED|Overall Study|There were 10 total subjects (5/group) who were retrospectively unenrolled for deviations.|30
9081093|NCT00943605|10144320|FG000|COMPLETED|Overall Study||0
9081094|NCT00943605|10144321|FG001|COMPLETED|Overall Study||0
9081095|NCT00943605|10144320|FG000|NOT COMPLETED|Overall Study||30
9081096|NCT00943605|10144321|FG001|NOT COMPLETED|Overall Study||30
9081097|NCT00942409|10144327|FG000|STARTED|Overall Study||5
9081098|NCT00942409|10144327|FG000|COMPLETED|Overall Study||2
9081099|NCT00942409|10144327|FG000|NOT COMPLETED|Overall Study||3
9081100|NCT00936585|10144331|FG000|STARTED|Overall Study||2
9081101|NCT00936585|10144331|FG000|COMPLETED|Overall Study||2
9081102|NCT00936585|10144331|FG000|NOT COMPLETED|Overall Study||0
9081103|NCT00936598|10144337|FG000|STARTED|Overall Study||4
9081104|NCT00936598|10144338|FG001|STARTED|Overall Study||1
9081105|NCT00936598|10144337|FG000|COMPLETED|Overall Study||2
9081106|NCT00936598|10144338|FG001|COMPLETED|Overall Study||1
9081107|NCT00936598|10144337|FG000|NOT COMPLETED|Overall Study||2
9081108|NCT00936598|10144338|FG001|NOT COMPLETED|Overall Study||0
9081109|NCT00920309|10144346|FG000|STARTED|Overall Study||14
9081110|NCT00920309|10144347|FG001|STARTED|Overall Study||7
9081111|NCT00920309|10144346|FG000|COMPLETED|Overall Study||14
9081112|NCT00920309|10144347|FG001|COMPLETED|Overall Study||7
9081113|NCT00920309|10144346|FG000|NOT COMPLETED|Overall Study||0
9081114|NCT00920309|10144347|FG001|NOT COMPLETED|Overall Study||0
9081115|NCT00935649|10144354|FG000|STARTED|Overall Study||139
9081116|NCT00935649|10144354|FG000|COMPLETED|Overall Study||134
9081117|NCT00935649|10144354|FG000|NOT COMPLETED|Overall Study||5
9081118|NCT00934791|10144362|FG000|STARTED|Overall Study||1
9081119|NCT00934791|10144363|FG001|STARTED|Overall Study||0
9081120|NCT00934791|10144362|FG000|COMPLETED|Overall Study||0
9081121|NCT00934791|10144363|FG001|COMPLETED|Overall Study||0
9081122|NCT00934791|10144362|FG000|NOT COMPLETED|Overall Study||1
9081123|NCT00934791|10144363|FG001|NOT COMPLETED|Overall Study||0
9081124|NCT00932152|10144371|FG000|STARTED|Overall Study||1
9081125|NCT00932152|10144372|FG001|STARTED|Overall Study||2
9081126|NCT00932152|10144371|FG000|COMPLETED|Overall Study||0
9081127|NCT00932152|10144372|FG001|COMPLETED|Overall Study||0
9081128|NCT00932152|10144371|FG000|NOT COMPLETED|Overall Study||1
9081129|NCT00932152|10144372|FG001|NOT COMPLETED|Overall Study||2
9081130|NCT00928499|10144380|FG000|STARTED|Overall Study||18
9081131|NCT00928499|10144381|FG001|STARTED|Overall Study||14
9081132|NCT00928499|10144380|FG000|COMPLETED|Overall Study||18
9081133|NCT00928499|10144381|FG001|COMPLETED|Overall Study||14
9081134|NCT00928499|10144380|FG000|NOT COMPLETED|Overall Study||0
9081135|NCT00928499|10144381|FG001|NOT COMPLETED|Overall Study||0
9081136|NCT00924807|10144387|FG000|STARTED|Overall Study||4
9081137|NCT00924807|10144387|FG000|COMPLETED|Overall Study||4
9081138|NCT00924807|10144387|FG000|NOT COMPLETED|Overall Study||0
9081139|NCT00930787|10144393|FG000|STARTED|Overall Study||14
9081140|NCT00930787|10144394|FG001|STARTED|Overall Study||9
9081141|NCT00930787|10144393|FG000|COMPLETED|Overall Study||14
9081142|NCT00930787|10144394|FG001|COMPLETED|Overall Study||9
9081143|NCT00930787|10144393|FG000|NOT COMPLETED|Overall Study||0
9081144|NCT00930787|10144394|FG001|NOT COMPLETED|Overall Study||0
9081145|NCT00929474|10144402|FG000|STARTED|Overall Study||8
9081146|NCT00929474|10144403|FG001|STARTED|Overall Study||9
9081147|NCT00929474|10144402|FG000|COMPLETED|Overall Study||0
9081148|NCT00929474|10144403|FG001|COMPLETED|Overall Study||0
9081149|NCT00929474|10144402|FG000|NOT COMPLETED|Overall Study||8
9081150|NCT00929474|10144403|FG001|NOT COMPLETED|Overall Study||9
9081151|NCT00925548|10144411|FG000|STARTED|Overall Study||11
9081152|NCT00925548|10144412|FG001|STARTED|Overall Study||5
9081153|NCT00925548|10144411|FG000|COMPLETED|Overall Study||1
9081154|NCT00925548|10144412|FG001|COMPLETED|Overall Study||0
9081155|NCT00925548|10144411|FG000|NOT COMPLETED|Overall Study||10
9081156|NCT00925548|10144412|FG001|NOT COMPLETED|Overall Study||5
8948115|NCT02427399|10010455|FG001|STARTED|Overall Study||220
8948116|NCT02427399|10010456|FG002|STARTED|Overall Study||220
8948117|NCT02427399|10010457|FG003|STARTED|Overall Study||220
8948118|NCT02427399|10010458|FG004|STARTED|Overall Study||220
8948119|NCT02427399|10010454|FG000|COMPLETED|Overall Study||206
8948120|NCT02427399|10010455|FG001|COMPLETED|Overall Study||204
8948121|NCT02427399|10010456|FG002|COMPLETED|Overall Study||208
8948122|NCT02427399|10010457|FG003|COMPLETED|Overall Study||202
8948123|NCT02427399|10010458|FG004|COMPLETED|Overall Study||205
8948124|NCT02427399|10010454|FG000|NOT COMPLETED|Overall Study||14
8948125|NCT02427399|10010455|FG001|NOT COMPLETED|Overall Study||16
8948126|NCT02427399|10010456|FG002|NOT COMPLETED|Overall Study||12
8948127|NCT02427399|10010457|FG003|NOT COMPLETED|Overall Study||18
9081157|NCT00926575|10144421|FG000|STARTED|Overall Study||70
9081158|NCT00926575|10144422|FG001|STARTED|Overall Study||70
9081159|NCT00926575|10144421|FG000|COMPLETED|Overall Study||54
9081160|NCT00926575|10144422|FG001|COMPLETED|Overall Study||53
9081161|NCT00926575|10144421|FG000|NOT COMPLETED|Overall Study||16
9081162|NCT00926575|10144422|FG001|NOT COMPLETED|Overall Study||17
9081163|NCT00911053|10144433|FG000|STARTED|Overall Study||0
9081164|NCT00911053|10144434|FG001|STARTED|Overall Study||0
9081165|NCT00911053|10144435|FG002|STARTED|Overall Study||0
9081166|NCT00911053|10144436|FG003|STARTED|Overall Study||0
9081167|NCT00911053|10144437|FG004|STARTED|Overall Study||0
9081168|NCT00911053|10144433|FG000|COMPLETED|Overall Study||0
9081169|NCT00911053|10144434|FG001|COMPLETED|Overall Study||0
9081170|NCT00911053|10144435|FG002|COMPLETED|Overall Study||0
9081171|NCT00911053|10144436|FG003|COMPLETED|Overall Study||0
9081172|NCT00911053|10144437|FG004|COMPLETED|Overall Study||0
9081173|NCT00911053|10144433|FG000|NOT COMPLETED|Overall Study||0
9081174|NCT00911053|10144434|FG001|NOT COMPLETED|Overall Study||0
9081175|NCT00911053|10144435|FG002|NOT COMPLETED|Overall Study||0
9081176|NCT00911053|10144436|FG003|NOT COMPLETED|Overall Study||0
9081177|NCT00911053|10144437|FG004|NOT COMPLETED|Overall Study||0
9081178|NCT00918463|10144449|FG000|STARTED|Overall Study||2
9081179|NCT00918463|10144449|FG000|COMPLETED|Overall Study||0
9081180|NCT00918463|10144449|FG000|NOT COMPLETED|Overall Study||2
9081181|NCT00913692|10144453|FG000|STARTED|Screening (4 Months)||11
9081182|NCT00913692|10144453|FG000|COMPLETED|Screening (4 Months)||2
9081183|NCT00913692|10144453|FG000|NOT COMPLETED|Screening (4 Months)||9
9081184|NCT00913692|10144453|FG000|STARTED|Treatment Phase 1 (5 Months)||2
9081185|NCT00913692|10144453|FG000|COMPLETED|Treatment Phase 1 (5 Months)||1
9081186|NCT00913692|10144453|FG000|NOT COMPLETED|Treatment Phase 1 (5 Months)||1
9081187|NCT00913692|10144453|FG000|STARTED|Washout (2 Weeks)||1
9081188|NCT00913692|10144453|FG000|COMPLETED|Washout (2 Weeks)||1
9081189|NCT00913692|10144453|FG000|NOT COMPLETED|Washout (2 Weeks)||0
9081190|NCT00913692|10144453|FG000|STARTED|Treatment Phase 2 (5 Months)||1
9081191|NCT00913692|10144453|FG000|COMPLETED|Treatment Phase 2 (5 Months)||1
9081192|NCT00913692|10144453|FG000|NOT COMPLETED|Treatment Phase 2 (5 Months)||0
9081193|NCT00918645|10144460|FG000|STARTED|Overall Study||13
9081194|NCT00918645|10144460|FG000|COMPLETED|Overall Study||12
9081195|NCT00918645|10144460|FG000|NOT COMPLETED|Overall Study||1
9081196|NCT00907218|10144464|FG000|STARTED|Overall Study||2
9081197|NCT00907218|10144464|FG000|COMPLETED|Overall Study||2
9081198|NCT00907218|10144464|FG000|NOT COMPLETED|Overall Study||0
9081199|NCT00895284|10144470|FG000|STARTED|Overall Study||3
9081200|NCT00895284|10144471|FG001|STARTED|Overall Study||0
9081201|NCT00895284|10144470|FG000|COMPLETED|Overall Study||3
9081202|NCT00895284|10144471|FG001|COMPLETED|Overall Study||0
9081203|NCT00895284|10144470|FG000|NOT COMPLETED|Overall Study||0
9081204|NCT00895284|10144471|FG001|NOT COMPLETED|Overall Study||0
9081205|NCT00897910|10144477|FG000|STARTED|Overall Study|None of the blood samples were analyzed due to lack of funding. No tissue sample was collected.|6
9081206|NCT00897910|10144477|FG000|COMPLETED|Overall Study|None of the blood samples were analyzed due to lack of funding. No tissue sample was collected|6
9081207|NCT00897910|10144477|FG000|NOT COMPLETED|Overall Study||0
9081208|NCT00901303|10144483|FG000|STARTED|Overall Study||5
9081209|NCT00901303|10144484|FG001|STARTED|Overall Study||1
9081210|NCT00901303|10144483|FG000|COMPLETED|Overall Study||5
9081211|NCT00901303|10144484|FG001|COMPLETED|Overall Study||1
9081212|NCT00901303|10144483|FG000|NOT COMPLETED|Overall Study||0
9081213|NCT00901303|10144484|FG001|NOT COMPLETED|Overall Study||0
9081214|NCT00906035|10144493|FG000|STARTED|Overall Study||8
9081215|NCT00906035|10144494|FG001|STARTED|Overall Study||9
9081216|NCT00906035|10144495|FG002|STARTED|Overall Study||8
9081217|NCT00906035|10144493|FG000|COMPLETED|Overall Study|One Drop-Out; SAE day before Visit 1 and One subject Withrew prior to visit 1|6
9081218|NCT00906035|10144494|FG001|COMPLETED|Overall Study|2 subjects Withdrew after Visit 1 and 1 subject Withdrew shortly after Visit 1due to an AE|6
9081219|NCT00906035|10144495|FG002|COMPLETED|Overall Study||8
9081220|NCT00906035|10144493|FG000|NOT COMPLETED|Overall Study||2
9081221|NCT00906035|10144494|FG001|NOT COMPLETED|Overall Study||3
9081222|NCT00906035|10144495|FG002|NOT COMPLETED|Overall Study||0
9081223|NCT00904423|10144503|FG000|STARTED|Overall Study||8
9081224|NCT00904423|10144503|FG000|COMPLETED|Overall Study||8
9081225|NCT00904423|10144503|FG000|NOT COMPLETED|Overall Study||0
9081226|NCT00903396|10144511|FG000|STARTED|Overall Study||2
9081227|NCT00903396|10144512|FG001|STARTED|Overall Study||1
9081228|NCT00903396|10144513|FG002|STARTED|Overall Study||3
9081229|NCT00903396|10144514|FG003|STARTED|Overall Study||1
9081230|NCT00903396|10144511|FG000|COMPLETED|Overall Study||2
9081231|NCT00903396|10144512|FG001|COMPLETED|Overall Study||1
9081232|NCT00903396|10144513|FG002|COMPLETED|Overall Study||3
9081233|NCT00903396|10144514|FG003|COMPLETED|Overall Study||1
9081234|NCT00903396|10144511|FG000|NOT COMPLETED|Overall Study||0
9081235|NCT00903396|10144512|FG001|NOT COMPLETED|Overall Study||0
9081236|NCT00903396|10144513|FG002|NOT COMPLETED|Overall Study||0
9081237|NCT00903396|10144514|FG003|NOT COMPLETED|Overall Study||0
9081238|NCT00894790|10144526|FG000|STARTED|Overall Study||4
9081239|NCT00894790|10144527|FG001|STARTED|Overall Study||4
9081240|NCT00894790|10144526|FG000|COMPLETED|Overall Study||3
9081241|NCT00894790|10144527|FG001|COMPLETED|Overall Study||2
9081242|NCT00894790|10144526|FG000|NOT COMPLETED|Overall Study||1
9081243|NCT00894790|10144527|FG001|NOT COMPLETED|Overall Study||2
9081244|NCT00902668|10144533|FG000|STARTED|Overall Study||3
9081245|NCT00902668|10144533|FG000|COMPLETED|Overall Study||0
9081246|NCT00902668|10144533|FG000|NOT COMPLETED|Overall Study||3
9081247|NCT00881205|10144539|FG000|STARTED|Overall Study||45
9081248|NCT00881205|10144540|FG001|STARTED|Overall Study||41
9081249|NCT00881205|10144539|FG000|COMPLETED|Overall Study||34
8624484|NCT00500578|9663815|FG001|COMPLETED|Overall Study|All completed|32
8624485|NCT00500578|9663814|FG000|NOT COMPLETED|Overall Study||0
8624486|NCT00500578|9663815|FG001|NOT COMPLETED|Overall Study||0
8624487|NCT00500656|9663825|FG000|STARTED|Controlled Phase||36
8624488|NCT00500656|9663826|FG001|STARTED|Controlled Phase||38
8624489|NCT00500656|9663827|FG002|STARTED|Controlled Phase||3
8624490|NCT00500656|9663828|FG003|STARTED|Controlled Phase||8
8624491|NCT00500656|9663825|FG000|COMPLETED|Controlled Phase||26
8624492|NCT00500656|9663826|FG001|COMPLETED|Controlled Phase||28
8624493|NCT00500656|9663827|FG002|COMPLETED|Controlled Phase||2
8624494|NCT00500656|9663828|FG003|COMPLETED|Controlled Phase||0
8624495|NCT00500656|9663825|FG000|NOT COMPLETED|Controlled Phase||10
8624496|NCT00500656|9663826|FG001|NOT COMPLETED|Controlled Phase||10
8624497|NCT00500656|9663827|FG002|NOT COMPLETED|Controlled Phase||1
8624498|NCT00500656|9663828|FG003|NOT COMPLETED|Controlled Phase||8
8624499|NCT00500656|9663825|FG000|STARTED|Open Label Extension (OLE) Phase|3 Subjects did not experience an angioedema attack after their first attack in the controlled phase|23
8624500|NCT00500656|9663826|FG001|STARTED|Open Label Extension (OLE) Phase|7 Subjects did not experience an angioedema attack after their first attack in the controlled phase|21
8624501|NCT00500656|9663827|FG002|STARTED|Open Label Extension (OLE) Phase||2
8624502|NCT00500656|9663828|FG003|STARTED|Open Label Extension (OLE) Phase|Subjects did not experience an angioedema attack during the controlled phase|8
8624503|NCT00500656|9663825|FG000|COMPLETED|Open Label Extension (OLE) Phase||16
8624504|NCT00500656|9663826|FG001|COMPLETED|Open Label Extension (OLE) Phase||9
8624505|NCT00500656|9663827|FG002|COMPLETED|Open Label Extension (OLE) Phase||1
8624506|NCT00500656|9663828|FG003|COMPLETED|Open Label Extension (OLE) Phase||6
8624507|NCT00500656|9663825|FG000|NOT COMPLETED|Open Label Extension (OLE) Phase||7
8624508|NCT00500656|9663826|FG001|NOT COMPLETED|Open Label Extension (OLE) Phase||12
8624509|NCT00500656|9663827|FG002|NOT COMPLETED|Open Label Extension (OLE) Phase||1
8624510|NCT00500656|9663828|FG003|NOT COMPLETED|Open Label Extension (OLE) Phase||2
8624511|NCT00500682|9663840|FG000|STARTED|Overall Study||510
8624512|NCT00500682|9663841|FG001|STARTED|Overall Study||510
8624513|NCT00500682|9663840|FG000|COMPLETED|Overall Study||204
8624514|NCT00500682|9663841|FG001|COMPLETED|Overall Study||223
8624515|NCT00500682|9663840|FG000|NOT COMPLETED|Overall Study||306
8624516|NCT00500682|9663841|FG001|NOT COMPLETED|Overall Study||287
8624517|NCT00500760|9663849|FG000|STARTED|Overall Study||89
8624518|NCT00500760|9663850|FG001|STARTED|Overall Study||64
8624519|NCT00500760|9663849|FG000|Received Treatment|Overall Study||87
8624520|NCT00500760|9663850|FG001|Received Treatment|Overall Study||63
8624521|NCT00500760|9663849|FG000|COMPLETED|Overall Study||46
8624522|NCT00500760|9663850|FG001|COMPLETED|Overall Study||40
8624523|NCT00500760|9663849|FG000|NOT COMPLETED|Overall Study||43
8624524|NCT00500760|9663850|FG001|NOT COMPLETED|Overall Study||24
8624525|NCT00500903|9663859|FG000|STARTED|Overall Study||65
8624526|NCT00500903|9663860|FG001|STARTED|Overall Study||2
8624527|NCT00500903|9663861|FG002|STARTED|Overall Study||20
8624528|NCT00500903|9663859|FG000|COMPLETED|Overall Study||0
8624529|NCT00500903|9663860|FG001|COMPLETED|Overall Study||0
8624530|NCT00500903|9663861|FG002|COMPLETED|Overall Study||0
8624531|NCT00500903|9663859|FG000|NOT COMPLETED|Overall Study||65
8624532|NCT00500903|9663860|FG001|NOT COMPLETED|Overall Study||2
8624533|NCT00500903|9663861|FG002|NOT COMPLETED|Overall Study||20
8624534|NCT00501007|9663899|FG000|STARTED|Overall Study||100
8624535|NCT00501007|9663900|FG001|STARTED|Overall Study||103
8624536|NCT00501007|9663899|FG000|COMPLETED|Overall Study||71
8624537|NCT00501007|9663900|FG001|COMPLETED|Overall Study||78
8624538|NCT00501007|9663899|FG000|NOT COMPLETED|Overall Study||29
8624539|NCT00501007|9663900|FG001|NOT COMPLETED|Overall Study||25
8624540|NCT00501046|9663908|FG000|STARTED|Overall Study||508
8624541|NCT00501046|9663909|FG001|STARTED|Overall Study||507
8624542|NCT00501046|9663908|FG000|COMPLETED|Overall Study||238
8624543|NCT00501046|9663909|FG001|COMPLETED|Overall Study||213
9081250|NCT00881205|10144540|FG001|COMPLETED|Overall Study||34
9081251|NCT00881205|10144539|FG000|NOT COMPLETED|Overall Study||11
9081252|NCT00881205|10144540|FG001|NOT COMPLETED|Overall Study||7
9081253|NCT00896025|10144547|FG000|STARTED|Overall Study||8
9081254|NCT00896025|10144547|FG000|COMPLETED|Overall Study||8
9081255|NCT00896025|10144547|FG000|NOT COMPLETED|Overall Study||0
9081256|NCT00903006|10144557|FG000|STARTED|Overall Study||2
9081257|NCT00903006|10144558|FG001|STARTED|Overall Study||3
8624544|NCT00501046|9663908|FG000|NOT COMPLETED|Overall Study||270
8624545|NCT00501046|9663909|FG001|NOT COMPLETED|Overall Study||294
8624546|NCT00501059|9663917|FG000|STARTED|Overall Study||6270
8624547|NCT00501059|9663918|FG001|STARTED|Overall Study||6276
8624548|NCT00501059|9663917|FG000|COMPLETED|Overall Study||4402
9081258|NCT00903006|10144559|FG002|STARTED|Overall Study||1
9081259|NCT00903006|10144560|FG003|STARTED|Overall Study|Zero participants started due to smaller sample size.|0
9081260|NCT00903006|10144557|FG000|COMPLETED|Overall Study||0
9081261|NCT00903006|10144558|FG001|COMPLETED|Overall Study||0
8624549|NCT00501059|9663918|FG001|COMPLETED|Overall Study||4384
8624550|NCT00501059|9663917|FG000|NOT COMPLETED|Overall Study||1868
8624551|NCT00501059|9663918|FG001|NOT COMPLETED|Overall Study||1892
8624552|NCT00501085|9663926|FG000|STARTED|Overall Study|Number of participants who were treated with the LAP-BAND System.|515
9081262|NCT00903006|10144559|FG002|COMPLETED|Overall Study||0
9081263|NCT00903006|10144560|FG003|COMPLETED|Overall Study||0
9081264|NCT00903006|10144557|FG000|NOT COMPLETED|Overall Study||2
9081265|NCT00903006|10144558|FG001|NOT COMPLETED|Overall Study||3
9081266|NCT00903006|10144559|FG002|NOT COMPLETED|Overall Study||1
9081267|NCT00903006|10144560|FG003|NOT COMPLETED|Overall Study||0
9081268|NCT00904189|10144570|FG000|STARTED|Overall Study||2
9081269|NCT00904189|10144570|FG000|COMPLETED|Overall Study||2
9081270|NCT00904189|10144570|FG000|NOT COMPLETED|Overall Study||0
9081271|NCT00887315|10144577|FG000|STARTED|Overall Study||7
9081272|NCT00887315|10144578|FG001|STARTED|Overall Study||4
9081273|NCT00887315|10144577|FG000|COMPLETED|Overall Study||0
9081274|NCT00887315|10144578|FG001|COMPLETED|Overall Study||0
9081275|NCT00887315|10144577|FG000|NOT COMPLETED|Overall Study||7
9081276|NCT00887315|10144578|FG001|NOT COMPLETED|Overall Study||4
9081277|NCT00891904|10144584|FG000|STARTED|Overall Study||2
9081278|NCT00891904|10144584|FG000|COMPLETED|Overall Study||0
9081279|NCT00891904|10144584|FG000|NOT COMPLETED|Overall Study||2
9081280|NCT00881608|10144593|FG000|STARTED|Overall Study||11
9081281|NCT00881608|10144593|FG000|COMPLETED|Overall Study||0
9081282|NCT00881608|10144593|FG000|NOT COMPLETED|Overall Study||11
9081283|NCT00889421|10144605|FG000|STARTED|Overall Study||3
9081284|NCT00889421|10144605|FG000|COMPLETED|Overall Study||0
9081285|NCT00889421|10144605|FG000|NOT COMPLETED|Overall Study||3
9081286|NCT00875394|10144612|FG000|STARTED|Overall Study||36
9081287|NCT00875394|10144613|FG001|STARTED|Overall Study||23
9081288|NCT00875394|10144614|FG002|STARTED|Overall Study||9
9081289|NCT00875394|10144612|FG000|COMPLETED|Overall Study||36
9081290|NCT00875394|10144613|FG001|COMPLETED|Overall Study||23
9081291|NCT00875394|10144614|FG002|COMPLETED|Overall Study||9
9081292|NCT00875394|10144612|FG000|NOT COMPLETED|Overall Study||0
9081293|NCT00875394|10144613|FG001|NOT COMPLETED|Overall Study||0
9081294|NCT00875394|10144614|FG002|NOT COMPLETED|Overall Study||0
9081295|NCT00882310|10144622|FG000|STARTED|Overall Study||37
9081296|NCT00882310|10144622|FG000|COMPLETED|Overall Study||15
9081297|NCT00882310|10144622|FG000|NOT COMPLETED|Overall Study||22
9081298|NCT00880542|10144626|FG000|STARTED|Treatment Period (Sorafenib+Ifosfamide)||7
9081299|NCT00880542|10144626|FG000|COMPLETED|Treatment Period (Sorafenib+Ifosfamide)||4
9081300|NCT00880542|10144626|FG000|NOT COMPLETED|Treatment Period (Sorafenib+Ifosfamide)||3
9081301|NCT00880542|10144626|FG000|STARTED|Response Evaluation Period(REP): PET/CT||4
9081302|NCT00880542|10144626|FG000|COMPLETED|Response Evaluation Period(REP): PET/CT||4
9081303|NCT00880542|10144626|FG000|NOT COMPLETED|Response Evaluation Period(REP): PET/CT||0
9081304|NCT00880542|10144626|FG000|STARTED|REP: Surgical Resection||4
9081305|NCT00880542|10144626|FG000|COMPLETED|REP: Surgical Resection||3
9081306|NCT00880542|10144626|FG000|NOT COMPLETED|REP: Surgical Resection||1
9081307|NCT00880542|10144626|FG000|STARTED|Post Surgical Evaluation||3
9081308|NCT00880542|10144626|FG000|COMPLETED|Post Surgical Evaluation|none of the 3 subjects met study criteria for continuation of therapy.|3
9081309|NCT00880542|10144626|FG000|NOT COMPLETED|Post Surgical Evaluation||0
9081310|NCT00880542|10144626|FG000|STARTED|Continued Treatment Period|None of the 3 subjects from previous period met study criteria for continuation of therapy.|0
9081311|NCT00880542|10144626|FG000|COMPLETED|Continued Treatment Period||0
9081312|NCT00880542|10144626|FG000|NOT COMPLETED|Continued Treatment Period||0
9081313|NCT00880542|10144626|FG000|STARTED|Follow-up Period|All 7 patients who started the treatment period completed the follow-up period.|7
9081314|NCT00880542|10144626|FG000|COMPLETED|Follow-up Period||7
9081315|NCT00880542|10144626|FG000|NOT COMPLETED|Follow-up Period||0
9081316|NCT00879619|10144630|FG000|STARTED|Overall Study||4
9081317|NCT00879619|10144630|FG000|COMPLETED|Overall Study||4
9081318|NCT00879619|10144630|FG000|NOT COMPLETED|Overall Study||0
9081319|NCT00874939|10144634|FG000|STARTED|Overall Study||4
9081320|NCT00874939|10144634|FG000|Treated|Overall Study||0
9081321|NCT00874939|10144634|FG000|COMPLETED|Overall Study||0
9081322|NCT00874939|10144634|FG000|NOT COMPLETED|Overall Study||4
9081323|NCT00878605|10144648|FG000|STARTED|Overall Study||10
9081324|NCT00878605|10144649|FG001|STARTED|Overall Study||10
9081325|NCT00878605|10144650|FG002|STARTED|Overall Study||9
9081326|NCT00878605|10144651|FG003|STARTED|Overall Study||9
9081327|NCT00878605|10144648|FG000|COMPLETED|Overall Study||7
9081328|NCT00878605|10144649|FG001|COMPLETED|Overall Study||7
9081329|NCT00878605|10144650|FG002|COMPLETED|Overall Study||8
9081330|NCT00878605|10144651|FG003|COMPLETED|Overall Study||6
9081331|NCT00878605|10144648|FG000|NOT COMPLETED|Overall Study||3
9081332|NCT00878605|10144649|FG001|NOT COMPLETED|Overall Study||3
9081333|NCT00878605|10144650|FG002|NOT COMPLETED|Overall Study||1
9081334|NCT00878605|10144651|FG003|NOT COMPLETED|Overall Study||3
9081335|NCT00877071|10144661|FG000|STARTED|Overall Study||2
9081336|NCT00877071|10144661|FG000|COMPLETED|Overall Study||0
9081337|NCT00877071|10144661|FG000|NOT COMPLETED|Overall Study||2
9081338|NCT00878969|10144668|FG000|STARTED|Overall Study||25
9081339|NCT00878969|10144669|FG001|STARTED|Overall Study||27
9081340|NCT00878969|10144670|FG002|STARTED|Overall Study||26
9081341|NCT00878969|10144668|FG000|COMPLETED|Overall Study||10
9081342|NCT00878969|10144669|FG001|COMPLETED|Overall Study||12
9081343|NCT00878969|10144670|FG002|COMPLETED|Overall Study||15
9081344|NCT00878969|10144668|FG000|NOT COMPLETED|Overall Study||15
9081345|NCT00878969|10144669|FG001|NOT COMPLETED|Overall Study||15
9081346|NCT00878969|10144670|FG002|NOT COMPLETED|Overall Study||11
9081347|NCT00865514|10144678|FG000|STARTED|Overall Study||2
9081348|NCT00865514|10144678|FG000|COMPLETED|Overall Study||0
9081349|NCT00865514|10144678|FG000|NOT COMPLETED|Overall Study||2
9081350|NCT00869414|10144683|FG000|STARTED|Overall Study||0
9081351|NCT00869414|10144684|FG001|STARTED|Overall Study||0
9081352|NCT00869414|10144685|FG002|STARTED|Overall Study||0
9081353|NCT00869414|10144683|FG000|COMPLETED|Overall Study||0
9081354|NCT00869414|10144684|FG001|COMPLETED|Overall Study||0
9081355|NCT00869414|10144685|FG002|COMPLETED|Overall Study||0
9081356|NCT00869414|10144683|FG000|NOT COMPLETED|Overall Study||0
9081357|NCT00869414|10144684|FG001|NOT COMPLETED|Overall Study||0
9081358|NCT00869414|10144685|FG002|NOT COMPLETED|Overall Study||0
9081359|NCT00863512|10144695|FG000|STARTED|Overall Study||17
9081360|NCT00863512|10144696|FG001|STARTED|Overall Study||17
9081361|NCT00863512|10144695|FG000|COMPLETED|Overall Study||3
9081362|NCT00863512|10144696|FG001|COMPLETED|Overall Study||17
9081363|NCT00863512|10144695|FG000|NOT COMPLETED|Overall Study||14
9081364|NCT00863512|10144696|FG001|NOT COMPLETED|Overall Study||0
9081365|NCT00868998|10144702|FG000|STARTED|Overall Study||5
9081366|NCT00868998|10144702|FG000|COMPLETED|Overall Study||0
9081367|NCT00868998|10144702|FG000|NOT COMPLETED|Overall Study||5
9081368|NCT00869258|10144706|FG000|STARTED|Overall Study||32
9081369|NCT00869258|10144706|FG000|COMPLETED|Overall Study||31
9081370|NCT00869258|10144706|FG000|NOT COMPLETED|Overall Study||1
9081371|NCT00863330|10144710|FG000|STARTED|Overall Study||6
9081372|NCT00863330|10144710|FG000|COMPLETED|Overall Study||0
9081373|NCT00863330|10144710|FG000|NOT COMPLETED|Overall Study||6
9081374|NCT00853229|10144716|FG000|STARTED|Phase 1: Initial Intervention||8
9081375|NCT00853229|10144717|FG001|STARTED|Phase 1: Initial Intervention||8
9081376|NCT00853229|10144716|FG000|COMPLETED|Phase 1: Initial Intervention||0
9081377|NCT00853229|10144717|FG001|COMPLETED|Phase 1: Initial Intervention||0
9081378|NCT00853229|10144716|FG000|NOT COMPLETED|Phase 1: Initial Intervention||8
9081379|NCT00853229|10144717|FG001|NOT COMPLETED|Phase 1: Initial Intervention||8
9081380|NCT00853229|10144716|FG000|STARTED|Phase 2: Cross Over||0
9081381|NCT00853229|10144717|FG001|STARTED|Phase 2: Cross Over||0
9081382|NCT00853229|10144716|FG000|COMPLETED|Phase 2: Cross Over||0
9081383|NCT00853229|10144717|FG001|COMPLETED|Phase 2: Cross Over||0
9081384|NCT00853229|10144716|FG000|NOT COMPLETED|Phase 2: Cross Over||0
9081385|NCT00853229|10144717|FG001|NOT COMPLETED|Phase 2: Cross Over||0
9081386|NCT00860249|10144728|FG000|STARTED|Overall Study||21
9081387|NCT00860249|10144729|FG001|STARTED|Overall Study||18
9081388|NCT00860249|10144730|FG002|STARTED|Overall Study||21
9081389|NCT00860249|10144728|FG000|COMPLETED|Overall Study||0
9081390|NCT00860249|10144729|FG001|COMPLETED|Overall Study||0
9081391|NCT00860249|10144730|FG002|COMPLETED|Overall Study||0
9081392|NCT00860249|10144728|FG000|NOT COMPLETED|Overall Study||21
9081393|NCT00860249|10144729|FG001|NOT COMPLETED|Overall Study||18
8624553|NCT00501085|9663926|FG000|COMPLETED|Overall Study|Number of participants completing 5 year follow-up visit.|83
8624554|NCT00501085|9663926|FG000|NOT COMPLETED|Overall Study||432
8624555|NCT00501293|9663932|FG000|STARTED|Optimization Period||110
8624556|NCT00501293|9663933|FG001|STARTED|Optimization Period||53
8624557|NCT00501293|9663932|FG000|COMPLETED|Optimization Period||109
9081394|NCT00860249|10144730|FG002|NOT COMPLETED|Overall Study||21
9081395|NCT00860158|10144738|FG000|STARTED|Overall Study||1
9081396|NCT00860158|10144738|FG000|COMPLETED|Overall Study||0
9081397|NCT00860158|10144738|FG000|NOT COMPLETED|Overall Study||1
9081398|NCT00853567|10144745|FG000|STARTED|Overall Study||71
9081399|NCT00853567|10144745|FG000|COMPLETED|Overall Study||0
9081400|NCT00853567|10144745|FG000|NOT COMPLETED|Overall Study||71
9081401|NCT00849524|10144753|FG000|STARTED|Overall Study||6
9081402|NCT00849524|10144753|FG000|COMPLETED|Overall Study||3
9081403|NCT00849524|10144753|FG000|NOT COMPLETED|Overall Study||3
9081404|NCT00843986|10144759|FG000|STARTED|Overall Study||3
9081405|NCT00843986|10144760|FG001|STARTED|Overall Study||6
9081406|NCT00843986|10144759|FG000|Completed Treatment (Infusion)|Overall Study||2
9081407|NCT00843986|10144760|FG001|Completed Treatment (Infusion)|Overall Study||6
9081408|NCT00843986|10144759|FG000|COMPLETED|Overall Study||2
9081409|NCT00843986|10144760|FG001|COMPLETED|Overall Study||5
9081410|NCT00843986|10144759|FG000|NOT COMPLETED|Overall Study||1
9081411|NCT00843986|10144760|FG001|NOT COMPLETED|Overall Study||1
9081412|NCT00851682|10144768|FG000|STARTED|Overall Study||60
9081413|NCT00851682|10144769|FG001|STARTED|Overall Study||5
9081414|NCT00851682|10144768|FG000|COMPLETED|Overall Study||55
9081415|NCT00851682|10144769|FG001|COMPLETED|Overall Study||5
8624558|NCT00501293|9663933|FG001|COMPLETED|Optimization Period||53
9081416|NCT00851682|10144768|FG000|NOT COMPLETED|Overall Study||5
9081417|NCT00851682|10144769|FG001|NOT COMPLETED|Overall Study||0
9081418|NCT00852124|10144777|FG000|STARTED|Overall Study||3
9081419|NCT00852124|10144778|FG001|STARTED|Overall Study||0
9081420|NCT00852124|10144777|FG000|COMPLETED|Overall Study||3
9081421|NCT00852124|10144778|FG001|COMPLETED|Overall Study||0
9081422|NCT00852124|10144777|FG000|NOT COMPLETED|Overall Study||0
9081423|NCT00852124|10144778|FG001|NOT COMPLETED|Overall Study||0
9081424|NCT00850421|10144783|FG000|STARTED|Overall Study||35
9081425|NCT00850421|10144783|FG000|COMPLETED|Overall Study||18
9081426|NCT00850421|10144783|FG000|NOT COMPLETED|Overall Study||17
9081427|NCT00851747|10144791|FG000|STARTED|Overall Study||6
9081428|NCT00851747|10144792|FG001|STARTED|Overall Study||6
9081429|NCT00851747|10144793|FG002|STARTED|Overall Study||6
9081430|NCT00851747|10144791|FG000|COMPLETED|Overall Study||0
9081431|NCT00851747|10144792|FG001|COMPLETED|Overall Study||0
9081432|NCT00851747|10144793|FG002|COMPLETED|Overall Study||0
9081433|NCT00851747|10144791|FG000|NOT COMPLETED|Overall Study||6
9081434|NCT00851747|10144792|FG001|NOT COMPLETED|Overall Study||6
9081435|NCT00851747|10144793|FG002|NOT COMPLETED|Overall Study||6
9081436|NCT00852241|10144800|FG000|STARTED|Overall Study||18
9081437|NCT00852241|10144800|FG000|COMPLETED|Overall Study||0
9081438|NCT00852241|10144800|FG000|NOT COMPLETED|Overall Study||18
9081439|NCT00851552|10144804|FG000|STARTED|Overall Study||9
9081440|NCT00851552|10144804|FG000|COMPLETED|Overall Study||2
9081441|NCT00851552|10144804|FG000|NOT COMPLETED|Overall Study||7
9081442|NCT00850720|10144808|FG000|STARTED|Overall Study||0
9081443|NCT00850720|10144808|FG000|COMPLETED|Overall Study||0
9081444|NCT00850720|10144808|FG000|NOT COMPLETED|Overall Study||0
9081445|NCT00845845|10144814|FG000|STARTED|Overall Study||3
9081446|NCT00845845|10144815|FG001|STARTED|Overall Study||6
9081447|NCT00845845|10144814|FG000|COMPLETED|Overall Study||3
9081448|NCT00845845|10144815|FG001|COMPLETED|Overall Study||2
9081449|NCT00845845|10144814|FG000|NOT COMPLETED|Overall Study||0
9081450|NCT00845845|10144815|FG001|NOT COMPLETED|Overall Study||4
9081451|NCT00851591|10144823|FG000|STARTED|Overall Study|These 2 participants did not receive treatment.|2
9081452|NCT00851591|10144824|FG001|STARTED|Overall Study|One received treatment.|1
9081453|NCT00851591|10144823|FG000|COMPLETED|Overall Study||0
9081454|NCT00851591|10144824|FG001|COMPLETED|Overall Study||1
9081455|NCT00851591|10144823|FG000|NOT COMPLETED|Overall Study||2
9081456|NCT00851591|10144824|FG001|NOT COMPLETED|Overall Study||0
9081457|NCT00847509|10144830|FG000|STARTED|Overall Study||49
9081458|NCT00847509|10144830|FG000|COMPLETED|Overall Study||38
9081459|NCT00847509|10144830|FG000|NOT COMPLETED|Overall Study||11
9081460|NCT00843310|10144834|FG000|STARTED|Overall Study||8
9081461|NCT00843310|10144834|FG000|COMPLETED|Overall Study||1
9081462|NCT00843310|10144834|FG000|NOT COMPLETED|Overall Study||7
9081463|NCT00847002|10144840|FG000|STARTED|Overall Study||4
9081464|NCT00847002|10144841|FG001|STARTED|Overall Study||4
9081465|NCT00847002|10144840|FG000|COMPLETED|Overall Study||4
9081466|NCT00847002|10144841|FG001|COMPLETED|Overall Study||4
9081467|NCT00847002|10144840|FG000|NOT COMPLETED|Overall Study||0
9081468|NCT00847002|10144841|FG001|NOT COMPLETED|Overall Study||0
9081469|NCT00845702|10144847|FG000|STARTED|TOF MRA||33
9081470|NCT00845702|10144847|FG000|COMPLETED|TOF MRA|One patient did not perform study MRA procedures.|32
9081471|NCT00845702|10144847|FG000|NOT COMPLETED|TOF MRA||1
9081472|NCT00845702|10144847|FG000|STARTED|Dotarem MRA||32
9081473|NCT00845702|10144847|FG000|COMPLETED|Dotarem MRA||32
9081474|NCT00845702|10144847|FG000|NOT COMPLETED|Dotarem MRA||0
9081475|NCT00843830|10144853|FG000|STARTED|Overall Study||4
9081476|NCT00843830|10144853|FG000|COMPLETED|Overall Study||4
9081477|NCT00843830|10144853|FG000|NOT COMPLETED|Overall Study||0
9081478|NCT00835679|10144861|FG000|STARTED|Overall Study||9
9081479|NCT00835679|10144862|FG001|STARTED|Overall Study|This study closed prematurely, thus no patients went on Cohort B, C or D.|0
9081480|NCT00835679|10144863|FG002|STARTED|Overall Study||0
9081481|NCT00835679|10144864|FG003|STARTED|Overall Study||0
9081482|NCT00835679|10144861|FG000|COMPLETED|Overall Study||8
9081483|NCT00835679|10144862|FG001|COMPLETED|Overall Study||0
9081484|NCT00835679|10144863|FG002|COMPLETED|Overall Study||0
9081485|NCT00835679|10144864|FG003|COMPLETED|Overall Study||0
9081486|NCT00835679|10144861|FG000|NOT COMPLETED|Overall Study||1
9081487|NCT00835679|10144862|FG001|NOT COMPLETED|Overall Study||0
9081488|NCT00835679|10144863|FG002|NOT COMPLETED|Overall Study||0
8624559|NCT00501293|9663932|FG000|NOT COMPLETED|Optimization Period||1
8624560|NCT00501293|9663933|FG001|NOT COMPLETED|Optimization Period||0
8624561|NCT00501293|9663932|FG000|STARTED|Maintenance Period||109
8624562|NCT00501293|9663933|FG001|STARTED|Maintenance Period||53
9081489|NCT00835679|10144864|FG003|NOT COMPLETED|Overall Study||0
9081490|NCT00841035|10144878|FG000|STARTED|Phase 1 Overall Study|2 phase enrollment,1st phase enrolled with cancer by fine needle aspiration in endoscopic ultrasound|19
9081491|NCT00841035|10144878|FG000|COMPLETED|Phase 1 Overall Study||6
9081492|NCT00841035|10144878|FG000|NOT COMPLETED|Phase 1 Overall Study||13
9081493|NCT00841035|10144878|FG000|STARTED|Phase 2 of Overall Study||6
9081494|NCT00841035|10144878|FG000|COMPLETED|Phase 2 of Overall Study||6
9081495|NCT00841035|10144878|FG000|NOT COMPLETED|Phase 2 of Overall Study||0
9081496|NCT00832520|10144883|FG000|STARTED|Overall Study||13
9081497|NCT00832520|10144883|FG000|COMPLETED|Overall Study||13
9081498|NCT00832520|10144883|FG000|NOT COMPLETED|Overall Study||0
9081499|NCT00833859|10144887|FG000|STARTED|Overall Study||2
9081500|NCT00833859|10144887|FG000|COMPLETED|Overall Study||2
9081501|NCT00833859|10144887|FG000|NOT COMPLETED|Overall Study||0
9081502|NCT00843050|10144891|FG000|STARTED|Overall Study||13
9081503|NCT00843050|10144891|FG000|COMPLETED|Overall Study||0
9081504|NCT00843050|10144891|FG000|NOT COMPLETED|Overall Study||13
9081505|NCT00840827|10144896|FG000|STARTED|Overall Study||6
9081506|NCT00840827|10144896|FG000|COMPLETED|Overall Study||0
9081507|NCT00840827|10144896|FG000|NOT COMPLETED|Overall Study||6
9081508|NCT00835328|10144904|FG000|STARTED|Cohort 1: Dose Level 1||5
9081509|NCT00835328|10144905|FG001|STARTED|Cohort 1: Dose Level 1||0
9081510|NCT00835328|10144906|FG002|STARTED|Cohort 1: Dose Level 1||0
9081511|NCT00835328|10144907|FG003|STARTED|Cohort 1: Dose Level 1||0
9081512|NCT00835328|10144904|FG000|COMPLETED|Cohort 1: Dose Level 1||5
9081513|NCT00835328|10144905|FG001|COMPLETED|Cohort 1: Dose Level 1||0
9081514|NCT00835328|10144906|FG002|COMPLETED|Cohort 1: Dose Level 1||0
9081515|NCT00835328|10144907|FG003|COMPLETED|Cohort 1: Dose Level 1||0
9081516|NCT00835328|10144904|FG000|NOT COMPLETED|Cohort 1: Dose Level 1||0
9081517|NCT00835328|10144905|FG001|NOT COMPLETED|Cohort 1: Dose Level 1||0
9081518|NCT00835328|10144906|FG002|NOT COMPLETED|Cohort 1: Dose Level 1||0
9081519|NCT00835328|10144907|FG003|NOT COMPLETED|Cohort 1: Dose Level 1||0
9081520|NCT00835328|10144904|FG000|STARTED|Cohort 2: Dose Level 2||0
9081521|NCT00835328|10144905|FG001|STARTED|Cohort 2: Dose Level 2||2
9081522|NCT00835328|10144906|FG002|STARTED|Cohort 2: Dose Level 2||0
9081523|NCT00835328|10144907|FG003|STARTED|Cohort 2: Dose Level 2||0
9081524|NCT00835328|10144904|FG000|COMPLETED|Cohort 2: Dose Level 2||0
9081525|NCT00835328|10144905|FG001|COMPLETED|Cohort 2: Dose Level 2||2
9081526|NCT00835328|10144906|FG002|COMPLETED|Cohort 2: Dose Level 2||0
9081527|NCT00835328|10144907|FG003|COMPLETED|Cohort 2: Dose Level 2||0
9081528|NCT00835328|10144904|FG000|NOT COMPLETED|Cohort 2: Dose Level 2||0
9081529|NCT00835328|10144905|FG001|NOT COMPLETED|Cohort 2: Dose Level 2||0
9081530|NCT00835328|10144906|FG002|NOT COMPLETED|Cohort 2: Dose Level 2||0
9081531|NCT00835328|10144907|FG003|NOT COMPLETED|Cohort 2: Dose Level 2||0
9081532|NCT00835328|10144904|FG000|STARTED|Cohort 3: Dose Level 3||0
9081533|NCT00835328|10144905|FG001|STARTED|Cohort 3: Dose Level 3||0
9081534|NCT00835328|10144906|FG002|STARTED|Cohort 3: Dose Level 3||2
8844659|NCT01710891|9899092|FG000|NOT COMPLETED|Overall Study||0
8844660|NCT01710891|9899093|FG001|NOT COMPLETED|Overall Study||0
8844661|NCT01711177|9899102|FG000|STARTED|Overall Study||10
8844662|NCT01711177|9899103|FG001|STARTED|Overall Study||3
8844663|NCT01711177|9899104|FG002|STARTED|Overall Study||3
8844664|NCT01711177|9899102|FG000|COMPLETED|Overall Study||10
8844665|NCT01711177|9899103|FG001|COMPLETED|Overall Study||3
8844666|NCT01711177|9899104|FG002|COMPLETED|Overall Study||3
9081535|NCT00835328|10144907|FG003|STARTED|Cohort 3: Dose Level 3||0
9081536|NCT00835328|10144904|FG000|COMPLETED|Cohort 3: Dose Level 3||0
9081537|NCT00835328|10144905|FG001|COMPLETED|Cohort 3: Dose Level 3||0
9081538|NCT00835328|10144906|FG002|COMPLETED|Cohort 3: Dose Level 3||2
9081539|NCT00835328|10144907|FG003|COMPLETED|Cohort 3: Dose Level 3||0
9081540|NCT00835328|10144904|FG000|NOT COMPLETED|Cohort 3: Dose Level 3||0
9081541|NCT00835328|10144905|FG001|NOT COMPLETED|Cohort 3: Dose Level 3||0
9081542|NCT00835328|10144906|FG002|NOT COMPLETED|Cohort 3: Dose Level 3||0
9081543|NCT00835328|10144907|FG003|NOT COMPLETED|Cohort 3: Dose Level 3||0
9081544|NCT00835328|10144904|FG000|STARTED|Cohort 4: Dose Level 4|Cohort#4 enrolled 4 subsequent subjects|0
9081545|NCT00835328|10144905|FG001|STARTED|Cohort 4: Dose Level 4||0
9081546|NCT00835328|10144906|FG002|STARTED|Cohort 4: Dose Level 4||0
9081547|NCT00835328|10144907|FG003|STARTED|Cohort 4: Dose Level 4||4
9081548|NCT00835328|10144904|FG000|COMPLETED|Cohort 4: Dose Level 4||0
9081549|NCT00835328|10144905|FG001|COMPLETED|Cohort 4: Dose Level 4||0
9081550|NCT00835328|10144906|FG002|COMPLETED|Cohort 4: Dose Level 4||0
9081551|NCT00835328|10144907|FG003|COMPLETED|Cohort 4: Dose Level 4||4
9081552|NCT00835328|10144904|FG000|NOT COMPLETED|Cohort 4: Dose Level 4||0
9081553|NCT00835328|10144905|FG001|NOT COMPLETED|Cohort 4: Dose Level 4||0
9081554|NCT00835328|10144906|FG002|NOT COMPLETED|Cohort 4: Dose Level 4||0
9081555|NCT00835328|10144907|FG003|NOT COMPLETED|Cohort 4: Dose Level 4||0
9081556|NCT00832572|10144921|FG000|STARTED|Period 1||3
9081557|NCT00832572|10144922|FG001|STARTED|Period 1||2
9081558|NCT00832572|10144921|FG000|COMPLETED|Period 1||3
9081559|NCT00832572|10144922|FG001|COMPLETED|Period 1||2
9081560|NCT00832572|10144921|FG000|NOT COMPLETED|Period 1||0
9081561|NCT00832572|10144922|FG001|NOT COMPLETED|Period 1||0
9081562|NCT00832572|10144921|FG000|STARTED|Period 2||3
9081563|NCT00832572|10144922|FG001|STARTED|Period 2||2
9081564|NCT00832572|10144921|FG000|COMPLETED|Period 2||3
9081565|NCT00832572|10144922|FG001|COMPLETED|Period 2||2
9081566|NCT00832572|10144921|FG000|NOT COMPLETED|Period 2||0
9081567|NCT00832572|10144922|FG001|NOT COMPLETED|Period 2||0
9081568|NCT00832624|10144930|FG000|STARTED|Overall Study||10
9081569|NCT00832624|10144930|FG000|COMPLETED|Overall Study||0
9081570|NCT00832624|10144930|FG000|NOT COMPLETED|Overall Study||10
9081571|NCT00832299|10144934|FG000|STARTED|Overall Study||2
9081572|NCT00832299|10144934|FG000|COMPLETED|Overall Study||2
9081573|NCT00832299|10144934|FG000|NOT COMPLETED|Overall Study||0
9081574|NCT00836355|10144942|FG000|STARTED|Overall Study||0
9081575|NCT00836355|10144943|FG001|STARTED|Overall Study||4
9081576|NCT00836355|10144944|FG002|STARTED|Overall Study||0
9081577|NCT00836355|10144945|FG003|STARTED|Overall Study||2
9081578|NCT00836355|10144942|FG000|COMPLETED|Overall Study||0
9081579|NCT00836355|10144943|FG001|COMPLETED|Overall Study||4
9081580|NCT00836355|10144944|FG002|COMPLETED|Overall Study||0
9081581|NCT00836355|10144945|FG003|COMPLETED|Overall Study||2
9081582|NCT00836355|10144942|FG000|NOT COMPLETED|Overall Study||0
9081583|NCT00836355|10144943|FG001|NOT COMPLETED|Overall Study||0
8844667|NCT01711177|9899102|FG000|NOT COMPLETED|Overall Study||0
8844668|NCT01711177|9899103|FG001|NOT COMPLETED|Overall Study||0
8844669|NCT01711177|9899104|FG002|NOT COMPLETED|Overall Study||0
9081584|NCT00836355|10144944|FG002|NOT COMPLETED|Overall Study||0
8844670|NCT01711216|9899112|FG000|STARTED|Overall Study||999
9081585|NCT00836355|10144945|FG003|NOT COMPLETED|Overall Study||0
9081586|NCT00832598|10144955|FG000|STARTED|Overall Study||13
9081587|NCT00832598|10144955|FG000|COMPLETED|Overall Study||13
9081588|NCT00832598|10144955|FG000|NOT COMPLETED|Overall Study||0
9081589|NCT00816777|10144961|FG000|STARTED|Overall Study||2
9081590|NCT00816777|10144962|FG001|STARTED|Overall Study||2
9081591|NCT00816777|10144961|FG000|COMPLETED|Overall Study||2
9081592|NCT00816777|10144962|FG001|COMPLETED|Overall Study||2
9081593|NCT00816777|10144961|FG000|NOT COMPLETED|Overall Study||0
9081594|NCT00816777|10144962|FG001|NOT COMPLETED|Overall Study||0
9081595|NCT00823095|10144968|FG000|STARTED|Overall Study||7
8844671|NCT01711216|9899112|FG000|COMPLETED|Overall Study||782
8624563|NCT00501293|9663932|FG000|COMPLETED|Maintenance Period||63
8624564|NCT00501293|9663933|FG001|COMPLETED|Maintenance Period||25
8624565|NCT00501293|9663932|FG000|NOT COMPLETED|Maintenance Period||46
8624566|NCT00501293|9663933|FG001|NOT COMPLETED|Maintenance Period||28
9081596|NCT00823095|10144968|FG000|COMPLETED|Overall Study||7
9081597|NCT00823095|10144968|FG000|NOT COMPLETED|Overall Study||0
9081598|NCT00827567|10144973|FG000|STARTED|Overall Study||4
9081599|NCT00827567|10144973|FG000|COMPLETED|Overall Study|2 screen failures, 4 withdrew from study to go on to other therapies|0
9081600|NCT00827567|10144973|FG000|NOT COMPLETED|Overall Study||4
9081601|NCT00815633|10144977|FG000|STARTED|Overall Study||1
9081602|NCT00815633|10144977|FG000|COMPLETED|Overall Study||0
9081603|NCT00815633|10144977|FG000|NOT COMPLETED|Overall Study||1
9081604|NCT00814983|10144983|FG000|STARTED|Overall Study||15
9081605|NCT00814983|10144984|FG001|STARTED|Overall Study||0
9081606|NCT00814983|10144983|FG000|COMPLETED|Overall Study||12
9081607|NCT00814983|10144984|FG001|COMPLETED|Overall Study||0
9081608|NCT00814983|10144983|FG000|NOT COMPLETED|Overall Study||3
9081609|NCT00814983|10144984|FG001|NOT COMPLETED|Overall Study||0
9081610|NCT00825227|10144992|FG000|STARTED|Overall Study||6
9081611|NCT00825227|10144993|FG001|STARTED|Overall Study||4
9081612|NCT00825227|10144992|FG000|COMPLETED|Overall Study||6
9081613|NCT00825227|10144993|FG001|COMPLETED|Overall Study||4
9081614|NCT00825227|10144992|FG000|NOT COMPLETED|Overall Study||0
9081615|NCT00825227|10144993|FG001|NOT COMPLETED|Overall Study||0
9081616|NCT00819832|10145007|FG000|STARTED|Overall Study|No patient data analysis.|3
9081617|NCT00819832|10145008|FG001|STARTED|Overall Study||0
9081618|NCT00819832|10145009|FG002|STARTED|Overall Study||0
9081619|NCT00819832|10145010|FG003|STARTED|Overall Study||0
9081620|NCT00819832|10145011|FG004|STARTED|Overall Study||0
9081621|NCT00819832|10145012|FG005|STARTED|Overall Study||0
9081622|NCT00819832|10145007|FG000|COMPLETED|Overall Study||0
9081623|NCT00819832|10145008|FG001|COMPLETED|Overall Study||0
9081624|NCT00819832|10145009|FG002|COMPLETED|Overall Study||0
9081625|NCT00819832|10145010|FG003|COMPLETED|Overall Study||0
9081626|NCT00819832|10145011|FG004|COMPLETED|Overall Study||0
9081627|NCT00819832|10145012|FG005|COMPLETED|Overall Study||0
9081628|NCT00819832|10145007|FG000|NOT COMPLETED|Overall Study||3
9081629|NCT00819832|10145008|FG001|NOT COMPLETED|Overall Study||0
9081630|NCT00819832|10145009|FG002|NOT COMPLETED|Overall Study||0
9081631|NCT00819832|10145010|FG003|NOT COMPLETED|Overall Study||0
9081632|NCT00819832|10145011|FG004|NOT COMPLETED|Overall Study||0
9081633|NCT00819832|10145012|FG005|NOT COMPLETED|Overall Study||0
9081634|NCT00822679|10145028|FG000|STARTED|Overall Study||0
9081635|NCT00822679|10145029|FG001|STARTED|Overall Study||0
9081636|NCT00822679|10145028|FG000|COMPLETED|Overall Study||0
9081637|NCT00822679|10145029|FG001|COMPLETED|Overall Study||0
9081638|NCT00822679|10145028|FG000|NOT COMPLETED|Overall Study||0
9081639|NCT00822679|10145029|FG001|NOT COMPLETED|Overall Study||0
9081640|NCT00814892|10145035|FG000|STARTED|Overall Study||2
9081641|NCT00814892|10145035|FG000|COMPLETED|Overall Study||0
9081642|NCT00814892|10145035|FG000|NOT COMPLETED|Overall Study||2
9081643|NCT00809458|10145041|FG000|STARTED|Overall Study||9
9081644|NCT00809458|10145042|FG001|STARTED|Overall Study||6
9081645|NCT00809458|10145041|FG000|COMPLETED|Overall Study||8
9081646|NCT00809458|10145042|FG001|COMPLETED|Overall Study||5
9081647|NCT00809458|10145041|FG000|NOT COMPLETED|Overall Study||1
9081648|NCT00809458|10145042|FG001|NOT COMPLETED|Overall Study||1
9081649|NCT00802659|10145052|FG000|STARTED|Overall Study||0
9081650|NCT00802659|10145053|FG001|STARTED|Overall Study||2
9081651|NCT00802659|10145054|FG002|STARTED|Overall Study||0
9081652|NCT00802659|10145055|FG003|STARTED|Overall Study||0
9081653|NCT00802659|10145052|FG000|COMPLETED|Overall Study||0
9081654|NCT00802659|10145053|FG001|COMPLETED|Overall Study||1
9081655|NCT00802659|10145054|FG002|COMPLETED|Overall Study||0
9081656|NCT00802659|10145055|FG003|COMPLETED|Overall Study||0
9081657|NCT00802659|10145052|FG000|NOT COMPLETED|Overall Study||0
9081658|NCT00802659|10145053|FG001|NOT COMPLETED|Overall Study||1
9081659|NCT00802659|10145054|FG002|NOT COMPLETED|Overall Study||0
9081660|NCT00802659|10145055|FG003|NOT COMPLETED|Overall Study||0
9081661|NCT00807365|10145065|FG000|STARTED|Overall Study||5
9081662|NCT00807365|10145065|FG000|COMPLETED|Overall Study||0
9081663|NCT00807365|10145065|FG000|NOT COMPLETED|Overall Study||5
9081664|NCT00814333|10145071|FG000|STARTED|Enrollment||1
9081665|NCT00814333|10145072|FG001|STARTED|Enrollment||0
9081666|NCT00814333|10145071|FG000|COMPLETED|Enrollment||0
9081667|NCT00814333|10145072|FG001|COMPLETED|Enrollment||0
9081668|NCT00814333|10145071|FG000|NOT COMPLETED|Enrollment||1
9081669|NCT00814333|10145072|FG001|NOT COMPLETED|Enrollment||0
8624567|NCT00501540|9663940|FG000|STARTED|Overall Study||15
9081670|NCT00814333|10145071|FG000|STARTED|Treatment Period||0
9081671|NCT00814333|10145072|FG001|STARTED|Treatment Period||0
9081672|NCT00814333|10145071|FG000|COMPLETED|Treatment Period||0
9081673|NCT00814333|10145072|FG001|COMPLETED|Treatment Period||0
9081674|NCT00814333|10145071|FG000|NOT COMPLETED|Treatment Period||0
9081675|NCT00814333|10145072|FG001|NOT COMPLETED|Treatment Period||0
9081676|NCT00808080|10145078|FG000|STARTED|Overall Study||6
8624568|NCT00501540|9663940|FG000|COMPLETED|Overall Study||10
9081677|NCT00808080|10145078|FG000|COMPLETED|Overall Study||0
9081678|NCT00808080|10145078|FG000|NOT COMPLETED|Overall Study||6
9081679|NCT00802893|10145083|FG000|STARTED|Overall Study||3
9081680|NCT00802893|10145083|FG000|COMPLETED|Overall Study||0
9081681|NCT00802893|10145083|FG000|NOT COMPLETED|Overall Study||3
9081682|NCT00809341|10145089|FG000|STARTED|Overall Study||20
9081683|NCT00809341|10145090|FG001|STARTED|Overall Study||5
9081684|NCT00809341|10145089|FG000|COMPLETED|Overall Study||20
9081685|NCT00809341|10145090|FG001|COMPLETED|Overall Study||4
9081686|NCT00809341|10145089|FG000|NOT COMPLETED|Overall Study||0
9081687|NCT00809341|10145090|FG001|NOT COMPLETED|Overall Study||1
9081688|NCT00804349|10145098|FG000|STARTED|Overall Study|0 analyzed PI no longer at institution;PI contacted, information not added; No data available.|0
9081689|NCT00804349|10145099|FG001|STARTED|Overall Study|0 analyzed PI no longer at institution;PI contacted, information not added; No data available|0
9081690|NCT00804349|10145098|FG000|COMPLETED|Overall Study|0 analyzed PI no longer at institution;PI contacted, information not added; No data available|0
9081691|NCT00804349|10145099|FG001|COMPLETED|Overall Study|0 analyzed PI no longer at institution;PI contacted, information not added; No data available|0
9081692|NCT00804349|10145098|FG000|NOT COMPLETED|Overall Study||0
9081693|NCT00804349|10145099|FG001|NOT COMPLETED|Overall Study||0
9081694|NCT00803283|10145107|FG000|STARTED|Overall Study||1
9081695|NCT00803283|10145108|FG001|STARTED|Overall Study||1
9081696|NCT00803283|10145107|FG000|COMPLETED|Overall Study||1
9081697|NCT00803283|10145108|FG001|COMPLETED|Overall Study||1
9081698|NCT00803283|10145107|FG000|NOT COMPLETED|Overall Study||0
9081699|NCT00803283|10145108|FG001|NOT COMPLETED|Overall Study||0
8624569|NCT00501540|9663940|FG000|NOT COMPLETED|Overall Study||5
8629508|NCT00530777|9669269|FG001|STARTED|Overall Study||74
8629509|NCT00530777|9669268|FG000|COMPLETED|Overall Study||67
8629510|NCT00530777|9669269|FG001|COMPLETED|Overall Study||69
9081700|NCT00811590|10145114|FG000|STARTED|Overall Study||3
9081701|NCT00811590|10145114|FG000|COMPLETED|Overall Study||3
9081702|NCT00811590|10145114|FG000|NOT COMPLETED|Overall Study||0
9081703|NCT00808899|10145118|FG000|STARTED|Overall Study||4
9081704|NCT00808899|10145118|FG000|COMPLETED|Overall Study||0
9081705|NCT00808899|10145118|FG000|NOT COMPLETED|Overall Study||4
9081706|NCT00808769|10145122|FG000|STARTED|First Intervention||15
9081707|NCT00808769|10145123|FG001|STARTED|First Intervention||15
9081708|NCT00808769|10145122|FG000|COMPLETED|First Intervention||15
9081709|NCT00808769|10145123|FG001|COMPLETED|First Intervention||15
9081710|NCT00808769|10145122|FG000|NOT COMPLETED|First Intervention||0
9081711|NCT00808769|10145123|FG001|NOT COMPLETED|First Intervention||0
9081712|NCT00808769|10145122|FG000|STARTED|Second Intervention||15
9081713|NCT00808769|10145123|FG001|STARTED|Second Intervention||15
9081714|NCT00808769|10145122|FG000|COMPLETED|Second Intervention||15
9081715|NCT00808769|10145123|FG001|COMPLETED|Second Intervention||15
9081716|NCT00808769|10145122|FG000|NOT COMPLETED|Second Intervention||0
9081717|NCT00808769|10145123|FG001|NOT COMPLETED|Second Intervention||0
9081718|NCT00803179|10145129|FG000|STARTED|Overall Study||5
9081719|NCT00803179|10145129|FG000|COMPLETED|Overall Study||2
9081720|NCT00803179|10145129|FG000|NOT COMPLETED|Overall Study||3
9081721|NCT00801931|10145133|FG000|STARTED|Overall Study||1
9081722|NCT00801931|10145133|FG000|COMPLETED|Overall Study||1
9081723|NCT00801931|10145133|FG000|NOT COMPLETED|Overall Study||0
9081724|NCT00793520|10145139|FG000|STARTED|Milnacipran Crossover to Placebo||1
9081725|NCT00793520|10145140|FG001|STARTED|Milnacipran Crossover to Placebo||0
9081726|NCT00793520|10145139|FG000|COMPLETED|Milnacipran Crossover to Placebo||0
9081727|NCT00793520|10145140|FG001|COMPLETED|Milnacipran Crossover to Placebo||0
9081728|NCT00793520|10145139|FG000|NOT COMPLETED|Milnacipran Crossover to Placebo||1
9081729|NCT00793520|10145140|FG001|NOT COMPLETED|Milnacipran Crossover to Placebo||0
9081730|NCT00793520|10145139|FG000|STARTED|Placebo Crossover to Milnacipran||0
9081731|NCT00793520|10145140|FG001|STARTED|Placebo Crossover to Milnacipran||1
9081732|NCT00793520|10145139|FG000|COMPLETED|Placebo Crossover to Milnacipran||0
9081733|NCT00793520|10145140|FG001|COMPLETED|Placebo Crossover to Milnacipran||0
9081734|NCT00793520|10145139|FG000|NOT COMPLETED|Placebo Crossover to Milnacipran||0
9081735|NCT00793520|10145140|FG001|NOT COMPLETED|Placebo Crossover to Milnacipran||1
9081736|NCT00795236|10145148|FG000|STARTED|Overall Study||0
9081737|NCT00795236|10145149|FG001|STARTED|Overall Study||0
9081738|NCT00795236|10145148|FG000|COMPLETED|Overall Study|Unable to consistently obtain saliva DLMO in subjects and thus couldn't measure circadian period|0
9081739|NCT00795236|10145149|FG001|COMPLETED|Overall Study||0
9081740|NCT00795236|10145148|FG000|NOT COMPLETED|Overall Study||0
9081741|NCT00795236|10145149|FG001|NOT COMPLETED|Overall Study||0
9081742|NCT00799773|10145159|FG000|STARTED|Overall Study||2
9081743|NCT00799773|10145160|FG001|STARTED|Overall Study||1
9081744|NCT00799773|10145159|FG000|COMPLETED|Overall Study||2
9081745|NCT00799773|10145160|FG001|COMPLETED|Overall Study||1
9081746|NCT00799773|10145159|FG000|NOT COMPLETED|Overall Study||0
9081747|NCT00799773|10145160|FG001|NOT COMPLETED|Overall Study||0
9081748|NCT00790452|10145168|FG000|STARTED|Overall Study||1
9081749|NCT00790452|10145169|FG001|STARTED|Overall Study||0
9081750|NCT00790452|10145168|FG000|COMPLETED|Overall Study||0
9081751|NCT00790452|10145169|FG001|COMPLETED|Overall Study||0
9081752|NCT00790452|10145168|FG000|NOT COMPLETED|Overall Study||1
9081753|NCT00790452|10145169|FG001|NOT COMPLETED|Overall Study||0
9081754|NCT00795665|10145175|FG000|STARTED|Overall Study||7
9081755|NCT00795665|10145175|FG000|COMPLETED|Overall Study||7
9081756|NCT00795665|10145175|FG000|NOT COMPLETED|Overall Study||0
9081757|NCT00787917|10145181|FG000|STARTED|Blinded Treatment||9
8629511|NCT00530777|9669268|FG000|NOT COMPLETED|Overall Study||7
9081758|NCT00787917|10145182|FG001|STARTED|Blinded Treatment||5
9081759|NCT00787917|10145181|FG000|COMPLETED|Blinded Treatment||4
9081760|NCT00787917|10145182|FG001|COMPLETED|Blinded Treatment||3
9081761|NCT00787917|10145181|FG000|NOT COMPLETED|Blinded Treatment||5
9081762|NCT00787917|10145182|FG001|NOT COMPLETED|Blinded Treatment||2
9081763|NCT00787917|10145181|FG000|STARTED|Open Label||7
9081764|NCT00787917|10145182|FG001|STARTED|Open Label|"Placebo was not an arm in open label treatment."|0
9081765|NCT00787917|10145181|FG000|COMPLETED|Open Label||3
9081766|NCT00787917|10145182|FG001|COMPLETED|Open Label||0
9081767|NCT00787917|10145181|FG000|NOT COMPLETED|Open Label||4
9081768|NCT00787917|10145182|FG001|NOT COMPLETED|Open Label||0
9081769|NCT00798590|10145192|FG000|STARTED|Overall Study||11
9081770|NCT00798590|10145193|FG001|STARTED|Overall Study||8
9081771|NCT00798590|10145192|FG000|COMPLETED|Overall Study||0
9081772|NCT00798590|10145193|FG001|COMPLETED|Overall Study||0
9081773|NCT00798590|10145192|FG000|NOT COMPLETED|Overall Study||11
9081774|NCT00798590|10145193|FG001|NOT COMPLETED|Overall Study||8
9081775|NCT00796510|10145201|FG000|STARTED|Overall Study||3
9081776|NCT00796510|10145202|FG001|STARTED|Overall Study||0
9081777|NCT00796510|10145201|FG000|COMPLETED|Overall Study||0
9081778|NCT00796510|10145202|FG001|COMPLETED|Overall Study||0
9081779|NCT00796510|10145201|FG000|NOT COMPLETED|Overall Study||3
9081780|NCT00796510|10145202|FG001|NOT COMPLETED|Overall Study||0
9081781|NCT00796861|10145208|FG000|STARTED|Overall Study||4
9081782|NCT00796861|10145208|FG000|COMPLETED|Overall Study||0
9081783|NCT00796861|10145208|FG000|NOT COMPLETED|Overall Study||4
9081784|NCT00791076|10145212|FG000|STARTED|Overall Study||8
9081785|NCT00791076|10145212|FG000|COMPLETED|Overall Study||0
9081786|NCT00791076|10145212|FG000|NOT COMPLETED|Overall Study||8
9081787|NCT00790478|10145220|FG000|STARTED|Overall Study||0
9081788|NCT00790478|10145221|FG001|STARTED|Overall Study||0
9081789|NCT00790478|10145220|FG000|COMPLETED|Overall Study||0
9081790|NCT00790478|10145221|FG001|COMPLETED|Overall Study||0
9081791|NCT00790478|10145220|FG000|NOT COMPLETED|Overall Study||0
9081792|NCT00790478|10145221|FG001|NOT COMPLETED|Overall Study||0
9081793|NCT00796107|10145227|FG000|STARTED|Overall Study||6
9081794|NCT00796107|10145227|FG000|COMPLETED|Overall Study||0
9081795|NCT00796107|10145227|FG000|NOT COMPLETED|Overall Study||6
9081796|NCT00791336|10145231|FG000|STARTED|Overall Study||1
9081797|NCT00791336|10145231|FG000|COMPLETED|Overall Study||1
9081798|NCT00791336|10145231|FG000|NOT COMPLETED|Overall Study||0
9081799|NCT00786682|10145235|FG000|STARTED|Overall Study||11
9081800|NCT00786682|10145235|FG000|COMPLETED|Overall Study||11
9081801|NCT00786682|10145235|FG000|NOT COMPLETED|Overall Study||0
9081802|NCT00787124|10145241|FG000|STARTED|Overall Study||4
9081803|NCT00787124|10145242|FG001|STARTED|Overall Study||4
9081804|NCT00787124|10145241|FG000|COMPLETED|Overall Study||4
9081805|NCT00787124|10145242|FG001|COMPLETED|Overall Study||4
9081806|NCT00787124|10145241|FG000|NOT COMPLETED|Overall Study||0
9081807|NCT00787124|10145242|FG001|NOT COMPLETED|Overall Study||0
9081808|NCT00785356|10145251|FG000|STARTED|Overall Study||8
9081809|NCT00785356|10145251|FG000|COMPLETED|Overall Study||0
9081810|NCT00785356|10145251|FG000|NOT COMPLETED|Overall Study||8
9081811|NCT00782483|10145259|FG000|STARTED|Overall Study|6 subjects enrolled beginning on 04/27/2009 with last enrollment on 04/13/2010.|6
9081812|NCT00782483|10145259|FG000|COMPLETED|Overall Study||0
9081813|NCT00782483|10145259|FG000|NOT COMPLETED|Overall Study||6
9081814|NCT00791843|10145263|FG000|STARTED|Overall Study|Data unavailable for the study|0
9081815|NCT00791843|10145263|FG000|COMPLETED|Overall Study|Data unavailable for the study|0
9081816|NCT00791843|10145263|FG000|NOT COMPLETED|Overall Study||0
9081817|NCT00784043|10145269|FG000|STARTED|Overall Study||31
9081818|NCT00784043|10145270|FG001|STARTED|Overall Study||6
9081819|NCT00784043|10145269|FG000|COMPLETED|Overall Study||0
9081820|NCT00784043|10145270|FG001|COMPLETED|Overall Study||0
8624570|NCT00501592|9663947|FG000|STARTED|Overall Study||20
8624571|NCT00501592|9663948|FG001|STARTED|Overall Study||21
8624572|NCT00501592|9663949|FG002|STARTED|Overall Study||23
8624573|NCT00501592|9663947|FG000|COMPLETED|Overall Study||20
8624574|NCT00501592|9663948|FG001|COMPLETED|Overall Study||16
8624575|NCT00501592|9663949|FG002|COMPLETED|Overall Study||20
8624576|NCT00501592|9663947|FG000|NOT COMPLETED|Overall Study||0
8624577|NCT00501592|9663948|FG001|NOT COMPLETED|Overall Study||5
8624578|NCT00501592|9663949|FG002|NOT COMPLETED|Overall Study||3
8624579|NCT00501631|9663959|FG000|STARTED|Part A (Double-blind Period)||152
8624580|NCT00501631|9663960|FG001|STARTED|Part A (Double-blind Period)||148
8624581|NCT00501631|9663959|FG000|COMPLETED|Part A (Double-blind Period)||90
9081821|NCT00784043|10145269|FG000|NOT COMPLETED|Overall Study||31
9081822|NCT00784043|10145270|FG001|NOT COMPLETED|Overall Study||6
9081823|NCT00787618|10145279|FG000|STARTED|Overall Study||3
9081824|NCT00787618|10145280|FG001|STARTED|Overall Study||0
9081825|NCT00787618|10145281|FG002|STARTED|Overall Study||3
9081826|NCT00787618|10145279|FG000|COMPLETED|Overall Study||3
9081827|NCT00787618|10145280|FG001|COMPLETED|Overall Study||0
9081828|NCT00787618|10145281|FG002|COMPLETED|Overall Study||3
9081829|NCT00787618|10145279|FG000|NOT COMPLETED|Overall Study||0
9081830|NCT00787618|10145280|FG001|NOT COMPLETED|Overall Study||0
9081831|NCT00787618|10145281|FG002|NOT COMPLETED|Overall Study||0
9081832|NCT00774306|10145293|FG000|STARTED|Overall Study||24
9081833|NCT00774306|10145294|FG001|STARTED|Overall Study||5
9081834|NCT00774306|10145295|FG002|STARTED|Overall Study||16
9081835|NCT00774306|10145296|FG003|STARTED|Overall Study||7
9081836|NCT00774306|10145293|FG000|COMPLETED|Overall Study||6
9081837|NCT00774306|10145294|FG001|COMPLETED|Overall Study||3
9081838|NCT00774306|10145295|FG002|COMPLETED|Overall Study||8
9081839|NCT00774306|10145296|FG003|COMPLETED|Overall Study||2
9081840|NCT00774306|10145293|FG000|NOT COMPLETED|Overall Study||18
9081841|NCT00774306|10145294|FG001|NOT COMPLETED|Overall Study||2
9081842|NCT00774306|10145295|FG002|NOT COMPLETED|Overall Study||8
9081843|NCT00774306|10145296|FG003|NOT COMPLETED|Overall Study||5
9081844|NCT00771602|10145309|FG000|STARTED|Overall Study||1
9081845|NCT00771602|10145310|FG001|STARTED|Overall Study||0
9081846|NCT00771602|10145311|FG002|STARTED|Overall Study||0
9081847|NCT00771602|10145309|FG000|COMPLETED|Overall Study||1
9081848|NCT00771602|10145310|FG001|COMPLETED|Overall Study||0
9081849|NCT00771602|10145311|FG002|COMPLETED|Overall Study||0
9081850|NCT00771602|10145309|FG000|NOT COMPLETED|Overall Study||0
9081851|NCT00771602|10145310|FG001|NOT COMPLETED|Overall Study||0
9081852|NCT00771602|10145311|FG002|NOT COMPLETED|Overall Study||0
8624582|NCT00501631|9663960|FG001|COMPLETED|Part A (Double-blind Period)||99
8624583|NCT00501631|9663959|FG000|NOT COMPLETED|Part A (Double-blind Period)||62
8624584|NCT00501631|9663960|FG001|NOT COMPLETED|Part A (Double-blind Period)||49
9081853|NCT00779038|10145319|FG000|STARTED|Overall Study||13
9081854|NCT00779038|10145319|FG000|COMPLETED|Overall Study||0
9081855|NCT00779038|10145319|FG000|NOT COMPLETED|Overall Study||13
9081856|NCT00780455|10145325|FG000|STARTED|Overall Study||2
9081857|NCT00780455|10145326|FG001|STARTED|Overall Study||2
9081858|NCT00780455|10145325|FG000|COMPLETED|Overall Study||2
9081859|NCT00780455|10145326|FG001|COMPLETED|Overall Study||2
9081860|NCT00780455|10145325|FG000|NOT COMPLETED|Overall Study||0
9081861|NCT00780455|10145326|FG001|NOT COMPLETED|Overall Study||0
9081862|NCT00776100|10145334|FG000|STARTED|Overall Study||1
9081863|NCT00776100|10145335|FG001|STARTED|Overall Study||1
9081864|NCT00776100|10145334|FG000|COMPLETED|Overall Study||0
9081865|NCT00776100|10145335|FG001|COMPLETED|Overall Study||1
8844672|NCT01711216|9899112|FG000|NOT COMPLETED|Overall Study||217
8844673|NCT01711294|9899119|FG000|STARTED|Overall Study||121
9081866|NCT00776100|10145334|FG000|NOT COMPLETED|Overall Study||1
9081867|NCT00776100|10145335|FG001|NOT COMPLETED|Overall Study||0
9081868|NCT00771316|10145343|FG000|STARTED|Overall Study||4
9081869|NCT00771316|10145344|FG001|STARTED|Overall Study||2
9081870|NCT00771316|10145343|FG000|COMPLETED|Overall Study||2
9081871|NCT00771316|10145344|FG001|COMPLETED|Overall Study||1
9081872|NCT00771316|10145343|FG000|NOT COMPLETED|Overall Study||2
9081873|NCT00771316|10145344|FG001|NOT COMPLETED|Overall Study||1
9081874|NCT00780481|10145350|FG000|STARTED|Overall Study||13
9081875|NCT00780481|10145350|FG000|COMPLETED|Overall Study||13
9081876|NCT00780481|10145350|FG000|NOT COMPLETED|Overall Study||0
9081877|NCT00769652|10145356|FG000|STARTED|Overall Study||6
9081878|NCT00769652|10145357|FG001|STARTED|Overall Study||1
9081879|NCT00769652|10145356|FG000|COMPLETED|Overall Study||6
9081880|NCT00769652|10145357|FG001|COMPLETED|Overall Study||1
9081881|NCT00769652|10145356|FG000|NOT COMPLETED|Overall Study||0
9081882|NCT00769652|10145357|FG001|NOT COMPLETED|Overall Study||0
9081883|NCT00768040|10145365|FG000|STARTED|Overall Study|"Started indicates randomized, safety and full analysis set."|20
9081884|NCT00768040|10145366|FG001|STARTED|Overall Study||19
9081885|NCT00768040|10145365|FG000|COMPLETED|Overall Study||16
9081886|NCT00768040|10145366|FG001|COMPLETED|Overall Study||16
9081887|NCT00768040|10145365|FG000|NOT COMPLETED|Overall Study||4
9081888|NCT00768040|10145366|FG001|NOT COMPLETED|Overall Study||3
9081889|NCT00776555|10145374|FG000|STARTED|Overall Study||3
9081890|NCT00776555|10145375|FG001|STARTED|Overall Study||0
9081891|NCT00776555|10145374|FG000|COMPLETED|Overall Study||0
9081892|NCT00776555|10145375|FG001|COMPLETED|Overall Study||0
9081893|NCT00776555|10145374|FG000|NOT COMPLETED|Overall Study||3
9081894|NCT00776555|10145375|FG001|NOT COMPLETED|Overall Study||0
9081895|NCT00775190|10145383|FG000|STARTED|Overall Study||7
9081896|NCT00775190|10145384|FG001|STARTED|Overall Study||5
9081897|NCT00775190|10145383|FG000|COMPLETED|Overall Study||3
9081898|NCT00775190|10145384|FG001|COMPLETED|Overall Study||0
9081899|NCT00775190|10145383|FG000|NOT COMPLETED|Overall Study||4
9081900|NCT00775190|10145384|FG001|NOT COMPLETED|Overall Study||5
9081901|NCT00755261|10145390|FG000|STARTED|Overall Study||6
9081902|NCT00755261|10145390|FG000|COMPLETED|Overall Study||4
9081903|NCT00755261|10145390|FG000|NOT COMPLETED|Overall Study||2
9081904|NCT00762723|10145397|FG000|STARTED|Overall Study||5
9081905|NCT00762723|10145398|FG001|STARTED|Overall Study||11
9081906|NCT00762723|10145399|FG002|STARTED|Overall Study||3
9081907|NCT00762723|10145397|FG000|COMPLETED|Overall Study||0
9081908|NCT00762723|10145398|FG001|COMPLETED|Overall Study||6
9081909|NCT00762723|10145399|FG002|COMPLETED|Overall Study||0
9081910|NCT00762723|10145397|FG000|NOT COMPLETED|Overall Study||5
9081911|NCT00762723|10145398|FG001|NOT COMPLETED|Overall Study||5
9081912|NCT00762723|10145399|FG002|NOT COMPLETED|Overall Study||3
9081913|NCT00770965|10145411|FG000|STARTED|Safety Set||2
9081914|NCT00770965|10145412|FG001|STARTED|Safety Set||4
9081915|NCT00770965|10145413|FG002|STARTED|Safety Set||4
9081916|NCT00770965|10145414|FG003|STARTED|Safety Set||5
9081917|NCT00770965|10145411|FG000|COMPLETED|Safety Set||2
9081918|NCT00770965|10145412|FG001|COMPLETED|Safety Set||4
9081919|NCT00770965|10145413|FG002|COMPLETED|Safety Set||3
9081920|NCT00770965|10145414|FG003|COMPLETED|Safety Set||4
9081921|NCT00770965|10145411|FG000|NOT COMPLETED|Safety Set||0
9081922|NCT00770965|10145412|FG001|NOT COMPLETED|Safety Set||0
9081923|NCT00770965|10145413|FG002|NOT COMPLETED|Safety Set||1
9081924|NCT00770965|10145414|FG003|NOT COMPLETED|Safety Set||1
9081925|NCT00770965|10145411|FG000|STARTED|Excluded Set||18
9081926|NCT00770965|10145412|FG001|STARTED|Excluded Set||16
9081927|NCT00770965|10145413|FG002|STARTED|Excluded Set||16
9081928|NCT00770965|10145414|FG003|STARTED|Excluded Set||15
9081929|NCT00770965|10145411|FG000|COMPLETED|Excluded Set||3
9081930|NCT00770965|10145412|FG001|COMPLETED|Excluded Set||3
9081931|NCT00770965|10145413|FG002|COMPLETED|Excluded Set||2
9081932|NCT00770965|10145414|FG003|COMPLETED|Excluded Set||2
9081933|NCT00770965|10145411|FG000|NOT COMPLETED|Excluded Set||15
9081934|NCT00770965|10145412|FG001|NOT COMPLETED|Excluded Set||13
9081935|NCT00770965|10145413|FG002|NOT COMPLETED|Excluded Set||14
9081936|NCT00770965|10145414|FG003|NOT COMPLETED|Excluded Set||13
9081937|NCT00769002|10145428|FG000|STARTED|Overall Study||9
9081938|NCT00769002|10145429|FG001|STARTED|Overall Study||9
9081939|NCT00769002|10145428|FG000|COMPLETED|Overall Study||0
9081940|NCT00769002|10145429|FG001|COMPLETED|Overall Study||0
9081941|NCT00769002|10145428|FG000|NOT COMPLETED|Overall Study||9
9081942|NCT00769002|10145429|FG001|NOT COMPLETED|Overall Study||9
9081943|NCT00766636|10145436|FG000|STARTED|Overall Study||3
9081944|NCT00766636|10145437|FG001|STARTED|Overall Study||2
9081945|NCT00766636|10145436|FG000|COMPLETED|Overall Study|Number that completed pre- and post-operative therapy as well as surgery.|0
9081946|NCT00766636|10145437|FG001|COMPLETED|Overall Study||0
9081947|NCT00766636|10145436|FG000|NOT COMPLETED|Overall Study||3
8844674|NCT01711294|9899120|FG001|STARTED|Overall Study||65
8844675|NCT01711294|9899121|FG002|STARTED|Overall Study||64
8844676|NCT01711294|9899119|FG000|COMPLETED|Overall Study||121
8844677|NCT01711294|9899120|FG001|COMPLETED|Overall Study||65
9081948|NCT00766636|10145437|FG001|NOT COMPLETED|Overall Study||2
9081949|NCT00768248|10145445|FG000|STARTED|Overall Study||1
9081950|NCT00768248|10145446|FG001|STARTED|Overall Study||1
9081951|NCT00768248|10145445|FG000|COMPLETED|Overall Study||0
9081952|NCT00768248|10145446|FG001|COMPLETED|Overall Study||0
9081953|NCT00768248|10145445|FG000|NOT COMPLETED|Overall Study||1
9081954|NCT00768248|10145446|FG001|NOT COMPLETED|Overall Study||1
9081955|NCT00765765|10145452|FG000|STARTED|Overall Study||6
9081956|NCT00765765|10145452|FG000|COMPLETED|Overall Study||6
9081957|NCT00765765|10145452|FG000|NOT COMPLETED|Overall Study||0
9081958|NCT00764699|10145456|FG000|STARTED|Overall Study||3
9081959|NCT00764699|10145456|FG000|COMPLETED|Overall Study||0
9081960|NCT00764699|10145456|FG000|NOT COMPLETED|Overall Study||3
9081961|NCT00759577|10145460|FG000|STARTED|Overall Study||36
9081962|NCT00759577|10145460|FG000|COMPLETED|Overall Study||36
9081963|NCT00759577|10145460|FG000|NOT COMPLETED|Overall Study||0
9081964|NCT00763009|10145464|FG000|STARTED|Overall Study||8
9081965|NCT00763009|10145464|FG000|COMPLETED|Overall Study||7
9081966|NCT00763009|10145464|FG000|NOT COMPLETED|Overall Study||1
9081967|NCT00761176|10145471|FG000|STARTED|Overall Study||4
9081968|NCT00761176|10145472|FG001|STARTED|Overall Study||4
9081969|NCT00761176|10145471|FG000|COMPLETED|Overall Study||2
9081970|NCT00761176|10145472|FG001|COMPLETED|Overall Study||3
9081971|NCT00761176|10145471|FG000|NOT COMPLETED|Overall Study||2
9081972|NCT00761176|10145472|FG001|NOT COMPLETED|Overall Study||1
9081973|NCT00749476|10145478|FG000|STARTED|Overall Study||1
9081974|NCT00749476|10145478|FG000|COMPLETED|Overall Study||1
9081975|NCT00749476|10145478|FG000|NOT COMPLETED|Overall Study||0
9081976|NCT00760461|10145482|FG000|STARTED|Overall Study||44
9081977|NCT00760461|10145482|FG000|COMPLETED|Overall Study||0
9081978|NCT00760461|10145482|FG000|NOT COMPLETED|Overall Study||44
9081979|NCT00749658|10145488|FG000|STARTED|Overall Study||60
9081980|NCT00749658|10145489|FG001|STARTED|Overall Study||61
9081981|NCT00749658|10145488|FG000|COMPLETED|Overall Study||60
9081982|NCT00749658|10145489|FG001|COMPLETED|Overall Study||61
9081983|NCT00749658|10145488|FG000|NOT COMPLETED|Overall Study||0
9081984|NCT00749658|10145489|FG001|NOT COMPLETED|Overall Study||0
9081985|NCT00754793|10145497|FG000|STARTED|Overall Study||1
9081986|NCT00754793|10145498|FG001|STARTED|Overall Study||2
9081987|NCT00754793|10145497|FG000|COMPLETED|Overall Study||1
9081988|NCT00754793|10145498|FG001|COMPLETED|Overall Study||1
9081989|NCT00754793|10145497|FG000|NOT COMPLETED|Overall Study||0
9081990|NCT00754793|10145498|FG001|NOT COMPLETED|Overall Study||1
9081991|NCT00754052|10145506|FG000|STARTED|Overall Study||5
9081992|NCT00754052|10145507|FG001|STARTED|Overall Study||3
9081993|NCT00754052|10145506|FG000|COMPLETED|Overall Study||0
9081994|NCT00754052|10145507|FG001|COMPLETED|Overall Study||0
9081995|NCT00754052|10145506|FG000|NOT COMPLETED|Overall Study||5
9081996|NCT00754052|10145507|FG001|NOT COMPLETED|Overall Study||3
9081997|NCT00750555|10145513|FG000|STARTED|Overall Study||0
9081998|NCT00750555|10145513|FG000|COMPLETED|Overall Study||0
9081999|NCT00750555|10145513|FG000|NOT COMPLETED|Overall Study||0
9082000|NCT00754767|10145520|FG000|STARTED|Overall Study||2
9082001|NCT00754767|10145521|FG001|STARTED|Overall Study||0
9082002|NCT00754767|10145520|FG000|COMPLETED|Overall Study||2
9082003|NCT00754767|10145521|FG001|COMPLETED|Overall Study||0
9082004|NCT00754767|10145520|FG000|NOT COMPLETED|Overall Study||0
9082005|NCT00754767|10145521|FG001|NOT COMPLETED|Overall Study||0
9082006|NCT00750204|10145529|FG000|STARTED|Overall Study||1
9082007|NCT00750204|10145530|FG001|STARTED|Overall Study||1
9082008|NCT00750204|10145529|FG000|COMPLETED|Overall Study||0
9082009|NCT00750204|10145530|FG001|COMPLETED|Overall Study||0
9082010|NCT00750204|10145529|FG000|NOT COMPLETED|Overall Study||1
9082011|NCT00750204|10145530|FG001|NOT COMPLETED|Overall Study||1
9082012|NCT00748579|10145538|FG000|STARTED|Overall Study||2
9082013|NCT00748579|10145539|FG001|STARTED|Overall Study||0
9082014|NCT00748579|10145538|FG000|COMPLETED|Overall Study||2
9082015|NCT00748579|10145539|FG001|COMPLETED|Overall Study||0
9082016|NCT00748579|10145538|FG000|NOT COMPLETED|Overall Study||0
9082017|NCT00748579|10145539|FG001|NOT COMPLETED|Overall Study||0
9082018|NCT00748085|10145545|FG000|STARTED|Overall Study||5
9082019|NCT00748085|10145545|FG000|COMPLETED|Overall Study|No analysis -study terminated for business reasons.|5
9082020|NCT00748085|10145545|FG000|NOT COMPLETED|Overall Study||0
9082021|NCT00752986|10145552|FG000|STARTED|Overall Study||16
9082022|NCT00752986|10145553|FG001|STARTED|Overall Study||12
9082023|NCT00752986|10145554|FG002|STARTED|Overall Study||11
9082024|NCT00752986|10145552|FG000|COMPLETED|Overall Study||11
8844678|NCT01711294|9899121|FG002|COMPLETED|Overall Study||64
9082025|NCT00752986|10145553|FG001|COMPLETED|Overall Study||11
9082026|NCT00752986|10145554|FG002|COMPLETED|Overall Study||9
9082027|NCT00752986|10145552|FG000|NOT COMPLETED|Overall Study||5
9082028|NCT00752986|10145553|FG001|NOT COMPLETED|Overall Study||1
9082029|NCT00752986|10145554|FG002|NOT COMPLETED|Overall Study||2
9082030|NCT00751335|10145564|FG000|STARTED|Overall Study||0
9082031|NCT00751335|10145565|FG001|STARTED|Overall Study||0
9082032|NCT00751335|10145564|FG000|COMPLETED|Overall Study||0
9082033|NCT00751335|10145565|FG001|COMPLETED|Overall Study||0
8844679|NCT01711294|9899119|FG000|NOT COMPLETED|Overall Study||0
9082034|NCT00751335|10145564|FG000|NOT COMPLETED|Overall Study||0
9082035|NCT00751335|10145565|FG001|NOT COMPLETED|Overall Study||0
9082036|NCT00746239|10145571|FG000|STARTED|Overall Study||11
9082037|NCT00746239|10145571|FG000|COMPLETED|Overall Study|11 subjects total were enrolled - 6 withdrew from study and 5 competed|5
9082038|NCT00746239|10145571|FG000|NOT COMPLETED|Overall Study||6
9082039|NCT00754013|10145577|FG000|STARTED|Overall Study||4
9082040|NCT00754013|10145578|FG001|STARTED|Overall Study||5
9082041|NCT00754013|10145577|FG000|COMPLETED|Overall Study||0
9082042|NCT00754013|10145578|FG001|COMPLETED|Overall Study||0
9082043|NCT00754013|10145577|FG000|NOT COMPLETED|Overall Study||4
9082044|NCT00754013|10145578|FG001|NOT COMPLETED|Overall Study||5
9082045|NCT00735553|10145587|FG000|STARTED|Overall Study||77
9082046|NCT00735553|10145587|FG000|COMPLETED|Overall Study||0
9082047|NCT00735553|10145587|FG000|NOT COMPLETED|Overall Study||77
9082048|NCT00751933|10145595|FG000|STARTED|Overall Study||0
9082049|NCT00751933|10145596|FG001|STARTED|Overall Study||1
9082050|NCT00751933|10145597|FG002|STARTED|Overall Study||1
9082051|NCT00751933|10145598|FG003|STARTED|Overall Study||1
9082052|NCT00751933|10145595|FG000|COMPLETED|Overall Study||0
9082053|NCT00751933|10145596|FG001|COMPLETED|Overall Study||0
9082054|NCT00751933|10145597|FG002|COMPLETED|Overall Study||0
9082055|NCT00751933|10145598|FG003|COMPLETED|Overall Study||0
9082056|NCT00751933|10145595|FG000|NOT COMPLETED|Overall Study||0
9082057|NCT00751933|10145596|FG001|NOT COMPLETED|Overall Study||1
9082058|NCT00751933|10145597|FG002|NOT COMPLETED|Overall Study||1
9082059|NCT00751933|10145598|FG003|NOT COMPLETED|Overall Study||1
9082060|NCT00747916|10145602|FG000|STARTED|Overall Study||3
9082061|NCT00747916|10145602|FG000|COMPLETED|Overall Study||3
9082062|NCT00747916|10145602|FG000|NOT COMPLETED|Overall Study||0
9082063|NCT00745030|10145608|FG000|STARTED|Overall Study||1
9082064|NCT00745030|10145609|FG001|STARTED|Overall Study||2
9082065|NCT00745030|10145608|FG000|COMPLETED|Overall Study||1
9082066|NCT00745030|10145609|FG001|COMPLETED|Overall Study||2
9082067|NCT00745030|10145608|FG000|NOT COMPLETED|Overall Study||0
9082068|NCT00745030|10145609|FG001|NOT COMPLETED|Overall Study||0
9082069|NCT00747461|10145615|FG000|STARTED|Overall Study||5
9082070|NCT00747461|10145615|FG000|COMPLETED|Overall Study||0
9082071|NCT00747461|10145615|FG000|NOT COMPLETED|Overall Study||5
9082072|NCT00746018|10145620|FG000|STARTED|Overall Study||39
9082073|NCT00746018|10145620|FG000|COMPLETED|Overall Study||39
9082074|NCT00746018|10145620|FG000|NOT COMPLETED|Overall Study||0
9082075|NCT00746603|10145624|FG000|STARTED|Overall Study||3
9082076|NCT00746603|10145624|FG000|COMPLETED|Overall Study||3
9082077|NCT00746603|10145624|FG000|NOT COMPLETED|Overall Study||0
9082078|NCT00736385|10145630|FG000|STARTED|Overall Study||4
9082079|NCT00736385|10145631|FG001|STARTED|Overall Study||5
9082080|NCT00736385|10145630|FG000|COMPLETED|Overall Study||2
9082081|NCT00736385|10145631|FG001|COMPLETED|Overall Study||2
9082082|NCT00736385|10145630|FG000|NOT COMPLETED|Overall Study||2
9082083|NCT00736385|10145631|FG001|NOT COMPLETED|Overall Study||3
9082084|NCT00738972|10145641|FG000|STARTED|Overall Study||3
9082085|NCT00738972|10145642|FG001|STARTED|Overall Study||3
9082086|NCT00738972|10145643|FG002|STARTED|Overall Study||3
9082087|NCT00738972|10145644|FG003|STARTED|Overall Study||3
9082088|NCT00738972|10145641|FG000|COMPLETED|Overall Study||3
9082089|NCT00738972|10145642|FG001|COMPLETED|Overall Study||3
9082090|NCT00738972|10145643|FG002|COMPLETED|Overall Study||3
9082091|NCT00738972|10145644|FG003|COMPLETED|Overall Study||2
9082092|NCT00738972|10145641|FG000|NOT COMPLETED|Overall Study||0
9082093|NCT00738972|10145642|FG001|NOT COMPLETED|Overall Study||0
9082094|NCT00738972|10145643|FG002|NOT COMPLETED|Overall Study||0
9082095|NCT00738972|10145644|FG003|NOT COMPLETED|Overall Study||1
9082096|NCT00739063|10145654|FG000|STARTED|Overall Study||11
9082097|NCT00739063|10145654|FG000|COMPLETED|Overall Study||3
9082098|NCT00739063|10145654|FG000|NOT COMPLETED|Overall Study||8
9082099|NCT00740597|10145658|FG000|STARTED|Overall Study||1
9082100|NCT00740597|10145658|FG000|COMPLETED|Overall Study||0
9082101|NCT00740597|10145658|FG000|NOT COMPLETED|Overall Study||1
9082102|NCT00737594|10145665|FG000|STARTED|Overall Study||0
9082103|NCT00737594|10145666|FG001|STARTED|Overall Study||0
9082104|NCT00737594|10145667|FG002|STARTED|Overall Study||0
9082105|NCT00737594|10145665|FG000|COMPLETED|Overall Study||0
9082106|NCT00737594|10145666|FG001|COMPLETED|Overall Study||0
9082107|NCT00737594|10145667|FG002|COMPLETED|Overall Study||0
9082108|NCT00737594|10145665|FG000|NOT COMPLETED|Overall Study||0
9082109|NCT00737594|10145666|FG001|NOT COMPLETED|Overall Study||0
9082110|NCT00737594|10145667|FG002|NOT COMPLETED|Overall Study||0
9082111|NCT00737282|10145677|FG000|STARTED|Overall Study||175
9082112|NCT00737282|10145677|FG000|COMPLETED|Overall Study||0
9082113|NCT00737282|10145677|FG000|NOT COMPLETED|Overall Study||175
9082114|NCT00739882|10145685|FG000|STARTED|Double-blind Period||51
9082115|NCT00739882|10145686|FG001|STARTED|Double-blind Period||25
9082116|NCT00739882|10145685|FG000|COMPLETED|Double-blind Period||32
9082117|NCT00739882|10145686|FG001|COMPLETED|Double-blind Period||14
9082118|NCT00739882|10145685|FG000|NOT COMPLETED|Double-blind Period||19
9082119|NCT00739882|10145686|FG001|NOT COMPLETED|Double-blind Period||11
9082120|NCT00739882|10145685|FG000|STARTED|Open-label Period||17
9082121|NCT00739882|10145686|FG001|STARTED|Open-label Period||14
9082122|NCT00739882|10145685|FG000|COMPLETED|Open-label Period||7
9082123|NCT00739882|10145686|FG001|COMPLETED|Open-label Period||9
9082124|NCT00739882|10145685|FG000|NOT COMPLETED|Open-label Period||10
9082125|NCT00739882|10145686|FG001|NOT COMPLETED|Open-label Period||5
9082126|NCT00739024|10145696|FG000|STARTED|Overall Study||7
9082127|NCT00739024|10145697|FG001|STARTED|Overall Study||6
9082128|NCT00739024|10145696|FG000|COMPLETED|Overall Study||7
9082129|NCT00739024|10145697|FG001|COMPLETED|Overall Study||6
9082130|NCT00739024|10145696|FG000|NOT COMPLETED|Overall Study||0
9082131|NCT00739024|10145697|FG001|NOT COMPLETED|Overall Study||0
9082132|NCT00731770|10145705|FG000|STARTED|Overall Study||5
9082133|NCT00731770|10145706|FG001|STARTED|Overall Study||5
9082134|NCT00731770|10145705|FG000|COMPLETED|Overall Study||5
9082135|NCT00731770|10145706|FG001|COMPLETED|Overall Study||5
9082136|NCT00731770|10145705|FG000|NOT COMPLETED|Overall Study||0
9082137|NCT00731770|10145706|FG001|NOT COMPLETED|Overall Study||0
9082138|NCT00735254|10145718|FG000|STARTED|Overall Study||1
9082139|NCT00735254|10145719|FG001|STARTED|Overall Study||1
9082140|NCT00735254|10145720|FG002|STARTED|Overall Study||1
9082141|NCT00735254|10145721|FG003|STARTED|Overall Study||0
9082142|NCT00735254|10145718|FG000|COMPLETED|Overall Study||0
9082143|NCT00735254|10145719|FG001|COMPLETED|Overall Study||0
9082144|NCT00735254|10145720|FG002|COMPLETED|Overall Study||0
9082145|NCT00735254|10145721|FG003|COMPLETED|Overall Study||0
9082146|NCT00735254|10145718|FG000|NOT COMPLETED|Overall Study||1
9082147|NCT00735254|10145719|FG001|NOT COMPLETED|Overall Study||1
9082148|NCT00735254|10145720|FG002|NOT COMPLETED|Overall Study||1
9082149|NCT00735254|10145721|FG003|NOT COMPLETED|Overall Study||0
9082150|NCT00729365|10145734|FG000|STARTED|Overall Study||33
9082151|NCT00729365|10145735|FG001|STARTED|Overall Study||6
9082152|NCT00729365|10145736|FG002|STARTED|Overall Study||7
9082153|NCT00729365|10145734|FG000|COMPLETED|Overall Study|Study terminated|0
9082154|NCT00729365|10145735|FG001|COMPLETED|Overall Study|Study Terminated|0
9082155|NCT00729365|10145736|FG002|COMPLETED|Overall Study|Study terminated|0
9082156|NCT00729365|10145734|FG000|NOT COMPLETED|Overall Study||33
9082157|NCT00729365|10145735|FG001|NOT COMPLETED|Overall Study||6
9082158|NCT00729365|10145736|FG002|NOT COMPLETED|Overall Study||7
9082159|NCT00732680|10145746|FG000|STARTED|Overall Study||9
9082160|NCT00732680|10145746|FG000|COMPLETED|Overall Study||9
9082161|NCT00732680|10145746|FG000|NOT COMPLETED|Overall Study||0
9082162|NCT00726180|10145750|FG000|STARTED|Overall Study||1
9082163|NCT00726180|10145750|FG000|COMPLETED|Overall Study||1
9082164|NCT00726180|10145750|FG000|NOT COMPLETED|Overall Study||0
9082165|NCT00724282|10145754|FG000|STARTED|Overall Study||20
9082166|NCT00724282|10145754|FG000|COMPLETED|Overall Study||16
9082167|NCT00724282|10145754|FG000|NOT COMPLETED|Overall Study||4
9082168|NCT00730886|10145760|FG000|STARTED|Overall Study||2
9082169|NCT00730886|10145761|FG001|STARTED|Overall Study|no subjects enrolled in this arm. Study enrollment terminated early.|0
9082170|NCT00730886|10145760|FG000|COMPLETED|Overall Study||0
9082171|NCT00730886|10145761|FG001|COMPLETED|Overall Study|no subjects enrolled in this arm. Study enrollment terminated early.|0
9082172|NCT00730886|10145760|FG000|NOT COMPLETED|Overall Study||2
9082173|NCT00730886|10145761|FG001|NOT COMPLETED|Overall Study||0
9082174|NCT00728845|10145769|FG000|STARTED|Overall Study||8
9082175|NCT00728845|10145770|FG001|STARTED|Overall Study||0
9082176|NCT00728845|10145769|FG000|COMPLETED|Overall Study||8
9082177|NCT00728845|10145770|FG001|COMPLETED|Overall Study||0
9082178|NCT00728845|10145769|FG000|NOT COMPLETED|Overall Study||0
9082179|NCT00728845|10145770|FG001|NOT COMPLETED|Overall Study||0
9082180|NCT00726830|10145778|FG000|STARTED|Overall Study||1
9082181|NCT00726830|10145779|FG001|STARTED|Overall Study||0
9082182|NCT00726830|10145778|FG000|COMPLETED|Overall Study||1
9082183|NCT00726830|10145779|FG001|COMPLETED|Overall Study||0
9082184|NCT00726830|10145778|FG000|NOT COMPLETED|Overall Study||0
9082185|NCT00726830|10145779|FG001|NOT COMPLETED|Overall Study||0
9082186|NCT00726037|10145785|FG000|STARTED|Overall Study||7
9082187|NCT00726037|10145785|FG000|COMPLETED|Overall Study||7
9082188|NCT00726037|10145785|FG000|NOT COMPLETED|Overall Study||0
9082189|NCT00729560|10145789|FG000|STARTED|Overall Study|Arm assignment can not be determined as study was ended prior to unblinding and no key found.|8
9082190|NCT00729560|10145789|FG000|COMPLETED|Overall Study||5
9082191|NCT00729560|10145789|FG000|NOT COMPLETED|Overall Study||3
9082192|NCT00716807|10145797|FG000|STARTED|Overall Study||8
9082193|NCT00716807|10145798|FG001|STARTED|Overall Study||5
9082194|NCT00716807|10145799|FG002|STARTED|Overall Study||18
9082195|NCT00716807|10145800|FG003|STARTED|Overall Study||15
9082196|NCT00716807|10145797|FG000|COMPLETED|Overall Study||8
9082197|NCT00716807|10145798|FG001|COMPLETED|Overall Study||5
9082198|NCT00716807|10145799|FG002|COMPLETED|Overall Study||18
9082199|NCT00716807|10145800|FG003|COMPLETED|Overall Study||15
9082200|NCT00716807|10145797|FG000|NOT COMPLETED|Overall Study||0
9082201|NCT00716807|10145798|FG001|NOT COMPLETED|Overall Study||0
9082202|NCT00716807|10145799|FG002|NOT COMPLETED|Overall Study||0
9082203|NCT00716807|10145800|FG003|NOT COMPLETED|Overall Study||0
9082204|NCT00714948|10145810|FG000|STARTED|Overall Study||2
9082205|NCT00714948|10145810|FG000|COMPLETED|Overall Study||0
9082206|NCT00714948|10145810|FG000|NOT COMPLETED|Overall Study||2
9082207|NCT00720343|10145814|FG000|STARTED|Overall Study||54
9082208|NCT00720343|10145814|FG000|COMPLETED|Overall Study|3 removed by physician. 3 unable to be determined; Columbia will never have access to this data.|48
9082209|NCT00720343|10145814|FG000|NOT COMPLETED|Overall Study||6
9082210|NCT00719914|10145822|FG000|STARTED|Overall Study||10
9082211|NCT00719914|10145823|FG001|STARTED|Overall Study||7
9082212|NCT00719914|10145822|FG000|COMPLETED|Overall Study||10
9082213|NCT00719914|10145823|FG001|COMPLETED|Overall Study||7
9082214|NCT00719914|10145822|FG000|NOT COMPLETED|Overall Study||0
9082215|NCT00719914|10145823|FG001|NOT COMPLETED|Overall Study||0
9082216|NCT00718640|10145829|FG000|STARTED|Overall Study||10
9082217|NCT00718640|10145829|FG000|COMPLETED|Overall Study||3
9082218|NCT00718640|10145829|FG000|NOT COMPLETED|Overall Study||7
9082219|NCT00720083|10145835|FG000|STARTED|Overall Study||17
9082220|NCT00720083|10145836|FG001|STARTED|Overall Study||15
9082221|NCT00720083|10145835|FG000|COMPLETED|Overall Study|Subjects with data for the primary analysis are considered to have completed the study.|16
9082222|NCT00720083|10145836|FG001|COMPLETED|Overall Study||13
9082223|NCT00720083|10145835|FG000|NOT COMPLETED|Overall Study||1
9082224|NCT00720083|10145836|FG001|NOT COMPLETED|Overall Study||2
9082225|NCT00717275|10145842|FG000|STARTED|Overall Study||3
9082226|NCT00717275|10145842|FG000|COMPLETED|Overall Study||0
9082227|NCT00717275|10145842|FG000|NOT COMPLETED|Overall Study||3
9082228|NCT00708734|10145846|FG000|STARTED|Overall Study|94 subjects were screened, 45 did not meet criteria, and 39 declined participation after screening.|10
9082229|NCT00708734|10145846|FG000|COMPLETED|Overall Study|Ten subjects enrolled, three completed the intervention and all follow up sessions.|3
9082230|NCT00708734|10145846|FG000|NOT COMPLETED|Overall Study||7
9082231|NCT00711087|10145852|FG000|STARTED|Overall Study||1
9082232|NCT00711087|10145853|FG001|STARTED|Overall Study||0
9082233|NCT00711087|10145852|FG000|COMPLETED|Overall Study||0
9082234|NCT00711087|10145853|FG001|COMPLETED|Overall Study||0
9082235|NCT00711087|10145852|FG000|NOT COMPLETED|Overall Study||1
9082236|NCT00711087|10145853|FG001|NOT COMPLETED|Overall Study||0
9082237|NCT00706797|10145861|FG000|STARTED|Overall Study||70
9082238|NCT00706797|10145862|FG001|STARTED|Overall Study||71
9082239|NCT00706797|10145861|FG000|Safety Population|Overall Study|Safety population=all randomly assigned subjects who had at least 1 dose of study treatment.|63
9082240|NCT00706797|10145862|FG001|Safety Population|Overall Study||71
9082241|NCT00706797|10145861|FG000|COMPLETED|Overall Study||1
9082242|NCT00706797|10145862|FG001|COMPLETED|Overall Study||0
9082243|NCT00706797|10145861|FG000|NOT COMPLETED|Overall Study||69
9082244|NCT00706797|10145862|FG001|NOT COMPLETED|Overall Study||71
9082245|NCT00713596|10145871|FG000|STARTED|Overall Study||9
9082246|NCT00713596|10145872|FG001|STARTED|Overall Study||8
9082247|NCT00713596|10145873|FG002|STARTED|Overall Study||8
9082248|NCT00713596|10145871|FG000|COMPLETED|Overall Study||7
9082249|NCT00713596|10145872|FG001|COMPLETED|Overall Study||5
9082250|NCT00713596|10145873|FG002|COMPLETED|Overall Study||6
9082251|NCT00713596|10145871|FG000|NOT COMPLETED|Overall Study||2
9082252|NCT00713596|10145872|FG001|NOT COMPLETED|Overall Study||3
9082253|NCT00713596|10145873|FG002|NOT COMPLETED|Overall Study||2
9082254|NCT00703885|10145881|FG000|STARTED|Overall Study||16
9082255|NCT00703885|10145881|FG000|COMPLETED|Overall Study||16
9082256|NCT00703885|10145881|FG000|NOT COMPLETED|Overall Study||0
9082257|NCT00703092|10145886|FG000|STARTED|Overall Study||2
9082258|NCT00703092|10145886|FG000|COMPLETED|Overall Study||0
9082259|NCT00703092|10145886|FG000|NOT COMPLETED|Overall Study||2
9082260|NCT00713258|10145892|FG000|STARTED|Overall Study||41
9082261|NCT00713258|10145893|FG001|STARTED|Overall Study||34
9082262|NCT00713258|10145892|FG000|COMPLETED|Overall Study||36
9082263|NCT00713258|10145893|FG001|COMPLETED|Overall Study||28
9082264|NCT00713258|10145892|FG000|NOT COMPLETED|Overall Study||5
9082265|NCT00713258|10145893|FG001|NOT COMPLETED|Overall Study||6
9082266|NCT00706329|10145899|FG000|STARTED|Overall Study||25
9082267|NCT00706329|10145899|FG000|COMPLETED|Overall Study||25
9082268|NCT00706329|10145899|FG000|NOT COMPLETED|Overall Study||0
9082269|NCT00707434|10145903|FG000|STARTED|Overall Study||6
9082270|NCT00707434|10145903|FG000|COMPLETED|Overall Study||5
9082271|NCT00707434|10145903|FG000|NOT COMPLETED|Overall Study||1
9082272|NCT00707161|10145907|FG000|STARTED|Overall Study|3 deceased (1-Huntsman Cancer Institute, 2- LDS Hospital).|6
9082273|NCT00707161|10145907|FG000|COMPLETED|Overall Study||0
9082274|NCT00707161|10145907|FG000|NOT COMPLETED|Overall Study||6
9082275|NCT00704496|10145913|FG000|STARTED|Overall Study||0
9082276|NCT00704496|10145914|FG001|STARTED|Overall Study||0
9082277|NCT00704496|10145913|FG000|COMPLETED|Overall Study||0
9082278|NCT00704496|10145914|FG001|COMPLETED|Overall Study||0
9082279|NCT00704496|10145913|FG000|NOT COMPLETED|Overall Study||0
9082280|NCT00704496|10145914|FG001|NOT COMPLETED|Overall Study||0
9082281|NCT00708916|10145920|FG000|STARTED|Overall Study||12
9082282|NCT00708916|10145920|FG000|COMPLETED|Overall Study||8
9082283|NCT00708916|10145920|FG000|NOT COMPLETED|Overall Study||4
9082284|NCT00700778|10145925|FG000|STARTED|Overall Study||2
9082285|NCT00700778|10145925|FG000|COMPLETED|Overall Study||0
9082286|NCT00700778|10145925|FG000|NOT COMPLETED|Overall Study||2
9082287|NCT00699842|10145932|FG000|STARTED|Overall Study||3
9082288|NCT00699842|10145933|FG001|STARTED|Overall Study||5
9082289|NCT00699842|10145934|FG002|STARTED|Overall Study||0
9082290|NCT00699842|10145932|FG000|COMPLETED|Overall Study||3
9082291|NCT00699842|10145933|FG001|COMPLETED|Overall Study||4
9082292|NCT00699842|10145934|FG002|COMPLETED|Overall Study||0
9082293|NCT00699842|10145932|FG000|NOT COMPLETED|Overall Study||0
9082294|NCT00699842|10145933|FG001|NOT COMPLETED|Overall Study||1
9082295|NCT00699842|10145934|FG002|NOT COMPLETED|Overall Study||0
9082296|NCT00702962|10145944|FG000|STARTED|Overall Study|One initiated treatment. Milestones not achieved due to premature closing due to low accrual.|1
9082297|NCT00702962|10145945|FG001|STARTED|Overall Study|Three treated. Milestone not met as Phase I closed prematurely as NCI research established the MTD.|3
9082298|NCT00702962|10145944|FG000|COMPLETED|Overall Study|The one participant off treatment after 2 doses due to concurrent health disorder.|0
9082299|NCT00702962|10145945|FG001|COMPLETED|Overall Study|Two completed all required cycles. One experienced progressive disease after 2 cycles|2
9082300|NCT00702962|10145944|FG000|NOT COMPLETED|Overall Study||1
9082301|NCT00702962|10145945|FG001|NOT COMPLETED|Overall Study||1
9082302|NCT00703534|10145955|FG000|STARTED|Overall Study||235
9082303|NCT00703534|10145956|FG001|STARTED|Overall Study||243
9082304|NCT00703534|10145955|FG000|COMPLETED|Overall Study||205
9082305|NCT00703534|10145956|FG001|COMPLETED|Overall Study||218
9082306|NCT00703534|10145955|FG000|NOT COMPLETED|Overall Study||30
9082307|NCT00703534|10145956|FG001|NOT COMPLETED|Overall Study||25
9082308|NCT00698009|10145962|FG000|STARTED|Overall Study||1
9082309|NCT00698009|10145962|FG000|COMPLETED|Overall Study||0
9082310|NCT00698009|10145962|FG000|NOT COMPLETED|Overall Study||1
9082311|NCT00703339|10145966|FG000|STARTED|Overall Study||1
9082312|NCT00703339|10145966|FG000|COMPLETED|Overall Study||1
9082313|NCT00703339|10145966|FG000|NOT COMPLETED|Overall Study||0
9082314|NCT00691444|10145973|FG000|STARTED|Overall Study||0
9082315|NCT00691444|10145974|FG001|STARTED|Overall Study||0
9082316|NCT00691444|10145975|FG002|STARTED|Overall Study||0
9082317|NCT00691444|10145973|FG000|COMPLETED|Overall Study||0
9082318|NCT00691444|10145974|FG001|COMPLETED|Overall Study||0
9082319|NCT00691444|10145975|FG002|COMPLETED|Overall Study||0
9082320|NCT00691444|10145973|FG000|NOT COMPLETED|Overall Study||0
9082321|NCT00691444|10145974|FG001|NOT COMPLETED|Overall Study||0
9082322|NCT00691444|10145975|FG002|NOT COMPLETED|Overall Study||0
9082323|NCT00702702|10145986|FG000|STARTED|Overall Study||56
9082324|NCT00702702|10145986|FG000|COMPLETED|Overall Study||0
9082325|NCT00702702|10145986|FG000|NOT COMPLETED|Overall Study||56
9082326|NCT00693628|10145996|FG000|STARTED|Overall Study|No data is available indicating to which group patients were assigned.|0
9082327|NCT00693628|10145997|FG001|STARTED|Overall Study|No data is available indicating to which group patients were assigned .|0
9082328|NCT00693628|10145996|FG000|COMPLETED|Overall Study|Only 4 patients enrolled in study. No data indicating their group assignment|0
9082329|NCT00693628|10145997|FG001|COMPLETED|Overall Study|Only 4 patients enrolled in study. No data indicating their group assignment.|0
9082330|NCT00693628|10145996|FG000|NOT COMPLETED|Overall Study||0
9082331|NCT00693628|10145997|FG001|NOT COMPLETED|Overall Study||0
9082332|NCT00699413|10146005|FG000|STARTED|Overall Study||4
9082333|NCT00699413|10146006|FG001|STARTED|Overall Study||4
9082334|NCT00699413|10146005|FG000|COMPLETED|Overall Study||0
9082335|NCT00699413|10146006|FG001|COMPLETED|Overall Study||0
9082336|NCT00699413|10146005|FG000|NOT COMPLETED|Overall Study||4
9082337|NCT00699413|10146006|FG001|NOT COMPLETED|Overall Study||4
9082338|NCT00691652|10146012|FG000|STARTED|Overall Study||2
9082339|NCT00691652|10146012|FG000|COMPLETED|Overall Study||1
9082340|NCT00691652|10146012|FG000|NOT COMPLETED|Overall Study||1
9082341|NCT00686972|10146016|FG000|STARTED|Overall Study||51
9082342|NCT00686972|10146016|FG000|COMPLETED|Overall Study||0
9082343|NCT00686972|10146016|FG000|NOT COMPLETED|Overall Study||51
9082344|NCT00693017|10146022|FG000|STARTED|Overall Study||2
9082345|NCT00693017|10146023|FG001|STARTED|Overall Study||2
9082346|NCT00693017|10146022|FG000|COMPLETED|Overall Study||0
9082347|NCT00693017|10146023|FG001|COMPLETED|Overall Study||0
9082348|NCT00693017|10146022|FG000|NOT COMPLETED|Overall Study||2
9082349|NCT00693017|10146023|FG001|NOT COMPLETED|Overall Study||2
9082350|NCT00691574|10146031|FG000|STARTED|Overall Study||0
9082351|NCT00691574|10146032|FG001|STARTED|Overall Study||0
9082352|NCT00691574|10146031|FG000|COMPLETED|Overall Study||0
9082353|NCT00691574|10146032|FG001|COMPLETED|Overall Study||0
9082354|NCT00691574|10146031|FG000|NOT COMPLETED|Overall Study||0
9082355|NCT00691574|10146032|FG001|NOT COMPLETED|Overall Study||0
9082356|NCT00692094|10146042|FG000|STARTED|Overall Study||0
9082357|NCT00692094|10146043|FG001|STARTED|Overall Study||0
9082358|NCT00692094|10146044|FG002|STARTED|Overall Study||0
9082359|NCT00692094|10146045|FG003|STARTED|Overall Study||0
9082360|NCT00692094|10146042|FG000|COMPLETED|Overall Study||0
9082361|NCT00692094|10146043|FG001|COMPLETED|Overall Study||0
9082362|NCT00692094|10146044|FG002|COMPLETED|Overall Study||0
9082363|NCT00692094|10146045|FG003|COMPLETED|Overall Study||0
9082364|NCT00692094|10146042|FG000|NOT COMPLETED|Overall Study||0
9082365|NCT00692094|10146043|FG001|NOT COMPLETED|Overall Study||0
9082366|NCT00692094|10146044|FG002|NOT COMPLETED|Overall Study||0
9082367|NCT00692094|10146045|FG003|NOT COMPLETED|Overall Study||0
9082368|NCT00689884|10146055|FG000|STARTED|Overall Study||7
9082369|NCT00689884|10146055|FG000|COMPLETED|Overall Study||7
9082370|NCT00689884|10146055|FG000|NOT COMPLETED|Overall Study||0
9082371|NCT00692003|10146062|FG000|STARTED|Overall Study||5
9082372|NCT00692003|10146063|FG001|STARTED|Overall Study||1
9082373|NCT00692003|10146062|FG000|COMPLETED|Overall Study||0
9082374|NCT00692003|10146063|FG001|COMPLETED|Overall Study||0
9082375|NCT00692003|10146062|FG000|NOT COMPLETED|Overall Study||5
9082376|NCT00692003|10146063|FG001|NOT COMPLETED|Overall Study||1
9082377|NCT00678288|10146071|FG000|STARTED|Overall Study||10
9082378|NCT00678288|10146072|FG001|STARTED|Overall Study||6
9082379|NCT00678288|10146071|FG000|COMPLETED|Overall Study||0
9082380|NCT00678288|10146072|FG001|COMPLETED|Overall Study||0
9082381|NCT00678288|10146071|FG000|NOT COMPLETED|Overall Study||10
9082382|NCT00678288|10146072|FG001|NOT COMPLETED|Overall Study||6
9082383|NCT00676026|10146078|FG000|STARTED|Overall Study||8
9082384|NCT00676026|10146078|FG000|COMPLETED|Overall Study||8
9082385|NCT00676026|10146078|FG000|NOT COMPLETED|Overall Study||0
9082386|NCT00689052|10146084|FG000|STARTED|Overall Study||31
9082387|NCT00689052|10146085|FG001|STARTED|Overall Study||30
9082388|NCT00689052|10146084|FG000|COMPLETED|Overall Study||0
9082389|NCT00689052|10146085|FG001|COMPLETED|Overall Study||0
9082390|NCT00689052|10146084|FG000|NOT COMPLETED|Overall Study||31
9082391|NCT00689052|10146085|FG001|NOT COMPLETED|Overall Study||30
9082392|NCT00678574|10146095|FG000|STARTED|Overall Study||18
9082393|NCT00678574|10146096|FG001|STARTED|Overall Study||27
9082394|NCT00678574|10146095|FG000|COMPLETED|Overall Study||18
9082395|NCT00678574|10146096|FG001|COMPLETED|Overall Study||27
9082396|NCT00678574|10146095|FG000|NOT COMPLETED|Overall Study||0
9082397|NCT00678574|10146096|FG001|NOT COMPLETED|Overall Study||0
9082398|NCT00683917|10146105|FG000|STARTED|Overall Study||10
9082399|NCT00683917|10146105|FG000|COMPLETED|Overall Study||0
9082400|NCT00683917|10146105|FG000|NOT COMPLETED|Overall Study||10
9082401|NCT00688935|10146113|FG000|STARTED|Overall Study||0
9082402|NCT00688935|10146113|FG000|COMPLETED|Overall Study||0
9082403|NCT00688935|10146113|FG000|NOT COMPLETED|Overall Study||0
9082404|NCT00685880|10146119|FG000|STARTED|Overall Study||0
9082405|NCT00685880|10146120|FG001|STARTED|Overall Study||2
9082406|NCT00685880|10146119|FG000|COMPLETED|Overall Study||0
9082407|NCT00685880|10146120|FG001|COMPLETED|Overall Study||2
9082408|NCT00685880|10146119|FG000|NOT COMPLETED|Overall Study||0
9082409|NCT00685880|10146120|FG001|NOT COMPLETED|Overall Study||0
9082410|NCT00686036|10146128|FG000|STARTED|Overall Study||9
9082411|NCT00686036|10146129|FG001|STARTED|Overall Study||8
9082412|NCT00686036|10146128|FG000|COMPLETED|Overall Study||0
9082413|NCT00686036|10146129|FG001|COMPLETED|Overall Study||2
9082414|NCT00686036|10146128|FG000|NOT COMPLETED|Overall Study||9
9082415|NCT00686036|10146129|FG001|NOT COMPLETED|Overall Study||6
9082416|NCT00681044|10146135|FG000|STARTED|Overall Study||4
9082417|NCT00681044|10146135|FG000|COMPLETED|Overall Study||4
9082418|NCT00681044|10146135|FG000|NOT COMPLETED|Overall Study||0
9082419|NCT00676455|10146139|FG000|STARTED|Overall Study||14
9082420|NCT00676455|10146139|FG000|COMPLETED|Overall Study||14
9082421|NCT00676455|10146139|FG000|NOT COMPLETED|Overall Study||0
9082422|NCT00684255|10146143|FG000|STARTED|Overall Study||1
9082423|NCT00684255|10146143|FG000|COMPLETED|Overall Study||1
9082424|NCT00684255|10146143|FG000|NOT COMPLETED|Overall Study||0
9082425|NCT00683787|10146151|FG000|STARTED|Overall Study||3
9082426|NCT00683787|10146152|FG001|STARTED|Overall Study||3
9082427|NCT00683787|10146153|FG002|STARTED|Overall Study||2
9082428|NCT00683787|10146151|FG000|COMPLETED|Overall Study||0
9082429|NCT00683787|10146152|FG001|COMPLETED|Overall Study||0
9082430|NCT00683787|10146153|FG002|COMPLETED|Overall Study||0
9082431|NCT00683787|10146151|FG000|NOT COMPLETED|Overall Study||3
9082432|NCT00683787|10146152|FG001|NOT COMPLETED|Overall Study||3
9082433|NCT00683787|10146153|FG002|NOT COMPLETED|Overall Study||2
9082434|NCT00679926|10146161|FG000|STARTED|Overall Study||15
9082435|NCT00679926|10146161|FG000|COMPLETED|Overall Study||2
9082436|NCT00679926|10146161|FG000|NOT COMPLETED|Overall Study||13
9082437|NCT00678041|10146168|FG000|STARTED|Overall Study||5
9082438|NCT00678041|10146169|FG001|STARTED|Overall Study||5
9082439|NCT00678041|10146168|FG000|COMPLETED|Overall Study||0
9082440|NCT00678041|10146169|FG001|COMPLETED|Overall Study||0
9082441|NCT00678041|10146168|FG000|NOT COMPLETED|Overall Study||5
9082442|NCT00678041|10146169|FG001|NOT COMPLETED|Overall Study||5
9082443|NCT00680316|10146178|FG000|STARTED|Overall Study||1
9082444|NCT00680316|10146179|FG001|STARTED|Overall Study||2
9082445|NCT00680316|10146178|FG000|COMPLETED|Overall Study||1
9082446|NCT00680316|10146179|FG001|COMPLETED|Overall Study||2
9082447|NCT00680316|10146178|FG000|NOT COMPLETED|Overall Study||0
9082448|NCT00680316|10146179|FG001|NOT COMPLETED|Overall Study||0
9082449|NCT00681629|10146187|FG000|STARTED|Overall Study|It was planned to recruit 100 patient|5
9082450|NCT00681629|10146188|FG001|STARTED|Overall Study|It was planned to recruit 100 patient|2
9082451|NCT00681629|10146187|FG000|COMPLETED|Overall Study||0
9082452|NCT00681629|10146188|FG001|COMPLETED|Overall Study||0
9082453|NCT00681629|10146187|FG000|NOT COMPLETED|Overall Study||5
9082454|NCT00681629|10146188|FG001|NOT COMPLETED|Overall Study||2
9082455|NCT00669461|10146194|FG000|STARTED|Overall Study||1
9082456|NCT00669461|10146194|FG000|COMPLETED|Overall Study||1
9082457|NCT00669461|10146194|FG000|NOT COMPLETED|Overall Study||0
9082458|NCT00671606|10146199|FG000|STARTED|Overall Study||5
9082459|NCT00671606|10146199|FG000|COMPLETED|Overall Study||5
9082460|NCT00671606|10146199|FG000|NOT COMPLETED|Overall Study||0
9082461|NCT00673309|10146213|FG000|STARTED|Overall Study||64
9082462|NCT00673309|10146214|FG001|STARTED|Overall Study||14
9082463|NCT00673309|10146215|FG002|STARTED|Overall Study||14
9082464|NCT00673309|10146216|FG003|STARTED|Overall Study||25
9082465|NCT00673309|10146217|FG004|STARTED|Overall Study||18
9082466|NCT00673309|10146218|FG005|STARTED|Overall Study||35
9082467|NCT00673309|10146219|FG006|STARTED|Overall Study||14
9082468|NCT00673309|10146220|FG007|STARTED|Overall Study||13
9082469|NCT00673309|10146221|FG008|STARTED|Overall Study||17
9082470|NCT00673309|10146222|FG009|STARTED|Overall Study||30
9082471|NCT00673309|10146213|FG000|COMPLETED|Overall Study||64
9082472|NCT00673309|10146214|FG001|COMPLETED|Overall Study||14
9082473|NCT00673309|10146215|FG002|COMPLETED|Overall Study||14
9082474|NCT00673309|10146216|FG003|COMPLETED|Overall Study||25
9082475|NCT00673309|10146217|FG004|COMPLETED|Overall Study||18
9082476|NCT00673309|10146218|FG005|COMPLETED|Overall Study||35
9082477|NCT00673309|10146219|FG006|COMPLETED|Overall Study||14
9082478|NCT00673309|10146220|FG007|COMPLETED|Overall Study||13
9082479|NCT00673309|10146221|FG008|COMPLETED|Overall Study||17
9082480|NCT00673309|10146222|FG009|COMPLETED|Overall Study||30
9082481|NCT00673309|10146213|FG000|NOT COMPLETED|Overall Study||0
9082482|NCT00673309|10146214|FG001|NOT COMPLETED|Overall Study||0
9082483|NCT00673309|10146215|FG002|NOT COMPLETED|Overall Study||0
9082484|NCT00673309|10146216|FG003|NOT COMPLETED|Overall Study||0
9082485|NCT00673309|10146217|FG004|NOT COMPLETED|Overall Study||0
9082486|NCT00673309|10146218|FG005|NOT COMPLETED|Overall Study||0
9082487|NCT00673309|10146219|FG006|NOT COMPLETED|Overall Study||0
9082488|NCT00673309|10146220|FG007|NOT COMPLETED|Overall Study||0
9082489|NCT00673309|10146221|FG008|NOT COMPLETED|Overall Study||0
9082490|NCT00673309|10146222|FG009|NOT COMPLETED|Overall Study||0
9082491|NCT00672178|10146235|FG000|STARTED|Overall Study||1
9082492|NCT00672178|10146235|FG000|COMPLETED|Overall Study||1
9082493|NCT00672178|10146235|FG000|NOT COMPLETED|Overall Study||0
9082494|NCT00673595|10146241|FG000|STARTED|Overall Study||8
9082495|NCT00673595|10146242|FG001|STARTED|Overall Study||11
9082496|NCT00673595|10146241|FG000|COMPLETED|Overall Study||8
9082497|NCT00673595|10146242|FG001|COMPLETED|Overall Study||11
9082498|NCT00673595|10146241|FG000|NOT COMPLETED|Overall Study||0
9082499|NCT00673595|10146242|FG001|NOT COMPLETED|Overall Study||0
9082500|NCT00673361|10146248|FG000|STARTED|Overall Study||9
9082501|NCT00673361|10146248|FG000|COMPLETED|Overall Study||7
9082502|NCT00673361|10146248|FG000|NOT COMPLETED|Overall Study||2
9082503|NCT00670631|10146252|FG000|STARTED|Overall Study||0
9082504|NCT00670631|10146252|FG000|COMPLETED|Overall Study||0
9082505|NCT00670631|10146252|FG000|NOT COMPLETED|Overall Study||0
9082506|NCT00668785|10146257|FG000|STARTED|Overall Study||6
9082507|NCT00668785|10146257|FG000|COMPLETED|Overall Study||6
9082508|NCT00668785|10146257|FG000|NOT COMPLETED|Overall Study||0
9082509|NCT00673179|10146265|FG000|STARTED|Overall Study||7
9082510|NCT00673179|10146266|FG001|STARTED|Overall Study||0
9082511|NCT00673179|10146265|FG000|COMPLETED|Overall Study||4
9082512|NCT00673179|10146266|FG001|COMPLETED|Overall Study||0
9082513|NCT00673179|10146265|FG000|NOT COMPLETED|Overall Study||3
9082514|NCT00673179|10146266|FG001|NOT COMPLETED|Overall Study||0
9082515|NCT00668265|10146274|FG000|STARTED|Overall Study||9
9082516|NCT00668265|10146275|FG001|STARTED|Overall Study||5
9082517|NCT00668265|10146274|FG000|COMPLETED|Overall Study|The PI left, no records avaialable; the number of subjects who completed the study is not known|0
9082518|NCT00668265|10146275|FG001|COMPLETED|Overall Study|The PI left, no records avaialable; the number of subjects who completed the study is not known|0
9082519|NCT00668265|10146274|FG000|NOT COMPLETED|Overall Study||9
9082520|NCT00668265|10146275|FG001|NOT COMPLETED|Overall Study||5
9082521|NCT00660348|10146285|FG000|STARTED|Overall Study||1
9082522|NCT00660348|10146286|FG001|STARTED|Overall Study||0
9082523|NCT00660348|10146285|FG000|COMPLETED|Overall Study||0
9082524|NCT00660348|10146286|FG001|COMPLETED|Overall Study||0
9082525|NCT00660348|10146285|FG000|NOT COMPLETED|Overall Study||1
9082526|NCT00660348|10146286|FG001|NOT COMPLETED|Overall Study||0
9082527|NCT00664066|10146292|FG000|STARTED|Overall Study||3
9082528|NCT00664066|10146292|FG000|COMPLETED|Overall Study||0
9082529|NCT00664066|10146292|FG000|NOT COMPLETED|Overall Study||3
9082530|NCT00667017|10146296|FG000|STARTED|Overall Study||1
9082531|NCT00667017|10146296|FG000|COMPLETED|Overall Study||0
9082532|NCT00667017|10146296|FG000|NOT COMPLETED|Overall Study||1
9082533|NCT00665444|10146300|FG000|STARTED|Overall Study||3
9082534|NCT00665444|10146300|FG000|COMPLETED|Overall Study||1
9082535|NCT00665444|10146300|FG000|NOT COMPLETED|Overall Study||2
9082536|NCT00656916|10146306|FG000|STARTED|Overall Study||1
9082537|NCT00656916|10146307|FG001|STARTED|Overall Study||0
9082538|NCT00656916|10146306|FG000|COMPLETED|Overall Study||1
9082539|NCT00656916|10146307|FG001|COMPLETED|Overall Study||0
9082540|NCT00656916|10146306|FG000|NOT COMPLETED|Overall Study||0
9082541|NCT00656916|10146307|FG001|NOT COMPLETED|Overall Study||0
9082542|NCT00660595|10146315|FG000|STARTED|Overall Study||19
9082543|NCT00660595|10146316|FG001|STARTED|Overall Study||10
9082544|NCT00660595|10146315|FG000|COMPLETED|Overall Study||1
9082545|NCT00660595|10146316|FG001|COMPLETED|Overall Study|One of the two was lost to follow-up|1
9082546|NCT00660595|10146315|FG000|NOT COMPLETED|Overall Study||18
9082547|NCT00660595|10146316|FG001|NOT COMPLETED|Overall Study||9
9082548|NCT00661466|10146324|FG000|STARTED|Overall Study|Participants|4
9082549|NCT00661466|10146325|FG001|STARTED|Overall Study|Participants|3
9082550|NCT00661466|10146324|FG000|COMPLETED|Overall Study|Participants|4
9082551|NCT00661466|10146325|FG001|COMPLETED|Overall Study|Participants|3
9082552|NCT00661466|10146324|FG000|NOT COMPLETED|Overall Study||0
9082553|NCT00661466|10146325|FG001|NOT COMPLETED|Overall Study||0
9082554|NCT00646282|10146333|FG000|STARTED|Overall Study||4
9082555|NCT00646282|10146334|FG001|STARTED|Overall Study||4
9082556|NCT00646282|10146333|FG000|COMPLETED|Overall Study||0
9082557|NCT00646282|10146334|FG001|COMPLETED|Overall Study||0
9082558|NCT00646282|10146333|FG000|NOT COMPLETED|Overall Study||4
9082559|NCT00646282|10146334|FG001|NOT COMPLETED|Overall Study||4
9082560|NCT00657553|10146342|FG000|STARTED|Overall Study||5
9082561|NCT00657553|10146343|FG001|STARTED|Overall Study||5
9082562|NCT00657553|10146342|FG000|COMPLETED|Overall Study||0
9082563|NCT00657553|10146343|FG001|COMPLETED|Overall Study||0
9082564|NCT00657553|10146342|FG000|NOT COMPLETED|Overall Study||5
9082565|NCT00657553|10146343|FG001|NOT COMPLETED|Overall Study||5
9082566|NCT00655057|10146352|FG000|STARTED|Overall Study||0
9082567|NCT00655057|10146353|FG001|STARTED|Overall Study||0
9082568|NCT00655057|10146354|FG002|STARTED|Overall Study||0
9082569|NCT00655057|10146352|FG000|COMPLETED|Overall Study||0
9082570|NCT00655057|10146353|FG001|COMPLETED|Overall Study||0
9082571|NCT00655057|10146354|FG002|COMPLETED|Overall Study||0
9082572|NCT00655057|10146352|FG000|NOT COMPLETED|Overall Study||0
9082573|NCT00655057|10146353|FG001|NOT COMPLETED|Overall Study||0
9082574|NCT00655057|10146354|FG002|NOT COMPLETED|Overall Study||0
9082575|NCT00648895|10146364|FG000|STARTED|Overall Study||6
9082576|NCT00648895|10146365|FG001|STARTED|Overall Study||6
9082577|NCT00648895|10146364|FG000|COMPLETED|Overall Study||6
9082578|NCT00648895|10146365|FG001|COMPLETED|Overall Study||5
9082579|NCT00648895|10146364|FG000|NOT COMPLETED|Overall Study||0
9082580|NCT00648895|10146365|FG001|NOT COMPLETED|Overall Study||1
9082581|NCT00647426|10146371|FG000|STARTED|Overall Study||7
9082582|NCT00647426|10146371|FG000|COMPLETED|Overall Study||5
9082583|NCT00647426|10146371|FG000|NOT COMPLETED|Overall Study||2
9082584|NCT00645567|10146376|FG000|STARTED|Overall Study||5
9082585|NCT00645567|10146376|FG000|COMPLETED|Overall Study|One individual provided consent & was dropped due to an unrelated injury to his hand at his home.|4
9082586|NCT00645567|10146376|FG000|NOT COMPLETED|Overall Study||1
9082587|NCT00637806|10146387|FG000|STARTED|Double-blind Phase||2
9082588|NCT00637806|10146388|FG001|STARTED|Double-blind Phase||0
9082589|NCT00637806|10146389|FG002|STARTED|Double-blind Phase||2
9082590|NCT00637806|10146390|FG003|STARTED|Double-blind Phase||0
9082591|NCT00637806|10146387|FG000|COMPLETED|Double-blind Phase||0
9082592|NCT00637806|10146388|FG001|COMPLETED|Double-blind Phase||0
9082593|NCT00637806|10146389|FG002|COMPLETED|Double-blind Phase||1
9082594|NCT00637806|10146390|FG003|COMPLETED|Double-blind Phase||0
9082595|NCT00637806|10146387|FG000|NOT COMPLETED|Double-blind Phase||2
9082596|NCT00637806|10146388|FG001|NOT COMPLETED|Double-blind Phase||0
9082597|NCT00637806|10146389|FG002|NOT COMPLETED|Double-blind Phase||1
9082598|NCT00637806|10146390|FG003|NOT COMPLETED|Double-blind Phase||0
9082599|NCT00637806|10146387|FG000|STARTED|Extension Phase||0
9082600|NCT00637806|10146388|FG001|STARTED|Extension Phase||0
9082601|NCT00637806|10146389|FG002|STARTED|Extension Phase||0
9082602|NCT00637806|10146390|FG003|STARTED|Extension Phase||1
9082603|NCT00637806|10146387|FG000|COMPLETED|Extension Phase||0
9082604|NCT00637806|10146388|FG001|COMPLETED|Extension Phase||0
9082605|NCT00637806|10146389|FG002|COMPLETED|Extension Phase||0
9082606|NCT00637806|10146390|FG003|COMPLETED|Extension Phase||0
9082607|NCT00637806|10146387|FG000|NOT COMPLETED|Extension Phase||0
9082608|NCT00637806|10146388|FG001|NOT COMPLETED|Extension Phase||0
9082609|NCT00637806|10146389|FG002|NOT COMPLETED|Extension Phase||0
9082610|NCT00637806|10146390|FG003|NOT COMPLETED|Extension Phase||1
9082611|NCT00652457|10146399|FG000|STARTED|Overall Study||23
9082612|NCT00652457|10146400|FG001|STARTED|Overall Study||27
9082613|NCT00652457|10146399|FG000|COMPLETED|Overall Study||23
9082614|NCT00652457|10146400|FG001|COMPLETED|Overall Study||27
9082615|NCT00652457|10146399|FG000|NOT COMPLETED|Overall Study||0
9082616|NCT00652457|10146400|FG001|NOT COMPLETED|Overall Study||0
9082617|NCT00642603|10146408|FG000|STARTED|Overall Study||21
9082618|NCT00642603|10146409|FG001|STARTED|Overall Study||20
9082619|NCT00642603|10146408|FG000|Safety Population|Overall Study||19
9082620|NCT00642603|10146409|FG001|Safety Population|Overall Study||20
9082621|NCT00642603|10146408|FG000|COMPLETED|Overall Study||0
9082622|NCT00642603|10146409|FG001|COMPLETED|Overall Study||2
9082623|NCT00642603|10146408|FG000|NOT COMPLETED|Overall Study||21
9082624|NCT00642603|10146409|FG001|NOT COMPLETED|Overall Study||18
9082625|NCT00629798|10146415|FG000|STARTED|Overall Study||64
9082626|NCT00629798|10146415|FG000|COMPLETED|Overall Study||60
9082627|NCT00629798|10146415|FG000|NOT COMPLETED|Overall Study||4
9082628|NCT00645359|10146419|FG000|STARTED|Overall Study||9
9082629|NCT00645359|10146419|FG000|COMPLETED|Overall Study||9
9082630|NCT00645359|10146419|FG000|NOT COMPLETED|Overall Study||0
9082631|NCT00637728|10146425|FG000|STARTED|Double-blind Phase||4
9082632|NCT00637728|10146426|FG001|STARTED|Double-blind Phase||1
9082633|NCT00637728|10146427|FG002|STARTED|Double-blind Phase||0
9082634|NCT00637728|10146425|FG000|COMPLETED|Double-blind Phase||0
9082635|NCT00637728|10146426|FG001|COMPLETED|Double-blind Phase||0
9082636|NCT00637728|10146427|FG002|COMPLETED|Double-blind Phase||0
9082637|NCT00637728|10146425|FG000|NOT COMPLETED|Double-blind Phase||4
9082638|NCT00637728|10146426|FG001|NOT COMPLETED|Double-blind Phase||1
9082639|NCT00637728|10146427|FG002|NOT COMPLETED|Double-blind Phase||0
9082640|NCT00637728|10146425|FG000|STARTED|Extension Phase||0
9082641|NCT00637728|10146426|FG001|STARTED|Extension Phase||0
9082642|NCT00637728|10146427|FG002|STARTED|Extension Phase||0
9082643|NCT00637728|10146425|FG000|COMPLETED|Extension Phase||0
9082644|NCT00637728|10146426|FG001|COMPLETED|Extension Phase||0
9082645|NCT00637728|10146427|FG002|COMPLETED|Extension Phase||0
9082646|NCT00637728|10146425|FG000|NOT COMPLETED|Extension Phase||0
9082647|NCT00637728|10146426|FG001|NOT COMPLETED|Extension Phase||0
9082648|NCT00637728|10146427|FG002|NOT COMPLETED|Extension Phase||0
9082649|NCT00639626|10146434|FG000|STARTED|Overall Study||0
9082650|NCT00639626|10146434|FG000|COMPLETED|Overall Study||0
9082651|NCT00639626|10146434|FG000|NOT COMPLETED|Overall Study||0
9082652|NCT00634582|10146438|FG000|STARTED|Overall Study||2
9082653|NCT00634582|10146438|FG000|COMPLETED|Overall Study||2
9082654|NCT00634582|10146438|FG000|NOT COMPLETED|Overall Study||0
9082655|NCT00641108|10146444|FG000|STARTED|Overall Study||0
9082656|NCT00641108|10146445|FG001|STARTED|Overall Study||0
9082657|NCT00641108|10146444|FG000|COMPLETED|Overall Study||0
9082658|NCT00641108|10146445|FG001|COMPLETED|Overall Study||0
9082659|NCT00641108|10146444|FG000|NOT COMPLETED|Overall Study||0
9082660|NCT00641108|10146445|FG001|NOT COMPLETED|Overall Study||0
9082661|NCT00642382|10146453|FG000|STARTED|Overall Study||0
9082662|NCT00642382|10146454|FG001|STARTED|Overall Study||0
9082663|NCT00642382|10146453|FG000|COMPLETED|Overall Study||0
9082664|NCT00642382|10146454|FG001|COMPLETED|Overall Study||0
9082665|NCT00642382|10146453|FG000|NOT COMPLETED|Overall Study||0
9082666|NCT00642382|10146454|FG001|NOT COMPLETED|Overall Study||0
9082667|NCT00637416|10146462|FG000|STARTED|Overall Study||4
9082668|NCT00637416|10146463|FG001|STARTED|Overall Study||5
9082669|NCT00637416|10146462|FG000|COMPLETED|Overall Study||3
9082670|NCT00637416|10146463|FG001|COMPLETED|Overall Study||3
9082671|NCT00637416|10146462|FG000|NOT COMPLETED|Overall Study||1
9082672|NCT00637416|10146463|FG001|NOT COMPLETED|Overall Study||2
9082673|NCT00635167|10146469|FG000|STARTED|Overall Study||1
9082674|NCT00635167|10146469|FG000|COMPLETED|Overall Study||1
9082675|NCT00635167|10146469|FG000|NOT COMPLETED|Overall Study||0
9082676|NCT00637312|10146475|FG000|STARTED|Overall Study||72
9082677|NCT00637312|10146476|FG001|STARTED|Overall Study||36
9082678|NCT00637312|10146475|FG000|COMPLETED|Overall Study||30
9082679|NCT00637312|10146476|FG001|COMPLETED|Overall Study||19
9082680|NCT00637312|10146475|FG000|NOT COMPLETED|Overall Study||42
9082681|NCT00637312|10146476|FG001|NOT COMPLETED|Overall Study||17
9082682|NCT00638222|10146485|FG000|STARTED|Overall Study||0
9082683|NCT00638222|10146486|FG001|STARTED|Overall Study||0
9082684|NCT00638222|10146487|FG002|STARTED|Overall Study||6
9082685|NCT00638222|10146485|FG000|COMPLETED|Overall Study||0
9082686|NCT00638222|10146486|FG001|COMPLETED|Overall Study||0
9082687|NCT00638222|10146487|FG002|COMPLETED|Overall Study||6
9082688|NCT00638222|10146485|FG000|NOT COMPLETED|Overall Study||0
9082689|NCT00638222|10146486|FG001|NOT COMPLETED|Overall Study||0
9082690|NCT00638222|10146487|FG002|NOT COMPLETED|Overall Study||0
9082691|NCT00634322|10146497|FG000|STARTED|Overall Study||1
9082692|NCT00634322|10146498|FG001|STARTED|Overall Study||1
9082693|NCT00634322|10146499|FG002|STARTED|Overall Study||5
9082694|NCT00634322|10146497|FG000|COMPLETED|Overall Study||1
9082695|NCT00634322|10146498|FG001|COMPLETED|Overall Study||1
9082696|NCT00634322|10146499|FG002|COMPLETED|Overall Study||5
9082697|NCT00634322|10146497|FG000|NOT COMPLETED|Overall Study||0
9082698|NCT00634322|10146498|FG001|NOT COMPLETED|Overall Study||0
9082699|NCT00634322|10146499|FG002|NOT COMPLETED|Overall Study||0
9082700|NCT00633087|10146507|FG000|STARTED|Overall Study||12
9082701|NCT00633087|10146507|FG000|COMPLETED|Overall Study||12
9082702|NCT00633087|10146507|FG000|NOT COMPLETED|Overall Study||0
9082703|NCT00631137|10146513|FG000|STARTED|Overall Study||1
9082704|NCT00631137|10146514|FG001|STARTED|Overall Study||0
9082705|NCT00631137|10146513|FG000|COMPLETED|Overall Study||0
9082706|NCT00631137|10146514|FG001|COMPLETED|Overall Study||0
9082707|NCT00631137|10146513|FG000|NOT COMPLETED|Overall Study||1
9082708|NCT00631137|10146514|FG001|NOT COMPLETED|Overall Study||0
9082709|NCT00634972|10146522|FG000|STARTED|Overall Study||40
9082710|NCT00634972|10146523|FG001|STARTED|Overall Study||43
9082711|NCT00634972|10146522|FG000|COMPLETED|Overall Study||40
9082712|NCT00634972|10146523|FG001|COMPLETED|Overall Study||43
9082713|NCT00634972|10146522|FG000|NOT COMPLETED|Overall Study||0
9082714|NCT00634972|10146523|FG001|NOT COMPLETED|Overall Study||0
9082715|NCT00633061|10146531|FG000|STARTED|Overall Study|Study was on hold for 2 months for continuing review|136
9082716|NCT00633061|10146532|FG001|STARTED|Overall Study||0
9082717|NCT00633061|10146531|FG000|Met Criteria for Imaging|Overall Study||25
9082718|NCT00633061|10146532|FG001|Met Criteria for Imaging|Overall Study||0
9082719|NCT00633061|10146531|FG000|Had Prior Thrombosis Identified|Overall Study||25
9082720|NCT00633061|10146532|FG001|Had Prior Thrombosis Identified|Overall Study||0
9082721|NCT00633061|10146531|FG000|COMPLETED|Overall Study||50
9082722|NCT00633061|10146532|FG001|COMPLETED|Overall Study||0
9082723|NCT00633061|10146531|FG000|NOT COMPLETED|Overall Study||86
9082724|NCT00633061|10146532|FG001|NOT COMPLETED|Overall Study||0
9082725|NCT00626444|10146540|FG000|STARTED|Overall Study||2
9082726|NCT00626444|10146540|FG000|COMPLETED|Overall Study||2
9082727|NCT00626444|10146540|FG000|NOT COMPLETED|Overall Study||0
9082728|NCT00630292|10146544|FG000|STARTED|Overall Study||6
9082729|NCT00630292|10146544|FG000|COMPLETED|Overall Study||5
9082730|NCT00630292|10146544|FG000|NOT COMPLETED|Overall Study||1
9082731|NCT00634010|10146550|FG000|STARTED|Overall Study||18
9082732|NCT00634010|10146551|FG001|STARTED|Overall Study||18
9082733|NCT00634010|10146550|FG000|COMPLETED|Overall Study||8
9082734|NCT00634010|10146551|FG001|COMPLETED|Overall Study||4
9082735|NCT00634010|10146550|FG000|NOT COMPLETED|Overall Study||10
9082736|NCT00634010|10146551|FG001|NOT COMPLETED|Overall Study||14
9082737|NCT00630487|10146559|FG000|STARTED|Overall Study||0
9082738|NCT00630487|10146560|FG001|STARTED|Overall Study||0
8624585|NCT00501631|9663959|FG000|STARTED|Part B (Open-label Period)||90
8624586|NCT00501631|9663960|FG001|STARTED|Part B (Open-label Period)||99
8624587|NCT00501631|9663959|FG000|COMPLETED|Part B (Open-label Period)||37
9082739|NCT00630487|10146559|FG000|COMPLETED|Overall Study||0
9082740|NCT00630487|10146560|FG001|COMPLETED|Overall Study||0
9082741|NCT00630487|10146559|FG000|NOT COMPLETED|Overall Study||0
9082742|NCT00630487|10146560|FG001|NOT COMPLETED|Overall Study||0
9082743|NCT00629850|10146568|FG000|STARTED|Overall Study||1
9082744|NCT00629850|10146569|FG001|STARTED|Overall Study||0
9082745|NCT00629850|10146568|FG000|COMPLETED|Overall Study||1
9082746|NCT00629850|10146569|FG001|COMPLETED|Overall Study||0
9082747|NCT00629850|10146568|FG000|NOT COMPLETED|Overall Study||0
9082748|NCT00629850|10146569|FG001|NOT COMPLETED|Overall Study||0
9082749|NCT00623974|10146579|FG000|STARTED|Overall Study||0
9082750|NCT00623974|10146580|FG001|STARTED|Overall Study||0
9082751|NCT00623974|10146581|FG002|STARTED|Overall Study||0
9082752|NCT00623974|10146582|FG003|STARTED|Overall Study||0
9082753|NCT00623974|10146579|FG000|COMPLETED|Overall Study||0
9082754|NCT00623974|10146580|FG001|COMPLETED|Overall Study||0
9082755|NCT00623974|10146581|FG002|COMPLETED|Overall Study||0
9082756|NCT00623974|10146582|FG003|COMPLETED|Overall Study||0
9082757|NCT00623974|10146579|FG000|NOT COMPLETED|Overall Study||0
9082758|NCT00623974|10146580|FG001|NOT COMPLETED|Overall Study||0
9082759|NCT00623974|10146581|FG002|NOT COMPLETED|Overall Study||0
9082760|NCT00623974|10146582|FG003|NOT COMPLETED|Overall Study||0
9082761|NCT00624650|10146594|FG000|STARTED|Overall Study||17
9082762|NCT00624650|10146595|FG001|STARTED|Overall Study||16
9082763|NCT00624650|10146594|FG000|COMPLETED|Overall Study||16
9082764|NCT00624650|10146595|FG001|COMPLETED|Overall Study||15
8624588|NCT00501631|9663960|FG001|COMPLETED|Part B (Open-label Period)||48
9082765|NCT00624650|10146594|FG000|NOT COMPLETED|Overall Study||1
9082766|NCT00624650|10146595|FG001|NOT COMPLETED|Overall Study||1
9082767|NCT00626561|10146601|FG000|STARTED|Overall Study||4
9082768|NCT00626561|10146601|FG000|COMPLETED|Overall Study||0
9082769|NCT00626561|10146601|FG000|NOT COMPLETED|Overall Study||4
9082770|NCT00613730|10146605|FG000|STARTED|Overall Study||3
9082771|NCT00613730|10146605|FG000|COMPLETED|Overall Study||0
9082772|NCT00613730|10146605|FG000|NOT COMPLETED|Overall Study||3
9082773|NCT00625586|10146609|FG000|STARTED|Overall Study||2
9082774|NCT00625586|10146609|FG000|COMPLETED|Overall Study||1
9082775|NCT00625586|10146609|FG000|NOT COMPLETED|Overall Study||1
9082776|NCT00625703|10146613|FG000|STARTED|Overall Study||0
9082777|NCT00625703|10146613|FG000|COMPLETED|Overall Study||0
9082778|NCT00625703|10146613|FG000|NOT COMPLETED|Overall Study||0
9082779|NCT00625742|10146617|FG000|STARTED|Overall Study||15
9082780|NCT00625742|10146617|FG000|COMPLETED|Overall Study||3
9082781|NCT00625742|10146617|FG000|NOT COMPLETED|Overall Study||12
9082782|NCT00619242|10146621|FG000|STARTED|Overall Study||3
9082783|NCT00619242|10146621|FG000|COMPLETED|Overall Study||3
9082784|NCT00619242|10146621|FG000|NOT COMPLETED|Overall Study||0
9082785|NCT00619151|10146627|FG000|STARTED|Overall Study||2
9082786|NCT00619151|10146628|FG001|STARTED|Overall Study||0
9082787|NCT00619151|10146627|FG000|COMPLETED|Overall Study||1
9082788|NCT00619151|10146628|FG001|COMPLETED|Overall Study||0
9082789|NCT00619151|10146627|FG000|NOT COMPLETED|Overall Study||1
9082790|NCT00619151|10146628|FG001|NOT COMPLETED|Overall Study||0
9082791|NCT00622167|10146634|FG000|STARTED|Overall Study||24
9082792|NCT00622167|10146634|FG000|COMPLETED|Overall Study||4
9082793|NCT00622167|10146634|FG000|NOT COMPLETED|Overall Study||20
9082794|NCT00616577|10146641|FG000|STARTED|Overall Study||6
9082795|NCT00616577|10146642|FG001|STARTED|Overall Study||9
9082796|NCT00616577|10146643|FG002|STARTED|Overall Study||7
9082797|NCT00616577|10146641|FG000|COMPLETED|Overall Study||6
9082798|NCT00616577|10146642|FG001|COMPLETED|Overall Study||9
9082799|NCT00616577|10146643|FG002|COMPLETED|Overall Study||7
9082800|NCT00616577|10146641|FG000|NOT COMPLETED|Overall Study||0
9082801|NCT00616577|10146642|FG001|NOT COMPLETED|Overall Study||0
9082802|NCT00616577|10146643|FG002|NOT COMPLETED|Overall Study||0
9082803|NCT00616759|10146653|FG000|STARTED|Overall Study||10
9082804|NCT00616759|10146654|FG001|STARTED|Overall Study||10
9082805|NCT00616759|10146653|FG000|COMPLETED|Overall Study||7
9082806|NCT00616759|10146654|FG001|COMPLETED|Overall Study||8
9082807|NCT00616759|10146653|FG000|NOT COMPLETED|Overall Study||3
9082808|NCT00616759|10146654|FG001|NOT COMPLETED|Overall Study||2
9082809|NCT00616642|10146662|FG000|STARTED|Overall Study||0
9082810|NCT00616642|10146663|FG001|STARTED|Overall Study||1
9082811|NCT00616642|10146662|FG000|COMPLETED|Overall Study||0
9082812|NCT00616642|10146663|FG001|COMPLETED|Overall Study||0
9082813|NCT00616642|10146662|FG000|NOT COMPLETED|Overall Study||0
9082814|NCT00616642|10146663|FG001|NOT COMPLETED|Overall Study||1
9082815|NCT00619515|10146669|FG000|STARTED|Overall Study||73
9082816|NCT00619515|10146669|FG000|COMPLETED|Overall Study||0
9082817|NCT00619515|10146669|FG000|NOT COMPLETED|Overall Study||73
9082818|NCT00616343|10146673|FG000|STARTED|Overall Study||9
9082819|NCT00616343|10146673|FG000|COMPLETED|Overall Study||9
9082820|NCT00616343|10146673|FG000|NOT COMPLETED|Overall Study||0
9082821|NCT00612677|10146677|FG000|STARTED|Overall Study||1
9082822|NCT00612677|10146677|FG000|COMPLETED|Overall Study||0
9082823|NCT00612677|10146677|FG000|NOT COMPLETED|Overall Study||1
9082824|NCT00616603|10146684|FG000|STARTED|Overall Study||14
9082825|NCT00616603|10146685|FG001|STARTED|Overall Study||14
9082826|NCT00616603|10146686|FG002|STARTED|Overall Study||15
9082827|NCT00616603|10146684|FG000|COMPLETED|Overall Study||12
9082828|NCT00616603|10146685|FG001|COMPLETED|Overall Study||14
9082829|NCT00616603|10146686|FG002|COMPLETED|Overall Study||13
9082830|NCT00616603|10146684|FG000|NOT COMPLETED|Overall Study||2
9082831|NCT00616603|10146685|FG001|NOT COMPLETED|Overall Study||0
9082832|NCT00616603|10146686|FG002|NOT COMPLETED|Overall Study||2
9082833|NCT00613886|10146694|FG000|STARTED|Overall Study||24
9082834|NCT00613886|10146694|FG000|COMPLETED|Overall Study||0
9082835|NCT00613886|10146694|FG000|NOT COMPLETED|Overall Study||24
9082836|NCT00610467|10146701|FG000|STARTED|Overall Study||1
8624589|NCT00501631|9663959|FG000|NOT COMPLETED|Part B (Open-label Period)||53
8624590|NCT00501631|9663960|FG001|NOT COMPLETED|Part B (Open-label Period)||51
8624591|NCT00501644|9663966|FG000|STARTED|Overall Study||59
8624592|NCT00501644|9663966|FG000|COMPLETED|Overall Study||54
8624593|NCT00501644|9663966|FG000|NOT COMPLETED|Overall Study||5
8624594|NCT00501852|9663970|FG000|STARTED|Overall Study||83
8624595|NCT00501852|9663970|FG000|NVA237 12.5µg|Overall Study||55
8624596|NCT00501852|9663970|FG000|NVA237 25µg|Overall Study||51
8624597|NCT00501852|9663970|FG000|NVA237 50µg|Overall Study||53
9082837|NCT00610467|10146702|FG001|STARTED|Overall Study||1
9082838|NCT00610467|10146701|FG000|COMPLETED|Overall Study||1
9082839|NCT00610467|10146702|FG001|COMPLETED|Overall Study||1
9082840|NCT00610467|10146701|FG000|NOT COMPLETED|Overall Study||0
9082841|NCT00610467|10146702|FG001|NOT COMPLETED|Overall Study||0
8624598|NCT00501852|9663970|FG000|NVA237 100µg|Overall Study||54
9082842|NCT00610558|10146711|FG000|STARTED|Overall Study||20
9082843|NCT00610558|10146712|FG001|STARTED|Overall Study||20
8624599|NCT00501852|9663970|FG000|Placebo|Overall Study||55
8624600|NCT00501852|9663970|FG000|Tiotropium|Overall Study||55
8624601|NCT00501852|9663970|FG000|COMPLETED|Overall Study||78
9082844|NCT00610558|10146713|FG002|STARTED|Overall Study||20
9082845|NCT00610558|10146711|FG000|COMPLETED|Overall Study||15
9082846|NCT00610558|10146712|FG001|COMPLETED|Overall Study||14
9082847|NCT00610558|10146713|FG002|COMPLETED|Overall Study||14
9082848|NCT00610558|10146711|FG000|NOT COMPLETED|Overall Study||5
9082849|NCT00610558|10146712|FG001|NOT COMPLETED|Overall Study||6
9082850|NCT00610558|10146713|FG002|NOT COMPLETED|Overall Study||6
9082851|NCT00610532|10146721|FG000|STARTED|Intravenous Phenytoin Alone||8
9082852|NCT00610532|10146721|FG000|COMPLETED|Intravenous Phenytoin Alone||8
9082853|NCT00610532|10146721|FG000|NOT COMPLETED|Intravenous Phenytoin Alone||0
9082854|NCT00610532|10146721|FG000|STARTED|Intravenous Phenytoin Plus Probenecid|one participant dropped out between periods|7
9082855|NCT00610532|10146721|FG000|COMPLETED|Intravenous Phenytoin Plus Probenecid||7
9082856|NCT00610532|10146721|FG000|NOT COMPLETED|Intravenous Phenytoin Plus Probenecid||0
9082857|NCT00609765|10146727|FG000|STARTED|Overall Study||1
9082858|NCT00609765|10146727|FG000|COMPLETED|Overall Study||0
9082859|NCT00609765|10146727|FG000|NOT COMPLETED|Overall Study||1
9082860|NCT00608465|10146731|FG000|STARTED|Overall Study||4
9082861|NCT00608465|10146731|FG000|COMPLETED|Overall Study||4
9082862|NCT00608465|10146731|FG000|NOT COMPLETED|Overall Study||0
9082863|NCT00608777|10146735|FG000|STARTED|Overall Study||6
9082864|NCT00608777|10146735|FG000|COMPLETED|Overall Study||6
9082865|NCT00608777|10146735|FG000|NOT COMPLETED|Overall Study||0
9082866|NCT00601848|10146739|FG000|STARTED|Overall Study||9
9082867|NCT00601848|10146739|FG000|COMPLETED|Overall Study||0
9082868|NCT00601848|10146739|FG000|NOT COMPLETED|Overall Study||9
9082869|NCT00607477|10146745|FG000|STARTED|Overall Study||0
9082870|NCT00607477|10146746|FG001|STARTED|Overall Study||2
9082871|NCT00607477|10146745|FG000|COMPLETED|Overall Study||0
9082872|NCT00607477|10146746|FG001|COMPLETED|Overall Study||2
9082873|NCT00607477|10146745|FG000|NOT COMPLETED|Overall Study||0
9082874|NCT00607477|10146746|FG001|NOT COMPLETED|Overall Study||0
9082875|NCT00595920|10146752|FG000|STARTED|Overall Study||116
9082876|NCT00595920|10146752|FG000|Patients Dosed|Overall Study|116 patients enrolled; however, only 38 received at least 1 dose.|38
9082877|NCT00595920|10146752|FG000|COMPLETED|Overall Study||0
9082878|NCT00595920|10146752|FG000|NOT COMPLETED|Overall Study||116
9082879|NCT00596947|10146758|FG000|STARTED|Overall Study||9
9082880|NCT00596947|10146759|FG001|STARTED|Overall Study||9
9082881|NCT00596947|10146758|FG000|COMPLETED|Overall Study||3
9082882|NCT00596947|10146759|FG001|COMPLETED|Overall Study||6
9082883|NCT00596947|10146758|FG000|NOT COMPLETED|Overall Study||6
9082884|NCT00596947|10146759|FG001|NOT COMPLETED|Overall Study||3
8556751|NCT05017493|9588536|FG000|NOT COMPLETED|Overall Study||122
8556752|NCT05017493|9588537|FG001|NOT COMPLETED|Overall Study||0
8556753|NCT04870138|9588546|FG000|STARTED|Overall Study||5
8556754|NCT04870138|9588547|FG001|STARTED|Overall Study||5
8556755|NCT04870138|9588548|FG002|STARTED|Overall Study||6
8556756|NCT04870138|9588546|FG000|COMPLETED|Overall Study||5
8556757|NCT04870138|9588547|FG001|COMPLETED|Overall Study||5
9082885|NCT00584012|10146765|FG000|STARTED|Overall Study||9
9082886|NCT00584012|10146765|FG000|COMPLETED|Overall Study||8
9082887|NCT00584012|10146765|FG000|NOT COMPLETED|Overall Study||1
9082888|NCT00599131|10146769|FG000|STARTED|Overall Study||4
9082889|NCT00599131|10146769|FG000|COMPLETED|Overall Study||4
9082890|NCT00599131|10146769|FG000|NOT COMPLETED|Overall Study||0
9082891|NCT00597909|10146776|FG000|STARTED|Overall Study||0
9082892|NCT00597909|10146777|FG001|STARTED|Overall Study||0
9082893|NCT00597909|10146778|FG002|STARTED|Overall Study||0
9082894|NCT00597909|10146776|FG000|COMPLETED|Overall Study||0
9082895|NCT00597909|10146777|FG001|COMPLETED|Overall Study||0
9082896|NCT00597909|10146778|FG002|COMPLETED|Overall Study||0
9082897|NCT00597909|10146776|FG000|NOT COMPLETED|Overall Study||0
9082898|NCT00597909|10146777|FG001|NOT COMPLETED|Overall Study||0
9082899|NCT00597909|10146778|FG002|NOT COMPLETED|Overall Study||0
9082900|NCT00593320|10146788|FG000|STARTED|Overall Study||1
9082901|NCT00593320|10146789|FG001|STARTED|Overall Study||1
9082902|NCT00593320|10146788|FG000|COMPLETED|Overall Study||1
9082903|NCT00593320|10146789|FG001|COMPLETED|Overall Study||1
9082904|NCT00593320|10146788|FG000|NOT COMPLETED|Overall Study||0
9082905|NCT00593320|10146789|FG001|NOT COMPLETED|Overall Study||0
9082906|NCT00589550|10146795|FG000|STARTED|Overall Study||1
9082907|NCT00589550|10146795|FG000|Withdrew From Study|Overall Study||1
9082908|NCT00589550|10146795|FG000|COMPLETED|Overall Study||0
9082909|NCT00589550|10146795|FG000|NOT COMPLETED|Overall Study||1
9082910|NCT00577772|10146801|FG000|STARTED|Overall Study||10
9082911|NCT00577772|10146802|FG001|STARTED|Overall Study||7
9082912|NCT00577772|10146801|FG000|COMPLETED|Overall Study||10
9082913|NCT00577772|10146802|FG001|COMPLETED|Overall Study||6
9082914|NCT00577772|10146801|FG000|NOT COMPLETED|Overall Study||0
9082915|NCT00577772|10146802|FG001|NOT COMPLETED|Overall Study||1
9082916|NCT00592007|10146808|FG000|STARTED|Overall Study||7
9082917|NCT00592007|10146808|FG000|COMPLETED|Overall Study||5
9082918|NCT00592007|10146808|FG000|NOT COMPLETED|Overall Study||2
9082919|NCT00595582|10146812|FG000|STARTED|Overall Study||10
9082920|NCT00595582|10146812|FG000|COMPLETED|Overall Study||0
9082921|NCT00595582|10146812|FG000|NOT COMPLETED|Overall Study||10
9082922|NCT00588146|10146816|FG000|STARTED|First Intervention (Baseline to 6 mo)||5
9082923|NCT00588146|10146817|FG001|STARTED|First Intervention (Baseline to 6 mo)||5
9082924|NCT00588146|10146816|FG000|COMPLETED|First Intervention (Baseline to 6 mo)||1
9082925|NCT00588146|10146817|FG001|COMPLETED|First Intervention (Baseline to 6 mo)||2
9082926|NCT00588146|10146816|FG000|NOT COMPLETED|First Intervention (Baseline to 6 mo)||4
9082927|NCT00588146|10146817|FG001|NOT COMPLETED|First Intervention (Baseline to 6 mo)||3
9082928|NCT00588146|10146816|FG000|STARTED|Second Intervention (6 Months to 1 Year)||1
9082929|NCT00588146|10146817|FG001|STARTED|Second Intervention (6 Months to 1 Year)||2
9082930|NCT00588146|10146816|FG000|COMPLETED|Second Intervention (6 Months to 1 Year)||1
9082931|NCT00588146|10146817|FG001|COMPLETED|Second Intervention (6 Months to 1 Year)||2
9082932|NCT00588146|10146816|FG000|NOT COMPLETED|Second Intervention (6 Months to 1 Year)||0
9082933|NCT00588146|10146817|FG001|NOT COMPLETED|Second Intervention (6 Months to 1 Year)||0
9082934|NCT00586209|10146825|FG000|STARTED|Overall Study||5
9082935|NCT00586209|10146826|FG001|STARTED|Overall Study||10
9082936|NCT00586209|10146825|FG000|COMPLETED|Overall Study||5
9082937|NCT00586209|10146826|FG001|COMPLETED|Overall Study||10
9082938|NCT00586209|10146825|FG000|NOT COMPLETED|Overall Study||0
9082939|NCT00586209|10146826|FG001|NOT COMPLETED|Overall Study||0
9082940|NCT00590538|10146832|FG000|STARTED|Overall Study|STUDY NOT UNBLINDED AT TIME OF TERMINATION; THEREFORE NUMBER ASSIGNED TO EACH GROUP IS NOT KNOWN.|9
9082941|NCT00590538|10146832|FG000|COMPLETED|Overall Study||7
9082942|NCT00590538|10146832|FG000|NOT COMPLETED|Overall Study||2
9082943|NCT00583115|10146836|FG000|STARTED|Overall Study||1
9082944|NCT00583115|10146836|FG000|COMPLETED|Overall Study||0
9082945|NCT00583115|10146836|FG000|NOT COMPLETED|Overall Study||1
9082946|NCT00582712|10146840|FG000|STARTED|Overall Study||5
9082947|NCT00582712|10146840|FG000|COMPLETED|Overall Study||1
9082948|NCT00582712|10146840|FG000|NOT COMPLETED|Overall Study||4
9082949|NCT00586716|10146846|FG000|STARTED|Overall Study||14
9082950|NCT00586716|10146847|FG001|STARTED|Overall Study||8
9082951|NCT00586716|10146846|FG000|COMPLETED|Overall Study||14
9082952|NCT00586716|10146847|FG001|COMPLETED|Overall Study||8
9082953|NCT00586716|10146846|FG000|NOT COMPLETED|Overall Study||0
9082954|NCT00586716|10146847|FG001|NOT COMPLETED|Overall Study||0
9082955|NCT00583466|10146854|FG000|STARTED|Overall Study||18
9082956|NCT00583466|10146854|FG000|COMPLETED|Overall Study||18
9082957|NCT00583466|10146854|FG000|NOT COMPLETED|Overall Study||0
9082958|NCT00588471|10146862|FG000|STARTED|Overall Study||28
9082959|NCT00588471|10146863|FG001|STARTED|Overall Study||29
9082960|NCT00588471|10146862|FG000|COMPLETED|Overall Study||28
9082961|NCT00588471|10146863|FG001|COMPLETED|Overall Study||29
9082962|NCT00588471|10146862|FG000|NOT COMPLETED|Overall Study||0
9082963|NCT00588471|10146863|FG001|NOT COMPLETED|Overall Study||0
9082964|NCT00587795|10146871|FG000|STARTED|Overall Study||1
9082965|NCT00587795|10146872|FG001|STARTED|Overall Study||0
9082966|NCT00587795|10146871|FG000|COMPLETED|Overall Study||0
9082967|NCT00587795|10146872|FG001|COMPLETED|Overall Study||0
9082968|NCT00587795|10146871|FG000|NOT COMPLETED|Overall Study||1
9082969|NCT00587795|10146872|FG001|NOT COMPLETED|Overall Study||0
9082970|NCT00590135|10146878|FG000|STARTED|Overall Study||59
9082971|NCT00590135|10146878|FG000|COMPLETED|Overall Study||0
9082972|NCT00590135|10146878|FG000|NOT COMPLETED|Overall Study||59
9082973|NCT00582036|10146885|FG000|STARTED|Overall Study||5
9082974|NCT00582036|10146886|FG001|STARTED|Overall Study||6
9082975|NCT00582036|10146885|FG000|COMPLETED|Overall Study||5
9082976|NCT00582036|10146886|FG001|COMPLETED|Overall Study|One patient withdrew consent|5
9082977|NCT00582036|10146885|FG000|NOT COMPLETED|Overall Study||0
9082978|NCT00582036|10146886|FG001|NOT COMPLETED|Overall Study||1
9082979|NCT00585585|10146892|FG000|STARTED|Overall Study||1
9082980|NCT00585585|10146892|FG000|Patients Receiving Drug|Overall Study||1
9082981|NCT00585585|10146892|FG000|COMPLETED|Overall Study||0
9082982|NCT00585585|10146892|FG000|NOT COMPLETED|Overall Study||1
9082983|NCT00585221|10146896|FG000|STARTED|Overall Study||8
9082984|NCT00585221|10146896|FG000|COMPLETED|Overall Study||0
9082985|NCT00585221|10146896|FG000|NOT COMPLETED|Overall Study||8
9082986|NCT00581113|10146902|FG000|STARTED|Overall Study||4
9082987|NCT00581113|10146903|FG001|STARTED|Overall Study||4
9082988|NCT00581113|10146902|FG000|COMPLETED|Overall Study||4
9082989|NCT00581113|10146903|FG001|COMPLETED|Overall Study||3
9082990|NCT00581113|10146902|FG000|NOT COMPLETED|Overall Study||0
9082991|NCT00581113|10146903|FG001|NOT COMPLETED|Overall Study||1
9082992|NCT00579254|10146909|FG000|STARTED|Overall Study||112
9082993|NCT00579254|10146909|FG000|COMPLETED|Overall Study||0
9082994|NCT00579254|10146909|FG000|NOT COMPLETED|Overall Study||112
9082995|NCT00587223|10146913|FG000|STARTED|Overall Study|Study design was within-subject control. Only 1 subject was enrolled in the study.|1
9082996|NCT00587223|10146913|FG000|COMPLETED|Overall Study|Subject withdrawn from study at Day 7.|0
9082997|NCT00587223|10146913|FG000|NOT COMPLETED|Overall Study||1
9082998|NCT00585611|10146922|FG000|STARTED|Overall Study||0
8624602|NCT00501852|9663970|FG000|NOT COMPLETED|Overall Study||5
8624603|NCT00501891|9663984|FG000|STARTED|Overall Study||32
8624604|NCT00501891|9663984|FG000|COMPLETED|Overall Study||32
8624605|NCT00501891|9663984|FG000|NOT COMPLETED|Overall Study||0
8844680|NCT01711294|9899120|FG001|NOT COMPLETED|Overall Study||0
9082999|NCT00585611|10146923|FG001|STARTED|Overall Study||0
9083000|NCT00585611|10146922|FG000|COMPLETED|Overall Study||0
9083001|NCT00585611|10146923|FG001|COMPLETED|Overall Study||0
9083002|NCT00585611|10146922|FG000|NOT COMPLETED|Overall Study||0
9083003|NCT00585611|10146923|FG001|NOT COMPLETED|Overall Study||0
9083004|NCT00572260|10146929|FG000|STARTED|Overall Study||11
9083005|NCT00572260|10146929|FG000|COMPLETED|Overall Study||11
9083006|NCT00572260|10146929|FG000|NOT COMPLETED|Overall Study||0
9083007|NCT00571194|10146933|FG000|STARTED|Overall Study||7
9083008|NCT00571194|10146933|FG000|COMPLETED|Overall Study||7
9083009|NCT00571194|10146933|FG000|NOT COMPLETED|Overall Study||0
9083010|NCT00584935|10146937|FG000|STARTED|Overall Study||3
9083011|NCT00584935|10146937|FG000|COMPLETED|Overall Study||3
9083012|NCT00584935|10146937|FG000|NOT COMPLETED|Overall Study||0
9083013|NCT00577395|10146944|FG000|STARTED|Overall Study|67 planned for Treatment 2, but due to enrollment difficulties this was not met.|7
9083014|NCT00577395|10146945|FG001|STARTED|Overall Study|67 were planned for Treatment 1, but due to enrollment difficulties this was not met.|6
9083015|NCT00577395|10146944|FG000|COMPLETED|Overall Study|The study was terminated early by the Sponsor for lack of enrollment|0
9083016|NCT00577395|10146945|FG001|COMPLETED|Overall Study|The study was terminated early by the Sponsor for lack of enrollment|0
9083017|NCT00577395|10146944|FG000|NOT COMPLETED|Overall Study||7
9083018|NCT00577395|10146945|FG001|NOT COMPLETED|Overall Study||6
9083019|NCT00573391|10146953|FG000|STARTED|Overall Study||3
9083020|NCT00573391|10146954|FG001|STARTED|Overall Study||2
9083021|NCT00573391|10146953|FG000|COMPLETED|Overall Study||0
9083022|NCT00573391|10146954|FG001|COMPLETED|Overall Study||0
9083023|NCT00573391|10146953|FG000|NOT COMPLETED|Overall Study||3
9083024|NCT00573391|10146954|FG001|NOT COMPLETED|Overall Study||2
9083025|NCT00570258|10146962|FG000|STARTED|Overall Study||12
9083026|NCT00570258|10146963|FG001|STARTED|Overall Study||15
9083027|NCT00570258|10146962|FG000|COMPLETED|Overall Study|Early termination due to a change in drug FDA approval.|0
9083028|NCT00570258|10146963|FG001|COMPLETED|Overall Study|Early termination due to a change in drug FDA approval.|0
9083029|NCT00570258|10146962|FG000|NOT COMPLETED|Overall Study||12
9083030|NCT00570258|10146963|FG001|NOT COMPLETED|Overall Study||15
9083031|NCT00568802|10146971|FG000|STARTED|Overall Study||27
9083032|NCT00568802|10146971|FG000|COMPLETED|Overall Study||24
9083033|NCT00568802|10146971|FG000|NOT COMPLETED|Overall Study||3
9083034|NCT00576524|10146979|FG000|STARTED|Overall Study||2
9083035|NCT00576524|10146980|FG001|STARTED|Overall Study||0
9083036|NCT00576524|10146979|FG000|COMPLETED|Overall Study||2
9083037|NCT00576524|10146980|FG001|COMPLETED|Overall Study||0
9083038|NCT00576524|10146979|FG000|NOT COMPLETED|Overall Study||0
9083039|NCT00576524|10146980|FG001|NOT COMPLETED|Overall Study||0
9083040|NCT00568698|10146990|FG000|STARTED|Overall Study||29
9083041|NCT00568698|10146990|FG000|COMPLETED|Overall Study||18
8624606|NCT00501943|9663991|FG000|STARTED|Overall Study||22
8844681|NCT01711294|9899121|FG002|NOT COMPLETED|Overall Study||0
9083042|NCT00568698|10146990|FG000|NOT COMPLETED|Overall Study||11
9083043|NCT00574080|10146998|FG000|STARTED|Overall Study||10
9083044|NCT00574080|10146999|FG001|STARTED|Overall Study||10
9083045|NCT00574080|10146998|FG000|COMPLETED|Overall Study||0
9083046|NCT00574080|10146999|FG001|COMPLETED|Overall Study||0
9083047|NCT00574080|10146998|FG000|NOT COMPLETED|Overall Study||10
9083048|NCT00574080|10146999|FG001|NOT COMPLETED|Overall Study||10
9083049|NCT00558558|10147005|FG000|STARTED|Overall Study||6
8624607|NCT00501943|9663992|FG001|STARTED|Overall Study||21
8624608|NCT00501943|9663991|FG000|COMPLETED|Overall Study||20
8624609|NCT00501943|9663992|FG001|COMPLETED|Overall Study||18
9083050|NCT00558558|10147005|FG000|COMPLETED|Overall Study||0
9083051|NCT00558558|10147005|FG000|NOT COMPLETED|Overall Study||6
9083052|NCT00577356|10147009|FG000|STARTED|Overall Study||6
9083053|NCT00577356|10147009|FG000|COMPLETED|Overall Study||6
9083054|NCT00577356|10147009|FG000|NOT COMPLETED|Overall Study||0
9083055|NCT00573937|10147015|FG000|STARTED|Overall Study||0
9083056|NCT00573937|10147016|FG001|STARTED|Overall Study||1
9083057|NCT00573937|10147015|FG000|COMPLETED|Overall Study||0
9083058|NCT00573937|10147016|FG001|COMPLETED|Overall Study||0
9083059|NCT00573937|10147015|FG000|NOT COMPLETED|Overall Study||0
9083060|NCT00573937|10147016|FG001|NOT COMPLETED|Overall Study||1
9083061|NCT00577317|10147024|FG000|STARTED|Overall Study||0
9083062|NCT00577317|10147025|FG001|STARTED|Overall Study||2
9083063|NCT00577317|10147024|FG000|COMPLETED|Overall Study||0
9083064|NCT00577317|10147025|FG001|COMPLETED|Overall Study||0
9083065|NCT00577317|10147024|FG000|NOT COMPLETED|Overall Study||0
9083066|NCT00577317|10147025|FG001|NOT COMPLETED|Overall Study||2
9083067|NCT00571922|10147033|FG000|STARTED|Overall Study||36
9083068|NCT00571922|10147034|FG001|STARTED|Overall Study||36
9083069|NCT00571922|10147033|FG000|COMPLETED|Overall Study||0
9083070|NCT00571922|10147034|FG001|COMPLETED|Overall Study||0
9083071|NCT00571922|10147033|FG000|NOT COMPLETED|Overall Study||36
9083072|NCT00571922|10147034|FG001|NOT COMPLETED|Overall Study||36
9083073|NCT00569868|10147040|FG000|STARTED|Overall Study||11
9083074|NCT00569868|10147040|FG000|COMPLETED|Overall Study||11
9083075|NCT00569868|10147040|FG000|NOT COMPLETED|Overall Study||0
9083076|NCT00573157|10147046|FG000|STARTED|Overall Study||4
9083077|NCT00573157|10147047|FG001|STARTED|Overall Study||2
9083078|NCT00573157|10147046|FG000|COMPLETED|Overall Study||0
9083079|NCT00573157|10147047|FG001|COMPLETED|Overall Study||0
9083080|NCT00573157|10147046|FG000|NOT COMPLETED|Overall Study||4
9083081|NCT00573157|10147047|FG001|NOT COMPLETED|Overall Study||2
9083082|NCT00570531|10147053|FG000|STARTED|Overall Study||6
9083083|NCT00570531|10147053|FG000|COMPLETED|Overall Study||6
9083084|NCT00570531|10147053|FG000|NOT COMPLETED|Overall Study||0
9083085|NCT00566462|10147059|FG000|STARTED|Overall Study||1
9083086|NCT00566462|10147060|FG001|STARTED|Overall Study||0
9083087|NCT00566462|10147059|FG000|COMPLETED|Overall Study||1
9083088|NCT00566462|10147060|FG001|COMPLETED|Overall Study||0
9083089|NCT00566462|10147059|FG000|NOT COMPLETED|Overall Study||0
9083090|NCT00566462|10147060|FG001|NOT COMPLETED|Overall Study||0
9083091|NCT00561912|10147066|FG000|STARTED|Overall Study||2
9083092|NCT00561912|10147066|FG000|COMPLETED|Overall Study||1
9083093|NCT00561912|10147066|FG000|NOT COMPLETED|Overall Study||1
9083094|NCT00561795|10147072|FG000|STARTED|Overall Study||6
9083095|NCT00561795|10147073|FG001|STARTED|Overall Study||6
9083096|NCT00561795|10147074|FG002|STARTED|Overall Study||0
9083097|NCT00561795|10147075|FG003|STARTED|Overall Study||0
9083098|NCT00561795|10147072|FG000|COMPLETED|Overall Study||2
9083099|NCT00561795|10147073|FG001|COMPLETED|Overall Study||0
9083100|NCT00561795|10147074|FG002|COMPLETED|Overall Study||0
9083101|NCT00561795|10147075|FG003|COMPLETED|Overall Study||0
9083102|NCT00561795|10147072|FG000|NOT COMPLETED|Overall Study||4
9083103|NCT00561795|10147073|FG001|NOT COMPLETED|Overall Study||6
9083104|NCT00561795|10147074|FG002|NOT COMPLETED|Overall Study||0
9083105|NCT00561795|10147075|FG003|NOT COMPLETED|Overall Study||0
9083106|NCT00564876|10147083|FG000|STARTED|Overall Study||2
9083107|NCT00564876|10147083|FG000|COMPLETED|Overall Study||2
9083108|NCT00564876|10147083|FG000|NOT COMPLETED|Overall Study||0
9083109|NCT00558870|10147089|FG000|STARTED|Overall Study||2
9083110|NCT00558870|10147090|FG001|STARTED|Overall Study||2
9083111|NCT00558870|10147089|FG000|COMPLETED|Overall Study||2
9083112|NCT00558870|10147090|FG001|COMPLETED|Overall Study||2
9083113|NCT00558870|10147089|FG000|NOT COMPLETED|Overall Study||0
9083114|NCT00558870|10147090|FG001|NOT COMPLETED|Overall Study||0
9083115|NCT00559897|10147096|FG000|STARTED|Overall Study||6
9083116|NCT00559897|10147096|FG000|COMPLETED|Overall Study||6
9083117|NCT00559897|10147096|FG000|NOT COMPLETED|Overall Study||0
9083118|NCT00556400|10147102|FG000|STARTED|Overall Study||1
9083119|NCT00556400|10147103|FG001|STARTED|Overall Study||0
9083120|NCT00556400|10147102|FG000|COMPLETED|Overall Study||1
9083121|NCT00556400|10147103|FG001|COMPLETED|Overall Study||0
9083122|NCT00556400|10147102|FG000|NOT COMPLETED|Overall Study||0
9083123|NCT00556400|10147103|FG001|NOT COMPLETED|Overall Study||0
9083124|NCT00556075|10147111|FG000|STARTED|Overall Study||22
9083125|NCT00556075|10147112|FG001|STARTED|Overall Study||22
9083126|NCT00556075|10147113|FG002|STARTED|Overall Study||23
9083127|NCT00556075|10147111|FG000|COMPLETED|Overall Study||9
9083128|NCT00556075|10147112|FG001|COMPLETED|Overall Study||13
9083129|NCT00556075|10147113|FG002|COMPLETED|Overall Study||15
9083130|NCT00556075|10147111|FG000|NOT COMPLETED|Overall Study||13
9083131|NCT00556075|10147112|FG001|NOT COMPLETED|Overall Study||9
9083132|NCT00556075|10147113|FG002|NOT COMPLETED|Overall Study||8
9083133|NCT00556166|10147125|FG000|STARTED|Overall Study||4
9083134|NCT00556166|10147125|FG000|COMPLETED|Overall Study||3
9083135|NCT00556166|10147125|FG000|NOT COMPLETED|Overall Study||1
9083136|NCT00521924|10147131|FG000|STARTED|Overall Study|Subjects randomized|4
9083137|NCT00521924|10147132|FG001|STARTED|Overall Study|Subjects randomized|4
9083138|NCT00521924|10147131|FG000|COMPLETED|Overall Study|At Early Termination, 1 patient completed Week 2 and 2 patients completed Week 6.|0
9083139|NCT00521924|10147132|FG001|COMPLETED|Overall Study|At Early Termination, 3 patients completed Week 6 and 1 completed Week 22.|0
9083140|NCT00521924|10147131|FG000|NOT COMPLETED|Overall Study||4
9083141|NCT00521924|10147132|FG001|NOT COMPLETED|Overall Study||4
9083142|NCT00548886|10147138|FG000|STARTED|Overall Study||7
9083143|NCT00548886|10147138|FG000|COMPLETED|Overall Study||7
9083144|NCT00548886|10147138|FG000|NOT COMPLETED|Overall Study||0
9083145|NCT00547456|10147142|FG000|STARTED|Overall Study||20
9083146|NCT00547456|10147142|FG000|COMPLETED|Overall Study||20
9083147|NCT00547456|10147142|FG000|NOT COMPLETED|Overall Study||0
9083148|NCT00539838|10147149|FG000|STARTED|Overall Study||12
9083149|NCT00539838|10147150|FG001|STARTED|Overall Study||11
9083150|NCT00539838|10147151|FG002|STARTED|Overall Study||10
9083151|NCT00539838|10147149|FG000|COMPLETED|Overall Study||5
9083152|NCT00539838|10147150|FG001|COMPLETED|Overall Study||5
9083153|NCT00539838|10147151|FG002|COMPLETED|Overall Study||1
9083154|NCT00539838|10147149|FG000|NOT COMPLETED|Overall Study||7
9083155|NCT00539838|10147150|FG001|NOT COMPLETED|Overall Study||6
9083156|NCT00539838|10147151|FG002|NOT COMPLETED|Overall Study||9
9083157|NCT00549328|10147161|FG000|STARTED|Overall Study||14
9083158|NCT00549328|10147161|FG000|COMPLETED|Overall Study||0
9083159|NCT00549328|10147161|FG000|NOT COMPLETED|Overall Study||14
9083160|NCT00548327|10147167|FG000|STARTED|Overall Study||6
9083161|NCT00548327|10147168|FG001|STARTED|Overall Study||5
9083162|NCT00548327|10147167|FG000|COMPLETED|Overall Study||6
9083163|NCT00548327|10147168|FG001|COMPLETED|Overall Study|Patient randomized to receive placebo first. While on placebo, Adverse Event lead to discontinuation|4
9083164|NCT00548327|10147167|FG000|NOT COMPLETED|Overall Study||0
9083165|NCT00548327|10147168|FG001|NOT COMPLETED|Overall Study||1
9083166|NCT00542542|10147181|FG000|STARTED|Overall Study||44
9083167|NCT00542542|10147182|FG001|STARTED|Overall Study||44
9083168|NCT00542542|10147181|FG000|COMPLETED|Overall Study||44
9083169|NCT00542542|10147182|FG001|COMPLETED|Overall Study||44
9083170|NCT00542542|10147181|FG000|NOT COMPLETED|Overall Study||0
9083171|NCT00542542|10147182|FG001|NOT COMPLETED|Overall Study||0
9083172|NCT00545506|10147190|FG000|STARTED|Overall Study||3
9083173|NCT00545506|10147191|FG001|STARTED|Overall Study||3
9083174|NCT00545506|10147190|FG000|COMPLETED|Overall Study||3
9083175|NCT00545506|10147191|FG001|COMPLETED|Overall Study||3
9083176|NCT00545506|10147190|FG000|NOT COMPLETED|Overall Study||0
9083177|NCT00545506|10147191|FG001|NOT COMPLETED|Overall Study||0
9083178|NCT00547300|10147199|FG000|STARTED|Overall Study||25
9083179|NCT00547300|10147200|FG001|STARTED|Overall Study|Two (2) patients were randomized in error, but no study medication taken.|26
9083180|NCT00547300|10147199|FG000|COMPLETED|Overall Study|No patients completed because the study was administratively terminated.|0
9083181|NCT00547300|10147200|FG001|COMPLETED|Overall Study|No patients completed because the study was administratively terminated.|0
9083182|NCT00547300|10147199|FG000|NOT COMPLETED|Overall Study||25
9083183|NCT00547300|10147200|FG001|NOT COMPLETED|Overall Study||26
9083184|NCT00539617|10147206|FG000|STARTED|Pre-screening Period||7
9083185|NCT00539617|10147206|FG000|COMPLETED|Pre-screening Period||4
9083186|NCT00539617|10147206|FG000|NOT COMPLETED|Pre-screening Period||3
9083187|NCT00539617|10147206|FG000|STARTED|Run-In Period||4
9083188|NCT00539617|10147206|FG000|COMPLETED|Run-In Period||3
9083189|NCT00539617|10147206|FG000|NOT COMPLETED|Run-In Period||1
9083190|NCT00539617|10147206|FG000|STARTED|Treatment Period||3
9083191|NCT00539617|10147206|FG000|COMPLETED|Treatment Period||3
9083192|NCT00539617|10147206|FG000|NOT COMPLETED|Treatment Period||0
9083193|NCT00546455|10147212|FG000|STARTED|Overall Study||0
9083194|NCT00546455|10147213|FG001|STARTED|Overall Study||0
9083195|NCT00546455|10147212|FG000|COMPLETED|Overall Study||0
9083196|NCT00546455|10147213|FG001|COMPLETED|Overall Study||0
9083197|NCT00546455|10147212|FG000|NOT COMPLETED|Overall Study||0
9083198|NCT00546455|10147213|FG001|NOT COMPLETED|Overall Study||0
9083199|NCT00538980|10147219|FG000|STARTED|Overall Study||10
9083200|NCT00538980|10147219|FG000|COMPLETED|Overall Study||0
9083201|NCT00538980|10147219|FG000|NOT COMPLETED|Overall Study||10
9083202|NCT00540969|10147225|FG000|STARTED|Overall Study||2
9083203|NCT00540969|10147226|FG001|STARTED|Overall Study||1
9083204|NCT00540969|10147225|FG000|COMPLETED|Overall Study||2
9083205|NCT00540969|10147226|FG001|COMPLETED|Overall Study||1
9083206|NCT00540969|10147225|FG000|NOT COMPLETED|Overall Study||0
9083207|NCT00540969|10147226|FG001|NOT COMPLETED|Overall Study||0
9083208|NCT00535262|10147232|FG000|STARTED|Overall Study|3 patients were enrolled in the study. Data was collected for only two weeks before funding expired.|3
9083209|NCT00535262|10147232|FG000|COMPLETED|Overall Study|Pharmaceutical company withdrew supply of EmSam prematurely before protocol was complete.|0
9083210|NCT00535262|10147232|FG000|NOT COMPLETED|Overall Study||3
9083211|NCT00529464|10147239|FG000|STARTED|Overall Study||0
9083212|NCT00529464|10147240|FG001|STARTED|Overall Study||0
9083213|NCT00529464|10147241|FG002|STARTED|Overall Study||0
9083214|NCT00529464|10147239|FG000|COMPLETED|Overall Study||0
9083215|NCT00529464|10147240|FG001|COMPLETED|Overall Study||0
9083216|NCT00529464|10147241|FG002|COMPLETED|Overall Study||0
9083217|NCT00529464|10147239|FG000|NOT COMPLETED|Overall Study||0
9083218|NCT00529464|10147240|FG001|NOT COMPLETED|Overall Study||0
9083219|NCT00529464|10147241|FG002|NOT COMPLETED|Overall Study||0
9083220|NCT00537199|10147249|FG000|STARTED|Overall Study||1
9083221|NCT00537199|10147249|FG000|COMPLETED|Overall Study||0
9083222|NCT00537199|10147249|FG000|NOT COMPLETED|Overall Study||1
9083223|NCT00537446|10147253|FG000|STARTED|Overall Study||8
9083224|NCT00537446|10147253|FG000|COMPLETED|Overall Study||8
9083225|NCT00537446|10147253|FG000|NOT COMPLETED|Overall Study||0
9083226|NCT00536978|10147259|FG000|STARTED|Overall Study||22
9083227|NCT00536978|10147259|FG000|COMPLETED|Overall Study||0
9083228|NCT00536978|10147259|FG000|NOT COMPLETED|Overall Study||22
9083229|NCT00524485|10147263|FG000|STARTED|Overall Study||12
9083230|NCT00524485|10147263|FG000|COMPLETED|Overall Study||7
9083231|NCT00524485|10147263|FG000|NOT COMPLETED|Overall Study||5
9083232|NCT00533351|10147269|FG000|STARTED|Period 1||7
9083233|NCT00533351|10147270|FG001|STARTED|Period 1||2
9083234|NCT00533351|10147269|FG000|COMPLETED|Period 1||5
9083235|NCT00533351|10147270|FG001|COMPLETED|Period 1||1
9083236|NCT00533351|10147269|FG000|NOT COMPLETED|Period 1||2
9083237|NCT00533351|10147270|FG001|NOT COMPLETED|Period 1||1
9083238|NCT00533351|10147269|FG000|STARTED|Period 2||5
9083239|NCT00533351|10147270|FG001|STARTED|Period 2||1
9083240|NCT00533351|10147269|FG000|COMPLETED|Period 2||5
9083241|NCT00533351|10147270|FG001|COMPLETED|Period 2||1
9083242|NCT00533351|10147269|FG000|NOT COMPLETED|Period 2||0
9083243|NCT00533351|10147270|FG001|NOT COMPLETED|Period 2||0
9083244|NCT00533351|10147269|FG000|STARTED|Period 3|Three out of the five patients who completed Period 2 continued to Period 3|3
9083245|NCT00533351|10147270|FG001|STARTED|Period 3|No patients continued to Period 3|0
9083246|NCT00533351|10147269|FG000|COMPLETED|Period 3||3
9083247|NCT00533351|10147270|FG001|COMPLETED|Period 3||0
9083248|NCT00533351|10147269|FG000|NOT COMPLETED|Period 3||0
9083249|NCT00533351|10147270|FG001|NOT COMPLETED|Period 3||0
9083250|NCT00529282|10147278|FG000|STARTED|Overall Study||0
9083251|NCT00529282|10147279|FG001|STARTED|Overall Study||2
9083252|NCT00529282|10147278|FG000|COMPLETED|Overall Study||0
9083253|NCT00529282|10147279|FG001|COMPLETED|Overall Study||2
9083254|NCT00529282|10147278|FG000|NOT COMPLETED|Overall Study||0
9083255|NCT00529282|10147279|FG001|NOT COMPLETED|Overall Study||0
9083256|NCT00524134|10147285|FG000|STARTED|Overall Study||6
9083257|NCT00524134|10147285|FG000|COMPLETED|Overall Study||4
9083258|NCT00524134|10147285|FG000|NOT COMPLETED|Overall Study||2
9083259|NCT00527748|10147289|FG000|STARTED|Overall Study||26
9083260|NCT00527748|10147289|FG000|COMPLETED|Overall Study||23
9083261|NCT00527748|10147289|FG000|NOT COMPLETED|Overall Study||3
9083262|NCT00517699|10147293|FG000|STARTED|Overall Study||5
9083263|NCT00517699|10147293|FG000|COMPLETED|Overall Study||0
9083264|NCT00517699|10147293|FG000|NOT COMPLETED|Overall Study||5
9083265|NCT00528775|10147297|FG000|STARTED|Overall Study||6
9083266|NCT00528775|10147297|FG000|COMPLETED|Overall Study||5
9083267|NCT00528775|10147297|FG000|NOT COMPLETED|Overall Study||1
9083268|NCT00528437|10147301|FG000|STARTED|Overall Study||46
9083269|NCT00528437|10147301|FG000|COMPLETED|Overall Study||46
9083270|NCT00528437|10147301|FG000|NOT COMPLETED|Overall Study||0
9083271|NCT00524511|10147307|FG000|STARTED|Overall Study||68
9083272|NCT00524511|10147308|FG001|STARTED|Overall Study||68
9083273|NCT00524511|10147307|FG000|COMPLETED|Overall Study||64
9083274|NCT00524511|10147308|FG001|COMPLETED|Overall Study||61
9083275|NCT00524511|10147307|FG000|NOT COMPLETED|Overall Study||4
9083276|NCT00524511|10147308|FG001|NOT COMPLETED|Overall Study||7
9083277|NCT00517075|10147318|FG000|STARTED|Overall Study||0
9083278|NCT00517075|10147319|FG001|STARTED|Overall Study||0
9083279|NCT00517075|10147320|FG002|STARTED|Overall Study||0
9083280|NCT00517075|10147321|FG003|STARTED|Overall Study||0
9083281|NCT00517075|10147318|FG000|COMPLETED|Overall Study||0
9083282|NCT00517075|10147319|FG001|COMPLETED|Overall Study||0
9083283|NCT00517075|10147320|FG002|COMPLETED|Overall Study||0
9083284|NCT00517075|10147321|FG003|COMPLETED|Overall Study||0
9083285|NCT00517075|10147318|FG000|NOT COMPLETED|Overall Study||0
9083286|NCT00517075|10147319|FG001|NOT COMPLETED|Overall Study||0
9083287|NCT00517075|10147320|FG002|NOT COMPLETED|Overall Study||0
9083288|NCT00517075|10147321|FG003|NOT COMPLETED|Overall Study||0
8624610|NCT00501943|9663991|FG000|NOT COMPLETED|Overall Study||2
8624611|NCT00501943|9663992|FG001|NOT COMPLETED|Overall Study||3
9083289|NCT00527982|10147333|FG000|STARTED|Overall Study||1
9083290|NCT00527982|10147334|FG001|STARTED|Overall Study||0
9083291|NCT00527982|10147333|FG000|COMPLETED|Overall Study||0
9083292|NCT00527982|10147334|FG001|COMPLETED|Overall Study||0
9083293|NCT00527982|10147333|FG000|NOT COMPLETED|Overall Study||1
9083294|NCT00527982|10147334|FG001|NOT COMPLETED|Overall Study||0
9083295|NCT00524459|10147340|FG000|STARTED|Overall Study||6
9083296|NCT00524459|10147340|FG000|COMPLETED|Overall Study||4
9083297|NCT00524459|10147340|FG000|NOT COMPLETED|Overall Study||2
9083298|NCT00517361|10147344|FG000|STARTED|Overall Study||11
9083299|NCT00517361|10147344|FG000|COMPLETED|Overall Study|This study has been terminated due to poor accrual.|0
9083300|NCT00517361|10147344|FG000|NOT COMPLETED|Overall Study||11
9083301|NCT00523939|10147350|FG000|STARTED|Overall Study||2
9083302|NCT00523939|10147351|FG001|STARTED|Overall Study||2
9083303|NCT00523939|10147350|FG000|COMPLETED|Overall Study||2
9083304|NCT00523939|10147351|FG001|COMPLETED|Overall Study||2
9083305|NCT00523939|10147350|FG000|NOT COMPLETED|Overall Study||0
9083306|NCT00523939|10147351|FG001|NOT COMPLETED|Overall Study||0
9083307|NCT00522457|10147356|FG000|STARTED|Overall Study||19
9083308|NCT00522457|10147356|FG000|COMPLETED|Overall Study||1
9083309|NCT00522457|10147356|FG000|NOT COMPLETED|Overall Study||18
9083310|NCT00526331|10147360|FG000|STARTED|Overall Study||55
9083311|NCT00526331|10147360|FG000|COMPLETED|Overall Study||0
9083312|NCT00526331|10147360|FG000|NOT COMPLETED|Overall Study||55
9083313|NCT00519090|10147366|FG000|STARTED|Overall Study||2
9083314|NCT00519090|10147367|FG001|STARTED|Overall Study||4
9083315|NCT00519090|10147366|FG000|COMPLETED|Overall Study||2
9083316|NCT00519090|10147367|FG001|COMPLETED|Overall Study||4
9083317|NCT00519090|10147366|FG000|NOT COMPLETED|Overall Study||0
9083318|NCT00519090|10147367|FG001|NOT COMPLETED|Overall Study||0
9083319|NCT00524394|10147373|FG000|STARTED|Overall Study||2
9083320|NCT00524394|10147373|FG000|COMPLETED|Overall Study||1
9083321|NCT00524394|10147373|FG000|NOT COMPLETED|Overall Study||1
9083322|NCT00523809|10147377|FG000|STARTED|Overall Study||5
9083323|NCT00523809|10147377|FG000|COMPLETED|Overall Study||5
9083324|NCT00523809|10147377|FG000|NOT COMPLETED|Overall Study||0
9083325|NCT00522301|10147381|FG000|STARTED|Overall Study||6
9083326|NCT00522301|10147381|FG000|COMPLETED|Overall Study||0
9083327|NCT00522301|10147381|FG000|NOT COMPLETED|Overall Study||6
9083328|NCT00517192|10147387|FG000|STARTED|Overall Study||19
9083329|NCT00517192|10147388|FG001|STARTED|Overall Study||20
9083330|NCT00517192|10147387|FG000|COMPLETED|Overall Study||0
9083331|NCT00517192|10147388|FG001|COMPLETED|Overall Study||0
9083332|NCT00517192|10147387|FG000|NOT COMPLETED|Overall Study||19
9083333|NCT00517192|10147388|FG001|NOT COMPLETED|Overall Study||20
9083334|NCT00504985|10147394|FG000|STARTED|Overall Study||14
9083335|NCT00504985|10147394|FG000|COMPLETED|Overall Study||14
9083336|NCT00504985|10147394|FG000|NOT COMPLETED|Overall Study||0
9083337|NCT00503581|10147401|FG000|STARTED|Overall Study||3
9083338|NCT00503581|10147402|FG001|STARTED|Overall Study||4
9083339|NCT00503581|10147403|FG002|STARTED|Overall Study||2
9083340|NCT00503581|10147401|FG000|COMPLETED|Overall Study||0
9083341|NCT00503581|10147402|FG001|COMPLETED|Overall Study||0
9083342|NCT00503581|10147403|FG002|COMPLETED|Overall Study||0
9083343|NCT00503581|10147401|FG000|NOT COMPLETED|Overall Study||3
9083344|NCT00503581|10147402|FG001|NOT COMPLETED|Overall Study||4
9083345|NCT00503581|10147403|FG002|NOT COMPLETED|Overall Study||2
9083346|NCT00509600|10147411|FG000|STARTED|Overall Study||1
9083347|NCT00509600|10147411|FG000|COMPLETED|Overall Study||0
9083348|NCT00509600|10147411|FG000|NOT COMPLETED|Overall Study||1
9083349|NCT00515112|10147417|FG000|STARTED|Overall Study||3
9083350|NCT00515112|10147418|FG001|STARTED|Overall Study||3
9083351|NCT00515112|10147417|FG000|COMPLETED|Overall Study||0
9083352|NCT00515112|10147418|FG001|COMPLETED|Overall Study||0
9083353|NCT00515112|10147417|FG000|NOT COMPLETED|Overall Study||3
9083354|NCT00515112|10147418|FG001|NOT COMPLETED|Overall Study||3
9083355|NCT00508872|10147424|FG000|STARTED|Overall Study||2
9083356|NCT00508872|10147424|FG000|COMPLETED|Overall Study||0
9083357|NCT00508872|10147424|FG000|NOT COMPLETED|Overall Study||2
9083358|NCT00514813|10147432|FG000|STARTED|Overall Study||15
9083359|NCT00514813|10147433|FG001|STARTED|Overall Study||86
9083360|NCT00514813|10147434|FG002|STARTED|Overall Study||47
9083361|NCT00514813|10147435|FG003|STARTED|Overall Study||4
9083362|NCT00514813|10147432|FG000|COMPLETED|Overall Study||0
9083363|NCT00514813|10147433|FG001|COMPLETED|Overall Study||0
9083364|NCT00514813|10147434|FG002|COMPLETED|Overall Study||0
9083365|NCT00514813|10147435|FG003|COMPLETED|Overall Study||0
9083366|NCT00514813|10147432|FG000|NOT COMPLETED|Overall Study||15
9083367|NCT00514813|10147433|FG001|NOT COMPLETED|Overall Study||86
9083368|NCT00514813|10147434|FG002|NOT COMPLETED|Overall Study||47
9083369|NCT00514813|10147435|FG003|NOT COMPLETED|Overall Study||4
9083370|NCT00506064|10147447|FG000|STARTED|Overall Study||1
9083371|NCT00506064|10147448|FG001|STARTED|Overall Study||0
8624612|NCT00501969|9664000|FG000|STARTED|Overall Study||395
8624613|NCT00501969|9664000|FG000|COMPLETED|Overall Study||189
8624614|NCT00501969|9664000|FG000|NOT COMPLETED|Overall Study||206
8624615|NCT00501995|9664004|FG000|STARTED|Overall Study||6
8624616|NCT00501995|9664004|FG000|COMPLETED|Overall Study||5
8624617|NCT00501995|9664004|FG000|NOT COMPLETED|Overall Study||1
9083372|NCT00506064|10147447|FG000|COMPLETED|Overall Study||1
9083373|NCT00506064|10147448|FG001|COMPLETED|Overall Study||0
9083374|NCT00506064|10147447|FG000|NOT COMPLETED|Overall Study||0
8624618|NCT00502203|9664008|FG000|STARTED|Overall Study||23
8624619|NCT00502203|9664008|FG000|COMPLETED|Overall Study||22
9083375|NCT00506064|10147448|FG001|NOT COMPLETED|Overall Study||0
9083376|NCT00503880|10147454|FG000|STARTED|Overall Study||2
9083377|NCT00503880|10147455|FG001|STARTED|Overall Study||0
9083378|NCT00503880|10147456|FG002|STARTED|Overall Study||0
9083379|NCT00503880|10147457|FG003|STARTED|Overall Study||0
9083380|NCT00503880|10147458|FG004|STARTED|Overall Study||0
9083381|NCT00503880|10147454|FG000|COMPLETED|Overall Study||0
9083382|NCT00503880|10147455|FG001|COMPLETED|Overall Study||0
9083383|NCT00503880|10147456|FG002|COMPLETED|Overall Study||0
8624620|NCT00502203|9664008|FG000|NOT COMPLETED|Overall Study||1
9083384|NCT00503880|10147457|FG003|COMPLETED|Overall Study||0
9083385|NCT00503880|10147458|FG004|COMPLETED|Overall Study||0
9083386|NCT00503880|10147454|FG000|NOT COMPLETED|Overall Study||2
9083387|NCT00503880|10147455|FG001|NOT COMPLETED|Overall Study||0
9083388|NCT00503880|10147456|FG002|NOT COMPLETED|Overall Study||0
9083389|NCT00503880|10147457|FG003|NOT COMPLETED|Overall Study||0
9083390|NCT00503880|10147458|FG004|NOT COMPLETED|Overall Study||0
9083391|NCT00511329|10147464|FG000|STARTED|Overall Study||0
9083392|NCT00511329|10147464|FG000|COMPLETED|Overall Study||0
9083393|NCT00511329|10147464|FG000|NOT COMPLETED|Overall Study||0
9083394|NCT00501228|10147468|FG000|STARTED|Overall Study||2
9083395|NCT00501228|10147468|FG000|COMPLETED|Overall Study||1
9083396|NCT00501228|10147468|FG000|NOT COMPLETED|Overall Study||1
9083397|NCT00496782|10147474|FG000|STARTED|Overall Study||9
9083398|NCT00496782|10147475|FG001|STARTED|Overall Study||7
9083399|NCT00496782|10147474|FG000|COMPLETED|Overall Study||8
9083400|NCT00496782|10147475|FG001|COMPLETED|Overall Study||5
9083401|NCT00496782|10147474|FG000|NOT COMPLETED|Overall Study||1
9083402|NCT00496782|10147475|FG001|NOT COMPLETED|Overall Study||2
9083403|NCT00506909|10147481|FG000|STARTED|Overall Study||0
9083404|NCT00506909|10147481|FG000|COMPLETED|Overall Study||0
9083405|NCT00506909|10147481|FG000|NOT COMPLETED|Overall Study||0
9083406|NCT00487578|10147487|FG000|STARTED|Overall Study||3
9083407|NCT00487578|10147488|FG001|STARTED|Overall Study||9
9083408|NCT00487578|10147487|FG000|COMPLETED|Overall Study||2
9083409|NCT00487578|10147488|FG001|COMPLETED|Overall Study||5
9083410|NCT00487578|10147487|FG000|NOT COMPLETED|Overall Study||1
9083411|NCT00487578|10147488|FG001|NOT COMPLETED|Overall Study||4
9083412|NCT00503009|10147497|FG000|STARTED|Overall Study||5
9083413|NCT00503009|10147498|FG001|STARTED|Overall Study||5
9083414|NCT00503009|10147499|FG002|STARTED|Overall Study||6
9083415|NCT00503009|10147497|FG000|COMPLETED|Overall Study||4
9083416|NCT00503009|10147498|FG001|COMPLETED|Overall Study||3
9083417|NCT00503009|10147499|FG002|COMPLETED|Overall Study||3
9083418|NCT00503009|10147497|FG000|NOT COMPLETED|Overall Study||1
9083419|NCT00503009|10147498|FG001|NOT COMPLETED|Overall Study||2
9083420|NCT00503009|10147499|FG002|NOT COMPLETED|Overall Study||3
9083421|NCT00500045|10147507|FG000|STARTED|Overall Study||0
9083422|NCT00500045|10147507|FG000|COMPLETED|Overall Study||0
9083423|NCT00500045|10147507|FG000|NOT COMPLETED|Overall Study||0
9083424|NCT00499590|10147514|FG000|STARTED|Overall Study||113
9083425|NCT00499590|10147515|FG001|STARTED|Overall Study||112
9083426|NCT00499590|10147516|FG002|STARTED|Overall Study||113
9083427|NCT00499590|10147514|FG000|COMPLETED|Overall Study||0
9083428|NCT00499590|10147515|FG001|COMPLETED|Overall Study||0
9083429|NCT00499590|10147516|FG002|COMPLETED|Overall Study||0
9083430|NCT00499590|10147514|FG000|NOT COMPLETED|Overall Study||113
9083431|NCT00499590|10147515|FG001|NOT COMPLETED|Overall Study||112
9083432|NCT00499590|10147516|FG002|NOT COMPLETED|Overall Study||113
9083433|NCT00501345|10147525|FG000|STARTED|Overall Study||5
9083434|NCT00501345|10147525|FG000|COMPLETED|Overall Study||5
9083435|NCT00501345|10147525|FG000|NOT COMPLETED|Overall Study||0
9083436|NCT00496756|10147529|FG000|STARTED|Overall Study||14
9083437|NCT00496756|10147529|FG000|COMPLETED|Overall Study||11
9083438|NCT00496756|10147529|FG000|NOT COMPLETED|Overall Study||3
9083439|NCT00495716|10147535|FG000|STARTED|Overall Study||35
9083440|NCT00495716|10147536|FG001|STARTED|Overall Study||37
9083441|NCT00495716|10147535|FG000|COMPLETED|Overall Study||20
9083442|NCT00495716|10147536|FG001|COMPLETED|Overall Study||24
9083443|NCT00495716|10147535|FG000|NOT COMPLETED|Overall Study||15
9083444|NCT00495716|10147536|FG001|NOT COMPLETED|Overall Study||13
9083445|NCT00500890|10147544|FG000|STARTED|Overall Study||1
9083446|NCT00500890|10147545|FG001|STARTED|Overall Study||1
9083447|NCT00500890|10147544|FG000|COMPLETED|Overall Study||1
9083448|NCT00500890|10147545|FG001|COMPLETED|Overall Study||1
9083449|NCT00500890|10147544|FG000|NOT COMPLETED|Overall Study||0
9083450|NCT00500890|10147545|FG001|NOT COMPLETED|Overall Study||0
9083451|NCT00503841|10147551|FG000|STARTED|Overall Study||44
9083452|NCT00503841|10147551|FG000|COMPLETED|Overall Study||0
9083453|NCT00503841|10147551|FG000|NOT COMPLETED|Overall Study||44
9083454|NCT00493025|10147557|FG000|STARTED|Overall Study||19
9083455|NCT00493025|10147557|FG000|COMPLETED|Overall Study|Trial stopped due to early stopping rule|0
9083456|NCT00493025|10147557|FG000|NOT COMPLETED|Overall Study||19
9083457|NCT00491400|10147564|FG000|STARTED|Overall Study||15
9083458|NCT00491400|10147565|FG001|STARTED|Overall Study||13
9083459|NCT00491400|10147564|FG000|Started First Treatment|Overall Study|1 withdrew prior to starting fenofibrate|14
9083460|NCT00491400|10147565|FG001|Started First Treatment|Overall Study|None withdrew prior to starting atorvastatin|13
9083461|NCT00491400|10147564|FG000|Completed First Treatment|Overall Study|None withdrew during fenofibrate treatment (first treatment)|14
9083462|NCT00491400|10147565|FG001|Completed First Treatment|Overall Study|4 withdrew during atorvastatin treatment (first treatment)|9
9083463|NCT00491400|10147564|FG000|Started Second Treatment|Overall Study|2 withdrew during washout period|12
8624621|NCT00502216|9664014|FG000|STARTED|Overall Study||21
8624622|NCT00502216|9664015|FG001|STARTED|Overall Study||19
8624623|NCT00502216|9664014|FG000|COMPLETED|Overall Study||21
8624624|NCT00502216|9664015|FG001|COMPLETED|Overall Study||19
9083464|NCT00491400|10147565|FG001|Started Second Treatment|Overall Study|None withdrew during the washout period|9
9083465|NCT00491400|10147564|FG000|Finished Second Treatment|Overall Study|2 withdrew during atorvastatin treatment (second treatment)|10
9083466|NCT00491400|10147565|FG001|Finished Second Treatment|Overall Study|None withdrew during fenofibrate treatment (second treatment)|9
9083467|NCT00491400|10147564|FG000|COMPLETED|Overall Study||10
9083468|NCT00491400|10147565|FG001|COMPLETED|Overall Study||9
9083469|NCT00491400|10147564|FG000|NOT COMPLETED|Overall Study||5
9083470|NCT00491400|10147565|FG001|NOT COMPLETED|Overall Study||4
9083471|NCT00490776|10147573|FG000|STARTED|Overall Study||9
9083472|NCT00490776|10147573|FG000|COMPLETED|Overall Study||0
9083473|NCT00490776|10147573|FG000|NOT COMPLETED|Overall Study||9
9083474|NCT00487162|10147579|FG000|STARTED|Overall Study||30
9083475|NCT00487162|10147580|FG001|STARTED|Overall Study||26
9083476|NCT00487162|10147579|FG000|COMPLETED|Overall Study||28
9083477|NCT00487162|10147580|FG001|COMPLETED|Overall Study||21
9083478|NCT00487162|10147579|FG000|NOT COMPLETED|Overall Study||2
9083479|NCT00487162|10147580|FG001|NOT COMPLETED|Overall Study||5
9083480|NCT00487981|10147586|FG000|STARTED|Overall Study||1
9083481|NCT00487981|10147586|FG000|COMPLETED|Overall Study||0
9083482|NCT00487981|10147586|FG000|NOT COMPLETED|Overall Study||1
9083483|NCT00491387|10147590|FG000|STARTED|Overall Study||24
9083484|NCT00491387|10147590|FG000|Study Enrollment|Overall Study||24
9083485|NCT00491387|10147590|FG000|COMPLETED|Overall Study||4
9083486|NCT00491387|10147590|FG000|NOT COMPLETED|Overall Study||20
9083487|NCT00475332|10147594|FG000|STARTED|Overall Study||2
9083488|NCT00475332|10147594|FG000|COMPLETED|Overall Study||2
9083489|NCT00475332|10147594|FG000|NOT COMPLETED|Overall Study||0
9083490|NCT00483119|10147601|FG000|STARTED|Overall Study||5
9083491|NCT00483119|10147602|FG001|STARTED|Overall Study||4
9083492|NCT00483119|10147601|FG000|COMPLETED|Overall Study||4
9083493|NCT00483119|10147602|FG001|COMPLETED|Overall Study||3
9083494|NCT00483119|10147601|FG000|NOT COMPLETED|Overall Study||1
9083495|NCT00483119|10147602|FG001|NOT COMPLETED|Overall Study||1
9083496|NCT00487461|10147611|FG000|STARTED|Overall Study||2
9083497|NCT00487461|10147612|FG001|STARTED|Overall Study||12
9083498|NCT00487461|10147613|FG002|STARTED|Overall Study||11
9083499|NCT00487461|10147611|FG000|COMPLETED|Overall Study||2
9083500|NCT00487461|10147612|FG001|COMPLETED|Overall Study||10
9083501|NCT00487461|10147613|FG002|COMPLETED|Overall Study||7
9083502|NCT00487461|10147611|FG000|NOT COMPLETED|Overall Study||0
9083503|NCT00487461|10147612|FG001|NOT COMPLETED|Overall Study||2
9083504|NCT00487461|10147613|FG002|NOT COMPLETED|Overall Study||4
9083505|NCT00484718|10147621|FG000|STARTED|Treatment Period 1 (2 Weeks)||1
9083506|NCT00484718|10147622|FG001|STARTED|Treatment Period 1 (2 Weeks)||1
9083507|NCT00484718|10147623|FG002|STARTED|Treatment Period 1 (2 Weeks)||1
9083508|NCT00484718|10147624|FG003|STARTED|Treatment Period 1 (2 Weeks)||1
9083509|NCT00484718|10147625|FG004|STARTED|Treatment Period 1 (2 Weeks)||1
9083510|NCT00484718|10147626|FG005|STARTED|Treatment Period 1 (2 Weeks)||1
9083511|NCT00484718|10147621|FG000|COMPLETED|Treatment Period 1 (2 Weeks)||1
9083512|NCT00484718|10147622|FG001|COMPLETED|Treatment Period 1 (2 Weeks)||1
9083513|NCT00484718|10147623|FG002|COMPLETED|Treatment Period 1 (2 Weeks)||1
9083514|NCT00484718|10147624|FG003|COMPLETED|Treatment Period 1 (2 Weeks)||1
9083515|NCT00484718|10147625|FG004|COMPLETED|Treatment Period 1 (2 Weeks)||1
9083516|NCT00484718|10147626|FG005|COMPLETED|Treatment Period 1 (2 Weeks)||1
9083517|NCT00484718|10147621|FG000|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
9083518|NCT00484718|10147622|FG001|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
9083519|NCT00484718|10147623|FG002|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
9083520|NCT00484718|10147624|FG003|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
9083521|NCT00484718|10147625|FG004|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
9083522|NCT00484718|10147626|FG005|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
9083523|NCT00484718|10147621|FG000|STARTED|Washout Period (2 Weeks)||1
9083524|NCT00484718|10147622|FG001|STARTED|Washout Period (2 Weeks)||1
9083525|NCT00484718|10147623|FG002|STARTED|Washout Period (2 Weeks)||1
9083526|NCT00484718|10147624|FG003|STARTED|Washout Period (2 Weeks)||1
9083527|NCT00484718|10147625|FG004|STARTED|Washout Period (2 Weeks)||1
9083528|NCT00484718|10147626|FG005|STARTED|Washout Period (2 Weeks)||1
9083529|NCT00484718|10147621|FG000|COMPLETED|Washout Period (2 Weeks)||1
9083530|NCT00484718|10147622|FG001|COMPLETED|Washout Period (2 Weeks)||1
9083531|NCT00484718|10147623|FG002|COMPLETED|Washout Period (2 Weeks)||1
9083532|NCT00484718|10147624|FG003|COMPLETED|Washout Period (2 Weeks)||1
9083533|NCT00484718|10147625|FG004|COMPLETED|Washout Period (2 Weeks)||1
9083534|NCT00484718|10147626|FG005|COMPLETED|Washout Period (2 Weeks)||1
9083535|NCT00484718|10147621|FG000|NOT COMPLETED|Washout Period (2 Weeks)||0
9083536|NCT00484718|10147622|FG001|NOT COMPLETED|Washout Period (2 Weeks)||0
9083537|NCT00484718|10147623|FG002|NOT COMPLETED|Washout Period (2 Weeks)||0
9083538|NCT00484718|10147624|FG003|NOT COMPLETED|Washout Period (2 Weeks)||0
9083539|NCT00484718|10147625|FG004|NOT COMPLETED|Washout Period (2 Weeks)||0
9083540|NCT00484718|10147626|FG005|NOT COMPLETED|Washout Period (2 Weeks)||0
9083541|NCT00484718|10147621|FG000|STARTED|Treatment Period 2 (2 Weeks)||1
9083542|NCT00484718|10147622|FG001|STARTED|Treatment Period 2 (2 Weeks)||1
9083543|NCT00484718|10147623|FG002|STARTED|Treatment Period 2 (2 Weeks)||1
9083544|NCT00484718|10147624|FG003|STARTED|Treatment Period 2 (2 Weeks)||1
9083545|NCT00484718|10147625|FG004|STARTED|Treatment Period 2 (2 Weeks)||1
9083546|NCT00484718|10147626|FG005|STARTED|Treatment Period 2 (2 Weeks)||1
9083547|NCT00484718|10147621|FG000|COMPLETED|Treatment Period 2 (2 Weeks)||1
9083548|NCT00484718|10147622|FG001|COMPLETED|Treatment Period 2 (2 Weeks)||1
9083549|NCT00484718|10147623|FG002|COMPLETED|Treatment Period 2 (2 Weeks)||1
9083550|NCT00484718|10147624|FG003|COMPLETED|Treatment Period 2 (2 Weeks)||1
9083551|NCT00484718|10147625|FG004|COMPLETED|Treatment Period 2 (2 Weeks)||1
9083552|NCT00484718|10147626|FG005|COMPLETED|Treatment Period 2 (2 Weeks)||1
9083553|NCT00484718|10147621|FG000|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
9083554|NCT00484718|10147622|FG001|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
9083555|NCT00484718|10147623|FG002|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
9083556|NCT00484718|10147624|FG003|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
9083557|NCT00484718|10147625|FG004|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
9083558|NCT00484718|10147626|FG005|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
9083559|NCT00484718|10147621|FG000|STARTED|Washout Period (2 Weeks)||1
9083560|NCT00484718|10147622|FG001|STARTED|Washout Period (2 Weeks)||1
9083561|NCT00484718|10147623|FG002|STARTED|Washout Period (2 Weeks)||1
9083562|NCT00484718|10147624|FG003|STARTED|Washout Period (2 Weeks)||1
9083563|NCT00484718|10147625|FG004|STARTED|Washout Period (2 Weeks)||1
9083564|NCT00484718|10147626|FG005|STARTED|Washout Period (2 Weeks)||1
9083565|NCT00484718|10147621|FG000|COMPLETED|Washout Period (2 Weeks)||1
9083566|NCT00484718|10147622|FG001|COMPLETED|Washout Period (2 Weeks)||1
9083567|NCT00484718|10147623|FG002|COMPLETED|Washout Period (2 Weeks)||1
9083568|NCT00484718|10147624|FG003|COMPLETED|Washout Period (2 Weeks)||1
9083569|NCT00484718|10147625|FG004|COMPLETED|Washout Period (2 Weeks)||1
9083570|NCT00484718|10147626|FG005|COMPLETED|Washout Period (2 Weeks)||1
9083571|NCT00484718|10147621|FG000|NOT COMPLETED|Washout Period (2 Weeks)||0
9083572|NCT00484718|10147622|FG001|NOT COMPLETED|Washout Period (2 Weeks)||0
9083573|NCT00484718|10147623|FG002|NOT COMPLETED|Washout Period (2 Weeks)||0
9083574|NCT00484718|10147624|FG003|NOT COMPLETED|Washout Period (2 Weeks)||0
9083575|NCT00484718|10147625|FG004|NOT COMPLETED|Washout Period (2 Weeks)||0
9083576|NCT00484718|10147626|FG005|NOT COMPLETED|Washout Period (2 Weeks)||0
9083577|NCT00484718|10147621|FG000|STARTED|Treatment Period 3 (2 Weeks)||1
9083578|NCT00484718|10147622|FG001|STARTED|Treatment Period 3 (2 Weeks)||1
9083579|NCT00484718|10147623|FG002|STARTED|Treatment Period 3 (2 Weeks)||1
9083580|NCT00484718|10147624|FG003|STARTED|Treatment Period 3 (2 Weeks)||1
9083581|NCT00484718|10147625|FG004|STARTED|Treatment Period 3 (2 Weeks)||1
9083582|NCT00484718|10147626|FG005|STARTED|Treatment Period 3 (2 Weeks)||1
9083583|NCT00484718|10147621|FG000|COMPLETED|Treatment Period 3 (2 Weeks)||1
9083584|NCT00484718|10147622|FG001|COMPLETED|Treatment Period 3 (2 Weeks)||1
9083585|NCT00484718|10147623|FG002|COMPLETED|Treatment Period 3 (2 Weeks)||1
9083586|NCT00484718|10147624|FG003|COMPLETED|Treatment Period 3 (2 Weeks)||1
9083587|NCT00484718|10147625|FG004|COMPLETED|Treatment Period 3 (2 Weeks)||1
9083588|NCT00484718|10147626|FG005|COMPLETED|Treatment Period 3 (2 Weeks)||1
9083589|NCT00484718|10147621|FG000|NOT COMPLETED|Treatment Period 3 (2 Weeks)||0
9083590|NCT00484718|10147622|FG001|NOT COMPLETED|Treatment Period 3 (2 Weeks)||0
9083591|NCT00484718|10147623|FG002|NOT COMPLETED|Treatment Period 3 (2 Weeks)||0
9083592|NCT00484718|10147624|FG003|NOT COMPLETED|Treatment Period 3 (2 Weeks)||0
9083593|NCT00484718|10147625|FG004|NOT COMPLETED|Treatment Period 3 (2 Weeks)||0
9083594|NCT00484718|10147626|FG005|NOT COMPLETED|Treatment Period 3 (2 Weeks)||0
9083595|NCT00477230|10147636|FG000|STARTED|Overall Study||32
9083596|NCT00477230|10147637|FG001|STARTED|Overall Study||32
9083597|NCT00477230|10147636|FG000|COMPLETED|Overall Study||12
9083598|NCT00477230|10147637|FG001|COMPLETED|Overall Study||1
9083599|NCT00477230|10147636|FG000|NOT COMPLETED|Overall Study||20
9083600|NCT00477230|10147637|FG001|NOT COMPLETED|Overall Study||31
9083601|NCT00470067|10147643|FG000|STARTED|Overall Study||9
9083602|NCT00470067|10147643|FG000|COMPLETED|Overall Study||2
9083603|NCT00470067|10147643|FG000|NOT COMPLETED|Overall Study||7
9083604|NCT00476827|10147653|FG000|STARTED|Overall Study||3
9083605|NCT00476827|10147654|FG001|STARTED|Overall Study||0
9083606|NCT00476827|10147655|FG002|STARTED|Overall Study||1
9083607|NCT00476827|10147656|FG003|STARTED|Overall Study||0
9083608|NCT00476827|10147657|FG004|STARTED|Overall Study||2
9083609|NCT00476827|10147658|FG005|STARTED|Overall Study||2
9083610|NCT00476827|10147653|FG000|COMPLETED|Overall Study||3
9083611|NCT00476827|10147654|FG001|COMPLETED|Overall Study||0
9083612|NCT00476827|10147655|FG002|COMPLETED|Overall Study||1
9083613|NCT00476827|10147656|FG003|COMPLETED|Overall Study||0
9083614|NCT00476827|10147657|FG004|COMPLETED|Overall Study||2
9083615|NCT00476827|10147658|FG005|COMPLETED|Overall Study||2
9083616|NCT00476827|10147653|FG000|NOT COMPLETED|Overall Study||0
9083617|NCT00476827|10147654|FG001|NOT COMPLETED|Overall Study||0
9083618|NCT00476827|10147655|FG002|NOT COMPLETED|Overall Study||0
9083619|NCT00476827|10147656|FG003|NOT COMPLETED|Overall Study||0
9083620|NCT00476827|10147657|FG004|NOT COMPLETED|Overall Study||0
9083621|NCT00476827|10147658|FG005|NOT COMPLETED|Overall Study||0
9083622|NCT00475657|10147670|FG000|STARTED|Overall Study||5
9083623|NCT00475657|10147670|FG000|COMPLETED|Overall Study||1
9083624|NCT00475657|10147670|FG000|NOT COMPLETED|Overall Study||4
9083625|NCT00472082|10147674|FG000|STARTED|Overall Study||5
9083626|NCT00472082|10147674|FG000|COMPLETED|Overall Study||0
9083627|NCT00472082|10147674|FG000|NOT COMPLETED|Overall Study||5
9083628|NCT00478062|10147678|FG000|STARTED|Overall Study||1
9083629|NCT00478062|10147678|FG000|COMPLETED|Overall Study||1
9083630|NCT00478062|10147678|FG000|NOT COMPLETED|Overall Study||0
9083631|NCT00470574|10147682|FG000|STARTED|Overall Study||7
9083632|NCT00470574|10147682|FG000|COMPLETED|Overall Study||7
9083633|NCT00470574|10147682|FG000|NOT COMPLETED|Overall Study||0
9083634|NCT00467753|10147688|FG000|STARTED|Overall Study||3
9083635|NCT00467753|10147689|FG001|STARTED|Overall Study||2
9083636|NCT00467753|10147688|FG000|COMPLETED|Overall Study||0
9083637|NCT00467753|10147689|FG001|COMPLETED|Overall Study||0
9083638|NCT00467753|10147688|FG000|NOT COMPLETED|Overall Study||3
9083639|NCT00467753|10147689|FG001|NOT COMPLETED|Overall Study||2
9083640|NCT00456612|10147699|FG000|STARTED|Overall Study||4
9083641|NCT00456612|10147699|FG000|COMPLETED|Overall Study||1
9083642|NCT00456612|10147699|FG000|NOT COMPLETED|Overall Study||3
9083643|NCT00469612|10147706|FG000|STARTED|Overall Study||2
9083644|NCT00469612|10147707|FG001|STARTED|Overall Study||0
9083645|NCT00469612|10147706|FG000|COMPLETED|Overall Study|Subjects enrolled, but no data collected. Study terminated before data collection.|0
9083646|NCT00469612|10147707|FG001|COMPLETED|Overall Study||0
9083647|NCT00469612|10147706|FG000|NOT COMPLETED|Overall Study||2
9083648|NCT00469612|10147707|FG001|NOT COMPLETED|Overall Study||0
9083649|NCT00461812|10147713|FG000|STARTED|Overall Study||10
9083650|NCT00461812|10147713|FG000|COMPLETED|Overall Study||0
9083651|NCT00461812|10147713|FG000|NOT COMPLETED|Overall Study||10
9083652|NCT00459121|10147718|FG000|STARTED|Overall Study||2
9083653|NCT00459121|10147718|FG000|COMPLETED|Overall Study||2
9083654|NCT00459121|10147718|FG000|NOT COMPLETED|Overall Study||0
9083655|NCT00461682|10147723|FG000|STARTED|Overall Study||1
9083656|NCT00461682|10147723|FG000|COMPLETED|Overall Study||0
9083657|NCT00461682|10147723|FG000|NOT COMPLETED|Overall Study||1
9083658|NCT00462904|10147729|FG000|STARTED|Overall Study||4
9083659|NCT00462904|10147729|FG000|COMPLETED|Overall Study||3
9083660|NCT00462904|10147729|FG000|NOT COMPLETED|Overall Study||1
9083661|NCT00450333|10147737|FG000|STARTED|Overall Study||98
9083662|NCT00450333|10147738|FG001|STARTED|Overall Study||107
9083663|NCT00450333|10147739|FG002|STARTED|Overall Study||100
9083664|NCT00450333|10147740|FG003|STARTED|Overall Study||102
9083665|NCT00450333|10147737|FG000|COMPLETED|Overall Study||44
9083666|NCT00450333|10147738|FG001|COMPLETED|Overall Study||44
9083667|NCT00450333|10147739|FG002|COMPLETED|Overall Study||75
9083668|NCT00450333|10147740|FG003|COMPLETED|Overall Study||74
9083669|NCT00450333|10147737|FG000|NOT COMPLETED|Overall Study||54
9083670|NCT00450333|10147738|FG001|NOT COMPLETED|Overall Study||63
9083671|NCT00450333|10147739|FG002|NOT COMPLETED|Overall Study||25
9083672|NCT00450333|10147740|FG003|NOT COMPLETED|Overall Study||28
9083673|NCT00455143|10147750|FG000|STARTED|Overall Study||27
9083674|NCT00455143|10147750|FG000|COMPLETED|Overall Study||21
9083675|NCT00455143|10147750|FG000|NOT COMPLETED|Overall Study||6
9083676|NCT00456989|10147755|FG000|STARTED|Overall Study||39
9083677|NCT00456989|10147755|FG000|COMPLETED|Overall Study||39
9083678|NCT00456989|10147755|FG000|NOT COMPLETED|Overall Study||0
9083679|NCT00448682|10147760|FG000|STARTED|Overall Study||25
9083680|NCT00448682|10147760|FG000|COMPLETED|Overall Study||25
9083681|NCT00448682|10147760|FG000|NOT COMPLETED|Overall Study||0
9083682|NCT00454571|10147766|FG000|STARTED|Overall Study||18
9083683|NCT00454571|10147767|FG001|STARTED|Overall Study||19
9083684|NCT00454571|10147766|FG000|COMPLETED|Overall Study||5
9083685|NCT00454571|10147767|FG001|COMPLETED|Overall Study||13
9083686|NCT00454571|10147766|FG000|NOT COMPLETED|Overall Study||13
9083687|NCT00454571|10147767|FG001|NOT COMPLETED|Overall Study||6
9083688|NCT00452361|10147775|FG000|STARTED|Overall Study||21
9083689|NCT00452361|10147776|FG001|STARTED|Overall Study||10
9083690|NCT00452361|10147775|FG000|COMPLETED|Overall Study||0
9083691|NCT00452361|10147776|FG001|COMPLETED|Overall Study||0
9083692|NCT00452361|10147775|FG000|NOT COMPLETED|Overall Study||21
9083693|NCT00452361|10147776|FG001|NOT COMPLETED|Overall Study||10
9083694|NCT00443040|10147785|FG000|STARTED|Overall Study||14
9083695|NCT00443040|10147786|FG001|STARTED|Overall Study||11
9083696|NCT00443040|10147787|FG002|STARTED|Overall Study||10
9083697|NCT00443040|10147785|FG000|COMPLETED|Overall Study||10
9083698|NCT00443040|10147786|FG001|COMPLETED|Overall Study||11
9083699|NCT00443040|10147787|FG002|COMPLETED|Overall Study||9
9083700|NCT00443040|10147785|FG000|NOT COMPLETED|Overall Study||4
9083701|NCT00443040|10147786|FG001|NOT COMPLETED|Overall Study||0
9083702|NCT00443040|10147787|FG002|NOT COMPLETED|Overall Study||1
9083703|NCT00447421|10147795|FG000|STARTED|Overall Study||9
9083704|NCT00447421|10147795|FG000|COMPLETED|Overall Study||3
9083705|NCT00447421|10147795|FG000|NOT COMPLETED|Overall Study||6
9083706|NCT00441272|10147801|FG000|STARTED|Overall Study||25
9083707|NCT00441272|10147802|FG001|STARTED|Overall Study||25
9083708|NCT00441272|10147801|FG000|COMPLETED|Overall Study|Study terminated prior to enrollment.|0
9083709|NCT00441272|10147802|FG001|COMPLETED|Overall Study|Study terminated prior to enrollment.|0
9083710|NCT00441272|10147801|FG000|NOT COMPLETED|Overall Study||25
9083711|NCT00441272|10147802|FG001|NOT COMPLETED|Overall Study||25
9083712|NCT00437398|10147808|FG000|STARTED|Overall Study||2
9083713|NCT00437398|10147808|FG000|COMPLETED|Overall Study||2
9083714|NCT00437398|10147808|FG000|NOT COMPLETED|Overall Study||0
9083715|NCT00440271|10147814|FG000|STARTED|Overall Study||15
9083716|NCT00440271|10147815|FG001|STARTED|Overall Study||18
9083717|NCT00440271|10147814|FG000|COMPLETED|Overall Study||3
9083718|NCT00440271|10147815|FG001|COMPLETED|Overall Study||3
9083719|NCT00440271|10147814|FG000|NOT COMPLETED|Overall Study||12
9083720|NCT00440271|10147815|FG001|NOT COMPLETED|Overall Study||15
9083721|NCT00442260|10147821|FG000|STARTED|Overall Study||2
9083722|NCT00442260|10147821|FG000|COMPLETED|Overall Study||2
9083723|NCT00442260|10147821|FG000|NOT COMPLETED|Overall Study||0
9083724|NCT00429026|10147825|FG000|STARTED|Overall Study||40
9083725|NCT00429026|10147825|FG000|COMPLETED|Overall Study||0
9083726|NCT00429026|10147825|FG000|NOT COMPLETED|Overall Study||40
9083727|NCT00428207|10147829|FG000|STARTED|Overall Study||2
9083728|NCT00428207|10147830|FG001|STARTED|Overall Study||2
9083729|NCT00428207|10147829|FG000|COMPLETED|Overall Study||2
9083730|NCT00428207|10147830|FG001|COMPLETED|Overall Study||2
9083731|NCT00428207|10147829|FG000|NOT COMPLETED|Overall Study||0
9083732|NCT00428207|10147830|FG001|NOT COMPLETED|Overall Study||0
9083733|NCT00439569|10147836|FG000|STARTED|Cohort 1 (500 mg/kg/Day)||7
9083734|NCT00439569|10147836|FG000|COMPLETED|Cohort 1 (500 mg/kg/Day)||3
9083735|NCT00439569|10147836|FG000|NOT COMPLETED|Cohort 1 (500 mg/kg/Day)||4
9083736|NCT00439569|10147836|FG000|STARTED|Cohort 2 (500 mg/kg/Day)|2 new subjects in Cohort 2 were enrolled into the study after Cohort 1 completed the study.|2
9083737|NCT00439569|10147836|FG000|COMPLETED|Cohort 2 (500 mg/kg/Day)||1
9083738|NCT00439569|10147836|FG000|NOT COMPLETED|Cohort 2 (500 mg/kg/Day)||1
9083739|NCT00422669|10147843|FG000|STARTED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|98
9083740|NCT00422669|10147844|FG001|STARTED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|100
9083741|NCT00422669|10147845|FG002|STARTED|Overall Study||7
9083742|NCT00422669|10147843|FG000|COMPLETED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|0
9083743|NCT00422669|10147844|FG001|COMPLETED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|0
9083744|NCT00422669|10147845|FG002|COMPLETED|Overall Study||0
9083745|NCT00422669|10147843|FG000|NOT COMPLETED|Overall Study||98
9083746|NCT00422669|10147844|FG001|NOT COMPLETED|Overall Study||100
9083747|NCT00422669|10147845|FG002|NOT COMPLETED|Overall Study||7
9083748|NCT00432445|10147851|FG000|STARTED|Overall Study||2
9083749|NCT00432445|10147851|FG000|COMPLETED|Overall Study||2
9083750|NCT00432445|10147851|FG000|NOT COMPLETED|Overall Study||0
9083751|NCT00434590|10147857|FG000|STARTED|Overall Study||5
9083752|NCT00434590|10147858|FG001|STARTED|Overall Study||5
9083753|NCT00434590|10147857|FG000|COMPLETED|Overall Study|All patients randomized had study discontinued because of premature study termination.|0
9083754|NCT00434590|10147858|FG001|COMPLETED|Overall Study||0
9083755|NCT00434590|10147857|FG000|NOT COMPLETED|Overall Study||5
9083756|NCT00434590|10147858|FG001|NOT COMPLETED|Overall Study||5
9083757|NCT00424645|10147866|FG000|STARTED|Overall Study||3
9083758|NCT00424645|10147867|FG001|STARTED|Overall Study||0
9083759|NCT00424645|10147866|FG000|COMPLETED|Overall Study||2
9083760|NCT00424645|10147867|FG001|COMPLETED|Overall Study||0
9083761|NCT00424645|10147866|FG000|NOT COMPLETED|Overall Study||1
9083762|NCT00424645|10147867|FG001|NOT COMPLETED|Overall Study||0
9083763|NCT00430027|10147873|FG000|STARTED|Overall Study||8
9083764|NCT00430027|10147873|FG000|COMPLETED|Overall Study||0
9083765|NCT00430027|10147873|FG000|NOT COMPLETED|Overall Study||8
9083766|NCT00429858|10147877|FG000|STARTED|Overall Study||21
9083767|NCT00429858|10147877|FG000|COMPLETED|Overall Study||19
9083768|NCT00429858|10147877|FG000|NOT COMPLETED|Overall Study||2
9083769|NCT00425438|10147884|FG000|STARTED|Overall Study||25
9083770|NCT00425438|10147885|FG001|STARTED|Overall Study||27
9083771|NCT00425438|10147884|FG000|COMPLETED|Overall Study||0
9083772|NCT00425438|10147885|FG001|COMPLETED|Overall Study||0
9083773|NCT00425438|10147884|FG000|NOT COMPLETED|Overall Study||25
9083774|NCT00425438|10147885|FG001|NOT COMPLETED|Overall Study||27
9083775|NCT00421954|10147891|FG000|STARTED|Overall Study||0
9083776|NCT00421954|10147891|FG000|COMPLETED|Overall Study||0
9083777|NCT00421954|10147891|FG000|NOT COMPLETED|Overall Study||0
9083778|NCT00422942|10147895|FG000|STARTED|Overall Study||3
9083779|NCT00422942|10147895|FG000|COMPLETED|Overall Study||0
9083780|NCT00422942|10147895|FG000|NOT COMPLETED|Overall Study||3
9083781|NCT00409344|10147901|FG000|STARTED|Overall Study|No participants enrolled|0
9083782|NCT00409344|10147902|FG001|STARTED|Overall Study|No participants enrolled|0
9083783|NCT00409344|10147901|FG000|COMPLETED|Overall Study|No participants were enrolled to completion|0
9083784|NCT00409344|10147902|FG001|COMPLETED|Overall Study|No participants were enrolled to completion|0
9083785|NCT00409344|10147901|FG000|NOT COMPLETED|Overall Study||0
9083786|NCT00409344|10147902|FG001|NOT COMPLETED|Overall Study||0
9083787|NCT00414453|10147908|FG000|STARTED|Overall Study||19
9083788|NCT00414453|10147908|FG000|COMPLETED|Overall Study||3
9083789|NCT00414453|10147908|FG000|NOT COMPLETED|Overall Study||16
9083790|NCT00417248|10147918|FG000|STARTED|Overall Study||8
9083791|NCT00417248|10147918|FG000|COMPLETED|Overall Study||0
9083792|NCT00417248|10147918|FG000|NOT COMPLETED|Overall Study||8
9083793|NCT00418145|10147923|FG000|STARTED|Overall Study||16
9083794|NCT00418145|10147923|FG000|COMPLETED|Overall Study||10
9083795|NCT00418145|10147923|FG000|NOT COMPLETED|Overall Study||6
9083796|NCT00409331|10147929|FG000|STARTED|Overall Study||1
9083797|NCT00409331|10147929|FG000|COMPLETED|Overall Study||0
9083798|NCT00409331|10147929|FG000|NOT COMPLETED|Overall Study||1
9083799|NCT00392860|10147935|FG000|STARTED|Overall Study||3
9083800|NCT00392860|10147936|FG001|STARTED|Overall Study||0
9083801|NCT00392860|10147937|FG002|STARTED|Overall Study||1
9083802|NCT00392860|10147935|FG000|COMPLETED|Overall Study||3
9083803|NCT00392860|10147936|FG001|COMPLETED|Overall Study||0
9083804|NCT00392860|10147937|FG002|COMPLETED|Overall Study||1
9083805|NCT00392860|10147935|FG000|NOT COMPLETED|Overall Study||0
9083806|NCT00392860|10147936|FG001|NOT COMPLETED|Overall Study||0
9083807|NCT00392860|10147937|FG002|NOT COMPLETED|Overall Study||0
9083808|NCT00391430|10147946|FG000|STARTED|Overall Study||8
9083809|NCT00391430|10147947|FG001|STARTED|Overall Study||0
9083810|NCT00391430|10147948|FG002|STARTED|Overall Study||31
9083811|NCT00391430|10147946|FG000|COMPLETED|Overall Study||5
9083812|NCT00391430|10147947|FG001|COMPLETED|Overall Study||0
9083813|NCT00391430|10147948|FG002|COMPLETED|Overall Study||19
9083814|NCT00391430|10147946|FG000|NOT COMPLETED|Overall Study||3
9083815|NCT00391430|10147947|FG001|NOT COMPLETED|Overall Study||0
9083816|NCT00391430|10147948|FG002|NOT COMPLETED|Overall Study||12
9083817|NCT00399841|10147956|FG000|STARTED|Overall Study||13
9083818|NCT00399841|10147957|FG001|STARTED|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
9083819|NCT00399841|10147958|FG002|STARTED|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
9083820|NCT00399841|10147956|FG000|Permanent Implant|Overall Study||6
9083821|NCT00399841|10147957|FG001|Permanent Implant|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
9083822|NCT00399841|10147958|FG002|Permanent Implant|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
9083823|NCT00399841|10147956|FG000|12-week|Overall Study||2
9083824|NCT00399841|10147957|FG001|12-week|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
9083825|NCT00399841|10147958|FG002|12-week|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
9083826|NCT00399841|10147956|FG000|COMPLETED|Overall Study||1
9083827|NCT00399841|10147957|FG001|COMPLETED|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
9083828|NCT00399841|10147958|FG002|COMPLETED|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
9083829|NCT00399841|10147956|FG000|NOT COMPLETED|Overall Study||12
9083830|NCT00399841|10147957|FG001|NOT COMPLETED|Overall Study||0
9083831|NCT00399841|10147958|FG002|NOT COMPLETED|Overall Study||0
9083832|NCT00387673|10147963|FG000|STARTED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
8844682|NCT01711359|9899132|FG000|STARTED|Treatment Period||213
8844683|NCT01711359|9899133|FG001|STARTED|Treatment Period||160
8844684|NCT01711359|9899134|FG002|STARTED|Treatment Period||215
9083833|NCT00387673|10147964|FG001|STARTED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
9083834|NCT00387673|10147965|FG002|STARTED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
9083835|NCT00387673|10147963|FG000|COMPLETED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
9083836|NCT00387673|10147964|FG001|COMPLETED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
9083837|NCT00387673|10147965|FG002|COMPLETED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
9083838|NCT00387673|10147963|FG000|NOT COMPLETED|Overall Study||0
9083839|NCT00387673|10147964|FG001|NOT COMPLETED|Overall Study||0
9083840|NCT00387673|10147965|FG002|NOT COMPLETED|Overall Study||0
9083841|NCT00386724|10147971|FG000|STARTED|Overall Study||8
9083842|NCT00386724|10147971|FG000|3 Months Post-activation|Overall Study||4
9083843|NCT00386724|10147971|FG000|COMPLETED|Overall Study||3
9083844|NCT00386724|10147971|FG000|NOT COMPLETED|Overall Study||5
9083845|NCT00387244|10147975|FG000|STARTED|Overall Study||7
9083846|NCT00387244|10147975|FG000|End of Trial|Overall Study||0
9083847|NCT00387244|10147975|FG000|COMPLETED|Overall Study||0
9083848|NCT00387244|10147975|FG000|NOT COMPLETED|Overall Study||7
9083849|NCT00384293|10147981|FG000|STARTED|MK0524A Active Run-In, Pre-randomization||937
9083850|NCT00384293|10147982|FG001|STARTED|MK0524A Active Run-In, Pre-randomization||0
9083851|NCT00384293|10147983|FG002|STARTED|MK0524A Active Run-In, Pre-randomization||0
9083852|NCT00384293|10147981|FG000|Entered Active run-in, MK0524A 1 g|MK0524A Active Run-In, Pre-randomization|Entered active run-in period and received MK0524A 1 g|937
9083853|NCT00384293|10147982|FG001|Entered Active run-in, MK0524A 1 g|MK0524A Active Run-In, Pre-randomization||0
9083854|NCT00384293|10147983|FG002|Entered Active run-in, MK0524A 1 g|MK0524A Active Run-In, Pre-randomization||0
9083855|NCT00384293|10147981|FG000|MK0524A Dose Increased to 2 g|MK0524A Active Run-In, Pre-randomization|MK0524A dose increased to 2 g in active run-in period|813
9083856|NCT00384293|10147982|FG001|MK0524A Dose Increased to 2 g|MK0524A Active Run-In, Pre-randomization||0
9083857|NCT00384293|10147983|FG002|MK0524A Dose Increased to 2 g|MK0524A Active Run-In, Pre-randomization||0
9083858|NCT00384293|10147981|FG000|COMPLETED|MK0524A Active Run-In, Pre-randomization||433
9083859|NCT00384293|10147982|FG001|COMPLETED|MK0524A Active Run-In, Pre-randomization||0
9083860|NCT00384293|10147983|FG002|COMPLETED|MK0524A Active Run-In, Pre-randomization||0
9083861|NCT00384293|10147981|FG000|NOT COMPLETED|MK0524A Active Run-In, Pre-randomization||504
9083862|NCT00384293|10147982|FG001|NOT COMPLETED|MK0524A Active Run-In, Pre-randomization||0
9083863|NCT00384293|10147983|FG002|NOT COMPLETED|MK0524A Active Run-In, Pre-randomization||0
9083864|NCT00384293|10147981|FG000|STARTED|Post-randomization Period||0
9083865|NCT00384293|10147982|FG001|STARTED|Post-randomization Period||214
9083866|NCT00384293|10147983|FG002|STARTED|Post-randomization Period||219
9083867|NCT00384293|10147981|FG000|Received ≥1 Dose of MK0524A Study Drug|Post-randomization Period||0
9083868|NCT00384293|10147982|FG001|Received ≥1 Dose of MK0524A Study Drug|Post-randomization Period|Received at least one dose of randomized study drug (All Patients as Treated Population)|214
9083869|NCT00384293|10147983|FG002|Received ≥1 Dose of MK0524A Study Drug|Post-randomization Period||218
9083870|NCT00384293|10147981|FG000|COMPLETED|Post-randomization Period||0
9083871|NCT00384293|10147982|FG001|COMPLETED|Post-randomization Period||0
9083872|NCT00384293|10147983|FG002|COMPLETED|Post-randomization Period||0
9083873|NCT00384293|10147981|FG000|NOT COMPLETED|Post-randomization Period||0
9083874|NCT00384293|10147982|FG001|NOT COMPLETED|Post-randomization Period||214
9083875|NCT00384293|10147983|FG002|NOT COMPLETED|Post-randomization Period||219
9083876|NCT00383630|10147991|FG000|STARTED|Overall Study||1
9083877|NCT00383630|10147991|FG000|COMPLETED|Overall Study||1
9083878|NCT00383630|10147991|FG000|NOT COMPLETED|Overall Study||0
9083879|NCT00374543|10147997|FG000|STARTED|Overall Study||2
9083880|NCT00374543|10147998|FG001|STARTED|Overall Study||1
8624625|NCT00502216|9664014|FG000|NOT COMPLETED|Overall Study||0
8624626|NCT00502216|9664015|FG001|NOT COMPLETED|Overall Study||0
8624627|NCT00502242|9664023|FG000|STARTED|Overall Study||155
9083881|NCT00374543|10147997|FG000|COMPLETED|Overall Study||2
9083882|NCT00374543|10147998|FG001|COMPLETED|Overall Study||1
8844685|NCT01711359|9899132|FG000|Received at Least One Dose of Study Drug|Treatment Period||210
8844686|NCT01711359|9899133|FG001|Received at Least One Dose of Study Drug|Treatment Period||159
9083883|NCT00374543|10147997|FG000|NOT COMPLETED|Overall Study||0
9083884|NCT00374543|10147998|FG001|NOT COMPLETED|Overall Study||0
9083885|NCT00377455|10148004|FG000|STARTED|Overall Study||5
9083886|NCT00377455|10148004|FG000|COMPLETED|Overall Study||4
9083887|NCT00377455|10148004|FG000|NOT COMPLETED|Overall Study||1
9083888|NCT00371462|10148010|FG000|STARTED|Overall Study||35
9083889|NCT00371462|10148011|FG001|STARTED|Overall Study||35
9083890|NCT00371462|10148010|FG000|COMPLETED|Overall Study||27
9083891|NCT00371462|10148011|FG001|COMPLETED|Overall Study||27
9083892|NCT00371462|10148010|FG000|NOT COMPLETED|Overall Study||8
9083893|NCT00371462|10148011|FG001|NOT COMPLETED|Overall Study||8
9083894|NCT00369265|10148019|FG000|STARTED|Overall Study||4
9083895|NCT00369265|10148020|FG001|STARTED|Overall Study||7
9083896|NCT00369265|10148019|FG000|COMPLETED|Overall Study||0
9083897|NCT00369265|10148020|FG001|COMPLETED|Overall Study||0
9083898|NCT00369265|10148019|FG000|NOT COMPLETED|Overall Study||4
9083899|NCT00369265|10148020|FG001|NOT COMPLETED|Overall Study||7
9083900|NCT00370695|10148026|FG000|STARTED|Overall Study||15
9083901|NCT00370695|10148026|FG000|12 Weeks Post-activation|Overall Study||2
9083902|NCT00370695|10148026|FG000|COMPLETED|Overall Study||0
9083903|NCT00370695|10148026|FG000|NOT COMPLETED|Overall Study||15
9083904|NCT00364689|10148033|FG000|STARTED|Overall Study||13
9083905|NCT00364689|10148033|FG000|COMPLETED|Overall Study||12
9083906|NCT00364689|10148033|FG000|NOT COMPLETED|Overall Study||1
9083907|NCT00352118|10148039|FG000|STARTED|Overall Study||4
9083908|NCT00352118|10148039|FG000|COMPLETED|Overall Study||0
9083909|NCT00352118|10148039|FG000|NOT COMPLETED|Overall Study||4
9083910|NCT00368654|10148047|FG000|STARTED|Overall Study||3
8624628|NCT00502242|9664024|FG001|STARTED|Overall Study||140
8624629|NCT00502242|9664023|FG000|COMPLETED|Overall Study||104
8624630|NCT00502242|9664024|FG001|COMPLETED|Overall Study||84
9083911|NCT00368654|10148048|FG001|STARTED|Overall Study||3
9083912|NCT00368654|10148049|FG002|STARTED|Overall Study||3
9083913|NCT00368654|10148050|FG003|STARTED|Overall Study||3
9083914|NCT00368654|10148047|FG000|COMPLETED|Overall Study||0
9083915|NCT00368654|10148048|FG001|COMPLETED|Overall Study||0
9083916|NCT00368654|10148049|FG002|COMPLETED|Overall Study||0
9083917|NCT00368654|10148050|FG003|COMPLETED|Overall Study||0
9083918|NCT00368654|10148047|FG000|NOT COMPLETED|Overall Study||3
9083919|NCT00368654|10148048|FG001|NOT COMPLETED|Overall Study||3
9083920|NCT00368654|10148049|FG002|NOT COMPLETED|Overall Study||3
9083921|NCT00368654|10148050|FG003|NOT COMPLETED|Overall Study||3
9083922|NCT00356421|10148062|FG000|STARTED|Overall Study||38
9083923|NCT00356421|10148063|FG001|STARTED|Overall Study||20
9083924|NCT00356421|10148062|FG000|COMPLETED|Overall Study||6
9083925|NCT00356421|10148063|FG001|COMPLETED|Overall Study||3
9083926|NCT00356421|10148062|FG000|NOT COMPLETED|Overall Study||32
9083927|NCT00356421|10148063|FG001|NOT COMPLETED|Overall Study||17
9083928|NCT00350623|10148072|FG000|STARTED|Overall Study||71
8624631|NCT00502242|9664023|FG000|NOT COMPLETED|Overall Study||51
8624632|NCT00502242|9664024|FG001|NOT COMPLETED|Overall Study||56
8624633|NCT00502307|9664030|FG000|STARTED|Open Label Period (16 Weeks)||272
8624634|NCT00502307|9664031|FG001|STARTED|Open Label Period (16 Weeks)||0
8624635|NCT00502307|9664032|FG002|STARTED|Open Label Period (16 Weeks)||0
8624636|NCT00502307|9664030|FG000|COMPLETED|Open Label Period (16 Weeks)||196
8624637|NCT00502307|9664031|FG001|COMPLETED|Open Label Period (16 Weeks)||0
8624638|NCT00502307|9664032|FG002|COMPLETED|Open Label Period (16 Weeks)||0
8624639|NCT00502307|9664030|FG000|NOT COMPLETED|Open Label Period (16 Weeks)||76
8624640|NCT00502307|9664031|FG001|NOT COMPLETED|Open Label Period (16 Weeks)||0
8624641|NCT00502307|9664032|FG002|NOT COMPLETED|Open Label Period (16 Weeks)||0
8624642|NCT00502307|9664030|FG000|STARTED|Double-Blind Period (12 Weeks)||0
8624643|NCT00502307|9664031|FG001|STARTED|Double-Blind Period (12 Weeks)||61
8624644|NCT00502307|9664032|FG002|STARTED|Double-Blind Period (12 Weeks)||57
8624645|NCT00502307|9664030|FG000|COMPLETED|Double-Blind Period (12 Weeks)||0
8624646|NCT00502307|9664031|FG001|COMPLETED|Double-Blind Period (12 Weeks)||35
8624647|NCT00502307|9664032|FG002|COMPLETED|Double-Blind Period (12 Weeks)||48
9083929|NCT00350623|10148073|FG001|STARTED|Overall Study||71
9083930|NCT00350623|10148074|FG002|STARTED|Overall Study||68
9083931|NCT00350623|10148072|FG000|COMPLETED|Overall Study||63
9083932|NCT00350623|10148073|FG001|COMPLETED|Overall Study||67
9083933|NCT00350623|10148074|FG002|COMPLETED|Overall Study||62
9083934|NCT00350623|10148072|FG000|NOT COMPLETED|Overall Study||8
9083935|NCT00350623|10148073|FG001|NOT COMPLETED|Overall Study||4
9083936|NCT00350623|10148074|FG002|NOT COMPLETED|Overall Study||6
9083937|NCT00356187|10148084|FG000|STARTED|Overall Study||0
9083938|NCT00356187|10148085|FG001|STARTED|Overall Study||0
9083939|NCT00356187|10148084|FG000|COMPLETED|Overall Study||0
9083940|NCT00356187|10148085|FG001|COMPLETED|Overall Study||0
9083941|NCT00356187|10148084|FG000|NOT COMPLETED|Overall Study||0
8624648|NCT00502307|9664030|FG000|NOT COMPLETED|Double-Blind Period (12 Weeks)||0
8624649|NCT00502307|9664031|FG001|NOT COMPLETED|Double-Blind Period (12 Weeks)||26
8624650|NCT00502307|9664032|FG002|NOT COMPLETED|Double-Blind Period (12 Weeks)||9
8624651|NCT00502307|9664030|FG000|STARTED|Maintenance Period||148
9083942|NCT00356187|10148085|FG001|NOT COMPLETED|Overall Study||0
9083943|NCT00353275|10148095|FG000|STARTED|Overall Study||2
9083944|NCT00353275|10148096|FG001|STARTED|Overall Study||3
9083945|NCT00353275|10148095|FG000|COMPLETED|Overall Study||2
9083946|NCT00353275|10148096|FG001|COMPLETED|Overall Study||3
9083947|NCT00353275|10148095|FG000|NOT COMPLETED|Overall Study||0
9083948|NCT00353275|10148096|FG001|NOT COMPLETED|Overall Study||0
9083949|NCT00350844|10148102|FG000|STARTED|Overall Study||6
9083950|NCT00350844|10148102|FG000|COMPLETED|Overall Study||5
9083951|NCT00350844|10148102|FG000|NOT COMPLETED|Overall Study||1
9083952|NCT00348556|10148106|FG000|STARTED|Overall Study||4
9083953|NCT00348556|10148106|FG000|COMPLETED|Overall Study||3
9083954|NCT00348556|10148106|FG000|NOT COMPLETED|Overall Study||1
9083955|NCT00319839|10148110|FG000|STARTED|Overall Study||7
9083956|NCT00319839|10148110|FG000|COMPLETED|Overall Study||1
9083957|NCT00319839|10148110|FG000|NOT COMPLETED|Overall Study||6
9083958|NCT00344019|10148117|FG000|STARTED|Overall Study||12
9083959|NCT00344019|10148118|FG001|STARTED|Overall Study||11
9083960|NCT00344019|10148119|FG002|STARTED|Overall Study||74
9083961|NCT00344019|10148117|FG000|COMPLETED|Overall Study||12
9083962|NCT00344019|10148118|FG001|COMPLETED|Overall Study||11
9083963|NCT00344019|10148119|FG002|COMPLETED|Overall Study||0
9083964|NCT00344019|10148117|FG000|NOT COMPLETED|Overall Study||0
9083965|NCT00344019|10148118|FG001|NOT COMPLETED|Overall Study||0
9083966|NCT00344019|10148119|FG002|NOT COMPLETED|Overall Study||74
9083967|NCT00338455|10148132|FG000|STARTED|Overall Study||9
9083968|NCT00338455|10148133|FG001|STARTED|Overall Study||7
9083969|NCT00338455|10148132|FG000|Administered Study Drug|Overall Study||8
9083970|NCT00338455|10148133|FG001|Administered Study Drug|Overall Study||7
9083971|NCT00338455|10148132|FG000|COMPLETED|Overall Study||6
9083972|NCT00338455|10148133|FG001|COMPLETED|Overall Study||6
9083973|NCT00338455|10148132|FG000|NOT COMPLETED|Overall Study||3
9083974|NCT00338455|10148133|FG001|NOT COMPLETED|Overall Study||1
9083975|NCT00329108|10148141|FG000|STARTED|Overall Study|study terminated due to poor recruitment|15
9083976|NCT00329108|10148142|FG001|STARTED|Overall Study|study terminated due to poor recruitment|14
9083977|NCT00329108|10148141|FG000|COMPLETED|Overall Study||5
9083978|NCT00329108|10148142|FG001|COMPLETED|Overall Study||2
9083979|NCT00329108|10148141|FG000|NOT COMPLETED|Overall Study||10
9083980|NCT00329108|10148142|FG001|NOT COMPLETED|Overall Study||12
9083981|NCT00325572|10148150|FG000|STARTED|PHASE I||45
9083982|NCT00325572|10148151|FG001|STARTED|PHASE I||44
9083983|NCT00325572|10148150|FG000|COMPLETED|PHASE I||45
9083984|NCT00325572|10148151|FG001|COMPLETED|PHASE I||44
9083985|NCT00325572|10148150|FG000|NOT COMPLETED|PHASE I||0
9083986|NCT00325572|10148151|FG001|NOT COMPLETED|PHASE I||0
9083987|NCT00325572|10148150|FG000|STARTED|PHASE ii||0
9083988|NCT00325572|10148151|FG001|STARTED|PHASE ii||0
9083989|NCT00325572|10148150|FG000|COMPLETED|PHASE ii||0
9083990|NCT00325572|10148151|FG001|COMPLETED|PHASE ii||0
9083991|NCT00325572|10148150|FG000|NOT COMPLETED|PHASE ii||0
9083992|NCT00325572|10148151|FG001|NOT COMPLETED|PHASE ii||0
9083993|NCT00333762|10148157|FG000|STARTED|Overall Study||4
9083994|NCT00333762|10148157|FG000|COMPLETED|Overall Study||0
9083995|NCT00333762|10148157|FG000|NOT COMPLETED|Overall Study||4
9083996|NCT00333229|10148163|FG000|STARTED|Overall Study||6
9083997|NCT00333229|10148164|FG001|STARTED|Overall Study||5
9083998|NCT00333229|10148163|FG000|COMPLETED|Overall Study||6
9083999|NCT00333229|10148164|FG001|COMPLETED|Overall Study||4
9084000|NCT00333229|10148163|FG000|NOT COMPLETED|Overall Study||0
9084001|NCT00333229|10148164|FG001|NOT COMPLETED|Overall Study||1
9084002|NCT00322855|10148170|FG000|STARTED|Overall Study||1
9084003|NCT00322855|10148170|FG000|COMPLETED|Overall Study||1
9084004|NCT00322855|10148170|FG000|NOT COMPLETED|Overall Study||0
9084005|NCT00323635|10148176|FG000|STARTED|Overall Study||10
9084006|NCT00323635|10148177|FG001|STARTED|Overall Study||9
9084007|NCT00323635|10148176|FG000|COMPLETED|Overall Study||10
9084008|NCT00323635|10148177|FG001|COMPLETED|Overall Study||9
9084009|NCT00323635|10148176|FG000|NOT COMPLETED|Overall Study||0
9084010|NCT00323635|10148177|FG001|NOT COMPLETED|Overall Study||0
9084011|NCT00329732|10148187|FG000|STARTED|Overall Study||2
9084012|NCT00329732|10148188|FG001|STARTED|Overall Study||0
9084013|NCT00329732|10148187|FG000|COMPLETED|Overall Study||2
9084014|NCT00329732|10148188|FG001|COMPLETED|Overall Study||0
9084015|NCT00329732|10148187|FG000|NOT COMPLETED|Overall Study||0
9084016|NCT00329732|10148188|FG001|NOT COMPLETED|Overall Study||0
9084017|NCT00320931|10148193|FG000|STARTED|Overall Study||30
9084018|NCT00320931|10148193|FG000|COMPLETED|Overall Study||30
9084019|NCT00320931|10148193|FG000|NOT COMPLETED|Overall Study||0
9084020|NCT00314353|10148199|FG000|STARTED|Protocol Therapy (8 Cycles)||4
9084021|NCT00314353|10148200|FG001|STARTED|Protocol Therapy (8 Cycles)||3
9084022|NCT00314353|10148199|FG000|COMPLETED|Protocol Therapy (8 Cycles)|COMPLETED refers to the participants completing 8 cycles of therapy.|2
9084023|NCT00314353|10148200|FG001|COMPLETED|Protocol Therapy (8 Cycles)|COMPLETED refers to the participants completing 8 cycles of therapy.|0
9084024|NCT00314353|10148199|FG000|NOT COMPLETED|Protocol Therapy (8 Cycles)||2
9084025|NCT00314353|10148200|FG001|NOT COMPLETED|Protocol Therapy (8 Cycles)||3
9084026|NCT00314353|10148199|FG000|STARTED|Follow-up|2 participants who completed 8 cycles plus 1 participant who did not complete 8 cycles therapy.|3
9084027|NCT00314353|10148200|FG001|STARTED|Follow-up||0
9084028|NCT00314353|10148199|FG000|COMPLETED|Follow-up||3
9084029|NCT00314353|10148200|FG001|COMPLETED|Follow-up||0
9084030|NCT00314353|10148199|FG000|NOT COMPLETED|Follow-up||0
9084031|NCT00314353|10148200|FG001|NOT COMPLETED|Follow-up||0
9084032|NCT00314093|10148206|FG000|STARTED|Overall Study||0
9084033|NCT00314093|10148206|FG000|COMPLETED|Overall Study||0
9084034|NCT00314093|10148206|FG000|NOT COMPLETED|Overall Study||0
9084035|NCT00314327|10148210|FG000|STARTED|Overall Study||1
9084036|NCT00314327|10148210|FG000|COMPLETED|Overall Study||0
9084037|NCT00314327|10148210|FG000|NOT COMPLETED|Overall Study||1
9084038|NCT00308113|10148218|FG000|STARTED|Overall Study||0
9084039|NCT00308113|10148219|FG001|STARTED|Overall Study||0
9084040|NCT00308113|10148220|FG002|STARTED|Overall Study||1
9084041|NCT00308113|10148221|FG003|STARTED|Overall Study||2
9084042|NCT00308113|10148218|FG000|COMPLETED|Overall Study||0
9084043|NCT00308113|10148219|FG001|COMPLETED|Overall Study||0
9084044|NCT00308113|10148220|FG002|COMPLETED|Overall Study||1
9084045|NCT00308113|10148221|FG003|COMPLETED|Overall Study||1
9084046|NCT00308113|10148218|FG000|NOT COMPLETED|Overall Study||0
9084047|NCT00308113|10148219|FG001|NOT COMPLETED|Overall Study||0
9084048|NCT00308113|10148220|FG002|NOT COMPLETED|Overall Study||0
9084049|NCT00308113|10148221|FG003|NOT COMPLETED|Overall Study||1
9084050|NCT00305643|10148233|FG000|STARTED|Overall Study||6
9084051|NCT00305643|10148234|FG001|STARTED|Overall Study||5
9084052|NCT00305643|10148233|FG000|COMPLETED|Overall Study||6
9084053|NCT00305643|10148234|FG001|COMPLETED|Overall Study||5
9084054|NCT00305643|10148233|FG000|NOT COMPLETED|Overall Study||0
9084055|NCT00305643|10148234|FG001|NOT COMPLETED|Overall Study||0
9084056|NCT00298740|10148241|FG000|STARTED|Overall Study||12
9084057|NCT00298740|10148241|FG000|COMPLETED|Overall Study||3
9084058|NCT00298740|10148241|FG000|NOT COMPLETED|Overall Study||9
9084059|NCT00301080|10148245|FG000|STARTED|Original Version (2 Arms & 4 Weeks)||4
9084060|NCT00301080|10148246|FG001|STARTED|Original Version (2 Arms & 4 Weeks)||3
9084061|NCT00301080|10148247|FG002|STARTED|Original Version (2 Arms & 4 Weeks)|This arm not part of the original version.|0
9084062|NCT00301080|10148248|FG003|STARTED|Original Version (2 Arms & 4 Weeks)|This arm not part of the original version.|0
9084063|NCT00301080|10148249|FG004|STARTED|Original Version (2 Arms & 4 Weeks)|This arm not part of the original version.|0
9084064|NCT00301080|10148245|FG000|Received an Intervention|Original Version (2 Arms & 4 Weeks)||3
9084065|NCT00301080|10148246|FG001|Received an Intervention|Original Version (2 Arms & 4 Weeks)||3
9084066|NCT00301080|10148247|FG002|Received an Intervention|Original Version (2 Arms & 4 Weeks)||0
9084067|NCT00301080|10148248|FG003|Received an Intervention|Original Version (2 Arms & 4 Weeks)||0
9084068|NCT00301080|10148249|FG004|Received an Intervention|Original Version (2 Arms & 4 Weeks)||0
8624652|NCT00502307|9664031|FG001|STARTED|Maintenance Period||0
8624653|NCT00502307|9664032|FG002|STARTED|Maintenance Period||0
8624654|NCT00502307|9664030|FG000|COMPLETED|Maintenance Period||0
8624655|NCT00502307|9664031|FG001|COMPLETED|Maintenance Period||0
8624656|NCT00502307|9664032|FG002|COMPLETED|Maintenance Period||0
8624657|NCT00502307|9664030|FG000|NOT COMPLETED|Maintenance Period||148
8624658|NCT00502307|9664031|FG001|NOT COMPLETED|Maintenance Period||0
8624659|NCT00502307|9664032|FG002|NOT COMPLETED|Maintenance Period||0
8624660|NCT00502320|9664051|FG000|STARTED|Overall Study||25
8624661|NCT00502320|9664052|FG001|STARTED|Overall Study||25
8624662|NCT00502320|9664051|FG000|Screening Visit|Overall Study||25
9084069|NCT00301080|10148245|FG000|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||3
9084070|NCT00301080|10148246|FG001|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||3
9084071|NCT00301080|10148247|FG002|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||0
9084072|NCT00301080|10148248|FG003|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||0
9084073|NCT00301080|10148249|FG004|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||0
9084074|NCT00301080|10148245|FG000|COMPLETED|Original Version (2 Arms & 4 Weeks)||3
9084075|NCT00301080|10148246|FG001|COMPLETED|Original Version (2 Arms & 4 Weeks)||3
9084076|NCT00301080|10148247|FG002|COMPLETED|Original Version (2 Arms & 4 Weeks)||0
9084077|NCT00301080|10148248|FG003|COMPLETED|Original Version (2 Arms & 4 Weeks)||0
9084078|NCT00301080|10148249|FG004|COMPLETED|Original Version (2 Arms & 4 Weeks)||0
9084079|NCT00301080|10148245|FG000|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||1
9084080|NCT00301080|10148246|FG001|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
9084081|NCT00301080|10148247|FG002|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
9084082|NCT00301080|10148248|FG003|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
9084083|NCT00301080|10148249|FG004|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
9084084|NCT00301080|10148245|FG000|STARTED|Revised Version (3 Arms & 12 Weeks)|This arm was not a part of the revised study design.|0
9084085|NCT00301080|10148246|FG001|STARTED|Revised Version (3 Arms & 12 Weeks)|This arm was not a part of the revised study design.|0
9084086|NCT00301080|10148247|FG002|STARTED|Revised Version (3 Arms & 12 Weeks)||0
9084087|NCT00301080|10148248|FG003|STARTED|Revised Version (3 Arms & 12 Weeks)||0
9084088|NCT00301080|10148249|FG004|STARTED|Revised Version (3 Arms & 12 Weeks)||0
9084089|NCT00301080|10148245|FG000|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
9084090|NCT00301080|10148246|FG001|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
9084091|NCT00301080|10148247|FG002|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
9084092|NCT00301080|10148248|FG003|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
9084093|NCT00301080|10148249|FG004|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
9084094|NCT00301080|10148245|FG000|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
9084095|NCT00301080|10148246|FG001|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
9084096|NCT00301080|10148247|FG002|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
9084097|NCT00301080|10148248|FG003|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
9084098|NCT00301080|10148249|FG004|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
8624663|NCT00502320|9664052|FG001|Screening Visit|Overall Study|Participant signed informed consent but was a screen failure because she was nursing at the time.|24
8624664|NCT00502320|9664051|FG000|COMPLETED|Overall Study||19
9084099|NCT00299195|10148260|FG000|STARTED|Overall Study||30
9084100|NCT00299195|10148261|FG001|STARTED|Overall Study||33
9084101|NCT00299195|10148260|FG000|COMPLETED|Overall Study||30
9084102|NCT00299195|10148261|FG001|COMPLETED|Overall Study||33
9084103|NCT00299195|10148260|FG000|NOT COMPLETED|Overall Study||0
9084104|NCT00299195|10148261|FG001|NOT COMPLETED|Overall Study||0
9084105|NCT00290407|10148267|FG000|STARTED|Overall Study||2
9084106|NCT00290407|10148267|FG000|COMPLETED|Overall Study||0
9084107|NCT00290407|10148267|FG000|NOT COMPLETED|Overall Study||2
9084108|NCT00295490|10148275|FG000|STARTED|Overall Study||15
9084109|NCT00295490|10148276|FG001|STARTED|Overall Study||19
9084110|NCT00295490|10148277|FG002|STARTED|Overall Study||16
9084111|NCT00295490|10148278|FG003|STARTED|Overall Study||17
9084112|NCT00295490|10148275|FG000|COMPLETED|Overall Study||14
9084113|NCT00295490|10148276|FG001|COMPLETED|Overall Study||15
9084114|NCT00295490|10148277|FG002|COMPLETED|Overall Study||12
9084115|NCT00295490|10148278|FG003|COMPLETED|Overall Study||12
9084116|NCT00295490|10148275|FG000|NOT COMPLETED|Overall Study||1
9084117|NCT00295490|10148276|FG001|NOT COMPLETED|Overall Study||4
9084118|NCT00295490|10148277|FG002|NOT COMPLETED|Overall Study||4
9084119|NCT00295490|10148278|FG003|NOT COMPLETED|Overall Study||5
9084120|NCT00268463|10148290|FG000|STARTED|Overall Study||10
9084121|NCT00268463|10148291|FG001|STARTED|Overall Study||12
9084122|NCT00268463|10148290|FG000|COMPLETED|Overall Study||0
9084123|NCT00268463|10148291|FG001|COMPLETED|Overall Study||0
9084124|NCT00268463|10148290|FG000|NOT COMPLETED|Overall Study||10
9084125|NCT00268463|10148291|FG001|NOT COMPLETED|Overall Study||12
9084126|NCT00271102|10148299|FG000|STARTED|Overall Study||35
9084127|NCT00271102|10148300|FG001|STARTED|Overall Study||35
9084128|NCT00271102|10148299|FG000|COMPLETED|Overall Study||30
9084129|NCT00271102|10148300|FG001|COMPLETED|Overall Study||30
9084130|NCT00271102|10148299|FG000|NOT COMPLETED|Overall Study||5
9084131|NCT00271102|10148300|FG001|NOT COMPLETED|Overall Study||5
9084132|NCT00276419|10148308|FG000|STARTED|First Intervention||8
9084133|NCT00276419|10148309|FG001|STARTED|First Intervention||10
9084134|NCT00276419|10148308|FG000|COMPLETED|First Intervention||7
9084135|NCT00276419|10148309|FG001|COMPLETED|First Intervention||8
9084136|NCT00276419|10148308|FG000|NOT COMPLETED|First Intervention||1
9084137|NCT00276419|10148309|FG001|NOT COMPLETED|First Intervention||2
9084138|NCT00276419|10148308|FG000|STARTED|Wash-out Phase||7
9084139|NCT00276419|10148309|FG001|STARTED|Wash-out Phase||8
9084140|NCT00276419|10148308|FG000|COMPLETED|Wash-out Phase||7
9084141|NCT00276419|10148309|FG001|COMPLETED|Wash-out Phase||8
9084142|NCT00276419|10148308|FG000|NOT COMPLETED|Wash-out Phase||0
9084143|NCT00276419|10148309|FG001|NOT COMPLETED|Wash-out Phase||0
9084144|NCT00276419|10148308|FG000|STARTED|Second Intervention||7
9084145|NCT00276419|10148309|FG001|STARTED|Second Intervention||8
9084146|NCT00276419|10148308|FG000|COMPLETED|Second Intervention||7
9084147|NCT00276419|10148309|FG001|COMPLETED|Second Intervention||8
9084148|NCT00276419|10148308|FG000|NOT COMPLETED|Second Intervention||0
9084149|NCT00276419|10148309|FG001|NOT COMPLETED|Second Intervention||0
9084150|NCT00279409|10148317|FG000|STARTED|Overall Study||0
9084151|NCT00279409|10148318|FG001|STARTED|Overall Study||0
9084152|NCT00279409|10148317|FG000|COMPLETED|Overall Study||0
9084153|NCT00279409|10148318|FG001|COMPLETED|Overall Study||0
9084154|NCT00279409|10148317|FG000|NOT COMPLETED|Overall Study||0
9084155|NCT00279409|10148318|FG001|NOT COMPLETED|Overall Study||0
9084156|NCT00281879|10148332|FG000|STARTED|Overall Study||128
9084157|NCT00281879|10148333|FG001|STARTED|Overall Study||36
9084158|NCT00281879|10148334|FG002|STARTED|Overall Study||20
9084159|NCT00281879|10148335|FG003|STARTED|Overall Study||0
9084160|NCT00281879|10148336|FG004|STARTED|Overall Study||6
9084161|NCT00281879|10148337|FG005|STARTED|Overall Study||9
9084162|NCT00281879|10148338|FG006|STARTED|Overall Study||0
9084163|NCT00281879|10148339|FG007|STARTED|Overall Study||1
9084164|NCT00281879|10148332|FG000|COMPLETED|Overall Study||0
9084165|NCT00281879|10148333|FG001|COMPLETED|Overall Study||0
9084166|NCT00281879|10148334|FG002|COMPLETED|Overall Study||0
9084167|NCT00281879|10148335|FG003|COMPLETED|Overall Study||0
9084168|NCT00281879|10148336|FG004|COMPLETED|Overall Study||0
9084169|NCT00281879|10148337|FG005|COMPLETED|Overall Study||0
9084170|NCT00281879|10148338|FG006|COMPLETED|Overall Study||0
9084171|NCT00281879|10148339|FG007|COMPLETED|Overall Study||0
9084172|NCT00281879|10148332|FG000|NOT COMPLETED|Overall Study||128
9084173|NCT00281879|10148333|FG001|NOT COMPLETED|Overall Study||36
9084174|NCT00281879|10148334|FG002|NOT COMPLETED|Overall Study||20
9084175|NCT00281879|10148335|FG003|NOT COMPLETED|Overall Study||0
9084176|NCT00281879|10148336|FG004|NOT COMPLETED|Overall Study||6
9084177|NCT00281879|10148337|FG005|NOT COMPLETED|Overall Study||9
9084178|NCT00281879|10148338|FG006|NOT COMPLETED|Overall Study||0
9084179|NCT00281879|10148339|FG007|NOT COMPLETED|Overall Study||1
9084180|NCT00271947|10148357|FG000|STARTED|Overall Study||1
9084181|NCT00271947|10148357|FG000|COMPLETED|Overall Study||0
9084182|NCT00271947|10148357|FG000|NOT COMPLETED|Overall Study||1
9084183|NCT00271011|10148361|FG000|STARTED|Overall Study||13
9084184|NCT00271011|10148361|FG000|COMPLETED|Overall Study||13
9084185|NCT00271011|10148361|FG000|NOT COMPLETED|Overall Study||0
9084186|NCT00253981|10148367|FG000|STARTED|Overall Study||16
9084187|NCT00253981|10148368|FG001|STARTED|Overall Study||14
9084188|NCT00253981|10148367|FG000|COMPLETED|Overall Study||16
9084189|NCT00253981|10148368|FG001|COMPLETED|Overall Study||14
9084190|NCT00253981|10148367|FG000|NOT COMPLETED|Overall Study||0
9084191|NCT00253981|10148368|FG001|NOT COMPLETED|Overall Study||0
9084192|NCT00252174|10148377|FG000|STARTED|Overall Study|No subjects were randomized into Active Arm as only 2 subjects were randomized into the Control Arm.|0
9084193|NCT00252174|10148378|FG001|STARTED|Overall Study|2 subjects entered the control arm in total|2
9084194|NCT00252174|10148379|FG002|STARTED|Overall Study|No subjects entered Stage 2|0
9084195|NCT00252174|10148377|FG000|COMPLETED|Overall Study||0
9084196|NCT00252174|10148378|FG001|COMPLETED|Overall Study||1
9084197|NCT00252174|10148379|FG002|COMPLETED|Overall Study||0
9084198|NCT00252174|10148377|FG000|NOT COMPLETED|Overall Study||0
9084199|NCT00252174|10148378|FG001|NOT COMPLETED|Overall Study||1
9084200|NCT00252174|10148379|FG002|NOT COMPLETED|Overall Study||0
9084201|NCT00256295|10148387|FG000|STARTED|Overall Study|Of the 8 subjects consented, 1 withdrew prior to treatment.|7
9084202|NCT00256295|10148387|FG000|COMPLETED|Overall Study||3
9084203|NCT00256295|10148387|FG000|NOT COMPLETED|Overall Study||4
9084204|NCT00245128|10148391|FG000|STARTED|Overall Study||10
9084205|NCT00245128|10148391|FG000|COMPLETED|Overall Study||0
9084206|NCT00245128|10148391|FG000|NOT COMPLETED|Overall Study||10
9084207|NCT00268450|10148395|FG000|STARTED|Overall Study||21
9084208|NCT00268450|10148395|FG000|COMPLETED|Overall Study||21
9084209|NCT00268450|10148395|FG000|NOT COMPLETED|Overall Study||0
9084210|NCT00239720|10148401|FG000|STARTED|Overall Study||3
9084211|NCT00239720|10148402|FG001|STARTED|Overall Study||1
9084212|NCT00239720|10148401|FG000|COMPLETED|Overall Study|One participant discontinued due to an adverse event|2
9084213|NCT00239720|10148402|FG001|COMPLETED|Overall Study|One participant lost to follow-up|0
9084214|NCT00239720|10148401|FG000|NOT COMPLETED|Overall Study||1
9084215|NCT00239720|10148402|FG001|NOT COMPLETED|Overall Study||1
9084216|NCT00250718|10148408|FG000|STARTED|Overall Study||17
9084217|NCT00250718|10148408|FG000|Received Treatment|Overall Study||16
9084218|NCT00250718|10148408|FG000|COMPLETED|Overall Study||14
9084219|NCT00250718|10148408|FG000|NOT COMPLETED|Overall Study||3
9084220|NCT00244010|10148414|FG000|STARTED|Overall Study||2
9084221|NCT00244010|10148415|FG001|STARTED|Overall Study||2
9084222|NCT00244010|10148414|FG000|COMPLETED|Overall Study||2
9084223|NCT00244010|10148415|FG001|COMPLETED|Overall Study||2
9084224|NCT00244010|10148414|FG000|NOT COMPLETED|Overall Study||0
9084225|NCT00244010|10148415|FG001|NOT COMPLETED|Overall Study||0
9084226|NCT00218036|10148426|FG000|STARTED|Overall Study||11
9084227|NCT00218036|10148427|FG001|STARTED|Overall Study||6
9084228|NCT00218036|10148428|FG002|STARTED|Overall Study||13
9084229|NCT00218036|10148429|FG003|STARTED|Overall Study||12
9084230|NCT00218036|10148430|FG004|STARTED|Overall Study||9
9084231|NCT00218036|10148426|FG000|COMPLETED|Overall Study||6
9084232|NCT00218036|10148427|FG001|COMPLETED|Overall Study||3
9084233|NCT00218036|10148428|FG002|COMPLETED|Overall Study||5
9084234|NCT00218036|10148429|FG003|COMPLETED|Overall Study||6
9084235|NCT00218036|10148430|FG004|COMPLETED|Overall Study||3
9084236|NCT00218036|10148426|FG000|NOT COMPLETED|Overall Study||5
9084237|NCT00218036|10148427|FG001|NOT COMPLETED|Overall Study||3
9084238|NCT00218036|10148428|FG002|NOT COMPLETED|Overall Study||8
9084239|NCT00218036|10148429|FG003|NOT COMPLETED|Overall Study||6
9084240|NCT00218036|10148430|FG004|NOT COMPLETED|Overall Study||6
9084241|NCT00240227|10148442|FG000|STARTED|Overall Study||8
9084242|NCT00240227|10148442|FG000|COMPLETED|Overall Study||8
9084243|NCT00240227|10148442|FG000|NOT COMPLETED|Overall Study||0
9084244|NCT00205868|10148449|FG000|STARTED|Overall Study||304
9084245|NCT00205868|10148449|FG000|COMPLETED|Overall Study||304
9084246|NCT00205868|10148449|FG000|NOT COMPLETED|Overall Study||0
9084247|NCT00206375|10148456|FG000|STARTED|Overall Study||6
9084248|NCT00206375|10148457|FG001|STARTED|Overall Study||3
8624665|NCT00502320|9664052|FG001|COMPLETED|Overall Study||18
8624666|NCT00502320|9664051|FG000|NOT COMPLETED|Overall Study||6
8624667|NCT00502320|9664052|FG001|NOT COMPLETED|Overall Study||7
8624668|NCT00502593|9664070|FG000|STARTED|Overall Study||51
9084249|NCT00206375|10148458|FG002|STARTED|Overall Study||7
9084250|NCT00206375|10148456|FG000|COMPLETED|Overall Study||3
9084251|NCT00206375|10148457|FG001|COMPLETED|Overall Study||1
9084252|NCT00206375|10148458|FG002|COMPLETED|Overall Study||3
9084253|NCT00206375|10148456|FG000|NOT COMPLETED|Overall Study||3
9084254|NCT00206375|10148457|FG001|NOT COMPLETED|Overall Study||2
9084255|NCT00206375|10148458|FG002|NOT COMPLETED|Overall Study||4
9084256|NCT00229931|10148468|FG000|STARTED|Overall Study||6
9084257|NCT00229931|10148469|FG001|STARTED|Overall Study||5
9084258|NCT00229931|10148468|FG000|COMPLETED|Overall Study||2
9084259|NCT00229931|10148469|FG001|COMPLETED|Overall Study||3
9084260|NCT00229931|10148468|FG000|NOT COMPLETED|Overall Study||4
9084261|NCT00229931|10148469|FG001|NOT COMPLETED|Overall Study||2
9084262|NCT00209131|10148477|FG000|STARTED|Overall Study|Patients enrolled for participation but did not complete the study.|15
9084263|NCT00209131|10148478|FG001|STARTED|Overall Study|Patients enrolled for participation but did not complete the study.|11
9084264|NCT00209131|10148477|FG000|COMPLETED|Overall Study|Lack of personnel for adequate followup and data collection.|0
9084265|NCT00209131|10148478|FG001|COMPLETED|Overall Study|Lack of personnel for adequate followup and data collection.|0
9084266|NCT00209131|10148477|FG000|NOT COMPLETED|Overall Study||15
9084267|NCT00209131|10148478|FG001|NOT COMPLETED|Overall Study||11
8624669|NCT00502593|9664071|FG001|STARTED|Overall Study||18
9084268|NCT00233090|10148486|FG000|STARTED|Overall Study||12
9084269|NCT00233090|10148487|FG001|STARTED|Overall Study||9
9084270|NCT00233090|10148486|FG000|COMPLETED|Overall Study||12
9084271|NCT00233090|10148487|FG001|COMPLETED|Overall Study||9
9084272|NCT00233090|10148486|FG000|NOT COMPLETED|Overall Study||0
9084273|NCT00233090|10148487|FG001|NOT COMPLETED|Overall Study||0
9084274|NCT00214149|10148493|FG000|STARTED|Overall Study||127
9084275|NCT00214149|10148493|FG000|COMPLETED|Overall Study|No data are available; study was terminated and PI has left the institution.|0
9084276|NCT00214149|10148493|FG000|NOT COMPLETED|Overall Study||127
9084277|NCT00205049|10148499|FG000|STARTED|Overall Study||0
9084278|NCT00205049|10148500|FG001|STARTED|Overall Study||0
8624670|NCT00502593|9664072|FG002|STARTED|Overall Study||51
8624671|NCT00502593|9664073|FG003|STARTED|Overall Study||18
8624672|NCT00502593|9664074|FG004|STARTED|Overall Study||51
8624673|NCT00502593|9664075|FG005|STARTED|Overall Study||17
8624674|NCT00502593|9664076|FG006|STARTED|Overall Study||49
8624675|NCT00502593|9664077|FG007|STARTED|Overall Study||17
8624676|NCT00502593|9664078|FG008|STARTED|Overall Study||49
8624677|NCT00502593|9664079|FG009|STARTED|Overall Study||17
9084279|NCT00205049|10148499|FG000|COMPLETED|Overall Study||0
9084280|NCT00205049|10148500|FG001|COMPLETED|Overall Study||0
9084281|NCT00205049|10148499|FG000|NOT COMPLETED|Overall Study||0
9084282|NCT00205049|10148500|FG001|NOT COMPLETED|Overall Study||0
9084283|NCT00209027|10148508|FG000|STARTED|Overall Study||10
9084284|NCT00209027|10148509|FG001|STARTED|Overall Study||10
9084285|NCT00209027|10148508|FG000|COMPLETED|Overall Study||0
9084286|NCT00209027|10148509|FG001|COMPLETED|Overall Study||10
9084287|NCT00209027|10148508|FG000|NOT COMPLETED|Overall Study||10
9084288|NCT00209027|10148509|FG001|NOT COMPLETED|Overall Study||0
9084289|NCT00182637|10148515|FG000|STARTED|Overall Study|active/on treatment date|5
9084290|NCT00182637|10148515|FG000|COMPLETED|Overall Study|off study date|2
9084291|NCT00182637|10148515|FG000|NOT COMPLETED|Overall Study||3
9084292|NCT00176488|10148520|FG000|STARTED|Overall Study||31
9084293|NCT00176488|10148520|FG000|COMPLETED|Overall Study||30
9084294|NCT00176488|10148520|FG000|NOT COMPLETED|Overall Study||1
9084295|NCT00179127|10148526|FG000|STARTED|Overall Study||0
9084296|NCT00179127|10148527|FG001|STARTED|Overall Study||0
9084297|NCT00179127|10148526|FG000|COMPLETED|Overall Study||0
9084298|NCT00179127|10148527|FG001|COMPLETED|Overall Study||0
9084299|NCT00179127|10148526|FG000|NOT COMPLETED|Overall Study||0
9084300|NCT00179127|10148527|FG001|NOT COMPLETED|Overall Study||0
9084301|NCT00183963|10148537|FG000|STARTED|Overall Study||1
9084302|NCT00183963|10148538|FG001|STARTED|Overall Study||1
9084303|NCT00183963|10148539|FG002|STARTED|Overall Study||1
9084304|NCT00183963|10148540|FG003|STARTED|Overall Study||1
9084305|NCT00183963|10148537|FG000|COMPLETED|Overall Study||0
9084306|NCT00183963|10148538|FG001|COMPLETED|Overall Study||0
9084307|NCT00183963|10148539|FG002|COMPLETED|Overall Study||0
9084308|NCT00183963|10148540|FG003|COMPLETED|Overall Study||0
9084309|NCT00183963|10148537|FG000|NOT COMPLETED|Overall Study||1
9084310|NCT00183963|10148538|FG001|NOT COMPLETED|Overall Study||1
9084311|NCT00183963|10148539|FG002|NOT COMPLETED|Overall Study||1
9084312|NCT00183963|10148540|FG003|NOT COMPLETED|Overall Study||1
9084313|NCT00178477|10148553|FG000|STARTED|Overall Study||10
9084314|NCT00178477|10148553|FG000|COMPLETED|Overall Study||5
9084315|NCT00178477|10148553|FG000|NOT COMPLETED|Overall Study||5
9084316|NCT00162773|10148557|FG000|STARTED|Overall Study||29
9084317|NCT00162773|10148557|FG000|COMPLETED|Overall Study||7
9084318|NCT00162773|10148557|FG000|NOT COMPLETED|Overall Study||22
9084319|NCT00176631|10148561|FG000|STARTED|Overall Study||10
9084320|NCT00176631|10148561|FG000|COMPLETED|Overall Study||10
9084321|NCT00176631|10148561|FG000|NOT COMPLETED|Overall Study||0
9084322|NCT00176501|10148565|FG000|STARTED|Overall Study||3
9084323|NCT00176501|10148565|FG000|COMPLETED|Overall Study||3
9084324|NCT00176501|10148565|FG000|NOT COMPLETED|Overall Study||0
9084325|NCT00177970|10148571|FG000|STARTED|Overall Study|No results available record destroyed due to age of study. no publications|0
9084326|NCT00177970|10148572|FG001|STARTED|Overall Study|No results available record destroyed due to age of study. no publications|0
9084327|NCT00177970|10148571|FG000|COMPLETED|Overall Study|No results available record destroyed due to age of study. no publications|0
9084328|NCT00177970|10148572|FG001|COMPLETED|Overall Study|No results available record destroyed due to age of study. no publications|0
9084329|NCT00177970|10148571|FG000|NOT COMPLETED|Overall Study||0
9084330|NCT00177970|10148572|FG001|NOT COMPLETED|Overall Study||0
9084331|NCT00177866|10148580|FG000|STARTED|Overall Study|No results or publication, data destroyed due to age of study.|0
9084332|NCT00177866|10148581|FG001|STARTED|Overall Study|No results or publication, data destroyed due to age of study.|0
9084333|NCT00177866|10148580|FG000|COMPLETED|Overall Study|No results or publication, data destroyed due to age of study.|0
9084334|NCT00177866|10148581|FG001|COMPLETED|Overall Study|No results or publication, data destroyed due to age of study.|0
9084335|NCT00177866|10148580|FG000|NOT COMPLETED|Overall Study||0
9084336|NCT00177866|10148581|FG001|NOT COMPLETED|Overall Study||0
9084337|NCT00147238|10148587|FG000|STARTED|Overall Study||10
9084338|NCT00147238|10148587|FG000|COMPLETED|Overall Study||2
9084339|NCT00147238|10148587|FG000|NOT COMPLETED|Overall Study||8
9084340|NCT00165503|10148591|FG000|STARTED|Overall Study||16
9084341|NCT00165503|10148591|FG000|COMPLETED|Overall Study||0
9084342|NCT00165503|10148591|FG000|NOT COMPLETED|Overall Study||16
9084343|NCT00160563|10148598|FG000|STARTED|Overall Study||59
9084344|NCT00160563|10148599|FG001|STARTED|Overall Study||47
9084345|NCT00160563|10148600|FG002|STARTED|Overall Study||101
9084346|NCT00160563|10148598|FG000|COMPLETED|Overall Study||8
9084347|NCT00160563|10148599|FG001|COMPLETED|Overall Study||2
9084348|NCT00160563|10148600|FG002|COMPLETED|Overall Study||11
9084349|NCT00160563|10148598|FG000|NOT COMPLETED|Overall Study||51
8624678|NCT00502593|9664080|FG010|STARTED|Overall Study||49
8624679|NCT00502593|9664081|FG011|STARTED|Overall Study||18
9084350|NCT00160563|10148599|FG001|NOT COMPLETED|Overall Study||45
9084351|NCT00160563|10148600|FG002|NOT COMPLETED|Overall Study||90
9084352|NCT00142519|10148611|FG000|STARTED|Overall Study||25
9084353|NCT00142519|10148612|FG001|STARTED|Overall Study||25
9084354|NCT00142519|10148611|FG000|COMPLETED|Overall Study||7
9084355|NCT00142519|10148612|FG001|COMPLETED|Overall Study||9
9084356|NCT00142519|10148611|FG000|NOT COMPLETED|Overall Study||18
9084357|NCT00142519|10148612|FG001|NOT COMPLETED|Overall Study||16
9084358|NCT00145704|10148620|FG000|STARTED|Overall Study||3
9084359|NCT00145704|10148621|FG001|STARTED|Overall Study||3
9084360|NCT00145704|10148620|FG000|COMPLETED|Overall Study||0
9084361|NCT00145704|10148621|FG001|COMPLETED|Overall Study||0
9084362|NCT00145704|10148620|FG000|NOT COMPLETED|Overall Study||3
9084363|NCT00145704|10148621|FG001|NOT COMPLETED|Overall Study||3
9084364|NCT00138073|10148627|FG000|STARTED|Overall Study||55
9084365|NCT00138073|10148627|FG000|Pre-intervention Testing|Overall Study||55
9084366|NCT00138073|10148627|FG000|COMPLETED|Overall Study||0
9084367|NCT00138073|10148627|FG000|NOT COMPLETED|Overall Study||55
9084368|NCT00113386|10148633|FG000|STARTED|Overall Study||10
9084369|NCT00113386|10148634|FG001|STARTED|Overall Study||9
9084370|NCT00113386|10148633|FG000|COMPLETED|Overall Study||3
9084371|NCT00113386|10148634|FG001|COMPLETED|Overall Study||5
9084372|NCT00113386|10148633|FG000|NOT COMPLETED|Overall Study||7
9084373|NCT00113386|10148634|FG001|NOT COMPLETED|Overall Study||4
9084374|NCT00138151|10148640|FG000|STARTED|Overall Study||33
9084375|NCT00138151|10148640|FG000|COMPLETED|Overall Study||29
9084376|NCT00138151|10148640|FG000|NOT COMPLETED|Overall Study||4
9084377|NCT00129974|10148644|FG000|STARTED|Overall Study||1
9084378|NCT00129974|10148644|FG000|COMPLETED|Overall Study||0
9084379|NCT00129974|10148644|FG000|NOT COMPLETED|Overall Study||1
9084380|NCT00126659|10148651|FG000|STARTED|Overall Study||3
9084381|NCT00126659|10148652|FG001|STARTED|Overall Study||3
9084382|NCT00126659|10148653|FG002|STARTED|Overall Study||4
9084383|NCT00126659|10148651|FG000|COMPLETED|Overall Study||3
9084384|NCT00126659|10148652|FG001|COMPLETED|Overall Study||3
9084385|NCT00126659|10148653|FG002|COMPLETED|Overall Study||2
9084386|NCT00126659|10148651|FG000|NOT COMPLETED|Overall Study||0
9084387|NCT00126659|10148652|FG001|NOT COMPLETED|Overall Study||0
9084388|NCT00126659|10148653|FG002|NOT COMPLETED|Overall Study||2
9084389|NCT00133679|10148661|FG000|STARTED|Overall Study||0
9084390|NCT00133679|10148662|FG001|STARTED|Overall Study||0
9084391|NCT00133679|10148661|FG000|COMPLETED|Overall Study||0
9084392|NCT00133679|10148662|FG001|COMPLETED|Overall Study||0
9084393|NCT00133679|10148661|FG000|NOT COMPLETED|Overall Study||0
9084394|NCT00133679|10148662|FG001|NOT COMPLETED|Overall Study||0
9084395|NCT00125268|10148670|FG000|STARTED|Overall Study||16
8624680|NCT00502593|9664070|FG000|COMPLETED|Overall Study||48
8844687|NCT01711359|9899134|FG002|Received at Least One Dose of Study Drug|Treatment Period||215
8844688|NCT01711359|9899132|FG000|Rescued|Treatment Period||26
9084396|NCT00125268|10148671|FG001|STARTED|Overall Study||14
9084397|NCT00125268|10148670|FG000|COMPLETED|Overall Study||15
9084398|NCT00125268|10148671|FG001|COMPLETED|Overall Study||13
9084399|NCT00125268|10148670|FG000|NOT COMPLETED|Overall Study||1
9084400|NCT00125268|10148671|FG001|NOT COMPLETED|Overall Study||1
9084401|NCT00113399|10148679|FG000|STARTED|Overall Study||7
9084402|NCT00113399|10148680|FG001|STARTED|Overall Study||8
9084403|NCT00113399|10148679|FG000|COMPLETED|Overall Study||5
9084404|NCT00113399|10148680|FG001|COMPLETED|Overall Study||3
9084405|NCT00113399|10148679|FG000|NOT COMPLETED|Overall Study||2
9084406|NCT00113399|10148680|FG001|NOT COMPLETED|Overall Study||5
9084407|NCT00118053|10148686|FG000|STARTED|Overall Study||5
9084408|NCT00118053|10148686|FG000|COMPLETED|Overall Study||5
9084409|NCT00118053|10148686|FG000|NOT COMPLETED|Overall Study||0
9084410|NCT00107614|10148690|FG000|STARTED|Overall Study||12
9084411|NCT00107614|10148690|FG000|COMPLETED|Overall Study||0
9084412|NCT00107614|10148690|FG000|NOT COMPLETED|Overall Study||12
9084413|NCT00107315|10148694|FG000|STARTED|Overall Study||16
9084414|NCT00107315|10148694|FG000|COMPLETED|Overall Study||1
9084415|NCT00107315|10148694|FG000|NOT COMPLETED|Overall Study||15
9084416|NCT00108433|10148700|FG000|STARTED|Overall Study||30
9084417|NCT00108433|10148701|FG001|STARTED|Overall Study||31
9084418|NCT00108433|10148700|FG000|COMPLETED|Overall Study||9
9084419|NCT00108433|10148701|FG001|COMPLETED|Overall Study||14
8844689|NCT01711359|9899133|FG001|Rescued|Treatment Period||7
9084420|NCT00108433|10148700|FG000|NOT COMPLETED|Overall Study||21
9084421|NCT00108433|10148701|FG001|NOT COMPLETED|Overall Study||17
9084422|NCT00113919|10148707|FG000|STARTED|Overall Study||14
9084423|NCT00113919|10148707|FG000|COMPLETED|Overall Study||0
9084424|NCT00113919|10148707|FG000|NOT COMPLETED|Overall Study||14
9084425|NCT00108342|10148713|FG000|STARTED|Overall Study||8
9084426|NCT00108342|10148714|FG001|STARTED|Overall Study||9
9084427|NCT00108342|10148713|FG000|COMPLETED|Overall Study||7
9084428|NCT00108342|10148714|FG001|COMPLETED|Overall Study||9
9084429|NCT00108342|10148713|FG000|NOT COMPLETED|Overall Study||1
9084430|NCT00108342|10148714|FG001|NOT COMPLETED|Overall Study||0
9084431|NCT00100828|10148720|FG000|STARTED|Overall Study||6
9084432|NCT00100828|10148720|FG000|COMPLETED|Overall Study||0
9084433|NCT00100828|10148720|FG000|NOT COMPLETED|Overall Study||6
8844690|NCT01711359|9899134|FG002|Rescued|Treatment Period||6
9084434|NCT00104728|10148724|FG000|STARTED|Overall Study|42 consented on study|42
8624681|NCT00502593|9664071|FG001|COMPLETED|Overall Study||16
9084435|NCT00104728|10148724|FG000|COMPLETED|Overall Study||23
9084436|NCT00104728|10148724|FG000|NOT COMPLETED|Overall Study||19
9084437|NCT00089414|10148731|FG000|STARTED|Overall Study||2
9084438|NCT00089414|10148732|FG001|STARTED|Overall Study||1
9084439|NCT00089414|10148733|FG002|STARTED|Overall Study||2
9084440|NCT00089414|10148731|FG000|COMPLETED|Overall Study||2
9084441|NCT00089414|10148732|FG001|COMPLETED|Overall Study||1
9084442|NCT00089414|10148733|FG002|COMPLETED|Overall Study||2
9084443|NCT00089414|10148731|FG000|NOT COMPLETED|Overall Study||0
9084444|NCT00089414|10148732|FG001|NOT COMPLETED|Overall Study||0
9084445|NCT00089414|10148733|FG002|NOT COMPLETED|Overall Study||0
9084446|NCT00083915|10148743|FG000|STARTED|Overall Study||52
9084447|NCT00083915|10148744|FG001|STARTED|Overall Study||45
9084448|NCT00083915|10148743|FG000|COMPLETED|Overall Study||2
9084449|NCT00083915|10148744|FG001|COMPLETED|Overall Study||8
9084450|NCT00083915|10148743|FG000|NOT COMPLETED|Overall Study||50
9084451|NCT00083915|10148744|FG001|NOT COMPLETED|Overall Study||37
9084452|NCT00090870|10148750|FG000|STARTED|Overall Study||10
9084453|NCT00090870|10148750|FG000|COMPLETED|Overall Study||10
9084454|NCT00090870|10148750|FG000|NOT COMPLETED|Overall Study||0
9084455|NCT00088972|10148756|FG000|STARTED|Overall Study||3
9084456|NCT00088972|10148757|FG001|STARTED|Overall Study||5
9084457|NCT00088972|10148756|FG000|COMPLETED|Overall Study||1
9084458|NCT00088972|10148757|FG001|COMPLETED|Overall Study||1
9084459|NCT00088972|10148756|FG000|NOT COMPLETED|Overall Study||2
9084460|NCT00088972|10148757|FG001|NOT COMPLETED|Overall Study||4
9084461|NCT00088829|10148763|FG000|STARTED|Overall Study||22
9084462|NCT00088829|10148763|FG000|COMPLETED|Overall Study||0
9084463|NCT00088829|10148763|FG000|NOT COMPLETED|Overall Study||22
9084464|NCT00089128|10148767|FG000|STARTED|Overall Study||16
9084465|NCT00089128|10148767|FG000|COMPLETED|Overall Study||16
9084466|NCT00089128|10148767|FG000|NOT COMPLETED|Overall Study||0
9084467|NCT00075608|10148771|FG000|STARTED|Overall Study||12
9084468|NCT00075608|10148771|FG000|COMPLETED|Overall Study||12
9084469|NCT00075608|10148771|FG000|NOT COMPLETED|Overall Study||0
9084470|NCT00074724|10148779|FG000|STARTED|Overall Study|The PI has left the institution and no results data is available. Efforts were made to contact the PI/study team members, as well as to review data on shared drives, IRB historical records and published resources, but were unsuccessful. No study data are available|0
9084471|NCT00074724|10148780|FG001|STARTED|Overall Study|The PI has left the institution and no results data is available. Efforts were made to contact the PI/study team members, as well as to review data on shared drives, IRB historical records and published resources, but were unsuccessful. No study data are available|0
9084472|NCT00074724|10148779|FG000|COMPLETED|Overall Study|The PI has left the institution and no results data is available. Efforts were made to contact the PI/study team members, as well as to review data on shared drives, IRB historical records and published resources, but were unsuccessful. No study data are available|0
9084473|NCT00074724|10148780|FG001|COMPLETED|Overall Study|The PI has left the institution and no results data is available. Efforts were made to contact the PI/study team members, as well as to review data on shared drives, IRB historical records and published resources, but were unsuccessful. No study data are available|0
9084474|NCT00074724|10148779|FG000|NOT COMPLETED|Overall Study||0
9084475|NCT00074724|10148780|FG001|NOT COMPLETED|Overall Study||0
9084476|NCT00085631|10148786|FG000|STARTED|Overall Study||13
9084477|NCT00085631|10148787|FG001|STARTED|Overall Study||49
9084478|NCT00085631|10148788|FG002|STARTED|Overall Study||39
9084479|NCT00085631|10148786|FG000|COMPLETED|Overall Study||9
9084480|NCT00085631|10148787|FG001|COMPLETED|Overall Study||38
9084481|NCT00085631|10148788|FG002|COMPLETED|Overall Study||32
9084482|NCT00085631|10148786|FG000|NOT COMPLETED|Overall Study||4
9084483|NCT00085631|10148787|FG001|NOT COMPLETED|Overall Study||11
9084484|NCT00085631|10148788|FG002|NOT COMPLETED|Overall Study||7
9084485|NCT00062751|10148800|FG000|STARTED|Overall Study||33
9084486|NCT00062751|10148801|FG001|STARTED|Overall Study||30
9084487|NCT00062751|10148802|FG002|STARTED|Overall Study||33
9084488|NCT00062751|10148803|FG003|STARTED|Overall Study||6
9084489|NCT00062751|10148804|FG004|STARTED|Overall Study||6
9084490|NCT00062751|10148800|FG000|COMPLETED|Overall Study||0
9084491|NCT00062751|10148801|FG001|COMPLETED|Overall Study||0
9084492|NCT00062751|10148802|FG002|COMPLETED|Overall Study||3
9084493|NCT00062751|10148803|FG003|COMPLETED|Overall Study||1
9084494|NCT00062751|10148804|FG004|COMPLETED|Overall Study||0
9084495|NCT00062751|10148800|FG000|NOT COMPLETED|Overall Study||33
9084496|NCT00062751|10148801|FG001|NOT COMPLETED|Overall Study||30
9084497|NCT00062751|10148802|FG002|NOT COMPLETED|Overall Study||30
9084498|NCT00062751|10148803|FG003|NOT COMPLETED|Overall Study||5
9084499|NCT00062751|10148804|FG004|NOT COMPLETED|Overall Study||6
9084500|NCT00066807|10148819|FG000|STARTED|Overall Study||14
9084501|NCT00066807|10148820|FG001|STARTED|Overall Study||15
9084502|NCT00066807|10148819|FG000|COMPLETED|Overall Study||0
9084503|NCT00066807|10148820|FG001|COMPLETED|Overall Study||0
9084504|NCT00066807|10148819|FG000|NOT COMPLETED|Overall Study||14
9084505|NCT00066807|10148820|FG001|NOT COMPLETED|Overall Study||15
9084506|NCT00058188|10148828|FG000|STARTED|Overall Study||0
9084507|NCT00058188|10148829|FG001|STARTED|Overall Study||0
9084508|NCT00058188|10148828|FG000|COMPLETED|Overall Study||0
9084509|NCT00058188|10148829|FG001|COMPLETED|Overall Study||0
9084510|NCT00058188|10148828|FG000|NOT COMPLETED|Overall Study||0
9084511|NCT00058188|10148829|FG001|NOT COMPLETED|Overall Study||0
9084512|NCT00014560|10148835|FG000|STARTED|Overall Study||3
9084513|NCT00014560|10148835|FG000|COMPLETED|Overall Study||0
9084514|NCT00014560|10148835|FG000|NOT COMPLETED|Overall Study||3
9084515|NCT00038142|10148841|FG000|STARTED|Overall Study||32
9084516|NCT00038142|10148842|FG001|STARTED|Overall Study||14
9084517|NCT00038142|10148841|FG000|COMPLETED|Overall Study||10
9084518|NCT00038142|10148842|FG001|COMPLETED|Overall Study||7
9084519|NCT00038142|10148841|FG000|NOT COMPLETED|Overall Study||22
9084520|NCT00038142|10148842|FG001|NOT COMPLETED|Overall Study||7
9084521|NCT00020722|10148848|FG000|STARTED|Overall Study||7
9084522|NCT00020722|10148848|FG000|COMPLETED|Overall Study||7
9084523|NCT00020722|10148848|FG000|NOT COMPLETED|Overall Study||0
9084524|NCT00002975|10148853|FG000|STARTED|Overall Study||180
9084525|NCT00002975|10148853|FG000|Treated With Study Therapy|Overall Study||175
9084526|NCT00002975|10148853|FG000|COMPLETED|Overall Study||175
9084527|NCT00002975|10148853|FG000|NOT COMPLETED|Overall Study||5
9084528|NCT00006478|10148857|FG000|STARTED|Overall Study||19
9084529|NCT00006478|10148857|FG000|COMPLETED|Overall Study||12
9084530|NCT00006478|10148857|FG000|NOT COMPLETED|Overall Study||7
9084531|NCT00019747|10148863|FG000|STARTED|Overall Study||23
9084532|NCT00019747|10148864|FG001|STARTED|Overall Study||16
9084533|NCT00019747|10148863|FG000|COMPLETED|Overall Study||23
9084534|NCT00019747|10148864|FG001|COMPLETED|Overall Study||16
9084535|NCT00019747|10148863|FG000|NOT COMPLETED|Overall Study||0
9084536|NCT00019747|10148864|FG001|NOT COMPLETED|Overall Study||0
9084537|NCT00006916|10148870|FG000|STARTED|Overall Study||19
9084538|NCT00006916|10148870|FG000|COMPLETED|Overall Study|Subjects with survival data for the primary analysis are considered to have completed the study.|14
9084539|NCT00006916|10148870|FG000|NOT COMPLETED|Overall Study||5
9084540|NCT00003726|10148874|FG000|STARTED|Overall Study||1
9084541|NCT00003726|10148874|FG000|COMPLETED|Overall Study|Funding was pulled on the trial and therefore no other participants were enrolled|0
9084542|NCT00003726|10148874|FG000|NOT COMPLETED|Overall Study||1
9084543|NCT04051996|10148880|FG000|STARTED|Overall Study||1
9084544|NCT04051996|10148881|FG001|STARTED|Overall Study||0
9084545|NCT04051996|10148880|FG000|COMPLETED|Overall Study||1
9084546|NCT04051996|10148881|FG001|COMPLETED|Overall Study||0
9084547|NCT04051996|10148880|FG000|NOT COMPLETED|Overall Study||0
9084548|NCT04051996|10148881|FG001|NOT COMPLETED|Overall Study||0
9084549|NCT02970799|10148889|FG000|STARTED|Overall Study||0
9084550|NCT02970799|10148890|FG001|STARTED|Overall Study||0
9084551|NCT02970799|10148889|FG000|COMPLETED|Overall Study||0
9084552|NCT02970799|10148890|FG001|COMPLETED|Overall Study||0
9084553|NCT02970799|10148889|FG000|NOT COMPLETED|Overall Study||0
9084554|NCT02970799|10148890|FG001|NOT COMPLETED|Overall Study||0
9084555|NCT02385292|10148898|FG000|STARTED|Overall Study||0
9084556|NCT02385292|10148899|FG001|STARTED|Overall Study||0
9084557|NCT02385292|10148898|FG000|COMPLETED|Overall Study||0
9084558|NCT02385292|10148899|FG001|COMPLETED|Overall Study||0
9084559|NCT02385292|10148898|FG000|NOT COMPLETED|Overall Study||0
9084560|NCT02385292|10148899|FG001|NOT COMPLETED|Overall Study||0
9084561|NCT02126878|10148908|FG000|STARTED|Overall Study||0
9084562|NCT02126878|10148909|FG001|STARTED|Overall Study||0
9084563|NCT02126878|10148910|FG002|STARTED|Overall Study||0
9084564|NCT02126878|10148908|FG000|COMPLETED|Overall Study||0
9084565|NCT02126878|10148909|FG001|COMPLETED|Overall Study||0
9084566|NCT02126878|10148910|FG002|COMPLETED|Overall Study||0
9084567|NCT02126878|10148908|FG000|NOT COMPLETED|Overall Study||0
9084568|NCT02126878|10148909|FG001|NOT COMPLETED|Overall Study||0
9084569|NCT02126878|10148910|FG002|NOT COMPLETED|Overall Study||0
9084570|NCT02221817|10148920|FG000|STARTED|Overall Study||0
9084571|NCT02221817|10148921|FG001|STARTED|Overall Study||0
9084572|NCT02221817|10148920|FG000|COMPLETED|Overall Study||0
9084573|NCT02221817|10148921|FG001|COMPLETED|Overall Study||0
9084574|NCT02221817|10148920|FG000|NOT COMPLETED|Overall Study||0
9084575|NCT02221817|10148921|FG001|NOT COMPLETED|Overall Study||0
9084576|NCT02595996|10148927|FG000|STARTED|Overall Study||1
9084577|NCT02595996|10148927|FG000|COMPLETED|Overall Study||1
9084578|NCT02595996|10148927|FG000|NOT COMPLETED|Overall Study||0
9084579|NCT03879044|10148931|FG000|STARTED|Overall Study||30
9084580|NCT03879044|10148931|FG000|COMPLETED|Overall Study||26
9084581|NCT03879044|10148931|FG000|NOT COMPLETED|Overall Study||4
9084582|NCT03198156|10148937|FG000|STARTED|Overall Study||19
9084583|NCT03198156|10148938|FG001|STARTED|Overall Study||19
9084584|NCT03198156|10148937|FG000|COMPLETED|Overall Study||19
9084585|NCT03198156|10148938|FG001|COMPLETED|Overall Study||19
9084586|NCT03198156|10148937|FG000|NOT COMPLETED|Overall Study||0
9084587|NCT03198156|10148938|FG001|NOT COMPLETED|Overall Study||0
9084588|NCT02009384|10148944|FG000|STARTED|Overall Study|Study was Terminated due to low subject enrollment Data was not analyzed|2
9084589|NCT02009384|10148944|FG000|COMPLETED|Overall Study|Study was Terminated due to low subject enrollment Data was not analyzed|0
9084590|NCT02009384|10148944|FG000|NOT COMPLETED|Overall Study||2
9084591|NCT04558125|10148948|FG000|STARTED|Overall Study||2
9084592|NCT04558125|10148948|FG000|COMPLETED|Overall Study||1
9084593|NCT04558125|10148948|FG000|NOT COMPLETED|Overall Study||1
9084594|NCT02401308|10148954|FG000|STARTED|Overall Study||0
9084595|NCT02401308|10148955|FG001|STARTED|Overall Study||1
9084596|NCT02401308|10148954|FG000|COMPLETED|Overall Study||0
9084597|NCT02401308|10148955|FG001|COMPLETED|Overall Study||0
9084598|NCT02401308|10148954|FG000|NOT COMPLETED|Overall Study||0
9084599|NCT02401308|10148955|FG001|NOT COMPLETED|Overall Study||1
9084600|NCT04381988|10148963|FG000|STARTED|Overall Study||4
9084601|NCT04381988|10148964|FG001|STARTED|Overall Study||0
9084602|NCT04381988|10148963|FG000|COMPLETED|Overall Study||0
9084603|NCT04381988|10148964|FG001|COMPLETED|Overall Study||0
9084604|NCT04381988|10148963|FG000|NOT COMPLETED|Overall Study||4
9084605|NCT04381988|10148964|FG001|NOT COMPLETED|Overall Study||0
9084606|NCT00521885|10148972|FG000|STARTED|Overall Study||0
9084607|NCT00521885|10148973|FG001|STARTED|Overall Study||0
9084608|NCT00521885|10148972|FG000|COMPLETED|Overall Study||0
9084609|NCT00521885|10148973|FG001|COMPLETED|Overall Study||0
9084610|NCT00521885|10148972|FG000|NOT COMPLETED|Overall Study||0
9084611|NCT00521885|10148973|FG001|NOT COMPLETED|Overall Study||0
9084612|NCT02376946|10148981|FG000|STARTED|Overall Study|study terminated prior to being conducted|0
9084613|NCT02376946|10148982|FG001|STARTED|Overall Study|study terminated prior to being conducted|0
9084614|NCT02376946|10148981|FG000|COMPLETED|Overall Study|study terminated prior to being conducted|0
9084615|NCT02376946|10148982|FG001|COMPLETED|Overall Study|study terminated prior to being conducted|0
9084616|NCT02376946|10148981|FG000|NOT COMPLETED|Overall Study||0
9084617|NCT02376946|10148982|FG001|NOT COMPLETED|Overall Study||0
9084618|NCT01780636|10148988|FG000|STARTED|Overall Study||7
9084619|NCT01780636|10148988|FG000|COMPLETED|Overall Study||7
9084620|NCT01780636|10148988|FG000|NOT COMPLETED|Overall Study||0
9084621|NCT00479167|10148992|FG000|STARTED|Overall Study||1
9084622|NCT00479167|10148992|FG000|COMPLETED|Overall Study||0
9084623|NCT00479167|10148992|FG000|NOT COMPLETED|Overall Study||1
9084624|NCT03998189|10148999|FG000|STARTED|Overall Study||0
9084625|NCT03998189|10149000|FG001|STARTED|Overall Study||1
9084626|NCT03998189|10148999|FG000|COMPLETED|Overall Study||0
9084627|NCT03998189|10149000|FG001|COMPLETED|Overall Study|Samples were collected but were not analyzed as the analysis would have been done once a proper batch of samples were collected. This did not occur as the study was found to no longer be feasible and was terminated.|0
9084628|NCT03998189|10148999|FG000|NOT COMPLETED|Overall Study||0
9084629|NCT03998189|10149000|FG001|NOT COMPLETED|Overall Study||1
9084630|NCT02212574|10149006|FG000|STARTED|Overall Study||6
9084631|NCT02212574|10149006|FG000|COMPLETED|Overall Study||6
9084632|NCT02212574|10149006|FG000|NOT COMPLETED|Overall Study||0
9084633|NCT04422210|10149019|FG000|STARTED|Overall Study||0
9084634|NCT04422210|10149020|FG001|STARTED|Overall Study||0
9084635|NCT04422210|10149021|FG002|STARTED|Overall Study||0
9084636|NCT04422210|10149022|FG003|STARTED|Overall Study||0
9084637|NCT04422210|10149023|FG004|STARTED|Overall Study||0
9084638|NCT04422210|10149024|FG005|STARTED|Overall Study||0
9084639|NCT04422210|10149025|FG006|STARTED|Overall Study||0
9084640|NCT04422210|10149026|FG007|STARTED|Overall Study||0
9084641|NCT04422210|10149019|FG000|COMPLETED|Overall Study||0
9084642|NCT04422210|10149020|FG001|COMPLETED|Overall Study||0
9084643|NCT04422210|10149021|FG002|COMPLETED|Overall Study||0
9084644|NCT04422210|10149022|FG003|COMPLETED|Overall Study||0
9084645|NCT04422210|10149023|FG004|COMPLETED|Overall Study||0
9084646|NCT04422210|10149024|FG005|COMPLETED|Overall Study||0
9084647|NCT04422210|10149025|FG006|COMPLETED|Overall Study||0
9084648|NCT04422210|10149026|FG007|COMPLETED|Overall Study||0
9084649|NCT04422210|10149019|FG000|NOT COMPLETED|Overall Study||0
9084650|NCT04422210|10149020|FG001|NOT COMPLETED|Overall Study||0
9084651|NCT04422210|10149021|FG002|NOT COMPLETED|Overall Study||0
9084652|NCT04422210|10149022|FG003|NOT COMPLETED|Overall Study||0
9084653|NCT04422210|10149023|FG004|NOT COMPLETED|Overall Study||0
9084654|NCT04422210|10149024|FG005|NOT COMPLETED|Overall Study||0
9084655|NCT04422210|10149025|FG006|NOT COMPLETED|Overall Study||0
9084656|NCT04422210|10149026|FG007|NOT COMPLETED|Overall Study||0
9084657|NCT04298918|10149049|FG000|STARTED|Overall Study||0
9084658|NCT04298918|10149050|FG001|STARTED|Overall Study||0
9084659|NCT04298918|10149051|FG002|STARTED|Overall Study||0
9084660|NCT04298918|10149052|FG003|STARTED|Overall Study||0
9084661|NCT04298918|10149049|FG000|COMPLETED|Overall Study||0
9084662|NCT04298918|10149050|FG001|COMPLETED|Overall Study||0
9084663|NCT04298918|10149051|FG002|COMPLETED|Overall Study||0
9084664|NCT04298918|10149052|FG003|COMPLETED|Overall Study||0
9084665|NCT04298918|10149049|FG000|NOT COMPLETED|Overall Study||0
9084666|NCT04298918|10149050|FG001|NOT COMPLETED|Overall Study||0
9084667|NCT04298918|10149051|FG002|NOT COMPLETED|Overall Study||0
9084668|NCT04298918|10149052|FG003|NOT COMPLETED|Overall Study||0
9084669|NCT01996371|10149070|FG000|STARTED|Overall Study||5
9084670|NCT01996371|10149071|FG001|STARTED|Overall Study||4
9084671|NCT01996371|10149072|FG002|STARTED|Overall Study||6
9084672|NCT01996371|10149070|FG000|COMPLETED|Overall Study||5
9084673|NCT01996371|10149071|FG001|COMPLETED|Overall Study||4
9084674|NCT01996371|10149072|FG002|COMPLETED|Overall Study||6
9084675|NCT01996371|10149070|FG000|NOT COMPLETED|Overall Study||0
9084676|NCT01996371|10149071|FG001|NOT COMPLETED|Overall Study||0
9084677|NCT01996371|10149072|FG002|NOT COMPLETED|Overall Study||0
9084678|NCT01561378|10149085|FG000|STARTED|Overall Study||11
9084679|NCT01561378|10149086|FG001|STARTED|Overall Study||11
9084680|NCT01561378|10149085|FG000|COMPLETED|Overall Study||11
9084681|NCT01561378|10149086|FG001|COMPLETED|Overall Study||11
9084682|NCT01561378|10149085|FG000|NOT COMPLETED|Overall Study||0
9084683|NCT01561378|10149086|FG001|NOT COMPLETED|Overall Study||0
9084684|NCT00955929|10149095|FG000|STARTED|Overall Study||13
9084685|NCT00955929|10149096|FG001|STARTED|Overall Study||30
9084686|NCT00955929|10149097|FG002|STARTED|Overall Study||33
9084687|NCT00955929|10149095|FG000|COMPLETED|Overall Study||13
9084688|NCT00955929|10149096|FG001|COMPLETED|Overall Study||30
9084689|NCT00955929|10149097|FG002|COMPLETED|Overall Study||33
9084690|NCT00955929|10149095|FG000|NOT COMPLETED|Overall Study||0
9084691|NCT00955929|10149096|FG001|NOT COMPLETED|Overall Study||0
9084692|NCT00955929|10149097|FG002|NOT COMPLETED|Overall Study||0
8624682|NCT00502593|9664072|FG002|COMPLETED|Overall Study||41
9084693|NCT00402883|10149105|FG000|STARTED|Induction Therapy||5
9084694|NCT00402883|10149105|FG000|COMPLETED|Induction Therapy||5
9084695|NCT00402883|10149105|FG000|NOT COMPLETED|Induction Therapy||0
9084696|NCT00402883|10149105|FG000|STARTED|Consolidation Therapy||5
9084697|NCT00402883|10149105|FG000|COMPLETED|Consolidation Therapy||5
9084698|NCT00402883|10149105|FG000|NOT COMPLETED|Consolidation Therapy||0
9084699|NCT00402883|10149105|FG000|STARTED|Maintenance Therapy||5
9084700|NCT00402883|10149105|FG000|COMPLETED|Maintenance Therapy|All 5 patients received limited maintenance therapy due to early trial closure.|5
9084701|NCT00402883|10149105|FG000|NOT COMPLETED|Maintenance Therapy||0
9084702|NCT03482505|10149110|FG000|STARTED|Overall Study||10
9084703|NCT03482505|10149110|FG000|COMPLETED|Overall Study||10
9084704|NCT03482505|10149110|FG000|NOT COMPLETED|Overall Study||0
9084705|NCT02934503|10149114|FG000|STARTED|Overall Study||5
8624683|NCT00502593|9664073|FG003|COMPLETED|Overall Study||14
9084706|NCT02934503|10149114|FG000|COMPLETED|Overall Study||1
9084707|NCT02934503|10149114|FG000|NOT COMPLETED|Overall Study||4
9084708|NCT02137252|10149120|FG000|STARTED|Overall Study||2
9084709|NCT02137252|10149121|FG001|STARTED|Overall Study||1
8624684|NCT00502593|9664074|FG004|COMPLETED|Overall Study||47
8624685|NCT00502593|9664075|FG005|COMPLETED|Overall Study||17
9084710|NCT02137252|10149120|FG000|COMPLETED|Overall Study||0
9084711|NCT02137252|10149121|FG001|COMPLETED|Overall Study||0
9084712|NCT02137252|10149120|FG000|NOT COMPLETED|Overall Study||2
9084713|NCT02137252|10149121|FG001|NOT COMPLETED|Overall Study||1
9084714|NCT03863522|10149127|FG000|STARTED|Overall Study||116
9084715|NCT03863522|10149127|FG000|COMPLETED|Overall Study||116
9084716|NCT03863522|10149127|FG000|NOT COMPLETED|Overall Study||0
9084717|NCT01294670|10149136|FG000|STARTED|Overall Study||7
9084718|NCT01294670|10149137|FG001|STARTED|Overall Study||3
9084719|NCT01294670|10149138|FG002|STARTED|Overall Study||3
9084720|NCT01294670|10149139|FG003|STARTED|Overall Study||9
9084721|NCT01294670|10149140|FG004|STARTED|Overall Study||5
9084722|NCT01294670|10149136|FG000|COMPLETED|Overall Study||6
9084723|NCT01294670|10149137|FG001|COMPLETED|Overall Study||3
9084724|NCT01294670|10149138|FG002|COMPLETED|Overall Study||3
9084725|NCT01294670|10149139|FG003|COMPLETED|Overall Study||9
9084726|NCT01294670|10149140|FG004|COMPLETED|Overall Study||5
9084727|NCT01294670|10149136|FG000|NOT COMPLETED|Overall Study||1
9084728|NCT01294670|10149137|FG001|NOT COMPLETED|Overall Study||0
9084729|NCT01294670|10149138|FG002|NOT COMPLETED|Overall Study||0
9084730|NCT01294670|10149139|FG003|NOT COMPLETED|Overall Study||0
9084731|NCT01294670|10149140|FG004|NOT COMPLETED|Overall Study||0
9084732|NCT03095287|10149152|FG000|STARTED|Overall Study||2
9084733|NCT03095287|10149152|FG000|COMPLETED|Overall Study||0
9084734|NCT03095287|10149152|FG000|NOT COMPLETED|Overall Study||2
9084735|NCT03236662|10149156|FG000|STARTED|Overall Study||2
9084736|NCT03236662|10149156|FG000|COMPLETED|Overall Study||2
9084737|NCT03236662|10149156|FG000|NOT COMPLETED|Overall Study||0
9084738|NCT02930122|10149162|FG000|STARTED|Overall Study||3
9084739|NCT02930122|10149163|FG001|STARTED|Overall Study||3
9084740|NCT02930122|10149162|FG000|COMPLETED|Overall Study||0
9084741|NCT02930122|10149163|FG001|COMPLETED|Overall Study||0
9084742|NCT02930122|10149162|FG000|NOT COMPLETED|Overall Study||3
9084743|NCT02930122|10149163|FG001|NOT COMPLETED|Overall Study||3
9084744|NCT01444209|10149170|FG000|STARTED|Overall Study||2
9084745|NCT01444209|10149170|FG000|COMPLETED|Overall Study||2
9084746|NCT01444209|10149170|FG000|NOT COMPLETED|Overall Study||0
9084747|NCT04267380|10149176|FG000|STARTED|Overall Study||149
9084748|NCT04267380|10149177|FG001|STARTED|Overall Study||149
9084749|NCT04267380|10149176|FG000|COMPLETED|Overall Study||149
9084750|NCT04267380|10149177|FG001|COMPLETED|Overall Study||149
9084751|NCT04267380|10149176|FG000|NOT COMPLETED|Overall Study||0
9084752|NCT04267380|10149177|FG001|NOT COMPLETED|Overall Study||0
9084753|NCT04144166|10149183|FG000|STARTED|Overall Study||60
9084754|NCT04144166|10149183|FG000|COMPLETED|Overall Study||57
9084755|NCT04144166|10149183|FG000|NOT COMPLETED|Overall Study||3
9084756|NCT04090164|10149194|FG000|STARTED|Overall Study|Number of patients retrivied from the hospital files.|650
9084757|NCT04090164|10149195|FG001|STARTED|Overall Study||145
9084758|NCT04090164|10149194|FG000|COMPLETED|Overall Study|Number of patients analyzed.|405
9084759|NCT04090164|10149195|FG001|COMPLETED|Overall Study||145
9084760|NCT04090164|10149194|FG000|NOT COMPLETED|Overall Study||245
9084761|NCT04090164|10149195|FG001|NOT COMPLETED|Overall Study||0
9084762|NCT04047121|10149208|FG000|STARTED|Overall Study||310
9084763|NCT04047121|10149209|FG001|STARTED|Overall Study||299
9084764|NCT04047121|10149210|FG002|STARTED|Overall Study||79
9084765|NCT04047121|10149211|FG003|STARTED|Overall Study||287
9084766|NCT04047121|10149212|FG004|STARTED|Overall Study||112
9084767|NCT04047121|10149213|FG005|STARTED|Overall Study||262
9084768|NCT04047121|10149208|FG000|COMPLETED|Overall Study||310
9084769|NCT04047121|10149209|FG001|COMPLETED|Overall Study||299
9084770|NCT04047121|10149210|FG002|COMPLETED|Overall Study||79
9084771|NCT04047121|10149211|FG003|COMPLETED|Overall Study||287
9084772|NCT04047121|10149212|FG004|COMPLETED|Overall Study||112
9084773|NCT04047121|10149213|FG005|COMPLETED|Overall Study||262
9084774|NCT04047121|10149208|FG000|NOT COMPLETED|Overall Study||0
9084775|NCT04047121|10149209|FG001|NOT COMPLETED|Overall Study||0
9084776|NCT04047121|10149210|FG002|NOT COMPLETED|Overall Study||0
9084777|NCT04047121|10149211|FG003|NOT COMPLETED|Overall Study||0
9084778|NCT04047121|10149212|FG004|NOT COMPLETED|Overall Study||0
9084779|NCT04047121|10149213|FG005|NOT COMPLETED|Overall Study||0
9084780|NCT04018001|10149229|FG000|STARTED|Overall Study||678
9084781|NCT04018001|10149230|FG001|STARTED|Overall Study||379
9084782|NCT04018001|10149229|FG000|COMPLETED|Overall Study||678
9084783|NCT04018001|10149230|FG001|COMPLETED|Overall Study||379
9084784|NCT04018001|10149229|FG000|NOT COMPLETED|Overall Study||0
9084785|NCT04018001|10149230|FG001|NOT COMPLETED|Overall Study||0
9084786|NCT04017754|10149236|FG000|STARTED|Overall Study||267
9084787|NCT04017754|10149237|FG001|STARTED|Overall Study||185
9084788|NCT04017754|10149236|FG000|COMPLETED|Overall Study||267
9084789|NCT04017754|10149237|FG001|COMPLETED|Overall Study||185
9084790|NCT04017754|10149236|FG000|NOT COMPLETED|Overall Study||0
9084791|NCT04017754|10149237|FG001|NOT COMPLETED|Overall Study||0
9084792|NCT04010370|10149280|FG000|STARTED|Overall Study||25
9084793|NCT04010370|10149280|FG000|COMPLETED|Overall Study||25
9084794|NCT04010370|10149280|FG000|NOT COMPLETED|Overall Study||0
9084795|NCT03997825|10149284|FG000|STARTED|Overall Study||117
9084796|NCT03997825|10149284|FG000|COMPLETED|Overall Study||100
9084797|NCT03997825|10149284|FG000|NOT COMPLETED|Overall Study||17
9084798|NCT03975790|10149291|FG000|STARTED|Overall Study||337
9084799|NCT03975790|10149292|FG001|STARTED|Overall Study||94
9084800|NCT03975790|10149293|FG002|STARTED|Overall Study||48
9084801|NCT03975790|10149291|FG000|COMPLETED|Overall Study||337
9084802|NCT03975790|10149292|FG001|COMPLETED|Overall Study||94
9084803|NCT03975790|10149293|FG002|COMPLETED|Overall Study||48
9084804|NCT03975790|10149291|FG000|NOT COMPLETED|Overall Study||0
9084805|NCT03975790|10149292|FG001|NOT COMPLETED|Overall Study||0
9084806|NCT03975790|10149293|FG002|NOT COMPLETED|Overall Study||0
9084807|NCT03979079|10149301|FG000|STARTED|Overall Study||2384
9084808|NCT03979079|10149301|FG000|COMPLETED|Overall Study||2384
9084809|NCT03979079|10149301|FG000|NOT COMPLETED|Overall Study||0
9084810|NCT03895632|10149306|FG000|STARTED|Overall Study||25
9084811|NCT03895632|10149306|FG000|COMPLETED|Overall Study||25
9084812|NCT03895632|10149306|FG000|NOT COMPLETED|Overall Study||0
9084813|NCT03859622|10149310|FG000|STARTED|Overall Study||289
9084814|NCT03859622|10149310|FG000|COMPLETED|Overall Study||289
9084815|NCT03859622|10149310|FG000|NOT COMPLETED|Overall Study||0
9084816|NCT03764813|10149321|FG000|STARTED|From Enrollment to the Age of 32 Weeks|Patients receiving no transfusions before the age of 32 weeks|14
9084817|NCT03764813|10149322|FG001|STARTED|From Enrollment to the Age of 32 Weeks|Patients receiving only cord-RBC transfusions before the age of 32 weeks|3
9084818|NCT03764813|10149323|FG002|STARTED|From Enrollment to the Age of 32 Weeks|Patients receiving only adult-RBC transfusions before the age of 32 weeks|4
9084819|NCT03764813|10149324|FG003|STARTED|From Enrollment to the Age of 32 Weeks|Patients receiving both adult-RBC and cord-RBCs before the age of 32 weeks|4
9084820|NCT03764813|10149321|FG000|COMPLETED|From Enrollment to the Age of 32 Weeks||14
9084821|NCT03764813|10149322|FG001|COMPLETED|From Enrollment to the Age of 32 Weeks||2
9084822|NCT03764813|10149323|FG002|COMPLETED|From Enrollment to the Age of 32 Weeks||3
9084823|NCT03764813|10149324|FG003|COMPLETED|From Enrollment to the Age of 32 Weeks||4
9084824|NCT03764813|10149321|FG000|NOT COMPLETED|From Enrollment to the Age of 32 Weeks||0
9084825|NCT03764813|10149322|FG001|NOT COMPLETED|From Enrollment to the Age of 32 Weeks||1
9084826|NCT03764813|10149323|FG002|NOT COMPLETED|From Enrollment to the Age of 32 Weeks||1
9084827|NCT03764813|10149324|FG003|NOT COMPLETED|From Enrollment to the Age of 32 Weeks||0
9084828|NCT03764813|10149321|FG000|STARTED|From Enrollment to the Last HbF Test|Patients receiving no transfusions before last HbF test (occurring at 36 weeks,discharge or death)|13
9084829|NCT03764813|10149322|FG001|STARTED|From Enrollment to the Last HbF Test|Patients receiving only cord-RBCs before last HbF test (occurring at 36 wks,discharge or death)|3
9084830|NCT03764813|10149323|FG002|STARTED|From Enrollment to the Last HbF Test|Patients receiving only adult-RBC before last HbF test (occurring at 36 wks,discharge or death)|4
9084831|NCT03764813|10149324|FG003|STARTED|From Enrollment to the Last HbF Test|Patients receiving both cord and adult-RBCs before the last HbFtest(age of 36 wk,discharge or death)|5
9084832|NCT03764813|10149321|FG000|COMPLETED|From Enrollment to the Last HbF Test||13
9084833|NCT03764813|10149322|FG001|COMPLETED|From Enrollment to the Last HbF Test||3
9084834|NCT03764813|10149323|FG002|COMPLETED|From Enrollment to the Last HbF Test||4
9084835|NCT03764813|10149324|FG003|COMPLETED|From Enrollment to the Last HbF Test||5
9084836|NCT03764813|10149321|FG000|NOT COMPLETED|From Enrollment to the Last HbF Test||0
9084837|NCT03764813|10149322|FG001|NOT COMPLETED|From Enrollment to the Last HbF Test||0
9084838|NCT03764813|10149323|FG002|NOT COMPLETED|From Enrollment to the Last HbF Test||0
9084839|NCT03764813|10149324|FG003|NOT COMPLETED|From Enrollment to the Last HbF Test||0
9084840|NCT00078806|10149340|FG000|STARTED|Part 1A||19
9084841|NCT00078806|10149341|FG001|STARTED|Part 1A||0
9084842|NCT00078806|10149342|FG002|STARTED|Part 1A||0
9084843|NCT00078806|10149343|FG003|STARTED|Part 1A||0
9084844|NCT00078806|10149340|FG000|COMPLETED|Part 1A||9
9084845|NCT00078806|10149341|FG001|COMPLETED|Part 1A||0
9084846|NCT00078806|10149342|FG002|COMPLETED|Part 1A||0
9084847|NCT00078806|10149343|FG003|COMPLETED|Part 1A||0
9084848|NCT00078806|10149340|FG000|NOT COMPLETED|Part 1A||10
9084849|NCT00078806|10149341|FG001|NOT COMPLETED|Part 1A||0
9084850|NCT00078806|10149342|FG002|NOT COMPLETED|Part 1A||0
9084851|NCT00078806|10149343|FG003|NOT COMPLETED|Part 1A||0
9084852|NCT00078806|10149340|FG000|STARTED|Part 1B||10
9084853|NCT00078806|10149341|FG001|STARTED|Part 1B||0
9084854|NCT00078806|10149342|FG002|STARTED|Part 1B||0
9084855|NCT00078806|10149343|FG003|STARTED|Part 1B||0
9084856|NCT00078806|10149340|FG000|COMPLETED|Part 1B||2
9084857|NCT00078806|10149341|FG001|COMPLETED|Part 1B||0
9084858|NCT00078806|10149342|FG002|COMPLETED|Part 1B||0
9084859|NCT00078806|10149343|FG003|COMPLETED|Part 1B||0
9084860|NCT00078806|10149340|FG000|NOT COMPLETED|Part 1B||8
9084861|NCT00078806|10149341|FG001|NOT COMPLETED|Part 1B||0
9084862|NCT00078806|10149342|FG002|NOT COMPLETED|Part 1B||0
9084863|NCT00078806|10149343|FG003|NOT COMPLETED|Part 1B||0
9084864|NCT00078806|10149340|FG000|STARTED|Part 2||0
9084865|NCT00078806|10149341|FG001|STARTED|Part 2||6
9084866|NCT00078806|10149342|FG002|STARTED|Part 2||4
9084867|NCT00078806|10149343|FG003|STARTED|Part 2||0
9084868|NCT00078806|10149340|FG000|Received Study Drug|Part 2||0
9084869|NCT00078806|10149341|FG001|Received Study Drug|Part 2||5
9084870|NCT00078806|10149342|FG002|Received Study Drug|Part 2||4
9084871|NCT00078806|10149343|FG003|Received Study Drug|Part 2||0
9084872|NCT00078806|10149340|FG000|COMPLETED|Part 2||0
9084873|NCT00078806|10149341|FG001|COMPLETED|Part 2||5
9084874|NCT00078806|10149342|FG002|COMPLETED|Part 2||4
9084875|NCT00078806|10149343|FG003|COMPLETED|Part 2||0
9084876|NCT00078806|10149340|FG000|NOT COMPLETED|Part 2||0
9084877|NCT00078806|10149341|FG001|NOT COMPLETED|Part 2||1
9084878|NCT00078806|10149342|FG002|NOT COMPLETED|Part 2||0
9084879|NCT00078806|10149343|FG003|NOT COMPLETED|Part 2||0
9084880|NCT00078806|10149340|FG000|STARTED|Part 3||0
9084881|NCT00078806|10149341|FG001|STARTED|Part 3||0
9084882|NCT00078806|10149342|FG002|STARTED|Part 3||0
9084883|NCT00078806|10149343|FG003|STARTED|Part 3||9
9084884|NCT00078806|10149340|FG000|COMPLETED|Part 3||0
9084885|NCT00078806|10149341|FG001|COMPLETED|Part 3||0
9084886|NCT00078806|10149342|FG002|COMPLETED|Part 3||0
9084887|NCT00078806|10149343|FG003|COMPLETED|Part 3||9
9084888|NCT00078806|10149340|FG000|NOT COMPLETED|Part 3||0
9084889|NCT00078806|10149341|FG001|NOT COMPLETED|Part 3||0
9084890|NCT00078806|10149342|FG002|NOT COMPLETED|Part 3||0
9084891|NCT00078806|10149343|FG003|NOT COMPLETED|Part 3||0
9084892|NCT00162370|10149358|FG000|STARTED|Completed Echocardiography Imaging|Received at least one dose of Definity|366
9084893|NCT00162370|10149358|FG000|COMPLETED|Completed Echocardiography Imaging|number of subjects who under went Definity-enhanced rest and stress echocardiogram|366
9084894|NCT00162370|10149358|FG000|NOT COMPLETED|Completed Echocardiography Imaging||0
9084895|NCT00162370|10149358|FG000|STARTED|Efficacy Population||366
9084896|NCT00162370|10149358|FG000|COMPLETED|Efficacy Population|Efficacy population, completed rest/stress echo with Definity & completed 2 and/or 5 year follow up|315
9084897|NCT00162370|10149358|FG000|NOT COMPLETED|Efficacy Population||51
9084898|NCT00204737|10149367|FG000|STARTED|Overall Study||6
9084899|NCT00204737|10149368|FG001|STARTED|Overall Study||6
9084900|NCT00204737|10149367|FG000|COMPLETED|Overall Study||6
9084901|NCT00204737|10149368|FG001|COMPLETED|Overall Study||6
9084902|NCT00204737|10149367|FG000|NOT COMPLETED|Overall Study||0
9084903|NCT00204737|10149368|FG001|NOT COMPLETED|Overall Study||0
9084904|NCT00214500|10149374|FG000|STARTED|Treatment Period|All eligible-enrolled participants who received at least 1 dose of study drug|9
9084905|NCT00214500|10149374|FG000|Safety Population|Treatment Period||9
9084906|NCT00214500|10149374|FG000|Pharmacokinetic (PK) Population|Treatment Period||9
9084907|NCT00214500|10149374|FG000|Pharmacodynamic (PD) Population|Treatment Period||9
9084908|NCT00214500|10149374|FG000|COMPLETED|Treatment Period||8
9084909|NCT00214500|10149374|FG000|NOT COMPLETED|Treatment Period||1
9084910|NCT00214500|10149374|FG000|STARTED|Extension Period||8
9084911|NCT00214500|10149374|FG000|COMPLETED|Extension Period||6
9084912|NCT00214500|10149374|FG000|NOT COMPLETED|Extension Period||2
9084913|NCT00278343|10149381|FG000|STARTED|Overall Study||74
9084914|NCT00278343|10149381|FG000|COMPLETED|Overall Study||74
9084915|NCT00278343|10149381|FG000|NOT COMPLETED|Overall Study||0
9084916|NCT00283959|10149386|FG000|STARTED|Treatment Period||4
9084917|NCT00283959|10149386|FG000|Safety Population|Treatment Period||4
9084918|NCT00283959|10149386|FG000|Pharmacodynamics (PD) Population|Treatment Period||4
9084919|NCT00283959|10149386|FG000|COMPLETED|Treatment Period||4
9084920|NCT00283959|10149386|FG000|NOT COMPLETED|Treatment Period||0
9084921|NCT00283959|10149386|FG000|STARTED|Extension Period||4
9084922|NCT00283959|10149386|FG000|COMPLETED|Extension Period||3
9084923|NCT00283959|10149386|FG000|NOT COMPLETED|Extension Period||1
9084924|NCT00290758|10149392|FG000|STARTED|Pre-Intervention rFNA Through Follow-Up||62
9084925|NCT00290758|10149393|FG001|STARTED|Pre-Intervention rFNA Through Follow-Up||64
9084926|NCT00290758|10149392|FG000|First rFNA Tissue Collection|Pre-Intervention rFNA Through Follow-Up||62
9084927|NCT00290758|10149393|FG001|First rFNA Tissue Collection|Pre-Intervention rFNA Through Follow-Up||64
9084928|NCT00290758|10149392|FG000|Randomization|Pre-Intervention rFNA Through Follow-Up||62
9084929|NCT00290758|10149393|FG001|Randomization|Pre-Intervention rFNA Through Follow-Up||62
9084930|NCT00290758|10149392|FG000|Treatment|Pre-Intervention rFNA Through Follow-Up||61
9084931|NCT00290758|10149393|FG001|Treatment|Pre-Intervention rFNA Through Follow-Up||64
9084932|NCT00290758|10149392|FG000|Post Intervention Follow-Up|Pre-Intervention rFNA Through Follow-Up||55
9084933|NCT00290758|10149393|FG001|Post Intervention Follow-Up|Pre-Intervention rFNA Through Follow-Up||54
9084934|NCT00290758|10149392|FG000|COMPLETED|Pre-Intervention rFNA Through Follow-Up||55
9084935|NCT00290758|10149393|FG001|COMPLETED|Pre-Intervention rFNA Through Follow-Up||54
9084936|NCT00290758|10149392|FG000|NOT COMPLETED|Pre-Intervention rFNA Through Follow-Up||7
9084937|NCT00290758|10149393|FG001|NOT COMPLETED|Pre-Intervention rFNA Through Follow-Up||10
9084938|NCT00290758|10149392|FG000|STARTED|Post Intervention rFNA||55
9084939|NCT00290758|10149393|FG001|STARTED|Post Intervention rFNA||54
9084940|NCT00290758|10149392|FG000|COMPLETED|Post Intervention rFNA||49
9084941|NCT00290758|10149393|FG001|COMPLETED|Post Intervention rFNA||49
9084942|NCT00290758|10149392|FG000|NOT COMPLETED|Post Intervention rFNA||6
9084943|NCT00290758|10149393|FG001|NOT COMPLETED|Post Intervention rFNA||5
9084944|NCT00310388|10149403|FG000|STARTED|Primary Reporting Phase||376
9084945|NCT00310388|10149404|FG001|STARTED|Primary Reporting Phase||0
9084946|NCT00310388|10149403|FG000|COMPLETED|Primary Reporting Phase||30
9084947|NCT00310388|10149404|FG001|COMPLETED|Primary Reporting Phase||0
9084948|NCT00310388|10149403|FG000|NOT COMPLETED|Primary Reporting Phase||346
9084949|NCT00310388|10149404|FG001|NOT COMPLETED|Primary Reporting Phase||0
9084950|NCT00310388|10149403|FG000|STARTED|Safety Follow-up Continuation Phase||0
9084951|NCT00310388|10149404|FG001|STARTED|Safety Follow-up Continuation Phase||26
9084952|NCT00310388|10149403|FG000|COMPLETED|Safety Follow-up Continuation Phase||0
9084953|NCT00310388|10149404|FG001|COMPLETED|Safety Follow-up Continuation Phase||13
9084954|NCT00310388|10149403|FG000|NOT COMPLETED|Safety Follow-up Continuation Phase||0
9084955|NCT00310388|10149404|FG001|NOT COMPLETED|Safety Follow-up Continuation Phase||13
9084956|NCT00345358|10149413|FG000|STARTED|Primary Vaccination Phase||150
9084957|NCT00345358|10149414|FG001|STARTED|Primary Vaccination Phase||150
9084958|NCT00345358|10149415|FG002|STARTED|Primary Vaccination Phase||150
9084959|NCT00345358|10149416|FG003|STARTED|Primary Vaccination Phase||150
9084960|NCT00345358|10149413|FG000|COMPLETED|Primary Vaccination Phase||145
9084961|NCT00345358|10149414|FG001|COMPLETED|Primary Vaccination Phase||146
9084962|NCT00345358|10149415|FG002|COMPLETED|Primary Vaccination Phase||142
9084963|NCT00345358|10149416|FG003|COMPLETED|Primary Vaccination Phase||148
9084964|NCT00345358|10149413|FG000|NOT COMPLETED|Primary Vaccination Phase||5
9084965|NCT00345358|10149414|FG001|NOT COMPLETED|Primary Vaccination Phase||4
9084966|NCT00345358|10149415|FG002|NOT COMPLETED|Primary Vaccination Phase||8
9084967|NCT00345358|10149416|FG003|NOT COMPLETED|Primary Vaccination Phase||2
9084968|NCT00345358|10149413|FG000|STARTED|Booster Vaccination Phase||145
9084969|NCT00345358|10149414|FG001|STARTED|Booster Vaccination Phase||145
9084970|NCT00345358|10149415|FG002|STARTED|Booster Vaccination Phase||0
9084971|NCT00345358|10149416|FG003|STARTED|Booster Vaccination Phase||0
9084972|NCT00345358|10149413|FG000|COMPLETED|Booster Vaccination Phase||141
9084973|NCT00345358|10149414|FG001|COMPLETED|Booster Vaccination Phase||145
9084974|NCT00345358|10149415|FG002|COMPLETED|Booster Vaccination Phase||0
9084975|NCT00345358|10149416|FG003|COMPLETED|Booster Vaccination Phase||0
9084976|NCT00345358|10149413|FG000|NOT COMPLETED|Booster Vaccination Phase||4
9084977|NCT00345358|10149414|FG001|NOT COMPLETED|Booster Vaccination Phase||0
9084978|NCT00345358|10149415|FG002|NOT COMPLETED|Booster Vaccination Phase||0
9084979|NCT00345358|10149416|FG003|NOT COMPLETED|Booster Vaccination Phase||0
9084980|NCT00345800|10149426|FG000|STARTED|Overall Study||25
9084981|NCT00345800|10149426|FG000|COMPLETED|Overall Study||25
9084982|NCT00345800|10149426|FG000|NOT COMPLETED|Overall Study||0
9084983|NCT00372229|10149432|FG000|STARTED|Study Phase||148
9084984|NCT00372229|10149433|FG001|STARTED|Study Phase||151
9084985|NCT00372229|10149432|FG000|COMPLETED|Study Phase||117
9084986|NCT00372229|10149433|FG001|COMPLETED|Study Phase||122
9084987|NCT00372229|10149432|FG000|NOT COMPLETED|Study Phase||31
9084988|NCT00372229|10149433|FG001|NOT COMPLETED|Study Phase||29
9084989|NCT00372229|10149432|FG000|STARTED|Follow-Up Phase||117
9084990|NCT00372229|10149433|FG001|STARTED|Follow-Up Phase||122
9084991|NCT00372229|10149432|FG000|COMPLETED|Follow-Up Phase||71
9084992|NCT00372229|10149433|FG001|COMPLETED|Follow-Up Phase||70
9084993|NCT00372229|10149432|FG000|NOT COMPLETED|Follow-Up Phase||46
9084994|NCT00372229|10149433|FG001|NOT COMPLETED|Follow-Up Phase||52
9084995|NCT00383708|10149443|FG000|STARTED|Enrolment Through Start Treatment||125
9084996|NCT00383708|10149443|FG000|COMPLETED|Enrolment Through Start Treatment||92
9084997|NCT00383708|10149443|FG000|NOT COMPLETED|Enrolment Through Start Treatment||33
8844691|NCT01711359|9899132|FG000|COMPLETED|Treatment Period||161
8844692|NCT01711359|9899133|FG001|COMPLETED|Treatment Period||136
8844693|NCT01711359|9899134|FG002|COMPLETED|Treatment Period||173
8844694|NCT01711359|9899132|FG000|NOT COMPLETED|Treatment Period||52
8844695|NCT01711359|9899133|FG001|NOT COMPLETED|Treatment Period||24
8844696|NCT01711359|9899134|FG002|NOT COMPLETED|Treatment Period||42
8844697|NCT01711359|9899132|FG000|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|25
8844698|NCT01711359|9899133|FG001|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|15
8844699|NCT01711359|9899134|FG002|STARTED|Follow Up|Participants from treatment and rescue who entered the post-treatment follow-up period.|28
8844700|NCT01711359|9899132|FG000|COMPLETED|Follow Up||0
8844701|NCT01711359|9899133|FG001|COMPLETED|Follow Up||0
8844702|NCT01711359|9899134|FG002|COMPLETED|Follow Up||0
8844703|NCT01711359|9899132|FG000|NOT COMPLETED|Follow Up||25
8844704|NCT01711359|9899133|FG001|NOT COMPLETED|Follow Up||15
8844705|NCT01711359|9899134|FG002|NOT COMPLETED|Follow Up||28
9084998|NCT00383708|10149443|FG000|STARTED|Run-in Period||92
9084999|NCT00383708|10149443|FG000|COMPLETED|Run-in Period||85
9085000|NCT00383708|10149443|FG000|NOT COMPLETED|Run-in Period||7
9085001|NCT00383708|10149443|FG000|STARTED|Co-administration Period||57
9085002|NCT00383708|10149443|FG000|COMPLETED|Co-administration Period||52
9085003|NCT00383708|10149443|FG000|NOT COMPLETED|Co-administration Period||5
9085004|NCT00413699|10149450|FG000|STARTED|Initial Period||1123
9085005|NCT00413699|10149451|FG001|STARTED|Initial Period||3358
9085006|NCT00413699|10149452|FG002|STARTED|Initial Period||0
9085007|NCT00413699|10149450|FG000|COMPLETED|Initial Period||484
9085008|NCT00413699|10149451|FG001|COMPLETED|Initial Period||1653
9085009|NCT00413699|10149452|FG002|COMPLETED|Initial Period||0
9085010|NCT00413699|10149450|FG000|NOT COMPLETED|Initial Period||639
9085011|NCT00413699|10149451|FG001|NOT COMPLETED|Initial Period||1705
8844706|NCT01711372|9899149|FG000|STARTED|Overall Study||66
8844707|NCT01711372|9899150|FG001|STARTED|Overall Study||47
9085012|NCT00413699|10149452|FG002|NOT COMPLETED|Initial Period||0
9085013|NCT00413699|10149450|FG000|STARTED|Extension Period||0
9085014|NCT00413699|10149451|FG001|STARTED|Extension Period||0
9085015|NCT00413699|10149452|FG002|STARTED|Extension Period||48
9085016|NCT00413699|10149450|FG000|COMPLETED|Extension Period||0
9085017|NCT00413699|10149451|FG001|COMPLETED|Extension Period||0
9085018|NCT00413699|10149452|FG002|COMPLETED|Extension Period||43
9085019|NCT00413699|10149450|FG000|NOT COMPLETED|Extension Period||0
9085020|NCT00413699|10149451|FG001|NOT COMPLETED|Extension Period||0
9085021|NCT00413699|10149452|FG002|NOT COMPLETED|Extension Period||5
8624686|NCT00502593|9664076|FG006|COMPLETED|Overall Study||44
8624687|NCT00502593|9664077|FG007|COMPLETED|Overall Study||17
8624688|NCT00502593|9664078|FG008|COMPLETED|Overall Study||43
8624689|NCT00502593|9664079|FG009|COMPLETED|Overall Study||17
8624690|NCT00502593|9664080|FG010|COMPLETED|Overall Study||47
8624691|NCT00502593|9664081|FG011|COMPLETED|Overall Study||18
9085022|NCT00435227|10149480|FG000|STARTED|Overall Study||5
9085023|NCT00435227|10149481|FG001|STARTED|Overall Study||7
9085024|NCT00435227|10149480|FG000|COMPLETED|Overall Study||5
9085025|NCT00435227|10149481|FG001|COMPLETED|Overall Study||7
9085026|NCT00435227|10149480|FG000|NOT COMPLETED|Overall Study||0
9085027|NCT00435227|10149481|FG001|NOT COMPLETED|Overall Study||0
9085082|NCT00442546|10149514|FG000|STARTED|Overall Study||103
9085083|NCT00442546|10149515|FG001|STARTED|Overall Study||100
9085084|NCT00442546|10149516|FG002|STARTED|Overall Study||104
9085085|NCT00442546|10149514|FG000|Received Treatment|Overall Study||98
9085086|NCT00442546|10149515|FG001|Received Treatment|Overall Study||96
9085087|NCT00442546|10149516|FG002|Received Treatment|Overall Study||98
9085088|NCT00442546|10149514|FG000|COMPLETED|Overall Study||77
9085089|NCT00442546|10149515|FG001|COMPLETED|Overall Study||63
9085090|NCT00442546|10149516|FG002|COMPLETED|Overall Study||71
9085091|NCT00442546|10149514|FG000|NOT COMPLETED|Overall Study||26
9085092|NCT00442546|10149515|FG001|NOT COMPLETED|Overall Study||37
9085093|NCT00442546|10149516|FG002|NOT COMPLETED|Overall Study||33
9085094|NCT04715932|10149528|FG000|STARTED|Overall Study||107
9085095|NCT04715932|10149529|FG001|STARTED|Overall Study||109
9085096|NCT04715932|10149528|FG000|COMPLETED|Overall Study||106
9085097|NCT04715932|10149529|FG001|COMPLETED|Overall Study||109
9085098|NCT04715932|10149528|FG000|NOT COMPLETED|Overall Study||1
9085099|NCT04715932|10149529|FG001|NOT COMPLETED|Overall Study||0
9085100|NCT04666441|10149543|FG000|STARTED|Overall Study||82
9085101|NCT04666441|10149544|FG001|STARTED|Overall Study||165
9085102|NCT04666441|10149545|FG002|STARTED|Overall Study||162
9085103|NCT04666441|10149546|FG003|STARTED|Overall Study||165
9085104|NCT04666441|10149547|FG004|STARTED|Overall Study||166
9085105|NCT04666441|10149548|FG005|STARTED|Overall Study||82
9085106|NCT04666441|10149549|FG006|STARTED|Overall Study||163
9085107|NCT04666441|10149550|FG007|STARTED|Overall Study||164
9085108|NCT04666441|10149543|FG000|COMPLETED|Overall Study||80
9085109|NCT04666441|10149544|FG001|COMPLETED|Overall Study||160
9085110|NCT04666441|10149545|FG002|COMPLETED|Overall Study||158
9085111|NCT04666441|10149546|FG003|COMPLETED|Overall Study||161
9085112|NCT04666441|10149547|FG004|COMPLETED|Overall Study||166
9085113|NCT04666441|10149548|FG005|COMPLETED|Overall Study||79
9085114|NCT04666441|10149549|FG006|COMPLETED|Overall Study||158
9085115|NCT04666441|10149550|FG007|COMPLETED|Overall Study||160
9085116|NCT04666441|10149543|FG000|NOT COMPLETED|Overall Study||2
9085117|NCT04666441|10149544|FG001|NOT COMPLETED|Overall Study||5
9085118|NCT04666441|10149545|FG002|NOT COMPLETED|Overall Study||4
9085119|NCT04666441|10149546|FG003|NOT COMPLETED|Overall Study||4
9085120|NCT04666441|10149547|FG004|NOT COMPLETED|Overall Study||0
9085121|NCT04666441|10149548|FG005|NOT COMPLETED|Overall Study||3
9085122|NCT04666441|10149549|FG006|NOT COMPLETED|Overall Study||5
9085123|NCT04666441|10149550|FG007|NOT COMPLETED|Overall Study||4
9085124|NCT04593641|10149581|FG000|STARTED|Overall Study||5
9085125|NCT04593641|10149582|FG001|STARTED|Overall Study||5
9085126|NCT04593641|10149583|FG002|STARTED|Overall Study||5
9085127|NCT04593641|10149584|FG003|STARTED|Overall Study||3
9085128|NCT04593641|10149581|FG000|COMPLETED|Overall Study||4
9085129|NCT04593641|10149582|FG001|COMPLETED|Overall Study||5
9085130|NCT04593641|10149583|FG002|COMPLETED|Overall Study||5
9085131|NCT04593641|10149584|FG003|COMPLETED|Overall Study||3
9085132|NCT04593641|10149581|FG000|NOT COMPLETED|Overall Study||1
9085133|NCT04593641|10149582|FG001|NOT COMPLETED|Overall Study||0
9085134|NCT04593641|10149583|FG002|NOT COMPLETED|Overall Study||0
9085135|NCT04593641|10149584|FG003|NOT COMPLETED|Overall Study||0
9085136|NCT04381052|10149596|FG000|STARTED|Overall Study||1
9085137|NCT04381052|10149596|FG000|COMPLETED|Overall Study||1
9085138|NCT04381052|10149596|FG000|NOT COMPLETED|Overall Study||0
9085139|NCT04259346|10149604|FG000|STARTED|Overall Study||126
9085140|NCT04259346|10149605|FG001|STARTED|Overall Study||119
9085141|NCT04259346|10149604|FG000|Received at Least One Dose of Study Drug|Overall Study||126
9085142|NCT04259346|10149605|FG001|Received at Least One Dose of Study Drug|Overall Study||119
9085143|NCT04259346|10149604|FG000|COMPLETED|Overall Study||122
9085144|NCT04259346|10149605|FG001|COMPLETED|Overall Study||115
9085145|NCT04259346|10149604|FG000|NOT COMPLETED|Overall Study||4
9085146|NCT04259346|10149605|FG001|NOT COMPLETED|Overall Study||4
9085147|NCT03959423|10149613|FG000|STARTED|Overall Study||160
9085148|NCT03959423|10149614|FG001|STARTED|Overall Study||128
9085149|NCT03959423|10149613|FG000|COMPLETED|Overall Study||151
9085150|NCT03959423|10149614|FG001|COMPLETED|Overall Study||124
9085151|NCT03959423|10149613|FG000|NOT COMPLETED|Overall Study||9
9085152|NCT03959423|10149614|FG001|NOT COMPLETED|Overall Study||4
9085153|NCT03713320|10149622|FG000|STARTED|Randomized Period||19
9085154|NCT03713320|10149623|FG001|STARTED|Randomized Period||18
9085155|NCT03713320|10149624|FG002|STARTED|Randomized Period||0
9085156|NCT03713320|10149622|FG000|COMPLETED|Randomized Period||4
9085157|NCT03713320|10149623|FG001|COMPLETED|Randomized Period||8
9085158|NCT03713320|10149624|FG002|COMPLETED|Randomized Period||0
9085159|NCT03713320|10149622|FG000|NOT COMPLETED|Randomized Period||15
9085160|NCT03713320|10149623|FG001|NOT COMPLETED|Randomized Period||10
9085161|NCT03713320|10149624|FG002|NOT COMPLETED|Randomized Period||0
9085162|NCT03713320|10149622|FG000|STARTED|Cobomarsen Crossover Period||0
9085163|NCT03713320|10149623|FG001|STARTED|Cobomarsen Crossover Period||0
9085164|NCT03713320|10149624|FG002|STARTED|Cobomarsen Crossover Period||7
9085165|NCT03713320|10149622|FG000|COMPLETED|Cobomarsen Crossover Period||0
9085166|NCT03713320|10149623|FG001|COMPLETED|Cobomarsen Crossover Period||0
9085028|NCT00436826|10149490|FG000|STARTED|Double Blind Period (DBP)||124
9085029|NCT00436826|10149491|FG001|STARTED|Double Blind Period (DBP)||48
9085030|NCT00436826|10149492|FG002|STARTED|Double Blind Period (DBP)||0
9085031|NCT00436826|10149493|FG003|STARTED|Double Blind Period (DBP)||0
9085032|NCT00436826|10149494|FG004|STARTED|Double Blind Period (DBP)||0
9085033|NCT00436826|10149495|FG005|STARTED|Double Blind Period (DBP)||0
9085034|NCT00436826|10149490|FG000|COMPLETED|Double Blind Period (DBP)||111
9085035|NCT00436826|10149491|FG001|COMPLETED|Double Blind Period (DBP)||37
9085036|NCT00436826|10149492|FG002|COMPLETED|Double Blind Period (DBP)||0
9085037|NCT00436826|10149493|FG003|COMPLETED|Double Blind Period (DBP)||0
9085038|NCT00436826|10149494|FG004|COMPLETED|Double Blind Period (DBP)||0
9085039|NCT00436826|10149495|FG005|COMPLETED|Double Blind Period (DBP)||0
9085040|NCT00436826|10149490|FG000|NOT COMPLETED|Double Blind Period (DBP)||13
9085041|NCT00436826|10149491|FG001|NOT COMPLETED|Double Blind Period (DBP)||11
9085042|NCT00436826|10149492|FG002|NOT COMPLETED|Double Blind Period (DBP)||0
9085043|NCT00436826|10149493|FG003|NOT COMPLETED|Double Blind Period (DBP)||0
9085044|NCT00436826|10149494|FG004|NOT COMPLETED|Double Blind Period (DBP)||0
9085045|NCT00436826|10149495|FG005|NOT COMPLETED|Double Blind Period (DBP)||0
9085046|NCT00436826|10149490|FG000|STARTED|Ext. Period (With Cladribine Treatment)||0
9085047|NCT00436826|10149491|FG001|STARTED|Ext. Period (With Cladribine Treatment)||0
9085048|NCT00436826|10149492|FG002|STARTED|Ext. Period (With Cladribine Treatment)||47
9085049|NCT00436826|10149493|FG003|STARTED|Ext. Period (With Cladribine Treatment)||28
9085050|NCT00436826|10149494|FG004|STARTED|Ext. Period (With Cladribine Treatment)||0
9085051|NCT00436826|10149495|FG005|STARTED|Ext. Period (With Cladribine Treatment)||0
9085052|NCT00436826|10149490|FG000|COMPLETED|Ext. Period (With Cladribine Treatment)||0
9085053|NCT00436826|10149491|FG001|COMPLETED|Ext. Period (With Cladribine Treatment)||0
9085054|NCT00436826|10149492|FG002|COMPLETED|Ext. Period (With Cladribine Treatment)||1
9085055|NCT00436826|10149493|FG003|COMPLETED|Ext. Period (With Cladribine Treatment)||2
9085056|NCT00436826|10149494|FG004|COMPLETED|Ext. Period (With Cladribine Treatment)||0
9085057|NCT00436826|10149495|FG005|COMPLETED|Ext. Period (With Cladribine Treatment)||0
9085058|NCT00436826|10149490|FG000|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
9085059|NCT00436826|10149491|FG001|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
9085060|NCT00436826|10149492|FG002|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||46
9085061|NCT00436826|10149493|FG003|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||26
9085062|NCT00436826|10149494|FG004|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
9085063|NCT00436826|10149495|FG005|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
9085064|NCT00436826|10149490|FG000|STARTED|Ext. Period (No Cladribine Treatment)||0
9085065|NCT00436826|10149491|FG001|STARTED|Ext. Period (No Cladribine Treatment)||0
9085066|NCT00436826|10149492|FG002|STARTED|Ext. Period (No Cladribine Treatment)||0
9085067|NCT00436826|10149493|FG003|STARTED|Ext. Period (No Cladribine Treatment)||0
9085068|NCT00436826|10149494|FG004|STARTED|Ext. Period (No Cladribine Treatment)||52
9085069|NCT00436826|10149495|FG005|STARTED|Ext. Period (No Cladribine Treatment)||7
9085070|NCT00436826|10149490|FG000|COMPLETED|Ext. Period (No Cladribine Treatment)||0
9085071|NCT00436826|10149491|FG001|COMPLETED|Ext. Period (No Cladribine Treatment)||0
9085072|NCT00436826|10149492|FG002|COMPLETED|Ext. Period (No Cladribine Treatment)||0
9085073|NCT00436826|10149493|FG003|COMPLETED|Ext. Period (No Cladribine Treatment)||0
9085074|NCT00436826|10149494|FG004|COMPLETED|Ext. Period (No Cladribine Treatment)||1
9085075|NCT00436826|10149495|FG005|COMPLETED|Ext. Period (No Cladribine Treatment)||0
9085076|NCT00436826|10149490|FG000|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
9085077|NCT00436826|10149491|FG001|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
9085078|NCT00436826|10149492|FG002|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
9085079|NCT00436826|10149493|FG003|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
9085080|NCT00436826|10149494|FG004|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||51
9085081|NCT00436826|10149495|FG005|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||7
9085167|NCT03713320|10149624|FG002|COMPLETED|Cobomarsen Crossover Period||0
9085168|NCT03713320|10149622|FG000|NOT COMPLETED|Cobomarsen Crossover Period||0
9085169|NCT03713320|10149623|FG001|NOT COMPLETED|Cobomarsen Crossover Period||0
9085170|NCT03713320|10149624|FG002|NOT COMPLETED|Cobomarsen Crossover Period||7
9085171|NCT03429049|10149633|FG000|STARTED|Overall Study||138
9085172|NCT03429049|10149634|FG001|STARTED|Overall Study||194
9085173|NCT03429049|10149633|FG000|Treated|Overall Study||136
9085174|NCT03429049|10149634|FG001|Treated|Overall Study||189
8624692|NCT00502593|9664070|FG000|NOT COMPLETED|Overall Study||3
8624693|NCT00502593|9664071|FG001|NOT COMPLETED|Overall Study||2
9085175|NCT03429049|10149633|FG000|COMPLETED|Overall Study||110
9085176|NCT03429049|10149634|FG001|COMPLETED|Overall Study||152
9085177|NCT03429049|10149633|FG000|NOT COMPLETED|Overall Study||28
9085178|NCT03429049|10149634|FG001|NOT COMPLETED|Overall Study||42
9085179|NCT03409731|10149640|FG000|STARTED|Overall Study||135
9085180|NCT03409731|10149640|FG000|COMPLETED|Overall Study||132
9085181|NCT03409731|10149640|FG000|NOT COMPLETED|Overall Study||3
9085182|NCT03283566|10149646|FG000|STARTED|Overall Study||4
9085183|NCT03283566|10149647|FG001|STARTED|Overall Study||5
9085184|NCT03283566|10149646|FG000|COMPLETED|Overall Study||3
9085185|NCT03283566|10149647|FG001|COMPLETED|Overall Study||3
9085186|NCT03283566|10149646|FG000|NOT COMPLETED|Overall Study||1
9085187|NCT03283566|10149647|FG001|NOT COMPLETED|Overall Study||2
8624694|NCT00502593|9664072|FG002|NOT COMPLETED|Overall Study||10
9085188|NCT03077412|10149656|FG000|STARTED|Overall Study||17
9085189|NCT03077412|10149657|FG001|STARTED|Overall Study||25
9085190|NCT03077412|10149658|FG002|STARTED|Overall Study||15
9085191|NCT03077412|10149656|FG000|COMPLETED|Overall Study||14
9085192|NCT03077412|10149657|FG001|COMPLETED|Overall Study||12
9085193|NCT03077412|10149658|FG002|COMPLETED|Overall Study||6
9085194|NCT03077412|10149656|FG000|NOT COMPLETED|Overall Study||3
9085195|NCT03077412|10149657|FG001|NOT COMPLETED|Overall Study||13
9085196|NCT03077412|10149658|FG002|NOT COMPLETED|Overall Study||9
9085197|NCT03026504|10149666|FG000|STARTED|Overall Study||15
9085198|NCT03026504|10149666|FG000|COMPLETED|Overall Study||14
9085199|NCT03026504|10149666|FG000|NOT COMPLETED|Overall Study||1
9085200|NCT02971956|10149670|FG000|STARTED|Overall Study||49
9085201|NCT02971956|10149670|FG000|COMPLETED|Overall Study||49
9085202|NCT02971956|10149670|FG000|NOT COMPLETED|Overall Study||0
9085203|NCT02915367|10149676|FG000|STARTED|Overall Study||173
9085204|NCT02915367|10149677|FG001|STARTED|Overall Study||175
9085205|NCT02915367|10149676|FG000|COMPLETED|Overall Study||136
9085206|NCT02915367|10149677|FG001|COMPLETED|Overall Study||144
9085207|NCT02915367|10149676|FG000|NOT COMPLETED|Overall Study||37
9085208|NCT02915367|10149677|FG001|NOT COMPLETED|Overall Study||31
9085209|NCT02665143|10149683|FG000|STARTED|Phase 1||6
9085210|NCT02665143|10149683|FG000|COMPLETED|Phase 1||6
9085211|NCT02665143|10149683|FG000|NOT COMPLETED|Phase 1||0
9085212|NCT02665143|10149683|FG000|STARTED|Phase 2|19 Participants were enrolled in Phase 2.|19
9085213|NCT02665143|10149683|FG000|Completed 0 Cycles|Phase 2||1
9085214|NCT02665143|10149683|FG000|Completed 1 Cycle|Phase 2||12
9085215|NCT02665143|10149683|FG000|Completed 2 Cycles|Phase 2||3
9085216|NCT02665143|10149683|FG000|Completed 3 Cycles|Phase 2||3
9085217|NCT02665143|10149683|FG000|COMPLETED|Phase 2||19
9085218|NCT02665143|10149683|FG000|NOT COMPLETED|Phase 2||0
9085219|NCT02550470|10149691|FG000|STARTED|Overall Study|"time to reach FiO2 of 4 mm Hg was recorded for each absorbent in the anesthesia circuit~Absorbent units other than participants were assigned to Arms/Groups"|
9085220|NCT02550470|10149692|FG001|STARTED|Overall Study|"time to reach FiO2 of 4 mm Hg was recorded for each absorbent in the anesthesia circuit~Absorbent units other than participants were assigned to Arms/Groups"|
9085221|NCT02550470|10149693|FG002|STARTED|Overall Study|"time to reach FiO2 of 4 mm Hg was recorded for each absorbent in the anesthesia circuit~Absorbent units other than participants were assigned to Arms/Groups"|
9085222|NCT02550470|10149691|FG000|COMPLETED|Overall Study|"time to reach FiO2 of 4 mm Hg was recorded for each absorbent in the anesthesia circuit~Absorbent units other than participants were assigned to Arms/Groups"|
9085223|NCT02550470|10149692|FG001|COMPLETED|Overall Study|"time to reach FiO2 of 4 mm Hg was recorded for each absorbent in the anesthesia circuit~Absorbent units other than participants were assigned to Arms/Groups"|
9085224|NCT02550470|10149693|FG002|COMPLETED|Overall Study|"time to reach FiO2 of 4 mm Hg was recorded for each absorbent in the anesthesia circuit~Absorbent units other than participants were assigned to Arms/Groups"|
9085225|NCT02550470|10149691|FG000|NOT COMPLETED|Overall Study||
9085226|NCT02550470|10149692|FG001|NOT COMPLETED|Overall Study||
9085227|NCT02550470|10149693|FG002|NOT COMPLETED|Overall Study||
9085228|NCT02384850|10149703|FG000|STARTED|Overall Study||4
9085229|NCT02384850|10149704|FG001|STARTED|Overall Study||6
9085230|NCT02384850|10149703|FG000|COMPLETED|Overall Study||2
9085231|NCT02384850|10149704|FG001|COMPLETED|Overall Study||4
9085232|NCT02384850|10149703|FG000|NOT COMPLETED|Overall Study||2
9085233|NCT02384850|10149704|FG001|NOT COMPLETED|Overall Study||2
9085234|NCT02352090|10149713|FG000|STARTED|Overall Study||20
9085235|NCT02352090|10149714|FG001|STARTED|Overall Study||20
9085236|NCT02352090|10149715|FG002|STARTED|Overall Study||19
9085237|NCT02352090|10149713|FG000|COMPLETED|Overall Study||19
9085238|NCT02352090|10149714|FG001|COMPLETED|Overall Study||20
9085239|NCT02352090|10149715|FG002|COMPLETED|Overall Study||17
9085240|NCT02352090|10149713|FG000|NOT COMPLETED|Overall Study||1
9085241|NCT02352090|10149714|FG001|NOT COMPLETED|Overall Study||0
9085242|NCT02352090|10149715|FG002|NOT COMPLETED|Overall Study||2
9085243|NCT01976091|10149726|FG000|STARTED|Overall Study||1
9085244|NCT01976091|10149727|FG001|STARTED|Overall Study||3
9085245|NCT01976091|10149728|FG002|STARTED|Overall Study||2
9085246|NCT01976091|10149726|FG000|Received at Least 1 Dose of Study Drug|Overall Study||1
9085247|NCT01976091|10149727|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
9085248|NCT01976091|10149728|FG002|Received at Least 1 Dose of Study Drug|Overall Study||2
9085249|NCT01976091|10149726|FG000|COMPLETED|Overall Study||1
9085250|NCT01976091|10149727|FG001|COMPLETED|Overall Study||3
9085251|NCT01976091|10149728|FG002|COMPLETED|Overall Study||2
9085252|NCT01976091|10149726|FG000|NOT COMPLETED|Overall Study||0
9085253|NCT01976091|10149727|FG001|NOT COMPLETED|Overall Study||0
9085254|NCT01976091|10149728|FG002|NOT COMPLETED|Overall Study||0
9085255|NCT01145209|10149738|FG000|STARTED|Overall Study||13
9085256|NCT01145209|10149739|FG001|STARTED|Overall Study||19
9085257|NCT01145209|10149738|FG000|COMPLETED|Overall Study||10
9085258|NCT01145209|10149739|FG001|COMPLETED|Overall Study||18
9085259|NCT01145209|10149738|FG000|NOT COMPLETED|Overall Study||3
9085260|NCT01145209|10149739|FG001|NOT COMPLETED|Overall Study||1
9085261|NCT01078662|10149750|FG000|STARTED|Overall Study||62
9085262|NCT01078662|10149751|FG001|STARTED|Overall Study||193
9085263|NCT01078662|10149752|FG002|STARTED|Overall Study||23
9085264|NCT01078662|10149753|FG003|STARTED|Overall Study||8
9085265|NCT01078662|10149754|FG004|STARTED|Overall Study||12
9085266|NCT01078662|10149750|FG000|COMPLETED|Overall Study||4
9085267|NCT01078662|10149751|FG001|COMPLETED|Overall Study||25
9085268|NCT01078662|10149752|FG002|COMPLETED|Overall Study||2
9085269|NCT01078662|10149753|FG003|COMPLETED|Overall Study||1
9085270|NCT01078662|10149754|FG004|COMPLETED|Overall Study||1
9085271|NCT01078662|10149750|FG000|NOT COMPLETED|Overall Study||58
9085272|NCT01078662|10149751|FG001|NOT COMPLETED|Overall Study||168
9085273|NCT01078662|10149752|FG002|NOT COMPLETED|Overall Study||21
8624695|NCT00502593|9664073|FG003|NOT COMPLETED|Overall Study||4
8624696|NCT00502593|9664074|FG004|NOT COMPLETED|Overall Study||4
8624697|NCT00502593|9664075|FG005|NOT COMPLETED|Overall Study||0
8624698|NCT00502593|9664076|FG006|NOT COMPLETED|Overall Study||5
8624699|NCT00502593|9664077|FG007|NOT COMPLETED|Overall Study||0
8624700|NCT00502593|9664078|FG008|NOT COMPLETED|Overall Study||6
8624701|NCT00502593|9664079|FG009|NOT COMPLETED|Overall Study||0
8624702|NCT00502593|9664080|FG010|NOT COMPLETED|Overall Study||2
8624703|NCT00502593|9664081|FG011|NOT COMPLETED|Overall Study||0
9085274|NCT01078662|10149753|FG003|NOT COMPLETED|Overall Study||7
9085275|NCT01078662|10149754|FG004|NOT COMPLETED|Overall Study||11
9085276|NCT00971867|10149763|FG000|STARTED|Overall Study||11
9085277|NCT00971867|10149763|FG000|COMPLETED|Overall Study||0
9085278|NCT00971867|10149763|FG000|NOT COMPLETED|Overall Study||11
9085279|NCT00853307|10149769|FG000|STARTED|Overall Study||6
9085280|NCT00853307|10149770|FG001|STARTED|Overall Study||25
9085281|NCT00853307|10149769|FG000|COMPLETED|Overall Study|Completed = participants who completed the study treatment.|4
9085282|NCT00853307|10149770|FG001|COMPLETED|Overall Study||20
9085283|NCT00853307|10149769|FG000|NOT COMPLETED|Overall Study||2
9085284|NCT00853307|10149770|FG001|NOT COMPLETED|Overall Study||5
9085285|NCT00583804|10149776|FG000|STARTED|Overall Study||10
9085286|NCT00583804|10149776|FG000|COMPLETED|Overall Study|Subjects were considered enrolled when they underwent implantation of the device. All completed.|10
9085287|NCT00583804|10149776|FG000|NOT COMPLETED|Overall Study||0
8624704|NCT00502671|9664130|FG000|STARTED|Overall Study||228
8624705|NCT00502671|9664130|FG000|COMPLETED|Overall Study||151
8624706|NCT00502671|9664130|FG000|NOT COMPLETED|Overall Study||77
8624707|NCT00502697|9664136|FG000|STARTED|Overall Study||122
8624708|NCT00502697|9664137|FG001|STARTED|Overall Study||114
8624709|NCT00502697|9664136|FG000|COMPLETED|Overall Study||109
9085288|NCT00545129|10149784|FG000|STARTED|Overall Study||29
9085289|NCT00545129|10149785|FG001|STARTED|Overall Study||30
9085290|NCT00545129|10149784|FG000|COMPLETED|Overall Study||12
9085291|NCT00545129|10149785|FG001|COMPLETED|Overall Study||6
9085292|NCT00545129|10149784|FG000|NOT COMPLETED|Overall Study||17
9085293|NCT00545129|10149785|FG001|NOT COMPLETED|Overall Study||24
9085300|NCT00554606|10149803|FG000|STARTED|Overall Study||115
9085301|NCT00554606|10149803|FG000|COMPLETED|Overall Study||30
9085302|NCT00554606|10149803|FG000|NOT COMPLETED|Overall Study||85
9085303|NCT00555009|10149811|FG000|STARTED|Overall Study||4
9085304|NCT00555009|10149812|FG001|STARTED|Overall Study||6
9085305|NCT00555009|10149811|FG000|COMPLETED|Overall Study||2
9085306|NCT00555009|10149812|FG001|COMPLETED|Overall Study||0
9085307|NCT00555009|10149811|FG000|NOT COMPLETED|Overall Study||2
9085308|NCT00555009|10149812|FG001|NOT COMPLETED|Overall Study||6
9085309|NCT00565461|10149822|FG000|STARTED|Overall Study||40
9085310|NCT00565461|10149823|FG001|STARTED|Overall Study||40
9085311|NCT00565461|10149824|FG002|STARTED|Overall Study||40
9085312|NCT00565461|10149825|FG003|STARTED|Overall Study||40
9085313|NCT00565461|10149822|FG000|COMPLETED|Overall Study||40
9085314|NCT00565461|10149823|FG001|COMPLETED|Overall Study||39
9085315|NCT00565461|10149824|FG002|COMPLETED|Overall Study||39
9085316|NCT00565461|10149825|FG003|COMPLETED|Overall Study||37
9085317|NCT00565461|10149822|FG000|NOT COMPLETED|Overall Study||0
9085318|NCT00565461|10149823|FG001|NOT COMPLETED|Overall Study||1
9085319|NCT00565461|10149824|FG002|NOT COMPLETED|Overall Study||1
9085320|NCT00565461|10149825|FG003|NOT COMPLETED|Overall Study||3
9085324|NCT00586924|10149851|FG000|STARTED|Overall Study||3
9085325|NCT00586924|10149852|FG001|STARTED|Overall Study||3
9085326|NCT00586924|10149853|FG002|STARTED|Overall Study||3
9085327|NCT00586924|10149854|FG003|STARTED|Overall Study||3
9085328|NCT00586924|10149855|FG004|STARTED|Overall Study||4
9085329|NCT00586924|10149856|FG005|STARTED|Overall Study||33
9085330|NCT00586924|10149851|FG000|COMPLETED|Overall Study||0
9085331|NCT00586924|10149852|FG001|COMPLETED|Overall Study||0
9085332|NCT00586924|10149853|FG002|COMPLETED|Overall Study||0
9085333|NCT00586924|10149854|FG003|COMPLETED|Overall Study||0
9085334|NCT00586924|10149855|FG004|COMPLETED|Overall Study||0
9085335|NCT00586924|10149856|FG005|COMPLETED|Overall Study||0
9085336|NCT00586924|10149851|FG000|NOT COMPLETED|Overall Study||3
9085337|NCT00586924|10149852|FG001|NOT COMPLETED|Overall Study||3
9085338|NCT00586924|10149853|FG002|NOT COMPLETED|Overall Study||3
9085339|NCT00586924|10149854|FG003|NOT COMPLETED|Overall Study||3
9085340|NCT00586924|10149855|FG004|NOT COMPLETED|Overall Study||4
9085341|NCT00586924|10149856|FG005|NOT COMPLETED|Overall Study||33
9085342|NCT00588861|10149872|FG000|STARTED|Pre-Operative|202 Patients were enrolled, however only 107 contributed preop data.|202
9085343|NCT00588861|10149873|FG001|STARTED|Pre-Operative|200 patients were enrolled, however only 114 contributed preop data.|200
9085344|NCT00588861|10149872|FG000|COMPLETED|Pre-Operative||107
9085345|NCT00588861|10149873|FG001|COMPLETED|Pre-Operative||114
9085346|NCT00588861|10149872|FG000|NOT COMPLETED|Pre-Operative||95
9085347|NCT00588861|10149873|FG001|NOT COMPLETED|Pre-Operative||86
9085348|NCT00588861|10149872|FG000|STARTED|6 Months|107 cases were due at 6 Months, however only 9 returned for follow-up.|107
9085349|NCT00588861|10149873|FG001|STARTED|6 Months|114 cases were due at 6 Months, however only 41 returned for follow-up.|114
9085350|NCT00588861|10149872|FG000|COMPLETED|6 Months||9
9085351|NCT00588861|10149873|FG001|COMPLETED|6 Months||41
9085352|NCT00588861|10149872|FG000|NOT COMPLETED|6 Months||98
9085353|NCT00588861|10149873|FG001|NOT COMPLETED|6 Months||73
9085354|NCT00588861|10149872|FG000|STARTED|1 Year|107 cases were due at 1 Year, however only 18 returned for follow-up.|107
9085355|NCT00588861|10149873|FG001|STARTED|1 Year|114 cases were due at 1 Year, however only 32 returned for follow-up.|114
9085356|NCT00588861|10149872|FG000|COMPLETED|1 Year||18
9085357|NCT00588861|10149873|FG001|COMPLETED|1 Year||32
9085358|NCT00588861|10149872|FG000|NOT COMPLETED|1 Year||89
9085359|NCT00588861|10149873|FG001|NOT COMPLETED|1 Year||82
9085360|NCT00588861|10149872|FG000|STARTED|2 Years|107 cases were due at 2 Years, however only 15 returned for follow-up.|107
9085361|NCT00588861|10149873|FG001|STARTED|2 Years|114 cases were due at 2 Years, however only 27 returned for follow-up.|114
9085362|NCT00588861|10149872|FG000|COMPLETED|2 Years||15
9085363|NCT00588861|10149873|FG001|COMPLETED|2 Years||27
8624710|NCT00502697|9664137|FG001|COMPLETED|Overall Study||102
8624711|NCT00502697|9664136|FG000|NOT COMPLETED|Overall Study||13
9085364|NCT00588861|10149872|FG000|NOT COMPLETED|2 Years||92
9085365|NCT00588861|10149873|FG001|NOT COMPLETED|2 Years||87
9085366|NCT00588861|10149872|FG000|STARTED|4 Years|107 cases were due at 4 Years, however only 16 returned for follow-up.|107
9085367|NCT00588861|10149873|FG001|STARTED|4 Years|114 cases were due at 4 Years, however only 11 returned for follow-up.|114
9085368|NCT00588861|10149872|FG000|COMPLETED|4 Years||16
9085369|NCT00588861|10149873|FG001|COMPLETED|4 Years||11
9085370|NCT00588861|10149872|FG000|NOT COMPLETED|4 Years||91
9085371|NCT00588861|10149873|FG001|NOT COMPLETED|4 Years||103
9085372|NCT00588861|10149872|FG000|STARTED|6 Years|107 cases were due at 6 Years, however only 3 returned for follow-up.|107
9085373|NCT00588861|10149873|FG001|STARTED|6 Years|114 cases were due at 6 Years, however only 5 returned for follow-up.|114
9085374|NCT00588861|10149872|FG000|COMPLETED|6 Years||3
9085375|NCT00588861|10149873|FG001|COMPLETED|6 Years||5
9085376|NCT00588861|10149872|FG000|NOT COMPLETED|6 Years||104
9085377|NCT00588861|10149873|FG001|NOT COMPLETED|6 Years||109
9085378|NCT00588861|10149872|FG000|STARTED|8 Years|107 cases were due at 8 Years, however only 2 returned for follow-up.|107
9085294|NCT00548093|10149793|FG000|STARTED|Overall Study||50
9085295|NCT00548093|10149794|FG001|STARTED|Overall Study||16
9085296|NCT00548093|10149793|FG000|COMPLETED|Overall Study||0
9085297|NCT00548093|10149794|FG001|COMPLETED|Overall Study||0
9085298|NCT00548093|10149793|FG000|NOT COMPLETED|Overall Study||50
9085299|NCT00548093|10149794|FG001|NOT COMPLETED|Overall Study||16
9085321|NCT00566995|10149841|FG000|STARTED|Overall Study||37
9085322|NCT00566995|10149841|FG000|COMPLETED|Overall Study||30
9085323|NCT00566995|10149841|FG000|NOT COMPLETED|Overall Study||7
9085379|NCT00588861|10149873|FG001|STARTED|8 Years|114 cases were due at 8 Years, however no patients returned for follow-up.|114
9085380|NCT00588861|10149872|FG000|COMPLETED|8 Years||2
9085381|NCT00588861|10149873|FG001|COMPLETED|8 Years||0
9085382|NCT00588861|10149872|FG000|NOT COMPLETED|8 Years||105
9085383|NCT00588861|10149873|FG001|NOT COMPLETED|8 Years||114
9085384|NCT00588861|10149872|FG000|STARTED|10 Years|107 cases were due at 10 Years, however no patients returned for follow-up.|107
9085385|NCT00588861|10149873|FG001|STARTED|10 Years|114 cases were due at 10 Years, however no patients returned for follow-up.|114
9085386|NCT00588861|10149872|FG000|COMPLETED|10 Years||0
9085387|NCT00588861|10149873|FG001|COMPLETED|10 Years||0
9085388|NCT00588861|10149872|FG000|NOT COMPLETED|10 Years||107
9085389|NCT00588861|10149873|FG001|NOT COMPLETED|10 Years||114
9085390|NCT04505722|10149881|FG000|STARTED|Overall Study||22174
9085391|NCT04505722|10149882|FG001|STARTED|Overall Study||22150
9085392|NCT04505722|10149881|FG000|Vaccinated|Overall Study||21898
9085393|NCT04505722|10149882|FG001|Vaccinated|Overall Study||21890
9085394|NCT04505722|10149881|FG000|Participants in Entire Double Blind Phase|Overall Study||21894
9085395|NCT04505722|10149882|FG001|Participants in Entire Double Blind Phase|Overall Study||21882
9085396|NCT04505722|10149881|FG000|COMPLETED|Overall Study||0
9085397|NCT04505722|10149882|FG001|COMPLETED|Overall Study||0
9085398|NCT04505722|10149881|FG000|NOT COMPLETED|Overall Study||22174
9085399|NCT04505722|10149882|FG001|NOT COMPLETED|Overall Study||22150
9085400|NCT03400943|10149892|FG000|STARTED|Treatment Period 1||23
9085401|NCT03400943|10149893|FG001|STARTED|Treatment Period 1||23
9085402|NCT03400943|10149894|FG002|STARTED|Treatment Period 1||24
9085403|NCT03400943|10149895|FG003|STARTED|Treatment Period 1||23
9085404|NCT03400943|10149892|FG000|Treated|Treatment Period 1||18
9085405|NCT03400943|10149893|FG001|Treated|Treatment Period 1||21
9085406|NCT03400943|10149894|FG002|Treated|Treatment Period 1||20
9085407|NCT03400943|10149895|FG003|Treated|Treatment Period 1||20
9085408|NCT03400943|10149892|FG000|COMPLETED|Treatment Period 1||18
9085409|NCT03400943|10149893|FG001|COMPLETED|Treatment Period 1||21
9085410|NCT03400943|10149894|FG002|COMPLETED|Treatment Period 1||18
9085411|NCT03400943|10149895|FG003|COMPLETED|Treatment Period 1||18
9085412|NCT03400943|10149892|FG000|NOT COMPLETED|Treatment Period 1||5
9085413|NCT03400943|10149893|FG001|NOT COMPLETED|Treatment Period 1||2
9085414|NCT03400943|10149894|FG002|NOT COMPLETED|Treatment Period 1||6
9085415|NCT03400943|10149895|FG003|NOT COMPLETED|Treatment Period 1||5
9085416|NCT03400943|10149892|FG000|STARTED|Post-treatment Period 1||18
9085417|NCT03400943|10149893|FG001|STARTED|Post-treatment Period 1||0
9085418|NCT03400943|10149894|FG002|STARTED|Post-treatment Period 1||18
9085419|NCT03400943|10149895|FG003|STARTED|Post-treatment Period 1||18
9085420|NCT03400943|10149892|FG000|COMPLETED|Post-treatment Period 1||7
9085421|NCT03400943|10149893|FG001|COMPLETED|Post-treatment Period 1||0
9085422|NCT03400943|10149894|FG002|COMPLETED|Post-treatment Period 1||7
9085423|NCT03400943|10149895|FG003|COMPLETED|Post-treatment Period 1||5
9085424|NCT03400943|10149892|FG000|NOT COMPLETED|Post-treatment Period 1||11
9085425|NCT03400943|10149893|FG001|NOT COMPLETED|Post-treatment Period 1||0
9085426|NCT03400943|10149894|FG002|NOT COMPLETED|Post-treatment Period 1||11
9085427|NCT03400943|10149895|FG003|NOT COMPLETED|Post-treatment Period 1||13
9085428|NCT03400943|10149892|FG000|STARTED|Treatment Period 2||7
9085429|NCT03400943|10149893|FG001|STARTED|Treatment Period 2||21
9085430|NCT03400943|10149894|FG002|STARTED|Treatment Period 2||7
9085431|NCT03400943|10149895|FG003|STARTED|Treatment Period 2||5
9085432|NCT03400943|10149892|FG000|COMPLETED|Treatment Period 2||6
9085433|NCT03400943|10149893|FG001|COMPLETED|Treatment Period 2||13
9085434|NCT03400943|10149894|FG002|COMPLETED|Treatment Period 2||7
9085435|NCT03400943|10149895|FG003|COMPLETED|Treatment Period 2||5
9085436|NCT03400943|10149892|FG000|NOT COMPLETED|Treatment Period 2||1
9085437|NCT03400943|10149893|FG001|NOT COMPLETED|Treatment Period 2||8
9085438|NCT03400943|10149894|FG002|NOT COMPLETED|Treatment Period 2||0
9085439|NCT03400943|10149895|FG003|NOT COMPLETED|Treatment Period 2||0
9085440|NCT03400943|10149892|FG000|STARTED|Follow-up Period||7
9085441|NCT03400943|10149893|FG001|STARTED|Follow-up Period||15
9085442|NCT03400943|10149894|FG002|STARTED|Follow-up Period||7
9085443|NCT03400943|10149895|FG003|STARTED|Follow-up Period||5
9085444|NCT03400943|10149892|FG000|COMPLETED|Follow-up Period||6
9085445|NCT03400943|10149893|FG001|COMPLETED|Follow-up Period||15
9085446|NCT03400943|10149894|FG002|COMPLETED|Follow-up Period||7
9085447|NCT03400943|10149895|FG003|COMPLETED|Follow-up Period||5
9085448|NCT03400943|10149892|FG000|NOT COMPLETED|Follow-up Period||1
9085449|NCT03400943|10149893|FG001|NOT COMPLETED|Follow-up Period||0
9085450|NCT03400943|10149894|FG002|NOT COMPLETED|Follow-up Period||0
9085451|NCT03400943|10149895|FG003|NOT COMPLETED|Follow-up Period||0
9085452|NCT03288142|10149909|FG000|STARTED|Overall Study||166
9085453|NCT03288142|10149910|FG001|STARTED|Overall Study||167
9085454|NCT03288142|10149909|FG000|COMPLETED|Overall Study||144
9085455|NCT03288142|10149910|FG001|COMPLETED|Overall Study||152
9085456|NCT03288142|10149909|FG000|NOT COMPLETED|Overall Study||22
9085457|NCT03288142|10149910|FG001|NOT COMPLETED|Overall Study||15
9085458|NCT03112603|10149920|FG000|STARTED|End of Randomization Period||165
9085459|NCT03112603|10149921|FG001|STARTED|End of Randomization Period||164
9085460|NCT03112603|10149922|FG002|STARTED|End of Randomization Period||0
9085461|NCT03112603|10149920|FG000|COMPLETED|End of Randomization Period||0
9085462|NCT03112603|10149921|FG001|COMPLETED|End of Randomization Period||0
9085463|NCT03112603|10149922|FG002|COMPLETED|End of Randomization Period||0
9085464|NCT03112603|10149920|FG000|NOT COMPLETED|End of Randomization Period||165
9085465|NCT03112603|10149921|FG001|NOT COMPLETED|End of Randomization Period||164
9085466|NCT03112603|10149922|FG002|NOT COMPLETED|End of Randomization Period||0
9085467|NCT03112603|10149920|FG000|STARTED|End of Cross Over Period||0
9085468|NCT03112603|10149921|FG001|STARTED|End of Cross Over Period||0
9085469|NCT03112603|10149922|FG002|STARTED|End of Cross Over Period||61
9085470|NCT03112603|10149920|FG000|COMPLETED|End of Cross Over Period||0
9085471|NCT03112603|10149921|FG001|COMPLETED|End of Cross Over Period||0
9085472|NCT03112603|10149922|FG002|COMPLETED|End of Cross Over Period||0
9085473|NCT03112603|10149920|FG000|NOT COMPLETED|End of Cross Over Period||0
9085474|NCT03112603|10149921|FG001|NOT COMPLETED|End of Cross Over Period||0
9085475|NCT03112603|10149922|FG002|NOT COMPLETED|End of Cross Over Period||61
9085476|NCT02949934|10149934|FG000|STARTED|Natural Drinking Period||16
9085477|NCT02949934|10149935|FG001|STARTED|Natural Drinking Period||12
9085478|NCT02949934|10149936|FG002|STARTED|Natural Drinking Period||17
9085479|NCT02949934|10149937|FG003|STARTED|Natural Drinking Period||16
9085480|NCT02949934|10149938|FG004|STARTED|Natural Drinking Period||15
9085481|NCT02949934|10149939|FG005|STARTED|Natural Drinking Period||14
9085482|NCT02949934|10149934|FG000|COMPLETED|Natural Drinking Period||15
9085483|NCT02949934|10149935|FG001|COMPLETED|Natural Drinking Period||12
9085484|NCT02949934|10149936|FG002|COMPLETED|Natural Drinking Period||17
9085485|NCT02949934|10149937|FG003|COMPLETED|Natural Drinking Period||15
9085486|NCT02949934|10149938|FG004|COMPLETED|Natural Drinking Period||14
9085487|NCT02949934|10149939|FG005|COMPLETED|Natural Drinking Period||14
9085488|NCT02949934|10149934|FG000|NOT COMPLETED|Natural Drinking Period||1
9085489|NCT02949934|10149935|FG001|NOT COMPLETED|Natural Drinking Period||0
8624712|NCT00502697|9664137|FG001|NOT COMPLETED|Overall Study||12
8624713|NCT00502775|9664146|FG000|STARTED|Overall Study||229
8624714|NCT00502775|9664147|FG001|STARTED|Overall Study||224
8624715|NCT00502775|9664148|FG002|STARTED|Overall Study||227
8624716|NCT00502775|9664146|FG000|COMPLETED|Overall Study||219
8624717|NCT00502775|9664147|FG001|COMPLETED|Overall Study||209
8624718|NCT00502775|9664148|FG002|COMPLETED|Overall Study||214
8624719|NCT00502775|9664146|FG000|NOT COMPLETED|Overall Study||10
8624720|NCT00502775|9664147|FG001|NOT COMPLETED|Overall Study||15
8624721|NCT00502775|9664148|FG002|NOT COMPLETED|Overall Study||13
8624722|NCT00502801|9664156|FG000|STARTED|Treatment Period||183
8624723|NCT00502801|9664156|FG000|COMPLETED|Treatment Period||129
8624724|NCT00502801|9664156|FG000|NOT COMPLETED|Treatment Period||54
8624725|NCT00502801|9664156|FG000|STARTED|End of Therapy to Test of Cure||129
8624726|NCT00502801|9664156|FG000|COMPLETED|End of Therapy to Test of Cure||121
8624727|NCT00502801|9664156|FG000|NOT COMPLETED|End of Therapy to Test of Cure||8
8624728|NCT00502840|9664160|FG000|STARTED|Overall Study||193
8624729|NCT00502840|9664160|FG000|COMPLETED|Overall Study||93
8624730|NCT00502840|9664160|FG000|NOT COMPLETED|Overall Study||100
8624731|NCT00502853|9664165|FG000|STARTED|Overall Study||10
8624732|NCT00502853|9664165|FG000|COMPLETED|Overall Study||10
8624733|NCT00502853|9664165|FG000|NOT COMPLETED|Overall Study||0
8624734|NCT00502905|9664170|FG000|STARTED|Overall Study||196
8624735|NCT00502905|9664170|FG000|COMPLETED|Overall Study||196
8624736|NCT00502905|9664170|FG000|NOT COMPLETED|Overall Study||0
8624737|NCT00502944|9664176|FG000|STARTED|Overall Study||2446
8624738|NCT00502944|9664177|FG001|STARTED|Overall Study||2409
8624739|NCT00502944|9664176|FG000|COMPLETED|Overall Study||1382
8624740|NCT00502944|9664177|FG001|COMPLETED|Overall Study||643
8624741|NCT00502944|9664176|FG000|NOT COMPLETED|Overall Study||1064
8624742|NCT00502944|9664177|FG001|NOT COMPLETED|Overall Study||1766
8624743|NCT00502996|9664183|FG000|STARTED|Overall Study||232
8624744|NCT00502996|9664183|FG000|COMPLETED|Overall Study||188
9085490|NCT02949934|10149936|FG002|NOT COMPLETED|Natural Drinking Period||0
9085491|NCT02949934|10149937|FG003|NOT COMPLETED|Natural Drinking Period||1
9085492|NCT02949934|10149938|FG004|NOT COMPLETED|Natural Drinking Period||1
9085493|NCT02949934|10149939|FG005|NOT COMPLETED|Natural Drinking Period||0
9085494|NCT02949934|10149934|FG000|STARTED|Neuroimaging||15
9085495|NCT02949934|10149935|FG001|STARTED|Neuroimaging||12
9085496|NCT02949934|10149936|FG002|STARTED|Neuroimaging||17
9085497|NCT02949934|10149937|FG003|STARTED|Neuroimaging||15
9085498|NCT02949934|10149938|FG004|STARTED|Neuroimaging||14
9085499|NCT02949934|10149939|FG005|STARTED|Neuroimaging||14
9085500|NCT02949934|10149934|FG000|COMPLETED|Neuroimaging||12
9085501|NCT02949934|10149935|FG001|COMPLETED|Neuroimaging||12
9085502|NCT02949934|10149936|FG002|COMPLETED|Neuroimaging||15
9085503|NCT02949934|10149937|FG003|COMPLETED|Neuroimaging||15
9085504|NCT02949934|10149938|FG004|COMPLETED|Neuroimaging||12
9085505|NCT02949934|10149939|FG005|COMPLETED|Neuroimaging||12
9085506|NCT02949934|10149934|FG000|NOT COMPLETED|Neuroimaging||3
9085507|NCT02949934|10149935|FG001|NOT COMPLETED|Neuroimaging||0
9085508|NCT02949934|10149936|FG002|NOT COMPLETED|Neuroimaging||2
9085509|NCT02949934|10149937|FG003|NOT COMPLETED|Neuroimaging||0
9085510|NCT02949934|10149938|FG004|NOT COMPLETED|Neuroimaging||2
9085511|NCT02949934|10149939|FG005|NOT COMPLETED|Neuroimaging||2
9085512|NCT02949934|10149934|FG000|STARTED|Bar Laboratory||15
9085513|NCT02949934|10149935|FG001|STARTED|Bar Laboratory||12
9085514|NCT02949934|10149936|FG002|STARTED|Bar Laboratory||17
9085515|NCT02949934|10149937|FG003|STARTED|Bar Laboratory||15
8624745|NCT00502996|9664183|FG000|NOT COMPLETED|Overall Study||44
8624746|NCT00503113|9664190|FG000|STARTED|Overall Study||268
8624747|NCT00503113|9664191|FG001|STARTED|Overall Study||264
8624748|NCT00503113|9664192|FG002|STARTED|Overall Study||269
8624749|NCT00503113|9664190|FG000|Intent to Treat Population (ITT)|Overall Study||262
8624750|NCT00503113|9664191|FG001|Intent to Treat Population (ITT)|Overall Study||261
8624751|NCT00503113|9664192|FG002|Intent to Treat Population (ITT)|Overall Study||268
8624752|NCT00503113|9664190|FG000|Per Protocol Population (PP)|Overall Study||246
8624753|NCT00503113|9664191|FG001|Per Protocol Population (PP)|Overall Study||243
8624754|NCT00503113|9664192|FG002|Per Protocol Population (PP)|Overall Study||241
8624755|NCT00503113|9664190|FG000|Safety Population|Overall Study||263
8624756|NCT00503113|9664191|FG001|Safety Population|Overall Study||263
8624757|NCT00503113|9664192|FG002|Safety Population|Overall Study||267
9085516|NCT02949934|10149938|FG004|STARTED|Bar Laboratory||14
9085517|NCT02949934|10149939|FG005|STARTED|Bar Laboratory||14
9085518|NCT02949934|10149934|FG000|COMPLETED|Bar Laboratory||14
9085519|NCT02949934|10149935|FG001|COMPLETED|Bar Laboratory||7
8624758|NCT00503113|9664190|FG000|COMPLETED|Overall Study||235
9085520|NCT02949934|10149936|FG002|COMPLETED|Bar Laboratory||10
9085521|NCT02949934|10149937|FG003|COMPLETED|Bar Laboratory||11
9085522|NCT02949934|10149938|FG004|COMPLETED|Bar Laboratory||8
9085523|NCT02949934|10149939|FG005|COMPLETED|Bar Laboratory||13
9085524|NCT02949934|10149934|FG000|NOT COMPLETED|Bar Laboratory||1
9085525|NCT02949934|10149935|FG001|NOT COMPLETED|Bar Laboratory||5
9085526|NCT02949934|10149936|FG002|NOT COMPLETED|Bar Laboratory||7
9085527|NCT02949934|10149937|FG003|NOT COMPLETED|Bar Laboratory||4
9085528|NCT02949934|10149938|FG004|NOT COMPLETED|Bar Laboratory||6
8624759|NCT00503113|9664191|FG001|COMPLETED|Overall Study||236
8624760|NCT00503113|9664192|FG002|COMPLETED|Overall Study||241
8624761|NCT00503113|9664190|FG000|NOT COMPLETED|Overall Study||33
8624762|NCT00503113|9664191|FG001|NOT COMPLETED|Overall Study||28
8624763|NCT00503113|9664192|FG002|NOT COMPLETED|Overall Study||28
8624764|NCT00503139|9664200|FG000|STARTED|Overall Study||684
8624765|NCT00503139|9664200|FG000|COMPLETED|Overall Study||676
8624766|NCT00503139|9664200|FG000|NOT COMPLETED|Overall Study||8
8624767|NCT00503308|9664206|FG000|STARTED|Overall Study||146
8624768|NCT00503308|9664207|FG001|STARTED|Overall Study||135
8624769|NCT00503308|9664206|FG000|COMPLETED|Overall Study||144
8624770|NCT00503308|9664207|FG001|COMPLETED|Overall Study||134
9085529|NCT02949934|10149939|FG005|NOT COMPLETED|Bar Laboratory||1
9085530|NCT02908672|10149955|FG000|STARTED|Overall Study||258
9085531|NCT02908672|10149956|FG001|STARTED|Overall Study||256
9085532|NCT02908672|10149955|FG000|COMPLETED|Overall Study||0
9085533|NCT02908672|10149956|FG001|COMPLETED|Overall Study||0
9085534|NCT02908672|10149955|FG000|NOT COMPLETED|Overall Study||258
9085535|NCT02908672|10149956|FG001|NOT COMPLETED|Overall Study||256
9085536|NCT02767570|10149964|FG000|STARTED|Overall Study||34
9085537|NCT02767570|10149965|FG001|STARTED|Overall Study||34
9085538|NCT02767570|10149964|FG000|Per Protocol Week 6|Overall Study||31
9085539|NCT02767570|10149965|FG001|Per Protocol Week 6|Overall Study||33
9085540|NCT02767570|10149964|FG000|COMPLETED|Overall Study||25
9085541|NCT02767570|10149965|FG001|COMPLETED|Overall Study||24
9085542|NCT02767570|10149964|FG000|NOT COMPLETED|Overall Study||9
9085543|NCT02767570|10149965|FG001|NOT COMPLETED|Overall Study||10
9085544|NCT02702180|10149974|FG000|STARTED|Double-blind Treatment Period||46
9085545|NCT02702180|10149975|FG001|STARTED|Double-blind Treatment Period||45
9085546|NCT02702180|10149976|FG002|STARTED|Double-blind Treatment Period||47
9085547|NCT02702180|10149974|FG000|COMPLETED|Double-blind Treatment Period||45
9085548|NCT02702180|10149975|FG001|COMPLETED|Double-blind Treatment Period||44
9085549|NCT02702180|10149976|FG002|COMPLETED|Double-blind Treatment Period||43
9085550|NCT02702180|10149974|FG000|NOT COMPLETED|Double-blind Treatment Period||1
9085551|NCT02702180|10149975|FG001|NOT COMPLETED|Double-blind Treatment Period||1
9085552|NCT02702180|10149976|FG002|NOT COMPLETED|Double-blind Treatment Period||4
9085553|NCT02702180|10149974|FG000|STARTED|Open-label Treatment Period||45
9085554|NCT02702180|10149975|FG001|STARTED|Open-label Treatment Period||43
9085555|NCT02702180|10149976|FG002|STARTED|Open-label Treatment Period||43
9085556|NCT02702180|10149974|FG000|COMPLETED|Open-label Treatment Period||45
9085557|NCT02702180|10149975|FG001|COMPLETED|Open-label Treatment Period||42
9085558|NCT02702180|10149976|FG002|COMPLETED|Open-label Treatment Period||41
9085559|NCT02702180|10149974|FG000|NOT COMPLETED|Open-label Treatment Period||0
9085560|NCT02702180|10149975|FG001|NOT COMPLETED|Open-label Treatment Period||1
9085561|NCT02702180|10149976|FG002|NOT COMPLETED|Open-label Treatment Period||2
8624771|NCT00503308|9664206|FG000|NOT COMPLETED|Overall Study||2
8624772|NCT00503308|9664207|FG001|NOT COMPLETED|Overall Study||1
8624773|NCT00503399|9664215|FG000|STARTED|Overall Study||45
8624774|NCT00503399|9664216|FG001|STARTED|Overall Study||47
9085562|NCT02545049|10149987|FG000|STARTED|Overall Study||3723
9085563|NCT02545049|10149988|FG001|STARTED|Overall Study||3714
9085564|NCT02545049|10149987|FG000|Treated|Overall Study||3683
9085565|NCT02545049|10149988|FG001|Treated|Overall Study||3658
9085566|NCT02545049|10149987|FG000|Included in FAS|Overall Study||3686
9085567|NCT02545049|10149988|FG001|Included in FAS|Overall Study||3666
9085568|NCT02545049|10149987|FG000|COMPLETED|Overall Study||3681
9085569|NCT02545049|10149988|FG001|COMPLETED|Overall Study||3653
9085570|NCT02545049|10149987|FG000|NOT COMPLETED|Overall Study||42
9085571|NCT02545049|10149988|FG001|NOT COMPLETED|Overall Study||61
9085572|NCT02448381|10149996|FG000|STARTED|Overall Study||118
9085573|NCT02448381|10149997|FG001|STARTED|Overall Study||51
9085574|NCT02448381|10149996|FG000|Randomized, Not Treated|Overall Study||2
9085575|NCT02448381|10149997|FG001|Randomized, Not Treated|Overall Study||1
9085576|NCT02448381|10149996|FG000|Cycle 1|Overall Study||116
9085577|NCT02448381|10149997|FG001|Cycle 1|Overall Study||50
9085578|NCT02448381|10149996|FG000|Cycle 2|Overall Study||110
9085579|NCT02448381|10149997|FG001|Cycle 2|Overall Study||45
9085580|NCT02448381|10149996|FG000|Cycle 3|Overall Study||78
9085581|NCT02448381|10149997|FG001|Cycle 3|Overall Study||32
9085582|NCT02448381|10149996|FG000|Follow-up Period|Overall Study||98
9085583|NCT02448381|10149997|FG001|Follow-up Period|Overall Study||39
9085584|NCT02448381|10149996|FG000|COMPLETED|Overall Study||83
9085585|NCT02448381|10149997|FG001|COMPLETED|Overall Study||32
9085586|NCT02448381|10149996|FG000|NOT COMPLETED|Overall Study||35
9085587|NCT02448381|10149997|FG001|NOT COMPLETED|Overall Study||19
9085588|NCT02151981|10150011|FG000|STARTED|Overall Study||279
9085589|NCT02151981|10150012|FG001|STARTED|Overall Study||140
9085590|NCT02151981|10150011|FG000|Received Randomised Treatment Only|Overall Study||279
9085591|NCT02151981|10150012|FG001|Received Randomised Treatment Only|Overall Study||136
9085592|NCT02151981|10150011|FG000|Did Not Receive Treatment|Overall Study||0
9085593|NCT02151981|10150012|FG001|Did Not Receive Treatment|Overall Study||4
9085594|NCT02151981|10150011|FG000|Crossed Over Osimertinib|Overall Study||0
9085595|NCT02151981|10150012|FG001|Crossed Over Osimertinib|Overall Study|Patients randomised to chemotherapy were allowed to crossover to Osimertinib after progression|99
9085596|NCT02151981|10150011|FG000|COMPLETED|Overall Study||0
9085597|NCT02151981|10150012|FG001|COMPLETED|Overall Study||0
9085598|NCT02151981|10150011|FG000|NOT COMPLETED|Overall Study||279
9085599|NCT02151981|10150012|FG001|NOT COMPLETED|Overall Study||140
9085600|NCT01972217|10150022|FG000|STARTED|Part A: Open-label Safety Run-in Period||3
9085601|NCT01972217|10150023|FG001|STARTED|Part A: Open-label Safety Run-in Period||13
9085602|NCT01972217|10150024|FG002|STARTED|Part A: Open-label Safety Run-in Period||0
9085603|NCT01972217|10150025|FG003|STARTED|Part A: Open-label Safety Run-in Period||0
9085604|NCT01972217|10150022|FG000|COMPLETED|Part A: Open-label Safety Run-in Period||2
9085605|NCT01972217|10150023|FG001|COMPLETED|Part A: Open-label Safety Run-in Period||1
9085606|NCT01972217|10150024|FG002|COMPLETED|Part A: Open-label Safety Run-in Period||0
9085607|NCT01972217|10150025|FG003|COMPLETED|Part A: Open-label Safety Run-in Period||0
9085608|NCT01972217|10150022|FG000|NOT COMPLETED|Part A: Open-label Safety Run-in Period||1
9085609|NCT01972217|10150023|FG001|NOT COMPLETED|Part A: Open-label Safety Run-in Period||12
9085610|NCT01972217|10150024|FG002|NOT COMPLETED|Part A: Open-label Safety Run-in Period||0
9085611|NCT01972217|10150025|FG003|NOT COMPLETED|Part A: Open-label Safety Run-in Period||0
9085612|NCT01972217|10150022|FG000|STARTED|Part B Double-blind, Randomised Period|Patients recruited to Part A did not participate in Part B.|0
9085613|NCT01972217|10150023|FG001|STARTED|Part B Double-blind, Randomised Period|Patients recruited to Part A did not participate in Part B.|0
9085614|NCT01972217|10150024|FG002|STARTED|Part B Double-blind, Randomised Period|Patients recruited to Part B did not participate in Part A.|71
9085615|NCT01972217|10150025|FG003|STARTED|Part B Double-blind, Randomised Period|Patients recruited to Part B did not participate in Part A.|71
9085616|NCT01972217|10150022|FG000|Received Olaparib/Placebo|Part B Double-blind, Randomised Period||0
9085617|NCT01972217|10150023|FG001|Received Olaparib/Placebo|Part B Double-blind, Randomised Period||0
9085618|NCT01972217|10150024|FG002|Received Olaparib/Placebo|Part B Double-blind, Randomised Period||71
9085619|NCT01972217|10150025|FG003|Received Olaparib/Placebo|Part B Double-blind, Randomised Period||71
9085620|NCT01972217|10150022|FG000|Received Abiraterone|Part B Double-blind, Randomised Period||0
9085621|NCT01972217|10150023|FG001|Received Abiraterone|Part B Double-blind, Randomised Period||0
9085622|NCT01972217|10150024|FG002|Received Abiraterone|Part B Double-blind, Randomised Period||71
9085623|NCT01972217|10150025|FG003|Received Abiraterone|Part B Double-blind, Randomised Period||71
9085624|NCT01972217|10150022|FG000|COMPLETED|Part B Double-blind, Randomised Period||0
9085625|NCT01972217|10150023|FG001|COMPLETED|Part B Double-blind, Randomised Period||0
9085626|NCT01972217|10150024|FG002|COMPLETED|Part B Double-blind, Randomised Period||25
9085627|NCT01972217|10150025|FG003|COMPLETED|Part B Double-blind, Randomised Period||24
9085628|NCT01972217|10150022|FG000|NOT COMPLETED|Part B Double-blind, Randomised Period||0
9085629|NCT01972217|10150023|FG001|NOT COMPLETED|Part B Double-blind, Randomised Period||0
9085630|NCT01972217|10150024|FG002|NOT COMPLETED|Part B Double-blind, Randomised Period||46
9085631|NCT01972217|10150025|FG003|NOT COMPLETED|Part B Double-blind, Randomised Period||47
9085632|NCT01849874|10150039|FG000|STARTED|Overall Study||201
9085633|NCT01849874|10150040|FG001|STARTED|Overall Study||102
9085634|NCT01849874|10150039|FG000|Treated|Overall Study||200
9085635|NCT01849874|10150040|FG001|Treated|Overall Study||94
9085636|NCT01849874|10150039|FG000|COMPLETED|Overall Study||0
9085637|NCT01849874|10150040|FG001|COMPLETED|Overall Study||0
9085638|NCT01849874|10150039|FG000|NOT COMPLETED|Overall Study||201
9085639|NCT01849874|10150040|FG001|NOT COMPLETED|Overall Study||102
9085640|NCT01724866|10150050|FG000|STARTED|Overall Study||39
9085641|NCT01724866|10150051|FG001|STARTED|Overall Study||37
9085642|NCT01724866|10150052|FG002|STARTED|Overall Study||36
9085643|NCT01724866|10150053|FG003|STARTED|Overall Study||36
9085644|NCT01724866|10150050|FG000|Evaluable Population|Overall Study||39
9085645|NCT01724866|10150051|FG001|Evaluable Population|Overall Study||36
9085646|NCT01724866|10150052|FG002|Evaluable Population|Overall Study||36
9085647|NCT01724866|10150053|FG003|Evaluable Population|Overall Study||36
8844708|NCT01711372|9899149|FG000|COMPLETED|Overall Study||66
8844709|NCT01711372|9899150|FG001|COMPLETED|Overall Study||47
8844710|NCT01711372|9899149|FG000|NOT COMPLETED|Overall Study||0
8844711|NCT01711372|9899150|FG001|NOT COMPLETED|Overall Study||0
9085648|NCT01724866|10150050|FG000|COMPLETED|Overall Study||38
9085649|NCT01724866|10150051|FG001|COMPLETED|Overall Study||32
9085650|NCT01724866|10150052|FG002|COMPLETED|Overall Study||33
9085651|NCT01724866|10150053|FG003|COMPLETED|Overall Study||35
9085652|NCT01724866|10150050|FG000|NOT COMPLETED|Overall Study||1
9085653|NCT01724866|10150051|FG001|NOT COMPLETED|Overall Study||5
9085654|NCT01724866|10150052|FG002|NOT COMPLETED|Overall Study||3
9085655|NCT01724866|10150053|FG003|NOT COMPLETED|Overall Study||1
9085656|NCT01670877|10150067|FG000|STARTED|Part I and Part 2||16
9085657|NCT01670877|10150068|FG001|STARTED|Part I and Part 2||5
8624775|NCT00503399|9664215|FG000|COMPLETED|Overall Study||38
8624776|NCT00503399|9664216|FG001|COMPLETED|Overall Study||39
8624777|NCT00503399|9664215|FG000|NOT COMPLETED|Overall Study||7
8844712|NCT01711424|9899155|FG000|STARTED|Overall Study||1209
8844713|NCT01711424|9899155|FG000|COMPLETED|Overall Study||1209
9085658|NCT01670877|10150069|FG002|STARTED|Part I and Part 2||11
9085659|NCT01670877|10150070|FG003|STARTED|Part I and Part 2||24
9085660|NCT01670877|10150071|FG004|STARTED|Part I and Part 2||0
9085661|NCT01670877|10150072|FG005|STARTED|Part I and Part 2||0
9085662|NCT01670877|10150067|FG000|COMPLETED|Part I and Part 2||16
9085663|NCT01670877|10150068|FG001|COMPLETED|Part I and Part 2||4
9085664|NCT01670877|10150069|FG002|COMPLETED|Part I and Part 2||10
9085665|NCT01670877|10150070|FG003|COMPLETED|Part I and Part 2||21
9085666|NCT01670877|10150071|FG004|COMPLETED|Part I and Part 2||0
9085667|NCT01670877|10150072|FG005|COMPLETED|Part I and Part 2||0
9085668|NCT01670877|10150067|FG000|NOT COMPLETED|Part I and Part 2||0
9085669|NCT01670877|10150068|FG001|NOT COMPLETED|Part I and Part 2||1
9085670|NCT01670877|10150069|FG002|NOT COMPLETED|Part I and Part 2||1
9085671|NCT01670877|10150070|FG003|NOT COMPLETED|Part I and Part 2||3
9085672|NCT01670877|10150071|FG004|NOT COMPLETED|Part I and Part 2||0
9085673|NCT01670877|10150072|FG005|NOT COMPLETED|Part I and Part 2||0
9085674|NCT01670877|10150067|FG000|STARTED|Crossover||0
9085675|NCT01670877|10150068|FG001|STARTED|Crossover||0
9085676|NCT01670877|10150069|FG002|STARTED|Crossover||0
9085677|NCT01670877|10150070|FG003|STARTED|Crossover||0
9085678|NCT01670877|10150071|FG004|STARTED|Crossover||3
9085679|NCT01670877|10150072|FG005|STARTED|Crossover||5
9085680|NCT01670877|10150067|FG000|COMPLETED|Crossover||0
9085681|NCT01670877|10150068|FG001|COMPLETED|Crossover||0
9085682|NCT01670877|10150069|FG002|COMPLETED|Crossover||0
9085683|NCT01670877|10150070|FG003|COMPLETED|Crossover||0
9085684|NCT01670877|10150071|FG004|COMPLETED|Crossover||3
9085685|NCT01670877|10150072|FG005|COMPLETED|Crossover||5
9085686|NCT01670877|10150067|FG000|NOT COMPLETED|Crossover||0
9085687|NCT01670877|10150068|FG001|NOT COMPLETED|Crossover||0
9085688|NCT01670877|10150069|FG002|NOT COMPLETED|Crossover||0
9085689|NCT01670877|10150070|FG003|NOT COMPLETED|Crossover||0
9085690|NCT01670877|10150071|FG004|NOT COMPLETED|Crossover||0
9085691|NCT01670877|10150072|FG005|NOT COMPLETED|Crossover||0
9085692|NCT01602380|10150088|FG000|STARTED|Overall Study||230
9085693|NCT01602380|10150089|FG001|STARTED|Overall Study||232
9085694|NCT01602380|10150088|FG000|COMPLETED|Overall Study|Completed: number of patients ongoing in the study at data cut-off for the primary analysis|137
9085695|NCT01602380|10150089|FG001|COMPLETED|Overall Study|Completed: number of patients ongoing in the study at data cut-off for the primary analysis|131
9085696|NCT01602380|10150088|FG000|NOT COMPLETED|Overall Study||93
9085697|NCT01602380|10150089|FG001|NOT COMPLETED|Overall Study||101
9085698|NCT01412333|10150097|FG000|STARTED|Overall Study||418
9085699|NCT01412333|10150098|FG001|STARTED|Overall Study||417
9085700|NCT01412333|10150097|FG000|COMPLETED|Overall Study||320
9085701|NCT01412333|10150098|FG001|COMPLETED|Overall Study||360
9085702|NCT01412333|10150097|FG000|NOT COMPLETED|Overall Study||98
9085703|NCT01412333|10150098|FG001|NOT COMPLETED|Overall Study||57
9085704|NCT01247324|10150107|FG000|STARTED|Overall Study||411
9085705|NCT01247324|10150108|FG001|STARTED|Overall Study||410
9085706|NCT01247324|10150107|FG000|COMPLETED|Overall Study||340
9085707|NCT01247324|10150108|FG001|COMPLETED|Overall Study||366
8844714|NCT01711424|9899155|FG000|NOT COMPLETED|Overall Study||0
9085708|NCT01247324|10150107|FG000|NOT COMPLETED|Overall Study||71
9085709|NCT01247324|10150108|FG001|NOT COMPLETED|Overall Study||44
9085710|NCT00667628|10150117|FG000|STARTED|Overall Study||25
9085711|NCT00667628|10150118|FG001|STARTED|Overall Study||27
9085712|NCT00667628|10150117|FG000|COMPLETED|Overall Study||0
8624778|NCT00503399|9664216|FG001|NOT COMPLETED|Overall Study||8
8624779|NCT00503425|9664222|FG000|STARTED|Overall Study||215
9085713|NCT00667628|10150118|FG001|COMPLETED|Overall Study||0
9085714|NCT00667628|10150117|FG000|NOT COMPLETED|Overall Study||25
9085715|NCT00667628|10150118|FG001|NOT COMPLETED|Overall Study||27
9085716|NCT04286529|10150128|FG000|STARTED|Overall Study||4
9085717|NCT04286529|10150129|FG001|STARTED|Overall Study||4
9085718|NCT04286529|10150130|FG002|STARTED|Overall Study||5
9085719|NCT04286529|10150131|FG003|STARTED|Overall Study||4
9085720|NCT04286529|10150128|FG000|COMPLETED|Overall Study||3
9085721|NCT04286529|10150129|FG001|COMPLETED|Overall Study||1
9085722|NCT04286529|10150130|FG002|COMPLETED|Overall Study||3
9085723|NCT04286529|10150131|FG003|COMPLETED|Overall Study||1
9085724|NCT04286529|10150128|FG000|NOT COMPLETED|Overall Study||1
9085725|NCT04286529|10150129|FG001|NOT COMPLETED|Overall Study||3
9085726|NCT04286529|10150130|FG002|NOT COMPLETED|Overall Study||2
9085727|NCT04286529|10150131|FG003|NOT COMPLETED|Overall Study||3
9085728|NCT03581786|10150143|FG000|STARTED|Overall Study||143
9085729|NCT03581786|10150144|FG001|STARTED|Overall Study||146
9085730|NCT03581786|10150143|FG000|COMPLETED|Overall Study||0
9085731|NCT03581786|10150144|FG001|COMPLETED|Overall Study||0
9085732|NCT03581786|10150143|FG000|NOT COMPLETED|Overall Study||143
9085733|NCT03581786|10150144|FG001|NOT COMPLETED|Overall Study||146
9085734|NCT03573518|10150154|FG000|STARTED|Overall Study||92
9085735|NCT03573518|10150155|FG001|STARTED|Overall Study||92
9085736|NCT03573518|10150156|FG002|STARTED|Overall Study||92
9085737|NCT03573518|10150157|FG003|STARTED|Overall Study||92
9085738|NCT03573518|10150154|FG000|COMPLETED|Overall Study||69
9085739|NCT03573518|10150155|FG001|COMPLETED|Overall Study||77
9085740|NCT03573518|10150156|FG002|COMPLETED|Overall Study||70
9085741|NCT03573518|10150157|FG003|COMPLETED|Overall Study||81
9085742|NCT03573518|10150154|FG000|NOT COMPLETED|Overall Study||23
9085743|NCT03573518|10150155|FG001|NOT COMPLETED|Overall Study||15
9085744|NCT03573518|10150156|FG002|NOT COMPLETED|Overall Study||22
9085745|NCT03573518|10150157|FG003|NOT COMPLETED|Overall Study||11
9085746|NCT03486314|10150167|FG000|STARTED|Part A||20
9085747|NCT03486314|10150168|FG001|STARTED|Part A||0
9085748|NCT03486314|10150169|FG002|STARTED|Part A||0
9085749|NCT03486314|10150167|FG000|COMPLETED|Part A||17
9085750|NCT03486314|10150168|FG001|COMPLETED|Part A||0
9085751|NCT03486314|10150169|FG002|COMPLETED|Part A||0
9085752|NCT03486314|10150167|FG000|NOT COMPLETED|Part A||3
9085753|NCT03486314|10150168|FG001|NOT COMPLETED|Part A||0
9085754|NCT03486314|10150169|FG002|NOT COMPLETED|Part A||0
9085755|NCT03486314|10150167|FG000|STARTED|Part B||0
9085756|NCT03486314|10150168|FG001|STARTED|Part B|These are the participants who completed Part A, met eligibility criteria, and provided consent for Part B.|9
9085757|NCT03486314|10150169|FG002|STARTED|Part B|These are the participants who completed Part A, met eligibility criteria, and provided consent for Part B.|8
9085758|NCT03486314|10150167|FG000|COMPLETED|Part B||0
9085759|NCT03486314|10150168|FG001|COMPLETED|Part B||9
9085760|NCT03486314|10150169|FG002|COMPLETED|Part B||8
9085761|NCT03486314|10150167|FG000|NOT COMPLETED|Part B||0
9085762|NCT03486314|10150168|FG001|NOT COMPLETED|Part B||0
9085763|NCT03486314|10150169|FG002|NOT COMPLETED|Part B||0
9085764|NCT02988713|10150177|FG000|STARTED|Overall Study||35
9085765|NCT02988713|10150177|FG000|COMPLETED|Overall Study||32
9085766|NCT02988713|10150177|FG000|NOT COMPLETED|Overall Study||3
9085767|NCT02794883|10150184|FG000|STARTED|Pre-Surgical Treatment||12
9085768|NCT02794883|10150185|FG001|STARTED|Pre-Surgical Treatment||12
9085769|NCT02794883|10150186|FG002|STARTED|Pre-Surgical Treatment||12
9085770|NCT02794883|10150184|FG000|Registered for Study|Pre-Surgical Treatment||12
9085771|NCT02794883|10150185|FG001|Registered for Study|Pre-Surgical Treatment||12
9085772|NCT02794883|10150186|FG002|Registered for Study|Pre-Surgical Treatment||12
9085773|NCT02794883|10150184|FG000|Received First Dose (Pre-surgical Dose) of Study Drug|Pre-Surgical Treatment||12
9085774|NCT02794883|10150185|FG001|Received First Dose (Pre-surgical Dose) of Study Drug|Pre-Surgical Treatment||11
9085775|NCT02794883|10150186|FG002|Received First Dose (Pre-surgical Dose) of Study Drug|Pre-Surgical Treatment||11
9085776|NCT02794883|10150184|FG000|COMPLETED|Pre-Surgical Treatment||12
9085777|NCT02794883|10150185|FG001|COMPLETED|Pre-Surgical Treatment||11
9085778|NCT02794883|10150186|FG002|COMPLETED|Pre-Surgical Treatment||11
9085779|NCT02794883|10150184|FG000|NOT COMPLETED|Pre-Surgical Treatment||0
9085780|NCT02794883|10150185|FG001|NOT COMPLETED|Pre-Surgical Treatment||1
9085781|NCT02794883|10150186|FG002|NOT COMPLETED|Pre-Surgical Treatment||1
9085782|NCT02794883|10150184|FG000|STARTED|Post-Surgery Treatment (Adjuvant)||12
9085783|NCT02794883|10150185|FG001|STARTED|Post-Surgery Treatment (Adjuvant)||11
9085784|NCT02794883|10150186|FG002|STARTED|Post-Surgery Treatment (Adjuvant)||11
9085785|NCT02794883|10150184|FG000|Started Cycle 1|Post-Surgery Treatment (Adjuvant)||11
9085786|NCT02794883|10150185|FG001|Started Cycle 1|Post-Surgery Treatment (Adjuvant)||8
9085787|NCT02794883|10150186|FG002|Started Cycle 1|Post-Surgery Treatment (Adjuvant)||11
9085788|NCT02794883|10150184|FG000|Started Cycle 2|Post-Surgery Treatment (Adjuvant)||7
9085789|NCT02794883|10150185|FG001|Started Cycle 2|Post-Surgery Treatment (Adjuvant)||8
9085790|NCT02794883|10150186|FG002|Started Cycle 2|Post-Surgery Treatment (Adjuvant)||11
9085791|NCT02794883|10150184|FG000|Started Cycle 3|Post-Surgery Treatment (Adjuvant)||3
9085792|NCT02794883|10150185|FG001|Started Cycle 3|Post-Surgery Treatment (Adjuvant)||7
9085793|NCT02794883|10150186|FG002|Started Cycle 3|Post-Surgery Treatment (Adjuvant)||4
9085794|NCT02794883|10150184|FG000|Started Cycle 4|Post-Surgery Treatment (Adjuvant)||2
9085795|NCT02794883|10150185|FG001|Started Cycle 4|Post-Surgery Treatment (Adjuvant)||5
9085796|NCT02794883|10150186|FG002|Started Cycle 4|Post-Surgery Treatment (Adjuvant)||2
9085797|NCT02794883|10150184|FG000|Started Cycle 5|Post-Surgery Treatment (Adjuvant)||2
9085798|NCT02794883|10150185|FG001|Started Cycle 5|Post-Surgery Treatment (Adjuvant)||3
9085799|NCT02794883|10150186|FG002|Started Cycle 5|Post-Surgery Treatment (Adjuvant)||2
9085800|NCT02794883|10150184|FG000|Started Cycle 6|Post-Surgery Treatment (Adjuvant)||0
8624780|NCT00503425|9664222|FG000|COMPLETED|Overall Study||161
8624781|NCT00503425|9664222|FG000|NOT COMPLETED|Overall Study||54
9085801|NCT02794883|10150185|FG001|Started Cycle 6|Post-Surgery Treatment (Adjuvant)||3
9085802|NCT02794883|10150186|FG002|Started Cycle 6|Post-Surgery Treatment (Adjuvant)||2
9085803|NCT02794883|10150184|FG000|Started Cycle 7|Post-Surgery Treatment (Adjuvant)||0
9085804|NCT02794883|10150185|FG001|Started Cycle 7|Post-Surgery Treatment (Adjuvant)||3
9085805|NCT02794883|10150186|FG002|Started Cycle 7|Post-Surgery Treatment (Adjuvant)||1
9085806|NCT02794883|10150184|FG000|Started Cycle 8|Post-Surgery Treatment (Adjuvant)||0
9085807|NCT02794883|10150185|FG001|Started Cycle 8|Post-Surgery Treatment (Adjuvant)||3
9085808|NCT02794883|10150186|FG002|Started Cycle 8|Post-Surgery Treatment (Adjuvant)||1
9085809|NCT02794883|10150184|FG000|Started Cycle 9|Post-Surgery Treatment (Adjuvant)||0
9085810|NCT02794883|10150185|FG001|Started Cycle 9|Post-Surgery Treatment (Adjuvant)||3
9085811|NCT02794883|10150186|FG002|Started Cycle 9|Post-Surgery Treatment (Adjuvant)||1
9085812|NCT02794883|10150184|FG000|Started Cycle 10|Post-Surgery Treatment (Adjuvant)||0
9085813|NCT02794883|10150185|FG001|Started Cycle 10|Post-Surgery Treatment (Adjuvant)||2
9085814|NCT02794883|10150186|FG002|Started Cycle 10|Post-Surgery Treatment (Adjuvant)||1
9085815|NCT02794883|10150184|FG000|Started Cycle 11|Post-Surgery Treatment (Adjuvant)||0
9085816|NCT02794883|10150185|FG001|Started Cycle 11|Post-Surgery Treatment (Adjuvant)||2
9085817|NCT02794883|10150186|FG002|Started Cycle 11|Post-Surgery Treatment (Adjuvant)||1
9085818|NCT02794883|10150184|FG000|Started Cycle 12|Post-Surgery Treatment (Adjuvant)||0
9085819|NCT02794883|10150185|FG001|Started Cycle 12|Post-Surgery Treatment (Adjuvant)||1
9085820|NCT02794883|10150186|FG002|Started Cycle 12|Post-Surgery Treatment (Adjuvant)||1
9085821|NCT02794883|10150184|FG000|Started Cycle 13|Post-Surgery Treatment (Adjuvant)||0
9085822|NCT02794883|10150185|FG001|Started Cycle 13|Post-Surgery Treatment (Adjuvant)||1
9085823|NCT02794883|10150186|FG002|Started Cycle 13|Post-Surgery Treatment (Adjuvant)||1
9085824|NCT02794883|10150184|FG000|Started Cycle 14|Post-Surgery Treatment (Adjuvant)||0
9085825|NCT02794883|10150185|FG001|Started Cycle 14|Post-Surgery Treatment (Adjuvant)||1
9085826|NCT02794883|10150186|FG002|Started Cycle 14|Post-Surgery Treatment (Adjuvant)||1
9085827|NCT02794883|10150184|FG000|Started Cycle 15|Post-Surgery Treatment (Adjuvant)||0
9085828|NCT02794883|10150185|FG001|Started Cycle 15|Post-Surgery Treatment (Adjuvant)||0
9085829|NCT02794883|10150186|FG002|Started Cycle 15|Post-Surgery Treatment (Adjuvant)||1
9085830|NCT02794883|10150184|FG000|Started Cycle 16|Post-Surgery Treatment (Adjuvant)||0
9085831|NCT02794883|10150185|FG001|Started Cycle 16|Post-Surgery Treatment (Adjuvant)||0
9085832|NCT02794883|10150186|FG002|Started Cycle 16|Post-Surgery Treatment (Adjuvant)||1
9085833|NCT02794883|10150184|FG000|Started Cycle 17|Post-Surgery Treatment (Adjuvant)||0
9085834|NCT02794883|10150185|FG001|Started Cycle 17|Post-Surgery Treatment (Adjuvant)||0
9085835|NCT02794883|10150186|FG002|Started Cycle 17|Post-Surgery Treatment (Adjuvant)||0
9085836|NCT02794883|10150184|FG000|COMPLETED|Post-Surgery Treatment (Adjuvant)||0
9085837|NCT02794883|10150185|FG001|COMPLETED|Post-Surgery Treatment (Adjuvant)||0
9085838|NCT02794883|10150186|FG002|COMPLETED|Post-Surgery Treatment (Adjuvant)||0
9085839|NCT02794883|10150184|FG000|NOT COMPLETED|Post-Surgery Treatment (Adjuvant)||12
9085840|NCT02794883|10150185|FG001|NOT COMPLETED|Post-Surgery Treatment (Adjuvant)||11
9085841|NCT02794883|10150186|FG002|NOT COMPLETED|Post-Surgery Treatment (Adjuvant)||11
9085842|NCT02794883|10150184|FG000|STARTED|Follow-up Period (up to 2 Years)||12
9085843|NCT02794883|10150185|FG001|STARTED|Follow-up Period (up to 2 Years)||11
9085844|NCT02794883|10150186|FG002|STARTED|Follow-up Period (up to 2 Years)||11
9085845|NCT02794883|10150184|FG000|COMPLETED|Follow-up Period (up to 2 Years)||0
9085846|NCT02794883|10150185|FG001|COMPLETED|Follow-up Period (up to 2 Years)||1
9085847|NCT02794883|10150186|FG002|COMPLETED|Follow-up Period (up to 2 Years)||1
9085848|NCT02794883|10150184|FG000|NOT COMPLETED|Follow-up Period (up to 2 Years)||12
9085849|NCT02794883|10150185|FG001|NOT COMPLETED|Follow-up Period (up to 2 Years)||10
9085850|NCT02794883|10150186|FG002|NOT COMPLETED|Follow-up Period (up to 2 Years)||10
9085851|NCT02677987|10150196|FG000|STARTED|Overall Study||23
9085852|NCT02677987|10150197|FG001|STARTED|Overall Study||24
9085853|NCT02677987|10150196|FG000|COMPLETED|Overall Study||19
9085854|NCT02677987|10150197|FG001|COMPLETED|Overall Study||24
9085855|NCT02677987|10150196|FG000|NOT COMPLETED|Overall Study||4
9085856|NCT02677987|10150197|FG001|NOT COMPLETED|Overall Study||0
9085857|NCT02659059|10150209|FG000|STARTED|Overall Study||288
9085858|NCT02659059|10150210|FG001|STARTED|Overall Study||36
9085859|NCT02659059|10150209|FG000|COMPLETED|Overall Study||88
9085860|NCT02659059|10150210|FG001|COMPLETED|Overall Study||4
9085861|NCT02659059|10150209|FG000|NOT COMPLETED|Overall Study||200
9085862|NCT02659059|10150210|FG001|NOT COMPLETED|Overall Study||32
9085863|NCT02337829|10150221|FG000|STARTED|Overall Study||18
9085864|NCT02337829|10150222|FG001|STARTED|Overall Study||14
9085865|NCT02337829|10150223|FG002|STARTED|Overall Study||6
9085866|NCT02337829|10150224|FG003|STARTED|Overall Study||10
9085867|NCT02337829|10150221|FG000|COMPLETED|Overall Study||0
9085868|NCT02337829|10150222|FG001|COMPLETED|Overall Study||0
9085869|NCT02337829|10150223|FG002|COMPLETED|Overall Study||0
9085870|NCT02337829|10150224|FG003|COMPLETED|Overall Study||0
9085871|NCT02337829|10150221|FG000|NOT COMPLETED|Overall Study||18
9085872|NCT02337829|10150222|FG001|NOT COMPLETED|Overall Study||14
9085873|NCT02337829|10150223|FG002|NOT COMPLETED|Overall Study||6
9085874|NCT02337829|10150224|FG003|NOT COMPLETED|Overall Study||10
9085875|NCT01928394|10150259|FG000|STARTED|Treatment Period||18
9085876|NCT01928394|10150260|FG001|STARTED|Treatment Period||3
9085877|NCT01928394|10150261|FG002|STARTED|Treatment Period||18
9085878|NCT01928394|10150262|FG003|STARTED|Treatment Period||59
9085879|NCT01928394|10150263|FG004|STARTED|Treatment Period||3
9085880|NCT01928394|10150264|FG005|STARTED|Treatment Period||49
9085881|NCT01928394|10150265|FG006|STARTED|Treatment Period||52
9085882|NCT01928394|10150266|FG007|STARTED|Treatment Period||18
9085883|NCT01928394|10150267|FG008|STARTED|Treatment Period||3
9085884|NCT01928394|10150268|FG009|STARTED|Treatment Period||18
9085885|NCT01928394|10150269|FG010|STARTED|Treatment Period||30
9085886|NCT01928394|10150270|FG011|STARTED|Treatment Period||98
9085887|NCT01928394|10150271|FG012|STARTED|Treatment Period||61
9085888|NCT01928394|10150272|FG013|STARTED|Treatment Period||147
9085889|NCT01928394|10150273|FG014|STARTED|Treatment Period||96
9085890|NCT01928394|10150274|FG015|STARTED|Treatment Period||3
9085891|NCT01928394|10150275|FG016|STARTED|Treatment Period||55
9085892|NCT01928394|10150276|FG017|STARTED|Treatment Period||78
9085893|NCT01928394|10150277|FG018|STARTED|Treatment Period||92
9085894|NCT01928394|10150278|FG019|STARTED|Treatment Period||104
9085895|NCT01928394|10150279|FG020|STARTED|Treatment Period||41
9085896|NCT01928394|10150280|FG021|STARTED|Treatment Period||43
9085897|NCT01928394|10150281|FG022|STARTED|Treatment Period||42
9085898|NCT01928394|10150259|FG000|Transition|Treatment Period||3
9085899|NCT01928394|10150260|FG001|Transition|Treatment Period||0
9085900|NCT01928394|10150261|FG002|Transition|Treatment Period||0
9085901|NCT01928394|10150262|FG003|Transition|Treatment Period||9
9085902|NCT01928394|10150263|FG004|Transition|Treatment Period||0
9085903|NCT01928394|10150264|FG005|Transition|Treatment Period||0
9085904|NCT01928394|10150265|FG006|Transition|Treatment Period||0
9085905|NCT01928394|10150266|FG007|Transition|Treatment Period||2
9085906|NCT01928394|10150267|FG008|Transition|Treatment Period||0
9085907|NCT01928394|10150268|FG009|Transition|Treatment Period||0
9085908|NCT01928394|10150269|FG010|Transition|Treatment Period||0
9085909|NCT01928394|10150270|FG011|Transition|Treatment Period||17
9085910|NCT01928394|10150271|FG012|Transition|Treatment Period||0
9085911|NCT01928394|10150272|FG013|Transition|Treatment Period||2
9085912|NCT01928394|10150273|FG014|Transition|Treatment Period||0
9085913|NCT01928394|10150274|FG015|Transition|Treatment Period||0
9085914|NCT01928394|10150275|FG016|Transition|Treatment Period||0
9085915|NCT01928394|10150276|FG017|Transition|Treatment Period||20
9085916|NCT01928394|10150277|FG018|Transition|Treatment Period||0
9085917|NCT01928394|10150278|FG019|Transition|Treatment Period||0
9085918|NCT01928394|10150279|FG020|Transition|Treatment Period||0
9085919|NCT01928394|10150280|FG021|Transition|Treatment Period||0
9085920|NCT01928394|10150281|FG022|Transition|Treatment Period||0
9085921|NCT01928394|10150259|FG000|Transition- Continued|Treatment Period||0
9085922|NCT01928394|10150260|FG001|Transition- Continued|Treatment Period||0
9085923|NCT01928394|10150261|FG002|Transition- Continued|Treatment Period||3
9085924|NCT01928394|10150262|FG003|Transition- Continued|Treatment Period||0
9085925|NCT01928394|10150263|FG004|Transition- Continued|Treatment Period||0
9085926|NCT01928394|10150264|FG005|Transition- Continued|Treatment Period||3
9085927|NCT01928394|10150265|FG006|Transition- Continued|Treatment Period||6
9085928|NCT01928394|10150266|FG007|Transition- Continued|Treatment Period||0
9085929|NCT01928394|10150267|FG008|Transition- Continued|Treatment Period||1
9085930|NCT01928394|10150268|FG009|Transition- Continued|Treatment Period||1
9085931|NCT01928394|10150269|FG010|Transition- Continued|Treatment Period||0
9085932|NCT01928394|10150270|FG011|Transition- Continued|Treatment Period||0
9085933|NCT01928394|10150271|FG012|Transition- Continued|Treatment Period||17
9085934|NCT01928394|10150272|FG013|Transition- Continued|Treatment Period||0
9085935|NCT01928394|10150273|FG014|Transition- Continued|Treatment Period||2
9085936|NCT01928394|10150274|FG015|Transition- Continued|Treatment Period||0
9085937|NCT01928394|10150275|FG016|Transition- Continued|Treatment Period||0
9085938|NCT01928394|10150276|FG017|Transition- Continued|Treatment Period||0
9085939|NCT01928394|10150277|FG018|Transition- Continued|Treatment Period||1
9085940|NCT01928394|10150278|FG019|Transition- Continued|Treatment Period||19
9085941|NCT01928394|10150279|FG020|Transition- Continued|Treatment Period||0
9085942|NCT01928394|10150280|FG021|Transition- Continued|Treatment Period||0
9085943|NCT01928394|10150281|FG022|Transition- Continued|Treatment Period||0
9085944|NCT01928394|10150259|FG000|COMPLETED|Treatment Period||0
9085945|NCT01928394|10150260|FG001|COMPLETED|Treatment Period||0
9085946|NCT01928394|10150261|FG002|COMPLETED|Treatment Period||0
9085947|NCT01928394|10150262|FG003|COMPLETED|Treatment Period||3
9085948|NCT01928394|10150263|FG004|COMPLETED|Treatment Period||0
9085949|NCT01928394|10150264|FG005|COMPLETED|Treatment Period||6
9085950|NCT01928394|10150265|FG006|COMPLETED|Treatment Period||3
9085951|NCT01928394|10150266|FG007|COMPLETED|Treatment Period||0
9085952|NCT01928394|10150267|FG008|COMPLETED|Treatment Period||0
9085953|NCT01928394|10150268|FG009|COMPLETED|Treatment Period||0
9085954|NCT01928394|10150269|FG010|COMPLETED|Treatment Period||0
9085955|NCT01928394|10150270|FG011|COMPLETED|Treatment Period||5
9085956|NCT01928394|10150271|FG012|COMPLETED|Treatment Period||6
9085957|NCT01928394|10150272|FG013|COMPLETED|Treatment Period||8
9085958|NCT01928394|10150273|FG014|COMPLETED|Treatment Period||8
9085959|NCT01928394|10150274|FG015|COMPLETED|Treatment Period||1
9085960|NCT01928394|10150275|FG016|COMPLETED|Treatment Period||5
9085961|NCT01928394|10150276|FG017|COMPLETED|Treatment Period||7
9085962|NCT01928394|10150277|FG018|COMPLETED|Treatment Period||22
9085963|NCT01928394|10150278|FG019|COMPLETED|Treatment Period||8
9085964|NCT01928394|10150279|FG020|COMPLETED|Treatment Period||1
9085965|NCT01928394|10150280|FG021|COMPLETED|Treatment Period||1
9085966|NCT01928394|10150281|FG022|COMPLETED|Treatment Period||3
9085967|NCT01928394|10150259|FG000|NOT COMPLETED|Treatment Period||18
9085968|NCT01928394|10150260|FG001|NOT COMPLETED|Treatment Period||3
9085969|NCT01928394|10150261|FG002|NOT COMPLETED|Treatment Period||18
9085970|NCT01928394|10150262|FG003|NOT COMPLETED|Treatment Period||56
9085971|NCT01928394|10150263|FG004|NOT COMPLETED|Treatment Period||3
9085972|NCT01928394|10150264|FG005|NOT COMPLETED|Treatment Period||43
9085973|NCT01928394|10150265|FG006|NOT COMPLETED|Treatment Period||49
9085974|NCT01928394|10150266|FG007|NOT COMPLETED|Treatment Period||18
9085975|NCT01928394|10150267|FG008|NOT COMPLETED|Treatment Period||3
9085976|NCT01928394|10150268|FG009|NOT COMPLETED|Treatment Period||18
9085977|NCT01928394|10150269|FG010|NOT COMPLETED|Treatment Period||30
9085978|NCT01928394|10150270|FG011|NOT COMPLETED|Treatment Period||93
9085979|NCT01928394|10150271|FG012|NOT COMPLETED|Treatment Period||55
9085980|NCT01928394|10150272|FG013|NOT COMPLETED|Treatment Period||139
9085981|NCT01928394|10150273|FG014|NOT COMPLETED|Treatment Period||88
9085982|NCT01928394|10150274|FG015|NOT COMPLETED|Treatment Period||2
9085983|NCT01928394|10150275|FG016|NOT COMPLETED|Treatment Period||50
9085984|NCT01928394|10150276|FG017|NOT COMPLETED|Treatment Period||71
9085985|NCT01928394|10150277|FG018|NOT COMPLETED|Treatment Period||70
9085986|NCT01928394|10150278|FG019|NOT COMPLETED|Treatment Period||96
9085987|NCT01928394|10150279|FG020|NOT COMPLETED|Treatment Period||40
9085988|NCT01928394|10150280|FG021|NOT COMPLETED|Treatment Period||42
9085989|NCT01928394|10150281|FG022|NOT COMPLETED|Treatment Period||39
9085990|NCT01928394|10150259|FG000|STARTED|Follow-up Period||15
9085991|NCT01928394|10150260|FG001|STARTED|Follow-up Period||3
9085992|NCT01928394|10150261|FG002|STARTED|Follow-up Period||18
9085993|NCT01928394|10150262|FG003|STARTED|Follow-up Period||50
9085994|NCT01928394|10150263|FG004|STARTED|Follow-up Period||3
9085995|NCT01928394|10150264|FG005|STARTED|Follow-up Period||49
9085996|NCT01928394|10150265|FG006|STARTED|Follow-up Period||52
9085997|NCT01928394|10150266|FG007|STARTED|Follow-up Period||16
9085998|NCT01928394|10150267|FG008|STARTED|Follow-up Period||3
9085999|NCT01928394|10150268|FG009|STARTED|Follow-up Period||18
9086000|NCT01928394|10150269|FG010|STARTED|Follow-up Period||30
9086001|NCT01928394|10150270|FG011|STARTED|Follow-up Period||81
9086002|NCT01928394|10150271|FG012|STARTED|Follow-up Period||61
9086003|NCT01928394|10150272|FG013|STARTED|Follow-up Period||145
9086004|NCT01928394|10150273|FG014|STARTED|Follow-up Period||96
9086005|NCT01928394|10150274|FG015|STARTED|Follow-up Period||3
9086006|NCT01928394|10150275|FG016|STARTED|Follow-up Period||55
9086007|NCT01928394|10150276|FG017|STARTED|Follow-up Period||58
9086008|NCT01928394|10150277|FG018|STARTED|Follow-up Period||92
9086009|NCT01928394|10150278|FG019|STARTED|Follow-up Period||104
9086010|NCT01928394|10150279|FG020|STARTED|Follow-up Period||41
9086011|NCT01928394|10150280|FG021|STARTED|Follow-up Period||43
9086012|NCT01928394|10150281|FG022|STARTED|Follow-up Period||42
9086013|NCT01928394|10150259|FG000|COMPLETED|Follow-up Period||12
9086014|NCT01928394|10150260|FG001|COMPLETED|Follow-up Period||3
9086015|NCT01928394|10150261|FG002|COMPLETED|Follow-up Period||15
9086016|NCT01928394|10150262|FG003|COMPLETED|Follow-up Period||40
9086017|NCT01928394|10150263|FG004|COMPLETED|Follow-up Period||3
9086018|NCT01928394|10150264|FG005|COMPLETED|Follow-up Period||41
9086019|NCT01928394|10150265|FG006|COMPLETED|Follow-up Period||40
9086020|NCT01928394|10150266|FG007|COMPLETED|Follow-up Period||10
9086021|NCT01928394|10150267|FG008|COMPLETED|Follow-up Period||2
9086022|NCT01928394|10150268|FG009|COMPLETED|Follow-up Period||16
9086023|NCT01928394|10150269|FG010|COMPLETED|Follow-up Period||19
9086024|NCT01928394|10150270|FG011|COMPLETED|Follow-up Period||59
9086025|NCT01928394|10150271|FG012|COMPLETED|Follow-up Period||47
9086026|NCT01928394|10150272|FG013|COMPLETED|Follow-up Period||107
9086027|NCT01928394|10150273|FG014|COMPLETED|Follow-up Period||66
9086028|NCT01928394|10150274|FG015|COMPLETED|Follow-up Period||3
9086029|NCT01928394|10150275|FG016|COMPLETED|Follow-up Period||41
9086030|NCT01928394|10150276|FG017|COMPLETED|Follow-up Period||50
9086031|NCT01928394|10150277|FG018|COMPLETED|Follow-up Period||76
8624782|NCT00503685|9664230|FG000|STARTED|Overall Study||23
8624783|NCT00503685|9664231|FG001|STARTED|Overall Study||22
8624784|NCT00503685|9664232|FG002|STARTED|Overall Study||20
8624785|NCT00503685|9664230|FG000|Received at Least 1 Dose of Study Drug|Overall Study||23
9086032|NCT01928394|10150278|FG019|COMPLETED|Follow-up Period||83
9086033|NCT01928394|10150279|FG020|COMPLETED|Follow-up Period||32
9086034|NCT01928394|10150280|FG021|COMPLETED|Follow-up Period||34
9086035|NCT01928394|10150281|FG022|COMPLETED|Follow-up Period||36
9086036|NCT01928394|10150259|FG000|NOT COMPLETED|Follow-up Period||3
9086037|NCT01928394|10150260|FG001|NOT COMPLETED|Follow-up Period||0
8624786|NCT00503685|9664231|FG001|Received at Least 1 Dose of Study Drug|Overall Study||21
9086038|NCT01928394|10150261|FG002|NOT COMPLETED|Follow-up Period||3
9086039|NCT01928394|10150262|FG003|NOT COMPLETED|Follow-up Period||10
9086040|NCT01928394|10150263|FG004|NOT COMPLETED|Follow-up Period||0
9086041|NCT01928394|10150264|FG005|NOT COMPLETED|Follow-up Period||8
9086042|NCT01928394|10150265|FG006|NOT COMPLETED|Follow-up Period||12
9086043|NCT01928394|10150266|FG007|NOT COMPLETED|Follow-up Period||6
9086044|NCT01928394|10150267|FG008|NOT COMPLETED|Follow-up Period||1
9086045|NCT01928394|10150268|FG009|NOT COMPLETED|Follow-up Period||2
9086046|NCT01928394|10150269|FG010|NOT COMPLETED|Follow-up Period||11
9086047|NCT01928394|10150270|FG011|NOT COMPLETED|Follow-up Period||22
9086048|NCT01928394|10150271|FG012|NOT COMPLETED|Follow-up Period||14
9086049|NCT01928394|10150272|FG013|NOT COMPLETED|Follow-up Period||38
9086050|NCT01928394|10150273|FG014|NOT COMPLETED|Follow-up Period||30
9086051|NCT01928394|10150274|FG015|NOT COMPLETED|Follow-up Period||0
9086052|NCT01928394|10150275|FG016|NOT COMPLETED|Follow-up Period||14
9086053|NCT01928394|10150276|FG017|NOT COMPLETED|Follow-up Period||8
9086054|NCT01928394|10150277|FG018|NOT COMPLETED|Follow-up Period||16
9086055|NCT01928394|10150278|FG019|NOT COMPLETED|Follow-up Period||21
9086056|NCT01928394|10150279|FG020|NOT COMPLETED|Follow-up Period||9
9086057|NCT01928394|10150280|FG021|NOT COMPLETED|Follow-up Period||9
9086058|NCT01928394|10150281|FG022|NOT COMPLETED|Follow-up Period||6
9086059|NCT01657500|10150331|FG000|STARTED|Overall Study||32
9086060|NCT01657500|10150332|FG001|STARTED|Overall Study||32
9086061|NCT01657500|10150331|FG000|COMPLETED|Overall Study||27
9086062|NCT01657500|10150332|FG001|COMPLETED|Overall Study||27
9086063|NCT01657500|10150331|FG000|NOT COMPLETED|Overall Study||5
9086064|NCT01657500|10150332|FG001|NOT COMPLETED|Overall Study||5
8624787|NCT00503685|9664232|FG002|Received at Least 1 Dose of Study Drug|Overall Study||20
8624788|NCT00503685|9664230|FG000|COMPLETED|Overall Study||23
8624789|NCT00503685|9664231|FG001|COMPLETED|Overall Study||19
8624790|NCT00503685|9664232|FG002|COMPLETED|Overall Study||18
8624791|NCT00503685|9664230|FG000|NOT COMPLETED|Overall Study||0
8624792|NCT00503685|9664231|FG001|NOT COMPLETED|Overall Study||3
8624793|NCT00503685|9664232|FG002|NOT COMPLETED|Overall Study||2
8624794|NCT00503698|9664243|FG000|STARTED|Overall Study|Randomised|357
9086065|NCT04810221|10150338|FG000|STARTED|Overall Study||16
9086066|NCT04810221|10150338|FG000|COMPLETED|Overall Study|"Included in the 13 subjects which completed the study, it is necessary to consider the case 0, a pilot test for the verification of study procedures. Data from this subject were not used in the statistical evaluation, which therefore included data from 12 eligible subjects that completed the study."|13
9086067|NCT04810221|10150338|FG000|NOT COMPLETED|Overall Study||3
9086068|NCT04575038|10150344|FG000|STARTED|Overall Study||56
9086069|NCT04575038|10150345|FG001|STARTED|Overall Study||59
9086070|NCT04575038|10150344|FG000|COMPLETED|Overall Study||55
9086071|NCT04575038|10150345|FG001|COMPLETED|Overall Study||58
9086072|NCT04575038|10150344|FG000|NOT COMPLETED|Overall Study||1
9086073|NCT04575038|10150345|FG001|NOT COMPLETED|Overall Study||1
9086074|NCT04545567|10150353|FG000|STARTED|Overall Study||10
9086075|NCT04545567|10150354|FG001|STARTED|Overall Study||11
9086076|NCT04545567|10150353|FG000|COMPLETED|Overall Study||9
9086077|NCT04545567|10150354|FG001|COMPLETED|Overall Study||9
9086078|NCT04545567|10150353|FG000|NOT COMPLETED|Overall Study||1
9086079|NCT04545567|10150354|FG001|NOT COMPLETED|Overall Study||2
9086080|NCT04425538|10150360|FG000|STARTED|Overall Study||17
9086081|NCT04425538|10150360|FG000|COMPLETED|Overall Study||17
9086082|NCT04425538|10150360|FG000|NOT COMPLETED|Overall Study||0
9086083|NCT04397757|10150366|FG000|STARTED|Overall Study||41
9086084|NCT04397757|10150367|FG001|STARTED|Overall Study||39
9086085|NCT04397757|10150366|FG000|Treated|Overall Study||39
9086086|NCT04397757|10150367|FG001|Treated|Overall Study||39
9086087|NCT04397757|10150366|FG000|COMPLETED|Overall Study||32
9086088|NCT04397757|10150367|FG001|COMPLETED|Overall Study||25
9086089|NCT04397757|10150366|FG000|NOT COMPLETED|Overall Study||9
9086090|NCT04397757|10150367|FG001|NOT COMPLETED|Overall Study||14
9086091|NCT04388683|10150380|FG000|STARTED|Overall Study||6
9086092|NCT04388683|10150381|FG001|STARTED|Overall Study||3
9086093|NCT04388683|10150380|FG000|COMPLETED|Overall Study||5
9086094|NCT04388683|10150381|FG001|COMPLETED|Overall Study||3
9086095|NCT04388683|10150380|FG000|NOT COMPLETED|Overall Study||1
9086096|NCT04388683|10150381|FG001|NOT COMPLETED|Overall Study||0
9086097|NCT04382651|10150389|FG000|STARTED|Overall Study||69
9086098|NCT04382651|10150390|FG001|STARTED|Overall Study||71
9086099|NCT04382651|10150389|FG000|Safety Analysis Set|Overall Study||68
9086100|NCT04382651|10150390|FG001|Safety Analysis Set|Overall Study||70
9086101|NCT04382651|10150389|FG000|Pharmacokinetics (PK) Analysis Set|Overall Study||63
9086102|NCT04382651|10150390|FG001|Pharmacokinetics (PK) Analysis Set|Overall Study||0
9086103|NCT04382651|10150389|FG000|COMPLETED|Overall Study||38
9086104|NCT04382651|10150390|FG001|COMPLETED|Overall Study||43
9086105|NCT04382651|10150389|FG000|NOT COMPLETED|Overall Study||31
9086106|NCT04382651|10150390|FG001|NOT COMPLETED|Overall Study||28
9086107|NCT04350593|10150399|FG000|STARTED|Overall Study||625
9086108|NCT04350593|10150400|FG001|STARTED|Overall Study||625
9086109|NCT04350593|10150399|FG000|COMPLETED|Overall Study||617
9086110|NCT04350593|10150400|FG001|COMPLETED|Overall Study||620
9086111|NCT04350593|10150399|FG000|NOT COMPLETED|Overall Study||8
9086112|NCT04350593|10150400|FG001|NOT COMPLETED|Overall Study||5
9086113|NCT04329832|10150408|FG000|STARTED|Overall Study||42
9086114|NCT04329832|10150409|FG001|STARTED|Overall Study||43
9086115|NCT04329832|10150408|FG000|COMPLETED|Overall Study||42
9086116|NCT04329832|10150409|FG001|COMPLETED|Overall Study||43
9086117|NCT04329832|10150408|FG000|NOT COMPLETED|Overall Study||0
9086118|NCT04329832|10150409|FG001|NOT COMPLETED|Overall Study||0
9086119|NCT04112303|10150423|FG000|STARTED|Overall Study||37
8624795|NCT00503698|9664244|FG001|STARTED|Overall Study|Randomised|355
8624796|NCT00503698|9664243|FG000|Exposed to Trial Drug|Overall Study|11 subjects randomised but not exposed to trial drug. Subjects not included in full analysis set.|346
8624797|NCT00503698|9664244|FG001|Exposed to Trial Drug|Overall Study|6 subjects randomised but not exposed to trial drug. Subjects not included in full analysis set.|349
9086120|NCT04112303|10150423|FG000|COMPLETED|Overall Study||36
9086121|NCT04112303|10150423|FG000|NOT COMPLETED|Overall Study||1
9086122|NCT03896477|10150430|FG000|STARTED|Overall Study||220
9086123|NCT03896477|10150431|FG001|STARTED|Overall Study||220
9086124|NCT03896477|10150432|FG002|STARTED|Overall Study||220
9086125|NCT03896477|10150430|FG000|Received First Vaccination|Overall Study||220
9086126|NCT03896477|10150431|FG001|Received First Vaccination|Overall Study||220
9086127|NCT03896477|10150432|FG002|Received First Vaccination|Overall Study||220
9086128|NCT03896477|10150430|FG000|Received Second Vaccination|Overall Study||217
9086129|NCT03896477|10150431|FG001|Received Second Vaccination|Overall Study||213
9086130|NCT03896477|10150432|FG002|Received Second Vaccination|Overall Study||213
9086131|NCT03896477|10150430|FG000|Received Booster Vaccination|Overall Study||208
9086132|NCT03896477|10150431|FG001|Received Booster Vaccination|Overall Study||206
9086133|NCT03896477|10150432|FG002|Received Booster Vaccination|Overall Study||206
9086134|NCT03896477|10150430|FG000|COMPLETED|Overall Study||203
9086135|NCT03896477|10150431|FG001|COMPLETED|Overall Study||200
9086136|NCT03896477|10150432|FG002|COMPLETED|Overall Study||200
9086137|NCT03896477|10150430|FG000|NOT COMPLETED|Overall Study||17
9086138|NCT03896477|10150431|FG001|NOT COMPLETED|Overall Study||20
9086139|NCT03896477|10150432|FG002|NOT COMPLETED|Overall Study||20
9086191|NCT03463993|10150516|FG000|STARTED|Overall Study||253
9086192|NCT03463993|10150517|FG001|STARTED|Overall Study||253
9086193|NCT03463993|10150516|FG000|COMPLETED|Overall Study||224
9086194|NCT03463993|10150517|FG001|COMPLETED|Overall Study||227
9086195|NCT03463993|10150516|FG000|NOT COMPLETED|Overall Study||29
9086196|NCT03463993|10150517|FG001|NOT COMPLETED|Overall Study||26
9086197|NCT03411031|10150525|FG000|STARTED|Overall Study||9
9086140|NCT03760185|10150443|FG000|STARTED|Overall Study||13
9086141|NCT03760185|10150444|FG001|STARTED|Overall Study||13
9086142|NCT03760185|10150443|FG000|COMPLETED|Overall Study||12
9086143|NCT03760185|10150444|FG001|COMPLETED|Overall Study||12
9086144|NCT03760185|10150443|FG000|NOT COMPLETED|Overall Study||1
9086145|NCT03760185|10150444|FG001|NOT COMPLETED|Overall Study||1
9086146|NCT03732534|10150452|FG000|STARTED|Overall Study||6
9086147|NCT03732534|10150452|FG000|COMPLETED|Overall Study||0
9086148|NCT03732534|10150452|FG000|NOT COMPLETED|Overall Study||6
9086149|NCT03692910|10150456|FG000|STARTED|Overall Study||35
9086150|NCT03692910|10150457|FG001|STARTED|Overall Study||0
9086151|NCT03692910|10150458|FG002|STARTED|Overall Study||0
9086152|NCT03692910|10150456|FG000|COMPLETED|Overall Study||29
9086153|NCT03692910|10150457|FG001|COMPLETED|Overall Study||0
9086154|NCT03692910|10150458|FG002|COMPLETED|Overall Study||0
9086155|NCT03692910|10150456|FG000|NOT COMPLETED|Overall Study||6
9086156|NCT03692910|10150457|FG001|NOT COMPLETED|Overall Study||0
8624798|NCT00503698|9664243|FG000|COMPLETED|Overall Study|Trial prematurely terminated|0
8624799|NCT00503698|9664244|FG001|COMPLETED|Overall Study|Trial prematurely terminated|0
8624800|NCT00503698|9664243|FG000|NOT COMPLETED|Overall Study||357
8624801|NCT00503698|9664244|FG001|NOT COMPLETED|Overall Study||355
8624802|NCT00503750|9664250|FG000|STARTED|Overall Study||27
8624803|NCT00503750|9664250|FG000|COMPLETED|Overall Study||27
8624804|NCT00503750|9664250|FG000|NOT COMPLETED|Overall Study||0
8624805|NCT00503776|9664258|FG000|STARTED|Overall Study||8
8624806|NCT00503776|9664259|FG001|STARTED|Overall Study||12
8624807|NCT00503776|9664260|FG002|STARTED|Overall Study|one patient withdrew before receiving protocol therapy|12
8624808|NCT00503776|9664261|FG003|STARTED|Overall Study|one patient withdrew before receiving protocol therapy|10
8624809|NCT00503776|9664258|FG000|COMPLETED|Overall Study||7
8624810|NCT00503776|9664259|FG001|COMPLETED|Overall Study||12
8624811|NCT00503776|9664260|FG002|COMPLETED|Overall Study||10
8624812|NCT00503776|9664261|FG003|COMPLETED|Overall Study||8
8624813|NCT00503776|9664258|FG000|NOT COMPLETED|Overall Study||1
8624814|NCT00503776|9664259|FG001|NOT COMPLETED|Overall Study||0
8624815|NCT00503776|9664260|FG002|NOT COMPLETED|Overall Study||2
8624816|NCT00503776|9664261|FG003|NOT COMPLETED|Overall Study||2
8624817|NCT00503867|9664276|FG000|STARTED|Overall Study||10
8624818|NCT00503867|9664276|FG000|COMPLETED|Overall Study||8
8624819|NCT00503867|9664276|FG000|NOT COMPLETED|Overall Study||2
8624820|NCT00503906|9664280|FG000|STARTED|Overall Study||30
8624821|NCT00503906|9664280|FG000|COMPLETED|Overall Study||29
8624822|NCT00503906|9664280|FG000|NOT COMPLETED|Overall Study||1
8624823|NCT00503984|9664287|FG000|STARTED|Overall Study||3
8624824|NCT00503984|9664288|FG001|STARTED|Overall Study||3
8624825|NCT00503984|9664289|FG002|STARTED|Overall Study||3
8624826|NCT00503984|9664290|FG003|STARTED|Overall Study||6
9086157|NCT03692910|10150458|FG002|NOT COMPLETED|Overall Study||0
9086158|NCT03673956|10150468|FG000|STARTED|Overall Study||12
9086159|NCT03673956|10150469|FG001|STARTED|Overall Study||1
9086160|NCT03673956|10150470|FG002|STARTED|Overall Study||5
9086161|NCT03673956|10150471|FG003|STARTED|Overall Study||1
9086162|NCT03673956|10150468|FG000|COMPLETED|Overall Study||10
9086163|NCT03673956|10150469|FG001|COMPLETED|Overall Study||1
9086164|NCT03673956|10150470|FG002|COMPLETED|Overall Study||5
9086165|NCT03673956|10150471|FG003|COMPLETED|Overall Study||1
9086166|NCT03673956|10150468|FG000|NOT COMPLETED|Overall Study||2
9086167|NCT03673956|10150469|FG001|NOT COMPLETED|Overall Study||0
9086168|NCT03673956|10150470|FG002|NOT COMPLETED|Overall Study||0
9086169|NCT03673956|10150471|FG003|NOT COMPLETED|Overall Study||0
9086170|NCT03649347|10150485|FG000|STARTED|Overall Study||13
9086171|NCT03649347|10150486|FG001|STARTED|Overall Study||12
9086172|NCT03649347|10150487|FG002|STARTED|Overall Study||0
9086173|NCT03649347|10150488|FG003|STARTED|Overall Study||0
9086174|NCT03649347|10150485|FG000|COMPLETED|Overall Study||13
9086175|NCT03649347|10150486|FG001|COMPLETED|Overall Study||12
9086176|NCT03649347|10150487|FG002|COMPLETED|Overall Study||0
9086177|NCT03649347|10150488|FG003|COMPLETED|Overall Study||0
9086178|NCT03649347|10150485|FG000|NOT COMPLETED|Overall Study||0
9086179|NCT03649347|10150486|FG001|NOT COMPLETED|Overall Study||0
9086180|NCT03649347|10150487|FG002|NOT COMPLETED|Overall Study||0
9086181|NCT03649347|10150488|FG003|NOT COMPLETED|Overall Study||0
9086182|NCT03641326|10150498|FG000|STARTED|Overall Study||2
9086183|NCT03641326|10150499|FG001|STARTED|Overall Study||3
9086184|NCT03641326|10150498|FG000|COMPLETED|Overall Study||2
9086185|NCT03641326|10150499|FG001|COMPLETED|Overall Study||3
9086186|NCT03641326|10150498|FG000|NOT COMPLETED|Overall Study||0
9086187|NCT03641326|10150499|FG001|NOT COMPLETED|Overall Study||0
9086188|NCT03618420|10150510|FG000|STARTED|Overall Study||50
9086189|NCT03618420|10150510|FG000|COMPLETED|Overall Study||50
8624827|NCT00503984|9664291|FG004|STARTED|Overall Study||6
8624828|NCT00503984|9664292|FG005|STARTED|Overall Study||1
9086190|NCT03618420|10150510|FG000|NOT COMPLETED|Overall Study||0
9086198|NCT03411031|10150526|FG001|STARTED|Overall Study||9
9086199|NCT03411031|10150525|FG000|COMPLETED|Overall Study||9
8624829|NCT00503984|9664287|FG000|COMPLETED|Overall Study||3
8624830|NCT00503984|9664288|FG001|COMPLETED|Overall Study||1
8624831|NCT00503984|9664289|FG002|COMPLETED|Overall Study||3
8624832|NCT00503984|9664290|FG003|COMPLETED|Overall Study||6
9086200|NCT03411031|10150526|FG001|COMPLETED|Overall Study||9
9086201|NCT03411031|10150525|FG000|NOT COMPLETED|Overall Study||0
9086202|NCT03411031|10150526|FG001|NOT COMPLETED|Overall Study||0
9086203|NCT03365752|10150535|FG000|STARTED|Overall Study||13
9086204|NCT03365752|10150536|FG001|STARTED|Overall Study||13
9086205|NCT03365752|10150537|FG002|STARTED|Overall Study||13
9086206|NCT03365752|10150535|FG000|COMPLETED|Overall Study||13
9086207|NCT03365752|10150536|FG001|COMPLETED|Overall Study||13
9086208|NCT03365752|10150537|FG002|COMPLETED|Overall Study||13
9086209|NCT03365752|10150535|FG000|NOT COMPLETED|Overall Study||0
9086210|NCT03365752|10150536|FG001|NOT COMPLETED|Overall Study||0
9086211|NCT03365752|10150537|FG002|NOT COMPLETED|Overall Study||0
9086212|NCT03364036|10150545|FG000|STARTED|Overall Study||270
9086213|NCT03364036|10150545|FG000|Full Analysis Set (FAS)|Overall Study||270
9086214|NCT03364036|10150545|FG000|COMPLETED|Overall Study||264
9086215|NCT03364036|10150545|FG000|NOT COMPLETED|Overall Study||6
9086216|NCT03205163|10150551|FG000|STARTED|ATP (LDC: 3 Days; HDC: 4 Days)||7
9086217|NCT03205163|10150552|FG001|STARTED|ATP (LDC: 3 Days; HDC: 4 Days)||9
9086218|NCT03205163|10150551|FG000|Safety Population|ATP (LDC: 3 Days; HDC: 4 Days)||7
9086219|NCT03205163|10150552|FG001|Safety Population|ATP (LDC: 3 Days; HDC: 4 Days)||9
9086220|NCT03205163|10150551|FG000|COMPLETED|ATP (LDC: 3 Days; HDC: 4 Days)||6
9086221|NCT03205163|10150552|FG001|COMPLETED|ATP (LDC: 3 Days; HDC: 4 Days)||9
9086222|NCT03205163|10150551|FG000|NOT COMPLETED|ATP (LDC: 3 Days; HDC: 4 Days)||1
9086223|NCT03205163|10150552|FG001|NOT COMPLETED|ATP (LDC: 3 Days; HDC: 4 Days)||0
9086224|NCT03205163|10150551|FG000|STARTED|BTP (LDC: 28 Days; HDC: 28 Days)||6
9086225|NCT03205163|10150552|FG001|STARTED|BTP (LDC: 28 Days; HDC: 28 Days)||9
9086226|NCT03205163|10150551|FG000|Safety Population|BTP (LDC: 28 Days; HDC: 28 Days)||6
9086227|NCT03205163|10150552|FG001|Safety Population|BTP (LDC: 28 Days; HDC: 28 Days)||9
9086228|NCT03205163|10150551|FG000|COMPLETED|BTP (LDC: 28 Days; HDC: 28 Days)||6
9086229|NCT03205163|10150552|FG001|COMPLETED|BTP (LDC: 28 Days; HDC: 28 Days)||9
9086230|NCT03205163|10150551|FG000|NOT COMPLETED|BTP (LDC: 28 Days; HDC: 28 Days)||0
9086231|NCT03205163|10150552|FG001|NOT COMPLETED|BTP (LDC: 28 Days; HDC: 28 Days)||0
9086232|NCT03178045|10150569|FG000|STARTED|Overall Study||1396
9086233|NCT03178045|10150570|FG001|STARTED|Overall Study||1397
9086234|NCT03178045|10150569|FG000|COMPLETED|Overall Study||1310
9086235|NCT03178045|10150570|FG001|COMPLETED|Overall Study||1314
9086236|NCT03178045|10150569|FG000|NOT COMPLETED|Overall Study||86
9086237|NCT03178045|10150570|FG001|NOT COMPLETED|Overall Study||83
9086238|NCT03145766|10150582|FG000|STARTED|Active Vaccination Phase (Day 0-Day 56)||80
9086239|NCT03145766|10150583|FG001|STARTED|Active Vaccination Phase (Day 0-Day 56)||80
9086240|NCT03145766|10150584|FG002|STARTED|Active Vaccination Phase (Day 0-Day 56)||80
9086241|NCT03145766|10150585|FG003|STARTED|Active Vaccination Phase (Day 0-Day 56)||40
9086242|NCT03145766|10150586|FG004|STARTED|Active Vaccination Phase (Day 0-Day 56)||40
9086243|NCT03145766|10150582|FG000|Vaccination 1|Active Vaccination Phase (Day 0-Day 56)||80
9086244|NCT03145766|10150583|FG001|Vaccination 1|Active Vaccination Phase (Day 0-Day 56)||80
9086245|NCT03145766|10150584|FG002|Vaccination 1|Active Vaccination Phase (Day 0-Day 56)||80
9086246|NCT03145766|10150585|FG003|Vaccination 1|Active Vaccination Phase (Day 0-Day 56)|1 participant of this arm received Imovax Rabies, and counted in Group 5 for safety analysis.|39
9086247|NCT03145766|10150586|FG004|Vaccination 1|Active Vaccination Phase (Day 0-Day 56)|1 participant of Group 4 received Imovax Rabies, and counted in Group 5 for safety analysis.|41
9086248|NCT03145766|10150582|FG000|Vaccination 2|Active Vaccination Phase (Day 0-Day 56)|1 participant received Group 2 vaccine: counted in Group 2 for post-vaccination 2 safety analysis.|77
9086249|NCT03145766|10150583|FG001|Vaccination 2|Active Vaccination Phase (Day 0-Day 56)|1 participant of Group 1 received Group 2 vaccine: counted in Group 2 for post-vaccination 2 safety.|81
9086250|NCT03145766|10150584|FG002|Vaccination 2|Active Vaccination Phase (Day 0-Day 56)||80
9086251|NCT03145766|10150585|FG003|Vaccination 2|Active Vaccination Phase (Day 0-Day 56)||39
9086252|NCT03145766|10150586|FG004|Vaccination 2|Active Vaccination Phase (Day 0-Day 56)||39
9086253|NCT03145766|10150582|FG000|Vaccination 3|Active Vaccination Phase (Day 0-Day 56)||78
9086254|NCT03145766|10150583|FG001|Vaccination 3|Active Vaccination Phase (Day 0-Day 56)||79
9086255|NCT03145766|10150584|FG002|Vaccination 3|Active Vaccination Phase (Day 0-Day 56)||80
9086256|NCT03145766|10150585|FG003|Vaccination 3|Active Vaccination Phase (Day 0-Day 56)||39
9086257|NCT03145766|10150586|FG004|Vaccination 3|Active Vaccination Phase (Day 0-Day 56)||38
9086258|NCT03145766|10150582|FG000|Vaccination 4|Active Vaccination Phase (Day 0-Day 56)||78
9086259|NCT03145766|10150583|FG001|Vaccination 4|Active Vaccination Phase (Day 0-Day 56)||79
9086260|NCT03145766|10150584|FG002|Vaccination 4|Active Vaccination Phase (Day 0-Day 56)||80
9086261|NCT03145766|10150585|FG003|Vaccination 4|Active Vaccination Phase (Day 0-Day 56)||38
9086262|NCT03145766|10150586|FG004|Vaccination 4|Active Vaccination Phase (Day 0-Day 56)||38
9086263|NCT03145766|10150582|FG000|Vaccination 5|Active Vaccination Phase (Day 0-Day 56)||75
9086264|NCT03145766|10150583|FG001|Vaccination 5|Active Vaccination Phase (Day 0-Day 56)||78
9086265|NCT03145766|10150584|FG002|Vaccination 5|Active Vaccination Phase (Day 0-Day 56)||79
9086266|NCT03145766|10150585|FG003|Vaccination 5|Active Vaccination Phase (Day 0-Day 56)||34
9086267|NCT03145766|10150586|FG004|Vaccination 5|Active Vaccination Phase (Day 0-Day 56)||37
9086268|NCT03145766|10150582|FG000|COMPLETED|Active Vaccination Phase (Day 0-Day 56)||74
9086269|NCT03145766|10150583|FG001|COMPLETED|Active Vaccination Phase (Day 0-Day 56)||77
9086270|NCT03145766|10150584|FG002|COMPLETED|Active Vaccination Phase (Day 0-Day 56)||78
9086271|NCT03145766|10150585|FG003|COMPLETED|Active Vaccination Phase (Day 0-Day 56)||33
9086272|NCT03145766|10150586|FG004|COMPLETED|Active Vaccination Phase (Day 0-Day 56)||37
9086273|NCT03145766|10150582|FG000|NOT COMPLETED|Active Vaccination Phase (Day 0-Day 56)||6
9086274|NCT03145766|10150583|FG001|NOT COMPLETED|Active Vaccination Phase (Day 0-Day 56)||3
9086275|NCT03145766|10150584|FG002|NOT COMPLETED|Active Vaccination Phase (Day 0-Day 56)||2
9086276|NCT03145766|10150585|FG003|NOT COMPLETED|Active Vaccination Phase (Day 0-Day 56)||7
9086277|NCT03145766|10150586|FG004|NOT COMPLETED|Active Vaccination Phase (Day 0-Day 56)||3
9086278|NCT03145766|10150582|FG000|STARTED|Follow-up Phase (Day 56 Till Month 7)||74
9086279|NCT03145766|10150583|FG001|STARTED|Follow-up Phase (Day 56 Till Month 7)||77
9086280|NCT03145766|10150584|FG002|STARTED|Follow-up Phase (Day 56 Till Month 7)||78
9086281|NCT03145766|10150585|FG003|STARTED|Follow-up Phase (Day 56 Till Month 7)||33
9086282|NCT03145766|10150586|FG004|STARTED|Follow-up Phase (Day 56 Till Month 7)||37
9086283|NCT03145766|10150582|FG000|COMPLETED|Follow-up Phase (Day 56 Till Month 7)||67
9086284|NCT03145766|10150583|FG001|COMPLETED|Follow-up Phase (Day 56 Till Month 7)||75
9086285|NCT03145766|10150584|FG002|COMPLETED|Follow-up Phase (Day 56 Till Month 7)||73
9086286|NCT03145766|10150585|FG003|COMPLETED|Follow-up Phase (Day 56 Till Month 7)||30
9086287|NCT03145766|10150586|FG004|COMPLETED|Follow-up Phase (Day 56 Till Month 7)||34
9086288|NCT03145766|10150582|FG000|NOT COMPLETED|Follow-up Phase (Day 56 Till Month 7)||7
9086289|NCT03145766|10150583|FG001|NOT COMPLETED|Follow-up Phase (Day 56 Till Month 7)||2
9086290|NCT03145766|10150584|FG002|NOT COMPLETED|Follow-up Phase (Day 56 Till Month 7)||5
9086291|NCT03145766|10150585|FG003|NOT COMPLETED|Follow-up Phase (Day 56 Till Month 7)||3
9086292|NCT03145766|10150586|FG004|NOT COMPLETED|Follow-up Phase (Day 56 Till Month 7)||3
9086293|NCT03106987|10150603|FG000|STARTED|Overall Study||74
9086294|NCT03106987|10150604|FG001|STARTED|Overall Study||38
9086295|NCT03106987|10150605|FG002|STARTED|Overall Study||72
9086296|NCT03106987|10150606|FG003|STARTED|Overall Study||36
9086297|NCT03106987|10150603|FG000|COMPLETED|Overall Study||30
9086298|NCT03106987|10150604|FG001|COMPLETED|Overall Study||15
9086299|NCT03106987|10150605|FG002|COMPLETED|Overall Study||54
9086300|NCT03106987|10150606|FG003|COMPLETED|Overall Study||25
9086301|NCT03106987|10150603|FG000|NOT COMPLETED|Overall Study||44
9086302|NCT03106987|10150604|FG001|NOT COMPLETED|Overall Study||23
9086303|NCT03106987|10150605|FG002|NOT COMPLETED|Overall Study||18
9086304|NCT03106987|10150606|FG003|NOT COMPLETED|Overall Study||11
9086305|NCT03103087|10150619|FG000|STARTED|Overall Study||126
9086306|NCT03103087|10150620|FG001|STARTED|Overall Study||127
9086307|NCT03103087|10150621|FG002|STARTED|Overall Study||129
9086308|NCT03103087|10150619|FG000|COMPLETED|Overall Study||102
9086309|NCT03103087|10150620|FG001|COMPLETED|Overall Study||98
9086310|NCT03103087|10150621|FG002|COMPLETED|Overall Study||102
9086311|NCT03103087|10150619|FG000|NOT COMPLETED|Overall Study||24
9086312|NCT03103087|10150620|FG001|NOT COMPLETED|Overall Study||29
9086313|NCT03103087|10150621|FG002|NOT COMPLETED|Overall Study||27
8624833|NCT00503984|9664291|FG004|COMPLETED|Overall Study||5
8624834|NCT00503984|9664292|FG005|COMPLETED|Overall Study||1
8624835|NCT00503984|9664287|FG000|NOT COMPLETED|Overall Study||0
8624836|NCT00503984|9664288|FG001|NOT COMPLETED|Overall Study||2
8624837|NCT00503984|9664289|FG002|NOT COMPLETED|Overall Study||0
8624838|NCT00503984|9664290|FG003|NOT COMPLETED|Overall Study||0
8624839|NCT00503984|9664291|FG004|NOT COMPLETED|Overall Study||1
8624840|NCT00503984|9664292|FG005|NOT COMPLETED|Overall Study||0
9086314|NCT03049735|10150634|FG000|STARTED|Overall Study||128
9086315|NCT03049735|10150635|FG001|STARTED|Overall Study||132
9086316|NCT03049735|10150636|FG002|STARTED|Overall Study||128
9086317|NCT03049735|10150634|FG000|Received at Least 1 Dose of Study Drug|Overall Study||128
9086318|NCT03049735|10150635|FG001|Received at Least 1 Dose of Study Drug|Overall Study||132
9086319|NCT03049735|10150636|FG002|Received at Least 1 Dose of Study Drug|Overall Study||127
9086320|NCT03049735|10150634|FG000|COMPLETED|Overall Study||100
9086321|NCT03049735|10150635|FG001|COMPLETED|Overall Study||103
9086322|NCT03049735|10150636|FG002|COMPLETED|Overall Study||105
9086323|NCT03049735|10150634|FG000|NOT COMPLETED|Overall Study||28
9086324|NCT03049735|10150635|FG001|NOT COMPLETED|Overall Study||29
9086325|NCT03049735|10150636|FG002|NOT COMPLETED|Overall Study||23
9086326|NCT03021551|10150644|FG000|STARTED|Overall Study||80
9086327|NCT03021551|10150644|FG000|COMPLETED|Overall Study||77
9086328|NCT03021551|10150644|FG000|NOT COMPLETED|Overall Study||3
9086329|NCT02990338|10150650|FG000|STARTED|Overall Study||153
9086330|NCT02990338|10150651|FG001|STARTED|Overall Study||154
9086331|NCT02990338|10150650|FG000|Treated|Overall Study||149
9086332|NCT02990338|10150651|FG001|Treated|Overall Study||152
9086333|NCT02990338|10150650|FG000|Ongoing|Overall Study||35
9086334|NCT02990338|10150651|FG001|Ongoing|Overall Study||65
9086335|NCT02990338|10150650|FG000|COMPLETED|Overall Study||35
9086336|NCT02990338|10150651|FG001|COMPLETED|Overall Study||65
9086337|NCT02990338|10150650|FG000|NOT COMPLETED|Overall Study||118
9086338|NCT02990338|10150651|FG001|NOT COMPLETED|Overall Study||89
9086339|NCT02972996|10150660|FG000|STARTED|Overall Study||27
9086340|NCT02972996|10150661|FG001|STARTED|Overall Study||28
9086341|NCT02972996|10150660|FG000|COMPLETED|Overall Study||26
9086342|NCT02972996|10150661|FG001|COMPLETED|Overall Study||26
9086343|NCT02972996|10150660|FG000|NOT COMPLETED|Overall Study||1
9086344|NCT02972996|10150661|FG001|NOT COMPLETED|Overall Study||2
9086345|NCT02932332|10150671|FG000|STARTED|Overall Study||5
9086346|NCT02932332|10150672|FG001|STARTED|Overall Study||4
9086347|NCT02932332|10150673|FG002|STARTED|Overall Study||5
9086348|NCT02932332|10150674|FG003|STARTED|Overall Study||5
9086349|NCT02932332|10150671|FG000|Intervention 1|Overall Study||4
9086350|NCT02932332|10150672|FG001|Intervention 1|Overall Study||4
9086351|NCT02932332|10150673|FG002|Intervention 1|Overall Study||5
9086352|NCT02932332|10150674|FG003|Intervention 1|Overall Study||4
9086353|NCT02932332|10150671|FG000|Intervention 2|Overall Study||4
9086354|NCT02932332|10150672|FG001|Intervention 2|Overall Study||3
9086355|NCT02932332|10150673|FG002|Intervention 2|Overall Study||4
9086356|NCT02932332|10150674|FG003|Intervention 2|Overall Study||4
9086357|NCT02932332|10150671|FG000|Intervention 3|Overall Study||3
9086358|NCT02932332|10150672|FG001|Intervention 3|Overall Study||2
9086359|NCT02932332|10150673|FG002|Intervention 3|Overall Study||4
9086360|NCT02932332|10150674|FG003|Intervention 3|Overall Study||3
9086361|NCT02932332|10150671|FG000|Intervention 4|Overall Study||3
9086362|NCT02932332|10150672|FG001|Intervention 4|Overall Study||1
9086363|NCT02932332|10150673|FG002|Intervention 4|Overall Study||4
9086364|NCT02932332|10150674|FG003|Intervention 4|Overall Study||3
9086365|NCT02932332|10150671|FG000|COMPLETED|Overall Study||3
9086366|NCT02932332|10150672|FG001|COMPLETED|Overall Study||1
9086367|NCT02932332|10150673|FG002|COMPLETED|Overall Study||4
9086368|NCT02932332|10150674|FG003|COMPLETED|Overall Study||3
9086369|NCT02932332|10150671|FG000|NOT COMPLETED|Overall Study||2
9086370|NCT02932332|10150672|FG001|NOT COMPLETED|Overall Study||3
9086371|NCT02932332|10150673|FG002|NOT COMPLETED|Overall Study||1
9086372|NCT02932332|10150674|FG003|NOT COMPLETED|Overall Study||2
9086373|NCT02845440|10150689|FG000|STARTED|Overall Study||333
9086374|NCT02845440|10150690|FG001|STARTED|Overall Study||336
9086375|NCT02845440|10150691|FG002|STARTED|Overall Study||341
9086376|NCT02845440|10150692|FG003|STARTED|Overall Study||78
9086377|NCT02845440|10150693|FG004|STARTED|Overall Study||77
9086378|NCT02845440|10150689|FG000|COMPLETED|Overall Study||201
9086379|NCT02845440|10150690|FG001|COMPLETED|Overall Study||203
9086380|NCT02845440|10150691|FG002|COMPLETED|Overall Study||204
9086381|NCT02845440|10150692|FG003|COMPLETED|Overall Study||49
9086382|NCT02845440|10150693|FG004|COMPLETED|Overall Study||39
9086383|NCT02845440|10150689|FG000|NOT COMPLETED|Overall Study||132
9086384|NCT02845440|10150690|FG001|NOT COMPLETED|Overall Study||133
9086385|NCT02845440|10150691|FG002|NOT COMPLETED|Overall Study||137
9086386|NCT02845440|10150692|FG003|NOT COMPLETED|Overall Study||29
9086387|NCT02845440|10150693|FG004|NOT COMPLETED|Overall Study||38
9086388|NCT02786394|10150710|FG000|STARTED|Overall Study||11
9086389|NCT02786394|10150710|FG000|COMPLETED|Overall Study||10
9086390|NCT02786394|10150710|FG000|NOT COMPLETED|Overall Study||1
9086391|NCT02588248|10150717|FG000|STARTED|Overall Study||42
9086392|NCT02588248|10150718|FG001|STARTED|Overall Study||40
9086393|NCT02588248|10150717|FG000|COMPLETED|Overall Study||38
9086394|NCT02588248|10150718|FG001|COMPLETED|Overall Study||37
9086395|NCT02588248|10150717|FG000|NOT COMPLETED|Overall Study||4
9086396|NCT02588248|10150718|FG001|NOT COMPLETED|Overall Study||3
9086397|NCT02535065|10150729|FG000|STARTED|Overall Study||62
9086398|NCT02535065|10150729|FG000|1-Month Follow-up|Overall Study||62
9086399|NCT02535065|10150729|FG000|12-Month Follow-up|Overall Study||61
9086400|NCT02535065|10150729|FG000|COMPLETED|Overall Study||42
9086401|NCT02535065|10150729|FG000|NOT COMPLETED|Overall Study||20
9086402|NCT02510885|10150733|FG000|STARTED|Overall Study||39
9086403|NCT02510885|10150733|FG000|COMPLETED|Overall Study||39
9086404|NCT02510885|10150733|FG000|NOT COMPLETED|Overall Study||0
9086405|NCT02451358|10150741|FG000|STARTED|Overall Study||100
9086406|NCT02451358|10150742|FG001|STARTED|Overall Study||100
9086407|NCT02451358|10150743|FG002|STARTED|Overall Study||100
9086408|NCT02451358|10150744|FG003|STARTED|Overall Study||100
9086409|NCT02451358|10150741|FG000|Vaccinated at Day 0|Overall Study||100
9086410|NCT02451358|10150742|FG001|Vaccinated at Day 0|Overall Study||100
9086411|NCT02451358|10150743|FG002|Vaccinated at Day 0|Overall Study||100
9086412|NCT02451358|10150744|FG003|Vaccinated at Day 0|Overall Study||100
9086413|NCT02451358|10150741|FG000|Vaccinated at Day 28|Overall Study||99
9086414|NCT02451358|10150742|FG001|Vaccinated at Day 28|Overall Study||98
9086415|NCT02451358|10150743|FG002|Vaccinated at Day 28|Overall Study|Participants aged 9 years and older received only 1 dose of Quadrivalent Influenza Vaccine.|0
9086416|NCT02451358|10150744|FG003|Vaccinated at Day 28|Overall Study|Participants aged 9 years and older received only 1 dose of Quadrivalent Influenza Vaccine.|0
9086417|NCT02451358|10150741|FG000|COMPLETED|Overall Study||99
9086418|NCT02451358|10150742|FG001|COMPLETED|Overall Study||98
9086419|NCT02451358|10150743|FG002|COMPLETED|Overall Study||99
9086420|NCT02451358|10150744|FG003|COMPLETED|Overall Study||100
9086421|NCT02451358|10150741|FG000|NOT COMPLETED|Overall Study||1
9086422|NCT02451358|10150742|FG001|NOT COMPLETED|Overall Study||2
9086423|NCT02451358|10150743|FG002|NOT COMPLETED|Overall Study||1
9086424|NCT02451358|10150744|FG003|NOT COMPLETED|Overall Study||0
9086425|NCT02268175|10150756|FG000|STARTED|Overall Study||50
9086426|NCT02268175|10150757|FG001|STARTED|Overall Study||25
9086427|NCT02268175|10150756|FG000|COMPLETED|Overall Study||50
9086428|NCT02268175|10150757|FG001|COMPLETED|Overall Study||25
9086429|NCT02268175|10150756|FG000|NOT COMPLETED|Overall Study||0
9086430|NCT02268175|10150757|FG001|NOT COMPLETED|Overall Study||0
9086431|NCT02178709|10150763|FG000|STARTED|Overall Study||48
9086432|NCT02178709|10150763|FG000|COMPLETED|Overall Study||32
9086433|NCT02178709|10150763|FG000|NOT COMPLETED|Overall Study||16
9086434|NCT02163681|10150767|FG000|STARTED|Overall Study||45
9086435|NCT02163681|10150767|FG000|COMPLETED|Overall Study||44
9086436|NCT02163681|10150767|FG000|NOT COMPLETED|Overall Study||1
9086437|NCT01980017|10150773|FG000|STARTED|Overall Study||114
9086438|NCT01980017|10150774|FG001|STARTED|Overall Study||199
9086439|NCT01980017|10150773|FG000|COMPLETED|Overall Study||84
9086440|NCT01980017|10150774|FG001|COMPLETED|Overall Study||177
9086441|NCT01980017|10150773|FG000|NOT COMPLETED|Overall Study||30
9086442|NCT01980017|10150774|FG001|NOT COMPLETED|Overall Study||22
9086443|NCT01890759|10150785|FG000|STARTED|Overall Study||100
9086444|NCT01890759|10150786|FG001|STARTED|Overall Study||200
9086445|NCT01890759|10150785|FG000|COMPLETED|Overall Study||98
9086446|NCT01890759|10150786|FG001|COMPLETED|Overall Study||188
9086447|NCT01890759|10150785|FG000|NOT COMPLETED|Overall Study||2
9086448|NCT01890759|10150786|FG001|NOT COMPLETED|Overall Study||12
9086449|NCT01855867|10150792|FG000|STARTED|Overall Study||100
9086450|NCT01855867|10150792|FG000|COMPLETED|Overall Study||100
9086451|NCT01855867|10150792|FG000|NOT COMPLETED|Overall Study||0
9086452|NCT01721746|10150799|FG000|STARTED|Pre-Treatment||272
9086453|NCT01721746|10150800|FG001|STARTED|Pre-Treatment||133
9086454|NCT01721746|10150799|FG000|COMPLETED|Pre-Treatment||268
9086455|NCT01721746|10150800|FG001|COMPLETED|Pre-Treatment||102
9086456|NCT01721746|10150799|FG000|NOT COMPLETED|Pre-Treatment||4
8624841|NCT00503997|9664316|FG000|STARTED|Overall Study||42
8624842|NCT00503997|9664316|FG000|COMPLETED|Overall Study||34
8624843|NCT00503997|9664316|FG000|NOT COMPLETED|Overall Study||8
8624844|NCT00504023|9664320|FG000|STARTED|Overall Study||8
8624845|NCT00504023|9664320|FG000|COMPLETED|Overall Study||8
9086457|NCT01721746|10150800|FG001|NOT COMPLETED|Pre-Treatment||31
9086458|NCT01721746|10150799|FG000|STARTED|Treatment||268
9086459|NCT01721746|10150800|FG001|STARTED|Treatment||102
9086460|NCT01721746|10150799|FG000|COMPLETED|Treatment||0
9086461|NCT01721746|10150800|FG001|COMPLETED|Treatment||0
9086462|NCT01721746|10150799|FG000|NOT COMPLETED|Treatment||268
9086463|NCT01721746|10150800|FG001|NOT COMPLETED|Treatment||102
9086464|NCT01705977|10150809|FG000|STARTED|Overall Study||2002
9086465|NCT01705977|10150810|FG001|STARTED|Overall Study||2001
9086466|NCT01705977|10150809|FG000|COMPLETED|Overall Study||1729
9086467|NCT01705977|10150810|FG001|COMPLETED|Overall Study||1741
9086468|NCT01705977|10150809|FG000|NOT COMPLETED|Overall Study||273
9086469|NCT01705977|10150810|FG001|NOT COMPLETED|Overall Study||260
9086470|NCT01587040|10150820|FG000|STARTED|Overall Study||17
9086471|NCT01587040|10150821|FG001|STARTED|Overall Study||3
9086472|NCT01587040|10150822|FG002|STARTED|Overall Study||37
9086473|NCT01587040|10150823|FG003|STARTED|Overall Study||4
9086474|NCT01587040|10150820|FG000|COMPLETED|Overall Study||0
9086475|NCT01587040|10150821|FG001|COMPLETED|Overall Study||0
9086476|NCT01587040|10150822|FG002|COMPLETED|Overall Study||0
9086477|NCT01587040|10150823|FG003|COMPLETED|Overall Study||0
9086478|NCT01587040|10150820|FG000|NOT COMPLETED|Overall Study||17
9086479|NCT01587040|10150821|FG001|NOT COMPLETED|Overall Study||3
9086480|NCT01587040|10150822|FG002|NOT COMPLETED|Overall Study||37
9086481|NCT01587040|10150823|FG003|NOT COMPLETED|Overall Study||4
9086482|NCT01293682|10150833|FG000|STARTED|Overall Study||12
9086483|NCT01293682|10150833|FG000|COMPLETED|Overall Study||12
9086484|NCT01293682|10150833|FG000|NOT COMPLETED|Overall Study||0
9086485|NCT01254409|10150841|FG000|STARTED|Overall Study||6
9086486|NCT01254409|10150842|FG001|STARTED|Overall Study||6
9086487|NCT01254409|10150843|FG002|STARTED|Overall Study||5
9086488|NCT01254409|10150844|FG003|STARTED|Overall Study||4
9086489|NCT01254409|10150841|FG000|COMPLETED|Overall Study||6
9086490|NCT01254409|10150842|FG001|COMPLETED|Overall Study||5
9086491|NCT01254409|10150843|FG002|COMPLETED|Overall Study||5
9086492|NCT01254409|10150844|FG003|COMPLETED|Overall Study||4
9086493|NCT01254409|10150841|FG000|NOT COMPLETED|Overall Study||0
9086494|NCT01254409|10150842|FG001|NOT COMPLETED|Overall Study||1
9086495|NCT01254409|10150843|FG002|NOT COMPLETED|Overall Study||0
9086496|NCT01254409|10150844|FG003|NOT COMPLETED|Overall Study||0
9086497|NCT01253161|10150857|FG000|STARTED|Overall Study||29
9086498|NCT01253161|10150857|FG000|COMPLETED|Overall Study||28
9086499|NCT01253161|10150857|FG000|NOT COMPLETED|Overall Study||1
9086500|NCT01084252|10150875|FG000|STARTED|Phase 1 (120 Weeks)||16
9086501|NCT01084252|10150876|FG001|STARTED|Phase 1 (120 Weeks)||6
9086502|NCT01084252|10150877|FG002|STARTED|Phase 1 (120 Weeks)||3
9086503|NCT01084252|10150878|FG003|STARTED|Phase 1 (120 Weeks)||26
9086504|NCT01084252|10150879|FG004|STARTED|Phase 1 (120 Weeks)||18
9086505|NCT01084252|10150880|FG005|STARTED|Phase 1 (120 Weeks)||6
9086506|NCT01084252|10150881|FG006|STARTED|Phase 1 (120 Weeks)||7
9086507|NCT01084252|10150882|FG007|STARTED|Phase 1 (120 Weeks)||7
9086508|NCT01084252|10150883|FG008|STARTED|Phase 1 (120 Weeks)||0
9086509|NCT01084252|10150884|FG009|STARTED|Phase 1 (120 Weeks)||0
9086510|NCT01084252|10150885|FG010|STARTED|Phase 1 (120 Weeks)||0
9086511|NCT01084252|10150886|FG011|STARTED|Phase 1 (120 Weeks)||0
9086512|NCT01084252|10150887|FG012|STARTED|Phase 1 (120 Weeks)||0
9086513|NCT01084252|10150888|FG013|STARTED|Phase 1 (120 Weeks)||0
9086514|NCT01084252|10150875|FG000|All Treated (AT) Population|Phase 1 (120 Weeks)||16
9086515|NCT01084252|10150876|FG001|All Treated (AT) Population|Phase 1 (120 Weeks)||6
9086516|NCT01084252|10150877|FG002|All Treated (AT) Population|Phase 1 (120 Weeks)||3
9086517|NCT01084252|10150878|FG003|All Treated (AT) Population|Phase 1 (120 Weeks)||26
9086518|NCT01084252|10150879|FG004|All Treated (AT) Population|Phase 1 (120 Weeks)||18
9086519|NCT01084252|10150880|FG005|All Treated (AT) Population|Phase 1 (120 Weeks)||6
9086520|NCT01084252|10150881|FG006|All Treated (AT) Population|Phase 1 (120 Weeks)||7
9086521|NCT01084252|10150882|FG007|All Treated (AT) Population|Phase 1 (120 Weeks)||7
8624846|NCT00504023|9664320|FG000|NOT COMPLETED|Overall Study||0
9086522|NCT01084252|10150883|FG008|All Treated (AT) Population|Phase 1 (120 Weeks)||0
9086523|NCT01084252|10150884|FG009|All Treated (AT) Population|Phase 1 (120 Weeks)||0
9086524|NCT01084252|10150885|FG010|All Treated (AT) Population|Phase 1 (120 Weeks)||0
9086525|NCT01084252|10150886|FG011|All Treated (AT) Population|Phase 1 (120 Weeks)||0
9086526|NCT01084252|10150887|FG012|All Treated (AT) Population|Phase 1 (120 Weeks)||0
9086527|NCT01084252|10150888|FG013|All Treated (AT) Population|Phase 1 (120 Weeks)||0
9086528|NCT01084252|10150875|FG000|COMPLETED|Phase 1 (120 Weeks)||0
9086529|NCT01084252|10150876|FG001|COMPLETED|Phase 1 (120 Weeks)||0
9086530|NCT01084252|10150877|FG002|COMPLETED|Phase 1 (120 Weeks)||0
9086531|NCT01084252|10150878|FG003|COMPLETED|Phase 1 (120 Weeks)||0
9086532|NCT01084252|10150879|FG004|COMPLETED|Phase 1 (120 Weeks)||0
9086533|NCT01084252|10150880|FG005|COMPLETED|Phase 1 (120 Weeks)||0
9086534|NCT01084252|10150881|FG006|COMPLETED|Phase 1 (120 Weeks)||0
9086535|NCT01084252|10150882|FG007|COMPLETED|Phase 1 (120 Weeks)||0
9086536|NCT01084252|10150883|FG008|COMPLETED|Phase 1 (120 Weeks)||0
9086537|NCT01084252|10150884|FG009|COMPLETED|Phase 1 (120 Weeks)||0
9086538|NCT01084252|10150885|FG010|COMPLETED|Phase 1 (120 Weeks)||0
8624847|NCT00504075|9664324|FG000|STARTED|Overall Study||35
8624848|NCT00504075|9664324|FG000|COMPLETED|Overall Study||27
8624849|NCT00504075|9664324|FG000|NOT COMPLETED|Overall Study||8
8624850|NCT00504153|9664329|FG000|STARTED|Overall Study||19
8624851|NCT00504153|9664329|FG000|COMPLETED|Overall Study||13
8624852|NCT00504153|9664329|FG000|NOT COMPLETED|Overall Study||6
8624853|NCT00504166|9664335|FG000|STARTED|Overall Study||26
8624854|NCT00504166|9664336|FG001|STARTED|Overall Study||27
8624855|NCT00504166|9664335|FG000|COMPLETED|Overall Study||20
8624856|NCT00504166|9664336|FG001|COMPLETED|Overall Study||13
8624857|NCT00504166|9664335|FG000|NOT COMPLETED|Overall Study||6
8624858|NCT00504166|9664336|FG001|NOT COMPLETED|Overall Study||14
8624859|NCT00504231|9664346|FG000|STARTED|Overall Study||65
8624860|NCT00504231|9664347|FG001|STARTED|Overall Study||64
8624861|NCT00504231|9664348|FG002|STARTED|Overall Study||64
9086539|NCT01084252|10150886|FG011|COMPLETED|Phase 1 (120 Weeks)||0
9086540|NCT01084252|10150887|FG012|COMPLETED|Phase 1 (120 Weeks)||0
9086541|NCT01084252|10150888|FG013|COMPLETED|Phase 1 (120 Weeks)||0
9086542|NCT01084252|10150875|FG000|NOT COMPLETED|Phase 1 (120 Weeks)||16
9086543|NCT01084252|10150876|FG001|NOT COMPLETED|Phase 1 (120 Weeks)||6
9086544|NCT01084252|10150877|FG002|NOT COMPLETED|Phase 1 (120 Weeks)||3
9086545|NCT01084252|10150878|FG003|NOT COMPLETED|Phase 1 (120 Weeks)||26
9086546|NCT01084252|10150879|FG004|NOT COMPLETED|Phase 1 (120 Weeks)||18
9086547|NCT01084252|10150880|FG005|NOT COMPLETED|Phase 1 (120 Weeks)||6
9086548|NCT01084252|10150881|FG006|NOT COMPLETED|Phase 1 (120 Weeks)||7
9086549|NCT01084252|10150882|FG007|NOT COMPLETED|Phase 1 (120 Weeks)||7
9086550|NCT01084252|10150883|FG008|NOT COMPLETED|Phase 1 (120 Weeks)||0
9086551|NCT01084252|10150884|FG009|NOT COMPLETED|Phase 1 (120 Weeks)||0
9086552|NCT01084252|10150885|FG010|NOT COMPLETED|Phase 1 (120 Weeks)||0
9086553|NCT01084252|10150886|FG011|NOT COMPLETED|Phase 1 (120 Weeks)||0
9086554|NCT01084252|10150887|FG012|NOT COMPLETED|Phase 1 (120 Weeks)||0
9086555|NCT01084252|10150888|FG013|NOT COMPLETED|Phase 1 (120 Weeks)||0
9086556|NCT01084252|10150875|FG000|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
9086557|NCT01084252|10150876|FG001|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
9086558|NCT01084252|10150877|FG002|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
9086559|NCT01084252|10150878|FG003|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
9086560|NCT01084252|10150879|FG004|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
9086561|NCT01084252|10150880|FG005|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
9086562|NCT01084252|10150881|FG006|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
9086563|NCT01084252|10150882|FG007|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
9086564|NCT01084252|10150883|FG008|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|23
9086565|NCT01084252|10150884|FG009|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|24
9086566|NCT01084252|10150885|FG010|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|25
9086567|NCT01084252|10150886|FG011|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|25
9086568|NCT01084252|10150887|FG012|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
9086569|NCT01084252|10150888|FG013|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
9086570|NCT01084252|10150875|FG000|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
9086571|NCT01084252|10150876|FG001|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
9086572|NCT01084252|10150877|FG002|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
9086573|NCT01084252|10150878|FG003|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
9086574|NCT01084252|10150879|FG004|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
9086575|NCT01084252|10150880|FG005|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
9086576|NCT01084252|10150881|FG006|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
9086577|NCT01084252|10150882|FG007|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
9086578|NCT01084252|10150883|FG008|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||23
9086579|NCT01084252|10150884|FG009|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||24
9086580|NCT01084252|10150885|FG010|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||25
9086581|NCT01084252|10150886|FG011|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||25
9086582|NCT01084252|10150887|FG012|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8624862|NCT00504231|9664349|FG003|STARTED|Overall Study||65
8624863|NCT00504231|9664346|FG000|COMPLETED|Overall Study||65
8624864|NCT00504231|9664347|FG001|COMPLETED|Overall Study||64
9086583|NCT01084252|10150888|FG013|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
9086584|NCT01084252|10150875|FG000|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
9086585|NCT01084252|10150876|FG001|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
9086586|NCT01084252|10150877|FG002|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
9086587|NCT01084252|10150878|FG003|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
9086588|NCT01084252|10150879|FG004|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
9086589|NCT01084252|10150880|FG005|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
9086590|NCT01084252|10150881|FG006|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
9086591|NCT01084252|10150882|FG007|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
9086592|NCT01084252|10150883|FG008|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
9086593|NCT01084252|10150884|FG009|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
9086594|NCT01084252|10150885|FG010|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
9086595|NCT01084252|10150886|FG011|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
9086596|NCT01084252|10150887|FG012|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
9086597|NCT01084252|10150888|FG013|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
9086598|NCT01084252|10150875|FG000|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
9086599|NCT01084252|10150876|FG001|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
9086600|NCT01084252|10150877|FG002|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
9086601|NCT01084252|10150878|FG003|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
9086602|NCT01084252|10150879|FG004|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
9086603|NCT01084252|10150880|FG005|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
9086604|NCT01084252|10150881|FG006|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
9086605|NCT01084252|10150882|FG007|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
9086606|NCT01084252|10150883|FG008|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||23
9086607|NCT01084252|10150884|FG009|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||24
9086608|NCT01084252|10150885|FG010|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||25
9086609|NCT01084252|10150886|FG011|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||25
9086610|NCT01084252|10150887|FG012|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
9086611|NCT01084252|10150888|FG013|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
9086612|NCT01084252|10150875|FG000|STARTED|Phase 2 Stage 2 (97 Weeks)||0
9086613|NCT01084252|10150876|FG001|STARTED|Phase 2 Stage 2 (97 Weeks)||0
9086614|NCT01084252|10150877|FG002|STARTED|Phase 2 Stage 2 (97 Weeks)||0
9086615|NCT01084252|10150878|FG003|STARTED|Phase 2 Stage 2 (97 Weeks)||0
9086616|NCT01084252|10150879|FG004|STARTED|Phase 2 Stage 2 (97 Weeks)||0
9086617|NCT01084252|10150880|FG005|STARTED|Phase 2 Stage 2 (97 Weeks)||0
9086618|NCT01084252|10150881|FG006|STARTED|Phase 2 Stage 2 (97 Weeks)||0
9086619|NCT01084252|10150882|FG007|STARTED|Phase 2 Stage 2 (97 Weeks)||0
9086620|NCT01084252|10150883|FG008|STARTED|Phase 2 Stage 2 (97 Weeks)||0
9086621|NCT01084252|10150884|FG009|STARTED|Phase 2 Stage 2 (97 Weeks)||0
9086622|NCT01084252|10150885|FG010|STARTED|Phase 2 Stage 2 (97 Weeks)||0
9086623|NCT01084252|10150886|FG011|STARTED|Phase 2 Stage 2 (97 Weeks)||0
9086624|NCT01084252|10150887|FG012|STARTED|Phase 2 Stage 2 (97 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|110
9086625|NCT01084252|10150888|FG013|STARTED|Phase 2 Stage 2 (97 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|55
9086626|NCT01084252|10150875|FG000|AT Population|Phase 2 Stage 2 (97 Weeks)||0
9086627|NCT01084252|10150876|FG001|AT Population|Phase 2 Stage 2 (97 Weeks)||0
9086628|NCT01084252|10150877|FG002|AT Population|Phase 2 Stage 2 (97 Weeks)||0
9086629|NCT01084252|10150878|FG003|AT Population|Phase 2 Stage 2 (97 Weeks)||0
9086630|NCT01084252|10150879|FG004|AT Population|Phase 2 Stage 2 (97 Weeks)||0
9086631|NCT01084252|10150880|FG005|AT Population|Phase 2 Stage 2 (97 Weeks)||0
9086632|NCT01084252|10150881|FG006|AT Population|Phase 2 Stage 2 (97 Weeks)||0
9086633|NCT01084252|10150882|FG007|AT Population|Phase 2 Stage 2 (97 Weeks)||0
9086634|NCT01084252|10150883|FG008|AT Population|Phase 2 Stage 2 (97 Weeks)||0
9086635|NCT01084252|10150884|FG009|AT Population|Phase 2 Stage 2 (97 Weeks)||0
9086636|NCT01084252|10150885|FG010|AT Population|Phase 2 Stage 2 (97 Weeks)||0
9086637|NCT01084252|10150886|FG011|AT Population|Phase 2 Stage 2 (97 Weeks)||0
9086638|NCT01084252|10150887|FG012|AT Population|Phase 2 Stage 2 (97 Weeks)||109
9086639|NCT01084252|10150888|FG013|AT Population|Phase 2 Stage 2 (97 Weeks)||55
9086640|NCT01084252|10150875|FG000|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
9086641|NCT01084252|10150876|FG001|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
9086642|NCT01084252|10150877|FG002|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
9086643|NCT01084252|10150878|FG003|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
9086644|NCT01084252|10150879|FG004|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
9086645|NCT01084252|10150880|FG005|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
9086646|NCT01084252|10150881|FG006|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
9086647|NCT01084252|10150882|FG007|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
9086648|NCT01084252|10150883|FG008|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
9086649|NCT01084252|10150884|FG009|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
8844715|NCT01711619|9899161|FG000|STARTED|Overall Study||56
8844716|NCT01711619|9899162|FG001|STARTED|Overall Study||60
8844717|NCT01711619|9899161|FG000|COMPLETED|Overall Study||38
8844718|NCT01711619|9899162|FG001|COMPLETED|Overall Study||36
8844719|NCT01711619|9899161|FG000|NOT COMPLETED|Overall Study||18
8844720|NCT01711619|9899162|FG001|NOT COMPLETED|Overall Study||24
8844721|NCT01711645|9899168|FG000|STARTED|Overall Study||55
8844722|NCT01711645|9899168|FG000|COMPLETED|Overall Study||36
9086650|NCT01084252|10150885|FG010|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
9086651|NCT01084252|10150886|FG011|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
9086652|NCT01084252|10150887|FG012|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
9086653|NCT01084252|10150888|FG013|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
9086654|NCT01084252|10150875|FG000|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
9086655|NCT01084252|10150876|FG001|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
9086656|NCT01084252|10150877|FG002|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
9086657|NCT01084252|10150878|FG003|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
9086658|NCT01084252|10150879|FG004|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
9086659|NCT01084252|10150880|FG005|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
9086660|NCT01084252|10150881|FG006|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
9086661|NCT01084252|10150882|FG007|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
9086662|NCT01084252|10150883|FG008|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
9086663|NCT01084252|10150884|FG009|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
9086664|NCT01084252|10150885|FG010|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
9086665|NCT01084252|10150886|FG011|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
9086666|NCT01084252|10150887|FG012|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||110
9086667|NCT01084252|10150888|FG013|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||55
9086668|NCT00867321|10150955|FG000|STARTED|Overall Study||4
9086669|NCT00867321|10150956|FG001|STARTED|Overall Study||3
9086670|NCT00867321|10150957|FG002|STARTED|Overall Study||3
9086671|NCT00867321|10150958|FG003|STARTED|Overall Study||6
9086672|NCT00867321|10150959|FG004|STARTED|Overall Study||5
9086673|NCT00867321|10150960|FG005|STARTED|Overall Study||3
9086674|NCT00867321|10150955|FG000|COMPLETED|Overall Study||4
9086675|NCT00867321|10150956|FG001|COMPLETED|Overall Study||2
9086676|NCT00867321|10150957|FG002|COMPLETED|Overall Study||3
9086677|NCT00867321|10150958|FG003|COMPLETED|Overall Study||6
9086678|NCT00867321|10150959|FG004|COMPLETED|Overall Study||5
9086679|NCT00867321|10150960|FG005|COMPLETED|Overall Study||3
9086680|NCT00867321|10150955|FG000|NOT COMPLETED|Overall Study||0
9086681|NCT00867321|10150956|FG001|NOT COMPLETED|Overall Study||1
9086682|NCT00867321|10150957|FG002|NOT COMPLETED|Overall Study||0
9086683|NCT00867321|10150958|FG003|NOT COMPLETED|Overall Study||0
9086684|NCT00867321|10150959|FG004|NOT COMPLETED|Overall Study||0
9086685|NCT00867321|10150960|FG005|NOT COMPLETED|Overall Study||0
9086686|NCT00728962|10150975|FG000|STARTED|Implant Placement Surgery||75
9086687|NCT00728962|10150975|FG000|COMPLETED|Implant Placement Surgery||65
9086688|NCT00728962|10150975|FG000|NOT COMPLETED|Implant Placement Surgery||10
9086689|NCT00728962|10150975|FG000|STARTED|Permanent Prosthesis Placement||65
9086690|NCT00728962|10150975|FG000|COMPLETED|Permanent Prosthesis Placement||62
9086691|NCT00728962|10150975|FG000|NOT COMPLETED|Permanent Prosthesis Placement||3
9086692|NCT00728962|10150975|FG000|STARTED|One Year Post Placement Follow-up||62
9086693|NCT00728962|10150975|FG000|COMPLETED|One Year Post Placement Follow-up||62
9086694|NCT00728962|10150975|FG000|NOT COMPLETED|One Year Post Placement Follow-up||0
9086695|NCT00728962|10150975|FG000|STARTED|Two Year Post Placement Follow-up||62
9086696|NCT00728962|10150975|FG000|COMPLETED|Two Year Post Placement Follow-up||59
9086697|NCT00728962|10150975|FG000|NOT COMPLETED|Two Year Post Placement Follow-up||3
9086698|NCT00728754|10150981|FG000|STARTED|Implant Placement Surgery|Individual test implant units is 75|29
9086699|NCT00728754|10150982|FG001|STARTED|Implant Placement Surgery|Individual control implant units is 78|32
9086700|NCT00728754|10150981|FG000|COMPLETED|Implant Placement Surgery|Individual test implant units completed = 75|29
9086701|NCT00728754|10150982|FG001|COMPLETED|Implant Placement Surgery|Individual control implant units completed = 78|32
9086702|NCT00728754|10150981|FG000|NOT COMPLETED|Implant Placement Surgery||0
9086703|NCT00728754|10150982|FG001|NOT COMPLETED|Implant Placement Surgery||0
9086704|NCT00728754|10150981|FG000|STARTED|Permanent Prosthesis Placement|Individual test implant units is 75|29
9086705|NCT00728754|10150982|FG001|STARTED|Permanent Prosthesis Placement|Individual control implant units is 78|32
9086706|NCT00728754|10150981|FG000|COMPLETED|Permanent Prosthesis Placement|Individual test implant units completed = 66|25
9086707|NCT00728754|10150982|FG001|COMPLETED|Permanent Prosthesis Placement|Individual control implant units completed = 68|28
9086708|NCT00728754|10150981|FG000|NOT COMPLETED|Permanent Prosthesis Placement||4
9086709|NCT00728754|10150982|FG001|NOT COMPLETED|Permanent Prosthesis Placement||4
9086710|NCT00728754|10150981|FG000|STARTED|One Year Post Placement Follow-up|individual test implant units is 66|25
9086711|NCT00728754|10150982|FG001|STARTED|One Year Post Placement Follow-up|individual control implant units is 68|28
9086712|NCT00728754|10150981|FG000|COMPLETED|One Year Post Placement Follow-up|individual test implant units completing is 65|24
9086713|NCT00728754|10150982|FG001|COMPLETED|One Year Post Placement Follow-up|individual control implant units completed= 68|28
9086714|NCT00728754|10150981|FG000|NOT COMPLETED|One Year Post Placement Follow-up||1
9086715|NCT00728754|10150982|FG001|NOT COMPLETED|One Year Post Placement Follow-up||0
9086716|NCT00728754|10150981|FG000|STARTED|Two Year Post Placement Follow-up|individual test implant units is 65|24
9086717|NCT00728754|10150982|FG001|STARTED|Two Year Post Placement Follow-up|individual control implant units is 68|28
9086718|NCT00728754|10150981|FG000|COMPLETED|Two Year Post Placement Follow-up|individual test implant units completed= 65|24
9086719|NCT00728754|10150982|FG001|COMPLETED|Two Year Post Placement Follow-up|individual test implant units completed= 68|28
9086720|NCT00728754|10150981|FG000|NOT COMPLETED|Two Year Post Placement Follow-up||0
9086721|NCT00728754|10150982|FG001|NOT COMPLETED|Two Year Post Placement Follow-up||0
9086722|NCT00723944|10150990|FG000|STARTED|Implant Placement Surgery|number of individual implant units is 148|52
9086723|NCT00723944|10150991|FG001|STARTED|Implant Placement Surgery|number of individual implant units is 138|50
9086724|NCT00723944|10150990|FG000|COMPLETED|Implant Placement Surgery|number of individual implant units completing is 148|52
9086725|NCT00723944|10150991|FG001|COMPLETED|Implant Placement Surgery|number of individual implant units completing is 138|50
9086726|NCT00723944|10150990|FG000|NOT COMPLETED|Implant Placement Surgery||0
9086727|NCT00723944|10150991|FG001|NOT COMPLETED|Implant Placement Surgery||0
9086728|NCT00723944|10150990|FG000|STARTED|Permanent Prosthesis Placement|number of individual implant units is 148|52
9086729|NCT00723944|10150991|FG001|STARTED|Permanent Prosthesis Placement|number of individual implant units is 138|50
9086730|NCT00723944|10150990|FG000|COMPLETED|Permanent Prosthesis Placement|number of individual implant units completing is 134|49
9086731|NCT00723944|10150991|FG001|COMPLETED|Permanent Prosthesis Placement|number of individual implant units completing is 112|41
9086732|NCT00723944|10150990|FG000|NOT COMPLETED|Permanent Prosthesis Placement||3
9086733|NCT00723944|10150991|FG001|NOT COMPLETED|Permanent Prosthesis Placement||9
9086734|NCT00723944|10150990|FG000|STARTED|One Year Post Placement Follow-up|number of individual implant units is 134|49
9086735|NCT00723944|10150991|FG001|STARTED|One Year Post Placement Follow-up|number of individual implant units is 112|41
9086736|NCT00723944|10150990|FG000|COMPLETED|One Year Post Placement Follow-up|number of individual implant units completing is 130|48
9086737|NCT00723944|10150991|FG001|COMPLETED|One Year Post Placement Follow-up|number of individual implant units completing is 108|37
9086738|NCT00723944|10150990|FG000|NOT COMPLETED|One Year Post Placement Follow-up||1
9086739|NCT00723944|10150991|FG001|NOT COMPLETED|One Year Post Placement Follow-up||4
9086740|NCT00723944|10150990|FG000|STARTED|Two Year Post Placement Follow-up|number of individual implant units is 130|48
9086741|NCT00723944|10150991|FG001|STARTED|Two Year Post Placement Follow-up|number of individual implant units is 108|37
9086742|NCT00723944|10150990|FG000|COMPLETED|Two Year Post Placement Follow-up|number of individual implant units completing is 130|48
9086743|NCT00723944|10150991|FG001|COMPLETED|Two Year Post Placement Follow-up|number of individual implant units completing is 108|37
9086744|NCT00723944|10150990|FG000|NOT COMPLETED|Two Year Post Placement Follow-up||0
9086745|NCT00723944|10150991|FG001|NOT COMPLETED|Two Year Post Placement Follow-up||0
9086746|NCT00467142|10150997|FG000|STARTED|Overall Study||62
9086747|NCT00467142|10150997|FG000|COMPLETED|Overall Study||59
9086748|NCT00467142|10150997|FG000|NOT COMPLETED|Overall Study||3
8624865|NCT00504231|9664348|FG002|COMPLETED|Overall Study||63
8624866|NCT00504231|9664349|FG003|COMPLETED|Overall Study||65
8624867|NCT00504231|9664346|FG000|NOT COMPLETED|Overall Study||0
8624868|NCT00504231|9664347|FG001|NOT COMPLETED|Overall Study||0
8624869|NCT00504231|9664348|FG002|NOT COMPLETED|Overall Study||1
9086749|NCT04878172|10151005|FG000|STARTED|Overall Study||2
9086750|NCT04878172|10151006|FG001|STARTED|Overall Study||2
9086751|NCT04878172|10151007|FG002|STARTED|Overall Study||2
9086752|NCT04878172|10151008|FG003|STARTED|Overall Study||3
9086753|NCT04878172|10151005|FG000|COMPLETED|Overall Study||2
9086754|NCT04878172|10151006|FG001|COMPLETED|Overall Study||2
9086755|NCT04878172|10151007|FG002|COMPLETED|Overall Study||2
9086756|NCT04878172|10151008|FG003|COMPLETED|Overall Study||3
9086757|NCT04878172|10151005|FG000|NOT COMPLETED|Overall Study||0
9086758|NCT04878172|10151006|FG001|NOT COMPLETED|Overall Study||0
9086759|NCT04878172|10151007|FG002|NOT COMPLETED|Overall Study||0
9086760|NCT04878172|10151008|FG003|NOT COMPLETED|Overall Study||0
9086761|NCT04671017|10151021|FG000|STARTED|Overall Study||51
9086762|NCT04671017|10151022|FG001|STARTED|Overall Study||51
9086763|NCT04671017|10151023|FG002|STARTED|Overall Study||51
9086764|NCT04671017|10151021|FG000|COMPLETED|Overall Study||51
9086765|NCT04671017|10151022|FG001|COMPLETED|Overall Study||51
9086766|NCT04671017|10151023|FG002|COMPLETED|Overall Study||51
9086767|NCT04671017|10151021|FG000|NOT COMPLETED|Overall Study||0
9086768|NCT04671017|10151022|FG001|NOT COMPLETED|Overall Study||0
9086769|NCT04671017|10151023|FG002|NOT COMPLETED|Overall Study||0
9086770|NCT04557371|10151034|FG000|STARTED|Overall Study||50
9086771|NCT04557371|10151035|FG001|STARTED|Overall Study||49
9086772|NCT04557371|10151036|FG002|STARTED|Overall Study||51
9086773|NCT04557371|10151034|FG000|COMPLETED|Overall Study||49
9086774|NCT04557371|10151035|FG001|COMPLETED|Overall Study||47
9086775|NCT04557371|10151036|FG002|COMPLETED|Overall Study||51
9086776|NCT04557371|10151034|FG000|NOT COMPLETED|Overall Study||1
9086777|NCT04557371|10151035|FG001|NOT COMPLETED|Overall Study||2
9086778|NCT04557371|10151036|FG002|NOT COMPLETED|Overall Study||0
9086779|NCT04540952|10151046|FG000|STARTED|Overall Study||34
9086780|NCT04540952|10151047|FG001|STARTED|Overall Study||34
9086781|NCT04540952|10151046|FG000|COMPLETED|Overall Study||34
9086782|NCT04540952|10151047|FG001|COMPLETED|Overall Study||34
9086783|NCT04540952|10151046|FG000|NOT COMPLETED|Overall Study||0
9086784|NCT04540952|10151047|FG001|NOT COMPLETED|Overall Study||0
9086785|NCT04369742|10151057|FG000|STARTED|Overall Study||67
9086786|NCT04369742|10151058|FG001|STARTED|Overall Study||61
9086787|NCT04369742|10151057|FG000|COMPLETED|Overall Study||53
9086788|NCT04369742|10151058|FG001|COMPLETED|Overall Study||50
9086789|NCT04369742|10151057|FG000|NOT COMPLETED|Overall Study||14
9086790|NCT04369742|10151058|FG001|NOT COMPLETED|Overall Study||11
9086791|NCT04346628|10151066|FG000|STARTED|Overall Study||74
9086792|NCT04346628|10151067|FG001|STARTED|Overall Study||75
9086793|NCT04346628|10151066|FG000|Intention-to-treat (ITT) Analysis Set|Overall Study||74
9086794|NCT04346628|10151067|FG001|Intention-to-treat (ITT) Analysis Set|Overall Study||75
9086795|NCT04346628|10151066|FG000|Symptomatic Modified ITT (smITT) Analysis Set|Overall Study||70
9086796|NCT04346628|10151067|FG001|Symptomatic Modified ITT (smITT) Analysis Set|Overall Study||65
9086797|NCT04346628|10151066|FG000|Modified ITT (mITT) Analysis|Overall Study||57
9086798|NCT04346628|10151067|FG001|Modified ITT (mITT) Analysis|Overall Study||59
9086799|NCT04346628|10151066|FG000|COMPLETED|Overall Study||68
9086800|NCT04346628|10151067|FG001|COMPLETED|Overall Study||62
9086801|NCT04346628|10151066|FG000|NOT COMPLETED|Overall Study||6
9086802|NCT04346628|10151067|FG001|NOT COMPLETED|Overall Study||13
9086803|NCT04115644|10151076|FG000|STARTED|Overall Study||26
9086804|NCT04115644|10151077|FG001|STARTED|Overall Study||30
9086805|NCT04115644|10151078|FG002|STARTED|Overall Study||26
9086806|NCT04115644|10151076|FG000|COMPLETED|Overall Study||26
9086807|NCT04115644|10151077|FG001|COMPLETED|Overall Study||30
9086808|NCT04115644|10151078|FG002|COMPLETED|Overall Study||25
9086809|NCT04115644|10151076|FG000|NOT COMPLETED|Overall Study||0
9086810|NCT04115644|10151077|FG001|NOT COMPLETED|Overall Study||0
9086811|NCT04115644|10151078|FG002|NOT COMPLETED|Overall Study||1
9086812|NCT04005859|10151088|FG000|STARTED|Overall Study||32
9086813|NCT04005859|10151089|FG001|STARTED|Overall Study||29
9086814|NCT04005859|10151088|FG000|COMPLETED|Overall Study||28
9086815|NCT04005859|10151089|FG001|COMPLETED|Overall Study||25
9086816|NCT04005859|10151088|FG000|NOT COMPLETED|Overall Study||4
9086817|NCT04005859|10151089|FG001|NOT COMPLETED|Overall Study||4
9086818|NCT03969589|10151097|FG000|STARTED|Overall Study||20
9086819|NCT03969589|10151098|FG001|STARTED|Overall Study||20
9086820|NCT03969589|10151097|FG000|COMPLETED|Overall Study||17
9086821|NCT03969589|10151098|FG001|COMPLETED|Overall Study||17
9086822|NCT03969589|10151097|FG000|NOT COMPLETED|Overall Study||3
9086823|NCT03969589|10151098|FG001|NOT COMPLETED|Overall Study||3
9086824|NCT03917472|10151106|FG000|STARTED|Overall Study||346
9086825|NCT03917472|10151107|FG001|STARTED|Overall Study||171
9086826|NCT03917472|10151106|FG000|COMPLETED|Overall Study||311
9086827|NCT03917472|10151107|FG001|COMPLETED|Overall Study||156
8624870|NCT00504231|9664349|FG003|NOT COMPLETED|Overall Study||0
9086828|NCT03917472|10151106|FG000|NOT COMPLETED|Overall Study||35
9086829|NCT03917472|10151107|FG001|NOT COMPLETED|Overall Study||15
9086830|NCT03875664|10151116|FG000|STARTED|Overall Study||37
9086831|NCT03875664|10151117|FG001|STARTED|Overall Study||35
9086832|NCT03875664|10151116|FG000|COMPLETED|Overall Study|vaginal surgery n=18; vaginal + abdominal surgery n=19|37
9086833|NCT03875664|10151117|FG001|COMPLETED|Overall Study|Vaginal surgery n=18; vaginal + abdominal surgery n=17|35
9086834|NCT03875664|10151116|FG000|NOT COMPLETED|Overall Study||0
9086835|NCT03875664|10151117|FG001|NOT COMPLETED|Overall Study||0
9086836|NCT03812588|10151127|FG000|STARTED|Overall Study||5
9086837|NCT03812588|10151128|FG001|STARTED|Overall Study||7
9086838|NCT03812588|10151129|FG002|STARTED|Overall Study||5
9086839|NCT03812588|10151130|FG003|STARTED|Overall Study||8
9086840|NCT03812588|10151127|FG000|COMPLETED|Overall Study||3
9086841|NCT03812588|10151128|FG001|COMPLETED|Overall Study||5
9086842|NCT03812588|10151129|FG002|COMPLETED|Overall Study||3
9086843|NCT03812588|10151130|FG003|COMPLETED|Overall Study||8
9086844|NCT03812588|10151127|FG000|NOT COMPLETED|Overall Study||2
9086845|NCT03812588|10151128|FG001|NOT COMPLETED|Overall Study||2
9086846|NCT03812588|10151129|FG002|NOT COMPLETED|Overall Study||2
9086847|NCT03812588|10151130|FG003|NOT COMPLETED|Overall Study||0
9086848|NCT03690674|10151140|FG000|STARTED|Overall Study||35
9086849|NCT03690674|10151141|FG001|STARTED|Overall Study||35
9086850|NCT03690674|10151140|FG000|COMPLETED|Overall Study||32
9086851|NCT03690674|10151141|FG001|COMPLETED|Overall Study||32
9086852|NCT03690674|10151140|FG000|NOT COMPLETED|Overall Study||3
9086853|NCT03690674|10151141|FG001|NOT COMPLETED|Overall Study||3
9086854|NCT03655691|10151151|FG000|STARTED|Overall Study||26
9086855|NCT03655691|10151152|FG001|STARTED|Overall Study||26
9086856|NCT03655691|10151153|FG002|STARTED|Overall Study||27
9086857|NCT03655691|10151151|FG000|COMPLETED|Overall Study||24
9086858|NCT03655691|10151152|FG001|COMPLETED|Overall Study||23
9086859|NCT03655691|10151153|FG002|COMPLETED|Overall Study||24
9086860|NCT03655691|10151151|FG000|NOT COMPLETED|Overall Study||2
9086861|NCT03655691|10151152|FG001|NOT COMPLETED|Overall Study||3
9086862|NCT03655691|10151153|FG002|NOT COMPLETED|Overall Study||3
9086863|NCT03608670|10151161|FG000|STARTED|Overall Study||26
9086864|NCT03608670|10151161|FG000|Implant Attempted|Overall Study||21
9086865|NCT03608670|10151161|FG000|Successfully Implanted|Overall Study||17
9086866|NCT03608670|10151161|FG000|2-week Follow-up|Overall Study||17
9086867|NCT03608670|10151161|FG000|4-6 Weeks Follow-up|Overall Study||17
9086868|NCT03608670|10151161|FG000|COMPLETED|Overall Study||16
9086869|NCT03608670|10151161|FG000|NOT COMPLETED|Overall Study||10
8624871|NCT00504257|9664363|FG000|STARTED|Overall Study||45
8624872|NCT00504257|9664363|FG000|COMPLETED|Overall Study||41
8624873|NCT00504257|9664363|FG000|NOT COMPLETED|Overall Study||4
8624874|NCT00504309|9664373|FG000|STARTED|Overall Study||7
8624875|NCT00504309|9664374|FG001|STARTED|Overall Study||5
8624876|NCT00504309|9664375|FG002|STARTED|Overall Study||2
8624877|NCT00504309|9664376|FG003|STARTED|Overall Study||3
8624878|NCT00504309|9664377|FG004|STARTED|Overall Study||8
8624879|NCT00504309|9664378|FG005|STARTED|Overall Study||3
8624880|NCT00504309|9664373|FG000|COMPLETED|Overall Study||7
8624881|NCT00504309|9664374|FG001|COMPLETED|Overall Study||5
8624882|NCT00504309|9664375|FG002|COMPLETED|Overall Study|Participant dropped out during second period|1
8624883|NCT00504309|9664376|FG003|COMPLETED|Overall Study||3
8629512|NCT00530777|9669269|FG001|NOT COMPLETED|Overall Study||5
9086870|NCT03364686|10151165|FG000|STARTED|Overall Study||6
9086871|NCT03364686|10151165|FG000|COMPLETED|Overall Study||4
9086872|NCT03364686|10151165|FG000|NOT COMPLETED|Overall Study||2
9086873|NCT03345771|10151171|FG000|STARTED|Overall Study||115
9086874|NCT03345771|10151172|FG001|STARTED|Overall Study||115
9086875|NCT03345771|10151171|FG000|COMPLETED|Overall Study||115
9086876|NCT03345771|10151172|FG001|COMPLETED|Overall Study||115
9086877|NCT03345771|10151171|FG000|NOT COMPLETED|Overall Study||0
9086878|NCT03345771|10151172|FG001|NOT COMPLETED|Overall Study||0
9086879|NCT03326856|10151183|FG000|STARTED|Overall Study||13
9086880|NCT03326856|10151184|FG001|STARTED|Overall Study||9
9086881|NCT03326856|10151185|FG002|STARTED|Overall Study||9
9086882|NCT03326856|10151186|FG003|STARTED|Overall Study||9
9086883|NCT03326856|10151187|FG004|STARTED|Overall Study||8
9086884|NCT03326856|10151183|FG000|COMPLETED|Overall Study||12
9086885|NCT03326856|10151184|FG001|COMPLETED|Overall Study||8
9086886|NCT03326856|10151185|FG002|COMPLETED|Overall Study||9
9086887|NCT03326856|10151186|FG003|COMPLETED|Overall Study||9
9086888|NCT03326856|10151187|FG004|COMPLETED|Overall Study||8
9086889|NCT03326856|10151183|FG000|NOT COMPLETED|Overall Study||1
9086890|NCT03326856|10151184|FG001|NOT COMPLETED|Overall Study||1
9086891|NCT03326856|10151185|FG002|NOT COMPLETED|Overall Study||0
9086892|NCT03326856|10151186|FG003|NOT COMPLETED|Overall Study||0
9086893|NCT03326856|10151187|FG004|NOT COMPLETED|Overall Study||0
9086894|NCT03287947|10151199|FG000|STARTED|Overall Study|Five subjects were enrolled to the study.|5
9086895|NCT03287947|10151199|FG000|COMPLETED|Overall Study|All subjects enrolled discontinued treatment and are now off study.|5
9086896|NCT03287947|10151199|FG000|NOT COMPLETED|Overall Study||0
9086897|NCT03287089|10151205|FG000|STARTED|Overall Study||82
9086898|NCT03287089|10151206|FG001|STARTED|Overall Study||82
9086899|NCT03287089|10151205|FG000|COMPLETED|Overall Study||82
9086900|NCT03287089|10151206|FG001|COMPLETED|Overall Study||76
9086901|NCT03287089|10151205|FG000|NOT COMPLETED|Overall Study||0
9086902|NCT03287089|10151206|FG001|NOT COMPLETED|Overall Study||6
9086903|NCT03240692|10151212|FG000|STARTED|Overall Study||23
9086904|NCT03240692|10151212|FG000|COMPLETED|Overall Study||21
9086905|NCT03240692|10151212|FG000|NOT COMPLETED|Overall Study||2
9086906|NCT03227029|10151219|FG000|STARTED|Overall Study||26
9086907|NCT03227029|10151220|FG001|STARTED|Overall Study||26
9086908|NCT03227029|10151221|FG002|STARTED|Overall Study||13
9086909|NCT03227029|10151219|FG000|Received Inoculation|Overall Study||26
9086910|NCT03227029|10151220|FG001|Received Inoculation|Overall Study||25
9086911|NCT03227029|10151221|FG002|Received Inoculation|Overall Study||12
9086912|NCT03227029|10151219|FG000|COMPLETED|Overall Study||22
9086913|NCT03227029|10151220|FG001|COMPLETED|Overall Study||22
9086914|NCT03227029|10151221|FG002|COMPLETED|Overall Study||9
9086915|NCT03227029|10151219|FG000|NOT COMPLETED|Overall Study||4
9086916|NCT03227029|10151220|FG001|NOT COMPLETED|Overall Study||4
9086917|NCT03227029|10151221|FG002|NOT COMPLETED|Overall Study||4
9086918|NCT03207776|10151231|FG000|STARTED|Overall Study||2479
9086919|NCT03207776|10151232|FG001|STARTED|Overall Study||2353
9086920|NCT03207776|10151231|FG000|COMPLETED|Overall Study||2479
9086921|NCT03207776|10151232|FG001|COMPLETED|Overall Study||2353
9086922|NCT03207776|10151231|FG000|NOT COMPLETED|Overall Study||0
9086923|NCT03207776|10151232|FG001|NOT COMPLETED|Overall Study||0
9086924|NCT03204643|10151240|FG000|STARTED|Overall Study||323
9086925|NCT03204643|10151241|FG001|STARTED|Overall Study||314
9086926|NCT03204643|10151240|FG000|COMPLETED|Overall Study||323
9086927|NCT03204643|10151241|FG001|COMPLETED|Overall Study||314
9086928|NCT03204643|10151240|FG000|NOT COMPLETED|Overall Study||0
9086929|NCT03204643|10151241|FG001|NOT COMPLETED|Overall Study||0
9086930|NCT03182829|10151249|FG000|STARTED|Overall Study||467
9086931|NCT03182829|10151250|FG001|STARTED|Overall Study||444
9086932|NCT03182829|10151249|FG000|COMPLETED|Overall Study||451
9086933|NCT03182829|10151250|FG001|COMPLETED|Overall Study||429
9086934|NCT03182829|10151249|FG000|NOT COMPLETED|Overall Study||16
9086935|NCT03182829|10151250|FG001|NOT COMPLETED|Overall Study||15
9086936|NCT03181789|10151260|FG000|STARTED|Overall Study||25
9086937|NCT03181789|10151261|FG001|STARTED|Overall Study||25
9086938|NCT03181789|10151262|FG002|STARTED|Overall Study||3
9086939|NCT03181789|10151263|FG003|STARTED|Overall Study||3
9086940|NCT03181789|10151260|FG000|Safety Population|Overall Study||25
9086941|NCT03181789|10151261|FG001|Safety Population|Overall Study||25
9086942|NCT03181789|10151262|FG002|Safety Population|Overall Study||3
9086943|NCT03181789|10151263|FG003|Safety Population|Overall Study||3
9086944|NCT03181789|10151260|FG000|COMPLETED|Overall Study||18
9086945|NCT03181789|10151261|FG001|COMPLETED|Overall Study||22
9086946|NCT03181789|10151262|FG002|COMPLETED|Overall Study||2
9086947|NCT03181789|10151263|FG003|COMPLETED|Overall Study||3
9086948|NCT03181789|10151260|FG000|NOT COMPLETED|Overall Study||7
9086949|NCT03181789|10151261|FG001|NOT COMPLETED|Overall Study||3
9086950|NCT03181789|10151262|FG002|NOT COMPLETED|Overall Study||1
9086951|NCT03181789|10151263|FG003|NOT COMPLETED|Overall Study||0
9086952|NCT03164356|10151278|FG000|STARTED|Overall Study||19
9086953|NCT03164356|10151279|FG001|STARTED|Overall Study||15
9086954|NCT03164356|10151280|FG002|STARTED|Overall Study||17
9086955|NCT03164356|10151281|FG003|STARTED|Overall Study||17
9086956|NCT03164356|10151278|FG000|COMPLETED|Overall Study||14
9086957|NCT03164356|10151279|FG001|COMPLETED|Overall Study||10
9086958|NCT03164356|10151280|FG002|COMPLETED|Overall Study||11
9086959|NCT03164356|10151281|FG003|COMPLETED|Overall Study||15
9086960|NCT03164356|10151278|FG000|NOT COMPLETED|Overall Study||5
9086961|NCT03164356|10151279|FG001|NOT COMPLETED|Overall Study||5
9086962|NCT03164356|10151280|FG002|NOT COMPLETED|Overall Study||6
9086963|NCT03164356|10151281|FG003|NOT COMPLETED|Overall Study||2
8624884|NCT00504309|9664377|FG004|COMPLETED|Overall Study|Participant died during washout after 2nd period|7
8624885|NCT00504309|9664378|FG005|COMPLETED|Overall Study||3
9086964|NCT02975700|10151301|FG000|STARTED|Overall Study||6
9086965|NCT02975700|10151301|FG000|COMPLETED|Overall Study||0
9086966|NCT02975700|10151301|FG000|NOT COMPLETED|Overall Study||6
9086967|NCT02941549|10151308|FG000|STARTED|Overall Study||31
9086968|NCT02941549|10151309|FG001|STARTED|Overall Study||32
9086969|NCT02941549|10151310|FG002|STARTED|Overall Study||33
9086970|NCT02941549|10151308|FG000|COMPLETED|Overall Study||28
9086971|NCT02941549|10151309|FG001|COMPLETED|Overall Study||31
9086972|NCT02941549|10151310|FG002|COMPLETED|Overall Study||31
9086973|NCT02941549|10151308|FG000|NOT COMPLETED|Overall Study||3
9086974|NCT02941549|10151309|FG001|NOT COMPLETED|Overall Study||1
9086975|NCT02941549|10151310|FG002|NOT COMPLETED|Overall Study||2
9086976|NCT02937766|10151323|FG000|STARTED|Overall Study||30
9086977|NCT02937766|10151324|FG001|STARTED|Overall Study||30
9086978|NCT02937766|10151323|FG000|COMPLETED|Overall Study||23
9086979|NCT02937766|10151324|FG001|COMPLETED|Overall Study||30
9086980|NCT02937766|10151323|FG000|NOT COMPLETED|Overall Study||7
9086981|NCT02937766|10151324|FG001|NOT COMPLETED|Overall Study||0
9086982|NCT02927938|10151334|FG000|STARTED|Overall Study||1
9086983|NCT02927938|10151335|FG001|STARTED|Overall Study||6
9086984|NCT02927938|10151336|FG002|STARTED|Overall Study||4
9086985|NCT02927938|10151337|FG003|STARTED|Overall Study||7
9086986|NCT02927938|10151334|FG000|COMPLETED|Overall Study||0
9086987|NCT02927938|10151335|FG001|COMPLETED|Overall Study||0
9086988|NCT02927938|10151336|FG002|COMPLETED|Overall Study||0
9086989|NCT02927938|10151337|FG003|COMPLETED|Overall Study||0
9086990|NCT02927938|10151334|FG000|NOT COMPLETED|Overall Study||1
9086991|NCT02927938|10151335|FG001|NOT COMPLETED|Overall Study||6
9086992|NCT02927938|10151336|FG002|NOT COMPLETED|Overall Study||4
9086993|NCT02927938|10151337|FG003|NOT COMPLETED|Overall Study||7
9086994|NCT02913131|10151347|FG000|STARTED|Overall Study||18
9086995|NCT02913131|10151348|FG001|STARTED|Overall Study|Two of the five participants enrolled in Part B were previously enrolled in Part A.|5
9086996|NCT02913131|10151347|FG000|COMPLETED|Overall Study||18
9086997|NCT02913131|10151348|FG001|COMPLETED|Overall Study||5
9086998|NCT02913131|10151347|FG000|NOT COMPLETED|Overall Study||0
9086999|NCT02913131|10151348|FG001|NOT COMPLETED|Overall Study||0
9087000|NCT02883400|10151357|FG000|STARTED|Overall Study||22
9087001|NCT02883400|10151358|FG001|STARTED|Overall Study||8
9087002|NCT02883400|10151357|FG000|COMPLETED|Overall Study||22
9087003|NCT02883400|10151358|FG001|COMPLETED|Overall Study||8
9087004|NCT02883400|10151357|FG000|NOT COMPLETED|Overall Study||0
9087005|NCT02883400|10151358|FG001|NOT COMPLETED|Overall Study||0
9087006|NCT02855060|10151366|FG000|STARTED|Overall Study||22
9087007|NCT02855060|10151367|FG001|STARTED|Overall Study||28
9087008|NCT02855060|10151366|FG000|COMPLETED|Overall Study||20
9087009|NCT02855060|10151367|FG001|COMPLETED|Overall Study||23
9087010|NCT02855060|10151366|FG000|NOT COMPLETED|Overall Study||2
9087011|NCT02855060|10151367|FG001|NOT COMPLETED|Overall Study||5
9087012|NCT02823574|10151377|FG000|STARTED|Pre-Treatment Period||159
9087013|NCT02823574|10151378|FG001|STARTED|Pre-Treatment Period||82
9087014|NCT02823574|10151379|FG002|STARTED|Pre-Treatment Period||123
9087015|NCT02823574|10151380|FG003|STARTED|Pre-Treatment Period||61
9087016|NCT02823574|10151377|FG000|COMPLETED|Pre-Treatment Period||158
9087017|NCT02823574|10151378|FG001|COMPLETED|Pre-Treatment Period||82
9087018|NCT02823574|10151379|FG002|COMPLETED|Pre-Treatment Period||122
9087019|NCT02823574|10151380|FG003|COMPLETED|Pre-Treatment Period||61
9087020|NCT02823574|10151377|FG000|NOT COMPLETED|Pre-Treatment Period||1
9087021|NCT02823574|10151378|FG001|NOT COMPLETED|Pre-Treatment Period||0
9087022|NCT02823574|10151379|FG002|NOT COMPLETED|Pre-Treatment Period||1
9087023|NCT02823574|10151380|FG003|NOT COMPLETED|Pre-Treatment Period||0
9087024|NCT02823574|10151377|FG000|STARTED|Treatment Period||158
9087025|NCT02823574|10151378|FG001|STARTED|Treatment Period||82
9087026|NCT02823574|10151379|FG002|STARTED|Treatment Period||122
9087027|NCT02823574|10151380|FG003|STARTED|Treatment Period||61
9087028|NCT02823574|10151377|FG000|COMPLETED|Treatment Period||19
9087029|NCT02823574|10151378|FG001|COMPLETED|Treatment Period||16
9087030|NCT02823574|10151379|FG002|COMPLETED|Treatment Period||14
9087031|NCT02823574|10151380|FG003|COMPLETED|Treatment Period||10
9087032|NCT02823574|10151377|FG000|NOT COMPLETED|Treatment Period||139
9087033|NCT02823574|10151378|FG001|NOT COMPLETED|Treatment Period||66
9087034|NCT02823574|10151379|FG002|NOT COMPLETED|Treatment Period||108
9087035|NCT02823574|10151380|FG003|NOT COMPLETED|Treatment Period||51
9087036|NCT02771990|10151395|FG000|STARTED|Overall Study||11
9087037|NCT02771990|10151396|FG001|STARTED|Overall Study||10
9087038|NCT02771990|10151395|FG000|COMPLETED|Overall Study||11
9087039|NCT02771990|10151396|FG001|COMPLETED|Overall Study||10
9087040|NCT02771990|10151395|FG000|NOT COMPLETED|Overall Study||0
9087041|NCT02771990|10151396|FG001|NOT COMPLETED|Overall Study||0
9087042|NCT02743819|10151402|FG000|STARTED|Overall Study||70
9087043|NCT02743819|10151402|FG000|COMPLETED|Overall Study||62
9087044|NCT02743819|10151402|FG000|NOT COMPLETED|Overall Study||8
9087045|NCT02729753|10151408|FG000|STARTED|Overall Study|First patient enrolled April 2016|3
9087046|NCT02729753|10151409|FG001|STARTED|Overall Study|First patient enrolled April 2016|7
9087047|NCT02729753|10151408|FG000|COMPLETED|Overall Study|Study Complete on 30 Oct 2016|3
9087048|NCT02729753|10151409|FG001|COMPLETED|Overall Study|Study Complete on 30 Oct 2016|6
9087049|NCT02729753|10151408|FG000|NOT COMPLETED|Overall Study||0
9087050|NCT02729753|10151409|FG001|NOT COMPLETED|Overall Study||1
9087051|NCT02704130|10151420|FG000|STARTED|Overall Study||5
9087052|NCT02704130|10151421|FG001|STARTED|Overall Study||3
9087053|NCT02704130|10151420|FG000|COMPLETED|Overall Study||0
9087054|NCT02704130|10151421|FG001|COMPLETED|Overall Study||0
9087055|NCT02704130|10151420|FG000|NOT COMPLETED|Overall Study||5
9087056|NCT02704130|10151421|FG001|NOT COMPLETED|Overall Study||3
9087057|NCT02701192|10151427|FG000|STARTED|Overall Study||100
9087058|NCT02701192|10151427|FG000|COMPLETED|Overall Study||94
9087059|NCT02701192|10151427|FG000|NOT COMPLETED|Overall Study||6
9087060|NCT02685709|10151435|FG000|STARTED|Run-in Phase||146
9087061|NCT02685709|10151436|FG001|STARTED|Run-in Phase||0
9087062|NCT02685709|10151437|FG002|STARTED|Run-in Phase||0
9087063|NCT02685709|10151438|FG003|STARTED|Run-in Phase||0
9087064|NCT02685709|10151435|FG000|COMPLETED|Run-in Phase|30 patients early terminated the Run-in phase and 24 patient were not randomized to RCT|116
9087065|NCT02685709|10151436|FG001|COMPLETED|Run-in Phase||0
9087066|NCT02685709|10151437|FG002|COMPLETED|Run-in Phase||0
9087067|NCT02685709|10151438|FG003|COMPLETED|Run-in Phase||0
9087068|NCT02685709|10151435|FG000|NOT COMPLETED|Run-in Phase||30
9087069|NCT02685709|10151436|FG001|NOT COMPLETED|Run-in Phase||0
9087070|NCT02685709|10151437|FG002|NOT COMPLETED|Run-in Phase||0
9087071|NCT02685709|10151438|FG003|NOT COMPLETED|Run-in Phase||0
9087072|NCT02685709|10151435|FG000|STARTED|RCT Phase|116 patients completed the Run-in phase, out of which 92 were randomized to the RCT phase, and 24 were not randomized to the RCT phase. Out of these 24, 11 patients eneterd the combination phase.|0
9087073|NCT02685709|10151436|FG001|STARTED|RCT Phase||55
9087074|NCT02685709|10151437|FG002|STARTED|RCT Phase||37
9087075|NCT02685709|10151438|FG003|STARTED|RCT Phase||0
9087076|NCT02685709|10151435|FG000|COMPLETED|RCT Phase||0
9087077|NCT02685709|10151436|FG001|COMPLETED|RCT Phase||54
9087078|NCT02685709|10151437|FG002|COMPLETED|RCT Phase||35
9087079|NCT02685709|10151438|FG003|COMPLETED|RCT Phase||0
9087080|NCT02685709|10151435|FG000|NOT COMPLETED|RCT Phase||0
9087081|NCT02685709|10151436|FG001|NOT COMPLETED|RCT Phase||1
9087082|NCT02685709|10151437|FG002|NOT COMPLETED|RCT Phase||2
9087083|NCT02685709|10151438|FG003|NOT COMPLETED|RCT Phase||0
9087084|NCT02685709|10151435|FG000|STARTED|Combination Phase||0
9087085|NCT02685709|10151436|FG001|STARTED|Combination Phase||0
9087086|NCT02685709|10151437|FG002|STARTED|Combination Phase||0
9087087|NCT02685709|10151438|FG003|STARTED|Combination Phase|14 patients entered the combination phase (3 patients early discontinued the Run-in phase, and 11 patients completed Run-in and were not eligible to RCT phase).|14
9087088|NCT02685709|10151435|FG000|COMPLETED|Combination Phase||0
9087089|NCT02685709|10151436|FG001|COMPLETED|Combination Phase||0
9087090|NCT02685709|10151437|FG002|COMPLETED|Combination Phase||0
9087091|NCT02685709|10151438|FG003|COMPLETED|Combination Phase||8
9087092|NCT02685709|10151435|FG000|NOT COMPLETED|Combination Phase||0
9087093|NCT02685709|10151436|FG001|NOT COMPLETED|Combination Phase||0
9087094|NCT02685709|10151437|FG002|NOT COMPLETED|Combination Phase||0
9087095|NCT02685709|10151438|FG003|NOT COMPLETED|Combination Phase||6
9087096|NCT02684851|10151450|FG000|STARTED|Overall Study||42
9087097|NCT02684851|10151451|FG001|STARTED|Overall Study||45
9087098|NCT02684851|10151450|FG000|COMPLETED|Overall Study||42
9087099|NCT02684851|10151451|FG001|COMPLETED|Overall Study||45
9087100|NCT02684851|10151450|FG000|NOT COMPLETED|Overall Study||0
9087101|NCT02684851|10151451|FG001|NOT COMPLETED|Overall Study||0
9087102|NCT02653482|10151461|FG000|STARTED|Overall Study||131
9087103|NCT02653482|10151462|FG001|STARTED|Overall Study||132
9087104|NCT02653482|10151461|FG000|COMPLETED|Overall Study||130
9087105|NCT02653482|10151462|FG001|COMPLETED|Overall Study||131
9087106|NCT02653482|10151461|FG000|NOT COMPLETED|Overall Study||1
9087107|NCT02653482|10151462|FG001|NOT COMPLETED|Overall Study||1
9087108|NCT02632409|10151470|FG000|STARTED|Randomized||356
9087109|NCT02632409|10151471|FG001|STARTED|Randomized||353
9087110|NCT02632409|10151470|FG000|COMPLETED|Randomized||348
9087111|NCT02632409|10151471|FG001|COMPLETED|Randomized||351
9087112|NCT02632409|10151470|FG000|NOT COMPLETED|Randomized||8
9087113|NCT02632409|10151471|FG001|NOT COMPLETED|Randomized||2
9087114|NCT02632409|10151470|FG000|STARTED|Treatment Period||348
9087115|NCT02632409|10151471|FG001|STARTED|Treatment Period||351
9087116|NCT02632409|10151470|FG000|COMPLETED|Treatment Period||132
9087117|NCT02632409|10151471|FG001|COMPLETED|Treatment Period||143
9087118|NCT02632409|10151470|FG000|NOT COMPLETED|Treatment Period||216
9087119|NCT02632409|10151471|FG001|NOT COMPLETED|Treatment Period||208
9087120|NCT02612194|10151480|FG000|STARTED|Overall Study||6
9087121|NCT02612194|10151481|FG001|STARTED|Overall Study||0
9087122|NCT02612194|10151482|FG002|STARTED|Overall Study||2
9087123|NCT02612194|10151480|FG000|COMPLETED|Overall Study||0
9087124|NCT02612194|10151481|FG001|COMPLETED|Overall Study||0
9087125|NCT02612194|10151482|FG002|COMPLETED|Overall Study||0
9087126|NCT02612194|10151480|FG000|NOT COMPLETED|Overall Study||6
9087127|NCT02612194|10151481|FG001|NOT COMPLETED|Overall Study||0
9087128|NCT02612194|10151482|FG002|NOT COMPLETED|Overall Study||2
9087129|NCT02586207|10151489|FG000|STARTED|Overall Study||59
9087130|NCT02586207|10151489|FG000|COMPLETED|Overall Study||57
9087131|NCT02586207|10151489|FG000|NOT COMPLETED|Overall Study||2
9087132|NCT02542397|10151493|FG000|STARTED|Overall Study|75 subjects were enrolled to the study (i.e., submitted buccal swab).|75
9087133|NCT02542397|10151493|FG000|COMPLETED|Overall Study|54 enrolled subjects provided pain scores at baseline and final assessments within 30 +/- 7 days.|59
9087134|NCT02542397|10151493|FG000|NOT COMPLETED|Overall Study||16
9087135|NCT02519777|10151501|FG000|STARTED|Overall Study||63
9087136|NCT02519777|10151502|FG001|STARTED|Overall Study||67
9087137|NCT02519777|10151503|FG002|STARTED|Overall Study||61
9087138|NCT02519777|10151501|FG000|COMPLETED|Overall Study||57
9087139|NCT02519777|10151502|FG001|COMPLETED|Overall Study||59
9087140|NCT02519777|10151503|FG002|COMPLETED|Overall Study||57
9087141|NCT02519777|10151501|FG000|NOT COMPLETED|Overall Study||6
9087142|NCT02519777|10151502|FG001|NOT COMPLETED|Overall Study||8
9087143|NCT02519777|10151503|FG002|NOT COMPLETED|Overall Study||4
9087144|NCT02484443|10151511|FG000|STARTED|Overall Study||41
9087145|NCT02484443|10151511|FG000|COMPLETED|Overall Study||9
9087146|NCT02484443|10151511|FG000|NOT COMPLETED|Overall Study||32
9087147|NCT02395666|10151517|FG000|STARTED|Overall Study||101
9087148|NCT02395666|10151518|FG001|STARTED|Overall Study||39
9087149|NCT02395666|10151517|FG000|COMPLETED|Overall Study||95
9087150|NCT02395666|10151518|FG001|COMPLETED|Overall Study||38
9087151|NCT02395666|10151517|FG000|NOT COMPLETED|Overall Study||6
9087152|NCT02395666|10151518|FG001|NOT COMPLETED|Overall Study||1
9087153|NCT02357810|10151528|FG000|STARTED|Registered and Started Treatment||178
9087154|NCT02357810|10151528|FG000|Signed Consent|Registered and Started Treatment||178
9087155|NCT02357810|10151528|FG000|Registered to Study|Registered and Started Treatment||152
9087156|NCT02357810|10151528|FG000|Initiated Treatment on Study|Registered and Started Treatment||151
9087157|NCT02357810|10151528|FG000|COMPLETED|Registered and Started Treatment||151
9087158|NCT02357810|10151528|FG000|NOT COMPLETED|Registered and Started Treatment||27
9087159|NCT02357810|10151528|FG000|STARTED|Reached 12 Weeks Response||151
9087160|NCT02357810|10151528|FG000|Completed 4 Weeks/1 Cycle|Reached 12 Weeks Response||151
9087161|NCT02357810|10151528|FG000|Reached 6 Week Response|Reached 12 Weeks Response||129
9087162|NCT02357810|10151528|FG000|Reached 12 Weeks/3 Cycles|Reached 12 Weeks Response||95
9087163|NCT02357810|10151528|FG000|COMPLETED|Reached 12 Weeks Response||95
9087164|NCT02357810|10151528|FG000|NOT COMPLETED|Reached 12 Weeks Response||56
9087165|NCT02357810|10151528|FG000|STARTED|12 Week Response and Further Treatment||95
9087166|NCT02357810|10151528|FG000|Assessed for 12 Week Response|12 Week Response and Further Treatment||95
9087167|NCT02357810|10151528|FG000|Went on to be Treated After Response|12 Week Response and Further Treatment||73
9087168|NCT02357810|10151528|FG000|COMPLETED|12 Week Response and Further Treatment||73
9087169|NCT02357810|10151528|FG000|NOT COMPLETED|12 Week Response and Further Treatment||22
9087170|NCT02357810|10151528|FG000|STARTED|Follow-up at Treatment Discontinuation|All patients that receive at least one dose of study treatment go into follow up phase of the study.|151
9087171|NCT02357810|10151528|FG000|COMPLETED|Follow-up at Treatment Discontinuation||144
9087172|NCT02357810|10151528|FG000|NOT COMPLETED|Follow-up at Treatment Discontinuation||7
9087173|NCT02343549|10151532|FG000|STARTED|Overall Study||13
9087174|NCT02343549|10151532|FG000|COMPLETED|Overall Study||0
9087175|NCT02343549|10151532|FG000|NOT COMPLETED|Overall Study||13
9087176|NCT02339233|10151536|FG000|STARTED|Overall Study||8
9087177|NCT02339233|10151536|FG000|COMPLETED|Overall Study||8
9087178|NCT02339233|10151536|FG000|NOT COMPLETED|Overall Study||0
9087179|NCT02328105|10151540|FG000|STARTED|Overall Study||11
9087180|NCT02328105|10151540|FG000|COMPLETED|Overall Study||0
9087181|NCT02328105|10151540|FG000|NOT COMPLETED|Overall Study||11
9087182|NCT02327195|10151546|FG000|STARTED|Overall Study||27
9087183|NCT02327195|10151547|FG001|STARTED|Overall Study||27
9087184|NCT02327195|10151546|FG000|COMPLETED|Overall Study||27
9087185|NCT02327195|10151547|FG001|COMPLETED|Overall Study||27
9087186|NCT02327195|10151546|FG000|NOT COMPLETED|Overall Study||0
9087187|NCT02327195|10151547|FG001|NOT COMPLETED|Overall Study||0
9087188|NCT02315066|10151567|FG000|STARTED|Overall Study||2
9087189|NCT02315066|10151568|FG001|STARTED|Overall Study||10
9087190|NCT02315066|10151569|FG002|STARTED|Overall Study||11
9087191|NCT02315066|10151570|FG003|STARTED|Overall Study||12
9087192|NCT02315066|10151571|FG004|STARTED|Overall Study||13
9087193|NCT02315066|10151572|FG005|STARTED|Overall Study||4
9087194|NCT02315066|10151573|FG006|STARTED|Overall Study||16
9087195|NCT02315066|10151574|FG007|STARTED|Overall Study||19
8624886|NCT00504309|9664373|FG000|NOT COMPLETED|Overall Study||0
8624887|NCT00504309|9664374|FG001|NOT COMPLETED|Overall Study||0
8624888|NCT00504309|9664375|FG002|NOT COMPLETED|Overall Study||1
8624889|NCT00504309|9664376|FG003|NOT COMPLETED|Overall Study||0
8624890|NCT00504309|9664377|FG004|NOT COMPLETED|Overall Study||1
8624891|NCT00504309|9664378|FG005|NOT COMPLETED|Overall Study||0
8624892|NCT00504348|9664390|FG000|STARTED|Overall Study||25
8624893|NCT00504348|9664390|FG000|COMPLETED|Overall Study||17
8624894|NCT00504348|9664390|FG000|NOT COMPLETED|Overall Study||8
9087196|NCT02315066|10151575|FG008|STARTED|Overall Study||11
9087197|NCT02315066|10151576|FG009|STARTED|Overall Study||12
9087198|NCT02315066|10151577|FG010|STARTED|Overall Study||12
8624895|NCT00504426|9664398|FG000|STARTED|Overall Study||32
8624896|NCT00504426|9664399|FG001|STARTED|Overall Study||23
8624897|NCT00504426|9664400|FG002|STARTED|Overall Study||22
8624898|NCT00504426|9664401|FG003|STARTED|Overall Study||24
8624899|NCT00504426|9664398|FG000|COMPLETED|Overall Study||29
8624900|NCT00504426|9664399|FG001|COMPLETED|Overall Study||22
8624901|NCT00504426|9664400|FG002|COMPLETED|Overall Study||18
8624902|NCT00504426|9664401|FG003|COMPLETED|Overall Study||24
8624903|NCT00504426|9664398|FG000|NOT COMPLETED|Overall Study||3
9087199|NCT02315066|10151578|FG011|STARTED|Overall Study||11
9087200|NCT02315066|10151579|FG012|STARTED|Overall Study||11
9087201|NCT02315066|10151580|FG013|STARTED|Overall Study||30
9087202|NCT02315066|10151567|FG000|COMPLETED|Overall Study||0
9087203|NCT02315066|10151568|FG001|COMPLETED|Overall Study||0
9087204|NCT02315066|10151569|FG002|COMPLETED|Overall Study||2
9087205|NCT02315066|10151570|FG003|COMPLETED|Overall Study||1
9087206|NCT02315066|10151571|FG004|COMPLETED|Overall Study||2
9087207|NCT02315066|10151572|FG005|COMPLETED|Overall Study||1
9087208|NCT02315066|10151573|FG006|COMPLETED|Overall Study||3
9087209|NCT02315066|10151574|FG007|COMPLETED|Overall Study||5
9087210|NCT02315066|10151575|FG008|COMPLETED|Overall Study||0
9087211|NCT02315066|10151576|FG009|COMPLETED|Overall Study||1
9087212|NCT02315066|10151577|FG010|COMPLETED|Overall Study||0
9087213|NCT02315066|10151578|FG011|COMPLETED|Overall Study||0
9087214|NCT02315066|10151579|FG012|COMPLETED|Overall Study||1
9087215|NCT02315066|10151580|FG013|COMPLETED|Overall Study||0
9087216|NCT02315066|10151567|FG000|NOT COMPLETED|Overall Study||2
9087217|NCT02315066|10151568|FG001|NOT COMPLETED|Overall Study||10
9087218|NCT02315066|10151569|FG002|NOT COMPLETED|Overall Study||9
9087219|NCT02315066|10151570|FG003|NOT COMPLETED|Overall Study||11
9087220|NCT02315066|10151571|FG004|NOT COMPLETED|Overall Study||11
9087221|NCT02315066|10151572|FG005|NOT COMPLETED|Overall Study||3
9087222|NCT02315066|10151573|FG006|NOT COMPLETED|Overall Study||13
9087223|NCT02315066|10151574|FG007|NOT COMPLETED|Overall Study||14
9087224|NCT02315066|10151575|FG008|NOT COMPLETED|Overall Study||11
9087225|NCT02315066|10151576|FG009|NOT COMPLETED|Overall Study||11
9087226|NCT02315066|10151577|FG010|NOT COMPLETED|Overall Study||12
9087227|NCT02315066|10151578|FG011|NOT COMPLETED|Overall Study||11
9087228|NCT02315066|10151579|FG012|NOT COMPLETED|Overall Study||10
9087229|NCT02315066|10151580|FG013|NOT COMPLETED|Overall Study||30
9087230|NCT02265367|10151612|FG000|STARTED|Overall Study||28
9087231|NCT02265367|10151613|FG001|STARTED|Overall Study||28
9087232|NCT02265367|10151612|FG000|Completed First 3-week Period|Overall Study||24
9087233|NCT02265367|10151613|FG001|Completed First 3-week Period|Overall Study||26
9087234|NCT02265367|10151612|FG000|COMPLETED|Overall Study||18
9087235|NCT02265367|10151613|FG001|COMPLETED|Overall Study||22
9087236|NCT02265367|10151612|FG000|NOT COMPLETED|Overall Study||10
9087237|NCT02265367|10151613|FG001|NOT COMPLETED|Overall Study||6
9087238|NCT02256631|10151626|FG000|STARTED|Overall Study||13
9087239|NCT02256631|10151627|FG001|STARTED|Overall Study||14
9087240|NCT02256631|10151628|FG002|STARTED|Overall Study||13
9087241|NCT02256631|10151629|FG003|STARTED|Overall Study||10
9087242|NCT02256631|10151630|FG004|STARTED|Overall Study||11
8624904|NCT00504426|9664399|FG001|NOT COMPLETED|Overall Study||1
8624905|NCT00504426|9664400|FG002|NOT COMPLETED|Overall Study||4
8624906|NCT00504426|9664401|FG003|NOT COMPLETED|Overall Study||0
9087243|NCT02256631|10151631|FG005|STARTED|Overall Study||11
8624907|NCT00504504|9664414|FG000|STARTED|Overall Study||82
8624908|NCT00504504|9664414|FG000|COMPLETED|Overall Study||82
9087244|NCT02256631|10151632|FG006|STARTED|Overall Study||11
9087245|NCT02256631|10151626|FG000|COMPLETED|Overall Study||12
9087246|NCT02256631|10151627|FG001|COMPLETED|Overall Study||11
9087247|NCT02256631|10151628|FG002|COMPLETED|Overall Study||13
9087248|NCT02256631|10151629|FG003|COMPLETED|Overall Study||6
9087249|NCT02256631|10151630|FG004|COMPLETED|Overall Study||10
9087250|NCT02256631|10151631|FG005|COMPLETED|Overall Study||9
8624909|NCT00504504|9664414|FG000|NOT COMPLETED|Overall Study||0
8624910|NCT00504556|9664423|FG000|STARTED|Overall Study||235
8624911|NCT00504556|9664424|FG001|STARTED|Overall Study||245
8624912|NCT00504556|9664425|FG002|STARTED|Overall Study||235
8624913|NCT00504556|9664426|FG003|STARTED|Overall Study||180
8624914|NCT00504556|9664427|FG004|STARTED|Overall Study||251
8624915|NCT00504556|9664423|FG000|Safety Analysis Set|Overall Study||235
8624916|NCT00504556|9664424|FG001|Safety Analysis Set|Overall Study||244
8624917|NCT00504556|9664425|FG002|Safety Analysis Set|Overall Study||234
8624918|NCT00504556|9664426|FG003|Safety Analysis Set|Overall Study||180
8624919|NCT00504556|9664427|FG004|Safety Analysis Set|Overall Study||250
8624920|NCT00504556|9664423|FG000|Per Protocol Analysis Set|Overall Study||235
8624921|NCT00504556|9664424|FG001|Per Protocol Analysis Set|Overall Study||243
8624922|NCT00504556|9664425|FG002|Per Protocol Analysis Set|Overall Study||234
8624923|NCT00504556|9664426|FG003|Per Protocol Analysis Set|Overall Study||180
8624924|NCT00504556|9664427|FG004|Per Protocol Analysis Set|Overall Study||250
8624925|NCT00504556|9664423|FG000|Pharmacodynamic Analysis Set|Overall Study||230
8624926|NCT00504556|9664424|FG001|Pharmacodynamic Analysis Set|Overall Study||236
8624927|NCT00504556|9664425|FG002|Pharmacodynamic Analysis Set|Overall Study||228
8624928|NCT00504556|9664426|FG003|Pharmacodynamic Analysis Set|Overall Study||170
8624929|NCT00504556|9664427|FG004|Pharmacodynamic Analysis Set|Overall Study||244
8624930|NCT00504556|9664423|FG000|COMPLETED|Overall Study||200
8624931|NCT00504556|9664424|FG001|COMPLETED|Overall Study||207
8624932|NCT00504556|9664425|FG002|COMPLETED|Overall Study||204
8624933|NCT00504556|9664426|FG003|COMPLETED|Overall Study||52
8624934|NCT00504556|9664427|FG004|COMPLETED|Overall Study||226
8624935|NCT00504556|9664423|FG000|NOT COMPLETED|Overall Study||35
8624936|NCT00504556|9664424|FG001|NOT COMPLETED|Overall Study||38
9087251|NCT02256631|10151632|FG006|COMPLETED|Overall Study||7
9087252|NCT02256631|10151626|FG000|NOT COMPLETED|Overall Study||1
9087253|NCT02256631|10151627|FG001|NOT COMPLETED|Overall Study||3
9087254|NCT02256631|10151628|FG002|NOT COMPLETED|Overall Study||0
9087255|NCT02256631|10151629|FG003|NOT COMPLETED|Overall Study||4
9087256|NCT02256631|10151630|FG004|NOT COMPLETED|Overall Study||1
9087257|NCT02256631|10151631|FG005|NOT COMPLETED|Overall Study||2
9087258|NCT02256631|10151632|FG006|NOT COMPLETED|Overall Study||4
9087259|NCT02173379|10151650|FG000|STARTED|Overall Study||1296
9087260|NCT02173379|10151651|FG001|STARTED|Overall Study||1308
9087261|NCT02173379|10151650|FG000|COMPLETED|Overall Study||1205
9087262|NCT02173379|10151651|FG001|COMPLETED|Overall Study||1231
9087263|NCT02173379|10151650|FG000|NOT COMPLETED|Overall Study||91
9087264|NCT02173379|10151651|FG001|NOT COMPLETED|Overall Study||77
9087265|NCT02129348|10151660|FG000|STARTED|Overall Study||38
9087266|NCT02129348|10151661|FG001|STARTED|Overall Study||39
9087267|NCT02129348|10151660|FG000|COMPLETED|Overall Study||29
9087268|NCT02129348|10151661|FG001|COMPLETED|Overall Study||29
9087269|NCT02129348|10151660|FG000|NOT COMPLETED|Overall Study||9
9087270|NCT02129348|10151661|FG001|NOT COMPLETED|Overall Study||10
9087271|NCT02080260|10151667|FG000|STARTED|Overall Study||20
9087272|NCT02080260|10151667|FG000|COMPLETED|Overall Study|Defined as still alive in follow-up when the study was terminated and the database was locked.|1
9087273|NCT02080260|10151667|FG000|NOT COMPLETED|Overall Study||19
9087274|NCT02051933|10151673|FG000|STARTED|Overall Study||5
9087275|NCT02051933|10151674|FG001|STARTED|Overall Study||5
9087276|NCT02051933|10151673|FG000|COMPLETED|Overall Study||5
9087277|NCT02051933|10151674|FG001|COMPLETED|Overall Study||4
9087278|NCT02051933|10151673|FG000|NOT COMPLETED|Overall Study||0
8624937|NCT00504556|9664425|FG002|NOT COMPLETED|Overall Study||31
8624938|NCT00504556|9664426|FG003|NOT COMPLETED|Overall Study||128
8624939|NCT00504556|9664427|FG004|NOT COMPLETED|Overall Study||25
8624940|NCT00504595|9664443|FG000|STARTED|Overall Study||50
8624941|NCT00504595|9664444|FG001|STARTED|Overall Study||10
8624942|NCT00504595|9664445|FG002|STARTED|Overall Study||10
8624943|NCT00504595|9664446|FG003|STARTED|Overall Study||10
8624944|NCT00504595|9664443|FG000|COMPLETED|Overall Study||49
8624945|NCT00504595|9664444|FG001|COMPLETED|Overall Study||10
9087279|NCT02051933|10151674|FG001|NOT COMPLETED|Overall Study||1
9087280|NCT02047929|10151688|FG000|STARTED|Overall Study||1503
9087281|NCT02047929|10151689|FG001|STARTED|Overall Study||2523
9087282|NCT02047929|10151690|FG002|STARTED|Overall Study||2248
8624946|NCT00504595|9664445|FG002|COMPLETED|Overall Study||8
8624947|NCT00504595|9664446|FG003|COMPLETED|Overall Study||10
8624948|NCT00504595|9664443|FG000|NOT COMPLETED|Overall Study||1
8624949|NCT00504595|9664444|FG001|NOT COMPLETED|Overall Study||0
8624950|NCT00504595|9664445|FG002|NOT COMPLETED|Overall Study||2
8624951|NCT00504595|9664446|FG003|NOT COMPLETED|Overall Study||0
8624952|NCT00504660|9664458|FG000|STARTED|Overall Study||31
8624953|NCT00504660|9664459|FG001|STARTED|Overall Study||43
8624954|NCT00504660|9664458|FG000|COMPLETED|Overall Study||31
8624955|NCT00504660|9664459|FG001|COMPLETED|Overall Study||43
9087283|NCT02047929|10151688|FG000|Practice Rollout|Overall Study||1503
9087284|NCT02047929|10151689|FG001|Practice Rollout|Overall Study||2523
9087285|NCT02047929|10151690|FG002|Practice Rollout|Overall Study|Per protocol, practice did not receive any intervention from practice facilitator|0
9087286|NCT02047929|10151688|FG000|Practice Refresher|Overall Study||1503
9087287|NCT02047929|10151689|FG001|Practice Refresher|Overall Study||2523
9087288|NCT02047929|10151690|FG002|Practice Refresher|Overall Study|Per protocol, practices did not receive any interaction from practice facilitator|0
9087289|NCT02047929|10151688|FG000|Surveys Collected|Overall Study||1503
9087290|NCT02047929|10151689|FG001|Surveys Collected|Overall Study||2523
9087291|NCT02047929|10151690|FG002|Surveys Collected|Overall Study|Per protocol, practice did not receive any interaction from practice facilitator|0
9087292|NCT02047929|10151688|FG000|COMPLETED|Overall Study||1503
9087293|NCT02047929|10151689|FG001|COMPLETED|Overall Study||2523
9087294|NCT02047929|10151690|FG002|COMPLETED|Overall Study||2248
9087295|NCT02047929|10151688|FG000|NOT COMPLETED|Overall Study||0
9087296|NCT02047929|10151689|FG001|NOT COMPLETED|Overall Study||0
9087297|NCT02047929|10151690|FG002|NOT COMPLETED|Overall Study||0
9087298|NCT01999569|10151701|FG000|STARTED|Control Cycle|First cycle no meds|10
9087299|NCT01999569|10151701|FG000|COMPLETED|Control Cycle||10
9087300|NCT01999569|10151701|FG000|NOT COMPLETED|Control Cycle||0
9087301|NCT01999569|10151701|FG000|STARTED|Letrozole Treatment Cycle||10
9087302|NCT01999569|10151701|FG000|COMPLETED|Letrozole Treatment Cycle||10
9087303|NCT01999569|10151701|FG000|NOT COMPLETED|Letrozole Treatment Cycle||0
9087304|NCT01969812|10151710|FG000|STARTED|Overall Study||12
9087305|NCT01969812|10151711|FG001|STARTED|Overall Study||10
9087306|NCT01969812|10151710|FG000|COMPLETED|Overall Study||12
9087307|NCT01969812|10151711|FG001|COMPLETED|Overall Study||10
9087308|NCT01969812|10151710|FG000|NOT COMPLETED|Overall Study||0
9087309|NCT01969812|10151711|FG001|NOT COMPLETED|Overall Study||0
9087310|NCT01959464|10151719|FG000|STARTED|Overall Study||10
9087311|NCT01959464|10151720|FG001|STARTED|Overall Study||10
9087312|NCT01959464|10151719|FG000|COMPLETED|Overall Study||9
9087313|NCT01959464|10151720|FG001|COMPLETED|Overall Study||10
9087314|NCT01959464|10151719|FG000|NOT COMPLETED|Overall Study||1
9087315|NCT01959464|10151720|FG001|NOT COMPLETED|Overall Study||0
9087316|NCT01921166|10151728|FG000|STARTED|Overall Study||8
9087317|NCT01921166|10151729|FG001|STARTED|Overall Study||15
9087318|NCT01921166|10151728|FG000|COMPLETED|Overall Study||8
9087319|NCT01921166|10151729|FG001|COMPLETED|Overall Study||15
9087320|NCT01921166|10151728|FG000|NOT COMPLETED|Overall Study||0
9087321|NCT01921166|10151729|FG001|NOT COMPLETED|Overall Study||0
9087322|NCT01886963|10151737|FG000|STARTED|Overall Study||57
9087323|NCT01886963|10151738|FG001|STARTED|Overall Study||58
9087324|NCT01886963|10151737|FG000|2 Week Follow Up|Overall Study||55
9087325|NCT01886963|10151738|FG001|2 Week Follow Up|Overall Study||55
9087326|NCT01886963|10151737|FG000|4 Week Follow Up|Overall Study||50
9087327|NCT01886963|10151738|FG001|4 Week Follow Up|Overall Study||51
9087328|NCT01886963|10151737|FG000|12 Week Follow Up|Overall Study||46
9087329|NCT01886963|10151738|FG001|12 Week Follow Up|Overall Study||49
9087330|NCT01886963|10151737|FG000|COMPLETED|Overall Study||46
9087331|NCT01886963|10151738|FG001|COMPLETED|Overall Study||49
9087332|NCT01886963|10151737|FG000|NOT COMPLETED|Overall Study||11
9087333|NCT01886963|10151738|FG001|NOT COMPLETED|Overall Study||9
8844723|NCT01711645|9899168|FG000|NOT COMPLETED|Overall Study||19
8844724|NCT01711658|9899174|FG000|STARTED|Overall Study||64
8844725|NCT01711658|9899175|FG001|STARTED|Overall Study||63
9087334|NCT01802281|10151746|FG000|STARTED|Overall Study||93
9087335|NCT01802281|10151747|FG001|STARTED|Overall Study||90
9087336|NCT01802281|10151746|FG000|Eligible and Received Randomized Treatment|Overall Study||88
9087337|NCT01802281|10151747|FG001|Eligible and Received Randomized Treatment|Overall Study||87
9087338|NCT01802281|10151746|FG000|Completed Year 1 Follow-up|Overall Study||88
9087339|NCT01802281|10151747|FG001|Completed Year 1 Follow-up|Overall Study||86
9087340|NCT01802281|10151746|FG000|Completed Year 2 Follow-up|Overall Study||87
9087341|NCT01802281|10151747|FG001|Completed Year 2 Follow-up|Overall Study||84
9087342|NCT01802281|10151746|FG000|COMPLETED|Overall Study||85
9087343|NCT01802281|10151747|FG001|COMPLETED|Overall Study||84
9087344|NCT01802281|10151746|FG000|NOT COMPLETED|Overall Study||8
9087345|NCT01802281|10151747|FG001|NOT COMPLETED|Overall Study||6
9087346|NCT01774253|10151753|FG000|STARTED|Overall Study||9
9087347|NCT01774253|10151753|FG000|COMPLETED|Overall Study||0
9087348|NCT01774253|10151753|FG000|NOT COMPLETED|Overall Study||9
9087349|NCT01666145|10151757|FG000|STARTED|Overall Study||14
9087350|NCT01666145|10151757|FG000|COMPLETED|Overall Study||14
9087351|NCT01666145|10151757|FG000|NOT COMPLETED|Overall Study||0
9087352|NCT01505608|10151763|FG000|STARTED|Phase I|Randomization to Arm A began in Phase 2. All patients in Phase I were enrolled to receive TPI 287.|0
9087353|NCT01505608|10151764|FG001|STARTED|Phase I||8
9087354|NCT01505608|10151763|FG000|COMPLETED|Phase I||0
9087355|NCT01505608|10151764|FG001|COMPLETED|Phase I||2
9087356|NCT01505608|10151763|FG000|NOT COMPLETED|Phase I||0
9087357|NCT01505608|10151764|FG001|NOT COMPLETED|Phase I||6
9087358|NCT01505608|10151763|FG000|STARTED|Phase II|Phase 2 was new enrollment, not the same patients from Phase 1.|2
9087359|NCT01505608|10151764|FG001|STARTED|Phase II|Phase 2 was new enrollment, not the same patients from Phase 1.|4
9087360|NCT01505608|10151763|FG000|COMPLETED|Phase II||0
9087361|NCT01505608|10151764|FG001|COMPLETED|Phase II||2
9087362|NCT01505608|10151763|FG000|NOT COMPLETED|Phase II||2
9087363|NCT01505608|10151764|FG001|NOT COMPLETED|Phase II||2
9087364|NCT01483820|10151773|FG000|STARTED|Overall Study||8
9087365|NCT01483820|10151773|FG000|COMPLETED|Overall Study||0
9087366|NCT01483820|10151773|FG000|NOT COMPLETED|Overall Study||8
9087367|NCT01355679|10151777|FG000|STARTED|Overall Study||16
8624956|NCT00504660|9664458|FG000|NOT COMPLETED|Overall Study||0
8624957|NCT00504660|9664459|FG001|NOT COMPLETED|Overall Study||0
8624958|NCT00504725|9664467|FG000|STARTED|Overall Study||21
8624959|NCT00504725|9664468|FG001|STARTED|Overall Study||20
8624960|NCT00504725|9664467|FG000|COMPLETED|Overall Study|Prior to unblinding, one subject was discontinued due to elevated CRP levels at baseline.|20
8624961|NCT00504725|9664468|FG001|COMPLETED|Overall Study||20
8624962|NCT00504725|9664467|FG000|NOT COMPLETED|Overall Study||1
8624963|NCT00504725|9664468|FG001|NOT COMPLETED|Overall Study||0
8624964|NCT00504751|9664474|FG000|STARTED|Overall Study||15
8624965|NCT00504751|9664474|FG000|COMPLETED|Overall Study||15
8624966|NCT00504751|9664474|FG000|NOT COMPLETED|Overall Study||0
8624967|NCT00504777|9664478|FG000|STARTED|Overall Study||36
8624968|NCT00504777|9664478|FG000|COMPLETED|Overall Study||35
8624969|NCT00504777|9664478|FG000|NOT COMPLETED|Overall Study||1
9087368|NCT01355679|10151777|FG000|COMPLETED|Overall Study||14
9087369|NCT01355679|10151777|FG000|NOT COMPLETED|Overall Study||2
9087370|NCT01227616|10151784|FG000|STARTED|Overall Study||196
9087371|NCT01227616|10151785|FG001|STARTED|Overall Study||97
9087372|NCT01227616|10151784|FG000|COMPLETED|Overall Study||142
9087373|NCT01227616|10151785|FG001|COMPLETED|Overall Study||74
9087374|NCT01227616|10151784|FG000|NOT COMPLETED|Overall Study||54
9087375|NCT01227616|10151785|FG001|NOT COMPLETED|Overall Study||23
9087376|NCT01192698|10151793|FG000|STARTED|Overall Study||10
9087377|NCT01192698|10151794|FG001|STARTED|Overall Study||5
9087378|NCT01192698|10151793|FG000|COMPLETED|Overall Study||10
9087379|NCT01192698|10151794|FG001|COMPLETED|Overall Study||5
9087380|NCT01192698|10151793|FG000|NOT COMPLETED|Overall Study||0
9087381|NCT01192698|10151794|FG001|NOT COMPLETED|Overall Study||0
9087382|NCT01166386|10151802|FG000|STARTED|Overall Study||82
9087383|NCT01166386|10151803|FG001|STARTED|Overall Study||83
9087384|NCT01166386|10151802|FG000|COMPLETED|Overall Study||79
9087385|NCT01166386|10151803|FG001|COMPLETED|Overall Study||78
9087386|NCT01166386|10151802|FG000|NOT COMPLETED|Overall Study||3
9087387|NCT01166386|10151803|FG001|NOT COMPLETED|Overall Study||5
9087388|NCT01114217|10151811|FG000|STARTED|Overall Study||337
8850210|NCT01745952|9905470|FG000|STARTED|Overall Study||4
9087389|NCT01114217|10151812|FG001|STARTED|Overall Study||297
9087390|NCT01114217|10151811|FG000|Received at Least 1 Dose of Ferumoxytol|Overall Study||337
8624970|NCT00504829|9664485|FG000|STARTED|Overall Study||73
8624971|NCT00504829|9664486|FG001|STARTED|Overall Study||74
8624972|NCT00504829|9664487|FG002|STARTED|Overall Study||73
8624973|NCT00504829|9664485|FG000|COMPLETED|Overall Study||67
8624974|NCT00504829|9664486|FG001|COMPLETED|Overall Study||70
8624975|NCT00504829|9664487|FG002|COMPLETED|Overall Study||63
8624976|NCT00504829|9664485|FG000|NOT COMPLETED|Overall Study||6
9087391|NCT01114217|10151812|FG001|Received at Least 1 Dose of Ferumoxytol|Overall Study||0
9087392|NCT01114217|10151811|FG000|COMPLETED|Overall Study|Two participants lacked study completion data: one site stopped communicating during the study.|262
9087393|NCT01114217|10151812|FG001|COMPLETED|Overall Study||199
9087394|NCT01114217|10151811|FG000|NOT COMPLETED|Overall Study||75
9087395|NCT01114217|10151812|FG001|NOT COMPLETED|Overall Study||98
8624977|NCT00504829|9664486|FG001|NOT COMPLETED|Overall Study||4
8624978|NCT00504829|9664487|FG002|NOT COMPLETED|Overall Study||10
9087396|NCT01114204|10151818|FG000|STARTED|Overall Study||406
9087397|NCT01114204|10151819|FG001|STARTED|Overall Study||199
9087398|NCT01114204|10151818|FG000|Received at Least 1 Dose of Study Drug|Overall Study||406
9087399|NCT01114204|10151819|FG001|Received at Least 1 Dose of Study Drug|Overall Study||199
9087400|NCT01114204|10151818|FG000|COMPLETED|Overall Study||385
9087401|NCT01114204|10151819|FG001|COMPLETED|Overall Study||191
9087402|NCT01114204|10151818|FG000|NOT COMPLETED|Overall Study||21
9087403|NCT01114204|10151819|FG001|NOT COMPLETED|Overall Study||8
9087404|NCT01114139|10151827|FG000|STARTED|Overall Study||609
9087405|NCT01114139|10151828|FG001|STARTED|Overall Study||203
9087406|NCT01114139|10151827|FG000|Received at Least 1 Dose of Study Drug|Overall Study||608
9087407|NCT01114139|10151828|FG001|Received at Least 1 Dose of Study Drug|Overall Study||200
9087408|NCT01114139|10151827|FG000|COMPLETED|Overall Study||569
9087409|NCT01114139|10151828|FG001|COMPLETED|Overall Study||187
9087410|NCT01114139|10151827|FG000|NOT COMPLETED|Overall Study||40
9087411|NCT01114139|10151828|FG001|NOT COMPLETED|Overall Study||16
9087412|NCT01059071|10151834|FG000|STARTED|Overall Study||4
9087413|NCT01059071|10151835|FG001|STARTED|Overall Study||5
9087414|NCT01059071|10151836|FG002|STARTED|Overall Study||3
9087415|NCT01059071|10151837|FG003|STARTED|Overall Study||9
9087416|NCT01059071|10151834|FG000|COMPLETED|Overall Study||2
9087417|NCT01059071|10151835|FG001|COMPLETED|Overall Study||1
9087418|NCT01059071|10151836|FG002|COMPLETED|Overall Study||1
9087419|NCT01059071|10151837|FG003|COMPLETED|Overall Study||3
9087420|NCT01059071|10151834|FG000|NOT COMPLETED|Overall Study||2
9087421|NCT01059071|10151835|FG001|NOT COMPLETED|Overall Study||4
9087422|NCT01059071|10151836|FG002|NOT COMPLETED|Overall Study||2
9087423|NCT01059071|10151837|FG003|NOT COMPLETED|Overall Study||6
9087424|NCT01027702|10151845|FG000|STARTED|Overall Study||4
9087425|NCT01027702|10151846|FG001|STARTED|Overall Study||4
9087426|NCT01027702|10151847|FG002|STARTED|Overall Study||3
9087427|NCT01027702|10151848|FG003|STARTED|Overall Study||14
9087428|NCT01027702|10151849|FG004|STARTED|Overall Study||10
9087429|NCT01027702|10151850|FG005|STARTED|Overall Study||1
9087430|NCT01027702|10151851|FG006|STARTED|Overall Study||2
9087431|NCT01027702|10151845|FG000|COMPLETED|Overall Study||3
9087432|NCT01027702|10151846|FG001|COMPLETED|Overall Study||2
9087433|NCT01027702|10151847|FG002|COMPLETED|Overall Study||2
9087434|NCT01027702|10151848|FG003|COMPLETED|Overall Study||10
9087435|NCT01027702|10151849|FG004|COMPLETED|Overall Study||9
9087436|NCT01027702|10151850|FG005|COMPLETED|Overall Study||1
9087437|NCT01027702|10151851|FG006|COMPLETED|Overall Study||1
8844726|NCT01711658|9899174|FG000|Participants Who Started Protocol Treatment|Overall Study||59
8844727|NCT01711658|9899175|FG001|Participants Who Started Protocol Treatment|Overall Study||60
8844728|NCT01711658|9899174|FG000|COMPLETED|Overall Study||64
8844729|NCT01711658|9899175|FG001|COMPLETED|Overall Study||63
8844730|NCT01711658|9899174|FG000|NOT COMPLETED|Overall Study||0
8844731|NCT01711658|9899175|FG001|NOT COMPLETED|Overall Study||0
8844732|NCT01711736|9899183|FG000|STARTED|Overall Study||299
9087438|NCT01027702|10151845|FG000|NOT COMPLETED|Overall Study||1
9087439|NCT01027702|10151846|FG001|NOT COMPLETED|Overall Study||2
9087440|NCT01027702|10151847|FG002|NOT COMPLETED|Overall Study||1
9087441|NCT01027702|10151848|FG003|NOT COMPLETED|Overall Study||4
9087442|NCT01027702|10151849|FG004|NOT COMPLETED|Overall Study||1
8624979|NCT00504881|9664497|FG000|STARTED|Overall Study||121
8624980|NCT00504881|9664498|FG001|STARTED|Overall Study||359
8844733|NCT01711736|9899184|FG001|STARTED|Overall Study||302
8844734|NCT01711736|9899183|FG000|COMPLETED|Overall Study|Up to Day 180|287
9087443|NCT01027702|10151850|FG005|NOT COMPLETED|Overall Study||0
9087444|NCT01027702|10151851|FG006|NOT COMPLETED|Overall Study||1
9087445|NCT00991887|10151864|FG000|STARTED|Overall Study||26
9087446|NCT00991887|10151865|FG001|STARTED|Overall Study||22
9087447|NCT00991887|10151864|FG000|COMPLETED|Overall Study||24
9087448|NCT00991887|10151865|FG001|COMPLETED|Overall Study||21
9087449|NCT00991887|10151864|FG000|NOT COMPLETED|Overall Study||2
9087450|NCT00991887|10151865|FG001|NOT COMPLETED|Overall Study||1
9087451|NCT00968864|10151871|FG000|STARTED|Overall Study|One patient, FDA and IRB approved to enroll as an exception, was not evaluable for study endpoints.|53
9087452|NCT00968864|10151871|FG000|COMPLETED|Overall Study||52
9087453|NCT00968864|10151871|FG000|NOT COMPLETED|Overall Study||1
9087454|NCT00934700|10151882|FG000|STARTED|Overall Study||46
9087455|NCT00934700|10151883|FG001|STARTED|Overall Study||46
9087456|NCT00934700|10151882|FG000|COMPLETED|Overall Study||33
9087457|NCT00934700|10151883|FG001|COMPLETED|Overall Study||34
9087458|NCT00934700|10151882|FG000|NOT COMPLETED|Overall Study||13
9087459|NCT00934700|10151883|FG001|NOT COMPLETED|Overall Study||12
9087460|NCT00867568|10151890|FG000|STARTED|Overall Study||18
9087461|NCT00867568|10151890|FG000|COMPLETED|Overall Study||3
8624981|NCT00504881|9664497|FG000|COMPLETED|Overall Study||111
8624982|NCT00504881|9664498|FG001|COMPLETED|Overall Study||323
9087462|NCT00867568|10151890|FG000|NOT COMPLETED|Overall Study||15
9087463|NCT00785291|10151897|FG000|STARTED|Overall Study||283
9087464|NCT00785291|10151898|FG001|STARTED|Overall Study||271
9087465|NCT00785291|10151899|FG002|STARTED|Overall Study||245
9087466|NCT00785291|10151897|FG000|COMPLETED|Overall Study||147
9087467|NCT00785291|10151898|FG001|COMPLETED|Overall Study||122
9087468|NCT00785291|10151899|FG002|COMPLETED|Overall Study||139
9087469|NCT00785291|10151897|FG000|NOT COMPLETED|Overall Study||136
9087470|NCT00785291|10151898|FG001|NOT COMPLETED|Overall Study||149
9087471|NCT00785291|10151899|FG002|NOT COMPLETED|Overall Study||106
9087472|NCT00782288|10151910|FG000|STARTED|Overall Study||8
9087473|NCT00782288|10151911|FG001|STARTED|Overall Study||8
9087474|NCT00782288|10151912|FG002|STARTED|Overall Study||8
9087475|NCT00782288|10151910|FG000|COMPLETED|Overall Study||8
9087476|NCT00782288|10151911|FG001|COMPLETED|Overall Study||8
9087477|NCT00782288|10151912|FG002|COMPLETED|Overall Study||8
9087478|NCT00782288|10151910|FG000|NOT COMPLETED|Overall Study||0
9087479|NCT00782288|10151911|FG001|NOT COMPLETED|Overall Study||0
9087480|NCT00782288|10151912|FG002|NOT COMPLETED|Overall Study||0
9087481|NCT00770809|10151925|FG000|STARTED|Overall Study||118
9087482|NCT00770809|10151926|FG001|STARTED|Overall Study||120
9087483|NCT00770809|10151927|FG002|STARTED|Overall Study||67
9087484|NCT00770809|10151925|FG000|COMPLETED|Overall Study||101
8844735|NCT01711736|9899184|FG001|COMPLETED|Overall Study|Up to Day 180|294
8844736|NCT01711736|9899183|FG000|NOT COMPLETED|Overall Study||12
8844737|NCT01711736|9899184|FG001|NOT COMPLETED|Overall Study||8
8844738|NCT01711853|9899191|FG000|STARTED|Overall Study||19
8844739|NCT01711853|9899191|FG000|COMPLETED|Overall Study||16
9087485|NCT00770809|10151926|FG001|COMPLETED|Overall Study||110
9087486|NCT00770809|10151927|FG002|COMPLETED|Overall Study||44
9087487|NCT00770809|10151925|FG000|NOT COMPLETED|Overall Study||17
9087488|NCT00770809|10151926|FG001|NOT COMPLETED|Overall Study||10
9087489|NCT00770809|10151927|FG002|NOT COMPLETED|Overall Study||23
9087490|NCT00643864|10151935|FG000|STARTED|Pre-test Assessment||3
9087491|NCT00643864|10151935|FG000|COMPLETED|Pre-test Assessment||3
9087492|NCT00643864|10151935|FG000|NOT COMPLETED|Pre-test Assessment||0
9087493|NCT00643864|10151935|FG000|STARTED|Post-test Assessment||3
9087494|NCT00643864|10151935|FG000|COMPLETED|Post-test Assessment||3
9087495|NCT00643864|10151935|FG000|NOT COMPLETED|Post-test Assessment||0
9087496|NCT00628446|10151940|FG000|STARTED|Overall Study||45
9087497|NCT00628446|10151940|FG000|COMPLETED|Overall Study||38
9087498|NCT00628446|10151940|FG000|NOT COMPLETED|Overall Study||7
9087499|NCT00621751|10151947|FG000|STARTED|Overall Study||35
9087500|NCT00621751|10151948|FG001|STARTED|Overall Study||35
9087501|NCT00621751|10151947|FG000|COMPLETED|Overall Study||35
9087502|NCT00621751|10151948|FG001|COMPLETED|Overall Study||34
9087503|NCT00621751|10151947|FG000|NOT COMPLETED|Overall Study||0
9087504|NCT00621751|10151948|FG001|NOT COMPLETED|Overall Study||1
9087505|NCT00605215|10151957|FG000|STARTED|Overall Study||450
9087506|NCT00605215|10151958|FG001|STARTED|Overall Study||434
9087507|NCT00605215|10151959|FG002|STARTED|Overall Study||447
9087508|NCT00605215|10151957|FG000|Received at Least 1 Dose of Study Drug|Overall Study||449
9087509|NCT00605215|10151958|FG001|Received at Least 1 Dose of Study Drug|Overall Study||433
9087510|NCT00605215|10151959|FG002|Received at Least 1 Dose of Study Drug|Overall Study||442
9087511|NCT00605215|10151957|FG000|COMPLETED|Overall Study||359
9087512|NCT00605215|10151958|FG001|COMPLETED|Overall Study||353
9087513|NCT00605215|10151959|FG002|COMPLETED|Overall Study||378
9087514|NCT00605215|10151957|FG000|NOT COMPLETED|Overall Study||91
9087515|NCT00605215|10151958|FG001|NOT COMPLETED|Overall Study||81
9087516|NCT00605215|10151959|FG002|NOT COMPLETED|Overall Study||69
9087517|NCT00605150|10151967|FG000|STARTED|Overall Study|11 started|11
9087518|NCT00605150|10151967|FG000|COMPLETED|Overall Study||10
9087519|NCT00605150|10151967|FG000|NOT COMPLETED|Overall Study||1
9087520|NCT00552513|10151973|FG000|STARTED|Overall Study||1593
9087521|NCT00552513|10151974|FG001|STARTED|Overall Study||1438
9087522|NCT00552513|10151973|FG000|COMPLETED|Overall Study||1588
9087523|NCT00552513|10151974|FG001|COMPLETED|Overall Study||1437
9087524|NCT00552513|10151973|FG000|NOT COMPLETED|Overall Study||5
9087525|NCT00552513|10151974|FG001|NOT COMPLETED|Overall Study||1
9087526|NCT00368836|10151984|FG000|STARTED|Phase II||350
9087527|NCT00368836|10151984|FG000|COMPLETED|Phase II||329
9087528|NCT00368836|10151984|FG000|NOT COMPLETED|Phase II||21
9087529|NCT00368836|10151984|FG000|STARTED|Phase I Pre-op/Post-op|The phases consisted of unique subjects. Those enrolled in Phase I did not carry over to Phase II.|125
9087530|NCT00368836|10151984|FG000|COMPLETED|Phase I Pre-op/Post-op||104
9087531|NCT00368836|10151984|FG000|NOT COMPLETED|Phase I Pre-op/Post-op||21
9087532|NCT00290511|10151991|FG000|STARTED|Overall Study||49
9087533|NCT00290511|10151991|FG000|No Treatment Per Protocol|Overall Study||2
9087534|NCT00290511|10151991|FG000|Toxicity Assessment|Overall Study||47
9087535|NCT00290511|10151991|FG000|Response Assessment|Overall Study||45
9087536|NCT00290511|10151991|FG000|COMPLETED|Overall Study||45
9087537|NCT00290511|10151991|FG000|NOT COMPLETED|Overall Study||4
9087538|NCT00265798|10151995|FG000|STARTED|Overall Study||38
9087539|NCT00265798|10151995|FG000|COMPLETED|Overall Study||38
9087540|NCT00265798|10151995|FG000|NOT COMPLETED|Overall Study||0
8624983|NCT00504881|9664497|FG000|NOT COMPLETED|Overall Study||10
8624984|NCT00504881|9664498|FG001|NOT COMPLETED|Overall Study||36
8624985|NCT00504894|9664509|FG000|STARTED|Overall Study||20
8624986|NCT00504894|9664510|FG001|STARTED|Overall Study||21
8624987|NCT00504894|9664511|FG002|STARTED|Overall Study||19
8624988|NCT00504894|9664509|FG000|COMPLETED|Overall Study||17
8624989|NCT00504894|9664510|FG001|COMPLETED|Overall Study||18
8624990|NCT00504894|9664511|FG002|COMPLETED|Overall Study||19
8624991|NCT00504894|9664509|FG000|NOT COMPLETED|Overall Study||3
8624992|NCT00504894|9664510|FG001|NOT COMPLETED|Overall Study||3
8624993|NCT00504894|9664511|FG002|NOT COMPLETED|Overall Study||0
8624994|NCT00505076|9664522|FG000|STARTED|Overall Study||22
8844740|NCT01711853|9899191|FG000|NOT COMPLETED|Overall Study||3
8844741|NCT01711866|9899195|FG000|STARTED|Overall Study||87
8624995|NCT00505076|9664523|FG001|STARTED|Overall Study||19
9087541|NCT00641537|10152004|FG000|STARTED|96-week Period||98
9087542|NCT00641537|10152005|FG001|STARTED|96-week Period||92
8624996|NCT00505076|9664524|FG002|STARTED|Overall Study||22
8624997|NCT00505076|9664522|FG000|COMPLETED|Overall Study||19
8624998|NCT00505076|9664523|FG001|COMPLETED|Overall Study||17
9087543|NCT00641537|10152006|FG002|STARTED|96-week Period||186
9087544|NCT00641537|10152007|FG003|STARTED|96-week Period||186
9087545|NCT00641537|10152008|FG004|STARTED|96-week Period||244
9087546|NCT00641537|10152009|FG005|STARTED|96-week Period||22
9087547|NCT00641537|10152010|FG006|STARTED|96-week Period||17
9087548|NCT00641537|10152011|FG007|STARTED|96-week Period||22
9087549|NCT00641537|10152004|FG000|COMPLETED|96-week Period||89
9087550|NCT00641537|10152005|FG001|COMPLETED|96-week Period||82
9087551|NCT00641537|10152006|FG002|COMPLETED|96-week Period||166
9087552|NCT00641537|10152007|FG003|COMPLETED|96-week Period||174
9087553|NCT00641537|10152008|FG004|COMPLETED|96-week Period||227
9087554|NCT00641537|10152009|FG005|COMPLETED|96-week Period||15
9087555|NCT00641537|10152010|FG006|COMPLETED|96-week Period||12
9087556|NCT00641537|10152011|FG007|COMPLETED|96-week Period||16
9087557|NCT00641537|10152004|FG000|NOT COMPLETED|96-week Period||9
9087558|NCT00641537|10152005|FG001|NOT COMPLETED|96-week Period||10
9087559|NCT00641537|10152006|FG002|NOT COMPLETED|96-week Period||20
9087560|NCT00641537|10152007|FG003|NOT COMPLETED|96-week Period||12
9087561|NCT00641537|10152008|FG004|NOT COMPLETED|96-week Period||17
9087562|NCT00641537|10152009|FG005|NOT COMPLETED|96-week Period||7
9087563|NCT00641537|10152010|FG006|NOT COMPLETED|96-week Period||5
9087564|NCT00641537|10152011|FG007|NOT COMPLETED|96-week Period||6
9087565|NCT00641537|10152004|FG000|STARTED|24-Week Supplemental Follow-up Period||75
9087566|NCT00641537|10152005|FG001|STARTED|24-Week Supplemental Follow-up Period||69
9087567|NCT00641537|10152006|FG002|STARTED|24-Week Supplemental Follow-up Period||143
9087568|NCT00641537|10152007|FG003|STARTED|24-Week Supplemental Follow-up Period||151
9087569|NCT00641537|10152008|FG004|STARTED|24-Week Supplemental Follow-up Period||198
9087570|NCT00641537|10152009|FG005|STARTED|24-Week Supplemental Follow-up Period||15
9087571|NCT00641537|10152010|FG006|STARTED|24-Week Supplemental Follow-up Period||9
9087572|NCT00641537|10152011|FG007|STARTED|24-Week Supplemental Follow-up Period||11
9087573|NCT00641537|10152004|FG000|COMPLETED|24-Week Supplemental Follow-up Period||75
9087574|NCT00641537|10152005|FG001|COMPLETED|24-Week Supplemental Follow-up Period||66
9087575|NCT00641537|10152006|FG002|COMPLETED|24-Week Supplemental Follow-up Period||140
9087576|NCT00641537|10152007|FG003|COMPLETED|24-Week Supplemental Follow-up Period||147
9087577|NCT00641537|10152008|FG004|COMPLETED|24-Week Supplemental Follow-up Period||193
9087578|NCT00641537|10152009|FG005|COMPLETED|24-Week Supplemental Follow-up Period||14
9087579|NCT00641537|10152010|FG006|COMPLETED|24-Week Supplemental Follow-up Period||8
9087580|NCT00641537|10152011|FG007|COMPLETED|24-Week Supplemental Follow-up Period||10
9087581|NCT00641537|10152004|FG000|NOT COMPLETED|24-Week Supplemental Follow-up Period||0
9087582|NCT00641537|10152005|FG001|NOT COMPLETED|24-Week Supplemental Follow-up Period||3
9087583|NCT00641537|10152006|FG002|NOT COMPLETED|24-Week Supplemental Follow-up Period||3
9087584|NCT00641537|10152007|FG003|NOT COMPLETED|24-Week Supplemental Follow-up Period||4
9087585|NCT00641537|10152008|FG004|NOT COMPLETED|24-Week Supplemental Follow-up Period||5
9087586|NCT00641537|10152009|FG005|NOT COMPLETED|24-Week Supplemental Follow-up Period||1
9087587|NCT00641537|10152010|FG006|NOT COMPLETED|24-Week Supplemental Follow-up Period||1
9087588|NCT00641537|10152011|FG007|NOT COMPLETED|24-Week Supplemental Follow-up Period||1
9087589|NCT00655824|10152029|FG000|STARTED|Overall Study||92
9087590|NCT00655824|10152029|FG000|COMPLETED|Overall Study||8
9087591|NCT00655824|10152029|FG000|NOT COMPLETED|Overall Study||84
9087592|NCT00663052|10152035|FG000|STARTED|Overall Study||136
9087593|NCT00663052|10152036|FG001|STARTED|Overall Study||137
9087594|NCT00663052|10152035|FG000|COMPLETED|Overall Study||124
9087595|NCT00663052|10152036|FG001|COMPLETED|Overall Study||127
9087596|NCT00663052|10152035|FG000|NOT COMPLETED|Overall Study||12
9087597|NCT00663052|10152036|FG001|NOT COMPLETED|Overall Study||10
9087598|NCT00686374|10152042|FG000|STARTED|Overall Study||100
9087599|NCT00686374|10152042|FG000|COMPLETED|Overall Study||39
9087600|NCT00686374|10152042|FG000|NOT COMPLETED|Overall Study||61
9087601|NCT00698828|10152049|FG000|STARTED|Overall Study||76
9087602|NCT00698828|10152050|FG001|STARTED|Overall Study||75
9087603|NCT00698828|10152051|FG002|STARTED|Overall Study||76
9087604|NCT00698828|10152049|FG000|COMPLETED|Overall Study||67
9087605|NCT00698828|10152050|FG001|COMPLETED|Overall Study||60
9087606|NCT00698828|10152051|FG002|COMPLETED|Overall Study||65
9087607|NCT00698828|10152049|FG000|NOT COMPLETED|Overall Study||9
9087608|NCT00698828|10152050|FG001|NOT COMPLETED|Overall Study||15
9087609|NCT00698828|10152051|FG002|NOT COMPLETED|Overall Study||11
9087610|NCT00712933|10152059|FG000|STARTED|Overall Study||735
9087611|NCT00712933|10152059|FG000|COMPLETED|Overall Study||368
9087612|NCT00712933|10152059|FG000|NOT COMPLETED|Overall Study||367
9087613|NCT00725985|10152070|FG000|STARTED|ITP- Treatment Disposition||205
9087614|NCT00725985|10152071|FG001|STARTED|ITP- Treatment Disposition||206
9087615|NCT00725985|10152072|FG002|STARTED|ITP- Treatment Disposition||206
9087616|NCT00725985|10152073|FG003|STARTED|ITP- Treatment Disposition||0
9087617|NCT00725985|10152074|FG004|STARTED|ITP- Treatment Disposition||0
9087618|NCT00725985|10152075|FG005|STARTED|ITP- Treatment Disposition||0
9087619|NCT00725985|10152076|FG006|STARTED|ITP- Treatment Disposition||0
9087620|NCT00725985|10152077|FG007|STARTED|ITP- Treatment Disposition||0
9087621|NCT00725985|10152078|FG008|STARTED|ITP- Treatment Disposition||0
9087622|NCT00725985|10152079|FG009|STARTED|ITP- Treatment Disposition||0
9087623|NCT00725985|10152080|FG010|STARTED|ITP- Treatment Disposition||0
9087624|NCT00725985|10152081|FG011|STARTED|ITP- Treatment Disposition||0
8624999|NCT00505076|9664524|FG002|COMPLETED|Overall Study||17
8625000|NCT00505076|9664522|FG000|NOT COMPLETED|Overall Study||3
8625001|NCT00505076|9664523|FG001|NOT COMPLETED|Overall Study||2
8625002|NCT00505076|9664524|FG002|NOT COMPLETED|Overall Study||5
8625003|NCT00505284|9664537|FG000|STARTED|Overall Study||73
8625004|NCT00505284|9664538|FG001|STARTED|Overall Study||72
8625005|NCT00505284|9664539|FG002|STARTED|Overall Study||69
8625006|NCT00505284|9664540|FG003|STARTED|Overall Study||68
9087625|NCT00725985|10152070|FG000|Treated|ITP- Treatment Disposition||204
9087626|NCT00725985|10152071|FG001|Treated|ITP- Treatment Disposition||206
9087627|NCT00725985|10152072|FG002|Treated|ITP- Treatment Disposition||206
9087628|NCT00725985|10152073|FG003|Treated|ITP- Treatment Disposition||0
9087629|NCT00725985|10152074|FG004|Treated|ITP- Treatment Disposition||0
9087630|NCT00725985|10152075|FG005|Treated|ITP- Treatment Disposition||0
8625007|NCT00505284|9664541|FG004|STARTED|Overall Study||70
8625008|NCT00505284|9664537|FG000|COMPLETED|Overall Study||63
8625009|NCT00505284|9664538|FG001|COMPLETED|Overall Study||56
8625010|NCT00505284|9664539|FG002|COMPLETED|Overall Study||57
8625011|NCT00505284|9664540|FG003|COMPLETED|Overall Study||49
9087631|NCT00725985|10152076|FG006|Treated|ITP- Treatment Disposition||0
9087632|NCT00725985|10152077|FG007|Treated|ITP- Treatment Disposition||0
9087633|NCT00725985|10152078|FG008|Treated|ITP- Treatment Disposition||0
9087634|NCT00725985|10152079|FG009|Treated|ITP- Treatment Disposition||0
9087635|NCT00725985|10152080|FG010|Treated|ITP- Treatment Disposition||0
9087636|NCT00725985|10152081|FG011|Treated|ITP- Treatment Disposition||0
9087637|NCT00725985|10152070|FG000|COMPLETED|ITP- Treatment Disposition||104
9087638|NCT00725985|10152071|FG001|COMPLETED|ITP- Treatment Disposition||131
9087639|NCT00725985|10152072|FG002|COMPLETED|ITP- Treatment Disposition||104
9087640|NCT00725985|10152073|FG003|COMPLETED|ITP- Treatment Disposition||0
9087641|NCT00725985|10152074|FG004|COMPLETED|ITP- Treatment Disposition||0
9087642|NCT00725985|10152075|FG005|COMPLETED|ITP- Treatment Disposition||0
9087643|NCT00725985|10152076|FG006|COMPLETED|ITP- Treatment Disposition||0
9087644|NCT00725985|10152077|FG007|COMPLETED|ITP- Treatment Disposition||0
9087645|NCT00725985|10152078|FG008|COMPLETED|ITP- Treatment Disposition||0
9087646|NCT00725985|10152079|FG009|COMPLETED|ITP- Treatment Disposition||0
9087647|NCT00725985|10152080|FG010|COMPLETED|ITP- Treatment Disposition||0
9087648|NCT00725985|10152081|FG011|COMPLETED|ITP- Treatment Disposition||0
9087649|NCT00725985|10152070|FG000|NOT COMPLETED|ITP- Treatment Disposition||101
9087650|NCT00725985|10152071|FG001|NOT COMPLETED|ITP- Treatment Disposition||75
9087651|NCT00725985|10152072|FG002|NOT COMPLETED|ITP- Treatment Disposition||102
9087652|NCT00725985|10152073|FG003|NOT COMPLETED|ITP- Treatment Disposition||0
9087653|NCT00725985|10152074|FG004|NOT COMPLETED|ITP- Treatment Disposition||0
9087654|NCT00725985|10152075|FG005|NOT COMPLETED|ITP- Treatment Disposition||0
9087655|NCT00725985|10152076|FG006|NOT COMPLETED|ITP- Treatment Disposition||0
9087656|NCT00725985|10152077|FG007|NOT COMPLETED|ITP- Treatment Disposition||0
9087657|NCT00725985|10152078|FG008|NOT COMPLETED|ITP- Treatment Disposition||0
9087658|NCT00725985|10152079|FG009|NOT COMPLETED|ITP- Treatment Disposition||0
9087659|NCT00725985|10152080|FG010|NOT COMPLETED|ITP- Treatment Disposition||0
9087660|NCT00725985|10152081|FG011|NOT COMPLETED|ITP- Treatment Disposition||0
9087661|NCT00725985|10152070|FG000|STARTED|OLMP (Up to 96 Weeks)||0
9087662|NCT00725985|10152071|FG001|STARTED|OLMP (Up to 96 Weeks)||0
9087663|NCT00725985|10152072|FG002|STARTED|OLMP (Up to 96 Weeks)||0
9087664|NCT00725985|10152073|FG003|STARTED|OLMP (Up to 96 Weeks)||24
9087665|NCT00725985|10152074|FG004|STARTED|OLMP (Up to 96 Weeks)||25
9087666|NCT00725985|10152075|FG005|STARTED|OLMP (Up to 96 Weeks)||60
9087667|NCT00725985|10152076|FG006|STARTED|OLMP (Up to 96 Weeks)||0
9087668|NCT00725985|10152077|FG007|STARTED|OLMP (Up to 96 Weeks)||0
9087669|NCT00725985|10152078|FG008|STARTED|OLMP (Up to 96 Weeks)||0
9087670|NCT00725985|10152079|FG009|STARTED|OLMP (Up to 96 Weeks)||0
9087671|NCT00725985|10152080|FG010|STARTED|OLMP (Up to 96 Weeks)||0
9087672|NCT00725985|10152081|FG011|STARTED|OLMP (Up to 96 Weeks)||0
9087673|NCT00725985|10152070|FG000|COMPLETED|OLMP (Up to 96 Weeks)||0
9087674|NCT00725985|10152071|FG001|COMPLETED|OLMP (Up to 96 Weeks)||0
9087675|NCT00725985|10152072|FG002|COMPLETED|OLMP (Up to 96 Weeks)||0
9087676|NCT00725985|10152073|FG003|COMPLETED|OLMP (Up to 96 Weeks)||6
9087677|NCT00725985|10152074|FG004|COMPLETED|OLMP (Up to 96 Weeks)||2
9087678|NCT00725985|10152075|FG005|COMPLETED|OLMP (Up to 96 Weeks)||7
9087679|NCT00725985|10152076|FG006|COMPLETED|OLMP (Up to 96 Weeks)||0
9087680|NCT00725985|10152077|FG007|COMPLETED|OLMP (Up to 96 Weeks)||0
9087681|NCT00725985|10152078|FG008|COMPLETED|OLMP (Up to 96 Weeks)||0
9087682|NCT00725985|10152079|FG009|COMPLETED|OLMP (Up to 96 Weeks)||0
9087683|NCT00725985|10152080|FG010|COMPLETED|OLMP (Up to 96 Weeks)||0
9087684|NCT00725985|10152081|FG011|COMPLETED|OLMP (Up to 96 Weeks)||0
9087685|NCT00725985|10152070|FG000|NOT COMPLETED|OLMP (Up to 96 Weeks)||0
9087686|NCT00725985|10152071|FG001|NOT COMPLETED|OLMP (Up to 96 Weeks)||0
9087687|NCT00725985|10152072|FG002|NOT COMPLETED|OLMP (Up to 96 Weeks)||0
9087688|NCT00725985|10152073|FG003|NOT COMPLETED|OLMP (Up to 96 Weeks)||18
8625012|NCT00505284|9664541|FG004|COMPLETED|Overall Study||37
9087689|NCT00725985|10152074|FG004|NOT COMPLETED|OLMP (Up to 96 Weeks)||23
8625013|NCT00505284|9664537|FG000|NOT COMPLETED|Overall Study||10
8625014|NCT00505284|9664538|FG001|NOT COMPLETED|Overall Study||16
8625015|NCT00505284|9664539|FG002|NOT COMPLETED|Overall Study||12
9087690|NCT00725985|10152075|FG005|NOT COMPLETED|OLMP (Up to 96 Weeks)||53
9087691|NCT00725985|10152076|FG006|NOT COMPLETED|OLMP (Up to 96 Weeks)||0
9087692|NCT00725985|10152077|FG007|NOT COMPLETED|OLMP (Up to 96 Weeks)||0
9087693|NCT00725985|10152078|FG008|NOT COMPLETED|OLMP (Up to 96 Weeks)||0
9087694|NCT00725985|10152079|FG009|NOT COMPLETED|OLMP (Up to 96 Weeks)||0
9087695|NCT00725985|10152080|FG010|NOT COMPLETED|OLMP (Up to 96 Weeks)||0
9087696|NCT00725985|10152081|FG011|NOT COMPLETED|OLMP (Up to 96 Weeks)||0
9087697|NCT00725985|10152070|FG000|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0
9087698|NCT00725985|10152071|FG001|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0
9087699|NCT00725985|10152072|FG002|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0
9087700|NCT00725985|10152073|FG003|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0
9087701|NCT00725985|10152074|FG004|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0
9087702|NCT00725985|10152075|FG005|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0
9087703|NCT00725985|10152076|FG006|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||9
9087704|NCT00725985|10152077|FG007|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||9
9087705|NCT00725985|10152078|FG008|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||17
9087706|NCT00725985|10152079|FG009|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0
9087707|NCT00725985|10152080|FG010|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0
9087708|NCT00725985|10152081|FG011|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0
9087709|NCT00725985|10152070|FG000|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
9087710|NCT00725985|10152071|FG001|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
9087711|NCT00725985|10152072|FG002|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
9087712|NCT00725985|10152073|FG003|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
9087713|NCT00725985|10152074|FG004|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
9087714|NCT00725985|10152075|FG005|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
9087715|NCT00725985|10152076|FG006|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
9087716|NCT00725985|10152077|FG007|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
9087717|NCT00725985|10152078|FG008|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
9087718|NCT00725985|10152079|FG009|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
9087719|NCT00725985|10152080|FG010|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
9087720|NCT00725985|10152081|FG011|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
9087721|NCT00725985|10152070|FG000|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
9087722|NCT00725985|10152071|FG001|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
9087723|NCT00725985|10152072|FG002|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
9087724|NCT00725985|10152073|FG003|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
8625016|NCT00505284|9664540|FG003|NOT COMPLETED|Overall Study||19
8625017|NCT00505284|9664541|FG004|NOT COMPLETED|Overall Study||33
8625018|NCT00505362|9664555|FG000|STARTED|Overall Study||35
8625019|NCT00505362|9664556|FG001|STARTED|Overall Study||28
8625020|NCT00505362|9664555|FG000|COMPLETED|Overall Study||35
8625021|NCT00505362|9664556|FG001|COMPLETED|Overall Study||28
9087725|NCT00725985|10152074|FG004|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
9087726|NCT00725985|10152075|FG005|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
9087727|NCT00725985|10152076|FG006|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||9
9087728|NCT00725985|10152077|FG007|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||9
9087729|NCT00725985|10152078|FG008|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||17
9087730|NCT00725985|10152079|FG009|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
9087731|NCT00725985|10152080|FG010|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
9087732|NCT00725985|10152081|FG011|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
9087733|NCT00725985|10152070|FG000|STARTED|LTFU (No Cladribine) (48 Weeks)||0
8625022|NCT00505362|9664555|FG000|NOT COMPLETED|Overall Study||0
8625023|NCT00505362|9664556|FG001|NOT COMPLETED|Overall Study||0
8625024|NCT00505375|9664564|FG000|STARTED|Overall Study||77
8625025|NCT00505375|9664565|FG001|STARTED|Overall Study||35
8625026|NCT00505375|9664564|FG000|COMPLETED|Overall Study||73
8625027|NCT00505375|9664565|FG001|COMPLETED|Overall Study||30
8625028|NCT00505375|9664564|FG000|NOT COMPLETED|Overall Study||4
8625029|NCT00505375|9664565|FG001|NOT COMPLETED|Overall Study||5
8625030|NCT00505414|9664573|FG000|STARTED|Titration Phase||0
8625031|NCT00505414|9664574|FG001|STARTED|Titration Phase||0
9087734|NCT00725985|10152071|FG001|STARTED|LTFU (No Cladribine) (48 Weeks)||0
9087735|NCT00725985|10152072|FG002|STARTED|LTFU (No Cladribine) (48 Weeks)||0
9087736|NCT00725985|10152073|FG003|STARTED|LTFU (No Cladribine) (48 Weeks)||0
9087737|NCT00725985|10152074|FG004|STARTED|LTFU (No Cladribine) (48 Weeks)||0
9087738|NCT00725985|10152075|FG005|STARTED|LTFU (No Cladribine) (48 Weeks)||0
9087739|NCT00725985|10152076|FG006|STARTED|LTFU (No Cladribine) (48 Weeks)||0
9087740|NCT00725985|10152077|FG007|STARTED|LTFU (No Cladribine) (48 Weeks)||0
9087741|NCT00725985|10152078|FG008|STARTED|LTFU (No Cladribine) (48 Weeks)||0
9087742|NCT00725985|10152079|FG009|STARTED|LTFU (No Cladribine) (48 Weeks)||34
9087743|NCT00725985|10152080|FG010|STARTED|LTFU (No Cladribine) (48 Weeks)||36
9087744|NCT00725985|10152081|FG011|STARTED|LTFU (No Cladribine) (48 Weeks)||14
9087745|NCT00725985|10152070|FG000|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
9087746|NCT00725985|10152071|FG001|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
9087747|NCT00725985|10152072|FG002|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
9087748|NCT00725985|10152073|FG003|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
8625032|NCT00505414|9664575|FG002|STARTED|Titration Phase||0
8625033|NCT00505414|9664576|FG003|STARTED|Titration Phase||62
8625034|NCT00505414|9664577|FG004|STARTED|Titration Phase||31
8625035|NCT00505414|9664573|FG000|COMPLETED|Titration Phase||0
8625036|NCT00505414|9664574|FG001|COMPLETED|Titration Phase||0
9087749|NCT00725985|10152074|FG004|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
9087750|NCT00725985|10152075|FG005|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
9087751|NCT00725985|10152076|FG006|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
9087752|NCT00725985|10152077|FG007|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
9087753|NCT00725985|10152078|FG008|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
9087754|NCT00725985|10152079|FG009|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
9087755|NCT00725985|10152080|FG010|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
9087756|NCT00725985|10152081|FG011|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
9087757|NCT00725985|10152070|FG000|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
9087758|NCT00725985|10152071|FG001|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
9087759|NCT00725985|10152072|FG002|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
9087760|NCT00725985|10152073|FG003|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
9087761|NCT00725985|10152074|FG004|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
9087762|NCT00725985|10152075|FG005|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
9087763|NCT00725985|10152076|FG006|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
9087764|NCT00725985|10152077|FG007|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
9087765|NCT00725985|10152078|FG008|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
9087766|NCT00725985|10152079|FG009|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||34
9087767|NCT00725985|10152080|FG010|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||36
9087768|NCT00725985|10152081|FG011|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||14
9087769|NCT04860258|10152114|FG000|STARTED|Overall Study||1
9087770|NCT04860258|10152115|FG001|STARTED|Overall Study||1
9087771|NCT04860258|10152116|FG002|STARTED|Overall Study||52
9087772|NCT04860258|10152117|FG003|STARTED|Overall Study||33
9087773|NCT04860258|10152118|FG004|STARTED|Overall Study||33
9087774|NCT04860258|10152119|FG005|STARTED|Overall Study||7
9087775|NCT04860258|10152120|FG006|STARTED|Overall Study||2
9087776|NCT04860258|10152114|FG000|COMPLETED|Overall Study||1
9087777|NCT04860258|10152115|FG001|COMPLETED|Overall Study||1
9087778|NCT04860258|10152116|FG002|COMPLETED|Overall Study||48
9087779|NCT04860258|10152117|FG003|COMPLETED|Overall Study||32
9087780|NCT04860258|10152118|FG004|COMPLETED|Overall Study||29
9087781|NCT04860258|10152119|FG005|COMPLETED|Overall Study||6
9087782|NCT04860258|10152120|FG006|COMPLETED|Overall Study||2
9087783|NCT04860258|10152114|FG000|NOT COMPLETED|Overall Study||0
9087784|NCT04860258|10152115|FG001|NOT COMPLETED|Overall Study||0
9087785|NCT04860258|10152116|FG002|NOT COMPLETED|Overall Study||4
9087786|NCT04860258|10152117|FG003|NOT COMPLETED|Overall Study||1
9087787|NCT04860258|10152118|FG004|NOT COMPLETED|Overall Study||4
9087788|NCT04860258|10152119|FG005|NOT COMPLETED|Overall Study||1
9087789|NCT04860258|10152120|FG006|NOT COMPLETED|Overall Study||0
9087790|NCT04428645|10152136|FG000|STARTED|Run in Visit Training (2 Hours)||25
9087791|NCT04428645|10152136|FG000|COMPLETED|Run in Visit Training (2 Hours)||25
9087792|NCT04428645|10152136|FG000|NOT COMPLETED|Run in Visit Training (2 Hours)||0
9087793|NCT04428645|10152136|FG000|STARTED|First at Home Period (~2 Weeks)||25
9087794|NCT04428645|10152136|FG000|COMPLETED|First at Home Period (~2 Weeks)||25
9087795|NCT04428645|10152136|FG000|NOT COMPLETED|First at Home Period (~2 Weeks)||0
9087796|NCT04428645|10152136|FG000|STARTED|DailyDose Training Visit (2 Hours)||25
9087797|NCT04428645|10152136|FG000|COMPLETED|DailyDose Training Visit (2 Hours)||25
9087798|NCT04428645|10152136|FG000|NOT COMPLETED|DailyDose Training Visit (2 Hours)||0
9087799|NCT04428645|10152136|FG000|STARTED|Second at Home Period (8 Weeks)||25
9087800|NCT04428645|10152136|FG000|COMPLETED|Second at Home Period (8 Weeks)||24
9087801|NCT04428645|10152136|FG000|NOT COMPLETED|Second at Home Period (8 Weeks)||1
9087802|NCT04428645|10152136|FG000|STARTED|Study Close-out Visit (30 Minutes)||24
9087803|NCT04428645|10152136|FG000|COMPLETED|Study Close-out Visit (30 Minutes)||24
9087804|NCT04428645|10152136|FG000|NOT COMPLETED|Study Close-out Visit (30 Minutes)||0
9087805|NCT04318210|10152140|FG000|STARTED|Overall Study||229
9087806|NCT04318210|10152140|FG000|COMPLETED|Overall Study||153
9087807|NCT04318210|10152140|FG000|NOT COMPLETED|Overall Study||76
9087808|NCT04237207|10152146|FG000|STARTED|Overall Study|Due to differences in speed of enrollment between the two cohorts and the delay in enrollment due to the Coronavirus (COVID-19) pandemic, enrollment for the electric only cohort was capped at 10 subjects, which exceeds the minimum sample size of 8 subjects per cohort.|10
9087809|NCT04237207|10152147|FG001|STARTED|Overall Study||12
9087810|NCT04237207|10152146|FG000|COMPLETED|Overall Study||10
9087811|NCT04237207|10152147|FG001|COMPLETED|Overall Study||12
9087812|NCT04237207|10152146|FG000|NOT COMPLETED|Overall Study||0
9087813|NCT04237207|10152147|FG001|NOT COMPLETED|Overall Study||0
9087814|NCT03787303|10152153|FG000|STARTED|Overall Study||7
9087815|NCT03787303|10152153|FG000|COMPLETED|Overall Study||5
9087816|NCT03787303|10152153|FG000|NOT COMPLETED|Overall Study||2
9087817|NCT03702283|10152157|FG000|STARTED|Overall Study|Recruitment and observation began on March 31, 2019|205
9087818|NCT03702283|10152157|FG000|COMPLETED|Overall Study|Recruitment and observation ended on March 31, 2021|205
9087819|NCT03702283|10152157|FG000|NOT COMPLETED|Overall Study||0
9087820|NCT03673098|10152163|FG000|STARTED|Overall Study||23
9087821|NCT03673098|10152164|FG001|STARTED|Overall Study||21
9087822|NCT03673098|10152163|FG000|COMPLETED|Overall Study||13
9087823|NCT03673098|10152164|FG001|COMPLETED|Overall Study||17
9087824|NCT03673098|10152163|FG000|NOT COMPLETED|Overall Study||10
9087825|NCT03673098|10152164|FG001|NOT COMPLETED|Overall Study||4
9087826|NCT03654651|10152179|FG000|STARTED|First Intervention (6 Weeks)||26
9087827|NCT03654651|10152180|FG001|STARTED|First Intervention (6 Weeks)||25
9087828|NCT03654651|10152179|FG000|COMPLETED|First Intervention (6 Weeks)||25
9087829|NCT03654651|10152180|FG001|COMPLETED|First Intervention (6 Weeks)||25
9087830|NCT03654651|10152179|FG000|NOT COMPLETED|First Intervention (6 Weeks)||1
9087831|NCT03654651|10152180|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0
9087832|NCT03654651|10152179|FG000|STARTED|Washout Period (2-weeks)||25
9087833|NCT03654651|10152180|FG001|STARTED|Washout Period (2-weeks)||25
9087834|NCT03654651|10152179|FG000|COMPLETED|Washout Period (2-weeks)||25
9087835|NCT03654651|10152180|FG001|COMPLETED|Washout Period (2-weeks)||25
9087836|NCT03654651|10152179|FG000|NOT COMPLETED|Washout Period (2-weeks)||0
9087837|NCT03654651|10152180|FG001|NOT COMPLETED|Washout Period (2-weeks)||0
9087838|NCT03654651|10152179|FG000|STARTED|Second Intervention (6 Weeks)||25
9087839|NCT03654651|10152180|FG001|STARTED|Second Intervention (6 Weeks)||25
9087840|NCT03654651|10152179|FG000|COMPLETED|Second Intervention (6 Weeks)||25
9087841|NCT03654651|10152180|FG001|COMPLETED|Second Intervention (6 Weeks)||25
9087842|NCT03654651|10152179|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
9087843|NCT03654651|10152180|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0
9087844|NCT03525678|10152190|FG000|STARTED|Overall Study||97
9087845|NCT03525678|10152191|FG001|STARTED|Overall Study||99
9087846|NCT03525678|10152192|FG002|STARTED|Overall Study||25
9087847|NCT03525678|10152190|FG000|Received Study Treatment|Overall Study||95
9087848|NCT03525678|10152191|FG001|Received Study Treatment|Overall Study||99
9087849|NCT03525678|10152192|FG002|Received Study Treatment|Overall Study||24
8556758|NCT04870138|9588548|FG002|COMPLETED|Overall Study||6
9087850|NCT03525678|10152190|FG000|COMPLETED|Overall Study||0
9087851|NCT03525678|10152191|FG001|COMPLETED|Overall Study||0
9087852|NCT03525678|10152192|FG002|COMPLETED|Overall Study||0
9087853|NCT03525678|10152190|FG000|NOT COMPLETED|Overall Study||97
9087854|NCT03525678|10152191|FG001|NOT COMPLETED|Overall Study||99
9087855|NCT03525678|10152192|FG002|NOT COMPLETED|Overall Study||25
9087856|NCT03520569|10152200|FG000|STARTED|Overall Study||15
9087857|NCT03520569|10152200|FG000|Octreotide-Euglycemia|Overall Study||13
9087858|NCT03520569|10152200|FG000|Octreotide-Euglycemia-Insulin Clamp|Overall Study||14
9087859|NCT03520569|10152200|FG000|Octreotide-Hyperglycemia|Overall Study||10
9087860|NCT03520569|10152200|FG000|Octreotide-Hyperglycemia-Insulin Clamp|Overall Study||12
9087861|NCT03520569|10152200|FG000|COMPLETED|Overall Study||14
9087862|NCT03520569|10152200|FG000|NOT COMPLETED|Overall Study||1
9087863|NCT03499899|10152213|FG000|STARTED|Overall Study||20
9087864|NCT03499899|10152214|FG001|STARTED|Overall Study||34
9087865|NCT03499899|10152215|FG002|STARTED|Overall Study||34
9087866|NCT03499899|10152213|FG000|COMPLETED|Overall Study||0
9087867|NCT03499899|10152214|FG001|COMPLETED|Overall Study||0
9087868|NCT03499899|10152215|FG002|COMPLETED|Overall Study||0
9087869|NCT03499899|10152213|FG000|NOT COMPLETED|Overall Study||20
9087870|NCT03499899|10152214|FG001|NOT COMPLETED|Overall Study||34
9087871|NCT03499899|10152215|FG002|NOT COMPLETED|Overall Study||34
9087872|NCT03462563|10152225|FG000|STARTED|Overall Study||94
9087873|NCT03462563|10152226|FG001|STARTED|Overall Study||81
9087874|NCT03462563|10152225|FG000|COMPLETED|Overall Study||79
9087875|NCT03462563|10152226|FG001|COMPLETED|Overall Study||64
9087876|NCT03462563|10152225|FG000|NOT COMPLETED|Overall Study||15
9087877|NCT03462563|10152226|FG001|NOT COMPLETED|Overall Study||17
9087878|NCT03419741|10152234|FG000|STARTED|Overall Study||5
9087879|NCT03419741|10152235|FG001|STARTED|Overall Study||6
9087880|NCT03419741|10152234|FG000|Treated|Overall Study||4
9087881|NCT03419741|10152235|FG001|Treated|Overall Study||4
9087882|NCT03419741|10152234|FG000|COMPLETED|Overall Study||3
9087883|NCT03419741|10152235|FG001|COMPLETED|Overall Study||4
9087884|NCT03419741|10152234|FG000|NOT COMPLETED|Overall Study||2
9087885|NCT03419741|10152235|FG001|NOT COMPLETED|Overall Study||2
9087886|NCT03401918|10152243|FG000|STARTED|Overall Study||25
9087887|NCT03401918|10152244|FG001|STARTED|Overall Study||16
9087888|NCT03401918|10152243|FG000|COMPLETED|Overall Study||25
9087889|NCT03401918|10152244|FG001|COMPLETED|Overall Study||16
9087890|NCT03401918|10152243|FG000|NOT COMPLETED|Overall Study||0
9087891|NCT03401918|10152244|FG001|NOT COMPLETED|Overall Study||0
9087892|NCT02759185|10152254|FG000|STARTED|Stage 1||20
9087893|NCT02759185|10152255|FG001|STARTED|Stage 1||20
9087894|NCT02759185|10152256|FG002|STARTED|Stage 1||20
9087895|NCT02759185|10152257|FG003|STARTED|Stage 1||20
9087896|NCT02759185|10152258|FG004|STARTED|Stage 1||0
9087897|NCT02759185|10152259|FG005|STARTED|Stage 1||0
9087898|NCT02759185|10152260|FG006|STARTED|Stage 1||0
9087899|NCT02759185|10152254|FG000|COMPLETED|Stage 1||19
9087900|NCT02759185|10152255|FG001|COMPLETED|Stage 1||19
9087901|NCT02759185|10152256|FG002|COMPLETED|Stage 1||17
9087902|NCT02759185|10152257|FG003|COMPLETED|Stage 1||20
9087903|NCT02759185|10152258|FG004|COMPLETED|Stage 1||0
9087904|NCT02759185|10152259|FG005|COMPLETED|Stage 1||0
9087905|NCT02759185|10152260|FG006|COMPLETED|Stage 1||0
9087906|NCT02759185|10152254|FG000|NOT COMPLETED|Stage 1||1
9087907|NCT02759185|10152255|FG001|NOT COMPLETED|Stage 1||1
9087908|NCT02759185|10152256|FG002|NOT COMPLETED|Stage 1||3
9087909|NCT02759185|10152257|FG003|NOT COMPLETED|Stage 1||0
9087910|NCT02759185|10152258|FG004|NOT COMPLETED|Stage 1||0
9087911|NCT02759185|10152259|FG005|NOT COMPLETED|Stage 1||0
9087912|NCT02759185|10152260|FG006|NOT COMPLETED|Stage 1||0
9087913|NCT02759185|10152254|FG000|STARTED|Stage 2||0
9087914|NCT02759185|10152255|FG001|STARTED|Stage 2||0
9087915|NCT02759185|10152256|FG002|STARTED|Stage 2||0
9087916|NCT02759185|10152257|FG003|STARTED|Stage 2||0
9087917|NCT02759185|10152258|FG004|STARTED|Stage 2||29
9087918|NCT02759185|10152259|FG005|STARTED|Stage 2||27
9087919|NCT02759185|10152260|FG006|STARTED|Stage 2||18
9087920|NCT02759185|10152254|FG000|COMPLETED|Stage 2||0
9087921|NCT02759185|10152255|FG001|COMPLETED|Stage 2||0
9087922|NCT02759185|10152256|FG002|COMPLETED|Stage 2||0
9087923|NCT02759185|10152257|FG003|COMPLETED|Stage 2||0
9087924|NCT02759185|10152258|FG004|COMPLETED|Stage 2||27
9087925|NCT02759185|10152259|FG005|COMPLETED|Stage 2||24
9087926|NCT02759185|10152260|FG006|COMPLETED|Stage 2||17
9087927|NCT02759185|10152254|FG000|NOT COMPLETED|Stage 2||0
9087928|NCT02759185|10152255|FG001|NOT COMPLETED|Stage 2||0
9087929|NCT02759185|10152256|FG002|NOT COMPLETED|Stage 2||0
9087930|NCT02759185|10152257|FG003|NOT COMPLETED|Stage 2||0
9087931|NCT02759185|10152258|FG004|NOT COMPLETED|Stage 2||2
9087932|NCT02759185|10152259|FG005|NOT COMPLETED|Stage 2||3
9087933|NCT02759185|10152260|FG006|NOT COMPLETED|Stage 2||1
9087934|NCT02704156|10152284|FG000|STARTED|Overall Study||85
9087935|NCT02704156|10152285|FG001|STARTED|Overall Study||85
9087936|NCT02704156|10152284|FG000|COMPLETED|Overall Study||85
9087937|NCT02704156|10152285|FG001|COMPLETED|Overall Study||85
9087938|NCT02704156|10152284|FG000|NOT COMPLETED|Overall Study||0
9087939|NCT02704156|10152285|FG001|NOT COMPLETED|Overall Study||0
9087940|NCT02688530|10152295|FG000|STARTED|Overall Study||35
9087941|NCT02688530|10152296|FG001|STARTED|Overall Study||35
9087942|NCT02688530|10152297|FG002|STARTED|Overall Study||35
9087943|NCT02688530|10152298|FG003|STARTED|Overall Study||35
9087944|NCT02688530|10152295|FG000|COMPLETED|Overall Study||35
9087945|NCT02688530|10152296|FG001|COMPLETED|Overall Study||34
9087946|NCT02688530|10152297|FG002|COMPLETED|Overall Study||33
9087947|NCT02688530|10152298|FG003|COMPLETED|Overall Study||35
9087948|NCT02688530|10152295|FG000|NOT COMPLETED|Overall Study||0
9087949|NCT02688530|10152296|FG001|NOT COMPLETED|Overall Study||1
9087950|NCT02688530|10152297|FG002|NOT COMPLETED|Overall Study||2
9087951|NCT02688530|10152298|FG003|NOT COMPLETED|Overall Study||0
9087952|NCT02657434|10152314|FG000|STARTED|Overall Study||286
9087953|NCT02657434|10152315|FG001|STARTED|Overall Study||292
9087954|NCT02657434|10152314|FG000|COMPLETED|Overall Study||0
9087955|NCT02657434|10152315|FG001|COMPLETED|Overall Study||0
9087956|NCT02657434|10152314|FG000|NOT COMPLETED|Overall Study||286
9087957|NCT02657434|10152315|FG001|NOT COMPLETED|Overall Study||292
9087958|NCT02421939|10152324|FG000|STARTED|Overall Study||247
9087959|NCT02421939|10152325|FG001|STARTED|Overall Study||124
9087960|NCT02421939|10152324|FG000|Treated|Overall Study||246
9087961|NCT02421939|10152325|FG001|Treated|Overall Study||109
9087962|NCT02421939|10152324|FG000|COMPLETED|Overall Study||38
9087963|NCT02421939|10152325|FG001|COMPLETED|Overall Study||0
9087964|NCT02421939|10152324|FG000|NOT COMPLETED|Overall Study||209
9087965|NCT02421939|10152325|FG001|NOT COMPLETED|Overall Study||124
9087966|NCT02383966|10152333|FG000|STARTED|Overall Study||164
9087967|NCT02383966|10152334|FG001|STARTED|Overall Study||79
9087968|NCT02383966|10152333|FG000|COMPLETED|Overall Study||138
9087969|NCT02383966|10152334|FG001|COMPLETED|Overall Study||72
9087970|NCT02383966|10152333|FG000|NOT COMPLETED|Overall Study||26
9087971|NCT02383966|10152334|FG001|NOT COMPLETED|Overall Study||7
9087972|NCT02073565|10152342|FG000|STARTED|Intention-To-Treat Subjects-Cohorts AB&C||287
9087973|NCT02073565|10152343|FG001|STARTED|Intention-To-Treat Subjects-Cohorts AB&C||285
9087974|NCT02073565|10152342|FG000|COMPLETED|Intention-To-Treat Subjects-Cohorts AB&C||285
9087975|NCT02073565|10152343|FG001|COMPLETED|Intention-To-Treat Subjects-Cohorts AB&C||279
9087976|NCT02073565|10152342|FG000|NOT COMPLETED|Intention-To-Treat Subjects-Cohorts AB&C||2
9087977|NCT02073565|10152343|FG001|NOT COMPLETED|Intention-To-Treat Subjects-Cohorts AB&C||6
9087978|NCT02073565|10152342|FG000|STARTED|Cohort A||16
9087979|NCT02073565|10152343|FG001|STARTED|Cohort A||14
9087980|NCT02073565|10152342|FG000|COMPLETED|Cohort A||15
9087981|NCT02073565|10152343|FG001|COMPLETED|Cohort A||14
9087982|NCT02073565|10152342|FG000|NOT COMPLETED|Cohort A||1
9087983|NCT02073565|10152343|FG001|NOT COMPLETED|Cohort A||0
9087984|NCT02073565|10152342|FG000|STARTED|Cohort B||54
9087985|NCT02073565|10152343|FG001|STARTED|Cohort B||56
9087986|NCT02073565|10152342|FG000|COMPLETED|Cohort B||53
9087987|NCT02073565|10152343|FG001|COMPLETED|Cohort B||54
9087988|NCT02073565|10152342|FG000|NOT COMPLETED|Cohort B||1
8625037|NCT00505414|9664575|FG002|COMPLETED|Titration Phase||0
8625038|NCT00505414|9664576|FG003|COMPLETED|Titration Phase||32
9087989|NCT02073565|10152343|FG001|NOT COMPLETED|Cohort B||2
9087990|NCT02073565|10152342|FG000|STARTED|Cohort C||217
9087991|NCT02073565|10152343|FG001|STARTED|Cohort C||215
9087992|NCT02073565|10152342|FG000|COMPLETED|Cohort C||217
9087993|NCT02073565|10152343|FG001|COMPLETED|Cohort C||211
9087994|NCT02073565|10152342|FG000|NOT COMPLETED|Cohort C||0
9087995|NCT02073565|10152343|FG001|NOT COMPLETED|Cohort C||4
9087996|NCT02060487|10152352|FG000|STARTED|Overall Study||129
9087997|NCT02060487|10152353|FG001|STARTED|Overall Study||128
9087998|NCT02060487|10152354|FG002|STARTED|Overall Study||128
9087999|NCT02060487|10152352|FG000|COMPLETED|Overall Study||0
9088000|NCT02060487|10152353|FG001|COMPLETED|Overall Study||0
9088001|NCT02060487|10152354|FG002|COMPLETED|Overall Study||0
9088002|NCT02060487|10152352|FG000|NOT COMPLETED|Overall Study||129
9088003|NCT02060487|10152353|FG001|NOT COMPLETED|Overall Study||128
9088004|NCT02060487|10152354|FG002|NOT COMPLETED|Overall Study||128
9088005|NCT00732212|10152366|FG000|STARTED|Overall Study||112
9088006|NCT00732212|10152367|FG001|STARTED|Overall Study||123
9088007|NCT00732212|10152366|FG000|Temporarily Suspended|Overall Study|Study was suspended for a 9 month period by the VA DMC because of slow enrollment, then restarted.|50
9088008|NCT00732212|10152367|FG001|Temporarily Suspended|Overall Study||50
9088009|NCT00732212|10152366|FG000|COMPLETED|Overall Study||112
9088010|NCT00732212|10152367|FG001|COMPLETED|Overall Study||123
9088011|NCT00732212|10152366|FG000|NOT COMPLETED|Overall Study||0
9088012|NCT00732212|10152367|FG001|NOT COMPLETED|Overall Study||0
9088013|NCT00331773|10152399|FG000|STARTED|Overall Study||558
9088014|NCT00331773|10152400|FG001|STARTED|Overall Study||557
9088015|NCT00331773|10152399|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|542
9088016|NCT00331773|10152400|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|550
9088017|NCT00331773|10152399|FG000|NOT COMPLETED|Overall Study||16
9088018|NCT00331773|10152400|FG001|NOT COMPLETED|Overall Study||7
9088019|NCT00321698|10152412|FG000|STARTED|Phase I, Rad Only & Dose 1-3||3
9088020|NCT00321698|10152413|FG001|STARTED|Phase I, Rad Only & Dose 1-3||3
9088021|NCT00321698|10152414|FG002|STARTED|Phase I, Rad Only & Dose 1-3||3
9088022|NCT00321698|10152415|FG003|STARTED|Phase I, Rad Only & Dose 1-3||3
9088023|NCT00321698|10152416|FG004|STARTED|Phase I, Rad Only & Dose 1-3||0
9088024|NCT00321698|10152412|FG000|COMPLETED|Phase I, Rad Only & Dose 1-3||3
9088025|NCT00321698|10152413|FG001|COMPLETED|Phase I, Rad Only & Dose 1-3||3
9088026|NCT00321698|10152414|FG002|COMPLETED|Phase I, Rad Only & Dose 1-3||3
9088027|NCT00321698|10152415|FG003|COMPLETED|Phase I, Rad Only & Dose 1-3||3
9088028|NCT00321698|10152416|FG004|COMPLETED|Phase I, Rad Only & Dose 1-3||0
9088029|NCT00321698|10152412|FG000|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
9088030|NCT00321698|10152413|FG001|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
9088031|NCT00321698|10152414|FG002|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
9088032|NCT00321698|10152415|FG003|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
9088033|NCT00321698|10152416|FG004|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
9088034|NCT00321698|10152412|FG000|STARTED|Phase II, MTD Dose||0
9088035|NCT00321698|10152413|FG001|STARTED|Phase II, MTD Dose||0
8723530|NCT01023711|9771056|FG000|COMPLETED|Overall Study||107
9088036|NCT00321698|10152414|FG002|STARTED|Phase II, MTD Dose||0
9088037|NCT00321698|10152415|FG003|STARTED|Phase II, MTD Dose||0
9088038|NCT00321698|10152416|FG004|STARTED|Phase II, MTD Dose|+1 screen failure|13
9088039|NCT00321698|10152412|FG000|COMPLETED|Phase II, MTD Dose||0
9088040|NCT00321698|10152413|FG001|COMPLETED|Phase II, MTD Dose||0
9088041|NCT00321698|10152414|FG002|COMPLETED|Phase II, MTD Dose||0
9088042|NCT00321698|10152415|FG003|COMPLETED|Phase II, MTD Dose||0
9088043|NCT00321698|10152416|FG004|COMPLETED|Phase II, MTD Dose||13
9088044|NCT00321698|10152412|FG000|NOT COMPLETED|Phase II, MTD Dose||0
9088045|NCT00321698|10152413|FG001|NOT COMPLETED|Phase II, MTD Dose||0
9088046|NCT00321698|10152414|FG002|NOT COMPLETED|Phase II, MTD Dose||0
9088047|NCT00321698|10152415|FG003|NOT COMPLETED|Phase II, MTD Dose||0
9088048|NCT00321698|10152416|FG004|NOT COMPLETED|Phase II, MTD Dose||0
8625039|NCT00505414|9664577|FG004|COMPLETED|Titration Phase||19
8625040|NCT00505414|9664573|FG000|NOT COMPLETED|Titration Phase||0
8625041|NCT00505414|9664574|FG001|NOT COMPLETED|Titration Phase||0
8625042|NCT00505414|9664575|FG002|NOT COMPLETED|Titration Phase||0
8625043|NCT00505414|9664576|FG003|NOT COMPLETED|Titration Phase||30
8625044|NCT00505414|9664577|FG004|NOT COMPLETED|Titration Phase||12
8625045|NCT00505414|9664573|FG000|STARTED|Maintenance Phase|18 of the 19 morphine participants continued with morphine in the maintenance phase.|18
8625046|NCT00505414|9664574|FG001|STARTED|Maintenance Phase|15 of 32 tapentadol titration participants continued with tapentadol in the maintenance phase|15
8625047|NCT00505414|9664575|FG002|STARTED|Maintenance Phase|14 of 32 tapentadol titration participants were treated with placebo in the maintenance phase.|14
8629513|NCT00530790|9669275|FG000|STARTED|Overall Study||35
8629514|NCT00530790|9669275|FG000|COMPLETED|Overall Study||30
8723531|NCT01023711|9771056|FG000|NOT COMPLETED|Overall Study||0
9088049|NCT00788671|10152428|FG000|STARTED|Overall Study||57
9088050|NCT00788671|10152428|FG000|COMPLETED|Overall Study||47
9088051|NCT00788671|10152428|FG000|NOT COMPLETED|Overall Study||10
9088052|NCT00799266|10152434|FG000|STARTED|Overall Study||18
9088053|NCT00799266|10152435|FG001|STARTED|Overall Study||16
9088054|NCT00799266|10152434|FG000|Modified Intention-to-treat (MITT)|Overall Study||17
9088055|NCT00799266|10152435|FG001|Modified Intention-to-treat (MITT)|Overall Study||16
9088056|NCT00799266|10152434|FG000|Safety Set|Overall Study||18
9088057|NCT00799266|10152435|FG001|Safety Set|Overall Study||16
9088058|NCT00799266|10152434|FG000|COMPLETED|Overall Study||15
9088059|NCT00799266|10152435|FG001|COMPLETED|Overall Study||15
9088060|NCT00799266|10152434|FG000|NOT COMPLETED|Overall Study||3
9088061|NCT00799266|10152435|FG001|NOT COMPLETED|Overall Study||1
9088062|NCT00810446|10152441|FG000|STARTED|Overall Study||72
9088063|NCT00810446|10152441|FG000|COMPLETED|Overall Study||72
9088064|NCT00810446|10152441|FG000|NOT COMPLETED|Overall Study||0
9088065|NCT00844480|10152447|FG000|STARTED|Overall Study||8
9088066|NCT00844480|10152448|FG001|STARTED|Overall Study||9
9088067|NCT00844480|10152447|FG000|COMPLETED|Overall Study||6
9088068|NCT00844480|10152448|FG001|COMPLETED|Overall Study||6
9088069|NCT00844480|10152447|FG000|NOT COMPLETED|Overall Study||2
9088070|NCT00844480|10152448|FG001|NOT COMPLETED|Overall Study||3
9088071|NCT00864474|10152454|FG000|STARTED|Overall Study||68
9088072|NCT00864474|10152454|FG000|COMPLETED|Overall Study||68
9088073|NCT00864474|10152454|FG000|NOT COMPLETED|Overall Study||0
9088074|NCT00873366|10152458|FG000|STARTED|Overall Study||77
9088075|NCT00873366|10152458|FG000|COMPLETED|Overall Study||71
9088076|NCT00873366|10152458|FG000|NOT COMPLETED|Overall Study||6
9088077|NCT00923247|10152464|FG000|STARTED|Overall Study||21
9088078|NCT00923247|10152465|FG001|STARTED|Overall Study||1
9088079|NCT00923247|10152464|FG000|COMPLETED|Overall Study||21
9088080|NCT00923247|10152465|FG001|COMPLETED|Overall Study||1
9088081|NCT00923247|10152464|FG000|NOT COMPLETED|Overall Study||0
9088082|NCT00923247|10152465|FG001|NOT COMPLETED|Overall Study||0
8625048|NCT00505414|9664576|FG003|STARTED|Maintenance Phase|29 of 32 participants were treated in the maintenance phase either with placebo or tapentadol|0
8625049|NCT00505414|9664577|FG004|STARTED|Maintenance Phase|18 of 19 participants completing the morphine titration phase were continued on morphine.|0
8625050|NCT00505414|9664573|FG000|Did Not Qualify for Maintenance Phase|Maintenance Phase||0
8625051|NCT00505414|9664574|FG001|Did Not Qualify for Maintenance Phase|Maintenance Phase||0
8625052|NCT00505414|9664575|FG002|Did Not Qualify for Maintenance Phase|Maintenance Phase||0
8625053|NCT00505414|9664576|FG003|Did Not Qualify for Maintenance Phase|Maintenance Phase||3
8625054|NCT00505414|9664577|FG004|Did Not Qualify for Maintenance Phase|Maintenance Phase||1
8625055|NCT00505414|9664573|FG000|COMPLETED|Maintenance Phase||12
8625056|NCT00505414|9664574|FG001|COMPLETED|Maintenance Phase||10
8625057|NCT00505414|9664575|FG002|COMPLETED|Maintenance Phase||6
8625058|NCT00505414|9664576|FG003|COMPLETED|Maintenance Phase||0
8625059|NCT00505414|9664577|FG004|COMPLETED|Maintenance Phase||0
8625060|NCT00505414|9664573|FG000|NOT COMPLETED|Maintenance Phase||6
8625061|NCT00505414|9664574|FG001|NOT COMPLETED|Maintenance Phase||5
8625062|NCT00505414|9664575|FG002|NOT COMPLETED|Maintenance Phase||8
8625063|NCT00505414|9664576|FG003|NOT COMPLETED|Maintenance Phase||0
8625064|NCT00505414|9664577|FG004|NOT COMPLETED|Maintenance Phase||0
8625065|NCT00505518|9664589|FG000|STARTED|Overall Study||9
8625066|NCT00505518|9664589|FG000|COMPLETED|Overall Study||9
8625067|NCT00505518|9664589|FG000|NOT COMPLETED|Overall Study||0
8844742|NCT01711866|9899195|FG000|COMPLETED|Overall Study||79
8844743|NCT01711866|9899195|FG000|NOT COMPLETED|Overall Study||8
8844744|NCT01711918|9899199|FG000|STARTED|Overall Study||9
8844745|NCT01711918|9899199|FG000|COMPLETED|Overall Study||7
8844746|NCT01711918|9899199|FG000|NOT COMPLETED|Overall Study||2
8844747|NCT01711983|9899203|FG000|STARTED|6-Month Clinical Success Evaluation||400
8625068|NCT00505622|9664596|FG000|STARTED|Overall Study||121
8625069|NCT00505622|9664597|FG001|STARTED|Overall Study||108
8625070|NCT00505622|9664598|FG002|STARTED|Overall Study||96
8625071|NCT00505622|9664596|FG000|COMPLETED|Overall Study||0
8625072|NCT00505622|9664597|FG001|COMPLETED|Overall Study||0
8625073|NCT00505622|9664598|FG002|COMPLETED|Overall Study||0
8625074|NCT00505622|9664596|FG000|NOT COMPLETED|Overall Study||121
8625075|NCT00505622|9664597|FG001|NOT COMPLETED|Overall Study||108
8625076|NCT00505622|9664598|FG002|NOT COMPLETED|Overall Study||96
8625077|NCT00505635|9664606|FG000|STARTED|Overall Study||5
8625078|NCT00505635|9664606|FG000|COMPLETED|Overall Study||5
8625079|NCT00505635|9664606|FG000|NOT COMPLETED|Overall Study||0
8625080|NCT00505661|9664610|FG000|STARTED|Overall Study||16
8625081|NCT00505661|9664610|FG000|COMPLETED|Overall Study||12
8625082|NCT00505661|9664610|FG000|NOT COMPLETED|Overall Study||4
8625083|NCT00505687|9664614|FG000|STARTED|Overall Study||186
8625084|NCT00505687|9664614|FG000|COMPLETED|Overall Study||91
8625085|NCT00505687|9664614|FG000|NOT COMPLETED|Overall Study||95
8625086|NCT00505752|9664622|FG000|STARTED|Overall Study||132
8625087|NCT00505752|9664623|FG001|STARTED|Overall Study||128
8625088|NCT00505752|9664624|FG002|STARTED|Overall Study||128
8625089|NCT00505752|9664625|FG003|STARTED|Overall Study||132
9088083|NCT00928226|10152481|FG000|STARTED|Overall Study||20
9088084|NCT00928226|10152482|FG001|STARTED|Overall Study||12
8844748|NCT01711983|9899203|FG000|COMPLETED|6-Month Clinical Success Evaluation||368
9088085|NCT00928226|10152483|FG002|STARTED|Overall Study||12
9088086|NCT00928226|10152484|FG003|STARTED|Overall Study||12
9088087|NCT00928226|10152481|FG000|Strata A: Small Tumor, Resected|Overall Study||6
9088088|NCT00928226|10152482|FG001|Strata A: Small Tumor, Resected|Overall Study||6
9088089|NCT00928226|10152483|FG002|Strata A: Small Tumor, Resected|Overall Study||6
9088090|NCT00928226|10152484|FG003|Strata A: Small Tumor, Resected|Overall Study||6
9088091|NCT00928226|10152481|FG000|Strata B: Small Tumor, Not Resected|Overall Study||5
9088092|NCT00928226|10152482|FG001|Strata B: Small Tumor, Not Resected|Overall Study||0
9088093|NCT00928226|10152483|FG002|Strata B: Small Tumor, Not Resected|Overall Study||0
9088094|NCT00928226|10152484|FG003|Strata B: Small Tumor, Not Resected|Overall Study||0
9088095|NCT00928226|10152481|FG000|Strata C: Large Tumor, Resected|Overall Study||8
9088096|NCT00928226|10152482|FG001|Strata C: Large Tumor, Resected|Overall Study||6
9088097|NCT00928226|10152483|FG002|Strata C: Large Tumor, Resected|Overall Study||6
9088098|NCT00928226|10152484|FG003|Strata C: Large Tumor, Resected|Overall Study||6
9088099|NCT00928226|10152481|FG000|Strata D: Large Tumor, Not Resected|Overall Study||1
9088100|NCT00928226|10152482|FG001|Strata D: Large Tumor, Not Resected|Overall Study||0
9088101|NCT00928226|10152483|FG002|Strata D: Large Tumor, Not Resected|Overall Study||0
9088102|NCT00928226|10152484|FG003|Strata D: Large Tumor, Not Resected|Overall Study||0
9088103|NCT00928226|10152481|FG000|COMPLETED|Overall Study||20
9088104|NCT00928226|10152482|FG001|COMPLETED|Overall Study||12
9088105|NCT00928226|10152483|FG002|COMPLETED|Overall Study||12
9088106|NCT00928226|10152484|FG003|COMPLETED|Overall Study||12
9088107|NCT00928226|10152481|FG000|NOT COMPLETED|Overall Study||0
9088108|NCT00928226|10152482|FG001|NOT COMPLETED|Overall Study||0
9088109|NCT00928226|10152483|FG002|NOT COMPLETED|Overall Study||0
9088110|NCT00928226|10152484|FG003|NOT COMPLETED|Overall Study||0
8948128|NCT02427399|10010458|FG004|NOT COMPLETED|Overall Study||15
8948129|NCT02427477|10010472|FG000|STARTED|Period 1||60
8948130|NCT02427477|10010473|FG001|STARTED|Period 1||60
8948131|NCT02427477|10010472|FG000|COMPLETED|Period 1||59
8948132|NCT02427477|10010473|FG001|COMPLETED|Period 1||60
8948133|NCT02427477|10010472|FG000|NOT COMPLETED|Period 1||1
8948134|NCT02427477|10010473|FG001|NOT COMPLETED|Period 1||0
8948135|NCT02427477|10010472|FG000|STARTED|Period 2||59
8948136|NCT02427477|10010473|FG001|STARTED|Period 2||60
9088111|NCT00930722|10152494|FG000|STARTED|Overall Study||329
9088112|NCT00930722|10152494|FG000|COMPLETED|Overall Study||302
9088113|NCT00930722|10152494|FG000|NOT COMPLETED|Overall Study||27
8625090|NCT00505752|9664622|FG000|COMPLETED|Overall Study||126
8625091|NCT00505752|9664623|FG001|COMPLETED|Overall Study||119
8625092|NCT00505752|9664624|FG002|COMPLETED|Overall Study||120
8625093|NCT00505752|9664625|FG003|COMPLETED|Overall Study||126
8625094|NCT00505752|9664622|FG000|NOT COMPLETED|Overall Study||6
9088114|NCT00940498|10152506|FG000|STARTED|Overall Study||4
9088115|NCT00940498|10152507|FG001|STARTED|Overall Study||4
9088116|NCT00940498|10152508|FG002|STARTED|Overall Study||4
9088117|NCT00940498|10152509|FG003|STARTED|Overall Study||4
9088118|NCT00940498|10152510|FG004|STARTED|Overall Study||43
9088119|NCT00940498|10152511|FG005|STARTED|Overall Study||7
9088120|NCT00940498|10152512|FG006|STARTED|Overall Study||8
9088121|NCT00940498|10152513|FG007|STARTED|Overall Study||4
9088122|NCT00940498|10152506|FG000|COMPLETED|Overall Study||1
9088123|NCT00940498|10152507|FG001|COMPLETED|Overall Study||3
9088124|NCT00940498|10152508|FG002|COMPLETED|Overall Study||1
9088125|NCT00940498|10152509|FG003|COMPLETED|Overall Study||2
9088126|NCT00940498|10152510|FG004|COMPLETED|Overall Study||34
9088127|NCT00940498|10152511|FG005|COMPLETED|Overall Study||6
9088128|NCT00940498|10152512|FG006|COMPLETED|Overall Study||7
9088129|NCT00940498|10152513|FG007|COMPLETED|Overall Study||3
9088130|NCT00940498|10152506|FG000|NOT COMPLETED|Overall Study||3
9088131|NCT00940498|10152507|FG001|NOT COMPLETED|Overall Study||1
9088132|NCT00940498|10152508|FG002|NOT COMPLETED|Overall Study||3
9088133|NCT00940498|10152509|FG003|NOT COMPLETED|Overall Study||2
9088134|NCT00940498|10152510|FG004|NOT COMPLETED|Overall Study||9
9088135|NCT00940498|10152511|FG005|NOT COMPLETED|Overall Study||1
9088136|NCT00940498|10152512|FG006|NOT COMPLETED|Overall Study||1
9088137|NCT00940498|10152513|FG007|NOT COMPLETED|Overall Study||1
9088138|NCT04720547|10152539|FG000|STARTED|Overall Study||6
9088139|NCT04720547|10152540|FG001|STARTED|Overall Study||8
9088140|NCT04720547|10152539|FG000|COMPLETED|Overall Study||6
9088141|NCT04720547|10152540|FG001|COMPLETED|Overall Study||5
9088142|NCT04720547|10152539|FG000|NOT COMPLETED|Overall Study||0
9088143|NCT04720547|10152540|FG001|NOT COMPLETED|Overall Study||3
9088144|NCT04553913|10152546|FG000|STARTED|Overall Study||15
9088145|NCT04553913|10152546|FG000|COMPLETED|Overall Study||9
9088146|NCT04553913|10152546|FG000|NOT COMPLETED|Overall Study||6
9088147|NCT04079452|10152551|FG000|STARTED|Overall Study||15
9088148|NCT04079452|10152551|FG000|COMPLETED|Overall Study||15
9088149|NCT04079452|10152551|FG000|NOT COMPLETED|Overall Study||0
9088150|NCT04009824|10152561|FG000|STARTED|Overall Study||10
9088151|NCT04009824|10152562|FG001|STARTED|Overall Study||10
9088152|NCT04009824|10152563|FG002|STARTED|Overall Study||11
9088153|NCT04009824|10152564|FG003|STARTED|Overall Study||10
9088154|NCT04009824|10152565|FG004|STARTED|Overall Study||10
9088155|NCT04009824|10152561|FG000|COMPLETED|Overall Study||8
9088156|NCT04009824|10152562|FG001|COMPLETED|Overall Study||7
9088157|NCT04009824|10152563|FG002|COMPLETED|Overall Study||6
9088158|NCT04009824|10152564|FG003|COMPLETED|Overall Study||8
9088159|NCT04009824|10152565|FG004|COMPLETED|Overall Study||7
9088160|NCT04009824|10152561|FG000|NOT COMPLETED|Overall Study||2
9088161|NCT04009824|10152562|FG001|NOT COMPLETED|Overall Study||3
9088162|NCT04009824|10152563|FG002|NOT COMPLETED|Overall Study||5
9088163|NCT04009824|10152564|FG003|NOT COMPLETED|Overall Study||2
9088164|NCT04009824|10152565|FG004|NOT COMPLETED|Overall Study||3
9088226|NCT02987959|10152615|FG000|STARTED|Overall Study||6
9088227|NCT02987959|10152615|FG000|COMPLETED|Overall Study||0
9088228|NCT02987959|10152615|FG000|NOT COMPLETED|Overall Study||6
9088229|NCT02985541|10152619|FG000|STARTED|Overall Study||364
9088230|NCT02985541|10152619|FG000|Valid for FAS|Overall Study||362
9088231|NCT02985541|10152619|FG000|Continued Into Year 7 of Mirena Use|Overall Study||305
9088232|NCT02985541|10152619|FG000|Continued Into Year 8 of Mirena Use|Overall Study||243
9088233|NCT02985541|10152619|FG000|COMPLETED|Overall Study||223
9088234|NCT02985541|10152619|FG000|NOT COMPLETED|Overall Study||141
9088235|NCT02960893|10152625|FG000|STARTED|Randomization Phase (8-week)||71
9088236|NCT02960893|10152626|FG001|STARTED|Randomization Phase (8-week)||70
9088237|NCT02960893|10152625|FG000|COMPLETED|Randomization Phase (8-week)||64
9088238|NCT02960893|10152626|FG001|COMPLETED|Randomization Phase (8-week)||68
9088239|NCT02960893|10152625|FG000|NOT COMPLETED|Randomization Phase (8-week)||7
9088240|NCT02960893|10152626|FG001|NOT COMPLETED|Randomization Phase (8-week)||2
9088241|NCT02960893|10152625|FG000|STARTED|Extension Phase (48-week)||64
9088242|NCT02960893|10152626|FG001|STARTED|Extension Phase (48-week)|One participant in placebo arm who completed Randomization Phase did not continue to Extension Phase|67
9088243|NCT02960893|10152625|FG000|COMPLETED|Extension Phase (48-week)||50
9088244|NCT02960893|10152626|FG001|COMPLETED|Extension Phase (48-week)||54
9088245|NCT02960893|10152625|FG000|NOT COMPLETED|Extension Phase (48-week)||14
9088246|NCT02960893|10152626|FG001|NOT COMPLETED|Extension Phase (48-week)||13
9088247|NCT02940522|10152641|FG000|STARTED|Overall Study||59
9088248|NCT02940522|10152642|FG001|STARTED|Overall Study||61
9088249|NCT02940522|10152641|FG000|COMPLETED|Overall Study||57
9088250|NCT02940522|10152642|FG001|COMPLETED|Overall Study||59
9088251|NCT02940522|10152641|FG000|NOT COMPLETED|Overall Study||2
9088252|NCT02940522|10152642|FG001|NOT COMPLETED|Overall Study||2
9088253|NCT02711137|10152663|FG000|STARTED|Overall Study||4
9088254|NCT02711137|10152664|FG001|STARTED|Overall Study||5
9088255|NCT02711137|10152665|FG002|STARTED|Overall Study||8
9088256|NCT02711137|10152666|FG003|STARTED|Overall Study||7
9088257|NCT02711137|10152667|FG004|STARTED|Overall Study||5
9088258|NCT02711137|10152668|FG005|STARTED|Overall Study||1
9088259|NCT02711137|10152669|FG006|STARTED|Overall Study||86
9088260|NCT02711137|10152670|FG007|STARTED|Overall Study||5
9088261|NCT02711137|10152671|FG008|STARTED|Overall Study||1
9088262|NCT02711137|10152672|FG009|STARTED|Overall Study||2
9088263|NCT02711137|10152673|FG010|STARTED|Overall Study||4
9088264|NCT02711137|10152674|FG011|STARTED|Overall Study||3
9088165|NCT03867383|10152579|FG000|STARTED|Overall Study||20
9088166|NCT03867383|10152580|FG001|STARTED|Overall Study||20
9088167|NCT03867383|10152579|FG000|COMPLETED|Overall Study||20
9088168|NCT03867383|10152580|FG001|COMPLETED|Overall Study||20
9088169|NCT03867383|10152579|FG000|NOT COMPLETED|Overall Study||0
9088170|NCT03867383|10152580|FG001|NOT COMPLETED|Overall Study||0
9088171|NCT03449758|10152587|FG000|STARTED|Overall Study||84
9088172|NCT03449758|10152587|FG000|COMPLETED|Overall Study||65
9088173|NCT03449758|10152587|FG000|NOT COMPLETED|Overall Study||19
9088174|NCT03222973|10152594|FG000|STARTED|Part 1 (Week 0 to Week 72)||131
9088175|NCT03222973|10152595|FG001|STARTED|Part 1 (Week 0 to Week 72)||132
9088176|NCT03222973|10152596|FG002|STARTED|Part 1 (Week 0 to Week 72)||0
9088177|NCT03222973|10152597|FG003|STARTED|Part 1 (Week 0 to Week 72)||0
9088178|NCT03222973|10152594|FG000|Intent-to-treat (ITT) Population|Part 1 (Week 0 to Week 72)||131
9088179|NCT03222973|10152595|FG001|Intent-to-treat (ITT) Population|Part 1 (Week 0 to Week 72)||132
9088180|NCT03222973|10152596|FG002|Intent-to-treat (ITT) Population|Part 1 (Week 0 to Week 72)||0
9088181|NCT03222973|10152597|FG003|Intent-to-treat (ITT) Population|Part 1 (Week 0 to Week 72)||0
9088182|NCT03222973|10152594|FG000|Safety Population|Part 1 (Week 0 to Week 72)||131
9088183|NCT03222973|10152595|FG001|Safety Population|Part 1 (Week 0 to Week 72)||132
9088184|NCT03222973|10152596|FG002|Safety Population|Part 1 (Week 0 to Week 72)||0
9088185|NCT03222973|10152597|FG003|Safety Population|Part 1 (Week 0 to Week 72)||0
9088186|NCT03222973|10152594|FG000|COMPLETED|Part 1 (Week 0 to Week 72)||107
9088187|NCT03222973|10152595|FG001|COMPLETED|Part 1 (Week 0 to Week 72)||118
9088188|NCT03222973|10152596|FG002|COMPLETED|Part 1 (Week 0 to Week 72)||0
9088189|NCT03222973|10152597|FG003|COMPLETED|Part 1 (Week 0 to Week 72)||0
9088190|NCT03222973|10152594|FG000|NOT COMPLETED|Part 1 (Week 0 to Week 72)||24
9088191|NCT03222973|10152595|FG001|NOT COMPLETED|Part 1 (Week 0 to Week 72)||14
9088192|NCT03222973|10152596|FG002|NOT COMPLETED|Part 1 (Week 0 to Week 72)||0
9088193|NCT03222973|10152597|FG003|NOT COMPLETED|Part 1 (Week 0 to Week 72)||0
9088194|NCT03222973|10152594|FG000|STARTED|Part 2 (Week 73 to Week 168)||0
9088195|NCT03222973|10152595|FG001|STARTED|Part 2 (Week 73 to Week 168)||0
9088196|NCT03222973|10152596|FG002|STARTED|Part 2 (Week 73 to Week 168)|6 participants who completed Part 1 did not enter Part 2.|101
9088197|NCT03222973|10152597|FG003|STARTED|Part 2 (Week 73 to Week 168)|5 participants who completed Part 1 did not enter Part 2.|113
9088198|NCT03222973|10152594|FG000|ITT Population|Part 2 (Week 73 to Week 168)||0
9088199|NCT03222973|10152595|FG001|ITT Population|Part 2 (Week 73 to Week 168)||0
9088200|NCT03222973|10152596|FG002|ITT Population|Part 2 (Week 73 to Week 168)||100
9088201|NCT03222973|10152597|FG003|ITT Population|Part 2 (Week 73 to Week 168)||113
9088202|NCT03222973|10152594|FG000|Safety Population|Part 2 (Week 73 to Week 168)||0
9088203|NCT03222973|10152595|FG001|Safety Population|Part 2 (Week 73 to Week 168)||0
9088204|NCT03222973|10152596|FG002|Safety Population|Part 2 (Week 73 to Week 168)||100
9088205|NCT03222973|10152597|FG003|Safety Population|Part 2 (Week 73 to Week 168)||113
9088206|NCT03222973|10152594|FG000|COMPLETED|Part 2 (Week 73 to Week 168)||0
9088207|NCT03222973|10152595|FG001|COMPLETED|Part 2 (Week 73 to Week 168)||0
9088208|NCT03222973|10152596|FG002|COMPLETED|Part 2 (Week 73 to Week 168)||0
9088209|NCT03222973|10152597|FG003|COMPLETED|Part 2 (Week 73 to Week 168)||0
9088210|NCT03222973|10152594|FG000|NOT COMPLETED|Part 2 (Week 73 to Week 168)||0
9088211|NCT03222973|10152595|FG001|NOT COMPLETED|Part 2 (Week 73 to Week 168)||0
9088212|NCT03222973|10152596|FG002|NOT COMPLETED|Part 2 (Week 73 to Week 168)||101
9088213|NCT03222973|10152597|FG003|NOT COMPLETED|Part 2 (Week 73 to Week 168)||113
9088214|NCT03187262|10152607|FG000|STARTED|Induction||13
9088215|NCT03187262|10152607|FG000|COMPLETED|Induction||7
9088216|NCT03187262|10152607|FG000|NOT COMPLETED|Induction||6
9088217|NCT03187262|10152607|FG000|STARTED|Consolidation||7
9088218|NCT03187262|10152607|FG000|COMPLETED|Consolidation||2
9088219|NCT03187262|10152607|FG000|NOT COMPLETED|Consolidation||5
9088220|NCT03187262|10152607|FG000|STARTED|Maintenance||2
9088221|NCT03187262|10152607|FG000|COMPLETED|Maintenance||2
9088222|NCT03187262|10152607|FG000|NOT COMPLETED|Maintenance||0
9088223|NCT03137693|10152611|FG000|STARTED|Overall Study||20
9088224|NCT03137693|10152611|FG000|COMPLETED|Overall Study||20
9088225|NCT03137693|10152611|FG000|NOT COMPLETED|Overall Study||0
9088265|NCT02711137|10152675|FG012|STARTED|Overall Study||1
9088266|NCT02711137|10152676|FG013|STARTED|Overall Study||2
9088267|NCT02711137|10152677|FG014|STARTED|Overall Study||3
9088268|NCT02711137|10152663|FG000|COMPLETED|Overall Study||0
9088269|NCT02711137|10152664|FG001|COMPLETED|Overall Study||0
9088270|NCT02711137|10152665|FG002|COMPLETED|Overall Study||0
9088271|NCT02711137|10152666|FG003|COMPLETED|Overall Study||0
9088272|NCT02711137|10152667|FG004|COMPLETED|Overall Study||0
9088273|NCT02711137|10152668|FG005|COMPLETED|Overall Study||0
9088274|NCT02711137|10152669|FG006|COMPLETED|Overall Study||0
9088275|NCT02711137|10152670|FG007|COMPLETED|Overall Study||0
9088276|NCT02711137|10152671|FG008|COMPLETED|Overall Study||0
9088277|NCT02711137|10152672|FG009|COMPLETED|Overall Study||0
9088278|NCT02711137|10152673|FG010|COMPLETED|Overall Study||0
9088279|NCT02711137|10152674|FG011|COMPLETED|Overall Study||0
9088280|NCT02711137|10152675|FG012|COMPLETED|Overall Study||0
9088281|NCT02711137|10152676|FG013|COMPLETED|Overall Study||0
9088282|NCT02711137|10152677|FG014|COMPLETED|Overall Study||0
9088283|NCT02711137|10152663|FG000|NOT COMPLETED|Overall Study||4
9088284|NCT02711137|10152664|FG001|NOT COMPLETED|Overall Study||5
9088285|NCT02711137|10152665|FG002|NOT COMPLETED|Overall Study||8
9088286|NCT02711137|10152666|FG003|NOT COMPLETED|Overall Study||7
9088287|NCT02711137|10152667|FG004|NOT COMPLETED|Overall Study||5
9088288|NCT02711137|10152668|FG005|NOT COMPLETED|Overall Study||1
9088289|NCT02711137|10152669|FG006|NOT COMPLETED|Overall Study||86
9088290|NCT02711137|10152670|FG007|NOT COMPLETED|Overall Study||5
9088291|NCT02711137|10152671|FG008|NOT COMPLETED|Overall Study||1
9088292|NCT02711137|10152672|FG009|NOT COMPLETED|Overall Study||2
9088293|NCT02711137|10152673|FG010|NOT COMPLETED|Overall Study||4
9088294|NCT02711137|10152674|FG011|NOT COMPLETED|Overall Study||3
9088295|NCT02711137|10152675|FG012|NOT COMPLETED|Overall Study||1
9088296|NCT02711137|10152676|FG013|NOT COMPLETED|Overall Study||2
9088297|NCT02711137|10152677|FG014|NOT COMPLETED|Overall Study||3
9088298|NCT02630459|10152718|FG000|STARTED|Double-Blind Treatment Phase (DBTP)||136
9088299|NCT02630459|10152719|FG001|STARTED|Double-Blind Treatment Phase (DBTP)||67
9088300|NCT02630459|10152720|FG002|STARTED|Double-Blind Treatment Phase (DBTP)||135
9088301|NCT02630459|10152721|FG003|STARTED|Double-Blind Treatment Phase (DBTP)||137
9088302|NCT02630459|10152722|FG004|STARTED|Double-Blind Treatment Phase (DBTP)||0
9088303|NCT02630459|10152723|FG005|STARTED|Double-Blind Treatment Phase (DBTP)||0
9088304|NCT02630459|10152724|FG006|STARTED|Double-Blind Treatment Phase (DBTP)||0
9088305|NCT02630459|10152725|FG007|STARTED|Double-Blind Treatment Phase (DBTP)||0
9088306|NCT02630459|10152718|FG000|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||136
9088307|NCT02630459|10152719|FG001|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||66
9088308|NCT02630459|10152720|FG002|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||135
9088309|NCT02630459|10152721|FG003|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||137
9088310|NCT02630459|10152722|FG004|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||0
9088311|NCT02630459|10152723|FG005|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||0
9088312|NCT02630459|10152724|FG006|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||0
9088313|NCT02630459|10152725|FG007|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||0
9088314|NCT02630459|10152718|FG000|COMPLETED|Double-Blind Treatment Phase (DBTP)||133
9088315|NCT02630459|10152719|FG001|COMPLETED|Double-Blind Treatment Phase (DBTP)||65
9088316|NCT02630459|10152720|FG002|COMPLETED|Double-Blind Treatment Phase (DBTP)||130
9088317|NCT02630459|10152721|FG003|COMPLETED|Double-Blind Treatment Phase (DBTP)||134
9088318|NCT02630459|10152722|FG004|COMPLETED|Double-Blind Treatment Phase (DBTP)||0
9088319|NCT02630459|10152723|FG005|COMPLETED|Double-Blind Treatment Phase (DBTP)||0
9088320|NCT02630459|10152724|FG006|COMPLETED|Double-Blind Treatment Phase (DBTP)||0
9088321|NCT02630459|10152725|FG007|COMPLETED|Double-Blind Treatment Phase (DBTP)||0
9088322|NCT02630459|10152718|FG000|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||3
9088323|NCT02630459|10152719|FG001|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||2
9088324|NCT02630459|10152720|FG002|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||5
9088325|NCT02630459|10152721|FG003|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||3
9088326|NCT02630459|10152722|FG004|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||0
9088327|NCT02630459|10152723|FG005|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||0
9088328|NCT02630459|10152724|FG006|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||0
9088329|NCT02630459|10152725|FG007|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||0
9088330|NCT02630459|10152718|FG000|STARTED|Open-Label Treatment Phase (OLTP)||0
9088331|NCT02630459|10152719|FG001|STARTED|Open-Label Treatment Phase (OLTP)||0
9088332|NCT02630459|10152720|FG002|STARTED|Open-Label Treatment Phase (OLTP)||0
9088333|NCT02630459|10152721|FG003|STARTED|Open-Label Treatment Phase (OLTP)||0
9088334|NCT02630459|10152722|FG004|STARTED|Open-Label Treatment Phase (OLTP)||386
9088335|NCT02630459|10152723|FG005|STARTED|Open-Label Treatment Phase (OLTP)||73
9088336|NCT02630459|10152724|FG006|STARTED|Open-Label Treatment Phase (OLTP)||0
9088337|NCT02630459|10152725|FG007|STARTED|Open-Label Treatment Phase (OLTP)||0
9088338|NCT02630459|10152718|FG000|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
9088339|NCT02630459|10152719|FG001|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
9088340|NCT02630459|10152720|FG002|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
9088341|NCT02630459|10152721|FG003|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
9088342|NCT02630459|10152722|FG004|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||270
9088343|NCT02630459|10152723|FG005|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
9088344|NCT02630459|10152724|FG006|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
9088345|NCT02630459|10152725|FG007|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
9088346|NCT02630459|10152718|FG000|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
9088347|NCT02630459|10152719|FG001|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
9088348|NCT02630459|10152720|FG002|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
9088349|NCT02630459|10152721|FG003|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
9088350|NCT02630459|10152722|FG004|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
9088351|NCT02630459|10152723|FG005|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||73
9088352|NCT02630459|10152724|FG006|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
9088353|NCT02630459|10152725|FG007|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
9088354|NCT02630459|10152718|FG000|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
9088355|NCT02630459|10152719|FG001|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
9088356|NCT02630459|10152720|FG002|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
9088357|NCT02630459|10152721|FG003|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
9088358|NCT02630459|10152722|FG004|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||116
9088359|NCT02630459|10152723|FG005|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
9088360|NCT02630459|10152724|FG006|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
9088361|NCT02630459|10152725|FG007|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
9088362|NCT02630459|10152718|FG000|COMPLETED|Open-Label Treatment Phase (OLTP)||0
9088363|NCT02630459|10152719|FG001|COMPLETED|Open-Label Treatment Phase (OLTP)||0
9088364|NCT02630459|10152720|FG002|COMPLETED|Open-Label Treatment Phase (OLTP)||0
9088365|NCT02630459|10152721|FG003|COMPLETED|Open-Label Treatment Phase (OLTP)||0
9088366|NCT02630459|10152722|FG004|COMPLETED|Open-Label Treatment Phase (OLTP)||357
9088367|NCT02630459|10152723|FG005|COMPLETED|Open-Label Treatment Phase (OLTP)||69
9088368|NCT02630459|10152724|FG006|COMPLETED|Open-Label Treatment Phase (OLTP)||0
9088369|NCT02630459|10152725|FG007|COMPLETED|Open-Label Treatment Phase (OLTP)||0
9088370|NCT02630459|10152718|FG000|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||0
9088371|NCT02630459|10152719|FG001|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||0
9088372|NCT02630459|10152720|FG002|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||0
9088373|NCT02630459|10152721|FG003|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||0
9088374|NCT02630459|10152722|FG004|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||29
9088375|NCT02630459|10152723|FG005|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||4
9088376|NCT02630459|10152724|FG006|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||0
9088377|NCT02630459|10152725|FG007|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||0
9088378|NCT02630459|10152718|FG000|STARTED|Optional CHU Sub-Study (During OLTP)||0
9088379|NCT02630459|10152719|FG001|STARTED|Optional CHU Sub-Study (During OLTP)||0
9088380|NCT02630459|10152720|FG002|STARTED|Optional CHU Sub-Study (During OLTP)||0
9088381|NCT02630459|10152721|FG003|STARTED|Optional CHU Sub-Study (During OLTP)||0
9088382|NCT02630459|10152722|FG004|STARTED|Optional CHU Sub-Study (During OLTP)||0
9088383|NCT02630459|10152723|FG005|STARTED|Optional CHU Sub-Study (During OLTP)||0
9088384|NCT02630459|10152724|FG006|STARTED|Optional CHU Sub-Study (During OLTP)||24
9088385|NCT02630459|10152725|FG007|STARTED|Optional CHU Sub-Study (During OLTP)||25
9088386|NCT02630459|10152718|FG000|COMPLETED|Optional CHU Sub-Study (During OLTP)||0
9088387|NCT02630459|10152719|FG001|COMPLETED|Optional CHU Sub-Study (During OLTP)||0
9088388|NCT02630459|10152720|FG002|COMPLETED|Optional CHU Sub-Study (During OLTP)||0
9088389|NCT02630459|10152721|FG003|COMPLETED|Optional CHU Sub-Study (During OLTP)||0
9088390|NCT02630459|10152722|FG004|COMPLETED|Optional CHU Sub-Study (During OLTP)||0
9088391|NCT02630459|10152723|FG005|COMPLETED|Optional CHU Sub-Study (During OLTP)||0
9088392|NCT02630459|10152724|FG006|COMPLETED|Optional CHU Sub-Study (During OLTP)||24
9088393|NCT02630459|10152725|FG007|COMPLETED|Optional CHU Sub-Study (During OLTP)||25
9088394|NCT02630459|10152718|FG000|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
9088395|NCT02630459|10152719|FG001|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
9088396|NCT02630459|10152720|FG002|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
9088397|NCT02630459|10152721|FG003|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
9088398|NCT02630459|10152722|FG004|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
9088399|NCT02630459|10152723|FG005|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
9088400|NCT02630459|10152724|FG006|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
9088401|NCT02630459|10152725|FG007|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
9088402|NCT02586857|10152752|FG000|STARTED|Overall Study||15
9088403|NCT02586857|10152753|FG001|STARTED|Overall Study||9
9088404|NCT02586857|10152752|FG000|Enrolled|Overall Study||15
9088405|NCT02586857|10152753|FG001|Enrolled|Overall Study||9
9088406|NCT02586857|10152752|FG000|Received Study Medication|Overall Study||15
9088407|NCT02586857|10152753|FG001|Received Study Medication|Overall Study||9
9088408|NCT02586857|10152752|FG000|Discontinued Study|Overall Study||14
9088409|NCT02586857|10152753|FG001|Discontinued Study|Overall Study||9
9088410|NCT02586857|10152752|FG000|COMPLETED|Overall Study||14
9088411|NCT02586857|10152753|FG001|COMPLETED|Overall Study||9
9088412|NCT02586857|10152752|FG000|NOT COMPLETED|Overall Study||1
9088413|NCT02586857|10152753|FG001|NOT COMPLETED|Overall Study||0
9088414|NCT02575976|10152762|FG000|STARTED|Overall Study||37
9088415|NCT02575976|10152763|FG001|STARTED|Overall Study||39
9088416|NCT02575976|10152764|FG002|STARTED|Overall Study||39
9088417|NCT02575976|10152762|FG000|COMPLETED|Overall Study||32
9088418|NCT02575976|10152763|FG001|COMPLETED|Overall Study||31
9088419|NCT02575976|10152764|FG002|COMPLETED|Overall Study||30
9088420|NCT02575976|10152762|FG000|NOT COMPLETED|Overall Study||5
9088421|NCT02575976|10152763|FG001|NOT COMPLETED|Overall Study||8
9088422|NCT02575976|10152764|FG002|NOT COMPLETED|Overall Study||9
9088423|NCT02545868|10152775|FG000|STARTED|Immunization Study Period (ISP)||33
9088424|NCT02545868|10152776|FG001|STARTED|Immunization Study Period (ISP)||35
9088425|NCT02545868|10152777|FG002|STARTED|Immunization Study Period (ISP)||34
9088426|NCT02545868|10152775|FG000|COMPLETED|Immunization Study Period (ISP)||33
9088427|NCT02545868|10152776|FG001|COMPLETED|Immunization Study Period (ISP)||35
9088428|NCT02545868|10152777|FG002|COMPLETED|Immunization Study Period (ISP)||34
9088429|NCT02545868|10152775|FG000|NOT COMPLETED|Immunization Study Period (ISP)||0
9088430|NCT02545868|10152776|FG001|NOT COMPLETED|Immunization Study Period (ISP)||0
9088431|NCT02545868|10152777|FG002|NOT COMPLETED|Immunization Study Period (ISP)||0
9088432|NCT02545868|10152775|FG000|STARTED|Optional Ocrelizumab Ext (OOE) Period||33
9088433|NCT02545868|10152776|FG001|STARTED|Optional Ocrelizumab Ext (OOE) Period||35
9088434|NCT02545868|10152777|FG002|STARTED|Optional Ocrelizumab Ext (OOE) Period||34
9088435|NCT02545868|10152775|FG000|COMPLETED|Optional Ocrelizumab Ext (OOE) Period||0
9088436|NCT02545868|10152776|FG001|COMPLETED|Optional Ocrelizumab Ext (OOE) Period||0
9088437|NCT02545868|10152777|FG002|COMPLETED|Optional Ocrelizumab Ext (OOE) Period||0
9088438|NCT02545868|10152775|FG000|NOT COMPLETED|Optional Ocrelizumab Ext (OOE) Period||33
9088439|NCT02545868|10152776|FG001|NOT COMPLETED|Optional Ocrelizumab Ext (OOE) Period||35
9088440|NCT02545868|10152777|FG002|NOT COMPLETED|Optional Ocrelizumab Ext (OOE) Period||34
9088441|NCT02470091|10152792|FG000|STARTED|Overall Study||16
9088442|NCT02470091|10152793|FG001|STARTED|Overall Study||40
9088443|NCT02470091|10152792|FG000|Follow-up Report|Overall Study||1
9088444|NCT02470091|10152793|FG001|Follow-up Report|Overall Study||10
9088445|NCT02470091|10152792|FG000|COMPLETED|Overall Study||15
9088446|NCT02470091|10152793|FG001|COMPLETED|Overall Study||38
9088447|NCT02470091|10152792|FG000|NOT COMPLETED|Overall Study||1
9088448|NCT02470091|10152793|FG001|NOT COMPLETED|Overall Study||2
9088449|NCT02440425|10152801|FG000|STARTED|Overall Study||42
9088450|NCT02440425|10152801|FG000|COMPLETED|Overall Study||37
9088451|NCT02440425|10152801|FG000|NOT COMPLETED|Overall Study||5
9088452|NCT02343120|10152810|FG000|STARTED|Part 1: Dose Escalation||3
9088453|NCT02343120|10152811|FG001|STARTED|Part 1: Dose Escalation||4
9088454|NCT02343120|10152812|FG002|STARTED|Part 1: Dose Escalation||5
9088455|NCT02343120|10152813|FG003|STARTED|Part 1: Dose Escalation||4
9088456|NCT02343120|10152814|FG004|STARTED|Part 1: Dose Escalation||1
9088457|NCT02343120|10152810|FG000|COMPLETED|Part 1: Dose Escalation||0
9088458|NCT02343120|10152811|FG001|COMPLETED|Part 1: Dose Escalation||0
9088459|NCT02343120|10152812|FG002|COMPLETED|Part 1: Dose Escalation||0
9088460|NCT02343120|10152813|FG003|COMPLETED|Part 1: Dose Escalation||0
9088461|NCT02343120|10152814|FG004|COMPLETED|Part 1: Dose Escalation||0
9088462|NCT02343120|10152810|FG000|NOT COMPLETED|Part 1: Dose Escalation||3
9088463|NCT02343120|10152811|FG001|NOT COMPLETED|Part 1: Dose Escalation||4
9088464|NCT02343120|10152812|FG002|NOT COMPLETED|Part 1: Dose Escalation||5
9088465|NCT02343120|10152813|FG003|NOT COMPLETED|Part 1: Dose Escalation||4
9088466|NCT02343120|10152814|FG004|NOT COMPLETED|Part 1: Dose Escalation||1
9088467|NCT02343120|10152810|FG000|STARTED|Part 2: Expansion||0
9088468|NCT02343120|10152811|FG001|STARTED|Part 2: Expansion||0
9088469|NCT02343120|10152812|FG002|STARTED|Part 2: Expansion||0
9088470|NCT02343120|10152813|FG003|STARTED|Part 2: Expansion||274
9088471|NCT02343120|10152814|FG004|STARTED|Part 2: Expansion||94
9088472|NCT02343120|10152810|FG000|COMPLETED|Part 2: Expansion||0
9088473|NCT02343120|10152811|FG001|COMPLETED|Part 2: Expansion||0
9088474|NCT02343120|10152812|FG002|COMPLETED|Part 2: Expansion||0
9088475|NCT02343120|10152813|FG003|COMPLETED|Part 2: Expansion||0
9088476|NCT02343120|10152814|FG004|COMPLETED|Part 2: Expansion||0
9088477|NCT02343120|10152810|FG000|NOT COMPLETED|Part 2: Expansion||0
9088478|NCT02343120|10152811|FG001|NOT COMPLETED|Part 2: Expansion||0
9088479|NCT02343120|10152812|FG002|NOT COMPLETED|Part 2: Expansion||0
9088480|NCT02343120|10152813|FG003|NOT COMPLETED|Part 2: Expansion||274
9088481|NCT02343120|10152814|FG004|NOT COMPLETED|Part 2: Expansion||94
9088482|NCT02066415|10152836|FG000|STARTED|Overall Study||286
9088483|NCT02066415|10152837|FG001|STARTED|Overall Study||191
9088484|NCT02066415|10152838|FG002|STARTED|Overall Study||190
9088485|NCT02066415|10152836|FG000|Received Study Drug|Overall Study||282
9088486|NCT02066415|10152837|FG001|Received Study Drug|Overall Study||190
9088487|NCT02066415|10152838|FG002|Received Study Drug|Overall Study||188
9088488|NCT02066415|10152836|FG000|COMPLETED|Overall Study||265
9088489|NCT02066415|10152837|FG001|COMPLETED|Overall Study||184
9088490|NCT02066415|10152838|FG002|COMPLETED|Overall Study||182
9088491|NCT02066415|10152836|FG000|NOT COMPLETED|Overall Study||21
9088492|NCT02066415|10152837|FG001|NOT COMPLETED|Overall Study||7
9088493|NCT02066415|10152838|FG002|NOT COMPLETED|Overall Study||8
9088494|NCT01952574|10152850|FG000|STARTED|Double-blind Treatment Phase||160
9088495|NCT01952574|10152851|FG001|STARTED|Double-blind Treatment Phase||108
9088496|NCT01952574|10152852|FG002|STARTED|Double-blind Treatment Phase||108
9088497|NCT01952574|10152853|FG003|STARTED|Double-blind Treatment Phase||107
9088498|NCT01952574|10152854|FG004|STARTED|Double-blind Treatment Phase||0
9088499|NCT01952574|10152855|FG005|STARTED|Double-blind Treatment Phase||0
9088500|NCT01952574|10152856|FG006|STARTED|Double-blind Treatment Phase||0
9088501|NCT01952574|10152850|FG000|Received Study Drug|Double-blind Treatment Phase||153
9088502|NCT01952574|10152851|FG001|Received Study Drug|Double-blind Treatment Phase||108
9088503|NCT01952574|10152852|FG002|Received Study Drug|Double-blind Treatment Phase||105
9088504|NCT01952574|10152853|FG003|Received Study Drug|Double-blind Treatment Phase||106
9088505|NCT01952574|10152854|FG004|Received Study Drug|Double-blind Treatment Phase||0
9088506|NCT01952574|10152855|FG005|Received Study Drug|Double-blind Treatment Phase||0
9088507|NCT01952574|10152856|FG006|Received Study Drug|Double-blind Treatment Phase||0
9088508|NCT01952574|10152850|FG000|COMPLETED|Double-blind Treatment Phase||143
9088509|NCT01952574|10152851|FG001|COMPLETED|Double-blind Treatment Phase||105
9088510|NCT01952574|10152852|FG002|COMPLETED|Double-blind Treatment Phase||99
9088511|NCT01952574|10152853|FG003|COMPLETED|Double-blind Treatment Phase||101
9088512|NCT01952574|10152854|FG004|COMPLETED|Double-blind Treatment Phase||0
9088513|NCT01952574|10152855|FG005|COMPLETED|Double-blind Treatment Phase||0
9088514|NCT01952574|10152856|FG006|COMPLETED|Double-blind Treatment Phase||0
9088515|NCT01952574|10152850|FG000|NOT COMPLETED|Double-blind Treatment Phase||17
9088516|NCT01952574|10152851|FG001|NOT COMPLETED|Double-blind Treatment Phase||3
9088517|NCT01952574|10152852|FG002|NOT COMPLETED|Double-blind Treatment Phase||9
9088518|NCT01952574|10152853|FG003|NOT COMPLETED|Double-blind Treatment Phase||6
9088519|NCT01952574|10152854|FG004|NOT COMPLETED|Double-blind Treatment Phase||0
9088520|NCT01952574|10152855|FG005|NOT COMPLETED|Double-blind Treatment Phase||0
9088521|NCT01952574|10152856|FG006|NOT COMPLETED|Double-blind Treatment Phase||0
9088522|NCT01952574|10152850|FG000|STARTED|Open-label Treatment Phase||0
9088523|NCT01952574|10152851|FG001|STARTED|Open-label Treatment Phase||0
9088524|NCT01952574|10152852|FG002|STARTED|Open-label Treatment Phase||0
9088525|NCT01952574|10152853|FG003|STARTED|Open-label Treatment Phase||0
9088526|NCT01952574|10152854|FG004|STARTED|Open-label Treatment Phase||383
9088527|NCT01952574|10152855|FG005|STARTED|Open-label Treatment Phase||0
9088528|NCT01952574|10152856|FG006|STARTED|Open-label Treatment Phase||0
9088529|NCT01952574|10152850|FG000|Received 70 mg Erenumab|Open-label Treatment Phase||0
9088530|NCT01952574|10152851|FG001|Received 70 mg Erenumab|Open-label Treatment Phase||0
9088531|NCT01952574|10152852|FG002|Received 70 mg Erenumab|Open-label Treatment Phase||0
9088532|NCT01952574|10152853|FG003|Received 70 mg Erenumab|Open-label Treatment Phase||0
9088533|NCT01952574|10152854|FG004|Received 70 mg Erenumab|Open-label Treatment Phase||383
9088534|NCT01952574|10152855|FG005|Received 70 mg Erenumab|Open-label Treatment Phase||0
9088535|NCT01952574|10152856|FG006|Received 70 mg Erenumab|Open-label Treatment Phase||0
9088536|NCT01952574|10152850|FG000|Received 140 mg Erenumab|Open-label Treatment Phase||0
9088537|NCT01952574|10152851|FG001|Received 140 mg Erenumab|Open-label Treatment Phase||0
9088538|NCT01952574|10152852|FG002|Received 140 mg Erenumab|Open-label Treatment Phase||0
9088539|NCT01952574|10152853|FG003|Received 140 mg Erenumab|Open-label Treatment Phase||0
9088540|NCT01952574|10152854|FG004|Received 140 mg Erenumab|Open-label Treatment Phase||250
9088541|NCT01952574|10152855|FG005|Received 140 mg Erenumab|Open-label Treatment Phase||0
9088542|NCT01952574|10152856|FG006|Received 140 mg Erenumab|Open-label Treatment Phase||0
9088543|NCT01952574|10152850|FG000|COMPLETED|Open-label Treatment Phase||0
9088544|NCT01952574|10152851|FG001|COMPLETED|Open-label Treatment Phase||0
9088545|NCT01952574|10152852|FG002|COMPLETED|Open-label Treatment Phase||0
9088546|NCT01952574|10152853|FG003|COMPLETED|Open-label Treatment Phase||0
9088547|NCT01952574|10152854|FG004|COMPLETED|Open-label Treatment Phase||221
9088548|NCT01952574|10152855|FG005|COMPLETED|Open-label Treatment Phase||0
9088549|NCT01952574|10152856|FG006|COMPLETED|Open-label Treatment Phase||0
9088550|NCT01952574|10152850|FG000|NOT COMPLETED|Open-label Treatment Phase||0
9088551|NCT01952574|10152851|FG001|NOT COMPLETED|Open-label Treatment Phase||0
9088552|NCT01952574|10152852|FG002|NOT COMPLETED|Open-label Treatment Phase||0
9088553|NCT01952574|10152853|FG003|NOT COMPLETED|Open-label Treatment Phase||0
9088554|NCT01952574|10152854|FG004|NOT COMPLETED|Open-label Treatment Phase||162
9088555|NCT01952574|10152855|FG005|NOT COMPLETED|Open-label Treatment Phase||0
9088556|NCT01952574|10152856|FG006|NOT COMPLETED|Open-label Treatment Phase||0
9088557|NCT01952574|10152850|FG000|STARTED|Clinical Home Use Substudy||0
9088558|NCT01952574|10152851|FG001|STARTED|Clinical Home Use Substudy||0
9088559|NCT01952574|10152852|FG002|STARTED|Clinical Home Use Substudy||0
9088560|NCT01952574|10152853|FG003|STARTED|Clinical Home Use Substudy||0
9088561|NCT01952574|10152854|FG004|STARTED|Clinical Home Use Substudy||0
9088562|NCT01952574|10152855|FG005|STARTED|Clinical Home Use Substudy||42
9088563|NCT01952574|10152856|FG006|STARTED|Clinical Home Use Substudy||41
9088564|NCT01952574|10152850|FG000|COMPLETED|Clinical Home Use Substudy||0
9088565|NCT01952574|10152851|FG001|COMPLETED|Clinical Home Use Substudy||0
9088566|NCT01952574|10152852|FG002|COMPLETED|Clinical Home Use Substudy||0
9088567|NCT01952574|10152853|FG003|COMPLETED|Clinical Home Use Substudy||0
9088568|NCT01952574|10152854|FG004|COMPLETED|Clinical Home Use Substudy||0
9088569|NCT01952574|10152855|FG005|COMPLETED|Clinical Home Use Substudy||39
9088570|NCT01952574|10152856|FG006|COMPLETED|Clinical Home Use Substudy||40
9088571|NCT01952574|10152850|FG000|NOT COMPLETED|Clinical Home Use Substudy||0
9088572|NCT01952574|10152851|FG001|NOT COMPLETED|Clinical Home Use Substudy||0
9088573|NCT01952574|10152852|FG002|NOT COMPLETED|Clinical Home Use Substudy||0
9088574|NCT01952574|10152853|FG003|NOT COMPLETED|Clinical Home Use Substudy||0
9088575|NCT01952574|10152854|FG004|NOT COMPLETED|Clinical Home Use Substudy||0
9088576|NCT01952574|10152855|FG005|NOT COMPLETED|Clinical Home Use Substudy||3
9088577|NCT01952574|10152856|FG006|NOT COMPLETED|Clinical Home Use Substudy||1
9088578|NCT01659151|10152881|FG000|STARTED|Overall Study||17
9088579|NCT01659151|10152881|FG000|COMPLETED|Overall Study||16
9088580|NCT01659151|10152881|FG000|NOT COMPLETED|Overall Study||1
9088581|NCT01634048|10152887|FG000|STARTED|Overall Study||21
9088582|NCT01634048|10152888|FG001|STARTED|Overall Study||18
9088583|NCT01634048|10152887|FG000|COMPLETED|Overall Study||15
9088584|NCT01634048|10152888|FG001|COMPLETED|Overall Study||15
9088585|NCT01634048|10152887|FG000|NOT COMPLETED|Overall Study||6
9088586|NCT01634048|10152888|FG001|NOT COMPLETED|Overall Study||3
9088587|NCT01539863|10152896|FG000|STARTED|Overall Study||166
9088588|NCT01539863|10152897|FG001|STARTED|Overall Study||162
9088589|NCT01539863|10152896|FG000|COMPLETED|Overall Study||161
9088590|NCT01539863|10152897|FG001|COMPLETED|Overall Study||158
9088591|NCT01539863|10152896|FG000|NOT COMPLETED|Overall Study||5
9088592|NCT01539863|10152897|FG001|NOT COMPLETED|Overall Study||4
9088593|NCT01505062|10152906|FG000|STARTED|Overall Study||3
9088594|NCT01505062|10152907|FG001|STARTED|Overall Study||3
9088595|NCT01505062|10152908|FG002|STARTED|Overall Study||3
9088596|NCT01505062|10152906|FG000|COMPLETED|Overall Study||3
9088597|NCT01505062|10152907|FG001|COMPLETED|Overall Study||3
9088598|NCT01505062|10152908|FG002|COMPLETED|Overall Study||3
9088599|NCT01505062|10152906|FG000|NOT COMPLETED|Overall Study||0
9088600|NCT01505062|10152907|FG001|NOT COMPLETED|Overall Study||0
9088601|NCT01505062|10152908|FG002|NOT COMPLETED|Overall Study||0
9088602|NCT01439165|10152918|FG000|STARTED|Overall Study||1002
9088603|NCT01439165|10152919|FG001|STARTED|Overall Study||328
9088604|NCT01439165|10152918|FG000|COMPLETED|Overall Study||981
9088605|NCT01439165|10152919|FG001|COMPLETED|Overall Study||326
9088606|NCT01439165|10152918|FG000|NOT COMPLETED|Overall Study||21
9088607|NCT01439165|10152919|FG001|NOT COMPLETED|Overall Study||2
9088608|NCT01264679|10152925|FG000|STARTED|Overall Study||8
9088609|NCT01264679|10152925|FG000|Received at Least 1 Dose of Study Drug|Overall Study||7
9088610|NCT01264679|10152925|FG000|COMPLETED|Overall Study||3
9088611|NCT01264679|10152925|FG000|NOT COMPLETED|Overall Study||5
9088612|NCT01155388|10152932|FG000|STARTED|Overall Study||8
9088613|NCT01155388|10152933|FG001|STARTED|Overall Study||6
9088614|NCT01155388|10152932|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
9088615|NCT01155388|10152933|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
9088616|NCT01155388|10152932|FG000|COMPLETED|Overall Study||7
9088617|NCT01155388|10152933|FG001|COMPLETED|Overall Study||6
9088618|NCT01155388|10152932|FG000|NOT COMPLETED|Overall Study||1
9088619|NCT01155388|10152933|FG001|NOT COMPLETED|Overall Study||0
9088620|NCT01137435|10152940|FG000|STARTED|Overall Study||687
9088621|NCT01137435|10152940|FG000|COMPLETED|Overall Study||659
9088622|NCT01137435|10152940|FG000|NOT COMPLETED|Overall Study||28
9088623|NCT01095003|10152946|FG000|STARTED|Overall Study||384
9088624|NCT01095003|10152947|FG001|STARTED|Overall Study||386
9088625|NCT01095003|10152946|FG000|COMPLETED|Overall Study||0
9088626|NCT01095003|10152947|FG001|COMPLETED|Overall Study||0
9088627|NCT01095003|10152946|FG000|NOT COMPLETED|Overall Study||384
9088628|NCT01095003|10152947|FG001|NOT COMPLETED|Overall Study||386
9088629|NCT01064817|10152957|FG000|STARTED|All Study Treatment Days 1-9||62
9088630|NCT01064817|10152958|FG001|STARTED|All Study Treatment Days 1-9||62
9088631|NCT01064817|10152957|FG000|COMPLETED|All Study Treatment Days 1-9||62
9088632|NCT01064817|10152958|FG001|COMPLETED|All Study Treatment Days 1-9||62
9088633|NCT01064817|10152957|FG000|NOT COMPLETED|All Study Treatment Days 1-9||0
9088634|NCT01064817|10152958|FG001|NOT COMPLETED|All Study Treatment Days 1-9||0
9088635|NCT01064817|10152957|FG000|STARTED|Study Completion||62
9088636|NCT01064817|10152958|FG001|STARTED|Study Completion||62
9088637|NCT01064817|10152957|FG000|COMPLETED|Study Completion||60
9088638|NCT01064817|10152958|FG001|COMPLETED|Study Completion||62
9088639|NCT01064817|10152957|FG000|NOT COMPLETED|Study Completion||2
9088640|NCT01064817|10152958|FG001|NOT COMPLETED|Study Completion||0
9088641|NCT01026220|10152964|FG000|STARTED|Induction||166
9088642|NCT01026220|10152965|FG001|STARTED|Induction||0
9088643|NCT01026220|10152966|FG002|STARTED|Induction||0
9088644|NCT01026220|10152964|FG000|COMPLETED|Induction||141
9088645|NCT01026220|10152965|FG001|COMPLETED|Induction||0
9088646|NCT01026220|10152966|FG002|COMPLETED|Induction||0
9088647|NCT01026220|10152964|FG000|NOT COMPLETED|Induction||25
9088648|NCT01026220|10152965|FG001|NOT COMPLETED|Induction||0
9088649|NCT01026220|10152966|FG002|NOT COMPLETED|Induction||0
9088650|NCT01026220|10152964|FG000|STARTED|Consolidation Maintenance||0
9088651|NCT01026220|10152965|FG001|STARTED|Consolidation Maintenance||81
9088652|NCT01026220|10152966|FG002|STARTED|Consolidation Maintenance||80
9088653|NCT01026220|10152964|FG000|COMPLETED|Consolidation Maintenance||0
9088654|NCT01026220|10152965|FG001|COMPLETED|Consolidation Maintenance||75
9088655|NCT01026220|10152966|FG002|COMPLETED|Consolidation Maintenance||66
9088656|NCT01026220|10152964|FG000|NOT COMPLETED|Consolidation Maintenance||0
9088657|NCT01026220|10152965|FG001|NOT COMPLETED|Consolidation Maintenance||6
9088658|NCT01026220|10152966|FG002|NOT COMPLETED|Consolidation Maintenance||14
9088659|NCT00961714|10152981|FG000|STARTED|Overall Study||15
9088660|NCT00961714|10152981|FG000|COMPLETED|Overall Study||13
9088661|NCT00961714|10152981|FG000|NOT COMPLETED|Overall Study||2
9088662|NCT00567567|10152988|FG000|STARTED|Overall Study||210
9088663|NCT00567567|10152989|FG001|STARTED|Overall Study||176
9088664|NCT00567567|10152990|FG002|STARTED|Overall Study||279
9088665|NCT00567567|10152988|FG000|COMPLETED|Overall Study||58
9088666|NCT00567567|10152989|FG001|COMPLETED|Overall Study||42
9088667|NCT00567567|10152990|FG002|COMPLETED|Overall Study||1
9088668|NCT00567567|10152988|FG000|NOT COMPLETED|Overall Study||152
9088669|NCT00567567|10152989|FG001|NOT COMPLETED|Overall Study||134
9088670|NCT00567567|10152990|FG002|NOT COMPLETED|Overall Study||278
9088671|NCT00450450|10153002|FG000|STARTED|Overall Study||13
9088672|NCT00450450|10153003|FG001|STARTED|Overall Study||14
9088673|NCT00450450|10153002|FG000|COMPLETED|Overall Study||8
9088674|NCT00450450|10153003|FG001|COMPLETED|Overall Study||11
9088675|NCT00450450|10153002|FG000|NOT COMPLETED|Overall Study||5
9088676|NCT00450450|10153003|FG001|NOT COMPLETED|Overall Study||3
9088677|NCT00392821|10153012|FG000|STARTED|Overall Study||3
9088678|NCT00392821|10153013|FG001|STARTED|Overall Study||6
9088679|NCT00392821|10153014|FG002|STARTED|Overall Study||69
9088680|NCT00392821|10153012|FG000|COMPLETED|Overall Study||0
9088681|NCT00392821|10153013|FG001|COMPLETED|Overall Study||0
9088682|NCT00392821|10153014|FG002|COMPLETED|Overall Study||0
9088683|NCT00392821|10153012|FG000|NOT COMPLETED|Overall Study||3
9088684|NCT00392821|10153013|FG001|NOT COMPLETED|Overall Study||6
9088685|NCT00392821|10153014|FG002|NOT COMPLETED|Overall Study||69
9088686|NCT00346164|10153024|FG000|STARTED|Overall Study||222
9088687|NCT00346164|10153025|FG001|STARTED|Overall Study||21
9088688|NCT00346164|10153026|FG002|STARTED|Overall Study||122
9088689|NCT00346164|10153027|FG003|STARTED|Overall Study||223
9088690|NCT00346164|10153024|FG000|COMPLETED|Overall Study||205
9088691|NCT00346164|10153025|FG001|COMPLETED|Overall Study||14
9088692|NCT00346164|10153026|FG002|COMPLETED|Overall Study||96
9088693|NCT00346164|10153027|FG003|COMPLETED|Overall Study||117
9088694|NCT00346164|10153024|FG000|NOT COMPLETED|Overall Study||17
9088695|NCT00346164|10153025|FG001|NOT COMPLETED|Overall Study||7
9088696|NCT00346164|10153026|FG002|NOT COMPLETED|Overall Study||26
9088697|NCT00346164|10153027|FG003|NOT COMPLETED|Overall Study||106
9088698|NCT00972179|10153060|FG000|STARTED|Overall Study||6
9088699|NCT00972179|10153061|FG001|STARTED|Overall Study||6
9088700|NCT00972179|10153062|FG002|STARTED|Overall Study||6
9088701|NCT00972179|10153063|FG003|STARTED|Overall Study||6
9088702|NCT00972179|10153064|FG004|STARTED|Overall Study||7
9088703|NCT00972179|10153065|FG005|STARTED|Overall Study||6
9088704|NCT00972179|10153066|FG006|STARTED|Overall Study||12
9088705|NCT00972179|10153060|FG000|COMPLETED|Overall Study||5
9088706|NCT00972179|10153061|FG001|COMPLETED|Overall Study||3
9088707|NCT00972179|10153062|FG002|COMPLETED|Overall Study||5
9088708|NCT00972179|10153063|FG003|COMPLETED|Overall Study||5
9088709|NCT00972179|10153064|FG004|COMPLETED|Overall Study||5
9088710|NCT00972179|10153065|FG005|COMPLETED|Overall Study||3
9088711|NCT00972179|10153066|FG006|COMPLETED|Overall Study||8
9088712|NCT00972179|10153060|FG000|NOT COMPLETED|Overall Study||1
9088713|NCT00972179|10153061|FG001|NOT COMPLETED|Overall Study||3
9088714|NCT00972179|10153062|FG002|NOT COMPLETED|Overall Study||1
9088715|NCT00972179|10153063|FG003|NOT COMPLETED|Overall Study||1
9088716|NCT00972179|10153064|FG004|NOT COMPLETED|Overall Study||2
9088717|NCT00972179|10153065|FG005|NOT COMPLETED|Overall Study||3
9088718|NCT00972179|10153066|FG006|NOT COMPLETED|Overall Study||4
9088719|NCT01009294|10153086|FG000|STARTED|Overall Study||6
9088720|NCT01009294|10153086|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
9088721|NCT01009294|10153086|FG000|COMPLETED|Overall Study||0
9088722|NCT01009294|10153086|FG000|NOT COMPLETED|Overall Study||6
9088723|NCT01053637|10153092|FG000|STARTED|Overall Study||43
9088724|NCT01053637|10153093|FG001|STARTED|Overall Study||42
9088725|NCT01053637|10153092|FG000|COMPLETED|Overall Study|2 with incomplete pain scores|43
9088726|NCT01053637|10153093|FG001|COMPLETED|Overall Study|4 incomplete pain scores 4 proceeded to procedural sedation|42
9088727|NCT01053637|10153092|FG000|NOT COMPLETED|Overall Study||0
9088728|NCT01053637|10153093|FG001|NOT COMPLETED|Overall Study||0
9088729|NCT01072175|10153111|FG000|STARTED|Part A (Drug-Drug Interaction)||8
9088730|NCT01072175|10153112|FG001|STARTED|Part A (Drug-Drug Interaction)||0
9088731|NCT01072175|10153113|FG002|STARTED|Part A (Drug-Drug Interaction)||0
9088732|NCT01072175|10153114|FG003|STARTED|Part A (Drug-Drug Interaction)||0
9088733|NCT01072175|10153115|FG004|STARTED|Part A (Drug-Drug Interaction)||0
9088734|NCT01072175|10153116|FG005|STARTED|Part A (Drug-Drug Interaction)||0
9088735|NCT01072175|10153117|FG006|STARTED|Part A (Drug-Drug Interaction)||0
9088736|NCT01072175|10153118|FG007|STARTED|Part A (Drug-Drug Interaction)||0
9088737|NCT01072175|10153119|FG008|STARTED|Part A (Drug-Drug Interaction)||0
9088738|NCT01072175|10153120|FG009|STARTED|Part A (Drug-Drug Interaction)||0
9088739|NCT01072175|10153121|FG010|STARTED|Part A (Drug-Drug Interaction)||0
9088740|NCT01072175|10153122|FG011|STARTED|Part A (Drug-Drug Interaction)||0
9088741|NCT01072175|10153123|FG012|STARTED|Part A (Drug-Drug Interaction)||0
9088742|NCT01072175|10153111|FG000|COMPLETED|Part A (Drug-Drug Interaction)||0
9088743|NCT01072175|10153112|FG001|COMPLETED|Part A (Drug-Drug Interaction)||0
9088744|NCT01072175|10153113|FG002|COMPLETED|Part A (Drug-Drug Interaction)||0
9088745|NCT01072175|10153114|FG003|COMPLETED|Part A (Drug-Drug Interaction)||0
9088746|NCT01072175|10153115|FG004|COMPLETED|Part A (Drug-Drug Interaction)||0
9088747|NCT01072175|10153116|FG005|COMPLETED|Part A (Drug-Drug Interaction)||0
9088748|NCT01072175|10153117|FG006|COMPLETED|Part A (Drug-Drug Interaction)||0
9088749|NCT01072175|10153118|FG007|COMPLETED|Part A (Drug-Drug Interaction)||0
9088750|NCT01072175|10153119|FG008|COMPLETED|Part A (Drug-Drug Interaction)||0
9088751|NCT01072175|10153120|FG009|COMPLETED|Part A (Drug-Drug Interaction)||0
9088752|NCT01072175|10153121|FG010|COMPLETED|Part A (Drug-Drug Interaction)||0
9088753|NCT01072175|10153122|FG011|COMPLETED|Part A (Drug-Drug Interaction)||0
9088754|NCT01072175|10153123|FG012|COMPLETED|Part A (Drug-Drug Interaction)||0
9088755|NCT01072175|10153111|FG000|NOT COMPLETED|Part A (Drug-Drug Interaction)||8
9088756|NCT01072175|10153112|FG001|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
9088757|NCT01072175|10153113|FG002|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
9088758|NCT01072175|10153114|FG003|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
9088759|NCT01072175|10153115|FG004|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
9088760|NCT01072175|10153116|FG005|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
9088761|NCT01072175|10153117|FG006|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
9088762|NCT01072175|10153118|FG007|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
9088763|NCT01072175|10153119|FG008|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
9088764|NCT01072175|10153120|FG009|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
9088765|NCT01072175|10153121|FG010|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
8625095|NCT00505752|9664623|FG001|NOT COMPLETED|Overall Study||9
8625096|NCT00505752|9664624|FG002|NOT COMPLETED|Overall Study||8
8625097|NCT00505752|9664625|FG003|NOT COMPLETED|Overall Study||6
8625098|NCT00505765|9664638|FG000|STARTED|Overall Study||21
9088766|NCT01072175|10153122|FG011|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
9088767|NCT01072175|10153123|FG012|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
9088768|NCT01072175|10153111|FG000|STARTED|Part B (Dose Escalation and Expansion)||0
9088769|NCT01072175|10153112|FG001|STARTED|Part B (Dose Escalation and Expansion)||6
9088770|NCT01072175|10153113|FG002|STARTED|Part B (Dose Escalation and Expansion)||23
9088771|NCT01072175|10153114|FG003|STARTED|Part B (Dose Escalation and Expansion)||27
9088772|NCT01072175|10153115|FG004|STARTED|Part B (Dose Escalation and Expansion)||94
9088773|NCT01072175|10153116|FG005|STARTED|Part B (Dose Escalation and Expansion)||0
8625099|NCT00505765|9664639|FG001|STARTED|Overall Study||20
8625100|NCT00505765|9664640|FG002|STARTED|Overall Study||22
8625101|NCT00505765|9664638|FG000|Mid-Point Assessment|Overall Study||20
9088774|NCT01072175|10153117|FG006|STARTED|Part B (Dose Escalation and Expansion)||0
9088775|NCT01072175|10153118|FG007|STARTED|Part B (Dose Escalation and Expansion)||0
9088776|NCT01072175|10153119|FG008|STARTED|Part B (Dose Escalation and Expansion)||0
9088777|NCT01072175|10153120|FG009|STARTED|Part B (Dose Escalation and Expansion)||0
9088778|NCT01072175|10153121|FG010|STARTED|Part B (Dose Escalation and Expansion)||0
9088779|NCT01072175|10153122|FG011|STARTED|Part B (Dose Escalation and Expansion)||0
9088780|NCT01072175|10153123|FG012|STARTED|Part B (Dose Escalation and Expansion)||0
9088781|NCT01072175|10153111|FG000|COMPLETED|Part B (Dose Escalation and Expansion)||0
9088782|NCT01072175|10153112|FG001|COMPLETED|Part B (Dose Escalation and Expansion)||0
9088783|NCT01072175|10153113|FG002|COMPLETED|Part B (Dose Escalation and Expansion)||0
9088784|NCT01072175|10153114|FG003|COMPLETED|Part B (Dose Escalation and Expansion)||0
9088785|NCT01072175|10153115|FG004|COMPLETED|Part B (Dose Escalation and Expansion)||0
9088786|NCT01072175|10153116|FG005|COMPLETED|Part B (Dose Escalation and Expansion)||0
9088787|NCT01072175|10153117|FG006|COMPLETED|Part B (Dose Escalation and Expansion)||0
9088788|NCT01072175|10153118|FG007|COMPLETED|Part B (Dose Escalation and Expansion)||0
9088789|NCT01072175|10153119|FG008|COMPLETED|Part B (Dose Escalation and Expansion)||0
9088790|NCT01072175|10153120|FG009|COMPLETED|Part B (Dose Escalation and Expansion)||0
9088791|NCT01072175|10153121|FG010|COMPLETED|Part B (Dose Escalation and Expansion)||0
9088792|NCT01072175|10153122|FG011|COMPLETED|Part B (Dose Escalation and Expansion)||0
9088793|NCT01072175|10153123|FG012|COMPLETED|Part B (Dose Escalation and Expansion)||0
9088794|NCT01072175|10153111|FG000|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
9088795|NCT01072175|10153112|FG001|NOT COMPLETED|Part B (Dose Escalation and Expansion)||6
9088796|NCT01072175|10153113|FG002|NOT COMPLETED|Part B (Dose Escalation and Expansion)||23
9088797|NCT01072175|10153114|FG003|NOT COMPLETED|Part B (Dose Escalation and Expansion)||27
9088798|NCT01072175|10153115|FG004|NOT COMPLETED|Part B (Dose Escalation and Expansion)||94
9088799|NCT01072175|10153116|FG005|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
9088800|NCT01072175|10153117|FG006|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
9088801|NCT01072175|10153118|FG007|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
9088802|NCT01072175|10153119|FG008|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
9088803|NCT01072175|10153120|FG009|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
9088804|NCT01072175|10153121|FG010|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
9088805|NCT01072175|10153122|FG011|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
9088806|NCT01072175|10153123|FG012|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
9088807|NCT01072175|10153111|FG000|STARTED|Part C (Phase II: Randomized Phase)||0
9088808|NCT01072175|10153112|FG001|STARTED|Part C (Phase II: Randomized Phase)||0
9088809|NCT01072175|10153113|FG002|STARTED|Part C (Phase II: Randomized Phase)||0
9088810|NCT01072175|10153114|FG003|STARTED|Part C (Phase II: Randomized Phase)||0
9088811|NCT01072175|10153115|FG004|STARTED|Part C (Phase II: Randomized Phase)||0
9088812|NCT01072175|10153116|FG005|STARTED|Part C (Phase II: Randomized Phase)||54
9088813|NCT01072175|10153117|FG006|STARTED|Part C (Phase II: Randomized Phase)||54
9088814|NCT01072175|10153118|FG007|STARTED|Part C (Phase II: Randomized Phase)||54
9088815|NCT01072175|10153119|FG008|STARTED|Part C (Phase II: Randomized Phase)||0
9088816|NCT01072175|10153120|FG009|STARTED|Part C (Phase II: Randomized Phase)||0
9088817|NCT01072175|10153121|FG010|STARTED|Part C (Phase II: Randomized Phase)||0
9088818|NCT01072175|10153122|FG011|STARTED|Part C (Phase II: Randomized Phase)||0
9088819|NCT01072175|10153123|FG012|STARTED|Part C (Phase II: Randomized Phase)||0
9088820|NCT01072175|10153111|FG000|COMPLETED|Part C (Phase II: Randomized Phase)||0
9088821|NCT01072175|10153112|FG001|COMPLETED|Part C (Phase II: Randomized Phase)||0
9088822|NCT01072175|10153113|FG002|COMPLETED|Part C (Phase II: Randomized Phase)||0
9088823|NCT01072175|10153114|FG003|COMPLETED|Part C (Phase II: Randomized Phase)||0
9088824|NCT01072175|10153115|FG004|COMPLETED|Part C (Phase II: Randomized Phase)||0
9088825|NCT01072175|10153116|FG005|COMPLETED|Part C (Phase II: Randomized Phase)||0
9088826|NCT01072175|10153117|FG006|COMPLETED|Part C (Phase II: Randomized Phase)||0
8625102|NCT00505765|9664639|FG001|Mid-Point Assessment|Overall Study||19
8625103|NCT00505765|9664640|FG002|Mid-Point Assessment|Overall Study||21
9088827|NCT01072175|10153118|FG007|COMPLETED|Part C (Phase II: Randomized Phase)||0
9088828|NCT01072175|10153119|FG008|COMPLETED|Part C (Phase II: Randomized Phase)||0
9088829|NCT01072175|10153120|FG009|COMPLETED|Part C (Phase II: Randomized Phase)||0
9088830|NCT01072175|10153121|FG010|COMPLETED|Part C (Phase II: Randomized Phase)||0
9088831|NCT01072175|10153122|FG011|COMPLETED|Part C (Phase II: Randomized Phase)||0
9088832|NCT01072175|10153123|FG012|COMPLETED|Part C (Phase II: Randomized Phase)||0
9088833|NCT01072175|10153111|FG000|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
9088834|NCT01072175|10153112|FG001|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
9088835|NCT01072175|10153113|FG002|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
9088836|NCT01072175|10153114|FG003|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
9088837|NCT01072175|10153115|FG004|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
9088838|NCT01072175|10153116|FG005|NOT COMPLETED|Part C (Phase II: Randomized Phase)||54
9088839|NCT01072175|10153117|FG006|NOT COMPLETED|Part C (Phase II: Randomized Phase)||54
9088840|NCT01072175|10153118|FG007|NOT COMPLETED|Part C (Phase II: Randomized Phase)||54
9088841|NCT01072175|10153119|FG008|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
9088842|NCT01072175|10153120|FG009|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
9088843|NCT01072175|10153121|FG010|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
9088844|NCT01072175|10153122|FG011|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
8625104|NCT00505765|9664638|FG000|COMPLETED|Overall Study||19
9088845|NCT01072175|10153123|FG012|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
9088846|NCT01072175|10153111|FG000|STARTED|Part C (Phase II: Crossover Phase [CP])||0
9088847|NCT01072175|10153112|FG001|STARTED|Part C (Phase II: Crossover Phase [CP])||0
9088848|NCT01072175|10153113|FG002|STARTED|Part C (Phase II: Crossover Phase [CP])||0
9088849|NCT01072175|10153114|FG003|STARTED|Part C (Phase II: Crossover Phase [CP])||0
9088850|NCT01072175|10153115|FG004|STARTED|Part C (Phase II: Crossover Phase [CP])||0
9088851|NCT01072175|10153116|FG005|STARTED|Part C (Phase II: Crossover Phase [CP])||0
9088852|NCT01072175|10153117|FG006|STARTED|Part C (Phase II: Crossover Phase [CP])||0
9088853|NCT01072175|10153118|FG007|STARTED|Part C (Phase II: Crossover Phase [CP])||0
9088854|NCT01072175|10153119|FG008|STARTED|Part C (Phase II: Crossover Phase [CP])||45
9088855|NCT01072175|10153120|FG009|STARTED|Part C (Phase II: Crossover Phase [CP])||0
9088856|NCT01072175|10153121|FG010|STARTED|Part C (Phase II: Crossover Phase [CP])||0
9088857|NCT01072175|10153122|FG011|STARTED|Part C (Phase II: Crossover Phase [CP])||0
9088858|NCT01072175|10153123|FG012|STARTED|Part C (Phase II: Crossover Phase [CP])||0
9088859|NCT01072175|10153111|FG000|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
9088860|NCT01072175|10153112|FG001|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
9088861|NCT01072175|10153113|FG002|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
9088862|NCT01072175|10153114|FG003|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
9088863|NCT01072175|10153115|FG004|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
9088864|NCT01072175|10153116|FG005|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
9088865|NCT01072175|10153117|FG006|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
9088866|NCT01072175|10153118|FG007|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
9088867|NCT01072175|10153119|FG008|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
9088868|NCT01072175|10153120|FG009|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
9088869|NCT01072175|10153121|FG010|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
9088870|NCT01072175|10153122|FG011|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
9088871|NCT01072175|10153123|FG012|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
9088872|NCT01072175|10153111|FG000|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
9088873|NCT01072175|10153112|FG001|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
9088874|NCT01072175|10153113|FG002|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
9088875|NCT01072175|10153114|FG003|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
9088876|NCT01072175|10153115|FG004|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
9088877|NCT01072175|10153116|FG005|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
9088878|NCT01072175|10153117|FG006|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
9088879|NCT01072175|10153118|FG007|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
9088880|NCT01072175|10153119|FG008|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||45
9088881|NCT01072175|10153120|FG009|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
9088882|NCT01072175|10153121|FG010|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
9088883|NCT01072175|10153122|FG011|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
9088884|NCT01072175|10153123|FG012|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
9088885|NCT01072175|10153111|FG000|STARTED|Part D (HPMC Capsules)||0
9088886|NCT01072175|10153112|FG001|STARTED|Part D (HPMC Capsules)||0
9088887|NCT01072175|10153113|FG002|STARTED|Part D (HPMC Capsules)||0
9088888|NCT01072175|10153114|FG003|STARTED|Part D (HPMC Capsules)||0
9088889|NCT01072175|10153115|FG004|STARTED|Part D (HPMC Capsules)||0
9088890|NCT01072175|10153116|FG005|STARTED|Part D (HPMC Capsules)||0
9088891|NCT01072175|10153117|FG006|STARTED|Part D (HPMC Capsules)||0
9088892|NCT01072175|10153118|FG007|STARTED|Part D (HPMC Capsules)||0
9088893|NCT01072175|10153119|FG008|STARTED|Part D (HPMC Capsules)||0
9088894|NCT01072175|10153120|FG009|STARTED|Part D (HPMC Capsules)||12
9088895|NCT01072175|10153121|FG010|STARTED|Part D (HPMC Capsules)||16
9088896|NCT01072175|10153122|FG011|STARTED|Part D (HPMC Capsules)||43
9088897|NCT01072175|10153123|FG012|STARTED|Part D (HPMC Capsules)||39
9088898|NCT01072175|10153111|FG000|COMPLETED|Part D (HPMC Capsules)||0
9088899|NCT01072175|10153112|FG001|COMPLETED|Part D (HPMC Capsules)||0
9088900|NCT01072175|10153113|FG002|COMPLETED|Part D (HPMC Capsules)||0
9088901|NCT01072175|10153114|FG003|COMPLETED|Part D (HPMC Capsules)||0
9088902|NCT01072175|10153115|FG004|COMPLETED|Part D (HPMC Capsules)||0
9088903|NCT01072175|10153116|FG005|COMPLETED|Part D (HPMC Capsules)||0
9088904|NCT01072175|10153117|FG006|COMPLETED|Part D (HPMC Capsules)||0
9088905|NCT01072175|10153118|FG007|COMPLETED|Part D (HPMC Capsules)||0
9088906|NCT01072175|10153119|FG008|COMPLETED|Part D (HPMC Capsules)||0
9088907|NCT01072175|10153120|FG009|COMPLETED|Part D (HPMC Capsules)||0
9088908|NCT01072175|10153121|FG010|COMPLETED|Part D (HPMC Capsules)||0
9088909|NCT01072175|10153122|FG011|COMPLETED|Part D (HPMC Capsules)||0
9088910|NCT01072175|10153123|FG012|COMPLETED|Part D (HPMC Capsules)||0
9088911|NCT01072175|10153111|FG000|NOT COMPLETED|Part D (HPMC Capsules)||0
9088912|NCT01072175|10153112|FG001|NOT COMPLETED|Part D (HPMC Capsules)||0
9088913|NCT01072175|10153113|FG002|NOT COMPLETED|Part D (HPMC Capsules)||0
9088914|NCT01072175|10153114|FG003|NOT COMPLETED|Part D (HPMC Capsules)||0
8625105|NCT00505765|9664639|FG001|COMPLETED|Overall Study||17
8625106|NCT00505765|9664640|FG002|COMPLETED|Overall Study||19
9088915|NCT01072175|10153115|FG004|NOT COMPLETED|Part D (HPMC Capsules)||0
9088916|NCT01072175|10153116|FG005|NOT COMPLETED|Part D (HPMC Capsules)||0
9088917|NCT01072175|10153117|FG006|NOT COMPLETED|Part D (HPMC Capsules)||0
9088918|NCT01072175|10153118|FG007|NOT COMPLETED|Part D (HPMC Capsules)||0
9088919|NCT01072175|10153119|FG008|NOT COMPLETED|Part D (HPMC Capsules)||0
9088920|NCT01072175|10153120|FG009|NOT COMPLETED|Part D (HPMC Capsules)||12
8625107|NCT00505765|9664638|FG000|NOT COMPLETED|Overall Study||2
8625108|NCT00505765|9664639|FG001|NOT COMPLETED|Overall Study||3
8625109|NCT00505765|9664640|FG002|NOT COMPLETED|Overall Study||3
8625110|NCT00505778|9664650|FG000|STARTED|Overall Study||514
8625111|NCT00505778|9664651|FG001|STARTED|Overall Study||513
8625112|NCT00505778|9664650|FG000|Intent to Treat (ITT) Population|Overall Study||512
8625113|NCT00505778|9664651|FG001|Intent to Treat (ITT) Population|Overall Study||511
8625114|NCT00505778|9664650|FG000|COMPLETED|Overall Study||380
8625115|NCT00505778|9664651|FG001|COMPLETED|Overall Study||378
8625116|NCT00505778|9664650|FG000|NOT COMPLETED|Overall Study||134
8625117|NCT00505778|9664651|FG001|NOT COMPLETED|Overall Study||135
8625118|NCT00505895|9664659|FG000|STARTED|Overall Study||27
8625119|NCT00505895|9664660|FG001|STARTED|Overall Study||23
8625120|NCT00505895|9664659|FG000|COMPLETED|Overall Study||27
8625121|NCT00505895|9664660|FG001|COMPLETED|Overall Study||23
8625122|NCT00505895|9664659|FG000|NOT COMPLETED|Overall Study||0
8625123|NCT00505895|9664660|FG001|NOT COMPLETED|Overall Study||0
8625124|NCT00505921|9664666|FG000|STARTED|Overall Study||27
8625125|NCT00505921|9664666|FG000|COMPLETED|Overall Study||18
8625126|NCT00505921|9664666|FG000|NOT COMPLETED|Overall Study||9
8625127|NCT00505934|9664670|FG000|STARTED|Overall Study|Of the 23 subjects screened, 19 were enrolled into the study and received levetiracetam IV (LEV IV).|19
8625128|NCT00505934|9664670|FG000|COMPLETED|Overall Study||16
8625129|NCT00505934|9664670|FG000|NOT COMPLETED|Overall Study||3
8625130|NCT00506025|9664677|FG000|STARTED|Overall Study||10
8625131|NCT00506025|9664678|FG001|STARTED|Overall Study||9
8625132|NCT00506025|9664679|FG002|STARTED|Overall Study||8
8625133|NCT00506025|9664677|FG000|COMPLETED|Overall Study||10
9088921|NCT01072175|10153121|FG010|NOT COMPLETED|Part D (HPMC Capsules)||16
9088922|NCT01072175|10153122|FG011|NOT COMPLETED|Part D (HPMC Capsules)||43
9088923|NCT01072175|10153123|FG012|NOT COMPLETED|Part D (HPMC Capsules)||39
8625134|NCT00506025|9664678|FG001|COMPLETED|Overall Study||9
8625135|NCT00506025|9664679|FG002|COMPLETED|Overall Study||8
8625136|NCT00506025|9664677|FG000|NOT COMPLETED|Overall Study||0
8625137|NCT00506025|9664678|FG001|NOT COMPLETED|Overall Study||0
8625138|NCT00506025|9664679|FG002|NOT COMPLETED|Overall Study||0
8625139|NCT00506077|9664689|FG000|STARTED|Treatment Period 1||28
8625140|NCT00506077|9664690|FG001|STARTED|Treatment Period 1||27
8625141|NCT00506077|9664689|FG000|COMPLETED|Treatment Period 1||24
8625142|NCT00506077|9664690|FG001|COMPLETED|Treatment Period 1||24
8625143|NCT00506077|9664689|FG000|NOT COMPLETED|Treatment Period 1||4
8625144|NCT00506077|9664690|FG001|NOT COMPLETED|Treatment Period 1||3
8625145|NCT00506077|9664689|FG000|STARTED|Washout||24
8625146|NCT00506077|9664690|FG001|STARTED|Washout||24
8625147|NCT00506077|9664689|FG000|COMPLETED|Washout||24
8625148|NCT00506077|9664690|FG001|COMPLETED|Washout||24
8625149|NCT00506077|9664689|FG000|NOT COMPLETED|Washout||0
9088924|NCT01087203|10153157|FG000|STARTED|Overall Study||35
9088925|NCT01087203|10153158|FG001|STARTED|Overall Study||38
9088926|NCT01087203|10153157|FG000|COMPLETED|Overall Study||3
9088927|NCT01087203|10153158|FG001|COMPLETED|Overall Study||3
9088928|NCT01087203|10153157|FG000|NOT COMPLETED|Overall Study||32
9088929|NCT01087203|10153158|FG001|NOT COMPLETED|Overall Study||35
9088933|NCT01108055|10153169|FG000|STARTED|Overall Study||43
9088934|NCT01108055|10153169|FG000|Eligible and Started Treatment|Overall Study||32
9088935|NCT01108055|10153169|FG000|COMPLETED|Overall Study||28
9088936|NCT01108055|10153169|FG000|NOT COMPLETED|Overall Study||15
9088937|NCT01111019|10153173|FG000|STARTED|Overall Study||19
9088938|NCT01111019|10153173|FG000|COMPLETED|Overall Study||16
9088939|NCT01111019|10153173|FG000|NOT COMPLETED|Overall Study||3
9088940|NCT01136967|10153179|FG000|STARTED|Overall Study||93
9088941|NCT01136967|10153180|FG001|STARTED|Overall Study||89
9088942|NCT01136967|10153179|FG000|Disease Progression|Overall Study||55
9088943|NCT01136967|10153180|FG001|Disease Progression|Overall Study||56
9088944|NCT01136967|10153179|FG000|Treatment Ongoing at Data Cutoff|Overall Study|Entered Extension Phase on treatment at data cut-off (18 January 2012)|14
9088945|NCT01136967|10153180|FG001|Treatment Ongoing at Data Cutoff|Overall Study|Entered Extension Phase on treatment at data cut-off (15 April 2013)|6
9088946|NCT01136967|10153179|FG000|COMPLETED|Overall Study|Disease Progression and treatment ongoing at data cutoff (18 January 2012)|69
9088947|NCT01136967|10153180|FG001|COMPLETED|Overall Study|Disease Progression and treatment ongoing at data cutoff (15 April 2013)|62
9088948|NCT01136967|10153179|FG000|NOT COMPLETED|Overall Study||24
9088949|NCT01136967|10153180|FG001|NOT COMPLETED|Overall Study||27
9088950|NCT01136980|10153188|FG000|STARTED|Overall Study||42
9088951|NCT01136980|10153189|FG001|STARTED|Overall Study||87
9088952|NCT01136980|10153188|FG000|COMPLETED|Overall Study||28
9088953|NCT01136980|10153189|FG001|COMPLETED|Overall Study||76
9088954|NCT01136980|10153188|FG000|NOT COMPLETED|Overall Study||14
9088955|NCT01136980|10153189|FG001|NOT COMPLETED|Overall Study||11
9088956|NCT01140451|10153197|FG000|STARTED|Overall Study||95
9088957|NCT01140451|10153198|FG001|STARTED|Overall Study||96
9088958|NCT01140451|10153197|FG000|Completed 24 Weeks|Overall Study||89
9088959|NCT01140451|10153198|FG001|Completed 24 Weeks|Overall Study||86
9088960|NCT01140451|10153197|FG000|Completed 48 Weeks|Overall Study||78
9088961|NCT01140451|10153198|FG001|Completed 48 Weeks|Overall Study||70
9088962|NCT01140451|10153197|FG000|Completed 72 Weeks|Overall Study||63
9088963|NCT01140451|10153198|FG001|Completed 72 Weeks|Overall Study||62
9088964|NCT01140451|10153197|FG000|Completed 96 Weeks|Overall Study||57
9088965|NCT01140451|10153198|FG001|Completed 96 Weeks|Overall Study||54
9088966|NCT01140451|10153197|FG000|As-Treated Population|Overall Study||95
9088967|NCT01140451|10153198|FG001|As-Treated Population|Overall Study||96
9088968|NCT01140451|10153197|FG000|96-Week Completer Population|Overall Study||78
9088969|NCT01140451|10153198|FG001|96-Week Completer Population|Overall Study||70
9088970|NCT01140451|10153197|FG000|144-Week Completer Population|Overall Study||57
9088971|NCT01140451|10153198|FG001|144-Week Completer Population|Overall Study||54
9088972|NCT01140451|10153197|FG000|COMPLETED|Overall Study||57
9088973|NCT01140451|10153198|FG001|COMPLETED|Overall Study||54
9088974|NCT01140451|10153197|FG000|NOT COMPLETED|Overall Study||38
9088975|NCT01140451|10153198|FG001|NOT COMPLETED|Overall Study||42
9088976|NCT01174563|10153205|FG000|STARTED|Overall Study||60
9088977|NCT01174563|10153205|FG000|Efficacy Set|Overall Study||59
9088978|NCT01174563|10153205|FG000|Safety Set|Overall Study||59
9088979|NCT01174563|10153205|FG000|COMPLETED|Overall Study||0
9088980|NCT01174563|10153205|FG000|NOT COMPLETED|Overall Study||60
9088981|NCT01190202|10153213|FG000|STARTED|Overall Study||6404
9088982|NCT01190202|10153214|FG001|STARTED|Overall Study||6414
9088983|NCT01190202|10153215|FG002|STARTED|Overall Study||6400
9088984|NCT01190202|10153216|FG003|STARTED|Overall Study||2400
9088985|NCT01190202|10153213|FG000|COMPLETED|Overall Study||6404
9088986|NCT01190202|10153214|FG001|COMPLETED|Overall Study||6414
9088987|NCT01190202|10153215|FG002|COMPLETED|Overall Study||6400
9088988|NCT01190202|10153216|FG003|COMPLETED|Overall Study||2400
9088989|NCT01190202|10153213|FG000|NOT COMPLETED|Overall Study||0
9088990|NCT01190202|10153214|FG001|NOT COMPLETED|Overall Study||0
9088991|NCT01190202|10153215|FG002|NOT COMPLETED|Overall Study||0
9088992|NCT01190202|10153216|FG003|NOT COMPLETED|Overall Study||0
9088993|NCT01200862|10153261|FG000|STARTED|Part 1||14
9088994|NCT01200862|10153262|FG001|STARTED|Part 1||0
9088995|NCT01200862|10153263|FG002|STARTED|Part 1||0
9088996|NCT01200862|10153261|FG000|COMPLETED|Part 1||13
9088997|NCT01200862|10153262|FG001|COMPLETED|Part 1||0
9088998|NCT01200862|10153263|FG002|COMPLETED|Part 1||0
9088999|NCT01200862|10153261|FG000|NOT COMPLETED|Part 1||1
9089000|NCT01200862|10153262|FG001|NOT COMPLETED|Part 1||0
9089001|NCT01200862|10153263|FG002|NOT COMPLETED|Part 1||0
9089002|NCT01200862|10153261|FG000|STARTED|Part 2||0
9089003|NCT01200862|10153262|FG001|STARTED|Part 2||7
9089004|NCT01200862|10153263|FG002|STARTED|Part 2||8
9089005|NCT01200862|10153261|FG000|COMPLETED|Part 2||0
9089006|NCT01200862|10153262|FG001|COMPLETED|Part 2||6
9089007|NCT01200862|10153263|FG002|COMPLETED|Part 2||8
9089008|NCT01200862|10153261|FG000|NOT COMPLETED|Part 2||0
9089009|NCT01200862|10153262|FG001|NOT COMPLETED|Part 2||1
9089010|NCT01200862|10153263|FG002|NOT COMPLETED|Part 2||0
9089011|NCT01225341|10153274|FG000|STARTED|Overall Study||0
9089012|NCT01225341|10153275|FG001|STARTED|Overall Study||0
9089013|NCT01225341|10153274|FG000|COMPLETED|Overall Study||0
9089014|NCT01225341|10153275|FG001|COMPLETED|Overall Study||0
9089015|NCT01225341|10153274|FG000|NOT COMPLETED|Overall Study||0
9088930|NCT01088815|10153165|FG000|STARTED|Overall Study||72
9088931|NCT01088815|10153165|FG000|COMPLETED|Overall Study||72
9088932|NCT01088815|10153165|FG000|NOT COMPLETED|Overall Study||0
9089016|NCT01225341|10153275|FG001|NOT COMPLETED|Overall Study||0
8625150|NCT00506077|9664690|FG001|NOT COMPLETED|Washout||0
8625151|NCT00506077|9664689|FG000|STARTED|Treatment Period 2||24
8625152|NCT00506077|9664690|FG001|STARTED|Treatment Period 2||24
8625153|NCT00506077|9664689|FG000|COMPLETED|Treatment Period 2||23
8625154|NCT00506077|9664690|FG001|COMPLETED|Treatment Period 2||23
8625155|NCT00506077|9664689|FG000|NOT COMPLETED|Treatment Period 2||1
8625156|NCT00506077|9664690|FG001|NOT COMPLETED|Treatment Period 2||1
8625157|NCT00506129|9664696|FG000|STARTED|Overall Study||33
8625158|NCT00506129|9664696|FG000|COMPLETED|Overall Study||11
8625159|NCT00506129|9664696|FG000|NOT COMPLETED|Overall Study||22
8625160|NCT00506142|9664702|FG000|STARTED|Overall Study||35
8625161|NCT00506142|9664703|FG001|STARTED|Overall Study||19
8625162|NCT00506142|9664702|FG000|COMPLETED|Overall Study||0
8625163|NCT00506142|9664703|FG001|COMPLETED|Overall Study||0
8625164|NCT00506142|9664702|FG000|NOT COMPLETED|Overall Study||35
8625165|NCT00506142|9664703|FG001|NOT COMPLETED|Overall Study||19
8625166|NCT00506155|9664709|FG000|STARTED|Overall Study||60
8625167|NCT00506155|9664709|FG000|COMPLETED|Overall Study||60
8625168|NCT00506155|9664709|FG000|NOT COMPLETED|Overall Study||0
8625169|NCT00506285|9664715|FG000|STARTED|3 Week Screening Phase||46
9089017|NCT01235962|10153285|FG000|STARTED|Overall Study||198
9089018|NCT01235962|10153286|FG001|STARTED|Overall Study||205
9089019|NCT01235962|10153287|FG002|STARTED|Overall Study||571
9089020|NCT01235962|10153288|FG003|STARTED|Overall Study||564
9089021|NCT01235962|10153285|FG000|Prem. Withdrawn = Did Not Complete Study|Overall Study||46
9089022|NCT01235962|10153286|FG001|Prem. Withdrawn = Did Not Complete Study|Overall Study||35
9089023|NCT01235962|10153287|FG002|Prem. Withdrawn = Did Not Complete Study|Overall Study||118
9089024|NCT01235962|10153288|FG003|Prem. Withdrawn = Did Not Complete Study|Overall Study||86
9089025|NCT01235962|10153285|FG000|All Deaths|Overall Study||43
9089026|NCT01235962|10153286|FG001|All Deaths|Overall Study||46
9089027|NCT01235962|10153287|FG002|All Deaths|Overall Study||102
9089028|NCT01235962|10153288|FG003|All Deaths|Overall Study||104
9089029|NCT01235962|10153285|FG000|COMPLETED|Overall Study||152
9089030|NCT01235962|10153286|FG001|COMPLETED|Overall Study||170
9089031|NCT01235962|10153287|FG002|COMPLETED|Overall Study||453
9089032|NCT01235962|10153288|FG003|COMPLETED|Overall Study||478
9089033|NCT01235962|10153285|FG000|NOT COMPLETED|Overall Study||46
9089034|NCT01235962|10153286|FG001|NOT COMPLETED|Overall Study||35
9089035|NCT01235962|10153287|FG002|NOT COMPLETED|Overall Study||118
9089036|NCT01235962|10153288|FG003|NOT COMPLETED|Overall Study||86
9089067|NCT01266031|10153361|FG000|STARTED|Overall Study||6
9089068|NCT01266031|10153362|FG001|STARTED|Overall Study||41
9089069|NCT01266031|10153363|FG002|STARTED|Overall Study||49
9089070|NCT01266031|10153361|FG000|COMPLETED|Overall Study||6
9089071|NCT01266031|10153362|FG001|COMPLETED|Overall Study||38
9089072|NCT01266031|10153363|FG002|COMPLETED|Overall Study||47
9089073|NCT01266031|10153361|FG000|NOT COMPLETED|Overall Study||0
9089074|NCT01266031|10153362|FG001|NOT COMPLETED|Overall Study||3
9089075|NCT01266031|10153363|FG002|NOT COMPLETED|Overall Study||2
9089076|NCT01287741|10153384|FG000|STARTED|Overall Study||712
9089077|NCT01287741|10153385|FG001|STARTED|Overall Study||706
9089078|NCT01287741|10153384|FG000|COMPLETED|Overall Study||86
9089079|NCT01287741|10153385|FG001|COMPLETED|Overall Study||91
9089080|NCT01287741|10153384|FG000|NOT COMPLETED|Overall Study||626
9089081|NCT01287741|10153385|FG001|NOT COMPLETED|Overall Study||615
9089082|NCT01304316|10153392|FG000|STARTED|Overall Study||12
9089083|NCT01304316|10153392|FG000|COMPLETED|Overall Study||12
9089084|NCT01304316|10153392|FG000|NOT COMPLETED|Overall Study||0
9089085|NCT01313689|10153402|FG000|STARTED|24-Week Randomization 1||79
9089086|NCT01313689|10153403|FG001|STARTED|24-Week Randomization 1|Of the 43 participants in the PC arm, 22 entered the OFA Salvage arm.|43
9089087|NCT01313689|10153404|FG002|STARTED|24-Week Randomization 1||0
9089088|NCT01313689|10153405|FG003|STARTED|24-Week Randomization 1||0
9089089|NCT01313689|10153406|FG004|STARTED|24-Week Randomization 1||0
9089090|NCT01313689|10153402|FG000|COMPLETED|24-Week Randomization 1|Par. not entering Randomization 2 continued visits for Follow-up and overall survival assessment|60
9089091|NCT01313689|10153403|FG001|COMPLETED|24-Week Randomization 1|Par. that did not receive OFA salvage continued visits for Follow-up and overall survival assessment|33
9089092|NCT01313689|10153404|FG002|COMPLETED|24-Week Randomization 1||0
9089093|NCT01313689|10153405|FG003|COMPLETED|24-Week Randomization 1||0
9089094|NCT01313689|10153406|FG004|COMPLETED|24-Week Randomization 1||0
9089095|NCT01313689|10153402|FG000|NOT COMPLETED|24-Week Randomization 1||19
9089096|NCT01313689|10153403|FG001|NOT COMPLETED|24-Week Randomization 1||10
9089097|NCT01313689|10153404|FG002|NOT COMPLETED|24-Week Randomization 1||0
9089098|NCT01313689|10153405|FG003|NOT COMPLETED|24-Week Randomization 1||0
9089099|NCT01313689|10153406|FG004|NOT COMPLETED|24-Week Randomization 1||0
9089100|NCT01313689|10153402|FG000|STARTED|24-Week Randomization 2||0
9089101|NCT01313689|10153403|FG001|STARTED|24-Week Randomization 2||0
9089102|NCT01313689|10153404|FG002|STARTED|24-Week Randomization 2|Not all participants from Randomization 1 continued to Randomization 2.|24
9089103|NCT01313689|10153405|FG003|STARTED|24-Week Randomization 2|Not all participants from Randomization 1 continued to Randomization 2.|13
9089104|NCT01313689|10153406|FG004|STARTED|24-Week Randomization 2|OFA Participants who did not enter Randomization 2.|42
9089105|NCT01313689|10153402|FG000|COMPLETED|24-Week Randomization 2||0
9089106|NCT01313689|10153403|FG001|COMPLETED|24-Week Randomization 2||0
9089107|NCT01313689|10153404|FG002|COMPLETED|24-Week Randomization 2||21
9089108|NCT01313689|10153405|FG003|COMPLETED|24-Week Randomization 2||12
9089109|NCT01313689|10153406|FG004|COMPLETED|24-Week Randomization 2||27
9089110|NCT01313689|10153402|FG000|NOT COMPLETED|24-Week Randomization 2||0
9089111|NCT01313689|10153403|FG001|NOT COMPLETED|24-Week Randomization 2||0
9089112|NCT01313689|10153404|FG002|NOT COMPLETED|24-Week Randomization 2||3
9089113|NCT01313689|10153405|FG003|NOT COMPLETED|24-Week Randomization 2||1
9089114|NCT01313689|10153406|FG004|NOT COMPLETED|24-Week Randomization 2||15
9089124|NCT01318993|10153438|FG000|STARTED|Overall Study||398
9089125|NCT01318993|10153438|FG000|COMPLETED|Overall Study||0
9089126|NCT01318993|10153438|FG000|NOT COMPLETED|Overall Study||398
9089127|NCT01335685|10153446|FG000|STARTED|Overall Study||7
9089128|NCT01335685|10153447|FG001|STARTED|Overall Study||4
9089129|NCT01335685|10153448|FG002|STARTED|Overall Study||3
9089130|NCT01335685|10153449|FG003|STARTED|Overall Study||26
8625170|NCT00506285|9664716|FG001|STARTED|3 Week Screening Phase||46
8625171|NCT00506285|9664715|FG000|COMPLETED|3 Week Screening Phase||29
9089037|NCT01239368|10153316|FG000|STARTED|Overall Study||2
9089038|NCT01239368|10153317|FG001|STARTED|Overall Study||1
9089039|NCT01239368|10153318|FG002|STARTED|Overall Study||1
9089040|NCT01239368|10153319|FG003|STARTED|Overall Study||2
9089041|NCT01239368|10153320|FG004|STARTED|Overall Study||7
9089042|NCT01239368|10153321|FG005|STARTED|Overall Study||5
9089043|NCT01239368|10153322|FG006|STARTED|Overall Study||7
9089044|NCT01239368|10153323|FG007|STARTED|Overall Study||0
9089045|NCT01239368|10153324|FG008|STARTED|Overall Study||1
9089046|NCT01239368|10153325|FG009|STARTED|Overall Study||5
9089047|NCT01239368|10153316|FG000|COMPLETED|Overall Study||0
9089048|NCT01239368|10153317|FG001|COMPLETED|Overall Study||0
9089049|NCT01239368|10153318|FG002|COMPLETED|Overall Study||0
9089050|NCT01239368|10153319|FG003|COMPLETED|Overall Study||1
9089051|NCT01239368|10153320|FG004|COMPLETED|Overall Study||2
9089052|NCT01239368|10153321|FG005|COMPLETED|Overall Study||1
9089053|NCT01239368|10153322|FG006|COMPLETED|Overall Study||1
9089054|NCT01239368|10153323|FG007|COMPLETED|Overall Study||0
9089055|NCT01239368|10153324|FG008|COMPLETED|Overall Study||1
9089056|NCT01239368|10153325|FG009|COMPLETED|Overall Study||1
9089057|NCT01239368|10153316|FG000|NOT COMPLETED|Overall Study||2
9089058|NCT01239368|10153317|FG001|NOT COMPLETED|Overall Study||1
9089059|NCT01239368|10153318|FG002|NOT COMPLETED|Overall Study||1
9089060|NCT01239368|10153319|FG003|NOT COMPLETED|Overall Study||1
9089061|NCT01239368|10153320|FG004|NOT COMPLETED|Overall Study||5
9089062|NCT01239368|10153321|FG005|NOT COMPLETED|Overall Study||4
9089063|NCT01239368|10153322|FG006|NOT COMPLETED|Overall Study||6
9089064|NCT01239368|10153323|FG007|NOT COMPLETED|Overall Study||0
9089065|NCT01239368|10153324|FG008|NOT COMPLETED|Overall Study||0
9089066|NCT01239368|10153325|FG009|NOT COMPLETED|Overall Study||4
9089115|NCT01315353|10153428|FG000|STARTED|Overall Study||145
9089116|NCT01315353|10153429|FG001|STARTED|Overall Study||143
9089117|NCT01315353|10153430|FG002|STARTED|Overall Study||179
9089118|NCT01315353|10153428|FG000|COMPLETED|Overall Study||116
9089119|NCT01315353|10153429|FG001|COMPLETED|Overall Study||120
9089120|NCT01315353|10153430|FG002|COMPLETED|Overall Study||166
9089121|NCT01315353|10153428|FG000|NOT COMPLETED|Overall Study||29
9089122|NCT01315353|10153429|FG001|NOT COMPLETED|Overall Study||23
9089123|NCT01315353|10153430|FG002|NOT COMPLETED|Overall Study||13
9089131|NCT01335685|10153450|FG004|STARTED|Overall Study||5
9089132|NCT01335685|10153451|FG005|STARTED|Overall Study||6
9089133|NCT01335685|10153452|FG006|STARTED|Overall Study||4
9089134|NCT01335685|10153453|FG007|STARTED|Overall Study||6
9089135|NCT01335685|10153446|FG000|COMPLETED|Overall Study||4
9089136|NCT01335685|10153447|FG001|COMPLETED|Overall Study||3
9089137|NCT01335685|10153448|FG002|COMPLETED|Overall Study||1
9089138|NCT01335685|10153449|FG003|COMPLETED|Overall Study||15
9089139|NCT01335685|10153450|FG004|COMPLETED|Overall Study||5
9089140|NCT01335685|10153451|FG005|COMPLETED|Overall Study||1
9089141|NCT01335685|10153452|FG006|COMPLETED|Overall Study||2
9089142|NCT01335685|10153453|FG007|COMPLETED|Overall Study||3
9089143|NCT01335685|10153446|FG000|NOT COMPLETED|Overall Study||3
9089144|NCT01335685|10153447|FG001|NOT COMPLETED|Overall Study||1
9089145|NCT01335685|10153448|FG002|NOT COMPLETED|Overall Study||2
9089146|NCT01335685|10153449|FG003|NOT COMPLETED|Overall Study||11
9089147|NCT01335685|10153450|FG004|NOT COMPLETED|Overall Study||0
9089148|NCT01335685|10153451|FG005|NOT COMPLETED|Overall Study||5
9089149|NCT01335685|10153452|FG006|NOT COMPLETED|Overall Study||2
9089150|NCT01335685|10153453|FG007|NOT COMPLETED|Overall Study||3
9089151|NCT01336621|10153476|FG000|STARTED|Primary Reporting Phase (Upto 5.8 Years)||98
9089152|NCT01336621|10153476|FG000|COMPLETED|Primary Reporting Phase (Upto 5.8 Years)||0
9089153|NCT01336621|10153476|FG000|NOT COMPLETED|Primary Reporting Phase (Upto 5.8 Years)||98
9089154|NCT01336621|10153476|FG000|STARTED|SFUCP (up to 2.6 Years)||9
9089155|NCT01336621|10153476|FG000|COMPLETED|SFUCP (up to 2.6 Years)||0
9089156|NCT01336621|10153476|FG000|NOT COMPLETED|SFUCP (up to 2.6 Years)||9
9089157|NCT04391036|10153485|FG000|STARTED|Overall Study||15
9089158|NCT04391036|10153486|FG001|STARTED|Overall Study||15
8625172|NCT00506285|9664716|FG001|COMPLETED|3 Week Screening Phase||36
8625173|NCT00506285|9664715|FG000|NOT COMPLETED|3 Week Screening Phase||17
8625174|NCT00506285|9664716|FG001|NOT COMPLETED|3 Week Screening Phase||10
8625175|NCT00506285|9664715|FG000|STARTED|Double Blind Cross-Over Phase||29
9089159|NCT04391036|10153485|FG000|COMPLETED|Overall Study||15
9089160|NCT04391036|10153486|FG001|COMPLETED|Overall Study||15
9089161|NCT04391036|10153485|FG000|NOT COMPLETED|Overall Study||0
9089162|NCT04391036|10153486|FG001|NOT COMPLETED|Overall Study||0
9089163|NCT04170296|10153496|FG000|STARTED|Overall Study||81
9089164|NCT04170296|10153497|FG001|STARTED|Overall Study||72
9089165|NCT04170296|10153496|FG000|COMPLETED|Overall Study||73
9089166|NCT04170296|10153497|FG001|COMPLETED|Overall Study||68
9089167|NCT04170296|10153496|FG000|NOT COMPLETED|Overall Study||8
9089168|NCT04170296|10153497|FG001|NOT COMPLETED|Overall Study||4
9089169|NCT04039217|10153509|FG000|STARTED|Overall Study||20
9089170|NCT04039217|10153509|FG000|Started Study Arm A.1|Overall Study||4
9089171|NCT04039217|10153509|FG000|Completed Study Arm A.1|Overall Study||4
9089172|NCT04039217|10153509|FG000|Started Study Arm A.2|Overall Study||4
9089173|NCT04039217|10153509|FG000|Completed Study Arm A.2|Overall Study||4
9089174|NCT04039217|10153509|FG000|Started Study Arm A.3|Overall Study||4
9089175|NCT04039217|10153509|FG000|Completed Study Arm A.3|Overall Study||4
9089176|NCT04039217|10153509|FG000|Started Study Arm B.1|Overall Study||4
9089177|NCT04039217|10153509|FG000|Completed Study Arm B.1|Overall Study||4
9089178|NCT04039217|10153509|FG000|Started Study Arm B.2|Overall Study||4
9089179|NCT04039217|10153509|FG000|Completed Study Arm B.2|Overall Study||4
9089180|NCT04039217|10153509|FG000|Started Study Arm C.1|Overall Study||5
9089181|NCT04039217|10153509|FG000|Completed Study Arm C.1|Overall Study||4
9089182|NCT04039217|10153509|FG000|Started Study Arm C.2|Overall Study||0
9089183|NCT04039217|10153509|FG000|Completed Study Arm C.2|Overall Study||0
9089184|NCT04039217|10153509|FG000|COMPLETED|Overall Study||19
9089185|NCT04039217|10153509|FG000|NOT COMPLETED|Overall Study||1
9089186|NCT03998046|10153519|FG000|STARTED|Overall Study||38
9089187|NCT03998046|10153520|FG001|STARTED|Overall Study||42
9089188|NCT03998046|10153519|FG000|COMPLETED|Overall Study||38
9089189|NCT03998046|10153520|FG001|COMPLETED|Overall Study||42
9089190|NCT03998046|10153519|FG000|NOT COMPLETED|Overall Study||0
9089191|NCT03998046|10153520|FG001|NOT COMPLETED|Overall Study||0
9089192|NCT03160521|10153530|FG000|STARTED|Overall Study|From 145 randomized patients in the 75 mg dose arm, one of them withdrew consent before receiving the study treatment. Due to, only 144 patients received allocated intervention.|144
9089193|NCT03160521|10153531|FG001|STARTED|Overall Study||146
9089194|NCT03160521|10153532|FG002|STARTED|Overall Study||147
9089195|NCT03160521|10153530|FG000|COMPLETED|Overall Study||107
9089196|NCT03160521|10153531|FG001|COMPLETED|Overall Study||95
9089197|NCT03160521|10153532|FG002|COMPLETED|Overall Study||88
9089198|NCT03160521|10153530|FG000|NOT COMPLETED|Overall Study||37
9089199|NCT03160521|10153531|FG001|NOT COMPLETED|Overall Study||51
9089200|NCT03160521|10153532|FG002|NOT COMPLETED|Overall Study||59
9089201|NCT03143816|10153548|FG000|STARTED|Overall Study||26
9089202|NCT03143816|10153549|FG001|STARTED|Overall Study||34
9089203|NCT03143816|10153548|FG000|COMPLETED|Overall Study||22
9089204|NCT03143816|10153549|FG001|COMPLETED|Overall Study||34
9089205|NCT03143816|10153548|FG000|NOT COMPLETED|Overall Study||4
9089206|NCT03143816|10153549|FG001|NOT COMPLETED|Overall Study||0
9089207|NCT03078192|10153563|FG000|STARTED|Overall Study||30
9089208|NCT03078192|10153564|FG001|STARTED|Overall Study||32
9089209|NCT03078192|10153563|FG000|COMPLETED|Overall Study||28
9089210|NCT03078192|10153564|FG001|COMPLETED|Overall Study||28
9089211|NCT03078192|10153563|FG000|NOT COMPLETED|Overall Study||2
9089212|NCT03078192|10153564|FG001|NOT COMPLETED|Overall Study||4
9089213|NCT02959944|10153572|FG000|STARTED|Overall Study||95
9089214|NCT02959944|10153573|FG001|STARTED|Overall Study||98
9089215|NCT02959944|10153572|FG000|Received at Least 1 Dose of Study Drug|Overall Study||94
9089216|NCT02959944|10153573|FG001|Received at Least 1 Dose of Study Drug|Overall Study||96
9089217|NCT02959944|10153572|FG000|COMPLETED|Overall Study||95
9089218|NCT02959944|10153573|FG001|COMPLETED|Overall Study||98
9089219|NCT02959944|10153572|FG000|NOT COMPLETED|Overall Study||0
9089220|NCT02959944|10153573|FG001|NOT COMPLETED|Overall Study||0
9089221|NCT02903823|10153579|FG000|STARTED|Overall Study|First subject enrollment|27
9089222|NCT02903823|10153579|FG000|COMPLETED|Overall Study||20
9089223|NCT02903823|10153579|FG000|NOT COMPLETED|Overall Study||7
8625176|NCT00506285|9664716|FG001|STARTED|Double Blind Cross-Over Phase||36
9089224|NCT02666183|10153587|FG000|STARTED|Overall Study||137
9089225|NCT02666183|10153588|FG001|STARTED|Overall Study||141
9089226|NCT02666183|10153589|FG002|STARTED|Overall Study||119
9089227|NCT02666183|10153587|FG000|COMPLETED|Overall Study||103
9089228|NCT02666183|10153588|FG001|COMPLETED|Overall Study||106
9089229|NCT02666183|10153589|FG002|COMPLETED|Overall Study||93
9089230|NCT02666183|10153587|FG000|NOT COMPLETED|Overall Study||34
9089231|NCT02666183|10153588|FG001|NOT COMPLETED|Overall Study||35
9089232|NCT02666183|10153589|FG002|NOT COMPLETED|Overall Study||26
9089233|NCT01547117|10153601|FG000|STARTED|Overall Study||12
9089234|NCT01547117|10153602|FG001|STARTED|Overall Study||5
9089235|NCT01547117|10153603|FG002|STARTED|Overall Study||10
9089236|NCT01547117|10153604|FG003|STARTED|Overall Study||11
9089237|NCT01547117|10153601|FG000|Phase 1 Baseline Labs|Overall Study||12
9089238|NCT01547117|10153602|FG001|Phase 1 Baseline Labs|Overall Study|1 healthy control was unable to find time to schedule study|4
9089239|NCT01547117|10153603|FG002|Phase 1 Baseline Labs|Overall Study|2 patients with POTS did not discontinue medication that was prohibited by protocol.|8
9089240|NCT01547117|10153604|FG003|Phase 1 Baseline Labs|Overall Study|1 patient with POTS did not discontinue medication that was prohibited by protocol, 1 patient was unable to find time to schedule the study, 1 was noted to be too old to participate, and 1 became pregnant between enrollment and the start of phase 1.|7
9089241|NCT01547117|10153601|FG000|Phase 1-150 mEq Sodium/Day|Overall Study||12
9089242|NCT01547117|10153602|FG001|Phase 1-150 mEq Sodium/Day|Overall Study||4
9089243|NCT01547117|10153603|FG002|Phase 1-150 mEq Sodium/Day|Overall Study||8
9089244|NCT01547117|10153604|FG003|Phase 1-150 mEq Sodium/Day|Overall Study||7
9089245|NCT01547117|10153601|FG000|Phase 1-start Low Sodium or High Sodium Diet|Overall Study||12
9089246|NCT01547117|10153602|FG001|Phase 1-start Low Sodium or High Sodium Diet|Overall Study||4
9089247|NCT01547117|10153603|FG002|Phase 1-start Low Sodium or High Sodium Diet|Overall Study||8
9089248|NCT01547117|10153604|FG003|Phase 1-start Low Sodium or High Sodium Diet|Overall Study||7
9089249|NCT01547117|10153601|FG000|Phase 1-finish|Overall Study|1 healthy control withdrew with migraines during phase 1 (low Na+).|11
9089250|NCT01547117|10153602|FG001|Phase 1-finish|Overall Study|2 healthy controls withdrew during phase 1 (high Na+): 1 unable to tolerate study diet and another with difficulty cooperating with investigators..|2
9089251|NCT01547117|10153603|FG002|Phase 1-finish|Overall Study||8
9089252|NCT01547117|10153604|FG003|Phase 1-finish|Overall Study|1 patient with POTS withdrew during phase 1 due to a family illness.|6
9089253|NCT01547117|10153601|FG000|Phase 2-150 mEq Sodium/Day|Overall Study||11
9089254|NCT01547117|10153602|FG001|Phase 2-150 mEq Sodium/Day|Overall Study||2
9089255|NCT01547117|10153603|FG002|Phase 2-150 mEq Sodium/Day|Overall Study||8
9089256|NCT01547117|10153604|FG003|Phase 2-150 mEq Sodium/Day|Overall Study||6
9089257|NCT01547117|10153601|FG000|Phase 2-start Low Sodium or High Sodium Diet|Overall Study||11
9089258|NCT01547117|10153602|FG001|Phase 2-start Low Sodium or High Sodium Diet|Overall Study||2
9089259|NCT01547117|10153603|FG002|Phase 2-start Low Sodium or High Sodium Diet|Overall Study||8
9089260|NCT01547117|10153604|FG003|Phase 2-start Low Sodium or High Sodium Diet|Overall Study||6
9089261|NCT01547117|10153601|FG000|Phase 2-finish|Overall Study||11
9089262|NCT01547117|10153602|FG001|Phase 2-finish|Overall Study||2
9089263|NCT01547117|10153603|FG002|Phase 2-finish|Overall Study||8
9089264|NCT01547117|10153604|FG003|Phase 2-finish|Overall Study||6
9089265|NCT01547117|10153601|FG000|COMPLETED|Overall Study||11
9089266|NCT01547117|10153602|FG001|COMPLETED|Overall Study||2
9089267|NCT01547117|10153603|FG002|COMPLETED|Overall Study||8
9089268|NCT01547117|10153604|FG003|COMPLETED|Overall Study||6
9089269|NCT01547117|10153601|FG000|NOT COMPLETED|Overall Study||1
9089270|NCT01547117|10153602|FG001|NOT COMPLETED|Overall Study||3
9089271|NCT01547117|10153603|FG002|NOT COMPLETED|Overall Study||2
8844749|NCT01711983|9899203|FG000|NOT COMPLETED|6-Month Clinical Success Evaluation||32
8844750|NCT01711983|9899203|FG000|STARTED|6-Month Closure Evaluation||368
8844751|NCT01711983|9899203|FG000|COMPLETED|6-Month Closure Evaluation||342
8844752|NCT01711983|9899203|FG000|NOT COMPLETED|6-Month Closure Evaluation||26
9089272|NCT01547117|10153604|FG003|NOT COMPLETED|Overall Study||5
9089273|NCT01431508|10153630|FG000|STARTED|Overall Study||15
9089274|NCT01431508|10153630|FG000|COMPLETED|Overall Study||13
9089275|NCT01431508|10153630|FG000|NOT COMPLETED|Overall Study||2
9089276|NCT00871351|10153637|FG000|STARTED|Overall Study||47
9089277|NCT00871351|10153638|FG001|STARTED|Overall Study||46
9089278|NCT00871351|10153639|FG002|STARTED|Overall Study||32
9089279|NCT00871351|10153637|FG000|COMPLETED|Overall Study||43
9089280|NCT00871351|10153638|FG001|COMPLETED|Overall Study||45
9089281|NCT00871351|10153639|FG002|COMPLETED|Overall Study||32
9089282|NCT00871351|10153637|FG000|NOT COMPLETED|Overall Study||4
9089283|NCT00871351|10153638|FG001|NOT COMPLETED|Overall Study||1
9089284|NCT00871351|10153639|FG002|NOT COMPLETED|Overall Study||0
9089285|NCT00832455|10153647|FG000|STARTED|Overall Study|445 - number of patients that signed the informed consent form (Safety population)|445
9089286|NCT00832455|10153647|FG000|Baseline|Overall Study|420 -patients that received at least one dose of study medication and had 1 follow-up visit (ITT)|420
9089287|NCT00832455|10153647|FG000|Week 4|Overall Study||411
9089288|NCT00832455|10153647|FG000|Week 8 (Optional)|Overall Study||247
9089289|NCT00832455|10153647|FG000|Week 12|Overall Study||373
8625177|NCT00506285|9664715|FG000|Received at Least 1 Dose MTS|Double Blind Cross-Over Phase||29
8625178|NCT00506285|9664716|FG001|Received at Least 1 Dose MTS|Double Blind Cross-Over Phase||31
8625179|NCT00506285|9664715|FG000|COMPLETED|Double Blind Cross-Over Phase||20
8844753|NCT01711983|9899203|FG000|STARTED|36-Month Closure Evaluation||342
9089290|NCT00832455|10153647|FG000|COMPLETED|Overall Study||373
9089291|NCT00832455|10153647|FG000|NOT COMPLETED|Overall Study||72
9089292|NCT00812006|10153663|FG000|STARTED|Overall Study||36
9089293|NCT00812006|10153664|FG001|STARTED|Overall Study||36
9089294|NCT00812006|10153665|FG002|STARTED|Overall Study||36
9089295|NCT00812006|10153663|FG000|COMPLETED|Overall Study||30
9089296|NCT00812006|10153664|FG001|COMPLETED|Overall Study||33
9089297|NCT00812006|10153665|FG002|COMPLETED|Overall Study||30
9089298|NCT00812006|10153663|FG000|NOT COMPLETED|Overall Study||6
9089299|NCT00812006|10153664|FG001|NOT COMPLETED|Overall Study||3
9089300|NCT00812006|10153665|FG002|NOT COMPLETED|Overall Study||6
9089301|NCT00739050|10153671|FG000|STARTED|Overall Study||4
9089302|NCT00739050|10153672|FG001|STARTED|Overall Study||0
9089303|NCT00739050|10153671|FG000|COMPLETED|Overall Study|These 3 patients completing treatment did not complete the required procedures during the trial.|3
9089304|NCT00739050|10153672|FG001|COMPLETED|Overall Study||0
9089305|NCT00739050|10153671|FG000|NOT COMPLETED|Overall Study||1
9089306|NCT00739050|10153672|FG001|NOT COMPLETED|Overall Study||0
9089307|NCT00687531|10153678|FG000|STARTED|Overall Study|Completed screening procedures|385
9089308|NCT00687531|10153678|FG000|RECEIVED TREATMENT|Overall Study||281
9089309|NCT00687531|10153678|FG000|COMPLETED|Overall Study||250
9089310|NCT00687531|10153678|FG000|NOT COMPLETED|Overall Study||135
9089311|NCT00654628|10153682|FG000|STARTED|6-week Active Treatment Period||173
9089312|NCT00654628|10153682|FG000|COMPLETED|6-week Active Treatment Period||152
9089313|NCT00654628|10153682|FG000|NOT COMPLETED|6-week Active Treatment Period||21
9089314|NCT00654628|10153682|FG000|STARTED|6 -Week Extension Period (Single Site)|Subjects who completed the first 6-week period and participated in the second 6-week study period.|60
9089315|NCT00654628|10153682|FG000|COMPLETED|6 -Week Extension Period (Single Site)||55
9089316|NCT00654628|10153682|FG000|NOT COMPLETED|6 -Week Extension Period (Single Site)||5
9089317|NCT00604812|10153689|FG000|STARTED|Overall Study||9
9089318|NCT00604812|10153690|FG001|STARTED|Overall Study||3
9089319|NCT00604812|10153691|FG002|STARTED|Overall Study||10
9089320|NCT00604812|10153692|FG003|STARTED|Overall Study||3
9089321|NCT00604812|10153693|FG004|STARTED|Overall Study||5
9089322|NCT00604812|10153694|FG005|STARTED|Overall Study||1
9089323|NCT00604812|10153689|FG000|COMPLETED|Overall Study||9
9089324|NCT00604812|10153690|FG001|COMPLETED|Overall Study||3
9089325|NCT00604812|10153691|FG002|COMPLETED|Overall Study||10
9089326|NCT00604812|10153692|FG003|COMPLETED|Overall Study||3
9089327|NCT00604812|10153693|FG004|COMPLETED|Overall Study||5
9089328|NCT00604812|10153694|FG005|COMPLETED|Overall Study||1
9089329|NCT00604812|10153689|FG000|NOT COMPLETED|Overall Study||0
9089330|NCT00604812|10153690|FG001|NOT COMPLETED|Overall Study||0
9089331|NCT00604812|10153691|FG002|NOT COMPLETED|Overall Study||0
9089332|NCT00604812|10153692|FG003|NOT COMPLETED|Overall Study||0
9089333|NCT00604812|10153693|FG004|NOT COMPLETED|Overall Study||0
9089334|NCT00604812|10153694|FG005|NOT COMPLETED|Overall Study||0
9089335|NCT00536380|10153708|FG000|STARTED|Overall Study||106
9089336|NCT00536380|10153709|FG001|STARTED|Overall Study||104
9089337|NCT00536380|10153710|FG002|STARTED|Overall Study||104
9089338|NCT00536380|10153708|FG000|COMPLETED|Overall Study||94
9089339|NCT00536380|10153709|FG001|COMPLETED|Overall Study||95
9089340|NCT00536380|10153710|FG002|COMPLETED|Overall Study||94
8625180|NCT00506285|9664716|FG001|COMPLETED|Double Blind Cross-Over Phase||31
8625181|NCT00506285|9664715|FG000|NOT COMPLETED|Double Blind Cross-Over Phase||9
8625182|NCT00506285|9664716|FG001|NOT COMPLETED|Double Blind Cross-Over Phase||5
8625183|NCT00506285|9664715|FG000|STARTED|6-month Open Label Phase||20
8625184|NCT00506285|9664716|FG001|STARTED|6-month Open Label Phase||31
8625185|NCT00506285|9664715|FG000|COMPLETED|6-month Open Label Phase||10
8625186|NCT00506285|9664716|FG001|COMPLETED|6-month Open Label Phase||19
8625187|NCT00506285|9664715|FG000|NOT COMPLETED|6-month Open Label Phase||10
9089341|NCT00536380|10153708|FG000|NOT COMPLETED|Overall Study||12
9089342|NCT00536380|10153709|FG001|NOT COMPLETED|Overall Study||9
9089343|NCT00536380|10153710|FG002|NOT COMPLETED|Overall Study||10
9089344|NCT00521599|10153721|FG000|STARTED|Overall Study||268
9089345|NCT00521599|10153722|FG001|STARTED|Overall Study||268
9089346|NCT00521599|10153723|FG002|STARTED|Overall Study||136
9089347|NCT00521599|10153721|FG000|COMPLETED|Overall Study||243
9089348|NCT00521599|10153722|FG001|COMPLETED|Overall Study||239
9089349|NCT00521599|10153723|FG002|COMPLETED|Overall Study||100
9089350|NCT00521599|10153721|FG000|NOT COMPLETED|Overall Study||25
9089351|NCT00521599|10153722|FG001|NOT COMPLETED|Overall Study||29
9089352|NCT00521599|10153723|FG002|NOT COMPLETED|Overall Study||36
9089353|NCT00496834|10153734|FG000|STARTED|Overall Study||101
8625188|NCT00506285|9664716|FG001|NOT COMPLETED|6-month Open Label Phase||12
8625189|NCT00506350|9664733|FG000|STARTED|Overall Study||36
8625190|NCT00506350|9664734|FG001|STARTED|Overall Study||40
8625191|NCT00506350|9664735|FG002|STARTED|Overall Study||37
8625192|NCT00506350|9664736|FG003|STARTED|Overall Study||36
8625193|NCT00506350|9664737|FG004|STARTED|Overall Study||50
8625194|NCT00506350|9664738|FG005|STARTED|Overall Study||40
8625195|NCT00506350|9664739|FG006|STARTED|Overall Study||35
8625196|NCT00506350|9664740|FG007|STARTED|Overall Study||41
8625197|NCT00506350|9664741|FG008|STARTED|Overall Study||35
8625198|NCT00506350|9664733|FG000|COMPLETED|Overall Study||33
8625199|NCT00506350|9664734|FG001|COMPLETED|Overall Study||37
8844754|NCT01711983|9899203|FG000|COMPLETED|36-Month Closure Evaluation||278
8844755|NCT01711983|9899203|FG000|NOT COMPLETED|36-Month Closure Evaluation||64
8844756|NCT01712009|9899210|FG000|STARTED|Overall Study||198
8844757|NCT01712009|9899211|FG001|STARTED|Overall Study||200
8844758|NCT01712009|9899212|FG002|STARTED|Overall Study||202
8844759|NCT01712009|9899210|FG000|Received Pegfilgrastim|Overall Study||191
8844760|NCT01712009|9899211|FG001|Received Pegfilgrastim|Overall Study||196
8844761|NCT01712009|9899212|FG002|Received Pegfilgrastim|Overall Study||200
9089354|NCT00496834|10153735|FG001|STARTED|Overall Study||100
9089355|NCT00496834|10153734|FG000|COMPLETED|Overall Study||83
9089356|NCT00496834|10153735|FG001|COMPLETED|Overall Study||87
9089357|NCT00496834|10153734|FG000|NOT COMPLETED|Overall Study||18
9089358|NCT00496834|10153735|FG001|NOT COMPLETED|Overall Study||13
9089359|NCT00442897|10153745|FG000|STARTED|Base Study (12 Week Follow-up)||118
9089360|NCT00442897|10153746|FG001|STARTED|Base Study (12 Week Follow-up)||111
9089361|NCT00442897|10153745|FG000|COMPLETED|Base Study (12 Week Follow-up)||101
9089362|NCT00442897|10153746|FG001|COMPLETED|Base Study (12 Week Follow-up)||99
9089363|NCT00442897|10153745|FG000|NOT COMPLETED|Base Study (12 Week Follow-up)||17
8844762|NCT01712009|9899210|FG000|Received Naproxen / Loratadine|Overall Study||0
8850211|NCT01745952|9905471|FG001|STARTED|Overall Study||4
9089364|NCT00442897|10153746|FG001|NOT COMPLETED|Base Study (12 Week Follow-up)||12
9089365|NCT00442897|10153745|FG000|STARTED|24 Weeks Follow-up (3 Centers)|66 Patients did not continue in the additional 12 week extension, for the 24 weeks follow-up period.|35
9089366|NCT00442897|10153746|FG001|STARTED|24 Weeks Follow-up (3 Centers)|65 Patients did not continue in the additional 12 week extension, for the 24 weeks follow-up period.|34
9089367|NCT00442897|10153745|FG000|COMPLETED|24 Weeks Follow-up (3 Centers)||29
9089368|NCT00442897|10153746|FG001|COMPLETED|24 Weeks Follow-up (3 Centers)||28
9089369|NCT00442897|10153745|FG000|NOT COMPLETED|24 Weeks Follow-up (3 Centers)||6
9089370|NCT00442897|10153746|FG001|NOT COMPLETED|24 Weeks Follow-up (3 Centers)||6
9089371|NCT00423579|10153754|FG000|STARTED|Overall Study|61 enrolled, however one subject was ineligible and was removed.|60
9089372|NCT00423579|10153755|FG001|STARTED|Overall Study||60
9089373|NCT00423579|10153754|FG000|COMPLETED|Overall Study|These 56 subjects were the Intent-to-Treat population. Analysis based on ITT population.|56
9089374|NCT00423579|10153755|FG001|COMPLETED|Overall Study|These 56 subjects were the Intent-to-Treat population. Analysis based on ITT population.|56
9089375|NCT00423579|10153754|FG000|NOT COMPLETED|Overall Study||4
9089376|NCT00423579|10153755|FG001|NOT COMPLETED|Overall Study||4
9089377|NCT00394355|10153765|FG000|STARTED|Overall Study||140
9089378|NCT00394355|10153766|FG001|STARTED|Overall Study||137
9089379|NCT00394355|10153767|FG002|STARTED|Overall Study||147
9089380|NCT00394355|10153768|FG003|STARTED|Overall Study||142
9089381|NCT00394355|10153765|FG000|COMPLETED|Overall Study||105
9089382|NCT00394355|10153766|FG001|COMPLETED|Overall Study||103
9089383|NCT00394355|10153767|FG002|COMPLETED|Overall Study||109
9089384|NCT00394355|10153768|FG003|COMPLETED|Overall Study||111
9089385|NCT00394355|10153765|FG000|NOT COMPLETED|Overall Study||35
9089386|NCT00394355|10153766|FG001|NOT COMPLETED|Overall Study||34
9089387|NCT00394355|10153767|FG002|NOT COMPLETED|Overall Study||38
9089388|NCT00394355|10153768|FG003|NOT COMPLETED|Overall Study||31
9089389|NCT00359216|10153780|FG000|STARTED|Overall Study||20
9089390|NCT00359216|10153781|FG001|STARTED|Overall Study||10
9089391|NCT00359216|10153780|FG000|COMPLETED|Overall Study||20
9089392|NCT00359216|10153781|FG001|COMPLETED|Overall Study|Completed treatment but simultaneously partaking in other study,final study procedures not performed|9
9089393|NCT00359216|10153780|FG000|NOT COMPLETED|Overall Study||0
9089394|NCT00359216|10153781|FG001|NOT COMPLETED|Overall Study||1
9089395|NCT00166504|10153789|FG000|STARTED|Overall Study||108
9089396|NCT00166504|10153790|FG001|STARTED|Overall Study||95
9089397|NCT00166504|10153789|FG000|COMPLETED|Overall Study||103
9089398|NCT00166504|10153790|FG001|COMPLETED|Overall Study||91
9089399|NCT00166504|10153789|FG000|NOT COMPLETED|Overall Study||5
9089400|NCT00166504|10153790|FG001|NOT COMPLETED|Overall Study||4
9089401|NCT01345240|10153801|FG000|STARTED|Overall Study||142
9089402|NCT01345240|10153802|FG001|STARTED|Overall Study||142
9089403|NCT01345240|10153803|FG002|STARTED|Overall Study||141
9089404|NCT01345240|10153804|FG003|STARTED|Overall Study||141
9089405|NCT01345240|10153805|FG004|STARTED|Overall Study||139
9089406|NCT01345240|10153801|FG000|COMPLETED|Overall Study||131
9089407|NCT01345240|10153802|FG001|COMPLETED|Overall Study||128
9089408|NCT01345240|10153803|FG002|COMPLETED|Overall Study||123
9089409|NCT01345240|10153804|FG003|COMPLETED|Overall Study||132
9089410|NCT01345240|10153805|FG004|COMPLETED|Overall Study||129
9089411|NCT01345240|10153801|FG000|NOT COMPLETED|Overall Study||11
9089412|NCT01345240|10153802|FG001|NOT COMPLETED|Overall Study||14
9089413|NCT01345240|10153803|FG002|NOT COMPLETED|Overall Study||18
9089414|NCT01345240|10153804|FG003|NOT COMPLETED|Overall Study||9
9089415|NCT01345240|10153805|FG004|NOT COMPLETED|Overall Study||10
9089416|NCT01371305|10153832|FG000|STARTED|Overall Study||6
9089417|NCT01371305|10153833|FG001|STARTED|Overall Study||6
9089418|NCT01371305|10153834|FG002|STARTED|Overall Study||6
9089419|NCT01371305|10153835|FG003|STARTED|Overall Study||7
9089420|NCT01371305|10153836|FG004|STARTED|Overall Study||6
9089421|NCT01371305|10153837|FG005|STARTED|Overall Study||10
9089422|NCT01371305|10153832|FG000|COMPLETED|Overall Study||6
9089423|NCT01371305|10153833|FG001|COMPLETED|Overall Study||6
9089424|NCT01371305|10153834|FG002|COMPLETED|Overall Study||6
9089425|NCT01371305|10153835|FG003|COMPLETED|Overall Study||5
9089426|NCT01371305|10153836|FG004|COMPLETED|Overall Study||2
9089427|NCT01371305|10153837|FG005|COMPLETED|Overall Study||8
9089428|NCT01371305|10153832|FG000|NOT COMPLETED|Overall Study||0
9089429|NCT01371305|10153833|FG001|NOT COMPLETED|Overall Study||0
9089430|NCT01371305|10153834|FG002|NOT COMPLETED|Overall Study||0
9089431|NCT01371305|10153835|FG003|NOT COMPLETED|Overall Study||2
9089432|NCT01371305|10153836|FG004|NOT COMPLETED|Overall Study||4
9089433|NCT01371305|10153837|FG005|NOT COMPLETED|Overall Study||2
9089434|NCT01376323|10153857|FG000|STARTED|Overall Study||20
9089435|NCT01376323|10153858|FG001|STARTED|Overall Study||18
9089436|NCT01376323|10153859|FG002|STARTED|Overall Study||19
9089437|NCT01376323|10153860|FG003|STARTED|Overall Study||19
9089438|NCT01376323|10153861|FG004|STARTED|Overall Study||18
9089439|NCT01376323|10153857|FG000|COMPLETED|Overall Study||18
9089440|NCT01376323|10153858|FG001|COMPLETED|Overall Study||17
9089441|NCT01376323|10153859|FG002|COMPLETED|Overall Study||16
9089442|NCT01376323|10153860|FG003|COMPLETED|Overall Study||14
9089443|NCT01376323|10153861|FG004|COMPLETED|Overall Study||17
9089444|NCT01376323|10153857|FG000|NOT COMPLETED|Overall Study||2
9089445|NCT01376323|10153858|FG001|NOT COMPLETED|Overall Study||1
9089446|NCT01376323|10153859|FG002|NOT COMPLETED|Overall Study||3
9089447|NCT01376323|10153860|FG003|NOT COMPLETED|Overall Study||5
9089448|NCT01376323|10153861|FG004|NOT COMPLETED|Overall Study||1
9089449|NCT01386658|10153885|FG000|STARTED|Initial Icatibant Exposure||11
9089450|NCT01386658|10153886|FG001|STARTED|Initial Icatibant Exposure||21
9089451|NCT01386658|10153885|FG000|COMPLETED|Initial Icatibant Exposure||11
9089452|NCT01386658|10153886|FG001|COMPLETED|Initial Icatibant Exposure||9
9089453|NCT01386658|10153885|FG000|NOT COMPLETED|Initial Icatibant Exposure||0
9089454|NCT01386658|10153886|FG001|NOT COMPLETED|Initial Icatibant Exposure||12
9089455|NCT01386658|10153885|FG000|STARTED|Icatibant Exposure 2||0
9089456|NCT01386658|10153886|FG001|STARTED|Icatibant Exposure 2||9
9089457|NCT01386658|10153885|FG000|COMPLETED|Icatibant Exposure 2||0
9089458|NCT01386658|10153886|FG001|COMPLETED|Icatibant Exposure 2||9
9089459|NCT01386658|10153885|FG000|NOT COMPLETED|Icatibant Exposure 2||0
9089460|NCT01386658|10153886|FG001|NOT COMPLETED|Icatibant Exposure 2||0
9089461|NCT01386658|10153885|FG000|STARTED|Icatibant Exposure 3||0
9089462|NCT01386658|10153886|FG001|STARTED|Icatibant Exposure 3||9
9089463|NCT01386658|10153885|FG000|COMPLETED|Icatibant Exposure 3||0
9089464|NCT01386658|10153886|FG001|COMPLETED|Icatibant Exposure 3||9
9089465|NCT01386658|10153885|FG000|NOT COMPLETED|Icatibant Exposure 3||0
9089466|NCT01386658|10153886|FG001|NOT COMPLETED|Icatibant Exposure 3||0
9089467|NCT01386684|10153896|FG000|STARTED|Overall Study||552
9089468|NCT01386684|10153896|FG000|COMPLETED|Overall Study||259
9089469|NCT01386684|10153896|FG000|NOT COMPLETED|Overall Study||293
9089470|NCT04980014|10153900|FG000|STARTED|Overall Study||730
9089471|NCT04980014|10153900|FG000|Safety Analysis Set|Overall Study||655
9089472|NCT04980014|10153900|FG000|Effectiveness Analysis Set|Overall Study||482
9089473|NCT04980014|10153900|FG000|COMPLETED|Overall Study||655
9089474|NCT04980014|10153900|FG000|NOT COMPLETED|Overall Study||75
9089475|NCT04503603|10153906|FG000|STARTED|Overall Study||9
9089476|NCT04503603|10153907|FG001|STARTED|Overall Study||3
9089477|NCT04503603|10153906|FG000|COMPLETED|Overall Study||9
9089478|NCT04503603|10153907|FG001|COMPLETED|Overall Study||3
9089479|NCT04503603|10153906|FG000|NOT COMPLETED|Overall Study||0
9089480|NCT04503603|10153907|FG001|NOT COMPLETED|Overall Study||0
9089481|NCT04454918|10153913|FG000|STARTED|Treatment Period 1 (Day 1)||6
9089482|NCT04454918|10153913|FG000|COMPLETED|Treatment Period 1 (Day 1)||6
9089483|NCT04454918|10153913|FG000|NOT COMPLETED|Treatment Period 1 (Day 1)||0
9089484|NCT04454918|10153913|FG000|STARTED|Washout Period (Day 2 to 8)||6
9089485|NCT04454918|10153913|FG000|COMPLETED|Washout Period (Day 2 to 8)||6
9089486|NCT04454918|10153913|FG000|NOT COMPLETED|Washout Period (Day 2 to 8)||0
9089487|NCT04454918|10153913|FG000|STARTED|Treatment Period 2(Day9[Day1of Period2])||6
9089488|NCT04454918|10153913|FG000|COMPLETED|Treatment Period 2(Day9[Day1of Period2])||6
9089489|NCT04454918|10153913|FG000|NOT COMPLETED|Treatment Period 2(Day9[Day1of Period2])||0
9089490|NCT04427501|10153931|FG000|STARTED|Overall Study||156
9089491|NCT04427501|10153932|FG001|STARTED|Overall Study||101
9089492|NCT04427501|10153933|FG002|STARTED|Overall Study||107
9089493|NCT04427501|10153934|FG003|STARTED|Overall Study||101
9089494|NCT04427501|10153935|FG004|STARTED|Overall Study||112
9089495|NCT04427501|10153936|FG005|STARTED|Overall Study|Participants in Placebo for Phase 3: 2800 mg Bamlanivimab + 2800 mg Etesevimab and Phase 3: 700 mg Bamlanivimab + 1400 mg Etesevimab were combined to avoid double counting.|776
9089496|NCT04427501|10153937|FG006|STARTED|Overall Study||518
9089497|NCT04427501|10153938|FG007|STARTED|Overall Study||513
9089498|NCT04427501|10153939|FG008|STARTED|Overall Study||141
9089499|NCT04427501|10153940|FG009|STARTED|Overall Study||213
9089500|NCT04427501|10153931|FG000|Received at Least One Dose of Study Drug|Overall Study||156
9089501|NCT04427501|10153932|FG001|Received at Least One Dose of Study Drug|Overall Study||101
9089502|NCT04427501|10153933|FG002|Received at Least One Dose of Study Drug|Overall Study||107
9089503|NCT04427501|10153934|FG003|Received at Least One Dose of Study Drug|Overall Study||101
9089504|NCT04427501|10153935|FG004|Received at Least One Dose of Study Drug|Overall Study||112
9089505|NCT04427501|10153936|FG005|Received at Least One Dose of Study Drug|Overall Study||776
9089506|NCT04427501|10153937|FG006|Received at Least One Dose of Study Drug|Overall Study||518
9089507|NCT04427501|10153938|FG007|Received at Least One Dose of Study Drug|Overall Study||513
9089508|NCT04427501|10153939|FG008|Received at Least One Dose of Study Drug|Overall Study||141
9089509|NCT04427501|10153940|FG009|Received at Least One Dose of Study Drug|Overall Study||213
9089510|NCT04427501|10153931|FG000|Phase 3: Placebo For 2800 mg Bamlanivimab + 2800 mg Etesevimab|Overall Study||0
9089511|NCT04427501|10153932|FG001|Phase 3: Placebo For 2800 mg Bamlanivimab + 2800 mg Etesevimab|Overall Study||0
9089512|NCT04427501|10153933|FG002|Phase 3: Placebo For 2800 mg Bamlanivimab + 2800 mg Etesevimab|Overall Study||0
9089513|NCT04427501|10153934|FG003|Phase 3: Placebo For 2800 mg Bamlanivimab + 2800 mg Etesevimab|Overall Study||0
9089514|NCT04427501|10153935|FG004|Phase 3: Placebo For 2800 mg Bamlanivimab + 2800 mg Etesevimab|Overall Study||0
9089515|NCT04427501|10153936|FG005|Phase 3: Placebo For 2800 mg Bamlanivimab + 2800 mg Etesevimab|Overall Study||517
9089516|NCT04427501|10153937|FG006|Phase 3: Placebo For 2800 mg Bamlanivimab + 2800 mg Etesevimab|Overall Study||0
9089517|NCT04427501|10153938|FG007|Phase 3: Placebo For 2800 mg Bamlanivimab + 2800 mg Etesevimab|Overall Study||0
9089518|NCT04427501|10153939|FG008|Phase 3: Placebo For 2800 mg Bamlanivimab + 2800 mg Etesevimab|Overall Study||0
9089519|NCT04427501|10153940|FG009|Phase 3: Placebo For 2800 mg Bamlanivimab + 2800 mg Etesevimab|Overall Study||0
9089520|NCT04427501|10153931|FG000|Phase 3: Placebo For 700 mg Bamlanivimab + 1400 mg Etesevimab|Overall Study||0
9089521|NCT04427501|10153932|FG001|Phase 3: Placebo For 700 mg Bamlanivimab + 1400 mg Etesevimab|Overall Study||0
9089522|NCT04427501|10153933|FG002|Phase 3: Placebo For 700 mg Bamlanivimab + 1400 mg Etesevimab|Overall Study||0
9089523|NCT04427501|10153934|FG003|Phase 3: Placebo For 700 mg Bamlanivimab + 1400 mg Etesevimab|Overall Study||0
9089524|NCT04427501|10153935|FG004|Phase 3: Placebo For 700 mg Bamlanivimab + 1400 mg Etesevimab|Overall Study||0
9089525|NCT04427501|10153936|FG005|Phase 3: Placebo For 700 mg Bamlanivimab + 1400 mg Etesevimab|Overall Study||776
9089526|NCT04427501|10153937|FG006|Phase 3: Placebo For 700 mg Bamlanivimab + 1400 mg Etesevimab|Overall Study||0
9089527|NCT04427501|10153938|FG007|Phase 3: Placebo For 700 mg Bamlanivimab + 1400 mg Etesevimab|Overall Study||0
9089528|NCT04427501|10153939|FG008|Phase 3: Placebo For 700 mg Bamlanivimab + 1400 mg Etesevimab|Overall Study||0
9089529|NCT04427501|10153940|FG009|Phase 3: Placebo For 700 mg Bamlanivimab + 1400 mg Etesevimab|Overall Study||0
9089530|NCT04427501|10153931|FG000|COMPLETED|Overall Study||141
9089531|NCT04427501|10153932|FG001|COMPLETED|Overall Study||95
9089532|NCT04427501|10153933|FG002|COMPLETED|Overall Study||103
9089533|NCT04427501|10153934|FG003|COMPLETED|Overall Study||98
9089534|NCT04427501|10153935|FG004|COMPLETED|Overall Study||103
9089535|NCT04427501|10153936|FG005|COMPLETED|Overall Study||719
9089536|NCT04427501|10153937|FG006|COMPLETED|Overall Study||485
9089537|NCT04427501|10153938|FG007|COMPLETED|Overall Study||496
9089538|NCT04427501|10153939|FG008|COMPLETED|Overall Study||135
9089539|NCT04427501|10153940|FG009|COMPLETED|Overall Study||207
9089540|NCT04427501|10153931|FG000|NOT COMPLETED|Overall Study||15
9089541|NCT04427501|10153932|FG001|NOT COMPLETED|Overall Study||6
9089542|NCT04427501|10153933|FG002|NOT COMPLETED|Overall Study||4
9089543|NCT04427501|10153934|FG003|NOT COMPLETED|Overall Study||3
9089544|NCT04427501|10153935|FG004|NOT COMPLETED|Overall Study||9
9089545|NCT04427501|10153936|FG005|NOT COMPLETED|Overall Study||57
9089546|NCT04427501|10153937|FG006|NOT COMPLETED|Overall Study||33
9089547|NCT04427501|10153938|FG007|NOT COMPLETED|Overall Study||17
9089548|NCT04427501|10153939|FG008|NOT COMPLETED|Overall Study||6
9089549|NCT04427501|10153940|FG009|NOT COMPLETED|Overall Study||6
9089550|NCT03735849|10153976|FG000|STARTED|Overall Study||11
9089551|NCT03735849|10153977|FG001|STARTED|Overall Study||13
9089552|NCT03735849|10153978|FG002|STARTED|Overall Study||4
8625200|NCT00506350|9664735|FG002|COMPLETED|Overall Study||31
8625201|NCT00506350|9664736|FG003|COMPLETED|Overall Study||34
8625202|NCT00506350|9664737|FG004|COMPLETED|Overall Study||40
9089553|NCT03735849|10153976|FG000|Safety Population|Overall Study||11
9089554|NCT03735849|10153977|FG001|Safety Population|Overall Study||13
9089555|NCT03735849|10153978|FG002|Safety Population|Overall Study||4
9089556|NCT03735849|10153976|FG000|COMPLETED|Overall Study||9
9089557|NCT03735849|10153977|FG001|COMPLETED|Overall Study||13
9089558|NCT03735849|10153978|FG002|COMPLETED|Overall Study||0
9089559|NCT03735849|10153976|FG000|NOT COMPLETED|Overall Study||2
9089560|NCT03735849|10153977|FG001|NOT COMPLETED|Overall Study||0
9089561|NCT03735849|10153978|FG002|NOT COMPLETED|Overall Study||4
8625203|NCT00506350|9664738|FG005|COMPLETED|Overall Study||38
8625204|NCT00506350|9664739|FG006|COMPLETED|Overall Study||33
8625205|NCT00506350|9664740|FG007|COMPLETED|Overall Study||36
8625206|NCT00506350|9664741|FG008|COMPLETED|Overall Study||30
8625207|NCT00506350|9664733|FG000|NOT COMPLETED|Overall Study||3
8625208|NCT00506350|9664734|FG001|NOT COMPLETED|Overall Study||3
8625209|NCT00506350|9664735|FG002|NOT COMPLETED|Overall Study||6
9089562|NCT03552822|10153987|FG000|STARTED|Overall Study||112
9089563|NCT03552822|10153988|FG001|STARTED|Overall Study||429
9089564|NCT03552822|10153987|FG000|COMPLETED|Overall Study||112
9089565|NCT03552822|10153988|FG001|COMPLETED|Overall Study||429
9089566|NCT03552822|10153987|FG000|NOT COMPLETED|Overall Study||0
8625210|NCT00506350|9664736|FG003|NOT COMPLETED|Overall Study||2
8625211|NCT00506350|9664737|FG004|NOT COMPLETED|Overall Study||10
9089567|NCT03552822|10153988|FG001|NOT COMPLETED|Overall Study||0
9089568|NCT03552393|10153994|FG000|STARTED|Core Period||40
9089569|NCT03552393|10153994|FG000|COMPLETED|Core Period||38
9089570|NCT03552393|10153994|FG000|NOT COMPLETED|Core Period||2
9089571|NCT03552393|10153994|FG000|STARTED|Safety Extension Period||25
9089572|NCT03552393|10153994|FG000|COMPLETED|Safety Extension Period||21
9089573|NCT03552393|10153994|FG000|NOT COMPLETED|Safety Extension Period||4
9089574|NCT03412747|10154001|FG000|STARTED|Initial Treatment Period: Wk0-Wk16||161
9089575|NCT03412747|10154002|FG001|STARTED|Initial Treatment Period: Wk0-Wk16||158
9089576|NCT03412747|10154003|FG002|STARTED|Initial Treatment Period: Wk0-Wk16||159
9089577|NCT03412747|10154001|FG000|COMPLETED|Initial Treatment Period: Wk0-Wk16||154
9089578|NCT03412747|10154002|FG001|COMPLETED|Initial Treatment Period: Wk0-Wk16||153
9089579|NCT03412747|10154003|FG002|COMPLETED|Initial Treatment Period: Wk0-Wk16||150
9089580|NCT03412747|10154001|FG000|NOT COMPLETED|Initial Treatment Period: Wk0-Wk16||7
9089581|NCT03412747|10154002|FG001|NOT COMPLETED|Initial Treatment Period: Wk0-Wk16||5
9089582|NCT03412747|10154003|FG002|NOT COMPLETED|Initial Treatment Period: Wk0-Wk16||9
9089583|NCT03412747|10154001|FG000|STARTED|Maintenance Treatment Period: Wk16-Wk24||154
9089584|NCT03412747|10154002|FG001|STARTED|Maintenance Treatment Period: Wk16-Wk24||153
9089585|NCT03412747|10154003|FG002|STARTED|Maintenance Treatment Period: Wk16-Wk24||150
9089586|NCT03412747|10154001|FG000|COMPLETED|Maintenance Treatment Period: Wk16-Wk24||149
9089587|NCT03412747|10154002|FG001|COMPLETED|Maintenance Treatment Period: Wk16-Wk24||152
9089588|NCT03412747|10154003|FG002|COMPLETED|Maintenance Treatment Period: Wk16-Wk24||149
9089589|NCT03412747|10154001|FG000|NOT COMPLETED|Maintenance Treatment Period: Wk16-Wk24||5
9089590|NCT03412747|10154002|FG001|NOT COMPLETED|Maintenance Treatment Period: Wk16-Wk24||1
9089591|NCT03412747|10154003|FG002|NOT COMPLETED|Maintenance Treatment Period: Wk16-Wk24||1
9089592|NCT03412747|10154001|FG000|STARTED|Maintenance Treatment Period: Wk24-Wk56||149
9089593|NCT03412747|10154002|FG001|STARTED|Maintenance Treatment Period: Wk24-Wk56||152
9089594|NCT03412747|10154003|FG002|STARTED|Maintenance Treatment Period: Wk24-Wk56||149
9089595|NCT03412747|10154001|FG000|COMPLETED|Maintenance Treatment Period: Wk24-Wk56||143
9089596|NCT03412747|10154002|FG001|COMPLETED|Maintenance Treatment Period: Wk24-Wk56||143
9089597|NCT03412747|10154003|FG002|COMPLETED|Maintenance Treatment Period: Wk24-Wk56||133
9089598|NCT03412747|10154001|FG000|NOT COMPLETED|Maintenance Treatment Period: Wk24-Wk56||6
9089599|NCT03412747|10154002|FG001|NOT COMPLETED|Maintenance Treatment Period: Wk24-Wk56||9
9089600|NCT03412747|10154003|FG002|NOT COMPLETED|Maintenance Treatment Period: Wk24-Wk56||16
9089601|NCT03333382|10154023|FG000|STARTED|Overall Study||1
9089602|NCT03333382|10154024|FG001|STARTED|Overall Study||0
9089603|NCT03333382|10154023|FG000|COMPLETED|Overall Study||0
9089604|NCT03333382|10154024|FG001|COMPLETED|Overall Study||0
9089605|NCT03333382|10154023|FG000|NOT COMPLETED|Overall Study||1
9089606|NCT03333382|10154024|FG001|NOT COMPLETED|Overall Study||0
9089607|NCT03129321|10154033|FG000|STARTED|Overall Study||351
9089608|NCT03129321|10154034|FG001|STARTED|Overall Study||350
9089609|NCT03129321|10154035|FG002|STARTED|Overall Study||175
9089610|NCT03129321|10154033|FG000|COMPLETED|Overall Study||253
9089611|NCT03129321|10154034|FG001|COMPLETED|Overall Study||241
9089612|NCT03129321|10154035|FG002|COMPLETED|Overall Study||120
9089613|NCT03129321|10154033|FG000|NOT COMPLETED|Overall Study||98
9089614|NCT03129321|10154034|FG001|NOT COMPLETED|Overall Study||109
9089615|NCT03129321|10154035|FG002|NOT COMPLETED|Overall Study||55
9089616|NCT03107611|10154048|FG000|STARTED|Overall Study||217
9089617|NCT03107611|10154049|FG001|STARTED|Overall Study||216
9089618|NCT03107611|10154050|FG002|STARTED|Overall Study||221
9089619|NCT03107611|10154048|FG000|Dosed|Overall Study||215
9089620|NCT03107611|10154049|FG001|Dosed|Overall Study||214
9089621|NCT03107611|10154050|FG002|Dosed|Overall Study||220
9089622|NCT03107611|10154048|FG000|COMPLETED|Overall Study||210
9089623|NCT03107611|10154049|FG001|COMPLETED|Overall Study||212
9089624|NCT03107611|10154050|FG002|COMPLETED|Overall Study||212
9089625|NCT03107611|10154048|FG000|NOT COMPLETED|Overall Study||7
9089626|NCT03107611|10154049|FG001|NOT COMPLETED|Overall Study||4
9089627|NCT03107611|10154050|FG002|NOT COMPLETED|Overall Study||9
9089628|NCT02720016|10154061|FG000|STARTED|Overall Study||92
9089629|NCT02720016|10154062|FG001|STARTED|Overall Study||92
9089630|NCT02720016|10154063|FG002|STARTED|Overall Study||90
9089631|NCT02720016|10154061|FG000|Y1|Overall Study||26
9089632|NCT02720016|10154062|FG001|Y1|Overall Study||26
9089633|NCT02720016|10154063|FG002|Y1|Overall Study||28
9089634|NCT02720016|10154061|FG000|Y2|Overall Study||34
9089635|NCT02720016|10154062|FG001|Y2|Overall Study||32
9089636|NCT02720016|10154063|FG002|Y2|Overall Study||34
9089637|NCT02720016|10154061|FG000|Y3|Overall Study||28
9089638|NCT02720016|10154062|FG001|Y3|Overall Study||30
9089639|NCT02720016|10154063|FG002|Y3|Overall Study||24
9089640|NCT02720016|10154061|FG000|Y4|Overall Study||4
9089641|NCT02720016|10154062|FG001|Y4|Overall Study||4
9089642|NCT02720016|10154063|FG002|Y4|Overall Study||4
9089643|NCT02720016|10154061|FG000|Veteran Total|Overall Study||46
9089644|NCT02720016|10154062|FG001|Veteran Total|Overall Study||46
9089645|NCT02720016|10154063|FG002|Veteran Total|Overall Study||45
8625212|NCT00506350|9664738|FG005|NOT COMPLETED|Overall Study||2
9089646|NCT02720016|10154061|FG000|Intimate Partner Total|Overall Study||46
9089647|NCT02720016|10154062|FG001|Intimate Partner Total|Overall Study||46
9089648|NCT02720016|10154063|FG002|Intimate Partner Total|Overall Study||45
9089649|NCT02720016|10154061|FG000|COMPLETED|Overall Study||72
9089650|NCT02720016|10154062|FG001|COMPLETED|Overall Study||72
9089651|NCT02720016|10154063|FG002|COMPLETED|Overall Study||70
9089652|NCT02720016|10154061|FG000|NOT COMPLETED|Overall Study||20
9089653|NCT02720016|10154062|FG001|NOT COMPLETED|Overall Study||20
9089654|NCT02720016|10154063|FG002|NOT COMPLETED|Overall Study||20
9089655|NCT02607956|10154074|FG000|STARTED|Double-Blinded Phase||327
9089656|NCT02607956|10154075|FG001|STARTED|Double-Blinded Phase||330
9089657|NCT02607956|10154076|FG002|STARTED|Double-Blinded Phase||0
8625213|NCT00506350|9664739|FG006|NOT COMPLETED|Overall Study||2
8625214|NCT00506350|9664740|FG007|NOT COMPLETED|Overall Study||5
8625215|NCT00506350|9664741|FG008|NOT COMPLETED|Overall Study||5
8625216|NCT00506389|9664771|FG000|STARTED|In-treatment Period||143
9089658|NCT02607956|10154077|FG003|STARTED|Double-Blinded Phase||0
9089659|NCT02607956|10154074|FG000|COMPLETED|Double-Blinded Phase||266
9089660|NCT02607956|10154075|FG001|COMPLETED|Double-Blinded Phase||277
9089661|NCT02607956|10154076|FG002|COMPLETED|Double-Blinded Phase||0
9089662|NCT02607956|10154077|FG003|COMPLETED|Double-Blinded Phase||0
9089663|NCT02607956|10154074|FG000|NOT COMPLETED|Double-Blinded Phase||61
9089664|NCT02607956|10154075|FG001|NOT COMPLETED|Double-Blinded Phase||53
9089665|NCT02607956|10154076|FG002|NOT COMPLETED|Double-Blinded Phase||0
9089666|NCT02607956|10154077|FG003|NOT COMPLETED|Double-Blinded Phase||0
9089667|NCT02607956|10154074|FG000|STARTED|Open-Label Extension Phase|At the End of Blinded Treatment Visit, participants were given the option to receive B/F/TAF FDC in an OL extension phase for up to 96 weeks.|0
9089668|NCT02607956|10154075|FG001|STARTED|Open-Label Extension Phase|At the End of Blinded Treatment Visit, participants were given the option to receive B/F/TAF FDC in an OL extension phase for up to 96 weeks.|0
9089669|NCT02607956|10154076|FG002|STARTED|Open-Label Extension Phase|66 participants from the Double-Blinded Phase did not enter the Open-Label Extension Phase.|254
9089670|NCT02607956|10154077|FG003|STARTED|Open-Label Extension Phase|60 participants from the Double-Blinded Phase did not enter the Open-Label Extension Phase.|265
9089671|NCT02607956|10154074|FG000|COMPLETED|Open-Label Extension Phase||0
9089672|NCT02607956|10154075|FG001|COMPLETED|Open-Label Extension Phase||0
9089673|NCT02607956|10154076|FG002|COMPLETED|Open-Label Extension Phase||225
9089674|NCT02607956|10154077|FG003|COMPLETED|Open-Label Extension Phase||235
9089675|NCT02607956|10154074|FG000|NOT COMPLETED|Open-Label Extension Phase||0
9089676|NCT02607956|10154075|FG001|NOT COMPLETED|Open-Label Extension Phase||0
9089677|NCT02607956|10154076|FG002|NOT COMPLETED|Open-Label Extension Phase||29
9089678|NCT02607956|10154077|FG003|NOT COMPLETED|Open-Label Extension Phase||30
9089679|NCT02564523|10154107|FG000|STARTED|Overall Study||225
9089680|NCT02564523|10154108|FG001|STARTED|Overall Study||43
9089681|NCT02564523|10154109|FG002|STARTED|Overall Study||224
9089682|NCT02564523|10154110|FG003|STARTED|Overall Study||44
9089683|NCT02564523|10154111|FG004|STARTED|Overall Study||110
9089684|NCT02564523|10154112|FG005|STARTED|Overall Study||22
9089685|NCT02564523|10154113|FG006|STARTED|Overall Study||59
9089686|NCT02564523|10154114|FG007|STARTED|Overall Study||12
9089687|NCT02564523|10154115|FG008|STARTED|Overall Study||59
9089688|NCT02564523|10154116|FG009|STARTED|Overall Study||12
9089689|NCT02564523|10154117|FG010|STARTED|Overall Study||55
9089690|NCT02564523|10154118|FG011|STARTED|Overall Study||11
9089691|NCT02564523|10154119|FG012|STARTED|Overall Study||55
9089692|NCT02564523|10154120|FG013|STARTED|Overall Study||10
9089693|NCT02564523|10154121|FG014|STARTED|Overall Study||54
9089694|NCT02564523|10154122|FG015|STARTED|Overall Study||12
9089695|NCT02564523|10154123|FG016|STARTED|Overall Study||54
9089696|NCT02564523|10154124|FG017|STARTED|Overall Study||12
9089697|NCT02564523|10154107|FG000|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||34
9089698|NCT02564523|10154108|FG001|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||8
9089699|NCT02564523|10154109|FG002|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||39
9089700|NCT02564523|10154110|FG003|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||9
9089701|NCT02564523|10154111|FG004|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0
9089702|NCT02564523|10154112|FG005|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0
9089703|NCT02564523|10154113|FG006|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0
9089704|NCT02564523|10154114|FG007|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0
9089705|NCT02564523|10154115|FG008|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0
9089706|NCT02564523|10154116|FG009|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0
9089707|NCT02564523|10154117|FG010|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0
9089708|NCT02564523|10154118|FG011|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0
9089709|NCT02564523|10154119|FG012|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0
9089710|NCT02564523|10154120|FG013|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0
9089711|NCT02564523|10154121|FG014|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0
9089712|NCT02564523|10154122|FG015|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0
8625217|NCT00506389|9664772|FG001|STARTED|In-treatment Period||139
9089713|NCT02564523|10154123|FG016|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0
9089714|NCT02564523|10154124|FG017|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0
9089715|NCT02564523|10154107|FG000|COMPLETED|Overall Study||215
9089716|NCT02564523|10154108|FG001|COMPLETED|Overall Study||40
9089717|NCT02564523|10154109|FG002|COMPLETED|Overall Study||214
9089718|NCT02564523|10154110|FG003|COMPLETED|Overall Study||43
9089719|NCT02564523|10154111|FG004|COMPLETED|Overall Study||106
9089720|NCT02564523|10154112|FG005|COMPLETED|Overall Study||22
9089721|NCT02564523|10154113|FG006|COMPLETED|Overall Study||56
8625218|NCT00506389|9664773|FG002|STARTED|In-treatment Period||137
8625219|NCT00506389|9664771|FG000|All Participants Treated|In-treatment Period||139
8625220|NCT00506389|9664772|FG001|All Participants Treated|In-treatment Period||138
9089722|NCT02564523|10154114|FG007|COMPLETED|Overall Study||12
9089723|NCT02564523|10154115|FG008|COMPLETED|Overall Study||59
9089724|NCT02564523|10154116|FG009|COMPLETED|Overall Study||12
9089725|NCT02564523|10154117|FG010|COMPLETED|Overall Study||52
9089726|NCT02564523|10154118|FG011|COMPLETED|Overall Study||10
9089727|NCT02564523|10154119|FG012|COMPLETED|Overall Study||53
9089728|NCT02564523|10154120|FG013|COMPLETED|Overall Study||10
9089729|NCT02564523|10154121|FG014|COMPLETED|Overall Study||54
9089730|NCT02564523|10154122|FG015|COMPLETED|Overall Study||12
9089731|NCT02564523|10154123|FG016|COMPLETED|Overall Study||54
9089732|NCT02564523|10154124|FG017|COMPLETED|Overall Study||11
9089733|NCT02564523|10154107|FG000|NOT COMPLETED|Overall Study||10
9089734|NCT02564523|10154108|FG001|NOT COMPLETED|Overall Study||3
9089735|NCT02564523|10154109|FG002|NOT COMPLETED|Overall Study||10
9089736|NCT02564523|10154110|FG003|NOT COMPLETED|Overall Study||1
9089737|NCT02564523|10154111|FG004|NOT COMPLETED|Overall Study||4
9089738|NCT02564523|10154112|FG005|NOT COMPLETED|Overall Study||0
9089739|NCT02564523|10154113|FG006|NOT COMPLETED|Overall Study||3
9089740|NCT02564523|10154114|FG007|NOT COMPLETED|Overall Study||0
9089741|NCT02564523|10154115|FG008|NOT COMPLETED|Overall Study||0
9089742|NCT02564523|10154116|FG009|NOT COMPLETED|Overall Study||0
9089743|NCT02564523|10154117|FG010|NOT COMPLETED|Overall Study||3
9089744|NCT02564523|10154118|FG011|NOT COMPLETED|Overall Study||1
9089745|NCT02564523|10154119|FG012|NOT COMPLETED|Overall Study||2
9089746|NCT02564523|10154120|FG013|NOT COMPLETED|Overall Study||0
9089747|NCT02564523|10154121|FG014|NOT COMPLETED|Overall Study||0
9089748|NCT02564523|10154122|FG015|NOT COMPLETED|Overall Study||0
9089749|NCT02564523|10154123|FG016|NOT COMPLETED|Overall Study||0
9089750|NCT02564523|10154124|FG017|NOT COMPLETED|Overall Study||1
9089751|NCT02094716|10154181|FG000|STARTED|Overall Study||43
9089752|NCT02094716|10154182|FG001|STARTED|Overall Study||43
9089753|NCT02094716|10154183|FG002|STARTED|Overall Study||44
9089754|NCT02094716|10154181|FG000|Received Second Dose at Day 14|Overall Study||15
9089755|NCT02094716|10154182|FG001|Received Second Dose at Day 14|Overall Study||10
9089756|NCT02094716|10154183|FG002|Received Second Dose at Day 14|Overall Study||17
9089757|NCT02094716|10154181|FG000|COMPLETED|Overall Study||41
9089758|NCT02094716|10154182|FG001|COMPLETED|Overall Study||36
9089759|NCT02094716|10154183|FG002|COMPLETED|Overall Study||40
9089760|NCT02094716|10154181|FG000|NOT COMPLETED|Overall Study||2
9089761|NCT02094716|10154182|FG001|NOT COMPLETED|Overall Study||7
9089762|NCT02094716|10154183|FG002|NOT COMPLETED|Overall Study||4
9089763|NCT02094261|10154203|FG000|STARTED|Overall Study||210
9089764|NCT02094261|10154203|FG000|COMPLETED|Overall Study||0
9089765|NCT02094261|10154203|FG000|NOT COMPLETED|Overall Study||210
9089766|NCT01988493|10154212|FG000|STARTED|Overall Study||7
9089767|NCT01988493|10154213|FG001|STARTED|Overall Study||14
9089768|NCT01988493|10154214|FG002|STARTED|Overall Study||6
9089769|NCT01988493|10154215|FG003|STARTED|Overall Study||45
9089770|NCT01988493|10154216|FG004|STARTED|Overall Study||45
9089771|NCT01988493|10154212|FG000|Treated|Overall Study||7
9089772|NCT01988493|10154213|FG001|Treated|Overall Study||14
9089773|NCT01988493|10154214|FG002|Treated|Overall Study||6
9089774|NCT01988493|10154215|FG003|Treated|Overall Study||45
9089775|NCT01988493|10154216|FG004|Treated|Overall Study||44
9089776|NCT01988493|10154212|FG000|Safety Population|Overall Study||7
9089777|NCT01988493|10154213|FG001|Safety Population|Overall Study||14
9089778|NCT01988493|10154214|FG002|Safety Population|Overall Study||6
9089779|NCT01988493|10154215|FG003|Safety Population|Overall Study||45
9089780|NCT01988493|10154216|FG004|Safety Population|Overall Study||44
9089781|NCT01988493|10154212|FG000|COMPLETED|Overall Study||7
9089782|NCT01988493|10154213|FG001|COMPLETED|Overall Study||14
9089783|NCT01988493|10154214|FG002|COMPLETED|Overall Study||6
9089784|NCT01988493|10154215|FG003|COMPLETED|Overall Study||45
9089785|NCT01988493|10154216|FG004|COMPLETED|Overall Study||44
9089786|NCT01988493|10154212|FG000|NOT COMPLETED|Overall Study||0
9089787|NCT01988493|10154213|FG001|NOT COMPLETED|Overall Study||0
9089788|NCT01988493|10154214|FG002|NOT COMPLETED|Overall Study||0
9089789|NCT01988493|10154215|FG003|NOT COMPLETED|Overall Study||0
9089790|NCT01988493|10154216|FG004|NOT COMPLETED|Overall Study||1
9089791|NCT01868139|10154228|FG000|STARTED|Overall Study||1
9089792|NCT01868139|10154228|FG000|COMPLETED|Overall Study||0
9089793|NCT01868139|10154228|FG000|NOT COMPLETED|Overall Study||1
9089794|NCT01798004|10154233|FG000|STARTED|Overall Study||150
9089795|NCT01798004|10154233|FG000|COMPLETED|Overall Study||63
9089796|NCT01798004|10154233|FG000|NOT COMPLETED|Overall Study||87
9089797|NCT01620658|10154240|FG000|STARTED|Overall Study||59
9089798|NCT01620658|10154241|FG001|STARTED|Overall Study||74
9089799|NCT01620658|10154242|FG002|STARTED|Overall Study||64
9089800|NCT01620658|10154240|FG000|COMPLETED|Overall Study||35
9089801|NCT01620658|10154241|FG001|COMPLETED|Overall Study||45
9089802|NCT01620658|10154242|FG002|COMPLETED|Overall Study||44
9089803|NCT01620658|10154240|FG000|NOT COMPLETED|Overall Study||24
9089804|NCT01620658|10154241|FG001|NOT COMPLETED|Overall Study||29
9089805|NCT01620658|10154242|FG002|NOT COMPLETED|Overall Study||20
9089806|NCT01447628|10154260|FG000|STARTED|Week 0 to Week 12 (1st Intervention)||19
9089807|NCT01447628|10154261|FG001|STARTED|Week 0 to Week 12 (1st Intervention)||20
9089808|NCT01447628|10154262|FG002|STARTED|Week 0 to Week 12 (1st Intervention)|Randomisation error meant the arms were not balanced- refer to protocol description for full details|12
9089809|NCT01447628|10154263|FG003|STARTED|Week 0 to Week 12 (1st Intervention)|Randomisation error meant the arms were not balanced- refer to protocol description for full details|5
9089810|NCT01447628|10154260|FG000|COMPLETED|Week 0 to Week 12 (1st Intervention)||19
9089811|NCT01447628|10154261|FG001|COMPLETED|Week 0 to Week 12 (1st Intervention)||20
9089812|NCT01447628|10154262|FG002|COMPLETED|Week 0 to Week 12 (1st Intervention)||12
9089813|NCT01447628|10154263|FG003|COMPLETED|Week 0 to Week 12 (1st Intervention)||4
9089814|NCT01447628|10154260|FG000|NOT COMPLETED|Week 0 to Week 12 (1st Intervention)||0
9089815|NCT01447628|10154261|FG001|NOT COMPLETED|Week 0 to Week 12 (1st Intervention)||0
9089816|NCT01447628|10154262|FG002|NOT COMPLETED|Week 0 to Week 12 (1st Intervention)||0
9089817|NCT01447628|10154263|FG003|NOT COMPLETED|Week 0 to Week 12 (1st Intervention)||1
9089818|NCT01447628|10154260|FG000|STARTED|Week 12 to Week 24 (2nd Intervention)||19
9089819|NCT01447628|10154261|FG001|STARTED|Week 12 to Week 24 (2nd Intervention)||20
9089820|NCT01447628|10154262|FG002|STARTED|Week 12 to Week 24 (2nd Intervention)||12
9089821|NCT01447628|10154263|FG003|STARTED|Week 12 to Week 24 (2nd Intervention)||4
9089822|NCT01447628|10154260|FG000|COMPLETED|Week 12 to Week 24 (2nd Intervention)||19
9089823|NCT01447628|10154261|FG001|COMPLETED|Week 12 to Week 24 (2nd Intervention)||20
9089824|NCT01447628|10154262|FG002|COMPLETED|Week 12 to Week 24 (2nd Intervention)||12
9089825|NCT01447628|10154263|FG003|COMPLETED|Week 12 to Week 24 (2nd Intervention)||4
9089826|NCT01447628|10154260|FG000|NOT COMPLETED|Week 12 to Week 24 (2nd Intervention)||0
9089827|NCT01447628|10154261|FG001|NOT COMPLETED|Week 12 to Week 24 (2nd Intervention)||0
9089828|NCT01447628|10154262|FG002|NOT COMPLETED|Week 12 to Week 24 (2nd Intervention)||0
9089829|NCT01447628|10154263|FG003|NOT COMPLETED|Week 12 to Week 24 (2nd Intervention)||0
9089830|NCT01175356|10154283|FG000|STARTED|Overall Study||99
9089831|NCT01175356|10154283|FG000|COMPLETED|Overall Study||18
9089832|NCT01175356|10154283|FG000|NOT COMPLETED|Overall Study||81
9089833|NCT00515853|10154289|FG000|STARTED|Overall Study||61
9089834|NCT00515853|10154290|FG001|STARTED|Overall Study||60
9089835|NCT00515853|10154289|FG000|COMPLETED|Overall Study||46
9089836|NCT00515853|10154290|FG001|COMPLETED|Overall Study||43
9089837|NCT00515853|10154289|FG000|NOT COMPLETED|Overall Study||15
9089838|NCT00515853|10154290|FG001|NOT COMPLETED|Overall Study||17
9089839|NCT00003458|10154296|FG000|STARTED|Overall Study||34
9089840|NCT00003458|10154296|FG000|COMPLETED|Overall Study||30
9089841|NCT00003458|10154296|FG000|NOT COMPLETED|Overall Study||4
9089842|NCT04871815|10154301|FG000|STARTED|Baseline Day 1-7||22
9089843|NCT04871815|10154301|FG000|COMPLETED|Baseline Day 1-7||22
9089844|NCT04871815|10154301|FG000|NOT COMPLETED|Baseline Day 1-7||0
9089845|NCT04871815|10154301|FG000|STARTED|N115 Treatment Day 8-14||22
9089846|NCT04871815|10154301|FG000|COMPLETED|N115 Treatment Day 8-14||22
9089847|NCT04871815|10154301|FG000|NOT COMPLETED|N115 Treatment Day 8-14||0
9089848|NCT04772560|10154313|FG000|STARTED|Overall Study||11
9089849|NCT04772560|10154314|FG001|STARTED|Overall Study||12
9089850|NCT04772560|10154313|FG000|COMPLETED|Overall Study||11
9089851|NCT04772560|10154314|FG001|COMPLETED|Overall Study||12
9089852|NCT04772560|10154313|FG000|NOT COMPLETED|Overall Study||0
9089853|NCT04772560|10154314|FG001|NOT COMPLETED|Overall Study||0
9089854|NCT04613739|10154321|FG000|STARTED|Overall Study||19
9089855|NCT04613739|10154322|FG001|STARTED|Overall Study||37
9089856|NCT04613739|10154321|FG000|COMPLETED|Overall Study||12
8629515|NCT00530790|9669275|FG000|NOT COMPLETED|Overall Study||5
8844763|NCT01712009|9899211|FG001|Received Naproxen / Loratadine|Overall Study||193
8844764|NCT01712009|9899212|FG002|Received Naproxen / Loratadine|Overall Study||198
9089857|NCT04613739|10154322|FG001|COMPLETED|Overall Study||25
9089858|NCT04613739|10154321|FG000|NOT COMPLETED|Overall Study||7
9089859|NCT04613739|10154322|FG001|NOT COMPLETED|Overall Study||12
9089866|NCT04432272|10154339|FG000|STARTED|Overall Study||43
9089867|NCT04432272|10154340|FG001|STARTED|Overall Study||28
9089868|NCT04432272|10154339|FG000|COMPLETED|Overall Study||43
9089869|NCT04432272|10154340|FG001|COMPLETED|Overall Study||28
9089870|NCT04432272|10154339|FG000|NOT COMPLETED|Overall Study||0
9089871|NCT04432272|10154340|FG001|NOT COMPLETED|Overall Study||0
9089872|NCT04407806|10154349|FG000|STARTED|Overall Study||3
9089873|NCT04407806|10154350|FG001|STARTED|Overall Study||3
9089874|NCT04407806|10154349|FG000|COMPLETED|Overall Study||2
9089875|NCT04407806|10154350|FG001|COMPLETED|Overall Study||1
9089876|NCT04407806|10154349|FG000|NOT COMPLETED|Overall Study||1
9089877|NCT04407806|10154350|FG001|NOT COMPLETED|Overall Study||2
9089878|NCT04324021|10154359|FG000|STARTED|Overall Study||5
9089879|NCT04324021|10154360|FG001|STARTED|Overall Study||5
8844765|NCT01712009|9899210|FG000|COMPLETED|Overall Study||160
8844766|NCT01712009|9899211|FG001|COMPLETED|Overall Study||171
8844767|NCT01712009|9899212|FG002|COMPLETED|Overall Study||181
8844768|NCT01712009|9899210|FG000|NOT COMPLETED|Overall Study||38
8844769|NCT01712009|9899211|FG001|NOT COMPLETED|Overall Study||29
8844770|NCT01712009|9899212|FG002|NOT COMPLETED|Overall Study||21
8844771|NCT01712061|9899222|FG000|STARTED|Overall Study||30
8844772|NCT01712061|9899223|FG001|STARTED|Overall Study||140
8844773|NCT01712061|9899224|FG002|STARTED|Overall Study||56
8844774|NCT01712061|9899222|FG000|COMPLETED|Overall Study||20
8844775|NCT01712061|9899223|FG001|COMPLETED|Overall Study||114
8844776|NCT01712061|9899224|FG002|COMPLETED|Overall Study||45
8844777|NCT01712061|9899222|FG000|NOT COMPLETED|Overall Study||10
8844778|NCT01712061|9899223|FG001|NOT COMPLETED|Overall Study||26
8844779|NCT01712061|9899224|FG002|NOT COMPLETED|Overall Study||11
8844780|NCT01712074|9899236|FG000|STARTED|Placebo Run-in Period||195
8844781|NCT01712074|9899237|FG001|STARTED|Placebo Run-in Period||0
8844782|NCT01712074|9899238|FG002|STARTED|Placebo Run-in Period||0
8844783|NCT01712074|9899236|FG000|COMPLETED|Placebo Run-in Period||185
8844784|NCT01712074|9899237|FG001|COMPLETED|Placebo Run-in Period||0
8844785|NCT01712074|9899238|FG002|COMPLETED|Placebo Run-in Period||0
9089880|NCT04324021|10154361|FG002|STARTED|Overall Study||6
9089881|NCT04324021|10154359|FG000|COMPLETED|Overall Study||3
9089882|NCT04324021|10154360|FG001|COMPLETED|Overall Study||4
9089883|NCT04324021|10154361|FG002|COMPLETED|Overall Study||5
9089884|NCT04324021|10154359|FG000|NOT COMPLETED|Overall Study||2
9089885|NCT04324021|10154360|FG001|NOT COMPLETED|Overall Study||1
9089886|NCT04324021|10154361|FG002|NOT COMPLETED|Overall Study||1
9089887|NCT04209621|10154372|FG000|STARTED|Overall Study||3
9089888|NCT04209621|10154372|FG000|Dose Level 1|Overall Study||3
9089889|NCT04209621|10154372|FG000|COMPLETED|Overall Study||0
9089890|NCT04209621|10154372|FG000|NOT COMPLETED|Overall Study||3
9089891|NCT04186663|10154377|FG000|STARTED|Overall Study||59
9089892|NCT04186663|10154377|FG000|COMPLETED|Overall Study||55
9089893|NCT04186663|10154377|FG000|NOT COMPLETED|Overall Study||4
9089894|NCT04158219|10154381|FG000|STARTED|Overall Study||8
9089895|NCT04158219|10154381|FG000|COMPLETED|Overall Study||7
9089896|NCT04158219|10154381|FG000|NOT COMPLETED|Overall Study||1
9089897|NCT04131959|10154385|FG000|STARTED|Overall Study||5
9089898|NCT04131959|10154385|FG000|COMPLETED|Overall Study||5
8844786|NCT01712074|9899236|FG000|NOT COMPLETED|Placebo Run-in Period||10
9089899|NCT04131959|10154385|FG000|NOT COMPLETED|Overall Study||0
9089900|NCT04084990|10154392|FG000|STARTED|Overall Study||2
9089901|NCT04084990|10154393|FG001|STARTED|Overall Study||1
9089902|NCT04084990|10154392|FG000|COMPLETED|Overall Study||2
9089903|NCT04084990|10154393|FG001|COMPLETED|Overall Study||1
9089904|NCT04084990|10154392|FG000|NOT COMPLETED|Overall Study||0
9089905|NCT04084990|10154393|FG001|NOT COMPLETED|Overall Study||0
8844787|NCT01712074|9899237|FG001|NOT COMPLETED|Placebo Run-in Period||0
8844788|NCT01712074|9899238|FG002|NOT COMPLETED|Placebo Run-in Period||0
8844789|NCT01712074|9899236|FG000|STARTED|Double Blind Period||0
8844790|NCT01712074|9899237|FG001|STARTED|Double Blind Period||91
9089906|NCT04056299|10154401|FG000|STARTED|Overall Study||9
9089907|NCT04056299|10154402|FG001|STARTED|Overall Study||6
9089860|NCT04573972|10154330|FG000|STARTED|Overall Study||88
9089861|NCT04573972|10154331|FG001|STARTED|Overall Study||84
9089862|NCT04573972|10154330|FG000|COMPLETED|Overall Study||56
9089863|NCT04573972|10154331|FG001|COMPLETED|Overall Study||70
9089864|NCT04573972|10154330|FG000|NOT COMPLETED|Overall Study||32
9089865|NCT04573972|10154331|FG001|NOT COMPLETED|Overall Study||14
9089908|NCT04056299|10154401|FG000|COMPLETED|Overall Study||6
9089909|NCT04056299|10154402|FG001|COMPLETED|Overall Study||3
9089910|NCT04056299|10154401|FG000|NOT COMPLETED|Overall Study||3
9089911|NCT04056299|10154402|FG001|NOT COMPLETED|Overall Study||3
9089912|NCT04020718|10154410|FG000|STARTED|Pre-assessment and Adaptation||16
9089913|NCT04020718|10154411|FG001|STARTED|Pre-assessment and Adaptation||19
9089914|NCT04020718|10154412|FG002|STARTED|Pre-assessment and Adaptation||0
9089915|NCT04020718|10154413|FG003|STARTED|Pre-assessment and Adaptation||0
9089916|NCT04020718|10154414|FG004|STARTED|Pre-assessment and Adaptation||0
9089917|NCT04020718|10154415|FG005|STARTED|Pre-assessment and Adaptation||0
9089918|NCT04020718|10154416|FG006|STARTED|Pre-assessment and Adaptation||0
9089919|NCT04020718|10154417|FG007|STARTED|Pre-assessment and Adaptation||0
9089920|NCT04020718|10154410|FG000|COMPLETED|Pre-assessment and Adaptation||16
9089921|NCT04020718|10154411|FG001|COMPLETED|Pre-assessment and Adaptation||15
9089922|NCT04020718|10154412|FG002|COMPLETED|Pre-assessment and Adaptation||0
9089923|NCT04020718|10154413|FG003|COMPLETED|Pre-assessment and Adaptation||0
9089924|NCT04020718|10154414|FG004|COMPLETED|Pre-assessment and Adaptation||0
9089925|NCT04020718|10154415|FG005|COMPLETED|Pre-assessment and Adaptation||0
9089926|NCT04020718|10154416|FG006|COMPLETED|Pre-assessment and Adaptation||0
9089927|NCT04020718|10154417|FG007|COMPLETED|Pre-assessment and Adaptation||0
9089928|NCT04020718|10154410|FG000|NOT COMPLETED|Pre-assessment and Adaptation||0
9089929|NCT04020718|10154411|FG001|NOT COMPLETED|Pre-assessment and Adaptation||4
9089930|NCT04020718|10154412|FG002|NOT COMPLETED|Pre-assessment and Adaptation||0
9089931|NCT04020718|10154413|FG003|NOT COMPLETED|Pre-assessment and Adaptation||0
9089932|NCT04020718|10154414|FG004|NOT COMPLETED|Pre-assessment and Adaptation||0
9089933|NCT04020718|10154415|FG005|NOT COMPLETED|Pre-assessment and Adaptation||0
9089934|NCT04020718|10154416|FG006|NOT COMPLETED|Pre-assessment and Adaptation||0
9089935|NCT04020718|10154417|FG007|NOT COMPLETED|Pre-assessment and Adaptation||0
9089936|NCT04020718|10154410|FG000|STARTED|Post-assessment and Adaptation||0
9089937|NCT04020718|10154411|FG001|STARTED|Post-assessment and Adaptation||0
9089938|NCT04020718|10154412|FG002|STARTED|Post-assessment and Adaptation||8
9089939|NCT04020718|10154413|FG003|STARTED|Post-assessment and Adaptation||6
9089940|NCT04020718|10154414|FG004|STARTED|Post-assessment and Adaptation||8
9089941|NCT04020718|10154415|FG005|STARTED|Post-assessment and Adaptation||7
9089942|NCT04020718|10154416|FG006|STARTED|Post-assessment and Adaptation||2
9089943|NCT04020718|10154417|FG007|STARTED|Post-assessment and Adaptation||0
9089944|NCT04020718|10154410|FG000|COMPLETED|Post-assessment and Adaptation||0
9089945|NCT04020718|10154411|FG001|COMPLETED|Post-assessment and Adaptation||0
9089946|NCT04020718|10154412|FG002|COMPLETED|Post-assessment and Adaptation||8
9089947|NCT04020718|10154413|FG003|COMPLETED|Post-assessment and Adaptation||5
9089948|NCT04020718|10154414|FG004|COMPLETED|Post-assessment and Adaptation||8
9089949|NCT04020718|10154415|FG005|COMPLETED|Post-assessment and Adaptation||7
9089950|NCT04020718|10154416|FG006|COMPLETED|Post-assessment and Adaptation||2
9089951|NCT04020718|10154417|FG007|COMPLETED|Post-assessment and Adaptation||0
9089952|NCT04020718|10154410|FG000|NOT COMPLETED|Post-assessment and Adaptation||0
9089953|NCT04020718|10154411|FG001|NOT COMPLETED|Post-assessment and Adaptation||0
9089954|NCT04020718|10154412|FG002|NOT COMPLETED|Post-assessment and Adaptation||0
9089955|NCT04020718|10154413|FG003|NOT COMPLETED|Post-assessment and Adaptation||1
9089956|NCT04020718|10154414|FG004|NOT COMPLETED|Post-assessment and Adaptation||0
9089957|NCT04020718|10154415|FG005|NOT COMPLETED|Post-assessment and Adaptation||0
9089958|NCT04020718|10154416|FG006|NOT COMPLETED|Post-assessment and Adaptation||0
9089959|NCT04020718|10154417|FG007|NOT COMPLETED|Post-assessment and Adaptation||0
9089960|NCT03970109|10154438|FG000|STARTED|Overall Study||15
9089961|NCT03970109|10154439|FG001|STARTED|Overall Study||13
9089962|NCT03970109|10154440|FG002|STARTED|Overall Study||15
9089963|NCT03970109|10154438|FG000|COMPLETED|Overall Study||14
9089964|NCT03970109|10154439|FG001|COMPLETED|Overall Study||10
9089965|NCT03970109|10154440|FG002|COMPLETED|Overall Study||15
9089966|NCT03970109|10154438|FG000|NOT COMPLETED|Overall Study||1
9089967|NCT03970109|10154439|FG001|NOT COMPLETED|Overall Study||3
9089968|NCT03970109|10154440|FG002|NOT COMPLETED|Overall Study||0
9089969|NCT03954743|10154450|FG000|STARTED|Overall Study||677
9089970|NCT03954743|10154451|FG001|STARTED|Overall Study||674
9089971|NCT03954743|10154450|FG000|COMPLETED|Overall Study||653
9089972|NCT03954743|10154451|FG001|COMPLETED|Overall Study||657
9089973|NCT03954743|10154450|FG000|NOT COMPLETED|Overall Study||24
9089974|NCT03954743|10154451|FG001|NOT COMPLETED|Overall Study||17
9089975|NCT03880565|10154459|FG000|STARTED|Overall Study||15
9089976|NCT03880565|10154460|FG001|STARTED|Overall Study||15
9089977|NCT03880565|10154459|FG000|COMPLETED|Overall Study||14
9089978|NCT03880565|10154460|FG001|COMPLETED|Overall Study||15
9089979|NCT03880565|10154459|FG000|NOT COMPLETED|Overall Study||1
9089980|NCT03880565|10154460|FG001|NOT COMPLETED|Overall Study||0
9089981|NCT03833661|10154466|FG000|STARTED|Overall Study||159
9089982|NCT03833661|10154466|FG000|COMPLETED|Overall Study||150
9089983|NCT03833661|10154466|FG000|NOT COMPLETED|Overall Study||9
9089984|NCT03809663|10154474|FG000|STARTED|Overall Study||63
9089985|NCT03809663|10154475|FG001|STARTED|Overall Study||62
9089986|NCT03809663|10154476|FG002|STARTED|Overall Study||63
9089987|NCT03809663|10154477|FG003|STARTED|Overall Study||63
8625221|NCT00506389|9664773|FG002|All Participants Treated|In-treatment Period||136
8625222|NCT00506389|9664771|FG000|COMPLETED|In-treatment Period||117
8625223|NCT00506389|9664772|FG001|COMPLETED|In-treatment Period||124
8625224|NCT00506389|9664773|FG002|COMPLETED|In-treatment Period||125
8625225|NCT00506389|9664771|FG000|NOT COMPLETED|In-treatment Period||26
8625226|NCT00506389|9664772|FG001|NOT COMPLETED|In-treatment Period||15
8625227|NCT00506389|9664773|FG002|NOT COMPLETED|In-treatment Period||12
8625228|NCT00506389|9664771|FG000|STARTED|Follow-up Period|22 participants who discontinued treatment entered the Follow-up Period.|139
8625229|NCT00506389|9664772|FG001|STARTED|Follow-up Period|14 participants who discontinued treatment entered the Follow-up Period.|138
8625230|NCT00506389|9664773|FG002|STARTED|Follow-up Period|11 participants who discontinued treatment entered the Follow-up Period.|136
9089988|NCT03809663|10154478|FG004|STARTED|Overall Study||0
9089989|NCT03809663|10154479|FG005|STARTED|Overall Study||0
9089990|NCT03809663|10154474|FG000|Participants Who Received Investigational Product|Overall Study||63
9089991|NCT03809663|10154475|FG001|Participants Who Received Investigational Product|Overall Study||61
9089992|NCT03809663|10154476|FG002|Participants Who Received Investigational Product|Overall Study||63
9089993|NCT03809663|10154477|FG003|Participants Who Received Investigational Product|Overall Study||63
9089994|NCT03809663|10154478|FG004|Participants Who Received Investigational Product|Overall Study||0
9089995|NCT03809663|10154479|FG005|Participants Who Received Investigational Product|Overall Study||0
9089996|NCT03809663|10154474|FG000|EASI 50 Non-responder at Week 16|Overall Study||40
9089997|NCT03809663|10154475|FG001|EASI 50 Non-responder at Week 16|Overall Study||26
9089998|NCT03809663|10154476|FG002|EASI 50 Non-responder at Week 16|Overall Study||30
9089999|NCT03809663|10154477|FG003|EASI 50 Non-responder at Week 16|Overall Study||38
9090000|NCT03809663|10154478|FG004|EASI 50 Non-responder at Week 16|Overall Study||0
9090001|NCT03809663|10154479|FG005|EASI 50 Non-responder at Week 16|Overall Study||0
9090002|NCT03809663|10154474|FG000|Switched to Tezepelumab 420 mg Q2W After Week 16|Overall Study||39
9090003|NCT03809663|10154475|FG001|Switched to Tezepelumab 420 mg Q2W After Week 16|Overall Study||24
9090004|NCT03809663|10154476|FG002|Switched to Tezepelumab 420 mg Q2W After Week 16|Overall Study||30
9090005|NCT03809663|10154477|FG003|Switched to Tezepelumab 420 mg Q2W After Week 16|Overall Study||38
9090006|NCT03809663|10154478|FG004|Switched to Tezepelumab 420 mg Q2W After Week 16|Overall Study||0
9090007|NCT03809663|10154479|FG005|Switched to Tezepelumab 420 mg Q2W After Week 16|Overall Study||0
9090008|NCT03809663|10154474|FG000|COMPLETED|Overall Study||12
9090009|NCT03809663|10154475|FG001|COMPLETED|Overall Study||18
9090010|NCT03809663|10154476|FG002|COMPLETED|Overall Study||15
9090011|NCT03809663|10154477|FG003|COMPLETED|Overall Study||16
9090012|NCT03809663|10154478|FG004|COMPLETED|Overall Study||0
9090013|NCT03809663|10154479|FG005|COMPLETED|Overall Study||0
9090014|NCT03809663|10154474|FG000|NOT COMPLETED|Overall Study||51
9090015|NCT03809663|10154475|FG001|NOT COMPLETED|Overall Study||44
9090016|NCT03809663|10154476|FG002|NOT COMPLETED|Overall Study||48
9090017|NCT03809663|10154477|FG003|NOT COMPLETED|Overall Study||47
9090018|NCT03809663|10154478|FG004|NOT COMPLETED|Overall Study||0
9090019|NCT03809663|10154479|FG005|NOT COMPLETED|Overall Study||0
9090020|NCT03782792|10154506|FG000|STARTED|Overall Study||18
9090021|NCT03782792|10154507|FG001|STARTED|Overall Study||35
9090022|NCT03782792|10154506|FG000|Received Open Label Treatment With Spesolimab at Wk1/D8|Overall Study||15
9090023|NCT03782792|10154507|FG001|Received Open Label Treatment With Spesolimab at Wk1/D8|Overall Study||12
9090024|NCT03782792|10154506|FG000|Received Rescue Treatment With Spesolimab After Wk1|Overall Study||2
9090025|NCT03782792|10154507|FG001|Received Rescue Treatment With Spesolimab After Wk1|Overall Study||4
9090026|NCT03782792|10154506|FG000|COMPLETED|Overall Study||17
9090027|NCT03782792|10154507|FG001|COMPLETED|Overall Study||32
9090028|NCT03782792|10154506|FG000|NOT COMPLETED|Overall Study||1
9090029|NCT03782792|10154507|FG001|NOT COMPLETED|Overall Study||3
9090030|NCT03750461|10154517|FG000|STARTED|Overall Study||20
9090031|NCT03750461|10154518|FG001|STARTED|Overall Study||92
9090032|NCT03750461|10154517|FG000|Primary Endpoint|Overall Study||20
9090033|NCT03750461|10154518|FG001|Primary Endpoint|Overall Study|Considered study completion for the Historical Controls.|92
9090034|NCT03750461|10154517|FG000|Secondary Endpoint|Overall Study||19
9090035|NCT03750461|10154518|FG001|Secondary Endpoint|Overall Study|Not applicable for the historical controls.|0
9090036|NCT03750461|10154517|FG000|COMPLETED|Overall Study||19
9090037|NCT03750461|10154518|FG001|COMPLETED|Overall Study|Not applicable for the historical controls; no follow-up data was collected.|0
9090038|NCT03750461|10154517|FG000|NOT COMPLETED|Overall Study||1
9090039|NCT03750461|10154518|FG001|NOT COMPLETED|Overall Study||92
9090040|NCT03733119|10154526|FG000|STARTED|Overall Study||2
8625231|NCT00506389|9664771|FG000|COMPLETED|Follow-up Period||139
8625232|NCT00506389|9664772|FG001|COMPLETED|Follow-up Period||138
8625233|NCT00506389|9664773|FG002|COMPLETED|Follow-up Period||136
9090041|NCT03733119|10154527|FG001|STARTED|Overall Study||2
9090042|NCT03733119|10154526|FG000|Treated|Overall Study||2
9090043|NCT03733119|10154527|FG001|Treated|Overall Study||1
9090044|NCT03733119|10154526|FG000|Stopped Treatment After 1 Dose|Overall Study||1
9090045|NCT03733119|10154527|FG001|Stopped Treatment After 1 Dose|Overall Study||0
9090046|NCT03733119|10154526|FG000|Stopped Treatment After 3 Cycles|Overall Study||1
9090047|NCT03733119|10154527|FG001|Stopped Treatment After 3 Cycles|Overall Study||1
9090048|NCT03733119|10154526|FG000|COMPLETED|Overall Study||0
9090049|NCT03733119|10154527|FG001|COMPLETED|Overall Study||0
9090050|NCT03733119|10154526|FG000|NOT COMPLETED|Overall Study||2
9090051|NCT03733119|10154527|FG001|NOT COMPLETED|Overall Study||2
9090052|NCT03661996|10154538|FG000|STARTED|Overall Study||162
9090053|NCT03661996|10154539|FG001|STARTED|Overall Study||180
9090054|NCT03661996|10154540|FG002|STARTED|Overall Study||176
9090055|NCT03661996|10154541|FG003|STARTED|Overall Study||163
9090056|NCT03661996|10154542|FG004|STARTED|Overall Study||173
9090057|NCT03661996|10154538|FG000|Treated|Overall Study||162
9090058|NCT03661996|10154539|FG001|Treated|Overall Study||179
9090059|NCT03661996|10154540|FG002|Treated|Overall Study||175
9090060|NCT03661996|10154541|FG003|Treated|Overall Study||160
9090061|NCT03661996|10154542|FG004|Treated|Overall Study||172
9090062|NCT03661996|10154538|FG000|COMPLETED|Overall Study||150
9090063|NCT03661996|10154539|FG001|COMPLETED|Overall Study||172
9090064|NCT03661996|10154540|FG002|COMPLETED|Overall Study||170
9090065|NCT03661996|10154541|FG003|COMPLETED|Overall Study||150
9090066|NCT03661996|10154542|FG004|COMPLETED|Overall Study||159
9090067|NCT03661996|10154538|FG000|NOT COMPLETED|Overall Study||12
9090068|NCT03661996|10154539|FG001|NOT COMPLETED|Overall Study||8
9090069|NCT03661996|10154540|FG002|NOT COMPLETED|Overall Study||6
9090070|NCT03661996|10154541|FG003|NOT COMPLETED|Overall Study||13
9090071|NCT03661996|10154542|FG004|NOT COMPLETED|Overall Study||14
9090072|NCT03633461|10154559|FG000|STARTED|Overall Study||34
9090073|NCT03633461|10154560|FG001|STARTED|Overall Study||19
9090074|NCT03633461|10154559|FG000|COMPLETED|Overall Study||34
9090075|NCT03633461|10154560|FG001|COMPLETED|Overall Study||18
9090076|NCT03633461|10154559|FG000|NOT COMPLETED|Overall Study||0
9090077|NCT03633461|10154560|FG001|NOT COMPLETED|Overall Study||1
9090078|NCT03622658|10154568|FG000|STARTED|Overall Study||6
9090079|NCT03622658|10154569|FG001|STARTED|Overall Study||36
9090080|NCT03622658|10154568|FG000|COMPLETED|Overall Study||3
9090081|NCT03622658|10154569|FG001|COMPLETED|Overall Study||32
9090082|NCT03622658|10154568|FG000|NOT COMPLETED|Overall Study||3
9090083|NCT03622658|10154569|FG001|NOT COMPLETED|Overall Study||4
9090084|NCT03600142|10154577|FG000|STARTED|Overall Study||777
9090085|NCT03600142|10154578|FG001|STARTED|Overall Study||762
9090086|NCT03600142|10154577|FG000|COMPLETED|Overall Study||773
9090087|NCT03600142|10154578|FG001|COMPLETED|Overall Study||758
9090088|NCT03600142|10154577|FG000|NOT COMPLETED|Overall Study||4
9090089|NCT03600142|10154578|FG001|NOT COMPLETED|Overall Study||4
9090090|NCT03517722|10154588|FG000|STARTED|Double Blind Period: Week 0-52||208
9090091|NCT03517722|10154589|FG001|STARTED|Double Blind Period: Week 0-52||308
9090092|NCT03517722|10154588|FG000|Treated|Double Blind Period: Week 0-52||208
9090093|NCT03517722|10154589|FG001|Treated|Double Blind Period: Week 0-52||307
9090094|NCT03517722|10154588|FG000|COMPLETED|Double Blind Period: Week 0-52||105
9090095|NCT03517722|10154589|FG001|COMPLETED|Double Blind Period: Week 0-52||153
9090096|NCT03517722|10154588|FG000|NOT COMPLETED|Double Blind Period: Week 0-52||103
9090097|NCT03517722|10154589|FG001|NOT COMPLETED|Double Blind Period: Week 0-52||155
9090098|NCT03517722|10154588|FG000|STARTED|Open-label Extension Period: Week 52-113||88
9090099|NCT03517722|10154589|FG001|STARTED|Open-label Extension Period: Week 52-113||137
9090100|NCT03517722|10154588|FG000|COMPLETED|Open-label Extension Period: Week 52-113||0
9090101|NCT03517722|10154589|FG001|COMPLETED|Open-label Extension Period: Week 52-113||0
9090102|NCT03517722|10154588|FG000|NOT COMPLETED|Open-label Extension Period: Week 52-113||88
9090103|NCT03517722|10154589|FG001|NOT COMPLETED|Open-label Extension Period: Week 52-113||137
9090104|NCT03499314|10154598|FG000|STARTED|Overall Study||33
9090105|NCT03499314|10154599|FG001|STARTED|Overall Study||32
9090106|NCT03499314|10154598|FG000|COMPLETED|Overall Study||31
9090107|NCT03499314|10154599|FG001|COMPLETED|Overall Study||29
9090108|NCT03499314|10154598|FG000|NOT COMPLETED|Overall Study||2
9090109|NCT03499314|10154599|FG001|NOT COMPLETED|Overall Study||3
9090110|NCT03439124|10154607|FG000|STARTED|Overall Study||94
9090111|NCT03439124|10154608|FG001|STARTED|Overall Study||44
9090112|NCT03439124|10154607|FG000|COMPLETED|Overall Study||90
9090113|NCT03439124|10154608|FG001|COMPLETED|Overall Study||44
9090114|NCT03439124|10154607|FG000|NOT COMPLETED|Overall Study||4
9090115|NCT03439124|10154608|FG001|NOT COMPLETED|Overall Study||0
9090116|NCT03369431|10154616|FG000|STARTED|Overall Study||35
9090117|NCT03369431|10154617|FG001|STARTED|Overall Study||34
9090118|NCT03369431|10154616|FG000|Taste Test (1 Week)|Overall Study||35
9090119|NCT03369431|10154617|FG001|Taste Test (1 Week)|Overall Study||34
9090120|NCT03369431|10154616|FG000|Part 1 Treatment (12 Weeks)|Overall Study||34
9090121|NCT03369431|10154617|FG001|Part 1 Treatment (12 Weeks)|Overall Study||34
9090122|NCT03369431|10154616|FG000|Washout (4 Weeks)|Overall Study||34
9090123|NCT03369431|10154617|FG001|Washout (4 Weeks)|Overall Study||32
9090124|NCT03369431|10154616|FG000|Part 2 Treatment (12 Weeks)|Overall Study||34
9090125|NCT03369431|10154617|FG001|Part 2 Treatment (12 Weeks)|Overall Study||32
9090126|NCT03369431|10154616|FG000|COMPLETED|Overall Study||31
9090127|NCT03369431|10154617|FG001|COMPLETED|Overall Study||27
9090128|NCT03369431|10154616|FG000|NOT COMPLETED|Overall Study||4
9090129|NCT03369431|10154617|FG001|NOT COMPLETED|Overall Study||7
9090130|NCT03343054|10154626|FG000|STARTED|Dose Escalation Period (Up to 286 Days)||3
9090131|NCT03343054|10154627|FG001|STARTED|Dose Escalation Period (Up to 286 Days)||6
9090132|NCT03343054|10154628|FG002|STARTED|Dose Escalation Period (Up to 286 Days)|Dose escalation and Dose expansion were separate populations.|0
9090133|NCT03343054|10154626|FG000|COMPLETED|Dose Escalation Period (Up to 286 Days)||0
9090134|NCT03343054|10154627|FG001|COMPLETED|Dose Escalation Period (Up to 286 Days)||0
9090135|NCT03343054|10154628|FG002|COMPLETED|Dose Escalation Period (Up to 286 Days)||0
9090136|NCT03343054|10154626|FG000|NOT COMPLETED|Dose Escalation Period (Up to 286 Days)||3
9090137|NCT03343054|10154627|FG001|NOT COMPLETED|Dose Escalation Period (Up to 286 Days)||6
9090138|NCT03343054|10154628|FG002|NOT COMPLETED|Dose Escalation Period (Up to 286 Days)||0
9090139|NCT03343054|10154626|FG000|STARTED|Dose Expansion Period (Up to 502 Days)||0
9090140|NCT03343054|10154627|FG001|STARTED|Dose Expansion Period (Up to 502 Days)||0
9090141|NCT03343054|10154628|FG002|STARTED|Dose Expansion Period (Up to 502 Days)|Dose escalation and Dose expansion were separate populations.|19
9090142|NCT03343054|10154626|FG000|COMPLETED|Dose Expansion Period (Up to 502 Days)||0
9090143|NCT03343054|10154627|FG001|COMPLETED|Dose Expansion Period (Up to 502 Days)||0
9090144|NCT03343054|10154628|FG002|COMPLETED|Dose Expansion Period (Up to 502 Days)||0
9090145|NCT03343054|10154626|FG000|NOT COMPLETED|Dose Expansion Period (Up to 502 Days)||0
9090146|NCT03343054|10154627|FG001|NOT COMPLETED|Dose Expansion Period (Up to 502 Days)||0
9090147|NCT03343054|10154628|FG002|NOT COMPLETED|Dose Expansion Period (Up to 502 Days)||19
9090148|NCT03336866|10154640|FG000|STARTED|Overall Study||20
9090149|NCT03336866|10154641|FG001|STARTED|Overall Study||18
9090150|NCT03336866|10154642|FG002|STARTED|Overall Study||18
9090151|NCT03336866|10154640|FG000|COMPLETED|Overall Study||17
9090152|NCT03336866|10154641|FG001|COMPLETED|Overall Study||17
9090153|NCT03336866|10154642|FG002|COMPLETED|Overall Study||14
9090154|NCT03336866|10154640|FG000|NOT COMPLETED|Overall Study||3
9090155|NCT03336866|10154641|FG001|NOT COMPLETED|Overall Study||1
9090156|NCT03336866|10154642|FG002|NOT COMPLETED|Overall Study||4
9090157|NCT03332173|10154655|FG000|STARTED|Overall Study||44
9090158|NCT03332173|10154655|FG000|COMPLETED|Overall Study||0
9090159|NCT03332173|10154655|FG000|NOT COMPLETED|Overall Study||44
9090160|NCT03322293|10154662|FG000|STARTED|Overall Study||8
9090161|NCT03322293|10154663|FG001|STARTED|Overall Study||8
9090162|NCT03322293|10154664|FG002|STARTED|Overall Study||8
9090163|NCT03322293|10154662|FG000|COMPLETED|Overall Study||8
9090164|NCT03322293|10154663|FG001|COMPLETED|Overall Study||8
9090165|NCT03322293|10154664|FG002|COMPLETED|Overall Study||7
9090166|NCT03322293|10154662|FG000|NOT COMPLETED|Overall Study||0
9090167|NCT03322293|10154663|FG001|NOT COMPLETED|Overall Study||0
9090168|NCT03322293|10154664|FG002|NOT COMPLETED|Overall Study||1
9090169|NCT03315039|10154674|FG000|STARTED|Overall Study||4
9090170|NCT03315039|10154675|FG001|STARTED|Overall Study||3
9090171|NCT03315039|10154674|FG000|COMPLETED|Overall Study||4
9090172|NCT03315039|10154675|FG001|COMPLETED|Overall Study||3
9090173|NCT03315039|10154674|FG000|NOT COMPLETED|Overall Study||0
9090174|NCT03315039|10154675|FG001|NOT COMPLETED|Overall Study||0
9090175|NCT03254394|10154686|FG000|STARTED|Overall Study||12
8844791|NCT01712074|9899238|FG002|STARTED|Double Blind Period||94
8844792|NCT01712074|9899236|FG000|COMPLETED|Double Blind Period||0
8844793|NCT01712074|9899237|FG001|COMPLETED|Double Blind Period||77
8844794|NCT01712074|9899238|FG002|COMPLETED|Double Blind Period||86
8844795|NCT01712074|9899236|FG000|NOT COMPLETED|Double Blind Period||0
9090176|NCT03254394|10154687|FG001|STARTED|Overall Study||14
9090177|NCT03254394|10154686|FG000|COMPLETED|Overall Study||12
9090178|NCT03254394|10154687|FG001|COMPLETED|Overall Study||12
9090179|NCT03254394|10154686|FG000|NOT COMPLETED|Overall Study||0
9090180|NCT03254394|10154687|FG001|NOT COMPLETED|Overall Study||2
9090181|NCT03253809|10154693|FG000|STARTED|Overall Study||14
9090182|NCT03253809|10154693|FG000|COMPLETED|Overall Study||0
9090183|NCT03253809|10154693|FG000|NOT COMPLETED|Overall Study||14
8844796|NCT01712074|9899237|FG001|NOT COMPLETED|Double Blind Period||14
9090184|NCT03180294|10154700|FG000|STARTED|Overall Study||79
9090185|NCT03180294|10154701|FG001|STARTED|Overall Study||74
9090186|NCT03180294|10154702|FG002|STARTED|Overall Study||77
9090187|NCT03180294|10154700|FG000|Eligible Population|Overall Study||79
9090188|NCT03180294|10154701|FG001|Eligible Population|Overall Study||74
9090189|NCT03180294|10154702|FG002|Eligible Population|Overall Study||77
9090190|NCT03180294|10154700|FG000|Adverse Event Population|Overall Study||77
9090191|NCT03180294|10154701|FG001|Adverse Event Population|Overall Study||73
9090192|NCT03180294|10154702|FG002|Adverse Event Population|Overall Study||76
9090193|NCT03180294|10154700|FG000|COMPLETED|Overall Study||79
9090194|NCT03180294|10154701|FG001|COMPLETED|Overall Study||74
9090195|NCT03180294|10154702|FG002|COMPLETED|Overall Study||77
9090196|NCT03180294|10154700|FG000|NOT COMPLETED|Overall Study||0
9090197|NCT03180294|10154701|FG001|NOT COMPLETED|Overall Study||0
9090198|NCT03180294|10154702|FG002|NOT COMPLETED|Overall Study||0
9090199|NCT03151408|10154713|FG000|STARTED|Overall Study|Screened patients|203
9090200|NCT03151408|10154714|FG001|STARTED|Overall Study|Screened patients|203
9090201|NCT03151408|10154713|FG000|Treated|Overall Study||201
9090202|NCT03151408|10154714|FG001|Treated|Overall Study||201
9090203|NCT03151408|10154713|FG000|COMPLETED|Overall Study||0
9090204|NCT03151408|10154714|FG001|COMPLETED|Overall Study||0
9090205|NCT03151408|10154713|FG000|NOT COMPLETED|Overall Study||203
9090206|NCT03151408|10154714|FG001|NOT COMPLETED|Overall Study||203
9090207|NCT03137173|10154722|FG000|STARTED|Overall Study||335
9090208|NCT03137173|10154723|FG001|STARTED|Overall Study||344
9090209|NCT03137173|10154722|FG000|COMPLETED|Overall Study||309
9090210|NCT03137173|10154723|FG001|COMPLETED|Overall Study||308
9090211|NCT03137173|10154722|FG000|NOT COMPLETED|Overall Study||26
9090212|NCT03137173|10154723|FG001|NOT COMPLETED|Overall Study||36
9090213|NCT03111030|10154732|FG000|STARTED|Overall Study||14
9090214|NCT03111030|10154733|FG001|STARTED|Overall Study||14
9090215|NCT03111030|10154732|FG000|COMPLETED|Overall Study||14
9090216|NCT03111030|10154733|FG001|COMPLETED|Overall Study||14
9090217|NCT03111030|10154732|FG000|NOT COMPLETED|Overall Study||0
9090218|NCT03111030|10154733|FG001|NOT COMPLETED|Overall Study||0
9090219|NCT03100149|10154742|FG000|STARTED|Overall Study||105
9090220|NCT03100149|10154743|FG001|STARTED|Overall Study||105
9090221|NCT03100149|10154744|FG002|STARTED|Overall Study||106
9090222|NCT03100149|10154742|FG000|COMPLETED|Overall Study||105
9090223|NCT03100149|10154743|FG001|COMPLETED|Overall Study||101
9090224|NCT03100149|10154744|FG002|COMPLETED|Overall Study||104
9090225|NCT03100149|10154742|FG000|NOT COMPLETED|Overall Study||0
9090226|NCT03100149|10154743|FG001|NOT COMPLETED|Overall Study||4
9090227|NCT03100149|10154744|FG002|NOT COMPLETED|Overall Study||2
9090228|NCT03081052|10154756|FG000|STARTED|Overall Study||98
9090229|NCT03081052|10154757|FG001|STARTED|Overall Study||103
9090230|NCT03081052|10154758|FG002|STARTED|Overall Study||111
9090231|NCT03081052|10154759|FG003|STARTED|Overall Study||120
9090232|NCT03081052|10154756|FG000|COMPLETED|Overall Study||98
9090233|NCT03081052|10154757|FG001|COMPLETED|Overall Study||103
8844797|NCT01712074|9899238|FG002|NOT COMPLETED|Double Blind Period||8
8844798|NCT01712178|9899255|FG000|STARTED|Overall Study||50
8844799|NCT01712178|9899256|FG001|STARTED|Overall Study||50
8844800|NCT01712178|9899255|FG000|COMPLETED|Overall Study||49
8844801|NCT01712178|9899256|FG001|COMPLETED|Overall Study||47
8844802|NCT01712178|9899255|FG000|NOT COMPLETED|Overall Study||1
8844803|NCT01712178|9899256|FG001|NOT COMPLETED|Overall Study||3
8844804|NCT01712204|9899264|FG000|STARTED|Overall Study||41
8844805|NCT01712204|9899265|FG001|STARTED|Overall Study||41
8844806|NCT01712204|9899264|FG000|COMPLETED|Overall Study||33
9090234|NCT03081052|10154758|FG002|COMPLETED|Overall Study||111
9090235|NCT03081052|10154759|FG003|COMPLETED|Overall Study||120
9090236|NCT03081052|10154756|FG000|NOT COMPLETED|Overall Study||0
9090237|NCT03081052|10154757|FG001|NOT COMPLETED|Overall Study||0
9090238|NCT03081052|10154758|FG002|NOT COMPLETED|Overall Study||0
9090239|NCT03081052|10154759|FG003|NOT COMPLETED|Overall Study||0
9090240|NCT03028740|10154775|FG000|STARTED|Overall Study||593
9090241|NCT03028740|10154776|FG001|STARTED|Overall Study||1185
9090242|NCT03028740|10154775|FG000|Full Study Cohort: Received Study Drug|Overall Study||589
9090243|NCT03028740|10154776|FG001|Full Study Cohort: Received Study Drug|Overall Study||1180
9090244|NCT03028740|10154775|FG000|Participated in Part 1|Overall Study||432
9090245|NCT03028740|10154776|FG001|Participated in Part 1|Overall Study||861
9090246|NCT03028740|10154775|FG000|Part 1: Received Study Drug|Overall Study||429
9090247|NCT03028740|10154776|FG001|Part 1: Received Study Drug|Overall Study||859
9090248|NCT03028740|10154775|FG000|COMPLETED|Overall Study||0
9090249|NCT03028740|10154776|FG001|COMPLETED|Overall Study||0
9090250|NCT03028740|10154775|FG000|NOT COMPLETED|Overall Study||593
9090251|NCT03028740|10154776|FG001|NOT COMPLETED|Overall Study||1185
9090252|NCT03015142|10154785|FG000|STARTED|Overall Study||21
8844807|NCT01712204|9899265|FG001|COMPLETED|Overall Study||36
8844808|NCT01712204|9899264|FG000|NOT COMPLETED|Overall Study||8
9090253|NCT03015142|10154785|FG000|COMPLETED|Overall Study||20
9090254|NCT03015142|10154785|FG000|NOT COMPLETED|Overall Study||1
8844809|NCT01712204|9899265|FG001|NOT COMPLETED|Overall Study||5
9090255|NCT03012672|10154793|FG000|STARTED|Overall Study||20
9090256|NCT03012672|10154794|FG001|STARTED|Overall Study||30
9090257|NCT03012672|10154793|FG000|COMPLETED|Overall Study||20
9090258|NCT03012672|10154794|FG001|COMPLETED|Overall Study||30
9090259|NCT03012672|10154793|FG000|NOT COMPLETED|Overall Study||0
9090260|NCT03012672|10154794|FG001|NOT COMPLETED|Overall Study||0
9090261|NCT03011775|10154801|FG000|STARTED|Overall Study||20
9090262|NCT03011775|10154802|FG001|STARTED|Overall Study||23
9090263|NCT03011775|10154801|FG000|COMPLETED|Overall Study||20
9090264|NCT03011775|10154802|FG001|COMPLETED|Overall Study||23
9090265|NCT03011775|10154801|FG000|NOT COMPLETED|Overall Study||0
9090266|NCT03011775|10154802|FG001|NOT COMPLETED|Overall Study||0
9090267|NCT03007485|10154814|FG000|STARTED|Overall Study||98
9090268|NCT03007485|10154815|FG001|STARTED|Overall Study||111
9090269|NCT03007485|10154814|FG000|COMPLETED|Overall Study||28
9090270|NCT03007485|10154815|FG001|COMPLETED|Overall Study||57
9090271|NCT03007485|10154814|FG000|NOT COMPLETED|Overall Study||70
9090272|NCT03007485|10154815|FG001|NOT COMPLETED|Overall Study||54
9090273|NCT02998476|10154828|FG000|STARTED|Overall Study||55
9090274|NCT02998476|10154829|FG001|STARTED|Overall Study||5
9090275|NCT02998476|10154828|FG000|COMPLETED|Overall Study||0
9090276|NCT02998476|10154829|FG001|COMPLETED|Overall Study||0
9090277|NCT02998476|10154828|FG000|NOT COMPLETED|Overall Study||55
9090278|NCT02998476|10154829|FG001|NOT COMPLETED|Overall Study||5
9090279|NCT02960997|10154838|FG000|STARTED|First Intervention, 12 Weeks||4
9090280|NCT02960997|10154839|FG001|STARTED|First Intervention, 12 Weeks||4
9090281|NCT02960997|10154838|FG000|COMPLETED|First Intervention, 12 Weeks||4
9090282|NCT02960997|10154839|FG001|COMPLETED|First Intervention, 12 Weeks||4
9090283|NCT02960997|10154838|FG000|NOT COMPLETED|First Intervention, 12 Weeks||0
9090284|NCT02960997|10154839|FG001|NOT COMPLETED|First Intervention, 12 Weeks||0
9090285|NCT02960997|10154838|FG000|STARTED|Washout Period, 4 Weeks||4
9090286|NCT02960997|10154839|FG001|STARTED|Washout Period, 4 Weeks||4
9090287|NCT02960997|10154838|FG000|COMPLETED|Washout Period, 4 Weeks||4
8844810|NCT01712230|9899274|FG000|STARTED|Overall Study||11
8844811|NCT01712230|9899275|FG001|STARTED|Overall Study||18
8844812|NCT01712230|9899276|FG002|STARTED|Overall Study||18
8844813|NCT01712230|9899274|FG000|COMPLETED|Overall Study||9
8844814|NCT01712230|9899275|FG001|COMPLETED|Overall Study||14
8844815|NCT01712230|9899276|FG002|COMPLETED|Overall Study||11
8844816|NCT01712230|9899274|FG000|NOT COMPLETED|Overall Study||2
8844817|NCT01712230|9899275|FG001|NOT COMPLETED|Overall Study||4
8844818|NCT01712230|9899276|FG002|NOT COMPLETED|Overall Study||7
9090288|NCT02960997|10154839|FG001|COMPLETED|Washout Period, 4 Weeks||4
9090289|NCT02960997|10154838|FG000|NOT COMPLETED|Washout Period, 4 Weeks||0
9090290|NCT02960997|10154839|FG001|NOT COMPLETED|Washout Period, 4 Weeks||0
9090291|NCT02960997|10154838|FG000|STARTED|Second Treatment, 12 Weeks||4
9090292|NCT02960997|10154839|FG001|STARTED|Second Treatment, 12 Weeks||4
9090293|NCT02960997|10154838|FG000|COMPLETED|Second Treatment, 12 Weeks||4
9090294|NCT02960997|10154839|FG001|COMPLETED|Second Treatment, 12 Weeks||4
9090295|NCT02960997|10154838|FG000|NOT COMPLETED|Second Treatment, 12 Weeks||0
9090296|NCT02960997|10154839|FG001|NOT COMPLETED|Second Treatment, 12 Weeks||0
9090297|NCT02960997|10154838|FG000|STARTED|Follow-up Period, 4 Weeks||4
9090298|NCT02960997|10154839|FG001|STARTED|Follow-up Period, 4 Weeks||4
9090299|NCT02960997|10154838|FG000|COMPLETED|Follow-up Period, 4 Weeks||4
9090300|NCT02960997|10154839|FG001|COMPLETED|Follow-up Period, 4 Weeks||4
9090301|NCT02960997|10154838|FG000|NOT COMPLETED|Follow-up Period, 4 Weeks||0
9090302|NCT02960997|10154839|FG001|NOT COMPLETED|Follow-up Period, 4 Weeks||0
9090303|NCT02949128|10154845|FG000|STARTED|Initial Evaluation Period||58
9090304|NCT02949128|10154845|FG000|Received At Least 1 Dose of Study Drug|Initial Evaluation Period||58
9090305|NCT02949128|10154845|FG000|COMPLETED|Initial Evaluation Period||49
9090306|NCT02949128|10154845|FG000|NOT COMPLETED|Initial Evaluation Period||9
9090307|NCT02949128|10154845|FG000|STARTED|Extension Period||49
9090308|NCT02949128|10154845|FG000|Received At Least 1 Dose of Study Drug|Extension Period||47
9090309|NCT02949128|10154845|FG000|COMPLETED|Extension Period||47
9090310|NCT02949128|10154845|FG000|NOT COMPLETED|Extension Period||2
9090314|NCT02924064|10154855|FG000|STARTED|Overall Study||123
9090315|NCT02924064|10154856|FG001|STARTED|Overall Study||124
9090316|NCT02924064|10154855|FG000|FAS|Overall Study||122
9090317|NCT02924064|10154856|FG001|FAS|Overall Study||124
9090318|NCT02924064|10154855|FG000|COMPLETED|Overall Study||99
9090319|NCT02924064|10154856|FG001|COMPLETED|Overall Study||81
9090320|NCT02924064|10154855|FG000|NOT COMPLETED|Overall Study||24
9090321|NCT02924064|10154856|FG001|NOT COMPLETED|Overall Study||43
9090322|NCT02916706|10154864|FG000|STARTED|Overall Study||127
9090323|NCT02916706|10154865|FG001|STARTED|Overall Study||127
9090324|NCT02916706|10154864|FG000|FAS|Overall Study||125
9090325|NCT02916706|10154865|FG001|FAS|Overall Study||126
9090326|NCT02916706|10154864|FG000|COMPLETED|Overall Study||112
9090327|NCT02916706|10154865|FG001|COMPLETED|Overall Study||96
9090328|NCT02916706|10154864|FG000|NOT COMPLETED|Overall Study||15
9090329|NCT02916706|10154865|FG001|NOT COMPLETED|Overall Study||31
9090330|NCT02889900|10154871|FG000|STARTED|Overall Study||62
9090331|NCT02889900|10154871|FG000|Received Treatment|Overall Study||60
9090332|NCT02889900|10154871|FG000|COMPLETED|Overall Study|Patients ongoing in study at primary analysis data cut off (DCO)|5
9090333|NCT02889900|10154871|FG000|NOT COMPLETED|Overall Study||57
8844819|NCT01712256|9899284|FG000|STARTED|Overall Study||33
8844820|NCT01712256|9899284|FG000|COMPLETED|Overall Study||32
9090334|NCT02866695|10154875|FG000|STARTED|Overall Study||20
9090335|NCT02866695|10154875|FG000|COMPLETED|Overall Study||18
9090336|NCT02866695|10154875|FG000|NOT COMPLETED|Overall Study||2
9090337|NCT02854436|10154879|FG000|STARTED|Overall Study||289
9090338|NCT02854436|10154879|FG000|Intent to Treat Participants (Breast Cancer Gene [BRCA] and Non-BRCA Participants)|Overall Study|There were 142 BRCA participants and 81 non-BRCA participants.|223
9090339|NCT02854436|10154879|FG000|COMPLETED|Overall Study||0
9090340|NCT02854436|10154879|FG000|NOT COMPLETED|Overall Study||289
9090341|NCT02834793|10154885|FG000|STARTED|Core Study (Up to 18 Weeks)||36
9090342|NCT02834793|10154886|FG001|STARTED|Core Study (Up to 18 Weeks)||34
9090343|NCT02834793|10154887|FG002|STARTED|Core Study (Up to 18 Weeks)||0
9090344|NCT02834793|10154888|FG003|STARTED|Core Study (Up to 18 Weeks)||0
9090345|NCT02834793|10154885|FG000|COMPLETED|Core Study (Up to 18 Weeks)||32
9090346|NCT02834793|10154886|FG001|COMPLETED|Core Study (Up to 18 Weeks)||29
9090347|NCT02834793|10154887|FG002|COMPLETED|Core Study (Up to 18 Weeks)||0
9090348|NCT02834793|10154888|FG003|COMPLETED|Core Study (Up to 18 Weeks)||0
9090349|NCT02834793|10154885|FG000|NOT COMPLETED|Core Study (Up to 18 Weeks)||4
9090350|NCT02834793|10154886|FG001|NOT COMPLETED|Core Study (Up to 18 Weeks)||5
9090351|NCT02834793|10154887|FG002|NOT COMPLETED|Core Study (Up to 18 Weeks)||0
9090352|NCT02834793|10154888|FG003|NOT COMPLETED|Core Study (Up to 18 Weeks)||0
9090353|NCT02834793|10154885|FG000|STARTED|Extension Phase A (up to 52 Weeks)||0
9090354|NCT02834793|10154886|FG001|STARTED|Extension Phase A (up to 52 Weeks)||0
9090355|NCT02834793|10154887|FG002|STARTED|Extension Phase A (up to 52 Weeks)|Only eligible participants who completed Core Study entered into Extension Phase A.|58
9090356|NCT02834793|10154888|FG003|STARTED|Extension Phase A (up to 52 Weeks)||0
9090357|NCT02834793|10154885|FG000|COMPLETED|Extension Phase A (up to 52 Weeks)||0
9090358|NCT02834793|10154886|FG001|COMPLETED|Extension Phase A (up to 52 Weeks)||0
9090359|NCT02834793|10154887|FG002|COMPLETED|Extension Phase A (up to 52 Weeks)||32
9090360|NCT02834793|10154888|FG003|COMPLETED|Extension Phase A (up to 52 Weeks)||0
9090361|NCT02834793|10154885|FG000|NOT COMPLETED|Extension Phase A (up to 52 Weeks)||0
9090362|NCT02834793|10154886|FG001|NOT COMPLETED|Extension Phase A (up to 52 Weeks)||0
9090363|NCT02834793|10154887|FG002|NOT COMPLETED|Extension Phase A (up to 52 Weeks)||26
9090364|NCT02834793|10154888|FG003|NOT COMPLETED|Extension Phase A (up to 52 Weeks)||0
9090365|NCT02834793|10154885|FG000|STARTED|Extension Phase B (up to 188 Weeks)||0
9090366|NCT02834793|10154886|FG001|STARTED|Extension Phase B (up to 188 Weeks)||0
9090367|NCT02834793|10154887|FG002|STARTED|Extension Phase B (up to 188 Weeks)||0
9090368|NCT02834793|10154888|FG003|STARTED|Extension Phase B (up to 188 Weeks)|Only eligible participants who completed Extension Phase A entered into Extension Phase B.|13
9090369|NCT02834793|10154885|FG000|COMPLETED|Extension Phase B (up to 188 Weeks)||0
9090370|NCT02834793|10154886|FG001|COMPLETED|Extension Phase B (up to 188 Weeks)||0
9090371|NCT02834793|10154887|FG002|COMPLETED|Extension Phase B (up to 188 Weeks)||0
9090372|NCT02834793|10154888|FG003|COMPLETED|Extension Phase B (up to 188 Weeks)||1
9090373|NCT02834793|10154885|FG000|NOT COMPLETED|Extension Phase B (up to 188 Weeks)||0
9090374|NCT02834793|10154886|FG001|NOT COMPLETED|Extension Phase B (up to 188 Weeks)||0
9090375|NCT02834793|10154887|FG002|NOT COMPLETED|Extension Phase B (up to 188 Weeks)||0
9090376|NCT02834793|10154888|FG003|NOT COMPLETED|Extension Phase B (up to 188 Weeks)||12
9090377|NCT02810457|10154898|FG000|STARTED|Overall Study|362 patients received study treatment|364
9090378|NCT02810457|10154899|FG001|STARTED|Overall Study|366 patients received study treatment|367
9090379|NCT02810457|10154898|FG000|COMPLETED|Overall Study||37
9090380|NCT02810457|10154899|FG001|COMPLETED|Overall Study||38
9090381|NCT02810457|10154898|FG000|NOT COMPLETED|Overall Study||327
9090382|NCT02810457|10154899|FG001|NOT COMPLETED|Overall Study||329
9090383|NCT02797964|10154911|FG000|STARTED|Overall Study||32
9090384|NCT02797964|10154912|FG001|STARTED|Overall Study||37
9090385|NCT02797964|10154913|FG002|STARTED|Overall Study||10
9090386|NCT02797964|10154914|FG003|STARTED|Overall Study||16
9090387|NCT02797964|10154915|FG004|STARTED|Overall Study||4
9090388|NCT02797964|10154916|FG005|STARTED|Overall Study||8
9090389|NCT02797964|10154911|FG000|COMPLETED|Overall Study||32
8625234|NCT00506389|9664771|FG000|NOT COMPLETED|Follow-up Period||0
8625235|NCT00506389|9664772|FG001|NOT COMPLETED|Follow-up Period||0
8625236|NCT00506389|9664773|FG002|NOT COMPLETED|Follow-up Period||0
9090390|NCT02797964|10154912|FG001|COMPLETED|Overall Study||37
9090391|NCT02797964|10154913|FG002|COMPLETED|Overall Study||10
9090392|NCT02797964|10154914|FG003|COMPLETED|Overall Study||16
9090393|NCT02797964|10154915|FG004|COMPLETED|Overall Study||4
9090394|NCT02797964|10154916|FG005|COMPLETED|Overall Study||8
9090395|NCT02797964|10154911|FG000|NOT COMPLETED|Overall Study||0
8625237|NCT00506415|9664784|FG000|STARTED|Initial Open Label (Maximum 48 Weeks)|Enrolled patients.|1584
8625238|NCT00506415|9664785|FG001|STARTED|Initial Open Label (Maximum 48 Weeks)||0
8625239|NCT00506415|9664786|FG002|STARTED|Initial Open Label (Maximum 48 Weeks)||0
8625240|NCT00506415|9664787|FG003|STARTED|Initial Open Label (Maximum 48 Weeks)||0
9090396|NCT02797964|10154912|FG001|NOT COMPLETED|Overall Study||0
9090397|NCT02797964|10154913|FG002|NOT COMPLETED|Overall Study||0
9090398|NCT02797964|10154914|FG003|NOT COMPLETED|Overall Study||0
9090399|NCT02797964|10154915|FG004|NOT COMPLETED|Overall Study||0
9090400|NCT02797964|10154916|FG005|NOT COMPLETED|Overall Study||0
8625241|NCT00506415|9664784|FG000|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||1582
9090401|NCT02746809|10154929|FG000|STARTED|Baseline- 30 Days||60
9090402|NCT02746809|10154929|FG000|COMPLETED|Baseline- 30 Days||59
9090403|NCT02746809|10154929|FG000|NOT COMPLETED|Baseline- 30 Days||1
9090404|NCT02746809|10154929|FG000|STARTED|Baseline-6 Months||59
9090405|NCT02746809|10154929|FG000|COMPLETED|Baseline-6 Months||54
9090406|NCT02746809|10154929|FG000|NOT COMPLETED|Baseline-6 Months||5
9090407|NCT02745535|10154935|FG000|STARTED|Overall Study||77
9090408|NCT02745535|10154935|FG000|Sustained Virologic Repsonse|Overall Study|Sustained Virologic response measured 24 weeks after completing study medication|70
9090409|NCT02745535|10154935|FG000|COMPLETED|Overall Study|Completed 12 weeks of study medication per protocol|71
9090410|NCT02745535|10154935|FG000|NOT COMPLETED|Overall Study||6
9090411|NCT02738853|10154939|FG000|STARTED|Baseline -30 Days||60
9090412|NCT02738853|10154939|FG000|COMPLETED|Baseline -30 Days||59
9090413|NCT02738853|10154939|FG000|NOT COMPLETED|Baseline -30 Days||1
9090414|NCT02738853|10154939|FG000|STARTED|30 Days- 6 Months||59
9090415|NCT02738853|10154939|FG000|COMPLETED|30 Days- 6 Months||57
9090416|NCT02738853|10154939|FG000|NOT COMPLETED|30 Days- 6 Months||2
9090417|NCT02729701|10154943|FG000|STARTED|Overall Study||28
9090418|NCT02729701|10154943|FG000|COMPLETED|Overall Study||28
9090419|NCT02729701|10154943|FG000|NOT COMPLETED|Overall Study||0
9090420|NCT02684253|10154949|FG000|STARTED|Overall Study||32
9090421|NCT02684253|10154950|FG001|STARTED|Overall Study||33
9090422|NCT02684253|10154949|FG000|COMPLETED|Overall Study||32
9090423|NCT02684253|10154950|FG001|COMPLETED|Overall Study||33
9090424|NCT02684253|10154949|FG000|NOT COMPLETED|Overall Study||0
9090425|NCT02684253|10154950|FG001|NOT COMPLETED|Overall Study||0
9090426|NCT02681406|10154960|FG000|STARTED|Overall Study||65
9090427|NCT02681406|10154961|FG001|STARTED|Overall Study||59
9090428|NCT02681406|10154962|FG002|STARTED|Overall Study||68
9090429|NCT02681406|10154963|FG003|STARTED|Overall Study||70
9090430|NCT02681406|10154960|FG000|COMPLETED|Overall Study||49
9090431|NCT02681406|10154961|FG001|COMPLETED|Overall Study||35
9090432|NCT02681406|10154962|FG002|COMPLETED|Overall Study||42
9090433|NCT02681406|10154963|FG003|COMPLETED|Overall Study||58
9090434|NCT02681406|10154960|FG000|NOT COMPLETED|Overall Study||16
9090435|NCT02681406|10154961|FG001|NOT COMPLETED|Overall Study||24
9090436|NCT02681406|10154962|FG002|NOT COMPLETED|Overall Study||26
9090437|NCT02681406|10154963|FG003|NOT COMPLETED|Overall Study||12
9090438|NCT02625090|10154973|FG000|STARTED|Overall Study||42
9090439|NCT02625090|10154973|FG000|COMPLETED|Overall Study||0
9090440|NCT02625090|10154973|FG000|NOT COMPLETED|Overall Study||42
9090441|NCT02539225|10154980|FG000|STARTED|Part A||97
9090442|NCT02539225|10154981|FG001|STARTED|Part A||94
9090443|NCT02539225|10154980|FG000|Received Any Quantity of Study Drug|Part A||96
9090444|NCT02539225|10154981|FG001|Received Any Quantity of Study Drug|Part A||93
9090445|NCT02539225|10154980|FG000|COMPLETED|Part A||77
9090446|NCT02539225|10154981|FG001|COMPLETED|Part A||78
9090447|NCT02539225|10154980|FG000|NOT COMPLETED|Part A||20
9090448|NCT02539225|10154981|FG001|NOT COMPLETED|Part A||16
9090449|NCT02539225|10154980|FG000|STARTED|Pre Treatment for Part B|Participants who met initiation criteria of Part B were allowed to pretreatment for part B.|63
9090450|NCT02539225|10154981|FG001|STARTED|Pre Treatment for Part B|Participants who met initiation criteria of Part B were allowed to pretreatment for part B.|66
9090451|NCT02539225|10154980|FG000|COMPLETED|Pre Treatment for Part B||58
9090452|NCT02539225|10154981|FG001|COMPLETED|Pre Treatment for Part B||64
9090453|NCT02539225|10154980|FG000|NOT COMPLETED|Pre Treatment for Part B||5
9090454|NCT02539225|10154981|FG001|NOT COMPLETED|Pre Treatment for Part B||2
9090455|NCT02539225|10154980|FG000|STARTED|Part B||58
9090456|NCT02539225|10154981|FG001|STARTED|Part B||64
9090457|NCT02539225|10154980|FG000|COMPLETED|Part B||54
9090458|NCT02539225|10154981|FG001|COMPLETED|Part B||48
9090459|NCT02539225|10154980|FG000|NOT COMPLETED|Part B||4
9090460|NCT02539225|10154981|FG001|NOT COMPLETED|Part B||16
9090461|NCT02528500|10154992|FG000|STARTED|Overall Study||10
9090462|NCT02528500|10154992|FG000|COMPLETED|Overall Study||10
9090463|NCT02528500|10154992|FG000|NOT COMPLETED|Overall Study||0
9090464|NCT02527681|10154996|FG000|STARTED|Overall Study||15
9090465|NCT02527681|10154996|FG000|COMPLETED|Overall Study||15
9090466|NCT02527681|10154996|FG000|NOT COMPLETED|Overall Study||0
9090467|NCT02526017|10155009|FG000|STARTED|Overall Study||3
9090468|NCT02526017|10155010|FG001|STARTED|Overall Study||10
9090469|NCT02526017|10155011|FG002|STARTED|Overall Study||11
9090470|NCT02526017|10155012|FG003|STARTED|Overall Study||4
9090471|NCT02526017|10155013|FG004|STARTED|Overall Study||4
9090472|NCT02526017|10155014|FG005|STARTED|Overall Study||3
9090473|NCT02526017|10155015|FG006|STARTED|Overall Study||6
9090474|NCT02526017|10155016|FG007|STARTED|Overall Study||10
8625242|NCT00506415|9664785|FG001|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||0
9090475|NCT02526017|10155017|FG008|STARTED|Overall Study||262
9090476|NCT02526017|10155009|FG000|Received Study Treatment|Overall Study||3
9090477|NCT02526017|10155010|FG001|Received Study Treatment|Overall Study||10
9090478|NCT02526017|10155011|FG002|Received Study Treatment|Overall Study||11
9090479|NCT02526017|10155012|FG003|Received Study Treatment|Overall Study||4
9090480|NCT02526017|10155013|FG004|Received Study Treatment|Overall Study||3
9090481|NCT02526017|10155014|FG005|Received Study Treatment|Overall Study||3
9090482|NCT02526017|10155015|FG006|Received Study Treatment|Overall Study||6
9090483|NCT02526017|10155016|FG007|Received Study Treatment|Overall Study||10
9090484|NCT02526017|10155017|FG008|Received Study Treatment|Overall Study||262
9090485|NCT02526017|10155009|FG000|COMPLETED|Overall Study||3
8629516|NCT00530803|9669281|FG000|STARTED|Overall Study||50
9090486|NCT02526017|10155010|FG001|COMPLETED|Overall Study||10
9090487|NCT02526017|10155011|FG002|COMPLETED|Overall Study||11
9090488|NCT02526017|10155012|FG003|COMPLETED|Overall Study||4
9090489|NCT02526017|10155013|FG004|COMPLETED|Overall Study||3
9090490|NCT02526017|10155014|FG005|COMPLETED|Overall Study||3
9090491|NCT02526017|10155015|FG006|COMPLETED|Overall Study||6
9090492|NCT02526017|10155016|FG007|COMPLETED|Overall Study||10
9090493|NCT02526017|10155017|FG008|COMPLETED|Overall Study||262
9090494|NCT02526017|10155009|FG000|NOT COMPLETED|Overall Study||0
9090495|NCT02526017|10155010|FG001|NOT COMPLETED|Overall Study||0
9090496|NCT02526017|10155011|FG002|NOT COMPLETED|Overall Study||0
9090497|NCT02526017|10155012|FG003|NOT COMPLETED|Overall Study||0
9090498|NCT02526017|10155013|FG004|NOT COMPLETED|Overall Study||1
9090499|NCT02526017|10155014|FG005|NOT COMPLETED|Overall Study||0
8844821|NCT01712256|9899284|FG000|NOT COMPLETED|Overall Study||1
8844822|NCT01712334|9899288|FG000|STARTED|Treatment Period 1||44
8844823|NCT01712334|9899289|FG001|STARTED|Treatment Period 1||43
8844824|NCT01712334|9899288|FG000|Received Treatment|Treatment Period 1||44
8844825|NCT01712334|9899289|FG001|Received Treatment|Treatment Period 1||41
8844826|NCT01712334|9899288|FG000|COMPLETED|Treatment Period 1||44
9090500|NCT02526017|10155015|FG006|NOT COMPLETED|Overall Study||0
9090501|NCT02526017|10155016|FG007|NOT COMPLETED|Overall Study||0
9090502|NCT02526017|10155017|FG008|NOT COMPLETED|Overall Study||0
9090503|NCT02482233|10155079|FG000|STARTED|Overall Study||10
9090504|NCT02482233|10155080|FG001|STARTED|Overall Study||20
9090505|NCT02482233|10155079|FG000|COMPLETED|Overall Study||9
9090506|NCT02482233|10155080|FG001|COMPLETED|Overall Study||19
9090507|NCT02482233|10155079|FG000|NOT COMPLETED|Overall Study||1
9090508|NCT02482233|10155080|FG001|NOT COMPLETED|Overall Study||1
9090509|NCT02450331|10155090|FG000|STARTED|Overall Study||403
9090510|NCT02450331|10155091|FG001|STARTED|Overall Study||406
9090511|NCT02450331|10155090|FG000|COMPLETED|Overall Study||0
9090512|NCT02450331|10155091|FG001|COMPLETED|Overall Study||0
9090513|NCT02450331|10155090|FG000|NOT COMPLETED|Overall Study||403
9090514|NCT02450331|10155091|FG001|NOT COMPLETED|Overall Study||406
8625243|NCT00506415|9664786|FG002|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||0
8625244|NCT00506415|9664787|FG003|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||0
8625245|NCT00506415|9664784|FG000|COMPLETED|Initial Open Label (Maximum 48 Weeks)||1085
8625246|NCT00506415|9664785|FG001|COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
8625247|NCT00506415|9664786|FG002|COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
8625248|NCT00506415|9664787|FG003|COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
8625249|NCT00506415|9664784|FG000|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||499
8625250|NCT00506415|9664785|FG001|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
8625251|NCT00506415|9664786|FG002|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
8625252|NCT00506415|9664787|FG003|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
8625253|NCT00506415|9664784|FG000|STARTED|Double Blind (Maximum 48 Weeks )||0
8625254|NCT00506415|9664785|FG001|STARTED|Double Blind (Maximum 48 Weeks )|1 patient was randomized in error and did not receive study drug, hence excluded from this arm.|286
8625255|NCT00506415|9664786|FG002|STARTED|Double Blind (Maximum 48 Weeks )||280
8625256|NCT00506415|9664787|FG003|STARTED|Double Blind (Maximum 48 Weeks )||0
8625257|NCT00506415|9664784|FG000|COMPLETED|Double Blind (Maximum 48 Weeks )||0
8625258|NCT00506415|9664785|FG001|COMPLETED|Double Blind (Maximum 48 Weeks )||203
8625259|NCT00506415|9664786|FG002|COMPLETED|Double Blind (Maximum 48 Weeks )||207
8625260|NCT00506415|9664787|FG003|COMPLETED|Double Blind (Maximum 48 Weeks )||0
8625261|NCT00506415|9664784|FG000|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||0
8625262|NCT00506415|9664785|FG001|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||83
8625263|NCT00506415|9664786|FG002|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||73
8625264|NCT00506415|9664787|FG003|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||0
8625265|NCT00506415|9664784|FG000|STARTED|Extended Open Label (Maximum 48 Weeks)||0
8625266|NCT00506415|9664785|FG001|STARTED|Extended Open Label (Maximum 48 Weeks)||0
8844827|NCT01712334|9899289|FG001|COMPLETED|Treatment Period 1||41
9090515|NCT02417415|10155098|FG000|STARTED|Overall Study||13
9090516|NCT02417415|10155099|FG001|STARTED|Overall Study||9
9090517|NCT02417415|10155098|FG000|COMPLETED|Overall Study||13
9090518|NCT02417415|10155099|FG001|COMPLETED|Overall Study||9
9090519|NCT02417415|10155098|FG000|NOT COMPLETED|Overall Study||0
9090520|NCT02417415|10155099|FG001|NOT COMPLETED|Overall Study||0
9090521|NCT02400736|10155107|FG000|STARTED|Overall Study||58
9090522|NCT02400736|10155108|FG001|STARTED|Overall Study||61
9090523|NCT02400736|10155107|FG000|COMPLETED|Overall Study||47
9090524|NCT02400736|10155108|FG001|COMPLETED|Overall Study||53
9090525|NCT02400736|10155107|FG000|NOT COMPLETED|Overall Study||11
9090526|NCT02400736|10155108|FG001|NOT COMPLETED|Overall Study||8
9090527|NCT02369653|10155120|FG000|STARTED|Overall Study||256
9090528|NCT02369653|10155121|FG001|STARTED|Overall Study||256
9090529|NCT02369653|10155120|FG000|Adverse Event Analysis Population|Overall Study|Out of the 256 participants randomized to Apixaban only 250 participants received an apixaban dose.|250
9090530|NCT02369653|10155121|FG001|Adverse Event Analysis Population|Overall Study|The 6 subjects who were randomized to apixaban but received no dose were analyzed in Standard of Care.|262
9090531|NCT02369653|10155120|FG000|COMPLETED|Overall Study||242
9090532|NCT02369653|10155121|FG001|COMPLETED|Overall Study||249
9090533|NCT02369653|10155120|FG000|NOT COMPLETED|Overall Study||14
9090534|NCT02369653|10155121|FG001|NOT COMPLETED|Overall Study||7
9090535|NCT02335424|10155131|FG000|STARTED|Overall Study||374
9090536|NCT02335424|10155131|FG000|Treated|Overall Study||370
9090537|NCT02335424|10155131|FG000|COMPLETED|Overall Study||0
9090538|NCT02335424|10155131|FG000|NOT COMPLETED|Overall Study||374
9090539|NCT02326974|10155135|FG000|STARTED|Overall Study||164
9090540|NCT02326974|10155135|FG000|Treated|Overall Study||163
9090541|NCT02326974|10155135|FG000|COMPLETED|Overall Study||157
9090542|NCT02326974|10155135|FG000|NOT COMPLETED|Overall Study||7
9090543|NCT02284568|10155146|FG000|STARTED|Overall Study|Intent to treat (ITT) population|140
9090544|NCT02284568|10155147|FG001|STARTED|Overall Study|Intent to treat (ITT) population|139
9090545|NCT02284568|10155148|FG002|STARTED|Overall Study|Intent to treat (ITT) population|95
9090546|NCT02284568|10155146|FG000|Safety Population|Overall Study||140
9090547|NCT02284568|10155147|FG001|Safety Population|Overall Study||138
9090548|NCT02284568|10155148|FG002|Safety Population|Overall Study||95
8948137|NCT02427477|10010472|FG000|COMPLETED|Period 2||59
8948138|NCT02427477|10010473|FG001|COMPLETED|Period 2||60
9090549|NCT02284568|10155146|FG000|Completed Week 48 MRI - on Treatment|Overall Study||113
9090550|NCT02284568|10155147|FG001|Completed Week 48 MRI - on Treatment|Overall Study||107
9090551|NCT02284568|10155148|FG002|Completed Week 48 MRI - on Treatment|Overall Study||0
9090552|NCT02284568|10155146|FG000|COMPLETED|Overall Study||109
9090553|NCT02284568|10155147|FG001|COMPLETED|Overall Study||93
9090554|NCT02284568|10155148|FG002|COMPLETED|Overall Study||0
9090555|NCT02284568|10155146|FG000|NOT COMPLETED|Overall Study||31
9090556|NCT02284568|10155147|FG001|NOT COMPLETED|Overall Study||46
9090557|NCT02284568|10155148|FG002|NOT COMPLETED|Overall Study||95
9090558|NCT02228525|10155156|FG000|STARTED|Overall Study||25
9090559|NCT02228525|10155156|FG000|COMPLETED|Overall Study||25
9090560|NCT02228525|10155156|FG000|NOT COMPLETED|Overall Study||0
9090561|NCT02227238|10155162|FG000|STARTED|Overall Study||312
9090562|NCT02227238|10155163|FG001|STARTED|Overall Study||312
9090563|NCT02227238|10155162|FG000|COMPLETED|Overall Study||275
9090564|NCT02227238|10155163|FG001|COMPLETED|Overall Study||245
9090565|NCT02227238|10155162|FG000|NOT COMPLETED|Overall Study||37
9090566|NCT02227238|10155163|FG001|NOT COMPLETED|Overall Study||67
9090567|NCT02195986|10155172|FG000|STARTED|Overall Study||146
9090568|NCT02195986|10155173|FG001|STARTED|Overall Study||147
9090569|NCT02195986|10155174|FG002|STARTED|Overall Study||73
9090570|NCT02195986|10155172|FG000|COMPLETED|Overall Study||143
9090571|NCT02195986|10155173|FG001|COMPLETED|Overall Study||142
9090572|NCT02195986|10155174|FG002|COMPLETED|Overall Study||71
9090573|NCT02195986|10155172|FG000|NOT COMPLETED|Overall Study||3
9090574|NCT02195986|10155173|FG001|NOT COMPLETED|Overall Study||5
9090575|NCT02195986|10155174|FG002|NOT COMPLETED|Overall Study||2
9090576|NCT02128958|10155184|FG000|STARTED|Overall Study||50
9090577|NCT02128958|10155185|FG001|STARTED|Overall Study||28
9090578|NCT02128958|10155184|FG000|COMPLETED|Overall Study||29
9090579|NCT02128958|10155185|FG001|COMPLETED|Overall Study||18
9090580|NCT02128958|10155184|FG000|NOT COMPLETED|Overall Study||21
9090581|NCT02128958|10155185|FG001|NOT COMPLETED|Overall Study||10
9090582|NCT02086448|10155195|FG000|STARTED|Overall Study||25
9090583|NCT02086448|10155196|FG001|STARTED|Overall Study||26
9090584|NCT02086448|10155197|FG002|STARTED|Overall Study||20
9090585|NCT02086448|10155198|FG003|STARTED|Overall Study||18
9090586|NCT02086448|10155195|FG000|COMPLETED|Overall Study||24
9090587|NCT02086448|10155196|FG001|COMPLETED|Overall Study||26
9090588|NCT02086448|10155197|FG002|COMPLETED|Overall Study||20
9090589|NCT02086448|10155198|FG003|COMPLETED|Overall Study||16
9090590|NCT02086448|10155195|FG000|NOT COMPLETED|Overall Study||1
9090591|NCT02086448|10155196|FG001|NOT COMPLETED|Overall Study||0
9090592|NCT02086448|10155197|FG002|NOT COMPLETED|Overall Study||0
9090593|NCT02086448|10155198|FG003|NOT COMPLETED|Overall Study||2
9090594|NCT01982630|10155216|FG000|STARTED|Overall Study||10
9090595|NCT01982630|10155217|FG001|STARTED|Overall Study||8
9090596|NCT01982630|10155218|FG002|STARTED|Overall Study||13
9090597|NCT01982630|10155219|FG003|STARTED|Overall Study||9
9090598|NCT01982630|10155220|FG004|STARTED|Overall Study||19
9090599|NCT01982630|10155221|FG005|STARTED|Overall Study||14
9090600|NCT01982630|10155222|FG006|STARTED|Overall Study||6
8948139|NCT02427477|10010472|FG000|NOT COMPLETED|Period 2||0
9090601|NCT01982630|10155223|FG007|STARTED|Overall Study||8
9090602|NCT01982630|10155216|FG000|Treated|Overall Study||9
9090603|NCT01982630|10155217|FG001|Treated|Overall Study||8
9090604|NCT01982630|10155218|FG002|Treated|Overall Study||11
9090605|NCT01982630|10155219|FG003|Treated|Overall Study||9
9090606|NCT01982630|10155220|FG004|Treated|Overall Study||18
9090607|NCT01982630|10155221|FG005|Treated|Overall Study||14
9090608|NCT01982630|10155222|FG006|Treated|Overall Study||6
9090609|NCT01982630|10155223|FG007|Treated|Overall Study||8
9090610|NCT01982630|10155216|FG000|COMPLETED|Overall Study||7
9090611|NCT01982630|10155217|FG001|COMPLETED|Overall Study||8
9090612|NCT01982630|10155218|FG002|COMPLETED|Overall Study||8
9090613|NCT01982630|10155219|FG003|COMPLETED|Overall Study||8
8844828|NCT01712334|9899288|FG000|NOT COMPLETED|Treatment Period 1||0
9090614|NCT01982630|10155220|FG004|COMPLETED|Overall Study||16
9090615|NCT01982630|10155221|FG005|COMPLETED|Overall Study||11
9090616|NCT01982630|10155222|FG006|COMPLETED|Overall Study||5
9090617|NCT01982630|10155223|FG007|COMPLETED|Overall Study||8
9090618|NCT01982630|10155216|FG000|NOT COMPLETED|Overall Study||3
9090619|NCT01982630|10155217|FG001|NOT COMPLETED|Overall Study||0
9090620|NCT01982630|10155218|FG002|NOT COMPLETED|Overall Study||5
9090621|NCT01982630|10155219|FG003|NOT COMPLETED|Overall Study||1
9090622|NCT01982630|10155220|FG004|NOT COMPLETED|Overall Study||3
9090623|NCT01982630|10155221|FG005|NOT COMPLETED|Overall Study||3
9090624|NCT01982630|10155222|FG006|NOT COMPLETED|Overall Study||1
9090625|NCT01982630|10155223|FG007|NOT COMPLETED|Overall Study||0
9090626|NCT01982448|10155278|FG000|STARTED|Preoperative Chemotherapy||75
9090627|NCT01982448|10155279|FG001|STARTED|Preoperative Chemotherapy||72
8625267|NCT00506415|9664786|FG002|STARTED|Extended Open Label (Maximum 48 Weeks)||0
8625268|NCT00506415|9664787|FG003|STARTED|Extended Open Label (Maximum 48 Weeks)|Two participants did not receive study drug, hence excluded from this arm.|457
8625269|NCT00506415|9664784|FG000|COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
8625270|NCT00506415|9664785|FG001|COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
8625271|NCT00506415|9664786|FG002|COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
8625272|NCT00506415|9664787|FG003|COMPLETED|Extended Open Label (Maximum 48 Weeks)||395
8625273|NCT00506415|9664784|FG000|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
8625274|NCT00506415|9664785|FG001|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
8625275|NCT00506415|9664786|FG002|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
8625276|NCT00506415|9664787|FG003|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||62
8625277|NCT00506441|9664800|FG000|STARTED|Period 1; Open-label Period||245
8625278|NCT00506441|9664801|FG001|STARTED|Period 1; Open-label Period||0
8625279|NCT00506441|9664800|FG000|COMPLETED|Period 1; Open-label Period||169
9090628|NCT01982448|10155278|FG000|Eligible & Treated|Preoperative Chemotherapy||72
9090629|NCT01982448|10155279|FG001|Eligible & Treated|Preoperative Chemotherapy||70
9090630|NCT01982448|10155278|FG000|Evaluable for Safety|Preoperative Chemotherapy||72
9090631|NCT01982448|10155279|FG001|Evaluable for Safety|Preoperative Chemotherapy||68
9090632|NCT01982448|10155278|FG000|COMPLETED|Preoperative Chemotherapy||72
9090633|NCT01982448|10155279|FG001|COMPLETED|Preoperative Chemotherapy||67
9090634|NCT01982448|10155278|FG000|NOT COMPLETED|Preoperative Chemotherapy||3
9090635|NCT01982448|10155279|FG001|NOT COMPLETED|Preoperative Chemotherapy||5
9090636|NCT01982448|10155278|FG000|STARTED|Definitive Breast Surgery||72
9090637|NCT01982448|10155279|FG001|STARTED|Definitive Breast Surgery||67
9090638|NCT01982448|10155278|FG000|Evaluable for Response by Homologous Recombination Deficiency (HRD)|Definitive Breast Surgery||56
9090639|NCT01982448|10155279|FG001|Evaluable for Response by Homologous Recombination Deficiency (HRD)|Definitive Breast Surgery||48
9090640|NCT01982448|10155278|FG000|COMPLETED|Definitive Breast Surgery||72
9090641|NCT01982448|10155279|FG001|COMPLETED|Definitive Breast Surgery||67
9090642|NCT01982448|10155278|FG000|NOT COMPLETED|Definitive Breast Surgery||0
9090643|NCT01982448|10155279|FG001|NOT COMPLETED|Definitive Breast Surgery||0
9090644|NCT01879228|10155291|FG000|STARTED|Overall Study||13
9090645|NCT01879228|10155292|FG001|STARTED|Overall Study||13
9090646|NCT01879228|10155291|FG000|COMPLETED|Overall Study||12
9090647|NCT01879228|10155292|FG001|COMPLETED|Overall Study||12
9090648|NCT01879228|10155291|FG000|NOT COMPLETED|Overall Study||1
9090649|NCT01879228|10155292|FG001|NOT COMPLETED|Overall Study||1
9090650|NCT01783041|10155300|FG000|STARTED|First 2 Weeks of Life||72
9090651|NCT01783041|10155301|FG001|STARTED|First 2 Weeks of Life||72
9090652|NCT01783041|10155300|FG000|COMPLETED|First 2 Weeks of Life||69
9090653|NCT01783041|10155301|FG001|COMPLETED|First 2 Weeks of Life||71
9090654|NCT01783041|10155300|FG000|NOT COMPLETED|First 2 Weeks of Life||3
9090655|NCT01783041|10155301|FG001|NOT COMPLETED|First 2 Weeks of Life||1
9090656|NCT01783041|10155300|FG000|STARTED|NNNS Examination at Term Equivalent Age||69
9090657|NCT01783041|10155301|FG001|STARTED|NNNS Examination at Term Equivalent Age||71
8625280|NCT00506441|9664801|FG001|COMPLETED|Period 1; Open-label Period||0
8625281|NCT00506441|9664800|FG000|NOT COMPLETED|Period 1; Open-label Period||76
8625282|NCT00506441|9664801|FG001|NOT COMPLETED|Period 1; Open-label Period||0
8625283|NCT00506441|9664800|FG000|STARTED|Period 2; Double-blind Period||85
8625284|NCT00506441|9664801|FG001|STARTED|Period 2; Double-blind Period||84
8625285|NCT00506441|9664800|FG000|COMPLETED|Period 2; Double-blind Period||82
8625286|NCT00506441|9664801|FG001|COMPLETED|Period 2; Double-blind Period||79
8625287|NCT00506441|9664800|FG000|NOT COMPLETED|Period 2; Double-blind Period||3
8844829|NCT01712334|9899289|FG001|NOT COMPLETED|Treatment Period 1||2
8844830|NCT01712334|9899288|FG000|STARTED|Treatment Period 2||44
9090658|NCT01783041|10155300|FG000|COMPLETED|NNNS Examination at Term Equivalent Age||60
9090659|NCT01783041|10155301|FG001|COMPLETED|NNNS Examination at Term Equivalent Age||59
9090660|NCT01783041|10155300|FG000|NOT COMPLETED|NNNS Examination at Term Equivalent Age||9
9090661|NCT01783041|10155301|FG001|NOT COMPLETED|NNNS Examination at Term Equivalent Age||12
9090662|NCT01752920|10155311|FG000|STARTED|Overall Study||29
9090663|NCT01752920|10155312|FG001|STARTED|Overall Study||13
9090664|NCT01752920|10155313|FG002|STARTED|Overall Study||19
9090665|NCT01752920|10155314|FG003|STARTED|Overall Study||58
9090666|NCT01752920|10155311|FG000|COMPLETED|Overall Study||0
9090667|NCT01752920|10155312|FG001|COMPLETED|Overall Study||0
9090668|NCT01752920|10155313|FG002|COMPLETED|Overall Study||0
9090669|NCT01752920|10155314|FG003|COMPLETED|Overall Study||0
9090670|NCT01752920|10155311|FG000|NOT COMPLETED|Overall Study||29
9090671|NCT01752920|10155312|FG001|NOT COMPLETED|Overall Study||13
9090672|NCT01752920|10155313|FG002|NOT COMPLETED|Overall Study||19
9090673|NCT01752920|10155314|FG003|NOT COMPLETED|Overall Study||58
9090674|NCT01744093|10155328|FG000|STARTED|Overall Study||18
9090675|NCT01744093|10155329|FG001|STARTED|Overall Study||9
9090676|NCT01744093|10155328|FG000|COMPLETED|Overall Study||12
9090677|NCT01744093|10155329|FG001|COMPLETED|Overall Study||8
9090678|NCT01744093|10155328|FG000|NOT COMPLETED|Overall Study||6
9090679|NCT01744093|10155329|FG001|NOT COMPLETED|Overall Study||1
9090680|NCT01740297|10155346|FG000|STARTED|Overall Study||19
9090681|NCT01740297|10155347|FG001|STARTED|Overall Study||100
9090682|NCT01740297|10155348|FG002|STARTED|Overall Study||98
9090683|NCT01740297|10155346|FG000|Received Talimogene Laherparepvec|Overall Study||19
9090684|NCT01740297|10155347|FG001|Received Talimogene Laherparepvec|Overall Study||0
9090685|NCT01740297|10155348|FG002|Received Talimogene Laherparepvec|Overall Study||95
9090686|NCT01740297|10155346|FG000|Received Ipilimumab|Overall Study||18
9090687|NCT01740297|10155347|FG001|Received Ipilimumab|Overall Study||95
9090688|NCT01740297|10155348|FG002|Received Ipilimumab|Overall Study||92
9090689|NCT01740297|10155346|FG000|COMPLETED|Overall Study||6
9090690|NCT01740297|10155347|FG001|COMPLETED|Overall Study||36
9090691|NCT01740297|10155348|FG002|COMPLETED|Overall Study||37
9090692|NCT01740297|10155346|FG000|NOT COMPLETED|Overall Study||13
9090693|NCT01740297|10155347|FG001|NOT COMPLETED|Overall Study||64
9090694|NCT01740297|10155348|FG002|NOT COMPLETED|Overall Study||61
9090695|NCT01729754|10155362|FG000|STARTED|Part 1||20
9090696|NCT01729754|10155363|FG001|STARTED|Part 1||184
9090697|NCT01729754|10155364|FG002|STARTED|Part 1||110
9090698|NCT01729754|10155365|FG003|STARTED|Part 1||18
9090699|NCT01729754|10155366|FG004|STARTED|Part 1||21
9090700|NCT01729754|10155367|FG005|STARTED|Part 1||268
9090701|NCT01729754|10155368|FG006|STARTED|Part 1||14
9090702|NCT01729754|10155369|FG007|STARTED|Part 1||72
9090703|NCT01729754|10155370|FG008|STARTED|Part 1||70
9090704|NCT01729754|10155371|FG009|STARTED|Part 1||313
9090705|NCT01729754|10155362|FG000|COMPLETED|Part 1||6
9090706|NCT01729754|10155363|FG001|COMPLETED|Part 1||184
9090707|NCT01729754|10155364|FG002|COMPLETED|Part 1||110
9090708|NCT01729754|10155365|FG003|COMPLETED|Part 1||6
9090709|NCT01729754|10155366|FG004|COMPLETED|Part 1||21
9090710|NCT01729754|10155367|FG005|COMPLETED|Part 1||268
9090711|NCT01729754|10155368|FG006|COMPLETED|Part 1||0
9090712|NCT01729754|10155369|FG007|COMPLETED|Part 1||72
9090713|NCT01729754|10155370|FG008|COMPLETED|Part 1||70
9090714|NCT01729754|10155371|FG009|COMPLETED|Part 1||289
9090715|NCT01729754|10155362|FG000|NOT COMPLETED|Part 1||14
9090716|NCT01729754|10155363|FG001|NOT COMPLETED|Part 1||0
9090717|NCT01729754|10155364|FG002|NOT COMPLETED|Part 1||0
9090718|NCT01729754|10155365|FG003|NOT COMPLETED|Part 1||12
9090719|NCT01729754|10155366|FG004|NOT COMPLETED|Part 1||0
9090720|NCT01729754|10155367|FG005|NOT COMPLETED|Part 1||0
9090721|NCT01729754|10155368|FG006|NOT COMPLETED|Part 1||14
9090722|NCT01729754|10155369|FG007|NOT COMPLETED|Part 1||0
9090723|NCT01729754|10155370|FG008|NOT COMPLETED|Part 1||0
9090724|NCT01729754|10155371|FG009|NOT COMPLETED|Part 1||24
9090725|NCT01729754|10155362|FG000|STARTED|Part 2||6
9090726|NCT01729754|10155363|FG001|STARTED|Part 2||184
9090727|NCT01729754|10155364|FG002|STARTED|Part 2||110
9090728|NCT01729754|10155365|FG003|STARTED|Part 2|1 participant completed Part 1 but did not enter Part 2|5
9090729|NCT01729754|10155366|FG004|STARTED|Part 2||21
9090730|NCT01729754|10155367|FG005|STARTED|Part 2||268
9090731|NCT01729754|10155368|FG006|STARTED|Part 2||0
9090732|NCT01729754|10155369|FG007|STARTED|Part 2||72
9090733|NCT01729754|10155370|FG008|STARTED|Part 2||70
9090734|NCT01729754|10155371|FG009|STARTED|Part 2||289
9090735|NCT01729754|10155362|FG000|COMPLETED|Part 2||0
9090736|NCT01729754|10155363|FG001|COMPLETED|Part 2||184
9090737|NCT01729754|10155364|FG002|COMPLETED|Part 2||110
9090738|NCT01729754|10155365|FG003|COMPLETED|Part 2||0
9090739|NCT01729754|10155366|FG004|COMPLETED|Part 2||21
9090740|NCT01729754|10155367|FG005|COMPLETED|Part 2||268
9090741|NCT01729754|10155368|FG006|COMPLETED|Part 2||0
9090742|NCT01729754|10155369|FG007|COMPLETED|Part 2||69
9090743|NCT01729754|10155370|FG008|COMPLETED|Part 2||66
9090744|NCT01729754|10155371|FG009|COMPLETED|Part 2||277
9090745|NCT01729754|10155362|FG000|NOT COMPLETED|Part 2||6
9090746|NCT01729754|10155363|FG001|NOT COMPLETED|Part 2||0
9090747|NCT01729754|10155364|FG002|NOT COMPLETED|Part 2||0
9090748|NCT01729754|10155365|FG003|NOT COMPLETED|Part 2||5
9090749|NCT01729754|10155366|FG004|NOT COMPLETED|Part 2||0
9090750|NCT01729754|10155367|FG005|NOT COMPLETED|Part 2||0
9090751|NCT01729754|10155368|FG006|NOT COMPLETED|Part 2||0
9090752|NCT01729754|10155369|FG007|NOT COMPLETED|Part 2||3
9090753|NCT01729754|10155370|FG008|NOT COMPLETED|Part 2||4
9090754|NCT01729754|10155371|FG009|NOT COMPLETED|Part 2||12
9090755|NCT01729754|10155362|FG000|STARTED|Part 3||0
9090756|NCT01729754|10155363|FG001|STARTED|Part 3|14 participants completed Part 2 but did not enter Part 3|170
9090757|NCT01729754|10155364|FG002|STARTED|Part 3||110
9090758|NCT01729754|10155365|FG003|STARTED|Part 3||0
9090759|NCT01729754|10155366|FG004|STARTED|Part 3||21
9090760|NCT01729754|10155367|FG005|STARTED|Part 3|31 participants completed Part 2 but did not enter Part 3|237
9090761|NCT01729754|10155368|FG006|STARTED|Part 3||0
9090762|NCT01729754|10155369|FG007|STARTED|Part 3||69
9090763|NCT01729754|10155370|FG008|STARTED|Part 3||66
9090764|NCT01729754|10155371|FG009|STARTED|Part 3|156 participants completed Part 2 but did not enter Part 3|121
9090765|NCT01729754|10155362|FG000|COMPLETED|Part 3||0
9090766|NCT01729754|10155363|FG001|COMPLETED|Part 3||165
9090767|NCT01729754|10155364|FG002|COMPLETED|Part 3||105
9090768|NCT01729754|10155365|FG003|COMPLETED|Part 3||0
9090769|NCT01729754|10155366|FG004|COMPLETED|Part 3||17
9090770|NCT01729754|10155367|FG005|COMPLETED|Part 3||224
9090771|NCT01729754|10155368|FG006|COMPLETED|Part 3||0
9090772|NCT01729754|10155369|FG007|COMPLETED|Part 3||66
9090773|NCT01729754|10155370|FG008|COMPLETED|Part 3||65
9090774|NCT01729754|10155371|FG009|COMPLETED|Part 3||114
9090775|NCT01729754|10155362|FG000|NOT COMPLETED|Part 3||0
9090776|NCT01729754|10155363|FG001|NOT COMPLETED|Part 3||5
9090777|NCT01729754|10155364|FG002|NOT COMPLETED|Part 3||5
9090778|NCT01729754|10155365|FG003|NOT COMPLETED|Part 3||0
9090779|NCT01729754|10155366|FG004|NOT COMPLETED|Part 3||4
9090780|NCT01729754|10155367|FG005|NOT COMPLETED|Part 3||13
9090781|NCT01729754|10155368|FG006|NOT COMPLETED|Part 3||0
9090782|NCT01729754|10155369|FG007|NOT COMPLETED|Part 3||3
9090783|NCT01729754|10155370|FG008|NOT COMPLETED|Part 3||1
9090784|NCT01729754|10155371|FG009|NOT COMPLETED|Part 3||7
9090785|NCT01684826|10155401|FG000|STARTED|Overall Study||49
9090786|NCT01684826|10155401|FG000|Collected Dose and Image Information|Overall Study||39
9090787|NCT01684826|10155401|FG000|COMPLETED|Overall Study||39
9090788|NCT01684826|10155401|FG000|NOT COMPLETED|Overall Study||10
9090789|NCT01672242|10155405|FG000|STARTED|Period 1||4
9090790|NCT01672242|10155406|FG001|STARTED|Period 1||2
9090791|NCT01672242|10155405|FG000|COMPLETED|Period 1||4
9090792|NCT01672242|10155406|FG001|COMPLETED|Period 1||2
9090793|NCT01672242|10155405|FG000|NOT COMPLETED|Period 1||0
9090794|NCT01672242|10155406|FG001|NOT COMPLETED|Period 1||0
9090795|NCT01672242|10155405|FG000|STARTED|Period 2||4
9090796|NCT01672242|10155406|FG001|STARTED|Period 2||2
9090797|NCT01672242|10155405|FG000|COMPLETED|Period 2||4
9090798|NCT01672242|10155406|FG001|COMPLETED|Period 2||2
9090799|NCT01672242|10155405|FG000|NOT COMPLETED|Period 2||0
9090800|NCT01672242|10155406|FG001|NOT COMPLETED|Period 2||0
9090801|NCT01668784|10155414|FG000|STARTED|Randomized (Pre-treatment)||410
9090802|NCT01668784|10155415|FG001|STARTED|Randomized (Pre-treatment)||411
9090803|NCT01668784|10155414|FG000|COMPLETED|Randomized (Pre-treatment)||406
9090804|NCT01668784|10155415|FG001|COMPLETED|Randomized (Pre-treatment)||397
9090805|NCT01668784|10155414|FG000|NOT COMPLETED|Randomized (Pre-treatment)||4
9090806|NCT01668784|10155415|FG001|NOT COMPLETED|Randomized (Pre-treatment)||14
9090807|NCT01668784|10155414|FG000|STARTED|Treated (Overall)||406
9090808|NCT01668784|10155415|FG001|STARTED|Treated (Overall)||397
9090809|NCT01668784|10155414|FG000|COMPLETED|Treated (Overall)||67
9090810|NCT01668784|10155415|FG001|COMPLETED|Treated (Overall)||28
9090811|NCT01668784|10155414|FG000|NOT COMPLETED|Treated (Overall)||339
9090812|NCT01668784|10155415|FG001|NOT COMPLETED|Treated (Overall)||369
9090813|NCT01599741|10155421|FG000|STARTED|Overall Study||51
9090814|NCT01599741|10155421|FG000|Collected Dose and Image Information|Overall Study||48
9090815|NCT01599741|10155421|FG000|COMPLETED|Overall Study||48
9090816|NCT01599741|10155421|FG000|NOT COMPLETED|Overall Study||3
9090817|NCT01593852|10155427|FG000|STARTED|Overall Study||68
9090818|NCT01593852|10155428|FG001|STARTED|Overall Study||68
9090819|NCT01593852|10155427|FG000|COMPLETED|Overall Study||68
9090820|NCT01593852|10155428|FG001|COMPLETED|Overall Study||68
9090821|NCT01593852|10155427|FG000|NOT COMPLETED|Overall Study||0
9090822|NCT01593852|10155428|FG001|NOT COMPLETED|Overall Study||0
9090823|NCT01564537|10155436|FG000|STARTED|Overall Study||360
9090824|NCT01564537|10155437|FG001|STARTED|Overall Study||362
9090825|NCT01564537|10155436|FG000|Safety Population: Received Study Drug|Overall Study||360
9090826|NCT01564537|10155437|FG001|Safety Population: Received Study Drug|Overall Study||360
9090827|NCT01564537|10155436|FG000|COMPLETED|Overall Study|Completed=Participants who are ongoing as of 30 October 2014 or who have died on study.|354
9090828|NCT01564537|10155437|FG001|COMPLETED|Overall Study|Completed=Participants who are ongoing as of 30 October 2014 or who have died on study.|356
9090829|NCT01564537|10155436|FG000|NOT COMPLETED|Overall Study||6
9090830|NCT01564537|10155437|FG001|NOT COMPLETED|Overall Study||6
9090831|NCT01515306|10155446|FG000|STARTED|Overall Study||24
9090832|NCT01515306|10155447|FG001|STARTED|Overall Study||16
9090833|NCT01515306|10155446|FG000|Received at Least 1 Dose of Study Drug|Overall Study||24
9090834|NCT01515306|10155447|FG001|Received at Least 1 Dose of Study Drug|Overall Study||16
9090835|NCT01515306|10155446|FG000|Cycle 1|Overall Study||24
9090836|NCT01515306|10155447|FG001|Cycle 1|Overall Study||16
9090837|NCT01515306|10155446|FG000|Cycle 2|Overall Study||21
9090838|NCT01515306|10155447|FG001|Cycle 2|Overall Study||15
9090839|NCT01515306|10155446|FG000|Drug-Drug Interaction Population|Overall Study|Completed Cycle 1 Day 1 and Cycle 2 Day 1 treatment.|21
9090840|NCT01515306|10155447|FG001|Drug-Drug Interaction Population|Overall Study|Drug-drug interaction was only assessed in Part A.|0
9090841|NCT01515306|10155446|FG000|COMPLETED|Overall Study||0
9090842|NCT01515306|10155447|FG001|COMPLETED|Overall Study||2
9090843|NCT01515306|10155446|FG000|NOT COMPLETED|Overall Study||24
9090844|NCT01515306|10155447|FG001|NOT COMPLETED|Overall Study||14
9090845|NCT01423851|10155468|FG000|STARTED|Whole Study||3
9090846|NCT01423851|10155469|FG001|STARTED|Whole Study||3
9090847|NCT01423851|10155470|FG002|STARTED|Whole Study||3
9090848|NCT01423851|10155471|FG003|STARTED|Whole Study||6
9090849|NCT01423851|10155472|FG004|STARTED|Whole Study||3
9090850|NCT01423851|10155473|FG005|STARTED|Whole Study||3
9090851|NCT01423851|10155474|FG006|STARTED|Whole Study||3
9090852|NCT01423851|10155475|FG007|STARTED|Whole Study||8
9090853|NCT01423851|10155476|FG008|STARTED|Whole Study||8
9090854|NCT01423851|10155477|FG009|STARTED|Whole Study||8
9090855|NCT01423851|10155478|FG010|STARTED|Whole Study||29
9090856|NCT01423851|10155468|FG000|COMPLETED|Whole Study||0
9090857|NCT01423851|10155469|FG001|COMPLETED|Whole Study||0
9090858|NCT01423851|10155470|FG002|COMPLETED|Whole Study||0
9090859|NCT01423851|10155471|FG003|COMPLETED|Whole Study||0
9090860|NCT01423851|10155472|FG004|COMPLETED|Whole Study||0
9090861|NCT01423851|10155473|FG005|COMPLETED|Whole Study||0
9090862|NCT01423851|10155474|FG006|COMPLETED|Whole Study||0
9090863|NCT01423851|10155475|FG007|COMPLETED|Whole Study||0
9090864|NCT01423851|10155476|FG008|COMPLETED|Whole Study||0
9090865|NCT01423851|10155477|FG009|COMPLETED|Whole Study||0
9090866|NCT01423851|10155478|FG010|COMPLETED|Whole Study||0
9090867|NCT01423851|10155468|FG000|NOT COMPLETED|Whole Study||3
9090868|NCT01423851|10155469|FG001|NOT COMPLETED|Whole Study||3
9090869|NCT01423851|10155470|FG002|NOT COMPLETED|Whole Study||3
9090870|NCT01423851|10155471|FG003|NOT COMPLETED|Whole Study||6
9090871|NCT01423851|10155472|FG004|NOT COMPLETED|Whole Study||3
9090872|NCT01423851|10155473|FG005|NOT COMPLETED|Whole Study||3
9090873|NCT01423851|10155474|FG006|NOT COMPLETED|Whole Study||3
9090874|NCT01423851|10155475|FG007|NOT COMPLETED|Whole Study||8
9090875|NCT01423851|10155476|FG008|NOT COMPLETED|Whole Study||8
9090876|NCT01423851|10155477|FG009|NOT COMPLETED|Whole Study||8
9090877|NCT01423851|10155478|FG010|NOT COMPLETED|Whole Study||29
9090878|NCT01423851|10155468|FG000|STARTED|Dose Finding Period - Escalation||0
9090879|NCT01423851|10155469|FG001|STARTED|Dose Finding Period - Escalation||1
9090880|NCT01423851|10155470|FG002|STARTED|Dose Finding Period - Escalation||4
9090881|NCT01423851|10155471|FG003|STARTED|Dose Finding Period - Escalation||4
9090882|NCT01423851|10155472|FG004|STARTED|Dose Finding Period - Escalation||0
9090883|NCT01423851|10155473|FG005|STARTED|Dose Finding Period - Escalation||0
9090884|NCT01423851|10155474|FG006|STARTED|Dose Finding Period - Escalation||2
9090885|NCT01423851|10155475|FG007|STARTED|Dose Finding Period - Escalation||0
9090886|NCT01423851|10155476|FG008|STARTED|Dose Finding Period - Escalation||1
9090887|NCT01423851|10155477|FG009|STARTED|Dose Finding Period - Escalation||0
9090888|NCT01423851|10155478|FG010|STARTED|Dose Finding Period - Escalation||0
9090889|NCT01423851|10155468|FG000|COMPLETED|Dose Finding Period - Escalation||0
9090890|NCT01423851|10155469|FG001|COMPLETED|Dose Finding Period - Escalation||0
9090891|NCT01423851|10155470|FG002|COMPLETED|Dose Finding Period - Escalation||0
9090892|NCT01423851|10155471|FG003|COMPLETED|Dose Finding Period - Escalation||0
9090893|NCT01423851|10155472|FG004|COMPLETED|Dose Finding Period - Escalation||0
9090894|NCT01423851|10155473|FG005|COMPLETED|Dose Finding Period - Escalation||0
9090895|NCT01423851|10155474|FG006|COMPLETED|Dose Finding Period - Escalation||0
9090896|NCT01423851|10155475|FG007|COMPLETED|Dose Finding Period - Escalation||0
9090897|NCT01423851|10155476|FG008|COMPLETED|Dose Finding Period - Escalation||0
9090898|NCT01423851|10155477|FG009|COMPLETED|Dose Finding Period - Escalation||0
9090899|NCT01423851|10155478|FG010|COMPLETED|Dose Finding Period - Escalation||0
9090900|NCT01423851|10155468|FG000|NOT COMPLETED|Dose Finding Period - Escalation||0
9090901|NCT01423851|10155469|FG001|NOT COMPLETED|Dose Finding Period - Escalation||1
9090902|NCT01423851|10155470|FG002|NOT COMPLETED|Dose Finding Period - Escalation||4
9090903|NCT01423851|10155471|FG003|NOT COMPLETED|Dose Finding Period - Escalation||4
9090904|NCT01423851|10155472|FG004|NOT COMPLETED|Dose Finding Period - Escalation||0
9090905|NCT01423851|10155473|FG005|NOT COMPLETED|Dose Finding Period - Escalation||0
9090906|NCT01423851|10155474|FG006|NOT COMPLETED|Dose Finding Period - Escalation||2
9090907|NCT01423851|10155475|FG007|NOT COMPLETED|Dose Finding Period - Escalation||0
9090908|NCT01423851|10155476|FG008|NOT COMPLETED|Dose Finding Period - Escalation||1
9090909|NCT01423851|10155477|FG009|NOT COMPLETED|Dose Finding Period - Escalation||0
9090910|NCT01423851|10155478|FG010|NOT COMPLETED|Dose Finding Period - Escalation||0
9090911|NCT01423851|10155468|FG000|STARTED|Dose Finding Period - Reduction||0
9090912|NCT01423851|10155469|FG001|STARTED|Dose Finding Period - Reduction||0
9090913|NCT01423851|10155470|FG002|STARTED|Dose Finding Period - Reduction||3
9090914|NCT01423851|10155471|FG003|STARTED|Dose Finding Period - Reduction||5
9090915|NCT01423851|10155472|FG004|STARTED|Dose Finding Period - Reduction||1
9090916|NCT01423851|10155473|FG005|STARTED|Dose Finding Period - Reduction||2
9090917|NCT01423851|10155474|FG006|STARTED|Dose Finding Period - Reduction||8
9090918|NCT01423851|10155475|FG007|STARTED|Dose Finding Period - Reduction||0
9090919|NCT01423851|10155476|FG008|STARTED|Dose Finding Period - Reduction||3
9090920|NCT01423851|10155477|FG009|STARTED|Dose Finding Period - Reduction||0
9090921|NCT01423851|10155478|FG010|STARTED|Dose Finding Period - Reduction||0
9090922|NCT01423851|10155468|FG000|COMPLETED|Dose Finding Period - Reduction||0
9090923|NCT01423851|10155469|FG001|COMPLETED|Dose Finding Period - Reduction||0
9090924|NCT01423851|10155470|FG002|COMPLETED|Dose Finding Period - Reduction||0
9090925|NCT01423851|10155471|FG003|COMPLETED|Dose Finding Period - Reduction||0
9090926|NCT01423851|10155472|FG004|COMPLETED|Dose Finding Period - Reduction||0
9090927|NCT01423851|10155473|FG005|COMPLETED|Dose Finding Period - Reduction||0
9090928|NCT01423851|10155474|FG006|COMPLETED|Dose Finding Period - Reduction||0
9090929|NCT01423851|10155475|FG007|COMPLETED|Dose Finding Period - Reduction||0
9090930|NCT01423851|10155476|FG008|COMPLETED|Dose Finding Period - Reduction||0
9090931|NCT01423851|10155477|FG009|COMPLETED|Dose Finding Period - Reduction||0
9090932|NCT01423851|10155478|FG010|COMPLETED|Dose Finding Period - Reduction||0
9090933|NCT01423851|10155468|FG000|NOT COMPLETED|Dose Finding Period - Reduction||0
9090934|NCT01423851|10155469|FG001|NOT COMPLETED|Dose Finding Period - Reduction||0
9090935|NCT01423851|10155470|FG002|NOT COMPLETED|Dose Finding Period - Reduction||3
9090936|NCT01423851|10155471|FG003|NOT COMPLETED|Dose Finding Period - Reduction||5
9090937|NCT01423851|10155472|FG004|NOT COMPLETED|Dose Finding Period - Reduction||1
9090938|NCT01423851|10155473|FG005|NOT COMPLETED|Dose Finding Period - Reduction||2
9090939|NCT01423851|10155474|FG006|NOT COMPLETED|Dose Finding Period - Reduction||8
9090940|NCT01423851|10155475|FG007|NOT COMPLETED|Dose Finding Period - Reduction||0
9090941|NCT01423851|10155476|FG008|NOT COMPLETED|Dose Finding Period - Reduction||3
9090942|NCT01423851|10155477|FG009|NOT COMPLETED|Dose Finding Period - Reduction||0
9090943|NCT01423851|10155478|FG010|NOT COMPLETED|Dose Finding Period - Reduction||0
9090944|NCT01385176|10155509|FG000|STARTED|Randomization Phase|The randomization phase of the study started after implant of the investigational device system.|63
9090945|NCT01385176|10155510|FG001|STARTED|Randomization Phase|The randomization phase of the study started after implant of the investigational device system.|32
9090946|NCT01385176|10155509|FG000|COMPLETED|Randomization Phase|The study randomization phase ended after all patients have had their 6 month follow-up visit.|62
9090947|NCT01385176|10155510|FG001|COMPLETED|Randomization Phase|The study randomization phase ended after all patients have had their 6 month follow-up visit.|30
8844831|NCT01712334|9899289|FG001|STARTED|Treatment Period 2||41
8844832|NCT01712334|9899288|FG000|COMPLETED|Treatment Period 2||44
9090948|NCT01385176|10155509|FG000|NOT COMPLETED|Randomization Phase||1
9090949|NCT01385176|10155510|FG001|NOT COMPLETED|Randomization Phase||2
9090950|NCT01385176|10155509|FG000|STARTED|6-18 Month All VNS Active|Primary Study Phase ended with completion of the 18 months follow-up visit for the last patient|62
9090951|NCT01385176|10155510|FG001|STARTED|6-18 Month All VNS Active|Primary Study Phase ended with completion of the 18 months follow-up visit for the last patient|30
9090952|NCT01385176|10155509|FG000|COMPLETED|6-18 Month All VNS Active||58
9090953|NCT01385176|10155510|FG001|COMPLETED|6-18 Month All VNS Active||27
9090954|NCT01385176|10155509|FG000|NOT COMPLETED|6-18 Month All VNS Active||4
9090955|NCT01385176|10155510|FG001|NOT COMPLETED|6-18 Month All VNS Active||3
8844833|NCT01712334|9899289|FG001|COMPLETED|Treatment Period 2||41
8844834|NCT01712334|9899288|FG000|NOT COMPLETED|Treatment Period 2||0
9090956|NCT01360593|10155521|FG000|STARTED|Overall Study||35
9090957|NCT01360593|10155521|FG000|COMPLETED|Overall Study||35
9090958|NCT01360593|10155521|FG000|NOT COMPLETED|Overall Study||0
9090959|NCT01354977|10155527|FG000|STARTED|Overall Study||12
9090960|NCT01354977|10155528|FG001|STARTED|Overall Study||8
9090961|NCT01354977|10155527|FG000|COMPLETED|Overall Study||12
9090962|NCT01354977|10155528|FG001|COMPLETED|Overall Study||8
9090963|NCT01354977|10155527|FG000|NOT COMPLETED|Overall Study||0
9090964|NCT01354977|10155528|FG001|NOT COMPLETED|Overall Study||0
9090965|NCT01334606|10155534|FG000|STARTED|Overall Study||21
9090966|NCT01334606|10155534|FG000|COMPLETED|Overall Study||3
9090967|NCT01334606|10155534|FG000|NOT COMPLETED|Overall Study||18
9090968|NCT01317875|10155550|FG000|STARTED|Overall Study||5
9090969|NCT01317875|10155551|FG001|STARTED|Overall Study||3
9090970|NCT01317875|10155552|FG002|STARTED|Overall Study||20
9090971|NCT01317875|10155553|FG003|STARTED|Overall Study||4
9090972|NCT01317875|10155554|FG004|STARTED|Overall Study||12
9090973|NCT01317875|10155555|FG005|STARTED|Overall Study||3
9090974|NCT01317875|10155556|FG006|STARTED|Overall Study||4
9090975|NCT01317875|10155557|FG007|STARTED|Overall Study||18
9090976|NCT01317875|10155558|FG008|STARTED|Overall Study|No participants enrolled in Stratum 2 : Cohort 4|0
9090977|NCT01317875|10155559|FG009|STARTED|Overall Study|No participants enrolled in Stratum 2 : Cohort 5|0
9090978|NCT01317875|10155550|FG000|COMPLETED|Overall Study||2
9090979|NCT01317875|10155551|FG001|COMPLETED|Overall Study||1
9090980|NCT01317875|10155552|FG002|COMPLETED|Overall Study||11
9090981|NCT01317875|10155553|FG003|COMPLETED|Overall Study||2
9090982|NCT01317875|10155554|FG004|COMPLETED|Overall Study||3
9090983|NCT01317875|10155555|FG005|COMPLETED|Overall Study||1
9090984|NCT01317875|10155556|FG006|COMPLETED|Overall Study||2
9090985|NCT01317875|10155557|FG007|COMPLETED|Overall Study||3
9090986|NCT01317875|10155558|FG008|COMPLETED|Overall Study||0
9090987|NCT01317875|10155559|FG009|COMPLETED|Overall Study||0
9090988|NCT01317875|10155550|FG000|NOT COMPLETED|Overall Study||3
9090989|NCT01317875|10155551|FG001|NOT COMPLETED|Overall Study||2
9090990|NCT01317875|10155552|FG002|NOT COMPLETED|Overall Study||9
9090991|NCT01317875|10155553|FG003|NOT COMPLETED|Overall Study||2
9090992|NCT01317875|10155554|FG004|NOT COMPLETED|Overall Study||9
9090993|NCT01317875|10155555|FG005|NOT COMPLETED|Overall Study||2
9090994|NCT01317875|10155556|FG006|NOT COMPLETED|Overall Study||2
9090995|NCT01317875|10155557|FG007|NOT COMPLETED|Overall Study||15
9090996|NCT01317875|10155558|FG008|NOT COMPLETED|Overall Study||0
9090997|NCT01317875|10155559|FG009|NOT COMPLETED|Overall Study||0
9090998|NCT01226732|10155595|FG000|STARTED|Overall Study||3
9090999|NCT01226732|10155596|FG001|STARTED|Overall Study||3
9091000|NCT01226732|10155597|FG002|STARTED|Overall Study||3
9091001|NCT01226732|10155598|FG003|STARTED|Overall Study||5
9091002|NCT01226732|10155599|FG004|STARTED|Overall Study||3
9091003|NCT01226732|10155600|FG005|STARTED|Overall Study||6
9091004|NCT01226732|10155595|FG000|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
9091005|NCT01226732|10155596|FG001|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
9091006|NCT01226732|10155597|FG002|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
9091007|NCT01226732|10155598|FG003|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
9091008|NCT01226732|10155599|FG004|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
9091009|NCT01226732|10155600|FG005|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
9091010|NCT01226732|10155595|FG000|NOT COMPLETED|Overall Study||3
9091011|NCT01226732|10155596|FG001|NOT COMPLETED|Overall Study||3
9091012|NCT01226732|10155597|FG002|NOT COMPLETED|Overall Study||3
9091013|NCT01226732|10155598|FG003|NOT COMPLETED|Overall Study||5
8625288|NCT00506441|9664801|FG001|NOT COMPLETED|Period 2; Double-blind Period||5
8625289|NCT00506454|9664811|FG000|STARTED|Overall Study||11
8625290|NCT00506454|9664812|FG001|STARTED|Overall Study||11
8625291|NCT00506454|9664811|FG000|COMPLETED|Overall Study||10
8625292|NCT00506454|9664812|FG001|COMPLETED|Overall Study||10
8625293|NCT00506454|9664811|FG000|NOT COMPLETED|Overall Study||1
8625294|NCT00506454|9664812|FG001|NOT COMPLETED|Overall Study||1
8625295|NCT00506493|9664818|FG000|STARTED|Overall Study||75
8625296|NCT00506493|9664818|FG000|COMPLETED|Overall Study||64
8625297|NCT00506493|9664818|FG000|NOT COMPLETED|Overall Study||11
8625298|NCT00506519|9664827|FG000|STARTED|Overall Study||10
8625299|NCT00506519|9664828|FG001|STARTED|Overall Study||10
8625300|NCT00506519|9664829|FG002|STARTED|Overall Study||5
8625301|NCT00506519|9664827|FG000|Completed Treatment (Day 5)|Overall Study||8
8625302|NCT00506519|9664828|FG001|Completed Treatment (Day 5)|Overall Study||7
8625303|NCT00506519|9664829|FG002|Completed Treatment (Day 5)|Overall Study||5
8625304|NCT00506519|9664827|FG000|Day 28 Follow up|Overall Study||8
9091014|NCT01226732|10155599|FG004|NOT COMPLETED|Overall Study||3
9091015|NCT01226732|10155600|FG005|NOT COMPLETED|Overall Study||6
9091016|NCT01216683|10155624|FG000|STARTED|Induction||65
9091017|NCT01216683|10155625|FG001|STARTED|Induction||99
9091018|NCT01216683|10155626|FG002|STARTED|Induction||125
9091019|NCT01216683|10155624|FG000|Received Treatment and Assessed for Toxicities|Induction||65
8625305|NCT00506519|9664828|FG001|Day 28 Follow up|Overall Study||6
8625306|NCT00506519|9664829|FG002|Day 28 Follow up|Overall Study||5
8625307|NCT00506519|9664827|FG000|COMPLETED|Overall Study||5
8625308|NCT00506519|9664828|FG001|COMPLETED|Overall Study||4
8625309|NCT00506519|9664829|FG002|COMPLETED|Overall Study||5
8625310|NCT00506519|9664827|FG000|NOT COMPLETED|Overall Study||5
8625311|NCT00506519|9664828|FG001|NOT COMPLETED|Overall Study||6
8625312|NCT00506519|9664829|FG002|NOT COMPLETED|Overall Study||0
8625313|NCT00506597|9664840|FG000|STARTED|Overall Study||33
8625314|NCT00506597|9664840|FG000|COMPLETED|Overall Study||33
8625315|NCT00506597|9664840|FG000|NOT COMPLETED|Overall Study||0
8625316|NCT00506662|9664846|FG000|STARTED|Overall Study||38
9091020|NCT01216683|10155625|FG001|Received Treatment and Assessed for Toxicities|Induction||93
9091021|NCT01216683|10155626|FG002|Received Treatment and Assessed for Toxicities|Induction||122
9091022|NCT01216683|10155624|FG000|Eligible and Treated|Induction||59
9091023|NCT01216683|10155625|FG001|Eligible and Treated|Induction||85
9091024|NCT01216683|10155626|FG002|Eligible and Treated|Induction||114
9091025|NCT01216683|10155624|FG000|Included in the Primary Analysis of Complete Remission Rate During Induction Treatment|Induction||48
9091026|NCT01216683|10155625|FG001|Included in the Primary Analysis of Complete Remission Rate During Induction Treatment|Induction||85
9091027|NCT01216683|10155626|FG002|Included in the Primary Analysis of Complete Remission Rate During Induction Treatment|Induction||89
9091028|NCT01216683|10155624|FG000|COMPLETED|Induction||61
9091029|NCT01216683|10155625|FG001|COMPLETED|Induction||80
9091030|NCT01216683|10155626|FG002|COMPLETED|Induction||104
9091031|NCT01216683|10155624|FG000|NOT COMPLETED|Induction||4
8625317|NCT00506662|9664847|FG001|STARTED|Overall Study||48
8625318|NCT00506662|9664846|FG000|COMPLETED|Overall Study||21
8625319|NCT00506662|9664847|FG001|COMPLETED|Overall Study||20
9091032|NCT01216683|10155625|FG001|NOT COMPLETED|Induction||19
9091033|NCT01216683|10155626|FG002|NOT COMPLETED|Induction||21
9091034|NCT01216683|10155624|FG000|STARTED|Continuation||59
9091035|NCT01216683|10155625|FG001|STARTED|Continuation||71
9091036|NCT01216683|10155626|FG002|STARTED|Continuation||94
9091037|NCT01216683|10155624|FG000|Received Continuation Treatment|Continuation||59
9091038|NCT01216683|10155625|FG001|Received Continuation Treatment|Continuation||70
9091039|NCT01216683|10155626|FG002|Received Continuation Treatment|Continuation||89
9091040|NCT01216683|10155624|FG000|COMPLETED|Continuation||44
9091041|NCT01216683|10155625|FG001|COMPLETED|Continuation||56
9091042|NCT01216683|10155626|FG002|COMPLETED|Continuation||51
9091043|NCT01216683|10155624|FG000|NOT COMPLETED|Continuation||15
9091044|NCT01216683|10155625|FG001|NOT COMPLETED|Continuation||15
9091045|NCT01216683|10155626|FG002|NOT COMPLETED|Continuation||43
9091046|NCT01085097|10155650|FG000|STARTED|Overall Study||15
9091047|NCT01085097|10155651|FG001|STARTED|Overall Study||16
9091048|NCT01085097|10155652|FG002|STARTED|Overall Study||15
9091049|NCT01085097|10155650|FG000|Received at Least 1 Dose of Study Drug|Overall Study||15
9091050|NCT01085097|10155651|FG001|Received at Least 1 Dose of Study Drug|Overall Study||16
9091051|NCT01085097|10155652|FG002|Received at Least 1 Dose of Study Drug|Overall Study||15
9091052|NCT01085097|10155650|FG000|COMPLETED|Overall Study||13
9091053|NCT01085097|10155651|FG001|COMPLETED|Overall Study||16
9091054|NCT01085097|10155652|FG002|COMPLETED|Overall Study||13
9091055|NCT01085097|10155650|FG000|NOT COMPLETED|Overall Study||2
9091056|NCT01085097|10155651|FG001|NOT COMPLETED|Overall Study||0
9091057|NCT01085097|10155652|FG002|NOT COMPLETED|Overall Study||2
9091058|NCT00920621|10155664|FG000|STARTED|Overall Study||440
9091059|NCT00920621|10155665|FG001|STARTED|Overall Study||436
9091060|NCT00920621|10155666|FG002|STARTED|Overall Study||440
9091061|NCT00920621|10155667|FG003|STARTED|Overall Study||436
9091062|NCT00920621|10155664|FG000|COMPLETED|Overall Study||386
9091063|NCT00920621|10155665|FG001|COMPLETED|Overall Study||391
9091064|NCT00920621|10155666|FG002|COMPLETED|Overall Study||405
9091065|NCT00920621|10155667|FG003|COMPLETED|Overall Study||401
9091066|NCT00920621|10155664|FG000|NOT COMPLETED|Overall Study||54
9091067|NCT00920621|10155665|FG001|NOT COMPLETED|Overall Study||45
9091068|NCT00920621|10155666|FG002|NOT COMPLETED|Overall Study||35
9091069|NCT00920621|10155667|FG003|NOT COMPLETED|Overall Study||35
9091070|NCT00828308|10155678|FG000|STARTED|Overall Study||16
9091071|NCT00828308|10155678|FG000|COMPLETED|Overall Study||16
9091072|NCT00828308|10155678|FG000|NOT COMPLETED|Overall Study||0
9091073|NCT00680901|10155684|FG000|STARTED|Overall Study||272
9091074|NCT00680901|10155685|FG001|STARTED|Overall Study||273
9091075|NCT00680901|10155684|FG000|Ongoing: On Study Treatment|Overall Study||16
9091076|NCT00680901|10155685|FG001|Ongoing: On Study Treatment|Overall Study||13
9091077|NCT00680901|10155684|FG000|Ongoing: In Follow Up|Overall Study||45
9091078|NCT00680901|10155685|FG001|Ongoing: In Follow Up|Overall Study||41
9091079|NCT00680901|10155684|FG000|COMPLETED|Overall Study||199
9091080|NCT00680901|10155685|FG001|COMPLETED|Overall Study||197
9091081|NCT00680901|10155684|FG000|NOT COMPLETED|Overall Study||73
9091082|NCT00680901|10155685|FG001|NOT COMPLETED|Overall Study||76
9091083|NCT00667251|10155693|FG000|STARTED|Overall Study||326
9091084|NCT00667251|10155694|FG001|STARTED|Overall Study||326
9091085|NCT00667251|10155693|FG000|Combination Rx|Overall Study||322
9091086|NCT00667251|10155694|FG001|Combination Rx|Overall Study||325
9091087|NCT00667251|10155693|FG000|Monotherapy|Overall Study||225
9091088|NCT00667251|10155694|FG001|Monotherapy|Overall Study||232
9091089|NCT00667251|10155693|FG000|Not Started|Overall Study||4
9091090|NCT00667251|10155694|FG001|Not Started|Overall Study||1
9091091|NCT00667251|10155693|FG000|COMPLETED|Overall Study||256
9091092|NCT00667251|10155694|FG001|COMPLETED|Overall Study||231
8625320|NCT00506662|9664846|FG000|NOT COMPLETED|Overall Study||17
8625321|NCT00506662|9664847|FG001|NOT COMPLETED|Overall Study||28
8625322|NCT00506675|9664855|FG000|STARTED|Overall Study||27
8625323|NCT00506675|9664856|FG001|STARTED|Overall Study||28
9091093|NCT00667251|10155693|FG000|NOT COMPLETED|Overall Study||70
9091094|NCT00667251|10155694|FG001|NOT COMPLETED|Overall Study||95
9091095|NCT00600015|10155702|FG000|STARTED|Overall Study||111
9091096|NCT00600015|10155703|FG001|STARTED|Overall Study||55
9091097|NCT00600015|10155702|FG000|COMPLETED|Overall Study|Completed >=2 cycles|51
9091098|NCT00600015|10155703|FG001|COMPLETED|Overall Study|Completed >=2 cycles|20
9091099|NCT00600015|10155702|FG000|NOT COMPLETED|Overall Study||60
9091100|NCT00600015|10155703|FG001|NOT COMPLETED|Overall Study||35
9091101|NCT00500071|10155710|FG000|STARTED|Screening and Washout Phase||318
9091102|NCT00500071|10155710|FG000|COMPLETED|Screening and Washout Phase||317
9091103|NCT00500071|10155710|FG000|NOT COMPLETED|Screening and Washout Phase||1
9091104|NCT00500071|10155710|FG000|STARTED|Dose-optimization and Maintenance Phase|Safety population (i.e., received at least one dose of study medication)|317
9091105|NCT00500071|10155710|FG000|COMPLETED|Dose-optimization and Maintenance Phase||295
9091106|NCT00500071|10155710|FG000|NOT COMPLETED|Dose-optimization and Maintenance Phase||22
9091107|NCT00500071|10155710|FG000|STARTED|30-day Safety Follow-up||295
9091108|NCT00500071|10155710|FG000|COMPLETED|30-day Safety Follow-up||278
9091109|NCT00500071|10155710|FG000|NOT COMPLETED|30-day Safety Follow-up||17
9091110|NCT00447122|10155718|FG000|STARTED|Overall Study||3
9091111|NCT00447122|10155719|FG001|STARTED|Overall Study||11
9091112|NCT00447122|10155720|FG002|STARTED|Overall Study||6
9091113|NCT00447122|10155721|FG003|STARTED|Overall Study||5
9091114|NCT00447122|10155718|FG000|COMPLETED|Overall Study||3
9091115|NCT00447122|10155719|FG001|COMPLETED|Overall Study||10
9091116|NCT00447122|10155720|FG002|COMPLETED|Overall Study||6
9091117|NCT00447122|10155721|FG003|COMPLETED|Overall Study||5
9091118|NCT00447122|10155718|FG000|NOT COMPLETED|Overall Study||0
9091119|NCT00447122|10155719|FG001|NOT COMPLETED|Overall Study||1
9091120|NCT00447122|10155720|FG002|NOT COMPLETED|Overall Study||0
9091121|NCT00447122|10155721|FG003|NOT COMPLETED|Overall Study||0
9091122|NCT00382252|10155731|FG000|STARTED|Overall Study||89
9091123|NCT00382252|10155731|FG000|COMPLETED|Overall Study||76
9091124|NCT00382252|10155731|FG000|NOT COMPLETED|Overall Study||13
9091125|NCT00324805|10155737|FG000|STARTED|Overall Study||749
9091126|NCT00324805|10155738|FG001|STARTED|Overall Study||752
9091127|NCT00324805|10155737|FG000|Started Assigned Therapy|Overall Study||737
9091128|NCT00324805|10155738|FG001|Started Assigned Therapy|Overall Study||735
9091129|NCT00324805|10155737|FG000|COMPLETED|Overall Study||599
9091130|NCT00324805|10155738|FG001|COMPLETED|Overall Study||269
9091131|NCT00324805|10155737|FG000|NOT COMPLETED|Overall Study||150
9091132|NCT00324805|10155738|FG001|NOT COMPLETED|Overall Study||483
9091133|NCT00310180|10155748|FG000|STARTED|Overall Study||1629
9091134|NCT00310180|10155749|FG001|STARTED|Overall Study||3458
9091135|NCT00310180|10155750|FG002|STARTED|Overall Study||3449
9091136|NCT00310180|10155751|FG003|STARTED|Overall Study||1737
9091137|NCT00310180|10155748|FG000|No On-study Data|Overall Study||0
9091138|NCT00310180|10155749|FG001|No On-study Data|Overall Study||2
9091139|NCT00310180|10155750|FG002|No On-study Data|Overall Study||10
9091140|NCT00310180|10155751|FG003|No On-study Data|Overall Study||172
9091141|NCT00310180|10155748|FG000|Ineligible|Overall Study||3
9091142|NCT00310180|10155749|FG001|Ineligible|Overall Study||4
9091143|NCT00310180|10155750|FG002|Ineligible|Overall Study||6
9091144|NCT00310180|10155751|FG003|Ineligible|Overall Study||7
9091145|NCT00310180|10155748|FG000|No Follow-up Data|Overall Study||7
9091146|NCT00310180|10155749|FG001|No Follow-up Data|Overall Study||55
9091147|NCT00310180|10155750|FG002|No Follow-up Data|Overall Study||131
9091148|NCT00310180|10155751|FG003|No Follow-up Data|Overall Study||245
9091149|NCT00310180|10155748|FG000|COMPLETED|Overall Study||1619
9091150|NCT00310180|10155749|FG001|COMPLETED|Overall Study||3399
9091151|NCT00310180|10155750|FG002|COMPLETED|Overall Study||3312
9091152|NCT00310180|10155751|FG003|COMPLETED|Overall Study||1389
9091153|NCT00310180|10155748|FG000|NOT COMPLETED|Overall Study||10
9091154|NCT00310180|10155749|FG001|NOT COMPLETED|Overall Study||59
9091155|NCT00310180|10155750|FG002|NOT COMPLETED|Overall Study||137
9091156|NCT00310180|10155751|FG003|NOT COMPLETED|Overall Study||348
9091157|NCT00309985|10155763|FG000|STARTED|Overall Study||397
9091158|NCT00309985|10155764|FG001|STARTED|Overall Study||393
9091159|NCT00309985|10155763|FG000|Toxicity Analysis|Overall Study||390
9091160|NCT00309985|10155764|FG001|Toxicity Analysis|Overall Study||392
9091161|NCT00309985|10155763|FG000|Both Baseline and 3-month FACT-P Evals|Overall Study||334
9091162|NCT00309985|10155764|FG001|Both Baseline and 3-month FACT-P Evals|Overall Study||299
9091163|NCT00309985|10155763|FG000|COMPLETED|Overall Study||335
9091164|NCT00309985|10155764|FG001|COMPLETED|Overall Study|"Arm B tx info was not collected so only 1 patient w/o follow-up data was considered not completed."|392
9091165|NCT00309985|10155763|FG000|NOT COMPLETED|Overall Study||62
9091166|NCT00309985|10155764|FG001|NOT COMPLETED|Overall Study||1
9091167|NCT00290251|10155773|FG000|STARTED|Baseline (Month 1)||14
9091168|NCT00290251|10155774|FG001|STARTED|Baseline (Month 1)||14
9091169|NCT00290251|10155775|FG002|STARTED|Baseline (Month 1)||14
9091170|NCT00290251|10155776|FG003|STARTED|Baseline (Month 1)||0
9091171|NCT00290251|10155777|FG004|STARTED|Baseline (Month 1)||0
9091172|NCT00290251|10155778|FG005|STARTED|Baseline (Month 1)||0
9091173|NCT00290251|10155773|FG000|COMPLETED|Baseline (Month 1)||14
9091174|NCT00290251|10155774|FG001|COMPLETED|Baseline (Month 1)||14
8844835|NCT01712334|9899289|FG001|NOT COMPLETED|Treatment Period 2||0
8844836|NCT01712360|9899299|FG000|STARTED|Overall Study||22
8844837|NCT01712360|9899300|FG001|STARTED|Overall Study||22
8844838|NCT01712360|9899301|FG002|STARTED|Overall Study||6
8844839|NCT01712360|9899302|FG003|STARTED|Overall Study||6
8844840|NCT01712360|9899299|FG000|COMPLETED|Overall Study||22
9091175|NCT00290251|10155775|FG002|COMPLETED|Baseline (Month 1)||14
9091176|NCT00290251|10155776|FG003|COMPLETED|Baseline (Month 1)||0
9091177|NCT00290251|10155777|FG004|COMPLETED|Baseline (Month 1)||0
9091178|NCT00290251|10155778|FG005|COMPLETED|Baseline (Month 1)||0
9091179|NCT00290251|10155773|FG000|NOT COMPLETED|Baseline (Month 1)||0
9091180|NCT00290251|10155774|FG001|NOT COMPLETED|Baseline (Month 1)||0
9091181|NCT00290251|10155775|FG002|NOT COMPLETED|Baseline (Month 1)||0
9091182|NCT00290251|10155776|FG003|NOT COMPLETED|Baseline (Month 1)||0
9091183|NCT00290251|10155777|FG004|NOT COMPLETED|Baseline (Month 1)||0
9091184|NCT00290251|10155778|FG005|NOT COMPLETED|Baseline (Month 1)||0
9091185|NCT00290251|10155773|FG000|STARTED|Treatment 1 (Months 2-4)|Subjects crossed over from no intervention baseline to treatment assignment|0
9091186|NCT00290251|10155774|FG001|STARTED|Treatment 1 (Months 2-4)|Subjects crossed over from no intervention baseline to treatment assignment|0
9091187|NCT00290251|10155775|FG002|STARTED|Treatment 1 (Months 2-4)|Subjects crossed over from no intervention baseline to treatment assignment|0
9091188|NCT00290251|10155776|FG003|STARTED|Treatment 1 (Months 2-4)|Subjects crossed over from no intervention baseline to treatment assignment|14
9091189|NCT00290251|10155777|FG004|STARTED|Treatment 1 (Months 2-4)|Subjects crossed over from no intervention baseline to treatment assignment|14
9091190|NCT00290251|10155778|FG005|STARTED|Treatment 1 (Months 2-4)|Subjects crossed over from no intervention baseline to treatment assignment|14
9091191|NCT00290251|10155773|FG000|COMPLETED|Treatment 1 (Months 2-4)||0
9091192|NCT00290251|10155774|FG001|COMPLETED|Treatment 1 (Months 2-4)||0
9091193|NCT00290251|10155775|FG002|COMPLETED|Treatment 1 (Months 2-4)||0
9091194|NCT00290251|10155776|FG003|COMPLETED|Treatment 1 (Months 2-4)||13
9091195|NCT00290251|10155777|FG004|COMPLETED|Treatment 1 (Months 2-4)||13
9091196|NCT00290251|10155778|FG005|COMPLETED|Treatment 1 (Months 2-4)||12
9091197|NCT00290251|10155773|FG000|NOT COMPLETED|Treatment 1 (Months 2-4)||0
9091198|NCT00290251|10155774|FG001|NOT COMPLETED|Treatment 1 (Months 2-4)||0
9091199|NCT00290251|10155775|FG002|NOT COMPLETED|Treatment 1 (Months 2-4)||0
9091200|NCT00290251|10155776|FG003|NOT COMPLETED|Treatment 1 (Months 2-4)||1
9091201|NCT00290251|10155777|FG004|NOT COMPLETED|Treatment 1 (Months 2-4)||1
9091202|NCT00290251|10155778|FG005|NOT COMPLETED|Treatment 1 (Months 2-4)||2
9091203|NCT00066963|10155794|FG000|STARTED|Overall Study||126
9091204|NCT00066963|10155795|FG001|STARTED|Overall Study||124
9091205|NCT00066963|10155796|FG002|STARTED|Overall Study||126
9091206|NCT00066963|10155794|FG000|COMPLETED|Overall Study|any follow-up|100
9091207|NCT00066963|10155795|FG001|COMPLETED|Overall Study||93
9091208|NCT00066963|10155796|FG002|COMPLETED|Overall Study||87
9091209|NCT00066963|10155794|FG000|NOT COMPLETED|Overall Study||26
9091210|NCT00066963|10155795|FG001|NOT COMPLETED|Overall Study||31
9091211|NCT00066963|10155796|FG002|NOT COMPLETED|Overall Study||39
9091212|NCT01403948|10155814|FG000|STARTED|Overall Study||1
9091213|NCT01403948|10155815|FG001|STARTED|Overall Study||4
9091214|NCT01403948|10155816|FG002|STARTED|Overall Study||3
9091215|NCT01403948|10155817|FG003|STARTED|Overall Study||4
9091216|NCT01403948|10155818|FG004|STARTED|Overall Study||6
9091217|NCT01403948|10155819|FG005|STARTED|Overall Study||7
9091218|NCT01403948|10155820|FG006|STARTED|Overall Study||6
9091219|NCT01403948|10155821|FG007|STARTED|Overall Study||4
9091220|NCT01403948|10155822|FG008|STARTED|Overall Study||6
9091221|NCT01403948|10155823|FG009|STARTED|Overall Study||7
9091222|NCT01403948|10155814|FG000|COMPLETED|Overall Study||0
9091223|NCT01403948|10155815|FG001|COMPLETED|Overall Study||0
9091224|NCT01403948|10155816|FG002|COMPLETED|Overall Study||0
9091225|NCT01403948|10155817|FG003|COMPLETED|Overall Study||0
9091226|NCT01403948|10155818|FG004|COMPLETED|Overall Study||0
9091227|NCT01403948|10155819|FG005|COMPLETED|Overall Study||0
9091228|NCT01403948|10155820|FG006|COMPLETED|Overall Study||0
9091229|NCT01403948|10155821|FG007|COMPLETED|Overall Study||0
9091230|NCT01403948|10155822|FG008|COMPLETED|Overall Study||0
9091231|NCT01403948|10155823|FG009|COMPLETED|Overall Study||0
9091232|NCT01403948|10155814|FG000|NOT COMPLETED|Overall Study||1
9091233|NCT01403948|10155815|FG001|NOT COMPLETED|Overall Study||4
9091234|NCT01403948|10155816|FG002|NOT COMPLETED|Overall Study||3
9091235|NCT01403948|10155817|FG003|NOT COMPLETED|Overall Study||4
9091236|NCT01403948|10155818|FG004|NOT COMPLETED|Overall Study||6
9091237|NCT01403948|10155819|FG005|NOT COMPLETED|Overall Study||7
9091238|NCT01403948|10155820|FG006|NOT COMPLETED|Overall Study||6
9091239|NCT01403948|10155821|FG007|NOT COMPLETED|Overall Study||4
9091240|NCT01403948|10155822|FG008|NOT COMPLETED|Overall Study||6
9091241|NCT01403948|10155823|FG009|NOT COMPLETED|Overall Study||7
9091242|NCT01404312|10155851|FG000|STARTED|Overall Study||1496
9091243|NCT01404312|10155852|FG001|STARTED|Overall Study||1504
9091244|NCT01404312|10155851|FG000|COMPLETED|Overall Study||1198
9091245|NCT01404312|10155852|FG001|COMPLETED|Overall Study||1193
9091246|NCT01404312|10155851|FG000|NOT COMPLETED|Overall Study||298
9091247|NCT01404312|10155852|FG001|NOT COMPLETED|Overall Study||311
9091248|NCT01425008|10155878|FG000|STARTED|Dose Escalation Phase||4
9091249|NCT01425008|10155879|FG001|STARTED|Dose Escalation Phase||3
9091250|NCT01425008|10155880|FG002|STARTED|Dose Escalation Phase||3
9091251|NCT01425008|10155881|FG003|STARTED|Dose Escalation Phase||3
9091252|NCT01425008|10155882|FG004|STARTED|Dose Escalation Phase||7
9091253|NCT01425008|10155883|FG005|STARTED|Dose Escalation Phase||7
9091254|NCT01425008|10155884|FG006|STARTED|Dose Escalation Phase||3
9091255|NCT01425008|10155885|FG007|STARTED|Dose Escalation Phase||3
9091256|NCT01425008|10155886|FG008|STARTED|Dose Escalation Phase||13
9091257|NCT01425008|10155887|FG009|STARTED|Dose Escalation Phase||4
9091258|NCT01425008|10155888|FG010|STARTED|Dose Escalation Phase||0
9091259|NCT01425008|10155889|FG011|STARTED|Dose Escalation Phase||0
9091260|NCT01425008|10155890|FG012|STARTED|Dose Escalation Phase||0
9091261|NCT01425008|10155891|FG013|STARTED|Dose Escalation Phase||0
9091262|NCT01425008|10155892|FG014|STARTED|Dose Escalation Phase||0
9091263|NCT01425008|10155893|FG015|STARTED|Dose Escalation Phase||0
9091264|NCT01425008|10155894|FG016|STARTED|Dose Escalation Phase||0
9091265|NCT01425008|10155895|FG017|STARTED|Dose Escalation Phase||0
9091266|NCT01425008|10155896|FG018|STARTED|Dose Escalation Phase||0
9091267|NCT01425008|10155878|FG000|COMPLETED|Dose Escalation Phase||0
9091268|NCT01425008|10155879|FG001|COMPLETED|Dose Escalation Phase||0
9091269|NCT01425008|10155880|FG002|COMPLETED|Dose Escalation Phase||0
9091270|NCT01425008|10155881|FG003|COMPLETED|Dose Escalation Phase||0
9091271|NCT01425008|10155882|FG004|COMPLETED|Dose Escalation Phase||0
9091272|NCT01425008|10155883|FG005|COMPLETED|Dose Escalation Phase||0
9091273|NCT01425008|10155884|FG006|COMPLETED|Dose Escalation Phase||0
9091274|NCT01425008|10155885|FG007|COMPLETED|Dose Escalation Phase||0
9091275|NCT01425008|10155886|FG008|COMPLETED|Dose Escalation Phase||0
9091276|NCT01425008|10155887|FG009|COMPLETED|Dose Escalation Phase||0
9091277|NCT01425008|10155888|FG010|COMPLETED|Dose Escalation Phase||0
9091278|NCT01425008|10155889|FG011|COMPLETED|Dose Escalation Phase||0
9091279|NCT01425008|10155890|FG012|COMPLETED|Dose Escalation Phase||0
9091280|NCT01425008|10155891|FG013|COMPLETED|Dose Escalation Phase||0
9091281|NCT01425008|10155892|FG014|COMPLETED|Dose Escalation Phase||0
9091282|NCT01425008|10155893|FG015|COMPLETED|Dose Escalation Phase||0
9091283|NCT01425008|10155894|FG016|COMPLETED|Dose Escalation Phase||0
9091284|NCT01425008|10155895|FG017|COMPLETED|Dose Escalation Phase||0
9091285|NCT01425008|10155896|FG018|COMPLETED|Dose Escalation Phase||0
9091286|NCT01425008|10155878|FG000|NOT COMPLETED|Dose Escalation Phase||4
9091287|NCT01425008|10155879|FG001|NOT COMPLETED|Dose Escalation Phase||3
9091288|NCT01425008|10155880|FG002|NOT COMPLETED|Dose Escalation Phase||3
9091289|NCT01425008|10155881|FG003|NOT COMPLETED|Dose Escalation Phase||3
9091290|NCT01425008|10155882|FG004|NOT COMPLETED|Dose Escalation Phase||7
9091291|NCT01425008|10155883|FG005|NOT COMPLETED|Dose Escalation Phase||7
9091292|NCT01425008|10155884|FG006|NOT COMPLETED|Dose Escalation Phase||3
9091293|NCT01425008|10155885|FG007|NOT COMPLETED|Dose Escalation Phase||3
9091294|NCT01425008|10155886|FG008|NOT COMPLETED|Dose Escalation Phase||13
9091295|NCT01425008|10155887|FG009|NOT COMPLETED|Dose Escalation Phase||4
9091296|NCT01425008|10155888|FG010|NOT COMPLETED|Dose Escalation Phase||0
9091297|NCT01425008|10155889|FG011|NOT COMPLETED|Dose Escalation Phase||0
9091298|NCT01425008|10155890|FG012|NOT COMPLETED|Dose Escalation Phase||0
9091299|NCT01425008|10155891|FG013|NOT COMPLETED|Dose Escalation Phase||0
9091300|NCT01425008|10155892|FG014|NOT COMPLETED|Dose Escalation Phase||0
9091301|NCT01425008|10155893|FG015|NOT COMPLETED|Dose Escalation Phase||0
9091302|NCT01425008|10155894|FG016|NOT COMPLETED|Dose Escalation Phase||0
9091303|NCT01425008|10155895|FG017|NOT COMPLETED|Dose Escalation Phase||0
9091304|NCT01425008|10155896|FG018|NOT COMPLETED|Dose Escalation Phase||0
9091305|NCT01425008|10155878|FG000|STARTED|Dose Expansion Phase||0
9091306|NCT01425008|10155879|FG001|STARTED|Dose Expansion Phase||0
9091307|NCT01425008|10155880|FG002|STARTED|Dose Expansion Phase||0
9091308|NCT01425008|10155881|FG003|STARTED|Dose Expansion Phase||0
9091309|NCT01425008|10155882|FG004|STARTED|Dose Expansion Phase||0
9091310|NCT01425008|10155883|FG005|STARTED|Dose Expansion Phase||0
9091311|NCT01425008|10155884|FG006|STARTED|Dose Expansion Phase||0
9091312|NCT01425008|10155885|FG007|STARTED|Dose Expansion Phase||0
9091313|NCT01425008|10155886|FG008|STARTED|Dose Expansion Phase||0
9091314|NCT01425008|10155887|FG009|STARTED|Dose Expansion Phase||0
9091315|NCT01425008|10155888|FG010|STARTED|Dose Expansion Phase||16
9091316|NCT01425008|10155889|FG011|STARTED|Dose Expansion Phase||8
9091317|NCT01425008|10155890|FG012|STARTED|Dose Expansion Phase||16
9091318|NCT01425008|10155891|FG013|STARTED|Dose Expansion Phase||1
9091319|NCT01425008|10155892|FG014|STARTED|Dose Expansion Phase||6
9091320|NCT01425008|10155893|FG015|STARTED|Dose Expansion Phase||11
9091321|NCT01425008|10155894|FG016|STARTED|Dose Expansion Phase||20
9091322|NCT01425008|10155895|FG017|STARTED|Dose Expansion Phase||2
9091323|NCT01425008|10155896|FG018|STARTED|Dose Expansion Phase||19
9091324|NCT01425008|10155878|FG000|COMPLETED|Dose Expansion Phase||0
9091325|NCT01425008|10155879|FG001|COMPLETED|Dose Expansion Phase||0
9091326|NCT01425008|10155880|FG002|COMPLETED|Dose Expansion Phase||0
9091327|NCT01425008|10155881|FG003|COMPLETED|Dose Expansion Phase||0
9091328|NCT01425008|10155882|FG004|COMPLETED|Dose Expansion Phase||0
9091329|NCT01425008|10155883|FG005|COMPLETED|Dose Expansion Phase||0
9091330|NCT01425008|10155884|FG006|COMPLETED|Dose Expansion Phase||0
9091331|NCT01425008|10155885|FG007|COMPLETED|Dose Expansion Phase||0
9091332|NCT01425008|10155886|FG008|COMPLETED|Dose Expansion Phase||0
9091333|NCT01425008|10155887|FG009|COMPLETED|Dose Expansion Phase||0
9091334|NCT01425008|10155888|FG010|COMPLETED|Dose Expansion Phase||1
9091335|NCT01425008|10155889|FG011|COMPLETED|Dose Expansion Phase||0
9091336|NCT01425008|10155890|FG012|COMPLETED|Dose Expansion Phase||0
9091337|NCT01425008|10155891|FG013|COMPLETED|Dose Expansion Phase||0
9091338|NCT01425008|10155892|FG014|COMPLETED|Dose Expansion Phase||0
9091339|NCT01425008|10155893|FG015|COMPLETED|Dose Expansion Phase||0
9091340|NCT01425008|10155894|FG016|COMPLETED|Dose Expansion Phase||0
9091341|NCT01425008|10155895|FG017|COMPLETED|Dose Expansion Phase||0
9091342|NCT01425008|10155896|FG018|COMPLETED|Dose Expansion Phase||0
9091343|NCT01425008|10155878|FG000|NOT COMPLETED|Dose Expansion Phase||0
9091344|NCT01425008|10155879|FG001|NOT COMPLETED|Dose Expansion Phase||0
9091345|NCT01425008|10155880|FG002|NOT COMPLETED|Dose Expansion Phase||0
9091346|NCT01425008|10155881|FG003|NOT COMPLETED|Dose Expansion Phase||0
9091347|NCT01425008|10155882|FG004|NOT COMPLETED|Dose Expansion Phase||0
9091348|NCT01425008|10155883|FG005|NOT COMPLETED|Dose Expansion Phase||0
9091349|NCT01425008|10155884|FG006|NOT COMPLETED|Dose Expansion Phase||0
9091350|NCT01425008|10155885|FG007|NOT COMPLETED|Dose Expansion Phase||0
9091351|NCT01425008|10155886|FG008|NOT COMPLETED|Dose Expansion Phase||0
9091352|NCT01425008|10155887|FG009|NOT COMPLETED|Dose Expansion Phase||0
9091353|NCT01425008|10155888|FG010|NOT COMPLETED|Dose Expansion Phase||15
9091354|NCT01425008|10155889|FG011|NOT COMPLETED|Dose Expansion Phase||8
9091355|NCT01425008|10155890|FG012|NOT COMPLETED|Dose Expansion Phase||16
9091356|NCT01425008|10155891|FG013|NOT COMPLETED|Dose Expansion Phase||1
9091357|NCT01425008|10155892|FG014|NOT COMPLETED|Dose Expansion Phase||6
9091358|NCT01425008|10155893|FG015|NOT COMPLETED|Dose Expansion Phase||11
9091359|NCT01425008|10155894|FG016|NOT COMPLETED|Dose Expansion Phase||20
9091360|NCT01425008|10155895|FG017|NOT COMPLETED|Dose Expansion Phase||2
9091361|NCT01425008|10155896|FG018|NOT COMPLETED|Dose Expansion Phase||19
9091362|NCT04425902|10155949|FG000|STARTED|Treatment Period 1 (Days 1 to 10)||20
9091363|NCT04425902|10155949|FG000|COMPLETED|Treatment Period 1 (Days 1 to 10)||20
9091364|NCT04425902|10155949|FG000|NOT COMPLETED|Treatment Period 1 (Days 1 to 10)||0
9091365|NCT04425902|10155949|FG000|STARTED|Treatment Period 2 (Days 11 to 20)||20
9091366|NCT04425902|10155949|FG000|COMPLETED|Treatment Period 2 (Days 11 to 20)||19
9091367|NCT04425902|10155949|FG000|NOT COMPLETED|Treatment Period 2 (Days 11 to 20)||1
9091368|NCT04425902|10155949|FG000|STARTED|Treatment Period 3 (Days 21 to 26)||19
9091369|NCT04425902|10155949|FG000|COMPLETED|Treatment Period 3 (Days 21 to 26)||19
9091370|NCT04425902|10155949|FG000|NOT COMPLETED|Treatment Period 3 (Days 21 to 26)||0
9091371|NCT04072146|10155962|FG000|STARTED|Overall Study||11
9091372|NCT04072146|10155963|FG001|STARTED|Overall Study||11
9091373|NCT04072146|10155962|FG000|COMPLETED|Overall Study||11
9091374|NCT04072146|10155963|FG001|COMPLETED|Overall Study||10
9091375|NCT04072146|10155962|FG000|NOT COMPLETED|Overall Study||0
9091376|NCT04072146|10155963|FG001|NOT COMPLETED|Overall Study||1
9091377|NCT03861481|10155977|FG000|STARTED|Overall Study||17
9091378|NCT03861481|10155978|FG001|STARTED|Overall Study||17
9091379|NCT03861481|10155977|FG000|COMPLETED|Overall Study||11
9091380|NCT03861481|10155978|FG001|COMPLETED|Overall Study||10
9091381|NCT03861481|10155977|FG000|NOT COMPLETED|Overall Study||6
9091382|NCT03861481|10155978|FG001|NOT COMPLETED|Overall Study||7
9091383|NCT03708198|10155984|FG000|STARTED|Overall Study||15
9091384|NCT03708198|10155984|FG000|COMPLETED|Overall Study||15
9091385|NCT03708198|10155984|FG000|NOT COMPLETED|Overall Study||0
9091386|NCT03692052|10155988|FG000|STARTED|Core Period (Day 1 to Week 24)||20
9091387|NCT03692052|10155988|FG000|COMPLETED|Core Period (Day 1 to Week 24)||19
9091388|NCT03692052|10155988|FG000|NOT COMPLETED|Core Period (Day 1 to Week 24)||1
9091389|NCT03692052|10155988|FG000|STARTED|Extension Period (Week 25 to 10 Years)||19
9091390|NCT03692052|10155988|FG000|COMPLETED|Extension Period (Week 25 to 10 Years)||0
9091391|NCT03692052|10155988|FG000|NOT COMPLETED|Extension Period (Week 25 to 10 Years)||19
9091392|NCT03648476|10155994|FG000|STARTED|Overall Study||10
9091393|NCT03648476|10155995|FG001|STARTED|Overall Study||14
9091394|NCT03648476|10155994|FG000|COMPLETED|Overall Study||8
9091395|NCT03648476|10155995|FG001|COMPLETED|Overall Study||13
9091396|NCT03648476|10155994|FG000|NOT COMPLETED|Overall Study||2
9091397|NCT03648476|10155995|FG001|NOT COMPLETED|Overall Study||1
9091398|NCT03375203|10156007|FG000|STARTED|Overall Study||75
9091399|NCT03375203|10156008|FG001|STARTED|Overall Study||72
9091400|NCT03375203|10156009|FG002|STARTED|Overall Study||74
9091401|NCT03375203|10156010|FG003|STARTED|Overall Study||71
9091402|NCT03375203|10156011|FG004|STARTED|Overall Study||73
9091403|NCT03375203|10156007|FG000|COMPLETED|Overall Study||69
9091404|NCT03375203|10156008|FG001|COMPLETED|Overall Study||68
9091405|NCT03375203|10156009|FG002|COMPLETED|Overall Study||72
9091406|NCT03375203|10156010|FG003|COMPLETED|Overall Study||69
9091407|NCT03375203|10156011|FG004|COMPLETED|Overall Study||69
9091408|NCT03375203|10156007|FG000|NOT COMPLETED|Overall Study||6
9091409|NCT03375203|10156008|FG001|NOT COMPLETED|Overall Study||4
9091410|NCT03375203|10156009|FG002|NOT COMPLETED|Overall Study||2
9091411|NCT03375203|10156010|FG003|NOT COMPLETED|Overall Study||2
9091412|NCT03375203|10156011|FG004|NOT COMPLETED|Overall Study||4
9091413|NCT02926833|10156028|FG000|STARTED|Overall Study||3
9091414|NCT02926833|10156029|FG001|STARTED|Overall Study||4
9091415|NCT02926833|10156030|FG002|STARTED|Overall Study||7
9091416|NCT02926833|10156031|FG003|STARTED|Overall Study||23
9091417|NCT02926833|10156028|FG000|COMPLETED|Overall Study||0
9091418|NCT02926833|10156029|FG001|COMPLETED|Overall Study||0
9091419|NCT02926833|10156030|FG002|COMPLETED|Overall Study||0
9091420|NCT02926833|10156031|FG003|COMPLETED|Overall Study||0
9091421|NCT02926833|10156028|FG000|NOT COMPLETED|Overall Study||3
9091422|NCT02926833|10156029|FG001|NOT COMPLETED|Overall Study||4
9091423|NCT02926833|10156030|FG002|NOT COMPLETED|Overall Study||7
9091424|NCT02926833|10156031|FG003|NOT COMPLETED|Overall Study||23
9091425|NCT02899299|10156044|FG000|STARTED|Pre-treatment||303
9091426|NCT02899299|10156045|FG001|STARTED|Pre-treatment||302
9091427|NCT02899299|10156044|FG000|COMPLETED|Pre-treatment||300
9091428|NCT02899299|10156045|FG001|COMPLETED|Pre-treatment||284
9091429|NCT02899299|10156044|FG000|NOT COMPLETED|Pre-treatment||3
9091430|NCT02899299|10156045|FG001|NOT COMPLETED|Pre-treatment||18
9091431|NCT02899299|10156044|FG000|STARTED|Treatment||300
9091432|NCT02899299|10156045|FG001|STARTED|Treatment||284
9091433|NCT02899299|10156044|FG000|COMPLETED|Treatment||5
9091434|NCT02899299|10156045|FG001|COMPLETED|Treatment||0
9091435|NCT02899299|10156044|FG000|NOT COMPLETED|Treatment||295
9091436|NCT02899299|10156045|FG001|NOT COMPLETED|Treatment||284
9091437|NCT02879448|10156053|FG000|STARTED|Overall Study||934
9091438|NCT02879448|10156054|FG001|STARTED|Overall Study||944
9091439|NCT02879448|10156053|FG000|COMPLETED|Overall Study||796
9091440|NCT02879448|10156054|FG001|COMPLETED|Overall Study||742
9091441|NCT02879448|10156053|FG000|NOT COMPLETED|Overall Study||138
9091442|NCT02879448|10156054|FG001|NOT COMPLETED|Overall Study||202
9091443|NCT02547662|10156060|FG000|STARTED|Overall Study||17
9091444|NCT02547662|10156060|FG000|COMPLETED|Overall Study||17
9091445|NCT02547662|10156060|FG000|NOT COMPLETED|Overall Study||0
9091446|NCT02348216|10156071|FG000|STARTED|Overall Study||8
9091447|NCT02348216|10156072|FG001|STARTED|Overall Study||81
9091448|NCT02348216|10156073|FG002|STARTED|Overall Study||30
9091449|NCT02348216|10156074|FG003|STARTED|Overall Study||42
9091450|NCT02348216|10156075|FG004|STARTED|Overall Study||46
9091451|NCT02348216|10156076|FG005|STARTED|Overall Study||58
9091452|NCT02348216|10156077|FG006|STARTED|Overall Study||42
9091453|NCT02348216|10156071|FG000|COMPLETED|Overall Study||0
9091454|NCT02348216|10156072|FG001|COMPLETED|Overall Study||0
9091455|NCT02348216|10156073|FG002|COMPLETED|Overall Study||0
9091456|NCT02348216|10156074|FG003|COMPLETED|Overall Study||0
9091457|NCT02348216|10156075|FG004|COMPLETED|Overall Study||0
9091458|NCT02348216|10156076|FG005|COMPLETED|Overall Study||0
9091459|NCT02348216|10156077|FG006|COMPLETED|Overall Study||0
9091460|NCT02348216|10156071|FG000|NOT COMPLETED|Overall Study||8
9091461|NCT02348216|10156072|FG001|NOT COMPLETED|Overall Study||81
9091462|NCT02348216|10156073|FG002|NOT COMPLETED|Overall Study||30
9091463|NCT02348216|10156074|FG003|NOT COMPLETED|Overall Study||42
9091464|NCT02348216|10156075|FG004|NOT COMPLETED|Overall Study||46
9091465|NCT02348216|10156076|FG005|NOT COMPLETED|Overall Study||58
9091466|NCT02348216|10156077|FG006|NOT COMPLETED|Overall Study||42
9091467|NCT02275559|10156117|FG000|STARTED|Overall Study||115
9091468|NCT02275559|10156118|FG001|STARTED|Overall Study||118
9091469|NCT02275559|10156117|FG000|COMPLETED|Overall Study||115
9091470|NCT02275559|10156118|FG001|COMPLETED|Overall Study||118
9091471|NCT02275559|10156117|FG000|NOT COMPLETED|Overall Study||0
9091472|NCT02275559|10156118|FG001|NOT COMPLETED|Overall Study||0
9091473|NCT01849263|10156126|FG000|STARTED|Overall Study||40
9091474|NCT01849263|10156126|FG000|COMPLETED|Overall Study||40
9091475|NCT01849263|10156126|FG000|NOT COMPLETED|Overall Study||0
9091476|NCT01451515|10156133|FG000|STARTED|Overall Study||12
9091477|NCT01451515|10156134|FG001|STARTED|Overall Study||7
9091478|NCT01451515|10156135|FG002|STARTED|Overall Study||4
9091479|NCT01451515|10156133|FG000|COMPLETED|Overall Study||11
9091480|NCT01451515|10156134|FG001|COMPLETED|Overall Study||4
9091481|NCT01451515|10156135|FG002|COMPLETED|Overall Study||3
9091482|NCT01451515|10156133|FG000|NOT COMPLETED|Overall Study||1
9091483|NCT01451515|10156134|FG001|NOT COMPLETED|Overall Study||3
9091484|NCT01451515|10156135|FG002|NOT COMPLETED|Overall Study||1
9091485|NCT01332968|10156148|FG000|STARTED|Induction Period||699
9091486|NCT01332968|10156149|FG001|STARTED|Induction Period||702
9091487|NCT01332968|10156150|FG002|STARTED|Induction Period||0
9091488|NCT01332968|10156151|FG003|STARTED|Induction Period||0
9091489|NCT01332968|10156152|FG004|STARTED|Induction Period||0
9091490|NCT01332968|10156153|FG005|STARTED|Induction Period||0
9091491|NCT01332968|10156154|FG006|STARTED|Induction Period||0
9091492|NCT01332968|10156155|FG007|STARTED|Induction Period||0
9091493|NCT01332968|10156148|FG000|COMPLETED|Induction Period||641
9091494|NCT01332968|10156149|FG001|COMPLETED|Induction Period||646
9091495|NCT01332968|10156150|FG002|COMPLETED|Induction Period||0
9091496|NCT01332968|10156151|FG003|COMPLETED|Induction Period||0
9091497|NCT01332968|10156152|FG004|COMPLETED|Induction Period||0
9091498|NCT01332968|10156153|FG005|COMPLETED|Induction Period||0
9091499|NCT01332968|10156154|FG006|COMPLETED|Induction Period||0
9091500|NCT01332968|10156155|FG007|COMPLETED|Induction Period||0
9091501|NCT01332968|10156148|FG000|NOT COMPLETED|Induction Period||58
9091502|NCT01332968|10156149|FG001|NOT COMPLETED|Induction Period||56
9091503|NCT01332968|10156150|FG002|NOT COMPLETED|Induction Period||0
9091504|NCT01332968|10156151|FG003|NOT COMPLETED|Induction Period||0
9091505|NCT01332968|10156152|FG004|NOT COMPLETED|Induction Period||0
9091506|NCT01332968|10156153|FG005|NOT COMPLETED|Induction Period||0
9091507|NCT01332968|10156154|FG006|NOT COMPLETED|Induction Period||0
9091508|NCT01332968|10156155|FG007|NOT COMPLETED|Induction Period||0
9091509|NCT01332968|10156148|FG000|STARTED|Maintenance/Observation Period||0
9091510|NCT01332968|10156149|FG001|STARTED|Maintenance/Observation Period||0
9091511|NCT01332968|10156150|FG002|STARTED|Maintenance/Observation Period||612
9091512|NCT01332968|10156151|FG003|STARTED|Maintenance/Observation Period||624
9091513|NCT01332968|10156152|FG004|STARTED|Maintenance/Observation Period||12
9091514|NCT01332968|10156153|FG005|STARTED|Maintenance/Observation Period||11
9091515|NCT01332968|10156154|FG006|STARTED|Maintenance/Observation Period||0
9091516|NCT01332968|10156155|FG007|STARTED|Maintenance/Observation Period||0
9091517|NCT01332968|10156148|FG000|COMPLETED|Maintenance/Observation Period||0
9091518|NCT01332968|10156149|FG001|COMPLETED|Maintenance/Observation Period||0
9091519|NCT01332968|10156150|FG002|COMPLETED|Maintenance/Observation Period||399
9091520|NCT01332968|10156151|FG003|COMPLETED|Maintenance/Observation Period||417
9091521|NCT01332968|10156152|FG004|COMPLETED|Maintenance/Observation Period||2
9091522|NCT01332968|10156153|FG005|COMPLETED|Maintenance/Observation Period||2
9091523|NCT01332968|10156154|FG006|COMPLETED|Maintenance/Observation Period||0
9091524|NCT01332968|10156155|FG007|COMPLETED|Maintenance/Observation Period||0
9091525|NCT01332968|10156148|FG000|NOT COMPLETED|Maintenance/Observation Period||0
9091526|NCT01332968|10156149|FG001|NOT COMPLETED|Maintenance/Observation Period||0
9091527|NCT01332968|10156150|FG002|NOT COMPLETED|Maintenance/Observation Period||213
9091528|NCT01332968|10156151|FG003|NOT COMPLETED|Maintenance/Observation Period||207
9091529|NCT01332968|10156152|FG004|NOT COMPLETED|Maintenance/Observation Period||10
9091530|NCT01332968|10156153|FG005|NOT COMPLETED|Maintenance/Observation Period||9
9091531|NCT01332968|10156154|FG006|NOT COMPLETED|Maintenance/Observation Period||0
9091532|NCT01332968|10156155|FG007|NOT COMPLETED|Maintenance/Observation Period||0
9091533|NCT01332968|10156148|FG000|STARTED|Follow-Up Period||0
9091534|NCT01332968|10156149|FG001|STARTED|Follow-Up Period||0
9091535|NCT01332968|10156150|FG002|STARTED|Follow-Up Period||0
9091536|NCT01332968|10156151|FG003|STARTED|Follow-Up Period||0
9091537|NCT01332968|10156152|FG004|STARTED|Follow-Up Period||0
9091538|NCT01332968|10156153|FG005|STARTED|Follow-Up Period||0
9091539|NCT01332968|10156154|FG006|STARTED|Follow-Up Period||542
9091540|NCT01332968|10156155|FG007|STARTED|Follow-Up Period||531
9091541|NCT01332968|10156148|FG000|COMPLETED|Follow-Up Period||0
9091542|NCT01332968|10156149|FG001|COMPLETED|Follow-Up Period||0
9091543|NCT01332968|10156150|FG002|COMPLETED|Follow-Up Period||0
9091544|NCT01332968|10156151|FG003|COMPLETED|Follow-Up Period||0
9091545|NCT01332968|10156152|FG004|COMPLETED|Follow-Up Period||0
9091546|NCT01332968|10156153|FG005|COMPLETED|Follow-Up Period||0
9091547|NCT01332968|10156154|FG006|COMPLETED|Follow-Up Period||0
9091548|NCT01332968|10156155|FG007|COMPLETED|Follow-Up Period||0
9091549|NCT01332968|10156148|FG000|NOT COMPLETED|Follow-Up Period||0
9091550|NCT01332968|10156149|FG001|NOT COMPLETED|Follow-Up Period||0
9091551|NCT01332968|10156150|FG002|NOT COMPLETED|Follow-Up Period||0
9091552|NCT01332968|10156151|FG003|NOT COMPLETED|Follow-Up Period||0
9091553|NCT01332968|10156152|FG004|NOT COMPLETED|Follow-Up Period||0
9091554|NCT01332968|10156153|FG005|NOT COMPLETED|Follow-Up Period||0
9091555|NCT01332968|10156154|FG006|NOT COMPLETED|Follow-Up Period||542
9091556|NCT01332968|10156155|FG007|NOT COMPLETED|Follow-Up Period||531
9091557|NCT01231906|10156165|FG000|STARTED|Overall Study||319
9091558|NCT01231906|10156166|FG001|STARTED|Overall Study||323
9091559|NCT01231906|10156165|FG000|Received Therapy|Overall Study||308
9091560|NCT01231906|10156166|FG001|Received Therapy|Overall Study||318
9091561|NCT01231906|10156165|FG000|COMPLETED|Overall Study||198
9091562|NCT01231906|10156166|FG001|COMPLETED|Overall Study||222
9091563|NCT01231906|10156165|FG000|NOT COMPLETED|Overall Study||121
9091564|NCT01231906|10156166|FG001|NOT COMPLETED|Overall Study||101
8844841|NCT01712360|9899300|FG001|COMPLETED|Overall Study||21
8844842|NCT01712360|9899301|FG002|COMPLETED|Overall Study||6
8844843|NCT01712360|9899302|FG003|COMPLETED|Overall Study||4
8844844|NCT01712360|9899299|FG000|NOT COMPLETED|Overall Study||0
8844845|NCT01712360|9899300|FG001|NOT COMPLETED|Overall Study||1
8844846|NCT01712360|9899301|FG002|NOT COMPLETED|Overall Study||0
8844847|NCT01712360|9899302|FG003|NOT COMPLETED|Overall Study||2
8844848|NCT01712399|9899318|FG000|STARTED|Overall Study||397
8844849|NCT01712399|9899318|FG000|COMPLETED|Overall Study||0
8844850|NCT01712399|9899318|FG000|NOT COMPLETED|Overall Study||397
8844851|NCT01712438|9899322|FG000|STARTED|Overall Study||110
8844852|NCT01712438|9899322|FG000|SAF Population|Overall Study||108
8844853|NCT01712438|9899322|FG000|ITT Population|Overall Study||108
8844854|NCT01712438|9899322|FG000|PP Population|Overall Study||95
8844855|NCT01712438|9899322|FG000|PROPH Population|Overall Study||103
8844856|NCT01712438|9899322|FG000|BLEED Population|Overall Study||94
8844857|NCT01712438|9899322|FG000|SURG Population|Overall Study||24
8844858|NCT01712438|9899322|FG000|COMPLETED|Overall Study||73
8844859|NCT01712438|9899322|FG000|NOT COMPLETED|Overall Study||37
8844860|NCT01712516|9899335|FG000|STARTED|Overall Study||250
8844861|NCT01712516|9899336|FG001|STARTED|Overall Study||251
9091565|NCT01470326|10156172|FG000|STARTED|Overall Study||3187
9091566|NCT01470326|10156172|FG000|COMPLETED|Overall Study||3034
9091567|NCT01470326|10156172|FG000|NOT COMPLETED|Overall Study||153
9091568|NCT01480180|10156178|FG000|STARTED|Main Phase||174
9091569|NCT01480180|10156179|FG001|STARTED|Main Phase||12
9091570|NCT01480180|10156180|FG002|STARTED|Main Phase|Not applicable for this phase|0
9091571|NCT01480180|10156181|FG003|STARTED|Main Phase|Not applicable for this phase|0
9091572|NCT01480180|10156182|FG004|STARTED|Main Phase|Not applicable for this phase|0
9091573|NCT01480180|10156183|FG005|STARTED|Main Phase|Not applicable for this phase|0
9091574|NCT01480180|10156178|FG000|Max. Participants After Switching|Main Phase||175
9091575|NCT01480180|10156179|FG001|Max. Participants After Switching|Main Phase||11
8844862|NCT01712516|9899337|FG002|STARTED|Overall Study||251
8844863|NCT01712516|9899338|FG003|STARTED|Overall Study||249
8844864|NCT01712516|9899335|FG000|Safety Set|Overall Study||250
8844865|NCT01712516|9899336|FG001|Safety Set|Overall Study||251
8844866|NCT01712516|9899337|FG002|Safety Set|Overall Study||251
8844867|NCT01712516|9899338|FG003|Safety Set|Overall Study||248
9091576|NCT01480180|10156180|FG002|Max. Participants After Switching|Main Phase||0
9091577|NCT01480180|10156181|FG003|Max. Participants After Switching|Main Phase||0
9091578|NCT01480180|10156182|FG004|Max. Participants After Switching|Main Phase||0
9091579|NCT01480180|10156183|FG005|Max. Participants After Switching|Main Phase||0
9091580|NCT01480180|10156178|FG000|COMPLETED|Main Phase||155
9091581|NCT01480180|10156179|FG001|COMPLETED|Main Phase||11
9091582|NCT01480180|10156180|FG002|COMPLETED|Main Phase|Not applicable for this phase|0
9091583|NCT01480180|10156181|FG003|COMPLETED|Main Phase|Not applicable for this phase|0
9091584|NCT01480180|10156182|FG004|COMPLETED|Main Phase|Not applicable for this phase|0
9091585|NCT01480180|10156183|FG005|COMPLETED|Main Phase|Not applicable for this phase|0
9091586|NCT01480180|10156178|FG000|NOT COMPLETED|Main Phase||19
9091587|NCT01480180|10156179|FG001|NOT COMPLETED|Main Phase||1
9091588|NCT01480180|10156180|FG002|NOT COMPLETED|Main Phase||0
9091589|NCT01480180|10156181|FG003|NOT COMPLETED|Main Phase||0
9091590|NCT01480180|10156182|FG004|NOT COMPLETED|Main Phase||0
9091591|NCT01480180|10156183|FG005|NOT COMPLETED|Main Phase||0
9091592|NCT01480180|10156178|FG000|STARTED|Extension Phase, Part 1||0
9091593|NCT01480180|10156179|FG001|STARTED|Extension Phase, Part 1||0
9091594|NCT01480180|10156180|FG002|STARTED|Extension Phase, Part 1||105
9091595|NCT01480180|10156181|FG003|STARTED|Extension Phase, Part 1||38
9091596|NCT01480180|10156182|FG004|STARTED|Extension Phase, Part 1||7
9091597|NCT01480180|10156183|FG005|STARTED|Extension Phase, Part 1||0
9091598|NCT01480180|10156178|FG000|COMPLETED|Extension Phase, Part 1||0
9091599|NCT01480180|10156179|FG001|COMPLETED|Extension Phase, Part 1||0
9091600|NCT01480180|10156180|FG002|COMPLETED|Extension Phase, Part 1||95
9091601|NCT01480180|10156181|FG003|COMPLETED|Extension Phase, Part 1||28
9091602|NCT01480180|10156182|FG004|COMPLETED|Extension Phase, Part 1||7
9091603|NCT01480180|10156183|FG005|COMPLETED|Extension Phase, Part 1||0
9091604|NCT01480180|10156178|FG000|NOT COMPLETED|Extension Phase, Part 1||0
9091605|NCT01480180|10156179|FG001|NOT COMPLETED|Extension Phase, Part 1||0
9091606|NCT01480180|10156180|FG002|NOT COMPLETED|Extension Phase, Part 1||10
9091607|NCT01480180|10156181|FG003|NOT COMPLETED|Extension Phase, Part 1||10
9091608|NCT01480180|10156182|FG004|NOT COMPLETED|Extension Phase, Part 1||0
9091609|NCT01480180|10156183|FG005|NOT COMPLETED|Extension Phase, Part 1||0
9091610|NCT01480180|10156178|FG000|STARTED|Extension Phase, Part 2||0
9091611|NCT01480180|10156179|FG001|STARTED|Extension Phase, Part 2||0
9091612|NCT01480180|10156180|FG002|STARTED|Extension Phase, Part 2||94
9091613|NCT01480180|10156181|FG003|STARTED|Extension Phase, Part 2||40
9091614|NCT01480180|10156182|FG004|STARTED|Extension Phase, Part 2||5
9091615|NCT01480180|10156183|FG005|STARTED|Extension Phase, Part 2||0
9091616|NCT01480180|10156178|FG000|COMPLETED|Extension Phase, Part 2||0
9091617|NCT01480180|10156179|FG001|COMPLETED|Extension Phase, Part 2||0
9091618|NCT01480180|10156180|FG002|COMPLETED|Extension Phase, Part 2||77
9091619|NCT01480180|10156181|FG003|COMPLETED|Extension Phase, Part 2||33
8844868|NCT01712516|9899335|FG000|Full Analysis Set|Overall Study||250
8844869|NCT01712516|9899336|FG001|Full Analysis Set|Overall Study||251
8844870|NCT01712516|9899337|FG002|Full Analysis Set|Overall Study||250
8844871|NCT01712516|9899338|FG003|Full Analysis Set|Overall Study||247
8844872|NCT01712516|9899335|FG000|COMPLETED|Overall Study||244
8844873|NCT01712516|9899336|FG001|COMPLETED|Overall Study||241
8844874|NCT01712516|9899337|FG002|COMPLETED|Overall Study||245
8844875|NCT01712516|9899338|FG003|COMPLETED|Overall Study||236
8844876|NCT01712516|9899335|FG000|NOT COMPLETED|Overall Study||6
8844877|NCT01712516|9899336|FG001|NOT COMPLETED|Overall Study||10
8844878|NCT01712516|9899337|FG002|NOT COMPLETED|Overall Study||6
8844879|NCT01712516|9899338|FG003|NOT COMPLETED|Overall Study||13
9091620|NCT01480180|10156182|FG004|COMPLETED|Extension Phase, Part 2||3
9091621|NCT01480180|10156183|FG005|COMPLETED|Extension Phase, Part 2||0
9091622|NCT01480180|10156178|FG000|NOT COMPLETED|Extension Phase, Part 2||0
9091623|NCT01480180|10156179|FG001|NOT COMPLETED|Extension Phase, Part 2||0
9091624|NCT01480180|10156180|FG002|NOT COMPLETED|Extension Phase, Part 2||17
9091625|NCT01480180|10156181|FG003|NOT COMPLETED|Extension Phase, Part 2||7
9091626|NCT01480180|10156182|FG004|NOT COMPLETED|Extension Phase, Part 2||2
9091627|NCT01480180|10156183|FG005|NOT COMPLETED|Extension Phase, Part 2||0
9091628|NCT01504438|10156206|FG000|STARTED|Overall Study||48
9091629|NCT01504438|10156207|FG001|STARTED|Overall Study||50
9091630|NCT01504438|10156206|FG000|COMPLETED|Overall Study||22
9091631|NCT01504438|10156207|FG001|COMPLETED|Overall Study||25
9091632|NCT01504438|10156206|FG000|NOT COMPLETED|Overall Study||26
9091633|NCT01504438|10156207|FG001|NOT COMPLETED|Overall Study||25
8556759|NCT04870138|9588546|FG000|NOT COMPLETED|Overall Study||0
9091634|NCT01545050|10156219|FG000|STARTED|Overall Study||18
9091635|NCT01545050|10156220|FG001|STARTED|Overall Study||9
9091636|NCT01545050|10156221|FG002|STARTED|Overall Study||9
9091637|NCT01545050|10156222|FG003|STARTED|Overall Study||18
9091638|NCT01545050|10156223|FG004|STARTED|Overall Study||18
9091639|NCT01545050|10156219|FG000|COMPLETED|Overall Study||11
9091640|NCT01545050|10156220|FG001|COMPLETED|Overall Study||4
9091641|NCT01545050|10156221|FG002|COMPLETED|Overall Study||4
9091642|NCT01545050|10156222|FG003|COMPLETED|Overall Study||6
9091643|NCT01545050|10156223|FG004|COMPLETED|Overall Study||9
9091644|NCT01545050|10156219|FG000|NOT COMPLETED|Overall Study||7
9091645|NCT01545050|10156220|FG001|NOT COMPLETED|Overall Study||5
9091646|NCT01545050|10156221|FG002|NOT COMPLETED|Overall Study||5
9091647|NCT01545050|10156222|FG003|NOT COMPLETED|Overall Study||12
9091648|NCT01545050|10156223|FG004|NOT COMPLETED|Overall Study||9
9091649|NCT01550302|10156241|FG000|STARTED|Overall Study||5
9091650|NCT01550302|10156242|FG001|STARTED|Overall Study||5
9091651|NCT01550302|10156241|FG000|COMPLETED|Overall Study||5
9091652|NCT01550302|10156242|FG001|COMPLETED|Overall Study||5
9091653|NCT01550302|10156241|FG000|NOT COMPLETED|Overall Study||0
9091654|NCT01550302|10156242|FG001|NOT COMPLETED|Overall Study||0
9091655|NCT01555021|10156250|FG000|STARTED|Overall Study||2
9091656|NCT01555021|10156251|FG001|STARTED|Overall Study||2
9091657|NCT01555021|10156250|FG000|COMPLETED|Overall Study|One treatment as usual subject completed 1 month, 3 month, and 6 month follow up visits|1
9091658|NCT01555021|10156251|FG001|COMPLETED|Overall Study|None of the AGT subjects competed month 1, month 3, or month 6 follow up visits.|0
9091659|NCT01555021|10156250|FG000|NOT COMPLETED|Overall Study||1
9091660|NCT01555021|10156251|FG001|NOT COMPLETED|Overall Study||2
9091661|NCT01561430|10156267|FG000|STARTED|Overall Study||9
9091662|NCT01561430|10156268|FG001|STARTED|Overall Study||23
9091663|NCT01561430|10156269|FG002|STARTED|Overall Study||18
9091664|NCT01561430|10156270|FG003|STARTED|Overall Study||20
9091665|NCT01561430|10156267|FG000|Received at Least One Dose of Study Drug|Overall Study||9
9091666|NCT01561430|10156268|FG001|Received at Least One Dose of Study Drug|Overall Study||23
9091667|NCT01561430|10156269|FG002|Received at Least One Dose of Study Drug|Overall Study||18
9091668|NCT01561430|10156270|FG003|Received at Least One Dose of Study Drug|Overall Study||20
9091669|NCT01561430|10156267|FG000|COMPLETED|Overall Study||8
9091670|NCT01561430|10156268|FG001|COMPLETED|Overall Study||8
9091671|NCT01561430|10156269|FG002|COMPLETED|Overall Study||1
9091672|NCT01561430|10156270|FG003|COMPLETED|Overall Study||7
9091673|NCT01561430|10156267|FG000|NOT COMPLETED|Overall Study||1
9091674|NCT01561430|10156268|FG001|NOT COMPLETED|Overall Study||15
9091675|NCT01561430|10156269|FG002|NOT COMPLETED|Overall Study||17
9091676|NCT01561430|10156270|FG003|NOT COMPLETED|Overall Study||13
9091677|NCT01580813|10156281|FG000|STARTED|Overall Study||4
9091678|NCT01580813|10156282|FG001|STARTED|Overall Study||3
9091679|NCT01580813|10156281|FG000|Completed First Intervention|Overall Study||4
9091680|NCT01580813|10156282|FG001|Completed First Intervention|Overall Study||3
9091681|NCT01580813|10156281|FG000|Completed 1 Week Washout|Overall Study||4
9091682|NCT01580813|10156282|FG001|Completed 1 Week Washout|Overall Study||3
9091683|NCT01580813|10156281|FG000|Started Second Intervention|Overall Study||4
9091684|NCT01580813|10156282|FG001|Started Second Intervention|Overall Study||3
9091685|NCT01580813|10156281|FG000|COMPLETED|Overall Study||4
9091686|NCT01580813|10156282|FG001|COMPLETED|Overall Study||3
9091687|NCT01580813|10156281|FG000|NOT COMPLETED|Overall Study||0
9091688|NCT01580813|10156282|FG001|NOT COMPLETED|Overall Study||0
9091689|NCT01595009|10156290|FG000|STARTED|Core||126
9091690|NCT01595009|10156291|FG001|STARTED|Core||120
9091691|NCT01595009|10156292|FG002|STARTED|Core||0
9091692|NCT01595009|10156293|FG003|STARTED|Core||0
9091693|NCT01595009|10156290|FG000|COMPLETED|Core||0
9091694|NCT01595009|10156291|FG001|COMPLETED|Core||0
9091695|NCT01595009|10156292|FG002|COMPLETED|Core||0
9091696|NCT01595009|10156293|FG003|COMPLETED|Core||0
9091697|NCT01595009|10156290|FG000|NOT COMPLETED|Core||126
9091698|NCT01595009|10156291|FG001|NOT COMPLETED|Core||120
9091699|NCT01595009|10156292|FG002|NOT COMPLETED|Core||0
9091700|NCT01595009|10156293|FG003|NOT COMPLETED|Core||0
9091701|NCT01595009|10156290|FG000|STARTED|Extension||0
9091702|NCT01595009|10156291|FG001|STARTED|Extension||0
9091703|NCT01595009|10156292|FG002|STARTED|Extension||4
9091704|NCT01595009|10156293|FG003|STARTED|Extension||11
9091705|NCT01595009|10156290|FG000|COMPLETED|Extension||0
9091706|NCT01595009|10156291|FG001|COMPLETED|Extension||0
9091707|NCT01595009|10156292|FG002|COMPLETED|Extension||0
9091708|NCT01595009|10156293|FG003|COMPLETED|Extension||0
9091709|NCT01595009|10156290|FG000|NOT COMPLETED|Extension||0
9091710|NCT01595009|10156291|FG001|NOT COMPLETED|Extension||0
9091711|NCT01595009|10156292|FG002|NOT COMPLETED|Extension||4
9091712|NCT01595009|10156293|FG003|NOT COMPLETED|Extension||11
9091713|NCT01620944|10156310|FG000|STARTED|Overall Study||2
9091714|NCT01620944|10156311|FG001|STARTED|Overall Study||1
9091715|NCT01620944|10156310|FG000|COMPLETED|Overall Study||0
9091716|NCT01620944|10156311|FG001|COMPLETED|Overall Study||0
9091717|NCT01620944|10156310|FG000|NOT COMPLETED|Overall Study||2
9091718|NCT01620944|10156311|FG001|NOT COMPLETED|Overall Study||1
9091719|NCT01627561|10156319|FG000|STARTED|Overall Study||74
9091720|NCT01627561|10156320|FG001|STARTED|Overall Study||74
9091721|NCT01627561|10156319|FG000|COMPLETED|Overall Study||73
9091722|NCT01627561|10156320|FG001|COMPLETED|Overall Study||71
9091723|NCT01627561|10156319|FG000|NOT COMPLETED|Overall Study||1
9091724|NCT01627561|10156320|FG001|NOT COMPLETED|Overall Study||3
9091725|NCT01629511|10156330|FG000|STARTED|Overall Study||4
9091726|NCT01629511|10156331|FG001|STARTED|Overall Study||0
9091727|NCT01629511|10156332|FG002|STARTED|Overall Study||8
9091728|NCT01629511|10156333|FG003|STARTED|Overall Study||3
9091729|NCT01629511|10156330|FG000|COMPLETED|Overall Study||4
9091730|NCT01629511|10156331|FG001|COMPLETED|Overall Study||0
9091731|NCT01629511|10156332|FG002|COMPLETED|Overall Study||8
9091732|NCT01629511|10156333|FG003|COMPLETED|Overall Study||3
9091733|NCT01629511|10156330|FG000|NOT COMPLETED|Overall Study||0
9091734|NCT01629511|10156331|FG001|NOT COMPLETED|Overall Study||0
9091735|NCT01629511|10156332|FG002|NOT COMPLETED|Overall Study||0
9091736|NCT01629511|10156333|FG003|NOT COMPLETED|Overall Study||0
9091737|NCT01652534|10156345|FG000|STARTED|Overall Study||2
9091738|NCT01652534|10156346|FG001|STARTED|Overall Study||1
9091739|NCT01652534|10156345|FG000|COMPLETED|Overall Study||1
9091740|NCT01652534|10156346|FG001|COMPLETED|Overall Study||1
9091741|NCT01652534|10156345|FG000|NOT COMPLETED|Overall Study||1
9091742|NCT01652534|10156346|FG001|NOT COMPLETED|Overall Study||0
8556760|NCT04870138|9588547|FG001|NOT COMPLETED|Overall Study||0
8556761|NCT04870138|9588548|FG002|NOT COMPLETED|Overall Study||0
8568737|NCT00093041|9600944|FG005|STARTED|Overall Study||7
8568738|NCT00093041|9600939|FG000|COMPLETED|Overall Study|One discontinued during single dose period and one during multiple dose period|2
8568739|NCT00093041|9600940|FG001|COMPLETED|Overall Study|Three discontinued during single dose period|1
9091743|NCT01670565|10156354|FG000|STARTED|Overall Study||10
9091744|NCT01670565|10156355|FG001|STARTED|Overall Study||10
9091745|NCT01670565|10156354|FG000|COMPLETED|Overall Study||9
9091746|NCT01670565|10156355|FG001|COMPLETED|Overall Study||9
9091747|NCT01670565|10156354|FG000|NOT COMPLETED|Overall Study||1
9091748|NCT01670565|10156355|FG001|NOT COMPLETED|Overall Study||1
9091749|NCT04871425|10156365|FG000|STARTED|Overall Study||57
9091750|NCT04871425|10156366|FG001|STARTED|Overall Study||53
9091751|NCT04871425|10156365|FG000|COMPLETED|Overall Study||42
9091752|NCT04871425|10156366|FG001|COMPLETED|Overall Study||45
9091753|NCT04871425|10156365|FG000|NOT COMPLETED|Overall Study||15
9091754|NCT04871425|10156366|FG001|NOT COMPLETED|Overall Study||8
9091755|NCT04799405|10156372|FG000|STARTED|Phase 1 - Acute Stimulation, Daily tDCS||5
9091756|NCT04799405|10156372|FG000|COMPLETED|Phase 1 - Acute Stimulation, Daily tDCS||3
9091757|NCT04799405|10156372|FG000|NOT COMPLETED|Phase 1 - Acute Stimulation, Daily tDCS||2
9091758|NCT04799405|10156372|FG000|STARTED|Phase 2 - Tapered Stimulation Schedule||3
9091759|NCT04799405|10156372|FG000|COMPLETED|Phase 2 - Tapered Stimulation Schedule||3
9091760|NCT04799405|10156372|FG000|NOT COMPLETED|Phase 2 - Tapered Stimulation Schedule||0
9091761|NCT04799405|10156372|FG000|STARTED|Phase 3 - Follow up Phase||3
9091762|NCT04799405|10156372|FG000|COMPLETED|Phase 3 - Follow up Phase||3
9091763|NCT04799405|10156372|FG000|NOT COMPLETED|Phase 3 - Follow up Phase||0
9091767|NCT04537949|10156388|FG000|STARTED|Overall Study||12
9091768|NCT04537949|10156389|FG001|STARTED|Overall Study||12
9091769|NCT04537949|10156390|FG002|STARTED|Overall Study||12
9091770|NCT04537949|10156391|FG003|STARTED|Overall Study||12
9091771|NCT04537949|10156392|FG004|STARTED|Overall Study||12
9091772|NCT04537949|10156393|FG005|STARTED|Overall Study||12
9091773|NCT04537949|10156394|FG006|STARTED|Overall Study||12
9091774|NCT04537949|10156395|FG007|STARTED|Overall Study||12
9091775|NCT04537949|10156388|FG000|COMPLETED|Overall Study||11
9091776|NCT04537949|10156389|FG001|COMPLETED|Overall Study||12
9091777|NCT04537949|10156390|FG002|COMPLETED|Overall Study||12
9091778|NCT04537949|10156391|FG003|COMPLETED|Overall Study||12
9091779|NCT04537949|10156392|FG004|COMPLETED|Overall Study||12
9091780|NCT04537949|10156393|FG005|COMPLETED|Overall Study||12
9091781|NCT04537949|10156394|FG006|COMPLETED|Overall Study||12
9091782|NCT04537949|10156395|FG007|COMPLETED|Overall Study||12
9091783|NCT04537949|10156388|FG000|NOT COMPLETED|Overall Study||1
9091784|NCT04537949|10156389|FG001|NOT COMPLETED|Overall Study||0
9091785|NCT04537949|10156390|FG002|NOT COMPLETED|Overall Study||0
9091786|NCT04537949|10156391|FG003|NOT COMPLETED|Overall Study||0
9091787|NCT04537949|10156392|FG004|NOT COMPLETED|Overall Study||0
9091788|NCT04537949|10156393|FG005|NOT COMPLETED|Overall Study||0
9091789|NCT04537949|10156394|FG006|NOT COMPLETED|Overall Study||0
9091790|NCT04537949|10156395|FG007|NOT COMPLETED|Overall Study||0
9091791|NCT04529499|10156415|FG000|STARTED|Overall Study||175
9091792|NCT04529499|10156416|FG001|STARTED|Overall Study||178
9091793|NCT04529499|10156415|FG000|Discharged From Hospital Before Day 28|Overall Study||136
9091794|NCT04529499|10156416|FG001|Discharged From Hospital Before Day 28|Overall Study||136
9091795|NCT04529499|10156415|FG000|Completed 10-day Treatment Course of IMP|Overall Study||150
9091796|NCT04529499|10156416|FG001|Completed 10-day Treatment Course of IMP|Overall Study||147
9091797|NCT04529499|10156415|FG000|Completed Day 14 Telephonic Visit|Overall Study||107
9091798|NCT04529499|10156416|FG001|Completed Day 14 Telephonic Visit|Overall Study||102
9091799|NCT04529499|10156415|FG000|Completed Day 21 Telephonic Visit|Overall Study||119
9091800|NCT04529499|10156416|FG001|Completed Day 21 Telephonic Visit|Overall Study||120
9091801|NCT04529499|10156415|FG000|Completed Day 28 Telephonic Visit|Overall Study||134
9091802|NCT04529499|10156416|FG001|Completed Day 28 Telephonic Visit|Overall Study||131
9091803|NCT04529499|10156415|FG000|Completed Days 14, 21 and 28 Telephonic Visits in Stage I|Overall Study||98
9091804|NCT04529499|10156416|FG001|Completed Days 14, 21 and 28 Telephonic Visits in Stage I|Overall Study||94
9091805|NCT04529499|10156415|FG000|Continue to be in Hospital as of Day 28|Overall Study||6
9091806|NCT04529499|10156416|FG001|Continue to be in Hospital as of Day 28|Overall Study||4
9091807|NCT04529499|10156415|FG000|Completed Day 42 Telephonic Visit|Overall Study||136
9091808|NCT04529499|10156416|FG001|Completed Day 42 Telephonic Visit|Overall Study||135
9091809|NCT04529499|10156415|FG000|Completed Day 60 Telephonic Visit|Overall Study||129
9091810|NCT04529499|10156416|FG001|Completed Day 60 Telephonic Visit|Overall Study||132
9091811|NCT04529499|10156415|FG000|Completed Days 42 and 60 Telephonic Visits in Stage II|Overall Study||126
9091812|NCT04529499|10156416|FG001|Completed Days 42 and 60 Telephonic Visits in Stage II|Overall Study||130
9091813|NCT04529499|10156415|FG000|Continued to be in Hospital When Study Was Terminated|Overall Study||11
9091814|NCT04529499|10156416|FG001|Continued to be in Hospital When Study Was Terminated|Overall Study||17
9091815|NCT04529499|10156415|FG000|COMPLETED|Overall Study||139
9091816|NCT04529499|10156416|FG001|COMPLETED|Overall Study||138
9091817|NCT04529499|10156415|FG000|NOT COMPLETED|Overall Study||36
8625324|NCT00506675|9664855|FG000|COMPLETED|Overall Study||27
8625325|NCT00506675|9664856|FG001|COMPLETED|Overall Study||28
8625326|NCT00506675|9664855|FG000|NOT COMPLETED|Overall Study||0
9091818|NCT04529499|10156416|FG001|NOT COMPLETED|Overall Study||40
9091819|NCT04501094|10156424|FG000|STARTED|Overall Study||1
8625327|NCT00506675|9664856|FG001|NOT COMPLETED|Overall Study||0
8625328|NCT00506714|9664864|FG000|STARTED|Overall Study||13
9091820|NCT04501094|10156425|FG001|STARTED|Overall Study||1
9091821|NCT04501094|10156424|FG000|COMPLETED|Overall Study||0
9091822|NCT04501094|10156425|FG001|COMPLETED|Overall Study||1
9091823|NCT04501094|10156424|FG000|NOT COMPLETED|Overall Study||1
9091824|NCT04501094|10156425|FG001|NOT COMPLETED|Overall Study||0
8625329|NCT00506714|9664865|FG001|STARTED|Overall Study||13
8625330|NCT00506714|9664864|FG000|COMPLETED|Overall Study||13
8625331|NCT00506714|9664865|FG001|COMPLETED|Overall Study||13
8625332|NCT00506714|9664864|FG000|NOT COMPLETED|Overall Study||0
9091764|NCT04748458|10156376|FG000|STARTED|Overall Study||85
9091765|NCT04748458|10156376|FG000|COMPLETED|Overall Study||85
9091766|NCT04748458|10156376|FG000|NOT COMPLETED|Overall Study||0
9091825|NCT04421027|10156433|FG000|STARTED|Overall Study||761
9091826|NCT04421027|10156434|FG001|STARTED|Overall Study||764
9091827|NCT04421027|10156433|FG000|Received at Least One Dose of Study Drug|Overall Study||752
9091828|NCT04421027|10156434|FG001|Received at Least One Dose of Study Drug|Overall Study||750
9091829|NCT04421027|10156433|FG000|COMPLETED|Overall Study||604
9091830|NCT04421027|10156434|FG001|COMPLETED|Overall Study||644
9091831|NCT04421027|10156433|FG000|NOT COMPLETED|Overall Study||157
9091832|NCT04421027|10156434|FG001|NOT COMPLETED|Overall Study||120
9091833|NCT04414618|10156444|FG000|STARTED|Overall Study||23
9091834|NCT04414618|10156445|FG001|STARTED|Overall Study||19
9091835|NCT04414618|10156444|FG000|COMPLETED|Overall Study||15
9091836|NCT04414618|10156445|FG001|COMPLETED|Overall Study||12
9091837|NCT04414618|10156444|FG000|NOT COMPLETED|Overall Study||8
9091838|NCT04414618|10156445|FG001|NOT COMPLETED|Overall Study||7
9091839|NCT04412057|10156454|FG000|STARTED|Overall Study||41
9091840|NCT04412057|10156455|FG001|STARTED|Overall Study||42
9091841|NCT04412057|10156454|FG000|Randomized Analysis Set|Overall Study||41
9091842|NCT04412057|10156455|FG001|Randomized Analysis Set|Overall Study||42
9091843|NCT04412057|10156454|FG000|Safety Analysis Set|Overall Study||40
9091844|NCT04412057|10156455|FG001|Safety Analysis Set|Overall Study||42
9091845|NCT04412057|10156454|FG000|Full Analysis Set|Overall Study||40
9091846|NCT04412057|10156455|FG001|Full Analysis Set|Overall Study||42
9091847|NCT04412057|10156454|FG000|Primary Analysis Set|Overall Study||31
9091848|NCT04412057|10156455|FG001|Primary Analysis Set|Overall Study||31
9091849|NCT04412057|10156454|FG000|COMPLETED|Overall Study||37
9091850|NCT04412057|10156455|FG001|COMPLETED|Overall Study||35
9091851|NCT04412057|10156454|FG000|NOT COMPLETED|Overall Study||4
9091852|NCT04412057|10156455|FG001|NOT COMPLETED|Overall Study||7
9091853|NCT04402060|10156464|FG000|STARTED|Overall Study||6
9091854|NCT04402060|10156465|FG001|STARTED|Overall Study||34
9091855|NCT04402060|10156466|FG002|STARTED|Overall Study||32
9091856|NCT04402060|10156464|FG000|Received Treatment|Overall Study||6
9091857|NCT04402060|10156465|FG001|Received Treatment|Overall Study||33
9091858|NCT04402060|10156466|FG002|Received Treatment|Overall Study||32
9091859|NCT04402060|10156464|FG000|COMPLETED|Overall Study||5
9091860|NCT04402060|10156465|FG001|COMPLETED|Overall Study||18
9091861|NCT04402060|10156466|FG002|COMPLETED|Overall Study||21
9091862|NCT04402060|10156464|FG000|NOT COMPLETED|Overall Study||1
9091863|NCT04402060|10156465|FG001|NOT COMPLETED|Overall Study||16
9091864|NCT04402060|10156466|FG002|NOT COMPLETED|Overall Study||11
9091865|NCT04396626|10156479|FG000|STARTED|Overall Study||975
9091866|NCT04396626|10156479|FG000|COMPLETED|Overall Study||0
9091867|NCT04396626|10156479|FG000|NOT COMPLETED|Overall Study||975
9091868|NCT04391179|10156485|FG000|STARTED|Overall Study||49
9091869|NCT04391179|10156486|FG001|STARTED|Overall Study||50
9091870|NCT04391179|10156485|FG000|COMPLETED|Overall Study||34
9091871|NCT04391179|10156486|FG001|COMPLETED|Overall Study||34
9091872|NCT04391179|10156485|FG000|NOT COMPLETED|Overall Study||15
9091873|NCT04391179|10156486|FG001|NOT COMPLETED|Overall Study||16
9091874|NCT04386096|10156494|FG000|STARTED|Overall Study||20
9091875|NCT04386096|10156495|FG001|STARTED|Overall Study||20
9091876|NCT04386096|10156494|FG000|COMPLETED|Overall Study||20
9091877|NCT04386096|10156495|FG001|COMPLETED|Overall Study||20
9091878|NCT04386096|10156494|FG000|NOT COMPLETED|Overall Study||0
9091879|NCT04386096|10156495|FG001|NOT COMPLETED|Overall Study||0
9091880|NCT04376684|10156505|FG000|STARTED|Part 1 (Up to Day 60)||403
9091881|NCT04376684|10156506|FG001|STARTED|Part 1 (Up to Day 60)||403
9091882|NCT04376684|10156507|FG002|STARTED|Part 1 (Up to Day 60)||0
9091883|NCT04376684|10156508|FG003|STARTED|Part 1 (Up to Day 60)||0
9091884|NCT04376684|10156505|FG000|COMPLETED|Part 1 (Up to Day 60)||388
9091885|NCT04376684|10156506|FG001|COMPLETED|Part 1 (Up to Day 60)||379
9091886|NCT04376684|10156507|FG002|COMPLETED|Part 1 (Up to Day 60)||0
9091887|NCT04376684|10156508|FG003|COMPLETED|Part 1 (Up to Day 60)||0
9091888|NCT04376684|10156505|FG000|NOT COMPLETED|Part 1 (Up to Day 60)||15
9091889|NCT04376684|10156506|FG001|NOT COMPLETED|Part 1 (Up to Day 60)||24
9091890|NCT04376684|10156507|FG002|NOT COMPLETED|Part 1 (Up to Day 60)||0
9091891|NCT04376684|10156508|FG003|NOT COMPLETED|Part 1 (Up to Day 60)||0
9091892|NCT04376684|10156505|FG000|STARTED|Part 2 (Up to Day 60)||0
9091893|NCT04376684|10156506|FG001|STARTED|Part 2 (Up to Day 60)||0
9091894|NCT04376684|10156507|FG002|STARTED|Part 2 (Up to Day 60)||175
8625333|NCT00506714|9664865|FG001|NOT COMPLETED|Overall Study||0
8625334|NCT00506753|9664875|FG000|STARTED|Overall Study||100
8625335|NCT00506753|9664876|FG001|STARTED|Overall Study||99
8625336|NCT00506753|9664875|FG000|COMPLETED|Overall Study||79
9091895|NCT04376684|10156508|FG003|STARTED|Part 2 (Up to Day 60)||175
9091896|NCT04376684|10156505|FG000|COMPLETED|Part 2 (Up to Day 60)||0
9091897|NCT04376684|10156506|FG001|COMPLETED|Part 2 (Up to Day 60)||0
8625337|NCT00506753|9664876|FG001|COMPLETED|Overall Study||84
9091898|NCT04376684|10156507|FG002|COMPLETED|Part 2 (Up to Day 60)||170
9091899|NCT04376684|10156508|FG003|COMPLETED|Part 2 (Up to Day 60)||171
9091900|NCT04376684|10156505|FG000|NOT COMPLETED|Part 2 (Up to Day 60)||0
9091901|NCT04376684|10156506|FG001|NOT COMPLETED|Part 2 (Up to Day 60)||0
9091902|NCT04376684|10156507|FG002|NOT COMPLETED|Part 2 (Up to Day 60)||5
9091903|NCT04376684|10156508|FG003|NOT COMPLETED|Part 2 (Up to Day 60)||4
8625338|NCT00506753|9664875|FG000|NOT COMPLETED|Overall Study||21
8625339|NCT00506753|9664876|FG001|NOT COMPLETED|Overall Study||15
8625340|NCT00506779|9664884|FG000|STARTED|Overall Study||4
8625341|NCT00506779|9664885|FG001|STARTED|Overall Study||6
8625342|NCT00506779|9664886|FG002|STARTED|Overall Study||2
9091904|NCT04353284|10156520|FG000|STARTED|Overall Study||35
9091905|NCT04353284|10156521|FG001|STARTED|Overall Study||35
9091906|NCT04353284|10156520|FG000|COMPLETED|Overall Study||33
9091907|NCT04353284|10156521|FG001|COMPLETED|Overall Study||34
9091908|NCT04353284|10156520|FG000|NOT COMPLETED|Overall Study||2
9091909|NCT04353284|10156521|FG001|NOT COMPLETED|Overall Study||1
9091910|NCT04294147|10156529|FG000|STARTED|Overall Study||32
9091911|NCT04294147|10156530|FG001|STARTED|Overall Study||33
9091912|NCT04294147|10156529|FG000|Received at Least One Dose of Study Drug|Overall Study||32
9091913|NCT04294147|10156530|FG001|Received at Least One Dose of Study Drug|Overall Study||33
8844880|NCT01712685|9899348|FG000|STARTED|Overall Study||12
8844881|NCT01712685|9899348|FG000|COMPLETED|Overall Study||11
8844882|NCT01712685|9899348|FG000|NOT COMPLETED|Overall Study||1
8844883|NCT01712711|9899354|FG000|STARTED|Overall Study||20
8844884|NCT01712711|9899355|FG001|STARTED|Overall Study||20
8844885|NCT01712711|9899354|FG000|COMPLETED|Overall Study||20
9091914|NCT04294147|10156529|FG000|COMPLETED|Overall Study||30
9091915|NCT04294147|10156530|FG001|COMPLETED|Overall Study||33
9091916|NCT04294147|10156529|FG000|NOT COMPLETED|Overall Study||2
9091917|NCT04294147|10156530|FG001|NOT COMPLETED|Overall Study||0
9091918|NCT04269707|10156536|FG000|STARTED|Overall Study||7
9091919|NCT04269707|10156536|FG000|COMPLETED|Overall Study||7
9091920|NCT04269707|10156536|FG000|NOT COMPLETED|Overall Study||0
8625343|NCT00506779|9664887|FG003|STARTED|Overall Study||5
8625344|NCT00506779|9664884|FG000|COMPLETED|Overall Study||3
8625345|NCT00506779|9664885|FG001|COMPLETED|Overall Study||5
8625346|NCT00506779|9664886|FG002|COMPLETED|Overall Study||0
8844886|NCT01712711|9899355|FG001|COMPLETED|Overall Study||20
8844887|NCT01712711|9899354|FG000|NOT COMPLETED|Overall Study||0
8844888|NCT01712711|9899355|FG001|NOT COMPLETED|Overall Study||0
8844889|NCT01712776|9899363|FG000|STARTED|Overall Study||50
8844890|NCT01712776|9899364|FG001|STARTED|Overall Study||50
8844891|NCT01712776|9899363|FG000|COMPLETED|Overall Study|trial to enroll 50 in each group for total of 100|50
8844892|NCT01712776|9899364|FG001|COMPLETED|Overall Study||50
8844893|NCT01712776|9899363|FG000|NOT COMPLETED|Overall Study||0
8844894|NCT01712776|9899364|FG001|NOT COMPLETED|Overall Study||0
8844895|NCT01712984|9899373|FG000|STARTED|Overall Study||1672
8844896|NCT01712984|9899374|FG001|STARTED|Overall Study||837
8844897|NCT01712984|9899375|FG002|STARTED|Overall Study||846
8844898|NCT01712984|9899373|FG000|COMPLETED|Overall Study||1656
8844899|NCT01712984|9899374|FG001|COMPLETED|Overall Study||821
8625347|NCT00506779|9664887|FG003|COMPLETED|Overall Study||4
8625348|NCT00506779|9664884|FG000|NOT COMPLETED|Overall Study||1
8844900|NCT01712984|9899375|FG002|COMPLETED|Overall Study||836
8844901|NCT01712984|9899373|FG000|NOT COMPLETED|Overall Study||16
8625349|NCT00506779|9664885|FG001|NOT COMPLETED|Overall Study||1
8844902|NCT01712984|9899374|FG001|NOT COMPLETED|Overall Study||16
9091921|NCT04231825|10156542|FG000|STARTED|Overall Study||23
9091922|NCT04231825|10156543|FG001|STARTED|Overall Study||24
9091923|NCT04231825|10156542|FG000|COMPLETED|Overall Study||20
9091924|NCT04231825|10156543|FG001|COMPLETED|Overall Study||20
9091925|NCT04231825|10156542|FG000|NOT COMPLETED|Overall Study||3
9091926|NCT04231825|10156543|FG001|NOT COMPLETED|Overall Study||4
9091927|NCT04196686|10156549|FG000|STARTED|First Treatment (4 Minutes)||78
9091928|NCT04196686|10156550|FG001|STARTED|First Treatment (4 Minutes)||78
9091929|NCT04196686|10156549|FG000|COMPLETED|First Treatment (4 Minutes)||78
9091930|NCT04196686|10156550|FG001|COMPLETED|First Treatment (4 Minutes)||75
9091931|NCT04196686|10156549|FG000|NOT COMPLETED|First Treatment (4 Minutes)||0
9091932|NCT04196686|10156550|FG001|NOT COMPLETED|First Treatment (4 Minutes)||3
9091933|NCT04196686|10156549|FG000|STARTED|Second Treatment (4 Minutes)||78
9091934|NCT04196686|10156550|FG001|STARTED|Second Treatment (4 Minutes)||75
9091935|NCT04196686|10156549|FG000|COMPLETED|Second Treatment (4 Minutes)||78
9091936|NCT04196686|10156550|FG001|COMPLETED|Second Treatment (4 Minutes)||75
9091937|NCT04196686|10156549|FG000|NOT COMPLETED|Second Treatment (4 Minutes)||0
9091938|NCT04196686|10156550|FG001|NOT COMPLETED|Second Treatment (4 Minutes)||0
9091939|NCT04178772|10156556|FG000|STARTED|Overall Study||27
9091940|NCT04178772|10156556|FG000|COMPLETED|Overall Study||19
9091941|NCT04178772|10156556|FG000|NOT COMPLETED|Overall Study||8
9091942|NCT04148651|10156560|FG000|STARTED|Overall Study||12
9091943|NCT04148651|10156560|FG000|COMPLETED|Overall Study|2 subjects did not complete the final follow-up due to COVID-19 pandemic|10
9091944|NCT04148651|10156560|FG000|NOT COMPLETED|Overall Study||2
9091945|NCT04113304|10156565|FG000|STARTED|Overall Study||6
9091946|NCT04113304|10156565|FG000|COMPLETED|Overall Study||6
9091947|NCT04113304|10156565|FG000|NOT COMPLETED|Overall Study||0
9091948|NCT03929588|10156569|FG000|STARTED|Overall Study||230
9091949|NCT03929588|10156569|FG000|COMPLETED|Overall Study||143
9091950|NCT03929588|10156569|FG000|NOT COMPLETED|Overall Study||87
9092041|NCT03811574|10156697|FG001|COMPLETED|Overall Study||195
9092042|NCT03811574|10156698|FG002|COMPLETED|Overall Study||101
9092043|NCT03811574|10156696|FG000|NOT COMPLETED|Overall Study||2
9092044|NCT03811574|10156697|FG001|NOT COMPLETED|Overall Study||4
9092045|NCT03811574|10156698|FG002|NOT COMPLETED|Overall Study||0
9092046|NCT03800420|10156708|FG000|STARTED|Overall Study||12
9092047|NCT03800420|10156709|FG001|STARTED|Overall Study||4
9092048|NCT03800420|10156708|FG000|COMPLETED|Overall Study||10
9092049|NCT03800420|10156709|FG001|COMPLETED|Overall Study||3
9092050|NCT03800420|10156708|FG000|NOT COMPLETED|Overall Study||2
9092051|NCT03800420|10156709|FG001|NOT COMPLETED|Overall Study||1
9091951|NCT03893448|10156575|FG000|STARTED|Overall Study||860
9091952|NCT03893448|10156576|FG001|STARTED|Overall Study||860
9091953|NCT03893448|10156575|FG000|Treated|Overall Study||858
9091954|NCT03893448|10156576|FG001|Treated|Overall Study||856
9091955|NCT03893448|10156575|FG000|COMPLETED|Overall Study||758
9091956|NCT03893448|10156576|FG001|COMPLETED|Overall Study||734
9091957|NCT03893448|10156575|FG000|NOT COMPLETED|Overall Study||102
9091958|NCT03893448|10156576|FG001|NOT COMPLETED|Overall Study||126
9091959|NCT03870880|10156589|FG000|STARTED|Overall Study||27
9091960|NCT03870880|10156590|FG001|STARTED|Overall Study||58
9091961|NCT03870880|10156591|FG002|STARTED|Overall Study||31
9091962|NCT03870880|10156592|FG003|STARTED|Overall Study||28
9091963|NCT03870880|10156593|FG004|STARTED|Overall Study||61
9091964|NCT03870880|10156594|FG005|STARTED|Overall Study||10
9091965|NCT03870880|10156589|FG000|COMPLETED|Overall Study||21
9091966|NCT03870880|10156590|FG001|COMPLETED|Overall Study||43
9091967|NCT03870880|10156591|FG002|COMPLETED|Overall Study||26
9091968|NCT03870880|10156592|FG003|COMPLETED|Overall Study||20
9091969|NCT03870880|10156593|FG004|COMPLETED|Overall Study||44
9091970|NCT03870880|10156594|FG005|COMPLETED|Overall Study||7
9091971|NCT03870880|10156589|FG000|NOT COMPLETED|Overall Study||6
9091972|NCT03870880|10156590|FG001|NOT COMPLETED|Overall Study||15
9091973|NCT03870880|10156591|FG002|NOT COMPLETED|Overall Study||5
9091974|NCT03870880|10156592|FG003|NOT COMPLETED|Overall Study||8
9091975|NCT03870880|10156593|FG004|NOT COMPLETED|Overall Study||17
9091976|NCT03870880|10156594|FG005|NOT COMPLETED|Overall Study||3
9091977|NCT03850444|10156615|FG000|STARTED|Overall Study||128
9091978|NCT03850444|10156616|FG001|STARTED|Overall Study||134
9091979|NCT03850444|10156615|FG000|COMPLETED|Overall Study||0
9091980|NCT03850444|10156616|FG001|COMPLETED|Overall Study||0
9091981|NCT03850444|10156615|FG000|NOT COMPLETED|Overall Study||128
9091982|NCT03850444|10156616|FG001|NOT COMPLETED|Overall Study||134
9091983|NCT03831347|10156622|FG000|STARTED|Overall Study||11
9091984|NCT03831347|10156622|FG000|COMPLETED|Overall Study||9
9091985|NCT03831347|10156622|FG000|NOT COMPLETED|Overall Study||2
9091986|NCT03814590|10156640|FG000|STARTED|Overall Study||12
9091987|NCT03814590|10156641|FG001|STARTED|Overall Study||12
9091988|NCT03814590|10156642|FG002|STARTED|Overall Study||12
9091989|NCT03814590|10156643|FG003|STARTED|Overall Study||12
9091990|NCT03814590|10156644|FG004|STARTED|Overall Study||101
9091991|NCT03814590|10156645|FG005|STARTED|Overall Study||97
9091992|NCT03814590|10156646|FG006|STARTED|Overall Study||100
9091993|NCT03814590|10156647|FG007|STARTED|Overall Study||101
9091994|NCT03814590|10156648|FG008|STARTED|Overall Study||101
9091995|NCT03814590|10156649|FG009|STARTED|Overall Study||100
9091996|NCT03814590|10156650|FG010|STARTED|Overall Study||103
9091997|NCT03814590|10156651|FG011|STARTED|Overall Study||100
9091998|NCT03814590|10156652|FG012|STARTED|Overall Study||101
9091999|NCT03814590|10156653|FG013|STARTED|Overall Study||101
9092000|NCT03814590|10156640|FG000|COMPLETED|Overall Study||12
9092001|NCT03814590|10156641|FG001|COMPLETED|Overall Study||10
9092002|NCT03814590|10156642|FG002|COMPLETED|Overall Study||11
9092003|NCT03814590|10156643|FG003|COMPLETED|Overall Study||12
9092004|NCT03814590|10156644|FG004|COMPLETED|Overall Study||100
9092005|NCT03814590|10156645|FG005|COMPLETED|Overall Study||92
9092006|NCT03814590|10156646|FG006|COMPLETED|Overall Study||97
9092007|NCT03814590|10156647|FG007|COMPLETED|Overall Study||95
9092008|NCT03814590|10156648|FG008|COMPLETED|Overall Study||101
9092009|NCT03814590|10156649|FG009|COMPLETED|Overall Study||95
9092010|NCT03814590|10156650|FG010|COMPLETED|Overall Study||100
9092011|NCT03814590|10156651|FG011|COMPLETED|Overall Study||100
9092012|NCT03814590|10156652|FG012|COMPLETED|Overall Study||97
9092013|NCT03814590|10156653|FG013|COMPLETED|Overall Study||98
9092014|NCT03814590|10156640|FG000|NOT COMPLETED|Overall Study||0
8844903|NCT01712984|9899375|FG002|NOT COMPLETED|Overall Study||10
8844904|NCT01713036|9899383|FG000|STARTED|Overall Study||6
9092015|NCT03814590|10156641|FG001|NOT COMPLETED|Overall Study||2
9092016|NCT03814590|10156642|FG002|NOT COMPLETED|Overall Study||1
9092017|NCT03814590|10156643|FG003|NOT COMPLETED|Overall Study||0
9092018|NCT03814590|10156644|FG004|NOT COMPLETED|Overall Study||1
9092019|NCT03814590|10156645|FG005|NOT COMPLETED|Overall Study||5
9092020|NCT03814590|10156646|FG006|NOT COMPLETED|Overall Study||3
9092021|NCT03814590|10156647|FG007|NOT COMPLETED|Overall Study||6
9092022|NCT03814590|10156648|FG008|NOT COMPLETED|Overall Study||0
9092023|NCT03814590|10156649|FG009|NOT COMPLETED|Overall Study||5
9092024|NCT03814590|10156650|FG010|NOT COMPLETED|Overall Study||3
9092025|NCT03814590|10156651|FG011|NOT COMPLETED|Overall Study||0
9092026|NCT03814590|10156652|FG012|NOT COMPLETED|Overall Study||4
9092027|NCT03814590|10156653|FG013|NOT COMPLETED|Overall Study||3
9092028|NCT03811574|10156696|FG000|STARTED|Overall Study||101
9092029|NCT03811574|10156697|FG001|STARTED|Overall Study||199
9092030|NCT03811574|10156698|FG002|STARTED|Overall Study||101
9092031|NCT03811574|10156696|FG000|Full Analysis Set (FAS)|Overall Study||101
8844905|NCT01713036|9899383|FG000|COMPLETED|Overall Study||5
9092032|NCT03811574|10156697|FG001|Full Analysis Set (FAS)|Overall Study||199
9092033|NCT03811574|10156698|FG002|Full Analysis Set (FAS)|Overall Study||101
9092034|NCT03811574|10156696|FG000|Safety Analysis Set (SAS)|Overall Study||100
9092035|NCT03811574|10156697|FG001|Safety Analysis Set (SAS)|Overall Study||199
9092036|NCT03811574|10156698|FG002|Safety Analysis Set (SAS)|Overall Study||101
9092037|NCT03811574|10156696|FG000|Treated|Overall Study||100
9092038|NCT03811574|10156697|FG001|Treated|Overall Study||199
9092039|NCT03811574|10156698|FG002|Treated|Overall Study||101
9092040|NCT03811574|10156696|FG000|COMPLETED|Overall Study||99
9092052|NCT03759184|10156719|FG000|STARTED|Overall Study||1
9092053|NCT03759184|10156719|FG000|COMPLETED|Overall Study||1
9092054|NCT03759184|10156719|FG000|NOT COMPLETED|Overall Study||0
9092055|NCT03747640|10156725|FG000|STARTED|Overall Study||15
9092056|NCT03747640|10156726|FG001|STARTED|Overall Study||15
9092057|NCT03747640|10156725|FG000|COMPLETED|Overall Study||15
9092058|NCT03747640|10156726|FG001|COMPLETED|Overall Study||15
9092059|NCT03747640|10156725|FG000|NOT COMPLETED|Overall Study||0
9092060|NCT03747640|10156726|FG001|NOT COMPLETED|Overall Study||0
9092061|NCT03727750|10156734|FG000|STARTED|Overall Study||51
9092062|NCT03727750|10156734|FG000|Safety Set|Overall Study||50
9092063|NCT03727750|10156734|FG000|COMPLETED|Overall Study||2
9092064|NCT03727750|10156734|FG000|NOT COMPLETED|Overall Study||49
9092065|NCT03726879|10156740|FG000|STARTED|Overall Study||226
8625350|NCT00506779|9664886|FG002|NOT COMPLETED|Overall Study||2
8625351|NCT00506779|9664887|FG003|NOT COMPLETED|Overall Study||1
8625352|NCT00506831|9664898|FG000|STARTED|Overall Study||9
8625353|NCT00506831|9664898|FG000|COMPLETED|Overall Study||7
8625354|NCT00506831|9664898|FG000|NOT COMPLETED|Overall Study||2
8625355|NCT00506857|9664902|FG000|STARTED|Overall Study||80
8625356|NCT00506857|9664902|FG000|COMPLETED|Overall Study||80
9092066|NCT03726879|10156741|FG001|STARTED|Overall Study||228
9092067|NCT03726879|10156740|FG000|COMPLETED|Overall Study||0
9092068|NCT03726879|10156741|FG001|COMPLETED|Overall Study||0
9092069|NCT03726879|10156740|FG000|NOT COMPLETED|Overall Study||226
9092070|NCT03726879|10156741|FG001|NOT COMPLETED|Overall Study||228
9092071|NCT03715829|10156753|FG000|STARTED|Dose Ranging Period||65
9092072|NCT03715829|10156754|FG001|STARTED|Dose Ranging Period||67
9092073|NCT03715829|10156755|FG002|STARTED|Dose Ranging Period||67
9092074|NCT03715829|10156756|FG003|STARTED|Dose Ranging Period||50
9092075|NCT03715829|10156757|FG004|STARTED|Dose Ranging Period||49
9092076|NCT03715829|10156758|FG005|STARTED|Dose Ranging Period||66
9092077|NCT03715829|10156759|FG006|STARTED|Dose Ranging Period||0
9092078|NCT03715829|10156760|FG007|STARTED|Dose Ranging Period||0
9092079|NCT03715829|10156761|FG008|STARTED|Dose Ranging Period||0
9092080|NCT03715829|10156762|FG009|STARTED|Dose Ranging Period||0
9092081|NCT03715829|10156763|FG010|STARTED|Dose Ranging Period||0
9092082|NCT03715829|10156753|FG000|COMPLETED|Dose Ranging Period||53
9092083|NCT03715829|10156754|FG001|COMPLETED|Dose Ranging Period||58
9092084|NCT03715829|10156755|FG002|COMPLETED|Dose Ranging Period||54
9092085|NCT03715829|10156756|FG003|COMPLETED|Dose Ranging Period||36
9092086|NCT03715829|10156757|FG004|COMPLETED|Dose Ranging Period||42
9092087|NCT03715829|10156758|FG005|COMPLETED|Dose Ranging Period||55
9092088|NCT03715829|10156759|FG006|COMPLETED|Dose Ranging Period||0
9092089|NCT03715829|10156760|FG007|COMPLETED|Dose Ranging Period||0
9092090|NCT03715829|10156761|FG008|COMPLETED|Dose Ranging Period||0
9092091|NCT03715829|10156762|FG009|COMPLETED|Dose Ranging Period||0
9092092|NCT03715829|10156763|FG010|COMPLETED|Dose Ranging Period||0
9092093|NCT03715829|10156753|FG000|NOT COMPLETED|Dose Ranging Period||12
9092094|NCT03715829|10156754|FG001|NOT COMPLETED|Dose Ranging Period||9
9092095|NCT03715829|10156755|FG002|NOT COMPLETED|Dose Ranging Period||13
9092096|NCT03715829|10156756|FG003|NOT COMPLETED|Dose Ranging Period||14
9092097|NCT03715829|10156757|FG004|NOT COMPLETED|Dose Ranging Period||7
9092098|NCT03715829|10156758|FG005|NOT COMPLETED|Dose Ranging Period||11
9092099|NCT03715829|10156759|FG006|NOT COMPLETED|Dose Ranging Period||0
9092100|NCT03715829|10156760|FG007|NOT COMPLETED|Dose Ranging Period||0
9092101|NCT03715829|10156761|FG008|NOT COMPLETED|Dose Ranging Period||0
9092102|NCT03715829|10156762|FG009|NOT COMPLETED|Dose Ranging Period||0
9092103|NCT03715829|10156763|FG010|NOT COMPLETED|Dose Ranging Period||0
9092104|NCT03715829|10156753|FG000|STARTED|Extension Period||0
9092105|NCT03715829|10156754|FG001|STARTED|Extension Period||0
9092106|NCT03715829|10156755|FG002|STARTED|Extension Period||0
9092107|NCT03715829|10156756|FG003|STARTED|Extension Period||0
9092108|NCT03715829|10156757|FG004|STARTED|Extension Period||0
9092109|NCT03715829|10156758|FG005|STARTED|Extension Period||0
9092110|NCT03715829|10156759|FG006|STARTED|Extension Period||55
9092111|NCT03715829|10156760|FG007|STARTED|Extension Period||43
9092112|NCT03715829|10156761|FG008|STARTED|Extension Period||187
9092113|NCT03715829|10156762|FG009|STARTED|Extension Period||6
9092114|NCT03715829|10156763|FG010|STARTED|Extension Period||2
9092115|NCT03715829|10156753|FG000|COMPLETED|Extension Period||0
8625357|NCT00506857|9664902|FG000|NOT COMPLETED|Overall Study||0
9092116|NCT03715829|10156754|FG001|COMPLETED|Extension Period||0
9092117|NCT03715829|10156755|FG002|COMPLETED|Extension Period||0
9092118|NCT03715829|10156756|FG003|COMPLETED|Extension Period||0
9092119|NCT03715829|10156757|FG004|COMPLETED|Extension Period||0
9092120|NCT03715829|10156758|FG005|COMPLETED|Extension Period||0
9092121|NCT03715829|10156759|FG006|COMPLETED|Extension Period||47
9092122|NCT03715829|10156760|FG007|COMPLETED|Extension Period||27
9092123|NCT03715829|10156761|FG008|COMPLETED|Extension Period||158
9092124|NCT03715829|10156762|FG009|COMPLETED|Extension Period||3
9092125|NCT03715829|10156763|FG010|COMPLETED|Extension Period||2
9092126|NCT03715829|10156753|FG000|NOT COMPLETED|Extension Period||0
8625358|NCT00506883|9664910|FG000|STARTED|Overall Study||52
8625359|NCT00506883|9664911|FG001|STARTED|Overall Study||74
9092127|NCT03715829|10156754|FG001|NOT COMPLETED|Extension Period||0
9092128|NCT03715829|10156755|FG002|NOT COMPLETED|Extension Period||0
9092129|NCT03715829|10156756|FG003|NOT COMPLETED|Extension Period||0
9092130|NCT03715829|10156757|FG004|NOT COMPLETED|Extension Period||0
9092131|NCT03715829|10156758|FG005|NOT COMPLETED|Extension Period||0
9092132|NCT03715829|10156759|FG006|NOT COMPLETED|Extension Period||8
9092133|NCT03715829|10156760|FG007|NOT COMPLETED|Extension Period||16
9092134|NCT03715829|10156761|FG008|NOT COMPLETED|Extension Period||29
9092135|NCT03715829|10156762|FG009|NOT COMPLETED|Extension Period||3
9092136|NCT03715829|10156763|FG010|NOT COMPLETED|Extension Period||0
9092137|NCT03693430|10156791|FG000|STARTED|Overall Study||152
9092138|NCT03693430|10156792|FG001|STARTED|Overall Study||152
9092139|NCT03693430|10156791|FG000|Full Analysis Set (FAS)|Overall Study||152
9092140|NCT03693430|10156792|FG001|Full Analysis Set (FAS)|Overall Study||152
9092141|NCT03693430|10156791|FG000|Safety Analysis Set (SAS)|Overall Study||152
9092142|NCT03693430|10156792|FG001|Safety Analysis Set (SAS)|Overall Study||152
9092143|NCT03693430|10156791|FG000|COMPLETED|Overall Study||148
9092144|NCT03693430|10156792|FG001|COMPLETED|Overall Study||134
9092145|NCT03693430|10156791|FG000|NOT COMPLETED|Overall Study||4
9092146|NCT03693430|10156792|FG001|NOT COMPLETED|Overall Study||18
9092147|NCT03677934|10156800|FG000|STARTED|Overall Study||248
9092148|NCT03677934|10156801|FG001|STARTED|Overall Study||167
9092149|NCT03677934|10156800|FG000|COMPLETED|Overall Study||0
9092150|NCT03677934|10156801|FG001|COMPLETED|Overall Study||0
9092151|NCT03677934|10156800|FG000|NOT COMPLETED|Overall Study||248
9092152|NCT03677934|10156801|FG001|NOT COMPLETED|Overall Study||167
9092153|NCT03660839|10156811|FG000|STARTED|Overall Study||35
9092154|NCT03660839|10156812|FG001|STARTED|Overall Study||36
9092155|NCT03660839|10156813|FG002|STARTED|Overall Study||36
9092156|NCT03660839|10156814|FG003|STARTED|Overall Study||33
9092157|NCT03660839|10156811|FG000|COMPLETED|Overall Study||35
9092158|NCT03660839|10156812|FG001|COMPLETED|Overall Study||36
9092159|NCT03660839|10156813|FG002|COMPLETED|Overall Study||36
9092160|NCT03660839|10156814|FG003|COMPLETED|Overall Study||33
9092161|NCT03660839|10156811|FG000|NOT COMPLETED|Overall Study||0
9092162|NCT03660839|10156812|FG001|NOT COMPLETED|Overall Study||0
9092163|NCT03660839|10156813|FG002|NOT COMPLETED|Overall Study||0
9092164|NCT03660839|10156814|FG003|NOT COMPLETED|Overall Study||0
9092165|NCT03660241|10156830|FG000|STARTED|Overall Study||8
9092166|NCT03660241|10156831|FG001|STARTED|Overall Study||7
9092167|NCT03660241|10156832|FG002|STARTED|Overall Study||8
9092168|NCT03660241|10156830|FG000|COMPLETED|Overall Study||8
9092169|NCT03660241|10156831|FG001|COMPLETED|Overall Study||7
9092170|NCT03660241|10156832|FG002|COMPLETED|Overall Study||8
9092171|NCT03660241|10156830|FG000|NOT COMPLETED|Overall Study||0
9092172|NCT03660241|10156831|FG001|NOT COMPLETED|Overall Study||0
9092173|NCT03660241|10156832|FG002|NOT COMPLETED|Overall Study||0
9092174|NCT03575104|10156843|FG000|STARTED|Overall Study||307
9092175|NCT03575104|10156844|FG001|STARTED|Overall Study||309
9092176|NCT03575104|10156845|FG002|STARTED|Overall Study||308
9092177|NCT03575104|10156843|FG000|COMPLETED|Overall Study||283
9092178|NCT03575104|10156844|FG001|COMPLETED|Overall Study||280
9092179|NCT03575104|10156845|FG002|COMPLETED|Overall Study||286
9092180|NCT03575104|10156843|FG000|NOT COMPLETED|Overall Study||24
9092181|NCT03575104|10156844|FG001|NOT COMPLETED|Overall Study||29
9092182|NCT03575104|10156845|FG002|NOT COMPLETED|Overall Study||22
9092183|NCT03569475|10156856|FG000|STARTED|Double-blind Treatment Period (8 Weeks)||164
9092184|NCT03569475|10156857|FG001|STARTED|Double-blind Treatment Period (8 Weeks)||169
9092185|NCT03569475|10156858|FG002|STARTED|Double-blind Treatment Period (8 Weeks)||168
9092186|NCT03569475|10156856|FG000|Safety Population|Double-blind Treatment Period (8 Weeks)||160
9092187|NCT03569475|10156857|FG001|Safety Population|Double-blind Treatment Period (8 Weeks)||166
9092188|NCT03569475|10156858|FG002|Safety Population|Double-blind Treatment Period (8 Weeks)||166
9092189|NCT03569475|10156856|FG000|COMPLETED|Double-blind Treatment Period (8 Weeks)||146
9092190|NCT03569475|10156857|FG001|COMPLETED|Double-blind Treatment Period (8 Weeks)||146
9092191|NCT03569475|10156858|FG002|COMPLETED|Double-blind Treatment Period (8 Weeks)||144
9092192|NCT03569475|10156856|FG000|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||18
9092193|NCT03569475|10156857|FG001|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||23
9092194|NCT03569475|10156858|FG002|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||24
9092195|NCT03569475|10156856|FG000|STARTED|Double-blind Down-taper Period (1 Week)||140
9092196|NCT03569475|10156857|FG001|STARTED|Double-blind Down-taper Period (1 Week)||141
9092197|NCT03569475|10156858|FG002|STARTED|Double-blind Down-taper Period (1 Week)||140
9092198|NCT03569475|10156856|FG000|COMPLETED|Double-blind Down-taper Period (1 Week)||140
9092199|NCT03569475|10156857|FG001|COMPLETED|Double-blind Down-taper Period (1 Week)||139
9092200|NCT03569475|10156858|FG002|COMPLETED|Double-blind Down-taper Period (1 Week)||138
9092201|NCT03569475|10156856|FG000|NOT COMPLETED|Double-blind Down-taper Period (1 Week)||0
9092202|NCT03569475|10156857|FG001|NOT COMPLETED|Double-blind Down-taper Period (1 Week)||2
9092203|NCT03569475|10156858|FG002|NOT COMPLETED|Double-blind Down-taper Period (1 Week)||2
9092204|NCT03554798|10156878|FG000|STARTED|Overall Study||50
9092205|NCT03554798|10156879|FG001|STARTED|Overall Study||50
9092206|NCT03554798|10156880|FG002|STARTED|Overall Study||51
9092207|NCT03554798|10156881|FG003|STARTED|Overall Study||156
9092208|NCT03554798|10156882|FG004|STARTED|Overall Study||144
9092209|NCT03554798|10156883|FG005|STARTED|Overall Study||138
9092210|NCT03554798|10156884|FG006|STARTED|Overall Study||150
9092211|NCT03554798|10156885|FG007|STARTED|Overall Study||135
9092212|NCT03554798|10156886|FG008|STARTED|Overall Study||151
9092213|NCT03554798|10156878|FG000|COMPLETED|Overall Study||45
9092214|NCT03554798|10156879|FG001|COMPLETED|Overall Study||47
9092215|NCT03554798|10156880|FG002|COMPLETED|Overall Study||48
9092216|NCT03554798|10156881|FG003|COMPLETED|Overall Study||154
9092217|NCT03554798|10156882|FG004|COMPLETED|Overall Study||141
9092218|NCT03554798|10156883|FG005|COMPLETED|Overall Study||137
9092219|NCT03554798|10156884|FG006|COMPLETED|Overall Study||149
9092220|NCT03554798|10156885|FG007|COMPLETED|Overall Study||133
9092221|NCT03554798|10156886|FG008|COMPLETED|Overall Study||149
9092222|NCT03554798|10156878|FG000|NOT COMPLETED|Overall Study||5
9092223|NCT03554798|10156879|FG001|NOT COMPLETED|Overall Study||3
9092224|NCT03554798|10156880|FG002|NOT COMPLETED|Overall Study||3
9092225|NCT03554798|10156881|FG003|NOT COMPLETED|Overall Study||2
9092226|NCT03554798|10156882|FG004|NOT COMPLETED|Overall Study||3
9092227|NCT03554798|10156883|FG005|NOT COMPLETED|Overall Study||1
9092228|NCT03554798|10156884|FG006|NOT COMPLETED|Overall Study||1
9092229|NCT03554798|10156885|FG007|NOT COMPLETED|Overall Study||2
9092230|NCT03554798|10156886|FG008|NOT COMPLETED|Overall Study||2
8625360|NCT00506883|9664912|FG002|STARTED|Overall Study||59
8625361|NCT00506883|9664910|FG000|COMPLETED|Overall Study||45
8625362|NCT00506883|9664911|FG001|COMPLETED|Overall Study||71
9092231|NCT03545191|10156912|FG000|STARTED|Overall Study||310
8625363|NCT00506883|9664912|FG002|COMPLETED|Overall Study||55
8625364|NCT00506883|9664910|FG000|NOT COMPLETED|Overall Study||7
8625365|NCT00506883|9664911|FG001|NOT COMPLETED|Overall Study||3
8625366|NCT00506883|9664912|FG002|NOT COMPLETED|Overall Study||4
8625367|NCT00506922|9664925|FG000|STARTED|Overall Study||37
8625368|NCT00506922|9664926|FG001|STARTED|Overall Study||10
8625369|NCT00506922|9664927|FG002|STARTED|Overall Study||29
8625370|NCT00506922|9664928|FG003|STARTED|Overall Study||63
8625371|NCT00506922|9664929|FG004|STARTED|Overall Study||11
8625372|NCT00506922|9664925|FG000|COMPLETED|Overall Study||37
8625373|NCT00506922|9664926|FG001|COMPLETED|Overall Study||10
9092232|NCT03545191|10156913|FG001|STARTED|Overall Study||310
9092233|NCT03545191|10156914|FG002|STARTED|Overall Study||310
9092234|NCT03545191|10156912|FG000|COMPLETED|Overall Study||288
9092235|NCT03545191|10156913|FG001|COMPLETED|Overall Study||285
9092236|NCT03545191|10156914|FG002|COMPLETED|Overall Study||280
9092237|NCT03545191|10156912|FG000|NOT COMPLETED|Overall Study||22
9092238|NCT03545191|10156913|FG001|NOT COMPLETED|Overall Study||25
9092239|NCT03545191|10156914|FG002|NOT COMPLETED|Overall Study||30
9092240|NCT03500549|10156924|FG000|STARTED|Run-in Period (Day -28 to ≤Day 1)||41
9092241|NCT03500549|10156925|FG001|STARTED|Run-in Period (Day -28 to ≤Day 1)||39
9092242|NCT03500549|10156924|FG000|COMPLETED|Run-in Period (Day -28 to ≤Day 1)||41
9092243|NCT03500549|10156925|FG001|COMPLETED|Run-in Period (Day -28 to ≤Day 1)||39
9092244|NCT03500549|10156924|FG000|NOT COMPLETED|Run-in Period (Day -28 to ≤Day 1)||0
9092245|NCT03500549|10156925|FG001|NOT COMPLETED|Run-in Period (Day -28 to ≤Day 1)||0
8625374|NCT00506922|9664927|FG002|COMPLETED|Overall Study||29
8625375|NCT00506922|9664928|FG003|COMPLETED|Overall Study||61
8625376|NCT00506922|9664929|FG004|COMPLETED|Overall Study||10
8625377|NCT00506922|9664925|FG000|NOT COMPLETED|Overall Study||0
8625378|NCT00506922|9664926|FG001|NOT COMPLETED|Overall Study||0
8625379|NCT00506922|9664927|FG002|NOT COMPLETED|Overall Study||0
8625380|NCT00506922|9664928|FG003|NOT COMPLETED|Overall Study||2
9092246|NCT03500549|10156924|FG000|STARTED|RCP (Day 1 - Week 16)||41
9092247|NCT03500549|10156925|FG001|STARTED|RCP (Day 1 - Week 16)||39
9092248|NCT03500549|10156924|FG000|COMPLETED|RCP (Day 1 - Week 16)||38
9092249|NCT03500549|10156925|FG001|COMPLETED|RCP (Day 1 - Week 16)||39
9092250|NCT03500549|10156924|FG000|NOT COMPLETED|RCP (Day 1 - Week 16)||3
9092251|NCT03500549|10156925|FG001|NOT COMPLETED|RCP (Day 1 - Week 16)||0
9092252|NCT03500549|10156924|FG000|STARTED|Open-label Period (Week 17 to Week 48)||38
9092253|NCT03500549|10156925|FG001|STARTED|Open-label Period (Week 17 to Week 48)||39
9092254|NCT03500549|10156924|FG000|COMPLETED|Open-label Period (Week 17 to Week 48)||35
9092255|NCT03500549|10156925|FG001|COMPLETED|Open-label Period (Week 17 to Week 48)||32
9092256|NCT03500549|10156924|FG000|NOT COMPLETED|Open-label Period (Week 17 to Week 48)||3
9092257|NCT03500549|10156925|FG001|NOT COMPLETED|Open-label Period (Week 17 to Week 48)||7
9092258|NCT03456700|10156936|FG000|STARTED|Overall Study||22
9092259|NCT03456700|10156936|FG000|COMPLETED|Overall Study||21
9092260|NCT03456700|10156936|FG000|NOT COMPLETED|Overall Study||1
9092261|NCT03435185|10156942|FG000|STARTED|Overall Study||44
9092262|NCT03435185|10156943|FG001|STARTED|Overall Study||43
9092263|NCT03435185|10156942|FG000|COMPLETED|Overall Study||43
9092264|NCT03435185|10156943|FG001|COMPLETED|Overall Study||28
9092265|NCT03435185|10156942|FG000|NOT COMPLETED|Overall Study||1
9092266|NCT03435185|10156943|FG001|NOT COMPLETED|Overall Study||15
8625381|NCT00506922|9664929|FG004|NOT COMPLETED|Overall Study||1
8625382|NCT00506948|9664937|FG000|STARTED|Overall Study||10
9092267|NCT03427411|10156951|FG000|STARTED|Overall Study||30
9092268|NCT03427411|10156952|FG001|STARTED|Overall Study||27
9092269|NCT03427411|10156951|FG000|COMPLETED|Overall Study||30
9092270|NCT03427411|10156952|FG001|COMPLETED|Overall Study||26
9092271|NCT03427411|10156951|FG000|NOT COMPLETED|Overall Study||0
9092272|NCT03427411|10156952|FG001|NOT COMPLETED|Overall Study||1
9092273|NCT03387150|10156965|FG000|STARTED|Overall Study||19
9092274|NCT03387150|10156966|FG001|STARTED|Overall Study||19
9092275|NCT03387150|10156967|FG002|STARTED|Overall Study||21
9092276|NCT03387150|10156968|FG003|STARTED|Overall Study||21
9092277|NCT03387150|10156969|FG004|STARTED|Overall Study||20
9092278|NCT03387150|10156970|FG005|STARTED|Overall Study||21
9092279|NCT03387150|10156971|FG006|STARTED|Overall Study||3
9092280|NCT03387150|10156965|FG000|Safety Population|Overall Study||19
9092281|NCT03387150|10156966|FG001|Safety Population|Overall Study||19
9092282|NCT03387150|10156967|FG002|Safety Population|Overall Study||21
9092283|NCT03387150|10156968|FG003|Safety Population|Overall Study||21
9092284|NCT03387150|10156969|FG004|Safety Population|Overall Study||20
9092285|NCT03387150|10156970|FG005|Safety Population|Overall Study||21
9092286|NCT03387150|10156971|FG006|Safety Population|Overall Study||3
9092287|NCT03387150|10156965|FG000|COMPLETED|Overall Study||13
9092288|NCT03387150|10156966|FG001|COMPLETED|Overall Study||16
9092289|NCT03387150|10156967|FG002|COMPLETED|Overall Study||16
9092290|NCT03387150|10156968|FG003|COMPLETED|Overall Study||14
9092291|NCT03387150|10156969|FG004|COMPLETED|Overall Study||14
9092292|NCT03387150|10156970|FG005|COMPLETED|Overall Study||14
9092293|NCT03387150|10156971|FG006|COMPLETED|Overall Study||3
9092294|NCT03387150|10156965|FG000|NOT COMPLETED|Overall Study||6
9092295|NCT03387150|10156966|FG001|NOT COMPLETED|Overall Study||3
9092296|NCT03387150|10156967|FG002|NOT COMPLETED|Overall Study||5
9092297|NCT03387150|10156968|FG003|NOT COMPLETED|Overall Study||7
9092298|NCT03387150|10156969|FG004|NOT COMPLETED|Overall Study||6
9092299|NCT03387150|10156970|FG005|NOT COMPLETED|Overall Study||7
9092300|NCT03387150|10156971|FG006|NOT COMPLETED|Overall Study||0
9092301|NCT03370133|10156990|FG000|STARTED|Initial Treatment Period (WK 16)||83
9092302|NCT03370133|10156991|FG001|STARTED|Initial Treatment Period (WK 16)||321
9092303|NCT03370133|10156992|FG002|STARTED|Initial Treatment Period (WK 16)||163
9092304|NCT03370133|10156993|FG003|STARTED|Initial Treatment Period (WK 16)||0
9092305|NCT03370133|10156994|FG004|STARTED|Initial Treatment Period (WK 16)||0
9092306|NCT03370133|10156995|FG005|STARTED|Initial Treatment Period (WK 16)||0
9092307|NCT03370133|10156990|FG000|COMPLETED|Initial Treatment Period (WK 16)||74
9092308|NCT03370133|10156991|FG001|COMPLETED|Initial Treatment Period (WK 16)||306
9092309|NCT03370133|10156992|FG002|COMPLETED|Initial Treatment Period (WK 16)||157
9092310|NCT03370133|10156993|FG003|COMPLETED|Initial Treatment Period (WK 16)||0
9092311|NCT03370133|10156994|FG004|COMPLETED|Initial Treatment Period (WK 16)||0
9092312|NCT03370133|10156995|FG005|COMPLETED|Initial Treatment Period (WK 16)||0
9092313|NCT03370133|10156990|FG000|NOT COMPLETED|Initial Treatment Period (WK 16)||9
9092314|NCT03370133|10156991|FG001|NOT COMPLETED|Initial Treatment Period (WK 16)||15
9092315|NCT03370133|10156992|FG002|NOT COMPLETED|Initial Treatment Period (WK 16)||6
9092316|NCT03370133|10156993|FG003|NOT COMPLETED|Initial Treatment Period (WK 16)||0
9092317|NCT03370133|10156994|FG004|NOT COMPLETED|Initial Treatment Period (WK 16)||0
9092318|NCT03370133|10156995|FG005|NOT COMPLETED|Initial Treatment Period (WK 16)||0
9092319|NCT03370133|10156990|FG000|STARTED|Maintenance Treatment Period (WK 52)||0
9092320|NCT03370133|10156991|FG001|STARTED|Maintenance Treatment Period (WK 52)||0
9092321|NCT03370133|10156992|FG002|STARTED|Maintenance Treatment Period (WK 52)||0
9092322|NCT03370133|10156993|FG003|STARTED|Maintenance Treatment Period (WK 52)||74
9092323|NCT03370133|10156994|FG004|STARTED|Maintenance Treatment Period (WK 52)||306
9092324|NCT03370133|10156995|FG005|STARTED|Maintenance Treatment Period (WK 52)||157
9092325|NCT03370133|10156990|FG000|COMPLETED|Maintenance Treatment Period (WK 52)||0
9092326|NCT03370133|10156991|FG001|COMPLETED|Maintenance Treatment Period (WK 52)||0
9092327|NCT03370133|10156992|FG002|COMPLETED|Maintenance Treatment Period (WK 52)||0
9092328|NCT03370133|10156993|FG003|COMPLETED|Maintenance Treatment Period (WK 52)||69
9092329|NCT03370133|10156994|FG004|COMPLETED|Maintenance Treatment Period (WK 52)||283
9092330|NCT03370133|10156995|FG005|COMPLETED|Maintenance Treatment Period (WK 52)||141
9092331|NCT03370133|10156990|FG000|NOT COMPLETED|Maintenance Treatment Period (WK 52)||0
9092332|NCT03370133|10156991|FG001|NOT COMPLETED|Maintenance Treatment Period (WK 52)||0
9092333|NCT03370133|10156992|FG002|NOT COMPLETED|Maintenance Treatment Period (WK 52)||0
9092334|NCT03370133|10156993|FG003|NOT COMPLETED|Maintenance Treatment Period (WK 52)||5
9092335|NCT03370133|10156994|FG004|NOT COMPLETED|Maintenance Treatment Period (WK 52)||23
9092336|NCT03370133|10156995|FG005|NOT COMPLETED|Maintenance Treatment Period (WK 52)||16
9092337|NCT03366792|10157013|FG000|STARTED|Overall Study||46
9092338|NCT03366792|10157013|FG000|COMPLETED|Overall Study||31
9092339|NCT03366792|10157013|FG000|NOT COMPLETED|Overall Study||15
9092340|NCT03366337|10157021|FG000|STARTED|Overall Study||31
9092341|NCT03366337|10157022|FG001|STARTED|Overall Study||26
9092342|NCT03366337|10157023|FG002|STARTED|Overall Study||28
9092343|NCT03366337|10157024|FG003|STARTED|Overall Study||18
9092344|NCT03366337|10157021|FG000|COMPLETED|Overall Study||28
9092345|NCT03366337|10157022|FG001|COMPLETED|Overall Study||26
9092346|NCT03366337|10157023|FG002|COMPLETED|Overall Study||26
9092347|NCT03366337|10157024|FG003|COMPLETED|Overall Study||17
9092348|NCT03366337|10157021|FG000|NOT COMPLETED|Overall Study||3
9092349|NCT03366337|10157022|FG001|NOT COMPLETED|Overall Study||0
9092350|NCT03366337|10157023|FG002|NOT COMPLETED|Overall Study||2
9092351|NCT03366337|10157024|FG003|NOT COMPLETED|Overall Study||1
9092352|NCT03342053|10157036|FG000|STARTED|Overall Study||23
9092353|NCT03342053|10157037|FG001|STARTED|Overall Study||23
9092354|NCT03342053|10157036|FG000|COMPLETED|Overall Study||21
9092355|NCT03342053|10157037|FG001|COMPLETED|Overall Study||22
9092356|NCT03342053|10157036|FG000|NOT COMPLETED|Overall Study||2
9092357|NCT03342053|10157037|FG001|NOT COMPLETED|Overall Study||1
9092358|NCT03330847|10157046|FG000|STARTED|Overall Study||114
9092359|NCT03330847|10157047|FG001|STARTED|Overall Study||112
9092360|NCT03330847|10157048|FG002|STARTED|Overall Study||47
9092361|NCT03330847|10157046|FG000|COMPLETED|Overall Study||52
9092362|NCT03330847|10157047|FG001|COMPLETED|Overall Study||47
9092363|NCT03330847|10157048|FG002|COMPLETED|Overall Study||32
9092364|NCT03330847|10157046|FG000|NOT COMPLETED|Overall Study||62
9092365|NCT03330847|10157047|FG001|NOT COMPLETED|Overall Study||65
9092366|NCT03330847|10157048|FG002|NOT COMPLETED|Overall Study||15
9092367|NCT03283241|10157060|FG000|STARTED|Overall Study||32
9092368|NCT03283241|10157061|FG001|STARTED|Overall Study||30
9092369|NCT03283241|10157060|FG000|Completed 12 Weeks|Overall Study|Completed 12 weeks|29
9092370|NCT03283241|10157061|FG001|Completed 12 Weeks|Overall Study|Completed 12 weeks|29
9092371|NCT03283241|10157060|FG000|COMPLETED|Overall Study|Completed 24 month|28
9092372|NCT03283241|10157061|FG001|COMPLETED|Overall Study|Completed 24 month|27
9092373|NCT03283241|10157060|FG000|NOT COMPLETED|Overall Study||4
9092374|NCT03283241|10157061|FG001|NOT COMPLETED|Overall Study||3
9092375|NCT03242772|10157069|FG000|STARTED|Overall Study||9
9092376|NCT03242772|10157070|FG001|STARTED|Overall Study||9
9092377|NCT03242772|10157069|FG000|COMPLETED|Overall Study||6
9092378|NCT03242772|10157070|FG001|COMPLETED|Overall Study||8
9092379|NCT03242772|10157069|FG000|NOT COMPLETED|Overall Study||3
9092380|NCT03242772|10157070|FG001|NOT COMPLETED|Overall Study||1
9092381|NCT03236311|10157078|FG000|STARTED|Overall Study||5
9092382|NCT03236311|10157079|FG001|STARTED|Overall Study||5
9092383|NCT03236311|10157078|FG000|COMPLETED|Overall Study||5
9092384|NCT03236311|10157079|FG001|COMPLETED|Overall Study||2
9092385|NCT03236311|10157078|FG000|NOT COMPLETED|Overall Study||0
9092386|NCT03236311|10157079|FG001|NOT COMPLETED|Overall Study||3
9092387|NCT03206476|10157087|FG000|STARTED|Overall Study||54
9092388|NCT03206476|10157088|FG001|STARTED|Overall Study||53
9092389|NCT03206476|10157087|FG000|COMPLETED|Overall Study||48
9092390|NCT03206476|10157088|FG001|COMPLETED|Overall Study||40
9092391|NCT03206476|10157087|FG000|NOT COMPLETED|Overall Study||6
9092392|NCT03206476|10157088|FG001|NOT COMPLETED|Overall Study||13
9092393|NCT03192046|10157096|FG000|STARTED|Overall Study||5
9092394|NCT03192046|10157097|FG001|STARTED|Overall Study||4
9092395|NCT03192046|10157096|FG000|COMPLETED|Overall Study||4
9092396|NCT03192046|10157097|FG001|COMPLETED|Overall Study||3
9092397|NCT03192046|10157096|FG000|NOT COMPLETED|Overall Study||1
9092398|NCT03192046|10157097|FG001|NOT COMPLETED|Overall Study||1
9092399|NCT03190369|10157105|FG000|STARTED|Overall Study||220
9092400|NCT03190369|10157106|FG001|STARTED|Overall Study||220
9092401|NCT03190369|10157105|FG000|Treated|Overall Study||220
9092402|NCT03190369|10157106|FG001|Treated|Overall Study||218
9092403|NCT03190369|10157105|FG000|COMPLETED|Overall Study||219
9092404|NCT03190369|10157106|FG001|COMPLETED|Overall Study||212
9092405|NCT03190369|10157105|FG000|NOT COMPLETED|Overall Study||1
9092406|NCT03190369|10157106|FG001|NOT COMPLETED|Overall Study||8
8625383|NCT00506948|9664937|FG000|COMPLETED|Overall Study||0
8625384|NCT00506948|9664937|FG000|NOT COMPLETED|Overall Study||10
8625385|NCT00507026|9664944|FG000|STARTED|Overall Study||145
8625386|NCT00507026|9664945|FG001|STARTED|Overall Study||60
8625387|NCT00507026|9664946|FG002|STARTED|Overall Study||72
8625388|NCT00507026|9664944|FG000|COMPLETED|Overall Study||132
8625389|NCT00507026|9664945|FG001|COMPLETED|Overall Study||56
8625390|NCT00507026|9664946|FG002|COMPLETED|Overall Study||51
8625391|NCT00507026|9664944|FG000|NOT COMPLETED|Overall Study||13
9092407|NCT03178487|10157114|FG000|STARTED|Overall Study||94
9092408|NCT03178487|10157115|FG001|STARTED|Overall Study||93
9092409|NCT03178487|10157114|FG000|Received Treatment|Overall Study||94
9092410|NCT03178487|10157115|FG001|Received Treatment|Overall Study||93
9092411|NCT03178487|10157114|FG000|COMPLETED|Overall Study||90
9092412|NCT03178487|10157115|FG001|COMPLETED|Overall Study||89
9092413|NCT03178487|10157114|FG000|NOT COMPLETED|Overall Study||4
9092414|NCT03178487|10157115|FG001|NOT COMPLETED|Overall Study||4
9092415|NCT03155932|10157121|FG000|STARTED|Overall Study||2
9092416|NCT03155932|10157121|FG000|Participants Escalated to 2 mg Dose of APD334 at Week 12 to Week 24|Overall Study||2
9092417|NCT03155932|10157121|FG000|COMPLETED|Overall Study||2
9092418|NCT03155932|10157121|FG000|NOT COMPLETED|Overall Study||0
9092419|NCT03106779|10157128|FG000|STARTED|Overall Study||157
9092420|NCT03106779|10157129|FG001|STARTED|Overall Study||76
9092421|NCT03106779|10157128|FG000|Treated|Overall Study||156
9092422|NCT03106779|10157129|FG001|Treated|Overall Study||0
9092423|NCT03106779|10157128|FG000|Not Treated|Overall Study||1
9092424|NCT03106779|10157129|FG001|Not Treated|Overall Study||0
9092425|NCT03106779|10157128|FG000|COMPLETED|Overall Study||97
9092426|NCT03106779|10157129|FG001|COMPLETED|Overall Study||22
9092427|NCT03106779|10157128|FG000|NOT COMPLETED|Overall Study||60
9092428|NCT03106779|10157129|FG001|NOT COMPLETED|Overall Study||54
9092429|NCT03096834|10157137|FG000|STARTED|Double-Blind Treatment Epoch||121
9092430|NCT03096834|10157138|FG001|STARTED|Double-Blind Treatment Epoch||125
9092431|NCT03096834|10157139|FG002|STARTED|Double-Blind Treatment Epoch||0
9092432|NCT03096834|10157140|FG003|STARTED|Double-Blind Treatment Epoch||0
9092433|NCT03096834|10157137|FG000|COMPLETED|Double-Blind Treatment Epoch||118
9092434|NCT03096834|10157138|FG001|COMPLETED|Double-Blind Treatment Epoch||122
9092435|NCT03096834|10157139|FG002|COMPLETED|Double-Blind Treatment Epoch||0
9092436|NCT03096834|10157140|FG003|COMPLETED|Double-Blind Treatment Epoch||0
9092437|NCT03096834|10157137|FG000|NOT COMPLETED|Double-Blind Treatment Epoch||3
9092438|NCT03096834|10157138|FG001|NOT COMPLETED|Double-Blind Treatment Epoch||3
9092439|NCT03096834|10157139|FG002|NOT COMPLETED|Double-Blind Treatment Epoch||0
9092440|NCT03096834|10157140|FG003|NOT COMPLETED|Double-Blind Treatment Epoch||0
9092441|NCT03096834|10157137|FG000|STARTED|Open-Label Treatment Epoch||0
9092442|NCT03096834|10157138|FG001|STARTED|Open-Label Treatment Epoch||0
9092443|NCT03096834|10157139|FG002|STARTED|Open-Label Treatment Epoch||118
9092444|NCT03096834|10157140|FG003|STARTED|Open-Label Treatment Epoch||122
9092445|NCT03096834|10157137|FG000|COMPLETED|Open-Label Treatment Epoch||0
9092446|NCT03096834|10157138|FG001|COMPLETED|Open-Label Treatment Epoch||0
9092447|NCT03096834|10157139|FG002|COMPLETED|Open-Label Treatment Epoch||86
9092448|NCT03096834|10157140|FG003|COMPLETED|Open-Label Treatment Epoch||83
9092449|NCT03096834|10157137|FG000|NOT COMPLETED|Open-Label Treatment Epoch||0
9092450|NCT03096834|10157138|FG001|NOT COMPLETED|Open-Label Treatment Epoch||0
9092451|NCT03096834|10157139|FG002|NOT COMPLETED|Open-Label Treatment Epoch||32
9092452|NCT03096834|10157140|FG003|NOT COMPLETED|Open-Label Treatment Epoch||39
9092453|NCT03096834|10157137|FG000|STARTED|Safety Follow-Up Epoch||0
9092454|NCT03096834|10157138|FG001|STARTED|Safety Follow-Up Epoch||0
9092455|NCT03096834|10157139|FG002|STARTED|Safety Follow-Up Epoch||66
9092456|NCT03096834|10157140|FG003|STARTED|Safety Follow-Up Epoch||61
9092457|NCT03096834|10157137|FG000|COMPLETED|Safety Follow-Up Epoch||0
9092458|NCT03096834|10157138|FG001|COMPLETED|Safety Follow-Up Epoch||0
9092459|NCT03096834|10157139|FG002|COMPLETED|Safety Follow-Up Epoch||65
9092460|NCT03096834|10157140|FG003|COMPLETED|Safety Follow-Up Epoch||59
9092461|NCT03096834|10157137|FG000|NOT COMPLETED|Safety Follow-Up Epoch||0
9092462|NCT03096834|10157138|FG001|NOT COMPLETED|Safety Follow-Up Epoch||0
9092463|NCT03096834|10157139|FG002|NOT COMPLETED|Safety Follow-Up Epoch||1
9092464|NCT03096834|10157140|FG003|NOT COMPLETED|Safety Follow-Up Epoch||2
9092465|NCT03096834|10157137|FG000|STARTED|Post-Trial Access Epoch||0
9092466|NCT03096834|10157138|FG001|STARTED|Post-Trial Access Epoch||0
9092467|NCT03096834|10157139|FG002|STARTED|Post-Trial Access Epoch||21
9092468|NCT03096834|10157140|FG003|STARTED|Post-Trial Access Epoch||15
9092469|NCT03096834|10157137|FG000|COMPLETED|Post-Trial Access Epoch||0
9092470|NCT03096834|10157138|FG001|COMPLETED|Post-Trial Access Epoch||0
9092471|NCT03096834|10157139|FG002|COMPLETED|Post-Trial Access Epoch||21
9092472|NCT03096834|10157140|FG003|COMPLETED|Post-Trial Access Epoch||15
9092473|NCT03096834|10157137|FG000|NOT COMPLETED|Post-Trial Access Epoch||0
9092474|NCT03096834|10157138|FG001|NOT COMPLETED|Post-Trial Access Epoch||0
9092475|NCT03096834|10157139|FG002|NOT COMPLETED|Post-Trial Access Epoch||0
9092476|NCT03096834|10157140|FG003|NOT COMPLETED|Post-Trial Access Epoch||0
9092477|NCT03089853|10157151|FG000|STARTED|Overall Study||4
9092478|NCT03089853|10157152|FG001|STARTED|Overall Study||3
9092479|NCT03089853|10157151|FG000|COMPLETED|Overall Study||2
9092480|NCT03089853|10157152|FG001|COMPLETED|Overall Study||2
9092481|NCT03089853|10157151|FG000|NOT COMPLETED|Overall Study||2
9092482|NCT03089853|10157152|FG001|NOT COMPLETED|Overall Study||1
9092483|NCT03070392|10157160|FG000|STARTED|Overall Study||252
9092484|NCT03070392|10157161|FG001|STARTED|Overall Study||7
9092485|NCT03070392|10157162|FG002|STARTED|Overall Study||16
9092486|NCT03070392|10157163|FG003|STARTED|Overall Study||103
9092487|NCT03070392|10157160|FG000|COMPLETED|Overall Study||0
9092488|NCT03070392|10157161|FG001|COMPLETED|Overall Study||0
9092489|NCT03070392|10157162|FG002|COMPLETED|Overall Study||10
9092490|NCT03070392|10157163|FG003|COMPLETED|Overall Study||0
9092491|NCT03070392|10157160|FG000|NOT COMPLETED|Overall Study||252
9092492|NCT03070392|10157161|FG001|NOT COMPLETED|Overall Study||7
9092493|NCT03070392|10157162|FG002|NOT COMPLETED|Overall Study||6
9092494|NCT03070392|10157163|FG003|NOT COMPLETED|Overall Study||103
9092495|NCT03048578|10157171|FG000|STARTED|Overall Study||89
9092496|NCT03048578|10157172|FG001|STARTED|Overall Study||43
9092497|NCT03048578|10157171|FG000|COMPLETED|Overall Study||58
9092498|NCT03048578|10157172|FG001|COMPLETED|Overall Study||23
9092499|NCT03048578|10157171|FG000|NOT COMPLETED|Overall Study||31
9092500|NCT03048578|10157172|FG001|NOT COMPLETED|Overall Study||20
9092501|NCT03015194|10157178|FG000|STARTED|Overall Study||30
9092502|NCT03015194|10157178|FG000|COMPLETED|Overall Study||18
9092503|NCT03015194|10157178|FG000|NOT COMPLETED|Overall Study||12
9092504|NCT03012815|10157185|FG000|STARTED|Overall Study||46
9092505|NCT03012815|10157186|FG001|STARTED|Overall Study||42
8625392|NCT00507026|9664945|FG001|NOT COMPLETED|Overall Study||4
8625393|NCT00507026|9664946|FG002|NOT COMPLETED|Overall Study||21
8625394|NCT00507130|9664958|FG000|STARTED|Overall Study||9
8625395|NCT00507130|9664959|FG001|STARTED|Overall Study||9
8625396|NCT00507130|9664960|FG002|STARTED|Overall Study||9
8625397|NCT00507130|9664961|FG003|STARTED|Overall Study||9
8625398|NCT00507130|9664958|FG000|COMPLETED|Overall Study||8
8625399|NCT00507130|9664959|FG001|COMPLETED|Overall Study||9
8625400|NCT00507130|9664960|FG002|COMPLETED|Overall Study||8
8625401|NCT00507130|9664961|FG003|COMPLETED|Overall Study||8
8625402|NCT00507130|9664958|FG000|NOT COMPLETED|Overall Study||1
8625403|NCT00507130|9664959|FG001|NOT COMPLETED|Overall Study||0
8625404|NCT00507130|9664960|FG002|NOT COMPLETED|Overall Study||1
8625405|NCT00507130|9664961|FG003|NOT COMPLETED|Overall Study||1
8625406|NCT00507208|9664973|FG000|STARTED|Overall Study||27
8844906|NCT01713036|9899383|FG000|NOT COMPLETED|Overall Study||1
8844907|NCT01713283|9899397|FG000|STARTED|Overall Study||31
8844908|NCT01713283|9899398|FG001|STARTED|Overall Study||29
9092506|NCT03012815|10157185|FG000|COMPLETED|Overall Study||41
9092507|NCT03012815|10157186|FG001|COMPLETED|Overall Study||40
9092508|NCT03012815|10157185|FG000|NOT COMPLETED|Overall Study||5
9092509|NCT03012815|10157186|FG001|NOT COMPLETED|Overall Study||2
9092510|NCT03001011|10157195|FG000|STARTED|Overall Study||101
9092511|NCT03001011|10157196|FG001|STARTED|Overall Study||101
9092512|NCT03001011|10157195|FG000|COMPLETED|Overall Study||74
9092513|NCT03001011|10157196|FG001|COMPLETED|Overall Study||80
9092514|NCT03001011|10157195|FG000|NOT COMPLETED|Overall Study||27
9092515|NCT03001011|10157196|FG001|NOT COMPLETED|Overall Study||21
9092516|NCT02999633|10157203|FG000|STARTED|Overall Study||14
9092517|NCT02999633|10157203|FG000|COMPLETED|Overall Study||0
9092518|NCT02999633|10157203|FG000|NOT COMPLETED|Overall Study||14
9092519|NCT02993757|10157209|FG000|STARTED|Overall Study||266
9092520|NCT02993757|10157210|FG001|STARTED|Overall Study||262
9092521|NCT02993757|10157209|FG000|Safety Analysis Set (SafAS)|Overall Study||263
9092522|NCT02993757|10157210|FG001|Safety Analysis Set (SafAS)|Overall Study||260
9092523|NCT02993757|10157209|FG000|COMPLETED|Overall Study||102
9092524|NCT02993757|10157210|FG001|COMPLETED|Overall Study||84
9092525|NCT02993757|10157209|FG000|NOT COMPLETED|Overall Study||164
9092526|NCT02993757|10157210|FG001|NOT COMPLETED|Overall Study||178
9092527|NCT02992418|10157218|FG000|STARTED|Overall Study||346
9092528|NCT02992418|10157219|FG001|STARTED|Overall Study||342
9092529|NCT02992418|10157218|FG000|Safety Analysis Set (SafAS)|Overall Study||338
9092530|NCT02992418|10157219|FG001|Safety Analysis Set (SafAS)|Overall Study||342
9092531|NCT02992418|10157218|FG000|COMPLETED|Overall Study||0
9092532|NCT02992418|10157219|FG001|COMPLETED|Overall Study||0
9092533|NCT02992418|10157218|FG000|NOT COMPLETED|Overall Study||346
9092534|NCT02992418|10157219|FG001|NOT COMPLETED|Overall Study||342
9092535|NCT02979535|10157227|FG000|STARTED|Overall Study||239
9092536|NCT02979535|10157228|FG001|STARTED|Overall Study||241
9092537|NCT02979535|10157227|FG000|Safety Analysis Set|Overall Study||237
9092538|NCT02979535|10157228|FG001|Safety Analysis Set|Overall Study||241
9092539|NCT02979535|10157227|FG000|COMPLETED|Overall Study||144
9092540|NCT02979535|10157228|FG001|COMPLETED|Overall Study||140
9092541|NCT02979535|10157227|FG000|NOT COMPLETED|Overall Study||95
9092542|NCT02979535|10157228|FG001|NOT COMPLETED|Overall Study||101
9092543|NCT02978716|10157237|FG000|STARTED|Overall Study||34
9092544|NCT02978716|10157238|FG001|STARTED|Overall Study||33
9092545|NCT02978716|10157239|FG002|STARTED|Overall Study||35
9092546|NCT02978716|10157237|FG000|ITT Population|Overall Study||34
9092547|NCT02978716|10157238|FG001|ITT Population|Overall Study||33
9092548|NCT02978716|10157239|FG002|ITT Population|Overall Study||35
9092549|NCT02978716|10157237|FG000|Safety Analysis Set|Overall Study||30
9092550|NCT02978716|10157238|FG001|Safety Analysis Set|Overall Study||33
9092551|NCT02978716|10157239|FG002|Safety Analysis Set|Overall Study||35
9092552|NCT02978716|10157237|FG000|Treated|Overall Study||30
9092553|NCT02978716|10157238|FG001|Treated|Overall Study||33
9092554|NCT02978716|10157239|FG002|Treated|Overall Study||35
9092555|NCT02978716|10157237|FG000|COMPLETED|Overall Study||0
9092556|NCT02978716|10157238|FG001|COMPLETED|Overall Study||0
9092557|NCT02978716|10157239|FG002|COMPLETED|Overall Study||0
9092558|NCT02978716|10157237|FG000|NOT COMPLETED|Overall Study||34
8625407|NCT00507208|9664974|FG001|STARTED|Overall Study||26
8625408|NCT00507208|9664973|FG000|Received Dynasplint in Crossover|Overall Study||0
8625409|NCT00507208|9664974|FG001|Received Dynasplint in Crossover|Overall Study||3
8625410|NCT00507208|9664973|FG000|COMPLETED|Overall Study||27
8844909|NCT01713283|9899397|FG000|COMPLETED|Overall Study||20
9092559|NCT02978716|10157238|FG001|NOT COMPLETED|Overall Study||33
8625411|NCT00507208|9664974|FG001|COMPLETED|Overall Study||26
8625412|NCT00507208|9664973|FG000|NOT COMPLETED|Overall Study||0
9092560|NCT02978716|10157239|FG002|NOT COMPLETED|Overall Study||35
9092561|NCT02973321|10157254|FG000|STARTED|Overall Study||33
9092562|NCT02973321|10157255|FG001|STARTED|Overall Study||66
9092563|NCT02973321|10157256|FG002|STARTED|Overall Study||66
9092564|NCT02973321|10157257|FG003|STARTED|Overall Study||64
9092565|NCT02973321|10157258|FG004|STARTED|Overall Study||67
9092566|NCT02973321|10157254|FG000|COMPLETED|Overall Study||32
9092567|NCT02973321|10157255|FG001|COMPLETED|Overall Study||51
9092568|NCT02973321|10157256|FG002|COMPLETED|Overall Study||52
9092569|NCT02973321|10157257|FG003|COMPLETED|Overall Study||48
9092570|NCT02973321|10157258|FG004|COMPLETED|Overall Study||62
9092571|NCT02973321|10157254|FG000|NOT COMPLETED|Overall Study||1
9092572|NCT02973321|10157255|FG001|NOT COMPLETED|Overall Study||15
9092573|NCT02973321|10157256|FG002|NOT COMPLETED|Overall Study||14
9092574|NCT02973321|10157257|FG003|NOT COMPLETED|Overall Study||16
9092575|NCT02973321|10157258|FG004|NOT COMPLETED|Overall Study||5
8844910|NCT01713283|9899398|FG001|COMPLETED|Overall Study||26
8844911|NCT01713283|9899397|FG000|NOT COMPLETED|Overall Study||11
8844912|NCT01713283|9899398|FG001|NOT COMPLETED|Overall Study||3
8844913|NCT01713348|9899412|FG000|STARTED|Overall Study||29
9092576|NCT02943785|10157273|FG000|STARTED|Overall Study||713
9092577|NCT02943785|10157274|FG001|STARTED|Overall Study||713
9092578|NCT02943785|10157273|FG000|COMPLETED|Overall Study||431
9092579|NCT02943785|10157274|FG001|COMPLETED|Overall Study||350
9092580|NCT02943785|10157273|FG000|NOT COMPLETED|Overall Study||282
9092581|NCT02943785|10157274|FG001|NOT COMPLETED|Overall Study||363
9092582|NCT02937818|10157284|FG000|STARTED|Overall Study||21
9092583|NCT02937818|10157285|FG001|STARTED|Overall Study||20
9092584|NCT02937818|10157286|FG002|STARTED|Overall Study||10
9092585|NCT02937818|10157287|FG003|STARTED|Overall Study||21
9092586|NCT02937818|10157284|FG000|COMPLETED|Overall Study||0
9092587|NCT02937818|10157285|FG001|COMPLETED|Overall Study||0
9092588|NCT02937818|10157286|FG002|COMPLETED|Overall Study||0
9092589|NCT02937818|10157287|FG003|COMPLETED|Overall Study||0
9092590|NCT02937818|10157284|FG000|NOT COMPLETED|Overall Study||21
9092591|NCT02937818|10157285|FG001|NOT COMPLETED|Overall Study||20
9092592|NCT02937818|10157286|FG002|NOT COMPLETED|Overall Study||10
9092593|NCT02937818|10157287|FG003|NOT COMPLETED|Overall Study||21
9092594|NCT02923674|10157303|FG000|STARTED|Overall Study||60
9092595|NCT02923674|10157304|FG001|STARTED|Overall Study||60
9092596|NCT02923674|10157305|FG002|STARTED|Overall Study||63
9092597|NCT02923674|10157303|FG000|COMPLETED|Overall Study||32
9092598|NCT02923674|10157304|FG001|COMPLETED|Overall Study||32
9092599|NCT02923674|10157305|FG002|COMPLETED|Overall Study||38
9092600|NCT02923674|10157303|FG000|NOT COMPLETED|Overall Study||28
9092601|NCT02923674|10157304|FG001|NOT COMPLETED|Overall Study||28
9092602|NCT02923674|10157305|FG002|NOT COMPLETED|Overall Study||25
9092603|NCT02921971|10157315|FG000|STARTED|Overall Study||49
9092604|NCT02921971|10157316|FG001|STARTED|Overall Study||48
9092605|NCT02921971|10157315|FG000|COMPLETED|Overall Study||43
9092606|NCT02921971|10157316|FG001|COMPLETED|Overall Study||44
9092607|NCT02921971|10157315|FG000|NOT COMPLETED|Overall Study||6
9092608|NCT02921971|10157316|FG001|NOT COMPLETED|Overall Study||4
9092609|NCT02908685|10157334|FG000|STARTED|Part 1 Exploratory||7
9092610|NCT02908685|10157335|FG001|STARTED|Part 1 Exploratory||7
9092611|NCT02908685|10157336|FG002|STARTED|Part 1 Exploratory||3
9092612|NCT02908685|10157337|FG003|STARTED|Part 1 Exploratory||3
9092613|NCT02908685|10157338|FG004|STARTED|Part 1 Exploratory||7
9092614|NCT02908685|10157339|FG005|STARTED|Part 1 Exploratory||7
9092615|NCT02908685|10157340|FG006|STARTED|Part 1 Exploratory||7
9092616|NCT02908685|10157341|FG007|STARTED|Part 1 Exploratory||3
9092617|NCT02908685|10157342|FG008|STARTED|Part 1 Exploratory||4
9092618|NCT02908685|10157343|FG009|STARTED|Part 1 Exploratory||3
9092619|NCT02908685|10157344|FG010|STARTED|Part 1 Exploratory||0
9092620|NCT02908685|10157345|FG011|STARTED|Part 1 Exploratory||0
9092621|NCT02908685|10157334|FG000|COMPLETED|Part 1 Exploratory||7
9092622|NCT02908685|10157335|FG001|COMPLETED|Part 1 Exploratory||6
9092623|NCT02908685|10157336|FG002|COMPLETED|Part 1 Exploratory||3
8844914|NCT01713348|9899413|FG001|STARTED|Overall Study||13
8844915|NCT01713348|9899414|FG002|STARTED|Overall Study||30
8844916|NCT01713348|9899415|FG003|STARTED|Overall Study||15
8844917|NCT01713348|9899412|FG000|COMPLETED|Overall Study||25
8844918|NCT01713348|9899413|FG001|COMPLETED|Overall Study||11
8844919|NCT01713348|9899414|FG002|COMPLETED|Overall Study||28
8844920|NCT01713348|9899415|FG003|COMPLETED|Overall Study||15
8844921|NCT01713348|9899412|FG000|NOT COMPLETED|Overall Study||4
8844922|NCT01713348|9899413|FG001|NOT COMPLETED|Overall Study||2
8844923|NCT01713348|9899414|FG002|NOT COMPLETED|Overall Study||2
8844924|NCT01713348|9899415|FG003|NOT COMPLETED|Overall Study||0
8844925|NCT01713400|9899427|FG000|STARTED|Overall Study||15
8844926|NCT01713400|9899428|FG001|STARTED|Overall Study||15
8844927|NCT01713400|9899427|FG000|COMPLETED|Overall Study||15
8844928|NCT01713400|9899428|FG001|COMPLETED|Overall Study||15
8844929|NCT01713400|9899427|FG000|NOT COMPLETED|Overall Study||0
8844930|NCT01713400|9899428|FG001|NOT COMPLETED|Overall Study||0
8844931|NCT01713530|9899436|FG000|STARTED|Overall Study||138
8844932|NCT01713530|9899437|FG001|STARTED|Overall Study||136
8844933|NCT01713530|9899436|FG000|Exposed|Overall Study|One (1) subject was randomised in error and 1 subject withdrew consent|136
8844934|NCT01713530|9899437|FG001|Exposed|Overall Study|One (1) subject was withdrawn by the investigator|135
9092624|NCT02908685|10157337|FG003|COMPLETED|Part 1 Exploratory||3
9092625|NCT02908685|10157338|FG004|COMPLETED|Part 1 Exploratory||7
9092626|NCT02908685|10157339|FG005|COMPLETED|Part 1 Exploratory||7
9092627|NCT02908685|10157340|FG006|COMPLETED|Part 1 Exploratory||7
8844935|NCT01713530|9899436|FG000|COMPLETED|Overall Study||113
8844936|NCT01713530|9899437|FG001|COMPLETED|Overall Study||117
8844937|NCT01713530|9899436|FG000|NOT COMPLETED|Overall Study||25
8844938|NCT01713530|9899437|FG001|NOT COMPLETED|Overall Study||19
8844939|NCT01713582|9899464|FG000|STARTED|Overall Study|Number treated|3
8844940|NCT01713582|9899465|FG001|STARTED|Overall Study|Number treated|3
8844941|NCT01713582|9899466|FG002|STARTED|Overall Study|Number treated|4
8844942|NCT01713582|9899467|FG003|STARTED|Overall Study|Number treated|3
8844943|NCT01713582|9899468|FG004|STARTED|Overall Study|Number treated|4
9092628|NCT02908685|10157341|FG007|COMPLETED|Part 1 Exploratory||3
9092629|NCT02908685|10157342|FG008|COMPLETED|Part 1 Exploratory||4
9092630|NCT02908685|10157343|FG009|COMPLETED|Part 1 Exploratory||3
9092631|NCT02908685|10157344|FG010|COMPLETED|Part 1 Exploratory||0
8844944|NCT01713582|9899469|FG005|STARTED|Overall Study|Number treated|8
8844945|NCT01713582|9899470|FG006|STARTED|Overall Study|Number treated|7
9092632|NCT02908685|10157345|FG011|COMPLETED|Part 1 Exploratory||0
9092633|NCT02908685|10157334|FG000|NOT COMPLETED|Part 1 Exploratory||0
9092634|NCT02908685|10157335|FG001|NOT COMPLETED|Part 1 Exploratory||1
9092635|NCT02908685|10157336|FG002|NOT COMPLETED|Part 1 Exploratory||0
9092636|NCT02908685|10157337|FG003|NOT COMPLETED|Part 1 Exploratory||0
9092637|NCT02908685|10157338|FG004|NOT COMPLETED|Part 1 Exploratory||0
9092638|NCT02908685|10157339|FG005|NOT COMPLETED|Part 1 Exploratory||0
9092639|NCT02908685|10157340|FG006|NOT COMPLETED|Part 1 Exploratory||0
9092640|NCT02908685|10157341|FG007|NOT COMPLETED|Part 1 Exploratory||0
9092641|NCT02908685|10157342|FG008|NOT COMPLETED|Part 1 Exploratory||0
9092642|NCT02908685|10157343|FG009|NOT COMPLETED|Part 1 Exploratory||0
9092643|NCT02908685|10157344|FG010|NOT COMPLETED|Part 1 Exploratory||0
9092644|NCT02908685|10157345|FG011|NOT COMPLETED|Part 1 Exploratory||0
9092645|NCT02908685|10157334|FG000|STARTED|Part 2 Confirmatory||0
9092646|NCT02908685|10157335|FG001|STARTED|Part 2 Confirmatory||0
9092647|NCT02908685|10157336|FG002|STARTED|Part 2 Confirmatory||0
9092648|NCT02908685|10157337|FG003|STARTED|Part 2 Confirmatory||0
9092649|NCT02908685|10157338|FG004|STARTED|Part 2 Confirmatory||0
9092650|NCT02908685|10157339|FG005|STARTED|Part 2 Confirmatory||0
9092651|NCT02908685|10157340|FG006|STARTED|Part 2 Confirmatory||0
9092652|NCT02908685|10157341|FG007|STARTED|Part 2 Confirmatory||0
9092653|NCT02908685|10157342|FG008|STARTED|Part 2 Confirmatory||0
9092654|NCT02908685|10157343|FG009|STARTED|Part 2 Confirmatory||0
9092655|NCT02908685|10157344|FG010|STARTED|Part 2 Confirmatory||120
9092656|NCT02908685|10157345|FG011|STARTED|Part 2 Confirmatory||60
9092657|NCT02908685|10157334|FG000|COMPLETED|Part 2 Confirmatory||0
9092658|NCT02908685|10157335|FG001|COMPLETED|Part 2 Confirmatory||0
9092659|NCT02908685|10157336|FG002|COMPLETED|Part 2 Confirmatory||0
9092660|NCT02908685|10157337|FG003|COMPLETED|Part 2 Confirmatory||0
9092661|NCT02908685|10157338|FG004|COMPLETED|Part 2 Confirmatory||0
9092662|NCT02908685|10157339|FG005|COMPLETED|Part 2 Confirmatory||0
9092663|NCT02908685|10157340|FG006|COMPLETED|Part 2 Confirmatory||0
9092664|NCT02908685|10157341|FG007|COMPLETED|Part 2 Confirmatory||0
9092665|NCT02908685|10157342|FG008|COMPLETED|Part 2 Confirmatory||0
9092666|NCT02908685|10157343|FG009|COMPLETED|Part 2 Confirmatory||0
9092667|NCT02908685|10157344|FG010|COMPLETED|Part 2 Confirmatory||117
9092668|NCT02908685|10157345|FG011|COMPLETED|Part 2 Confirmatory||59
9092669|NCT02908685|10157334|FG000|NOT COMPLETED|Part 2 Confirmatory||0
9092670|NCT02908685|10157335|FG001|NOT COMPLETED|Part 2 Confirmatory||0
9092671|NCT02908685|10157336|FG002|NOT COMPLETED|Part 2 Confirmatory||0
9092672|NCT02908685|10157337|FG003|NOT COMPLETED|Part 2 Confirmatory||0
9092673|NCT02908685|10157338|FG004|NOT COMPLETED|Part 2 Confirmatory||0
9092674|NCT02908685|10157339|FG005|NOT COMPLETED|Part 2 Confirmatory||0
9092675|NCT02908685|10157340|FG006|NOT COMPLETED|Part 2 Confirmatory||0
9092676|NCT02908685|10157341|FG007|NOT COMPLETED|Part 2 Confirmatory||0
9092677|NCT02908685|10157342|FG008|NOT COMPLETED|Part 2 Confirmatory||0
9092678|NCT02908685|10157343|FG009|NOT COMPLETED|Part 2 Confirmatory||0
9092679|NCT02908685|10157344|FG010|NOT COMPLETED|Part 2 Confirmatory||3
9092680|NCT02908685|10157345|FG011|NOT COMPLETED|Part 2 Confirmatory||1
9092681|NCT02886286|10157364|FG000|STARTED|Overall Study||8
9092682|NCT02886286|10157365|FG001|STARTED|Overall Study||9
9092683|NCT02886286|10157364|FG000|COMPLETED|Overall Study||8
9092684|NCT02886286|10157365|FG001|COMPLETED|Overall Study||8
9092685|NCT02886286|10157364|FG000|NOT COMPLETED|Overall Study||0
9092686|NCT02886286|10157365|FG001|NOT COMPLETED|Overall Study||1
9092687|NCT02874742|10157374|FG000|STARTED|Overall Study||103
9092688|NCT02874742|10157375|FG001|STARTED|Overall Study||104
9092689|NCT02874742|10157376|FG002|STARTED|Overall Study||16
9092690|NCT02874742|10157374|FG000|Safety|Overall Study||102
9092691|NCT02874742|10157375|FG001|Safety|Overall Study||99
9092692|NCT02874742|10157376|FG002|Safety|Overall Study||16
9092693|NCT02874742|10157374|FG000|COMPLETED|Overall Study||0
9092694|NCT02874742|10157375|FG001|COMPLETED|Overall Study||0
9092695|NCT02874742|10157376|FG002|COMPLETED|Overall Study||0
9092696|NCT02874742|10157374|FG000|NOT COMPLETED|Overall Study||103
9092697|NCT02874742|10157375|FG001|NOT COMPLETED|Overall Study||104
9092698|NCT02874742|10157376|FG002|NOT COMPLETED|Overall Study||16
9092699|NCT02865187|10157386|FG000|STARTED|Overall Study||33
9092700|NCT02865187|10157387|FG001|STARTED|Overall Study||14
9092701|NCT02865187|10157386|FG000|Visit 2 - at 3 Months|Overall Study||23
9092702|NCT02865187|10157387|FG001|Visit 2 - at 3 Months|Overall Study||7
9092703|NCT02865187|10157386|FG000|COMPLETED|Overall Study||20
9092704|NCT02865187|10157387|FG001|COMPLETED|Overall Study||7
9092705|NCT02865187|10157386|FG000|NOT COMPLETED|Overall Study||13
9092706|NCT02865187|10157387|FG001|NOT COMPLETED|Overall Study||7
9092707|NCT02836249|10157395|FG000|STARTED|Overall Study||123
9092708|NCT02836249|10157396|FG001|STARTED|Overall Study||58
9092709|NCT02836249|10157395|FG000|COMPLETED|Overall Study||0
9092710|NCT02836249|10157396|FG001|COMPLETED|Overall Study||0
9092711|NCT02836249|10157395|FG000|NOT COMPLETED|Overall Study||123
9092712|NCT02836249|10157396|FG001|NOT COMPLETED|Overall Study||58
9092713|NCT02829918|10157402|FG000|STARTED|Overall Study||54
9092714|NCT02829918|10157402|FG000|COMPLETED|Overall Study||46
9092715|NCT02829918|10157402|FG000|NOT COMPLETED|Overall Study||8
9092716|NCT02824198|10157408|FG000|STARTED|Overall Study||89
9092717|NCT02824198|10157409|FG001|STARTED|Overall Study||29
9092718|NCT02824198|10157408|FG000|COMPLETED|Overall Study||74
9092719|NCT02824198|10157409|FG001|COMPLETED|Overall Study||26
9092720|NCT02824198|10157408|FG000|NOT COMPLETED|Overall Study||15
9092721|NCT02824198|10157409|FG001|NOT COMPLETED|Overall Study||3
9092722|NCT02821754|10157420|FG000|STARTED|Overall Study||36
9092723|NCT02821754|10157421|FG001|STARTED|Overall Study||16
9092724|NCT02821754|10157422|FG002|STARTED|Overall Study|No results data were collected for these participants.|2
9092725|NCT02821754|10157420|FG000|COMPLETED|Overall Study||20
9092726|NCT02821754|10157421|FG001|COMPLETED|Overall Study||4
9092727|NCT02821754|10157422|FG002|COMPLETED|Overall Study||0
9092728|NCT02821754|10157420|FG000|NOT COMPLETED|Overall Study||16
9092729|NCT02821754|10157421|FG001|NOT COMPLETED|Overall Study||12
9092730|NCT02821754|10157422|FG002|NOT COMPLETED|Overall Study||2
9092731|NCT02787551|10157430|FG000|STARTED|Core Period: 26 Weeks||257
9092732|NCT02787551|10157431|FG001|STARTED|Core Period: 26 Weeks||257
9092733|NCT02787551|10157430|FG000|Treated|Core Period: 26 Weeks||255
9092734|NCT02787551|10157431|FG001|Treated|Core Period: 26 Weeks||256
9092735|NCT02787551|10157430|FG000|COMPLETED|Core Period: 26 Weeks|Out of 230 participants, 206 participants entered in single arm extension period.|230
9092736|NCT02787551|10157431|FG001|COMPLETED|Core Period: 26 Weeks||246
9092737|NCT02787551|10157430|FG000|NOT COMPLETED|Core Period: 26 Weeks||27
9092738|NCT02787551|10157431|FG001|NOT COMPLETED|Core Period: 26 Weeks||11
9092739|NCT02787551|10157430|FG000|STARTED|Extension Period:26 Weeks(Upto 52 Weeks)|Participants who completed core period and met eligibility criteria for extension period.|206
9092740|NCT02787551|10157431|FG001|STARTED|Extension Period:26 Weeks(Upto 52 Weeks)||0
9092741|NCT02787551|10157430|FG000|COMPLETED|Extension Period:26 Weeks(Upto 52 Weeks)||197
9092742|NCT02787551|10157431|FG001|COMPLETED|Extension Period:26 Weeks(Upto 52 Weeks)||0
9092743|NCT02787551|10157430|FG000|NOT COMPLETED|Extension Period:26 Weeks(Upto 52 Weeks)||9
9092744|NCT02787551|10157431|FG001|NOT COMPLETED|Extension Period:26 Weeks(Upto 52 Weeks)||0
9092745|NCT02747121|10157442|FG000|STARTED|Overall Study||3594
9092746|NCT02747121|10157443|FG001|STARTED|Overall Study||3813
9092747|NCT02747121|10157442|FG000|COMPLETED|Overall Study||3594
9092748|NCT02747121|10157443|FG001|COMPLETED|Overall Study||3813
9092749|NCT02747121|10157442|FG000|NOT COMPLETED|Overall Study||0
9092750|NCT02747121|10157443|FG001|NOT COMPLETED|Overall Study||0
9092751|NCT02735044|10157451|FG000|STARTED|Overall Study||233
9092752|NCT02735044|10157452|FG001|STARTED|Overall Study||230
9092753|NCT02735044|10157451|FG000|Treated|Overall Study||233
9092754|NCT02735044|10157452|FG001|Treated|Overall Study||228
9092755|NCT02735044|10157451|FG000|COMPLETED|Overall Study||217
9092756|NCT02735044|10157452|FG001|COMPLETED|Overall Study||207
9092757|NCT02735044|10157451|FG000|NOT COMPLETED|Overall Study||16
9092758|NCT02735044|10157452|FG001|NOT COMPLETED|Overall Study||23
9092759|NCT02720744|10157460|FG000|STARTED|Overall Study||107
9092760|NCT02720744|10157461|FG001|STARTED|Overall Study||105
9092761|NCT02720744|10157460|FG000|COMPLETED|Overall Study||69
9092762|NCT02720744|10157461|FG001|COMPLETED|Overall Study||79
9092763|NCT02720744|10157460|FG000|NOT COMPLETED|Overall Study||38
9092764|NCT02720744|10157461|FG001|NOT COMPLETED|Overall Study||26
9092765|NCT02713867|10157469|FG000|STARTED|Randomization||180
9092766|NCT02713867|10157470|FG001|STARTED|Randomization||183
9092767|NCT02713867|10157469|FG000|COMPLETED|Randomization||178
9092768|NCT02713867|10157470|FG001|COMPLETED|Randomization||180
9092769|NCT02713867|10157469|FG000|NOT COMPLETED|Randomization||2
8556762|NCT04374149|9588561|FG000|STARTED|Overall Study||10
8556763|NCT04374149|9588562|FG001|STARTED|Overall Study||10
8556764|NCT04374149|9588561|FG000|COMPLETED|Overall Study||10
8556765|NCT04374149|9588562|FG001|COMPLETED|Overall Study||10
8556766|NCT04374149|9588561|FG000|NOT COMPLETED|Overall Study||0
8556767|NCT04374149|9588562|FG001|NOT COMPLETED|Overall Study||0
9092770|NCT02713867|10157470|FG001|NOT COMPLETED|Randomization||3
9092771|NCT02713867|10157469|FG000|STARTED|Treatment Period||178
9092772|NCT02713867|10157470|FG001|STARTED|Treatment Period||180
9092773|NCT02713867|10157469|FG000|COMPLETED|Treatment Period||31
8625413|NCT00507208|9664974|FG001|NOT COMPLETED|Overall Study||0
8625414|NCT00507416|9664983|FG000|STARTED|Overall Study||168
8625415|NCT00507416|9664984|FG001|STARTED|Overall Study||167
8625416|NCT00507416|9664985|FG002|STARTED|Overall Study||167
8625417|NCT00507416|9664983|FG000|Treated (Safety Population)|Overall Study||165
8625418|NCT00507416|9664984|FG001|Treated (Safety Population)|Overall Study||158
8625419|NCT00507416|9664985|FG002|Treated (Safety Population)|Overall Study||163
9092774|NCT02713867|10157470|FG001|COMPLETED|Treatment Period||30
9092775|NCT02713867|10157469|FG000|NOT COMPLETED|Treatment Period||147
9092776|NCT02713867|10157470|FG001|NOT COMPLETED|Treatment Period||150
9092777|NCT02704403|10157478|FG000|STARTED|Overall Study||1437
9092778|NCT02704403|10157479|FG001|STARTED|Overall Study||720
9092779|NCT02704403|10157478|FG000|Full Intent-to-Treat Population|Overall Study||1437
9092780|NCT02704403|10157479|FG001|Full Intent-to-Treat Population|Overall Study||720
9092781|NCT02704403|10157478|FG000|Full Safety Population|Overall Study||1433
9092782|NCT02704403|10157479|FG001|Full Safety Population|Overall Study||717
9092783|NCT02704403|10157478|FG000|COMPLETED|Overall Study||0
8556768|NCT04348500|9588570|FG000|STARTED|Overall Study||8
8556769|NCT04348500|9588571|FG001|STARTED|Overall Study||9
8556770|NCT04348500|9588570|FG000|Treated|Overall Study||8
8556771|NCT04348500|9588571|FG001|Treated|Overall Study||8
8556772|NCT04348500|9588570|FG000|COMPLETED|Overall Study||6
8556773|NCT04348500|9588571|FG001|COMPLETED|Overall Study||6
8556774|NCT04348500|9588570|FG000|NOT COMPLETED|Overall Study||2
8556775|NCT04348500|9588571|FG001|NOT COMPLETED|Overall Study||3
8556776|NCT04347941|9588579|FG000|STARTED|Overall Study||12
8556777|NCT04347941|9588580|FG001|STARTED|Overall Study||12
8625420|NCT00507416|9664983|FG000|Completed 8 Treatment Cycles|Overall Study||82
8625421|NCT00507416|9664984|FG001|Completed 8 Treatment Cycles|Overall Study||60
8556778|NCT04347941|9588579|FG000|COMPLETED|Overall Study||12
9092784|NCT02704403|10157479|FG001|COMPLETED|Overall Study||0
9092785|NCT02704403|10157478|FG000|NOT COMPLETED|Overall Study||1437
9092786|NCT02704403|10157479|FG001|NOT COMPLETED|Overall Study||720
9092787|NCT02694185|10157487|FG000|STARTED|Overall Study||476
9092788|NCT02694185|10157488|FG001|STARTED|Overall Study||4793
9092789|NCT02694185|10157487|FG000|COMPLETED|Overall Study||431
9092790|NCT02694185|10157488|FG001|COMPLETED|Overall Study||4793
9092791|NCT02694185|10157487|FG000|NOT COMPLETED|Overall Study||45
9092792|NCT02694185|10157488|FG001|NOT COMPLETED|Overall Study||0
9092793|NCT02692651|10157496|FG000|STARTED|Study Treatment||70
9092794|NCT02692651|10157497|FG001|STARTED|Study Treatment||74
9092795|NCT02692651|10157496|FG000|COMPLETED|Study Treatment||54
9092796|NCT02692651|10157497|FG001|COMPLETED|Study Treatment||64
9092797|NCT02692651|10157496|FG000|NOT COMPLETED|Study Treatment||16
9092798|NCT02692651|10157497|FG001|NOT COMPLETED|Study Treatment||10
9092799|NCT02692651|10157496|FG000|STARTED|Post Study Treatment Follow-up||54
9092800|NCT02692651|10157497|FG001|STARTED|Post Study Treatment Follow-up||64
9092801|NCT02692651|10157496|FG000|COMPLETED|Post Study Treatment Follow-up||50
9092802|NCT02692651|10157497|FG001|COMPLETED|Post Study Treatment Follow-up||60
9092803|NCT02692651|10157496|FG000|NOT COMPLETED|Post Study Treatment Follow-up||4
9092804|NCT02692651|10157497|FG001|NOT COMPLETED|Post Study Treatment Follow-up||4
8556779|NCT04347941|9588580|FG001|COMPLETED|Overall Study||12
8556780|NCT04347941|9588579|FG000|NOT COMPLETED|Overall Study||0
8556781|NCT04347941|9588580|FG001|NOT COMPLETED|Overall Study||0
8556782|NCT04308694|9588589|FG000|STARTED|Overall Study||20
8556783|NCT04308694|9588589|FG000|COMPLETED|Overall Study||16
8556784|NCT04308694|9588589|FG000|NOT COMPLETED|Overall Study||4
8625422|NCT00507416|9664985|FG002|Completed 8 Treatment Cycles|Overall Study||69
8625423|NCT00507416|9664983|FG000|COMPLETED|Overall Study|Completed is defined as having completed 13 treatment cycles.|50
8625424|NCT00507416|9664984|FG001|COMPLETED|Overall Study|Completed is defined as having completed 13 treatment cycles.|42
8556785|NCT03999411|9588596|FG000|STARTED|Overall Study||13
8556786|NCT03999411|9588597|FG001|STARTED|Overall Study||13
8556787|NCT03999411|9588598|FG002|STARTED|Overall Study||13
8556788|NCT03999411|9588596|FG000|COMPLETED|Overall Study||12
8556789|NCT03999411|9588597|FG001|COMPLETED|Overall Study||11
8556790|NCT03999411|9588598|FG002|COMPLETED|Overall Study||13
8556791|NCT03999411|9588596|FG000|NOT COMPLETED|Overall Study||1
8556792|NCT03999411|9588597|FG001|NOT COMPLETED|Overall Study||2
8556793|NCT03999411|9588598|FG002|NOT COMPLETED|Overall Study||0
8568740|NCT00093041|9600941|FG002|COMPLETED|Overall Study|Two discontinued during single dose period|3
8568741|NCT00093041|9600942|FG003|COMPLETED|Overall Study|One discontinued during single dose period|3
8568742|NCT00093041|9600943|FG004|COMPLETED|Overall Study|One discontinued during multiple dose period|3
9092805|NCT02674061|10157505|FG000|STARTED|Overall Study||285
9092806|NCT02674061|10157506|FG001|STARTED|Overall Study||91
9092807|NCT02674061|10157505|FG000|COMPLETED|Overall Study||0
9092808|NCT02674061|10157506|FG001|COMPLETED|Overall Study||0
9092809|NCT02674061|10157505|FG000|NOT COMPLETED|Overall Study||285
9092810|NCT02674061|10157506|FG001|NOT COMPLETED|Overall Study||91
9092811|NCT02656706|10157514|FG000|STARTED|Overall Study||22
9092812|NCT02656706|10157514|FG000|COMPLETED|Overall Study||21
9092813|NCT02656706|10157514|FG000|NOT COMPLETED|Overall Study||1
9092814|NCT02654314|10157520|FG000|STARTED|Overall Study||136
9092815|NCT02654314|10157521|FG001|STARTED|Overall Study||141
9092816|NCT02654314|10157520|FG000|COMPLETED|Overall Study||136
9092817|NCT02654314|10157521|FG001|COMPLETED|Overall Study||141
9092818|NCT02654314|10157520|FG000|NOT COMPLETED|Overall Study||0
9092819|NCT02654314|10157521|FG001|NOT COMPLETED|Overall Study||0
9092820|NCT02642042|10157527|FG000|STARTED|Overall Study||54
9092821|NCT02642042|10157527|FG000|COMPLETED|Overall Study||0
9092822|NCT02642042|10157527|FG000|NOT COMPLETED|Overall Study||54
8625425|NCT00507416|9664985|FG002|COMPLETED|Overall Study|Completed is defined as having completed 13 treatment cycles.|53
8625426|NCT00507416|9664983|FG000|NOT COMPLETED|Overall Study||118
8625427|NCT00507416|9664984|FG001|NOT COMPLETED|Overall Study||125
8625428|NCT00507416|9664985|FG002|NOT COMPLETED|Overall Study||114
8625429|NCT00507429|9664995|FG000|STARTED|Treatment Phase|Randomized|55
8625430|NCT00507429|9664996|FG001|STARTED|Treatment Phase|Randomized|25
8625431|NCT00507429|9664995|FG000|COMPLETED|Treatment Phase||18
8625432|NCT00507429|9664996|FG001|COMPLETED|Treatment Phase||7
8625433|NCT00507429|9664995|FG000|NOT COMPLETED|Treatment Phase||37
8625434|NCT00507429|9664996|FG001|NOT COMPLETED|Treatment Phase||18
8625435|NCT00507429|9664995|FG000|STARTED|Maintenance Phase|2 subjects did not enter maintenance: 1/18 progressive disease; 1/18 lost to follow-up.|16
8625436|NCT00507429|9664996|FG001|STARTED|Maintenance Phase|Control arm subjects followed for survival only; not enrolled in Maintenance period|0
8723532|NCT01023724|9771063|FG000|STARTED|Overall Study||25
8723533|NCT01023724|9771064|FG001|STARTED|Overall Study||25
8844946|NCT01713582|9899471|FG007|STARTED|Overall Study|Number treated|6
8844947|NCT01713582|9899472|FG008|STARTED|Overall Study|Number treated|6
8844948|NCT01713582|9899473|FG009|STARTED|Overall Study|Number treated|18
8844949|NCT01713582|9899474|FG010|STARTED|Overall Study|Number treated|16
9092823|NCT02628444|10157534|FG000|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||350
9092824|NCT02628444|10157535|FG001|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||348
9092825|NCT02628444|10157536|FG002|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||352
9092826|NCT02628444|10157537|FG003|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||0
8844950|NCT01713582|9899475|FG011|STARTED|Overall Study|Number treated|5
8844951|NCT01713582|9899476|FG012|STARTED|Overall Study|Number treated|3
8844952|NCT01713582|9899477|FG013|STARTED|Overall Study|Number treated|4
8844953|NCT01713582|9899478|FG014|STARTED|Overall Study|Number treated|7
8844954|NCT01713582|9899479|FG015|STARTED|Overall Study|Number treated|6
8844955|NCT01713582|9899480|FG016|STARTED|Overall Study|Number treated|7
8844956|NCT01713582|9899481|FG017|STARTED|Overall Study|Number treated|3
8844957|NCT01713582|9899482|FG018|STARTED|Overall Study|Number treated|5
8844958|NCT01713582|9899483|FG019|STARTED|Overall Study|Number treated|5
8844959|NCT01713582|9899484|FG020|STARTED|Overall Study|Number treated|15
8844960|NCT01713582|9899464|FG000|COMPLETED|Overall Study||0
8723534|NCT01023724|9771063|FG000|COMPLETED|Overall Study||21
8844961|NCT01713582|9899465|FG001|COMPLETED|Overall Study||0
8844962|NCT01713582|9899466|FG002|COMPLETED|Overall Study||0
8844963|NCT01713582|9899467|FG003|COMPLETED|Overall Study||0
8844964|NCT01713582|9899468|FG004|COMPLETED|Overall Study||0
9092827|NCT02628444|10157538|FG004|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||0
9092828|NCT02628444|10157539|FG005|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||0
9092829|NCT02628444|10157540|FG006|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||0
9092830|NCT02628444|10157541|FG007|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||0
8723535|NCT01023724|9771064|FG001|COMPLETED|Overall Study||22
8723536|NCT01023724|9771063|FG000|NOT COMPLETED|Overall Study||4
8723537|NCT01023724|9771064|FG001|NOT COMPLETED|Overall Study||3
8725166|NCT01029691|9772359|FG001|NOT COMPLETED|APAP Initiation to Week 1 or Delivery||11
9092831|NCT02628444|10157542|FG008|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||0
9092832|NCT02628444|10157534|FG000|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||348
9092833|NCT02628444|10157535|FG001|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||348
9092834|NCT02628444|10157536|FG002|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||352
9092835|NCT02628444|10157537|FG003|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||0
9092836|NCT02628444|10157538|FG004|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||0
9092837|NCT02628444|10157539|FG005|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||0
8625437|NCT00507429|9664995|FG000|COMPLETED|Maintenance Phase|14 subjects were withdrawn due to progressive disease, 2 subjects continued beyond data cut-off|2
9092838|NCT02628444|10157540|FG006|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||0
9092839|NCT02628444|10157541|FG007|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||0
9092840|NCT02628444|10157542|FG008|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||0
8556794|NCT03803605|9588607|FG000|STARTED|Overall Study||15
8556795|NCT03803605|9588607|FG000|Step 1: Participants With an RCI Measurement > 0.30 Per Million Cells|Overall Study||8
8556796|NCT03803605|9588607|FG000|Steps 2-4: Participants Receiving Study Intervention|Overall Study||8
8556797|NCT03803605|9588607|FG000|COMPLETED|Overall Study||8
8556798|NCT03803605|9588607|FG000|NOT COMPLETED|Overall Study||7
8556799|NCT03799198|9588614|FG000|STARTED|Overall Study||100
8556800|NCT03799198|9588615|FG001|STARTED|Overall Study||100
8556801|NCT03799198|9588614|FG000|Full Analysis Set (FAS)|Overall Study||100
8556802|NCT03799198|9588615|FG001|Full Analysis Set (FAS)|Overall Study||100
8556803|NCT03799198|9588614|FG000|COMPLETED|Overall Study||96
8556804|NCT03799198|9588615|FG001|COMPLETED|Overall Study||91
8556805|NCT03799198|9588614|FG000|NOT COMPLETED|Overall Study||4
8556806|NCT03799198|9588615|FG001|NOT COMPLETED|Overall Study||9
8556807|NCT03770728|9588625|FG000|STARTED|Overall Study||79
8556808|NCT03770728|9588626|FG001|STARTED|Overall Study||78
8556809|NCT03770728|9588627|FG002|STARTED|Overall Study||77
8556810|NCT03770728|9588628|FG003|STARTED|Overall Study||78
8556811|NCT03770728|9588625|FG000|Safety Population|Overall Study||79
8556812|NCT03770728|9588626|FG001|Safety Population|Overall Study||78
8556813|NCT03770728|9588627|FG002|Safety Population|Overall Study|For safety analysis, participants were included in the treatment group that they were exposed for longer duration. 3 participants randomized to Efpeglenatide 6 mg received 4 mg dose for longer duration; and considered in Efpeglenatide 4 mg group for safety analysis.|80
8556814|NCT03770728|9588628|FG003|Safety Population|Overall Study||75
8556815|NCT03770728|9588625|FG000|COMPLETED|Overall Study||41
8556816|NCT03770728|9588626|FG001|COMPLETED|Overall Study||47
8556817|NCT03770728|9588627|FG002|COMPLETED|Overall Study||45
8556818|NCT03770728|9588628|FG003|COMPLETED|Overall Study||43
8556819|NCT03770728|9588625|FG000|NOT COMPLETED|Overall Study||38
8556820|NCT03770728|9588626|FG001|NOT COMPLETED|Overall Study||31
8556821|NCT03770728|9588627|FG002|NOT COMPLETED|Overall Study||32
9092841|NCT02628444|10157534|FG000|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||333
9092842|NCT02628444|10157535|FG001|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||328
9092843|NCT02628444|10157536|FG002|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||332
9092844|NCT02628444|10157537|FG003|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||0
9092845|NCT02628444|10157538|FG004|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||0
9092846|NCT02628444|10157539|FG005|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||0
9092847|NCT02628444|10157540|FG006|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||0
9092848|NCT02628444|10157541|FG007|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||0
9092849|NCT02628444|10157542|FG008|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||0
9092850|NCT02628444|10157534|FG000|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||314
9092851|NCT02628444|10157535|FG001|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||309
9092852|NCT02628444|10157536|FG002|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||310
9092853|NCT02628444|10157537|FG003|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
9092854|NCT02628444|10157538|FG004|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
9092855|NCT02628444|10157539|FG005|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
9092856|NCT02628444|10157540|FG006|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
9092857|NCT02628444|10157541|FG007|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
9092858|NCT02628444|10157542|FG008|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
9092859|NCT02628444|10157534|FG000|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||36
9092860|NCT02628444|10157535|FG001|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||39
9092861|NCT02628444|10157536|FG002|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||42
9092862|NCT02628444|10157537|FG003|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
9092863|NCT02628444|10157538|FG004|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
9092864|NCT02628444|10157539|FG005|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
9092865|NCT02628444|10157540|FG006|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
9092866|NCT02628444|10157541|FG007|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
9092867|NCT02628444|10157542|FG008|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
9092868|NCT02628444|10157534|FG000|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
9092869|NCT02628444|10157535|FG001|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
8556822|NCT03770728|9588628|FG003|NOT COMPLETED|Overall Study||35
8556823|NCT03760146|9588646|FG000|STARTED|Overall Study||1514
8556824|NCT03760146|9588647|FG001|STARTED|Overall Study||1495
8556825|NCT03760146|9588648|FG002|STARTED|Overall Study||334
8556826|NCT03760146|9588649|FG003|STARTED|Overall Study||111
8556827|NCT03760146|9588650|FG004|STARTED|Overall Study||336
9092870|NCT02628444|10157536|FG002|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
9092871|NCT02628444|10157537|FG003|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||145
9092872|NCT02628444|10157538|FG004|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||152
9092873|NCT02628444|10157539|FG005|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||157
9092874|NCT02628444|10157540|FG006|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||149
9092875|NCT02628444|10157541|FG007|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||152
9092876|NCT02628444|10157542|FG008|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||151
9092877|NCT02628444|10157534|FG000|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||0
9092878|NCT02628444|10157535|FG001|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||0
9092879|NCT02628444|10157536|FG002|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||0
9092880|NCT02628444|10157537|FG003|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||55
9092881|NCT02628444|10157538|FG004|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||59
9092882|NCT02628444|10157539|FG005|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||62
9092883|NCT02628444|10157540|FG006|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||53
9092884|NCT02628444|10157541|FG007|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||56
9092885|NCT02628444|10157542|FG008|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||53
9092886|NCT02628444|10157534|FG000|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
9092887|NCT02628444|10157535|FG001|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
9092888|NCT02628444|10157536|FG002|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
9092889|NCT02628444|10157537|FG003|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||55
9092890|NCT02628444|10157538|FG004|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||59
9092891|NCT02628444|10157539|FG005|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||62
9092892|NCT02628444|10157540|FG006|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||53
9092893|NCT02628444|10157541|FG007|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||54
9092894|NCT02628444|10157542|FG008|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||52
9092895|NCT02628444|10157534|FG000|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
9092896|NCT02628444|10157535|FG001|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
9092897|NCT02628444|10157536|FG002|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
9092898|NCT02628444|10157537|FG003|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||90
9092899|NCT02628444|10157538|FG004|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||93
9092900|NCT02628444|10157539|FG005|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||95
9092901|NCT02628444|10157540|FG006|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||96
9092902|NCT02628444|10157541|FG007|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||98
9092903|NCT02628444|10157542|FG008|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||99
9092904|NCT02623998|10157569|FG000|STARTED|Overall Study||50
9092905|NCT02623998|10157570|FG001|STARTED|Overall Study||52
9092906|NCT02623998|10157569|FG000|COMPLETED|Overall Study||48
9092907|NCT02623998|10157570|FG001|COMPLETED|Overall Study||51
9092908|NCT02623998|10157569|FG000|NOT COMPLETED|Overall Study||2
9092909|NCT02623998|10157570|FG001|NOT COMPLETED|Overall Study||1
9092910|NCT02623725|10157578|FG000|STARTED|Overall Study||187
9092911|NCT02623725|10157579|FG001|STARTED|Overall Study||64
8625438|NCT00507429|9664996|FG001|COMPLETED|Maintenance Phase||0
8625439|NCT00507429|9664995|FG000|NOT COMPLETED|Maintenance Phase||14
8625440|NCT00507429|9664996|FG001|NOT COMPLETED|Maintenance Phase||0
8629517|NCT00530803|9669282|FG001|STARTED|Overall Study||50
8629518|NCT00530803|9669281|FG000|COMPLETED|Overall Study||50
8629519|NCT00530803|9669282|FG001|COMPLETED|Overall Study||50
8629520|NCT00530803|9669281|FG000|NOT COMPLETED|Overall Study||0
8629521|NCT00530803|9669282|FG001|NOT COMPLETED|Overall Study||0
8629522|NCT00530816|9669291|FG000|STARTED|Overall Study||35
8629523|NCT00530816|9669292|FG001|STARTED|Overall Study||59
8629524|NCT00530816|9669293|FG002|STARTED|Overall Study||70
8629525|NCT00530816|9669291|FG000|COMPLETED|Overall Study||9
8629526|NCT00530816|9669292|FG001|COMPLETED|Overall Study||17
8629527|NCT00530816|9669293|FG002|COMPLETED|Overall Study||29
8629528|NCT00530816|9669291|FG000|NOT COMPLETED|Overall Study||26
8629529|NCT00530816|9669292|FG001|NOT COMPLETED|Overall Study||42
8629530|NCT00530816|9669293|FG002|NOT COMPLETED|Overall Study||41
8629531|NCT00530842|9669303|FG000|STARTED|Overall Study||172
8629532|NCT00530842|9669304|FG001|STARTED|Overall Study||172
8629533|NCT00530842|9669303|FG000|COMPLETED|Overall Study||149
8629534|NCT00530842|9669304|FG001|COMPLETED|Overall Study||151
8723538|NCT01023776|9771070|FG000|STARTED|Overall Study|Subjects received 2 dose of vaccine 0.1 ml in each nostril intra nasally 28 days apart|20
8723539|NCT01023776|9771070|FG000|COMPLETED|Overall Study||20
8844965|NCT01713582|9899469|FG005|COMPLETED|Overall Study||0
8844966|NCT01713582|9899470|FG006|COMPLETED|Overall Study||0
8844967|NCT01713582|9899471|FG007|COMPLETED|Overall Study||0
8844968|NCT01713582|9899472|FG008|COMPLETED|Overall Study||0
8844969|NCT01713582|9899473|FG009|COMPLETED|Overall Study||0
8844970|NCT01713582|9899474|FG010|COMPLETED|Overall Study||0
8844971|NCT01713582|9899475|FG011|COMPLETED|Overall Study||0
8844972|NCT01713582|9899476|FG012|COMPLETED|Overall Study||0
8844973|NCT01713582|9899477|FG013|COMPLETED|Overall Study||0
8629535|NCT00530842|9669303|FG000|NOT COMPLETED|Overall Study||23
8629536|NCT00530842|9669304|FG001|NOT COMPLETED|Overall Study||21
8629537|NCT00530842|9669303|FG000|STARTED|Period 1||172
8844974|NCT01713582|9899478|FG014|COMPLETED|Overall Study||0
8844975|NCT01713582|9899479|FG015|COMPLETED|Overall Study||0
8844976|NCT01713582|9899480|FG016|COMPLETED|Overall Study||0
8629538|NCT00530842|9669304|FG001|STARTED|Period 1||172
8629539|NCT00530842|9669303|FG000|COMPLETED|Period 1||158
9092912|NCT02623725|10157578|FG000|COMPLETED|Overall Study||171
9092913|NCT02623725|10157579|FG001|COMPLETED|Overall Study||58
9092914|NCT02623725|10157578|FG000|NOT COMPLETED|Overall Study||16
9092915|NCT02623725|10157579|FG001|NOT COMPLETED|Overall Study||6
9092916|NCT02608684|10157587|FG000|STARTED|Overall Study||21
9092917|NCT02608684|10157587|FG000|COMPLETED|Overall Study||18
9092918|NCT02608684|10157587|FG000|NOT COMPLETED|Overall Study||3
9092919|NCT02603887|10157591|FG000|STARTED|Stage 1||12
9092920|NCT02603887|10157591|FG000|Cycle 1|Stage 1||12
9092921|NCT02603887|10157591|FG000|Cycle 8|Stage 1||7
9092922|NCT02603887|10157591|FG000|COMPLETED|Stage 1||7
9092923|NCT02603887|10157591|FG000|NOT COMPLETED|Stage 1||5
9092924|NCT02603887|10157591|FG000|STARTED|Stage 2||1
9092925|NCT02603887|10157591|FG000|Cycle 1|Stage 2||1
9092926|NCT02603887|10157591|FG000|Cycle 8|Stage 2||0
9092927|NCT02603887|10157591|FG000|COMPLETED|Stage 2||0
9092928|NCT02603887|10157591|FG000|NOT COMPLETED|Stage 2||1
9092929|NCT02601209|10157602|FG000|STARTED|Initial Treatment (Up to 4 Months)|Pre-registered|4
9092930|NCT02601209|10157603|FG001|STARTED|Initial Treatment (Up to 4 Months)|Pre-registered|4
9092931|NCT02601209|10157604|FG002|STARTED|Initial Treatment (Up to 4 Months)|Pre-registered|4
9092932|NCT02601209|10157605|FG003|STARTED|Initial Treatment (Up to 4 Months)|Randomized|6
9092933|NCT02601209|10157606|FG004|STARTED|Initial Treatment (Up to 4 Months)|Randomized|13
9092934|NCT02601209|10157607|FG005|STARTED|Initial Treatment (Up to 4 Months)|Randomized|15
9092935|NCT02601209|10157608|FG006|STARTED|Initial Treatment (Up to 4 Months)|Randomized|56
9092936|NCT02601209|10157609|FG007|STARTED|Initial Treatment (Up to 4 Months)|Randomized|6
9092937|NCT02601209|10157610|FG008|STARTED|Initial Treatment (Up to 4 Months)|Randomized|43
9092938|NCT02601209|10157602|FG000|COMPLETED|Initial Treatment (Up to 4 Months)|Registered|3
9092939|NCT02601209|10157603|FG001|COMPLETED|Initial Treatment (Up to 4 Months)|Registered|3
9092940|NCT02601209|10157604|FG002|COMPLETED|Initial Treatment (Up to 4 Months)|Registered|3
9092941|NCT02601209|10157605|FG003|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|6
9092942|NCT02601209|10157606|FG004|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|12
9092943|NCT02601209|10157607|FG005|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|13
9092944|NCT02601209|10157608|FG006|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|55
9092945|NCT02601209|10157609|FG007|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|6
9092946|NCT02601209|10157610|FG008|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|43
9092947|NCT02601209|10157602|FG000|NOT COMPLETED|Initial Treatment (Up to 4 Months)||1
9092948|NCT02601209|10157603|FG001|NOT COMPLETED|Initial Treatment (Up to 4 Months)||1
9092949|NCT02601209|10157604|FG002|NOT COMPLETED|Initial Treatment (Up to 4 Months)||1
9092950|NCT02601209|10157605|FG003|NOT COMPLETED|Initial Treatment (Up to 4 Months)||0
9092951|NCT02601209|10157606|FG004|NOT COMPLETED|Initial Treatment (Up to 4 Months)||1
9092952|NCT02601209|10157607|FG005|NOT COMPLETED|Initial Treatment (Up to 4 Months)||2
9092953|NCT02601209|10157608|FG006|NOT COMPLETED|Initial Treatment (Up to 4 Months)||1
9092954|NCT02601209|10157609|FG007|NOT COMPLETED|Initial Treatment (Up to 4 Months)||0
9092955|NCT02601209|10157610|FG008|NOT COMPLETED|Initial Treatment (Up to 4 Months)||0
9092956|NCT02601209|10157602|FG000|STARTED|Optional Crossover (Up to 2 Months)||0
9092957|NCT02601209|10157603|FG001|STARTED|Optional Crossover (Up to 2 Months)||0
9092958|NCT02601209|10157604|FG002|STARTED|Optional Crossover (Up to 2 Months)||0
9092959|NCT02601209|10157605|FG003|STARTED|Optional Crossover (Up to 2 Months)||0
9092960|NCT02601209|10157606|FG004|STARTED|Optional Crossover (Up to 2 Months)||0
9092961|NCT02601209|10157607|FG005|STARTED|Optional Crossover (Up to 2 Months)||0
9092962|NCT02601209|10157608|FG006|STARTED|Optional Crossover (Up to 2 Months)||0
9092963|NCT02601209|10157609|FG007|STARTED|Optional Crossover (Up to 2 Months)|PD on pazopanib|6
9092964|NCT02601209|10157610|FG008|STARTED|Optional Crossover (Up to 2 Months)|PD on pazopanib|43
9092965|NCT02601209|10157602|FG000|COMPLETED|Optional Crossover (Up to 2 Months)||0
9092966|NCT02601209|10157603|FG001|COMPLETED|Optional Crossover (Up to 2 Months)||0
9092967|NCT02601209|10157604|FG002|COMPLETED|Optional Crossover (Up to 2 Months)||0
9092968|NCT02601209|10157605|FG003|COMPLETED|Optional Crossover (Up to 2 Months)||0
9092969|NCT02601209|10157606|FG004|COMPLETED|Optional Crossover (Up to 2 Months)||0
9092970|NCT02601209|10157607|FG005|COMPLETED|Optional Crossover (Up to 2 Months)||0
9092971|NCT02601209|10157608|FG006|COMPLETED|Optional Crossover (Up to 2 Months)||0
9092972|NCT02601209|10157609|FG007|COMPLETED|Optional Crossover (Up to 2 Months)|Initiated crossover to MLN0128 following PD on pazopanib|4
9092973|NCT02601209|10157610|FG008|COMPLETED|Optional Crossover (Up to 2 Months)|Initiated crossover to MLN0128 following PD on pazopanib|26
9092974|NCT02601209|10157602|FG000|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
9092975|NCT02601209|10157603|FG001|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
9092976|NCT02601209|10157604|FG002|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
9092977|NCT02601209|10157605|FG003|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
9092978|NCT02601209|10157606|FG004|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
9092979|NCT02601209|10157607|FG005|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
9092980|NCT02601209|10157608|FG006|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
9092981|NCT02601209|10157609|FG007|NOT COMPLETED|Optional Crossover (Up to 2 Months)||2
9092982|NCT02601209|10157610|FG008|NOT COMPLETED|Optional Crossover (Up to 2 Months)||17
9092983|NCT02587520|10157642|FG000|STARTED|Overall Study||80
9092984|NCT02587520|10157643|FG001|STARTED|Overall Study||71
9092985|NCT02587520|10157644|FG002|STARTED|Overall Study||78
9092986|NCT02587520|10157645|FG003|STARTED|Overall Study||79
9092987|NCT02587520|10157646|FG004|STARTED|Overall Study||75
9092988|NCT02587520|10157647|FG005|STARTED|Overall Study||75
9092989|NCT02587520|10157648|FG006|STARTED|Overall Study||76
9092990|NCT02587520|10157649|FG007|STARTED|Overall Study||73
9092991|NCT02587520|10157650|FG008|STARTED|Overall Study||76
9092992|NCT02587520|10157651|FG009|STARTED|Overall Study||76
9092993|NCT02587520|10157652|FG010|STARTED|Overall Study||76
9092994|NCT02587520|10157653|FG011|STARTED|Overall Study||73
9092995|NCT02587520|10157654|FG012|STARTED|Overall Study||77
9092996|NCT02587520|10157655|FG013|STARTED|Overall Study||74
9092997|NCT02587520|10157656|FG014|STARTED|Overall Study||78
9092998|NCT02587520|10157657|FG015|STARTED|Overall Study||72
9092999|NCT02587520|10157658|FG016|STARTED|Overall Study||76
9093000|NCT02587520|10157659|FG017|STARTED|Overall Study||78
9093001|NCT02587520|10157642|FG000|Safety Analysis Set (SafAS)|Overall Study||79
9093002|NCT02587520|10157643|FG001|Safety Analysis Set (SafAS)|Overall Study||71
9093003|NCT02587520|10157644|FG002|Safety Analysis Set (SafAS)|Overall Study||77
9093004|NCT02587520|10157645|FG003|Safety Analysis Set (SafAS)|Overall Study||77
9093005|NCT02587520|10157646|FG004|Safety Analysis Set (SafAS)|Overall Study||75
9093006|NCT02587520|10157647|FG005|Safety Analysis Set (SafAS)|Overall Study||75
9093007|NCT02587520|10157648|FG006|Safety Analysis Set (SafAS)|Overall Study||76
9093008|NCT02587520|10157649|FG007|Safety Analysis Set (SafAS)|Overall Study||73
9093009|NCT02587520|10157650|FG008|Safety Analysis Set (SafAS)|Overall Study||76
9093010|NCT02587520|10157651|FG009|Safety Analysis Set (SafAS)|Overall Study||76
9093011|NCT02587520|10157652|FG010|Safety Analysis Set (SafAS)|Overall Study||76
9093012|NCT02587520|10157653|FG011|Safety Analysis Set (SafAS)|Overall Study||72
9093013|NCT02587520|10157654|FG012|Safety Analysis Set (SafAS)|Overall Study||77
9093014|NCT02587520|10157655|FG013|Safety Analysis Set (SafAS)|Overall Study||73
9093015|NCT02587520|10157656|FG014|Safety Analysis Set (SafAS)|Overall Study||78
9093016|NCT02587520|10157657|FG015|Safety Analysis Set (SafAS)|Overall Study||72
9093017|NCT02587520|10157658|FG016|Safety Analysis Set (SafAS)|Overall Study||76
9093018|NCT02587520|10157659|FG017|Safety Analysis Set (SafAS)|Overall Study||78
9093019|NCT02587520|10157642|FG000|COMPLETED|Overall Study||78
9093020|NCT02587520|10157643|FG001|COMPLETED|Overall Study||69
9093021|NCT02587520|10157644|FG002|COMPLETED|Overall Study||77
9093022|NCT02587520|10157645|FG003|COMPLETED|Overall Study||74
9093023|NCT02587520|10157646|FG004|COMPLETED|Overall Study||75
9093024|NCT02587520|10157647|FG005|COMPLETED|Overall Study||72
9093025|NCT02587520|10157648|FG006|COMPLETED|Overall Study||73
9093026|NCT02587520|10157649|FG007|COMPLETED|Overall Study||71
9093027|NCT02587520|10157650|FG008|COMPLETED|Overall Study||73
9093028|NCT02587520|10157651|FG009|COMPLETED|Overall Study||71
9093029|NCT02587520|10157652|FG010|COMPLETED|Overall Study||73
9093030|NCT02587520|10157653|FG011|COMPLETED|Overall Study||69
9093031|NCT02587520|10157654|FG012|COMPLETED|Overall Study||77
9093032|NCT02587520|10157655|FG013|COMPLETED|Overall Study||73
9093033|NCT02587520|10157656|FG014|COMPLETED|Overall Study||78
9093034|NCT02587520|10157657|FG015|COMPLETED|Overall Study||72
9093035|NCT02587520|10157658|FG016|COMPLETED|Overall Study||76
9093036|NCT02587520|10157659|FG017|COMPLETED|Overall Study||78
9093037|NCT02587520|10157642|FG000|NOT COMPLETED|Overall Study||2
9093038|NCT02587520|10157643|FG001|NOT COMPLETED|Overall Study||2
9093039|NCT02587520|10157644|FG002|NOT COMPLETED|Overall Study||1
9093040|NCT02587520|10157645|FG003|NOT COMPLETED|Overall Study||5
9093041|NCT02587520|10157646|FG004|NOT COMPLETED|Overall Study||0
9093042|NCT02587520|10157647|FG005|NOT COMPLETED|Overall Study||3
9093043|NCT02587520|10157648|FG006|NOT COMPLETED|Overall Study||3
9093044|NCT02587520|10157649|FG007|NOT COMPLETED|Overall Study||2
9093045|NCT02587520|10157650|FG008|NOT COMPLETED|Overall Study||3
9093046|NCT02587520|10157651|FG009|NOT COMPLETED|Overall Study||5
9093047|NCT02587520|10157652|FG010|NOT COMPLETED|Overall Study||3
9093048|NCT02587520|10157653|FG011|NOT COMPLETED|Overall Study||4
9093049|NCT02587520|10157654|FG012|NOT COMPLETED|Overall Study||0
9093050|NCT02587520|10157655|FG013|NOT COMPLETED|Overall Study||1
9093051|NCT02587520|10157656|FG014|NOT COMPLETED|Overall Study||0
9093052|NCT02587520|10157657|FG015|NOT COMPLETED|Overall Study||0
9093053|NCT02587520|10157658|FG016|NOT COMPLETED|Overall Study||0
9093054|NCT02587520|10157659|FG017|NOT COMPLETED|Overall Study||0
9093055|NCT02584829|10157699|FG000|STARTED|Overall Study||1
9093056|NCT02584829|10157700|FG001|STARTED|Overall Study||7
9093057|NCT02584829|10157699|FG000|COMPLETED|Overall Study||0
9093058|NCT02584829|10157700|FG001|COMPLETED|Overall Study||3
9093059|NCT02584829|10157699|FG000|NOT COMPLETED|Overall Study||1
9093060|NCT02584829|10157700|FG001|NOT COMPLETED|Overall Study||4
9093061|NCT02570308|10157713|FG000|STARTED|Overall Study||3
9093062|NCT02570308|10157714|FG001|STARTED|Overall Study||6
9093063|NCT02570308|10157715|FG002|STARTED|Overall Study||4
9093064|NCT02570308|10157716|FG003|STARTED|Overall Study||6
9093065|NCT02570308|10157717|FG004|STARTED|Overall Study||127
9093066|NCT02570308|10157713|FG000|COMPLETED|Overall Study||2
9093067|NCT02570308|10157714|FG001|COMPLETED|Overall Study||1
9093068|NCT02570308|10157715|FG002|COMPLETED|Overall Study||0
9093069|NCT02570308|10157716|FG003|COMPLETED|Overall Study||2
9093070|NCT02570308|10157717|FG004|COMPLETED|Overall Study||53
9093071|NCT02570308|10157713|FG000|NOT COMPLETED|Overall Study||1
9093072|NCT02570308|10157714|FG001|NOT COMPLETED|Overall Study||5
9093073|NCT02570308|10157715|FG002|NOT COMPLETED|Overall Study||4
9093074|NCT02570308|10157716|FG003|NOT COMPLETED|Overall Study||4
9093075|NCT02570308|10157717|FG004|NOT COMPLETED|Overall Study||74
9093076|NCT02516241|10157738|FG000|STARTED|Overall Study||342
9093077|NCT02516241|10157739|FG001|STARTED|Overall Study||346
9093078|NCT02516241|10157740|FG002|STARTED|Overall Study||344
9093079|NCT02516241|10157738|FG000|Received Treatment|Overall Study||340
9093080|NCT02516241|10157739|FG001|Received Treatment|Overall Study||345
9093081|NCT02516241|10157740|FG002|Received Treatment|Overall Study||313
9093082|NCT02516241|10157738|FG000|COMPLETED|Overall Study||0
9093083|NCT02516241|10157739|FG001|COMPLETED|Overall Study||0
9093084|NCT02516241|10157740|FG002|COMPLETED|Overall Study||0
9093085|NCT02516241|10157738|FG000|NOT COMPLETED|Overall Study||342
9093086|NCT02516241|10157739|FG001|NOT COMPLETED|Overall Study||346
9093087|NCT02516241|10157740|FG002|NOT COMPLETED|Overall Study||344
9093088|NCT02514083|10157753|FG000|STARTED|Overall Study||29
9093089|NCT02514083|10157753|FG000|COMPLETED|Overall Study||28
9093090|NCT02514083|10157753|FG000|NOT COMPLETED|Overall Study||1
9093091|NCT02497612|10157761|FG000|STARTED|Overall Study||93
9093092|NCT02497612|10157762|FG001|STARTED|Overall Study||94
9093093|NCT02497612|10157763|FG002|STARTED|Overall Study||97
9093094|NCT02497612|10157764|FG003|STARTED|Overall Study||93
9093095|NCT02497612|10157761|FG000|Treated|Overall Study||92
9093096|NCT02497612|10157762|FG001|Treated|Overall Study||94
9093097|NCT02497612|10157763|FG002|Treated|Overall Study||96
9093098|NCT02497612|10157764|FG003|Treated|Overall Study||91
9093099|NCT02497612|10157761|FG000|Cohort 1: >14 Years to <70 Years|Overall Study||14
9093100|NCT02497612|10157762|FG001|Cohort 1: >14 Years to <70 Years|Overall Study||15
9093101|NCT02497612|10157763|FG002|Cohort 1: >14 Years to <70 Years|Overall Study||18
9093102|NCT02497612|10157764|FG003|Cohort 1: >14 Years to <70 Years|Overall Study||16
9093103|NCT02497612|10157761|FG000|Cohort 2: >5 Years to <=14 Years|Overall Study||6
9093104|NCT02497612|10157762|FG001|Cohort 2: >5 Years to <=14 Years|Overall Study||5
9093105|NCT02497612|10157763|FG002|Cohort 2: >5 Years to <=14 Years|Overall Study||6
9093106|NCT02497612|10157764|FG003|Cohort 2: >5 Years to <=14 Years|Overall Study||5
9093107|NCT02497612|10157761|FG000|Cohort 3: >2 Years to <=5 Years|Overall Study||66
9093108|NCT02497612|10157762|FG001|Cohort 3: >2 Years to <=5 Years|Overall Study||66
9093109|NCT02497612|10157763|FG002|Cohort 3: >2 Years to <=5 Years|Overall Study||67
9093110|NCT02497612|10157764|FG003|Cohort 3: >2 Years to <=5 Years|Overall Study||65
9093111|NCT02497612|10157761|FG000|Cohort 4: >6 Months to <=2 Years|Overall Study||7
9093112|NCT02497612|10157762|FG001|Cohort 4: >6 Months to <=2 Years|Overall Study||8
9093113|NCT02497612|10157763|FG002|Cohort 4: >6 Months to <=2 Years|Overall Study||6
9093114|NCT02497612|10157764|FG003|Cohort 4: >6 Months to <=2 Years|Overall Study||7
9093115|NCT02497612|10157761|FG000|COMPLETED|Overall Study||27
9093116|NCT02497612|10157762|FG001|COMPLETED|Overall Study||37
9093117|NCT02497612|10157763|FG002|COMPLETED|Overall Study||48
9093118|NCT02497612|10157764|FG003|COMPLETED|Overall Study||46
9093119|NCT02497612|10157761|FG000|NOT COMPLETED|Overall Study||66
9093120|NCT02497612|10157762|FG001|NOT COMPLETED|Overall Study||57
9093121|NCT02497612|10157763|FG002|NOT COMPLETED|Overall Study||49
9093122|NCT02497612|10157764|FG003|NOT COMPLETED|Overall Study||47
9093123|NCT02460458|10157774|FG000|STARTED|Retrospective Phase||265
9093124|NCT02460458|10157774|FG000|COMPLETED|Retrospective Phase||265
9093125|NCT02460458|10157774|FG000|NOT COMPLETED|Retrospective Phase||0
8625441|NCT00507442|9665008|FG000|STARTED|Overall Study||42
8625442|NCT00507442|9665009|FG001|STARTED|Overall Study||66
8625443|NCT00507442|9665010|FG002|STARTED|Overall Study||33
8625444|NCT00507442|9665011|FG003|STARTED|Overall Study||17
8625445|NCT00507442|9665008|FG000|COMPLETED|Overall Study||26
8625446|NCT00507442|9665009|FG001|COMPLETED|Overall Study||39
8625447|NCT00507442|9665010|FG002|COMPLETED|Overall Study||18
8625448|NCT00507442|9665011|FG003|COMPLETED|Overall Study||12
8625449|NCT00507442|9665008|FG000|NOT COMPLETED|Overall Study||16
8625450|NCT00507442|9665009|FG001|NOT COMPLETED|Overall Study||27
8625451|NCT00507442|9665010|FG002|NOT COMPLETED|Overall Study||15
8844977|NCT01713582|9899481|FG017|COMPLETED|Overall Study||0
8844978|NCT01713582|9899482|FG018|COMPLETED|Overall Study||0
8844979|NCT01713582|9899483|FG019|COMPLETED|Overall Study||0
8844980|NCT01713582|9899484|FG020|COMPLETED|Overall Study||0
8844981|NCT01713582|9899464|FG000|NOT COMPLETED|Overall Study||3
8844982|NCT01713582|9899465|FG001|NOT COMPLETED|Overall Study||3
8844983|NCT01713582|9899466|FG002|NOT COMPLETED|Overall Study||4
8844984|NCT01713582|9899467|FG003|NOT COMPLETED|Overall Study||3
8844985|NCT01713582|9899468|FG004|NOT COMPLETED|Overall Study||4
8844986|NCT01713582|9899469|FG005|NOT COMPLETED|Overall Study||8
8844987|NCT01713582|9899470|FG006|NOT COMPLETED|Overall Study||7
8844988|NCT01713582|9899471|FG007|NOT COMPLETED|Overall Study||6
8844989|NCT01713582|9899472|FG008|NOT COMPLETED|Overall Study||6
8844990|NCT01713582|9899473|FG009|NOT COMPLETED|Overall Study||18
8844991|NCT01713582|9899474|FG010|NOT COMPLETED|Overall Study||16
8625452|NCT00507442|9665011|FG003|NOT COMPLETED|Overall Study||5
8844992|NCT01713582|9899475|FG011|NOT COMPLETED|Overall Study||5
9093126|NCT02460458|10157774|FG000|STARTED|Confirmatory Phase||265
8625453|NCT00507455|9665028|FG000|STARTED|Overall Study||74
9093127|NCT02460458|10157774|FG000|COMPLETED|Confirmatory Phase||177
9093128|NCT02460458|10157774|FG000|NOT COMPLETED|Confirmatory Phase||88
9093129|NCT02460458|10157774|FG000|STARTED|First Prospective Phase||177
9093130|NCT02460458|10157774|FG000|COMPLETED|First Prospective Phase||161
9093131|NCT02460458|10157774|FG000|NOT COMPLETED|First Prospective Phase||16
9093132|NCT02460458|10157774|FG000|STARTED|Confirmation of Clinical Phase Data||161
9093133|NCT02460458|10157774|FG000|COMPLETED|Confirmation of Clinical Phase Data||152
8625454|NCT00507455|9665029|FG001|STARTED|Overall Study||74
9093134|NCT02460458|10157774|FG000|NOT COMPLETED|Confirmation of Clinical Phase Data||9
9093135|NCT02460458|10157774|FG000|STARTED|Second Prospective Phase||152
9093136|NCT02460458|10157774|FG000|COMPLETED|Second Prospective Phase|Information not available yet, anticipated date is december 2022|0
9093137|NCT02460458|10157774|FG000|NOT COMPLETED|Second Prospective Phase||152
9093138|NCT02457559|10157789|FG000|STARTED|Overall Study||2
9093139|NCT02457559|10157790|FG001|STARTED|Overall Study||3
9093140|NCT02457559|10157791|FG002|STARTED|Overall Study||7
9093141|NCT02457559|10157792|FG003|STARTED|Overall Study||2
9093142|NCT02457559|10157793|FG004|STARTED|Overall Study||1
9093143|NCT02457559|10157794|FG005|STARTED|Overall Study||2
9093144|NCT02457559|10157795|FG006|STARTED|Overall Study||2
9093145|NCT02457559|10157796|FG007|STARTED|Overall Study||1
9093146|NCT02457559|10157797|FG008|STARTED|Overall Study||3
9093147|NCT02457559|10157798|FG009|STARTED|Overall Study||4
9093148|NCT02457559|10157799|FG010|STARTED|Overall Study||2
9093149|NCT02457559|10157789|FG000|COMPLETED|Overall Study||0
9093150|NCT02457559|10157790|FG001|COMPLETED|Overall Study||0
9093151|NCT02457559|10157791|FG002|COMPLETED|Overall Study||0
9093152|NCT02457559|10157792|FG003|COMPLETED|Overall Study||2
9093153|NCT02457559|10157793|FG004|COMPLETED|Overall Study||0
9093154|NCT02457559|10157794|FG005|COMPLETED|Overall Study||0
9093155|NCT02457559|10157795|FG006|COMPLETED|Overall Study||0
9093156|NCT02457559|10157796|FG007|COMPLETED|Overall Study||1
9093157|NCT02457559|10157797|FG008|COMPLETED|Overall Study||0
9093158|NCT02457559|10157798|FG009|COMPLETED|Overall Study||0
9093159|NCT02457559|10157799|FG010|COMPLETED|Overall Study||0
9093160|NCT02457559|10157789|FG000|NOT COMPLETED|Overall Study||2
9093161|NCT02457559|10157790|FG001|NOT COMPLETED|Overall Study||3
9093162|NCT02457559|10157791|FG002|NOT COMPLETED|Overall Study||7
9093163|NCT02457559|10157792|FG003|NOT COMPLETED|Overall Study||0
9093164|NCT02457559|10157793|FG004|NOT COMPLETED|Overall Study||1
9093165|NCT02457559|10157794|FG005|NOT COMPLETED|Overall Study||2
9093166|NCT02457559|10157795|FG006|NOT COMPLETED|Overall Study||2
9093167|NCT02457559|10157796|FG007|NOT COMPLETED|Overall Study||0
9093168|NCT02457559|10157797|FG008|NOT COMPLETED|Overall Study||3
9093169|NCT02457559|10157798|FG009|NOT COMPLETED|Overall Study||4
9093170|NCT02457559|10157799|FG010|NOT COMPLETED|Overall Study||2
9093171|NCT02442349|10157837|FG000|STARTED|Overall Study||171
9093172|NCT02442349|10157837|FG000|COMPLETED|Overall Study||0
9093173|NCT02442349|10157837|FG000|NOT COMPLETED|Overall Study||171
9093174|NCT02434354|10157841|FG000|STARTED|Overall Study|Consented|33
9093175|NCT02434354|10157841|FG000|Post Consent Screening|Overall Study||30
9093176|NCT02434354|10157841|FG000|COMPLETED|Overall Study||30
9093177|NCT02434354|10157841|FG000|NOT COMPLETED|Overall Study||3
9093178|NCT02417974|10157847|FG000|STARTED|Overall Study||15
9093179|NCT02417974|10157848|FG001|STARTED|Overall Study||9
9093180|NCT02417974|10157847|FG000|COMPLETED|Overall Study||15
9093181|NCT02417974|10157848|FG001|COMPLETED|Overall Study||9
8844993|NCT01713582|9899476|FG012|NOT COMPLETED|Overall Study||3
8844994|NCT01713582|9899477|FG013|NOT COMPLETED|Overall Study||4
8844995|NCT01713582|9899478|FG014|NOT COMPLETED|Overall Study||7
8844996|NCT01713582|9899479|FG015|NOT COMPLETED|Overall Study||6
8844997|NCT01713582|9899480|FG016|NOT COMPLETED|Overall Study||7
8844998|NCT01713582|9899481|FG017|NOT COMPLETED|Overall Study||3
8844999|NCT01713582|9899482|FG018|NOT COMPLETED|Overall Study||5
8845000|NCT01713582|9899483|FG019|NOT COMPLETED|Overall Study||5
8845001|NCT01713582|9899484|FG020|NOT COMPLETED|Overall Study||15
8845002|NCT01713608|9899546|FG000|STARTED|Overall Study||8
8845003|NCT01713608|9899547|FG001|STARTED|Overall Study||6
8845004|NCT01713608|9899548|FG002|STARTED|Overall Study||8
8845005|NCT01713608|9899549|FG003|STARTED|Overall Study||12
8845006|NCT01713608|9899546|FG000|COMPLETED|Overall Study||8
8845007|NCT01713608|9899547|FG001|COMPLETED|Overall Study||6
8845008|NCT01713608|9899548|FG002|COMPLETED|Overall Study||8
8845009|NCT01713608|9899549|FG003|COMPLETED|Overall Study||12
8845010|NCT01713608|9899546|FG000|NOT COMPLETED|Overall Study||0
8845011|NCT01713608|9899547|FG001|NOT COMPLETED|Overall Study||0
8845012|NCT01713608|9899548|FG002|NOT COMPLETED|Overall Study||0
8845013|NCT01713608|9899549|FG003|NOT COMPLETED|Overall Study||0
8845014|NCT01713621|9899560|FG000|STARTED|Overall Study||8
8845015|NCT01713621|9899561|FG001|STARTED|Overall Study||17
8845016|NCT01713621|9899560|FG000|COMPLETED|Overall Study||1
8845017|NCT01713621|9899561|FG001|COMPLETED|Overall Study||1
8845018|NCT01713621|9899560|FG000|NOT COMPLETED|Overall Study||7
8845019|NCT01713621|9899561|FG001|NOT COMPLETED|Overall Study||16
8845020|NCT01713660|9899567|FG000|STARTED|Overall Study||37
8845021|NCT01713660|9899567|FG000|COMPLETED|Overall Study||37
8845022|NCT01713660|9899567|FG000|NOT COMPLETED|Overall Study||0
9093182|NCT02417974|10157847|FG000|NOT COMPLETED|Overall Study||0
9093183|NCT02417974|10157848|FG001|NOT COMPLETED|Overall Study||0
9093184|NCT02381652|10157857|FG000|STARTED|Overall Study|Cingal injection in 13-01 study; receiving a 2nd Cingal injection in 13-02|94
9093185|NCT02381652|10157858|FG001|STARTED|Overall Study|Monovisc injection in 13-01 study; receiving a Cingal injection in 13-02|98
9093186|NCT02381652|10157859|FG002|STARTED|Overall Study|Saline injection in 13-01 study; receiving a Cingal injection in 13-02|50
9093187|NCT02381652|10157857|FG000|COMPLETED|Overall Study||94
9093188|NCT02381652|10157858|FG001|COMPLETED|Overall Study||98
9093189|NCT02381652|10157859|FG002|COMPLETED|Overall Study||49
9093190|NCT02381652|10157857|FG000|NOT COMPLETED|Overall Study||0
9093191|NCT02381652|10157858|FG001|NOT COMPLETED|Overall Study||0
9093192|NCT02381652|10157859|FG002|NOT COMPLETED|Overall Study||1
9093193|NCT02367794|10157868|FG000|STARTED|Overall Study||340
9093194|NCT02367794|10157869|FG001|STARTED|Overall Study||343
9093195|NCT02367794|10157870|FG002|STARTED|Overall Study||338
9093196|NCT02367794|10157868|FG000|COMPLETED|Overall Study||0
9093197|NCT02367794|10157869|FG001|COMPLETED|Overall Study||0
9093198|NCT02367794|10157870|FG002|COMPLETED|Overall Study||0
9093199|NCT02367794|10157868|FG000|NOT COMPLETED|Overall Study||340
9093200|NCT02367794|10157869|FG001|NOT COMPLETED|Overall Study||343
9093201|NCT02367794|10157870|FG002|NOT COMPLETED|Overall Study||338
9093211|NCT02363998|10157901|FG000|STARTED|Overall Study||286
9093212|NCT02363998|10157901|FG000|COMPLETED|Overall Study|A subject was defined as completed if at least one dose was taken on Day 7.|168
9093213|NCT02363998|10157901|FG000|NOT COMPLETED|Overall Study||118
9093214|NCT02358031|10157924|FG000|STARTED|Overall Study||301
9093215|NCT02358031|10157925|FG001|STARTED|Overall Study||281
9093216|NCT02358031|10157926|FG002|STARTED|Overall Study||300
9093217|NCT02358031|10157924|FG000|Treated|Overall Study||300
9093218|NCT02358031|10157925|FG001|Treated|Overall Study||276
9093219|NCT02358031|10157926|FG002|Treated|Overall Study||287
9093220|NCT02358031|10157924|FG000|Pembro Mono v Control Efficacy Analyses|Overall Study||301
9093221|NCT02358031|10157925|FG001|Pembro Mono v Control Efficacy Analyses|Overall Study||0
9093222|NCT02358031|10157926|FG002|Pembro Mono v Control Efficacy Analyses|Overall Study||300
9093223|NCT02358031|10157924|FG000|Pembro Combo v Control Efficacy Analyses|Overall Study||0
9093224|NCT02358031|10157925|FG001|Pembro Combo v Control Efficacy Analyses|Overall Study||281
9093225|NCT02358031|10157926|FG002|Pembro Combo v Control Efficacy Analyses|Overall Study||278
9093226|NCT02358031|10157924|FG000|COMPLETED|Overall Study||0
9093227|NCT02358031|10157925|FG001|COMPLETED|Overall Study||0
9093228|NCT02358031|10157926|FG002|COMPLETED|Overall Study||0
9093229|NCT02358031|10157924|FG000|NOT COMPLETED|Overall Study||301
9093230|NCT02358031|10157925|FG001|NOT COMPLETED|Overall Study||281
9093231|NCT02358031|10157926|FG002|NOT COMPLETED|Overall Study||300
9093232|NCT02353832|10157934|FG000|STARTED|Overall Study||44
9093233|NCT02353832|10157934|FG000|COMPLETED|Overall Study||42
9093234|NCT02353832|10157934|FG000|NOT COMPLETED|Overall Study||2
9093235|NCT02353728|10157938|FG000|STARTED|Overall Study||16
9093236|NCT02353728|10157938|FG000|COMPLETED|Overall Study||15
9093237|NCT02353728|10157938|FG000|NOT COMPLETED|Overall Study||1
9093238|NCT02345070|10157945|FG000|STARTED|Overall Study||110
9093239|NCT02345070|10157946|FG001|STARTED|Overall Study||109
9093240|NCT02345070|10157947|FG002|STARTED|Overall Study||108
9093241|NCT02345070|10157945|FG000|Treated|Overall Study||109
9093242|NCT02345070|10157946|FG001|Treated|Overall Study||108
9093243|NCT02345070|10157947|FG002|Treated|Overall Study||108
9093244|NCT02345070|10157945|FG000|COMPLETED|Overall Study||90
9093245|NCT02345070|10157946|FG001|COMPLETED|Overall Study||98
9093246|NCT02345070|10157947|FG002|COMPLETED|Overall Study||85
9093247|NCT02345070|10157945|FG000|NOT COMPLETED|Overall Study||20
9093248|NCT02345070|10157946|FG001|NOT COMPLETED|Overall Study||11
9093249|NCT02345070|10157947|FG002|NOT COMPLETED|Overall Study||23
9093250|NCT02325466|10157955|FG000|STARTED|Period 1 Timeframe - Baseline to Week 4||23
9093251|NCT02325466|10157956|FG001|STARTED|Period 1 Timeframe - Baseline to Week 4||23
9093252|NCT02325466|10157957|FG002|STARTED|Period 1 Timeframe - Baseline to Week 4||24
9093253|NCT02325466|10157955|FG000|COMPLETED|Period 1 Timeframe - Baseline to Week 4||22
9093254|NCT02325466|10157956|FG001|COMPLETED|Period 1 Timeframe - Baseline to Week 4||21
9093255|NCT02325466|10157957|FG002|COMPLETED|Period 1 Timeframe - Baseline to Week 4||21
9093256|NCT02325466|10157955|FG000|NOT COMPLETED|Period 1 Timeframe - Baseline to Week 4||1
9093257|NCT02325466|10157956|FG001|NOT COMPLETED|Period 1 Timeframe - Baseline to Week 4||2
9093258|NCT02325466|10157957|FG002|NOT COMPLETED|Period 1 Timeframe - Baseline to Week 4||3
9093259|NCT02325466|10157955|FG000|STARTED|Period 2 - Timeframe Week 4 to Week 10||22
9093260|NCT02325466|10157956|FG001|STARTED|Period 2 - Timeframe Week 4 to Week 10||21
9093261|NCT02325466|10157957|FG002|STARTED|Period 2 - Timeframe Week 4 to Week 10||21
9093262|NCT02325466|10157955|FG000|COMPLETED|Period 2 - Timeframe Week 4 to Week 10||19
9093263|NCT02325466|10157956|FG001|COMPLETED|Period 2 - Timeframe Week 4 to Week 10||20
9093264|NCT02325466|10157957|FG002|COMPLETED|Period 2 - Timeframe Week 4 to Week 10||21
9093265|NCT02325466|10157955|FG000|NOT COMPLETED|Period 2 - Timeframe Week 4 to Week 10||3
9093266|NCT02325466|10157956|FG001|NOT COMPLETED|Period 2 - Timeframe Week 4 to Week 10||1
9093267|NCT02325466|10157957|FG002|NOT COMPLETED|Period 2 - Timeframe Week 4 to Week 10||0
8845023|NCT01713686|9899571|FG000|STARTED|Overall Study|129 enrolled, 125 treated. 2 withdrew consent prior to treatment; 2 excluded after enrollment.|125
8845024|NCT01713686|9899571|FG000|COMPLETED|Overall Study||110
8845025|NCT01713686|9899571|FG000|NOT COMPLETED|Overall Study||15
8845026|NCT01713868|9899579|FG000|STARTED|Overall Study||400
8845027|NCT01713868|9899580|FG001|STARTED|Overall Study||400
9093268|NCT02325466|10157955|FG000|STARTED|3rd Crossover - Week 10 to Week 16||19
9093269|NCT02325466|10157956|FG001|STARTED|3rd Crossover - Week 10 to Week 16||20
9093270|NCT02325466|10157957|FG002|STARTED|3rd Crossover - Week 10 to Week 16||21
9093271|NCT02325466|10157955|FG000|COMPLETED|3rd Crossover - Week 10 to Week 16||18
9093272|NCT02325466|10157956|FG001|COMPLETED|3rd Crossover - Week 10 to Week 16||18
9093273|NCT02325466|10157957|FG002|COMPLETED|3rd Crossover - Week 10 to Week 16||21
9093274|NCT02325466|10157955|FG000|NOT COMPLETED|3rd Crossover - Week 10 to Week 16||1
9093275|NCT02325466|10157956|FG001|NOT COMPLETED|3rd Crossover - Week 10 to Week 16||2
9093276|NCT02325466|10157957|FG002|NOT COMPLETED|3rd Crossover - Week 10 to Week 16||0
9093277|NCT02322710|10157968|FG000|STARTED|Overall Study||105
9093278|NCT02322710|10157969|FG001|STARTED|Overall Study||99
9093279|NCT02322710|10157968|FG000|Safety Population|Overall Study||105
9093280|NCT02322710|10157969|FG001|Safety Population|Overall Study||99
9093281|NCT02322710|10157968|FG000|Full Analysis Population|Overall Study||105
9093282|NCT02322710|10157969|FG001|Full Analysis Population|Overall Study||98
9093283|NCT02322710|10157968|FG000|COMPLETED|Overall Study||85
9093284|NCT02322710|10157969|FG001|COMPLETED|Overall Study||73
9093285|NCT02322710|10157968|FG000|NOT COMPLETED|Overall Study||20
9093286|NCT02322710|10157969|FG001|NOT COMPLETED|Overall Study||26
9093287|NCT02303548|10157977|FG000|STARTED|Overall Study||25
9093288|NCT02303548|10157978|FG001|STARTED|Overall Study||25
9093289|NCT02303548|10157977|FG000|COMPLETED|Overall Study||25
9093290|NCT02303548|10157978|FG001|COMPLETED|Overall Study||25
9093291|NCT02303548|10157977|FG000|NOT COMPLETED|Overall Study||0
9093292|NCT02303548|10157978|FG001|NOT COMPLETED|Overall Study||0
9093293|NCT02292654|10157987|FG000|STARTED|Overall Study||4
9093294|NCT02292654|10157988|FG001|STARTED|Overall Study||9
9093295|NCT02292654|10157989|FG002|STARTED|Overall Study||7
9093296|NCT02292654|10157987|FG000|COMPLETED|Overall Study||4
9093297|NCT02292654|10157988|FG001|COMPLETED|Overall Study||9
9093298|NCT02292654|10157989|FG002|COMPLETED|Overall Study||7
9093299|NCT02292654|10157987|FG000|NOT COMPLETED|Overall Study||0
9093300|NCT02292654|10157988|FG001|NOT COMPLETED|Overall Study||0
9093301|NCT02292654|10157989|FG002|NOT COMPLETED|Overall Study||0
9093302|NCT02251548|10158003|FG000|STARTED|Overall Study||85
9093303|NCT02251548|10158003|FG000|COMPLETED|Overall Study||0
9093304|NCT02251548|10158003|FG000|NOT COMPLETED|Overall Study||85
9093305|NCT02239354|10158010|FG000|STARTED|Overall Study||19
9093306|NCT02239354|10158011|FG001|STARTED|Overall Study||0
9093307|NCT02239354|10158010|FG000|COMPLETED|Overall Study||9
9093308|NCT02239354|10158011|FG001|COMPLETED|Overall Study||0
9093309|NCT02239354|10158010|FG000|NOT COMPLETED|Overall Study||10
9093310|NCT02239354|10158011|FG001|NOT COMPLETED|Overall Study||0
9093311|NCT02234310|10158017|FG000|STARTED|Overall Study||33
9093312|NCT02234310|10158017|FG000|Episodic Treatment Regimen|Overall Study|Participants were treated in more than one regimen and counted in all categories wherever applicable|22
9093313|NCT02234310|10158017|FG000|Prophylactic Treatment Regimen|Overall Study|17 participants among the 22 who started in episodic regimen, switched to the prophylactic regimen.|28
9093314|NCT02234310|10158017|FG000|COMPLETED|Overall Study||27
9093315|NCT02234310|10158017|FG000|NOT COMPLETED|Overall Study||6
9093316|NCT02212015|10158021|FG000|STARTED|Overall Study||26
9093317|NCT02212015|10158021|FG000|COMPLETED|Overall Study||25
9093318|NCT02212015|10158021|FG000|NOT COMPLETED|Overall Study||1
9093319|NCT02158091|10158031|FG000|STARTED|Overall Study||6
9093320|NCT02158091|10158032|FG001|STARTED|Overall Study||6
9093321|NCT02158091|10158033|FG002|STARTED|Overall Study||20
9093322|NCT02158091|10158031|FG000|COMPLETED|Overall Study||4
9093323|NCT02158091|10158032|FG001|COMPLETED|Overall Study||5
9093324|NCT02158091|10158033|FG002|COMPLETED|Overall Study||20
9093325|NCT02158091|10158031|FG000|NOT COMPLETED|Overall Study||2
9093326|NCT02158091|10158032|FG001|NOT COMPLETED|Overall Study||1
9093327|NCT02158091|10158033|FG002|NOT COMPLETED|Overall Study||0
9093328|NCT02139436|10158044|FG000|STARTED|Overall Study||41
9093329|NCT02139436|10158045|FG001|STARTED|Overall Study||14
9093330|NCT02139436|10158046|FG002|STARTED|Overall Study||13
9093331|NCT02139436|10158044|FG000|COMPLETED|Overall Study||41
9093332|NCT02139436|10158045|FG001|COMPLETED|Overall Study||14
9093333|NCT02139436|10158046|FG002|COMPLETED|Overall Study||13
9093334|NCT02139436|10158044|FG000|NOT COMPLETED|Overall Study||0
9093335|NCT02139436|10158045|FG001|NOT COMPLETED|Overall Study||0
9093336|NCT02139436|10158046|FG002|NOT COMPLETED|Overall Study||0
9093337|NCT02120079|10158062|FG000|STARTED|Baseline||17
9093338|NCT02120079|10158063|FG001|STARTED|Baseline||20
9093339|NCT02120079|10158062|FG000|COMPLETED|Baseline||17
9093340|NCT02120079|10158063|FG001|COMPLETED|Baseline||20
9093341|NCT02120079|10158062|FG000|NOT COMPLETED|Baseline||0
9093342|NCT02120079|10158063|FG001|NOT COMPLETED|Baseline||0
8845028|NCT01713868|9899581|FG002|STARTED|Overall Study||400
8845029|NCT01713868|9899582|FG003|STARTED|Overall Study||400
8845030|NCT01713868|9899579|FG000|COMPLETED|Overall Study||303
8845031|NCT01713868|9899580|FG001|COMPLETED|Overall Study||335
8845032|NCT01713868|9899581|FG002|COMPLETED|Overall Study||320
8845033|NCT01713868|9899582|FG003|COMPLETED|Overall Study||305
8845034|NCT01713868|9899579|FG000|NOT COMPLETED|Overall Study||97
8845035|NCT01713868|9899580|FG001|NOT COMPLETED|Overall Study||65
8845036|NCT01713868|9899581|FG002|NOT COMPLETED|Overall Study||80
8845037|NCT01713868|9899582|FG003|NOT COMPLETED|Overall Study||95
8845038|NCT01713933|9899594|FG000|STARTED|Overall Study||37
8845039|NCT01713933|9899594|FG000|COMPLETED|Overall Study||31
8845040|NCT01713933|9899594|FG000|NOT COMPLETED|Overall Study||6
8845041|NCT01713946|9899601|FG000|STARTED|Overall Study||117
8845042|NCT01713946|9899602|FG001|STARTED|Overall Study||130
8845043|NCT01713946|9899603|FG002|STARTED|Overall Study|Of the 119 patients initially randomized to the Placebo arm, 5 patients never switched to everolimus|119
8845044|NCT01713946|9899601|FG000|Completed Core Phase|Overall Study||110
8845045|NCT01713946|9899602|FG001|Completed Core Phase|Overall Study||122
8845046|NCT01713946|9899603|FG002|Completed Core Phase|Overall Study||114
8845047|NCT01713946|9899601|FG000|Continued in Ext. Phase|Overall Study||110
8845048|NCT01713946|9899602|FG001|Continued in Ext. Phase|Overall Study||119
8845049|NCT01713946|9899603|FG002|Continued in Ext. Phase|Overall Study||114
8845050|NCT01713946|9899601|FG000|Completed Ext. Phase|Overall Study||79
8845051|NCT01713946|9899602|FG001|Completed Ext. Phase|Overall Study||92
8845052|NCT01713946|9899603|FG002|Completed Ext. Phase|Overall Study||81
8845053|NCT01713946|9899601|FG000|Continued in Post-Ext. Phase|Overall Study||78
8845054|NCT01713946|9899602|FG001|Continued in Post-Ext. Phase|Overall Study||90
8845055|NCT01713946|9899603|FG002|Continued in Post-Ext. Phase|Overall Study||81
8845056|NCT01713946|9899601|FG000|Completed Post-Ext Phase|Overall Study||74
8845057|NCT01713946|9899602|FG001|Completed Post-Ext Phase|Overall Study||85
8845058|NCT01713946|9899603|FG002|Completed Post-Ext Phase|Overall Study||75
8845059|NCT01713946|9899601|FG000|Did Not Continue in Ext Phase|Overall Study||0
8845060|NCT01713946|9899602|FG001|Did Not Continue in Ext Phase|Overall Study||3
9093343|NCT02120079|10158062|FG000|STARTED|2 Weeks||17
9093344|NCT02120079|10158063|FG001|STARTED|2 Weeks||20
9093345|NCT02120079|10158062|FG000|COMPLETED|2 Weeks||17
9093346|NCT02120079|10158063|FG001|COMPLETED|2 Weeks||20
9093347|NCT02120079|10158062|FG000|NOT COMPLETED|2 Weeks||0
9093348|NCT02120079|10158063|FG001|NOT COMPLETED|2 Weeks||0
9093349|NCT02120079|10158062|FG000|STARTED|6 Weeks||17
9093350|NCT02120079|10158063|FG001|STARTED|6 Weeks||20
9093351|NCT02120079|10158062|FG000|COMPLETED|6 Weeks||17
9093352|NCT02120079|10158063|FG001|COMPLETED|6 Weeks||20
9093353|NCT02120079|10158062|FG000|NOT COMPLETED|6 Weeks||0
9093354|NCT02120079|10158063|FG001|NOT COMPLETED|6 Weeks||0
9093355|NCT02112526|10158072|FG000|STARTED|Overall Study||11
9093356|NCT02112526|10158073|FG001|STARTED|Overall Study||10
9093357|NCT02112526|10158072|FG000|Enrolled|Overall Study||11
9093358|NCT02112526|10158073|FG001|Enrolled|Overall Study||10
9093359|NCT02112526|10158072|FG000|Received Study Medication|Overall Study||11
9093360|NCT02112526|10158073|FG001|Received Study Medication|Overall Study||10
9093361|NCT02112526|10158072|FG000|Discontinued Study|Overall Study||11
9093362|NCT02112526|10158073|FG001|Discontinued Study|Overall Study||9
9093363|NCT02112526|10158072|FG000|Subjects Continuing Study Medication|Overall Study||0
9093364|NCT02112526|10158073|FG001|Subjects Continuing Study Medication|Overall Study||1
9093365|NCT02112526|10158072|FG000|COMPLETED|Overall Study||0
9093366|NCT02112526|10158073|FG001|COMPLETED|Overall Study||1
9093367|NCT02112526|10158072|FG000|NOT COMPLETED|Overall Study||11
9093368|NCT02112526|10158073|FG001|NOT COMPLETED|Overall Study||9
9093369|NCT02106195|10158079|FG000|STARTED|Overall Study||8
9093370|NCT02106195|10158079|FG000|COMPLETED|Overall Study|Includes all 3 periods of study: Screening, Treatment, Post-treatment|5
9093371|NCT02106195|10158079|FG000|NOT COMPLETED|Overall Study||3
8625455|NCT00507455|9665030|FG002|STARTED|Overall Study||74
8625456|NCT00507455|9665028|FG000|COMPLETED|Overall Study||62
8625457|NCT00507455|9665029|FG001|COMPLETED|Overall Study||68
8625458|NCT00507455|9665030|FG002|COMPLETED|Overall Study||62
8625459|NCT00507455|9665028|FG000|NOT COMPLETED|Overall Study||12
8625460|NCT00507455|9665029|FG001|NOT COMPLETED|Overall Study||6
9093372|NCT02104180|10158091|FG000|STARTED|Overall Study||31
9093373|NCT02104180|10158092|FG001|STARTED|Overall Study||31
9093374|NCT02104180|10158091|FG000|COMPLETED|Overall Study||30
9093375|NCT02104180|10158092|FG001|COMPLETED|Overall Study||31
9093376|NCT02104180|10158091|FG000|NOT COMPLETED|Overall Study||1
9093377|NCT02104180|10158092|FG001|NOT COMPLETED|Overall Study||0
9093378|NCT02075840|10158100|FG000|STARTED|Overall Study||152
9093379|NCT02075840|10158101|FG001|STARTED|Overall Study||151
9093380|NCT02075840|10158100|FG000|COMPLETED|Overall Study||0
9093381|NCT02075840|10158101|FG001|COMPLETED|Overall Study||0
9093382|NCT02075840|10158100|FG000|NOT COMPLETED|Overall Study||152
9093383|NCT02075840|10158101|FG001|NOT COMPLETED|Overall Study||151
9093384|NCT02066181|10158109|FG000|STARTED|Overall Study||50
9093385|NCT02066181|10158110|FG001|STARTED|Overall Study||37
9093386|NCT02066181|10158109|FG000|Crossed Over|Overall Study||0
9093387|NCT02066181|10158110|FG001|Crossed Over|Overall Study||28
9093388|NCT02066181|10158109|FG000|COMPLETED|Overall Study||49
9093389|NCT02066181|10158110|FG001|COMPLETED|Overall Study||36
9093390|NCT02066181|10158109|FG000|NOT COMPLETED|Overall Study||1
9093391|NCT02066181|10158110|FG001|NOT COMPLETED|Overall Study||1
9093392|NCT02050919|10158119|FG000|STARTED|Overall Study||20
9093393|NCT02050919|10158119|FG000|COMPLETED|Overall Study||20
9093394|NCT02050919|10158119|FG000|NOT COMPLETED|Overall Study||0
9093395|NCT02040857|10158123|FG000|STARTED|Overall Study||162
9093396|NCT02040857|10158123|FG000|Treatment Discontinuation Evaluable|Overall Study|Evaluable population excludes participants who discontinue early for reasons unrelated to treatment.|152
9093397|NCT02040857|10158123|FG000|COMPLETED|Overall Study||102
9093398|NCT02040857|10158123|FG000|NOT COMPLETED|Overall Study||60
9093399|NCT01997463|10158132|FG000|STARTED|Overall Study||192
9093400|NCT01997463|10158133|FG001|STARTED|Overall Study||250
9093401|NCT01997463|10158132|FG000|COMPLETED|Overall Study||107
9093402|NCT01997463|10158133|FG001|COMPLETED|Overall Study||147
9093403|NCT01997463|10158132|FG000|NOT COMPLETED|Overall Study||85
8625461|NCT00507455|9665030|FG002|NOT COMPLETED|Overall Study||12
8845061|NCT01713946|9899603|FG002|Did Not Continue in Ext Phase|Overall Study||0
8625462|NCT00507507|9665040|FG000|STARTED|Treatment Period||64
8625463|NCT00507507|9665041|FG001|STARTED|Treatment Period||62
8625464|NCT00507507|9665040|FG000|Completed 192 Weeks of Treatment|Treatment Period||52
8625465|NCT00507507|9665041|FG001|Completed 192 Weeks of Treatment|Treatment Period||52
8625466|NCT00507507|9665040|FG000|COMPLETED|Treatment Period||12
8625467|NCT00507507|9665041|FG001|COMPLETED|Treatment Period||9
8723540|NCT01023776|9771070|FG000|NOT COMPLETED|Overall Study||0
8723541|NCT01023789|9771074|FG000|STARTED|30-day Follow-up Visit|Intent-to-treat population (ITT).|812
8723542|NCT01023789|9771074|FG000|COMPLETED|30-day Follow-up Visit||812
8723543|NCT01023789|9771074|FG000|NOT COMPLETED|30-day Follow-up Visit||0
8723544|NCT01023789|9771074|FG000|STARTED|180-day Clinical Follow-up||812
8723545|NCT01023789|9771074|FG000|COMPLETED|180-day Clinical Follow-up||812
8723546|NCT01023789|9771074|FG000|NOT COMPLETED|180-day Clinical Follow-up||0
8723547|NCT01023789|9771074|FG000|STARTED|1 - Year Visit||812
8723548|NCT01023789|9771074|FG000|COMPLETED|1 - Year Visit||812
8845062|NCT01713946|9899601|FG000|Did Not Cont. in Post-Ext Phase|Overall Study||1
9093404|NCT01997463|10158133|FG001|NOT COMPLETED|Overall Study||103
9093405|NCT01943825|10158143|FG000|STARTED|Overall Study||25
8625468|NCT00507507|9665040|FG000|NOT COMPLETED|Treatment Period||52
8625469|NCT00507507|9665041|FG001|NOT COMPLETED|Treatment Period||53
8723549|NCT01023789|9771074|FG000|NOT COMPLETED|1 - Year Visit||0
8723550|NCT01023789|9771074|FG000|STARTED|2 - Year Visit||812
8723551|NCT01023789|9771074|FG000|COMPLETED|2 - Year Visit||812
8723552|NCT01023789|9771074|FG000|NOT COMPLETED|2 - Year Visit||0
8723553|NCT01023789|9771074|FG000|STARTED|3 - Year Visit||812
8723554|NCT01023789|9771074|FG000|COMPLETED|3 - Year Visit||769
8723555|NCT01023789|9771074|FG000|NOT COMPLETED|3 - Year Visit||43
8845063|NCT01713946|9899602|FG001|Did Not Cont. in Post-Ext Phase|Overall Study||2
8845064|NCT01713946|9899603|FG002|Did Not Cont. in Post-Ext Phase|Overall Study||0
8845065|NCT01713946|9899601|FG000|COMPLETED|Overall Study||74
8845066|NCT01713946|9899602|FG001|COMPLETED|Overall Study||85
8845067|NCT01713946|9899603|FG002|COMPLETED|Overall Study||75
8845068|NCT01713946|9899601|FG000|NOT COMPLETED|Overall Study||43
8845069|NCT01713946|9899602|FG001|NOT COMPLETED|Overall Study||45
8845070|NCT01713946|9899603|FG002|NOT COMPLETED|Overall Study||44
8845071|NCT01713998|9899632|FG000|STARTED|Overall Study||16
8845072|NCT01713998|9899633|FG001|STARTED|Overall Study||15
8845073|NCT01713998|9899634|FG002|STARTED|Overall Study||16
8845074|NCT01713998|9899632|FG000|COMPLETED|Overall Study||13
8845075|NCT01713998|9899633|FG001|COMPLETED|Overall Study||15
8845076|NCT01713998|9899634|FG002|COMPLETED|Overall Study||14
8845077|NCT01713998|9899632|FG000|NOT COMPLETED|Overall Study||3
8845078|NCT01713998|9899633|FG001|NOT COMPLETED|Overall Study||0
9093406|NCT01943825|10158144|FG001|STARTED|Overall Study||15
9093407|NCT01943825|10158145|FG002|STARTED|Overall Study||25
9093408|NCT01943825|10158146|FG003|STARTED|Overall Study||25
9093409|NCT01943825|10158143|FG000|COMPLETED|Overall Study||15
9093410|NCT01943825|10158144|FG001|COMPLETED|Overall Study||11
9093411|NCT01943825|10158145|FG002|COMPLETED|Overall Study||10
9093412|NCT01943825|10158146|FG003|COMPLETED|Overall Study||14
9093413|NCT01943825|10158143|FG000|NOT COMPLETED|Overall Study||10
9093414|NCT01943825|10158144|FG001|NOT COMPLETED|Overall Study||4
9093415|NCT01943825|10158145|FG002|NOT COMPLETED|Overall Study||15
9093416|NCT01943825|10158146|FG003|NOT COMPLETED|Overall Study||11
9093417|NCT01940471|10158162|FG000|STARTED|Double-Blind Phase||582
9093418|NCT01940471|10158163|FG001|STARTED|Double-Blind Phase||293
9093419|NCT01940471|10158162|FG000|COMPLETED|Double-Blind Phase||14
9093420|NCT01940471|10158163|FG001|COMPLETED|Double-Blind Phase||8
9093421|NCT01940471|10158162|FG000|NOT COMPLETED|Double-Blind Phase||568
9093422|NCT01940471|10158163|FG001|NOT COMPLETED|Double-Blind Phase||285
9093423|NCT01940471|10158162|FG000|STARTED|Open-Label Extension||14
9093424|NCT01940471|10158163|FG001|STARTED|Open-Label Extension||8
9093425|NCT01940471|10158162|FG000|COMPLETED|Open-Label Extension||0
9093426|NCT01940471|10158163|FG001|COMPLETED|Open-Label Extension||0
9093427|NCT01940471|10158162|FG000|NOT COMPLETED|Open-Label Extension||14
9093428|NCT01940471|10158163|FG001|NOT COMPLETED|Open-Label Extension||8
9093429|NCT01874353|10158172|FG000|STARTED|Overall Study||196
9093430|NCT01874353|10158173|FG001|STARTED|Overall Study||99
9093431|NCT01874353|10158174|FG002|STARTED|Overall Study||22
9093432|NCT01874353|10158175|FG003|STARTED|Overall Study||10
9093433|NCT01874353|10158172|FG000|COMPLETED|Overall Study||69
9093434|NCT01874353|10158173|FG001|COMPLETED|Overall Study||26
9093435|NCT01874353|10158174|FG002|COMPLETED|Overall Study||7
9093436|NCT01874353|10158175|FG003|COMPLETED|Overall Study||3
9093437|NCT01874353|10158172|FG000|NOT COMPLETED|Overall Study||127
9093438|NCT01874353|10158173|FG001|NOT COMPLETED|Overall Study||73
9093439|NCT01874353|10158174|FG002|NOT COMPLETED|Overall Study||15
9093440|NCT01874353|10158175|FG003|NOT COMPLETED|Overall Study||7
9093441|NCT01863186|10158190|FG000|STARTED|Double-blind Phase|Original number of 230. One participant was randomly assigned into the study, but not dosed.|229
9093442|NCT01863186|10158191|FG001|STARTED|Double-blind Phase||222
9093443|NCT01863186|10158192|FG002|STARTED|Double-blind Phase||151
9093444|NCT01863186|10158193|FG003|STARTED|Double-blind Phase||0
9093445|NCT01863186|10158190|FG000|COMPLETED|Double-blind Phase||95
9093446|NCT01863186|10158191|FG001|COMPLETED|Double-blind Phase||88
9093447|NCT01863186|10158192|FG002|COMPLETED|Double-blind Phase||42
9093448|NCT01863186|10158193|FG003|COMPLETED|Double-blind Phase||0
9093449|NCT01863186|10158190|FG000|NOT COMPLETED|Double-blind Phase||134
9093450|NCT01863186|10158191|FG001|NOT COMPLETED|Double-blind Phase||134
9093451|NCT01863186|10158192|FG002|NOT COMPLETED|Double-blind Phase||109
9093452|NCT01863186|10158193|FG003|NOT COMPLETED|Double-blind Phase||0
9093453|NCT01863186|10158190|FG000|STARTED|Open-label Phase||0
9093454|NCT01863186|10158191|FG001|STARTED|Open-label Phase||0
9093455|NCT01863186|10158192|FG002|STARTED|Open-label Phase|No placebo group in the Open-label Phase.|0
9093456|NCT01863186|10158193|FG003|STARTED|Open-label Phase|36 from 2.4 mg group, 28 from 3.2mg group, and 19 from Placebo continued to the Open-label phase.|83
9093457|NCT01863186|10158190|FG000|COMPLETED|Open-label Phase||0
9093458|NCT01863186|10158191|FG001|COMPLETED|Open-label Phase||0
9093459|NCT01863186|10158192|FG002|COMPLETED|Open-label Phase||0
9093460|NCT01863186|10158193|FG003|COMPLETED|Open-label Phase||70
9093461|NCT01863186|10158190|FG000|NOT COMPLETED|Open-label Phase||0
8723556|NCT01023815|9771082|FG000|STARTED|Pre-randomization Period (Day 1 to 90)|Out of 330 enrolled, 2 patients never received everolimus.|328
8845079|NCT01713998|9899634|FG002|NOT COMPLETED|Overall Study||2
8845080|NCT01714024|9899645|FG000|STARTED|Overall Study||13
8845081|NCT01714024|9899646|FG001|STARTED|Overall Study||18
9093462|NCT01863186|10158191|FG001|NOT COMPLETED|Open-label Phase||0
9093463|NCT01863186|10158192|FG002|NOT COMPLETED|Open-label Phase||0
9093464|NCT01863186|10158193|FG003|NOT COMPLETED|Open-label Phase||13
8845082|NCT01714024|9899647|FG002|STARTED|Overall Study||11
8845083|NCT01714024|9899645|FG000|COMPLETED|Overall Study||12
8845084|NCT01714024|9899646|FG001|COMPLETED|Overall Study||12
8845085|NCT01714024|9899647|FG002|COMPLETED|Overall Study||8
9093465|NCT01853748|10158204|FG000|STARTED|Allocation||384
9093466|NCT01853748|10158205|FG001|STARTED|Allocation||128
9093467|NCT01853748|10158204|FG000|COMPLETED|Allocation||383
9093468|NCT01853748|10158205|FG001|COMPLETED|Allocation||114
9093469|NCT01853748|10158204|FG000|NOT COMPLETED|Allocation||1
9093470|NCT01853748|10158205|FG001|NOT COMPLETED|Allocation||14
9093471|NCT01853748|10158204|FG000|STARTED|Follow-Up||383
9093472|NCT01853748|10158205|FG001|STARTED|Follow-Up||114
9093473|NCT01853748|10158204|FG000|COMPLETED|Follow-Up||293
9093474|NCT01853748|10158205|FG001|COMPLETED|Follow-Up||97
9093475|NCT01853748|10158204|FG000|NOT COMPLETED|Follow-Up||90
9093476|NCT01853748|10158205|FG001|NOT COMPLETED|Follow-Up||17
9093477|NCT01843374|10158222|FG000|STARTED|Overall Study||189
9093478|NCT01843374|10158223|FG001|STARTED|Overall Study||382
9093479|NCT01843374|10158222|FG000|RANDOMIZED|Overall Study||189
9093480|NCT01843374|10158223|FG001|RANDOMIZED|Overall Study||382
9093481|NCT01843374|10158222|FG000|COMPLETED|Overall Study||0
9093482|NCT01843374|10158223|FG001|COMPLETED|Overall Study||3
9093483|NCT01843374|10158222|FG000|NOT COMPLETED|Overall Study||189
9093484|NCT01843374|10158223|FG001|NOT COMPLETED|Overall Study||379
9093485|NCT01841736|10158234|FG000|STARTED|Overall Study||97
9093486|NCT01841736|10158235|FG001|STARTED|Overall Study||74
9093487|NCT01841736|10158234|FG000|Crossover|Overall Study||0
9093488|NCT01841736|10158235|FG001|Crossover|Overall Study||49
9093489|NCT01841736|10158234|FG000|COMPLETED|Overall Study||97
9093490|NCT01841736|10158235|FG001|COMPLETED|Overall Study||74
9093491|NCT01841736|10158234|FG000|NOT COMPLETED|Overall Study||0
9093492|NCT01841736|10158235|FG001|NOT COMPLETED|Overall Study||0
9093493|NCT01817751|10158242|FG000|STARTED|Overall Study||47
9093494|NCT01817751|10158242|FG000|COMPLETED|Overall Study||46
9093495|NCT01817751|10158242|FG000|NOT COMPLETED|Overall Study||1
9093496|NCT01722331|10158249|FG000|STARTED|Part 1||308
9093497|NCT01722331|10158250|FG001|STARTED|Part 1||249
9093498|NCT01722331|10158251|FG002|STARTED|Part 1||41
9093499|NCT01722331|10158252|FG003|STARTED|Part 1||19
9093500|NCT01722331|10158253|FG004|STARTED|Part 1||9
9093501|NCT01722331|10158254|FG005|STARTED|Part 1||72
9093502|NCT01722331|10158255|FG006|STARTED|Part 1||74
9093503|NCT01722331|10158249|FG000|COMPLETED|Part 1||298
9093504|NCT01722331|10158250|FG001|COMPLETED|Part 1||249
9093505|NCT01722331|10158251|FG002|COMPLETED|Part 1||32
9093506|NCT01722331|10158252|FG003|COMPLETED|Part 1||19
9093507|NCT01722331|10158253|FG004|COMPLETED|Part 1||0
9093508|NCT01722331|10158254|FG005|COMPLETED|Part 1||72
9093509|NCT01722331|10158255|FG006|COMPLETED|Part 1||74
9093510|NCT01722331|10158249|FG000|NOT COMPLETED|Part 1||10
9093511|NCT01722331|10158250|FG001|NOT COMPLETED|Part 1||0
9093512|NCT01722331|10158251|FG002|NOT COMPLETED|Part 1||9
9093513|NCT01722331|10158252|FG003|NOT COMPLETED|Part 1||0
9093514|NCT01722331|10158253|FG004|NOT COMPLETED|Part 1||9
9093515|NCT01722331|10158254|FG005|NOT COMPLETED|Part 1||0
9093516|NCT01722331|10158255|FG006|NOT COMPLETED|Part 1||0
9093517|NCT01722331|10158249|FG000|STARTED|Part 2||298
9093518|NCT01722331|10158250|FG001|STARTED|Part 2||249
9093519|NCT01722331|10158251|FG002|STARTED|Part 2|1 participant who completed Part 1 did not enter Part 2|31
9093520|NCT01722331|10158252|FG003|STARTED|Part 2||19
9093521|NCT01722331|10158253|FG004|STARTED|Part 2||0
9093522|NCT01722331|10158254|FG005|STARTED|Part 2||72
9093523|NCT01722331|10158255|FG006|STARTED|Part 2||74
9093524|NCT01722331|10158249|FG000|COMPLETED|Part 2||279
9093525|NCT01722331|10158250|FG001|COMPLETED|Part 2||249
9093526|NCT01722331|10158251|FG002|COMPLETED|Part 2||0
9093527|NCT01722331|10158252|FG003|COMPLETED|Part 2||19
9093528|NCT01722331|10158253|FG004|COMPLETED|Part 2||0
9093529|NCT01722331|10158254|FG005|COMPLETED|Part 2||62
9093530|NCT01722331|10158255|FG006|COMPLETED|Part 2||67
9093531|NCT01722331|10158249|FG000|NOT COMPLETED|Part 2||19
9093532|NCT01722331|10158250|FG001|NOT COMPLETED|Part 2||0
9093533|NCT01722331|10158251|FG002|NOT COMPLETED|Part 2||31
9093534|NCT01722331|10158252|FG003|NOT COMPLETED|Part 2||0
9093535|NCT01722331|10158253|FG004|NOT COMPLETED|Part 2||0
9093536|NCT01722331|10158254|FG005|NOT COMPLETED|Part 2||10
9093537|NCT01722331|10158255|FG006|NOT COMPLETED|Part 2||7
9093538|NCT01722331|10158249|FG000|STARTED|Part 3||279
9093539|NCT01722331|10158250|FG001|STARTED|Part 3||249
9093540|NCT01722331|10158251|FG002|STARTED|Part 3||0
9093541|NCT01722331|10158252|FG003|STARTED|Part 3||19
9093542|NCT01722331|10158253|FG004|STARTED|Part 3||0
9093543|NCT01722331|10158254|FG005|STARTED|Part 3||62
9093544|NCT01722331|10158255|FG006|STARTED|Part 3||67
9093545|NCT01722331|10158249|FG000|COMPLETED|Part 3||264
9093546|NCT01722331|10158250|FG001|COMPLETED|Part 3||232
9093547|NCT01722331|10158251|FG002|COMPLETED|Part 3||0
9093548|NCT01722331|10158252|FG003|COMPLETED|Part 3||18
9093549|NCT01722331|10158253|FG004|COMPLETED|Part 3||0
9093550|NCT01722331|10158254|FG005|COMPLETED|Part 3||59
9093551|NCT01722331|10158255|FG006|COMPLETED|Part 3||65
9093552|NCT01722331|10158249|FG000|NOT COMPLETED|Part 3||15
9093553|NCT01722331|10158250|FG001|NOT COMPLETED|Part 3||17
9093554|NCT01722331|10158251|FG002|NOT COMPLETED|Part 3||0
9093555|NCT01722331|10158252|FG003|NOT COMPLETED|Part 3||1
9093556|NCT01722331|10158253|FG004|NOT COMPLETED|Part 3||0
9093557|NCT01722331|10158254|FG005|NOT COMPLETED|Part 3||3
9093558|NCT01722331|10158255|FG006|NOT COMPLETED|Part 3||2
9093559|NCT01716117|10158269|FG000|STARTED|Overall Study||180
9093560|NCT01716117|10158270|FG001|STARTED|Overall Study||33
9093561|NCT01716117|10158269|FG000|Discharge|Overall Study||177
9093562|NCT01716117|10158270|FG001|Discharge|Overall Study||33
9093563|NCT01716117|10158269|FG000|1-Month Visit|Overall Study||176
9093564|NCT01716117|10158270|FG001|1-Month Visit|Overall Study||33
9093565|NCT01716117|10158269|FG000|6-Month Visit|Overall Study||174
9093566|NCT01716117|10158270|FG001|6-Month Visit|Overall Study||32
9093567|NCT01716117|10158269|FG000|COMPLETED|Overall Study||173
9093568|NCT01716117|10158270|FG001|COMPLETED|Overall Study||31
9093569|NCT01716117|10158269|FG000|NOT COMPLETED|Overall Study||7
9093570|NCT01716117|10158270|FG001|NOT COMPLETED|Overall Study||2
9093571|NCT01698905|10158284|FG000|STARTED|Overall Study||163
9093572|NCT01698905|10158284|FG000|Still on Study Phase|Overall Study||0
9093573|NCT01698905|10158284|FG000|TFR Phase|Overall Study||126
9093574|NCT01698905|10158284|FG000|NTRI Phase|Overall Study||51
9093575|NCT01698905|10158284|FG000|NTCT Phase|Overall Study||26
9093576|NCT01698905|10158284|FG000|TFR-2 Phase|Overall Study||2
9093577|NCT01698905|10158284|FG000|NTRI-2 Phase|Overall Study||1
9093578|NCT01698905|10158284|FG000|NTCT-P Phase Phase|Overall Study||6
9093579|NCT01698905|10158284|FG000|COMPLETED|Overall Study||152
9093580|NCT01698905|10158284|FG000|NOT COMPLETED|Overall Study||11
9093581|NCT01676350|10158297|FG000|STARTED|Overall Study||11
9093582|NCT01676350|10158298|FG001|STARTED|Overall Study||11
9093583|NCT01676350|10158297|FG000|COMPLETED|Overall Study||11
9093584|NCT01676350|10158298|FG001|COMPLETED|Overall Study||11
9093585|NCT01676350|10158297|FG000|NOT COMPLETED|Overall Study||0
9093586|NCT01676350|10158298|FG001|NOT COMPLETED|Overall Study||0
9093587|NCT01630590|10158305|FG000|STARTED|Overall Study||62
9093588|NCT01630590|10158305|FG000|COMPLETED|Overall Study||5
9093589|NCT01630590|10158305|FG000|NOT COMPLETED|Overall Study||57
9093590|NCT01619085|10158309|FG000|STARTED|Overall Study||752
9093591|NCT01619085|10158309|FG000|Treated|Overall Study||751
9093592|NCT01619085|10158309|FG000|COMPLETED|Overall Study||227
9093593|NCT01619085|10158309|FG000|NOT COMPLETED|Overall Study||525
9093594|NCT01499095|10158322|FG000|STARTED|Overall Study||404
9093595|NCT01499095|10158323|FG001|STARTED|Overall Study||407
9093596|NCT01499095|10158322|FG000|Treated|Overall Study||403
9093597|NCT01499095|10158323|FG001|Treated|Overall Study||406
9093598|NCT01499095|10158322|FG000|Participated in Substudy|Overall Study|45 participants received adaptable dosing regimen and 44 participants received fixed dosing regimen|89
9093599|NCT01499095|10158323|FG001|Participated in Substudy|Overall Study||0
9093600|NCT01499095|10158322|FG000|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|403
9093601|NCT01499095|10158323|FG001|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|405
9093602|NCT01499095|10158322|FG000|COMPLETED|Overall Study||315
9093603|NCT01499095|10158323|FG001|COMPLETED|Overall Study||314
9093604|NCT01499095|10158322|FG000|NOT COMPLETED|Overall Study||89
9093605|NCT01499095|10158323|FG001|NOT COMPLETED|Overall Study||93
9093606|NCT01499082|10158334|FG000|STARTED|Overall Study||404
9093607|NCT01499082|10158335|FG001|STARTED|Overall Study||403
9093608|NCT01499082|10158334|FG000|Treated|Overall Study||404
9093609|NCT01499082|10158335|FG001|Treated|Overall Study||402
9093610|NCT01499082|10158334|FG000|Participated in Substudy|Overall Study|56 participants received adaptable dosing regimen and 53 participants received fixed dosing regimen|109
9093611|NCT01499082|10158335|FG001|Participated in Substudy|Overall Study||0
9093612|NCT01499082|10158334|FG000|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|404
9093613|NCT01499082|10158335|FG001|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|400
9093614|NCT01499082|10158334|FG000|COMPLETED|Overall Study||359
9093615|NCT01499082|10158335|FG001|COMPLETED|Overall Study||355
9093616|NCT01499082|10158334|FG000|NOT COMPLETED|Overall Study||45
9093617|NCT01499082|10158335|FG001|NOT COMPLETED|Overall Study||48
9093618|NCT01496976|10158343|FG000|STARTED|Overall Study||45
9093619|NCT01496976|10158343|FG000|COMPLETED|Overall Study||44
9093620|NCT01496976|10158343|FG000|NOT COMPLETED|Overall Study||1
9093621|NCT01488890|10158351|FG000|STARTED|Overall Study||120
9093622|NCT01488890|10158352|FG001|STARTED|Overall Study||120
9093623|NCT01488890|10158353|FG002|STARTED|Overall Study||120
9093624|NCT01488890|10158354|FG003|STARTED|Overall Study||30
9093625|NCT01488890|10158351|FG000|Treated|Overall Study||120
9093626|NCT01488890|10158352|FG001|Treated|Overall Study||120
9093627|NCT01488890|10158353|FG002|Treated|Overall Study||119
9093628|NCT01488890|10158354|FG003|Treated|Overall Study||30
9093629|NCT01488890|10158351|FG000|COMPLETED|Overall Study||88
9093630|NCT01488890|10158352|FG001|COMPLETED|Overall Study||100
9093631|NCT01488890|10158353|FG002|COMPLETED|Overall Study||85
9093632|NCT01488890|10158354|FG003|COMPLETED|Overall Study||25
9093633|NCT01488890|10158351|FG000|NOT COMPLETED|Overall Study||32
9093634|NCT01488890|10158352|FG001|NOT COMPLETED|Overall Study||20
9093635|NCT01488890|10158353|FG002|NOT COMPLETED|Overall Study||35
9093636|NCT01488890|10158354|FG003|NOT COMPLETED|Overall Study||5
9093637|NCT01436396|10158370|FG000|STARTED|Overall Study||396
9093638|NCT01436396|10158371|FG001|STARTED|Overall Study||396
9093639|NCT01436396|10158370|FG000|Vaccinated|Overall Study||394
9093640|NCT01436396|10158371|FG001|Vaccinated|Overall Study||393
9093641|NCT01436396|10158370|FG000|COMPLETED|Overall Study||364
9093642|NCT01436396|10158371|FG001|COMPLETED|Overall Study||354
9093643|NCT01436396|10158370|FG000|NOT COMPLETED|Overall Study||32
9093644|NCT01436396|10158371|FG001|NOT COMPLETED|Overall Study||42
9093645|NCT01411241|10158379|FG000|STARTED|Overall Study||309
9093646|NCT01411241|10158380|FG001|STARTED|Overall Study||315
9093647|NCT01411241|10158379|FG000|COMPLETED|Overall Study||298
9093648|NCT01411241|10158380|FG001|COMPLETED|Overall Study||293
9093649|NCT01411241|10158379|FG000|NOT COMPLETED|Overall Study||11
9093650|NCT01411241|10158380|FG001|NOT COMPLETED|Overall Study||22
8845086|NCT01714024|9899645|FG000|NOT COMPLETED|Overall Study||1
8845087|NCT01714024|9899646|FG001|NOT COMPLETED|Overall Study||6
8845088|NCT01714024|9899647|FG002|NOT COMPLETED|Overall Study||3
8845089|NCT01714063|9899664|FG000|STARTED|Overall Study||34
8845090|NCT01714063|9899664|FG000|COMPLETED|Overall Study||32
8845091|NCT01714063|9899664|FG000|NOT COMPLETED|Overall Study||2
8845092|NCT01714232|9899672|FG000|STARTED|Overall Study||106
8845093|NCT01714232|9899672|FG000|COMPLETED|Overall Study||106
8845094|NCT01714232|9899672|FG000|NOT COMPLETED|Overall Study||0
8845095|NCT01714310|9899679|FG000|STARTED|Open Lisdexamfetamine Titration||0
8845096|NCT01714310|9899680|FG001|STARTED|Open Lisdexamfetamine Titration||0
8845097|NCT01714310|9899681|FG002|STARTED|Open Lisdexamfetamine Titration||34
8845098|NCT01714310|9899679|FG000|COMPLETED|Open Lisdexamfetamine Titration||0
8845099|NCT01714310|9899680|FG001|COMPLETED|Open Lisdexamfetamine Titration||0
8845100|NCT01714310|9899681|FG002|COMPLETED|Open Lisdexamfetamine Titration||30
8845101|NCT01714310|9899679|FG000|NOT COMPLETED|Open Lisdexamfetamine Titration||0
9093651|NCT01374516|10158388|FG000|STARTED|Vaccination Phase (Up to 25 Months)||13920
9093652|NCT01374516|10158389|FG001|STARTED|Vaccination Phase (Up to 25 Months)||6949
9093653|NCT01374516|10158388|FG000|COMPLETED|Vaccination Phase (Up to 25 Months)||13281
8845102|NCT01714310|9899680|FG001|NOT COMPLETED|Open Lisdexamfetamine Titration||0
8845103|NCT01714310|9899681|FG002|NOT COMPLETED|Open Lisdexamfetamine Titration||4
8845104|NCT01714310|9899679|FG000|STARTED|Double Blind Adjunctive Treatment|Adjunctive fluoxetine treatment was initiated at beginning of Period 2, at study week 4.|12
8850212|NCT01745952|9905472|FG002|STARTED|Overall Study||3
9093654|NCT01374516|10158389|FG001|COMPLETED|Vaccination Phase (Up to 25 Months)||6640
9093655|NCT01374516|10158388|FG000|NOT COMPLETED|Vaccination Phase (Up to 25 Months)||639
9093656|NCT01374516|10158389|FG001|NOT COMPLETED|Vaccination Phase (Up to 25 Months)||309
9093657|NCT01374516|10158388|FG000|STARTED|Surveillance Expansion Period||13281
9093658|NCT01374516|10158389|FG001|STARTED|Surveillance Expansion Period||6640
9093659|NCT01374516|10158388|FG000|COMPLETED|Surveillance Expansion Period||10932
9093660|NCT01374516|10158389|FG001|COMPLETED|Surveillance Expansion Period||5387
9093661|NCT01374516|10158388|FG000|NOT COMPLETED|Surveillance Expansion Period||2349
9093662|NCT01374516|10158389|FG001|NOT COMPLETED|Surveillance Expansion Period||1253
9093663|NCT01373281|10158404|FG000|STARTED|Vaccination Phase (Up to 25 Months)||6851
9093664|NCT01373281|10158405|FG001|STARTED|Vaccination Phase (Up to 25 Months)||3424
9093665|NCT01373281|10158404|FG000|COMPLETED|Vaccination Phase (Up to 25 Months)||6797
9093666|NCT01373281|10158405|FG001|COMPLETED|Vaccination Phase (Up to 25 Months)||3397
9093667|NCT01373281|10158404|FG000|NOT COMPLETED|Vaccination Phase (Up to 25 Months)||54
9093668|NCT01373281|10158405|FG001|NOT COMPLETED|Vaccination Phase (Up to 25 Months)||27
9093669|NCT01373281|10158404|FG000|STARTED|Surveillance Expansion Period||6797
9093670|NCT01373281|10158405|FG001|STARTED|Surveillance Expansion Period||3397
9093671|NCT01373281|10158404|FG000|COMPLETED|Surveillance Expansion Period||6595
9093672|NCT01373281|10158405|FG001|COMPLETED|Surveillance Expansion Period||3279
9093673|NCT01373281|10158404|FG000|NOT COMPLETED|Surveillance Expansion Period||202
9093674|NCT01373281|10158405|FG001|NOT COMPLETED|Surveillance Expansion Period||118
9093675|NCT01302847|10158426|FG000|STARTED|Overall Study||23
9093676|NCT01302847|10158427|FG001|STARTED|Overall Study||23
9093677|NCT01302847|10158428|FG002|STARTED|Overall Study||17
9093678|NCT01302847|10158429|FG003|STARTED|Overall Study||15
9093679|NCT01302847|10158430|FG004|STARTED|Overall Study||7
9093680|NCT01302847|10158431|FG005|STARTED|Overall Study||36
9093681|NCT01302847|10158432|FG006|STARTED|Overall Study||35
9093682|NCT01302847|10158433|FG007|STARTED|Overall Study||25
9093683|NCT01302847|10158426|FG000|COMPLETED|Overall Study||10
9093684|NCT01302847|10158427|FG001|COMPLETED|Overall Study||16
9093685|NCT01302847|10158428|FG002|COMPLETED|Overall Study||15
9093686|NCT01302847|10158429|FG003|COMPLETED|Overall Study||14
9093687|NCT01302847|10158430|FG004|COMPLETED|Overall Study||5
9093688|NCT01302847|10158431|FG005|COMPLETED|Overall Study||6
9093689|NCT01302847|10158432|FG006|COMPLETED|Overall Study||9
9093690|NCT01302847|10158433|FG007|COMPLETED|Overall Study||3
9093691|NCT01302847|10158426|FG000|NOT COMPLETED|Overall Study||13
9093692|NCT01302847|10158427|FG001|NOT COMPLETED|Overall Study||7
9093693|NCT01302847|10158428|FG002|NOT COMPLETED|Overall Study||2
9093694|NCT01302847|10158429|FG003|NOT COMPLETED|Overall Study||1
9093695|NCT01302847|10158430|FG004|NOT COMPLETED|Overall Study||2
9093696|NCT01302847|10158431|FG005|NOT COMPLETED|Overall Study||30
9093697|NCT01302847|10158432|FG006|NOT COMPLETED|Overall Study||26
9093698|NCT01302847|10158433|FG007|NOT COMPLETED|Overall Study||22
9093699|NCT01287611|10158462|FG000|STARTED|Overall Study||84
9093700|NCT01287611|10158463|FG001|STARTED|Overall Study||84
9093701|NCT01287611|10158462|FG000|The Number of Patients Who Underwent C/S|Overall Study||84
9093702|NCT01287611|10158463|FG001|The Number of Patients Who Underwent C/S|Overall Study||84
9093703|NCT01287611|10158462|FG000|COMPLETED|Overall Study||51
9093704|NCT01287611|10158463|FG001|COMPLETED|Overall Study||65
9093705|NCT01287611|10158462|FG000|NOT COMPLETED|Overall Study||33
9093706|NCT01287611|10158463|FG001|NOT COMPLETED|Overall Study||19
9093713|NCT01254422|10158482|FG000|STARTED|Overall Study||199
9093714|NCT01254422|10158483|FG001|STARTED|Overall Study||51
9093715|NCT01254422|10158482|FG000|COMPLETED|Overall Study||196
9093716|NCT01254422|10158483|FG001|COMPLETED|Overall Study||50
9093717|NCT01254422|10158482|FG000|NOT COMPLETED|Overall Study||3
9093718|NCT01254422|10158483|FG001|NOT COMPLETED|Overall Study||1
9093719|NCT01187433|10158491|FG000|STARTED|Overall Study||100
9093720|NCT01187433|10158492|FG001|STARTED|Overall Study||50
9093721|NCT01187433|10158491|FG000|COMPLETED|Overall Study||89
9093722|NCT01187433|10158492|FG001|COMPLETED|Overall Study||46
9093723|NCT01187433|10158491|FG000|NOT COMPLETED|Overall Study||11
9093724|NCT01187433|10158492|FG001|NOT COMPLETED|Overall Study||4
9093725|NCT01150045|10158502|FG000|STARTED|Overall Study||615
9093726|NCT01150045|10158503|FG001|STARTED|Overall Study||647
9093727|NCT01150045|10158504|FG002|STARTED|Overall Study||646
9093728|NCT01150045|10158505|FG003|STARTED|Overall Study||618
9093729|NCT01150045|10158502|FG000|COMPLETED|Overall Study||615
9093730|NCT01150045|10158503|FG001|COMPLETED|Overall Study||646
9093731|NCT01150045|10158504|FG002|COMPLETED|Overall Study||646
9093732|NCT01150045|10158505|FG003|COMPLETED|Overall Study||617
9093733|NCT01150045|10158502|FG000|NOT COMPLETED|Overall Study||0
9093734|NCT01150045|10158503|FG001|NOT COMPLETED|Overall Study||1
9093735|NCT01150045|10158504|FG002|NOT COMPLETED|Overall Study||0
9093736|NCT01150045|10158505|FG003|NOT COMPLETED|Overall Study||1
9093737|NCT01098032|10158515|FG000|STARTED|Overall Study|1 patient di not receive the treatment. Therefore this patient was excluded from the analysis.|147
9093738|NCT01098032|10158516|FG001|STARTED|Overall Study|1 patient di not receive the treatment. Therefore this patient was excluded from the analysis.|147
9093739|NCT01098032|10158515|FG000|COMPLETED|Overall Study||146
9093740|NCT01098032|10158516|FG001|COMPLETED|Overall Study||146
9093741|NCT01098032|10158515|FG000|NOT COMPLETED|Overall Study||1
9093742|NCT01098032|10158516|FG001|NOT COMPLETED|Overall Study||1
9093743|NCT01034306|10158524|FG000|STARTED|Overall Study||42
9093744|NCT01034306|10158525|FG001|STARTED|Overall Study||37
9093745|NCT01034306|10158524|FG000|COMPLETED|Overall Study||37
9093746|NCT01034306|10158525|FG001|COMPLETED|Overall Study||34
9093747|NCT01034306|10158524|FG000|NOT COMPLETED|Overall Study||5
9093748|NCT01034306|10158525|FG001|NOT COMPLETED|Overall Study||3
9093749|NCT01005745|10158531|FG000|STARTED|Overall Study||19
9093750|NCT01005745|10158531|FG000|COMPLETED|Overall Study||13
9093751|NCT01005745|10158531|FG000|NOT COMPLETED|Overall Study||6
9093752|NCT00993447|10158537|FG000|STARTED|Overall Study||401
9093753|NCT00993447|10158538|FG001|STARTED|Overall Study||199
9093754|NCT00993447|10158537|FG000|COMPLETED|Overall Study||364
9093755|NCT00993447|10158538|FG001|COMPLETED|Overall Study||180
9093756|NCT00993447|10158537|FG000|NOT COMPLETED|Overall Study||37
9093757|NCT00993447|10158538|FG001|NOT COMPLETED|Overall Study||19
9093758|NCT00945009|10158547|FG000|STARTED|Overall Study||201
9093759|NCT00945009|10158548|FG001|STARTED|Overall Study||39
9093760|NCT00945009|10158549|FG002|STARTED|Overall Study||9
9093761|NCT00945009|10158547|FG000|COMPLETED|Overall Study||156
9093762|NCT00945009|10158548|FG001|COMPLETED|Overall Study||32
9093763|NCT00945009|10158549|FG002|COMPLETED|Overall Study||6
9093764|NCT00945009|10158547|FG000|NOT COMPLETED|Overall Study||45
9093765|NCT00945009|10158548|FG001|NOT COMPLETED|Overall Study||7
9093766|NCT00945009|10158549|FG002|NOT COMPLETED|Overall Study||3
9093767|NCT00942877|10158559|FG000|STARTED|Overall Study||46
9093768|NCT00942877|10158560|FG001|STARTED|Overall Study||7
9093769|NCT00942877|10158559|FG000|COMPLETED|Overall Study||1
9093770|NCT00942877|10158560|FG001|COMPLETED|Overall Study||3
9093771|NCT00942877|10158559|FG000|NOT COMPLETED|Overall Study||45
9093772|NCT00942877|10158560|FG001|NOT COMPLETED|Overall Study||4
9093773|NCT00896389|10158567|FG000|STARTED|Salt Loading||124
9093774|NCT00896389|10158567|FG000|COMPLETED|Salt Loading||124
9093775|NCT00896389|10158567|FG000|NOT COMPLETED|Salt Loading||0
9093776|NCT00896389|10158567|FG000|STARTED|HCTZ Low Dose|Only subjects with SBP > 120 mmHg and agreeable to the HCTZ protocol continued to the next period.|28
9093777|NCT00896389|10158567|FG000|COMPLETED|HCTZ Low Dose||28
9093778|NCT00896389|10158567|FG000|NOT COMPLETED|HCTZ Low Dose||0
9093779|NCT00896389|10158567|FG000|STARTED|HCTZ High Dose||25
9093780|NCT00896389|10158567|FG000|COMPLETED|HCTZ High Dose||25
9093781|NCT00896389|10158567|FG000|NOT COMPLETED|HCTZ High Dose||0
9093782|NCT00880893|10158575|FG000|STARTED|Overall Study||898
9093783|NCT00880893|10158576|FG001|STARTED|Overall Study||300
9093784|NCT00880893|10158575|FG000|COMPLETED|Overall Study||791
9093785|NCT00880893|10158576|FG001|COMPLETED|Overall Study||255
9093786|NCT00880893|10158575|FG000|NOT COMPLETED|Overall Study||107
9093787|NCT00880893|10158576|FG001|NOT COMPLETED|Overall Study||45
8845105|NCT01714310|9899680|FG001|STARTED|Double Blind Adjunctive Treatment|Adjunctive placebo was initiated at beginning of Period 2, at study week 4.|14
8845106|NCT01714310|9899681|FG002|STARTED|Double Blind Adjunctive Treatment|No one remained on lisdexamfetamine alone in Period 2.|0
8845107|NCT01714310|9899679|FG000|COMPLETED|Double Blind Adjunctive Treatment||10
8845108|NCT01714310|9899680|FG001|COMPLETED|Double Blind Adjunctive Treatment||11
8845109|NCT01714310|9899681|FG002|COMPLETED|Double Blind Adjunctive Treatment||0
8845110|NCT01714310|9899679|FG000|NOT COMPLETED|Double Blind Adjunctive Treatment||2
8845111|NCT01714310|9899680|FG001|NOT COMPLETED|Double Blind Adjunctive Treatment||3
8845112|NCT01714310|9899681|FG002|NOT COMPLETED|Double Blind Adjunctive Treatment||0
8845113|NCT01714323|9899701|FG000|STARTED|Overall Study||677
8845114|NCT01714323|9899702|FG001|STARTED|Overall Study||680
8845115|NCT01714323|9899701|FG000|COMPLETED|Overall Study||513
8845116|NCT01714323|9899702|FG001|COMPLETED|Overall Study||508
8845117|NCT01714323|9899701|FG000|NOT COMPLETED|Overall Study||164
8845118|NCT01714323|9899702|FG001|NOT COMPLETED|Overall Study||172
8845119|NCT01714336|9899710|FG000|STARTED|Overall Study||69
8845120|NCT01714336|9899711|FG001|STARTED|Overall Study||69
8845121|NCT01714336|9899710|FG000|COMPLETED|Overall Study||69
8845122|NCT01714336|9899711|FG001|COMPLETED|Overall Study||69
8845123|NCT01714336|9899710|FG000|NOT COMPLETED|Overall Study||0
8845124|NCT01714336|9899711|FG001|NOT COMPLETED|Overall Study||0
8845125|NCT01714492|9899717|FG000|STARTED|Overall Study||8
8845126|NCT01714492|9899717|FG000|COMPLETED|Overall Study||8
8845127|NCT01714492|9899717|FG000|NOT COMPLETED|Overall Study||0
8845128|NCT01714505|9899722|FG000|STARTED|Admission 1 (40 Hours)||10
8845129|NCT01714505|9899723|FG001|STARTED|Admission 1 (40 Hours)||10
9093788|NCT00866918|10158584|FG000|STARTED|Overall Study||69
9093789|NCT00866918|10158585|FG001|STARTED|Overall Study||39
9093790|NCT00866918|10158584|FG000|COMPLETED|Overall Study||53
9093791|NCT00866918|10158585|FG001|COMPLETED|Overall Study||27
9093792|NCT00866918|10158584|FG000|NOT COMPLETED|Overall Study||16
9093793|NCT00866918|10158585|FG001|NOT COMPLETED|Overall Study||12
9093794|NCT00753545|10158593|FG000|STARTED|Overall Study|Patients randomized|136
9093795|NCT00753545|10158594|FG001|STARTED|Overall Study|Patients randomized|129
8845130|NCT01714505|9899722|FG000|COMPLETED|Admission 1 (40 Hours)||9
8845131|NCT01714505|9899723|FG001|COMPLETED|Admission 1 (40 Hours)||9
9093796|NCT00753545|10158593|FG000|COMPLETED|Overall Study|Patients completing the Study|28
9093797|NCT00753545|10158594|FG001|COMPLETED|Overall Study|Patients completing the Study|11
9093798|NCT00753545|10158593|FG000|NOT COMPLETED|Overall Study||108
9093799|NCT00753545|10158594|FG001|NOT COMPLETED|Overall Study||118
9093810|NCT00587301|10158609|FG000|STARTED|Overall Study||119
9093811|NCT00587301|10158609|FG000|COMPLETED|Overall Study||74
9093812|NCT00587301|10158609|FG000|NOT COMPLETED|Overall Study||45
9093813|NCT00579527|10158613|FG000|STARTED|Overall Study||14
9093814|NCT00579527|10158613|FG000|COMPLETED|Overall Study||10
9093815|NCT00579527|10158613|FG000|NOT COMPLETED|Overall Study||4
9093816|NCT00576836|10158618|FG000|STARTED|Overall Study||0
9093817|NCT00576836|10158619|FG001|STARTED|Overall Study||7
9093818|NCT00576836|10158618|FG000|COMPLETED|Overall Study||0
9093819|NCT00576836|10158619|FG001|COMPLETED|Overall Study||5
9093820|NCT00576836|10158618|FG000|NOT COMPLETED|Overall Study||0
9093821|NCT00576836|10158619|FG001|NOT COMPLETED|Overall Study||2
9093822|NCT00576407|10158623|FG000|STARTED|Overall Study||26
9093823|NCT00576407|10158623|FG000|COMPLETED|Overall Study||18
9093824|NCT00576407|10158623|FG000|NOT COMPLETED|Overall Study||8
9093825|NCT00557193|10158628|FG000|STARTED|Induction||218
9093826|NCT00557193|10158629|FG001|STARTED|Induction||0
9093827|NCT00557193|10158630|FG002|STARTED|Induction||0
9093828|NCT00557193|10158631|FG003|STARTED|Induction||0
9093829|NCT00557193|10158632|FG004|STARTED|Induction||0
9093830|NCT00557193|10158633|FG005|STARTED|Induction||0
9093831|NCT00557193|10158628|FG000|COMPLETED|Induction||192
9093832|NCT00557193|10158629|FG001|COMPLETED|Induction||0
9093833|NCT00557193|10158630|FG002|COMPLETED|Induction||0
9093834|NCT00557193|10158631|FG003|COMPLETED|Induction||0
9093835|NCT00557193|10158632|FG004|COMPLETED|Induction||0
9093836|NCT00557193|10158633|FG005|COMPLETED|Induction||0
9093837|NCT00557193|10158628|FG000|NOT COMPLETED|Induction||26
9093838|NCT00557193|10158629|FG001|NOT COMPLETED|Induction||0
9093839|NCT00557193|10158630|FG002|NOT COMPLETED|Induction||0
9093840|NCT00557193|10158631|FG003|NOT COMPLETED|Induction||0
9093841|NCT00557193|10158632|FG004|NOT COMPLETED|Induction||0
9093842|NCT00557193|10158633|FG005|NOT COMPLETED|Induction||0
9093843|NCT00557193|10158628|FG000|STARTED|Post Induction Therapy by Tx Assignment||0
9093844|NCT00557193|10158629|FG001|STARTED|Post Induction Therapy by Tx Assignment||60
9093845|NCT00557193|10158630|FG002|STARTED|Post Induction Therapy by Tx Assignment||54
9093846|NCT00557193|10158631|FG003|STARTED|Post Induction Therapy by Tx Assignment||11
9093847|NCT00557193|10158632|FG004|STARTED|Post Induction Therapy by Tx Assignment||11
9093848|NCT00557193|10158633|FG005|STARTED|Post Induction Therapy by Tx Assignment||56
9093849|NCT00557193|10158628|FG000|COMPLETED|Post Induction Therapy by Tx Assignment||0
9093850|NCT00557193|10158629|FG001|COMPLETED|Post Induction Therapy by Tx Assignment||50
9093851|NCT00557193|10158630|FG002|COMPLETED|Post Induction Therapy by Tx Assignment||22
9093852|NCT00557193|10158631|FG003|COMPLETED|Post Induction Therapy by Tx Assignment||4
9093853|NCT00557193|10158632|FG004|COMPLETED|Post Induction Therapy by Tx Assignment||4
9093854|NCT00557193|10158633|FG005|COMPLETED|Post Induction Therapy by Tx Assignment||19
9093855|NCT00557193|10158628|FG000|NOT COMPLETED|Post Induction Therapy by Tx Assignment||0
9093856|NCT00557193|10158629|FG001|NOT COMPLETED|Post Induction Therapy by Tx Assignment||10
9093857|NCT00557193|10158630|FG002|NOT COMPLETED|Post Induction Therapy by Tx Assignment||32
9093858|NCT00557193|10158631|FG003|NOT COMPLETED|Post Induction Therapy by Tx Assignment||7
9093859|NCT00557193|10158632|FG004|NOT COMPLETED|Post Induction Therapy by Tx Assignment||7
9093860|NCT00557193|10158633|FG005|NOT COMPLETED|Post Induction Therapy by Tx Assignment||37
9093861|NCT00547339|10158662|FG000|STARTED|Overall Study||15
8625470|NCT00507507|9665040|FG000|STARTED|24-week Treatment-free Follow-up Period|Participants who discontinued treatment early may have entered the treatment-free follow-up period.|26
8845132|NCT01714505|9899722|FG000|NOT COMPLETED|Admission 1 (40 Hours)||1
8845133|NCT01714505|9899723|FG001|NOT COMPLETED|Admission 1 (40 Hours)||1
9093862|NCT00547339|10158663|FG001|STARTED|Overall Study||15
9093863|NCT00547339|10158664|FG002|STARTED|Overall Study||15
9093864|NCT00547339|10158665|FG003|STARTED|Overall Study||47
9093865|NCT00547339|10158662|FG000|COMPLETED|Overall Study||15
9093866|NCT00547339|10158663|FG001|COMPLETED|Overall Study||15
9093867|NCT00547339|10158664|FG002|COMPLETED|Overall Study||14
9093868|NCT00547339|10158665|FG003|COMPLETED|Overall Study||47
9093869|NCT00547339|10158662|FG000|NOT COMPLETED|Overall Study||0
9093870|NCT00547339|10158663|FG001|NOT COMPLETED|Overall Study||0
9093871|NCT00547339|10158664|FG002|NOT COMPLETED|Overall Study||1
9093872|NCT00547339|10158665|FG003|NOT COMPLETED|Overall Study||0
8845134|NCT01714505|9899722|FG000|STARTED|Admission 2 (40 Hours)||9
8845135|NCT01714505|9899723|FG001|STARTED|Admission 2 (40 Hours)||9
8845136|NCT01714505|9899722|FG000|COMPLETED|Admission 2 (40 Hours)||9
8845137|NCT01714505|9899723|FG001|COMPLETED|Admission 2 (40 Hours)||9
8845138|NCT01714505|9899722|FG000|NOT COMPLETED|Admission 2 (40 Hours)||0
9093873|NCT00531232|10158687|FG000|STARTED|Overall Study||4
9093874|NCT00531232|10158688|FG001|STARTED|Overall Study||9
9093875|NCT00531232|10158689|FG002|STARTED|Overall Study||25
9093876|NCT00531232|10158687|FG000|Treated|Overall Study||4
9093877|NCT00531232|10158688|FG001|Treated|Overall Study||8
9093878|NCT00531232|10158689|FG002|Treated|Overall Study||24
9093879|NCT00531232|10158687|FG000|COMPLETED|Overall Study||0
9093880|NCT00531232|10158688|FG001|COMPLETED|Overall Study||0
9093881|NCT00531232|10158689|FG002|COMPLETED|Overall Study||0
9093882|NCT00531232|10158687|FG000|NOT COMPLETED|Overall Study||4
9093883|NCT00531232|10158688|FG001|NOT COMPLETED|Overall Study||9
9093884|NCT00531232|10158689|FG002|NOT COMPLETED|Overall Study||25
9093885|NCT00379340|10158705|FG000|STARTED|Overall Study||120
9093886|NCT00379340|10158706|FG001|STARTED|Overall Study||135
9093887|NCT00379340|10158707|FG002|STARTED|Overall Study||52
9093888|NCT00379340|10158708|FG003|STARTED|Overall Study||50
9093889|NCT00379340|10158709|FG004|STARTED|Overall Study||23
9093890|NCT00379340|10158705|FG000|COMPLETED|Overall Study||107
9093891|NCT00379340|10158706|FG001|COMPLETED|Overall Study||132
9093892|NCT00379340|10158707|FG002|COMPLETED|Overall Study||50
9093893|NCT00379340|10158708|FG003|COMPLETED|Overall Study||37
9093894|NCT00379340|10158709|FG004|COMPLETED|Overall Study||9
9093895|NCT00379340|10158705|FG000|NOT COMPLETED|Overall Study||13
9093896|NCT00379340|10158706|FG001|NOT COMPLETED|Overall Study||3
9093897|NCT00379340|10158707|FG002|NOT COMPLETED|Overall Study||2
9093898|NCT00379340|10158708|FG003|NOT COMPLETED|Overall Study||13
9093899|NCT00379340|10158709|FG004|NOT COMPLETED|Overall Study||14
9093900|NCT00304070|10158725|FG000|STARTED|Overall Study||24
9093901|NCT00304070|10158726|FG001|STARTED|Overall Study||15
9093902|NCT00304070|10158727|FG002|STARTED|Overall Study||39
9093903|NCT00304070|10158725|FG000|COMPLETED|Overall Study||21
9093904|NCT00304070|10158726|FG001|COMPLETED|Overall Study||8
9093905|NCT00304070|10158727|FG002|COMPLETED|Overall Study||27
9093906|NCT00304070|10158725|FG000|NOT COMPLETED|Overall Study||3
9093907|NCT00304070|10158726|FG001|NOT COMPLETED|Overall Study||7
9093908|NCT00304070|10158727|FG002|NOT COMPLETED|Overall Study||12
8845139|NCT01714505|9899723|FG001|NOT COMPLETED|Admission 2 (40 Hours)||0
8845140|NCT01714544|9899729|FG000|STARTED|Overall Study||60
8845141|NCT01714544|9899729|FG000|COMPLETED|Overall Study||57
8845142|NCT01714544|9899729|FG000|NOT COMPLETED|Overall Study||3
8845143|NCT01714609|9899735|FG000|STARTED|Overall Study||5
8845144|NCT01714609|9899736|FG001|STARTED|Overall Study||5
8845145|NCT01714609|9899735|FG000|COMPLETED|Overall Study||4
8845146|NCT01714609|9899736|FG001|COMPLETED|Overall Study||5
9093909|NCT00001322|10158739|FG000|STARTED|Phase 1 - Lupron Only||92
9093910|NCT00001322|10158740|FG001|STARTED|Phase 1 - Lupron Only||0
9093911|NCT00001322|10158741|FG002|STARTED|Phase 1 - Lupron Only||0
9093912|NCT00001322|10158739|FG000|COMPLETED|Phase 1 - Lupron Only||92
9093913|NCT00001322|10158740|FG001|COMPLETED|Phase 1 - Lupron Only||0
9093914|NCT00001322|10158741|FG002|COMPLETED|Phase 1 - Lupron Only||0
9093915|NCT00001322|10158739|FG000|NOT COMPLETED|Phase 1 - Lupron Only||0
9093916|NCT00001322|10158740|FG001|NOT COMPLETED|Phase 1 - Lupron Only||0
9093917|NCT00001322|10158741|FG002|NOT COMPLETED|Phase 1 - Lupron Only||0
9093918|NCT00001322|10158739|FG000|STARTED|Phase 2, Period 1 - Crossover Phase||0
9093919|NCT00001322|10158740|FG001|STARTED|Phase 2, Period 1 - Crossover Phase||42
9093920|NCT00001322|10158741|FG002|STARTED|Phase 2, Period 1 - Crossover Phase||40
9093921|NCT00001322|10158739|FG000|COMPLETED|Phase 2, Period 1 - Crossover Phase||0
9093922|NCT00001322|10158740|FG001|COMPLETED|Phase 2, Period 1 - Crossover Phase||42
9093923|NCT00001322|10158741|FG002|COMPLETED|Phase 2, Period 1 - Crossover Phase||40
9093924|NCT00001322|10158739|FG000|NOT COMPLETED|Phase 2, Period 1 - Crossover Phase||0
9093925|NCT00001322|10158740|FG001|NOT COMPLETED|Phase 2, Period 1 - Crossover Phase||0
9093926|NCT00001322|10158741|FG002|NOT COMPLETED|Phase 2, Period 1 - Crossover Phase||0
9093927|NCT00001322|10158739|FG000|STARTED|Phase 2, Period 2 - Crossover Phase||0
9093928|NCT00001322|10158740|FG001|STARTED|Phase 2, Period 2 - Crossover Phase||42
9093929|NCT00001322|10158741|FG002|STARTED|Phase 2, Period 2 - Crossover Phase||40
9093930|NCT00001322|10158739|FG000|COMPLETED|Phase 2, Period 2 - Crossover Phase||0
9093931|NCT00001322|10158740|FG001|COMPLETED|Phase 2, Period 2 - Crossover Phase||42
9093932|NCT00001322|10158741|FG002|COMPLETED|Phase 2, Period 2 - Crossover Phase||40
9093933|NCT00001322|10158739|FG000|NOT COMPLETED|Phase 2, Period 2 - Crossover Phase||0
9093934|NCT00001322|10158740|FG001|NOT COMPLETED|Phase 2, Period 2 - Crossover Phase||0
9093935|NCT00001322|10158741|FG002|NOT COMPLETED|Phase 2, Period 2 - Crossover Phase||0
9093936|NCT01701583|10158751|FG000|STARTED|Overall Study||7
9093937|NCT01701583|10158752|FG001|STARTED|Overall Study||3
9093938|NCT01701583|10158751|FG000|COMPLETED|Overall Study||5
9093939|NCT01701583|10158752|FG001|COMPLETED|Overall Study||3
9093940|NCT01701583|10158751|FG000|NOT COMPLETED|Overall Study||2
9093941|NCT01701583|10158752|FG001|NOT COMPLETED|Overall Study||0
9093942|NCT01714817|10158761|FG000|STARTED|Year 1 Period||203
9093943|NCT01714817|10158762|FG001|STARTED|Year 1 Period||203
9093944|NCT01714817|10158761|FG000|Treated|Year 1 Period||202
9093945|NCT01714817|10158762|FG001|Treated|Year 1 Period||203
9093946|NCT01714817|10158761|FG000|COMPLETED|Year 1 Period|Completed = continued study through Year 1|155
9093947|NCT01714817|10158762|FG001|COMPLETED|Year 1 Period|Completed = continued study through Year 1|161
9093948|NCT01714817|10158761|FG000|NOT COMPLETED|Year 1 Period||48
9093949|NCT01714817|10158762|FG001|NOT COMPLETED|Year 1 Period||42
9093950|NCT01714817|10158761|FG000|STARTED|Year 2 Period|Started = Completed Year 1|155
9093951|NCT01714817|10158762|FG001|STARTED|Year 2 Period|Started = Completed Year 1|161
9093952|NCT01714817|10158761|FG000|COMPLETED|Year 2 Period|Completed = Continued study through Year 2|129
9093953|NCT01714817|10158762|FG001|COMPLETED|Year 2 Period|Completed = Continued study through Year 2|123
9093954|NCT01714817|10158761|FG000|NOT COMPLETED|Year 2 Period||26
9093955|NCT01714817|10158762|FG001|NOT COMPLETED|Year 2 Period||38
9093956|NCT01714817|10158761|FG000|STARTED|Long-Term Extension (LTE) Period|Started = Completed Year 2|129
9093957|NCT01714817|10158762|FG001|STARTED|Long-Term Extension (LTE) Period|Started = Completed Year 2|123
9093958|NCT01714817|10158761|FG000|COMPLETED|Long-Term Extension (LTE) Period|Completed = Continued study through LTE|62
9093959|NCT01714817|10158762|FG001|COMPLETED|Long-Term Extension (LTE) Period|Completed = Continued study through LTE|53
9093960|NCT01714817|10158761|FG000|NOT COMPLETED|Long-Term Extension (LTE) Period||67
9093961|NCT01714817|10158762|FG001|NOT COMPLETED|Long-Term Extension (LTE) Period||70
9093962|NCT01755689|10158775|FG000|STARTED|Overall Study||259
9093963|NCT01755689|10158776|FG001|STARTED|Overall Study||259
9093964|NCT01755689|10158777|FG002|STARTED|Overall Study||261
9093965|NCT01755689|10158778|FG003|STARTED|Overall Study||260
9093966|NCT01755689|10158779|FG004|STARTED|Overall Study||261
9093967|NCT01755689|10158775|FG000|COMPLETED|Overall Study||256
9093968|NCT01755689|10158776|FG001|COMPLETED|Overall Study||254
9093969|NCT01755689|10158777|FG002|COMPLETED|Overall Study||255
9093970|NCT01755689|10158778|FG003|COMPLETED|Overall Study||254
9093971|NCT01755689|10158779|FG004|COMPLETED|Overall Study||255
9093972|NCT01755689|10158775|FG000|NOT COMPLETED|Overall Study||3
9093973|NCT01755689|10158776|FG001|NOT COMPLETED|Overall Study||5
9093974|NCT01755689|10158777|FG002|NOT COMPLETED|Overall Study||6
9093975|NCT01755689|10158778|FG003|NOT COMPLETED|Overall Study||6
9093976|NCT01755689|10158779|FG004|NOT COMPLETED|Overall Study||6
9093977|NCT01762761|10158801|FG000|STARTED|Overall Study||51
9093978|NCT01762761|10158802|FG001|STARTED|Overall Study||104
9093979|NCT01762761|10158801|FG000|COMPLETED|Overall Study||12
9093980|NCT01762761|10158802|FG001|COMPLETED|Overall Study||39
9093981|NCT01762761|10158801|FG000|NOT COMPLETED|Overall Study||39
9093982|NCT01762761|10158802|FG001|NOT COMPLETED|Overall Study||65
9093999|NCT01774370|10158826|FG000|STARTED|Overall Study||3182
9094000|NCT01774370|10158826|FG000|COMPLETED|Overall Study||3053
9094001|NCT01774370|10158826|FG000|NOT COMPLETED|Overall Study||129
9094002|NCT01777295|10158832|FG000|STARTED|Overall Study||40
9094003|NCT01777295|10158833|FG001|STARTED|Overall Study||41
9094004|NCT01777295|10158832|FG000|COMPLETED|Overall Study||36
9094005|NCT01777295|10158833|FG001|COMPLETED|Overall Study||38
9094006|NCT01777295|10158832|FG000|NOT COMPLETED|Overall Study||4
9093983|NCT01763788|10158813|FG000|STARTED|Overall Study||3
9093984|NCT01763788|10158814|FG001|STARTED|Overall Study||6
9093985|NCT01763788|10158815|FG002|STARTED|Overall Study||91
9093986|NCT01763788|10158816|FG003|STARTED|Overall Study||92
9093987|NCT01763788|10158813|FG000|Received at Least 1dose of Study Drug|Overall Study||3
9093988|NCT01763788|10158814|FG001|Received at Least 1dose of Study Drug|Overall Study||6
9093989|NCT01763788|10158815|FG002|Received at Least 1dose of Study Drug|Overall Study||90
9093990|NCT01763788|10158816|FG003|Received at Least 1dose of Study Drug|Overall Study||91
9093991|NCT01763788|10158813|FG000|COMPLETED|Overall Study||3
9093992|NCT01763788|10158814|FG001|COMPLETED|Overall Study||6
9093993|NCT01763788|10158815|FG002|COMPLETED|Overall Study||90
9093994|NCT01763788|10158816|FG003|COMPLETED|Overall Study||92
9093995|NCT01763788|10158813|FG000|NOT COMPLETED|Overall Study||0
8845147|NCT01714609|9899735|FG000|NOT COMPLETED|Overall Study||1
8845148|NCT01714609|9899736|FG001|NOT COMPLETED|Overall Study||0
8845149|NCT01714635|9899745|FG000|STARTED|Overall Study||147
8845150|NCT01714635|9899746|FG001|STARTED|Overall Study||150
8845151|NCT01714635|9899747|FG002|STARTED|Overall Study||148
8845152|NCT01714635|9899745|FG000|COMPLETED|Overall Study||145
9093996|NCT01763788|10158814|FG001|NOT COMPLETED|Overall Study||0
9093997|NCT01763788|10158815|FG002|NOT COMPLETED|Overall Study||1
9093998|NCT01763788|10158816|FG003|NOT COMPLETED|Overall Study||0
9094007|NCT01777295|10158833|FG001|NOT COMPLETED|Overall Study||3
8629540|NCT00530842|9669304|FG001|COMPLETED|Period 1||161
8845153|NCT01714635|9899746|FG001|COMPLETED|Overall Study||150
8845154|NCT01714635|9899747|FG002|COMPLETED|Overall Study||146
8845155|NCT01714635|9899745|FG000|NOT COMPLETED|Overall Study||2
8845156|NCT01714635|9899746|FG001|NOT COMPLETED|Overall Study||0
8845157|NCT01714635|9899747|FG002|NOT COMPLETED|Overall Study||2
8845158|NCT01714687|9899757|FG000|STARTED|Overall Study||29
8845159|NCT01714687|9899758|FG001|STARTED|Overall Study||30
8845160|NCT01714687|9899757|FG000|COMPLETED|Overall Study||26
8845161|NCT01714687|9899758|FG001|COMPLETED|Overall Study||26
8845162|NCT01714687|9899757|FG000|NOT COMPLETED|Overall Study||3
8845163|NCT01714687|9899758|FG001|NOT COMPLETED|Overall Study||4
8845164|NCT01714726|9899768|FG000|STARTED|Double-Blinded Induction Period||60
8845165|NCT01714726|9899769|FG001|STARTED|Double-Blinded Induction Period||59
8845166|NCT01714726|9899770|FG002|STARTED|Double-Blinded Induction Period||0
8845167|NCT01714726|9899771|FG003|STARTED|Double-Blinded Induction Period||0
8845168|NCT01714726|9899768|FG000|COMPLETED|Double-Blinded Induction Period||52
8845169|NCT01714726|9899769|FG001|COMPLETED|Double-Blinded Induction Period||52
8845170|NCT01714726|9899770|FG002|COMPLETED|Double-Blinded Induction Period||0
8845171|NCT01714726|9899771|FG003|COMPLETED|Double-Blinded Induction Period||0
8845172|NCT01714726|9899768|FG000|NOT COMPLETED|Double-Blinded Induction Period||8
8845173|NCT01714726|9899769|FG001|NOT COMPLETED|Double-Blinded Induction Period||7
8845174|NCT01714726|9899770|FG002|NOT COMPLETED|Double-Blinded Induction Period||0
8845175|NCT01714726|9899771|FG003|NOT COMPLETED|Double-Blinded Induction Period||0
8845176|NCT01714726|9899768|FG000|STARTED|Open-Label Period||0
8845177|NCT01714726|9899769|FG001|STARTED|Open-Label Period||0
8845178|NCT01714726|9899770|FG002|STARTED|Open-Label Period||52
8845179|NCT01714726|9899771|FG003|STARTED|Open-Label Period||52
8845180|NCT01714726|9899768|FG000|COMPLETED|Open-Label Period||0
8845181|NCT01714726|9899769|FG001|COMPLETED|Open-Label Period||0
8845182|NCT01714726|9899770|FG002|COMPLETED|Open-Label Period||33
8845183|NCT01714726|9899771|FG003|COMPLETED|Open-Label Period||24
8845184|NCT01714726|9899768|FG000|NOT COMPLETED|Open-Label Period||0
8845185|NCT01714726|9899769|FG001|NOT COMPLETED|Open-Label Period||0
8845186|NCT01714726|9899770|FG002|NOT COMPLETED|Open-Label Period||19
8845187|NCT01714726|9899771|FG003|NOT COMPLETED|Open-Label Period||28
8845188|NCT01714804|9899783|FG000|STARTED|Overall Study||30
8845189|NCT01714804|9899784|FG001|STARTED|Overall Study||30
8845190|NCT01714804|9899783|FG000|COMPLETED|Overall Study||29
8845191|NCT01714804|9899784|FG001|COMPLETED|Overall Study||30
8845192|NCT01714804|9899783|FG000|NOT COMPLETED|Overall Study||1
8845193|NCT01714804|9899784|FG001|NOT COMPLETED|Overall Study||0
8845194|NCT01714921|9899792|FG000|STARTED|Overall Study||504
8845195|NCT01714921|9899792|FG000|COMPLETED|Overall Study||311
8845196|NCT01714921|9899792|FG000|NOT COMPLETED|Overall Study||193
8845197|NCT01714947|9899797|FG000|STARTED|Part A||3
8845198|NCT01714947|9899797|FG000|COMPLETED|Part A||3
8845199|NCT01714947|9899797|FG000|NOT COMPLETED|Part A||0
8845200|NCT01714947|9899797|FG000|STARTED|Part B||3
8845201|NCT01714947|9899797|FG000|COMPLETED|Part B||0
8845202|NCT01714947|9899797|FG000|NOT COMPLETED|Part B||3
8845203|NCT01715064|9899803|FG000|STARTED|Overall Study||18
8845204|NCT01715064|9899804|FG001|STARTED|Overall Study||18
8845205|NCT01715064|9899803|FG000|COMPLETED|Overall Study||18
8845206|NCT01715064|9899804|FG001|COMPLETED|Overall Study||18
9094008|NCT01787552|10158853|FG000|STARTED|Overall Study||8
9094009|NCT01787552|10158854|FG001|STARTED|Overall Study||10
9094010|NCT01787552|10158855|FG002|STARTED|Overall Study||5
9094011|NCT01787552|10158856|FG003|STARTED|Overall Study||27
9094012|NCT01787552|10158853|FG000|COMPLETED|Overall Study||0
9094013|NCT01787552|10158854|FG001|COMPLETED|Overall Study||1
9094014|NCT01787552|10158855|FG002|COMPLETED|Overall Study||0
9094015|NCT01787552|10158856|FG003|COMPLETED|Overall Study||0
9094016|NCT01787552|10158853|FG000|NOT COMPLETED|Overall Study||8
9094017|NCT01787552|10158854|FG001|NOT COMPLETED|Overall Study||9
9094018|NCT01787552|10158855|FG002|NOT COMPLETED|Overall Study||5
9094019|NCT01787552|10158856|FG003|NOT COMPLETED|Overall Study||27
9094020|NCT01807117|10158871|FG000|STARTED|Overall Study||15
9094021|NCT01807117|10158871|FG000|COMPLETED|Overall Study||12
9094022|NCT01807117|10158871|FG000|NOT COMPLETED|Overall Study||3
9094029|NCT01814826|10158899|FG000|STARTED|Overall Study|6 participants were enrolled into the dose escalation phase and 26 in the MTD expansion phase.|32
9094030|NCT01814826|10158900|FG001|STARTED|Overall Study|29 participants were enrolled into the MTD expansion phase.|29
9094031|NCT01814826|10158901|FG002|STARTED|Overall Study|3 participants were enrolled into the dose escalation phase.|3
9094032|NCT01814826|10158899|FG000|COMPLETED|Overall Study||0
9094033|NCT01814826|10158900|FG001|COMPLETED|Overall Study||0
9094034|NCT01814826|10158901|FG002|COMPLETED|Overall Study||0
9094035|NCT01814826|10158899|FG000|NOT COMPLETED|Overall Study||32
9094036|NCT01814826|10158900|FG001|NOT COMPLETED|Overall Study||29
9094037|NCT01814826|10158901|FG002|NOT COMPLETED|Overall Study||3
9094038|NCT01829711|10158910|FG000|STARTED|Overall Study||80
9094039|NCT01829711|10158910|FG000|COMPLETED|Overall Study||37
9094040|NCT01829711|10158910|FG000|NOT COMPLETED|Overall Study||43
9094041|NCT01846273|10158917|FG000|STARTED|Overall Study||168
9094042|NCT01846273|10158918|FG001|STARTED|Overall Study||113
9094043|NCT01846273|10158919|FG002|STARTED|Overall Study||41
9094044|NCT01846273|10158917|FG000|Safety Analysis Set|Overall Study||172
9094045|NCT01846273|10158918|FG001|Safety Analysis Set|Overall Study||135
9094046|NCT01846273|10158919|FG002|Safety Analysis Set|Overall Study||14
9094047|NCT01846273|10158917|FG000|COMPLETED|Overall Study||146
8625471|NCT00507507|9665041|FG001|STARTED|24-week Treatment-free Follow-up Period|Participants who discontinued treatment early may have entered the treatment-free follow-up period.|29
8625472|NCT00507507|9665040|FG000|COMPLETED|24-week Treatment-free Follow-up Period||16
8625473|NCT00507507|9665041|FG001|COMPLETED|24-week Treatment-free Follow-up Period||12
8625474|NCT00507507|9665040|FG000|NOT COMPLETED|24-week Treatment-free Follow-up Period||10
8625475|NCT00507507|9665041|FG001|NOT COMPLETED|24-week Treatment-free Follow-up Period||17
9094048|NCT01846273|10158918|FG001|COMPLETED|Overall Study||87
9094049|NCT01846273|10158919|FG002|COMPLETED|Overall Study||41
9094050|NCT01846273|10158917|FG000|NOT COMPLETED|Overall Study||22
9094051|NCT01846273|10158918|FG001|NOT COMPLETED|Overall Study||26
9094052|NCT01846273|10158919|FG002|NOT COMPLETED|Overall Study||0
9094053|NCT01875185|10158929|FG000|STARTED|Overall Study||52
9094054|NCT01875185|10158930|FG001|STARTED|Overall Study||48
9094055|NCT01875185|10158929|FG000|COMPLETED|Overall Study||0
9094056|NCT01875185|10158930|FG001|COMPLETED|Overall Study||0
9094057|NCT01875185|10158929|FG000|NOT COMPLETED|Overall Study||52
9094058|NCT01875185|10158930|FG001|NOT COMPLETED|Overall Study||48
9094059|NCT01887743|10158943|FG000|STARTED|Overall Study||20
9094060|NCT01887743|10158944|FG001|STARTED|Overall Study||19
9094061|NCT01887743|10158945|FG002|STARTED|Overall Study||32
9094062|NCT01887743|10158943|FG000|COMPLETED|Overall Study||19
9094063|NCT01887743|10158944|FG001|COMPLETED|Overall Study||17
9094064|NCT01887743|10158945|FG002|COMPLETED|Overall Study||29
9094065|NCT01887743|10158943|FG000|NOT COMPLETED|Overall Study||1
9094066|NCT01887743|10158944|FG001|NOT COMPLETED|Overall Study||2
9094067|NCT01887743|10158945|FG002|NOT COMPLETED|Overall Study||3
9094068|NCT01891643|10158956|FG000|STARTED|Overall Study||13
9094069|NCT01891643|10158957|FG001|STARTED|Overall Study||10
9094070|NCT01891643|10158956|FG000|COMPLETED|Overall Study||3
9094071|NCT01891643|10158957|FG001|COMPLETED|Overall Study||0
9094072|NCT01891643|10158956|FG000|NOT COMPLETED|Overall Study||10
9094073|NCT01891643|10158957|FG001|NOT COMPLETED|Overall Study||10
9094074|NCT01900691|10158963|FG000|STARTED|Overall Study||130
9094075|NCT01900691|10158963|FG000|COMPLETED|Overall Study||111
9094076|NCT01900691|10158963|FG000|NOT COMPLETED|Overall Study||19
9094077|NCT01901432|10158973|FG000|STARTED|Overall Study||3
9094078|NCT01901432|10158974|FG001|STARTED|Overall Study||3
9094079|NCT01901432|10158975|FG002|STARTED|Overall Study||3
9094080|NCT01901432|10158976|FG003|STARTED|Overall Study||3
9094081|NCT01901432|10158977|FG004|STARTED|Overall Study||36
9094082|NCT01901432|10158973|FG000|Received Study Drug|Overall Study||3
9094083|NCT01901432|10158974|FG001|Received Study Drug|Overall Study||3
9094084|NCT01901432|10158975|FG002|Received Study Drug|Overall Study||3
9094085|NCT01901432|10158976|FG003|Received Study Drug|Overall Study||3
9094086|NCT01901432|10158977|FG004|Received Study Drug|Overall Study||35
9094087|NCT01901432|10158973|FG000|COMPLETED|Overall Study||3
9094088|NCT01901432|10158974|FG001|COMPLETED|Overall Study||2
8625476|NCT00507546|9665051|FG000|STARTED|Overall Study||4
9094089|NCT01901432|10158975|FG002|COMPLETED|Overall Study||1
9094090|NCT01901432|10158976|FG003|COMPLETED|Overall Study||3
9094091|NCT01901432|10158977|FG004|COMPLETED|Overall Study||27
9094092|NCT01901432|10158973|FG000|NOT COMPLETED|Overall Study||0
9094093|NCT01901432|10158974|FG001|NOT COMPLETED|Overall Study||1
9094094|NCT01901432|10158975|FG002|NOT COMPLETED|Overall Study||2
9094095|NCT01901432|10158976|FG003|NOT COMPLETED|Overall Study||0
9094023|NCT01808261|10158879|FG000|STARTED|Overall Study||68
9094024|NCT01808261|10158880|FG001|STARTED|Overall Study||65
9094025|NCT01808261|10158879|FG000|COMPLETED|Overall Study||32
9094026|NCT01808261|10158880|FG001|COMPLETED|Overall Study||32
9094027|NCT01808261|10158879|FG000|NOT COMPLETED|Overall Study||36
9094028|NCT01808261|10158880|FG001|NOT COMPLETED|Overall Study||33
9094096|NCT01901432|10158977|FG004|NOT COMPLETED|Overall Study||9
8845207|NCT01715064|9899803|FG000|NOT COMPLETED|Overall Study||0
8845208|NCT01715064|9899804|FG001|NOT COMPLETED|Overall Study||0
8845209|NCT01715129|9899810|FG000|STARTED|Overall Study||126
8845210|NCT01715129|9899810|FG000|COMPLETED|Overall Study||117
8845211|NCT01715129|9899810|FG000|NOT COMPLETED|Overall Study||9
8845212|NCT01715207|9899816|FG000|STARTED|Overall Study||15
8845213|NCT01715207|9899817|FG001|STARTED|Overall Study||15
8845214|NCT01715207|9899816|FG000|COMPLETED|Overall Study||14
8845215|NCT01715207|9899817|FG001|COMPLETED|Overall Study||14
8845216|NCT01715207|9899816|FG000|NOT COMPLETED|Overall Study||1
8845217|NCT01715207|9899817|FG001|NOT COMPLETED|Overall Study||1
8845218|NCT01715233|9899825|FG000|STARTED|Overall Study||21
8845219|NCT01715233|9899825|FG000|COMPLETED|Overall Study||21
8845220|NCT01715233|9899825|FG000|NOT COMPLETED|Overall Study||0
8845221|NCT01715298|9899832|FG000|STARTED|Overall Study||216
8845222|NCT01715298|9899833|FG001|STARTED|Overall Study||216
8845223|NCT01715298|9899832|FG000|Full Analysis Set (FAS)|Overall Study|patients were analyzed according to the treatment to which they were randomized|215
8845224|NCT01715298|9899833|FG001|Full Analysis Set (FAS)|Overall Study||214
8845225|NCT01715298|9899832|FG000|COMPLETED|Overall Study||209
8845226|NCT01715298|9899833|FG001|COMPLETED|Overall Study||205
8845227|NCT01715298|9899832|FG000|NOT COMPLETED|Overall Study||7
8845228|NCT01715298|9899833|FG001|NOT COMPLETED|Overall Study||11
8845229|NCT01715415|9899841|FG000|STARTED|Double-blind Treatment||297
8845230|NCT01715415|9899842|FG001|STARTED|Double-blind Treatment||98
8845231|NCT01715415|9899841|FG000|Randomized But Not Treated|Double-blind Treatment||0
8845232|NCT01715415|9899842|FG001|Randomized But Not Treated|Double-blind Treatment||1
8845233|NCT01715415|9899841|FG000|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|292
8845234|NCT01715415|9899842|FG001|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|96
8845235|NCT01715415|9899841|FG000|NOT COMPLETED|Double-blind Treatment||5
8845236|NCT01715415|9899842|FG001|NOT COMPLETED|Double-blind Treatment||2
8845237|NCT01715415|9899841|FG000|STARTED|Open-label Treatment|not applicable to this arm|0
8845238|NCT01715415|9899842|FG001|STARTED|Open-label Treatment||96
8845239|NCT01715415|9899841|FG000|COMPLETED|Open-label Treatment|not applicable to this arm|0
8845240|NCT01715415|9899842|FG001|COMPLETED|Open-label Treatment|The number of participants who completed open-label study drug.|94
8845241|NCT01715415|9899841|FG000|NOT COMPLETED|Open-label Treatment||0
8845242|NCT01715415|9899842|FG001|NOT COMPLETED|Open-label Treatment||2
8845243|NCT01715571|9899849|FG000|STARTED|Overall Study||11
8845244|NCT01715571|9899849|FG000|COMPLETED|Overall Study||3
8845245|NCT01715571|9899849|FG000|NOT COMPLETED|Overall Study||8
8845246|NCT01715805|9899853|FG000|STARTED|Placebo + ADT Lead-in Period||1022
8845247|NCT01715805|9899854|FG001|STARTED|Placebo + ADT Lead-in Period||0
9094097|NCT01904279|10158998|FG000|STARTED|Overall Study||27
9094098|NCT01904279|10158999|FG001|STARTED|Overall Study||25
9094099|NCT01904279|10158998|FG000|COMPLETED|Overall Study||24
9094100|NCT01904279|10158999|FG001|COMPLETED|Overall Study||22
9094101|NCT01904279|10158998|FG000|NOT COMPLETED|Overall Study||3
9094102|NCT01904279|10158999|FG001|NOT COMPLETED|Overall Study||3
9094103|NCT01917318|10159008|FG000|STARTED|First Treatment||0
9094104|NCT01917318|10159009|FG001|STARTED|First Treatment||1
9094105|NCT01917318|10159008|FG000|COMPLETED|First Treatment||0
9094106|NCT01917318|10159009|FG001|COMPLETED|First Treatment||0
9094107|NCT01917318|10159008|FG000|NOT COMPLETED|First Treatment||0
9094108|NCT01917318|10159009|FG001|NOT COMPLETED|First Treatment||1
9094109|NCT01917318|10159008|FG000|STARTED|Second Treatment||0
9094110|NCT01917318|10159009|FG001|STARTED|Second Treatment||0
9094111|NCT01917318|10159008|FG000|COMPLETED|Second Treatment||0
9094112|NCT01917318|10159009|FG001|COMPLETED|Second Treatment||0
9094113|NCT01917318|10159008|FG000|NOT COMPLETED|Second Treatment||0
8625477|NCT00507546|9665052|FG001|STARTED|Overall Study||4
8625478|NCT00507546|9665051|FG000|COMPLETED|Overall Study||2
8625479|NCT00507546|9665052|FG001|COMPLETED|Overall Study||3
8625480|NCT00507546|9665051|FG000|NOT COMPLETED|Overall Study||2
8845248|NCT01715805|9899855|FG002|STARTED|Placebo + ADT Lead-in Period||0
8845249|NCT01715805|9899856|FG003|STARTED|Placebo + ADT Lead-in Period||0
9094114|NCT01917318|10159009|FG001|NOT COMPLETED|Second Treatment||0
9094115|NCT01921218|10159017|FG000|STARTED|Overall Study||6
9094116|NCT01921218|10159018|FG001|STARTED|Overall Study||7
9094117|NCT01921218|10159017|FG000|COMPLETED|Overall Study||3
9094118|NCT01921218|10159018|FG001|COMPLETED|Overall Study||3
9094119|NCT01921218|10159017|FG000|NOT COMPLETED|Overall Study||3
9094120|NCT01921218|10159018|FG001|NOT COMPLETED|Overall Study||4
9094166|NCT01931098|10159059|FG000|STARTED|Overall Study||9
9094167|NCT01931098|10159060|FG001|STARTED|Overall Study||26
9094168|NCT01931098|10159059|FG000|COMPLETED|Overall Study||9
9094169|NCT01931098|10159060|FG001|COMPLETED|Overall Study||22
9094170|NCT01931098|10159059|FG000|NOT COMPLETED|Overall Study||0
9094171|NCT01931098|10159060|FG001|NOT COMPLETED|Overall Study||4
9094172|NCT01945021|10159068|FG000|STARTED|Overall Study||127
9094173|NCT01945021|10159068|FG000|Safety Population|Overall Study|Received at least 1 dose of study medication.|127
9094174|NCT01945021|10159068|FG000|Response Evaluable Population|Overall Study|Received at least 1 dose of study drug and an adequate baseline tumor assessment.|127
9094175|NCT01945021|10159068|FG000|Patient Reported Outcome Evaluable|Overall Study|Received at least 1 dose of study drug, completed baseline with at least 1 post-baseline assessment.|123
9094176|NCT01945021|10159068|FG000|COMPLETED|Overall Study||44
9094177|NCT01945021|10159068|FG000|NOT COMPLETED|Overall Study||83
9094178|NCT01956669|10159079|FG000|STARTED|Overall Study||12
9094179|NCT01956669|10159080|FG001|STARTED|Overall Study||11
9094180|NCT01956669|10159081|FG002|STARTED|Overall Study||10
9094181|NCT01956669|10159082|FG003|STARTED|Overall Study||10
9094182|NCT01956669|10159083|FG004|STARTED|Overall Study||4
9094183|NCT01956669|10159084|FG005|STARTED|Overall Study||4
8845250|NCT01715805|9899853|FG000|COMPLETED|Placebo + ADT Lead-in Period||807
8845251|NCT01715805|9899854|FG001|COMPLETED|Placebo + ADT Lead-in Period||0
8845252|NCT01715805|9899855|FG002|COMPLETED|Placebo + ADT Lead-in Period||0
8845253|NCT01715805|9899856|FG003|COMPLETED|Placebo + ADT Lead-in Period||0
8845254|NCT01715805|9899853|FG000|NOT COMPLETED|Placebo + ADT Lead-in Period||215
8845255|NCT01715805|9899854|FG001|NOT COMPLETED|Placebo + ADT Lead-in Period||0
8845256|NCT01715805|9899855|FG002|NOT COMPLETED|Placebo + ADT Lead-in Period||0
8845257|NCT01715805|9899856|FG003|NOT COMPLETED|Placebo + ADT Lead-in Period||0
8845258|NCT01715805|9899853|FG000|STARTED|Double-Blind or Continued Treatment||0
8845259|NCT01715805|9899854|FG001|STARTED|Double-Blind or Continued Treatment||261
8845260|NCT01715805|9899855|FG002|STARTED|Double-Blind or Continued Treatment||269
8845261|NCT01715805|9899856|FG003|STARTED|Double-Blind or Continued Treatment||270
8845262|NCT01715805|9899853|FG000|Double-Blind Safety Population|Double-Blind or Continued Treatment||0
8845263|NCT01715805|9899854|FG001|Double-Blind Safety Population|Double-Blind or Continued Treatment||258
8845264|NCT01715805|9899855|FG002|Double-Blind Safety Population|Double-Blind or Continued Treatment||269
8845265|NCT01715805|9899856|FG003|Double-Blind Safety Population|Double-Blind or Continued Treatment||0
8845266|NCT01715805|9899853|FG000|COMPLETED|Double-Blind or Continued Treatment||0
8845267|NCT01715805|9899854|FG001|COMPLETED|Double-Blind or Continued Treatment||222
8845268|NCT01715805|9899855|FG002|COMPLETED|Double-Blind or Continued Treatment||213
8845269|NCT01715805|9899856|FG003|COMPLETED|Double-Blind or Continued Treatment||222
8845270|NCT01715805|9899853|FG000|NOT COMPLETED|Double-Blind or Continued Treatment||0
8845271|NCT01715805|9899854|FG001|NOT COMPLETED|Double-Blind or Continued Treatment||39
8845272|NCT01715805|9899855|FG002|NOT COMPLETED|Double-Blind or Continued Treatment||56
8845273|NCT01715805|9899856|FG003|NOT COMPLETED|Double-Blind or Continued Treatment||48
8845274|NCT01715831|9899864|FG000|STARTED|Overall Study||26
8845275|NCT01715831|9899864|FG000|COMPLETED|Overall Study||25
8845276|NCT01715831|9899864|FG000|NOT COMPLETED|Overall Study||1
8845277|NCT01715857|9899868|FG000|STARTED|Overall Study||4100
8845278|NCT01715857|9899868|FG000|COMPLETED|Overall Study||4004
8845279|NCT01715857|9899868|FG000|NOT COMPLETED|Overall Study||96
9094184|NCT01956669|10159085|FG006|STARTED|Overall Study||6
9094185|NCT01956669|10159079|FG000|PK Set|Overall Study||11
9094186|NCT01956669|10159080|FG001|PK Set|Overall Study||11
9094187|NCT01956669|10159081|FG002|PK Set|Overall Study||10
8625481|NCT00507546|9665052|FG001|NOT COMPLETED|Overall Study||1
9094121|NCT01923168|10159027|FG000|STARTED|Overall Study||131
9094122|NCT01923168|10159028|FG001|STARTED|Overall Study||83
9094123|NCT01923168|10159029|FG002|STARTED|Overall Study||126
9094124|NCT01923168|10159027|FG000|COMPLETED|Overall Study||94
9094125|NCT01923168|10159028|FG001|COMPLETED|Overall Study||44
9094126|NCT01923168|10159029|FG002|COMPLETED|Overall Study||109
9094127|NCT01923168|10159027|FG000|NOT COMPLETED|Overall Study||37
9094128|NCT01923168|10159028|FG001|NOT COMPLETED|Overall Study||39
9094129|NCT01923168|10159029|FG002|NOT COMPLETED|Overall Study||17
9094130|NCT01923480|10159040|FG000|STARTED|Period 1 (Hours 1-7)||1
9094131|NCT01923480|10159041|FG001|STARTED|Period 1 (Hours 1-7)||2
9094132|NCT01923480|10159042|FG002|STARTED|Period 1 (Hours 1-7)||2
9094133|NCT01923480|10159043|FG003|STARTED|Period 1 (Hours 1-7)||2
9094134|NCT01923480|10159044|FG004|STARTED|Period 1 (Hours 1-7)||2
9094135|NCT01923480|10159045|FG005|STARTED|Period 1 (Hours 1-7)||2
9094136|NCT01923480|10159040|FG000|COMPLETED|Period 1 (Hours 1-7)||1
9094137|NCT01923480|10159041|FG001|COMPLETED|Period 1 (Hours 1-7)|One subject completed Period 1, but withdrew from the study prior to the start of Period 2.|2
9094138|NCT01923480|10159042|FG002|COMPLETED|Period 1 (Hours 1-7)||2
9094139|NCT01923480|10159043|FG003|COMPLETED|Period 1 (Hours 1-7)||2
9094140|NCT01923480|10159044|FG004|COMPLETED|Period 1 (Hours 1-7)||2
9094141|NCT01923480|10159045|FG005|COMPLETED|Period 1 (Hours 1-7)||2
9094142|NCT01923480|10159040|FG000|NOT COMPLETED|Period 1 (Hours 1-7)||0
9094143|NCT01923480|10159041|FG001|NOT COMPLETED|Period 1 (Hours 1-7)||0
9094144|NCT01923480|10159042|FG002|NOT COMPLETED|Period 1 (Hours 1-7)||0
9094145|NCT01923480|10159043|FG003|NOT COMPLETED|Period 1 (Hours 1-7)||0
9094146|NCT01923480|10159044|FG004|NOT COMPLETED|Period 1 (Hours 1-7)||0
9094147|NCT01923480|10159045|FG005|NOT COMPLETED|Period 1 (Hours 1-7)||0
9094148|NCT01923480|10159040|FG000|STARTED|Period 2 (Hours 1-7)||1
9094149|NCT01923480|10159041|FG001|STARTED|Period 2 (Hours 1-7)|One subject completed Period 1, but withdrew from the study prior to the start of Period 2.|1
9094150|NCT01923480|10159042|FG002|STARTED|Period 2 (Hours 1-7)||2
9094151|NCT01923480|10159043|FG003|STARTED|Period 2 (Hours 1-7)||2
9094152|NCT01923480|10159044|FG004|STARTED|Period 2 (Hours 1-7)||2
9094153|NCT01923480|10159045|FG005|STARTED|Period 2 (Hours 1-7)||2
9094154|NCT01923480|10159040|FG000|COMPLETED|Period 2 (Hours 1-7)||1
9094155|NCT01923480|10159041|FG001|COMPLETED|Period 2 (Hours 1-7)||1
9094156|NCT01923480|10159042|FG002|COMPLETED|Period 2 (Hours 1-7)||2
9094157|NCT01923480|10159043|FG003|COMPLETED|Period 2 (Hours 1-7)||2
9094158|NCT01923480|10159044|FG004|COMPLETED|Period 2 (Hours 1-7)||2
9094159|NCT01923480|10159045|FG005|COMPLETED|Period 2 (Hours 1-7)||2
9094160|NCT01923480|10159040|FG000|NOT COMPLETED|Period 2 (Hours 1-7)||0
9094161|NCT01923480|10159041|FG001|NOT COMPLETED|Period 2 (Hours 1-7)||0
9094162|NCT01923480|10159042|FG002|NOT COMPLETED|Period 2 (Hours 1-7)||0
9094163|NCT01923480|10159043|FG003|NOT COMPLETED|Period 2 (Hours 1-7)||0
9094164|NCT01923480|10159044|FG004|NOT COMPLETED|Period 2 (Hours 1-7)||0
9094165|NCT01923480|10159045|FG005|NOT COMPLETED|Period 2 (Hours 1-7)||0
9094188|NCT01956669|10159082|FG003|PK Set|Overall Study||10
9094189|NCT01956669|10159083|FG004|PK Set|Overall Study||4
9094190|NCT01956669|10159084|FG005|PK Set|Overall Study||4
9094191|NCT01956669|10159085|FG006|PK Set|Overall Study||6
9094192|NCT01956669|10159079|FG000|PKES Set|Overall Study||4
9094193|NCT01956669|10159080|FG001|PKES Set|Overall Study||0
9094194|NCT01956669|10159081|FG002|PKES Set|Overall Study||3
9094195|NCT01956669|10159082|FG003|PKES Set|Overall Study||0
9094196|NCT01956669|10159083|FG004|PKES Set|Overall Study||1
9094197|NCT01956669|10159084|FG005|PKES Set|Overall Study||1
9094198|NCT01956669|10159085|FG006|PKES Set|Overall Study||5
9094199|NCT01956669|10159079|FG000|Biomarker Set|Overall Study||12
9094200|NCT01956669|10159080|FG001|Biomarker Set|Overall Study||11
9094201|NCT01956669|10159081|FG002|Biomarker Set|Overall Study||9
9094202|NCT01956669|10159082|FG003|Biomarker Set|Overall Study||9
9094203|NCT01956669|10159083|FG004|Biomarker Set|Overall Study||3
9094204|NCT01956669|10159084|FG005|Biomarker Set|Overall Study||4
9094205|NCT01956669|10159085|FG006|Biomarker Set|Overall Study||3
9094206|NCT01956669|10159079|FG000|Per Protocol Set (PP Set)|Overall Study||9
8845280|NCT01715883|9899872|FG000|STARTED|Overall Study||3
8845281|NCT01715883|9899872|FG000|COMPLETED|Overall Study||2
8845282|NCT01715883|9899872|FG000|NOT COMPLETED|Overall Study||1
8845283|NCT01715896|9899879|FG000|STARTED|Overall Study||68
8845284|NCT01715896|9899880|FG001|STARTED|Overall Study||70
8845285|NCT01715896|9899879|FG000|COMPLETED|Overall Study||65
9094207|NCT01956669|10159080|FG001|Per Protocol Set (PP Set)|Overall Study||10
9094208|NCT01956669|10159081|FG002|Per Protocol Set (PP Set)|Overall Study||6
9094209|NCT01956669|10159082|FG003|Per Protocol Set (PP Set)|Overall Study||9
9094210|NCT01956669|10159083|FG004|Per Protocol Set (PP Set)|Overall Study||4
9094211|NCT01956669|10159084|FG005|Per Protocol Set (PP Set)|Overall Study||4
9094212|NCT01956669|10159085|FG006|Per Protocol Set (PP Set)|Overall Study||5
9094213|NCT01956669|10159079|FG000|COMPLETED|Overall Study||0
9094214|NCT01956669|10159080|FG001|COMPLETED|Overall Study||0
8845286|NCT01715896|9899880|FG001|COMPLETED|Overall Study||59
9094215|NCT01956669|10159081|FG002|COMPLETED|Overall Study||0
9094216|NCT01956669|10159082|FG003|COMPLETED|Overall Study||0
9094217|NCT01956669|10159083|FG004|COMPLETED|Overall Study||0
9094218|NCT01956669|10159084|FG005|COMPLETED|Overall Study||0
9094219|NCT01956669|10159085|FG006|COMPLETED|Overall Study||0
9094220|NCT01956669|10159079|FG000|NOT COMPLETED|Overall Study||12
8845287|NCT01715896|9899879|FG000|NOT COMPLETED|Overall Study||3
8845288|NCT01715896|9899880|FG001|NOT COMPLETED|Overall Study||11
9094221|NCT01956669|10159080|FG001|NOT COMPLETED|Overall Study||11
9094222|NCT01956669|10159081|FG002|NOT COMPLETED|Overall Study||10
9094223|NCT01956669|10159082|FG003|NOT COMPLETED|Overall Study||10
9094224|NCT01956669|10159083|FG004|NOT COMPLETED|Overall Study||4
9094225|NCT01956669|10159084|FG005|NOT COMPLETED|Overall Study||4
9094226|NCT01956669|10159085|FG006|NOT COMPLETED|Overall Study||6
8845289|NCT01715948|9899887|FG000|STARTED|Overall Study||9
8845290|NCT01715948|9899887|FG000|COMPLETED|Overall Study||8
8845291|NCT01715948|9899887|FG000|NOT COMPLETED|Overall Study||1
8845292|NCT01716013|9899908|FG000|STARTED|Overall Study||108
8845293|NCT01716013|9899909|FG001|STARTED|Overall Study||54
8845294|NCT01716013|9899908|FG000|COMPLETED|Overall Study||105
8845295|NCT01716013|9899909|FG001|COMPLETED|Overall Study||54
8845296|NCT01716013|9899908|FG000|NOT COMPLETED|Overall Study||3
8845297|NCT01716013|9899909|FG001|NOT COMPLETED|Overall Study||0
8845298|NCT01716039|9899918|FG000|STARTED|Overall Study||4
8845299|NCT01716039|9899919|FG001|STARTED|Overall Study||8
8845300|NCT01716039|9899920|FG002|STARTED|Overall Study||10
8845301|NCT01716039|9899918|FG000|COMPLETED|Overall Study||3
8845302|NCT01716039|9899919|FG001|COMPLETED|Overall Study||6
8845303|NCT01716039|9899920|FG002|COMPLETED|Overall Study||8
8845304|NCT01716039|9899918|FG000|NOT COMPLETED|Overall Study||1
8845305|NCT01716039|9899919|FG001|NOT COMPLETED|Overall Study||2
8845306|NCT01716039|9899920|FG002|NOT COMPLETED|Overall Study||2
8845307|NCT01716104|9899932|FG000|STARTED|Overall Study||125
8845308|NCT01716104|9899933|FG001|STARTED|Overall Study||124
8845309|NCT01716104|9899932|FG000|COMPLETED|Overall Study||119
8845310|NCT01716104|9899933|FG001|COMPLETED|Overall Study||117
8845311|NCT01716104|9899932|FG000|NOT COMPLETED|Overall Study||6
8845312|NCT01716104|9899933|FG001|NOT COMPLETED|Overall Study||7
8845313|NCT01716156|9899942|FG000|STARTED|Overall Study||9
8845314|NCT01716156|9899943|FG001|STARTED|Overall Study||4
8845315|NCT01716156|9899944|FG002|STARTED|Overall Study||13
8845316|NCT01716156|9899942|FG000|COMPLETED|Overall Study||7
8845317|NCT01716156|9899943|FG001|COMPLETED|Overall Study||3
8845318|NCT01716156|9899944|FG002|COMPLETED|Overall Study||11
8845319|NCT01716156|9899942|FG000|NOT COMPLETED|Overall Study||2
8845320|NCT01716156|9899943|FG001|NOT COMPLETED|Overall Study||1
8845321|NCT01716156|9899944|FG002|NOT COMPLETED|Overall Study||2
8845322|NCT01716169|9899956|FG000|STARTED|Overall Study||10
8845323|NCT01716169|9899956|FG000|Standard of Care Dressings Used|Overall Study||7
8845324|NCT01716169|9899956|FG000|COMPLETED|Overall Study||6
9094227|NCT01967823|10159110|FG000|STARTED|Overall Study||11
9094228|NCT01967823|10159110|FG000|COMPLETED|Overall Study||10
9094229|NCT01967823|10159110|FG000|NOT COMPLETED|Overall Study||1
9094230|NCT01989676|10159120|FG000|STARTED|Overall Study||352
9094231|NCT01989676|10159121|FG001|STARTED|Overall Study||355
9094232|NCT01989676|10159120|FG000|Treated|Overall Study||349
9094233|NCT01989676|10159121|FG001|Treated|Overall Study||353
9094234|NCT01989676|10159120|FG000|COMPLETED|Overall Study||234
9094235|NCT01989676|10159121|FG001|COMPLETED|Overall Study||217
9094236|NCT01989676|10159120|FG000|NOT COMPLETED|Overall Study||118
9094237|NCT01989676|10159121|FG001|NOT COMPLETED|Overall Study||138
9094238|NCT01992653|10159136|FG000|STARTED|Overall Study||3
9094239|NCT01992653|10159137|FG001|STARTED|Overall Study||3
9094240|NCT01992653|10159138|FG002|STARTED|Overall Study||6
9094241|NCT01992653|10159139|FG003|STARTED|Overall Study||1
9094242|NCT01992653|10159140|FG004|STARTED|Overall Study||6
9094243|NCT01992653|10159141|FG005|STARTED|Overall Study||6
9094244|NCT01992653|10159142|FG006|STARTED|Overall Study||40
9094245|NCT01992653|10159143|FG007|STARTED|Overall Study||17
9094246|NCT01992653|10159136|FG000|COMPLETED|Overall Study||3
9094247|NCT01992653|10159137|FG001|COMPLETED|Overall Study||3
9094248|NCT01992653|10159138|FG002|COMPLETED|Overall Study||5
9094249|NCT01992653|10159139|FG003|COMPLETED|Overall Study||1
9094250|NCT01992653|10159140|FG004|COMPLETED|Overall Study||5
9094251|NCT01992653|10159141|FG005|COMPLETED|Overall Study||6
9094252|NCT01992653|10159142|FG006|COMPLETED|Overall Study||32
9094253|NCT01992653|10159143|FG007|COMPLETED|Overall Study||13
9094254|NCT01992653|10159136|FG000|NOT COMPLETED|Overall Study||0
9094255|NCT01992653|10159137|FG001|NOT COMPLETED|Overall Study||0
9094256|NCT01992653|10159138|FG002|NOT COMPLETED|Overall Study||1
9094257|NCT01992653|10159139|FG003|NOT COMPLETED|Overall Study||0
9094258|NCT01992653|10159140|FG004|NOT COMPLETED|Overall Study||1
9094259|NCT01992653|10159141|FG005|NOT COMPLETED|Overall Study||0
9094260|NCT01992653|10159142|FG006|NOT COMPLETED|Overall Study||8
9094261|NCT01992653|10159143|FG007|NOT COMPLETED|Overall Study||4
9094262|NCT02001974|10159164|FG000|STARTED|Run-in Period||4
9094263|NCT02001974|10159165|FG001|STARTED|Run-in Period||3
9094264|NCT02001974|10159166|FG002|STARTED|Run-in Period||26
9094265|NCT02001974|10159164|FG000|COMPLETED|Run-in Period||4
9094266|NCT02001974|10159165|FG001|COMPLETED|Run-in Period||3
9094267|NCT02001974|10159166|FG002|COMPLETED|Run-in Period||26
9094268|NCT02001974|10159164|FG000|NOT COMPLETED|Run-in Period||0
9094269|NCT02001974|10159165|FG001|NOT COMPLETED|Run-in Period||0
9094270|NCT02001974|10159166|FG002|NOT COMPLETED|Run-in Period||0
9094271|NCT02001974|10159164|FG000|STARTED|Reparixin + Paclitaxel (28-day Cycles)||4
9094272|NCT02001974|10159165|FG001|STARTED|Reparixin + Paclitaxel (28-day Cycles)||3
9094273|NCT02001974|10159166|FG002|STARTED|Reparixin + Paclitaxel (28-day Cycles)||26
9094274|NCT02001974|10159164|FG000|COMPLETED|Reparixin + Paclitaxel (28-day Cycles)||0
9094275|NCT02001974|10159165|FG001|COMPLETED|Reparixin + Paclitaxel (28-day Cycles)||0
8845325|NCT01716169|9899956|FG000|NOT COMPLETED|Overall Study||4
8845326|NCT01716195|9899962|FG000|STARTED|Overall Study||18
8845327|NCT01716195|9899962|FG000|COMPLETED|Overall Study||17
8845328|NCT01716195|9899962|FG000|NOT COMPLETED|Overall Study||1
8845329|NCT01716208|9899966|FG000|STARTED|Overall Study||12
8845330|NCT01716208|9899966|FG000|COMPLETED|Overall Study||12
8845331|NCT01716208|9899966|FG000|NOT COMPLETED|Overall Study||0
8845332|NCT01716221|9899970|FG000|STARTED|Overall Study||1
8845333|NCT01716221|9899970|FG000|COMPLETED|Overall Study||1
8845334|NCT01716221|9899970|FG000|NOT COMPLETED|Overall Study||0
8845335|NCT01716234|9899993|FG000|STARTED|Overall Study||24
8845336|NCT01716234|9899994|FG001|STARTED|Overall Study||22
8845337|NCT01716234|9899995|FG002|STARTED|Overall Study||20
8845338|NCT01716234|9899996|FG003|STARTED|Overall Study||28
8845339|NCT01716234|9899997|FG004|STARTED|Overall Study||15
8845340|NCT01716234|9899998|FG005|STARTED|Overall Study||32
8845341|NCT01716234|9899999|FG006|STARTED|Overall Study||1
8845342|NCT01716234|9899993|FG000|Treated|Overall Study||22
8845343|NCT01716234|9899994|FG001|Treated|Overall Study||21
8845344|NCT01716234|9899995|FG002|Treated|Overall Study||19
8845345|NCT01716234|9899996|FG003|Treated|Overall Study||28
8845346|NCT01716234|9899997|FG004|Treated|Overall Study||15
8845347|NCT01716234|9899998|FG005|Treated|Overall Study||30
8845348|NCT01716234|9899999|FG006|Treated|Overall Study||1
8845349|NCT01716234|9899993|FG000|COMPLETED|Overall Study||14
8845350|NCT01716234|9899994|FG001|COMPLETED|Overall Study||12
8845351|NCT01716234|9899995|FG002|COMPLETED|Overall Study||15
8845352|NCT01716234|9899996|FG003|COMPLETED|Overall Study||16
8845353|NCT01716234|9899997|FG004|COMPLETED|Overall Study||10
9094276|NCT02001974|10159166|FG002|COMPLETED|Reparixin + Paclitaxel (28-day Cycles)||0
9094277|NCT02001974|10159164|FG000|NOT COMPLETED|Reparixin + Paclitaxel (28-day Cycles)||4
9094278|NCT02001974|10159165|FG001|NOT COMPLETED|Reparixin + Paclitaxel (28-day Cycles)||3
9094279|NCT02001974|10159166|FG002|NOT COMPLETED|Reparixin + Paclitaxel (28-day Cycles)||26
9094280|NCT02014558|10159187|FG000|STARTED|Overall Study||5
9094281|NCT02014558|10159188|FG001|STARTED|Overall Study||3
9094282|NCT02014558|10159189|FG002|STARTED|Overall Study||3
9094283|NCT02014558|10159190|FG003|STARTED|Overall Study||3
9094284|NCT02014558|10159191|FG004|STARTED|Overall Study||4
8845354|NCT01716234|9899998|FG005|COMPLETED|Overall Study||18
8845355|NCT01716234|9899999|FG006|COMPLETED|Overall Study||1
8845356|NCT01716234|9899993|FG000|NOT COMPLETED|Overall Study||10
8845357|NCT01716234|9899994|FG001|NOT COMPLETED|Overall Study||10
8845358|NCT01716234|9899995|FG002|NOT COMPLETED|Overall Study||5
9094285|NCT02014558|10159192|FG005|STARTED|Overall Study||3
9094286|NCT02014558|10159193|FG006|STARTED|Overall Study||4
8625482|NCT00507559|9665060|FG000|STARTED|Overall Study||155
8625483|NCT00507559|9665060|FG000|COMPLETED|Overall Study||84
9094287|NCT02014558|10159194|FG007|STARTED|Overall Study||11
9094288|NCT02014558|10159195|FG008|STARTED|Overall Study||15
9094289|NCT02014558|10159196|FG009|STARTED|Overall Study||21
9094290|NCT02014558|10159197|FG010|STARTED|Overall Study||69
9094291|NCT02014558|10159198|FG011|STARTED|Overall Study||102
9094292|NCT02014558|10159199|FG012|STARTED|Overall Study||17
9094293|NCT02014558|10159187|FG000|Treated|Overall Study||5
9094294|NCT02014558|10159188|FG001|Treated|Overall Study||3
9094295|NCT02014558|10159189|FG002|Treated|Overall Study||3
9094296|NCT02014558|10159190|FG003|Treated|Overall Study||3
9094297|NCT02014558|10159191|FG004|Treated|Overall Study||3
9094298|NCT02014558|10159192|FG005|Treated|Overall Study||3
9094299|NCT02014558|10159193|FG006|Treated|Overall Study||3
9094300|NCT02014558|10159194|FG007|Treated|Overall Study|A participant randomized to the 120 mg was treated with an initial dose of 20 mg by mistake.|12
9094301|NCT02014558|10159195|FG008|Treated|Overall Study||13
9094302|NCT02014558|10159196|FG009|Treated|Overall Study||21
9094303|NCT02014558|10159197|FG010|Treated|Overall Study|A participant randomized to the 120 mg was treated with an initial dose of 20 mg by mistake.|66
9094304|NCT02014558|10159198|FG011|Treated|Overall Study||100
9094305|NCT02014558|10159199|FG012|Treated|Overall Study||17
9094306|NCT02014558|10159187|FG000|COMPLETED|Overall Study||0
9094307|NCT02014558|10159188|FG001|COMPLETED|Overall Study||0
9094308|NCT02014558|10159189|FG002|COMPLETED|Overall Study||0
9094309|NCT02014558|10159190|FG003|COMPLETED|Overall Study||0
9094310|NCT02014558|10159191|FG004|COMPLETED|Overall Study||0
9094311|NCT02014558|10159192|FG005|COMPLETED|Overall Study||0
9094312|NCT02014558|10159193|FG006|COMPLETED|Overall Study||0
9094313|NCT02014558|10159194|FG007|COMPLETED|Overall Study||0
9094314|NCT02014558|10159195|FG008|COMPLETED|Overall Study||0
9094315|NCT02014558|10159196|FG009|COMPLETED|Overall Study||0
9094316|NCT02014558|10159197|FG010|COMPLETED|Overall Study||0
9094317|NCT02014558|10159198|FG011|COMPLETED|Overall Study||0
9094318|NCT02014558|10159199|FG012|COMPLETED|Overall Study||0
9094319|NCT02014558|10159187|FG000|NOT COMPLETED|Overall Study||5
9094320|NCT02014558|10159188|FG001|NOT COMPLETED|Overall Study||3
9094321|NCT02014558|10159189|FG002|NOT COMPLETED|Overall Study||3
9094322|NCT02014558|10159190|FG003|NOT COMPLETED|Overall Study||3
9094323|NCT02014558|10159191|FG004|NOT COMPLETED|Overall Study||4
9094324|NCT02014558|10159192|FG005|NOT COMPLETED|Overall Study||3
9094325|NCT02014558|10159193|FG006|NOT COMPLETED|Overall Study||4
9094326|NCT02014558|10159194|FG007|NOT COMPLETED|Overall Study||11
9094327|NCT02014558|10159195|FG008|NOT COMPLETED|Overall Study||15
9094328|NCT02014558|10159196|FG009|NOT COMPLETED|Overall Study||21
9094329|NCT02014558|10159197|FG010|NOT COMPLETED|Overall Study||69
9094330|NCT02014558|10159198|FG011|NOT COMPLETED|Overall Study||102
9094331|NCT02014558|10159199|FG012|NOT COMPLETED|Overall Study||17
9094332|NCT02015455|10159243|FG000|STARTED|Step 0 - Oct 2013 to Mar 2014||48233
9094333|NCT02015455|10159244|FG001|STARTED|Step 0 - Oct 2013 to Mar 2014||0
9094334|NCT02015455|10159243|FG000|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 0 - Oct 2013 to Mar 2014||135
9094335|NCT02015455|10159244|FG001|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 0 - Oct 2013 to Mar 2014||0
9094336|NCT02015455|10159243|FG000|COMPLETED|Step 0 - Oct 2013 to Mar 2014||48233
9094337|NCT02015455|10159244|FG001|COMPLETED|Step 0 - Oct 2013 to Mar 2014||0
9094338|NCT02015455|10159243|FG000|NOT COMPLETED|Step 0 - Oct 2013 to Mar 2014||0
9094339|NCT02015455|10159244|FG001|NOT COMPLETED|Step 0 - Oct 2013 to Mar 2014||0
9094340|NCT02015455|10159243|FG000|STARTED|Step 1 - Apr 2014 to Sep 2014||24074
9094341|NCT02015455|10159244|FG001|STARTED|Step 1 - Apr 2014 to Sep 2014||6455
9094342|NCT02015455|10159243|FG000|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 1 - Apr 2014 to Sep 2014||390
9094343|NCT02015455|10159244|FG001|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 1 - Apr 2014 to Sep 2014||2208
9094344|NCT02015455|10159243|FG000|COMPLETED|Step 1 - Apr 2014 to Sep 2014||24074
9094345|NCT02015455|10159244|FG001|COMPLETED|Step 1 - Apr 2014 to Sep 2014||6455
9094346|NCT02015455|10159243|FG000|NOT COMPLETED|Step 1 - Apr 2014 to Sep 2014||0
9094347|NCT02015455|10159244|FG001|NOT COMPLETED|Step 1 - Apr 2014 to Sep 2014||0
9094348|NCT02015455|10159243|FG000|STARTED|Step 2 - Oct 2014 to Mar 2015||23139
9094349|NCT02015455|10159244|FG001|STARTED|Step 2 - Oct 2014 to Mar 2015||16285
9094350|NCT02015455|10159243|FG000|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 2 - Oct 2014 to Mar 2015||98
9094351|NCT02015455|10159244|FG001|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 2 - Oct 2014 to Mar 2015||1511
9094352|NCT02015455|10159243|FG000|COMPLETED|Step 2 - Oct 2014 to Mar 2015||23139
9094353|NCT02015455|10159244|FG001|COMPLETED|Step 2 - Oct 2014 to Mar 2015||16285
9094354|NCT02015455|10159243|FG000|NOT COMPLETED|Step 2 - Oct 2014 to Mar 2015||0
9094355|NCT02015455|10159244|FG001|NOT COMPLETED|Step 2 - Oct 2014 to Mar 2015||0
9094356|NCT02015455|10159243|FG000|STARTED|Step 3 - Apr 2015 to Sep 2015||14135
9094357|NCT02015455|10159244|FG001|STARTED|Step 3 - Apr 2015 to Sep 2015||27661
9094358|NCT02015455|10159243|FG000|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 3 - Apr 2015 to Sep 2015||72
9094359|NCT02015455|10159244|FG001|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 3 - Apr 2015 to Sep 2015||4915
9094360|NCT02015455|10159243|FG000|COMPLETED|Step 3 - Apr 2015 to Sep 2015||14135
8625484|NCT00507559|9665060|FG000|NOT COMPLETED|Overall Study||71
9094361|NCT02015455|10159244|FG001|COMPLETED|Step 3 - Apr 2015 to Sep 2015||27661
9094362|NCT02015455|10159243|FG000|NOT COMPLETED|Step 3 - Apr 2015 to Sep 2015||0
9094363|NCT02015455|10159244|FG001|NOT COMPLETED|Step 3 - Apr 2015 to Sep 2015||0
9094364|NCT02015455|10159243|FG000|STARTED|Step 4 - Oct 2015 to Mar 2016||7874
9094365|NCT02015455|10159244|FG001|STARTED|Step 4 - Oct 2015 to Mar 2016||31316
9094366|NCT02015455|10159243|FG000|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 4 - Oct 2015 to Mar 2016||76
9094367|NCT02015455|10159244|FG001|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 4 - Oct 2015 to Mar 2016||3742
9094368|NCT02015455|10159243|FG000|COMPLETED|Step 4 - Oct 2015 to Mar 2016||7874
9094369|NCT02015455|10159244|FG001|COMPLETED|Step 4 - Oct 2015 to Mar 2016||31316
9094370|NCT02015455|10159243|FG000|NOT COMPLETED|Step 4 - Oct 2015 to Mar 2016||0
9094371|NCT02015455|10159244|FG001|NOT COMPLETED|Step 4 - Oct 2015 to Mar 2016||0
9094372|NCT02015455|10159243|FG000|STARTED|Step 5 - Apr 2016 to Sep 2016||0
9094373|NCT02015455|10159244|FG001|STARTED|Step 5 - Apr 2016 to Sep 2016||39714
9094374|NCT02015455|10159243|FG000|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 5 - Apr 2016 to Sep 2016||0
9094375|NCT02015455|10159244|FG001|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 5 - Apr 2016 to Sep 2016||3512
9094376|NCT02015455|10159243|FG000|COMPLETED|Step 5 - Apr 2016 to Sep 2016||0
9094377|NCT02015455|10159244|FG001|COMPLETED|Step 5 - Apr 2016 to Sep 2016||39714
9094378|NCT02015455|10159243|FG000|NOT COMPLETED|Step 5 - Apr 2016 to Sep 2016||0
9094379|NCT02015455|10159244|FG001|NOT COMPLETED|Step 5 - Apr 2016 to Sep 2016||0
8845359|NCT01716234|9899996|FG003|NOT COMPLETED|Overall Study||12
8845360|NCT01716234|9899997|FG004|NOT COMPLETED|Overall Study||5
8845361|NCT01716234|9899998|FG005|NOT COMPLETED|Overall Study||14
8845362|NCT01716234|9899999|FG006|NOT COMPLETED|Overall Study||0
8845363|NCT01716455|9900021|FG000|STARTED|Overall Study||8
8845364|NCT01716455|9900022|FG001|STARTED|Overall Study||8
8845365|NCT01716455|9900023|FG002|STARTED|Overall Study||8
8845366|NCT01716455|9900024|FG003|STARTED|Overall Study||8
8845367|NCT01716455|9900025|FG004|STARTED|Overall Study||26
8845368|NCT01716455|9900026|FG005|STARTED|Overall Study||8
8845369|NCT01716455|9900021|FG000|COMPLETED|Overall Study||8
8845370|NCT01716455|9900022|FG001|COMPLETED|Overall Study||8
8845371|NCT01716455|9900023|FG002|COMPLETED|Overall Study||8
8845372|NCT01716455|9900024|FG003|COMPLETED|Overall Study||8
8845373|NCT01716455|9900025|FG004|COMPLETED|Overall Study||26
8845374|NCT01716455|9900026|FG005|COMPLETED|Overall Study||8
8845375|NCT01716455|9900021|FG000|NOT COMPLETED|Overall Study||0
8845376|NCT01716455|9900022|FG001|NOT COMPLETED|Overall Study||0
8845377|NCT01716455|9900023|FG002|NOT COMPLETED|Overall Study||0
8845378|NCT01716455|9900024|FG003|NOT COMPLETED|Overall Study||0
8845379|NCT01716455|9900025|FG004|NOT COMPLETED|Overall Study||0
8845380|NCT01716455|9900026|FG005|NOT COMPLETED|Overall Study||0
8845381|NCT01716468|9900037|FG000|STARTED|Overall Study||17
8845382|NCT01716468|9900037|FG000|COMPLETED|Overall Study||11
8845383|NCT01716468|9900037|FG000|NOT COMPLETED|Overall Study||6
8845384|NCT01716520|9900041|FG000|STARTED|Treatment Period 1 (14 Days)||31
8845385|NCT01716520|9900042|FG001|STARTED|Treatment Period 1 (14 Days)||30
8845386|NCT01716520|9900043|FG002|STARTED|Treatment Period 1 (14 Days)||30
8845387|NCT01716520|9900044|FG003|STARTED|Treatment Period 1 (14 Days)||30
8845388|NCT01716520|9900045|FG004|STARTED|Treatment Period 1 (14 Days)||31
8845389|NCT01716520|9900046|FG005|STARTED|Treatment Period 1 (14 Days)||30
8845390|NCT01716520|9900041|FG000|COMPLETED|Treatment Period 1 (14 Days)||29
8845391|NCT01716520|9900042|FG001|COMPLETED|Treatment Period 1 (14 Days)||29
8845392|NCT01716520|9900043|FG002|COMPLETED|Treatment Period 1 (14 Days)||28
8845393|NCT01716520|9900044|FG003|COMPLETED|Treatment Period 1 (14 Days)||29
8845394|NCT01716520|9900045|FG004|COMPLETED|Treatment Period 1 (14 Days)||31
8845395|NCT01716520|9900046|FG005|COMPLETED|Treatment Period 1 (14 Days)||29
8845396|NCT01716520|9900041|FG000|NOT COMPLETED|Treatment Period 1 (14 Days)||2
8845397|NCT01716520|9900042|FG001|NOT COMPLETED|Treatment Period 1 (14 Days)||1
8845398|NCT01716520|9900043|FG002|NOT COMPLETED|Treatment Period 1 (14 Days)||2
8845399|NCT01716520|9900044|FG003|NOT COMPLETED|Treatment Period 1 (14 Days)||1
9094380|NCT02024555|10159254|FG000|STARTED|Overall Study||49
9094381|NCT02024555|10159255|FG001|STARTED|Overall Study||48
9094382|NCT02024555|10159254|FG000|COMPLETED|Overall Study||43
9094383|NCT02024555|10159255|FG001|COMPLETED|Overall Study||46
9094384|NCT02024555|10159254|FG000|NOT COMPLETED|Overall Study||6
9094385|NCT02024555|10159255|FG001|NOT COMPLETED|Overall Study||2
9094386|NCT02034123|10159279|FG000|STARTED|Part1(Median of 7.286 Weeks of Exposure)||1
9094387|NCT02034123|10159280|FG001|STARTED|Part1(Median of 7.286 Weeks of Exposure)||1
9094388|NCT02034123|10159281|FG002|STARTED|Part1(Median of 7.286 Weeks of Exposure)||5
9094389|NCT02034123|10159282|FG003|STARTED|Part1(Median of 7.286 Weeks of Exposure)||3
9094390|NCT02034123|10159283|FG004|STARTED|Part1(Median of 7.286 Weeks of Exposure)||7
9094391|NCT02034123|10159284|FG005|STARTED|Part1(Median of 7.286 Weeks of Exposure)||3
9094392|NCT02034123|10159285|FG006|STARTED|Part1(Median of 7.286 Weeks of Exposure)||2
9094393|NCT02034123|10159286|FG007|STARTED|Part1(Median of 7.286 Weeks of Exposure)||5
9094394|NCT02034123|10159287|FG008|STARTED|Part1(Median of 7.286 Weeks of Exposure)||2
9094395|NCT02034123|10159288|FG009|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
9094396|NCT02034123|10159289|FG010|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
9094397|NCT02034123|10159290|FG011|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
9094398|NCT02034123|10159291|FG012|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
9094399|NCT02034123|10159292|FG013|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
9094400|NCT02034123|10159293|FG014|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
9094401|NCT02034123|10159294|FG015|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
9094402|NCT02034123|10159295|FG016|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
8845400|NCT01716520|9900045|FG004|NOT COMPLETED|Treatment Period 1 (14 Days)||0
8845401|NCT01716520|9900046|FG005|NOT COMPLETED|Treatment Period 1 (14 Days)||1
8845402|NCT01716520|9900041|FG000|STARTED|Washout Period 1 (10 to 14 Days)||29
8845403|NCT01716520|9900042|FG001|STARTED|Washout Period 1 (10 to 14 Days)||29
8845404|NCT01716520|9900043|FG002|STARTED|Washout Period 1 (10 to 14 Days)||28
8845405|NCT01716520|9900044|FG003|STARTED|Washout Period 1 (10 to 14 Days)||29
8845406|NCT01716520|9900045|FG004|STARTED|Washout Period 1 (10 to 14 Days)||31
8845407|NCT01716520|9900046|FG005|STARTED|Washout Period 1 (10 to 14 Days)||29
8845408|NCT01716520|9900041|FG000|COMPLETED|Washout Period 1 (10 to 14 Days)||29
8845409|NCT01716520|9900042|FG001|COMPLETED|Washout Period 1 (10 to 14 Days)||28
8845410|NCT01716520|9900043|FG002|COMPLETED|Washout Period 1 (10 to 14 Days)||27
8845411|NCT01716520|9900044|FG003|COMPLETED|Washout Period 1 (10 to 14 Days)||29
8845412|NCT01716520|9900045|FG004|COMPLETED|Washout Period 1 (10 to 14 Days)||31
8845413|NCT01716520|9900046|FG005|COMPLETED|Washout Period 1 (10 to 14 Days)||27
8845414|NCT01716520|9900041|FG000|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
8845415|NCT01716520|9900042|FG001|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||1
8845416|NCT01716520|9900043|FG002|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||1
8845417|NCT01716520|9900044|FG003|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
8845418|NCT01716520|9900045|FG004|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
8845419|NCT01716520|9900046|FG005|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||2
8845420|NCT01716520|9900041|FG000|STARTED|Treatment Period 2 (14 Days)||29
8845421|NCT01716520|9900042|FG001|STARTED|Treatment Period 2 (14 Days)||28
8845422|NCT01716520|9900043|FG002|STARTED|Treatment Period 2 (14 Days)||27
8845423|NCT01716520|9900044|FG003|STARTED|Treatment Period 2 (14 Days)||29
8845424|NCT01716520|9900045|FG004|STARTED|Treatment Period 2 (14 Days)||31
8845425|NCT01716520|9900046|FG005|STARTED|Treatment Period 2 (14 Days)||27
8845426|NCT01716520|9900041|FG000|COMPLETED|Treatment Period 2 (14 Days)||29
8845427|NCT01716520|9900042|FG001|COMPLETED|Treatment Period 2 (14 Days)||28
8845428|NCT01716520|9900043|FG002|COMPLETED|Treatment Period 2 (14 Days)||27
8845429|NCT01716520|9900044|FG003|COMPLETED|Treatment Period 2 (14 Days)||28
8845430|NCT01716520|9900045|FG004|COMPLETED|Treatment Period 2 (14 Days)||29
8845431|NCT01716520|9900046|FG005|COMPLETED|Treatment Period 2 (14 Days)||27
8845432|NCT01716520|9900041|FG000|NOT COMPLETED|Treatment Period 2 (14 Days)||0
8845433|NCT01716520|9900042|FG001|NOT COMPLETED|Treatment Period 2 (14 Days)||0
8845434|NCT01716520|9900043|FG002|NOT COMPLETED|Treatment Period 2 (14 Days)||0
8845435|NCT01716520|9900044|FG003|NOT COMPLETED|Treatment Period 2 (14 Days)||1
8845436|NCT01716520|9900045|FG004|NOT COMPLETED|Treatment Period 2 (14 Days)||2
8845437|NCT01716520|9900046|FG005|NOT COMPLETED|Treatment Period 2 (14 Days)||0
8845438|NCT01716520|9900041|FG000|STARTED|Washout Period 2 (10 to 14 Days)||29
8845439|NCT01716520|9900042|FG001|STARTED|Washout Period 2 (10 to 14 Days)||28
8845440|NCT01716520|9900043|FG002|STARTED|Washout Period 2 (10 to 14 Days)||27
8845441|NCT01716520|9900044|FG003|STARTED|Washout Period 2 (10 to 14 Days)||28
8845442|NCT01716520|9900045|FG004|STARTED|Washout Period 2 (10 to 14 Days)||29
8845443|NCT01716520|9900046|FG005|STARTED|Washout Period 2 (10 to 14 Days)||27
8845444|NCT01716520|9900041|FG000|COMPLETED|Washout Period 2 (10 to 14 Days)||27
9094403|NCT02034123|10159296|FG017|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
8845445|NCT01716520|9900042|FG001|COMPLETED|Washout Period 2 (10 to 14 Days)||27
8845446|NCT01716520|9900043|FG002|COMPLETED|Washout Period 2 (10 to 14 Days)||26
8845447|NCT01716520|9900044|FG003|COMPLETED|Washout Period 2 (10 to 14 Days)||28
8845448|NCT01716520|9900045|FG004|COMPLETED|Washout Period 2 (10 to 14 Days)||29
8845449|NCT01716520|9900046|FG005|COMPLETED|Washout Period 2 (10 to 14 Days)||25
8845450|NCT01716520|9900041|FG000|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||2
8845451|NCT01716520|9900042|FG001|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||1
9094404|NCT02034123|10159279|FG000|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||1
9094405|NCT02034123|10159280|FG001|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||1
9094406|NCT02034123|10159281|FG002|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||5
9094407|NCT02034123|10159282|FG003|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||1
9094408|NCT02034123|10159283|FG004|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||5
9094409|NCT02034123|10159284|FG005|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||3
9094410|NCT02034123|10159285|FG006|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||2
9094411|NCT02034123|10159286|FG007|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||4
9094412|NCT02034123|10159287|FG008|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
9094413|NCT02034123|10159288|FG009|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
9094414|NCT02034123|10159289|FG010|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
9094415|NCT02034123|10159290|FG011|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
9094416|NCT02034123|10159291|FG012|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
9094417|NCT02034123|10159292|FG013|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
9094418|NCT02034123|10159293|FG014|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
9094419|NCT02034123|10159294|FG015|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
9094420|NCT02034123|10159295|FG016|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
9094421|NCT02034123|10159296|FG017|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
9094422|NCT02034123|10159279|FG000|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
9094423|NCT02034123|10159280|FG001|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
9094424|NCT02034123|10159281|FG002|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
8845452|NCT01716520|9900043|FG002|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||1
8845453|NCT01716520|9900044|FG003|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
8845454|NCT01716520|9900045|FG004|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
8845455|NCT01716520|9900046|FG005|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||2
8845456|NCT01716520|9900041|FG000|STARTED|Treatment Period 3 (14 Days)||27
8845457|NCT01716520|9900042|FG001|STARTED|Treatment Period 3 (14 Days)||27
8845458|NCT01716520|9900043|FG002|STARTED|Treatment Period 3 (14 Days)||26
8845459|NCT01716520|9900044|FG003|STARTED|Treatment Period 3 (14 Days)||28
8845460|NCT01716520|9900045|FG004|STARTED|Treatment Period 3 (14 Days)||29
8845461|NCT01716520|9900046|FG005|STARTED|Treatment Period 3 (14 Days)||25
8845462|NCT01716520|9900041|FG000|COMPLETED|Treatment Period 3 (14 Days)||27
8845463|NCT01716520|9900042|FG001|COMPLETED|Treatment Period 3 (14 Days)||27
8845464|NCT01716520|9900043|FG002|COMPLETED|Treatment Period 3 (14 Days)||25
8845465|NCT01716520|9900044|FG003|COMPLETED|Treatment Period 3 (14 Days)||28
8845466|NCT01716520|9900045|FG004|COMPLETED|Treatment Period 3 (14 Days)||29
8845467|NCT01716520|9900046|FG005|COMPLETED|Treatment Period 3 (14 Days)||23
8845468|NCT01716520|9900041|FG000|NOT COMPLETED|Treatment Period 3 (14 Days)||0
8845469|NCT01716520|9900042|FG001|NOT COMPLETED|Treatment Period 3 (14 Days)||0
8845470|NCT01716520|9900043|FG002|NOT COMPLETED|Treatment Period 3 (14 Days)||1
8845471|NCT01716520|9900044|FG003|NOT COMPLETED|Treatment Period 3 (14 Days)||0
8845472|NCT01716520|9900045|FG004|NOT COMPLETED|Treatment Period 3 (14 Days)||0
8845473|NCT01716520|9900046|FG005|NOT COMPLETED|Treatment Period 3 (14 Days)||2
8845474|NCT01716533|9900058|FG000|STARTED|Overall Study||7
8845475|NCT01716533|9900059|FG001|STARTED|Overall Study||25
8845476|NCT01716533|9900060|FG002|STARTED|Overall Study||5
8845477|NCT01716533|9900061|FG003|STARTED|Overall Study||9
8845478|NCT01716533|9900058|FG000|COMPLETED|Overall Study||7
8845479|NCT01716533|9900059|FG001|COMPLETED|Overall Study||25
8845480|NCT01716533|9900060|FG002|COMPLETED|Overall Study||0
8845481|NCT01716533|9900061|FG003|COMPLETED|Overall Study||1
8845482|NCT01716533|9900058|FG000|NOT COMPLETED|Overall Study||0
8845483|NCT01716533|9900059|FG001|NOT COMPLETED|Overall Study||0
8845484|NCT01716533|9900060|FG002|NOT COMPLETED|Overall Study||5
8845485|NCT01716533|9900061|FG003|NOT COMPLETED|Overall Study||8
8845486|NCT01716559|9900075|FG000|STARTED|Overall Study||160
8845487|NCT01716559|9900075|FG000|COMPLETED|Overall Study||49
8845488|NCT01716559|9900075|FG000|NOT COMPLETED|Overall Study||111
8845489|NCT01716585|9900081|FG000|STARTED|Double-blind Treatment||477
8845490|NCT01716585|9900082|FG001|STARTED|Double-blind Treatment||159
8845491|NCT01716585|9900081|FG000|Randomized But Not Treated|Double-blind Treatment||4
8845492|NCT01716585|9900082|FG001|Randomized But Not Treated|Double-blind Treatment||1
8845493|NCT01716585|9900081|FG000|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|464
8845494|NCT01716585|9900082|FG001|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|157
8845495|NCT01716585|9900081|FG000|NOT COMPLETED|Double-blind Treatment||13
8845496|NCT01716585|9900082|FG001|NOT COMPLETED|Double-blind Treatment||2
8845497|NCT01716585|9900081|FG000|STARTED|Open-label Treatment|not applicable to this arm|0
8845498|NCT01716585|9900082|FG001|STARTED|Open-label Treatment||157
8845499|NCT01716585|9900081|FG000|COMPLETED|Open-label Treatment|not applicable to this arm|0
8845500|NCT01716585|9900082|FG001|COMPLETED|Open-label Treatment|The number of participants who completed open-label study drug.|150
8845501|NCT01716585|9900081|FG000|NOT COMPLETED|Open-label Treatment||0
8845502|NCT01716585|9900082|FG001|NOT COMPLETED|Open-label Treatment||7
8845503|NCT01716663|9900089|FG000|STARTED|Overall Study|Enrolled = signed informed consent and met eligibility requirements|234
8845504|NCT01716663|9900089|FG000|Safety|Overall Study|Enrolled patients who had a study device inserted.|230
8845505|NCT01716663|9900089|FG000|COMPLETED|Overall Study|Effectiveness population = enrolled and treated (study device inserted and RF energy applied)|228
8845506|NCT01716663|9900089|FG000|NOT COMPLETED|Overall Study||6
9094425|NCT02034123|10159282|FG003|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||2
9094426|NCT02034123|10159283|FG004|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||2
9094427|NCT02034123|10159284|FG005|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
9094428|NCT02034123|10159285|FG006|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
9094429|NCT02034123|10159286|FG007|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||1
9094430|NCT02034123|10159287|FG008|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||2
9094431|NCT02034123|10159288|FG009|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
9094432|NCT02034123|10159289|FG010|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
9094433|NCT02034123|10159290|FG011|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
9094434|NCT02034123|10159291|FG012|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
9094435|NCT02034123|10159292|FG013|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
9094436|NCT02034123|10159293|FG014|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
9094437|NCT02034123|10159294|FG015|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
9094438|NCT02034123|10159295|FG016|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
9094439|NCT02034123|10159296|FG017|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
9094440|NCT02034123|10159279|FG000|STARTED|Part2(Up to 2 Years)||0
9094441|NCT02034123|10159280|FG001|STARTED|Part2(Up to 2 Years)||0
9094442|NCT02034123|10159281|FG002|STARTED|Part2(Up to 2 Years)||0
9094443|NCT02034123|10159282|FG003|STARTED|Part2(Up to 2 Years)||0
9094444|NCT02034123|10159283|FG004|STARTED|Part2(Up to 2 Years)||0
9094445|NCT02034123|10159284|FG005|STARTED|Part2(Up to 2 Years)||0
9094446|NCT02034123|10159285|FG006|STARTED|Part2(Up to 2 Years)||0
9094447|NCT02034123|10159286|FG007|STARTED|Part2(Up to 2 Years)||0
9094448|NCT02034123|10159287|FG008|STARTED|Part2(Up to 2 Years)||0
9094449|NCT02034123|10159288|FG009|STARTED|Part2(Up to 2 Years)||0
9094450|NCT02034123|10159289|FG010|STARTED|Part2(Up to 2 Years)||0
9094451|NCT02034123|10159290|FG011|STARTED|Part2(Up to 2 Years)||0
9094452|NCT02034123|10159291|FG012|STARTED|Part2(Up to 2 Years)||0
9094453|NCT02034123|10159292|FG013|STARTED|Part2(Up to 2 Years)||0
9094454|NCT02034123|10159293|FG014|STARTED|Part2(Up to 2 Years)||0
9094455|NCT02034123|10159294|FG015|STARTED|Part2(Up to 2 Years)||0
9094456|NCT02034123|10159295|FG016|STARTED|Part2(Up to 2 Years)||0
9094457|NCT02034123|10159296|FG017|STARTED|Part2(Up to 2 Years)||0
9094458|NCT02034123|10159279|FG000|COMPLETED|Part2(Up to 2 Years)||0
9094459|NCT02034123|10159280|FG001|COMPLETED|Part2(Up to 2 Years)||0
9094460|NCT02034123|10159281|FG002|COMPLETED|Part2(Up to 2 Years)||0
9094461|NCT02034123|10159282|FG003|COMPLETED|Part2(Up to 2 Years)||0
9094462|NCT02034123|10159283|FG004|COMPLETED|Part2(Up to 2 Years)||0
9094463|NCT02034123|10159284|FG005|COMPLETED|Part2(Up to 2 Years)||0
9094464|NCT02034123|10159285|FG006|COMPLETED|Part2(Up to 2 Years)||0
9094465|NCT02034123|10159286|FG007|COMPLETED|Part2(Up to 2 Years)||0
9094466|NCT02034123|10159287|FG008|COMPLETED|Part2(Up to 2 Years)||0
9094467|NCT02034123|10159288|FG009|COMPLETED|Part2(Up to 2 Years)||0
9094468|NCT02034123|10159289|FG010|COMPLETED|Part2(Up to 2 Years)||0
8845507|NCT01716715|9900095|FG000|STARTED|Overall Study||57
8845508|NCT01716715|9900096|FG001|STARTED|Overall Study||54
8845509|NCT01716715|9900095|FG000|COMPLETED|Overall Study||55
8845510|NCT01716715|9900096|FG001|COMPLETED|Overall Study||50
8845511|NCT01716715|9900095|FG000|NOT COMPLETED|Overall Study||2
8845512|NCT01716715|9900096|FG001|NOT COMPLETED|Overall Study||4
8845513|NCT01716754|9900108|FG000|STARTED|Overall Study||199
8845514|NCT01716754|9900109|FG001|STARTED|Overall Study||40
8845515|NCT01716754|9900110|FG002|STARTED|Overall Study||135
8845516|NCT01716754|9900111|FG003|STARTED|Overall Study||97
8845517|NCT01716754|9900108|FG000|FAS|Overall Study||199
8845518|NCT01716754|9900109|FG001|FAS|Overall Study||40
8845519|NCT01716754|9900110|FG002|FAS|Overall Study||131
8845520|NCT01716754|9900111|FG003|FAS|Overall Study||96
8845521|NCT01716754|9900108|FG000|Safety Set|Overall Study||199
8845522|NCT01716754|9900109|FG001|Safety Set|Overall Study||40
8845523|NCT01716754|9900110|FG002|Safety Set|Overall Study||131
8845524|NCT01716754|9900111|FG003|Safety Set|Overall Study||96
8845525|NCT01716754|9900108|FG000|COMPLETED|Overall Study||188
8845526|NCT01716754|9900109|FG001|COMPLETED|Overall Study||36
8845527|NCT01716754|9900110|FG002|COMPLETED|Overall Study||121
8845528|NCT01716754|9900111|FG003|COMPLETED|Overall Study||89
8845529|NCT01716754|9900108|FG000|NOT COMPLETED|Overall Study||11
8845530|NCT01716754|9900109|FG001|NOT COMPLETED|Overall Study||4
8845531|NCT01716754|9900110|FG002|NOT COMPLETED|Overall Study||14
8845532|NCT01716754|9900111|FG003|NOT COMPLETED|Overall Study||8
8850213|NCT01745952|9905470|FG000|COMPLETED|Overall Study||3
8850214|NCT01745952|9905471|FG001|COMPLETED|Overall Study|data of one patient not used due to no seizure diary entries on multiple occasions|3
8850215|NCT01745952|9905472|FG002|COMPLETED|Overall Study||3
8850216|NCT01745952|9905470|FG000|NOT COMPLETED|Overall Study||1
9094469|NCT02034123|10159290|FG011|COMPLETED|Part2(Up to 2 Years)||0
8850217|NCT01745952|9905471|FG001|NOT COMPLETED|Overall Study||1
8850218|NCT01745952|9905472|FG002|NOT COMPLETED|Overall Study||0
8850219|NCT01746017|9905497|FG000|STARTED|Period 1||2
8850220|NCT01746017|9905498|FG001|STARTED|Period 1||2
8850221|NCT01746017|9905499|FG002|STARTED|Period 1||2
8850222|NCT01746017|9905500|FG003|STARTED|Period 1||2
8850223|NCT01746017|9905501|FG004|STARTED|Period 1||2
8850224|NCT01746017|9905502|FG005|STARTED|Period 1||2
8850225|NCT01746017|9905503|FG006|STARTED|Period 1||3
8850226|NCT01746017|9905504|FG007|STARTED|Period 1||2
8850227|NCT01746017|9905505|FG008|STARTED|Period 1||3
9094470|NCT02034123|10159291|FG012|COMPLETED|Part2(Up to 2 Years)||0
9094471|NCT02034123|10159292|FG013|COMPLETED|Part2(Up to 2 Years)||0
9094472|NCT02034123|10159293|FG014|COMPLETED|Part2(Up to 2 Years)||0
9094473|NCT02034123|10159294|FG015|COMPLETED|Part2(Up to 2 Years)||0
9094474|NCT02034123|10159295|FG016|COMPLETED|Part2(Up to 2 Years)||0
9094475|NCT02034123|10159296|FG017|COMPLETED|Part2(Up to 2 Years)||0
9094476|NCT02034123|10159279|FG000|NOT COMPLETED|Part2(Up to 2 Years)||0
8845533|NCT01717001|9900122|FG000|STARTED|Overall Study||38
8845534|NCT01717001|9900123|FG001|STARTED|Overall Study||28
8845535|NCT01717001|9900122|FG000|COMPLETED|Overall Study||32
8845536|NCT01717001|9900123|FG001|COMPLETED|Overall Study||24
8845537|NCT01717001|9900122|FG000|NOT COMPLETED|Overall Study||6
8845538|NCT01717001|9900123|FG001|NOT COMPLETED|Overall Study||4
8845539|NCT01717014|9900129|FG000|STARTED|Overall Study||8
8845540|NCT01717014|9900129|FG000|COMPLETED|Overall Study||8
8845541|NCT01717014|9900129|FG000|NOT COMPLETED|Overall Study||0
8845542|NCT01717040|9900135|FG000|STARTED|Overall Study||17
8845543|NCT01717040|9900136|FG001|STARTED|Overall Study||20
8845544|NCT01717040|9900135|FG000|COMPLETED|Overall Study||12
8845545|NCT01717040|9900136|FG001|COMPLETED|Overall Study||15
8845546|NCT01717040|9900135|FG000|NOT COMPLETED|Overall Study||5
8845547|NCT01717040|9900136|FG001|NOT COMPLETED|Overall Study||5
8845548|NCT01717053|9900142|FG000|STARTED|Overall Study||37
8845549|NCT01717053|9900142|FG000|COMPLETED|Overall Study||33
8845550|NCT01717053|9900142|FG000|NOT COMPLETED|Overall Study||4
8723557|NCT01023815|9771083|FG001|STARTED|Pre-randomization Period (Day 1 to 90)||0
8723558|NCT01023815|9771084|FG002|STARTED|Pre-randomization Period (Day 1 to 90)||0
8723559|NCT01023815|9771085|FG003|STARTED|Pre-randomization Period (Day 1 to 90)||0
8723560|NCT01023815|9771082|FG000|COMPLETED|Pre-randomization Period (Day 1 to 90)||184
8723561|NCT01023815|9771083|FG001|COMPLETED|Pre-randomization Period (Day 1 to 90)||0
8723562|NCT01023815|9771084|FG002|COMPLETED|Pre-randomization Period (Day 1 to 90)||0
8723563|NCT01023815|9771085|FG003|COMPLETED|Pre-randomization Period (Day 1 to 90)||0
8723564|NCT01023815|9771082|FG000|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||144
8723565|NCT01023815|9771083|FG001|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||0
8723566|NCT01023815|9771084|FG002|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||0
8723567|NCT01023815|9771085|FG003|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||0
8845551|NCT01717209|9900146|FG000|STARTED|Overall Study||14
8845552|NCT01717209|9900146|FG000|COMPLETED|Overall Study||14
8845553|NCT01717209|9900146|FG000|NOT COMPLETED|Overall Study||0
8845554|NCT01717287|9900152|FG000|STARTED|Overall Study||4
8845555|NCT01717287|9900153|FG001|STARTED|Overall Study||28
8845556|NCT01717287|9900152|FG000|COMPLETED|Overall Study||4
8845557|NCT01717287|9900153|FG001|COMPLETED|Overall Study||25
8845558|NCT01717287|9900152|FG000|NOT COMPLETED|Overall Study||0
8845559|NCT01717287|9900153|FG001|NOT COMPLETED|Overall Study||3
8845560|NCT01717313|9900161|FG000|STARTED|Phase A (Weeks 0 to 24)||165
8845561|NCT01717313|9900162|FG001|STARTED|Phase A (Weeks 0 to 24)||164
8845562|NCT01717313|9900161|FG000|COMPLETED|Phase A (Weeks 0 to 24)||147
8845563|NCT01717313|9900162|FG001|COMPLETED|Phase A (Weeks 0 to 24)||151
8845564|NCT01717313|9900161|FG000|NOT COMPLETED|Phase A (Weeks 0 to 24)||18
8845565|NCT01717313|9900162|FG001|NOT COMPLETED|Phase A (Weeks 0 to 24)||13
8845566|NCT01717313|9900161|FG000|STARTED|Interphase||147
8845567|NCT01717313|9900162|FG001|STARTED|Interphase||151
8845568|NCT01717313|9900161|FG000|COMPLETED|Interphase||146
8845569|NCT01717313|9900162|FG001|COMPLETED|Interphase||151
8845570|NCT01717313|9900161|FG000|NOT COMPLETED|Interphase||1
8845571|NCT01717313|9900162|FG001|NOT COMPLETED|Interphase||0
8845572|NCT01717313|9900161|FG000|STARTED|Phase B (Weeks 24 to 54)||146
8845573|NCT01717313|9900162|FG001|STARTED|Phase B (Weeks 24 to 54)||151
8845574|NCT01717313|9900161|FG000|COMPLETED|Phase B (Weeks 24 to 54)||134
8845575|NCT01717313|9900162|FG001|COMPLETED|Phase B (Weeks 24 to 54)||135
8845576|NCT01717313|9900161|FG000|NOT COMPLETED|Phase B (Weeks 24 to 54)||12
8845577|NCT01717313|9900162|FG001|NOT COMPLETED|Phase B (Weeks 24 to 54)||16
8845578|NCT01717326|9900188|FG000|STARTED|Overall Study||25
8845579|NCT01717326|9900189|FG001|STARTED|Overall Study||27
8845580|NCT01717326|9900190|FG002|STARTED|Overall Study||13
8845581|NCT01717326|9900191|FG003|STARTED|Overall Study||30
8845582|NCT01717326|9900192|FG004|STARTED|Overall Study||33
8845583|NCT01717326|9900193|FG005|STARTED|Overall Study||31
8845584|NCT01717326|9900194|FG006|STARTED|Overall Study||31
8845585|NCT01717326|9900195|FG007|STARTED|Overall Study||29
8845586|NCT01717326|9900196|FG008|STARTED|Overall Study||32
8845587|NCT01717326|9900197|FG009|STARTED|Overall Study||31
8845588|NCT01717326|9900198|FG010|STARTED|Overall Study||32
8845589|NCT01717326|9900199|FG011|STARTED|Overall Study||33
8845590|NCT01717326|9900200|FG012|STARTED|Overall Study||33
8845591|NCT01717326|9900201|FG013|STARTED|Overall Study||32
9094477|NCT02034123|10159280|FG001|NOT COMPLETED|Part2(Up to 2 Years)||0
9094478|NCT02034123|10159281|FG002|NOT COMPLETED|Part2(Up to 2 Years)||0
9094479|NCT02034123|10159282|FG003|NOT COMPLETED|Part2(Up to 2 Years)||0
8845592|NCT01717326|9900202|FG014|STARTED|Overall Study||29
8845593|NCT01717326|9900203|FG015|STARTED|Overall Study||30
8845594|NCT01717326|9900204|FG016|STARTED|Overall Study||30
8845595|NCT01717326|9900205|FG017|STARTED|Overall Study||31
8845596|NCT01717326|9900206|FG018|STARTED|Overall Study||20
8845597|NCT01717326|9900207|FG019|STARTED|Overall Study||21
8845598|NCT01717326|9900188|FG000|Treated|Overall Study||25
8845599|NCT01717326|9900189|FG001|Treated|Overall Study|Number includes 1 additional participant randomized to A3 but treated on A2|28
9094480|NCT02034123|10159283|FG004|NOT COMPLETED|Part2(Up to 2 Years)||0
9094481|NCT02034123|10159284|FG005|NOT COMPLETED|Part2(Up to 2 Years)||0
9094482|NCT02034123|10159285|FG006|NOT COMPLETED|Part2(Up to 2 Years)||0
9094483|NCT02034123|10159286|FG007|NOT COMPLETED|Part2(Up to 2 Years)||0
9094484|NCT02034123|10159287|FG008|NOT COMPLETED|Part2(Up to 2 Years)||0
9094485|NCT02034123|10159288|FG009|NOT COMPLETED|Part2(Up to 2 Years)||0
8845600|NCT01717326|9900190|FG002|Treated|Overall Study|Number excludes 1 participant randomized to A3 but treated on Arm A2|12
8845601|NCT01717326|9900191|FG003|Treated|Overall Study||30
8845602|NCT01717326|9900192|FG004|Treated|Overall Study||33
8845603|NCT01717326|9900193|FG005|Treated|Overall Study||31
8845604|NCT01717326|9900194|FG006|Treated|Overall Study||31
8845605|NCT01717326|9900195|FG007|Treated|Overall Study||29
8845606|NCT01717326|9900196|FG008|Treated|Overall Study||32
8845607|NCT01717326|9900197|FG009|Treated|Overall Study||31
8845608|NCT01717326|9900198|FG010|Treated|Overall Study||32
8845609|NCT01717326|9900199|FG011|Treated|Overall Study||33
8845610|NCT01717326|9900200|FG012|Treated|Overall Study||33
8845611|NCT01717326|9900201|FG013|Treated|Overall Study||32
8845612|NCT01717326|9900202|FG014|Treated|Overall Study||29
8845613|NCT01717326|9900203|FG015|Treated|Overall Study||30
8845614|NCT01717326|9900204|FG016|Treated|Overall Study||30
8845615|NCT01717326|9900205|FG017|Treated|Overall Study||31
8845616|NCT01717326|9900206|FG018|Treated|Overall Study||20
8845617|NCT01717326|9900207|FG019|Treated|Overall Study||21
8845618|NCT01717326|9900188|FG000|COMPLETED|Overall Study||22
8845619|NCT01717326|9900189|FG001|COMPLETED|Overall Study||26
8845620|NCT01717326|9900190|FG002|COMPLETED|Overall Study||13
8845621|NCT01717326|9900191|FG003|COMPLETED|Overall Study||28
8845622|NCT01717326|9900192|FG004|COMPLETED|Overall Study||31
8845623|NCT01717326|9900193|FG005|COMPLETED|Overall Study||31
8845624|NCT01717326|9900194|FG006|COMPLETED|Overall Study||30
8845625|NCT01717326|9900195|FG007|COMPLETED|Overall Study||29
8845626|NCT01717326|9900196|FG008|COMPLETED|Overall Study||32
8845627|NCT01717326|9900197|FG009|COMPLETED|Overall Study||29
8845628|NCT01717326|9900198|FG010|COMPLETED|Overall Study||30
8845629|NCT01717326|9900199|FG011|COMPLETED|Overall Study||33
8845630|NCT01717326|9900200|FG012|COMPLETED|Overall Study||32
8845631|NCT01717326|9900201|FG013|COMPLETED|Overall Study||32
8845632|NCT01717326|9900202|FG014|COMPLETED|Overall Study||29
8845633|NCT01717326|9900203|FG015|COMPLETED|Overall Study||27
8845634|NCT01717326|9900204|FG016|COMPLETED|Overall Study||29
8845635|NCT01717326|9900205|FG017|COMPLETED|Overall Study||31
8845636|NCT01717326|9900206|FG018|COMPLETED|Overall Study||16
8845637|NCT01717326|9900207|FG019|COMPLETED|Overall Study||15
8845638|NCT01717326|9900188|FG000|NOT COMPLETED|Overall Study||3
8845639|NCT01717326|9900189|FG001|NOT COMPLETED|Overall Study||1
8845640|NCT01717326|9900190|FG002|NOT COMPLETED|Overall Study||0
8845641|NCT01717326|9900191|FG003|NOT COMPLETED|Overall Study||2
8845642|NCT01717326|9900192|FG004|NOT COMPLETED|Overall Study||2
8845643|NCT01717326|9900193|FG005|NOT COMPLETED|Overall Study||0
8845644|NCT01717326|9900194|FG006|NOT COMPLETED|Overall Study||1
8845645|NCT01717326|9900195|FG007|NOT COMPLETED|Overall Study||0
8845646|NCT01717326|9900196|FG008|NOT COMPLETED|Overall Study||0
8845647|NCT01717326|9900197|FG009|NOT COMPLETED|Overall Study||2
8845648|NCT01717326|9900198|FG010|NOT COMPLETED|Overall Study||2
8845649|NCT01717326|9900199|FG011|NOT COMPLETED|Overall Study||0
8845650|NCT01717326|9900200|FG012|NOT COMPLETED|Overall Study||1
8845651|NCT01717326|9900201|FG013|NOT COMPLETED|Overall Study||0
8845652|NCT01717326|9900202|FG014|NOT COMPLETED|Overall Study||0
8845653|NCT01717326|9900203|FG015|NOT COMPLETED|Overall Study||3
8845654|NCT01717326|9900204|FG016|NOT COMPLETED|Overall Study||1
8845655|NCT01717326|9900205|FG017|NOT COMPLETED|Overall Study||0
8845656|NCT01717326|9900206|FG018|NOT COMPLETED|Overall Study||4
8845657|NCT01717326|9900207|FG019|NOT COMPLETED|Overall Study||6
8845658|NCT01717391|9900249|FG000|STARTED|Overall Study||36
8845659|NCT01717391|9900249|FG000|COMPLETED|Overall Study||27
8845660|NCT01717391|9900249|FG000|NOT COMPLETED|Overall Study||9
8845661|NCT01717456|9900257|FG000|STARTED|End of Treatment||11
8845662|NCT01717456|9900258|FG001|STARTED|End of Treatment||8
8845663|NCT01717456|9900257|FG000|COMPLETED|End of Treatment||11
8845664|NCT01717456|9900258|FG001|COMPLETED|End of Treatment||6
8845665|NCT01717456|9900257|FG000|NOT COMPLETED|End of Treatment||0
8845666|NCT01717456|9900258|FG001|NOT COMPLETED|End of Treatment||2
8845667|NCT01717456|9900257|FG000|STARTED|Follow-Up 6 Months After End of Tx||11
8845668|NCT01717456|9900258|FG001|STARTED|Follow-Up 6 Months After End of Tx||6
8845669|NCT01717456|9900257|FG000|COMPLETED|Follow-Up 6 Months After End of Tx||7
8845670|NCT01717456|9900258|FG001|COMPLETED|Follow-Up 6 Months After End of Tx||2
8845671|NCT01717456|9900257|FG000|NOT COMPLETED|Follow-Up 6 Months After End of Tx||4
8845672|NCT01717456|9900258|FG001|NOT COMPLETED|Follow-Up 6 Months After End of Tx||4
8845673|NCT01717521|9900265|FG000|STARTED|Overall Study||20
8845674|NCT01717521|9900265|FG000|COMPLETED|Overall Study||20
8845675|NCT01717521|9900265|FG000|NOT COMPLETED|Overall Study||0
8845676|NCT01717638|9900282|FG000|STARTED|Overall Study||67
8845677|NCT01717638|9900283|FG001|STARTED|Overall Study||61
8845678|NCT01717638|9900284|FG002|STARTED|Overall Study||60
8845679|NCT01717638|9900285|FG003|STARTED|Overall Study||66
8845680|NCT01717638|9900286|FG004|STARTED|Overall Study||64
8845681|NCT01717638|9900287|FG005|STARTED|Overall Study||55
8845682|NCT01717638|9900288|FG006|STARTED|Overall Study||43
8845683|NCT01717638|9900289|FG007|STARTED|Overall Study||29
8845684|NCT01717638|9900290|FG008|STARTED|Overall Study||28
8845685|NCT01717638|9900291|FG009|STARTED|Overall Study||100
9094486|NCT02034123|10159289|FG010|NOT COMPLETED|Part2(Up to 2 Years)||0
9094487|NCT02034123|10159290|FG011|NOT COMPLETED|Part2(Up to 2 Years)||0
9094488|NCT02034123|10159291|FG012|NOT COMPLETED|Part2(Up to 2 Years)||0
9094489|NCT02034123|10159292|FG013|NOT COMPLETED|Part2(Up to 2 Years)||0
9094490|NCT02034123|10159293|FG014|NOT COMPLETED|Part2(Up to 2 Years)||0
9094491|NCT02034123|10159294|FG015|NOT COMPLETED|Part2(Up to 2 Years)||0
9094492|NCT02034123|10159295|FG016|NOT COMPLETED|Part2(Up to 2 Years)||0
9094493|NCT02034123|10159296|FG017|NOT COMPLETED|Part2(Up to 2 Years)||0
8845686|NCT01717638|9900292|FG010|STARTED|Overall Study||11
8845687|NCT01717638|9900293|FG011|STARTED|Overall Study||12
8845688|NCT01717638|9900294|FG012|STARTED|Overall Study||209
8845689|NCT01717638|9900282|FG000|COMPLETED|Overall Study||67
8845690|NCT01717638|9900283|FG001|COMPLETED|Overall Study||60
8845691|NCT01717638|9900284|FG002|COMPLETED|Overall Study||59
8845692|NCT01717638|9900285|FG003|COMPLETED|Overall Study||66
8845693|NCT01717638|9900286|FG004|COMPLETED|Overall Study||63
8845694|NCT01717638|9900287|FG005|COMPLETED|Overall Study||54
8845695|NCT01717638|9900288|FG006|COMPLETED|Overall Study||41
8845696|NCT01717638|9900289|FG007|COMPLETED|Overall Study||28
8845697|NCT01717638|9900290|FG008|COMPLETED|Overall Study||26
8845698|NCT01717638|9900291|FG009|COMPLETED|Overall Study||99
8845699|NCT01717638|9900292|FG010|COMPLETED|Overall Study||11
8845700|NCT01717638|9900293|FG011|COMPLETED|Overall Study||12
8845701|NCT01717638|9900294|FG012|COMPLETED|Overall Study||190
8845702|NCT01717638|9900282|FG000|NOT COMPLETED|Overall Study||0
8845703|NCT01717638|9900283|FG001|NOT COMPLETED|Overall Study||1
8845704|NCT01717638|9900284|FG002|NOT COMPLETED|Overall Study||1
8845705|NCT01717638|9900285|FG003|NOT COMPLETED|Overall Study||0
8845706|NCT01717638|9900286|FG004|NOT COMPLETED|Overall Study||1
8845707|NCT01717638|9900287|FG005|NOT COMPLETED|Overall Study||1
8845708|NCT01717638|9900288|FG006|NOT COMPLETED|Overall Study||2
8845709|NCT01717638|9900289|FG007|NOT COMPLETED|Overall Study||1
8845710|NCT01717638|9900290|FG008|NOT COMPLETED|Overall Study||2
8845711|NCT01717638|9900291|FG009|NOT COMPLETED|Overall Study||1
8845712|NCT01717638|9900292|FG010|NOT COMPLETED|Overall Study||0
8845713|NCT01717638|9900293|FG011|NOT COMPLETED|Overall Study||0
8845714|NCT01717638|9900294|FG012|NOT COMPLETED|Overall Study||19
8845715|NCT01717742|9900330|FG000|STARTED|Overall Study||48
8845716|NCT01717742|9900331|FG001|STARTED|Overall Study||49
8845717|NCT01717742|9900330|FG000|COMPLETED|Overall Study||43
8845718|NCT01717742|9900331|FG001|COMPLETED|Overall Study||47
8845719|NCT01717742|9900330|FG000|NOT COMPLETED|Overall Study||5
8845720|NCT01717742|9900331|FG001|NOT COMPLETED|Overall Study||2
8845721|NCT01717768|9900347|FG000|STARTED|Part 1 (Duration of 15 Days)||17
8845722|NCT01717768|9900348|FG001|STARTED|Part 1 (Duration of 15 Days)||17
8845723|NCT01717768|9900349|FG002|STARTED|Part 1 (Duration of 15 Days)||0
8845724|NCT01717768|9900350|FG003|STARTED|Part 1 (Duration of 15 Days)||0
8845725|NCT01717768|9900351|FG004|STARTED|Part 1 (Duration of 15 Days)||0
8845726|NCT01717768|9900352|FG005|STARTED|Part 1 (Duration of 15 Days)||0
8845727|NCT01717768|9900353|FG006|STARTED|Part 1 (Duration of 15 Days)||0
8845728|NCT01717768|9900354|FG007|STARTED|Part 1 (Duration of 15 Days)||0
8845729|NCT01717768|9900355|FG008|STARTED|Part 1 (Duration of 15 Days)||0
8845730|NCT01717768|9900356|FG009|STARTED|Part 1 (Duration of 15 Days)||0
8845731|NCT01717768|9900357|FG010|STARTED|Part 1 (Duration of 15 Days)||0
8845732|NCT01717768|9900358|FG011|STARTED|Part 1 (Duration of 15 Days)||0
8845733|NCT01717768|9900347|FG000|COMPLETED|Part 1 (Duration of 15 Days)||17
8845734|NCT01717768|9900348|FG001|COMPLETED|Part 1 (Duration of 15 Days)||16
8845735|NCT01717768|9900349|FG002|COMPLETED|Part 1 (Duration of 15 Days)||0
8845736|NCT01717768|9900350|FG003|COMPLETED|Part 1 (Duration of 15 Days)||0
8845737|NCT01717768|9900351|FG004|COMPLETED|Part 1 (Duration of 15 Days)||0
8845738|NCT01717768|9900352|FG005|COMPLETED|Part 1 (Duration of 15 Days)||0
8845739|NCT01717768|9900353|FG006|COMPLETED|Part 1 (Duration of 15 Days)||0
8845740|NCT01717768|9900354|FG007|COMPLETED|Part 1 (Duration of 15 Days)||0
8845741|NCT01717768|9900355|FG008|COMPLETED|Part 1 (Duration of 15 Days)||0
8845742|NCT01717768|9900356|FG009|COMPLETED|Part 1 (Duration of 15 Days)||0
8845743|NCT01717768|9900357|FG010|COMPLETED|Part 1 (Duration of 15 Days)||0
8845744|NCT01717768|9900358|FG011|COMPLETED|Part 1 (Duration of 15 Days)||0
8845745|NCT01717768|9900347|FG000|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
8845746|NCT01717768|9900348|FG001|NOT COMPLETED|Part 1 (Duration of 15 Days)||1
8845747|NCT01717768|9900349|FG002|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
8845748|NCT01717768|9900350|FG003|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
8845749|NCT01717768|9900351|FG004|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
8845750|NCT01717768|9900352|FG005|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
8845751|NCT01717768|9900353|FG006|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
8845752|NCT01717768|9900354|FG007|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
8845753|NCT01717768|9900355|FG008|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
9094494|NCT02040584|10159341|FG000|STARTED|Overall Study||105
8845754|NCT01717768|9900356|FG009|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
8845755|NCT01717768|9900357|FG010|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
8845756|NCT01717768|9900358|FG011|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
8845757|NCT01717768|9900347|FG000|STARTED|Part 2 (Duration of 15 Days)||0
8845758|NCT01717768|9900348|FG001|STARTED|Part 2 (Duration of 15 Days)||0
8845759|NCT01717768|9900349|FG002|STARTED|Part 2 (Duration of 15 Days)||17
8845760|NCT01717768|9900350|FG003|STARTED|Part 2 (Duration of 15 Days)||0
8845761|NCT01717768|9900351|FG004|STARTED|Part 2 (Duration of 15 Days)||0
8845762|NCT01717768|9900352|FG005|STARTED|Part 2 (Duration of 15 Days)||0
8845763|NCT01717768|9900353|FG006|STARTED|Part 2 (Duration of 15 Days)||0
8845764|NCT01717768|9900354|FG007|STARTED|Part 2 (Duration of 15 Days)||0
8845765|NCT01717768|9900355|FG008|STARTED|Part 2 (Duration of 15 Days)||0
8845766|NCT01717768|9900356|FG009|STARTED|Part 2 (Duration of 15 Days)||0
8845767|NCT01717768|9900357|FG010|STARTED|Part 2 (Duration of 15 Days)||0
8845768|NCT01717768|9900358|FG011|STARTED|Part 2 (Duration of 15 Days)||0
8845769|NCT01717768|9900347|FG000|COMPLETED|Part 2 (Duration of 15 Days)||0
8845770|NCT01717768|9900348|FG001|COMPLETED|Part 2 (Duration of 15 Days)||0
8845771|NCT01717768|9900349|FG002|COMPLETED|Part 2 (Duration of 15 Days)||17
8845772|NCT01717768|9900350|FG003|COMPLETED|Part 2 (Duration of 15 Days)||0
8845773|NCT01717768|9900351|FG004|COMPLETED|Part 2 (Duration of 15 Days)||0
8845774|NCT01717768|9900352|FG005|COMPLETED|Part 2 (Duration of 15 Days)||0
8845775|NCT01717768|9900353|FG006|COMPLETED|Part 2 (Duration of 15 Days)||0
8845776|NCT01717768|9900354|FG007|COMPLETED|Part 2 (Duration of 15 Days)||0
8845777|NCT01717768|9900355|FG008|COMPLETED|Part 2 (Duration of 15 Days)||0
8845778|NCT01717768|9900356|FG009|COMPLETED|Part 2 (Duration of 15 Days)||0
8845779|NCT01717768|9900357|FG010|COMPLETED|Part 2 (Duration of 15 Days)||0
8845780|NCT01717768|9900358|FG011|COMPLETED|Part 2 (Duration of 15 Days)||0
8845781|NCT01717768|9900347|FG000|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
8845782|NCT01717768|9900348|FG001|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
8845783|NCT01717768|9900349|FG002|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
8845784|NCT01717768|9900350|FG003|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
8845785|NCT01717768|9900351|FG004|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
8845786|NCT01717768|9900352|FG005|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
8845787|NCT01717768|9900353|FG006|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
8845788|NCT01717768|9900354|FG007|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
8845789|NCT01717768|9900355|FG008|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
8845790|NCT01717768|9900356|FG009|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
8845791|NCT01717768|9900357|FG010|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
8845792|NCT01717768|9900358|FG011|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
8845793|NCT01717768|9900347|FG000|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8845794|NCT01717768|9900348|FG001|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8845795|NCT01717768|9900349|FG002|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8845796|NCT01717768|9900350|FG003|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||4
8845797|NCT01717768|9900351|FG004|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||5
8845798|NCT01717768|9900352|FG005|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||5
8845799|NCT01717768|9900353|FG006|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8845800|NCT01717768|9900354|FG007|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8845801|NCT01717768|9900355|FG008|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8845802|NCT01717768|9900356|FG009|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8845803|NCT01717768|9900357|FG010|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8845804|NCT01717768|9900358|FG011|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8845805|NCT01717768|9900347|FG000|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8845806|NCT01717768|9900348|FG001|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8845807|NCT01717768|9900349|FG002|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8845808|NCT01717768|9900350|FG003|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||4
8845809|NCT01717768|9900351|FG004|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||5
8845810|NCT01717768|9900352|FG005|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||5
8845811|NCT01717768|9900353|FG006|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8845812|NCT01717768|9900354|FG007|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8845813|NCT01717768|9900355|FG008|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8845814|NCT01717768|9900356|FG009|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8845815|NCT01717768|9900357|FG010|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8845816|NCT01717768|9900358|FG011|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8845817|NCT01717768|9900347|FG000|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8845818|NCT01717768|9900348|FG001|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8845819|NCT01717768|9900349|FG002|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8845820|NCT01717768|9900350|FG003|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8845821|NCT01717768|9900351|FG004|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8845822|NCT01717768|9900352|FG005|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8845823|NCT01717768|9900353|FG006|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8845824|NCT01717768|9900354|FG007|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8845825|NCT01717768|9900355|FG008|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8850228|NCT01746017|9905506|FG009|STARTED|Period 1||3
9094495|NCT02040584|10159342|FG001|STARTED|Overall Study||106
9094496|NCT02040584|10159341|FG000|COMPLETED|Overall Study||70
9094497|NCT02040584|10159342|FG001|COMPLETED|Overall Study||74
9094498|NCT02040584|10159341|FG000|NOT COMPLETED|Overall Study||35
9094499|NCT02040584|10159342|FG001|NOT COMPLETED|Overall Study||32
8625485|NCT00507689|9665067|FG000|STARTED|Pre-Randomization Period||40
8625486|NCT00507689|9665068|FG001|STARTED|Pre-Randomization Period||0
8625487|NCT00507689|9665067|FG000|COMPLETED|Pre-Randomization Period||37
8625488|NCT00507689|9665068|FG001|COMPLETED|Pre-Randomization Period||0
9094500|NCT02045797|10159361|FG000|STARTED|Overall Study||58
9094501|NCT02045797|10159362|FG001|STARTED|Overall Study||39
9094502|NCT02045797|10159363|FG002|STARTED|Overall Study||25
9094503|NCT02045797|10159361|FG000|COMPLETED|Overall Study||51
9094504|NCT02045797|10159362|FG001|COMPLETED|Overall Study||32
9094505|NCT02045797|10159363|FG002|COMPLETED|Overall Study||24
9094506|NCT02045797|10159361|FG000|NOT COMPLETED|Overall Study||7
9094507|NCT02045797|10159362|FG001|NOT COMPLETED|Overall Study||7
9094508|NCT02045797|10159363|FG002|NOT COMPLETED|Overall Study||1
9094509|NCT02049710|10159373|FG000|STARTED|Overall Study||653
9094510|NCT02049710|10159374|FG001|STARTED|Overall Study||664
9094511|NCT02049710|10159373|FG000|COMPLETED|Overall Study||334
9094512|NCT02049710|10159374|FG001|COMPLETED|Overall Study||340
9094513|NCT02049710|10159373|FG000|NOT COMPLETED|Overall Study||319
9094514|NCT02049710|10159374|FG001|NOT COMPLETED|Overall Study||324
9094515|NCT02055547|10159380|FG000|STARTED|Overall Study||2
9094516|NCT02055547|10159381|FG001|STARTED|Overall Study||2
9094517|NCT02055547|10159382|FG002|STARTED|Overall Study||5
9094518|NCT02055547|10159383|FG003|STARTED|Overall Study||2
9094519|NCT02055547|10159384|FG004|STARTED|Overall Study||2
9094520|NCT02055547|10159385|FG005|STARTED|Overall Study||2
9094521|NCT02055547|10159386|FG006|STARTED|Overall Study||2
9094522|NCT02055547|10159387|FG007|STARTED|Overall Study||6
9094523|NCT02055547|10159388|FG008|STARTED|Overall Study||6
9094524|NCT02055547|10159389|FG009|STARTED|Overall Study||6
9094525|NCT02055547|10159390|FG010|STARTED|Overall Study||6
9094526|NCT02055547|10159391|FG011|STARTED|Overall Study||6
9094527|NCT02055547|10159392|FG012|STARTED|Overall Study||2
9094528|NCT02055547|10159393|FG013|STARTED|Overall Study||2
9094529|NCT02055547|10159394|FG014|STARTED|Overall Study||2
9094530|NCT02055547|10159395|FG015|STARTED|Overall Study||2
9094531|NCT02055547|10159396|FG016|STARTED|Overall Study||2
9094532|NCT02055547|10159397|FG017|STARTED|Overall Study||2
9094533|NCT02055547|10159398|FG018|STARTED|Overall Study||2
9094534|NCT02055547|10159380|FG000|COMPLETED|Overall Study||2
9094535|NCT02055547|10159381|FG001|COMPLETED|Overall Study||1
9094536|NCT02055547|10159382|FG002|COMPLETED|Overall Study||2
9094537|NCT02055547|10159383|FG003|COMPLETED|Overall Study||2
9094538|NCT02055547|10159384|FG004|COMPLETED|Overall Study||1
9094539|NCT02055547|10159385|FG005|COMPLETED|Overall Study||1
8845826|NCT01717768|9900356|FG009|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8845827|NCT01717768|9900357|FG010|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8845828|NCT01717768|9900358|FG011|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8845829|NCT01717768|9900347|FG000|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8845830|NCT01717768|9900348|FG001|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8845831|NCT01717768|9900349|FG002|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8845832|NCT01717768|9900350|FG003|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||4
8845833|NCT01717768|9900351|FG004|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||5
8845834|NCT01717768|9900352|FG005|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||5
8845835|NCT01717768|9900353|FG006|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8845836|NCT01717768|9900354|FG007|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8845837|NCT01717768|9900355|FG008|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8845838|NCT01717768|9900356|FG009|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8845839|NCT01717768|9900357|FG010|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8845840|NCT01717768|9900358|FG011|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8845841|NCT01717768|9900347|FG000|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8845842|NCT01717768|9900348|FG001|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8845843|NCT01717768|9900349|FG002|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8845844|NCT01717768|9900350|FG003|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||4
8845845|NCT01717768|9900351|FG004|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||5
8845846|NCT01717768|9900352|FG005|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||5
8845847|NCT01717768|9900353|FG006|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8845848|NCT01717768|9900354|FG007|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8845849|NCT01717768|9900355|FG008|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8845850|NCT01717768|9900356|FG009|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8845851|NCT01717768|9900357|FG010|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8845852|NCT01717768|9900358|FG011|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8845853|NCT01717768|9900347|FG000|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8845854|NCT01717768|9900348|FG001|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8845855|NCT01717768|9900349|FG002|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8845856|NCT01717768|9900350|FG003|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8850229|NCT01746017|9905507|FG010|STARTED|Period 1||3
9094540|NCT02055547|10159386|FG006|COMPLETED|Overall Study||0
9094541|NCT02055547|10159387|FG007|COMPLETED|Overall Study||6
9094542|NCT02055547|10159388|FG008|COMPLETED|Overall Study||4
9094543|NCT02055547|10159389|FG009|COMPLETED|Overall Study||5
9094544|NCT02055547|10159390|FG010|COMPLETED|Overall Study||5
9094545|NCT02055547|10159391|FG011|COMPLETED|Overall Study||6
9094546|NCT02055547|10159392|FG012|COMPLETED|Overall Study||2
9094547|NCT02055547|10159393|FG013|COMPLETED|Overall Study||1
9094548|NCT02055547|10159394|FG014|COMPLETED|Overall Study||2
9094549|NCT02055547|10159395|FG015|COMPLETED|Overall Study||1
9094550|NCT02055547|10159396|FG016|COMPLETED|Overall Study||2
9094551|NCT02055547|10159397|FG017|COMPLETED|Overall Study||2
9094552|NCT02055547|10159398|FG018|COMPLETED|Overall Study||2
9094553|NCT02055547|10159380|FG000|NOT COMPLETED|Overall Study||0
9094554|NCT02055547|10159381|FG001|NOT COMPLETED|Overall Study||1
9094555|NCT02055547|10159382|FG002|NOT COMPLETED|Overall Study||3
9094556|NCT02055547|10159383|FG003|NOT COMPLETED|Overall Study||0
9094557|NCT02055547|10159384|FG004|NOT COMPLETED|Overall Study||1
9094558|NCT02055547|10159385|FG005|NOT COMPLETED|Overall Study||1
9094559|NCT02055547|10159386|FG006|NOT COMPLETED|Overall Study||2
9094560|NCT02055547|10159387|FG007|NOT COMPLETED|Overall Study||0
9094561|NCT02055547|10159388|FG008|NOT COMPLETED|Overall Study||2
9094562|NCT02055547|10159389|FG009|NOT COMPLETED|Overall Study||1
9094563|NCT02055547|10159390|FG010|NOT COMPLETED|Overall Study||1
9094564|NCT02055547|10159391|FG011|NOT COMPLETED|Overall Study||0
9094565|NCT02055547|10159392|FG012|NOT COMPLETED|Overall Study||0
9094566|NCT02055547|10159393|FG013|NOT COMPLETED|Overall Study||1
9094567|NCT02055547|10159394|FG014|NOT COMPLETED|Overall Study||0
9094568|NCT02055547|10159395|FG015|NOT COMPLETED|Overall Study||1
9094569|NCT02055547|10159396|FG016|NOT COMPLETED|Overall Study||0
9094570|NCT02055547|10159397|FG017|NOT COMPLETED|Overall Study||0
9094571|NCT02055547|10159398|FG018|NOT COMPLETED|Overall Study||0
9094572|NCT02064387|10159444|FG000|STARTED|Part 1 Max 23.5 Months Followup Duration||1
9094573|NCT02064387|10159445|FG001|STARTED|Part 1 Max 23.5 Months Followup Duration||1
9094574|NCT02064387|10159446|FG002|STARTED|Part 1 Max 23.5 Months Followup Duration||4
9094575|NCT02064387|10159447|FG003|STARTED|Part 1 Max 23.5 Months Followup Duration||4
9094576|NCT02064387|10159448|FG004|STARTED|Part 1 Max 23.5 Months Followup Duration||4
9094577|NCT02064387|10159449|FG005|STARTED|Part 1 Max 23.5 Months Followup Duration||3
9094578|NCT02064387|10159450|FG006|STARTED|Part 1 Max 23.5 Months Followup Duration||4
9094579|NCT02064387|10159451|FG007|STARTED|Part 1 Max 23.5 Months Followup Duration||8
9094580|NCT02064387|10159452|FG008|STARTED|Part 1 Max 23.5 Months Followup Duration||3
9094581|NCT02064387|10159453|FG009|STARTED|Part 1 Max 23.5 Months Followup Duration||6
9094582|NCT02064387|10159454|FG010|STARTED|Part 1 Max 23.5 Months Followup Duration||0
9094583|NCT02064387|10159455|FG011|STARTED|Part 1 Max 23.5 Months Followup Duration||0
9094584|NCT02064387|10159444|FG000|COMPLETED|Part 1 Max 23.5 Months Followup Duration||1
9094585|NCT02064387|10159445|FG001|COMPLETED|Part 1 Max 23.5 Months Followup Duration||1
9094586|NCT02064387|10159446|FG002|COMPLETED|Part 1 Max 23.5 Months Followup Duration||4
9094587|NCT02064387|10159447|FG003|COMPLETED|Part 1 Max 23.5 Months Followup Duration||4
9094588|NCT02064387|10159448|FG004|COMPLETED|Part 1 Max 23.5 Months Followup Duration||4
9094589|NCT02064387|10159449|FG005|COMPLETED|Part 1 Max 23.5 Months Followup Duration||3
9094590|NCT02064387|10159450|FG006|COMPLETED|Part 1 Max 23.5 Months Followup Duration||4
9094591|NCT02064387|10159451|FG007|COMPLETED|Part 1 Max 23.5 Months Followup Duration||6
9094592|NCT02064387|10159452|FG008|COMPLETED|Part 1 Max 23.5 Months Followup Duration||2
9094593|NCT02064387|10159453|FG009|COMPLETED|Part 1 Max 23.5 Months Followup Duration||5
9094594|NCT02064387|10159454|FG010|COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
9094595|NCT02064387|10159455|FG011|COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
9094596|NCT02064387|10159444|FG000|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
9094597|NCT02064387|10159445|FG001|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
9094598|NCT02064387|10159446|FG002|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
9094599|NCT02064387|10159447|FG003|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
9094600|NCT02064387|10159448|FG004|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
9094601|NCT02064387|10159449|FG005|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
9094602|NCT02064387|10159450|FG006|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
9094603|NCT02064387|10159451|FG007|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||2
9094604|NCT02064387|10159452|FG008|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||1
9094605|NCT02064387|10159453|FG009|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||1
9094606|NCT02064387|10159454|FG010|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
9094607|NCT02064387|10159455|FG011|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
9094608|NCT02064387|10159444|FG000|STARTED|Part 2 Max 35 Months Followup Duration||0
9094609|NCT02064387|10159445|FG001|STARTED|Part 2 Max 35 Months Followup Duration||0
9094610|NCT02064387|10159446|FG002|STARTED|Part 2 Max 35 Months Followup Duration||0
9094611|NCT02064387|10159447|FG003|STARTED|Part 2 Max 35 Months Followup Duration||0
9094612|NCT02064387|10159448|FG004|STARTED|Part 2 Max 35 Months Followup Duration||0
9094613|NCT02064387|10159449|FG005|STARTED|Part 2 Max 35 Months Followup Duration||0
9094614|NCT02064387|10159450|FG006|STARTED|Part 2 Max 35 Months Followup Duration||0
9094615|NCT02064387|10159451|FG007|STARTED|Part 2 Max 35 Months Followup Duration||0
9094616|NCT02064387|10159452|FG008|STARTED|Part 2 Max 35 Months Followup Duration||0
9094617|NCT02064387|10159453|FG009|STARTED|Part 2 Max 35 Months Followup Duration||0
9094618|NCT02064387|10159454|FG010|STARTED|Part 2 Max 35 Months Followup Duration||35
9094619|NCT02064387|10159455|FG011|STARTED|Part 2 Max 35 Months Followup Duration||6
9094620|NCT02064387|10159444|FG000|COMPLETED|Part 2 Max 35 Months Followup Duration||0
9094621|NCT02064387|10159445|FG001|COMPLETED|Part 2 Max 35 Months Followup Duration||0
9094622|NCT02064387|10159446|FG002|COMPLETED|Part 2 Max 35 Months Followup Duration||0
9094623|NCT02064387|10159447|FG003|COMPLETED|Part 2 Max 35 Months Followup Duration||0
9094624|NCT02064387|10159448|FG004|COMPLETED|Part 2 Max 35 Months Followup Duration||0
9094625|NCT02064387|10159449|FG005|COMPLETED|Part 2 Max 35 Months Followup Duration||0
9094626|NCT02064387|10159450|FG006|COMPLETED|Part 2 Max 35 Months Followup Duration||0
9094627|NCT02064387|10159451|FG007|COMPLETED|Part 2 Max 35 Months Followup Duration||0
9094628|NCT02064387|10159452|FG008|COMPLETED|Part 2 Max 35 Months Followup Duration||0
9094629|NCT02064387|10159453|FG009|COMPLETED|Part 2 Max 35 Months Followup Duration||0
9094630|NCT02064387|10159454|FG010|COMPLETED|Part 2 Max 35 Months Followup Duration||29
9094631|NCT02064387|10159455|FG011|COMPLETED|Part 2 Max 35 Months Followup Duration||3
9094632|NCT02064387|10159444|FG000|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
9094633|NCT02064387|10159445|FG001|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
9094634|NCT02064387|10159446|FG002|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
9094635|NCT02064387|10159447|FG003|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
9094636|NCT02064387|10159448|FG004|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
9094637|NCT02064387|10159449|FG005|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
9094638|NCT02064387|10159450|FG006|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
9094639|NCT02064387|10159451|FG007|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
9094640|NCT02064387|10159452|FG008|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
9094641|NCT02064387|10159453|FG009|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
9094642|NCT02064387|10159454|FG010|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||6
9094643|NCT02064387|10159455|FG011|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||3
9094644|NCT02076178|10159496|FG000|STARTED|Oral Phase||21
9094645|NCT02076178|10159497|FG001|STARTED|Oral Phase||106
9094646|NCT02076178|10159496|FG000|COMPLETED|Oral Phase||21
9094647|NCT02076178|10159497|FG001|COMPLETED|Oral Phase||94
9094648|NCT02076178|10159496|FG000|NOT COMPLETED|Oral Phase||0
9094649|NCT02076178|10159497|FG001|NOT COMPLETED|Oral Phase||12
9094650|NCT02076178|10159496|FG000|STARTED|Injection Phase||21
9094651|NCT02076178|10159497|FG001|STARTED|Injection Phase||94
9094652|NCT02076178|10159496|FG000|COMPLETED|Injection Phase||20
9094653|NCT02076178|10159497|FG001|COMPLETED|Injection Phase||87
9094654|NCT02076178|10159496|FG000|NOT COMPLETED|Injection Phase||1
9094655|NCT02076178|10159497|FG001|NOT COMPLETED|Injection Phase||7
8625489|NCT00507689|9665067|FG000|NOT COMPLETED|Pre-Randomization Period||3
8625490|NCT00507689|9665068|FG001|NOT COMPLETED|Pre-Randomization Period||0
8625491|NCT00507689|9665067|FG000|STARTED|Randomized Period|19 of 37 participants who completed the pre-randomization period were randomized to FTC/TDF+HBIg.|19
8625492|NCT00507689|9665068|FG001|STARTED|Randomized Period|18 of 37 participants who completed the pre-randomization period were randomized to FTC/TDF.|18
8625493|NCT00507689|9665067|FG000|COMPLETED|Randomized Period||18
8625494|NCT00507689|9665068|FG001|COMPLETED|Randomized Period||16
8625495|NCT00507689|9665067|FG000|NOT COMPLETED|Randomized Period||1
8625496|NCT00507689|9665068|FG001|NOT COMPLETED|Randomized Period||2
9094656|NCT02079766|10159507|FG000|STARTED|Overall Study||30
9094657|NCT02079766|10159508|FG001|STARTED|Overall Study||11
9094658|NCT02079766|10159507|FG000|COMPLETED|Overall Study||28
9094659|NCT02079766|10159508|FG001|COMPLETED|Overall Study||11
9094660|NCT02079766|10159507|FG000|NOT COMPLETED|Overall Study||2
9094661|NCT02079766|10159508|FG001|NOT COMPLETED|Overall Study||0
9094686|NCT02087189|10159541|FG000|STARTED|Overall Study||30
9094687|NCT02087189|10159541|FG000|COMPLETED|Overall Study||28
9094688|NCT02087189|10159541|FG000|NOT COMPLETED|Overall Study||2
9094689|NCT02096055|10159549|FG000|STARTED|Overall Study||13
9094690|NCT02096055|10159550|FG001|STARTED|Overall Study||9
9094691|NCT02096055|10159551|FG002|STARTED|Overall Study||13
9094692|NCT02096055|10159552|FG003|STARTED|Overall Study||9
9094693|NCT02096055|10159549|FG000|COMPLETED|Overall Study||13
9094694|NCT02096055|10159550|FG001|COMPLETED|Overall Study||9
9094695|NCT02096055|10159551|FG002|COMPLETED|Overall Study||13
9094696|NCT02096055|10159552|FG003|COMPLETED|Overall Study||9
9094697|NCT02096055|10159549|FG000|NOT COMPLETED|Overall Study||0
9094698|NCT02096055|10159550|FG001|NOT COMPLETED|Overall Study||0
9094699|NCT02096055|10159551|FG002|NOT COMPLETED|Overall Study||0
9094700|NCT02096055|10159552|FG003|NOT COMPLETED|Overall Study||0
9094701|NCT02112916|10159566|FG000|STARTED|Overall Study||312
9094702|NCT02112916|10159567|FG001|STARTED|Overall Study||315
9094703|NCT02112916|10159568|FG002|STARTED|Overall Study||111
9094704|NCT02112916|10159569|FG003|STARTED|Overall Study||109
9094705|NCT02112916|10159566|FG000|COMPLETED|Overall Study||108
9094706|NCT02112916|10159567|FG001|COMPLETED|Overall Study||123
9094707|NCT02112916|10159568|FG002|COMPLETED|Overall Study||52
9094708|NCT02112916|10159569|FG003|COMPLETED|Overall Study||62
9094709|NCT02112916|10159566|FG000|NOT COMPLETED|Overall Study||204
9094710|NCT02112916|10159567|FG001|NOT COMPLETED|Overall Study||192
9094711|NCT02112916|10159568|FG002|NOT COMPLETED|Overall Study||59
9094712|NCT02112916|10159569|FG003|NOT COMPLETED|Overall Study||47
9094721|NCT02134717|10159593|FG000|STARTED|Overall Study||3
9094722|NCT02134717|10159593|FG000|COMPLETED|Overall Study||3
8625497|NCT00507728|9665078|FG000|STARTED|Randomization to Month 3||75
8625498|NCT00507728|9665079|FG001|STARTED|Randomization to Month 3||89
9094723|NCT02134717|10159593|FG000|NOT COMPLETED|Overall Study||0
9094724|NCT02135029|10159600|FG000|STARTED|Overall Study||73
9094725|NCT02135029|10159601|FG001|STARTED|Overall Study||74
9094726|NCT02135029|10159602|FG002|STARTED|Overall Study||37
9094727|NCT02135029|10159600|FG000|Treated|Overall Study||73
9094728|NCT02135029|10159601|FG001|Treated|Overall Study||74
9094729|NCT02135029|10159602|FG002|Treated|Overall Study||36
9094730|NCT02135029|10159600|FG000|COMPLETED|Overall Study||69
9094731|NCT02135029|10159601|FG001|COMPLETED|Overall Study||69
9094732|NCT02135029|10159602|FG002|COMPLETED|Overall Study||34
9094733|NCT02135029|10159600|FG000|NOT COMPLETED|Overall Study||4
9094734|NCT02135029|10159601|FG001|NOT COMPLETED|Overall Study||5
9094735|NCT02135029|10159602|FG002|NOT COMPLETED|Overall Study||3
9094742|NCT02148133|10159620|FG000|STARTED|Overall Study||21
9094743|NCT02148133|10159620|FG000|Safety Set (SS)|Overall Study||21
9094744|NCT02148133|10159620|FG000|Pharmacokinetic Analysis Set (PAS)|Overall Study||21
9094745|NCT02148133|10159620|FG000|COMPLETED|Overall Study||16
9094746|NCT02148133|10159620|FG000|NOT COMPLETED|Overall Study||5
9094747|NCT02151383|10159627|FG000|STARTED|Overall Study||8
9094748|NCT02151383|10159628|FG001|STARTED|Overall Study||3
9094749|NCT02151383|10159629|FG002|STARTED|Overall Study||1
9094750|NCT02151383|10159627|FG000|Low-dose|Overall Study||2
9094751|NCT02151383|10159628|FG001|Low-dose|Overall Study||3
9094752|NCT02151383|10159629|FG002|Low-dose|Overall Study||1
9094753|NCT02151383|10159627|FG000|High-dose|Overall Study||6
9094754|NCT02151383|10159628|FG001|High-dose|Overall Study||0
9094755|NCT02151383|10159629|FG002|High-dose|Overall Study||0
9094756|NCT02151383|10159627|FG000|COMPLETED|Overall Study||8
9094757|NCT02151383|10159628|FG001|COMPLETED|Overall Study||3
9094758|NCT02151383|10159629|FG002|COMPLETED|Overall Study||1
9094759|NCT02151383|10159627|FG000|NOT COMPLETED|Overall Study||0
9094760|NCT02151383|10159628|FG001|NOT COMPLETED|Overall Study||0
9094761|NCT02151383|10159629|FG002|NOT COMPLETED|Overall Study||0
9094762|NCT02165215|10159640|FG000|STARTED|Induction Phase||359
9094763|NCT02165215|10159641|FG001|STARTED|Induction Phase||0
9094764|NCT02165215|10159642|FG002|STARTED|Induction Phase||0
9094765|NCT02165215|10159640|FG000|Dosed|Induction Phase||358
9094766|NCT02165215|10159641|FG001|Dosed|Induction Phase||0
9094767|NCT02165215|10159642|FG002|Dosed|Induction Phase||0
9094768|NCT02165215|10159640|FG000|COMPLETED|Induction Phase||336
8625499|NCT00507728|9665080|FG002|STARTED|Randomization to Month 3||90
8625500|NCT00507728|9665078|FG000|COMPLETED|Randomization to Month 3||60
9094769|NCT02165215|10159641|FG001|COMPLETED|Induction Phase||0
9094770|NCT02165215|10159642|FG002|COMPLETED|Induction Phase||0
9094771|NCT02165215|10159640|FG000|NOT COMPLETED|Induction Phase||23
9094772|NCT02165215|10159641|FG001|NOT COMPLETED|Induction Phase||0
9094773|NCT02165215|10159642|FG002|NOT COMPLETED|Induction Phase||0
9094774|NCT02165215|10159640|FG000|STARTED|Maintenance Phase||0
9094775|NCT02165215|10159641|FG001|STARTED|Maintenance Phase||108
9094776|NCT02165215|10159642|FG002|STARTED|Maintenance Phase||106
9094777|NCT02165215|10159640|FG000|Dosed|Maintenance Phase||0
9094778|NCT02165215|10159641|FG001|Dosed|Maintenance Phase||108
9094779|NCT02165215|10159642|FG002|Dosed|Maintenance Phase||102
9094780|NCT02165215|10159640|FG000|COMPLETED|Maintenance Phase||0
9094781|NCT02165215|10159641|FG001|COMPLETED|Maintenance Phase||96
9094782|NCT02165215|10159642|FG002|COMPLETED|Maintenance Phase||101
9094662|NCT02081391|10159518|FG000|STARTED|12-hour Treatment||108
9094663|NCT02081391|10159519|FG001|STARTED|12-hour Treatment||52
9094664|NCT02081391|10159520|FG002|STARTED|12-hour Treatment||11
9094665|NCT02081391|10159521|FG003|STARTED|12-hour Treatment||4
9094666|NCT02081391|10159518|FG000|COMPLETED|12-hour Treatment||90
8625501|NCT00507728|9665079|FG001|COMPLETED|Randomization to Month 3||75
8625502|NCT00507728|9665080|FG002|COMPLETED|Randomization to Month 3||70
8625503|NCT00507728|9665078|FG000|NOT COMPLETED|Randomization to Month 3||15
8625504|NCT00507728|9665079|FG001|NOT COMPLETED|Randomization to Month 3||14
8625505|NCT00507728|9665080|FG002|NOT COMPLETED|Randomization to Month 3||20
8625506|NCT00507728|9665078|FG000|STARTED|From 3 Months to 6 Months||60
9094667|NCT02081391|10159519|FG001|COMPLETED|12-hour Treatment||46
8625507|NCT00507728|9665079|FG001|STARTED|From 3 Months to 6 Months||75
8625508|NCT00507728|9665080|FG002|STARTED|From 3 Months to 6 Months||70
8625509|NCT00507728|9665078|FG000|COMPLETED|From 3 Months to 6 Months||54
9094668|NCT02081391|10159520|FG002|COMPLETED|12-hour Treatment||10
9094669|NCT02081391|10159521|FG003|COMPLETED|12-hour Treatment||4
9094670|NCT02081391|10159518|FG000|NOT COMPLETED|12-hour Treatment||18
9094671|NCT02081391|10159519|FG001|NOT COMPLETED|12-hour Treatment||6
9094672|NCT02081391|10159520|FG002|NOT COMPLETED|12-hour Treatment||1
9094673|NCT02081391|10159521|FG003|NOT COMPLETED|12-hour Treatment||0
9094674|NCT02081391|10159518|FG000|STARTED|24-hour Treatment and Trial Completion||90
9094675|NCT02081391|10159519|FG001|STARTED|24-hour Treatment and Trial Completion||46
9094676|NCT02081391|10159520|FG002|STARTED|24-hour Treatment and Trial Completion||10
9094677|NCT02081391|10159521|FG003|STARTED|24-hour Treatment and Trial Completion||4
9094678|NCT02081391|10159518|FG000|COMPLETED|24-hour Treatment and Trial Completion||63
9094679|NCT02081391|10159519|FG001|COMPLETED|24-hour Treatment and Trial Completion||28
9094680|NCT02081391|10159520|FG002|COMPLETED|24-hour Treatment and Trial Completion||9
9094681|NCT02081391|10159521|FG003|COMPLETED|24-hour Treatment and Trial Completion||4
9094682|NCT02081391|10159518|FG000|NOT COMPLETED|24-hour Treatment and Trial Completion||27
9094683|NCT02081391|10159519|FG001|NOT COMPLETED|24-hour Treatment and Trial Completion||18
9094684|NCT02081391|10159520|FG002|NOT COMPLETED|24-hour Treatment and Trial Completion||1
9094685|NCT02081391|10159521|FG003|NOT COMPLETED|24-hour Treatment and Trial Completion||0
9094713|NCT02114697|10159586|FG000|STARTED|Overall Study||5
9094714|NCT02114697|10159587|FG001|STARTED|Overall Study||4
9094715|NCT02114697|10159586|FG000|Completed Month 18 Visit|Overall Study||0
9094716|NCT02114697|10159587|FG001|Completed Month 18 Visit|Overall Study||1
9094717|NCT02114697|10159586|FG000|COMPLETED|Overall Study||0
9094718|NCT02114697|10159587|FG001|COMPLETED|Overall Study||0
9094719|NCT02114697|10159586|FG000|NOT COMPLETED|Overall Study||5
9094720|NCT02114697|10159587|FG001|NOT COMPLETED|Overall Study||4
9094736|NCT02137239|10159613|FG000|STARTED|Overall Study||26
9094737|NCT02137239|10159614|FG001|STARTED|Overall Study||32
9094738|NCT02137239|10159613|FG000|COMPLETED|Overall Study||23
9094739|NCT02137239|10159614|FG001|COMPLETED|Overall Study||26
9094740|NCT02137239|10159613|FG000|NOT COMPLETED|Overall Study||3
9094741|NCT02137239|10159614|FG001|NOT COMPLETED|Overall Study||6
9094783|NCT02165215|10159640|FG000|NOT COMPLETED|Maintenance Phase||0
9094784|NCT02165215|10159641|FG001|NOT COMPLETED|Maintenance Phase||12
9094785|NCT02165215|10159642|FG002|NOT COMPLETED|Maintenance Phase||5
8625510|NCT00507728|9665079|FG001|COMPLETED|From 3 Months to 6 Months||65
8625511|NCT00507728|9665080|FG002|COMPLETED|From 3 Months to 6 Months||61
8625512|NCT00507728|9665078|FG000|NOT COMPLETED|From 3 Months to 6 Months||6
8625513|NCT00507728|9665079|FG001|NOT COMPLETED|From 3 Months to 6 Months||10
8625514|NCT00507728|9665080|FG002|NOT COMPLETED|From 3 Months to 6 Months||9
8625515|NCT00507767|9665094|FG000|STARTED|Overall Study||15
8625516|NCT00507767|9665094|FG000|COMPLETED|Overall Study||15
8625517|NCT00507767|9665094|FG000|NOT COMPLETED|Overall Study||0
8625518|NCT00507819|9665098|FG000|STARTED|First Intervention (6 Weeks)||14
8625519|NCT00507819|9665099|FG001|STARTED|First Intervention (6 Weeks)||14
9094786|NCT02180217|10159656|FG000|STARTED|Overall Study||36
9094787|NCT02180217|10159657|FG001|STARTED|Overall Study||35
9094788|NCT02180217|10159658|FG002|STARTED|Overall Study||66
9094789|NCT02180217|10159656|FG000|Discontinued at/Prior to Week 12 (W12)|Overall Study||0
9094790|NCT02180217|10159657|FG001|Discontinued at/Prior to Week 12 (W12)|Overall Study||0
9094791|NCT02180217|10159658|FG002|Discontinued at/Prior to Week 12 (W12)|Overall Study||7
9094792|NCT02180217|10159656|FG000|Discont. at/Prior to W26 But After W12|Overall Study||0
9094793|NCT02180217|10159657|FG001|Discont. at/Prior to W26 But After W12|Overall Study||0
9094794|NCT02180217|10159658|FG002|Discont. at/Prior to W26 But After W12|Overall Study||12
9094795|NCT02180217|10159656|FG000|Discontinued Prior to W48 But After W26|Overall Study||0
9094796|NCT02180217|10159657|FG001|Discontinued Prior to W48 But After W26|Overall Study||2
9094797|NCT02180217|10159658|FG002|Discontinued Prior to W48 But After W26|Overall Study||3
9094798|NCT02180217|10159656|FG000|Completed Week 48 (Core Phase)|Overall Study||36
9094799|NCT02180217|10159657|FG001|Completed Week 48 (Core Phase)|Overall Study||33
9094800|NCT02180217|10159658|FG002|Completed Week 48 (Core Phase)|Overall Study||44
9094801|NCT02180217|10159656|FG000|Completed W48, Did Not Enter Ext. Phase|Overall Study||1
9094802|NCT02180217|10159657|FG001|Completed W48, Did Not Enter Ext. Phase|Overall Study||3
9094803|NCT02180217|10159658|FG002|Completed W48, Did Not Enter Ext. Phase|Overall Study||3
9094804|NCT02180217|10159656|FG000|Completed W48, Entered Ext. Phase|Overall Study||35
9094805|NCT02180217|10159657|FG001|Completed W48, Entered Ext. Phase|Overall Study||30
9094806|NCT02180217|10159658|FG002|Completed W48, Entered Ext. Phase|Overall Study||41
9094807|NCT02180217|10159656|FG000|Discontinued Extension Phase|Overall Study||12
9094808|NCT02180217|10159657|FG001|Discontinued Extension Phase|Overall Study||6
9094809|NCT02180217|10159658|FG002|Discontinued Extension Phase|Overall Study||16
9094810|NCT02180217|10159656|FG000|Completed Ext. Phase|Overall Study||23
9094811|NCT02180217|10159657|FG001|Completed Ext. Phase|Overall Study||24
9094812|NCT02180217|10159658|FG002|Completed Ext. Phase|Overall Study||25
9094813|NCT02180217|10159656|FG000|COMPLETED|Overall Study||24
9094814|NCT02180217|10159657|FG001|COMPLETED|Overall Study||27
9094815|NCT02180217|10159658|FG002|COMPLETED|Overall Study||28
9094816|NCT02180217|10159656|FG000|NOT COMPLETED|Overall Study||12
9094817|NCT02180217|10159657|FG001|NOT COMPLETED|Overall Study||8
9094818|NCT02180217|10159658|FG002|NOT COMPLETED|Overall Study||38
9094819|NCT02186457|10159675|FG000|STARTED|Overall Study||95
9094820|NCT02186457|10159676|FG001|STARTED|Overall Study||95
9094821|NCT02186457|10159675|FG000|COMPLETED|Overall Study||95
9094822|NCT02186457|10159676|FG001|COMPLETED|Overall Study||95
9094823|NCT02186457|10159675|FG000|NOT COMPLETED|Overall Study||0
9094824|NCT02186457|10159676|FG001|NOT COMPLETED|Overall Study||0
9094825|NCT02193867|10159682|FG000|STARTED|Overall Study||10
9094826|NCT02193867|10159682|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||10
9094827|NCT02193867|10159682|FG000|Completed 18 Months Of Treatment|Overall Study||8
9094828|NCT02193867|10159682|FG000|COMPLETED|Overall Study||6
9094829|NCT02193867|10159682|FG000|NOT COMPLETED|Overall Study||4
9094830|NCT02215096|10159689|FG000|STARTED|Run-In Period (Up to Week 2)||37
9094831|NCT02215096|10159690|FG001|STARTED|Run-In Period (Up to Week 2)||0
9094832|NCT02215096|10159691|FG002|STARTED|Run-In Period (Up to Week 2)||0
9094833|NCT02215096|10159692|FG003|STARTED|Run-In Period (Up to Week 2)||0
9094834|NCT02215096|10159693|FG004|STARTED|Run-In Period (Up to Week 2)||0
9094835|NCT02215096|10159689|FG000|COMPLETED|Run-In Period (Up to Week 2)||36
9094836|NCT02215096|10159690|FG001|COMPLETED|Run-In Period (Up to Week 2)||0
9094837|NCT02215096|10159691|FG002|COMPLETED|Run-In Period (Up to Week 2)||0
9094838|NCT02215096|10159692|FG003|COMPLETED|Run-In Period (Up to Week 2)||0
9094839|NCT02215096|10159693|FG004|COMPLETED|Run-In Period (Up to Week 2)||0
9094840|NCT02215096|10159689|FG000|NOT COMPLETED|Run-In Period (Up to Week 2)||1
9094841|NCT02215096|10159690|FG001|NOT COMPLETED|Run-In Period (Up to Week 2)||0
9094842|NCT02215096|10159691|FG002|NOT COMPLETED|Run-In Period (Up to Week 2)||0
9094843|NCT02215096|10159692|FG003|NOT COMPLETED|Run-In Period (Up to Week 2)||0
9094844|NCT02215096|10159693|FG004|NOT COMPLETED|Run-In Period (Up to Week 2)||0
9094845|NCT02215096|10159689|FG000|STARTED|Combination TP (Up to Maximum 654 Days)||0
9094846|NCT02215096|10159690|FG001|STARTED|Combination TP (Up to Maximum 654 Days)||11
9094847|NCT02215096|10159691|FG002|STARTED|Combination TP (Up to Maximum 654 Days)||11
9094848|NCT02215096|10159692|FG003|STARTED|Combination TP (Up to Maximum 654 Days)||12
9094849|NCT02215096|10159693|FG004|STARTED|Combination TP (Up to Maximum 654 Days)||2
9094850|NCT02215096|10159689|FG000|COMPLETED|Combination TP (Up to Maximum 654 Days)||0
9094851|NCT02215096|10159690|FG001|COMPLETED|Combination TP (Up to Maximum 654 Days)||9
9094852|NCT02215096|10159691|FG002|COMPLETED|Combination TP (Up to Maximum 654 Days)||10
9094853|NCT02215096|10159692|FG003|COMPLETED|Combination TP (Up to Maximum 654 Days)||10
9094854|NCT02215096|10159693|FG004|COMPLETED|Combination TP (Up to Maximum 654 Days)||1
9094855|NCT02215096|10159689|FG000|NOT COMPLETED|Combination TP (Up to Maximum 654 Days)||0
9094856|NCT02215096|10159690|FG001|NOT COMPLETED|Combination TP (Up to Maximum 654 Days)||2
9094857|NCT02215096|10159691|FG002|NOT COMPLETED|Combination TP (Up to Maximum 654 Days)||1
8556828|NCT03760146|9588651|FG005|STARTED|Overall Study||112
8556829|NCT03760146|9588646|FG000|Evaluable 13-Matched Immunogenicity Population|Overall Study||1435
8556830|NCT03760146|9588647|FG001|Evaluable 13-Matched Immunogenicity Population|Overall Study||1420
8556831|NCT03760146|9588648|FG002|Evaluable 13-Matched Immunogenicity Population|Overall Study||0
8556832|NCT03760146|9588649|FG003|Evaluable 13-Matched Immunogenicity Population|Overall Study||0
9094858|NCT02215096|10159692|FG003|NOT COMPLETED|Combination TP (Up to Maximum 654 Days)||2
9094859|NCT02215096|10159693|FG004|NOT COMPLETED|Combination TP (Up to Maximum 654 Days)||1
9094860|NCT02218697|10159711|FG000|STARTED|Overall Study||179
9094861|NCT02218697|10159712|FG001|STARTED|Overall Study||177
9094862|NCT02218697|10159711|FG000|COMPLETED|Overall Study||177
9094863|NCT02218697|10159712|FG001|COMPLETED|Overall Study||171
9094864|NCT02218697|10159711|FG000|NOT COMPLETED|Overall Study||2
9094865|NCT02218697|10159712|FG001|NOT COMPLETED|Overall Study||6
9094866|NCT02221037|10159722|FG000|STARTED|Overall Study||5
9094867|NCT02221037|10159723|FG001|STARTED|Overall Study||11
9094868|NCT02221037|10159724|FG002|STARTED|Overall Study||8
9094869|NCT02221037|10159725|FG003|STARTED|Overall Study||9
9094870|NCT02221037|10159722|FG000|COMPLETED|Overall Study||5
9094871|NCT02221037|10159723|FG001|COMPLETED|Overall Study||11
9094872|NCT02221037|10159724|FG002|COMPLETED|Overall Study||7
9094873|NCT02221037|10159725|FG003|COMPLETED|Overall Study||9
9094874|NCT02221037|10159722|FG000|NOT COMPLETED|Overall Study||0
9094875|NCT02221037|10159723|FG001|NOT COMPLETED|Overall Study||0
9094876|NCT02221037|10159724|FG002|NOT COMPLETED|Overall Study||1
9094877|NCT02221037|10159725|FG003|NOT COMPLETED|Overall Study||0
9094878|NCT02224456|10159739|FG000|STARTED|Overall Study||197
9094879|NCT02224456|10159739|FG000|COMPLETED|Overall Study||161
9094880|NCT02224456|10159739|FG000|NOT COMPLETED|Overall Study||36
9094881|NCT02231762|10159743|FG000|STARTED|Combination Phase||57
9094882|NCT02231762|10159744|FG001|STARTED|Combination Phase|This arm was not included in period 1 (combination phase).|0
9094883|NCT02231762|10159745|FG002|STARTED|Combination Phase|This arm was not included in period 1 (combination phase).|0
9094884|NCT02231762|10159746|FG003|STARTED|Combination Phase|This arm was not included in period 1 (combination phase).|0
9094885|NCT02231762|10159743|FG000|COMPLETED|Combination Phase||37
9094886|NCT02231762|10159744|FG001|COMPLETED|Combination Phase||0
9094887|NCT02231762|10159745|FG002|COMPLETED|Combination Phase||0
9094888|NCT02231762|10159746|FG003|COMPLETED|Combination Phase||0
9094889|NCT02231762|10159743|FG000|NOT COMPLETED|Combination Phase||20
9094890|NCT02231762|10159744|FG001|NOT COMPLETED|Combination Phase||0
9094891|NCT02231762|10159745|FG002|NOT COMPLETED|Combination Phase||0
9094892|NCT02231762|10159746|FG003|NOT COMPLETED|Combination Phase||0
9094893|NCT02231762|10159743|FG000|STARTED|Maintenance Phase|This arm was not included in period 2 (maintenance phase).|0
9094894|NCT02231762|10159744|FG001|STARTED|Maintenance Phase|The 37 subjects completing period 1 were split between the 3 arms in period 2.|11
9094895|NCT02231762|10159745|FG002|STARTED|Maintenance Phase|The 37 subjects completing period 1 were split between the 3 arms in period 2.|14
9094896|NCT02231762|10159746|FG003|STARTED|Maintenance Phase|The 37 subjects completing period 1 were split between the 3 arms in period 2.|12
9094897|NCT02231762|10159743|FG000|COMPLETED|Maintenance Phase||0
9094898|NCT02231762|10159744|FG001|COMPLETED|Maintenance Phase||8
9094899|NCT02231762|10159745|FG002|COMPLETED|Maintenance Phase||9
9094900|NCT02231762|10159746|FG003|COMPLETED|Maintenance Phase||7
9094901|NCT02231762|10159743|FG000|NOT COMPLETED|Maintenance Phase||0
9094902|NCT02231762|10159744|FG001|NOT COMPLETED|Maintenance Phase||3
9094903|NCT02231762|10159745|FG002|NOT COMPLETED|Maintenance Phase||5
9094904|NCT02231762|10159746|FG003|NOT COMPLETED|Maintenance Phase||5
9094905|NCT02234843|10159770|FG000|STARTED|Overall Study||184
9094906|NCT02234843|10159771|FG001|STARTED|Overall Study||67
9094907|NCT02234843|10159772|FG002|STARTED|Overall Study||47
9094908|NCT02234843|10159773|FG003|STARTED|Overall Study||21
9094909|NCT02234843|10159774|FG004|STARTED|Overall Study||16
9094910|NCT02234843|10159775|FG005|STARTED|Overall Study||92
9094911|NCT02234843|10159776|FG006|STARTED|Overall Study||34
9094912|NCT02234843|10159777|FG007|STARTED|Overall Study||22
9094913|NCT02234843|10159778|FG008|STARTED|Overall Study||9
9094914|NCT02234843|10159779|FG009|STARTED|Overall Study||8
9094915|NCT02234843|10159770|FG000|COMPLETED|Overall Study||162
9094916|NCT02234843|10159771|FG001|COMPLETED|Overall Study||61
9094917|NCT02234843|10159772|FG002|COMPLETED|Overall Study||44
9094918|NCT02234843|10159773|FG003|COMPLETED|Overall Study||16
9094919|NCT02234843|10159774|FG004|COMPLETED|Overall Study||14
9094920|NCT02234843|10159775|FG005|COMPLETED|Overall Study||79
9094921|NCT02234843|10159776|FG006|COMPLETED|Overall Study||32
9094922|NCT02234843|10159777|FG007|COMPLETED|Overall Study||20
9094923|NCT02234843|10159778|FG008|COMPLETED|Overall Study||8
9094924|NCT02234843|10159779|FG009|COMPLETED|Overall Study||8
9094925|NCT02234843|10159770|FG000|NOT COMPLETED|Overall Study||22
9094926|NCT02234843|10159771|FG001|NOT COMPLETED|Overall Study||6
9094927|NCT02234843|10159772|FG002|NOT COMPLETED|Overall Study||3
9094928|NCT02234843|10159773|FG003|NOT COMPLETED|Overall Study||5
9094929|NCT02234843|10159774|FG004|NOT COMPLETED|Overall Study||2
9094930|NCT02234843|10159775|FG005|NOT COMPLETED|Overall Study||13
9094931|NCT02234843|10159776|FG006|NOT COMPLETED|Overall Study||2
9094932|NCT02234843|10159777|FG007|NOT COMPLETED|Overall Study||2
9094933|NCT02234843|10159778|FG008|NOT COMPLETED|Overall Study||1
9094934|NCT02234843|10159779|FG009|NOT COMPLETED|Overall Study||0
9094935|NCT02243306|10159814|FG000|STARTED|Overall Study||1
9094936|NCT02243306|10159815|FG001|STARTED|Overall Study||7
9094937|NCT02243306|10159814|FG000|COMPLETED|Overall Study||1
9094938|NCT02243306|10159815|FG001|COMPLETED|Overall Study||4
9094939|NCT02243306|10159814|FG000|NOT COMPLETED|Overall Study||0
9094940|NCT02243306|10159815|FG001|NOT COMPLETED|Overall Study||3
9094941|NCT02246621|10159824|FG000|STARTED|Overall Study||328
9094942|NCT02246621|10159825|FG001|STARTED|Overall Study||165
9094943|NCT02246621|10159824|FG000|Received At Least One Dose of Study Drug|Overall Study||327
9094944|NCT02246621|10159825|FG001|Received At Least One Dose of Study Drug|Overall Study||161
9094945|NCT02246621|10159824|FG000|COMPLETED|Overall Study||63
9094946|NCT02246621|10159825|FG001|COMPLETED|Overall Study||30
9094947|NCT02246621|10159824|FG000|NOT COMPLETED|Overall Study||265
9094948|NCT02246621|10159825|FG001|NOT COMPLETED|Overall Study||135
9094949|NCT04435795|10159833|FG000|STARTED|Overall Study||108
9094950|NCT04435795|10159834|FG001|STARTED|Overall Study||107
9094951|NCT04435795|10159833|FG000|COMPLETED|Overall Study||105
9094952|NCT04435795|10159834|FG001|COMPLETED|Overall Study||98
9094953|NCT04435795|10159833|FG000|NOT COMPLETED|Overall Study||3
9094954|NCT04435795|10159834|FG001|NOT COMPLETED|Overall Study||9
9094955|NCT04093843|10159840|FG000|STARTED|Overall Study||6
9094956|NCT04093843|10159840|FG000|COMPLETED|Overall Study||6
9094957|NCT04093843|10159840|FG000|NOT COMPLETED|Overall Study||0
9094958|NCT03926611|10159851|FG000|STARTED|Overall Study||44
9094959|NCT03926611|10159852|FG001|STARTED|Overall Study||44
9094960|NCT03926611|10159853|FG002|STARTED|Overall Study||47
9094961|NCT03926611|10159854|FG003|STARTED|Overall Study||44
9094962|NCT03926611|10159855|FG004|STARTED|Overall Study||44
9094963|NCT03926611|10159856|FG005|STARTED|Overall Study||45
9094964|NCT03926611|10159857|FG006|STARTED|Overall Study||43
9094965|NCT03926611|10159851|FG000|Randomized Set (RAN)|Overall Study||44
9094966|NCT03926611|10159852|FG001|Randomized Set (RAN)|Overall Study||44
9094967|NCT03926611|10159853|FG002|Randomized Set (RAN)|Overall Study||47
9094968|NCT03926611|10159854|FG003|Randomized Set (RAN)|Overall Study||44
9094969|NCT03926611|10159855|FG004|Randomized Set (RAN)|Overall Study||44
9094970|NCT03926611|10159856|FG005|Randomized Set (RAN)|Overall Study||45
9094971|NCT03926611|10159857|FG006|Randomized Set (RAN)|Overall Study||43
9094972|NCT03926611|10159851|FG000|Full Analysis Set (FAS)|Overall Study||44
9094973|NCT03926611|10159852|FG001|Full Analysis Set (FAS)|Overall Study||44
9094974|NCT03926611|10159853|FG002|Full Analysis Set (FAS)|Overall Study||47
9094975|NCT03926611|10159854|FG003|Full Analysis Set (FAS)|Overall Study||44
9094976|NCT03926611|10159855|FG004|Full Analysis Set (FAS)|Overall Study||43
9094977|NCT03926611|10159856|FG005|Full Analysis Set (FAS)|Overall Study||45
9094978|NCT03926611|10159857|FG006|Full Analysis Set (FAS)|Overall Study||42
9094979|NCT03926611|10159851|FG000|Safety Set (SAF)|Overall Study||44
9094980|NCT03926611|10159852|FG001|Safety Set (SAF)|Overall Study||44
9094981|NCT03926611|10159853|FG002|Safety Set (SAF)|Overall Study||47
9094982|NCT03926611|10159854|FG003|Safety Set (SAF)|Overall Study||44
9094983|NCT03926611|10159855|FG004|Safety Set (SAF)|Overall Study||43
9094984|NCT03926611|10159856|FG005|Safety Set (SAF)|Overall Study||45
9094985|NCT03926611|10159857|FG006|Safety Set (SAF)|Overall Study||42
9094986|NCT03926611|10159851|FG000|COMPLETED|Overall Study||41
9094987|NCT03926611|10159852|FG001|COMPLETED|Overall Study||41
9094988|NCT03926611|10159853|FG002|COMPLETED|Overall Study||45
9094989|NCT03926611|10159854|FG003|COMPLETED|Overall Study||40
9094990|NCT03926611|10159855|FG004|COMPLETED|Overall Study||40
9094991|NCT03926611|10159856|FG005|COMPLETED|Overall Study||36
9094992|NCT03926611|10159857|FG006|COMPLETED|Overall Study||38
9094993|NCT03926611|10159851|FG000|NOT COMPLETED|Overall Study||3
9094994|NCT03926611|10159852|FG001|NOT COMPLETED|Overall Study||3
9094995|NCT03926611|10159853|FG002|NOT COMPLETED|Overall Study||2
9094996|NCT03926611|10159854|FG003|NOT COMPLETED|Overall Study||4
9094997|NCT03926611|10159855|FG004|NOT COMPLETED|Overall Study||4
9094998|NCT03926611|10159856|FG005|NOT COMPLETED|Overall Study||9
9094999|NCT03926611|10159857|FG006|NOT COMPLETED|Overall Study||5
9095000|NCT03838484|10159881|FG000|STARTED|Overall Study||5
9095001|NCT03838484|10159882|FG001|STARTED|Overall Study||5
9095002|NCT03838484|10159883|FG002|STARTED|Overall Study||4
9095003|NCT03838484|10159884|FG003|STARTED|Overall Study||4
9095004|NCT03838484|10159881|FG000|COMPLETED|Overall Study||5
9095005|NCT03838484|10159882|FG001|COMPLETED|Overall Study||4
9095006|NCT03838484|10159883|FG002|COMPLETED|Overall Study||4
9095007|NCT03838484|10159884|FG003|COMPLETED|Overall Study||4
9095008|NCT03838484|10159881|FG000|NOT COMPLETED|Overall Study||0
9095009|NCT03838484|10159882|FG001|NOT COMPLETED|Overall Study||1
9095010|NCT03838484|10159883|FG002|NOT COMPLETED|Overall Study||0
9095011|NCT03838484|10159884|FG003|NOT COMPLETED|Overall Study||0
9095012|NCT03814720|10159905|FG000|STARTED|Overall Study||5
9095013|NCT03814720|10159906|FG001|STARTED|Overall Study||12
9095014|NCT03814720|10159907|FG002|STARTED|Overall Study||12
9095015|NCT03814720|10159908|FG003|STARTED|Overall Study||12
9095016|NCT03814720|10159909|FG004|STARTED|Overall Study||11
9095017|NCT03814720|10159905|FG000|Received First Product Administration|Overall Study||5
9095018|NCT03814720|10159906|FG001|Received First Product Administration|Overall Study||12
9095019|NCT03814720|10159907|FG002|Received First Product Administration|Overall Study||12
9095020|NCT03814720|10159908|FG003|Received First Product Administration|Overall Study||12
9095021|NCT03814720|10159909|FG004|Received First Product Administration|Overall Study||11
9095022|NCT03814720|10159905|FG000|Received All Product Administrations|Overall Study||5
9095023|NCT03814720|10159906|FG001|Received All Product Administrations|Overall Study||12
9095024|NCT03814720|10159907|FG002|Received All Product Administrations|Overall Study|One participant did not receive the second dose due to moving out of area and 4 participants did not receive the second dose due to the COVID-19 pandemic|7
9095025|NCT03814720|10159908|FG003|Received All Product Administrations|Overall Study|Three (3) participants did not receive the second dose due to the COVID-19 pandemic|9
9095026|NCT03814720|10159909|FG004|Received All Product Administrations|Overall Study|Four (4) participants did not receive the second dose due to the COVID-19 pandemic|7
9095027|NCT03814720|10159905|FG000|COMPLETED|Overall Study||5
9095028|NCT03814720|10159906|FG001|COMPLETED|Overall Study||11
9095029|NCT03814720|10159907|FG002|COMPLETED|Overall Study||12
9095030|NCT03814720|10159908|FG003|COMPLETED|Overall Study||12
9095031|NCT03814720|10159909|FG004|COMPLETED|Overall Study||11
9095032|NCT03814720|10159905|FG000|NOT COMPLETED|Overall Study||0
9095033|NCT03814720|10159906|FG001|NOT COMPLETED|Overall Study||1
9095034|NCT03814720|10159907|FG002|NOT COMPLETED|Overall Study||0
9095035|NCT03814720|10159908|FG003|NOT COMPLETED|Overall Study||0
9095036|NCT03814720|10159909|FG004|NOT COMPLETED|Overall Study||0
9095037|NCT03635424|10159923|FG000|STARTED|Overall Study||150
9095038|NCT03635424|10159923|FG000|COMPLETED|Overall Study||147
9095039|NCT03635424|10159923|FG000|NOT COMPLETED|Overall Study||3
9095040|NCT03529110|10159929|FG000|STARTED|Overall Study||261
9095041|NCT03529110|10159930|FG001|STARTED|Overall Study||263
9095042|NCT03529110|10159929|FG000|COMPLETED|Overall Study||136
9095043|NCT03529110|10159930|FG001|COMPLETED|Overall Study||49
9095044|NCT03529110|10159929|FG000|NOT COMPLETED|Overall Study||125
9095045|NCT03529110|10159930|FG001|NOT COMPLETED|Overall Study||214
9095046|NCT03517540|10159940|FG000|STARTED|Overall Study||50
9095047|NCT03517540|10159941|FG001|STARTED|Overall Study||48
9095048|NCT03517540|10159942|FG002|STARTED|Overall Study||47
9095049|NCT03517540|10159943|FG003|STARTED|Overall Study||48
9095050|NCT03517540|10159940|FG000|COMPLETED|Overall Study||36
9095051|NCT03517540|10159941|FG001|COMPLETED|Overall Study||41
9095052|NCT03517540|10159942|FG002|COMPLETED|Overall Study||38
9095053|NCT03517540|10159943|FG003|COMPLETED|Overall Study||43
9095054|NCT03517540|10159940|FG000|NOT COMPLETED|Overall Study||14
9095055|NCT03517540|10159941|FG001|NOT COMPLETED|Overall Study||7
9095056|NCT03517540|10159942|FG002|NOT COMPLETED|Overall Study||9
9095057|NCT03517540|10159943|FG003|NOT COMPLETED|Overall Study||5
8625520|NCT00507819|9665098|FG000|COMPLETED|First Intervention (6 Weeks)||14
8625521|NCT00507819|9665099|FG001|COMPLETED|First Intervention (6 Weeks)||14
8625522|NCT00507819|9665098|FG000|NOT COMPLETED|First Intervention (6 Weeks)||0
8625523|NCT00507819|9665099|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0
8625524|NCT00507819|9665098|FG000|STARTED|Washout (6 Weeks)||14
8625525|NCT00507819|9665099|FG001|STARTED|Washout (6 Weeks)||14
8625526|NCT00507819|9665098|FG000|COMPLETED|Washout (6 Weeks)||13
8625527|NCT00507819|9665099|FG001|COMPLETED|Washout (6 Weeks)||14
8625528|NCT00507819|9665098|FG000|NOT COMPLETED|Washout (6 Weeks)||1
8625529|NCT00507819|9665099|FG001|NOT COMPLETED|Washout (6 Weeks)||0
8625530|NCT00507819|9665098|FG000|STARTED|Second Intervention (6 Weeks)||13
9095058|NCT03443635|10159955|FG000|STARTED|Overall Study||2616
9095059|NCT03443635|10159956|FG001|STARTED|Overall Study||4576
9095060|NCT03443635|10159955|FG000|COMPLETED|Overall Study||2127
9095061|NCT03443635|10159956|FG001|COMPLETED|Overall Study||3720
9095062|NCT03443635|10159955|FG000|NOT COMPLETED|Overall Study||489
9095063|NCT03443635|10159956|FG001|NOT COMPLETED|Overall Study||856
9095064|NCT03437278|10159965|FG000|STARTED|Overall Study||24
9095065|NCT03437278|10159966|FG001|STARTED|Overall Study||13
9095066|NCT03437278|10159967|FG002|STARTED|Overall Study||12
9095067|NCT03437278|10159965|FG000|COMPLETED|Overall Study||22
9095068|NCT03437278|10159966|FG001|COMPLETED|Overall Study||13
9095069|NCT03437278|10159967|FG002|COMPLETED|Overall Study||10
9095070|NCT03437278|10159965|FG000|NOT COMPLETED|Overall Study||2
9095071|NCT03437278|10159966|FG001|NOT COMPLETED|Overall Study||0
9095072|NCT03437278|10159967|FG002|NOT COMPLETED|Overall Study||2
9095073|NCT03350815|10159977|FG000|STARTED|Period 1||322
9095074|NCT03350815|10159978|FG001|STARTED|Period 1||0
9095075|NCT03350815|10159979|FG002|STARTED|Period 1||0
9095076|NCT03350815|10159980|FG003|STARTED|Period 1||0
9095077|NCT03350815|10159977|FG000|Non-responders|Period 1||50
9095078|NCT03350815|10159978|FG001|Non-responders|Period 1||0
9095079|NCT03350815|10159979|FG002|Non-responders|Period 1||0
9095080|NCT03350815|10159980|FG003|Non-responders|Period 1||0
9095081|NCT03350815|10159977|FG000|Inadequate Responders|Period 1||207
9095082|NCT03350815|10159978|FG001|Inadequate Responders|Period 1||0
9095083|NCT03350815|10159979|FG002|Inadequate Responders|Period 1||0
9095084|NCT03350815|10159980|FG003|Inadequate Responders|Period 1||0
9095085|NCT03350815|10159977|FG000|Responders|Period 1||22
9095086|NCT03350815|10159978|FG001|Responders|Period 1||0
9095087|NCT03350815|10159979|FG002|Responders|Period 1||0
9095088|NCT03350815|10159980|FG003|Responders|Period 1||0
9095089|NCT03350815|10159977|FG000|COMPLETED|Period 1||279
9095090|NCT03350815|10159978|FG001|COMPLETED|Period 1||0
9095091|NCT03350815|10159979|FG002|COMPLETED|Period 1||0
9095092|NCT03350815|10159980|FG003|COMPLETED|Period 1||0
9095093|NCT03350815|10159977|FG000|NOT COMPLETED|Period 1||43
9095094|NCT03350815|10159978|FG001|NOT COMPLETED|Period 1||0
9095095|NCT03350815|10159979|FG002|NOT COMPLETED|Period 1||0
9095096|NCT03350815|10159980|FG003|NOT COMPLETED|Period 1||0
9095097|NCT03350815|10159977|FG000|STARTED|Period 2||0
9095098|NCT03350815|10159978|FG001|STARTED|Period 2||102
9095099|NCT03350815|10159979|FG002|STARTED|Period 2||105
9095100|NCT03350815|10159980|FG003|STARTED|Period 2||22
9095101|NCT03350815|10159977|FG000|COMPLETED|Period 2||0
9095102|NCT03350815|10159978|FG001|COMPLETED|Period 2||86
9095103|NCT03350815|10159979|FG002|COMPLETED|Period 2||88
9095104|NCT03350815|10159980|FG003|COMPLETED|Period 2||22
9095105|NCT03350815|10159977|FG000|NOT COMPLETED|Period 2||0
9095106|NCT03350815|10159978|FG001|NOT COMPLETED|Period 2||16
9095107|NCT03350815|10159979|FG002|NOT COMPLETED|Period 2||17
9095108|NCT03350815|10159980|FG003|NOT COMPLETED|Period 2||0
9095109|NCT03249714|10159993|FG000|STARTED|Double-blind Treatment (Core Part)||43
9095110|NCT03249714|10159994|FG001|STARTED|Double-blind Treatment (Core Part)||21
9095111|NCT03249714|10159993|FG000|COMPLETED|Double-blind Treatment (Core Part)||40
9095112|NCT03249714|10159994|FG001|COMPLETED|Double-blind Treatment (Core Part)||19
9095113|NCT03249714|10159993|FG000|NOT COMPLETED|Double-blind Treatment (Core Part)||3
9095114|NCT03249714|10159994|FG001|NOT COMPLETED|Double-blind Treatment (Core Part)||2
9095115|NCT03249714|10159993|FG000|STARTED|Open-label Treatment (Extension Part)||40
9095116|NCT03249714|10159994|FG001|STARTED|Open-label Treatment (Extension Part)||19
9095117|NCT03249714|10159993|FG000|COMPLETED|Open-label Treatment (Extension Part)||38
9095118|NCT03249714|10159994|FG001|COMPLETED|Open-label Treatment (Extension Part)||19
9095119|NCT03249714|10159993|FG000|NOT COMPLETED|Open-label Treatment (Extension Part)||2
9095120|NCT03249714|10159994|FG001|NOT COMPLETED|Open-label Treatment (Extension Part)||0
9095121|NCT03170882|10160018|FG000|STARTED|Overall Study||49
9095122|NCT03170882|10160019|FG001|STARTED|Overall Study||73
9095123|NCT03170882|10160018|FG000|Treated: Safety Population|Overall Study||47
9095124|NCT03170882|10160019|FG001|Treated: Safety Population|Overall Study||72
9095125|NCT03170882|10160018|FG000|ITT PRO Population|Overall Study||45
9095126|NCT03170882|10160019|FG001|ITT PRO Population|Overall Study||70
9095127|NCT03170882|10160018|FG000|COMPLETED|Overall Study||20
9095128|NCT03170882|10160019|FG001|COMPLETED|Overall Study||22
9095129|NCT03170882|10160018|FG000|NOT COMPLETED|Overall Study||29
8625531|NCT00507819|9665099|FG001|STARTED|Second Intervention (6 Weeks)||14
9095130|NCT03170882|10160019|FG001|NOT COMPLETED|Overall Study||51
9095131|NCT03074318|10160029|FG000|STARTED|Overall Study||6
8625532|NCT00507819|9665098|FG000|COMPLETED|Second Intervention (6 Weeks)||13
9095132|NCT03074318|10160030|FG001|STARTED|Overall Study||7
9095133|NCT03074318|10160031|FG002|STARTED|Overall Study||6
9095134|NCT03074318|10160032|FG003|STARTED|Overall Study||16
9095135|NCT03074318|10160029|FG000|COMPLETED|Overall Study||2
9095136|NCT03074318|10160030|FG001|COMPLETED|Overall Study||2
9095137|NCT03074318|10160031|FG002|COMPLETED|Overall Study||0
9095138|NCT03074318|10160032|FG003|COMPLETED|Overall Study||0
9095139|NCT03074318|10160029|FG000|NOT COMPLETED|Overall Study||4
9095140|NCT03074318|10160030|FG001|NOT COMPLETED|Overall Study||5
9095141|NCT03074318|10160031|FG002|NOT COMPLETED|Overall Study||6
9095142|NCT03074318|10160032|FG003|NOT COMPLETED|Overall Study||16
9095155|NCT03010319|10160062|FG000|STARTED|Overall Study||110
9095156|NCT03010319|10160063|FG001|STARTED|Overall Study||116
9095157|NCT03010319|10160062|FG000|COMPLETED|Overall Study||84
9095158|NCT03010319|10160063|FG001|COMPLETED|Overall Study||87
9095159|NCT03010319|10160062|FG000|NOT COMPLETED|Overall Study||26
9095160|NCT03010319|10160063|FG001|NOT COMPLETED|Overall Study||29
9095161|NCT02915016|10160077|FG000|STARTED|Overall Study||30
9095162|NCT02915016|10160078|FG001|STARTED|Overall Study||50
9095163|NCT02915016|10160079|FG002|STARTED|Overall Study||50
9095164|NCT02915016|10160080|FG003|STARTED|Overall Study||30
9095165|NCT02915016|10160081|FG004|STARTED|Overall Study||50
9095166|NCT02915016|10160082|FG005|STARTED|Overall Study||50
9095167|NCT02915016|10160083|FG006|STARTED|Overall Study||50
9095168|NCT02915016|10160084|FG007|STARTED|Overall Study||24
9095169|NCT02915016|10160077|FG000|Month 6.5 Immunogenicity Timepoint|Overall Study||23
9095170|NCT02915016|10160078|FG001|Month 6.5 Immunogenicity Timepoint|Overall Study||49
9095171|NCT02915016|10160079|FG002|Month 6.5 Immunogenicity Timepoint|Overall Study||46
9095172|NCT02915016|10160080|FG003|Month 6.5 Immunogenicity Timepoint|Overall Study||26
9095173|NCT02915016|10160081|FG004|Month 6.5 Immunogenicity Timepoint|Overall Study||43
9095174|NCT02915016|10160082|FG005|Month 6.5 Immunogenicity Timepoint|Overall Study||42
9095175|NCT02915016|10160083|FG006|Month 6.5 Immunogenicity Timepoint|Overall Study||42
9095176|NCT02915016|10160084|FG007|Month 6.5 Immunogenicity Timepoint|Overall Study||21
9095177|NCT02915016|10160077|FG000|COMPLETED|Overall Study||23
9095178|NCT02915016|10160078|FG001|COMPLETED|Overall Study||47
9095179|NCT02915016|10160079|FG002|COMPLETED|Overall Study||42
9095180|NCT02915016|10160080|FG003|COMPLETED|Overall Study||26
9095181|NCT02915016|10160081|FG004|COMPLETED|Overall Study||43
9095182|NCT02915016|10160082|FG005|COMPLETED|Overall Study||44
9095183|NCT02915016|10160083|FG006|COMPLETED|Overall Study||38
8625533|NCT00507819|9665099|FG001|COMPLETED|Second Intervention (6 Weeks)||14
8625534|NCT00507819|9665098|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
8625535|NCT00507819|9665099|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0
8625536|NCT00508001|9665108|FG000|STARTED|Overall Study||19
8625537|NCT00508001|9665109|FG001|STARTED|Overall Study||25
8625538|NCT00508001|9665110|FG002|STARTED|Overall Study||23
8625539|NCT00508001|9665108|FG000|Secondary Treatment Phase|Overall Study||0
8625540|NCT00508001|9665109|FG001|Secondary Treatment Phase|Overall Study||13
8625541|NCT00508001|9665110|FG002|Secondary Treatment Phase|Overall Study||16
8625542|NCT00508001|9665108|FG000|COMPLETED|Overall Study||0
8625543|NCT00508001|9665109|FG001|COMPLETED|Overall Study||13
8625544|NCT00508001|9665110|FG002|COMPLETED|Overall Study||16
8625545|NCT00508001|9665108|FG000|NOT COMPLETED|Overall Study||19
8625546|NCT00508001|9665109|FG001|NOT COMPLETED|Overall Study||12
8625547|NCT00508001|9665110|FG002|NOT COMPLETED|Overall Study||7
8625548|NCT00508027|9665118|FG000|STARTED|Dose Level 1|The participants starting each dose period is a new cohort of subjects. 20 subjects started dose 1|20
8625549|NCT00508027|9665118|FG000|COMPLETED|Dose Level 1||12
8625550|NCT00508027|9665118|FG000|NOT COMPLETED|Dose Level 1||8
8625551|NCT00508027|9665118|FG000|STARTED|Dose Level 2|The participants starting each dose period is a new cohort of subjects. 20 new subjects in dose 2|20
8625552|NCT00508027|9665118|FG000|COMPLETED|Dose Level 2||16
8625553|NCT00508027|9665118|FG000|NOT COMPLETED|Dose Level 2||4
8625554|NCT00508027|9665118|FG000|STARTED|Dose Level 3|enrollment discontinued due to FDA recommendations regarding high dose (80mg/day) simvastatin|2
8625555|NCT00508027|9665118|FG000|COMPLETED|Dose Level 3||2
8625556|NCT00508027|9665118|FG000|NOT COMPLETED|Dose Level 3||0
8625557|NCT00508105|9665133|FG000|STARTED|Overall Study||44
8625558|NCT00508105|9665134|FG001|STARTED|Overall Study||43
8625559|NCT00508105|9665133|FG000|COMPLETED|Overall Study||40
8625560|NCT00508105|9665134|FG001|COMPLETED|Overall Study||37
8625561|NCT00508105|9665133|FG000|NOT COMPLETED|Overall Study||4
8625562|NCT00508105|9665134|FG001|NOT COMPLETED|Overall Study||6
8625563|NCT00508118|9665143|FG000|STARTED|Overall Study||3
8625564|NCT00508118|9665144|FG001|STARTED|Overall Study|Documentation is not available for the 7th subject and treatment arm.|4
8625565|NCT00508118|9665143|FG000|COMPLETED|Overall Study||3
8625566|NCT00508118|9665144|FG001|COMPLETED|Overall Study||4
8625567|NCT00508118|9665143|FG000|NOT COMPLETED|Overall Study||0
8625568|NCT00508118|9665144|FG001|NOT COMPLETED|Overall Study||0
8625569|NCT00508144|9665151|FG000|STARTED|Overall Study||64
8625570|NCT00508144|9665151|FG000|COMPLETED|Overall Study||53
8625571|NCT00508144|9665151|FG000|NOT COMPLETED|Overall Study||11
8625572|NCT00508157|9665157|FG000|STARTED|Overall Study||26
8625573|NCT00508157|9665158|FG001|STARTED|Overall Study||26
9095184|NCT02915016|10160084|FG007|COMPLETED|Overall Study||20
9095185|NCT02915016|10160077|FG000|NOT COMPLETED|Overall Study||7
9095186|NCT02915016|10160078|FG001|NOT COMPLETED|Overall Study||3
9095187|NCT02915016|10160079|FG002|NOT COMPLETED|Overall Study||8
9095188|NCT02915016|10160080|FG003|NOT COMPLETED|Overall Study||4
9095189|NCT02915016|10160081|FG004|NOT COMPLETED|Overall Study||7
9095190|NCT02915016|10160082|FG005|NOT COMPLETED|Overall Study||6
9095191|NCT02915016|10160083|FG006|NOT COMPLETED|Overall Study||12
9095192|NCT02915016|10160084|FG007|NOT COMPLETED|Overall Study||4
9095193|NCT02871401|10160104|FG000|STARTED|Overall Study||20
9095194|NCT02871401|10160105|FG001|STARTED|Overall Study||11
9095195|NCT02871401|10160104|FG000|COMPLETED|Overall Study||19
9095196|NCT02871401|10160105|FG001|COMPLETED|Overall Study||11
9095197|NCT02871401|10160104|FG000|NOT COMPLETED|Overall Study||1
9095198|NCT02871401|10160105|FG001|NOT COMPLETED|Overall Study||0
9095199|NCT02811913|10160111|FG000|STARTED|Overall Study||20
9095200|NCT02811913|10160111|FG000|COMPLETED|Overall Study||16
9095201|NCT02811913|10160111|FG000|NOT COMPLETED|Overall Study||4
9095202|NCT02701283|10160123|FG000|STARTED|Overall Study||737
9095203|NCT02701283|10160124|FG001|STARTED|Overall Study||741
9095204|NCT02701283|10160125|FG002|STARTED|Overall Study||745
9095205|NCT02701283|10160123|FG000|As Treated (Attempted Implant)|Overall Study||730
9095206|NCT02701283|10160124|FG001|As Treated (Attempted Implant)|Overall Study||684
9095207|NCT02701283|10160125|FG002|As Treated (Attempted Implant)|Overall Study||745
9095208|NCT02701283|10160123|FG000|Implanted|Overall Study||727
9095209|NCT02701283|10160124|FG001|Implanted|Overall Study||686
9095210|NCT02701283|10160125|FG002|Implanted|Overall Study||745
9095211|NCT02701283|10160123|FG000|COMPLETED|Overall Study||668
9095212|NCT02701283|10160124|FG001|COMPLETED|Overall Study||579
9095213|NCT02701283|10160125|FG002|COMPLETED|Overall Study||724
9095214|NCT02701283|10160123|FG000|NOT COMPLETED|Overall Study||69
9095215|NCT02701283|10160124|FG001|NOT COMPLETED|Overall Study||162
9095216|NCT02701283|10160125|FG002|NOT COMPLETED|Overall Study||21
9095217|NCT02696031|10160139|FG000|STARTED|Up to Week 24||185
9095218|NCT02696031|10160140|FG001|STARTED|Up to Week 24||184
9095219|NCT02696031|10160141|FG002|STARTED|Up to Week 24||186
9095220|NCT02696031|10160142|FG003|STARTED|Up to Week 24||0
9095221|NCT02696031|10160143|FG004|STARTED|Up to Week 24||0
9095222|NCT02696031|10160144|FG005|STARTED|Up to Week 24||0
9095223|NCT02696031|10160139|FG000|COMPLETED|Up to Week 24||175
9095224|NCT02696031|10160140|FG001|COMPLETED|Up to Week 24||177
9095225|NCT02696031|10160141|FG002|COMPLETED|Up to Week 24||175
9095226|NCT02696031|10160142|FG003|COMPLETED|Up to Week 24||0
9095227|NCT02696031|10160143|FG004|COMPLETED|Up to Week 24||0
9095228|NCT02696031|10160144|FG005|COMPLETED|Up to Week 24||0
9095229|NCT02696031|10160139|FG000|NOT COMPLETED|Up to Week 24||10
9095230|NCT02696031|10160140|FG001|NOT COMPLETED|Up to Week 24||7
9095231|NCT02696031|10160141|FG002|NOT COMPLETED|Up to Week 24||11
9095232|NCT02696031|10160142|FG003|NOT COMPLETED|Up to Week 24||0
9095233|NCT02696031|10160143|FG004|NOT COMPLETED|Up to Week 24||0
9095234|NCT02696031|10160144|FG005|NOT COMPLETED|Up to Week 24||0
9095235|NCT02696031|10160139|FG000|STARTED|Up to Week 52||185
9095236|NCT02696031|10160140|FG001|STARTED|Up to Week 52||184
9095237|NCT02696031|10160141|FG002|STARTED|Up to Week 52||186
9095238|NCT02696031|10160142|FG003|STARTED|Up to Week 52||0
9095239|NCT02696031|10160143|FG004|STARTED|Up to Week 52||0
9095240|NCT02696031|10160144|FG005|STARTED|Up to Week 52||0
9095241|NCT02696031|10160139|FG000|COMPLETED|Up to Week 52||156
9095242|NCT02696031|10160140|FG001|COMPLETED|Up to Week 52||165
9095243|NCT02696031|10160141|FG002|COMPLETED|Up to Week 52||160
9095244|NCT02696031|10160142|FG003|COMPLETED|Up to Week 52||0
9095245|NCT02696031|10160143|FG004|COMPLETED|Up to Week 52||0
9095246|NCT02696031|10160144|FG005|COMPLETED|Up to Week 52||0
9095247|NCT02696031|10160139|FG000|NOT COMPLETED|Up to Week 52||29
9095248|NCT02696031|10160140|FG001|NOT COMPLETED|Up to Week 52||19
9095249|NCT02696031|10160141|FG002|NOT COMPLETED|Up to Week 52||26
9095250|NCT02696031|10160142|FG003|NOT COMPLETED|Up to Week 52||0
9095251|NCT02696031|10160143|FG004|NOT COMPLETED|Up to Week 52||0
9095252|NCT02696031|10160144|FG005|NOT COMPLETED|Up to Week 52||0
9095253|NCT02696031|10160139|FG000|STARTED|Up to Week 104||185
9095254|NCT02696031|10160140|FG001|STARTED|Up to Week 104||184
9095255|NCT02696031|10160141|FG002|STARTED|Up to Week 104||186
9095256|NCT02696031|10160142|FG003|STARTED|Up to Week 104||0
9095257|NCT02696031|10160143|FG004|STARTED|Up to Week 104||0
9095258|NCT02696031|10160144|FG005|STARTED|Up to Week 104||0
9095259|NCT02696031|10160139|FG000|COMPLETED|Up to Week 104||146
9095260|NCT02696031|10160140|FG001|COMPLETED|Up to Week 104||143
8625574|NCT00508157|9665157|FG000|Randomized Sample|Overall Study||26
8625575|NCT00508157|9665158|FG001|Randomized Sample|Overall Study||26
8625576|NCT00508157|9665157|FG000|Safety Sample|Overall Study||26
8625577|NCT00508157|9665158|FG001|Safety Sample|Overall Study|1 participant was withdrawn from study prior to receiving study drug & excluded from safety sample.|25
9095261|NCT02696031|10160141|FG002|COMPLETED|Up to Week 104||149
9095262|NCT02696031|10160142|FG003|COMPLETED|Up to Week 104||0
9095263|NCT02696031|10160143|FG004|COMPLETED|Up to Week 104||0
9095264|NCT02696031|10160144|FG005|COMPLETED|Up to Week 104||0
9095265|NCT02696031|10160139|FG000|NOT COMPLETED|Up to Week 104||39
9095266|NCT02696031|10160140|FG001|NOT COMPLETED|Up to Week 104||41
9095267|NCT02696031|10160141|FG002|NOT COMPLETED|Up to Week 104||37
9095268|NCT02696031|10160142|FG003|NOT COMPLETED|Up to Week 104||0
9095269|NCT02696031|10160143|FG004|NOT COMPLETED|Up to Week 104||0
9095270|NCT02696031|10160144|FG005|NOT COMPLETED|Up to Week 104||0
9095271|NCT02696031|10160139|FG000|STARTED|Extension Phase From wk 104 to wk 208||0
9095272|NCT02696031|10160140|FG001|STARTED|Extension Phase From wk 104 to wk 208||0
9095273|NCT02696031|10160141|FG002|STARTED|Extension Phase From wk 104 to wk 208||0
9095274|NCT02696031|10160142|FG003|STARTED|Extension Phase From wk 104 to wk 208||147
9095275|NCT02696031|10160143|FG004|STARTED|Extension Phase From wk 104 to wk 208||147
9095276|NCT02696031|10160144|FG005|STARTED|Extension Phase From wk 104 to wk 208||78
9095277|NCT02696031|10160139|FG000|COMPLETED|Extension Phase From wk 104 to wk 208||0
9095278|NCT02696031|10160140|FG001|COMPLETED|Extension Phase From wk 104 to wk 208||0
9095279|NCT02696031|10160141|FG002|COMPLETED|Extension Phase From wk 104 to wk 208||0
9095280|NCT02696031|10160142|FG003|COMPLETED|Extension Phase From wk 104 to wk 208||137
9095281|NCT02696031|10160143|FG004|COMPLETED|Extension Phase From wk 104 to wk 208||132
9095282|NCT02696031|10160144|FG005|COMPLETED|Extension Phase From wk 104 to wk 208||72
9095283|NCT02696031|10160139|FG000|NOT COMPLETED|Extension Phase From wk 104 to wk 208||0
9095284|NCT02696031|10160140|FG001|NOT COMPLETED|Extension Phase From wk 104 to wk 208||0
9095285|NCT02696031|10160141|FG002|NOT COMPLETED|Extension Phase From wk 104 to wk 208||0
9095286|NCT02696031|10160142|FG003|NOT COMPLETED|Extension Phase From wk 104 to wk 208||10
9095287|NCT02696031|10160143|FG004|NOT COMPLETED|Extension Phase From wk 104 to wk 208||15
9095288|NCT02696031|10160144|FG005|NOT COMPLETED|Extension Phase From wk 104 to wk 208||6
9095289|NCT02689453|10160156|FG000|STARTED|Overall Study||3
9095290|NCT02689453|10160157|FG001|STARTED|Overall Study||4
9095291|NCT02689453|10160158|FG002|STARTED|Overall Study||4
9095292|NCT02689453|10160156|FG000|COMPLETED|Overall Study||3
9095293|NCT02689453|10160157|FG001|COMPLETED|Overall Study||3
9095294|NCT02689453|10160158|FG002|COMPLETED|Overall Study||3
9095295|NCT02689453|10160156|FG000|NOT COMPLETED|Overall Study||0
9095296|NCT02689453|10160157|FG001|NOT COMPLETED|Overall Study||1
9095297|NCT02689453|10160158|FG002|NOT COMPLETED|Overall Study||1
8625578|NCT00508157|9665157|FG000|COMPLETED|Overall Study||24
8625579|NCT00508157|9665158|FG001|COMPLETED|Overall Study||23
8625580|NCT00508157|9665157|FG000|NOT COMPLETED|Overall Study||2
8625581|NCT00508157|9665158|FG001|NOT COMPLETED|Overall Study||3
8625582|NCT00508183|9665166|FG000|STARTED|Overall Study||48
8625583|NCT00508183|9665167|FG001|STARTED|Overall Study||42
8625584|NCT00508183|9665166|FG000|COMPLETED|Overall Study||39
8625585|NCT00508183|9665167|FG001|COMPLETED|Overall Study||34
8625586|NCT00508183|9665166|FG000|NOT COMPLETED|Overall Study||9
8625587|NCT00508183|9665167|FG001|NOT COMPLETED|Overall Study||8
8625588|NCT00508196|9665173|FG000|STARTED|Overall Study||11
8625589|NCT00508196|9665174|FG001|STARTED|Overall Study||11
8625590|NCT00508196|9665173|FG000|COMPLETED|Overall Study||11
8625591|NCT00508196|9665174|FG001|COMPLETED|Overall Study||11
8625592|NCT00508196|9665173|FG000|NOT COMPLETED|Overall Study||0
8845857|NCT01717768|9900351|FG004|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8845858|NCT01717768|9900352|FG005|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8845859|NCT01717768|9900353|FG006|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8845860|NCT01717768|9900354|FG007|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8845861|NCT01717768|9900355|FG008|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8845862|NCT01717768|9900356|FG009|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8845863|NCT01717768|9900357|FG010|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8845864|NCT01717768|9900358|FG011|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8845865|NCT01717768|9900347|FG000|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8625593|NCT00508196|9665174|FG001|NOT COMPLETED|Overall Study||0
8625594|NCT00508261|9665184|FG000|STARTED|Overall Study||222
8625595|NCT00508261|9665185|FG001|STARTED|Overall Study||220
8625596|NCT00508261|9665186|FG002|STARTED|Overall Study||224
8625597|NCT00508261|9665187|FG003|STARTED|Overall Study||127
9095298|NCT02476851|10160170|FG000|STARTED|Overall Study||31
9095299|NCT02476851|10160171|FG001|STARTED|Overall Study||31
9095300|NCT02476851|10160170|FG000|COMPLETED|Overall Study||30
9095301|NCT02476851|10160171|FG001|COMPLETED|Overall Study||30
9095302|NCT02476851|10160170|FG000|NOT COMPLETED|Overall Study||1
9095303|NCT02476851|10160171|FG001|NOT COMPLETED|Overall Study||1
9095304|NCT02389946|10160179|FG000|STARTED|Overall Study||884
9095305|NCT02389946|10160180|FG001|STARTED|Overall Study||450
9095306|NCT02389946|10160179|FG000|COMPLETED|Overall Study||860
9095307|NCT02389946|10160180|FG001|COMPLETED|Overall Study||435
9095308|NCT02389946|10160179|FG000|NOT COMPLETED|Overall Study||24
9095309|NCT02389946|10160180|FG001|NOT COMPLETED|Overall Study||15
9095310|NCT02310919|10160188|FG000|STARTED|Overall Study||54
9095311|NCT02310919|10160189|FG001|STARTED|Overall Study||51
9095312|NCT02310919|10160188|FG000|COMPLETED|Overall Study|Four participants receiving the study trigger deviated from protocol. One patient was randomized before her E2 resulted >5,000 pg/ml. Another elected to convert to intrauterine insemination while another underwent oocyte cryopreservation as their male partner was unable to produce a fresh sperm sample for fertilization. The 4th patient inadvertently spilled a portion of the trigger prior to injection. Since her post-trigger hCG was <18 IU/L, she was unblinded and re-triggered with 10,000 IU hCG.|54
9095313|NCT02310919|10160189|FG001|COMPLETED|Overall Study|Two participants that received the standard trigger requested exclusionary embryo co-culture to be added post-trigger.|51
9095314|NCT02310919|10160188|FG000|NOT COMPLETED|Overall Study||0
9095315|NCT02310919|10160189|FG001|NOT COMPLETED|Overall Study||0
9095316|NCT02208024|10160196|FG000|STARTED|Overall Study||18
9095317|NCT02208024|10160196|FG000|COMPLETED|Overall Study||17
9095318|NCT02208024|10160196|FG000|NOT COMPLETED|Overall Study||1
9095319|NCT02180867|10160207|FG000|STARTED|Overall Study||10
9095320|NCT02180867|10160208|FG001|STARTED|Overall Study||11
9095321|NCT02180867|10160209|FG002|STARTED|Overall Study||10
9095322|NCT02180867|10160210|FG003|STARTED|Overall Study||49
9095323|NCT02180867|10160211|FG004|STARTED|Overall Study||48
9095324|NCT02180867|10160212|FG005|STARTED|Overall Study||6
9095325|NCT02180867|10160213|FG006|STARTED|Overall Study||6
9095326|NCT02180867|10160207|FG000|Pediatric Patients|Overall Study||6
9095327|NCT02180867|10160208|FG001|Pediatric Patients|Overall Study||4
9095328|NCT02180867|10160209|FG002|Pediatric Patients|Overall Study||3
9095329|NCT02180867|10160210|FG003|Pediatric Patients|Overall Study||18
9095330|NCT02180867|10160211|FG004|Pediatric Patients|Overall Study||19
9095331|NCT02180867|10160212|FG005|Pediatric Patients|Overall Study||1
9095332|NCT02180867|10160213|FG006|Pediatric Patients|Overall Study||0
9095333|NCT02180867|10160207|FG000|Adult Patients|Overall Study||4
9095334|NCT02180867|10160208|FG001|Adult Patients|Overall Study||7
9095335|NCT02180867|10160209|FG002|Adult Patients|Overall Study||7
9095336|NCT02180867|10160210|FG003|Adult Patients|Overall Study||31
9095337|NCT02180867|10160211|FG004|Adult Patients|Overall Study||29
9095338|NCT02180867|10160212|FG005|Adult Patients|Overall Study||5
9095339|NCT02180867|10160213|FG006|Adult Patients|Overall Study||6
9095340|NCT02180867|10160207|FG000|COMPLETED|Overall Study||4
9095341|NCT02180867|10160208|FG001|COMPLETED|Overall Study||0
9095342|NCT02180867|10160209|FG002|COMPLETED|Overall Study||6
9095343|NCT02180867|10160210|FG003|COMPLETED|Overall Study||23
9095344|NCT02180867|10160211|FG004|COMPLETED|Overall Study||21
9095345|NCT02180867|10160212|FG005|COMPLETED|Overall Study||3
9095346|NCT02180867|10160213|FG006|COMPLETED|Overall Study||1
9095347|NCT02180867|10160207|FG000|NOT COMPLETED|Overall Study||6
9095348|NCT02180867|10160208|FG001|NOT COMPLETED|Overall Study||11
9095349|NCT02180867|10160209|FG002|NOT COMPLETED|Overall Study||4
9095350|NCT02180867|10160210|FG003|NOT COMPLETED|Overall Study||26
8845866|NCT01717768|9900348|FG001|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8845867|NCT01717768|9900349|FG002|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8845868|NCT01717768|9900350|FG003|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||4
8845869|NCT01717768|9900351|FG004|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||5
8625598|NCT00508261|9665184|FG000|COMPLETED|Overall Study||219
8625599|NCT00508261|9665185|FG001|COMPLETED|Overall Study||212
8625600|NCT00508261|9665186|FG002|COMPLETED|Overall Study||218
8845870|NCT01717768|9900352|FG005|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||5
8845871|NCT01717768|9900353|FG006|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8845872|NCT01717768|9900354|FG007|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
9095351|NCT02180867|10160211|FG004|NOT COMPLETED|Overall Study||27
9095352|NCT02180867|10160212|FG005|NOT COMPLETED|Overall Study||3
9095353|NCT02180867|10160213|FG006|NOT COMPLETED|Overall Study||5
9095354|NCT01866111|10160245|FG000|STARTED|Double-blind Period of Study YKP3089C017||108
9095355|NCT01866111|10160246|FG001|STARTED|Double-blind Period of Study YKP3089C017||108
9095356|NCT01866111|10160247|FG002|STARTED|Double-blind Period of Study YKP3089C017||110
9095357|NCT01866111|10160248|FG003|STARTED|Double-blind Period of Study YKP3089C017||111
9095358|NCT01866111|10160245|FG000|COMPLETED|Double-blind Period of Study YKP3089C017||94
9095359|NCT01866111|10160246|FG001|COMPLETED|Double-blind Period of Study YKP3089C017||95
9095360|NCT01866111|10160247|FG002|COMPLETED|Double-blind Period of Study YKP3089C017||90
8625601|NCT00508261|9665187|FG003|COMPLETED|Overall Study||126
8845873|NCT01717768|9900355|FG008|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
9095361|NCT01866111|10160248|FG003|COMPLETED|Double-blind Period of Study YKP3089C017||81
9095362|NCT01866111|10160245|FG000|NOT COMPLETED|Double-blind Period of Study YKP3089C017||14
9095363|NCT01866111|10160246|FG001|NOT COMPLETED|Double-blind Period of Study YKP3089C017||13
9095364|NCT01866111|10160247|FG002|NOT COMPLETED|Double-blind Period of Study YKP3089C017||20
9095365|NCT01866111|10160248|FG003|NOT COMPLETED|Double-blind Period of Study YKP3089C017||30
9095366|NCT01866111|10160245|FG000|STARTED|Open-label Extension Study YKP3089C017|Not all patients from double-blind rolled over to open-label|91
9095367|NCT01866111|10160246|FG001|STARTED|Open-label Extension Study YKP3089C017||95
9095368|NCT01866111|10160247|FG002|STARTED|Open-label Extension Study YKP3089C017||90
9095369|NCT01866111|10160248|FG003|STARTED|Open-label Extension Study YKP3089C017|Not all patients from double-blind rolled over to open-label|80
9095370|NCT01866111|10160245|FG000|COMPLETED|Open-label Extension Study YKP3089C017||26
9095371|NCT01866111|10160246|FG001|COMPLETED|Open-label Extension Study YKP3089C017||28
9095372|NCT01866111|10160247|FG002|COMPLETED|Open-label Extension Study YKP3089C017||27
9095373|NCT01866111|10160248|FG003|COMPLETED|Open-label Extension Study YKP3089C017||28
9095374|NCT01866111|10160245|FG000|NOT COMPLETED|Open-label Extension Study YKP3089C017||65
9095375|NCT01866111|10160246|FG001|NOT COMPLETED|Open-label Extension Study YKP3089C017||67
9095376|NCT01866111|10160247|FG002|NOT COMPLETED|Open-label Extension Study YKP3089C017||63
9095377|NCT01866111|10160248|FG003|NOT COMPLETED|Open-label Extension Study YKP3089C017||52
9095378|NCT01767194|10160260|FG000|STARTED|Overall Study||19
9095379|NCT01767194|10160261|FG001|STARTED|Overall Study||54
9095380|NCT01767194|10160260|FG000|COMPLETED|Overall Study||1
9095381|NCT01767194|10160261|FG001|COMPLETED|Overall Study||11
9095382|NCT01767194|10160260|FG000|NOT COMPLETED|Overall Study||18
9095383|NCT01767194|10160261|FG001|NOT COMPLETED|Overall Study||43
9095384|NCT01767129|10160268|FG000|STARTED|Treatment Period 1 (14 Days)||7
9095385|NCT01767129|10160269|FG001|STARTED|Treatment Period 1 (14 Days)||7
9095386|NCT01767129|10160268|FG000|COMPLETED|Treatment Period 1 (14 Days)||6
9095387|NCT01767129|10160269|FG001|COMPLETED|Treatment Period 1 (14 Days)||7
9095388|NCT01767129|10160268|FG000|NOT COMPLETED|Treatment Period 1 (14 Days)||1
9095389|NCT01767129|10160269|FG001|NOT COMPLETED|Treatment Period 1 (14 Days)||0
9095390|NCT01767129|10160268|FG000|STARTED|Treatment Period 2 (14 Days)||6
9095391|NCT01767129|10160269|FG001|STARTED|Treatment Period 2 (14 Days)||7
9095392|NCT01767129|10160268|FG000|COMPLETED|Treatment Period 2 (14 Days)||6
9095393|NCT01767129|10160269|FG001|COMPLETED|Treatment Period 2 (14 Days)||7
9095394|NCT01767129|10160268|FG000|NOT COMPLETED|Treatment Period 2 (14 Days)||0
9095395|NCT01767129|10160269|FG001|NOT COMPLETED|Treatment Period 2 (14 Days)||0
9095396|NCT01708954|10160279|FG000|STARTED|Step 1||42
9095397|NCT01708954|10160280|FG001|STARTED|Step 1||40
9095398|NCT01708954|10160281|FG002|STARTED|Step 1||43
9095399|NCT01708954|10160279|FG000|Started Protocol Therapy|Step 1||40
9095400|NCT01708954|10160280|FG001|Started Protocol Therapy|Step 1||40
9095401|NCT01708954|10160281|FG002|Started Protocol Therapy|Step 1||39
9095402|NCT01708954|10160279|FG000|Eligible and Treated|Step 1||38
9095403|NCT01708954|10160280|FG001|Eligible and Treated|Step 1||38
9095404|NCT01708954|10160281|FG002|Eligible and Treated|Step 1||35
9095405|NCT01708954|10160279|FG000|Patients With MET Status Data Available|Step 1||30
9095406|NCT01708954|10160280|FG001|Patients With MET Status Data Available|Step 1||32
9095407|NCT01708954|10160281|FG002|Patients With MET Status Data Available|Step 1||24
9095408|NCT01708954|10160279|FG000|COMPLETED|Step 1|Treatment continued until progressive disease or unacceptable toxicity.|0
9095409|NCT01708954|10160280|FG001|COMPLETED|Step 1|Treatment continued until progressive disease or unacceptable toxicity.|0
9095410|NCT01708954|10160281|FG002|COMPLETED|Step 1|Treatment continued until progressive disease or unacceptable toxicity.|0
9095411|NCT01708954|10160279|FG000|NOT COMPLETED|Step 1||42
9095412|NCT01708954|10160280|FG001|NOT COMPLETED|Step 1||40
9095413|NCT01708954|10160281|FG002|NOT COMPLETED|Step 1||43
9095414|NCT01708954|10160279|FG000|STARTED|Step 2|Only patients with disease progression in Step 1 are eligible to register to Step 2.|13
9095415|NCT01708954|10160280|FG001|STARTED|Step 2|Only patients with disease progression in Step 1 are eligible to register to Step 2.|7
9095416|NCT01708954|10160281|FG002|STARTED|Step 2|Only patients with disease progression on Arms A and B were allowed to register to Step 2.|0
9095417|NCT01708954|10160279|FG000|COMPLETED|Step 2|Treatment continued until progressive disease or unacceptable toxicity.|0
9095418|NCT01708954|10160280|FG001|COMPLETED|Step 2|Treatment continued until progressive disease or unacceptable toxicity.|0
9095419|NCT01708954|10160281|FG002|COMPLETED|Step 2||0
9095420|NCT01708954|10160279|FG000|NOT COMPLETED|Step 2||13
9095421|NCT01708954|10160280|FG001|NOT COMPLETED|Step 2||7
9095422|NCT01708954|10160281|FG002|NOT COMPLETED|Step 2||0
9095423|NCT01708941|10160294|FG000|STARTED|Overall Study||21
9095424|NCT01708941|10160295|FG001|STARTED|Overall Study||23
9095425|NCT01708941|10160296|FG002|STARTED|Overall Study||22
9095426|NCT01708941|10160297|FG003|STARTED|Overall Study||22
9095427|NCT01708941|10160294|FG000|Eligible and Started Treatment|Overall Study||18
9095428|NCT01708941|10160295|FG001|Eligible and Started Treatment|Overall Study||22
9095429|NCT01708941|10160296|FG002|Eligible and Started Treatment|Overall Study||19
9095430|NCT01708941|10160297|FG003|Eligible and Started Treatment|Overall Study||22
9095431|NCT01708941|10160294|FG000|COMPLETED|Overall Study||3
9095432|NCT01708941|10160295|FG001|COMPLETED|Overall Study||5
9095433|NCT01708941|10160296|FG002|COMPLETED|Overall Study||3
9095434|NCT01708941|10160297|FG003|COMPLETED|Overall Study||4
9095435|NCT01708941|10160294|FG000|NOT COMPLETED|Overall Study||18
9095436|NCT01708941|10160295|FG001|NOT COMPLETED|Overall Study||18
9095437|NCT01708941|10160296|FG002|NOT COMPLETED|Overall Study||19
9095438|NCT01708941|10160297|FG003|NOT COMPLETED|Overall Study||18
9095439|NCT01622868|10160309|FG000|STARTED|Overall Study||72
9095440|NCT01622868|10160310|FG001|STARTED|Overall Study||71
9095441|NCT01622868|10160309|FG000|Eligible|Overall Study||65
9095442|NCT01622868|10160310|FG001|Eligible|Overall Study||71
9095443|NCT01622868|10160309|FG000|Eligible, Started Study Treatment, Has Adverse Event Data|Overall Study||63
9095444|NCT01622868|10160310|FG001|Eligible, Started Study Treatment, Has Adverse Event Data|Overall Study||71
9095445|NCT01622868|10160309|FG000|COMPLETED|Overall Study||65
9095446|NCT01622868|10160310|FG001|COMPLETED|Overall Study||71
9095447|NCT01622868|10160309|FG000|NOT COMPLETED|Overall Study||7
9095448|NCT01622868|10160310|FG001|NOT COMPLETED|Overall Study||0
8625602|NCT00508261|9665184|FG000|NOT COMPLETED|Overall Study||3
8625603|NCT00508261|9665185|FG001|NOT COMPLETED|Overall Study||8
8625604|NCT00508261|9665186|FG002|NOT COMPLETED|Overall Study||6
9095449|NCT01609790|10160319|FG000|STARTED|Overall Study||7
9095450|NCT01609790|10160320|FG001|STARTED|Overall Study||65
9095451|NCT01609790|10160321|FG002|STARTED|Overall Study||65
9095452|NCT01609790|10160319|FG000|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|6
9095453|NCT01609790|10160320|FG001|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|58
9095454|NCT01609790|10160321|FG002|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|57
9095455|NCT01609790|10160319|FG000|NOT COMPLETED|Overall Study||1
9095456|NCT01609790|10160320|FG001|NOT COMPLETED|Overall Study||7
9095457|NCT01609790|10160321|FG002|NOT COMPLETED|Overall Study||8
9095458|NCT01586910|10160331|FG000|STARTED|Overall Study||879
9095459|NCT01586910|10160332|FG001|STARTED|Overall Study||867
9095460|NCT01586910|10160331|FG000|COMPLETED|Overall Study||864
9095461|NCT01586910|10160332|FG001|COMPLETED|Overall Study||796
9095462|NCT01586910|10160331|FG000|NOT COMPLETED|Overall Study||15
9095463|NCT01586910|10160332|FG001|NOT COMPLETED|Overall Study||71
9095464|NCT01553149|10160342|FG000|STARTED|Overall Study||37
9095465|NCT01553149|10160343|FG001|STARTED|Overall Study||38
9095466|NCT01553149|10160342|FG000|COMPLETED|Overall Study||32
9095467|NCT01553149|10160343|FG001|COMPLETED|Overall Study||18
9095468|NCT01553149|10160342|FG000|NOT COMPLETED|Overall Study||5
9095469|NCT01553149|10160343|FG001|NOT COMPLETED|Overall Study||20
9095470|NCT01531374|10160352|FG000|STARTED|Overall Study||1285
9095471|NCT01531374|10160353|FG001|STARTED|Overall Study||373
9095472|NCT01531374|10160354|FG002|STARTED|Overall Study||1119
9095473|NCT01531374|10160352|FG000|COMPLETED|Overall Study||921
9095474|NCT01531374|10160353|FG001|COMPLETED|Overall Study||231
9095475|NCT01531374|10160354|FG002|COMPLETED|Overall Study||836
9095476|NCT01531374|10160352|FG000|NOT COMPLETED|Overall Study||364
9095477|NCT01531374|10160353|FG001|NOT COMPLETED|Overall Study||142
9095478|NCT01531374|10160354|FG002|NOT COMPLETED|Overall Study||283
9095479|NCT01371981|10160370|FG000|STARTED|Overall Study||580
9095480|NCT01371981|10160371|FG001|STARTED|Overall Study||591
9095481|NCT01371981|10160372|FG002|STARTED|Overall Study||12
9095482|NCT01371981|10160373|FG003|STARTED|Overall Study||33
9095483|NCT01371981|10160374|FG004|STARTED|Overall Study||47
9095484|NCT01371981|10160375|FG005|STARTED|Overall Study||382
9095485|NCT01371981|10160370|FG000|COMPLETED|Overall Study||396
9095486|NCT01371981|10160371|FG001|COMPLETED|Overall Study||399
9095487|NCT01371981|10160372|FG002|COMPLETED|Overall Study||6
9095488|NCT01371981|10160373|FG003|COMPLETED|Overall Study||12
9095489|NCT01371981|10160374|FG004|COMPLETED|Overall Study||15
9095490|NCT01371981|10160375|FG005|COMPLETED|Overall Study||368
9095491|NCT01371981|10160370|FG000|NOT COMPLETED|Overall Study||184
9095492|NCT01371981|10160371|FG001|NOT COMPLETED|Overall Study||192
9095493|NCT01371981|10160372|FG002|NOT COMPLETED|Overall Study||6
9095494|NCT01371981|10160373|FG003|NOT COMPLETED|Overall Study||21
9095495|NCT01371981|10160374|FG004|NOT COMPLETED|Overall Study||32
9095496|NCT01371981|10160375|FG005|NOT COMPLETED|Overall Study||14
9095497|NCT01240902|10160398|FG000|STARTED|Overall Study||500
9095498|NCT01240902|10160399|FG001|STARTED|Overall Study||156
9095499|NCT01240902|10160400|FG002|STARTED|Overall Study||395
9095500|NCT01240902|10160401|FG003|STARTED|Overall Study||402
9095501|NCT01240902|10160398|FG000|COMPLETED|Overall Study||289
9095502|NCT01240902|10160399|FG001|COMPLETED|Overall Study||77
9095503|NCT01240902|10160400|FG002|COMPLETED|Overall Study||295
9095504|NCT01240902|10160401|FG003|COMPLETED|Overall Study||237
9095505|NCT01240902|10160398|FG000|NOT COMPLETED|Overall Study||211
9095506|NCT01240902|10160399|FG001|NOT COMPLETED|Overall Study||79
9095507|NCT01240902|10160400|FG002|NOT COMPLETED|Overall Study||100
9095508|NCT01240902|10160401|FG003|NOT COMPLETED|Overall Study||165
9095509|NCT01236560|10160417|FG000|STARTED|Overall Study||6
9095510|NCT01236560|10160418|FG001|STARTED|Overall Study||32
9095511|NCT01236560|10160419|FG002|STARTED|Overall Study||31
9095512|NCT01236560|10160420|FG003|STARTED|Overall Study||32
9095513|NCT01236560|10160421|FG004|STARTED|Overall Study||0
9095514|NCT01236560|10160422|FG005|STARTED|Overall Study||0
9095515|NCT01236560|10160417|FG000|COMPLETED|Overall Study||1
8625605|NCT00508261|9665187|FG003|NOT COMPLETED|Overall Study||1
9095516|NCT01236560|10160418|FG001|COMPLETED|Overall Study||8
9095517|NCT01236560|10160419|FG002|COMPLETED|Overall Study||11
9095518|NCT01236560|10160420|FG003|COMPLETED|Overall Study||10
9095519|NCT01236560|10160421|FG004|COMPLETED|Overall Study||0
9095520|NCT01236560|10160422|FG005|COMPLETED|Overall Study||0
9095521|NCT01236560|10160417|FG000|NOT COMPLETED|Overall Study||5
9095522|NCT01236560|10160418|FG001|NOT COMPLETED|Overall Study||24
9095523|NCT01236560|10160419|FG002|NOT COMPLETED|Overall Study||20
9095524|NCT01236560|10160420|FG003|NOT COMPLETED|Overall Study||22
9095525|NCT01236560|10160421|FG004|NOT COMPLETED|Overall Study||0
9095526|NCT01236560|10160422|FG005|NOT COMPLETED|Overall Study||0
9095527|NCT01236547|10160437|FG000|STARTED|Overall Study||11
9095528|NCT01236547|10160438|FG001|STARTED|Overall Study||11
9095529|NCT01236547|10160439|FG002|STARTED|Overall Study||12
9095530|NCT01236547|10160440|FG003|STARTED|Overall Study||42
9095531|NCT01236547|10160441|FG004|STARTED|Overall Study||47
9095532|NCT01236547|10160437|FG000|Eligible|Overall Study||11
9095533|NCT01236547|10160438|FG001|Eligible|Overall Study||10
9095534|NCT01236547|10160439|FG002|Eligible|Overall Study||11
9095535|NCT01236547|10160440|FG003|Eligible|Overall Study||36
9095536|NCT01236547|10160441|FG004|Eligible|Overall Study||35
9095537|NCT01236547|10160437|FG000|Eligible and Started Study Treatment|Overall Study||11
9095538|NCT01236547|10160438|FG001|Eligible and Started Study Treatment|Overall Study||10
9095539|NCT01236547|10160439|FG002|Eligible and Started Study Treatment|Overall Study||11
9095540|NCT01236547|10160440|FG003|Eligible and Started Study Treatment|Overall Study||36
9095541|NCT01236547|10160441|FG004|Eligible and Started Study Treatment|Overall Study||34
9095542|NCT01236547|10160437|FG000|Eligible and Response Assessed|Overall Study||0
9095543|NCT01236547|10160438|FG001|Eligible and Response Assessed|Overall Study||0
9095544|NCT01236547|10160439|FG002|Eligible and Response Assessed|Overall Study||0
9095545|NCT01236547|10160440|FG003|Eligible and Response Assessed|Overall Study||23
9095546|NCT01236547|10160441|FG004|Eligible and Response Assessed|Overall Study||27
9095547|NCT01236547|10160437|FG000|COMPLETED|Overall Study||11
9095548|NCT01236547|10160438|FG001|COMPLETED|Overall Study||10
9095549|NCT01236547|10160439|FG002|COMPLETED|Overall Study||11
9095550|NCT01236547|10160440|FG003|COMPLETED|Overall Study||36
9095551|NCT01236547|10160441|FG004|COMPLETED|Overall Study||35
9095552|NCT01236547|10160437|FG000|NOT COMPLETED|Overall Study||0
9095553|NCT01236547|10160438|FG001|NOT COMPLETED|Overall Study||1
9095554|NCT01236547|10160439|FG002|NOT COMPLETED|Overall Study||1
9095555|NCT01236547|10160440|FG003|NOT COMPLETED|Overall Study||6
9095556|NCT01236547|10160441|FG004|NOT COMPLETED|Overall Study||12
9095557|NCT01142388|10160456|FG000|STARTED|Overall Study||47
9095558|NCT01142388|10160457|FG001|STARTED|Overall Study||47
9095559|NCT01142388|10160456|FG000|Eligible|Overall Study||43
9095560|NCT01142388|10160457|FG001|Eligible|Overall Study||44
9095561|NCT01142388|10160456|FG000|Treated|Overall Study||40
9095562|NCT01142388|10160457|FG001|Treated|Overall Study||44
9095563|NCT01142388|10160456|FG000|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity.|0
9095564|NCT01142388|10160457|FG001|COMPLETED|Overall Study||0
9095565|NCT01142388|10160456|FG000|NOT COMPLETED|Overall Study||47
9095566|NCT01142388|10160457|FG001|NOT COMPLETED|Overall Study||47
9095567|NCT01062425|10160465|FG000|STARTED|Overall Study||55
9095568|NCT01062425|10160466|FG001|STARTED|Overall Study||103
9095569|NCT01062425|10160465|FG000|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|52
9095570|NCT01062425|10160466|FG001|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|97
9095571|NCT01062425|10160465|FG000|NOT COMPLETED|Overall Study||3
9095572|NCT01062425|10160466|FG001|NOT COMPLETED|Overall Study||6
9095573|NCT00980460|10160477|FG000|STARTED|Overall Study||8
9095574|NCT00980460|10160478|FG001|STARTED|Overall Study||51
9095575|NCT00980460|10160479|FG002|STARTED|Overall Study||105
9095576|NCT00980460|10160480|FG003|STARTED|Overall Study||32
9095577|NCT00980460|10160481|FG004|STARTED|Overall Study||40
9095578|NCT00980460|10160477|FG000|COMPLETED|Overall Study||8
9095579|NCT00980460|10160478|FG001|COMPLETED|Overall Study||47
9095580|NCT00980460|10160479|FG002|COMPLETED|Overall Study||70
9095581|NCT00980460|10160480|FG003|COMPLETED|Overall Study||14
9095582|NCT00980460|10160481|FG004|COMPLETED|Overall Study||24
9095583|NCT00980460|10160477|FG000|NOT COMPLETED|Overall Study||0
9095584|NCT00980460|10160478|FG001|NOT COMPLETED|Overall Study||4
9095585|NCT00980460|10160479|FG002|NOT COMPLETED|Overall Study||35
9095586|NCT00980460|10160480|FG003|NOT COMPLETED|Overall Study||18
9095587|NCT00980460|10160481|FG004|NOT COMPLETED|Overall Study||16
9095588|NCT00843882|10160503|FG000|STARTED|Step 1||38
9095589|NCT00843882|10160504|FG001|STARTED|Step 1||103
9095590|NCT00843882|10160505|FG002|STARTED|Step 1||106
9095591|NCT00843882|10160503|FG000|Treated Patients|Step 1||36
9095592|NCT00843882|10160504|FG001|Treated Patients|Step 1||103
9095593|NCT00843882|10160505|FG002|Treated Patients|Step 1||106
9095594|NCT00843882|10160503|FG000|Evaluable Patients Included in Primary Analysis|Step 1||0
9095595|NCT00843882|10160504|FG001|Evaluable Patients Included in Primary Analysis|Step 1||96
9095596|NCT00843882|10160505|FG002|Evaluable Patients Included in Primary Analysis|Step 1||99
9095597|NCT00843882|10160503|FG000|Patients With Cytogenetic Response Data Available|Step 1||0
9095598|NCT00843882|10160504|FG001|Patients With Cytogenetic Response Data Available|Step 1||55
9095599|NCT00843882|10160505|FG002|Patients With Cytogenetic Response Data Available|Step 1||51
9095600|NCT00843882|10160503|FG000|COMPLETED|Step 1||6
9095601|NCT00843882|10160504|FG001|COMPLETED|Step 1||48
9095602|NCT00843882|10160505|FG002|COMPLETED|Step 1||41
9095603|NCT00843882|10160503|FG000|NOT COMPLETED|Step 1||32
9095604|NCT00843882|10160504|FG001|NOT COMPLETED|Step 1||55
9095605|NCT00843882|10160505|FG002|NOT COMPLETED|Step 1||65
9095606|NCT00843882|10160503|FG000|STARTED|Step 2 (Cross-over to Arm B)|All patients in Arm A that did not achieve major erythroid response (MER) were offered to receive combined treatment in Step 2.|7
9095607|NCT00843882|10160504|FG001|STARTED|Step 2 (Cross-over to Arm B)|All patients in Arm A that did not achieve major erythroid response (MER) were offered to receive combined treatment in Step 2.|46
9095608|NCT00843882|10160505|FG002|STARTED|Step 2 (Cross-over to Arm B)|Only patients in Arm A that did not achieve major erythroid response (MER) were offered to receive combined treatment in Step 2.|0
9095609|NCT00843882|10160503|FG000|Evaluable Patients Included in Primary Analysis|Step 2 (Cross-over to Arm B)||7
9095610|NCT00843882|10160504|FG001|Evaluable Patients Included in Primary Analysis|Step 2 (Cross-over to Arm B)||37
9095611|NCT00843882|10160505|FG002|Evaluable Patients Included in Primary Analysis|Step 2 (Cross-over to Arm B)||0
9095612|NCT00843882|10160503|FG000|COMPLETED|Step 2 (Cross-over to Arm B)||3
9095613|NCT00843882|10160504|FG001|COMPLETED|Step 2 (Cross-over to Arm B)||20
9095614|NCT00843882|10160505|FG002|COMPLETED|Step 2 (Cross-over to Arm B)||0
9095615|NCT00843882|10160503|FG000|NOT COMPLETED|Step 2 (Cross-over to Arm B)||4
9095616|NCT00843882|10160504|FG001|NOT COMPLETED|Step 2 (Cross-over to Arm B)||26
9095617|NCT00843882|10160505|FG002|NOT COMPLETED|Step 2 (Cross-over to Arm B)||0
9095618|NCT00644228|10160520|FG000|STARTED|Randomization & Eligibility||261
9095619|NCT00644228|10160521|FG001|STARTED|Randomization & Eligibility||264
9095620|NCT00644228|10160520|FG000|Eligible and Analyzable|Randomization & Eligibility||229
9095621|NCT00644228|10160521|FG001|Eligible and Analyzable|Randomization & Eligibility||242
9095622|NCT00644228|10160520|FG000|COMPLETED|Randomization & Eligibility||229
9095623|NCT00644228|10160521|FG001|COMPLETED|Randomization & Eligibility||242
9095624|NCT00644228|10160520|FG000|NOT COMPLETED|Randomization & Eligibility||32
9095625|NCT00644228|10160521|FG001|NOT COMPLETED|Randomization & Eligibility||22
9095626|NCT00644228|10160520|FG000|STARTED|Induction Therapy||229
9095627|NCT00644228|10160521|FG001|STARTED|Induction Therapy||242
9095628|NCT00644228|10160520|FG000|COMPLETED|Induction Therapy||146
9095629|NCT00644228|10160521|FG001|COMPLETED|Induction Therapy||137
9095630|NCT00644228|10160520|FG000|NOT COMPLETED|Induction Therapy||83
9095631|NCT00644228|10160521|FG001|NOT COMPLETED|Induction Therapy||105
9095632|NCT00644228|10160520|FG000|STARTED|Maintenance|3 patients who completed induction did not continue on to maintenance due to refusal (1), other (2).|143
9095633|NCT00644228|10160521|FG001|STARTED|Maintenance|2 patients who completed induction did not continue on to maintenance due to other (2).|135
9095634|NCT00644228|10160520|FG000|COMPLETED|Maintenance||0
9095635|NCT00644228|10160521|FG001|COMPLETED|Maintenance||0
9095636|NCT00644228|10160520|FG000|NOT COMPLETED|Maintenance||143
9095637|NCT00644228|10160521|FG001|NOT COMPLETED|Maintenance||135
9095638|NCT00602641|10160529|FG000|STARTED|Overall Study||154
9095639|NCT00602641|10160530|FG001|STARTED|Overall Study||152
9095640|NCT00602641|10160529|FG000|Started Protocol Therapy|Overall Study||148
9095641|NCT00602641|10160530|FG001|Started Protocol Therapy|Overall Study||150
9095642|NCT00602641|10160529|FG000|COMPLETED|Overall Study|Treatment continued until progression of disease, unacceptable toxicity or patient withdrawal.|0
9095643|NCT00602641|10160530|FG001|COMPLETED|Overall Study|Treatment continued until progression of disease, unacceptable toxicity or patient withdrawal.|0
9095644|NCT00602641|10160529|FG000|NOT COMPLETED|Overall Study||154
9095645|NCT00602641|10160530|FG001|NOT COMPLETED|Overall Study||152
9095646|NCT00559936|10160536|FG000|STARTED|Overall Study||24
9095647|NCT00559936|10160536|FG000|COMPLETED|Overall Study||20
9095648|NCT00559936|10160536|FG000|NOT COMPLETED|Overall Study||4
9095649|NCT00504582|10160543|FG000|STARTED|Overall Study||47
9095650|NCT00504582|10160544|FG001|STARTED|Overall Study||45
9095651|NCT00504582|10160545|FG002|STARTED|Overall Study||20
9095652|NCT00504582|10160543|FG000|COMPLETED|Overall Study||46
9095653|NCT00504582|10160544|FG001|COMPLETED|Overall Study||45
9095654|NCT00504582|10160545|FG002|COMPLETED|Overall Study||20
9095655|NCT00504582|10160543|FG000|NOT COMPLETED|Overall Study||1
9095656|NCT00504582|10160544|FG001|NOT COMPLETED|Overall Study||0
9095657|NCT00504582|10160545|FG002|NOT COMPLETED|Overall Study||0
9095658|NCT00408005|10160555|FG000|STARTED|Induction||1596
9095659|NCT00408005|10160556|FG001|STARTED|Induction||299
9095660|NCT00408005|10160557|FG002|STARTED|Induction||0
8625606|NCT00508274|9665201|FG000|STARTED|Overall Study||52
8625607|NCT00508274|9665201|FG000|COMPLETED|Overall Study||2
8625608|NCT00508274|9665201|FG000|NOT COMPLETED|Overall Study||50
8625609|NCT00508300|9665207|FG000|STARTED|Overall Study||67
8625610|NCT00508300|9665208|FG001|STARTED|Overall Study||61
9095661|NCT00408005|10160558|FG003|STARTED|Induction||0
9095662|NCT00408005|10160559|FG004|STARTED|Induction||0
9095663|NCT00408005|10160560|FG005|STARTED|Induction||0
9095664|NCT00408005|10160561|FG006|STARTED|Induction||0
9095665|NCT00408005|10160562|FG007|STARTED|Induction||0
9095666|NCT00408005|10160555|FG000|COMPLETED|Induction||1189
9095667|NCT00408005|10160556|FG001|COMPLETED|Induction||205
9095668|NCT00408005|10160557|FG002|COMPLETED|Induction||0
9095669|NCT00408005|10160558|FG003|COMPLETED|Induction||0
9095670|NCT00408005|10160559|FG004|COMPLETED|Induction||0
9095671|NCT00408005|10160560|FG005|COMPLETED|Induction||0
9095672|NCT00408005|10160561|FG006|COMPLETED|Induction||0
8625611|NCT00508300|9665207|FG000|COMPLETED|Overall Study||65
8625612|NCT00508300|9665208|FG001|COMPLETED|Overall Study||57
8625613|NCT00508300|9665207|FG000|NOT COMPLETED|Overall Study||2
9095673|NCT00408005|10160562|FG007|COMPLETED|Induction||0
9095674|NCT00408005|10160555|FG000|NOT COMPLETED|Induction||407
9095675|NCT00408005|10160556|FG001|NOT COMPLETED|Induction||94
9095676|NCT00408005|10160557|FG002|NOT COMPLETED|Induction||0
8625614|NCT00508300|9665208|FG001|NOT COMPLETED|Overall Study||4
8625615|NCT00508391|9665216|FG000|STARTED|First Treatment||60
9095677|NCT00408005|10160558|FG003|NOT COMPLETED|Induction||0
9095678|NCT00408005|10160559|FG004|NOT COMPLETED|Induction||0
9095679|NCT00408005|10160560|FG005|NOT COMPLETED|Induction||0
9095680|NCT00408005|10160561|FG006|NOT COMPLETED|Induction||0
9095681|NCT00408005|10160562|FG007|NOT COMPLETED|Induction||0
9095682|NCT00408005|10160555|FG000|STARTED|Post Induction Therapy by Tx Assignment||0
9095683|NCT00408005|10160556|FG001|STARTED|Post Induction Therapy by Tx Assignment||0
9095684|NCT00408005|10160557|FG002|STARTED|Post Induction Therapy by Tx Assignment||372
9095685|NCT00408005|10160558|FG003|STARTED|Post Induction Therapy by Tx Assignment||147
9095686|NCT00408005|10160559|FG004|STARTED|Post Induction Therapy by Tx Assignment||451
9095687|NCT00408005|10160560|FG005|STARTED|Post Induction Therapy by Tx Assignment||219
9095688|NCT00408005|10160561|FG006|STARTED|Post Induction Therapy by Tx Assignment||143
9095689|NCT00408005|10160562|FG007|STARTED|Post Induction Therapy by Tx Assignment||62
9095690|NCT00408005|10160555|FG000|Low Risk|Post Induction Therapy by Tx Assignment||0
9095691|NCT00408005|10160556|FG001|Low Risk|Post Induction Therapy by Tx Assignment||0
9095692|NCT00408005|10160557|FG002|Low Risk|Post Induction Therapy by Tx Assignment||217
9095693|NCT00408005|10160558|FG003|Low Risk|Post Induction Therapy by Tx Assignment||0
9095694|NCT00408005|10160559|FG004|Low Risk|Post Induction Therapy by Tx Assignment||55
9095695|NCT00408005|10160560|FG005|Low Risk|Post Induction Therapy by Tx Assignment||0
9095696|NCT00408005|10160561|FG006|Low Risk|Post Induction Therapy by Tx Assignment||0
9095697|NCT00408005|10160562|FG007|Low Risk|Post Induction Therapy by Tx Assignment||0
9095698|NCT00408005|10160555|FG000|Intermediate Risk|Post Induction Therapy by Tx Assignment||0
9095699|NCT00408005|10160556|FG001|Intermediate Risk|Post Induction Therapy by Tx Assignment||0
9095700|NCT00408005|10160557|FG002|Intermediate Risk|Post Induction Therapy by Tx Assignment||99
9095701|NCT00408005|10160558|FG003|Intermediate Risk|Post Induction Therapy by Tx Assignment||95
9095702|NCT00408005|10160559|FG004|Intermediate Risk|Post Induction Therapy by Tx Assignment||257
9095703|NCT00408005|10160560|FG005|Intermediate Risk|Post Induction Therapy by Tx Assignment||93
9095704|NCT00408005|10160561|FG006|Intermediate Risk|Post Induction Therapy by Tx Assignment||0
9095705|NCT00408005|10160562|FG007|Intermediate Risk|Post Induction Therapy by Tx Assignment||0
9095706|NCT00408005|10160555|FG000|High Risk|Post Induction Therapy by Tx Assignment||0
9095707|NCT00408005|10160556|FG001|High Risk|Post Induction Therapy by Tx Assignment||0
9095708|NCT00408005|10160557|FG002|High Risk|Post Induction Therapy by Tx Assignment||56
9095709|NCT00408005|10160558|FG003|High Risk|Post Induction Therapy by Tx Assignment||52
9095710|NCT00408005|10160559|FG004|High Risk|Post Induction Therapy by Tx Assignment||55
9095711|NCT00408005|10160560|FG005|High Risk|Post Induction Therapy by Tx Assignment||52
9095712|NCT00408005|10160561|FG006|High Risk|Post Induction Therapy by Tx Assignment||0
9095713|NCT00408005|10160562|FG007|High Risk|Post Induction Therapy by Tx Assignment||0
9095714|NCT00408005|10160555|FG000|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
9095715|NCT00408005|10160556|FG001|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
9095716|NCT00408005|10160557|FG002|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
9095717|NCT00408005|10160558|FG003|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
9095718|NCT00408005|10160559|FG004|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||84
9095719|NCT00408005|10160560|FG005|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||31
9095720|NCT00408005|10160561|FG006|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
9095721|NCT00408005|10160562|FG007|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
9095722|NCT00408005|10160555|FG000|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
9095723|NCT00408005|10160556|FG001|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
9095724|NCT00408005|10160557|FG002|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
9095725|NCT00408005|10160558|FG003|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
9095726|NCT00408005|10160559|FG004|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
9095727|NCT00408005|10160560|FG005|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||43
9095728|NCT00408005|10160561|FG006|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
9095729|NCT00408005|10160562|FG007|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
9095730|NCT00408005|10160555|FG000|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
9095731|NCT00408005|10160556|FG001|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
9095732|NCT00408005|10160557|FG002|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
9095733|NCT00408005|10160558|FG003|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
9095734|NCT00408005|10160559|FG004|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
9095735|NCT00408005|10160560|FG005|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
9095736|NCT00408005|10160561|FG006|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||82
9095737|NCT00408005|10160562|FG007|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
9095738|NCT00408005|10160555|FG000|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
9095739|NCT00408005|10160556|FG001|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
9095740|NCT00408005|10160557|FG002|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
9095741|NCT00408005|10160558|FG003|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
9095742|NCT00408005|10160559|FG004|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
9095743|NCT00408005|10160560|FG005|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
9095744|NCT00408005|10160561|FG006|T-LLy High Risk|Post Induction Therapy by Tx Assignment||61
9095745|NCT00408005|10160562|FG007|T-LLy High Risk|Post Induction Therapy by Tx Assignment||60
9095746|NCT00408005|10160555|FG000|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
9095747|NCT00408005|10160556|FG001|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
9095748|NCT00408005|10160557|FG002|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
9095749|NCT00408005|10160558|FG003|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
9095750|NCT00408005|10160559|FG004|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
9095751|NCT00408005|10160560|FG005|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
9095752|NCT00408005|10160561|FG006|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
9095753|NCT00408005|10160562|FG007|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||2
9095754|NCT00408005|10160555|FG000|COMPLETED|Post Induction Therapy by Tx Assignment||0
9095755|NCT00408005|10160556|FG001|COMPLETED|Post Induction Therapy by Tx Assignment||0
9095756|NCT00408005|10160557|FG002|COMPLETED|Post Induction Therapy by Tx Assignment||287
9095757|NCT00408005|10160558|FG003|COMPLETED|Post Induction Therapy by Tx Assignment||103
9095758|NCT00408005|10160559|FG004|COMPLETED|Post Induction Therapy by Tx Assignment||319
9095759|NCT00408005|10160560|FG005|COMPLETED|Post Induction Therapy by Tx Assignment||118
9095760|NCT00408005|10160561|FG006|COMPLETED|Post Induction Therapy by Tx Assignment||115
9095761|NCT00408005|10160562|FG007|COMPLETED|Post Induction Therapy by Tx Assignment||48
9095762|NCT00408005|10160555|FG000|NOT COMPLETED|Post Induction Therapy by Tx Assignment||0
9095763|NCT00408005|10160556|FG001|NOT COMPLETED|Post Induction Therapy by Tx Assignment||0
9095764|NCT00408005|10160557|FG002|NOT COMPLETED|Post Induction Therapy by Tx Assignment||85
9095765|NCT00408005|10160558|FG003|NOT COMPLETED|Post Induction Therapy by Tx Assignment||44
9095766|NCT00408005|10160559|FG004|NOT COMPLETED|Post Induction Therapy by Tx Assignment||132
9095767|NCT00408005|10160560|FG005|NOT COMPLETED|Post Induction Therapy by Tx Assignment||101
9095768|NCT00408005|10160561|FG006|NOT COMPLETED|Post Induction Therapy by Tx Assignment||28
9095769|NCT00408005|10160562|FG007|NOT COMPLETED|Post Induction Therapy by Tx Assignment||14
9095770|NCT00026312|10160584|FG000|STARTED|Overall Study||116
9095771|NCT00026312|10160585|FG001|STARTED|Overall Study||1333
9095772|NCT00026312|10160584|FG000|COMPLETED|Overall Study||82
9095773|NCT00026312|10160585|FG001|COMPLETED|Overall Study||1064
9095774|NCT00026312|10160584|FG000|NOT COMPLETED|Overall Study||34
9095775|NCT00026312|10160585|FG001|NOT COMPLETED|Overall Study||269
9095776|NCT02255487|10160597|FG000|STARTED|Overall Study||309
9095777|NCT02255487|10160598|FG001|STARTED|Overall Study||308
9095778|NCT02255487|10160597|FG000|Modified Intent to Treat (mITT)|Overall Study|"Within the ITT population, subjects with unknown age entries (modified ITT or mITT) were considered non-evaluable and excluded from the analysis. The mITT population was defined as patients 18 years of age or older."|293
9095779|NCT02255487|10160598|FG001|Modified Intent to Treat (mITT)|Overall Study|"Within the ITT population, subjects with unknown age entries (modified ITT or mITT) were considered non-evaluable and excluded from the analysis. The mITT population was defined as patients 18 years of age or older."|291
9095780|NCT02255487|10160597|FG000|COMPLETED|Overall Study||218
9095781|NCT02255487|10160598|FG001|COMPLETED|Overall Study||230
9095782|NCT02255487|10160597|FG000|NOT COMPLETED|Overall Study||91
9095783|NCT02255487|10160598|FG001|NOT COMPLETED|Overall Study||78
9095816|NCT02290431|10160653|FG000|STARTED|Overall Study||31
9095817|NCT02290431|10160653|FG000|Subjects. Discont. Prematurely|Overall Study||27
9095818|NCT02290431|10160653|FG000|Subjects Completed Study Per Protocol|Overall Study||8
9095819|NCT02290431|10160653|FG000|Subjs. Ntered Post-treatment Eval. Phase|Overall Study||31
9095820|NCT02290431|10160653|FG000|Subjects Entered Survival f/u Phase|Overall Study||24
9095821|NCT02290431|10160653|FG000|Entered Treatment Phase 2|Overall Study||17
9095822|NCT02290431|10160653|FG000|COMPLETED|Overall Study||4
9095823|NCT02290431|10160653|FG000|NOT COMPLETED|Overall Study||27
9095824|NCT02314923|10160667|FG000|STARTED|Overall Study||64
9095825|NCT02314923|10160668|FG001|STARTED|Overall Study||64
9095826|NCT02314923|10160669|FG002|STARTED|Overall Study||64
9095827|NCT02314923|10160670|FG003|STARTED|Overall Study||64
9095828|NCT02314923|10160671|FG004|STARTED|Overall Study||74
9095829|NCT02314923|10160672|FG005|STARTED|Overall Study||20
9095830|NCT02314923|10160673|FG006|STARTED|Overall Study||48
9095831|NCT02314923|10160674|FG007|STARTED|Overall Study||47
9095832|NCT02314923|10160675|FG008|STARTED|Overall Study||48
9095833|NCT02314923|10160676|FG009|STARTED|Overall Study||20
9095834|NCT02314923|10160667|FG000|Treated|Overall Study||64
9095835|NCT02314923|10160668|FG001|Treated|Overall Study||64
9095836|NCT02314923|10160669|FG002|Treated|Overall Study||64
9095837|NCT02314923|10160670|FG003|Treated|Overall Study||64
9095838|NCT02314923|10160671|FG004|Treated|Overall Study||74
9095839|NCT02314923|10160672|FG005|Treated|Overall Study||20
9095840|NCT02314923|10160673|FG006|Treated|Overall Study|One participant did not receive vaccination due to missing blood sample at randomization.|47
9095841|NCT02314923|10160674|FG007|Treated|Overall Study||47
9095842|NCT02314923|10160675|FG008|Treated|Overall Study||48
9095843|NCT02314923|10160676|FG009|Treated|Overall Study||20
9095844|NCT02314923|10160667|FG000|COMPLETED|Overall Study||61
9095845|NCT02314923|10160668|FG001|COMPLETED|Overall Study||60
9095846|NCT02314923|10160669|FG002|COMPLETED|Overall Study||62
9095847|NCT02314923|10160670|FG003|COMPLETED|Overall Study||63
9095848|NCT02314923|10160671|FG004|COMPLETED|Overall Study||73
9095849|NCT02314923|10160672|FG005|COMPLETED|Overall Study||19
9095850|NCT02314923|10160673|FG006|COMPLETED|Overall Study||43
9095851|NCT02314923|10160674|FG007|COMPLETED|Overall Study||42
9095852|NCT02314923|10160675|FG008|COMPLETED|Overall Study||46
9095853|NCT02314923|10160676|FG009|COMPLETED|Overall Study||20
9095854|NCT02314923|10160667|FG000|NOT COMPLETED|Overall Study||3
9095855|NCT02314923|10160668|FG001|NOT COMPLETED|Overall Study||4
9095856|NCT02314923|10160669|FG002|NOT COMPLETED|Overall Study||2
9095857|NCT02314923|10160670|FG003|NOT COMPLETED|Overall Study||1
9095858|NCT02314923|10160671|FG004|NOT COMPLETED|Overall Study||1
9095859|NCT02314923|10160672|FG005|NOT COMPLETED|Overall Study||1
9095860|NCT02314923|10160673|FG006|NOT COMPLETED|Overall Study||5
8625616|NCT00508391|9665217|FG001|STARTED|First Treatment||62
8625617|NCT00508391|9665216|FG000|COMPLETED|First Treatment||54
8625618|NCT00508391|9665217|FG001|COMPLETED|First Treatment||59
8625619|NCT00508391|9665216|FG000|NOT COMPLETED|First Treatment||6
8625620|NCT00508391|9665217|FG001|NOT COMPLETED|First Treatment||3
9095861|NCT02314923|10160674|FG007|NOT COMPLETED|Overall Study||5
9095862|NCT02314923|10160675|FG008|NOT COMPLETED|Overall Study||2
9095863|NCT02314923|10160676|FG009|NOT COMPLETED|Overall Study||0
9095864|NCT04821362|10160702|FG000|STARTED|Overall Study||90
9095865|NCT04821362|10160703|FG001|STARTED|Overall Study||90
9095866|NCT04821362|10160704|FG002|STARTED|Overall Study||90
9095867|NCT04821362|10160702|FG000|COMPLETED|Overall Study||90
9095868|NCT04821362|10160703|FG001|COMPLETED|Overall Study||90
9095869|NCT04821362|10160704|FG002|COMPLETED|Overall Study||90
9095870|NCT04821362|10160702|FG000|NOT COMPLETED|Overall Study||0
9095871|NCT04821362|10160703|FG001|NOT COMPLETED|Overall Study||0
9095872|NCT04821362|10160704|FG002|NOT COMPLETED|Overall Study||0
9095873|NCT04524507|10160717|FG000|STARTED|Overall Study||15
9095874|NCT04524507|10160718|FG001|STARTED|Overall Study||41
9095875|NCT04524507|10160717|FG000|Received Intervention|Overall Study||14
9095876|NCT04524507|10160718|FG001|Received Intervention|Overall Study||41
9095877|NCT04524507|10160717|FG000|Hospital Discharge|Overall Study||13
9095878|NCT04524507|10160718|FG001|Hospital Discharge|Overall Study||27
8625621|NCT00508391|9665216|FG000|STARTED|Second Treatment||54
8625622|NCT00508391|9665217|FG001|STARTED|Second Treatment||59
9095879|NCT04524507|10160717|FG000|COMPLETED|Overall Study||9
9095880|NCT04524507|10160718|FG001|COMPLETED|Overall Study||18
9095881|NCT04524507|10160717|FG000|NOT COMPLETED|Overall Study||6
9095882|NCT04524507|10160718|FG001|NOT COMPLETED|Overall Study||23
9095883|NCT04382924|10160727|FG000|STARTED|Overall Study||52
9095884|NCT04382924|10160728|FG001|STARTED|Overall Study||56
9095885|NCT04382924|10160729|FG002|STARTED|Overall Study||60
9095784|NCT02257918|10160608|FG000|STARTED|Overall Study||72
9095785|NCT02257918|10160609|FG001|STARTED|Overall Study||67
9095786|NCT02257918|10160610|FG002|STARTED|Overall Study||41
9095787|NCT02257918|10160608|FG000|Test of Cure Visit|Overall Study||72
9095788|NCT02257918|10160609|FG001|Test of Cure Visit|Overall Study||67
9095789|NCT02257918|10160610|FG002|Test of Cure Visit|Overall Study||40
9095790|NCT02257918|10160608|FG000|COMPLETED|Overall Study||68
9095791|NCT02257918|10160609|FG001|COMPLETED|Overall Study||66
9095792|NCT02257918|10160610|FG002|COMPLETED|Overall Study||39
8845874|NCT01717768|9900356|FG009|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8845875|NCT01717768|9900357|FG010|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
9095793|NCT02257918|10160608|FG000|NOT COMPLETED|Overall Study||4
9095794|NCT02257918|10160609|FG001|NOT COMPLETED|Overall Study||1
9095795|NCT02257918|10160610|FG002|NOT COMPLETED|Overall Study||2
9095796|NCT02258542|10160622|FG000|STARTED|Overall Study||953
9095797|NCT02258542|10160623|FG001|STARTED|Overall Study||973
9095798|NCT02258542|10160624|FG002|STARTED|Overall Study||100
9095799|NCT02258542|10160625|FG003|STARTED|Overall Study||97
9095800|NCT02258542|10160622|FG000|Treated|Overall Study||953
9095801|NCT02258542|10160623|FG001|Treated|Overall Study||971
9095802|NCT02258542|10160624|FG002|Treated|Overall Study||100
9095803|NCT02258542|10160625|FG003|Treated|Overall Study||97
9095804|NCT02258542|10160622|FG000|Adolescents Only|Overall Study||25
9095805|NCT02258542|10160623|FG001|Adolescents Only|Overall Study||61
9095806|NCT02258542|10160624|FG002|Adolescents Only|Overall Study||0
9095807|NCT02258542|10160625|FG003|Adolescents Only|Overall Study||0
9095808|NCT02258542|10160622|FG000|COMPLETED|Overall Study|170 enrolled into study MELTEMI|911
9095809|NCT02258542|10160623|FG001|COMPLETED|Overall Study|178 enrolled into study MELTEMI|924
9095810|NCT02258542|10160624|FG002|COMPLETED|Overall Study|51 enrolled into study MELTEMI|92
9095811|NCT02258542|10160625|FG003|COMPLETED|Overall Study|48 enrolled into study MELTEMI|92
9095812|NCT02258542|10160622|FG000|NOT COMPLETED|Overall Study||42
9095813|NCT02258542|10160623|FG001|NOT COMPLETED|Overall Study||49
9095814|NCT02258542|10160624|FG002|NOT COMPLETED|Overall Study||8
9095815|NCT02258542|10160625|FG003|NOT COMPLETED|Overall Study||5
9095886|NCT04382924|10160727|FG000|COMPLETED|Overall Study||44
9095887|NCT04382924|10160728|FG001|COMPLETED|Overall Study||46
9095888|NCT04382924|10160729|FG002|COMPLETED|Overall Study||48
9095889|NCT04382924|10160727|FG000|NOT COMPLETED|Overall Study||8
9095890|NCT04382924|10160728|FG001|NOT COMPLETED|Overall Study||10
9095891|NCT04382924|10160729|FG002|NOT COMPLETED|Overall Study||12
9095892|NCT04166214|10160739|FG000|STARTED|Overall Study||12
9095893|NCT04166214|10160740|FG001|STARTED|Overall Study||39
9095894|NCT04166214|10160739|FG000|COMPLETED|Overall Study||12
9095895|NCT04166214|10160740|FG001|COMPLETED|Overall Study||39
9095896|NCT04166214|10160739|FG000|NOT COMPLETED|Overall Study||0
9095897|NCT04166214|10160740|FG001|NOT COMPLETED|Overall Study||0
9095898|NCT03947788|10160748|FG000|STARTED|Overall Study||69
9095899|NCT03947788|10160749|FG001|STARTED|Overall Study||74
9095900|NCT03947788|10160748|FG000|COMPLETED|Overall Study||69
9095901|NCT03947788|10160749|FG001|COMPLETED|Overall Study||74
9095902|NCT03947788|10160748|FG000|NOT COMPLETED|Overall Study||0
9095903|NCT03947788|10160749|FG001|NOT COMPLETED|Overall Study||0
9095904|NCT03842436|10160760|FG000|STARTED|Overall Study||16
9095905|NCT03842436|10160760|FG000|COMPLETED|Overall Study||15
9095906|NCT03842436|10160760|FG000|NOT COMPLETED|Overall Study||1
9095907|NCT03646162|10160767|FG000|STARTED|Overall Study||31
9095908|NCT03646162|10160768|FG001|STARTED|Overall Study||31
9095909|NCT03646162|10160769|FG002|STARTED|Overall Study||31
9095910|NCT03646162|10160767|FG000|COMPLETED|Overall Study||26
9095911|NCT03646162|10160768|FG001|COMPLETED|Overall Study||27
9095912|NCT03646162|10160769|FG002|COMPLETED|Overall Study||30
9095913|NCT03646162|10160767|FG000|NOT COMPLETED|Overall Study||5
9095914|NCT03646162|10160768|FG001|NOT COMPLETED|Overall Study||4
9095915|NCT03646162|10160769|FG002|NOT COMPLETED|Overall Study||1
9095916|NCT03462030|10160781|FG000|STARTED|Overall Study||15
9095917|NCT03462030|10160782|FG001|STARTED|Overall Study||15
9095918|NCT03462030|10160781|FG000|End of Build-up|Overall Study||14
9095919|NCT03462030|10160782|FG001|End of Build-up|Overall Study||14
9095920|NCT03462030|10160781|FG000|Month 12 Food Challenge|Overall Study||14
9095921|NCT03462030|10160782|FG001|Month 12 Food Challenge|Overall Study||14
9095922|NCT03462030|10160781|FG000|COMPLETED|Overall Study||14
9095923|NCT03462030|10160782|FG001|COMPLETED|Overall Study||14
9095924|NCT03462030|10160781|FG000|NOT COMPLETED|Overall Study||1
9095925|NCT03462030|10160782|FG001|NOT COMPLETED|Overall Study||1
9095926|NCT03446768|10160790|FG000|STARTED|Overall Study||141
9095927|NCT03446768|10160791|FG001|STARTED|Overall Study||153
9095928|NCT03446768|10160790|FG000|COMPLETED|Overall Study||141
9095929|NCT03446768|10160791|FG001|COMPLETED|Overall Study||152
9095930|NCT03446768|10160790|FG000|NOT COMPLETED|Overall Study||0
9095931|NCT03446768|10160791|FG001|NOT COMPLETED|Overall Study||1
9095932|NCT03348514|10160805|FG000|STARTED|Overall Study||1
9095933|NCT03348514|10160806|FG001|STARTED|Overall Study||1
9095934|NCT03348514|10160807|FG002|STARTED|Overall Study||1
9095935|NCT03348514|10160808|FG003|STARTED|Overall Study||1
9095936|NCT03348514|10160809|FG004|STARTED|Overall Study||3
9095937|NCT03348514|10160810|FG005|STARTED|Overall Study||4
9095938|NCT03348514|10160811|FG006|STARTED|Overall Study||6
9095939|NCT03348514|10160812|FG007|STARTED|Overall Study||2
9095940|NCT03348514|10160805|FG000|COMPLETED|Overall Study||1
9095941|NCT03348514|10160806|FG001|COMPLETED|Overall Study||1
9095942|NCT03348514|10160807|FG002|COMPLETED|Overall Study||1
9095943|NCT03348514|10160808|FG003|COMPLETED|Overall Study||1
9095944|NCT03348514|10160809|FG004|COMPLETED|Overall Study||3
9095945|NCT03348514|10160810|FG005|COMPLETED|Overall Study||4
9095946|NCT03348514|10160811|FG006|COMPLETED|Overall Study||6
9095947|NCT03348514|10160812|FG007|COMPLETED|Overall Study||2
9095948|NCT03348514|10160805|FG000|NOT COMPLETED|Overall Study||0
9095949|NCT03348514|10160806|FG001|NOT COMPLETED|Overall Study||0
9095950|NCT03348514|10160807|FG002|NOT COMPLETED|Overall Study||0
9095951|NCT03348514|10160808|FG003|NOT COMPLETED|Overall Study||0
9095952|NCT03348514|10160809|FG004|NOT COMPLETED|Overall Study||0
9095953|NCT03348514|10160810|FG005|NOT COMPLETED|Overall Study||0
9095954|NCT03348514|10160811|FG006|NOT COMPLETED|Overall Study||0
9095955|NCT03348514|10160812|FG007|NOT COMPLETED|Overall Study||0
9095956|NCT03253393|10160836|FG000|STARTED|First Intervention||12
9095957|NCT03253393|10160837|FG001|STARTED|First Intervention||13
9095958|NCT03253393|10160838|FG002|STARTED|First Intervention||0
9095959|NCT03253393|10160836|FG000|COMPLETED|First Intervention||12
9095960|NCT03253393|10160837|FG001|COMPLETED|First Intervention||13
9095961|NCT03253393|10160838|FG002|COMPLETED|First Intervention||0
9095962|NCT03253393|10160836|FG000|NOT COMPLETED|First Intervention||0
9095963|NCT03253393|10160837|FG001|NOT COMPLETED|First Intervention||0
9095964|NCT03253393|10160838|FG002|NOT COMPLETED|First Intervention||0
9095965|NCT03253393|10160836|FG000|STARTED|Washout (Minimum 48 Hours)||12
9095966|NCT03253393|10160837|FG001|STARTED|Washout (Minimum 48 Hours)||13
9095967|NCT03253393|10160838|FG002|STARTED|Washout (Minimum 48 Hours)|Participants in this group were only assigned to one visit/intervention|0
9095968|NCT03253393|10160836|FG000|COMPLETED|Washout (Minimum 48 Hours)||12
9095969|NCT03253393|10160837|FG001|COMPLETED|Washout (Minimum 48 Hours)||13
9095970|NCT03253393|10160838|FG002|COMPLETED|Washout (Minimum 48 Hours)|Participants in this group were only assigned to one visit/intervention|0
9095971|NCT03253393|10160836|FG000|NOT COMPLETED|Washout (Minimum 48 Hours)||0
9095972|NCT03253393|10160837|FG001|NOT COMPLETED|Washout (Minimum 48 Hours)||0
9095973|NCT03253393|10160838|FG002|NOT COMPLETED|Washout (Minimum 48 Hours)||0
9095974|NCT03253393|10160836|FG000|STARTED|Second Intervention||12
9095975|NCT03253393|10160837|FG001|STARTED|Second Intervention||13
9095976|NCT03253393|10160838|FG002|STARTED|Second Intervention|Participants in this group were only assigned to one visit/intervention|0
9095977|NCT03253393|10160836|FG000|COMPLETED|Second Intervention||12
9095978|NCT03253393|10160837|FG001|COMPLETED|Second Intervention||13
9095979|NCT03253393|10160838|FG002|COMPLETED|Second Intervention|Participants in this group were only assigned to one visit/intervention|0
9095980|NCT03253393|10160836|FG000|NOT COMPLETED|Second Intervention||0
9095981|NCT03253393|10160837|FG001|NOT COMPLETED|Second Intervention||0
9095982|NCT03253393|10160838|FG002|NOT COMPLETED|Second Intervention||0
9095983|NCT03253393|10160836|FG000|STARTED|Washout (Minimum 48 Hours)||12
9095984|NCT03253393|10160837|FG001|STARTED|Washout (Minimum 48 Hours)||13
9095985|NCT03253393|10160838|FG002|STARTED|Washout (Minimum 48 Hours)|Participants in this group were only assigned to one visit/intervention|0
9095986|NCT03253393|10160836|FG000|COMPLETED|Washout (Minimum 48 Hours)||6
9095987|NCT03253393|10160837|FG001|COMPLETED|Washout (Minimum 48 Hours)||6
9095988|NCT03253393|10160838|FG002|COMPLETED|Washout (Minimum 48 Hours)|Participants in this group were only assigned to one visit/intervention|0
9095989|NCT03253393|10160836|FG000|NOT COMPLETED|Washout (Minimum 48 Hours)||6
9095990|NCT03253393|10160837|FG001|NOT COMPLETED|Washout (Minimum 48 Hours)||7
9095991|NCT03253393|10160838|FG002|NOT COMPLETED|Washout (Minimum 48 Hours)||0
9095992|NCT03253393|10160836|FG000|STARTED|Third Intervention||6
9095993|NCT03253393|10160837|FG001|STARTED|Third Intervention||6
9095994|NCT03253393|10160838|FG002|STARTED|Third Intervention|Participants in this group were only assigned to one visit/intervention|13
9095995|NCT03253393|10160836|FG000|COMPLETED|Third Intervention||6
9095996|NCT03253393|10160837|FG001|COMPLETED|Third Intervention||6
9095997|NCT03253393|10160838|FG002|COMPLETED|Third Intervention|Participants in this group were only assigned to one visit/intervention|13
9095998|NCT03253393|10160836|FG000|NOT COMPLETED|Third Intervention||0
9095999|NCT03253393|10160837|FG001|NOT COMPLETED|Third Intervention||0
9096000|NCT03253393|10160838|FG002|NOT COMPLETED|Third Intervention||0
9096001|NCT03188822|10160852|FG000|STARTED|Overall Study||9
9096002|NCT03188822|10160852|FG000|COMPLETED|Overall Study||2
9096003|NCT03188822|10160852|FG000|NOT COMPLETED|Overall Study||7
9096004|NCT03128671|10160858|FG000|STARTED|Enrollment||89
9096005|NCT03128671|10160859|FG001|STARTED|Enrollment||89
9096006|NCT03128671|10160858|FG000|COMPLETED|Enrollment||89
9096007|NCT03128671|10160859|FG001|COMPLETED|Enrollment||89
9096008|NCT03128671|10160858|FG000|NOT COMPLETED|Enrollment||0
9096009|NCT03128671|10160859|FG001|NOT COMPLETED|Enrollment||0
9096010|NCT03128671|10160858|FG000|STARTED|Allocation||89
9096011|NCT03128671|10160859|FG001|STARTED|Allocation||89
9096012|NCT03128671|10160858|FG000|COMPLETED|Allocation||80
9096013|NCT03128671|10160859|FG001|COMPLETED|Allocation||89
9096014|NCT03128671|10160858|FG000|NOT COMPLETED|Allocation||9
9096015|NCT03128671|10160859|FG001|NOT COMPLETED|Allocation||0
9096016|NCT03128671|10160858|FG000|STARTED|Intervention||80
9096017|NCT03128671|10160859|FG001|STARTED|Intervention||89
9096018|NCT03128671|10160858|FG000|COMPLETED|Intervention||44
9096019|NCT03128671|10160859|FG001|COMPLETED|Intervention||55
9096020|NCT03128671|10160858|FG000|NOT COMPLETED|Intervention||36
9096021|NCT03128671|10160859|FG001|NOT COMPLETED|Intervention||34
9096022|NCT03111732|10160865|FG000|STARTED|Overall Study||11
9096023|NCT03111732|10160865|FG000|COMPLETED|Overall Study||6
9096024|NCT03111732|10160865|FG000|NOT COMPLETED|Overall Study||5
9096025|NCT03065244|10160876|FG000|STARTED|Overall Study||50
9096026|NCT03065244|10160877|FG001|STARTED|Overall Study||55
9096027|NCT03065244|10160876|FG000|Participants Who Failed 1st Treatment and Crossed Over to Receive Other Treatment|Overall Study||22
9096028|NCT03065244|10160877|FG001|Participants Who Failed 1st Treatment and Crossed Over to Receive Other Treatment|Overall Study||9
9096029|NCT03065244|10160876|FG000|COMPLETED|Overall Study||47
9096030|NCT03065244|10160877|FG001|COMPLETED|Overall Study||51
9096031|NCT03065244|10160876|FG000|NOT COMPLETED|Overall Study||3
9096032|NCT03065244|10160877|FG001|NOT COMPLETED|Overall Study||4
9096033|NCT02879305|10160885|FG000|STARTED|Overall Study||1487
9096034|NCT02879305|10160886|FG001|STARTED|Overall Study||1477
9096035|NCT02879305|10160885|FG000|COMPLETED|Overall Study||1370
9096036|NCT02879305|10160886|FG001|COMPLETED|Overall Study||1366
9096037|NCT02879305|10160885|FG000|NOT COMPLETED|Overall Study||117
9096038|NCT02879305|10160886|FG001|NOT COMPLETED|Overall Study||111
9096039|NCT02816736|10160894|FG000|STARTED|Overall Study||179
9096040|NCT02816736|10160895|FG001|STARTED|Overall Study||186
9096041|NCT02816736|10160894|FG000|COMPLETED|Overall Study||164
9096042|NCT02816736|10160895|FG001|COMPLETED|Overall Study||166
9096043|NCT02816736|10160894|FG000|NOT COMPLETED|Overall Study||15
9096044|NCT02816736|10160895|FG001|NOT COMPLETED|Overall Study||20
9096045|NCT02787850|10160903|FG000|STARTED|Overall Study||10
9096046|NCT02787850|10160904|FG001|STARTED|Overall Study||10
9096047|NCT02787850|10160903|FG000|COMPLETED|Overall Study||10
9096048|NCT02787850|10160904|FG001|COMPLETED|Overall Study||9
9096049|NCT02787850|10160903|FG000|NOT COMPLETED|Overall Study||0
9096050|NCT02787850|10160904|FG001|NOT COMPLETED|Overall Study||1
9096051|NCT02713373|10160919|FG000|STARTED|Overall Study||44
9096052|NCT02713373|10160919|FG000|COMPLETED|Overall Study||44
9096053|NCT02713373|10160919|FG000|NOT COMPLETED|Overall Study||0
9096054|NCT02676284|10160923|FG000|STARTED|Overall Study||36
9096055|NCT02676284|10160923|FG000|COMPLETED|Overall Study||35
9096056|NCT02676284|10160923|FG000|NOT COMPLETED|Overall Study||1
9096057|NCT02431702|10160927|FG000|STARTED|Part 1: 2-Month Oral Run-in Phase||273
9096058|NCT02431702|10160928|FG001|STARTED|Part 1: 2-Month Oral Run-in Phase||0
9096059|NCT02431702|10160929|FG002|STARTED|Part 1: 2-Month Oral Run-in Phase||0
9096060|NCT02431702|10160930|FG003|STARTED|Part 1: 2-Month Oral Run-in Phase||0
9096061|NCT02431702|10160931|FG004|STARTED|Part 1: 2-Month Oral Run-in Phase||0
9096062|NCT02431702|10160932|FG005|STARTED|Part 1: 2-Month Oral Run-in Phase||0
9096063|NCT02431702|10160933|FG006|STARTED|Part 1: 2-Month Oral Run-in Phase||64
9096064|NCT02431702|10160927|FG000|COMPLETED|Part 1: 2-Month Oral Run-in Phase||239
9096065|NCT02431702|10160928|FG001|COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
9096066|NCT02431702|10160929|FG002|COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
9096067|NCT02431702|10160930|FG003|COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
9096068|NCT02431702|10160931|FG004|COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
9096069|NCT02431702|10160932|FG005|COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
9096070|NCT02431702|10160933|FG006|COMPLETED|Part 1: 2-Month Oral Run-in Phase||32
9096071|NCT02431702|10160927|FG000|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||34
9096072|NCT02431702|10160928|FG001|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
9096073|NCT02431702|10160929|FG002|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
9096074|NCT02431702|10160930|FG003|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
9096075|NCT02431702|10160931|FG004|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
9096076|NCT02431702|10160932|FG005|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
9096077|NCT02431702|10160933|FG006|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||32
9096078|NCT02431702|10160927|FG000|STARTED|Part 2: 9Month Disease Progression Phase||0
9096079|NCT02431702|10160928|FG001|STARTED|Part 2: 9Month Disease Progression Phase|Participants who completed Part 1 and were eligible to be randomized in this group.|78
9096080|NCT02431702|10160929|FG002|STARTED|Part 2: 9Month Disease Progression Phase|Participants who completed Part 1 and were eligible to be randomized in this group.|157
9096081|NCT02431702|10160930|FG003|STARTED|Part 2: 9Month Disease Progression Phase||0
9096082|NCT02431702|10160931|FG004|STARTED|Part 2: 9Month Disease Progression Phase||0
9096083|NCT02431702|10160932|FG005|STARTED|Part 2: 9Month Disease Progression Phase||0
9096084|NCT02431702|10160933|FG006|STARTED|Part 2: 9Month Disease Progression Phase||0
9096085|NCT02431702|10160927|FG000|COMPLETED|Part 2: 9Month Disease Progression Phase||0
9096086|NCT02431702|10160928|FG001|COMPLETED|Part 2: 9Month Disease Progression Phase||52
9096087|NCT02431702|10160929|FG002|COMPLETED|Part 2: 9Month Disease Progression Phase||128
9096088|NCT02431702|10160930|FG003|COMPLETED|Part 2: 9Month Disease Progression Phase||0
9096089|NCT02431702|10160931|FG004|COMPLETED|Part 2: 9Month Disease Progression Phase||0
9096090|NCT02431702|10160932|FG005|COMPLETED|Part 2: 9Month Disease Progression Phase||0
9096091|NCT02431702|10160933|FG006|COMPLETED|Part 2: 9Month Disease Progression Phase||0
9096092|NCT02431702|10160927|FG000|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||0
9096093|NCT02431702|10160928|FG001|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||26
8625623|NCT00508391|9665216|FG000|COMPLETED|Second Treatment||52
8625624|NCT00508391|9665217|FG001|COMPLETED|Second Treatment||59
8625625|NCT00508391|9665216|FG000|NOT COMPLETED|Second Treatment||2
8625626|NCT00508391|9665217|FG001|NOT COMPLETED|Second Treatment||0
9096094|NCT02431702|10160929|FG002|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||29
9096095|NCT02431702|10160930|FG003|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||0
9096096|NCT02431702|10160931|FG004|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||0
9096097|NCT02431702|10160932|FG005|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||0
9096098|NCT02431702|10160933|FG006|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||0
9096099|NCT02431702|10160927|FG000|STARTED|Part 3: 9 Month of Additional Treatment||0
9096100|NCT02431702|10160928|FG001|STARTED|Part 3: 9 Month of Additional Treatment||0
9096101|NCT02431702|10160929|FG002|STARTED|Part 3: 9 Month of Additional Treatment||0
9096102|NCT02431702|10160930|FG003|STARTED|Part 3: 9 Month of Additional Treatment|Participants who completed Part 2 and were eligible to continue treatment in this group.|49
9096103|NCT02431702|10160931|FG004|STARTED|Part 3: 9 Month of Additional Treatment|Participants who completed Part 2 and were eligible to be re-randomized in this group.|57
9096104|NCT02431702|10160932|FG005|STARTED|Part 3: 9 Month of Additional Treatment|Participants who completed Part 2 and were eligible to be re-randomized in this group.|63
9096105|NCT02431702|10160933|FG006|STARTED|Part 3: 9 Month of Additional Treatment||0
9096106|NCT02431702|10160927|FG000|COMPLETED|Part 3: 9 Month of Additional Treatment||0
9096107|NCT02431702|10160928|FG001|COMPLETED|Part 3: 9 Month of Additional Treatment||0
9096108|NCT02431702|10160929|FG002|COMPLETED|Part 3: 9 Month of Additional Treatment||0
9096109|NCT02431702|10160930|FG003|COMPLETED|Part 3: 9 Month of Additional Treatment||40
9096110|NCT02431702|10160931|FG004|COMPLETED|Part 3: 9 Month of Additional Treatment||47
9096111|NCT02431702|10160932|FG005|COMPLETED|Part 3: 9 Month of Additional Treatment||46
9096112|NCT02431702|10160933|FG006|COMPLETED|Part 3: 9 Month of Additional Treatment||0
9096113|NCT02431702|10160927|FG000|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||0
9096114|NCT02431702|10160928|FG001|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||0
9096115|NCT02431702|10160929|FG002|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||0
9096116|NCT02431702|10160930|FG003|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||9
9096117|NCT02431702|10160931|FG004|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||10
9096118|NCT02431702|10160932|FG005|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||17
9096119|NCT02431702|10160933|FG006|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||0
9096120|NCT02368002|10160953|FG000|STARTED|Stage 1 Intervention (Up to 20 Weeks)||233
9096121|NCT02368002|10160954|FG001|STARTED|Stage 1 Intervention (Up to 20 Weeks)||0
9096122|NCT02368002|10160955|FG002|STARTED|Stage 1 Intervention (Up to 20 Weeks)||0
9096123|NCT02368002|10160956|FG003|STARTED|Stage 1 Intervention (Up to 20 Weeks)||235
9096124|NCT02368002|10160957|FG004|STARTED|Stage 1 Intervention (Up to 20 Weeks)||0
9096125|NCT02368002|10160958|FG005|STARTED|Stage 1 Intervention (Up to 20 Weeks)||0
9096126|NCT02368002|10160953|FG000|COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||228
9096127|NCT02368002|10160954|FG001|COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||0
9096128|NCT02368002|10160955|FG002|COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||0
9096129|NCT02368002|10160956|FG003|COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||214
8625627|NCT00508404|9665225|FG000|STARTED|Overall Study||154
8625628|NCT00508404|9665225|FG000|COMPLETED|Overall Study|Completion of safety follow-up visit conducted 8 weeks after last dose|112
8625629|NCT00508404|9665225|FG000|NOT COMPLETED|Overall Study||42
8625630|NCT00508469|9665232|FG000|STARTED|Overall Study||52
9096130|NCT02368002|10160957|FG004|COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||0
9096131|NCT02368002|10160958|FG005|COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||0
9096132|NCT02368002|10160953|FG000|NOT COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||5
9096133|NCT02368002|10160954|FG001|NOT COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||0
9096134|NCT02368002|10160955|FG002|NOT COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||0
9096135|NCT02368002|10160956|FG003|NOT COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||21
9096136|NCT02368002|10160957|FG004|NOT COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||0
9096137|NCT02368002|10160958|FG005|NOT COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||0
9096138|NCT02368002|10160953|FG000|STARTED|Stage 2 Intervention (Up to 17 Weeks)||88
9096139|NCT02368002|10160954|FG001|STARTED|Stage 2 Intervention (Up to 17 Weeks)||70
9096140|NCT02368002|10160955|FG002|STARTED|Stage 2 Intervention (Up to 17 Weeks)||70
9096141|NCT02368002|10160956|FG003|STARTED|Stage 2 Intervention (Up to 17 Weeks)||0
9096142|NCT02368002|10160957|FG004|STARTED|Stage 2 Intervention (Up to 17 Weeks)||0
9096143|NCT02368002|10160958|FG005|STARTED|Stage 2 Intervention (Up to 17 Weeks)||0
9096144|NCT02368002|10160953|FG000|COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||86
9096145|NCT02368002|10160954|FG001|COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||60
9096146|NCT02368002|10160955|FG002|COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||64
9096147|NCT02368002|10160956|FG003|COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||0
9096148|NCT02368002|10160957|FG004|COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||0
9096149|NCT02368002|10160958|FG005|COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||0
9096150|NCT02368002|10160953|FG000|NOT COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||2
9096151|NCT02368002|10160954|FG001|NOT COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||10
9096152|NCT02368002|10160955|FG002|NOT COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||6
9096153|NCT02368002|10160956|FG003|NOT COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||0
9096154|NCT02368002|10160957|FG004|NOT COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||0
9096155|NCT02368002|10160958|FG005|NOT COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||0
9096156|NCT02368002|10160953|FG000|STARTED|Stage 2 Intervention (Up to 13 Weeks)||0
9096157|NCT02368002|10160954|FG001|STARTED|Stage 2 Intervention (Up to 13 Weeks)||0
9096158|NCT02368002|10160955|FG002|STARTED|Stage 2 Intervention (Up to 13 Weeks)||0
9096159|NCT02368002|10160956|FG003|STARTED|Stage 2 Intervention (Up to 13 Weeks)||95
9096160|NCT02368002|10160957|FG004|STARTED|Stage 2 Intervention (Up to 13 Weeks)||57
9096161|NCT02368002|10160958|FG005|STARTED|Stage 2 Intervention (Up to 13 Weeks)||62
8948140|NCT02427477|10010473|FG001|NOT COMPLETED|Period 2||0
8948141|NCT02427477|10010472|FG000|STARTED|Period 3||59
9096162|NCT02368002|10160953|FG000|COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||0
9096163|NCT02368002|10160954|FG001|COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||0
9096164|NCT02368002|10160955|FG002|COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||0
9096165|NCT02368002|10160956|FG003|COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||94
9096166|NCT02368002|10160957|FG004|COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||53
9096167|NCT02368002|10160958|FG005|COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||59
9096168|NCT02368002|10160953|FG000|NOT COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||0
9096169|NCT02368002|10160954|FG001|NOT COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||0
9096170|NCT02368002|10160955|FG002|NOT COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||0
9096171|NCT02368002|10160956|FG003|NOT COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||1
9096172|NCT02368002|10160957|FG004|NOT COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||4
9096173|NCT02368002|10160958|FG005|NOT COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||3
9096174|NCT02200770|10160970|FG000|STARTED|Randomized-controlled Period (RCP)||56
9096175|NCT02200770|10160971|FG001|STARTED|Randomized-controlled Period (RCP)||175
9096176|NCT02200770|10160970|FG000|Treated|Randomized-controlled Period (RCP)||56
9096177|NCT02200770|10160971|FG001|Treated|Randomized-controlled Period (RCP)||174
9096178|NCT02200770|10160970|FG000|COMPLETED|Randomized-controlled Period (RCP)||54
9096179|NCT02200770|10160971|FG001|COMPLETED|Randomized-controlled Period (RCP)||169
9096180|NCT02200770|10160970|FG000|NOT COMPLETED|Randomized-controlled Period (RCP)||2
9096181|NCT02200770|10160971|FG001|NOT COMPLETED|Randomized-controlled Period (RCP)||6
9096182|NCT02200770|10160970|FG000|STARTED|Open-label Period (OLP)|3 participants completed RCP but did not roll over to OLP.|51
9096183|NCT02200770|10160971|FG001|STARTED|Open-label Period (OLP)|4 participants completed RCP but did not roll over to OLP.|165
9096184|NCT02200770|10160970|FG000|COMPLETED|Open-label Period (OLP)||43
9096185|NCT02200770|10160971|FG001|COMPLETED|Open-label Period (OLP)||131
9096186|NCT02200770|10160970|FG000|NOT COMPLETED|Open-label Period (OLP)||8
9096187|NCT02200770|10160971|FG001|NOT COMPLETED|Open-label Period (OLP)||34
9096188|NCT02136069|10160981|FG000|STARTED|Overall Study||199
9096189|NCT02136069|10160982|FG001|STARTED|Overall Study||198
9096190|NCT02136069|10160981|FG000|COMPLETED|Overall Study||165
9096191|NCT02136069|10160982|FG001|COMPLETED|Overall Study||170
9096192|NCT02136069|10160981|FG000|NOT COMPLETED|Overall Study||34
9096193|NCT02136069|10160982|FG001|NOT COMPLETED|Overall Study||28
9096194|NCT02086552|10160988|FG000|STARTED|Overall Study||28
9096195|NCT02086552|10160988|FG000|COMPLETED|Overall Study||27
9096196|NCT02086552|10160988|FG000|NOT COMPLETED|Overall Study||1
9096197|NCT01517659|10160992|FG000|STARTED|Overall Study||45
8625631|NCT00508469|9665233|FG001|STARTED|Overall Study||50
8625632|NCT00508469|9665232|FG000|COMPLETED|Overall Study||35
8625633|NCT00508469|9665233|FG001|COMPLETED|Overall Study||40
8625634|NCT00508469|9665232|FG000|NOT COMPLETED|Overall Study||17
8625635|NCT00508469|9665233|FG001|NOT COMPLETED|Overall Study||10
8625636|NCT00508482|9665242|FG000|STARTED|Over 4 Weeks of Treatment||237
8948142|NCT02427477|10010473|FG001|STARTED|Period 3||60
9096198|NCT01517659|10160992|FG000|COMPLETED|Overall Study||45
9096199|NCT01517659|10160992|FG000|NOT COMPLETED|Overall Study||0
9096200|NCT01209767|10160997|FG000|STARTED|Overall Study||22
9096201|NCT01209767|10160997|FG000|COMPLETED|Overall Study||18
9096202|NCT01209767|10160997|FG000|NOT COMPLETED|Overall Study||4
9096203|NCT01186848|10161005|FG000|STARTED|Overall Study||30
9096204|NCT01186848|10161005|FG000|COMPLETED|Overall Study||22
9096205|NCT01186848|10161005|FG000|NOT COMPLETED|Overall Study||8
9096206|NCT01040624|10161013|FG000|STARTED|Overall Study||58
9096207|NCT01040624|10161014|FG001|STARTED|Overall Study||19
9096208|NCT01040624|10161013|FG000|COMPLETED|Overall Study||58
9096209|NCT01040624|10161014|FG001|COMPLETED|Overall Study||19
9096210|NCT01040624|10161013|FG000|NOT COMPLETED|Overall Study||0
9096211|NCT01040624|10161014|FG001|NOT COMPLETED|Overall Study||0
9096212|NCT01024608|10161022|FG000|STARTED|Overall Study||169
9096213|NCT01024608|10161023|FG001|STARTED|Overall Study||171
9096214|NCT01024608|10161022|FG000|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|167
9096215|NCT01024608|10161023|FG001|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|171
9096216|NCT01024608|10161022|FG000|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|167
9096217|NCT01024608|10161023|FG001|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|171
9096218|NCT01024608|10161022|FG000|COMPLETED|Overall Study||165
9096219|NCT01024608|10161023|FG001|COMPLETED|Overall Study||167
9096220|NCT01024608|10161022|FG000|NOT COMPLETED|Overall Study||4
9096221|NCT01024608|10161023|FG001|NOT COMPLETED|Overall Study||4
9096222|NCT00988247|10161031|FG000|STARTED|Overall Study||418
9096223|NCT00988247|10161032|FG001|STARTED|Overall Study||111
9096224|NCT00988247|10161031|FG000|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|415
9096225|NCT00988247|10161032|FG001|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|111
9096226|NCT00988247|10161031|FG000|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|414
8556833|NCT03760146|9588650|FG004|Evaluable 13-Matched Immunogenicity Population|Overall Study||0
8556834|NCT03760146|9588651|FG005|Evaluable 13-Matched Immunogenicity Population|Overall Study||0
8556835|NCT03760146|9588646|FG000|Evaluable 7-Additional Immunogenicity Population|Overall Study||1433
8556836|NCT03760146|9588647|FG001|Evaluable 7-Additional Immunogenicity Population|Overall Study||1383
8556837|NCT03760146|9588648|FG002|Evaluable 7-Additional Immunogenicity Population|Overall Study||0
8556838|NCT03760146|9588649|FG003|Evaluable 7-Additional Immunogenicity Population|Overall Study||0
8556839|NCT03760146|9588650|FG004|Evaluable 7-Additional Immunogenicity Population|Overall Study||0
8556840|NCT03760146|9588651|FG005|Evaluable 7-Additional Immunogenicity Population|Overall Study||0
8556841|NCT03760146|9588646|FG000|Vaccination 1|Overall Study||1507
9096227|NCT00988247|10161032|FG001|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|110
9096228|NCT00988247|10161031|FG000|COMPLETED|Overall Study||335
9096229|NCT00988247|10161032|FG001|COMPLETED|Overall Study||85
9096230|NCT00988247|10161031|FG000|NOT COMPLETED|Overall Study||83
9096231|NCT00988247|10161032|FG001|NOT COMPLETED|Overall Study||26
9096232|NCT00838981|10161042|FG000|STARTED|Week 1 Days 1-3||26
9096233|NCT00838981|10161043|FG001|STARTED|Week 1 Days 1-3||19
9096234|NCT00838981|10161044|FG002|STARTED|Week 1 Days 1-3||27
9096235|NCT00838981|10161045|FG003|STARTED|Week 1 Days 1-3||19
9096236|NCT00838981|10161042|FG000|COMPLETED|Week 1 Days 1-3||26
9096237|NCT00838981|10161043|FG001|COMPLETED|Week 1 Days 1-3||19
9096238|NCT00838981|10161044|FG002|COMPLETED|Week 1 Days 1-3||27
9096239|NCT00838981|10161045|FG003|COMPLETED|Week 1 Days 1-3||19
9096240|NCT00838981|10161042|FG000|NOT COMPLETED|Week 1 Days 1-3||0
9096241|NCT00838981|10161043|FG001|NOT COMPLETED|Week 1 Days 1-3||0
9096242|NCT00838981|10161044|FG002|NOT COMPLETED|Week 1 Days 1-3||0
9096243|NCT00838981|10161045|FG003|NOT COMPLETED|Week 1 Days 1-3||0
9096244|NCT00838981|10161042|FG000|STARTED|Day 4 to Week 11||26
9096245|NCT00838981|10161043|FG001|STARTED|Day 4 to Week 11||19
9096246|NCT00838981|10161044|FG002|STARTED|Day 4 to Week 11||27
9096247|NCT00838981|10161045|FG003|STARTED|Day 4 to Week 11||19
9096248|NCT00838981|10161042|FG000|Completed Main Treatment on 400mg|Day 4 to Week 11||22
9096249|NCT00838981|10161043|FG001|Completed Main Treatment on 400mg|Day 4 to Week 11||13
9096250|NCT00838981|10161044|FG002|Completed Main Treatment on 400mg|Day 4 to Week 11||17
9096251|NCT00838981|10161045|FG003|Completed Main Treatment on 400mg|Day 4 to Week 11||14
9096252|NCT00838981|10161042|FG000|COMPLETED|Day 4 to Week 11||19
9096253|NCT00838981|10161043|FG001|COMPLETED|Day 4 to Week 11||11
9096254|NCT00838981|10161044|FG002|COMPLETED|Day 4 to Week 11||16
9096255|NCT00838981|10161045|FG003|COMPLETED|Day 4 to Week 11||12
9096256|NCT00838981|10161042|FG000|NOT COMPLETED|Day 4 to Week 11||7
9096257|NCT00838981|10161043|FG001|NOT COMPLETED|Day 4 to Week 11||8
9096258|NCT00838981|10161044|FG002|NOT COMPLETED|Day 4 to Week 11||11
9096259|NCT00838981|10161045|FG003|NOT COMPLETED|Day 4 to Week 11||7
9096260|NCT00730639|10161064|FG000|STARTED|Overall Study||17
9096261|NCT00730639|10161065|FG001|STARTED|Overall Study||18
9096262|NCT00730639|10161066|FG002|STARTED|Overall Study||86
9096263|NCT00730639|10161067|FG003|STARTED|Overall Study||54
9096264|NCT00730639|10161068|FG004|STARTED|Overall Study||131
9096265|NCT00730639|10161064|FG000|COMPLETED|Overall Study||0
9096266|NCT00730639|10161065|FG001|COMPLETED|Overall Study||0
9096267|NCT00730639|10161066|FG002|COMPLETED|Overall Study||0
9096268|NCT00730639|10161067|FG003|COMPLETED|Overall Study||0
9096269|NCT00730639|10161068|FG004|COMPLETED|Overall Study||0
9096270|NCT00730639|10161064|FG000|NOT COMPLETED|Overall Study||17
9096271|NCT00730639|10161065|FG001|NOT COMPLETED|Overall Study||18
9096272|NCT00730639|10161066|FG002|NOT COMPLETED|Overall Study||86
9096273|NCT00730639|10161067|FG003|NOT COMPLETED|Overall Study||54
9096274|NCT00730639|10161068|FG004|NOT COMPLETED|Overall Study||131
9096275|NCT00693238|10161093|FG000|STARTED|Overall Study||122
9096276|NCT00693238|10161094|FG001|STARTED|Overall Study||106
9096277|NCT00693238|10161093|FG000|COMPLETED|Overall Study||122
9096278|NCT00693238|10161094|FG001|COMPLETED|Overall Study||106
9096279|NCT00693238|10161093|FG000|NOT COMPLETED|Overall Study||0
9096280|NCT00693238|10161094|FG001|NOT COMPLETED|Overall Study||0
9096281|NCT00363038|10161100|FG000|STARTED|Overall Study||16
9096282|NCT00363038|10161100|FG000|COMPLETED|Overall Study||16
9096283|NCT00363038|10161100|FG000|NOT COMPLETED|Overall Study||0
9096284|NCT04834362|10161106|FG000|STARTED|Overall Study||53
9096285|NCT04834362|10161107|FG001|STARTED|Overall Study||52
9096286|NCT04834362|10161106|FG000|COMPLETED|Overall Study||52
9096287|NCT04834362|10161107|FG001|COMPLETED|Overall Study||50
9096288|NCT04834362|10161106|FG000|NOT COMPLETED|Overall Study||1
9096289|NCT04834362|10161107|FG001|NOT COMPLETED|Overall Study||2
8845876|NCT01717768|9900358|FG011|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8845877|NCT01717768|9900347|FG000|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8845878|NCT01717768|9900348|FG001|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8845879|NCT01717768|9900349|FG002|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8845880|NCT01717768|9900350|FG003|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||4
8845881|NCT01717768|9900351|FG004|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||5
8850489|NCT01746784|9905681|FG000|COMPLETED|Overall Study||19
9096290|NCT04681482|10161117|FG000|STARTED|Overall Study||35051
9096291|NCT04681482|10161118|FG001|STARTED|Overall Study||38756
9096292|NCT04681482|10161119|FG002|STARTED|Overall Study||12148
9096293|NCT04681482|10161120|FG003|STARTED|Overall Study||21428
9096294|NCT04681482|10161117|FG000|COMPLETED|Overall Study||35051
9096295|NCT04681482|10161118|FG001|COMPLETED|Overall Study||38756
9096296|NCT04681482|10161119|FG002|COMPLETED|Overall Study||12148
9096297|NCT04681482|10161120|FG003|COMPLETED|Overall Study||21428
9096298|NCT04681482|10161117|FG000|NOT COMPLETED|Overall Study||0
9096299|NCT04681482|10161118|FG001|NOT COMPLETED|Overall Study||0
9096300|NCT04681482|10161119|FG002|NOT COMPLETED|Overall Study||0
9096301|NCT04681482|10161120|FG003|NOT COMPLETED|Overall Study||0
9096302|NCT04611789|10161133|FG000|STARTED|Overall Study||4
9096303|NCT04611789|10161134|FG001|STARTED|Overall Study||7
9096304|NCT04611789|10161135|FG002|STARTED|Overall Study||7
9096305|NCT04611789|10161133|FG000|COMPLETED|Overall Study||3
9096306|NCT04611789|10161134|FG001|COMPLETED|Overall Study||7
9096307|NCT04611789|10161135|FG002|COMPLETED|Overall Study||7
9096308|NCT04611789|10161133|FG000|NOT COMPLETED|Overall Study||1
9096309|NCT04611789|10161134|FG001|NOT COMPLETED|Overall Study||0
9096310|NCT04611789|10161135|FG002|NOT COMPLETED|Overall Study||0
9096311|NCT04537910|10161146|FG000|STARTED|Overall Study||6
9096312|NCT04537910|10161147|FG001|STARTED|Overall Study||5
9096313|NCT04537910|10161148|FG002|STARTED|Overall Study||7
9096314|NCT04537910|10161149|FG003|STARTED|Overall Study||7
9096315|NCT04537910|10161146|FG000|Received at Least One Dose of Study Drug|Overall Study||6
9096316|NCT04537910|10161147|FG001|Received at Least One Dose of Study Drug|Overall Study||5
9096317|NCT04537910|10161148|FG002|Received at Least One Dose of Study Drug|Overall Study||7
9096318|NCT04537910|10161149|FG003|Received at Least One Dose of Study Drug|Overall Study||7
9096319|NCT04537910|10161146|FG000|COMPLETED|Overall Study||6
9096320|NCT04537910|10161147|FG001|COMPLETED|Overall Study||5
9096321|NCT04537910|10161148|FG002|COMPLETED|Overall Study||7
9096322|NCT04537910|10161149|FG003|COMPLETED|Overall Study||7
9096323|NCT04537910|10161146|FG000|NOT COMPLETED|Overall Study||0
9096324|NCT04537910|10161147|FG001|NOT COMPLETED|Overall Study||0
9096325|NCT04537910|10161148|FG002|NOT COMPLETED|Overall Study||0
9096326|NCT04537910|10161149|FG003|NOT COMPLETED|Overall Study||0
9096327|NCT04441931|10161162|FG000|STARTED|Overall Study||6
9096328|NCT04441931|10161163|FG001|STARTED|Overall Study||7
9096329|NCT04441931|10161164|FG002|STARTED|Overall Study||7
9096330|NCT04441931|10161165|FG003|STARTED|Overall Study||6
9096331|NCT04441931|10161162|FG000|Received at Least One Dose of Study Drug|Overall Study||6
9096332|NCT04441931|10161163|FG001|Received at Least One Dose of Study Drug|Overall Study||7
9096333|NCT04441931|10161164|FG002|Received at Least One Dose of Study Drug|Overall Study||7
9096334|NCT04441931|10161165|FG003|Received at Least One Dose of Study Drug|Overall Study||6
9096335|NCT04441931|10161162|FG000|COMPLETED|Overall Study||6
9096336|NCT04441931|10161163|FG001|COMPLETED|Overall Study||7
9096337|NCT04441931|10161164|FG002|COMPLETED|Overall Study||7
9096338|NCT04441931|10161165|FG003|COMPLETED|Overall Study||6
9096339|NCT04441931|10161162|FG000|NOT COMPLETED|Overall Study||0
9096340|NCT04441931|10161163|FG001|NOT COMPLETED|Overall Study||0
9096341|NCT04441931|10161164|FG002|NOT COMPLETED|Overall Study||0
9096342|NCT04441931|10161165|FG003|NOT COMPLETED|Overall Study||0
9096343|NCT04355728|10161180|FG000|STARTED|Overall Study||12
9096344|NCT04355728|10161181|FG001|STARTED|Overall Study||12
9096345|NCT04355728|10161180|FG000|COMPLETED|Overall Study||12
9096346|NCT04355728|10161181|FG001|COMPLETED|Overall Study||12
9096347|NCT04355728|10161180|FG000|NOT COMPLETED|Overall Study||0
9096348|NCT04355728|10161181|FG001|NOT COMPLETED|Overall Study||0
9096349|NCT04344535|10161189|FG000|STARTED|Overall Study||59
9096350|NCT04344535|10161190|FG001|STARTED|Overall Study||15
9096351|NCT04344535|10161189|FG000|COMPLETED|Overall Study||59
9096352|NCT04344535|10161190|FG001|COMPLETED|Overall Study||15
9096353|NCT04344535|10161189|FG000|NOT COMPLETED|Overall Study||0
9096354|NCT04344535|10161190|FG001|NOT COMPLETED|Overall Study||0
9096355|NCT04254809|10161198|FG000|STARTED|Overall Study||48
8625637|NCT00508482|9665243|FG001|STARTED|Over 4 Weeks of Treatment||119
8625638|NCT00508482|9665244|FG002|STARTED|Over 4 Weeks of Treatment||119
8625639|NCT00508482|9665242|FG000|COMPLETED|Over 4 Weeks of Treatment||216
8625640|NCT00508482|9665243|FG001|COMPLETED|Over 4 Weeks of Treatment||102
8625641|NCT00508482|9665244|FG002|COMPLETED|Over 4 Weeks of Treatment||99
9096356|NCT04254809|10161199|FG001|STARTED|Overall Study||48
9096357|NCT04254809|10161198|FG000|COMPLETED|Overall Study||43
9096358|NCT04254809|10161199|FG001|COMPLETED|Overall Study||38
9096359|NCT04254809|10161198|FG000|NOT COMPLETED|Overall Study||5
9096360|NCT04254809|10161199|FG001|NOT COMPLETED|Overall Study||10
9096361|NCT04230122|10161207|FG000|STARTED|Overall Study||3
9096362|NCT04230122|10161208|FG001|STARTED|Overall Study||1
9096363|NCT04230122|10161207|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
8625642|NCT00508482|9665242|FG000|NOT COMPLETED|Over 4 Weeks of Treatment||21
9096364|NCT04230122|10161208|FG001|Received at Least 1 Dose of Study Drug|Overall Study||1
9096365|NCT04230122|10161207|FG000|COMPLETED|Overall Study||2
9096366|NCT04230122|10161208|FG001|COMPLETED|Overall Study||1
9096367|NCT04230122|10161207|FG000|NOT COMPLETED|Overall Study||1
9096368|NCT04230122|10161208|FG001|NOT COMPLETED|Overall Study||0
9096369|NCT04110366|10161216|FG000|STARTED|Overall Study||40
9096370|NCT04110366|10161217|FG001|STARTED|Overall Study||8
9096371|NCT04110366|10161216|FG000|COMPLETED|Overall Study||40
9096372|NCT04110366|10161217|FG001|COMPLETED|Overall Study||8
9096373|NCT04110366|10161216|FG000|NOT COMPLETED|Overall Study||0
9096374|NCT04110366|10161217|FG001|NOT COMPLETED|Overall Study||0
9096375|NCT04086693|10161226|FG000|STARTED|Overall Study||175
9096376|NCT04086693|10161227|FG001|STARTED|Overall Study||175
9096377|NCT04086693|10161226|FG000|COMPLETED|Overall Study||174
9096378|NCT04086693|10161227|FG001|COMPLETED|Overall Study||171
9096379|NCT04086693|10161226|FG000|NOT COMPLETED|Overall Study||1
9096380|NCT04086693|10161227|FG001|NOT COMPLETED|Overall Study||4
9096381|NCT04033068|10161237|FG000|STARTED|Overall Study||14
9096382|NCT04033068|10161238|FG001|STARTED|Overall Study||14
9096383|NCT04033068|10161239|FG002|STARTED|Overall Study||12
9096384|NCT04033068|10161240|FG003|STARTED|Overall Study||8
9096385|NCT04033068|10161237|FG000|First Dose|Overall Study||14
9096386|NCT04033068|10161238|FG001|First Dose|Overall Study||14
9096387|NCT04033068|10161239|FG002|First Dose|Overall Study||12
9096388|NCT04033068|10161240|FG003|First Dose|Overall Study||8
9096389|NCT04033068|10161237|FG000|Second Dose|Overall Study||14
9096390|NCT04033068|10161238|FG001|Second Dose|Overall Study||14
9096391|NCT04033068|10161239|FG002|Second Dose|Overall Study||11
9096392|NCT04033068|10161240|FG003|Second Dose|Overall Study||7
9096393|NCT04033068|10161237|FG000|COMPLETED|Overall Study||14
9096394|NCT04033068|10161238|FG001|COMPLETED|Overall Study||13
9096395|NCT04033068|10161239|FG002|COMPLETED|Overall Study||11
9096396|NCT04033068|10161240|FG003|COMPLETED|Overall Study||7
9096397|NCT04033068|10161237|FG000|NOT COMPLETED|Overall Study||0
9096398|NCT04033068|10161238|FG001|NOT COMPLETED|Overall Study||1
9096399|NCT04033068|10161239|FG002|NOT COMPLETED|Overall Study||1
9096400|NCT04033068|10161240|FG003|NOT COMPLETED|Overall Study||1
9096401|NCT03561597|10161250|FG000|STARTED|Overall Study|Recruited|40
9096402|NCT03561597|10161250|FG000|3 Month Follow up|Overall Study|Attended 3 month follow up|21
9096403|NCT03561597|10161250|FG000|COMPLETED|Overall Study|Attend month 6 follow up|20
9096404|NCT03561597|10161250|FG000|NOT COMPLETED|Overall Study||20
9096405|NCT03402607|10161256|FG000|STARTED|Overall Study||6
9096406|NCT03402607|10161257|FG001|STARTED|Overall Study||6
9096407|NCT03402607|10161256|FG000|COMPLETED|Overall Study||6
9096408|NCT03402607|10161257|FG001|COMPLETED|Overall Study||6
9096409|NCT03402607|10161256|FG000|NOT COMPLETED|Overall Study||0
9096410|NCT03402607|10161257|FG001|NOT COMPLETED|Overall Study||0
9096411|NCT03350984|10161265|FG000|STARTED|Overall Study||39
9096412|NCT03350984|10161266|FG001|STARTED|Overall Study||36
9096413|NCT03350984|10161265|FG000|COMPLETED|Overall Study||31
9096414|NCT03350984|10161266|FG001|COMPLETED|Overall Study||28
9096415|NCT03350984|10161265|FG000|NOT COMPLETED|Overall Study||8
9096416|NCT03350984|10161266|FG001|NOT COMPLETED|Overall Study||8
9096417|NCT03277261|10161274|FG000|STARTED|Overall Study||274
9096418|NCT03277261|10161275|FG001|STARTED|Overall Study||275
9096419|NCT03277261|10161274|FG000|COMPLETED|Overall Study||240
9096420|NCT03277261|10161275|FG001|COMPLETED|Overall Study||252
9096421|NCT03277261|10161274|FG000|NOT COMPLETED|Overall Study||34
9096422|NCT03277261|10161275|FG001|NOT COMPLETED|Overall Study||23
9096423|NCT03277248|10161284|FG000|STARTED|Overall Study||272
9096424|NCT03277248|10161285|FG001|STARTED|Overall Study||273
9096425|NCT03277248|10161284|FG000|COMPLETED|Overall Study||254
9096426|NCT03277248|10161285|FG001|COMPLETED|Overall Study||239
9096427|NCT03277248|10161284|FG000|NOT COMPLETED|Overall Study||18
9096428|NCT03277248|10161285|FG001|NOT COMPLETED|Overall Study||34
9096429|NCT03179462|10161294|FG000|STARTED|Overall Study||9
9096430|NCT03179462|10161295|FG001|STARTED|Overall Study||10
9096431|NCT03179462|10161296|FG002|STARTED|Overall Study||8
9096432|NCT03179462|10161294|FG000|COMPLETED|Overall Study||8
9096433|NCT03179462|10161295|FG001|COMPLETED|Overall Study||8
9096434|NCT03179462|10161296|FG002|COMPLETED|Overall Study||8
9096435|NCT03179462|10161294|FG000|NOT COMPLETED|Overall Study||1
9096436|NCT03179462|10161295|FG001|NOT COMPLETED|Overall Study||2
9096437|NCT03179462|10161296|FG002|NOT COMPLETED|Overall Study||0
9096438|NCT03099707|10161306|FG000|STARTED|Overall Study||43
9096439|NCT03099707|10161307|FG001|STARTED|Overall Study||41
9096440|NCT03099707|10161306|FG000|COMPLETED|Overall Study||43
9096441|NCT03099707|10161307|FG001|COMPLETED|Overall Study||37
9096442|NCT03099707|10161306|FG000|NOT COMPLETED|Overall Study||0
9096443|NCT03099707|10161307|FG001|NOT COMPLETED|Overall Study||4
9096444|NCT03064763|10161313|FG000|STARTED|Overall Study||18
9096445|NCT03064763|10161313|FG000|Received Treatment|Overall Study||18
9096446|NCT03064763|10161313|FG000|COMPLETED|Overall Study||0
9096447|NCT03064763|10161313|FG000|NOT COMPLETED|Overall Study||18
9096448|NCT03036267|10161317|FG000|STARTED|Overall Study||46
9096449|NCT03036267|10161317|FG000|COMPLETED|Overall Study||46
9096450|NCT03036267|10161317|FG000|NOT COMPLETED|Overall Study||0
9096451|NCT02941146|10161321|FG000|STARTED|Overall Study||15
9096452|NCT02941146|10161321|FG000|COMPLETED|Overall Study||15
9096453|NCT02941146|10161321|FG000|NOT COMPLETED|Overall Study||0
9096454|NCT02922985|10161327|FG000|STARTED|Overall Study||60
8845882|NCT01717768|9900352|FG005|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||5
8845883|NCT01717768|9900353|FG006|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8845884|NCT01717768|9900354|FG007|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8845885|NCT01717768|9900355|FG008|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8845886|NCT01717768|9900356|FG009|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
9096455|NCT02922985|10161328|FG001|STARTED|Overall Study||60
9096456|NCT02922985|10161327|FG000|COMPLETED|Overall Study||60
9096457|NCT02922985|10161328|FG001|COMPLETED|Overall Study||60
8556842|NCT03760146|9588647|FG001|Vaccination 1|Overall Study||1490
8850490|NCT01746784|9905682|FG001|COMPLETED|Overall Study||10
9096458|NCT02922985|10161327|FG000|NOT COMPLETED|Overall Study||0
9096459|NCT02922985|10161328|FG001|NOT COMPLETED|Overall Study||0
9096460|NCT02906033|10161338|FG000|STARTED|Baseline||231
9096461|NCT02906033|10161339|FG001|STARTED|Baseline||222
9096462|NCT02906033|10161338|FG000|15 D at Baseline|Baseline||211
9096463|NCT02906033|10161339|FG001|15 D at Baseline|Baseline||189
9096464|NCT02906033|10161338|FG000|STATE at Baseline|Baseline||199
9096465|NCT02906033|10161339|FG001|STATE at Baseline|Baseline||190
9096466|NCT02906033|10161338|FG000|TRAIT at Baseline|Baseline||194
9096467|NCT02906033|10161339|FG001|TRAIT at Baseline|Baseline||189
9096468|NCT02906033|10161338|FG000|COMPLETED|Baseline|Analyzed at baseline for 15 D and STATE anxiety and TRAIT anxiety|194
9096469|NCT02906033|10161339|FG001|COMPLETED|Baseline|Analyzed at baseline for 15 D and STATE anxiety and TRAIT anxiety.|189
9096470|NCT02906033|10161338|FG000|NOT COMPLETED|Baseline||37
9096471|NCT02906033|10161339|FG001|NOT COMPLETED|Baseline||33
9096472|NCT02906033|10161338|FG000|STARTED|Follow-up||194
9096473|NCT02906033|10161339|FG001|STARTED|Follow-up||189
9096474|NCT02906033|10161338|FG000|15 D at Follow-up|Follow-up||151
9096475|NCT02906033|10161339|FG001|15 D at Follow-up|Follow-up||135
9096476|NCT02906033|10161338|FG000|STATE at Follow-up|Follow-up||154
9096477|NCT02906033|10161339|FG001|STATE at Follow-up|Follow-up||135
9096478|NCT02906033|10161338|FG000|TRAIT at Follow-up|Follow-up||148
9096479|NCT02906033|10161339|FG001|TRAIT at Follow-up|Follow-up||127
9096480|NCT02906033|10161338|FG000|COMPLETED|Follow-up|Analyzed for 15 D and STATE anxiety and TRAIT anxiety at follow-up|148
9096481|NCT02906033|10161339|FG001|COMPLETED|Follow-up|Analyzed at follow-up 15 D and STATE anxiety and TRAIT anxiety.|127
9096482|NCT02906033|10161338|FG000|NOT COMPLETED|Follow-up||46
9096483|NCT02906033|10161339|FG001|NOT COMPLETED|Follow-up||62
9096484|NCT02837783|10161347|FG000|STARTED|Overall Study||9
9096485|NCT02837783|10161348|FG001|STARTED|Overall Study||11
9096486|NCT02837783|10161347|FG000|Received >= 1 Dose of Study Drug|Overall Study||9
9096487|NCT02837783|10161348|FG001|Received >= 1 Dose of Study Drug|Overall Study||10
9096488|NCT02837783|10161347|FG000|COMPLETED|Overall Study||7
9096489|NCT02837783|10161348|FG001|COMPLETED|Overall Study||9
9096490|NCT02837783|10161347|FG000|NOT COMPLETED|Overall Study||2
9096491|NCT02837783|10161348|FG001|NOT COMPLETED|Overall Study||2
9096492|NCT02786537|10161360|FG000|STARTED|As Randomized||56
9096493|NCT02786537|10161361|FG001|STARTED|As Randomized||644
9096494|NCT02786537|10161362|FG002|STARTED|As Randomized||15
9096495|NCT02786537|10161363|FG003|STARTED|As Randomized||413
9096496|NCT02786537|10161364|FG004|STARTED|As Randomized||99
9096497|NCT02786537|10161365|FG005|STARTED|As Randomized||48
9096498|NCT02786537|10161360|FG000|COMPLETED|As Randomized||50
9096499|NCT02786537|10161361|FG001|COMPLETED|As Randomized||582
9096500|NCT02786537|10161362|FG002|COMPLETED|As Randomized||15
9096501|NCT02786537|10161363|FG003|COMPLETED|As Randomized||378
9096502|NCT02786537|10161364|FG004|COMPLETED|As Randomized||87
9096503|NCT02786537|10161365|FG005|COMPLETED|As Randomized||41
9096504|NCT02786537|10161360|FG000|NOT COMPLETED|As Randomized||6
9096505|NCT02786537|10161361|FG001|NOT COMPLETED|As Randomized||62
9096506|NCT02786537|10161362|FG002|NOT COMPLETED|As Randomized||0
9096507|NCT02786537|10161363|FG003|NOT COMPLETED|As Randomized||35
9096508|NCT02786537|10161364|FG004|NOT COMPLETED|As Randomized||12
9096509|NCT02786537|10161365|FG005|NOT COMPLETED|As Randomized||7
9096510|NCT02786537|10161360|FG000|STARTED|As Treated||56
9096511|NCT02786537|10161361|FG001|STARTED|As Treated||664
9096512|NCT02786537|10161362|FG002|STARTED|As Treated||15
9096513|NCT02786537|10161363|FG003|STARTED|As Treated||394
9096514|NCT02786537|10161364|FG004|STARTED|As Treated||99
9096515|NCT02786537|10161365|FG005|STARTED|As Treated||47
9096516|NCT02786537|10161360|FG000|COMPLETED|As Treated||50
9096517|NCT02786537|10161361|FG001|COMPLETED|As Treated||602
9096518|NCT02786537|10161362|FG002|COMPLETED|As Treated||15
9096519|NCT02786537|10161363|FG003|COMPLETED|As Treated||359
9096520|NCT02786537|10161364|FG004|COMPLETED|As Treated||87
9096521|NCT02786537|10161365|FG005|COMPLETED|As Treated||40
9096522|NCT02786537|10161360|FG000|NOT COMPLETED|As Treated||6
9096523|NCT02786537|10161361|FG001|NOT COMPLETED|As Treated||62
9096524|NCT02786537|10161362|FG002|NOT COMPLETED|As Treated||0
9096525|NCT02786537|10161363|FG003|NOT COMPLETED|As Treated||35
9096526|NCT02786537|10161364|FG004|NOT COMPLETED|As Treated||12
9096527|NCT02786537|10161365|FG005|NOT COMPLETED|As Treated||7
9096528|NCT02740231|10161475|FG000|STARTED|Overall Study||41
9096529|NCT02740231|10161476|FG001|STARTED|Overall Study||41
9096530|NCT02740231|10161477|FG002|STARTED|Overall Study||41
9096531|NCT02740231|10161478|FG003|STARTED|Overall Study||41
9096532|NCT02740231|10161475|FG000|COMPLETED|Overall Study||39
9096533|NCT02740231|10161476|FG001|COMPLETED|Overall Study||35
9096534|NCT02740231|10161477|FG002|COMPLETED|Overall Study||40
9096535|NCT02740231|10161478|FG003|COMPLETED|Overall Study||33
9096536|NCT02740231|10161475|FG000|NOT COMPLETED|Overall Study||2
9096537|NCT02740231|10161476|FG001|NOT COMPLETED|Overall Study||6
9096538|NCT02740231|10161477|FG002|NOT COMPLETED|Overall Study||1
9096539|NCT02740231|10161478|FG003|NOT COMPLETED|Overall Study||8
9096540|NCT02710084|10161490|FG000|STARTED|First Phase - 12 Weeks||10
9096541|NCT02710084|10161491|FG001|STARTED|First Phase - 12 Weeks||8
9096542|NCT02710084|10161490|FG000|COMPLETED|First Phase - 12 Weeks||7
9096543|NCT02710084|10161491|FG001|COMPLETED|First Phase - 12 Weeks||7
9096544|NCT02710084|10161490|FG000|NOT COMPLETED|First Phase - 12 Weeks||3
9096545|NCT02710084|10161491|FG001|NOT COMPLETED|First Phase - 12 Weeks||1
9096546|NCT02710084|10161490|FG000|STARTED|Open Label Phase: Week 12 to 24||7
9096547|NCT02710084|10161491|FG001|STARTED|Open Label Phase: Week 12 to 24||7
9096548|NCT02710084|10161490|FG000|COMPLETED|Open Label Phase: Week 12 to 24||7
9096549|NCT02710084|10161491|FG001|COMPLETED|Open Label Phase: Week 12 to 24||7
9096550|NCT02710084|10161490|FG000|NOT COMPLETED|Open Label Phase: Week 12 to 24||0
9096551|NCT02710084|10161491|FG001|NOT COMPLETED|Open Label Phase: Week 12 to 24||0
9096552|NCT02660034|10161512|FG000|STARTED|Overall Study||12
9096553|NCT02660034|10161513|FG001|STARTED|Overall Study||12
9096554|NCT02660034|10161514|FG002|STARTED|Overall Study||6
9096555|NCT02660034|10161515|FG003|STARTED|Overall Study||13
9096556|NCT02660034|10161516|FG004|STARTED|Overall Study||6
9096557|NCT02660034|10161517|FG005|STARTED|Overall Study||23
9096558|NCT02660034|10161518|FG006|STARTED|Overall Study||23
9096559|NCT02660034|10161519|FG007|STARTED|Overall Study||19
9096560|NCT02660034|10161520|FG008|STARTED|Overall Study||20
9096561|NCT02660034|10161521|FG009|STARTED|Overall Study||23
9096562|NCT02660034|10161522|FG010|STARTED|Overall Study||20
9096563|NCT02660034|10161523|FG011|STARTED|Overall Study||21
9096564|NCT02660034|10161524|FG012|STARTED|Overall Study||21
9096565|NCT02660034|10161525|FG013|STARTED|Overall Study||10
9096566|NCT02660034|10161512|FG000|Received At Least 1 Dose of Study Drug(s)|Overall Study||12
9096567|NCT02660034|10161513|FG001|Received At Least 1 Dose of Study Drug(s)|Overall Study||12
9096568|NCT02660034|10161514|FG002|Received At Least 1 Dose of Study Drug(s)|Overall Study||6
9096569|NCT02660034|10161515|FG003|Received At Least 1 Dose of Study Drug(s)|Overall Study||13
9096570|NCT02660034|10161516|FG004|Received At Least 1 Dose of Study Drug(s)|Overall Study||6
9096571|NCT02660034|10161517|FG005|Received At Least 1 Dose of Study Drug(s)|Overall Study||23
9096572|NCT02660034|10161518|FG006|Received At Least 1 Dose of Study Drug(s)|Overall Study||23
9096573|NCT02660034|10161519|FG007|Received At Least 1 Dose of Study Drug(s)|Overall Study||19
9096574|NCT02660034|10161520|FG008|Received At Least 1 Dose of Study Drug(s)|Overall Study||20
9096575|NCT02660034|10161521|FG009|Received At Least 1 Dose of Study Drug(s)|Overall Study||23
9096576|NCT02660034|10161522|FG010|Received At Least 1 Dose of Study Drug(s)|Overall Study||20
9096577|NCT02660034|10161523|FG011|Received At Least 1 Dose of Study Drug(s)|Overall Study||21
9096578|NCT02660034|10161524|FG012|Received At Least 1 Dose of Study Drug(s)|Overall Study||21
9096579|NCT02660034|10161525|FG013|Received At Least 1 Dose of Study Drug(s)|Overall Study||10
9096580|NCT02660034|10161512|FG000|COMPLETED|Overall Study||0
9096581|NCT02660034|10161513|FG001|COMPLETED|Overall Study||0
9096582|NCT02660034|10161514|FG002|COMPLETED|Overall Study||0
9096583|NCT02660034|10161515|FG003|COMPLETED|Overall Study||0
9096584|NCT02660034|10161516|FG004|COMPLETED|Overall Study||0
9096585|NCT02660034|10161517|FG005|COMPLETED|Overall Study||0
9096586|NCT02660034|10161518|FG006|COMPLETED|Overall Study||0
9096587|NCT02660034|10161519|FG007|COMPLETED|Overall Study||0
9096588|NCT02660034|10161520|FG008|COMPLETED|Overall Study||0
9096589|NCT02660034|10161521|FG009|COMPLETED|Overall Study||0
9096590|NCT02660034|10161522|FG010|COMPLETED|Overall Study||0
9096591|NCT02660034|10161523|FG011|COMPLETED|Overall Study||0
9096592|NCT02660034|10161524|FG012|COMPLETED|Overall Study||0
9096593|NCT02660034|10161525|FG013|COMPLETED|Overall Study||0
9096594|NCT02660034|10161512|FG000|NOT COMPLETED|Overall Study||12
9096595|NCT02660034|10161513|FG001|NOT COMPLETED|Overall Study||12
9096596|NCT02660034|10161514|FG002|NOT COMPLETED|Overall Study||6
9096597|NCT02660034|10161515|FG003|NOT COMPLETED|Overall Study||13
9096598|NCT02660034|10161516|FG004|NOT COMPLETED|Overall Study||6
9096599|NCT02660034|10161517|FG005|NOT COMPLETED|Overall Study||23
9096600|NCT02660034|10161518|FG006|NOT COMPLETED|Overall Study||23
9096601|NCT02660034|10161519|FG007|NOT COMPLETED|Overall Study||19
9096602|NCT02660034|10161520|FG008|NOT COMPLETED|Overall Study||20
9096603|NCT02660034|10161521|FG009|NOT COMPLETED|Overall Study||23
9096604|NCT02660034|10161522|FG010|NOT COMPLETED|Overall Study||20
9096605|NCT02660034|10161523|FG011|NOT COMPLETED|Overall Study||21
9096606|NCT02660034|10161524|FG012|NOT COMPLETED|Overall Study||21
9096607|NCT02660034|10161525|FG013|NOT COMPLETED|Overall Study||10
9096608|NCT02640625|10161559|FG000|STARTED|Overall Study||20
9096609|NCT02640625|10161559|FG000|COMPLETED|Overall Study||19
9096610|NCT02640625|10161559|FG000|NOT COMPLETED|Overall Study||1
9096611|NCT02561962|10161573|FG000|STARTED|Overall Study||3
9096612|NCT02561962|10161574|FG001|STARTED|Overall Study||3
9096613|NCT02561962|10161575|FG002|STARTED|Overall Study||3
9096614|NCT02561962|10161576|FG003|STARTED|Overall Study||3
9096615|NCT02561962|10161577|FG004|STARTED|Overall Study||6
9096616|NCT02561962|10161578|FG005|STARTED|Overall Study||6
9096617|NCT02561962|10161579|FG006|STARTED|Overall Study||5
9096618|NCT02561962|10161580|FG007|STARTED|Overall Study||11
9096619|NCT02561962|10161581|FG008|STARTED|Overall Study||2
9096620|NCT02561962|10161573|FG000|Received Treatment|Overall Study||3
9096621|NCT02561962|10161574|FG001|Received Treatment|Overall Study||3
9096622|NCT02561962|10161575|FG002|Received Treatment|Overall Study||3
9096623|NCT02561962|10161576|FG003|Received Treatment|Overall Study||3
9096624|NCT02561962|10161577|FG004|Received Treatment|Overall Study||6
9096625|NCT02561962|10161578|FG005|Received Treatment|Overall Study||6
9096626|NCT02561962|10161579|FG006|Received Treatment|Overall Study||5
9096627|NCT02561962|10161580|FG007|Received Treatment|Overall Study||9
9096628|NCT02561962|10161581|FG008|Received Treatment|Overall Study||2
9096629|NCT02561962|10161573|FG000|COMPLETED|Overall Study||1
9096630|NCT02561962|10161574|FG001|COMPLETED|Overall Study||3
9096631|NCT02561962|10161575|FG002|COMPLETED|Overall Study||3
9096632|NCT02561962|10161576|FG003|COMPLETED|Overall Study||2
9096633|NCT02561962|10161577|FG004|COMPLETED|Overall Study||4
9096634|NCT02561962|10161578|FG005|COMPLETED|Overall Study||2
9096635|NCT02561962|10161579|FG006|COMPLETED|Overall Study||3
9096636|NCT02561962|10161580|FG007|COMPLETED|Overall Study||3
9096637|NCT02561962|10161581|FG008|COMPLETED|Overall Study||1
9096638|NCT02561962|10161573|FG000|NOT COMPLETED|Overall Study||2
9096639|NCT02561962|10161574|FG001|NOT COMPLETED|Overall Study||0
9096640|NCT02561962|10161575|FG002|NOT COMPLETED|Overall Study||0
9096641|NCT02561962|10161576|FG003|NOT COMPLETED|Overall Study||1
9096642|NCT02561962|10161577|FG004|NOT COMPLETED|Overall Study||2
9096643|NCT02561962|10161578|FG005|NOT COMPLETED|Overall Study||4
9096644|NCT02561962|10161579|FG006|NOT COMPLETED|Overall Study||2
9096645|NCT02561962|10161580|FG007|NOT COMPLETED|Overall Study||8
9096646|NCT02561962|10161581|FG008|NOT COMPLETED|Overall Study||1
9096647|NCT02500589|10161603|FG000|STARTED|Overall Study||175
9096648|NCT02500589|10161604|FG001|STARTED|Overall Study||175
9096649|NCT02500589|10161603|FG000|COMPLETED|Overall Study||147
9096650|NCT02500589|10161604|FG001|COMPLETED|Overall Study||143
9096651|NCT02500589|10161603|FG000|NOT COMPLETED|Overall Study||28
9096652|NCT02500589|10161604|FG001|NOT COMPLETED|Overall Study||32
9096653|NCT02474329|10161614|FG000|STARTED|Overall Study|Participants (People with Parkinson's Disease) who signed a consent form.|304
9096654|NCT02474329|10161614|FG000|COMPLETED|Overall Study|Participants (People with Parkinson's Disease) who contributed data for 13 weeks.|291
9096655|NCT02474329|10161614|FG000|NOT COMPLETED|Overall Study||13
9096656|NCT02471339|10161621|FG000|STARTED|Overall Study||32
9096657|NCT02471339|10161622|FG001|STARTED|Overall Study||34
9096658|NCT02471339|10161621|FG000|COMPLETED|Overall Study||30
9096659|NCT02471339|10161622|FG001|COMPLETED|Overall Study||34
9096660|NCT02471339|10161621|FG000|NOT COMPLETED|Overall Study||2
9096661|NCT02471339|10161622|FG001|NOT COMPLETED|Overall Study||0
9096662|NCT01976273|10161630|FG000|STARTED|Overall Study||10
9096663|NCT01976273|10161631|FG001|STARTED|Overall Study||10
9096664|NCT01976273|10161630|FG000|COMPLETED|Overall Study||9
9096665|NCT01976273|10161631|FG001|COMPLETED|Overall Study||9
9096666|NCT01976273|10161630|FG000|NOT COMPLETED|Overall Study||1
9096667|NCT01976273|10161631|FG001|NOT COMPLETED|Overall Study||1
9096668|NCT01722929|10161637|FG000|STARTED|Overall Study||4
9096669|NCT01722929|10161637|FG000|COMPLETED|Overall Study||4
9096670|NCT01722929|10161637|FG000|NOT COMPLETED|Overall Study||0
9096671|NCT01500733|10161644|FG000|STARTED|Overall Study||35
9096672|NCT01500733|10161645|FG001|STARTED|Overall Study||51
9096673|NCT01500733|10161644|FG000|COMPLETED|Overall Study||33
9096674|NCT01500733|10161645|FG001|COMPLETED|Overall Study||48
9096675|NCT01500733|10161644|FG000|NOT COMPLETED|Overall Study||2
9096676|NCT01500733|10161645|FG001|NOT COMPLETED|Overall Study||3
9096677|NCT01388491|10161653|FG000|STARTED|Overall Study|number randomized|150
9096678|NCT01388491|10161654|FG001|STARTED|Overall Study||143
9096679|NCT01388491|10161653|FG000|Safety Population|Overall Study|Safety: all randomized participants who took 1 or more doses of study drug|145
9096680|NCT01388491|10161654|FG001|Safety Population|Overall Study||142
9096681|NCT01388491|10161653|FG000|Intent-to-Treat (ITT) Population|Overall Study|ITT:participants in safety population with baseline (BL) + ≥1 post-BL prothrombin fragment 1+2 value|140
9096682|NCT01388491|10161654|FG001|Intent-to-Treat (ITT) Population|Overall Study||136
9096683|NCT01388491|10161653|FG000|Per Protocol (PP) Population|Overall Study|PP: all data from ITT participants obtained prior to any major protocol violations|125
9096684|NCT01388491|10161654|FG001|Per Protocol (PP) Population|Overall Study||121
9096685|NCT01388491|10161653|FG000|COMPLETED|Overall Study||116
9096686|NCT01388491|10161654|FG001|COMPLETED|Overall Study||114
9096687|NCT01388491|10161653|FG000|NOT COMPLETED|Overall Study||34
9096688|NCT01388491|10161654|FG001|NOT COMPLETED|Overall Study||29
9096689|NCT01373151|10161667|FG000|STARTED|Period 1||61
9096690|NCT01373151|10161668|FG001|STARTED|Period 1||59
9096691|NCT01373151|10161669|FG002|STARTED|Period 1||60
9096692|NCT01373151|10161670|FG003|STARTED|Period 1||60
9096693|NCT01373151|10161671|FG004|STARTED|Period 1||59
9096694|NCT01373151|10161672|FG005|STARTED|Period 1||60
9096695|NCT01373151|10161673|FG006|STARTED|Period 1||59
9096696|NCT01373151|10161667|FG000|COMPLETED|Period 1||56
9096697|NCT01373151|10161668|FG001|COMPLETED|Period 1||59
9096698|NCT01373151|10161669|FG002|COMPLETED|Period 1||56
9096699|NCT01373151|10161670|FG003|COMPLETED|Period 1||59
9096700|NCT01373151|10161671|FG004|COMPLETED|Period 1||54
9096701|NCT01373151|10161672|FG005|COMPLETED|Period 1||56
9096702|NCT01373151|10161673|FG006|COMPLETED|Period 1||59
9096703|NCT01373151|10161667|FG000|NOT COMPLETED|Period 1||5
9096704|NCT01373151|10161668|FG001|NOT COMPLETED|Period 1||0
9096705|NCT01373151|10161669|FG002|NOT COMPLETED|Period 1||4
9096706|NCT01373151|10161670|FG003|NOT COMPLETED|Period 1||1
9096707|NCT01373151|10161671|FG004|NOT COMPLETED|Period 1||5
9096708|NCT01373151|10161672|FG005|NOT COMPLETED|Period 1||4
9096709|NCT01373151|10161673|FG006|NOT COMPLETED|Period 1||0
9096710|NCT01373151|10161667|FG000|STARTED|Period 2||56
9096711|NCT01373151|10161668|FG001|STARTED|Period 2||58
9096712|NCT01373151|10161669|FG002|STARTED|Period 2||56
9096713|NCT01373151|10161670|FG003|STARTED|Period 2||59
9096714|NCT01373151|10161671|FG004|STARTED|Period 2||54
9096715|NCT01373151|10161672|FG005|STARTED|Period 2||55
9096716|NCT01373151|10161673|FG006|STARTED|Period 2||59
9096717|NCT01373151|10161667|FG000|COMPLETED|Period 2||47
9096718|NCT01373151|10161668|FG001|COMPLETED|Period 2||57
9096719|NCT01373151|10161669|FG002|COMPLETED|Period 2||52
9096720|NCT01373151|10161670|FG003|COMPLETED|Period 2||54
9096721|NCT01373151|10161671|FG004|COMPLETED|Period 2||52
9096722|NCT01373151|10161672|FG005|COMPLETED|Period 2||55
9096723|NCT01373151|10161673|FG006|COMPLETED|Period 2||54
9096724|NCT01373151|10161667|FG000|NOT COMPLETED|Period 2||9
9096725|NCT01373151|10161668|FG001|NOT COMPLETED|Period 2||1
9096726|NCT01373151|10161669|FG002|NOT COMPLETED|Period 2||4
9096727|NCT01373151|10161670|FG003|NOT COMPLETED|Period 2||5
9096728|NCT01373151|10161671|FG004|NOT COMPLETED|Period 2||2
9096729|NCT01373151|10161672|FG005|NOT COMPLETED|Period 2||0
9096730|NCT01373151|10161673|FG006|NOT COMPLETED|Period 2||5
9096731|NCT01328587|10161689|FG000|STARTED|Overall Study||34
9096732|NCT01328587|10161689|FG000|COMPLETED|Overall Study||34
9096733|NCT01328587|10161689|FG000|NOT COMPLETED|Overall Study||0
9096734|NCT01285947|10161695|FG000|STARTED|Overall Study||10
9096735|NCT01285947|10161696|FG001|STARTED|Overall Study||10
9096736|NCT01285947|10161695|FG000|COMPLETED|Overall Study||10
9096737|NCT01285947|10161696|FG001|COMPLETED|Overall Study||10
9096738|NCT01285947|10161695|FG000|NOT COMPLETED|Overall Study||0
9096739|NCT01285947|10161696|FG001|NOT COMPLETED|Overall Study||0
9096740|NCT01281644|10161702|FG000|STARTED|Overall Study||23
9096741|NCT01281644|10161702|FG000|COMPLETED|Overall Study||18
9096742|NCT01281644|10161702|FG000|NOT COMPLETED|Overall Study||5
9096743|NCT01274611|10161708|FG000|STARTED|Overall Study||20
9096744|NCT01274611|10161708|FG000|COMPLETED|Overall Study||20
9096745|NCT01274611|10161708|FG000|NOT COMPLETED|Overall Study||0
9096746|NCT00960297|10161714|FG000|STARTED|Overall Study||4
9096747|NCT00960297|10161714|FG000|COMPLETED|Overall Study||1
9096748|NCT00960297|10161714|FG000|NOT COMPLETED|Overall Study||3
9096749|NCT00910650|10161718|FG000|STARTED|Overall Study||14
9096750|NCT00910650|10161718|FG000|COMPLETED|Overall Study||12
9096751|NCT00910650|10161718|FG000|NOT COMPLETED|Overall Study||2
9096752|NCT00793169|10161722|FG000|STARTED|Overall Study||19
9096753|NCT00793169|10161722|FG000|COMPLETED|Overall Study||19
9096754|NCT00793169|10161722|FG000|NOT COMPLETED|Overall Study||0
9096755|NCT00703326|10161728|FG000|STARTED|Overall Study||759
9096756|NCT00703326|10161729|FG001|STARTED|Overall Study||385
9096757|NCT00703326|10161728|FG000|Received at Least 1 Dose of Study Drug|Overall Study||752
9096758|NCT00703326|10161729|FG001|Received at Least 1 Dose of Study Drug|Overall Study||382
9096759|NCT00703326|10161728|FG000|COMPLETED|Overall Study||657
9096760|NCT00703326|10161729|FG001|COMPLETED|Overall Study||347
9096761|NCT00703326|10161728|FG000|NOT COMPLETED|Overall Study||102
9096762|NCT00703326|10161729|FG001|NOT COMPLETED|Overall Study||38
9096763|NCT00602667|10161739|FG000|STARTED|Overall Study||57
9096764|NCT00602667|10161740|FG001|STARTED|Overall Study||156
9096765|NCT00602667|10161741|FG002|STARTED|Overall Study||77
9096766|NCT00602667|10161739|FG000|COMPLETED|Overall Study||38
9096767|NCT00602667|10161740|FG001|COMPLETED|Overall Study||75
9096768|NCT00602667|10161741|FG002|COMPLETED|Overall Study||14
9096769|NCT00602667|10161739|FG000|NOT COMPLETED|Overall Study||19
9096770|NCT00602667|10161740|FG001|NOT COMPLETED|Overall Study||81
9096771|NCT00602667|10161741|FG002|NOT COMPLETED|Overall Study||63
9096772|NCT00535990|10161776|FG000|STARTED|Overall Study||250
9096773|NCT00535990|10161776|FG000|COMPLETED|Overall Study||250
9096774|NCT00535990|10161776|FG000|NOT COMPLETED|Overall Study||0
9096775|NCT00472186|10161782|FG000|STARTED|Overall Study||2
9096776|NCT00472186|10161783|FG001|STARTED|Overall Study||0
9096777|NCT00472186|10161782|FG000|COMPLETED|Overall Study||1
9096778|NCT00472186|10161783|FG001|COMPLETED|Overall Study||0
9096779|NCT00472186|10161782|FG000|NOT COMPLETED|Overall Study||1
9096780|NCT00472186|10161783|FG001|NOT COMPLETED|Overall Study||0
9096781|NCT03996876|10161793|FG000|STARTED|Overall Study||14
9096782|NCT03996876|10161794|FG001|STARTED|Overall Study||14
9096783|NCT03996876|10161793|FG000|COMPLETED|Overall Study||12
9096784|NCT03996876|10161794|FG001|COMPLETED|Overall Study||10
9096785|NCT03996876|10161793|FG000|NOT COMPLETED|Overall Study||2
9096786|NCT03996876|10161794|FG001|NOT COMPLETED|Overall Study||4
9096855|NCT02740972|10161913|FG001|NOT COMPLETED|4-week Double-blinded Placebo-controlled||0
9096856|NCT02740972|10161914|FG002|NOT COMPLETED|4-week Double-blinded Placebo-controlled||0
9096857|NCT02740972|10161915|FG003|NOT COMPLETED|4-week Double-blinded Placebo-controlled||0
9096858|NCT02740972|10161916|FG004|NOT COMPLETED|4-week Double-blinded Placebo-controlled||0
9096859|NCT02740972|10161912|FG000|STARTED|20-week Open Label Treatment Period||0
9096860|NCT02740972|10161913|FG001|STARTED|20-week Open Label Treatment Period||0
9096861|NCT02740972|10161914|FG002|STARTED|20-week Open Label Treatment Period||0
9096862|NCT02740972|10161915|FG003|STARTED|20-week Open Label Treatment Period||8
9096863|NCT02740972|10161916|FG004|STARTED|20-week Open Label Treatment Period||8
9096864|NCT02740972|10161912|FG000|COMPLETED|20-week Open Label Treatment Period||0
9096865|NCT02740972|10161913|FG001|COMPLETED|20-week Open Label Treatment Period||0
9096866|NCT02740972|10161914|FG002|COMPLETED|20-week Open Label Treatment Period||0
9096867|NCT02740972|10161915|FG003|COMPLETED|20-week Open Label Treatment Period||8
9096868|NCT02740972|10161916|FG004|COMPLETED|20-week Open Label Treatment Period||8
9096869|NCT02740972|10161912|FG000|NOT COMPLETED|20-week Open Label Treatment Period||0
9096870|NCT02740972|10161913|FG001|NOT COMPLETED|20-week Open Label Treatment Period||0
9096871|NCT02740972|10161914|FG002|NOT COMPLETED|20-week Open Label Treatment Period||0
9096872|NCT02740972|10161915|FG003|NOT COMPLETED|20-week Open Label Treatment Period||0
9096873|NCT02740972|10161916|FG004|NOT COMPLETED|20-week Open Label Treatment Period||0
9096874|NCT02662985|10161935|FG000|STARTED|Treatment Period 1||83
9096875|NCT02662985|10161936|FG001|STARTED|Treatment Period 1||83
9096876|NCT02662985|10161935|FG000|COMPLETED|Treatment Period 1||82
9096877|NCT02662985|10161936|FG001|COMPLETED|Treatment Period 1||79
9096878|NCT02662985|10161935|FG000|NOT COMPLETED|Treatment Period 1||1
9096879|NCT02662985|10161936|FG001|NOT COMPLETED|Treatment Period 1||4
9096880|NCT02662985|10161935|FG000|STARTED|Treatment Period 2||82
9096881|NCT02662985|10161936|FG001|STARTED|Treatment Period 2||79
9096882|NCT02662985|10161935|FG000|COMPLETED|Treatment Period 2||81
9096883|NCT02662985|10161936|FG001|COMPLETED|Treatment Period 2||78
9096884|NCT02662985|10161935|FG000|NOT COMPLETED|Treatment Period 2||1
9096885|NCT02662985|10161936|FG001|NOT COMPLETED|Treatment Period 2||1
9096886|NCT02662985|10161935|FG000|STARTED|Treatment Period 3 (Extension Period)||81
9096887|NCT02662985|10161936|FG001|STARTED|Treatment Period 3 (Extension Period)||78
9096888|NCT02662985|10161935|FG000|COMPLETED|Treatment Period 3 (Extension Period)||75
9096889|NCT02662985|10161936|FG001|COMPLETED|Treatment Period 3 (Extension Period)||69
9096890|NCT02662985|10161935|FG000|NOT COMPLETED|Treatment Period 3 (Extension Period)||6
9096891|NCT02662985|10161936|FG001|NOT COMPLETED|Treatment Period 3 (Extension Period)||9
9096892|NCT02606461|10161946|FG000|STARTED|Overall Study||27
9096893|NCT02606461|10161947|FG001|STARTED|Overall Study||30
9096894|NCT02606461|10161948|FG002|STARTED|Overall Study||188
9096895|NCT02606461|10161949|FG003|STARTED|Overall Study||97
9096787|NCT03589976|10161803|FG000|STARTED|Overall Study||35
9096788|NCT03589976|10161804|FG001|STARTED|Overall Study||12
9096789|NCT03589976|10161803|FG000|COMPLETED|Overall Study||16
9096790|NCT03589976|10161804|FG001|COMPLETED|Overall Study||6
9096791|NCT03589976|10161803|FG000|NOT COMPLETED|Overall Study||19
9096792|NCT03589976|10161804|FG001|NOT COMPLETED|Overall Study||6
9096793|NCT03490227|10161810|FG000|STARTED|Overall Study||10
9096794|NCT03490227|10161810|FG000|COMPLETED|Overall Study||10
9096795|NCT03490227|10161810|FG000|NOT COMPLETED|Overall Study||0
9096796|NCT03401190|10161819|FG000|STARTED|Overall Study||8
9096797|NCT03401190|10161820|FG001|STARTED|Overall Study||6
9096798|NCT03401190|10161821|FG002|STARTED|Overall Study||7
9096799|NCT03401190|10161819|FG000|COMPLETED|Overall Study||8
9096800|NCT03401190|10161820|FG001|COMPLETED|Overall Study||4
9096801|NCT03401190|10161821|FG002|COMPLETED|Overall Study||7
9096802|NCT03401190|10161819|FG000|NOT COMPLETED|Overall Study||0
9096803|NCT03401190|10161820|FG001|NOT COMPLETED|Overall Study||2
9096804|NCT03401190|10161821|FG002|NOT COMPLETED|Overall Study||0
9096805|NCT03392753|10161835|FG000|STARTED|Overall Study||83
9096806|NCT03392753|10161836|FG001|STARTED|Overall Study||84
9096807|NCT03392753|10161835|FG000|COMPLETED|Overall Study||47
9096808|NCT03392753|10161836|FG001|COMPLETED|Overall Study||50
9096809|NCT03392753|10161835|FG000|NOT COMPLETED|Overall Study||36
9096810|NCT03392753|10161836|FG001|NOT COMPLETED|Overall Study||34
9096811|NCT03212963|10161842|FG000|STARTED|Overall Study||16
9096812|NCT03212963|10161842|FG000|COMPLETED|Overall Study||16
9096813|NCT03212963|10161842|FG000|NOT COMPLETED|Overall Study||0
9096814|NCT03135262|10161851|FG000|STARTED|Overall Study||9
9096815|NCT03135262|10161852|FG001|STARTED|Overall Study||6
9096816|NCT03135262|10161853|FG002|STARTED|Overall Study||7
9096817|NCT03135262|10161854|FG003|STARTED|Overall Study||6
9096818|NCT03135262|10161855|FG004|STARTED|Overall Study||1
9096819|NCT03135262|10161851|FG000|COMPLETED|Overall Study|The study was terminated after escalation phase. The planned expansion phase did not take place due to the early termination.|0
9096820|NCT03135262|10161852|FG001|COMPLETED|Overall Study|The study was terminated after escalation phase. The planned expansion phase did not take place due to the early termination.|0
9096821|NCT03135262|10161853|FG002|COMPLETED|Overall Study|The study was terminated after escalation phase. The planned expansion phase did not take place due to the early termination.|0
9096822|NCT03135262|10161854|FG003|COMPLETED|Overall Study|The study was terminated after escalation phase. The planned expansion phase did not take place due to the early termination.|0
9096823|NCT03135262|10161855|FG004|COMPLETED|Overall Study|The study was terminated after escalation phase. The planned expansion phase did not take place due to the early termination.|0
9096824|NCT03135262|10161851|FG000|NOT COMPLETED|Overall Study||9
9096825|NCT03135262|10161852|FG001|NOT COMPLETED|Overall Study||6
9096826|NCT03135262|10161853|FG002|NOT COMPLETED|Overall Study||7
9096827|NCT03135262|10161854|FG003|NOT COMPLETED|Overall Study||6
9096828|NCT03135262|10161855|FG004|NOT COMPLETED|Overall Study||1
9096829|NCT03104075|10161887|FG000|STARTED|Overall Study||20
9096830|NCT03104075|10161888|FG001|STARTED|Overall Study||20
9096831|NCT03104075|10161887|FG000|COMPLETED|Overall Study||19
9096832|NCT03104075|10161888|FG001|COMPLETED|Overall Study||20
9096833|NCT03104075|10161887|FG000|NOT COMPLETED|Overall Study||1
9096834|NCT03104075|10161888|FG001|NOT COMPLETED|Overall Study||0
9096835|NCT03038087|10161895|FG000|STARTED|Overall Study||10
9096836|NCT03038087|10161895|FG000|COMPLETED|Overall Study||9
9096837|NCT03038087|10161895|FG000|NOT COMPLETED|Overall Study||1
9096838|NCT02880540|10161903|FG000|STARTED|Overall Study||13
9096839|NCT02880540|10161904|FG001|STARTED|Overall Study||13
9096840|NCT02880540|10161903|FG000|COMPLETED|Overall Study||13
9096841|NCT02880540|10161904|FG001|COMPLETED|Overall Study||13
9096842|NCT02880540|10161903|FG000|NOT COMPLETED|Overall Study||0
9096843|NCT02880540|10161904|FG001|NOT COMPLETED|Overall Study||0
9096844|NCT02740972|10161912|FG000|STARTED|4-week Double-blinded Placebo-controlled||5
9096845|NCT02740972|10161913|FG001|STARTED|4-week Double-blinded Placebo-controlled||6
9096846|NCT02740972|10161914|FG002|STARTED|4-week Double-blinded Placebo-controlled||5
9096847|NCT02740972|10161915|FG003|STARTED|4-week Double-blinded Placebo-controlled||0
9096848|NCT02740972|10161916|FG004|STARTED|4-week Double-blinded Placebo-controlled||0
9096849|NCT02740972|10161912|FG000|COMPLETED|4-week Double-blinded Placebo-controlled||5
9096850|NCT02740972|10161913|FG001|COMPLETED|4-week Double-blinded Placebo-controlled||6
9096851|NCT02740972|10161914|FG002|COMPLETED|4-week Double-blinded Placebo-controlled||5
9096852|NCT02740972|10161915|FG003|COMPLETED|4-week Double-blinded Placebo-controlled||0
9096853|NCT02740972|10161916|FG004|COMPLETED|4-week Double-blinded Placebo-controlled||0
9096854|NCT02740972|10161912|FG000|NOT COMPLETED|4-week Double-blinded Placebo-controlled||0
8625643|NCT00508482|9665243|FG001|NOT COMPLETED|Over 4 Weeks of Treatment||17
8625644|NCT00508482|9665244|FG002|NOT COMPLETED|Over 4 Weeks of Treatment||20
8625645|NCT00508482|9665242|FG000|STARTED|at the 4th Week of Follow-up||216
8625646|NCT00508482|9665243|FG001|STARTED|at the 4th Week of Follow-up||102
8625647|NCT00508482|9665244|FG002|STARTED|at the 4th Week of Follow-up||99
8625648|NCT00508482|9665242|FG000|COMPLETED|at the 4th Week of Follow-up||196
8625649|NCT00508482|9665243|FG001|COMPLETED|at the 4th Week of Follow-up||96
8625650|NCT00508482|9665244|FG002|COMPLETED|at the 4th Week of Follow-up||98
8625651|NCT00508482|9665242|FG000|NOT COMPLETED|at the 4th Week of Follow-up||20
8625652|NCT00508482|9665243|FG001|NOT COMPLETED|at the 4th Week of Follow-up||6
8625653|NCT00508482|9665244|FG002|NOT COMPLETED|at the 4th Week of Follow-up||1
8625654|NCT00508482|9665242|FG000|STARTED|at the 12th Week of Follow-up||196
9096896|NCT02606461|10161946|FG000|Treated|Overall Study||27
9096897|NCT02606461|10161947|FG001|Treated|Overall Study||30
9096898|NCT02606461|10161948|FG002|Treated|Overall Study||187
9096899|NCT02606461|10161949|FG003|Treated|Overall Study||97
9096900|NCT02606461|10161946|FG000|Open Label|Overall Study||0
9096901|NCT02606461|10161947|FG001|Open Label|Overall Study|Participants in the placebo group who had PD during the Phase 2 double-blinded treatment, switched to open-label selinexor.|24
9096902|NCT02606461|10161948|FG002|Open Label|Overall Study||0
9096903|NCT02606461|10161949|FG003|Open Label|Overall Study|Participants in the placebo group who had PD during the Phase 3 double-blinded treatment, switched to open-label selinexor.|57
9096904|NCT02606461|10161946|FG000|COMPLETED|Overall Study||0
9096905|NCT02606461|10161947|FG001|COMPLETED|Overall Study||0
9096906|NCT02606461|10161948|FG002|COMPLETED|Overall Study||0
9096907|NCT02606461|10161949|FG003|COMPLETED|Overall Study||0
9096908|NCT02606461|10161946|FG000|NOT COMPLETED|Overall Study||27
9096909|NCT02606461|10161947|FG001|NOT COMPLETED|Overall Study||30
9096910|NCT02606461|10161948|FG002|NOT COMPLETED|Overall Study||188
9096911|NCT02606461|10161949|FG003|NOT COMPLETED|Overall Study||97
9096912|NCT02536339|10161962|FG000|STARTED|Overall Study||40
9096913|NCT02536339|10161962|FG000|Received at Least One Dose of Study Drug|Overall Study||39
9096914|NCT02536339|10161962|FG000|Efficacy-Evaluable Population|Overall Study|2 participants did not have post-baseline assessments and were not evaluable for efficacy.|37
9096915|NCT02536339|10161962|FG000|COMPLETED|Overall Study||12
9096916|NCT02536339|10161962|FG000|NOT COMPLETED|Overall Study||28
9096917|NCT02323295|10161968|FG000|STARTED|Overall Study||2
9096918|NCT02323295|10161969|FG001|STARTED|Overall Study||10
9096919|NCT02323295|10161968|FG000|COMPLETED|Overall Study||2
9096920|NCT02323295|10161969|FG001|COMPLETED|Overall Study||7
9096921|NCT02323295|10161968|FG000|NOT COMPLETED|Overall Study||0
9096922|NCT02323295|10161969|FG001|NOT COMPLETED|Overall Study||3
9096923|NCT02050308|10161977|FG000|STARTED|Overall Study||127
9096924|NCT02050308|10161978|FG001|STARTED|Overall Study||124
9096925|NCT02050308|10161977|FG000|COMPLETED|Overall Study||28
9096926|NCT02050308|10161978|FG001|COMPLETED|Overall Study||22
9096927|NCT02050308|10161977|FG000|NOT COMPLETED|Overall Study||99
8625655|NCT00508482|9665243|FG001|STARTED|at the 12th Week of Follow-up||96
8625656|NCT00508482|9665244|FG002|STARTED|at the 12th Week of Follow-up||98
8625657|NCT00508482|9665242|FG000|COMPLETED|at the 12th Week of Follow-up||196
8625658|NCT00508482|9665243|FG001|COMPLETED|at the 12th Week of Follow-up||96
8625659|NCT00508482|9665244|FG002|COMPLETED|at the 12th Week of Follow-up||98
9096928|NCT02050308|10161978|FG001|NOT COMPLETED|Overall Study||102
9096929|NCT02036970|10161999|FG000|STARTED|Part 1: Day 1 Through Week 16||6
9096930|NCT02036970|10162000|FG001|STARTED|Part 1: Day 1 Through Week 16||12
9096931|NCT02036970|10162001|FG002|STARTED|Part 1: Day 1 Through Week 16||11
9096932|NCT02036970|10162002|FG003|STARTED|Part 1: Day 1 Through Week 16||12
9096933|NCT02036970|10162003|FG004|STARTED|Part 1: Day 1 Through Week 16||2
9096934|NCT02036970|10162004|FG005|STARTED|Part 1: Day 1 Through Week 16||4
9096935|NCT02036970|10162005|FG006|STARTED|Part 1: Day 1 Through Week 16||3
9096936|NCT02036970|10162006|FG007|STARTED|Part 1: Day 1 Through Week 16||4
9096937|NCT02036970|10162007|FG008|STARTED|Part 1: Day 1 Through Week 16||74
9096938|NCT02036970|10162008|FG009|STARTED|Part 1: Day 1 Through Week 16||38
9096939|NCT02036970|10161999|FG000|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||6
9096940|NCT02036970|10162000|FG001|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||6
9096941|NCT02036970|10162001|FG002|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||11
9096942|NCT02036970|10162002|FG003|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||6
9096943|NCT02036970|10162003|FG004|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||2
9096944|NCT02036970|10162004|FG005|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||2
9096945|NCT02036970|10162005|FG006|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||3
9096946|NCT02036970|10162006|FG007|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||2
9096947|NCT02036970|10162007|FG008|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||0
9096948|NCT02036970|10162008|FG009|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||0
9096949|NCT02036970|10161999|FG000|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||0
9096950|NCT02036970|10162000|FG001|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||6
9096951|NCT02036970|10162001|FG002|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||0
9096952|NCT02036970|10162002|FG003|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||6
9096953|NCT02036970|10162003|FG004|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||0
9096954|NCT02036970|10162004|FG005|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||2
9096955|NCT02036970|10162005|FG006|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||0
9096956|NCT02036970|10162006|FG007|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||2
9096957|NCT02036970|10162007|FG008|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||0
9096958|NCT02036970|10162008|FG009|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||0
9096959|NCT02036970|10161999|FG000|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0
9096960|NCT02036970|10162000|FG001|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0
9096961|NCT02036970|10162001|FG002|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0
8625660|NCT00508482|9665242|FG000|NOT COMPLETED|at the 12th Week of Follow-up||0
8625661|NCT00508482|9665243|FG001|NOT COMPLETED|at the 12th Week of Follow-up||0
8629541|NCT00530842|9669303|FG000|NOT COMPLETED|Period 1||14
9096962|NCT02036970|10162002|FG003|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0
9096963|NCT02036970|10162003|FG004|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0
9096964|NCT02036970|10162004|FG005|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0
9096965|NCT02036970|10162005|FG006|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0
9096966|NCT02036970|10162006|FG007|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0
9096967|NCT02036970|10162007|FG008|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||14
9096968|NCT02036970|10162008|FG009|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||8
9096969|NCT02036970|10161999|FG000|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0
9096970|NCT02036970|10162000|FG001|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0
9096971|NCT02036970|10162001|FG002|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0
9096972|NCT02036970|10162002|FG003|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0
9096973|NCT02036970|10162003|FG004|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0
9096974|NCT02036970|10162004|FG005|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0
9096975|NCT02036970|10162005|FG006|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0
9096976|NCT02036970|10162006|FG007|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0
9096977|NCT02036970|10162007|FG008|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||16
9096978|NCT02036970|10162008|FG009|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||9
9096979|NCT02036970|10161999|FG000|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0
9096980|NCT02036970|10162000|FG001|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0
9096981|NCT02036970|10162001|FG002|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0
9096982|NCT02036970|10162002|FG003|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0
9096983|NCT02036970|10162003|FG004|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0
9096984|NCT02036970|10162004|FG005|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0
9096985|NCT02036970|10162005|FG006|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0
9096986|NCT02036970|10162006|FG007|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0
9096987|NCT02036970|10162007|FG008|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||17
9096988|NCT02036970|10162008|FG009|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||8
9096989|NCT02036970|10161999|FG000|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0
9096990|NCT02036970|10162000|FG001|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0
9096991|NCT02036970|10162001|FG002|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0
9096992|NCT02036970|10162002|FG003|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0
9096993|NCT02036970|10162003|FG004|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0
9096994|NCT02036970|10162004|FG005|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0
9096995|NCT02036970|10162005|FG006|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0
9096996|NCT02036970|10162006|FG007|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0
9096997|NCT02036970|10162007|FG008|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||6
9096998|NCT02036970|10162008|FG009|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||2
9096999|NCT02036970|10161999|FG000|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0
9097000|NCT02036970|10162000|FG001|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0
9097001|NCT02036970|10162001|FG002|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0
9097002|NCT02036970|10162002|FG003|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0
9097003|NCT02036970|10162003|FG004|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0
9097004|NCT02036970|10162004|FG005|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0
9097005|NCT02036970|10162005|FG006|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0
9097006|NCT02036970|10162006|FG007|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0
9097007|NCT02036970|10162007|FG008|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||4
9097008|NCT02036970|10162008|FG009|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||1
9097009|NCT02036970|10161999|FG000|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0
9097010|NCT02036970|10162000|FG001|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0
9097011|NCT02036970|10162001|FG002|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0
9097012|NCT02036970|10162002|FG003|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0
9097013|NCT02036970|10162003|FG004|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0
9097014|NCT02036970|10162004|FG005|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0
9097015|NCT02036970|10162005|FG006|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0
9097016|NCT02036970|10162006|FG007|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0
9097017|NCT02036970|10162007|FG008|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||17
9097018|NCT02036970|10162008|FG009|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||1
9097019|NCT02036970|10161999|FG000|COMPLETED|Part 1: Day 1 Through Week 16||5
9097020|NCT02036970|10162000|FG001|COMPLETED|Part 1: Day 1 Through Week 16||12
9097021|NCT02036970|10162001|FG002|COMPLETED|Part 1: Day 1 Through Week 16||7
8625662|NCT00508482|9665244|FG002|NOT COMPLETED|at the 12th Week of Follow-up||0
8625663|NCT00508521|9665253|FG000|STARTED|Overall Study||4
8625664|NCT00508521|9665253|FG000|COMPLETED|Overall Study||4
8625665|NCT00508521|9665253|FG000|NOT COMPLETED|Overall Study||0
9097022|NCT02036970|10162002|FG003|COMPLETED|Part 1: Day 1 Through Week 16||9
9097023|NCT02036970|10162003|FG004|COMPLETED|Part 1: Day 1 Through Week 16||1
9097024|NCT02036970|10162004|FG005|COMPLETED|Part 1: Day 1 Through Week 16||3
9097025|NCT02036970|10162005|FG006|COMPLETED|Part 1: Day 1 Through Week 16||3
9097026|NCT02036970|10162006|FG007|COMPLETED|Part 1: Day 1 Through Week 16||3
9097027|NCT02036970|10162007|FG008|COMPLETED|Part 1: Day 1 Through Week 16||66
9097028|NCT02036970|10162008|FG009|COMPLETED|Part 1: Day 1 Through Week 16||33
9097029|NCT02036970|10161999|FG000|NOT COMPLETED|Part 1: Day 1 Through Week 16||1
9097030|NCT02036970|10162000|FG001|NOT COMPLETED|Part 1: Day 1 Through Week 16||0
9097031|NCT02036970|10162001|FG002|NOT COMPLETED|Part 1: Day 1 Through Week 16||4
9097032|NCT02036970|10162002|FG003|NOT COMPLETED|Part 1: Day 1 Through Week 16||3
9097033|NCT02036970|10162003|FG004|NOT COMPLETED|Part 1: Day 1 Through Week 16||1
9097034|NCT02036970|10162004|FG005|NOT COMPLETED|Part 1: Day 1 Through Week 16||1
9097035|NCT02036970|10162005|FG006|NOT COMPLETED|Part 1: Day 1 Through Week 16||0
9097036|NCT02036970|10162006|FG007|NOT COMPLETED|Part 1: Day 1 Through Week 16||1
9097037|NCT02036970|10162007|FG008|NOT COMPLETED|Part 1: Day 1 Through Week 16||8
9097038|NCT02036970|10162008|FG009|NOT COMPLETED|Part 1: Day 1 Through Week 16||5
9097039|NCT02036970|10161999|FG000|STARTED|Part 2: Week 16 Onwards||5
9097040|NCT02036970|10162000|FG001|STARTED|Part 2: Week 16 Onwards|One patient who completed Part 1 elected not to continue to Part 2.|11
9097041|NCT02036970|10162001|FG002|STARTED|Part 2: Week 16 Onwards|One patient who completed Part 1 elected not to continue to Part 2.|6
9097042|NCT02036970|10162002|FG003|STARTED|Part 2: Week 16 Onwards||9
9097043|NCT02036970|10162003|FG004|STARTED|Part 2: Week 16 Onwards||1
9097044|NCT02036970|10162004|FG005|STARTED|Part 2: Week 16 Onwards||3
9097045|NCT02036970|10162005|FG006|STARTED|Part 2: Week 16 Onwards||3
9097046|NCT02036970|10162006|FG007|STARTED|Part 2: Week 16 Onwards||3
9097047|NCT02036970|10162007|FG008|STARTED|Part 2: Week 16 Onwards|Three patients who completed Part 1 elected not to continue to Part 2.|63
9097048|NCT02036970|10162008|FG009|STARTED|Part 2: Week 16 Onwards||33
9097049|NCT02036970|10161999|FG000|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||5
9097050|NCT02036970|10162000|FG001|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||5
9097051|NCT02036970|10162001|FG002|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||6
9097052|NCT02036970|10162002|FG003|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||5
9097053|NCT02036970|10162003|FG004|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||1
9097054|NCT02036970|10162004|FG005|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||1
9097055|NCT02036970|10162005|FG006|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||3
9097056|NCT02036970|10162006|FG007|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||2
9097057|NCT02036970|10162007|FG008|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||0
9097058|NCT02036970|10162008|FG009|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||0
9097059|NCT02036970|10161999|FG000|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||0
9097060|NCT02036970|10162000|FG001|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||6
9097061|NCT02036970|10162001|FG002|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||0
9097062|NCT02036970|10162002|FG003|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||4
9097063|NCT02036970|10162003|FG004|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||0
9097064|NCT02036970|10162004|FG005|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||2
9097065|NCT02036970|10162005|FG006|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||0
9097066|NCT02036970|10162006|FG007|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||1
9097067|NCT02036970|10162007|FG008|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||0
9097068|NCT02036970|10162008|FG009|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||0
9097069|NCT02036970|10161999|FG000|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0
9097070|NCT02036970|10162000|FG001|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0
9097071|NCT02036970|10162001|FG002|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0
9097072|NCT02036970|10162002|FG003|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0
9097073|NCT02036970|10162003|FG004|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0
9097074|NCT02036970|10162004|FG005|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0
9097075|NCT02036970|10162005|FG006|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0
9097076|NCT02036970|10162006|FG007|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0
9097077|NCT02036970|10162007|FG008|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||12
9097078|NCT02036970|10162008|FG009|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||8
9097079|NCT02036970|10161999|FG000|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0
9097080|NCT02036970|10162000|FG001|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0
9097081|NCT02036970|10162001|FG002|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0
9097082|NCT02036970|10162002|FG003|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0
9097083|NCT02036970|10162003|FG004|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0
9097084|NCT02036970|10162004|FG005|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0
9097085|NCT02036970|10162005|FG006|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0
9097086|NCT02036970|10162006|FG007|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0
9097087|NCT02036970|10162007|FG008|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||12
9097088|NCT02036970|10162008|FG009|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||7
9097089|NCT02036970|10161999|FG000|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0
9097090|NCT02036970|10162000|FG001|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0
9097091|NCT02036970|10162001|FG002|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0
9097092|NCT02036970|10162002|FG003|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0
9097093|NCT02036970|10162003|FG004|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0
9097094|NCT02036970|10162004|FG005|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0
9097095|NCT02036970|10162005|FG006|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0
9097096|NCT02036970|10162006|FG007|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0
9097097|NCT02036970|10162007|FG008|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||16
9097098|NCT02036970|10162008|FG009|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||7
9097099|NCT02036970|10161999|FG000|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0
9097100|NCT02036970|10162000|FG001|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0
9097101|NCT02036970|10162001|FG002|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0
9097102|NCT02036970|10162002|FG003|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0
9097103|NCT02036970|10162003|FG004|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0
9097104|NCT02036970|10162004|FG005|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0
9097105|NCT02036970|10162005|FG006|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0
9097106|NCT02036970|10162006|FG007|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0
9097107|NCT02036970|10162007|FG008|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||5
9097108|NCT02036970|10162008|FG009|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||2
9097109|NCT02036970|10161999|FG000|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0
9097110|NCT02036970|10162000|FG001|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0
9097111|NCT02036970|10162001|FG002|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0
9097112|NCT02036970|10162002|FG003|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0
9097113|NCT02036970|10162003|FG004|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0
9097114|NCT02036970|10162004|FG005|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0
9097115|NCT02036970|10162005|FG006|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0
9097116|NCT02036970|10162006|FG007|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0
9097117|NCT02036970|10162007|FG008|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||3
9097118|NCT02036970|10162008|FG009|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||1
9097119|NCT02036970|10161999|FG000|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0
9097120|NCT02036970|10162000|FG001|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0
9097121|NCT02036970|10162001|FG002|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0
9097122|NCT02036970|10162002|FG003|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0
9097123|NCT02036970|10162003|FG004|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0
9097124|NCT02036970|10162004|FG005|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0
9097125|NCT02036970|10162005|FG006|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0
9097126|NCT02036970|10162006|FG007|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0
9097127|NCT02036970|10162007|FG008|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||15
9097128|NCT02036970|10162008|FG009|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||8
9097129|NCT02036970|10161999|FG000|COMPLETED|Part 2: Week 16 Onwards||5
9097130|NCT02036970|10162000|FG001|COMPLETED|Part 2: Week 16 Onwards||6
9097131|NCT02036970|10162001|FG002|COMPLETED|Part 2: Week 16 Onwards||3
9097132|NCT02036970|10162002|FG003|COMPLETED|Part 2: Week 16 Onwards||7
9097133|NCT02036970|10162003|FG004|COMPLETED|Part 2: Week 16 Onwards||0
9097134|NCT02036970|10162004|FG005|COMPLETED|Part 2: Week 16 Onwards||3
9097135|NCT02036970|10162005|FG006|COMPLETED|Part 2: Week 16 Onwards||2
9097136|NCT02036970|10162006|FG007|COMPLETED|Part 2: Week 16 Onwards||2
9097137|NCT02036970|10162007|FG008|COMPLETED|Part 2: Week 16 Onwards||54
9097138|NCT02036970|10162008|FG009|COMPLETED|Part 2: Week 16 Onwards||28
9097139|NCT02036970|10161999|FG000|NOT COMPLETED|Part 2: Week 16 Onwards||0
9097140|NCT02036970|10162000|FG001|NOT COMPLETED|Part 2: Week 16 Onwards||5
9097141|NCT02036970|10162001|FG002|NOT COMPLETED|Part 2: Week 16 Onwards||3
9097142|NCT02036970|10162002|FG003|NOT COMPLETED|Part 2: Week 16 Onwards||2
9097143|NCT02036970|10162003|FG004|NOT COMPLETED|Part 2: Week 16 Onwards||1
9097144|NCT02036970|10162004|FG005|NOT COMPLETED|Part 2: Week 16 Onwards||0
9097145|NCT02036970|10162005|FG006|NOT COMPLETED|Part 2: Week 16 Onwards||1
9097146|NCT02036970|10162006|FG007|NOT COMPLETED|Part 2: Week 16 Onwards||1
9097147|NCT02036970|10162007|FG008|NOT COMPLETED|Part 2: Week 16 Onwards||9
9097148|NCT02036970|10162008|FG009|NOT COMPLETED|Part 2: Week 16 Onwards||5
8625666|NCT00508651|9665259|FG000|STARTED|Overall Study||20
8723568|NCT01023815|9771082|FG000|STARTED|Randomized Period (Day 90 to Month 12)||0
8725167|NCT01029691|9772360|FG002|NOT COMPLETED|APAP Initiation to Week 1 or Delivery||0
8625667|NCT00508651|9665260|FG001|STARTED|Overall Study||10
8625668|NCT00508651|9665259|FG000|COMPLETED|Overall Study||16
9097149|NCT01941719|10162042|FG000|STARTED|Overall Study||48
9097150|NCT01941719|10162043|FG001|STARTED|Overall Study||51
9097151|NCT01941719|10162042|FG000|Month 1|Overall Study||43
9097152|NCT01941719|10162043|FG001|Month 1|Overall Study||48
9097153|NCT01941719|10162042|FG000|Month 3|Overall Study||38
9097154|NCT01941719|10162043|FG001|Month 3|Overall Study||44
9097155|NCT01941719|10162042|FG000|Month 6|Overall Study||34
9097156|NCT01941719|10162043|FG001|Month 6|Overall Study||42
9097157|NCT01941719|10162042|FG000|Month 9|Overall Study||29
8625669|NCT00508651|9665260|FG001|COMPLETED|Overall Study||8
8625670|NCT00508651|9665259|FG000|NOT COMPLETED|Overall Study||4
8625671|NCT00508651|9665260|FG001|NOT COMPLETED|Overall Study||2
8625672|NCT00508716|9665268|FG000|STARTED|Overall Study||61
9097158|NCT01941719|10162043|FG001|Month 9|Overall Study||37
9097159|NCT01941719|10162042|FG000|Month 12|Overall Study||28
9097160|NCT01941719|10162043|FG001|Month 12|Overall Study||32
9097161|NCT01941719|10162042|FG000|COMPLETED|Overall Study||28
9097162|NCT01941719|10162043|FG001|COMPLETED|Overall Study||32
9097163|NCT01941719|10162042|FG000|NOT COMPLETED|Overall Study||20
9097164|NCT01941719|10162043|FG001|NOT COMPLETED|Overall Study||19
9097165|NCT01828099|10162052|FG000|STARTED|Overall Study||189
9097166|NCT01828099|10162053|FG001|STARTED|Overall Study||187
9097167|NCT01828099|10162052|FG000|Untreated Patients|Overall Study||0
9097168|NCT01828099|10162053|FG001|Untreated Patients|Overall Study||12
9097169|NCT01828099|10162052|FG000|Treated|Overall Study|discontinued from treatment phase = Not completed|189
9097170|NCT01828099|10162053|FG001|Treated|Overall Study||175
9097171|NCT01828099|10162052|FG000|Discontinued From Treatment Phase|Overall Study||94
9097172|NCT01828099|10162053|FG001|Discontinued From Treatment Phase|Overall Study||157
9097173|NCT01828099|10162052|FG000|Entered Extension-treatment Phase|Overall Study||0
9097174|NCT01828099|10162053|FG001|Entered Extension-treatment Phase|Overall Study||81
9097175|NCT01828099|10162052|FG000|Entered Post-treatment Follow-up Phase|Overall Study||10
9097176|NCT01828099|10162053|FG001|Entered Post-treatment Follow-up Phase|Overall Study||16
9097177|NCT01828099|10162052|FG000|Entered Survival Follow-up Phase|Overall Study||64
9097178|NCT01828099|10162053|FG001|Entered Survival Follow-up Phase|Overall Study||31
9097179|NCT01828099|10162052|FG000|Discontinued From Study|Overall Study||20
9097180|NCT01828099|10162053|FG001|Discontinued From Study|Overall Study||29
9097181|NCT01828099|10162052|FG000|COMPLETED|Overall Study|Completed = Patients ongoing at the time of data cut-off of 24-Jun-2016|95
9097182|NCT01828099|10162053|FG001|COMPLETED|Overall Study|Completed = Patients ongoing at the time of data cut-off of 24-Jun-2016|30
9097183|NCT01828099|10162052|FG000|NOT COMPLETED|Overall Study||94
9097184|NCT01828099|10162053|FG001|NOT COMPLETED|Overall Study||157
9097185|NCT01578967|10162059|FG000|STARTED|Overall Study||41
9097186|NCT01578967|10162059|FG000|COMPLETED|Overall Study||41
9097187|NCT01578967|10162059|FG000|NOT COMPLETED|Overall Study||0
9097188|NCT01186003|10162068|FG000|STARTED|Overall Study||14
9097189|NCT01186003|10162069|FG001|STARTED|Overall Study||16
9097190|NCT01186003|10162068|FG000|COMPLETED|Overall Study||14
9097191|NCT01186003|10162069|FG001|COMPLETED|Overall Study||16
9097192|NCT01186003|10162068|FG000|NOT COMPLETED|Overall Study||0
9097193|NCT01186003|10162069|FG001|NOT COMPLETED|Overall Study||0
9097194|NCT00943618|10162078|FG000|STARTED|Overall Study||163
9097195|NCT00943618|10162079|FG001|STARTED|Overall Study||166
9097196|NCT00943618|10162080|FG002|STARTED|Overall Study||56
9097197|NCT00943618|10162078|FG000|COMPLETED|Overall Study||108
9097198|NCT00943618|10162079|FG001|COMPLETED|Overall Study||89
9097199|NCT00943618|10162080|FG002|COMPLETED|Overall Study||25
9097200|NCT00943618|10162078|FG000|NOT COMPLETED|Overall Study||55
9097201|NCT00943618|10162079|FG001|NOT COMPLETED|Overall Study||77
9097202|NCT00943618|10162080|FG002|NOT COMPLETED|Overall Study||31
8625673|NCT00508716|9665269|FG001|STARTED|Overall Study||63
9097203|NCT03938272|10162090|FG000|STARTED|Overall Study||11
9097204|NCT03938272|10162091|FG001|STARTED|Overall Study||11
9097205|NCT03938272|10162090|FG000|COMPLETED|Overall Study||0
9097206|NCT03938272|10162091|FG001|COMPLETED|Overall Study||1
9097207|NCT03938272|10162090|FG000|NOT COMPLETED|Overall Study||11
9097208|NCT03938272|10162091|FG001|NOT COMPLETED|Overall Study||10
9097209|NCT03641339|10162103|FG000|STARTED|Overall Study||16
9097210|NCT03641339|10162104|FG001|STARTED|Overall Study||17
9097211|NCT03641339|10162105|FG002|STARTED|Overall Study||15
9097212|NCT03641339|10162106|FG003|STARTED|Overall Study||16
9097213|NCT03641339|10162107|FG004|STARTED|Overall Study||15
9097214|NCT03641339|10162108|FG005|STARTED|Overall Study||16
9097215|NCT03641339|10162103|FG000|COMPLETED|Overall Study||15
9097216|NCT03641339|10162104|FG001|COMPLETED|Overall Study||15
9097217|NCT03641339|10162105|FG002|COMPLETED|Overall Study||15
9097218|NCT03641339|10162106|FG003|COMPLETED|Overall Study||14
9097219|NCT03641339|10162107|FG004|COMPLETED|Overall Study||15
9097220|NCT03641339|10162108|FG005|COMPLETED|Overall Study||15
9097221|NCT03641339|10162103|FG000|NOT COMPLETED|Overall Study||1
9097222|NCT03641339|10162104|FG001|NOT COMPLETED|Overall Study||2
9097223|NCT03641339|10162105|FG002|NOT COMPLETED|Overall Study||0
9097224|NCT03641339|10162106|FG003|NOT COMPLETED|Overall Study||2
9097225|NCT03641339|10162107|FG004|NOT COMPLETED|Overall Study||0
9097226|NCT03641339|10162108|FG005|NOT COMPLETED|Overall Study||1
9097227|NCT03625466|10162124|FG000|STARTED|Overall Study||16
9097228|NCT03625466|10162125|FG001|STARTED|Overall Study||35
9097229|NCT03625466|10162124|FG000|COMPLETED|Overall Study||16
9097230|NCT03625466|10162125|FG001|COMPLETED|Overall Study||33
9097231|NCT03625466|10162124|FG000|NOT COMPLETED|Overall Study||0
9097232|NCT03625466|10162125|FG001|NOT COMPLETED|Overall Study||2
9097233|NCT03317795|10162133|FG000|STARTED|Overall Study||9
9097234|NCT03317795|10162134|FG001|STARTED|Overall Study||9
8625674|NCT00508716|9665268|FG000|COMPLETED|Overall Study||61
8625675|NCT00508716|9665269|FG001|COMPLETED|Overall Study||63
8625676|NCT00508716|9665268|FG000|NOT COMPLETED|Overall Study||0
9097235|NCT03317795|10162133|FG000|COMPLETED|Overall Study||7
9097236|NCT03317795|10162134|FG001|COMPLETED|Overall Study||2
9097237|NCT03317795|10162133|FG000|NOT COMPLETED|Overall Study||2
9097238|NCT03317795|10162134|FG001|NOT COMPLETED|Overall Study||7
9097329|NCT02587598|10162266|FG000|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
9097330|NCT02587598|10162267|FG001|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
8625677|NCT00508716|9665269|FG001|NOT COMPLETED|Overall Study||0
8625678|NCT00508742|9665277|FG000|STARTED|Period 1: Infant Series||932
8625679|NCT00508742|9665278|FG001|STARTED|Period 1: Infant Series||934
9097331|NCT02587598|10162268|FG002|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
9097332|NCT02587598|10162269|FG003|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
9097333|NCT02587598|10162270|FG004|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
9097334|NCT02587598|10162271|FG005|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
9097335|NCT02587598|10162272|FG006|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
9097336|NCT02587598|10162273|FG007|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
9097337|NCT02587598|10162274|FG008|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
9097338|NCT02587598|10162275|FG009|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
9097339|NCT02587598|10162276|FG010|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
9097340|NCT02587598|10162266|FG000|NOT COMPLETED|Overall Study||4
9097341|NCT02587598|10162267|FG001|NOT COMPLETED|Overall Study||11
9097342|NCT02587598|10162268|FG002|NOT COMPLETED|Overall Study||4
9097343|NCT02587598|10162269|FG003|NOT COMPLETED|Overall Study||21
9097344|NCT02587598|10162270|FG004|NOT COMPLETED|Overall Study||12
8625680|NCT00508742|9665277|FG000|Vaccinated Dose 1 (at 2 Months of Age)|Period 1: Infant Series||930
8625681|NCT00508742|9665278|FG001|Vaccinated Dose 1 (at 2 Months of Age)|Period 1: Infant Series||933
8625682|NCT00508742|9665277|FG000|Vaccinated Dose 2 (at 4 Months of Age)|Period 1: Infant Series||904
8625683|NCT00508742|9665278|FG001|Vaccinated Dose 2 (at 4 Months of Age)|Period 1: Infant Series||902
9097345|NCT02587598|10162271|FG005|NOT COMPLETED|Overall Study||6
9097346|NCT02587598|10162272|FG006|NOT COMPLETED|Overall Study||6
9097347|NCT02587598|10162273|FG007|NOT COMPLETED|Overall Study||7
9097348|NCT02587598|10162274|FG008|NOT COMPLETED|Overall Study||9
9097349|NCT02587598|10162275|FG009|NOT COMPLETED|Overall Study||3
9097350|NCT02587598|10162276|FG010|NOT COMPLETED|Overall Study||14
9097351|NCT02485574|10162312|FG000|STARTED|Overall Study||69
9097352|NCT02485574|10162312|FG000|COMPLETED|Overall Study||65
9097353|NCT02485574|10162312|FG000|NOT COMPLETED|Overall Study||4
9097354|NCT02214160|10162324|FG000|STARTED|Overall Study||24
9097355|NCT02214160|10162325|FG001|STARTED|Overall Study||37
9097356|NCT02214160|10162326|FG002|STARTED|Overall Study||33
9097357|NCT02214160|10162324|FG000|COMPLETED|Overall Study||20
9097358|NCT02214160|10162325|FG001|COMPLETED|Overall Study||29
9097359|NCT02214160|10162326|FG002|COMPLETED|Overall Study||23
8625684|NCT00508742|9665277|FG000|Vaccinated Dose 3 (at 6 Months of Age)|Period 1: Infant Series||898
9097360|NCT02214160|10162324|FG000|NOT COMPLETED|Overall Study||4
9097361|NCT02214160|10162325|FG001|NOT COMPLETED|Overall Study||8
9097239|NCT03287245|10162144|FG000|STARTED|Overall Study||15
9097240|NCT03287245|10162145|FG001|STARTED|Overall Study||5
9097241|NCT03287245|10162146|FG002|STARTED|Overall Study||6
9097242|NCT03287245|10162147|FG003|STARTED|Overall Study||1
9097243|NCT03287245|10162144|FG000|COMPLETED|Overall Study||0
9097244|NCT03287245|10162145|FG001|COMPLETED|Overall Study||0
9097245|NCT03287245|10162146|FG002|COMPLETED|Overall Study||0
9097246|NCT03287245|10162147|FG003|COMPLETED|Overall Study||0
9097247|NCT03287245|10162144|FG000|NOT COMPLETED|Overall Study||15
9097248|NCT03287245|10162145|FG001|NOT COMPLETED|Overall Study||5
9097249|NCT03287245|10162146|FG002|NOT COMPLETED|Overall Study||6
9097250|NCT03287245|10162147|FG003|NOT COMPLETED|Overall Study||1
9097251|NCT03165916|10162179|FG000|STARTED|Overall Study||58
9097252|NCT03165916|10162180|FG001|STARTED|Overall Study||57
9097253|NCT03165916|10162179|FG000|Reconstruction Interventions|Overall Study||59
9097254|NCT03165916|10162180|FG001|Reconstruction Interventions|Overall Study||57
9097255|NCT03165916|10162179|FG000|COMPLETED|Overall Study||58
9097256|NCT03165916|10162180|FG001|COMPLETED|Overall Study||57
9097257|NCT03165916|10162179|FG000|NOT COMPLETED|Overall Study||0
9097258|NCT03165916|10162180|FG001|NOT COMPLETED|Overall Study||0
9097259|NCT03092219|10162188|FG000|STARTED|Overall Study||150
9097260|NCT03092219|10162189|FG001|STARTED|Overall Study||52
9097261|NCT03092219|10162188|FG000|Baseline / ITT Population|Overall Study||150
9097262|NCT03092219|10162189|FG001|Baseline / ITT Population|Overall Study|Subject randomized to No Treatment group but received treatment at Visit 1.|51
9097263|NCT03092219|10162188|FG000|Primary Analysis Endpoint|Overall Study||150
9097264|NCT03092219|10162189|FG001|Primary Analysis Endpoint|Overall Study||51
9097265|NCT03092219|10162188|FG000|Pooled SAFT Population|Overall Study||150
9097266|NCT03092219|10162189|FG001|Pooled SAFT Population|Overall Study|2 subjects did not receive treatment at Visit 1b.|50
9097267|NCT03092219|10162188|FG000|COMPLETED|Overall Study||143
9097268|NCT03092219|10162189|FG001|COMPLETED|Overall Study||48
9097269|NCT03092219|10162188|FG000|NOT COMPLETED|Overall Study||7
9097270|NCT03092219|10162189|FG001|NOT COMPLETED|Overall Study||4
9097271|NCT03033069|10162202|FG000|STARTED|Overall Study||82
9097272|NCT03033069|10162203|FG001|STARTED|Overall Study||75
9097273|NCT03033069|10162204|FG002|STARTED|Overall Study||81
9097274|NCT03033069|10162205|FG003|STARTED|Overall Study||83
9097275|NCT03033069|10162202|FG000|Safety Sample|Overall Study||80
9097276|NCT03033069|10162203|FG001|Safety Sample|Overall Study||75
9097277|NCT03033069|10162204|FG002|Safety Sample|Overall Study||79
9097278|NCT03033069|10162205|FG003|Safety Sample|Overall Study||82
9097279|NCT03033069|10162202|FG000|Intent to Treat (ITT) Sample|Overall Study||79
9097280|NCT03033069|10162203|FG001|Intent to Treat (ITT) Sample|Overall Study||72
9097281|NCT03033069|10162204|FG002|Intent to Treat (ITT) Sample|Overall Study||77
9097282|NCT03033069|10162205|FG003|Intent to Treat (ITT) Sample|Overall Study||80
9097283|NCT03033069|10162202|FG000|COMPLETED|Overall Study||58
9097284|NCT03033069|10162203|FG001|COMPLETED|Overall Study||50
9097285|NCT03033069|10162204|FG002|COMPLETED|Overall Study||59
9097286|NCT03033069|10162205|FG003|COMPLETED|Overall Study||64
9097287|NCT03033069|10162202|FG000|NOT COMPLETED|Overall Study||24
9097288|NCT03033069|10162203|FG001|NOT COMPLETED|Overall Study||25
9097289|NCT03033069|10162204|FG002|NOT COMPLETED|Overall Study||22
9097290|NCT03033069|10162205|FG003|NOT COMPLETED|Overall Study||19
9097291|NCT02956434|10162219|FG000|STARTED|Overall Study||10
9097292|NCT02956434|10162220|FG001|STARTED|Overall Study||10
9097293|NCT02956434|10162221|FG002|STARTED|Overall Study||10
9097294|NCT02956434|10162222|FG003|STARTED|Overall Study||10
9097295|NCT02956434|10162219|FG000|COMPLETED|Overall Study||10
9097296|NCT02956434|10162220|FG001|COMPLETED|Overall Study||10
9097297|NCT02956434|10162221|FG002|COMPLETED|Overall Study||10
9097298|NCT02956434|10162222|FG003|COMPLETED|Overall Study||10
9097299|NCT02956434|10162219|FG000|NOT COMPLETED|Overall Study||0
9097300|NCT02956434|10162220|FG001|NOT COMPLETED|Overall Study||0
9097301|NCT02956434|10162221|FG002|NOT COMPLETED|Overall Study||0
9097302|NCT02956434|10162222|FG003|NOT COMPLETED|Overall Study||0
9097303|NCT02663622|10162234|FG000|STARTED|Overall Study||6
9097304|NCT02663622|10162235|FG001|STARTED|Overall Study||6
9097305|NCT02663622|10162236|FG002|STARTED|Overall Study||6
9097306|NCT02663622|10162237|FG003|STARTED|Overall Study||26
9097307|NCT02663622|10162234|FG000|COMPLETED|Overall Study||3
9097308|NCT02663622|10162235|FG001|COMPLETED|Overall Study||5
9097309|NCT02663622|10162236|FG002|COMPLETED|Overall Study||5
9097310|NCT02663622|10162237|FG003|COMPLETED|Overall Study||11
9097311|NCT02663622|10162234|FG000|NOT COMPLETED|Overall Study||3
9097312|NCT02663622|10162235|FG001|NOT COMPLETED|Overall Study||1
9097313|NCT02663622|10162236|FG002|NOT COMPLETED|Overall Study||1
9097314|NCT02663622|10162237|FG003|NOT COMPLETED|Overall Study||15
9097315|NCT02609503|10162248|FG000|STARTED|Overall Study||29
9097316|NCT02609503|10162248|FG000|COMPLETED|Overall Study||25
9097317|NCT02609503|10162248|FG000|NOT COMPLETED|Overall Study||4
9097318|NCT02587598|10162266|FG000|STARTED|Overall Study||4
9097319|NCT02587598|10162267|FG001|STARTED|Overall Study||11
9097320|NCT02587598|10162268|FG002|STARTED|Overall Study||4
9097321|NCT02587598|10162269|FG003|STARTED|Overall Study||21
9097322|NCT02587598|10162270|FG004|STARTED|Overall Study||12
9097323|NCT02587598|10162271|FG005|STARTED|Overall Study||6
9097324|NCT02587598|10162272|FG006|STARTED|Overall Study||6
9097325|NCT02587598|10162273|FG007|STARTED|Overall Study||7
9097326|NCT02587598|10162274|FG008|STARTED|Overall Study||9
9097327|NCT02587598|10162275|FG009|STARTED|Overall Study||3
9097328|NCT02587598|10162276|FG010|STARTED|Overall Study||14
9097362|NCT02214160|10162326|FG002|NOT COMPLETED|Overall Study||10
9097363|NCT01899261|10162338|FG000|STARTED|Overall Study||20
9097364|NCT01899261|10162338|FG000|COMPLETED|Overall Study||20
9097365|NCT01899261|10162338|FG000|NOT COMPLETED|Overall Study||0
9097366|NCT01595503|10162342|FG000|STARTED|Overall Study||5
9097367|NCT01595503|10162342|FG000|COMPLETED|Overall Study||5
9097368|NCT01595503|10162342|FG000|NOT COMPLETED|Overall Study||0
9097369|NCT01460160|10162346|FG000|STARTED|Treatment Phase||106
9097370|NCT01460160|10162346|FG000|COMPLETED|Treatment Phase||78
9097371|NCT01460160|10162346|FG000|NOT COMPLETED|Treatment Phase||28
9097372|NCT01460160|10162346|FG000|STARTED|Follow-up Phase|Some of the participants who did not completed the Treatment Phase were still moved to the Follow-up Phase|100
9097373|NCT01460160|10162346|FG000|COMPLETED|Follow-up Phase||0
9097374|NCT01460160|10162346|FG000|NOT COMPLETED|Follow-up Phase||100
9097375|NCT01413399|10162352|FG000|STARTED|Overall Study||208
9097376|NCT01413399|10162353|FG001|STARTED|Overall Study||334
9097377|NCT01413399|10162352|FG000|COMPLETED|Overall Study||208
9097378|NCT01413399|10162353|FG001|COMPLETED|Overall Study||334
9097379|NCT01413399|10162352|FG000|NOT COMPLETED|Overall Study||0
9097380|NCT01413399|10162353|FG001|NOT COMPLETED|Overall Study||0
9097381|NCT01170702|10162363|FG000|STARTED|Overall Study||34
9097382|NCT01170702|10162364|FG001|STARTED|Overall Study||32
9097383|NCT01170702|10162365|FG002|STARTED|Overall Study||25
9097384|NCT01170702|10162366|FG003|STARTED|Overall Study||29
9097385|NCT01170702|10162363|FG000|COMPLETED|Overall Study||33
9097386|NCT01170702|10162364|FG001|COMPLETED|Overall Study||30
9097387|NCT01170702|10162365|FG002|COMPLETED|Overall Study||25
9097388|NCT01170702|10162366|FG003|COMPLETED|Overall Study||27
9097389|NCT01170702|10162363|FG000|NOT COMPLETED|Overall Study||1
9097390|NCT01170702|10162364|FG001|NOT COMPLETED|Overall Study||2
9097391|NCT01170702|10162365|FG002|NOT COMPLETED|Overall Study||0
9097392|NCT01170702|10162366|FG003|NOT COMPLETED|Overall Study||2
9097393|NCT01018563|10162376|FG000|STARTED|Overall Study||2
9097394|NCT01018563|10162377|FG001|STARTED|Overall Study||1
9097395|NCT01018563|10162376|FG000|COMPLETED|Overall Study||0
9097396|NCT01018563|10162377|FG001|COMPLETED|Overall Study||0
9097397|NCT01018563|10162376|FG000|NOT COMPLETED|Overall Study||2
9097398|NCT01018563|10162377|FG001|NOT COMPLETED|Overall Study||1
9097399|NCT00805961|10162387|FG000|STARTED|Modality Therapy||68
9097400|NCT00805961|10162387|FG000|COMPLETED|Modality Therapy||64
9097401|NCT00805961|10162387|FG000|NOT COMPLETED|Modality Therapy||4
9097402|NCT00805961|10162387|FG000|STARTED|Treatment-Free Interval||64
9097403|NCT00805961|10162387|FG000|COMPLETED|Treatment-Free Interval||57
9097404|NCT00805961|10162387|FG000|NOT COMPLETED|Treatment-Free Interval||7
9097405|NCT00805961|10162387|FG000|STARTED|Maintenance Treatment||57
9097406|NCT00805961|10162387|FG000|COMPLETED|Maintenance Treatment||23
9097407|NCT00805961|10162387|FG000|NOT COMPLETED|Maintenance Treatment||34
9097408|NCT04056182|10162391|FG000|STARTED|Overall Study||20
9097409|NCT04056182|10162391|FG000|COMPLETED|Overall Study||3
9097410|NCT04056182|10162391|FG000|NOT COMPLETED|Overall Study||17
8625685|NCT00508742|9665278|FG001|Vaccinated Dose 3 (at 6 Months of Age)|Period 1: Infant Series||892
8625686|NCT00508742|9665277|FG000|COMPLETED|Period 1: Infant Series||890
8625687|NCT00508742|9665278|FG001|COMPLETED|Period 1: Infant Series||889
8625688|NCT00508742|9665277|FG000|NOT COMPLETED|Period 1: Infant Series||42
8625689|NCT00508742|9665278|FG001|NOT COMPLETED|Period 1: Infant Series||45
9097411|NCT03954106|10162397|FG000|STARTED|Part 1: Safety Lead In Phase||4
9097412|NCT03954106|10162398|FG001|STARTED|Part 1: Safety Lead In Phase||0
9097413|NCT03954106|10162397|FG000|COMPLETED|Part 1: Safety Lead In Phase||4
9097414|NCT03954106|10162398|FG001|COMPLETED|Part 1: Safety Lead In Phase||0
9097415|NCT03954106|10162397|FG000|NOT COMPLETED|Part 1: Safety Lead In Phase||0
9097416|NCT03954106|10162398|FG001|NOT COMPLETED|Part 1: Safety Lead In Phase||0
9097417|NCT03954106|10162397|FG000|STARTED|Phase 2: Treatment at RP2D||0
9097418|NCT03954106|10162398|FG001|STARTED|Phase 2: Treatment at RP2D||21
9097419|NCT03954106|10162397|FG000|COMPLETED|Phase 2: Treatment at RP2D||0
9097420|NCT03954106|10162398|FG001|COMPLETED|Phase 2: Treatment at RP2D||21
9097421|NCT03954106|10162397|FG000|NOT COMPLETED|Phase 2: Treatment at RP2D||0
9097422|NCT03954106|10162398|FG001|NOT COMPLETED|Phase 2: Treatment at RP2D||0
9097423|NCT03921424|10162408|FG000|STARTED|Overall Study||203
9097424|NCT03921424|10162409|FG001|STARTED|Overall Study||204
9097425|NCT03921424|10162408|FG000|Vaccination 1 - (Day 1)|Overall Study||203
9097426|NCT03921424|10162409|FG001|Vaccination 1 - (Day 1)|Overall Study||204
9097427|NCT03921424|10162408|FG000|Vaccination 2 - (Week 8)|Overall Study||203
9097428|NCT03921424|10162409|FG001|Vaccination 2 - (Week 8)|Overall Study|Two participants did not receive Vaccination 2.|202
9097429|NCT03921424|10162408|FG000|COMPLETED|Overall Study||203
9097430|NCT03921424|10162409|FG001|COMPLETED|Overall Study||201
9097431|NCT03921424|10162408|FG000|NOT COMPLETED|Overall Study||0
9097432|NCT03921424|10162409|FG001|NOT COMPLETED|Overall Study||3
9097433|NCT03598777|10162422|FG000|STARTED|Overall Study||13
9097434|NCT03598777|10162423|FG001|STARTED|Overall Study||8
9097435|NCT03598777|10162424|FG002|STARTED|Overall Study||8
9097436|NCT03598777|10162425|FG003|STARTED|Overall Study||14
9097437|NCT03598777|10162426|FG004|STARTED|Overall Study||17
9097438|NCT03598777|10162422|FG000|Received Treatment in Cycle 1 DB Treatment Period|Overall Study||13
9097439|NCT03598777|10162423|FG001|Received Treatment in Cycle 1 DB Treatment Period|Overall Study||8
9097440|NCT03598777|10162424|FG002|Received Treatment in Cycle 1 DB Treatment Period|Overall Study||8
9097441|NCT03598777|10162425|FG003|Received Treatment in Cycle 1 DB Treatment Period|Overall Study||14
9097442|NCT03598777|10162426|FG004|Received Treatment in Cycle 1 DB Treatment Period|Overall Study||17
9097443|NCT03598777|10162422|FG000|Retreated in Cycle 2 OL Treatment Period|Overall Study||13
9097444|NCT03598777|10162423|FG001|Retreated in Cycle 2 OL Treatment Period|Overall Study||7
9097445|NCT03598777|10162424|FG002|Retreated in Cycle 2 OL Treatment Period|Overall Study||8
9097446|NCT03598777|10162425|FG003|Retreated in Cycle 2 OL Treatment Period|Overall Study||13
9097447|NCT03598777|10162426|FG004|Retreated in Cycle 2 OL Treatment Period|Overall Study||11
9097448|NCT03598777|10162422|FG000|Retreated in Cycle 3 OL Treatment Period|Overall Study||8
9097449|NCT03598777|10162423|FG001|Retreated in Cycle 3 OL Treatment Period|Overall Study||6
9097450|NCT03598777|10162424|FG002|Retreated in Cycle 3 OL Treatment Period|Overall Study||6
9097451|NCT03598777|10162425|FG003|Retreated in Cycle 3 OL Treatment Period|Overall Study||12
9097452|NCT03598777|10162426|FG004|Retreated in Cycle 3 OL Treatment Period|Overall Study||2
9097453|NCT03598777|10162422|FG000|Retreated in Cycle 4 OL Treatment Period|Overall Study||1
9097454|NCT03598777|10162423|FG001|Retreated in Cycle 4 OL Treatment Period|Overall Study||0
9097455|NCT03598777|10162424|FG002|Retreated in Cycle 4 OL Treatment Period|Overall Study||1
9097456|NCT03598777|10162425|FG003|Retreated in Cycle 4 OL Treatment Period|Overall Study||3
9097457|NCT03598777|10162426|FG004|Retreated in Cycle 4 OL Treatment Period|Overall Study||0
9097458|NCT03598777|10162422|FG000|COMPLETED|Overall Study||7
9097459|NCT03598777|10162423|FG001|COMPLETED|Overall Study||7
9097460|NCT03598777|10162424|FG002|COMPLETED|Overall Study||8
9097461|NCT03598777|10162425|FG003|COMPLETED|Overall Study||14
9097462|NCT03598777|10162426|FG004|COMPLETED|Overall Study||2
9097463|NCT03598777|10162422|FG000|NOT COMPLETED|Overall Study||6
9097464|NCT03598777|10162423|FG001|NOT COMPLETED|Overall Study||1
9097465|NCT03598777|10162424|FG002|NOT COMPLETED|Overall Study||0
9097466|NCT03598777|10162425|FG003|NOT COMPLETED|Overall Study||0
9097467|NCT03598777|10162426|FG004|NOT COMPLETED|Overall Study||15
9097468|NCT03406078|10162443|FG000|STARTED|Overall Study||74
9097469|NCT03406078|10162444|FG001|STARTED|Overall Study||76
9097470|NCT03406078|10162443|FG000|COMPLETED|Overall Study||68
9097471|NCT03406078|10162444|FG001|COMPLETED|Overall Study||73
9097472|NCT03406078|10162443|FG000|NOT COMPLETED|Overall Study||6
9097473|NCT03406078|10162444|FG001|NOT COMPLETED|Overall Study||3
9097474|NCT03397589|10162452|FG000|STARTED|Overall Study||211
9097475|NCT03397589|10162453|FG001|STARTED|Overall Study||209
9097476|NCT03397589|10162452|FG000|COMPLETED|Overall Study||175
9097477|NCT03397589|10162453|FG001|COMPLETED|Overall Study||187
9097478|NCT03397589|10162452|FG000|NOT COMPLETED|Overall Study||36
9097479|NCT03397589|10162453|FG001|NOT COMPLETED|Overall Study||22
9097480|NCT03368066|10162459|FG000|STARTED|Overall Study||58
9097481|NCT03368066|10162460|FG001|STARTED|Overall Study||37
9097482|NCT03368066|10162459|FG000|COMPLETED|Overall Study||58
9097483|NCT03368066|10162460|FG001|COMPLETED|Overall Study||37
9097484|NCT03368066|10162459|FG000|NOT COMPLETED|Overall Study||0
9097485|NCT03368066|10162460|FG001|NOT COMPLETED|Overall Study||0
9097486|NCT03345342|10162466|FG000|STARTED|Open-Label Phase||838
9097487|NCT03345342|10162467|FG001|STARTED|Open-Label Phase||0
9097488|NCT03345342|10162468|FG002|STARTED|Open-Label Phase||0
9097489|NCT03345342|10162469|FG003|STARTED|Open-Label Phase||0
9097490|NCT03345342|10162470|FG004|STARTED|Open-Label Phase||0
9097491|NCT03345342|10162466|FG000|COMPLETED|Open-Label Phase||702
9097492|NCT03345342|10162467|FG001|COMPLETED|Open-Label Phase||0
9097493|NCT03345342|10162468|FG002|COMPLETED|Open-Label Phase||0
9097494|NCT03345342|10162469|FG003|COMPLETED|Open-Label Phase||0
9097495|NCT03345342|10162470|FG004|COMPLETED|Open-Label Phase||0
9097496|NCT03345342|10162466|FG000|NOT COMPLETED|Open-Label Phase||136
9097497|NCT03345342|10162467|FG001|NOT COMPLETED|Open-Label Phase||0
9097498|NCT03345342|10162468|FG002|NOT COMPLETED|Open-Label Phase||0
9097499|NCT03345342|10162469|FG003|NOT COMPLETED|Open-Label Phase||0
9097500|NCT03345342|10162470|FG004|NOT COMPLETED|Open-Label Phase||0
9097501|NCT03345342|10162466|FG000|STARTED|Double-Blind Phase||0
9097502|NCT03345342|10162467|FG001|STARTED|Double-Blind Phase|Participants from the OL phase have continued in the DB phase.|224
9097503|NCT03345342|10162468|FG002|STARTED|Double-Blind Phase|Participants from the OL phase have continued in the DB phase.|478
9097504|NCT03345342|10162469|FG003|STARTED|Double-Blind Phase||0
9097505|NCT03345342|10162470|FG004|STARTED|Double-Blind Phase||0
9097506|NCT03345342|10162466|FG000|COMPLETED|Double-Blind Phase||0
9097507|NCT03345342|10162467|FG001|COMPLETED|Double-Blind Phase||202
9097508|NCT03345342|10162468|FG002|COMPLETED|Double-Blind Phase||416
9097509|NCT03345342|10162469|FG003|COMPLETED|Double-Blind Phase||0
9097510|NCT03345342|10162470|FG004|COMPLETED|Double-Blind Phase||0
9097511|NCT03345342|10162466|FG000|NOT COMPLETED|Double-Blind Phase||0
9097512|NCT03345342|10162467|FG001|NOT COMPLETED|Double-Blind Phase||22
9097513|NCT03345342|10162468|FG002|NOT COMPLETED|Double-Blind Phase||62
9097514|NCT03345342|10162469|FG003|NOT COMPLETED|Double-Blind Phase||0
9097515|NCT03345342|10162470|FG004|NOT COMPLETED|Double-Blind Phase||0
9097516|NCT03345342|10162466|FG000|STARTED|Follow-Up Phase||0
9097517|NCT03345342|10162467|FG001|STARTED|Follow-Up Phase||0
9097518|NCT03345342|10162468|FG002|STARTED|Follow-Up Phase||0
9097519|NCT03345342|10162469|FG003|STARTED|Follow-Up Phase|Participants from the DB phase have continued in the FU phase.|42
9097520|NCT03345342|10162470|FG004|STARTED|Follow-Up Phase|Participants from the DB phase have continued in the FU phase.|109
9097521|NCT03345342|10162466|FG000|COMPLETED|Follow-Up Phase||0
9097522|NCT03345342|10162467|FG001|COMPLETED|Follow-Up Phase||0
9097523|NCT03345342|10162468|FG002|COMPLETED|Follow-Up Phase||0
9097524|NCT03345342|10162469|FG003|COMPLETED|Follow-Up Phase||34
9097525|NCT03345342|10162470|FG004|COMPLETED|Follow-Up Phase||78
9097526|NCT03345342|10162466|FG000|NOT COMPLETED|Follow-Up Phase||0
9097527|NCT03345342|10162467|FG001|NOT COMPLETED|Follow-Up Phase||0
9097528|NCT03345342|10162468|FG002|NOT COMPLETED|Follow-Up Phase||0
9097529|NCT03345342|10162469|FG003|NOT COMPLETED|Follow-Up Phase||8
9097530|NCT03345342|10162470|FG004|NOT COMPLETED|Follow-Up Phase||31
9097531|NCT03265145|10162484|FG000|STARTED|Overall Study||356
9097532|NCT03265145|10162485|FG001|STARTED|Overall Study||358
9097533|NCT03265145|10162484|FG000|COMPLETED|Overall Study||285
9097534|NCT03265145|10162485|FG001|COMPLETED|Overall Study||302
9097535|NCT03265145|10162484|FG000|NOT COMPLETED|Overall Study||71
9097536|NCT03265145|10162485|FG001|NOT COMPLETED|Overall Study||56
9097537|NCT03218995|10162492|FG000|STARTED|Overall Study||15
9097538|NCT03218995|10162492|FG000|Received at Least 1 Dose of Study Drug|Overall Study||15
9097539|NCT03218995|10162492|FG000|COMPLETED|Overall Study||15
9097540|NCT03218995|10162492|FG000|NOT COMPLETED|Overall Study||0
9097541|NCT03030222|10162500|FG000|STARTED|Overall Study||33
9097542|NCT03030222|10162501|FG001|STARTED|Overall Study||32
9097543|NCT03030222|10162500|FG000|COMPLETED|Overall Study||33
9097544|NCT03030222|10162501|FG001|COMPLETED|Overall Study||32
9097545|NCT03030222|10162500|FG000|NOT COMPLETED|Overall Study||0
9097546|NCT03030222|10162501|FG001|NOT COMPLETED|Overall Study||0
9097547|NCT02880241|10162513|FG000|STARTED|Overall Study|Study terminated|8
9097548|NCT02880241|10162514|FG001|STARTED|Overall Study|Study terminated|0
9097549|NCT02880241|10162515|FG002|STARTED|Overall Study|Study terminated|0
9097550|NCT02880241|10162516|FG003|STARTED|Overall Study|Study terminated|0
9097551|NCT02880241|10162517|FG004|STARTED|Overall Study|Study terminated|0
9097552|NCT02880241|10162518|FG005|STARTED|Overall Study|Study terminated|0
9097553|NCT02880241|10162513|FG000|COMPLETED|Overall Study|Study terminated|7
9097554|NCT02880241|10162514|FG001|COMPLETED|Overall Study|Study terminated|0
9097555|NCT02880241|10162515|FG002|COMPLETED|Overall Study|Study terminated|0
9097556|NCT02880241|10162516|FG003|COMPLETED|Overall Study|Study terminated|0
9097557|NCT02880241|10162517|FG004|COMPLETED|Overall Study|Study terminated|0
9097558|NCT02880241|10162518|FG005|COMPLETED|Overall Study|Study terminated|0
9097559|NCT02880241|10162513|FG000|NOT COMPLETED|Overall Study||1
9097560|NCT02880241|10162514|FG001|NOT COMPLETED|Overall Study||0
9097561|NCT02880241|10162515|FG002|NOT COMPLETED|Overall Study||0
9097562|NCT02880241|10162516|FG003|NOT COMPLETED|Overall Study||0
9097563|NCT02880241|10162517|FG004|NOT COMPLETED|Overall Study||0
9097564|NCT02880241|10162518|FG005|NOT COMPLETED|Overall Study||0
9097565|NCT02832687|10162536|FG000|STARTED|Overall Study||41
8625690|NCT00508742|9665277|FG000|STARTED|Period 2: After Infant Series||890
8625691|NCT00508742|9665278|FG001|STARTED|Period 2: After Infant Series||889
8625692|NCT00508742|9665277|FG000|COMPLETED|Period 2: After Infant Series||883
8625693|NCT00508742|9665278|FG001|COMPLETED|Period 2: After Infant Series||878
9097566|NCT02832687|10162537|FG001|STARTED|Overall Study||47
9097567|NCT02832687|10162536|FG000|Participants Who Were Included in the Analysis|Overall Study||31
9097568|NCT02832687|10162537|FG001|Participants Who Were Included in the Analysis|Overall Study||34
9097569|NCT02832687|10162536|FG000|COMPLETED|Overall Study||41
9097570|NCT02832687|10162537|FG001|COMPLETED|Overall Study||45
9097571|NCT02832687|10162536|FG000|NOT COMPLETED|Overall Study||0
9097572|NCT02832687|10162537|FG001|NOT COMPLETED|Overall Study||2
9097573|NCT02568449|10162543|FG000|STARTED|Overall Study||20
9097574|NCT02568449|10162543|FG000|COMPLETED|Overall Study||20
8625694|NCT00508742|9665277|FG000|NOT COMPLETED|Period 2: After Infant Series||7
8625695|NCT00508742|9665278|FG001|NOT COMPLETED|Period 2: After Infant Series||11
8625696|NCT00508742|9665277|FG000|STARTED|Period 3: Toddler Dose||883
9097575|NCT02568449|10162543|FG000|NOT COMPLETED|Overall Study||0
9097576|NCT02499900|10162549|FG000|STARTED|Core Study Period||430
9097577|NCT02499900|10162550|FG001|STARTED|Core Study Period||431
9097578|NCT02499900|10162549|FG000|Safety Analysis Set|Core Study Period||427
9097579|NCT02499900|10162550|FG001|Safety Analysis Set|Core Study Period||430
9097580|NCT02499900|10162549|FG000|COMPLETED|Core Study Period||395
9097581|NCT02499900|10162550|FG001|COMPLETED|Core Study Period||399
9097582|NCT02499900|10162549|FG000|NOT COMPLETED|Core Study Period||35
9097583|NCT02499900|10162550|FG001|NOT COMPLETED|Core Study Period||32
9097584|NCT02499900|10162549|FG000|STARTED|Completed Core, Continued Into Extension||395
9097585|NCT02499900|10162550|FG001|STARTED|Completed Core, Continued Into Extension||399
9097586|NCT02499900|10162549|FG000|COMPLETED|Completed Core, Continued Into Extension||392
9097587|NCT02499900|10162550|FG001|COMPLETED|Completed Core, Continued Into Extension||397
9097588|NCT02499900|10162549|FG000|NOT COMPLETED|Completed Core, Continued Into Extension||3
9097589|NCT02499900|10162550|FG001|NOT COMPLETED|Completed Core, Continued Into Extension||2
9097590|NCT02499900|10162549|FG000|STARTED|Extension Study Period||392
9097591|NCT02499900|10162550|FG001|STARTED|Extension Study Period||397
9097592|NCT02499900|10162549|FG000|Safety Analysis Set|Extension Study Period||392
9097593|NCT02499900|10162550|FG001|Safety Analysis Set|Extension Study Period|One participant was not treated in the Extension Study Period|396
9097594|NCT02499900|10162549|FG000|COMPLETED|Extension Study Period||380
9097595|NCT02499900|10162550|FG001|COMPLETED|Extension Study Period||377
9097596|NCT02499900|10162549|FG000|NOT COMPLETED|Extension Study Period||12
9097597|NCT02499900|10162550|FG001|NOT COMPLETED|Extension Study Period||20
9097598|NCT02481986|10162564|FG000|STARTED|Overall Study||108
9097599|NCT02481986|10162565|FG001|STARTED|Overall Study||115
9097600|NCT02481986|10162564|FG000|COMPLETED|Overall Study||103
9097601|NCT02481986|10162565|FG001|COMPLETED|Overall Study||106
9097602|NCT02481986|10162564|FG000|NOT COMPLETED|Overall Study||5
9097603|NCT02481986|10162565|FG001|NOT COMPLETED|Overall Study||9
8625697|NCT00508742|9665278|FG001|STARTED|Period 3: Toddler Dose||878
9097604|NCT02394548|10162571|FG000|STARTED|Overall Study||26
9097605|NCT02394548|10162571|FG000|COMPLETED|Overall Study||25
9097606|NCT02394548|10162571|FG000|NOT COMPLETED|Overall Study||1
9097607|NCT02269917|10162577|FG000|STARTED|BL to EOE-Test and BL to Switch-Control||766
9097608|NCT02269917|10162578|FG001|STARTED|BL to EOE-Test and BL to Switch-Control||383
9097609|NCT02269917|10162579|FG002|STARTED|BL to EOE-Test and BL to Switch-Control||0
9097610|NCT02269917|10162577|FG000|Treated|BL to EOE-Test and BL to Switch-Control||763
9097611|NCT02269917|10162578|FG001|Treated|BL to EOE-Test and BL to Switch-Control||378
9097612|NCT02269917|10162579|FG002|Treated|BL to EOE-Test and BL to Switch-Control||0
9097613|NCT02269917|10162577|FG000|COMPLETED|BL to EOE-Test and BL to Switch-Control||649
9097614|NCT02269917|10162578|FG001|COMPLETED|BL to EOE-Test and BL to Switch-Control||352
9097615|NCT02269917|10162579|FG002|COMPLETED|BL to EOE-Test and BL to Switch-Control||0
9097616|NCT02269917|10162577|FG000|NOT COMPLETED|BL to EOE-Test and BL to Switch-Control||117
9097617|NCT02269917|10162578|FG001|NOT COMPLETED|BL to EOE-Test and BL to Switch-Control||31
9097618|NCT02269917|10162579|FG002|NOT COMPLETED|BL to EOE-Test and BL to Switch-Control||0
9097619|NCT02269917|10162577|FG000|STARTED|Switch to D/C/F/TAF (Until EOE)||0
9097620|NCT02269917|10162578|FG001|STARTED|Switch to D/C/F/TAF (Until EOE)||0
9097621|NCT02269917|10162579|FG002|STARTED|Switch to D/C/F/TAF (Until EOE)||352
9097622|NCT02269917|10162577|FG000|COMPLETED|Switch to D/C/F/TAF (Until EOE)||0
9097623|NCT02269917|10162578|FG001|COMPLETED|Switch to D/C/F/TAF (Until EOE)||0
9097624|NCT02269917|10162579|FG002|COMPLETED|Switch to D/C/F/TAF (Until EOE)||314
9097625|NCT02269917|10162577|FG000|NOT COMPLETED|Switch to D/C/F/TAF (Until EOE)||0
9097626|NCT02269917|10162578|FG001|NOT COMPLETED|Switch to D/C/F/TAF (Until EOE)||0
9097627|NCT02269917|10162579|FG002|NOT COMPLETED|Switch to D/C/F/TAF (Until EOE)||38
9097628|NCT02225366|10162590|FG000|STARTED|Overall Study||2
9097629|NCT02225366|10162591|FG001|STARTED|Overall Study||1
9097630|NCT02225366|10162590|FG000|COMPLETED|Overall Study||1
9097631|NCT02225366|10162591|FG001|COMPLETED|Overall Study||1
9097632|NCT02225366|10162590|FG000|NOT COMPLETED|Overall Study||1
9097633|NCT02225366|10162591|FG001|NOT COMPLETED|Overall Study||0
9097634|NCT01530997|10162597|FG000|STARTED|Overall Study||45
9097635|NCT01530997|10162597|FG000|COMPLETED|Overall Study||43
9097636|NCT01530997|10162597|FG000|NOT COMPLETED|Overall Study||2
9097637|NCT01109004|10162611|FG000|STARTED|Overall Study||247
9097638|NCT01109004|10162612|FG001|STARTED|Overall Study||254
9097639|NCT01109004|10162613|FG002|STARTED|Overall Study||257
9097640|NCT01109004|10162611|FG000|COMPLETED|Overall Study||247
9097641|NCT01109004|10162612|FG001|COMPLETED|Overall Study||254
9097642|NCT01109004|10162613|FG002|COMPLETED|Overall Study||257
9097643|NCT01109004|10162611|FG000|NOT COMPLETED|Overall Study||0
9097644|NCT01109004|10162612|FG001|NOT COMPLETED|Overall Study||0
9097645|NCT01109004|10162613|FG002|NOT COMPLETED|Overall Study||0
9097646|NCT01067521|10162623|FG000|STARTED|Double-Blind Placebo-Controlled Period||943
9097647|NCT01067521|10162624|FG001|STARTED|Double-Blind Placebo-Controlled Period||461
9097648|NCT01067521|10162623|FG000|COMPLETED|Double-Blind Placebo-Controlled Period||859
9097649|NCT01067521|10162624|FG001|COMPLETED|Double-Blind Placebo-Controlled Period||430
9097650|NCT01067521|10162623|FG000|NOT COMPLETED|Double-Blind Placebo-Controlled Period||84
9097651|NCT01067521|10162624|FG001|NOT COMPLETED|Double-Blind Placebo-Controlled Period||31
9097652|NCT01067521|10162623|FG000|STARTED|Open-Label Period|Some participants did not continue into the open-label period.|834
9097653|NCT01067521|10162624|FG001|STARTED|Open-Label Period|Some participants did not continue into the open-label period.|419
9097654|NCT01067521|10162623|FG000|COMPLETED|Open-Label Period||580
9097655|NCT01067521|10162624|FG001|COMPLETED|Open-Label Period||261
9097656|NCT01067521|10162623|FG000|NOT COMPLETED|Open-Label Period||254
9097657|NCT01067521|10162624|FG001|NOT COMPLETED|Open-Label Period||158
9097658|NCT01047319|10162638|FG000|STARTED|Overall Study||345
9097659|NCT01047319|10162639|FG001|STARTED|Overall Study||350
9097660|NCT01047319|10162640|FG002|STARTED|Overall Study||352
8625698|NCT00508742|9665277|FG000|COMPLETED|Period 3: Toddler Dose||858
8625699|NCT00508742|9665278|FG001|COMPLETED|Period 3: Toddler Dose||863
8625700|NCT00508742|9665277|FG000|NOT COMPLETED|Period 3: Toddler Dose||25
9097661|NCT01047319|10162638|FG000|COMPLETED|Overall Study||0
9097662|NCT01047319|10162639|FG001|COMPLETED|Overall Study||0
9097663|NCT01047319|10162640|FG002|COMPLETED|Overall Study||0
9097664|NCT01047319|10162638|FG000|NOT COMPLETED|Overall Study||345
9097665|NCT01047319|10162639|FG001|NOT COMPLETED|Overall Study||350
9097666|NCT01047319|10162640|FG002|NOT COMPLETED|Overall Study||352
9097667|NCT00988052|10162650|FG000|STARTED|Overall Study||423
9097668|NCT00988052|10162651|FG001|STARTED|Overall Study||416
9097669|NCT00988052|10162650|FG000|COMPLETED|Overall Study||0
9097670|NCT00988052|10162651|FG001|COMPLETED|Overall Study||0
9097671|NCT00988052|10162650|FG000|NOT COMPLETED|Overall Study||423
8625701|NCT00508742|9665278|FG001|NOT COMPLETED|Period 3: Toddler Dose||15
8625702|NCT00508755|9665290|FG000|STARTED|Overall Study||6
8625703|NCT00508755|9665290|FG000|COMPLETED|Overall Study||5
8625704|NCT00508755|9665290|FG000|NOT COMPLETED|Overall Study||1
8625705|NCT00508820|9665298|FG000|STARTED|Overall Study||168
8625706|NCT00508820|9665299|FG001|STARTED|Overall Study||239
8625707|NCT00508820|9665298|FG000|COMPLETED|Overall Study||113
8625708|NCT00508820|9665299|FG001|COMPLETED|Overall Study||175
8625709|NCT00508820|9665298|FG000|NOT COMPLETED|Overall Study||55
8625710|NCT00508820|9665299|FG001|NOT COMPLETED|Overall Study||64
8625711|NCT00508924|9665309|FG000|STARTED|Overall Study||36
8625712|NCT00508924|9665310|FG001|STARTED|Overall Study||38
8625713|NCT00508924|9665311|FG002|STARTED|Overall Study||32
8625714|NCT00508924|9665312|FG003|STARTED|Overall Study||34
9097672|NCT00988052|10162651|FG001|NOT COMPLETED|Overall Study||416
9097673|NCT02021773|10162660|FG000|STARTED|Overall Study||89
9097674|NCT02021773|10162661|FG001|STARTED|Overall Study||88
9097675|NCT02021773|10162662|FG002|STARTED|Overall Study||87
9097676|NCT02021773|10162660|FG000|Safety Analysis Set|Overall Study||89
9097677|NCT02021773|10162661|FG001|Safety Analysis Set|Overall Study||88
9097678|NCT02021773|10162662|FG002|Safety Analysis Set|Overall Study||86
9097679|NCT02021773|10162660|FG000|Intent-to-treat (ITT)|Overall Study||89
9097680|NCT02021773|10162661|FG001|Intent-to-treat (ITT)|Overall Study||87
9097681|NCT02021773|10162662|FG002|Intent-to-treat (ITT)|Overall Study||85
9097682|NCT02021773|10162660|FG000|COMPLETED|Overall Study||77
9097683|NCT02021773|10162661|FG001|COMPLETED|Overall Study||72
9097684|NCT02021773|10162662|FG002|COMPLETED|Overall Study||76
9097685|NCT02021773|10162660|FG000|NOT COMPLETED|Overall Study||12
9097686|NCT02021773|10162661|FG001|NOT COMPLETED|Overall Study||16
9097687|NCT02021773|10162662|FG002|NOT COMPLETED|Overall Study||11
9097688|NCT04689932|10162670|FG000|STARTED|Overall Study||12
9097689|NCT04689932|10162670|FG000|COMPLETED|Overall Study||12
9097690|NCT04689932|10162670|FG000|NOT COMPLETED|Overall Study||0
9097691|NCT04635579|10162677|FG000|STARTED|Overall Study||20
9097692|NCT04635579|10162678|FG001|STARTED|Overall Study||20
9097693|NCT04635579|10162677|FG000|COMPLETED|Overall Study||20
9097694|NCT04635579|10162678|FG001|COMPLETED|Overall Study||20
9097695|NCT04635579|10162677|FG000|NOT COMPLETED|Overall Study||0
9097696|NCT04635579|10162678|FG001|NOT COMPLETED|Overall Study||0
9097697|NCT04553406|10162686|FG000|STARTED|Overall Study||1
9097698|NCT04553406|10162687|FG001|STARTED|Overall Study||1
9097699|NCT04553406|10162686|FG000|COMPLETED|Overall Study||1
9097700|NCT04553406|10162687|FG001|COMPLETED|Overall Study||0
9097701|NCT04553406|10162686|FG000|NOT COMPLETED|Overall Study||0
9097702|NCT04553406|10162687|FG001|NOT COMPLETED|Overall Study||1
9097703|NCT03792750|10162693|FG000|STARTED|Overall Study||12
9097704|NCT03792750|10162693|FG000|COMPLETED|Overall Study||9
9097705|NCT03792750|10162693|FG000|NOT COMPLETED|Overall Study||3
9097706|NCT03739593|10162701|FG000|STARTED|Overall Study||5
9097707|NCT03739593|10162702|FG001|STARTED|Overall Study||22
9097708|NCT03739593|10162703|FG002|STARTED|Overall Study||22
9097709|NCT03739593|10162701|FG000|COMPLETED|Overall Study||2
9097710|NCT03739593|10162702|FG001|COMPLETED|Overall Study||16
9097711|NCT03739593|10162703|FG002|COMPLETED|Overall Study||14
9097712|NCT03739593|10162701|FG000|NOT COMPLETED|Overall Study||3
9097713|NCT03739593|10162702|FG001|NOT COMPLETED|Overall Study||6
9097714|NCT03739593|10162703|FG002|NOT COMPLETED|Overall Study||8
9097715|NCT03739138|10162714|FG000|STARTED|Overall Study||0
9097716|NCT03739138|10162715|FG001|STARTED|Overall Study||7
9097717|NCT03739138|10162716|FG002|STARTED|Overall Study||5
9097718|NCT03739138|10162717|FG003|STARTED|Overall Study||18
9097719|NCT03739138|10162718|FG004|STARTED|Overall Study||0
9097720|NCT03739138|10162714|FG000|COMPLETED|Overall Study||0
9097721|NCT03739138|10162715|FG001|COMPLETED|Overall Study||0
9097722|NCT03739138|10162716|FG002|COMPLETED|Overall Study||0
9097723|NCT03739138|10162717|FG003|COMPLETED|Overall Study||0
9097724|NCT03739138|10162718|FG004|COMPLETED|Overall Study||0
9097725|NCT03739138|10162714|FG000|NOT COMPLETED|Overall Study||0
9097726|NCT03739138|10162715|FG001|NOT COMPLETED|Overall Study||7
9097727|NCT03739138|10162716|FG002|NOT COMPLETED|Overall Study||5
9097728|NCT03739138|10162717|FG003|NOT COMPLETED|Overall Study||18
9097729|NCT03739138|10162718|FG004|NOT COMPLETED|Overall Study||0
9097730|NCT03518086|10162728|FG000|STARTED|Overall Study||322
9097731|NCT03518086|10162729|FG001|STARTED|Overall Study||959
9097732|NCT03518086|10162730|FG002|STARTED|Overall Study||0
9097733|NCT03518086|10162731|FG003|STARTED|Overall Study||0
9097734|NCT03518086|10162728|FG000|Received at Least One Dose of Study Drug|Overall Study||321
9097735|NCT03518086|10162729|FG001|Received at Least One Dose of Study Drug|Overall Study||958
9097736|NCT03518086|10162730|FG002|Received at Least One Dose of Study Drug|Overall Study||0
9097737|NCT03518086|10162731|FG003|Received at Least One Dose of Study Drug|Overall Study||0
9097738|NCT03518086|10162728|FG000|COMPLETED|Overall Study||285
9097739|NCT03518086|10162729|FG001|COMPLETED|Overall Study||920
9097740|NCT03518086|10162730|FG002|COMPLETED|Overall Study||0
9097741|NCT03518086|10162731|FG003|COMPLETED|Overall Study||0
9097742|NCT03518086|10162728|FG000|NOT COMPLETED|Overall Study||37
9097743|NCT03518086|10162729|FG001|NOT COMPLETED|Overall Study||39
9097744|NCT03518086|10162730|FG002|NOT COMPLETED|Overall Study||0
9097745|NCT03518086|10162731|FG003|NOT COMPLETED|Overall Study||0
9097746|NCT03468309|10162738|FG000|STARTED|Overall Study||53
9097747|NCT03468309|10162738|FG000|COMPLETED|Overall Study||47
9097748|NCT03468309|10162738|FG000|NOT COMPLETED|Overall Study||6
9097749|NCT03347123|10162744|FG000|STARTED|Overall Study||5
9097750|NCT03347123|10162745|FG001|STARTED|Overall Study||6
9097751|NCT03347123|10162746|FG002|STARTED|Overall Study||0
9097752|NCT03347123|10162747|FG003|STARTED|Overall Study||0
9097753|NCT03347123|10162748|FG004|STARTED|Overall Study||0
9097754|NCT03347123|10162749|FG005|STARTED|Overall Study||0
9097755|NCT03347123|10162750|FG006|STARTED|Overall Study||0
9097756|NCT03347123|10162744|FG000|COMPLETED|Overall Study||0
9097757|NCT03347123|10162745|FG001|COMPLETED|Overall Study||0
9097758|NCT03347123|10162746|FG002|COMPLETED|Overall Study||0
9097759|NCT03347123|10162747|FG003|COMPLETED|Overall Study||0
9097760|NCT03347123|10162748|FG004|COMPLETED|Overall Study||0
9097761|NCT03347123|10162749|FG005|COMPLETED|Overall Study||0
9097762|NCT03347123|10162750|FG006|COMPLETED|Overall Study||0
9097763|NCT03347123|10162744|FG000|NOT COMPLETED|Overall Study||5
9097764|NCT03347123|10162745|FG001|NOT COMPLETED|Overall Study||6
9097765|NCT03347123|10162746|FG002|NOT COMPLETED|Overall Study||0
9097766|NCT03347123|10162747|FG003|NOT COMPLETED|Overall Study||0
9097767|NCT03347123|10162748|FG004|NOT COMPLETED|Overall Study||0
9097768|NCT03347123|10162749|FG005|NOT COMPLETED|Overall Study||0
9097769|NCT03347123|10162750|FG006|NOT COMPLETED|Overall Study||0
9097770|NCT03318523|10162765|FG000|STARTED|PC Period: Up to Year 1||100
9097771|NCT03318523|10162766|FG001|STARTED|PC Period: Up to Year 1||55
9097772|NCT03318523|10162767|FG002|STARTED|PC Period: Up to Year 1||102
9097773|NCT03318523|10162768|FG003|STARTED|PC Period: Up to Year 1||100
9097774|NCT03318523|10162769|FG004|STARTED|PC Period: Up to Year 1||0
9097775|NCT03318523|10162770|FG005|STARTED|PC Period: Up to Year 1||0
9097776|NCT03318523|10162771|FG006|STARTED|PC Period: Up to Year 1||0
9097777|NCT03318523|10162772|FG007|STARTED|PC Period: Up to Year 1||0
9097778|NCT03318523|10162773|FG008|STARTED|PC Period: Up to Year 1||0
9097779|NCT03318523|10162774|FG009|STARTED|PC Period: Up to Year 1||0
9097780|NCT03318523|10162765|FG000|COMPLETED|PC Period: Up to Year 1||96
9097781|NCT03318523|10162766|FG001|COMPLETED|PC Period: Up to Year 1||53
9097782|NCT03318523|10162767|FG002|COMPLETED|PC Period: Up to Year 1||100
9097783|NCT03318523|10162768|FG003|COMPLETED|PC Period: Up to Year 1||96
9097784|NCT03318523|10162769|FG004|COMPLETED|PC Period: Up to Year 1||0
9097785|NCT03318523|10162770|FG005|COMPLETED|PC Period: Up to Year 1||0
9097786|NCT03318523|10162771|FG006|COMPLETED|PC Period: Up to Year 1||0
9097787|NCT03318523|10162772|FG007|COMPLETED|PC Period: Up to Year 1||0
9097788|NCT03318523|10162773|FG008|COMPLETED|PC Period: Up to Year 1||0
9097789|NCT03318523|10162774|FG009|COMPLETED|PC Period: Up to Year 1||0
9097790|NCT03318523|10162765|FG000|NOT COMPLETED|PC Period: Up to Year 1||4
9097791|NCT03318523|10162766|FG001|NOT COMPLETED|PC Period: Up to Year 1||2
9097792|NCT03318523|10162767|FG002|NOT COMPLETED|PC Period: Up to Year 1||2
9097793|NCT03318523|10162768|FG003|NOT COMPLETED|PC Period: Up to Year 1||4
9097794|NCT03318523|10162769|FG004|NOT COMPLETED|PC Period: Up to Year 1||0
9097795|NCT03318523|10162770|FG005|NOT COMPLETED|PC Period: Up to Year 1||0
9097796|NCT03318523|10162771|FG006|NOT COMPLETED|PC Period: Up to Year 1||0
9097797|NCT03318523|10162772|FG007|NOT COMPLETED|PC Period: Up to Year 1||0
9097798|NCT03318523|10162773|FG008|NOT COMPLETED|PC Period: Up to Year 1||0
9097799|NCT03318523|10162774|FG009|NOT COMPLETED|PC Period: Up to Year 1||0
9097800|NCT03318523|10162765|FG000|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
9097801|NCT03318523|10162766|FG001|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
9097802|NCT03318523|10162767|FG002|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
9097803|NCT03318523|10162768|FG003|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
9097804|NCT03318523|10162769|FG004|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||20
9097805|NCT03318523|10162770|FG005|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||37
9097806|NCT03318523|10162771|FG006|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||39
9097807|NCT03318523|10162772|FG007|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||52
9097808|NCT03318523|10162773|FG008|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||100
9097809|NCT03318523|10162774|FG009|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||96
9097810|NCT03318523|10162765|FG000|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||0
9097811|NCT03318523|10162766|FG001|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||0
9097812|NCT03318523|10162767|FG002|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||0
9097813|NCT03318523|10162768|FG003|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||0
9097814|NCT03318523|10162769|FG004|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||20
9097815|NCT03318523|10162770|FG005|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||37
9097816|NCT03318523|10162771|FG006|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||39
9097817|NCT03318523|10162772|FG007|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||52
9097818|NCT03318523|10162773|FG008|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||100
9097819|NCT03318523|10162774|FG009|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||94
9097820|NCT03318523|10162765|FG000|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
9097821|NCT03318523|10162766|FG001|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
9097822|NCT03318523|10162767|FG002|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
9097823|NCT03318523|10162768|FG003|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
9097824|NCT03318523|10162769|FG004|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
9097825|NCT03318523|10162770|FG005|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
9097826|NCT03318523|10162771|FG006|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
9097827|NCT03318523|10162772|FG007|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
9097828|NCT03318523|10162773|FG008|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
9097829|NCT03318523|10162774|FG009|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
9097830|NCT03318523|10162765|FG000|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
9097831|NCT03318523|10162766|FG001|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
9097832|NCT03318523|10162767|FG002|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
9097833|NCT03318523|10162768|FG003|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
9097834|NCT03318523|10162769|FG004|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||20
9097835|NCT03318523|10162770|FG005|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||37
9097836|NCT03318523|10162771|FG006|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||39
9097837|NCT03318523|10162772|FG007|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||52
9097838|NCT03318523|10162773|FG008|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||100
9097839|NCT03318523|10162774|FG009|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||96
9097840|NCT03260894|10162800|FG000|STARTED|Overall Study||64
9097841|NCT03260894|10162801|FG001|STARTED|Overall Study||65
9097842|NCT03260894|10162800|FG000|Intention-to-Treat (ITT)|Overall Study||64
9097843|NCT03260894|10162801|FG001|Intention-to-Treat (ITT)|Overall Study||65
9097844|NCT03260894|10162800|FG000|All Subjects as Treated (ASaT)|Overall Study||64
9097845|NCT03260894|10162801|FG001|All Subjects as Treated (ASaT)|Overall Study||63
9097846|NCT03260894|10162800|FG000|COMPLETED|Overall Study||18
9097847|NCT03260894|10162801|FG001|COMPLETED|Overall Study||15
9097848|NCT03260894|10162800|FG000|NOT COMPLETED|Overall Study||46
9097849|NCT03260894|10162801|FG001|NOT COMPLETED|Overall Study||50
9097850|NCT02906020|10162817|FG000|STARTED|Part 1: Dose Escalation Period||4
9097851|NCT02906020|10162818|FG001|STARTED|Part 1: Dose Escalation Period||4
9097852|NCT02906020|10162819|FG002|STARTED|Part 1: Dose Escalation Period||5
9097853|NCT02906020|10162820|FG003|STARTED|Part 1: Dose Escalation Period||4
9097854|NCT02906020|10162821|FG004|STARTED|Part 1: Dose Escalation Period||3
9097855|NCT02906020|10162822|FG005|STARTED|Part 1: Dose Escalation Period||3
9097856|NCT02906020|10162823|FG006|STARTED|Part 1: Dose Escalation Period||3
9097857|NCT02906020|10162824|FG007|STARTED|Part 1: Dose Escalation Period||3
9097858|NCT02906020|10162825|FG008|STARTED|Part 1: Dose Escalation Period||0
9097859|NCT02906020|10162826|FG009|STARTED|Part 1: Dose Escalation Period||0
9097860|NCT02906020|10162827|FG010|STARTED|Part 1: Dose Escalation Period||0
9097861|NCT02906020|10162828|FG011|STARTED|Part 1: Dose Escalation Period||0
9097862|NCT02906020|10162829|FG012|STARTED|Part 1: Dose Escalation Period||0
9097863|NCT02906020|10162830|FG013|STARTED|Part 1: Dose Escalation Period||0
9097864|NCT02906020|10162831|FG014|STARTED|Part 1: Dose Escalation Period||0
9097865|NCT02906020|10162832|FG015|STARTED|Part 1: Dose Escalation Period||0
9097866|NCT02906020|10162817|FG000|Treated|Part 1: Dose Escalation Period||4
9097867|NCT02906020|10162818|FG001|Treated|Part 1: Dose Escalation Period||4
9097868|NCT02906020|10162819|FG002|Treated|Part 1: Dose Escalation Period||5
9097869|NCT02906020|10162820|FG003|Treated|Part 1: Dose Escalation Period||4
9097870|NCT02906020|10162821|FG004|Treated|Part 1: Dose Escalation Period||3
9097871|NCT02906020|10162822|FG005|Treated|Part 1: Dose Escalation Period||3
9097872|NCT02906020|10162823|FG006|Treated|Part 1: Dose Escalation Period||3
9097873|NCT02906020|10162824|FG007|Treated|Part 1: Dose Escalation Period||3
9097874|NCT02906020|10162825|FG008|Treated|Part 1: Dose Escalation Period||0
9097875|NCT02906020|10162826|FG009|Treated|Part 1: Dose Escalation Period||0
9097876|NCT02906020|10162827|FG010|Treated|Part 1: Dose Escalation Period||0
9097877|NCT02906020|10162828|FG011|Treated|Part 1: Dose Escalation Period||0
9097878|NCT02906020|10162829|FG012|Treated|Part 1: Dose Escalation Period||0
9097879|NCT02906020|10162830|FG013|Treated|Part 1: Dose Escalation Period||0
9097880|NCT02906020|10162831|FG014|Treated|Part 1: Dose Escalation Period||0
9097881|NCT02906020|10162832|FG015|Treated|Part 1: Dose Escalation Period||0
9097882|NCT02906020|10162817|FG000|COMPLETED|Part 1: Dose Escalation Period||4
9097883|NCT02906020|10162818|FG001|COMPLETED|Part 1: Dose Escalation Period||3
9097884|NCT02906020|10162819|FG002|COMPLETED|Part 1: Dose Escalation Period||5
9097885|NCT02906020|10162820|FG003|COMPLETED|Part 1: Dose Escalation Period||3
9097886|NCT02906020|10162821|FG004|COMPLETED|Part 1: Dose Escalation Period||3
9097887|NCT02906020|10162822|FG005|COMPLETED|Part 1: Dose Escalation Period||3
9097888|NCT02906020|10162823|FG006|COMPLETED|Part 1: Dose Escalation Period||3
9097889|NCT02906020|10162824|FG007|COMPLETED|Part 1: Dose Escalation Period||3
9097890|NCT02906020|10162825|FG008|COMPLETED|Part 1: Dose Escalation Period||0
9097891|NCT02906020|10162826|FG009|COMPLETED|Part 1: Dose Escalation Period||0
9097892|NCT02906020|10162827|FG010|COMPLETED|Part 1: Dose Escalation Period||0
9097893|NCT02906020|10162828|FG011|COMPLETED|Part 1: Dose Escalation Period||0
9097894|NCT02906020|10162829|FG012|COMPLETED|Part 1: Dose Escalation Period||0
9097895|NCT02906020|10162830|FG013|COMPLETED|Part 1: Dose Escalation Period||0
9097896|NCT02906020|10162831|FG014|COMPLETED|Part 1: Dose Escalation Period||0
9097897|NCT02906020|10162832|FG015|COMPLETED|Part 1: Dose Escalation Period||0
9097898|NCT02906020|10162817|FG000|NOT COMPLETED|Part 1: Dose Escalation Period||0
9097899|NCT02906020|10162818|FG001|NOT COMPLETED|Part 1: Dose Escalation Period||1
9097900|NCT02906020|10162819|FG002|NOT COMPLETED|Part 1: Dose Escalation Period||0
9097901|NCT02906020|10162820|FG003|NOT COMPLETED|Part 1: Dose Escalation Period||1
9097902|NCT02906020|10162821|FG004|NOT COMPLETED|Part 1: Dose Escalation Period||0
9097903|NCT02906020|10162822|FG005|NOT COMPLETED|Part 1: Dose Escalation Period||0
9097904|NCT02906020|10162823|FG006|NOT COMPLETED|Part 1: Dose Escalation Period||0
9097905|NCT02906020|10162824|FG007|NOT COMPLETED|Part 1: Dose Escalation Period||0
9097906|NCT02906020|10162825|FG008|NOT COMPLETED|Part 1: Dose Escalation Period||0
9097907|NCT02906020|10162826|FG009|NOT COMPLETED|Part 1: Dose Escalation Period||0
9097908|NCT02906020|10162827|FG010|NOT COMPLETED|Part 1: Dose Escalation Period||0
9097909|NCT02906020|10162828|FG011|NOT COMPLETED|Part 1: Dose Escalation Period||0
9097910|NCT02906020|10162829|FG012|NOT COMPLETED|Part 1: Dose Escalation Period||0
9097911|NCT02906020|10162830|FG013|NOT COMPLETED|Part 1: Dose Escalation Period||0
9097912|NCT02906020|10162831|FG014|NOT COMPLETED|Part 1: Dose Escalation Period||0
9097913|NCT02906020|10162832|FG015|NOT COMPLETED|Part 1: Dose Escalation Period||0
9097914|NCT02906020|10162817|FG000|STARTED|Part 2: Double-blind Treatment Period||0
9097915|NCT02906020|10162818|FG001|STARTED|Part 2: Double-blind Treatment Period||0
9097916|NCT02906020|10162819|FG002|STARTED|Part 2: Double-blind Treatment Period||0
9097917|NCT02906020|10162820|FG003|STARTED|Part 2: Double-blind Treatment Period||0
9097918|NCT02906020|10162821|FG004|STARTED|Part 2: Double-blind Treatment Period||0
9097919|NCT02906020|10162822|FG005|STARTED|Part 2: Double-blind Treatment Period||0
9097920|NCT02906020|10162823|FG006|STARTED|Part 2: Double-blind Treatment Period||0
9097921|NCT02906020|10162824|FG007|STARTED|Part 2: Double-blind Treatment Period||0
9097922|NCT02906020|10162825|FG008|STARTED|Part 2: Double-blind Treatment Period||111
9097923|NCT02906020|10162826|FG009|STARTED|Part 2: Double-blind Treatment Period||110
9097924|NCT02906020|10162827|FG010|STARTED|Part 2: Double-blind Treatment Period||10
9097925|NCT02906020|10162828|FG011|STARTED|Part 2: Double-blind Treatment Period||13
9097926|NCT02906020|10162829|FG012|STARTED|Part 2: Double-blind Treatment Period||0
9097927|NCT02906020|10162830|FG013|STARTED|Part 2: Double-blind Treatment Period||0
9097928|NCT02906020|10162831|FG014|STARTED|Part 2: Double-blind Treatment Period||0
9097929|NCT02906020|10162832|FG015|STARTED|Part 2: Double-blind Treatment Period||0
9097930|NCT02906020|10162817|FG000|Treated|Part 2: Double-blind Treatment Period||0
9097931|NCT02906020|10162818|FG001|Treated|Part 2: Double-blind Treatment Period||0
9097932|NCT02906020|10162819|FG002|Treated|Part 2: Double-blind Treatment Period||0
9097933|NCT02906020|10162820|FG003|Treated|Part 2: Double-blind Treatment Period||0
9097934|NCT02906020|10162821|FG004|Treated|Part 2: Double-blind Treatment Period||0
9097935|NCT02906020|10162822|FG005|Treated|Part 2: Double-blind Treatment Period||0
9097936|NCT02906020|10162823|FG006|Treated|Part 2: Double-blind Treatment Period||0
9097937|NCT02906020|10162824|FG007|Treated|Part 2: Double-blind Treatment Period||0
9097938|NCT02906020|10162825|FG008|Treated|Part 2: Double-blind Treatment Period||111
9097939|NCT02906020|10162826|FG009|Treated|Part 2: Double-blind Treatment Period||110
9097940|NCT02906020|10162827|FG010|Treated|Part 2: Double-blind Treatment Period||10
9097941|NCT02906020|10162828|FG011|Treated|Part 2: Double-blind Treatment Period||13
9097942|NCT02906020|10162829|FG012|Treated|Part 2: Double-blind Treatment Period||0
9097943|NCT02906020|10162830|FG013|Treated|Part 2: Double-blind Treatment Period||0
9097944|NCT02906020|10162831|FG014|Treated|Part 2: Double-blind Treatment Period||0
9097945|NCT02906020|10162832|FG015|Treated|Part 2: Double-blind Treatment Period||0
9097946|NCT02906020|10162817|FG000|COMPLETED|Part 2: Double-blind Treatment Period||0
9097947|NCT02906020|10162818|FG001|COMPLETED|Part 2: Double-blind Treatment Period||0
9097948|NCT02906020|10162819|FG002|COMPLETED|Part 2: Double-blind Treatment Period||0
9097949|NCT02906020|10162820|FG003|COMPLETED|Part 2: Double-blind Treatment Period||0
9097950|NCT02906020|10162821|FG004|COMPLETED|Part 2: Double-blind Treatment Period||0
9097951|NCT02906020|10162822|FG005|COMPLETED|Part 2: Double-blind Treatment Period||0
9097952|NCT02906020|10162823|FG006|COMPLETED|Part 2: Double-blind Treatment Period||0
9097953|NCT02906020|10162824|FG007|COMPLETED|Part 2: Double-blind Treatment Period||0
9097954|NCT02906020|10162825|FG008|COMPLETED|Part 2: Double-blind Treatment Period||99
9097955|NCT02906020|10162826|FG009|COMPLETED|Part 2: Double-blind Treatment Period||85
9097956|NCT02906020|10162827|FG010|COMPLETED|Part 2: Double-blind Treatment Period||10
9097957|NCT02906020|10162828|FG011|COMPLETED|Part 2: Double-blind Treatment Period||13
9097958|NCT02906020|10162829|FG012|COMPLETED|Part 2: Double-blind Treatment Period||0
9097959|NCT02906020|10162830|FG013|COMPLETED|Part 2: Double-blind Treatment Period||0
9097960|NCT02906020|10162831|FG014|COMPLETED|Part 2: Double-blind Treatment Period||0
9097961|NCT02906020|10162832|FG015|COMPLETED|Part 2: Double-blind Treatment Period||0
9097962|NCT02906020|10162817|FG000|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
9097963|NCT02906020|10162818|FG001|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
9097964|NCT02906020|10162819|FG002|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
9097965|NCT02906020|10162820|FG003|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
9097966|NCT02906020|10162821|FG004|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
9097967|NCT02906020|10162822|FG005|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
9097968|NCT02906020|10162823|FG006|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
9097969|NCT02906020|10162824|FG007|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
9097970|NCT02906020|10162825|FG008|NOT COMPLETED|Part 2: Double-blind Treatment Period||12
9097971|NCT02906020|10162826|FG009|NOT COMPLETED|Part 2: Double-blind Treatment Period||25
9097972|NCT02906020|10162827|FG010|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
9097973|NCT02906020|10162828|FG011|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
9097974|NCT02906020|10162829|FG012|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
9097975|NCT02906020|10162830|FG013|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
9097976|NCT02906020|10162831|FG014|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
9097977|NCT02906020|10162832|FG015|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
9097978|NCT02906020|10162817|FG000|STARTED|Part 2: Long-term Follow-up Period||0
9097979|NCT02906020|10162818|FG001|STARTED|Part 2: Long-term Follow-up Period||0
9097980|NCT02906020|10162819|FG002|STARTED|Part 2: Long-term Follow-up Period||0
9097981|NCT02906020|10162820|FG003|STARTED|Part 2: Long-term Follow-up Period||0
9097982|NCT02906020|10162821|FG004|STARTED|Part 2: Long-term Follow-up Period||0
9097983|NCT02906020|10162822|FG005|STARTED|Part 2: Long-term Follow-up Period||0
9097984|NCT02906020|10162823|FG006|STARTED|Part 2: Long-term Follow-up Period||0
9097985|NCT02906020|10162824|FG007|STARTED|Part 2: Long-term Follow-up Period||0
9097986|NCT02906020|10162825|FG008|STARTED|Part 2: Long-term Follow-up Period||0
9097987|NCT02906020|10162826|FG009|STARTED|Part 2: Long-term Follow-up Period||0
9097988|NCT02906020|10162827|FG010|STARTED|Part 2: Long-term Follow-up Period||0
9097989|NCT02906020|10162828|FG011|STARTED|Part 2: Long-term Follow-up Period||0
9097990|NCT02906020|10162829|FG012|STARTED|Part 2: Long-term Follow-up Period||99
9097991|NCT02906020|10162830|FG013|STARTED|Part 2: Long-term Follow-up Period||85
9097992|NCT02906020|10162831|FG014|STARTED|Part 2: Long-term Follow-up Period||10
9097993|NCT02906020|10162832|FG015|STARTED|Part 2: Long-term Follow-up Period|Out of 13 completed participants in the previous part 2 DB period-arm, 2 didn't enter LTFU period.|11
9097994|NCT02906020|10162817|FG000|Treated|Part 2: Long-term Follow-up Period||0
9097995|NCT02906020|10162818|FG001|Treated|Part 2: Long-term Follow-up Period||0
9097996|NCT02906020|10162819|FG002|Treated|Part 2: Long-term Follow-up Period||0
9097997|NCT02906020|10162820|FG003|Treated|Part 2: Long-term Follow-up Period||0
9097998|NCT02906020|10162821|FG004|Treated|Part 2: Long-term Follow-up Period||0
9097999|NCT02906020|10162822|FG005|Treated|Part 2: Long-term Follow-up Period||0
9098000|NCT02906020|10162823|FG006|Treated|Part 2: Long-term Follow-up Period||0
9098001|NCT02906020|10162824|FG007|Treated|Part 2: Long-term Follow-up Period||0
9098002|NCT02906020|10162825|FG008|Treated|Part 2: Long-term Follow-up Period||0
9098003|NCT02906020|10162826|FG009|Treated|Part 2: Long-term Follow-up Period||0
9098004|NCT02906020|10162827|FG010|Treated|Part 2: Long-term Follow-up Period||0
9098005|NCT02906020|10162828|FG011|Treated|Part 2: Long-term Follow-up Period||0
9098006|NCT02906020|10162829|FG012|Treated|Part 2: Long-term Follow-up Period||87
9098007|NCT02906020|10162830|FG013|Treated|Part 2: Long-term Follow-up Period||75
9098008|NCT02906020|10162831|FG014|Treated|Part 2: Long-term Follow-up Period||10
9098009|NCT02906020|10162832|FG015|Treated|Part 2: Long-term Follow-up Period||11
9098010|NCT02906020|10162817|FG000|COMPLETED|Part 2: Long-term Follow-up Period||0
9098011|NCT02906020|10162818|FG001|COMPLETED|Part 2: Long-term Follow-up Period||0
9098012|NCT02906020|10162819|FG002|COMPLETED|Part 2: Long-term Follow-up Period||0
9098013|NCT02906020|10162820|FG003|COMPLETED|Part 2: Long-term Follow-up Period||0
9098014|NCT02906020|10162821|FG004|COMPLETED|Part 2: Long-term Follow-up Period||0
9098015|NCT02906020|10162822|FG005|COMPLETED|Part 2: Long-term Follow-up Period||0
9098016|NCT02906020|10162823|FG006|COMPLETED|Part 2: Long-term Follow-up Period||0
9098017|NCT02906020|10162824|FG007|COMPLETED|Part 2: Long-term Follow-up Period||0
9098018|NCT02906020|10162825|FG008|COMPLETED|Part 2: Long-term Follow-up Period||0
9098019|NCT02906020|10162826|FG009|COMPLETED|Part 2: Long-term Follow-up Period||0
9098020|NCT02906020|10162827|FG010|COMPLETED|Part 2: Long-term Follow-up Period||0
9098021|NCT02906020|10162828|FG011|COMPLETED|Part 2: Long-term Follow-up Period||0
9098022|NCT02906020|10162829|FG012|COMPLETED|Part 2: Long-term Follow-up Period||0
9098023|NCT02906020|10162830|FG013|COMPLETED|Part 2: Long-term Follow-up Period||0
9098024|NCT02906020|10162831|FG014|COMPLETED|Part 2: Long-term Follow-up Period||0
9098025|NCT02906020|10162832|FG015|COMPLETED|Part 2: Long-term Follow-up Period||0
9098026|NCT02906020|10162817|FG000|NOT COMPLETED|Part 2: Long-term Follow-up Period||0
9098027|NCT02906020|10162818|FG001|NOT COMPLETED|Part 2: Long-term Follow-up Period||0
9098028|NCT02906020|10162819|FG002|NOT COMPLETED|Part 2: Long-term Follow-up Period||0
9098029|NCT02906020|10162820|FG003|NOT COMPLETED|Part 2: Long-term Follow-up Period||0
9098030|NCT02906020|10162821|FG004|NOT COMPLETED|Part 2: Long-term Follow-up Period||0
9098031|NCT02906020|10162822|FG005|NOT COMPLETED|Part 2: Long-term Follow-up Period||0
9098032|NCT02906020|10162823|FG006|NOT COMPLETED|Part 2: Long-term Follow-up Period||0
9098033|NCT02906020|10162824|FG007|NOT COMPLETED|Part 2: Long-term Follow-up Period||0
9098034|NCT02906020|10162825|FG008|NOT COMPLETED|Part 2: Long-term Follow-up Period||0
9098035|NCT02906020|10162826|FG009|NOT COMPLETED|Part 2: Long-term Follow-up Period||0
9098036|NCT02906020|10162827|FG010|NOT COMPLETED|Part 2: Long-term Follow-up Period||0
9098037|NCT02906020|10162828|FG011|NOT COMPLETED|Part 2: Long-term Follow-up Period||0
9098038|NCT02906020|10162829|FG012|NOT COMPLETED|Part 2: Long-term Follow-up Period||99
9098039|NCT02906020|10162830|FG013|NOT COMPLETED|Part 2: Long-term Follow-up Period||85
9098040|NCT02906020|10162831|FG014|NOT COMPLETED|Part 2: Long-term Follow-up Period||10
9098041|NCT02906020|10162832|FG015|NOT COMPLETED|Part 2: Long-term Follow-up Period||11
9098042|NCT02891226|10162864|FG000|STARTED|Period 1 (Weeks 0 to 12)||64
9098043|NCT02891226|10162865|FG001|STARTED|Period 1 (Weeks 0 to 12)||31
9098044|NCT02891226|10162866|FG002|STARTED|Period 1 (Weeks 0 to 12)||32
9098045|NCT02891226|10162867|FG003|STARTED|Period 1 (Weeks 0 to 12)||64
9098046|NCT02891226|10162868|FG004|STARTED|Period 1 (Weeks 0 to 12)||0
9098047|NCT02891226|10162869|FG005|STARTED|Period 1 (Weeks 0 to 12)||0
9098048|NCT02891226|10162870|FG006|STARTED|Period 1 (Weeks 0 to 12)||0
9098049|NCT02891226|10162871|FG007|STARTED|Period 1 (Weeks 0 to 12)||0
9098050|NCT02891226|10162872|FG008|STARTED|Period 1 (Weeks 0 to 12)||0
9098051|NCT02891226|10162873|FG009|STARTED|Period 1 (Weeks 0 to 12)||0
9098052|NCT02891226|10162874|FG010|STARTED|Period 1 (Weeks 0 to 12)||0
9098053|NCT02891226|10162875|FG011|STARTED|Period 1 (Weeks 0 to 12)||0
9098054|NCT02891226|10162876|FG012|STARTED|Period 1 (Weeks 0 to 12)||0
9098055|NCT02891226|10162877|FG013|STARTED|Period 1 (Weeks 0 to 12)||0
9098056|NCT02891226|10162878|FG014|STARTED|Period 1 (Weeks 0 to 12)||0
9098057|NCT02891226|10162879|FG015|STARTED|Period 1 (Weeks 0 to 12)||0
9098058|NCT02891226|10162864|FG000|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||64
9098059|NCT02891226|10162865|FG001|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||31
9098060|NCT02891226|10162866|FG002|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||32
9098061|NCT02891226|10162867|FG003|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||64
9098062|NCT02891226|10162868|FG004|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0
9098063|NCT02891226|10162869|FG005|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0
9098064|NCT02891226|10162870|FG006|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0
9098065|NCT02891226|10162871|FG007|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0
9098066|NCT02891226|10162872|FG008|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0
9098067|NCT02891226|10162873|FG009|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0
9098068|NCT02891226|10162874|FG010|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0
9098069|NCT02891226|10162875|FG011|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0
9098070|NCT02891226|10162876|FG012|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0
9098071|NCT02891226|10162877|FG013|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0
9098072|NCT02891226|10162878|FG014|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0
9098073|NCT02891226|10162879|FG015|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0
9098074|NCT02891226|10162864|FG000|COMPLETED|Period 1 (Weeks 0 to 12)||59
9098075|NCT02891226|10162865|FG001|COMPLETED|Period 1 (Weeks 0 to 12)||29
9098076|NCT02891226|10162866|FG002|COMPLETED|Period 1 (Weeks 0 to 12)||28
9098077|NCT02891226|10162867|FG003|COMPLETED|Period 1 (Weeks 0 to 12)||60
9098078|NCT02891226|10162868|FG004|COMPLETED|Period 1 (Weeks 0 to 12)||0
9098079|NCT02891226|10162869|FG005|COMPLETED|Period 1 (Weeks 0 to 12)||0
9098080|NCT02891226|10162870|FG006|COMPLETED|Period 1 (Weeks 0 to 12)||0
9098081|NCT02891226|10162871|FG007|COMPLETED|Period 1 (Weeks 0 to 12)||0
9098082|NCT02891226|10162872|FG008|COMPLETED|Period 1 (Weeks 0 to 12)||0
9098083|NCT02891226|10162873|FG009|COMPLETED|Period 1 (Weeks 0 to 12)||0
9098084|NCT02891226|10162874|FG010|COMPLETED|Period 1 (Weeks 0 to 12)||0
9098085|NCT02891226|10162875|FG011|COMPLETED|Period 1 (Weeks 0 to 12)||0
9098086|NCT02891226|10162876|FG012|COMPLETED|Period 1 (Weeks 0 to 12)||0
9098087|NCT02891226|10162877|FG013|COMPLETED|Period 1 (Weeks 0 to 12)||0
9098088|NCT02891226|10162878|FG014|COMPLETED|Period 1 (Weeks 0 to 12)||0
9098089|NCT02891226|10162879|FG015|COMPLETED|Period 1 (Weeks 0 to 12)||0
9098090|NCT02891226|10162864|FG000|NOT COMPLETED|Period 1 (Weeks 0 to 12)||5
9098091|NCT02891226|10162865|FG001|NOT COMPLETED|Period 1 (Weeks 0 to 12)||2
9098092|NCT02891226|10162866|FG002|NOT COMPLETED|Period 1 (Weeks 0 to 12)||4
9098093|NCT02891226|10162867|FG003|NOT COMPLETED|Period 1 (Weeks 0 to 12)||4
9098094|NCT02891226|10162868|FG004|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0
9098095|NCT02891226|10162869|FG005|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0
9098096|NCT02891226|10162870|FG006|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0
9098097|NCT02891226|10162871|FG007|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0
9098098|NCT02891226|10162872|FG008|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0
9098099|NCT02891226|10162873|FG009|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0
9098100|NCT02891226|10162874|FG010|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0
9098101|NCT02891226|10162875|FG011|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0
9098102|NCT02891226|10162876|FG012|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0
9098103|NCT02891226|10162877|FG013|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0
9098104|NCT02891226|10162878|FG014|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0
9098105|NCT02891226|10162879|FG015|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0
9098106|NCT02891226|10162864|FG000|STARTED|Period 2 (Weeks 12 to 52)|Participants were assigned to this arm during period 1.|0
9098107|NCT02891226|10162865|FG001|STARTED|Period 2 (Weeks 12 to 52)|Participants were assigned to this arm during period 1.|0
9098108|NCT02891226|10162866|FG002|STARTED|Period 2 (Weeks 12 to 52)|Participants were assigned to this arm during period 1.|0
9098109|NCT02891226|10162867|FG003|STARTED|Period 2 (Weeks 12 to 52)|Participants were assigned to this arm during period 1.|0
9098110|NCT02891226|10162868|FG004|STARTED|Period 2 (Weeks 12 to 52)|Participants were assigned to this arm during period 2.|9
9098111|NCT02891226|10162869|FG005|STARTED|Period 2 (Weeks 12 to 52)|Participants were assigned to this arm during period 2.|9
9098112|NCT02891226|10162870|FG006|STARTED|Period 2 (Weeks 12 to 52)|Participants were assigned to this arm during period 2.|23
9098113|NCT02891226|10162871|FG007|STARTED|Period 2 (Weeks 12 to 52)|Participants were assigned to this arm during period 2.|46
9098114|NCT02891226|10162872|FG008|STARTED|Period 2 (Weeks 12 to 52)|Participants were assigned to this arm during period 2.|30
9098115|NCT02891226|10162873|FG009|STARTED|Period 2 (Weeks 12 to 52)|Participants were assigned to this arm during period 2.|59
9098116|NCT02891226|10162874|FG010|STARTED|Period 2 (Weeks 12 to 52)||0
9098117|NCT02891226|10162875|FG011|STARTED|Period 2 (Weeks 12 to 52)||0
9098118|NCT02891226|10162876|FG012|STARTED|Period 2 (Weeks 12 to 52)||0
9098119|NCT02891226|10162877|FG013|STARTED|Period 2 (Weeks 12 to 52)||0
9098120|NCT02891226|10162878|FG014|STARTED|Period 2 (Weeks 12 to 52)||0
9098121|NCT02891226|10162879|FG015|STARTED|Period 2 (Weeks 12 to 52)||0
9098122|NCT02891226|10162864|FG000|COMPLETED|Period 2 (Weeks 12 to 52)||0
9098123|NCT02891226|10162865|FG001|COMPLETED|Period 2 (Weeks 12 to 52)||0
9098124|NCT02891226|10162866|FG002|COMPLETED|Period 2 (Weeks 12 to 52)||0
9098125|NCT02891226|10162867|FG003|COMPLETED|Period 2 (Weeks 12 to 52)||0
9098126|NCT02891226|10162868|FG004|COMPLETED|Period 2 (Weeks 12 to 52)||8
9098127|NCT02891226|10162869|FG005|COMPLETED|Period 2 (Weeks 12 to 52)||8
9098128|NCT02891226|10162870|FG006|COMPLETED|Period 2 (Weeks 12 to 52)||20
9098129|NCT02891226|10162871|FG007|COMPLETED|Period 2 (Weeks 12 to 52)||41
9098130|NCT02891226|10162872|FG008|COMPLETED|Period 2 (Weeks 12 to 52)||24
9098131|NCT02891226|10162873|FG009|COMPLETED|Period 2 (Weeks 12 to 52)||42
9098132|NCT02891226|10162874|FG010|COMPLETED|Period 2 (Weeks 12 to 52)||0
9098133|NCT02891226|10162875|FG011|COMPLETED|Period 2 (Weeks 12 to 52)||0
9098134|NCT02891226|10162876|FG012|COMPLETED|Period 2 (Weeks 12 to 52)||0
9098135|NCT02891226|10162877|FG013|COMPLETED|Period 2 (Weeks 12 to 52)||0
9098136|NCT02891226|10162878|FG014|COMPLETED|Period 2 (Weeks 12 to 52)||0
9098137|NCT02891226|10162879|FG015|COMPLETED|Period 2 (Weeks 12 to 52)||0
9098138|NCT02891226|10162864|FG000|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0
9098139|NCT02891226|10162865|FG001|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0
9098140|NCT02891226|10162866|FG002|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0
9098141|NCT02891226|10162867|FG003|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0
9098142|NCT02891226|10162868|FG004|NOT COMPLETED|Period 2 (Weeks 12 to 52)||1
9098143|NCT02891226|10162869|FG005|NOT COMPLETED|Period 2 (Weeks 12 to 52)||1
8723569|NCT01023815|9771083|FG001|STARTED|Randomized Period (Day 90 to Month 12)|Randomized patients to Group A, B and C are also intent to treat population.|45
8723570|NCT01023815|9771084|FG002|STARTED|Randomized Period (Day 90 to Month 12)||68
8723571|NCT01023815|9771085|FG003|STARTED|Randomized Period (Day 90 to Month 12)||71
8723572|NCT01023815|9771082|FG000|COMPLETED|Randomized Period (Day 90 to Month 12)||0
8723573|NCT01023815|9771083|FG001|COMPLETED|Randomized Period (Day 90 to Month 12)||42
8723574|NCT01023815|9771084|FG002|COMPLETED|Randomized Period (Day 90 to Month 12)||60
8723575|NCT01023815|9771085|FG003|COMPLETED|Randomized Period (Day 90 to Month 12)||68
8723576|NCT01023815|9771082|FG000|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||0
8723577|NCT01023815|9771083|FG001|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||3
8723578|NCT01023815|9771084|FG002|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||8
8723579|NCT01023815|9771085|FG003|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||3
8723580|NCT01023841|9771098|FG000|STARTED|Overall Study||48
8723581|NCT01023841|9771099|FG001|STARTED|Overall Study||23
8723582|NCT01023841|9771098|FG000|COMPLETED|Overall Study||47
8723583|NCT01023841|9771099|FG001|COMPLETED|Overall Study||23
8723584|NCT01023841|9771098|FG000|NOT COMPLETED|Overall Study||1
8723585|NCT01023841|9771099|FG001|NOT COMPLETED|Overall Study||0
8723586|NCT01023958|9771105|FG000|STARTED|Overall Study||50
9098144|NCT02891226|10162870|FG006|NOT COMPLETED|Period 2 (Weeks 12 to 52)||3
9098145|NCT02891226|10162871|FG007|NOT COMPLETED|Period 2 (Weeks 12 to 52)||5
9098146|NCT02891226|10162872|FG008|NOT COMPLETED|Period 2 (Weeks 12 to 52)||6
9098147|NCT02891226|10162873|FG009|NOT COMPLETED|Period 2 (Weeks 12 to 52)||17
9098148|NCT02891226|10162874|FG010|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0
9098149|NCT02891226|10162875|FG011|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0
9098150|NCT02891226|10162876|FG012|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0
9098151|NCT02891226|10162877|FG013|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0
9098152|NCT02891226|10162878|FG014|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0
9098153|NCT02891226|10162879|FG015|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0
9098154|NCT02891226|10162864|FG000|STARTED|Period 3 (Weeks 52 to 208)||0
9098155|NCT02891226|10162865|FG001|STARTED|Period 3 (Weeks 52 to 208)||0
9098156|NCT02891226|10162866|FG002|STARTED|Period 3 (Weeks 52 to 208)||0
9098157|NCT02891226|10162867|FG003|STARTED|Period 3 (Weeks 52 to 208)||0
9098158|NCT02891226|10162868|FG004|STARTED|Period 3 (Weeks 52 to 208)|Participants were assigned to this arm during period 2.|0
9098159|NCT02891226|10162869|FG005|STARTED|Period 3 (Weeks 52 to 208)|Participants were assigned to this arm during period 2.|0
9098160|NCT02891226|10162870|FG006|STARTED|Period 3 (Weeks 52 to 208)|Participants were assigned to this arm during period 2.|0
9098161|NCT02891226|10162871|FG007|STARTED|Period 3 (Weeks 52 to 208)|Participants were assigned to this arm during period 2.|0
9098162|NCT02891226|10162872|FG008|STARTED|Period 3 (Weeks 52 to 208)|Participants were assigned to this arm during period 2.|0
9098163|NCT02891226|10162873|FG009|STARTED|Period 3 (Weeks 52 to 208)|Participants were assigned to this arm during period 2.|0
9098164|NCT02891226|10162874|FG010|STARTED|Period 3 (Weeks 52 to 208)|Participants were assigned to this arm during period 3.|137
9098165|NCT02891226|10162875|FG011|STARTED|Period 3 (Weeks 52 to 208)||0
9098166|NCT02891226|10162876|FG012|STARTED|Period 3 (Weeks 52 to 208)||0
9098167|NCT02891226|10162877|FG013|STARTED|Period 3 (Weeks 52 to 208)||0
9098168|NCT02891226|10162878|FG014|STARTED|Period 3 (Weeks 52 to 208)||0
9098169|NCT02891226|10162879|FG015|STARTED|Period 3 (Weeks 52 to 208)||0
9098170|NCT02891226|10162864|FG000|COMPLETED|Period 3 (Weeks 52 to 208)||0
9098171|NCT02891226|10162865|FG001|COMPLETED|Period 3 (Weeks 52 to 208)||0
9098172|NCT02891226|10162866|FG002|COMPLETED|Period 3 (Weeks 52 to 208)||0
9098173|NCT02891226|10162867|FG003|COMPLETED|Period 3 (Weeks 52 to 208)||0
9098174|NCT02891226|10162868|FG004|COMPLETED|Period 3 (Weeks 52 to 208)||0
9098175|NCT02891226|10162869|FG005|COMPLETED|Period 3 (Weeks 52 to 208)||0
9098176|NCT02891226|10162870|FG006|COMPLETED|Period 3 (Weeks 52 to 208)||0
9098177|NCT02891226|10162871|FG007|COMPLETED|Period 3 (Weeks 52 to 208)||0
9098178|NCT02891226|10162872|FG008|COMPLETED|Period 3 (Weeks 52 to 208)||0
9098179|NCT02891226|10162873|FG009|COMPLETED|Period 3 (Weeks 52 to 208)||0
9098180|NCT02891226|10162874|FG010|COMPLETED|Period 3 (Weeks 52 to 208)||0
9098181|NCT02891226|10162875|FG011|COMPLETED|Period 3 (Weeks 52 to 208)||0
9098182|NCT02891226|10162876|FG012|COMPLETED|Period 3 (Weeks 52 to 208)||0
9098183|NCT02891226|10162877|FG013|COMPLETED|Period 3 (Weeks 52 to 208)||0
9098184|NCT02891226|10162878|FG014|COMPLETED|Period 3 (Weeks 52 to 208)||0
9098185|NCT02891226|10162879|FG015|COMPLETED|Period 3 (Weeks 52 to 208)||0
9098186|NCT02891226|10162864|FG000|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
9098187|NCT02891226|10162865|FG001|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
9098188|NCT02891226|10162866|FG002|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
9098189|NCT02891226|10162867|FG003|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
9098190|NCT02891226|10162868|FG004|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
9098191|NCT02891226|10162869|FG005|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
9098192|NCT02891226|10162870|FG006|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
9098193|NCT02891226|10162871|FG007|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
9098194|NCT02891226|10162872|FG008|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
9098195|NCT02891226|10162873|FG009|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
9098196|NCT02891226|10162874|FG010|NOT COMPLETED|Period 3 (Weeks 52 to 208)||137
9098197|NCT02891226|10162875|FG011|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
9098198|NCT02891226|10162876|FG012|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
9098199|NCT02891226|10162877|FG013|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
9098200|NCT02891226|10162878|FG014|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
9098201|NCT02891226|10162879|FG015|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
9098202|NCT02891226|10162864|FG000|STARTED|Follow-up Period||0
9098203|NCT02891226|10162865|FG001|STARTED|Follow-up Period||0
9098204|NCT02891226|10162866|FG002|STARTED|Follow-up Period||0
8556843|NCT03760146|9588648|FG002|Vaccination 1|Overall Study||334
8556844|NCT03760146|9588649|FG003|Vaccination 1|Overall Study||111
8556845|NCT03760146|9588650|FG004|Vaccination 1|Overall Study||335
8556846|NCT03760146|9588651|FG005|Vaccination 1|Overall Study||112
8556847|NCT03760146|9588646|FG000|Vaccination 2|Overall Study||1461
8556848|NCT03760146|9588647|FG001|Vaccination 2|Overall Study||1446
8556849|NCT03760146|9588648|FG002|Vaccination 2|Overall Study||0
8556850|NCT03760146|9588649|FG003|Vaccination 2|Overall Study||0
8556851|NCT03760146|9588650|FG004|Vaccination 2|Overall Study||0
8556852|NCT03760146|9588651|FG005|Vaccination 2|Overall Study||0
8556853|NCT03760146|9588646|FG000|Safety Population|Overall Study||1507
9098205|NCT02891226|10162867|FG003|STARTED|Follow-up Period||0
9098206|NCT02891226|10162868|FG004|STARTED|Follow-up Period||0
9098207|NCT02891226|10162869|FG005|STARTED|Follow-up Period||0
9098208|NCT02891226|10162870|FG006|STARTED|Follow-up Period||0
9098209|NCT02891226|10162871|FG007|STARTED|Follow-up Period||0
9098210|NCT02891226|10162872|FG008|STARTED|Follow-up Period||0
9098211|NCT02891226|10162873|FG009|STARTED|Follow-up Period||0
9098212|NCT02891226|10162874|FG010|STARTED|Follow-up Period||0
9098213|NCT02891226|10162875|FG011|STARTED|Follow-up Period|Participants were assigned to this arm during follow-up period.|1
9098214|NCT02891226|10162876|FG012|STARTED|Follow-up Period|Participants were assigned to this arm during follow-up period.|2
9098215|NCT02891226|10162877|FG013|STARTED|Follow-up Period|Participants were assigned to this arm during follow-up period.|1
9098216|NCT02891226|10162878|FG014|STARTED|Follow-up Period|Participants were assigned to this arm during follow-up period.|1
9098217|NCT02891226|10162879|FG015|STARTED|Follow-up Period|Participants were assigned to this arm during follow-up period.|3
9098218|NCT02891226|10162864|FG000|COMPLETED|Follow-up Period||0
9098219|NCT02891226|10162865|FG001|COMPLETED|Follow-up Period||0
9098220|NCT02891226|10162866|FG002|COMPLETED|Follow-up Period||0
9098221|NCT02891226|10162867|FG003|COMPLETED|Follow-up Period||0
9098222|NCT02891226|10162868|FG004|COMPLETED|Follow-up Period||0
9098223|NCT02891226|10162869|FG005|COMPLETED|Follow-up Period||0
9098224|NCT02891226|10162870|FG006|COMPLETED|Follow-up Period||0
9098225|NCT02891226|10162871|FG007|COMPLETED|Follow-up Period||0
9098226|NCT02891226|10162872|FG008|COMPLETED|Follow-up Period||0
9098227|NCT02891226|10162873|FG009|COMPLETED|Follow-up Period||0
9098228|NCT02891226|10162874|FG010|COMPLETED|Follow-up Period||0
9098229|NCT02891226|10162875|FG011|COMPLETED|Follow-up Period||0
9098230|NCT02891226|10162876|FG012|COMPLETED|Follow-up Period||2
9098231|NCT02891226|10162877|FG013|COMPLETED|Follow-up Period||1
9098232|NCT02891226|10162878|FG014|COMPLETED|Follow-up Period||0
9098233|NCT02891226|10162879|FG015|COMPLETED|Follow-up Period||2
9098234|NCT02891226|10162864|FG000|NOT COMPLETED|Follow-up Period||0
9098235|NCT02891226|10162865|FG001|NOT COMPLETED|Follow-up Period||0
9098236|NCT02891226|10162866|FG002|NOT COMPLETED|Follow-up Period||0
9098237|NCT02891226|10162867|FG003|NOT COMPLETED|Follow-up Period||0
9098238|NCT02891226|10162868|FG004|NOT COMPLETED|Follow-up Period||0
9098239|NCT02891226|10162869|FG005|NOT COMPLETED|Follow-up Period||0
9098240|NCT02891226|10162870|FG006|NOT COMPLETED|Follow-up Period||0
9098241|NCT02891226|10162871|FG007|NOT COMPLETED|Follow-up Period||0
9098242|NCT02891226|10162872|FG008|NOT COMPLETED|Follow-up Period||0
9098243|NCT02891226|10162873|FG009|NOT COMPLETED|Follow-up Period||0
9098244|NCT02891226|10162874|FG010|NOT COMPLETED|Follow-up Period||0
9098245|NCT02891226|10162875|FG011|NOT COMPLETED|Follow-up Period||1
9098246|NCT02891226|10162876|FG012|NOT COMPLETED|Follow-up Period||0
9098247|NCT02891226|10162877|FG013|NOT COMPLETED|Follow-up Period||0
9098248|NCT02891226|10162878|FG014|NOT COMPLETED|Follow-up Period||1
9098249|NCT02891226|10162879|FG015|NOT COMPLETED|Follow-up Period||1
9098250|NCT02703480|10162903|FG000|STARTED|Overall Study||11
9098251|NCT02703480|10162904|FG001|STARTED|Overall Study||11
9098252|NCT02703480|10162903|FG000|COMPLETED|Overall Study||10
9098253|NCT02703480|10162904|FG001|COMPLETED|Overall Study||10
9098254|NCT02703480|10162903|FG000|NOT COMPLETED|Overall Study||1
9098255|NCT02703480|10162904|FG001|NOT COMPLETED|Overall Study||1
9098256|NCT02549092|10162912|FG000|STARTED|Treatment Period||44
9098257|NCT02549092|10162913|FG001|STARTED|Treatment Period||45
9098258|NCT02549092|10162912|FG000|COMPLETED|Treatment Period||41
9098259|NCT02549092|10162913|FG001|COMPLETED|Treatment Period||38
9098260|NCT02549092|10162912|FG000|NOT COMPLETED|Treatment Period||3
9098261|NCT02549092|10162913|FG001|NOT COMPLETED|Treatment Period||7
9098262|NCT02549092|10162912|FG000|STARTED|Extension/Transition Period||10
9098263|NCT02549092|10162913|FG001|STARTED|Extension/Transition Period||14
9098264|NCT02549092|10162912|FG000|COMPLETED|Extension/Transition Period||5
9098265|NCT02549092|10162913|FG001|COMPLETED|Extension/Transition Period||5
9098266|NCT02549092|10162912|FG000|NOT COMPLETED|Extension/Transition Period||5
9098267|NCT02549092|10162913|FG001|NOT COMPLETED|Extension/Transition Period||9
9098268|NCT02506465|10162924|FG000|STARTED|Overall Study||128
9098269|NCT02506465|10162925|FG001|STARTED|Overall Study||57
9098270|NCT02506465|10162924|FG000|COMPLETED|Overall Study|78 patients reached 12 months FU visit.|78
9098271|NCT02506465|10162925|FG001|COMPLETED|Overall Study|The Sham arm was analyzed up to 3 months FU visit as primary endpoint timeframe in accordance with the FDA guideline for BPH treatments, published in 2010, the most recent guidance available at the time of the study.|57
9098272|NCT02506465|10162924|FG000|NOT COMPLETED|Overall Study||50
9098273|NCT02506465|10162925|FG001|NOT COMPLETED|Overall Study||0
9098274|NCT02323126|10162934|FG000|STARTED|Overall Study||18
9098275|NCT02323126|10162935|FG001|STARTED|Overall Study||16
9098276|NCT02323126|10162936|FG002|STARTED|Overall Study||30
9098277|NCT02323126|10162934|FG000|COMPLETED|Overall Study||0
9098278|NCT02323126|10162935|FG001|COMPLETED|Overall Study||0
9098279|NCT02323126|10162936|FG002|COMPLETED|Overall Study||0
9098280|NCT02323126|10162934|FG000|NOT COMPLETED|Overall Study||18
9098281|NCT02323126|10162935|FG001|NOT COMPLETED|Overall Study||16
9098282|NCT02323126|10162936|FG002|NOT COMPLETED|Overall Study||30
9098283|NCT01902290|10162949|FG000|STARTED|Overall Study||210
9098284|NCT01902290|10162950|FG001|STARTED|Overall Study||211
9098285|NCT01902290|10162949|FG000|Received Study Drug|Overall Study||207
9098286|NCT01902290|10162950|FG001|Received Study Drug|Overall Study||208
9098287|NCT01902290|10162949|FG000|COMPLETED|Overall Study||162
9098288|NCT01902290|10162950|FG001|COMPLETED|Overall Study||158
9098289|NCT01902290|10162949|FG000|NOT COMPLETED|Overall Study||48
9098290|NCT01902290|10162950|FG001|NOT COMPLETED|Overall Study||53
9098291|NCT01126749|10162961|FG000|STARTED|Phase 1b||3
9098292|NCT01126749|10162962|FG001|STARTED|Phase 1b||6
9098293|NCT01126749|10162963|FG002|STARTED|Phase 1b||0
9098294|NCT01126749|10162964|FG003|STARTED|Phase 1b||0
9098295|NCT01126749|10162961|FG000|COMPLETED|Phase 1b||0
9098296|NCT01126749|10162962|FG001|COMPLETED|Phase 1b||0
9098297|NCT01126749|10162963|FG002|COMPLETED|Phase 1b||0
9098298|NCT01126749|10162964|FG003|COMPLETED|Phase 1b||0
9098299|NCT01126749|10162961|FG000|NOT COMPLETED|Phase 1b||3
9098300|NCT01126749|10162962|FG001|NOT COMPLETED|Phase 1b||6
9098301|NCT01126749|10162963|FG002|NOT COMPLETED|Phase 1b||0
9098302|NCT01126749|10162964|FG003|NOT COMPLETED|Phase 1b||0
9098303|NCT01126749|10162961|FG000|STARTED|Phase 2||0
9098304|NCT01126749|10162962|FG001|STARTED|Phase 2||0
9098305|NCT01126749|10162963|FG002|STARTED|Phase 2||42
9098306|NCT01126749|10162964|FG003|STARTED|Phase 2||41
9098307|NCT01126749|10162961|FG000|Safety Analysis Set (SAS)/Treated|Phase 2||0
9098308|NCT01126749|10162962|FG001|Safety Analysis Set (SAS)/Treated|Phase 2||0
9098309|NCT01126749|10162963|FG002|Safety Analysis Set (SAS)/Treated|Phase 2||41
9098310|NCT01126749|10162964|FG003|Safety Analysis Set (SAS)/Treated|Phase 2||39
9098311|NCT01126749|10162961|FG000|Modified-intent-to-treat (MITT)|Phase 2||0
9098312|NCT01126749|10162962|FG001|Modified-intent-to-treat (MITT)|Phase 2||0
9098313|NCT01126749|10162963|FG002|Modified-intent-to-treat (MITT)|Phase 2||40
9098314|NCT01126749|10162964|FG003|Modified-intent-to-treat (MITT)|Phase 2||39
9098315|NCT01126749|10162961|FG000|COMPLETED|Phase 2||0
9098316|NCT01126749|10162962|FG001|COMPLETED|Phase 2||0
9098317|NCT01126749|10162963|FG002|COMPLETED|Phase 2||0
9098318|NCT01126749|10162964|FG003|COMPLETED|Phase 2||0
9098319|NCT01126749|10162961|FG000|NOT COMPLETED|Phase 2||0
9098320|NCT01126749|10162962|FG001|NOT COMPLETED|Phase 2||0
9098321|NCT01126749|10162963|FG002|NOT COMPLETED|Phase 2||42
9098322|NCT01126749|10162964|FG003|NOT COMPLETED|Phase 2||41
9098323|NCT01111110|10162976|FG000|STARTED|Overall Study||3
9098324|NCT01111110|10162977|FG001|STARTED|Overall Study||4
9098325|NCT01111110|10162976|FG000|COMPLETED|Overall Study||3
9098326|NCT01111110|10162977|FG001|COMPLETED|Overall Study||4
9098327|NCT01111110|10162976|FG000|NOT COMPLETED|Overall Study||0
9098328|NCT01111110|10162977|FG001|NOT COMPLETED|Overall Study||0
9098329|NCT01059448|10162987|FG000|STARTED|Overall Study||49
9098330|NCT01059448|10162988|FG001|STARTED|Overall Study||55
9098331|NCT01059448|10162989|FG002|STARTED|Overall Study||53
9098332|NCT01059448|10162990|FG003|STARTED|Overall Study||54
9098333|NCT01059448|10162987|FG000|COMPLETED|Overall Study||0
9098334|NCT01059448|10162988|FG001|COMPLETED|Overall Study||0
9098335|NCT01059448|10162989|FG002|COMPLETED|Overall Study||0
9098336|NCT01059448|10162990|FG003|COMPLETED|Overall Study||0
9098337|NCT01059448|10162987|FG000|NOT COMPLETED|Overall Study||49
9098338|NCT01059448|10162988|FG001|NOT COMPLETED|Overall Study||55
9098339|NCT01059448|10162989|FG002|NOT COMPLETED|Overall Study||53
9098340|NCT01059448|10162990|FG003|NOT COMPLETED|Overall Study||54
9098341|NCT00821587|10163002|FG000|STARTED|Overall Study||20
9098342|NCT00821587|10163003|FG001|STARTED|Overall Study||19
9098343|NCT00821587|10163002|FG000|COMPLETED|Overall Study||20
9098344|NCT00821587|10163003|FG001|COMPLETED|Overall Study||18
9098345|NCT00821587|10163002|FG000|NOT COMPLETED|Overall Study||0
9098346|NCT00821587|10163003|FG001|NOT COMPLETED|Overall Study||1
9098347|NCT00585195|10163030|FG000|STARTED|Overall Study||3
9098348|NCT00585195|10163031|FG001|STARTED|Overall Study||4
9098349|NCT00585195|10163032|FG002|STARTED|Overall Study||9
9098350|NCT00585195|10163033|FG003|STARTED|Overall Study||7
9098351|NCT00585195|10163034|FG004|STARTED|Overall Study||9
9098352|NCT00585195|10163035|FG005|STARTED|Overall Study||6
9098353|NCT00585195|10163036|FG006|STARTED|Overall Study||7
9098354|NCT00585195|10163037|FG007|STARTED|Overall Study||5
9098355|NCT00585195|10163038|FG008|STARTED|Overall Study||3
9098356|NCT00585195|10163039|FG009|STARTED|Overall Study||6
9098357|NCT00585195|10163040|FG010|STARTED|Overall Study||11
9098358|NCT00585195|10163041|FG011|STARTED|Overall Study||53
9098359|NCT00585195|10163042|FG012|STARTED|Overall Study||85
9098360|NCT00585195|10163043|FG013|STARTED|Overall Study||41
9098361|NCT00585195|10163044|FG014|STARTED|Overall Study||48
9098362|NCT00585195|10163045|FG015|STARTED|Overall Study||19
9098363|NCT00585195|10163046|FG016|STARTED|Overall Study||154
9098364|NCT00585195|10163047|FG017|STARTED|Overall Study||67
9098365|NCT00585195|10163048|FG018|STARTED|Overall Study||21
9098366|NCT00585195|10163049|FG019|STARTED|Overall Study||18
9098367|NCT00585195|10163050|FG020|STARTED|Overall Study||14
9098368|NCT00585195|10163030|FG000|Treated|Overall Study||3
9098369|NCT00585195|10163031|FG001|Treated|Overall Study||4
9098370|NCT00585195|10163032|FG002|Treated|Overall Study||8
9098371|NCT00585195|10163033|FG003|Treated|Overall Study||7
9098372|NCT00585195|10163034|FG004|Treated|Overall Study||8
9098373|NCT00585195|10163035|FG005|Treated|Overall Study||6
9098374|NCT00585195|10163036|FG006|Treated|Overall Study||6
9098375|NCT00585195|10163037|FG007|Treated|Overall Study||5
9098376|NCT00585195|10163038|FG008|Treated|Overall Study||3
9098377|NCT00585195|10163039|FG009|Treated|Overall Study||6
9098378|NCT00585195|10163040|FG010|Treated|Overall Study||9
9098379|NCT00585195|10163041|FG011|Treated|Overall Study||53
9098380|NCT00585195|10163042|FG012|Treated|Overall Study||85
9098381|NCT00585195|10163043|FG013|Treated|Overall Study||41
9098382|NCT00585195|10163044|FG014|Treated|Overall Study||48
9098383|NCT00585195|10163045|FG015|Treated|Overall Study||18
9098384|NCT00585195|10163046|FG016|Treated|Overall Study||154
9098385|NCT00585195|10163047|FG017|Treated|Overall Study||66
9098386|NCT00585195|10163048|FG018|Treated|Overall Study||18
9098387|NCT00585195|10163049|FG019|Treated|Overall Study||18
9098388|NCT00585195|10163050|FG020|Treated|Overall Study||12
9098389|NCT00585195|10163030|FG000|COMPLETED|Overall Study||0
9098390|NCT00585195|10163031|FG001|COMPLETED|Overall Study||0
9098391|NCT00585195|10163032|FG002|COMPLETED|Overall Study||0
9098392|NCT00585195|10163033|FG003|COMPLETED|Overall Study||0
9098393|NCT00585195|10163034|FG004|COMPLETED|Overall Study||0
9098394|NCT00585195|10163035|FG005|COMPLETED|Overall Study||0
9098395|NCT00585195|10163036|FG006|COMPLETED|Overall Study||0
9098396|NCT00585195|10163037|FG007|COMPLETED|Overall Study||0
9098397|NCT00585195|10163038|FG008|COMPLETED|Overall Study||0
9098398|NCT00585195|10163039|FG009|COMPLETED|Overall Study||0
9098399|NCT00585195|10163040|FG010|COMPLETED|Overall Study||0
9098400|NCT00585195|10163041|FG011|COMPLETED|Overall Study||0
9098401|NCT00585195|10163042|FG012|COMPLETED|Overall Study||0
9098402|NCT00585195|10163043|FG013|COMPLETED|Overall Study||0
9098403|NCT00585195|10163044|FG014|COMPLETED|Overall Study||0
9098404|NCT00585195|10163045|FG015|COMPLETED|Overall Study||0
9098405|NCT00585195|10163046|FG016|COMPLETED|Overall Study||0
9098406|NCT00585195|10163047|FG017|COMPLETED|Overall Study||0
9098407|NCT00585195|10163048|FG018|COMPLETED|Overall Study||0
9098408|NCT00585195|10163049|FG019|COMPLETED|Overall Study||0
9098409|NCT00585195|10163050|FG020|COMPLETED|Overall Study||0
9098410|NCT00585195|10163030|FG000|NOT COMPLETED|Overall Study||3
9098411|NCT00585195|10163031|FG001|NOT COMPLETED|Overall Study||4
9098412|NCT00585195|10163032|FG002|NOT COMPLETED|Overall Study||9
9098413|NCT00585195|10163033|FG003|NOT COMPLETED|Overall Study||7
9098414|NCT00585195|10163034|FG004|NOT COMPLETED|Overall Study||9
9098415|NCT00585195|10163035|FG005|NOT COMPLETED|Overall Study||6
9098416|NCT00585195|10163036|FG006|NOT COMPLETED|Overall Study||7
9098417|NCT00585195|10163037|FG007|NOT COMPLETED|Overall Study||5
9098418|NCT00585195|10163038|FG008|NOT COMPLETED|Overall Study||3
9098419|NCT00585195|10163039|FG009|NOT COMPLETED|Overall Study||6
9098420|NCT00585195|10163040|FG010|NOT COMPLETED|Overall Study||11
9098421|NCT00585195|10163041|FG011|NOT COMPLETED|Overall Study||53
9098422|NCT00585195|10163042|FG012|NOT COMPLETED|Overall Study||85
9098423|NCT00585195|10163043|FG013|NOT COMPLETED|Overall Study||41
9098424|NCT00585195|10163044|FG014|NOT COMPLETED|Overall Study||48
9098425|NCT00585195|10163045|FG015|NOT COMPLETED|Overall Study||19
9098426|NCT00585195|10163046|FG016|NOT COMPLETED|Overall Study||154
9098427|NCT00585195|10163047|FG017|NOT COMPLETED|Overall Study||67
9098428|NCT00585195|10163048|FG018|NOT COMPLETED|Overall Study||21
9098429|NCT00585195|10163049|FG019|NOT COMPLETED|Overall Study||18
9098430|NCT00585195|10163050|FG020|NOT COMPLETED|Overall Study||14
9098431|NCT00278915|10163133|FG000|STARTED|Overall Study|First 6 patients were dosed at 2mg/kg then increased to 4 mg/kg. Remaining 24 were dosed at 4mg/kg.|30
9098432|NCT00278915|10163133|FG000|COMPLETED|Overall Study||29
8625715|NCT00508924|9665309|FG000|COMPLETED|Overall Study||36
8625716|NCT00508924|9665310|FG001|COMPLETED|Overall Study||38
8625717|NCT00508924|9665311|FG002|COMPLETED|Overall Study||31
9098433|NCT00278915|10163133|FG000|NOT COMPLETED|Overall Study||1
8625718|NCT00508924|9665312|FG003|COMPLETED|Overall Study||33
8625719|NCT00508924|9665309|FG000|NOT COMPLETED|Overall Study||0
8625720|NCT00508924|9665310|FG001|NOT COMPLETED|Overall Study||0
8625721|NCT00508924|9665311|FG002|NOT COMPLETED|Overall Study||1
8625722|NCT00508924|9665312|FG003|NOT COMPLETED|Overall Study||1
8625723|NCT00509002|9665322|FG000|STARTED|Overall Study||37
8625724|NCT00509002|9665322|FG000|COMPLETED|Overall Study||37
9098434|NCT04446429|10163139|FG000|STARTED|Overall Study||134
9098435|NCT04446429|10163140|FG001|STARTED|Overall Study||134
9098436|NCT04446429|10163139|FG000|COMPLETED|Overall Study|In placebo group, 6 patients were lost to follow-up but were included in intention-to-treat analysis.|128
9098437|NCT04446429|10163140|FG001|COMPLETED|Overall Study||134
9098438|NCT04446429|10163139|FG000|NOT COMPLETED|Overall Study||6
9098439|NCT04446429|10163140|FG001|NOT COMPLETED|Overall Study||0
9098440|NCT04372017|10163150|FG000|STARTED|Overall Study||1
9098441|NCT04372017|10163151|FG001|STARTED|Overall Study||0
9098442|NCT04372017|10163152|FG002|STARTED|Overall Study||0
9098443|NCT04372017|10163153|FG003|STARTED|Overall Study||0
9098444|NCT04372017|10163150|FG000|COMPLETED|Overall Study||1
9098445|NCT04372017|10163151|FG001|COMPLETED|Overall Study||0
9098446|NCT04372017|10163152|FG002|COMPLETED|Overall Study||0
9098447|NCT04372017|10163153|FG003|COMPLETED|Overall Study||0
9098448|NCT04372017|10163150|FG000|NOT COMPLETED|Overall Study||0
9098449|NCT04372017|10163151|FG001|NOT COMPLETED|Overall Study||0
9098450|NCT04372017|10163152|FG002|NOT COMPLETED|Overall Study||0
9098451|NCT04372017|10163153|FG003|NOT COMPLETED|Overall Study||0
9098452|NCT04194528|10163163|FG000|STARTED|Overall Study||2
9098453|NCT04194528|10163163|FG000|COMPLETED|Overall Study||1
9098454|NCT04194528|10163163|FG000|NOT COMPLETED|Overall Study||1
9098455|NCT04147650|10163171|FG000|STARTED|Overall Study||127
9098456|NCT04147650|10163172|FG001|STARTED|Overall Study||126
9098457|NCT04147650|10163173|FG002|STARTED|Overall Study||128
9098458|NCT04147650|10163174|FG003|STARTED|Overall Study||127
9098459|NCT04147650|10163171|FG000|Modified Intent to Treat (mITT)|Overall Study||120
9098460|NCT04147650|10163172|FG001|Modified Intent to Treat (mITT)|Overall Study||119
9098461|NCT04147650|10163173|FG002|Modified Intent to Treat (mITT)|Overall Study||122
9098462|NCT04147650|10163174|FG003|Modified Intent to Treat (mITT)|Overall Study||121
9098463|NCT04147650|10163171|FG000|COMPLETED|Overall Study||116
9098464|NCT04147650|10163172|FG001|COMPLETED|Overall Study||107
9098465|NCT04147650|10163173|FG002|COMPLETED|Overall Study||121
9098466|NCT04147650|10163174|FG003|COMPLETED|Overall Study||120
9098467|NCT04147650|10163171|FG000|NOT COMPLETED|Overall Study||11
9098468|NCT04147650|10163172|FG001|NOT COMPLETED|Overall Study||19
9098469|NCT04147650|10163173|FG002|NOT COMPLETED|Overall Study||7
9098470|NCT04147650|10163174|FG003|NOT COMPLETED|Overall Study||7
9098471|NCT03527238|10163186|FG000|STARTED|Overall Study||31
9098472|NCT03527238|10163187|FG001|STARTED|Overall Study||31
9098473|NCT03527238|10163186|FG000|COMPLETED|Overall Study||29
9098474|NCT03527238|10163187|FG001|COMPLETED|Overall Study||27
9098475|NCT03527238|10163186|FG000|NOT COMPLETED|Overall Study||2
9098476|NCT03527238|10163187|FG001|NOT COMPLETED|Overall Study||4
8625725|NCT00509002|9665322|FG000|NOT COMPLETED|Overall Study||0
8625726|NCT00509028|9665328|FG000|STARTED|Overall Study||121
8625727|NCT00509028|9665329|FG001|STARTED|Overall Study||120
8625728|NCT00509028|9665328|FG000|COMPLETED|Overall Study||109
8625729|NCT00509028|9665329|FG001|COMPLETED|Overall Study||113
8625730|NCT00509028|9665328|FG000|NOT COMPLETED|Overall Study||12
8625731|NCT00509028|9665329|FG001|NOT COMPLETED|Overall Study||7
8625732|NCT00509041|9665335|FG000|STARTED|Overall Study||43
8625733|NCT00509041|9665335|FG000|COMPLETED|Overall Study||43
8625734|NCT00509041|9665335|FG000|NOT COMPLETED|Overall Study||0
8625735|NCT00509067|9665341|FG000|STARTED|Overall Study||19
9098477|NCT03116685|10163195|FG000|STARTED|Overall Study||13
9098478|NCT03116685|10163196|FG001|STARTED|Overall Study||12
9098479|NCT03116685|10163195|FG000|COMPLETED|Overall Study||13
9098480|NCT03116685|10163196|FG001|COMPLETED|Overall Study||11
9098481|NCT03116685|10163195|FG000|NOT COMPLETED|Overall Study||0
9098482|NCT03116685|10163196|FG001|NOT COMPLETED|Overall Study||1
9098483|NCT03099304|10163207|FG000|STARTED|DB Period Day 1 to Week 24||32
9098484|NCT03099304|10163208|FG001|STARTED|DB Period Day 1 to Week 24||31
9098485|NCT03099304|10163209|FG002|STARTED|DB Period Day 1 to Week 24||31
9098486|NCT03099304|10163210|FG003|STARTED|DB Period Day 1 to Week 24||30
9098487|NCT03099304|10163211|FG004|STARTED|DB Period Day 1 to Week 24||33
9098488|NCT03099304|10163207|FG000|COMPLETED|DB Period Day 1 to Week 24||27
9098489|NCT03099304|10163208|FG001|COMPLETED|DB Period Day 1 to Week 24||26
9098490|NCT03099304|10163209|FG002|COMPLETED|DB Period Day 1 to Week 24||30
9098491|NCT03099304|10163210|FG003|COMPLETED|DB Period Day 1 to Week 24||26
9098492|NCT03099304|10163211|FG004|COMPLETED|DB Period Day 1 to Week 24||30
9098493|NCT03099304|10163207|FG000|NOT COMPLETED|DB Period Day 1 to Week 24||5
9098494|NCT03099304|10163208|FG001|NOT COMPLETED|DB Period Day 1 to Week 24||5
9098495|NCT03099304|10163209|FG002|NOT COMPLETED|DB Period Day 1 to Week 24||1
9098496|NCT03099304|10163210|FG003|NOT COMPLETED|DB Period Day 1 to Week 24||4
9098497|NCT03099304|10163211|FG004|NOT COMPLETED|DB Period Day 1 to Week 24||3
9098498|NCT03099304|10163207|FG000|STARTED|DB Period Weeks 24 to 52|Vehicle cream was not used after Week 24. After DB 24 week period, participants who met criteria were rerandomized to 1 of the 3 higher active blinded treatment groups.|0
9098499|NCT03099304|10163208|FG001|STARTED|DB Period Weeks 24 to 52|These subjects continued on the initial .15% QD treatment.|11
9098500|NCT03099304|10163209|FG002|STARTED|DB Period Weeks 24 to 52|Total participants include those initially randomized to 0.5% QD and those re-randomized from vehicle cream and .15% QD to 0.5% QD.|45
9098501|NCT03099304|10163210|FG003|STARTED|DB Period Weeks 24 to 52|Total participants include those initially randomized to 1.5% QD and those re-randomized from vehicle cream and .15% QD to 1.5% QD.|44
9098502|NCT03099304|10163211|FG004|STARTED|DB Period Weeks 24 to 52|Total participants include those initially randomized to 1.5% BID and those re-randomized from vehicle cream and .15% QD to 1.5% BID|47
9098503|NCT03099304|10163207|FG000|COMPLETED|DB Period Weeks 24 to 52||0
9098504|NCT03099304|10163208|FG001|COMPLETED|DB Period Weeks 24 to 52||10
9098505|NCT03099304|10163209|FG002|COMPLETED|DB Period Weeks 24 to 52||43
9098506|NCT03099304|10163210|FG003|COMPLETED|DB Period Weeks 24 to 52||37
9098507|NCT03099304|10163211|FG004|COMPLETED|DB Period Weeks 24 to 52||45
9098508|NCT03099304|10163207|FG000|NOT COMPLETED|DB Period Weeks 24 to 52||0
9098509|NCT03099304|10163208|FG001|NOT COMPLETED|DB Period Weeks 24 to 52||1
9098510|NCT03099304|10163209|FG002|NOT COMPLETED|DB Period Weeks 24 to 52||2
9098511|NCT03099304|10163210|FG003|NOT COMPLETED|DB Period Weeks 24 to 52||7
9098512|NCT03099304|10163211|FG004|NOT COMPLETED|DB Period Weeks 24 to 52||2
9098513|NCT03034863|10163232|FG000|STARTED|Overall Study||38
9098514|NCT03034863|10163233|FG001|STARTED|Overall Study||40
9098515|NCT03034863|10163232|FG000|Veterans|Overall Study||19
9098516|NCT03034863|10163233|FG001|Veterans|Overall Study||20
9098517|NCT03034863|10163232|FG000|Supporting Partners|Overall Study||19
9098518|NCT03034863|10163233|FG001|Supporting Partners|Overall Study||20
9098519|NCT03034863|10163232|FG000|COMPLETED|Overall Study||28
9098520|NCT03034863|10163233|FG001|COMPLETED|Overall Study||28
9098521|NCT03034863|10163232|FG000|NOT COMPLETED|Overall Study||10
9098522|NCT03034863|10163233|FG001|NOT COMPLETED|Overall Study||12
9098523|NCT02819050|10163246|FG000|STARTED|Overall Study||40
9098524|NCT02819050|10163247|FG001|STARTED|Overall Study||40
9098525|NCT02819050|10163246|FG000|COMPLETED|Overall Study||40
9098526|NCT02819050|10163247|FG001|COMPLETED|Overall Study||40
9098527|NCT02819050|10163246|FG000|NOT COMPLETED|Overall Study||0
9098528|NCT02819050|10163247|FG001|NOT COMPLETED|Overall Study||0
9098529|NCT02682901|10163257|FG000|STARTED|Overall Study||43
9098530|NCT02682901|10163258|FG001|STARTED|Overall Study||41
9098531|NCT02682901|10163257|FG000|Completed 4 Weeks|Overall Study||38
9098532|NCT02682901|10163258|FG001|Completed 4 Weeks|Overall Study||39
9098533|NCT02682901|10163257|FG000|Completed 12 Weeks|Overall Study||36
9098534|NCT02682901|10163258|FG001|Completed 12 Weeks|Overall Study||37
9098535|NCT02682901|10163257|FG000|COMPLETED|Overall Study||33
9098536|NCT02682901|10163258|FG001|COMPLETED|Overall Study||37
9098537|NCT02682901|10163257|FG000|NOT COMPLETED|Overall Study||10
9098538|NCT02682901|10163258|FG001|NOT COMPLETED|Overall Study||4
9098539|NCT02567825|10163266|FG000|STARTED|Overall Study||129
9098540|NCT02567825|10163267|FG001|STARTED|Overall Study||121
9098541|NCT02567825|10163266|FG000|COMPLETED|Overall Study||108
9098542|NCT02567825|10163267|FG001|COMPLETED|Overall Study||100
9098543|NCT02567825|10163266|FG000|NOT COMPLETED|Overall Study||21
9098544|NCT02567825|10163267|FG001|NOT COMPLETED|Overall Study||21
9098545|NCT02555657|10163275|FG000|STARTED|Overall Study||312
9098546|NCT02555657|10163276|FG001|STARTED|Overall Study||310
9098547|NCT02555657|10163275|FG000|Treated|Overall Study||309
9098548|NCT02555657|10163276|FG001|Treated|Overall Study||292
9098549|NCT02555657|10163275|FG000|COMPLETED|Overall Study||0
9098550|NCT02555657|10163276|FG001|COMPLETED|Overall Study||0
9098551|NCT02555657|10163275|FG000|NOT COMPLETED|Overall Study||312
9098552|NCT02555657|10163276|FG001|NOT COMPLETED|Overall Study||310
9098553|NCT02190721|10163286|FG000|STARTED|Overall Study||2
9098554|NCT02190721|10163287|FG001|STARTED|Overall Study||30
9098555|NCT02190721|10163288|FG002|STARTED|Overall Study||18
9098556|NCT02190721|10163286|FG000|Completed Treatment|Overall Study||2
9098557|NCT02190721|10163287|FG001|Completed Treatment|Overall Study||30
9098558|NCT02190721|10163288|FG002|Completed Treatment|Overall Study||18
9098559|NCT02190721|10163286|FG000|Completed 30 Day Follow-up|Overall Study||2
9098560|NCT02190721|10163287|FG001|Completed 30 Day Follow-up|Overall Study||29
9098561|NCT02190721|10163288|FG002|Completed 30 Day Follow-up|Overall Study||18
9098562|NCT02190721|10163286|FG000|Completed 90 Day Follow-up|Overall Study||2
9098563|NCT02190721|10163287|FG001|Completed 90 Day Follow-up|Overall Study||29
9098564|NCT02190721|10163288|FG002|Completed 90 Day Follow-up|Overall Study||18
9098565|NCT02190721|10163286|FG000|COMPLETED|Overall Study||2
9098566|NCT02190721|10163287|FG001|COMPLETED|Overall Study||29
9098567|NCT02190721|10163288|FG002|COMPLETED|Overall Study||18
9098568|NCT02190721|10163286|FG000|NOT COMPLETED|Overall Study||0
9098569|NCT02190721|10163287|FG001|NOT COMPLETED|Overall Study||1
9098570|NCT02190721|10163288|FG002|NOT COMPLETED|Overall Study||0
9098571|NCT00908687|10163302|FG000|STARTED|Overall Study||50
9098572|NCT00908687|10163303|FG001|STARTED|Overall Study||100
9098573|NCT00908687|10163304|FG002|STARTED|Overall Study||102
9098574|NCT00908687|10163305|FG003|STARTED|Overall Study||50
9098575|NCT00908687|10163306|FG004|STARTED|Overall Study||98
9098576|NCT00908687|10163307|FG005|STARTED|Overall Study||100
9098577|NCT00908687|10163302|FG000|COMPLETED|Overall Study||49
9098578|NCT00908687|10163303|FG001|COMPLETED|Overall Study||99
9098579|NCT00908687|10163304|FG002|COMPLETED|Overall Study||99
9098580|NCT00908687|10163305|FG003|COMPLETED|Overall Study||47
9098581|NCT00908687|10163306|FG004|COMPLETED|Overall Study||94
9098582|NCT00908687|10163307|FG005|COMPLETED|Overall Study||94
9098583|NCT00908687|10163302|FG000|NOT COMPLETED|Overall Study||1
9098584|NCT00908687|10163303|FG001|NOT COMPLETED|Overall Study||1
9098585|NCT00908687|10163304|FG002|NOT COMPLETED|Overall Study||3
9098586|NCT00908687|10163305|FG003|NOT COMPLETED|Overall Study||3
9098587|NCT00908687|10163306|FG004|NOT COMPLETED|Overall Study||4
9098588|NCT00908687|10163307|FG005|NOT COMPLETED|Overall Study||6
9098589|NCT00739401|10163321|FG000|STARTED|Overall Study||44
9098590|NCT00739401|10163321|FG000|COMPLETED|Overall Study||3
9098591|NCT00739401|10163321|FG000|NOT COMPLETED|Overall Study||41
9098592|NCT00651742|10163325|FG000|STARTED|Overall Study||28
9098593|NCT00651742|10163325|FG000|Treated|Overall Study||27
9098594|NCT00651742|10163325|FG000|Efficacy Analysis Per Investigator|Overall Study||21
9098595|NCT00651742|10163325|FG000|Efficacy Analysis Per Independent Reader|Overall Study||25
9098596|NCT00651742|10163325|FG000|COMPLETED|Overall Study||0
9098597|NCT00651742|10163325|FG000|NOT COMPLETED|Overall Study||28
9098598|NCT00308516|10163331|FG000|STARTED|Overall Study||35
9098599|NCT00308516|10163332|FG001|STARTED|Overall Study||31
9098600|NCT00308516|10163331|FG000|COMPLETED|Overall Study||6
9098601|NCT00308516|10163332|FG001|COMPLETED|Overall Study||10
9098602|NCT00308516|10163331|FG000|NOT COMPLETED|Overall Study||29
9098603|NCT00308516|10163332|FG001|NOT COMPLETED|Overall Study||21
9098604|NCT04331366|10163338|FG000|STARTED|Overall Study||2
9098605|NCT04331366|10163338|FG000|COMPLETED|Overall Study||2
9098606|NCT04331366|10163338|FG000|NOT COMPLETED|Overall Study||0
9098607|NCT04930263|10163344|FG000|STARTED|Overall Study||33
9098608|NCT04930263|10163345|FG001|STARTED|Overall Study||33
9098609|NCT04930263|10163344|FG000|COMPLETED|Overall Study||30
9098610|NCT04930263|10163345|FG001|COMPLETED|Overall Study||28
9098611|NCT04930263|10163344|FG000|NOT COMPLETED|Overall Study||3
9098612|NCT04930263|10163345|FG001|NOT COMPLETED|Overall Study||5
9098613|NCT04321252|10163360|FG000|STARTED|Overall Study||6
9098614|NCT04321252|10163361|FG001|STARTED|Overall Study||6
9098615|NCT04321252|10163362|FG002|STARTED|Overall Study||6
9098616|NCT04321252|10163363|FG003|STARTED|Overall Study||6
9098617|NCT04321252|10163364|FG004|STARTED|Overall Study||6
9098618|NCT04321252|10163365|FG005|STARTED|Overall Study||9
9098619|NCT04321252|10163366|FG006|STARTED|Overall Study||6
9098620|NCT04321252|10163367|FG007|STARTED|Overall Study||6
9098621|NCT04321252|10163368|FG008|STARTED|Overall Study||6
9098622|NCT04321252|10163360|FG000|PK Analysis Set|Overall Study||6
9098623|NCT04321252|10163361|FG001|PK Analysis Set|Overall Study||6
9098624|NCT04321252|10163362|FG002|PK Analysis Set|Overall Study||6
9098625|NCT04321252|10163363|FG003|PK Analysis Set|Overall Study||6
9098626|NCT04321252|10163364|FG004|PK Analysis Set|Overall Study||6
9098627|NCT04321252|10163365|FG005|PK Analysis Set|Overall Study||0
9098628|NCT04321252|10163366|FG006|PK Analysis Set|Overall Study||6
9098629|NCT04321252|10163367|FG007|PK Analysis Set|Overall Study||6
9098630|NCT04321252|10163368|FG008|PK Analysis Set|Overall Study||0
9098631|NCT04321252|10163360|FG000|COMPLETED|Overall Study||6
9098632|NCT04321252|10163361|FG001|COMPLETED|Overall Study||6
9098633|NCT04321252|10163362|FG002|COMPLETED|Overall Study||6
9098634|NCT04321252|10163363|FG003|COMPLETED|Overall Study||6
9098635|NCT04321252|10163364|FG004|COMPLETED|Overall Study||6
9098636|NCT04321252|10163365|FG005|COMPLETED|Overall Study||8
9098637|NCT04321252|10163366|FG006|COMPLETED|Overall Study||6
9098638|NCT04321252|10163367|FG007|COMPLETED|Overall Study||6
9098639|NCT04321252|10163368|FG008|COMPLETED|Overall Study||6
9098640|NCT04321252|10163360|FG000|NOT COMPLETED|Overall Study||0
9098641|NCT04321252|10163361|FG001|NOT COMPLETED|Overall Study||0
9098642|NCT04321252|10163362|FG002|NOT COMPLETED|Overall Study||0
9098643|NCT04321252|10163363|FG003|NOT COMPLETED|Overall Study||0
9098644|NCT04321252|10163364|FG004|NOT COMPLETED|Overall Study||0
9098645|NCT04321252|10163365|FG005|NOT COMPLETED|Overall Study||1
9098646|NCT04321252|10163366|FG006|NOT COMPLETED|Overall Study||0
9098647|NCT04321252|10163367|FG007|NOT COMPLETED|Overall Study||0
9098648|NCT04321252|10163368|FG008|NOT COMPLETED|Overall Study||0
9098649|NCT04285684|10163394|FG000|STARTED|Overall Study||4
9098650|NCT04285684|10163394|FG000|COMPLETED|Overall Study||4
9098651|NCT04285684|10163394|FG000|NOT COMPLETED|Overall Study||0
9098652|NCT04176445|10163398|FG000|STARTED|Overall Study||12
9098653|NCT04176445|10163399|FG001|STARTED|Overall Study||7
9098654|NCT04176445|10163398|FG000|COMPLETED|Overall Study||12
8625736|NCT00509067|9665342|FG001|STARTED|Overall Study||24
8625737|NCT00509067|9665341|FG000|COMPLETED|Overall Study||15
8625738|NCT00509067|9665342|FG001|COMPLETED|Overall Study||19
8625739|NCT00509067|9665341|FG000|NOT COMPLETED|Overall Study||4
8625740|NCT00509067|9665342|FG001|NOT COMPLETED|Overall Study||5
8625741|NCT00509093|9665352|FG000|STARTED|Overall Study||32
8625742|NCT00509093|9665352|FG000|COMPLETED|Overall Study||8
8625743|NCT00509093|9665352|FG000|NOT COMPLETED|Overall Study||24
8625744|NCT00509106|9665358|FG000|STARTED|Overall Study||315
8625745|NCT00509106|9665359|FG001|STARTED|Overall Study||307
8625746|NCT00509106|9665358|FG000|COMPLETED|Overall Study||284
8625747|NCT00509106|9665359|FG001|COMPLETED|Overall Study||278
8625748|NCT00509106|9665358|FG000|NOT COMPLETED|Overall Study||31
8625749|NCT00509106|9665359|FG001|NOT COMPLETED|Overall Study||29
8625750|NCT00509145|9665367|FG000|STARTED|Overall Study||550
8625751|NCT00509145|9665368|FG001|STARTED|Overall Study||556
8625752|NCT00509145|9665367|FG000|COMPLETED|Overall Study||437
8625753|NCT00509145|9665368|FG001|COMPLETED|Overall Study||427
8625754|NCT00509145|9665367|FG000|NOT COMPLETED|Overall Study||113
8625755|NCT00509145|9665368|FG001|NOT COMPLETED|Overall Study||129
8625756|NCT00509171|9665376|FG000|STARTED|Overall Study||11
8625757|NCT00509171|9665377|FG001|STARTED|Overall Study||11
8625758|NCT00509171|9665376|FG000|COMPLETED|Overall Study||11
8625759|NCT00509171|9665377|FG001|COMPLETED|Overall Study||11
8625760|NCT00509171|9665376|FG000|NOT COMPLETED|Overall Study||0
8625761|NCT00509171|9665377|FG001|NOT COMPLETED|Overall Study||0
8625762|NCT00509197|9665385|FG000|STARTED|Overall Study||6
8625763|NCT00509197|9665386|FG001|STARTED|Overall Study||6
8625764|NCT00509197|9665385|FG000|COMPLETED|Overall Study||6
8625765|NCT00509197|9665386|FG001|COMPLETED|Overall Study||6
8625766|NCT00509197|9665385|FG000|NOT COMPLETED|Overall Study||0
8625767|NCT00509197|9665386|FG001|NOT COMPLETED|Overall Study||0
8625768|NCT00509223|9665396|FG000|STARTED|Overall Study||207
8625769|NCT00509223|9665397|FG001|STARTED|Overall Study||209
8625770|NCT00509223|9665396|FG000|COMPLETED|Overall Study||119
9098655|NCT04176445|10163399|FG001|COMPLETED|Overall Study||5
9098656|NCT04176445|10163398|FG000|NOT COMPLETED|Overall Study||0
9098657|NCT04176445|10163399|FG001|NOT COMPLETED|Overall Study||2
9098658|NCT04126213|10163411|FG000|STARTED|Overall Study||70
9098659|NCT04126213|10163412|FG001|STARTED|Overall Study||75
9098660|NCT04126213|10163413|FG002|STARTED|Overall Study||68
9098661|NCT04126213|10163414|FG003|STARTED|Overall Study||67
9098662|NCT04126213|10163415|FG004|STARTED|Overall Study||73
9098663|NCT04126213|10163416|FG005|STARTED|Overall Study||66
9098664|NCT04126213|10163411|FG000|COMPLETED|Overall Study||58
8625771|NCT00509223|9665397|FG001|COMPLETED|Overall Study||137
8625772|NCT00509223|9665396|FG000|NOT COMPLETED|Overall Study||88
8625773|NCT00509223|9665397|FG001|NOT COMPLETED|Overall Study||72
8625774|NCT00509236|9665405|FG000|STARTED|Overall Study||64
8625775|NCT00509236|9665406|FG001|STARTED|Overall Study||65
8625776|NCT00509236|9665405|FG000|COMPLETED|Overall Study||47
9098665|NCT04126213|10163412|FG001|COMPLETED|Overall Study||70
9098666|NCT04126213|10163413|FG002|COMPLETED|Overall Study||59
9098667|NCT04126213|10163414|FG003|COMPLETED|Overall Study||54
9098668|NCT04126213|10163415|FG004|COMPLETED|Overall Study||67
9098669|NCT04126213|10163416|FG005|COMPLETED|Overall Study||55
9098670|NCT04126213|10163411|FG000|NOT COMPLETED|Overall Study||12
9098671|NCT04126213|10163412|FG001|NOT COMPLETED|Overall Study||5
9098672|NCT04126213|10163413|FG002|NOT COMPLETED|Overall Study||9
9098673|NCT04126213|10163414|FG003|NOT COMPLETED|Overall Study||13
9098674|NCT04126213|10163415|FG004|NOT COMPLETED|Overall Study||6
9098675|NCT04126213|10163416|FG005|NOT COMPLETED|Overall Study||11
9098676|NCT03916458|10163433|FG000|STARTED|Overall Study||62
9098677|NCT03916458|10163433|FG000|COMPLETED|Overall Study|Out of these 62 participants, 2 participants died. But data available before censoring date for these 2 participants were observed and included in results.|62
9098678|NCT03916458|10163433|FG000|NOT COMPLETED|Overall Study||0
9098679|NCT03672188|10163452|FG000|STARTED|Overall Study||6
9098680|NCT03672188|10163453|FG001|STARTED|Overall Study||6
9098681|NCT03672188|10163454|FG002|STARTED|Overall Study||6
9098682|NCT03672188|10163455|FG003|STARTED|Overall Study||8
9098683|NCT03672188|10163456|FG004|STARTED|Overall Study||6
9098684|NCT03672188|10163457|FG005|STARTED|Overall Study||6
9098685|NCT03672188|10163458|FG006|STARTED|Overall Study||12
9098686|NCT03672188|10163459|FG007|STARTED|Overall Study||3
9098687|NCT03672188|10163460|FG008|STARTED|Overall Study||6
9098688|NCT03672188|10163461|FG009|STARTED|Overall Study||6
9098689|NCT03672188|10163462|FG010|STARTED|Overall Study||3
9098690|NCT03672188|10163463|FG011|STARTED|Overall Study||3
9098691|NCT03672188|10163464|FG012|STARTED|Overall Study||3
9098692|NCT03672188|10163465|FG013|STARTED|Overall Study||6
9098693|NCT03672188|10163466|FG014|STARTED|Overall Study||2
9098694|NCT03672188|10163452|FG000|Dosed|Overall Study||6
9098695|NCT03672188|10163453|FG001|Dosed|Overall Study||6
9098696|NCT03672188|10163454|FG002|Dosed|Overall Study||6
9098697|NCT03672188|10163455|FG003|Dosed|Overall Study|1 subject was not dosed and therefore not included in any analyses.|7
9098698|NCT03672188|10163456|FG004|Dosed|Overall Study||6
9098699|NCT03672188|10163457|FG005|Dosed|Overall Study||6
9098700|NCT03672188|10163458|FG006|Dosed|Overall Study||12
9098701|NCT03672188|10163459|FG007|Dosed|Overall Study||3
9098702|NCT03672188|10163460|FG008|Dosed|Overall Study||6
9098703|NCT03672188|10163461|FG009|Dosed|Overall Study||6
9098704|NCT03672188|10163462|FG010|Dosed|Overall Study||3
9098705|NCT03672188|10163463|FG011|Dosed|Overall Study||3
9098706|NCT03672188|10163464|FG012|Dosed|Overall Study||3
9098707|NCT03672188|10163465|FG013|Dosed|Overall Study||6
9098708|NCT03672188|10163466|FG014|Dosed|Overall Study||2
9098709|NCT03672188|10163452|FG000|COMPLETED|Overall Study||6
9098710|NCT03672188|10163453|FG001|COMPLETED|Overall Study||6
9098711|NCT03672188|10163454|FG002|COMPLETED|Overall Study|1 Subject could not attend last follow up (Week 12 visit)|5
9098712|NCT03672188|10163455|FG003|COMPLETED|Overall Study||5
9098713|NCT03672188|10163456|FG004|COMPLETED|Overall Study||6
9098714|NCT03672188|10163457|FG005|COMPLETED|Overall Study||6
9098715|NCT03672188|10163458|FG006|COMPLETED|Overall Study||12
9098716|NCT03672188|10163459|FG007|COMPLETED|Overall Study||3
9098717|NCT03672188|10163460|FG008|COMPLETED|Overall Study||6
9098718|NCT03672188|10163461|FG009|COMPLETED|Overall Study||6
9098719|NCT03672188|10163462|FG010|COMPLETED|Overall Study||3
9098720|NCT03672188|10163463|FG011|COMPLETED|Overall Study||3
9098721|NCT03672188|10163464|FG012|COMPLETED|Overall Study|1 non-treatment related SAE of suicide during follow up period|2
9098722|NCT03672188|10163465|FG013|COMPLETED|Overall Study||6
9098723|NCT03672188|10163466|FG014|COMPLETED|Overall Study||2
9098724|NCT03672188|10163452|FG000|NOT COMPLETED|Overall Study||0
9098725|NCT03672188|10163453|FG001|NOT COMPLETED|Overall Study||0
9098726|NCT03672188|10163454|FG002|NOT COMPLETED|Overall Study||1
9098727|NCT03672188|10163455|FG003|NOT COMPLETED|Overall Study||3
9098728|NCT03672188|10163456|FG004|NOT COMPLETED|Overall Study||0
9098729|NCT03672188|10163457|FG005|NOT COMPLETED|Overall Study||0
8625777|NCT00509236|9665406|FG001|COMPLETED|Overall Study||45
8625778|NCT00509236|9665405|FG000|NOT COMPLETED|Overall Study||17
9098730|NCT03672188|10163458|FG006|NOT COMPLETED|Overall Study||0
9098731|NCT03672188|10163459|FG007|NOT COMPLETED|Overall Study||0
9098732|NCT03672188|10163460|FG008|NOT COMPLETED|Overall Study||0
8625779|NCT00509236|9665406|FG001|NOT COMPLETED|Overall Study||20
8625780|NCT00509249|9665412|FG000|STARTED|Overall Study||18
9098733|NCT03672188|10163461|FG009|NOT COMPLETED|Overall Study||0
9098734|NCT03672188|10163462|FG010|NOT COMPLETED|Overall Study||0
9098735|NCT03672188|10163463|FG011|NOT COMPLETED|Overall Study||0
9098736|NCT03672188|10163464|FG012|NOT COMPLETED|Overall Study||1
9098737|NCT03672188|10163465|FG013|NOT COMPLETED|Overall Study||0
9098738|NCT03672188|10163466|FG014|NOT COMPLETED|Overall Study||0
9098739|NCT03637959|10163532|FG000|STARTED|Overall Study||270
9098740|NCT03637959|10163532|FG000|COMPLETED|Overall Study||270
9098741|NCT03637959|10163532|FG000|NOT COMPLETED|Overall Study||0
9098742|NCT03230916|10163547|FG000|STARTED|Overall Study||7
9098743|NCT03230916|10163548|FG001|STARTED|Overall Study||6
9098744|NCT03230916|10163549|FG002|STARTED|Overall Study||6
9098745|NCT03230916|10163550|FG003|STARTED|Overall Study||4
9098746|NCT03230916|10163551|FG004|STARTED|Overall Study||4
9098747|NCT03230916|10163552|FG005|STARTED|Overall Study||6
9098748|NCT03230916|10163553|FG006|STARTED|Overall Study||3
9098749|NCT03230916|10163554|FG007|STARTED|Overall Study||2
9098750|NCT03230916|10163555|FG008|STARTED|Overall Study||2
9098751|NCT03230916|10163556|FG009|STARTED|Overall Study||3
9098752|NCT03230916|10163557|FG010|STARTED|Overall Study||4
9098753|NCT03230916|10163547|FG000|Treated|Overall Study||7
9098754|NCT03230916|10163548|FG001|Treated|Overall Study||6
9098755|NCT03230916|10163549|FG002|Treated|Overall Study||6
9098756|NCT03230916|10163550|FG003|Treated|Overall Study||4
9098757|NCT03230916|10163551|FG004|Treated|Overall Study||4
9098758|NCT03230916|10163552|FG005|Treated|Overall Study||5
9098759|NCT03230916|10163553|FG006|Treated|Overall Study||3
9098760|NCT03230916|10163554|FG007|Treated|Overall Study||2
9098761|NCT03230916|10163555|FG008|Treated|Overall Study||2
9098762|NCT03230916|10163556|FG009|Treated|Overall Study||3
9098763|NCT03230916|10163557|FG010|Treated|Overall Study||4
9098764|NCT03230916|10163547|FG000|COMPLETED|Overall Study||7
9098765|NCT03230916|10163548|FG001|COMPLETED|Overall Study||6
9098766|NCT03230916|10163549|FG002|COMPLETED|Overall Study||6
9098767|NCT03230916|10163550|FG003|COMPLETED|Overall Study||4
9098768|NCT03230916|10163551|FG004|COMPLETED|Overall Study||4
9098769|NCT03230916|10163552|FG005|COMPLETED|Overall Study||5
9098770|NCT03230916|10163553|FG006|COMPLETED|Overall Study||3
9098771|NCT03230916|10163554|FG007|COMPLETED|Overall Study||2
9098772|NCT03230916|10163555|FG008|COMPLETED|Overall Study||2
9098773|NCT03230916|10163556|FG009|COMPLETED|Overall Study||3
9098774|NCT03230916|10163557|FG010|COMPLETED|Overall Study||4
9098775|NCT03230916|10163547|FG000|NOT COMPLETED|Overall Study||0
9098776|NCT03230916|10163548|FG001|NOT COMPLETED|Overall Study||0
9098777|NCT03230916|10163549|FG002|NOT COMPLETED|Overall Study||0
9098778|NCT03230916|10163550|FG003|NOT COMPLETED|Overall Study||0
9098779|NCT03230916|10163551|FG004|NOT COMPLETED|Overall Study||0
9098780|NCT03230916|10163552|FG005|NOT COMPLETED|Overall Study||1
9098781|NCT03230916|10163553|FG006|NOT COMPLETED|Overall Study||0
9098782|NCT03230916|10163554|FG007|NOT COMPLETED|Overall Study||0
9098783|NCT03230916|10163555|FG008|NOT COMPLETED|Overall Study||0
9098784|NCT03230916|10163556|FG009|NOT COMPLETED|Overall Study||0
9098785|NCT03230916|10163557|FG010|NOT COMPLETED|Overall Study||0
9098786|NCT03195894|10163600|FG000|STARTED|Overall Study||59
9098787|NCT03195894|10163601|FG001|STARTED|Overall Study||56
9098788|NCT03195894|10163600|FG000|COMPLETED|Overall Study||26
9098789|NCT03195894|10163601|FG001|COMPLETED|Overall Study||28
9098790|NCT03195894|10163600|FG000|NOT COMPLETED|Overall Study||33
9098791|NCT03195894|10163601|FG001|NOT COMPLETED|Overall Study||28
9098792|NCT03032705|10163612|FG000|STARTED|Overall Study|"Number of participants are same (repeated) for both groups~unit = teeth"|51
9098793|NCT03032705|10163613|FG001|STARTED|Overall Study|"Number of participants are same (repeated) for both groups~unit = teeth"|51
9098794|NCT03032705|10163612|FG000|Completion of Restorations (V2)|Overall Study|"Number of participants are same (repeated) for both groups~unit = teeth"|45
9098795|NCT03032705|10163613|FG001|Completion of Restorations (V2)|Overall Study|"Number of participants are same (repeated) for both groups~unit = teeth"|45
9098796|NCT03032705|10163612|FG000|COMPLETED|Overall Study|"Number of participants are same (repeated) for both groups~unit = teeth"|29
9098797|NCT03032705|10163613|FG001|COMPLETED|Overall Study|"Number of participants are same (repeated) for both groups~unit = teeth"|28
9098798|NCT03032705|10163612|FG000|NOT COMPLETED|Overall Study||22
9098799|NCT03032705|10163613|FG001|NOT COMPLETED|Overall Study||23
9098800|NCT02573259|10163626|FG000|STARTED|Overall Study||2
9098801|NCT02573259|10163627|FG001|STARTED|Overall Study||8
9098802|NCT02573259|10163628|FG002|STARTED|Overall Study||8
9098803|NCT02573259|10163629|FG003|STARTED|Overall Study||7
9098804|NCT02573259|10163630|FG004|STARTED|Overall Study||15
9098805|NCT02573259|10163631|FG005|STARTED|Overall Study||68
9098806|NCT02573259|10163632|FG006|STARTED|Overall Study||39
9098807|NCT02573259|10163626|FG000|Treated|Overall Study||2
9098808|NCT02573259|10163627|FG001|Treated|Overall Study||8
9098809|NCT02573259|10163628|FG002|Treated|Overall Study||8
9098810|NCT02573259|10163629|FG003|Treated|Overall Study||7
9098811|NCT02573259|10163630|FG004|Treated|Overall Study||15
9098812|NCT02573259|10163631|FG005|Treated|Overall Study||68
9098813|NCT02573259|10163632|FG006|Treated|Overall Study||38
9098814|NCT02573259|10163626|FG000|COMPLETED|Overall Study||1
9098815|NCT02573259|10163627|FG001|COMPLETED|Overall Study||0
9098816|NCT02573259|10163628|FG002|COMPLETED|Overall Study||2
9098817|NCT02573259|10163629|FG003|COMPLETED|Overall Study||1
9098818|NCT02573259|10163630|FG004|COMPLETED|Overall Study||2
9098819|NCT02573259|10163631|FG005|COMPLETED|Overall Study||10
9098820|NCT02573259|10163632|FG006|COMPLETED|Overall Study||5
9098821|NCT02573259|10163626|FG000|NOT COMPLETED|Overall Study||1
9098822|NCT02573259|10163627|FG001|NOT COMPLETED|Overall Study||8
9098823|NCT02573259|10163628|FG002|NOT COMPLETED|Overall Study||6
9098824|NCT02573259|10163629|FG003|NOT COMPLETED|Overall Study||6
9098825|NCT02573259|10163630|FG004|NOT COMPLETED|Overall Study||13
9098826|NCT02573259|10163631|FG005|NOT COMPLETED|Overall Study||58
9098827|NCT02573259|10163632|FG006|NOT COMPLETED|Overall Study||34
9098828|NCT02318329|10163674|FG000|STARTED|Overall Study||3
9098829|NCT02318329|10163675|FG001|STARTED|Overall Study||4
9098830|NCT02318329|10163676|FG002|STARTED|Overall Study||3
9098831|NCT02318329|10163677|FG003|STARTED|Overall Study||3
9098832|NCT02318329|10163678|FG004|STARTED|Overall Study||3
9098833|NCT02318329|10163679|FG005|STARTED|Overall Study||3
9098834|NCT02318329|10163680|FG006|STARTED|Overall Study||1
9098835|NCT02318329|10163681|FG007|STARTED|Overall Study||1
9098836|NCT02318329|10163682|FG008|STARTED|Overall Study||6
9098837|NCT02318329|10163683|FG009|STARTED|Overall Study||52
9098838|NCT02318329|10163674|FG000|COMPLETED|Overall Study||0
9098839|NCT02318329|10163675|FG001|COMPLETED|Overall Study||0
9098840|NCT02318329|10163676|FG002|COMPLETED|Overall Study||0
9098841|NCT02318329|10163677|FG003|COMPLETED|Overall Study||0
9098842|NCT02318329|10163678|FG004|COMPLETED|Overall Study||0
9098843|NCT02318329|10163679|FG005|COMPLETED|Overall Study||0
9098844|NCT02318329|10163680|FG006|COMPLETED|Overall Study||0
9098845|NCT02318329|10163681|FG007|COMPLETED|Overall Study||0
9098846|NCT02318329|10163682|FG008|COMPLETED|Overall Study||0
9098847|NCT02318329|10163683|FG009|COMPLETED|Overall Study||0
9098848|NCT02318329|10163674|FG000|NOT COMPLETED|Overall Study||3
9098849|NCT02318329|10163675|FG001|NOT COMPLETED|Overall Study||4
9098850|NCT02318329|10163676|FG002|NOT COMPLETED|Overall Study||3
9098851|NCT02318329|10163677|FG003|NOT COMPLETED|Overall Study||3
9098852|NCT02318329|10163678|FG004|NOT COMPLETED|Overall Study||3
9098853|NCT02318329|10163679|FG005|NOT COMPLETED|Overall Study||3
9098854|NCT02318329|10163680|FG006|NOT COMPLETED|Overall Study||1
9098855|NCT02318329|10163681|FG007|NOT COMPLETED|Overall Study||1
9098856|NCT02318329|10163682|FG008|NOT COMPLETED|Overall Study||6
9098857|NCT02318329|10163683|FG009|NOT COMPLETED|Overall Study||52
8625781|NCT00509249|9665412|FG000|COMPLETED|Overall Study||18
8625782|NCT00509249|9665412|FG000|NOT COMPLETED|Overall Study||0
8625783|NCT00509262|9665418|FG000|STARTED|Overall Study||211
8625784|NCT00509262|9665419|FG001|STARTED|Overall Study||212
8625785|NCT00509262|9665418|FG000|COMPLETED|Overall Study||164
8625786|NCT00509262|9665419|FG001|COMPLETED|Overall Study||170
8625787|NCT00509262|9665418|FG000|NOT COMPLETED|Overall Study||47
8625788|NCT00509262|9665419|FG001|NOT COMPLETED|Overall Study||42
8625789|NCT00509288|9665427|FG000|STARTED|Overall Study||21
8625790|NCT00509288|9665428|FG001|STARTED|Overall Study||3
8625791|NCT00509288|9665427|FG000|COMPLETED|Overall Study||21
8625792|NCT00509288|9665428|FG001|COMPLETED|Overall Study||3
8625793|NCT00509288|9665427|FG000|NOT COMPLETED|Overall Study||0
8625794|NCT00509288|9665428|FG001|NOT COMPLETED|Overall Study||0
8625795|NCT00509366|9665439|FG000|STARTED|Overall Study|Registered patients who were assigned cisplatin/gemcitabine treatment.|18
8625796|NCT00509366|9665440|FG001|STARTED|Overall Study|Registered patients who were assigned cisplatin/pemetrexed treatment.|8
8625797|NCT00509366|9665441|FG002|STARTED|Overall Study|Registered patients who were assigned pemetrexed/gemcitabine treatment.|22
8625798|NCT00509366|9665442|FG003|STARTED|Overall Study|Registered patients who were assigned docetaxel/gemcitabine treatment.|2
8625799|NCT00509366|9665443|FG004|STARTED|Overall Study|Registered patients who were neither assigned nor treated with protocol-based therapy.|51
9098858|NCT01602666|10163726|FG000|STARTED|Induction Chemotherapy||107
9098859|NCT01602666|10163727|FG001|STARTED|Induction Chemotherapy||137
9098860|NCT01602666|10163726|FG000|COMPLETED|Induction Chemotherapy||70
9098861|NCT01602666|10163727|FG001|COMPLETED|Induction Chemotherapy||113
9098862|NCT01602666|10163726|FG000|NOT COMPLETED|Induction Chemotherapy||37
9098863|NCT01602666|10163727|FG001|NOT COMPLETED|Induction Chemotherapy||24
9098864|NCT01602666|10163726|FG000|STARTED|Radiation Therapy on Protocol||70
9098865|NCT01602666|10163727|FG001|STARTED|Radiation Therapy on Protocol||113
9098866|NCT01602666|10163726|FG000|Evaluable for Reduced Dose (30Gy)|Radiation Therapy on Protocol||66
9098867|NCT01602666|10163727|FG001|Evaluable for Reduced Dose (30Gy)|Radiation Therapy on Protocol||0
9098868|NCT01602666|10163726|FG000|Evaluable for Reduced Dose (18 Gy)|Radiation Therapy on Protocol||0
9098869|NCT01602666|10163727|FG001|Evaluable for Reduced Dose (18 Gy)|Radiation Therapy on Protocol||74
9098870|NCT01602666|10163726|FG000|Evaluable for RT Dose (24Gy)|Radiation Therapy on Protocol||0
9098871|NCT01602666|10163727|FG001|Evaluable for RT Dose (24Gy)|Radiation Therapy on Protocol||16
9098872|NCT01602666|10163726|FG000|COMPLETED|Radiation Therapy on Protocol||60
9098873|NCT01602666|10163727|FG001|COMPLETED|Radiation Therapy on Protocol||82
9098874|NCT01602666|10163726|FG000|NOT COMPLETED|Radiation Therapy on Protocol||10
9098875|NCT01602666|10163727|FG001|NOT COMPLETED|Radiation Therapy on Protocol||31
9098876|NCT01375959|10163737|FG000|STARTED|First Intervention (6 Weeks)||17
9098877|NCT01375959|10163738|FG001|STARTED|First Intervention (6 Weeks)||21
9098878|NCT01375959|10163737|FG000|Received Invertention|First Intervention (6 Weeks)||17
9098879|NCT01375959|10163738|FG001|Received Invertention|First Intervention (6 Weeks)||21
9098880|NCT01375959|10163737|FG000|COMPLETED|First Intervention (6 Weeks)|Two participants were withdrawn due to adverse events.|15
9098881|NCT01375959|10163738|FG001|COMPLETED|First Intervention (6 Weeks)|Three participants were withdrawn due to adverse events.|18
9098882|NCT01375959|10163737|FG000|NOT COMPLETED|First Intervention (6 Weeks)||2
9098883|NCT01375959|10163738|FG001|NOT COMPLETED|First Intervention (6 Weeks)||3
9098884|NCT01375959|10163737|FG000|STARTED|Wash-Out (3 Weeks)||15
9098885|NCT01375959|10163738|FG001|STARTED|Wash-Out (3 Weeks)||18
9098886|NCT01375959|10163737|FG000|COMPLETED|Wash-Out (3 Weeks)||15
9098887|NCT01375959|10163738|FG001|COMPLETED|Wash-Out (3 Weeks)||18
9098888|NCT01375959|10163737|FG000|NOT COMPLETED|Wash-Out (3 Weeks)||0
9098889|NCT01375959|10163738|FG001|NOT COMPLETED|Wash-Out (3 Weeks)||0
9098890|NCT01375959|10163737|FG000|STARTED|Second Intervention (6 Weeks)||15
9098891|NCT01375959|10163738|FG001|STARTED|Second Intervention (6 Weeks)||18
9098892|NCT01375959|10163737|FG000|COMPLETED|Second Intervention (6 Weeks)||15
9098893|NCT01375959|10163738|FG001|COMPLETED|Second Intervention (6 Weeks)||15
9098894|NCT01375959|10163737|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
9098895|NCT01375959|10163738|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||3
9098896|NCT01224106|10163749|FG000|STARTED|Double-Blind Treatment Phase||266
9098897|NCT01224106|10163750|FG001|STARTED|Double-Blind Treatment Phase||271
9098898|NCT01224106|10163751|FG002|STARTED|Double-Blind Treatment Phase||260
9098899|NCT01224106|10163752|FG003|STARTED|Double-Blind Treatment Phase||0
9098900|NCT01224106|10163753|FG004|STARTED|Double-Blind Treatment Phase||0
9098901|NCT01224106|10163749|FG000|COMPLETED|Double-Blind Treatment Phase||187
9098902|NCT01224106|10163750|FG001|COMPLETED|Double-Blind Treatment Phase||185
9098903|NCT01224106|10163751|FG002|COMPLETED|Double-Blind Treatment Phase||180
9098904|NCT01224106|10163752|FG003|COMPLETED|Double-Blind Treatment Phase||0
9098905|NCT01224106|10163753|FG004|COMPLETED|Double-Blind Treatment Phase||0
9098906|NCT01224106|10163749|FG000|NOT COMPLETED|Double-Blind Treatment Phase||79
9098907|NCT01224106|10163750|FG001|NOT COMPLETED|Double-Blind Treatment Phase||86
9098908|NCT01224106|10163751|FG002|NOT COMPLETED|Double-Blind Treatment Phase||80
9098909|NCT01224106|10163752|FG003|NOT COMPLETED|Double-Blind Treatment Phase||0
9098910|NCT01224106|10163753|FG004|NOT COMPLETED|Double-Blind Treatment Phase||0
9098911|NCT01224106|10163749|FG000|STARTED|Open-Label Extension (OLE) Phase||0
9098912|NCT01224106|10163750|FG001|STARTED|Open-Label Extension (OLE) Phase||0
9098913|NCT01224106|10163751|FG002|STARTED|Open-Label Extension (OLE) Phase||0
9098914|NCT01224106|10163752|FG003|STARTED|Open-Label Extension (OLE) Phase||49
9098915|NCT01224106|10163753|FG004|STARTED|Open-Label Extension (OLE) Phase||105
9098916|NCT01224106|10163749|FG000|COMPLETED|Open-Label Extension (OLE) Phase||0
9098917|NCT01224106|10163750|FG001|COMPLETED|Open-Label Extension (OLE) Phase||0
9098918|NCT01224106|10163751|FG002|COMPLETED|Open-Label Extension (OLE) Phase||0
9098919|NCT01224106|10163752|FG003|COMPLETED|Open-Label Extension (OLE) Phase||33
9098920|NCT01224106|10163753|FG004|COMPLETED|Open-Label Extension (OLE) Phase||71
9098921|NCT01224106|10163749|FG000|NOT COMPLETED|Open-Label Extension (OLE) Phase||0
9098922|NCT01224106|10163750|FG001|NOT COMPLETED|Open-Label Extension (OLE) Phase||0
9098923|NCT01224106|10163751|FG002|NOT COMPLETED|Open-Label Extension (OLE) Phase||0
9098924|NCT01224106|10163752|FG003|NOT COMPLETED|Open-Label Extension (OLE) Phase||16
9098925|NCT01224106|10163753|FG004|NOT COMPLETED|Open-Label Extension (OLE) Phase||34
9098926|NCT00999609|10163773|FG000|STARTED|Overall Study|Before intervention|21
9098927|NCT00999609|10163774|FG001|STARTED|Overall Study||10
9098928|NCT00999609|10163773|FG000|COMPLETED|Overall Study|1 year post intervention|20
9098929|NCT00999609|10163774|FG001|COMPLETED|Overall Study|1 year post intervention|9
9098930|NCT00999609|10163773|FG000|NOT COMPLETED|Overall Study||1
9098931|NCT00999609|10163774|FG001|NOT COMPLETED|Overall Study||1
9098932|NCT00354835|10163782|FG000|STARTED|Overall Study||239
9098933|NCT00354835|10163783|FG001|STARTED|Overall Study||242
9098934|NCT00354835|10163782|FG000|COMPLETED|Overall Study||187
9098935|NCT00354835|10163783|FG001|COMPLETED|Overall Study||181
9098936|NCT00354835|10163782|FG000|NOT COMPLETED|Overall Study||52
9098937|NCT00354835|10163783|FG001|NOT COMPLETED|Overall Study||61
8556854|NCT03760146|9588647|FG001|Safety Population|Overall Study||1490
9098938|NCT04531241|10163804|FG000|STARTED|Period 1||68
9098939|NCT04531241|10163805|FG001|STARTED|Period 1||67
9098940|NCT04531241|10163804|FG000|COMPLETED|Period 1||64
9098941|NCT04531241|10163805|FG001|COMPLETED|Period 1||65
8723587|NCT01023958|9771105|FG000|COMPLETED|Overall Study||0
8723588|NCT01023958|9771105|FG000|NOT COMPLETED|Overall Study||50
8723589|NCT01024010|9771111|FG000|STARTED|Overall Study||48
8723590|NCT01024010|9771112|FG001|STARTED|Overall Study||34
8723591|NCT01024010|9771111|FG000|COMPLETED|Overall Study||48
8723592|NCT01024010|9771112|FG001|COMPLETED|Overall Study||34
8723593|NCT01024010|9771111|FG000|NOT COMPLETED|Overall Study||0
8723594|NCT01024010|9771112|FG001|NOT COMPLETED|Overall Study||0
8723595|NCT01024036|9771120|FG000|STARTED|Blinded Treatment||53
8723596|NCT01024036|9771121|FG001|STARTED|Blinded Treatment||26
8723597|NCT01024036|9771120|FG000|COMPLETED|Blinded Treatment||31
8723598|NCT01024036|9771121|FG001|COMPLETED|Blinded Treatment||6
8723599|NCT01024036|9771120|FG000|NOT COMPLETED|Blinded Treatment||22
8723600|NCT01024036|9771121|FG001|NOT COMPLETED|Blinded Treatment||20
8723601|NCT01024036|9771120|FG000|STARTED|Unblinded Treatment|No participants in this group received treatment during unblinded treatment period|0
8723602|NCT01024036|9771121|FG001|STARTED|Unblinded Treatment|Placebo participants had an option to receive siltuximab in unblinded treatment period|13
8723603|NCT01024036|9771120|FG000|COMPLETED|Unblinded Treatment||0
8723604|NCT01024036|9771121|FG001|COMPLETED|Unblinded Treatment||10
8723605|NCT01024036|9771120|FG000|NOT COMPLETED|Unblinded Treatment||0
8723606|NCT01024036|9771121|FG001|NOT COMPLETED|Unblinded Treatment||3
8723607|NCT01024036|9771120|FG000|STARTED|Follow-Up Period||14
8723608|NCT01024036|9771121|FG001|STARTED|Follow-Up Period||6
8723609|NCT01024036|9771120|FG000|COMPLETED|Follow-Up Period||9
8723610|NCT01024036|9771121|FG001|COMPLETED|Follow-Up Period||3
8723611|NCT01024036|9771120|FG000|NOT COMPLETED|Follow-Up Period||5
8723612|NCT01024036|9771121|FG001|NOT COMPLETED|Follow-Up Period||3
8723613|NCT01024231|9771137|FG000|STARTED|Overall Study||14
9098942|NCT04531241|10163804|FG000|NOT COMPLETED|Period 1||4
9098943|NCT04531241|10163805|FG001|NOT COMPLETED|Period 1||2
9098944|NCT04531241|10163804|FG000|STARTED|Period 2||64
9098945|NCT04531241|10163805|FG001|STARTED|Period 2||65
9098946|NCT04531241|10163804|FG000|COMPLETED|Period 2||63
9098947|NCT04531241|10163805|FG001|COMPLETED|Period 2||64
9098948|NCT04531241|10163804|FG000|NOT COMPLETED|Period 2||1
9098949|NCT04531241|10163805|FG001|NOT COMPLETED|Period 2||1
9098950|NCT04456153|10163813|FG000|STARTED|Overall Study||19
9098951|NCT04456153|10163814|FG001|STARTED|Overall Study||41
9098952|NCT04456153|10163813|FG000|COMPLETED|Overall Study||19
9098953|NCT04456153|10163814|FG001|COMPLETED|Overall Study||41
9098954|NCT04456153|10163813|FG000|NOT COMPLETED|Overall Study||0
9098955|NCT04456153|10163814|FG001|NOT COMPLETED|Overall Study||0
9098956|NCT04351243|10163836|FG000|STARTED|Overall Study||114
9098957|NCT04351243|10163837|FG001|STARTED|Overall Study||113
8625800|NCT00509366|9665439|FG000|Assigned Treatment|Overall Study|Patients who were assigned to cisplatin/gemcitabine treatment arm.|18
8625801|NCT00509366|9665440|FG001|Assigned Treatment|Overall Study|Patients who were assigned to cisplatin/pemetrexed treatment arm.|8
8625802|NCT00509366|9665441|FG002|Assigned Treatment|Overall Study|Patients who were assigned to pemetrexed/gemcitabine treatment arm.|22
9098958|NCT04351243|10163836|FG000|Completed Baseline Assessment|Overall Study||113
9098959|NCT04351243|10163837|FG001|Completed Baseline Assessment|Overall Study||112
9098960|NCT04351243|10163836|FG000|COMPLETED|Overall Study||74
9098961|NCT04351243|10163837|FG001|COMPLETED|Overall Study||75
8625803|NCT00509366|9665442|FG003|Assigned Treatment|Overall Study|Patients who were assigned to docetaxel/gemcitabine treatment arm.|2
8625804|NCT00509366|9665443|FG004|Assigned Treatment|Overall Study||0
8625805|NCT00509366|9665439|FG000|COMPLETED|Overall Study|Patients assigned to treatment and treated with cisplatin/gemcitabine treatment combination.|17
8625806|NCT00509366|9665440|FG001|COMPLETED|Overall Study|Patients assigned to treatment and treated with cisplatin/pemetrexed treatment combination.|7
8625807|NCT00509366|9665441|FG002|COMPLETED|Overall Study|Patients assigned to treatment and treated with pemetrexed/gemcitabine treatment combination.|21
8625808|NCT00509366|9665442|FG003|COMPLETED|Overall Study|Patients assigned to treatment and treated with docetaxel/gemcitabine treatment combination.|2
8625809|NCT00509366|9665443|FG004|COMPLETED|Overall Study|Patients who were neither assigned nor treated with protocol-based therapy.|51
8625810|NCT00509366|9665439|FG000|NOT COMPLETED|Overall Study||1
8625811|NCT00509366|9665440|FG001|NOT COMPLETED|Overall Study||1
8625812|NCT00509366|9665441|FG002|NOT COMPLETED|Overall Study||1
8625813|NCT00509366|9665442|FG003|NOT COMPLETED|Overall Study||0
8625814|NCT00509366|9665443|FG004|NOT COMPLETED|Overall Study||0
8625815|NCT00509392|9665455|FG000|STARTED|Overall Study||32
8625816|NCT00509392|9665456|FG001|STARTED|Overall Study||33
8723614|NCT01024231|9771138|FG001|STARTED|Overall Study||17
8723615|NCT01024231|9771139|FG002|STARTED|Overall Study||16
8723616|NCT01024231|9771140|FG003|STARTED|Overall Study||6
8723617|NCT01024231|9771141|FG004|STARTED|Overall Study||17
8723618|NCT01024231|9771142|FG005|STARTED|Overall Study||16
8723619|NCT01024231|9771143|FG006|STARTED|Overall Study||41
9098962|NCT04351243|10163836|FG000|NOT COMPLETED|Overall Study||40
9098963|NCT04351243|10163837|FG001|NOT COMPLETED|Overall Study||38
9098964|NCT04312256|10163843|FG000|STARTED|Overall Study||81
9098965|NCT04312256|10163843|FG000|COMPLETED|Overall Study||81
9098966|NCT04312256|10163843|FG000|NOT COMPLETED|Overall Study||0
9098967|NCT04185220|10163850|FG000|STARTED|Dose Escalation||3
9098968|NCT04185220|10163851|FG001|STARTED|Dose Escalation||3
9098969|NCT04185220|10163850|FG000|COMPLETED|Dose Escalation||3
9098970|NCT04185220|10163851|FG001|COMPLETED|Dose Escalation||1
9098971|NCT04185220|10163850|FG000|NOT COMPLETED|Dose Escalation||0
9098972|NCT04185220|10163851|FG001|NOT COMPLETED|Dose Escalation||2
9098973|NCT04185220|10163850|FG000|STARTED|Dose Expansion||0
9098974|NCT04185220|10163851|FG001|STARTED|Dose Expansion||0
9098975|NCT04185220|10163850|FG000|COMPLETED|Dose Expansion||0
9098976|NCT04185220|10163851|FG001|COMPLETED|Dose Expansion||0
9098977|NCT04185220|10163850|FG000|NOT COMPLETED|Dose Expansion||0
9098978|NCT04185220|10163851|FG001|NOT COMPLETED|Dose Expansion||0
8625817|NCT00509392|9665457|FG002|STARTED|Overall Study||4
8625818|NCT00509392|9665455|FG000|COMPLETED|Overall Study||32
8625819|NCT00509392|9665456|FG001|COMPLETED|Overall Study||33
8625820|NCT00509392|9665457|FG002|COMPLETED|Overall Study||4
8625821|NCT00509392|9665455|FG000|NOT COMPLETED|Overall Study||0
8625822|NCT00509392|9665456|FG001|NOT COMPLETED|Overall Study||0
8625823|NCT00509392|9665457|FG002|NOT COMPLETED|Overall Study||0
8625824|NCT00509496|9665465|FG000|STARTED|Overall Study||19
8625825|NCT00509496|9665466|FG001|STARTED|Overall Study||2
8625826|NCT00509496|9665465|FG000|COMPLETED|Overall Study||19
8625827|NCT00509496|9665466|FG001|COMPLETED|Overall Study||2
8625828|NCT00509496|9665465|FG000|NOT COMPLETED|Overall Study||0
8625829|NCT00509496|9665466|FG001|NOT COMPLETED|Overall Study||0
8625830|NCT00509587|9665472|FG000|STARTED|Overall Study||21
8625831|NCT00509587|9665472|FG000|COMPLETED|Overall Study||21
8625832|NCT00509587|9665472|FG000|NOT COMPLETED|Overall Study||0
8625833|NCT00509665|9665476|FG000|STARTED|Overall Study||18
8625834|NCT00509665|9665476|FG000|COMPLETED|Overall Study||18
8625835|NCT00509665|9665476|FG000|NOT COMPLETED|Overall Study||0
8625836|NCT00509769|9665480|FG000|STARTED|Overall Study||112
8625837|NCT00509769|9665480|FG000|COMPLETED|Overall Study||21
8625838|NCT00509769|9665480|FG000|NOT COMPLETED|Overall Study||91
8625839|NCT00509795|9665488|FG000|STARTED|Overall Study||306
8625840|NCT00509795|9665489|FG001|STARTED|Overall Study||304
8625841|NCT00509795|9665490|FG002|STARTED|Overall Study||304
8625842|NCT00509795|9665491|FG003|STARTED|Overall Study||303
8625843|NCT00509795|9665488|FG000|Patients Received Treatment (SAF)|Overall Study||304
8625844|NCT00509795|9665489|FG001|Patients Received Treatment (SAF)|Overall Study||304
9098979|NCT03851107|10163858|FG000|STARTED|Overall Study||9
9098980|NCT03851107|10163858|FG000|COMPLETED|Overall Study||7
9098981|NCT03851107|10163858|FG000|NOT COMPLETED|Overall Study||2
9098982|NCT03600714|10163868|FG000|STARTED|Overall Study||26
9098983|NCT03600714|10163868|FG000|COMPLETED|Overall Study||25
9098984|NCT03600714|10163868|FG000|NOT COMPLETED|Overall Study||1
9098985|NCT03479307|10163875|FG000|STARTED|Overall Study||91
9098986|NCT03479307|10163876|FG001|STARTED|Overall Study||90
9098987|NCT03479307|10163877|FG002|STARTED|Overall Study||47
9098988|NCT03479307|10163875|FG000|COMPLETED|Overall Study||90
9098989|NCT03479307|10163876|FG001|COMPLETED|Overall Study||89
9098990|NCT03479307|10163877|FG002|COMPLETED|Overall Study||47
9098991|NCT03479307|10163875|FG000|NOT COMPLETED|Overall Study||1
9098992|NCT03479307|10163876|FG001|NOT COMPLETED|Overall Study||1
9098993|NCT03479307|10163877|FG002|NOT COMPLETED|Overall Study||0
9098994|NCT03470441|10163889|FG000|STARTED|Overall Study||29
9098995|NCT03470441|10163890|FG001|STARTED|Overall Study||31
9098996|NCT03470441|10163891|FG002|STARTED|Overall Study||31
9098997|NCT03470441|10163892|FG003|STARTED|Overall Study||29
9098998|NCT03470441|10163889|FG000|COMPLETED|Overall Study||28
9098999|NCT03470441|10163890|FG001|COMPLETED|Overall Study||26
9099000|NCT03470441|10163891|FG002|COMPLETED|Overall Study||29
9099001|NCT03470441|10163892|FG003|COMPLETED|Overall Study||25
9099002|NCT03470441|10163889|FG000|NOT COMPLETED|Overall Study||1
9099003|NCT03470441|10163890|FG001|NOT COMPLETED|Overall Study||5
9099004|NCT03470441|10163891|FG002|NOT COMPLETED|Overall Study||2
9099005|NCT03470441|10163892|FG003|NOT COMPLETED|Overall Study||4
9099006|NCT03452397|10163906|FG000|STARTED|Overall Study||41
9099007|NCT03452397|10163907|FG001|STARTED|Overall Study||41
9099008|NCT03452397|10163908|FG002|STARTED|Overall Study||41
9099009|NCT03452397|10163909|FG003|STARTED|Overall Study||42
9099010|NCT03452397|10163906|FG000|COMPLETED|Overall Study||40
9099011|NCT03452397|10163907|FG001|COMPLETED|Overall Study||41
9099012|NCT03452397|10163908|FG002|COMPLETED|Overall Study||39
9099013|NCT03452397|10163909|FG003|COMPLETED|Overall Study||41
9099014|NCT03452397|10163906|FG000|NOT COMPLETED|Overall Study||1
9099015|NCT03452397|10163907|FG001|NOT COMPLETED|Overall Study||0
9099016|NCT03452397|10163908|FG002|NOT COMPLETED|Overall Study||2
9099017|NCT03452397|10163909|FG003|NOT COMPLETED|Overall Study||1
9099018|NCT03448939|10163923|FG000|STARTED|Overall Study||243
9099019|NCT03448939|10163924|FG001|STARTED|Overall Study||118
9099020|NCT03448939|10163923|FG000|Received at Least 1 Dose of Study Drug|Overall Study||239
9099021|NCT03448939|10163924|FG001|Received at Least 1 Dose of Study Drug|Overall Study||113
9099022|NCT03448939|10163923|FG000|COMPLETED|Overall Study||222
9099023|NCT03448939|10163924|FG001|COMPLETED|Overall Study||107
9099024|NCT03448939|10163923|FG000|NOT COMPLETED|Overall Study||21
9099025|NCT03448939|10163924|FG001|NOT COMPLETED|Overall Study||11
9099026|NCT03410108|10163930|FG000|STARTED|Overall Study||104
9099027|NCT03410108|10163930|FG000|Safety Evaluation Lead-in Part|Overall Study||9
9099028|NCT03410108|10163930|FG000|Refractory Expansion Part: Main Cohort|Overall Study||47
9099029|NCT03410108|10163930|FG000|Refractory Expansion Part: Sub-Cohort|Overall Study||16
9099030|NCT03410108|10163930|FG000|Refractory Expansion Part|Overall Study||63
9099031|NCT03410108|10163930|FG000|All Refractory Participants|Overall Study||72
9099032|NCT03410108|10163930|FG000|TKI-Naive Expansion Cohort|Overall Study||32
9099033|NCT03410108|10163930|FG000|Completed|Overall Study||0
9099034|NCT03410108|10163930|FG000|COMPLETED|Overall Study||0
9099035|NCT03410108|10163930|FG000|NOT COMPLETED|Overall Study||104
9099036|NCT03377803|10163939|FG000|STARTED|Overall Study||150
9099037|NCT03377803|10163940|FG001|STARTED|Overall Study||112
9099038|NCT03377803|10163939|FG000|COMPLETED|Overall Study||139
9099039|NCT03377803|10163940|FG001|COMPLETED|Overall Study||108
9099040|NCT03377803|10163939|FG000|NOT COMPLETED|Overall Study||11
9099041|NCT03377803|10163940|FG001|NOT COMPLETED|Overall Study||4
9099042|NCT03283371|10163948|FG000|STARTED|Placebo-controlled||34
9099043|NCT03283371|10163949|FG001|STARTED|Placebo-controlled||33
9099044|NCT03283371|10163950|FG002|STARTED|Placebo-controlled||0
9099045|NCT03283371|10163951|FG003|STARTED|Placebo-controlled||0
9099046|NCT03283371|10163948|FG000|Number of Participants Dosed|Placebo-controlled||34
9099047|NCT03283371|10163949|FG001|Number of Participants Dosed|Placebo-controlled||32
9099048|NCT03283371|10163950|FG002|Number of Participants Dosed|Placebo-controlled||0
9099049|NCT03283371|10163951|FG003|Number of Participants Dosed|Placebo-controlled||0
8625845|NCT00509795|9665490|FG002|Patients Received Treatment (SAF)|Overall Study||304
8625846|NCT00509795|9665491|FG003|Patients Received Treatment (SAF)|Overall Study||303
8625847|NCT00509795|9665488|FG000|Full Analysis Set (FAS) Population|Overall Study||304
8625848|NCT00509795|9665489|FG001|Full Analysis Set (FAS) Population|Overall Study||304
8625849|NCT00509795|9665490|FG002|Full Analysis Set (FAS) Population|Overall Study||301
9099050|NCT03283371|10163948|FG000|COMPLETED|Placebo-controlled||31
9099051|NCT03283371|10163949|FG001|COMPLETED|Placebo-controlled||30
9099052|NCT03283371|10163950|FG002|COMPLETED|Placebo-controlled||0
9099053|NCT03283371|10163951|FG003|COMPLETED|Placebo-controlled||0
9099054|NCT03283371|10163948|FG000|NOT COMPLETED|Placebo-controlled||3
9099055|NCT03283371|10163949|FG001|NOT COMPLETED|Placebo-controlled||3
9099056|NCT03283371|10163950|FG002|NOT COMPLETED|Placebo-controlled||0
9099057|NCT03283371|10163951|FG003|NOT COMPLETED|Placebo-controlled||0
9099058|NCT03283371|10163948|FG000|STARTED|Open-label Phase||0
9099059|NCT03283371|10163949|FG001|STARTED|Open-label Phase||0
9099060|NCT03283371|10163950|FG002|STARTED|Open-label Phase||31
9099061|NCT03283371|10163951|FG003|STARTED|Open-label Phase||30
9099062|NCT03283371|10163948|FG000|COMPLETED|Open-label Phase||0
9099063|NCT03283371|10163949|FG001|COMPLETED|Open-label Phase||0
9099064|NCT03283371|10163950|FG002|COMPLETED|Open-label Phase||27
9099065|NCT03283371|10163951|FG003|COMPLETED|Open-label Phase||29
9099066|NCT03283371|10163948|FG000|NOT COMPLETED|Open-label Phase||0
9099067|NCT03283371|10163949|FG001|NOT COMPLETED|Open-label Phase||0
9099068|NCT03283371|10163950|FG002|NOT COMPLETED|Open-label Phase||4
9099069|NCT03283371|10163951|FG003|NOT COMPLETED|Open-label Phase||1
9099070|NCT03257254|10163961|FG000|STARTED|Overall Study||76
9099071|NCT03257254|10163961|FG000|COMPLETED|Overall Study||55
9099072|NCT03257254|10163961|FG000|NOT COMPLETED|Overall Study||21
9099073|NCT03084718|10163970|FG000|STARTED|Overall Study||120
9099074|NCT03084718|10163971|FG001|STARTED|Overall Study||120
9099075|NCT03084718|10163972|FG002|STARTED|Overall Study||122
9099076|NCT03084718|10163973|FG003|STARTED|Overall Study||124
9099077|NCT03084718|10163974|FG004|STARTED|Overall Study||124
8625850|NCT00509795|9665491|FG003|Full Analysis Set (FAS) Population|Overall Study||301
8625851|NCT00509795|9665488|FG000|Per Protocol Set (PPS) Population|Overall Study||269
8625852|NCT00509795|9665489|FG001|Per Protocol Set (PPS) Population|Overall Study||285
8625853|NCT00509795|9665490|FG002|Per Protocol Set (PPS) Population|Overall Study||270
8625854|NCT00509795|9665491|FG003|Per Protocol Set (PPS) Population|Overall Study||265
8625855|NCT00509795|9665488|FG000|COMPLETED|Overall Study||284
9099078|NCT03084718|10163970|FG000|COMPLETED|Overall Study||109
9099079|NCT03084718|10163971|FG001|COMPLETED|Overall Study||110
9099080|NCT03084718|10163972|FG002|COMPLETED|Overall Study||110
9099081|NCT03084718|10163973|FG003|COMPLETED|Overall Study||110
9099082|NCT03084718|10163974|FG004|COMPLETED|Overall Study||120
9099083|NCT03084718|10163970|FG000|NOT COMPLETED|Overall Study||11
9099084|NCT03084718|10163971|FG001|NOT COMPLETED|Overall Study||10
9099085|NCT03084718|10163972|FG002|NOT COMPLETED|Overall Study||12
9099086|NCT03084718|10163973|FG003|NOT COMPLETED|Overall Study||14
9099087|NCT03084718|10163974|FG004|NOT COMPLETED|Overall Study||4
9099088|NCT03069417|10163991|FG000|STARTED|Overall Study||14
9099089|NCT03069417|10163992|FG001|STARTED|Overall Study||9
9099090|NCT03069417|10163991|FG000|Post-Treatment Assessment|Overall Study||12
9099091|NCT03069417|10163992|FG001|Post-Treatment Assessment|Overall Study||6
9099092|NCT03069417|10163991|FG000|COMPLETED|Overall Study||8
9099093|NCT03069417|10163992|FG001|COMPLETED|Overall Study||2
9099094|NCT03069417|10163991|FG000|NOT COMPLETED|Overall Study||6
9099095|NCT03069417|10163992|FG001|NOT COMPLETED|Overall Study||7
9099096|NCT03063164|10163999|FG000|STARTED|Overall Study||7
9099097|NCT03063164|10164000|FG001|STARTED|Overall Study||7
9099098|NCT03063164|10163999|FG000|COMPLETED|Overall Study||7
9099099|NCT03063164|10164000|FG001|COMPLETED|Overall Study||7
9099100|NCT03063164|10163999|FG000|NOT COMPLETED|Overall Study||0
9099101|NCT03063164|10164000|FG001|NOT COMPLETED|Overall Study||0
9099102|NCT02952365|10164007|FG000|STARTED|Overall Study||2
9099103|NCT02952365|10164007|FG000|COMPLETED|Overall Study||2
9099104|NCT02952365|10164007|FG000|NOT COMPLETED|Overall Study||0
9099105|NCT02936323|10164021|FG000|STARTED|Phase 1 Dose Escalation|Participants in Phase 1 did not advance to Phase 2a.|2
9099106|NCT02936323|10164022|FG001|STARTED|Phase 1 Dose Escalation|Participants in Phase 1 did not advance to Phase 2a.|3
9099107|NCT02936323|10164023|FG002|STARTED|Phase 1 Dose Escalation|Participants in Phase 1 did not advance to Phase 2a.|3
9099108|NCT02936323|10164024|FG003|STARTED|Phase 1 Dose Escalation|Participants in Phase 1 did not advance to Phase 2a.|3
9099109|NCT02936323|10164025|FG004|STARTED|Phase 1 Dose Escalation|Participants in Phase 1 did not advance to Phase 2a.|3
9099110|NCT02936323|10164026|FG005|STARTED|Phase 1 Dose Escalation|Participants in Phase 1 did not advance to Phase 2a.|6
9099111|NCT02936323|10164027|FG006|STARTED|Phase 1 Dose Escalation|Participants in Phase 1 did not advance to Phase 2a.|3
9099112|NCT02936323|10164028|FG007|STARTED|Phase 1 Dose Escalation||0
9099113|NCT02936323|10164029|FG008|STARTED|Phase 1 Dose Escalation||0
9099114|NCT02936323|10164030|FG009|STARTED|Phase 1 Dose Escalation||0
9099115|NCT02936323|10164021|FG000|COMPLETED|Phase 1 Dose Escalation||0
9099116|NCT02936323|10164022|FG001|COMPLETED|Phase 1 Dose Escalation||1
9099117|NCT02936323|10164023|FG002|COMPLETED|Phase 1 Dose Escalation||0
9099118|NCT02936323|10164024|FG003|COMPLETED|Phase 1 Dose Escalation||1
9099119|NCT02936323|10164025|FG004|COMPLETED|Phase 1 Dose Escalation||0
9099120|NCT02936323|10164026|FG005|COMPLETED|Phase 1 Dose Escalation||1
9099121|NCT02936323|10164027|FG006|COMPLETED|Phase 1 Dose Escalation||0
9099122|NCT02936323|10164028|FG007|COMPLETED|Phase 1 Dose Escalation||0
9099123|NCT02936323|10164029|FG008|COMPLETED|Phase 1 Dose Escalation||0
9099124|NCT02936323|10164030|FG009|COMPLETED|Phase 1 Dose Escalation||0
9099125|NCT02936323|10164021|FG000|NOT COMPLETED|Phase 1 Dose Escalation||2
9099126|NCT02936323|10164022|FG001|NOT COMPLETED|Phase 1 Dose Escalation||2
9099127|NCT02936323|10164023|FG002|NOT COMPLETED|Phase 1 Dose Escalation||3
9099128|NCT02936323|10164024|FG003|NOT COMPLETED|Phase 1 Dose Escalation||2
9099129|NCT02936323|10164025|FG004|NOT COMPLETED|Phase 1 Dose Escalation||3
9099130|NCT02936323|10164026|FG005|NOT COMPLETED|Phase 1 Dose Escalation||5
9099131|NCT02936323|10164027|FG006|NOT COMPLETED|Phase 1 Dose Escalation||3
9099132|NCT02936323|10164028|FG007|NOT COMPLETED|Phase 1 Dose Escalation||0
9099133|NCT02936323|10164029|FG008|NOT COMPLETED|Phase 1 Dose Escalation||0
9099134|NCT02936323|10164030|FG009|NOT COMPLETED|Phase 1 Dose Escalation||0
9099135|NCT02936323|10164021|FG000|STARTED|Phase 2a Dose Expansion||0
9099136|NCT02936323|10164022|FG001|STARTED|Phase 2a Dose Expansion||0
9099137|NCT02936323|10164023|FG002|STARTED|Phase 2a Dose Expansion||0
9099138|NCT02936323|10164024|FG003|STARTED|Phase 2a Dose Expansion||0
9099139|NCT02936323|10164025|FG004|STARTED|Phase 2a Dose Expansion||0
9099140|NCT02936323|10164026|FG005|STARTED|Phase 2a Dose Expansion||0
9099141|NCT02936323|10164027|FG006|STARTED|Phase 2a Dose Expansion||0
9099142|NCT02936323|10164028|FG007|STARTED|Phase 2a Dose Expansion|Participants in Phase 2a did not participate in Phase 1|32
9099143|NCT02936323|10164029|FG008|STARTED|Phase 2a Dose Expansion|Participants in Phase 2a did not participate in Phase 1|15
9099144|NCT02936323|10164030|FG009|STARTED|Phase 2a Dose Expansion|Participants in Phase 2a did not participate in Phase 1|19
9099145|NCT02936323|10164021|FG000|COMPLETED|Phase 2a Dose Expansion||0
9099146|NCT02936323|10164022|FG001|COMPLETED|Phase 2a Dose Expansion||0
9099147|NCT02936323|10164023|FG002|COMPLETED|Phase 2a Dose Expansion||0
9099148|NCT02936323|10164024|FG003|COMPLETED|Phase 2a Dose Expansion||0
9099149|NCT02936323|10164025|FG004|COMPLETED|Phase 2a Dose Expansion||0
9099150|NCT02936323|10164026|FG005|COMPLETED|Phase 2a Dose Expansion||0
9099151|NCT02936323|10164027|FG006|COMPLETED|Phase 2a Dose Expansion||0
9099152|NCT02936323|10164028|FG007|COMPLETED|Phase 2a Dose Expansion||15
9099153|NCT02936323|10164029|FG008|COMPLETED|Phase 2a Dose Expansion||2
9099154|NCT02936323|10164030|FG009|COMPLETED|Phase 2a Dose Expansion||5
9099155|NCT02936323|10164021|FG000|NOT COMPLETED|Phase 2a Dose Expansion||0
9099156|NCT02936323|10164022|FG001|NOT COMPLETED|Phase 2a Dose Expansion||0
9099157|NCT02936323|10164023|FG002|NOT COMPLETED|Phase 2a Dose Expansion||0
9099158|NCT02936323|10164024|FG003|NOT COMPLETED|Phase 2a Dose Expansion||0
9099159|NCT02936323|10164025|FG004|NOT COMPLETED|Phase 2a Dose Expansion||0
9099160|NCT02936323|10164026|FG005|NOT COMPLETED|Phase 2a Dose Expansion||0
9099161|NCT02936323|10164027|FG006|NOT COMPLETED|Phase 2a Dose Expansion||0
9099162|NCT02936323|10164028|FG007|NOT COMPLETED|Phase 2a Dose Expansion||17
9099163|NCT02936323|10164029|FG008|NOT COMPLETED|Phase 2a Dose Expansion||13
9099164|NCT02936323|10164030|FG009|NOT COMPLETED|Phase 2a Dose Expansion||14
9099165|NCT02631837|10164064|FG000|STARTED|Overall Study||35
9099166|NCT02631837|10164065|FG001|STARTED|Overall Study||35
9099167|NCT02631837|10164064|FG000|COMPLETED|Overall Study||35
9099168|NCT02631837|10164065|FG001|COMPLETED|Overall Study||35
9099169|NCT02631837|10164064|FG000|NOT COMPLETED|Overall Study||0
9099170|NCT02631837|10164065|FG001|NOT COMPLETED|Overall Study||0
9099171|NCT02437318|10164073|FG000|STARTED|Overall Study||284
9099172|NCT02437318|10164074|FG001|STARTED|Overall Study||288
9099173|NCT02437318|10164073|FG000|End of Treatment (Didn't Complete)|Overall Study||229
9099174|NCT02437318|10164074|FG001|End of Treatment (Didn't Complete)|Overall Study||241
9099175|NCT02437318|10164073|FG000|Untreated (Protocol Deviation)|Overall Study||0
9099176|NCT02437318|10164074|FG001|Untreated (Protocol Deviation)|Overall Study||1
9099177|NCT02437318|10164073|FG000|COMPLETED|Overall Study||55
9099178|NCT02437318|10164074|FG001|COMPLETED|Overall Study||46
9099179|NCT02437318|10164073|FG000|NOT COMPLETED|Overall Study||229
9099180|NCT02437318|10164074|FG001|NOT COMPLETED|Overall Study||242
9099181|NCT02429791|10164082|FG000|STARTED|Early Switch Phase (Up to Week 52)||252
9099182|NCT02429791|10164083|FG001|STARTED|Early Switch Phase (Up to Week 52)||256
9099183|NCT02429791|10164082|FG000|COMPLETED|Early Switch Phase (Up to Week 52)||239
9099184|NCT02429791|10164083|FG001|COMPLETED|Early Switch Phase (Up to Week 52)||238
9099185|NCT02429791|10164082|FG000|NOT COMPLETED|Early Switch Phase (Up to Week 52)||13
9099186|NCT02429791|10164083|FG001|NOT COMPLETED|Early Switch Phase (Up to Week 52)||18
9099187|NCT02429791|10164082|FG000|STARTED|Late Switch Phase (Week 52 to Week 148)||239
9099188|NCT02429791|10164083|FG001|STARTED|Late Switch Phase (Week 52 to Week 148)||238
9099189|NCT02429791|10164082|FG000|COMPLETED|Late Switch Phase (Week 52 to Week 148)||214
9099190|NCT02429791|10164083|FG001|COMPLETED|Late Switch Phase (Week 52 to Week 148)||210
9099191|NCT02429791|10164082|FG000|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||25
9099192|NCT02429791|10164083|FG001|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||28
9099193|NCT02422797|10164098|FG000|STARTED|Early Switch Phase (Up to Week 52)||261
9099194|NCT02422797|10164099|FG001|STARTED|Early Switch Phase (Up to Week 52)||255
9099195|NCT02422797|10164098|FG000|COMPLETED|Early Switch Phase (Up to Week 52)||245
9099196|NCT02422797|10164099|FG001|COMPLETED|Early Switch Phase (Up to Week 52)||239
9099197|NCT02422797|10164098|FG000|NOT COMPLETED|Early Switch Phase (Up to Week 52)||16
9099198|NCT02422797|10164099|FG001|NOT COMPLETED|Early Switch Phase (Up to Week 52)||16
9099199|NCT02422797|10164098|FG000|STARTED|Late Switch Phase (Week 52 to Week 148)||245
9099200|NCT02422797|10164099|FG001|STARTED|Late Switch Phase (Week 52 to Week 148)||239
9099201|NCT02422797|10164098|FG000|COMPLETED|Late Switch Phase (Week 52 to Week 148)||222
9099202|NCT02422797|10164099|FG001|COMPLETED|Late Switch Phase (Week 52 to Week 148)||221
9099203|NCT02422797|10164098|FG000|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||23
9099204|NCT02422797|10164099|FG001|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||18
9099205|NCT02287493|10164117|FG000|STARTED|Overall Study||19
9099206|NCT02287493|10164118|FG001|STARTED|Overall Study||16
9099207|NCT02287493|10164117|FG000|COMPLETED|Overall Study||19
9099208|NCT02287493|10164118|FG001|COMPLETED|Overall Study||16
9099209|NCT02287493|10164117|FG000|NOT COMPLETED|Overall Study||0
9099210|NCT02287493|10164118|FG001|NOT COMPLETED|Overall Study||0
9099211|NCT02132611|10164128|FG000|STARTED|Overall Study||100
9099212|NCT02132611|10164128|FG000|COMPLETED|Overall Study||98
9099213|NCT02132611|10164128|FG000|NOT COMPLETED|Overall Study||2
9099214|NCT01147822|10164134|FG000|STARTED|Overall Study||188
9099215|NCT01147822|10164135|FG001|STARTED|Overall Study||179
9099216|NCT01147822|10164134|FG000|Not Completed/Ongoing|Overall Study||111
9099217|NCT01147822|10164135|FG001|Not Completed/Ongoing|Overall Study||102
9099218|NCT01147822|10164134|FG000|COMPLETED|Overall Study||0
9099219|NCT01147822|10164135|FG001|COMPLETED|Overall Study||0
9099220|NCT01147822|10164134|FG000|NOT COMPLETED|Overall Study||188
9099221|NCT01147822|10164135|FG001|NOT COMPLETED|Overall Study||179
9099222|NCT00328653|10164144|FG000|STARTED|Period I||40
9099223|NCT00328653|10164145|FG001|STARTED|Period I||39
9099224|NCT00328653|10164146|FG002|STARTED|Period I||39
9099225|NCT00328653|10164144|FG000|COMPLETED|Period I||36
9099226|NCT00328653|10164145|FG001|COMPLETED|Period I||39
9099227|NCT00328653|10164146|FG002|COMPLETED|Period I||36
9099228|NCT00328653|10164144|FG000|NOT COMPLETED|Period I||4
9099229|NCT00328653|10164145|FG001|NOT COMPLETED|Period I||0
9099230|NCT00328653|10164146|FG002|NOT COMPLETED|Period I||3
9099231|NCT00328653|10164144|FG000|STARTED|Period II|Following completion of the first period of the trial, all patients were to be administered NOVA22007 (i.e. CsA 0.05% or 0.1%) as four times or twice daily instillations in both eyes for an additional 3 month period.|0
9099232|NCT00328653|10164145|FG001|STARTED|Period II||58
9099233|NCT00328653|10164146|FG002|STARTED|Period II||53
9099234|NCT00328653|10164144|FG000|COMPLETED|Period II||0
9099235|NCT00328653|10164145|FG001|COMPLETED|Period II||50
8625856|NCT00509795|9665489|FG001|COMPLETED|Overall Study||293
8625857|NCT00509795|9665490|FG002|COMPLETED|Overall Study||277
8625858|NCT00509795|9665491|FG003|COMPLETED|Overall Study||276
9099236|NCT00328653|10164146|FG002|COMPLETED|Period II||49
9099237|NCT00328653|10164144|FG000|NOT COMPLETED|Period II||0
9099238|NCT00328653|10164145|FG001|NOT COMPLETED|Period II||8
9099239|NCT00328653|10164146|FG002|NOT COMPLETED|Period II||4
8625859|NCT00509795|9665488|FG000|NOT COMPLETED|Overall Study||22
8625860|NCT00509795|9665489|FG001|NOT COMPLETED|Overall Study||11
8625861|NCT00509795|9665490|FG002|NOT COMPLETED|Overall Study||27
8625862|NCT00509795|9665491|FG003|NOT COMPLETED|Overall Study||27
8625863|NCT00509821|9665504|FG000|STARTED|Study Period 1 (Induction)||3
8625864|NCT00509821|9665505|FG001|STARTED|Study Period 1 (Induction)||57
8625865|NCT00509821|9665504|FG000|Received at Least 1 Dose of Study Drug|Study Period 1 (Induction)||3
9099240|NCT04476251|10164156|FG000|STARTED|Overall Study||1
9099241|NCT04476251|10164156|FG000|COMPLETED|Overall Study||0
9099242|NCT04476251|10164156|FG000|NOT COMPLETED|Overall Study||1
9099243|NCT03924765|10164160|FG000|STARTED|Overall Study||5
9099244|NCT03924765|10164160|FG000|COMPLETED|Overall Study||5
9099245|NCT03924765|10164160|FG000|NOT COMPLETED|Overall Study||0
9099246|NCT03915860|10164164|FG000|STARTED|Overall Study||47
9099247|NCT03915860|10164164|FG000|Treated|Overall Study||46
9099248|NCT03915860|10164164|FG000|COMPLETED|Overall Study||33
9099249|NCT03915860|10164164|FG000|NOT COMPLETED|Overall Study||14
9099250|NCT03817606|10164170|FG000|STARTED|Overall Study||2
9099251|NCT03817606|10164171|FG001|STARTED|Overall Study||2
9099252|NCT03817606|10164170|FG000|COMPLETED|Overall Study||0
9099253|NCT03817606|10164171|FG001|COMPLETED|Overall Study||0
9099254|NCT03817606|10164170|FG000|NOT COMPLETED|Overall Study||2
9099255|NCT03817606|10164171|FG001|NOT COMPLETED|Overall Study||2
9099256|NCT03795233|10164183|FG000|STARTED|Overall Study||4
9099257|NCT03795233|10164184|FG001|STARTED|Overall Study||1
9099258|NCT03795233|10164183|FG000|COMPLETED|Overall Study||0
9099259|NCT03795233|10164184|FG001|COMPLETED|Overall Study||0
9099260|NCT03795233|10164183|FG000|NOT COMPLETED|Overall Study||4
9099261|NCT03795233|10164184|FG001|NOT COMPLETED|Overall Study||1
9099262|NCT03786380|10164195|FG000|STARTED|Overall Study||35
9099263|NCT03786380|10164196|FG001|STARTED|Overall Study||22
9099264|NCT03786380|10164197|FG002|STARTED|Overall Study||54
9099265|NCT03786380|10164198|FG003|STARTED|Overall Study||63
9099266|NCT03786380|10164199|FG004|STARTED|Overall Study||28
9099267|NCT03786380|10164195|FG000|Safety Population|Overall Study||35
9099268|NCT03786380|10164196|FG001|Safety Population|Overall Study||22
9099269|NCT03786380|10164197|FG002|Safety Population|Overall Study||54
9099270|NCT03786380|10164198|FG003|Safety Population|Overall Study||62
9099271|NCT03786380|10164199|FG004|Safety Population|Overall Study||28
9099272|NCT03786380|10164195|FG000|COMPLETED|Overall Study||0
9099273|NCT03786380|10164196|FG001|COMPLETED|Overall Study||0
9099274|NCT03786380|10164197|FG002|COMPLETED|Overall Study||0
9099275|NCT03786380|10164198|FG003|COMPLETED|Overall Study||0
9099276|NCT03786380|10164199|FG004|COMPLETED|Overall Study||0
9099277|NCT03786380|10164195|FG000|NOT COMPLETED|Overall Study||35
9099278|NCT03786380|10164196|FG001|NOT COMPLETED|Overall Study||22
9099279|NCT03786380|10164197|FG002|NOT COMPLETED|Overall Study||54
9099280|NCT03786380|10164198|FG003|NOT COMPLETED|Overall Study||63
9099281|NCT03786380|10164199|FG004|NOT COMPLETED|Overall Study||28
9099282|NCT03769376|10164213|FG000|STARTED|Overall Study||20
9099283|NCT03769376|10164214|FG001|STARTED|Overall Study||18
9099284|NCT03769376|10164213|FG000|COMPLETED|Overall Study||13
9099285|NCT03769376|10164214|FG001|COMPLETED|Overall Study||11
9099286|NCT03769376|10164213|FG000|NOT COMPLETED|Overall Study||7
9099287|NCT03769376|10164214|FG001|NOT COMPLETED|Overall Study||7
9099288|NCT03645863|10164223|FG000|STARTED|Overall Study||21
9099289|NCT03645863|10164224|FG001|STARTED|Overall Study||20
9099290|NCT03645863|10164225|FG002|STARTED|Overall Study||20
9099291|NCT03645863|10164223|FG000|COMPLETED|Overall Study||20
9099292|NCT03645863|10164224|FG001|COMPLETED|Overall Study||20
9099293|NCT03645863|10164225|FG002|COMPLETED|Overall Study||20
9099294|NCT03645863|10164223|FG000|NOT COMPLETED|Overall Study||1
9099295|NCT03645863|10164224|FG001|NOT COMPLETED|Overall Study||0
9099296|NCT03645863|10164225|FG002|NOT COMPLETED|Overall Study||0
9099297|NCT03564145|10164233|FG000|STARTED|Overall Study||547
9099298|NCT03564145|10164233|FG000|Received at Least 1 Dose of Study Drug|Overall Study||535
9099299|NCT03564145|10164233|FG000|COMPLETED|Overall Study||323
9099300|NCT03564145|10164233|FG000|NOT COMPLETED|Overall Study||224
9099301|NCT03564119|10164239|FG000|STARTED|Overall Study||250
9099302|NCT03564119|10164240|FG001|STARTED|Overall Study||122
9099303|NCT03564119|10164239|FG000|Received at Least 1 Dose of Study Drug|Overall Study||249
9099304|NCT03564119|10164240|FG001|Received at Least 1 Dose of Study Drug|Overall Study||120
9099305|NCT03564119|10164239|FG000|COMPLETED|Overall Study||235
9099306|NCT03564119|10164240|FG001|COMPLETED|Overall Study||113
9099307|NCT03564119|10164239|FG000|NOT COMPLETED|Overall Study||15
9099308|NCT03564119|10164240|FG001|NOT COMPLETED|Overall Study||9
9099309|NCT03365635|10164252|FG000|STARTED|Overall Study||3
9099310|NCT03365635|10164253|FG001|STARTED|Overall Study||0
9099311|NCT03365635|10164254|FG002|STARTED|Overall Study||1
9099312|NCT03365635|10164255|FG003|STARTED|Overall Study||0
9099313|NCT03365635|10164256|FG004|STARTED|Overall Study||0
9099314|NCT03365635|10164257|FG005|STARTED|Overall Study||0
9099315|NCT03365635|10164252|FG000|COMPLETED|Overall Study||3
9099316|NCT03365635|10164253|FG001|COMPLETED|Overall Study||0
9099317|NCT03365635|10164254|FG002|COMPLETED|Overall Study||1
9099318|NCT03365635|10164255|FG003|COMPLETED|Overall Study||0
9099319|NCT03365635|10164256|FG004|COMPLETED|Overall Study||0
9099320|NCT03365635|10164257|FG005|COMPLETED|Overall Study||0
9099321|NCT03365635|10164252|FG000|NOT COMPLETED|Overall Study||0
9099322|NCT03365635|10164253|FG001|NOT COMPLETED|Overall Study||0
9099323|NCT03365635|10164254|FG002|NOT COMPLETED|Overall Study||0
9099324|NCT03365635|10164255|FG003|NOT COMPLETED|Overall Study||0
9099325|NCT03365635|10164256|FG004|NOT COMPLETED|Overall Study||0
9099326|NCT03365635|10164257|FG005|NOT COMPLETED|Overall Study||0
9099327|NCT03287050|10164271|FG000|STARTED|Overall Study||6
9099328|NCT03287050|10164271|FG000|COMPLETED|Overall Study||6
9099329|NCT03287050|10164271|FG000|NOT COMPLETED|Overall Study||0
9099330|NCT03223350|10164277|FG000|STARTED|Overall Study||17
9099331|NCT03223350|10164278|FG001|STARTED|Overall Study||13
9099332|NCT03223350|10164277|FG000|COMPLETED|Overall Study||17
9099333|NCT03223350|10164278|FG001|COMPLETED|Overall Study||13
9099334|NCT03223350|10164277|FG000|NOT COMPLETED|Overall Study||0
9099335|NCT03223350|10164278|FG001|NOT COMPLETED|Overall Study||0
9099336|NCT03181828|10164286|FG000|STARTED|Overall Study||2
9099337|NCT03181828|10164287|FG001|STARTED|Overall Study||2
9099338|NCT03181828|10164286|FG000|COMPLETED|Overall Study||2
9099339|NCT03181828|10164287|FG001|COMPLETED|Overall Study||2
9099340|NCT03181828|10164286|FG000|NOT COMPLETED|Overall Study||0
9099341|NCT03181828|10164287|FG001|NOT COMPLETED|Overall Study||0
9099342|NCT03181529|10164295|FG000|STARTED|Overall Study||15
9099343|NCT03181529|10164296|FG001|STARTED|Overall Study||12
9099344|NCT03181529|10164295|FG000|COMPLETED|Overall Study||13
9099345|NCT03181529|10164296|FG001|COMPLETED|Overall Study||11
9099346|NCT03181529|10164295|FG000|NOT COMPLETED|Overall Study||2
9099347|NCT03181529|10164296|FG001|NOT COMPLETED|Overall Study||1
9099348|NCT02946931|10164302|FG000|STARTED|Overall Study||1387
9099349|NCT02946931|10164302|FG000|Case Report Forms (CRFs) Collected|Overall Study||814
9099350|NCT02946931|10164302|FG000|COMPLETED|Overall Study||569
9099351|NCT02946931|10164302|FG000|NOT COMPLETED|Overall Study||818
9099352|NCT02779556|10164308|FG000|STARTED|Baseline||394
9099353|NCT02779556|10164309|FG001|STARTED|Baseline||362
9099354|NCT02779556|10164308|FG000|COMPLETED|Baseline||393
9099355|NCT02779556|10164309|FG001|COMPLETED|Baseline||362
9099356|NCT02779556|10164308|FG000|NOT COMPLETED|Baseline||1
9099357|NCT02779556|10164309|FG001|NOT COMPLETED|Baseline||0
9099358|NCT02779556|10164308|FG000|STARTED|3 Months||393
9099359|NCT02779556|10164309|FG001|STARTED|3 Months||362
9099360|NCT02779556|10164308|FG000|COMPLETED|3 Months||326
9099361|NCT02779556|10164309|FG001|COMPLETED|3 Months||314
8625866|NCT00509821|9665505|FG001|Received at Least 1 Dose of Study Drug|Study Period 1 (Induction)||57
8625867|NCT00509821|9665504|FG000|COMPLETED|Study Period 1 (Induction)||3
8625868|NCT00509821|9665505|FG001|COMPLETED|Study Period 1 (Induction)||53
8625869|NCT00509821|9665504|FG000|NOT COMPLETED|Study Period 1 (Induction)||0
9099362|NCT02779556|10164308|FG000|NOT COMPLETED|3 Months||67
9099363|NCT02779556|10164309|FG001|NOT COMPLETED|3 Months||48
9099364|NCT02779556|10164308|FG000|STARTED|6 Month|Those who were not lost to follow-up but missed the visit from the previous period were allowed to continue in the study and complete future interviews (314+19=333 Enhanced Usual Care).|353
9099365|NCT02779556|10164309|FG001|STARTED|6 Month|Those who were not lost to follow-up but missed the visit from the previous period were allowed to continue in the study and complete future interviews (326+27=353 Intervention).|333
9099366|NCT02779556|10164308|FG000|COMPLETED|6 Month||320
9099367|NCT02779556|10164309|FG001|COMPLETED|6 Month||294
9099368|NCT02779556|10164308|FG000|NOT COMPLETED|6 Month||33
9099369|NCT02779556|10164309|FG001|NOT COMPLETED|6 Month||39
9099370|NCT02779556|10164308|FG000|STARTED|6 Month HbA1c|All enrolled participants were eligible for the analysis of clinical values regardless of completion of 3 and 6 month interviews.|394
9099371|NCT02779556|10164309|FG001|STARTED|6 Month HbA1c|All enrolled participants were eligible for the analysis of clinical values regardless of completion of 3 and 6 month interviews.|362
9099372|NCT02779556|10164308|FG000|COMPLETED|6 Month HbA1c||325
9099373|NCT02779556|10164309|FG001|COMPLETED|6 Month HbA1c||312
8845887|NCT01717768|9900357|FG010|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8845888|NCT01717768|9900358|FG011|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8845889|NCT01717768|9900347|FG000|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8845890|NCT01717768|9900348|FG001|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8845891|NCT01717768|9900349|FG002|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8845892|NCT01717768|9900350|FG003|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8845893|NCT01717768|9900351|FG004|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8845894|NCT01717768|9900352|FG005|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8845895|NCT01717768|9900353|FG006|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8845896|NCT01717768|9900354|FG007|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8845897|NCT01717768|9900355|FG008|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8845898|NCT01717768|9900356|FG009|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8845899|NCT01717768|9900357|FG010|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8845900|NCT01717768|9900358|FG011|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8845901|NCT01717768|9900347|FG000|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
8845902|NCT01717768|9900348|FG001|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
8845903|NCT01717768|9900349|FG002|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
8845904|NCT01717768|9900350|FG003|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
9099374|NCT02779556|10164308|FG000|NOT COMPLETED|6 Month HbA1c||69
9099375|NCT02779556|10164309|FG001|NOT COMPLETED|6 Month HbA1c||50
9099376|NCT02779556|10164308|FG000|STARTED|12 Month HbA1c|All enrolled participants were eligible for the analysis of clinical values regardless of completion of 3 and 6 month interviews.|394
9099377|NCT02779556|10164309|FG001|STARTED|12 Month HbA1c|All enrolled participants were eligible for the analysis of clinical values regardless of completion of 3 and 6 month interviews.|362
9099378|NCT02779556|10164308|FG000|COMPLETED|12 Month HbA1c||256
9099379|NCT02779556|10164309|FG001|COMPLETED|12 Month HbA1c||260
9099380|NCT02779556|10164308|FG000|NOT COMPLETED|12 Month HbA1c||138
9099381|NCT02779556|10164309|FG001|NOT COMPLETED|12 Month HbA1c||102
8625870|NCT00509821|9665505|FG001|NOT COMPLETED|Study Period 1 (Induction)||4
9099382|NCT02724774|10164317|FG000|STARTED|Overall Study||127
9099383|NCT02724774|10164318|FG001|STARTED|Overall Study||125
9099384|NCT02724774|10164317|FG000|Infant 6 Months|Overall Study||122
9099385|NCT02724774|10164318|FG001|Infant 6 Months|Overall Study||122
9099386|NCT02724774|10164317|FG000|Infant 12 Months|Overall Study||120
9099387|NCT02724774|10164318|FG001|Infant 12 Months|Overall Study||123
8845905|NCT01717768|9900351|FG004|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
9099388|NCT02724774|10164317|FG000|COMPLETED|Overall Study||120
9099389|NCT02724774|10164318|FG001|COMPLETED|Overall Study||123
9099390|NCT02724774|10164317|FG000|NOT COMPLETED|Overall Study||7
9099391|NCT02724774|10164318|FG001|NOT COMPLETED|Overall Study||2
9099392|NCT02722941|10164326|FG000|STARTED|Overall Study||15
9099393|NCT02722941|10164327|FG001|STARTED|Overall Study||15
9099394|NCT02722941|10164326|FG000|COMPLETED|Overall Study||15
9099395|NCT02722941|10164327|FG001|COMPLETED|Overall Study||15
9099396|NCT02722941|10164326|FG000|NOT COMPLETED|Overall Study||0
9099397|NCT02722941|10164327|FG001|NOT COMPLETED|Overall Study||0
9099398|NCT02675751|10164333|FG000|STARTED|Overall Study||167
9099399|NCT02675751|10164333|FG000|COMPLETED|Overall Study||151
9099400|NCT02675751|10164333|FG000|NOT COMPLETED|Overall Study||16
9099401|NCT02643381|10164339|FG000|STARTED|Overall Study||400
9099402|NCT02643381|10164340|FG001|STARTED|Overall Study||401
9099403|NCT02643381|10164339|FG000|COMPLETED|Overall Study||396
9099404|NCT02643381|10164340|FG001|COMPLETED|Overall Study||395
9099405|NCT02643381|10164339|FG000|NOT COMPLETED|Overall Study||4
9099406|NCT02643381|10164340|FG001|NOT COMPLETED|Overall Study||6
9099407|NCT02621424|10164348|FG000|STARTED|Overall Study||14
9099408|NCT02621424|10164349|FG001|STARTED|Overall Study||18
9099409|NCT02621424|10164348|FG000|COMPLETED|Overall Study||13
9099410|NCT02621424|10164349|FG001|COMPLETED|Overall Study||16
9099411|NCT02621424|10164348|FG000|NOT COMPLETED|Overall Study||1
9099412|NCT02621424|10164349|FG001|NOT COMPLETED|Overall Study||2
9099413|NCT02595372|10164355|FG000|STARTED|Overall Study||42
9099414|NCT02595372|10164355|FG000|COMPLETED|Overall Study||33
9099415|NCT02595372|10164355|FG000|NOT COMPLETED|Overall Study||9
9099416|NCT02447133|10164359|FG000|STARTED|Overall Study||12
9099417|NCT02447133|10164359|FG000|COMPLETED|Overall Study||12
9099418|NCT02447133|10164359|FG000|NOT COMPLETED|Overall Study||0
9099419|NCT02334722|10164367|FG000|STARTED|Overall Study||40
9099420|NCT02334722|10164368|FG001|STARTED|Overall Study||41
9099421|NCT02334722|10164367|FG000|COMPLETED|Overall Study||33
9099422|NCT02334722|10164368|FG001|COMPLETED|Overall Study||34
9099423|NCT02334722|10164367|FG000|NOT COMPLETED|Overall Study||7
9099424|NCT02334722|10164368|FG001|NOT COMPLETED|Overall Study||7
9099425|NCT02259725|10164374|FG000|STARTED|Overall Study||3
9099426|NCT02259725|10164374|FG000|COMPLETED|Overall Study||3
9099427|NCT02259725|10164374|FG000|NOT COMPLETED|Overall Study||0
9099428|NCT01966731|10164378|FG000|STARTED|Overall Study||635
9099429|NCT01966731|10164378|FG000|Initiated Hydroxyurea|Overall Study||606
9099430|NCT01966731|10164378|FG000|Completed 3 Months of Treatment|Overall Study||600
9099431|NCT01966731|10164378|FG000|Completed Study|Overall Study||0
9099432|NCT01966731|10164378|FG000|COMPLETED|Overall Study||0
9099433|NCT01966731|10164378|FG000|NOT COMPLETED|Overall Study||635
9099434|NCT01952288|10164384|FG000|STARTED|Overall Study||3
9099435|NCT01952288|10164385|FG001|STARTED|Overall Study||2
9099436|NCT01952288|10164384|FG000|COMPLETED|Overall Study||3
9099437|NCT01952288|10164385|FG001|COMPLETED|Overall Study||2
9099438|NCT01952288|10164384|FG000|NOT COMPLETED|Overall Study||0
9099439|NCT01952288|10164385|FG001|NOT COMPLETED|Overall Study||0
9099440|NCT01850082|10164393|FG000|STARTED|Overall Study||576
9099441|NCT01850082|10164394|FG001|STARTED|Overall Study||574
9099442|NCT01850082|10164393|FG000|COMPLETED|Overall Study||576
9099443|NCT01850082|10164394|FG001|COMPLETED|Overall Study||574
9099444|NCT01850082|10164393|FG000|NOT COMPLETED|Overall Study||0
9099445|NCT01850082|10164394|FG001|NOT COMPLETED|Overall Study||0
9099446|NCT01844518|10164402|FG000|STARTED|Overall Study||173
9099447|NCT01844518|10164403|FG001|STARTED|Overall Study||46
9099448|NCT01844518|10164402|FG000|COMPLETED|Overall Study||132
9099449|NCT01844518|10164403|FG001|COMPLETED|Overall Study||39
9099450|NCT01844518|10164402|FG000|NOT COMPLETED|Overall Study||41
9099451|NCT01844518|10164403|FG001|NOT COMPLETED|Overall Study||7
9099452|NCT01675479|10164412|FG000|STARTED|Overall Study||69
9099453|NCT01675479|10164412|FG000|COMPLETED|Overall Study||58
9099454|NCT01675479|10164412|FG000|NOT COMPLETED|Overall Study||11
9099455|NCT01398839|10164418|FG000|STARTED|Overall Study||35
9099456|NCT01398839|10164419|FG001|STARTED|Overall Study||37
9099457|NCT01398839|10164418|FG000|COMPLETED|Overall Study|The study was terminated. The exact number of patients completing all visits is unknown.|35
9099458|NCT01398839|10164419|FG001|COMPLETED|Overall Study|The study was terminated. The exact number of patients completing all visits is unknown.|37
9099459|NCT01398839|10164418|FG000|NOT COMPLETED|Overall Study||0
9099460|NCT01398839|10164419|FG001|NOT COMPLETED|Overall Study||0
9099461|NCT01349959|10164425|FG000|STARTED|Overall Study||40
9099462|NCT01349959|10164425|FG000|COMPLETED|Overall Study||33
9099463|NCT01349959|10164425|FG000|NOT COMPLETED|Overall Study||7
9099464|NCT01168219|10164429|FG000|STARTED|Overall Study||68
9099465|NCT01168219|10164429|FG000|COMPLETED|Overall Study||63
9099466|NCT01168219|10164429|FG000|NOT COMPLETED|Overall Study||5
9099467|NCT00812708|10164433|FG000|STARTED|Overall Study|6 patients withdrew from the study before being taken to the operating room.|72
9099468|NCT00812708|10164433|FG000|Taken to Surgery for Device Implantation|Overall Study|2 patients could not be implanted because of intraoperative complications.|66
9099469|NCT00812708|10164433|FG000|COMPLETED|Overall Study||64
9099470|NCT00812708|10164433|FG000|NOT COMPLETED|Overall Study||8
9099471|NCT00792259|10164441|FG000|STARTED|Overall Study||15
9099472|NCT00792259|10164442|FG001|STARTED|Overall Study||20
9099473|NCT00792259|10164443|FG002|STARTED|Overall Study||13
9099474|NCT00792259|10164441|FG000|COMPLETED|Overall Study||14
9099475|NCT00792259|10164442|FG001|COMPLETED|Overall Study||20
9099476|NCT00792259|10164443|FG002|COMPLETED|Overall Study||13
9099477|NCT00792259|10164441|FG000|NOT COMPLETED|Overall Study||1
9099478|NCT00792259|10164442|FG001|NOT COMPLETED|Overall Study||0
9099479|NCT00792259|10164443|FG002|NOT COMPLETED|Overall Study||0
9099480|NCT00741988|10164453|FG000|STARTED|Overall Study||42
9099481|NCT00741988|10164454|FG001|STARTED|Overall Study||40
9099482|NCT00741988|10164453|FG000|COMPLETED|Overall Study||38
9099483|NCT00741988|10164454|FG001|COMPLETED|Overall Study||36
9099484|NCT00741988|10164453|FG000|NOT COMPLETED|Overall Study||4
9099485|NCT00741988|10164454|FG001|NOT COMPLETED|Overall Study||4
9099486|NCT00563576|10164462|FG000|STARTED|Overall Study||35
9099487|NCT00563576|10164463|FG001|STARTED|Overall Study||36
9099488|NCT00563576|10164462|FG000|COMPLETED|Overall Study||21
9099489|NCT00563576|10164463|FG001|COMPLETED|Overall Study||22
9099490|NCT00563576|10164462|FG000|NOT COMPLETED|Overall Study||14
9099491|NCT00563576|10164463|FG001|NOT COMPLETED|Overall Study||14
9099492|NCT00515671|10164471|FG000|STARTED|Overall Study||60
9099493|NCT00515671|10164472|FG001|STARTED|Overall Study||58
9099494|NCT00515671|10164471|FG000|COMPLETED|Overall Study||43
9099495|NCT00515671|10164472|FG001|COMPLETED|Overall Study||41
9099496|NCT00515671|10164471|FG000|NOT COMPLETED|Overall Study||17
9099497|NCT00515671|10164472|FG001|NOT COMPLETED|Overall Study||17
9099498|NCT00455403|10164480|FG000|STARTED|Overall Study||59
9099499|NCT00455403|10164481|FG001|STARTED|Overall Study||57
9099500|NCT00455403|10164480|FG000|COMPLETED|Overall Study||56
9099501|NCT00455403|10164481|FG001|COMPLETED|Overall Study||51
9099502|NCT00455403|10164480|FG000|NOT COMPLETED|Overall Study||3
9099503|NCT00455403|10164481|FG001|NOT COMPLETED|Overall Study||6
9099504|NCT00238420|10164489|FG000|STARTED|Overall Study||22
9099505|NCT00238420|10164490|FG001|STARTED|Overall Study||48
9099506|NCT00238420|10164489|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|21
9099507|NCT00238420|10164490|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|47
9099508|NCT00238420|10164489|FG000|NOT COMPLETED|Overall Study||1
9099509|NCT00238420|10164490|FG001|NOT COMPLETED|Overall Study||1
9099510|NCT04328961|10164498|FG000|STARTED|Overall Study||422
9099511|NCT04328961|10164499|FG001|STARTED|Overall Study||407
9099512|NCT04328961|10164498|FG000|COMPLETED|Overall Study||336
9099513|NCT04328961|10164499|FG001|COMPLETED|Overall Study||353
9099514|NCT04328961|10164498|FG000|NOT COMPLETED|Overall Study||86
9099515|NCT04328961|10164499|FG001|NOT COMPLETED|Overall Study||54
9099516|NCT04128319|10164505|FG000|STARTED|Overall Study||3
9099517|NCT04128319|10164505|FG000|Initiated T-Guard Treatment|Overall Study||3
9099518|NCT04128319|10164505|FG000|COMPLETED|Overall Study||0
9099519|NCT04128319|10164505|FG000|NOT COMPLETED|Overall Study||3
9099520|NCT03761810|10164511|FG000|STARTED|Overall Study||290
9099521|NCT03761810|10164512|FG001|STARTED|Overall Study||144
9099522|NCT03761810|10164511|FG000|Received at Least 1 Dose of Study Drug|Overall Study||281
9099523|NCT03761810|10164512|FG001|Received at Least 1 Dose of Study Drug|Overall Study||138
9099524|NCT03761810|10164511|FG000|COMPLETED|Overall Study||242
9099525|NCT03761810|10164512|FG001|COMPLETED|Overall Study||132
9099526|NCT03761810|10164511|FG000|NOT COMPLETED|Overall Study||48
9099527|NCT03761810|10164512|FG001|NOT COMPLETED|Overall Study||12
9099528|NCT03761784|10164520|FG000|STARTED|Overall Study||281
9099529|NCT03761784|10164521|FG001|STARTED|Overall Study||143
9099530|NCT03761784|10164520|FG000|Received at Least 1 Dose of Study Drug|Overall Study||274
9099531|NCT03761784|10164521|FG001|Received at Least 1 Dose of Study Drug|Overall Study||139
9099532|NCT03761784|10164520|FG000|COMPLETED|Overall Study||249
9099533|NCT03761784|10164521|FG001|COMPLETED|Overall Study||131
9099534|NCT03761784|10164520|FG000|NOT COMPLETED|Overall Study||32
9099535|NCT03761784|10164521|FG001|NOT COMPLETED|Overall Study||12
9099536|NCT03541317|10164529|FG000|STARTED|Stage 1 of the Implementation||6
9099537|NCT03541317|10164530|FG001|STARTED|Stage 1 of the Implementation||37
9099538|NCT03541317|10164531|FG002|STARTED|Stage 1 of the Implementation||38
9099539|NCT03541317|10164532|FG003|STARTED|Stage 1 of the Implementation||9
9099540|NCT03541317|10164533|FG004|STARTED|Stage 1 of the Implementation||43
9099541|NCT03541317|10164534|FG005|STARTED|Stage 1 of the Implementation||36
9099542|NCT03541317|10164529|FG000|COMPLETED|Stage 1 of the Implementation||6
9099543|NCT03541317|10164530|FG001|COMPLETED|Stage 1 of the Implementation||37
9099544|NCT03541317|10164531|FG002|COMPLETED|Stage 1 of the Implementation||38
9099545|NCT03541317|10164532|FG003|COMPLETED|Stage 1 of the Implementation||9
9099546|NCT03541317|10164533|FG004|COMPLETED|Stage 1 of the Implementation||43
9099547|NCT03541317|10164534|FG005|COMPLETED|Stage 1 of the Implementation||36
9099548|NCT03541317|10164529|FG000|NOT COMPLETED|Stage 1 of the Implementation||0
9099549|NCT03541317|10164530|FG001|NOT COMPLETED|Stage 1 of the Implementation||0
9099550|NCT03541317|10164531|FG002|NOT COMPLETED|Stage 1 of the Implementation||0
9099551|NCT03541317|10164532|FG003|NOT COMPLETED|Stage 1 of the Implementation||0
9099552|NCT03541317|10164533|FG004|NOT COMPLETED|Stage 1 of the Implementation||0
9099553|NCT03541317|10164534|FG005|NOT COMPLETED|Stage 1 of the Implementation||0
9099554|NCT03541317|10164529|FG000|STARTED|Stage 2 of the Implementation||6
9099555|NCT03541317|10164530|FG001|STARTED|Stage 2 of the Implementation||37
9099556|NCT03541317|10164531|FG002|STARTED|Stage 2 of the Implementation||38
9099557|NCT03541317|10164532|FG003|STARTED|Stage 2 of the Implementation||9
9099558|NCT03541317|10164533|FG004|STARTED|Stage 2 of the Implementation||43
9099559|NCT03541317|10164534|FG005|STARTED|Stage 2 of the Implementation||36
9099560|NCT03541317|10164529|FG000|COMPLETED|Stage 2 of the Implementation||5
9099561|NCT03541317|10164530|FG001|COMPLETED|Stage 2 of the Implementation||37
9099562|NCT03541317|10164531|FG002|COMPLETED|Stage 2 of the Implementation||38
9099563|NCT03541317|10164532|FG003|COMPLETED|Stage 2 of the Implementation||9
9099564|NCT03541317|10164533|FG004|COMPLETED|Stage 2 of the Implementation||43
9099565|NCT03541317|10164534|FG005|COMPLETED|Stage 2 of the Implementation||36
9099566|NCT03541317|10164529|FG000|NOT COMPLETED|Stage 2 of the Implementation||1
9099567|NCT03541317|10164530|FG001|NOT COMPLETED|Stage 2 of the Implementation||0
9099568|NCT03541317|10164531|FG002|NOT COMPLETED|Stage 2 of the Implementation||0
9099569|NCT03541317|10164532|FG003|NOT COMPLETED|Stage 2 of the Implementation||0
9099570|NCT03541317|10164533|FG004|NOT COMPLETED|Stage 2 of the Implementation||0
9099571|NCT03541317|10164534|FG005|NOT COMPLETED|Stage 2 of the Implementation||0
9099572|NCT03457129|10164548|FG000|STARTED|Overall Study||10
9099573|NCT03457129|10164549|FG001|STARTED|Overall Study||10
9099574|NCT03457129|10164548|FG000|COMPLETED|Overall Study||7
9099575|NCT03457129|10164549|FG001|COMPLETED|Overall Study||8
9099576|NCT03457129|10164548|FG000|NOT COMPLETED|Overall Study||3
9099577|NCT03457129|10164549|FG001|NOT COMPLETED|Overall Study||2
9099578|NCT03361865|10164557|FG000|STARTED|Overall Study||44
9099579|NCT03361865|10164558|FG001|STARTED|Overall Study||49
9099580|NCT03361865|10164557|FG000|Intention-to-Treat (ITT)|Overall Study||44
9099581|NCT03361865|10164558|FG001|Intention-to-Treat (ITT)|Overall Study||49
9099582|NCT03361865|10164557|FG000|All Participants as Treated (APaT)|Overall Study||43
9099583|NCT03361865|10164558|FG001|All Participants as Treated (APaT)|Overall Study||49
9099584|NCT03361865|10164557|FG000|COMPLETED|Overall Study||25
9099585|NCT03361865|10164558|FG001|COMPLETED|Overall Study||22
9099586|NCT03361865|10164557|FG000|NOT COMPLETED|Overall Study||19
9099587|NCT03361865|10164558|FG001|NOT COMPLETED|Overall Study||27
9099588|NCT03294304|10164565|FG000|STARTED|Overall Study||43
9099589|NCT03294304|10164565|FG000|COMPLETED|Overall Study||43
9099590|NCT03294304|10164565|FG000|NOT COMPLETED|Overall Study||0
9099591|NCT03122431|10164572|FG000|STARTED|Overall Study||41
9099592|NCT03122431|10164573|FG001|STARTED|Overall Study||32
9099593|NCT03122431|10164574|FG002|STARTED|Overall Study||20
9099594|NCT03122431|10164572|FG000|COMPLETED|Overall Study||41
9099595|NCT03122431|10164573|FG001|COMPLETED|Overall Study||32
9099596|NCT03122431|10164574|FG002|COMPLETED|Overall Study||9
9099597|NCT03122431|10164572|FG000|NOT COMPLETED|Overall Study||0
9099598|NCT03122431|10164573|FG001|NOT COMPLETED|Overall Study||0
9099599|NCT03122431|10164574|FG002|NOT COMPLETED|Overall Study||11
9099600|NCT02929056|10164584|FG000|STARTED|Overall Study||1
9099601|NCT02929056|10164585|FG001|STARTED|Overall Study||1
9099602|NCT02929056|10164584|FG000|COMPLETED|Overall Study||1
9099603|NCT02929056|10164585|FG001|COMPLETED|Overall Study||0
9099604|NCT02929056|10164584|FG000|NOT COMPLETED|Overall Study||0
9099605|NCT02929056|10164585|FG001|NOT COMPLETED|Overall Study||1
9099606|NCT02896855|10164593|FG000|STARTED|Overall Study||121
9099607|NCT02896855|10164594|FG001|STARTED|Overall Study||122
9099608|NCT02896855|10164593|FG000|Received Any Study Treatment|Overall Study||120
9099609|NCT02896855|10164594|FG001|Received Any Study Treatment|Overall Study||122
9099610|NCT02896855|10164593|FG000|Crossed Over From Placebo to Receive Pertuzumab|Overall Study|From 07-March-2020, 12 participants randomized to the Placebo arm crossed over to open-label pertuzumab.|12
9099611|NCT02896855|10164594|FG001|Crossed Over From Placebo to Receive Pertuzumab|Overall Study||0
9099612|NCT02896855|10164593|FG000|COMPLETED|Overall Study||49
9099613|NCT02896855|10164594|FG001|COMPLETED|Overall Study||69
9099614|NCT02896855|10164593|FG000|NOT COMPLETED|Overall Study||72
9099615|NCT02896855|10164594|FG001|NOT COMPLETED|Overall Study||53
9099616|NCT02871778|10164607|FG000|STARTED|Part A: Treatment Period 1||43
9099617|NCT02871778|10164608|FG001|STARTED|Part A: Treatment Period 1||41
9099618|NCT02871778|10164609|FG002|STARTED|Part A: Treatment Period 1||21
9099619|NCT02871778|10164610|FG003|STARTED|Part A: Treatment Period 1||18
9099620|NCT02871778|10164611|FG004|STARTED|Part A: Treatment Period 1||0
9099621|NCT02871778|10164612|FG005|STARTED|Part A: Treatment Period 1||0
9099622|NCT02871778|10164613|FG006|STARTED|Part A: Treatment Period 1||0
9099623|NCT02871778|10164614|FG007|STARTED|Part A: Treatment Period 1||0
9099624|NCT02871778|10164607|FG000|Safety Analysis Set|Part A: Treatment Period 1|1 participant was randomized to receive HS in Period 1, but instead received VX-371 in HS in Period 1.|44
9099625|NCT02871778|10164608|FG001|Safety Analysis Set|Part A: Treatment Period 1||40
9099626|NCT02871778|10164609|FG002|Safety Analysis Set|Part A: Treatment Period 1||21
9099627|NCT02871778|10164610|FG003|Safety Analysis Set|Part A: Treatment Period 1||18
9099628|NCT02871778|10164611|FG004|Safety Analysis Set|Part A: Treatment Period 1||0
9099629|NCT02871778|10164612|FG005|Safety Analysis Set|Part A: Treatment Period 1||0
9099630|NCT02871778|10164613|FG006|Safety Analysis Set|Part A: Treatment Period 1||0
9099631|NCT02871778|10164614|FG007|Safety Analysis Set|Part A: Treatment Period 1||0
9099632|NCT02871778|10164607|FG000|COMPLETED|Part A: Treatment Period 1||40
9099633|NCT02871778|10164608|FG001|COMPLETED|Part A: Treatment Period 1||37
9099634|NCT02871778|10164609|FG002|COMPLETED|Part A: Treatment Period 1||18
9099635|NCT02871778|10164610|FG003|COMPLETED|Part A: Treatment Period 1||16
9099636|NCT02871778|10164611|FG004|COMPLETED|Part A: Treatment Period 1||0
9099637|NCT02871778|10164612|FG005|COMPLETED|Part A: Treatment Period 1||0
9099638|NCT02871778|10164613|FG006|COMPLETED|Part A: Treatment Period 1||0
9099639|NCT02871778|10164614|FG007|COMPLETED|Part A: Treatment Period 1||0
9099640|NCT02871778|10164607|FG000|NOT COMPLETED|Part A: Treatment Period 1||3
9099641|NCT02871778|10164608|FG001|NOT COMPLETED|Part A: Treatment Period 1||4
9099642|NCT02871778|10164609|FG002|NOT COMPLETED|Part A: Treatment Period 1||3
9099643|NCT02871778|10164610|FG003|NOT COMPLETED|Part A: Treatment Period 1||2
9099644|NCT02871778|10164611|FG004|NOT COMPLETED|Part A: Treatment Period 1||0
9099645|NCT02871778|10164612|FG005|NOT COMPLETED|Part A: Treatment Period 1||0
9099646|NCT02871778|10164613|FG006|NOT COMPLETED|Part A: Treatment Period 1||0
9099647|NCT02871778|10164614|FG007|NOT COMPLETED|Part A: Treatment Period 1||0
9099648|NCT02871778|10164607|FG000|STARTED|Part A: Treatment Period 2||40
9099649|NCT02871778|10164608|FG001|STARTED|Part A: Treatment Period 2||37
9099650|NCT02871778|10164609|FG002|STARTED|Part A: Treatment Period 2||18
9099651|NCT02871778|10164610|FG003|STARTED|Part A: Treatment Period 2||16
9099652|NCT02871778|10164611|FG004|STARTED|Part A: Treatment Period 2||0
9099653|NCT02871778|10164612|FG005|STARTED|Part A: Treatment Period 2||0
9099654|NCT02871778|10164613|FG006|STARTED|Part A: Treatment Period 2||0
9099655|NCT02871778|10164614|FG007|STARTED|Part A: Treatment Period 2||0
9099656|NCT02871778|10164607|FG000|Safety Analysis Set|Part A: Treatment Period 2||40
9099657|NCT02871778|10164608|FG001|Safety Analysis Set|Part A: Treatment Period 2||37
9099658|NCT02871778|10164609|FG002|Safety Analysis Set|Part A: Treatment Period 2||18
9099659|NCT02871778|10164610|FG003|Safety Analysis Set|Part A: Treatment Period 2||16
9099660|NCT02871778|10164611|FG004|Safety Analysis Set|Part A: Treatment Period 2||0
9099661|NCT02871778|10164612|FG005|Safety Analysis Set|Part A: Treatment Period 2||0
9099662|NCT02871778|10164613|FG006|Safety Analysis Set|Part A: Treatment Period 2||0
9099663|NCT02871778|10164614|FG007|Safety Analysis Set|Part A: Treatment Period 2||0
9099664|NCT02871778|10164607|FG000|COMPLETED|Part A: Treatment Period 2||37
9099665|NCT02871778|10164608|FG001|COMPLETED|Part A: Treatment Period 2||35
9099666|NCT02871778|10164609|FG002|COMPLETED|Part A: Treatment Period 2||17
9099667|NCT02871778|10164610|FG003|COMPLETED|Part A: Treatment Period 2||15
9099668|NCT02871778|10164611|FG004|COMPLETED|Part A: Treatment Period 2||0
9099669|NCT02871778|10164612|FG005|COMPLETED|Part A: Treatment Period 2||0
9099670|NCT02871778|10164613|FG006|COMPLETED|Part A: Treatment Period 2||0
9099671|NCT02871778|10164614|FG007|COMPLETED|Part A: Treatment Period 2||0
9099672|NCT02871778|10164607|FG000|NOT COMPLETED|Part A: Treatment Period 2||3
9099673|NCT02871778|10164608|FG001|NOT COMPLETED|Part A: Treatment Period 2||2
9099674|NCT02871778|10164609|FG002|NOT COMPLETED|Part A: Treatment Period 2||1
9099675|NCT02871778|10164610|FG003|NOT COMPLETED|Part A: Treatment Period 2||1
9099676|NCT02871778|10164611|FG004|NOT COMPLETED|Part A: Treatment Period 2||0
9099677|NCT02871778|10164612|FG005|NOT COMPLETED|Part A: Treatment Period 2||0
9099678|NCT02871778|10164613|FG006|NOT COMPLETED|Part A: Treatment Period 2||0
9099679|NCT02871778|10164614|FG007|NOT COMPLETED|Part A: Treatment Period 2||0
9099680|NCT02871778|10164607|FG000|STARTED|Part B: Treatment Period 3||0
9099681|NCT02871778|10164608|FG001|STARTED|Part B: Treatment Period 3||0
9099682|NCT02871778|10164609|FG002|STARTED|Part B: Treatment Period 3||0
9099683|NCT02871778|10164610|FG003|STARTED|Part B: Treatment Period 3||0
9099684|NCT02871778|10164611|FG004|STARTED|Part B: Treatment Period 3|Out of 35 participants who were on VX-371 in HS in Treatment period 2 and completed Part A, 11 participants rolled-over to Part B.|11
9099685|NCT02871778|10164612|FG005|STARTED|Part B: Treatment Period 3|Out of 37 participants who were on HS in Treatment period 2 and completed Part A, 27 participants rolled-over to Part B.|27
9099686|NCT02871778|10164613|FG006|STARTED|Part B: Treatment Period 3|Out of 15 participants who were on VX-371 in Treatment period 2 and completed Part A, 7 participants rolled-over to Part B.|7
9099687|NCT02871778|10164614|FG007|STARTED|Part B: Treatment Period 3|Out of 17 participants who were on Placebo in Treatment period 2 and completed Part A, 12 participants rolled-over to Part B.|12
9099688|NCT02871778|10164607|FG000|Safety Analysis Set|Part B: Treatment Period 3||0
9099689|NCT02871778|10164608|FG001|Safety Analysis Set|Part B: Treatment Period 3||0
9099690|NCT02871778|10164609|FG002|Safety Analysis Set|Part B: Treatment Period 3||0
9099691|NCT02871778|10164610|FG003|Safety Analysis Set|Part B: Treatment Period 3||0
9099692|NCT02871778|10164611|FG004|Safety Analysis Set|Part B: Treatment Period 3||11
9099693|NCT02871778|10164612|FG005|Safety Analysis Set|Part B: Treatment Period 3||27
9099694|NCT02871778|10164613|FG006|Safety Analysis Set|Part B: Treatment Period 3||7
9099695|NCT02871778|10164614|FG007|Safety Analysis Set|Part B: Treatment Period 3||12
9099696|NCT02871778|10164607|FG000|COMPLETED|Part B: Treatment Period 3||0
9099697|NCT02871778|10164608|FG001|COMPLETED|Part B: Treatment Period 3||0
9099698|NCT02871778|10164609|FG002|COMPLETED|Part B: Treatment Period 3||0
9099699|NCT02871778|10164610|FG003|COMPLETED|Part B: Treatment Period 3||0
9099700|NCT02871778|10164611|FG004|COMPLETED|Part B: Treatment Period 3||10
9099701|NCT02871778|10164612|FG005|COMPLETED|Part B: Treatment Period 3||26
9099702|NCT02871778|10164613|FG006|COMPLETED|Part B: Treatment Period 3||6
9099703|NCT02871778|10164614|FG007|COMPLETED|Part B: Treatment Period 3||12
9099704|NCT02871778|10164607|FG000|NOT COMPLETED|Part B: Treatment Period 3||0
9099705|NCT02871778|10164608|FG001|NOT COMPLETED|Part B: Treatment Period 3||0
9099706|NCT02871778|10164609|FG002|NOT COMPLETED|Part B: Treatment Period 3||0
9099707|NCT02871778|10164610|FG003|NOT COMPLETED|Part B: Treatment Period 3||0
9099708|NCT02871778|10164611|FG004|NOT COMPLETED|Part B: Treatment Period 3||1
9099709|NCT02871778|10164612|FG005|NOT COMPLETED|Part B: Treatment Period 3||1
9099710|NCT02871778|10164613|FG006|NOT COMPLETED|Part B: Treatment Period 3||1
9099711|NCT02871778|10164614|FG007|NOT COMPLETED|Part B: Treatment Period 3||0
9099712|NCT02769000|10164638|FG000|STARTED|Overall Study||5
9099713|NCT02769000|10164639|FG001|STARTED|Overall Study||0
9099714|NCT02769000|10164638|FG000|COMPLETED|Overall Study||5
9099715|NCT02769000|10164639|FG001|COMPLETED|Overall Study||0
9099716|NCT02769000|10164638|FG000|NOT COMPLETED|Overall Study||0
9099717|NCT02769000|10164639|FG001|NOT COMPLETED|Overall Study||0
9099718|NCT02756208|10164647|FG000|STARTED|Overall Study||18
9099719|NCT02756208|10164648|FG001|STARTED|Overall Study||16
9099720|NCT02756208|10164649|FG002|STARTED|Overall Study||15
9099721|NCT02756208|10164650|FG003|STARTED|Overall Study||16
9099722|NCT02756208|10164647|FG000|COMPLETED|Overall Study||13
9099723|NCT02756208|10164648|FG001|COMPLETED|Overall Study||14
9099724|NCT02756208|10164649|FG002|COMPLETED|Overall Study||13
9099725|NCT02756208|10164650|FG003|COMPLETED|Overall Study||12
9099726|NCT02756208|10164647|FG000|NOT COMPLETED|Overall Study||5
9099727|NCT02756208|10164648|FG001|NOT COMPLETED|Overall Study||2
9099728|NCT02756208|10164649|FG002|NOT COMPLETED|Overall Study||2
9099729|NCT02756208|10164650|FG003|NOT COMPLETED|Overall Study||4
9099730|NCT02714218|10164663|FG000|STARTED|Overall Study||180
9099731|NCT02714218|10164664|FG001|STARTED|Overall Study||178
9099732|NCT02714218|10164665|FG002|STARTED|Overall Study||27
9099733|NCT02714218|10164663|FG000|COMPLETED|Overall Study||50
9099734|NCT02714218|10164664|FG001|COMPLETED|Overall Study||35
9099735|NCT02714218|10164665|FG002|COMPLETED|Overall Study||8
9099736|NCT02714218|10164663|FG000|NOT COMPLETED|Overall Study||130
9099737|NCT02714218|10164664|FG001|NOT COMPLETED|Overall Study||143
9099738|NCT02714218|10164665|FG002|NOT COMPLETED|Overall Study||19
9099739|NCT02564263|10164674|FG000|STARTED|Overall Study||314
9099740|NCT02564263|10164675|FG001|STARTED|Overall Study||314
9099741|NCT02564263|10164674|FG000|Treated|Overall Study||314
9099742|NCT02564263|10164675|FG001|Treated|Overall Study||296
9099743|NCT02564263|10164674|FG000|COMPLETED|Overall Study||0
9099744|NCT02564263|10164675|FG001|COMPLETED|Overall Study||0
9099745|NCT02564263|10164674|FG000|NOT COMPLETED|Overall Study||314
9099746|NCT02564263|10164675|FG001|NOT COMPLETED|Overall Study||314
9099747|NCT02149121|10164688|FG000|STARTED|Main Study Period||161
9099748|NCT02149121|10164689|FG001|STARTED|Main Study Period||151
9099749|NCT02149121|10164690|FG002|STARTED|Main Study Period||60
9099750|NCT02149121|10164691|FG003|STARTED|Main Study Period||0
9099751|NCT02149121|10164692|FG004|STARTED|Main Study Period||0
9099752|NCT02149121|10164693|FG005|STARTED|Main Study Period||0
9099753|NCT02149121|10164694|FG006|STARTED|Main Study Period||0
9099754|NCT02149121|10164688|FG000|COMPLETED|Main Study Period||140
9099755|NCT02149121|10164689|FG001|COMPLETED|Main Study Period||134
9099756|NCT02149121|10164690|FG002|COMPLETED|Main Study Period||56
9099757|NCT02149121|10164691|FG003|COMPLETED|Main Study Period||0
9099758|NCT02149121|10164692|FG004|COMPLETED|Main Study Period||0
9099759|NCT02149121|10164693|FG005|COMPLETED|Main Study Period||0
9099760|NCT02149121|10164694|FG006|COMPLETED|Main Study Period||0
9099761|NCT02149121|10164688|FG000|NOT COMPLETED|Main Study Period||21
9099762|NCT02149121|10164689|FG001|NOT COMPLETED|Main Study Period||17
9099763|NCT02149121|10164690|FG002|NOT COMPLETED|Main Study Period||4
9099764|NCT02149121|10164691|FG003|NOT COMPLETED|Main Study Period||0
9099765|NCT02149121|10164692|FG004|NOT COMPLETED|Main Study Period||0
9099766|NCT02149121|10164693|FG005|NOT COMPLETED|Main Study Period||0
9099767|NCT02149121|10164694|FG006|NOT COMPLETED|Main Study Period||0
9099768|NCT02149121|10164688|FG000|STARTED|Extension Study Period|This group is for the Main Study Period, not for the Extension Study Period.|0
9099769|NCT02149121|10164689|FG001|STARTED|Extension Study Period|This group is for the Main Study Period, not for the Extension Study Period.|0
9099770|NCT02149121|10164690|FG002|STARTED|Extension Study Period|This group is for the Main Study Period, not for the Extension Study Period.|0
9099771|NCT02149121|10164691|FG003|STARTED|Extension Study Period|"Some participants did not initiate the Extension Study Period (CT-P10: 19, Rituxan: 8, MabThera: 9).~From 19 patients in CT-P10 who did not initiate the extension study period, one patient did not initiate the treatment course but had been included to extension period and was monitored up to week 48"|122
9099772|NCT02149121|10164692|FG004|STARTED|Extension Study Period|Some participants did not initiate the Extension Study Period (CT-P10: 19, Rituxan: 8, MabThera: 9)|64
9099773|NCT02149121|10164693|FG005|STARTED|Extension Study Period|Some participants did not initiate the Extension Study Period (CT-P10: 19, Rituxan: 8, MabThera: 9)|62
9099774|NCT02149121|10164694|FG006|STARTED|Extension Study Period|Some participants did not initiate the Extension Study Period (CT-P10: 19, Rituxan: 8, MabThera: 9)|47
9099775|NCT02149121|10164688|FG000|COMPLETED|Extension Study Period||0
9099776|NCT02149121|10164689|FG001|COMPLETED|Extension Study Period||0
9099777|NCT02149121|10164690|FG002|COMPLETED|Extension Study Period||0
9099778|NCT02149121|10164691|FG003|COMPLETED|Extension Study Period||121
9099779|NCT02149121|10164692|FG004|COMPLETED|Extension Study Period||64
9099780|NCT02149121|10164693|FG005|COMPLETED|Extension Study Period||60
9099781|NCT02149121|10164694|FG006|COMPLETED|Extension Study Period||47
9099782|NCT02149121|10164688|FG000|NOT COMPLETED|Extension Study Period||0
9099783|NCT02149121|10164689|FG001|NOT COMPLETED|Extension Study Period||0
9099784|NCT02149121|10164690|FG002|NOT COMPLETED|Extension Study Period||0
9099785|NCT02149121|10164691|FG003|NOT COMPLETED|Extension Study Period||1
9099786|NCT02149121|10164692|FG004|NOT COMPLETED|Extension Study Period||0
9099787|NCT02149121|10164693|FG005|NOT COMPLETED|Extension Study Period||2
9099788|NCT02149121|10164694|FG006|NOT COMPLETED|Extension Study Period||0
9099789|NCT01889186|10164717|FG000|STARTED|Overall Study||107
9099790|NCT01889186|10164718|FG001|STARTED|Overall Study||51
9099791|NCT01889186|10164717|FG000|COMPLETED|Overall Study||0
9099792|NCT01889186|10164718|FG001|COMPLETED|Overall Study||0
9099793|NCT01889186|10164717|FG000|NOT COMPLETED|Overall Study||107
9099794|NCT01889186|10164718|FG001|NOT COMPLETED|Overall Study||51
9099795|NCT01850004|10164726|FG000|STARTED|Overall Study||84
9099796|NCT01850004|10164726|FG000|COMPLETED|Overall Study||76
9099797|NCT01850004|10164726|FG000|NOT COMPLETED|Overall Study||8
9099798|NCT01757535|10164733|FG000|STARTED|Overall Study||238
9099799|NCT01757535|10164734|FG001|STARTED|Overall Study||234
9099800|NCT01757535|10164733|FG000|Received Treatment|Overall Study||236
9099801|NCT01757535|10164734|FG001|Received Treatment|Overall Study||233
9099802|NCT01757535|10164733|FG000|COMPLETED|Overall Study||45
9099803|NCT01757535|10164734|FG001|COMPLETED|Overall Study||26
9099804|NCT01757535|10164733|FG000|NOT COMPLETED|Overall Study||193
9099805|NCT01757535|10164734|FG001|NOT COMPLETED|Overall Study||208
8845906|NCT01717768|9900352|FG005|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
8723620|NCT01024231|9771137|FG000|COMPLETED|Overall Study||2
8723621|NCT01024231|9771138|FG001|COMPLETED|Overall Study||2
8723622|NCT01024231|9771139|FG002|COMPLETED|Overall Study||6
8723623|NCT01024231|9771140|FG003|COMPLETED|Overall Study||1
8723624|NCT01024231|9771141|FG004|COMPLETED|Overall Study||0
8723625|NCT01024231|9771142|FG005|COMPLETED|Overall Study||0
8723626|NCT01024231|9771143|FG006|COMPLETED|Overall Study||20
8723627|NCT01024231|9771137|FG000|NOT COMPLETED|Overall Study||12
8723628|NCT01024231|9771138|FG001|NOT COMPLETED|Overall Study||15
8723629|NCT01024231|9771139|FG002|NOT COMPLETED|Overall Study||10
8723630|NCT01024231|9771140|FG003|NOT COMPLETED|Overall Study||5
9099806|NCT01510184|10164742|FG000|STARTED|Overall Study||36
9099807|NCT01510184|10164743|FG001|STARTED|Overall Study||43
9099808|NCT01510184|10164742|FG000|COMPLETED|Overall Study||6
9099809|NCT01510184|10164743|FG001|COMPLETED|Overall Study||8
9099810|NCT01510184|10164742|FG000|NOT COMPLETED|Overall Study||30
9099811|NCT01510184|10164743|FG001|NOT COMPLETED|Overall Study||35
9099812|NCT01471444|10164751|FG000|STARTED|Overall Study||133
9099813|NCT01471444|10164752|FG001|STARTED|Overall Study||123
9099814|NCT01471444|10164751|FG000|COMPLETED|Overall Study||130
9099815|NCT01471444|10164752|FG001|COMPLETED|Overall Study||120
9099816|NCT01471444|10164751|FG000|NOT COMPLETED|Overall Study||3
9099817|NCT01471444|10164752|FG001|NOT COMPLETED|Overall Study||3
9099818|NCT01238211|10164759|FG000|STARTED|Overall Study||61
9099819|NCT01238211|10164759|FG000|COMPLETED|Overall Study||3
9099820|NCT01238211|10164759|FG000|NOT COMPLETED|Overall Study||58
9099821|NCT00545766|10164763|FG000|STARTED|Overall Study||41
9099822|NCT00545766|10164763|FG000|COMPLETED|Overall Study||36
9099823|NCT00545766|10164763|FG000|NOT COMPLETED|Overall Study||5
9099824|NCT04101890|10164767|FG000|STARTED|Routine Diaper Care||5
9099825|NCT04101890|10164767|FG000|COMPLETED|Routine Diaper Care||5
9099826|NCT04101890|10164767|FG000|NOT COMPLETED|Routine Diaper Care||0
9099827|NCT04101890|10164767|FG000|STARTED|Diaper Care With Theraworx||5
9099828|NCT04101890|10164767|FG000|COMPLETED|Diaper Care With Theraworx||5
9099829|NCT04101890|10164767|FG000|NOT COMPLETED|Diaper Care With Theraworx||0
9099830|NCT03993314|10164775|FG000|STARTED|Overall Study||9
9099831|NCT03993314|10164776|FG001|STARTED|Overall Study||6
9099832|NCT03993314|10164775|FG000|COMPLETED|Overall Study||9
9099833|NCT03993314|10164776|FG001|COMPLETED|Overall Study||6
9099834|NCT03993314|10164775|FG000|NOT COMPLETED|Overall Study||0
9099835|NCT03993314|10164776|FG001|NOT COMPLETED|Overall Study||0
9099836|NCT03874351|10164784|FG000|STARTED|Overall Study||11
9099837|NCT03874351|10164785|FG001|STARTED|Overall Study||11
9099838|NCT03874351|10164784|FG000|COMPLETED|Overall Study||7
9099839|NCT03874351|10164785|FG001|COMPLETED|Overall Study||9
9099840|NCT03874351|10164784|FG000|NOT COMPLETED|Overall Study||4
9099841|NCT03874351|10164785|FG001|NOT COMPLETED|Overall Study||2
9099842|NCT03856359|10164791|FG000|STARTED|Overall Study||10
9099843|NCT03856359|10164791|FG000|COMPLETED|Overall Study||9
9099844|NCT03856359|10164791|FG000|NOT COMPLETED|Overall Study||1
9099845|NCT03769519|10164797|FG000|STARTED|Overall Study||14
9099846|NCT03769519|10164798|FG001|STARTED|Overall Study||15
9099847|NCT03769519|10164797|FG000|COMPLETED|Overall Study||14
9099848|NCT03769519|10164798|FG001|COMPLETED|Overall Study||14
9099849|NCT03769519|10164797|FG000|NOT COMPLETED|Overall Study||0
9099850|NCT03769519|10164798|FG001|NOT COMPLETED|Overall Study||1
9099851|NCT03745651|10164807|FG000|STARTED|Vehicle Control Period (Day 1 to Week 8)||124
9099852|NCT03745651|10164808|FG001|STARTED|Vehicle Control Period (Day 1 to Week 8)||248
9099853|NCT03745651|10164809|FG002|STARTED|Vehicle Control Period (Day 1 to Week 8)||246
9099854|NCT03745651|10164810|FG003|STARTED|Vehicle Control Period (Day 1 to Week 8)||0
9099855|NCT03745651|10164811|FG004|STARTED|Vehicle Control Period (Day 1 to Week 8)||0
9099856|NCT03745651|10164812|FG005|STARTED|Vehicle Control Period (Day 1 to Week 8)||0
9099857|NCT03745651|10164813|FG006|STARTED|Vehicle Control Period (Day 1 to Week 8)||0
9099858|NCT03745651|10164807|FG000|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||105
9099859|NCT03745651|10164808|FG001|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||209
9099860|NCT03745651|10164809|FG002|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||224
9099861|NCT03745651|10164810|FG003|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
8625871|NCT00509821|9665504|FG000|STARTED|Study Period 2 (Radiation)|Participants moved to Radiation Phase.|3
8625872|NCT00509821|9665505|FG001|STARTED|Study Period 2 (Radiation)|Participants moved to Radiation Phase.|53
8625873|NCT00509821|9665504|FG000|COMPLETED|Study Period 2 (Radiation)||3
8625874|NCT00509821|9665505|FG001|COMPLETED|Study Period 2 (Radiation)||0
8625875|NCT00509821|9665504|FG000|NOT COMPLETED|Study Period 2 (Radiation)||0
9099862|NCT03745651|10164811|FG004|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
9099863|NCT03745651|10164812|FG005|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
9099864|NCT03745651|10164813|FG006|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
9099865|NCT03745651|10164807|FG000|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||19
9099866|NCT03745651|10164808|FG001|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||39
9099867|NCT03745651|10164809|FG002|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||22
9099868|NCT03745651|10164810|FG003|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
9099869|NCT03745651|10164811|FG004|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
9099870|NCT03745651|10164812|FG005|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
9099871|NCT03745651|10164813|FG006|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
9099872|NCT03745651|10164807|FG000|STARTED|Long-Term Safety Period (Weeks 8 to 52)||0
9099873|NCT03745651|10164808|FG001|STARTED|Long-Term Safety Period (Weeks 8 to 52)||0
9099874|NCT03745651|10164809|FG002|STARTED|Long-Term Safety Period (Weeks 8 to 52)||0
9099875|NCT03745651|10164810|FG003|STARTED|Long-Term Safety Period (Weeks 8 to 52)||53
9099876|NCT03745651|10164811|FG004|STARTED|Long-Term Safety Period (Weeks 8 to 52)||52
9099877|NCT03745651|10164812|FG005|STARTED|Long-Term Safety Period (Weeks 8 to 52)||204
9099878|NCT03745651|10164813|FG006|STARTED|Long-Term Safety Period (Weeks 8 to 52)||221
9099879|NCT03745651|10164807|FG000|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
9099880|NCT03745651|10164808|FG001|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
8625876|NCT00509821|9665505|FG001|NOT COMPLETED|Study Period 2 (Radiation)||53
8625877|NCT00509821|9665504|FG000|STARTED|Study Period 3 (Maintenance)||3
9099881|NCT03745651|10164809|FG002|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
9099882|NCT03745651|10164810|FG003|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||33
9099883|NCT03745651|10164811|FG004|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||41
9099884|NCT03745651|10164812|FG005|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||151
9099885|NCT03745651|10164813|FG006|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||170
9099886|NCT03745651|10164807|FG000|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
9099887|NCT03745651|10164808|FG001|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
9099888|NCT03745651|10164809|FG002|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
9099889|NCT03745651|10164810|FG003|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||20
9099890|NCT03745651|10164811|FG004|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||11
9099891|NCT03745651|10164812|FG005|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||53
9099892|NCT03745651|10164813|FG006|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||51
9099893|NCT03745638|10164832|FG000|STARTED|Vehicle Control Period (Day 1 to Week 8)||126
9099894|NCT03745638|10164833|FG001|STARTED|Vehicle Control Period (Day 1 to Week 8)||252
9099895|NCT03745638|10164834|FG002|STARTED|Vehicle Control Period (Day 1 to Week 8)||253
9099896|NCT03745638|10164835|FG003|STARTED|Vehicle Control Period (Day 1 to Week 8)||0
9099897|NCT03745638|10164836|FG004|STARTED|Vehicle Control Period (Day 1 to Week 8)||0
9099898|NCT03745638|10164837|FG005|STARTED|Vehicle Control Period (Day 1 to Week 8)||0
9099899|NCT03745638|10164838|FG006|STARTED|Vehicle Control Period (Day 1 to Week 8)||0
9099900|NCT03745638|10164832|FG000|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||95
9099901|NCT03745638|10164833|FG001|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||222
9099902|NCT03745638|10164834|FG002|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||225
9099903|NCT03745638|10164835|FG003|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
9099904|NCT03745638|10164836|FG004|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
9099905|NCT03745638|10164837|FG005|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
9099906|NCT03745638|10164838|FG006|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
9099907|NCT03745638|10164832|FG000|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||31
9099908|NCT03745638|10164833|FG001|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||30
9099909|NCT03745638|10164834|FG002|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||28
9099910|NCT03745638|10164835|FG003|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
9099911|NCT03745638|10164836|FG004|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
9099912|NCT03745638|10164837|FG005|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
9099913|NCT03745638|10164838|FG006|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
9099914|NCT03745638|10164832|FG000|STARTED|Long-Term Safety Period (Weeks 8 to 52)||0
9099915|NCT03745638|10164833|FG001|STARTED|Long-Term Safety Period (Weeks 8 to 52)||0
9099916|NCT03745638|10164834|FG002|STARTED|Long-Term Safety Period (Weeks 8 to 52)||0
9099917|NCT03745638|10164835|FG003|STARTED|Long-Term Safety Period (Weeks 8 to 52)||48
9099918|NCT03745638|10164836|FG004|STARTED|Long-Term Safety Period (Weeks 8 to 52)||47
9099919|NCT03745638|10164837|FG005|STARTED|Long-Term Safety Period (Weeks 8 to 52)||222
9099920|NCT03745638|10164838|FG006|STARTED|Long-Term Safety Period (Weeks 8 to 52)||225
9099921|NCT03745638|10164832|FG000|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
9099922|NCT03745638|10164833|FG001|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
9099923|NCT03745638|10164834|FG002|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
9099924|NCT03745638|10164835|FG003|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||37
9099925|NCT03745638|10164836|FG004|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||38
9099926|NCT03745638|10164837|FG005|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||176
9099927|NCT03745638|10164838|FG006|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||174
9099928|NCT03745638|10164832|FG000|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
9099929|NCT03745638|10164833|FG001|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
9099930|NCT03745638|10164834|FG002|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
9099931|NCT03745638|10164835|FG003|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||11
9099932|NCT03745638|10164836|FG004|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||9
9099933|NCT03745638|10164837|FG005|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||46
9099934|NCT03745638|10164838|FG006|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||51
8845907|NCT01717768|9900353|FG006|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||17
9099935|NCT03715764|10164857|FG000|STARTED|Baseline (Randomized (n=69)||35
9099936|NCT03715764|10164858|FG001|STARTED|Baseline (Randomized (n=69)||34
9099937|NCT03715764|10164857|FG000|COMPLETED|Baseline (Randomized (n=69)||33
9099938|NCT03715764|10164858|FG001|COMPLETED|Baseline (Randomized (n=69)||31
9099939|NCT03715764|10164857|FG000|NOT COMPLETED|Baseline (Randomized (n=69)||2
9099940|NCT03715764|10164858|FG001|NOT COMPLETED|Baseline (Randomized (n=69)||3
9099941|NCT03715764|10164857|FG000|STARTED|3 Month Follow-up||33
9099942|NCT03715764|10164858|FG001|STARTED|3 Month Follow-up||31
9099943|NCT03715764|10164857|FG000|COMPLETED|3 Month Follow-up||30
9099944|NCT03715764|10164858|FG001|COMPLETED|3 Month Follow-up||28
9099945|NCT03715764|10164857|FG000|NOT COMPLETED|3 Month Follow-up||3
9099946|NCT03715764|10164858|FG001|NOT COMPLETED|3 Month Follow-up||3
9099947|NCT03715764|10164857|FG000|STARTED|6 Month Follow-up||30
9099948|NCT03715764|10164858|FG001|STARTED|6 Month Follow-up||28
9099949|NCT03715764|10164857|FG000|COMPLETED|6 Month Follow-up||27
9099950|NCT03715764|10164858|FG001|COMPLETED|6 Month Follow-up||28
9099951|NCT03715764|10164857|FG000|NOT COMPLETED|6 Month Follow-up||3
9099952|NCT03715764|10164858|FG001|NOT COMPLETED|6 Month Follow-up||0
8845908|NCT01717768|9900354|FG007|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
8845909|NCT01717768|9900355|FG008|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||16
8556855|NCT03760146|9588648|FG002|Safety Population|Overall Study||334
8556856|NCT03760146|9588649|FG003|Safety Population|Overall Study||111
8556857|NCT03760146|9588650|FG004|Safety Population|Overall Study||335
8556858|NCT03760146|9588651|FG005|Safety Population|Overall Study||112
8556859|NCT03760146|9588646|FG000|Evaluable-20 Immunogenicity Population|Overall Study|Only for 60-64 years of age.|946
8556860|NCT03760146|9588647|FG001|Evaluable-20 Immunogenicity Population|Overall Study||0
9099953|NCT03715764|10164857|FG000|STARTED|12 Month Follow-up||27
9099954|NCT03715764|10164858|FG001|STARTED|12 Month Follow-up||28
9099955|NCT03715764|10164857|FG000|COMPLETED|12 Month Follow-up||21
9099956|NCT03715764|10164858|FG001|COMPLETED|12 Month Follow-up||23
9099957|NCT03715764|10164857|FG000|NOT COMPLETED|12 Month Follow-up||6
9099958|NCT03715764|10164858|FG001|NOT COMPLETED|12 Month Follow-up||5
9099959|NCT03663855|10164864|FG000|STARTED|Overall Study||10
9099960|NCT03663855|10164864|FG000|COMPLETED|Overall Study||10
9099961|NCT03663855|10164864|FG000|NOT COMPLETED|Overall Study||0
9099962|NCT03654729|10164871|FG000|STARTED|Overall Study||97
9099963|NCT03654729|10164872|FG001|STARTED|Overall Study||96
9099964|NCT03654729|10164873|FG002|STARTED|Overall Study||98
9099965|NCT03654729|10164871|FG000|Treated|Overall Study||96
9099966|NCT03654729|10164872|FG001|Treated|Overall Study||93
9099967|NCT03654729|10164873|FG002|Treated|Overall Study||96
9099968|NCT03654729|10164871|FG000|COMPLETED|Overall Study||66
9099969|NCT03654729|10164872|FG001|COMPLETED|Overall Study||70
9099970|NCT03654729|10164873|FG002|COMPLETED|Overall Study||69
9099971|NCT03654729|10164871|FG000|NOT COMPLETED|Overall Study||31
9099972|NCT03654729|10164872|FG001|NOT COMPLETED|Overall Study||26
9099973|NCT03654729|10164873|FG002|NOT COMPLETED|Overall Study||29
8556861|NCT03760146|9588648|FG002|Evaluable-20 Immunogenicity Population|Overall Study||321
9099974|NCT03531112|10164883|FG000|STARTED|Overall Study||20
9099975|NCT03531112|10164884|FG001|STARTED|Overall Study||0
9099976|NCT03531112|10164883|FG000|Month 4|Overall Study||17
9099977|NCT03531112|10164884|FG001|Month 4|Overall Study||0
9099978|NCT03531112|10164883|FG000|Month 6 (Follow-Up)|Overall Study||13
9099979|NCT03531112|10164884|FG001|Month 6 (Follow-Up)|Overall Study||0
9099980|NCT03531112|10164883|FG000|COMPLETED|Overall Study||13
9099981|NCT03531112|10164884|FG001|COMPLETED|Overall Study||0
9099982|NCT03531112|10164883|FG000|NOT COMPLETED|Overall Study||7
9099983|NCT03531112|10164884|FG001|NOT COMPLETED|Overall Study||0
9099984|NCT03112902|10164900|FG000|STARTED|Overall Study||2
9099985|NCT03112902|10164901|FG001|STARTED|Overall Study||2
9099986|NCT03112902|10164902|FG002|STARTED|Overall Study||3
9099987|NCT03112902|10164903|FG003|STARTED|Overall Study||1
9099988|NCT03112902|10164904|FG004|STARTED|Overall Study||1
9099989|NCT03112902|10164905|FG005|STARTED|Overall Study||3
9099990|NCT03112902|10164906|FG006|STARTED|Overall Study||9
9099991|NCT03112902|10164907|FG007|STARTED|Overall Study||3
9099992|NCT03112902|10164908|FG008|STARTED|Overall Study||0
9099993|NCT03112902|10164909|FG009|STARTED|Overall Study||0
9099994|NCT03112902|10164900|FG000|COMPLETED|Overall Study||0
9099995|NCT03112902|10164901|FG001|COMPLETED|Overall Study||2
9099996|NCT03112902|10164902|FG002|COMPLETED|Overall Study||2
9099997|NCT03112902|10164903|FG003|COMPLETED|Overall Study||0
9099998|NCT03112902|10164904|FG004|COMPLETED|Overall Study||1
9099999|NCT03112902|10164905|FG005|COMPLETED|Overall Study||0
9100000|NCT03112902|10164906|FG006|COMPLETED|Overall Study||1
9100001|NCT03112902|10164907|FG007|COMPLETED|Overall Study||1
9100002|NCT03112902|10164908|FG008|COMPLETED|Overall Study||0
9100003|NCT03112902|10164909|FG009|COMPLETED|Overall Study||0
9100004|NCT03112902|10164900|FG000|NOT COMPLETED|Overall Study||2
9100005|NCT03112902|10164901|FG001|NOT COMPLETED|Overall Study||0
9100006|NCT03112902|10164902|FG002|NOT COMPLETED|Overall Study||1
9100007|NCT03112902|10164903|FG003|NOT COMPLETED|Overall Study||1
9100008|NCT03112902|10164904|FG004|NOT COMPLETED|Overall Study||0
9100009|NCT03112902|10164905|FG005|NOT COMPLETED|Overall Study||3
9100010|NCT03112902|10164906|FG006|NOT COMPLETED|Overall Study||8
9100011|NCT03112902|10164907|FG007|NOT COMPLETED|Overall Study||2
9100012|NCT03112902|10164908|FG008|NOT COMPLETED|Overall Study||0
9100013|NCT03112902|10164909|FG009|NOT COMPLETED|Overall Study||0
9100014|NCT02976038|10164925|FG000|STARTED|Overall Study||28
9100015|NCT02976038|10164925|FG000|COMPLETED|Overall Study||0
9100016|NCT02976038|10164925|FG000|NOT COMPLETED|Overall Study||28
9100017|NCT02631070|10164941|FG000|STARTED|Overall Study||153
9100018|NCT02631070|10164942|FG001|STARTED|Overall Study||76
9100019|NCT02631070|10164941|FG000|COMPLETED|Overall Study||4
9100020|NCT02631070|10164942|FG001|COMPLETED|Overall Study||12
9100021|NCT02631070|10164941|FG000|NOT COMPLETED|Overall Study||149
9100022|NCT02631070|10164942|FG001|NOT COMPLETED|Overall Study||64
9100023|NCT02281955|10164948|FG000|STARTED|Overall Study||114
9100024|NCT02281955|10164948|FG000|COMPLETED|Overall Study||113
9100025|NCT02281955|10164948|FG000|NOT COMPLETED|Overall Study||1
9100026|NCT02202434|10164956|FG000|STARTED|Overall Study||607
9100027|NCT02202434|10164957|FG001|STARTED|Overall Study||305
9100028|NCT02202434|10164958|FG002|STARTED|Overall Study||102
9100029|NCT02202434|10164959|FG003|STARTED|Overall Study||295
9100030|NCT02202434|10164956|FG000|COMPLETED|Overall Study||498
9100031|NCT02202434|10164957|FG001|COMPLETED|Overall Study||236
9100032|NCT02202434|10164958|FG002|COMPLETED|Overall Study||87
9100033|NCT02202434|10164959|FG003|COMPLETED|Overall Study||258
9100034|NCT02202434|10164956|FG000|NOT COMPLETED|Overall Study||109
9100035|NCT02202434|10164957|FG001|NOT COMPLETED|Overall Study||69
9100036|NCT02202434|10164958|FG002|NOT COMPLETED|Overall Study||15
9100037|NCT02202434|10164959|FG003|NOT COMPLETED|Overall Study||37
9100038|NCT02097134|10164969|FG000|STARTED|Overall Study||14
9100039|NCT02097134|10164969|FG000|COMPLETED|Overall Study||5
9100040|NCT02097134|10164969|FG000|NOT COMPLETED|Overall Study||9
9100041|NCT01727011|10164974|FG000|STARTED|Overall Study||31
9100042|NCT01727011|10164974|FG000|COMPLETED|Overall Study||26
9100043|NCT01727011|10164974|FG000|NOT COMPLETED|Overall Study||5
9100044|NCT01230242|10164978|FG000|STARTED|Overall Study||4
9100045|NCT01230242|10164978|FG000|COMPLETED|Overall Study||1
9100046|NCT01230242|10164978|FG000|NOT COMPLETED|Overall Study||3
9100047|NCT00983437|10164982|FG000|STARTED|Overall Study||47
9100048|NCT00983437|10164982|FG000|Safety Analysis Set (SAS)|Overall Study|Participants who received at least 1 dose of study drug were evaluable for safety.|47
9100049|NCT00983437|10164982|FG000|Full Analysis Set (FAS)|Overall Study|Participants had to have at least 1 postbaseline efficacy assessment to be evaluable for efficacy.|45
9100050|NCT00983437|10164982|FG000|COMPLETED|Overall Study|Completed 12 months of treatment with armodafinil.|0
9100051|NCT00983437|10164982|FG000|NOT COMPLETED|Overall Study||47
9100052|NCT00965757|10164988|FG000|STARTED|Double-blind Phase||165
9100053|NCT00965757|10164989|FG001|STARTED|Double-blind Phase||88
9100054|NCT00965757|10164990|FG002|STARTED|Double-blind Phase||0
9100055|NCT00965757|10164991|FG003|STARTED|Double-blind Phase||0
9100056|NCT00965757|10164988|FG000|COMPLETED|Double-blind Phase||148
9100057|NCT00965757|10164989|FG001|COMPLETED|Double-blind Phase||70
9100058|NCT00965757|10164990|FG002|COMPLETED|Double-blind Phase||0
9100059|NCT00965757|10164991|FG003|COMPLETED|Double-blind Phase||0
9100060|NCT00965757|10164988|FG000|NOT COMPLETED|Double-blind Phase||17
9100061|NCT00965757|10164989|FG001|NOT COMPLETED|Double-blind Phase||18
9100062|NCT00965757|10164990|FG002|NOT COMPLETED|Double-blind Phase||0
9100063|NCT00965757|10164991|FG003|NOT COMPLETED|Double-blind Phase||0
9100064|NCT00965757|10164988|FG000|STARTED|Extension Phase||0
9100065|NCT00965757|10164989|FG001|STARTED|Extension Phase||0
9100066|NCT00965757|10164990|FG002|STARTED|Extension Phase||165
9100067|NCT00965757|10164991|FG003|STARTED|Extension Phase||88
9100068|NCT00965757|10164988|FG000|COMPLETED|Extension Phase||0
9100069|NCT00965757|10164989|FG001|COMPLETED|Extension Phase||0
9100070|NCT00965757|10164990|FG002|COMPLETED|Extension Phase||132
9100071|NCT00965757|10164991|FG003|COMPLETED|Extension Phase||64
9100072|NCT00965757|10164988|FG000|NOT COMPLETED|Extension Phase||0
9100073|NCT00965757|10164989|FG001|NOT COMPLETED|Extension Phase||0
9100074|NCT00965757|10164990|FG002|NOT COMPLETED|Extension Phase||33
9100075|NCT00965757|10164991|FG003|NOT COMPLETED|Extension Phase||24
9100076|NCT00928447|10164999|FG000|STARTED|Overall Study||22
9100077|NCT00928447|10164999|FG000|Received at Least 1 Dose of rHuPH20|Overall Study||21
9100078|NCT00928447|10164999|FG000|Received at Least 1 Dose of Placebo|Overall Study||21
9100079|NCT00928447|10164999|FG000|COMPLETED|Overall Study||20
9100080|NCT00928447|10164999|FG000|NOT COMPLETED|Overall Study||2
9100081|NCT00893789|10165007|FG000|STARTED|Overall Study||29
9100082|NCT00893789|10165008|FG001|STARTED|Overall Study||30
9100083|NCT00893789|10165009|FG002|STARTED|Overall Study||29
9100084|NCT00893789|10165010|FG003|STARTED|Overall Study||29
9100085|NCT00893789|10165007|FG000|Safety Analysis Set (SAS)|Overall Study|SAS = all participants who received 1 or more doses of study drug.|29
9100086|NCT00893789|10165008|FG001|Safety Analysis Set (SAS)|Overall Study||30
9100087|NCT00893789|10165009|FG002|Safety Analysis Set (SAS)|Overall Study||29
9100088|NCT00893789|10165010|FG003|Safety Analysis Set (SAS)|Overall Study||29
9100089|NCT00893789|10165007|FG000|Full Analysis Set (FAS)|Overall Study|FAS = participants in the safety analysis set with ≥1 postbaseline primary efficacy assessment.|29
9100090|NCT00893789|10165008|FG001|Full Analysis Set (FAS)|Overall Study||29
9100091|NCT00893789|10165009|FG002|Full Analysis Set (FAS)|Overall Study||28
9100092|NCT00893789|10165010|FG003|Full Analysis Set (FAS)|Overall Study||27
9100093|NCT00893789|10165007|FG000|COMPLETED|Overall Study||23
9100094|NCT00893789|10165008|FG001|COMPLETED|Overall Study||26
9100095|NCT00893789|10165009|FG002|COMPLETED|Overall Study||22
9100096|NCT00893789|10165010|FG003|COMPLETED|Overall Study||16
9100097|NCT00893789|10165007|FG000|NOT COMPLETED|Overall Study||6
9100098|NCT00893789|10165008|FG001|NOT COMPLETED|Overall Study||4
9100099|NCT00893789|10165009|FG002|NOT COMPLETED|Overall Study||7
9100100|NCT00893789|10165010|FG003|NOT COMPLETED|Overall Study||13
9100101|NCT04349150|10165020|FG000|STARTED|Overall Study||31
9100102|NCT04349150|10165020|FG000|COMPLETED|Overall Study||27
9100103|NCT04349150|10165020|FG000|NOT COMPLETED|Overall Study||4
9100173|NCT02639910|10165116|FG000|STARTED|Overall Study||11
9100174|NCT02639910|10165117|FG001|STARTED|Overall Study||13
9100175|NCT02639910|10165116|FG000|COMPLETED|Overall Study||7
9100176|NCT02639910|10165117|FG001|COMPLETED|Overall Study||5
9100177|NCT02639910|10165116|FG000|NOT COMPLETED|Overall Study||4
9100178|NCT02639910|10165117|FG001|NOT COMPLETED|Overall Study||8
9100179|NCT02409368|10165126|FG000|STARTED|Overall Study||173
9100180|NCT02409368|10165127|FG001|STARTED|Overall Study||534
9100181|NCT02409368|10165128|FG002|STARTED|Overall Study||103
9100182|NCT02409368|10165126|FG000|COMPLETED|Overall Study||25
9100183|NCT02409368|10165127|FG001|COMPLETED|Overall Study||45
9100184|NCT02409368|10165128|FG002|COMPLETED|Overall Study||4
9100185|NCT02409368|10165126|FG000|NOT COMPLETED|Overall Study||148
9100186|NCT02409368|10165127|FG001|NOT COMPLETED|Overall Study||489
9100187|NCT02409368|10165128|FG002|NOT COMPLETED|Overall Study||99
9100188|NCT02322593|10165139|FG000|STARTED|Overall Study||356
9100189|NCT02322593|10165140|FG001|STARTED|Overall Study||355
9100190|NCT02322593|10165139|FG000|COMPLETED|Overall Study||356
9100191|NCT02322593|10165140|FG001|COMPLETED|Overall Study||355
9100192|NCT02322593|10165139|FG000|NOT COMPLETED|Overall Study||0
9100193|NCT02322593|10165140|FG001|NOT COMPLETED|Overall Study||0
9100194|NCT02277119|10165149|FG000|STARTED|Overall Study||58
9100195|NCT02277119|10165150|FG001|STARTED|Overall Study||24
9100196|NCT02277119|10165151|FG002|STARTED|Overall Study||27
9100197|NCT02277119|10165149|FG000|COMPLETED|Overall Study||55
9100198|NCT02277119|10165150|FG001|COMPLETED|Overall Study||20
9100199|NCT02277119|10165151|FG002|COMPLETED|Overall Study||19
9100200|NCT02277119|10165149|FG000|NOT COMPLETED|Overall Study||3
9100201|NCT02277119|10165150|FG001|NOT COMPLETED|Overall Study||4
9100202|NCT02277119|10165151|FG002|NOT COMPLETED|Overall Study||8
9100203|NCT02220894|10165161|FG000|STARTED|Overall Study|1 additional participant was randomized in error|637
9100204|NCT02220894|10165162|FG001|STARTED|Overall Study||637
9100205|NCT02220894|10165161|FG000|Treated|Overall Study||636
9100206|NCT02220894|10165162|FG001|Treated|Overall Study||615
9100207|NCT02220894|10165161|FG000|COMPLETED|Overall Study||0
9100208|NCT02220894|10165162|FG001|COMPLETED|Overall Study||0
9100209|NCT02220894|10165161|FG000|NOT COMPLETED|Overall Study||637
9100210|NCT02220894|10165162|FG001|NOT COMPLETED|Overall Study||637
9100211|NCT02124824|10165170|FG000|STARTED|Overall Study||15
9100212|NCT02124824|10165171|FG001|STARTED|Overall Study||15
9100213|NCT02124824|10165170|FG000|COMPLETED|Overall Study||15
9100214|NCT02124824|10165171|FG001|COMPLETED|Overall Study||15
9100215|NCT02124824|10165170|FG000|NOT COMPLETED|Overall Study||0
9100216|NCT02124824|10165171|FG001|NOT COMPLETED|Overall Study||0
9100217|NCT01772004|10165200|FG000|STARTED|Dose Escalation Phase||4
9100218|NCT01772004|10165201|FG001|STARTED|Dose Escalation Phase||13
9100219|NCT01772004|10165202|FG002|STARTED|Dose Escalation Phase||15
9100220|NCT01772004|10165203|FG003|STARTED|Dose Escalation Phase||21
9100221|NCT01772004|10165204|FG004|STARTED|Dose Escalation Phase||8
9100222|NCT01772004|10165205|FG005|STARTED|Dose Escalation Phase||0
9100223|NCT01772004|10165206|FG006|STARTED|Dose Escalation Phase||0
9100224|NCT01772004|10165207|FG007|STARTED|Dose Escalation Phase||0
9100225|NCT01772004|10165208|FG008|STARTED|Dose Escalation Phase||0
9100226|NCT01772004|10165209|FG009|STARTED|Dose Escalation Phase||0
9100227|NCT01772004|10165210|FG010|STARTED|Dose Escalation Phase||0
9100228|NCT01772004|10165211|FG011|STARTED|Dose Escalation Phase||0
9100229|NCT01772004|10165212|FG012|STARTED|Dose Escalation Phase||0
9100230|NCT01772004|10165213|FG013|STARTED|Dose Escalation Phase||0
9100231|NCT01772004|10165214|FG014|STARTED|Dose Escalation Phase||0
9100232|NCT01772004|10165215|FG015|STARTED|Dose Escalation Phase||0
9100233|NCT01772004|10165216|FG016|STARTED|Dose Escalation Phase||0
9100234|NCT01772004|10165217|FG017|STARTED|Dose Escalation Phase||0
9100235|NCT01772004|10165218|FG018|STARTED|Dose Escalation Phase||0
9100236|NCT01772004|10165219|FG019|STARTED|Dose Escalation Phase||0
9100237|NCT01772004|10165220|FG020|STARTED|Dose Escalation Phase||0
9100238|NCT01772004|10165221|FG021|STARTED|Dose Escalation Phase||0
9100239|NCT01772004|10165222|FG022|STARTED|Dose Escalation Phase||0
9100240|NCT01772004|10165200|FG000|COMPLETED|Dose Escalation Phase||4
9100241|NCT01772004|10165201|FG001|COMPLETED|Dose Escalation Phase||13
9100242|NCT01772004|10165202|FG002|COMPLETED|Dose Escalation Phase||15
9100243|NCT01772004|10165203|FG003|COMPLETED|Dose Escalation Phase||21
9100244|NCT01772004|10165204|FG004|COMPLETED|Dose Escalation Phase||8
9100245|NCT01772004|10165205|FG005|COMPLETED|Dose Escalation Phase||0
9100246|NCT01772004|10165206|FG006|COMPLETED|Dose Escalation Phase||0
9100247|NCT01772004|10165207|FG007|COMPLETED|Dose Escalation Phase||0
9100248|NCT01772004|10165208|FG008|COMPLETED|Dose Escalation Phase||0
9100249|NCT01772004|10165209|FG009|COMPLETED|Dose Escalation Phase||0
9100250|NCT01772004|10165210|FG010|COMPLETED|Dose Escalation Phase||0
9100251|NCT01772004|10165211|FG011|COMPLETED|Dose Escalation Phase||0
9100252|NCT01772004|10165212|FG012|COMPLETED|Dose Escalation Phase||0
9100253|NCT01772004|10165213|FG013|COMPLETED|Dose Escalation Phase||0
9100254|NCT01772004|10165214|FG014|COMPLETED|Dose Escalation Phase||0
9100255|NCT01772004|10165215|FG015|COMPLETED|Dose Escalation Phase||0
9100256|NCT01772004|10165216|FG016|COMPLETED|Dose Escalation Phase||0
9100257|NCT01772004|10165217|FG017|COMPLETED|Dose Escalation Phase||0
9100258|NCT01772004|10165218|FG018|COMPLETED|Dose Escalation Phase||0
9100259|NCT01772004|10165219|FG019|COMPLETED|Dose Escalation Phase||0
9100104|NCT03948698|10165024|FG000|STARTED|Overall Study||4159533
9100105|NCT03948698|10165024|FG000|COMPLETED|Overall Study||4159533
9100106|NCT03948698|10165024|FG000|NOT COMPLETED|Overall Study||0
9100107|NCT03901144|10165028|FG000|STARTED|Overall Study||50
9100108|NCT03901144|10165029|FG001|STARTED|Overall Study||50
9100109|NCT03901144|10165030|FG002|STARTED|Overall Study||50
9100110|NCT03901144|10165031|FG003|STARTED|Overall Study||50
9100111|NCT03901144|10165028|FG000|COMPLETED|Overall Study||49
9100112|NCT03901144|10165029|FG001|COMPLETED|Overall Study||49
9100113|NCT03901144|10165030|FG002|COMPLETED|Overall Study||49
9100114|NCT03901144|10165031|FG003|COMPLETED|Overall Study||49
9100115|NCT03901144|10165028|FG000|NOT COMPLETED|Overall Study||1
9100116|NCT03901144|10165029|FG001|NOT COMPLETED|Overall Study||1
9100117|NCT03901144|10165030|FG002|NOT COMPLETED|Overall Study||1
9100118|NCT03901144|10165031|FG003|NOT COMPLETED|Overall Study||1
8845910|NCT01717768|9900356|FG009|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
8845911|NCT01717768|9900357|FG010|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||16
8845912|NCT01717768|9900358|FG011|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||16
8845913|NCT01717768|9900347|FG000|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
9100119|NCT03561701|10165043|FG000|STARTED|Overall Study||220
9100120|NCT03561701|10165044|FG001|STARTED|Overall Study||110
9100121|NCT03561701|10165043|FG000|COMPLETED|Overall Study||191
9100122|NCT03561701|10165044|FG001|COMPLETED|Overall Study||91
9100123|NCT03561701|10165043|FG000|NOT COMPLETED|Overall Study||29
9100124|NCT03561701|10165044|FG001|NOT COMPLETED|Overall Study||19
9100125|NCT03525808|10165050|FG000|STARTED|Overall Study||40
9100126|NCT03525808|10165050|FG000|COMPLETED|Overall Study||34
9100127|NCT03525808|10165050|FG000|NOT COMPLETED|Overall Study||6
9100128|NCT03461211|10165056|FG000|STARTED|Overall Study||37
9100129|NCT03461211|10165057|FG001|STARTED|Overall Study||14
9100130|NCT03461211|10165056|FG000|Proptosis Non-Responders in OPTIC|Overall Study||36
9100131|NCT03461211|10165057|FG001|Proptosis Non-Responders in OPTIC|Overall Study||5
9100132|NCT03461211|10165056|FG000|Relapsed During Follow-Up Period of OPTIC|Overall Study||1
9100133|NCT03461211|10165057|FG001|Relapsed During Follow-Up Period of OPTIC|Overall Study||9
9100134|NCT03461211|10165056|FG000|COMPLETED|Overall Study||36
9100135|NCT03461211|10165057|FG001|COMPLETED|Overall Study||12
9100136|NCT03461211|10165056|FG000|NOT COMPLETED|Overall Study||1
9100137|NCT03461211|10165057|FG001|NOT COMPLETED|Overall Study||2
9100138|NCT03282123|10165065|FG000|STARTED|Overall Study||38
9100139|NCT03282123|10165065|FG000|COMPLETED|Overall Study||33
9100140|NCT03282123|10165065|FG000|NOT COMPLETED|Overall Study||5
9100141|NCT03276780|10165072|FG000|STARTED|Overall Study||41
9100142|NCT03276780|10165073|FG001|STARTED|Overall Study||39
9100143|NCT03276780|10165072|FG000|COMPLETED|Overall Study||23
9100144|NCT03276780|10165073|FG001|COMPLETED|Overall Study||29
9100145|NCT03276780|10165072|FG000|NOT COMPLETED|Overall Study||18
9100146|NCT03276780|10165073|FG001|NOT COMPLETED|Overall Study||10
9100147|NCT03205553|10165083|FG000|STARTED|Overall Study||2
9100148|NCT03205553|10165084|FG001|STARTED|Overall Study||1
9100149|NCT03205553|10165083|FG000|COMPLETED|Overall Study||2
9100150|NCT03205553|10165084|FG001|COMPLETED|Overall Study||1
9100151|NCT03205553|10165083|FG000|NOT COMPLETED|Overall Study||0
9100152|NCT03205553|10165084|FG001|NOT COMPLETED|Overall Study||0
9100153|NCT03104205|10165090|FG000|STARTED|Overall Study||53
9100154|NCT03104205|10165090|FG000|COMPLETED|Overall Study||44
9100155|NCT03104205|10165090|FG000|NOT COMPLETED|Overall Study||9
9100156|NCT03050814|10165097|FG000|STARTED|Overall Study||10
9100157|NCT03050814|10165098|FG001|STARTED|Overall Study||16
9100158|NCT03050814|10165099|FG002|STARTED|Overall Study||4
9100159|NCT03050814|10165097|FG000|COMPLETED|Overall Study||10
9100160|NCT03050814|10165098|FG001|COMPLETED|Overall Study||16
9100161|NCT03050814|10165099|FG002|COMPLETED|Overall Study||0
9100162|NCT03050814|10165097|FG000|NOT COMPLETED|Overall Study||0
9100163|NCT03050814|10165098|FG001|NOT COMPLETED|Overall Study||0
9100164|NCT03050814|10165099|FG002|NOT COMPLETED|Overall Study||4
9100165|NCT02797262|10165107|FG000|STARTED|Overall Study||65
9100166|NCT02797262|10165108|FG001|STARTED|Overall Study||65
9100167|NCT02797262|10165107|FG000|Baseline|Overall Study||54
8845914|NCT01717768|9900348|FG001|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
9100168|NCT02797262|10165108|FG001|Baseline|Overall Study||58
9100169|NCT02797262|10165107|FG000|COMPLETED|Overall Study||45
9100170|NCT02797262|10165108|FG001|COMPLETED|Overall Study||54
8845915|NCT01717768|9900349|FG002|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
8845916|NCT01717768|9900350|FG003|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
9100171|NCT02797262|10165107|FG000|NOT COMPLETED|Overall Study||20
9100172|NCT02797262|10165108|FG001|NOT COMPLETED|Overall Study||11
9100260|NCT01772004|10165220|FG020|COMPLETED|Dose Escalation Phase||0
9100261|NCT01772004|10165221|FG021|COMPLETED|Dose Escalation Phase||0
9100262|NCT01772004|10165222|FG022|COMPLETED|Dose Escalation Phase||0
9100263|NCT01772004|10165200|FG000|NOT COMPLETED|Dose Escalation Phase||0
9100264|NCT01772004|10165201|FG001|NOT COMPLETED|Dose Escalation Phase||0
9100265|NCT01772004|10165202|FG002|NOT COMPLETED|Dose Escalation Phase||0
9100266|NCT01772004|10165203|FG003|NOT COMPLETED|Dose Escalation Phase||0
9100267|NCT01772004|10165204|FG004|NOT COMPLETED|Dose Escalation Phase||0
9100268|NCT01772004|10165205|FG005|NOT COMPLETED|Dose Escalation Phase||0
9100269|NCT01772004|10165206|FG006|NOT COMPLETED|Dose Escalation Phase||0
9100270|NCT01772004|10165207|FG007|NOT COMPLETED|Dose Escalation Phase||0
9100271|NCT01772004|10165208|FG008|NOT COMPLETED|Dose Escalation Phase||0
9100272|NCT01772004|10165209|FG009|NOT COMPLETED|Dose Escalation Phase||0
9100273|NCT01772004|10165210|FG010|NOT COMPLETED|Dose Escalation Phase||0
9100274|NCT01772004|10165211|FG011|NOT COMPLETED|Dose Escalation Phase||0
9100275|NCT01772004|10165212|FG012|NOT COMPLETED|Dose Escalation Phase||0
9100276|NCT01772004|10165213|FG013|NOT COMPLETED|Dose Escalation Phase||0
9100277|NCT01772004|10165214|FG014|NOT COMPLETED|Dose Escalation Phase||0
9100278|NCT01772004|10165215|FG015|NOT COMPLETED|Dose Escalation Phase||0
9100279|NCT01772004|10165216|FG016|NOT COMPLETED|Dose Escalation Phase||0
9100280|NCT01772004|10165217|FG017|NOT COMPLETED|Dose Escalation Phase||0
9100281|NCT01772004|10165218|FG018|NOT COMPLETED|Dose Escalation Phase||0
9100282|NCT01772004|10165219|FG019|NOT COMPLETED|Dose Escalation Phase||0
9100283|NCT01772004|10165220|FG020|NOT COMPLETED|Dose Escalation Phase||0
9100284|NCT01772004|10165221|FG021|NOT COMPLETED|Dose Escalation Phase||0
9100285|NCT01772004|10165222|FG022|NOT COMPLETED|Dose Escalation Phase||0
9100286|NCT01772004|10165200|FG000|STARTED|Dose Expansion Phase||0
9100287|NCT01772004|10165201|FG001|STARTED|Dose Expansion Phase||0
9100288|NCT01772004|10165202|FG002|STARTED|Dose Expansion Phase||0
9100289|NCT01772004|10165203|FG003|STARTED|Dose Expansion Phase||0
9100290|NCT01772004|10165204|FG004|STARTED|Dose Expansion Phase||0
9100291|NCT01772004|10165205|FG005|STARTED|Dose Expansion Phase||184
9100292|NCT01772004|10165206|FG006|STARTED|Dose Expansion Phase||156
9100293|NCT01772004|10165207|FG007|STARTED|Dose Expansion Phase||168
9100294|NCT01772004|10165208|FG008|STARTED|Dose Expansion Phase||60
9100295|NCT01772004|10165209|FG009|STARTED|Dose Expansion Phase||90
9100296|NCT01772004|10165210|FG010|STARTED|Dose Expansion Phase||21
9100297|NCT01772004|10165211|FG011|STARTED|Dose Expansion Phase||18
9100298|NCT01772004|10165212|FG012|STARTED|Dose Expansion Phase||50
9100299|NCT01772004|10165213|FG013|STARTED|Dose Expansion Phase||51
9100300|NCT01772004|10165214|FG014|STARTED|Dose Expansion Phase||53
9100301|NCT01772004|10165215|FG015|STARTED|Dose Expansion Phase||44
9100302|NCT01772004|10165216|FG016|STARTED|Dose Expansion Phase||125
9100303|NCT01772004|10165217|FG017|STARTED|Dose Expansion Phase||62
9100304|NCT01772004|10165218|FG018|STARTED|Dose Expansion Phase||20
9100305|NCT01772004|10165219|FG019|STARTED|Dose Expansion Phase||103
9100306|NCT01772004|10165220|FG020|STARTED|Dose Expansion Phase||205
9100307|NCT01772004|10165221|FG021|STARTED|Dose Expansion Phase||132
9100308|NCT01772004|10165222|FG022|STARTED|Dose Expansion Phase||153
9100309|NCT01772004|10165200|FG000|COMPLETED|Dose Expansion Phase||0
9100310|NCT01772004|10165201|FG001|COMPLETED|Dose Expansion Phase||0
9100311|NCT01772004|10165202|FG002|COMPLETED|Dose Expansion Phase||0
9100312|NCT01772004|10165203|FG003|COMPLETED|Dose Expansion Phase||0
9100313|NCT01772004|10165204|FG004|COMPLETED|Dose Expansion Phase||0
9100314|NCT01772004|10165205|FG005|COMPLETED|Dose Expansion Phase||184
9100315|NCT01772004|10165206|FG006|COMPLETED|Dose Expansion Phase||156
9100316|NCT01772004|10165207|FG007|COMPLETED|Dose Expansion Phase||168
9100317|NCT01772004|10165208|FG008|COMPLETED|Dose Expansion Phase||60
9100318|NCT01772004|10165209|FG009|COMPLETED|Dose Expansion Phase||90
9100319|NCT01772004|10165210|FG010|COMPLETED|Dose Expansion Phase||21
9100320|NCT01772004|10165211|FG011|COMPLETED|Dose Expansion Phase||18
9100321|NCT01772004|10165212|FG012|COMPLETED|Dose Expansion Phase||50
9100322|NCT01772004|10165213|FG013|COMPLETED|Dose Expansion Phase||51
9100323|NCT01772004|10165214|FG014|COMPLETED|Dose Expansion Phase||53
9100324|NCT01772004|10165215|FG015|COMPLETED|Dose Expansion Phase||44
9100325|NCT01772004|10165216|FG016|COMPLETED|Dose Expansion Phase||125
9100326|NCT01772004|10165217|FG017|COMPLETED|Dose Expansion Phase||62
9100327|NCT01772004|10165218|FG018|COMPLETED|Dose Expansion Phase||20
9100328|NCT01772004|10165219|FG019|COMPLETED|Dose Expansion Phase||103
9100329|NCT01772004|10165220|FG020|COMPLETED|Dose Expansion Phase||205
9100330|NCT01772004|10165221|FG021|COMPLETED|Dose Expansion Phase||132
9100331|NCT01772004|10165222|FG022|COMPLETED|Dose Expansion Phase||153
9100332|NCT01772004|10165200|FG000|NOT COMPLETED|Dose Expansion Phase||0
9100333|NCT01772004|10165201|FG001|NOT COMPLETED|Dose Expansion Phase||0
9100334|NCT01772004|10165202|FG002|NOT COMPLETED|Dose Expansion Phase||0
9100335|NCT01772004|10165203|FG003|NOT COMPLETED|Dose Expansion Phase||0
9100336|NCT01772004|10165204|FG004|NOT COMPLETED|Dose Expansion Phase||0
9100337|NCT01772004|10165205|FG005|NOT COMPLETED|Dose Expansion Phase||0
9100338|NCT01772004|10165206|FG006|NOT COMPLETED|Dose Expansion Phase||0
9100339|NCT01772004|10165207|FG007|NOT COMPLETED|Dose Expansion Phase||0
9100340|NCT01772004|10165208|FG008|NOT COMPLETED|Dose Expansion Phase||0
9100341|NCT01772004|10165209|FG009|NOT COMPLETED|Dose Expansion Phase||0
9100342|NCT01772004|10165210|FG010|NOT COMPLETED|Dose Expansion Phase||0
9100343|NCT01772004|10165211|FG011|NOT COMPLETED|Dose Expansion Phase||0
9100344|NCT01772004|10165212|FG012|NOT COMPLETED|Dose Expansion Phase||0
9100345|NCT01772004|10165213|FG013|NOT COMPLETED|Dose Expansion Phase||0
8556862|NCT03760146|9588649|FG003|Evaluable-20 Immunogenicity Population|Overall Study||0
8556863|NCT03760146|9588650|FG004|Evaluable-20 Immunogenicity Population|Overall Study||317
8556864|NCT03760146|9588651|FG005|Evaluable-20 Immunogenicity Population|Overall Study||0
8556865|NCT03760146|9588646|FG000|COMPLETED|Overall Study||1418
8556866|NCT03760146|9588647|FG001|COMPLETED|Overall Study||1417
9100346|NCT01772004|10165214|FG014|NOT COMPLETED|Dose Expansion Phase||0
9100347|NCT01772004|10165215|FG015|NOT COMPLETED|Dose Expansion Phase||0
9100348|NCT01772004|10165216|FG016|NOT COMPLETED|Dose Expansion Phase||0
9100349|NCT01772004|10165217|FG017|NOT COMPLETED|Dose Expansion Phase||0
9100350|NCT01772004|10165218|FG018|NOT COMPLETED|Dose Expansion Phase||0
9100351|NCT01772004|10165219|FG019|NOT COMPLETED|Dose Expansion Phase||0
9100352|NCT01772004|10165220|FG020|NOT COMPLETED|Dose Expansion Phase||0
9100353|NCT01772004|10165221|FG021|NOT COMPLETED|Dose Expansion Phase||0
9100354|NCT01772004|10165222|FG022|NOT COMPLETED|Dose Expansion Phase||0
9100355|NCT01721759|10165317|FG000|STARTED|Overall Study||117
9100356|NCT01721759|10165317|FG000|COMPLETED|Overall Study|Completed=continuing to receive treatment|15
9100357|NCT01721759|10165317|FG000|NOT COMPLETED|Overall Study||102
9100358|NCT01322971|10165323|FG000|STARTED|Overall Study||1
9100359|NCT01322971|10165324|FG001|STARTED|Overall Study||1
9100360|NCT01322971|10165323|FG000|COMPLETED|Overall Study||0
9100361|NCT01322971|10165324|FG001|COMPLETED|Overall Study||0
9100362|NCT01322971|10165323|FG000|NOT COMPLETED|Overall Study||1
9100363|NCT01322971|10165324|FG001|NOT COMPLETED|Overall Study||1
9100364|NCT01285102|10165330|FG000|STARTED|Overall Study||4
9100365|NCT01285102|10165330|FG000|COMPLETED|Overall Study||0
9100366|NCT01285102|10165330|FG000|NOT COMPLETED|Overall Study||4
9100367|NCT00952692|10165334|FG000|STARTED|Overall Study||12
9100368|NCT00952692|10165334|FG000|COMPLETED|Overall Study||12
9100369|NCT00952692|10165334|FG000|NOT COMPLETED|Overall Study||0
9100370|NCT00804713|10165338|FG000|STARTED|Overall Study||1978
9100371|NCT00804713|10165338|FG000|COMPLETED|Overall Study||1978
9100372|NCT00804713|10165338|FG000|NOT COMPLETED|Overall Study||0
9100373|NCT00677560|10165349|FG000|STARTED|Overall Study||20
9100374|NCT00677560|10165350|FG001|STARTED|Overall Study||23
9100375|NCT00677560|10165351|FG002|STARTED|Overall Study||29
9100376|NCT00677560|10165352|FG003|STARTED|Overall Study||20
9100377|NCT00677560|10165353|FG004|STARTED|Overall Study||34
9100378|NCT00677560|10165349|FG000|COMPLETED|Overall Study||5
9100379|NCT00677560|10165350|FG001|COMPLETED|Overall Study||13
9100380|NCT00677560|10165351|FG002|COMPLETED|Overall Study||6
9100381|NCT00677560|10165352|FG003|COMPLETED|Overall Study||3
9100382|NCT00677560|10165353|FG004|COMPLETED|Overall Study||21
9100383|NCT00677560|10165349|FG000|NOT COMPLETED|Overall Study||15
9100384|NCT00677560|10165350|FG001|NOT COMPLETED|Overall Study||10
9100385|NCT00677560|10165351|FG002|NOT COMPLETED|Overall Study||23
9100386|NCT00677560|10165352|FG003|NOT COMPLETED|Overall Study||17
9100387|NCT00677560|10165353|FG004|NOT COMPLETED|Overall Study||13
9100388|NCT00389649|10165378|FG000|STARTED|Overall Study||2
9100389|NCT00389649|10165379|FG001|STARTED|Overall Study||2
9100390|NCT00389649|10165380|FG002|STARTED|Overall Study||3
9100391|NCT00389649|10165381|FG003|STARTED|Overall Study||2
9100392|NCT00389649|10165382|FG004|STARTED|Overall Study||2
9100393|NCT00389649|10165383|FG005|STARTED|Overall Study||2
9100394|NCT00389649|10165378|FG000|COMPLETED|Overall Study||2
9100395|NCT00389649|10165379|FG001|COMPLETED|Overall Study||2
9100396|NCT00389649|10165380|FG002|COMPLETED|Overall Study||3
9100397|NCT00389649|10165381|FG003|COMPLETED|Overall Study||2
9100398|NCT00389649|10165382|FG004|COMPLETED|Overall Study||2
9100399|NCT00389649|10165383|FG005|COMPLETED|Overall Study||2
9100400|NCT00389649|10165378|FG000|NOT COMPLETED|Overall Study||0
9100401|NCT00389649|10165379|FG001|NOT COMPLETED|Overall Study||0
9100402|NCT00389649|10165380|FG002|NOT COMPLETED|Overall Study||0
9100403|NCT00389649|10165381|FG003|NOT COMPLETED|Overall Study||0
9100404|NCT00389649|10165382|FG004|NOT COMPLETED|Overall Study||0
9100405|NCT00389649|10165383|FG005|NOT COMPLETED|Overall Study||0
9100406|NCT04644328|10165393|FG000|STARTED|Thanksgiving Period|"Two separate, sequential experiments were run within the study using the same counties (with differences in exclusion criteria explained in the pre-assignment details).~Thanksgiving experiment: 410 counties were assigned to high-intensity treatment. A total of 3,545 ZCTAs (of which 2,702 were in high-intensity counties) were treated.~Counties randomized to intervention, data collected at the population level, actual number of participants unknown."|
9100407|NCT04644328|10165394|FG001|STARTED|Thanksgiving Period|"Two separate, sequential experiments were run within the study using the same counties (with differences in exclusion criteria explained in the pre-assignment details).~Thanksgiving experiment: 410 counties were assigned to low-intensity treatment. A total of 3,453 ZCTAs (of which 2,549 were in low-intensity counties) were not treated.~Counties randomized to intervention, data collected at the population level, actual number of participants unknown."|
9100408|NCT04644328|10165393|FG000|COMPLETED|Thanksgiving Period|Counties randomized to intervention, data collected at the population level, actual number of participants unknown.|
9100409|NCT04644328|10165394|FG001|COMPLETED|Thanksgiving Period|Counties randomized to intervention, data collected at the population level, actual number of participants unknown.|
9100410|NCT04644328|10165393|FG000|NOT COMPLETED|Thanksgiving Period||
9100411|NCT04644328|10165394|FG001|NOT COMPLETED|Thanksgiving Period||
9100412|NCT04644328|10165393|FG000|STARTED|Christmas Period|"Two separate, sequential experiments were run within the study using the same counties (with differences in exclusion criteria explained in the pre-assignment details).~Christmas experiment: 386 counties were assigned to high-intensity treatment. A total of 5,077 ZCTAs (of which 3,818 were in high-intensity counties) were treated.~Counties randomized to intervention, data collected at the population level, actual number of participants unknown."|
9100413|NCT04644328|10165394|FG001|STARTED|Christmas Period|"Two separate, sequential experiments were run within the study using the same counties (with differences in exclusion criteria explained in the pre-assignment details).~Christmas experiment: 381 counties were assigned to low-intensity treatment. A total of 5,102 ZCTAs (of which 3,833 were in low-intensity counties) were not treated.~Counties randomized to intervention, data collected at the population level, actual number of participants unknown."|
9100414|NCT04644328|10165393|FG000|COMPLETED|Christmas Period|Counties randomized to intervention, data collected at the population level, actual number of participants unknown.|
9100415|NCT04644328|10165394|FG001|COMPLETED|Christmas Period|Counties randomized to intervention, data collected at the population level, actual number of participants unknown.|
9100416|NCT04644328|10165393|FG000|NOT COMPLETED|Christmas Period||
9100417|NCT04644328|10165394|FG001|NOT COMPLETED|Christmas Period||
9100493|NCT04881175|10165509|FG000|STARTED|Overall Study||3
9100494|NCT04881175|10165509|FG000|COMPLETED|Overall Study||3
9100495|NCT04881175|10165509|FG000|NOT COMPLETED|Overall Study||0
9100496|NCT04273737|10165513|FG000|STARTED|Overall Study||11
9100497|NCT04273737|10165513|FG000|COMPLETED|Overall Study||11
9100498|NCT04273737|10165513|FG000|NOT COMPLETED|Overall Study||0
9100499|NCT04075734|10165520|FG000|STARTED|Overall Study||25
9100500|NCT04075734|10165521|FG001|STARTED|Overall Study||25
9100501|NCT04075734|10165522|FG002|STARTED|Overall Study||10
9100502|NCT04075734|10165520|FG000|COMPLETED|Overall Study||21
9100503|NCT04075734|10165521|FG001|COMPLETED|Overall Study||24
9100504|NCT04075734|10165522|FG002|COMPLETED|Overall Study||10
9100505|NCT04075734|10165520|FG000|NOT COMPLETED|Overall Study||4
9100506|NCT04075734|10165521|FG001|NOT COMPLETED|Overall Study||1
9100507|NCT04075734|10165522|FG002|NOT COMPLETED|Overall Study||0
9100508|NCT04064684|10165533|FG000|STARTED|Overall Study||1
9100509|NCT04064684|10165534|FG001|STARTED|Overall Study||1
9100510|NCT04064684|10165533|FG000|COMPLETED|Overall Study||1
9100511|NCT04064684|10165534|FG001|COMPLETED|Overall Study||1
9100512|NCT04064684|10165533|FG000|NOT COMPLETED|Overall Study||0
9100513|NCT04064684|10165534|FG001|NOT COMPLETED|Overall Study||0
9100514|NCT04019561|10165543|FG000|STARTED|Overall Study||25
9100515|NCT04019561|10165544|FG001|STARTED|Overall Study||25
9100516|NCT04019561|10165545|FG002|STARTED|Overall Study||24
9100517|NCT04019561|10165543|FG000|COMPLETED|Overall Study||21
9100518|NCT04019561|10165544|FG001|COMPLETED|Overall Study||23
9100519|NCT04019561|10165545|FG002|COMPLETED|Overall Study||19
9100520|NCT04019561|10165543|FG000|NOT COMPLETED|Overall Study||4
9100521|NCT04019561|10165544|FG001|NOT COMPLETED|Overall Study||2
9100522|NCT04019561|10165545|FG002|NOT COMPLETED|Overall Study||5
9100523|NCT03874325|10165553|FG000|STARTED|Overall Study||17
9100524|NCT03874325|10165554|FG001|STARTED|Overall Study||0
9100525|NCT03874325|10165553|FG000|COMPLETED|Overall Study||17
9100526|NCT03874325|10165554|FG001|COMPLETED|Overall Study||0
9100527|NCT03874325|10165553|FG000|NOT COMPLETED|Overall Study||0
9100528|NCT03874325|10165554|FG001|NOT COMPLETED|Overall Study||0
9100529|NCT03861611|10165561|FG000|STARTED|Overall Study||66
9100530|NCT03861611|10165562|FG001|STARTED|Overall Study||66
9100531|NCT03861611|10165563|FG002|STARTED|Overall Study||66
9100532|NCT03861611|10165561|FG000|COMPLETED|Overall Study||59
9100533|NCT03861611|10165562|FG001|COMPLETED|Overall Study||61
9100534|NCT03861611|10165563|FG002|COMPLETED|Overall Study||62
9100535|NCT03861611|10165561|FG000|NOT COMPLETED|Overall Study||7
9100536|NCT03861611|10165562|FG001|NOT COMPLETED|Overall Study||5
9100537|NCT03861611|10165563|FG002|NOT COMPLETED|Overall Study||4
9100538|NCT03700047|10165577|FG000|STARTED|Overall Study||142
9100539|NCT03700047|10165578|FG001|STARTED|Overall Study||60
9100540|NCT03700047|10165579|FG002|STARTED|Overall Study||68
9100541|NCT03700047|10165577|FG000|COMPLETED|Overall Study||126
9100542|NCT03700047|10165578|FG001|COMPLETED|Overall Study||50
9100543|NCT03700047|10165579|FG002|COMPLETED|Overall Study||58
9100544|NCT03700047|10165577|FG000|NOT COMPLETED|Overall Study||16
9100545|NCT03700047|10165578|FG001|NOT COMPLETED|Overall Study||10
9100546|NCT03700047|10165579|FG002|NOT COMPLETED|Overall Study||10
9100418|NCT04246554|10165404|FG000|STARTED|Overall Study||26
9100419|NCT04246554|10165405|FG001|STARTED|Overall Study||23
9100420|NCT04246554|10165404|FG000|COMPLETED|Overall Study||26
9100421|NCT04246554|10165405|FG001|COMPLETED|Overall Study||22
9100422|NCT04246554|10165404|FG000|NOT COMPLETED|Overall Study||0
9100423|NCT04246554|10165405|FG001|NOT COMPLETED|Overall Study||1
9100424|NCT03877926|10165415|FG000|STARTED|Overall Study||1103
9100425|NCT03877926|10165416|FG001|STARTED|Overall Study||1103
9100426|NCT03877926|10165417|FG002|STARTED|Overall Study||1098
9100427|NCT03877926|10165418|FG003|STARTED|Overall Study||558
9100428|NCT03877926|10165415|FG000|Received at Least One Study Vaccination|Overall Study||1100
9100429|NCT03877926|10165416|FG001|Received at Least One Study Vaccination|Overall Study||1102
9100430|NCT03877926|10165417|FG002|Received at Least One Study Vaccination|Overall Study||1097
9100431|NCT03877926|10165418|FG003|Received at Least One Study Vaccination|Overall Study||558
9100432|NCT03877926|10165415|FG000|Did Not Receive Any Study Vaccination|Overall Study||3
9100433|NCT03877926|10165416|FG001|Did Not Receive Any Study Vaccination|Overall Study||1
9100434|NCT03877926|10165417|FG002|Did Not Receive Any Study Vaccination|Overall Study||1
9100435|NCT03877926|10165418|FG003|Did Not Receive Any Study Vaccination|Overall Study||0
9100436|NCT03877926|10165415|FG000|COMPLETED|Overall Study||1032
9100437|NCT03877926|10165416|FG001|COMPLETED|Overall Study||1026
9100438|NCT03877926|10165417|FG002|COMPLETED|Overall Study||1035
9100439|NCT03877926|10165418|FG003|COMPLETED|Overall Study||537
9100440|NCT03877926|10165415|FG000|NOT COMPLETED|Overall Study||71
9100441|NCT03877926|10165416|FG001|NOT COMPLETED|Overall Study||77
9100442|NCT03877926|10165417|FG002|NOT COMPLETED|Overall Study||63
9100443|NCT03877926|10165418|FG003|NOT COMPLETED|Overall Study||21
9100444|NCT03862807|10165441|FG000|STARTED|Overall Study||24
9100445|NCT03862807|10165441|FG000|Treated|Overall Study||23
9100446|NCT03862807|10165441|FG000|Completed Treatment|Overall Study||22
9100447|NCT03862807|10165441|FG000|COMPLETED|Overall Study||23
9100448|NCT03862807|10165441|FG000|NOT COMPLETED|Overall Study||1
9100449|NCT03857867|10165445|FG000|STARTED|Overall Study||7
9100450|NCT03857867|10165445|FG000|COMPLETED|Overall Study||6
9100451|NCT03857867|10165445|FG000|NOT COMPLETED|Overall Study||1
9100452|NCT03691571|10165452|FG000|STARTED|Overall Study||31
9100453|NCT03691571|10165453|FG001|STARTED|Overall Study||24
9100454|NCT03691571|10165452|FG000|COMPLETED|Overall Study||22
9100455|NCT03691571|10165453|FG001|COMPLETED|Overall Study||22
9100456|NCT03691571|10165452|FG000|NOT COMPLETED|Overall Study||9
9100457|NCT03691571|10165453|FG001|NOT COMPLETED|Overall Study||2
9100458|NCT03436199|10165463|FG000|STARTED|Overall Study||187
9100459|NCT03436199|10165464|FG001|STARTED|Overall Study||185
9100460|NCT03436199|10165465|FG002|STARTED|Overall Study||186
9100461|NCT03436199|10165463|FG000|COMPLETED|Overall Study||165
9100462|NCT03436199|10165464|FG001|COMPLETED|Overall Study||132
9100463|NCT03436199|10165465|FG002|COMPLETED|Overall Study||174
9100464|NCT03436199|10165463|FG000|NOT COMPLETED|Overall Study||22
9100465|NCT03436199|10165464|FG001|NOT COMPLETED|Overall Study||53
9100466|NCT03436199|10165465|FG002|NOT COMPLETED|Overall Study||12
9100467|NCT03353233|10165475|FG000|STARTED|Overall Study||25
9100468|NCT03353233|10165476|FG001|STARTED|Overall Study||25
9100469|NCT03353233|10165475|FG000|COMPLETED|Overall Study||25
9100470|NCT03353233|10165476|FG001|COMPLETED|Overall Study||25
9100471|NCT03353233|10165475|FG000|NOT COMPLETED|Overall Study||0
9100472|NCT03353233|10165476|FG001|NOT COMPLETED|Overall Study||0
9100473|NCT03250273|10165484|FG000|STARTED|Overall Study||13
9100474|NCT03250273|10165485|FG001|STARTED|Overall Study||30
9100475|NCT03250273|10165484|FG000|COMPLETED|Overall Study||11
9100476|NCT03250273|10165485|FG001|COMPLETED|Overall Study||18
9100477|NCT03250273|10165484|FG000|NOT COMPLETED|Overall Study||2
9100478|NCT03250273|10165485|FG001|NOT COMPLETED|Overall Study||12
9100479|NCT03217136|10165493|FG000|STARTED|Overall Study||71
9100480|NCT03217136|10165494|FG001|STARTED|Overall Study||23
8625878|NCT00509821|9665505|FG001|STARTED|Study Period 3 (Maintenance)|4 participants completed Radiation Phase but did not enter Maintenance Phase.|49
8625879|NCT00509821|9665504|FG000|COMPLETED|Study Period 3 (Maintenance)||3
8625880|NCT00509821|9665505|FG001|COMPLETED|Study Period 3 (Maintenance)||0
9100481|NCT03217136|10165493|FG000|Treated|Overall Study||70
8625881|NCT00509821|9665504|FG000|NOT COMPLETED|Study Period 3 (Maintenance)||0
9100482|NCT03217136|10165494|FG001|Treated|Overall Study||21
9100483|NCT03217136|10165493|FG000|COMPLETED|Overall Study||67
9100484|NCT03217136|10165494|FG001|COMPLETED|Overall Study||20
9100485|NCT03217136|10165493|FG000|NOT COMPLETED|Overall Study||4
9100486|NCT03217136|10165494|FG001|NOT COMPLETED|Overall Study||3
9100487|NCT03181542|10165502|FG000|STARTED|Overall Study||80
9100488|NCT03181542|10165503|FG001|STARTED|Overall Study||80
9100489|NCT03181542|10165502|FG000|COMPLETED|Overall Study||79
9100490|NCT03181542|10165503|FG001|COMPLETED|Overall Study||80
9100491|NCT03181542|10165502|FG000|NOT COMPLETED|Overall Study||1
9100492|NCT03181542|10165503|FG001|NOT COMPLETED|Overall Study||0
9100547|NCT03633396|10165589|FG000|STARTED|Overall Study||29
9100548|NCT03633396|10165590|FG001|STARTED|Overall Study||30
9100549|NCT03633396|10165589|FG000|COMPLETED|Overall Study||23
9100550|NCT03633396|10165590|FG001|COMPLETED|Overall Study||24
9100551|NCT03633396|10165589|FG000|NOT COMPLETED|Overall Study||6
9100552|NCT03633396|10165590|FG001|NOT COMPLETED|Overall Study||6
9100553|NCT03612856|10165599|FG000|STARTED|Pre-dose Period||8
9100554|NCT03612856|10165600|FG001|STARTED|Pre-dose Period||10
9100555|NCT03612856|10165601|FG002|STARTED|Pre-dose Period||9
9100556|NCT03612856|10165599|FG000|COMPLETED|Pre-dose Period||8
9100557|NCT03612856|10165600|FG001|COMPLETED|Pre-dose Period||8
9100558|NCT03612856|10165601|FG002|COMPLETED|Pre-dose Period||8
9100559|NCT03612856|10165599|FG000|NOT COMPLETED|Pre-dose Period||0
9100560|NCT03612856|10165600|FG001|NOT COMPLETED|Pre-dose Period||2
9100561|NCT03612856|10165601|FG002|NOT COMPLETED|Pre-dose Period||1
9100562|NCT03612856|10165599|FG000|STARTED|Post-dose Period||8
9100563|NCT03612856|10165600|FG001|STARTED|Post-dose Period||8
9100564|NCT03612856|10165601|FG002|STARTED|Post-dose Period||8
9100565|NCT03612856|10165599|FG000|COMPLETED|Post-dose Period||8
9100566|NCT03612856|10165600|FG001|COMPLETED|Post-dose Period||8
9100567|NCT03612856|10165601|FG002|COMPLETED|Post-dose Period||8
9100568|NCT03612856|10165599|FG000|NOT COMPLETED|Post-dose Period||0
9100569|NCT03612856|10165600|FG001|NOT COMPLETED|Post-dose Period||0
9100570|NCT03612856|10165601|FG002|NOT COMPLETED|Post-dose Period||0
9100571|NCT03607994|10165611|FG000|STARTED|Overall Study||10
9100572|NCT03607994|10165612|FG001|STARTED|Overall Study||12
9100573|NCT03607994|10165611|FG000|COMPLETED|Overall Study||9
9100574|NCT03607994|10165612|FG001|COMPLETED|Overall Study||11
9100575|NCT03607994|10165611|FG000|NOT COMPLETED|Overall Study||1
9100576|NCT03607994|10165612|FG001|NOT COMPLETED|Overall Study||1
9100577|NCT03602560|10165621|FG000|STARTED|Overall Study||89
9100578|NCT03602560|10165622|FG001|STARTED|Overall Study||89
9100579|NCT03602560|10165623|FG002|STARTED|Overall Study||87
9100580|NCT03602560|10165621|FG000|COMPLETED|Overall Study||1
9100581|NCT03602560|10165622|FG001|COMPLETED|Overall Study||1
9100582|NCT03602560|10165623|FG002|COMPLETED|Overall Study||1
9100583|NCT03602560|10165621|FG000|NOT COMPLETED|Overall Study||88
9100584|NCT03602560|10165622|FG001|NOT COMPLETED|Overall Study||88
9100585|NCT03602560|10165623|FG002|NOT COMPLETED|Overall Study||86
9100586|NCT03150862|10165639|FG000|STARTED|Overall Study||3
9100587|NCT03150862|10165640|FG001|STARTED|Overall Study||8
9100588|NCT03150862|10165641|FG002|STARTED|Overall Study||9
9100589|NCT03150862|10165642|FG003|STARTED|Overall Study||40
9100590|NCT03150862|10165643|FG004|STARTED|Overall Study||9
9100591|NCT03150862|10165644|FG005|STARTED|Overall Study||9
9100592|NCT03150862|10165645|FG006|STARTED|Overall Study||8
9100593|NCT03150862|10165646|FG007|STARTED|Overall Study||30
9100594|NCT03150862|10165639|FG000|COMPLETED|Overall Study||0
9100595|NCT03150862|10165640|FG001|COMPLETED|Overall Study||0
9100596|NCT03150862|10165641|FG002|COMPLETED|Overall Study||0
9100597|NCT03150862|10165642|FG003|COMPLETED|Overall Study||0
9100598|NCT03150862|10165643|FG004|COMPLETED|Overall Study||0
9100599|NCT03150862|10165644|FG005|COMPLETED|Overall Study||0
9100600|NCT03150862|10165645|FG006|COMPLETED|Overall Study||0
9100601|NCT03150862|10165646|FG007|COMPLETED|Overall Study||0
9100602|NCT03150862|10165639|FG000|NOT COMPLETED|Overall Study||3
9100603|NCT03150862|10165640|FG001|NOT COMPLETED|Overall Study||8
9100604|NCT03150862|10165641|FG002|NOT COMPLETED|Overall Study||9
9100605|NCT03150862|10165642|FG003|NOT COMPLETED|Overall Study||40
9100606|NCT03150862|10165643|FG004|NOT COMPLETED|Overall Study||9
9100607|NCT03150862|10165644|FG005|NOT COMPLETED|Overall Study||9
9100608|NCT03150862|10165645|FG006|NOT COMPLETED|Overall Study||8
9100609|NCT03150862|10165646|FG007|NOT COMPLETED|Overall Study||30
9100610|NCT03052608|10165675|FG000|STARTED|Treatment Phase||149
9100611|NCT03052608|10165676|FG001|STARTED|Treatment Phase||147
9100612|NCT03052608|10165675|FG000|COMPLETED|Treatment Phase||26
9100613|NCT03052608|10165676|FG001|COMPLETED|Treatment Phase||83
9100614|NCT03052608|10165675|FG000|NOT COMPLETED|Treatment Phase||123
9100615|NCT03052608|10165676|FG001|NOT COMPLETED|Treatment Phase||64
9100616|NCT03052608|10165675|FG000|STARTED|Long-Term Follow-up Phase||149
9100617|NCT03052608|10165676|FG001|STARTED|Long-Term Follow-up Phase||147
9100618|NCT03052608|10165675|FG000|COMPLETED|Long-Term Follow-up Phase||0
9100619|NCT03052608|10165676|FG001|COMPLETED|Long-Term Follow-up Phase||0
9100620|NCT03052608|10165675|FG000|NOT COMPLETED|Long-Term Follow-up Phase||149
9100621|NCT03052608|10165676|FG001|NOT COMPLETED|Long-Term Follow-up Phase||147
9100622|NCT02944071|10165682|FG000|STARTED|Overall Study||123
9100623|NCT02944071|10165682|FG000|COMPLETED|Overall Study||113
9100624|NCT02944071|10165682|FG000|NOT COMPLETED|Overall Study||10
9100625|NCT02922725|10165689|FG000|STARTED|Overall Study||12
9100626|NCT02922725|10165690|FG001|STARTED|Overall Study||12
9100627|NCT02922725|10165691|FG002|STARTED|Overall Study||8
9100628|NCT02922725|10165689|FG000|COMPLETED|Overall Study||11
9100629|NCT02922725|10165690|FG001|COMPLETED|Overall Study||12
9100630|NCT02922725|10165691|FG002|COMPLETED|Overall Study||8
9100631|NCT02922725|10165689|FG000|NOT COMPLETED|Overall Study||1
9100632|NCT02922725|10165690|FG001|NOT COMPLETED|Overall Study||0
9100633|NCT02922725|10165691|FG002|NOT COMPLETED|Overall Study||0
9100634|NCT02805257|10165700|FG000|STARTED|Overall Study||60
9100635|NCT02805257|10165701|FG001|STARTED|Overall Study||59
9100636|NCT02805257|10165700|FG000|COMPLETED|Overall Study||53
9100637|NCT02805257|10165701|FG001|COMPLETED|Overall Study||52
9100638|NCT02805257|10165700|FG000|NOT COMPLETED|Overall Study||7
9100639|NCT02805257|10165701|FG001|NOT COMPLETED|Overall Study||7
9100640|NCT02780609|10165711|FG000|STARTED|Overall Study||3
9100641|NCT02780609|10165712|FG001|STARTED|Overall Study||3
9100642|NCT02780609|10165713|FG002|STARTED|Overall Study||6
9100643|NCT02780609|10165714|FG003|STARTED|Overall Study||10
9100644|NCT02780609|10165711|FG000|COMPLETED|Overall Study||3
9100645|NCT02780609|10165712|FG001|COMPLETED|Overall Study||3
9100646|NCT02780609|10165713|FG002|COMPLETED|Overall Study||6
9100647|NCT02780609|10165714|FG003|COMPLETED|Overall Study||10
9100648|NCT02780609|10165711|FG000|NOT COMPLETED|Overall Study||0
9100649|NCT02780609|10165712|FG001|NOT COMPLETED|Overall Study||0
9100650|NCT02780609|10165713|FG002|NOT COMPLETED|Overall Study||0
9100651|NCT02780609|10165714|FG003|NOT COMPLETED|Overall Study||0
9100652|NCT02747433|10165728|FG000|STARTED|Overall Study||5
9100653|NCT02747433|10165729|FG001|STARTED|Overall Study||5
9100654|NCT02747433|10165728|FG000|COMPLETED|Overall Study||5
9100655|NCT02747433|10165729|FG001|COMPLETED|Overall Study||5
9100656|NCT02747433|10165728|FG000|NOT COMPLETED|Overall Study||0
9100657|NCT02747433|10165729|FG001|NOT COMPLETED|Overall Study||0
9100658|NCT02650986|10165742|FG000|STARTED|Overall Study||3
9100659|NCT02650986|10165743|FG001|STARTED|Overall Study||3
9100660|NCT02650986|10165744|FG002|STARTED|Overall Study||3
9100661|NCT02650986|10165745|FG003|STARTED|Overall Study||6
9100662|NCT02650986|10165742|FG000|COMPLETED|Overall Study||3
9100663|NCT02650986|10165743|FG001|COMPLETED|Overall Study||3
9100664|NCT02650986|10165744|FG002|COMPLETED|Overall Study||3
9100665|NCT02650986|10165745|FG003|COMPLETED|Overall Study||6
9100666|NCT02650986|10165742|FG000|NOT COMPLETED|Overall Study||0
9100667|NCT02650986|10165743|FG001|NOT COMPLETED|Overall Study||0
9100668|NCT02650986|10165744|FG002|NOT COMPLETED|Overall Study||0
9100669|NCT02650986|10165745|FG003|NOT COMPLETED|Overall Study||0
9100670|NCT02367456|10165758|FG000|STARTED|Overall Study||12
9100671|NCT02367456|10165759|FG001|STARTED|Overall Study||30
9100672|NCT02367456|10165760|FG002|STARTED|Overall Study||30
9100673|NCT02367456|10165758|FG000|COMPLETED|Overall Study||0
9100674|NCT02367456|10165759|FG001|COMPLETED|Overall Study||0
9100675|NCT02367456|10165760|FG002|COMPLETED|Overall Study||0
9100676|NCT02367456|10165758|FG000|NOT COMPLETED|Overall Study||12
9100677|NCT02367456|10165759|FG001|NOT COMPLETED|Overall Study||30
9100678|NCT02367456|10165760|FG002|NOT COMPLETED|Overall Study||30
9100679|NCT01275677|10165775|FG000|STARTED|Overall Study||1630
9100680|NCT01275677|10165776|FG001|STARTED|Overall Study||1640
9100681|NCT01275677|10165775|FG000|COMPLETED|Overall Study||1602
9100682|NCT01275677|10165776|FG001|COMPLETED|Overall Study||1598
9100683|NCT01275677|10165775|FG000|NOT COMPLETED|Overall Study||28
9100684|NCT01275677|10165776|FG001|NOT COMPLETED|Overall Study||42
9100685|NCT01103349|10165785|FG000|STARTED|Overall Study||95
9100686|NCT01103349|10165786|FG001|STARTED|Overall Study||81
9100687|NCT01103349|10165787|FG002|STARTED|Overall Study||67
9100688|NCT01103349|10165785|FG000|COMPLETED|Overall Study||84
9100689|NCT01103349|10165786|FG001|COMPLETED|Overall Study||74
9100690|NCT01103349|10165787|FG002|COMPLETED|Overall Study||63
9100691|NCT01103349|10165785|FG000|NOT COMPLETED|Overall Study||11
9100692|NCT01103349|10165786|FG001|NOT COMPLETED|Overall Study||7
9100693|NCT01103349|10165787|FG002|NOT COMPLETED|Overall Study||4
9100694|NCT01092143|10165800|FG000|STARTED|Overall Study||78
9100695|NCT01092143|10165801|FG001|STARTED|Overall Study||77
9100696|NCT01092143|10165802|FG002|STARTED|Overall Study||84
9100697|NCT01092143|10165803|FG003|STARTED|Overall Study||79
9100698|NCT01092143|10165804|FG004|STARTED|Overall Study||71
9100699|NCT01092143|10165800|FG000|Treated|Overall Study||78
9100700|NCT01092143|10165801|FG001|Treated|Overall Study||77
9100701|NCT01092143|10165802|FG002|Treated|Overall Study||83
9100702|NCT01092143|10165803|FG003|Treated|Overall Study||79
9100703|NCT01092143|10165804|FG004|Treated|Overall Study||71
9100704|NCT01092143|10165800|FG000|COMPLETED|Overall Study||63
9100705|NCT01092143|10165801|FG001|COMPLETED|Overall Study||70
9100706|NCT01092143|10165802|FG002|COMPLETED|Overall Study||80
9100707|NCT01092143|10165803|FG003|COMPLETED|Overall Study||72
9100708|NCT01092143|10165804|FG004|COMPLETED|Overall Study||63
9100709|NCT01092143|10165800|FG000|NOT COMPLETED|Overall Study||15
9100710|NCT01092143|10165801|FG001|NOT COMPLETED|Overall Study||7
9100711|NCT01092143|10165802|FG002|NOT COMPLETED|Overall Study||4
9100712|NCT01092143|10165803|FG003|NOT COMPLETED|Overall Study||7
9100713|NCT01092143|10165804|FG004|NOT COMPLETED|Overall Study||8
9100714|NCT01064648|10165819|FG000|STARTED|Phase I Cohort1: Dose Level 1||7
9100715|NCT01064648|10165820|FG001|STARTED|Phase I Cohort1: Dose Level 1||0
9100716|NCT01064648|10165821|FG002|STARTED|Phase I Cohort1: Dose Level 1||0
9100717|NCT01064648|10165822|FG003|STARTED|Phase I Cohort1: Dose Level 1||0
9100718|NCT01064648|10165819|FG000|COMPLETED|Phase I Cohort1: Dose Level 1||0
9100719|NCT01064648|10165820|FG001|COMPLETED|Phase I Cohort1: Dose Level 1||0
9100720|NCT01064648|10165821|FG002|COMPLETED|Phase I Cohort1: Dose Level 1||0
9100721|NCT01064648|10165822|FG003|COMPLETED|Phase I Cohort1: Dose Level 1||0
9100722|NCT01064648|10165819|FG000|NOT COMPLETED|Phase I Cohort1: Dose Level 1||7
8556867|NCT03760146|9588648|FG002|COMPLETED|Overall Study||323
8556868|NCT03760146|9588649|FG003|COMPLETED|Overall Study||109
8556869|NCT03760146|9588650|FG004|COMPLETED|Overall Study||319
8556870|NCT03760146|9588651|FG005|COMPLETED|Overall Study||104
8556871|NCT03760146|9588646|FG000|NOT COMPLETED|Overall Study||96
8556872|NCT03760146|9588647|FG001|NOT COMPLETED|Overall Study||78
8556873|NCT03760146|9588648|FG002|NOT COMPLETED|Overall Study||11
8556874|NCT03760146|9588649|FG003|NOT COMPLETED|Overall Study||2
8556875|NCT03760146|9588650|FG004|NOT COMPLETED|Overall Study||17
9100723|NCT01064648|10165820|FG001|NOT COMPLETED|Phase I Cohort1: Dose Level 1||0
9100724|NCT01064648|10165821|FG002|NOT COMPLETED|Phase I Cohort1: Dose Level 1||0
9100725|NCT01064648|10165822|FG003|NOT COMPLETED|Phase I Cohort1: Dose Level 1||0
9100726|NCT01064648|10165819|FG000|STARTED|Phase I Cohort 2: Dose Level 2||0
9100727|NCT01064648|10165820|FG001|STARTED|Phase I Cohort 2: Dose Level 2||13
9100728|NCT01064648|10165821|FG002|STARTED|Phase I Cohort 2: Dose Level 2||0
9100729|NCT01064648|10165822|FG003|STARTED|Phase I Cohort 2: Dose Level 2||0
9100730|NCT01064648|10165819|FG000|COMPLETED|Phase I Cohort 2: Dose Level 2||0
9100731|NCT01064648|10165820|FG001|COMPLETED|Phase I Cohort 2: Dose Level 2||0
9100732|NCT01064648|10165821|FG002|COMPLETED|Phase I Cohort 2: Dose Level 2||0
9100733|NCT01064648|10165822|FG003|COMPLETED|Phase I Cohort 2: Dose Level 2||0
9100734|NCT01064648|10165819|FG000|NOT COMPLETED|Phase I Cohort 2: Dose Level 2||0
9100735|NCT01064648|10165820|FG001|NOT COMPLETED|Phase I Cohort 2: Dose Level 2||13
9100736|NCT01064648|10165821|FG002|NOT COMPLETED|Phase I Cohort 2: Dose Level 2||0
9100737|NCT01064648|10165822|FG003|NOT COMPLETED|Phase I Cohort 2: Dose Level 2||0
9100738|NCT01064648|10165819|FG000|STARTED|Phase II||0
9100739|NCT01064648|10165820|FG001|STARTED|Phase II||0
9100740|NCT01064648|10165821|FG002|STARTED|Phase II||49
9100741|NCT01064648|10165822|FG003|STARTED|Phase II||48
9100742|NCT01064648|10165819|FG000|COMPLETED|Phase II||0
9100743|NCT01064648|10165820|FG001|COMPLETED|Phase II||0
9100744|NCT01064648|10165821|FG002|COMPLETED|Phase II||0
9100745|NCT01064648|10165822|FG003|COMPLETED|Phase II||0
9100746|NCT01064648|10165819|FG000|NOT COMPLETED|Phase II||0
9100747|NCT01064648|10165820|FG001|NOT COMPLETED|Phase II||0
9100748|NCT01064648|10165821|FG002|NOT COMPLETED|Phase II||49
9100749|NCT01064648|10165822|FG003|NOT COMPLETED|Phase II||48
9100750|NCT00593567|10165837|FG000|STARTED|Overall Study||48
9100751|NCT00593567|10165838|FG001|STARTED|Overall Study||22
9100752|NCT00593567|10165837|FG000|COMPLETED|Overall Study||28
9100753|NCT00593567|10165838|FG001|COMPLETED|Overall Study||12
9100754|NCT00593567|10165837|FG000|NOT COMPLETED|Overall Study||20
9100755|NCT00593567|10165838|FG001|NOT COMPLETED|Overall Study||10
9100756|NCT00588770|10165846|FG000|STARTED|Overall Study||200
9100757|NCT00588770|10165847|FG001|STARTED|Overall Study||203
9100758|NCT00588770|10165846|FG000|Eligible|Overall Study||188
9100759|NCT00588770|10165847|FG001|Eligible|Overall Study||183
9100760|NCT00588770|10165846|FG000|Start Protocol Therapy|Overall Study||200
9100761|NCT00588770|10165847|FG001|Start Protocol Therapy|Overall Study||194
9100762|NCT00588770|10165846|FG000|COMPLETED|Overall Study||41
9100763|NCT00588770|10165847|FG001|COMPLETED|Overall Study||3
9100764|NCT00588770|10165846|FG000|NOT COMPLETED|Overall Study||159
9100765|NCT00588770|10165847|FG001|NOT COMPLETED|Overall Study||200
9100766|NCT00412880|10165853|FG000|STARTED|Overall Study||23
9100767|NCT00412880|10165853|FG000|COMPLETED|Overall Study||0
9100768|NCT00412880|10165853|FG000|NOT COMPLETED|Overall Study||23
8625882|NCT00509821|9665505|FG001|NOT COMPLETED|Study Period 3 (Maintenance)||49
8625883|NCT00509821|9665504|FG000|STARTED|Study Period 4 (Follow Up)|1 Participant completed Maintenance Phase but did not enter Follow-Up.|2
8625884|NCT00509821|9665505|FG001|STARTED|Study Period 4 (Follow Up)|1 Participant completed Radiation Phase, did not enter Maintenance Phase but entered Follow Up.|50
8625885|NCT00509821|9665504|FG000|COMPLETED|Study Period 4 (Follow Up)||2
8625886|NCT00509821|9665505|FG001|COMPLETED|Study Period 4 (Follow Up)||50
8625887|NCT00509821|9665504|FG000|NOT COMPLETED|Study Period 4 (Follow Up)||0
8625888|NCT00509821|9665505|FG001|NOT COMPLETED|Study Period 4 (Follow Up)||0
8948143|NCT02427477|10010472|FG000|COMPLETED|Period 3||59
8948144|NCT02427477|10010473|FG001|COMPLETED|Period 3||60
8948145|NCT02427477|10010472|FG000|NOT COMPLETED|Period 3||0
8948146|NCT02427477|10010473|FG001|NOT COMPLETED|Period 3||0
8948147|NCT02427607|10010479|FG000|STARTED|Overall Study||7
8948148|NCT02427607|10010479|FG000|COMPLETED|Overall Study||6
8948149|NCT02427607|10010479|FG000|NOT COMPLETED|Overall Study||1
8948150|NCT02427646|10010485|FG000|STARTED|Overall Study||24
8948151|NCT02427646|10010486|FG001|STARTED|Overall Study||28
8948152|NCT02427646|10010485|FG000|COMPLETED|Overall Study||16
8948153|NCT02427646|10010486|FG001|COMPLETED|Overall Study||14
8948154|NCT02427646|10010485|FG000|NOT COMPLETED|Overall Study||8
8625889|NCT00509873|9665518|FG000|STARTED|Overall Study||287
8625890|NCT00509873|9665519|FG001|STARTED|Overall Study||291
8625891|NCT00509873|9665518|FG000|COMPLETED|Overall Study||276
8625892|NCT00509873|9665519|FG001|COMPLETED|Overall Study||276
8625893|NCT00509873|9665518|FG000|NOT COMPLETED|Overall Study||11
8625894|NCT00509873|9665519|FG001|NOT COMPLETED|Overall Study||15
8625895|NCT00509899|9665533|FG000|STARTED|Overall Study||30
8625896|NCT00509899|9665534|FG001|STARTED|Overall Study||35
8625897|NCT00509899|9665535|FG002|STARTED|Overall Study||47
8625898|NCT00509899|9665536|FG003|STARTED|Overall Study||5
8625899|NCT00509899|9665537|FG004|STARTED|Overall Study||6
8625900|NCT00509899|9665538|FG005|STARTED|Overall Study||22
8625901|NCT00509899|9665539|FG006|STARTED|Overall Study||6
8625902|NCT00509899|9665540|FG007|STARTED|Overall Study||3
8625903|NCT00509899|9665533|FG000|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|14
8629542|NCT00530842|9669304|FG001|NOT COMPLETED|Period 1||11
8723631|NCT01024231|9771141|FG004|NOT COMPLETED|Overall Study||17
8723632|NCT01024231|9771142|FG005|NOT COMPLETED|Overall Study||16
8723633|NCT01024231|9771143|FG006|NOT COMPLETED|Overall Study||21
8723634|NCT01024244|9771169|FG000|STARTED|Overall Study||22
8723635|NCT01024244|9771170|FG001|STARTED|Overall Study||12
8723636|NCT01024244|9771171|FG002|STARTED|Overall Study||15
8723637|NCT01024244|9771172|FG003|STARTED|Overall Study||14
8723638|NCT01024244|9771173|FG004|STARTED|Overall Study||15
8723639|NCT01024244|9771169|FG000|COMPLETED|Overall Study||5
8723640|NCT01024244|9771170|FG001|COMPLETED|Overall Study||1
8723641|NCT01024244|9771171|FG002|COMPLETED|Overall Study||1
8723642|NCT01024244|9771172|FG003|COMPLETED|Overall Study||1
8723643|NCT01024244|9771173|FG004|COMPLETED|Overall Study||1
8948155|NCT02427646|10010486|FG001|NOT COMPLETED|Overall Study||14
8723644|NCT01024244|9771169|FG000|NOT COMPLETED|Overall Study||17
8723645|NCT01024244|9771170|FG001|NOT COMPLETED|Overall Study||11
8723646|NCT01024244|9771171|FG002|NOT COMPLETED|Overall Study||14
8948156|NCT02427672|10010496|FG000|STARTED|Overall Study||40
8723647|NCT01024244|9771172|FG003|NOT COMPLETED|Overall Study||13
8723648|NCT01024244|9771173|FG004|NOT COMPLETED|Overall Study||14
8723649|NCT01024296|9771185|FG000|STARTED|Overall Study||4
8723650|NCT01024296|9771185|FG000|COMPLETED|Overall Study||4
8723651|NCT01024296|9771185|FG000|NOT COMPLETED|Overall Study||0
8723652|NCT01024309|9771191|FG000|STARTED|Overall Study||35
8723653|NCT01024309|9771192|FG001|STARTED|Overall Study||31
8723654|NCT01024309|9771191|FG000|COMPLETED|Overall Study||27
8723655|NCT01024309|9771192|FG001|COMPLETED|Overall Study||27
8723656|NCT01024309|9771191|FG000|NOT COMPLETED|Overall Study||8
8723657|NCT01024309|9771192|FG001|NOT COMPLETED|Overall Study||4
8723658|NCT01024335|9771200|FG000|STARTED|Overall Study||20
8723659|NCT01024335|9771201|FG001|STARTED|Overall Study||40
8723660|NCT01024335|9771200|FG000|COMPLETED|Overall Study||7
8723661|NCT01024335|9771201|FG001|COMPLETED|Overall Study||14
8723662|NCT01024335|9771200|FG000|NOT COMPLETED|Overall Study||13
8723663|NCT01024335|9771201|FG001|NOT COMPLETED|Overall Study||26
8723664|NCT01024387|9771207|FG000|STARTED|Overall Study||60
8723665|NCT01024387|9771207|FG000|Evaluable for PFS|Overall Study||54
8723666|NCT01024387|9771207|FG000|Evaluable for Response|Overall Study||53
8723667|NCT01024387|9771207|FG000|COMPLETED|Overall Study||0
8723668|NCT01024387|9771207|FG000|NOT COMPLETED|Overall Study||60
8723669|NCT01024465|9771211|FG000|STARTED|Overall Study||26
8723670|NCT01024465|9771211|FG000|COMPLETED|Overall Study||23
8723671|NCT01024465|9771211|FG000|NOT COMPLETED|Overall Study||3
8723672|NCT01024569|9771217|FG000|STARTED|Overall Study||276
8723673|NCT01024569|9771218|FG001|STARTED|Overall Study||279
8723674|NCT01024569|9771217|FG000|COMPLETED|Overall Study||251
8723675|NCT01024569|9771218|FG001|COMPLETED|Overall Study||268
8723676|NCT01024569|9771217|FG000|NOT COMPLETED|Overall Study||25
8723677|NCT01024569|9771218|FG001|NOT COMPLETED|Overall Study||11
8723678|NCT01024686|9771229|FG000|STARTED|Overall Study|July 11, 2010: unexpected adverse event, (1) participant|6
8723679|NCT01024686|9771230|FG001|STARTED|Overall Study||0
8723680|NCT01024686|9771231|FG002|STARTED|Overall Study||0
8723681|NCT01024686|9771229|FG000|COMPLETED|Overall Study||6
8723682|NCT01024686|9771230|FG001|COMPLETED|Overall Study|(0) participants because the clinical trial was terminated prior to enrollment.|0
8723683|NCT01024686|9771231|FG002|COMPLETED|Overall Study|(0) participants because the clinical trial was terminated prior to enrollment.|0
8723684|NCT01024686|9771229|FG000|NOT COMPLETED|Overall Study||0
8723685|NCT01024686|9771230|FG001|NOT COMPLETED|Overall Study||0
8625904|NCT00509899|9665534|FG001|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|26
8625905|NCT00509899|9665535|FG002|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|27
8625906|NCT00509899|9665536|FG003|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|1
8629543|NCT00530842|9669303|FG000|STARTED|Period 2||157
8625907|NCT00509899|9665537|FG004|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|1
8625908|NCT00509899|9665538|FG005|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|12
8625909|NCT00509899|9665539|FG006|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|5
8625910|NCT00509899|9665540|FG007|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|2
8625911|NCT00509899|9665533|FG000|NOT COMPLETED|Overall Study||16
8625912|NCT00509899|9665534|FG001|NOT COMPLETED|Overall Study||9
8625913|NCT00509899|9665535|FG002|NOT COMPLETED|Overall Study||20
8625914|NCT00509899|9665536|FG003|NOT COMPLETED|Overall Study||4
8625915|NCT00509899|9665537|FG004|NOT COMPLETED|Overall Study||5
8625916|NCT00509899|9665538|FG005|NOT COMPLETED|Overall Study||10
8625917|NCT00509899|9665539|FG006|NOT COMPLETED|Overall Study||1
8625918|NCT00509899|9665540|FG007|NOT COMPLETED|Overall Study||1
8625919|NCT00509925|9665554|FG000|STARTED|Overall Study||12
8625920|NCT00509925|9665555|FG001|STARTED|Overall Study||11
8625921|NCT00509925|9665554|FG000|COMPLETED|Overall Study||12
8625922|NCT00509925|9665555|FG001|COMPLETED|Overall Study||10
8625923|NCT00509925|9665554|FG000|NOT COMPLETED|Overall Study||0
8625924|NCT00509925|9665555|FG001|NOT COMPLETED|Overall Study||1
8625925|NCT00510068|9665565|FG000|STARTED|Double-blind Period||207
8625926|NCT00510068|9665566|FG001|STARTED|Double-blind Period||203
8625927|NCT00510068|9665565|FG000|Safety Population|Double-blind Period||204
8625928|NCT00510068|9665566|FG001|Safety Population|Double-blind Period||203
8625929|NCT00510068|9665565|FG000|COMPLETED|Double-blind Period||0
8625930|NCT00510068|9665566|FG001|COMPLETED|Double-blind Period||0
8625931|NCT00510068|9665565|FG000|NOT COMPLETED|Double-blind Period||207
8625932|NCT00510068|9665566|FG001|NOT COMPLETED|Double-blind Period||203
8625933|NCT00510068|9665565|FG000|STARTED|Open-label Period|172 patients switched over from placebo & 53 who were initially randomized to Everolimus arm.|225
8625934|NCT00510068|9665566|FG001|STARTED|Open-label Period||0
8625935|NCT00510068|9665565|FG000|COMPLETED|Open-label Period||0
8625936|NCT00510068|9665566|FG001|COMPLETED|Open-label Period||0
8625937|NCT00510068|9665565|FG000|NOT COMPLETED|Open-label Period||225
8625938|NCT00510068|9665566|FG001|NOT COMPLETED|Open-label Period||0
8625939|NCT00510146|9665576|FG000|STARTED|Double-Blind Treatment||343
8625940|NCT00510146|9665577|FG001|STARTED|Double-Blind Treatment||171
8625941|NCT00510146|9665576|FG000|COMPLETED|Double-Blind Treatment||267
8625942|NCT00510146|9665577|FG001|COMPLETED|Double-Blind Treatment||122
8625943|NCT00510146|9665576|FG000|NOT COMPLETED|Double-Blind Treatment||76
8625944|NCT00510146|9665577|FG001|NOT COMPLETED|Double-Blind Treatment||49
8625945|NCT00510146|9665576|FG000|STARTED|Open-Label Treatment||267
8625946|NCT00510146|9665577|FG001|STARTED|Open-Label Treatment||122
8625947|NCT00510146|9665576|FG000|COMPLETED|Open-Label Treatment||196
8625948|NCT00510146|9665577|FG001|COMPLETED|Open-Label Treatment||96
8625949|NCT00510146|9665576|FG000|NOT COMPLETED|Open-Label Treatment||71
8845917|NCT01717768|9900351|FG004|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
8845918|NCT01717768|9900352|FG005|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
8625950|NCT00510146|9665577|FG001|NOT COMPLETED|Open-Label Treatment||26
8625951|NCT00510198|9665587|FG000|STARTED|Overall Study||59
8845919|NCT01717768|9900353|FG006|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||17
8625952|NCT00510198|9665588|FG001|STARTED|Overall Study||58
8625953|NCT00510198|9665587|FG000|COMPLETED|Overall Study||54
8625954|NCT00510198|9665588|FG001|COMPLETED|Overall Study||54
8845920|NCT01717768|9900354|FG007|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
8845921|NCT01717768|9900355|FG008|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||16
8845922|NCT01717768|9900356|FG009|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
8845923|NCT01717768|9900357|FG010|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||16
8845924|NCT01717768|9900358|FG011|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||15
8845925|NCT01717768|9900347|FG000|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
8845926|NCT01717768|9900348|FG001|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
8845927|NCT01717768|9900349|FG002|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
8845928|NCT01717768|9900350|FG003|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
8845929|NCT01717768|9900351|FG004|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
8845930|NCT01717768|9900352|FG005|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
8625955|NCT00510198|9665587|FG000|NOT COMPLETED|Overall Study||5
8556876|NCT03760146|9588651|FG005|NOT COMPLETED|Overall Study||8
8556877|NCT03760081|9588671|FG000|STARTED|Overall Study||6
8556878|NCT03760081|9588672|FG001|STARTED|Overall Study||13
8556879|NCT03760081|9588671|FG000|COMPLETED|Overall Study||0
8556880|NCT03760081|9588672|FG001|COMPLETED|Overall Study||1
8556881|NCT03760081|9588671|FG000|NOT COMPLETED|Overall Study||6
8556882|NCT03760081|9588672|FG001|NOT COMPLETED|Overall Study||12
8556883|NCT03737110|9588682|FG000|STARTED|Run-in (RI) Period||86
8556884|NCT03737110|9588683|FG001|STARTED|Run-in (RI) Period||0
8556885|NCT03737110|9588684|FG002|STARTED|Run-in (RI) Period||0
8625956|NCT00510198|9665588|FG001|NOT COMPLETED|Overall Study||4
8845931|NCT01717768|9900353|FG006|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
8845932|NCT01717768|9900354|FG007|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
8845933|NCT01717768|9900355|FG008|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
8845934|NCT01717768|9900356|FG009|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
8845935|NCT01717768|9900357|FG010|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
8845936|NCT01717768|9900358|FG011|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||1
8845937|NCT01717768|9900347|FG000|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
8845938|NCT01717768|9900348|FG001|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
8845939|NCT01717768|9900349|FG002|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
8845940|NCT01717768|9900350|FG003|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
8845941|NCT01717768|9900351|FG004|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
8625957|NCT00510224|9665596|FG000|STARTED|Overall Study||13
8625958|NCT00510224|9665596|FG000|COMPLETED|Overall Study||10
8625959|NCT00510224|9665596|FG000|NOT COMPLETED|Overall Study||3
8625960|NCT00510276|9665602|FG000|STARTED|Acute Double-Blind Phase||220
8625961|NCT00510276|9665603|FG001|STARTED|Acute Double-Blind Phase||225
8625962|NCT00510276|9665602|FG000|COMPLETED|Acute Double-Blind Phase||115
8625963|NCT00510276|9665603|FG001|COMPLETED|Acute Double-Blind Phase||130
8625964|NCT00510276|9665602|FG000|NOT COMPLETED|Acute Double-Blind Phase||105
8625965|NCT00510276|9665603|FG001|NOT COMPLETED|Acute Double-Blind Phase||95
8625966|NCT00510276|9665602|FG000|STARTED|Extension Open-Label Phase|4 patients who completed acute phase did not participate in the optional atomoxetine extension phase|111
8625967|NCT00510276|9665603|FG001|STARTED|Extension Open-Label Phase|1 patient who completed acute phase did not participate in the optional atometine extension phase|129
8625968|NCT00510276|9665602|FG000|COMPLETED|Extension Open-Label Phase||78
8845942|NCT01717768|9900352|FG005|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
8845943|NCT01717768|9900353|FG006|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
8845944|NCT01717768|9900354|FG007|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||17
8845945|NCT01717768|9900355|FG008|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
8845946|NCT01717768|9900356|FG009|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||16
8845947|NCT01717768|9900357|FG010|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
8845948|NCT01717768|9900358|FG011|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
8948157|NCT02427672|10010497|FG001|STARTED|Overall Study||44
8845949|NCT01717768|9900347|FG000|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
8845950|NCT01717768|9900348|FG001|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
8625969|NCT00510276|9665603|FG001|COMPLETED|Extension Open-Label Phase||81
8625970|NCT00510276|9665602|FG000|NOT COMPLETED|Extension Open-Label Phase||33
8625971|NCT00510276|9665603|FG001|NOT COMPLETED|Extension Open-Label Phase||48
8625972|NCT00510289|9665616|FG000|STARTED|Overall Study|All patients who consented|19
8625973|NCT00510289|9665616|FG000|Started Study Drug|Overall Study|3 patients progressed prior to starting study drug|16
8625974|NCT00510289|9665616|FG000|COMPLETED|Overall Study|Completed at least one cycle of study drug and had disease assessments|7
8625975|NCT00510289|9665616|FG000|NOT COMPLETED|Overall Study||12
8625976|NCT00510458|9665621|FG000|STARTED|Overall Study||74
8625977|NCT00510458|9665621|FG000|COMPLETED|Overall Study||27
8625978|NCT00510458|9665621|FG000|NOT COMPLETED|Overall Study||47
8625979|NCT00510484|9665628|FG000|STARTED|Period 1||16
8625980|NCT00510484|9665629|FG001|STARTED|Period 1||16
8625981|NCT00510484|9665628|FG000|COMPLETED|Period 1||16
8625982|NCT00510484|9665629|FG001|COMPLETED|Period 1||16
8625983|NCT00510484|9665628|FG000|NOT COMPLETED|Period 1||0
8625984|NCT00510484|9665629|FG001|NOT COMPLETED|Period 1||0
8625985|NCT00510484|9665628|FG000|STARTED|Wash-out Period||16
8625986|NCT00510484|9665629|FG001|STARTED|Wash-out Period||16
8625987|NCT00510484|9665628|FG000|COMPLETED|Wash-out Period||16
8625988|NCT00510484|9665629|FG001|COMPLETED|Wash-out Period||15
8625989|NCT00510484|9665628|FG000|NOT COMPLETED|Wash-out Period||0
8625990|NCT00510484|9665629|FG001|NOT COMPLETED|Wash-out Period||1
8625991|NCT00510484|9665628|FG000|STARTED|Period 2||16
8625992|NCT00510484|9665629|FG001|STARTED|Period 2||15
8625993|NCT00510484|9665628|FG000|COMPLETED|Period 2||16
8625994|NCT00510484|9665629|FG001|COMPLETED|Period 2||15
8625995|NCT00510484|9665628|FG000|NOT COMPLETED|Period 2||0
8625996|NCT00510484|9665629|FG001|NOT COMPLETED|Period 2||0
8625997|NCT00510497|9665635|FG000|STARTED|Overall Study||11
8625998|NCT00510497|9665635|FG000|COMPLETED|Overall Study||8
8625999|NCT00510497|9665635|FG000|NOT COMPLETED|Overall Study||3
8626000|NCT00510510|9665642|FG000|STARTED|Overall Study||92
8626001|NCT00510510|9665643|FG001|STARTED|Overall Study||98
8626002|NCT00510510|9665644|FG002|STARTED|Overall Study||91
8626003|NCT00510510|9665642|FG000|COMPLETED|Overall Study||87
8626004|NCT00510510|9665643|FG001|COMPLETED|Overall Study||89
8626005|NCT00510510|9665644|FG002|COMPLETED|Overall Study||74
8626006|NCT00510510|9665642|FG000|NOT COMPLETED|Overall Study||5
8626007|NCT00510510|9665643|FG001|NOT COMPLETED|Overall Study||9
8626008|NCT00510510|9665644|FG002|NOT COMPLETED|Overall Study||17
8626009|NCT00510653|9665652|FG000|STARTED|Overall Study||24
8626010|NCT00510653|9665652|FG000|COMPLETED|Overall Study||13
8626011|NCT00510653|9665652|FG000|NOT COMPLETED|Overall Study||11
8626012|NCT00510692|9665658|FG000|STARTED|Overall Study||29
8626013|NCT00510692|9665659|FG001|STARTED|Overall Study||29
8626014|NCT00510692|9665658|FG000|COMPLETED|Overall Study||27
8626015|NCT00510692|9665659|FG001|COMPLETED|Overall Study||26
8626016|NCT00510692|9665658|FG000|NOT COMPLETED|Overall Study||2
8626017|NCT00510692|9665659|FG001|NOT COMPLETED|Overall Study||3
8626018|NCT00510718|9665674|FG000|STARTED|Single Dose Period: 1 Week||15
8626019|NCT00510718|9665675|FG001|STARTED|Single Dose Period: 1 Week||12
8626020|NCT00510718|9665674|FG000|30 mg/Day|Single Dose Period: 1 Week||3
8626021|NCT00510718|9665675|FG001|30 mg/Day|Single Dose Period: 1 Week||0
8626022|NCT00510718|9665674|FG000|60 mg/Day|Single Dose Period: 1 Week||3
8626023|NCT00510718|9665675|FG001|60 mg/Day|Single Dose Period: 1 Week||0
8626024|NCT00510718|9665674|FG000|150/160 mg/Day|Single Dose Period: 1 Week||2
8626025|NCT00510718|9665675|FG001|150/160 mg/Day|Single Dose Period: 1 Week||1
8626026|NCT00510718|9665674|FG000|240 mg/Day|Single Dose Period: 1 Week||3
8626027|NCT00510718|9665675|FG001|240 mg/Day|Single Dose Period: 1 Week||0
8626028|NCT00510718|9665674|FG000|360 mg/Day|Single Dose Period: 1 Week||4
8626029|NCT00510718|9665675|FG001|360 mg/Day|Single Dose Period: 1 Week||2
8626030|NCT00510718|9665674|FG000|480 mg/Day|Single Dose Period: 1 Week||0
8626031|NCT00510718|9665675|FG001|480 mg/Day|Single Dose Period: 1 Week||6
8626032|NCT00510718|9665674|FG000|600 mg/Day|Single Dose Period: 1 Week||0
8626033|NCT00510718|9665675|FG001|600 mg/Day|Single Dose Period: 1 Week||3
8626034|NCT00510718|9665674|FG000|COMPLETED|Single Dose Period: 1 Week||15
8626035|NCT00510718|9665675|FG001|COMPLETED|Single Dose Period: 1 Week||12
8626036|NCT00510718|9665674|FG000|NOT COMPLETED|Single Dose Period: 1 Week||0
8626037|NCT00510718|9665675|FG001|NOT COMPLETED|Single Dose Period: 1 Week||0
8626038|NCT00510718|9665674|FG000|STARTED|Multiple Dose Period: 12 Weeks|Participants who completed single dose period + new participants enrolled in multiple dose period.|65
8626039|NCT00510718|9665675|FG001|STARTED|Multiple Dose Period: 12 Weeks|Participants who completed single dose period + new participants enrolled in multiple dose period.|75
8626040|NCT00510718|9665674|FG000|30 mg/Day|Multiple Dose Period: 12 Weeks||3
8626041|NCT00510718|9665675|FG001|30 mg/Day|Multiple Dose Period: 12 Weeks||0
8626042|NCT00510718|9665674|FG000|60 mg/Day|Multiple Dose Period: 12 Weeks||15
8626043|NCT00510718|9665675|FG001|60 mg/Day|Multiple Dose Period: 12 Weeks||12
8626044|NCT00510718|9665674|FG000|150/160 mg/Day|Multiple Dose Period: 12 Weeks||15
8626045|NCT00510718|9665675|FG001|150/160 mg/Day|Multiple Dose Period: 12 Weeks||13
8626046|NCT00510718|9665674|FG000|240 mg/Day|Multiple Dose Period: 12 Weeks||17
8626047|NCT00510718|9665675|FG001|240 mg/Day|Multiple Dose Period: 12 Weeks||12
8626048|NCT00510718|9665674|FG000|360 mg/Day|Multiple Dose Period: 12 Weeks||15
8626049|NCT00510718|9665675|FG001|360 mg/Day|Multiple Dose Period: 12 Weeks||13
8626050|NCT00510718|9665674|FG000|480 mg/Day|Multiple Dose Period: 12 Weeks||0
8626051|NCT00510718|9665675|FG001|480 mg/Day|Multiple Dose Period: 12 Weeks||22
8626052|NCT00510718|9665674|FG000|600 mg/Day|Multiple Dose Period: 12 Weeks||0
8626053|NCT00510718|9665675|FG001|600 mg/Day|Multiple Dose Period: 12 Weeks||3
8626054|NCT00510718|9665674|FG000|COMPLETED|Multiple Dose Period: 12 Weeks||50
8626055|NCT00510718|9665675|FG001|COMPLETED|Multiple Dose Period: 12 Weeks||43
8626056|NCT00510718|9665674|FG000|NOT COMPLETED|Multiple Dose Period: 12 Weeks||15
8626057|NCT00510718|9665675|FG001|NOT COMPLETED|Multiple Dose Period: 12 Weeks||32
8626058|NCT00510744|9665694|FG000|STARTED|Overall Study||5
8626059|NCT00510744|9665694|FG000|COMPLETED|Overall Study||5
8626060|NCT00510744|9665694|FG000|NOT COMPLETED|Overall Study||0
8626061|NCT00510783|9665700|FG000|STARTED|Overall Study||82
8626062|NCT00510783|9665701|FG001|STARTED|Overall Study||76
8626063|NCT00510783|9665700|FG000|COMPLETED|Overall Study||51
8626064|NCT00510783|9665701|FG001|COMPLETED|Overall Study||47
8626065|NCT00510783|9665700|FG000|NOT COMPLETED|Overall Study||31
8626066|NCT00510783|9665701|FG001|NOT COMPLETED|Overall Study||29
8626067|NCT00510809|9665710|FG000|STARTED|Overall Study||18
8626068|NCT00510809|9665711|FG001|STARTED|Overall Study||18
8626069|NCT00510809|9665712|FG002|STARTED|Overall Study||18
8626070|NCT00510809|9665710|FG000|COMPLETED|Overall Study||18
8626071|NCT00510809|9665711|FG001|COMPLETED|Overall Study||18
8626072|NCT00510809|9665712|FG002|COMPLETED|Overall Study||18
8626073|NCT00510809|9665710|FG000|NOT COMPLETED|Overall Study||0
8626074|NCT00510809|9665711|FG001|NOT COMPLETED|Overall Study||0
8626075|NCT00510809|9665712|FG002|NOT COMPLETED|Overall Study||0
8626076|NCT00510835|9665723|FG000|STARTED|Overall Study||445
8626077|NCT00510835|9665724|FG001|STARTED|Overall Study||448
8626078|NCT00510835|9665725|FG002|STARTED|Overall Study||458
8626079|NCT00510835|9665723|FG000|COMPLETED|Overall Study||439
8626080|NCT00510835|9665724|FG001|COMPLETED|Overall Study||446
8626081|NCT00510835|9665725|FG002|COMPLETED|Overall Study||456
8626082|NCT00510835|9665723|FG000|NOT COMPLETED|Overall Study||6
8626083|NCT00510835|9665724|FG001|NOT COMPLETED|Overall Study||2
8626084|NCT00510835|9665725|FG002|NOT COMPLETED|Overall Study||2
8626085|NCT00510874|9665740|FG000|STARTED|Overall Study||78
8556886|NCT03737110|9588682|FG000|Continue to RW Period|Run-in (RI) Period||61
8556887|NCT03737110|9588683|FG001|Continue to RW Period|Run-in (RI) Period||0
8556888|NCT03737110|9588684|FG002|Continue to RW Period|Run-in (RI) Period||0
8556889|NCT03737110|9588682|FG000|Continue Directly to LTE Period|Run-in (RI) Period||15
8626086|NCT00510874|9665741|FG001|STARTED|Overall Study||152
8626087|NCT00510874|9665742|FG002|STARTED|Overall Study||151
8626088|NCT00510874|9665743|FG003|STARTED|Overall Study||151
8626089|NCT00510874|9665744|FG004|STARTED|Overall Study||148
8626090|NCT00510874|9665745|FG005|STARTED|Overall Study||50
8626091|NCT00510874|9665746|FG006|STARTED|Overall Study||50
8626092|NCT00510874|9665740|FG000|COMPLETED|Overall Study|Upto Day 182|75
8626093|NCT00510874|9665741|FG001|COMPLETED|Overall Study|Upto Day 182|148
8556890|NCT03737110|9588683|FG001|Continue Directly to LTE Period|Run-in (RI) Period||0
8556891|NCT03737110|9588684|FG002|Continue Directly to LTE Period|Run-in (RI) Period||0
8556892|NCT03737110|9588682|FG000|COMPLETED|Run-in (RI) Period||76
8556893|NCT03737110|9588683|FG001|COMPLETED|Run-in (RI) Period||0
8556894|NCT03737110|9588684|FG002|COMPLETED|Run-in (RI) Period||0
8556895|NCT03737110|9588682|FG000|NOT COMPLETED|Run-in (RI) Period||10
8556896|NCT03737110|9588683|FG001|NOT COMPLETED|Run-in (RI) Period||0
8556897|NCT03737110|9588684|FG002|NOT COMPLETED|Run-in (RI) Period||0
8556898|NCT03737110|9588682|FG000|STARTED|Randomized Withdrawal (RW) Period||0
8556899|NCT03737110|9588683|FG001|STARTED|Randomized Withdrawal (RW) Period||30
8556900|NCT03737110|9588684|FG002|STARTED|Randomized Withdrawal (RW) Period||31
8556901|NCT03737110|9588682|FG000|COMPLETED|Randomized Withdrawal (RW) Period||0
8556902|NCT03737110|9588683|FG001|COMPLETED|Randomized Withdrawal (RW) Period||29
8556903|NCT03737110|9588684|FG002|COMPLETED|Randomized Withdrawal (RW) Period||30
8556904|NCT03737110|9588682|FG000|NOT COMPLETED|Randomized Withdrawal (RW) Period||0
8556905|NCT03737110|9588683|FG001|NOT COMPLETED|Randomized Withdrawal (RW) Period||1
8556906|NCT03737110|9588684|FG002|NOT COMPLETED|Randomized Withdrawal (RW) Period||1
8556907|NCT03737110|9588682|FG000|STARTED|Long-Term Extension (LTE) Period|Participants who entered the LTE directly from RI after protocol-specified 22 adjudicated pericarditis recurrence events had accrued.|15
8556908|NCT03737110|9588683|FG001|STARTED|Long-Term Extension (LTE) Period|1 participant withdrew consent prior to entering LTE.|29
8556909|NCT03737110|9588684|FG002|STARTED|Long-Term Extension (LTE) Period||30
8556910|NCT03737110|9588682|FG000|COMPLETED|Long-Term Extension (LTE) Period||0
8556911|NCT03737110|9588683|FG001|COMPLETED|Long-Term Extension (LTE) Period||0
8556912|NCT03737110|9588684|FG002|COMPLETED|Long-Term Extension (LTE) Period||0
8556913|NCT03737110|9588682|FG000|NOT COMPLETED|Long-Term Extension (LTE) Period||15
8556914|NCT03737110|9588683|FG001|NOT COMPLETED|Long-Term Extension (LTE) Period||29
8556915|NCT03737110|9588684|FG002|NOT COMPLETED|Long-Term Extension (LTE) Period||30
8556916|NCT03713684|9588706|FG000|STARTED|Overall Study||92
8626094|NCT00510874|9665742|FG002|COMPLETED|Overall Study|Upto Day 182|150
8626095|NCT00510874|9665743|FG003|COMPLETED|Overall Study|Upto Day 182|148
8626096|NCT00510874|9665744|FG004|COMPLETED|Overall Study|Upto Day 182|141
8626097|NCT00510874|9665745|FG005|COMPLETED|Overall Study|Upto Day 182|50
8626098|NCT00510874|9665746|FG006|COMPLETED|Overall Study|Upto Day 182|49
8626099|NCT00510874|9665740|FG000|NOT COMPLETED|Overall Study||3
8626100|NCT00510874|9665741|FG001|NOT COMPLETED|Overall Study||4
8626101|NCT00510874|9665742|FG002|NOT COMPLETED|Overall Study||1
8626102|NCT00510874|9665743|FG003|NOT COMPLETED|Overall Study||3
8626103|NCT00510874|9665744|FG004|NOT COMPLETED|Overall Study||7
8626104|NCT00510874|9665745|FG005|NOT COMPLETED|Overall Study||0
8626105|NCT00510874|9665746|FG006|NOT COMPLETED|Overall Study||1
8626106|NCT00510887|9665763|FG000|STARTED|Overall Study||12
8626107|NCT00510887|9665763|FG000|COMPLETED|Overall Study||11
8626108|NCT00510887|9665763|FG000|NOT COMPLETED|Overall Study||1
8626109|NCT00510952|9665769|FG000|STARTED|Overall Study||235
8626110|NCT00510952|9665770|FG001|STARTED|Overall Study||236
8626111|NCT00510952|9665769|FG000|Full Analysis Set (Intent to Treat)|Overall Study||229
8629544|NCT00530842|9669304|FG001|STARTED|Period 2||160
8626112|NCT00510952|9665770|FG001|Full Analysis Set (Intent to Treat)|Overall Study||229
8626113|NCT00510952|9665769|FG000|COMPLETED|Overall Study||209
8626114|NCT00510952|9665770|FG001|COMPLETED|Overall Study||220
8626115|NCT00510952|9665769|FG000|NOT COMPLETED|Overall Study||26
8626116|NCT00510952|9665770|FG001|NOT COMPLETED|Overall Study||16
8626117|NCT00511004|9665779|FG000|STARTED|Overall Study||13
8626118|NCT00511004|9665780|FG001|STARTED|Overall Study||13
8626119|NCT00511004|9665781|FG002|STARTED|Overall Study||14
8626120|NCT00511004|9665779|FG000|COMPLETED|Overall Study||13
8626121|NCT00511004|9665780|FG001|COMPLETED|Overall Study||13
8626122|NCT00511004|9665781|FG002|COMPLETED|Overall Study||10
8626123|NCT00511004|9665779|FG000|NOT COMPLETED|Overall Study||0
8626124|NCT00511004|9665780|FG001|NOT COMPLETED|Overall Study||0
8626125|NCT00511004|9665781|FG002|NOT COMPLETED|Overall Study||4
8626126|NCT00511095|9665792|FG000|STARTED|Overall Study||207
8626127|NCT00511095|9665792|FG000|COMPLETED|Overall Study||196
8626128|NCT00511095|9665792|FG000|NOT COMPLETED|Overall Study||11
8626129|NCT00511108|9665806|FG000|STARTED|Overall Study||52
8626130|NCT00511108|9665807|FG001|STARTED|Overall Study||54
8626131|NCT00511108|9665808|FG002|STARTED|Overall Study||52
8626132|NCT00511108|9665809|FG003|STARTED|Overall Study||53
8626133|NCT00511108|9665806|FG000|COMPLETED|Overall Study||46
8626134|NCT00511108|9665807|FG001|COMPLETED|Overall Study||52
8626135|NCT00511108|9665808|FG002|COMPLETED|Overall Study||47
8626136|NCT00511108|9665809|FG003|COMPLETED|Overall Study||48
8626137|NCT00511108|9665806|FG000|NOT COMPLETED|Overall Study||6
8626138|NCT00511108|9665807|FG001|NOT COMPLETED|Overall Study||2
8626139|NCT00511108|9665808|FG002|NOT COMPLETED|Overall Study||5
8626140|NCT00511108|9665809|FG003|NOT COMPLETED|Overall Study||5
8626141|NCT00511147|9665819|FG000|STARTED|Overall Study||64
8626142|NCT00511147|9665819|FG000|COMPLETED|Overall Study||57
8626143|NCT00511147|9665819|FG000|NOT COMPLETED|Overall Study||7
8626144|NCT00511173|9665823|FG000|STARTED|Overall Study||102
8626145|NCT00511173|9665823|FG000|COMPLETED|Overall Study||102
8626146|NCT00511173|9665823|FG000|NOT COMPLETED|Overall Study||0
8626147|NCT00511238|9665830|FG000|STARTED|Overall Study||46
8845951|NCT01717768|9900349|FG002|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
8845952|NCT01717768|9900350|FG003|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
8845953|NCT01717768|9900351|FG004|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
8845954|NCT01717768|9900352|FG005|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
8845955|NCT01717768|9900353|FG006|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
8845956|NCT01717768|9900354|FG007|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||15
8845957|NCT01717768|9900355|FG008|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
8845958|NCT01717768|9900356|FG009|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||15
8845959|NCT01717768|9900357|FG010|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
8845960|NCT01717768|9900358|FG011|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
8845961|NCT01717768|9900347|FG000|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
8845962|NCT01717768|9900348|FG001|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
8845963|NCT01717768|9900349|FG002|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
8845964|NCT01717768|9900350|FG003|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
8845965|NCT01717768|9900351|FG004|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
8850491|NCT01746784|9905683|FG002|COMPLETED|Overall Study||9
8626148|NCT00511238|9665831|FG001|STARTED|Overall Study||266
8626149|NCT00511238|9665830|FG000|COMPLETED|Overall Study|Number of patients who completed 12 cycles of treatment|4
8626150|NCT00511238|9665831|FG001|COMPLETED|Overall Study|Number of patients who completed 12 cycles of treatment|40
8626151|NCT00511238|9665830|FG000|NOT COMPLETED|Overall Study||42
8626152|NCT00511238|9665831|FG001|NOT COMPLETED|Overall Study||226
8626153|NCT00511472|9665849|FG000|STARTED|Overall Study||47
8626154|NCT00511472|9665850|FG001|STARTED|Overall Study||23
8723686|NCT01024686|9771231|FG002|NOT COMPLETED|Overall Study||0
8723687|NCT01024738|9771242|FG000|STARTED|First Intervention:||7
8723688|NCT01024738|9771243|FG001|STARTED|First Intervention:||7
8723689|NCT01024738|9771244|FG002|STARTED|First Intervention:||8
8723690|NCT01024738|9771242|FG000|COMPLETED|First Intervention:||7
8723691|NCT01024738|9771243|FG001|COMPLETED|First Intervention:||7
8626155|NCT00511472|9665849|FG000|COMPLETED|Overall Study||44
8626156|NCT00511472|9665850|FG001|COMPLETED|Overall Study||17
8626157|NCT00511472|9665849|FG000|NOT COMPLETED|Overall Study||3
8626158|NCT00511472|9665850|FG001|NOT COMPLETED|Overall Study||6
8626159|NCT00511667|9665867|FG000|STARTED|Overall Study||52
8626160|NCT00511667|9665868|FG001|STARTED|Overall Study||18
8626161|NCT00511667|9665867|FG000|COMPLETED|Overall Study||40
8626162|NCT00511667|9665868|FG001|COMPLETED|Overall Study||15
8626163|NCT00511667|9665867|FG000|NOT COMPLETED|Overall Study||12
8626164|NCT00511667|9665868|FG001|NOT COMPLETED|Overall Study||3
8626165|NCT00511706|9665882|FG000|STARTED|Overall Study||123
8626166|NCT00511706|9665883|FG001|STARTED|Overall Study||120
8626167|NCT00511706|9665882|FG000|COMPLETED|Overall Study||115
8626168|NCT00511706|9665883|FG001|COMPLETED|Overall Study||115
8626169|NCT00511706|9665882|FG000|NOT COMPLETED|Overall Study||8
8626170|NCT00511706|9665883|FG001|NOT COMPLETED|Overall Study||5
8626171|NCT00511797|9665893|FG000|STARTED|Overall Study||62
8626172|NCT00511797|9665894|FG001|STARTED|Overall Study||63
8626173|NCT00511797|9665895|FG002|STARTED|Overall Study||62
8626174|NCT00511797|9665896|FG003|STARTED|Overall Study||62
8626175|NCT00511797|9665893|FG000|Subjects Dispensed Drugs|Overall Study||61
8626176|NCT00511797|9665894|FG001|Subjects Dispensed Drugs|Overall Study||63
8626177|NCT00511797|9665895|FG002|Subjects Dispensed Drugs|Overall Study||61
8626178|NCT00511797|9665896|FG003|Subjects Dispensed Drugs|Overall Study||59
8626179|NCT00511797|9665893|FG000|Subjects Received Treatment|Overall Study|FAS|61
8845966|NCT01717768|9900352|FG005|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
8845967|NCT01717768|9900353|FG006|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
8845968|NCT01717768|9900354|FG007|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||2
8845969|NCT01717768|9900355|FG008|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
8845970|NCT01717768|9900356|FG009|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||1
8845971|NCT01717768|9900357|FG010|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
8845972|NCT01717768|9900358|FG011|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
8948158|NCT02427672|10010496|FG000|COMPLETED|Overall Study||39
8626180|NCT00511797|9665894|FG001|Subjects Received Treatment|Overall Study|FAS|62
8626181|NCT00511797|9665895|FG002|Subjects Received Treatment|Overall Study|FAS|61
8626182|NCT00511797|9665896|FG003|Subjects Received Treatment|Overall Study|FAS|58
8845973|NCT01717859|9900384|FG000|STARTED|Overall Study||54
8626183|NCT00511797|9665893|FG000|COMPLETED|Overall Study||55
8626184|NCT00511797|9665894|FG001|COMPLETED|Overall Study||55
8626185|NCT00511797|9665895|FG002|COMPLETED|Overall Study||51
8626186|NCT00511797|9665896|FG003|COMPLETED|Overall Study||47
8626187|NCT00511797|9665893|FG000|NOT COMPLETED|Overall Study||7
8626188|NCT00511797|9665894|FG001|NOT COMPLETED|Overall Study||8
8626189|NCT00511797|9665895|FG002|NOT COMPLETED|Overall Study||11
8626190|NCT00511797|9665896|FG003|NOT COMPLETED|Overall Study||15
8626191|NCT00511810|9665908|FG000|STARTED|Overall Study||8
8626192|NCT00511810|9665909|FG001|STARTED|Overall Study||12
8626193|NCT00511810|9665908|FG000|COMPLETED|Overall Study||7
8629545|NCT00530842|9669303|FG000|COMPLETED|Period 2||149
8629546|NCT00530842|9669304|FG001|COMPLETED|Period 2||151
8626194|NCT00511810|9665909|FG001|COMPLETED|Overall Study|2 terminated for worsening symptoms;1 refused a scan;2 lost to follow up (could not be contacted)|7
8626195|NCT00511810|9665908|FG000|NOT COMPLETED|Overall Study||1
8626196|NCT00511810|9665909|FG001|NOT COMPLETED|Overall Study||5
8626197|NCT00511836|9665917|FG000|STARTED|Double-blind Period||16
8626198|NCT00511836|9665918|FG001|STARTED|Double-blind Period||15
8626199|NCT00511836|9665917|FG000|COMPLETED|Double-blind Period||15
8626200|NCT00511836|9665918|FG001|COMPLETED|Double-blind Period||15
8626201|NCT00511836|9665917|FG000|NOT COMPLETED|Double-blind Period||1
8626202|NCT00511836|9665918|FG001|NOT COMPLETED|Double-blind Period||0
8626203|NCT00511836|9665917|FG000|STARTED|Optional Open-label VIVITROL (2 Months)|Subjects who received placebo during Month 1 switched to VIVITROL for the optional extension phase.|22
8626204|NCT00511836|9665918|FG001|STARTED|Optional Open-label VIVITROL (2 Months)|Not all subjects from the double-blind phase entered the optional open-label extension.|0
8626205|NCT00511836|9665917|FG000|COMPLETED|Optional Open-label VIVITROL (2 Months)||6
8626206|NCT00511836|9665918|FG001|COMPLETED|Optional Open-label VIVITROL (2 Months)||0
8626207|NCT00511836|9665917|FG000|NOT COMPLETED|Optional Open-label VIVITROL (2 Months)||16
8626208|NCT00511836|9665918|FG001|NOT COMPLETED|Optional Open-label VIVITROL (2 Months)||0
8626209|NCT00511862|9665928|FG000|STARTED|Overall Study||61
8626210|NCT00511862|9665929|FG001|STARTED|Overall Study||43
8626211|NCT00511862|9665930|FG002|STARTED|Overall Study||47
8626212|NCT00511862|9665928|FG000|COMPLETED|Overall Study||61
8626213|NCT00511862|9665929|FG001|COMPLETED|Overall Study||43
8626214|NCT00511862|9665930|FG002|COMPLETED|Overall Study||47
8626215|NCT00511862|9665928|FG000|NOT COMPLETED|Overall Study||0
8626216|NCT00511862|9665929|FG001|NOT COMPLETED|Overall Study||0
8626217|NCT00511862|9665930|FG002|NOT COMPLETED|Overall Study||0
8626218|NCT00511875|9665942|FG000|STARTED|Overall Study||15
8626219|NCT00511875|9665943|FG001|STARTED|Overall Study||15
8626220|NCT00511875|9665942|FG000|COMPLETED|Overall Study||10
8626221|NCT00511875|9665943|FG001|COMPLETED|Overall Study||15
8626222|NCT00511875|9665942|FG000|NOT COMPLETED|Overall Study||5
8626223|NCT00511875|9665943|FG001|NOT COMPLETED|Overall Study||0
8626224|NCT00511901|9665951|FG000|STARTED|Overall Study||11
8626225|NCT00511901|9665952|FG001|STARTED|Overall Study||11
8626226|NCT00511901|9665951|FG000|COMPLETED|Overall Study||10
8626227|NCT00511901|9665952|FG001|COMPLETED|Overall Study||8
8626228|NCT00511901|9665951|FG000|NOT COMPLETED|Overall Study||1
8626229|NCT00511901|9665952|FG001|NOT COMPLETED|Overall Study||3
8626230|NCT00511914|9665960|FG000|STARTED|Overall Study||68
8626231|NCT00511914|9665961|FG001|STARTED|Overall Study||67
8626232|NCT00511914|9665960|FG000|COMPLETED|Overall Study||68
8626233|NCT00511914|9665961|FG001|COMPLETED|Overall Study||67
8626234|NCT00511914|9665960|FG000|NOT COMPLETED|Overall Study||0
8626235|NCT00511914|9665961|FG001|NOT COMPLETED|Overall Study||0
8626236|NCT00511992|9665967|FG000|STARTED|Overall Study||20
8626237|NCT00511992|9665967|FG000|COMPLETED|Overall Study||13
8626238|NCT00511992|9665967|FG000|NOT COMPLETED|Overall Study||7
8626239|NCT00512096|9665971|FG000|STARTED|Overall Study||30
8626240|NCT00512096|9665971|FG000|COMPLETED|Overall Study||23
8626241|NCT00512096|9665971|FG000|NOT COMPLETED|Overall Study||7
8626242|NCT00512135|9665975|FG000|STARTED|Overall Study||801
8626243|NCT00512135|9665975|FG000|Treated|Overall Study||796
8626244|NCT00512135|9665975|FG000|COMPLETED|Overall Study||717
8626245|NCT00512135|9665975|FG000|NOT COMPLETED|Overall Study||84
8626246|NCT00512148|9665980|FG000|STARTED|Primay Study Period||7
8626247|NCT00512148|9665980|FG000|COMPLETED|Primay Study Period||6
8626248|NCT00512148|9665980|FG000|NOT COMPLETED|Primay Study Period||1
8626249|NCT00512148|9665980|FG000|STARTED|Long Term Follow Up Period||6
8626250|NCT00512148|9665980|FG000|COMPLETED|Long Term Follow Up Period|6 patients are being followed in long term follow up|0
8626251|NCT00512148|9665980|FG000|NOT COMPLETED|Long Term Follow Up Period||6
8626252|NCT00512252|9665989|FG000|STARTED|Overall Study||3
8626253|NCT00512252|9665990|FG001|STARTED|Overall Study||3
8626254|NCT00512252|9665991|FG002|STARTED|Overall Study||46
8626255|NCT00512252|9665989|FG000|COMPLETED|Overall Study||3
8626256|NCT00512252|9665990|FG001|COMPLETED|Overall Study||3
8626257|NCT00512252|9665991|FG002|COMPLETED|Overall Study||43
8626258|NCT00512252|9665989|FG000|NOT COMPLETED|Overall Study||0
8626259|NCT00512252|9665990|FG001|NOT COMPLETED|Overall Study||0
8626260|NCT00512252|9665991|FG002|NOT COMPLETED|Overall Study||3
8626261|NCT00512278|9666008|FG000|STARTED|Overall Study||73
8626262|NCT00512278|9666009|FG001|STARTED|Overall Study||73
8626263|NCT00512278|9666008|FG000|COMPLETED|Overall Study||45
8626264|NCT00512278|9666009|FG001|COMPLETED|Overall Study||56
8626265|NCT00512278|9666008|FG000|NOT COMPLETED|Overall Study||28
8626266|NCT00512278|9666009|FG001|NOT COMPLETED|Overall Study||17
8626267|NCT00512707|9666019|FG000|STARTED|Overall Study||70
8626268|NCT00512707|9666020|FG001|STARTED|Overall Study||70
8626269|NCT00512707|9666019|FG000|COMPLETED|Overall Study||60
8626270|NCT00512707|9666020|FG001|COMPLETED|Overall Study||58
8626271|NCT00512707|9666019|FG000|NOT COMPLETED|Overall Study||10
8626272|NCT00512707|9666020|FG001|NOT COMPLETED|Overall Study||12
8626273|NCT00512798|9666028|FG000|STARTED|Overall Study||19
8626274|NCT00512798|9666029|FG001|STARTED|Overall Study||28
8626275|NCT00512798|9666028|FG000|COMPLETED|Overall Study||0
8626276|NCT00512798|9666029|FG001|COMPLETED|Overall Study||1
8626277|NCT00512798|9666028|FG000|NOT COMPLETED|Overall Study||19
8626278|NCT00512798|9666029|FG001|NOT COMPLETED|Overall Study||27
8629547|NCT00530842|9669303|FG000|NOT COMPLETED|Period 2||8
8629548|NCT00530842|9669304|FG001|NOT COMPLETED|Period 2||9
8629549|NCT00530855|9669312|FG000|STARTED|Overall Study||322
8629550|NCT00530855|9669312|FG000|COMPLETED|Overall Study||210
8629551|NCT00530855|9669312|FG000|NOT COMPLETED|Overall Study||112
8629552|NCT00530894|9669320|FG000|STARTED|Overall Study||348
8629553|NCT00530894|9669321|FG001|STARTED|Overall Study||351
8629554|NCT00530894|9669322|FG002|STARTED|Overall Study||179
8629555|NCT00530894|9669323|FG003|STARTED|Overall Study||179
8629556|NCT00530894|9669320|FG000|COMPLETED|Overall Study||260
8629557|NCT00530894|9669321|FG001|COMPLETED|Overall Study||236
8629558|NCT00530894|9669322|FG002|COMPLETED|Overall Study||124
8629559|NCT00530894|9669323|FG003|COMPLETED|Overall Study||85
8626279|NCT00512876|9666036|FG000|STARTED|Overall Study||24
8626280|NCT00512876|9666036|FG000|COMPLETED|Overall Study||20
8626281|NCT00512876|9666036|FG000|NOT COMPLETED|Overall Study||4
8626282|NCT00512902|9666040|FG000|STARTED|Overall Study||20
8626283|NCT00512902|9666040|FG000|COMPLETED|Overall Study||12
8626284|NCT00512902|9666040|FG000|NOT COMPLETED|Overall Study||8
8626285|NCT00513019|9666046|FG000|STARTED|Overall Study||17
8626286|NCT00513019|9666047|FG001|STARTED|Overall Study||18
8626287|NCT00513019|9666046|FG000|COMPLETED|Overall Study||12
8626288|NCT00513019|9666047|FG001|COMPLETED|Overall Study||13
8626289|NCT00513019|9666046|FG000|NOT COMPLETED|Overall Study||5
8626290|NCT00513019|9666047|FG001|NOT COMPLETED|Overall Study||5
8626291|NCT00513071|9666053|FG000|STARTED|Overall Study||28
8626292|NCT00513071|9666053|FG000|COMPLETED|Overall Study||23
8626293|NCT00513071|9666053|FG000|NOT COMPLETED|Overall Study||5
8626294|NCT00513240|9666059|FG000|STARTED|Overall Study|3 did not have intended surgery; 28 had all 3 doses; 4 had 1 dose but no more due to delayed surgery|35
8626295|NCT00513240|9666060|FG001|STARTED|Overall Study|25 had 3 doses; 1 had 1 dose due to rash; 1 had 2 doses and 1 dose of EPO due to pharmacy error|27
8626296|NCT00513240|9666059|FG000|Clinical Data Collection &Pre/Postop MRI|Overall Study|3 not having intended surgery are subtracted from original 35 subjects, leaving 32|32
8626297|NCT00513240|9666060|FG001|Clinical Data Collection &Pre/Postop MRI|Overall Study||27
8626298|NCT00513240|9666059|FG000|COMPLETED|Overall Study|Competed 12 month neurodevelopmental exam, which are the only results published at this time.|22
8626299|NCT00513240|9666060|FG001|COMPLETED|Overall Study|Competed 12 month neurodevelopmental exam, which are the only results published at this time.|20
8626300|NCT00513240|9666059|FG000|NOT COMPLETED|Overall Study||13
8626301|NCT00513240|9666060|FG001|NOT COMPLETED|Overall Study||7
8626302|NCT00513292|9666071|FG000|STARTED|Overall Study||138
8626303|NCT00513292|9666072|FG001|STARTED|Overall Study||142
8626304|NCT00513292|9666071|FG000|COMPLETED|Overall Study||138
8626305|NCT00513292|9666072|FG001|COMPLETED|Overall Study||142
8626306|NCT00513292|9666071|FG000|NOT COMPLETED|Overall Study||0
8626307|NCT00513292|9666072|FG001|NOT COMPLETED|Overall Study||0
8626308|NCT00513305|9666080|FG000|STARTED|Overall Study||33
8626309|NCT00513305|9666081|FG001|STARTED|Overall Study|One subject withdrew prior to receiving study medication|34
8626310|NCT00513305|9666080|FG000|COMPLETED|Overall Study||5
8626311|NCT00513305|9666081|FG001|COMPLETED|Overall Study||7
8626312|NCT00513305|9666080|FG000|NOT COMPLETED|Overall Study||28
8626313|NCT00513305|9666081|FG001|NOT COMPLETED|Overall Study||27
8626314|NCT00513344|9666087|FG000|STARTED|Diet Restriction (3 Days)||5
8626315|NCT00513344|9666087|FG000|COMPLETED|Diet Restriction (3 Days)||5
8626316|NCT00513344|9666087|FG000|NOT COMPLETED|Diet Restriction (3 Days)||0
8626317|NCT00513344|9666087|FG000|STARTED|1st Intervention 1 Day||5
8626318|NCT00513344|9666087|FG000|COMPLETED|1st Intervention 1 Day||5
8626319|NCT00513344|9666087|FG000|NOT COMPLETED|1st Intervention 1 Day||0
8626320|NCT00513344|9666087|FG000|STARTED|Washout Period 3 Days||5
8626321|NCT00513344|9666087|FG000|COMPLETED|Washout Period 3 Days||5
8626322|NCT00513344|9666087|FG000|NOT COMPLETED|Washout Period 3 Days||0
8626323|NCT00513344|9666087|FG000|STARTED|2nd Intervention 1 Day||5
8626324|NCT00513344|9666087|FG000|COMPLETED|2nd Intervention 1 Day||5
8626325|NCT00513344|9666087|FG000|NOT COMPLETED|2nd Intervention 1 Day||0
8626326|NCT00513344|9666087|FG000|STARTED|Washout Period 3 Days||5
8626327|NCT00513344|9666087|FG000|COMPLETED|Washout Period 3 Days||5
8626328|NCT00513344|9666087|FG000|NOT COMPLETED|Washout Period 3 Days||0
8626329|NCT00513344|9666087|FG000|STARTED|3rd Intervention 1 Day||5
8626330|NCT00513344|9666087|FG000|COMPLETED|3rd Intervention 1 Day||5
8845974|NCT01717859|9900384|FG000|3 Month|Overall Study||50
8845975|NCT01717859|9900384|FG000|COMPLETED|Overall Study||44
8845976|NCT01717859|9900384|FG000|NOT COMPLETED|Overall Study||10
8845977|NCT01717872|9900397|FG000|STARTED|Overall Study||25
8845978|NCT01717872|9900398|FG001|STARTED|Overall Study||25
8626331|NCT00513344|9666087|FG000|NOT COMPLETED|3rd Intervention 1 Day||0
8626332|NCT00513357|9666097|FG000|STARTED|Overall Study||38
8626333|NCT00513357|9666098|FG001|STARTED|Overall Study||35
8626334|NCT00513357|9666097|FG000|COMPLETED|Overall Study||23
8626335|NCT00513357|9666098|FG001|COMPLETED|Overall Study||25
8626336|NCT00513357|9666097|FG000|NOT COMPLETED|Overall Study||15
8626337|NCT00513357|9666098|FG001|NOT COMPLETED|Overall Study||10
8626338|NCT00513370|9666104|FG000|STARTED|Overall Study||203
8626339|NCT00513370|9666104|FG000|COMPLETED|Overall Study||179
8626340|NCT00513370|9666104|FG000|NOT COMPLETED|Overall Study||24
8626341|NCT00513409|9666112|FG000|STARTED|Overall Study||84
8626342|NCT00513409|9666113|FG001|STARTED|Overall Study||79
8626343|NCT00513409|9666112|FG000|COMPLETED|Overall Study||82
8626344|NCT00513409|9666113|FG001|COMPLETED|Overall Study||73
8626345|NCT00513409|9666112|FG000|NOT COMPLETED|Overall Study||2
8626346|NCT00513409|9666113|FG001|NOT COMPLETED|Overall Study||6
8626347|NCT00513435|9666119|FG000|STARTED|Overall Study||9
8626348|NCT00513435|9666119|FG000|COMPLETED|Overall Study||9
8626349|NCT00513435|9666119|FG000|NOT COMPLETED|Overall Study||0
8626350|NCT00513461|9666125|FG000|STARTED|Overall Study||57
8626351|NCT00513461|9666126|FG001|STARTED|Overall Study||53
8626352|NCT00513461|9666125|FG000|COMPLETED|Overall Study||44
8626353|NCT00513461|9666126|FG001|COMPLETED|Overall Study||43
8626354|NCT00513461|9666125|FG000|NOT COMPLETED|Overall Study||13
8626355|NCT00513461|9666126|FG001|NOT COMPLETED|Overall Study||10
8626356|NCT00513474|9666134|FG000|STARTED|Overall Study||25
8626357|NCT00513474|9666135|FG001|STARTED|Overall Study||21
8626358|NCT00513474|9666134|FG000|Received Rasburicase Per Protocol|Overall Study||24
8626359|NCT00513474|9666135|FG001|Received Rasburicase Per Protocol|Overall Study||0
8626360|NCT00513474|9666134|FG000|COMPLETED|Overall Study||18
8626361|NCT00513474|9666135|FG001|COMPLETED|Overall Study||12
8626362|NCT00513474|9666134|FG000|NOT COMPLETED|Overall Study||7
8626363|NCT00513474|9666135|FG001|NOT COMPLETED|Overall Study||9
8626364|NCT00513500|9666143|FG000|STARTED|Overall Study||1017
8626365|NCT00513500|9666144|FG001|STARTED|Overall Study||2108
8626366|NCT00513500|9666143|FG000|COMPLETED|Overall Study||976
8626367|NCT00513500|9666144|FG001|COMPLETED|Overall Study||2054
8626368|NCT00513500|9666143|FG000|NOT COMPLETED|Overall Study||41
8626369|NCT00513500|9666144|FG001|NOT COMPLETED|Overall Study||54
8626370|NCT00513526|9666150|FG000|STARTED|Overall Study||109
8626371|NCT00513526|9666150|FG000|COMPLETED|Overall Study||92
8626372|NCT00513526|9666150|FG000|NOT COMPLETED|Overall Study||17
8626373|NCT00513604|9666161|FG000|STARTED|Overall Study|Cohort 1 = unselected TIL|26
8626374|NCT00513604|9666162|FG001|STARTED|Overall Study|Cohort 2 = CD4+ depleted (selected) TIL|39
8626375|NCT00513604|9666163|FG002|STARTED|Overall Study|Cohort 3 = CD4+ depleted (selected) TIL + 600Gy radiation|24
8626376|NCT00513604|9666164|FG003|STARTED|Overall Study|Cohort 4 = unselected TIL - it is the SAME as cohort 1|34
8626377|NCT00513604|9666165|FG004|STARTED|Overall Study|Cohort 5 = CD4+ depleted TIL-it is the SAME as cohort 2|35
8626378|NCT00513604|9666161|FG000|COMPLETED|Overall Study||24
8626379|NCT00513604|9666162|FG001|COMPLETED|Overall Study||36
8626380|NCT00513604|9666163|FG002|COMPLETED|Overall Study||21
8626381|NCT00513604|9666164|FG003|COMPLETED|Overall Study||34
8626382|NCT00513604|9666165|FG004|COMPLETED|Overall Study||35
8626383|NCT00513604|9666161|FG000|NOT COMPLETED|Overall Study||2
8626384|NCT00513604|9666162|FG001|NOT COMPLETED|Overall Study||3
8626385|NCT00513604|9666163|FG002|NOT COMPLETED|Overall Study||3
8845979|NCT01717872|9900397|FG000|COMPLETED|Overall Study||25
8845980|NCT01717872|9900398|FG001|COMPLETED|Overall Study||25
8626386|NCT00513604|9666164|FG003|NOT COMPLETED|Overall Study||0
8845981|NCT01717872|9900397|FG000|NOT COMPLETED|Overall Study||0
8626387|NCT00513604|9666165|FG004|NOT COMPLETED|Overall Study||0
8626388|NCT00513682|9666177|FG000|STARTED|Screening Phase||9
8626389|NCT00513682|9666177|FG000|COMPLETED|Screening Phase||9
8626390|NCT00513682|9666177|FG000|NOT COMPLETED|Screening Phase||0
8626391|NCT00513682|9666177|FG000|STARTED|Washout Phase||9
8626392|NCT00513682|9666177|FG000|COMPLETED|Washout Phase||7
8626393|NCT00513682|9666177|FG000|NOT COMPLETED|Washout Phase||2
8626394|NCT00513682|9666177|FG000|STARTED|Treatment Phase||7
8626395|NCT00513682|9666177|FG000|COMPLETED|Treatment Phase||7
8626396|NCT00513682|9666177|FG000|NOT COMPLETED|Treatment Phase||0
8626397|NCT00513695|9666184|FG000|STARTED|Overall Study||68
8626398|NCT00513695|9666184|FG000|COMPLETED|Overall Study||63
8626399|NCT00513695|9666184|FG000|NOT COMPLETED|Overall Study||5
8626400|NCT00513708|9666191|FG000|STARTED|Overall Study||50
8626401|NCT00513708|9666192|FG001|STARTED|Overall Study||50
8626402|NCT00513708|9666193|FG002|STARTED|Overall Study||50
8626403|NCT00513708|9666191|FG000|COMPLETED|Overall Study||46
8626404|NCT00513708|9666192|FG001|COMPLETED|Overall Study||46
8626405|NCT00513708|9666193|FG002|COMPLETED|Overall Study||46
8626406|NCT00513708|9666191|FG000|NOT COMPLETED|Overall Study||4
8626407|NCT00513708|9666192|FG001|NOT COMPLETED|Overall Study||4
8626408|NCT00513708|9666193|FG002|NOT COMPLETED|Overall Study||4
8626409|NCT00513747|9666204|FG000|STARTED|Overall Study||17
8626410|NCT00513747|9666205|FG001|STARTED|Overall Study||11
8626411|NCT00513747|9666206|FG002|STARTED|Overall Study||55
8626412|NCT00513747|9666204|FG000|Received at Least One Dose of Treatment|Overall Study||9
8626413|NCT00513747|9666205|FG001|Received at Least One Dose of Treatment|Overall Study||11
8626414|NCT00513747|9666206|FG002|Received at Least One Dose of Treatment|Overall Study||40
8626415|NCT00513747|9666204|FG000|COMPLETED|Overall Study||17
8626416|NCT00513747|9666205|FG001|COMPLETED|Overall Study||11
8626417|NCT00513747|9666206|FG002|COMPLETED|Overall Study||55
8626418|NCT00513747|9666204|FG000|NOT COMPLETED|Overall Study||0
8626419|NCT00513747|9666205|FG001|NOT COMPLETED|Overall Study||0
8626420|NCT00513747|9666206|FG002|NOT COMPLETED|Overall Study||0
8626421|NCT00513799|9666220|FG000|STARTED|One-Month Follow-Up||75
8626422|NCT00513799|9666221|FG001|STARTED|One-Month Follow-Up||75
8626423|NCT00513799|9666222|FG002|STARTED|One-Month Follow-Up||75
8626424|NCT00513799|9666223|FG003|STARTED|One-Month Follow-Up||75
8626425|NCT00513799|9666220|FG000|COMPLETED|One-Month Follow-Up||64
8626426|NCT00513799|9666221|FG001|COMPLETED|One-Month Follow-Up||62
8626427|NCT00513799|9666222|FG002|COMPLETED|One-Month Follow-Up||64
8626428|NCT00513799|9666223|FG003|COMPLETED|One-Month Follow-Up||54
8626429|NCT00513799|9666220|FG000|NOT COMPLETED|One-Month Follow-Up||11
8626430|NCT00513799|9666221|FG001|NOT COMPLETED|One-Month Follow-Up||13
8626431|NCT00513799|9666222|FG002|NOT COMPLETED|One-Month Follow-Up||11
8845982|NCT01717872|9900398|FG001|NOT COMPLETED|Overall Study||0
8845983|NCT01717898|9900408|FG000|STARTED|Overall Study||6
8845984|NCT01717898|9900409|FG001|STARTED|Overall Study|Study was terminated during Phase I, Dose level 1 due to toxicity.|0
8626432|NCT00513799|9666223|FG003|NOT COMPLETED|One-Month Follow-Up||21
8626433|NCT00513799|9666220|FG000|STARTED|Four-Month Follow-Up||64
8845985|NCT01717898|9900410|FG002|STARTED|Overall Study|Study was terminated during Phase I, Dose level 1 due to toxicity.|0
8626434|NCT00513799|9666221|FG001|STARTED|Four-Month Follow-Up||62
8626435|NCT00513799|9666222|FG002|STARTED|Four-Month Follow-Up||64
8626436|NCT00513799|9666223|FG003|STARTED|Four-Month Follow-Up||54
8626437|NCT00513799|9666220|FG000|COMPLETED|Four-Month Follow-Up||64
8626438|NCT00513799|9666221|FG001|COMPLETED|Four-Month Follow-Up||57
8626439|NCT00513799|9666222|FG002|COMPLETED|Four-Month Follow-Up||57
8626440|NCT00513799|9666223|FG003|COMPLETED|Four-Month Follow-Up||51
8626441|NCT00513799|9666220|FG000|NOT COMPLETED|Four-Month Follow-Up||0
8626442|NCT00513799|9666221|FG001|NOT COMPLETED|Four-Month Follow-Up||5
8626443|NCT00513799|9666222|FG002|NOT COMPLETED|Four-Month Follow-Up||7
8626444|NCT00513799|9666223|FG003|NOT COMPLETED|Four-Month Follow-Up||3
8626445|NCT00514020|9666237|FG000|STARTED|Overall Study|two patients withdrew before treatment; one withdrew after treatment|33
8626446|NCT00514020|9666237|FG000|COMPLETED|Overall Study||5
8626447|NCT00514020|9666237|FG000|NOT COMPLETED|Overall Study||28
8626448|NCT00514046|9666250|FG000|STARTED|Overall Study||5
8626449|NCT00514046|9666251|FG001|STARTED|Overall Study||1
8626450|NCT00514046|9666252|FG002|STARTED|Overall Study||5
8626451|NCT00514046|9666253|FG003|STARTED|Overall Study||1
8626452|NCT00514046|9666254|FG004|STARTED|Overall Study||1
8626453|NCT00514046|9666255|FG005|STARTED|Overall Study||1
8626454|NCT00514046|9666256|FG006|STARTED|Overall Study||1
8626455|NCT00514046|9666257|FG007|STARTED|Overall Study||1
8626456|NCT00514046|9666258|FG008|STARTED|Overall Study||1
8626457|NCT00514046|9666250|FG000|COMPLETED|Overall Study||2
8626458|NCT00514046|9666251|FG001|COMPLETED|Overall Study||0
8626459|NCT00514046|9666252|FG002|COMPLETED|Overall Study||0
8626460|NCT00514046|9666253|FG003|COMPLETED|Overall Study||1
8626461|NCT00514046|9666254|FG004|COMPLETED|Overall Study||0
8626462|NCT00514046|9666255|FG005|COMPLETED|Overall Study||0
8626463|NCT00514046|9666256|FG006|COMPLETED|Overall Study||1
8626464|NCT00514046|9666257|FG007|COMPLETED|Overall Study||0
8626465|NCT00514046|9666258|FG008|COMPLETED|Overall Study||0
8626466|NCT00514046|9666250|FG000|NOT COMPLETED|Overall Study||3
8626467|NCT00514046|9666251|FG001|NOT COMPLETED|Overall Study||1
8626468|NCT00514046|9666252|FG002|NOT COMPLETED|Overall Study||5
8626469|NCT00514046|9666253|FG003|NOT COMPLETED|Overall Study||0
8626470|NCT00514046|9666254|FG004|NOT COMPLETED|Overall Study||1
8626471|NCT00514046|9666255|FG005|NOT COMPLETED|Overall Study||1
8626472|NCT00514046|9666256|FG006|NOT COMPLETED|Overall Study||0
8626473|NCT00514046|9666257|FG007|NOT COMPLETED|Overall Study||1
8626474|NCT00514046|9666258|FG008|NOT COMPLETED|Overall Study||1
8626475|NCT00514137|9666280|FG000|STARTED|Overall Study||13
8626476|NCT00514137|9666280|FG000|COMPLETED|Overall Study||13
8626477|NCT00514137|9666280|FG000|NOT COMPLETED|Overall Study||0
8626478|NCT00514215|9666284|FG000|STARTED|Overall Study||8
8626479|NCT00514215|9666284|FG000|COMPLETED|Overall Study||8
8626480|NCT00514215|9666284|FG000|NOT COMPLETED|Overall Study||0
8626481|NCT00514449|9666290|FG000|STARTED|Overall Study||12
8626482|NCT00514449|9666291|FG001|STARTED|Overall Study||12
8626483|NCT00514449|9666290|FG000|COMPLETED|Overall Study||9
8626484|NCT00514449|9666291|FG001|COMPLETED|Overall Study||8
8626485|NCT00514449|9666290|FG000|NOT COMPLETED|Overall Study||3
8626486|NCT00514449|9666291|FG001|NOT COMPLETED|Overall Study||4
8626487|NCT00514501|9666300|FG000|STARTED|Overall Study||510
8626488|NCT00514501|9666300|FG000|COMPLETED|Overall Study||507
8626489|NCT00514501|9666300|FG000|NOT COMPLETED|Overall Study||3
8626490|NCT00514514|9666307|FG000|STARTED|Pre-phase|All enrolled patients received standard regimen for 3 months|802
8626491|NCT00514514|9666308|FG001|STARTED|Pre-phase||0
8626492|NCT00514514|9666309|FG002|STARTED|Pre-phase||0
8626493|NCT00514514|9666307|FG000|COMPLETED|Pre-phase||499
8723692|NCT01024738|9771244|FG002|COMPLETED|First Intervention:||8
8723693|NCT01024738|9771242|FG000|NOT COMPLETED|First Intervention:||0
8723694|NCT01024738|9771243|FG001|NOT COMPLETED|First Intervention:||0
8723695|NCT01024738|9771244|FG002|NOT COMPLETED|First Intervention:||0
8723696|NCT01024738|9771242|FG000|STARTED|Washout After 1st Intervention||7
8723697|NCT01024738|9771243|FG001|STARTED|Washout After 1st Intervention||7
8723698|NCT01024738|9771244|FG002|STARTED|Washout After 1st Intervention||8
8723699|NCT01024738|9771242|FG000|COMPLETED|Washout After 1st Intervention||7
8723700|NCT01024738|9771243|FG001|COMPLETED|Washout After 1st Intervention||7
8626494|NCT00514514|9666308|FG001|COMPLETED|Pre-phase||0
8626495|NCT00514514|9666309|FG002|COMPLETED|Pre-phase||0
8626496|NCT00514514|9666307|FG000|NOT COMPLETED|Pre-phase||303
8626497|NCT00514514|9666308|FG001|NOT COMPLETED|Pre-phase||0
8626498|NCT00514514|9666309|FG002|NOT COMPLETED|Pre-phase||0
8626499|NCT00514514|9666307|FG000|STARTED|Randomized - 9 Month||166
8626500|NCT00514514|9666308|FG001|STARTED|Randomized - 9 Month||171
8626501|NCT00514514|9666309|FG002|STARTED|Randomized - 9 Month||162
8626502|NCT00514514|9666307|FG000|Randomized - Received Treatment|Randomized - 9 Month||165
8626503|NCT00514514|9666308|FG001|Randomized - Received Treatment|Randomized - 9 Month||171
8626504|NCT00514514|9666309|FG002|Randomized - Received Treatment|Randomized - 9 Month||161
8626505|NCT00514514|9666307|FG000|COMPLETED|Randomized - 9 Month||127
8626506|NCT00514514|9666308|FG001|COMPLETED|Randomized - 9 Month||110
8626507|NCT00514514|9666309|FG002|COMPLETED|Randomized - 9 Month||124
8845986|NCT01717898|9900411|FG003|STARTED|Overall Study|Study was terminated during Phase I, Dose level 1 due to toxicity.|0
8845987|NCT01717898|9900408|FG000|COMPLETED|Overall Study|Study was terminated during Phase I, Dose level 1 due to toxicity.|0
8845988|NCT01717898|9900409|FG001|COMPLETED|Overall Study||0
8845989|NCT01717898|9900410|FG002|COMPLETED|Overall Study||0
8845990|NCT01717898|9900411|FG003|COMPLETED|Overall Study||0
8845991|NCT01717898|9900408|FG000|NOT COMPLETED|Overall Study||6
8845992|NCT01717898|9900409|FG001|NOT COMPLETED|Overall Study||0
8845993|NCT01717898|9900410|FG002|NOT COMPLETED|Overall Study||0
8845994|NCT01717898|9900411|FG003|NOT COMPLETED|Overall Study||0
8845995|NCT01717976|9900423|FG000|STARTED|Overall Study||257
8845996|NCT01717976|9900424|FG001|STARTED|Overall Study||257
8845997|NCT01717976|9900423|FG000|COMPLETED|Overall Study||257
8845998|NCT01717976|9900424|FG001|COMPLETED|Overall Study||256
8845999|NCT01717976|9900423|FG000|NOT COMPLETED|Overall Study||0
8846000|NCT01717976|9900424|FG001|NOT COMPLETED|Overall Study||1
8846001|NCT01717989|9900430|FG000|STARTED|Overall Study||2248
8846002|NCT01717989|9900430|FG000|COMPLETED|Overall Study||1182
8846003|NCT01717989|9900430|FG000|NOT COMPLETED|Overall Study||1066
8846004|NCT01718028|9900451|FG000|STARTED|Overall Study||25
8846005|NCT01718028|9900452|FG001|STARTED|Overall Study||24
8846006|NCT01718028|9900451|FG000|COMPLETED|Overall Study||25
8846007|NCT01718028|9900452|FG001|COMPLETED|Overall Study||24
8846008|NCT01718028|9900451|FG000|NOT COMPLETED|Overall Study||0
8846009|NCT01718028|9900452|FG001|NOT COMPLETED|Overall Study||0
8846010|NCT01718353|9900460|FG000|STARTED|Overall Study||41
8846011|NCT01718353|9900461|FG001|STARTED|Overall Study||22
8846012|NCT01718353|9900460|FG000|Treated|Overall Study||39
8846013|NCT01718353|9900461|FG001|Treated|Overall Study||22
8846014|NCT01718353|9900460|FG000|Treated up to End of Cycle 4|Overall Study|7 participants discontinued before Cycle 5|32
8846015|NCT01718353|9900461|FG001|Treated up to End of Cycle 4|Overall Study|6 participants discontinued before Cycle 5|16
8846016|NCT01718353|9900460|FG000|Treated From Cycle 5|Overall Study|12 participants switched from Treatment A to B & 3 participants switched from Treatment B to A.|23
8846017|NCT01718353|9900461|FG001|Treated From Cycle 5|Overall Study|3 participants switched from Treatment B to A & 12 participants switched from Treatment A to B.|25
8846018|NCT01718353|9900460|FG000|COMPLETED|Overall Study|Participants at study cut-off, Adverse Event (AE), DP & consent withdrawn were considered completed.|29
8846019|NCT01718353|9900461|FG001|COMPLETED|Overall Study|Participants at study cut-off, AE, DP and consent withdrawn were considered completed.|17
8846020|NCT01718353|9900460|FG000|NOT COMPLETED|Overall Study||12
8846021|NCT01718353|9900461|FG001|NOT COMPLETED|Overall Study||5
8846022|NCT01718483|9900471|FG000|STARTED|Overall Study||191
8846023|NCT01718483|9900472|FG001|STARTED|Overall Study||192
8846024|NCT01718483|9900471|FG000|Treated|Overall Study||187
8846025|NCT01718483|9900472|FG001|Treated|Overall Study||192
8846026|NCT01718483|9900471|FG000|COMPLETED|Overall Study||157
8846027|NCT01718483|9900472|FG001|COMPLETED|Overall Study||158
8846028|NCT01718483|9900471|FG000|NOT COMPLETED|Overall Study||34
8846029|NCT01718483|9900472|FG001|NOT COMPLETED|Overall Study||34
8846030|NCT01718509|9900480|FG000|STARTED|Overall Study||195
8846031|NCT01718509|9900481|FG001|STARTED|Overall Study||195
8846032|NCT01718509|9900480|FG000|COMPLETED|Overall Study||147
8846033|NCT01718509|9900481|FG001|COMPLETED|Overall Study||147
8846034|NCT01718509|9900480|FG000|NOT COMPLETED|Overall Study||48
8846035|NCT01718509|9900481|FG001|NOT COMPLETED|Overall Study||48
8846036|NCT01718522|9900487|FG000|STARTED|Overall Study||75
8846037|NCT01718522|9900487|FG000|COMPLETED|Overall Study||67
8846038|NCT01718522|9900487|FG000|NOT COMPLETED|Overall Study||8
8846039|NCT01718535|9900504|FG000|STARTED|Overall Study||131
8846040|NCT01718535|9900505|FG001|STARTED|Overall Study||95
8846041|NCT01718535|9900506|FG002|STARTED|Overall Study||19
8846042|NCT01718535|9900507|FG003|STARTED|Overall Study||8
8846043|NCT01718535|9900508|FG004|STARTED|Overall Study||1
8846044|NCT01718535|9900509|FG005|STARTED|Overall Study||40
8846045|NCT01718535|9900510|FG006|STARTED|Overall Study||11
8846046|NCT01718535|9900511|FG007|STARTED|Overall Study||6
8846047|NCT01718535|9900512|FG008|STARTED|Overall Study||15
8846048|NCT01718535|9900513|FG009|STARTED|Overall Study||1
8846049|NCT01718535|9900504|FG000|First Pass|Overall Study||128
8846050|NCT01718535|9900505|FG001|First Pass|Overall Study||94
8846051|NCT01718535|9900506|FG002|First Pass|Overall Study||19
8846052|NCT01718535|9900507|FG003|First Pass|Overall Study||7
8846053|NCT01718535|9900508|FG004|First Pass|Overall Study||1
8846054|NCT01718535|9900509|FG005|First Pass|Overall Study||39
8626508|NCT00514514|9666307|FG000|NOT COMPLETED|Randomized - 9 Month||39
8626509|NCT00514514|9666308|FG001|NOT COMPLETED|Randomized - 9 Month||61
8626510|NCT00514514|9666309|FG002|NOT COMPLETED|Randomized - 9 Month||38
8626511|NCT00514514|9666307|FG000|STARTED|Extension - 4 Years||145
8626512|NCT00514514|9666308|FG001|STARTED|Extension - 4 Years||139
8626513|NCT00514514|9666309|FG002|STARTED|Extension - 4 Years||134
8626514|NCT00514514|9666307|FG000|Non-randomized (Followed)|Extension - 4 Years|Patients were not randomized but continued on standard regimen and entered follow up.|95
8626515|NCT00514514|9666308|FG001|Non-randomized (Followed)|Extension - 4 Years||0
8626516|NCT00514514|9666309|FG002|Non-randomized (Followed)|Extension - 4 Years||0
8626517|NCT00514514|9666307|FG000|COMPLETED|Extension - 4 Years||108
8626518|NCT00514514|9666308|FG001|COMPLETED|Extension - 4 Years||117
8626519|NCT00514514|9666309|FG002|COMPLETED|Extension - 4 Years||113
8626520|NCT00514514|9666307|FG000|NOT COMPLETED|Extension - 4 Years||37
8626521|NCT00514514|9666308|FG001|NOT COMPLETED|Extension - 4 Years||22
8626522|NCT00514514|9666309|FG002|NOT COMPLETED|Extension - 4 Years||21
8626523|NCT00514540|9666317|FG000|STARTED|First-Line Chemo||113
8626524|NCT00514540|9666317|FG000|COMPLETED|First-Line Chemo||105
8626525|NCT00514540|9666317|FG000|NOT COMPLETED|First-Line Chemo||8
8626526|NCT00514540|9666317|FG000|STARTED|Second-Line||105
8626527|NCT00514540|9666317|FG000|COMPLETED|Second-Line||74
8626528|NCT00514540|9666317|FG000|NOT COMPLETED|Second-Line||31
8626529|NCT00514592|9666325|FG000|STARTED|Overall Study||230
8626530|NCT00514592|9666325|FG000|COMPLETED|Overall Study||230
8626531|NCT00514592|9666325|FG000|NOT COMPLETED|Overall Study||0
8626532|NCT00514683|9666334|FG000|STARTED|Overall Study|Randomised|87
8723701|NCT01024738|9771244|FG002|COMPLETED|Washout After 1st Intervention||8
8723702|NCT01024738|9771242|FG000|NOT COMPLETED|Washout After 1st Intervention||0
8723703|NCT01024738|9771243|FG001|NOT COMPLETED|Washout After 1st Intervention||0
8723704|NCT01024738|9771244|FG002|NOT COMPLETED|Washout After 1st Intervention||0
8723705|NCT01024738|9771242|FG000|STARTED|Second Intervention:||7
8723706|NCT01024738|9771243|FG001|STARTED|Second Intervention:||7
8723707|NCT01024738|9771244|FG002|STARTED|Second Intervention:||8
8723708|NCT01024738|9771242|FG000|COMPLETED|Second Intervention:||7
8626533|NCT00514683|9666335|FG001|STARTED|Overall Study|Randomised|87
8626534|NCT00514683|9666336|FG002|STARTED|Overall Study|Randomised|86
8626535|NCT00514683|9666337|FG003|STARTED|Overall Study|Randomised|86
8626536|NCT00514683|9666338|FG004|STARTED|Overall Study|Randomised|86
8626537|NCT00514683|9666334|FG000|COMPLETED|Overall Study||61
8626538|NCT00514683|9666335|FG001|COMPLETED|Overall Study||62
8626539|NCT00514683|9666336|FG002|COMPLETED|Overall Study||68
8626540|NCT00514683|9666337|FG003|COMPLETED|Overall Study||72
8626541|NCT00514683|9666338|FG004|COMPLETED|Overall Study||53
8626542|NCT00514683|9666334|FG000|NOT COMPLETED|Overall Study||26
8626543|NCT00514683|9666335|FG001|NOT COMPLETED|Overall Study||25
8626544|NCT00514683|9666336|FG002|NOT COMPLETED|Overall Study||18
8626545|NCT00514683|9666337|FG003|NOT COMPLETED|Overall Study||14
8626546|NCT00514683|9666338|FG004|NOT COMPLETED|Overall Study||33
8626547|NCT00514709|9666356|FG000|STARTED|Overall Study||1230
8626548|NCT00514709|9666357|FG001|STARTED|Overall Study||613
8626549|NCT00514709|9666356|FG000|COMPLETED|Overall Study||1230
8626550|NCT00514709|9666357|FG001|COMPLETED|Overall Study||613
8626551|NCT00514709|9666356|FG000|NOT COMPLETED|Overall Study||0
8626552|NCT00514709|9666357|FG001|NOT COMPLETED|Overall Study||0
8626553|NCT00514735|9666367|FG000|STARTED|Overall Study||138
8626554|NCT00514735|9666368|FG001|STARTED|Overall Study||72
8626555|NCT00514735|9666367|FG000|COMPLETED|Overall Study||124
8626556|NCT00514735|9666368|FG001|COMPLETED|Overall Study||66
8626557|NCT00514735|9666367|FG000|NOT COMPLETED|Overall Study||14
8626558|NCT00514735|9666368|FG001|NOT COMPLETED|Overall Study||6
8626559|NCT00514852|9666378|FG000|STARTED|Overall Study||157
8626560|NCT00514852|9666379|FG001|STARTED|Overall Study||159
8626561|NCT00514852|9666378|FG000|COMPLETED|Overall Study||152
8626562|NCT00514852|9666379|FG001|COMPLETED|Overall Study||154
8626563|NCT00514852|9666378|FG000|NOT COMPLETED|Overall Study||5
8626564|NCT00514852|9666379|FG001|NOT COMPLETED|Overall Study||5
8626565|NCT00514904|9666387|FG000|STARTED|Overall Study||1125
8723709|NCT01024738|9771243|FG001|COMPLETED|Second Intervention:||7
8723710|NCT01024738|9771244|FG002|COMPLETED|Second Intervention:||8
8723711|NCT01024738|9771242|FG000|NOT COMPLETED|Second Intervention:||0
8723712|NCT01024738|9771243|FG001|NOT COMPLETED|Second Intervention:||0
8723713|NCT01024738|9771244|FG002|NOT COMPLETED|Second Intervention:||0
8723714|NCT01024738|9771242|FG000|STARTED|Washout After 2nd Intervention||7
8723715|NCT01024738|9771243|FG001|STARTED|Washout After 2nd Intervention||7
8723716|NCT01024738|9771244|FG002|STARTED|Washout After 2nd Intervention||8
8723717|NCT01024738|9771242|FG000|COMPLETED|Washout After 2nd Intervention||7
8723718|NCT01024738|9771243|FG001|COMPLETED|Washout After 2nd Intervention||7
8723719|NCT01024738|9771244|FG002|COMPLETED|Washout After 2nd Intervention||8
8626566|NCT00514904|9666388|FG001|STARTED|Overall Study||376
8626567|NCT00514904|9666387|FG000|COMPLETED|Overall Study||1101
8626568|NCT00514904|9666388|FG001|COMPLETED|Overall Study||371
8626569|NCT00514904|9666387|FG000|NOT COMPLETED|Overall Study||24
8626570|NCT00514904|9666388|FG001|NOT COMPLETED|Overall Study||5
8626571|NCT00514917|9666396|FG000|STARTED|Overall Study||207
8626572|NCT00514917|9666397|FG001|STARTED|Overall Study||206
8626573|NCT00514917|9666396|FG000|Treated|Overall Study||196
8626574|NCT00514917|9666397|FG001|Treated|Overall Study||204
8626575|NCT00514917|9666396|FG000|Completed Study Treatment|Overall Study||170
8626576|NCT00514917|9666397|FG001|Completed Study Treatment|Overall Study||182
8626577|NCT00514917|9666396|FG000|Testosterone-Specific Evaluable|Overall Study||122
8626578|NCT00514917|9666397|FG001|Testosterone-Specific Evaluable|Overall Study||124
8626579|NCT00514917|9666396|FG000|COMPLETED|Overall Study||81
8626580|NCT00514917|9666397|FG001|COMPLETED|Overall Study||91
8626581|NCT00514917|9666396|FG000|NOT COMPLETED|Overall Study||126
8626582|NCT00514917|9666397|FG001|NOT COMPLETED|Overall Study||115
8626583|NCT00514943|9666407|FG000|STARTED|Stage 1|1 randomized patient was not treated|62
8626584|NCT00514943|9666408|FG001|STARTED|Stage 1|2 randomized patients were not treated|62
8626585|NCT00514943|9666407|FG000|COMPLETED|Stage 1||32
8626586|NCT00514943|9666408|FG001|COMPLETED|Stage 1||36
8626587|NCT00514943|9666407|FG000|NOT COMPLETED|Stage 1||30
8626588|NCT00514943|9666408|FG001|NOT COMPLETED|Stage 1||26
8626589|NCT00514943|9666407|FG000|STARTED|Stage 2||32
8626590|NCT00514943|9666408|FG001|STARTED|Stage 2||36
8626591|NCT00514943|9666407|FG000|COMPLETED|Stage 2||0
8556917|NCT03713684|9588707|FG001|STARTED|Overall Study||92
8556918|NCT03713684|9588708|FG002|STARTED|Overall Study||93
8556919|NCT03713684|9588709|FG003|STARTED|Overall Study||93
8556920|NCT03713684|9588706|FG000|Safety Population|Overall Study||92
8556921|NCT03713684|9588707|FG001|Safety Population|Overall Study||92
8556922|NCT03713684|9588708|FG002|Safety Population|Overall Study|For safety analysis participants were included in the treatment arm that they were exposed for longer duration. 3 participants randomized to Efpeglenatide 6 mg arm received 4 mg dose for longer duration; and considered in Efpeglenatide 4 mg arm for safety analysis.|96
8556923|NCT03713684|9588709|FG003|Safety Population|Overall Study||90
8556924|NCT03713684|9588706|FG000|Completed 30-Week Core Treatment Period|Overall Study||50
8556925|NCT03713684|9588707|FG001|Completed 30-Week Core Treatment Period|Overall Study||52
8556926|NCT03713684|9588708|FG002|Completed 30-Week Core Treatment Period|Overall Study||51
8556927|NCT03713684|9588709|FG003|Completed 30-Week Core Treatment Period|Overall Study||49
8626592|NCT00514943|9666408|FG001|COMPLETED|Stage 2||0
8626593|NCT00514943|9666407|FG000|NOT COMPLETED|Stage 2||32
8626594|NCT00514943|9666408|FG001|NOT COMPLETED|Stage 2||36
8626595|NCT00515008|9666431|FG000|STARTED|Overall Study||33
8626596|NCT00515008|9666432|FG001|STARTED|Overall Study||33
8626597|NCT00515008|9666431|FG000|Completed 12 Week Evaluation|Overall Study||32
8626598|NCT00515008|9666432|FG001|Completed 12 Week Evaluation|Overall Study||29
8626599|NCT00515008|9666431|FG000|COMPLETED|Overall Study||30
8626600|NCT00515008|9666432|FG001|COMPLETED|Overall Study||29
8626601|NCT00515008|9666431|FG000|NOT COMPLETED|Overall Study||3
8626602|NCT00515008|9666432|FG001|NOT COMPLETED|Overall Study||4
8626603|NCT00515021|9666443|FG000|STARTED|Overall Study||9
8626604|NCT00515021|9666444|FG001|STARTED|Overall Study||11
8626605|NCT00515021|9666443|FG000|COMPLETED|Overall Study||9
8626606|NCT00515021|9666444|FG001|COMPLETED|Overall Study||11
8626607|NCT00515021|9666443|FG000|NOT COMPLETED|Overall Study||0
8626608|NCT00515021|9666444|FG001|NOT COMPLETED|Overall Study||0
8626609|NCT00515034|9666456|FG000|STARTED|Overall Study||49
8626610|NCT00515034|9666457|FG001|STARTED|Overall Study||15
8626611|NCT00515034|9666458|FG002|STARTED|Overall Study||62
8626612|NCT00515034|9666459|FG003|STARTED|Overall Study||20
8626613|NCT00515034|9666456|FG000|TREATED|Overall Study||48
8626614|NCT00515034|9666457|FG001|TREATED|Overall Study||15
8626615|NCT00515034|9666458|FG002|TREATED|Overall Study||61
8846055|NCT01718535|9900510|FG006|First Pass|Overall Study||11
8846056|NCT01718535|9900511|FG007|First Pass|Overall Study||6
8846057|NCT01718535|9900512|FG008|First Pass|Overall Study||15
8846058|NCT01718535|9900513|FG009|First Pass|Overall Study||1
8846059|NCT01718535|9900504|FG000|COMPLETED|Overall Study||130
8846060|NCT01718535|9900505|FG001|COMPLETED|Overall Study||95
8846061|NCT01718535|9900506|FG002|COMPLETED|Overall Study||19
8846062|NCT01718535|9900507|FG003|COMPLETED|Overall Study||7
8846063|NCT01718535|9900508|FG004|COMPLETED|Overall Study||1
8846064|NCT01718535|9900509|FG005|COMPLETED|Overall Study||40
8846065|NCT01718535|9900510|FG006|COMPLETED|Overall Study||11
8846066|NCT01718535|9900511|FG007|COMPLETED|Overall Study||6
8626616|NCT00515034|9666459|FG003|TREATED|Overall Study||19
8846067|NCT01718535|9900512|FG008|COMPLETED|Overall Study||15
8846068|NCT01718535|9900513|FG009|COMPLETED|Overall Study||1
8846069|NCT01718535|9900504|FG000|NOT COMPLETED|Overall Study||1
8846070|NCT01718535|9900505|FG001|NOT COMPLETED|Overall Study||0
8846071|NCT01718535|9900506|FG002|NOT COMPLETED|Overall Study||0
8846072|NCT01718535|9900507|FG003|NOT COMPLETED|Overall Study||1
8846073|NCT01718535|9900508|FG004|NOT COMPLETED|Overall Study||0
8846074|NCT01718535|9900509|FG005|NOT COMPLETED|Overall Study||0
8846075|NCT01718535|9900510|FG006|NOT COMPLETED|Overall Study||0
8846076|NCT01718535|9900511|FG007|NOT COMPLETED|Overall Study||0
8846077|NCT01718535|9900512|FG008|NOT COMPLETED|Overall Study||0
8846078|NCT01718535|9900513|FG009|NOT COMPLETED|Overall Study||0
8846079|NCT01718691|9900537|FG000|STARTED|Overall Study||60
8846080|NCT01718691|9900538|FG001|STARTED|Overall Study||10
8626617|NCT00515034|9666456|FG000|COMPLETED|Overall Study||41
8626618|NCT00515034|9666457|FG001|COMPLETED|Overall Study||13
8626619|NCT00515034|9666458|FG002|COMPLETED|Overall Study||54
8626620|NCT00515034|9666459|FG003|COMPLETED|Overall Study||15
8626621|NCT00515034|9666456|FG000|NOT COMPLETED|Overall Study||8
8626622|NCT00515034|9666457|FG001|NOT COMPLETED|Overall Study||2
8626623|NCT00515034|9666458|FG002|NOT COMPLETED|Overall Study||8
8626624|NCT00515034|9666459|FG003|NOT COMPLETED|Overall Study||5
8626625|NCT00515073|9666469|FG000|STARTED|Overall Study||30
8626626|NCT00515073|9666469|FG000|COMPLETED|Overall Study||28
8626627|NCT00515073|9666469|FG000|NOT COMPLETED|Overall Study||2
8626628|NCT00515086|9666477|FG000|STARTED|Overall Study||24
8626629|NCT00515086|9666478|FG001|STARTED|Overall Study||6
8626630|NCT00515086|9666479|FG002|STARTED|Overall Study||5
8626631|NCT00515086|9666480|FG003|STARTED|Overall Study||6
8626632|NCT00515086|9666477|FG000|COMPLETED|Overall Study||0
8626633|NCT00515086|9666478|FG001|COMPLETED|Overall Study||0
8626634|NCT00515086|9666479|FG002|COMPLETED|Overall Study||0
8626635|NCT00515086|9666480|FG003|COMPLETED|Overall Study||0
8626636|NCT00515086|9666477|FG000|NOT COMPLETED|Overall Study||24
8626637|NCT00515086|9666478|FG001|NOT COMPLETED|Overall Study||6
8626638|NCT00515086|9666479|FG002|NOT COMPLETED|Overall Study||5
8626639|NCT00515086|9666480|FG003|NOT COMPLETED|Overall Study||6
8626640|NCT00515099|9666498|FG000|STARTED|Overall Study||38
8626641|NCT00515099|9666499|FG001|STARTED|Overall Study||20
8846081|NCT01718691|9900537|FG000|COMPLETED|Overall Study||42
8846082|NCT01718691|9900538|FG001|COMPLETED|Overall Study||9
8846083|NCT01718691|9900537|FG000|NOT COMPLETED|Overall Study||18
8846084|NCT01718691|9900538|FG001|NOT COMPLETED|Overall Study||1
8846085|NCT01719003|9900557|FG000|STARTED|Overall Study||170
8846086|NCT01719003|9900558|FG001|STARTED|Overall Study||170
8846087|NCT01719003|9900559|FG002|STARTED|Overall Study||171
8846088|NCT01719003|9900560|FG003|STARTED|Overall Study||169
8846089|NCT01719003|9900561|FG004|STARTED|Overall Study||167
8846090|NCT01719003|9900562|FG005|STARTED|Overall Study||172
8846091|NCT01719003|9900563|FG006|STARTED|Overall Study||170
8846092|NCT01719003|9900564|FG007|STARTED|Overall Study||171
8846093|NCT01719003|9900565|FG008|STARTED|Overall Study||53
8846094|NCT01719003|9900557|FG000|COMPLETED|Overall Study||161
8846095|NCT01719003|9900558|FG001|COMPLETED|Overall Study||153
8846096|NCT01719003|9900559|FG002|COMPLETED|Overall Study||154
8626642|NCT00515099|9666498|FG000|COMPLETED|Overall Study||35
8626643|NCT00515099|9666499|FG001|COMPLETED|Overall Study||16
8626644|NCT00515099|9666498|FG000|NOT COMPLETED|Overall Study||3
8626645|NCT00515099|9666499|FG001|NOT COMPLETED|Overall Study||4
8626646|NCT00515177|9666507|FG000|STARTED|Overall Study||20
8626647|NCT00515177|9666508|FG001|STARTED|Overall Study||10
8846097|NCT01719003|9900560|FG003|COMPLETED|Overall Study||156
8846098|NCT01719003|9900561|FG004|COMPLETED|Overall Study||150
8846099|NCT01719003|9900562|FG005|COMPLETED|Overall Study||160
8626648|NCT00515177|9666507|FG000|COMPLETED|Overall Study||18
8626649|NCT00515177|9666508|FG001|COMPLETED|Overall Study||9
8626650|NCT00515177|9666507|FG000|NOT COMPLETED|Overall Study||2
8626651|NCT00515177|9666508|FG001|NOT COMPLETED|Overall Study||1
8626652|NCT00515203|9666517|FG000|STARTED|Overall Study||17
8626653|NCT00515203|9666518|FG001|STARTED|Overall Study||5
8846100|NCT01719003|9900563|FG006|COMPLETED|Overall Study||150
8626654|NCT00515203|9666517|FG000|COMPLETED|Overall Study||17
8626655|NCT00515203|9666518|FG001|COMPLETED|Overall Study||5
8626656|NCT00515203|9666517|FG000|NOT COMPLETED|Overall Study||0
8626657|NCT00515203|9666518|FG001|NOT COMPLETED|Overall Study||0
8626658|NCT00515216|9666524|FG000|STARTED|Overall Study||26
8626659|NCT00515216|9666524|FG000|COMPLETED|Overall Study||25
8626660|NCT00515216|9666524|FG000|NOT COMPLETED|Overall Study||1
8846101|NCT01719003|9900564|FG007|COMPLETED|Overall Study||151
8846102|NCT01719003|9900565|FG008|COMPLETED|Overall Study||49
8846103|NCT01719003|9900557|FG000|NOT COMPLETED|Overall Study||9
8846104|NCT01719003|9900558|FG001|NOT COMPLETED|Overall Study||17
8846105|NCT01719003|9900559|FG002|NOT COMPLETED|Overall Study||17
8846106|NCT01719003|9900560|FG003|NOT COMPLETED|Overall Study||13
8626661|NCT00515294|9666533|FG000|STARTED|Overall Study||38
8626662|NCT00515294|9666534|FG001|STARTED|Overall Study||39
8846107|NCT01719003|9900561|FG004|NOT COMPLETED|Overall Study||17
8626663|NCT00515294|9666535|FG002|STARTED|Overall Study||38
8626664|NCT00515294|9666536|FG003|STARTED|Overall Study||39
8626665|NCT00515294|9666533|FG000|COMPLETED|Overall Study||29
8626666|NCT00515294|9666534|FG001|COMPLETED|Overall Study||36
8626667|NCT00515294|9666535|FG002|COMPLETED|Overall Study||27
8626668|NCT00515294|9666536|FG003|COMPLETED|Overall Study||35
8626669|NCT00515294|9666533|FG000|NOT COMPLETED|Overall Study||9
8626670|NCT00515294|9666534|FG001|NOT COMPLETED|Overall Study||3
8626671|NCT00515294|9666535|FG002|NOT COMPLETED|Overall Study||11
8626672|NCT00515294|9666536|FG003|NOT COMPLETED|Overall Study||4
8626673|NCT00515411|9666549|FG000|STARTED|Overall Study||54
8626674|NCT00515411|9666550|FG001|STARTED|Overall Study||31
8626675|NCT00515411|9666551|FG002|STARTED|Overall Study||26
8626676|NCT00515411|9666549|FG000|COMPLETED|Overall Study||54
8626677|NCT00515411|9666550|FG001|COMPLETED|Overall Study||31
8626678|NCT00515411|9666551|FG002|COMPLETED|Overall Study||26
8626679|NCT00515411|9666549|FG000|NOT COMPLETED|Overall Study||0
8626680|NCT00515411|9666550|FG001|NOT COMPLETED|Overall Study||0
8626681|NCT00515411|9666551|FG002|NOT COMPLETED|Overall Study||0
8846108|NCT01719003|9900562|FG005|NOT COMPLETED|Overall Study||12
8846109|NCT01719003|9900563|FG006|NOT COMPLETED|Overall Study||20
8846110|NCT01719003|9900564|FG007|NOT COMPLETED|Overall Study||20
8846111|NCT01719003|9900565|FG008|NOT COMPLETED|Overall Study||4
8846112|NCT01719172|9900584|FG000|STARTED|Overall Study||30
8846113|NCT01719172|9900584|FG000|COMPLETED|Overall Study||28
8846114|NCT01719172|9900584|FG000|NOT COMPLETED|Overall Study||2
8846115|NCT01719224|9900588|FG000|STARTED|Intervention 1: Sleeping Position 1||18
8846116|NCT01719224|9900589|FG001|STARTED|Intervention 1: Sleeping Position 1||18
8846117|NCT01719224|9900588|FG000|COMPLETED|Intervention 1: Sleeping Position 1||14
8846118|NCT01719224|9900589|FG001|COMPLETED|Intervention 1: Sleeping Position 1||16
8846119|NCT01719224|9900588|FG000|NOT COMPLETED|Intervention 1: Sleeping Position 1||4
8846120|NCT01719224|9900589|FG001|NOT COMPLETED|Intervention 1: Sleeping Position 1||2
8846121|NCT01719224|9900588|FG000|STARTED|Intervention 2: Position Change(At 3.5h)||14
8846122|NCT01719224|9900589|FG001|STARTED|Intervention 2: Position Change(At 3.5h)||16
8846123|NCT01719224|9900588|FG000|COMPLETED|Intervention 2: Position Change(At 3.5h)||14
8846124|NCT01719224|9900589|FG001|COMPLETED|Intervention 2: Position Change(At 3.5h)||16
8846125|NCT01719224|9900588|FG000|NOT COMPLETED|Intervention 2: Position Change(At 3.5h)||0
8846126|NCT01719224|9900589|FG001|NOT COMPLETED|Intervention 2: Position Change(At 3.5h)||0
8846127|NCT01719367|9900598|FG000|STARTED|Overall Study||19
8846128|NCT01719367|9900599|FG001|STARTED|Overall Study||19
8846129|NCT01719367|9900598|FG000|COMPLETED|Overall Study||19
8846130|NCT01719367|9900599|FG001|COMPLETED|Overall Study||19
8846131|NCT01719367|9900598|FG000|NOT COMPLETED|Overall Study||0
8846132|NCT01719367|9900599|FG001|NOT COMPLETED|Overall Study||0
8846133|NCT01719380|9900615|FG000|STARTED|Overall Study||2
8846134|NCT01719380|9900616|FG001|STARTED|Overall Study||7
8846135|NCT01719380|9900617|FG002|STARTED|Overall Study||9
8846136|NCT01719380|9900618|FG003|STARTED|Overall Study||8
8846137|NCT01719380|9900619|FG004|STARTED|Overall Study||3
8846138|NCT01719380|9900620|FG005|STARTED|Overall Study||8
8846139|NCT01719380|9900621|FG006|STARTED|Overall Study||10
8846140|NCT01719380|9900622|FG007|STARTED|Overall Study||7
8846141|NCT01719380|9900623|FG008|STARTED|Overall Study||50
8846142|NCT01719380|9900624|FG009|STARTED|Overall Study||52
8846143|NCT01719380|9900615|FG000|COMPLETED|Overall Study||0
8846144|NCT01719380|9900616|FG001|COMPLETED|Overall Study||0
8846145|NCT01719380|9900617|FG002|COMPLETED|Overall Study||0
8846146|NCT01719380|9900618|FG003|COMPLETED|Overall Study||0
8846147|NCT01719380|9900619|FG004|COMPLETED|Overall Study||0
8846148|NCT01719380|9900620|FG005|COMPLETED|Overall Study||0
8846149|NCT01719380|9900621|FG006|COMPLETED|Overall Study||0
8846150|NCT01719380|9900622|FG007|COMPLETED|Overall Study||0
8846151|NCT01719380|9900623|FG008|COMPLETED|Overall Study||0
8846152|NCT01719380|9900624|FG009|COMPLETED|Overall Study||1
8846153|NCT01719380|9900615|FG000|NOT COMPLETED|Overall Study||2
8846154|NCT01719380|9900616|FG001|NOT COMPLETED|Overall Study||7
8846155|NCT01719380|9900617|FG002|NOT COMPLETED|Overall Study||9
8846156|NCT01719380|9900618|FG003|NOT COMPLETED|Overall Study||8
8846157|NCT01719380|9900619|FG004|NOT COMPLETED|Overall Study||3
8846158|NCT01719380|9900620|FG005|NOT COMPLETED|Overall Study||8
8846159|NCT01719380|9900621|FG006|NOT COMPLETED|Overall Study||10
8846160|NCT01719380|9900622|FG007|NOT COMPLETED|Overall Study||7
8846161|NCT01719380|9900623|FG008|NOT COMPLETED|Overall Study||50
8846162|NCT01719380|9900624|FG009|NOT COMPLETED|Overall Study||51
8846163|NCT01719653|9900658|FG000|STARTED|Overall Study||209
8846164|NCT01719653|9900659|FG001|STARTED|Overall Study||213
8846165|NCT01719653|9900660|FG002|STARTED|Overall Study||218
8846166|NCT01719653|9900661|FG003|STARTED|Overall Study||218
8846167|NCT01719653|9900662|FG004|STARTED|Overall Study||221
8846168|NCT01719653|9900658|FG000|COMPLETED|Overall Study||200
8846169|NCT01719653|9900659|FG001|COMPLETED|Overall Study||200
8846170|NCT01719653|9900660|FG002|COMPLETED|Overall Study||200
8846171|NCT01719653|9900661|FG003|COMPLETED|Overall Study||200
8846172|NCT01719653|9900662|FG004|COMPLETED|Overall Study||200
8846173|NCT01719653|9900658|FG000|NOT COMPLETED|Overall Study||9
8846174|NCT01719653|9900659|FG001|NOT COMPLETED|Overall Study||13
8846175|NCT01719653|9900660|FG002|NOT COMPLETED|Overall Study||18
8626682|NCT00515437|9666563|FG000|STARTED|Overall Study||14
8626683|NCT00515437|9666564|FG001|STARTED|Overall Study||12
8626684|NCT00515437|9666565|FG002|STARTED|Overall Study||13
8846176|NCT01719653|9900661|FG003|NOT COMPLETED|Overall Study||18
8846177|NCT01719653|9900662|FG004|NOT COMPLETED|Overall Study||21
8626685|NCT00515437|9666566|FG003|STARTED|Overall Study||15
8626686|NCT00515437|9666563|FG000|COMPLETED|Overall Study||14
8626687|NCT00515437|9666564|FG001|COMPLETED|Overall Study||12
8626688|NCT00515437|9666565|FG002|COMPLETED|Overall Study||13
8626689|NCT00515437|9666566|FG003|COMPLETED|Overall Study||14
8626690|NCT00515437|9666563|FG000|NOT COMPLETED|Overall Study||0
8626691|NCT00515437|9666564|FG001|NOT COMPLETED|Overall Study||0
8626692|NCT00515437|9666565|FG002|NOT COMPLETED|Overall Study||0
8626693|NCT00515437|9666566|FG003|NOT COMPLETED|Overall Study||1
8626694|NCT00515463|9666578|FG000|STARTED|Overall Study||155
8626695|NCT00515463|9666579|FG001|STARTED|Overall Study||156
8626696|NCT00515463|9666578|FG000|Received Study Medication|Overall Study||154
8626697|NCT00515463|9666579|FG001|Received Study Medication|Overall Study||156
8626698|NCT00515463|9666578|FG000|COMPLETED|Overall Study||141
8626699|NCT00515463|9666579|FG001|COMPLETED|Overall Study||142
8626700|NCT00515463|9666578|FG000|NOT COMPLETED|Overall Study||14
8626701|NCT00515463|9666579|FG001|NOT COMPLETED|Overall Study||14
8626702|NCT00515502|9666586|FG000|STARTED|Treatment Period 1||1
8626703|NCT00515502|9666587|FG001|STARTED|Treatment Period 1||4
8626704|NCT00515502|9666588|FG002|STARTED|Treatment Period 1||4
8626705|NCT00515502|9666589|FG003|STARTED|Treatment Period 1||3
8626706|NCT00515502|9666590|FG004|STARTED|Treatment Period 1||3
8626707|NCT00515502|9666591|FG005|STARTED|Treatment Period 1||1
8626708|NCT00515502|9666592|FG006|STARTED|Treatment Period 1||2
8626709|NCT00515502|9666593|FG007|STARTED|Treatment Period 1||1
8846178|NCT01719744|9900674|FG000|STARTED|Overall Study||25
8846179|NCT01719744|9900674|FG000|COMPLETED|Overall Study||25
8846180|NCT01719744|9900674|FG000|NOT COMPLETED|Overall Study||0
8846181|NCT01719757|9900678|FG000|STARTED|Overall Study||359
8846182|NCT01719757|9900678|FG000|COMPLETED|Overall Study||258
8846183|NCT01719757|9900678|FG000|NOT COMPLETED|Overall Study||101
8846184|NCT01719783|9900686|FG000|STARTED|Dose 1||30
8846185|NCT01719783|9900687|FG001|STARTED|Dose 1||10
8846186|NCT01719783|9900686|FG000|COMPLETED|Dose 1||30
8846187|NCT01719783|9900687|FG001|COMPLETED|Dose 1||10
8846188|NCT01719783|9900686|FG000|NOT COMPLETED|Dose 1||0
8846189|NCT01719783|9900687|FG001|NOT COMPLETED|Dose 1||0
8846190|NCT01719783|9900686|FG000|STARTED|Dose 2||30
8846191|NCT01719783|9900687|FG001|STARTED|Dose 2||10
8846192|NCT01719783|9900686|FG000|COMPLETED|Dose 2||29
8846193|NCT01719783|9900687|FG001|COMPLETED|Dose 2||10
8846194|NCT01719783|9900686|FG000|NOT COMPLETED|Dose 2||1
8846195|NCT01719783|9900687|FG001|NOT COMPLETED|Dose 2||0
8846196|NCT01719861|9900713|FG000|STARTED|Cycle 1||6
8846197|NCT01719861|9900713|FG000|COMPLETED|Cycle 1||2
8846198|NCT01719861|9900713|FG000|NOT COMPLETED|Cycle 1||4
8846199|NCT01719861|9900713|FG000|STARTED|Cycle 2||2
8846200|NCT01719861|9900713|FG000|COMPLETED|Cycle 2||1
8846201|NCT01719861|9900713|FG000|NOT COMPLETED|Cycle 2||1
8846202|NCT01719900|9900720|FG000|STARTED|Overall Study||29
8846203|NCT01719900|9900721|FG001|STARTED|Overall Study||24
8846204|NCT01719900|9900720|FG000|COMPLETED|Overall Study||22
8846205|NCT01719900|9900721|FG001|COMPLETED|Overall Study||22
8846206|NCT01719900|9900720|FG000|NOT COMPLETED|Overall Study||7
8846207|NCT01719900|9900721|FG001|NOT COMPLETED|Overall Study||2
8846208|NCT01720043|9900727|FG000|STARTED|Overall Study||8
8846209|NCT01720043|9900727|FG000|COMPLETED|Overall Study||7
8846210|NCT01720043|9900727|FG000|NOT COMPLETED|Overall Study||1
8846211|NCT01720069|9900734|FG000|STARTED|Overall Study||62
8846212|NCT01720069|9900735|FG001|STARTED|Overall Study||71
8846213|NCT01720069|9900736|FG002|STARTED|Overall Study||63
8846214|NCT01720069|9900734|FG000|Full Anaylsis Set|Overall Study||62
8846215|NCT01720069|9900735|FG001|Full Anaylsis Set|Overall Study||71
8846216|NCT01720069|9900736|FG002|Full Anaylsis Set|Overall Study||63
8846217|NCT01720069|9900734|FG000|COMPLETED|Overall Study||57
8846218|NCT01720069|9900735|FG001|COMPLETED|Overall Study||56
8846219|NCT01720069|9900736|FG002|COMPLETED|Overall Study||48
8846220|NCT01720069|9900734|FG000|NOT COMPLETED|Overall Study||5
8846221|NCT01720069|9900735|FG001|NOT COMPLETED|Overall Study||15
8846222|NCT01720069|9900736|FG002|NOT COMPLETED|Overall Study||15
8846223|NCT01720173|9900744|FG000|STARTED|Overall Study||30
8846224|NCT01720173|9900744|FG000|COMPLETED|Overall Study||30
8846225|NCT01720173|9900744|FG000|NOT COMPLETED|Overall Study||0
8846226|NCT01720225|9900750|FG000|STARTED|Overall Study||73
8846227|NCT01720225|9900751|FG001|STARTED|Overall Study||40
8846228|NCT01720225|9900750|FG000|COMPLETED|Overall Study||70
8846229|NCT01720225|9900751|FG001|COMPLETED|Overall Study||39
8846230|NCT01720225|9900750|FG000|NOT COMPLETED|Overall Study||3
8846231|NCT01720225|9900751|FG001|NOT COMPLETED|Overall Study||1
8846232|NCT01720251|9900760|FG000|STARTED|Overall Study||79
8846233|NCT01720251|9900761|FG001|STARTED|Overall Study||79
8846234|NCT01720251|9900762|FG002|STARTED|Overall Study||82
8846235|NCT01720251|9900760|FG000|COMPLETED|Overall Study||78
8846236|NCT01720251|9900761|FG001|COMPLETED|Overall Study||77
8846237|NCT01720251|9900762|FG002|COMPLETED|Overall Study||82
8846238|NCT01720251|9900760|FG000|NOT COMPLETED|Overall Study||1
8846239|NCT01720251|9900761|FG001|NOT COMPLETED|Overall Study||2
8846240|NCT01720251|9900762|FG002|NOT COMPLETED|Overall Study||0
8846241|NCT01720264|9900770|FG000|STARTED|Transplant With Sitagliptin for 15 Days||15
8846242|NCT01720264|9900770|FG000|COMPLETED|Transplant With Sitagliptin for 15 Days||14
8846243|NCT01720264|9900770|FG000|NOT COMPLETED|Transplant With Sitagliptin for 15 Days||1
8846244|NCT01720264|9900770|FG000|STARTED|Post-transplant (Day 16) to 1 Year||14
8846245|NCT01720264|9900770|FG000|COMPLETED|Post-transplant (Day 16) to 1 Year||2
8846246|NCT01720264|9900770|FG000|NOT COMPLETED|Post-transplant (Day 16) to 1 Year||12
8846247|NCT01720277|9900776|FG000|STARTED|Overall Study||1461
8846248|NCT01720277|9900777|FG001|STARTED|Overall Study||1496
8846249|NCT01720277|9900776|FG000|COMPLETED|Overall Study|intent-to-treat approach|958
8846250|NCT01720277|9900777|FG001|COMPLETED|Overall Study|intent-to-treat approach|938
8846251|NCT01720277|9900776|FG000|NOT COMPLETED|Overall Study||503
8846252|NCT01720277|9900777|FG001|NOT COMPLETED|Overall Study||558
8846253|NCT01720316|9900787|FG000|STARTED|Double-Blind Glycine Placebo Crossover||1
8846254|NCT01720316|9900788|FG001|STARTED|Double-Blind Glycine Placebo Crossover||1
8846255|NCT01720316|9900787|FG000|COMPLETED|Double-Blind Glycine Placebo Crossover||1
8846256|NCT01720316|9900788|FG001|COMPLETED|Double-Blind Glycine Placebo Crossover||1
8846257|NCT01720316|9900787|FG000|NOT COMPLETED|Double-Blind Glycine Placebo Crossover||0
8846258|NCT01720316|9900788|FG001|NOT COMPLETED|Double-Blind Glycine Placebo Crossover||0
8846259|NCT01720316|9900787|FG000|STARTED|Open-label Glycine||1
8846260|NCT01720316|9900788|FG001|STARTED|Open-label Glycine||1
8846261|NCT01720316|9900787|FG000|COMPLETED|Open-label Glycine||1
8846262|NCT01720316|9900788|FG001|COMPLETED|Open-label Glycine||1
8846263|NCT01720316|9900787|FG000|NOT COMPLETED|Open-label Glycine||0
8846264|NCT01720316|9900788|FG001|NOT COMPLETED|Open-label Glycine||0
8846265|NCT01720446|9900824|FG000|STARTED|Overall Study||826
8846266|NCT01720446|9900825|FG001|STARTED|Overall Study||822
8846267|NCT01720446|9900826|FG002|STARTED|Overall Study||824
8846268|NCT01720446|9900827|FG003|STARTED|Overall Study||825
8846269|NCT01720446|9900824|FG000|Premature Treatment Discontinuers|Overall Study|Premature treatment discontinuers were allowed to continue participation in the trial.|164
8846270|NCT01720446|9900825|FG001|Premature Treatment Discontinuers|Overall Study|Premature treatment discontinuers were allowed to continue participation in the trial.|186
8846271|NCT01720446|9900826|FG002|Premature Treatment Discontinuers|Overall Study|Premature treatment discontinuers were allowed to continue participation in the trial.|151
8846272|NCT01720446|9900827|FG003|Premature Treatment Discontinuers|Overall Study|Premature treatment discontinuers were allowed to continue participation in the trial.|159
8846273|NCT01720446|9900824|FG000|COMPLETED|Overall Study|Subjects who did not permanently discontinue treatment prematurely.|812
8846274|NCT01720446|9900825|FG001|COMPLETED|Overall Study|Subjects who did not permanently discontinue treatment prematurely.|811
8846275|NCT01720446|9900826|FG002|COMPLETED|Overall Study|Subjects who did not permanently discontinue treatment prematurely.|804
8846276|NCT01720446|9900827|FG003|COMPLETED|Overall Study|Subjects who did not permanently discontinue treatment prematurely.|805
8846277|NCT01720446|9900824|FG000|NOT COMPLETED|Overall Study||14
8846278|NCT01720446|9900825|FG001|NOT COMPLETED|Overall Study||11
8846279|NCT01720446|9900826|FG002|NOT COMPLETED|Overall Study||20
8846280|NCT01720446|9900827|FG003|NOT COMPLETED|Overall Study||20
8846281|NCT01720524|9900842|FG000|STARTED|Part A||29
8846282|NCT01720524|9900843|FG001|STARTED|Part A||30
8846283|NCT01720524|9900842|FG000|COMPLETED|Part A||22
8846284|NCT01720524|9900843|FG001|COMPLETED|Part A||18
8846285|NCT01720524|9900842|FG000|NOT COMPLETED|Part A||7
8846286|NCT01720524|9900843|FG001|NOT COMPLETED|Part A||12
8846287|NCT01720524|9900842|FG000|STARTED|Part B|Participants who did not complete Part A could also participate in Part B.|27
8846288|NCT01720524|9900843|FG001|STARTED|Part B|Participants who did not complete Part A could also participate in Part B.|26
8846289|NCT01720524|9900842|FG000|COMPLETED|Part B||22
8846290|NCT01720524|9900843|FG001|COMPLETED|Part B||17
8846291|NCT01720524|9900842|FG000|NOT COMPLETED|Part B||5
8846292|NCT01720524|9900843|FG001|NOT COMPLETED|Part B||9
8846293|NCT01720602|9900851|FG000|STARTED|Overall Study||15
8846294|NCT01720602|9900851|FG000|COMPLETED|Overall Study||10
8846295|NCT01720602|9900851|FG000|NOT COMPLETED|Overall Study||5
8846296|NCT01720667|9900857|FG000|STARTED|Overall Study||64
8846297|NCT01720667|9900858|FG001|STARTED|Overall Study||42
8846298|NCT01720667|9900857|FG000|Recieved Second Infusion of Same Drug|Overall Study||50
8850492|NCT01746784|9905684|FG003|COMPLETED|Overall Study||9
8626710|NCT00515502|9666594|FG008|STARTED|Treatment Period 1||1
8626711|NCT00515502|9666595|FG009|STARTED|Treatment Period 1||2
8626712|NCT00515502|9666596|FG010|STARTED|Treatment Period 1||1
8626713|NCT00515502|9666597|FG011|STARTED|Treatment Period 1||1
8846299|NCT01720667|9900858|FG001|Recieved Second Infusion of Same Drug|Overall Study||20
8846300|NCT01720667|9900857|FG000|Recieved Alternate Intervention|Overall Study||45
8846301|NCT01720667|9900858|FG001|Recieved Alternate Intervention|Overall Study||10
8846302|NCT01720667|9900857|FG000|Received 2nd Infusion of Alternate Drug|Overall Study||27
8846303|NCT01720667|9900858|FG001|Received 2nd Infusion of Alternate Drug|Overall Study||6
8846304|NCT01720667|9900857|FG000|Modified ITT|Overall Study||53
8846305|NCT01720667|9900858|FG001|Modified ITT|Overall Study||30
8846306|NCT01720667|9900857|FG000|COMPLETED|Overall Study||60
8846307|NCT01720667|9900858|FG001|COMPLETED|Overall Study||41
8846308|NCT01720667|9900857|FG000|NOT COMPLETED|Overall Study||4
8846309|NCT01720667|9900858|FG001|NOT COMPLETED|Overall Study||1
8846310|NCT01720797|9900868|FG000|STARTED|Overall Study||12
8846311|NCT01720797|9900869|FG001|STARTED|Overall Study||9
8846312|NCT01720797|9900868|FG000|COMPLETED|Overall Study||9
8846313|NCT01720797|9900869|FG001|COMPLETED|Overall Study||9
8846314|NCT01720797|9900868|FG000|NOT COMPLETED|Overall Study||3
8846315|NCT01720797|9900869|FG001|NOT COMPLETED|Overall Study||0
8846316|NCT01721044|9900878|FG000|STARTED|Treatment Period||176
8846317|NCT01721044|9900879|FG001|STARTED|Treatment Period|Randomized to 4mg (N=11) but received 2mg due to moderate renal impairment were included in 4mg arm|174
8846318|NCT01721044|9900880|FG002|STARTED|Treatment Period||177
8846319|NCT01721044|9900878|FG000|Rescue Week 16-24|Treatment Period||56
8846320|NCT01721044|9900879|FG001|Rescue Week 16-24|Treatment Period||38
8626714|NCT00515502|9666586|FG000|COMPLETED|Treatment Period 1||1
8846321|NCT01721044|9900880|FG002|Rescue Week 16-24|Treatment Period||33
8846322|NCT01721044|9900878|FG000|COMPLETED|Treatment Period||144
8846323|NCT01721044|9900879|FG001|COMPLETED|Treatment Period||157
8846324|NCT01721044|9900880|FG002|COMPLETED|Treatment Period||158
8846325|NCT01721044|9900878|FG000|NOT COMPLETED|Treatment Period||32
8846326|NCT01721044|9900879|FG001|NOT COMPLETED|Treatment Period||17
8846327|NCT01721044|9900880|FG002|NOT COMPLETED|Treatment Period||19
8846328|NCT01721044|9900878|FG000|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|19
8846329|NCT01721044|9900879|FG001|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|9
8846330|NCT01721044|9900880|FG002|STARTED|Follow Up|Participants from treatment and rescue who entered the post-treatment follow-up period.|20
8846331|NCT01721044|9900878|FG000|COMPLETED|Follow Up||19
8846332|NCT01721044|9900879|FG001|COMPLETED|Follow Up||9
8846333|NCT01721044|9900880|FG002|COMPLETED|Follow Up||20
8846334|NCT01721044|9900878|FG000|NOT COMPLETED|Follow Up||0
8846335|NCT01721044|9900879|FG001|NOT COMPLETED|Follow Up||0
8846336|NCT01721044|9900880|FG002|NOT COMPLETED|Follow Up||0
8846337|NCT01721057|9900902|FG000|STARTED|Treatment Period||228
8846338|NCT01721057|9900903|FG001|STARTED|Treatment Period||229
8846339|NCT01721057|9900904|FG002|STARTED|Treatment Period||227
8626715|NCT00515502|9666587|FG001|COMPLETED|Treatment Period 1||4
8626716|NCT00515502|9666588|FG002|COMPLETED|Treatment Period 1||4
8626717|NCT00515502|9666589|FG003|COMPLETED|Treatment Period 1||3
8626718|NCT00515502|9666590|FG004|COMPLETED|Treatment Period 1||3
8626719|NCT00515502|9666591|FG005|COMPLETED|Treatment Period 1||1
8626720|NCT00515502|9666592|FG006|COMPLETED|Treatment Period 1||1
8626721|NCT00515502|9666593|FG007|COMPLETED|Treatment Period 1||1
8626722|NCT00515502|9666594|FG008|COMPLETED|Treatment Period 1||0
8626723|NCT00515502|9666595|FG009|COMPLETED|Treatment Period 1||2
8626724|NCT00515502|9666596|FG010|COMPLETED|Treatment Period 1||1
8626725|NCT00515502|9666597|FG011|COMPLETED|Treatment Period 1||0
8626726|NCT00515502|9666586|FG000|NOT COMPLETED|Treatment Period 1||0
8626727|NCT00515502|9666587|FG001|NOT COMPLETED|Treatment Period 1||0
8626728|NCT00515502|9666588|FG002|NOT COMPLETED|Treatment Period 1||0
8626729|NCT00515502|9666589|FG003|NOT COMPLETED|Treatment Period 1||0
8846340|NCT01721057|9900905|FG003|STARTED|Treatment Period||0
8846341|NCT01721057|9900906|FG004|STARTED|Treatment Period||0
8846342|NCT01721057|9900907|FG005|STARTED|Treatment Period||0
8846343|NCT01721057|9900908|FG006|STARTED|Treatment Period||0
8846344|NCT01721057|9900902|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||228
8846345|NCT01721057|9900903|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||229
8846346|NCT01721057|9900904|FG002|Received at Least 1 Dose of Study Drug|Treatment Period||227
8846347|NCT01721057|9900905|FG003|Received at Least 1 Dose of Study Drug|Treatment Period||0
8846348|NCT01721057|9900906|FG004|Received at Least 1 Dose of Study Drug|Treatment Period||0
8846349|NCT01721057|9900907|FG005|Received at Least 1 Dose of Study Drug|Treatment Period||0
8846350|NCT01721057|9900908|FG006|Received at Least 1 Dose of Study Drug|Treatment Period||0
8846351|NCT01721057|9900902|FG000|Rescued|Treatment Period||55
8846352|NCT01721057|9900903|FG001|Rescued|Treatment Period||21
8846353|NCT01721057|9900904|FG002|Rescued|Treatment Period||15
8846354|NCT01721057|9900905|FG003|Rescued|Treatment Period||0
8846355|NCT01721057|9900906|FG004|Rescued|Treatment Period||0
8846356|NCT01721057|9900907|FG005|Rescued|Treatment Period||0
8846357|NCT01721057|9900908|FG006|Rescued|Treatment Period||0
8846358|NCT01721057|9900902|FG000|COMPLETED|Treatment Period|"Completers include rescued participants."|200
8846359|NCT01721057|9900903|FG001|COMPLETED|Treatment Period|"Completers include rescued participants."|210
8626730|NCT00515502|9666590|FG004|NOT COMPLETED|Treatment Period 1||0
8626731|NCT00515502|9666591|FG005|NOT COMPLETED|Treatment Period 1||0
8626732|NCT00515502|9666592|FG006|NOT COMPLETED|Treatment Period 1||1
8846360|NCT01721057|9900904|FG002|COMPLETED|Treatment Period|"Completers include rescued participants."|204
8846361|NCT01721057|9900905|FG003|COMPLETED|Treatment Period||0
8846362|NCT01721057|9900906|FG004|COMPLETED|Treatment Period||0
8846363|NCT01721057|9900907|FG005|COMPLETED|Treatment Period||0
8846364|NCT01721057|9900908|FG006|COMPLETED|Treatment Period||0
8846365|NCT01721057|9900902|FG000|NOT COMPLETED|Treatment Period||28
8846366|NCT01721057|9900903|FG001|NOT COMPLETED|Treatment Period||19
8846367|NCT01721057|9900904|FG002|NOT COMPLETED|Treatment Period||23
8846368|NCT01721057|9900905|FG003|NOT COMPLETED|Treatment Period||0
8846369|NCT01721057|9900906|FG004|NOT COMPLETED|Treatment Period||0
8846370|NCT01721057|9900907|FG005|NOT COMPLETED|Treatment Period||0
8846371|NCT01721057|9900908|FG006|NOT COMPLETED|Treatment Period||0
8846372|NCT01721057|9900902|FG000|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
8846373|NCT01721057|9900903|FG001|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
8846374|NCT01721057|9900904|FG002|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
8846375|NCT01721057|9900905|FG003|STARTED|Rescue Period|Participants who were determined to be nonresponders based on tender/swollen joint count.|91
8846376|NCT01721057|9900906|FG004|STARTED|Rescue Period||0
8846377|NCT01721057|9900907|FG005|STARTED|Rescue Period||0
8846378|NCT01721057|9900908|FG006|STARTED|Rescue Period||0
8846379|NCT01721057|9900902|FG000|COMPLETED|Rescue Period||0
8846380|NCT01721057|9900903|FG001|COMPLETED|Rescue Period||0
8846381|NCT01721057|9900904|FG002|COMPLETED|Rescue Period||0
8846382|NCT01721057|9900905|FG003|COMPLETED|Rescue Period||88
8846383|NCT01721057|9900906|FG004|COMPLETED|Rescue Period||0
8846384|NCT01721057|9900907|FG005|COMPLETED|Rescue Period||0
8846385|NCT01721057|9900908|FG006|COMPLETED|Rescue Period||0
8846386|NCT01721057|9900902|FG000|NOT COMPLETED|Rescue Period||0
8846387|NCT01721057|9900903|FG001|NOT COMPLETED|Rescue Period||0
8846388|NCT01721057|9900904|FG002|NOT COMPLETED|Rescue Period||0
8846389|NCT01721057|9900905|FG003|NOT COMPLETED|Rescue Period||3
8846390|NCT01721057|9900906|FG004|NOT COMPLETED|Rescue Period||0
8846391|NCT01721057|9900907|FG005|NOT COMPLETED|Rescue Period||0
8846392|NCT01721057|9900908|FG006|NOT COMPLETED|Rescue Period||0
8846393|NCT01721057|9900902|FG000|STARTED|Follow Up||0
8846394|NCT01721057|9900903|FG001|STARTED|Follow Up||0
8846395|NCT01721057|9900904|FG002|STARTED|Follow Up||0
8846396|NCT01721057|9900905|FG003|STARTED|Follow Up|Rescued participants who entered post-treatment follow-up are included in Baricitinib 4 mg FollowUp|0
8846397|NCT01721057|9900906|FG004|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|17
8846398|NCT01721057|9900907|FG005|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|19
8846399|NCT01721057|9900908|FG006|STARTED|Follow Up|Participants from treatment and rescue who entered the post-treatment follow-up period.|22
8846400|NCT01721057|9900902|FG000|COMPLETED|Follow Up||0
8846401|NCT01721057|9900903|FG001|COMPLETED|Follow Up||0
8846402|NCT01721057|9900904|FG002|COMPLETED|Follow Up||0
8846403|NCT01721057|9900905|FG003|COMPLETED|Follow Up||0
8846404|NCT01721057|9900906|FG004|COMPLETED|Follow Up||17
8846405|NCT01721057|9900907|FG005|COMPLETED|Follow Up||19
8846406|NCT01721057|9900908|FG006|COMPLETED|Follow Up||22
8846407|NCT01721057|9900902|FG000|NOT COMPLETED|Follow Up||0
8846408|NCT01721057|9900903|FG001|NOT COMPLETED|Follow Up||0
8846409|NCT01721057|9900904|FG002|NOT COMPLETED|Follow Up||0
8846410|NCT01721057|9900905|FG003|NOT COMPLETED|Follow Up||0
8846411|NCT01721057|9900906|FG004|NOT COMPLETED|Follow Up||0
8846412|NCT01721057|9900907|FG005|NOT COMPLETED|Follow Up||0
8846413|NCT01721057|9900908|FG006|NOT COMPLETED|Follow Up||0
8846414|NCT01721070|9900935|FG000|STARTED|SUF NT 15 mcg||19
8846415|NCT01721070|9900935|FG000|COMPLETED|SUF NT 15 mcg||19
8846416|NCT01721070|9900935|FG000|NOT COMPLETED|SUF NT 15 mcg||0
8846417|NCT01721070|9900935|FG000|STARTED|Ketoconazole 400 mg and SUF NT 15 mcg||19
8846418|NCT01721070|9900935|FG000|COMPLETED|Ketoconazole 400 mg and SUF NT 15 mcg||18
8846419|NCT01721070|9900935|FG000|NOT COMPLETED|Ketoconazole 400 mg and SUF NT 15 mcg||1
8846420|NCT01721096|9900944|FG000|STARTED|Overall Study||323
8846421|NCT01721096|9900945|FG001|STARTED|Overall Study||213
8846422|NCT01721096|9900944|FG000|COMPLETED|Overall Study||3
8846423|NCT01721096|9900945|FG001|COMPLETED|Overall Study||9
8846424|NCT01721096|9900944|FG000|NOT COMPLETED|Overall Study||320
8846425|NCT01721096|9900945|FG001|NOT COMPLETED|Overall Study||204
8846426|NCT01721109|9900953|FG000|STARTED|Overall Study||50
8846427|NCT01721109|9900953|FG000|COMPLETED|Overall Study|34 participants transitioned to commercial Stribild or to an individual patient use (IPU) program|43
8846428|NCT01721109|9900953|FG000|NOT COMPLETED|Overall Study||7
8846429|NCT01721161|9900959|FG000|STARTED|Overall Study||41
8626733|NCT00515502|9666593|FG007|NOT COMPLETED|Treatment Period 1||0
8626734|NCT00515502|9666594|FG008|NOT COMPLETED|Treatment Period 1||1
8626735|NCT00515502|9666595|FG009|NOT COMPLETED|Treatment Period 1||0
8626736|NCT00515502|9666596|FG010|NOT COMPLETED|Treatment Period 1||0
8626737|NCT00515502|9666597|FG011|NOT COMPLETED|Treatment Period 1||1
8626738|NCT00515502|9666586|FG000|STARTED|Washout Period 1||1
8626739|NCT00515502|9666587|FG001|STARTED|Washout Period 1||4
8556928|NCT03713684|9588706|FG000|COMPLETED|Overall Study||6
8626740|NCT00515502|9666588|FG002|STARTED|Washout Period 1||4
8626741|NCT00515502|9666589|FG003|STARTED|Washout Period 1||3
8626742|NCT00515502|9666590|FG004|STARTED|Washout Period 1||3
8846430|NCT01721161|9900960|FG001|STARTED|Overall Study||41
8846431|NCT01721161|9900959|FG000|COMPLETED|Overall Study||37
8846432|NCT01721161|9900960|FG001|COMPLETED|Overall Study||34
8846433|NCT01721161|9900959|FG000|NOT COMPLETED|Overall Study||4
8846434|NCT01721161|9900960|FG001|NOT COMPLETED|Overall Study||7
8846435|NCT01721200|9900969|FG000|STARTED|Overall Study||62
8846436|NCT01721200|9900970|FG001|STARTED|Overall Study||63
8846437|NCT01721200|9900969|FG000|Completed 2 Week Follow-up|Overall Study||60
8846438|NCT01721200|9900970|FG001|Completed 2 Week Follow-up|Overall Study||61
8846439|NCT01721200|9900969|FG000|COMPLETED|Overall Study||59
8846440|NCT01721200|9900970|FG001|COMPLETED|Overall Study||58
8846441|NCT01721200|9900969|FG000|NOT COMPLETED|Overall Study||3
8846442|NCT01721200|9900970|FG001|NOT COMPLETED|Overall Study||5
8846443|NCT01721226|9900983|FG000|STARTED|Overall Study||55
8846444|NCT01721226|9900984|FG001|STARTED|Overall Study||57
8846445|NCT01721226|9900983|FG000|Baseline|Overall Study||53
8846446|NCT01721226|9900984|FG001|Baseline|Overall Study||57
8846447|NCT01721226|9900983|FG000|Week 12|Overall Study||48
8846448|NCT01721226|9900984|FG001|Week 12|Overall Study||53
8846449|NCT01721226|9900983|FG000|Week 24|Overall Study||50
8846450|NCT01721226|9900984|FG001|Week 24|Overall Study||50
8846451|NCT01721226|9900983|FG000|COMPLETED|Overall Study||50
8846452|NCT01721226|9900984|FG001|COMPLETED|Overall Study||50
8846453|NCT01721226|9900983|FG000|NOT COMPLETED|Overall Study||5
8846454|NCT01721226|9900984|FG001|NOT COMPLETED|Overall Study||7
8846455|NCT01721317|9900992|FG000|STARTED|Overall Study||2
8846456|NCT01721317|9900993|FG001|STARTED|Overall Study||4
8846457|NCT01721317|9900992|FG000|COMPLETED|Overall Study||0
8846458|NCT01721317|9900993|FG001|COMPLETED|Overall Study||0
8846459|NCT01721317|9900992|FG000|NOT COMPLETED|Overall Study||2
8846460|NCT01721317|9900993|FG001|NOT COMPLETED|Overall Study||4
8846461|NCT01721330|9901001|FG000|STARTED|Overall Study||1
8846462|NCT01721330|9901002|FG001|STARTED|Overall Study||2
8846463|NCT01721330|9901001|FG000|COMPLETED|Overall Study||1
8846464|NCT01721330|9901002|FG001|COMPLETED|Overall Study||1
8846465|NCT01721330|9901001|FG000|NOT COMPLETED|Overall Study||0
8846466|NCT01721330|9901002|FG001|NOT COMPLETED|Overall Study||1
8846467|NCT01721369|9901008|FG000|STARTED|Overall Study||581
8846468|NCT01721369|9901008|FG000|COMPLETED|Overall Study||569
8846469|NCT01721369|9901008|FG000|NOT COMPLETED|Overall Study||12
8846470|NCT01721408|9901014|FG000|STARTED|Overall Study|Number of participants treated.|232
8846471|NCT01721408|9901015|FG001|STARTED|Overall Study|Number of participants treated.|231
8846472|NCT01721408|9901014|FG000|COMPLETED|Overall Study||196
8626743|NCT00515502|9666591|FG005|STARTED|Washout Period 1||1
8846473|NCT01721408|9901015|FG001|COMPLETED|Overall Study||207
8846474|NCT01721408|9901014|FG000|NOT COMPLETED|Overall Study||36
8846475|NCT01721408|9901015|FG001|NOT COMPLETED|Overall Study||24
8846476|NCT01721447|9901021|FG000|STARTED|Overall Study||100
8846477|NCT01721447|9901021|FG000|COMPLETED|Overall Study||100
8846478|NCT01721447|9901021|FG000|NOT COMPLETED|Overall Study||0
8846479|NCT01721460|9901026|FG000|STARTED|Overall Study||6
8846480|NCT01721460|9901026|FG000|COMPLETED|Overall Study||5
8846481|NCT01721460|9901026|FG000|NOT COMPLETED|Overall Study||1
8846482|NCT01721473|9901038|FG000|STARTED|Overall Study||47
8846483|NCT01721473|9901039|FG001|STARTED|Overall Study||22
8846484|NCT01721473|9901040|FG002|STARTED|Overall Study||41
8846485|NCT01721473|9901041|FG003|STARTED|Overall Study||34
8846486|NCT01721473|9901042|FG004|STARTED|Overall Study||22
8626744|NCT00515502|9666592|FG006|STARTED|Washout Period 1||1
8626745|NCT00515502|9666593|FG007|STARTED|Washout Period 1||1
8626746|NCT00515502|9666594|FG008|STARTED|Washout Period 1||0
8626747|NCT00515502|9666595|FG009|STARTED|Washout Period 1||2
8626748|NCT00515502|9666596|FG010|STARTED|Washout Period 1||1
8846487|NCT01721473|9901043|FG005|STARTED|Overall Study||18
8626749|NCT00515502|9666597|FG011|STARTED|Washout Period 1||0
8846488|NCT01721473|9901038|FG000|COMPLETED|Overall Study||47
8846489|NCT01721473|9901039|FG001|COMPLETED|Overall Study||22
8846490|NCT01721473|9901040|FG002|COMPLETED|Overall Study||41
8846491|NCT01721473|9901041|FG003|COMPLETED|Overall Study||34
8846492|NCT01721473|9901042|FG004|COMPLETED|Overall Study||22
8846493|NCT01721473|9901043|FG005|COMPLETED|Overall Study||18
8846494|NCT01721473|9901038|FG000|NOT COMPLETED|Overall Study||0
8846495|NCT01721473|9901039|FG001|NOT COMPLETED|Overall Study||0
8846496|NCT01721473|9901040|FG002|NOT COMPLETED|Overall Study||0
8846497|NCT01721473|9901041|FG003|NOT COMPLETED|Overall Study||0
8846498|NCT01721473|9901042|FG004|NOT COMPLETED|Overall Study||0
8846499|NCT01721473|9901043|FG005|NOT COMPLETED|Overall Study||0
8846500|NCT01721486|9901054|FG000|STARTED|Overall Study||21
8846501|NCT01721486|9901055|FG001|STARTED|Overall Study||20
8846502|NCT01721486|9901054|FG000|COMPLETED|Overall Study||20
8846503|NCT01721486|9901055|FG001|COMPLETED|Overall Study||19
8846504|NCT01721486|9901054|FG000|NOT COMPLETED|Overall Study||1
8846505|NCT01721486|9901055|FG001|NOT COMPLETED|Overall Study||1
8846506|NCT01721564|9901061|FG000|STARTED|Overall Study||8
8846507|NCT01721564|9901061|FG000|COMPLETED|Overall Study||8
8846508|NCT01721564|9901061|FG000|NOT COMPLETED|Overall Study||0
8846509|NCT01721603|9901065|FG000|STARTED|Overall Study||2
8846510|NCT01721603|9901065|FG000|COMPLETED|Overall Study||2
8846511|NCT01721603|9901065|FG000|NOT COMPLETED|Overall Study||0
8846512|NCT01721681|9901069|FG000|STARTED|Overall Study||9
8846513|NCT01721681|9901069|FG000|COMPLETED|Overall Study||9
8846514|NCT01721681|9901069|FG000|NOT COMPLETED|Overall Study||0
8846515|NCT01721772|9901075|FG000|STARTED|Overall Study||206
8846516|NCT01721772|9901076|FG001|STARTED|Overall Study||205
8846517|NCT01721772|9901075|FG000|COMPLETED|Overall Study|Continuing in treatment period|95
8846518|NCT01721772|9901076|FG001|COMPLETED|Overall Study|Continuing in treatment period|13
8846519|NCT01721772|9901075|FG000|NOT COMPLETED|Overall Study||111
8846520|NCT01721772|9901076|FG001|NOT COMPLETED|Overall Study||192
8846521|NCT01721837|9901082|FG000|STARTED|Overall Study||2120
8846522|NCT01721837|9901082|FG000|COMPLETED|Overall Study||2120
8846523|NCT01721837|9901082|FG000|NOT COMPLETED|Overall Study||0
8846524|NCT01721876|9901088|FG000|STARTED|Overall Study||222
8846525|NCT01721876|9901089|FG001|STARTED|Overall Study||444
8846526|NCT01721876|9901088|FG000|Treated|Overall Study||221
8846527|NCT01721876|9901089|FG001|Treated|Overall Study||440
8846528|NCT01721876|9901088|FG000|COMPLETED|Overall Study||0
8846529|NCT01721876|9901089|FG001|COMPLETED|Overall Study||0
8846530|NCT01721876|9901088|FG000|NOT COMPLETED|Overall Study||222
8846531|NCT01721876|9901089|FG001|NOT COMPLETED|Overall Study||444
8846532|NCT01721954|9901097|FG000|STARTED|Overall Study||105
8846533|NCT01721954|9901098|FG001|STARTED|Overall Study||104
8846534|NCT01721954|9901097|FG000|COMPLETED|Overall Study||35
8626750|NCT00515502|9666586|FG000|COMPLETED|Washout Period 1||1
8626751|NCT00515502|9666587|FG001|COMPLETED|Washout Period 1||4
8846535|NCT01721954|9901098|FG001|COMPLETED|Overall Study||35
8846536|NCT01721954|9901097|FG000|NOT COMPLETED|Overall Study||70
8846537|NCT01721954|9901098|FG001|NOT COMPLETED|Overall Study||69
8626752|NCT00515502|9666588|FG002|COMPLETED|Washout Period 1||4
8626753|NCT00515502|9666589|FG003|COMPLETED|Washout Period 1||3
8846538|NCT01721967|9901104|FG000|STARTED|Overall Study||14
8846539|NCT01721967|9901104|FG000|COMPLETED|Overall Study||11
8846540|NCT01721967|9901104|FG000|NOT COMPLETED|Overall Study||3
8846541|NCT01722045|9901108|FG000|STARTED|Overall Study||154
8846542|NCT01722045|9901108|FG000|COMPLETED|Overall Study||126
8846543|NCT01722045|9901108|FG000|NOT COMPLETED|Overall Study||28
8846544|NCT01722071|9901112|FG000|STARTED|Overall Study||10
8846545|NCT01722071|9901113|FG001|STARTED|Overall Study||10
8846546|NCT01722071|9901112|FG000|COMPLETED|Overall Study||9
8846547|NCT01722071|9901113|FG001|COMPLETED|Overall Study||10
8846548|NCT01722071|9901112|FG000|NOT COMPLETED|Overall Study||1
8846549|NCT01722071|9901113|FG001|NOT COMPLETED|Overall Study||0
8846550|NCT01722097|9901121|FG000|STARTED|Overall Study||55
8846551|NCT01722097|9901122|FG001|STARTED|Overall Study||55
8846552|NCT01722097|9901121|FG000|COMPLETED|Overall Study||49
8846553|NCT01722097|9901122|FG001|COMPLETED|Overall Study||50
8846554|NCT01722097|9901121|FG000|NOT COMPLETED|Overall Study||6
8846555|NCT01722097|9901122|FG001|NOT COMPLETED|Overall Study||5
8846556|NCT01722162|9901130|FG000|STARTED|Overall Study||23
8846557|NCT01722162|9901131|FG001|STARTED|Overall Study||24
8846558|NCT01722162|9901130|FG000|COMPLETED|Overall Study||18
8846559|NCT01722162|9901131|FG001|COMPLETED|Overall Study||18
8846560|NCT01722162|9901130|FG000|NOT COMPLETED|Overall Study||5
8846561|NCT01722162|9901131|FG001|NOT COMPLETED|Overall Study||6
8846562|NCT01722266|9901141|FG000|STARTED|Overall Study||18
8846563|NCT01722266|9901142|FG001|STARTED|Overall Study||18
8846564|NCT01722266|9901143|FG002|STARTED|Overall Study||18
8846565|NCT01722266|9901144|FG003|STARTED|Overall Study|3 withdrew consent; 1 dropped out due to nausea|18
8846566|NCT01722266|9901141|FG000|COMPLETED|Overall Study||17
8846567|NCT01722266|9901142|FG001|COMPLETED|Overall Study||15
8846568|NCT01722266|9901143|FG002|COMPLETED|Overall Study||13
8846569|NCT01722266|9901144|FG003|COMPLETED|Overall Study|3 subjects randomized to 1.2 mg group and 1 to 1.8 mg group tolerated only 0.6 mg|18
8846570|NCT01722266|9901141|FG000|NOT COMPLETED|Overall Study||1
8846571|NCT01722266|9901142|FG001|NOT COMPLETED|Overall Study||3
8846572|NCT01722266|9901143|FG002|NOT COMPLETED|Overall Study||5
8846573|NCT01722266|9901144|FG003|NOT COMPLETED|Overall Study||0
8846574|NCT01722292|9901157|FG000|STARTED|Overall Study||6
8846575|NCT01722292|9901158|FG001|STARTED|Overall Study||6
8846576|NCT01722292|9901159|FG002|STARTED|Overall Study||14
8846577|NCT01722292|9901157|FG000|Received at Least One Dose of Study Drug|Overall Study||6
8846578|NCT01722292|9901158|FG001|Received at Least One Dose of Study Drug|Overall Study||6
8846579|NCT01722292|9901159|FG002|Received at Least One Dose of Study Drug|Overall Study||14
8846580|NCT01722292|9901157|FG000|COMPLETED|Overall Study||6
8846581|NCT01722292|9901158|FG001|COMPLETED|Overall Study||6
8846582|NCT01722292|9901159|FG002|COMPLETED|Overall Study||14
8846583|NCT01722292|9901157|FG000|NOT COMPLETED|Overall Study||0
8846584|NCT01722292|9901158|FG001|NOT COMPLETED|Overall Study||0
8626754|NCT00515502|9666590|FG004|COMPLETED|Washout Period 1||3
8626755|NCT00515502|9666591|FG005|COMPLETED|Washout Period 1||1
8626756|NCT00515502|9666592|FG006|COMPLETED|Washout Period 1||1
8846585|NCT01722292|9901159|FG002|NOT COMPLETED|Overall Study||0
8846586|NCT01722318|9901189|FG000|STARTED|Overall Study||86
8846587|NCT01722318|9901190|FG001|STARTED|Overall Study||85
8846588|NCT01722318|9901191|FG002|STARTED|Overall Study||86
8846589|NCT01722318|9901192|FG003|STARTED|Overall Study||85
8846590|NCT01722318|9901193|FG004|STARTED|Overall Study||86
8846591|NCT01722318|9901189|FG000|COMPLETED|Overall Study||72
8846592|NCT01722318|9901190|FG001|COMPLETED|Overall Study||65
8846593|NCT01722318|9901191|FG002|COMPLETED|Overall Study||66
8846594|NCT01722318|9901192|FG003|COMPLETED|Overall Study||65
8846595|NCT01722318|9901193|FG004|COMPLETED|Overall Study||68
8846596|NCT01722318|9901189|FG000|NOT COMPLETED|Overall Study||14
8846597|NCT01722318|9901190|FG001|NOT COMPLETED|Overall Study||20
8626757|NCT00515502|9666593|FG007|COMPLETED|Washout Period 1||1
8626758|NCT00515502|9666594|FG008|COMPLETED|Washout Period 1||0
8846598|NCT01722318|9901191|FG002|NOT COMPLETED|Overall Study||20
8846599|NCT01722318|9901192|FG003|NOT COMPLETED|Overall Study||20
8846600|NCT01722318|9901193|FG004|NOT COMPLETED|Overall Study||18
8846601|NCT01722435|9901205|FG000|STARTED|Overall Study||78
8846602|NCT01722435|9901205|FG000|COMPLETED|Overall Study||78
8846603|NCT01722435|9901205|FG000|NOT COMPLETED|Overall Study||0
8846604|NCT01722487|9901215|FG000|STARTED|Overall Study||136
8846605|NCT01722487|9901216|FG001|STARTED|Overall Study||133
8846606|NCT01722487|9901215|FG000|COMPLETED|Overall Study|Participants who were still on study or died at study closure|134
8846607|NCT01722487|9901216|FG001|COMPLETED|Overall Study|Participants who were still on study or died at study closure|126
8846608|NCT01722487|9901215|FG000|NOT COMPLETED|Overall Study||2
8846609|NCT01722487|9901216|FG001|NOT COMPLETED|Overall Study||7
8846610|NCT01722552|9901223|FG000|STARTED|Overall Study|Number of subjects enrolled|120
8846611|NCT01722552|9901223|FG000|COMPLETED|Overall Study|Number of subjects who completed the intervention|116
8846612|NCT01722552|9901223|FG000|NOT COMPLETED|Overall Study||4
8846613|NCT01722604|9901231|FG000|STARTED|Overall Study||129
8846614|NCT01722604|9901232|FG001|STARTED|Overall Study||129
8846615|NCT01722604|9901231|FG000|COMPLETED|Overall Study||123
8846616|NCT01722604|9901232|FG001|COMPLETED|Overall Study||120
8846617|NCT01722604|9901231|FG000|NOT COMPLETED|Overall Study||6
8846618|NCT01722604|9901232|FG001|NOT COMPLETED|Overall Study||9
8846619|NCT01722643|9901240|FG000|STARTED|Overall Study||30
8846620|NCT01722643|9901241|FG001|STARTED|Overall Study||31
8846621|NCT01722643|9901240|FG000|COMPLETED|Overall Study||30
8846622|NCT01722643|9901241|FG001|COMPLETED|Overall Study||30
8846623|NCT01722643|9901240|FG000|NOT COMPLETED|Overall Study||0
8846624|NCT01722643|9901241|FG001|NOT COMPLETED|Overall Study||1
8846625|NCT01722669|9901253|FG000|STARTED|Overall Study||5
8846626|NCT01722669|9901254|FG001|STARTED|Overall Study||5
8846627|NCT01722669|9901255|FG002|STARTED|Overall Study||5
8846628|NCT01722669|9901256|FG003|STARTED|Overall Study||5
8846629|NCT01722669|9901257|FG004|STARTED|Overall Study||10
8846630|NCT01722669|9901258|FG005|STARTED|Overall Study|Antiphospholipid Antibody (ARM D): 6 evaluable and 2 withdrew consent without any data collected|8
8846631|NCT01722669|9901253|FG000|COMPLETED|Overall Study||5
8846632|NCT01722669|9901254|FG001|COMPLETED|Overall Study||5
8846633|NCT01722669|9901255|FG002|COMPLETED|Overall Study||5
8846634|NCT01722669|9901256|FG003|COMPLETED|Overall Study||5
8846635|NCT01722669|9901257|FG004|COMPLETED|Overall Study||10
8846636|NCT01722669|9901258|FG005|COMPLETED|Overall Study||6
8846637|NCT01722669|9901253|FG000|NOT COMPLETED|Overall Study||0
8626759|NCT00515502|9666595|FG009|COMPLETED|Washout Period 1||2
8626760|NCT00515502|9666596|FG010|COMPLETED|Washout Period 1||1
8626761|NCT00515502|9666597|FG011|COMPLETED|Washout Period 1||0
8846638|NCT01722669|9901254|FG001|NOT COMPLETED|Overall Study||0
8846639|NCT01722669|9901255|FG002|NOT COMPLETED|Overall Study||0
8846640|NCT01722669|9901256|FG003|NOT COMPLETED|Overall Study||0
8846641|NCT01722669|9901257|FG004|NOT COMPLETED|Overall Study||0
8846642|NCT01722669|9901258|FG005|NOT COMPLETED|Overall Study||2
8846643|NCT01722734|9901281|FG000|STARTED|Overall Study||554
8846644|NCT01722734|9901282|FG001|STARTED|Overall Study||277
8846645|NCT01722734|9901283|FG002|STARTED|Overall Study||309
8846646|NCT01722734|9901281|FG000|COMPLETED|Overall Study||552
8846647|NCT01722734|9901282|FG001|COMPLETED|Overall Study||276
8846648|NCT01722734|9901283|FG002|COMPLETED|Overall Study||307
8846649|NCT01722734|9901281|FG000|NOT COMPLETED|Overall Study||2
8846650|NCT01722734|9901282|FG001|NOT COMPLETED|Overall Study||1
8846651|NCT01722734|9901283|FG002|NOT COMPLETED|Overall Study||2
8846652|NCT01722877|9901291|FG000|STARTED|Overall Study||29
8846653|NCT01722877|9901291|FG000|COMPLETED|Overall Study||27
8846654|NCT01722877|9901291|FG000|NOT COMPLETED|Overall Study||2
8846655|NCT01722994|9901299|FG000|STARTED|Overall Study||49
8846656|NCT01722994|9901300|FG001|STARTED|Overall Study||48
8846657|NCT01722994|9901299|FG000|COMPLETED|Overall Study||24
8846658|NCT01722994|9901300|FG001|COMPLETED|Overall Study||31
8846659|NCT01722994|9901299|FG000|NOT COMPLETED|Overall Study||25
8846660|NCT01722994|9901300|FG001|NOT COMPLETED|Overall Study||17
8846661|NCT01723072|9901310|FG000|STARTED|Overall Study|28-week treatment period and 8-week follow-up period|44
8846662|NCT01723072|9901311|FG001|STARTED|Overall Study|28-week treatment period and 8-week follow-up period|47
8846663|NCT01723072|9901310|FG000|COMPLETED|Overall Study||33
8846664|NCT01723072|9901311|FG001|COMPLETED|Overall Study||26
8846665|NCT01723072|9901310|FG000|NOT COMPLETED|Overall Study||11
8846666|NCT01723072|9901311|FG001|NOT COMPLETED|Overall Study||21
8846667|NCT01723163|9901319|FG000|STARTED|Baseline||156
8846668|NCT01723163|9901320|FG001|STARTED|Baseline||154
8846669|NCT01723163|9901319|FG000|COMPLETED|Baseline||156
8846670|NCT01723163|9901320|FG001|COMPLETED|Baseline||154
8846671|NCT01723163|9901319|FG000|NOT COMPLETED|Baseline||0
8846672|NCT01723163|9901320|FG001|NOT COMPLETED|Baseline||0
8846673|NCT01723163|9901319|FG000|STARTED|Treatment Phase||156
8846674|NCT01723163|9901320|FG001|STARTED|Treatment Phase||154
8846675|NCT01723163|9901319|FG000|COMPLETED|Treatment Phase||137
8846676|NCT01723163|9901320|FG001|COMPLETED|Treatment Phase||147
8846677|NCT01723163|9901319|FG000|NOT COMPLETED|Treatment Phase||19
8846678|NCT01723163|9901320|FG001|NOT COMPLETED|Treatment Phase||7
8846679|NCT01723163|9901319|FG000|STARTED|3-Month Follow-up||137
8846680|NCT01723163|9901320|FG001|STARTED|3-Month Follow-up||147
8846681|NCT01723163|9901319|FG000|COMPLETED|3-Month Follow-up||124
8846682|NCT01723163|9901320|FG001|COMPLETED|3-Month Follow-up||128
8846683|NCT01723163|9901319|FG000|NOT COMPLETED|3-Month Follow-up||13
8846684|NCT01723163|9901320|FG001|NOT COMPLETED|3-Month Follow-up||19
8846685|NCT01723163|9901319|FG000|STARTED|6-Month Follow-up||136
8846686|NCT01723163|9901320|FG001|STARTED|6-Month Follow-up||147
8846687|NCT01723163|9901319|FG000|COMPLETED|6-Month Follow-up||118
8846688|NCT01723163|9901320|FG001|COMPLETED|6-Month Follow-up||132
8846689|NCT01723163|9901319|FG000|NOT COMPLETED|6-Month Follow-up||18
8846690|NCT01723163|9901320|FG001|NOT COMPLETED|6-Month Follow-up||15
8846691|NCT01723163|9901319|FG000|STARTED|12-Month Follow-up||135
8846692|NCT01723163|9901320|FG001|STARTED|12-Month Follow-up||147
8846693|NCT01723163|9901319|FG000|COMPLETED|12-Month Follow-up||111
8846694|NCT01723163|9901320|FG001|COMPLETED|12-Month Follow-up||119
8846695|NCT01723163|9901319|FG000|NOT COMPLETED|12-Month Follow-up||24
8846696|NCT01723163|9901320|FG001|NOT COMPLETED|12-Month Follow-up||28
8846697|NCT01723228|9901328|FG000|STARTED|Overall Study||86
8846698|NCT01723228|9901329|FG001|STARTED|Overall Study||84
8846699|NCT01723228|9901328|FG000|COMPLETED|Overall Study||78
8846700|NCT01723228|9901329|FG001|COMPLETED|Overall Study||73
8846701|NCT01723228|9901328|FG000|NOT COMPLETED|Overall Study||8
8846702|NCT01723228|9901329|FG001|NOT COMPLETED|Overall Study||11
8846703|NCT01723254|9901343|FG000|STARTED|Overall Study||6
8846704|NCT01723254|9901344|FG001|STARTED|Overall Study||21
8846705|NCT01723254|9901345|FG002|STARTED|Overall Study||20
8846706|NCT01723254|9901346|FG003|STARTED|Overall Study||20
8846707|NCT01723254|9901347|FG004|STARTED|Overall Study||20
8846708|NCT01723254|9901348|FG005|STARTED|Overall Study||20
8846709|NCT01723254|9901349|FG006|STARTED|Overall Study||20
8846710|NCT01723254|9901350|FG007|STARTED|Overall Study||63
8846711|NCT01723254|9901343|FG000|COMPLETED|Overall Study||5
8846712|NCT01723254|9901344|FG001|COMPLETED|Overall Study||18
8846713|NCT01723254|9901345|FG002|COMPLETED|Overall Study||17
8846714|NCT01723254|9901346|FG003|COMPLETED|Overall Study||18
8846715|NCT01723254|9901347|FG004|COMPLETED|Overall Study||18
8846716|NCT01723254|9901348|FG005|COMPLETED|Overall Study||18
8846717|NCT01723254|9901349|FG006|COMPLETED|Overall Study||19
8846718|NCT01723254|9901350|FG007|COMPLETED|Overall Study||60
8846719|NCT01723254|9901343|FG000|NOT COMPLETED|Overall Study||1
8846720|NCT01723254|9901344|FG001|NOT COMPLETED|Overall Study||3
8846721|NCT01723254|9901345|FG002|NOT COMPLETED|Overall Study||3
8846722|NCT01723254|9901346|FG003|NOT COMPLETED|Overall Study||2
8846723|NCT01723254|9901347|FG004|NOT COMPLETED|Overall Study||2
8846724|NCT01723254|9901348|FG005|NOT COMPLETED|Overall Study||2
8846725|NCT01723254|9901349|FG006|NOT COMPLETED|Overall Study||1
8846726|NCT01723254|9901350|FG007|NOT COMPLETED|Overall Study||3
8846727|NCT01723384|9901370|FG000|STARTED|Overall Study||15
8846728|NCT01723384|9901371|FG001|STARTED|Overall Study||15
8846729|NCT01723384|9901370|FG000|COMPLETED|Overall Study||15
8846730|NCT01723384|9901371|FG001|COMPLETED|Overall Study||15
8846731|NCT01723384|9901370|FG000|NOT COMPLETED|Overall Study||0
8846732|NCT01723384|9901371|FG001|NOT COMPLETED|Overall Study||0
8846733|NCT01723397|9901379|FG000|STARTED|Study Period 1||7
8846734|NCT01723397|9901380|FG001|STARTED|Study Period 1||7
8846735|NCT01723397|9901379|FG000|COMPLETED|Study Period 1||7
8846736|NCT01723397|9901380|FG001|COMPLETED|Study Period 1||6
8846737|NCT01723397|9901379|FG000|NOT COMPLETED|Study Period 1||0
8846738|NCT01723397|9901380|FG001|NOT COMPLETED|Study Period 1||1
8846739|NCT01723397|9901379|FG000|STARTED|Washout||7
8846740|NCT01723397|9901380|FG001|STARTED|Washout||6
8846741|NCT01723397|9901379|FG000|COMPLETED|Washout||7
8846742|NCT01723397|9901380|FG001|COMPLETED|Washout||6
8846743|NCT01723397|9901379|FG000|NOT COMPLETED|Washout||0
8846744|NCT01723397|9901380|FG001|NOT COMPLETED|Washout||0
8846745|NCT01723397|9901379|FG000|STARTED|Study Period 2||7
8846746|NCT01723397|9901380|FG001|STARTED|Study Period 2||6
8846747|NCT01723397|9901379|FG000|COMPLETED|Study Period 2||7
8846748|NCT01723397|9901380|FG001|COMPLETED|Study Period 2||5
8846749|NCT01723397|9901379|FG000|NOT COMPLETED|Study Period 2||0
8846750|NCT01723397|9901380|FG001|NOT COMPLETED|Study Period 2||1
8846751|NCT01723514|9901394|FG000|STARTED|Overall Study||8
8846752|NCT01723514|9901395|FG001|STARTED|Overall Study||6
8846753|NCT01723514|9901396|FG002|STARTED|Overall Study||6
8846754|NCT01723514|9901397|FG003|STARTED|Overall Study||6
8846755|NCT01723514|9901398|FG004|STARTED|Overall Study||6
8846756|NCT01723514|9901399|FG005|STARTED|Overall Study||4
8846757|NCT01723514|9901400|FG006|STARTED|Overall Study||6
8846758|NCT01723514|9901401|FG007|STARTED|Overall Study||6
8846759|NCT01723514|9901394|FG000|COMPLETED|Overall Study||8
8846760|NCT01723514|9901395|FG001|COMPLETED|Overall Study||6
8846761|NCT01723514|9901396|FG002|COMPLETED|Overall Study||6
8846762|NCT01723514|9901397|FG003|COMPLETED|Overall Study||6
8846763|NCT01723514|9901398|FG004|COMPLETED|Overall Study||6
8846764|NCT01723514|9901399|FG005|COMPLETED|Overall Study||4
8846765|NCT01723514|9901400|FG006|COMPLETED|Overall Study||6
8846766|NCT01723514|9901401|FG007|COMPLETED|Overall Study||6
8846767|NCT01723514|9901394|FG000|NOT COMPLETED|Overall Study||0
8846768|NCT01723514|9901395|FG001|NOT COMPLETED|Overall Study||0
8846769|NCT01723514|9901396|FG002|NOT COMPLETED|Overall Study||0
8846770|NCT01723514|9901397|FG003|NOT COMPLETED|Overall Study||0
8846771|NCT01723514|9901398|FG004|NOT COMPLETED|Overall Study||0
8846772|NCT01723514|9901399|FG005|NOT COMPLETED|Overall Study||0
8846773|NCT01723514|9901400|FG006|NOT COMPLETED|Overall Study||0
8846774|NCT01723514|9901401|FG007|NOT COMPLETED|Overall Study||0
8846775|NCT01723696|9901421|FG000|STARTED|Overall Study||126
8846776|NCT01723696|9901422|FG001|STARTED|Overall Study||126
8846777|NCT01723696|9901421|FG000|COMPLETED|Overall Study||109
8846778|NCT01723696|9901422|FG001|COMPLETED|Overall Study||113
8846779|NCT01723696|9901421|FG000|NOT COMPLETED|Overall Study||17
8846780|NCT01723696|9901422|FG001|NOT COMPLETED|Overall Study||13
8846781|NCT01723722|9901432|FG000|STARTED|Overall Study||20
8846782|NCT01723722|9901433|FG001|STARTED|Overall Study||20
8846783|NCT01723722|9901432|FG000|COMPLETED|Overall Study||20
8846784|NCT01723722|9901433|FG001|COMPLETED|Overall Study||20
8846785|NCT01723722|9901432|FG000|NOT COMPLETED|Overall Study||0
8846786|NCT01723722|9901433|FG001|NOT COMPLETED|Overall Study||0
8846787|NCT01723826|9901443|FG000|STARTED|Overall Study||47
8846788|NCT01723826|9901444|FG001|STARTED|Overall Study||63
8846789|NCT01723826|9901445|FG002|STARTED|Overall Study||101
8846790|NCT01723826|9901446|FG003|STARTED|Overall Study||149
8846791|NCT01723826|9901443|FG000|COMPLETED|Overall Study||20
8846792|NCT01723826|9901444|FG001|COMPLETED|Overall Study||27
8846793|NCT01723826|9901445|FG002|COMPLETED|Overall Study||44
8846794|NCT01723826|9901446|FG003|COMPLETED|Overall Study||59
8846795|NCT01723826|9901443|FG000|NOT COMPLETED|Overall Study||27
8846796|NCT01723826|9901444|FG001|NOT COMPLETED|Overall Study||36
8846797|NCT01723826|9901445|FG002|NOT COMPLETED|Overall Study||57
8846798|NCT01723826|9901446|FG003|NOT COMPLETED|Overall Study||90
8850230|NCT01746017|9905497|FG000|Received at Least 1 Dose of Study Drug|Period 1||2
8850231|NCT01746017|9905498|FG001|Received at Least 1 Dose of Study Drug|Period 1||2
8850232|NCT01746017|9905499|FG002|Received at Least 1 Dose of Study Drug|Period 1||2
8850233|NCT01746017|9905500|FG003|Received at Least 1 Dose of Study Drug|Period 1||2
8850234|NCT01746017|9905501|FG004|Received at Least 1 Dose of Study Drug|Period 1||2
8850235|NCT01746017|9905502|FG005|Received at Least 1 Dose of Study Drug|Period 1||2
8850236|NCT01746017|9905503|FG006|Received at Least 1 Dose of Study Drug|Period 1||3
8850237|NCT01746017|9905504|FG007|Received at Least 1 Dose of Study Drug|Period 1||2
8850238|NCT01746017|9905505|FG008|Received at Least 1 Dose of Study Drug|Period 1||3
8850239|NCT01746017|9905506|FG009|Received at Least 1 Dose of Study Drug|Period 1||3
8850240|NCT01746017|9905507|FG010|Received at Least 1 Dose of Study Drug|Period 1||3
8850241|NCT01746017|9905497|FG000|COMPLETED|Period 1||2
8850242|NCT01746017|9905498|FG001|COMPLETED|Period 1||2
8846799|NCT01723904|9901456|FG000|STARTED|Overall Study||90
8846800|NCT01723904|9901456|FG000|COMPLETED|Overall Study||79
8846801|NCT01723904|9901456|FG000|NOT COMPLETED|Overall Study||11
8846802|NCT01724021|9901462|FG000|STARTED|Overall Study||371
8846803|NCT01724021|9901463|FG001|STARTED|Overall Study||369
8846804|NCT01724021|9901462|FG000|COMPLETED|Overall Study||244
8846805|NCT01724021|9901463|FG001|COMPLETED|Overall Study||236
8846806|NCT01724021|9901462|FG000|NOT COMPLETED|Overall Study||127
8846807|NCT01724021|9901463|FG001|NOT COMPLETED|Overall Study||133
8846808|NCT01724060|9901479|FG000|STARTED|Overall Study||10
8846809|NCT01724060|9901480|FG001|STARTED|Overall Study||10
8846810|NCT01724060|9901481|FG002|STARTED|Overall Study||10
8846811|NCT01724060|9901482|FG003|STARTED|Overall Study||10
8846812|NCT01724060|9901483|FG004|STARTED|Overall Study||10
8846813|NCT01724060|9901484|FG005|STARTED|Overall Study||10
8846814|NCT01724060|9901485|FG006|STARTED|Overall Study||10
8846815|NCT01724060|9901486|FG007|STARTED|Overall Study||10
8846816|NCT01724060|9901479|FG000|COMPLETED|Overall Study||10
8846817|NCT01724060|9901480|FG001|COMPLETED|Overall Study||10
8846818|NCT01724060|9901481|FG002|COMPLETED|Overall Study||10
8846819|NCT01724060|9901482|FG003|COMPLETED|Overall Study||10
8846820|NCT01724060|9901483|FG004|COMPLETED|Overall Study||10
8846821|NCT01724060|9901484|FG005|COMPLETED|Overall Study||10
8846822|NCT01724060|9901485|FG006|COMPLETED|Overall Study||10
8846823|NCT01724060|9901486|FG007|COMPLETED|Overall Study||10
8846824|NCT01724060|9901479|FG000|NOT COMPLETED|Overall Study||0
8846825|NCT01724060|9901480|FG001|NOT COMPLETED|Overall Study||0
8846826|NCT01724060|9901481|FG002|NOT COMPLETED|Overall Study||0
8846827|NCT01724060|9901482|FG003|NOT COMPLETED|Overall Study||0
8846828|NCT01724060|9901483|FG004|NOT COMPLETED|Overall Study||0
8846829|NCT01724060|9901484|FG005|NOT COMPLETED|Overall Study||0
8846830|NCT01724060|9901485|FG006|NOT COMPLETED|Overall Study||0
8846831|NCT01724060|9901486|FG007|NOT COMPLETED|Overall Study||0
8846832|NCT01724177|9901504|FG000|STARTED|Overall Study||26
8846833|NCT01724177|9901504|FG000|Safety Population|Overall Study|Safety Population includes participants who received at least one dose of lenalidomide|26
8846834|NCT01724177|9901504|FG000|COMPLETED|Overall Study||0
8846835|NCT01724177|9901504|FG000|NOT COMPLETED|Overall Study||26
8846836|NCT01724216|9901509|FG000|STARTED|Overall Study||11
8846837|NCT01724216|9901509|FG000|COMPLETED|Overall Study||10
8846838|NCT01724216|9901509|FG000|NOT COMPLETED|Overall Study||1
8846839|NCT01724359|9901513|FG000|STARTED|Overall Study||95
8846840|NCT01724359|9901513|FG000|COMPLETED|Overall Study||64
8846841|NCT01724359|9901513|FG000|NOT COMPLETED|Overall Study||31
8846842|NCT01724489|9901521|FG000|STARTED|Overall Study||39
8846843|NCT01724489|9901522|FG001|STARTED|Overall Study||38
8846844|NCT01724489|9901521|FG000|COMPLETED|Overall Study||23
8846845|NCT01724489|9901522|FG001|COMPLETED|Overall Study||26
8846846|NCT01724489|9901521|FG000|NOT COMPLETED|Overall Study||16
8846847|NCT01724489|9901522|FG001|NOT COMPLETED|Overall Study||12
8846848|NCT01724528|9901530|FG000|STARTED|Overall Study||173
8846849|NCT01724528|9901531|FG001|STARTED|Overall Study||173
8846850|NCT01724528|9901530|FG000|COMPLETED|Overall Study||169
8846851|NCT01724528|9901531|FG001|COMPLETED|Overall Study||170
8846852|NCT01724528|9901530|FG000|NOT COMPLETED|Overall Study||4
8846853|NCT01724528|9901531|FG001|NOT COMPLETED|Overall Study||3
8846854|NCT01725126|9901543|FG000|STARTED|Overall Study||4
8846855|NCT01725126|9901544|FG001|STARTED|Overall Study||11
8846856|NCT01725126|9901545|FG002|STARTED|Overall Study||6
8846857|NCT01725126|9901546|FG003|STARTED|Overall Study||14
8846858|NCT01725126|9901547|FG004|STARTED|Overall Study||6
8846859|NCT01725126|9901548|FG005|STARTED|Overall Study||12
8846860|NCT01725126|9901543|FG000|COMPLETED|Overall Study||4
8846861|NCT01725126|9901544|FG001|COMPLETED|Overall Study||10
8846862|NCT01725126|9901545|FG002|COMPLETED|Overall Study||6
8846863|NCT01725126|9901546|FG003|COMPLETED|Overall Study||13
8846864|NCT01725126|9901547|FG004|COMPLETED|Overall Study||6
8846865|NCT01725126|9901548|FG005|COMPLETED|Overall Study||12
8846866|NCT01725126|9901543|FG000|NOT COMPLETED|Overall Study||0
8846867|NCT01725126|9901544|FG001|NOT COMPLETED|Overall Study||1
8626762|NCT00515502|9666586|FG000|NOT COMPLETED|Washout Period 1||0
8626763|NCT00515502|9666587|FG001|NOT COMPLETED|Washout Period 1||0
8626764|NCT00515502|9666588|FG002|NOT COMPLETED|Washout Period 1||0
8626765|NCT00515502|9666589|FG003|NOT COMPLETED|Washout Period 1||0
8626766|NCT00515502|9666590|FG004|NOT COMPLETED|Washout Period 1||0
8846868|NCT01725126|9901545|FG002|NOT COMPLETED|Overall Study||0
8846869|NCT01725126|9901546|FG003|NOT COMPLETED|Overall Study||1
8846870|NCT01725126|9901547|FG004|NOT COMPLETED|Overall Study||0
8846871|NCT01725126|9901548|FG005|NOT COMPLETED|Overall Study||0
8846872|NCT01725217|9901574|FG000|STARTED|Overall Study||66
8846873|NCT01725217|9901575|FG001|STARTED|Overall Study||66
8846874|NCT01725217|9901576|FG002|STARTED|Overall Study||66
8846875|NCT01725217|9901574|FG000|COMPLETED|Overall Study||65
8846876|NCT01725217|9901575|FG001|COMPLETED|Overall Study||66
8846877|NCT01725217|9901576|FG002|COMPLETED|Overall Study||66
8846878|NCT01725217|9901574|FG000|NOT COMPLETED|Overall Study||1
8846879|NCT01725217|9901575|FG001|NOT COMPLETED|Overall Study||0
8846880|NCT01725217|9901576|FG002|NOT COMPLETED|Overall Study||0
8846881|NCT01725282|9901597|FG000|STARTED|Overall Study||44
8846882|NCT01725282|9901598|FG001|STARTED|Overall Study||44
8846883|NCT01725282|9901599|FG002|STARTED|Overall Study||41
8846884|NCT01725282|9901600|FG003|STARTED|Overall Study||43
8846885|NCT01725282|9901597|FG000|COMPLETED|Overall Study||42
8846886|NCT01725282|9901598|FG001|COMPLETED|Overall Study||39
8846887|NCT01725282|9901599|FG002|COMPLETED|Overall Study||33
8846888|NCT01725282|9901600|FG003|COMPLETED|Overall Study||36
8846889|NCT01725282|9901597|FG000|NOT COMPLETED|Overall Study||2
8846890|NCT01725282|9901598|FG001|NOT COMPLETED|Overall Study||5
8846891|NCT01725282|9901599|FG002|NOT COMPLETED|Overall Study||8
8846892|NCT01725282|9901600|FG003|NOT COMPLETED|Overall Study||7
8846893|NCT01725308|9901613|FG000|STARTED|Treatment Period I||178
8846894|NCT01725308|9901614|FG001|STARTED|Treatment Period I||74
8846895|NCT01725308|9901615|FG002|STARTED|Treatment Period I||179
8846896|NCT01725308|9901613|FG000|Treated|Treatment Period I||177
8846897|NCT01725308|9901614|FG001|Treated|Treatment Period I||74
8846898|NCT01725308|9901615|FG002|Treated|Treatment Period I||179
8846899|NCT01725308|9901613|FG000|COMPLETED|Treatment Period I||134
8846900|NCT01725308|9901614|FG001|COMPLETED|Treatment Period I||60
8846901|NCT01725308|9901615|FG002|COMPLETED|Treatment Period I||138
8846902|NCT01725308|9901613|FG000|NOT COMPLETED|Treatment Period I||44
8846903|NCT01725308|9901614|FG001|NOT COMPLETED|Treatment Period I||14
8846904|NCT01725308|9901615|FG002|NOT COMPLETED|Treatment Period I||41
8846905|NCT01725308|9901613|FG000|STARTED|Treatment Period II||134
8846906|NCT01725308|9901614|FG001|STARTED|Treatment Period II||60
8846907|NCT01725308|9901615|FG002|STARTED|Treatment Period II||138
8846908|NCT01725308|9901613|FG000|Treated|Treatment Period II||120
8846909|NCT01725308|9901614|FG001|Treated|Treatment Period II||53
8846910|NCT01725308|9901615|FG002|Treated|Treatment Period II||130
8846911|NCT01725308|9901613|FG000|COMPLETED|Treatment Period II||79
8846912|NCT01725308|9901614|FG001|COMPLETED|Treatment Period II||31
8846913|NCT01725308|9901615|FG002|COMPLETED|Treatment Period II||74
8846914|NCT01725308|9901613|FG000|NOT COMPLETED|Treatment Period II||55
8846915|NCT01725308|9901614|FG001|NOT COMPLETED|Treatment Period II||29
8846916|NCT01725308|9901615|FG002|NOT COMPLETED|Treatment Period II||64
8846917|NCT01725386|9901632|FG000|STARTED|Overall Study||188
8626767|NCT00515502|9666591|FG005|NOT COMPLETED|Washout Period 1||0
8846918|NCT01725386|9901633|FG001|STARTED|Overall Study||63
8846919|NCT01725386|9901632|FG000|COMPLETED|Overall Study||13
8846920|NCT01725386|9901633|FG001|COMPLETED|Overall Study||17
8846921|NCT01725386|9901632|FG000|NOT COMPLETED|Overall Study||175
8846922|NCT01725386|9901633|FG001|NOT COMPLETED|Overall Study||46
8846923|NCT01725451|9901639|FG000|STARTED|Period 1||8
8846924|NCT01725451|9901640|FG001|STARTED|Period 1||7
8846925|NCT01725451|9901641|FG002|STARTED|Period 1||8
8626768|NCT00515502|9666592|FG006|NOT COMPLETED|Washout Period 1||0
8846926|NCT01725451|9901642|FG003|STARTED|Period 1||7
8626769|NCT00515502|9666593|FG007|NOT COMPLETED|Washout Period 1||0
8846927|NCT01725451|9901639|FG000|COMPLETED|Period 1||7
8846928|NCT01725451|9901640|FG001|COMPLETED|Period 1||7
8846929|NCT01725451|9901641|FG002|COMPLETED|Period 1||8
8846930|NCT01725451|9901642|FG003|COMPLETED|Period 1||7
8846931|NCT01725451|9901639|FG000|NOT COMPLETED|Period 1||1
8846932|NCT01725451|9901640|FG001|NOT COMPLETED|Period 1||0
8846933|NCT01725451|9901641|FG002|NOT COMPLETED|Period 1||0
8846934|NCT01725451|9901642|FG003|NOT COMPLETED|Period 1||0
8846935|NCT01725451|9901639|FG000|STARTED|Washout From Period 1||7
8846936|NCT01725451|9901640|FG001|STARTED|Washout From Period 1||7
8846937|NCT01725451|9901641|FG002|STARTED|Washout From Period 1||8
8846938|NCT01725451|9901642|FG003|STARTED|Washout From Period 1||7
8846939|NCT01725451|9901639|FG000|COMPLETED|Washout From Period 1||7
8846940|NCT01725451|9901640|FG001|COMPLETED|Washout From Period 1||7
8846941|NCT01725451|9901641|FG002|COMPLETED|Washout From Period 1||8
8846942|NCT01725451|9901642|FG003|COMPLETED|Washout From Period 1||7
8846943|NCT01725451|9901639|FG000|NOT COMPLETED|Washout From Period 1||0
8846944|NCT01725451|9901640|FG001|NOT COMPLETED|Washout From Period 1||0
8846945|NCT01725451|9901641|FG002|NOT COMPLETED|Washout From Period 1||0
8846946|NCT01725451|9901642|FG003|NOT COMPLETED|Washout From Period 1||0
8846947|NCT01725451|9901639|FG000|STARTED|Period 2||7
8846948|NCT01725451|9901640|FG001|STARTED|Period 2||7
8846949|NCT01725451|9901641|FG002|STARTED|Period 2||8
8846950|NCT01725451|9901642|FG003|STARTED|Period 2||7
8846951|NCT01725451|9901639|FG000|COMPLETED|Period 2||7
8846952|NCT01725451|9901640|FG001|COMPLETED|Period 2||7
8846953|NCT01725451|9901641|FG002|COMPLETED|Period 2||8
8846954|NCT01725451|9901642|FG003|COMPLETED|Period 2||7
8846955|NCT01725451|9901639|FG000|NOT COMPLETED|Period 2||0
8846956|NCT01725451|9901640|FG001|NOT COMPLETED|Period 2||0
8846957|NCT01725451|9901641|FG002|NOT COMPLETED|Period 2||0
8556929|NCT03713684|9588707|FG001|COMPLETED|Overall Study||5
8846958|NCT01725451|9901642|FG003|NOT COMPLETED|Period 2||0
8846959|NCT01725451|9901639|FG000|STARTED|Washout From Period 2||7
8846960|NCT01725451|9901640|FG001|STARTED|Washout From Period 2||7
8846961|NCT01725451|9901641|FG002|STARTED|Washout From Period 2||8
8846962|NCT01725451|9901642|FG003|STARTED|Washout From Period 2||7
8846963|NCT01725451|9901639|FG000|COMPLETED|Washout From Period 2||7
8846964|NCT01725451|9901640|FG001|COMPLETED|Washout From Period 2||7
8846965|NCT01725451|9901641|FG002|COMPLETED|Washout From Period 2||8
8846966|NCT01725451|9901642|FG003|COMPLETED|Washout From Period 2||7
8846967|NCT01725451|9901639|FG000|NOT COMPLETED|Washout From Period 2||0
8846968|NCT01725451|9901640|FG001|NOT COMPLETED|Washout From Period 2||0
8846969|NCT01725451|9901641|FG002|NOT COMPLETED|Washout From Period 2||0
8846970|NCT01725451|9901642|FG003|NOT COMPLETED|Washout From Period 2||0
8846971|NCT01725451|9901639|FG000|STARTED|Period 3||7
8846972|NCT01725451|9901640|FG001|STARTED|Period 3||7
8846973|NCT01725451|9901641|FG002|STARTED|Period 3||8
8846974|NCT01725451|9901642|FG003|STARTED|Period 3||7
8846975|NCT01725451|9901639|FG000|COMPLETED|Period 3||7
8846976|NCT01725451|9901640|FG001|COMPLETED|Period 3||7
8846977|NCT01725451|9901641|FG002|COMPLETED|Period 3||8
8846978|NCT01725451|9901642|FG003|COMPLETED|Period 3||7
8846979|NCT01725451|9901639|FG000|NOT COMPLETED|Period 3||0
8846980|NCT01725451|9901640|FG001|NOT COMPLETED|Period 3||0
8846981|NCT01725451|9901641|FG002|NOT COMPLETED|Period 3||0
8846982|NCT01725451|9901642|FG003|NOT COMPLETED|Period 3||0
8846983|NCT01725451|9901639|FG000|STARTED|Washout From Period 3||7
8846984|NCT01725451|9901640|FG001|STARTED|Washout From Period 3||7
8846985|NCT01725451|9901641|FG002|STARTED|Washout From Period 3||8
8846986|NCT01725451|9901642|FG003|STARTED|Washout From Period 3||7
8846987|NCT01725451|9901639|FG000|COMPLETED|Washout From Period 3||7
8846988|NCT01725451|9901640|FG001|COMPLETED|Washout From Period 3||6
8846989|NCT01725451|9901641|FG002|COMPLETED|Washout From Period 3||7
8846990|NCT01725451|9901642|FG003|COMPLETED|Washout From Period 3||7
8846991|NCT01725451|9901639|FG000|NOT COMPLETED|Washout From Period 3||0
8846992|NCT01725451|9901640|FG001|NOT COMPLETED|Washout From Period 3||1
8846993|NCT01725451|9901641|FG002|NOT COMPLETED|Washout From Period 3||1
8846994|NCT01725451|9901642|FG003|NOT COMPLETED|Washout From Period 3||0
8846995|NCT01725451|9901639|FG000|STARTED|Period 4||7
8846996|NCT01725451|9901640|FG001|STARTED|Period 4||6
8846997|NCT01725451|9901641|FG002|STARTED|Period 4||7
8846998|NCT01725451|9901642|FG003|STARTED|Period 4||7
8846999|NCT01725451|9901639|FG000|COMPLETED|Period 4||7
8847000|NCT01725451|9901640|FG001|COMPLETED|Period 4||6
8847001|NCT01725451|9901641|FG002|COMPLETED|Period 4||6
8847002|NCT01725451|9901642|FG003|COMPLETED|Period 4||7
8847003|NCT01725451|9901639|FG000|NOT COMPLETED|Period 4||0
8847004|NCT01725451|9901640|FG001|NOT COMPLETED|Period 4||0
8847005|NCT01725451|9901641|FG002|NOT COMPLETED|Period 4||1
8847006|NCT01725451|9901642|FG003|NOT COMPLETED|Period 4||0
8847007|NCT01725451|9901639|FG000|STARTED|Washout From Period 4||7
8847008|NCT01725451|9901640|FG001|STARTED|Washout From Period 4||6
8847009|NCT01725451|9901641|FG002|STARTED|Washout From Period 4||6
8847010|NCT01725451|9901642|FG003|STARTED|Washout From Period 4||7
8847011|NCT01725451|9901639|FG000|COMPLETED|Washout From Period 4||7
8847012|NCT01725451|9901640|FG001|COMPLETED|Washout From Period 4||6
8847013|NCT01725451|9901641|FG002|COMPLETED|Washout From Period 4||6
8847014|NCT01725451|9901642|FG003|COMPLETED|Washout From Period 4||7
8847015|NCT01725451|9901639|FG000|NOT COMPLETED|Washout From Period 4||0
8847016|NCT01725451|9901640|FG001|NOT COMPLETED|Washout From Period 4||0
8847017|NCT01725451|9901641|FG002|NOT COMPLETED|Washout From Period 4||0
8847018|NCT01725451|9901642|FG003|NOT COMPLETED|Washout From Period 4||0
8847019|NCT01725451|9901639|FG000|STARTED|Period 5||7
8847020|NCT01725451|9901640|FG001|STARTED|Period 5||6
8847021|NCT01725451|9901641|FG002|STARTED|Period 5||6
8847022|NCT01725451|9901642|FG003|STARTED|Period 5||7
8847023|NCT01725451|9901639|FG000|COMPLETED|Period 5||7
8847024|NCT01725451|9901640|FG001|COMPLETED|Period 5||6
8847025|NCT01725451|9901641|FG002|COMPLETED|Period 5||6
8847026|NCT01725451|9901642|FG003|COMPLETED|Period 5||7
8556930|NCT03713684|9588708|FG002|COMPLETED|Overall Study||5
8556931|NCT03713684|9588709|FG003|COMPLETED|Overall Study||6
8847027|NCT01725451|9901639|FG000|NOT COMPLETED|Period 5||0
8847028|NCT01725451|9901640|FG001|NOT COMPLETED|Period 5||0
8847029|NCT01725451|9901641|FG002|NOT COMPLETED|Period 5||0
8847030|NCT01725451|9901642|FG003|NOT COMPLETED|Period 5||0
8847031|NCT01725451|9901639|FG000|STARTED|Washout From Period 5||7
8847032|NCT01725451|9901640|FG001|STARTED|Washout From Period 5||6
8847033|NCT01725451|9901641|FG002|STARTED|Washout From Period 5||6
8847034|NCT01725451|9901642|FG003|STARTED|Washout From Period 5||7
8847035|NCT01725451|9901639|FG000|COMPLETED|Washout From Period 5||7
8847036|NCT01725451|9901640|FG001|COMPLETED|Washout From Period 5||6
8847037|NCT01725451|9901641|FG002|COMPLETED|Washout From Period 5||6
8847038|NCT01725451|9901642|FG003|COMPLETED|Washout From Period 5||7
8847039|NCT01725451|9901639|FG000|NOT COMPLETED|Washout From Period 5||0
8847040|NCT01725451|9901640|FG001|NOT COMPLETED|Washout From Period 5||0
8847041|NCT01725451|9901641|FG002|NOT COMPLETED|Washout From Period 5||0
8847042|NCT01725451|9901642|FG003|NOT COMPLETED|Washout From Period 5||0
8847043|NCT01725451|9901639|FG000|STARTED|Period 6||7
8847044|NCT01725451|9901640|FG001|STARTED|Period 6||6
8847045|NCT01725451|9901641|FG002|STARTED|Period 6||6
8847046|NCT01725451|9901642|FG003|STARTED|Period 6||7
8847047|NCT01725451|9901639|FG000|COMPLETED|Period 6||7
8847048|NCT01725451|9901640|FG001|COMPLETED|Period 6||6
8847049|NCT01725451|9901641|FG002|COMPLETED|Period 6||6
8847050|NCT01725451|9901642|FG003|COMPLETED|Period 6||7
8847051|NCT01725451|9901639|FG000|NOT COMPLETED|Period 6||0
8847052|NCT01725451|9901640|FG001|NOT COMPLETED|Period 6||0
8847053|NCT01725451|9901641|FG002|NOT COMPLETED|Period 6||0
8847054|NCT01725451|9901642|FG003|NOT COMPLETED|Period 6||0
8847055|NCT01725529|9901660|FG000|STARTED|Overall Study||152
8847056|NCT01725529|9901661|FG001|STARTED|Overall Study||153
8847057|NCT01725529|9901662|FG002|STARTED|Overall Study||152
8847058|NCT01725529|9901660|FG000|COMPLETED|Overall Study||137
8847059|NCT01725529|9901661|FG001|COMPLETED|Overall Study||137
8847060|NCT01725529|9901662|FG002|COMPLETED|Overall Study||142
8847061|NCT01725529|9901660|FG000|NOT COMPLETED|Overall Study||15
8847062|NCT01725529|9901661|FG001|NOT COMPLETED|Overall Study||16
8847063|NCT01725529|9901662|FG002|NOT COMPLETED|Overall Study||10
8847064|NCT01725750|9901672|FG000|STARTED|Overall Study||44
8847065|NCT01725750|9901673|FG001|STARTED|Overall Study||44
8847066|NCT01725750|9901672|FG000|COMPLETED|Overall Study||42
8847067|NCT01725750|9901673|FG001|COMPLETED|Overall Study||34
8847068|NCT01725750|9901672|FG000|NOT COMPLETED|Overall Study||2
8847069|NCT01725750|9901673|FG001|NOT COMPLETED|Overall Study||10
8847070|NCT01725815|9901683|FG000|STARTED|Overall Study||198
8847071|NCT01725815|9901684|FG001|STARTED|Overall Study||202
8847072|NCT01725815|9901683|FG000|COMPLETED|Overall Study||198
8847073|NCT01725815|9901684|FG001|COMPLETED|Overall Study||202
8847074|NCT01725815|9901683|FG000|NOT COMPLETED|Overall Study||0
8847075|NCT01725815|9901684|FG001|NOT COMPLETED|Overall Study||0
8847076|NCT01725984|9901692|FG000|STARTED|Overall Study||39
8847077|NCT01725984|9901693|FG001|STARTED|Overall Study||41
8847078|NCT01725984|9901692|FG000|COMPLETED|Overall Study||39
8847079|NCT01725984|9901693|FG001|COMPLETED|Overall Study||41
8847080|NCT01725984|9901692|FG000|NOT COMPLETED|Overall Study||0
8847081|NCT01725984|9901693|FG001|NOT COMPLETED|Overall Study||0
8847082|NCT01726023|9901701|FG000|STARTED|Overall Study||219
8847083|NCT01726023|9901702|FG001|STARTED|Overall Study||222
8847084|NCT01726023|9901701|FG000|COMPLETED|Overall Study||190
8847085|NCT01726023|9901702|FG001|COMPLETED|Overall Study||196
8847086|NCT01726023|9901701|FG000|NOT COMPLETED|Overall Study||29
8847087|NCT01726023|9901702|FG001|NOT COMPLETED|Overall Study||26
8847088|NCT01726036|9901717|FG000|STARTED|Overall Study||137
8847089|NCT01726036|9901718|FG001|STARTED|Overall Study||137
8847090|NCT01726036|9901717|FG000|COMPLETED|Overall Study||121
8847091|NCT01726036|9901718|FG001|COMPLETED|Overall Study||130
8847092|NCT01726036|9901717|FG000|NOT COMPLETED|Overall Study||16
8847093|NCT01726036|9901718|FG001|NOT COMPLETED|Overall Study||7
8847094|NCT01726049|9901726|FG000|STARTED|Overall Study||26
8847095|NCT01726049|9901727|FG001|STARTED|Overall Study||26
8847096|NCT01726049|9901726|FG000|COMPLETED|Overall Study||21
8847097|NCT01726049|9901727|FG001|COMPLETED|Overall Study||22
8847098|NCT01726049|9901726|FG000|NOT COMPLETED|Overall Study||5
8847099|NCT01726049|9901727|FG001|NOT COMPLETED|Overall Study||4
8847100|NCT01726270|9901733|FG000|STARTED|Part 1, Self-Selection Phase||689
8847101|NCT01726270|9901733|FG000|COMPLETED|Part 1, Self-Selection Phase||679
8847102|NCT01726270|9901733|FG000|NOT COMPLETED|Part 1, Self-Selection Phase||10
8847103|NCT01726270|9901733|FG000|STARTED|Eligibility for Part 2|No. of subjects potentially eligible for Part 2|389
8847104|NCT01726270|9901733|FG000|COMPLETED|Eligibility for Part 2||369
8847105|NCT01726270|9901733|FG000|NOT COMPLETED|Eligibility for Part 2||20
8847106|NCT01726270|9901733|FG000|STARTED|Part 2, Actual-Use Phase|20 subjects were eligible for Part 2 but did not enter Part 2|369
8847107|NCT01726270|9901733|FG000|COMPLETED|Part 2, Actual-Use Phase||330
8847108|NCT01726270|9901733|FG000|NOT COMPLETED|Part 2, Actual-Use Phase||39
8847109|NCT01726335|9901739|FG000|STARTED|Overall Study||53
8847110|NCT01726335|9901739|FG000|COMPLETED|Overall Study||29
8847111|NCT01726335|9901739|FG000|NOT COMPLETED|Overall Study||24
8847112|NCT01726504|9901745|FG000|STARTED|Overall Study||536
8847113|NCT01726504|9901746|FG001|STARTED|Overall Study||539
8847114|NCT01726504|9901745|FG000|COMPLETED|Overall Study||524
8847115|NCT01726504|9901746|FG001|COMPLETED|Overall Study||511
8847116|NCT01726504|9901745|FG000|NOT COMPLETED|Overall Study||12
8847117|NCT01726504|9901746|FG001|NOT COMPLETED|Overall Study||28
8847118|NCT01726517|9901757|FG000|STARTED|Overall Study||20
8847119|NCT01726517|9901758|FG001|STARTED|Overall Study||21
8847120|NCT01726517|9901759|FG002|STARTED|Overall Study||19
8847121|NCT01726517|9901760|FG003|STARTED|Overall Study||19
8847122|NCT01726517|9901761|FG004|STARTED|Overall Study||21
8847123|NCT01726517|9901757|FG000|COMPLETED|Overall Study||20
8847124|NCT01726517|9901758|FG001|COMPLETED|Overall Study||21
8847125|NCT01726517|9901759|FG002|COMPLETED|Overall Study||18
8847126|NCT01726517|9901760|FG003|COMPLETED|Overall Study||19
8847127|NCT01726517|9901761|FG004|COMPLETED|Overall Study||21
8847128|NCT01726517|9901757|FG000|NOT COMPLETED|Overall Study||0
8847129|NCT01726517|9901758|FG001|NOT COMPLETED|Overall Study||0
8847130|NCT01726517|9901759|FG002|NOT COMPLETED|Overall Study||1
8847131|NCT01726517|9901760|FG003|NOT COMPLETED|Overall Study||0
8847132|NCT01726517|9901761|FG004|NOT COMPLETED|Overall Study||0
8847133|NCT01726621|9901773|FG000|STARTED|Overall Study||55
8847134|NCT01726621|9901773|FG000|COMPLETED|Overall Study||51
8847135|NCT01726621|9901773|FG000|NOT COMPLETED|Overall Study||4
8847136|NCT01726673|9901779|FG000|STARTED|Overall Study||30
8847137|NCT01726673|9901780|FG001|STARTED|Overall Study||24
8626770|NCT00515502|9666594|FG008|NOT COMPLETED|Washout Period 1||0
8626771|NCT00515502|9666595|FG009|NOT COMPLETED|Washout Period 1||0
8626772|NCT00515502|9666596|FG010|NOT COMPLETED|Washout Period 1||0
8626773|NCT00515502|9666597|FG011|NOT COMPLETED|Washout Period 1||0
8626774|NCT00515502|9666586|FG000|STARTED|Treatment Period 2||1
8847138|NCT01726673|9901779|FG000|COMPLETED|Overall Study||24
8847139|NCT01726673|9901780|FG001|COMPLETED|Overall Study||21
8847140|NCT01726673|9901779|FG000|NOT COMPLETED|Overall Study||6
8847141|NCT01726673|9901780|FG001|NOT COMPLETED|Overall Study||3
8847142|NCT01726738|9901786|FG000|STARTED|Overall Study||17
8847143|NCT01726738|9901786|FG000|COMPLETED|Overall Study||17
8847144|NCT01726738|9901786|FG000|NOT COMPLETED|Overall Study||0
8847145|NCT01726803|9901792|FG000|STARTED|Overall Study||112
8847146|NCT01726803|9901793|FG001|STARTED|Overall Study||108
8847147|NCT01726803|9901792|FG000|COMPLETED|Overall Study||105
8847148|NCT01726803|9901793|FG001|COMPLETED|Overall Study||107
8847149|NCT01726803|9901792|FG000|NOT COMPLETED|Overall Study||7
8847150|NCT01726803|9901793|FG001|NOT COMPLETED|Overall Study||1
8847151|NCT01727024|9901799|FG000|STARTED|Period 1||71
8847152|NCT01727024|9901800|FG001|STARTED|Period 1||68
8847153|NCT01727024|9901799|FG000|COMPLETED|Period 1||68
8847154|NCT01727024|9901800|FG001|COMPLETED|Period 1||64
8847155|NCT01727024|9901799|FG000|NOT COMPLETED|Period 1||3
8847156|NCT01727024|9901800|FG001|NOT COMPLETED|Period 1||4
8847157|NCT01727024|9901799|FG000|STARTED|Period 2||68
8847158|NCT01727024|9901800|FG001|STARTED|Period 2||64
8847159|NCT01727024|9901799|FG000|COMPLETED|Period 2||68
8847160|NCT01727024|9901800|FG001|COMPLETED|Period 2||64
8847161|NCT01727024|9901799|FG000|NOT COMPLETED|Period 2||0
8847162|NCT01727024|9901800|FG001|NOT COMPLETED|Period 2||0
8847163|NCT01727089|9901808|FG000|STARTED|Overall Study||29
8847164|NCT01727089|9901809|FG001|STARTED|Overall Study||30
8847165|NCT01727089|9901808|FG000|COMPLETED|Overall Study||29
8847166|NCT01727089|9901809|FG001|COMPLETED|Overall Study||30
8847167|NCT01727089|9901808|FG000|NOT COMPLETED|Overall Study||0
8847168|NCT01727089|9901809|FG001|NOT COMPLETED|Overall Study||0
8847169|NCT01727141|9901819|FG000|STARTED|Overall Study||260
8847170|NCT01727141|9901820|FG001|STARTED|Overall Study||260
8847171|NCT01727141|9901821|FG002|STARTED|Overall Study||261
8847172|NCT01727141|9901822|FG003|STARTED|Overall Study||261
8847173|NCT01727141|9901819|FG000|Safety Set|Overall Study||258
8847174|NCT01727141|9901820|FG001|Safety Set|Overall Study||260
8847175|NCT01727141|9901821|FG002|Safety Set|Overall Study||262
8847176|NCT01727141|9901822|FG003|Safety Set|Overall Study||260
8847177|NCT01727141|9901819|FG000|Full Analysis Set|Overall Study||258
8847178|NCT01727141|9901820|FG001|Full Analysis Set|Overall Study||260
8847179|NCT01727141|9901821|FG002|Full Analysis Set|Overall Study||261
8847180|NCT01727141|9901822|FG003|Full Analysis Set|Overall Study||261
8847181|NCT01727141|9901819|FG000|COMPLETED|Overall Study||255
8847182|NCT01727141|9901820|FG001|COMPLETED|Overall Study||251
8847183|NCT01727141|9901821|FG002|COMPLETED|Overall Study||258
8847184|NCT01727141|9901822|FG003|COMPLETED|Overall Study||246
8847185|NCT01727141|9901819|FG000|NOT COMPLETED|Overall Study||5
8847186|NCT01727141|9901820|FG001|NOT COMPLETED|Overall Study||9
8847187|NCT01727141|9901821|FG002|NOT COMPLETED|Overall Study||3
8847188|NCT01727141|9901822|FG003|NOT COMPLETED|Overall Study||15
8847189|NCT01727154|9901832|FG000|STARTED|Overall Study||139
8847190|NCT01727154|9901832|FG000|COMPLETED|Overall Study||80
8847191|NCT01727154|9901832|FG000|NOT COMPLETED|Overall Study||59
8847192|NCT01727180|9901836|FG000|STARTED|Overall Study||108
8847193|NCT01727180|9901836|FG000|COMPLETED|Overall Study||108
8847194|NCT01727180|9901836|FG000|NOT COMPLETED|Overall Study||0
8847195|NCT01727258|9901843|FG000|STARTED|Overall Study||51
8847196|NCT01727258|9901844|FG001|STARTED|Overall Study||51
8847197|NCT01727258|9901845|FG002|STARTED|Overall Study||51
8847198|NCT01727258|9901843|FG000|COMPLETED|Overall Study||49
8847199|NCT01727258|9901844|FG001|COMPLETED|Overall Study||48
8847200|NCT01727258|9901845|FG002|COMPLETED|Overall Study||50
8847201|NCT01727258|9901843|FG000|NOT COMPLETED|Overall Study||2
8847202|NCT01727258|9901844|FG001|NOT COMPLETED|Overall Study||3
8847203|NCT01727258|9901845|FG002|NOT COMPLETED|Overall Study||1
8847204|NCT01727297|9901853|FG000|STARTED|Overall Study||395
8847205|NCT01727297|9901854|FG001|STARTED|Overall Study||51
8847206|NCT01727297|9901853|FG000|COMPLETED|Overall Study||293
8847207|NCT01727297|9901854|FG001|COMPLETED|Overall Study||0
8847208|NCT01727297|9901853|FG000|NOT COMPLETED|Overall Study||102
8847209|NCT01727297|9901854|FG001|NOT COMPLETED|Overall Study||51
8847210|NCT01727336|9901873|FG000|STARTED|Part 1 Dalantercept Dose Escalation||6
8847211|NCT01727336|9901874|FG001|STARTED|Part 1 Dalantercept Dose Escalation||9
8847212|NCT01727336|9901875|FG002|STARTED|Part 1 Dalantercept Dose Escalation||14
8847213|NCT01727336|9901876|FG003|STARTED|Part 1 Dalantercept Dose Escalation||0
8847214|NCT01727336|9901877|FG004|STARTED|Part 1 Dalantercept Dose Escalation||0
8847215|NCT01727336|9901878|FG005|STARTED|Part 1 Dalantercept Dose Escalation||0
8847216|NCT01727336|9901873|FG000|COMPLETED|Part 1 Dalantercept Dose Escalation||3
8847217|NCT01727336|9901874|FG001|COMPLETED|Part 1 Dalantercept Dose Escalation||7
8847218|NCT01727336|9901875|FG002|COMPLETED|Part 1 Dalantercept Dose Escalation||6
8847219|NCT01727336|9901876|FG003|COMPLETED|Part 1 Dalantercept Dose Escalation||0
8847220|NCT01727336|9901877|FG004|COMPLETED|Part 1 Dalantercept Dose Escalation||0
8847221|NCT01727336|9901878|FG005|COMPLETED|Part 1 Dalantercept Dose Escalation||0
8847222|NCT01727336|9901873|FG000|NOT COMPLETED|Part 1 Dalantercept Dose Escalation||3
8847223|NCT01727336|9901874|FG001|NOT COMPLETED|Part 1 Dalantercept Dose Escalation||2
8847224|NCT01727336|9901875|FG002|NOT COMPLETED|Part 1 Dalantercept Dose Escalation||8
8847225|NCT01727336|9901876|FG003|NOT COMPLETED|Part 1 Dalantercept Dose Escalation||0
8847226|NCT01727336|9901877|FG004|NOT COMPLETED|Part 1 Dalantercept Dose Escalation||0
8847227|NCT01727336|9901878|FG005|NOT COMPLETED|Part 1 Dalantercept Dose Escalation||0
8847228|NCT01727336|9901873|FG000|STARTED|Part 2 Blinded||0
8847229|NCT01727336|9901874|FG001|STARTED|Part 2 Blinded||0
8847230|NCT01727336|9901875|FG002|STARTED|Part 2 Blinded||0
8847231|NCT01727336|9901876|FG003|STARTED|Part 2 Blinded||0
8626775|NCT00515502|9666587|FG001|STARTED|Treatment Period 2||4
8626776|NCT00515502|9666588|FG002|STARTED|Treatment Period 2||4
8626777|NCT00515502|9666589|FG003|STARTED|Treatment Period 2||3
8847232|NCT01727336|9901877|FG004|STARTED|Part 2 Blinded||63
8847233|NCT01727336|9901878|FG005|STARTED|Part 2 Blinded||68
8847234|NCT01727336|9901873|FG000|COMPLETED|Part 2 Blinded||0
8847235|NCT01727336|9901874|FG001|COMPLETED|Part 2 Blinded||0
8847236|NCT01727336|9901875|FG002|COMPLETED|Part 2 Blinded||0
8847237|NCT01727336|9901876|FG003|COMPLETED|Part 2 Blinded||0
8847238|NCT01727336|9901877|FG004|COMPLETED|Part 2 Blinded||0
8847239|NCT01727336|9901878|FG005|COMPLETED|Part 2 Blinded||0
8847240|NCT01727336|9901873|FG000|NOT COMPLETED|Part 2 Blinded||0
8847241|NCT01727336|9901874|FG001|NOT COMPLETED|Part 2 Blinded||0
8847242|NCT01727336|9901875|FG002|NOT COMPLETED|Part 2 Blinded||0
8847243|NCT01727336|9901876|FG003|NOT COMPLETED|Part 2 Blinded||0
8847244|NCT01727336|9901877|FG004|NOT COMPLETED|Part 2 Blinded||63
8847245|NCT01727336|9901878|FG005|NOT COMPLETED|Part 2 Blinded||68
8847246|NCT01727414|9901900|FG000|STARTED|Overall Study||126
8847247|NCT01727414|9901901|FG001|STARTED|Overall Study||45
8847248|NCT01727414|9901900|FG000|COMPLETED|Overall Study||123
8847249|NCT01727414|9901901|FG001|COMPLETED|Overall Study||45
8847250|NCT01727414|9901900|FG000|NOT COMPLETED|Overall Study||3
8847251|NCT01727414|9901901|FG001|NOT COMPLETED|Overall Study||0
8847252|NCT01727505|9901907|FG000|STARTED|First 24 Hours||14
8847253|NCT01727505|9901908|FG001|STARTED|First 24 Hours||12
8847254|NCT01727505|9901907|FG000|COMPLETED|First 24 Hours||14
8847255|NCT01727505|9901908|FG001|COMPLETED|First 24 Hours||11
8847256|NCT01727505|9901907|FG000|NOT COMPLETED|First 24 Hours||0
8847257|NCT01727505|9901908|FG001|NOT COMPLETED|First 24 Hours||1
8847258|NCT01727505|9901907|FG000|STARTED|Second 24 Hours||14
8847259|NCT01727505|9901908|FG001|STARTED|Second 24 Hours||11
8847260|NCT01727505|9901907|FG000|COMPLETED|Second 24 Hours||14
8847261|NCT01727505|9901908|FG001|COMPLETED|Second 24 Hours||10
8847262|NCT01727505|9901907|FG000|NOT COMPLETED|Second 24 Hours||0
8847263|NCT01727505|9901908|FG001|NOT COMPLETED|Second 24 Hours||1
8847264|NCT01727700|9901917|FG000|STARTED|Overall Study||44
8847265|NCT01727700|9901918|FG001|STARTED|Overall Study||45
8847266|NCT01727700|9901919|FG002|STARTED|Overall Study||44
8847267|NCT01727700|9901917|FG000|COMPLETED|Overall Study||42
8847268|NCT01727700|9901918|FG001|COMPLETED|Overall Study||35
8847269|NCT01727700|9901919|FG002|COMPLETED|Overall Study||42
8847270|NCT01727700|9901917|FG000|NOT COMPLETED|Overall Study||2
8847271|NCT01727700|9901918|FG001|NOT COMPLETED|Overall Study||10
8847272|NCT01727700|9901919|FG002|NOT COMPLETED|Overall Study||2
8847273|NCT01727713|9901927|FG000|STARTED|Overall Study||110
8847274|NCT01727713|9901927|FG000|COMPLETED|Overall Study||75
8847275|NCT01727713|9901927|FG000|NOT COMPLETED|Overall Study||35
8847276|NCT01727726|9901934|FG000|STARTED|Overall Study||197
8847277|NCT01727726|9901935|FG001|STARTED|Overall Study||100
8847278|NCT01727726|9901936|FG002|STARTED|Overall Study||206
8847279|NCT01727726|9901934|FG000|COMPLETED|Overall Study||171
8847280|NCT01727726|9901935|FG001|COMPLETED|Overall Study||86
8847281|NCT01727726|9901936|FG002|COMPLETED|Overall Study||186
8847282|NCT01727726|9901934|FG000|NOT COMPLETED|Overall Study||26
8847283|NCT01727726|9901935|FG001|NOT COMPLETED|Overall Study||14
8847284|NCT01727726|9901936|FG002|NOT COMPLETED|Overall Study||20
8847285|NCT01727765|9901946|FG000|STARTED|Overall Study||8
8847286|NCT01727765|9901947|FG001|STARTED|Overall Study||8
8847287|NCT01727765|9901946|FG000|COMPLETED|Overall Study||8
8847288|NCT01727765|9901947|FG001|COMPLETED|Overall Study||8
8626778|NCT00515502|9666590|FG004|STARTED|Treatment Period 2||3
8626779|NCT00515502|9666591|FG005|STARTED|Treatment Period 2||1
8626780|NCT00515502|9666592|FG006|STARTED|Treatment Period 2||1
8626781|NCT00515502|9666593|FG007|STARTED|Treatment Period 2||1
8847289|NCT01727765|9901946|FG000|NOT COMPLETED|Overall Study||0
8847290|NCT01727765|9901947|FG001|NOT COMPLETED|Overall Study||0
8847291|NCT01727791|9901953|FG000|STARTED|Overall Study||10
8847292|NCT01727791|9901953|FG000|COMPLETED|Overall Study||10
8847293|NCT01727791|9901953|FG000|NOT COMPLETED|Overall Study||0
8626782|NCT00515502|9666594|FG008|STARTED|Treatment Period 2||0
8626783|NCT00515502|9666595|FG009|STARTED|Treatment Period 2||2
8626784|NCT00515502|9666596|FG010|STARTED|Treatment Period 2||1
8626785|NCT00515502|9666597|FG011|STARTED|Treatment Period 2||0
8626786|NCT00515502|9666586|FG000|COMPLETED|Treatment Period 2||1
8626787|NCT00515502|9666587|FG001|COMPLETED|Treatment Period 2||3
8847294|NCT01727895|9901959|FG000|STARTED|Overall Study||10
8847295|NCT01727895|9901960|FG001|STARTED|Overall Study||5
8847296|NCT01727895|9901959|FG000|COMPLETED|Overall Study||10
8847297|NCT01727895|9901960|FG001|COMPLETED|Overall Study||5
8847298|NCT01727895|9901959|FG000|NOT COMPLETED|Overall Study||0
8847299|NCT01727895|9901960|FG001|NOT COMPLETED|Overall Study||0
8847300|NCT01728077|9901968|FG000|STARTED|Overall Study||19
8847301|NCT01728077|9901969|FG001|STARTED|Overall Study||7
8847302|NCT01728077|9901968|FG000|COMPLETED|Overall Study||11
8847303|NCT01728077|9901969|FG001|COMPLETED|Overall Study||2
8847304|NCT01728077|9901968|FG000|NOT COMPLETED|Overall Study||8
8847305|NCT01728077|9901969|FG001|NOT COMPLETED|Overall Study||5
8847306|NCT01728116|9901978|FG000|STARTED|Overall Study|EndoBarrier mITT Subjects|213
8626788|NCT00515502|9666588|FG002|COMPLETED|Treatment Period 2||4
8626789|NCT00515502|9666589|FG003|COMPLETED|Treatment Period 2||3
8723720|NCT01024738|9771242|FG000|NOT COMPLETED|Washout After 2nd Intervention||0
8723721|NCT01024738|9771243|FG001|NOT COMPLETED|Washout After 2nd Intervention||0
8723722|NCT01024738|9771244|FG002|NOT COMPLETED|Washout After 2nd Intervention||0
8723723|NCT01024738|9771242|FG000|STARTED|Third Intervention:||7
8723724|NCT01024738|9771243|FG001|STARTED|Third Intervention:||7
8723725|NCT01024738|9771244|FG002|STARTED|Third Intervention:||8
8723726|NCT01024738|9771242|FG000|COMPLETED|Third Intervention:||7
8723727|NCT01024738|9771243|FG001|COMPLETED|Third Intervention:||7
8723728|NCT01024738|9771244|FG002|COMPLETED|Third Intervention:||8
8723729|NCT01024738|9771242|FG000|NOT COMPLETED|Third Intervention:||0
8723730|NCT01024738|9771243|FG001|NOT COMPLETED|Third Intervention:||0
8723731|NCT01024738|9771244|FG002|NOT COMPLETED|Third Intervention:||0
8723732|NCT01024751|9771254|FG000|STARTED|Enrolled Participants||156
8723733|NCT01024751|9771255|FG001|STARTED|Enrolled Participants||156
8626790|NCT00515502|9666590|FG004|COMPLETED|Treatment Period 2||3
8626791|NCT00515502|9666591|FG005|COMPLETED|Treatment Period 2||1
8626792|NCT00515502|9666592|FG006|COMPLETED|Treatment Period 2||1
8626793|NCT00515502|9666593|FG007|COMPLETED|Treatment Period 2||1
8626794|NCT00515502|9666594|FG008|COMPLETED|Treatment Period 2||0
8626795|NCT00515502|9666595|FG009|COMPLETED|Treatment Period 2||2
8626796|NCT00515502|9666596|FG010|COMPLETED|Treatment Period 2||1
8626797|NCT00515502|9666597|FG011|COMPLETED|Treatment Period 2||0
8626798|NCT00515502|9666586|FG000|NOT COMPLETED|Treatment Period 2||0
8723734|NCT01024751|9771254|FG000|COMPLETED|Enrolled Participants||153
8723735|NCT01024751|9771255|FG001|COMPLETED|Enrolled Participants||152
8723736|NCT01024751|9771254|FG000|NOT COMPLETED|Enrolled Participants||3
8723737|NCT01024751|9771255|FG001|NOT COMPLETED|Enrolled Participants||4
8723738|NCT01024751|9771254|FG000|STARTED|Eligible Participants||153
8723739|NCT01024751|9771255|FG001|STARTED|Eligible Participants||152
8723740|NCT01024751|9771254|FG000|COMPLETED|Eligible Participants||153
8723741|NCT01024751|9771255|FG001|COMPLETED|Eligible Participants||149
8723742|NCT01024751|9771254|FG000|NOT COMPLETED|Eligible Participants||0
8723743|NCT01024751|9771255|FG001|NOT COMPLETED|Eligible Participants||3
8723744|NCT01024855|9771261|FG000|STARTED|Overall Study|30 subjects enrolled in a paired/split-eye evaluation; each subject used both study treatments|30
8723745|NCT01024855|9771261|FG000|COMPLETED|Overall Study|One subject of the 30 seen for baseline did not meet the inclusion/exclusion criteria|29
8626799|NCT00515502|9666587|FG001|NOT COMPLETED|Treatment Period 2||1
8626800|NCT00515502|9666588|FG002|NOT COMPLETED|Treatment Period 2||0
8626801|NCT00515502|9666589|FG003|NOT COMPLETED|Treatment Period 2||0
8626802|NCT00515502|9666590|FG004|NOT COMPLETED|Treatment Period 2||0
8626803|NCT00515502|9666591|FG005|NOT COMPLETED|Treatment Period 2||0
8626804|NCT00515502|9666592|FG006|NOT COMPLETED|Treatment Period 2||0
8626805|NCT00515502|9666593|FG007|NOT COMPLETED|Treatment Period 2||0
8626806|NCT00515502|9666594|FG008|NOT COMPLETED|Treatment Period 2||0
8847307|NCT01728116|9901979|FG001|STARTED|Overall Study|Sham mITT subjects|107
8847308|NCT01728116|9901978|FG000|COMPLETED|Overall Study|Completed to Week 78|52
8847309|NCT01728116|9901979|FG001|COMPLETED|Overall Study|Completed to Week 52|60
8847310|NCT01728116|9901978|FG000|NOT COMPLETED|Overall Study||161
8847311|NCT01728116|9901979|FG001|NOT COMPLETED|Overall Study||47
8847312|NCT01728194|9901988|FG000|STARTED|Overall Study||54
8847313|NCT01728194|9901989|FG001|STARTED|Overall Study||67
8847314|NCT01728194|9901988|FG000|COMPLETED|Overall Study||34
8847315|NCT01728194|9901989|FG001|COMPLETED|Overall Study||61
8847316|NCT01728194|9901988|FG000|NOT COMPLETED|Overall Study||20
8847317|NCT01728194|9901989|FG001|NOT COMPLETED|Overall Study||6
8847318|NCT01728246|9901997|FG000|STARTED|Overall Study||242
8847319|NCT01728246|9901998|FG001|STARTED|Overall Study||231
8847320|NCT01728246|9901997|FG000|COMPLETED|Overall Study||206
8847321|NCT01728246|9901998|FG001|COMPLETED|Overall Study||195
8847322|NCT01728246|9901997|FG000|NOT COMPLETED|Overall Study||36
8847323|NCT01728246|9901998|FG001|NOT COMPLETED|Overall Study||36
8847324|NCT01728324|9902007|FG000|STARTED|Termination of DBV||211
8626807|NCT00515502|9666595|FG009|NOT COMPLETED|Treatment Period 2||0
8626808|NCT00515502|9666596|FG010|NOT COMPLETED|Treatment Period 2||0
8723746|NCT01024855|9771261|FG000|NOT COMPLETED|Overall Study||1
8847325|NCT01728324|9902008|FG001|STARTED|Termination of DBV||213
8847326|NCT01728324|9902009|FG002|STARTED|Termination of DBV||72
8847327|NCT01728324|9902007|FG000|COMPLETED|Termination of DBV||173
8847328|NCT01728324|9902008|FG001|COMPLETED|Termination of DBV||177
8847329|NCT01728324|9902009|FG002|COMPLETED|Termination of DBV||58
8847330|NCT01728324|9902007|FG000|NOT COMPLETED|Termination of DBV||38
8847331|NCT01728324|9902008|FG001|NOT COMPLETED|Termination of DBV||36
8847332|NCT01728324|9902009|FG002|NOT COMPLETED|Termination of DBV||14
8847333|NCT01728324|9902007|FG000|STARTED|Termination of FDV||211
8847334|NCT01728324|9902008|FG001|STARTED|Termination of FDV||213
8847335|NCT01728324|9902009|FG002|STARTED|Termination of FDV||72
8847336|NCT01728324|9902007|FG000|COMPLETED|Termination of FDV||173
8847337|NCT01728324|9902008|FG001|COMPLETED|Termination of FDV||177
8847338|NCT01728324|9902009|FG002|COMPLETED|Termination of FDV||58
8847339|NCT01728324|9902007|FG000|NOT COMPLETED|Termination of FDV||38
8847340|NCT01728324|9902008|FG001|NOT COMPLETED|Termination of FDV||36
8847341|NCT01728324|9902009|FG002|NOT COMPLETED|Termination of FDV||14
8847342|NCT01728324|9902007|FG000|STARTED|Termination of RBV||211
8847343|NCT01728324|9902008|FG001|STARTED|Termination of RBV||213
8847344|NCT01728324|9902009|FG002|STARTED|Termination of RBV||72
8847345|NCT01728324|9902007|FG000|COMPLETED|Termination of RBV||172
8847346|NCT01728324|9902008|FG001|COMPLETED|Termination of RBV||176
8847347|NCT01728324|9902009|FG002|COMPLETED|Termination of RBV||57
8847348|NCT01728324|9902007|FG000|NOT COMPLETED|Termination of RBV||39
8847349|NCT01728324|9902008|FG001|NOT COMPLETED|Termination of RBV||37
8847350|NCT01728324|9902009|FG002|NOT COMPLETED|Termination of RBV||15
8847351|NCT01728337|9902019|FG000|STARTED|Overall Study||80
8847352|NCT01728337|9902019|FG000|COMPLETED|Overall Study||80
8847353|NCT01728337|9902019|FG000|NOT COMPLETED|Overall Study||0
8847354|NCT01728376|9902031|FG000|STARTED|Overall Study||22
8847355|NCT01728376|9902032|FG001|STARTED|Overall Study||11
8847356|NCT01728376|9902033|FG002|STARTED|Overall Study||19
8847357|NCT01728376|9902034|FG003|STARTED|Overall Study||9
8847358|NCT01728376|9902035|FG004|STARTED|Overall Study||14
8847359|NCT01728376|9902036|FG005|STARTED|Overall Study||7
8847360|NCT01728376|9902031|FG000|Treated|Overall Study||22
8847361|NCT01728376|9902032|FG001|Treated|Overall Study||10
8847362|NCT01728376|9902033|FG002|Treated|Overall Study||19
8847363|NCT01728376|9902034|FG003|Treated|Overall Study||9
8847364|NCT01728376|9902035|FG004|Treated|Overall Study||14
8847365|NCT01728376|9902036|FG005|Treated|Overall Study||7
8847366|NCT01728376|9902031|FG000|COMPLETED|Overall Study||18
8847367|NCT01728376|9902032|FG001|COMPLETED|Overall Study||9
8847368|NCT01728376|9902033|FG002|COMPLETED|Overall Study||17
8847369|NCT01728376|9902034|FG003|COMPLETED|Overall Study||7
8847370|NCT01728376|9902035|FG004|COMPLETED|Overall Study||12
8847371|NCT01728376|9902036|FG005|COMPLETED|Overall Study||5
8847372|NCT01728376|9902031|FG000|NOT COMPLETED|Overall Study||4
8847373|NCT01728376|9902032|FG001|NOT COMPLETED|Overall Study||2
8847374|NCT01728376|9902033|FG002|NOT COMPLETED|Overall Study||2
8847375|NCT01728376|9902034|FG003|NOT COMPLETED|Overall Study||2
8847376|NCT01728376|9902035|FG004|NOT COMPLETED|Overall Study||2
8847377|NCT01728376|9902036|FG005|NOT COMPLETED|Overall Study||2
8847378|NCT01728454|9902053|FG000|STARTED|Stage 1 and 2||17
8847379|NCT01728454|9902054|FG001|STARTED|Stage 1 and 2||20
8847380|NCT01728454|9902055|FG002|STARTED|Stage 1 and 2||23
8847381|NCT01728454|9902053|FG000|COMPLETED|Stage 1 and 2||12
8847382|NCT01728454|9902054|FG001|COMPLETED|Stage 1 and 2||16
8847383|NCT01728454|9902055|FG002|COMPLETED|Stage 1 and 2||19
8847384|NCT01728454|9902053|FG000|NOT COMPLETED|Stage 1 and 2||5
8847385|NCT01728454|9902054|FG001|NOT COMPLETED|Stage 1 and 2||4
8847386|NCT01728454|9902055|FG002|NOT COMPLETED|Stage 1 and 2||4
8847387|NCT01728454|9902053|FG000|STARTED|Stage 3|Eligible participants who opted to participate in Stage 3.|6
8847388|NCT01728454|9902054|FG001|STARTED|Stage 3|Eligible participants who opted to participate in Stage 3.|5
8847389|NCT01728454|9902055|FG002|STARTED|Stage 3|Eligible participants who opted to participate in Stage 3.|11
8847390|NCT01728454|9902053|FG000|COMPLETED|Stage 3||3
8847391|NCT01728454|9902054|FG001|COMPLETED|Stage 3||1
8847392|NCT01728454|9902055|FG002|COMPLETED|Stage 3||7
8847393|NCT01728454|9902053|FG000|NOT COMPLETED|Stage 3||3
8847394|NCT01728454|9902054|FG001|NOT COMPLETED|Stage 3||4
8847395|NCT01728454|9902055|FG002|NOT COMPLETED|Stage 3||4
8847396|NCT01728584|9902070|FG000|STARTED|Overall Study|Randomized|36
8847397|NCT01728584|9902071|FG001|STARTED|Overall Study|Randomized - NMB/pressure conditions were changed in 7 (2 to Std/Std, 4 to Deep/Std, 1 to Deep/Low)|30
8847398|NCT01728584|9902072|FG002|STARTED|Overall Study|Randomized|31
8847399|NCT01728584|9902073|FG003|STARTED|Overall Study|Randomized - NMB/pressure conditions were changed in 5 (all to Deep/Std)|30
8847400|NCT01728584|9902070|FG000|COMPLETED|Overall Study||28
8847401|NCT01728584|9902071|FG001|COMPLETED|Overall Study||30
8847402|NCT01728584|9902072|FG002|COMPLETED|Overall Study||30
8847403|NCT01728584|9902073|FG003|COMPLETED|Overall Study||29
8847404|NCT01728584|9902070|FG000|NOT COMPLETED|Overall Study||8
8847405|NCT01728584|9902071|FG001|NOT COMPLETED|Overall Study||0
8847406|NCT01728584|9902072|FG002|NOT COMPLETED|Overall Study||1
8847407|NCT01728584|9902073|FG003|NOT COMPLETED|Overall Study||1
8847408|NCT01728623|9902090|FG000|STARTED|Overall Study||51
8847409|NCT01728623|9902090|FG000|DTC|Overall Study||25
8847410|NCT01728623|9902090|FG000|MTC|Overall Study||9
8847411|NCT01728623|9902090|FG000|ATC|Overall Study||17
8847412|NCT01728623|9902090|FG000|COMPLETED|Overall Study||23
8847413|NCT01728623|9902090|FG000|NOT COMPLETED|Overall Study||28
8847414|NCT01728636|9902099|FG000|STARTED|Overall Study||31
8847415|NCT01728636|9902100|FG001|STARTED|Overall Study||30
8847416|NCT01728636|9902099|FG000|COMPLETED|Overall Study||31
8847417|NCT01728636|9902100|FG001|COMPLETED|Overall Study||30
8847418|NCT01728636|9902099|FG000|NOT COMPLETED|Overall Study||0
8847419|NCT01728636|9902100|FG001|NOT COMPLETED|Overall Study||0
8847420|NCT01728779|9902106|FG000|STARTED|Overall Study||38
8723747|NCT01024920|9771268|FG000|STARTED|Overall Study||67
8723748|NCT01024920|9771269|FG001|STARTED|Overall Study||32
8723749|NCT01024920|9771268|FG000|Treated|Overall Study||64
8723750|NCT01024920|9771269|FG001|Treated|Overall Study||32
8723751|NCT01024920|9771268|FG000|COMPLETED|Overall Study||0
8723752|NCT01024920|9771269|FG001|COMPLETED|Overall Study||0
8723753|NCT01024920|9771268|FG000|NOT COMPLETED|Overall Study||67
8723754|NCT01024920|9771269|FG001|NOT COMPLETED|Overall Study||32
8723755|NCT01024946|9771275|FG000|STARTED|Overall Study||11
8723756|NCT01024946|9771275|FG000|COMPLETED|Overall Study||6
8723757|NCT01024946|9771275|FG000|NOT COMPLETED|Overall Study||5
8723758|NCT01024959|9771279|FG000|STARTED|Overall Study||507
8723759|NCT01024959|9771279|FG000|COMPLETED|Overall Study||466
8723760|NCT01024959|9771279|FG000|NOT COMPLETED|Overall Study||41
8723761|NCT01024972|9771290|FG000|STARTED|Overall Study||16
8723762|NCT01024972|9771291|FG001|STARTED|Overall Study||15
8723763|NCT01024972|9771290|FG000|COMPLETED|Overall Study||16
8723764|NCT01024972|9771291|FG001|COMPLETED|Overall Study||15
8723765|NCT01024972|9771290|FG000|NOT COMPLETED|Overall Study||0
8723766|NCT01024972|9771291|FG001|NOT COMPLETED|Overall Study||0
8723767|NCT01025037|9771298|FG000|STARTED|Overall Study||61
8723768|NCT01025037|9771298|FG000|COMPLETED|Overall Study||50
8723769|NCT01025037|9771298|FG000|NOT COMPLETED|Overall Study||11
8723770|NCT01025076|9771302|FG000|STARTED|Overall Study||14
8723771|NCT01025076|9771302|FG000|COMPLETED|Overall Study||14
8723772|NCT01025076|9771302|FG000|NOT COMPLETED|Overall Study||0
8723773|NCT01025154|9771306|FG000|STARTED|Overall Study||59
8723774|NCT01025154|9771306|FG000|COMPLETED|Overall Study||57
8723775|NCT01025154|9771306|FG000|NOT COMPLETED|Overall Study||2
8723776|NCT01025193|9771310|FG000|STARTED|Overall Study||8
8723777|NCT01025193|9771310|FG000|COMPLETED|Overall Study|one patient was transplanted 2 weeks after 8 month belimumab dose and did not receive further doses.|4
8723778|NCT01025193|9771310|FG000|NOT COMPLETED|Overall Study||4
8723779|NCT01025232|9771320|FG000|STARTED|Overall Study||46
8723780|NCT01025232|9771321|FG001|STARTED|Overall Study||42
8626809|NCT00515502|9666597|FG011|NOT COMPLETED|Treatment Period 2||0
8626810|NCT00515502|9666586|FG000|STARTED|Washout Period 2||1
8626811|NCT00515502|9666587|FG001|STARTED|Washout Period 2||3
8626812|NCT00515502|9666588|FG002|STARTED|Washout Period 2||4
8626813|NCT00515502|9666589|FG003|STARTED|Washout Period 2||3
8626814|NCT00515502|9666590|FG004|STARTED|Washout Period 2||3
8626815|NCT00515502|9666591|FG005|STARTED|Washout Period 2||1
8626816|NCT00515502|9666592|FG006|STARTED|Washout Period 2||1
8626817|NCT00515502|9666593|FG007|STARTED|Washout Period 2||1
8626818|NCT00515502|9666594|FG008|STARTED|Washout Period 2||0
8626819|NCT00515502|9666595|FG009|STARTED|Washout Period 2||2
8626820|NCT00515502|9666596|FG010|STARTED|Washout Period 2||1
8626821|NCT00515502|9666597|FG011|STARTED|Washout Period 2||0
8626822|NCT00515502|9666586|FG000|COMPLETED|Washout Period 2||1
8626823|NCT00515502|9666587|FG001|COMPLETED|Washout Period 2||3
8626824|NCT00515502|9666588|FG002|COMPLETED|Washout Period 2||4
8626825|NCT00515502|9666589|FG003|COMPLETED|Washout Period 2||3
8626826|NCT00515502|9666590|FG004|COMPLETED|Washout Period 2||3
8626827|NCT00515502|9666591|FG005|COMPLETED|Washout Period 2||1
8626828|NCT00515502|9666592|FG006|COMPLETED|Washout Period 2||1
8626829|NCT00515502|9666593|FG007|COMPLETED|Washout Period 2||1
8626830|NCT00515502|9666594|FG008|COMPLETED|Washout Period 2||0
8626831|NCT00515502|9666595|FG009|COMPLETED|Washout Period 2||2
8626832|NCT00515502|9666596|FG010|COMPLETED|Washout Period 2||1
8626833|NCT00515502|9666597|FG011|COMPLETED|Washout Period 2||0
8626834|NCT00515502|9666586|FG000|NOT COMPLETED|Washout Period 2||0
8626835|NCT00515502|9666587|FG001|NOT COMPLETED|Washout Period 2||0
8626836|NCT00515502|9666588|FG002|NOT COMPLETED|Washout Period 2||0
8626837|NCT00515502|9666589|FG003|NOT COMPLETED|Washout Period 2||0
8626838|NCT00515502|9666590|FG004|NOT COMPLETED|Washout Period 2||0
8626839|NCT00515502|9666591|FG005|NOT COMPLETED|Washout Period 2||0
8626840|NCT00515502|9666592|FG006|NOT COMPLETED|Washout Period 2||0
8626841|NCT00515502|9666593|FG007|NOT COMPLETED|Washout Period 2||0
8626842|NCT00515502|9666594|FG008|NOT COMPLETED|Washout Period 2||0
8626843|NCT00515502|9666595|FG009|NOT COMPLETED|Washout Period 2||0
8626844|NCT00515502|9666596|FG010|NOT COMPLETED|Washout Period 2||0
8626845|NCT00515502|9666597|FG011|NOT COMPLETED|Washout Period 2||0
8626846|NCT00515502|9666586|FG000|STARTED|Treatment Period 3||1
8626847|NCT00515502|9666587|FG001|STARTED|Treatment Period 3||3
8626848|NCT00515502|9666588|FG002|STARTED|Treatment Period 3||4
8626849|NCT00515502|9666589|FG003|STARTED|Treatment Period 3||3
8626850|NCT00515502|9666590|FG004|STARTED|Treatment Period 3||3
8626851|NCT00515502|9666591|FG005|STARTED|Treatment Period 3||1
8626852|NCT00515502|9666592|FG006|STARTED|Treatment Period 3||1
8626853|NCT00515502|9666593|FG007|STARTED|Treatment Period 3||1
8626854|NCT00515502|9666594|FG008|STARTED|Treatment Period 3||0
8626855|NCT00515502|9666595|FG009|STARTED|Treatment Period 3||2
8626856|NCT00515502|9666596|FG010|STARTED|Treatment Period 3||1
8626857|NCT00515502|9666597|FG011|STARTED|Treatment Period 3||0
8626858|NCT00515502|9666586|FG000|COMPLETED|Treatment Period 3||1
8626859|NCT00515502|9666587|FG001|COMPLETED|Treatment Period 3||3
8626860|NCT00515502|9666588|FG002|COMPLETED|Treatment Period 3||4
8626861|NCT00515502|9666589|FG003|COMPLETED|Treatment Period 3||3
8626862|NCT00515502|9666590|FG004|COMPLETED|Treatment Period 3||3
8626863|NCT00515502|9666591|FG005|COMPLETED|Treatment Period 3||1
8626864|NCT00515502|9666592|FG006|COMPLETED|Treatment Period 3||1
8626865|NCT00515502|9666593|FG007|COMPLETED|Treatment Period 3||1
8626866|NCT00515502|9666594|FG008|COMPLETED|Treatment Period 3||0
8626867|NCT00515502|9666595|FG009|COMPLETED|Treatment Period 3||2
8626868|NCT00515502|9666596|FG010|COMPLETED|Treatment Period 3||1
8626869|NCT00515502|9666597|FG011|COMPLETED|Treatment Period 3||0
8626870|NCT00515502|9666586|FG000|NOT COMPLETED|Treatment Period 3||0
8626871|NCT00515502|9666587|FG001|NOT COMPLETED|Treatment Period 3||0
8626872|NCT00515502|9666588|FG002|NOT COMPLETED|Treatment Period 3||0
8626873|NCT00515502|9666589|FG003|NOT COMPLETED|Treatment Period 3||0
8626874|NCT00515502|9666590|FG004|NOT COMPLETED|Treatment Period 3||0
8626875|NCT00515502|9666591|FG005|NOT COMPLETED|Treatment Period 3||0
8626876|NCT00515502|9666592|FG006|NOT COMPLETED|Treatment Period 3||0
8626877|NCT00515502|9666593|FG007|NOT COMPLETED|Treatment Period 3||0
8626878|NCT00515502|9666594|FG008|NOT COMPLETED|Treatment Period 3||0
8626879|NCT00515502|9666595|FG009|NOT COMPLETED|Treatment Period 3||0
8626880|NCT00515502|9666596|FG010|NOT COMPLETED|Treatment Period 3||0
8626881|NCT00515502|9666597|FG011|NOT COMPLETED|Treatment Period 3||0
8626882|NCT00515502|9666586|FG000|STARTED|Washout Period 3||1
8626883|NCT00515502|9666587|FG001|STARTED|Washout Period 3||3
8626884|NCT00515502|9666588|FG002|STARTED|Washout Period 3||4
8626885|NCT00515502|9666589|FG003|STARTED|Washout Period 3||3
8626886|NCT00515502|9666590|FG004|STARTED|Washout Period 3||3
8626887|NCT00515502|9666591|FG005|STARTED|Washout Period 3||1
8626888|NCT00515502|9666592|FG006|STARTED|Washout Period 3||1
8626889|NCT00515502|9666593|FG007|STARTED|Washout Period 3||1
8723781|NCT01025232|9771320|FG000|COMPLETED|Overall Study||43
8723782|NCT01025232|9771321|FG001|COMPLETED|Overall Study||36
8723783|NCT01025232|9771320|FG000|NOT COMPLETED|Overall Study||3
8723784|NCT01025232|9771321|FG001|NOT COMPLETED|Overall Study||6
8626890|NCT00515502|9666594|FG008|STARTED|Washout Period 3||0
8626891|NCT00515502|9666595|FG009|STARTED|Washout Period 3||2
8626892|NCT00515502|9666596|FG010|STARTED|Washout Period 3||1
8626893|NCT00515502|9666597|FG011|STARTED|Washout Period 3||0
8626894|NCT00515502|9666586|FG000|COMPLETED|Washout Period 3||1
8626895|NCT00515502|9666587|FG001|COMPLETED|Washout Period 3||3
8626896|NCT00515502|9666588|FG002|COMPLETED|Washout Period 3||4
8626897|NCT00515502|9666589|FG003|COMPLETED|Washout Period 3||3
8723785|NCT01025284|9771330|FG000|STARTED|Overall Study||38
8723786|NCT01025284|9771331|FG001|STARTED|Overall Study||18
8723787|NCT01025284|9771332|FG002|STARTED|Overall Study||8
8723788|NCT01025284|9771330|FG000|Received at Least 1 Dose of Study Drug|Overall Study||38
8723789|NCT01025284|9771331|FG001|Received at Least 1 Dose of Study Drug|Overall Study||18
8723790|NCT01025284|9771332|FG002|Received at Least 1 Dose of Study Drug|Overall Study||8
8626898|NCT00515502|9666590|FG004|COMPLETED|Washout Period 3||3
8626899|NCT00515502|9666591|FG005|COMPLETED|Washout Period 3||1
8626900|NCT00515502|9666592|FG006|COMPLETED|Washout Period 3||1
8626901|NCT00515502|9666593|FG007|COMPLETED|Washout Period 3||1
8626902|NCT00515502|9666594|FG008|COMPLETED|Washout Period 3||0
8626903|NCT00515502|9666595|FG009|COMPLETED|Washout Period 3||2
8626904|NCT00515502|9666596|FG010|COMPLETED|Washout Period 3||1
8626905|NCT00515502|9666597|FG011|COMPLETED|Washout Period 3||0
8626906|NCT00515502|9666586|FG000|NOT COMPLETED|Washout Period 3||0
8626907|NCT00515502|9666587|FG001|NOT COMPLETED|Washout Period 3||0
8626908|NCT00515502|9666588|FG002|NOT COMPLETED|Washout Period 3||0
8626909|NCT00515502|9666589|FG003|NOT COMPLETED|Washout Period 3||0
8626910|NCT00515502|9666590|FG004|NOT COMPLETED|Washout Period 3||0
8626911|NCT00515502|9666591|FG005|NOT COMPLETED|Washout Period 3||0
8626912|NCT00515502|9666592|FG006|NOT COMPLETED|Washout Period 3||0
8626913|NCT00515502|9666593|FG007|NOT COMPLETED|Washout Period 3||0
8626914|NCT00515502|9666594|FG008|NOT COMPLETED|Washout Period 3||0
8626915|NCT00515502|9666595|FG009|NOT COMPLETED|Washout Period 3||0
8626916|NCT00515502|9666596|FG010|NOT COMPLETED|Washout Period 3||0
8626917|NCT00515502|9666597|FG011|NOT COMPLETED|Washout Period 3||0
8626918|NCT00515502|9666586|FG000|STARTED|Treatment Period 4||1
8723791|NCT01025284|9771330|FG000|COMPLETED|Overall Study||38
8723792|NCT01025284|9771331|FG001|COMPLETED|Overall Study||16
8723793|NCT01025284|9771332|FG002|COMPLETED|Overall Study||8
8723794|NCT01025284|9771330|FG000|NOT COMPLETED|Overall Study||0
8723795|NCT01025284|9771331|FG001|NOT COMPLETED|Overall Study||2
8723796|NCT01025284|9771332|FG002|NOT COMPLETED|Overall Study||0
8723797|NCT01025336|9771347|FG000|STARTED|Overall Study||130
8723798|NCT01025336|9771348|FG001|STARTED|Overall Study||210
8723799|NCT01025336|9771349|FG002|STARTED|Overall Study||179
8723800|NCT01025336|9771350|FG003|STARTED|Overall Study||221
8723801|NCT01025336|9771351|FG004|STARTED|Overall Study||222
8723802|NCT01025336|9771347|FG000|COMPLETED|Overall Study||130
8723803|NCT01025336|9771348|FG001|COMPLETED|Overall Study||210
8723804|NCT01025336|9771349|FG002|COMPLETED|Overall Study||179
8723805|NCT01025336|9771350|FG003|COMPLETED|Overall Study||219
8723806|NCT01025336|9771351|FG004|COMPLETED|Overall Study||222
8847421|NCT01728779|9902106|FG000|COMPLETED|Overall Study||37
8847422|NCT01728779|9902106|FG000|NOT COMPLETED|Overall Study||1
8626919|NCT00515502|9666587|FG001|STARTED|Treatment Period 4||3
8626920|NCT00515502|9666588|FG002|STARTED|Treatment Period 4||4
8626921|NCT00515502|9666589|FG003|STARTED|Treatment Period 4||3
8626922|NCT00515502|9666590|FG004|STARTED|Treatment Period 4||3
8626923|NCT00515502|9666591|FG005|STARTED|Treatment Period 4||1
8626924|NCT00515502|9666592|FG006|STARTED|Treatment Period 4||1
8723807|NCT01025336|9771347|FG000|NOT COMPLETED|Overall Study||0
8723808|NCT01025336|9771348|FG001|NOT COMPLETED|Overall Study||0
8723809|NCT01025336|9771349|FG002|NOT COMPLETED|Overall Study||0
8723810|NCT01025336|9771350|FG003|NOT COMPLETED|Overall Study||2
8723811|NCT01025336|9771351|FG004|NOT COMPLETED|Overall Study||0
8723812|NCT01025427|9771375|FG000|STARTED|Overall Study||16
8723813|NCT01025427|9771375|FG000|COMPLETED|Overall Study||16
8847423|NCT01728792|9902115|FG000|STARTED|Overall Study||14
8723814|NCT01025427|9771375|FG000|NOT COMPLETED|Overall Study||0
8626925|NCT00515502|9666593|FG007|STARTED|Treatment Period 4||1
8626926|NCT00515502|9666594|FG008|STARTED|Treatment Period 4||0
8626927|NCT00515502|9666595|FG009|STARTED|Treatment Period 4||2
8847424|NCT01728792|9902116|FG001|STARTED|Overall Study||16
8847425|NCT01728792|9902117|FG002|STARTED|Overall Study||17
8847426|NCT01728792|9902118|FG003|STARTED|Overall Study||17
8626928|NCT00515502|9666596|FG010|STARTED|Treatment Period 4||1
8626929|NCT00515502|9666597|FG011|STARTED|Treatment Period 4||0
8626930|NCT00515502|9666586|FG000|COMPLETED|Treatment Period 4||1
8626931|NCT00515502|9666587|FG001|COMPLETED|Treatment Period 4||3
8626932|NCT00515502|9666588|FG002|COMPLETED|Treatment Period 4||4
8723815|NCT01025453|9771379|FG000|STARTED|Overall Study||37
8723816|NCT01025453|9771379|FG000|COMPLETED|Overall Study||37
8723817|NCT01025453|9771379|FG000|NOT COMPLETED|Overall Study||0
8723818|NCT01025635|9771385|FG000|STARTED|Overall Study||198
8626933|NCT00515502|9666589|FG003|COMPLETED|Treatment Period 4||3
8723819|NCT01025635|9771386|FG001|STARTED|Overall Study||203
8723820|NCT01025635|9771385|FG000|COMPLETED|Overall Study||175
8626934|NCT00515502|9666590|FG004|COMPLETED|Treatment Period 4||3
8626935|NCT00515502|9666591|FG005|COMPLETED|Treatment Period 4||1
8723821|NCT01025635|9771386|FG001|COMPLETED|Overall Study||178
8626936|NCT00515502|9666592|FG006|COMPLETED|Treatment Period 4||1
8626937|NCT00515502|9666593|FG007|COMPLETED|Treatment Period 4||1
8626938|NCT00515502|9666594|FG008|COMPLETED|Treatment Period 4||0
8626939|NCT00515502|9666595|FG009|COMPLETED|Treatment Period 4||2
8626940|NCT00515502|9666596|FG010|COMPLETED|Treatment Period 4||1
8626941|NCT00515502|9666597|FG011|COMPLETED|Treatment Period 4||0
8626942|NCT00515502|9666586|FG000|NOT COMPLETED|Treatment Period 4||0
8626943|NCT00515502|9666587|FG001|NOT COMPLETED|Treatment Period 4||0
8626944|NCT00515502|9666588|FG002|NOT COMPLETED|Treatment Period 4||0
8626945|NCT00515502|9666589|FG003|NOT COMPLETED|Treatment Period 4||0
8626946|NCT00515502|9666590|FG004|NOT COMPLETED|Treatment Period 4||0
8626947|NCT00515502|9666591|FG005|NOT COMPLETED|Treatment Period 4||0
8626948|NCT00515502|9666592|FG006|NOT COMPLETED|Treatment Period 4||0
8626949|NCT00515502|9666593|FG007|NOT COMPLETED|Treatment Period 4||0
8626950|NCT00515502|9666594|FG008|NOT COMPLETED|Treatment Period 4||0
8626951|NCT00515502|9666595|FG009|NOT COMPLETED|Treatment Period 4||0
8626952|NCT00515502|9666596|FG010|NOT COMPLETED|Treatment Period 4||0
8626953|NCT00515502|9666597|FG011|NOT COMPLETED|Treatment Period 4||0
8626954|NCT00515528|9666616|FG000|STARTED|Overall Study||10
8626955|NCT00515528|9666617|FG001|STARTED|Overall Study||7
8626956|NCT00515528|9666616|FG000|COMPLETED|Overall Study||10
8626957|NCT00515528|9666617|FG001|COMPLETED|Overall Study||7
8626958|NCT00515528|9666616|FG000|NOT COMPLETED|Overall Study||0
8626959|NCT00515528|9666617|FG001|NOT COMPLETED|Overall Study||0
8626960|NCT00515541|9666627|FG000|STARTED|Overall Study||10
8626961|NCT00515541|9666628|FG001|STARTED|Overall Study||12
8626962|NCT00515541|9666629|FG002|STARTED|Overall Study||10
8626963|NCT00515541|9666630|FG003|STARTED|Overall Study||11
8626964|NCT00515541|9666627|FG000|6 Weeks (1 gm Lovaza)|Overall Study||10
8629560|NCT00530894|9669320|FG000|NOT COMPLETED|Overall Study||88
8626965|NCT00515541|9666628|FG001|6 Weeks (1 gm Lovaza)|Overall Study|One subject pulled after baseline. One subject pulled due to no show for appt.after baseline|10
8626966|NCT00515541|9666629|FG002|6 Weeks (1 gm Lovaza)|Overall Study||10
8629561|NCT00530894|9669321|FG001|NOT COMPLETED|Overall Study||115
8847427|NCT01728792|9902119|FG004|STARTED|Overall Study||16
8847428|NCT01728792|9902115|FG000|COMPLETED|Overall Study||11
8847429|NCT01728792|9902116|FG001|COMPLETED|Overall Study||14
8847430|NCT01728792|9902117|FG002|COMPLETED|Overall Study||13
8847431|NCT01728792|9902118|FG003|COMPLETED|Overall Study||14
8626967|NCT00515541|9666630|FG003|6 Weeks (1 gm Lovaza)|Overall Study|One subject pulled due to no show for appt. after baseline.|10
8626968|NCT00515541|9666627|FG000|12 Weeks (2 gm Lovaza)|Overall Study||10
8626969|NCT00515541|9666628|FG001|12 Weeks (2 gm Lovaza)|Overall Study||10
8626970|NCT00515541|9666629|FG002|12 Weeks (2 gm Lovaza)|Overall Study||10
8626971|NCT00515541|9666630|FG003|12 Weeks (2 gm Lovaza)|Overall Study||10
8626972|NCT00515541|9666627|FG000|18 Weeks (4 gm Lovaza)|Overall Study||10
8723822|NCT01025635|9771385|FG000|NOT COMPLETED|Overall Study||23
8723823|NCT01025635|9771386|FG001|NOT COMPLETED|Overall Study||25
8723824|NCT01025752|9771394|FG000|STARTED|Overall Study||62
8723825|NCT01025752|9771395|FG001|STARTED|Overall Study||63
8847432|NCT01728792|9902119|FG004|COMPLETED|Overall Study||16
8847433|NCT01728792|9902115|FG000|NOT COMPLETED|Overall Study||3
8626973|NCT00515541|9666628|FG001|18 Weeks (4 gm Lovaza)|Overall Study|One subject withdrew at 12 weeks due to acquired bleeding disorder present before enrolling.|9
8847434|NCT01728792|9902116|FG001|NOT COMPLETED|Overall Study||2
8723826|NCT01025752|9771394|FG000|COMPLETED|Overall Study||54
8723827|NCT01025752|9771395|FG001|COMPLETED|Overall Study||50
8847435|NCT01728792|9902117|FG002|NOT COMPLETED|Overall Study||4
8847436|NCT01728792|9902118|FG003|NOT COMPLETED|Overall Study||3
8847437|NCT01728792|9902119|FG004|NOT COMPLETED|Overall Study||0
8847438|NCT01728805|9902133|FG000|STARTED|Randomization Period||186
8847439|NCT01728805|9902134|FG001|STARTED|Randomization Period||186
8723828|NCT01025752|9771394|FG000|NOT COMPLETED|Overall Study||8
8723829|NCT01025752|9771395|FG001|NOT COMPLETED|Overall Study||13
8723830|NCT01025791|9771404|FG000|STARTED|Period 1||2
8723831|NCT01025791|9771405|FG001|STARTED|Period 1||2
8847440|NCT01728805|9902135|FG002|STARTED|Randomization Period||0
8847441|NCT01728805|9902133|FG000|COMPLETED|Randomization Period||186
8723832|NCT01025791|9771406|FG002|STARTED|Period 1||2
8723833|NCT01025791|9771407|FG003|STARTED|Period 1||2
8626974|NCT00515541|9666629|FG002|18 Weeks (4 gm Lovaza)|Overall Study||10
8626975|NCT00515541|9666630|FG003|18 Weeks (4 gm Lovaza)|Overall Study|One subject withdrew at 14 weeks with GI problems.|9
8626976|NCT00515541|9666627|FG000|24 Weeks (8 gm Lovaza)|Overall Study||10
8626977|NCT00515541|9666628|FG001|24 Weeks (8 gm Lovaza)|Overall Study|Two subjects withdrew at 20 and 21 weeks due to nausea. Subjects were closed out early.|7
8626978|NCT00515541|9666629|FG002|24 Weeks (8 gm Lovaza)|Overall Study||10
8626979|NCT00515541|9666630|FG003|24 Weeks (8 gm Lovaza)|Overall Study|Three subjects withdrew after 18 weeks (1 GI problem, 1 undefined medical problem, 1 no show)|6
8626980|NCT00515541|9666627|FG000|COMPLETED|Overall Study|All subjects completed 24 weeks.|10
8626981|NCT00515541|9666628|FG001|COMPLETED|Overall Study||7
8626982|NCT00515541|9666629|FG002|COMPLETED|Overall Study|All subjects completed 24 weeks.|10
8626983|NCT00515541|9666630|FG003|COMPLETED|Overall Study||6
8626984|NCT00515541|9666627|FG000|NOT COMPLETED|Overall Study||0
8626985|NCT00515541|9666628|FG001|NOT COMPLETED|Overall Study||5
8626986|NCT00515541|9666629|FG002|NOT COMPLETED|Overall Study||0
8626987|NCT00515541|9666630|FG003|NOT COMPLETED|Overall Study||5
8626988|NCT00515619|9666640|FG000|STARTED|Overall Study||376
8626989|NCT00515619|9666640|FG000|Safety Set|Overall Study||376
8626990|NCT00515619|9666640|FG000|COMPLETED|Overall Study||160
8626991|NCT00515619|9666640|FG000|NOT COMPLETED|Overall Study||216
8626992|NCT00515697|9666644|FG000|STARTED|Overall Study||39
8626993|NCT00515697|9666644|FG000|Received at Least 1 Dose of Study Drug|Overall Study||39
8626994|NCT00515697|9666644|FG000|COMPLETED|Overall Study||39
8626995|NCT00515697|9666644|FG000|NOT COMPLETED|Overall Study||0
8626996|NCT00515723|9666652|FG000|STARTED|Overall Study||25
8626997|NCT00515723|9666653|FG001|STARTED|Overall Study||22
8626998|NCT00515723|9666654|FG002|STARTED|Overall Study||22
8626999|NCT00515723|9666655|FG003|STARTED|Overall Study||27
8627000|NCT00515723|9666652|FG000|COMPLETED|Overall Study||20
8627001|NCT00515723|9666653|FG001|COMPLETED|Overall Study||21
8627002|NCT00515723|9666654|FG002|COMPLETED|Overall Study||21
8627003|NCT00515723|9666655|FG003|COMPLETED|Overall Study||21
8627004|NCT00515723|9666652|FG000|NOT COMPLETED|Overall Study||5
8627005|NCT00515723|9666653|FG001|NOT COMPLETED|Overall Study||1
8627006|NCT00515723|9666654|FG002|NOT COMPLETED|Overall Study||1
8627007|NCT00515723|9666655|FG003|NOT COMPLETED|Overall Study||6
8627008|NCT00515827|9666668|FG000|STARTED|First Intervention (12 Weeks)||27
8627009|NCT00515827|9666669|FG001|STARTED|First Intervention (12 Weeks)||26
8627010|NCT00515827|9666668|FG000|COMPLETED|First Intervention (12 Weeks)||26
8627011|NCT00515827|9666669|FG001|COMPLETED|First Intervention (12 Weeks)||25
8627012|NCT00515827|9666668|FG000|NOT COMPLETED|First Intervention (12 Weeks)||1
8627013|NCT00515827|9666669|FG001|NOT COMPLETED|First Intervention (12 Weeks)||1
8627014|NCT00515827|9666668|FG000|STARTED|Second Intervention (12 Weeks)||26
8627015|NCT00515827|9666669|FG001|STARTED|Second Intervention (12 Weeks)||25
8627016|NCT00515827|9666668|FG000|COMPLETED|Second Intervention (12 Weeks)||25
8627017|NCT00515827|9666669|FG001|COMPLETED|Second Intervention (12 Weeks)||25
8627018|NCT00515827|9666668|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||1
8627019|NCT00515827|9666669|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||0
8627020|NCT00515879|9666679|FG000|STARTED|Overall Study||87
8627021|NCT00515879|9666680|FG001|STARTED|Overall Study||82
8627022|NCT00515879|9666679|FG000|COMPLETED|Overall Study||62
8627023|NCT00515879|9666680|FG001|COMPLETED|Overall Study||62
8627024|NCT00515879|9666679|FG000|NOT COMPLETED|Overall Study||25
8627025|NCT00515879|9666680|FG001|NOT COMPLETED|Overall Study||20
8627026|NCT00516048|9666690|FG000|STARTED|Overall Study||15
8627027|NCT00516048|9666691|FG001|STARTED|Overall Study||42
8627028|NCT00516048|9666692|FG002|STARTED|Overall Study||1
8627029|NCT00516048|9666690|FG000|COMPLETED|Overall Study||15
8627030|NCT00516048|9666691|FG001|COMPLETED|Overall Study||40
8627031|NCT00516048|9666692|FG002|COMPLETED|Overall Study||0
8627032|NCT00516048|9666690|FG000|NOT COMPLETED|Overall Study||0
8627033|NCT00516048|9666691|FG001|NOT COMPLETED|Overall Study||2
8627034|NCT00516048|9666692|FG002|NOT COMPLETED|Overall Study||1
8627035|NCT00516074|9666702|FG000|STARTED|Overall Study||28
8627036|NCT00516074|9666703|FG001|STARTED|Overall Study||26
8627037|NCT00516074|9666702|FG000|COMPLETED|Overall Study||22
8627038|NCT00516074|9666703|FG001|COMPLETED|Overall Study||23
8627039|NCT00516074|9666702|FG000|NOT COMPLETED|Overall Study||6
8627040|NCT00516074|9666703|FG001|NOT COMPLETED|Overall Study||3
8627041|NCT00516139|9666709|FG000|STARTED|Overall Study||122
8627042|NCT00516139|9666709|FG000|COMPLETED|Overall Study|Study completers completed Escalation, AM, and either AO or both Conversion and Monotherapy Phases.|84
8627043|NCT00516139|9666709|FG000|NOT COMPLETED|Overall Study||38
8627044|NCT00516165|9666717|FG000|STARTED|Overall Study||28
8627045|NCT00516165|9666717|FG000|COMPLETED|Overall Study||28
8627046|NCT00516165|9666717|FG000|NOT COMPLETED|Overall Study||0
8627047|NCT00516217|9666721|FG000|STARTED|Overall Study||29
8627048|NCT00516217|9666721|FG000|COMPLETED|Overall Study||29
8627049|NCT00516217|9666721|FG000|NOT COMPLETED|Overall Study||0
8627050|NCT00516269|9666727|FG000|STARTED|Overall Study||19
8627051|NCT00516269|9666728|FG001|STARTED|Overall Study||19
8627052|NCT00516269|9666727|FG000|COMPLETED|Overall Study|2 patients had an early termination|17
8627053|NCT00516269|9666728|FG001|COMPLETED|Overall Study|2 patients did not complete the study and 1 randomized to placebo twice.|16
8627054|NCT00516269|9666727|FG000|NOT COMPLETED|Overall Study||2
8627055|NCT00516269|9666728|FG001|NOT COMPLETED|Overall Study||3
8627056|NCT00516295|9666737|FG000|STARTED|Overall Study||7
8627057|NCT00516295|9666738|FG001|STARTED|Overall Study||0
8627058|NCT00516295|9666739|FG002|STARTED|Overall Study||0
8627059|NCT00516295|9666737|FG000|COMPLETED|Overall Study||4
8627060|NCT00516295|9666738|FG001|COMPLETED|Overall Study||0
8627061|NCT00516295|9666739|FG002|COMPLETED|Overall Study||0
8723834|NCT01025791|9771408|FG004|STARTED|Period 1||2
8723835|NCT01025791|9771409|FG005|STARTED|Period 1||2
8723836|NCT01025791|9771410|FG006|STARTED|Period 1||2
8723837|NCT01025791|9771411|FG007|STARTED|Period 1||2
8723838|NCT01025791|9771412|FG008|STARTED|Period 1||2
8723839|NCT01025791|9771413|FG009|STARTED|Period 1||1
8723840|NCT01025791|9771414|FG010|STARTED|Period 1||2
8723841|NCT01025791|9771415|FG011|STARTED|Period 1||1
8723842|NCT01025791|9771416|FG012|STARTED|Period 1||2
8723843|NCT01025791|9771417|FG013|STARTED|Period 1||1
8723844|NCT01025791|9771404|FG000|COMPLETED|Period 1||2
8723845|NCT01025791|9771405|FG001|COMPLETED|Period 1||2
8723846|NCT01025791|9771406|FG002|COMPLETED|Period 1||2
8723847|NCT01025791|9771407|FG003|COMPLETED|Period 1||2
8723848|NCT01025791|9771408|FG004|COMPLETED|Period 1||2
8627062|NCT00516295|9666737|FG000|NOT COMPLETED|Overall Study||3
8627063|NCT00516295|9666738|FG001|NOT COMPLETED|Overall Study||0
8627064|NCT00516295|9666739|FG002|NOT COMPLETED|Overall Study||0
8627065|NCT00516321|9666749|FG000|STARTED|Open-label (OL) Pre-Antiviral Treatment||715
8627066|NCT00516321|9666750|FG001|STARTED|Open-label (OL) Pre-Antiviral Treatment||0
8627067|NCT00516321|9666751|FG002|STARTED|Open-label (OL) Pre-Antiviral Treatment||0
8723849|NCT01025791|9771409|FG005|COMPLETED|Period 1||2
8723850|NCT01025791|9771410|FG006|COMPLETED|Period 1||2
8723851|NCT01025791|9771411|FG007|COMPLETED|Period 1||2
8847442|NCT01728805|9902134|FG001|COMPLETED|Randomization Period||186
8847443|NCT01728805|9902135|FG002|COMPLETED|Randomization Period||0
8847444|NCT01728805|9902133|FG000|NOT COMPLETED|Randomization Period||0
8847445|NCT01728805|9902134|FG001|NOT COMPLETED|Randomization Period||0
8847446|NCT01728805|9902135|FG002|NOT COMPLETED|Randomization Period||0
8847447|NCT01728805|9902133|FG000|STARTED|Crossover Period||0
8847448|NCT01728805|9902134|FG001|STARTED|Crossover Period||0
8847449|NCT01728805|9902135|FG002|STARTED|Crossover Period||136
8627068|NCT00516321|9666749|FG000|COMPLETED|Open-label (OL) Pre-Antiviral Treatment||682
8627069|NCT00516321|9666750|FG001|COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
8627070|NCT00516321|9666751|FG002|COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
8627071|NCT00516321|9666749|FG000|NOT COMPLETED|Open-label (OL) Pre-Antiviral Treatment||33
8627072|NCT00516321|9666750|FG001|NOT COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
8627073|NCT00516321|9666751|FG002|NOT COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
8629562|NCT00530894|9669322|FG002|NOT COMPLETED|Overall Study||55
8847450|NCT01728805|9902133|FG000|COMPLETED|Crossover Period||0
8847451|NCT01728805|9902134|FG001|COMPLETED|Crossover Period||0
8627074|NCT00516321|9666749|FG000|STARTED|Double-blind (DB) Antiviral Treatment||0
8627075|NCT00516321|9666750|FG001|STARTED|Double-blind (DB) Antiviral Treatment||232
8627076|NCT00516321|9666751|FG002|STARTED|Double-blind (DB) Antiviral Treatment||450
8627077|NCT00516321|9666749|FG000|COMPLETED|Double-blind (DB) Antiviral Treatment||0
8627078|NCT00516321|9666750|FG001|COMPLETED|Double-blind (DB) Antiviral Treatment||197
8723852|NCT01025791|9771412|FG008|COMPLETED|Period 1||2
8723853|NCT01025791|9771413|FG009|COMPLETED|Period 1||1
8723854|NCT01025791|9771414|FG010|COMPLETED|Period 1||2
8627079|NCT00516321|9666751|FG002|COMPLETED|Double-blind (DB) Antiviral Treatment||396
8627080|NCT00516321|9666749|FG000|NOT COMPLETED|Double-blind (DB) Antiviral Treatment||0
8627081|NCT00516321|9666750|FG001|NOT COMPLETED|Double-blind (DB) Antiviral Treatment||35
8627082|NCT00516321|9666751|FG002|NOT COMPLETED|Double-blind (DB) Antiviral Treatment||54
8627083|NCT00516386|9666759|FG000|STARTED|Overall Study||16
8627084|NCT00516386|9666759|FG000|COMPLETED|Overall Study||10
8627085|NCT00516386|9666759|FG000|NOT COMPLETED|Overall Study||6
8627086|NCT00516503|9666765|FG000|STARTED|Overall Study||101
8627087|NCT00516503|9666766|FG001|STARTED|Overall Study||102
8627088|NCT00516503|9666765|FG000|COMPLETED|Overall Study||101
8627089|NCT00516503|9666766|FG001|COMPLETED|Overall Study||102
8627090|NCT00516503|9666765|FG000|NOT COMPLETED|Overall Study||0
8723855|NCT01025791|9771415|FG011|COMPLETED|Period 1||1
8723856|NCT01025791|9771416|FG012|COMPLETED|Period 1||2
8723857|NCT01025791|9771417|FG013|COMPLETED|Period 1||1
8723858|NCT01025791|9771404|FG000|NOT COMPLETED|Period 1||0
8723859|NCT01025791|9771405|FG001|NOT COMPLETED|Period 1||0
8723860|NCT01025791|9771406|FG002|NOT COMPLETED|Period 1||0
8723861|NCT01025791|9771407|FG003|NOT COMPLETED|Period 1||0
8723862|NCT01025791|9771408|FG004|NOT COMPLETED|Period 1||0
8723863|NCT01025791|9771409|FG005|NOT COMPLETED|Period 1||0
8723864|NCT01025791|9771410|FG006|NOT COMPLETED|Period 1||0
8723865|NCT01025791|9771411|FG007|NOT COMPLETED|Period 1||0
8723866|NCT01025791|9771412|FG008|NOT COMPLETED|Period 1||0
8627091|NCT00516503|9666766|FG001|NOT COMPLETED|Overall Study||0
8847452|NCT01728805|9902135|FG002|COMPLETED|Crossover Period||136
8847453|NCT01728805|9902133|FG000|NOT COMPLETED|Crossover Period||0
8847454|NCT01728805|9902134|FG001|NOT COMPLETED|Crossover Period||0
8847455|NCT01728805|9902135|FG002|NOT COMPLETED|Crossover Period||0
8627092|NCT00516893|9666772|FG000|STARTED|Overall Study||113
8627093|NCT00516893|9666772|FG000|Received Study Treatment|Overall Study||112
8627094|NCT00516893|9666772|FG000|COMPLETED|Overall Study||92
8627095|NCT00516893|9666772|FG000|NOT COMPLETED|Overall Study||21
8627096|NCT00516906|9666778|FG000|STARTED|Overall Study||36
8627097|NCT00516906|9666779|FG001|STARTED|Overall Study|33 patients were randomized but one patient was discharged prior to treatment.|32
8627098|NCT00516906|9666778|FG000|COMPLETED|Overall Study|Thirty patients were required to complete. Patients not completing were replaced.|30
8627099|NCT00516906|9666779|FG001|COMPLETED|Overall Study|Thirty patients were required to complete. Patients not completing were replaced.|30
8627100|NCT00516906|9666778|FG000|NOT COMPLETED|Overall Study||6
8627101|NCT00516906|9666779|FG001|NOT COMPLETED|Overall Study||2
8627102|NCT00516919|9666785|FG000|STARTED|Overall Study||40
8627103|NCT00516919|9666786|FG001|STARTED|Overall Study||39
8627104|NCT00516919|9666785|FG000|COMPLETED|Overall Study||30
8627105|NCT00516919|9666786|FG001|COMPLETED|Overall Study||32
8627106|NCT00516919|9666785|FG000|NOT COMPLETED|Overall Study||10
8627107|NCT00516919|9666786|FG001|NOT COMPLETED|Overall Study||7
8627108|NCT00517010|9666792|FG000|STARTED|Overall Study||6
8627109|NCT00517010|9666792|FG000|COMPLETED|Overall Study||5
8627110|NCT00517010|9666792|FG000|NOT COMPLETED|Overall Study||1
8627111|NCT00517296|9666798|FG000|STARTED|Overall Study||10
8627112|NCT00517296|9666799|FG001|STARTED|Overall Study||11
8627113|NCT00517296|9666798|FG000|COMPLETED|Overall Study||9
8627114|NCT00517296|9666799|FG001|COMPLETED|Overall Study||11
8627115|NCT00517296|9666798|FG000|NOT COMPLETED|Overall Study||1
8627116|NCT00517296|9666799|FG001|NOT COMPLETED|Overall Study||0
8627117|NCT00517413|9666805|FG000|STARTED|Overall Study||163
8627118|NCT00517413|9666805|FG000|COMPLETED|Overall Study||102
8627119|NCT00517413|9666805|FG000|NOT COMPLETED|Overall Study||61
8627120|NCT00517530|9666816|FG000|STARTED|Overall Study||21
8627121|NCT00517530|9666817|FG001|STARTED|Overall Study||13
8627122|NCT00517530|9666818|FG002|STARTED|Overall Study||18
8627123|NCT00517530|9666819|FG003|STARTED|Overall Study||22
8627124|NCT00517530|9666820|FG004|STARTED|Overall Study||21
8627125|NCT00517530|9666821|FG005|STARTED|Overall Study||19
8627126|NCT00517530|9666822|FG006|STARTED|Overall Study||20
8627127|NCT00517530|9666816|FG000|Completed Treatment|Overall Study||11
8627128|NCT00517530|9666817|FG001|Completed Treatment|Overall Study||13
8627129|NCT00517530|9666818|FG002|Completed Treatment|Overall Study||13
8627130|NCT00517530|9666819|FG003|Completed Treatment|Overall Study||18
8627131|NCT00517530|9666820|FG004|Completed Treatment|Overall Study||9
8627132|NCT00517530|9666821|FG005|Completed Treatment|Overall Study||9
8627133|NCT00517530|9666822|FG006|Completed Treatment|Overall Study||13
8627134|NCT00517530|9666816|FG000|Started Follow-up|Overall Study||20
8627135|NCT00517530|9666817|FG001|Started Follow-up|Overall Study||13
8847456|NCT01728844|9902146|FG000|STARTED|Overall Study||22
8847457|NCT01728844|9902147|FG001|STARTED|Overall Study||21
8847458|NCT01728844|9902148|FG002|STARTED|Overall Study||22
8847459|NCT01728844|9902149|FG003|STARTED|Overall Study||23
8847460|NCT01728844|9902146|FG000|COMPLETED|Overall Study||21
8847461|NCT01728844|9902147|FG001|COMPLETED|Overall Study||21
8847462|NCT01728844|9902148|FG002|COMPLETED|Overall Study||22
8627136|NCT00517530|9666818|FG002|Started Follow-up|Overall Study||17
8627137|NCT00517530|9666819|FG003|Started Follow-up|Overall Study||21
8556932|NCT03713684|9588706|FG000|NOT COMPLETED|Overall Study||86
8556933|NCT03713684|9588707|FG001|NOT COMPLETED|Overall Study||87
8556934|NCT03713684|9588708|FG002|NOT COMPLETED|Overall Study||88
8723867|NCT01025791|9771413|FG009|NOT COMPLETED|Period 1||0
8723868|NCT01025791|9771414|FG010|NOT COMPLETED|Period 1||0
8723869|NCT01025791|9771415|FG011|NOT COMPLETED|Period 1||0
8723870|NCT01025791|9771416|FG012|NOT COMPLETED|Period 1||0
8723871|NCT01025791|9771417|FG013|NOT COMPLETED|Period 1||0
8723872|NCT01025791|9771404|FG000|STARTED|Period 2||2
8723873|NCT01025791|9771405|FG001|STARTED|Period 2||2
8723874|NCT01025791|9771406|FG002|STARTED|Period 2||2
8723875|NCT01025791|9771407|FG003|STARTED|Period 2||2
8723876|NCT01025791|9771408|FG004|STARTED|Period 2||2
8723877|NCT01025791|9771409|FG005|STARTED|Period 2||2
8723878|NCT01025791|9771410|FG006|STARTED|Period 2||2
8723879|NCT01025791|9771411|FG007|STARTED|Period 2||2
8723880|NCT01025791|9771412|FG008|STARTED|Period 2||2
8723881|NCT01025791|9771413|FG009|STARTED|Period 2||1
8723882|NCT01025791|9771414|FG010|STARTED|Period 2||2
8723883|NCT01025791|9771415|FG011|STARTED|Period 2||1
8723884|NCT01025791|9771416|FG012|STARTED|Period 2||2
8723885|NCT01025791|9771417|FG013|STARTED|Period 2||1
8723886|NCT01025791|9771404|FG000|COMPLETED|Period 2||2
8723887|NCT01025791|9771405|FG001|COMPLETED|Period 2||2
8556935|NCT03713684|9588709|FG003|NOT COMPLETED|Overall Study||87
8556936|NCT03644550|9588719|FG000|STARTED|Overall Study||18
8556937|NCT03644550|9588719|FG000|COMPLETED|Overall Study||0
8556938|NCT03644550|9588719|FG000|NOT COMPLETED|Overall Study||18
8556939|NCT03557970|9588726|FG000|STARTED|Overall Study||1
8556940|NCT03557970|9588727|FG001|STARTED|Overall Study||2
8556941|NCT03557970|9588726|FG000|COMPLETED|Overall Study||0
8556942|NCT03557970|9588727|FG001|COMPLETED|Overall Study||0
8556943|NCT03557970|9588726|FG000|NOT COMPLETED|Overall Study||1
8556944|NCT03557970|9588727|FG001|NOT COMPLETED|Overall Study||2
8556945|NCT03369197|9588735|FG000|STARTED|Overall Study||53
8723888|NCT01025791|9771406|FG002|COMPLETED|Period 2||2
8556946|NCT03369197|9588736|FG001|STARTED|Overall Study||57
8556947|NCT03369197|9588735|FG000|COMPLETED|Overall Study||53
8556948|NCT03369197|9588736|FG001|COMPLETED|Overall Study||57
8556949|NCT03369197|9588735|FG000|NOT COMPLETED|Overall Study||0
8556950|NCT03369197|9588736|FG001|NOT COMPLETED|Overall Study||0
8556951|NCT03368196|9588742|FG000|STARTED|Overall Study||12
8556952|NCT03368196|9588742|FG000|COMPLETED|Overall Study||12
8556953|NCT03368196|9588742|FG000|NOT COMPLETED|Overall Study||0
8556954|NCT03022461|9588746|FG000|STARTED|Overall Study||25
8556955|NCT03022461|9588746|FG000|COMPLETED|Overall Study||22
8556956|NCT03022461|9588746|FG000|NOT COMPLETED|Overall Study||3
8556957|NCT02979587|9588751|FG000|STARTED|Overall Study||50
8556958|NCT02979587|9588751|FG000|Catheterized|Overall Study||50
8556959|NCT02979587|9588751|FG000|Implanted|Overall Study||50
8556960|NCT02979587|9588751|FG000|Implanted > 24 Hours|Overall Study||48
8627138|NCT00517530|9666820|FG004|Started Follow-up|Overall Study||17
8627139|NCT00517530|9666821|FG005|Started Follow-up|Overall Study||16
8627140|NCT00517530|9666822|FG006|Started Follow-up|Overall Study||19
8556961|NCT02979587|9588751|FG000|COMPLETED|Overall Study||48
8556962|NCT02979587|9588751|FG000|NOT COMPLETED|Overall Study||2
8556963|NCT02964039|9588762|FG000|STARTED|Overall Study||18
8556964|NCT02964039|9588763|FG001|STARTED|Overall Study||18
8556965|NCT02964039|9588764|FG002|STARTED|Overall Study||18
8627141|NCT00517530|9666816|FG000|Completed Follow-up|Overall Study||2
8627142|NCT00517530|9666817|FG001|Completed Follow-up|Overall Study||0
8627143|NCT00517530|9666818|FG002|Completed Follow-up|Overall Study||0
8627144|NCT00517530|9666819|FG003|Completed Follow-up|Overall Study||1
8627145|NCT00517530|9666820|FG004|Completed Follow-up|Overall Study||0
8556966|NCT02964039|9588762|FG000|Received Allocated Intervention|Overall Study||15
8556967|NCT02964039|9588763|FG001|Received Allocated Intervention|Overall Study||17
8556968|NCT02964039|9588764|FG002|Received Allocated Intervention|Overall Study||14
8627146|NCT00517530|9666821|FG005|Completed Follow-up|Overall Study||0
8627147|NCT00517530|9666822|FG006|Completed Follow-up|Overall Study||1
8627148|NCT00517530|9666816|FG000|Retreated Population|Overall Study||2
8627149|NCT00517530|9666817|FG001|Retreated Population|Overall Study||2
8627150|NCT00517530|9666818|FG002|Retreated Population|Overall Study||1
8627151|NCT00517530|9666819|FG003|Retreated Population|Overall Study||4
8627152|NCT00517530|9666820|FG004|Retreated Population|Overall Study||2
8627153|NCT00517530|9666821|FG005|Retreated Population|Overall Study||2
8627154|NCT00517530|9666822|FG006|Retreated Population|Overall Study||0
8627155|NCT00517530|9666816|FG000|COMPLETED|Overall Study||2
8627156|NCT00517530|9666817|FG001|COMPLETED|Overall Study||0
8627157|NCT00517530|9666818|FG002|COMPLETED|Overall Study||0
8627158|NCT00517530|9666819|FG003|COMPLETED|Overall Study||1
8627159|NCT00517530|9666820|FG004|COMPLETED|Overall Study||1
8627160|NCT00517530|9666821|FG005|COMPLETED|Overall Study||0
8627161|NCT00517530|9666822|FG006|COMPLETED|Overall Study||1
8627162|NCT00517530|9666816|FG000|NOT COMPLETED|Overall Study||19
8627163|NCT00517530|9666817|FG001|NOT COMPLETED|Overall Study||13
8627164|NCT00517530|9666818|FG002|NOT COMPLETED|Overall Study||18
8627165|NCT00517530|9666819|FG003|NOT COMPLETED|Overall Study||21
8627166|NCT00517530|9666820|FG004|NOT COMPLETED|Overall Study||20
8627167|NCT00517530|9666821|FG005|NOT COMPLETED|Overall Study||19
8627168|NCT00517530|9666822|FG006|NOT COMPLETED|Overall Study||19
8627169|NCT00517556|9666855|FG000|STARTED|Overall Study||19
8627170|NCT00517556|9666856|FG001|STARTED|Overall Study||19
8627171|NCT00517556|9666855|FG000|COMPLETED|Overall Study||15
8627172|NCT00517556|9666856|FG001|COMPLETED|Overall Study||14
8627173|NCT00517556|9666855|FG000|NOT COMPLETED|Overall Study||4
8627174|NCT00517556|9666856|FG001|NOT COMPLETED|Overall Study||5
8627175|NCT00517595|9666862|FG000|STARTED|Overall Study||48
8627176|NCT00517595|9666862|FG000|COMPLETED|Overall Study||48
8627177|NCT00517595|9666862|FG000|NOT COMPLETED|Overall Study||0
8627178|NCT00517634|9666866|FG000|STARTED|First Treatment Period||4
8627179|NCT00517634|9666867|FG001|STARTED|First Treatment Period||4
8627180|NCT00517634|9666868|FG002|STARTED|First Treatment Period||4
8627181|NCT00517634|9666869|FG003|STARTED|First Treatment Period||3
8627182|NCT00517634|9666870|FG004|STARTED|First Treatment Period||4
8627183|NCT00517634|9666871|FG005|STARTED|First Treatment Period||4
8627184|NCT00517634|9666866|FG000|COMPLETED|First Treatment Period||4
8627185|NCT00517634|9666867|FG001|COMPLETED|First Treatment Period||4
8627186|NCT00517634|9666868|FG002|COMPLETED|First Treatment Period||4
8627187|NCT00517634|9666869|FG003|COMPLETED|First Treatment Period||3
8627188|NCT00517634|9666870|FG004|COMPLETED|First Treatment Period||4
8627189|NCT00517634|9666871|FG005|COMPLETED|First Treatment Period||4
8627190|NCT00517634|9666866|FG000|NOT COMPLETED|First Treatment Period||0
8627191|NCT00517634|9666867|FG001|NOT COMPLETED|First Treatment Period||0
8627192|NCT00517634|9666868|FG002|NOT COMPLETED|First Treatment Period||0
8627193|NCT00517634|9666869|FG003|NOT COMPLETED|First Treatment Period||0
8627194|NCT00517634|9666870|FG004|NOT COMPLETED|First Treatment Period||0
8627195|NCT00517634|9666871|FG005|NOT COMPLETED|First Treatment Period||0
8627196|NCT00517634|9666866|FG000|STARTED|Second Treatment Period||4
8627197|NCT00517634|9666867|FG001|STARTED|Second Treatment Period||4
8627198|NCT00517634|9666868|FG002|STARTED|Second Treatment Period||4
8627199|NCT00517634|9666869|FG003|STARTED|Second Treatment Period||3
8627200|NCT00517634|9666870|FG004|STARTED|Second Treatment Period||4
8627201|NCT00517634|9666871|FG005|STARTED|Second Treatment Period||4
8627202|NCT00517634|9666866|FG000|COMPLETED|Second Treatment Period||4
8627203|NCT00517634|9666867|FG001|COMPLETED|Second Treatment Period||4
8627204|NCT00517634|9666868|FG002|COMPLETED|Second Treatment Period||4
8627205|NCT00517634|9666869|FG003|COMPLETED|Second Treatment Period||3
8627206|NCT00517634|9666870|FG004|COMPLETED|Second Treatment Period||3
8627207|NCT00517634|9666871|FG005|COMPLETED|Second Treatment Period||4
8627208|NCT00517634|9666866|FG000|NOT COMPLETED|Second Treatment Period||0
8627209|NCT00517634|9666867|FG001|NOT COMPLETED|Second Treatment Period||0
8627210|NCT00517634|9666868|FG002|NOT COMPLETED|Second Treatment Period||0
8627211|NCT00517634|9666869|FG003|NOT COMPLETED|Second Treatment Period||0
8627212|NCT00517634|9666870|FG004|NOT COMPLETED|Second Treatment Period||1
8627213|NCT00517634|9666871|FG005|NOT COMPLETED|Second Treatment Period||0
8627214|NCT00517634|9666866|FG000|STARTED|Third Treatment Period||4
8627215|NCT00517634|9666867|FG001|STARTED|Third Treatment Period||4
8627216|NCT00517634|9666868|FG002|STARTED|Third Treatment Period||4
8627217|NCT00517634|9666869|FG003|STARTED|Third Treatment Period||3
8627218|NCT00517634|9666870|FG004|STARTED|Third Treatment Period||3
8847463|NCT01728844|9902149|FG003|COMPLETED|Overall Study||21
8847464|NCT01728844|9902146|FG000|NOT COMPLETED|Overall Study||1
8847465|NCT01728844|9902147|FG001|NOT COMPLETED|Overall Study||0
8847466|NCT01728844|9902148|FG002|NOT COMPLETED|Overall Study||0
8627219|NCT00517634|9666871|FG005|STARTED|Third Treatment Period||4
8627220|NCT00517634|9666866|FG000|COMPLETED|Third Treatment Period||4
8847467|NCT01728844|9902149|FG003|NOT COMPLETED|Overall Study||2
8850243|NCT01746017|9905499|FG002|COMPLETED|Period 1||2
8627221|NCT00517634|9666867|FG001|COMPLETED|Third Treatment Period||4
8627222|NCT00517634|9666868|FG002|COMPLETED|Third Treatment Period||4
8627223|NCT00517634|9666869|FG003|COMPLETED|Third Treatment Period||3
8627224|NCT00517634|9666870|FG004|COMPLETED|Third Treatment Period||3
8627225|NCT00517634|9666871|FG005|COMPLETED|Third Treatment Period||4
8627226|NCT00517634|9666866|FG000|NOT COMPLETED|Third Treatment Period||0
8627227|NCT00517634|9666867|FG001|NOT COMPLETED|Third Treatment Period||0
8627228|NCT00517634|9666868|FG002|NOT COMPLETED|Third Treatment Period||0
8627229|NCT00517634|9666869|FG003|NOT COMPLETED|Third Treatment Period||0
8723889|NCT01025791|9771407|FG003|COMPLETED|Period 2||2
8723890|NCT01025791|9771408|FG004|COMPLETED|Period 2||2
8723891|NCT01025791|9771409|FG005|COMPLETED|Period 2||2
8723892|NCT01025791|9771410|FG006|COMPLETED|Period 2||2
8723893|NCT01025791|9771411|FG007|COMPLETED|Period 2||2
8627230|NCT00517634|9666870|FG004|NOT COMPLETED|Third Treatment Period||0
8627231|NCT00517634|9666871|FG005|NOT COMPLETED|Third Treatment Period||0
8627232|NCT00517751|9666879|FG000|STARTED|Overall Study||162
8627233|NCT00517751|9666879|FG000|COMPLETED|Overall Study||33
8627234|NCT00517751|9666879|FG000|NOT COMPLETED|Overall Study||129
8627235|NCT00517829|9666885|FG000|STARTED|Overall Study||75
8627236|NCT00517829|9666886|FG001|STARTED|Overall Study||75
8627237|NCT00517829|9666885|FG000|COMPLETED|Overall Study||0
8627238|NCT00517829|9666886|FG001|COMPLETED|Overall Study||0
8627239|NCT00517829|9666885|FG000|NOT COMPLETED|Overall Study||75
8627240|NCT00517829|9666886|FG001|NOT COMPLETED|Overall Study||75
8627241|NCT00517881|9666892|FG000|STARTED|Overall Study||29
8627242|NCT00517881|9666892|FG000|COMPLETED|Overall Study||24
8627243|NCT00517881|9666892|FG000|NOT COMPLETED|Overall Study||5
8627244|NCT00517933|9666898|FG000|STARTED|Period 1|Patients decreased due to death, adverse event, lost to follow up and other (see below)|89
8627245|NCT00517933|9666899|FG001|STARTED|Period 1|Patients decreased due to death, adverse event and other (see below)|91
8627246|NCT00517933|9666898|FG000|COMPLETED|Period 1||81
8627247|NCT00517933|9666899|FG001|COMPLETED|Period 1||85
8627248|NCT00517933|9666898|FG000|NOT COMPLETED|Period 1||8
8627249|NCT00517933|9666899|FG001|NOT COMPLETED|Period 1||6
8627250|NCT00517933|9666898|FG000|STARTED|Period 2|2 patients terminated after completion of period one, but before starting period 2|79
8627251|NCT00517933|9666899|FG001|STARTED|Period 2|2 patients terminated after completion of period one, but before starting period 2|83
8627252|NCT00517933|9666898|FG000|COMPLETED|Period 2||73
8627253|NCT00517933|9666899|FG001|COMPLETED|Period 2||70
8627254|NCT00517933|9666898|FG000|NOT COMPLETED|Period 2||6
8627255|NCT00517933|9666899|FG001|NOT COMPLETED|Period 2||13
8847468|NCT01729026|9902161|FG000|STARTED|Randomization to 3-month Follow-up||9
8847469|NCT01729026|9902162|FG001|STARTED|Randomization to 3-month Follow-up||10
8627256|NCT00518011|9666910|FG000|STARTED|Overall Study||9
8627257|NCT00518011|9666911|FG001|STARTED|Overall Study||8
8627258|NCT00518011|9666910|FG000|COMPLETED|Overall Study||0
8847470|NCT01729026|9902161|FG000|COMPLETED|Randomization to 3-month Follow-up||7
8847471|NCT01729026|9902162|FG001|COMPLETED|Randomization to 3-month Follow-up||8
8847472|NCT01729026|9902161|FG000|NOT COMPLETED|Randomization to 3-month Follow-up||2
8847473|NCT01729026|9902162|FG001|NOT COMPLETED|Randomization to 3-month Follow-up||2
8847474|NCT01729026|9902161|FG000|STARTED|3-month to 6-month (Final) Follow-up||7
8847475|NCT01729026|9902162|FG001|STARTED|3-month to 6-month (Final) Follow-up||8
8723894|NCT01025791|9771412|FG008|COMPLETED|Period 2||2
8723895|NCT01025791|9771413|FG009|COMPLETED|Period 2||1
8723896|NCT01025791|9771414|FG010|COMPLETED|Period 2||2
8723897|NCT01025791|9771415|FG011|COMPLETED|Period 2||1
8723898|NCT01025791|9771416|FG012|COMPLETED|Period 2||2
8723899|NCT01025791|9771417|FG013|COMPLETED|Period 2||1
8723900|NCT01025791|9771404|FG000|NOT COMPLETED|Period 2||0
8723901|NCT01025791|9771405|FG001|NOT COMPLETED|Period 2||0
8723902|NCT01025791|9771406|FG002|NOT COMPLETED|Period 2||0
8627259|NCT00518011|9666911|FG001|COMPLETED|Overall Study||0
8627260|NCT00518011|9666910|FG000|NOT COMPLETED|Overall Study||9
8627261|NCT00518011|9666911|FG001|NOT COMPLETED|Overall Study||8
8627262|NCT00518089|9666920|FG000|STARTED|Overall Study||430
8627263|NCT00518089|9666921|FG001|STARTED|Overall Study||429
8627264|NCT00518089|9666920|FG000|COMPLETED|Overall Study||402
8627265|NCT00518089|9666921|FG001|COMPLETED|Overall Study||398
8627266|NCT00518089|9666920|FG000|NOT COMPLETED|Overall Study||28
8627267|NCT00518089|9666921|FG001|NOT COMPLETED|Overall Study||31
8627268|NCT00518115|9666937|FG000|STARTED|Overall Study||52
8627269|NCT00518115|9666938|FG001|STARTED|Overall Study||35
8627270|NCT00518115|9666939|FG002|STARTED|Overall Study||36
8627271|NCT00518115|9666940|FG003|STARTED|Overall Study||35
8627272|NCT00518115|9666941|FG004|STARTED|Overall Study||31
8627273|NCT00518115|9666942|FG005|STARTED|Overall Study||34
8627274|NCT00518115|9666943|FG006|STARTED|Overall Study||33
8627275|NCT00518115|9666944|FG007|STARTED|Overall Study||35
8627276|NCT00518115|9666945|FG008|STARTED|Overall Study||35
8627277|NCT00518115|9666946|FG009|STARTED|Overall Study||35
8627278|NCT00518115|9666937|FG000|Safety Population|Overall Study|These participants received at least one dose of study drug.|51
8627279|NCT00518115|9666938|FG001|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
8627280|NCT00518115|9666939|FG002|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
8627281|NCT00518115|9666940|FG003|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
8627282|NCT00518115|9666941|FG004|Safety Population|Overall Study|These participants received at least one dose of study drug.|31
8627283|NCT00518115|9666942|FG005|Safety Population|Overall Study|These participants received at least one dose of study drug.|33
8627284|NCT00518115|9666943|FG006|Safety Population|Overall Study|These participants received at least one dose of study drug.|32
8627285|NCT00518115|9666944|FG007|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
8627286|NCT00518115|9666945|FG008|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
8847476|NCT01729026|9902161|FG000|COMPLETED|3-month to 6-month (Final) Follow-up||6
8847477|NCT01729026|9902162|FG001|COMPLETED|3-month to 6-month (Final) Follow-up||6
8847478|NCT01729026|9902161|FG000|NOT COMPLETED|3-month to 6-month (Final) Follow-up||1
8847479|NCT01729026|9902162|FG001|NOT COMPLETED|3-month to 6-month (Final) Follow-up||2
8847480|NCT01729039|9902173|FG000|STARTED|Overall Study||23
8847481|NCT01729039|9902174|FG001|STARTED|Overall Study||26
8627287|NCT00518115|9666946|FG009|Safety Population|Overall Study|These participants received at least one dose of study drug.|34
8627288|NCT00518115|9666937|FG000|COMPLETED|Overall Study||40
8627289|NCT00518115|9666938|FG001|COMPLETED|Overall Study||29
8627290|NCT00518115|9666939|FG002|COMPLETED|Overall Study||19
8627291|NCT00518115|9666940|FG003|COMPLETED|Overall Study||24
8627292|NCT00518115|9666941|FG004|COMPLETED|Overall Study||21
8627293|NCT00518115|9666942|FG005|COMPLETED|Overall Study||19
8627294|NCT00518115|9666943|FG006|COMPLETED|Overall Study||25
8627295|NCT00518115|9666944|FG007|COMPLETED|Overall Study||20
8627296|NCT00518115|9666945|FG008|COMPLETED|Overall Study||30
8627297|NCT00518115|9666946|FG009|COMPLETED|Overall Study||20
8847482|NCT01729039|9902173|FG000|COMPLETED|Overall Study||13
8847483|NCT01729039|9902174|FG001|COMPLETED|Overall Study||14
8847484|NCT01729039|9902173|FG000|NOT COMPLETED|Overall Study||10
8847485|NCT01729039|9902174|FG001|NOT COMPLETED|Overall Study||12
8847486|NCT01729156|9902186|FG000|STARTED|Overall Study||12
8847487|NCT01729156|9902187|FG001|STARTED|Overall Study||12
8847488|NCT01729156|9902188|FG002|STARTED|Overall Study||12
8847489|NCT01729156|9902186|FG000|COMPLETED|Overall Study||11
8847490|NCT01729156|9902187|FG001|COMPLETED|Overall Study||12
8847491|NCT01729156|9902188|FG002|COMPLETED|Overall Study||12
8847492|NCT01729156|9902186|FG000|NOT COMPLETED|Overall Study||1
8847493|NCT01729156|9902187|FG001|NOT COMPLETED|Overall Study||0
8627298|NCT00518115|9666937|FG000|NOT COMPLETED|Overall Study||12
8627299|NCT00518115|9666938|FG001|NOT COMPLETED|Overall Study||6
8627300|NCT00518115|9666939|FG002|NOT COMPLETED|Overall Study||17
8627301|NCT00518115|9666940|FG003|NOT COMPLETED|Overall Study||11
8627302|NCT00518115|9666941|FG004|NOT COMPLETED|Overall Study||10
8627303|NCT00518115|9666942|FG005|NOT COMPLETED|Overall Study||15
8627304|NCT00518115|9666943|FG006|NOT COMPLETED|Overall Study||8
8627305|NCT00518115|9666944|FG007|NOT COMPLETED|Overall Study||15
8627306|NCT00518115|9666945|FG008|NOT COMPLETED|Overall Study||5
8627307|NCT00518115|9666946|FG009|NOT COMPLETED|Overall Study||15
8627308|NCT00518154|9666969|FG000|STARTED|Overall Study||7
8627309|NCT00518154|9666969|FG000|COMPLETED|Overall Study||7
8627310|NCT00518154|9666969|FG000|NOT COMPLETED|Overall Study||0
8627311|NCT00518180|9666976|FG000|STARTED|Overall Study||540
8847494|NCT01729156|9902188|FG002|NOT COMPLETED|Overall Study||0
8847495|NCT01729208|9902199|FG000|STARTED|Baseline||70
8847496|NCT01729208|9902200|FG001|STARTED|Baseline||74
8847497|NCT01729208|9902199|FG000|COMPLETED|Baseline||65
8847498|NCT01729208|9902200|FG001|COMPLETED|Baseline||70
8847499|NCT01729208|9902199|FG000|NOT COMPLETED|Baseline||5
8627312|NCT00518180|9666977|FG001|STARTED|Overall Study||541
8627313|NCT00518180|9666978|FG002|STARTED|Overall Study||539
8627314|NCT00518180|9666976|FG000|COMPLETED|Overall Study||475
8627315|NCT00518180|9666977|FG001|COMPLETED|Overall Study||472
8627316|NCT00518180|9666978|FG002|COMPLETED|Overall Study||457
8627317|NCT00518180|9666976|FG000|NOT COMPLETED|Overall Study||65
8627318|NCT00518180|9666977|FG001|NOT COMPLETED|Overall Study||69
8627319|NCT00518180|9666978|FG002|NOT COMPLETED|Overall Study||82
8627320|NCT00518206|9666997|FG000|STARTED|Overall Study||27
8627321|NCT00518206|9666998|FG001|STARTED|Overall Study||19
8627322|NCT00518206|9666997|FG000|COMPLETED|Overall Study||16
8627323|NCT00518206|9666998|FG001|COMPLETED|Overall Study||13
8627324|NCT00518206|9666997|FG000|NOT COMPLETED|Overall Study||11
8627325|NCT00518206|9666998|FG001|NOT COMPLETED|Overall Study||6
8627326|NCT00518284|9667008|FG000|STARTED|Overall Study||0
8627327|NCT00518284|9667009|FG001|STARTED|Overall Study||3
8627328|NCT00518284|9667010|FG002|STARTED|Overall Study||1
8627329|NCT00518284|9667011|FG003|STARTED|Overall Study||2
8627330|NCT00518284|9667008|FG000|COMPLETED|Overall Study||0
8627331|NCT00518284|9667009|FG001|COMPLETED|Overall Study||0
8627332|NCT00518284|9667010|FG002|COMPLETED|Overall Study||0
8627333|NCT00518284|9667011|FG003|COMPLETED|Overall Study||0
8627334|NCT00518284|9667008|FG000|NOT COMPLETED|Overall Study||0
8627335|NCT00518284|9667009|FG001|NOT COMPLETED|Overall Study||3
8627336|NCT00518284|9667010|FG002|NOT COMPLETED|Overall Study||1
8627337|NCT00518284|9667011|FG003|NOT COMPLETED|Overall Study||2
8627338|NCT00518323|9667025|FG000|STARTED|Overall Study||54
8627339|NCT00518323|9667026|FG001|STARTED|Overall Study||48
8627340|NCT00518323|9667027|FG002|STARTED|Overall Study||48
8627341|NCT00518323|9667028|FG003|STARTED|Overall Study||51
8627342|NCT00518323|9667025|FG000|COMPLETED|Overall Study||35
8627343|NCT00518323|9667026|FG001|COMPLETED|Overall Study||40
8627344|NCT00518323|9667027|FG002|COMPLETED|Overall Study||37
8627345|NCT00518323|9667028|FG003|COMPLETED|Overall Study||26
8627346|NCT00518323|9667025|FG000|NOT COMPLETED|Overall Study||19
8627347|NCT00518323|9667026|FG001|NOT COMPLETED|Overall Study||8
8627348|NCT00518323|9667027|FG002|NOT COMPLETED|Overall Study||11
8627349|NCT00518323|9667028|FG003|NOT COMPLETED|Overall Study||25
8627350|NCT00518336|9667040|FG000|STARTED|Year 7||222
8627351|NCT00518336|9667041|FG001|STARTED|Year 7||211
8627352|NCT00518336|9667040|FG000|COMPLETED|Year 7||220
8627353|NCT00518336|9667041|FG001|COMPLETED|Year 7||208
8627354|NCT00518336|9667040|FG000|NOT COMPLETED|Year 7||2
8627355|NCT00518336|9667041|FG001|NOT COMPLETED|Year 7||3
8627356|NCT00518336|9667040|FG000|STARTED|Year 8|1 subject withdrawn at Year 7 came back and was therefore no longer considered as withdrawn.|223
8627357|NCT00518336|9667041|FG001|STARTED|Year 8|2 subjects withdrawn at Year 7 came back and were therefore no longer considered as withdrawn.|213
8627358|NCT00518336|9667040|FG000|COMPLETED|Year 8||222
8627359|NCT00518336|9667041|FG001|COMPLETED|Year 8||211
8627360|NCT00518336|9667040|FG000|NOT COMPLETED|Year 8||1
8627361|NCT00518336|9667041|FG001|NOT COMPLETED|Year 8||2
8627362|NCT00518336|9667040|FG000|STARTED|Year 9|1 subject did not particpate at the previous timepoint, came back and was added in the Total cohort|224
8627363|NCT00518336|9667041|FG001|STARTED|Year 9||213
8627364|NCT00518336|9667040|FG000|COMPLETED|Year 9||219
8627365|NCT00518336|9667041|FG001|COMPLETED|Year 9||212
8627366|NCT00518336|9667040|FG000|NOT COMPLETED|Year 9||5
8627367|NCT00518336|9667041|FG001|NOT COMPLETED|Year 9||1
8627368|NCT00518349|9667049|FG000|STARTED|Overall Study||60
8627369|NCT00518349|9667050|FG001|STARTED|Overall Study||60
8627370|NCT00518349|9667049|FG000|COMPLETED|Overall Study||60
8627371|NCT00518349|9667050|FG001|COMPLETED|Overall Study||60
8627372|NCT00518349|9667049|FG000|NOT COMPLETED|Overall Study||0
8627373|NCT00518349|9667050|FG001|NOT COMPLETED|Overall Study||0
8627374|NCT00518531|9667058|FG000|STARTED|Treatment Period 1||124
8627375|NCT00518531|9667059|FG001|STARTED|Treatment Period 1||126
8627376|NCT00518531|9667058|FG000|Received Treatment|Treatment Period 1||119
8627377|NCT00518531|9667059|FG001|Received Treatment|Treatment Period 1||124
8627378|NCT00518531|9667058|FG000|COMPLETED|Treatment Period 1||106
8627379|NCT00518531|9667059|FG001|COMPLETED|Treatment Period 1|Participants who completed Treatment Period 1 may choose not to start Treatment Period 2|114
8627380|NCT00518531|9667058|FG000|NOT COMPLETED|Treatment Period 1||18
8627381|NCT00518531|9667059|FG001|NOT COMPLETED|Treatment Period 1||12
8627382|NCT00518531|9667058|FG000|STARTED|Treatment Period 2||106
8627383|NCT00518531|9667059|FG001|STARTED|Treatment Period 2|Participants can start Treatment Period 2 without completing Treatment Period 1.|115
8627384|NCT00518531|9667058|FG000|Received Treatment|Treatment Period 2||106
8627385|NCT00518531|9667059|FG001|Received Treatment|Treatment Period 2||110
8627386|NCT00518531|9667058|FG000|COMPLETED|Treatment Period 2||103
8627387|NCT00518531|9667059|FG001|COMPLETED|Treatment Period 2||95
8627388|NCT00518531|9667058|FG000|NOT COMPLETED|Treatment Period 2||3
8627389|NCT00518531|9667059|FG001|NOT COMPLETED|Treatment Period 2||20
8627390|NCT00518622|9667075|FG000|STARTED|Overall Study||3
8627391|NCT00518622|9667076|FG001|STARTED|Overall Study||6
8627392|NCT00518622|9667077|FG002|STARTED|Overall Study||6
8627393|NCT00518622|9667078|FG003|STARTED|Overall Study||5
8627394|NCT00518622|9667079|FG004|STARTED|Overall Study||6
8627395|NCT00518622|9667080|FG005|STARTED|Overall Study||5
8627396|NCT00518622|9667081|FG006|STARTED|Overall Study||4
8627397|NCT00518622|9667082|FG007|STARTED|Overall Study||5
8627398|NCT00518622|9667075|FG000|Completed Therapy|Overall Study|Completed therapy defined if participant has taken 8 days of study medication per the protocol.|3
8627399|NCT00518622|9667076|FG001|Completed Therapy|Overall Study||5
8627400|NCT00518622|9667077|FG002|Completed Therapy|Overall Study||6
8627401|NCT00518622|9667078|FG003|Completed Therapy|Overall Study||5
8627402|NCT00518622|9667079|FG004|Completed Therapy|Overall Study||6
8627403|NCT00518622|9667080|FG005|Completed Therapy|Overall Study||5
8627404|NCT00518622|9667081|FG006|Completed Therapy|Overall Study||4
8627405|NCT00518622|9667082|FG007|Completed Therapy|Overall Study||5
8723903|NCT01025791|9771407|FG003|NOT COMPLETED|Period 2||0
8723904|NCT01025791|9771408|FG004|NOT COMPLETED|Period 2||0
8723905|NCT01025791|9771409|FG005|NOT COMPLETED|Period 2||0
8723906|NCT01025791|9771410|FG006|NOT COMPLETED|Period 2||0
8723907|NCT01025791|9771411|FG007|NOT COMPLETED|Period 2||0
8723908|NCT01025791|9771412|FG008|NOT COMPLETED|Period 2||0
8723909|NCT01025791|9771413|FG009|NOT COMPLETED|Period 2||0
8723910|NCT01025791|9771414|FG010|NOT COMPLETED|Period 2||0
8723911|NCT01025791|9771415|FG011|NOT COMPLETED|Period 2||0
8723912|NCT01025791|9771416|FG012|NOT COMPLETED|Period 2||0
8723913|NCT01025791|9771417|FG013|NOT COMPLETED|Period 2||0
8723914|NCT01025791|9771404|FG000|STARTED|Period 3||2
8723915|NCT01025791|9771405|FG001|STARTED|Period 3||2
8723916|NCT01025791|9771406|FG002|STARTED|Period 3||2
8723917|NCT01025791|9771407|FG003|STARTED|Period 3||2
8723918|NCT01025791|9771408|FG004|STARTED|Period 3||2
8723919|NCT01025791|9771409|FG005|STARTED|Period 3||2
8723920|NCT01025791|9771410|FG006|STARTED|Period 3||2
8723921|NCT01025791|9771411|FG007|STARTED|Period 3||2
8723922|NCT01025791|9771412|FG008|STARTED|Period 3||2
8723923|NCT01025791|9771413|FG009|STARTED|Period 3||1
8723924|NCT01025791|9771414|FG010|STARTED|Period 3||2
8723925|NCT01025791|9771415|FG011|STARTED|Period 3||1
8723926|NCT01025791|9771416|FG012|STARTED|Period 3||2
8723927|NCT01025791|9771417|FG013|STARTED|Period 3||1
8723928|NCT01025791|9771404|FG000|COMPLETED|Period 3||2
8723929|NCT01025791|9771405|FG001|COMPLETED|Period 3||2
8723930|NCT01025791|9771406|FG002|COMPLETED|Period 3||2
8723931|NCT01025791|9771407|FG003|COMPLETED|Period 3||2
8723932|NCT01025791|9771408|FG004|COMPLETED|Period 3||2
8723933|NCT01025791|9771409|FG005|COMPLETED|Period 3||2
8627406|NCT00518622|9667075|FG000|Discontinued Therapy|Overall Study|Discontinued therapy defined if participant has not taken 8 days of medication per the protocol.|0
8627407|NCT00518622|9667076|FG001|Discontinued Therapy|Overall Study||1
8627408|NCT00518622|9667077|FG002|Discontinued Therapy|Overall Study||0
8627409|NCT00518622|9667078|FG003|Discontinued Therapy|Overall Study||0
8627410|NCT00518622|9667079|FG004|Discontinued Therapy|Overall Study||0
8627411|NCT00518622|9667080|FG005|Discontinued Therapy|Overall Study||0
8627412|NCT00518622|9667081|FG006|Discontinued Therapy|Overall Study||0
8627413|NCT00518622|9667082|FG007|Discontinued Therapy|Overall Study||0
8627414|NCT00518622|9667075|FG000|COMPLETED|Overall Study||3
8627415|NCT00518622|9667076|FG001|COMPLETED|Overall Study||5
8847500|NCT01729208|9902200|FG001|NOT COMPLETED|Baseline||4
8627416|NCT00518622|9667077|FG002|COMPLETED|Overall Study||5
8627417|NCT00518622|9667078|FG003|COMPLETED|Overall Study||5
8627418|NCT00518622|9667079|FG004|COMPLETED|Overall Study||6
8847501|NCT01729208|9902199|FG000|STARTED|12 Months Follow-up||65
8627419|NCT00518622|9667080|FG005|COMPLETED|Overall Study||5
8627420|NCT00518622|9667081|FG006|COMPLETED|Overall Study||4
8627421|NCT00518622|9667082|FG007|COMPLETED|Overall Study||5
8627422|NCT00518622|9667075|FG000|NOT COMPLETED|Overall Study||0
8627423|NCT00518622|9667076|FG001|NOT COMPLETED|Overall Study||1
8627424|NCT00518622|9667077|FG002|NOT COMPLETED|Overall Study||1
8627425|NCT00518622|9667078|FG003|NOT COMPLETED|Overall Study||0
8627426|NCT00518622|9667079|FG004|NOT COMPLETED|Overall Study||0
8627427|NCT00518622|9667080|FG005|NOT COMPLETED|Overall Study||0
8627428|NCT00518622|9667081|FG006|NOT COMPLETED|Overall Study||0
8723934|NCT01025791|9771410|FG006|COMPLETED|Period 3||2
8723935|NCT01025791|9771411|FG007|COMPLETED|Period 3||2
8723936|NCT01025791|9771412|FG008|COMPLETED|Period 3||2
8723937|NCT01025791|9771413|FG009|COMPLETED|Period 3||1
8723938|NCT01025791|9771414|FG010|COMPLETED|Period 3||2
8723939|NCT01025791|9771415|FG011|COMPLETED|Period 3||1
8723940|NCT01025791|9771416|FG012|COMPLETED|Period 3||2
8723941|NCT01025791|9771417|FG013|COMPLETED|Period 3||1
8723942|NCT01025791|9771404|FG000|NOT COMPLETED|Period 3||0
8723943|NCT01025791|9771405|FG001|NOT COMPLETED|Period 3||0
8627429|NCT00518622|9667082|FG007|NOT COMPLETED|Overall Study||0
8627430|NCT00518687|9667102|FG000|STARTED|Overall Study|An additional 10 participants were not analyzed because of questionable clinical practices at 1 site|4005
8627431|NCT00518687|9667103|FG001|STARTED|Overall Study|An additional 11 participants were not analyzed because of questionable clinical practices at 1 site|4005
8627432|NCT00518687|9667102|FG000|Vaccinated|Overall Study||3981
8627433|NCT00518687|9667103|FG001|Vaccinated|Overall Study||3982
8627434|NCT00518687|9667102|FG000|COMPLETED|Overall Study||2568
8627435|NCT00518687|9667103|FG001|COMPLETED|Overall Study||2585
8627436|NCT00518687|9667102|FG000|NOT COMPLETED|Overall Study||1437
8627437|NCT00518687|9667103|FG001|NOT COMPLETED|Overall Study||1420
8627438|NCT00518713|9667113|FG000|STARTED|Overall Study||58
8627439|NCT00518713|9667114|FG001|STARTED|Overall Study||62
8627440|NCT00518713|9667115|FG002|STARTED|Overall Study||59
8627441|NCT00518713|9667116|FG003|STARTED|Overall Study||59
8627442|NCT00518713|9667113|FG000|Modified Intent-to-Treat Population|Overall Study||53
8627443|NCT00518713|9667114|FG001|Modified Intent-to-Treat Population|Overall Study||58
8627444|NCT00518713|9667115|FG002|Modified Intent-to-Treat Population|Overall Study||49
8627445|NCT00518713|9667116|FG003|Modified Intent-to-Treat Population|Overall Study||57
8627446|NCT00518713|9667113|FG000|COMPLETED|Overall Study||50
8847502|NCT01729208|9902200|FG001|STARTED|12 Months Follow-up||70
8847503|NCT01729208|9902199|FG000|COMPLETED|12 Months Follow-up||58
8847504|NCT01729208|9902200|FG001|COMPLETED|12 Months Follow-up||60
8723944|NCT01025791|9771406|FG002|NOT COMPLETED|Period 3||0
8723945|NCT01025791|9771407|FG003|NOT COMPLETED|Period 3||0
8723946|NCT01025791|9771408|FG004|NOT COMPLETED|Period 3||0
8723947|NCT01025791|9771409|FG005|NOT COMPLETED|Period 3||0
8723948|NCT01025791|9771410|FG006|NOT COMPLETED|Period 3||0
8723949|NCT01025791|9771411|FG007|NOT COMPLETED|Period 3||0
8723950|NCT01025791|9771412|FG008|NOT COMPLETED|Period 3||0
8723951|NCT01025791|9771413|FG009|NOT COMPLETED|Period 3||0
8723952|NCT01025791|9771414|FG010|NOT COMPLETED|Period 3||0
8723953|NCT01025791|9771415|FG011|NOT COMPLETED|Period 3||0
8723954|NCT01025791|9771416|FG012|NOT COMPLETED|Period 3||0
8723955|NCT01025791|9771417|FG013|NOT COMPLETED|Period 3||0
8723956|NCT01025791|9771404|FG000|STARTED|Period 4||2
8723957|NCT01025791|9771405|FG001|STARTED|Period 4||2
8723958|NCT01025791|9771406|FG002|STARTED|Period 4||2
8723959|NCT01025791|9771407|FG003|STARTED|Period 4||2
8723960|NCT01025791|9771408|FG004|STARTED|Period 4||2
8723961|NCT01025791|9771409|FG005|STARTED|Period 4||2
8723962|NCT01025791|9771410|FG006|STARTED|Period 4||2
8723963|NCT01025791|9771411|FG007|STARTED|Period 4||2
8723964|NCT01025791|9771412|FG008|STARTED|Period 4||2
8723965|NCT01025791|9771413|FG009|STARTED|Period 4||1
8723966|NCT01025791|9771414|FG010|STARTED|Period 4||2
8847505|NCT01729208|9902199|FG000|NOT COMPLETED|12 Months Follow-up||7
8847506|NCT01729208|9902200|FG001|NOT COMPLETED|12 Months Follow-up||10
8847507|NCT01729208|9902199|FG000|STARTED|24 Months Follow-up||58
8847508|NCT01729208|9902200|FG001|STARTED|24 Months Follow-up||60
8847509|NCT01729208|9902199|FG000|COMPLETED|24 Months Follow-up||55
8723967|NCT01025791|9771415|FG011|STARTED|Period 4||1
8723968|NCT01025791|9771416|FG012|STARTED|Period 4||2
8723969|NCT01025791|9771417|FG013|STARTED|Period 4||1
8723970|NCT01025791|9771404|FG000|COMPLETED|Period 4||2
8723971|NCT01025791|9771405|FG001|COMPLETED|Period 4||2
8723972|NCT01025791|9771406|FG002|COMPLETED|Period 4||2
8723973|NCT01025791|9771407|FG003|COMPLETED|Period 4||2
8723974|NCT01025791|9771408|FG004|COMPLETED|Period 4||2
8723975|NCT01025791|9771409|FG005|COMPLETED|Period 4||2
8723976|NCT01025791|9771410|FG006|COMPLETED|Period 4||2
8723977|NCT01025791|9771411|FG007|COMPLETED|Period 4||2
8723978|NCT01025791|9771412|FG008|COMPLETED|Period 4||2
8723979|NCT01025791|9771413|FG009|COMPLETED|Period 4||1
8723980|NCT01025791|9771414|FG010|COMPLETED|Period 4||2
8723981|NCT01025791|9771415|FG011|COMPLETED|Period 4||1
8723982|NCT01025791|9771416|FG012|COMPLETED|Period 4||2
8723983|NCT01025791|9771417|FG013|COMPLETED|Period 4||1
8723984|NCT01025791|9771404|FG000|NOT COMPLETED|Period 4||0
8723985|NCT01025791|9771405|FG001|NOT COMPLETED|Period 4||0
8723986|NCT01025791|9771406|FG002|NOT COMPLETED|Period 4||0
8723987|NCT01025791|9771407|FG003|NOT COMPLETED|Period 4||0
8723988|NCT01025791|9771408|FG004|NOT COMPLETED|Period 4||0
8723989|NCT01025791|9771409|FG005|NOT COMPLETED|Period 4||0
8723990|NCT01025791|9771410|FG006|NOT COMPLETED|Period 4||0
8723991|NCT01025791|9771411|FG007|NOT COMPLETED|Period 4||0
8723992|NCT01025791|9771412|FG008|NOT COMPLETED|Period 4||0
8723993|NCT01025791|9771413|FG009|NOT COMPLETED|Period 4||0
8723994|NCT01025791|9771414|FG010|NOT COMPLETED|Period 4||0
8723995|NCT01025791|9771415|FG011|NOT COMPLETED|Period 4||0
8723996|NCT01025791|9771416|FG012|NOT COMPLETED|Period 4||0
8847510|NCT01729208|9902200|FG001|COMPLETED|24 Months Follow-up||60
8847511|NCT01729208|9902199|FG000|NOT COMPLETED|24 Months Follow-up||3
8847512|NCT01729208|9902200|FG001|NOT COMPLETED|24 Months Follow-up||0
8847513|NCT01729208|9902199|FG000|STARTED|36 Months Follow-up||55
8723997|NCT01025791|9771417|FG013|NOT COMPLETED|Period 4||0
8723998|NCT01025791|9771404|FG000|STARTED|Period 5||2
8723999|NCT01025791|9771405|FG001|STARTED|Period 5||2
8724000|NCT01025791|9771406|FG002|STARTED|Period 5||2
8724001|NCT01025791|9771407|FG003|STARTED|Period 5||2
8724002|NCT01025791|9771408|FG004|STARTED|Period 5||0
8724003|NCT01025791|9771409|FG005|STARTED|Period 5||0
8724004|NCT01025791|9771410|FG006|STARTED|Period 5||0
8724005|NCT01025791|9771411|FG007|STARTED|Period 5||0
8724006|NCT01025791|9771412|FG008|STARTED|Period 5||0
8724007|NCT01025791|9771413|FG009|STARTED|Period 5||0
8724008|NCT01025791|9771414|FG010|STARTED|Period 5||0
8724009|NCT01025791|9771415|FG011|STARTED|Period 5||0
8724010|NCT01025791|9771416|FG012|STARTED|Period 5||0
8724011|NCT01025791|9771417|FG013|STARTED|Period 5||0
8724012|NCT01025791|9771404|FG000|COMPLETED|Period 5||2
8724013|NCT01025791|9771405|FG001|COMPLETED|Period 5||2
8724014|NCT01025791|9771406|FG002|COMPLETED|Period 5||2
8724015|NCT01025791|9771407|FG003|COMPLETED|Period 5||2
8724016|NCT01025791|9771408|FG004|COMPLETED|Period 5||0
8724017|NCT01025791|9771409|FG005|COMPLETED|Period 5||0
8724018|NCT01025791|9771410|FG006|COMPLETED|Period 5||0
8724019|NCT01025791|9771411|FG007|COMPLETED|Period 5||0
8724020|NCT01025791|9771412|FG008|COMPLETED|Period 5||0
8724021|NCT01025791|9771413|FG009|COMPLETED|Period 5||0
8724022|NCT01025791|9771414|FG010|COMPLETED|Period 5||0
8724023|NCT01025791|9771415|FG011|COMPLETED|Period 5||0
8724024|NCT01025791|9771416|FG012|COMPLETED|Period 5||0
8724025|NCT01025791|9771417|FG013|COMPLETED|Period 5||0
8724026|NCT01025791|9771404|FG000|NOT COMPLETED|Period 5||0
8724027|NCT01025791|9771405|FG001|NOT COMPLETED|Period 5||0
8724028|NCT01025791|9771406|FG002|NOT COMPLETED|Period 5||0
8724029|NCT01025791|9771407|FG003|NOT COMPLETED|Period 5||0
8724030|NCT01025791|9771408|FG004|NOT COMPLETED|Period 5||0
8724031|NCT01025791|9771409|FG005|NOT COMPLETED|Period 5||0
8724032|NCT01025791|9771410|FG006|NOT COMPLETED|Period 5||0
8724033|NCT01025791|9771411|FG007|NOT COMPLETED|Period 5||0
8724034|NCT01025791|9771412|FG008|NOT COMPLETED|Period 5||0
8724035|NCT01025791|9771413|FG009|NOT COMPLETED|Period 5||0
8724036|NCT01025791|9771414|FG010|NOT COMPLETED|Period 5||0
8724037|NCT01025791|9771415|FG011|NOT COMPLETED|Period 5||0
8724038|NCT01025791|9771416|FG012|NOT COMPLETED|Period 5||0
8724039|NCT01025791|9771417|FG013|NOT COMPLETED|Period 5||0
8724040|NCT01025817|9771470|FG000|STARTED|Completed Study Medication||309
8724041|NCT01025817|9771471|FG001|STARTED|Completed Study Medication||304
8724042|NCT01025817|9771470|FG000|COMPLETED|Completed Study Medication||204
8724043|NCT01025817|9771471|FG001|COMPLETED|Completed Study Medication||232
8724044|NCT01025817|9771470|FG000|NOT COMPLETED|Completed Study Medication||105
8724045|NCT01025817|9771471|FG001|NOT COMPLETED|Completed Study Medication||72
8724046|NCT01025817|9771470|FG000|STARTED|Completed Study||309
8724047|NCT01025817|9771471|FG001|STARTED|Completed Study||304
8724048|NCT01025817|9771470|FG000|COMPLETED|Completed Study|Completed study phase|293
8724049|NCT01025817|9771471|FG001|COMPLETED|Completed Study|Completed study phase|282
8724050|NCT01025817|9771470|FG000|NOT COMPLETED|Completed Study||16
8724051|NCT01025817|9771471|FG001|NOT COMPLETED|Completed Study||22
8724052|NCT01025830|9771477|FG000|STARTED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||8
8724053|NCT01025830|9771478|FG001|STARTED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||12
8724054|NCT01025830|9771477|FG000|COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||8
8724055|NCT01025830|9771478|FG001|COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||12
8724056|NCT01025830|9771477|FG000|NOT COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||0
8724057|NCT01025830|9771478|FG001|NOT COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||0
8724058|NCT01025830|9771477|FG000|STARTED|Washout Period of 30 Days||8
8724059|NCT01025830|9771478|FG001|STARTED|Washout Period of 30 Days||12
8724060|NCT01025830|9771477|FG000|COMPLETED|Washout Period of 30 Days||8
8724061|NCT01025830|9771478|FG001|COMPLETED|Washout Period of 30 Days||12
8724062|NCT01025830|9771477|FG000|NOT COMPLETED|Washout Period of 30 Days||0
8724063|NCT01025830|9771478|FG001|NOT COMPLETED|Washout Period of 30 Days||0
8724064|NCT01025830|9771477|FG000|STARTED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||8
8724065|NCT01025830|9771478|FG001|STARTED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||12
8724066|NCT01025830|9771477|FG000|COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||8
8724067|NCT01025830|9771478|FG001|COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||12
8724068|NCT01025830|9771477|FG000|NOT COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||0
8724069|NCT01025830|9771478|FG001|NOT COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||0
8724070|NCT01025843|9771499|FG000|STARTED|Period 1||2
8724071|NCT01025843|9771500|FG001|STARTED|Period 1||2
8724072|NCT01025843|9771501|FG002|STARTED|Period 1||2
8724073|NCT01025843|9771502|FG003|STARTED|Period 1||2
8724074|NCT01025843|9771503|FG004|STARTED|Period 1||2
8724075|NCT01025843|9771504|FG005|STARTED|Period 1||2
8724076|NCT01025843|9771505|FG006|STARTED|Period 1||2
8724077|NCT01025843|9771506|FG007|STARTED|Period 1||2
8724078|NCT01025843|9771507|FG008|STARTED|Period 1||2
8724079|NCT01025843|9771508|FG009|STARTED|Period 1||2
8724080|NCT01025843|9771499|FG000|COMPLETED|Period 1||2
8724081|NCT01025843|9771500|FG001|COMPLETED|Period 1||2
8724082|NCT01025843|9771501|FG002|COMPLETED|Period 1||2
8724083|NCT01025843|9771502|FG003|COMPLETED|Period 1||2
8724084|NCT01025843|9771503|FG004|COMPLETED|Period 1||2
8724085|NCT01025843|9771504|FG005|COMPLETED|Period 1||2
8627447|NCT00518713|9667114|FG001|COMPLETED|Overall Study||45
8627448|NCT00518713|9667115|FG002|COMPLETED|Overall Study||41
8627449|NCT00518713|9667116|FG003|COMPLETED|Overall Study||41
8724086|NCT01025843|9771505|FG006|COMPLETED|Period 1||2
8724087|NCT01025843|9771506|FG007|COMPLETED|Period 1||2
8724088|NCT01025843|9771507|FG008|COMPLETED|Period 1||2
8627450|NCT00518713|9667113|FG000|NOT COMPLETED|Overall Study||8
8847514|NCT01729208|9902200|FG001|STARTED|36 Months Follow-up||60
8847515|NCT01729208|9902199|FG000|COMPLETED|36 Months Follow-up||52
8847516|NCT01729208|9902200|FG001|COMPLETED|36 Months Follow-up||56
8847517|NCT01729208|9902199|FG000|NOT COMPLETED|36 Months Follow-up||3
8847518|NCT01729208|9902200|FG001|NOT COMPLETED|36 Months Follow-up||4
8847519|NCT01729247|9902206|FG000|STARTED|Overall Study||50
8847520|NCT01729247|9902206|FG000|COMPLETED|Overall Study||50
8847521|NCT01729247|9902206|FG000|NOT COMPLETED|Overall Study||0
8847522|NCT01729338|9902217|FG000|STARTED|Overall Study||16
8847523|NCT01729338|9902217|FG000|COMPLETED|Overall Study||14
8847524|NCT01729338|9902217|FG000|NOT COMPLETED|Overall Study||2
8847525|NCT01729494|9902224|FG000|STARTED|Overall Study||107
8847526|NCT01729494|9902225|FG001|STARTED|Overall Study||104
8847527|NCT01729494|9902226|FG002|STARTED|Overall Study||105
8847528|NCT01729494|9902224|FG000|COMPLETED|Overall Study||97
8847529|NCT01729494|9902225|FG001|COMPLETED|Overall Study||93
8847530|NCT01729494|9902226|FG002|COMPLETED|Overall Study||94
8847531|NCT01729494|9902224|FG000|NOT COMPLETED|Overall Study||10
8847532|NCT01729494|9902225|FG001|NOT COMPLETED|Overall Study||11
8847533|NCT01729494|9902226|FG002|NOT COMPLETED|Overall Study||11
8847534|NCT01729559|9902236|FG000|STARTED|Overall Study||251
8627451|NCT00518713|9667114|FG001|NOT COMPLETED|Overall Study||17
8627452|NCT00518713|9667115|FG002|NOT COMPLETED|Overall Study||18
8627453|NCT00518713|9667116|FG003|NOT COMPLETED|Overall Study||18
8629563|NCT00530894|9669323|FG003|NOT COMPLETED|Overall Study||94
8847535|NCT01729559|9902237|FG001|STARTED|Overall Study||244
8847536|NCT01729559|9902236|FG000|COMPLETED|Overall Study||220
8847537|NCT01729559|9902237|FG001|COMPLETED|Overall Study||216
8847538|NCT01729559|9902236|FG000|NOT COMPLETED|Overall Study||31
8847539|NCT01729559|9902237|FG001|NOT COMPLETED|Overall Study||28
8847540|NCT01729598|9902245|FG000|STARTED|Overall Study||10
8629564|NCT00530920|9669338|FG000|STARTED|Overall Study||30
8847541|NCT01729598|9902246|FG001|STARTED|Overall Study||4
8847542|NCT01729598|9902245|FG000|COMPLETED|Overall Study||10
8847543|NCT01729598|9902246|FG001|COMPLETED|Overall Study||4
8847544|NCT01729598|9902245|FG000|NOT COMPLETED|Overall Study||0
8627454|NCT00518882|9667128|FG000|STARTED|Double-Blind, Week 0-26|2 subjects exposed to study drug before randomisation. Subjects only included in safety analysis set|235
8627455|NCT00518882|9667129|FG001|STARTED|Double-Blind, Week 0-26|1 subject exposed to study drug before randomisation. Subject only included in safety analysis set|232
8847545|NCT01729598|9902246|FG001|NOT COMPLETED|Overall Study||0
8847546|NCT01729728|9902255|FG000|STARTED|Overall Study||21
8847547|NCT01729728|9902256|FG001|STARTED|Overall Study||28
8847548|NCT01729728|9902257|FG002|STARTED|Overall Study||17
8847549|NCT01729728|9902255|FG000|COMPLETED|Overall Study||20
8847550|NCT01729728|9902256|FG001|COMPLETED|Overall Study||22
8847551|NCT01729728|9902257|FG002|COMPLETED|Overall Study||16
8847552|NCT01729728|9902255|FG000|NOT COMPLETED|Overall Study||1
8847553|NCT01729728|9902256|FG001|NOT COMPLETED|Overall Study||6
8847554|NCT01729728|9902257|FG002|NOT COMPLETED|Overall Study||1
8847555|NCT01729819|9902390|FG000|STARTED|Overall Study||49
8847556|NCT01729819|9902391|FG001|STARTED|Overall Study||57
8847557|NCT01729819|9902390|FG000|COMPLETED|Overall Study||43
8847558|NCT01729819|9902391|FG001|COMPLETED|Overall Study||50
8847559|NCT01729819|9902390|FG000|NOT COMPLETED|Overall Study||6
8847560|NCT01729819|9902391|FG001|NOT COMPLETED|Overall Study||7
8847561|NCT01729845|9902403|FG000|STARTED|Safety/Tolerability of Dec/MEC||6
8847562|NCT01729845|9902404|FG001|STARTED|Safety/Tolerability of Dec/MEC||34
8847563|NCT01729845|9902405|FG002|STARTED|Safety/Tolerability of Dec/MEC||12
8847564|NCT01729845|9902403|FG000|COMPLETED|Safety/Tolerability of Dec/MEC||6
8847565|NCT01729845|9902404|FG001|COMPLETED|Safety/Tolerability of Dec/MEC||34
8847566|NCT01729845|9902405|FG002|COMPLETED|Safety/Tolerability of Dec/MEC||12
8847567|NCT01729845|9902403|FG000|NOT COMPLETED|Safety/Tolerability of Dec/MEC||0
8847568|NCT01729845|9902404|FG001|NOT COMPLETED|Safety/Tolerability of Dec/MEC||0
8847569|NCT01729845|9902405|FG002|NOT COMPLETED|Safety/Tolerability of Dec/MEC||0
8847570|NCT01729845|9902403|FG000|STARTED|Efficacy of Dec/MEC||0
8847571|NCT01729845|9902404|FG001|STARTED|Efficacy of Dec/MEC||22
8847572|NCT01729845|9902405|FG002|STARTED|Efficacy of Dec/MEC||0
8847573|NCT01729845|9902403|FG000|COMPLETED|Efficacy of Dec/MEC||0
8847574|NCT01729845|9902404|FG001|COMPLETED|Efficacy of Dec/MEC||22
8847575|NCT01729845|9902405|FG002|COMPLETED|Efficacy of Dec/MEC||0
8847576|NCT01729845|9902403|FG000|NOT COMPLETED|Efficacy of Dec/MEC||0
8847577|NCT01729845|9902404|FG001|NOT COMPLETED|Efficacy of Dec/MEC||0
8847578|NCT01729845|9902405|FG002|NOT COMPLETED|Efficacy of Dec/MEC||0
8847579|NCT01729871|9902417|FG000|STARTED|Overall Study||124
8847580|NCT01729871|9902418|FG001|STARTED|Overall Study||124
8847581|NCT01729871|9902417|FG000|COMPLETED|Overall Study||112
8847582|NCT01729871|9902418|FG001|COMPLETED|Overall Study||101
8847583|NCT01729871|9902417|FG000|NOT COMPLETED|Overall Study||12
8948159|NCT02427672|10010497|FG001|COMPLETED|Overall Study||42
8847584|NCT01729871|9902418|FG001|NOT COMPLETED|Overall Study||23
8847585|NCT01729923|9902424|FG000|STARTED|Overall Study||27
8948160|NCT02427672|10010496|FG000|NOT COMPLETED|Overall Study||1
8948161|NCT02427672|10010497|FG001|NOT COMPLETED|Overall Study||2
8948162|NCT02427737|10010505|FG000|STARTED|OSU Baseline Q4FY15||4158
8948163|NCT02427737|10010506|FG001|STARTED|OSU Baseline Q4FY15||3446
8948164|NCT02427737|10010505|FG000|COMPLETED|OSU Baseline Q4FY15||3940
8847586|NCT01729923|9902424|FG000|COMPLETED|Overall Study||0
8847587|NCT01729923|9902424|FG000|NOT COMPLETED|Overall Study||27
8847588|NCT01730040|9902435|FG000|STARTED|Overall Study||57
8847589|NCT01730040|9902436|FG001|STARTED|Overall Study||55
8847590|NCT01730040|9902437|FG002|STARTED|Overall Study||57
8847591|NCT01730040|9902438|FG003|STARTED|Overall Study||47
8847592|NCT01730040|9902439|FG004|STARTED|Overall Study||45
8847593|NCT01730040|9902440|FG005|STARTED|Overall Study||47
8627456|NCT00518882|9667128|FG000|Randomised|Double-Blind, Week 0-26||233
8627457|NCT00518882|9667129|FG001|Randomised|Double-Blind, Week 0-26||231
8627458|NCT00518882|9667128|FG000|COMPLETED|Double-Blind, Week 0-26||202
8627459|NCT00518882|9667129|FG001|COMPLETED|Double-Blind, Week 0-26||187
8627460|NCT00518882|9667128|FG000|NOT COMPLETED|Double-Blind, Week 0-26||33
8627461|NCT00518882|9667129|FG001|NOT COMPLETED|Double-Blind, Week 0-26||45
8627462|NCT00518882|9667128|FG000|STARTED|Open-Label Extension, Week 26-78||202
8627463|NCT00518882|9667129|FG001|STARTED|Open-Label Extension, Week 26-78||187
8627464|NCT00518882|9667128|FG000|COMPLETED|Open-Label Extension, Week 26-78||161
8627465|NCT00518882|9667129|FG001|COMPLETED|Open-Label Extension, Week 26-78||138
8627466|NCT00518882|9667128|FG000|NOT COMPLETED|Open-Label Extension, Week 26-78||41
8627467|NCT00518882|9667129|FG001|NOT COMPLETED|Open-Label Extension, Week 26-78||49
8627468|NCT00518973|9667137|FG000|STARTED|Overall Study||9
8627469|NCT00518973|9667138|FG001|STARTED|Overall Study||6
8627470|NCT00518973|9667137|FG000|COMPLETED|Overall Study||6
8847594|NCT01730040|9902441|FG006|STARTED|Overall Study||47
8847595|NCT01730040|9902435|FG000|Treated|Overall Study||57
8847596|NCT01730040|9902436|FG001|Treated|Overall Study||55
8847597|NCT01730040|9902437|FG002|Treated|Overall Study||57
8847598|NCT01730040|9902438|FG003|Treated|Overall Study||47
8847599|NCT01730040|9902439|FG004|Treated|Overall Study||45
8847600|NCT01730040|9902440|FG005|Treated|Overall Study||46
8847601|NCT01730040|9902441|FG006|Treated|Overall Study||47
8847602|NCT01730040|9902435|FG000|COMPLETED|Overall Study||44
8847603|NCT01730040|9902436|FG001|COMPLETED|Overall Study||40
8847604|NCT01730040|9902437|FG002|COMPLETED|Overall Study||46
8627471|NCT00518973|9667138|FG001|COMPLETED|Overall Study||4
8627472|NCT00518973|9667137|FG000|NOT COMPLETED|Overall Study||3
8847605|NCT01730040|9902438|FG003|COMPLETED|Overall Study||39
8627473|NCT00518973|9667138|FG001|NOT COMPLETED|Overall Study||2
8629565|NCT00530920|9669339|FG001|STARTED|Overall Study||27
8847606|NCT01730040|9902439|FG004|COMPLETED|Overall Study||39
8847607|NCT01730040|9902440|FG005|COMPLETED|Overall Study||40
8627474|NCT00518986|9667146|FG000|STARTED|Overall Study|One subject discontinued before treatment, only 124 subjects in each treatment group were dosed.|125
8627475|NCT00518986|9667147|FG001|STARTED|Overall Study||124
8627476|NCT00518986|9667146|FG000|COMPLETED|Overall Study||99
8627477|NCT00518986|9667147|FG001|COMPLETED|Overall Study||98
8627478|NCT00518986|9667146|FG000|NOT COMPLETED|Overall Study||26
8627479|NCT00518986|9667147|FG001|NOT COMPLETED|Overall Study||26
8629566|NCT00530920|9669340|FG002|STARTED|Overall Study||28
8629567|NCT00530920|9669338|FG000|COMPLETED|Overall Study||30
8847608|NCT01730040|9902441|FG006|COMPLETED|Overall Study||38
8847609|NCT01730040|9902435|FG000|NOT COMPLETED|Overall Study||13
8847610|NCT01730040|9902436|FG001|NOT COMPLETED|Overall Study||15
8847611|NCT01730040|9902437|FG002|NOT COMPLETED|Overall Study||11
8847612|NCT01730040|9902438|FG003|NOT COMPLETED|Overall Study||8
8847613|NCT01730040|9902439|FG004|NOT COMPLETED|Overall Study||6
8847614|NCT01730040|9902440|FG005|NOT COMPLETED|Overall Study||7
8847615|NCT01730040|9902441|FG006|NOT COMPLETED|Overall Study||9
8847616|NCT01730053|9902463|FG000|STARTED|Overall Study||48
8847617|NCT01730053|9902464|FG001|STARTED|Overall Study||48
8847618|NCT01730053|9902465|FG002|STARTED|Overall Study||49
8847619|NCT01730053|9902466|FG003|STARTED|Overall Study||53
8847620|NCT01730053|9902467|FG004|STARTED|Overall Study||53
8847621|NCT01730053|9902468|FG005|STARTED|Overall Study||54
8847622|NCT01730053|9902463|FG000|Treated|Overall Study||48
8847623|NCT01730053|9902464|FG001|Treated|Overall Study||48
8847624|NCT01730053|9902465|FG002|Treated|Overall Study||49
8847625|NCT01730053|9902466|FG003|Treated|Overall Study||53
8847626|NCT01730053|9902467|FG004|Treated|Overall Study||53
8847627|NCT01730053|9902468|FG005|Treated|Overall Study||54
8847628|NCT01730053|9902463|FG000|COMPLETED|Overall Study||43
8847629|NCT01730053|9902464|FG001|COMPLETED|Overall Study||34
8847630|NCT01730053|9902465|FG002|COMPLETED|Overall Study||38
8847631|NCT01730053|9902466|FG003|COMPLETED|Overall Study||45
8847632|NCT01730053|9902467|FG004|COMPLETED|Overall Study||44
8847633|NCT01730053|9902468|FG005|COMPLETED|Overall Study||41
8627480|NCT00519077|9667153|FG000|STARTED|Overall Study||44
8724089|NCT01025843|9771508|FG009|COMPLETED|Period 1||2
8724090|NCT01025843|9771499|FG000|NOT COMPLETED|Period 1||0
8724091|NCT01025843|9771500|FG001|NOT COMPLETED|Period 1||0
8724092|NCT01025843|9771501|FG002|NOT COMPLETED|Period 1||0
8724093|NCT01025843|9771502|FG003|NOT COMPLETED|Period 1||0
8724094|NCT01025843|9771503|FG004|NOT COMPLETED|Period 1||0
8724095|NCT01025843|9771504|FG005|NOT COMPLETED|Period 1||0
8847634|NCT01730053|9902463|FG000|NOT COMPLETED|Overall Study||5
8847635|NCT01730053|9902464|FG001|NOT COMPLETED|Overall Study||14
8847636|NCT01730053|9902465|FG002|NOT COMPLETED|Overall Study||11
8847637|NCT01730053|9902466|FG003|NOT COMPLETED|Overall Study||8
8847638|NCT01730053|9902467|FG004|NOT COMPLETED|Overall Study||9
8847639|NCT01730053|9902468|FG005|NOT COMPLETED|Overall Study||13
8847640|NCT01730339|9902485|FG000|STARTED|Overall Study||45
8847641|NCT01730339|9902486|FG001|STARTED|Overall Study||55
8847642|NCT01730339|9902485|FG000|COMPLETED|Overall Study||40
8847643|NCT01730339|9902486|FG001|COMPLETED|Overall Study||52
8847644|NCT01730339|9902485|FG000|NOT COMPLETED|Overall Study||5
8847645|NCT01730339|9902486|FG001|NOT COMPLETED|Overall Study||3
8847646|NCT01730378|9902504|FG000|STARTED|Overall Study||84
8847647|NCT01730378|9902505|FG001|STARTED|Overall Study||47
8724096|NCT01025843|9771505|FG006|NOT COMPLETED|Period 1||0
8724097|NCT01025843|9771506|FG007|NOT COMPLETED|Period 1||0
8724098|NCT01025843|9771507|FG008|NOT COMPLETED|Period 1||0
8724099|NCT01025843|9771508|FG009|NOT COMPLETED|Period 1||0
8724100|NCT01025843|9771499|FG000|STARTED|Washout 1||2
8724101|NCT01025843|9771500|FG001|STARTED|Washout 1||2
8724102|NCT01025843|9771501|FG002|STARTED|Washout 1||2
8724103|NCT01025843|9771502|FG003|STARTED|Washout 1||2
8724104|NCT01025843|9771503|FG004|STARTED|Washout 1||2
8724105|NCT01025843|9771504|FG005|STARTED|Washout 1||2
8724106|NCT01025843|9771505|FG006|STARTED|Washout 1||2
8847648|NCT01730378|9902504|FG000|COMPLETED|Overall Study||83
8847649|NCT01730378|9902505|FG001|COMPLETED|Overall Study||47
8847650|NCT01730378|9902504|FG000|NOT COMPLETED|Overall Study||1
8847651|NCT01730378|9902505|FG001|NOT COMPLETED|Overall Study||0
8847652|NCT01730534|9902514|FG000|STARTED|Overall Study||8582
8847653|NCT01730534|9902515|FG001|STARTED|Overall Study||8578
8847654|NCT01730534|9902514|FG000|COMPLETED|Overall Study||8473
8847655|NCT01730534|9902515|FG001|COMPLETED|Overall Study||8433
8847656|NCT01730534|9902514|FG000|NOT COMPLETED|Overall Study||109
8847657|NCT01730534|9902515|FG001|NOT COMPLETED|Overall Study||145
8847658|NCT01730586|9902521|FG000|STARTED|Overall Study||34
8847659|NCT01730586|9902521|FG000|COMPLETED|Overall Study||21
8847660|NCT01730586|9902521|FG000|NOT COMPLETED|Overall Study||13
8847661|NCT01730729|9902527|FG000|STARTED|Overall Study||20
8847662|NCT01730729|9902527|FG000|Completed 2 Cycles/Reached 1st Response|Overall Study||18
8847663|NCT01730729|9902527|FG000|Treated Cycle 3 and Beyond|Overall Study||6
8847664|NCT01730729|9902527|FG000|COMPLETED|Overall Study||6
8847665|NCT01730729|9902527|FG000|NOT COMPLETED|Overall Study||14
8847666|NCT01730846|9902534|FG000|STARTED|Overall Study||11
8847667|NCT01730846|9902535|FG001|STARTED|Overall Study||11
8847668|NCT01730846|9902536|FG002|STARTED|Overall Study||13
8847669|NCT01730846|9902534|FG000|COMPLETED|Overall Study||11
8847670|NCT01730846|9902535|FG001|COMPLETED|Overall Study||11
8627481|NCT00519077|9667153|FG000|COMPLETED|Overall Study||36
8627482|NCT00519077|9667153|FG000|NOT COMPLETED|Overall Study||8
8627483|NCT00519194|9667157|FG000|STARTED|Overall Study||112
8627484|NCT00519194|9667157|FG000|COMPLETED|Overall Study||91
8627485|NCT00519194|9667157|FG000|NOT COMPLETED|Overall Study||21
8627486|NCT00519285|9667163|FG000|STARTED|Overall Study|Randomized|612
8627487|NCT00519285|9667164|FG001|STARTED|Overall Study|Randomized|612
8627488|NCT00519285|9667163|FG000|TREATED|Overall Study|Received at least part of one dose of placebo|604
8627489|NCT00519285|9667164|FG001|TREATED|Overall Study|Received at least part of one dose of aflibercept|605
8627490|NCT00519285|9667163|FG000|Still Treated at Cut-off Date|Overall Study|The cut-off date for analysis was defined as 07 February 2012, date at which 873 deaths has occurred|1
8627491|NCT00519285|9667164|FG001|Still Treated at Cut-off Date|Overall Study||2
8627492|NCT00519285|9667163|FG000|COMPLETED|Overall Study|Participants were treated until progressive disease, unacceptable toxicity, or refusal of treatment|0
8627493|NCT00519285|9667164|FG001|COMPLETED|Overall Study||0
8627494|NCT00519285|9667163|FG000|NOT COMPLETED|Overall Study||612
8627495|NCT00519285|9667164|FG001|NOT COMPLETED|Overall Study||612
8627496|NCT00519376|9667170|FG000|STARTED|Treatment Period 1||2
8627497|NCT00519376|9667171|FG001|STARTED|Treatment Period 1||2
8627498|NCT00519376|9667172|FG002|STARTED|Treatment Period 1||2
8627499|NCT00519376|9667173|FG003|STARTED|Treatment Period 1||2
8627500|NCT00519376|9667174|FG004|STARTED|Treatment Period 1||1
8627501|NCT00519376|9667175|FG005|STARTED|Treatment Period 1||1
8627502|NCT00519376|9667176|FG006|STARTED|Treatment Period 1||1
8627503|NCT00519376|9667177|FG007|STARTED|Treatment Period 1||1
8627504|NCT00519376|9667178|FG008|STARTED|Treatment Period 1||1
8627505|NCT00519376|9667179|FG009|STARTED|Treatment Period 1||1
8627506|NCT00519376|9667180|FG010|STARTED|Treatment Period 1||1
8627507|NCT00519376|9667181|FG011|STARTED|Treatment Period 1||1
8627508|NCT00519376|9667182|FG012|STARTED|Treatment Period 1||1
8627509|NCT00519376|9667183|FG013|STARTED|Treatment Period 1||1
8627510|NCT00519376|9667184|FG014|STARTED|Treatment Period 1||1
8627511|NCT00519376|9667185|FG015|STARTED|Treatment Period 1||1
8847671|NCT01730846|9902536|FG002|COMPLETED|Overall Study||13
8847672|NCT01730846|9902534|FG000|NOT COMPLETED|Overall Study||0
8847673|NCT01730846|9902535|FG001|NOT COMPLETED|Overall Study||0
8847674|NCT01730846|9902536|FG002|NOT COMPLETED|Overall Study||0
8847675|NCT01730872|9902547|FG000|STARTED|Overall Study||8
8627512|NCT00519376|9667170|FG000|COMPLETED|Treatment Period 1||2
8627513|NCT00519376|9667171|FG001|COMPLETED|Treatment Period 1||2
8847676|NCT01730872|9902548|FG001|STARTED|Overall Study||5
8847677|NCT01730872|9902549|FG002|STARTED|Overall Study||3
8847678|NCT01730872|9902547|FG000|Full Analysis Set|Overall Study||8
8847679|NCT01730872|9902548|FG001|Full Analysis Set|Overall Study|1 subject did not complete the last post-CAE measurement on Day 6 and was excluded from the FAS|4
8847680|NCT01730872|9902549|FG002|Full Analysis Set|Overall Study||0
8847681|NCT01730872|9902547|FG000|COMPLETED|Overall Study||8
8847682|NCT01730872|9902548|FG001|COMPLETED|Overall Study||5
8847683|NCT01730872|9902549|FG002|COMPLETED|Overall Study||3
8847684|NCT01730872|9902547|FG000|NOT COMPLETED|Overall Study||0
8847685|NCT01730872|9902548|FG001|NOT COMPLETED|Overall Study||0
8847686|NCT01730872|9902549|FG002|NOT COMPLETED|Overall Study||0
8847687|NCT01730950|9902558|FG000|STARTED|Overall Study||90
8847688|NCT01730950|9902559|FG001|STARTED|Overall Study||92
8847689|NCT01730950|9902558|FG000|Eligible Population|Overall Study||84
8847690|NCT01730950|9902559|FG001|Eligible Population|Overall Study||86
8847691|NCT01730950|9902558|FG000|Adverse Event Population|Overall Study||76
8847692|NCT01730950|9902559|FG001|Adverse Event Population|Overall Study||83
8847693|NCT01730950|9902558|FG000|Response Population|Overall Study||78
8847694|NCT01730950|9902559|FG001|Response Population|Overall Study||77
8847695|NCT01730950|9902558|FG000|6-month Progression-free Analysis|Overall Study||79
8847696|NCT01730950|9902559|FG001|6-month Progression-free Analysis|Overall Study||81
8847697|NCT01730950|9902558|FG000|Delayed Toxicity Population|Overall Study||0
8847698|NCT01730950|9902559|FG001|Delayed Toxicity Population|Overall Study||83
8847699|NCT01730950|9902558|FG000|COMPLETED|Overall Study||84
8847700|NCT01730950|9902559|FG001|COMPLETED|Overall Study||86
8847701|NCT01730950|9902558|FG000|NOT COMPLETED|Overall Study||6
8847702|NCT01730950|9902559|FG001|NOT COMPLETED|Overall Study||6
8847703|NCT01731002|9902569|FG000|STARTED|Overall Study||75
8847704|NCT01731002|9902570|FG001|STARTED|Overall Study||72
8847705|NCT01731002|9902571|FG002|STARTED|Overall Study||77
8847706|NCT01731002|9902569|FG000|COMPLETED|Overall Study||71
8847707|NCT01731002|9902570|FG001|COMPLETED|Overall Study||68
8847708|NCT01731002|9902571|FG002|COMPLETED|Overall Study||74
8847709|NCT01731002|9902569|FG000|NOT COMPLETED|Overall Study||4
8847710|NCT01731002|9902570|FG001|NOT COMPLETED|Overall Study||4
8847711|NCT01731002|9902571|FG002|NOT COMPLETED|Overall Study||3
8847712|NCT01731041|9902581|FG000|STARTED|Overall Study||30
8847713|NCT01731041|9902582|FG001|STARTED|Overall Study||30
8627514|NCT00519376|9667172|FG002|COMPLETED|Treatment Period 1||2
8847714|NCT01731041|9902581|FG000|COMPLETED|Overall Study||30
8847715|NCT01731041|9902582|FG001|COMPLETED|Overall Study||30
8847716|NCT01731041|9902581|FG000|NOT COMPLETED|Overall Study||0
8847717|NCT01731041|9902582|FG001|NOT COMPLETED|Overall Study||0
8847718|NCT01731119|9902588|FG000|STARTED|Overall Study||9
8847719|NCT01731119|9902588|FG000|COMPLETED|Overall Study||7
8847720|NCT01731119|9902588|FG000|NOT COMPLETED|Overall Study||2
8847721|NCT01731171|9902594|FG000|STARTED|Overall Study||33
8847722|NCT01731171|9902595|FG001|STARTED|Overall Study||33
8847723|NCT01731171|9902594|FG000|COMPLETED|Overall Study||26
8847724|NCT01731171|9902595|FG001|COMPLETED|Overall Study||26
8847725|NCT01731171|9902594|FG000|NOT COMPLETED|Overall Study||7
8847726|NCT01731171|9902595|FG001|NOT COMPLETED|Overall Study||7
8847727|NCT01731470|9902601|FG000|STARTED|Overall Study|Number of patients consented to participate in the study|16
8847728|NCT01731470|9902601|FG000|COMPLETED|Overall Study|Number of patients enrolled in the study|14
8847729|NCT01731470|9902601|FG000|NOT COMPLETED|Overall Study||2
8847730|NCT01731600|9902607|FG000|STARTED|Overall Study||34
8847731|NCT01731600|9902608|FG001|STARTED|Overall Study||34
8847732|NCT01731600|9902607|FG000|COMPLETED|Overall Study||28
8847733|NCT01731600|9902608|FG001|COMPLETED|Overall Study||34
8847734|NCT01731600|9902607|FG000|NOT COMPLETED|Overall Study||6
8847735|NCT01731600|9902608|FG001|NOT COMPLETED|Overall Study||0
8847736|NCT01731678|9902618|FG000|STARTED|Overall Study||39
8847737|NCT01731678|9902618|FG000|COMPLETED|Overall Study||32
8627515|NCT00519376|9667173|FG003|COMPLETED|Treatment Period 1||2
8627516|NCT00519376|9667174|FG004|COMPLETED|Treatment Period 1||1
8627517|NCT00519376|9667175|FG005|COMPLETED|Treatment Period 1||1
8627518|NCT00519376|9667176|FG006|COMPLETED|Treatment Period 1||1
8627519|NCT00519376|9667177|FG007|COMPLETED|Treatment Period 1||1
8627520|NCT00519376|9667178|FG008|COMPLETED|Treatment Period 1||1
8627521|NCT00519376|9667179|FG009|COMPLETED|Treatment Period 1||1
8627522|NCT00519376|9667180|FG010|COMPLETED|Treatment Period 1||1
8627523|NCT00519376|9667181|FG011|COMPLETED|Treatment Period 1||1
8627524|NCT00519376|9667182|FG012|COMPLETED|Treatment Period 1||1
8627525|NCT00519376|9667183|FG013|COMPLETED|Treatment Period 1||1
8627526|NCT00519376|9667184|FG014|COMPLETED|Treatment Period 1||1
8627527|NCT00519376|9667185|FG015|COMPLETED|Treatment Period 1||1
8627528|NCT00519376|9667170|FG000|NOT COMPLETED|Treatment Period 1||0
8627529|NCT00519376|9667171|FG001|NOT COMPLETED|Treatment Period 1||0
8627530|NCT00519376|9667172|FG002|NOT COMPLETED|Treatment Period 1||0
8627531|NCT00519376|9667173|FG003|NOT COMPLETED|Treatment Period 1||0
8627532|NCT00519376|9667174|FG004|NOT COMPLETED|Treatment Period 1||0
8627533|NCT00519376|9667175|FG005|NOT COMPLETED|Treatment Period 1||0
8627534|NCT00519376|9667176|FG006|NOT COMPLETED|Treatment Period 1||0
8627535|NCT00519376|9667177|FG007|NOT COMPLETED|Treatment Period 1||0
8627536|NCT00519376|9667178|FG008|NOT COMPLETED|Treatment Period 1||0
8627537|NCT00519376|9667179|FG009|NOT COMPLETED|Treatment Period 1||0
8847738|NCT01731678|9902618|FG000|NOT COMPLETED|Overall Study||7
8847739|NCT01731691|9902625|FG000|STARTED|Overall Study||3
8847740|NCT01731691|9902626|FG001|STARTED|Overall Study||5
8847741|NCT01731691|9902627|FG002|STARTED|Overall Study||4
8847742|NCT01731691|9902625|FG000|COMPLETED|Overall Study||3
8847743|NCT01731691|9902626|FG001|COMPLETED|Overall Study||5
8847744|NCT01731691|9902627|FG002|COMPLETED|Overall Study||4
8847745|NCT01731691|9902625|FG000|NOT COMPLETED|Overall Study||0
8847746|NCT01731691|9902626|FG001|NOT COMPLETED|Overall Study||0
8847747|NCT01731691|9902627|FG002|NOT COMPLETED|Overall Study||0
8847748|NCT01731886|9902640|FG000|STARTED|Overall Study||31
8847749|NCT01731886|9902641|FG001|STARTED|Overall Study||29
8847750|NCT01731886|9902640|FG000|COMPLETED|Overall Study||29
8847751|NCT01731886|9902641|FG001|COMPLETED|Overall Study||28
8847752|NCT01731886|9902640|FG000|NOT COMPLETED|Overall Study||2
8847753|NCT01731886|9902641|FG001|NOT COMPLETED|Overall Study||1
8847754|NCT01731912|9902648|FG000|STARTED|Overall Study||16
8847755|NCT01731912|9902648|FG000|COMPLETED|Overall Study||14
8847756|NCT01731912|9902648|FG000|NOT COMPLETED|Overall Study||2
8847757|NCT01731938|9902656|FG000|STARTED|Preliminary Part I||51
8847758|NCT01731938|9902657|FG001|STARTED|Preliminary Part I||52
8627538|NCT00519376|9667180|FG010|NOT COMPLETED|Treatment Period 1||0
8627539|NCT00519376|9667181|FG011|NOT COMPLETED|Treatment Period 1||0
8627540|NCT00519376|9667182|FG012|NOT COMPLETED|Treatment Period 1||0
8847759|NCT01731938|9902656|FG000|COMPLETED|Preliminary Part I||48
8847760|NCT01731938|9902657|FG001|COMPLETED|Preliminary Part I||44
8847761|NCT01731938|9902656|FG000|NOT COMPLETED|Preliminary Part I||3
8847762|NCT01731938|9902657|FG001|NOT COMPLETED|Preliminary Part I||8
8847763|NCT01731938|9902656|FG000|STARTED|Primary Part II|Preliminary Part I was for study team familiarization with FS Grifols application.|116
8847764|NCT01731938|9902657|FG001|STARTED|Primary Part II|Subjects from Preliminary Part I were not carried over to Primary Part II to assess safety/efficacy.|108
8847765|NCT01731938|9902656|FG000|COMPLETED|Primary Part II||103
8847766|NCT01731938|9902657|FG001|COMPLETED|Primary Part II||95
8847767|NCT01731938|9902656|FG000|NOT COMPLETED|Primary Part II||13
8847768|NCT01731938|9902657|FG001|NOT COMPLETED|Primary Part II||13
8847769|NCT01731951|9902670|FG000|STARTED|Overall Study||19
8847770|NCT01731951|9902671|FG001|STARTED|Overall Study||16
8847771|NCT01731951|9902672|FG002|STARTED|Overall Study||9
8847772|NCT01731951|9902673|FG003|STARTED|Overall Study||9
8847773|NCT01731951|9902674|FG004|STARTED|Overall Study||18
8847774|NCT01731951|9902675|FG005|STARTED|Overall Study||9
8847775|NCT01731951|9902670|FG000|COMPLETED|Overall Study||2
8847776|NCT01731951|9902671|FG001|COMPLETED|Overall Study||1
8847777|NCT01731951|9902672|FG002|COMPLETED|Overall Study||0
8847778|NCT01731951|9902673|FG003|COMPLETED|Overall Study||0
8847779|NCT01731951|9902674|FG004|COMPLETED|Overall Study||6
8847780|NCT01731951|9902675|FG005|COMPLETED|Overall Study||0
8847781|NCT01731951|9902670|FG000|NOT COMPLETED|Overall Study||17
8847782|NCT01731951|9902671|FG001|NOT COMPLETED|Overall Study||15
8847783|NCT01731951|9902672|FG002|NOT COMPLETED|Overall Study||9
8847784|NCT01731951|9902673|FG003|NOT COMPLETED|Overall Study||9
8847785|NCT01731951|9902674|FG004|NOT COMPLETED|Overall Study||12
8847786|NCT01731951|9902675|FG005|NOT COMPLETED|Overall Study||9
8847787|NCT01731990|9902695|FG000|STARTED|Overall Study|"Started indicates Safety and Pharmacodynamics set ."|18
8847788|NCT01731990|9902696|FG001|STARTED|Overall Study||20
8847789|NCT01731990|9902695|FG000|COMPLETED|Overall Study||14
8847790|NCT01731990|9902696|FG001|COMPLETED|Overall Study||12
8847791|NCT01731990|9902695|FG000|NOT COMPLETED|Overall Study||4
8847792|NCT01731990|9902696|FG001|NOT COMPLETED|Overall Study||8
8847793|NCT01732107|9902702|FG000|STARTED|Overall Study||13
8847794|NCT01732107|9902702|FG000|COMPLETED|Overall Study||0
8847795|NCT01732107|9902702|FG000|NOT COMPLETED|Overall Study||13
8847796|NCT01732263|9902708|FG000|STARTED|Overall Study||23
8847797|NCT01732263|9902709|FG001|STARTED|Overall Study||20
8847798|NCT01732263|9902708|FG000|COMPLETED|Overall Study||23
8847799|NCT01732263|9902709|FG001|COMPLETED|Overall Study||20
8847800|NCT01732263|9902708|FG000|NOT COMPLETED|Overall Study||0
8847801|NCT01732263|9902709|FG001|NOT COMPLETED|Overall Study||0
8847802|NCT01732406|9902722|FG000|STARTED|Overall Study||31
8847803|NCT01732406|9902723|FG001|STARTED|Overall Study||60
8847804|NCT01732406|9902724|FG002|STARTED|Overall Study||35
8847805|NCT01732406|9902722|FG000|COMPLETED|Overall Study||31
8847806|NCT01732406|9902723|FG001|COMPLETED|Overall Study||60
8847807|NCT01732406|9902724|FG002|COMPLETED|Overall Study||35
8847808|NCT01732406|9902722|FG000|NOT COMPLETED|Overall Study||0
8847809|NCT01732406|9902723|FG001|NOT COMPLETED|Overall Study||0
8847810|NCT01732406|9902724|FG002|NOT COMPLETED|Overall Study||0
8850244|NCT01746017|9905500|FG003|COMPLETED|Period 1||2
8850245|NCT01746017|9905501|FG004|COMPLETED|Period 1||2
8850246|NCT01746017|9905502|FG005|COMPLETED|Period 1||2
8850247|NCT01746017|9905503|FG006|COMPLETED|Period 1||2
8850248|NCT01746017|9905504|FG007|COMPLETED|Period 1||2
8850249|NCT01746017|9905505|FG008|COMPLETED|Period 1||3
8850250|NCT01746017|9905506|FG009|COMPLETED|Period 1||3
8850251|NCT01746017|9905507|FG010|COMPLETED|Period 1||3
8850252|NCT01746017|9905497|FG000|NOT COMPLETED|Period 1||0
8850253|NCT01746017|9905498|FG001|NOT COMPLETED|Period 1||0
8850254|NCT01746017|9905499|FG002|NOT COMPLETED|Period 1||0
8850255|NCT01746017|9905500|FG003|NOT COMPLETED|Period 1||0
8850256|NCT01746017|9905501|FG004|NOT COMPLETED|Period 1||0
8850257|NCT01746017|9905502|FG005|NOT COMPLETED|Period 1||0
8850258|NCT01746017|9905503|FG006|NOT COMPLETED|Period 1||1
8850259|NCT01746017|9905504|FG007|NOT COMPLETED|Period 1||0
8850260|NCT01746017|9905505|FG008|NOT COMPLETED|Period 1||0
8850261|NCT01746017|9905506|FG009|NOT COMPLETED|Period 1||0
8850262|NCT01746017|9905507|FG010|NOT COMPLETED|Period 1||0
8850263|NCT01746017|9905497|FG000|STARTED|Period 2||2
8850264|NCT01746017|9905498|FG001|STARTED|Period 2||2
8850265|NCT01746017|9905499|FG002|STARTED|Period 2||2
8850266|NCT01746017|9905500|FG003|STARTED|Period 2||2
8850267|NCT01746017|9905501|FG004|STARTED|Period 2||2
8850268|NCT01746017|9905502|FG005|STARTED|Period 2||2
8850269|NCT01746017|9905503|FG006|STARTED|Period 2||2
8850270|NCT01746017|9905504|FG007|STARTED|Period 2||2
8850271|NCT01746017|9905505|FG008|STARTED|Period 2||3
8850272|NCT01746017|9905506|FG009|STARTED|Period 2||3
8850273|NCT01746017|9905507|FG010|STARTED|Period 2||3
8850274|NCT01746017|9905497|FG000|COMPLETED|Period 2||2
8850275|NCT01746017|9905498|FG001|COMPLETED|Period 2||2
8850276|NCT01746017|9905499|FG002|COMPLETED|Period 2||2
8850277|NCT01746017|9905500|FG003|COMPLETED|Period 2||2
8850278|NCT01746017|9905501|FG004|COMPLETED|Period 2||2
8850279|NCT01746017|9905502|FG005|COMPLETED|Period 2||2
8850280|NCT01746017|9905503|FG006|COMPLETED|Period 2||2
8850281|NCT01746017|9905504|FG007|COMPLETED|Period 2||2
8850282|NCT01746017|9905505|FG008|COMPLETED|Period 2||3
8850283|NCT01746017|9905506|FG009|COMPLETED|Period 2||3
8850284|NCT01746017|9905507|FG010|COMPLETED|Period 2||3
8847811|NCT01732419|9902738|FG000|STARTED|Overall Study||45
8847812|NCT01732419|9902739|FG001|STARTED|Overall Study||45
8847813|NCT01732419|9902738|FG000|COMPLETED|Overall Study||37
8847814|NCT01732419|9902739|FG001|COMPLETED|Overall Study||41
8847815|NCT01732419|9902738|FG000|NOT COMPLETED|Overall Study||8
8847816|NCT01732419|9902739|FG001|NOT COMPLETED|Overall Study||4
8847817|NCT01732445|9902745|FG000|STARTED|Overall Study||14
8847818|NCT01732445|9902745|FG000|COMPLETED|Overall Study||14
8847819|NCT01732445|9902745|FG000|NOT COMPLETED|Overall Study||0
8847820|NCT01732458|9902753|FG000|STARTED|Overall Study||60
8847821|NCT01732458|9902754|FG001|STARTED|Overall Study||58
8847822|NCT01732458|9902755|FG002|STARTED|Overall Study||58
8847823|NCT01732458|9902756|FG003|STARTED|Overall Study||52
8847824|NCT01732458|9902753|FG000|Treated|Overall Study||57
8847825|NCT01732458|9902754|FG001|Treated|Overall Study||55
8847826|NCT01732458|9902755|FG002|Treated|Overall Study||56
8847827|NCT01732458|9902756|FG003|Treated|Overall Study||52
8847828|NCT01732458|9902753|FG000|COMPLETED|Overall Study||57
8847829|NCT01732458|9902754|FG001|COMPLETED|Overall Study||53
8847830|NCT01732458|9902755|FG002|COMPLETED|Overall Study||55
8847831|NCT01732458|9902756|FG003|COMPLETED|Overall Study||50
8847832|NCT01732458|9902753|FG000|NOT COMPLETED|Overall Study||3
8847833|NCT01732458|9902754|FG001|NOT COMPLETED|Overall Study||5
8847834|NCT01732458|9902755|FG002|NOT COMPLETED|Overall Study||3
8847835|NCT01732458|9902756|FG003|NOT COMPLETED|Overall Study||2
8847836|NCT01732471|9902778|FG000|STARTED|Overall Study||90
8847837|NCT01732471|9902778|FG000|COMPLETED|Overall Study||89
8847838|NCT01732471|9902778|FG000|NOT COMPLETED|Overall Study||1
8847839|NCT01732484|9902782|FG000|STARTED|Overall Study||100
8847840|NCT01732484|9902782|FG000|Randomized|Overall Study|Randomized implantation SN60WF IOL in on eye and iMics NY-60 in the other eye.|100
8847841|NCT01732484|9902782|FG000|Allocation|Overall Study||100
8847842|NCT01732484|9902782|FG000|COMPLETED|Overall Study||74
8847843|NCT01732484|9902782|FG000|NOT COMPLETED|Overall Study||26
8847844|NCT01732510|9902795|FG000|STARTED|Overall Study||9
8847845|NCT01732510|9902796|FG001|STARTED|Overall Study||9
8847846|NCT01732510|9902797|FG002|STARTED|Overall Study||8
8847847|NCT01732510|9902798|FG003|STARTED|Overall Study||10
8847848|NCT01732510|9902799|FG004|STARTED|Overall Study||8
8847849|NCT01732510|9902800|FG005|STARTED|Overall Study||13
8847850|NCT01732510|9902801|FG006|STARTED|Overall Study||8
8847851|NCT01732510|9902795|FG000|COMPLETED|Overall Study||8
8847852|NCT01732510|9902796|FG001|COMPLETED|Overall Study||4
8847853|NCT01732510|9902797|FG002|COMPLETED|Overall Study||4
8847854|NCT01732510|9902798|FG003|COMPLETED|Overall Study||5
8847855|NCT01732510|9902799|FG004|COMPLETED|Overall Study||3
8847856|NCT01732510|9902800|FG005|COMPLETED|Overall Study||0
8847857|NCT01732510|9902801|FG006|COMPLETED|Overall Study||0
8847858|NCT01732510|9902795|FG000|NOT COMPLETED|Overall Study||1
8847859|NCT01732510|9902796|FG001|NOT COMPLETED|Overall Study||5
8627541|NCT00519376|9667183|FG013|NOT COMPLETED|Treatment Period 1||0
8627542|NCT00519376|9667184|FG014|NOT COMPLETED|Treatment Period 1||0
8847860|NCT01732510|9902797|FG002|NOT COMPLETED|Overall Study||4
8847861|NCT01732510|9902798|FG003|NOT COMPLETED|Overall Study||5
8847862|NCT01732510|9902799|FG004|NOT COMPLETED|Overall Study||5
8847863|NCT01732510|9902800|FG005|NOT COMPLETED|Overall Study||13
8847864|NCT01732510|9902801|FG006|NOT COMPLETED|Overall Study||8
8847865|NCT01732536|9902822|FG000|STARTED|Overall Study||53
8847866|NCT01732536|9902823|FG001|STARTED|Overall Study||47
8847867|NCT01732536|9902822|FG000|COMPLETED|Overall Study||52
8847868|NCT01732536|9902823|FG001|COMPLETED|Overall Study||46
8847869|NCT01732536|9902822|FG000|NOT COMPLETED|Overall Study||1
8847870|NCT01732536|9902823|FG001|NOT COMPLETED|Overall Study||1
8847871|NCT01732549|9902834|FG000|STARTED|Overall Study||71
8847872|NCT01732549|9902835|FG001|STARTED|Overall Study||73
8847873|NCT01732549|9902834|FG000|Ongoing in Treatment Period:Data Cut-off|Overall Study||12
8847874|NCT01732549|9902835|FG001|Ongoing in Treatment Period:Data Cut-off|Overall Study||12
8847875|NCT01732549|9902834|FG000|Withdrawn During Treatment:Data Cut-off|Overall Study|Withdrawn during treatment period 59 (AE 13, Consent withdrawn 13, Disease progression 31, Other 2)|59
8847876|NCT01732549|9902835|FG001|Withdrawn During Treatment:Data Cut-off|Overall Study|Withdrawn during treatment period 61 (AE 3, Consent withdrawn 6, Disease progression 46, Other 6)|61
8847877|NCT01732549|9902834|FG000|Ongoing Treatment Period:Final Analysis|Overall Study||0
8847878|NCT01732549|9902835|FG001|Ongoing Treatment Period:Final Analysis|Overall Study||0
8847879|NCT01732549|9902834|FG000|Withdrawn During Treatment:Final Analysi|Overall Study||71
8847880|NCT01732549|9902835|FG001|Withdrawn During Treatment:Final Analysi|Overall Study||73
8847881|NCT01732549|9902834|FG000|COMPLETED|Overall Study||0
8847882|NCT01732549|9902835|FG001|COMPLETED|Overall Study||0
8847883|NCT01732549|9902834|FG000|NOT COMPLETED|Overall Study||71
8847884|NCT01732549|9902835|FG001|NOT COMPLETED|Overall Study||73
8847885|NCT01732588|9902845|FG000|STARTED|First Intervention (7 Days)||4
8847886|NCT01732588|9902846|FG001|STARTED|First Intervention (7 Days)||3
8847887|NCT01732588|9902847|FG002|STARTED|First Intervention (7 Days)||4
8847888|NCT01732588|9902845|FG000|COMPLETED|First Intervention (7 Days)||4
8847889|NCT01732588|9902846|FG001|COMPLETED|First Intervention (7 Days)||2
8847890|NCT01732588|9902847|FG002|COMPLETED|First Intervention (7 Days)||4
8847891|NCT01732588|9902845|FG000|NOT COMPLETED|First Intervention (7 Days)||0
8847892|NCT01732588|9902846|FG001|NOT COMPLETED|First Intervention (7 Days)||1
8847893|NCT01732588|9902847|FG002|NOT COMPLETED|First Intervention (7 Days)||0
8847894|NCT01732588|9902845|FG000|STARTED|Second Intervention (7 Days)||4
8847895|NCT01732588|9902846|FG001|STARTED|Second Intervention (7 Days)||2
8847896|NCT01732588|9902847|FG002|STARTED|Second Intervention (7 Days)||4
8847897|NCT01732588|9902845|FG000|COMPLETED|Second Intervention (7 Days)||4
8847898|NCT01732588|9902846|FG001|COMPLETED|Second Intervention (7 Days)||2
8847899|NCT01732588|9902847|FG002|COMPLETED|Second Intervention (7 Days)||4
8847900|NCT01732588|9902845|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
8847901|NCT01732588|9902846|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
8847902|NCT01732588|9902847|FG002|NOT COMPLETED|Second Intervention (7 Days)||0
8847903|NCT01732588|9902845|FG000|STARTED|Third Intervention (7 Days)||4
8847904|NCT01732588|9902846|FG001|STARTED|Third Intervention (7 Days)||2
8847905|NCT01732588|9902847|FG002|STARTED|Third Intervention (7 Days)||4
8847906|NCT01732588|9902845|FG000|COMPLETED|Third Intervention (7 Days)||4
8847907|NCT01732588|9902846|FG001|COMPLETED|Third Intervention (7 Days)||2
8847908|NCT01732588|9902847|FG002|COMPLETED|Third Intervention (7 Days)||4
8847909|NCT01732588|9902845|FG000|NOT COMPLETED|Third Intervention (7 Days)||0
8847910|NCT01732588|9902846|FG001|NOT COMPLETED|Third Intervention (7 Days)||0
8847911|NCT01732588|9902847|FG002|NOT COMPLETED|Third Intervention (7 Days)||0
8847912|NCT01732640|9902855|FG000|STARTED|Overall Study||6
8847913|NCT01732640|9902856|FG001|STARTED|Overall Study||3
8847914|NCT01732640|9902855|FG000|COMPLETED|Overall Study||6
8847915|NCT01732640|9902856|FG001|COMPLETED|Overall Study||1
8847916|NCT01732640|9902855|FG000|NOT COMPLETED|Overall Study||0
8847917|NCT01732640|9902856|FG001|NOT COMPLETED|Overall Study||2
8847918|NCT01732692|9902868|FG000|STARTED|Overall Study||70
8847919|NCT01732692|9902869|FG001|STARTED|Overall Study||70
8847920|NCT01732692|9902868|FG000|COMPLETED|Overall Study||70
8847921|NCT01732692|9902869|FG001|COMPLETED|Overall Study||69
8847922|NCT01732692|9902868|FG000|NOT COMPLETED|Overall Study||0
8847923|NCT01732692|9902869|FG001|NOT COMPLETED|Overall Study||1
8847924|NCT01732718|9902875|FG000|STARTED|First Intervention||7
8847925|NCT01732718|9902876|FG001|STARTED|First Intervention||6
8847926|NCT01732718|9902875|FG000|COMPLETED|First Intervention||7
8847927|NCT01732718|9902876|FG001|COMPLETED|First Intervention||6
8847928|NCT01732718|9902875|FG000|NOT COMPLETED|First Intervention||0
8847929|NCT01732718|9902876|FG001|NOT COMPLETED|First Intervention||0
8847930|NCT01732718|9902875|FG000|STARTED|Washout (4 Weeks)||7
8847931|NCT01732718|9902876|FG001|STARTED|Washout (4 Weeks)||6
8847932|NCT01732718|9902875|FG000|COMPLETED|Washout (4 Weeks)||7
8847933|NCT01732718|9902876|FG001|COMPLETED|Washout (4 Weeks)||6
8847934|NCT01732718|9902875|FG000|NOT COMPLETED|Washout (4 Weeks)||0
8847935|NCT01732718|9902876|FG001|NOT COMPLETED|Washout (4 Weeks)||0
8847936|NCT01732718|9902875|FG000|STARTED|Second Intervention||7
8847937|NCT01732718|9902876|FG001|STARTED|Second Intervention||6
8847938|NCT01732718|9902875|FG000|COMPLETED|Second Intervention||7
8847939|NCT01732718|9902876|FG001|COMPLETED|Second Intervention||6
8847940|NCT01732718|9902875|FG000|NOT COMPLETED|Second Intervention||0
8847941|NCT01732718|9902876|FG001|NOT COMPLETED|Second Intervention||0
8847942|NCT01732757|9902891|FG000|STARTED|Overall Study||53
8847943|NCT01732757|9902892|FG001|STARTED|Overall Study||52
8847944|NCT01732757|9902893|FG002|STARTED|Overall Study||52
8847945|NCT01732757|9902891|FG000|COMPLETED|Overall Study||52
8847946|NCT01732757|9902892|FG001|COMPLETED|Overall Study||52
8847947|NCT01732757|9902893|FG002|COMPLETED|Overall Study||52
8847948|NCT01732757|9902891|FG000|NOT COMPLETED|Overall Study||1
8847949|NCT01732757|9902892|FG001|NOT COMPLETED|Overall Study||0
8847950|NCT01732757|9902893|FG002|NOT COMPLETED|Overall Study||0
8847951|NCT01732770|9902903|FG000|STARTED|Overall Study||322
8847952|NCT01732770|9902904|FG001|STARTED|Overall Study||321
8847953|NCT01732770|9902903|FG000|Received Study Treatment|Overall Study||320
8847954|NCT01732770|9902904|FG001|Received Study Treatment|Overall Study||320
8847955|NCT01732770|9902903|FG000|COMPLETED|Overall Study||312
8847956|NCT01732770|9902904|FG001|COMPLETED|Overall Study||313
8847957|NCT01732770|9902903|FG000|NOT COMPLETED|Overall Study||10
8847958|NCT01732770|9902904|FG001|NOT COMPLETED|Overall Study||8
8847959|NCT01732783|9902913|FG000|STARTED|Overall Study||164
8627543|NCT00519376|9667185|FG015|NOT COMPLETED|Treatment Period 1||0
8627544|NCT00519376|9667170|FG000|STARTED|Washout Period 1||2
8627545|NCT00519376|9667171|FG001|STARTED|Washout Period 1||2
8627546|NCT00519376|9667172|FG002|STARTED|Washout Period 1||2
8627547|NCT00519376|9667173|FG003|STARTED|Washout Period 1||2
8627548|NCT00519376|9667174|FG004|STARTED|Washout Period 1||1
8847960|NCT01732783|9902914|FG001|STARTED|Overall Study||37
8847961|NCT01732783|9902915|FG002|STARTED|Overall Study||12
8847962|NCT01732783|9902913|FG000|COMPLETED|Overall Study|Completed 12-month observation period.|29
8847963|NCT01732783|9902914|FG001|COMPLETED|Overall Study|Completed 12-month observation period.|5
8847964|NCT01732783|9902915|FG002|COMPLETED|Overall Study|Completed 12-month observation period.|2
8847965|NCT01732783|9902913|FG000|NOT COMPLETED|Overall Study||135
8847966|NCT01732783|9902914|FG001|NOT COMPLETED|Overall Study||32
8847967|NCT01732783|9902915|FG002|NOT COMPLETED|Overall Study||10
8847968|NCT01732796|9902926|FG000|STARTED|Overall Study||208
8847969|NCT01732796|9902927|FG001|STARTED|Overall Study||211
8847970|NCT01732796|9902928|FG002|STARTED|Overall Study||51
8847971|NCT01732796|9902926|FG000|COMPLETED|Overall Study||162
8847972|NCT01732796|9902927|FG001|COMPLETED|Overall Study||169
8847973|NCT01732796|9902928|FG002|COMPLETED|Overall Study||38
8847974|NCT01732796|9902926|FG000|NOT COMPLETED|Overall Study||46
8847975|NCT01732796|9902927|FG001|NOT COMPLETED|Overall Study||42
8847976|NCT01732796|9902928|FG002|NOT COMPLETED|Overall Study||13
8850285|NCT01746017|9905497|FG000|NOT COMPLETED|Period 2||0
8850286|NCT01746017|9905498|FG001|NOT COMPLETED|Period 2||0
8850287|NCT01746017|9905499|FG002|NOT COMPLETED|Period 2||0
8850288|NCT01746017|9905500|FG003|NOT COMPLETED|Period 2||0
8850289|NCT01746017|9905501|FG004|NOT COMPLETED|Period 2||0
8850290|NCT01746017|9905502|FG005|NOT COMPLETED|Period 2||0
8850291|NCT01746017|9905503|FG006|NOT COMPLETED|Period 2||0
8850292|NCT01746017|9905504|FG007|NOT COMPLETED|Period 2||0
8850293|NCT01746017|9905505|FG008|NOT COMPLETED|Period 2||0
8850294|NCT01746017|9905506|FG009|NOT COMPLETED|Period 2||0
8850295|NCT01746017|9905507|FG010|NOT COMPLETED|Period 2||0
8850296|NCT01746017|9905497|FG000|STARTED|Period 3||2
8850297|NCT01746017|9905498|FG001|STARTED|Period 3||2
8850298|NCT01746017|9905499|FG002|STARTED|Period 3||2
8850299|NCT01746017|9905500|FG003|STARTED|Period 3||2
8850300|NCT01746017|9905501|FG004|STARTED|Period 3||2
8850301|NCT01746017|9905502|FG005|STARTED|Period 3||2
8850302|NCT01746017|9905503|FG006|STARTED|Period 3||2
8850303|NCT01746017|9905504|FG007|STARTED|Period 3||2
8850304|NCT01746017|9905505|FG008|STARTED|Period 3||3
8850305|NCT01746017|9905506|FG009|STARTED|Period 3||3
8850306|NCT01746017|9905507|FG010|STARTED|Period 3||3
8850307|NCT01746017|9905497|FG000|COMPLETED|Period 3||2
8850308|NCT01746017|9905498|FG001|COMPLETED|Period 3||2
8850309|NCT01746017|9905499|FG002|COMPLETED|Period 3||2
8627549|NCT00519376|9667175|FG005|STARTED|Washout Period 1||1
8850310|NCT01746017|9905500|FG003|COMPLETED|Period 3||2
8850311|NCT01746017|9905501|FG004|COMPLETED|Period 3||2
8850312|NCT01746017|9905502|FG005|COMPLETED|Period 3||1
8850313|NCT01746017|9905503|FG006|COMPLETED|Period 3||2
8847977|NCT04537234|9902940|FG000|STARTED|Overall Study||82
8847978|NCT04537234|9902941|FG001|STARTED|Overall Study||83
8847979|NCT04537234|9902940|FG000|COMPLETED|Overall Study||80
8847980|NCT04537234|9902941|FG001|COMPLETED|Overall Study||83
8847981|NCT04537234|9902940|FG000|NOT COMPLETED|Overall Study||2
8847982|NCT04537234|9902941|FG001|NOT COMPLETED|Overall Study||0
8847983|NCT04371471|9902947|FG000|STARTED|Overall Study||91
8847984|NCT04371471|9902947|FG000|COMPLETED|Overall Study||81
8847985|NCT04371471|9902947|FG000|NOT COMPLETED|Overall Study||10
8848003|NCT03478956|9902977|FG000|STARTED|Overall Study||12
8848004|NCT03478956|9902978|FG001|STARTED|Overall Study||12
8848005|NCT03478956|9902977|FG000|Received at Least One Dose of Study Drug|Overall Study||12
8848006|NCT03478956|9902978|FG001|Received at Least One Dose of Study Drug|Overall Study||12
8848007|NCT03478956|9902977|FG000|Completed Randomized Treatment Phase|Overall Study||11
8848008|NCT03478956|9902978|FG001|Completed Randomized Treatment Phase|Overall Study||10
8848009|NCT03478956|9902977|FG000|Started OLE Treatment Phase|Overall Study||11
8848010|NCT03478956|9902978|FG001|Started OLE Treatment Phase|Overall Study||10
8848011|NCT03478956|9902977|FG000|Completed OLE Treatment Phase|Overall Study||0
8848012|NCT03478956|9902978|FG001|Completed OLE Treatment Phase|Overall Study||0
8848013|NCT03478956|9902977|FG000|Started PML Safety Monitoring Phase|Overall Study||1
8848014|NCT03478956|9902978|FG001|Started PML Safety Monitoring Phase|Overall Study||2
8848015|NCT03478956|9902977|FG000|COMPLETED|Overall Study||0
8848016|NCT03478956|9902978|FG001|COMPLETED|Overall Study||0
8848017|NCT03478956|9902977|FG000|NOT COMPLETED|Overall Study||12
8848018|NCT03478956|9902978|FG001|NOT COMPLETED|Overall Study||12
8848019|NCT03348930|9902984|FG000|STARTED|First Intervention (2 Weeks)||10
8848020|NCT03348930|9902985|FG001|STARTED|First Intervention (2 Weeks)||10
8848021|NCT03348930|9902984|FG000|COMPLETED|First Intervention (2 Weeks)||10
8848022|NCT03348930|9902985|FG001|COMPLETED|First Intervention (2 Weeks)||10
8848023|NCT03348930|9902984|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0
8848024|NCT03348930|9902985|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0
8848025|NCT03348930|9902984|FG000|STARTED|Washout (1 Week)||10
8848026|NCT03348930|9902985|FG001|STARTED|Washout (1 Week)||10
8848027|NCT03348930|9902984|FG000|COMPLETED|Washout (1 Week)||9
8848028|NCT03348930|9902985|FG001|COMPLETED|Washout (1 Week)||9
8848029|NCT03348930|9902984|FG000|NOT COMPLETED|Washout (1 Week)||1
8848030|NCT03348930|9902985|FG001|NOT COMPLETED|Washout (1 Week)||1
8848031|NCT03348930|9902984|FG000|STARTED|Second Intervention (2 Weeks)||9
8848032|NCT03348930|9902985|FG001|STARTED|Second Intervention (2 Weeks)||9
8848033|NCT03348930|9902984|FG000|COMPLETED|Second Intervention (2 Weeks)||9
8848034|NCT03348930|9902985|FG001|COMPLETED|Second Intervention (2 Weeks)||9
8848035|NCT03348930|9902984|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0
8848036|NCT03348930|9902985|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0
8848037|NCT03282240|9902994|FG000|STARTED|Overall Study||1777
8848038|NCT03282240|9902995|FG001|STARTED|Overall Study||443
8848039|NCT03282240|9902996|FG002|STARTED|Overall Study||450
8848040|NCT03282240|9902994|FG000|COMPLETED|Overall Study||1767
8848041|NCT03282240|9902995|FG001|COMPLETED|Overall Study||440
8848042|NCT03282240|9902996|FG002|COMPLETED|Overall Study||447
8848043|NCT03282240|9902994|FG000|NOT COMPLETED|Overall Study||10
8848044|NCT03282240|9902995|FG001|NOT COMPLETED|Overall Study||3
8848045|NCT03282240|9902996|FG002|NOT COMPLETED|Overall Study||3
8848046|NCT03260868|9903009|FG000|STARTED|Overall Study||8
8848047|NCT03260868|9903010|FG001|STARTED|Overall Study||7
8848048|NCT03260868|9903009|FG000|Safety Population|Overall Study||8
8848049|NCT03260868|9903010|FG001|Safety Population|Overall Study||6
8848050|NCT03260868|9903009|FG000|COMPLETED|Overall Study||5
8848051|NCT03260868|9903010|FG001|COMPLETED|Overall Study||4
8847986|NCT04172701|9902955|FG000|STARTED|Overall Study||6352
8847987|NCT04172701|9902956|FG001|STARTED|Overall Study||2932
8847988|NCT04172701|9902955|FG000|Propensity Score (PS) Matched Population|Overall Study||2444
8847989|NCT04172701|9902956|FG001|Propensity Score (PS) Matched Population|Overall Study||2444
8847990|NCT04172701|9902955|FG000|COMPLETED|Overall Study||6352
8847991|NCT04172701|9902956|FG001|COMPLETED|Overall Study||2932
8847992|NCT04172701|9902955|FG000|NOT COMPLETED|Overall Study||0
8847993|NCT04172701|9902956|FG001|NOT COMPLETED|Overall Study||0
8847994|NCT03813199|9902965|FG000|STARTED|Overall Study||21
8847995|NCT03813199|9902966|FG001|STARTED|Overall Study||19
8847996|NCT03813199|9902967|FG002|STARTED|Overall Study||20
8847997|NCT03813199|9902965|FG000|COMPLETED|Overall Study||18
8847998|NCT03813199|9902966|FG001|COMPLETED|Overall Study||6
8847999|NCT03813199|9902967|FG002|COMPLETED|Overall Study||19
8848000|NCT03813199|9902965|FG000|NOT COMPLETED|Overall Study||3
8848001|NCT03813199|9902966|FG001|NOT COMPLETED|Overall Study||13
8848002|NCT03813199|9902967|FG002|NOT COMPLETED|Overall Study||1
8848052|NCT03260868|9903009|FG000|NOT COMPLETED|Overall Study||3
8848053|NCT03260868|9903010|FG001|NOT COMPLETED|Overall Study||3
8848054|NCT03245580|9903018|FG000|STARTED|Overall Study||75
8848055|NCT03245580|9903019|FG001|STARTED|Overall Study||78
8848056|NCT03245580|9903018|FG000|COMPLETED|Overall Study||75
8848057|NCT03245580|9903019|FG001|COMPLETED|Overall Study||78
8848058|NCT03245580|9903018|FG000|NOT COMPLETED|Overall Study||0
8848059|NCT03245580|9903019|FG001|NOT COMPLETED|Overall Study||0
8848060|NCT03164616|9903028|FG000|STARTED|Overall Study||338
8848061|NCT03164616|9903029|FG001|STARTED|Overall Study||338
8848062|NCT03164616|9903030|FG002|STARTED|Overall Study||337
8848063|NCT03164616|9903028|FG000|Received Treatment|Overall Study||331
8848064|NCT03164616|9903029|FG001|Received Treatment|Overall Study||335
8848065|NCT03164616|9903030|FG002|Received Treatment|Overall Study||331
8848066|NCT03164616|9903028|FG000|COMPLETED|Overall Study||80
8848067|NCT03164616|9903029|FG001|COMPLETED|Overall Study||65
8848068|NCT03164616|9903030|FG002|COMPLETED|Overall Study||40
8848069|NCT03164616|9903028|FG000|NOT COMPLETED|Overall Study||258
8848070|NCT03164616|9903029|FG001|NOT COMPLETED|Overall Study||273
8848071|NCT03164616|9903030|FG002|NOT COMPLETED|Overall Study||297
8848072|NCT03157037|9903040|FG000|STARTED|Overall Study||15
8848073|NCT03157037|9903040|FG000|COMPLETED|Overall Study||14
8848074|NCT03157037|9903040|FG000|NOT COMPLETED|Overall Study||1
8848075|NCT03143218|9903054|FG000|STARTED|Overall Study||1965
8848076|NCT03143218|9903055|FG001|STARTED|Overall Study||1988
8848077|NCT03143218|9903056|FG002|STARTED|Overall Study||1967
8848078|NCT03143218|9903054|FG000|COMPLETED|Overall Study||1716
8848079|NCT03143218|9903055|FG001|COMPLETED|Overall Study||1734
8848080|NCT03143218|9903056|FG002|COMPLETED|Overall Study||1740
8848081|NCT03143218|9903054|FG000|NOT COMPLETED|Overall Study||249
8848082|NCT03143218|9903055|FG001|NOT COMPLETED|Overall Study||254
8848083|NCT03143218|9903056|FG002|NOT COMPLETED|Overall Study||227
8848084|NCT03128931|9903064|FG000|STARTED|Overall Study||45
8848085|NCT03128931|9903064|FG000|COMPLETED|Overall Study||41
8848086|NCT03128931|9903064|FG000|NOT COMPLETED|Overall Study||4
8850314|NCT01746017|9905504|FG007|COMPLETED|Period 3||2
8850315|NCT01746017|9905505|FG008|COMPLETED|Period 3||3
8850316|NCT01746017|9905506|FG009|COMPLETED|Period 3||3
8850317|NCT01746017|9905507|FG010|COMPLETED|Period 3||3
8850318|NCT01746017|9905497|FG000|NOT COMPLETED|Period 3||0
8850319|NCT01746017|9905498|FG001|NOT COMPLETED|Period 3||0
8850320|NCT01746017|9905499|FG002|NOT COMPLETED|Period 3||0
8850321|NCT01746017|9905500|FG003|NOT COMPLETED|Period 3||0
8850322|NCT01746017|9905501|FG004|NOT COMPLETED|Period 3||0
8850323|NCT01746017|9905502|FG005|NOT COMPLETED|Period 3||1
8850324|NCT01746017|9905503|FG006|NOT COMPLETED|Period 3||0
8850325|NCT01746017|9905504|FG007|NOT COMPLETED|Period 3||0
8850326|NCT01746017|9905505|FG008|NOT COMPLETED|Period 3||0
8850327|NCT01746017|9905506|FG009|NOT COMPLETED|Period 3||0
8850328|NCT01746017|9905507|FG010|NOT COMPLETED|Period 3||0
8850329|NCT01746017|9905497|FG000|STARTED|Period 4||2
8850330|NCT01746017|9905498|FG001|STARTED|Period 4||2
8850331|NCT01746017|9905499|FG002|STARTED|Period 4||2
8850332|NCT01746017|9905500|FG003|STARTED|Period 4||2
8850333|NCT01746017|9905501|FG004|STARTED|Period 4||2
8850334|NCT01746017|9905502|FG005|STARTED|Period 4||1
8850335|NCT01746017|9905503|FG006|STARTED|Period 4||2
8850336|NCT01746017|9905504|FG007|STARTED|Period 4||2
8850337|NCT01746017|9905505|FG008|STARTED|Period 4|Part B occurred only for 3 periods.|0
8850338|NCT01746017|9905506|FG009|STARTED|Period 4|Part B occurred only for 3 periods.|0
8850493|NCT01746784|9905685|FG004|COMPLETED|Overall Study||19
8848087|NCT02611960|9903070|FG000|STARTED|Overall Study||117
8848088|NCT02611960|9903071|FG001|STARTED|Overall Study||116
8848089|NCT02611960|9903070|FG000|Treated|Overall Study||116
8848090|NCT02611960|9903071|FG001|Treated|Overall Study||112
8848091|NCT02611960|9903070|FG000|COMPLETED|Overall Study||0
8848092|NCT02611960|9903071|FG001|COMPLETED|Overall Study||0
8848093|NCT02611960|9903070|FG000|NOT COMPLETED|Overall Study||117
8848094|NCT02611960|9903071|FG001|NOT COMPLETED|Overall Study||116
8848095|NCT02498392|9903080|FG000|STARTED|Double-blind(DB) Lead-in Period(3 Weeks)||160
8848096|NCT02498392|9903081|FG001|STARTED|Double-blind(DB) Lead-in Period(3 Weeks)||0
8848097|NCT02498392|9903080|FG000|Treated|Double-blind(DB) Lead-in Period(3 Weeks)||153
8848098|NCT02498392|9903081|FG001|Treated|Double-blind(DB) Lead-in Period(3 Weeks)||0
8848099|NCT02498392|9903080|FG000|COMPLETED|Double-blind(DB) Lead-in Period(3 Weeks)||153
8848100|NCT02498392|9903081|FG001|COMPLETED|Double-blind(DB) Lead-in Period(3 Weeks)||0
8848101|NCT02498392|9903080|FG000|NOT COMPLETED|Double-blind(DB) Lead-in Period(3 Weeks)||7
8848102|NCT02498392|9903081|FG001|NOT COMPLETED|Double-blind(DB) Lead-in Period(3 Weeks)||0
8848103|NCT02498392|9903080|FG000|STARTED|DB Treatment (6 Weeks)+Withdrawal Period||76
8848104|NCT02498392|9903081|FG001|STARTED|DB Treatment (6 Weeks)+Withdrawal Period||77
8850494|NCT01746784|9905681|FG000|NOT COMPLETED|Overall Study||0
8848105|NCT02498392|9903080|FG000|COMPLETED|DB Treatment (6 Weeks)+Withdrawal Period||70
8848106|NCT02498392|9903081|FG001|COMPLETED|DB Treatment (6 Weeks)+Withdrawal Period||67
8848107|NCT02498392|9903080|FG000|NOT COMPLETED|DB Treatment (6 Weeks)+Withdrawal Period||6
8848108|NCT02498392|9903081|FG001|NOT COMPLETED|DB Treatment (6 Weeks)+Withdrawal Period||10
8848109|NCT02478775|9903092|FG000|STARTED|Overall Study||6
8848110|NCT02478775|9903093|FG001|STARTED|Overall Study||27
8848111|NCT02478775|9903094|FG002|STARTED|Overall Study||27
8848112|NCT02478775|9903092|FG000|COMPLETED|Overall Study||6
8848113|NCT02478775|9903093|FG001|COMPLETED|Overall Study||27
8848114|NCT02478775|9903094|FG002|COMPLETED|Overall Study||27
8848115|NCT02478775|9903092|FG000|NOT COMPLETED|Overall Study||0
8848116|NCT02478775|9903093|FG001|NOT COMPLETED|Overall Study||0
8848117|NCT02478775|9903094|FG002|NOT COMPLETED|Overall Study||0
8848118|NCT01899729|9903106|FG000|STARTED|Overall Study||9
8848119|NCT01899729|9903107|FG001|STARTED|Overall Study||9
8848120|NCT01899729|9903108|FG002|STARTED|Overall Study||8
8848121|NCT01899729|9903109|FG003|STARTED|Overall Study||9
8848122|NCT01899729|9903110|FG004|STARTED|Overall Study||11
8848123|NCT01899729|9903106|FG000|COMPLETED|Overall Study||7
8848124|NCT01899729|9903107|FG001|COMPLETED|Overall Study||7
8848125|NCT01899729|9903108|FG002|COMPLETED|Overall Study||6
8848126|NCT01899729|9903109|FG003|COMPLETED|Overall Study||9
8848127|NCT01899729|9903110|FG004|COMPLETED|Overall Study||9
8848128|NCT01899729|9903106|FG000|NOT COMPLETED|Overall Study||2
8848129|NCT01899729|9903107|FG001|NOT COMPLETED|Overall Study||2
8848130|NCT01899729|9903108|FG002|NOT COMPLETED|Overall Study||2
8848131|NCT01899729|9903109|FG003|NOT COMPLETED|Overall Study||0
8848132|NCT01899729|9903110|FG004|NOT COMPLETED|Overall Study||2
8848133|NCT01784848|9903124|FG000|STARTED|Overall Study||50
8848134|NCT01784848|9903125|FG001|STARTED|Overall Study||50
8848135|NCT01784848|9903124|FG000|COMPLETED|Overall Study||49
8848136|NCT01784848|9903125|FG001|COMPLETED|Overall Study||47
8848137|NCT01784848|9903124|FG000|NOT COMPLETED|Overall Study||1
8848138|NCT01784848|9903125|FG001|NOT COMPLETED|Overall Study||3
8848139|NCT01648205|9903131|FG000|STARTED|Placebo||25
8848140|NCT01648205|9903131|FG000|COMPLETED|Placebo||21
8848141|NCT01648205|9903131|FG000|NOT COMPLETED|Placebo||4
8848142|NCT01648205|9903131|FG000|STARTED|Ranolazine||23
8848143|NCT01648205|9903131|FG000|COMPLETED|Ranolazine||18
8848144|NCT01648205|9903131|FG000|NOT COMPLETED|Ranolazine||5
8850339|NCT01746017|9905507|FG010|STARTED|Period 4|Part B occurred only for 3 periods.|0
8850340|NCT01746017|9905497|FG000|COMPLETED|Period 4||2
8850341|NCT01746017|9905498|FG001|COMPLETED|Period 4||2
8850342|NCT01746017|9905499|FG002|COMPLETED|Period 4||2
8850343|NCT01746017|9905500|FG003|COMPLETED|Period 4||2
8850344|NCT01746017|9905501|FG004|COMPLETED|Period 4||2
8850345|NCT01746017|9905502|FG005|COMPLETED|Period 4||1
8850346|NCT01746017|9905503|FG006|COMPLETED|Period 4||2
8850347|NCT01746017|9905504|FG007|COMPLETED|Period 4||2
8850348|NCT01746017|9905505|FG008|COMPLETED|Period 4||0
8850349|NCT01746017|9905506|FG009|COMPLETED|Period 4||0
8850350|NCT01746017|9905507|FG010|COMPLETED|Period 4||0
8850351|NCT01746017|9905497|FG000|NOT COMPLETED|Period 4||0
8850352|NCT01746017|9905498|FG001|NOT COMPLETED|Period 4||0
8850353|NCT01746017|9905499|FG002|NOT COMPLETED|Period 4||0
8850354|NCT01746017|9905500|FG003|NOT COMPLETED|Period 4||0
8850355|NCT01746017|9905501|FG004|NOT COMPLETED|Period 4||0
8627550|NCT00519376|9667176|FG006|STARTED|Washout Period 1||1
8627551|NCT00519376|9667177|FG007|STARTED|Washout Period 1||1
8627552|NCT00519376|9667178|FG008|STARTED|Washout Period 1||1
8848145|NCT01312922|9903142|FG000|STARTED|Overall Study||185
8848146|NCT01312922|9903143|FG001|STARTED|Overall Study||185
8848147|NCT01312922|9903144|FG002|STARTED|Overall Study||185
8848148|NCT01312922|9903142|FG000|COMPLETED|Overall Study||117
8848149|NCT01312922|9903143|FG001|COMPLETED|Overall Study||131
8848150|NCT01312922|9903144|FG002|COMPLETED|Overall Study||135
8848151|NCT01312922|9903142|FG000|NOT COMPLETED|Overall Study||68
8848152|NCT01312922|9903143|FG001|NOT COMPLETED|Overall Study||54
8848153|NCT01312922|9903144|FG002|NOT COMPLETED|Overall Study||50
8848154|NCT01063517|9903154|FG000|STARTED|Overall Study||62
8848155|NCT01063517|9903155|FG001|STARTED|Overall Study||62
8848156|NCT01063517|9903154|FG000|Received Randomised Treatment|Overall Study||61
8848157|NCT01063517|9903155|FG001|Received Randomised Treatment|Overall Study||62
8848158|NCT01063517|9903154|FG000|COMPLETED|Overall Study||4
8848159|NCT01063517|9903155|FG001|COMPLETED|Overall Study||2
8848160|NCT01063517|9903154|FG000|NOT COMPLETED|Overall Study||58
8848161|NCT01063517|9903155|FG001|NOT COMPLETED|Overall Study||60
8848162|NCT00915681|9903161|FG000|STARTED|Overall Study||148
8848163|NCT00915681|9903161|FG000|COMPLETED|Overall Study||102
8848164|NCT00915681|9903161|FG000|NOT COMPLETED|Overall Study||46
8848165|NCT00145158|9903167|FG000|STARTED|Overall Study||16
8848166|NCT00145158|9903168|FG001|STARTED|Overall Study||7
8848167|NCT00145158|9903167|FG000|COMPLETED|Overall Study||14
8848168|NCT00145158|9903168|FG001|COMPLETED|Overall Study||4
8627553|NCT00519376|9667179|FG009|STARTED|Washout Period 1||1
8848169|NCT00145158|9903167|FG000|NOT COMPLETED|Overall Study||2
8848170|NCT00145158|9903168|FG001|NOT COMPLETED|Overall Study||3
8848171|NCT01732809|9903177|FG000|STARTED|Overall Study||9
8848172|NCT01732809|9903178|FG001|STARTED|Overall Study||10
8848173|NCT01732809|9903177|FG000|COMPLETED|Overall Study||9
8848174|NCT01732809|9903178|FG001|COMPLETED|Overall Study||9
8848175|NCT01732809|9903177|FG000|NOT COMPLETED|Overall Study||0
8848176|NCT01732809|9903178|FG001|NOT COMPLETED|Overall Study||1
8848177|NCT01732822|9903186|FG000|STARTED|Overall Study||6930
8848178|NCT01732822|9903187|FG001|STARTED|Overall Study||6955
8848179|NCT01732822|9903186|FG000|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the PACD|6807
8848180|NCT01732822|9903187|FG001|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the PACD|6842
8848181|NCT01732822|9903186|FG000|NOT COMPLETED|Overall Study||123
8848182|NCT01732822|9903187|FG001|NOT COMPLETED|Overall Study||113
8848183|NCT01732835|9903215|FG000|STARTED|6-month Primary Endpoint||68
8848184|NCT01732835|9903215|FG000|COMPLETED|6-month Primary Endpoint||44
8848185|NCT01732835|9903215|FG000|NOT COMPLETED|6-month Primary Endpoint||24
8848186|NCT01732835|9903215|FG000|STARTED|2-year Extended Follow-up||44
8848187|NCT01732835|9903215|FG000|COMPLETED|2-year Extended Follow-up||39
8848188|NCT01732835|9903215|FG000|NOT COMPLETED|2-year Extended Follow-up||5
8848189|NCT01732874|9903221|FG000|STARTED|Overall Study||16
8848190|NCT01732874|9903222|FG001|STARTED|Overall Study||11
8848191|NCT01732874|9903221|FG000|COMPLETED|Overall Study||8
8848192|NCT01732874|9903222|FG001|COMPLETED|Overall Study||8
8848193|NCT01732874|9903221|FG000|NOT COMPLETED|Overall Study||8
8848194|NCT01732874|9903222|FG001|NOT COMPLETED|Overall Study||3
8848195|NCT01733056|9903231|FG000|STARTED|Overall Study||21
8848196|NCT01733056|9903232|FG001|STARTED|Overall Study||10
8848197|NCT01733056|9903233|FG002|STARTED|Overall Study||12
8848198|NCT01733056|9903231|FG000|COMPLETED|Overall Study||21
8848199|NCT01733056|9903232|FG001|COMPLETED|Overall Study||10
8848200|NCT01733056|9903233|FG002|COMPLETED|Overall Study||12
8627554|NCT00519376|9667180|FG010|STARTED|Washout Period 1||1
8627555|NCT00519376|9667181|FG011|STARTED|Washout Period 1||1
8848201|NCT01733056|9903231|FG000|NOT COMPLETED|Overall Study||0
8848202|NCT01733056|9903232|FG001|NOT COMPLETED|Overall Study||0
8848203|NCT01733056|9903233|FG002|NOT COMPLETED|Overall Study||0
8848204|NCT01733069|9903246|FG000|STARTED|Overall Study||264
8848205|NCT01733069|9903247|FG001|STARTED|Overall Study||1598
8848206|NCT01733069|9903246|FG000|COMPLETED|Overall Study||264
8848207|NCT01733069|9903247|FG001|COMPLETED|Overall Study||1598
8848208|NCT01733069|9903246|FG000|NOT COMPLETED|Overall Study||0
8848209|NCT01733069|9903247|FG001|NOT COMPLETED|Overall Study||0
8848210|NCT01733121|9903255|FG000|STARTED|Double-Blind Period (Week 0 to 6)||51
8848211|NCT01733121|9903256|FG001|STARTED|Double-Blind Period (Week 0 to 6)||51
8848212|NCT01733121|9903255|FG000|COMPLETED|Double-Blind Period (Week 0 to 6)||44
8848213|NCT01733121|9903256|FG001|COMPLETED|Double-Blind Period (Week 0 to 6)||46
8848214|NCT01733121|9903255|FG000|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||7
8848215|NCT01733121|9903256|FG001|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||5
8848216|NCT01733121|9903255|FG000|STARTED|Follow-Up Period (Week 6 to 8)||44
8848217|NCT01733121|9903256|FG001|STARTED|Follow-Up Period (Week 6 to 8)||46
8848218|NCT01733121|9903255|FG000|COMPLETED|Follow-Up Period (Week 6 to 8)||44
8848219|NCT01733121|9903256|FG001|COMPLETED|Follow-Up Period (Week 6 to 8)||46
8848220|NCT01733121|9903255|FG000|NOT COMPLETED|Follow-Up Period (Week 6 to 8)||0
8848221|NCT01733121|9903256|FG001|NOT COMPLETED|Follow-Up Period (Week 6 to 8)||0
8848222|NCT01733186|9903266|FG000|STARTED|Overall Study||6
8848223|NCT01733186|9903267|FG001|STARTED|Overall Study||6
8848224|NCT01733186|9903266|FG000|COMPLETED|Overall Study||6
8848225|NCT01733186|9903267|FG001|COMPLETED|Overall Study||6
8848226|NCT01733186|9903266|FG000|NOT COMPLETED|Overall Study||0
8848227|NCT01733186|9903267|FG001|NOT COMPLETED|Overall Study||0
8848228|NCT01733212|9903275|FG000|STARTED|Overall Study||116
8848229|NCT01733212|9903276|FG001|STARTED|Overall Study||123
8848230|NCT01733212|9903275|FG000|COMPLETED|Overall Study||116
8848231|NCT01733212|9903276|FG001|COMPLETED|Overall Study||123
8848232|NCT01733212|9903275|FG000|NOT COMPLETED|Overall Study||0
8848233|NCT01733212|9903276|FG001|NOT COMPLETED|Overall Study||0
8848234|NCT01733238|9903282|FG000|STARTED|Overall Study||13
8848235|NCT01733238|9903282|FG000|COMPLETED|Overall Study|8 subjects completed the Induction Phase and 7 subjects started Maintenance Phase|8
8848236|NCT01733238|9903282|FG000|NOT COMPLETED|Overall Study||5
8848237|NCT01733277|9903288|FG000|STARTED|Overall Study||25
8848238|NCT01733277|9903289|FG001|STARTED|Overall Study||25
8848239|NCT01733277|9903288|FG000|COMPLETED|Overall Study||25
8848240|NCT01733277|9903289|FG001|COMPLETED|Overall Study||25
8848241|NCT01733277|9903288|FG000|NOT COMPLETED|Overall Study||0
8848242|NCT01733277|9903289|FG001|NOT COMPLETED|Overall Study||0
8848243|NCT01733316|9903295|FG000|STARTED|Cystagon® Phase||41
8627556|NCT00519376|9667182|FG012|STARTED|Washout Period 1||1
8627557|NCT00519376|9667183|FG013|STARTED|Washout Period 1||1
8627558|NCT00519376|9667184|FG014|STARTED|Washout Period 1||1
8848244|NCT01733316|9903295|FG000|COMPLETED|Cystagon® Phase||41
8848245|NCT01733316|9903295|FG000|NOT COMPLETED|Cystagon® Phase||0
8848246|NCT01733316|9903295|FG000|STARTED|RP103 Phase||41
8848247|NCT01733316|9903295|FG000|COMPLETED|RP103 Phase||40
8627559|NCT00519376|9667185|FG015|STARTED|Washout Period 1||1
8627560|NCT00519376|9667170|FG000|COMPLETED|Washout Period 1||2
8627561|NCT00519376|9667171|FG001|COMPLETED|Washout Period 1||2
8627562|NCT00519376|9667172|FG002|COMPLETED|Washout Period 1||2
8627563|NCT00519376|9667173|FG003|COMPLETED|Washout Period 1||2
8848248|NCT01733316|9903295|FG000|NOT COMPLETED|RP103 Phase||1
8848249|NCT01733316|9903295|FG000|STARTED|Long Term Extension Phase|Two participants did not enter the long term follow up period.|38
8848250|NCT01733316|9903295|FG000|COMPLETED|Long Term Extension Phase||33
8848251|NCT01733316|9903295|FG000|NOT COMPLETED|Long Term Extension Phase||5
8848252|NCT01733329|9903308|FG000|STARTED|Overall Study||62
8848253|NCT01733329|9903309|FG001|STARTED|Overall Study||61
8848254|NCT01733329|9903308|FG000|COMPLETED|Overall Study||60
8848255|NCT01733329|9903309|FG001|COMPLETED|Overall Study||60
8848256|NCT01733329|9903308|FG000|NOT COMPLETED|Overall Study||2
8848257|NCT01733329|9903309|FG001|NOT COMPLETED|Overall Study||1
8848258|NCT01733368|9903315|FG000|STARTED|Overall Study||198
8848259|NCT01733368|9903315|FG000|COMPLETED|Overall Study||167
8848260|NCT01733368|9903315|FG000|NOT COMPLETED|Overall Study||31
8848261|NCT01733407|9903323|FG000|STARTED|Overall Study||9
8848262|NCT01733407|9903324|FG001|STARTED|Overall Study||9
8848263|NCT01733407|9903323|FG000|COMPLETED|Overall Study||7
8848264|NCT01733407|9903324|FG001|COMPLETED|Overall Study||9
8848265|NCT01733407|9903323|FG000|NOT COMPLETED|Overall Study||2
8848266|NCT01733407|9903324|FG001|NOT COMPLETED|Overall Study||0
8848267|NCT01733472|9903332|FG000|STARTED|Overall Study||60
8848268|NCT01733472|9903333|FG001|STARTED|Overall Study||60
8848269|NCT01733472|9903332|FG000|COMPLETED|Overall Study||60
8848270|NCT01733472|9903333|FG001|COMPLETED|Overall Study||60
8848271|NCT01733472|9903332|FG000|NOT COMPLETED|Overall Study||0
8848272|NCT01733472|9903333|FG001|NOT COMPLETED|Overall Study||0
8848273|NCT01733628|9903340|FG000|STARTED|Overall Study||143
8848274|NCT01733628|9903340|FG000|COMPLETED|Overall Study||143
8848275|NCT01733628|9903340|FG000|NOT COMPLETED|Overall Study||0
8848276|NCT01733680|9903346|FG000|STARTED|Overall Study||2
8848277|NCT01733680|9903347|FG001|STARTED|Overall Study||1
8848278|NCT01733680|9903346|FG000|COMPLETED|Overall Study||2
8848279|NCT01733680|9903347|FG001|COMPLETED|Overall Study||0
8848280|NCT01733680|9903346|FG000|NOT COMPLETED|Overall Study||0
8848281|NCT01733680|9903347|FG001|NOT COMPLETED|Overall Study||1
8848282|NCT01733732|9903359|FG000|STARTED|Overall Study||27
8848283|NCT01733732|9903360|FG001|STARTED|Overall Study||27
8848284|NCT01733732|9903359|FG000|COMPLETED|Overall Study||25
8848285|NCT01733732|9903360|FG001|COMPLETED|Overall Study||27
8848286|NCT01733732|9903359|FG000|NOT COMPLETED|Overall Study||2
8848287|NCT01733732|9903360|FG001|NOT COMPLETED|Overall Study||0
8848288|NCT01733745|9903378|FG000|STARTED|Overall Study||13
8848289|NCT01733745|9903379|FG001|STARTED|Overall Study||13
8848290|NCT01733745|9903378|FG000|COMPLETED|Overall Study||13
8848291|NCT01733745|9903379|FG001|COMPLETED|Overall Study||13
8848292|NCT01733745|9903378|FG000|NOT COMPLETED|Overall Study||0
8848293|NCT01733745|9903379|FG001|NOT COMPLETED|Overall Study||0
8848294|NCT01733758|9903389|FG000|STARTED|Overall Study||77
8848295|NCT01733758|9903390|FG001|STARTED|Overall Study||160
8848296|NCT01733758|9903391|FG002|STARTED|Overall Study||150
8848297|NCT01733758|9903392|FG003|STARTED|Overall Study||103
8848298|NCT01733758|9903389|FG000|COMPLETED|Overall Study||62
8848299|NCT01733758|9903390|FG001|COMPLETED|Overall Study||148
8848300|NCT01733758|9903391|FG002|COMPLETED|Overall Study||135
8848301|NCT01733758|9903392|FG003|COMPLETED|Overall Study||95
8848302|NCT01733758|9903389|FG000|NOT COMPLETED|Overall Study||15
8848303|NCT01733758|9903390|FG001|NOT COMPLETED|Overall Study||12
8848304|NCT01733758|9903391|FG002|NOT COMPLETED|Overall Study||15
8848305|NCT01733758|9903392|FG003|NOT COMPLETED|Overall Study||8
8848306|NCT01733953|9903406|FG000|STARTED|Overall Study||14
8848307|NCT01733953|9903407|FG001|STARTED|Overall Study||13
8848308|NCT01733953|9903406|FG000|COMPLETED|Overall Study||9
8848309|NCT01733953|9903407|FG001|COMPLETED|Overall Study||6
8848310|NCT01733953|9903406|FG000|NOT COMPLETED|Overall Study||5
8848311|NCT01733953|9903407|FG001|NOT COMPLETED|Overall Study||7
8848312|NCT01734161|9903415|FG000|STARTED|Overall Study||61
8848313|NCT01734161|9903416|FG001|STARTED|Overall Study||61
8848314|NCT01734161|9903415|FG000|COMPLETED|Overall Study||55
8848315|NCT01734161|9903416|FG001|COMPLETED|Overall Study||53
8848316|NCT01734161|9903415|FG000|NOT COMPLETED|Overall Study||6
8848317|NCT01734161|9903416|FG001|NOT COMPLETED|Overall Study||8
8848318|NCT01734239|9903424|FG000|STARTED|Overall Study||52
8848319|NCT01734239|9903425|FG001|STARTED|Overall Study||50
8848320|NCT01734239|9903424|FG000|COMPLETED|Overall Study||52
8848321|NCT01734239|9903425|FG001|COMPLETED|Overall Study||50
8848322|NCT01734239|9903424|FG000|NOT COMPLETED|Overall Study||0
8848323|NCT01734239|9903425|FG001|NOT COMPLETED|Overall Study||0
8848324|NCT01734317|9903430|FG000|STARTED|Overall Study||10
8848325|NCT01734317|9903430|FG000|COMPLETED|Overall Study||10
8848326|NCT01734317|9903430|FG000|NOT COMPLETED|Overall Study||0
8848327|NCT01734382|9903438|FG000|STARTED|Part 1||19
8848328|NCT01734382|9903439|FG001|STARTED|Part 1||0
8848329|NCT01734382|9903440|FG002|STARTED|Part 1||0
8848330|NCT01734382|9903438|FG000|COMPLETED|Part 1||17
8848331|NCT01734382|9903439|FG001|COMPLETED|Part 1||0
8848332|NCT01734382|9903440|FG002|COMPLETED|Part 1||0
8848333|NCT01734382|9903438|FG000|NOT COMPLETED|Part 1||2
8848334|NCT01734382|9903439|FG001|NOT COMPLETED|Part 1||0
8848335|NCT01734382|9903440|FG002|NOT COMPLETED|Part 1||0
8848336|NCT01734382|9903438|FG000|STARTED|Part 2||0
8848337|NCT01734382|9903439|FG001|STARTED|Part 2||7
8848338|NCT01734382|9903440|FG002|STARTED|Part 2||15
8848339|NCT01734382|9903438|FG000|COMPLETED|Part 2||0
8848340|NCT01734382|9903439|FG001|COMPLETED|Part 2||5
8848341|NCT01734382|9903440|FG002|COMPLETED|Part 2||8
8848342|NCT01734382|9903438|FG000|NOT COMPLETED|Part 2||0
8848343|NCT01734382|9903439|FG001|NOT COMPLETED|Part 2||2
8848344|NCT01734382|9903440|FG002|NOT COMPLETED|Part 2||7
8848345|NCT01734395|9903452|FG000|STARTED|Overall Study||1882
8848346|NCT01734395|9903452|FG000|COMPLETED|Overall Study||1472
8848347|NCT01734395|9903452|FG000|NOT COMPLETED|Overall Study||410
8848348|NCT01734434|9903460|FG000|STARTED|Overall Study||500
8848349|NCT01734434|9903461|FG001|STARTED|Overall Study||500
8848350|NCT01734434|9903462|FG002|STARTED|Overall Study||1992
8848351|NCT01734434|9903463|FG003|STARTED|Overall Study||251
8848352|NCT01734434|9903460|FG000|COMPLETED|Overall Study||490
8848353|NCT01734434|9903461|FG001|COMPLETED|Overall Study||488
8848354|NCT01734434|9903462|FG002|COMPLETED|Overall Study||1863
8848355|NCT01734434|9903463|FG003|COMPLETED|Overall Study||228
8848356|NCT01734434|9903460|FG000|NOT COMPLETED|Overall Study||10
8848357|NCT01734434|9903461|FG001|NOT COMPLETED|Overall Study||12
8848358|NCT01734434|9903462|FG002|NOT COMPLETED|Overall Study||129
8848359|NCT01734434|9903463|FG003|NOT COMPLETED|Overall Study||23
8848360|NCT01734512|9903481|FG000|STARTED|Overall Study||65
8848361|NCT01734512|9903481|FG000|COMPLETED|Overall Study||65
8848362|NCT01734512|9903481|FG000|NOT COMPLETED|Overall Study||0
8848363|NCT01734525|9903485|FG000|STARTED|Overall Study||85
8848364|NCT01734525|9903485|FG000|COMPLETED|Overall Study||85
8848365|NCT01734525|9903485|FG000|NOT COMPLETED|Overall Study||0
8848366|NCT01734551|9903491|FG000|STARTED|Overall Study||15
8848367|NCT01734551|9903492|FG001|STARTED|Overall Study||16
8848368|NCT01734551|9903491|FG000|COMPLETED|Overall Study||15
8848369|NCT01734551|9903492|FG001|COMPLETED|Overall Study||16
8848370|NCT01734551|9903491|FG000|NOT COMPLETED|Overall Study||0
8848371|NCT01734551|9903492|FG001|NOT COMPLETED|Overall Study||0
8848372|NCT01734655|9903498|FG000|STARTED|Overall Study||40
8848373|NCT01734655|9903498|FG000|COMPLETED|Overall Study||40
8848374|NCT01734655|9903498|FG000|NOT COMPLETED|Overall Study||0
8848375|NCT01734746|9903505|FG000|STARTED|Overall Study||22
8848376|NCT01734746|9903505|FG000|COMPLETED|Overall Study||21
8848377|NCT01734746|9903505|FG000|NOT COMPLETED|Overall Study||1
8848378|NCT01734772|9903512|FG000|STARTED|Overall Study||24
8848379|NCT01734772|9903513|FG001|STARTED|Overall Study||24
8848380|NCT01734772|9903512|FG000|COMPLETED|Overall Study||23
8848381|NCT01734772|9903513|FG001|COMPLETED|Overall Study||21
8848382|NCT01734772|9903512|FG000|NOT COMPLETED|Overall Study||1
8848383|NCT01734772|9903513|FG001|NOT COMPLETED|Overall Study||3
8848384|NCT01734785|9903528|FG000|STARTED|Open-Label Period||0
8848385|NCT01734785|9903529|FG001|STARTED|Open-Label Period||0
8848386|NCT01734785|9903530|FG002|STARTED|Open-Label Period||0
8848387|NCT01734785|9903531|FG003|STARTED|Open-Label Period||606
8848388|NCT01734785|9903528|FG000|COMPLETED|Open-Label Period||0
8848389|NCT01734785|9903529|FG001|COMPLETED|Open-Label Period||0
8848390|NCT01734785|9903530|FG002|COMPLETED|Open-Label Period||0
8848391|NCT01734785|9903531|FG003|COMPLETED|Open-Label Period||333
8848392|NCT01734785|9903528|FG000|NOT COMPLETED|Open-Label Period||0
8848393|NCT01734785|9903529|FG001|NOT COMPLETED|Open-Label Period||0
8848394|NCT01734785|9903530|FG002|NOT COMPLETED|Open-Label Period||0
8848395|NCT01734785|9903531|FG003|NOT COMPLETED|Open-Label Period||273
8848396|NCT01734785|9903528|FG000|STARTED|Double-Blind Period||111
8848397|NCT01734785|9903529|FG001|STARTED|Double-Blind Period||112
8848398|NCT01734785|9903530|FG002|STARTED|Double-Blind Period||110
8848399|NCT01734785|9903531|FG003|STARTED|Double-Blind Period||0
8848400|NCT01734785|9903528|FG000|COMPLETED|Double-Blind Period||106
8848401|NCT01734785|9903529|FG001|COMPLETED|Double-Blind Period||103
8848402|NCT01734785|9903530|FG002|COMPLETED|Double-Blind Period||105
8848403|NCT01734785|9903531|FG003|COMPLETED|Double-Blind Period||0
8848404|NCT01734785|9903528|FG000|NOT COMPLETED|Double-Blind Period||5
8848405|NCT01734785|9903529|FG001|NOT COMPLETED|Double-Blind Period||9
8848406|NCT01734785|9903530|FG002|NOT COMPLETED|Double-Blind Period||5
8848407|NCT01734785|9903531|FG003|NOT COMPLETED|Double-Blind Period||0
8848408|NCT01734811|9903542|FG000|STARTED|Overall Study||58
8848409|NCT01734811|9903543|FG001|STARTED|Overall Study||62
8848410|NCT01734811|9903542|FG000|COMPLETED|Overall Study||54
8848411|NCT01734811|9903543|FG001|COMPLETED|Overall Study||59
8848412|NCT01734811|9903542|FG000|NOT COMPLETED|Overall Study||4
8848413|NCT01734811|9903543|FG001|NOT COMPLETED|Overall Study||3
8848414|NCT01734850|9903552|FG000|STARTED|Overall Study||4
8848415|NCT01734850|9903553|FG001|STARTED|Overall Study||4
8848416|NCT01734850|9903554|FG002|STARTED|Overall Study||5
8848417|NCT01734850|9903552|FG000|COMPLETED|Overall Study||1
8848418|NCT01734850|9903553|FG001|COMPLETED|Overall Study||2
8848419|NCT01734850|9903554|FG002|COMPLETED|Overall Study||1
8848420|NCT01734850|9903552|FG000|NOT COMPLETED|Overall Study||3
8848421|NCT01734850|9903553|FG001|NOT COMPLETED|Overall Study||2
8848422|NCT01734850|9903554|FG002|NOT COMPLETED|Overall Study||4
8848423|NCT01734889|9903565|FG000|STARTED|Overall Study||18
8848424|NCT01734889|9903565|FG000|COMPLETED|Overall Study||18
8848425|NCT01734889|9903565|FG000|NOT COMPLETED|Overall Study||0
8848426|NCT01734902|9903572|FG000|STARTED|Overall Study||14
8848427|NCT01734902|9903573|FG001|STARTED|Overall Study||16
8848428|NCT01734902|9903572|FG000|COMPLETED|Overall Study||14
8848429|NCT01734902|9903573|FG001|COMPLETED|Overall Study||14
8848430|NCT01734902|9903572|FG000|NOT COMPLETED|Overall Study||0
8848431|NCT01734902|9903573|FG001|NOT COMPLETED|Overall Study||2
8848432|NCT01734993|9903579|FG000|STARTED|Overall Study||11
8848433|NCT01734993|9903579|FG000|COMPLETED|Overall Study||9
8848434|NCT01734993|9903579|FG000|NOT COMPLETED|Overall Study||2
8848435|NCT01735175|9903586|FG000|STARTED|Overall Study||159
8848436|NCT01735175|9903587|FG001|STARTED|Overall Study||157
8848437|NCT01735175|9903586|FG000|Completed All Cycles|Overall Study||141
8848438|NCT01735175|9903587|FG001|Completed All Cycles|Overall Study||150
8848439|NCT01735175|9903586|FG000|Completed All Treatments as Planned|Overall Study||140
8848440|NCT01735175|9903587|FG001|Completed All Treatments as Planned|Overall Study||150
8848441|NCT01735175|9903586|FG000|Completed the 6-month SFU Visit|Overall Study||120
8848442|NCT01735175|9903587|FG001|Completed the 6-month SFU Visit|Overall Study||138
8848443|NCT01735175|9903586|FG000|COMPLETED|Overall Study||130
8848444|NCT01735175|9903587|FG001|COMPLETED|Overall Study||144
8848445|NCT01735175|9903586|FG000|NOT COMPLETED|Overall Study||29
8848446|NCT01735175|9903587|FG001|NOT COMPLETED|Overall Study||13
8848447|NCT01735201|9903601|FG000|STARTED|Overall Study||45
8848448|NCT01735201|9903602|FG001|STARTED|Overall Study||44
8848449|NCT01735201|9903603|FG002|STARTED|Overall Study||44
8848450|NCT01735201|9903604|FG003|STARTED|Overall Study||44
8848451|NCT01735201|9903605|FG004|STARTED|Overall Study||45
8848452|NCT01735201|9903606|FG005|STARTED|Overall Study||45
8848453|NCT01735201|9903607|FG006|STARTED|Overall Study||45
8848454|NCT01735201|9903608|FG007|STARTED|Overall Study||44
8848455|NCT01735201|9903601|FG000|COMPLETED|Overall Study||42
8848456|NCT01735201|9903602|FG001|COMPLETED|Overall Study||43
8848457|NCT01735201|9903603|FG002|COMPLETED|Overall Study||44
8848458|NCT01735201|9903604|FG003|COMPLETED|Overall Study||42
8848459|NCT01735201|9903605|FG004|COMPLETED|Overall Study||44
8848460|NCT01735201|9903606|FG005|COMPLETED|Overall Study||40
8848461|NCT01735201|9903607|FG006|COMPLETED|Overall Study||42
8848462|NCT01735201|9903608|FG007|COMPLETED|Overall Study||42
8848463|NCT01735201|9903601|FG000|NOT COMPLETED|Overall Study||3
8848464|NCT01735201|9903602|FG001|NOT COMPLETED|Overall Study||1
8848465|NCT01735201|9903603|FG002|NOT COMPLETED|Overall Study||0
8848466|NCT01735201|9903604|FG003|NOT COMPLETED|Overall Study||2
8848467|NCT01735201|9903605|FG004|NOT COMPLETED|Overall Study||1
8848468|NCT01735201|9903606|FG005|NOT COMPLETED|Overall Study||5
8848469|NCT01735201|9903607|FG006|NOT COMPLETED|Overall Study||3
8848470|NCT01735201|9903608|FG007|NOT COMPLETED|Overall Study||2
8848471|NCT01735214|9903626|FG000|STARTED|Overall Study||358
8848472|NCT01735214|9903626|FG000|COMPLETED|Overall Study||358
8848473|NCT01735214|9903626|FG000|NOT COMPLETED|Overall Study||0
8848474|NCT01735279|9903632|FG000|STARTED|Overall Study||29
8848475|NCT01735279|9903633|FG001|STARTED|Overall Study||29
8848476|NCT01735279|9903632|FG000|COMPLETED|Overall Study||18
8848477|NCT01735279|9903633|FG001|COMPLETED|Overall Study||21
8848478|NCT01735279|9903632|FG000|NOT COMPLETED|Overall Study||11
8848479|NCT01735279|9903633|FG001|NOT COMPLETED|Overall Study||8
8848480|NCT01735396|9903639|FG000|STARTED|Overall Study||11
8848481|NCT01735396|9903639|FG000|COMPLETED|Overall Study||10
8848482|NCT01735396|9903639|FG000|NOT COMPLETED|Overall Study||1
8848483|NCT01735617|9903643|FG000|STARTED|Overall Study||16
8848484|NCT01735617|9903643|FG000|COMPLETED|Overall Study||16
8848485|NCT01735617|9903643|FG000|NOT COMPLETED|Overall Study||0
8848486|NCT01735630|9903652|FG000|STARTED|Overall Study||175
8848487|NCT01735630|9903653|FG001|STARTED|Overall Study||175
8848488|NCT01735630|9903652|FG000|COMPLETED|Overall Study||157
8848489|NCT01735630|9903653|FG001|COMPLETED|Overall Study||157
8848490|NCT01735630|9903652|FG000|NOT COMPLETED|Overall Study||18
8848491|NCT01735630|9903653|FG001|NOT COMPLETED|Overall Study||18
8848492|NCT01735877|9903661|FG000|STARTED|Overall Study||27
8848493|NCT01735877|9903662|FG001|STARTED|Overall Study||21
8848494|NCT01735877|9903661|FG000|COMPLETED|Overall Study||26
8848495|NCT01735877|9903662|FG001|COMPLETED|Overall Study||21
8848496|NCT01735877|9903661|FG000|NOT COMPLETED|Overall Study||1
8848497|NCT01735877|9903662|FG001|NOT COMPLETED|Overall Study||0
8848498|NCT01735916|9903671|FG000|STARTED|Overall Study||18
8848499|NCT01735916|9903672|FG001|STARTED|Overall Study||19
8848500|NCT01735916|9903673|FG002|STARTED|Overall Study||7
8848501|NCT01735916|9903671|FG000|COMPLETED|Overall Study||0
8848502|NCT01735916|9903672|FG001|COMPLETED|Overall Study|Study was cancelled before any subjects completed 24 months of follow-up or met any study endpoints.|0
8848503|NCT01735916|9903673|FG002|COMPLETED|Overall Study|Study was cancelled before any subjects completed 24 months of follow-up or met any study endpoints.|0
8848504|NCT01735916|9903671|FG000|NOT COMPLETED|Overall Study||18
8848505|NCT01735916|9903672|FG001|NOT COMPLETED|Overall Study||19
8848506|NCT01735916|9903673|FG002|NOT COMPLETED|Overall Study||7
8848507|NCT01735981|9903682|FG000|STARTED|Allocated||13
8848508|NCT01735981|9903683|FG001|STARTED|Allocated||11
8848509|NCT01735981|9903682|FG000|COMPLETED|Allocated||11
8848510|NCT01735981|9903683|FG001|COMPLETED|Allocated||8
8848511|NCT01735981|9903682|FG000|NOT COMPLETED|Allocated||2
8848512|NCT01735981|9903683|FG001|NOT COMPLETED|Allocated||3
8848513|NCT01735981|9903682|FG000|STARTED|Crossed Over||11
8848514|NCT01735981|9903683|FG001|STARTED|Crossed Over|N=1 lost to cross over before DDR intervention|7
8848515|NCT01735981|9903682|FG000|COMPLETED|Crossed Over||11
8848516|NCT01735981|9903683|FG001|COMPLETED|Crossed Over||7
8848517|NCT01735981|9903682|FG000|NOT COMPLETED|Crossed Over||0
8848518|NCT01735981|9903683|FG001|NOT COMPLETED|Crossed Over||0
8848519|NCT01735994|9903693|FG000|STARTED|Overall Study||263
8848520|NCT01735994|9903694|FG001|STARTED|Overall Study||218
8848521|NCT01735994|9903693|FG000|Post Intervention (3 Weeks)|Overall Study||239
8848522|NCT01735994|9903694|FG001|Post Intervention (3 Weeks)|Overall Study||198
8848523|NCT01735994|9903693|FG000|Follow-Up #1 (6 Months)|Overall Study||213
8848524|NCT01735994|9903694|FG001|Follow-Up #1 (6 Months)|Overall Study||163
8848525|NCT01735994|9903693|FG000|Follow-Up #2 (12 Months)|Overall Study||212
8848526|NCT01735994|9903694|FG001|Follow-Up #2 (12 Months)|Overall Study||174
8848527|NCT01735994|9903693|FG000|COMPLETED|Overall Study||200
8848528|NCT01735994|9903694|FG001|COMPLETED|Overall Study||152
8848529|NCT01735994|9903693|FG000|NOT COMPLETED|Overall Study||63
8848530|NCT01735994|9903694|FG001|NOT COMPLETED|Overall Study||66
8848531|NCT01736085|9903706|FG000|STARTED|Overall Study||529
8848532|NCT01736085|9903707|FG001|STARTED|Overall Study||530
8848533|NCT01736085|9903708|FG002|STARTED|Overall Study||793
8848534|NCT01736085|9903709|FG003|STARTED|Overall Study||530
8848535|NCT01736085|9903710|FG004|STARTED|Overall Study||530
8848536|NCT01736085|9903711|FG005|STARTED|Overall Study||794
8848537|NCT01736085|9903706|FG000|COMPLETED|Overall Study||529
8848538|NCT01736085|9903707|FG001|COMPLETED|Overall Study||530
8848539|NCT01736085|9903708|FG002|COMPLETED|Overall Study||793
8848540|NCT01736085|9903709|FG003|COMPLETED|Overall Study||530
8848541|NCT01736085|9903710|FG004|COMPLETED|Overall Study||530
8848542|NCT01736085|9903711|FG005|COMPLETED|Overall Study||794
8848543|NCT01736085|9903706|FG000|NOT COMPLETED|Overall Study||0
8848544|NCT01736085|9903707|FG001|NOT COMPLETED|Overall Study||0
8848545|NCT01736085|9903708|FG002|NOT COMPLETED|Overall Study||0
8848546|NCT01736085|9903709|FG003|NOT COMPLETED|Overall Study||0
8848547|NCT01736085|9903710|FG004|NOT COMPLETED|Overall Study||0
8848548|NCT01736085|9903711|FG005|NOT COMPLETED|Overall Study||0
8848549|NCT01736124|9903724|FG000|STARTED|Baseline||90
8848550|NCT01736124|9903725|FG001|STARTED|Baseline||90
8848551|NCT01736124|9903724|FG000|COMPLETED|Baseline||90
8848552|NCT01736124|9903725|FG001|COMPLETED|Baseline||90
8848553|NCT01736124|9903724|FG000|NOT COMPLETED|Baseline||0
8848554|NCT01736124|9903725|FG001|NOT COMPLETED|Baseline||0
8848555|NCT01736124|9903724|FG000|STARTED|Post-intervention Assessment||90
8848556|NCT01736124|9903725|FG001|STARTED|Post-intervention Assessment||90
8848557|NCT01736124|9903724|FG000|COMPLETED|Post-intervention Assessment||59
8848558|NCT01736124|9903725|FG001|COMPLETED|Post-intervention Assessment||69
8848559|NCT01736124|9903724|FG000|NOT COMPLETED|Post-intervention Assessment||31
8848560|NCT01736124|9903725|FG001|NOT COMPLETED|Post-intervention Assessment||21
8848561|NCT01736124|9903724|FG000|STARTED|6 Mo. Post-Intervention Assessment|"Includes 3 who were temporarily away at Period 2 who did not permanently withdraw from the study."|62
8848562|NCT01736124|9903725|FG001|STARTED|6 Mo. Post-Intervention Assessment|"Includes 1 who was temporarily away at Period 2 but did not permanently withdraw."|70
8848563|NCT01736124|9903724|FG000|COMPLETED|6 Mo. Post-Intervention Assessment||57
8848564|NCT01736124|9903725|FG001|COMPLETED|6 Mo. Post-Intervention Assessment||58
8848565|NCT01736124|9903724|FG000|NOT COMPLETED|6 Mo. Post-Intervention Assessment||5
8848566|NCT01736124|9903725|FG001|NOT COMPLETED|6 Mo. Post-Intervention Assessment||12
8848567|NCT01736124|9903724|FG000|STARTED|12 Mo. Post-Intervention Assessment|"Includes 1 who was temporarily away at Period 3 but did not permanently withdraw."|58
8848568|NCT01736124|9903725|FG001|STARTED|12 Mo. Post-Intervention Assessment|"Includes 4 who were temporarily away at Period 3 but did not permanently withdraw."|62
8848569|NCT01736124|9903724|FG000|COMPLETED|12 Mo. Post-Intervention Assessment||46
8848570|NCT01736124|9903725|FG001|COMPLETED|12 Mo. Post-Intervention Assessment||50
8848571|NCT01736124|9903724|FG000|NOT COMPLETED|12 Mo. Post-Intervention Assessment||12
8848572|NCT01736124|9903725|FG001|NOT COMPLETED|12 Mo. Post-Intervention Assessment||12
8848573|NCT01736176|9903733|FG000|STARTED|Overall Study|Enrolled participants who underwent the PEG-J placement procedure|39
8848574|NCT01736176|9903733|FG000|Received LCIG|Overall Study||38
8848575|NCT01736176|9903733|FG000|COMPLETED|Overall Study||28
8848576|NCT01736176|9903733|FG000|NOT COMPLETED|Overall Study||11
8848577|NCT01736189|9903741|FG000|STARTED|Overall Study||346
8848578|NCT01736189|9903741|FG000|COMPLETED|Overall Study||300
8724107|NCT01025843|9771506|FG007|STARTED|Washout 1||2
8724108|NCT01025843|9771507|FG008|STARTED|Washout 1||2
8848579|NCT01736189|9903741|FG000|NOT COMPLETED|Overall Study||46
8848580|NCT01736215|9903745|FG000|STARTED|Overall Study||33
8848581|NCT01736215|9903745|FG000|Treated|Overall Study||25
8848582|NCT01736215|9903745|FG000|COMPLETED|Overall Study||19
8848583|NCT01736215|9903745|FG000|NOT COMPLETED|Overall Study||14
8848584|NCT01736241|9903756|FG000|STARTED|Overall Study||6
8848585|NCT01736241|9903757|FG001|STARTED|Overall Study||6
8848586|NCT01736241|9903758|FG002|STARTED|Overall Study||6
8848587|NCT01736241|9903759|FG003|STARTED|Overall Study||5
8848588|NCT01736241|9903760|FG004|STARTED|Overall Study||6
8848589|NCT01736241|9903761|FG005|STARTED|Overall Study||6
8848590|NCT01736241|9903762|FG006|STARTED|Overall Study||6
8848591|NCT01736241|9903756|FG000|Received at Least One Dose of Study Drug|Overall Study||6
8848592|NCT01736241|9903757|FG001|Received at Least One Dose of Study Drug|Overall Study||6
8848593|NCT01736241|9903758|FG002|Received at Least One Dose of Study Drug|Overall Study||6
8848594|NCT01736241|9903759|FG003|Received at Least One Dose of Study Drug|Overall Study||5
8848595|NCT01736241|9903760|FG004|Received at Least One Dose of Study Drug|Overall Study||6
8848596|NCT01736241|9903761|FG005|Received at Least One Dose of Study Drug|Overall Study||6
8848597|NCT01736241|9903762|FG006|Received at Least One Dose of Study Drug|Overall Study||6
8848598|NCT01736241|9903756|FG000|COMPLETED|Overall Study||6
8848599|NCT01736241|9903757|FG001|COMPLETED|Overall Study||6
8848600|NCT01736241|9903758|FG002|COMPLETED|Overall Study||6
8848601|NCT01736241|9903759|FG003|COMPLETED|Overall Study||5
8848602|NCT01736241|9903760|FG004|COMPLETED|Overall Study||6
8724109|NCT01025843|9771508|FG009|STARTED|Washout 1||2
8724110|NCT01025843|9771499|FG000|COMPLETED|Washout 1||2
8848603|NCT01736241|9903761|FG005|COMPLETED|Overall Study||6
8848604|NCT01736241|9903762|FG006|COMPLETED|Overall Study||6
8848605|NCT01736241|9903756|FG000|NOT COMPLETED|Overall Study||0
8848606|NCT01736241|9903757|FG001|NOT COMPLETED|Overall Study||0
8848607|NCT01736241|9903758|FG002|NOT COMPLETED|Overall Study||0
8848608|NCT01736241|9903759|FG003|NOT COMPLETED|Overall Study||0
8848609|NCT01736241|9903760|FG004|NOT COMPLETED|Overall Study||0
8848610|NCT01736241|9903761|FG005|NOT COMPLETED|Overall Study||0
8848611|NCT01736241|9903762|FG006|NOT COMPLETED|Overall Study||0
8848612|NCT01736254|9903779|FG000|STARTED|Period 1 (Day 1)||24
8848613|NCT01736254|9903779|FG000|Received at Least One Dose of Study Drug|Period 1 (Day 1)||24
8848614|NCT01736254|9903779|FG000|COMPLETED|Period 1 (Day 1)||24
8848615|NCT01736254|9903779|FG000|NOT COMPLETED|Period 1 (Day 1)||0
8848616|NCT01736254|9903779|FG000|STARTED|Period 2 (Days 2 to 12)||24
8848617|NCT01736254|9903779|FG000|COMPLETED|Period 2 (Days 2 to 12)||21
8848618|NCT01736254|9903779|FG000|NOT COMPLETED|Period 2 (Days 2 to 12)||3
8848619|NCT01736254|9903779|FG000|STARTED|Period 3 (Days 13 to 23)||21
8848620|NCT01736254|9903779|FG000|COMPLETED|Period 3 (Days 13 to 23)||20
8848621|NCT01736254|9903779|FG000|NOT COMPLETED|Period 3 (Days 13 to 23)||1
8848622|NCT01736267|9903787|FG000|STARTED|Overall Study||3
8848623|NCT01736267|9903787|FG000|COMPLETED|Overall Study||3
8848624|NCT01736267|9903787|FG000|NOT COMPLETED|Overall Study||0
8848625|NCT01736358|9903793|FG000|STARTED|Overall Study||25
8848626|NCT01736358|9903794|FG001|STARTED|Overall Study||25
8848627|NCT01736358|9903793|FG000|COMPLETED|Overall Study||20
8848628|NCT01736358|9903794|FG001|COMPLETED|Overall Study||23
8848629|NCT01736358|9903793|FG000|NOT COMPLETED|Overall Study||5
8848630|NCT01736358|9903794|FG001|NOT COMPLETED|Overall Study||2
8848631|NCT01736397|9903802|FG000|STARTED|Overall Study||75
8848632|NCT01736397|9903803|FG001|STARTED|Overall Study||74
8848633|NCT01736397|9903802|FG000|COMPLETED|Overall Study||61
8848634|NCT01736397|9903803|FG001|COMPLETED|Overall Study||50
8848635|NCT01736397|9903802|FG000|NOT COMPLETED|Overall Study||14
8848636|NCT01736397|9903803|FG001|NOT COMPLETED|Overall Study||24
8848637|NCT01736475|9903811|FG000|STARTED|Overall Study||121
8848638|NCT01736475|9903812|FG001|STARTED|Overall Study||17
8848639|NCT01736475|9903811|FG000|COMPLETED|Overall Study||109
8848640|NCT01736475|9903812|FG001|COMPLETED|Overall Study||17
8848641|NCT01736475|9903811|FG000|NOT COMPLETED|Overall Study||12
8848642|NCT01736475|9903812|FG001|NOT COMPLETED|Overall Study||0
8848643|NCT01736527|9903829|FG000|STARTED|Overall Study||12
8848644|NCT01736527|9903829|FG000|COMPLETED|Overall Study||12
8848645|NCT01736527|9903829|FG000|NOT COMPLETED|Overall Study||0
8848646|NCT01736540|9903833|FG000|STARTED|Overall Study||243
8848647|NCT01736540|9903833|FG000|COMPLETED|Overall Study||228
8848648|NCT01736540|9903833|FG000|NOT COMPLETED|Overall Study||15
8848649|NCT01736553|9903846|FG000|STARTED|Overall Study||26
8848650|NCT01736553|9903847|FG001|STARTED|Overall Study||27
8848651|NCT01736553|9903846|FG000|COMPLETED|Overall Study||7
8724111|NCT01025843|9771500|FG001|COMPLETED|Washout 1||2
8848652|NCT01736553|9903847|FG001|COMPLETED|Overall Study||23
8848653|NCT01736553|9903846|FG000|NOT COMPLETED|Overall Study||19
8848654|NCT01736553|9903847|FG001|NOT COMPLETED|Overall Study||4
8848655|NCT01736566|9903876|FG000|STARTED|Main Study||51
8848656|NCT01736566|9903877|FG001|STARTED|Main Study||50
8848657|NCT01736566|9903878|FG002|STARTED|Main Study||50
8848658|NCT01736566|9903879|FG003|STARTED|Main Study||52
8848659|NCT01736566|9903880|FG004|STARTED|Main Study||10
8848660|NCT01736566|9903876|FG000|COMPLETED|Main Study||50
8724112|NCT01025843|9771501|FG002|COMPLETED|Washout 1||2
8848661|NCT01736566|9903877|FG001|COMPLETED|Main Study||50
8848662|NCT01736566|9903878|FG002|COMPLETED|Main Study||49
8848663|NCT01736566|9903879|FG003|COMPLETED|Main Study||51
8848664|NCT01736566|9903880|FG004|COMPLETED|Main Study||6
8848665|NCT01736566|9903876|FG000|NOT COMPLETED|Main Study||1
8848666|NCT01736566|9903877|FG001|NOT COMPLETED|Main Study||0
8848667|NCT01736566|9903878|FG002|NOT COMPLETED|Main Study||1
8848668|NCT01736566|9903879|FG003|NOT COMPLETED|Main Study||1
8848669|NCT01736566|9903880|FG004|NOT COMPLETED|Main Study||4
8848670|NCT01736566|9903876|FG000|STARTED|Long Term Follow-up||42
8848671|NCT01736566|9903877|FG001|STARTED|Long Term Follow-up||0
8848672|NCT01736566|9903878|FG002|STARTED|Long Term Follow-up||49
8848673|NCT01736566|9903879|FG003|STARTED|Long Term Follow-up||0
8848674|NCT01736566|9903880|FG004|STARTED|Long Term Follow-up||1
8848675|NCT01736566|9903876|FG000|COMPLETED|Long Term Follow-up||0
8848676|NCT01736566|9903877|FG001|COMPLETED|Long Term Follow-up||0
8848677|NCT01736566|9903878|FG002|COMPLETED|Long Term Follow-up||0
8848678|NCT01736566|9903879|FG003|COMPLETED|Long Term Follow-up||0
8848679|NCT01736566|9903880|FG004|COMPLETED|Long Term Follow-up||0
8848680|NCT01736566|9903876|FG000|NOT COMPLETED|Long Term Follow-up||42
8848681|NCT01736566|9903877|FG001|NOT COMPLETED|Long Term Follow-up||0
8848682|NCT01736566|9903878|FG002|NOT COMPLETED|Long Term Follow-up||49
8848683|NCT01736566|9903879|FG003|NOT COMPLETED|Long Term Follow-up||0
8848684|NCT01736566|9903880|FG004|NOT COMPLETED|Long Term Follow-up||1
8848685|NCT01736579|9903907|FG000|STARTED|Overall Study||2
8848686|NCT01736579|9903908|FG001|STARTED|Overall Study||2
8848687|NCT01736579|9903907|FG000|COMPLETED|Overall Study||0
8848688|NCT01736579|9903908|FG001|COMPLETED|Overall Study||0
8848689|NCT01736579|9903907|FG000|NOT COMPLETED|Overall Study||2
8848690|NCT01736579|9903908|FG001|NOT COMPLETED|Overall Study||2
8848691|NCT01736657|9903914|FG000|STARTED|Overall Study||73
8848692|NCT01736657|9903914|FG000|COMPLETED|Overall Study||72
8848693|NCT01736657|9903914|FG000|NOT COMPLETED|Overall Study||1
8848694|NCT01736683|9903923|FG000|STARTED|Overall Study||7
8848695|NCT01736683|9903924|FG001|STARTED|Overall Study||6
8848696|NCT01736683|9903925|FG002|STARTED|Overall Study||21
8724113|NCT01025843|9771502|FG003|COMPLETED|Washout 1||2
8724114|NCT01025843|9771503|FG004|COMPLETED|Washout 1||2
8724115|NCT01025843|9771504|FG005|COMPLETED|Washout 1||2
8724116|NCT01025843|9771505|FG006|COMPLETED|Washout 1||2
8724117|NCT01025843|9771506|FG007|COMPLETED|Washout 1||2
8724118|NCT01025843|9771507|FG008|COMPLETED|Washout 1||2
8724119|NCT01025843|9771508|FG009|COMPLETED|Washout 1||2
8848697|NCT01736683|9903926|FG003|STARTED|Overall Study||35
8848698|NCT01736683|9903927|FG004|STARTED|Overall Study||5
8848699|NCT01736683|9903923|FG000|COMPLETED|Overall Study|# who completed treatment|0
8848700|NCT01736683|9903924|FG001|COMPLETED|Overall Study|# who completed treatment|0
8848701|NCT01736683|9903925|FG002|COMPLETED|Overall Study|# who completed treatment|0
8848702|NCT01736683|9903926|FG003|COMPLETED|Overall Study|# who completed treatment|0
8848703|NCT01736683|9903927|FG004|COMPLETED|Overall Study|# who completed treatment|0
8848704|NCT01736683|9903923|FG000|NOT COMPLETED|Overall Study||7
8848705|NCT01736683|9903924|FG001|NOT COMPLETED|Overall Study||6
8848706|NCT01736683|9903925|FG002|NOT COMPLETED|Overall Study||21
8848707|NCT01736683|9903926|FG003|NOT COMPLETED|Overall Study||35
8848708|NCT01736683|9903927|FG004|NOT COMPLETED|Overall Study||5
8848709|NCT01736696|9903948|FG000|STARTED|Overall Study||5
8848710|NCT01736696|9903949|FG001|STARTED|Overall Study||5
8848711|NCT01736696|9903950|FG002|STARTED|Overall Study||10
8848712|NCT01736696|9903951|FG003|STARTED|Overall Study||9
8848713|NCT01736696|9903952|FG004|STARTED|Overall Study||9
8848714|NCT01736696|9903953|FG005|STARTED|Overall Study||8
8848715|NCT01736696|9903954|FG006|STARTED|Overall Study||13
8848716|NCT01736696|9903948|FG000|COMPLETED|Overall Study||5
8848717|NCT01736696|9903949|FG001|COMPLETED|Overall Study||5
8848718|NCT01736696|9903950|FG002|COMPLETED|Overall Study||9
8848719|NCT01736696|9903951|FG003|COMPLETED|Overall Study||9
8848720|NCT01736696|9903952|FG004|COMPLETED|Overall Study||9
8848721|NCT01736696|9903953|FG005|COMPLETED|Overall Study||8
8848722|NCT01736696|9903954|FG006|COMPLETED|Overall Study||13
8848723|NCT01736696|9903948|FG000|NOT COMPLETED|Overall Study||0
8848724|NCT01736696|9903949|FG001|NOT COMPLETED|Overall Study||0
8848725|NCT01736696|9903950|FG002|NOT COMPLETED|Overall Study||1
8848726|NCT01736696|9903951|FG003|NOT COMPLETED|Overall Study||0
8848727|NCT01736696|9903952|FG004|NOT COMPLETED|Overall Study||0
8848728|NCT01736696|9903953|FG005|NOT COMPLETED|Overall Study||0
8848729|NCT01736696|9903954|FG006|NOT COMPLETED|Overall Study||0
8848730|NCT01736852|9903980|FG000|STARTED|Overall Study||65
8724120|NCT01025843|9771499|FG000|NOT COMPLETED|Washout 1||0
8724121|NCT01025843|9771500|FG001|NOT COMPLETED|Washout 1||0
8848731|NCT01736852|9903981|FG001|STARTED|Overall Study||64
8848732|NCT01736852|9903980|FG000|COMPLETED|Overall Study||63
8848733|NCT01736852|9903981|FG001|COMPLETED|Overall Study||61
8848734|NCT01736852|9903980|FG000|NOT COMPLETED|Overall Study||2
8848735|NCT01736852|9903981|FG001|NOT COMPLETED|Overall Study||3
8848736|NCT01736865|9903989|FG000|STARTED|Overall Study||61
8848737|NCT01736865|9903990|FG001|STARTED|Overall Study||66
8848738|NCT01736865|9903989|FG000|COMPLETED|Overall Study||61
8848739|NCT01736865|9903990|FG001|COMPLETED|Overall Study||66
8848740|NCT01736865|9903989|FG000|NOT COMPLETED|Overall Study||0
8848741|NCT01736865|9903990|FG001|NOT COMPLETED|Overall Study||0
8848742|NCT01736917|9903996|FG000|STARTED|Overall Study||65
8848743|NCT01736917|9903996|FG000|COMPLETED|Overall Study||54
8848744|NCT01736917|9903996|FG000|NOT COMPLETED|Overall Study||11
8848745|NCT01736930|9904002|FG000|STARTED|Overall Study|Each night randomized to have either Predictive Low Glucose suspend or inactive (control).|20
8848746|NCT01736930|9904002|FG000|COMPLETED|Overall Study|Each night randomized to have either Predictive Low Glucose suspend or inactive (control).|19
8848747|NCT01736930|9904002|FG000|NOT COMPLETED|Overall Study||1
8848748|NCT01736943|9904008|FG000|STARTED|Overall Study||25
8848749|NCT01736943|9904008|FG000|COMPLETED|Overall Study||25
8848750|NCT01736943|9904008|FG000|NOT COMPLETED|Overall Study||0
8848751|NCT01737268|9904012|FG000|STARTED|Overall Study||20
8848752|NCT01737268|9904012|FG000|Treated|Overall Study||20
8848753|NCT01737268|9904012|FG000|COMPLETED|Overall Study||11
8848754|NCT01737268|9904012|FG000|NOT COMPLETED|Overall Study||9
8850356|NCT01746017|9905502|FG005|NOT COMPLETED|Period 4||0
8850357|NCT01746017|9905503|FG006|NOT COMPLETED|Period 4||0
8850358|NCT01746017|9905504|FG007|NOT COMPLETED|Period 4||0
8850359|NCT01746017|9905505|FG008|NOT COMPLETED|Period 4||0
8850360|NCT01746017|9905506|FG009|NOT COMPLETED|Period 4||0
8850361|NCT01746017|9905507|FG010|NOT COMPLETED|Period 4||0
8850362|NCT01746043|9905550|FG000|STARTED|Overall Study||5
8850363|NCT01746043|9905551|FG001|STARTED|Overall Study||4
8850364|NCT01746043|9905552|FG002|STARTED|Overall Study||5
8850365|NCT01746043|9905553|FG003|STARTED|Overall Study||5
8850366|NCT01746043|9905550|FG000|COMPLETED|Overall Study||5
8850367|NCT01746043|9905551|FG001|COMPLETED|Overall Study||4
8850368|NCT01746043|9905552|FG002|COMPLETED|Overall Study||5
8850369|NCT01746043|9905553|FG003|COMPLETED|Overall Study||5
8850370|NCT01746043|9905550|FG000|NOT COMPLETED|Overall Study||0
8850371|NCT01746043|9905551|FG001|NOT COMPLETED|Overall Study||0
8850372|NCT01746043|9905552|FG002|NOT COMPLETED|Overall Study||0
8850373|NCT01746043|9905553|FG003|NOT COMPLETED|Overall Study||0
8850374|NCT01746095|9905567|FG000|STARTED|Overall Study||20
8850375|NCT01746095|9905568|FG001|STARTED|Overall Study||20
8850376|NCT01746095|9905569|FG002|STARTED|Overall Study||24
8850377|NCT01746095|9905570|FG003|STARTED|Overall Study||23
8850378|NCT01746095|9905567|FG000|COMPLETED|Overall Study||16
8850379|NCT01746095|9905568|FG001|COMPLETED|Overall Study||16
8850380|NCT01746095|9905569|FG002|COMPLETED|Overall Study||11
8850381|NCT01746095|9905570|FG003|COMPLETED|Overall Study||15
8850382|NCT01746095|9905567|FG000|NOT COMPLETED|Overall Study||4
8850383|NCT01746095|9905568|FG001|NOT COMPLETED|Overall Study||4
8850384|NCT01746095|9905569|FG002|NOT COMPLETED|Overall Study||13
8850385|NCT01746095|9905570|FG003|NOT COMPLETED|Overall Study||8
8850386|NCT01746108|9905583|FG000|STARTED|Overall Study||18
8850387|NCT01746108|9905584|FG001|STARTED|Overall Study||28
8850388|NCT01746108|9905585|FG002|STARTED|Overall Study||6
8850389|NCT01746108|9905583|FG000|COMPLETED|Overall Study||18
8850390|NCT01746108|9905584|FG001|COMPLETED|Overall Study||24
8850391|NCT01746108|9905585|FG002|COMPLETED|Overall Study||6
8850392|NCT01746108|9905583|FG000|NOT COMPLETED|Overall Study||0
8850393|NCT01746108|9905584|FG001|NOT COMPLETED|Overall Study||4
8850394|NCT01746108|9905585|FG002|NOT COMPLETED|Overall Study||0
8850395|NCT01746173|9905601|FG000|STARTED|Overall Study||5
8850396|NCT01746173|9905601|FG000|COMPLETED|Overall Study||3
8850397|NCT01746173|9905601|FG000|NOT COMPLETED|Overall Study||2
8850398|NCT01746225|9905608|FG000|STARTED|Overall Study||83
8850399|NCT01746225|9905609|FG001|STARTED|Overall Study||86
8850400|NCT01746225|9905610|FG002|STARTED|Overall Study||86
8850401|NCT01746225|9905608|FG000|COMPLETED|Overall Study||43
8850402|NCT01746225|9905609|FG001|COMPLETED|Overall Study||40
8850403|NCT01746225|9905610|FG002|COMPLETED|Overall Study||43
8850404|NCT01746225|9905608|FG000|NOT COMPLETED|Overall Study||40
8850405|NCT01746225|9905609|FG001|NOT COMPLETED|Overall Study||46
8850406|NCT01746225|9905610|FG002|NOT COMPLETED|Overall Study||43
8850407|NCT01746264|9905618|FG000|STARTED|Overall Study||19
8850408|NCT01746264|9905618|FG000|COMPLETED|Overall Study||19
8850409|NCT01746264|9905618|FG000|NOT COMPLETED|Overall Study||0
8850410|NCT01746368|9905624|FG000|STARTED|Overall Study||33
8850411|NCT01746368|9905625|FG001|STARTED|Overall Study||17
8850412|NCT01746368|9905624|FG000|Recieved Allocated Intervention|Overall Study||31
8850413|NCT01746368|9905625|FG001|Recieved Allocated Intervention|Overall Study||8
8850414|NCT01746368|9905624|FG000|Assessment Completed|Overall Study||31
8850415|NCT01746368|9905625|FG001|Assessment Completed|Overall Study||16
8850416|NCT01746368|9905624|FG000|Analyzed for AD Completion Rate|Overall Study||32
8850417|NCT01746368|9905625|FG001|Analyzed for AD Completion Rate|Overall Study||17
8850418|NCT01746368|9905624|FG000|Analyzed for Satisfaction|Overall Study||30
8850419|NCT01746368|9905625|FG001|Analyzed for Satisfaction|Overall Study||16
8850420|NCT01746368|9905624|FG000|COMPLETED|Overall Study||31
8850421|NCT01746368|9905625|FG001|COMPLETED|Overall Study||16
8850422|NCT01746368|9905624|FG000|NOT COMPLETED|Overall Study||2
8848755|NCT01737281|9904019|FG000|STARTED|Overall Study||969
8848756|NCT01737281|9904020|FG001|STARTED|Overall Study||969
8848757|NCT01737281|9904019|FG000|COMPLETED|Overall Study||603
8848758|NCT01737281|9904020|FG001|COMPLETED|Overall Study||689
8848759|NCT01737281|9904019|FG000|NOT COMPLETED|Overall Study||366
8848760|NCT01737281|9904020|FG001|NOT COMPLETED|Overall Study||280
8848761|NCT01737398|9904028|FG000|STARTED|Overall Study||113
8848762|NCT01737398|9904029|FG001|STARTED|Overall Study||60
8848763|NCT01737398|9904028|FG000|Received at Least 1 Dose of Study Drug|Overall Study||112
8848764|NCT01737398|9904029|FG001|Received at Least 1 Dose of Study Drug|Overall Study||60
8848765|NCT01737398|9904028|FG000|Safety Set|Overall Study||112
8848766|NCT01737398|9904029|FG001|Safety Set|Overall Study||60
8848767|NCT01737398|9904028|FG000|COMPLETED|Overall Study||87
8848768|NCT01737398|9904029|FG001|COMPLETED|Overall Study||52
8848769|NCT01737398|9904028|FG000|NOT COMPLETED|Overall Study||26
8848770|NCT01737398|9904029|FG001|NOT COMPLETED|Overall Study||8
8848771|NCT01737593|9904041|FG000|STARTED|Overall Study||37
8848772|NCT01737593|9904042|FG001|STARTED|Overall Study||32
8848773|NCT01737593|9904043|FG002|STARTED|Overall Study||39
8848774|NCT01737593|9904041|FG000|COMPLETED|Overall Study||37
8848775|NCT01737593|9904042|FG001|COMPLETED|Overall Study||32
8848776|NCT01737593|9904043|FG002|COMPLETED|Overall Study||39
8848777|NCT01737593|9904041|FG000|NOT COMPLETED|Overall Study||0
8848778|NCT01737593|9904042|FG001|NOT COMPLETED|Overall Study||0
8848779|NCT01737593|9904043|FG002|NOT COMPLETED|Overall Study||0
8848780|NCT01737684|9904056|FG000|STARTED|Overall Study||8
8848781|NCT01737684|9904057|FG001|STARTED|Overall Study||8
8848782|NCT01737684|9904058|FG002|STARTED|Overall Study|Participants with mild hepatic insufficiency were not enrolled in study.|0
8848783|NCT01737684|9904056|FG000|COMPLETED|Overall Study||8
8848784|NCT01737684|9904057|FG001|COMPLETED|Overall Study||8
8848785|NCT01737684|9904058|FG002|COMPLETED|Overall Study|Participants with mild hepatic insufficiency were not enrolled in study.|0
8848786|NCT01737684|9904056|FG000|NOT COMPLETED|Overall Study||0
8848787|NCT01737684|9904057|FG001|NOT COMPLETED|Overall Study||0
8848788|NCT01737684|9904058|FG002|NOT COMPLETED|Overall Study||0
8848789|NCT01737697|9904069|FG000|STARTED|Acute Phase-Initial 48 Hours||158
8848790|NCT01737697|9904070|FG001|STARTED|Acute Phase-Initial 48 Hours||154
8848791|NCT01737697|9904071|FG002|STARTED|Acute Phase-Initial 48 Hours||141
8848792|NCT01737697|9904072|FG003|STARTED|Acute Phase-Initial 48 Hours||158
8848793|NCT01737697|9904073|FG004|STARTED|Acute Phase-Initial 48 Hours||143
8848794|NCT01737697|9904074|FG005|STARTED|Acute Phase-Initial 48 Hours||0
8848795|NCT01737697|9904075|FG006|STARTED|Acute Phase-Initial 48 Hours||0
8848796|NCT01737697|9904076|FG007|STARTED|Acute Phase-Initial 48 Hours||0
8848797|NCT01737697|9904077|FG008|STARTED|Acute Phase-Initial 48 Hours||0
8848798|NCT01737697|9904078|FG009|STARTED|Acute Phase-Initial 48 Hours||0
8848799|NCT01737697|9904079|FG010|STARTED|Acute Phase-Initial 48 Hours||0
8848800|NCT01737697|9904080|FG011|STARTED|Acute Phase-Initial 48 Hours||0
8848801|NCT01737697|9904081|FG012|STARTED|Acute Phase-Initial 48 Hours||0
8848802|NCT01737697|9904082|FG013|STARTED|Acute Phase-Initial 48 Hours||0
8848803|NCT01737697|9904083|FG014|STARTED|Acute Phase-Initial 48 Hours||0
8848804|NCT01737697|9904069|FG000|COMPLETED|Acute Phase-Initial 48 Hours||157
8848805|NCT01737697|9904070|FG001|COMPLETED|Acute Phase-Initial 48 Hours||150
8848806|NCT01737697|9904071|FG002|COMPLETED|Acute Phase-Initial 48 Hours||137
8848807|NCT01737697|9904072|FG003|COMPLETED|Acute Phase-Initial 48 Hours||152
8848808|NCT01737697|9904073|FG004|COMPLETED|Acute Phase-Initial 48 Hours||140
8848809|NCT01737697|9904074|FG005|COMPLETED|Acute Phase-Initial 48 Hours||0
8848810|NCT01737697|9904075|FG006|COMPLETED|Acute Phase-Initial 48 Hours||0
8848811|NCT01737697|9904076|FG007|COMPLETED|Acute Phase-Initial 48 Hours||0
8848812|NCT01737697|9904077|FG008|COMPLETED|Acute Phase-Initial 48 Hours||0
8848813|NCT01737697|9904078|FG009|COMPLETED|Acute Phase-Initial 48 Hours||0
8848814|NCT01737697|9904079|FG010|COMPLETED|Acute Phase-Initial 48 Hours||0
8848815|NCT01737697|9904080|FG011|COMPLETED|Acute Phase-Initial 48 Hours||0
8848816|NCT01737697|9904081|FG012|COMPLETED|Acute Phase-Initial 48 Hours||0
8848817|NCT01737697|9904082|FG013|COMPLETED|Acute Phase-Initial 48 Hours||0
8848818|NCT01737697|9904083|FG014|COMPLETED|Acute Phase-Initial 48 Hours||0
8848819|NCT01737697|9904069|FG000|NOT COMPLETED|Acute Phase-Initial 48 Hours||1
8848820|NCT01737697|9904070|FG001|NOT COMPLETED|Acute Phase-Initial 48 Hours||4
8848821|NCT01737697|9904071|FG002|NOT COMPLETED|Acute Phase-Initial 48 Hours||4
8848822|NCT01737697|9904072|FG003|NOT COMPLETED|Acute Phase-Initial 48 Hours||6
8848823|NCT01737697|9904073|FG004|NOT COMPLETED|Acute Phase-Initial 48 Hours||3
8848824|NCT01737697|9904074|FG005|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
8848825|NCT01737697|9904075|FG006|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
8848826|NCT01737697|9904076|FG007|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
8848827|NCT01737697|9904077|FG008|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
8848828|NCT01737697|9904078|FG009|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
8848829|NCT01737697|9904079|FG010|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
8848830|NCT01737697|9904080|FG011|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
8848831|NCT01737697|9904081|FG012|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
8848832|NCT01737697|9904082|FG013|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
8848833|NCT01737697|9904083|FG014|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
8848834|NCT01737697|9904069|FG000|STARTED|Subacute Phase||0
8848835|NCT01737697|9904070|FG001|STARTED|Subacute Phase||0
8848836|NCT01737697|9904071|FG002|STARTED|Subacute Phase||0
8848837|NCT01737697|9904072|FG003|STARTED|Subacute Phase||0
8848838|NCT01737697|9904073|FG004|STARTED|Subacute Phase||0
8848839|NCT01737697|9904074|FG005|STARTED|Subacute Phase||41
8848840|NCT01737697|9904075|FG006|STARTED|Subacute Phase||49
8848841|NCT01737697|9904076|FG007|STARTED|Subacute Phase||46
8848842|NCT01737697|9904077|FG008|STARTED|Subacute Phase||54
8848843|NCT01737697|9904078|FG009|STARTED|Subacute Phase||68
8848844|NCT01737697|9904079|FG010|STARTED|Subacute Phase||65
8848845|NCT01737697|9904080|FG011|STARTED|Subacute Phase||61
8848846|NCT01737697|9904081|FG012|STARTED|Subacute Phase||63
8848847|NCT01737697|9904082|FG013|STARTED|Subacute Phase||46
8848848|NCT01737697|9904083|FG014|STARTED|Subacute Phase||50
8848849|NCT01737697|9904069|FG000|COMPLETED|Subacute Phase||0
8848850|NCT01737697|9904070|FG001|COMPLETED|Subacute Phase||0
8848851|NCT01737697|9904071|FG002|COMPLETED|Subacute Phase||0
8848852|NCT01737697|9904072|FG003|COMPLETED|Subacute Phase||0
8848853|NCT01737697|9904073|FG004|COMPLETED|Subacute Phase||0
8848854|NCT01737697|9904074|FG005|COMPLETED|Subacute Phase||38
8848855|NCT01737697|9904075|FG006|COMPLETED|Subacute Phase||48
8848856|NCT01737697|9904076|FG007|COMPLETED|Subacute Phase||43
8848857|NCT01737697|9904077|FG008|COMPLETED|Subacute Phase||52
8848858|NCT01737697|9904078|FG009|COMPLETED|Subacute Phase||66
8848859|NCT01737697|9904079|FG010|COMPLETED|Subacute Phase||59
8848860|NCT01737697|9904080|FG011|COMPLETED|Subacute Phase||58
8848861|NCT01737697|9904081|FG012|COMPLETED|Subacute Phase||61
8848862|NCT01737697|9904082|FG013|COMPLETED|Subacute Phase||44
8848863|NCT01737697|9904083|FG014|COMPLETED|Subacute Phase||49
8848864|NCT01737697|9904069|FG000|NOT COMPLETED|Subacute Phase||0
8848865|NCT01737697|9904070|FG001|NOT COMPLETED|Subacute Phase||0
8848866|NCT01737697|9904071|FG002|NOT COMPLETED|Subacute Phase||0
8848867|NCT01737697|9904072|FG003|NOT COMPLETED|Subacute Phase||0
8848868|NCT01737697|9904073|FG004|NOT COMPLETED|Subacute Phase||0
8848869|NCT01737697|9904074|FG005|NOT COMPLETED|Subacute Phase||3
8848870|NCT01737697|9904075|FG006|NOT COMPLETED|Subacute Phase||1
8848871|NCT01737697|9904076|FG007|NOT COMPLETED|Subacute Phase||3
8848872|NCT01737697|9904077|FG008|NOT COMPLETED|Subacute Phase||2
8848873|NCT01737697|9904078|FG009|NOT COMPLETED|Subacute Phase||2
8848874|NCT01737697|9904079|FG010|NOT COMPLETED|Subacute Phase||6
8848875|NCT01737697|9904080|FG011|NOT COMPLETED|Subacute Phase||3
8848876|NCT01737697|9904081|FG012|NOT COMPLETED|Subacute Phase||2
8848877|NCT01737697|9904082|FG013|NOT COMPLETED|Subacute Phase||2
8848878|NCT01737697|9904083|FG014|NOT COMPLETED|Subacute Phase||1
8848879|NCT01737710|9904121|FG000|STARTED|Overall Study||114
8848880|NCT01737710|9904122|FG001|STARTED|Overall Study||105
8848881|NCT01737710|9904123|FG002|STARTED|Overall Study||105
8848882|NCT01737710|9904124|FG003|STARTED|Overall Study||23
8848883|NCT01737710|9904125|FG004|STARTED|Overall Study||21
8848884|NCT01737710|9904121|FG000|COMPLETED|Overall Study||112
8848885|NCT01737710|9904122|FG001|COMPLETED|Overall Study||101
8848886|NCT01737710|9904123|FG002|COMPLETED|Overall Study||102
8848887|NCT01737710|9904124|FG003|COMPLETED|Overall Study||23
8848888|NCT01737710|9904125|FG004|COMPLETED|Overall Study||21
8848889|NCT01737710|9904121|FG000|NOT COMPLETED|Overall Study||2
8848890|NCT01737710|9904122|FG001|NOT COMPLETED|Overall Study||4
8848891|NCT01737710|9904123|FG002|NOT COMPLETED|Overall Study||3
8848892|NCT01737710|9904124|FG003|NOT COMPLETED|Overall Study||0
8848893|NCT01737710|9904125|FG004|NOT COMPLETED|Overall Study||0
8848894|NCT01737762|9904138|FG000|STARTED|Overall Study||77
8848895|NCT01737762|9904139|FG001|STARTED|Overall Study||78
8848896|NCT01737762|9904138|FG000|COMPLETED|Overall Study||57
8848897|NCT01737762|9904139|FG001|COMPLETED|Overall Study||61
8848898|NCT01737762|9904138|FG000|NOT COMPLETED|Overall Study||20
8848899|NCT01737762|9904139|FG001|NOT COMPLETED|Overall Study||17
8848900|NCT01737840|9904147|FG000|STARTED|Overall Study||35
8848901|NCT01737840|9904148|FG001|STARTED|Overall Study||35
8848902|NCT01737840|9904147|FG000|COMPLETED|Overall Study||33
8848903|NCT01737840|9904148|FG001|COMPLETED|Overall Study||33
8848904|NCT01737840|9904147|FG000|NOT COMPLETED|Overall Study||2
8848905|NCT01737840|9904148|FG001|NOT COMPLETED|Overall Study||2
8848906|NCT01737879|9904156|FG000|STARTED|Overall Study||41
8848907|NCT01737879|9904156|FG000|Received Peginesatide|Overall Study||34
8848908|NCT01737879|9904156|FG000|Transitioned to Epoetin Alfa|Overall Study||0
8848909|NCT01737879|9904156|FG000|COMPLETED|Overall Study||0
8848910|NCT01737879|9904156|FG000|NOT COMPLETED|Overall Study||41
8848911|NCT01737931|9904163|FG000|STARTED|Overall Study||38
8848912|NCT01737931|9904164|FG001|STARTED|Overall Study||40
8848913|NCT01737931|9904165|FG002|STARTED|Overall Study||39
8848914|NCT01737931|9904163|FG000|COMPLETED|Overall Study||38
8848915|NCT01737931|9904164|FG001|COMPLETED|Overall Study||38
8848916|NCT01737931|9904165|FG002|COMPLETED|Overall Study||38
8848917|NCT01737931|9904163|FG000|NOT COMPLETED|Overall Study||0
8848918|NCT01737931|9904164|FG001|NOT COMPLETED|Overall Study||2
8848919|NCT01737931|9904165|FG002|NOT COMPLETED|Overall Study||1
8848920|NCT01737944|9904175|FG000|STARTED|Overall Study||9
8848921|NCT01737944|9904176|FG001|STARTED|Overall Study||9
8848922|NCT01737944|9904177|FG002|STARTED|Overall Study|10 patients randomized, one patient discontinued before first study drug dose|9
8848923|NCT01737944|9904178|FG003|STARTED|Overall Study|10 patients randomized, one patient discontinued before first study drug dose|9
8848924|NCT01737944|9904175|FG000|COMPLETED|Overall Study||9
8848925|NCT01737944|9904176|FG001|COMPLETED|Overall Study||9
8848926|NCT01737944|9904177|FG002|COMPLETED|Overall Study||9
8848927|NCT01737944|9904178|FG003|COMPLETED|Overall Study||9
8848928|NCT01737944|9904175|FG000|NOT COMPLETED|Overall Study||0
8848929|NCT01737944|9904176|FG001|NOT COMPLETED|Overall Study||0
8724122|NCT01025843|9771501|FG002|NOT COMPLETED|Washout 1||0
8724123|NCT01025843|9771502|FG003|NOT COMPLETED|Washout 1||0
8724124|NCT01025843|9771503|FG004|NOT COMPLETED|Washout 1||0
8724125|NCT01025843|9771504|FG005|NOT COMPLETED|Washout 1||0
8724126|NCT01025843|9771505|FG006|NOT COMPLETED|Washout 1||0
8724127|NCT01025843|9771506|FG007|NOT COMPLETED|Washout 1||0
8724128|NCT01025843|9771507|FG008|NOT COMPLETED|Washout 1||0
8724129|NCT01025843|9771508|FG009|NOT COMPLETED|Washout 1||0
8724130|NCT01025843|9771499|FG000|STARTED|Period 2||2
8848930|NCT01737944|9904177|FG002|NOT COMPLETED|Overall Study||0
8848931|NCT01737944|9904178|FG003|NOT COMPLETED|Overall Study||0
8627564|NCT00519376|9667174|FG004|COMPLETED|Washout Period 1||1
8848932|NCT01737996|9904190|FG000|STARTED|Overall Study||8
8848933|NCT01737996|9904191|FG001|STARTED|Overall Study||8
8848934|NCT01737996|9904192|FG002|STARTED|Overall Study||16
8848935|NCT01737996|9904190|FG000|COMPLETED|Overall Study||8
8848936|NCT01737996|9904191|FG001|COMPLETED|Overall Study||7
8848937|NCT01737996|9904192|FG002|COMPLETED|Overall Study|One patient withdrew consent after the first dose due to private reasons.|14
8848938|NCT01737996|9904190|FG000|NOT COMPLETED|Overall Study||0
8848939|NCT01737996|9904191|FG001|NOT COMPLETED|Overall Study||1
8848940|NCT01737996|9904192|FG002|NOT COMPLETED|Overall Study||2
8848941|NCT01738191|9904202|FG000|STARTED|Overall Study||15
8848942|NCT01738191|9904203|FG001|STARTED|Overall Study||15
8848943|NCT01738191|9904202|FG000|COMPLETED|Overall Study||11
8848944|NCT01738191|9904203|FG001|COMPLETED|Overall Study||14
8848945|NCT01738191|9904202|FG000|NOT COMPLETED|Overall Study||4
8848946|NCT01738191|9904203|FG001|NOT COMPLETED|Overall Study||1
8848947|NCT01738321|9904211|FG000|STARTED|Overall Study||33
8848948|NCT01738321|9904212|FG001|STARTED|Overall Study||30
8848949|NCT01738321|9904211|FG000|COMPLETED|Overall Study||33
8848950|NCT01738321|9904212|FG001|COMPLETED|Overall Study||30
8848951|NCT01738321|9904211|FG000|NOT COMPLETED|Overall Study||0
8848952|NCT01738321|9904212|FG001|NOT COMPLETED|Overall Study||0
8848953|NCT01738438|9904218|FG000|STARTED|Overall Study||35
8848954|NCT01738438|9904218|FG000|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
8848955|NCT01738438|9904218|FG000|NOT COMPLETED|Overall Study||35
8848956|NCT01738477|9904224|FG000|STARTED|Overall Study||37
8848957|NCT01738477|9904225|FG001|STARTED|Overall Study||128
8848958|NCT01738477|9904224|FG000|COMPLETED|Overall Study||36
8848959|NCT01738477|9904225|FG001|COMPLETED|Overall Study||124
8848960|NCT01738477|9904224|FG000|NOT COMPLETED|Overall Study||1
8848961|NCT01738477|9904225|FG001|NOT COMPLETED|Overall Study||4
8848962|NCT01738503|9904239|FG000|STARTED|Induction/Stabilization (Days -14 to -1)||124
8848963|NCT01738503|9904240|FG001|STARTED|Induction/Stabilization (Days -14 to -1)||0
8848964|NCT01738503|9904241|FG002|STARTED|Induction/Stabilization (Days -14 to -1)||0
8848965|NCT01738503|9904242|FG003|STARTED|Induction/Stabilization (Days -14 to -1)||0
8848966|NCT01738503|9904243|FG004|STARTED|Induction/Stabilization (Days -14 to -1)||0
8848967|NCT01738503|9904244|FG005|STARTED|Induction/Stabilization (Days -14 to -1)||0
8848968|NCT01738503|9904245|FG006|STARTED|Induction/Stabilization (Days -14 to -1)||0
8848969|NCT01738503|9904239|FG000|COMPLETED|Induction/Stabilization (Days -14 to -1)||89
8848970|NCT01738503|9904240|FG001|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
8848971|NCT01738503|9904241|FG002|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
8848972|NCT01738503|9904242|FG003|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
8848973|NCT01738503|9904243|FG004|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
8848974|NCT01738503|9904244|FG005|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
8848975|NCT01738503|9904245|FG006|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
8848976|NCT01738503|9904239|FG000|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||35
8848977|NCT01738503|9904240|FG001|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
8848978|NCT01738503|9904241|FG002|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
8627565|NCT00519376|9667175|FG005|COMPLETED|Washout Period 1||1
8627566|NCT00519376|9667176|FG006|COMPLETED|Washout Period 1||1
8627567|NCT00519376|9667177|FG007|COMPLETED|Washout Period 1||1
8627568|NCT00519376|9667178|FG008|COMPLETED|Washout Period 1||1
8627569|NCT00519376|9667179|FG009|COMPLETED|Washout Period 1||1
8627570|NCT00519376|9667180|FG010|COMPLETED|Washout Period 1||1
8627571|NCT00519376|9667181|FG011|COMPLETED|Washout Period 1||1
8627572|NCT00519376|9667182|FG012|COMPLETED|Washout Period 1||1
8627573|NCT00519376|9667183|FG013|COMPLETED|Washout Period 1||1
8627574|NCT00519376|9667184|FG014|COMPLETED|Washout Period 1||1
8848979|NCT01738503|9904242|FG003|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
8848980|NCT01738503|9904243|FG004|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
8848981|NCT01738503|9904244|FG005|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
8848982|NCT01738503|9904245|FG006|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
8848983|NCT01738503|9904239|FG000|STARTED|Treatment Period||0
8724131|NCT01025843|9771500|FG001|STARTED|Period 2||2
8724132|NCT01025843|9771501|FG002|STARTED|Period 2||2
8724133|NCT01025843|9771502|FG003|STARTED|Period 2||2
8724134|NCT01025843|9771503|FG004|STARTED|Period 2||2
8848984|NCT01738503|9904240|FG001|STARTED|Treatment Period||15
8848985|NCT01738503|9904241|FG002|STARTED|Treatment Period||15
8848986|NCT01738503|9904242|FG003|STARTED|Treatment Period||15
8848987|NCT01738503|9904243|FG004|STARTED|Treatment Period||15
8848988|NCT01738503|9904244|FG005|STARTED|Treatment Period||15
8848989|NCT01738503|9904245|FG006|STARTED|Treatment Period||14
8848990|NCT01738503|9904239|FG000|COMPLETED|Treatment Period||0
8848991|NCT01738503|9904240|FG001|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|10
8848992|NCT01738503|9904241|FG002|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|10
8848993|NCT01738503|9904242|FG003|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|9
8848994|NCT01738503|9904243|FG004|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|7
8848995|NCT01738503|9904244|FG005|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|9
8848996|NCT01738503|9904245|FG006|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|6
8848997|NCT01738503|9904239|FG000|NOT COMPLETED|Treatment Period||0
8848998|NCT01738503|9904240|FG001|NOT COMPLETED|Treatment Period||5
8848999|NCT01738503|9904241|FG002|NOT COMPLETED|Treatment Period||5
8849000|NCT01738503|9904242|FG003|NOT COMPLETED|Treatment Period||6
8849001|NCT01738503|9904243|FG004|NOT COMPLETED|Treatment Period||8
8849002|NCT01738503|9904244|FG005|NOT COMPLETED|Treatment Period||6
8849003|NCT01738503|9904245|FG006|NOT COMPLETED|Treatment Period||8
8849004|NCT01738503|9904239|FG000|STARTED|PET Imaging Sub-study||0
8849005|NCT01738503|9904240|FG001|STARTED|PET Imaging Sub-study||0
8849006|NCT01738503|9904241|FG002|STARTED|PET Imaging Sub-study||0
8849007|NCT01738503|9904242|FG003|STARTED|PET Imaging Sub-study||0
8849008|NCT01738503|9904243|FG004|STARTED|PET Imaging Sub-study||0
8849009|NCT01738503|9904244|FG005|STARTED|PET Imaging Sub-study||3
8849010|NCT01738503|9904245|FG006|STARTED|PET Imaging Sub-study||2
8849011|NCT01738503|9904239|FG000|COMPLETED|PET Imaging Sub-study||0
8849012|NCT01738503|9904240|FG001|COMPLETED|PET Imaging Sub-study||0
8849013|NCT01738503|9904241|FG002|COMPLETED|PET Imaging Sub-study||0
8849014|NCT01738503|9904242|FG003|COMPLETED|PET Imaging Sub-study||0
8849015|NCT01738503|9904243|FG004|COMPLETED|PET Imaging Sub-study||0
8849016|NCT01738503|9904244|FG005|COMPLETED|PET Imaging Sub-study|Completion defined as a total of 12 injections plus all PET images|1
8849017|NCT01738503|9904245|FG006|COMPLETED|PET Imaging Sub-study|Completion defined as a total of 6 injections plus all PET images|1
8849018|NCT01738503|9904239|FG000|NOT COMPLETED|PET Imaging Sub-study||0
8849019|NCT01738503|9904240|FG001|NOT COMPLETED|PET Imaging Sub-study||0
8849020|NCT01738503|9904241|FG002|NOT COMPLETED|PET Imaging Sub-study||0
8849021|NCT01738503|9904242|FG003|NOT COMPLETED|PET Imaging Sub-study||0
8849022|NCT01738503|9904243|FG004|NOT COMPLETED|PET Imaging Sub-study||0
8849023|NCT01738503|9904244|FG005|NOT COMPLETED|PET Imaging Sub-study||2
8849024|NCT01738503|9904245|FG006|NOT COMPLETED|PET Imaging Sub-study||1
8849025|NCT01738581|9904269|FG000|STARTED|Overall Study||5
8849026|NCT01738581|9904270|FG001|STARTED|Overall Study||4
8849027|NCT01738581|9904269|FG000|COMPLETED|Overall Study||4
8849028|NCT01738581|9904270|FG001|COMPLETED|Overall Study||4
8849029|NCT01738581|9904269|FG000|NOT COMPLETED|Overall Study||1
8849030|NCT01738581|9904270|FG001|NOT COMPLETED|Overall Study||0
8849031|NCT01738594|9904279|FG000|STARTED|Registration and Treatment Start||0
8849032|NCT01738594|9904280|FG001|STARTED|Registration and Treatment Start||3
8849033|NCT01738594|9904281|FG002|STARTED|Registration and Treatment Start||0
8849034|NCT01738594|9904282|FG003|STARTED|Registration and Treatment Start||0
8849035|NCT01738594|9904283|FG004|STARTED|Registration and Treatment Start||1
8849036|NCT01738594|9904284|FG005|STARTED|Registration and Treatment Start||3
8849037|NCT01738594|9904285|FG006|STARTED|Registration and Treatment Start||0
8849038|NCT01738594|9904286|FG007|STARTED|Registration and Treatment Start||0
8849039|NCT01738594|9904279|FG000|Registered to Study|Registration and Treatment Start||0
8849040|NCT01738594|9904280|FG001|Registered to Study|Registration and Treatment Start||3
8849041|NCT01738594|9904281|FG002|Registered to Study|Registration and Treatment Start||0
8849042|NCT01738594|9904282|FG003|Registered to Study|Registration and Treatment Start||0
8849043|NCT01738594|9904283|FG004|Registered to Study|Registration and Treatment Start||1
8849044|NCT01738594|9904284|FG005|Registered to Study|Registration and Treatment Start||3
8849045|NCT01738594|9904285|FG006|Registered to Study|Registration and Treatment Start||0
8849046|NCT01738594|9904286|FG007|Registered to Study|Registration and Treatment Start||0
8849047|NCT01738594|9904279|FG000|Treatment Started|Registration and Treatment Start||0
8849048|NCT01738594|9904280|FG001|Treatment Started|Registration and Treatment Start||2
8849049|NCT01738594|9904281|FG002|Treatment Started|Registration and Treatment Start||0
8849050|NCT01738594|9904282|FG003|Treatment Started|Registration and Treatment Start||0
8849051|NCT01738594|9904283|FG004|Treatment Started|Registration and Treatment Start||1
8849052|NCT01738594|9904284|FG005|Treatment Started|Registration and Treatment Start||3
8849053|NCT01738594|9904285|FG006|Treatment Started|Registration and Treatment Start||0
8849054|NCT01738594|9904286|FG007|Treatment Started|Registration and Treatment Start||0
8849055|NCT01738594|9904279|FG000|COMPLETED|Registration and Treatment Start||0
8849056|NCT01738594|9904280|FG001|COMPLETED|Registration and Treatment Start||2
8849057|NCT01738594|9904281|FG002|COMPLETED|Registration and Treatment Start||0
8849058|NCT01738594|9904282|FG003|COMPLETED|Registration and Treatment Start||0
8849059|NCT01738594|9904283|FG004|COMPLETED|Registration and Treatment Start||1
8849060|NCT01738594|9904284|FG005|COMPLETED|Registration and Treatment Start||3
8849061|NCT01738594|9904285|FG006|COMPLETED|Registration and Treatment Start||0
8694166|NCT00869791|9739595|FG000|COMPLETED|Period 2 Treatment for 7 Days||14
8694167|NCT00869791|9739596|FG001|COMPLETED|Period 2 Treatment for 7 Days||13
8694168|NCT00869791|9739595|FG000|NOT COMPLETED|Period 2 Treatment for 7 Days||0
8694169|NCT00869791|9739596|FG001|NOT COMPLETED|Period 2 Treatment for 7 Days||0
8694170|NCT00869947|9739604|FG000|STARTED|Overall Study||8
8694171|NCT00869947|9739605|FG001|STARTED|Overall Study||8
8948834|NCT02433288|10011319|FG001|STARTED|Overall Study||442
8948835|NCT02433288|10011318|FG000|COMPLETED|Overall Study||320
8948836|NCT02433288|10011319|FG001|COMPLETED|Overall Study||316
8694172|NCT00869947|9739604|FG000|COMPLETED|Overall Study||8
8694173|NCT00869947|9739605|FG001|COMPLETED|Overall Study||8
8694174|NCT00869947|9739604|FG000|NOT COMPLETED|Overall Study||0
8694175|NCT00869947|9739605|FG001|NOT COMPLETED|Overall Study||0
8694176|NCT00869960|9739613|FG000|STARTED|Overall Study||24
8694177|NCT00869960|9739613|FG000|COMPLETED|Overall Study||22
8694178|NCT00869960|9739613|FG000|NOT COMPLETED|Overall Study||2
8694179|NCT00869999|9739617|FG000|STARTED|Overall Study||26
8694180|NCT00869999|9739617|FG000|COMPLETED|Overall Study||24
8694181|NCT00869999|9739617|FG000|NOT COMPLETED|Overall Study||2
8694182|NCT00870103|9739621|FG000|STARTED|Overall Study||64
8694183|NCT00870103|9739621|FG000|COMPLETED|Overall Study||60
8694184|NCT00870103|9739621|FG000|NOT COMPLETED|Overall Study||4
8694185|NCT00870194|9739627|FG000|STARTED|Overall Study||127
8694186|NCT00870194|9739628|FG001|STARTED|Overall Study||128
8694187|NCT00870194|9739627|FG000|Per Protocol Set|Overall Study||97
8694188|NCT00870194|9739628|FG001|Per Protocol Set|Overall Study||111
8694189|NCT00870194|9739627|FG000|COMPLETED|Overall Study||101
8694190|NCT00870194|9739628|FG001|COMPLETED|Overall Study||114
8694191|NCT00870194|9739627|FG000|NOT COMPLETED|Overall Study||26
8694192|NCT00870194|9739628|FG001|NOT COMPLETED|Overall Study||14
8694193|NCT00870233|9739634|FG000|STARTED|Overall Study||120
8694194|NCT00870233|9739634|FG000|COMPLETED|Overall Study||96
8694195|NCT00870233|9739634|FG000|NOT COMPLETED|Overall Study||24
8694196|NCT00870363|9739643|FG000|STARTED|Overall Study||10
8694197|NCT00870363|9739644|FG001|STARTED|Overall Study||11
8694198|NCT00870363|9739645|FG002|STARTED|Overall Study||11
8694199|NCT00870363|9739646|FG003|STARTED|Overall Study||12
8694200|NCT00870363|9739643|FG000|COMPLETED|Overall Study||10
8694201|NCT00870363|9739644|FG001|COMPLETED|Overall Study||8
8694202|NCT00870363|9739645|FG002|COMPLETED|Overall Study||8
8694203|NCT00870363|9739646|FG003|COMPLETED|Overall Study||12
8694204|NCT00870363|9739643|FG000|NOT COMPLETED|Overall Study||0
8694205|NCT00870363|9739644|FG001|NOT COMPLETED|Overall Study||3
8694206|NCT00870363|9739645|FG002|NOT COMPLETED|Overall Study||3
8694207|NCT00870363|9739646|FG003|NOT COMPLETED|Overall Study||0
8694208|NCT00870467|9739658|FG000|STARTED|Double-blind||171
8694209|NCT00870467|9739659|FG001|STARTED|Double-blind||163
8694210|NCT00870467|9739660|FG002|STARTED|Double-blind||0
8694211|NCT00870467|9739661|FG003|STARTED|Double-blind||0
8694212|NCT00870467|9739662|FG004|STARTED|Double-blind||0
8694213|NCT00870467|9739663|FG005|STARTED|Double-blind||0
8694214|NCT00870467|9739658|FG000|COMPLETED|Double-blind|10 participants who completed 26 weeks received open-label adalimumab 40 mg eow as rescue therapy|155
8694215|NCT00870467|9739659|FG001|COMPLETED|Double-blind|24 participants who completed 26 weeks received open-label adalimumab 40 mg eow as rescue therapy|151
8694216|NCT00870467|9739660|FG002|COMPLETED|Double-blind||0
8694217|NCT00870467|9739661|FG003|COMPLETED|Double-blind||0
8694218|NCT00870467|9739662|FG004|COMPLETED|Double-blind||0
8694219|NCT00870467|9739663|FG005|COMPLETED|Double-blind||0
8694220|NCT00870467|9739658|FG000|NOT COMPLETED|Double-blind||16
8694221|NCT00870467|9739659|FG001|NOT COMPLETED|Double-blind||12
8694222|NCT00870467|9739660|FG002|NOT COMPLETED|Double-blind||0
8694223|NCT00870467|9739661|FG003|NOT COMPLETED|Double-blind||0
8694224|NCT00870467|9739662|FG004|NOT COMPLETED|Double-blind||0
8694225|NCT00870467|9739663|FG005|NOT COMPLETED|Double-blind||0
8694226|NCT00870467|9739658|FG000|STARTED|Open-label||0
8694227|NCT00870467|9739659|FG001|STARTED|Open-label||0
8694228|NCT00870467|9739660|FG002|STARTED|Open-label||145
8694229|NCT00870467|9739661|FG003|STARTED|Open-label||127
8694230|NCT00870467|9739662|FG004|STARTED|Open-label||10
8694231|NCT00870467|9739663|FG005|STARTED|Open-label||24
8694232|NCT00870467|9739658|FG000|COMPLETED|Open-label||0
8694233|NCT00870467|9739659|FG001|COMPLETED|Open-label||0
8694234|NCT00870467|9739660|FG002|COMPLETED|Open-label||132
8694235|NCT00870467|9739661|FG003|COMPLETED|Open-label||120
8694236|NCT00870467|9739662|FG004|COMPLETED|Open-label||5
8694237|NCT00870467|9739663|FG005|COMPLETED|Open-label||21
8694238|NCT00870467|9739658|FG000|NOT COMPLETED|Open-label||0
8694239|NCT00870467|9739659|FG001|NOT COMPLETED|Open-label||0
8694240|NCT00870467|9739660|FG002|NOT COMPLETED|Open-label||13
8694241|NCT00870467|9739661|FG003|NOT COMPLETED|Open-label||7
8694242|NCT00870467|9739662|FG004|NOT COMPLETED|Open-label||5
8850495|NCT01746784|9905682|FG001|NOT COMPLETED|Overall Study||0
8850496|NCT01746784|9905683|FG002|NOT COMPLETED|Overall Study||0
8850497|NCT01746784|9905684|FG003|NOT COMPLETED|Overall Study||0
8850498|NCT01746784|9905685|FG004|NOT COMPLETED|Overall Study||0
8694243|NCT00870467|9739663|FG005|NOT COMPLETED|Open-label||3
8694244|NCT00870545|9739675|FG000|STARTED|Overall Study||86
8948837|NCT02433288|10011318|FG000|NOT COMPLETED|Overall Study||123
8694245|NCT00870545|9739675|FG000|COMPLETED|Overall Study||69
8694246|NCT00870545|9739675|FG000|NOT COMPLETED|Overall Study||17
8694247|NCT00870584|9739681|FG000|STARTED|Overall Study||136
8948838|NCT02433288|10011319|FG001|NOT COMPLETED|Overall Study||126
8850499|NCT01746862|9905708|FG000|STARTED|Overall Study||60
8850500|NCT01746862|9905709|FG001|STARTED|Overall Study||30
8850501|NCT01746862|9905708|FG000|Treated|Overall Study||59
8850502|NCT01746862|9905709|FG001|Treated|Overall Study||30
8850503|NCT01746862|9905708|FG000|COMPLETED|Overall Study||52
8850504|NCT01746862|9905709|FG001|COMPLETED|Overall Study||27
8850505|NCT01746862|9905708|FG000|NOT COMPLETED|Overall Study||8
8850506|NCT01746862|9905709|FG001|NOT COMPLETED|Overall Study||3
8850507|NCT01746901|9905716|FG000|STARTED|Naloxone Challenge Phase||75
8850508|NCT01746901|9905717|FG001|STARTED|Naloxone Challenge Phase||0
8850509|NCT01746901|9905718|FG002|STARTED|Naloxone Challenge Phase||0
8850510|NCT01746901|9905719|FG003|STARTED|Naloxone Challenge Phase||0
8850511|NCT01746901|9905720|FG004|STARTED|Naloxone Challenge Phase||0
8850512|NCT01746901|9905721|FG005|STARTED|Naloxone Challenge Phase||0
8850513|NCT01746901|9905722|FG006|STARTED|Naloxone Challenge Phase||0
8850514|NCT01746901|9905723|FG007|STARTED|Naloxone Challenge Phase||0
8850515|NCT01746901|9905724|FG008|STARTED|Naloxone Challenge Phase||0
8850516|NCT01746901|9905716|FG000|COMPLETED|Naloxone Challenge Phase||72
8850517|NCT01746901|9905717|FG001|COMPLETED|Naloxone Challenge Phase||0
8850518|NCT01746901|9905718|FG002|COMPLETED|Naloxone Challenge Phase||0
8850519|NCT01746901|9905719|FG003|COMPLETED|Naloxone Challenge Phase||0
8850520|NCT01746901|9905720|FG004|COMPLETED|Naloxone Challenge Phase||0
8850521|NCT01746901|9905721|FG005|COMPLETED|Naloxone Challenge Phase||0
8850522|NCT01746901|9905722|FG006|COMPLETED|Naloxone Challenge Phase||0
8850523|NCT01746901|9905723|FG007|COMPLETED|Naloxone Challenge Phase||0
8850524|NCT01746901|9905724|FG008|COMPLETED|Naloxone Challenge Phase||0
8850525|NCT01746901|9905716|FG000|NOT COMPLETED|Naloxone Challenge Phase||3
8850526|NCT01746901|9905717|FG001|NOT COMPLETED|Naloxone Challenge Phase||0
8850527|NCT01746901|9905718|FG002|NOT COMPLETED|Naloxone Challenge Phase||0
8850528|NCT01746901|9905719|FG003|NOT COMPLETED|Naloxone Challenge Phase||0
8850529|NCT01746901|9905720|FG004|NOT COMPLETED|Naloxone Challenge Phase||0
8850530|NCT01746901|9905721|FG005|NOT COMPLETED|Naloxone Challenge Phase||0
8850531|NCT01746901|9905722|FG006|NOT COMPLETED|Naloxone Challenge Phase||0
8850532|NCT01746901|9905723|FG007|NOT COMPLETED|Naloxone Challenge Phase||0
8850533|NCT01746901|9905724|FG008|NOT COMPLETED|Naloxone Challenge Phase||0
8850534|NCT01746901|9905716|FG000|STARTED|Drug Discrimination Phase: Day 1||0
8850535|NCT01746901|9905717|FG001|STARTED|Drug Discrimination Phase: Day 1||36
8850536|NCT01746901|9905718|FG002|STARTED|Drug Discrimination Phase: Day 1||36
8850537|NCT01746901|9905719|FG003|STARTED|Drug Discrimination Phase: Day 1||0
8850538|NCT01746901|9905720|FG004|STARTED|Drug Discrimination Phase: Day 1||0
8850539|NCT01746901|9905721|FG005|STARTED|Drug Discrimination Phase: Day 1||0
8850540|NCT01746901|9905722|FG006|STARTED|Drug Discrimination Phase: Day 1||0
8850541|NCT01746901|9905723|FG007|STARTED|Drug Discrimination Phase: Day 1||0
8850542|NCT01746901|9905724|FG008|STARTED|Drug Discrimination Phase: Day 1||0
8850543|NCT01746901|9905716|FG000|COMPLETED|Drug Discrimination Phase: Day 1||0
8850544|NCT01746901|9905717|FG001|COMPLETED|Drug Discrimination Phase: Day 1||33
8850545|NCT01746901|9905718|FG002|COMPLETED|Drug Discrimination Phase: Day 1||36
8850546|NCT01746901|9905719|FG003|COMPLETED|Drug Discrimination Phase: Day 1||0
8850547|NCT01746901|9905720|FG004|COMPLETED|Drug Discrimination Phase: Day 1||0
8850548|NCT01746901|9905721|FG005|COMPLETED|Drug Discrimination Phase: Day 1||0
8850549|NCT01746901|9905722|FG006|COMPLETED|Drug Discrimination Phase: Day 1||0
8850550|NCT01746901|9905723|FG007|COMPLETED|Drug Discrimination Phase: Day 1||0
8850551|NCT01746901|9905724|FG008|COMPLETED|Drug Discrimination Phase: Day 1||0
8850552|NCT01746901|9905716|FG000|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
8850553|NCT01746901|9905717|FG001|NOT COMPLETED|Drug Discrimination Phase: Day 1||3
8850554|NCT01746901|9905718|FG002|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
8850555|NCT01746901|9905719|FG003|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
8850556|NCT01746901|9905720|FG004|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
8850557|NCT01746901|9905721|FG005|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
8850558|NCT01746901|9905722|FG006|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
8850559|NCT01746901|9905723|FG007|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
8850560|NCT01746901|9905724|FG008|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
8850561|NCT01746901|9905716|FG000|STARTED|Drug Discrimination Phase: Day 2||0
8850562|NCT01746901|9905717|FG001|STARTED|Drug Discrimination Phase: Day 2||33
8850563|NCT01746901|9905718|FG002|STARTED|Drug Discrimination Phase: Day 2||36
8850564|NCT01746901|9905719|FG003|STARTED|Drug Discrimination Phase: Day 2||0
8850565|NCT01746901|9905720|FG004|STARTED|Drug Discrimination Phase: Day 2||0
8850566|NCT01746901|9905721|FG005|STARTED|Drug Discrimination Phase: Day 2||0
8850567|NCT01746901|9905722|FG006|STARTED|Drug Discrimination Phase: Day 2||0
8850568|NCT01746901|9905723|FG007|STARTED|Drug Discrimination Phase: Day 2||0
8850569|NCT01746901|9905724|FG008|STARTED|Drug Discrimination Phase: Day 2||0
8850570|NCT01746901|9905716|FG000|COMPLETED|Drug Discrimination Phase: Day 2||0
8850571|NCT01746901|9905717|FG001|COMPLETED|Drug Discrimination Phase: Day 2||19
8850572|NCT01746901|9905718|FG002|COMPLETED|Drug Discrimination Phase: Day 2||22
8850573|NCT01746901|9905719|FG003|COMPLETED|Drug Discrimination Phase: Day 2||0
8850574|NCT01746901|9905720|FG004|COMPLETED|Drug Discrimination Phase: Day 2||0
8850575|NCT01746901|9905721|FG005|COMPLETED|Drug Discrimination Phase: Day 2||0
8850576|NCT01746901|9905722|FG006|COMPLETED|Drug Discrimination Phase: Day 2||0
8850577|NCT01746901|9905723|FG007|COMPLETED|Drug Discrimination Phase: Day 2||0
8850578|NCT01746901|9905724|FG008|COMPLETED|Drug Discrimination Phase: Day 2||0
8850579|NCT01746901|9905716|FG000|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
8850580|NCT01746901|9905717|FG001|NOT COMPLETED|Drug Discrimination Phase: Day 2||14
8850581|NCT01746901|9905718|FG002|NOT COMPLETED|Drug Discrimination Phase: Day 2||14
8850582|NCT01746901|9905719|FG003|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
8850583|NCT01746901|9905720|FG004|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
8850584|NCT01746901|9905721|FG005|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
8850585|NCT01746901|9905722|FG006|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
8850586|NCT01746901|9905723|FG007|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
8850587|NCT01746901|9905724|FG008|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
8850588|NCT01746901|9905716|FG000|STARTED|Treatment Phase: First Intervention||0
8850589|NCT01746901|9905717|FG001|STARTED|Treatment Phase: First Intervention||0
8850590|NCT01746901|9905718|FG002|STARTED|Treatment Phase: First Intervention||0
8850591|NCT01746901|9905719|FG003|STARTED|Treatment Phase: First Intervention||6
8850592|NCT01746901|9905720|FG004|STARTED|Treatment Phase: First Intervention||6
8850593|NCT01746901|9905721|FG005|STARTED|Treatment Phase: First Intervention||7
8850594|NCT01746901|9905722|FG006|STARTED|Treatment Phase: First Intervention||8
8850595|NCT01746901|9905723|FG007|STARTED|Treatment Phase: First Intervention||7
8850596|NCT01746901|9905724|FG008|STARTED|Treatment Phase: First Intervention||7
8850597|NCT01746901|9905716|FG000|COMPLETED|Treatment Phase: First Intervention||0
8850598|NCT01746901|9905717|FG001|COMPLETED|Treatment Phase: First Intervention||0
8850599|NCT01746901|9905718|FG002|COMPLETED|Treatment Phase: First Intervention||0
8850600|NCT01746901|9905719|FG003|COMPLETED|Treatment Phase: First Intervention||6
8850601|NCT01746901|9905720|FG004|COMPLETED|Treatment Phase: First Intervention||6
8850602|NCT01746901|9905721|FG005|COMPLETED|Treatment Phase: First Intervention||7
8850603|NCT01746901|9905722|FG006|COMPLETED|Treatment Phase: First Intervention||7
8850604|NCT01746901|9905723|FG007|COMPLETED|Treatment Phase: First Intervention||7
8850605|NCT01746901|9905724|FG008|COMPLETED|Treatment Phase: First Intervention||7
8850606|NCT01746901|9905716|FG000|NOT COMPLETED|Treatment Phase: First Intervention||0
8850607|NCT01746901|9905717|FG001|NOT COMPLETED|Treatment Phase: First Intervention||0
8850608|NCT01746901|9905718|FG002|NOT COMPLETED|Treatment Phase: First Intervention||0
8850609|NCT01746901|9905719|FG003|NOT COMPLETED|Treatment Phase: First Intervention||0
8850610|NCT01746901|9905720|FG004|NOT COMPLETED|Treatment Phase: First Intervention||0
8850611|NCT01746901|9905721|FG005|NOT COMPLETED|Treatment Phase: First Intervention||0
8850612|NCT01746901|9905722|FG006|NOT COMPLETED|Treatment Phase: First Intervention||1
8850613|NCT01746901|9905723|FG007|NOT COMPLETED|Treatment Phase: First Intervention||0
8850614|NCT01746901|9905724|FG008|NOT COMPLETED|Treatment Phase: First Intervention||0
8850615|NCT01746901|9905716|FG000|STARTED|Treatment Phase: Washout Period 1||0
8850616|NCT01746901|9905717|FG001|STARTED|Treatment Phase: Washout Period 1||0
8850617|NCT01746901|9905718|FG002|STARTED|Treatment Phase: Washout Period 1||0
8850618|NCT01746901|9905719|FG003|STARTED|Treatment Phase: Washout Period 1||6
8850619|NCT01746901|9905720|FG004|STARTED|Treatment Phase: Washout Period 1||6
8850620|NCT01746901|9905721|FG005|STARTED|Treatment Phase: Washout Period 1||7
8850621|NCT01746901|9905722|FG006|STARTED|Treatment Phase: Washout Period 1||7
8850622|NCT01746901|9905723|FG007|STARTED|Treatment Phase: Washout Period 1||7
8850623|NCT01746901|9905724|FG008|STARTED|Treatment Phase: Washout Period 1||7
8850624|NCT01746901|9905716|FG000|COMPLETED|Treatment Phase: Washout Period 1||0
8850625|NCT01746901|9905717|FG001|COMPLETED|Treatment Phase: Washout Period 1||0
8850626|NCT01746901|9905718|FG002|COMPLETED|Treatment Phase: Washout Period 1||0
8850627|NCT01746901|9905719|FG003|COMPLETED|Treatment Phase: Washout Period 1||6
8850628|NCT01746901|9905720|FG004|COMPLETED|Treatment Phase: Washout Period 1||6
8850629|NCT01746901|9905721|FG005|COMPLETED|Treatment Phase: Washout Period 1||7
8850630|NCT01746901|9905722|FG006|COMPLETED|Treatment Phase: Washout Period 1||7
8850631|NCT01746901|9905723|FG007|COMPLETED|Treatment Phase: Washout Period 1||7
8850632|NCT01746901|9905724|FG008|COMPLETED|Treatment Phase: Washout Period 1||7
8850633|NCT01746901|9905716|FG000|NOT COMPLETED|Treatment Phase: Washout Period 1||0
8850634|NCT01746901|9905717|FG001|NOT COMPLETED|Treatment Phase: Washout Period 1||0
8850635|NCT01746901|9905718|FG002|NOT COMPLETED|Treatment Phase: Washout Period 1||0
8850636|NCT01746901|9905719|FG003|NOT COMPLETED|Treatment Phase: Washout Period 1||0
8850637|NCT01746901|9905720|FG004|NOT COMPLETED|Treatment Phase: Washout Period 1||0
8850638|NCT01746901|9905721|FG005|NOT COMPLETED|Treatment Phase: Washout Period 1||0
8629671|NCT00531050|9669383|FG002|COMPLETED|Part 2: Period 2||4
8629672|NCT00531050|9669384|FG003|COMPLETED|Part 2: Period 2||4
8629673|NCT00531050|9669385|FG004|COMPLETED|Part 2: Period 2||4
8850639|NCT01746901|9905722|FG006|NOT COMPLETED|Treatment Phase: Washout Period 1||0
8850640|NCT01746901|9905723|FG007|NOT COMPLETED|Treatment Phase: Washout Period 1||0
8850641|NCT01746901|9905724|FG008|NOT COMPLETED|Treatment Phase: Washout Period 1||0
8850642|NCT01746901|9905716|FG000|STARTED|Treatment Phase: Second Intervention||0
8850643|NCT01746901|9905717|FG001|STARTED|Treatment Phase: Second Intervention||0
8850644|NCT01746901|9905718|FG002|STARTED|Treatment Phase: Second Intervention||0
8629674|NCT00531050|9669386|FG005|COMPLETED|Part 2: Period 2||4
8850645|NCT01746901|9905719|FG003|STARTED|Treatment Phase: Second Intervention||6
8850646|NCT01746901|9905720|FG004|STARTED|Treatment Phase: Second Intervention||6
8948839|NCT02433340|10011329|FG000|STARTED|Overall Study||42
8948840|NCT02433340|10011330|FG001|STARTED|Overall Study||37
8850647|NCT01746901|9905721|FG005|STARTED|Treatment Phase: Second Intervention||7
8850648|NCT01746901|9905722|FG006|STARTED|Treatment Phase: Second Intervention||7
8850649|NCT01746901|9905723|FG007|STARTED|Treatment Phase: Second Intervention||7
8850650|NCT01746901|9905724|FG008|STARTED|Treatment Phase: Second Intervention||7
8850651|NCT01746901|9905716|FG000|COMPLETED|Treatment Phase: Second Intervention||0
8850652|NCT01746901|9905717|FG001|COMPLETED|Treatment Phase: Second Intervention||0
8850653|NCT01746901|9905718|FG002|COMPLETED|Treatment Phase: Second Intervention||0
8850654|NCT01746901|9905719|FG003|COMPLETED|Treatment Phase: Second Intervention||6
8850655|NCT01746901|9905720|FG004|COMPLETED|Treatment Phase: Second Intervention||6
8850656|NCT01746901|9905721|FG005|COMPLETED|Treatment Phase: Second Intervention||7
8850657|NCT01746901|9905722|FG006|COMPLETED|Treatment Phase: Second Intervention||7
8850658|NCT01746901|9905723|FG007|COMPLETED|Treatment Phase: Second Intervention||6
8850659|NCT01746901|9905724|FG008|COMPLETED|Treatment Phase: Second Intervention||7
8850660|NCT01746901|9905716|FG000|NOT COMPLETED|Treatment Phase: Second Intervention||0
8850661|NCT01746901|9905717|FG001|NOT COMPLETED|Treatment Phase: Second Intervention||0
8850662|NCT01746901|9905718|FG002|NOT COMPLETED|Treatment Phase: Second Intervention||0
8850663|NCT01746901|9905719|FG003|NOT COMPLETED|Treatment Phase: Second Intervention||0
8850664|NCT01746901|9905720|FG004|NOT COMPLETED|Treatment Phase: Second Intervention||0
8850665|NCT01746901|9905721|FG005|NOT COMPLETED|Treatment Phase: Second Intervention||0
8850666|NCT01746901|9905722|FG006|NOT COMPLETED|Treatment Phase: Second Intervention||0
8850667|NCT01746901|9905723|FG007|NOT COMPLETED|Treatment Phase: Second Intervention||1
8850668|NCT01746901|9905724|FG008|NOT COMPLETED|Treatment Phase: Second Intervention||0
8850669|NCT01746901|9905716|FG000|STARTED|Treatment Phase: Washout Period 2||0
8850670|NCT01746901|9905717|FG001|STARTED|Treatment Phase: Washout Period 2||0
8850671|NCT01746901|9905718|FG002|STARTED|Treatment Phase: Washout Period 2||0
8850672|NCT01746901|9905719|FG003|STARTED|Treatment Phase: Washout Period 2||6
8850673|NCT01746901|9905720|FG004|STARTED|Treatment Phase: Washout Period 2||6
8850674|NCT01746901|9905721|FG005|STARTED|Treatment Phase: Washout Period 2||7
8850675|NCT01746901|9905722|FG006|STARTED|Treatment Phase: Washout Period 2||7
8850676|NCT01746901|9905723|FG007|STARTED|Treatment Phase: Washout Period 2||6
8850677|NCT01746901|9905724|FG008|STARTED|Treatment Phase: Washout Period 2||7
8850678|NCT01746901|9905716|FG000|COMPLETED|Treatment Phase: Washout Period 2||0
8850679|NCT01746901|9905717|FG001|COMPLETED|Treatment Phase: Washout Period 2||0
8850680|NCT01746901|9905718|FG002|COMPLETED|Treatment Phase: Washout Period 2||0
8850681|NCT01746901|9905719|FG003|COMPLETED|Treatment Phase: Washout Period 2||6
8850682|NCT01746901|9905720|FG004|COMPLETED|Treatment Phase: Washout Period 2||6
8850683|NCT01746901|9905721|FG005|COMPLETED|Treatment Phase: Washout Period 2||7
8850684|NCT01746901|9905722|FG006|COMPLETED|Treatment Phase: Washout Period 2||7
8850685|NCT01746901|9905723|FG007|COMPLETED|Treatment Phase: Washout Period 2||6
8850686|NCT01746901|9905724|FG008|COMPLETED|Treatment Phase: Washout Period 2||7
8850687|NCT01746901|9905716|FG000|NOT COMPLETED|Treatment Phase: Washout Period 2||0
8850688|NCT01746901|9905717|FG001|NOT COMPLETED|Treatment Phase: Washout Period 2||0
8850689|NCT01746901|9905718|FG002|NOT COMPLETED|Treatment Phase: Washout Period 2||0
8850690|NCT01746901|9905719|FG003|NOT COMPLETED|Treatment Phase: Washout Period 2||0
8850691|NCT01746901|9905720|FG004|NOT COMPLETED|Treatment Phase: Washout Period 2||0
8850692|NCT01746901|9905721|FG005|NOT COMPLETED|Treatment Phase: Washout Period 2||0
8850693|NCT01746901|9905722|FG006|NOT COMPLETED|Treatment Phase: Washout Period 2||0
8850694|NCT01746901|9905723|FG007|NOT COMPLETED|Treatment Phase: Washout Period 2||0
8850695|NCT01746901|9905724|FG008|NOT COMPLETED|Treatment Phase: Washout Period 2||0
8850696|NCT01746901|9905716|FG000|STARTED|Treatment Phase: Third Intervention||0
8850697|NCT01746901|9905717|FG001|STARTED|Treatment Phase: Third Intervention||0
8850698|NCT01746901|9905718|FG002|STARTED|Treatment Phase: Third Intervention||0
8850699|NCT01746901|9905719|FG003|STARTED|Treatment Phase: Third Intervention||6
8850700|NCT01746901|9905720|FG004|STARTED|Treatment Phase: Third Intervention||6
8850701|NCT01746901|9905721|FG005|STARTED|Treatment Phase: Third Intervention||7
8850702|NCT01746901|9905722|FG006|STARTED|Treatment Phase: Third Intervention||7
8850703|NCT01746901|9905723|FG007|STARTED|Treatment Phase: Third Intervention||6
8850704|NCT01746901|9905724|FG008|STARTED|Treatment Phase: Third Intervention||7
8850705|NCT01746901|9905716|FG000|COMPLETED|Treatment Phase: Third Intervention||0
8850706|NCT01746901|9905717|FG001|COMPLETED|Treatment Phase: Third Intervention||0
8850707|NCT01746901|9905718|FG002|COMPLETED|Treatment Phase: Third Intervention||0
8850708|NCT01746901|9905719|FG003|COMPLETED|Treatment Phase: Third Intervention||6
8850709|NCT01746901|9905720|FG004|COMPLETED|Treatment Phase: Third Intervention||6
8850710|NCT01746901|9905721|FG005|COMPLETED|Treatment Phase: Third Intervention||6
8850711|NCT01746901|9905722|FG006|COMPLETED|Treatment Phase: Third Intervention||6
8850712|NCT01746901|9905723|FG007|COMPLETED|Treatment Phase: Third Intervention||6
8850713|NCT01746901|9905724|FG008|COMPLETED|Treatment Phase: Third Intervention||7
8850714|NCT01746901|9905716|FG000|NOT COMPLETED|Treatment Phase: Third Intervention||0
8850715|NCT01746901|9905717|FG001|NOT COMPLETED|Treatment Phase: Third Intervention||0
8850716|NCT01746901|9905718|FG002|NOT COMPLETED|Treatment Phase: Third Intervention||0
8850717|NCT01746901|9905719|FG003|NOT COMPLETED|Treatment Phase: Third Intervention||0
8850718|NCT01746901|9905720|FG004|NOT COMPLETED|Treatment Phase: Third Intervention||0
8850719|NCT01746901|9905721|FG005|NOT COMPLETED|Treatment Phase: Third Intervention||1
8850720|NCT01746901|9905722|FG006|NOT COMPLETED|Treatment Phase: Third Intervention||1
8948841|NCT02433340|10011331|FG002|STARTED|Overall Study||39
8850721|NCT01746901|9905723|FG007|NOT COMPLETED|Treatment Phase: Third Intervention||0
8850722|NCT01746901|9905724|FG008|NOT COMPLETED|Treatment Phase: Third Intervention||0
8850723|NCT01746901|9905716|FG000|STARTED|Treatment Phase: Washout Period 3||0
8850724|NCT01746901|9905717|FG001|STARTED|Treatment Phase: Washout Period 3||0
8850725|NCT01746901|9905718|FG002|STARTED|Treatment Phase: Washout Period 3||0
8850726|NCT01746901|9905719|FG003|STARTED|Treatment Phase: Washout Period 3||6
8850727|NCT01746901|9905720|FG004|STARTED|Treatment Phase: Washout Period 3||6
8850728|NCT01746901|9905721|FG005|STARTED|Treatment Phase: Washout Period 3||6
8850729|NCT01746901|9905722|FG006|STARTED|Treatment Phase: Washout Period 3||6
8850730|NCT01746901|9905723|FG007|STARTED|Treatment Phase: Washout Period 3||6
8850731|NCT01746901|9905724|FG008|STARTED|Treatment Phase: Washout Period 3||7
8850732|NCT01746901|9905716|FG000|COMPLETED|Treatment Phase: Washout Period 3||0
8850733|NCT01746901|9905717|FG001|COMPLETED|Treatment Phase: Washout Period 3||0
8850734|NCT01746901|9905718|FG002|COMPLETED|Treatment Phase: Washout Period 3||0
8850735|NCT01746901|9905719|FG003|COMPLETED|Treatment Phase: Washout Period 3||6
8850736|NCT01746901|9905720|FG004|COMPLETED|Treatment Phase: Washout Period 3||6
8850737|NCT01746901|9905721|FG005|COMPLETED|Treatment Phase: Washout Period 3||6
8850738|NCT01746901|9905722|FG006|COMPLETED|Treatment Phase: Washout Period 3||6
8850739|NCT01746901|9905723|FG007|COMPLETED|Treatment Phase: Washout Period 3||6
8850740|NCT01746901|9905724|FG008|COMPLETED|Treatment Phase: Washout Period 3||7
8850741|NCT01746901|9905716|FG000|NOT COMPLETED|Treatment Phase: Washout Period 3||0
8850742|NCT01746901|9905717|FG001|NOT COMPLETED|Treatment Phase: Washout Period 3||0
8850743|NCT01746901|9905718|FG002|NOT COMPLETED|Treatment Phase: Washout Period 3||0
8850744|NCT01746901|9905719|FG003|NOT COMPLETED|Treatment Phase: Washout Period 3||0
8850745|NCT01746901|9905720|FG004|NOT COMPLETED|Treatment Phase: Washout Period 3||0
8850746|NCT01746901|9905721|FG005|NOT COMPLETED|Treatment Phase: Washout Period 3||0
8850747|NCT01746901|9905722|FG006|NOT COMPLETED|Treatment Phase: Washout Period 3||0
8850748|NCT01746901|9905723|FG007|NOT COMPLETED|Treatment Phase: Washout Period 3||0
8850749|NCT01746901|9905724|FG008|NOT COMPLETED|Treatment Phase: Washout Period 3||0
8850750|NCT01746901|9905716|FG000|STARTED|Treatment Phase: Fourth Intervention||0
8850751|NCT01746901|9905717|FG001|STARTED|Treatment Phase: Fourth Intervention||0
8850752|NCT01746901|9905718|FG002|STARTED|Treatment Phase: Fourth Intervention||0
8850753|NCT01746901|9905719|FG003|STARTED|Treatment Phase: Fourth Intervention||6
8850754|NCT01746901|9905720|FG004|STARTED|Treatment Phase: Fourth Intervention||6
8850755|NCT01746901|9905721|FG005|STARTED|Treatment Phase: Fourth Intervention||6
8850756|NCT01746901|9905722|FG006|STARTED|Treatment Phase: Fourth Intervention||6
8850757|NCT01746901|9905723|FG007|STARTED|Treatment Phase: Fourth Intervention||6
8850758|NCT01746901|9905724|FG008|STARTED|Treatment Phase: Fourth Intervention||7
8850759|NCT01746901|9905716|FG000|COMPLETED|Treatment Phase: Fourth Intervention||0
8850760|NCT01746901|9905717|FG001|COMPLETED|Treatment Phase: Fourth Intervention||0
8850761|NCT01746901|9905718|FG002|COMPLETED|Treatment Phase: Fourth Intervention||0
8850762|NCT01746901|9905719|FG003|COMPLETED|Treatment Phase: Fourth Intervention||5
8850763|NCT01746901|9905720|FG004|COMPLETED|Treatment Phase: Fourth Intervention||6
8850764|NCT01746901|9905721|FG005|COMPLETED|Treatment Phase: Fourth Intervention||5
8850765|NCT01746901|9905722|FG006|COMPLETED|Treatment Phase: Fourth Intervention||5
8850766|NCT01746901|9905723|FG007|COMPLETED|Treatment Phase: Fourth Intervention||6
8850767|NCT01746901|9905724|FG008|COMPLETED|Treatment Phase: Fourth Intervention||5
8850768|NCT01746901|9905716|FG000|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
8850769|NCT01746901|9905717|FG001|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
8850770|NCT01746901|9905718|FG002|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
8850771|NCT01746901|9905719|FG003|NOT COMPLETED|Treatment Phase: Fourth Intervention||1
8850772|NCT01746901|9905720|FG004|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
8850773|NCT01746901|9905721|FG005|NOT COMPLETED|Treatment Phase: Fourth Intervention||1
8850774|NCT01746901|9905722|FG006|NOT COMPLETED|Treatment Phase: Fourth Intervention||1
8850775|NCT01746901|9905723|FG007|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
8850776|NCT01746901|9905724|FG008|NOT COMPLETED|Treatment Phase: Fourth Intervention||2
8850777|NCT01746901|9905716|FG000|STARTED|Treatment Phase: Washout Period 4||0
8850778|NCT01746901|9905717|FG001|STARTED|Treatment Phase: Washout Period 4||0
8850779|NCT01746901|9905718|FG002|STARTED|Treatment Phase: Washout Period 4||0
8850780|NCT01746901|9905719|FG003|STARTED|Treatment Phase: Washout Period 4||5
8850781|NCT01746901|9905720|FG004|STARTED|Treatment Phase: Washout Period 4||6
8569457|NCT00097539|9601695|FG002|COMPLETED|Overall Study||3411
8569458|NCT00097539|9601696|FG003|COMPLETED|Overall Study||2066
8569459|NCT00097539|9601697|FG004|COMPLETED|Overall Study||386
8569460|NCT00097539|9601698|FG005|COMPLETED|Overall Study||2118
8569461|NCT00097539|9601699|FG006|COMPLETED|Overall Study||68
8569462|NCT00097539|9601693|FG000|NOT COMPLETED|Overall Study||19066
8850782|NCT01746901|9905721|FG005|STARTED|Treatment Phase: Washout Period 4||5
8850783|NCT01746901|9905722|FG006|STARTED|Treatment Phase: Washout Period 4||5
8569463|NCT00097539|9601694|FG001|NOT COMPLETED|Overall Study||6531
8569464|NCT00097539|9601695|FG002|NOT COMPLETED|Overall Study||9108
8569465|NCT00097539|9601696|FG003|NOT COMPLETED|Overall Study||3585
8569466|NCT00097539|9601697|FG004|NOT COMPLETED|Overall Study||1758
8569467|NCT00097539|9601698|FG005|NOT COMPLETED|Overall Study||5892
8569468|NCT00097539|9601699|FG006|NOT COMPLETED|Overall Study||171
8569469|NCT00097591|9601717|FG000|STARTED|Overall Study|7 subjects randomized but not analyzed due to an incomplete informed consent document|6813
8850784|NCT01746901|9905723|FG007|STARTED|Treatment Phase: Washout Period 4||6
8850785|NCT01746901|9905724|FG008|STARTED|Treatment Phase: Washout Period 4||5
8850786|NCT01746901|9905716|FG000|COMPLETED|Treatment Phase: Washout Period 4||0
8850787|NCT01746901|9905717|FG001|COMPLETED|Treatment Phase: Washout Period 4||0
8850788|NCT01746901|9905718|FG002|COMPLETED|Treatment Phase: Washout Period 4||0
8850789|NCT01746901|9905719|FG003|COMPLETED|Treatment Phase: Washout Period 4||5
8850790|NCT01746901|9905720|FG004|COMPLETED|Treatment Phase: Washout Period 4||6
8850791|NCT01746901|9905721|FG005|COMPLETED|Treatment Phase: Washout Period 4||5
8850792|NCT01746901|9905722|FG006|COMPLETED|Treatment Phase: Washout Period 4||5
8850793|NCT01746901|9905723|FG007|COMPLETED|Treatment Phase: Washout Period 4||6
8850794|NCT01746901|9905724|FG008|COMPLETED|Treatment Phase: Washout Period 4||5
8850795|NCT01746901|9905716|FG000|NOT COMPLETED|Treatment Phase: Washout Period 4||0
8850796|NCT01746901|9905717|FG001|NOT COMPLETED|Treatment Phase: Washout Period 4||0
8850797|NCT01746901|9905718|FG002|NOT COMPLETED|Treatment Phase: Washout Period 4||0
8850798|NCT01746901|9905719|FG003|NOT COMPLETED|Treatment Phase: Washout Period 4||0
8850799|NCT01746901|9905720|FG004|NOT COMPLETED|Treatment Phase: Washout Period 4||0
8850800|NCT01746901|9905721|FG005|NOT COMPLETED|Treatment Phase: Washout Period 4||0
8850801|NCT01746901|9905722|FG006|NOT COMPLETED|Treatment Phase: Washout Period 4||0
8850802|NCT01746901|9905723|FG007|NOT COMPLETED|Treatment Phase: Washout Period 4||0
8850803|NCT01746901|9905724|FG008|NOT COMPLETED|Treatment Phase: Washout Period 4||0
8850804|NCT01746901|9905716|FG000|STARTED|Treatment Phase: Fifth Intervention||0
8850805|NCT01746901|9905717|FG001|STARTED|Treatment Phase: Fifth Intervention||0
8850806|NCT01746901|9905718|FG002|STARTED|Treatment Phase: Fifth Intervention||0
8629675|NCT00531050|9669381|FG000|NOT COMPLETED|Part 2: Period 2||0
8629676|NCT00531050|9669382|FG001|NOT COMPLETED|Part 2: Period 2||0
8629677|NCT00531050|9669383|FG002|NOT COMPLETED|Part 2: Period 2||0
8629678|NCT00531050|9669384|FG003|NOT COMPLETED|Part 2: Period 2||0
8629679|NCT00531050|9669385|FG004|NOT COMPLETED|Part 2: Period 2||0
8629680|NCT00531050|9669386|FG005|NOT COMPLETED|Part 2: Period 2||0
8629681|NCT00531050|9669381|FG000|STARTED|Part 2: Period 3||3
8629682|NCT00531050|9669382|FG001|STARTED|Part 2: Period 3||4
8629683|NCT00531050|9669383|FG002|STARTED|Part 2: Period 3||4
8629684|NCT00531050|9669384|FG003|STARTED|Part 2: Period 3||4
8850807|NCT01746901|9905719|FG003|STARTED|Treatment Phase: Fifth Intervention||5
8850808|NCT01746901|9905720|FG004|STARTED|Treatment Phase: Fifth Intervention||6
8850809|NCT01746901|9905721|FG005|STARTED|Treatment Phase: Fifth Intervention||5
8850810|NCT01746901|9905722|FG006|STARTED|Treatment Phase: Fifth Intervention||5
8850811|NCT01746901|9905723|FG007|STARTED|Treatment Phase: Fifth Intervention||6
8850812|NCT01746901|9905724|FG008|STARTED|Treatment Phase: Fifth Intervention||5
8850813|NCT01746901|9905716|FG000|COMPLETED|Treatment Phase: Fifth Intervention||0
8850814|NCT01746901|9905717|FG001|COMPLETED|Treatment Phase: Fifth Intervention||0
8850815|NCT01746901|9905718|FG002|COMPLETED|Treatment Phase: Fifth Intervention||0
8850816|NCT01746901|9905719|FG003|COMPLETED|Treatment Phase: Fifth Intervention||5
8850817|NCT01746901|9905720|FG004|COMPLETED|Treatment Phase: Fifth Intervention||6
8850818|NCT01746901|9905721|FG005|COMPLETED|Treatment Phase: Fifth Intervention||5
8850819|NCT01746901|9905722|FG006|COMPLETED|Treatment Phase: Fifth Intervention||5
8850820|NCT01746901|9905723|FG007|COMPLETED|Treatment Phase: Fifth Intervention||6
8850821|NCT01746901|9905724|FG008|COMPLETED|Treatment Phase: Fifth Intervention||5
8850822|NCT01746901|9905716|FG000|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
8850823|NCT01746901|9905717|FG001|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
8850824|NCT01746901|9905718|FG002|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
8850825|NCT01746901|9905719|FG003|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
8850826|NCT01746901|9905720|FG004|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
8850827|NCT01746901|9905721|FG005|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
8850828|NCT01746901|9905722|FG006|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
8850829|NCT01746901|9905723|FG007|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
8850830|NCT01746901|9905724|FG008|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
8850831|NCT01746901|9905716|FG000|STARTED|Treatment Phase: Washout Period 5||0
8850832|NCT01746901|9905717|FG001|STARTED|Treatment Phase: Washout Period 5||0
8850833|NCT01746901|9905718|FG002|STARTED|Treatment Phase: Washout Period 5||0
8850834|NCT01746901|9905719|FG003|STARTED|Treatment Phase: Washout Period 5||5
8850835|NCT01746901|9905720|FG004|STARTED|Treatment Phase: Washout Period 5||6
8850836|NCT01746901|9905721|FG005|STARTED|Treatment Phase: Washout Period 5||5
8850837|NCT01746901|9905722|FG006|STARTED|Treatment Phase: Washout Period 5||5
8850838|NCT01746901|9905723|FG007|STARTED|Treatment Phase: Washout Period 5||6
8850839|NCT01746901|9905724|FG008|STARTED|Treatment Phase: Washout Period 5||5
8850840|NCT01746901|9905716|FG000|COMPLETED|Treatment Phase: Washout Period 5||0
8850841|NCT01746901|9905717|FG001|COMPLETED|Treatment Phase: Washout Period 5||0
8850842|NCT01746901|9905718|FG002|COMPLETED|Treatment Phase: Washout Period 5||0
8850843|NCT01746901|9905719|FG003|COMPLETED|Treatment Phase: Washout Period 5||5
8850844|NCT01746901|9905720|FG004|COMPLETED|Treatment Phase: Washout Period 5||6
8850845|NCT01746901|9905721|FG005|COMPLETED|Treatment Phase: Washout Period 5||5
8850846|NCT01746901|9905722|FG006|COMPLETED|Treatment Phase: Washout Period 5||5
8850847|NCT01746901|9905723|FG007|COMPLETED|Treatment Phase: Washout Period 5||6
8850848|NCT01746901|9905724|FG008|COMPLETED|Treatment Phase: Washout Period 5||5
8850849|NCT01746901|9905716|FG000|NOT COMPLETED|Treatment Phase: Washout Period 5||0
8629685|NCT00531050|9669385|FG004|STARTED|Part 2: Period 3||4
8629686|NCT00531050|9669386|FG005|STARTED|Part 2: Period 3||4
8850850|NCT01746901|9905717|FG001|NOT COMPLETED|Treatment Phase: Washout Period 5||0
8850851|NCT01746901|9905718|FG002|NOT COMPLETED|Treatment Phase: Washout Period 5||0
8850852|NCT01746901|9905719|FG003|NOT COMPLETED|Treatment Phase: Washout Period 5||0
8850853|NCT01746901|9905720|FG004|NOT COMPLETED|Treatment Phase: Washout Period 5||0
8850854|NCT01746901|9905721|FG005|NOT COMPLETED|Treatment Phase: Washout Period 5||0
8850855|NCT01746901|9905722|FG006|NOT COMPLETED|Treatment Phase: Washout Period 5||0
8850856|NCT01746901|9905723|FG007|NOT COMPLETED|Treatment Phase: Washout Period 5||0
8850857|NCT01746901|9905724|FG008|NOT COMPLETED|Treatment Phase: Washout Period 5||0
8850858|NCT01746901|9905716|FG000|STARTED|Treatment Phase: Sixth Intervention||0
8850859|NCT01746901|9905717|FG001|STARTED|Treatment Phase: Sixth Intervention||0
8850860|NCT01746901|9905718|FG002|STARTED|Treatment Phase: Sixth Intervention||0
8850861|NCT01746901|9905719|FG003|STARTED|Treatment Phase: Sixth Intervention||5
8850862|NCT01746901|9905720|FG004|STARTED|Treatment Phase: Sixth Intervention||6
8850863|NCT01746901|9905721|FG005|STARTED|Treatment Phase: Sixth Intervention||5
8850864|NCT01746901|9905722|FG006|STARTED|Treatment Phase: Sixth Intervention||5
8850865|NCT01746901|9905723|FG007|STARTED|Treatment Phase: Sixth Intervention||6
8850866|NCT01746901|9905724|FG008|STARTED|Treatment Phase: Sixth Intervention||5
8850867|NCT01746901|9905716|FG000|COMPLETED|Treatment Phase: Sixth Intervention||0
8850868|NCT01746901|9905717|FG001|COMPLETED|Treatment Phase: Sixth Intervention||0
8850869|NCT01746901|9905718|FG002|COMPLETED|Treatment Phase: Sixth Intervention||0
8850870|NCT01746901|9905719|FG003|COMPLETED|Treatment Phase: Sixth Intervention||5
8850871|NCT01746901|9905720|FG004|COMPLETED|Treatment Phase: Sixth Intervention||6
8850872|NCT01746901|9905721|FG005|COMPLETED|Treatment Phase: Sixth Intervention||5
8850873|NCT01746901|9905722|FG006|COMPLETED|Treatment Phase: Sixth Intervention||5
8850874|NCT01746901|9905723|FG007|COMPLETED|Treatment Phase: Sixth Intervention||6
8850875|NCT01746901|9905724|FG008|COMPLETED|Treatment Phase: Sixth Intervention||5
8850876|NCT01746901|9905716|FG000|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
8850877|NCT01746901|9905717|FG001|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
8850878|NCT01746901|9905718|FG002|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
8850879|NCT01746901|9905719|FG003|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
8850880|NCT01746901|9905720|FG004|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
8850881|NCT01746901|9905721|FG005|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
8850882|NCT01746901|9905722|FG006|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
8850883|NCT01746901|9905723|FG007|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
8850884|NCT01746901|9905724|FG008|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
8850885|NCT01746940|9905764|FG000|STARTED|Safety and Efficacy First Phase||39
8850886|NCT01746940|9905765|FG001|STARTED|Safety and Efficacy First Phase||41
8850887|NCT01746940|9905766|FG002|STARTED|Safety and Efficacy First Phase||40
8850888|NCT01746940|9905767|FG003|STARTED|Safety and Efficacy First Phase||3
8850889|NCT01746940|9905764|FG000|COMPLETED|Safety and Efficacy First Phase||39
8850890|NCT01746940|9905765|FG001|COMPLETED|Safety and Efficacy First Phase||41
8850891|NCT01746940|9905766|FG002|COMPLETED|Safety and Efficacy First Phase||40
8850892|NCT01746940|9905767|FG003|COMPLETED|Safety and Efficacy First Phase||0
8850893|NCT01746940|9905764|FG000|NOT COMPLETED|Safety and Efficacy First Phase||0
8850894|NCT01746940|9905765|FG001|NOT COMPLETED|Safety and Efficacy First Phase||0
8850895|NCT01746940|9905766|FG002|NOT COMPLETED|Safety and Efficacy First Phase||0
8850896|NCT01746940|9905767|FG003|NOT COMPLETED|Safety and Efficacy First Phase||3
8850897|NCT01746940|9905764|FG000|STARTED|Safety Second Phase||18
8850898|NCT01746940|9905765|FG001|STARTED|Safety Second Phase||18
8850899|NCT01746940|9905766|FG002|STARTED|Safety Second Phase||0
8850900|NCT01746940|9905767|FG003|STARTED|Safety Second Phase||0
8850901|NCT01746940|9905764|FG000|COMPLETED|Safety Second Phase||18
8850902|NCT01746940|9905765|FG001|COMPLETED|Safety Second Phase||18
8850903|NCT01746940|9905766|FG002|COMPLETED|Safety Second Phase||0
8850904|NCT01746940|9905767|FG003|COMPLETED|Safety Second Phase||0
8850905|NCT01746940|9905764|FG000|NOT COMPLETED|Safety Second Phase||0
8850906|NCT01746940|9905765|FG001|NOT COMPLETED|Safety Second Phase||0
8850907|NCT01746940|9905766|FG002|NOT COMPLETED|Safety Second Phase||0
8850908|NCT01746940|9905767|FG003|NOT COMPLETED|Safety Second Phase||0
8850909|NCT01746979|9905777|FG000|STARTED|Overall Study||346
8850910|NCT01746979|9905778|FG001|STARTED|Overall Study||347
8850911|NCT01746979|9905777|FG000|COMPLETED|Overall Study||0
8850912|NCT01746979|9905778|FG001|COMPLETED|Overall Study||0
8850913|NCT01746979|9905777|FG000|NOT COMPLETED|Overall Study||346
8850914|NCT01746979|9905778|FG001|NOT COMPLETED|Overall Study||347
8850915|NCT01747330|9905784|FG000|STARTED|Overall Study||40
8850916|NCT01747330|9905784|FG000|COMPLETED|Overall Study||40
8850917|NCT01747330|9905784|FG000|NOT COMPLETED|Overall Study||0
8850918|NCT01747343|9905788|FG000|STARTED|Baseline||4
8850919|NCT01747343|9905788|FG000|COMPLETED|Baseline||4
8850920|NCT01747343|9905788|FG000|NOT COMPLETED|Baseline||0
8850921|NCT01747343|9905788|FG000|STARTED|Underwear||4
8850922|NCT01747343|9905788|FG000|COMPLETED|Underwear||4
8850923|NCT01747343|9905788|FG000|NOT COMPLETED|Underwear||0
8850924|NCT01747343|9905788|FG000|STARTED|Underwear/Differential Reinforcement||4
8850925|NCT01747343|9905788|FG000|COMPLETED|Underwear/Differential Reinforcement||4
8850926|NCT01747343|9905788|FG000|NOT COMPLETED|Underwear/Differential Reinforcement||0
8850927|NCT01747486|9905794|FG000|STARTED|Stage 1||15
8850928|NCT01747486|9905795|FG001|STARTED|Stage 1||15
8850929|NCT01747486|9905794|FG000|COMPLETED|Stage 1||3
8850930|NCT01747486|9905795|FG001|COMPLETED|Stage 1||2
8850931|NCT01747486|9905794|FG000|NOT COMPLETED|Stage 1||12
8850932|NCT01747486|9905795|FG001|NOT COMPLETED|Stage 1||13
8850933|NCT01747486|9905794|FG000|STARTED|Stage 2||12
8850934|NCT01747486|9905795|FG001|STARTED|Stage 2||0
8850935|NCT01747486|9905794|FG000|COMPLETED|Stage 2||3
8850936|NCT01747486|9905795|FG001|COMPLETED|Stage 2||0
8850937|NCT01747486|9905794|FG000|NOT COMPLETED|Stage 2||9
8850938|NCT01747486|9905795|FG001|NOT COMPLETED|Stage 2||0
8850939|NCT01747499|9905806|FG000|STARTED|Overall Study||3
8850940|NCT01747499|9905807|FG001|STARTED|Overall Study||3
8850941|NCT01747499|9905808|FG002|STARTED|Overall Study||3
8850942|NCT01747499|9905809|FG003|STARTED|Overall Study||6
8850943|NCT01747499|9905810|FG004|STARTED|Overall Study||39
8850944|NCT01747499|9905806|FG000|COMPLETED|Overall Study||2
8850945|NCT01747499|9905807|FG001|COMPLETED|Overall Study||2
8850946|NCT01747499|9905808|FG002|COMPLETED|Overall Study||3
8850947|NCT01747499|9905809|FG003|COMPLETED|Overall Study||4
8850948|NCT01747499|9905810|FG004|COMPLETED|Overall Study||24
8850949|NCT01747499|9905806|FG000|NOT COMPLETED|Overall Study||1
8850950|NCT01747499|9905807|FG001|NOT COMPLETED|Overall Study||1
8850951|NCT01747499|9905808|FG002|NOT COMPLETED|Overall Study||0
8850952|NCT01747499|9905809|FG003|NOT COMPLETED|Overall Study||2
8850953|NCT01747499|9905810|FG004|NOT COMPLETED|Overall Study||15
8850954|NCT01747551|9905826|FG000|STARTED|Overall Study||43
8850955|NCT01747551|9905827|FG001|STARTED|Overall Study||21
8850956|NCT01747551|9905826|FG000|COMPLETED|Overall Study||0
8850957|NCT01747551|9905827|FG001|COMPLETED|Overall Study||0
8850958|NCT01747551|9905826|FG000|NOT COMPLETED|Overall Study||43
8850959|NCT01747551|9905827|FG001|NOT COMPLETED|Overall Study||21
8850960|NCT01747629|9905835|FG000|STARTED|Overall Study||85
8850961|NCT01747629|9905836|FG001|STARTED|Overall Study||75
8850962|NCT01747629|9905835|FG000|Treated|Overall Study|Safety set and full analysis set|84
8850963|NCT01747629|9905836|FG001|Treated|Overall Study|Safety set and full analysis set|75
8850964|NCT01747629|9905835|FG000|COMPLETED|Overall Study||77
8850965|NCT01747629|9905836|FG001|COMPLETED|Overall Study||69
8850966|NCT01747629|9905835|FG000|NOT COMPLETED|Overall Study||8
8850967|NCT01747629|9905836|FG001|NOT COMPLETED|Overall Study||6
8850968|NCT01747655|9905842|FG000|STARTED|Temporary Naso-jejunal Tube Period|Main Analysis Set (MAS): participants with baseline and 1 further visit and ≥ 1 Duodopa treatment|64
8850969|NCT01747655|9905843|FG001|STARTED|Temporary Naso-jejunal Tube Period||0
8850970|NCT01747655|9905842|FG000|COMPLETED|Temporary Naso-jejunal Tube Period||64
8850971|NCT01747655|9905843|FG001|COMPLETED|Temporary Naso-jejunal Tube Period||0
8850972|NCT01747655|9905842|FG000|NOT COMPLETED|Temporary Naso-jejunal Tube Period||0
8850973|NCT01747655|9905843|FG001|NOT COMPLETED|Temporary Naso-jejunal Tube Period||0
8850974|NCT01747655|9905842|FG000|STARTED|PEG-J Period (Duodopa Treatment)|Dudopa MAS: Participants in the MAS that received Duodopa via PEG-J.|58
8850975|NCT01747655|9905843|FG001|STARTED|PEG-J Period (Duodopa Treatment)|Participants in the MAS that returned to SoC (no PEG-J introduced; did not meet selection criteria)|6
8850976|NCT01747655|9905842|FG000|COMPLETED|PEG-J Period (Duodopa Treatment)||44
8850977|NCT01747655|9905843|FG001|COMPLETED|PEG-J Period (Duodopa Treatment)||6
8850978|NCT01747655|9905842|FG000|NOT COMPLETED|PEG-J Period (Duodopa Treatment)||14
8850979|NCT01747655|9905843|FG001|NOT COMPLETED|PEG-J Period (Duodopa Treatment)||0
8850980|NCT01747655|9905842|FG000|STARTED|PEG-J Period (Continued Treatment)||41
8850981|NCT01747655|9905843|FG001|STARTED|PEG-J Period (Continued Treatment)|SoC MAS: 6 SoC participants plus 9 participants who received Duodopa via PEG-J then returned to SoC|15
8850982|NCT01747655|9905842|FG000|COMPLETED|PEG-J Period (Continued Treatment)||41
8850983|NCT01747655|9905843|FG001|COMPLETED|PEG-J Period (Continued Treatment)||15
8629687|NCT00531050|9669381|FG000|COMPLETED|Part 2: Period 3||2
8629688|NCT00531050|9669382|FG001|COMPLETED|Part 2: Period 3||4
8850984|NCT01747655|9905842|FG000|NOT COMPLETED|PEG-J Period (Continued Treatment)||0
8850985|NCT01747655|9905843|FG001|NOT COMPLETED|PEG-J Period (Continued Treatment)||0
8850986|NCT01747772|9905849|FG000|STARTED|Overall Study||180
8850987|NCT01747772|9905849|FG000|Analysis Population|Overall Study|All participants who completed the study and had adequate SWE and liver biopsy data.|164
8850988|NCT01747772|9905849|FG000|COMPLETED|Overall Study||171
8850989|NCT01747772|9905849|FG000|NOT COMPLETED|Overall Study||9
8850990|NCT01747811|9905859|FG000|STARTED|Overall Study||16
8850991|NCT01747811|9905860|FG001|STARTED|Overall Study||16
8850992|NCT01747811|9905859|FG000|COMPLETED|Overall Study||14
8850993|NCT01747811|9905860|FG001|COMPLETED|Overall Study||12
8850994|NCT01747811|9905859|FG000|NOT COMPLETED|Overall Study||2
8850995|NCT01747811|9905860|FG001|NOT COMPLETED|Overall Study||4
8850996|NCT01747837|9905870|FG000|STARTED|Overall Study||25
8850997|NCT01747837|9905871|FG001|STARTED|Overall Study||23
8850998|NCT01747837|9905870|FG000|COMPLETED|Overall Study||16
8850999|NCT01747837|9905871|FG001|COMPLETED|Overall Study||17
8851000|NCT01747837|9905870|FG000|NOT COMPLETED|Overall Study||9
8851001|NCT01747837|9905871|FG001|NOT COMPLETED|Overall Study||6
8851002|NCT01747850|9905880|FG000|STARTED|Overall Study||5
8851003|NCT01747850|9905881|FG001|STARTED|Overall Study||20
8851004|NCT01747850|9905882|FG002|STARTED|Overall Study||20
8851005|NCT01747850|9905880|FG000|COMPLETED|Overall Study||4
8851006|NCT01747850|9905881|FG001|COMPLETED|Overall Study||13
8851007|NCT01747850|9905882|FG002|COMPLETED|Overall Study||14
8851008|NCT01747850|9905880|FG000|NOT COMPLETED|Overall Study||1
8851009|NCT01747850|9905881|FG001|NOT COMPLETED|Overall Study||7
8851010|NCT01747850|9905882|FG002|NOT COMPLETED|Overall Study||6
8851011|NCT01747876|9905905|FG000|STARTED|Overall Study||5
8851012|NCT01747876|9905906|FG001|STARTED|Overall Study||15
8851013|NCT01747876|9905907|FG002|STARTED|Overall Study||12
8851014|NCT01747876|9905905|FG000|COMPLETED|Overall Study||0
8851015|NCT01747876|9905906|FG001|COMPLETED|Overall Study||0
8851016|NCT01747876|9905907|FG002|COMPLETED|Overall Study||0
8851017|NCT01747876|9905905|FG000|NOT COMPLETED|Overall Study||5
8851018|NCT01747876|9905906|FG001|NOT COMPLETED|Overall Study||15
8851019|NCT01747876|9905907|FG002|NOT COMPLETED|Overall Study||12
8851020|NCT01747915|9905921|FG000|STARTED|Overall Study||75
8851021|NCT01747915|9905922|FG001|STARTED|Overall Study||72
8851022|NCT01747915|9905923|FG002|STARTED|Overall Study||72
8851023|NCT01747915|9905921|FG000|COMPLETED|Overall Study||60
8851024|NCT01747915|9905922|FG001|COMPLETED|Overall Study||61
8851025|NCT01747915|9905923|FG002|COMPLETED|Overall Study||66
8851026|NCT01747915|9905921|FG000|NOT COMPLETED|Overall Study||15
8851027|NCT01747915|9905922|FG001|NOT COMPLETED|Overall Study||11
8851028|NCT01747915|9905923|FG002|NOT COMPLETED|Overall Study||6
8851029|NCT01747928|9905939|FG000|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
8851030|NCT01747928|9905940|FG001|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
8851031|NCT01747928|9905941|FG002|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
8851032|NCT01747928|9905942|FG003|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
8851033|NCT01747928|9905943|FG004|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
8851034|NCT01747928|9905944|FG005|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
8851035|NCT01747928|9905945|FG006|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
8948842|NCT02433340|10011332|FG003|STARTED|Overall Study||40
8948843|NCT02433340|10011329|FG000|COMPLETED|Overall Study||40
8948844|NCT02433340|10011330|FG001|COMPLETED|Overall Study||35
8948845|NCT02433340|10011331|FG002|COMPLETED|Overall Study||37
8948846|NCT02433340|10011332|FG003|COMPLETED|Overall Study||38
8948847|NCT02433340|10011329|FG000|NOT COMPLETED|Overall Study||2
8948848|NCT02433340|10011330|FG001|NOT COMPLETED|Overall Study||2
8948849|NCT02433340|10011331|FG002|NOT COMPLETED|Overall Study||2
8948850|NCT02433340|10011332|FG003|NOT COMPLETED|Overall Study||2
8948851|NCT02433366|10011346|FG000|STARTED|Overall Study||411
8948852|NCT02433366|10011347|FG001|STARTED|Overall Study||802
8948853|NCT02433366|10011346|FG000|COMPLETED|Overall Study||411
8948854|NCT02433366|10011347|FG001|COMPLETED|Overall Study||802
8948855|NCT02433366|10011346|FG000|NOT COMPLETED|Overall Study||0
8948856|NCT02433366|10011347|FG001|NOT COMPLETED|Overall Study||0
8948857|NCT02433379|10011353|FG000|STARTED|Overall Study||1173
8948858|NCT02433379|10011353|FG000|COMPLETED|Overall Study||852
8948859|NCT02433379|10011353|FG000|NOT COMPLETED|Overall Study||321
8948860|NCT02433483|10011359|FG000|STARTED|Overall Study||2
8948861|NCT02433483|10011359|FG000|COMPLETED|Overall Study||0
8948862|NCT02433483|10011359|FG000|NOT COMPLETED|Overall Study||2
8948863|NCT02433496|10011366|FG000|STARTED|Overall Study|This includes patients (29956) and providers (34).|29990
8948864|NCT02433496|10011367|FG001|STARTED|Overall Study|This includes patients (13296) and providers (13).|13309
8948865|NCT02433496|10011368|FG002|STARTED|Overall Study|This includes patients (9813) and providers (20).|9833
8948866|NCT02433496|10011366|FG000|COMPLETED|Overall Study|This includes patients (29956) and providers (34).|29990
8948867|NCT02433496|10011367|FG001|COMPLETED|Overall Study|This includes patients (13296) and providers (13).|13309
8948868|NCT02433496|10011368|FG002|COMPLETED|Overall Study|This includes patients (9813) and providers (20).|9833
8948869|NCT02433496|10011366|FG000|NOT COMPLETED|Overall Study||0
8948870|NCT02433496|10011367|FG001|NOT COMPLETED|Overall Study||0
8948871|NCT02433496|10011368|FG002|NOT COMPLETED|Overall Study||0
8948872|NCT02433613|10011375|FG000|STARTED|Overall Study||1071
8948873|NCT02433613|10011375|FG000|COMPLETED|Overall Study||1054
8948874|NCT02433613|10011375|FG000|NOT COMPLETED|Overall Study||17
8948875|NCT02433665|10011381|FG000|STARTED|Overall Study||77
8948876|NCT02433665|10011382|FG001|STARTED|Overall Study||79
8948877|NCT02433665|10011381|FG000|COMPLETED|Overall Study||77
8948878|NCT02433665|10011382|FG001|COMPLETED|Overall Study||79
8948879|NCT02433665|10011381|FG000|NOT COMPLETED|Overall Study||0
8948880|NCT02433665|10011382|FG001|NOT COMPLETED|Overall Study||0
8948881|NCT02433678|10011390|FG000|STARTED|Overall Study||26
8948882|NCT02433678|10011391|FG001|STARTED|Overall Study||26
8948883|NCT02433678|10011390|FG000|COMPLETED|Overall Study||25
8948884|NCT02433678|10011391|FG001|COMPLETED|Overall Study||24
8948885|NCT02433678|10011390|FG000|NOT COMPLETED|Overall Study||1
8948886|NCT02433678|10011391|FG001|NOT COMPLETED|Overall Study||2
8948887|NCT02433834|10011397|FG000|STARTED|Overall Study||248
8948888|NCT02433834|10011397|FG000|GP MDI 28.8 µg|Overall Study||112
8948889|NCT02433834|10011397|FG000|GP MDI 14.4 µg|Overall Study||230
8948890|NCT02433834|10011397|FG000|GP MDI 7.2 µg|Overall Study||228
8948891|NCT02433834|10011397|FG000|GP MDI 3.6 µg|Overall Study||118
8948892|NCT02433834|10011397|FG000|GP MDI 1.9 µg|Overall Study||107
8948893|NCT02433834|10011397|FG000|Placebo MDI|Overall Study||174
8948894|NCT02433834|10011397|FG000|SAL 50 µg|Overall Study||167
8948895|NCT02433834|10011397|FG000|COMPLETED|Overall Study|Subject PT001101-040014 did not complete Period 4 but completed the study. CSR states 210 completed.|211
8948896|NCT02433834|10011397|FG000|NOT COMPLETED|Overall Study||37
8948897|NCT02433977|10011413|FG000|STARTED|Overall Study||6
8851036|NCT01747928|9905946|FG007|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
8923289|NCT02239263|9983824|FG000|COMPLETED|Overall Study||34
8948898|NCT02433977|10011413|FG000|COMPLETED|Overall Study||6
8948899|NCT02433977|10011413|FG000|NOT COMPLETED|Overall Study||0
8851037|NCT01747928|9905939|FG000|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
8851038|NCT01747928|9905940|FG001|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
8851039|NCT01747928|9905941|FG002|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
8851040|NCT01747928|9905942|FG003|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
8851041|NCT01747928|9905943|FG004|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
8851042|NCT01747928|9905944|FG005|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
8851043|NCT01747928|9905945|FG006|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
8851044|NCT01747928|9905946|FG007|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
8851045|NCT01747928|9905939|FG000|NOT COMPLETED|Overall Study||0
8851046|NCT01747928|9905940|FG001|NOT COMPLETED|Overall Study||0
8851047|NCT01747928|9905941|FG002|NOT COMPLETED|Overall Study||0
8851048|NCT01747928|9905942|FG003|NOT COMPLETED|Overall Study||0
8851049|NCT01747928|9905943|FG004|NOT COMPLETED|Overall Study||0
8851050|NCT01747928|9905944|FG005|NOT COMPLETED|Overall Study||0
8851051|NCT01747928|9905945|FG006|NOT COMPLETED|Overall Study||0
8851052|NCT01747928|9905946|FG007|NOT COMPLETED|Overall Study||0
8851053|NCT01748045|9905967|FG000|STARTED|Overall Study||2
8851054|NCT01748045|9905968|FG001|STARTED|Overall Study||1
8851055|NCT01748045|9905967|FG000|COMPLETED|Overall Study||2
8851056|NCT01748045|9905968|FG001|COMPLETED|Overall Study||1
8851057|NCT01748045|9905967|FG000|NOT COMPLETED|Overall Study||0
8851058|NCT01748045|9905968|FG001|NOT COMPLETED|Overall Study||0
8851059|NCT01748071|9905983|FG000|STARTED|Overall Study||40
8851060|NCT01748071|9905984|FG001|STARTED|Overall Study||40
8851061|NCT01748071|9905985|FG002|STARTED|Overall Study||40
8851062|NCT01748071|9905983|FG000|COMPLETED|Overall Study||38
8851063|NCT01748071|9905984|FG001|COMPLETED|Overall Study||38
8851064|NCT01748071|9905985|FG002|COMPLETED|Overall Study||40
8851065|NCT01748071|9905983|FG000|NOT COMPLETED|Overall Study||2
8851066|NCT01748071|9905984|FG001|NOT COMPLETED|Overall Study||2
8851067|NCT01748071|9905985|FG002|NOT COMPLETED|Overall Study||0
8851068|NCT01748227|9905993|FG000|STARTED|Overall Study||20
8851069|NCT01748227|9905993|FG000|COMPLETED|Overall Study||17
8851070|NCT01748227|9905993|FG000|NOT COMPLETED|Overall Study||3
8851071|NCT01748240|9905998|FG000|STARTED|Overall Study||21
8851072|NCT01748240|9905998|FG000|COMPLETED|Overall Study||21
8851073|NCT01748240|9905998|FG000|NOT COMPLETED|Overall Study||0
8851074|NCT01748292|9906004|FG000|STARTED|Overall Study||20
8851075|NCT01748292|9906005|FG001|STARTED|Overall Study||40
8851076|NCT01748292|9906004|FG000|COMPLETED|Overall Study||18
8851077|NCT01748292|9906005|FG001|COMPLETED|Overall Study||28
8851078|NCT01748292|9906004|FG000|NOT COMPLETED|Overall Study||2
8851079|NCT01748292|9906005|FG001|NOT COMPLETED|Overall Study||12
8851080|NCT01748552|9906023|FG000|STARTED|Intervention Period 1 and Washout||3
8851081|NCT01748552|9906024|FG001|STARTED|Intervention Period 1 and Washout||3
8851082|NCT01748552|9906025|FG002|STARTED|Intervention Period 1 and Washout||3
8851083|NCT01748552|9906026|FG003|STARTED|Intervention Period 1 and Washout||3
8851084|NCT01748552|9906027|FG004|STARTED|Intervention Period 1 and Washout||3
8851085|NCT01748552|9906028|FG005|STARTED|Intervention Period 1 and Washout||3
8851086|NCT01748552|9906029|FG006|STARTED|Intervention Period 1 and Washout||3
8851087|NCT01748552|9906030|FG007|STARTED|Intervention Period 1 and Washout||3
8851088|NCT01748552|9906031|FG008|STARTED|Intervention Period 1 and Washout||3
8851089|NCT01748552|9906032|FG009|STARTED|Intervention Period 1 and Washout||3
8851090|NCT01748552|9906033|FG010|STARTED|Intervention Period 1 and Washout||3
8851091|NCT01748552|9906034|FG011|STARTED|Intervention Period 1 and Washout||3
8851092|NCT01748552|9906023|FG000|COMPLETED|Intervention Period 1 and Washout||3
8851093|NCT01748552|9906024|FG001|COMPLETED|Intervention Period 1 and Washout||3
8851094|NCT01748552|9906025|FG002|COMPLETED|Intervention Period 1 and Washout||3
8851095|NCT01748552|9906026|FG003|COMPLETED|Intervention Period 1 and Washout||3
8851096|NCT01748552|9906027|FG004|COMPLETED|Intervention Period 1 and Washout||3
8851097|NCT01748552|9906028|FG005|COMPLETED|Intervention Period 1 and Washout||3
8851098|NCT01748552|9906029|FG006|COMPLETED|Intervention Period 1 and Washout||3
8851099|NCT01748552|9906030|FG007|COMPLETED|Intervention Period 1 and Washout||3
8851100|NCT01748552|9906031|FG008|COMPLETED|Intervention Period 1 and Washout||3
8851101|NCT01748552|9906032|FG009|COMPLETED|Intervention Period 1 and Washout||3
8851102|NCT01748552|9906033|FG010|COMPLETED|Intervention Period 1 and Washout||3
8851103|NCT01748552|9906034|FG011|COMPLETED|Intervention Period 1 and Washout||3
8851104|NCT01748552|9906023|FG000|NOT COMPLETED|Intervention Period 1 and Washout||0
8851105|NCT01748552|9906024|FG001|NOT COMPLETED|Intervention Period 1 and Washout||0
8851106|NCT01748552|9906025|FG002|NOT COMPLETED|Intervention Period 1 and Washout||0
8851107|NCT01748552|9906026|FG003|NOT COMPLETED|Intervention Period 1 and Washout||0
8851108|NCT01748552|9906027|FG004|NOT COMPLETED|Intervention Period 1 and Washout||0
8851109|NCT01748552|9906028|FG005|NOT COMPLETED|Intervention Period 1 and Washout||0
8851110|NCT01748552|9906029|FG006|NOT COMPLETED|Intervention Period 1 and Washout||0
8851111|NCT01748552|9906030|FG007|NOT COMPLETED|Intervention Period 1 and Washout||0
8851112|NCT01748552|9906031|FG008|NOT COMPLETED|Intervention Period 1 and Washout||0
8851113|NCT01748552|9906032|FG009|NOT COMPLETED|Intervention Period 1 and Washout||0
8851114|NCT01748552|9906033|FG010|NOT COMPLETED|Intervention Period 1 and Washout||0
8851115|NCT01748552|9906034|FG011|NOT COMPLETED|Intervention Period 1 and Washout||0
8851116|NCT01748552|9906023|FG000|STARTED|Intervention Period 2 and Washout||3
8851117|NCT01748552|9906024|FG001|STARTED|Intervention Period 2 and Washout||3
8851118|NCT01748552|9906025|FG002|STARTED|Intervention Period 2 and Washout||3
8851119|NCT01748552|9906026|FG003|STARTED|Intervention Period 2 and Washout||3
8851120|NCT01748552|9906027|FG004|STARTED|Intervention Period 2 and Washout||3
8851121|NCT01748552|9906028|FG005|STARTED|Intervention Period 2 and Washout||3
8851122|NCT01748552|9906029|FG006|STARTED|Intervention Period 2 and Washout||3
8851123|NCT01748552|9906030|FG007|STARTED|Intervention Period 2 and Washout||3
8851124|NCT01748552|9906031|FG008|STARTED|Intervention Period 2 and Washout||3
8851125|NCT01748552|9906032|FG009|STARTED|Intervention Period 2 and Washout||3
8851126|NCT01748552|9906033|FG010|STARTED|Intervention Period 2 and Washout||3
8851127|NCT01748552|9906034|FG011|STARTED|Intervention Period 2 and Washout||3
8851128|NCT01748552|9906023|FG000|COMPLETED|Intervention Period 2 and Washout||3
8851129|NCT01748552|9906024|FG001|COMPLETED|Intervention Period 2 and Washout||3
8851130|NCT01748552|9906025|FG002|COMPLETED|Intervention Period 2 and Washout||2
8851131|NCT01748552|9906026|FG003|COMPLETED|Intervention Period 2 and Washout||3
8851132|NCT01748552|9906027|FG004|COMPLETED|Intervention Period 2 and Washout||3
8851133|NCT01748552|9906028|FG005|COMPLETED|Intervention Period 2 and Washout||3
8851134|NCT01748552|9906029|FG006|COMPLETED|Intervention Period 2 and Washout||0
8851135|NCT01748552|9906030|FG007|COMPLETED|Intervention Period 2 and Washout||0
8851136|NCT01748552|9906031|FG008|COMPLETED|Intervention Period 2 and Washout||0
8851137|NCT01748552|9906032|FG009|COMPLETED|Intervention Period 2 and Washout||3
8851138|NCT01748552|9906033|FG010|COMPLETED|Intervention Period 2 and Washout||3
8851139|NCT01748552|9906034|FG011|COMPLETED|Intervention Period 2 and Washout||3
8851140|NCT01748552|9906023|FG000|NOT COMPLETED|Intervention Period 2 and Washout||0
8851141|NCT01748552|9906024|FG001|NOT COMPLETED|Intervention Period 2 and Washout||0
8851142|NCT01748552|9906025|FG002|NOT COMPLETED|Intervention Period 2 and Washout||1
8851143|NCT01748552|9906026|FG003|NOT COMPLETED|Intervention Period 2 and Washout||0
8851144|NCT01748552|9906027|FG004|NOT COMPLETED|Intervention Period 2 and Washout||0
8851145|NCT01748552|9906028|FG005|NOT COMPLETED|Intervention Period 2 and Washout||0
8851146|NCT01748552|9906029|FG006|NOT COMPLETED|Intervention Period 2 and Washout||3
8851147|NCT01748552|9906030|FG007|NOT COMPLETED|Intervention Period 2 and Washout||3
8851148|NCT01748552|9906031|FG008|NOT COMPLETED|Intervention Period 2 and Washout||3
8851149|NCT01748552|9906032|FG009|NOT COMPLETED|Intervention Period 2 and Washout||0
8851150|NCT01748552|9906033|FG010|NOT COMPLETED|Intervention Period 2 and Washout||0
8851151|NCT01748552|9906034|FG011|NOT COMPLETED|Intervention Period 2 and Washout||0
8851152|NCT01748552|9906023|FG000|STARTED|Intervention Period 3 and Washout||3
8851153|NCT01748552|9906024|FG001|STARTED|Intervention Period 3 and Washout||3
8851154|NCT01748552|9906025|FG002|STARTED|Intervention Period 3 and Washout||2
8851155|NCT01748552|9906026|FG003|STARTED|Intervention Period 3 and Washout||3
8851156|NCT01748552|9906027|FG004|STARTED|Intervention Period 3 and Washout||3
8851157|NCT01748552|9906028|FG005|STARTED|Intervention Period 3 and Washout||3
8851158|NCT01748552|9906029|FG006|STARTED|Intervention Period 3 and Washout||0
8851159|NCT01748552|9906030|FG007|STARTED|Intervention Period 3 and Washout||0
8851160|NCT01748552|9906031|FG008|STARTED|Intervention Period 3 and Washout||0
8851161|NCT01748552|9906032|FG009|STARTED|Intervention Period 3 and Washout||3
8851162|NCT01748552|9906033|FG010|STARTED|Intervention Period 3 and Washout||3
8851163|NCT01748552|9906034|FG011|STARTED|Intervention Period 3 and Washout||3
8851164|NCT01748552|9906023|FG000|COMPLETED|Intervention Period 3 and Washout||3
8923290|NCT02239263|9983824|FG000|NOT COMPLETED|Overall Study||6
8948900|NCT02434081|10011417|FG000|STARTED|Overall Study|Only patients enrolled after protocol amendments 1 (n=43) and 2 (n=36) were analysed (concurrent CRT+Nivo). Patients who received CRT and sequentially Nivo (enrolled under original protocol (n=12) or protocol amendment 1 (n=3)) were not included in the analysis population.|79
8948901|NCT02434081|10011417|FG000|COMPLETED|Overall Study||31
8948902|NCT02434081|10011417|FG000|NOT COMPLETED|Overall Study||48
8948903|NCT02434328|10011423|FG000|STARTED|Overall Study||372
8948904|NCT02434328|10011424|FG001|STARTED|Overall Study||371
8948905|NCT02434328|10011423|FG000|Randomized and Treated|Overall Study||370
8948906|NCT02434328|10011424|FG001|Randomized and Treated|Overall Study||369
8948907|NCT02434328|10011423|FG000|COMPLETED|Overall Study||342
8948908|NCT02434328|10011424|FG001|COMPLETED|Overall Study||329
8948909|NCT02434328|10011423|FG000|NOT COMPLETED|Overall Study||30
8948910|NCT02434328|10011424|FG001|NOT COMPLETED|Overall Study||42
8948911|NCT02434471|10011431|FG000|STARTED|Overall Study||34
8569470|NCT00097591|9601718|FG001|STARTED|Overall Study|4 subjects randomized but not analyzed due to an incomplete informed consent document|6795
8948912|NCT02434471|10011431|FG000|COMPLETED|Overall Study||25
8948913|NCT02434471|10011431|FG000|NOT COMPLETED|Overall Study||9
8948914|NCT02434497|10011436|FG000|STARTED|Overall Study||9
8948915|NCT02434497|10011436|FG000|COMPLETED|Overall Study||4
8569471|NCT00097591|9601717|FG000|COMPLETED|Overall Study||6403
8569472|NCT00097591|9601718|FG001|COMPLETED|Overall Study||6401
8569473|NCT00097591|9601717|FG000|NOT COMPLETED|Overall Study||410
8569474|NCT00097591|9601718|FG001|NOT COMPLETED|Overall Study||394
8569475|NCT00097669|9601726|FG000|STARTED|Overall Study||4089
8569476|NCT00097669|9601727|FG001|STARTED|Overall Study||4075
8569477|NCT00097669|9601726|FG000|COMPLETED|Overall Study||4089
8948916|NCT02434497|10011436|FG000|NOT COMPLETED|Overall Study||5
8948917|NCT02434523|10011444|FG000|STARTED|Overall Study||15
8851165|NCT01748552|9906024|FG001|COMPLETED|Intervention Period 3 and Washout||3
8851166|NCT01748552|9906025|FG002|COMPLETED|Intervention Period 3 and Washout||2
8851167|NCT01748552|9906026|FG003|COMPLETED|Intervention Period 3 and Washout||3
8851168|NCT01748552|9906027|FG004|COMPLETED|Intervention Period 3 and Washout||3
8851169|NCT01748552|9906028|FG005|COMPLETED|Intervention Period 3 and Washout||3
8851170|NCT01748552|9906029|FG006|COMPLETED|Intervention Period 3 and Washout||0
8851171|NCT01748552|9906030|FG007|COMPLETED|Intervention Period 3 and Washout||0
8851172|NCT01748552|9906031|FG008|COMPLETED|Intervention Period 3 and Washout||0
8851173|NCT01748552|9906032|FG009|COMPLETED|Intervention Period 3 and Washout||3
8851174|NCT01748552|9906033|FG010|COMPLETED|Intervention Period 3 and Washout||3
8851175|NCT01748552|9906034|FG011|COMPLETED|Intervention Period 3 and Washout||3
8851176|NCT01748552|9906023|FG000|NOT COMPLETED|Intervention Period 3 and Washout||0
8851177|NCT01748552|9906024|FG001|NOT COMPLETED|Intervention Period 3 and Washout||0
8851178|NCT01748552|9906025|FG002|NOT COMPLETED|Intervention Period 3 and Washout||0
8851179|NCT01748552|9906026|FG003|NOT COMPLETED|Intervention Period 3 and Washout||0
8851180|NCT01748552|9906027|FG004|NOT COMPLETED|Intervention Period 3 and Washout||0
8851181|NCT01748552|9906028|FG005|NOT COMPLETED|Intervention Period 3 and Washout||0
8851182|NCT01748552|9906029|FG006|NOT COMPLETED|Intervention Period 3 and Washout||0
8851183|NCT01748552|9906030|FG007|NOT COMPLETED|Intervention Period 3 and Washout||0
8851184|NCT01748552|9906031|FG008|NOT COMPLETED|Intervention Period 3 and Washout||0
8851185|NCT01748552|9906032|FG009|NOT COMPLETED|Intervention Period 3 and Washout||0
8851186|NCT01748552|9906033|FG010|NOT COMPLETED|Intervention Period 3 and Washout||0
8851187|NCT01748552|9906034|FG011|NOT COMPLETED|Intervention Period 3 and Washout||0
8851188|NCT01748643|9906076|FG000|STARTED|Overall Study||30
8851189|NCT01748643|9906077|FG001|STARTED|Overall Study||30
8851190|NCT01748643|9906076|FG000|COMPLETED|Overall Study||30
8851191|NCT01748643|9906077|FG001|COMPLETED|Overall Study||30
8851192|NCT01748643|9906076|FG000|NOT COMPLETED|Overall Study||0
8851193|NCT01748643|9906077|FG001|NOT COMPLETED|Overall Study||0
8851194|NCT01748695|9906083|FG000|STARTED|First Intervention (4 Weeks)||14
8851195|NCT01748695|9906084|FG001|STARTED|First Intervention (4 Weeks)||11
8851196|NCT01748695|9906083|FG000|COMPLETED|First Intervention (4 Weeks)||14
8851197|NCT01748695|9906084|FG001|COMPLETED|First Intervention (4 Weeks)||11
8851198|NCT01748695|9906083|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0
8851199|NCT01748695|9906084|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0
8851200|NCT01748695|9906083|FG000|STARTED|Second Intervention (4 Weeks)||14
8851201|NCT01748695|9906084|FG001|STARTED|Second Intervention (4 Weeks)||11
8851202|NCT01748695|9906083|FG000|COMPLETED|Second Intervention (4 Weeks)||14
8851203|NCT01748695|9906084|FG001|COMPLETED|Second Intervention (4 Weeks)||11
8851204|NCT01748695|9906083|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0
8851205|NCT01748695|9906084|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||0
8851206|NCT01748760|9906092|FG000|STARTED|Overall Study||25
8851207|NCT01748760|9906093|FG001|STARTED|Overall Study||25
8851208|NCT01748760|9906092|FG000|COMPLETED|Overall Study||19
8851209|NCT01748760|9906093|FG001|COMPLETED|Overall Study||23
8851210|NCT01748760|9906092|FG000|NOT COMPLETED|Overall Study||6
8851211|NCT01748760|9906093|FG001|NOT COMPLETED|Overall Study||2
8851212|NCT01748799|9906107|FG000|STARTED|Overall Study||6
8851213|NCT01748799|9906108|FG001|STARTED|Overall Study||1
8851214|NCT01748799|9906109|FG002|STARTED|Overall Study||1
8851215|NCT01748799|9906110|FG003|STARTED|Overall Study||2
8851216|NCT01748799|9906111|FG004|STARTED|Overall Study||1
8851217|NCT01748799|9906112|FG005|STARTED|Overall Study||2
8851218|NCT01748799|9906113|FG006|STARTED|Overall Study||2
8851219|NCT01748799|9906114|FG007|STARTED|Overall Study||1
8851220|NCT01748799|9906107|FG000|Completed SAU of Fixed Dose Placebo|Overall Study||2
8851221|NCT01748799|9906108|FG001|Completed SAU of Fixed Dose Placebo|Overall Study||1
8851222|NCT01748799|9906109|FG002|Completed SAU of Fixed Dose Placebo|Overall Study||1
8851223|NCT01748799|9906110|FG003|Completed SAU of Fixed Dose Placebo|Overall Study||2
8851224|NCT01748799|9906111|FG004|Completed SAU of Fixed Dose Placebo|Overall Study||1
8851225|NCT01748799|9906112|FG005|Completed SAU of Fixed Dose Placebo|Overall Study||1
8851226|NCT01748799|9906113|FG006|Completed SAU of Fixed Dose Placebo|Overall Study||1
8851227|NCT01748799|9906114|FG007|Completed SAU of Fixed Dose Placebo|Overall Study||1
8851228|NCT01748799|9906107|FG000|Completed Fixed Dose Placebo|Overall Study||2
8851229|NCT01748799|9906108|FG001|Completed Fixed Dose Placebo|Overall Study||1
8851230|NCT01748799|9906109|FG002|Completed Fixed Dose Placebo|Overall Study||1
8851231|NCT01748799|9906110|FG003|Completed Fixed Dose Placebo|Overall Study||2
8851232|NCT01748799|9906111|FG004|Completed Fixed Dose Placebo|Overall Study||1
8851233|NCT01748799|9906112|FG005|Completed Fixed Dose Placebo|Overall Study||1
8851234|NCT01748799|9906113|FG006|Completed Fixed Dose Placebo|Overall Study||1
8851235|NCT01748799|9906114|FG007|Completed Fixed Dose Placebo|Overall Study||1
8851236|NCT01748799|9906107|FG000|Completed SAU of Fixed Dose Sativex|Overall Study||1
8851237|NCT01748799|9906108|FG001|Completed SAU of Fixed Dose Sativex|Overall Study||1
8851238|NCT01748799|9906109|FG002|Completed SAU of Fixed Dose Sativex|Overall Study||1
8569478|NCT00097669|9601727|FG001|COMPLETED|Overall Study||4075
8851239|NCT01748799|9906110|FG003|Completed SAU of Fixed Dose Sativex|Overall Study||2
8851240|NCT01748799|9906111|FG004|Completed SAU of Fixed Dose Sativex|Overall Study||1
8851241|NCT01748799|9906112|FG005|Completed SAU of Fixed Dose Sativex|Overall Study||1
8851242|NCT01748799|9906113|FG006|Completed SAU of Fixed Dose Sativex|Overall Study||1
8851243|NCT01748799|9906114|FG007|Completed SAU of Fixed Dose Sativex|Overall Study||1
8851244|NCT01748799|9906107|FG000|Completed Fixed Dose Sativex|Overall Study||1
8851245|NCT01748799|9906108|FG001|Completed Fixed Dose Sativex|Overall Study||1
8851246|NCT01748799|9906109|FG002|Completed Fixed Dose Sativex|Overall Study||1
8851247|NCT01748799|9906110|FG003|Completed Fixed Dose Sativex|Overall Study||2
8851248|NCT01748799|9906111|FG004|Completed Fixed Dose Sativex|Overall Study||1
8851249|NCT01748799|9906112|FG005|Completed Fixed Dose Sativex|Overall Study||1
8851250|NCT01748799|9906113|FG006|Completed Fixed Dose Sativex|Overall Study||1
8851251|NCT01748799|9906114|FG007|Completed Fixed Dose Sativex|Overall Study||1
8851252|NCT01748799|9906107|FG000|Completed SAU of Self-titrated Placebo|Overall Study||5
8851253|NCT01748799|9906108|FG001|Completed SAU of Self-titrated Placebo|Overall Study||1
8851254|NCT01748799|9906109|FG002|Completed SAU of Self-titrated Placebo|Overall Study||1
8851255|NCT01748799|9906110|FG003|Completed SAU of Self-titrated Placebo|Overall Study||2
8851256|NCT01748799|9906111|FG004|Completed SAU of Self-titrated Placebo|Overall Study||1
8851257|NCT01748799|9906112|FG005|Completed SAU of Self-titrated Placebo|Overall Study||2
8851258|NCT01748799|9906113|FG006|Completed SAU of Self-titrated Placebo|Overall Study||1
8851259|NCT01748799|9906114|FG007|Completed SAU of Self-titrated Placebo|Overall Study||1
8851260|NCT01748799|9906107|FG000|Completed Self-titrated Placebo|Overall Study||4
8851261|NCT01748799|9906108|FG001|Completed Self-titrated Placebo|Overall Study||1
8851262|NCT01748799|9906109|FG002|Completed Self-titrated Placebo|Overall Study||1
8851263|NCT01748799|9906110|FG003|Completed Self-titrated Placebo|Overall Study||2
8851264|NCT01748799|9906111|FG004|Completed Self-titrated Placebo|Overall Study||1
8851265|NCT01748799|9906112|FG005|Completed Self-titrated Placebo|Overall Study||2
8851266|NCT01748799|9906113|FG006|Completed Self-titrated Placebo|Overall Study||1
8851267|NCT01748799|9906114|FG007|Completed Self-titrated Placebo|Overall Study||1
8851268|NCT01748799|9906107|FG000|Completed SAU of Self-titrated Sativex|Overall Study||2
8851269|NCT01748799|9906108|FG001|Completed SAU of Self-titrated Sativex|Overall Study||1
8851270|NCT01748799|9906109|FG002|Completed SAU of Self-titrated Sativex|Overall Study||1
8851271|NCT01748799|9906110|FG003|Completed SAU of Self-titrated Sativex|Overall Study||2
8851272|NCT01748799|9906111|FG004|Completed SAU of Self-titrated Sativex|Overall Study||1
8851273|NCT01748799|9906112|FG005|Completed SAU of Self-titrated Sativex|Overall Study||2
8851274|NCT01748799|9906113|FG006|Completed SAU of Self-titrated Sativex|Overall Study||1
8851275|NCT01748799|9906114|FG007|Completed SAU of Self-titrated Sativex|Overall Study||1
8851276|NCT01748799|9906107|FG000|Completed Self-titrated Sativex|Overall Study||1
8851277|NCT01748799|9906108|FG001|Completed Self-titrated Sativex|Overall Study||1
8851278|NCT01748799|9906109|FG002|Completed Self-titrated Sativex|Overall Study||1
8851279|NCT01748799|9906110|FG003|Completed Self-titrated Sativex|Overall Study||2
8851280|NCT01748799|9906111|FG004|Completed Self-titrated Sativex|Overall Study||1
8851281|NCT01748799|9906112|FG005|Completed Self-titrated Sativex|Overall Study||1
8851282|NCT01748799|9906113|FG006|Completed Self-titrated Sativex|Overall Study||1
8851283|NCT01748799|9906114|FG007|Completed Self-titrated Sativex|Overall Study||1
8851284|NCT01748799|9906107|FG000|COMPLETED|Overall Study||1
8851285|NCT01748799|9906108|FG001|COMPLETED|Overall Study||1
8851286|NCT01748799|9906109|FG002|COMPLETED|Overall Study||1
8851287|NCT01748799|9906110|FG003|COMPLETED|Overall Study||2
8851288|NCT01748799|9906111|FG004|COMPLETED|Overall Study||1
8851289|NCT01748799|9906112|FG005|COMPLETED|Overall Study||1
8851290|NCT01748799|9906113|FG006|COMPLETED|Overall Study||1
8851291|NCT01748799|9906114|FG007|COMPLETED|Overall Study||1
8851292|NCT01748799|9906107|FG000|NOT COMPLETED|Overall Study||5
8851293|NCT01748799|9906108|FG001|NOT COMPLETED|Overall Study||0
8851294|NCT01748799|9906109|FG002|NOT COMPLETED|Overall Study||0
8851295|NCT01748799|9906110|FG003|NOT COMPLETED|Overall Study||0
8851296|NCT01748799|9906111|FG004|NOT COMPLETED|Overall Study||0
8851297|NCT01748799|9906112|FG005|NOT COMPLETED|Overall Study||1
8851298|NCT01748799|9906113|FG006|NOT COMPLETED|Overall Study||1
8851299|NCT01748799|9906114|FG007|NOT COMPLETED|Overall Study||0
8851300|NCT01748825|9906150|FG000|STARTED|Dose Escalation||6
8851301|NCT01748825|9906151|FG001|STARTED|Dose Escalation||4
8851302|NCT01748825|9906152|FG002|STARTED|Dose Escalation||6
8851303|NCT01748825|9906153|FG003|STARTED|Dose Escalation||3
8851304|NCT01748825|9906154|FG004|STARTED|Dose Escalation||3
8851305|NCT01748825|9906155|FG005|STARTED|Dose Escalation||6
8851306|NCT01748825|9906156|FG006|STARTED|Dose Escalation||3
8851307|NCT01748825|9906157|FG007|STARTED|Dose Escalation||3
8851308|NCT01748825|9906158|FG008|STARTED|Dose Escalation||0
8851309|NCT01748825|9906159|FG009|STARTED|Dose Escalation||0
8851310|NCT01748825|9906150|FG000|COMPLETED|Dose Escalation||4
8851311|NCT01748825|9906151|FG001|COMPLETED|Dose Escalation||2
8851312|NCT01748825|9906152|FG002|COMPLETED|Dose Escalation||6
8851313|NCT01748825|9906153|FG003|COMPLETED|Dose Escalation||2
8851314|NCT01748825|9906154|FG004|COMPLETED|Dose Escalation||2
8851315|NCT01748825|9906155|FG005|COMPLETED|Dose Escalation||4
8851316|NCT01748825|9906156|FG006|COMPLETED|Dose Escalation||2
8851317|NCT01748825|9906157|FG007|COMPLETED|Dose Escalation||3
8851318|NCT01748825|9906158|FG008|COMPLETED|Dose Escalation||0
8851319|NCT01748825|9906159|FG009|COMPLETED|Dose Escalation||0
8851320|NCT01748825|9906150|FG000|NOT COMPLETED|Dose Escalation||2
8851321|NCT01748825|9906151|FG001|NOT COMPLETED|Dose Escalation||2
8851322|NCT01748825|9906152|FG002|NOT COMPLETED|Dose Escalation||0
8851323|NCT01748825|9906153|FG003|NOT COMPLETED|Dose Escalation||1
8851324|NCT01748825|9906154|FG004|NOT COMPLETED|Dose Escalation||1
8948918|NCT02434523|10011445|FG001|STARTED|Overall Study||15
8851325|NCT01748825|9906155|FG005|NOT COMPLETED|Dose Escalation||2
8851326|NCT01748825|9906156|FG006|NOT COMPLETED|Dose Escalation||1
8851327|NCT01748825|9906157|FG007|NOT COMPLETED|Dose Escalation||0
8851328|NCT01748825|9906158|FG008|NOT COMPLETED|Dose Escalation||0
8851329|NCT01748825|9906159|FG009|NOT COMPLETED|Dose Escalation||0
8851330|NCT01748825|9906150|FG000|STARTED|Dose Expansion||0
8851331|NCT01748825|9906151|FG001|STARTED|Dose Expansion||0
8851332|NCT01748825|9906152|FG002|STARTED|Dose Expansion||0
8851333|NCT01748825|9906153|FG003|STARTED|Dose Expansion||0
8851334|NCT01748825|9906154|FG004|STARTED|Dose Expansion||0
8851335|NCT01748825|9906155|FG005|STARTED|Dose Expansion||0
8851336|NCT01748825|9906156|FG006|STARTED|Dose Expansion||0
8851337|NCT01748825|9906157|FG007|STARTED|Dose Expansion||0
8851338|NCT01748825|9906158|FG008|STARTED|Dose Expansion||13
8851339|NCT01748825|9906159|FG009|STARTED|Dose Expansion||20
8851340|NCT01748825|9906150|FG000|COMPLETED|Dose Expansion||0
8851341|NCT01748825|9906151|FG001|COMPLETED|Dose Expansion||0
8851342|NCT01748825|9906152|FG002|COMPLETED|Dose Expansion||0
8851343|NCT01748825|9906153|FG003|COMPLETED|Dose Expansion||0
8851344|NCT01748825|9906154|FG004|COMPLETED|Dose Expansion||0
8851345|NCT01748825|9906155|FG005|COMPLETED|Dose Expansion||0
8851346|NCT01748825|9906156|FG006|COMPLETED|Dose Expansion||0
8851347|NCT01748825|9906157|FG007|COMPLETED|Dose Expansion||0
8851348|NCT01748825|9906158|FG008|COMPLETED|Dose Expansion||11
8851349|NCT01748825|9906159|FG009|COMPLETED|Dose Expansion||15
8851350|NCT01748825|9906150|FG000|NOT COMPLETED|Dose Expansion||0
8851351|NCT01748825|9906151|FG001|NOT COMPLETED|Dose Expansion||0
8851352|NCT01748825|9906152|FG002|NOT COMPLETED|Dose Expansion||0
8851353|NCT01748825|9906153|FG003|NOT COMPLETED|Dose Expansion||0
8851354|NCT01748825|9906154|FG004|NOT COMPLETED|Dose Expansion||0
8851355|NCT01748825|9906155|FG005|NOT COMPLETED|Dose Expansion||0
8851356|NCT01748825|9906156|FG006|NOT COMPLETED|Dose Expansion||0
8851357|NCT01748825|9906157|FG007|NOT COMPLETED|Dose Expansion||0
8851358|NCT01748825|9906158|FG008|NOT COMPLETED|Dose Expansion||2
8851359|NCT01748825|9906159|FG009|NOT COMPLETED|Dose Expansion||5
8851360|NCT01748916|9906188|FG000|STARTED|Overall Study||2
8851361|NCT01748916|9906189|FG001|STARTED|Overall Study||3
8851362|NCT01748916|9906190|FG002|STARTED|Overall Study||2
8851363|NCT01748916|9906191|FG003|STARTED|Overall Study||3
8851364|NCT01748916|9906192|FG004|STARTED|Overall Study||3
8851365|NCT01748916|9906193|FG005|STARTED|Overall Study||3
8851366|NCT01748916|9906188|FG000|COMPLETED|Overall Study||2
8851367|NCT01748916|9906189|FG001|COMPLETED|Overall Study||3
8851368|NCT01748916|9906190|FG002|COMPLETED|Overall Study||2
8851369|NCT01748916|9906191|FG003|COMPLETED|Overall Study||3
8851370|NCT01748916|9906192|FG004|COMPLETED|Overall Study||3
8851371|NCT01748916|9906193|FG005|COMPLETED|Overall Study||3
8851372|NCT01748916|9906188|FG000|NOT COMPLETED|Overall Study||0
8851373|NCT01748916|9906189|FG001|NOT COMPLETED|Overall Study||0
8851374|NCT01748916|9906190|FG002|NOT COMPLETED|Overall Study||0
8851375|NCT01748916|9906191|FG003|NOT COMPLETED|Overall Study||0
8851376|NCT01748916|9906192|FG004|NOT COMPLETED|Overall Study||0
8851377|NCT01748916|9906193|FG005|NOT COMPLETED|Overall Study||0
8851378|NCT01748942|9906203|FG000|STARTED|Overall Study||39
8851379|NCT01748942|9906204|FG001|STARTED|Overall Study||37
8851380|NCT01748942|9906203|FG000|COMPLETED|Overall Study||35
8851381|NCT01748942|9906204|FG001|COMPLETED|Overall Study||33
8851382|NCT01748942|9906203|FG000|NOT COMPLETED|Overall Study||4
8851383|NCT01748942|9906204|FG001|NOT COMPLETED|Overall Study||4
8851384|NCT01748955|9906212|FG000|STARTED|Overall Study||6
8851385|NCT01748955|9906213|FG001|STARTED|Overall Study||9
8851386|NCT01748955|9906212|FG000|COMPLETED|Overall Study||3
8851387|NCT01748955|9906213|FG001|COMPLETED|Overall Study||4
8851388|NCT01748955|9906212|FG000|NOT COMPLETED|Overall Study||3
8851389|NCT01748955|9906213|FG001|NOT COMPLETED|Overall Study||5
8851390|NCT01748994|9906221|FG000|STARTED|Overall Study||31
8851391|NCT01748994|9906222|FG001|STARTED|Overall Study||32
8851392|NCT01748994|9906221|FG000|COMPLETED|Overall Study||23
8851393|NCT01748994|9906222|FG001|COMPLETED|Overall Study||26
8851394|NCT01748994|9906221|FG000|NOT COMPLETED|Overall Study||8
8851395|NCT01748994|9906222|FG001|NOT COMPLETED|Overall Study||6
8851396|NCT01749033|9906231|FG000|STARTED|Overall Study||150
8851397|NCT01749033|9906232|FG001|STARTED|Overall Study||150
8851398|NCT01749033|9906233|FG002|STARTED|Overall Study||150
8851399|NCT01749033|9906231|FG000|COMPLETED|Overall Study||147
8851400|NCT01749033|9906232|FG001|COMPLETED|Overall Study||145
8851401|NCT01749033|9906233|FG002|COMPLETED|Overall Study||149
8851402|NCT01749033|9906231|FG000|NOT COMPLETED|Overall Study||3
8851403|NCT01749033|9906232|FG001|NOT COMPLETED|Overall Study||5
8851404|NCT01749033|9906233|FG002|NOT COMPLETED|Overall Study||1
8851405|NCT01749215|9906244|FG000|STARTED|Overall Study||72
8851406|NCT01749215|9906245|FG001|STARTED|Overall Study||79
8851407|NCT01749215|9906244|FG000|COMPLETED|Overall Study||47
8851408|NCT01749215|9906245|FG001|COMPLETED|Overall Study||53
8851409|NCT01749215|9906244|FG000|NOT COMPLETED|Overall Study||25
8851410|NCT01749215|9906245|FG001|NOT COMPLETED|Overall Study||26
8851411|NCT01749293|9906251|FG000|STARTED|Overall Study||3
8851412|NCT01749293|9906251|FG000|COMPLETED|Overall Study||3
8851413|NCT01749293|9906251|FG000|NOT COMPLETED|Overall Study||0
8851414|NCT01749410|9906256|FG000|STARTED|Overall Study||33
8851415|NCT01749410|9906256|FG000|COMPLETED|Overall Study||33
8851416|NCT01749410|9906256|FG000|NOT COMPLETED|Overall Study||0
8851417|NCT01749501|9906262|FG000|STARTED|Overall Study||22
8851418|NCT01749501|9906263|FG001|STARTED|Overall Study||23
8851419|NCT01749501|9906262|FG000|COMPLETED|Overall Study||22
8851420|NCT01749501|9906263|FG001|COMPLETED|Overall Study||23
8851421|NCT01749501|9906262|FG000|NOT COMPLETED|Overall Study||0
8851422|NCT01749501|9906263|FG001|NOT COMPLETED|Overall Study||0
8851423|NCT01749605|9906271|FG000|STARTED|Overall Study||18
8851424|NCT01749605|9906272|FG001|STARTED|Overall Study||17
8851425|NCT01749605|9906271|FG000|COMPLETED|Overall Study||14
8851426|NCT01749605|9906272|FG001|COMPLETED|Overall Study||14
8851427|NCT01749605|9906271|FG000|NOT COMPLETED|Overall Study||4
8851428|NCT01749605|9906272|FG001|NOT COMPLETED|Overall Study||3
8851429|NCT01749631|9906278|FG000|STARTED|Overall Study||97
8851430|NCT01749631|9906278|FG000|COMPLETED|Overall Study||97
8851431|NCT01749631|9906278|FG000|NOT COMPLETED|Overall Study||0
8851432|NCT01749735|9906284|FG000|STARTED|Overall Study||2
8851433|NCT01749735|9906285|FG001|STARTED|Overall Study||0
8851434|NCT01749735|9906284|FG000|COMPLETED|Overall Study||1
8851435|NCT01749735|9906285|FG001|COMPLETED|Overall Study||0
8851436|NCT01749735|9906284|FG000|NOT COMPLETED|Overall Study||1
8851437|NCT01749735|9906285|FG001|NOT COMPLETED|Overall Study||0
8851438|NCT01749800|9906294|FG000|STARTED|Overall Study|3 subjects did not show significant attention span deficit (required inclusion criterion)|6
8851439|NCT01749800|9906295|FG001|STARTED|Overall Study|1 subject showed significant motor impairments but decided to undergo therapy (exclusion criterion)|1
8851440|NCT01749800|9906296|FG002|STARTED|Overall Study||0
8851441|NCT01749800|9906294|FG000|COMPLETED|Overall Study||3
8851442|NCT01749800|9906295|FG001|COMPLETED|Overall Study||0
8851443|NCT01749800|9906296|FG002|COMPLETED|Overall Study||0
8851444|NCT01749800|9906294|FG000|NOT COMPLETED|Overall Study||3
8851445|NCT01749800|9906295|FG001|NOT COMPLETED|Overall Study||1
8851446|NCT01749800|9906296|FG002|NOT COMPLETED|Overall Study||0
8851447|NCT01749904|9906306|FG000|STARTED|Overall Study|randomized population|286
8851448|NCT01749904|9906307|FG001|STARTED|Overall Study|randomized population|134
8851449|NCT01749904|9906306|FG000|COMPLETED|Overall Study|randomized population|264
8851450|NCT01749904|9906307|FG001|COMPLETED|Overall Study|randomized population|123
8851451|NCT01749904|9906306|FG000|NOT COMPLETED|Overall Study||22
8851452|NCT01749904|9906307|FG001|NOT COMPLETED|Overall Study||11
8851453|NCT01749930|9906319|FG000|STARTED|Overall Study|randomized population|283
8851454|NCT01749930|9906320|FG001|STARTED|Overall Study|randomized population|137
8851455|NCT01749930|9906319|FG000|COMPLETED|Overall Study|randomized population|253
8851456|NCT01749930|9906320|FG001|COMPLETED|Overall Study|randomized population|125
8851457|NCT01749930|9906319|FG000|NOT COMPLETED|Overall Study||30
8851458|NCT01749930|9906320|FG001|NOT COMPLETED|Overall Study||12
8851459|NCT01749956|9906330|FG000|STARTED|Overall Study||39
8851460|NCT01749956|9906330|FG000|COMPLETED|Overall Study||24
8851461|NCT01749956|9906330|FG000|NOT COMPLETED|Overall Study||15
8851462|NCT01749982|9906339|FG000|STARTED|Overall Study||15
8851463|NCT01749982|9906340|FG001|STARTED|Overall Study||15
8851464|NCT01749982|9906341|FG002|STARTED|Overall Study||15
8851465|NCT01749982|9906342|FG003|STARTED|Overall Study||15
8851466|NCT01749982|9906339|FG000|COMPLETED|Overall Study||15
8851467|NCT01749982|9906340|FG001|COMPLETED|Overall Study||15
8851468|NCT01749982|9906341|FG002|COMPLETED|Overall Study||15
8851469|NCT01749982|9906342|FG003|COMPLETED|Overall Study||12
8851470|NCT01749982|9906339|FG000|NOT COMPLETED|Overall Study||0
8851471|NCT01749982|9906340|FG001|NOT COMPLETED|Overall Study||0
8851472|NCT01749982|9906341|FG002|NOT COMPLETED|Overall Study||0
8851473|NCT01749982|9906342|FG003|NOT COMPLETED|Overall Study||3
8851474|NCT01749995|9906352|FG000|STARTED|Overall Study||200
8851475|NCT01749995|9906352|FG000|COMPLETED|Overall Study||196
8851476|NCT01749995|9906352|FG000|NOT COMPLETED|Overall Study||4
8851477|NCT01750086|9906358|FG000|STARTED|Overall Study||13
8851478|NCT01750086|9906359|FG001|STARTED|Overall Study||14
8851479|NCT01750086|9906358|FG000|COMPLETED|Overall Study||12
8851480|NCT01750086|9906359|FG001|COMPLETED|Overall Study||13
8851481|NCT01750086|9906358|FG000|NOT COMPLETED|Overall Study||1
8851482|NCT01750086|9906359|FG001|NOT COMPLETED|Overall Study||1
8851483|NCT01750190|9906367|FG000|STARTED|Overall Study||616
8851484|NCT01750190|9906368|FG001|STARTED|Overall Study||306
8851485|NCT01750190|9906367|FG000|Safety Population|Overall Study||611
8851486|NCT01750190|9906368|FG001|Safety Population|Overall Study||305
8851487|NCT01750190|9906367|FG000|Full Analysis Set (FAS)|Overall Study||608
8851488|NCT01750190|9906368|FG001|Full Analysis Set (FAS)|Overall Study||305
8851489|NCT01750190|9906367|FG000|COMPLETED|Overall Study||349
8851490|NCT01750190|9906368|FG001|COMPLETED|Overall Study||98
8851491|NCT01750190|9906367|FG000|NOT COMPLETED|Overall Study||267
8851492|NCT01750190|9906368|FG001|NOT COMPLETED|Overall Study||208
8851493|NCT01750229|9906374|FG000|STARTED|Randomized Crossover Phase||30
8851494|NCT01750229|9906374|FG000|Subject Received Sham|Randomized Crossover Phase||24
8851495|NCT01750229|9906374|FG000|Subjects Received 1200 Hz|Randomized Crossover Phase||24
8851496|NCT01750229|9906374|FG000|Subjects Received 3030 Hz|Randomized Crossover Phase||24
8851497|NCT01750229|9906374|FG000|Subjects Received 5882 Hz|Randomized Crossover Phase||24
8851498|NCT01750229|9906374|FG000|Protocol Violation|Randomized Crossover Phase||4
8851499|NCT01750229|9906374|FG000|COMPLETED|Randomized Crossover Phase||28
8851500|NCT01750229|9906374|FG000|NOT COMPLETED|Randomized Crossover Phase||2
8851501|NCT01750229|9906374|FG000|STARTED|Long-term Follow-up Phase|Four subjects who had protocol violations continued to be followed in long-term follow-up phase.|28
8851502|NCT01750229|9906374|FG000|COMPLETED|Long-term Follow-up Phase||25
8851503|NCT01750229|9906374|FG000|NOT COMPLETED|Long-term Follow-up Phase||3
8851504|NCT01750242|9906384|FG000|STARTED|Overall Study||23
8851505|NCT01750242|9906384|FG000|Readable Images|Overall Study|Subjects with readable images were analyzed and there were 3 subjects with unreadable images.|20
8851506|NCT01750242|9906384|FG000|COMPLETED|Overall Study||20
8851507|NCT01750242|9906384|FG000|NOT COMPLETED|Overall Study||3
8851508|NCT01750255|9906391|FG000|STARTED|Overall Study||49
8851509|NCT01750255|9906392|FG001|STARTED|Overall Study||43
8851510|NCT01750255|9906391|FG000|COMPLETED|Overall Study||43
8851511|NCT01750255|9906392|FG001|COMPLETED|Overall Study||38
8851512|NCT01750255|9906391|FG000|NOT COMPLETED|Overall Study||6
8851513|NCT01750255|9906392|FG001|NOT COMPLETED|Overall Study||5
8851514|NCT01750268|9906401|FG000|STARTED|Overall Study||15
8851515|NCT01750268|9906402|FG001|STARTED|Overall Study||17
8851516|NCT01750268|9906401|FG000|COMPLETED|Overall Study||13
8851517|NCT01750268|9906402|FG001|COMPLETED|Overall Study||12
8851518|NCT01750268|9906401|FG000|NOT COMPLETED|Overall Study||2
8851519|NCT01750268|9906402|FG001|NOT COMPLETED|Overall Study||5
8851520|NCT01750294|9906408|FG000|STARTED|Overall Study||14
8851521|NCT01750294|9906408|FG000|COMPLETED|Overall Study||12
8851522|NCT01750294|9906408|FG000|NOT COMPLETED|Overall Study||2
8851523|NCT01750346|9906415|FG000|STARTED|Overall Study||3
8851524|NCT01750346|9906416|FG001|STARTED|Overall Study||2
8851525|NCT01750346|9906417|FG002|STARTED|Overall Study||3
8851526|NCT01750346|9906415|FG000|COMPLETED|Overall Study||2
8851527|NCT01750346|9906416|FG001|COMPLETED|Overall Study||2
8851528|NCT01750346|9906417|FG002|COMPLETED|Overall Study||3
8851529|NCT01750346|9906415|FG000|NOT COMPLETED|Overall Study||1
8851530|NCT01750346|9906416|FG001|NOT COMPLETED|Overall Study||0
8851531|NCT01750346|9906417|FG002|NOT COMPLETED|Overall Study||0
8851532|NCT01750398|9906425|FG000|STARTED|ADT Lead In Phase||33
8851533|NCT01750398|9906425|FG000|COMPLETED|ADT Lead In Phase||29
8851534|NCT01750398|9906425|FG000|NOT COMPLETED|ADT Lead In Phase||4
8851535|NCT01750398|9906425|FG000|STARTED|Bipolar Androgen Thearpy Phase||29
8629689|NCT00531050|9669383|FG002|COMPLETED|Part 2: Period 3||4
8629690|NCT00531050|9669384|FG003|COMPLETED|Part 2: Period 3||4
8851536|NCT01750398|9906425|FG000|COMPLETED|Bipolar Androgen Thearpy Phase||26
8851537|NCT01750398|9906425|FG000|NOT COMPLETED|Bipolar Androgen Thearpy Phase||3
8851538|NCT01750502|9906431|FG000|STARTED|Overall Study||70
8851539|NCT01750502|9906432|FG001|STARTED|Overall Study||186
8851540|NCT01750502|9906431|FG000|COMPLETED|Overall Study||70
8851541|NCT01750502|9906432|FG001|COMPLETED|Overall Study||186
8851542|NCT01750502|9906431|FG000|NOT COMPLETED|Overall Study||0
8851543|NCT01750502|9906432|FG001|NOT COMPLETED|Overall Study||0
8851544|NCT01750684|9906445|FG000|STARTED|Overall Study||6
8851545|NCT01750684|9906446|FG001|STARTED|Overall Study||7
8851546|NCT01750684|9906445|FG000|COMPLETED|Overall Study||4
8851547|NCT01750684|9906446|FG001|COMPLETED|Overall Study||5
8851548|NCT01750684|9906445|FG000|NOT COMPLETED|Overall Study||2
8851549|NCT01750684|9906446|FG001|NOT COMPLETED|Overall Study||2
8851550|NCT01750697|9906453|FG000|STARTED|Overall Study||25
8851551|NCT01750697|9906453|FG000|Completed|Overall Study||25
8851552|NCT01750697|9906453|FG000|Follow-up Phase|Overall Study|Completed required follow-up|24
8851553|NCT01750697|9906453|FG000|COMPLETED|Overall Study|Completed to CCO. 6 participants entered Extended Safety Follow-up, 10 participants completed Study.|16
8851554|NCT01750697|9906453|FG000|NOT COMPLETED|Overall Study||9
8851555|NCT01750840|9906460|FG000|STARTED|Overall Study||8
8851556|NCT01750840|9906460|FG000|COMPLETED|Overall Study||4
8851557|NCT01750840|9906460|FG000|NOT COMPLETED|Overall Study||4
8851558|NCT01750879|9906467|FG000|STARTED|Overall Study||30
8851559|NCT01750879|9906468|FG001|STARTED|Overall Study||11
8851560|NCT01750879|9906467|FG000|DBPCFC2|Overall Study||20
8851561|NCT01750879|9906468|FG001|DBPCFC2|Overall Study||8
8851562|NCT01750879|9906467|FG000|DBPCFC3|Overall Study||20
8851563|NCT01750879|9906468|FG001|DBPCFC3|Overall Study||0
8851564|NCT01750879|9906467|FG000|COMPLETED|Overall Study||20
8851565|NCT01750879|9906468|FG001|COMPLETED|Overall Study||8
8851566|NCT01750879|9906467|FG000|NOT COMPLETED|Overall Study||10
8851567|NCT01750879|9906468|FG001|NOT COMPLETED|Overall Study||3
8851568|NCT01750918|9906495|FG000|STARTED|Overall Study||3
8851569|NCT01750918|9906496|FG001|STARTED|Overall Study||4
8851570|NCT01750918|9906497|FG002|STARTED|Overall Study||36
8851571|NCT01750918|9906498|FG003|STARTED|Overall Study||50
8851572|NCT01750918|9906499|FG004|STARTED|Overall Study||13
8851573|NCT01750918|9906500|FG005|STARTED|Overall Study||20
8851574|NCT01750918|9906501|FG006|STARTED|Overall Study||20
8851575|NCT01750918|9906502|FG007|STARTED|Overall Study||20
8851576|NCT01750918|9906495|FG000|Pharmacokinetic Population|Overall Study||3
8629691|NCT00531050|9669385|FG004|COMPLETED|Part 2: Period 3||4
8851577|NCT01750918|9906496|FG001|Pharmacokinetic Population|Overall Study||4
8851578|NCT01750918|9906497|FG002|Pharmacokinetic Population|Overall Study||35
8851579|NCT01750918|9906498|FG003|Pharmacokinetic Population|Overall Study||48
8851580|NCT01750918|9906499|FG004|Pharmacokinetic Population|Overall Study||12
8851581|NCT01750918|9906500|FG005|Pharmacokinetic Population|Overall Study||19
8851582|NCT01750918|9906501|FG006|Pharmacokinetic Population|Overall Study||18
8948919|NCT02434523|10011444|FG000|COMPLETED|Overall Study||10
8851583|NCT01750918|9906502|FG007|Pharmacokinetic Population|Overall Study||20
8629692|NCT00531050|9669386|FG005|COMPLETED|Part 2: Period 3||3
8851584|NCT01750918|9906495|FG000|Biomarker Population|Overall Study||3
8851585|NCT01750918|9906496|FG001|Biomarker Population|Overall Study||4
8851586|NCT01750918|9906497|FG002|Biomarker Population|Overall Study||36
8948920|NCT02434523|10011445|FG001|COMPLETED|Overall Study||9
8851587|NCT01750918|9906498|FG003|Biomarker Population|Overall Study||50
8851588|NCT01750918|9906499|FG004|Biomarker Population|Overall Study||13
8851589|NCT01750918|9906500|FG005|Biomarker Population|Overall Study||17
8851590|NCT01750918|9906501|FG006|Biomarker Population|Overall Study||19
8851591|NCT01750918|9906502|FG007|Biomarker Population|Overall Study||20
8851592|NCT01750918|9906495|FG000|Crossover Population|Overall Study||0
8851593|NCT01750918|9906496|FG001|Crossover Population|Overall Study||0
8851594|NCT01750918|9906497|FG002|Crossover Population|Overall Study||0
8851595|NCT01750918|9906498|FG003|Crossover Population|Overall Study||0
8851596|NCT01750918|9906499|FG004|Crossover Population|Overall Study||4
8851597|NCT01750918|9906500|FG005|Crossover Population|Overall Study||2
8851598|NCT01750918|9906501|FG006|Crossover Population|Overall Study||5
8851599|NCT01750918|9906502|FG007|Crossover Population|Overall Study||5
8851600|NCT01750918|9906495|FG000|COMPLETED|Overall Study||3
8851601|NCT01750918|9906496|FG001|COMPLETED|Overall Study||4
8851602|NCT01750918|9906497|FG002|COMPLETED|Overall Study||28
8851603|NCT01750918|9906498|FG003|COMPLETED|Overall Study||44
8851604|NCT01750918|9906499|FG004|COMPLETED|Overall Study||12
8851605|NCT01750918|9906500|FG005|COMPLETED|Overall Study||17
8851606|NCT01750918|9906501|FG006|COMPLETED|Overall Study||17
8851607|NCT01750918|9906502|FG007|COMPLETED|Overall Study||16
8851608|NCT01750918|9906495|FG000|NOT COMPLETED|Overall Study||0
8851609|NCT01750918|9906496|FG001|NOT COMPLETED|Overall Study||0
8851610|NCT01750918|9906497|FG002|NOT COMPLETED|Overall Study||8
8851611|NCT01750918|9906498|FG003|NOT COMPLETED|Overall Study||6
8851612|NCT01750918|9906499|FG004|NOT COMPLETED|Overall Study||1
8851613|NCT01750918|9906500|FG005|NOT COMPLETED|Overall Study||3
8851614|NCT01750918|9906501|FG006|NOT COMPLETED|Overall Study||3
8851615|NCT01750918|9906502|FG007|NOT COMPLETED|Overall Study||4
8851616|NCT01750931|9906532|FG000|STARTED|Period 1||14
8851617|NCT01750931|9906533|FG001|STARTED|Period 1||14
8851618|NCT01750931|9906532|FG000|COMPLETED|Period 1||14
8851619|NCT01750931|9906533|FG001|COMPLETED|Period 1||14
8851620|NCT01750931|9906532|FG000|NOT COMPLETED|Period 1||0
8851621|NCT01750931|9906533|FG001|NOT COMPLETED|Period 1||0
8851622|NCT01750931|9906532|FG000|STARTED|Wash Out||14
8851623|NCT01750931|9906533|FG001|STARTED|Wash Out||14
8851624|NCT01750931|9906532|FG000|COMPLETED|Wash Out||14
8851625|NCT01750931|9906533|FG001|COMPLETED|Wash Out||14
8629693|NCT00531050|9669381|FG000|NOT COMPLETED|Part 2: Period 3||1
8629694|NCT00531050|9669382|FG001|NOT COMPLETED|Part 2: Period 3||0
8629695|NCT00531050|9669383|FG002|NOT COMPLETED|Part 2: Period 3||0
8629696|NCT00531050|9669384|FG003|NOT COMPLETED|Part 2: Period 3||0
8851626|NCT01750931|9906532|FG000|NOT COMPLETED|Wash Out||0
8851627|NCT01750931|9906533|FG001|NOT COMPLETED|Wash Out||0
8851628|NCT01750931|9906532|FG000|STARTED|Period 2||14
8851629|NCT01750931|9906533|FG001|STARTED|Period 2||14
8851630|NCT01750931|9906532|FG000|COMPLETED|Period 2||14
8851631|NCT01750931|9906533|FG001|COMPLETED|Period 2||14
8851632|NCT01750931|9906532|FG000|NOT COMPLETED|Period 2||0
8851633|NCT01750931|9906533|FG001|NOT COMPLETED|Period 2||0
8851634|NCT01751022|9906542|FG000|STARTED|Overall Study||499
8851635|NCT01751022|9906543|FG001|STARTED|Overall Study||326
8851636|NCT01751022|9906544|FG002|STARTED|Overall Study||300
8851637|NCT01751022|9906542|FG000|COMPLETED|Overall Study|6 month visit|443
8851638|NCT01751022|9906543|FG001|COMPLETED|Overall Study|6 month visit|282
8851639|NCT01751022|9906544|FG002|COMPLETED|Overall Study|6 month visit|273
8851640|NCT01751022|9906542|FG000|NOT COMPLETED|Overall Study||56
8851641|NCT01751022|9906543|FG001|NOT COMPLETED|Overall Study||44
8851642|NCT01751022|9906544|FG002|NOT COMPLETED|Overall Study||27
8851643|NCT01751061|9906573|FG000|STARTED|Overall Study||210
8851644|NCT01751061|9906574|FG001|STARTED|Overall Study||206
8851645|NCT01751061|9906573|FG000|COMPLETED|Overall Study||154
8851646|NCT01751061|9906574|FG001|COMPLETED|Overall Study||172
8851647|NCT01751061|9906573|FG000|NOT COMPLETED|Overall Study||56
8851648|NCT01751061|9906574|FG001|NOT COMPLETED|Overall Study||34
8851649|NCT01751087|9906583|FG000|STARTED|Overall Study||100
8851650|NCT01751087|9906584|FG001|STARTED|Overall Study||100
8851651|NCT01751087|9906585|FG002|STARTED|Overall Study||100
8851652|NCT01751087|9906583|FG000|COMPLETED|Overall Study||99
8851653|NCT01751087|9906584|FG001|COMPLETED|Overall Study||100
8851654|NCT01751087|9906585|FG002|COMPLETED|Overall Study||99
8851655|NCT01751087|9906583|FG000|NOT COMPLETED|Overall Study||1
8851656|NCT01751087|9906584|FG001|NOT COMPLETED|Overall Study||0
8851657|NCT01751087|9906585|FG002|NOT COMPLETED|Overall Study||1
8851658|NCT01751113|9906593|FG000|STARTED|Treatment Period 1 (4 Weeks)||8
8629697|NCT00531050|9669385|FG004|NOT COMPLETED|Part 2: Period 3||0
8851659|NCT01751113|9906594|FG001|STARTED|Treatment Period 1 (4 Weeks)||8
8851660|NCT01751113|9906595|FG002|STARTED|Treatment Period 1 (4 Weeks)||9
8851661|NCT01751113|9906596|FG003|STARTED|Treatment Period 1 (4 Weeks)||9
8851662|NCT01751113|9906597|FG004|STARTED|Treatment Period 1 (4 Weeks)||9
8851663|NCT01751113|9906598|FG005|STARTED|Treatment Period 1 (4 Weeks)||10
8851664|NCT01751113|9906593|FG000|COMPLETED|Treatment Period 1 (4 Weeks)||8
8851665|NCT01751113|9906594|FG001|COMPLETED|Treatment Period 1 (4 Weeks)||8
8851666|NCT01751113|9906595|FG002|COMPLETED|Treatment Period 1 (4 Weeks)||9
8851667|NCT01751113|9906596|FG003|COMPLETED|Treatment Period 1 (4 Weeks)||8
8851668|NCT01751113|9906597|FG004|COMPLETED|Treatment Period 1 (4 Weeks)||8
8851669|NCT01751113|9906598|FG005|COMPLETED|Treatment Period 1 (4 Weeks)||10
8851670|NCT01751113|9906593|FG000|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
8851671|NCT01751113|9906594|FG001|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
8851672|NCT01751113|9906595|FG002|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
8851673|NCT01751113|9906596|FG003|NOT COMPLETED|Treatment Period 1 (4 Weeks)||1
8851674|NCT01751113|9906597|FG004|NOT COMPLETED|Treatment Period 1 (4 Weeks)||1
8851675|NCT01751113|9906598|FG005|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
8851676|NCT01751113|9906593|FG000|STARTED|Washout Period 1 (2 Weeks)||8
8851677|NCT01751113|9906594|FG001|STARTED|Washout Period 1 (2 Weeks)||8
8851678|NCT01751113|9906595|FG002|STARTED|Washout Period 1 (2 Weeks)||9
8851679|NCT01751113|9906596|FG003|STARTED|Washout Period 1 (2 Weeks)||8
8948921|NCT02434523|10011444|FG000|NOT COMPLETED|Overall Study||5
8948922|NCT02434523|10011445|FG001|NOT COMPLETED|Overall Study||6
8948923|NCT02434770|10011456|FG000|STARTED|Week 1 to Week 18||250
8948924|NCT02434770|10011457|FG001|STARTED|Week 1 to Week 18||250
8948925|NCT02434770|10011458|FG002|STARTED|Week 1 to Week 18||250
8948926|NCT02434770|10011456|FG000|Received at Least One Vaccination|Week 1 to Week 18||249
8948927|NCT02434770|10011457|FG001|Received at Least One Vaccination|Week 1 to Week 18||250
8948928|NCT02434770|10011458|FG002|Received at Least One Vaccination|Week 1 to Week 18||250
8948929|NCT02434770|10011456|FG000|COMPLETED|Week 1 to Week 18||235
8948930|NCT02434770|10011457|FG001|COMPLETED|Week 1 to Week 18||228
8948931|NCT02434770|10011458|FG002|COMPLETED|Week 1 to Week 18||233
8948932|NCT02434770|10011456|FG000|NOT COMPLETED|Week 1 to Week 18||15
8948933|NCT02434770|10011457|FG001|NOT COMPLETED|Week 1 to Week 18||22
8948934|NCT02434770|10011458|FG002|NOT COMPLETED|Week 1 to Week 18||17
8948935|NCT02434770|10011456|FG000|STARTED|Week 18 to Week||235
8948936|NCT02434770|10011457|FG001|STARTED|Week 18 to Week||228
8948937|NCT02434770|10011458|FG002|STARTED|Week 18 to Week||233
8948938|NCT02434770|10011456|FG000|COMPLETED|Week 18 to Week||227
8948939|NCT02434770|10011457|FG001|COMPLETED|Week 18 to Week||220
8948940|NCT02434770|10011458|FG002|COMPLETED|Week 18 to Week||227
8948941|NCT02434770|10011456|FG000|NOT COMPLETED|Week 18 to Week||8
8948942|NCT02434770|10011457|FG001|NOT COMPLETED|Week 18 to Week||8
8948943|NCT02434770|10011458|FG002|NOT COMPLETED|Week 18 to Week||6
8948944|NCT02434939|10011470|FG000|STARTED|Overall Study||120
8948945|NCT02434939|10011471|FG001|STARTED|Overall Study||120
8948946|NCT02434939|10011470|FG000|COMPLETED|Overall Study||83
8948947|NCT02434939|10011471|FG001|COMPLETED|Overall Study||71
8948948|NCT02434939|10011470|FG000|NOT COMPLETED|Overall Study||37
8948949|NCT02434939|10011471|FG001|NOT COMPLETED|Overall Study||49
8948950|NCT02435069|10011478|FG000|STARTED|Preoperative Baseline Phase||5
8948951|NCT02435069|10011479|FG001|STARTED|Preoperative Baseline Phase||0
8948952|NCT02435069|10011480|FG002|STARTED|Preoperative Baseline Phase||0
8948953|NCT02435069|10011481|FG003|STARTED|Preoperative Baseline Phase||0
8948954|NCT02435069|10011482|FG004|STARTED|Preoperative Baseline Phase||0
8948955|NCT02435069|10011478|FG000|COMPLETED|Preoperative Baseline Phase||5
8948956|NCT02435069|10011479|FG001|COMPLETED|Preoperative Baseline Phase||0
8948957|NCT02435069|10011480|FG002|COMPLETED|Preoperative Baseline Phase||0
8948958|NCT02435069|10011481|FG003|COMPLETED|Preoperative Baseline Phase||0
8948959|NCT02435069|10011482|FG004|COMPLETED|Preoperative Baseline Phase||0
8948960|NCT02435069|10011478|FG000|NOT COMPLETED|Preoperative Baseline Phase||0
8948961|NCT02435069|10011479|FG001|NOT COMPLETED|Preoperative Baseline Phase||0
8948962|NCT02435069|10011480|FG002|NOT COMPLETED|Preoperative Baseline Phase||0
8948963|NCT02435069|10011481|FG003|NOT COMPLETED|Preoperative Baseline Phase||0
8948964|NCT02435069|10011482|FG004|NOT COMPLETED|Preoperative Baseline Phase||0
8948965|NCT02435069|10011478|FG000|STARTED|Dose Response - First Intervention||0
8948966|NCT02435069|10011479|FG001|STARTED|Dose Response - First Intervention||3
8948967|NCT02435069|10011480|FG002|STARTED|Dose Response - First Intervention||2
8948968|NCT02435069|10011481|FG003|STARTED|Dose Response - First Intervention||0
8948969|NCT02435069|10011482|FG004|STARTED|Dose Response - First Intervention||0
8948970|NCT02435069|10011478|FG000|COMPLETED|Dose Response - First Intervention||0
8948971|NCT02435069|10011479|FG001|COMPLETED|Dose Response - First Intervention||2
8948972|NCT02435069|10011480|FG002|COMPLETED|Dose Response - First Intervention||1
8948973|NCT02435069|10011481|FG003|COMPLETED|Dose Response - First Intervention||0
8948974|NCT02435069|10011482|FG004|COMPLETED|Dose Response - First Intervention||0
8948975|NCT02435069|10011478|FG000|NOT COMPLETED|Dose Response - First Intervention||0
8948976|NCT02435069|10011479|FG001|NOT COMPLETED|Dose Response - First Intervention||1
8948977|NCT02435069|10011480|FG002|NOT COMPLETED|Dose Response - First Intervention||1
8948978|NCT02435069|10011481|FG003|NOT COMPLETED|Dose Response - First Intervention||0
8948979|NCT02435069|10011482|FG004|NOT COMPLETED|Dose Response - First Intervention||0
8948980|NCT02435069|10011478|FG000|STARTED|Effectiveness - Second Intervention||0
8948981|NCT02435069|10011479|FG001|STARTED|Effectiveness - Second Intervention||0
8948982|NCT02435069|10011480|FG002|STARTED|Effectiveness - Second Intervention||0
8948983|NCT02435069|10011481|FG003|STARTED|Effectiveness - Second Intervention||1
8948984|NCT02435069|10011482|FG004|STARTED|Effectiveness - Second Intervention||1
8948985|NCT02435069|10011478|FG000|COMPLETED|Effectiveness - Second Intervention||0
8948986|NCT02435069|10011479|FG001|COMPLETED|Effectiveness - Second Intervention||0
8851680|NCT01751113|9906597|FG004|STARTED|Washout Period 1 (2 Weeks)||8
8851681|NCT01751113|9906598|FG005|STARTED|Washout Period 1 (2 Weeks)||10
8851682|NCT01751113|9906593|FG000|COMPLETED|Washout Period 1 (2 Weeks)||8
8851683|NCT01751113|9906594|FG001|COMPLETED|Washout Period 1 (2 Weeks)||8
8851684|NCT01751113|9906595|FG002|COMPLETED|Washout Period 1 (2 Weeks)||9
8851685|NCT01751113|9906596|FG003|COMPLETED|Washout Period 1 (2 Weeks)||8
8851686|NCT01751113|9906597|FG004|COMPLETED|Washout Period 1 (2 Weeks)||8
8851687|NCT01751113|9906598|FG005|COMPLETED|Washout Period 1 (2 Weeks)||10
8851688|NCT01751113|9906593|FG000|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
8851689|NCT01751113|9906594|FG001|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
8851690|NCT01751113|9906595|FG002|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
8851691|NCT01751113|9906596|FG003|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
8851692|NCT01751113|9906597|FG004|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
8851693|NCT01751113|9906598|FG005|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
8851694|NCT01751113|9906593|FG000|STARTED|Treatment Period 2 (4 Weeks)||8
8851695|NCT01751113|9906594|FG001|STARTED|Treatment Period 2 (4 Weeks)||8
8851696|NCT01751113|9906595|FG002|STARTED|Treatment Period 2 (4 Weeks)||9
8851697|NCT01751113|9906596|FG003|STARTED|Treatment Period 2 (4 Weeks)||8
8851698|NCT01751113|9906597|FG004|STARTED|Treatment Period 2 (4 Weeks)||8
8851699|NCT01751113|9906598|FG005|STARTED|Treatment Period 2 (4 Weeks)||10
8851700|NCT01751113|9906593|FG000|COMPLETED|Treatment Period 2 (4 Weeks)||8
8851701|NCT01751113|9906594|FG001|COMPLETED|Treatment Period 2 (4 Weeks)||8
8851702|NCT01751113|9906595|FG002|COMPLETED|Treatment Period 2 (4 Weeks)||9
8851703|NCT01751113|9906596|FG003|COMPLETED|Treatment Period 2 (4 Weeks)||8
8851704|NCT01751113|9906597|FG004|COMPLETED|Treatment Period 2 (4 Weeks)||8
8851705|NCT01751113|9906598|FG005|COMPLETED|Treatment Period 2 (4 Weeks)||10
8851706|NCT01751113|9906593|FG000|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
8851707|NCT01751113|9906594|FG001|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
8851708|NCT01751113|9906595|FG002|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
8851709|NCT01751113|9906596|FG003|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
8851710|NCT01751113|9906597|FG004|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
8851711|NCT01751113|9906598|FG005|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
8851712|NCT01751113|9906593|FG000|STARTED|Washout Period 2 (2 Weeks)||8
8851713|NCT01751113|9906594|FG001|STARTED|Washout Period 2 (2 Weeks)||8
8851714|NCT01751113|9906595|FG002|STARTED|Washout Period 2 (2 Weeks)||9
8851715|NCT01751113|9906596|FG003|STARTED|Washout Period 2 (2 Weeks)||8
8851716|NCT01751113|9906597|FG004|STARTED|Washout Period 2 (2 Weeks)||8
8851717|NCT01751113|9906598|FG005|STARTED|Washout Period 2 (2 Weeks)||10
8851718|NCT01751113|9906593|FG000|COMPLETED|Washout Period 2 (2 Weeks)||8
8851719|NCT01751113|9906594|FG001|COMPLETED|Washout Period 2 (2 Weeks)||8
8851720|NCT01751113|9906595|FG002|COMPLETED|Washout Period 2 (2 Weeks)||9
8851721|NCT01751113|9906596|FG003|COMPLETED|Washout Period 2 (2 Weeks)||8
8851722|NCT01751113|9906597|FG004|COMPLETED|Washout Period 2 (2 Weeks)||8
8851723|NCT01751113|9906598|FG005|COMPLETED|Washout Period 2 (2 Weeks)||10
8851724|NCT01751113|9906593|FG000|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
8851725|NCT01751113|9906594|FG001|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
8851726|NCT01751113|9906595|FG002|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
8851727|NCT01751113|9906596|FG003|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
8851728|NCT01751113|9906597|FG004|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
8851729|NCT01751113|9906598|FG005|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
8851730|NCT01751113|9906593|FG000|STARTED|Treatment Period 3 (4 Weeks)||8
8851731|NCT01751113|9906594|FG001|STARTED|Treatment Period 3 (4 Weeks)||8
8851732|NCT01751113|9906595|FG002|STARTED|Treatment Period 3 (4 Weeks)||9
8851733|NCT01751113|9906596|FG003|STARTED|Treatment Period 3 (4 Weeks)||8
8851734|NCT01751113|9906597|FG004|STARTED|Treatment Period 3 (4 Weeks)||8
8851735|NCT01751113|9906598|FG005|STARTED|Treatment Period 3 (4 Weeks)||10
8851736|NCT01751113|9906593|FG000|COMPLETED|Treatment Period 3 (4 Weeks)||8
8851737|NCT01751113|9906594|FG001|COMPLETED|Treatment Period 3 (4 Weeks)||8
8851738|NCT01751113|9906595|FG002|COMPLETED|Treatment Period 3 (4 Weeks)||9
8851739|NCT01751113|9906596|FG003|COMPLETED|Treatment Period 3 (4 Weeks)||8
8851740|NCT01751113|9906597|FG004|COMPLETED|Treatment Period 3 (4 Weeks)||8
8851741|NCT01751113|9906598|FG005|COMPLETED|Treatment Period 3 (4 Weeks)||9
8851742|NCT01751113|9906593|FG000|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
8851743|NCT01751113|9906594|FG001|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
8851744|NCT01751113|9906595|FG002|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
8851745|NCT01751113|9906596|FG003|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
8851746|NCT01751113|9906597|FG004|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
8851747|NCT01751113|9906598|FG005|NOT COMPLETED|Treatment Period 3 (4 Weeks)||1
8851748|NCT01751139|9906607|FG000|STARTED|Overall Study||3300
8851749|NCT01751139|9906607|FG000|COMPLETED|Overall Study||1033
8851750|NCT01751139|9906607|FG000|NOT COMPLETED|Overall Study||2267
8851751|NCT01751165|9906614|FG000|STARTED|Overall Study||119
8851752|NCT01751165|9906615|FG001|STARTED|Overall Study||119
8851753|NCT01751165|9906616|FG002|STARTED|Overall Study||116
8851754|NCT01751165|9906614|FG000|COMPLETED|Overall Study||117
8851755|NCT01751165|9906615|FG001|COMPLETED|Overall Study||116
8851756|NCT01751165|9906616|FG002|COMPLETED|Overall Study||113
8851757|NCT01751165|9906614|FG000|NOT COMPLETED|Overall Study||2
8851758|NCT01751165|9906615|FG001|NOT COMPLETED|Overall Study||3
8851759|NCT01751165|9906616|FG002|NOT COMPLETED|Overall Study||3
8851760|NCT01751178|9906629|FG000|STARTED|Overall Study||108
8851761|NCT01751178|9906630|FG001|STARTED|Overall Study||109
8851762|NCT01751178|9906631|FG002|STARTED|Overall Study||107
8851763|NCT01751178|9906629|FG000|COMPLETED|Overall Study||105
8851764|NCT01751178|9906630|FG001|COMPLETED|Overall Study||109
8851765|NCT01751178|9906631|FG002|COMPLETED|Overall Study||105
8851766|NCT01751178|9906629|FG000|NOT COMPLETED|Overall Study||3
8851767|NCT01751178|9906630|FG001|NOT COMPLETED|Overall Study||0
8851768|NCT01751178|9906631|FG002|NOT COMPLETED|Overall Study||2
8851769|NCT01751230|9906645|FG000|STARTED|Overall Study||20
8851770|NCT01751230|9906646|FG001|STARTED|Overall Study||20
8851771|NCT01751230|9906645|FG000|COMPLETED|Overall Study||19
8851772|NCT01751230|9906646|FG001|COMPLETED|Overall Study||16
8629698|NCT00531050|9669386|FG005|NOT COMPLETED|Part 2: Period 3||1
8629699|NCT00531206|9669403|FG000|STARTED|Overall Study||65
8629700|NCT00531206|9669403|FG000|COMPLETED|Overall Study||45
8629701|NCT00531206|9669403|FG000|NOT COMPLETED|Overall Study||20
8629702|NCT00531284|9669424|FG000|STARTED|Overall Study||3
8851773|NCT01751230|9906645|FG000|NOT COMPLETED|Overall Study||1
8851774|NCT01751230|9906646|FG001|NOT COMPLETED|Overall Study||4
8851775|NCT01751308|9906661|FG000|STARTED|Phase 1||6
8851776|NCT01751308|9906662|FG001|STARTED|Phase 1||3
8851777|NCT01751308|9906663|FG002|STARTED|Phase 1||7
8851778|NCT01751308|9906664|FG003|STARTED|Phase 1||7
8851779|NCT01751308|9906665|FG004|STARTED|Phase 1|Phase 1 and Phase 2 were separate populations.|0
8851780|NCT01751308|9906661|FG000|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|6
8851781|NCT01751308|9906662|FG001|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|3
8851782|NCT01751308|9906663|FG002|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|7
8851783|NCT01751308|9906664|FG003|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|7
8851784|NCT01751308|9906665|FG004|COMPLETED|Phase 1||0
8851785|NCT01751308|9906661|FG000|NOT COMPLETED|Phase 1||0
8851786|NCT01751308|9906662|FG001|NOT COMPLETED|Phase 1||0
8851787|NCT01751308|9906663|FG002|NOT COMPLETED|Phase 1||0
8851788|NCT01751308|9906664|FG003|NOT COMPLETED|Phase 1||0
8851789|NCT01751308|9906665|FG004|NOT COMPLETED|Phase 1||0
8851790|NCT01751308|9906661|FG000|STARTED|Phase 2||0
8851791|NCT01751308|9906662|FG001|STARTED|Phase 2||0
8851792|NCT01751308|9906663|FG002|STARTED|Phase 2||0
8851793|NCT01751308|9906664|FG003|STARTED|Phase 2||0
8851794|NCT01751308|9906665|FG004|STARTED|Phase 2|Phase 1 and Phase 2 were separate populations.|16
8851795|NCT01751308|9906661|FG000|COMPLETED|Phase 2||0
8851796|NCT01751308|9906662|FG001|COMPLETED|Phase 2||0
8851797|NCT01751308|9906663|FG002|COMPLETED|Phase 2||0
8851798|NCT01751308|9906664|FG003|COMPLETED|Phase 2||0
8851799|NCT01751308|9906665|FG004|COMPLETED|Phase 2|DP, AE and death were considered as completed (defined in protocol)|16
8851800|NCT01751308|9906661|FG000|NOT COMPLETED|Phase 2||0
8851801|NCT01751308|9906662|FG001|NOT COMPLETED|Phase 2||0
8851802|NCT01751308|9906663|FG002|NOT COMPLETED|Phase 2||0
8851803|NCT01751308|9906664|FG003|NOT COMPLETED|Phase 2||0
8851804|NCT01751308|9906665|FG004|NOT COMPLETED|Phase 2||0
8923291|NCT02239289|9983830|FG000|STARTED|Overall Study||21
8923292|NCT02239289|9983830|FG000|COMPLETED|Overall Study||21
8923293|NCT02239289|9983830|FG000|NOT COMPLETED|Overall Study||0
8923294|NCT02239328|9983834|FG000|STARTED|Overall Study||182
8923295|NCT02239328|9983834|FG000|COMPLETED|Overall Study||174
8923296|NCT02239328|9983834|FG000|NOT COMPLETED|Overall Study||8
8923297|NCT02239380|9983838|FG000|STARTED|Overall Study||26
8923298|NCT02239380|9983838|FG000|COMPLETED|Overall Study||26
8923299|NCT02239380|9983838|FG000|NOT COMPLETED|Overall Study||0
8923300|NCT02239510|9983844|FG000|STARTED|Overall Study||5
8923301|NCT02239510|9983845|FG001|STARTED|Overall Study||4
8923302|NCT02239510|9983844|FG000|COMPLETED|Overall Study||3
8923303|NCT02239510|9983845|FG001|COMPLETED|Overall Study||3
8923304|NCT02239510|9983844|FG000|NOT COMPLETED|Overall Study||2
8923305|NCT02239510|9983845|FG001|NOT COMPLETED|Overall Study||1
8923306|NCT02239536|9983853|FG000|STARTED|Overall Study||190
8923307|NCT02239536|9983854|FG001|STARTED|Overall Study||172
8923308|NCT02239536|9983853|FG000|COMPLETED|Overall Study||167
8923309|NCT02239536|9983854|FG001|COMPLETED|Overall Study||155
8923310|NCT02239536|9983853|FG000|NOT COMPLETED|Overall Study||23
8923311|NCT02239536|9983854|FG001|NOT COMPLETED|Overall Study||17
8923312|NCT02239562|9983866|FG000|STARTED|Overall Study||6
8923313|NCT02239562|9983867|FG001|STARTED|Overall Study||6
8923314|NCT02239562|9983868|FG002|STARTED|Overall Study||6
8923315|NCT02239562|9983869|FG003|STARTED|Overall Study||6
8923316|NCT02239562|9983870|FG004|STARTED|Overall Study||6
8923317|NCT02239562|9983871|FG005|STARTED|Overall Study||6
8923318|NCT02239562|9983866|FG000|COMPLETED|Overall Study||6
8923319|NCT02239562|9983867|FG001|COMPLETED|Overall Study||6
8923320|NCT02239562|9983868|FG002|COMPLETED|Overall Study||6
8629703|NCT00531284|9669425|FG001|STARTED|Overall Study||4
8629704|NCT00531284|9669426|FG002|STARTED|Overall Study||7
8923321|NCT02239562|9983869|FG003|COMPLETED|Overall Study||6
8923322|NCT02239562|9983870|FG004|COMPLETED|Overall Study||6
8923323|NCT02239562|9983871|FG005|COMPLETED|Overall Study||6
8923324|NCT02239562|9983866|FG000|NOT COMPLETED|Overall Study||0
8923325|NCT02239562|9983867|FG001|NOT COMPLETED|Overall Study||0
8923326|NCT02239562|9983868|FG002|NOT COMPLETED|Overall Study||0
8923327|NCT02239562|9983869|FG003|NOT COMPLETED|Overall Study||0
8923328|NCT02239562|9983870|FG004|NOT COMPLETED|Overall Study||0
8923329|NCT02239562|9983871|FG005|NOT COMPLETED|Overall Study||0
8923330|NCT02239601|9983889|FG000|STARTED|Overall Study||29
8923331|NCT02239601|9983890|FG001|STARTED|Overall Study||32
8923332|NCT02239601|9983889|FG000|COMPLETED|Overall Study||22
8923333|NCT02239601|9983890|FG001|COMPLETED|Overall Study||26
8923334|NCT02239601|9983889|FG000|NOT COMPLETED|Overall Study||7
8923335|NCT02239601|9983890|FG001|NOT COMPLETED|Overall Study||6
8923336|NCT02239640|9983901|FG000|STARTED|Overall Study||984
8923337|NCT02239640|9983901|FG000|COMPLETED|Overall Study||767
8629705|NCT00531284|9669427|FG003|STARTED|Overall Study||65
8851805|NCT01751386|9906683|FG000|STARTED|Overall Study||20
8851806|NCT01751386|9906684|FG001|STARTED|Overall Study||19
8851807|NCT01751386|9906683|FG000|COMPLETED|Overall Study||18
8851808|NCT01751386|9906684|FG001|COMPLETED|Overall Study||16
8851809|NCT01751386|9906683|FG000|NOT COMPLETED|Overall Study||2
8851810|NCT01751386|9906684|FG001|NOT COMPLETED|Overall Study||3
8851811|NCT01751399|9906694|FG000|STARTED|Overall Study||12
8851812|NCT01751399|9906695|FG001|STARTED|Overall Study||8
8851813|NCT01751399|9906696|FG002|STARTED|Overall Study||8
8851814|NCT01751399|9906697|FG003|STARTED|Overall Study||7
8851815|NCT01751399|9906694|FG000|Received 1 Dose of Study Drug|Overall Study||12
8851816|NCT01751399|9906695|FG001|Received 1 Dose of Study Drug|Overall Study||8
8851817|NCT01751399|9906696|FG002|Received 1 Dose of Study Drug|Overall Study||8
8851818|NCT01751399|9906697|FG003|Received 1 Dose of Study Drug|Overall Study||7
8851819|NCT01751399|9906694|FG000|COMPLETED|Overall Study||12
8851820|NCT01751399|9906695|FG001|COMPLETED|Overall Study||8
8851821|NCT01751399|9906696|FG002|COMPLETED|Overall Study||8
8851822|NCT01751399|9906697|FG003|COMPLETED|Overall Study||7
8851823|NCT01751399|9906694|FG000|NOT COMPLETED|Overall Study||0
8851824|NCT01751399|9906695|FG001|NOT COMPLETED|Overall Study||0
8851825|NCT01751399|9906696|FG002|NOT COMPLETED|Overall Study||0
8851826|NCT01751399|9906697|FG003|NOT COMPLETED|Overall Study||0
8851827|NCT01751412|9906707|FG000|STARTED|Overall Study||12
8851828|NCT01751412|9906707|FG000|COMPLETED|Overall Study||11
8851829|NCT01751412|9906707|FG000|NOT COMPLETED|Overall Study||1
8851830|NCT01751451|9906714|FG000|STARTED|Overall Study||42
8851831|NCT01751451|9906715|FG001|STARTED|Overall Study||40
8851832|NCT01751451|9906716|FG002|STARTED|Overall Study||42
8851833|NCT01751451|9906714|FG000|COMPLETED|Overall Study||42
8851834|NCT01751451|9906715|FG001|COMPLETED|Overall Study||40
8851835|NCT01751451|9906716|FG002|COMPLETED|Overall Study||42
8851836|NCT01751451|9906714|FG000|NOT COMPLETED|Overall Study||0
8851837|NCT01751451|9906715|FG001|NOT COMPLETED|Overall Study||0
8851838|NCT01751451|9906716|FG002|NOT COMPLETED|Overall Study||0
8851839|NCT01751568|9906727|FG000|STARTED|Overall Study||13
8851840|NCT01751568|9906728|FG001|STARTED|Overall Study||14
8851841|NCT01751568|9906729|FG002|STARTED|Overall Study||13
8851842|NCT01751568|9906727|FG000|COMPLETED|Overall Study||12
8851843|NCT01751568|9906728|FG001|COMPLETED|Overall Study||14
8851844|NCT01751568|9906729|FG002|COMPLETED|Overall Study||13
8851845|NCT01751568|9906727|FG000|NOT COMPLETED|Overall Study||1
8851846|NCT01751568|9906728|FG001|NOT COMPLETED|Overall Study||0
8851847|NCT01751568|9906729|FG002|NOT COMPLETED|Overall Study||0
8851848|NCT01751646|9906739|FG000|STARTED|Overall Study||109
8851849|NCT01751646|9906740|FG001|STARTED|Overall Study||105
8851850|NCT01751646|9906739|FG000|COMPLETED|Overall Study||98
8851851|NCT01751646|9906740|FG001|COMPLETED|Overall Study||87
8851852|NCT01751646|9906739|FG000|NOT COMPLETED|Overall Study||11
8851853|NCT01751646|9906740|FG001|NOT COMPLETED|Overall Study||18
8851854|NCT01751724|9906752|FG000|STARTED|Overall Study||42
8851855|NCT01751724|9906753|FG001|STARTED|Overall Study||44
8851856|NCT01751724|9906752|FG000|COMPLETED|Overall Study||41
8851857|NCT01751724|9906753|FG001|COMPLETED|Overall Study||42
8851858|NCT01751724|9906752|FG000|NOT COMPLETED|Overall Study||1
8851859|NCT01751724|9906753|FG001|NOT COMPLETED|Overall Study||2
8851860|NCT01751802|9906761|FG000|STARTED|Overall Study||5
8851861|NCT01751802|9906762|FG001|STARTED|Overall Study||4
8851862|NCT01751802|9906761|FG000|Completed Period 1|Overall Study||2
8851863|NCT01751802|9906762|FG001|Completed Period 1|Overall Study||4
8851864|NCT01751802|9906761|FG000|Completed Period 2|Overall Study||2
8851865|NCT01751802|9906762|FG001|Completed Period 2|Overall Study||1
8851866|NCT01751802|9906761|FG000|Completed Period 3|Overall Study||2
8851867|NCT01751802|9906762|FG001|Completed Period 3|Overall Study||1
8851868|NCT01751802|9906761|FG000|COMPLETED|Overall Study||1
8851869|NCT01751802|9906762|FG001|COMPLETED|Overall Study||2
8851870|NCT01751802|9906761|FG000|NOT COMPLETED|Overall Study||4
8851871|NCT01751802|9906762|FG001|NOT COMPLETED|Overall Study||2
8851872|NCT01751867|9906776|FG000|STARTED|Overall Study||36
8851873|NCT01751867|9906777|FG001|STARTED|Overall Study||99
8851874|NCT01751867|9906776|FG000|Treated|Overall Study||34
8569479|NCT00097669|9601726|FG000|NOT COMPLETED|Overall Study||0
8569480|NCT00097669|9601727|FG001|NOT COMPLETED|Overall Study||0
8851875|NCT01751867|9906777|FG001|Treated|Overall Study||98
8851876|NCT01751867|9906776|FG000|COMPLETED|Overall Study||0
8851877|NCT01751867|9906777|FG001|COMPLETED|Overall Study||0
8851878|NCT01751867|9906776|FG000|NOT COMPLETED|Overall Study||36
8851879|NCT01751867|9906777|FG001|NOT COMPLETED|Overall Study||99
8851880|NCT01751971|9906785|FG000|STARTED|Overall Study||22
8851881|NCT01751971|9906786|FG001|STARTED|Overall Study||25
8851882|NCT01751971|9906785|FG000|COMPLETED|Overall Study||20
8851883|NCT01751971|9906786|FG001|COMPLETED|Overall Study||24
8851884|NCT01751971|9906785|FG000|NOT COMPLETED|Overall Study||2
8851885|NCT01751971|9906786|FG001|NOT COMPLETED|Overall Study||1
8851886|NCT01752036|9906798|FG000|STARTED|Overall Study||33
8851887|NCT01752036|9906798|FG000|COMPLETED|Overall Study||31
8851888|NCT01752036|9906798|FG000|NOT COMPLETED|Overall Study||2
8851889|NCT01752400|9906803|FG000|STARTED|Overall Study||6
8851890|NCT01752400|9906803|FG000|COMPLETED|Overall Study||6
8851891|NCT01752400|9906803|FG000|NOT COMPLETED|Overall Study||0
8851892|NCT01752413|9906809|FG000|STARTED|Overall Study||170
8851893|NCT01752413|9906810|FG001|STARTED|Overall Study||27
8851894|NCT01752413|9906809|FG000|COMPLETED|Overall Study||58
8851895|NCT01752413|9906810|FG001|COMPLETED|Overall Study||6
8851896|NCT01752413|9906809|FG000|NOT COMPLETED|Overall Study||112
8851897|NCT01752413|9906810|FG001|NOT COMPLETED|Overall Study||21
8851898|NCT01752426|9906816|FG000|STARTED|Overall Study||30
8851899|NCT01752426|9906816|FG000|COMPLETED|Overall Study||30
8851900|NCT01752426|9906816|FG000|NOT COMPLETED|Overall Study||0
8851901|NCT01752634|9906826|FG000|STARTED|Up to Week 24 (Primary Analysis)||99
8851902|NCT01752634|9906827|FG001|STARTED|Up to Week 24 (Primary Analysis)||100
8851903|NCT01752634|9906828|FG002|STARTED|Up to Week 24 (Primary Analysis)||100
8851904|NCT01752634|9906829|FG003|STARTED|Up to Week 24 (Primary Analysis)||43
8851905|NCT01752634|9906830|FG004|STARTED|Up to Week 24 (Primary Analysis)||45
8851906|NCT01752634|9906831|FG005|STARTED|Up to Week 24 (Primary Analysis)||10
8948987|NCT02435069|10011480|FG002|COMPLETED|Effectiveness - Second Intervention||0
8948988|NCT02435069|10011481|FG003|COMPLETED|Effectiveness - Second Intervention||1
8948989|NCT02435069|10011482|FG004|COMPLETED|Effectiveness - Second Intervention||0
8948990|NCT02435069|10011478|FG000|NOT COMPLETED|Effectiveness - Second Intervention||0
8948991|NCT02435069|10011479|FG001|NOT COMPLETED|Effectiveness - Second Intervention||0
8948992|NCT02435069|10011480|FG002|NOT COMPLETED|Effectiveness - Second Intervention||0
8948993|NCT02435069|10011481|FG003|NOT COMPLETED|Effectiveness - Second Intervention||0
8948994|NCT02435069|10011482|FG004|NOT COMPLETED|Effectiveness - Second Intervention||1
8948995|NCT02435147|10011502|FG000|STARTED|Overall Study||86
8948996|NCT02435147|10011502|FG000|COMPLETED|Overall Study||75
8948997|NCT02435147|10011502|FG000|NOT COMPLETED|Overall Study||11
8948998|NCT02435277|10011510|FG000|STARTED|Overall Study||12
8948999|NCT02435277|10011511|FG001|STARTED|Overall Study||16
8949000|NCT02435277|10011512|FG002|STARTED|Overall Study||11
8949001|NCT02435277|10011513|FG003|STARTED|Overall Study||11
8949002|NCT02435277|10011510|FG000|COMPLETED|Overall Study||10
8949003|NCT02435277|10011511|FG001|COMPLETED|Overall Study||15
8949004|NCT02435277|10011512|FG002|COMPLETED|Overall Study||11
8949005|NCT02435277|10011513|FG003|COMPLETED|Overall Study||11
8949006|NCT02435277|10011510|FG000|NOT COMPLETED|Overall Study||2
8949007|NCT02435277|10011511|FG001|NOT COMPLETED|Overall Study||1
8949008|NCT02435277|10011512|FG002|NOT COMPLETED|Overall Study||0
8949009|NCT02435277|10011513|FG003|NOT COMPLETED|Overall Study||0
8949010|NCT02435381|10011523|FG000|STARTED|Overall Study||5
8949011|NCT02435381|10011524|FG001|STARTED|Overall Study||6
8949012|NCT02435381|10011523|FG000|COMPLETED|Overall Study||3
8949013|NCT02435381|10011524|FG001|COMPLETED|Overall Study||5
8949014|NCT02435381|10011523|FG000|NOT COMPLETED|Overall Study||2
8949015|NCT02435381|10011524|FG001|NOT COMPLETED|Overall Study||1
8569481|NCT00097695|9601737|FG000|STARTED|The Controlled Phase||27
8569482|NCT00097695|9601738|FG001|STARTED|The Controlled Phase||29
8569483|NCT00097695|9601739|FG002|STARTED|The Controlled Phase||8
8569484|NCT00097695|9601740|FG003|STARTED|The Controlled Phase||20
8569485|NCT00097695|9601737|FG000|COMPLETED|The Controlled Phase||23
8851907|NCT01752634|9906826|FG000|COMPLETED|Up to Week 24 (Primary Analysis)||93
8851908|NCT01752634|9906827|FG001|COMPLETED|Up to Week 24 (Primary Analysis)||95
8851909|NCT01752634|9906828|FG002|COMPLETED|Up to Week 24 (Primary Analysis)||97
8949016|NCT02435524|10011542|FG000|STARTED|Baseline Survey||1111
8949017|NCT02435524|10011543|FG001|STARTED|Baseline Survey||1177
8569486|NCT00097695|9601738|FG001|COMPLETED|The Controlled Phase||26
8851910|NCT01752634|9906829|FG003|COMPLETED|Up to Week 24 (Primary Analysis)||43
8851911|NCT01752634|9906830|FG004|COMPLETED|Up to Week 24 (Primary Analysis)||45
8851912|NCT01752634|9906831|FG005|COMPLETED|Up to Week 24 (Primary Analysis)||0
8851913|NCT01752634|9906826|FG000|NOT COMPLETED|Up to Week 24 (Primary Analysis)||6
8851914|NCT01752634|9906827|FG001|NOT COMPLETED|Up to Week 24 (Primary Analysis)||5
8851915|NCT01752634|9906828|FG002|NOT COMPLETED|Up to Week 24 (Primary Analysis)||3
8851916|NCT01752634|9906829|FG003|NOT COMPLETED|Up to Week 24 (Primary Analysis)||0
8851917|NCT01752634|9906830|FG004|NOT COMPLETED|Up to Week 24 (Primary Analysis)||0
8851918|NCT01752634|9906831|FG005|NOT COMPLETED|Up to Week 24 (Primary Analysis)||10
8851919|NCT01752634|9906826|FG000|STARTED|Week 24 to Week 260||93
8851920|NCT01752634|9906827|FG001|STARTED|Week 24 to Week 260||95
8851921|NCT01752634|9906828|FG002|STARTED|Week 24 to Week 260||97
8851922|NCT01752634|9906829|FG003|STARTED|Week 24 to Week 260||43
8851923|NCT01752634|9906830|FG004|STARTED|Week 24 to Week 260||45
8851924|NCT01752634|9906831|FG005|STARTED|Week 24 to Week 260||0
8851925|NCT01752634|9906826|FG000|COMPLETED|Week 24 to Week 260||59
8851926|NCT01752634|9906827|FG001|COMPLETED|Week 24 to Week 260||65
8851927|NCT01752634|9906828|FG002|COMPLETED|Week 24 to Week 260||64
8629706|NCT00531284|9669428|FG004|STARTED|Overall Study||6
8629707|NCT00531284|9669429|FG005|STARTED|Overall Study||7
8629708|NCT00531284|9669430|FG006|STARTED|Overall Study||6
8629709|NCT00531284|9669431|FG007|STARTED|Overall Study||10
8629710|NCT00531284|9669432|FG008|STARTED|Overall Study||11
8629711|NCT00531284|9669433|FG009|STARTED|Overall Study||4
8629712|NCT00531284|9669434|FG010|STARTED|Overall Study||3
8629713|NCT00531284|9669435|FG011|STARTED|Overall Study||24
8629714|NCT00531284|9669436|FG012|STARTED|Overall Study||2
8851928|NCT01752634|9906829|FG003|COMPLETED|Week 24 to Week 260||29
8851929|NCT01752634|9906830|FG004|COMPLETED|Week 24 to Week 260||31
8851930|NCT01752634|9906831|FG005|COMPLETED|Week 24 to Week 260||0
8851931|NCT01752634|9906826|FG000|NOT COMPLETED|Week 24 to Week 260||34
8851932|NCT01752634|9906827|FG001|NOT COMPLETED|Week 24 to Week 260||30
8851933|NCT01752634|9906828|FG002|NOT COMPLETED|Week 24 to Week 260||33
8851934|NCT01752634|9906829|FG003|NOT COMPLETED|Week 24 to Week 260||14
8851935|NCT01752634|9906830|FG004|NOT COMPLETED|Week 24 to Week 260||14
8851936|NCT01752634|9906831|FG005|NOT COMPLETED|Week 24 to Week 260||0
8851937|NCT01752712|9906843|FG000|STARTED|Overall Study||31
8851938|NCT01752712|9906844|FG001|STARTED|Overall Study||31
8851939|NCT01752712|9906843|FG000|COMPLETED|Overall Study||22
8851940|NCT01752712|9906844|FG001|COMPLETED|Overall Study||21
8851941|NCT01752712|9906843|FG000|NOT COMPLETED|Overall Study||9
8851942|NCT01752712|9906844|FG001|NOT COMPLETED|Overall Study||10
8851943|NCT01752842|9906852|FG000|STARTED|Overall Study||34
8851944|NCT01752842|9906853|FG001|STARTED|Overall Study||36
8851945|NCT01752842|9906852|FG000|COMPLETED|Overall Study||31
8851946|NCT01752842|9906853|FG001|COMPLETED|Overall Study||34
8851947|NCT01752842|9906852|FG000|NOT COMPLETED|Overall Study||3
8851948|NCT01752842|9906853|FG001|NOT COMPLETED|Overall Study||2
8851949|NCT01752855|9906861|FG000|STARTED|Overall Study||44
8851950|NCT01752855|9906862|FG001|STARTED|Overall Study||44
8851951|NCT01752855|9906861|FG000|COMPLETED|Overall Study||43
8851952|NCT01752855|9906862|FG001|COMPLETED|Overall Study||40
8851953|NCT01752855|9906861|FG000|NOT COMPLETED|Overall Study||1
8851954|NCT01752855|9906862|FG001|NOT COMPLETED|Overall Study||4
8851955|NCT01752907|9906870|FG000|STARTED|Overall Study||151
8851956|NCT01752907|9906871|FG001|STARTED|Overall Study||153
8851957|NCT01752907|9906870|FG000|Received Pegfilgrastim|Overall Study||149
8851958|NCT01752907|9906871|FG001|Received Pegfilgrastim|Overall Study||151
8851959|NCT01752907|9906870|FG000|COMPLETED|Overall Study||139
8851960|NCT01752907|9906871|FG001|COMPLETED|Overall Study||133
8851961|NCT01752907|9906870|FG000|NOT COMPLETED|Overall Study||12
8851962|NCT01752907|9906871|FG001|NOT COMPLETED|Overall Study||20
8851963|NCT01752933|9906879|FG000|STARTED|Treatment|Includes all patients who received any treatment|4
8851964|NCT01752933|9906880|FG001|STARTED|Treatment|Includes all patients who received any treatment|46
8851965|NCT01752933|9906879|FG000|COMPLETED|Treatment|Completion not applicable for this survival study|0
8851966|NCT01752933|9906880|FG001|COMPLETED|Treatment|Completion not applicable for this survival study|0
8851967|NCT01752933|9906879|FG000|NOT COMPLETED|Treatment||4
8851968|NCT01752933|9906880|FG001|NOT COMPLETED|Treatment||46
8851969|NCT01752933|9906879|FG000|STARTED|Overall Study and Follow-up|Includes all patients who received any treatment|4
8851970|NCT01752933|9906880|FG001|STARTED|Overall Study and Follow-up|Includes all patients who received any treatment|46
8851971|NCT01752933|9906879|FG000|COMPLETED|Overall Study and Follow-up|Completion not applicable for this survival study|0
8851972|NCT01752933|9906880|FG001|COMPLETED|Overall Study and Follow-up|Completion not applicable for this survival study|0
8851973|NCT01752933|9906879|FG000|NOT COMPLETED|Overall Study and Follow-up||4
8851974|NCT01752933|9906880|FG001|NOT COMPLETED|Overall Study and Follow-up||46
8851975|NCT01752985|9906890|FG000|STARTED|Treatment Period||29
8851976|NCT01752985|9906891|FG001|STARTED|Treatment Period||30
8851977|NCT01752985|9906892|FG002|STARTED|Treatment Period||29
8851978|NCT01752985|9906890|FG000|COMPLETED|Treatment Period||25
8851979|NCT01752985|9906891|FG001|COMPLETED|Treatment Period||27
8851980|NCT01752985|9906892|FG002|COMPLETED|Treatment Period||24
8851981|NCT01752985|9906890|FG000|NOT COMPLETED|Treatment Period||4
8851982|NCT01752985|9906891|FG001|NOT COMPLETED|Treatment Period||3
8851983|NCT01752985|9906892|FG002|NOT COMPLETED|Treatment Period||5
8851984|NCT01752985|9906890|FG000|STARTED|Follow-up Period|Includes 25 participants in this period and 3 participants re-joined for follow-up|28
8851985|NCT01752985|9906891|FG001|STARTED|Follow-up Period||27
8851986|NCT01752985|9906892|FG002|STARTED|Follow-up Period|Includes 24 participants in this period and 2 participants re-joined for follow-up|26
8851987|NCT01752985|9906890|FG000|COMPLETED|Follow-up Period||28
8851988|NCT01752985|9906891|FG001|COMPLETED|Follow-up Period||27
8851989|NCT01752985|9906892|FG002|COMPLETED|Follow-up Period||26
8851990|NCT01752985|9906890|FG000|NOT COMPLETED|Follow-up Period||0
8851991|NCT01752985|9906891|FG001|NOT COMPLETED|Follow-up Period||0
8851992|NCT01752985|9906892|FG002|NOT COMPLETED|Follow-up Period||0
8851993|NCT01753076|9906902|FG000|STARTED|Overall Study||151
8629715|NCT00531284|9669437|FG013|STARTED|Overall Study||3
8629716|NCT00531284|9669438|FG014|STARTED|Overall Study||7
8629717|NCT00531284|9669439|FG015|STARTED|Overall Study||14
8629718|NCT00531284|9669440|FG016|STARTED|Overall Study||8
8629719|NCT00531284|9669424|FG000|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|0
8851994|NCT01753076|9906903|FG001|STARTED|Overall Study||152
8851995|NCT01753076|9906902|FG000|COMPLETED|Overall Study||110
8851996|NCT01753076|9906903|FG001|COMPLETED|Overall Study||106
8851997|NCT01753076|9906902|FG000|NOT COMPLETED|Overall Study||41
8851998|NCT01753076|9906903|FG001|NOT COMPLETED|Overall Study||46
8851999|NCT01753115|9906914|FG000|STARTED|Overall Study||44
8852000|NCT01753115|9906915|FG001|STARTED|Overall Study||40
8852001|NCT01753115|9906916|FG002|STARTED|Overall Study||70
8852002|NCT01753115|9906914|FG000|Treated|Overall Study||38
8852003|NCT01753115|9906915|FG001|Treated|Overall Study||39
8852004|NCT01753115|9906916|FG002|Treated|Overall Study||67
8852005|NCT01753115|9906914|FG000|COMPLETED|Overall Study||32
8852006|NCT01753115|9906915|FG001|COMPLETED|Overall Study||25
8852007|NCT01753115|9906916|FG002|COMPLETED|Overall Study||56
8852008|NCT01753115|9906914|FG000|NOT COMPLETED|Overall Study||12
8852009|NCT01753115|9906915|FG001|NOT COMPLETED|Overall Study||15
8852010|NCT01753115|9906916|FG002|NOT COMPLETED|Overall Study||14
8852011|NCT01753193|9906924|FG000|STARTED|Overall Study||218
8852012|NCT01753193|9906924|FG000|COMPLETED|Overall Study||172
8852013|NCT01753193|9906924|FG000|NOT COMPLETED|Overall Study||46
8852014|NCT01753297|9906930|FG000|STARTED|Overall Study||117
8852015|NCT01753297|9906931|FG001|STARTED|Overall Study||109
8852016|NCT01753297|9906930|FG000|Received Triptorelin Treatment|Overall Study||0
8852017|NCT01753297|9906931|FG001|Received Triptorelin Treatment|Overall Study||105
8852018|NCT01753297|9906930|FG000|COMPLETED|Overall Study||76
8852019|NCT01753297|9906931|FG001|COMPLETED|Overall Study||73
8852020|NCT01753297|9906930|FG000|NOT COMPLETED|Overall Study||41
8852021|NCT01753297|9906931|FG001|NOT COMPLETED|Overall Study||36
8852022|NCT01753310|9906941|FG000|STARTED|Overall Study||89
8852023|NCT01753310|9906942|FG001|STARTED|Overall Study||45
8852024|NCT01753310|9906941|FG000|COMPLETED|Overall Study||57
8852025|NCT01753310|9906942|FG001|COMPLETED|Overall Study||21
8852026|NCT01753310|9906941|FG000|NOT COMPLETED|Overall Study||32
8852027|NCT01753310|9906942|FG001|NOT COMPLETED|Overall Study||24
8852028|NCT01753323|9906951|FG000|STARTED|Overall Study||11
8852029|NCT01753323|9906952|FG001|STARTED|Overall Study||10
8852030|NCT01753323|9906953|FG002|STARTED|Overall Study||22
8852031|NCT01753323|9906951|FG000|Pharmacodynamic (PD) Set|Overall Study||10
8852032|NCT01753323|9906952|FG001|Pharmacodynamic (PD) Set|Overall Study||10
8852033|NCT01753323|9906953|FG002|Pharmacodynamic (PD) Set|Overall Study||21
8852034|NCT01753323|9906951|FG000|Pharmacokinetic(PK) Set|Overall Study||10
8949018|NCT02435524|10011542|FG000|COMPLETED|Baseline Survey|Design: 2 independent cross-sectional surveys; baseline & endline participants not same individuals|1111
8949019|NCT02435524|10011543|FG001|COMPLETED|Baseline Survey|Design: 2 independent cross-sectional surveys; baseline & endline participants not same individuals|1177
8949020|NCT02435524|10011542|FG000|NOT COMPLETED|Baseline Survey||0
8949021|NCT02435524|10011543|FG001|NOT COMPLETED|Baseline Survey||0
8949022|NCT02435524|10011542|FG000|STARTED|Endline Survey||1092
8949023|NCT02435524|10011543|FG001|STARTED|Endline Survey||1161
8949024|NCT02435524|10011542|FG000|COMPLETED|Endline Survey|Design: 2 independent cross-sectional surveys; baseline & endline participants not same individuals|1092
8949025|NCT02435524|10011543|FG001|COMPLETED|Endline Survey|Design: 2 independent cross-sectional surveys; baseline & endline participants not same individuals|1161
8949026|NCT02435524|10011542|FG000|NOT COMPLETED|Endline Survey||0
8949027|NCT02435524|10011543|FG001|NOT COMPLETED|Endline Survey||0
8949028|NCT02435680|10011552|FG000|STARTED|Overall Study||21
8949029|NCT02435680|10011553|FG001|STARTED|Overall Study||13
8949030|NCT02435680|10011554|FG002|STARTED|Overall Study||16
8949031|NCT02435680|10011552|FG000|COMPLETED|Overall Study||0
8949032|NCT02435680|10011553|FG001|COMPLETED|Overall Study||0
8949033|NCT02435680|10011554|FG002|COMPLETED|Overall Study||0
8949034|NCT02435680|10011552|FG000|NOT COMPLETED|Overall Study||21
8949035|NCT02435680|10011553|FG001|NOT COMPLETED|Overall Study||13
8949036|NCT02435680|10011554|FG002|NOT COMPLETED|Overall Study||16
8949037|NCT02435706|10011568|FG000|STARTED|Overall Study||18
8949038|NCT02435706|10011569|FG001|STARTED|Overall Study||21
8949039|NCT02435706|10011568|FG000|COMPLETED|Overall Study||16
8949040|NCT02435706|10011569|FG001|COMPLETED|Overall Study||20
8949041|NCT02435706|10011568|FG000|NOT COMPLETED|Overall Study||2
8949042|NCT02435706|10011569|FG001|NOT COMPLETED|Overall Study||1
8949043|NCT02435836|10011575|FG000|STARTED|Overall Study||631
8949044|NCT02435836|10011575|FG000|COMPLETED|Overall Study||0
8949045|NCT02435836|10011575|FG000|NOT COMPLETED|Overall Study||631
8949046|NCT02435901|10011579|FG000|STARTED|Overall Study||29
8949047|NCT02435901|10011579|FG000|COMPLETED|Overall Study||29
8949048|NCT02435901|10011579|FG000|NOT COMPLETED|Overall Study||0
8949049|NCT02435914|10011588|FG000|STARTED|Overall Study||58
8949050|NCT02435914|10011589|FG001|STARTED|Overall Study||59
8949051|NCT02435914|10011590|FG002|STARTED|Overall Study||60
8949052|NCT02435914|10011591|FG003|STARTED|Overall Study||59
8949053|NCT02435914|10011588|FG000|COMPLETED|Overall Study||57
8949054|NCT02435914|10011589|FG001|COMPLETED|Overall Study||58
8949055|NCT02435914|10011590|FG002|COMPLETED|Overall Study||59
8949056|NCT02435914|10011591|FG003|COMPLETED|Overall Study||59
8949057|NCT02435914|10011588|FG000|NOT COMPLETED|Overall Study||1
8949058|NCT02435914|10011589|FG001|NOT COMPLETED|Overall Study||1
8949059|NCT02435914|10011590|FG002|NOT COMPLETED|Overall Study||1
8629720|NCT00531284|9669425|FG001|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|0
8629721|NCT00531284|9669426|FG002|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|1
8629722|NCT00531284|9669427|FG003|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|2
8629723|NCT00531284|9669428|FG004|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
8949060|NCT02435914|10011591|FG003|NOT COMPLETED|Overall Study||0
8949061|NCT02435966|10011604|FG000|STARTED|Overall Study||47
8629724|NCT00531284|9669429|FG005|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
8629725|NCT00531284|9669430|FG006|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
8629726|NCT00531284|9669431|FG007|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
8949062|NCT02435966|10011605|FG001|STARTED|Overall Study||54
8949063|NCT02435966|10011606|FG002|STARTED|Overall Study||30
8852035|NCT01753323|9906952|FG001|Pharmacokinetic(PK) Set|Overall Study||10
8852036|NCT01753323|9906953|FG002|Pharmacokinetic(PK) Set|Overall Study||21
8852037|NCT01753323|9906951|FG000|Safety Set|Overall Study||11
8852038|NCT01753323|9906952|FG001|Safety Set|Overall Study||10
8852039|NCT01753323|9906953|FG002|Safety Set|Overall Study||22
8852040|NCT01753323|9906951|FG000|Intent-to-treat Analysis Set|Overall Study||11
8852041|NCT01753323|9906952|FG001|Intent-to-treat Analysis Set|Overall Study||10
8852042|NCT01753323|9906953|FG002|Intent-to-treat Analysis Set|Overall Study||22
8852043|NCT01753323|9906951|FG000|COMPLETED|Overall Study||10
8852044|NCT01753323|9906952|FG001|COMPLETED|Overall Study||10
8852045|NCT01753323|9906953|FG002|COMPLETED|Overall Study||13
8852046|NCT01753323|9906951|FG000|NOT COMPLETED|Overall Study||1
8852047|NCT01753323|9906952|FG001|NOT COMPLETED|Overall Study||0
8852048|NCT01753323|9906953|FG002|NOT COMPLETED|Overall Study||9
8852049|NCT01753336|9906962|FG000|STARTED|Overall Study||112
8852050|NCT01753336|9906962|FG000|Cycle 1|Overall Study||112
8852051|NCT01753336|9906962|FG000|Cycle 2|Overall Study||98
8852052|NCT01753336|9906962|FG000|Cycle 3|Overall Study||93
8852053|NCT01753336|9906962|FG000|COMPLETED|Overall Study||92
8852054|NCT01753336|9906962|FG000|NOT COMPLETED|Overall Study||20
8852055|NCT01753362|9906968|FG000|STARTED|Overall Study||36
8852056|NCT01753362|9906969|FG001|STARTED|Overall Study||48
8852057|NCT01753362|9906968|FG000|COMPLETED|Overall Study||26
8852058|NCT01753362|9906969|FG001|COMPLETED|Overall Study||40
8852059|NCT01753362|9906968|FG000|NOT COMPLETED|Overall Study||10
8852060|NCT01753362|9906969|FG001|NOT COMPLETED|Overall Study||8
8852061|NCT01753401|9906977|FG000|STARTED|Double-blind Period (8 Weeks)||12
8852062|NCT01753401|9906978|FG001|STARTED|Double-blind Period (8 Weeks)||26
8852063|NCT01753401|9906979|FG002|STARTED|Double-blind Period (8 Weeks)|This arm was not included in the double-blind period|0
8852064|NCT01753401|9906980|FG003|STARTED|Double-blind Period (8 Weeks)|This arm was not included in the double-blind period|0
8852065|NCT01753401|9906977|FG000|Modified Intent to Treat (mITT)|Double-blind Period (8 Weeks)||11
8852066|NCT01753401|9906978|FG001|Modified Intent to Treat (mITT)|Double-blind Period (8 Weeks)||25
8852067|NCT01753401|9906979|FG002|Modified Intent to Treat (mITT)|Double-blind Period (8 Weeks)||0
8852068|NCT01753401|9906980|FG003|Modified Intent to Treat (mITT)|Double-blind Period (8 Weeks)||0
8852069|NCT01753401|9906977|FG000|COMPLETED|Double-blind Period (8 Weeks)||11
8852070|NCT01753401|9906978|FG001|COMPLETED|Double-blind Period (8 Weeks)||22
8852071|NCT01753401|9906979|FG002|COMPLETED|Double-blind Period (8 Weeks)||0
8852072|NCT01753401|9906980|FG003|COMPLETED|Double-blind Period (8 Weeks)||0
8852073|NCT01753401|9906977|FG000|NOT COMPLETED|Double-blind Period (8 Weeks)||1
8852074|NCT01753401|9906978|FG001|NOT COMPLETED|Double-blind Period (8 Weeks)||4
8852075|NCT01753401|9906979|FG002|NOT COMPLETED|Double-blind Period (8 Weeks)||0
8852076|NCT01753401|9906980|FG003|NOT COMPLETED|Double-blind Period (8 Weeks)||0
8852077|NCT01753401|9906977|FG000|STARTED|Open Label Period (44 Weeks)|This arm was not included in the open label period|0
8852078|NCT01753401|9906978|FG001|STARTED|Open Label Period (44 Weeks)|This arm was not included in the open label period|0
8852079|NCT01753401|9906979|FG002|STARTED|Open Label Period (44 Weeks)||11
8852080|NCT01753401|9906980|FG003|STARTED|Open Label Period (44 Weeks)||22
8852081|NCT01753401|9906977|FG000|mITT|Open Label Period (44 Weeks)||0
8852082|NCT01753401|9906978|FG001|mITT|Open Label Period (44 Weeks)||0
8852083|NCT01753401|9906979|FG002|mITT|Open Label Period (44 Weeks)||11
8852084|NCT01753401|9906980|FG003|mITT|Open Label Period (44 Weeks)||22
8852085|NCT01753401|9906977|FG000|Safety Analysis Set|Open Label Period (44 Weeks)||0
8852086|NCT01753401|9906978|FG001|Safety Analysis Set|Open Label Period (44 Weeks)||0
8852087|NCT01753401|9906979|FG002|Safety Analysis Set|Open Label Period (44 Weeks)||11
8852088|NCT01753401|9906980|FG003|Safety Analysis Set|Open Label Period (44 Weeks)||22
8852089|NCT01753401|9906977|FG000|COMPLETED|Open Label Period (44 Weeks)||0
8852090|NCT01753401|9906978|FG001|COMPLETED|Open Label Period (44 Weeks)||0
8852091|NCT01753401|9906979|FG002|COMPLETED|Open Label Period (44 Weeks)||7
8852092|NCT01753401|9906980|FG003|COMPLETED|Open Label Period (44 Weeks)||13
8852093|NCT01753401|9906977|FG000|NOT COMPLETED|Open Label Period (44 Weeks)||0
8852094|NCT01753401|9906978|FG001|NOT COMPLETED|Open Label Period (44 Weeks)||0
8852095|NCT01753401|9906979|FG002|NOT COMPLETED|Open Label Period (44 Weeks)||4
8852096|NCT01753401|9906980|FG003|NOT COMPLETED|Open Label Period (44 Weeks)||9
8852097|NCT01753518|9906992|FG000|STARTED|Intention-to-Treat Analysis||110
8852098|NCT01753518|9906993|FG001|STARTED|Intention-to-Treat Analysis||110
8852099|NCT01753518|9906992|FG000|COMPLETED|Intention-to-Treat Analysis||103
8852100|NCT01753518|9906993|FG001|COMPLETED|Intention-to-Treat Analysis||103
8852101|NCT01753518|9906992|FG000|NOT COMPLETED|Intention-to-Treat Analysis||7
8852102|NCT01753518|9906993|FG001|NOT COMPLETED|Intention-to-Treat Analysis||7
8852103|NCT01753518|9906992|FG000|STARTED|Postpartum Follow-up||103
8852104|NCT01753518|9906993|FG001|STARTED|Postpartum Follow-up||103
8852105|NCT01753518|9906992|FG000|COMPLETED|Postpartum Follow-up||81
8852106|NCT01753518|9906993|FG001|COMPLETED|Postpartum Follow-up||88
8852107|NCT01753518|9906992|FG000|NOT COMPLETED|Postpartum Follow-up||22
8852108|NCT01753518|9906993|FG001|NOT COMPLETED|Postpartum Follow-up||15
8852109|NCT01753557|9907001|FG000|STARTED|Overall Study||35
8852110|NCT01753557|9907002|FG001|STARTED|Overall Study||19
8852111|NCT01753557|9907001|FG000|COMPLETED|Overall Study||35
8852112|NCT01753557|9907002|FG001|COMPLETED|Overall Study||19
8852113|NCT01753557|9907001|FG000|NOT COMPLETED|Overall Study||0
8852114|NCT01753557|9907002|FG001|NOT COMPLETED|Overall Study||0
8852115|NCT01753570|9907012|FG000|STARTED|Overall Study||30
8852116|NCT01753570|9907013|FG001|STARTED|Overall Study||30
8852117|NCT01753570|9907014|FG002|STARTED|Overall Study||14
8852118|NCT01753570|9907012|FG000|COMPLETED|Overall Study||28
8852119|NCT01753570|9907013|FG001|COMPLETED|Overall Study||25
8852120|NCT01753570|9907014|FG002|COMPLETED|Overall Study||13
8852121|NCT01753570|9907012|FG000|NOT COMPLETED|Overall Study||2
8852122|NCT01753570|9907013|FG001|NOT COMPLETED|Overall Study||5
8852123|NCT01753570|9907014|FG002|NOT COMPLETED|Overall Study||1
8852124|NCT01753713|9907025|FG000|STARTED|Overall Study||14
8852125|NCT01753713|9907026|FG001|STARTED|Overall Study||19
8852126|NCT01753713|9907025|FG000|COMPLETED|Overall Study||14
8852127|NCT01753713|9907026|FG001|COMPLETED|Overall Study||19
8852128|NCT01753713|9907025|FG000|NOT COMPLETED|Overall Study||0
8852129|NCT01753713|9907026|FG001|NOT COMPLETED|Overall Study||0
8852130|NCT01753739|9907037|FG000|STARTED|Overall Study||124
8852131|NCT01753739|9907038|FG001|STARTED|Overall Study||123
8852132|NCT01753739|9907039|FG002|STARTED|Overall Study||123
8852133|NCT01753739|9907040|FG003|STARTED|Overall Study||124
8852134|NCT01753739|9907041|FG004|STARTED|Overall Study||123
8852135|NCT01753739|9907037|FG000|COMPLETED|Overall Study||120
8852136|NCT01753739|9907038|FG001|COMPLETED|Overall Study||118
8852137|NCT01753739|9907039|FG002|COMPLETED|Overall Study||118
8852138|NCT01753739|9907040|FG003|COMPLETED|Overall Study||117
8852139|NCT01753739|9907041|FG004|COMPLETED|Overall Study||120
8852140|NCT01753739|9907037|FG000|NOT COMPLETED|Overall Study||4
8852141|NCT01753739|9907038|FG001|NOT COMPLETED|Overall Study||5
8852142|NCT01753739|9907039|FG002|NOT COMPLETED|Overall Study||5
8852143|NCT01753739|9907040|FG003|NOT COMPLETED|Overall Study||7
8852144|NCT01753739|9907041|FG004|NOT COMPLETED|Overall Study||3
8852145|NCT01753830|9907055|FG000|STARTED|Overall Study||37
8852146|NCT01753830|9907056|FG001|STARTED|Overall Study||38
8852147|NCT01753830|9907055|FG000|COMPLETED|Overall Study||30
8852148|NCT01753830|9907056|FG001|COMPLETED|Overall Study||35
8852149|NCT01753830|9907055|FG000|NOT COMPLETED|Overall Study||7
8852150|NCT01753830|9907056|FG001|NOT COMPLETED|Overall Study||3
8852151|NCT01753856|9907064|FG000|STARTED|Overall Study||33
8852152|NCT01753856|9907065|FG001|STARTED|Overall Study||36
8852153|NCT01753856|9907064|FG000|Received at Least 1 Dose of Study Drug|Overall Study||33
8569487|NCT00097695|9601739|FG002|COMPLETED|The Controlled Phase||3
8569488|NCT00097695|9601740|FG003|COMPLETED|The Controlled Phase|Patients screened and found eligible but did not have HAE attack or attack was not severe enough|0
8569489|NCT00097695|9601737|FG000|NOT COMPLETED|The Controlled Phase||4
8569490|NCT00097695|9601738|FG001|NOT COMPLETED|The Controlled Phase||3
8852154|NCT01753856|9907065|FG001|Received at Least 1 Dose of Study Drug|Overall Study||36
8852155|NCT01753856|9907064|FG000|Completed 3-Month Bone Biopsy|Overall Study||31
8852156|NCT01753856|9907065|FG001|Completed 3-Month Bone Biopsy|Overall Study||35
8852157|NCT01753856|9907064|FG000|COMPLETED|Overall Study||30
8852158|NCT01753856|9907065|FG001|COMPLETED|Overall Study||34
8852159|NCT01753856|9907064|FG000|NOT COMPLETED|Overall Study||3
8569491|NCT00097695|9601739|FG002|NOT COMPLETED|The Controlled Phase||5
8569492|NCT00097695|9601740|FG003|NOT COMPLETED|The Controlled Phase||20
8569493|NCT00097695|9601737|FG000|STARTED|The Open Label Extension (OLE) Phase||23
8569494|NCT00097695|9601738|FG001|STARTED|The Open Label Extension (OLE) Phase||26
8569495|NCT00097695|9601739|FG002|STARTED|The Open Label Extension (OLE) Phase||3
8569496|NCT00097695|9601740|FG003|STARTED|The Open Label Extension (OLE) Phase||20
8569497|NCT00097695|9601737|FG000|COMPLETED|The Open Label Extension (OLE) Phase||10
8569498|NCT00097695|9601738|FG001|COMPLETED|The Open Label Extension (OLE) Phase||11
8569499|NCT00097695|9601739|FG002|COMPLETED|The Open Label Extension (OLE) Phase||1
8569500|NCT00097695|9601740|FG003|COMPLETED|The Open Label Extension (OLE) Phase||15
8569501|NCT00097695|9601737|FG000|NOT COMPLETED|The Open Label Extension (OLE) Phase||13
8569502|NCT00097695|9601738|FG001|NOT COMPLETED|The Open Label Extension (OLE) Phase||15
8852160|NCT01753856|9907065|FG001|NOT COMPLETED|Overall Study||2
8852161|NCT01753999|9907074|FG000|STARTED|Period 1 - Initial Assignment||155
8852162|NCT01753999|9907075|FG001|STARTED|Period 1 - Initial Assignment||162
8852163|NCT01753999|9907074|FG000|Received Intervention|Period 1 - Initial Assignment||144
8852164|NCT01753999|9907075|FG001|Received Intervention|Period 1 - Initial Assignment||146
8852165|NCT01753999|9907074|FG000|COMPLETED|Period 1 - Initial Assignment||116
8852166|NCT01753999|9907075|FG001|COMPLETED|Period 1 - Initial Assignment||112
8852167|NCT01753999|9907074|FG000|NOT COMPLETED|Period 1 - Initial Assignment||39
8852168|NCT01753999|9907075|FG001|NOT COMPLETED|Period 1 - Initial Assignment||50
8852169|NCT01753999|9907074|FG000|STARTED|Period 2 -Cross to Alternate Arm||116
8852170|NCT01753999|9907075|FG001|STARTED|Period 2 -Cross to Alternate Arm||112
8852171|NCT01753999|9907074|FG000|Received Intervention|Period 2 -Cross to Alternate Arm||103
8852172|NCT01753999|9907075|FG001|Received Intervention|Period 2 -Cross to Alternate Arm||95
8852173|NCT01753999|9907074|FG000|COMPLETED|Period 2 -Cross to Alternate Arm||99
8852174|NCT01753999|9907075|FG001|COMPLETED|Period 2 -Cross to Alternate Arm||89
8852175|NCT01753999|9907074|FG000|NOT COMPLETED|Period 2 -Cross to Alternate Arm||17
8852176|NCT01753999|9907075|FG001|NOT COMPLETED|Period 2 -Cross to Alternate Arm||23
8852177|NCT01754129|9907086|FG000|STARTED|Overall Study||148
8852178|NCT01754129|9907086|FG000|Visit 1 (Enrollment Day)|Overall Study||145
8852179|NCT01754129|9907086|FG000|Visit 2 (Year 1)|Overall Study||129
8852180|NCT01754129|9907086|FG000|Visit 3 (Year 2)|Overall Study||115
8852181|NCT01754129|9907086|FG000|COMPLETED|Overall Study||115
8852182|NCT01754129|9907086|FG000|NOT COMPLETED|Overall Study||33
8852183|NCT01754194|9907099|FG000|STARTED|Overall Study||169
8852184|NCT01754194|9907100|FG001|STARTED|Overall Study||124
8852185|NCT01754194|9907099|FG000|COMPLETED|Overall Study||117
8852186|NCT01754194|9907100|FG001|COMPLETED|Overall Study||97
8852187|NCT01754194|9907099|FG000|NOT COMPLETED|Overall Study||52
8852188|NCT01754194|9907100|FG001|NOT COMPLETED|Overall Study||27
8852189|NCT01754207|9907108|FG000|STARTED|Overall Study||20
8852190|NCT01754207|9907108|FG000|COMPLETED|Overall Study||17
8852191|NCT01754207|9907108|FG000|NOT COMPLETED|Overall Study||3
8852192|NCT01754259|9907114|FG000|STARTED|Overall Study||23
8852193|NCT01754259|9907115|FG001|STARTED|Overall Study||24
8852194|NCT01754259|9907114|FG000|COMPLETED|Overall Study||18
8852195|NCT01754259|9907115|FG001|COMPLETED|Overall Study||18
8852196|NCT01754259|9907114|FG000|NOT COMPLETED|Overall Study||5
8852197|NCT01754259|9907115|FG001|NOT COMPLETED|Overall Study||6
8852198|NCT01754350|9907123|FG000|STARTED|Overall Study||25
8852199|NCT01754350|9907124|FG001|STARTED|Overall Study||25
8852200|NCT01754350|9907123|FG000|COMPLETED|Overall Study||20
8852201|NCT01754350|9907124|FG001|COMPLETED|Overall Study||22
8852202|NCT01754350|9907123|FG000|NOT COMPLETED|Overall Study||5
8852203|NCT01754350|9907124|FG001|NOT COMPLETED|Overall Study||3
8852204|NCT01754376|9907130|FG000|STARTED|Overall Study||6
8852205|NCT01754376|9907130|FG000|Completed 2-week Lead in of Vemurafenib|Overall Study||6
8852206|NCT01754376|9907130|FG000|COMPLETED|Overall Study||3
8852207|NCT01754376|9907130|FG000|NOT COMPLETED|Overall Study||3
8852208|NCT01754389|9907138|FG000|STARTED|Overall Study||46
8852209|NCT01754389|9907139|FG001|STARTED|Overall Study||45
8852210|NCT01754389|9907140|FG002|STARTED|Overall Study||47
8852211|NCT01754389|9907138|FG000|COMPLETED|Overall Study||46
8852212|NCT01754389|9907139|FG001|COMPLETED|Overall Study||45
8852213|NCT01754389|9907140|FG002|COMPLETED|Overall Study||47
8852214|NCT01754389|9907138|FG000|NOT COMPLETED|Overall Study||0
8852215|NCT01754389|9907139|FG001|NOT COMPLETED|Overall Study||0
8852216|NCT01754389|9907140|FG002|NOT COMPLETED|Overall Study||0
8852217|NCT01754402|9907151|FG000|STARTED|Overall Study||6
8852218|NCT01754402|9907152|FG001|STARTED|Overall Study||2
8852219|NCT01754402|9907153|FG002|STARTED|Overall Study||30
8852220|NCT01754402|9907151|FG000|COMPLETED|Overall Study||4
8852221|NCT01754402|9907152|FG001|COMPLETED|Overall Study||0
8852222|NCT01754402|9907153|FG002|COMPLETED|Overall Study||26
8852223|NCT01754402|9907151|FG000|NOT COMPLETED|Overall Study||2
8852224|NCT01754402|9907152|FG001|NOT COMPLETED|Overall Study||2
8852225|NCT01754402|9907153|FG002|NOT COMPLETED|Overall Study||4
8852226|NCT01754467|9907162|FG000|STARTED|Overall Study||9
8852227|NCT01754467|9907162|FG000|COMPLETED|Overall Study||8
8852228|NCT01754467|9907162|FG000|NOT COMPLETED|Overall Study||1
8852229|NCT01754480|9907168|FG000|STARTED|Part I + Part II (Overall Study)||163
8852230|NCT01754480|9907169|FG001|STARTED|Part I + Part II (Overall Study)||162
8852231|NCT01754480|9907168|FG000|Completed Study up to Week 6|Part I + Part II (Overall Study)||147
8852232|NCT01754480|9907169|FG001|Completed Study up to Week 6|Part I + Part II (Overall Study)||153
8852233|NCT01754480|9907168|FG000|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6 (not required for 2 pediatric subjects)|138
8852234|NCT01754480|9907169|FG001|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6 (not required for 3 pediatric subjects)|139
8852235|NCT01754480|9907168|FG000|NOT COMPLETED|Part I + Part II (Overall Study)||25
8852236|NCT01754480|9907169|FG001|NOT COMPLETED|Part I + Part II (Overall Study)||23
8852237|NCT01754480|9907168|FG000|STARTED|Primary Part II||111
8852238|NCT01754480|9907169|FG001|STARTED|Primary Part II||113
8852239|NCT01754480|9907168|FG000|Completed Study up to Week 6|Primary Part II||100
8852240|NCT01754480|9907169|FG001|Completed Study up to Week 6|Primary Part II||108
8852241|NCT01754480|9907168|FG000|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6 (not required for pediatric subjects)|96
8852242|NCT01754480|9907169|FG001|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6 (not required for pediatric subjects)|102
8852243|NCT01754480|9907168|FG000|NOT COMPLETED|Primary Part II||15
8852244|NCT01754480|9907169|FG001|NOT COMPLETED|Primary Part II||11
8852245|NCT01754493|9907176|FG000|STARTED|Overall Study||17
8852246|NCT01754493|9907176|FG000|COMPLETED|Overall Study||10
8852247|NCT01754493|9907176|FG000|NOT COMPLETED|Overall Study||7
8852248|NCT01754519|9907180|FG000|STARTED|Overall Study||1
8852249|NCT01754519|9907180|FG000|COMPLETED|Overall Study||1
8852250|NCT01754519|9907180|FG000|NOT COMPLETED|Overall Study||0
8852251|NCT01754623|9907184|FG000|STARTED|Overall Study||9
8852252|NCT01754623|9907184|FG000|COMPLETED|Overall Study||9
8852253|NCT01754623|9907184|FG000|NOT COMPLETED|Overall Study||0
8852254|NCT01754688|9907190|FG000|STARTED|Overall Study||624
8852255|NCT01754688|9907190|FG000|COMPLETED|Overall Study||624
8852256|NCT01754688|9907190|FG000|NOT COMPLETED|Overall Study||0
8852257|NCT01754714|9907199|FG000|STARTED|Overall Study||27
8852258|NCT01754714|9907200|FG001|STARTED|Overall Study||27
8852259|NCT01754714|9907201|FG002|STARTED|Overall Study||26
8852260|NCT01754714|9907202|FG003|STARTED|Overall Study||28
8852261|NCT01754714|9907199|FG000|COMPLETED|Overall Study||27
8852262|NCT01754714|9907200|FG001|COMPLETED|Overall Study||26
8852263|NCT01754714|9907201|FG002|COMPLETED|Overall Study||24
8852264|NCT01754714|9907202|FG003|COMPLETED|Overall Study||27
8852265|NCT01754714|9907199|FG000|NOT COMPLETED|Overall Study||0
8852266|NCT01754714|9907200|FG001|NOT COMPLETED|Overall Study||1
8852267|NCT01754714|9907201|FG002|NOT COMPLETED|Overall Study||2
8852268|NCT01754714|9907202|FG003|NOT COMPLETED|Overall Study||1
8852269|NCT01754727|9907213|FG000|STARTED|Overall Study||452
8852270|NCT01754727|9907213|FG000|COMPLETED|Overall Study||450
8852271|NCT01754727|9907213|FG000|NOT COMPLETED|Overall Study||2
8852272|NCT01754753|9907219|FG000|STARTED|Overall Study||78
8852273|NCT01754753|9907220|FG001|STARTED|Overall Study||79
8852274|NCT01754753|9907219|FG000|COMPLETED|Overall Study||26
8852275|NCT01754753|9907220|FG001|COMPLETED|Overall Study||30
8852276|NCT01754753|9907219|FG000|NOT COMPLETED|Overall Study||52
8852277|NCT01754753|9907220|FG001|NOT COMPLETED|Overall Study||49
8852278|NCT01754766|9907229|FG000|STARTED|Overall Study||31
8852279|NCT01754766|9907230|FG001|STARTED|Overall Study||29
8852280|NCT01754766|9907231|FG002|STARTED|Overall Study||30
8852281|NCT01754766|9907229|FG000|COMPLETED|Overall Study||30
8852282|NCT01754766|9907230|FG001|COMPLETED|Overall Study||28
8852283|NCT01754766|9907231|FG002|COMPLETED|Overall Study||30
8852284|NCT01754766|9907229|FG000|NOT COMPLETED|Overall Study||1
8852285|NCT01754766|9907230|FG001|NOT COMPLETED|Overall Study||1
8852286|NCT01754766|9907231|FG002|NOT COMPLETED|Overall Study||0
8852287|NCT01754909|9907241|FG000|STARTED|Overall Study||20
8852288|NCT01754909|9907242|FG001|STARTED|Overall Study||23
8852289|NCT01754909|9907241|FG000|COMPLETED|Overall Study||20
8852290|NCT01754909|9907242|FG001|COMPLETED|Overall Study||23
8852291|NCT01754909|9907241|FG000|NOT COMPLETED|Overall Study||0
8852292|NCT01754909|9907242|FG001|NOT COMPLETED|Overall Study||0
8852293|NCT01754922|9907250|FG000|STARTED|Overall Study||32
8852294|NCT01754922|9907251|FG001|STARTED|Overall Study||18
8852295|NCT01754922|9907250|FG000|COMPLETED|Overall Study||32
8852296|NCT01754922|9907251|FG001|COMPLETED|Overall Study||17
8852297|NCT01754922|9907250|FG000|NOT COMPLETED|Overall Study||0
8852298|NCT01754922|9907251|FG001|NOT COMPLETED|Overall Study||1
8852299|NCT01755026|9907260|FG000|STARTED|Overall Study||11
8852300|NCT01755026|9907261|FG001|STARTED|Overall Study||12
8852301|NCT01755026|9907260|FG000|COMPLETED|Overall Study||9
8852302|NCT01755026|9907261|FG001|COMPLETED|Overall Study||11
8852303|NCT01755026|9907260|FG000|NOT COMPLETED|Overall Study||2
8852304|NCT01755026|9907261|FG001|NOT COMPLETED|Overall Study||1
8852305|NCT01755091|9907270|FG000|STARTED|Overall Study||26
8852306|NCT01755091|9907271|FG001|STARTED|Overall Study||22
8852307|NCT01755091|9907272|FG002|STARTED|Overall Study||27
8852308|NCT01755091|9907270|FG000|COMPLETED|Overall Study||17
8852309|NCT01755091|9907271|FG001|COMPLETED|Overall Study||19
8852310|NCT01755091|9907272|FG002|COMPLETED|Overall Study||20
8852311|NCT01755091|9907270|FG000|NOT COMPLETED|Overall Study||9
8852312|NCT01755091|9907271|FG001|NOT COMPLETED|Overall Study||3
8852313|NCT01755091|9907272|FG002|NOT COMPLETED|Overall Study||7
8852314|NCT01755143|9907282|FG000|STARTED|Overall Study||177
8852315|NCT01755143|9907283|FG001|STARTED|Overall Study||89
8852316|NCT01755143|9907282|FG000|COMPLETED|Overall Study||166
8852317|NCT01755143|9907283|FG001|COMPLETED|Overall Study||86
8852318|NCT01755143|9907282|FG000|NOT COMPLETED|Overall Study||11
8852319|NCT01755143|9907283|FG001|NOT COMPLETED|Overall Study||3
8852320|NCT01755156|9907291|FG000|STARTED|Phase A (Weeks 0-24)||201
8852321|NCT01755156|9907292|FG001|STARTED|Phase A (Weeks 0-24)||201
8852322|NCT01755156|9907291|FG000|COMPLETED|Phase A (Weeks 0-24)||184
8852323|NCT01755156|9907292|FG001|COMPLETED|Phase A (Weeks 0-24)||177
8852324|NCT01755156|9907291|FG000|NOT COMPLETED|Phase A (Weeks 0-24)||17
8852325|NCT01755156|9907292|FG001|NOT COMPLETED|Phase A (Weeks 0-24)||24
8852326|NCT01755156|9907291|FG000|STARTED|Phase B (Weeks 24-104)|1 participant who completed Phase A did not continue to Phase B.|183
8852327|NCT01755156|9907292|FG001|STARTED|Phase B (Weeks 24-104)||177
8852328|NCT01755156|9907291|FG000|COMPLETED|Phase B (Weeks 24-104)||144
8852329|NCT01755156|9907292|FG001|COMPLETED|Phase B (Weeks 24-104)||141
8852330|NCT01755156|9907291|FG000|NOT COMPLETED|Phase B (Weeks 24-104)||39
8852331|NCT01755156|9907292|FG001|NOT COMPLETED|Phase B (Weeks 24-104)||36
8852332|NCT01755169|9907306|FG000|STARTED|Overall Study||2
8852333|NCT01755169|9907307|FG001|STARTED|Overall Study||1
8852334|NCT01755169|9907308|FG002|STARTED|Overall Study||0
8852335|NCT01755169|9907309|FG003|STARTED|Overall Study||1
8852336|NCT01755169|9907306|FG000|COMPLETED|Overall Study||2
8852337|NCT01755169|9907307|FG001|COMPLETED|Overall Study||1
8852338|NCT01755169|9907308|FG002|COMPLETED|Overall Study||0
8852339|NCT01755169|9907309|FG003|COMPLETED|Overall Study||1
8852340|NCT01755169|9907306|FG000|NOT COMPLETED|Overall Study||0
8852341|NCT01755169|9907307|FG001|NOT COMPLETED|Overall Study||0
8852342|NCT01755169|9907308|FG002|NOT COMPLETED|Overall Study||0
8852343|NCT01755169|9907309|FG003|NOT COMPLETED|Overall Study||0
8852344|NCT01755195|9907319|FG000|STARTED|Overall Study||55
8852345|NCT01755195|9907319|FG000|COMPLETED|Overall Study||42
8852346|NCT01755195|9907319|FG000|NOT COMPLETED|Overall Study||13
8852347|NCT01755234|9907325|FG000|STARTED|Overall Study||45
8852348|NCT01755234|9907326|FG001|STARTED|Overall Study||45
8852349|NCT01755234|9907325|FG000|COMPLETED|Overall Study||30
8852350|NCT01755234|9907326|FG001|COMPLETED|Overall Study||37
8852351|NCT01755234|9907325|FG000|NOT COMPLETED|Overall Study||15
8852352|NCT01755234|9907326|FG001|NOT COMPLETED|Overall Study||8
8852353|NCT01755416|9907332|FG000|STARTED|First Intervention ( Upto 2 Days)||9
8852354|NCT01755416|9907333|FG001|STARTED|First Intervention ( Upto 2 Days)||9
8852355|NCT01755416|9907332|FG000|COMPLETED|First Intervention ( Upto 2 Days)||8
8852356|NCT01755416|9907333|FG001|COMPLETED|First Intervention ( Upto 2 Days)||7
8852357|NCT01755416|9907332|FG000|NOT COMPLETED|First Intervention ( Upto 2 Days)||1
8852358|NCT01755416|9907333|FG001|NOT COMPLETED|First Intervention ( Upto 2 Days)||2
8852359|NCT01755416|9907332|FG000|STARTED|Second Intervention (Upto 2 Days)||8
8852360|NCT01755416|9907333|FG001|STARTED|Second Intervention (Upto 2 Days)||7
8852361|NCT01755416|9907332|FG000|COMPLETED|Second Intervention (Upto 2 Days)||8
8852362|NCT01755416|9907333|FG001|COMPLETED|Second Intervention (Upto 2 Days)||7
8852363|NCT01755416|9907332|FG000|NOT COMPLETED|Second Intervention (Upto 2 Days)||0
8852364|NCT01755416|9907333|FG001|NOT COMPLETED|Second Intervention (Upto 2 Days)||0
8852365|NCT01755455|9907339|FG000|STARTED|First Intervention (6 Weeks)||11
8852366|NCT01755455|9907340|FG001|STARTED|First Intervention (6 Weeks)||11
8852367|NCT01755455|9907339|FG000|COMPLETED|First Intervention (6 Weeks)||11
8852368|NCT01755455|9907340|FG001|COMPLETED|First Intervention (6 Weeks)||11
8852369|NCT01755455|9907339|FG000|NOT COMPLETED|First Intervention (6 Weeks)||0
8852370|NCT01755455|9907340|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0
8852371|NCT01755455|9907339|FG000|STARTED|Washout (4 Weeks)||11
8852372|NCT01755455|9907340|FG001|STARTED|Washout (4 Weeks)||11
8852373|NCT01755455|9907339|FG000|COMPLETED|Washout (4 Weeks)||11
8852374|NCT01755455|9907340|FG001|COMPLETED|Washout (4 Weeks)||11
8852375|NCT01755455|9907339|FG000|NOT COMPLETED|Washout (4 Weeks)||0
8852376|NCT01755455|9907340|FG001|NOT COMPLETED|Washout (4 Weeks)||0
8852377|NCT01755455|9907339|FG000|STARTED|Second Intervention (6 Weeks)||11
8852378|NCT01755455|9907340|FG001|STARTED|Second Intervention (6 Weeks)||11
8852379|NCT01755455|9907339|FG000|COMPLETED|Second Intervention (6 Weeks)||11
8852380|NCT01755455|9907340|FG001|COMPLETED|Second Intervention (6 Weeks)||11
8852381|NCT01755455|9907339|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
8852382|NCT01755455|9907340|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0
8852383|NCT01755546|9907346|FG000|STARTED|Screened and Taper (Rollover and DeNovo)||304
8852384|NCT01755546|9907346|FG000|COMPLETED|Screened and Taper (Rollover and DeNovo)||294
8852385|NCT01755546|9907346|FG000|NOT COMPLETED|Screened and Taper (Rollover and DeNovo)||10
8852386|NCT01755546|9907346|FG000|STARTED|Titration Phase||294
8852387|NCT01755546|9907346|FG000|COMPLETED|Titration Phase||224
8852388|NCT01755546|9907346|FG000|NOT COMPLETED|Titration Phase||70
8852389|NCT01755546|9907346|FG000|STARTED|Long Term Treatment||224
8852390|NCT01755546|9907346|FG000|COMPLETED|Long Term Treatment||103
8852391|NCT01755546|9907346|FG000|NOT COMPLETED|Long Term Treatment||121
8852392|NCT01755598|9907352|FG000|STARTED|Overall Study||1786
8852393|NCT01755598|9907353|FG001|STARTED|Overall Study||1787
8852394|NCT01755598|9907352|FG000|COMPLETED|Overall Study||1521
8852395|NCT01755598|9907353|FG001|COMPLETED|Overall Study||1504
8852396|NCT01755598|9907352|FG000|NOT COMPLETED|Overall Study||265
8852397|NCT01755598|9907353|FG001|NOT COMPLETED|Overall Study||283
8852398|NCT01755637|9907359|FG000|STARTED|Period 1||28
8852399|NCT01755637|9907360|FG001|STARTED|Period 1||28
8852400|NCT01755637|9907359|FG000|COMPLETED|Period 1||28
8629727|NCT00531284|9669432|FG008|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
8691254|NCT00853840|9736489|FG000|STARTED|Period 1||9
8852401|NCT01755637|9907360|FG001|COMPLETED|Period 1||27
8852402|NCT01755637|9907359|FG000|NOT COMPLETED|Period 1||0
8852403|NCT01755637|9907360|FG001|NOT COMPLETED|Period 1||1
8852404|NCT01755637|9907359|FG000|STARTED|Period 2||28
8852405|NCT01755637|9907360|FG001|STARTED|Period 2||27
8852406|NCT01755637|9907359|FG000|COMPLETED|Period 2||28
8852407|NCT01755637|9907360|FG001|COMPLETED|Period 2||27
8852408|NCT01755637|9907359|FG000|NOT COMPLETED|Period 2||0
8852409|NCT01755637|9907360|FG001|NOT COMPLETED|Period 2||0
8852410|NCT01755702|9907372|FG000|STARTED|Period I||66
8852411|NCT01755702|9907372|FG000|Received Paracetamol|Period I||16
8852412|NCT01755702|9907372|FG000|Received Placebo|Period I||17
8852413|NCT01755702|9907372|FG000|Received Ibuprofen|Period I||16
8852414|NCT01755702|9907372|FG000|Received Paracetamol/Caffeine|Period I||17
8852415|NCT01755702|9907372|FG000|COMPLETED|Period I||66
8852416|NCT01755702|9907372|FG000|NOT COMPLETED|Period I||0
8852417|NCT01755702|9907372|FG000|STARTED|Wash Out Period I||66
8852418|NCT01755702|9907372|FG000|COMPLETED|Wash Out Period I||63
8852419|NCT01755702|9907372|FG000|NOT COMPLETED|Wash Out Period I||3
8852420|NCT01755702|9907372|FG000|STARTED|Period II||63
8852421|NCT01755702|9907372|FG000|Received Ibuprofen|Period II||11
8852422|NCT01755702|9907372|FG000|Received Placebo|Period II||15
8852423|NCT01755702|9907372|FG000|Received Paracetamol/Caffeine|Period II||20
8949064|NCT02435966|10011604|FG000|First Intervention|Overall Study||47
8949065|NCT02435966|10011605|FG001|First Intervention|Overall Study||54
8949066|NCT02435966|10011606|FG002|First Intervention|Overall Study||30
8949067|NCT02435966|10011604|FG000|Second Intervention|Overall Study||47
8949068|NCT02435966|10011605|FG001|Second Intervention|Overall Study||53
8949069|NCT02435966|10011606|FG002|Second Intervention|Overall Study||30
8852424|NCT01755702|9907372|FG000|Received Paracetamol|Period II||17
8852425|NCT01755702|9907372|FG000|COMPLETED|Period II||63
8852426|NCT01755702|9907372|FG000|NOT COMPLETED|Period II||0
8852427|NCT01755702|9907372|FG000|STARTED|Washout Period II||63
8852428|NCT01755702|9907372|FG000|COMPLETED|Washout Period II||58
8852429|NCT01755702|9907372|FG000|NOT COMPLETED|Washout Period II||5
8852430|NCT01755702|9907372|FG000|STARTED|Period III||58
8852431|NCT01755702|9907372|FG000|Received Paracetamol|Period III||17
8852432|NCT01755702|9907372|FG000|Received Placebo|Period III||13
8852433|NCT01755702|9907372|FG000|Received Paracetamol/Caffeine|Period III||10
8852434|NCT01755702|9907372|FG000|Received Ibuprofen|Period III||18
8852435|NCT01755702|9907372|FG000|COMPLETED|Period III||58
8852436|NCT01755702|9907372|FG000|NOT COMPLETED|Period III||0
8852437|NCT01755767|9907386|FG000|STARTED|Overall Study||28
8852438|NCT01755767|9907387|FG001|STARTED|Overall Study||15
8852439|NCT01755767|9907388|FG002|STARTED|Overall Study||226
8852440|NCT01755767|9907389|FG003|STARTED|Overall Study||114
8852441|NCT01755767|9907386|FG000|COMPLETED|Overall Study||0
8852442|NCT01755767|9907387|FG001|COMPLETED|Overall Study||0
8852443|NCT01755767|9907388|FG002|COMPLETED|Overall Study||0
8852444|NCT01755767|9907389|FG003|COMPLETED|Overall Study||0
8852445|NCT01755767|9907386|FG000|NOT COMPLETED|Overall Study||28
8852446|NCT01755767|9907387|FG001|NOT COMPLETED|Overall Study||15
8852447|NCT01755767|9907388|FG002|NOT COMPLETED|Overall Study||226
8852448|NCT01755767|9907389|FG003|NOT COMPLETED|Overall Study||114
8852449|NCT01755858|9907401|FG000|STARTED|Overall Study||7
8852450|NCT01755858|9907402|FG001|STARTED|Overall Study||9
8852451|NCT01755858|9907401|FG000|COMPLETED|Overall Study||6
8852452|NCT01755858|9907402|FG001|COMPLETED|Overall Study||8
8852453|NCT01755858|9907401|FG000|NOT COMPLETED|Overall Study||1
8852454|NCT01755858|9907402|FG001|NOT COMPLETED|Overall Study||1
8852455|NCT01755949|9907416|FG000|STARTED|Overall Study||5
8852456|NCT01755949|9907417|FG001|STARTED|Overall Study||5
8852457|NCT01755949|9907418|FG002|STARTED|Overall Study||4
8852458|NCT01755949|9907419|FG003|STARTED|Overall Study||5
8852459|NCT01755949|9907420|FG004|STARTED|Overall Study||4
8852460|NCT01755949|9907421|FG005|STARTED|Overall Study||3
8852461|NCT01755949|9907416|FG000|COMPLETED|Overall Study||5
8852462|NCT01755949|9907417|FG001|COMPLETED|Overall Study||5
8852463|NCT01755949|9907418|FG002|COMPLETED|Overall Study||4
8852464|NCT01755949|9907419|FG003|COMPLETED|Overall Study||5
8577530|NCT00159263|9610315|FG005|NOT COMPLETED|Fifth Intervention||0
8852465|NCT01755949|9907420|FG004|COMPLETED|Overall Study||4
8852466|NCT01755949|9907421|FG005|COMPLETED|Overall Study||3
8852467|NCT01755949|9907416|FG000|NOT COMPLETED|Overall Study||0
8852468|NCT01755949|9907417|FG001|NOT COMPLETED|Overall Study||0
8852469|NCT01755949|9907418|FG002|NOT COMPLETED|Overall Study||0
8852470|NCT01755949|9907419|FG003|NOT COMPLETED|Overall Study||0
8852471|NCT01755949|9907420|FG004|NOT COMPLETED|Overall Study||0
8852472|NCT01755949|9907421|FG005|NOT COMPLETED|Overall Study||0
8852473|NCT01756053|9907435|FG000|STARTED|Period 1 (10 Days)||8
8852474|NCT01756053|9907436|FG001|STARTED|Period 1 (10 Days)||9
8852475|NCT01756053|9907435|FG000|COMPLETED|Period 1 (10 Days)||7
8569503|NCT00097695|9601739|FG002|NOT COMPLETED|The Open Label Extension (OLE) Phase||2
8569504|NCT00097695|9601740|FG003|NOT COMPLETED|The Open Label Extension (OLE) Phase||5
8852476|NCT01756053|9907436|FG001|COMPLETED|Period 1 (10 Days)||8
8852477|NCT01756053|9907435|FG000|NOT COMPLETED|Period 1 (10 Days)||1
8852478|NCT01756053|9907436|FG001|NOT COMPLETED|Period 1 (10 Days)||1
8852479|NCT01756053|9907435|FG000|STARTED|Washout Period (~21 Days)||7
8852480|NCT01756053|9907436|FG001|STARTED|Washout Period (~21 Days)||8
8852481|NCT01756053|9907435|FG000|COMPLETED|Washout Period (~21 Days)||7
8852482|NCT01756053|9907436|FG001|COMPLETED|Washout Period (~21 Days)||8
8852483|NCT01756053|9907435|FG000|NOT COMPLETED|Washout Period (~21 Days)||0
8852484|NCT01756053|9907436|FG001|NOT COMPLETED|Washout Period (~21 Days)||0
8852485|NCT01756053|9907435|FG000|STARTED|Period 2 (10 Days)||7
8852486|NCT01756053|9907436|FG001|STARTED|Period 2 (10 Days)||8
8852487|NCT01756053|9907435|FG000|COMPLETED|Period 2 (10 Days)||7
8852488|NCT01756053|9907436|FG001|COMPLETED|Period 2 (10 Days)||6
8852489|NCT01756053|9907435|FG000|NOT COMPLETED|Period 2 (10 Days)||0
8852490|NCT01756053|9907436|FG001|NOT COMPLETED|Period 2 (10 Days)||2
8852491|NCT01756079|9907442|FG000|STARTED|Lead-in: Day 0 to Week 4||58
8852492|NCT01756079|9907442|FG000|COMPLETED|Lead-in: Day 0 to Week 4||58
8852493|NCT01756079|9907442|FG000|NOT COMPLETED|Lead-in: Day 0 to Week 4||0
8852494|NCT01756079|9907442|FG000|STARTED|Treatment / Follow-up: Week 4 to Week 72||58
8852495|NCT01756079|9907442|FG000|Treated in Treatment Period|Treatment / Follow-up: Week 4 to Week 72||54
8852496|NCT01756079|9907442|FG000|COMPLETED|Treatment / Follow-up: Week 4 to Week 72||23
8852497|NCT01756079|9907442|FG000|NOT COMPLETED|Treatment / Follow-up: Week 4 to Week 72||35
8852498|NCT01756157|9907447|FG000|STARTED|First Intervention Period||23
8852499|NCT01756157|9907448|FG001|STARTED|First Intervention Period||24
8852500|NCT01756157|9907447|FG000|COMPLETED|First Intervention Period||22
8852501|NCT01756157|9907448|FG001|COMPLETED|First Intervention Period||22
8852502|NCT01756157|9907447|FG000|NOT COMPLETED|First Intervention Period||1
8852503|NCT01756157|9907448|FG001|NOT COMPLETED|First Intervention Period||2
8852504|NCT01756157|9907447|FG000|STARTED|Washout Period (at Least 7 Days)||22
8852505|NCT01756157|9907448|FG001|STARTED|Washout Period (at Least 7 Days)||22
8852506|NCT01756157|9907447|FG000|COMPLETED|Washout Period (at Least 7 Days)||22
8852507|NCT01756157|9907448|FG001|COMPLETED|Washout Period (at Least 7 Days)||22
8852508|NCT01756157|9907447|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8852509|NCT01756157|9907448|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8852510|NCT01756157|9907447|FG000|STARTED|Second Intervention Period||22
8852511|NCT01756157|9907448|FG001|STARTED|Second Intervention Period||22
8852512|NCT01756157|9907447|FG000|COMPLETED|Second Intervention Period||22
8852513|NCT01756157|9907448|FG001|COMPLETED|Second Intervention Period||22
8852514|NCT01756157|9907447|FG000|NOT COMPLETED|Second Intervention Period||0
8852515|NCT01756157|9907448|FG001|NOT COMPLETED|Second Intervention Period||0
8852516|NCT01756209|9907458|FG000|STARTED|Overall Study||40
8852517|NCT01756209|9907459|FG001|STARTED|Overall Study||40
8852518|NCT01756209|9907460|FG002|STARTED|Overall Study||40
8852519|NCT01756209|9907461|FG003|STARTED|Overall Study||40
8852520|NCT01756209|9907458|FG000|COMPLETED|Overall Study||40
8852521|NCT01756209|9907459|FG001|COMPLETED|Overall Study||40
8852522|NCT01756209|9907460|FG002|COMPLETED|Overall Study||40
8852523|NCT01756209|9907461|FG003|COMPLETED|Overall Study||40
8852524|NCT01756209|9907458|FG000|NOT COMPLETED|Overall Study||0
8852525|NCT01756209|9907459|FG001|NOT COMPLETED|Overall Study||0
8852526|NCT01756209|9907460|FG002|NOT COMPLETED|Overall Study||0
8852527|NCT01756209|9907461|FG003|NOT COMPLETED|Overall Study||0
8852528|NCT01756235|9907471|FG000|STARTED|Overall Study||462
8852529|NCT01756235|9907471|FG000|COMPLETED|Overall Study||460
8852530|NCT01756235|9907471|FG000|NOT COMPLETED|Overall Study||2
8852531|NCT01756274|9907475|FG000|STARTED|Overall Study||162
8852532|NCT01756274|9907475|FG000|COMPLETED|Overall Study||159
8852533|NCT01756274|9907475|FG000|NOT COMPLETED|Overall Study||3
8852534|NCT01756300|9907480|FG000|STARTED|Overall Study|Subjects underwent renal denervation treatment with the study catheter.|35
8852535|NCT01756300|9907480|FG000|COMPLETED|Overall Study|Subjects with follow up available at 12 months|33
8852536|NCT01756300|9907480|FG000|NOT COMPLETED|Overall Study||2
8852537|NCT01756352|9907501|FG000|STARTED|Overall Study||13
8852538|NCT01756352|9907501|FG000|COMPLETED|Overall Study||12
8852539|NCT01756352|9907501|FG000|NOT COMPLETED|Overall Study||1
8852540|NCT01756391|9907505|FG000|STARTED|Overall Study||351
8852541|NCT01756391|9907505|FG000|COMPLETED|Overall Study||319
8569505|NCT00097708|9601755|FG000|STARTED|Overall Study||173
8852542|NCT01756391|9907505|FG000|NOT COMPLETED|Overall Study||32
8852543|NCT01756456|9907515|FG000|STARTED|Treatment Period: Phase I/II||7
8852544|NCT01756456|9907516|FG001|STARTED|Treatment Period: Phase I/II||7
8852545|NCT01756456|9907517|FG002|STARTED|Treatment Period: Phase I/II||4
8852546|NCT01756456|9907518|FG003|STARTED|Treatment Period: Phase I/II||52
8852547|NCT01756456|9907519|FG004|STARTED|Treatment Period: Phase I/II||52
8852548|NCT01756456|9907520|FG005|STARTED|Treatment Period: Phase I/II||52
8852549|NCT01756456|9907515|FG000|COMPLETED|Treatment Period: Phase I/II||6
8852550|NCT01756456|9907516|FG001|COMPLETED|Treatment Period: Phase I/II||6
8629728|NCT00531284|9669433|FG009|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
8629729|NCT00531284|9669434|FG010|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
8629730|NCT00531284|9669435|FG011|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
8629731|NCT00531284|9669436|FG012|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
8629732|NCT00531284|9669437|FG013|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
8852551|NCT01756456|9907517|FG002|COMPLETED|Treatment Period: Phase I/II||2
8852552|NCT01756456|9907518|FG003|COMPLETED|Treatment Period: Phase I/II||45
8852553|NCT01756456|9907519|FG004|COMPLETED|Treatment Period: Phase I/II||39
8852554|NCT01756456|9907520|FG005|COMPLETED|Treatment Period: Phase I/II||48
8852555|NCT01756456|9907515|FG000|NOT COMPLETED|Treatment Period: Phase I/II||1
8852556|NCT01756456|9907516|FG001|NOT COMPLETED|Treatment Period: Phase I/II||1
8949070|NCT02435966|10011604|FG000|Follow-up|Overall Study||47
8949071|NCT02435966|10011605|FG001|Follow-up|Overall Study||53
8949072|NCT02435966|10011606|FG002|Follow-up|Overall Study||30
8949073|NCT02435966|10011604|FG000|COMPLETED|Overall Study||47
8949074|NCT02435966|10011605|FG001|COMPLETED|Overall Study||53
8949075|NCT02435966|10011606|FG002|COMPLETED|Overall Study||30
8949076|NCT02435966|10011604|FG000|NOT COMPLETED|Overall Study||0
8949077|NCT02435966|10011605|FG001|NOT COMPLETED|Overall Study||1
8949078|NCT02435966|10011606|FG002|NOT COMPLETED|Overall Study||0
8949079|NCT02435992|10011619|FG000|STARTED|Overall Study||429
8949080|NCT02435992|10011620|FG001|STARTED|Overall Study||216
8949081|NCT02435992|10011621|FG002|STARTED|Overall Study||367
8949082|NCT02435992|10011622|FG003|STARTED|Overall Study||0
8949083|NCT02435992|10011623|FG004|STARTED|Overall Study||0
8949084|NCT02435992|10011619|FG000|Transition to Maintenance Period|Overall Study||233
8949085|NCT02435992|10011620|FG001|Transition to Maintenance Period|Overall Study||69
8949086|NCT02435992|10011621|FG002|Transition to Maintenance Period|Overall Study||224
8949087|NCT02435992|10011622|FG003|Transition to Maintenance Period|Overall Study||0
8949088|NCT02435992|10011623|FG004|Transition to Maintenance Period|Overall Study||0
8949089|NCT02435992|10011619|FG000|Treated in Maintenance Period|Overall Study||0
8949090|NCT02435992|10011620|FG001|Treated in Maintenance Period|Overall Study||69
8949091|NCT02435992|10011621|FG002|Treated in Maintenance Period|Overall Study||0
8949092|NCT02435992|10011622|FG003|Treated in Maintenance Period|Overall Study|Randomized from cohort 1 and 2 RCP1063 treatment|230
8949093|NCT02435992|10011623|FG004|Treated in Maintenance Period|Overall Study|Randomized from cohort 1 and 2 RCP1063 treatment|227
8949094|NCT02435992|10011619|FG000|COMPLETED|Overall Study||401
8949095|NCT02435992|10011620|FG001|COMPLETED|Overall Study||192
8852557|NCT01756456|9907517|FG002|NOT COMPLETED|Treatment Period: Phase I/II||2
8852558|NCT01756456|9907518|FG003|NOT COMPLETED|Treatment Period: Phase I/II||7
8852559|NCT01756456|9907519|FG004|NOT COMPLETED|Treatment Period: Phase I/II||13
8852560|NCT01756456|9907520|FG005|NOT COMPLETED|Treatment Period: Phase I/II||4
8852561|NCT01756456|9907515|FG000|STARTED|Follow Up Period Phase I/II||6
8852562|NCT01756456|9907516|FG001|STARTED|Follow Up Period Phase I/II||6
8852563|NCT01756456|9907517|FG002|STARTED|Follow Up Period Phase I/II||2
8852564|NCT01756456|9907518|FG003|STARTED|Follow Up Period Phase I/II||45
8852565|NCT01756456|9907519|FG004|STARTED|Follow Up Period Phase I/II||39
8852566|NCT01756456|9907520|FG005|STARTED|Follow Up Period Phase I/II||48
8852567|NCT01756456|9907515|FG000|COMPLETED|Follow Up Period Phase I/II||5
8852568|NCT01756456|9907516|FG001|COMPLETED|Follow Up Period Phase I/II||5
8852569|NCT01756456|9907517|FG002|COMPLETED|Follow Up Period Phase I/II||1
8852570|NCT01756456|9907518|FG003|COMPLETED|Follow Up Period Phase I/II||12
8852571|NCT01756456|9907519|FG004|COMPLETED|Follow Up Period Phase I/II||13
8852572|NCT01756456|9907520|FG005|COMPLETED|Follow Up Period Phase I/II||15
8852573|NCT01756456|9907515|FG000|NOT COMPLETED|Follow Up Period Phase I/II||1
8852574|NCT01756456|9907516|FG001|NOT COMPLETED|Follow Up Period Phase I/II||1
8852575|NCT01756456|9907517|FG002|NOT COMPLETED|Follow Up Period Phase I/II||1
8852576|NCT01756456|9907518|FG003|NOT COMPLETED|Follow Up Period Phase I/II||33
8852577|NCT01756456|9907519|FG004|NOT COMPLETED|Follow Up Period Phase I/II||26
8852578|NCT01756456|9907520|FG005|NOT COMPLETED|Follow Up Period Phase I/II||33
8852579|NCT01756833|9907545|FG000|STARTED|Overall Study||133
8852580|NCT01756833|9907546|FG001|STARTED|Overall Study||128
8852581|NCT01756833|9907545|FG000|COMPLETED|Overall Study||129
8852582|NCT01756833|9907546|FG001|COMPLETED|Overall Study||125
8852583|NCT01756833|9907545|FG000|NOT COMPLETED|Overall Study||4
8852584|NCT01756833|9907546|FG001|NOT COMPLETED|Overall Study||3
8852585|NCT01756846|9907554|FG000|STARTED|Overall Study||1833
8852586|NCT01756846|9907555|FG001|STARTED|Overall Study||1833
8852587|NCT01756846|9907554|FG000|COMPLETED|Overall Study||1827
8852588|NCT01756846|9907555|FG001|COMPLETED|Overall Study||1821
8852589|NCT01756846|9907554|FG000|NOT COMPLETED|Overall Study||6
8852590|NCT01756846|9907555|FG001|NOT COMPLETED|Overall Study||12
8852591|NCT01756885|9907563|FG000|STARTED|Overall Study||102
8852592|NCT01756885|9907564|FG001|STARTED|Overall Study||105
8852593|NCT01756885|9907563|FG000|COMPLETED|Overall Study||79
8852594|NCT01756885|9907564|FG001|COMPLETED|Overall Study||79
8852595|NCT01756885|9907563|FG000|NOT COMPLETED|Overall Study||23
8852596|NCT01756885|9907564|FG001|NOT COMPLETED|Overall Study||26
8852597|NCT01756898|9907574|FG000|STARTED|Overall Study||92
8852598|NCT01756898|9907575|FG001|STARTED|Overall Study||92
8852599|NCT01756898|9907576|FG002|STARTED|Overall Study||93
8852600|NCT01756898|9907577|FG003|STARTED|Overall Study||93
8852601|NCT01756898|9907574|FG000|COMPLETED|Overall Study||73
8852602|NCT01756898|9907575|FG001|COMPLETED|Overall Study||73
8852603|NCT01756898|9907576|FG002|COMPLETED|Overall Study||76
8852604|NCT01756898|9907577|FG003|COMPLETED|Overall Study||77
8852605|NCT01756898|9907574|FG000|NOT COMPLETED|Overall Study||19
8852606|NCT01756898|9907575|FG001|NOT COMPLETED|Overall Study||19
8852607|NCT01756898|9907576|FG002|NOT COMPLETED|Overall Study||17
8852608|NCT01756898|9907577|FG003|NOT COMPLETED|Overall Study||16
8852609|NCT01756976|9907592|FG000|STARTED|Overall Study||76
8852610|NCT01756976|9907593|FG001|STARTED|Overall Study||8
8852611|NCT01756976|9907592|FG000|COMPLETED|Overall Study||73
8852612|NCT01756976|9907593|FG001|COMPLETED|Overall Study||8
8852613|NCT01756976|9907592|FG000|NOT COMPLETED|Overall Study||3
8852614|NCT01756976|9907593|FG001|NOT COMPLETED|Overall Study||0
8852615|NCT01757067|9907601|FG000|STARTED|Overall Study||2
8852616|NCT01757067|9907602|FG001|STARTED|Overall Study|The study was closed due to low enrollment.|1
8852617|NCT01757067|9907601|FG000|COMPLETED|Overall Study|The study was closed due to low enrollment.|2
8852618|NCT01757067|9907602|FG001|COMPLETED|Overall Study|The study was closed due to low enrollment.|1
8852619|NCT01757067|9907601|FG000|NOT COMPLETED|Overall Study||0
8852620|NCT01757067|9907602|FG001|NOT COMPLETED|Overall Study||0
8852621|NCT01757171|9907610|FG000|STARTED|Overall Study||61
8852622|NCT01757171|9907611|FG001|STARTED|Overall Study||24
8852623|NCT01757171|9907610|FG000|COMPLETED|Overall Study||53
8852624|NCT01757171|9907611|FG001|COMPLETED|Overall Study||23
8852625|NCT01757171|9907610|FG000|NOT COMPLETED|Overall Study||8
8852626|NCT01757171|9907611|FG001|NOT COMPLETED|Overall Study||1
8852627|NCT01757184|9907619|FG000|STARTED|Double-blind Period||36
8852628|NCT01757184|9907620|FG001|STARTED|Double-blind Period||30
8852629|NCT01757184|9907621|FG002|STARTED|Double-blind Period||0
8852630|NCT01757184|9907622|FG003|STARTED|Double-blind Period||0
8852631|NCT01757184|9907619|FG000|Received at Least 1 Dose of Study Drug|Double-blind Period||36
8852632|NCT01757184|9907620|FG001|Received at Least 1 Dose of Study Drug|Double-blind Period||30
8852633|NCT01757184|9907621|FG002|Received at Least 1 Dose of Study Drug|Double-blind Period||0
8852634|NCT01757184|9907622|FG003|Received at Least 1 Dose of Study Drug|Double-blind Period||0
8852635|NCT01757184|9907619|FG000|COMPLETED|Double-blind Period||35
8852636|NCT01757184|9907620|FG001|COMPLETED|Double-blind Period||30
8852637|NCT01757184|9907621|FG002|COMPLETED|Double-blind Period||0
8852638|NCT01757184|9907622|FG003|COMPLETED|Double-blind Period||0
8852639|NCT01757184|9907619|FG000|NOT COMPLETED|Double-blind Period||1
8852640|NCT01757184|9907620|FG001|NOT COMPLETED|Double-blind Period||0
8852641|NCT01757184|9907621|FG002|NOT COMPLETED|Double-blind Period||0
8852642|NCT01757184|9907622|FG003|NOT COMPLETED|Double-blind Period||0
8852643|NCT01757184|9907619|FG000|STARTED|Open-label Period||0
8852644|NCT01757184|9907620|FG001|STARTED|Open-label Period||0
8852645|NCT01757184|9907621|FG002|STARTED|Open-label Period|1 participant who did not complete Double-blind Period due to AE rechallenged for Open-label Period|36
8852646|NCT01757184|9907622|FG003|STARTED|Open-label Period||30
8852647|NCT01757184|9907619|FG000|Received at Least 1 Dose of Study Drug|Open-label Period||0
8852648|NCT01757184|9907620|FG001|Received at Least 1 Dose of Study Drug|Open-label Period||0
8852649|NCT01757184|9907621|FG002|Received at Least 1 Dose of Study Drug|Open-label Period||36
8852650|NCT01757184|9907622|FG003|Received at Least 1 Dose of Study Drug|Open-label Period||30
8852651|NCT01757184|9907619|FG000|COMPLETED|Open-label Period||0
8852652|NCT01757184|9907620|FG001|COMPLETED|Open-label Period||0
8852653|NCT01757184|9907621|FG002|COMPLETED|Open-label Period||32
8852654|NCT01757184|9907622|FG003|COMPLETED|Open-label Period||27
8852655|NCT01757184|9907619|FG000|NOT COMPLETED|Open-label Period||0
8852656|NCT01757184|9907620|FG001|NOT COMPLETED|Open-label Period||0
8852657|NCT01757184|9907621|FG002|NOT COMPLETED|Open-label Period||4
8852658|NCT01757184|9907622|FG003|NOT COMPLETED|Open-label Period||3
8852659|NCT01757197|9907636|FG000|STARTED|Overall Study||2
8852660|NCT01757197|9907636|FG000|COMPLETED|Overall Study||0
8852661|NCT01757197|9907636|FG000|NOT COMPLETED|Overall Study||2
8852662|NCT01757275|9907642|FG000|STARTED|Overall Study||111
8852663|NCT01757275|9907643|FG001|STARTED|Overall Study||111
8852664|NCT01757275|9907642|FG000|COMPLETED|Overall Study||102
8852665|NCT01757275|9907643|FG001|COMPLETED|Overall Study||98
8852666|NCT01757275|9907642|FG000|NOT COMPLETED|Overall Study||9
8852667|NCT01757275|9907643|FG001|NOT COMPLETED|Overall Study||13
8852668|NCT01757288|9907652|FG000|STARTED|Overall Study||6
8852669|NCT01757288|9907653|FG001|STARTED|Overall Study||46
8852670|NCT01757288|9907654|FG002|STARTED|Overall Study||46
8852671|NCT01757288|9907652|FG000|COMPLETED|Overall Study||6
8852672|NCT01757288|9907653|FG001|COMPLETED|Overall Study||38
8852673|NCT01757288|9907654|FG002|COMPLETED|Overall Study||37
8852674|NCT01757288|9907652|FG000|NOT COMPLETED|Overall Study||0
8852675|NCT01757288|9907653|FG001|NOT COMPLETED|Overall Study||8
8852676|NCT01757288|9907654|FG002|NOT COMPLETED|Overall Study||9
8852677|NCT01757301|9907665|FG000|STARTED|Overall Study||147
8852678|NCT01757301|9907666|FG001|STARTED|Overall Study||147
8852679|NCT01757301|9907665|FG000|COMPLETED|Overall Study||134
8852680|NCT01757301|9907666|FG001|COMPLETED|Overall Study||133
8852681|NCT01757301|9907665|FG000|NOT COMPLETED|Overall Study||13
8852682|NCT01757301|9907666|FG001|NOT COMPLETED|Overall Study||14
8852683|NCT01757392|9907674|FG000|STARTED|Overall Study||39
8852684|NCT01757392|9907674|FG000|COMPLETED|Overall Study||35
8852685|NCT01757392|9907674|FG000|NOT COMPLETED|Overall Study||4
8852686|NCT01757405|9907680|FG000|STARTED|Overall Study||18
8852687|NCT01757405|9907681|FG001|STARTED|Overall Study||20
8852688|NCT01757405|9907680|FG000|COMPLETED|Overall Study||17
8852689|NCT01757405|9907681|FG001|COMPLETED|Overall Study||18
8852690|NCT01757405|9907680|FG000|NOT COMPLETED|Overall Study||1
8852691|NCT01757405|9907681|FG001|NOT COMPLETED|Overall Study||2
8852692|NCT01757561|9907691|FG000|STARTED|Overall Study||38
8852693|NCT01757561|9907692|FG001|STARTED|Overall Study||34
8852694|NCT01757561|9907693|FG002|STARTED|Overall Study||38
8852695|NCT01757561|9907694|FG003|STARTED|Overall Study||34
8852696|NCT01757561|9907691|FG000|COMPLETED|Overall Study||32
8852697|NCT01757561|9907692|FG001|COMPLETED|Overall Study||28
8852698|NCT01757561|9907693|FG002|COMPLETED|Overall Study||31
8852699|NCT01757561|9907694|FG003|COMPLETED|Overall Study||25
8852700|NCT01757561|9907691|FG000|NOT COMPLETED|Overall Study||6
8852701|NCT01757561|9907692|FG001|NOT COMPLETED|Overall Study||6
8852702|NCT01757561|9907693|FG002|NOT COMPLETED|Overall Study||7
8852703|NCT01757561|9907694|FG003|NOT COMPLETED|Overall Study||9
8852704|NCT01757678|9907704|FG000|STARTED|Overall Study||276
8852705|NCT01757678|9907704|FG000|COMPLETED|Overall Study||276
8852706|NCT01757678|9907704|FG000|NOT COMPLETED|Overall Study||0
8923338|NCT02239640|9983901|FG000|NOT COMPLETED|Overall Study||217
8923339|NCT02239679|9983914|FG000|STARTED|Overall Study||53
8923340|NCT02239679|9983915|FG001|STARTED|Overall Study||59
8923341|NCT02239679|9983916|FG002|STARTED|Overall Study||54
8923342|NCT02239679|9983914|FG000|COMPLETED|Overall Study||50
8923343|NCT02239679|9983915|FG001|COMPLETED|Overall Study||56
8923344|NCT02239679|9983916|FG002|COMPLETED|Overall Study||53
8923345|NCT02239679|9983914|FG000|NOT COMPLETED|Overall Study||3
8923346|NCT02239679|9983915|FG001|NOT COMPLETED|Overall Study||3
8923347|NCT02239679|9983916|FG002|NOT COMPLETED|Overall Study||1
8923348|NCT02239692|9983926|FG000|STARTED|Overall Study||73
8923349|NCT02239692|9983927|FG001|STARTED|Overall Study||131
8923350|NCT02239692|9983926|FG000|Intention-to-treat Analysis Set|Overall Study||73
8923351|NCT02239692|9983927|FG001|Intention-to-treat Analysis Set|Overall Study||131
8923352|NCT02239692|9983926|FG000|Per-protocol Analysis Set|Overall Study||66
8923353|NCT02239692|9983927|FG001|Per-protocol Analysis Set|Overall Study||120
8923354|NCT02239692|9983926|FG000|Safety Analysis Set|Overall Study||70
8923355|NCT02239692|9983927|FG001|Safety Analysis Set|Overall Study||125
8923356|NCT02239692|9983926|FG000|COMPLETED|Overall Study||67
8923357|NCT02239692|9983927|FG001|COMPLETED|Overall Study||118
8923358|NCT02239692|9983926|FG000|NOT COMPLETED|Overall Study||6
8923359|NCT02239692|9983927|FG001|NOT COMPLETED|Overall Study||13
8923360|NCT02239744|9983935|FG000|STARTED|Period 1||17
8923361|NCT02239744|9983936|FG001|STARTED|Period 1||18
8923362|NCT02239744|9983935|FG000|COMPLETED|Period 1||17
8923363|NCT02239744|9983936|FG001|COMPLETED|Period 1||18
8852707|NCT01757691|9907712|FG000|STARTED|Overall Study||2
8852708|NCT01757691|9907713|FG001|STARTED|Overall Study||0
8852709|NCT01757691|9907712|FG000|COMPLETED|Overall Study||0
8852710|NCT01757691|9907713|FG001|COMPLETED|Overall Study||0
8852711|NCT01757691|9907712|FG000|NOT COMPLETED|Overall Study||2
8852712|NCT01757691|9907713|FG001|NOT COMPLETED|Overall Study||0
8852713|NCT01757704|9907721|FG000|STARTED|Overall Study|One patient was excluded at start of surgery due to opening of the pleurae during sternotomy.|11
8852714|NCT01757704|9907722|FG001|STARTED|Overall Study|Two patients excluded intraoperatively due to failure to obtain TCD signals and one due to adhesion.|13
8852715|NCT01757704|9907721|FG000|COMPLETED|Overall Study||10
8852716|NCT01757704|9907722|FG001|COMPLETED|Overall Study||10
8852717|NCT01757704|9907721|FG000|NOT COMPLETED|Overall Study||1
8852718|NCT01757704|9907722|FG001|NOT COMPLETED|Overall Study||3
8852719|NCT01757717|9907728|FG000|STARTED|Overall Study||3
8852720|NCT01757717|9907728|FG000|COMPLETED|Overall Study||3
8852721|NCT01757717|9907728|FG000|NOT COMPLETED|Overall Study||0
8852722|NCT01757821|9907732|FG000|STARTED|Overall Study|11 subjects|11
8852723|NCT01757821|9907732|FG000|COMPLETED|Overall Study|10 subjects|10
8852724|NCT01757821|9907732|FG000|NOT COMPLETED|Overall Study||1
8852725|NCT01757847|9907742|FG000|STARTED|Overall Study||44
8852726|NCT01757847|9907743|FG001|STARTED|Overall Study||46
8852727|NCT01757847|9907742|FG000|COMPLETED|Overall Study||41
8852728|NCT01757847|9907743|FG001|COMPLETED|Overall Study||42
8852729|NCT01757847|9907742|FG000|NOT COMPLETED|Overall Study||3
8852730|NCT01757847|9907743|FG001|NOT COMPLETED|Overall Study||4
8852731|NCT01757964|9907751|FG000|STARTED|Overall Study||9
8852732|NCT01757964|9907752|FG001|STARTED|Overall Study||4
8852733|NCT01757964|9907751|FG000|COMPLETED|Overall Study||9
8852734|NCT01757964|9907752|FG001|COMPLETED|Overall Study||4
8852735|NCT01757964|9907751|FG000|NOT COMPLETED|Overall Study||0
8852736|NCT01757964|9907752|FG001|NOT COMPLETED|Overall Study||0
8852737|NCT01758289|9907756|FG000|STARTED|Overall Study||105
8852738|NCT01758289|9907756|FG000|COMPLETED|Overall Study||52
8852739|NCT01758289|9907756|FG000|NOT COMPLETED|Overall Study||53
8852740|NCT01758432|9907771|FG000|STARTED|Overall Study||18
8852741|NCT01758432|9907772|FG001|STARTED|Overall Study||6
8852742|NCT01758432|9907773|FG002|STARTED|Overall Study||6
8852743|NCT01758432|9907774|FG003|STARTED|Overall Study||6
8852744|NCT01758432|9907775|FG004|STARTED|Overall Study||6
8852745|NCT01758432|9907776|FG005|STARTED|Overall Study||6
8852746|NCT01758432|9907777|FG006|STARTED|Overall Study||6
8852747|NCT01758432|9907771|FG000|COMPLETED|Overall Study||18
8852748|NCT01758432|9907772|FG001|COMPLETED|Overall Study||6
8852749|NCT01758432|9907773|FG002|COMPLETED|Overall Study||6
8852750|NCT01758432|9907774|FG003|COMPLETED|Overall Study||6
8852751|NCT01758432|9907775|FG004|COMPLETED|Overall Study||6
8852752|NCT01758432|9907776|FG005|COMPLETED|Overall Study||6
8852753|NCT01758432|9907777|FG006|COMPLETED|Overall Study||6
8852754|NCT01758432|9907771|FG000|NOT COMPLETED|Overall Study||0
8852755|NCT01758432|9907772|FG001|NOT COMPLETED|Overall Study||0
8852756|NCT01758432|9907773|FG002|NOT COMPLETED|Overall Study||0
8852757|NCT01758432|9907774|FG003|NOT COMPLETED|Overall Study||0
8852758|NCT01758432|9907775|FG004|NOT COMPLETED|Overall Study||0
8852759|NCT01758432|9907776|FG005|NOT COMPLETED|Overall Study||0
8852760|NCT01758432|9907777|FG006|NOT COMPLETED|Overall Study||0
8852761|NCT01758523|9907795|FG000|STARTED|Overall Study||74
8852762|NCT01758523|9907796|FG001|STARTED|Overall Study||68
8852763|NCT01758523|9907795|FG000|Attended >/= 1 Visit Post-randomization|Overall Study||68
8852764|NCT01758523|9907796|FG001|Attended >/= 1 Visit Post-randomization|Overall Study||67
8852765|NCT01758523|9907795|FG000|COMPLETED|Overall Study||53
8852766|NCT01758523|9907796|FG001|COMPLETED|Overall Study||54
8629733|NCT00531284|9669438|FG014|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|3
8629734|NCT00531284|9669439|FG015|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|2
8629735|NCT00531284|9669440|FG016|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
8629736|NCT00531284|9669424|FG000|NOT COMPLETED|Overall Study||3
8629737|NCT00531284|9669425|FG001|NOT COMPLETED|Overall Study||4
8694248|NCT00870584|9739682|FG001|STARTED|Overall Study||135
8852767|NCT01758523|9907795|FG000|NOT COMPLETED|Overall Study||21
8852768|NCT01758523|9907796|FG001|NOT COMPLETED|Overall Study||14
8852769|NCT01758588|9907808|FG000|STARTED|Overall Study||5
8852770|NCT01758588|9907809|FG001|STARTED|Overall Study||3
8852771|NCT01758588|9907808|FG000|COMPLETED|Overall Study||5
8852772|NCT01758588|9907809|FG001|COMPLETED|Overall Study||3
8852773|NCT01758588|9907808|FG000|NOT COMPLETED|Overall Study||0
8852774|NCT01758588|9907809|FG001|NOT COMPLETED|Overall Study||0
8852775|NCT01758731|9907817|FG000|STARTED|Overall Study||17
8852776|NCT01758731|9907817|FG000|COMPLETED|Overall Study||16
8629738|NCT00531284|9669426|FG002|NOT COMPLETED|Overall Study||6
8629739|NCT00531284|9669427|FG003|NOT COMPLETED|Overall Study||63
8629740|NCT00531284|9669428|FG004|NOT COMPLETED|Overall Study||6
8629741|NCT00531284|9669429|FG005|NOT COMPLETED|Overall Study||7
8852777|NCT01758731|9907817|FG000|NOT COMPLETED|Overall Study||1
8852778|NCT01758900|9907823|FG000|STARTED|Overall Study||106
8852779|NCT01758900|9907824|FG001|STARTED|Overall Study||108
8852780|NCT01758900|9907823|FG000|COMPLETED|Overall Study||99
8852781|NCT01758900|9907824|FG001|COMPLETED|Overall Study||100
8852782|NCT01758900|9907823|FG000|NOT COMPLETED|Overall Study||7
8852783|NCT01758900|9907824|FG001|NOT COMPLETED|Overall Study||8
8852784|NCT01759160|9907832|FG000|STARTED|Overall Study||30
8852785|NCT01759160|9907833|FG001|STARTED|Overall Study||30
8852786|NCT01759160|9907832|FG000|COMPLETED|Overall Study||30
8852787|NCT01759160|9907833|FG001|COMPLETED|Overall Study||30
8852788|NCT01759160|9907832|FG000|NOT COMPLETED|Overall Study||0
8852789|NCT01759160|9907833|FG001|NOT COMPLETED|Overall Study||0
8852790|NCT01759251|9907839|FG000|STARTED|30 Days Treatment Period||309
8852791|NCT01759251|9907839|FG000|COMPLETED|30 Days Treatment Period||305
8852792|NCT01759251|9907839|FG000|NOT COMPLETED|30 Days Treatment Period||4
8852793|NCT01759251|9907839|FG000|STARTED|60 Days Treatment Period||305
8852794|NCT01759251|9907839|FG000|COMPLETED|60 Days Treatment Period||305
8852795|NCT01759251|9907839|FG000|NOT COMPLETED|60 Days Treatment Period||0
8852796|NCT01759251|9907839|FG000|STARTED|Follow-up Period||305
8852797|NCT01759251|9907839|FG000|COMPLETED|Follow-up Period||305
8852798|NCT01759251|9907839|FG000|NOT COMPLETED|Follow-up Period||0
8852799|NCT01759264|9907843|FG000|STARTED|Overall Study||101
8852800|NCT01759264|9907843|FG000|COMPLETED|Overall Study||91
8852801|NCT01759264|9907843|FG000|NOT COMPLETED|Overall Study||10
8852802|NCT01759277|9907850|FG000|STARTED|Overall Study||41
8852803|NCT01759277|9907851|FG001|STARTED|Overall Study||39
8852804|NCT01759277|9907850|FG000|COMPLETED|Overall Study||41
8852805|NCT01759277|9907851|FG001|COMPLETED|Overall Study||39
8852806|NCT01759277|9907850|FG000|NOT COMPLETED|Overall Study||0
8852807|NCT01759277|9907851|FG001|NOT COMPLETED|Overall Study||0
8852808|NCT01759290|9907859|FG000|STARTED|Overall Study||1800
8852809|NCT01759290|9907859|FG000|COMPLETED|Overall Study||1719
8852810|NCT01759290|9907859|FG000|NOT COMPLETED|Overall Study||81
8852811|NCT01759368|9907865|FG000|STARTED|Overall Study||47
8852812|NCT01759368|9907866|FG001|STARTED|Overall Study||47
8852813|NCT01759368|9907865|FG000|COMPLETED|Overall Study||46
8852814|NCT01759368|9907866|FG001|COMPLETED|Overall Study||47
8852815|NCT01759368|9907865|FG000|NOT COMPLETED|Overall Study||1
8852816|NCT01759368|9907866|FG001|NOT COMPLETED|Overall Study||0
8852817|NCT01759381|9907876|FG000|STARTED|Overall Study||8
8852818|NCT01759381|9907877|FG001|STARTED|Overall Study||11
8852819|NCT01759381|9907876|FG000|COMPLETED|Overall Study||7
8852820|NCT01759381|9907877|FG001|COMPLETED|Overall Study||11
8852821|NCT01759381|9907876|FG000|NOT COMPLETED|Overall Study||1
8852822|NCT01759381|9907877|FG001|NOT COMPLETED|Overall Study||0
8852823|NCT01759407|9907885|FG000|STARTED|Overall Study||10
8852824|NCT01759407|9907886|FG001|STARTED|Overall Study||9
8852825|NCT01759407|9907885|FG000|COMPLETED|Overall Study||10
8852826|NCT01759407|9907886|FG001|COMPLETED|Overall Study||7
8852827|NCT01759407|9907885|FG000|NOT COMPLETED|Overall Study||0
8852828|NCT01759407|9907886|FG001|NOT COMPLETED|Overall Study||2
8852829|NCT01759420|9907892|FG000|STARTED|Overall Study||28
8852830|NCT01759420|9907892|FG000|COMPLETED|Overall Study||22
8852831|NCT01759420|9907892|FG000|NOT COMPLETED|Overall Study||6
8852832|NCT01759446|9907901|FG000|STARTED|Overall Study||9
8852833|NCT01759446|9907902|FG001|STARTED|Overall Study||9
8852834|NCT01759446|9907903|FG002|STARTED|Overall Study||9
8852835|NCT01759446|9907904|FG003|STARTED|Overall Study||9
8852836|NCT01759446|9907905|FG004|STARTED|Overall Study||8
8852837|NCT01759446|9907901|FG000|COMPLETED|Overall Study||8
8852838|NCT01759446|9907902|FG001|COMPLETED|Overall Study||8
8852839|NCT01759446|9907903|FG002|COMPLETED|Overall Study||8
8852840|NCT01759446|9907904|FG003|COMPLETED|Overall Study||8
8852841|NCT01759446|9907905|FG004|COMPLETED|Overall Study||8
8852842|NCT01759446|9907901|FG000|NOT COMPLETED|Overall Study||1
8852843|NCT01759446|9907902|FG001|NOT COMPLETED|Overall Study||1
8852844|NCT01759446|9907903|FG002|NOT COMPLETED|Overall Study||1
8852845|NCT01759446|9907904|FG003|NOT COMPLETED|Overall Study||1
8852846|NCT01759446|9907905|FG004|NOT COMPLETED|Overall Study||0
8852847|NCT01759511|9907917|FG000|STARTED|Overall Study||34
8852848|NCT01759511|9907917|FG000|COMPLETED|Overall Study||0
8852849|NCT01759511|9907917|FG000|NOT COMPLETED|Overall Study||34
8852850|NCT01759602|9907921|FG000|STARTED|Overall Study||10
8852851|NCT01759602|9907921|FG000|COMPLETED|Overall Study||10
8852852|NCT01759602|9907921|FG000|NOT COMPLETED|Overall Study||0
8852853|NCT01759862|9907927|FG000|STARTED|Overall Study||23
8852854|NCT01759862|9907928|FG001|STARTED|Overall Study||27
8852855|NCT01759862|9907927|FG000|COMPLETED|Overall Study||20
8852856|NCT01759862|9907928|FG001|COMPLETED|Overall Study||25
8852857|NCT01759862|9907927|FG000|NOT COMPLETED|Overall Study||3
8852858|NCT01759862|9907928|FG001|NOT COMPLETED|Overall Study||2
8852859|NCT01760187|9907944|FG000|STARTED|Overall Study||20
8852860|NCT01760187|9907945|FG001|STARTED|Overall Study||12
8852861|NCT01760187|9907946|FG002|STARTED|Overall Study||12
8852862|NCT01760187|9907947|FG003|STARTED|Overall Study||12
8852863|NCT01760187|9907948|FG004|STARTED|Overall Study||16
8852864|NCT01760187|9907944|FG000|COMPLETED|Overall Study||19
8852865|NCT01760187|9907945|FG001|COMPLETED|Overall Study||12
8852866|NCT01760187|9907946|FG002|COMPLETED|Overall Study||12
8852867|NCT01760187|9907947|FG003|COMPLETED|Overall Study||10
8852868|NCT01760187|9907948|FG004|COMPLETED|Overall Study||16
8852869|NCT01760187|9907944|FG000|NOT COMPLETED|Overall Study||1
8852870|NCT01760187|9907945|FG001|NOT COMPLETED|Overall Study||0
8852871|NCT01760187|9907946|FG002|NOT COMPLETED|Overall Study||0
8852872|NCT01760187|9907947|FG003|NOT COMPLETED|Overall Study||2
8852873|NCT01760187|9907948|FG004|NOT COMPLETED|Overall Study||0
8852874|NCT01760239|9907970|FG000|STARTED|Overall Study||17037
8852875|NCT01760239|9907971|FG001|STARTED|Overall Study||14542
8852876|NCT01760239|9907970|FG000|COMPLETED|Overall Study||296
8852877|NCT01760239|9907971|FG001|COMPLETED|Overall Study||226
8852878|NCT01760239|9907970|FG000|NOT COMPLETED|Overall Study||16741
8852879|NCT01760239|9907971|FG001|NOT COMPLETED|Overall Study||14316
8852880|NCT01760304|9907980|FG000|STARTED|Overall Study||2
8852881|NCT01760304|9907981|FG001|STARTED|Overall Study||3
8852882|NCT01760304|9907980|FG000|COMPLETED|Overall Study||2
8852883|NCT01760304|9907981|FG001|COMPLETED|Overall Study||3
8852884|NCT01760304|9907980|FG000|NOT COMPLETED|Overall Study||0
8852885|NCT01760304|9907981|FG001|NOT COMPLETED|Overall Study||0
8852886|NCT01760447|9907995|FG000|STARTED|Weeks 0-20|The first randomization for the participant who withdrew and re-randomized is not counted in the 62.|62
8852887|NCT01760447|9907996|FG001|STARTED|Weeks 0-20||62
8852888|NCT01760447|9907997|FG002|STARTED|Weeks 0-20||47
8852889|NCT01760447|9907998|FG003|STARTED|Weeks 0-20||51
8852890|NCT01760447|9907995|FG000|Treated|Weeks 0-20||62
8852891|NCT01760447|9907996|FG001|Treated|Weeks 0-20||62
8852892|NCT01760447|9907997|FG002|Treated|Weeks 0-20||45
8852893|NCT01760447|9907998|FG003|Treated|Weeks 0-20||51
8852894|NCT01760447|9907995|FG000|COMPLETED|Weeks 0-20||59
8852895|NCT01760447|9907996|FG001|COMPLETED|Weeks 0-20||62
8852896|NCT01760447|9907997|FG002|COMPLETED|Weeks 0-20||42
8852897|NCT01760447|9907998|FG003|COMPLETED|Weeks 0-20||47
8852898|NCT01760447|9907995|FG000|NOT COMPLETED|Weeks 0-20||3
8852899|NCT01760447|9907996|FG001|NOT COMPLETED|Weeks 0-20||0
8852900|NCT01760447|9907997|FG002|NOT COMPLETED|Weeks 0-20||5
8852901|NCT01760447|9907998|FG003|NOT COMPLETED|Weeks 0-20||4
8852902|NCT01760447|9907995|FG000|STARTED|Weeks 20-54|MK-0431A-170 added Weeks 20-54 via amendment, but not all participants were eligible for this period|28
8852903|NCT01760447|9907996|FG001|STARTED|Weeks 20-54|MK-0431A-170 added Weeks 20-54 via amendment, but not all participants were eligible for this period|30
8852904|NCT01760447|9907997|FG002|STARTED|Weeks 20-54||42
8852905|NCT01760447|9907998|FG003|STARTED|Weeks 20-54||47
8852906|NCT01760447|9907995|FG000|COMPLETED|Weeks 20-54||25
8852907|NCT01760447|9907996|FG001|COMPLETED|Weeks 20-54||28
8852908|NCT01760447|9907997|FG002|COMPLETED|Weeks 20-54||39
8852909|NCT01760447|9907998|FG003|COMPLETED|Weeks 20-54||43
8852910|NCT01760447|9907995|FG000|NOT COMPLETED|Weeks 20-54||3
8629742|NCT00531284|9669430|FG006|NOT COMPLETED|Overall Study||6
8629743|NCT00531284|9669431|FG007|NOT COMPLETED|Overall Study||10
8629744|NCT00531284|9669432|FG008|NOT COMPLETED|Overall Study||11
8629745|NCT00531284|9669433|FG009|NOT COMPLETED|Overall Study||4
8852911|NCT01760447|9907996|FG001|NOT COMPLETED|Weeks 20-54||2
8852912|NCT01760447|9907997|FG002|NOT COMPLETED|Weeks 20-54||3
8852913|NCT01760447|9907998|FG003|NOT COMPLETED|Weeks 20-54||4
8852914|NCT01760473|9908014|FG000|STARTED|Overall Study||27
8852915|NCT01760473|9908014|FG000|COMPLETED|Overall Study||12
8852916|NCT01760473|9908014|FG000|NOT COMPLETED|Overall Study||15
8852917|NCT01760733|9908026|FG000|STARTED|Waiting List|All patients included started in the waiting list group.|289
8852918|NCT01760733|9908026|FG000|COMPLETED|Waiting List|217 patients have been transplanted|217
8852919|NCT01760733|9908026|FG000|NOT COMPLETED|Waiting List||72
8852920|NCT01760733|9908026|FG000|STARTED|Transplanted||217
8852921|NCT01760733|9908026|FG000|COMPLETED|Transplanted||0
8852922|NCT01760733|9908026|FG000|NOT COMPLETED|Transplanted||217
8852923|NCT01760785|9908033|FG000|STARTED|Overall Study||23
8852924|NCT01760785|9908034|FG001|STARTED|Overall Study||27
8852925|NCT01760785|9908033|FG000|COMPLETED|Overall Study||23
8852926|NCT01760785|9908034|FG001|COMPLETED|Overall Study||27
8852927|NCT01760785|9908033|FG000|NOT COMPLETED|Overall Study||0
8852928|NCT01760785|9908034|FG001|NOT COMPLETED|Overall Study||0
8852929|NCT01760876|9908040|FG000|STARTED|Overall Study||106
8852930|NCT01760876|9908040|FG000|COMPLETED|Overall Study|12 months clinical FU of last patient in July 2015.|100
8852931|NCT01760876|9908040|FG000|NOT COMPLETED|Overall Study||6
8852932|NCT01760954|9908048|FG000|STARTED|Treatment Period (6 Months)||149
8852933|NCT01760954|9908049|FG001|STARTED|Treatment Period (6 Months)||138
8852934|NCT01760954|9908050|FG002|STARTED|Treatment Period (6 Months)||108
8852935|NCT01760954|9908051|FG003|STARTED|Treatment Period (6 Months)||109
8852936|NCT01760954|9908048|FG000|COMPLETED|Treatment Period (6 Months)||116
8852937|NCT01760954|9908049|FG001|COMPLETED|Treatment Period (6 Months)||110
8852938|NCT01760954|9908050|FG002|COMPLETED|Treatment Period (6 Months)||87
8852939|NCT01760954|9908051|FG003|COMPLETED|Treatment Period (6 Months)||83
8852940|NCT01760954|9908048|FG000|NOT COMPLETED|Treatment Period (6 Months)||33
8852941|NCT01760954|9908049|FG001|NOT COMPLETED|Treatment Period (6 Months)||28
8852942|NCT01760954|9908050|FG002|NOT COMPLETED|Treatment Period (6 Months)||21
8852943|NCT01760954|9908051|FG003|NOT COMPLETED|Treatment Period (6 Months)||26
8852944|NCT01760954|9908048|FG000|STARTED|Post-treatment Follow-up (12 Months)||126
8852945|NCT01760954|9908049|FG001|STARTED|Post-treatment Follow-up (12 Months)||118
8852946|NCT01760954|9908050|FG002|STARTED|Post-treatment Follow-up (12 Months)||86
8852947|NCT01760954|9908051|FG003|STARTED|Post-treatment Follow-up (12 Months)||87
8852948|NCT01760954|9908048|FG000|COMPLETED|Post-treatment Follow-up (12 Months)||96
8852949|NCT01760954|9908049|FG001|COMPLETED|Post-treatment Follow-up (12 Months)||83
8629746|NCT00531284|9669434|FG010|NOT COMPLETED|Overall Study||3
8852950|NCT01760954|9908050|FG002|COMPLETED|Post-treatment Follow-up (12 Months)||65
8852951|NCT01760954|9908051|FG003|COMPLETED|Post-treatment Follow-up (12 Months)||67
8852952|NCT01760954|9908048|FG000|NOT COMPLETED|Post-treatment Follow-up (12 Months)||30
8852953|NCT01760954|9908049|FG001|NOT COMPLETED|Post-treatment Follow-up (12 Months)||35
8852954|NCT01760954|9908050|FG002|NOT COMPLETED|Post-treatment Follow-up (12 Months)||21
8852955|NCT01760954|9908051|FG003|NOT COMPLETED|Post-treatment Follow-up (12 Months)||20
8852956|NCT01761019|9908061|FG000|STARTED|Overall Study||8
8852957|NCT01761019|9908061|FG000|COMPLETED|Overall Study||8
8852958|NCT01761019|9908061|FG000|NOT COMPLETED|Overall Study||0
8852959|NCT01761084|9908067|FG000|STARTED|Overall Study||71
8852960|NCT01761084|9908068|FG001|STARTED|Overall Study||70
8852961|NCT01761084|9908067|FG000|COMPLETED|Overall Study||66
8852962|NCT01761084|9908068|FG001|COMPLETED|Overall Study||64
8852963|NCT01761084|9908067|FG000|NOT COMPLETED|Overall Study||5
8852964|NCT01761084|9908068|FG001|NOT COMPLETED|Overall Study||6
8852965|NCT01761162|9908075|FG000|STARTED|Overall Study||229
8852966|NCT01761162|9908075|FG000|COMPLETED|Overall Study||226
8852967|NCT01761162|9908075|FG000|NOT COMPLETED|Overall Study||3
8852968|NCT01761175|9908081|FG000|STARTED|Overall Study||112
8852969|NCT01761175|9908082|FG001|STARTED|Overall Study||112
8852970|NCT01761175|9908081|FG000|COMPLETED|Overall Study||112
8852971|NCT01761175|9908082|FG001|COMPLETED|Overall Study||112
8852972|NCT01761175|9908081|FG000|NOT COMPLETED|Overall Study||0
8852973|NCT01761175|9908082|FG001|NOT COMPLETED|Overall Study||0
8629747|NCT00531284|9669435|FG011|NOT COMPLETED|Overall Study||24
8629748|NCT00531284|9669436|FG012|NOT COMPLETED|Overall Study||2
8629749|NCT00531284|9669437|FG013|NOT COMPLETED|Overall Study||3
8629750|NCT00531284|9669438|FG014|NOT COMPLETED|Overall Study||4
8629751|NCT00531284|9669439|FG015|NOT COMPLETED|Overall Study||12
8629752|NCT00531284|9669440|FG016|NOT COMPLETED|Overall Study||8
8629753|NCT00531427|9669498|FG000|STARTED|Overall Study||282
8629754|NCT00531427|9669499|FG001|STARTED|Overall Study||285
8629755|NCT00531427|9669498|FG000|COMPLETED|Overall Study||209
8629756|NCT00531427|9669499|FG001|COMPLETED|Overall Study||191
8629757|NCT00531427|9669498|FG000|NOT COMPLETED|Overall Study||73
8629758|NCT00531427|9669499|FG001|NOT COMPLETED|Overall Study||94
8852974|NCT01761279|9908089|FG000|STARTED|Overall Study||84
8852975|NCT01761279|9908089|FG000|COMPLETED|Overall Study||84
8852976|NCT01761279|9908089|FG000|NOT COMPLETED|Overall Study||0
8852977|NCT01761292|9908097|FG000|STARTED|Part 1||20
8629759|NCT00531453|9669508|FG000|STARTED|Overall Study|02 October 2007|49
8629760|NCT00531453|9669509|FG001|STARTED|Overall Study|02 October 2007|49
8852978|NCT01761292|9908097|FG000|Patients Receiving Drug in Part 1|Part 1|One patient was enrolled in Part 1 and started treatment in Part 2.|19
8852979|NCT01761292|9908097|FG000|COMPLETED|Part 1||18
8852980|NCT01761292|9908097|FG000|NOT COMPLETED|Part 1||2
8629761|NCT00531453|9669508|FG000|COMPLETED|Overall Study|10 April 2009|49
8629762|NCT00531453|9669509|FG001|COMPLETED|Overall Study|10 April 2009|49
8629763|NCT00531453|9669508|FG000|NOT COMPLETED|Overall Study||0
8629764|NCT00531453|9669509|FG001|NOT COMPLETED|Overall Study||0
8629765|NCT00531479|9669517|FG000|STARTED|Overall Study||230
8629766|NCT00531479|9669518|FG001|STARTED|Overall Study||229
8852981|NCT01761292|9908097|FG000|STARTED|Part 2|1 pt was enrolled in Part 1 but started the treatment in Part 2. So 19 pts started Part 2.|19
8852982|NCT01761292|9908097|FG000|COMPLETED|Part 2||19
8852983|NCT01761292|9908097|FG000|NOT COMPLETED|Part 2||0
8852984|NCT01761292|9908097|FG000|STARTED|Extension 1||19
8852985|NCT01761292|9908097|FG000|COMPLETED|Extension 1||18
8852986|NCT01761292|9908097|FG000|NOT COMPLETED|Extension 1||1
8852987|NCT01761292|9908097|FG000|STARTED|Extension 2||18
8852988|NCT01761292|9908097|FG000|COMPLETED|Extension 2||18
8852989|NCT01761292|9908097|FG000|NOT COMPLETED|Extension 2||0
8852990|NCT01761292|9908097|FG000|STARTED|Extension 3||18
8852991|NCT01761292|9908097|FG000|COMPLETED|Extension 3||18
8852992|NCT01761292|9908097|FG000|NOT COMPLETED|Extension 3||0
8629767|NCT00531479|9669517|FG000|Treated|Overall Study||228
8852993|NCT01761565|9908108|FG000|STARTED|Single Dose of SUF NT 15 mcg||40
8852994|NCT01761565|9908108|FG000|COMPLETED|Single Dose of SUF NT 15 mcg||40
8852995|NCT01761565|9908108|FG000|NOT COMPLETED|Single Dose of SUF NT 15 mcg||0
8852996|NCT01761565|9908108|FG000|STARTED|40 Consecutive Doses of SUF 15 mcg|Subject was withdrawn from the study prior to the second arm/period due to non-compliance|39
8852997|NCT01761565|9908108|FG000|COMPLETED|40 Consecutive Doses of SUF 15 mcg||38
8852998|NCT01761565|9908108|FG000|NOT COMPLETED|40 Consecutive Doses of SUF 15 mcg||1
8949096|NCT02435992|10011621|FG002|COMPLETED|Overall Study||324
8949097|NCT02435992|10011622|FG003|COMPLETED|Overall Study||0
8949098|NCT02435992|10011623|FG004|COMPLETED|Overall Study||0
8949099|NCT02435992|10011619|FG000|NOT COMPLETED|Overall Study||28
8949100|NCT02435992|10011620|FG001|NOT COMPLETED|Overall Study||24
8949101|NCT02435992|10011621|FG002|NOT COMPLETED|Overall Study||43
8949102|NCT02435992|10011622|FG003|NOT COMPLETED|Overall Study||0
8949103|NCT02435992|10011623|FG004|NOT COMPLETED|Overall Study||0
8852999|NCT01761643|9908118|FG000|STARTED|Overall Study||198
8853000|NCT01761643|9908119|FG001|STARTED|Overall Study||200
8949104|NCT02436005|10011635|FG000|STARTED|First Intervention||12
8629768|NCT00531479|9669518|FG001|Treated|Overall Study||226
8629769|NCT00531479|9669517|FG000|COMPLETED|Overall Study||154
8629770|NCT00531479|9669518|FG001|COMPLETED|Overall Study||146
8629771|NCT00531479|9669517|FG000|NOT COMPLETED|Overall Study||76
8853001|NCT01761643|9908118|FG000|COMPLETED|Overall Study||166
8853002|NCT01761643|9908119|FG001|COMPLETED|Overall Study||158
8853003|NCT01761643|9908118|FG000|NOT COMPLETED|Overall Study||32
8853004|NCT01761643|9908119|FG001|NOT COMPLETED|Overall Study||42
8853005|NCT01761747|9908125|FG000|STARTED|Overall Study||3
8853006|NCT01761747|9908125|FG000|COMPLETED|Overall Study||2
8853007|NCT01761747|9908125|FG000|NOT COMPLETED|Overall Study||1
8853008|NCT01762059|9908129|FG000|STARTED|Overall Study||20
8853009|NCT01762059|9908129|FG000|COMPLETED|Overall Study||20
8853010|NCT01762059|9908129|FG000|NOT COMPLETED|Overall Study||0
8853011|NCT01762345|9908138|FG000|STARTED|Overall Study||83
8853012|NCT01762345|9908138|FG000|COMPLETED|Overall Study||76
8853013|NCT01762345|9908138|FG000|NOT COMPLETED|Overall Study||7
8853014|NCT01762501|9908145|FG000|STARTED|Overall Study||359
8853015|NCT01762501|9908146|FG001|STARTED|Overall Study||359
8853016|NCT01762501|9908145|FG000|COMPLETED|Overall Study||332
8853017|NCT01762501|9908146|FG001|COMPLETED|Overall Study||336
8853018|NCT01762501|9908145|FG000|NOT COMPLETED|Overall Study||27
8853019|NCT01762501|9908146|FG001|NOT COMPLETED|Overall Study||23
8853020|NCT01762631|9908154|FG000|STARTED|Overall Study||53
8853021|NCT01762631|9908155|FG001|STARTED|Overall Study||22
8853022|NCT01762631|9908154|FG000|COMPLETED|Overall Study||53
8853023|NCT01762631|9908155|FG001|COMPLETED|Overall Study||22
8853024|NCT01762631|9908154|FG000|NOT COMPLETED|Overall Study||0
8853025|NCT01762631|9908155|FG001|NOT COMPLETED|Overall Study||0
8853026|NCT01762722|9908163|FG000|STARTED|Overall Study||12
8853027|NCT01762722|9908164|FG001|STARTED|Overall Study||11
8853028|NCT01762722|9908163|FG000|COMPLETED|Overall Study||12
8853029|NCT01762722|9908164|FG001|COMPLETED|Overall Study||11
8853030|NCT01762722|9908163|FG000|NOT COMPLETED|Overall Study||0
8853031|NCT01762722|9908164|FG001|NOT COMPLETED|Overall Study||0
8853032|NCT01762800|9908172|FG000|STARTED|Overall Study||202
8853033|NCT01762800|9908173|FG001|STARTED|Overall Study||204
8853034|NCT01762800|9908172|FG000|COMPLETED|Overall Study||183
8853035|NCT01762800|9908173|FG001|COMPLETED|Overall Study||183
8853036|NCT01762800|9908172|FG000|NOT COMPLETED|Overall Study||19
8853037|NCT01762800|9908173|FG001|NOT COMPLETED|Overall Study||21
8853038|NCT01762904|9908185|FG000|STARTED|Overall Study|January, 2013|135
8853039|NCT01762904|9908185|FG000|COMPLETED|Overall Study|October, 2013|135
8853040|NCT01762904|9908185|FG000|NOT COMPLETED|Overall Study||0
8853041|NCT01762943|9908194|FG000|STARTED|Overall Study||19
8853042|NCT01762943|9908195|FG001|STARTED|Overall Study||17
8853043|NCT01762943|9908194|FG000|Hypogonadism|Overall Study||18
8853044|NCT01762943|9908195|FG001|Hypogonadism|Overall Study||15
8853045|NCT01762943|9908194|FG000|Addback|Overall Study||16
8853046|NCT01762943|9908195|FG001|Addback|Overall Study||15
8853047|NCT01762943|9908194|FG000|Withdrawal|Overall Study||15
8853048|NCT01762943|9908195|FG001|Withdrawal|Overall Study||15
8853049|NCT01762943|9908194|FG000|COMPLETED|Overall Study||15
8853050|NCT01762943|9908195|FG001|COMPLETED|Overall Study||15
8853051|NCT01762943|9908194|FG000|NOT COMPLETED|Overall Study||4
8853052|NCT01762943|9908195|FG001|NOT COMPLETED|Overall Study||2
8853053|NCT01762982|9908201|FG000|STARTED|Overall Study||36
8853054|NCT01762982|9908201|FG000|Received Saline Water|Overall Study||36
8853055|NCT01762982|9908201|FG000|Received Benzalkonium Chloride|Overall Study||36
8853056|NCT01762982|9908201|FG000|Received SLS|Overall Study||36
8853057|NCT01762982|9908201|FG000|Received Empty Finn Chamber|Overall Study||36
8853058|NCT01762982|9908201|FG000|COMPLETED|Overall Study||36
8853059|NCT01762982|9908201|FG000|NOT COMPLETED|Overall Study||0
8853060|NCT01763047|9908211|FG000|STARTED|Period 1||139
8853061|NCT01763047|9908212|FG001|STARTED|Period 1||137
8853062|NCT01763047|9908211|FG000|Myopes|Period 1||77
8853063|NCT01763047|9908212|FG001|Myopes|Period 1||76
8853064|NCT01763047|9908211|FG000|Hyperopes|Period 1||62
8853065|NCT01763047|9908212|FG001|Hyperopes|Period 1||61
8853066|NCT01763047|9908211|FG000|COMPLETED|Period 1||130
8853067|NCT01763047|9908212|FG001|COMPLETED|Period 1||126
8853068|NCT01763047|9908211|FG000|NOT COMPLETED|Period 1||9
8853069|NCT01763047|9908212|FG001|NOT COMPLETED|Period 1||11
8853070|NCT01763047|9908211|FG000|STARTED|Period 2||130
8853071|NCT01763047|9908212|FG001|STARTED|Period 2||126
8853072|NCT01763047|9908211|FG000|Myopes|Period 2||74
8853073|NCT01763047|9908212|FG001|Myopes|Period 2||72
8853074|NCT01763047|9908211|FG000|Hyperopes|Period 2||56
8853075|NCT01763047|9908212|FG001|Hyperopes|Period 2||54
8853076|NCT01763047|9908211|FG000|COMPLETED|Period 2||126
8853077|NCT01763047|9908212|FG001|COMPLETED|Period 2||121
8853078|NCT01763047|9908211|FG000|NOT COMPLETED|Period 2||4
8853079|NCT01763047|9908212|FG001|NOT COMPLETED|Period 2||5
8853080|NCT01763164|9908223|FG000|STARTED|Treatment Phase||269
8853081|NCT01763164|9908224|FG001|STARTED|Treatment Phase||133
8853082|NCT01763164|9908223|FG000|Treated/Safety Set|Treatment Phase||269
8853083|NCT01763164|9908224|FG001|Treated/Safety Set|Treatment Phase||114
8853084|NCT01763164|9908223|FG000|Full Analysis Set|Treatment Phase||269
8853085|NCT01763164|9908224|FG001|Full Analysis Set|Treatment Phase||133
8853086|NCT01763164|9908223|FG000|COMPLETED|Treatment Phase||0
8853087|NCT01763164|9908224|FG001|COMPLETED|Treatment Phase||0
8853088|NCT01763164|9908223|FG000|NOT COMPLETED|Treatment Phase||269
8853089|NCT01763164|9908224|FG001|NOT COMPLETED|Treatment Phase||133
8853090|NCT01763164|9908223|FG000|STARTED|Follow up Phase|Participants were followed up after completion or discontinuation of treatment.|200
8853091|NCT01763164|9908224|FG001|STARTED|Follow up Phase|Participants were followed up after completion or discontinuation of treatment.|78
8853092|NCT01763164|9908223|FG000|COMPLETED|Follow up Phase||3
8853093|NCT01763164|9908224|FG001|COMPLETED|Follow up Phase||3
8853094|NCT01763164|9908223|FG000|NOT COMPLETED|Follow up Phase||197
8853095|NCT01763164|9908224|FG001|NOT COMPLETED|Follow up Phase||75
8853096|NCT01763203|9908232|FG000|STARTED|Overall Study||241
8853097|NCT01763203|9908233|FG001|STARTED|Overall Study||246
8853098|NCT01763203|9908232|FG000|COMPLETED|Overall Study||208
8853099|NCT01763203|9908233|FG001|COMPLETED|Overall Study||204
8853100|NCT01763203|9908232|FG000|NOT COMPLETED|Overall Study||33
8853101|NCT01763203|9908233|FG001|NOT COMPLETED|Overall Study||42
8853102|NCT01763333|9908253|FG000|STARTED|Overall Study||6
8853103|NCT01763333|9908254|FG001|STARTED|Overall Study||6
8853104|NCT01763333|9908255|FG002|STARTED|Overall Study||6
8853105|NCT01763333|9908256|FG003|STARTED|Overall Study||6
8853106|NCT01763333|9908257|FG004|STARTED|Overall Study||4
8853107|NCT01763333|9908258|FG005|STARTED|Overall Study||6
8853108|NCT01763333|9908259|FG006|STARTED|Overall Study||5
8853109|NCT01763333|9908260|FG007|STARTED|Overall Study||6
8853110|NCT01763333|9908261|FG008|STARTED|Overall Study||5
8853111|NCT01763333|9908262|FG009|STARTED|Overall Study||18
8853112|NCT01763333|9908263|FG010|STARTED|Overall Study||3
8853113|NCT01763333|9908264|FG011|STARTED|Overall Study||3
8853114|NCT01763333|9908265|FG012|STARTED|Overall Study||3
8853115|NCT01763333|9908266|FG013|STARTED|Overall Study||3
8853116|NCT01763333|9908253|FG000|COMPLETED|Overall Study||6
8853117|NCT01763333|9908254|FG001|COMPLETED|Overall Study||6
8853118|NCT01763333|9908255|FG002|COMPLETED|Overall Study||6
8853119|NCT01763333|9908256|FG003|COMPLETED|Overall Study||6
8569506|NCT00097708|9601756|FG001|STARTED|Overall Study||176
8569507|NCT00097708|9601757|FG002|STARTED|Overall Study||162
8569508|NCT00097708|9601755|FG000|Intent-to-Treat (ITT)|Overall Study||165
8569509|NCT00097708|9601756|FG001|Intent-to-Treat (ITT)|Overall Study||169
8569510|NCT00097708|9601757|FG002|Intent-to-Treat (ITT)|Overall Study||149
8569511|NCT00097708|9601755|FG000|Treated|Overall Study||171
8569512|NCT00097708|9601756|FG001|Treated|Overall Study||176
8569513|NCT00097708|9601757|FG002|Treated|Overall Study||160
8569514|NCT00097708|9601755|FG000|COMPLETED|Overall Study||109
8569515|NCT00097708|9601756|FG001|COMPLETED|Overall Study||120
8569516|NCT00097708|9601757|FG002|COMPLETED|Overall Study||97
8569517|NCT00097708|9601755|FG000|NOT COMPLETED|Overall Study||64
8569518|NCT00097708|9601756|FG001|NOT COMPLETED|Overall Study||56
8569519|NCT00097708|9601757|FG002|NOT COMPLETED|Overall Study||65
8569520|NCT00097721|9601767|FG000|STARTED|Overall Study|The number started is all enrolled subjects.BL Characteristics consists of Safety Population.|71
8569521|NCT00097721|9601768|FG001|STARTED|Overall Study||33
8569522|NCT00097721|9601767|FG000|COMPLETED|Overall Study||0
8569523|NCT00097721|9601768|FG001|COMPLETED|Overall Study||0
8569524|NCT00097721|9601767|FG000|NOT COMPLETED|Overall Study||71
8853120|NCT01763333|9908257|FG004|COMPLETED|Overall Study||4
8853121|NCT01763333|9908258|FG005|COMPLETED|Overall Study||6
8853122|NCT01763333|9908259|FG006|COMPLETED|Overall Study||5
8853123|NCT01763333|9908260|FG007|COMPLETED|Overall Study||6
8853124|NCT01763333|9908261|FG008|COMPLETED|Overall Study||5
8853125|NCT01763333|9908262|FG009|COMPLETED|Overall Study||18
8853126|NCT01763333|9908263|FG010|COMPLETED|Overall Study||3
8853127|NCT01763333|9908264|FG011|COMPLETED|Overall Study||3
8853128|NCT01763333|9908265|FG012|COMPLETED|Overall Study||3
8853129|NCT01763333|9908266|FG013|COMPLETED|Overall Study||3
8853130|NCT01763333|9908253|FG000|NOT COMPLETED|Overall Study||0
8853131|NCT01763333|9908254|FG001|NOT COMPLETED|Overall Study||0
8853132|NCT01763333|9908255|FG002|NOT COMPLETED|Overall Study||0
8853133|NCT01763333|9908256|FG003|NOT COMPLETED|Overall Study||0
8853134|NCT01763333|9908257|FG004|NOT COMPLETED|Overall Study||0
8853135|NCT01763333|9908258|FG005|NOT COMPLETED|Overall Study||0
8853136|NCT01763333|9908259|FG006|NOT COMPLETED|Overall Study||0
8853137|NCT01763333|9908260|FG007|NOT COMPLETED|Overall Study||0
8853138|NCT01763333|9908261|FG008|NOT COMPLETED|Overall Study||0
8853139|NCT01763333|9908262|FG009|NOT COMPLETED|Overall Study||0
8853140|NCT01763333|9908263|FG010|NOT COMPLETED|Overall Study||0
8853141|NCT01763333|9908264|FG011|NOT COMPLETED|Overall Study||0
8853142|NCT01763333|9908265|FG012|NOT COMPLETED|Overall Study||0
8853143|NCT01763333|9908266|FG013|NOT COMPLETED|Overall Study||0
8853144|NCT01763346|9908302|FG000|STARTED|Overall Study|"Five subjects who enrolled in the study refused to initiate metformin therapy, thus did not start"|44
8853145|NCT01763346|9908303|FG001|STARTED|Overall Study|"Six subjects randomized to gastric banding refused the banding surgery and, thus, did not start"|44
8853146|NCT01763346|9908302|FG000|Received Intervention|Overall Study||39
8853147|NCT01763346|9908303|FG001|Received Intervention|Overall Study||38
8853148|NCT01763346|9908302|FG000|COMPLETED|Overall Study||34
8853149|NCT01763346|9908303|FG001|COMPLETED|Overall Study||36
8853150|NCT01763346|9908302|FG000|NOT COMPLETED|Overall Study||10
8853151|NCT01763346|9908303|FG001|NOT COMPLETED|Overall Study||8
8853152|NCT01763567|9908309|FG000|STARTED|Overall Study||19
8853153|NCT01763567|9908309|FG000|COMPLETED|Overall Study||19
8853154|NCT01763567|9908309|FG000|NOT COMPLETED|Overall Study||0
8853155|NCT01763606|9908315|FG000|STARTED|Overall Study||10
8853156|NCT01763606|9908316|FG001|STARTED|Overall Study||10
8853157|NCT01763606|9908315|FG000|COMPLETED|Overall Study||10
8853158|NCT01763606|9908316|FG001|COMPLETED|Overall Study||10
8853159|NCT01763606|9908315|FG000|NOT COMPLETED|Overall Study||0
8853160|NCT01763606|9908316|FG001|NOT COMPLETED|Overall Study||0
8853161|NCT01763645|9908325|FG000|STARTED|Overall Study||69
8853162|NCT01763645|9908326|FG001|STARTED|Overall Study||69
8853163|NCT01763645|9908325|FG000|Received at Least 1 Dose of Study Drug|Overall Study||68
8853164|NCT01763645|9908326|FG001|Received at Least 1 Dose of Study Drug|Overall Study||66
8853165|NCT01763645|9908325|FG000|COMPLETED|Overall Study|Completed the study according the protocol.|43
8853166|NCT01763645|9908326|FG001|COMPLETED|Overall Study|Completed the study according the protocol.|45
8853167|NCT01763645|9908325|FG000|NOT COMPLETED|Overall Study||26
8853168|NCT01763645|9908326|FG001|NOT COMPLETED|Overall Study||24
8853169|NCT01763684|9908335|FG000|STARTED|Overall Study||133
8853170|NCT01763684|9908336|FG001|STARTED|Overall Study||133
8853171|NCT01763684|9908335|FG000|Completed Surgery|Overall Study||126
8853172|NCT01763684|9908336|FG001|Completed Surgery|Overall Study||127
8853173|NCT01763684|9908335|FG000|COMPLETED|Overall Study||0
8853174|NCT01763684|9908336|FG001|COMPLETED|Overall Study||0
8853175|NCT01763684|9908335|FG000|NOT COMPLETED|Overall Study||133
8853176|NCT01763684|9908336|FG001|NOT COMPLETED|Overall Study||133
8853177|NCT01763827|9908348|FG000|STARTED|Overall Study||77
8853178|NCT01763827|9908349|FG001|STARTED|Overall Study||78
8853179|NCT01763827|9908350|FG002|STARTED|Overall Study||77
8853180|NCT01763827|9908351|FG003|STARTED|Overall Study||77
8853181|NCT01763827|9908352|FG004|STARTED|Overall Study||153
8853182|NCT01763827|9908353|FG005|STARTED|Overall Study||153
8853183|NCT01763827|9908348|FG000|Received at Least 1 Dose of Study Drug|Overall Study||76
8853184|NCT01763827|9908349|FG001|Received at Least 1 Dose of Study Drug|Overall Study||78
8853185|NCT01763827|9908350|FG002|Received at Least 1 Dose of Study Drug|Overall Study||77
8853186|NCT01763827|9908351|FG003|Received at Least 1 Dose of Study Drug|Overall Study||77
8853187|NCT01763827|9908352|FG004|Received at Least 1 Dose of Study Drug|Overall Study||153
8853188|NCT01763827|9908353|FG005|Received at Least 1 Dose of Study Drug|Overall Study||153
8853189|NCT01763827|9908348|FG000|COMPLETED|Overall Study||74
8853190|NCT01763827|9908349|FG001|COMPLETED|Overall Study||77
8853191|NCT01763827|9908350|FG002|COMPLETED|Overall Study||73
8853192|NCT01763827|9908351|FG003|COMPLETED|Overall Study||76
8853193|NCT01763827|9908352|FG004|COMPLETED|Overall Study||147
8853194|NCT01763827|9908353|FG005|COMPLETED|Overall Study||151
8853195|NCT01763827|9908348|FG000|NOT COMPLETED|Overall Study||3
8853196|NCT01763827|9908349|FG001|NOT COMPLETED|Overall Study||1
8853197|NCT01763827|9908350|FG002|NOT COMPLETED|Overall Study||4
8853198|NCT01763827|9908351|FG003|NOT COMPLETED|Overall Study||1
8853199|NCT01763827|9908352|FG004|NOT COMPLETED|Overall Study||6
8853200|NCT01763827|9908353|FG005|NOT COMPLETED|Overall Study||2
8853201|NCT01763866|9908391|FG000|STARTED|Overall Study||56
8853202|NCT01763866|9908392|FG001|STARTED|Overall Study||55
8853203|NCT01763866|9908393|FG002|STARTED|Overall Study||56
8853204|NCT01763866|9908394|FG003|STARTED|Overall Study||55
8853205|NCT01763866|9908395|FG004|STARTED|Overall Study||110
8853206|NCT01763866|9908396|FG005|STARTED|Overall Study||110
8853207|NCT01763866|9908397|FG006|STARTED|Overall Study||55
8853208|NCT01763866|9908398|FG007|STARTED|Overall Study||55
8853209|NCT01763866|9908399|FG008|STARTED|Overall Study||56
8853210|NCT01763866|9908400|FG009|STARTED|Overall Study||54
8853211|NCT01763866|9908401|FG010|STARTED|Overall Study||110
8853212|NCT01763866|9908402|FG011|STARTED|Overall Study||110
8853213|NCT01763866|9908403|FG012|STARTED|Overall Study||58
8853214|NCT01763866|9908404|FG013|STARTED|Overall Study||57
8853215|NCT01763866|9908405|FG014|STARTED|Overall Study||114
8853216|NCT01763866|9908406|FG015|STARTED|Overall Study||115
8853217|NCT01763866|9908407|FG016|STARTED|Overall Study||56
8853218|NCT01763866|9908408|FG017|STARTED|Overall Study||56
8853219|NCT01763866|9908409|FG018|STARTED|Overall Study||111
8853220|NCT01763866|9908410|FG019|STARTED|Overall Study||112
8853221|NCT01763866|9908411|FG020|STARTED|Overall Study||56
8853222|NCT01763866|9908412|FG021|STARTED|Overall Study||55
8853223|NCT01763866|9908413|FG022|STARTED|Overall Study||112
8853224|NCT01763866|9908414|FG023|STARTED|Overall Study||115
8853225|NCT01763866|9908391|FG000|Received Treatment|Overall Study||56
8853226|NCT01763866|9908392|FG001|Received Treatment|Overall Study||55
8853227|NCT01763866|9908393|FG002|Received Treatment|Overall Study||56
8853228|NCT01763866|9908394|FG003|Received Treatment|Overall Study||55
8853229|NCT01763866|9908395|FG004|Received Treatment|Overall Study||110
8853230|NCT01763866|9908396|FG005|Received Treatment|Overall Study||110
8853231|NCT01763866|9908397|FG006|Received Treatment|Overall Study||55
8853232|NCT01763866|9908398|FG007|Received Treatment|Overall Study||55
8853233|NCT01763866|9908399|FG008|Received Treatment|Overall Study||56
8853234|NCT01763866|9908400|FG009|Received Treatment|Overall Study||54
8853235|NCT01763866|9908401|FG010|Received Treatment|Overall Study||109
8853236|NCT01763866|9908402|FG011|Received Treatment|Overall Study||110
8853237|NCT01763866|9908403|FG012|Received Treatment|Overall Study||58
8853238|NCT01763866|9908404|FG013|Received Treatment|Overall Study||57
8853239|NCT01763866|9908405|FG014|Received Treatment|Overall Study||113
8853240|NCT01763866|9908406|FG015|Received Treatment|Overall Study||115
8853241|NCT01763866|9908407|FG016|Received Treatment|Overall Study||56
8853242|NCT01763866|9908408|FG017|Received Treatment|Overall Study||55
8853243|NCT01763866|9908409|FG018|Received Treatment|Overall Study||111
8853244|NCT01763866|9908410|FG019|Received Treatment|Overall Study||112
8853245|NCT01763866|9908411|FG020|Received Treatment|Overall Study||56
8853246|NCT01763866|9908412|FG021|Received Treatment|Overall Study||55
8853247|NCT01763866|9908413|FG022|Received Treatment|Overall Study||112
8853248|NCT01763866|9908414|FG023|Received Treatment|Overall Study||115
8949105|NCT02436005|10011636|FG001|STARTED|First Intervention||13
8949106|NCT02436005|10011635|FG000|COMPLETED|First Intervention||12
8949107|NCT02436005|10011636|FG001|COMPLETED|First Intervention||13
8949108|NCT02436005|10011635|FG000|NOT COMPLETED|First Intervention||0
8949109|NCT02436005|10011636|FG001|NOT COMPLETED|First Intervention||0
8949110|NCT02436005|10011635|FG000|STARTED|Second Intervention||12
8949111|NCT02436005|10011636|FG001|STARTED|Second Intervention||13
8949112|NCT02436005|10011635|FG000|COMPLETED|Second Intervention||12
8949113|NCT02436005|10011636|FG001|COMPLETED|Second Intervention||12
8949114|NCT02436005|10011635|FG000|NOT COMPLETED|Second Intervention||0
8949115|NCT02436005|10011636|FG001|NOT COMPLETED|Second Intervention||1
8949116|NCT02436031|10011642|FG000|STARTED|First Study Night||8
8949117|NCT02436031|10011643|FG001|STARTED|First Study Night||8
8949118|NCT02436031|10011642|FG000|COMPLETED|First Study Night||8
8949119|NCT02436031|10011643|FG001|COMPLETED|First Study Night||8
8949120|NCT02436031|10011642|FG000|NOT COMPLETED|First Study Night||0
8949121|NCT02436031|10011643|FG001|NOT COMPLETED|First Study Night||0
9037454|NCT03314662|10098615|FG001|NOT COMPLETED|Overall Study||5
8853249|NCT01763866|9908391|FG000|COMPLETED|Overall Study||54
8853250|NCT01763866|9908392|FG001|COMPLETED|Overall Study||54
8853251|NCT01763866|9908393|FG002|COMPLETED|Overall Study||51
8853252|NCT01763866|9908394|FG003|COMPLETED|Overall Study||55
8853253|NCT01763866|9908395|FG004|COMPLETED|Overall Study||108
8853254|NCT01763866|9908396|FG005|COMPLETED|Overall Study||107
8853255|NCT01763866|9908397|FG006|COMPLETED|Overall Study||48
8853256|NCT01763866|9908398|FG007|COMPLETED|Overall Study||55
8853257|NCT01763866|9908399|FG008|COMPLETED|Overall Study||53
8853258|NCT01763866|9908400|FG009|COMPLETED|Overall Study||53
8853259|NCT01763866|9908401|FG010|COMPLETED|Overall Study||102
8853260|NCT01763866|9908402|FG011|COMPLETED|Overall Study||108
8853261|NCT01763866|9908403|FG012|COMPLETED|Overall Study||54
8853262|NCT01763866|9908404|FG013|COMPLETED|Overall Study||57
8853263|NCT01763866|9908405|FG014|COMPLETED|Overall Study||102
8853264|NCT01763866|9908406|FG015|COMPLETED|Overall Study||112
8629772|NCT00531479|9669518|FG001|NOT COMPLETED|Overall Study||83
8629773|NCT00531518|9669526|FG000|STARTED|Overall Study||87
8629774|NCT00531518|9669527|FG001|STARTED|Overall Study||205
8853265|NCT01763866|9908407|FG016|COMPLETED|Overall Study||55
8853266|NCT01763866|9908408|FG017|COMPLETED|Overall Study||55
8853267|NCT01763866|9908409|FG018|COMPLETED|Overall Study||105
8853268|NCT01763866|9908410|FG019|COMPLETED|Overall Study||110
8853269|NCT01763866|9908411|FG020|COMPLETED|Overall Study||52
8853270|NCT01763866|9908412|FG021|COMPLETED|Overall Study||54
8853271|NCT01763866|9908413|FG022|COMPLETED|Overall Study||109
8853272|NCT01763866|9908414|FG023|COMPLETED|Overall Study||113
8853273|NCT01763866|9908391|FG000|NOT COMPLETED|Overall Study||2
8853274|NCT01763866|9908392|FG001|NOT COMPLETED|Overall Study||1
8853275|NCT01763866|9908393|FG002|NOT COMPLETED|Overall Study||5
8853276|NCT01763866|9908394|FG003|NOT COMPLETED|Overall Study||0
8853277|NCT01763866|9908395|FG004|NOT COMPLETED|Overall Study||2
8629775|NCT00531518|9669526|FG000|COMPLETED|Overall Study||55
8629776|NCT00531518|9669527|FG001|COMPLETED|Overall Study||134
8629777|NCT00531518|9669526|FG000|NOT COMPLETED|Overall Study||32
8629778|NCT00531518|9669527|FG001|NOT COMPLETED|Overall Study||71
8629779|NCT00531661|9669535|FG000|STARTED|6 Months||270
8853278|NCT01763866|9908396|FG005|NOT COMPLETED|Overall Study||3
8853279|NCT01763866|9908397|FG006|NOT COMPLETED|Overall Study||7
8853280|NCT01763866|9908398|FG007|NOT COMPLETED|Overall Study||0
8853281|NCT01763866|9908399|FG008|NOT COMPLETED|Overall Study||3
8853282|NCT01763866|9908400|FG009|NOT COMPLETED|Overall Study||1
8853283|NCT01763866|9908401|FG010|NOT COMPLETED|Overall Study||8
8853284|NCT01763866|9908402|FG011|NOT COMPLETED|Overall Study||2
8853285|NCT01763866|9908403|FG012|NOT COMPLETED|Overall Study||4
8853286|NCT01763866|9908404|FG013|NOT COMPLETED|Overall Study||0
8853287|NCT01763866|9908405|FG014|NOT COMPLETED|Overall Study||12
8853288|NCT01763866|9908406|FG015|NOT COMPLETED|Overall Study||3
8853289|NCT01763866|9908407|FG016|NOT COMPLETED|Overall Study||1
8853290|NCT01763866|9908408|FG017|NOT COMPLETED|Overall Study||1
8853291|NCT01763866|9908409|FG018|NOT COMPLETED|Overall Study||6
8853292|NCT01763866|9908410|FG019|NOT COMPLETED|Overall Study||2
8853293|NCT01763866|9908411|FG020|NOT COMPLETED|Overall Study||4
8853294|NCT01763866|9908412|FG021|NOT COMPLETED|Overall Study||1
8853295|NCT01763866|9908413|FG022|NOT COMPLETED|Overall Study||3
8853296|NCT01763866|9908414|FG023|NOT COMPLETED|Overall Study||2
8853297|NCT01763905|9908468|FG000|STARTED|Overall Study||51
8853298|NCT01763905|9908469|FG001|STARTED|Overall Study||51
8853299|NCT01763905|9908470|FG002|STARTED|Overall Study||103
8853300|NCT01763905|9908471|FG003|STARTED|Overall Study||102
8853301|NCT01763905|9908468|FG000|COMPLETED|Overall Study||45
8853302|NCT01763905|9908469|FG001|COMPLETED|Overall Study||50
8853303|NCT01763905|9908470|FG002|COMPLETED|Overall Study||94
8853304|NCT01763905|9908471|FG003|COMPLETED|Overall Study||101
8853305|NCT01763905|9908468|FG000|NOT COMPLETED|Overall Study||6
8853306|NCT01763905|9908469|FG001|NOT COMPLETED|Overall Study||1
8853307|NCT01763905|9908470|FG002|NOT COMPLETED|Overall Study||9
8853308|NCT01763905|9908471|FG003|NOT COMPLETED|Overall Study||1
8853309|NCT01763918|9908485|FG000|STARTED|Overall Study||55
8853310|NCT01763918|9908486|FG001|STARTED|Overall Study||55
8853311|NCT01763918|9908487|FG002|STARTED|Overall Study||111
8853312|NCT01763918|9908488|FG003|STARTED|Overall Study||110
8853313|NCT01763918|9908485|FG000|Received Treatment|Overall Study||54
8853314|NCT01763918|9908486|FG001|Received Treatment|Overall Study||55
8853315|NCT01763918|9908487|FG002|Received Treatment|Overall Study||110
8853316|NCT01763918|9908488|FG003|Received Treatment|Overall Study||110
8853317|NCT01763918|9908485|FG000|COMPLETED|Overall Study||49
8853318|NCT01763918|9908486|FG001|COMPLETED|Overall Study||54
8853319|NCT01763918|9908487|FG002|COMPLETED|Overall Study||101
8853320|NCT01763918|9908488|FG003|COMPLETED|Overall Study||108
8853321|NCT01763918|9908485|FG000|NOT COMPLETED|Overall Study||6
8853322|NCT01763918|9908486|FG001|NOT COMPLETED|Overall Study||1
8853323|NCT01763918|9908487|FG002|NOT COMPLETED|Overall Study||10
8853324|NCT01763918|9908488|FG003|NOT COMPLETED|Overall Study||2
8853325|NCT01763931|9908500|FG000|STARTED|Overall Study||2
8853326|NCT01763931|9908501|FG001|STARTED|Overall Study||4
8853327|NCT01763931|9908500|FG000|COMPLETED|Overall Study||2
8853328|NCT01763931|9908501|FG001|COMPLETED|Overall Study||3
8853329|NCT01763931|9908500|FG000|NOT COMPLETED|Overall Study||0
8853330|NCT01763931|9908501|FG001|NOT COMPLETED|Overall Study||1
8629780|NCT00531661|9669536|FG001|STARTED|6 Months||280
8629781|NCT00531661|9669535|FG000|COMPLETED|6 Months||244
8629782|NCT00531661|9669536|FG001|COMPLETED|6 Months||254
8629783|NCT00531661|9669535|FG000|NOT COMPLETED|6 Months||26
8629784|NCT00531661|9669536|FG001|NOT COMPLETED|6 Months||26
8853331|NCT01763970|9908507|FG000|STARTED|Overall Study||14
8853332|NCT01763970|9908507|FG000|COMPLETED|Overall Study||14
8853333|NCT01763970|9908507|FG000|NOT COMPLETED|Overall Study||0
8853334|NCT01763996|9908514|FG000|STARTED|Treatment Period 1||15
8853335|NCT01763996|9908515|FG001|STARTED|Treatment Period 1||15
8853336|NCT01763996|9908514|FG000|COMPLETED|Treatment Period 1||15
8853337|NCT01763996|9908515|FG001|COMPLETED|Treatment Period 1||15
8853338|NCT01763996|9908514|FG000|NOT COMPLETED|Treatment Period 1||0
8853339|NCT01763996|9908515|FG001|NOT COMPLETED|Treatment Period 1||0
8853340|NCT01763996|9908514|FG000|STARTED|Treatment Period 2||15
8853341|NCT01763996|9908515|FG001|STARTED|Treatment Period 2||15
8853342|NCT01763996|9908514|FG000|COMPLETED|Treatment Period 2||15
8853343|NCT01763996|9908515|FG001|COMPLETED|Treatment Period 2||14
8853344|NCT01763996|9908514|FG000|NOT COMPLETED|Treatment Period 2||0
8853345|NCT01763996|9908515|FG001|NOT COMPLETED|Treatment Period 2||1
8853346|NCT01764022|9908523|FG000|STARTED|Overall Study||115
8853347|NCT01764022|9908524|FG001|STARTED|Overall Study||110
8853348|NCT01764022|9908523|FG000|Received at Least 1 Dose of Study Drug|Overall Study||113
8853349|NCT01764022|9908524|FG001|Received at Least 1 Dose of Study Drug|Overall Study||110
8853350|NCT01764022|9908523|FG000|COMPLETED|Overall Study||107
8853351|NCT01764022|9908524|FG001|COMPLETED|Overall Study||96
8853352|NCT01764022|9908523|FG000|NOT COMPLETED|Overall Study||8
8853353|NCT01764022|9908524|FG001|NOT COMPLETED|Overall Study||14
8853354|NCT01764256|9908536|FG000|STARTED|Received All Vaccinations||12
8853355|NCT01764256|9908537|FG001|STARTED|Received All Vaccinations||12
8853356|NCT01764256|9908538|FG002|STARTED|Received All Vaccinations||12
8853357|NCT01764256|9908539|FG003|STARTED|Received All Vaccinations||12
8853358|NCT01764256|9908536|FG000|COMPLETED|Received All Vaccinations||10
8853359|NCT01764256|9908537|FG001|COMPLETED|Received All Vaccinations||11
8853360|NCT01764256|9908538|FG002|COMPLETED|Received All Vaccinations||11
8853361|NCT01764256|9908539|FG003|COMPLETED|Received All Vaccinations||12
8853362|NCT01764256|9908536|FG000|NOT COMPLETED|Received All Vaccinations||2
8853363|NCT01764256|9908537|FG001|NOT COMPLETED|Received All Vaccinations||1
8853364|NCT01764256|9908538|FG002|NOT COMPLETED|Received All Vaccinations||1
8853365|NCT01764256|9908539|FG003|NOT COMPLETED|Received All Vaccinations||0
8853366|NCT01764256|9908536|FG000|STARTED|Completed Study||10
8853367|NCT01764256|9908537|FG001|STARTED|Completed Study||11
8853368|NCT01764256|9908538|FG002|STARTED|Completed Study||11
8853369|NCT01764256|9908539|FG003|STARTED|Completed Study||12
8853370|NCT01764256|9908536|FG000|COMPLETED|Completed Study||10
8853371|NCT01764256|9908537|FG001|COMPLETED|Completed Study||11
8853372|NCT01764256|9908538|FG002|COMPLETED|Completed Study||11
8853373|NCT01764256|9908539|FG003|COMPLETED|Completed Study||11
8853374|NCT01764256|9908536|FG000|NOT COMPLETED|Completed Study||0
8853375|NCT01764256|9908537|FG001|NOT COMPLETED|Completed Study||0
8853376|NCT01764256|9908538|FG002|NOT COMPLETED|Completed Study||0
8853377|NCT01764256|9908539|FG003|NOT COMPLETED|Completed Study||1
8853378|NCT01764386|9908555|FG000|STARTED|Controlled Treatment Period (CTP)||153
8853379|NCT01764386|9908556|FG001|STARTED|Controlled Treatment Period (CTP)||89
8853380|NCT01764386|9908555|FG000|COMPLETED|Controlled Treatment Period (CTP)|Completed the 26-week Controlled Treatment Period.|71
8853381|NCT01764386|9908556|FG001|COMPLETED|Controlled Treatment Period (CTP)|Completed the 26-week Controlled Treatment Period.|82
8853382|NCT01764386|9908555|FG000|NOT COMPLETED|Controlled Treatment Period (CTP)||82
8853383|NCT01764386|9908556|FG001|NOT COMPLETED|Controlled Treatment Period (CTP)||7
8853384|NCT01764386|9908555|FG000|STARTED|Uncontrolled Treatment Period (UTP)||71
8853385|NCT01764386|9908556|FG001|STARTED|Uncontrolled Treatment Period (UTP)|One subject completed the 26-week CTP, but did not continue in the UTP.|81
8853386|NCT01764386|9908555|FG000|Completed 52 Weeks|Uncontrolled Treatment Period (UTP)||61
8853387|NCT01764386|9908556|FG001|Completed 52 Weeks|Uncontrolled Treatment Period (UTP)||35
8853388|NCT01764386|9908555|FG000|COMPLETED|Uncontrolled Treatment Period (UTP)|Completed the 78-week study.|55
8853389|NCT01764386|9908556|FG001|COMPLETED|Uncontrolled Treatment Period (UTP)|Completed the 78-week study.|28
8853390|NCT01764386|9908555|FG000|NOT COMPLETED|Uncontrolled Treatment Period (UTP)||16
8853391|NCT01764386|9908556|FG001|NOT COMPLETED|Uncontrolled Treatment Period (UTP)||53
8853392|NCT01764464|9908565|FG000|STARTED|First Intervention|Started Gralise|16
8853393|NCT01764464|9908566|FG001|STARTED|First Intervention|Started Placebo|16
8853394|NCT01764464|9908565|FG000|COMPLETED|First Intervention|Completed Gralise|14
8853395|NCT01764464|9908566|FG001|COMPLETED|First Intervention|Completed Placebo|13
8853396|NCT01764464|9908565|FG000|NOT COMPLETED|First Intervention||2
8853397|NCT01764464|9908566|FG001|NOT COMPLETED|First Intervention||3
8853398|NCT01764464|9908565|FG000|STARTED|Second Intervention (Cross-over)|Started Placebo|14
8853399|NCT01764464|9908566|FG001|STARTED|Second Intervention (Cross-over)|Started Gralise|13
8853400|NCT01764464|9908565|FG000|COMPLETED|Second Intervention (Cross-over)|Completed Placebo|12
8853401|NCT01764464|9908566|FG001|COMPLETED|Second Intervention (Cross-over)|Completed Gralise|13
8853402|NCT01764464|9908565|FG000|NOT COMPLETED|Second Intervention (Cross-over)||2
8853403|NCT01764464|9908566|FG001|NOT COMPLETED|Second Intervention (Cross-over)||0
8853404|NCT01764607|9908572|FG000|STARTED|Overall Study||1
8853405|NCT01764607|9908572|FG000|COMPLETED|Overall Study||1
8853406|NCT01764607|9908572|FG000|NOT COMPLETED|Overall Study||0
8853407|NCT01764633|9908578|FG000|STARTED|Overall Study||13780
8853408|NCT01764633|9908579|FG001|STARTED|Overall Study||13784
8853409|NCT01764633|9908578|FG000|Received Treatment|Overall Study||13756
8853410|NCT01764633|9908579|FG001|Received Treatment|Overall Study||13769
8853411|NCT01764633|9908578|FG000|COMPLETED|Overall Study||13662
8853412|NCT01764633|9908579|FG001|COMPLETED|Overall Study||13691
8853413|NCT01764633|9908578|FG000|NOT COMPLETED|Overall Study||118
8853414|NCT01764633|9908579|FG001|NOT COMPLETED|Overall Study||93
8853415|NCT01764659|9908585|FG000|STARTED|Overall Study||14
8853416|NCT01764659|9908585|FG000|COMPLETED|Overall Study||12
8853417|NCT01764659|9908585|FG000|NOT COMPLETED|Overall Study||2
8853418|NCT01764685|9908593|FG000|STARTED|Overall Study||0
8853419|NCT01764685|9908594|FG001|STARTED|Overall Study||4
8853420|NCT01764685|9908593|FG000|COMPLETED|Overall Study||0
8853421|NCT01764685|9908594|FG001|COMPLETED|Overall Study||3
8853422|NCT01764685|9908593|FG000|NOT COMPLETED|Overall Study||0
8853423|NCT01764685|9908594|FG001|NOT COMPLETED|Overall Study||1
8853424|NCT01764841|9908604|FG000|STARTED|Overall Study||141
8853425|NCT01764841|9908605|FG001|STARTED|Overall Study||137
8853426|NCT01764841|9908606|FG002|STARTED|Overall Study||70
8853427|NCT01764841|9908607|FG003|STARTED|Overall Study||68
8853428|NCT01764841|9908604|FG000|Participants Received Treatment|Overall Study|safety population|141
8853429|NCT01764841|9908605|FG001|Participants Received Treatment|Overall Study|safety population|136
8853430|NCT01764841|9908606|FG002|Participants Received Treatment|Overall Study|safety population|69
8853431|NCT01764841|9908607|FG003|Participants Received Treatment|Overall Study|safety population|68
8853432|NCT01764841|9908604|FG000|COMPLETED|Overall Study||118
8853433|NCT01764841|9908605|FG001|COMPLETED|Overall Study||111
8853434|NCT01764841|9908606|FG002|COMPLETED|Overall Study||56
8853435|NCT01764841|9908607|FG003|COMPLETED|Overall Study||49
8853436|NCT01764841|9908604|FG000|NOT COMPLETED|Overall Study||23
8853437|NCT01764841|9908605|FG001|NOT COMPLETED|Overall Study||26
8853438|NCT01764841|9908606|FG002|NOT COMPLETED|Overall Study||14
8853439|NCT01764841|9908607|FG003|NOT COMPLETED|Overall Study||19
8853440|NCT01764854|9908621|FG000|STARTED|Overall Study||8
8853441|NCT01764854|9908622|FG001|STARTED|Overall Study||8
8853442|NCT01764854|9908623|FG002|STARTED|Overall Study||37
8853443|NCT01764854|9908624|FG003|STARTED|Overall Study||35
8853444|NCT01764854|9908621|FG000|COMPLETED|Overall Study||8
8853445|NCT01764854|9908622|FG001|COMPLETED|Overall Study||8
8853446|NCT01764854|9908623|FG002|COMPLETED|Overall Study||31
8853447|NCT01764854|9908624|FG003|COMPLETED|Overall Study||33
8853448|NCT01764854|9908621|FG000|NOT COMPLETED|Overall Study||0
8853449|NCT01764854|9908622|FG001|NOT COMPLETED|Overall Study||0
8853450|NCT01764854|9908623|FG002|NOT COMPLETED|Overall Study||6
8853451|NCT01764854|9908624|FG003|NOT COMPLETED|Overall Study||2
8853452|NCT01764919|9908634|FG000|STARTED|Overall Study||4
8853453|NCT01764919|9908634|FG000|COMPLETED|Overall Study||4
8853454|NCT01764919|9908634|FG000|NOT COMPLETED|Overall Study||0
8853455|NCT01764945|9908646|FG000|STARTED|Overall Study||5
8853456|NCT01764945|9908647|FG001|STARTED|Overall Study||5
8853457|NCT01764945|9908648|FG002|STARTED|Overall Study||5
8853458|NCT01764945|9908649|FG003|STARTED|Overall Study||5
8853459|NCT01764945|9908650|FG004|STARTED|Overall Study||10
8853460|NCT01764945|9908651|FG005|STARTED|Overall Study||8
8853461|NCT01764945|9908652|FG006|STARTED|Overall Study||9
8853462|NCT01764945|9908653|FG007|STARTED|Overall Study||9
8853463|NCT01764945|9908646|FG000|COMPLETED|Overall Study||5
8853464|NCT01764945|9908647|FG001|COMPLETED|Overall Study||4
8853465|NCT01764945|9908648|FG002|COMPLETED|Overall Study||5
8853466|NCT01764945|9908649|FG003|COMPLETED|Overall Study||5
8853467|NCT01764945|9908650|FG004|COMPLETED|Overall Study||10
8853468|NCT01764945|9908651|FG005|COMPLETED|Overall Study||8
8853469|NCT01764945|9908652|FG006|COMPLETED|Overall Study||8
8853470|NCT01764945|9908653|FG007|COMPLETED|Overall Study||9
8853471|NCT01764945|9908646|FG000|NOT COMPLETED|Overall Study||0
8853472|NCT01764945|9908647|FG001|NOT COMPLETED|Overall Study||1
8853473|NCT01764945|9908648|FG002|NOT COMPLETED|Overall Study||0
8853474|NCT01764945|9908649|FG003|NOT COMPLETED|Overall Study||0
8853475|NCT01764945|9908650|FG004|NOT COMPLETED|Overall Study||0
8853476|NCT01764945|9908651|FG005|NOT COMPLETED|Overall Study||0
8853477|NCT01764945|9908652|FG006|NOT COMPLETED|Overall Study||1
8853478|NCT01764945|9908653|FG007|NOT COMPLETED|Overall Study||0
8853479|NCT01765153|9908673|FG000|STARTED|Training Phase 1||10
8853480|NCT01765153|9908674|FG001|STARTED|Training Phase 1||11
8853481|NCT01765153|9908673|FG000|COMPLETED|Training Phase 1||9
8853482|NCT01765153|9908674|FG001|COMPLETED|Training Phase 1||10
8853483|NCT01765153|9908673|FG000|NOT COMPLETED|Training Phase 1||1
8853484|NCT01765153|9908674|FG001|NOT COMPLETED|Training Phase 1||1
8853485|NCT01765153|9908673|FG000|STARTED|Rest Phase 1||9
8853486|NCT01765153|9908674|FG001|STARTED|Rest Phase 1||10
8853487|NCT01765153|9908673|FG000|COMPLETED|Rest Phase 1||9
8853488|NCT01765153|9908674|FG001|COMPLETED|Rest Phase 1||9
8853489|NCT01765153|9908673|FG000|NOT COMPLETED|Rest Phase 1||0
8853490|NCT01765153|9908674|FG001|NOT COMPLETED|Rest Phase 1||1
8853491|NCT01765153|9908673|FG000|STARTED|Training Phase 2|1st subject didn't use same training(phase 1) as subsequent participants Phase 1 and 2 data removed.|10
8853492|NCT01765153|9908674|FG001|STARTED|Training Phase 2||9
8853493|NCT01765153|9908673|FG000|COMPLETED|Training Phase 2||10
8853494|NCT01765153|9908674|FG001|COMPLETED|Training Phase 2||8
8853495|NCT01765153|9908673|FG000|NOT COMPLETED|Training Phase 2||0
8853496|NCT01765153|9908674|FG001|NOT COMPLETED|Training Phase 2||1
8853497|NCT01765153|9908673|FG000|STARTED|Rest Phase 2||10
8853498|NCT01765153|9908674|FG001|STARTED|Rest Phase 2||8
8853499|NCT01765153|9908673|FG000|COMPLETED|Rest Phase 2||8
8853500|NCT01765153|9908674|FG001|COMPLETED|Rest Phase 2||7
8853501|NCT01765153|9908673|FG000|NOT COMPLETED|Rest Phase 2||2
8853502|NCT01765153|9908674|FG001|NOT COMPLETED|Rest Phase 2||1
8853503|NCT01765179|9908684|FG000|STARTED|Overall Study||144
8853504|NCT01765179|9908684|FG000|COMPLETED|Overall Study||117
8853505|NCT01765179|9908684|FG000|NOT COMPLETED|Overall Study||27
8853506|NCT01765192|9908690|FG000|STARTED|Treatment Period 1||32
8853507|NCT01765192|9908691|FG001|STARTED|Treatment Period 1||32
8853508|NCT01765192|9908690|FG000|COMPLETED|Treatment Period 1||32
8853509|NCT01765192|9908691|FG001|COMPLETED|Treatment Period 1||31
8853510|NCT01765192|9908690|FG000|NOT COMPLETED|Treatment Period 1||0
8853511|NCT01765192|9908691|FG001|NOT COMPLETED|Treatment Period 1||1
8853512|NCT01765192|9908690|FG000|STARTED|Washout Period||32
8853513|NCT01765192|9908691|FG001|STARTED|Washout Period||31
8853514|NCT01765192|9908690|FG000|COMPLETED|Washout Period||30
8853515|NCT01765192|9908691|FG001|COMPLETED|Washout Period||30
8853516|NCT01765192|9908690|FG000|NOT COMPLETED|Washout Period||2
8853517|NCT01765192|9908691|FG001|NOT COMPLETED|Washout Period||1
8853518|NCT01765192|9908690|FG000|STARTED|Treatment Period 2||30
8853519|NCT01765192|9908691|FG001|STARTED|Treatment Period 2||30
8853520|NCT01765192|9908690|FG000|COMPLETED|Treatment Period 2||30
8853521|NCT01765192|9908691|FG001|COMPLETED|Treatment Period 2||28
8853522|NCT01765192|9908690|FG000|NOT COMPLETED|Treatment Period 2||0
8853523|NCT01765192|9908691|FG001|NOT COMPLETED|Treatment Period 2||2
8853524|NCT01765192|9908690|FG000|STARTED|End of Treatment Period 2 to Final Visit||30
8853525|NCT01765192|9908691|FG001|STARTED|End of Treatment Period 2 to Final Visit||28
8853526|NCT01765192|9908690|FG000|COMPLETED|End of Treatment Period 2 to Final Visit||30
8853527|NCT01765192|9908691|FG001|COMPLETED|End of Treatment Period 2 to Final Visit||27
8853528|NCT01765192|9908690|FG000|NOT COMPLETED|End of Treatment Period 2 to Final Visit||0
8853529|NCT01765192|9908691|FG001|NOT COMPLETED|End of Treatment Period 2 to Final Visit||1
8853530|NCT01765270|9908699|FG000|STARTED|Overall Study||5
8853531|NCT01765270|9908700|FG001|STARTED|Overall Study||7
8949122|NCT02436031|10011642|FG000|STARTED|Second Study Night|1 participant did not tolerate the study setup so did not participate in the second study night|7
8949123|NCT02436031|10011643|FG001|STARTED|Second Study Night||8
8949124|NCT02436031|10011642|FG000|COMPLETED|Second Study Night||7
8949125|NCT02436031|10011643|FG001|COMPLETED|Second Study Night||8
8949126|NCT02436031|10011642|FG000|NOT COMPLETED|Second Study Night||0
8949127|NCT02436031|10011643|FG001|NOT COMPLETED|Second Study Night||0
8949128|NCT02436135|10011651|FG000|STARTED|Overall Study||6
8949129|NCT02436135|10011652|FG001|STARTED|Overall Study||4
8949130|NCT02436135|10011651|FG000|COMPLETED|Overall Study||0
8949131|NCT02436135|10011652|FG001|COMPLETED|Overall Study||0
8949132|NCT02436135|10011651|FG000|NOT COMPLETED|Overall Study||6
8949133|NCT02436135|10011652|FG001|NOT COMPLETED|Overall Study||4
8949134|NCT02436200|10011658|FG000|STARTED|Overall Study||21
8949135|NCT02436200|10011658|FG000|COMPLETED|Overall Study||20
8949136|NCT02436200|10011658|FG000|NOT COMPLETED|Overall Study||1
8949137|NCT02436239|10011666|FG000|STARTED|Open-Lable Treatment Period||122
8853532|NCT01765270|9908699|FG000|COMPLETED|Overall Study||4
8853533|NCT01765270|9908700|FG001|COMPLETED|Overall Study||6
8853534|NCT01765270|9908699|FG000|NOT COMPLETED|Overall Study||1
8853535|NCT01765270|9908700|FG001|NOT COMPLETED|Overall Study||1
8853536|NCT01765426|9908711|FG000|STARTED|Overall Study||18
8853537|NCT01765426|9908712|FG001|STARTED|Overall Study||17
8853538|NCT01765426|9908713|FG002|STARTED|Overall Study||17
8853539|NCT01765426|9908714|FG003|STARTED|Overall Study||15
8853540|NCT01765426|9908711|FG000|Completed All Vaccinations|Overall Study||17
8853541|NCT01765426|9908712|FG001|Completed All Vaccinations|Overall Study||16
8853542|NCT01765426|9908713|FG002|Completed All Vaccinations|Overall Study||17
8853543|NCT01765426|9908714|FG003|Completed All Vaccinations|Overall Study||15
8853544|NCT01765426|9908711|FG000|COMPLETED|Overall Study||18
8853545|NCT01765426|9908712|FG001|COMPLETED|Overall Study||16
8853546|NCT01765426|9908713|FG002|COMPLETED|Overall Study||17
8853547|NCT01765426|9908714|FG003|COMPLETED|Overall Study||15
8853548|NCT01765426|9908711|FG000|NOT COMPLETED|Overall Study||0
8853549|NCT01765426|9908712|FG001|NOT COMPLETED|Overall Study||1
8853550|NCT01765426|9908713|FG002|NOT COMPLETED|Overall Study||0
8853551|NCT01765426|9908714|FG003|NOT COMPLETED|Overall Study||0
8853552|NCT01765465|9908726|FG000|STARTED|Overall Study||71
8853553|NCT01765465|9908727|FG001|STARTED|Overall Study||67
8853554|NCT01765465|9908726|FG000|COMPLETED|Overall Study||64
8853555|NCT01765465|9908727|FG001|COMPLETED|Overall Study||63
8853556|NCT01765465|9908726|FG000|NOT COMPLETED|Overall Study||7
8853557|NCT01765465|9908727|FG001|NOT COMPLETED|Overall Study||4
8853558|NCT01765530|9908737|FG000|STARTED|Overall Study||37
8853559|NCT01765530|9908738|FG001|STARTED|Overall Study||37
8853560|NCT01765530|9908737|FG000|COMPLETED|Overall Study||36
8853561|NCT01765530|9908738|FG001|COMPLETED|Overall Study||36
8853562|NCT01765530|9908737|FG000|NOT COMPLETED|Overall Study||1
8853563|NCT01765530|9908738|FG001|NOT COMPLETED|Overall Study||1
8853564|NCT01765543|9908744|FG000|STARTED|Overall Study||27
8853565|NCT01765543|9908744|FG000|COMPLETED|Overall Study||24
8853566|NCT01765543|9908744|FG000|NOT COMPLETED|Overall Study||3
8853567|NCT01765569|9908752|FG000|STARTED|Period A||29
8853568|NCT01765569|9908752|FG000|COMPLETED|Period A||29
8853569|NCT01765569|9908752|FG000|NOT COMPLETED|Period A||0
8853570|NCT01765569|9908752|FG000|STARTED|Period B||29
8853571|NCT01765569|9908752|FG000|COMPLETED|Period B||28
8853572|NCT01765569|9908752|FG000|NOT COMPLETED|Period B||1
8853573|NCT01765569|9908752|FG000|STARTED|Period C||28
8853574|NCT01765569|9908752|FG000|COMPLETED|Period C||27
8853575|NCT01765569|9908752|FG000|NOT COMPLETED|Period C||1
8853576|NCT01765582|9908762|FG000|STARTED|Overall Study||93
8853577|NCT01765582|9908763|FG001|STARTED|Overall Study||92
8853578|NCT01765582|9908764|FG002|STARTED|Overall Study||95
8853579|NCT01765582|9908762|FG000|COMPLETED|Overall Study||0
8853580|NCT01765582|9908763|FG001|COMPLETED|Overall Study||0
8853581|NCT01765582|9908764|FG002|COMPLETED|Overall Study||0
8853582|NCT01765582|9908762|FG000|NOT COMPLETED|Overall Study||93
8853583|NCT01765582|9908763|FG001|NOT COMPLETED|Overall Study||92
8853584|NCT01765582|9908764|FG002|NOT COMPLETED|Overall Study||95
8853585|NCT01765647|9908773|FG000|STARTED|Overall Study|One began the run-in period, but was withdrawn prior to beginning treatment with AGY|10
8853586|NCT01765647|9908773|FG000|COMPLETED|Overall Study|10 entered the AGY treatment phase and all 10 completed treatment.|10
8853587|NCT01765647|9908773|FG000|NOT COMPLETED|Overall Study||0
8853588|NCT01765673|9908777|FG000|STARTED|Overall Study||12
8853589|NCT01765673|9908777|FG000|COMPLETED|Overall Study||11
8853590|NCT01765673|9908777|FG000|NOT COMPLETED|Overall Study||1
8853591|NCT01765712|9908786|FG000|STARTED|Overall Study||27
8853592|NCT01765712|9908787|FG001|STARTED|Overall Study||23
8853593|NCT01765712|9908786|FG000|COMPLETED|Overall Study||27
8853594|NCT01765712|9908787|FG001|COMPLETED|Overall Study||23
8853595|NCT01765712|9908786|FG000|NOT COMPLETED|Overall Study||0
8853596|NCT01765712|9908787|FG001|NOT COMPLETED|Overall Study||0
8853597|NCT01765751|9908796|FG000|STARTED|Overall Study||16
8853598|NCT01765751|9908797|FG001|STARTED|Overall Study||16
8853599|NCT01765751|9908798|FG002|STARTED|Overall Study||16
8853600|NCT01765751|9908796|FG000|COMPLETED|Overall Study||16
8853601|NCT01765751|9908797|FG001|COMPLETED|Overall Study||14
8853602|NCT01765751|9908798|FG002|COMPLETED|Overall Study||15
8853603|NCT01765751|9908796|FG000|NOT COMPLETED|Overall Study||0
8853604|NCT01765751|9908797|FG001|NOT COMPLETED|Overall Study||2
8853605|NCT01765751|9908798|FG002|NOT COMPLETED|Overall Study||1
8853606|NCT01765764|9908812|FG000|STARTED|Treatment Period||118
8853607|NCT01765764|9908813|FG001|STARTED|Treatment Period||118
8853608|NCT01765764|9908814|FG002|STARTED|Treatment Period||121
8853609|NCT01765764|9908812|FG000|COMPLETED|Treatment Period||115
8853610|NCT01765764|9908813|FG001|COMPLETED|Treatment Period||109
8853611|NCT01765764|9908814|FG002|COMPLETED|Treatment Period||115
8853612|NCT01765764|9908812|FG000|NOT COMPLETED|Treatment Period||3
8853613|NCT01765764|9908813|FG001|NOT COMPLETED|Treatment Period||9
8853614|NCT01765764|9908814|FG002|NOT COMPLETED|Treatment Period||6
8853615|NCT01765764|9908812|FG000|STARTED|Post-treatment Period|1 participant did not enter the Post-treatment Period. [Personal Reasons]|114
8853616|NCT01765764|9908813|FG001|STARTED|Post-treatment Period|2 participants did not enter the Post-treatment Period [2 Lost-to-Follow-up (LFU)]|107
8853617|NCT01765764|9908814|FG002|STARTED|Post-treatment Period|3 participants did not enter the Post-treatment Period [1 Personal Reasons,2 LFU].|112
8853618|NCT01765764|9908812|FG000|COMPLETED|Post-treatment Period||114
8853619|NCT01765764|9908813|FG001|COMPLETED|Post-treatment Period||107
8853620|NCT01765764|9908814|FG002|COMPLETED|Post-treatment Period||112
8853621|NCT01765764|9908812|FG000|NOT COMPLETED|Post-treatment Period||0
8853622|NCT01765764|9908813|FG001|NOT COMPLETED|Post-treatment Period||0
8853623|NCT01765764|9908814|FG002|NOT COMPLETED|Post-treatment Period||0
8853624|NCT01765803|9908822|FG000|STARTED|Overall Study||6
8853625|NCT01765803|9908822|FG000|COMPLETED|Overall Study||6
8853626|NCT01765803|9908822|FG000|NOT COMPLETED|Overall Study||0
8853627|NCT01765920|9908828|FG000|STARTED|Overall Study||169
8853628|NCT01765920|9908829|FG001|STARTED|Overall Study||173
8853629|NCT01765920|9908828|FG000|COMPLETED|Overall Study||167
8853630|NCT01765920|9908829|FG001|COMPLETED|Overall Study||167
8853631|NCT01765920|9908828|FG000|NOT COMPLETED|Overall Study||2
8853632|NCT01765920|9908829|FG001|NOT COMPLETED|Overall Study||6
8853633|NCT01765972|9908835|FG000|STARTED|Overall Study||6
8853634|NCT01765972|9908836|FG001|STARTED|Overall Study||6
8853635|NCT01765972|9908837|FG002|STARTED|Overall Study||6
8853636|NCT01765972|9908838|FG003|STARTED|Overall Study||6
8853637|NCT01765972|9908835|FG000|COMPLETED|Overall Study||6
8853638|NCT01765972|9908836|FG001|COMPLETED|Overall Study||6
8853639|NCT01765972|9908837|FG002|COMPLETED|Overall Study||6
8853640|NCT01765972|9908838|FG003|COMPLETED|Overall Study||6
8853641|NCT01765972|9908835|FG000|NOT COMPLETED|Overall Study||0
8853642|NCT01765972|9908836|FG001|NOT COMPLETED|Overall Study||0
8853643|NCT01765972|9908837|FG002|NOT COMPLETED|Overall Study||0
8853644|NCT01765972|9908838|FG003|NOT COMPLETED|Overall Study||0
8853645|NCT01766024|9908850|FG000|STARTED|Overall Study||16
8853646|NCT01766024|9908851|FG001|STARTED|Overall Study||16
8853647|NCT01766024|9908850|FG000|COMPLETED|Overall Study||16
8853648|NCT01766024|9908851|FG001|COMPLETED|Overall Study||16
8853649|NCT01766024|9908850|FG000|NOT COMPLETED|Overall Study||0
8853650|NCT01766024|9908851|FG001|NOT COMPLETED|Overall Study||0
8853651|NCT01766037|9908861|FG000|STARTED|Overall Study||111
8853652|NCT01766037|9908862|FG001|STARTED|Overall Study||60
8853653|NCT01766037|9908861|FG000|COMPLETED|Overall Study||82
8853654|NCT01766037|9908862|FG001|COMPLETED|Overall Study||31
8853655|NCT01766037|9908861|FG000|NOT COMPLETED|Overall Study||29
8853656|NCT01766037|9908862|FG001|NOT COMPLETED|Overall Study||29
8923364|NCT02239744|9983935|FG000|NOT COMPLETED|Period 1||0
8923365|NCT02239744|9983936|FG001|NOT COMPLETED|Period 1||0
8923366|NCT02239744|9983935|FG000|STARTED|Period 2||17
8923367|NCT02239744|9983936|FG001|STARTED|Period 2||18
8923368|NCT02239744|9983935|FG000|COMPLETED|Period 2||17
8923369|NCT02239744|9983936|FG001|COMPLETED|Period 2||18
8923370|NCT02239744|9983935|FG000|NOT COMPLETED|Period 2||0
8923371|NCT02239744|9983936|FG001|NOT COMPLETED|Period 2||0
8923372|NCT02239770|9983949|FG000|STARTED|Part 1||4
8923373|NCT02239770|9983950|FG001|STARTED|Part 1||4
8923374|NCT02239770|9983951|FG002|STARTED|Part 1||4
8923375|NCT02239770|9983952|FG003|STARTED|Part 1||0
8923376|NCT02239770|9983953|FG004|STARTED|Part 1||0
8923377|NCT02239770|9983954|FG005|STARTED|Part 1||0
8923378|NCT02239770|9983949|FG000|COMPLETED|Part 1||4
8923379|NCT02239770|9983950|FG001|COMPLETED|Part 1||4
8923380|NCT02239770|9983951|FG002|COMPLETED|Part 1||4
8923381|NCT02239770|9983952|FG003|COMPLETED|Part 1||0
8923382|NCT02239770|9983953|FG004|COMPLETED|Part 1||0
8923383|NCT02239770|9983954|FG005|COMPLETED|Part 1||0
8923384|NCT02239770|9983949|FG000|NOT COMPLETED|Part 1||0
8923385|NCT02239770|9983950|FG001|NOT COMPLETED|Part 1||0
8923386|NCT02239770|9983951|FG002|NOT COMPLETED|Part 1||0
8923387|NCT02239770|9983952|FG003|NOT COMPLETED|Part 1||0
8923388|NCT02239770|9983953|FG004|NOT COMPLETED|Part 1||0
8923389|NCT02239770|9983954|FG005|NOT COMPLETED|Part 1||0
8923390|NCT02239770|9983949|FG000|STARTED|Part 2||0
8923391|NCT02239770|9983950|FG001|STARTED|Part 2||0
8923392|NCT02239770|9983951|FG002|STARTED|Part 2||0
8923393|NCT02239770|9983952|FG003|STARTED|Part 2||4
8923394|NCT02239770|9983953|FG004|STARTED|Part 2||4
8923395|NCT02239770|9983954|FG005|STARTED|Part 2||4
8923396|NCT02239770|9983949|FG000|COMPLETED|Part 2||0
8923397|NCT02239770|9983950|FG001|COMPLETED|Part 2||0
8923398|NCT02239770|9983951|FG002|COMPLETED|Part 2||0
8923399|NCT02239770|9983952|FG003|COMPLETED|Part 2||4
8923400|NCT02239770|9983953|FG004|COMPLETED|Part 2||4
8923401|NCT02239770|9983954|FG005|COMPLETED|Part 2||4
8923402|NCT02239770|9983949|FG000|NOT COMPLETED|Part 2||0
8923403|NCT02239770|9983950|FG001|NOT COMPLETED|Part 2||0
8923404|NCT02239770|9983951|FG002|NOT COMPLETED|Part 2||0
8923405|NCT02239770|9983952|FG003|NOT COMPLETED|Part 2||0
8923406|NCT02239770|9983953|FG004|NOT COMPLETED|Part 2||0
8923407|NCT02239770|9983954|FG005|NOT COMPLETED|Part 2||0
8923408|NCT02239939|9983978|FG000|STARTED|Overall Study||20
8923409|NCT02239939|9983979|FG001|STARTED|Overall Study||17
8923410|NCT02239939|9983978|FG000|COMPLETED|Overall Study||18
8923411|NCT02239939|9983979|FG001|COMPLETED|Overall Study||15
8923412|NCT02239939|9983978|FG000|NOT COMPLETED|Overall Study||2
8923413|NCT02239939|9983979|FG001|NOT COMPLETED|Overall Study||2
8923414|NCT02239978|9983989|FG000|STARTED|Overall Study||30
8923415|NCT02239978|9983990|FG001|STARTED|Overall Study||12
8923416|NCT02239978|9983989|FG000|COMPLETED|Overall Study||28
8923417|NCT02239978|9983990|FG001|COMPLETED|Overall Study||12
8923418|NCT02239978|9983989|FG000|NOT COMPLETED|Overall Study||2
8923419|NCT02239978|9983990|FG001|NOT COMPLETED|Overall Study||0
8923420|NCT02240030|9984001|FG000|STARTED|Overall Study||113
8923421|NCT02240030|9984002|FG001|STARTED|Overall Study||114
8923422|NCT02240030|9984003|FG002|STARTED|Overall Study||112
8923423|NCT02240030|9984001|FG000|COMPLETED|Overall Study||96
8923424|NCT02240030|9984002|FG001|COMPLETED|Overall Study||97
8853657|NCT01766050|9908868|FG000|STARTED|Overall Study||22
8853658|NCT01766050|9908868|FG000|COMPLETED|Overall Study||18
8853659|NCT01766050|9908868|FG000|NOT COMPLETED|Overall Study||4
8853660|NCT01766076|9908888|FG000|STARTED|Overall Study||15
8853661|NCT01766076|9908889|FG001|STARTED|Overall Study||15
8853662|NCT01766076|9908888|FG000|COMPLETED|Overall Study||15
8853663|NCT01766076|9908889|FG001|COMPLETED|Overall Study||15
8853664|NCT01766076|9908888|FG000|NOT COMPLETED|Overall Study||0
8853665|NCT01766076|9908889|FG001|NOT COMPLETED|Overall Study||0
8853666|NCT01766102|9908897|FG000|STARTED|Overall Study||36
8629785|NCT00531661|9669535|FG000|STARTED|Study Duration: 15 Months Avg. Follow-up||244
8629786|NCT00531661|9669536|FG001|STARTED|Study Duration: 15 Months Avg. Follow-up||254
8853667|NCT01766102|9908898|FG001|STARTED|Overall Study||36
8853668|NCT01766102|9908897|FG000|COMPLETED|Overall Study||36
8853669|NCT01766102|9908898|FG001|COMPLETED|Overall Study||36
8853670|NCT01766102|9908897|FG000|NOT COMPLETED|Overall Study||0
8853671|NCT01766102|9908898|FG001|NOT COMPLETED|Overall Study||0
8853672|NCT01766206|9908904|FG000|STARTED|Overall Study||3939
8853673|NCT01766206|9908904|FG000|COMPLETED|Overall Study||3888
8853674|NCT01766206|9908904|FG000|NOT COMPLETED|Overall Study||51
8853675|NCT01766219|9908911|FG000|STARTED|Overall Study||4
8853676|NCT01766219|9908912|FG001|STARTED|Overall Study||2
8853677|NCT01766219|9908913|FG002|STARTED|Overall Study||11
8853678|NCT01766219|9908911|FG000|COMPLETED|Overall Study||4
8853679|NCT01766219|9908912|FG001|COMPLETED|Overall Study||2
8853680|NCT01766219|9908913|FG002|COMPLETED|Overall Study||11
8853681|NCT01766219|9908911|FG000|NOT COMPLETED|Overall Study||0
8853682|NCT01766219|9908912|FG001|NOT COMPLETED|Overall Study||0
8853683|NCT01766219|9908913|FG002|NOT COMPLETED|Overall Study||0
8853684|NCT01766310|9908924|FG000|STARTED|Overall Study||24
8853685|NCT01766310|9908925|FG001|STARTED|Overall Study||26
8853686|NCT01766310|9908924|FG000|COMPLETED|Overall Study||23
8853687|NCT01766310|9908925|FG001|COMPLETED|Overall Study||23
8853688|NCT01766310|9908924|FG000|NOT COMPLETED|Overall Study||1
8853689|NCT01766310|9908925|FG001|NOT COMPLETED|Overall Study||3
8853690|NCT01766336|9908933|FG000|STARTED|Overall Study||150
8853691|NCT01766336|9908934|FG001|STARTED|Overall Study||146
8853692|NCT01766336|9908933|FG000|COMPLETED|Overall Study||60
8853693|NCT01766336|9908934|FG001|COMPLETED|Overall Study||71
8853694|NCT01766336|9908933|FG000|NOT COMPLETED|Overall Study||90
8853695|NCT01766336|9908934|FG001|NOT COMPLETED|Overall Study||75
8853696|NCT01766401|9908942|FG000|STARTED|Overall Study||198
8853697|NCT01766401|9908943|FG001|STARTED|Overall Study||200
8853698|NCT01766401|9908942|FG000|COMPLETED|Overall Study||161
8853699|NCT01766401|9908943|FG001|COMPLETED|Overall Study||144
8853700|NCT01766401|9908942|FG000|NOT COMPLETED|Overall Study||37
8853701|NCT01766401|9908943|FG001|NOT COMPLETED|Overall Study||56
8853702|NCT01766440|9908949|FG000|STARTED|Overall Study||18
8853703|NCT01766440|9908949|FG000|COMPLETED|Overall Study||17
8853704|NCT01766440|9908949|FG000|NOT COMPLETED|Overall Study||1
8853705|NCT01766466|9908955|FG000|STARTED|Day 1||6
8853706|NCT01766466|9908956|FG001|STARTED|Day 1||0
8853707|NCT01766466|9908957|FG002|STARTED|Day 1||6
8853708|NCT01766466|9908958|FG003|STARTED|Day 1||0
8853709|NCT01766466|9908955|FG000|COMPLETED|Day 1||6
8853710|NCT01766466|9908956|FG001|COMPLETED|Day 1||0
8853711|NCT01766466|9908957|FG002|COMPLETED|Day 1||6
8853712|NCT01766466|9908958|FG003|COMPLETED|Day 1||0
8853713|NCT01766466|9908955|FG000|NOT COMPLETED|Day 1||0
8853714|NCT01766466|9908956|FG001|NOT COMPLETED|Day 1||0
8853715|NCT01766466|9908957|FG002|NOT COMPLETED|Day 1||0
8853716|NCT01766466|9908958|FG003|NOT COMPLETED|Day 1||0
8853717|NCT01766466|9908955|FG000|STARTED|Day 5||0
8853718|NCT01766466|9908956|FG001|STARTED|Day 5||6
8853719|NCT01766466|9908957|FG002|STARTED|Day 5||0
8853720|NCT01766466|9908958|FG003|STARTED|Day 5||6
8853721|NCT01766466|9908955|FG000|COMPLETED|Day 5||0
8853722|NCT01766466|9908956|FG001|COMPLETED|Day 5||6
8853723|NCT01766466|9908957|FG002|COMPLETED|Day 5||0
8853724|NCT01766466|9908958|FG003|COMPLETED|Day 5||6
8853725|NCT01766466|9908955|FG000|NOT COMPLETED|Day 5||0
8853726|NCT01766466|9908956|FG001|NOT COMPLETED|Day 5||0
8853727|NCT01766466|9908957|FG002|NOT COMPLETED|Day 5||0
8853728|NCT01766466|9908958|FG003|NOT COMPLETED|Day 5||0
8853729|NCT01766713|9908969|FG000|STARTED|Overall Study||25
8853730|NCT01766713|9908970|FG001|STARTED|Overall Study||25
8949138|NCT02436239|10011667|FG001|STARTED|Open-Lable Treatment Period||131
8949139|NCT02436239|10011668|FG002|STARTED|Open-Lable Treatment Period||65
8853731|NCT01766713|9908969|FG000|COMPLETED|Overall Study||23
8853732|NCT01766713|9908970|FG001|COMPLETED|Overall Study||22
8853733|NCT01766713|9908969|FG000|NOT COMPLETED|Overall Study||2
8853734|NCT01766713|9908970|FG001|NOT COMPLETED|Overall Study||3
8629787|NCT00531661|9669535|FG000|COMPLETED|Study Duration: 15 Months Avg. Follow-up||186
8853735|NCT01766778|9908978|FG000|STARTED|Overall Study|Intent to treat population|56
8853736|NCT01766778|9908979|FG001|STARTED|Overall Study||61
8853737|NCT01766778|9908978|FG000|COMPLETED|Overall Study||51
8853738|NCT01766778|9908979|FG001|COMPLETED|Overall Study||57
8853739|NCT01766778|9908978|FG000|NOT COMPLETED|Overall Study||5
8853740|NCT01766778|9908979|FG001|NOT COMPLETED|Overall Study||4
8853741|NCT01766817|9908988|FG000|STARTED|Overall Study||48
8853742|NCT01766817|9908989|FG001|STARTED|Overall Study||48
8853743|NCT01766817|9908990|FG002|STARTED|Overall Study||47
8853744|NCT01766817|9908988|FG000|COMPLETED|Overall Study||37
8853745|NCT01766817|9908989|FG001|COMPLETED|Overall Study||37
8853746|NCT01766817|9908990|FG002|COMPLETED|Overall Study||34
8853747|NCT01766817|9908988|FG000|NOT COMPLETED|Overall Study||11
8853748|NCT01766817|9908989|FG001|NOT COMPLETED|Overall Study||11
8853749|NCT01766817|9908990|FG002|NOT COMPLETED|Overall Study||13
8853750|NCT01766921|9909000|FG000|STARTED|Overall Study||700
8853751|NCT01766921|9909001|FG001|STARTED|Overall Study||693
8853752|NCT01766921|9909000|FG000|COMPLETED|Overall Study||676
8853753|NCT01766921|9909001|FG001|COMPLETED|Overall Study||676
8853754|NCT01766921|9909000|FG000|NOT COMPLETED|Overall Study||24
8853755|NCT01766921|9909001|FG001|NOT COMPLETED|Overall Study||17
8853756|NCT01766986|9909011|FG000|STARTED|Overall Study||41
8853757|NCT01766986|9909012|FG001|STARTED|Overall Study||51
8853758|NCT01766986|9909013|FG002|STARTED|Overall Study||38
8853759|NCT01766986|9909011|FG000|COMPLETED|Overall Study||41
8853760|NCT01766986|9909012|FG001|COMPLETED|Overall Study||51
8853761|NCT01766986|9909013|FG002|COMPLETED|Overall Study||38
8853762|NCT01766986|9909011|FG000|NOT COMPLETED|Overall Study||0
8853763|NCT01766986|9909012|FG001|NOT COMPLETED|Overall Study||0
8853764|NCT01766986|9909013|FG002|NOT COMPLETED|Overall Study||0
8853765|NCT01767064|9909023|FG000|STARTED|Overall Study||7
8853766|NCT01767064|9909024|FG001|STARTED|Overall Study||7
8853767|NCT01767064|9909023|FG000|COMPLETED|Overall Study||7
8853768|NCT01767064|9909024|FG001|COMPLETED|Overall Study||7
8853769|NCT01767064|9909023|FG000|NOT COMPLETED|Overall Study||0
8853770|NCT01767064|9909024|FG001|NOT COMPLETED|Overall Study||0
8853771|NCT01767103|9909033|FG000|STARTED|Overall Study||7
8853772|NCT01767103|9909034|FG001|STARTED|Overall Study||7
8853773|NCT01767103|9909035|FG002|STARTED|Overall Study||7
8853774|NCT01767103|9909033|FG000|COMPLETED|Overall Study||7
8853775|NCT01767103|9909034|FG001|COMPLETED|Overall Study||7
8949140|NCT02436239|10011669|FG003|STARTED|Open-Lable Treatment Period||12
8949141|NCT02436239|10011666|FG000|COMPLETED|Open-Lable Treatment Period||89
8949142|NCT02436239|10011667|FG001|COMPLETED|Open-Lable Treatment Period||97
8949143|NCT02436239|10011668|FG002|COMPLETED|Open-Lable Treatment Period||38
8949144|NCT02436239|10011669|FG003|COMPLETED|Open-Lable Treatment Period||7
8949145|NCT02436239|10011666|FG000|NOT COMPLETED|Open-Lable Treatment Period||33
8949146|NCT02436239|10011667|FG001|NOT COMPLETED|Open-Lable Treatment Period||34
8949147|NCT02436239|10011668|FG002|NOT COMPLETED|Open-Lable Treatment Period||27
8949148|NCT02436239|10011669|FG003|NOT COMPLETED|Open-Lable Treatment Period||5
8949149|NCT02436239|10011666|FG000|STARTED|Down-Taper Period|Enrollment permitted for participants who had not completed previous open-label treatment period.|90
8949150|NCT02436239|10011667|FG001|STARTED|Down-Taper Period|Enrollment permitted for participants who had not completed previous open-label treatment period.|103
8949151|NCT02436239|10011668|FG002|STARTED|Down-Taper Period|Enrollment permitted for participants who had not completed previous open-label treatment period.|44
8949152|NCT02436239|10011669|FG003|STARTED|Down-Taper Period|One participant who completed the open-label treatment period did not enter the down-taper period.|6
8949153|NCT02436239|10011666|FG000|COMPLETED|Down-Taper Period||86
8949154|NCT02436239|10011667|FG001|COMPLETED|Down-Taper Period||99
8949155|NCT02436239|10011668|FG002|COMPLETED|Down-Taper Period||43
8949156|NCT02436239|10011669|FG003|COMPLETED|Down-Taper Period||4
8949157|NCT02436239|10011666|FG000|NOT COMPLETED|Down-Taper Period||4
8949158|NCT02436239|10011667|FG001|NOT COMPLETED|Down-Taper Period||4
8949159|NCT02436239|10011668|FG002|NOT COMPLETED|Down-Taper Period||1
8949160|NCT02436239|10011669|FG003|NOT COMPLETED|Down-Taper Period||2
8949161|NCT02436304|10011682|FG000|STARTED|Overall Study||153
8949162|NCT02436304|10011683|FG001|STARTED|Overall Study||102
8949163|NCT02436304|10011684|FG002|STARTED|Overall Study||101
8949164|NCT02436304|10011682|FG000|COMPLETED|Overall Study||153
8949165|NCT02436304|10011683|FG001|COMPLETED|Overall Study||100
8949166|NCT02436304|10011684|FG002|COMPLETED|Overall Study||100
8949167|NCT02436304|10011682|FG000|NOT COMPLETED|Overall Study||0
8949168|NCT02436304|10011683|FG001|NOT COMPLETED|Overall Study||2
8949169|NCT02436304|10011684|FG002|NOT COMPLETED|Overall Study||1
8949170|NCT02436330|10011695|FG000|STARTED|Cohort 1||14
8949171|NCT02436330|10011696|FG001|STARTED|Cohort 1||4
8949172|NCT02436330|10011695|FG000|COMPLETED|Cohort 1||9
8949173|NCT02436330|10011696|FG001|COMPLETED|Cohort 1||1
8949174|NCT02436330|10011695|FG000|NOT COMPLETED|Cohort 1||5
8949175|NCT02436330|10011696|FG001|NOT COMPLETED|Cohort 1||3
8949176|NCT02436330|10011695|FG000|STARTED|Cohort 2||14
8949177|NCT02436330|10011696|FG001|STARTED|Cohort 2||10
8949178|NCT02436330|10011695|FG000|COMPLETED|Cohort 2||10
8949179|NCT02436330|10011696|FG001|COMPLETED|Cohort 2||7
8949180|NCT02436330|10011695|FG000|NOT COMPLETED|Cohort 2||4
8949181|NCT02436330|10011696|FG001|NOT COMPLETED|Cohort 2||3
8949182|NCT02436330|10011695|FG000|STARTED|Cohort 3||12
8949183|NCT02436330|10011696|FG001|STARTED|Cohort 3|Enrollment too low to have control group. All subjects in this cohort received intervention.|0
8949184|NCT02436330|10011695|FG000|COMPLETED|Cohort 3||7
8949185|NCT02436330|10011696|FG001|COMPLETED|Cohort 3||0
8949186|NCT02436330|10011695|FG000|NOT COMPLETED|Cohort 3||5
8853776|NCT01767103|9909035|FG002|COMPLETED|Overall Study||7
8853777|NCT01767103|9909033|FG000|NOT COMPLETED|Overall Study||0
8853778|NCT01767103|9909034|FG001|NOT COMPLETED|Overall Study||0
8853779|NCT01767103|9909035|FG002|NOT COMPLETED|Overall Study||0
8853780|NCT01767116|9909046|FG000|STARTED|Overall Study||210
8853781|NCT01767116|9909047|FG001|STARTED|Overall Study||209
8853782|NCT01767116|9909046|FG000|COMPLETED|Overall Study||208
8853783|NCT01767116|9909047|FG001|COMPLETED|Overall Study||207
8853784|NCT01767116|9909046|FG000|NOT COMPLETED|Overall Study||2
8853785|NCT01767116|9909047|FG001|NOT COMPLETED|Overall Study||2
8853786|NCT01767142|9909053|FG000|STARTED|Overall Study|Each subject was treated on a single thigh. therefore the number of units is 40.|40
8853787|NCT01767142|9909053|FG000|COMPLETED|Overall Study||37
8853788|NCT01767142|9909053|FG000|NOT COMPLETED|Overall Study||3
8853789|NCT01767155|9909059|FG000|STARTED|Overall Study|Patients allocated to AEZS-108|256
8853790|NCT01767155|9909060|FG001|STARTED|Overall Study|Patients allocated to doxorubicin|255
8853791|NCT01767155|9909059|FG000|Modified ITT (mITT)|Overall Study||252
8853792|NCT01767155|9909060|FG001|Modified ITT (mITT)|Overall Study||249
8853793|NCT01767155|9909059|FG000|Safety Population (SAF)|Overall Study||252
8853794|NCT01767155|9909060|FG001|Safety Population (SAF)|Overall Study||249
8853795|NCT01767155|9909059|FG000|COMPLETED|Overall Study||243
8853796|NCT01767155|9909060|FG001|COMPLETED|Overall Study||240
8853797|NCT01767155|9909059|FG000|NOT COMPLETED|Overall Study||13
8853798|NCT01767155|9909060|FG001|NOT COMPLETED|Overall Study||15
8853799|NCT01767285|9909068|FG000|STARTED|Overall Study||29
8853800|NCT01767285|9909069|FG001|STARTED|Overall Study||30
8853801|NCT01767285|9909068|FG000|COMPLETED|Overall Study||22
8853802|NCT01767285|9909069|FG001|COMPLETED|Overall Study||24
8853803|NCT01767285|9909068|FG000|NOT COMPLETED|Overall Study||7
8853804|NCT01767285|9909069|FG001|NOT COMPLETED|Overall Study||6
8853805|NCT01767376|9909078|FG000|STARTED|Overall Study||231
8853806|NCT01767376|9909079|FG001|STARTED|Overall Study||228
8853807|NCT01767376|9909080|FG002|STARTED|Overall Study||232
8853808|NCT01767376|9909078|FG000|COMPLETED|Overall Study||227
8853809|NCT01767376|9909079|FG001|COMPLETED|Overall Study||225
8853810|NCT01767376|9909080|FG002|COMPLETED|Overall Study||232
8853811|NCT01767376|9909078|FG000|NOT COMPLETED|Overall Study||4
8853812|NCT01767376|9909079|FG001|NOT COMPLETED|Overall Study||3
8853813|NCT01767376|9909080|FG002|NOT COMPLETED|Overall Study||0
8853814|NCT01767415|9909090|FG000|STARTED|Overall Study||10
8853815|NCT01767415|9909090|FG000|COMPLETED|Overall Study||10
8853816|NCT01767415|9909090|FG000|NOT COMPLETED|Overall Study||0
8853817|NCT01767467|9909096|FG000|STARTED|Vaccination Phase (up to Month 2)||283
8853818|NCT01767467|9909097|FG001|STARTED|Vaccination Phase (up to Month 2)||279
8853819|NCT01767467|9909096|FG000|COMPLETED|Vaccination Phase (up to Month 2)||266
8853820|NCT01767467|9909097|FG001|COMPLETED|Vaccination Phase (up to Month 2)||259
8853821|NCT01767467|9909096|FG000|NOT COMPLETED|Vaccination Phase (up to Month 2)||17
8853822|NCT01767467|9909097|FG001|NOT COMPLETED|Vaccination Phase (up to Month 2)||20
8853823|NCT01767467|9909096|FG000|STARTED|End of Study Phase (up to Month 13)||283
8853824|NCT01767467|9909097|FG001|STARTED|End of Study Phase (up to Month 13)||279
8853825|NCT01767467|9909096|FG000|COMPLETED|End of Study Phase (up to Month 13)||236
8853826|NCT01767467|9909097|FG001|COMPLETED|End of Study Phase (up to Month 13)||216
8853827|NCT01767467|9909096|FG000|NOT COMPLETED|End of Study Phase (up to Month 13)||47
8853828|NCT01767467|9909097|FG001|NOT COMPLETED|End of Study Phase (up to Month 13)||63
8853829|NCT01767493|9909110|FG000|STARTED|Overall Study||19
8853830|NCT01767493|9909110|FG000|COMPLETED|Overall Study||16
8853831|NCT01767493|9909110|FG000|NOT COMPLETED|Overall Study||3
8853832|NCT01767506|9909116|FG000|STARTED|Overall Study|"26 communities were randomized to intervention group~The study was conducted at the community level."|
8853833|NCT01767506|9909117|FG001|STARTED|Overall Study|"26 communities were randomized to control group~The study was conducted at the community level."|
8853834|NCT01767506|9909116|FG000|COMPLETED|Overall Study|The study was conducted at the community level.|
8853835|NCT01767506|9909117|FG001|COMPLETED|Overall Study|The study was conducted at the community level.|
8853836|NCT01767506|9909116|FG000|NOT COMPLETED|Overall Study||
8853837|NCT01767506|9909117|FG001|NOT COMPLETED|Overall Study||
8853838|NCT01767519|9909126|FG000|STARTED|Overall Study||145
8853839|NCT01767519|9909127|FG001|STARTED|Overall Study||151
8853840|NCT01767519|9909128|FG002|STARTED|Overall Study||60
8853841|NCT01767519|9909126|FG000|COMPLETED|Overall Study||131
8853842|NCT01767519|9909127|FG001|COMPLETED|Overall Study||138
8853843|NCT01767519|9909128|FG002|COMPLETED|Overall Study||55
8853844|NCT01767519|9909126|FG000|NOT COMPLETED|Overall Study||14
8853845|NCT01767519|9909127|FG001|NOT COMPLETED|Overall Study||13
8853846|NCT01767519|9909128|FG002|NOT COMPLETED|Overall Study||5
8853847|NCT01767597|9909138|FG000|STARTED|Overall Study||500
8853848|NCT01767597|9909139|FG001|STARTED|Overall Study||500
8853849|NCT01767597|9909138|FG000|COMPLETED|Overall Study||496
8853850|NCT01767597|9909139|FG001|COMPLETED|Overall Study||499
8853851|NCT01767597|9909138|FG000|NOT COMPLETED|Overall Study||4
8853852|NCT01767597|9909139|FG001|NOT COMPLETED|Overall Study||1
8853853|NCT01767636|9909145|FG000|STARTED|Overall Study||38
8853854|NCT01767636|9909145|FG000|COMPLETED|Overall Study||35
8853855|NCT01767636|9909145|FG000|NOT COMPLETED|Overall Study||3
8853856|NCT01767688|9909151|FG000|STARTED|Overall Study||8
8853857|NCT01767688|9909152|FG001|STARTED|Overall Study||8
8853858|NCT01767688|9909151|FG000|COMPLETED|Overall Study||8
8853859|NCT01767688|9909152|FG001|COMPLETED|Overall Study||8
8853860|NCT01767688|9909151|FG000|NOT COMPLETED|Overall Study||0
8853861|NCT01767688|9909152|FG001|NOT COMPLETED|Overall Study||0
8853862|NCT01767701|9909158|FG000|STARTED|Overall Study|All 20 patients who entered the treatment phase completed the six months trial period.|20
8853863|NCT01767701|9909158|FG000|COMPLETED|Overall Study||20
8853864|NCT01767701|9909158|FG000|NOT COMPLETED|Overall Study||0
8853865|NCT01767792|9909163|FG000|STARTED|Overall Study||22
8853866|NCT01767792|9909163|FG000|COMPLETED|Overall Study||20
8853867|NCT01767792|9909163|FG000|NOT COMPLETED|Overall Study||2
8853868|NCT01767857|9909170|FG000|STARTED|Overall Study||430
8853869|NCT01767857|9909171|FG001|STARTED|Overall Study||213
8853870|NCT01767857|9909170|FG000|Treated|Overall Study||411
8853871|NCT01767857|9909171|FG001|Treated|Overall Study||200
8853872|NCT01767857|9909170|FG000|COMPLETED|Overall Study||0
8853873|NCT01767857|9909171|FG001|COMPLETED|Overall Study||0
8853874|NCT01767857|9909170|FG000|NOT COMPLETED|Overall Study||430
8853875|NCT01767857|9909171|FG001|NOT COMPLETED|Overall Study||213
8853876|NCT01767909|9909180|FG000|STARTED|Overall Study||121
8853877|NCT01767909|9909181|FG001|STARTED|Overall Study||119
8853878|NCT01767909|9909180|FG000|COMPLETED|Overall Study||108
8853879|NCT01767909|9909181|FG001|COMPLETED|Overall Study||107
8853880|NCT01767909|9909180|FG000|NOT COMPLETED|Overall Study||13
8853881|NCT01767909|9909181|FG001|NOT COMPLETED|Overall Study||12
8853882|NCT01767935|9909189|FG000|STARTED|Overall Study||1
8853883|NCT01767935|9909189|FG000|COMPLETED|Overall Study||1
8853884|NCT01767935|9909189|FG000|NOT COMPLETED|Overall Study||0
8853885|NCT01767987|9909195|FG000|STARTED|Overall Study||4
8853886|NCT01767987|9909196|FG001|STARTED|Overall Study||2
8853887|NCT01767987|9909195|FG000|COMPLETED|Overall Study||0
8853888|NCT01767987|9909196|FG001|COMPLETED|Overall Study||1
8853889|NCT01767987|9909195|FG000|NOT COMPLETED|Overall Study||4
8853890|NCT01767987|9909196|FG001|NOT COMPLETED|Overall Study||1
8853891|NCT01768000|9909206|FG000|STARTED|Overall Study||10
8853892|NCT01768000|9909207|FG001|STARTED|Overall Study||10
8853893|NCT01768000|9909208|FG002|STARTED|Overall Study||10
8853894|NCT01768000|9909209|FG003|STARTED|Overall Study||10
8853895|NCT01768000|9909206|FG000|COMPLETED|Overall Study||9
8853896|NCT01768000|9909207|FG001|COMPLETED|Overall Study||8
8853897|NCT01768000|9909208|FG002|COMPLETED|Overall Study||9
8853898|NCT01768000|9909209|FG003|COMPLETED|Overall Study||8
8853899|NCT01768000|9909206|FG000|NOT COMPLETED|Overall Study||1
8853900|NCT01768000|9909207|FG001|NOT COMPLETED|Overall Study||2
8853901|NCT01768000|9909208|FG002|NOT COMPLETED|Overall Study||1
8853902|NCT01768000|9909209|FG003|NOT COMPLETED|Overall Study||2
8853903|NCT01768013|9909221|FG000|STARTED|Overall Study||13
8853904|NCT01768013|9909221|FG000|COMPLETED|Overall Study||13
8853905|NCT01768013|9909221|FG000|NOT COMPLETED|Overall Study||0
8853906|NCT01768117|9909225|FG000|STARTED|Overall Study||13
8853907|NCT01768117|9909225|FG000|COMPLETED|Overall Study||7
8853908|NCT01768117|9909225|FG000|NOT COMPLETED|Overall Study||6
8853909|NCT01768286|9909233|FG000|STARTED|Overall Study||109
8853910|NCT01768286|9909234|FG001|STARTED|Overall Study||111
8853911|NCT01768286|9909235|FG002|STARTED|Overall Study||110
8853912|NCT01768286|9909236|FG003|STARTED|Overall Study||111
8853913|NCT01768286|9909233|FG000|COMPLETED|Overall Study||102
8853914|NCT01768286|9909234|FG001|COMPLETED|Overall Study||107
8853915|NCT01768286|9909235|FG002|COMPLETED|Overall Study||108
8853916|NCT01768286|9909236|FG003|COMPLETED|Overall Study||110
8853917|NCT01768286|9909233|FG000|NOT COMPLETED|Overall Study||7
8853918|NCT01768286|9909234|FG001|NOT COMPLETED|Overall Study||4
8853919|NCT01768286|9909235|FG002|NOT COMPLETED|Overall Study||2
8853920|NCT01768286|9909236|FG003|NOT COMPLETED|Overall Study||1
8629788|NCT00531661|9669536|FG001|COMPLETED|Study Duration: 15 Months Avg. Follow-up||197
8629789|NCT00531661|9669535|FG000|NOT COMPLETED|Study Duration: 15 Months Avg. Follow-up||58
8629790|NCT00531661|9669536|FG001|NOT COMPLETED|Study Duration: 15 Months Avg. Follow-up||57
8853921|NCT01768325|9909248|FG000|STARTED|Overall Study||37
8853922|NCT01768325|9909249|FG001|STARTED|Overall Study||41
8853923|NCT01768325|9909248|FG000|COMPLETED|Overall Study||37
8853924|NCT01768325|9909249|FG001|COMPLETED|Overall Study||41
8853925|NCT01768325|9909248|FG000|NOT COMPLETED|Overall Study||0
8853926|NCT01768325|9909249|FG001|NOT COMPLETED|Overall Study||0
8853927|NCT01768520|9909260|FG000|STARTED|Overall Study||152
8853928|NCT01768520|9909261|FG001|STARTED|Overall Study||147
8853929|NCT01768520|9909262|FG002|STARTED|Overall Study||39
8853930|NCT01768520|9909260|FG000|COMPLETED|Overall Study||120
8853931|NCT01768520|9909261|FG001|COMPLETED|Overall Study||121
8853932|NCT01768520|9909262|FG002|COMPLETED|Overall Study||30
8853933|NCT01768520|9909260|FG000|NOT COMPLETED|Overall Study||32
8853934|NCT01768520|9909261|FG001|NOT COMPLETED|Overall Study||26
8853935|NCT01768520|9909262|FG002|NOT COMPLETED|Overall Study||9
8853936|NCT01768559|9909273|FG000|STARTED|Overall Study||298
8853937|NCT01768559|9909274|FG001|STARTED|Overall Study||298
8853938|NCT01768559|9909275|FG002|STARTED|Overall Study||298
8853939|NCT01768559|9909273|FG000|Treated|Overall Study||298
8853940|NCT01768559|9909274|FG001|Treated|Overall Study|1 participant received Insulin Glulisine TID (for more than 50%)|298
8853941|NCT01768559|9909275|FG002|Treated|Overall Study|4 participants received Insulin Glulisine QD (for more than 50%)|297
8853942|NCT01768559|9909273|FG000|COMPLETED|Overall Study||268
8853943|NCT01768559|9909274|FG001|COMPLETED|Overall Study||281
8853944|NCT01768559|9909275|FG002|COMPLETED|Overall Study||285
8853945|NCT01768559|9909273|FG000|NOT COMPLETED|Overall Study||30
8853946|NCT01768559|9909274|FG001|NOT COMPLETED|Overall Study||17
8853947|NCT01768559|9909275|FG002|NOT COMPLETED|Overall Study||13
8949187|NCT02436330|10011696|FG001|NOT COMPLETED|Cohort 3||0
8853948|NCT01768572|9909290|FG000|STARTED|Overall Study||49
8853949|NCT01768572|9909291|FG001|STARTED|Overall Study||51
8853950|NCT01768572|9909292|FG002|STARTED|Overall Study||102
8853951|NCT01768572|9909290|FG000|COMPLETED|Overall Study||40
8853952|NCT01768572|9909291|FG001|COMPLETED|Overall Study||39
8949188|NCT02436330|10011695|FG000|STARTED|Cohort 4||6
8853953|NCT01768572|9909292|FG002|COMPLETED|Overall Study||96
8853954|NCT01768572|9909290|FG000|NOT COMPLETED|Overall Study||9
8853955|NCT01768572|9909291|FG001|NOT COMPLETED|Overall Study||12
8629791|NCT00531752|9669549|FG000|STARTED|First Double-blind Intervention Period||17
8629792|NCT00531752|9669550|FG001|STARTED|First Double-blind Intervention Period||17
8629793|NCT00531752|9669551|FG002|STARTED|First Double-blind Intervention Period||16
8629794|NCT00531752|9669552|FG003|STARTED|First Double-blind Intervention Period||16
8629795|NCT00531752|9669549|FG000|Treated|First Double-blind Intervention Period||16
8629796|NCT00531752|9669550|FG001|Treated|First Double-blind Intervention Period||17
8853956|NCT01768572|9909292|FG002|NOT COMPLETED|Overall Study||6
8853957|NCT01768637|9909302|FG000|STARTED|Overall Study||29
8853958|NCT01768637|9909303|FG001|STARTED|Overall Study||19
8853959|NCT01768637|9909302|FG000|Completed Visit 1|Overall Study||28
8853960|NCT01768637|9909303|FG001|Completed Visit 1|Overall Study||16
8853961|NCT01768637|9909302|FG000|Completed Visit 2|Overall Study||26
8853962|NCT01768637|9909303|FG001|Completed Visit 2|Overall Study||13
8853963|NCT01768637|9909302|FG000|COMPLETED|Overall Study||26
8853964|NCT01768637|9909303|FG001|COMPLETED|Overall Study||12
8853965|NCT01768637|9909302|FG000|NOT COMPLETED|Overall Study||3
8853966|NCT01768637|9909303|FG001|NOT COMPLETED|Overall Study||7
8853967|NCT01768676|9909311|FG000|STARTED|Overall Study||90
8853968|NCT01768676|9909312|FG001|STARTED|Overall Study||91
8853969|NCT01768676|9909311|FG000|COMPLETED|Overall Study||66
8853970|NCT01768676|9909312|FG001|COMPLETED|Overall Study||60
8853971|NCT01768676|9909311|FG000|NOT COMPLETED|Overall Study||24
8853972|NCT01768676|9909312|FG001|NOT COMPLETED|Overall Study||31
8853973|NCT01768832|9909321|FG000|STARTED|Overall Study||41
8853974|NCT01768832|9909322|FG001|STARTED|Overall Study||43
8853975|NCT01768832|9909323|FG002|STARTED|Overall Study||35
8853976|NCT01768832|9909321|FG000|COMPLETED|Overall Study||31
8853977|NCT01768832|9909322|FG001|COMPLETED|Overall Study||39
8853978|NCT01768832|9909323|FG002|COMPLETED|Overall Study||26
8853979|NCT01768832|9909321|FG000|NOT COMPLETED|Overall Study||10
8853980|NCT01768832|9909322|FG001|NOT COMPLETED|Overall Study||4
8853981|NCT01768832|9909323|FG002|NOT COMPLETED|Overall Study||9
8853982|NCT01768845|9909331|FG000|STARTED|Overall Study||34
8853983|NCT01768845|9909331|FG000|COMPLETED|Overall Study||11
8853984|NCT01768845|9909331|FG000|NOT COMPLETED|Overall Study||23
8853985|NCT01768858|9909335|FG000|STARTED|Overall Study||96
8629797|NCT00531752|9669551|FG002|Treated|First Double-blind Intervention Period||16
8853986|NCT01768858|9909335|FG000|COMPLETED|Overall Study||74
8853987|NCT01768858|9909335|FG000|NOT COMPLETED|Overall Study||22
8853988|NCT01769105|9909341|FG000|STARTED|First Intervention||16
8853989|NCT01769105|9909342|FG001|STARTED|First Intervention||19
8853990|NCT01769105|9909341|FG000|COMPLETED|First Intervention||14
8853991|NCT01769105|9909342|FG001|COMPLETED|First Intervention||17
8853992|NCT01769105|9909341|FG000|NOT COMPLETED|First Intervention||2
8853993|NCT01769105|9909342|FG001|NOT COMPLETED|First Intervention||2
8853994|NCT01769105|9909341|FG000|STARTED|Cross-over||14
8853995|NCT01769105|9909342|FG001|STARTED|Cross-over|Cross-over was only intended for the Lid margin hygiene group|0
8853996|NCT01769105|9909341|FG000|COMPLETED|Cross-over||9
8853997|NCT01769105|9909342|FG001|COMPLETED|Cross-over|Was not intended by the study protocol|0
8853998|NCT01769105|9909341|FG000|NOT COMPLETED|Cross-over||5
8853999|NCT01769105|9909342|FG001|NOT COMPLETED|Cross-over||0
8854000|NCT01769170|9909352|FG000|STARTED|Overall Study||303
8854001|NCT01769170|9909353|FG001|STARTED|Overall Study||149
8854002|NCT01769170|9909352|FG000|COMPLETED|Overall Study||232
8854003|NCT01769170|9909353|FG001|COMPLETED|Overall Study||122
8854004|NCT01769170|9909352|FG000|NOT COMPLETED|Overall Study||71
8854005|NCT01769170|9909353|FG001|NOT COMPLETED|Overall Study||27
8854006|NCT01769196|9909361|FG000|STARTED|Overall Study||272
8854007|NCT01769196|9909362|FG001|STARTED|Overall Study||272
8854008|NCT01769196|9909361|FG000|COMPLETED|Overall Study||0
8854009|NCT01769196|9909362|FG001|COMPLETED|Overall Study||0
8854010|NCT01769196|9909361|FG000|NOT COMPLETED|Overall Study||272
8854011|NCT01769196|9909362|FG001|NOT COMPLETED|Overall Study||272
8854012|NCT01769209|9909368|FG000|STARTED|Overall Study||18
8854013|NCT01769209|9909368|FG000|COMPLETED|Overall Study||18
8854014|NCT01769209|9909368|FG000|NOT COMPLETED|Overall Study||0
8854015|NCT01769222|9909374|FG000|STARTED|Overall Study||3
8854016|NCT01769222|9909375|FG001|STARTED|Overall Study||0
8854017|NCT01769222|9909374|FG000|COMPLETED|Overall Study||3
8854018|NCT01769222|9909375|FG001|COMPLETED|Overall Study||0
8854019|NCT01769222|9909374|FG000|NOT COMPLETED|Overall Study||0
8854020|NCT01769222|9909375|FG001|NOT COMPLETED|Overall Study||0
8854021|NCT01769248|9909383|FG000|STARTED|Overall Study||70
8854022|NCT01769248|9909384|FG001|STARTED|Overall Study||70
8854023|NCT01769248|9909383|FG000|Participants Who Crossed-over|Overall Study||28
8854024|NCT01769248|9909384|FG001|Participants Who Crossed-over|Overall Study||12
8629798|NCT00531752|9669552|FG003|Treated|First Double-blind Intervention Period||16
8854025|NCT01769248|9909383|FG000|COMPLETED|Overall Study||42
8854026|NCT01769248|9909384|FG001|COMPLETED|Overall Study||58
8854027|NCT01769248|9909383|FG000|NOT COMPLETED|Overall Study||28
8854028|NCT01769248|9909384|FG001|NOT COMPLETED|Overall Study||12
8854029|NCT01769274|9909392|FG000|STARTED|Part A||5
8854030|NCT01769274|9909393|FG001|STARTED|Part A||0
8854031|NCT01769274|9909394|FG002|STARTED|Part A||0
8854032|NCT01769274|9909392|FG000|COMPLETED|Part A||5
8854033|NCT01769274|9909393|FG001|COMPLETED|Part A||0
8854034|NCT01769274|9909394|FG002|COMPLETED|Part A||0
8854035|NCT01769274|9909392|FG000|NOT COMPLETED|Part A||0
8854036|NCT01769274|9909393|FG001|NOT COMPLETED|Part A||0
8854037|NCT01769274|9909394|FG002|NOT COMPLETED|Part A||0
8854038|NCT01769274|9909392|FG000|STARTED|Part B:Treatment Session1-Period1||0
8854039|NCT01769274|9909393|FG001|STARTED|Part B:Treatment Session1-Period1||2
8854040|NCT01769274|9909394|FG002|STARTED|Part B:Treatment Session1-Period1||3
8854041|NCT01769274|9909392|FG000|COMPLETED|Part B:Treatment Session1-Period1||0
8854042|NCT01769274|9909393|FG001|COMPLETED|Part B:Treatment Session1-Period1||2
8854043|NCT01769274|9909394|FG002|COMPLETED|Part B:Treatment Session1-Period1||3
8854044|NCT01769274|9909392|FG000|NOT COMPLETED|Part B:Treatment Session1-Period1||0
8949189|NCT02436330|10011696|FG001|STARTED|Cohort 4|Enrollment too low to have control group. All subjects in this cohort received intervention.|0
8949190|NCT02436330|10011695|FG000|COMPLETED|Cohort 4||4
8949191|NCT02436330|10011696|FG001|COMPLETED|Cohort 4||0
8949192|NCT02436330|10011695|FG000|NOT COMPLETED|Cohort 4||2
8949193|NCT02436330|10011696|FG001|NOT COMPLETED|Cohort 4||0
8949194|NCT02436330|10011695|FG000|STARTED|Cohort 5||10
8949195|NCT02436330|10011696|FG001|STARTED|Cohort 5||5
8949196|NCT02436330|10011695|FG000|COMPLETED|Cohort 5||4
8949197|NCT02436330|10011696|FG001|COMPLETED|Cohort 5||1
8949198|NCT02436330|10011695|FG000|NOT COMPLETED|Cohort 5||6
8949199|NCT02436330|10011696|FG001|NOT COMPLETED|Cohort 5||4
8949200|NCT02436330|10011695|FG000|STARTED|Cohort 6||4
8949201|NCT02436330|10011696|FG001|STARTED|Cohort 6||5
8949202|NCT02436330|10011695|FG000|COMPLETED|Cohort 6||1
8949203|NCT02436330|10011696|FG001|COMPLETED|Cohort 6||4
8949204|NCT02436330|10011695|FG000|NOT COMPLETED|Cohort 6||3
8949205|NCT02436330|10011696|FG001|NOT COMPLETED|Cohort 6||1
8949206|NCT02436356|10011711|FG000|STARTED|Overall Study||33
8949207|NCT02436356|10011712|FG001|STARTED|Overall Study||11
8949208|NCT02436356|10011713|FG002|STARTED|Overall Study||4
8949209|NCT02436356|10011711|FG000|High Energy Fracture|Overall Study||14
8949210|NCT02436356|10011712|FG001|High Energy Fracture|Overall Study||0
8949211|NCT02436356|10011713|FG002|High Energy Fracture|Overall Study||4
8949212|NCT02436356|10011711|FG000|Low Energy Fracture|Overall Study||19
8949213|NCT02436356|10011712|FG001|Low Energy Fracture|Overall Study||0
8949214|NCT02436356|10011713|FG002|Low Energy Fracture|Overall Study||0
8949215|NCT02436356|10011711|FG000|COMPLETED|Overall Study||28
8949216|NCT02436356|10011712|FG001|COMPLETED|Overall Study||10
8949217|NCT02436356|10011713|FG002|COMPLETED|Overall Study||2
8949218|NCT02436356|10011711|FG000|NOT COMPLETED|Overall Study||5
8949219|NCT02436356|10011712|FG001|NOT COMPLETED|Overall Study||1
8949220|NCT02436356|10011713|FG002|NOT COMPLETED|Overall Study||2
8949221|NCT02436408|10011726|FG000|STARTED|Overall Study||35
8949222|NCT02436408|10011726|FG000|COMPLETED|Overall Study||34
8949223|NCT02436408|10011726|FG000|NOT COMPLETED|Overall Study||1
8949224|NCT02436577|10011736|FG000|STARTED|Overall Study||7
8629799|NCT00531752|9669549|FG000|COMPLETED|First Double-blind Intervention Period||11
8629800|NCT00531752|9669550|FG001|COMPLETED|First Double-blind Intervention Period||13
8629801|NCT00531752|9669551|FG002|COMPLETED|First Double-blind Intervention Period||9
8629802|NCT00531752|9669552|FG003|COMPLETED|First Double-blind Intervention Period||13
8629803|NCT00531752|9669549|FG000|NOT COMPLETED|First Double-blind Intervention Period||6
8629804|NCT00531752|9669550|FG001|NOT COMPLETED|First Double-blind Intervention Period||4
8629805|NCT00531752|9669551|FG002|NOT COMPLETED|First Double-blind Intervention Period||7
8629806|NCT00531752|9669552|FG003|NOT COMPLETED|First Double-blind Intervention Period||3
8629807|NCT00531752|9669549|FG000|STARTED|Wash-out Period (at Least 7 Days)||11
8629808|NCT00531752|9669550|FG001|STARTED|Wash-out Period (at Least 7 Days)||13
8629809|NCT00531752|9669551|FG002|STARTED|Wash-out Period (at Least 7 Days)||9
8629810|NCT00531752|9669552|FG003|STARTED|Wash-out Period (at Least 7 Days)||13
8629811|NCT00531752|9669549|FG000|COMPLETED|Wash-out Period (at Least 7 Days)||11
8629812|NCT00531752|9669550|FG001|COMPLETED|Wash-out Period (at Least 7 Days)||13
8629813|NCT00531752|9669551|FG002|COMPLETED|Wash-out Period (at Least 7 Days)||9
8629814|NCT00531752|9669552|FG003|COMPLETED|Wash-out Period (at Least 7 Days)||13
8629815|NCT00531752|9669549|FG000|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
8629816|NCT00531752|9669550|FG001|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
8629817|NCT00531752|9669551|FG002|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
8949225|NCT02436577|10011737|FG001|STARTED|Overall Study||7
8949226|NCT02436577|10011738|FG002|STARTED|Overall Study||7
8949227|NCT02436577|10011739|FG003|STARTED|Overall Study||7
8949228|NCT02436577|10011740|FG004|STARTED|Overall Study||7
8949229|NCT02436577|10011741|FG005|STARTED|Overall Study||7
8569525|NCT00097721|9601768|FG001|NOT COMPLETED|Overall Study||33
8569526|NCT00097773|9601778|FG000|STARTED|Overall Study||76
8569527|NCT00097773|9601779|FG001|STARTED|Overall Study||76
8569528|NCT00097773|9601780|FG002|STARTED|Overall Study||76
8569529|NCT00097773|9601781|FG003|STARTED|Overall Study||76
8569530|NCT00097773|9601778|FG000|COMPLETED|Overall Study||68
8569531|NCT00097773|9601779|FG001|COMPLETED|Overall Study||68
8569532|NCT00097773|9601780|FG002|COMPLETED|Overall Study||68
8569533|NCT00097773|9601781|FG003|COMPLETED|Overall Study||73
8569534|NCT00097773|9601778|FG000|NOT COMPLETED|Overall Study||8
8569535|NCT00097773|9601779|FG001|NOT COMPLETED|Overall Study||8
8569536|NCT00097773|9601780|FG002|NOT COMPLETED|Overall Study||8
8569537|NCT00097773|9601781|FG003|NOT COMPLETED|Overall Study||3
8577531|NCT00159263|9610310|FG000|STARTED|Washout||1
8949230|NCT02436577|10011736|FG000|COMPLETED|Overall Study||7
8949231|NCT02436577|10011737|FG001|COMPLETED|Overall Study||6
8577532|NCT00159263|9610311|FG001|STARTED|Washout||1
8854045|NCT01769274|9909393|FG001|NOT COMPLETED|Part B:Treatment Session1-Period1||0
8854046|NCT01769274|9909394|FG002|NOT COMPLETED|Part B:Treatment Session1-Period1||0
8854047|NCT01769274|9909392|FG000|STARTED|Washout Period||0
8854048|NCT01769274|9909393|FG001|STARTED|Washout Period||2
8854049|NCT01769274|9909394|FG002|STARTED|Washout Period||3
8854050|NCT01769274|9909392|FG000|COMPLETED|Washout Period||0
8854051|NCT01769274|9909393|FG001|COMPLETED|Washout Period||2
8854052|NCT01769274|9909394|FG002|COMPLETED|Washout Period||3
8854053|NCT01769274|9909392|FG000|NOT COMPLETED|Washout Period||0
8854054|NCT01769274|9909393|FG001|NOT COMPLETED|Washout Period||0
8854055|NCT01769274|9909394|FG002|NOT COMPLETED|Washout Period||0
8854056|NCT01769274|9909392|FG000|STARTED|Part B:Treatment Session1-Period2||0
8854057|NCT01769274|9909393|FG001|STARTED|Part B:Treatment Session1-Period2||2
8854058|NCT01769274|9909394|FG002|STARTED|Part B:Treatment Session1-Period2||3
8854059|NCT01769274|9909392|FG000|COMPLETED|Part B:Treatment Session1-Period2||0
8854060|NCT01769274|9909393|FG001|COMPLETED|Part B:Treatment Session1-Period2||2
8854061|NCT01769274|9909394|FG002|COMPLETED|Part B:Treatment Session1-Period2||3
8854062|NCT01769274|9909392|FG000|NOT COMPLETED|Part B:Treatment Session1-Period2||0
8854063|NCT01769274|9909393|FG001|NOT COMPLETED|Part B:Treatment Session1-Period2||0
8854064|NCT01769274|9909394|FG002|NOT COMPLETED|Part B:Treatment Session1-Period2||0
8854065|NCT01769274|9909392|FG000|STARTED|Washout Period||0
8854066|NCT01769274|9909393|FG001|STARTED|Washout Period||2
8854067|NCT01769274|9909394|FG002|STARTED|Washout Period||3
8854068|NCT01769274|9909392|FG000|COMPLETED|Washout Period||0
8854069|NCT01769274|9909393|FG001|COMPLETED|Washout Period||2
8854070|NCT01769274|9909394|FG002|COMPLETED|Washout Period||3
8854071|NCT01769274|9909392|FG000|NOT COMPLETED|Washout Period||0
8854072|NCT01769274|9909393|FG001|NOT COMPLETED|Washout Period||0
8854073|NCT01769274|9909394|FG002|NOT COMPLETED|Washout Period||0
8854074|NCT01769274|9909392|FG000|STARTED|Part B:Treatment Session2-Period3||0
8854075|NCT01769274|9909393|FG001|STARTED|Part B:Treatment Session2-Period3||2
8854076|NCT01769274|9909394|FG002|STARTED|Part B:Treatment Session2-Period3||3
8854077|NCT01769274|9909392|FG000|COMPLETED|Part B:Treatment Session2-Period3||0
8854078|NCT01769274|9909393|FG001|COMPLETED|Part B:Treatment Session2-Period3||2
8854079|NCT01769274|9909394|FG002|COMPLETED|Part B:Treatment Session2-Period3||3
8854080|NCT01769274|9909392|FG000|NOT COMPLETED|Part B:Treatment Session2-Period3||0
8854081|NCT01769274|9909393|FG001|NOT COMPLETED|Part B:Treatment Session2-Period3||0
8854082|NCT01769274|9909394|FG002|NOT COMPLETED|Part B:Treatment Session2-Period3||0
8854083|NCT01769274|9909392|FG000|STARTED|Washout Period||0
8854084|NCT01769274|9909393|FG001|STARTED|Washout Period||2
8854085|NCT01769274|9909394|FG002|STARTED|Washout Period||3
8854086|NCT01769274|9909392|FG000|COMPLETED|Washout Period||0
8854087|NCT01769274|9909393|FG001|COMPLETED|Washout Period||2
8854088|NCT01769274|9909394|FG002|COMPLETED|Washout Period||3
8854089|NCT01769274|9909392|FG000|NOT COMPLETED|Washout Period||0
8854090|NCT01769274|9909393|FG001|NOT COMPLETED|Washout Period||0
8854091|NCT01769274|9909394|FG002|NOT COMPLETED|Washout Period||0
8854092|NCT01769274|9909392|FG000|STARTED|Part B:Treatment Session2-Period4||0
8854093|NCT01769274|9909393|FG001|STARTED|Part B:Treatment Session2-Period4||2
8854094|NCT01769274|9909394|FG002|STARTED|Part B:Treatment Session2-Period4||3
8854095|NCT01769274|9909392|FG000|COMPLETED|Part B:Treatment Session2-Period4||0
8854096|NCT01769274|9909393|FG001|COMPLETED|Part B:Treatment Session2-Period4||2
8854097|NCT01769274|9909394|FG002|COMPLETED|Part B:Treatment Session2-Period4||3
8854098|NCT01769274|9909392|FG000|NOT COMPLETED|Part B:Treatment Session2-Period4||0
8854099|NCT01769274|9909393|FG001|NOT COMPLETED|Part B:Treatment Session2-Period4||0
8854100|NCT01769274|9909394|FG002|NOT COMPLETED|Part B:Treatment Session2-Period4||0
8854101|NCT01769326|9909409|FG000|STARTED|Overall Study||11
8854102|NCT01769326|9909410|FG001|STARTED|Overall Study||12
8854103|NCT01769326|9909411|FG002|STARTED|Overall Study||9
8854104|NCT01769326|9909412|FG003|STARTED|Overall Study||8
8854105|NCT01769326|9909409|FG000|COMPLETED|Overall Study||9
8854106|NCT01769326|9909410|FG001|COMPLETED|Overall Study||8
8854107|NCT01769326|9909411|FG002|COMPLETED|Overall Study||8
8854108|NCT01769326|9909412|FG003|COMPLETED|Overall Study||8
8854109|NCT01769326|9909409|FG000|NOT COMPLETED|Overall Study||2
8854110|NCT01769326|9909410|FG001|NOT COMPLETED|Overall Study||4
8854111|NCT01769326|9909411|FG002|NOT COMPLETED|Overall Study||1
8854112|NCT01769326|9909412|FG003|NOT COMPLETED|Overall Study||0
8854113|NCT01769339|9909422|FG000|STARTED|Overall Study||115
8854114|NCT01769339|9909422|FG000|COMPLETED|Overall Study||72
8854115|NCT01769339|9909422|FG000|NOT COMPLETED|Overall Study||43
8854116|NCT01769352|9909430|FG000|STARTED|Overall Study||13
8854117|NCT01769352|9909431|FG001|STARTED|Overall Study||12
8854118|NCT01769352|9909432|FG002|STARTED|Overall Study||9
8854119|NCT01769352|9909433|FG003|STARTED|Overall Study||8
8854120|NCT01769352|9909430|FG000|COMPLETED|Overall Study||13
8854121|NCT01769352|9909431|FG001|COMPLETED|Overall Study||12
8854122|NCT01769352|9909432|FG002|COMPLETED|Overall Study||9
8854123|NCT01769352|9909433|FG003|COMPLETED|Overall Study||8
8854124|NCT01769352|9909430|FG000|NOT COMPLETED|Overall Study||0
8854125|NCT01769352|9909431|FG001|NOT COMPLETED|Overall Study||0
8854126|NCT01769352|9909432|FG002|NOT COMPLETED|Overall Study||0
8854127|NCT01769352|9909433|FG003|NOT COMPLETED|Overall Study||0
8854128|NCT01769365|9909447|FG000|STARTED|Overall Study||102
8854129|NCT01769365|9909448|FG001|STARTED|Overall Study||102
8854130|NCT01769365|9909449|FG002|STARTED|Overall Study||103
8949232|NCT02436577|10011738|FG002|COMPLETED|Overall Study||7
8854131|NCT01769365|9909447|FG000|COMPLETED|Overall Study||102
8854132|NCT01769365|9909448|FG001|COMPLETED|Overall Study||100
8854133|NCT01769365|9909449|FG002|COMPLETED|Overall Study||101
8854134|NCT01769365|9909447|FG000|NOT COMPLETED|Overall Study||0
8854135|NCT01769365|9909448|FG001|NOT COMPLETED|Overall Study||2
8854136|NCT01769365|9909449|FG002|NOT COMPLETED|Overall Study||2
8854137|NCT01769378|9909459|FG000|STARTED|Overall Study||240
8854138|NCT01769378|9909460|FG001|STARTED|Overall Study||60
8854139|NCT01769378|9909459|FG000|Received at Least 1 Dose of Study Drug|Overall Study||239
8854140|NCT01769378|9909460|FG001|Received at Least 1 Dose of Study Drug|Overall Study||60
8854141|NCT01769378|9909459|FG000|COMPLETED|Overall Study|Completed the study on study treatment|215
8854142|NCT01769378|9909460|FG001|COMPLETED|Overall Study|Completed the study on study treatment|56
8854143|NCT01769378|9909459|FG000|NOT COMPLETED|Overall Study||25
8854144|NCT01769378|9909460|FG001|NOT COMPLETED|Overall Study||4
8854145|NCT01769391|9909468|FG000|STARTED|Overall Study||110
8854146|NCT01769391|9909469|FG001|STARTED|Overall Study||57
8854147|NCT01769391|9909468|FG000|Received at Least One Dose of Study Drug|Overall Study||106
8854148|NCT01769391|9909469|FG001|Received at Least One Dose of Study Drug|Overall Study||55
8854149|NCT01769391|9909468|FG000|COMPLETED|Overall Study||93
8854150|NCT01769391|9909469|FG001|COMPLETED|Overall Study||48
8854151|NCT01769391|9909468|FG000|NOT COMPLETED|Overall Study||17
8854152|NCT01769391|9909469|FG001|NOT COMPLETED|Overall Study||9
8854153|NCT01769404|9909481|FG000|STARTED|Treatment Period 1||12
8569538|NCT00097786|9601800|FG000|STARTED|Overall Study|"Started indicates Full Analysis Set (FAS) population. Initially enrolled 9518, 212 excluded."|2316
8569539|NCT00097786|9601801|FG001|STARTED|Overall Study||2315
8569540|NCT00097786|9601802|FG002|STARTED|Overall Study||2329
8569541|NCT00097786|9601803|FG003|STARTED|Overall Study||2346
8569542|NCT00097786|9601800|FG000|Complete FU for Progression to Diabetes|Overall Study||1709
8569543|NCT00097786|9601801|FG001|Complete FU for Progression to Diabetes|Overall Study||1712
8569544|NCT00097786|9601802|FG002|Complete FU for Progression to Diabetes|Overall Study||1734
8569545|NCT00097786|9601803|FG003|Complete FU for Progression to Diabetes|Overall Study||1762
8569546|NCT00097786|9601800|FG000|Complete Follow-up for Extended CV EPs|Overall Study||1969
8569547|NCT00097786|9601801|FG001|Complete Follow-up for Extended CV EPs|Overall Study||1985
8569548|NCT00097786|9601802|FG002|Complete Follow-up for Extended CV EPs|Overall Study||1987
8569549|NCT00097786|9601803|FG003|Complete Follow-up for Extended CV EPs|Overall Study||2015
8569550|NCT00097786|9601800|FG000|Complete Follow-up for Core CV EPs|Overall Study||1948
8569551|NCT00097786|9601801|FG001|Complete Follow-up for Core CV EPs|Overall Study||1963
8569552|NCT00097786|9601802|FG002|Complete Follow-up for Core CV EPs|Overall Study||1966
8569553|NCT00097786|9601803|FG003|Complete Follow-up for Core CV EPs|Overall Study||1988
8569554|NCT00097786|9601800|FG000|COMPLETED|Overall Study|"Completed means completed follow up for all cause death."|2020
8569555|NCT00097786|9601801|FG001|COMPLETED|Overall Study||2023
8569556|NCT00097786|9601802|FG002|COMPLETED|Overall Study||2016
8569557|NCT00097786|9601803|FG003|COMPLETED|Overall Study||2036
8569558|NCT00097786|9601800|FG000|NOT COMPLETED|Overall Study||296
8569559|NCT00097786|9601801|FG001|NOT COMPLETED|Overall Study||292
8854154|NCT01769404|9909482|FG001|STARTED|Treatment Period 1||13
8854155|NCT01769404|9909481|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1||9
8854156|NCT01769404|9909482|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1||13
8854157|NCT01769404|9909481|FG000|COMPLETED|Treatment Period 1||7
8854158|NCT01769404|9909482|FG001|COMPLETED|Treatment Period 1||13
8854159|NCT01769404|9909481|FG000|NOT COMPLETED|Treatment Period 1||5
8854160|NCT01769404|9909482|FG001|NOT COMPLETED|Treatment Period 1||0
8854161|NCT01769404|9909481|FG000|STARTED|Treatment Period 2||7
8854162|NCT01769404|9909482|FG001|STARTED|Treatment Period 2||13
8854163|NCT01769404|9909481|FG000|COMPLETED|Treatment Period 2||0
8854164|NCT01769404|9909482|FG001|COMPLETED|Treatment Period 2||13
8854165|NCT01769404|9909481|FG000|NOT COMPLETED|Treatment Period 2||7
8854166|NCT01769404|9909482|FG001|NOT COMPLETED|Treatment Period 2||0
8854167|NCT01769456|9909490|FG000|STARTED|Overall Study|1 subject inadvertently enrolled, discontin'd after baseline, re-enrolled later and completed study|78
8854168|NCT01769456|9909490|FG000|COMPLETED|Overall Study||41
8854169|NCT01769456|9909490|FG000|NOT COMPLETED|Overall Study||37
8854170|NCT01769469|9909495|FG000|STARTED|Overall Study||101
8854171|NCT01769469|9909495|FG000|COMPLETED|Overall Study||66
8854172|NCT01769469|9909495|FG000|NOT COMPLETED|Overall Study||35
8854173|NCT01769508|9909501|FG000|STARTED|Overall Study||12
8854174|NCT01769508|9909501|FG000|COMPLETED|Overall Study||6
8854175|NCT01769508|9909501|FG000|NOT COMPLETED|Overall Study||6
8854176|NCT01769573|9909510|FG000|STARTED|Overall Study||10
8854177|NCT01769573|9909511|FG001|STARTED|Overall Study||6
8854178|NCT01769573|9909512|FG002|STARTED|Overall Study||10
8854179|NCT01769573|9909513|FG003|STARTED|Overall Study||0
8854180|NCT01769573|9909514|FG004|STARTED|Overall Study||10
8854181|NCT01769573|9909510|FG000|COMPLETED|Overall Study||10
8854182|NCT01769573|9909511|FG001|COMPLETED|Overall Study||6
8854183|NCT01769573|9909512|FG002|COMPLETED|Overall Study||10
8854184|NCT01769573|9909513|FG003|COMPLETED|Overall Study||0
8854185|NCT01769573|9909514|FG004|COMPLETED|Overall Study||10
8854186|NCT01769573|9909510|FG000|NOT COMPLETED|Overall Study||0
8854187|NCT01769573|9909511|FG001|NOT COMPLETED|Overall Study||0
8854188|NCT01769573|9909512|FG002|NOT COMPLETED|Overall Study||0
8949233|NCT02436577|10011739|FG003|COMPLETED|Overall Study||7
8949234|NCT02436577|10011740|FG004|COMPLETED|Overall Study||7
8949235|NCT02436577|10011741|FG005|COMPLETED|Overall Study||7
8854189|NCT01769573|9909513|FG003|NOT COMPLETED|Overall Study||0
8854190|NCT01769573|9909514|FG004|NOT COMPLETED|Overall Study||0
8854191|NCT01769586|9909528|FG000|STARTED|Overall Study||100
8854192|NCT01769586|9909529|FG001|STARTED|Overall Study||100
8854193|NCT01769586|9909528|FG000|COMPLETED|Overall Study||100
8854194|NCT01769586|9909529|FG001|COMPLETED|Overall Study||100
8854195|NCT01769586|9909528|FG000|NOT COMPLETED|Overall Study||0
8854196|NCT01769586|9909529|FG001|NOT COMPLETED|Overall Study||0
8854197|NCT01769612|9909535|FG000|STARTED|Overall Study||168
8854198|NCT01769612|9909535|FG000|COMPLETED|Overall Study||168
8854199|NCT01769612|9909535|FG000|NOT COMPLETED|Overall Study||0
8854200|NCT01770145|9909541|FG000|STARTED|Baseline||127
8854201|NCT01770145|9909541|FG000|COMPLETED|Baseline||101
8854202|NCT01770145|9909541|FG000|NOT COMPLETED|Baseline||26
8854203|NCT01770145|9909541|FG000|STARTED|Treatment||101
8854204|NCT01770145|9909541|FG000|COMPLETED|Treatment||97
8854205|NCT01770145|9909541|FG000|NOT COMPLETED|Treatment||4
8854206|NCT01770314|9909547|FG000|STARTED|Overall Study||86
8854207|NCT01770314|9909548|FG001|STARTED|Overall Study||90
8854208|NCT01770314|9909547|FG000|Contributed Data to Baseline|Overall Study||68
8854209|NCT01770314|9909548|FG001|Contributed Data to Baseline|Overall Study||72
8854210|NCT01770314|9909547|FG000|Contributed Data to Post-test|Overall Study||65
8854211|NCT01770314|9909548|FG001|Contributed Data to Post-test|Overall Study||67
8854212|NCT01770314|9909547|FG000|Contributed Data to One-month Follow-up|Overall Study||61
8854213|NCT01770314|9909548|FG001|Contributed Data to One-month Follow-up|Overall Study||66
8854214|NCT01770314|9909547|FG000|COMPLETED|Overall Study||86
8854215|NCT01770314|9909548|FG001|COMPLETED|Overall Study||90
8854216|NCT01770314|9909547|FG000|NOT COMPLETED|Overall Study||0
8854217|NCT01770314|9909548|FG001|NOT COMPLETED|Overall Study||0
8854218|NCT01770353|9909556|FG000|STARTED|Overall Study||15
8854219|NCT01770353|9909557|FG001|STARTED|Overall Study||30
8854220|NCT01770353|9909556|FG000|Received FMX|Overall Study|2 subjects excluded from MM-398 safety population.|15
8854221|NCT01770353|9909557|FG001|Received FMX|Overall Study|1 subject excluded from MM-398 safety population.|30
8854222|NCT01770353|9909556|FG000|Received FMX and MM-398|Overall Study||13
8854223|NCT01770353|9909557|FG001|Received FMX and MM-398|Overall Study||29
8854224|NCT01770353|9909556|FG000|COMPLETED|Overall Study||9
8854225|NCT01770353|9909557|FG001|COMPLETED|Overall Study||18
8854226|NCT01770353|9909556|FG000|NOT COMPLETED|Overall Study||6
8854227|NCT01770353|9909557|FG001|NOT COMPLETED|Overall Study||12
8854228|NCT01770366|9909573|FG000|STARTED|Overall Study||4
8854229|NCT01770366|9909574|FG001|STARTED|Overall Study||6
8854230|NCT01770366|9909573|FG000|COMPLETED|Overall Study||2
8854231|NCT01770366|9909574|FG001|COMPLETED|Overall Study||4
8854232|NCT01770366|9909573|FG000|NOT COMPLETED|Overall Study||2
8854233|NCT01770366|9909574|FG001|NOT COMPLETED|Overall Study||2
8854234|NCT01770379|9909583|FG000|STARTED|Overall Study||80
8854235|NCT01770379|9909584|FG001|STARTED|Overall Study||81
8854236|NCT01770379|9909585|FG002|STARTED|Overall Study||81
8854237|NCT01770379|9909583|FG000|COMPLETED|Overall Study||41
8854238|NCT01770379|9909584|FG001|COMPLETED|Overall Study||37
8949236|NCT02436577|10011736|FG000|NOT COMPLETED|Overall Study||0
8854239|NCT01770379|9909585|FG002|COMPLETED|Overall Study||39
8854240|NCT01770379|9909583|FG000|NOT COMPLETED|Overall Study||39
8854241|NCT01770379|9909584|FG001|NOT COMPLETED|Overall Study||44
8854242|NCT01770379|9909585|FG002|NOT COMPLETED|Overall Study||42
8854243|NCT01770392|9909595|FG000|STARTED|Nintedanib||26
8854244|NCT01770392|9909595|FG000|COMPLETED|Nintedanib||26
8854245|NCT01770392|9909595|FG000|NOT COMPLETED|Nintedanib||0
8854246|NCT01770392|9909595|FG000|STARTED|Washout Period of at Least 14 Days||26
8854247|NCT01770392|9909595|FG000|COMPLETED|Washout Period of at Least 14 Days||25
8854248|NCT01770392|9909595|FG000|NOT COMPLETED|Washout Period of at Least 14 Days||1
8854249|NCT01770392|9909595|FG000|STARTED|Nintedanib+ Rifampicin||25
8854250|NCT01770392|9909595|FG000|COMPLETED|Nintedanib+ Rifampicin||25
8854251|NCT01770392|9909595|FG000|NOT COMPLETED|Nintedanib+ Rifampicin||0
8854252|NCT01770431|9909607|FG000|STARTED|Overall Study||696
8854253|NCT01770431|9909608|FG001|STARTED|Overall Study||348
8854254|NCT01770431|9909607|FG000|COMPLETED|Overall Study||686
8854255|NCT01770431|9909608|FG001|COMPLETED|Overall Study||316
8854256|NCT01770431|9909607|FG000|NOT COMPLETED|Overall Study||10
8854257|NCT01770431|9909608|FG001|NOT COMPLETED|Overall Study||32
8854258|NCT01770483|9909617|FG000|STARTED|Overall Study||33
8854259|NCT01770483|9909618|FG001|STARTED|Overall Study||33
8854260|NCT01770483|9909617|FG000|COMPLETED|Overall Study||33
8854261|NCT01770483|9909618|FG001|COMPLETED|Overall Study||33
8854262|NCT01770483|9909617|FG000|NOT COMPLETED|Overall Study||0
8854263|NCT01770483|9909618|FG001|NOT COMPLETED|Overall Study||0
8854264|NCT01770509|9909626|FG000|STARTED|Overall Study||12
8854265|NCT01770509|9909627|FG001|STARTED|Overall Study||17
8854266|NCT01770509|9909626|FG000|COMPLETED|Overall Study||11
8854267|NCT01770509|9909627|FG001|COMPLETED|Overall Study||14
8854268|NCT01770509|9909626|FG000|NOT COMPLETED|Overall Study||1
8854269|NCT01770509|9909627|FG001|NOT COMPLETED|Overall Study||3
8854270|NCT01770652|9909637|FG000|STARTED|Overall Study||8
8854271|NCT01770652|9909638|FG001|STARTED|Overall Study||8
8854272|NCT01770652|9909639|FG002|STARTED|Overall Study||8
8854273|NCT01770652|9909640|FG003|STARTED|Overall Study||8
8854274|NCT01770652|9909637|FG000|COMPLETED|Overall Study||8
8854275|NCT01770652|9909638|FG001|COMPLETED|Overall Study||8
8854276|NCT01770652|9909639|FG002|COMPLETED|Overall Study||8
8569560|NCT00097786|9601802|FG002|NOT COMPLETED|Overall Study||313
8569561|NCT00097786|9601803|FG003|NOT COMPLETED|Overall Study||310
8569562|NCT00097981|9601815|FG000|STARTED|Overall Study|Enrollment at randomization|113
8569563|NCT00097981|9601816|FG001|STARTED|Overall Study|Enrollment at randomization|112
8569564|NCT00097981|9601815|FG000|Received Study Medication|Overall Study||110
8569565|NCT00097981|9601816|FG001|Received Study Medication|Overall Study||106
8569566|NCT00097981|9601815|FG000|COMPLETED|Overall Study|Completion of 2 or more cycles after CR or nCR, or completion of 12 cycles.|7
8569567|NCT00097981|9601816|FG001|COMPLETED|Overall Study|Completion of 2 or more cycles after CR or nCR, or completion of 12 cycles.|12
8569568|NCT00097981|9601815|FG000|NOT COMPLETED|Overall Study||106
8569569|NCT00097981|9601816|FG001|NOT COMPLETED|Overall Study||100
8569570|NCT00098020|9601822|FG000|STARTED|Overall Study||12
8569571|NCT00098020|9601822|FG000|Started Isotretinoin|Overall Study||8
8569572|NCT00098020|9601822|FG000|COMPLETED|Overall Study||6
8569573|NCT00098020|9601822|FG000|NOT COMPLETED|Overall Study||6
8569574|NCT00098059|9601828|FG000|STARTED|Overall Study||27
8569575|NCT00098059|9601829|FG001|STARTED|Overall Study||47
8569576|NCT00098059|9601828|FG000|COMPLETED|Overall Study||27
8569577|NCT00098059|9601829|FG001|COMPLETED|Overall Study||46
8569578|NCT00098059|9601828|FG000|NOT COMPLETED|Overall Study||0
8569579|NCT00098059|9601829|FG001|NOT COMPLETED|Overall Study||1
8569580|NCT00098254|9601840|FG000|STARTED|Overall Study||37
8569581|NCT00098254|9601840|FG000|COMPLETED|Overall Study||34
8569582|NCT00098254|9601840|FG000|NOT COMPLETED|Overall Study||3
8569583|NCT00098293|9601847|FG000|STARTED|Double-blind (DB) Phase||177
8569584|NCT00098293|9601848|FG001|STARTED|Double-blind (DB) Phase||368
8569585|NCT00098293|9601849|FG002|STARTED|Double-blind (DB) Phase||372
8569586|NCT00098293|9601850|FG003|STARTED|Double-blind (DB) Phase||0
8569587|NCT00098293|9601851|FG004|STARTED|Double-blind (DB) Phase||0
8854277|NCT01770652|9909640|FG003|COMPLETED|Overall Study||8
8854278|NCT01770652|9909637|FG000|NOT COMPLETED|Overall Study||0
8854279|NCT01770652|9909638|FG001|NOT COMPLETED|Overall Study||0
8854280|NCT01770652|9909639|FG002|NOT COMPLETED|Overall Study||0
8854281|NCT01770652|9909640|FG003|NOT COMPLETED|Overall Study||0
8854282|NCT01770691|9909654|FG000|STARTED|Overall Study||7
8854283|NCT01770691|9909654|FG000|COMPLETED|Overall Study||7
8854284|NCT01770691|9909654|FG000|NOT COMPLETED|Overall Study||0
8854285|NCT01770743|9909666|FG000|STARTED|Overall Study||44
8854286|NCT01770743|9909667|FG001|STARTED|Overall Study||34
8854287|NCT01770743|9909668|FG002|STARTED|Overall Study||23
8854288|NCT01770743|9909669|FG003|STARTED|Overall Study||44
8854289|NCT01770743|9909670|FG004|STARTED|Overall Study||23
8854290|NCT01770743|9909666|FG000|Treated|Overall Study||44
8854291|NCT01770743|9909667|FG001|Treated|Overall Study||34
8854292|NCT01770743|9909668|FG002|Treated|Overall Study||23
8854293|NCT01770743|9909669|FG003|Treated|Overall Study||44
8854294|NCT01770743|9909670|FG004|Treated|Overall Study||23
8569588|NCT00098293|9601847|FG000|Treated|Double-blind (DB) Phase||174
8569589|NCT00098293|9601848|FG001|Treated|Double-blind (DB) Phase||360
8569590|NCT00098293|9601849|FG002|Treated|Double-blind (DB) Phase||361
8569591|NCT00098293|9601850|FG003|Treated|Double-blind (DB) Phase||0
8854295|NCT01770743|9909666|FG000|COMPLETED|Overall Study||42
8854296|NCT01770743|9909667|FG001|COMPLETED|Overall Study||31
8854297|NCT01770743|9909668|FG002|COMPLETED|Overall Study||22
8854298|NCT01770743|9909669|FG003|COMPLETED|Overall Study||42
8854299|NCT01770743|9909670|FG004|COMPLETED|Overall Study||21
8854300|NCT01770743|9909666|FG000|NOT COMPLETED|Overall Study||2
8854301|NCT01770743|9909667|FG001|NOT COMPLETED|Overall Study||3
8854302|NCT01770743|9909668|FG002|NOT COMPLETED|Overall Study||1
8854303|NCT01770743|9909669|FG003|NOT COMPLETED|Overall Study||2
8854304|NCT01770743|9909670|FG004|NOT COMPLETED|Overall Study||2
8854305|NCT01770860|9909682|FG000|STARTED|Overall Study|Forty-six subjects were enrolled but one subject withdrew before randomization.|46
8854306|NCT01770860|9909682|FG000|Randomization|Overall Study|One participant withdrew before randomization|45
8854307|NCT01770860|9909682|FG000|COMPLETED|Overall Study||40
8854308|NCT01770860|9909682|FG000|NOT COMPLETED|Overall Study||6
8854309|NCT01770912|9909692|FG000|STARTED|Overall Study||12
8854310|NCT01770912|9909693|FG001|STARTED|Overall Study||12
8854311|NCT01770912|9909692|FG000|COMPLETED|Overall Study||10
8854312|NCT01770912|9909693|FG001|COMPLETED|Overall Study||12
8854313|NCT01770912|9909692|FG000|NOT COMPLETED|Overall Study||2
8854314|NCT01770912|9909693|FG001|NOT COMPLETED|Overall Study||0
8854315|NCT01771055|9909701|FG000|STARTED|Overall Study||4
8854316|NCT01771055|9909702|FG001|STARTED|Overall Study||3
8854317|NCT01771055|9909701|FG000|COMPLETED|Overall Study||4
8854318|NCT01771055|9909702|FG001|COMPLETED|Overall Study||3
8854319|NCT01771055|9909701|FG000|NOT COMPLETED|Overall Study||0
8854320|NCT01771055|9909702|FG001|NOT COMPLETED|Overall Study||0
8854321|NCT01771172|9909708|FG000|STARTED|Overall Study||48
8854322|NCT01771172|9909708|FG000|COMPLETED|Overall Study||46
8854323|NCT01771172|9909708|FG000|NOT COMPLETED|Overall Study||2
8854324|NCT01771250|9909712|FG000|STARTED|Period 1||8
8854325|NCT01771250|9909713|FG001|STARTED|Period 1||7
8854326|NCT01771250|9909712|FG000|Received at Least One Dose of Study Drug|Period 1||7
8854327|NCT01771250|9909713|FG001|Received at Least One Dose of Study Drug|Period 1||7
8854328|NCT01771250|9909712|FG000|COMPLETED|Period 1||7
8854329|NCT01771250|9909713|FG001|COMPLETED|Period 1||7
8854330|NCT01771250|9909712|FG000|NOT COMPLETED|Period 1||1
8854331|NCT01771250|9909713|FG001|NOT COMPLETED|Period 1||0
8854332|NCT01771250|9909712|FG000|STARTED|Period 2||7
8854333|NCT01771250|9909713|FG001|STARTED|Period 2||7
8854334|NCT01771250|9909712|FG000|COMPLETED|Period 2||7
8854335|NCT01771250|9909713|FG001|COMPLETED|Period 2||7
8854336|NCT01771250|9909712|FG000|NOT COMPLETED|Period 2||0
8854337|NCT01771250|9909713|FG001|NOT COMPLETED|Period 2||0
8854338|NCT01771627|9909721|FG000|STARTED|Overall Study||200
8854339|NCT01771627|9909722|FG001|STARTED|Overall Study||100
8854340|NCT01771627|9909721|FG000|COMPLETED|Overall Study||92
8854341|NCT01771627|9909722|FG001|COMPLETED|Overall Study||50
8854342|NCT01771627|9909721|FG000|NOT COMPLETED|Overall Study||108
8854343|NCT01771627|9909722|FG001|NOT COMPLETED|Overall Study||50
8854344|NCT01771666|9909728|FG000|STARTED|Overall Study||23
8854345|NCT01771666|9909728|FG000|COMPLETED|Overall Study||23
8854346|NCT01771666|9909728|FG000|NOT COMPLETED|Overall Study||0
8854347|NCT01771731|9909734|FG000|STARTED|Overall Study||13
8854348|NCT01771731|9909735|FG001|STARTED|Overall Study||14
8854349|NCT01771731|9909734|FG000|COMPLETED|Overall Study||11
8854350|NCT01771731|9909735|FG001|COMPLETED|Overall Study||12
8854351|NCT01771731|9909734|FG000|NOT COMPLETED|Overall Study||2
8854352|NCT01771731|9909735|FG001|NOT COMPLETED|Overall Study||2
8854353|NCT01771809|9909743|FG000|STARTED|Overall Study||164
8854354|NCT01771809|9909744|FG001|STARTED|Overall Study||166
8854355|NCT01771809|9909743|FG000|COMPLETED|Overall Study||93
8854356|NCT01771809|9909744|FG001|COMPLETED|Overall Study||83
8854357|NCT01771809|9909743|FG000|NOT COMPLETED|Overall Study||71
8854358|NCT01771809|9909744|FG001|NOT COMPLETED|Overall Study||83
8854359|NCT01771913|9909752|FG000|STARTED|Overall Study||9
8854360|NCT01771913|9909753|FG001|STARTED|Overall Study||11
8854361|NCT01771913|9909752|FG000|COMPLETED|Overall Study||8
8854362|NCT01771913|9909753|FG001|COMPLETED|Overall Study||11
8854363|NCT01771913|9909752|FG000|NOT COMPLETED|Overall Study||1
8854364|NCT01771913|9909753|FG001|NOT COMPLETED|Overall Study||0
8854365|NCT01771952|9909761|FG000|STARTED|Overall Study||45
8854366|NCT01771952|9909762|FG001|STARTED|Overall Study||41
8569592|NCT00098293|9601851|FG004|Treated|Double-blind (DB) Phase||0
8854367|NCT01771952|9909761|FG000|COMPLETED|Overall Study||42
8854368|NCT01771952|9909762|FG001|COMPLETED|Overall Study||38
8569593|NCT00098293|9601847|FG000|COMPLETED|Double-blind (DB) Phase||0
8854369|NCT01771952|9909761|FG000|NOT COMPLETED|Overall Study||3
8854370|NCT01771952|9909762|FG001|NOT COMPLETED|Overall Study||3
8569594|NCT00098293|9601848|FG001|COMPLETED|Double-blind (DB) Phase||202
8694249|NCT00870584|9739681|FG000|COMPLETED|Overall Study||120
8694250|NCT00870584|9739682|FG001|COMPLETED|Overall Study||122
8694251|NCT00870584|9739681|FG000|NOT COMPLETED|Overall Study||16
8694252|NCT00870584|9739682|FG001|NOT COMPLETED|Overall Study||13
8694253|NCT00870727|9739690|FG000|STARTED|Overall Study||17
8694254|NCT00870727|9739691|FG001|STARTED|Overall Study||16
8854371|NCT01771965|9909770|FG000|STARTED|Overall Study||10
8854372|NCT01771965|9909771|FG001|STARTED|Overall Study||9
8854373|NCT01771965|9909770|FG000|COMPLETED|Overall Study||7
8854374|NCT01771965|9909771|FG001|COMPLETED|Overall Study||4
8854375|NCT01771965|9909770|FG000|NOT COMPLETED|Overall Study||3
8854376|NCT01771965|9909771|FG001|NOT COMPLETED|Overall Study||5
8694255|NCT00870727|9739690|FG000|COMPLETED|Overall Study||16
8694256|NCT00870727|9739691|FG001|COMPLETED|Overall Study||11
8854377|NCT01771991|9909779|FG000|STARTED|Overall Study||38
8854378|NCT01771991|9909780|FG001|STARTED|Overall Study||36
8854379|NCT01771991|9909779|FG000|Started Treatment|Overall Study||37
8854380|NCT01771991|9909780|FG001|Started Treatment|Overall Study||34
8854381|NCT01771991|9909779|FG000|COMPLETED|Overall Study||30
8854382|NCT01771991|9909780|FG001|COMPLETED|Overall Study||30
8854383|NCT01771991|9909779|FG000|NOT COMPLETED|Overall Study||8
8854384|NCT01771991|9909780|FG001|NOT COMPLETED|Overall Study||6
8854385|NCT01772134|9909790|FG000|STARTED|Overall Study|These participants were randomized but did not all receive study treatment.|207
8854386|NCT01772134|9909791|FG001|STARTED|Overall Study|These participants were randomized but did not all receive study treatment.|204
8854387|NCT01772134|9909792|FG002|STARTED|Overall Study|These participants were randomized but did not all receive study treatment.|206
8854388|NCT01772134|9909790|FG000|Received Randomized Study Medication|Overall Study||205
8854389|NCT01772134|9909791|FG001|Received Randomized Study Medication|Overall Study||204
8854390|NCT01772134|9909792|FG002|Received Randomized Study Medication|Overall Study||205
8854391|NCT01772134|9909790|FG000|COMPLETED|Overall Study||178
8854392|NCT01772134|9909791|FG001|COMPLETED|Overall Study||190
8854393|NCT01772134|9909792|FG002|COMPLETED|Overall Study||184
8854394|NCT01772134|9909790|FG000|NOT COMPLETED|Overall Study||29
8854395|NCT01772134|9909791|FG001|NOT COMPLETED|Overall Study||14
8854396|NCT01772134|9909792|FG002|NOT COMPLETED|Overall Study||22
8854397|NCT01772147|9909803|FG000|STARTED|Overall Study||201
8854398|NCT01772147|9909804|FG001|STARTED|Overall Study||203
8854399|NCT01772147|9909805|FG002|STARTED|Overall Study||202
8854400|NCT01772147|9909803|FG000|COMPLETED|Overall Study||170
8854401|NCT01772147|9909804|FG001|COMPLETED|Overall Study||178
8854402|NCT01772147|9909805|FG002|COMPLETED|Overall Study||184
8854403|NCT01772147|9909803|FG000|NOT COMPLETED|Overall Study||31
8854404|NCT01772147|9909804|FG001|NOT COMPLETED|Overall Study||25
8854405|NCT01772147|9909805|FG002|NOT COMPLETED|Overall Study||18
8854406|NCT01772160|9909813|FG000|STARTED|Overall Study||394
8854407|NCT01772160|9909813|FG000|COMPLETED|Overall Study||346
8854408|NCT01772160|9909813|FG000|NOT COMPLETED|Overall Study||48
8854409|NCT01772316|9909817|FG000|STARTED|Overall Study||47
8854410|NCT01772316|9909817|FG000|COMPLETED|Overall Study||40
8854411|NCT01772316|9909817|FG000|NOT COMPLETED|Overall Study||7
8854412|NCT01772368|9909821|FG000|STARTED|Overall Study||72
8854413|NCT01772368|9909821|FG000|Received Fp MDPI 100 mcg|Overall Study||67
8854414|NCT01772368|9909821|FG000|Received FS MDPI 100/6.25 mcg|Overall Study||68
8854415|NCT01772368|9909821|FG000|Received FS MDPI 100/12.5mcg|Overall Study||69
8854416|NCT01772368|9909821|FG000|Received FS MDPI 100/25 mcg|Overall Study||67
8854417|NCT01772368|9909821|FG000|Received FS MDPI 100/50 mcg|Overall Study||68
8854418|NCT01772368|9909821|FG000|Received Advair Diskus 100/50 mcg|Overall Study||66
8854419|NCT01772368|9909821|FG000|COMPLETED|Overall Study||65
8854420|NCT01772368|9909821|FG000|NOT COMPLETED|Overall Study||7
8854421|NCT01772537|9909840|FG000|STARTED|Overall Study||5
8854422|NCT01772537|9909841|FG001|STARTED|Overall Study||3
8854423|NCT01772537|9909842|FG002|STARTED|Overall Study||6
8854424|NCT01772537|9909840|FG000|COMPLETED|Overall Study||4
8854425|NCT01772537|9909841|FG001|COMPLETED|Overall Study||3
8854426|NCT01772537|9909842|FG002|COMPLETED|Overall Study||6
8854427|NCT01772537|9909840|FG000|NOT COMPLETED|Overall Study||1
8854428|NCT01772537|9909841|FG001|NOT COMPLETED|Overall Study||0
8854429|NCT01772537|9909842|FG002|NOT COMPLETED|Overall Study||0
8923425|NCT02240030|9984003|FG002|COMPLETED|Overall Study||97
8923426|NCT02240030|9984001|FG000|NOT COMPLETED|Overall Study||17
8923427|NCT02240030|9984002|FG001|NOT COMPLETED|Overall Study||17
8923428|NCT02240030|9984003|FG002|NOT COMPLETED|Overall Study||15
8923429|NCT02240108|9984015|FG000|STARTED|Overall Study||35
8923430|NCT02240108|9984016|FG001|STARTED|Overall Study||46
8923431|NCT02240108|9984015|FG000|Intent-to-treat (ITT) Population|Overall Study||35
8923432|NCT02240108|9984016|FG001|Intent-to-treat (ITT) Population|Overall Study||45
8923433|NCT02240108|9984015|FG000|COMPLETED|Overall Study||21
8923434|NCT02240108|9984016|FG001|COMPLETED|Overall Study||21
8923435|NCT02240108|9984015|FG000|NOT COMPLETED|Overall Study||14
8923436|NCT02240108|9984016|FG001|NOT COMPLETED|Overall Study||25
8923437|NCT02240121|9984024|FG000|STARTED|Overall Study||40
8923438|NCT02240121|9984025|FG001|STARTED|Overall Study||40
8923439|NCT02240121|9984024|FG000|COMPLETED|Overall Study||22
8923440|NCT02240121|9984025|FG001|COMPLETED|Overall Study||20
8923441|NCT02240121|9984024|FG000|NOT COMPLETED|Overall Study||18
8923442|NCT02240121|9984025|FG001|NOT COMPLETED|Overall Study||20
8923443|NCT02240186|9984031|FG000|STARTED|Overall Study||50
8923444|NCT02240186|9984031|FG000|COMPLETED|Overall Study||23
8923445|NCT02240186|9984031|FG000|NOT COMPLETED|Overall Study||27
8923446|NCT02240329|9984038|FG000|STARTED|Overall Study||4
8923447|NCT02240329|9984038|FG000|Determination of Urge to Cough|Overall Study||4
8923448|NCT02240329|9984038|FG000|COMPLETED|Overall Study||4
8923449|NCT02240329|9984038|FG000|NOT COMPLETED|Overall Study||0
8923450|NCT02240368|9984045|FG000|STARTED|Overall Study||9
8923451|NCT02240368|9984046|FG001|STARTED|Overall Study||22
8923452|NCT02240368|9984047|FG002|STARTED|Overall Study||19
8923453|NCT02240368|9984045|FG000|COMPLETED|Overall Study||8
8923454|NCT02240368|9984046|FG001|COMPLETED|Overall Study||22
8854430|NCT01772550|9909855|FG000|STARTED|Overall Study||102
8854431|NCT01772550|9909856|FG001|STARTED|Overall Study||103
8854432|NCT01772550|9909857|FG002|STARTED|Overall Study||33
8854433|NCT01772550|9909855|FG000|CT Pancreas|Overall Study||40
8854434|NCT01772550|9909856|FG001|CT Pancreas|Overall Study||36
8854435|NCT01772550|9909857|FG002|CT Pancreas|Overall Study||8
8854436|NCT01772550|9909855|FG000|CT Angiogram|Overall Study||24
8854437|NCT01772550|9909856|FG001|CT Angiogram|Overall Study||25
8854438|NCT01772550|9909857|FG002|CT Angiogram|Overall Study||4
8854439|NCT01772550|9909855|FG000|CT Liver|Overall Study||18
8854440|NCT01772550|9909856|FG001|CT Liver|Overall Study||14
8854441|NCT01772550|9909857|FG002|CT Liver|Overall Study||8
8854442|NCT01772550|9909855|FG000|CT Kidney|Overall Study||12
8854443|NCT01772550|9909856|FG001|CT Kidney|Overall Study||19
8854444|NCT01772550|9909857|FG002|CT Kidney|Overall Study||6
8854445|NCT01772550|9909855|FG000|CT Cardiac|Overall Study||7
8854446|NCT01772550|9909856|FG001|CT Cardiac|Overall Study||7
8854447|NCT01772550|9909857|FG002|CT Cardiac|Overall Study||1
8854448|NCT01772550|9909855|FG000|COMPLETED|Overall Study||101
8854449|NCT01772550|9909856|FG001|COMPLETED|Overall Study||102
8854450|NCT01772550|9909857|FG002|COMPLETED|Overall Study||27
8854451|NCT01772550|9909855|FG000|NOT COMPLETED|Overall Study||1
8854452|NCT01772550|9909856|FG001|NOT COMPLETED|Overall Study||1
8854453|NCT01772550|9909857|FG002|NOT COMPLETED|Overall Study||6
8854454|NCT01772576|9909865|FG000|STARTED|Overall Study||167
8854455|NCT01772576|9909865|FG000|COMPLETED|Overall Study||133
8854456|NCT01772576|9909865|FG000|NOT COMPLETED|Overall Study||34
8854457|NCT01772654|9909871|FG000|STARTED|Overall Study||2
8854458|NCT01772654|9909872|FG001|STARTED|Overall Study||15
8854459|NCT01772654|9909871|FG000|COMPLETED|Overall Study||2
8854460|NCT01772654|9909872|FG001|COMPLETED|Overall Study||15
8854461|NCT01772654|9909871|FG000|NOT COMPLETED|Overall Study||0
8854462|NCT01772654|9909872|FG001|NOT COMPLETED|Overall Study||0
8854463|NCT01772693|9909880|FG000|STARTED|Overall Study||20
8854464|NCT01772693|9909881|FG001|STARTED|Overall Study||7
8854465|NCT01772693|9909880|FG000|COMPLETED|Overall Study||14
8854466|NCT01772693|9909881|FG001|COMPLETED|Overall Study||6
8854467|NCT01772693|9909880|FG000|NOT COMPLETED|Overall Study||6
8854468|NCT01772693|9909881|FG001|NOT COMPLETED|Overall Study||1
8854469|NCT01772758|9909891|FG000|STARTED|Overall Study||18
8854470|NCT01772758|9909892|FG001|STARTED|Overall Study||17
8854471|NCT01772758|9909893|FG002|STARTED|Overall Study||12
8854472|NCT01772758|9909894|FG003|STARTED|Overall Study||17
8854473|NCT01772758|9909891|FG000|COMPLETED|Overall Study||18
8854474|NCT01772758|9909892|FG001|COMPLETED|Overall Study||17
8854475|NCT01772758|9909893|FG002|COMPLETED|Overall Study||12
8854476|NCT01772758|9909894|FG003|COMPLETED|Overall Study||17
8854477|NCT01772758|9909891|FG000|NOT COMPLETED|Overall Study||0
8854478|NCT01772758|9909892|FG001|NOT COMPLETED|Overall Study||0
8854479|NCT01772758|9909893|FG002|NOT COMPLETED|Overall Study||0
8854480|NCT01772758|9909894|FG003|NOT COMPLETED|Overall Study||0
8854481|NCT01772823|9909906|FG000|STARTED|Behavioral Intervention (BL -3MV or PCC)||128
8854482|NCT01772823|9909907|FG001|STARTED|Behavioral Intervention (BL -3MV or PCC)||72
8854483|NCT01772823|9909906|FG000|COMPLETED|Behavioral Intervention (BL -3MV or PCC)||116
8854484|NCT01772823|9909907|FG001|COMPLETED|Behavioral Intervention (BL -3MV or PCC)||70
8854485|NCT01772823|9909906|FG000|NOT COMPLETED|Behavioral Intervention (BL -3MV or PCC)||12
8854486|NCT01772823|9909907|FG001|NOT COMPLETED|Behavioral Intervention (BL -3MV or PCC)||2
8854487|NCT01772823|9909906|FG000|STARTED|Treatment Phase (Week 0- Week 48)||116
8854488|NCT01772823|9909907|FG001|STARTED|Treatment Phase (Week 0- Week 48)||70
8854489|NCT01772823|9909906|FG000|COMPLETED|Treatment Phase (Week 0- Week 48)||88
8854490|NCT01772823|9909907|FG001|COMPLETED|Treatment Phase (Week 0- Week 48)||52
8854491|NCT01772823|9909906|FG000|NOT COMPLETED|Treatment Phase (Week 0- Week 48)||28
8854492|NCT01772823|9909907|FG001|NOT COMPLETED|Treatment Phase (Week 0- Week 48)||18
8854493|NCT01772823|9909906|FG000|STARTED|Extension Phase (Visits 24,48wks Post tx|25 of the 88 subjects that completed the Treatment Phase were not eligible for the Extension Phase|63
8854494|NCT01772823|9909907|FG001|STARTED|Extension Phase (Visits 24,48wks Post tx|10 of the 52 subjects that completed the Treatment Phase were not eligible for the Extension Phase|42
8854495|NCT01772823|9909906|FG000|COMPLETED|Extension Phase (Visits 24,48wks Post tx||53
8854496|NCT01772823|9909907|FG001|COMPLETED|Extension Phase (Visits 24,48wks Post tx||33
8854497|NCT01772823|9909906|FG000|NOT COMPLETED|Extension Phase (Visits 24,48wks Post tx||10
8854498|NCT01772823|9909907|FG001|NOT COMPLETED|Extension Phase (Visits 24,48wks Post tx||9
8854499|NCT01773070|9909918|FG000|STARTED|Overall Study||478
8854500|NCT01773070|9909918|FG000|COMPLETED|Overall Study||397
8854501|NCT01773070|9909918|FG000|NOT COMPLETED|Overall Study||81
8854502|NCT01773109|9909922|FG000|STARTED|Overall Study||40
8854503|NCT01773109|9909922|FG000|COMPLETED|Overall Study||37
8854504|NCT01773109|9909922|FG000|NOT COMPLETED|Overall Study||3
8854505|NCT01773122|9909930|FG000|STARTED|Overall Study||20
8854506|NCT01773122|9909931|FG001|STARTED|Overall Study||19
8854507|NCT01773122|9909932|FG002|STARTED|Overall Study||19
8854508|NCT01773122|9909933|FG003|STARTED|Overall Study||19
8854509|NCT01773122|9909930|FG000|COMPLETED|Overall Study||17
8854510|NCT01773122|9909931|FG001|COMPLETED|Overall Study||18
8854511|NCT01773122|9909932|FG002|COMPLETED|Overall Study||19
8854512|NCT01773122|9909933|FG003|COMPLETED|Overall Study||18
8854513|NCT01773122|9909930|FG000|NOT COMPLETED|Overall Study||3
8854514|NCT01773122|9909931|FG001|NOT COMPLETED|Overall Study||1
8854515|NCT01773122|9909932|FG002|NOT COMPLETED|Overall Study||0
8854516|NCT01773122|9909933|FG003|NOT COMPLETED|Overall Study||1
8854517|NCT01773135|9909945|FG000|STARTED|Overall Study||262
8854518|NCT01773135|9909945|FG000|COMPLETED|Overall Study||262
8854519|NCT01773135|9909945|FG000|NOT COMPLETED|Overall Study||0
8854520|NCT01773187|9909952|FG000|STARTED|Overall Study||220
8854521|NCT01773187|9909953|FG001|STARTED|Overall Study||107
8854522|NCT01773187|9909952|FG000|COMPLETED|Overall Study||167
8854523|NCT01773187|9909953|FG001|COMPLETED|Overall Study||75
8854524|NCT01773187|9909952|FG000|NOT COMPLETED|Overall Study||53
8854525|NCT01773187|9909953|FG001|NOT COMPLETED|Overall Study||32
8854526|NCT01773226|9909959|FG000|STARTED|Overall Study||11
8854527|NCT01773226|9909959|FG000|COMPLETED|Overall Study|Withdrawal of one subject after one-month assessment due to persistent OA symptoms|10
8854528|NCT01773226|9909959|FG000|NOT COMPLETED|Overall Study||1
8854529|NCT01773291|9909966|FG000|STARTED|Overall Study||8
8854530|NCT01773291|9909967|FG001|STARTED|Overall Study||9
8854531|NCT01773291|9909968|FG002|STARTED|Overall Study||7
8854532|NCT01773291|9909966|FG000|COMPLETED|Overall Study||7
8854533|NCT01773291|9909967|FG001|COMPLETED|Overall Study||9
8854534|NCT01773291|9909968|FG002|COMPLETED|Overall Study||6
8854535|NCT01773291|9909966|FG000|NOT COMPLETED|Overall Study||1
8854536|NCT01773291|9909967|FG001|NOT COMPLETED|Overall Study||0
8694257|NCT00870727|9739690|FG000|NOT COMPLETED|Overall Study||1
8694258|NCT00870727|9739691|FG001|NOT COMPLETED|Overall Study||5
8854537|NCT01773291|9909968|FG002|NOT COMPLETED|Overall Study||1
8854538|NCT01773421|9909981|FG000|STARTED|Treatment Phase||7
8854539|NCT01773421|9909982|FG001|STARTED|Treatment Phase||8
8854540|NCT01773421|9909983|FG002|STARTED|Treatment Phase||19
8854541|NCT01773421|9909984|FG003|STARTED|Treatment Phase||7
8854542|NCT01773421|9909985|FG004|STARTED|Treatment Phase||0
8854543|NCT01773421|9909986|FG005|STARTED|Treatment Phase||0
8854544|NCT01773421|9909987|FG006|STARTED|Treatment Phase||0
8854545|NCT01773421|9909981|FG000|COMPLETED|Treatment Phase||7
8854546|NCT01773421|9909982|FG001|COMPLETED|Treatment Phase||8
8854547|NCT01773421|9909983|FG002|COMPLETED|Treatment Phase||13
8854548|NCT01773421|9909984|FG003|COMPLETED|Treatment Phase||5
8854549|NCT01773421|9909985|FG004|COMPLETED|Treatment Phase||0
8854550|NCT01773421|9909986|FG005|COMPLETED|Treatment Phase||0
8854551|NCT01773421|9909987|FG006|COMPLETED|Treatment Phase||0
8854552|NCT01773421|9909981|FG000|NOT COMPLETED|Treatment Phase||0
8854553|NCT01773421|9909982|FG001|NOT COMPLETED|Treatment Phase||0
8854554|NCT01773421|9909983|FG002|NOT COMPLETED|Treatment Phase||6
8854555|NCT01773421|9909984|FG003|NOT COMPLETED|Treatment Phase||2
8854556|NCT01773421|9909985|FG004|NOT COMPLETED|Treatment Phase||0
8854557|NCT01773421|9909986|FG005|NOT COMPLETED|Treatment Phase||0
8854558|NCT01773421|9909987|FG006|NOT COMPLETED|Treatment Phase||0
8854559|NCT01773421|9909981|FG000|STARTED|Extension Phase||0
8854560|NCT01773421|9909982|FG001|STARTED|Extension Phase||0
8854561|NCT01773421|9909983|FG002|STARTED|Extension Phase||0
8854562|NCT01773421|9909984|FG003|STARTED|Extension Phase||0
8854563|NCT01773421|9909985|FG004|STARTED|Extension Phase||15
8854564|NCT01773421|9909986|FG005|STARTED|Extension Phase||3
8854565|NCT01773421|9909987|FG006|STARTED|Extension Phase||0
8854566|NCT01773421|9909981|FG000|COMPLETED|Extension Phase||0
8854567|NCT01773421|9909982|FG001|COMPLETED|Extension Phase||0
8854568|NCT01773421|9909983|FG002|COMPLETED|Extension Phase||0
8854569|NCT01773421|9909984|FG003|COMPLETED|Extension Phase||0
8854570|NCT01773421|9909985|FG004|COMPLETED|Extension Phase||12
8854571|NCT01773421|9909986|FG005|COMPLETED|Extension Phase||1
8854572|NCT01773421|9909987|FG006|COMPLETED|Extension Phase||0
8854573|NCT01773421|9909981|FG000|NOT COMPLETED|Extension Phase||0
8854574|NCT01773421|9909982|FG001|NOT COMPLETED|Extension Phase||0
8854575|NCT01773421|9909983|FG002|NOT COMPLETED|Extension Phase||0
8629818|NCT00531752|9669552|FG003|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
8854576|NCT01773421|9909984|FG003|NOT COMPLETED|Extension Phase||0
8854577|NCT01773421|9909985|FG004|NOT COMPLETED|Extension Phase||3
8854578|NCT01773421|9909986|FG005|NOT COMPLETED|Extension Phase||2
8854579|NCT01773421|9909987|FG006|NOT COMPLETED|Extension Phase||0
8949237|NCT02436577|10011737|FG001|NOT COMPLETED|Overall Study||1
8949238|NCT02436577|10011738|FG002|NOT COMPLETED|Overall Study||0
8949239|NCT02436577|10011739|FG003|NOT COMPLETED|Overall Study||0
8949240|NCT02436577|10011740|FG004|NOT COMPLETED|Overall Study||0
8949241|NCT02436577|10011741|FG005|NOT COMPLETED|Overall Study||0
8949242|NCT02436668|10011751|FG000|STARTED|Overall Study||213
8949243|NCT02436668|10011752|FG001|STARTED|Overall Study||211
8629819|NCT00531752|9669549|FG000|STARTED|Second Double-blind Intervention Period||11
8949244|NCT02436668|10011751|FG000|COMPLETED|Overall Study||212
8949245|NCT02436668|10011752|FG001|COMPLETED|Overall Study||207
8629820|NCT00531752|9669550|FG001|STARTED|Second Double-blind Intervention Period||13
8629821|NCT00531752|9669551|FG002|STARTED|Second Double-blind Intervention Period||9
8629822|NCT00531752|9669552|FG003|STARTED|Second Double-blind Intervention Period||13
8629823|NCT00531752|9669549|FG000|COMPLETED|Second Double-blind Intervention Period||9
8629824|NCT00531752|9669550|FG001|COMPLETED|Second Double-blind Intervention Period||11
8629825|NCT00531752|9669551|FG002|COMPLETED|Second Double-blind Intervention Period||9
8854580|NCT01773473|9910005|FG000|STARTED|Overall Study||207
8854581|NCT01773473|9910006|FG001|STARTED|Overall Study||196
8854582|NCT01773473|9910005|FG000|Received at Least 1 Dose of Study Drug|Overall Study||207
8854583|NCT01773473|9910006|FG001|Received at Least 1 Dose of Study Drug|Overall Study||196
8854584|NCT01773473|9910005|FG000|COMPLETED|Overall Study||191
8694259|NCT00870740|9739703|FG000|STARTED|Overall Study|number randomized and dosed|86
8854585|NCT01773473|9910006|FG001|COMPLETED|Overall Study||177
8854586|NCT01773473|9910005|FG000|NOT COMPLETED|Overall Study||16
8854587|NCT01773473|9910006|FG001|NOT COMPLETED|Overall Study||19
8854588|NCT01773889|9910012|FG000|STARTED|Overall Study||2
8854589|NCT01773889|9910012|FG000|COMPLETED|Overall Study||0
8854590|NCT01773889|9910012|FG000|NOT COMPLETED|Overall Study||2
8854591|NCT01773954|9910016|FG000|STARTED|Overall Study||40
8854592|NCT01773954|9910016|FG000|COMPLETED|Overall Study||31
8854593|NCT01773954|9910016|FG000|NOT COMPLETED|Overall Study||9
8854594|NCT01773967|9910022|FG000|STARTED|Overall Study||483
8854595|NCT01773967|9910023|FG001|STARTED|Overall Study||488
8854596|NCT01773967|9910022|FG000|COMPLETED|Overall Study||468
8854597|NCT01773967|9910023|FG001|COMPLETED|Overall Study||475
8854598|NCT01773967|9910022|FG000|NOT COMPLETED|Overall Study||15
8854599|NCT01773967|9910023|FG001|NOT COMPLETED|Overall Study||13
8854600|NCT01773993|9910029|FG000|STARTED|Overall Study||534
8854601|NCT01773993|9910029|FG000|COMPLETED|Overall Study|Number of participants whose survey form were collected and included in analyses is shown.|499
8854602|NCT01773993|9910029|FG000|NOT COMPLETED|Overall Study||35
8854603|NCT01774045|9910035|FG000|STARTED|Overall Study||23
8854604|NCT01774045|9910036|FG001|STARTED|Overall Study||7
8854605|NCT01774045|9910035|FG000|COMPLETED|Overall Study||23
8854606|NCT01774045|9910036|FG001|COMPLETED|Overall Study||7
8854607|NCT01774045|9910035|FG000|NOT COMPLETED|Overall Study||0
8854608|NCT01774045|9910036|FG001|NOT COMPLETED|Overall Study||0
8854609|NCT01774084|9910045|FG000|STARTED|Overall Study||11
8854610|NCT01774084|9910046|FG001|STARTED|Overall Study||12
8854611|NCT01774084|9910045|FG000|COMPLETED|Overall Study||10
8854612|NCT01774084|9910046|FG001|COMPLETED|Overall Study||12
8854613|NCT01774084|9910045|FG000|NOT COMPLETED|Overall Study||1
8854614|NCT01774084|9910046|FG001|NOT COMPLETED|Overall Study||0
8854615|NCT01774097|9910054|FG000|STARTED|Overall Study||40
8854616|NCT01774097|9910055|FG001|STARTED|Overall Study||42
8854617|NCT01774097|9910054|FG000|COMPLETED|Overall Study||38
8854618|NCT01774097|9910055|FG001|COMPLETED|Overall Study||40
8854619|NCT01774097|9910054|FG000|NOT COMPLETED|Overall Study||2
8854620|NCT01774097|9910055|FG001|NOT COMPLETED|Overall Study||2
8854621|NCT01774110|9910063|FG000|STARTED|Overall Study||12
8854622|NCT01774110|9910063|FG000|COMPLETED|Overall Study||5
8854623|NCT01774110|9910063|FG000|NOT COMPLETED|Overall Study||7
8854624|NCT01774149|9910070|FG000|STARTED|Overall Study||15
8854625|NCT01774149|9910071|FG001|STARTED|Overall Study||15
8854626|NCT01774149|9910070|FG000|COMPLETED|Overall Study||14
8854627|NCT01774149|9910071|FG001|COMPLETED|Overall Study||12
8854628|NCT01774149|9910070|FG000|NOT COMPLETED|Overall Study||1
8854629|NCT01774149|9910071|FG001|NOT COMPLETED|Overall Study||3
8854630|NCT01774305|9910079|FG000|STARTED|Overall Study||71
8854631|NCT01774305|9910080|FG001|STARTED|Overall Study||71
8854632|NCT01774305|9910079|FG000|COMPLETED|Overall Study||70
8854633|NCT01774305|9910080|FG001|COMPLETED|Overall Study||71
8854634|NCT01774305|9910079|FG000|NOT COMPLETED|Overall Study||1
8854635|NCT01774305|9910080|FG001|NOT COMPLETED|Overall Study||0
8854636|NCT01774344|9910088|FG000|STARTED|Overall Study||194
8854637|NCT01774344|9910089|FG001|STARTED|Overall Study||379
8854638|NCT01774344|9910088|FG000|Treated|Overall Study||193
8854639|NCT01774344|9910089|FG001|Treated|Overall Study||374
8854640|NCT01774344|9910088|FG000|Entered Survival FU|Overall Study||145
8854641|NCT01774344|9910089|FG001|Entered Survival FU|Overall Study||291
8854642|NCT01774344|9910088|FG000|COMPLETED|Overall Study||132
8854643|NCT01774344|9910089|FG001|COMPLETED|Overall Study||258
8854644|NCT01774344|9910088|FG000|NOT COMPLETED|Overall Study||62
8854645|NCT01774344|9910089|FG001|NOT COMPLETED|Overall Study||121
8854646|NCT01774591|9910097|FG000|STARTED|Overall Study||10
8854647|NCT01774591|9910098|FG001|STARTED|Overall Study||11
8854648|NCT01774591|9910097|FG000|COMPLETED|Overall Study||9
8854649|NCT01774591|9910098|FG001|COMPLETED|Overall Study||7
8854650|NCT01774591|9910097|FG000|NOT COMPLETED|Overall Study||1
8854651|NCT01774591|9910098|FG001|NOT COMPLETED|Overall Study||4
8854652|NCT01774604|9910106|FG000|STARTED|Overall Study||223
8854653|NCT01774604|9910107|FG001|STARTED|Overall Study||226
8854654|NCT01774604|9910106|FG000|COMPLETED|Overall Study||223
8854655|NCT01774604|9910107|FG001|COMPLETED|Overall Study||226
8854656|NCT01774604|9910106|FG000|NOT COMPLETED|Overall Study||0
8854657|NCT01774604|9910107|FG001|NOT COMPLETED|Overall Study||0
8854658|NCT01774760|9910113|FG000|STARTED|Overall Study||10
8854659|NCT01774760|9910113|FG000|COMPLETED|Overall Study||10
8854660|NCT01774760|9910113|FG000|NOT COMPLETED|Overall Study||0
8854661|NCT01774786|9910119|FG000|STARTED|Overall Study||388
8854662|NCT01774786|9910120|FG001|STARTED|Overall Study||392
8854663|NCT01774786|9910119|FG000|Did Not Receive Any Study Treatment|Overall Study|2 patients found ineligible after enrollment and 2 patients died before treatment.|4
8854664|NCT01774786|9910120|FG001|Did Not Receive Any Study Treatment|Overall Study|All 3 patients found ineligible for the study after enrollment and before treatment.|3
8854665|NCT01774786|9910119|FG000|Received at Least One Dose of Pertuzumab|Overall Study||384
8854666|NCT01774786|9910120|FG001|Received at Least One Dose of Pertuzumab|Overall Study|One participant randomized to placebo arm received 1 dose of pertuzumab by error.|1
8949246|NCT02436668|10011751|FG000|NOT COMPLETED|Overall Study||1
8854667|NCT01774786|9910119|FG000|Received Placebo (No Pertuzumab)|Overall Study||0
8854668|NCT01774786|9910120|FG001|Received Placebo (No Pertuzumab)|Overall Study||388
8854669|NCT01774786|9910119|FG000|COMPLETED|Overall Study||60
8854670|NCT01774786|9910120|FG001|COMPLETED|Overall Study||46
8854671|NCT01774786|9910119|FG000|NOT COMPLETED|Overall Study||328
8854672|NCT01774786|9910120|FG001|NOT COMPLETED|Overall Study||346
8854673|NCT01774799|9910130|FG000|STARTED|Overall Study||212
8854674|NCT01774799|9910131|FG001|STARTED|Overall Study||190
8854675|NCT01774799|9910132|FG002|STARTED|Overall Study||212
8854676|NCT01774799|9910133|FG003|STARTED|Overall Study||190
8854677|NCT01774799|9910130|FG000|COMPLETED|Overall Study||211
8854678|NCT01774799|9910131|FG001|COMPLETED|Overall Study||189
8854679|NCT01774799|9910132|FG002|COMPLETED|Overall Study||212
8854680|NCT01774799|9910133|FG003|COMPLETED|Overall Study||190
8854681|NCT01774799|9910130|FG000|NOT COMPLETED|Overall Study||1
8854682|NCT01774799|9910131|FG001|NOT COMPLETED|Overall Study||1
8854683|NCT01774799|9910132|FG002|NOT COMPLETED|Overall Study||0
8854684|NCT01774799|9910133|FG003|NOT COMPLETED|Overall Study||0
8854685|NCT01774851|9910141|FG000|STARTED|Overall Study||42
8854686|NCT01774851|9910142|FG001|STARTED|Overall Study||42
8854687|NCT01774851|9910141|FG000|COMPLETED|Overall Study||42
8854688|NCT01774851|9910142|FG001|COMPLETED|Overall Study||42
8854689|NCT01774851|9910141|FG000|NOT COMPLETED|Overall Study||0
8854690|NCT01774851|9910142|FG001|NOT COMPLETED|Overall Study||0
8854691|NCT01774903|9910148|FG000|STARTED|Overall Study||45
8854692|NCT01774903|9910148|FG000|COMPLETED|Overall Study||34
8854693|NCT01774903|9910148|FG000|NOT COMPLETED|Overall Study||11
8854694|NCT01774929|9910153|FG000|STARTED|Overall Study||35
8854695|NCT01774929|9910153|FG000|COMPLETED|Overall Study||32
8854696|NCT01774929|9910153|FG000|NOT COMPLETED|Overall Study||3
8854697|NCT01774968|9910159|FG000|STARTED|Overall Study||162
8854698|NCT01774968|9910160|FG001|STARTED|Overall Study||163
8854699|NCT01774968|9910159|FG000|Received at Least 1 Dose of Study Drug|Overall Study||162
8854700|NCT01774968|9910160|FG001|Received at Least 1 Dose of Study Drug|Overall Study||161
8854701|NCT01774968|9910159|FG000|COMPLETED|Overall Study||132
8854702|NCT01774968|9910160|FG001|COMPLETED|Overall Study||128
8854703|NCT01774968|9910159|FG000|NOT COMPLETED|Overall Study||30
8854704|NCT01774968|9910160|FG001|NOT COMPLETED|Overall Study||35
8854705|NCT01774981|9910174|FG000|STARTED|Overall Study||3
8854706|NCT01774981|9910175|FG001|STARTED|Overall Study||4
8854707|NCT01774981|9910176|FG002|STARTED|Overall Study||4
8854708|NCT01774981|9910177|FG003|STARTED|Overall Study||4
8854709|NCT01774981|9910178|FG004|STARTED|Overall Study||6
8854710|NCT01774981|9910179|FG005|STARTED|Overall Study||14
8854711|NCT01774981|9910180|FG006|STARTED|Overall Study||13
8854712|NCT01774981|9910181|FG007|STARTED|Overall Study||12
8854713|NCT01774981|9910174|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
8854714|NCT01774981|9910175|FG001|Received at Least 1 Dose of Study Drug|Overall Study||4
8854715|NCT01774981|9910176|FG002|Received at Least 1 Dose of Study Drug|Overall Study||4
8854716|NCT01774981|9910177|FG003|Received at Least 1 Dose of Study Drug|Overall Study||4
8854717|NCT01774981|9910178|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6
8854718|NCT01774981|9910179|FG005|Received at Least 1 Dose of Study Drug|Overall Study||14
8854719|NCT01774981|9910180|FG006|Received at Least 1 Dose of Study Drug|Overall Study||13
8854720|NCT01774981|9910181|FG007|Received at Least 1 Dose of Study Drug|Overall Study||12
8854721|NCT01774981|9910174|FG000|COMPLETED|Overall Study||3
8854722|NCT01774981|9910175|FG001|COMPLETED|Overall Study||4
8854723|NCT01774981|9910176|FG002|COMPLETED|Overall Study||4
8854724|NCT01774981|9910177|FG003|COMPLETED|Overall Study||4
8854725|NCT01774981|9910178|FG004|COMPLETED|Overall Study||5
8854726|NCT01774981|9910179|FG005|COMPLETED|Overall Study||13
8854727|NCT01774981|9910180|FG006|COMPLETED|Overall Study||13
8854728|NCT01774981|9910181|FG007|COMPLETED|Overall Study||11
8854729|NCT01774981|9910174|FG000|NOT COMPLETED|Overall Study||0
8854730|NCT01774981|9910175|FG001|NOT COMPLETED|Overall Study||0
8854731|NCT01774981|9910176|FG002|NOT COMPLETED|Overall Study||0
8854732|NCT01774981|9910177|FG003|NOT COMPLETED|Overall Study||0
8854733|NCT01774981|9910178|FG004|NOT COMPLETED|Overall Study||1
8854734|NCT01774981|9910179|FG005|NOT COMPLETED|Overall Study||1
8854735|NCT01774981|9910180|FG006|NOT COMPLETED|Overall Study||0
8854736|NCT01774981|9910181|FG007|NOT COMPLETED|Overall Study||1
8854737|NCT01775124|9910206|FG000|STARTED|Core Period||168
8854738|NCT01775124|9910207|FG001|STARTED|Core Period||166
8854739|NCT01775124|9910206|FG000|Full Analysis Set|Core Period||167
8629826|NCT00531752|9669552|FG003|COMPLETED|Second Double-blind Intervention Period||11
8629827|NCT00531752|9669549|FG000|NOT COMPLETED|Second Double-blind Intervention Period||2
8854740|NCT01775124|9910207|FG001|Full Analysis Set|Core Period||166
8854741|NCT01775124|9910206|FG000|Per Protocol Set|Core Period||157
8854742|NCT01775124|9910207|FG001|Per Protocol Set|Core Period||155
8854743|NCT01775124|9910206|FG000|Safety Set|Core Period|1 patient was mis-randomized & 1 patient discontinued due to AE. No treatment given|166
8854744|NCT01775124|9910207|FG001|Safety Set|Core Period||166
8854745|NCT01775124|9910206|FG000|COMPLETED|Core Period||157
8854746|NCT01775124|9910207|FG001|COMPLETED|Core Period||156
8854747|NCT01775124|9910206|FG000|NOT COMPLETED|Core Period||11
8854748|NCT01775124|9910207|FG001|NOT COMPLETED|Core Period||10
8854749|NCT01775124|9910206|FG000|STARTED|Extension Period||157
8854750|NCT01775124|9910207|FG001|STARTED|Extension Period||156
8854751|NCT01775124|9910206|FG000|COMPLETED|Extension Period||145
8854752|NCT01775124|9910207|FG001|COMPLETED|Extension Period||138
8854753|NCT01775124|9910206|FG000|NOT COMPLETED|Extension Period||12
8854754|NCT01775124|9910207|FG001|NOT COMPLETED|Extension Period||18
8854755|NCT01775137|9910214|FG000|STARTED|Overall Study||45
8854756|NCT01775137|9910214|FG000|COMPLETED|Overall Study||34
8854757|NCT01775137|9910214|FG000|NOT COMPLETED|Overall Study||11
8854758|NCT01775189|9910221|FG000|STARTED|Naloxone Challenge Phase||45
8854759|NCT01775189|9910222|FG001|STARTED|Naloxone Challenge Phase||0
8854760|NCT01775189|9910223|FG002|STARTED|Naloxone Challenge Phase||0
8854761|NCT01775189|9910224|FG003|STARTED|Naloxone Challenge Phase||0
8854762|NCT01775189|9910225|FG004|STARTED|Naloxone Challenge Phase||0
8854763|NCT01775189|9910226|FG005|STARTED|Naloxone Challenge Phase||0
8854764|NCT01775189|9910227|FG006|STARTED|Naloxone Challenge Phase||0
8854765|NCT01775189|9910221|FG000|COMPLETED|Naloxone Challenge Phase||45
8854766|NCT01775189|9910222|FG001|COMPLETED|Naloxone Challenge Phase||0
8854767|NCT01775189|9910223|FG002|COMPLETED|Naloxone Challenge Phase||0
8854768|NCT01775189|9910224|FG003|COMPLETED|Naloxone Challenge Phase||0
8854769|NCT01775189|9910225|FG004|COMPLETED|Naloxone Challenge Phase||0
8854770|NCT01775189|9910226|FG005|COMPLETED|Naloxone Challenge Phase||0
8854771|NCT01775189|9910227|FG006|COMPLETED|Naloxone Challenge Phase||0
8854772|NCT01775189|9910221|FG000|NOT COMPLETED|Naloxone Challenge Phase||0
8854773|NCT01775189|9910222|FG001|NOT COMPLETED|Naloxone Challenge Phase||0
8854774|NCT01775189|9910223|FG002|NOT COMPLETED|Naloxone Challenge Phase||0
8854775|NCT01775189|9910224|FG003|NOT COMPLETED|Naloxone Challenge Phase||0
8854776|NCT01775189|9910225|FG004|NOT COMPLETED|Naloxone Challenge Phase||0
8854777|NCT01775189|9910226|FG005|NOT COMPLETED|Naloxone Challenge Phase||0
8694260|NCT00870740|9739704|FG001|STARTED|Overall Study|number randomized and dosed|84
8694261|NCT00870740|9739705|FG002|STARTED|Overall Study|number randomized and dosed|86
8694262|NCT00870740|9739706|FG003|STARTED|Overall Study|number randomized and dosed|86
8694263|NCT00870740|9739707|FG004|STARTED|Overall Study|number randomized and dosed|88
8694264|NCT00870740|9739708|FG005|STARTED|Overall Study|number randomized and dosed|87
8694265|NCT00870740|9739703|FG000|COMPLETED|Overall Study||74
8694266|NCT00870740|9739704|FG001|COMPLETED|Overall Study||75
8694267|NCT00870740|9739705|FG002|COMPLETED|Overall Study||76
8854778|NCT01775189|9910227|FG006|NOT COMPLETED|Naloxone Challenge Phase||0
8854779|NCT01775189|9910221|FG000|STARTED|Drug Discrimination Phase: Day 1||0
8854780|NCT01775189|9910222|FG001|STARTED|Drug Discrimination Phase: Day 1||22
8854781|NCT01775189|9910223|FG002|STARTED|Drug Discrimination Phase: Day 1||23
8854782|NCT01775189|9910224|FG003|STARTED|Drug Discrimination Phase: Day 1||0
8854783|NCT01775189|9910225|FG004|STARTED|Drug Discrimination Phase: Day 1||0
8854784|NCT01775189|9910226|FG005|STARTED|Drug Discrimination Phase: Day 1||0
8854785|NCT01775189|9910227|FG006|STARTED|Drug Discrimination Phase: Day 1||0
8854786|NCT01775189|9910221|FG000|COMPLETED|Drug Discrimination Phase: Day 1||0
8854787|NCT01775189|9910222|FG001|COMPLETED|Drug Discrimination Phase: Day 1||19
8854788|NCT01775189|9910223|FG002|COMPLETED|Drug Discrimination Phase: Day 1||23
8854789|NCT01775189|9910224|FG003|COMPLETED|Drug Discrimination Phase: Day 1||0
8854790|NCT01775189|9910225|FG004|COMPLETED|Drug Discrimination Phase: Day 1||0
8854791|NCT01775189|9910226|FG005|COMPLETED|Drug Discrimination Phase: Day 1||0
8949247|NCT02436668|10011752|FG001|NOT COMPLETED|Overall Study||4
8949248|NCT02436681|10011761|FG000|STARTED|Overall Study||41
8949249|NCT02436681|10011761|FG000|COMPLETED|Overall Study||27
8949250|NCT02436681|10011761|FG000|NOT COMPLETED|Overall Study||14
8949251|NCT02436759|10011767|FG000|STARTED|Overall Study||94
8949252|NCT02436759|10011768|FG001|STARTED|Overall Study||46
8949253|NCT02436759|10011767|FG000|Subjects Randomized|Overall Study||94
8949254|NCT02436759|10011768|FG001|Subjects Randomized|Overall Study||46
8949255|NCT02436759|10011767|FG000|Subjects Treated|Overall Study||94
8949256|NCT02436759|10011768|FG001|Subjects Treated|Overall Study||46
8949257|NCT02436759|10011767|FG000|COMPLETED|Overall Study||90
8949258|NCT02436759|10011768|FG001|COMPLETED|Overall Study||45
8949259|NCT02436759|10011767|FG000|NOT COMPLETED|Overall Study||4
8949260|NCT02436759|10011768|FG001|NOT COMPLETED|Overall Study||1
8949261|NCT02436811|10011777|FG000|STARTED|Overall Study||60
8949262|NCT02436811|10011778|FG001|STARTED|Overall Study||60
8949263|NCT02436811|10011779|FG002|STARTED|Overall Study||60
8949264|NCT02436811|10011777|FG000|COMPLETED|Overall Study||58
8949265|NCT02436811|10011778|FG001|COMPLETED|Overall Study||51
8949266|NCT02436811|10011779|FG002|COMPLETED|Overall Study||53
8949267|NCT02436811|10011777|FG000|NOT COMPLETED|Overall Study||2
8949268|NCT02436811|10011778|FG001|NOT COMPLETED|Overall Study||9
8949269|NCT02436811|10011779|FG002|NOT COMPLETED|Overall Study||7
8949270|NCT02436876|10011791|FG000|STARTED|Overall Study||6
8694268|NCT00870740|9739706|FG003|COMPLETED|Overall Study||74
8949271|NCT02436876|10011792|FG001|STARTED|Overall Study||9
8949272|NCT02436876|10011793|FG002|STARTED|Overall Study||7
8949273|NCT02436876|10011794|FG003|STARTED|Overall Study||7
8694269|NCT00870740|9739707|FG004|COMPLETED|Overall Study||77
8854792|NCT01775189|9910227|FG006|COMPLETED|Drug Discrimination Phase: Day 1||0
8854793|NCT01775189|9910221|FG000|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
8854794|NCT01775189|9910222|FG001|NOT COMPLETED|Drug Discrimination Phase: Day 1||3
8854795|NCT01775189|9910223|FG002|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
8854796|NCT01775189|9910224|FG003|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
8854797|NCT01775189|9910225|FG004|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
8854798|NCT01775189|9910226|FG005|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
8854799|NCT01775189|9910227|FG006|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
8854800|NCT01775189|9910221|FG000|STARTED|Drug Discrimination Phase: Day 2||0
8854801|NCT01775189|9910222|FG001|STARTED|Drug Discrimination Phase: Day 2||19
8854802|NCT01775189|9910223|FG002|STARTED|Drug Discrimination Phase: Day 2||23
8854803|NCT01775189|9910224|FG003|STARTED|Drug Discrimination Phase: Day 2||0
8854804|NCT01775189|9910225|FG004|STARTED|Drug Discrimination Phase: Day 2||0
8854805|NCT01775189|9910226|FG005|STARTED|Drug Discrimination Phase: Day 2||0
8854806|NCT01775189|9910227|FG006|STARTED|Drug Discrimination Phase: Day 2||0
8854807|NCT01775189|9910221|FG000|COMPLETED|Drug Discrimination Phase: Day 2||0
8854808|NCT01775189|9910222|FG001|COMPLETED|Drug Discrimination Phase: Day 2||16
8854809|NCT01775189|9910223|FG002|COMPLETED|Drug Discrimination Phase: Day 2||16
8854810|NCT01775189|9910224|FG003|COMPLETED|Drug Discrimination Phase: Day 2||0
8854811|NCT01775189|9910225|FG004|COMPLETED|Drug Discrimination Phase: Day 2||0
8854812|NCT01775189|9910226|FG005|COMPLETED|Drug Discrimination Phase: Day 2||0
8854813|NCT01775189|9910227|FG006|COMPLETED|Drug Discrimination Phase: Day 2||0
8854814|NCT01775189|9910221|FG000|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
8694270|NCT00870740|9739708|FG005|COMPLETED|Overall Study||70
8694271|NCT00870740|9739703|FG000|NOT COMPLETED|Overall Study||12
8694272|NCT00870740|9739704|FG001|NOT COMPLETED|Overall Study||9
8694273|NCT00870740|9739705|FG002|NOT COMPLETED|Overall Study||10
8694274|NCT00870740|9739706|FG003|NOT COMPLETED|Overall Study||12
8854815|NCT01775189|9910222|FG001|NOT COMPLETED|Drug Discrimination Phase: Day 2||3
8854816|NCT01775189|9910223|FG002|NOT COMPLETED|Drug Discrimination Phase: Day 2||7
8854817|NCT01775189|9910224|FG003|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
8854818|NCT01775189|9910225|FG004|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
8854819|NCT01775189|9910226|FG005|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
8854820|NCT01775189|9910227|FG006|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
8854821|NCT01775189|9910221|FG000|STARTED|Treatment Phase: First Intervention||0
8854822|NCT01775189|9910222|FG001|STARTED|Treatment Phase: First Intervention||0
8854823|NCT01775189|9910223|FG002|STARTED|Treatment Phase: First Intervention||0
8854824|NCT01775189|9910224|FG003|STARTED|Treatment Phase: First Intervention||8
8854825|NCT01775189|9910225|FG004|STARTED|Treatment Phase: First Intervention||8
8854826|NCT01775189|9910226|FG005|STARTED|Treatment Phase: First Intervention||8
8854827|NCT01775189|9910227|FG006|STARTED|Treatment Phase: First Intervention||8
8854828|NCT01775189|9910221|FG000|COMPLETED|Treatment Phase: First Intervention||0
8854829|NCT01775189|9910222|FG001|COMPLETED|Treatment Phase: First Intervention||0
8854830|NCT01775189|9910223|FG002|COMPLETED|Treatment Phase: First Intervention||0
8854831|NCT01775189|9910224|FG003|COMPLETED|Treatment Phase: First Intervention||8
8854832|NCT01775189|9910225|FG004|COMPLETED|Treatment Phase: First Intervention||8
8854833|NCT01775189|9910226|FG005|COMPLETED|Treatment Phase: First Intervention||8
8854834|NCT01775189|9910227|FG006|COMPLETED|Treatment Phase: First Intervention||8
8854835|NCT01775189|9910221|FG000|NOT COMPLETED|Treatment Phase: First Intervention||0
8854836|NCT01775189|9910222|FG001|NOT COMPLETED|Treatment Phase: First Intervention||0
8854837|NCT01775189|9910223|FG002|NOT COMPLETED|Treatment Phase: First Intervention||0
8854838|NCT01775189|9910224|FG003|NOT COMPLETED|Treatment Phase: First Intervention||0
8854839|NCT01775189|9910225|FG004|NOT COMPLETED|Treatment Phase: First Intervention||0
8854840|NCT01775189|9910226|FG005|NOT COMPLETED|Treatment Phase: First Intervention||0
8854841|NCT01775189|9910227|FG006|NOT COMPLETED|Treatment Phase: First Intervention||0
8854842|NCT01775189|9910221|FG000|STARTED|Treatment Phase: Washout Period 1||0
8949274|NCT02436876|10011791|FG000|Treated|Overall Study||6
8949275|NCT02436876|10011792|FG001|Treated|Overall Study||6
8949276|NCT02436876|10011793|FG002|Treated|Overall Study||6
8949277|NCT02436876|10011794|FG003|Treated|Overall Study||7
8949278|NCT02436876|10011791|FG000|COMPLETED|Overall Study||5
8949279|NCT02436876|10011792|FG001|COMPLETED|Overall Study||5
8949280|NCT02436876|10011793|FG002|COMPLETED|Overall Study||5
8949281|NCT02436876|10011794|FG003|COMPLETED|Overall Study||5
8949282|NCT02436876|10011791|FG000|NOT COMPLETED|Overall Study||1
8694275|NCT00870740|9739707|FG004|NOT COMPLETED|Overall Study||11
8694276|NCT00870740|9739708|FG005|NOT COMPLETED|Overall Study||17
8854843|NCT01775189|9910222|FG001|STARTED|Treatment Phase: Washout Period 1||0
8854844|NCT01775189|9910223|FG002|STARTED|Treatment Phase: Washout Period 1||0
8854845|NCT01775189|9910224|FG003|STARTED|Treatment Phase: Washout Period 1||8
8854846|NCT01775189|9910225|FG004|STARTED|Treatment Phase: Washout Period 1||8
8854847|NCT01775189|9910226|FG005|STARTED|Treatment Phase: Washout Period 1||8
8629828|NCT00531752|9669550|FG001|NOT COMPLETED|Second Double-blind Intervention Period||2
8629829|NCT00531752|9669551|FG002|NOT COMPLETED|Second Double-blind Intervention Period||0
8854848|NCT01775189|9910227|FG006|STARTED|Treatment Phase: Washout Period 1||8
8854849|NCT01775189|9910221|FG000|COMPLETED|Treatment Phase: Washout Period 1||0
8854850|NCT01775189|9910222|FG001|COMPLETED|Treatment Phase: Washout Period 1||0
8854851|NCT01775189|9910223|FG002|COMPLETED|Treatment Phase: Washout Period 1||0
8854852|NCT01775189|9910224|FG003|COMPLETED|Treatment Phase: Washout Period 1||8
8854853|NCT01775189|9910225|FG004|COMPLETED|Treatment Phase: Washout Period 1||8
8854854|NCT01775189|9910226|FG005|COMPLETED|Treatment Phase: Washout Period 1||7
8854855|NCT01775189|9910227|FG006|COMPLETED|Treatment Phase: Washout Period 1||8
8725204|NCT01029730|9772406|FG000|STARTED|Combination Therapy||55
8725205|NCT01029730|9772406|FG000|COMPLETED|Combination Therapy|Patients remained on-study until completing 6 cycles or coming off-treatment for any other reason|39
8725206|NCT01029730|9772406|FG000|NOT COMPLETED|Combination Therapy||16
8725207|NCT01029730|9772406|FG000|STARTED|Maintenance Therapy|Two patients complete study treatment but declined subsequent maintenance therapy|37
8725208|NCT01029730|9772406|FG000|COMPLETED|Maintenance Therapy||14
8725209|NCT01029730|9772406|FG000|NOT COMPLETED|Maintenance Therapy||23
8854856|NCT01775189|9910221|FG000|NOT COMPLETED|Treatment Phase: Washout Period 1||0
8854857|NCT01775189|9910222|FG001|NOT COMPLETED|Treatment Phase: Washout Period 1||0
8854858|NCT01775189|9910223|FG002|NOT COMPLETED|Treatment Phase: Washout Period 1||0
8854859|NCT01775189|9910224|FG003|NOT COMPLETED|Treatment Phase: Washout Period 1||0
8854860|NCT01775189|9910225|FG004|NOT COMPLETED|Treatment Phase: Washout Period 1||0
8854861|NCT01775189|9910226|FG005|NOT COMPLETED|Treatment Phase: Washout Period 1||1
8854862|NCT01775189|9910227|FG006|NOT COMPLETED|Treatment Phase: Washout Period 1||0
8854863|NCT01775189|9910221|FG000|STARTED|Treatment Phase: Second Intervention||0
8854864|NCT01775189|9910222|FG001|STARTED|Treatment Phase: Second Intervention||0
8854865|NCT01775189|9910223|FG002|STARTED|Treatment Phase: Second Intervention||0
8854866|NCT01775189|9910224|FG003|STARTED|Treatment Phase: Second Intervention||8
8854867|NCT01775189|9910225|FG004|STARTED|Treatment Phase: Second Intervention||8
8854868|NCT01775189|9910226|FG005|STARTED|Treatment Phase: Second Intervention||7
8854869|NCT01775189|9910227|FG006|STARTED|Treatment Phase: Second Intervention||8
8854870|NCT01775189|9910221|FG000|COMPLETED|Treatment Phase: Second Intervention||0
8854871|NCT01775189|9910222|FG001|COMPLETED|Treatment Phase: Second Intervention||0
8854872|NCT01775189|9910223|FG002|COMPLETED|Treatment Phase: Second Intervention||0
8854873|NCT01775189|9910224|FG003|COMPLETED|Treatment Phase: Second Intervention||8
8854874|NCT01775189|9910225|FG004|COMPLETED|Treatment Phase: Second Intervention||8
8854875|NCT01775189|9910226|FG005|COMPLETED|Treatment Phase: Second Intervention||7
8854876|NCT01775189|9910227|FG006|COMPLETED|Treatment Phase: Second Intervention||8
8629830|NCT00531752|9669552|FG003|NOT COMPLETED|Second Double-blind Intervention Period||2
8629831|NCT00531817|9669562|FG000|STARTED|Randomized||412
8629832|NCT00531817|9669563|FG001|STARTED|Randomized||207
8629833|NCT00531817|9669562|FG000|Received Study Drug in Core Study|Randomized|3 patients did not receive any study medication. Intent-to-treat population = 409.|409
8629834|NCT00531817|9669563|FG001|Received Study Drug in Core Study|Randomized|2 patients did not receive any study medication. Intent-to-treat population = 205.|205
8629835|NCT00531817|9669562|FG000|COMPLETED|Randomized||353
8629836|NCT00531817|9669563|FG001|COMPLETED|Randomized||173
8629837|NCT00531817|9669562|FG000|NOT COMPLETED|Randomized||59
8629838|NCT00531817|9669563|FG001|NOT COMPLETED|Randomized||34
8629839|NCT00531817|9669562|FG000|STARTED|Entered Extended Treatment Period|Eligible patients completing core study could participate in extension at investigator's discretion.|343
8629840|NCT00531817|9669563|FG001|STARTED|Entered Extended Treatment Period|Eligible patients completing core study could participate in extension at investigator's discretion.|170
8629841|NCT00531817|9669562|FG000|COMPLETED|Entered Extended Treatment Period||206
8629842|NCT00531817|9669563|FG001|COMPLETED|Entered Extended Treatment Period||113
8629843|NCT00531817|9669562|FG000|NOT COMPLETED|Entered Extended Treatment Period||137
8629844|NCT00531817|9669563|FG001|NOT COMPLETED|Entered Extended Treatment Period||57
8629845|NCT00531843|9669572|FG000|STARTED|Overall Study||81
8629846|NCT00531843|9669573|FG001|STARTED|Overall Study||6
8629847|NCT00531843|9669572|FG000|COMPLETED|Overall Study||81
8629848|NCT00531843|9669573|FG001|COMPLETED|Overall Study||6
8629849|NCT00531843|9669572|FG000|NOT COMPLETED|Overall Study||0
8629850|NCT00531843|9669573|FG001|NOT COMPLETED|Overall Study||0
8629851|NCT00531882|9669582|FG000|STARTED|Overall Study||10
8629852|NCT00531882|9669583|FG001|STARTED|Overall Study||10
8629853|NCT00531882|9669584|FG002|STARTED|Overall Study||5
8629854|NCT00531882|9669582|FG000|COMPLETED|Overall Study||10
8629855|NCT00531882|9669583|FG001|COMPLETED|Overall Study||10
8629856|NCT00531882|9669584|FG002|COMPLETED|Overall Study||5
8725210|NCT01029782|9772412|FG000|STARTED|Overall Study||102
8725211|NCT01029782|9772413|FG001|STARTED|Overall Study||104
8854877|NCT01775189|9910221|FG000|NOT COMPLETED|Treatment Phase: Second Intervention||0
8854878|NCT01775189|9910222|FG001|NOT COMPLETED|Treatment Phase: Second Intervention||0
8854879|NCT01775189|9910223|FG002|NOT COMPLETED|Treatment Phase: Second Intervention||0
8854880|NCT01775189|9910224|FG003|NOT COMPLETED|Treatment Phase: Second Intervention||0
8854881|NCT01775189|9910225|FG004|NOT COMPLETED|Treatment Phase: Second Intervention||0
8854882|NCT01775189|9910226|FG005|NOT COMPLETED|Treatment Phase: Second Intervention||0
8854883|NCT01775189|9910227|FG006|NOT COMPLETED|Treatment Phase: Second Intervention||0
8854884|NCT01775189|9910221|FG000|STARTED|Treatment Phase: Washout Period 2||0
8854885|NCT01775189|9910222|FG001|STARTED|Treatment Phase: Washout Period 2||0
8854886|NCT01775189|9910223|FG002|STARTED|Treatment Phase: Washout Period 2||0
8854887|NCT01775189|9910224|FG003|STARTED|Treatment Phase: Washout Period 2||8
8854888|NCT01775189|9910225|FG004|STARTED|Treatment Phase: Washout Period 2||8
8854889|NCT01775189|9910226|FG005|STARTED|Treatment Phase: Washout Period 2||7
8854890|NCT01775189|9910227|FG006|STARTED|Treatment Phase: Washout Period 2||8
8854891|NCT01775189|9910221|FG000|COMPLETED|Treatment Phase: Washout Period 2||0
8854892|NCT01775189|9910222|FG001|COMPLETED|Treatment Phase: Washout Period 2||0
8854893|NCT01775189|9910223|FG002|COMPLETED|Treatment Phase: Washout Period 2||0
8854894|NCT01775189|9910224|FG003|COMPLETED|Treatment Phase: Washout Period 2||7
8854895|NCT01775189|9910225|FG004|COMPLETED|Treatment Phase: Washout Period 2||8
8854896|NCT01775189|9910226|FG005|COMPLETED|Treatment Phase: Washout Period 2||7
8854897|NCT01775189|9910227|FG006|COMPLETED|Treatment Phase: Washout Period 2||8
8949283|NCT02436876|10011792|FG001|NOT COMPLETED|Overall Study||4
8949284|NCT02436876|10011793|FG002|NOT COMPLETED|Overall Study||2
8949285|NCT02436876|10011794|FG003|NOT COMPLETED|Overall Study||2
8949286|NCT02436889|10011811|FG000|STARTED|Overall Study||12
8949287|NCT02436889|10011812|FG001|STARTED|Overall Study||11
8949288|NCT02436889|10011811|FG000|COMPLETED|Overall Study||11
8949289|NCT02436889|10011812|FG001|COMPLETED|Overall Study||10
8949290|NCT02436889|10011811|FG000|NOT COMPLETED|Overall Study||1
8949291|NCT02436889|10011812|FG001|NOT COMPLETED|Overall Study||1
8949292|NCT02436915|10011820|FG000|STARTED|Overall Study||9
8949293|NCT02436915|10011821|FG001|STARTED|Overall Study||10
8949294|NCT02436915|10011820|FG000|COMPLETED|Overall Study||9
8949295|NCT02436915|10011821|FG001|COMPLETED|Overall Study||9
8949296|NCT02436915|10011820|FG000|NOT COMPLETED|Overall Study||0
8949297|NCT02436915|10011821|FG001|NOT COMPLETED|Overall Study||1
8949298|NCT02437084|10011829|FG000|STARTED|Overall Study||75
8949299|NCT02437084|10011829|FG000|COMPLETED|Overall Study||72
8949300|NCT02437084|10011829|FG000|NOT COMPLETED|Overall Study||3
8949301|NCT02437162|10011836|FG000|STARTED|Overall Study||116
8949302|NCT02437162|10011837|FG001|STARTED|Overall Study||116
8949303|NCT02437162|10011838|FG002|STARTED|Overall Study||115
8949304|NCT02437162|10011836|FG000|Treated|Overall Study||116
8949305|NCT02437162|10011837|FG001|Treated|Overall Study||116
8949306|NCT02437162|10011838|FG002|Treated|Overall Study||114
8949307|NCT02437162|10011836|FG000|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|26
8949308|NCT02437162|10011837|FG001|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|21
8949309|NCT02437162|10011838|FG002|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|14
8949310|NCT02437162|10011836|FG000|Cross Over at Week 24|Overall Study|Out of 87: crossed over to Ustekinumab 45 mg (n=44) and Ustekinumab 90 mg (n=43)|87
8949311|NCT02437162|10011837|FG001|Cross Over at Week 24|Overall Study||0
8949312|NCT02437162|10011838|FG002|Cross Over at Week 24|Overall Study||0
8949313|NCT02437162|10011836|FG000|COMPLETED|Overall Study||9
8949314|NCT02437162|10011837|FG001|COMPLETED|Overall Study||8
8949315|NCT02437162|10011838|FG002|COMPLETED|Overall Study||6
8949316|NCT02437162|10011836|FG000|NOT COMPLETED|Overall Study||107
8949317|NCT02437162|10011837|FG001|NOT COMPLETED|Overall Study||108
8949318|NCT02437162|10011838|FG002|NOT COMPLETED|Overall Study||109
8949319|NCT02437188|10011853|FG000|STARTED|Overall Study||44
8949320|NCT02437188|10011854|FG001|STARTED|Overall Study||44
8949321|NCT02437188|10011853|FG000|COMPLETED|Overall Study||40
8949322|NCT02437188|10011854|FG001|COMPLETED|Overall Study||35
8949323|NCT02437188|10011853|FG000|NOT COMPLETED|Overall Study||4
8949324|NCT02437188|10011854|FG001|NOT COMPLETED|Overall Study||9
8949325|NCT02437253|10011865|FG000|STARTED|Overall Study||1
8949326|NCT02437253|10011866|FG001|STARTED|Overall Study||1
8949327|NCT02437253|10011865|FG000|COMPLETED|Overall Study||1
8949328|NCT02437253|10011866|FG001|COMPLETED|Overall Study||1
8949329|NCT02437253|10011865|FG000|NOT COMPLETED|Overall Study||0
8949330|NCT02437253|10011866|FG001|NOT COMPLETED|Overall Study||0
8949331|NCT02437305|10011876|FG000|STARTED|Overall Study||50
8949332|NCT02437305|10011877|FG001|STARTED|Overall Study||50
8949333|NCT02437305|10011876|FG000|COMPLETED|Overall Study||32
8949334|NCT02437305|10011877|FG001|COMPLETED|Overall Study||38
8949335|NCT02437305|10011876|FG000|NOT COMPLETED|Overall Study||18
8949336|NCT02437305|10011877|FG001|NOT COMPLETED|Overall Study||12
8949337|NCT02437344|10011883|FG000|STARTED|Overall Study||16
8949338|NCT02437344|10011883|FG000|COMPLETED|Overall Study||15
8949339|NCT02437344|10011883|FG000|NOT COMPLETED|Overall Study||1
8949340|NCT02437383|10011889|FG000|STARTED|Overall Study||100
8949341|NCT02437383|10011890|FG001|STARTED|Overall Study||100
8949342|NCT02437383|10011889|FG000|COMPLETED|Overall Study||87
8949343|NCT02437383|10011890|FG001|COMPLETED|Overall Study||87
8949344|NCT02437383|10011889|FG000|NOT COMPLETED|Overall Study||13
8949345|NCT02437383|10011890|FG001|NOT COMPLETED|Overall Study||13
8854898|NCT01775189|9910221|FG000|NOT COMPLETED|Treatment Phase: Washout Period 2||0
8854899|NCT01775189|9910222|FG001|NOT COMPLETED|Treatment Phase: Washout Period 2||0
8854900|NCT01775189|9910223|FG002|NOT COMPLETED|Treatment Phase: Washout Period 2||0
8854901|NCT01775189|9910224|FG003|NOT COMPLETED|Treatment Phase: Washout Period 2||1
8854902|NCT01775189|9910225|FG004|NOT COMPLETED|Treatment Phase: Washout Period 2||0
8854903|NCT01775189|9910226|FG005|NOT COMPLETED|Treatment Phase: Washout Period 2||0
8854904|NCT01775189|9910227|FG006|NOT COMPLETED|Treatment Phase: Washout Period 2||0
8854905|NCT01775189|9910221|FG000|STARTED|Treatment Phase: Third Intervention||0
8854906|NCT01775189|9910222|FG001|STARTED|Treatment Phase: Third Intervention||0
8854907|NCT01775189|9910223|FG002|STARTED|Treatment Phase: Third Intervention||0
8854908|NCT01775189|9910224|FG003|STARTED|Treatment Phase: Third Intervention||7
8854909|NCT01775189|9910225|FG004|STARTED|Treatment Phase: Third Intervention||8
8854910|NCT01775189|9910226|FG005|STARTED|Treatment Phase: Third Intervention||7
8854911|NCT01775189|9910227|FG006|STARTED|Treatment Phase: Third Intervention||8
8854912|NCT01775189|9910221|FG000|COMPLETED|Treatment Phase: Third Intervention||0
8854913|NCT01775189|9910222|FG001|COMPLETED|Treatment Phase: Third Intervention||0
8854914|NCT01775189|9910223|FG002|COMPLETED|Treatment Phase: Third Intervention||0
8854915|NCT01775189|9910224|FG003|COMPLETED|Treatment Phase: Third Intervention||7
8854916|NCT01775189|9910225|FG004|COMPLETED|Treatment Phase: Third Intervention||8
8854917|NCT01775189|9910226|FG005|COMPLETED|Treatment Phase: Third Intervention||7
8854918|NCT01775189|9910227|FG006|COMPLETED|Treatment Phase: Third Intervention||8
8854919|NCT01775189|9910221|FG000|NOT COMPLETED|Treatment Phase: Third Intervention||0
8854920|NCT01775189|9910222|FG001|NOT COMPLETED|Treatment Phase: Third Intervention||0
8854921|NCT01775189|9910223|FG002|NOT COMPLETED|Treatment Phase: Third Intervention||0
8854922|NCT01775189|9910224|FG003|NOT COMPLETED|Treatment Phase: Third Intervention||0
8854923|NCT01775189|9910225|FG004|NOT COMPLETED|Treatment Phase: Third Intervention||0
8854924|NCT01775189|9910226|FG005|NOT COMPLETED|Treatment Phase: Third Intervention||0
8854925|NCT01775189|9910227|FG006|NOT COMPLETED|Treatment Phase: Third Intervention||0
8854926|NCT01775189|9910221|FG000|STARTED|Treatment Phase: Washout Period 3||0
8854927|NCT01775189|9910222|FG001|STARTED|Treatment Phase: Washout Period 3||0
8854928|NCT01775189|9910223|FG002|STARTED|Treatment Phase: Washout Period 3||0
8854929|NCT01775189|9910224|FG003|STARTED|Treatment Phase: Washout Period 3||7
8854930|NCT01775189|9910225|FG004|STARTED|Treatment Phase: Washout Period 3||8
8854931|NCT01775189|9910226|FG005|STARTED|Treatment Phase: Washout Period 3||7
8854932|NCT01775189|9910227|FG006|STARTED|Treatment Phase: Washout Period 3||8
8854933|NCT01775189|9910221|FG000|COMPLETED|Treatment Phase: Washout Period 3||0
8854934|NCT01775189|9910222|FG001|COMPLETED|Treatment Phase: Washout Period 3||0
8854935|NCT01775189|9910223|FG002|COMPLETED|Treatment Phase: Washout Period 3||0
8854936|NCT01775189|9910224|FG003|COMPLETED|Treatment Phase: Washout Period 3||6
8854937|NCT01775189|9910225|FG004|COMPLETED|Treatment Phase: Washout Period 3||8
8854938|NCT01775189|9910226|FG005|COMPLETED|Treatment Phase: Washout Period 3||7
8854939|NCT01775189|9910227|FG006|COMPLETED|Treatment Phase: Washout Period 3||7
8854940|NCT01775189|9910221|FG000|NOT COMPLETED|Treatment Phase: Washout Period 3||0
8854941|NCT01775189|9910222|FG001|NOT COMPLETED|Treatment Phase: Washout Period 3||0
8854942|NCT01775189|9910223|FG002|NOT COMPLETED|Treatment Phase: Washout Period 3||0
8854943|NCT01775189|9910224|FG003|NOT COMPLETED|Treatment Phase: Washout Period 3||1
8854944|NCT01775189|9910225|FG004|NOT COMPLETED|Treatment Phase: Washout Period 3||0
8854945|NCT01775189|9910226|FG005|NOT COMPLETED|Treatment Phase: Washout Period 3||0
8854946|NCT01775189|9910227|FG006|NOT COMPLETED|Treatment Phase: Washout Period 3||1
8854947|NCT01775189|9910221|FG000|STARTED|Treatment Phase: Fourth Intervention||0
8854948|NCT01775189|9910222|FG001|STARTED|Treatment Phase: Fourth Intervention||0
8854949|NCT01775189|9910223|FG002|STARTED|Treatment Phase: Fourth Intervention||0
8854950|NCT01775189|9910224|FG003|STARTED|Treatment Phase: Fourth Intervention||6
8854951|NCT01775189|9910225|FG004|STARTED|Treatment Phase: Fourth Intervention||8
8854952|NCT01775189|9910226|FG005|STARTED|Treatment Phase: Fourth Intervention||7
8854953|NCT01775189|9910227|FG006|STARTED|Treatment Phase: Fourth Intervention||7
8854954|NCT01775189|9910221|FG000|COMPLETED|Treatment Phase: Fourth Intervention||0
8854955|NCT01775189|9910222|FG001|COMPLETED|Treatment Phase: Fourth Intervention||0
8854956|NCT01775189|9910223|FG002|COMPLETED|Treatment Phase: Fourth Intervention||0
8854957|NCT01775189|9910224|FG003|COMPLETED|Treatment Phase: Fourth Intervention||6
8854958|NCT01775189|9910225|FG004|COMPLETED|Treatment Phase: Fourth Intervention||8
8854959|NCT01775189|9910226|FG005|COMPLETED|Treatment Phase: Fourth Intervention||7
8854960|NCT01775189|9910227|FG006|COMPLETED|Treatment Phase: Fourth Intervention||7
8854961|NCT01775189|9910221|FG000|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
8854962|NCT01775189|9910222|FG001|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
8854963|NCT01775189|9910223|FG002|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
8854964|NCT01775189|9910224|FG003|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
8854965|NCT01775189|9910225|FG004|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
8854966|NCT01775189|9910226|FG005|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
8854967|NCT01775189|9910227|FG006|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
8854968|NCT01775371|9910257|FG000|STARTED|Overall Study||306
8854969|NCT01775371|9910258|FG001|STARTED|Overall Study||330
8854970|NCT01775371|9910257|FG000|COMPLETED|Overall Study||306
8854971|NCT01775371|9910258|FG001|COMPLETED|Overall Study||330
8854972|NCT01775371|9910257|FG000|NOT COMPLETED|Overall Study||0
8854973|NCT01775371|9910258|FG001|NOT COMPLETED|Overall Study||0
8854974|NCT01775410|9910266|FG000|STARTED|Overall Study||4
8854975|NCT01775410|9910266|FG000|COMPLETED|Overall Study||4
8854976|NCT01775410|9910266|FG000|NOT COMPLETED|Overall Study||0
8854977|NCT01775501|9910270|FG000|STARTED|Overall Study||40
8854978|NCT01775501|9910270|FG000|COMPLETED|Overall Study||39
8854979|NCT01775501|9910270|FG000|NOT COMPLETED|Overall Study||1
8854980|NCT01775553|9910274|FG000|STARTED|Overall Study||13
8854981|NCT01775553|9910274|FG000|COMPLETED|Overall Study||0
8854982|NCT01775553|9910274|FG000|NOT COMPLETED|Overall Study||13
8854983|NCT01775670|9910280|FG000|STARTED|Overall Study||1
8854984|NCT01775670|9910281|FG001|STARTED|Overall Study||3
8854985|NCT01775670|9910280|FG000|COMPLETED|Overall Study||0
8854986|NCT01775670|9910281|FG001|COMPLETED|Overall Study||2
8854987|NCT01775670|9910280|FG000|NOT COMPLETED|Overall Study||1
8854988|NCT01775670|9910281|FG001|NOT COMPLETED|Overall Study||1
8854989|NCT01775722|9910287|FG000|STARTED|Overall Study||22
8854990|NCT01775722|9910287|FG000|COMPLETED|Overall Study||20
8854991|NCT01775722|9910287|FG000|NOT COMPLETED|Overall Study||2
8854992|NCT01775735|9910295|FG000|STARTED|Intervention (6 Months)||8
8854993|NCT01775735|9910296|FG001|STARTED|Intervention (6 Months)||7
8854994|NCT01775735|9910295|FG000|COMPLETED|Intervention (6 Months)||8
8854995|NCT01775735|9910296|FG001|COMPLETED|Intervention (6 Months)||7
8854996|NCT01775735|9910295|FG000|NOT COMPLETED|Intervention (6 Months)||0
8854997|NCT01775735|9910296|FG001|NOT COMPLETED|Intervention (6 Months)||0
8854998|NCT01775735|9910295|FG000|STARTED|Open Label (24 Months)||8
8854999|NCT01775735|9910296|FG001|STARTED|Open Label (24 Months)||7
8855000|NCT01775735|9910295|FG000|COMPLETED|Open Label (24 Months)||7
8855001|NCT01775735|9910296|FG001|COMPLETED|Open Label (24 Months)||3
8855002|NCT01775735|9910295|FG000|NOT COMPLETED|Open Label (24 Months)||1
8855003|NCT01775735|9910296|FG001|NOT COMPLETED|Open Label (24 Months)||4
8855004|NCT01775774|9910305|FG000|STARTED|Overall Study||3
8855005|NCT01775774|9910306|FG001|STARTED|Overall Study||3
8855006|NCT01775774|9910307|FG002|STARTED|Overall Study||3
8855007|NCT01775774|9910305|FG000|COMPLETED|Overall Study||3
8855008|NCT01775774|9910306|FG001|COMPLETED|Overall Study||3
8855009|NCT01775774|9910307|FG002|COMPLETED|Overall Study||3
8855010|NCT01775774|9910305|FG000|NOT COMPLETED|Overall Study||0
8855011|NCT01775774|9910306|FG001|NOT COMPLETED|Overall Study||0
8855012|NCT01775774|9910307|FG002|NOT COMPLETED|Overall Study||0
8855013|NCT01775787|9910315|FG000|STARTED|First 7-10 Days||13
8855014|NCT01775787|9910316|FG001|STARTED|First 7-10 Days||14
8855015|NCT01775787|9910315|FG000|COMPLETED|First 7-10 Days||12
8855016|NCT01775787|9910316|FG001|COMPLETED|First 7-10 Days||8
8855017|NCT01775787|9910315|FG000|NOT COMPLETED|First 7-10 Days||1
8855018|NCT01775787|9910316|FG001|NOT COMPLETED|First 7-10 Days||6
8855019|NCT01775787|9910315|FG000|STARTED|Second 7-10 Days||12
8855020|NCT01775787|9910316|FG001|STARTED|Second 7-10 Days||8
8855021|NCT01775787|9910315|FG000|COMPLETED|Second 7-10 Days||12
8855022|NCT01775787|9910316|FG001|COMPLETED|Second 7-10 Days||6
8855023|NCT01775787|9910315|FG000|NOT COMPLETED|Second 7-10 Days||0
8855024|NCT01775787|9910316|FG001|NOT COMPLETED|Second 7-10 Days||2
8855025|NCT01775800|9910326|FG000|STARTED|Overall Study||8
8855026|NCT01775800|9910327|FG001|STARTED|Overall Study||8
8855027|NCT01775800|9910326|FG000|COMPLETED|Overall Study||8
8855028|NCT01775800|9910327|FG001|COMPLETED|Overall Study||8
8855029|NCT01775800|9910326|FG000|NOT COMPLETED|Overall Study||0
8855030|NCT01775800|9910327|FG001|NOT COMPLETED|Overall Study||0
8855031|NCT01775852|9910336|FG000|STARTED|Overall Study||31
8855032|NCT01775852|9910337|FG001|STARTED|Overall Study||14
8855033|NCT01775852|9910336|FG000|COMPLETED|Overall Study||31
8855034|NCT01775852|9910337|FG001|COMPLETED|Overall Study||13
8855035|NCT01775852|9910336|FG000|NOT COMPLETED|Overall Study||0
8855036|NCT01775852|9910337|FG001|NOT COMPLETED|Overall Study||1
8855037|NCT01775865|9910346|FG000|STARTED|Overall Study||14
8855038|NCT01775865|9910347|FG001|STARTED|Overall Study||14
8855039|NCT01775865|9910348|FG002|STARTED|Overall Study||17
8855040|NCT01775865|9910346|FG000|COMPLETED|Overall Study||11
8855041|NCT01775865|9910347|FG001|COMPLETED|Overall Study||13
8855042|NCT01775865|9910348|FG002|COMPLETED|Overall Study||17
8855043|NCT01775865|9910346|FG000|NOT COMPLETED|Overall Study||3
8855044|NCT01775865|9910347|FG001|NOT COMPLETED|Overall Study||1
8855045|NCT01775865|9910348|FG002|NOT COMPLETED|Overall Study||0
8855046|NCT01775904|9910361|FG000|STARTED|LY2886721 ODT (no Water, Fasting)||26
8855047|NCT01775904|9910361|FG000|Received at Least One Dose of Drug|LY2886721 ODT (no Water, Fasting)||26
8855048|NCT01775904|9910361|FG000|COMPLETED|LY2886721 ODT (no Water, Fasting)||26
8629857|NCT00531882|9669582|FG000|NOT COMPLETED|Overall Study||0
8629858|NCT00531882|9669583|FG001|NOT COMPLETED|Overall Study||0
8629859|NCT00531882|9669584|FG002|NOT COMPLETED|Overall Study||0
8629860|NCT00531934|9669594|FG000|STARTED|Overall Study||73
8855049|NCT01775904|9910361|FG000|NOT COMPLETED|LY2886721 ODT (no Water, Fasting)||0
8855050|NCT01775904|9910361|FG000|STARTED|First Washout (7 Days)||26
8855051|NCT01775904|9910361|FG000|COMPLETED|First Washout (7 Days)||26
8855052|NCT01775904|9910361|FG000|NOT COMPLETED|First Washout (7 Days)||0
8855053|NCT01775904|9910361|FG000|STARTED|LY2886721 Capsule (Water, Fasting)||26
8855054|NCT01775904|9910361|FG000|Received at Least One Dose of Drug|LY2886721 Capsule (Water, Fasting)||26
8855055|NCT01775904|9910361|FG000|COMPLETED|LY2886721 Capsule (Water, Fasting)||25
8855056|NCT01775904|9910361|FG000|NOT COMPLETED|LY2886721 Capsule (Water, Fasting)||1
8855057|NCT01775904|9910361|FG000|STARTED|Second Washout (7 Days)||25
8855058|NCT01775904|9910361|FG000|COMPLETED|Second Washout (7 Days)||25
8855059|NCT01775904|9910361|FG000|NOT COMPLETED|Second Washout (7 Days)||0
8855060|NCT01775904|9910361|FG000|STARTED|LY2886721 ODT (Water, Fed)||25
8855061|NCT01775904|9910361|FG000|Received at Least One Dose of Drug|LY2886721 ODT (Water, Fed)||25
8855062|NCT01775904|9910361|FG000|COMPLETED|LY2886721 ODT (Water, Fed)||25
8855063|NCT01775904|9910361|FG000|NOT COMPLETED|LY2886721 ODT (Water, Fed)||0
8855064|NCT01775904|9910361|FG000|STARTED|Third Washout (7 Days)||25
8855065|NCT01775904|9910361|FG000|COMPLETED|Third Washout (7 Days)||25
8855066|NCT01775904|9910361|FG000|NOT COMPLETED|Third Washout (7 Days)||0
8855067|NCT01775904|9910361|FG000|STARTED|LY2886721 ODT (Water, Fasting)||25
8855068|NCT01775904|9910361|FG000|Received at Least One Dose of Drug|LY2886721 ODT (Water, Fasting)|One participant was not dosed in this period due to an adverse event (AE).|24
8855069|NCT01775904|9910361|FG000|COMPLETED|LY2886721 ODT (Water, Fasting)||24
8855070|NCT01775904|9910361|FG000|NOT COMPLETED|LY2886721 ODT (Water, Fasting)||1
8855071|NCT01775930|9910371|FG000|STARTED|Overall Study||10
8855072|NCT01775930|9910371|FG000|COMPLETED|Overall Study||9
8855073|NCT01775930|9910371|FG000|NOT COMPLETED|Overall Study||1
8855074|NCT01775995|9910377|FG000|STARTED|Overall Study||21
8855075|NCT01775995|9910378|FG001|STARTED|Overall Study||14
8855076|NCT01775995|9910377|FG000|COMPLETED|Overall Study|One experimental participant was unable to reach at 26 week follow up|20
8855077|NCT01775995|9910378|FG001|COMPLETED|Overall Study|One control participant was unable to reach at 26 week follow up|13
8855078|NCT01775995|9910377|FG000|NOT COMPLETED|Overall Study||1
8855079|NCT01775995|9910378|FG001|NOT COMPLETED|Overall Study||1
8855080|NCT01776008|9910384|FG000|STARTED|Overall Study||16
8855081|NCT01776008|9910384|FG000|COMPLETED|Overall Study||14
8855082|NCT01776008|9910384|FG000|NOT COMPLETED|Overall Study||2
8855083|NCT01776268|9910390|FG000|STARTED|Overall Study||48
8855084|NCT01776268|9910391|FG001|STARTED|Overall Study||51
8855085|NCT01776268|9910390|FG000|COMPLETED|Overall Study||48
8855086|NCT01776268|9910391|FG001|COMPLETED|Overall Study||51
8855087|NCT01776268|9910390|FG000|NOT COMPLETED|Overall Study||0
8855088|NCT01776268|9910391|FG001|NOT COMPLETED|Overall Study||0
8855089|NCT01776424|9910401|FG000|STARTED|Overall Study||9152
8855090|NCT01776424|9910402|FG001|STARTED|Overall Study||9117
8855091|NCT01776424|9910403|FG002|STARTED|Overall Study||9126
8855092|NCT01776424|9910401|FG000|Treated|Overall Study||9134
8855093|NCT01776424|9910402|FG001|Treated|Overall Study||9110
8855094|NCT01776424|9910403|FG002|Treated|Overall Study||9107
8855095|NCT01776424|9910401|FG000|COMPLETED|Overall Study||9132
8855096|NCT01776424|9910402|FG001|COMPLETED|Overall Study||9098
8855097|NCT01776424|9910403|FG002|COMPLETED|Overall Study||9102
8855098|NCT01776424|9910401|FG000|NOT COMPLETED|Overall Study||20
8855099|NCT01776424|9910402|FG001|NOT COMPLETED|Overall Study||19
8855100|NCT01776424|9910403|FG002|NOT COMPLETED|Overall Study||24
8855101|NCT01776541|9910413|FG000|STARTED|Overall Study||488
8855102|NCT01776541|9910414|FG001|STARTED|Overall Study||491
8855103|NCT01776541|9910413|FG000|COMPLETED|Overall Study||432
8855104|NCT01776541|9910414|FG001|COMPLETED|Overall Study||416
8855105|NCT01776541|9910413|FG000|NOT COMPLETED|Overall Study||56
8855106|NCT01776541|9910414|FG001|NOT COMPLETED|Overall Study||75
8855107|NCT01776554|9910423|FG000|STARTED|Overall Study||332
8855108|NCT01776554|9910424|FG001|STARTED|Overall Study||330
8855109|NCT01776554|9910423|FG000|COMPLETED|Overall Study||315
8855110|NCT01776554|9910424|FG001|COMPLETED|Overall Study||307
8855111|NCT01776554|9910423|FG000|NOT COMPLETED|Overall Study||17
8855112|NCT01776554|9910424|FG001|NOT COMPLETED|Overall Study||23
8855113|NCT01776632|9910433|FG000|STARTED|Overall Study||217
8855114|NCT01776632|9910434|FG001|STARTED|Overall Study||219
8855115|NCT01776632|9910433|FG000|COMPLETED|Overall Study||190
8855116|NCT01776632|9910434|FG001|COMPLETED|Overall Study||190
8855117|NCT01776632|9910433|FG000|NOT COMPLETED|Overall Study||27
8855118|NCT01776632|9910434|FG001|NOT COMPLETED|Overall Study||29
8855119|NCT01776645|9910442|FG000|STARTED|Overall Study||28
8855120|NCT01776645|9910443|FG001|STARTED|Overall Study||28
8855121|NCT01776645|9910442|FG000|COMPLETED|Overall Study||14
8855122|NCT01776645|9910443|FG001|COMPLETED|Overall Study||14
8855123|NCT01776645|9910442|FG000|NOT COMPLETED|Overall Study||14
8855124|NCT01776645|9910443|FG001|NOT COMPLETED|Overall Study||14
8855125|NCT01777126|9910450|FG000|STARTED|Overall Study||48
8855126|NCT01777126|9910451|FG001|STARTED|Overall Study||46
8855127|NCT01777126|9910450|FG000|COMPLETED|Overall Study||48
8855128|NCT01777126|9910451|FG001|COMPLETED|Overall Study||46
8855129|NCT01777126|9910450|FG000|NOT COMPLETED|Overall Study||0
8855130|NCT01777126|9910451|FG001|NOT COMPLETED|Overall Study||0
8855131|NCT01777139|9910459|FG000|STARTED|Primary Reporting Phase (Up to 4 Years)||30
8855132|NCT01777139|9910460|FG001|STARTED|Primary Reporting Phase (Up to 4 Years)||0
8855133|NCT01777139|9910459|FG000|COMPLETED|Primary Reporting Phase (Up to 4 Years)||0
8855134|NCT01777139|9910460|FG001|COMPLETED|Primary Reporting Phase (Up to 4 Years)||0
8855135|NCT01777139|9910459|FG000|NOT COMPLETED|Primary Reporting Phase (Up to 4 Years)||30
8855136|NCT01777139|9910460|FG001|NOT COMPLETED|Primary Reporting Phase (Up to 4 Years)||0
8855137|NCT01777139|9910459|FG000|STARTED|SFUCP (Up to 1.4 Years)||0
8855138|NCT01777139|9910460|FG001|STARTED|SFUCP (Up to 1.4 Years)||4
8855139|NCT01777139|9910459|FG000|COMPLETED|SFUCP (Up to 1.4 Years)||0
8855140|NCT01777139|9910460|FG001|COMPLETED|SFUCP (Up to 1.4 Years)||0
8855141|NCT01777139|9910459|FG000|NOT COMPLETED|SFUCP (Up to 1.4 Years)||0
8855142|NCT01777139|9910460|FG001|NOT COMPLETED|SFUCP (Up to 1.4 Years)||4
8855143|NCT01777152|9910469|FG000|STARTED|Overall Study||226
8855144|NCT01777152|9910470|FG001|STARTED|Overall Study||226
8855145|NCT01777152|9910469|FG000|COMPLETED|Overall Study||131
8855146|NCT01777152|9910470|FG001|COMPLETED|Overall Study||116
8855147|NCT01777152|9910469|FG000|NOT COMPLETED|Overall Study||95
8855148|NCT01777152|9910470|FG001|NOT COMPLETED|Overall Study||110
8855149|NCT01777191|9910479|FG000|STARTED|Treatment Period (Per) (Week 0-Week 12)||102
8855150|NCT01777191|9910480|FG001|STARTED|Treatment Period (Per) (Week 0-Week 12)||102
8855151|NCT01777191|9910479|FG000|COMPLETED|Treatment Period (Per) (Week 0-Week 12)||96
8855152|NCT01777191|9910480|FG001|COMPLETED|Treatment Period (Per) (Week 0-Week 12)||94
8855153|NCT01777191|9910479|FG000|NOT COMPLETED|Treatment Period (Per) (Week 0-Week 12)||6
8855154|NCT01777191|9910480|FG001|NOT COMPLETED|Treatment Period (Per) (Week 0-Week 12)||8
8855155|NCT01777191|9910479|FG000|STARTED|Safety Extension Per (Week 12-Week 48)|Participation in the safety extension period was optional.|94
8855156|NCT01777191|9910480|FG001|STARTED|Safety Extension Per (Week 12-Week 48)|Participation in the safety extension period was optional.|91
8855157|NCT01777191|9910479|FG000|COMPLETED|Safety Extension Per (Week 12-Week 48)||85
8855158|NCT01777191|9910480|FG001|COMPLETED|Safety Extension Per (Week 12-Week 48)||78
8855159|NCT01777191|9910479|FG000|NOT COMPLETED|Safety Extension Per (Week 12-Week 48)||9
8855160|NCT01777191|9910480|FG001|NOT COMPLETED|Safety Extension Per (Week 12-Week 48)||13
8855161|NCT01777217|9910491|FG000|STARTED|Overall Study||4
8855162|NCT01777217|9910492|FG001|STARTED|Overall Study||4
8855163|NCT01777217|9910491|FG000|COMPLETED|Overall Study||4
8855164|NCT01777217|9910492|FG001|COMPLETED|Overall Study||4
8855165|NCT01777217|9910491|FG000|NOT COMPLETED|Overall Study||0
8855166|NCT01777217|9910492|FG001|NOT COMPLETED|Overall Study||0
8855167|NCT01777269|9910500|FG000|STARTED|Overall Study||246
8855168|NCT01777269|9910501|FG001|STARTED|Overall Study||243
8855169|NCT01777269|9910500|FG000|COMPLETED|Overall Study||191
8855170|NCT01777269|9910501|FG001|COMPLETED|Overall Study||184
8855171|NCT01777269|9910500|FG000|NOT COMPLETED|Overall Study||55
8855172|NCT01777269|9910501|FG001|NOT COMPLETED|Overall Study||59
8855173|NCT01777282|9910512|FG000|STARTED|Overall Study||120
8855174|NCT01777282|9910513|FG001|STARTED|Overall Study||67
8855175|NCT01777282|9910514|FG002|STARTED|Overall Study||65
8855176|NCT01777282|9910515|FG003|STARTED|Overall Study||61
8855177|NCT01777282|9910516|FG004|STARTED|Overall Study||61
8855178|NCT01777282|9910512|FG000|Completing Treatment Period|Overall Study||109
8855179|NCT01777282|9910513|FG001|Completing Treatment Period|Overall Study||63
8855180|NCT01777282|9910514|FG002|Completing Treatment Period|Overall Study||59
8855181|NCT01777282|9910515|FG003|Completing Treatment Period|Overall Study||59
8855182|NCT01777282|9910516|FG004|Completing Treatment Period|Overall Study||54
8855183|NCT01777282|9910512|FG000|Completing Follow-up Period|Overall Study||109
8855184|NCT01777282|9910513|FG001|Completing Follow-up Period|Overall Study||63
8855185|NCT01777282|9910514|FG002|Completing Follow-up Period|Overall Study||59
8855186|NCT01777282|9910515|FG003|Completing Follow-up Period|Overall Study||59
8855187|NCT01777282|9910516|FG004|Completing Follow-up Period|Overall Study||54
8855188|NCT01777282|9910512|FG000|COMPLETED|Overall Study||109
8855189|NCT01777282|9910513|FG001|COMPLETED|Overall Study||63
8855190|NCT01777282|9910514|FG002|COMPLETED|Overall Study||59
8855191|NCT01777282|9910515|FG003|COMPLETED|Overall Study||59
8855192|NCT01777282|9910516|FG004|COMPLETED|Overall Study||54
8855193|NCT01777282|9910512|FG000|NOT COMPLETED|Overall Study||11
8855194|NCT01777282|9910513|FG001|NOT COMPLETED|Overall Study||4
8855195|NCT01777282|9910514|FG002|NOT COMPLETED|Overall Study||6
8855196|NCT01777282|9910515|FG003|NOT COMPLETED|Overall Study||2
8855197|NCT01777282|9910516|FG004|NOT COMPLETED|Overall Study||7
8855198|NCT01777308|9910530|FG000|STARTED|Overall Study||119
8855199|NCT01777308|9910531|FG001|STARTED|Overall Study||37
8855200|NCT01777308|9910530|FG000|Completed up to Month 73|Overall Study||118
8855201|NCT01777308|9910531|FG001|Completed up to Month 73|Overall Study||37
8855202|NCT01777308|9910530|FG000|COMPLETED|Overall Study||105
8855203|NCT01777308|9910531|FG001|COMPLETED|Overall Study||34
8855204|NCT01777308|9910530|FG000|NOT COMPLETED|Overall Study||14
8855205|NCT01777308|9910531|FG001|NOT COMPLETED|Overall Study||3
8855206|NCT01777321|9910540|FG000|STARTED|Overall Study||30
8855207|NCT01777321|9910541|FG001|STARTED|Overall Study||30
8855208|NCT01777321|9910540|FG000|COMPLETED|Overall Study||30
8629861|NCT00531934|9669595|FG001|STARTED|Overall Study||74
8855209|NCT01777321|9910541|FG001|COMPLETED|Overall Study||29
8855210|NCT01777321|9910540|FG000|NOT COMPLETED|Overall Study||0
8855211|NCT01777321|9910541|FG001|NOT COMPLETED|Overall Study||1
8855212|NCT01777334|9910549|FG000|STARTED|Overall Study||454
8855213|NCT01777334|9910550|FG001|STARTED|Overall Study||451
8855214|NCT01777334|9910549|FG000|COMPLETED|Overall Study||401
8855215|NCT01777334|9910550|FG001|COMPLETED|Overall Study||388
8855216|NCT01777334|9910549|FG000|NOT COMPLETED|Overall Study||53
8855217|NCT01777334|9910550|FG001|NOT COMPLETED|Overall Study||63
8855218|NCT01777412|9910556|FG000|STARTED|Overall Study||10
8855219|NCT01777412|9910556|FG000|COMPLETED|Overall Study||10
8855220|NCT01777412|9910556|FG000|NOT COMPLETED|Overall Study||0
8855221|NCT01777425|9910560|FG000|STARTED|Overall Study||389
8855222|NCT01777425|9910560|FG000|COMPLETED|Overall Study||389
8855223|NCT01777425|9910560|FG000|NOT COMPLETED|Overall Study||0
8855224|NCT01777438|9910567|FG000|STARTED|Overall Study||352
8855225|NCT01777438|9910568|FG001|STARTED|Overall Study||82
8855226|NCT01777438|9910567|FG000|COMPLETED|Overall Study||352
8855227|NCT01777438|9910568|FG001|COMPLETED|Overall Study||82
8855228|NCT01777438|9910567|FG000|NOT COMPLETED|Overall Study||0
8855229|NCT01777438|9910568|FG001|NOT COMPLETED|Overall Study||0
8855230|NCT01777490|9910578|FG000|STARTED|Overall Study||123
8855231|NCT01777490|9910579|FG001|STARTED|Overall Study||123
8855232|NCT01777490|9910580|FG002|STARTED|Overall Study||119
8629862|NCT00531934|9669594|FG000|COMPLETED|Overall Study||7
8629863|NCT00531934|9669595|FG001|COMPLETED|Overall Study||11
8629864|NCT00531934|9669594|FG000|NOT COMPLETED|Overall Study||66
8629865|NCT00531934|9669595|FG001|NOT COMPLETED|Overall Study||63
8855233|NCT01777490|9910581|FG003|STARTED|Overall Study||119
8855234|NCT01777490|9910578|FG000|COMPLETED|Overall Study||123
8855235|NCT01777490|9910579|FG001|COMPLETED|Overall Study||123
8855236|NCT01777490|9910580|FG002|COMPLETED|Overall Study||118
8855237|NCT01777490|9910581|FG003|COMPLETED|Overall Study||118
8855238|NCT01777490|9910578|FG000|NOT COMPLETED|Overall Study||0
8855239|NCT01777490|9910579|FG001|NOT COMPLETED|Overall Study||0
8855240|NCT01777490|9910580|FG002|NOT COMPLETED|Overall Study||1
8855241|NCT01777490|9910581|FG003|NOT COMPLETED|Overall Study||1
8855242|NCT01777542|9910593|FG000|STARTED|First Intervention (20 Weeks)||15
8855243|NCT01777542|9910594|FG001|STARTED|First Intervention (20 Weeks)||15
8855244|NCT01777542|9910593|FG000|COMPLETED|First Intervention (20 Weeks)||15
8855245|NCT01777542|9910594|FG001|COMPLETED|First Intervention (20 Weeks)||15
8855246|NCT01777542|9910593|FG000|NOT COMPLETED|First Intervention (20 Weeks)||0
8855247|NCT01777542|9910594|FG001|NOT COMPLETED|First Intervention (20 Weeks)||0
8855248|NCT01777542|9910593|FG000|STARTED|Washout Period (28 +/- 2 Weeks)||15
8855249|NCT01777542|9910594|FG001|STARTED|Washout Period (28 +/- 2 Weeks)||15
8855250|NCT01777542|9910593|FG000|COMPLETED|Washout Period (28 +/- 2 Weeks)||15
8855251|NCT01777542|9910594|FG001|COMPLETED|Washout Period (28 +/- 2 Weeks)||15
8855252|NCT01777542|9910593|FG000|NOT COMPLETED|Washout Period (28 +/- 2 Weeks)||0
8855253|NCT01777542|9910594|FG001|NOT COMPLETED|Washout Period (28 +/- 2 Weeks)||0
8855254|NCT01777542|9910593|FG000|STARTED|Second Intervention (20 Weeks)||15
8855255|NCT01777542|9910594|FG001|STARTED|Second Intervention (20 Weeks)||15
8855256|NCT01777542|9910593|FG000|COMPLETED|Second Intervention (20 Weeks)||15
8855257|NCT01777542|9910594|FG001|COMPLETED|Second Intervention (20 Weeks)||14
8855258|NCT01777542|9910593|FG000|NOT COMPLETED|Second Intervention (20 Weeks)||0
8855259|NCT01777542|9910594|FG001|NOT COMPLETED|Second Intervention (20 Weeks)||1
8855260|NCT01777568|9910603|FG000|STARTED|Overall Study||2853
8855261|NCT01777568|9910604|FG001|STARTED|Overall Study||2896
8855262|NCT01777568|9910603|FG000|COMPLETED|Overall Study||2853
8855263|NCT01777568|9910604|FG001|COMPLETED|Overall Study||2896
8855264|NCT01777568|9910603|FG000|NOT COMPLETED|Overall Study||0
8855265|NCT01777568|9910604|FG001|NOT COMPLETED|Overall Study||0
8855266|NCT01777581|9910612|FG000|STARTED|Overall Study|Includes one subject screened/consented but not assigned to either arm.|8
8855267|NCT01777581|9910613|FG001|STARTED|Overall Study|Includes one subject screened/consented but not assigned to either arm.|5
8855268|NCT01777581|9910612|FG000|COMPLETED|Overall Study||5
8855269|NCT01777581|9910613|FG001|COMPLETED|Overall Study||3
8855270|NCT01777581|9910612|FG000|NOT COMPLETED|Overall Study||3
8855271|NCT01777581|9910613|FG001|NOT COMPLETED|Overall Study||2
8855272|NCT01777620|9910621|FG000|STARTED|Overall Study||63
8855273|NCT01777620|9910622|FG001|STARTED|Overall Study||62
8855274|NCT01777620|9910621|FG000|COMPLETED|Overall Study||62
8855275|NCT01777620|9910622|FG001|COMPLETED|Overall Study||62
8855276|NCT01777620|9910621|FG000|NOT COMPLETED|Overall Study||1
8855277|NCT01777620|9910622|FG001|NOT COMPLETED|Overall Study||0
8855278|NCT01777763|9910630|FG000|STARTED|Overall Study||20
8855279|NCT01777763|9910631|FG001|STARTED|Overall Study||210
8855280|NCT01777763|9910630|FG000|COMPLETED|Overall Study||16
8855281|NCT01777763|9910631|FG001|COMPLETED|Overall Study||163
8855282|NCT01777763|9910630|FG000|NOT COMPLETED|Overall Study||4
8855283|NCT01777763|9910631|FG001|NOT COMPLETED|Overall Study||47
8855284|NCT01777776|9910641|FG000|STARTED|Overall Study||6
8855285|NCT01777776|9910642|FG001|STARTED|Overall Study||12
8855286|NCT01777776|9910643|FG002|STARTED|Overall Study||6
8855287|NCT01777776|9910644|FG003|STARTED|Overall Study||4
8855288|NCT01777776|9910641|FG000|COMPLETED|Overall Study||0
8855289|NCT01777776|9910642|FG001|COMPLETED|Overall Study||0
8855290|NCT01777776|9910643|FG002|COMPLETED|Overall Study||0
8855291|NCT01777776|9910644|FG003|COMPLETED|Overall Study||0
8855292|NCT01777776|9910641|FG000|NOT COMPLETED|Overall Study||6
8855293|NCT01777776|9910642|FG001|NOT COMPLETED|Overall Study||12
8855294|NCT01777776|9910643|FG002|NOT COMPLETED|Overall Study||6
8855295|NCT01777776|9910644|FG003|NOT COMPLETED|Overall Study||4
8855296|NCT01777932|9910663|FG000|STARTED|Overall Study||220
8855297|NCT01777932|9910663|FG000|COMPLETED|Overall Study||15
8855298|NCT01777932|9910663|FG000|NOT COMPLETED|Overall Study||205
8855299|NCT01777945|9910667|FG000|STARTED|Overall Study||46
8855300|NCT01777945|9910667|FG000|Evaluable Participants|Overall Study||45
8855301|NCT01777945|9910667|FG000|COMPLETED|Overall Study||46
8855302|NCT01777945|9910667|FG000|NOT COMPLETED|Overall Study||0
8855303|NCT01777997|9910671|FG000|STARTED|12 Week lead-in of no ART||38
8855304|NCT01777997|9910671|FG000|COMPLETED|12 Week lead-in of no ART||36
8855305|NCT01777997|9910671|FG000|NOT COMPLETED|12 Week lead-in of no ART||2
8855306|NCT01777997|9910671|FG000|STARTED|Weeks 0 to 24/48 on ART||36
8855307|NCT01777997|9910671|FG000|COMPLETED|Weeks 0 to 24/48 on ART|7 of these participants opted not to continue ART into next period|35
8855308|NCT01777997|9910671|FG000|NOT COMPLETED|Weeks 0 to 24/48 on ART||1
8855309|NCT01777997|9910671|FG000|STARTED|Weeks 48 to 72/96 on ART||28
8855310|NCT01777997|9910671|FG000|COMPLETED|Weeks 48 to 72/96 on ART||26
8949346|NCT02437409|10011896|FG000|STARTED|Overall Study|Eventually 100 evaluable patients, attrition rate of 15%|115
8949347|NCT02437409|10011896|FG000|COMPLETED|Overall Study|In total 100 patients fulfilled the in-and exclusion criteria,15 patients were excluded/discontinued|100
8855311|NCT01777997|9910671|FG000|NOT COMPLETED|Weeks 48 to 72/96 on ART||2
8855312|NCT01778010|9910675|FG000|STARTED|Overall Study||13
8855313|NCT01778010|9910675|FG000|COMPLETED|Overall Study||8
8855314|NCT01778010|9910675|FG000|NOT COMPLETED|Overall Study||5
8855315|NCT01778023|9910694|FG000|STARTED|Overall Study||36
8855316|NCT01778023|9910695|FG001|STARTED|Overall Study||18
8855317|NCT01778023|9910694|FG000|Exposed|Overall Study||36
8855318|NCT01778023|9910695|FG001|Exposed|Overall Study||15
8855319|NCT01778023|9910694|FG000|COMPLETED|Overall Study||36
8855320|NCT01778023|9910695|FG001|COMPLETED|Overall Study||15
8855321|NCT01778023|9910694|FG000|NOT COMPLETED|Overall Study||0
8855322|NCT01778023|9910695|FG001|NOT COMPLETED|Overall Study||3
8855323|NCT01778049|9910703|FG000|STARTED|Open Label Treatment Period||354
8855324|NCT01778049|9910704|FG001|STARTED|Open Label Treatment Period||355
8855325|NCT01778049|9910705|FG002|STARTED|Open Label Treatment Period||0
8629866|NCT00531947|9669603|FG000|STARTED|Overall Study|all randomized subjects who received at least one dose of placebo study medication|156
8629867|NCT00531947|9669604|FG001|STARTED|Overall Study|all randomized subjects who received at least one dose of EMSAM study medication|152
8629868|NCT00531947|9669603|FG000|COMPLETED|Overall Study||114
8629869|NCT00531947|9669604|FG001|COMPLETED|Overall Study||101
8629870|NCT00531947|9669603|FG000|NOT COMPLETED|Overall Study||42
8629871|NCT00531947|9669604|FG001|NOT COMPLETED|Overall Study||51
8629872|NCT00531960|9669612|FG000|STARTED|Overall Study||61
8629873|NCT00531960|9669613|FG001|STARTED|Overall Study||63
8629874|NCT00531960|9669612|FG000|COMPLETED|Overall Study||0
8629875|NCT00531960|9669613|FG001|COMPLETED|Overall Study||0
8629876|NCT00531960|9669612|FG000|NOT COMPLETED|Overall Study||61
8629877|NCT00531960|9669613|FG001|NOT COMPLETED|Overall Study||63
8629878|NCT00532129|9669619|FG000|STARTED|Treatment Period||100
8629879|NCT00532129|9669619|FG000|COMPLETED|Treatment Period||51
8629880|NCT00532129|9669619|FG000|NOT COMPLETED|Treatment Period||49
8629881|NCT00532129|9669619|FG000|STARTED|Follow-up Period||98
8629882|NCT00532129|9669619|FG000|COMPLETED|Follow-up Period||33
8629883|NCT00532129|9669619|FG000|NOT COMPLETED|Follow-up Period||65
8629884|NCT00532155|9669625|FG000|STARTED|Overall Study||457
8725212|NCT01029782|9772412|FG000|COMPLETED|Overall Study||99
8725213|NCT01029782|9772413|FG001|COMPLETED|Overall Study||96
8725214|NCT01029782|9772412|FG000|NOT COMPLETED|Overall Study||3
8725215|NCT01029782|9772413|FG001|NOT COMPLETED|Overall Study||8
8725216|NCT01029795|9772421|FG000|STARTED|Overall Study||16
8725217|NCT01029795|9772422|FG001|STARTED|Overall Study||22
8725218|NCT01029795|9772421|FG000|COMPLETED|Overall Study||0
8725219|NCT01029795|9772422|FG001|COMPLETED|Overall Study||0
8725220|NCT01029795|9772421|FG000|NOT COMPLETED|Overall Study||16
8725221|NCT01029795|9772422|FG001|NOT COMPLETED|Overall Study||22
8725222|NCT01029886|9772430|FG000|STARTED|Overall Study||461
8725223|NCT01029886|9772431|FG001|STARTED|Overall Study||451
8725224|NCT01029886|9772430|FG000|Intent to Treat (ITT)|Overall Study||461
8725225|NCT01029886|9772431|FG001|Intent to Treat (ITT)|Overall Study||450
8725226|NCT01029886|9772430|FG000|COMPLETED|Overall Study||400
8725227|NCT01029886|9772431|FG001|COMPLETED|Overall Study||391
8725228|NCT01029886|9772430|FG000|NOT COMPLETED|Overall Study||61
8725229|NCT01029886|9772431|FG001|NOT COMPLETED|Overall Study||60
8725230|NCT01029912|9772443|FG000|STARTED|Overall Study||14
8725231|NCT01029912|9772444|FG001|STARTED|Overall Study||12
8725232|NCT01029912|9772443|FG000|COMPLETED|Overall Study||12
8725233|NCT01029912|9772444|FG001|COMPLETED|Overall Study||12
8725234|NCT01029912|9772443|FG000|NOT COMPLETED|Overall Study||2
8725235|NCT01029912|9772444|FG001|NOT COMPLETED|Overall Study||0
8725236|NCT01029925|9772450|FG000|STARTED|Completion of Cycle 1 (28 Days)||7
8725237|NCT01029925|9772450|FG000|COMPLETED|Completion of Cycle 1 (28 Days)||3
8725238|NCT01029925|9772450|FG000|NOT COMPLETED|Completion of Cycle 1 (28 Days)||4
8725239|NCT01029925|9772450|FG000|STARTED|Completion of Cycle 2 (56 Days)||3
8725240|NCT01029925|9772450|FG000|COMPLETED|Completion of Cycle 2 (56 Days)||2
8725241|NCT01029925|9772450|FG000|NOT COMPLETED|Completion of Cycle 2 (56 Days)||1
8725242|NCT01030133|9772456|FG000|STARTED|Overall Study||14
8725243|NCT01030133|9772457|FG001|STARTED|Overall Study||14
8725244|NCT01030133|9772456|FG000|COMPLETED|Overall Study||12
8725245|NCT01030133|9772457|FG001|COMPLETED|Overall Study||12
8725246|NCT01030133|9772456|FG000|NOT COMPLETED|Overall Study||2
8725247|NCT01030133|9772457|FG001|NOT COMPLETED|Overall Study||2
8725248|NCT01030289|9772467|FG000|STARTED|Overall Study||9
8725249|NCT01030289|9772468|FG001|STARTED|Overall Study||10
8725250|NCT01030289|9772467|FG000|COMPLETED|Overall Study||9
8725251|NCT01030289|9772468|FG001|COMPLETED|Overall Study||10
8725252|NCT01030289|9772467|FG000|NOT COMPLETED|Overall Study||0
8725253|NCT01030289|9772468|FG001|NOT COMPLETED|Overall Study||0
8725254|NCT01030406|9772480|FG000|STARTED|Overall Study||10
8725255|NCT01030406|9772481|FG001|STARTED|Overall Study||10
8725256|NCT01030406|9772482|FG002|STARTED|Overall Study||10
8725257|NCT01030406|9772483|FG003|STARTED|Overall Study||10
8725258|NCT01030406|9772484|FG004|STARTED|Overall Study||9
8725259|NCT01030406|9772480|FG000|COMPLETED|Overall Study||10
8725260|NCT01030406|9772481|FG001|COMPLETED|Overall Study||10
8725261|NCT01030406|9772482|FG002|COMPLETED|Overall Study||9
8725262|NCT01030406|9772483|FG003|COMPLETED|Overall Study||9
8725263|NCT01030406|9772484|FG004|COMPLETED|Overall Study||9
8725264|NCT01030406|9772480|FG000|NOT COMPLETED|Overall Study||0
8855326|NCT01778049|9910706|FG003|STARTED|Open Label Treatment Period||0
8855327|NCT01778049|9910707|FG004|STARTED|Open Label Treatment Period||0
8855328|NCT01778049|9910708|FG005|STARTED|Open Label Treatment Period||0
8855329|NCT01778049|9910703|FG000|COMPLETED|Open Label Treatment Period||256
8855330|NCT01778049|9910704|FG001|COMPLETED|Open Label Treatment Period||226
8855331|NCT01778049|9910705|FG002|COMPLETED|Open Label Treatment Period||0
8855332|NCT01778049|9910706|FG003|COMPLETED|Open Label Treatment Period||0
8855333|NCT01778049|9910707|FG004|COMPLETED|Open Label Treatment Period||0
8855334|NCT01778049|9910708|FG005|COMPLETED|Open Label Treatment Period||0
8855335|NCT01778049|9910703|FG000|NOT COMPLETED|Open Label Treatment Period||98
8855336|NCT01778049|9910704|FG001|NOT COMPLETED|Open Label Treatment Period||129
8855337|NCT01778049|9910705|FG002|NOT COMPLETED|Open Label Treatment Period||0
8855338|NCT01778049|9910706|FG003|NOT COMPLETED|Open Label Treatment Period||0
8855339|NCT01778049|9910707|FG004|NOT COMPLETED|Open Label Treatment Period||0
8855340|NCT01778049|9910708|FG005|NOT COMPLETED|Open Label Treatment Period||0
8855341|NCT01778049|9910703|FG000|STARTED|Double Blind Treatment Period||0
8855342|NCT01778049|9910704|FG001|STARTED|Double Blind Treatment Period||0
8855343|NCT01778049|9910705|FG002|STARTED|Double Blind Treatment Period||126
8855344|NCT01778049|9910706|FG003|STARTED|Double Blind Treatment Period||130
8855345|NCT01778049|9910707|FG004|STARTED|Double Blind Treatment Period||114
8855346|NCT01778049|9910708|FG005|STARTED|Double Blind Treatment Period||112
8855347|NCT01778049|9910703|FG000|COMPLETED|Double Blind Treatment Period||0
8855348|NCT01778049|9910704|FG001|COMPLETED|Double Blind Treatment Period||0
8855349|NCT01778049|9910705|FG002|COMPLETED|Double Blind Treatment Period||111
8855350|NCT01778049|9910706|FG003|COMPLETED|Double Blind Treatment Period||118
8629885|NCT00532155|9669626|FG001|STARTED|Overall Study||456
8725265|NCT01030406|9772481|FG001|NOT COMPLETED|Overall Study||0
8855351|NCT01778049|9910707|FG004|COMPLETED|Double Blind Treatment Period||102
8855352|NCT01778049|9910708|FG005|COMPLETED|Double Blind Treatment Period||105
8855353|NCT01778049|9910703|FG000|NOT COMPLETED|Double Blind Treatment Period||0
8855354|NCT01778049|9910704|FG001|NOT COMPLETED|Double Blind Treatment Period||0
8855355|NCT01778049|9910705|FG002|NOT COMPLETED|Double Blind Treatment Period||15
8855356|NCT01778049|9910706|FG003|NOT COMPLETED|Double Blind Treatment Period||12
8855357|NCT01778049|9910707|FG004|NOT COMPLETED|Double Blind Treatment Period||12
8855358|NCT01778049|9910708|FG005|NOT COMPLETED|Double Blind Treatment Period||7
8855359|NCT01778062|9910722|FG000|STARTED|Overall Study||68
8855360|NCT01778062|9910723|FG001|STARTED|Overall Study||68
8855361|NCT01778062|9910722|FG000|Safety Set|Overall Study||68
8855362|NCT01778062|9910723|FG001|Safety Set|Overall Study||68
8855363|NCT01778062|9910722|FG000|Intent to Treat (ITT)|Overall Study||68
8855364|NCT01778062|9910723|FG001|Intent to Treat (ITT)|Overall Study|One failed to perform primary efficacy evaluation and was excluded, 135 were included in the ITT set|67
8855365|NCT01778062|9910722|FG000|COMPLETED|Overall Study||62
8855366|NCT01778062|9910723|FG001|COMPLETED|Overall Study||57
8855367|NCT01778062|9910722|FG000|NOT COMPLETED|Overall Study||6
8855368|NCT01778062|9910723|FG001|NOT COMPLETED|Overall Study||11
8855369|NCT01778127|9910732|FG000|STARTED|Overall Study||33
8855370|NCT01778127|9910733|FG001|STARTED|Overall Study||33
8855371|NCT01778127|9910734|FG002|STARTED|Overall Study||32
8855372|NCT01778127|9910732|FG000|COMPLETED|Overall Study||25
8855373|NCT01778127|9910733|FG001|COMPLETED|Overall Study||31
8855374|NCT01778127|9910734|FG002|COMPLETED|Overall Study||26
8855375|NCT01778127|9910732|FG000|NOT COMPLETED|Overall Study||8
8855376|NCT01778127|9910733|FG001|NOT COMPLETED|Overall Study||2
8855377|NCT01778127|9910734|FG002|NOT COMPLETED|Overall Study||6
8855378|NCT01778179|9910744|FG000|STARTED|Overall Study||25
8855379|NCT01778179|9910745|FG001|STARTED|Overall Study||25
8855380|NCT01778179|9910744|FG000|COMPLETED|Overall Study||23
8855381|NCT01778179|9910745|FG001|COMPLETED|Overall Study||22
8855382|NCT01778179|9910744|FG000|NOT COMPLETED|Overall Study||2
8855383|NCT01778179|9910745|FG001|NOT COMPLETED|Overall Study||3
8855384|NCT01778296|9910751|FG000|STARTED|Overall Study|There were 12 patients included in the study in the initial stage.|12
8855385|NCT01778296|9910751|FG000|COMPLETED|Overall Study|No patient was lost to follow-up.|12
8855386|NCT01778296|9910751|FG000|NOT COMPLETED|Overall Study||0
8855387|NCT01778426|9910757|FG000|STARTED|Overall Study - Full Analysis Set (FAS)||264
8855388|NCT01778426|9910758|FG001|STARTED|Overall Study - Full Analysis Set (FAS)||138
8855389|NCT01778426|9910757|FG000|COMPLETED|Overall Study - Full Analysis Set (FAS)||208
8629886|NCT00532155|9669625|FG000|SAFETY POPULATION|Overall Study||455
8629887|NCT00532155|9669626|FG001|SAFETY POPULATION|Overall Study||450
8629888|NCT00532155|9669625|FG000|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria|0
8629889|NCT00532155|9669626|FG001|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria|0
8629890|NCT00532155|9669625|FG000|NOT COMPLETED|Overall Study||457
8629891|NCT00532155|9669626|FG001|NOT COMPLETED|Overall Study||456
8629892|NCT00532259|9669632|FG000|STARTED|Overall Study||72
8725266|NCT01030406|9772482|FG002|NOT COMPLETED|Overall Study||1
8725267|NCT01030406|9772483|FG003|NOT COMPLETED|Overall Study||1
8725268|NCT01030406|9772484|FG004|NOT COMPLETED|Overall Study||0
8725269|NCT01030458|9772498|FG000|STARTED|Overall Study||94
8725270|NCT01030458|9772499|FG001|STARTED|Overall Study||89
8725271|NCT01030458|9772498|FG000|COMPLETED|Overall Study||67
8725272|NCT01030458|9772499|FG001|COMPLETED|Overall Study||57
8629893|NCT00532259|9669632|FG000|COMPLETED|Overall Study||40
8725273|NCT01030458|9772498|FG000|NOT COMPLETED|Overall Study||27
8725274|NCT01030458|9772499|FG001|NOT COMPLETED|Overall Study||32
8855390|NCT01778426|9910758|FG001|COMPLETED|Overall Study - Full Analysis Set (FAS)||113
8855391|NCT01778426|9910757|FG000|NOT COMPLETED|Overall Study - Full Analysis Set (FAS)||56
8855392|NCT01778426|9910758|FG001|NOT COMPLETED|Overall Study - Full Analysis Set (FAS)||25
8855393|NCT01778426|9910757|FG000|STARTED|Intention-To-Treat (ITT) - Completer||198
8855394|NCT01778426|9910758|FG001|STARTED|Intention-To-Treat (ITT) - Completer|Not applicable: ITT-completer contains only primo-implant subjects.|0
8855395|NCT01778426|9910757|FG000|COMPLETED|Intention-To-Treat (ITT) - Completer||198
8855396|NCT01778426|9910758|FG001|COMPLETED|Intention-To-Treat (ITT) - Completer|Not applicable: ITT-completer contains only primo-implant subjects.|0
8855397|NCT01778426|9910757|FG000|NOT COMPLETED|Intention-To-Treat (ITT) - Completer||0
8855398|NCT01778426|9910758|FG001|NOT COMPLETED|Intention-To-Treat (ITT) - Completer||0
8855399|NCT01778465|9910767|FG000|STARTED|First Intervention (7 Days)||3
8855400|NCT01778465|9910768|FG001|STARTED|First Intervention (7 Days)||4
8855401|NCT01778465|9910767|FG000|COMPLETED|First Intervention (7 Days)||3
8855402|NCT01778465|9910768|FG001|COMPLETED|First Intervention (7 Days)||4
8855403|NCT01778465|9910767|FG000|NOT COMPLETED|First Intervention (7 Days)||0
8855404|NCT01778465|9910768|FG001|NOT COMPLETED|First Intervention (7 Days)||0
8855405|NCT01778465|9910767|FG000|STARTED|Second Intervention (7 Days)||3
8855406|NCT01778465|9910768|FG001|STARTED|Second Intervention (7 Days)||4
8855407|NCT01778465|9910767|FG000|COMPLETED|Second Intervention (7 Days)||3
8855408|NCT01778465|9910768|FG001|COMPLETED|Second Intervention (7 Days)||4
8855409|NCT01778465|9910767|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
8855410|NCT01778465|9910768|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
8855411|NCT01778530|9910777|FG000|STARTED|Overall Study||2
8855412|NCT01778530|9910777|FG000|COMPLETED|Overall Study||0
8855413|NCT01778530|9910777|FG000|NOT COMPLETED|Overall Study||2
8855414|NCT01778556|9910783|FG000|STARTED|Intervention 1 (5 Days)||15
8855415|NCT01778556|9910784|FG001|STARTED|Intervention 1 (5 Days)||10
8855416|NCT01778556|9910783|FG000|COMPLETED|Intervention 1 (5 Days)||15
8855417|NCT01778556|9910784|FG001|COMPLETED|Intervention 1 (5 Days)||8
8855418|NCT01778556|9910783|FG000|NOT COMPLETED|Intervention 1 (5 Days)||0
8855419|NCT01778556|9910784|FG001|NOT COMPLETED|Intervention 1 (5 Days)||2
8855420|NCT01778556|9910783|FG000|STARTED|Intervention 2 (14 Days)||15
8855421|NCT01778556|9910784|FG001|STARTED|Intervention 2 (14 Days)||8
8855422|NCT01778556|9910783|FG000|COMPLETED|Intervention 2 (14 Days)||14
8855423|NCT01778556|9910784|FG001|COMPLETED|Intervention 2 (14 Days)||8
8855424|NCT01778556|9910783|FG000|NOT COMPLETED|Intervention 2 (14 Days)||1
8855425|NCT01778556|9910784|FG001|NOT COMPLETED|Intervention 2 (14 Days)||0
8855426|NCT01778556|9910783|FG000|STARTED|Long-term Follow-up||15
8855427|NCT01778556|9910784|FG001|STARTED|Long-term Follow-up|no long-term follow-up period in on-leptin arm|0
8855428|NCT01778556|9910783|FG000|COMPLETED|Long-term Follow-up||14
8855429|NCT01778556|9910784|FG001|COMPLETED|Long-term Follow-up|no long-term follow-up period in on-leptin arm|0
8855430|NCT01778556|9910783|FG000|NOT COMPLETED|Long-term Follow-up||1
8855431|NCT01778556|9910784|FG001|NOT COMPLETED|Long-term Follow-up||0
8855432|NCT01778634|9910795|FG000|STARTED|Overall Study||61
8855433|NCT01778634|9910796|FG001|STARTED|Overall Study||60
8855434|NCT01778634|9910795|FG000|COMPLETED|Overall Study||61
8855435|NCT01778634|9910796|FG001|COMPLETED|Overall Study||60
8855436|NCT01778634|9910795|FG000|NOT COMPLETED|Overall Study||0
8855437|NCT01778634|9910796|FG001|NOT COMPLETED|Overall Study||0
8855438|NCT01778751|9910805|FG000|STARTED|Overall Study||25
8855439|NCT01778751|9910806|FG001|STARTED|Overall Study||25
8855440|NCT01778751|9910805|FG000|COMPLETED|Overall Study||23
8855441|NCT01778751|9910806|FG001|COMPLETED|Overall Study||23
8855442|NCT01778751|9910805|FG000|NOT COMPLETED|Overall Study||2
8855443|NCT01778751|9910806|FG001|NOT COMPLETED|Overall Study||2
8855444|NCT01778855|9910814|FG000|STARTED|Overall Study||2
8855445|NCT01778855|9910815|FG001|STARTED|Overall Study||4
8855446|NCT01778855|9910814|FG000|COMPLETED|Overall Study||2
8855447|NCT01778855|9910815|FG001|COMPLETED|Overall Study||3
8855448|NCT01778855|9910814|FG000|NOT COMPLETED|Overall Study||0
8855449|NCT01778855|9910815|FG001|NOT COMPLETED|Overall Study||1
8855450|NCT01778985|9910823|FG000|STARTED|Overall Study||15
8855451|NCT01778985|9910824|FG001|STARTED|Overall Study||15
8855452|NCT01778985|9910823|FG000|COMPLETED|Overall Study||8
8855453|NCT01778985|9910824|FG001|COMPLETED|Overall Study||12
8855454|NCT01778985|9910823|FG000|NOT COMPLETED|Overall Study||7
8855455|NCT01778985|9910824|FG001|NOT COMPLETED|Overall Study||3
8855456|NCT01779024|9910830|FG000|STARTED|1st Visit - Alcohol Self-Administration||8
8855457|NCT01779024|9910831|FG001|STARTED|1st Visit - Alcohol Self-Administration||9
8855458|NCT01779024|9910830|FG000|COMPLETED|1st Visit - Alcohol Self-Administration||8
8855459|NCT01779024|9910831|FG001|COMPLETED|1st Visit - Alcohol Self-Administration||9
8855460|NCT01779024|9910830|FG000|NOT COMPLETED|1st Visit - Alcohol Self-Administration||0
8855461|NCT01779024|9910831|FG001|NOT COMPLETED|1st Visit - Alcohol Self-Administration||0
8855462|NCT01779024|9910830|FG000|STARTED|2nd Visit - Alcohol Self-Administration||8
8855463|NCT01779024|9910831|FG001|STARTED|2nd Visit - Alcohol Self-Administration||9
8855464|NCT01779024|9910830|FG000|COMPLETED|2nd Visit - Alcohol Self-Administration||6
8855465|NCT01779024|9910831|FG001|COMPLETED|2nd Visit - Alcohol Self-Administration||9
8855466|NCT01779024|9910830|FG000|NOT COMPLETED|2nd Visit - Alcohol Self-Administration||2
8855467|NCT01779024|9910831|FG001|NOT COMPLETED|2nd Visit - Alcohol Self-Administration||0
8855468|NCT01779024|9910830|FG000|STARTED|1st Visit - Functional MRI||6
8855469|NCT01779024|9910831|FG001|STARTED|1st Visit - Functional MRI||7
8855470|NCT01779024|9910830|FG000|COMPLETED|1st Visit - Functional MRI||4
8855471|NCT01779024|9910831|FG001|COMPLETED|1st Visit - Functional MRI||5
8855472|NCT01779024|9910830|FG000|NOT COMPLETED|1st Visit - Functional MRI||2
8855473|NCT01779024|9910831|FG001|NOT COMPLETED|1st Visit - Functional MRI||2
8855474|NCT01779024|9910830|FG000|STARTED|2nd Visit - Functional MRI||5
8855475|NCT01779024|9910831|FG001|STARTED|2nd Visit - Functional MRI||6
8855476|NCT01779024|9910830|FG000|COMPLETED|2nd Visit - Functional MRI||5
8855477|NCT01779024|9910831|FG001|COMPLETED|2nd Visit - Functional MRI||6
8855478|NCT01779024|9910830|FG000|NOT COMPLETED|2nd Visit - Functional MRI||0
8855479|NCT01779024|9910831|FG001|NOT COMPLETED|2nd Visit - Functional MRI||0
8923455|NCT02240368|9984047|FG002|COMPLETED|Overall Study||18
8923456|NCT02240368|9984045|FG000|NOT COMPLETED|Overall Study||1
8923457|NCT02240368|9984046|FG001|NOT COMPLETED|Overall Study||0
8923458|NCT02240368|9984047|FG002|NOT COMPLETED|Overall Study||1
8923459|NCT02240589|9984057|FG000|STARTED|Overall Study||5
8923460|NCT02240589|9984058|FG001|STARTED|Overall Study||6
8923461|NCT02240589|9984057|FG000|COMPLETED|Overall Study||3
8923462|NCT02240589|9984058|FG001|COMPLETED|Overall Study||4
8923463|NCT02240589|9984057|FG000|NOT COMPLETED|Overall Study||2
8923464|NCT02240589|9984058|FG001|NOT COMPLETED|Overall Study||2
8923465|NCT02240628|9984066|FG000|STARTED|Overall Study||38
8923466|NCT02240628|9984067|FG001|STARTED|Overall Study||38
8923467|NCT02240628|9984066|FG000|COMPLETED|Overall Study||32
8923468|NCT02240628|9984067|FG001|COMPLETED|Overall Study||33
8923469|NCT02240628|9984066|FG000|NOT COMPLETED|Overall Study||6
8923470|NCT02240628|9984067|FG001|NOT COMPLETED|Overall Study||5
8923471|NCT02240654|9984078|FG000|STARTED|Overall Study||1706
8923472|NCT02240654|9984079|FG001|STARTED|Overall Study||2813
8923473|NCT02240654|9984080|FG002|STARTED|Overall Study||28619
8923474|NCT02240654|9984081|FG003|STARTED|Overall Study||2150
8923475|NCT02240654|9984082|FG004|STARTED|Overall Study||1285
8923476|NCT02240654|9984078|FG000|COMPLETED|Overall Study||1706
8923477|NCT02240654|9984079|FG001|COMPLETED|Overall Study||2813
8923478|NCT02240654|9984080|FG002|COMPLETED|Overall Study||28619
8923479|NCT02240654|9984081|FG003|COMPLETED|Overall Study||2150
8923480|NCT02240654|9984082|FG004|COMPLETED|Overall Study||1285
8923481|NCT02240654|9984078|FG000|NOT COMPLETED|Overall Study||0
8923482|NCT02240654|9984079|FG001|NOT COMPLETED|Overall Study||0
8923483|NCT02240654|9984080|FG002|NOT COMPLETED|Overall Study||0
8923484|NCT02240654|9984081|FG003|NOT COMPLETED|Overall Study||0
8923485|NCT02240654|9984082|FG004|NOT COMPLETED|Overall Study||0
8923486|NCT02240667|9984096|FG000|STARTED|Overall Study||771
8923487|NCT02240667|9984097|FG001|STARTED|Overall Study||650
8923488|NCT02240667|9984096|FG000|COMPLETED|Overall Study||771
8923489|NCT02240667|9984097|FG001|COMPLETED|Overall Study||650
8923490|NCT02240667|9984096|FG000|NOT COMPLETED|Overall Study||0
8923491|NCT02240667|9984097|FG001|NOT COMPLETED|Overall Study||0
8923492|NCT02240680|9984105|FG000|STARTED|Overall Study (Up to 24 Weeks)||151
8923493|NCT02240680|9984106|FG001|STARTED|Overall Study (Up to 24 Weeks)||151
8923494|NCT02240680|9984107|FG002|STARTED|Overall Study (Up to 24 Weeks)||0
8923495|NCT02240680|9984108|FG003|STARTED|Overall Study (Up to 24 Weeks)||0
8923496|NCT02240680|9984105|FG000|COMPLETED|Overall Study (Up to 24 Weeks)||136
8949348|NCT02437409|10011896|FG000|NOT COMPLETED|Overall Study||15
8949349|NCT02437487|10011903|FG000|STARTED|Overall Study||59
8949350|NCT02437487|10011904|FG001|STARTED|Overall Study||30
8949351|NCT02437487|10011903|FG000|Actual Treatment Received|Overall Study||60
8949352|NCT02437487|10011904|FG001|Actual Treatment Received|Overall Study||29
8949353|NCT02437487|10011903|FG000|Intention-to-Treat Population|Overall Study||59
8949354|NCT02437487|10011904|FG001|Intention-to-Treat Population|Overall Study||30
8949355|NCT02437487|10011903|FG000|COMPLETED|Overall Study||32
8949356|NCT02437487|10011904|FG001|COMPLETED|Overall Study||16
8949357|NCT02437487|10011903|FG000|NOT COMPLETED|Overall Study||27
8949358|NCT02437487|10011904|FG001|NOT COMPLETED|Overall Study||14
8949359|NCT02437513|10011910|FG000|STARTED|Overall Study||2
8949360|NCT02437513|10011910|FG000|COMPLETED|Overall Study||0
8949361|NCT02437513|10011910|FG000|NOT COMPLETED|Overall Study||2
8949362|NCT02437669|10011914|FG000|STARTED|Overall Study||35
8949363|NCT02437669|10011914|FG000|COMPLETED|Overall Study||35
8949364|NCT02437669|10011914|FG000|NOT COMPLETED|Overall Study||0
8949365|NCT02437864|10011921|FG000|STARTED|Overall Study||200
8949366|NCT02437864|10011922|FG001|STARTED|Overall Study||160
8949367|NCT02437864|10011921|FG000|COMPLETED|Overall Study||196
8949368|NCT02437864|10011922|FG001|COMPLETED|Overall Study||160
8949369|NCT02437864|10011921|FG000|NOT COMPLETED|Overall Study||4
8949370|NCT02437864|10011922|FG001|NOT COMPLETED|Overall Study||0
8949371|NCT02437890|10011933|FG000|STARTED|Overall Study||62
8949372|NCT02437890|10011934|FG001|STARTED|Overall Study||64
8923497|NCT02240680|9984106|FG001|COMPLETED|Overall Study (Up to 24 Weeks)||143
8923498|NCT02240680|9984107|FG002|COMPLETED|Overall Study (Up to 24 Weeks)||0
8923499|NCT02240680|9984108|FG003|COMPLETED|Overall Study (Up to 24 Weeks)||0
8923500|NCT02240680|9984105|FG000|NOT COMPLETED|Overall Study (Up to 24 Weeks)||15
8923501|NCT02240680|9984106|FG001|NOT COMPLETED|Overall Study (Up to 24 Weeks)||8
8923502|NCT02240680|9984107|FG002|NOT COMPLETED|Overall Study (Up to 24 Weeks)||0
8923503|NCT02240680|9984108|FG003|NOT COMPLETED|Overall Study (Up to 24 Weeks)||0
8923504|NCT02240680|9984105|FG000|STARTED|Japanese Patients (Up to 52 Weeks)||0
8923505|NCT02240680|9984106|FG001|STARTED|Japanese Patients (Up to 52 Weeks)||0
8923506|NCT02240680|9984107|FG002|STARTED|Japanese Patients (Up to 52 Weeks)||50
8949373|NCT02437890|10011935|FG002|STARTED|Overall Study||62
8855480|NCT01779141|9910837|FG000|STARTED|Overall Study||481
8855481|NCT01779141|9910837|FG000|COMPLETED|Overall Study||300
8855482|NCT01779141|9910837|FG000|NOT COMPLETED|Overall Study||181
8855483|NCT01779167|9910841|FG000|STARTED|Overall Study||4
8855484|NCT01779167|9910841|FG000|COMPLETED|Overall Study||3
8855485|NCT01779167|9910841|FG000|NOT COMPLETED|Overall Study||1
8855486|NCT01779219|9910847|FG000|STARTED|Overall Study|First interim analysis|21
8855487|NCT01779219|9910848|FG001|STARTED|Overall Study|First interim analysis|21
8855488|NCT01779219|9910847|FG000|COMPLETED|Overall Study|First interim analysis|21
8855489|NCT01779219|9910848|FG001|COMPLETED|Overall Study|First interim analysis|21
8629894|NCT00532259|9669632|FG000|NOT COMPLETED|Overall Study||32
8629895|NCT00532298|9669643|FG000|STARTED|Overall Study||269
8629896|NCT00532298|9669644|FG001|STARTED|Overall Study||266
8629897|NCT00532298|9669645|FG002|STARTED|Overall Study||264
8629898|NCT00532298|9669646|FG003|STARTED|Overall Study||264
8629899|NCT00532298|9669647|FG004|STARTED|Overall Study||268
8629900|NCT00532298|9669648|FG005|STARTED|Overall Study||263
8629901|NCT00532298|9669643|FG000|COMPLETED|Overall Study||267
8629902|NCT00532298|9669644|FG001|COMPLETED|Overall Study||265
8725275|NCT01030523|9772507|FG000|STARTED|Overall Study||50
8855490|NCT01779219|9910847|FG000|NOT COMPLETED|Overall Study||0
8725276|NCT01030523|9772508|FG001|STARTED|Overall Study||51
8855491|NCT01779219|9910848|FG001|NOT COMPLETED|Overall Study||0
8855492|NCT01779375|9910856|FG000|STARTED|Overall Study||47
8855493|NCT01779375|9910857|FG001|STARTED|Overall Study||44
8855494|NCT01779375|9910856|FG000|COMPLETED|Overall Study||45
8855495|NCT01779375|9910857|FG001|COMPLETED|Overall Study||41
8855496|NCT01779375|9910856|FG000|NOT COMPLETED|Overall Study||2
8855497|NCT01779375|9910857|FG001|NOT COMPLETED|Overall Study||3
8855498|NCT01779440|9910867|FG000|STARTED|Overall Study||30
8855499|NCT01779440|9910868|FG001|STARTED|Overall Study||28
8855500|NCT01779440|9910867|FG000|COMPLETED|Overall Study||27
8855501|NCT01779440|9910868|FG001|COMPLETED|Overall Study||23
8855502|NCT01779440|9910867|FG000|NOT COMPLETED|Overall Study||3
8855503|NCT01779440|9910868|FG001|NOT COMPLETED|Overall Study||5
8855504|NCT01779648|9910876|FG000|STARTED|Overall Study||28
8855505|NCT01779648|9910877|FG001|STARTED|Overall Study||27
8855506|NCT01779648|9910876|FG000|COMPLETED|Overall Study||27
8855507|NCT01779648|9910877|FG001|COMPLETED|Overall Study||27
8855508|NCT01779648|9910876|FG000|NOT COMPLETED|Overall Study||1
8855509|NCT01779648|9910877|FG001|NOT COMPLETED|Overall Study||0
8855510|NCT01779700|9910885|FG000|STARTED|Overall Study||18
8855511|NCT01779700|9910886|FG001|STARTED|Overall Study||22
8855512|NCT01779700|9910885|FG000|COMPLETED|Overall Study||14
8855513|NCT01779700|9910886|FG001|COMPLETED|Overall Study||17
8855514|NCT01779700|9910885|FG000|NOT COMPLETED|Overall Study||4
8855515|NCT01779700|9910886|FG001|NOT COMPLETED|Overall Study||5
8855516|NCT01779856|9910892|FG000|STARTED|Overall Study||81
8855517|NCT01779856|9910892|FG000|COMPLETED|Overall Study||57
8855518|NCT01779856|9910892|FG000|NOT COMPLETED|Overall Study||24
8855519|NCT01779869|9910903|FG000|STARTED|Overall Study||16
8855520|NCT01779869|9910903|FG000|COMPLETED|Overall Study||14
8855521|NCT01779869|9910903|FG000|NOT COMPLETED|Overall Study||2
8855522|NCT01780324|9910909|FG000|STARTED|Overall Study||41
8855523|NCT01780324|9910910|FG001|STARTED|Overall Study||39
8855524|NCT01780324|9910909|FG000|COMPLETED|Overall Study||40
8855525|NCT01780324|9910910|FG001|COMPLETED|Overall Study||33
8855526|NCT01780324|9910909|FG000|NOT COMPLETED|Overall Study||1
8855527|NCT01780324|9910910|FG001|NOT COMPLETED|Overall Study||6
8855528|NCT01780337|9910918|FG000|STARTED|Overall Study||6
8855529|NCT01780337|9910919|FG001|STARTED|Overall Study||6
8855530|NCT01780337|9910918|FG000|COMPLETED|Overall Study||6
8855531|NCT01780337|9910919|FG001|COMPLETED|Overall Study||6
8725277|NCT01030523|9772507|FG000|COMPLETED|Overall Study||44
8725278|NCT01030523|9772508|FG001|COMPLETED|Overall Study||46
8725279|NCT01030523|9772507|FG000|NOT COMPLETED|Overall Study||6
8725280|NCT01030523|9772508|FG001|NOT COMPLETED|Overall Study||5
8725281|NCT01030536|9772519|FG000|STARTED|Overall Study||7
8725282|NCT01030536|9772520|FG001|STARTED|Overall Study||6
8725283|NCT01030536|9772521|FG002|STARTED|Overall Study||6
8725284|NCT01030536|9772522|FG003|STARTED|Overall Study||3
8725285|NCT01030536|9772523|FG004|STARTED|Overall Study||1
8855532|NCT01780337|9910918|FG000|NOT COMPLETED|Overall Study||0
8855533|NCT01780337|9910919|FG001|NOT COMPLETED|Overall Study||0
8855534|NCT01780350|9910925|FG000|STARTED|Overall Study||200
8855535|NCT01780350|9910925|FG000|COMPLETED|Overall Study||200
8855536|NCT01780350|9910925|FG000|NOT COMPLETED|Overall Study||0
8855537|NCT01780389|9910929|FG000|STARTED|Overall Study||5
8855538|NCT01780389|9910929|FG000|COMPLETED|Overall Study|One patient discontinued due to adverse event.|4
8855539|NCT01780389|9910929|FG000|NOT COMPLETED|Overall Study||1
8855540|NCT01780454|9910934|FG000|STARTED|Overall Study||2
8629903|NCT00532298|9669645|FG002|COMPLETED|Overall Study||263
8629904|NCT00532298|9669646|FG003|COMPLETED|Overall Study||264
8855541|NCT01780454|9910934|FG000|COMPLETED|Overall Study||2
8855542|NCT01780454|9910934|FG000|NOT COMPLETED|Overall Study||0
8855543|NCT01780506|9910940|FG000|STARTED|Double-Blind Phase||438
8855544|NCT01780506|9910941|FG001|STARTED|Double-Blind Phase||434
8855545|NCT01780506|9910940|FG000|COMPLETED|Double-Blind Phase||368
8855546|NCT01780506|9910941|FG001|COMPLETED|Double-Blind Phase||356
8629905|NCT00532298|9669647|FG004|COMPLETED|Overall Study||267
8725286|NCT01030536|9772519|FG000|COMPLETED|Overall Study||0
8725287|NCT01030536|9772520|FG001|COMPLETED|Overall Study||0
8855547|NCT01780506|9910940|FG000|NOT COMPLETED|Double-Blind Phase||70
8855548|NCT01780506|9910941|FG001|NOT COMPLETED|Double-Blind Phase||78
8855549|NCT01780506|9910940|FG000|STARTED|Open-Label Extension Phase|278 participants completed the Double-Blind Phase but did not enter the Open-Label Extension Phase|90
8855550|NCT01780506|9910941|FG001|STARTED|Open-Label Extension Phase|261 participants completed the Double-Blind Phase but did not enter the Open-Label Extension Phase|95
8855551|NCT01780506|9910940|FG000|COMPLETED|Open-Label Extension Phase||90
8949374|NCT02437890|10011936|FG003|STARTED|Overall Study||62
8949375|NCT02437890|10011937|FG004|STARTED|Overall Study||62
8949376|NCT02437890|10011933|FG000|COMPLETED|Overall Study||54
8949377|NCT02437890|10011934|FG001|COMPLETED|Overall Study||48
8949378|NCT02437890|10011935|FG002|COMPLETED|Overall Study||47
8949379|NCT02437890|10011936|FG003|COMPLETED|Overall Study||40
8949380|NCT02437890|10011937|FG004|COMPLETED|Overall Study||46
8949381|NCT02437890|10011933|FG000|NOT COMPLETED|Overall Study||8
8949382|NCT02437890|10011934|FG001|NOT COMPLETED|Overall Study||16
8949383|NCT02437890|10011935|FG002|NOT COMPLETED|Overall Study||15
8949384|NCT02437890|10011936|FG003|NOT COMPLETED|Overall Study||22
8949385|NCT02437890|10011937|FG004|NOT COMPLETED|Overall Study||16
8949386|NCT02437903|10011953|FG000|STARTED|Overall Study||30
8949387|NCT02437903|10011953|FG000|COMPLETED|Overall Study||25
8949388|NCT02437903|10011953|FG000|NOT COMPLETED|Overall Study||5
8949389|NCT02438137|10011960|FG000|STARTED|Overall Study||44
8949390|NCT02438137|10011961|FG001|STARTED|Overall Study||21
8949391|NCT02438137|10011960|FG000|COMPLETED|Overall Study||36
8949392|NCT02438137|10011961|FG001|COMPLETED|Overall Study||15
8949393|NCT02438137|10011960|FG000|NOT COMPLETED|Overall Study||8
8949394|NCT02438137|10011961|FG001|NOT COMPLETED|Overall Study||6
8949395|NCT02438280|10011971|FG000|STARTED|Overall Study||14
8949396|NCT02438280|10011972|FG001|STARTED|Overall Study||13
8949397|NCT02438280|10011971|FG000|COMPLETED|Overall Study||13
8949398|NCT02438280|10011972|FG001|COMPLETED|Overall Study||13
8949399|NCT02438280|10011971|FG000|NOT COMPLETED|Overall Study||1
8949400|NCT02438280|10011972|FG001|NOT COMPLETED|Overall Study||0
8949401|NCT02438371|10011981|FG000|STARTED|Overall Study||24
8949402|NCT02438371|10011982|FG001|STARTED|Overall Study||25
8949403|NCT02438371|10011981|FG000|Received Intervention|Overall Study||24
8949404|NCT02438371|10011982|FG001|Received Intervention|Overall Study||25
8949405|NCT02438371|10011981|FG000|COMPLETED|Overall Study||20
8949406|NCT02438371|10011982|FG001|COMPLETED|Overall Study||22
8949407|NCT02438371|10011981|FG000|NOT COMPLETED|Overall Study||4
8949408|NCT02438371|10011982|FG001|NOT COMPLETED|Overall Study||3
8949409|NCT02438384|10011991|FG000|STARTED|Overall Study||25
8949410|NCT02438384|10011992|FG001|STARTED|Overall Study||25
8949411|NCT02438384|10011993|FG002|STARTED|Overall Study||25
8949412|NCT02438384|10011991|FG000|COMPLETED|Overall Study||17
8949413|NCT02438384|10011992|FG001|COMPLETED|Overall Study||19
8949414|NCT02438384|10011993|FG002|COMPLETED|Overall Study||21
8949415|NCT02438384|10011991|FG000|NOT COMPLETED|Overall Study||8
8949416|NCT02438384|10011992|FG001|NOT COMPLETED|Overall Study||6
8949417|NCT02438384|10011993|FG002|NOT COMPLETED|Overall Study||4
8949418|NCT02438423|10012005|FG000|STARTED|Overall Study||25
8855552|NCT01780506|9910941|FG001|COMPLETED|Open-Label Extension Phase||94
8855553|NCT01780506|9910940|FG000|NOT COMPLETED|Open-Label Extension Phase||0
8855554|NCT01780506|9910941|FG001|NOT COMPLETED|Open-Label Extension Phase||1
8855555|NCT01780545|9910951|FG000|STARTED|Overall Study||99
8949419|NCT02438423|10012006|FG001|STARTED|Overall Study||25
8949420|NCT02438423|10012007|FG002|STARTED|Overall Study||25
8855556|NCT01780545|9910952|FG001|STARTED|Overall Study||101
8855557|NCT01780545|9910951|FG000|COMPLETED|Overall Study||95
8855558|NCT01780545|9910952|FG001|COMPLETED|Overall Study||99
8855559|NCT01780545|9910951|FG000|NOT COMPLETED|Overall Study||4
8855560|NCT01780545|9910952|FG001|NOT COMPLETED|Overall Study||2
8855561|NCT01780584|9910964|FG000|STARTED|Overall Study||15
8855562|NCT01780584|9910965|FG001|STARTED|Overall Study||15
8855563|NCT01780584|9910966|FG002|STARTED|Overall Study||15
8855564|NCT01780584|9910964|FG000|COMPLETED|Overall Study||14
8855565|NCT01780584|9910965|FG001|COMPLETED|Overall Study||14
8855566|NCT01780584|9910966|FG002|COMPLETED|Overall Study||13
8855567|NCT01780584|9910964|FG000|NOT COMPLETED|Overall Study||1
8855568|NCT01780584|9910965|FG001|NOT COMPLETED|Overall Study||1
8855569|NCT01780584|9910966|FG002|NOT COMPLETED|Overall Study||2
8855570|NCT01780662|9910977|FG000|STARTED|Overall Study||3
8855571|NCT01780662|9910978|FG001|STARTED|Overall Study||13
8855572|NCT01780662|9910979|FG002|STARTED|Overall Study||30
8855573|NCT01780662|9910977|FG000|COMPLETED|Overall Study||2
8855574|NCT01780662|9910978|FG001|COMPLETED|Overall Study||7
8855575|NCT01780662|9910979|FG002|COMPLETED|Overall Study||20
8855576|NCT01780662|9910977|FG000|NOT COMPLETED|Overall Study||1
8855577|NCT01780662|9910978|FG001|NOT COMPLETED|Overall Study||6
8855578|NCT01780662|9910979|FG002|NOT COMPLETED|Overall Study||10
8855579|NCT01780831|9910992|FG000|STARTED|Overall Study||10
8855580|NCT01780831|9910993|FG001|STARTED|Overall Study||6
8855581|NCT01780831|9910994|FG002|STARTED|Overall Study||26
8855582|NCT01780831|9910995|FG003|STARTED|Overall Study||10
8855583|NCT01780831|9910992|FG000|COMPLETED|Overall Study||10
8855584|NCT01780831|9910993|FG001|COMPLETED|Overall Study||6
8855585|NCT01780831|9910994|FG002|COMPLETED|Overall Study||22
8855586|NCT01780831|9910995|FG003|COMPLETED|Overall Study||9
8855587|NCT01780831|9910992|FG000|NOT COMPLETED|Overall Study||0
8855588|NCT01780831|9910993|FG001|NOT COMPLETED|Overall Study||0
8855589|NCT01780831|9910994|FG002|NOT COMPLETED|Overall Study||4
8855590|NCT01780831|9910995|FG003|NOT COMPLETED|Overall Study||1
8855591|NCT01780870|9911054|FG000|STARTED|Overall Study||0
8855592|NCT01780870|9911055|FG001|STARTED|Overall Study||5
8855593|NCT01780870|9911054|FG000|COMPLETED|Overall Study||0
8855594|NCT01780870|9911055|FG001|COMPLETED|Overall Study||5
8855595|NCT01780870|9911054|FG000|NOT COMPLETED|Overall Study||0
8855596|NCT01780870|9911055|FG001|NOT COMPLETED|Overall Study||0
8855597|NCT01780922|9911061|FG000|STARTED|First Intervention (1 Day)||2
8855598|NCT01780922|9911062|FG001|STARTED|First Intervention (1 Day)||2
8855599|NCT01780922|9911063|FG002|STARTED|First Intervention (1 Day)||2
8855600|NCT01780922|9911064|FG003|STARTED|First Intervention (1 Day)||2
8855601|NCT01780922|9911065|FG004|STARTED|First Intervention (1 Day)||2
8855602|NCT01780922|9911066|FG005|STARTED|First Intervention (1 Day)||2
8855603|NCT01780922|9911061|FG000|COMPLETED|First Intervention (1 Day)||2
8855604|NCT01780922|9911062|FG001|COMPLETED|First Intervention (1 Day)||2
8855605|NCT01780922|9911063|FG002|COMPLETED|First Intervention (1 Day)||2
8855606|NCT01780922|9911064|FG003|COMPLETED|First Intervention (1 Day)||2
8855607|NCT01780922|9911065|FG004|COMPLETED|First Intervention (1 Day)||2
8855608|NCT01780922|9911066|FG005|COMPLETED|First Intervention (1 Day)||2
8855609|NCT01780922|9911061|FG000|NOT COMPLETED|First Intervention (1 Day)||0
8855610|NCT01780922|9911062|FG001|NOT COMPLETED|First Intervention (1 Day)||0
8855611|NCT01780922|9911063|FG002|NOT COMPLETED|First Intervention (1 Day)||0
8855612|NCT01780922|9911064|FG003|NOT COMPLETED|First Intervention (1 Day)||0
8855613|NCT01780922|9911065|FG004|NOT COMPLETED|First Intervention (1 Day)||0
8855614|NCT01780922|9911066|FG005|NOT COMPLETED|First Intervention (1 Day)||0
8855615|NCT01780922|9911061|FG000|STARTED|Washout (7 Days)||2
8855616|NCT01780922|9911062|FG001|STARTED|Washout (7 Days)||2
8855617|NCT01780922|9911063|FG002|STARTED|Washout (7 Days)||2
8855618|NCT01780922|9911064|FG003|STARTED|Washout (7 Days)||2
8855619|NCT01780922|9911065|FG004|STARTED|Washout (7 Days)||2
8855620|NCT01780922|9911066|FG005|STARTED|Washout (7 Days)||2
8855621|NCT01780922|9911061|FG000|COMPLETED|Washout (7 Days)||2
8855622|NCT01780922|9911062|FG001|COMPLETED|Washout (7 Days)||2
8855623|NCT01780922|9911063|FG002|COMPLETED|Washout (7 Days)||2
8855624|NCT01780922|9911064|FG003|COMPLETED|Washout (7 Days)||2
8855625|NCT01780922|9911065|FG004|COMPLETED|Washout (7 Days)||2
8855626|NCT01780922|9911066|FG005|COMPLETED|Washout (7 Days)||2
8855627|NCT01780922|9911061|FG000|NOT COMPLETED|Washout (7 Days)||0
8855628|NCT01780922|9911062|FG001|NOT COMPLETED|Washout (7 Days)||0
8855629|NCT01780922|9911063|FG002|NOT COMPLETED|Washout (7 Days)||0
8855630|NCT01780922|9911064|FG003|NOT COMPLETED|Washout (7 Days)||0
8855631|NCT01780922|9911065|FG004|NOT COMPLETED|Washout (7 Days)||0
8855632|NCT01780922|9911066|FG005|NOT COMPLETED|Washout (7 Days)||0
8855633|NCT01780922|9911061|FG000|STARTED|Second Intervention (1 Day)||2
8855634|NCT01780922|9911062|FG001|STARTED|Second Intervention (1 Day)||2
8855635|NCT01780922|9911063|FG002|STARTED|Second Intervention (1 Day)||2
8855636|NCT01780922|9911064|FG003|STARTED|Second Intervention (1 Day)||2
8855637|NCT01780922|9911065|FG004|STARTED|Second Intervention (1 Day)||2
8855638|NCT01780922|9911066|FG005|STARTED|Second Intervention (1 Day)||2
8855639|NCT01780922|9911061|FG000|COMPLETED|Second Intervention (1 Day)||2
8855640|NCT01780922|9911062|FG001|COMPLETED|Second Intervention (1 Day)||2
8855641|NCT01780922|9911063|FG002|COMPLETED|Second Intervention (1 Day)||2
8855642|NCT01780922|9911064|FG003|COMPLETED|Second Intervention (1 Day)||2
8855643|NCT01780922|9911065|FG004|COMPLETED|Second Intervention (1 Day)||2
8855644|NCT01780922|9911066|FG005|COMPLETED|Second Intervention (1 Day)||2
8855645|NCT01780922|9911061|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
8855646|NCT01780922|9911062|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
8855647|NCT01780922|9911063|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
8855648|NCT01780922|9911064|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
8855649|NCT01780922|9911065|FG004|NOT COMPLETED|Second Intervention (1 Day)||0
8855650|NCT01780922|9911066|FG005|NOT COMPLETED|Second Intervention (1 Day)||0
8855651|NCT01780922|9911061|FG000|STARTED|Washout (7 Days)||2
8855652|NCT01780922|9911062|FG001|STARTED|Washout (7 Days)||2
8855653|NCT01780922|9911063|FG002|STARTED|Washout (7 Days)||2
8855654|NCT01780922|9911064|FG003|STARTED|Washout (7 Days)||2
8855655|NCT01780922|9911065|FG004|STARTED|Washout (7 Days)||2
8855656|NCT01780922|9911066|FG005|STARTED|Washout (7 Days)||2
8855657|NCT01780922|9911061|FG000|COMPLETED|Washout (7 Days)||2
8855658|NCT01780922|9911062|FG001|COMPLETED|Washout (7 Days)||2
8855659|NCT01780922|9911063|FG002|COMPLETED|Washout (7 Days)||2
8855660|NCT01780922|9911064|FG003|COMPLETED|Washout (7 Days)||2
8855661|NCT01780922|9911065|FG004|COMPLETED|Washout (7 Days)||2
8855662|NCT01780922|9911066|FG005|COMPLETED|Washout (7 Days)||2
8855663|NCT01780922|9911061|FG000|NOT COMPLETED|Washout (7 Days)||0
8855664|NCT01780922|9911062|FG001|NOT COMPLETED|Washout (7 Days)||0
8855665|NCT01780922|9911063|FG002|NOT COMPLETED|Washout (7 Days)||0
8855666|NCT01780922|9911064|FG003|NOT COMPLETED|Washout (7 Days)||0
8855667|NCT01780922|9911065|FG004|NOT COMPLETED|Washout (7 Days)||0
8855668|NCT01780922|9911066|FG005|NOT COMPLETED|Washout (7 Days)||0
8855669|NCT01780922|9911061|FG000|STARTED|Third Intervention (1 Day)||2
8855670|NCT01780922|9911062|FG001|STARTED|Third Intervention (1 Day)||2
8855671|NCT01780922|9911063|FG002|STARTED|Third Intervention (1 Day)||2
8855672|NCT01780922|9911064|FG003|STARTED|Third Intervention (1 Day)||2
8855673|NCT01780922|9911065|FG004|STARTED|Third Intervention (1 Day)||2
8855674|NCT01780922|9911066|FG005|STARTED|Third Intervention (1 Day)||2
8855675|NCT01780922|9911061|FG000|COMPLETED|Third Intervention (1 Day)||2
8855676|NCT01780922|9911062|FG001|COMPLETED|Third Intervention (1 Day)||2
8855677|NCT01780922|9911063|FG002|COMPLETED|Third Intervention (1 Day)||2
8855678|NCT01780922|9911064|FG003|COMPLETED|Third Intervention (1 Day)||2
8855679|NCT01780922|9911065|FG004|COMPLETED|Third Intervention (1 Day)||2
8855680|NCT01780922|9911066|FG005|COMPLETED|Third Intervention (1 Day)||2
8855681|NCT01780922|9911061|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
8725288|NCT01030536|9772521|FG002|COMPLETED|Overall Study||0
8725289|NCT01030536|9772522|FG003|COMPLETED|Overall Study||0
8725290|NCT01030536|9772523|FG004|COMPLETED|Overall Study||0
8725291|NCT01030536|9772519|FG000|NOT COMPLETED|Overall Study||7
8725292|NCT01030536|9772520|FG001|NOT COMPLETED|Overall Study||6
8725293|NCT01030536|9772521|FG002|NOT COMPLETED|Overall Study||6
8725294|NCT01030536|9772522|FG003|NOT COMPLETED|Overall Study||3
8725295|NCT01030536|9772523|FG004|NOT COMPLETED|Overall Study||1
8725296|NCT01030653|9772541|FG000|STARTED|Loading Dose & First Maintenance Regimen||4
8725297|NCT01030653|9772542|FG001|STARTED|Loading Dose & First Maintenance Regimen||4
8855682|NCT01780922|9911062|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
8855683|NCT01780922|9911063|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
8855684|NCT01780922|9911064|FG003|NOT COMPLETED|Third Intervention (1 Day)||0
8855685|NCT01780922|9911065|FG004|NOT COMPLETED|Third Intervention (1 Day)||0
8855686|NCT01780922|9911066|FG005|NOT COMPLETED|Third Intervention (1 Day)||0
8855687|NCT01780935|9911076|FG000|STARTED|Overall Study||335
8855688|NCT01780935|9911077|FG001|STARTED|Overall Study||336
8855689|NCT01780935|9911076|FG000|Safety Set|Overall Study||334
8855690|NCT01780935|9911077|FG001|Safety Set|Overall Study||336
8855691|NCT01780935|9911076|FG000|COMPLETED|Overall Study||0
8855692|NCT01780935|9911077|FG001|COMPLETED|Overall Study||0
8855693|NCT01780935|9911076|FG000|NOT COMPLETED|Overall Study||335
8725298|NCT01030653|9772541|FG000|COMPLETED|Loading Dose & First Maintenance Regimen||4
8855694|NCT01780935|9911077|FG001|NOT COMPLETED|Overall Study||336
8855695|NCT01780974|9911085|FG000|STARTED|Overall Study||21
8855696|NCT01780974|9911086|FG001|STARTED|Overall Study||21
8855697|NCT01780974|9911085|FG000|COMPLETED|Overall Study||19
8855698|NCT01780974|9911086|FG001|COMPLETED|Overall Study||18
8855699|NCT01780974|9911085|FG000|NOT COMPLETED|Overall Study||2
8855700|NCT01780974|9911086|FG001|NOT COMPLETED|Overall Study||3
8855701|NCT01780987|9911094|FG000|STARTED|Overall Study||40
8855702|NCT01780987|9911095|FG001|STARTED|Overall Study|Including one participant who withdrew from the study prior to receiving any study medication.|40
8855703|NCT01780987|9911094|FG000|COMPLETED|Overall Study||37
8855704|NCT01780987|9911095|FG001|COMPLETED|Overall Study||34
8855705|NCT01780987|9911094|FG000|NOT COMPLETED|Overall Study||3
8855706|NCT01780987|9911095|FG001|NOT COMPLETED|Overall Study||6
8855707|NCT01781078|9911103|FG000|STARTED|Overall Study|Randomized post implantation|229
8855708|NCT01781078|9911104|FG001|STARTED|Overall Study|Randomized post implantation|118
8855709|NCT01781078|9911105|FG002|STARTED|Overall Study||16
8855710|NCT01781078|9911103|FG000|COMPLETED|Overall Study|Patients having completed the MRI + 1 month (Primary endpoint assessment)|217
8855711|NCT01781078|9911104|FG001|COMPLETED|Overall Study|Patients having completed the MRI + 1 month (Primary endpoint assessment)|113
8855712|NCT01781078|9911105|FG002|COMPLETED|Overall Study||0
8855713|NCT01781078|9911103|FG000|NOT COMPLETED|Overall Study||12
8855714|NCT01781078|9911104|FG001|NOT COMPLETED|Overall Study||5
8855715|NCT01781078|9911105|FG002|NOT COMPLETED|Overall Study||16
8855716|NCT01781169|9911116|FG000|STARTED|Overall Study||22
8855717|NCT01781169|9911117|FG001|STARTED|Overall Study||21
8855718|NCT01781169|9911116|FG000|COMPLETED|Overall Study||21
8855719|NCT01781169|9911117|FG001|COMPLETED|Overall Study||21
8855720|NCT01781169|9911116|FG000|NOT COMPLETED|Overall Study||1
8855721|NCT01781169|9911117|FG001|NOT COMPLETED|Overall Study||0
8855722|NCT01781208|9911123|FG000|STARTED|Overall Study||62
8855723|NCT01781208|9911123|FG000|Overall Study|Overall Study||62
8855724|NCT01781208|9911123|FG000|COMPLETED|Overall Study||62
8855725|NCT01781208|9911123|FG000|NOT COMPLETED|Overall Study||0
8855726|NCT01781234|9911130|FG000|STARTED|Overall Study||27
8855727|NCT01781234|9911131|FG001|STARTED|Overall Study||24
8855728|NCT01781234|9911130|FG000|COMPLETED|Overall Study||18
8855729|NCT01781234|9911131|FG001|COMPLETED|Overall Study||21
8855730|NCT01781234|9911130|FG000|NOT COMPLETED|Overall Study||9
8949421|NCT02438423|10012008|FG003|STARTED|Overall Study||25
8949422|NCT02438423|10012005|FG000|COMPLETED|Overall Study||25
8949423|NCT02438423|10012006|FG001|COMPLETED|Overall Study||25
8949424|NCT02438423|10012007|FG002|COMPLETED|Overall Study||25
8949425|NCT02438423|10012008|FG003|COMPLETED|Overall Study||25
8949426|NCT02438423|10012005|FG000|NOT COMPLETED|Overall Study||0
8949427|NCT02438423|10012006|FG001|NOT COMPLETED|Overall Study||0
8949428|NCT02438423|10012007|FG002|NOT COMPLETED|Overall Study||0
8949429|NCT02438423|10012008|FG003|NOT COMPLETED|Overall Study||0
8949430|NCT02438475|10012022|FG000|STARTED|Overall Study||104
8949431|NCT02438475|10012023|FG001|STARTED|Overall Study||104
8949432|NCT02438475|10012022|FG000|COMPLETED|Overall Study||102
8949433|NCT02438475|10012023|FG001|COMPLETED|Overall Study||104
8949434|NCT02438475|10012022|FG000|NOT COMPLETED|Overall Study||2
8949435|NCT02438475|10012023|FG001|NOT COMPLETED|Overall Study||0
8949436|NCT02438540|10012031|FG000|STARTED|Overall Study||19
8949437|NCT02438540|10012032|FG001|STARTED|Overall Study||20
8949438|NCT02438540|10012031|FG000|COMPLETED|Overall Study||19
8949439|NCT02438540|10012032|FG001|COMPLETED|Overall Study||20
8949440|NCT02438540|10012031|FG000|NOT COMPLETED|Overall Study||0
8949441|NCT02438540|10012032|FG001|NOT COMPLETED|Overall Study||0
8949442|NCT02438787|10012042|FG000|STARTED|Overall Study||104
8949443|NCT02438787|10012043|FG001|STARTED|Overall Study||106
8949444|NCT02438787|10012044|FG002|STARTED|Overall Study||105
8949445|NCT02438787|10012042|FG000|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|21
8949446|NCT02438787|10012043|FG001|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|21
8949447|NCT02438787|10012044|FG002|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|20
8949448|NCT02438787|10012042|FG000|Cross Over at Week 24|Overall Study|Out of 43: crossed over to Ustekinumab 45 mg (n=21) and Ustekinumab 90 mg (n=22)|43
8949449|NCT02438787|10012043|FG001|Cross Over at Week 24|Overall Study||0
8949450|NCT02438787|10012044|FG002|Cross Over at Week 24|Overall Study||0
8949451|NCT02438787|10012042|FG000|COMPLETED|Overall Study||23
8949452|NCT02438787|10012043|FG001|COMPLETED|Overall Study||23
8949453|NCT02438787|10012044|FG002|COMPLETED|Overall Study||22
8949454|NCT02438787|10012042|FG000|NOT COMPLETED|Overall Study||81
8949455|NCT02438787|10012043|FG001|NOT COMPLETED|Overall Study||83
8949456|NCT02438787|10012044|FG002|NOT COMPLETED|Overall Study||83
8949457|NCT02438813|10012057|FG000|STARTED|Overall Study||1029
8949458|NCT02438813|10012057|FG000|Received Treatment for SMF|Overall Study||676
8949459|NCT02438813|10012057|FG000|Did Not ReceiveTreatment for SMF|Overall Study||353
8949460|NCT02438813|10012057|FG000|COMPLETED|Overall Study||504
8949461|NCT02438813|10012057|FG000|NOT COMPLETED|Overall Study||525
8949462|NCT02438826|10012073|FG000|STARTED|Double-Blind Treatment Phase||123
8949463|NCT02438826|10012074|FG001|STARTED|Double-Blind Treatment Phase||117
8949464|NCT02438826|10012075|FG002|STARTED|Double-Blind Treatment Phase||0
8949465|NCT02438826|10012076|FG003|STARTED|Double-Blind Treatment Phase||0
8949466|NCT02438826|10012073|FG000|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||120
8949467|NCT02438826|10012074|FG001|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||117
8855731|NCT01781234|9911131|FG001|NOT COMPLETED|Overall Study||3
8855732|NCT01781286|9911139|FG000|STARTED|Overall Study||7
8855733|NCT01781286|9911140|FG001|STARTED|Overall Study||4
8855734|NCT01781286|9911141|FG002|STARTED|Overall Study||9
8855735|NCT01781286|9911142|FG003|STARTED|Overall Study||8
8855736|NCT01781286|9911143|FG004|STARTED|Overall Study||6
8855737|NCT01781286|9911144|FG005|STARTED|Overall Study||3
8855738|NCT01781286|9911139|FG000|Started 1st Intervention|Overall Study||6
8855739|NCT01781286|9911140|FG001|Started 1st Intervention|Overall Study||4
8855740|NCT01781286|9911141|FG002|Started 1st Intervention|Overall Study||9
8855741|NCT01781286|9911142|FG003|Started 1st Intervention|Overall Study||8
8855742|NCT01781286|9911143|FG004|Started 1st Intervention|Overall Study||6
8855743|NCT01781286|9911144|FG005|Started 1st Intervention|Overall Study||2
8855744|NCT01781286|9911139|FG000|Started 2nd Intervention|Overall Study||5
8855745|NCT01781286|9911140|FG001|Started 2nd Intervention|Overall Study||4
8855746|NCT01781286|9911141|FG002|Started 2nd Intervention|Overall Study||9
8855747|NCT01781286|9911142|FG003|Started 2nd Intervention|Overall Study||8
8855748|NCT01781286|9911143|FG004|Started 2nd Intervention|Overall Study||6
8855749|NCT01781286|9911144|FG005|Started 2nd Intervention|Overall Study||2
8855750|NCT01781286|9911139|FG000|Started 3rd Intervention|Overall Study||5
8855751|NCT01781286|9911140|FG001|Started 3rd Intervention|Overall Study||4
8855752|NCT01781286|9911141|FG002|Started 3rd Intervention|Overall Study||7
8855753|NCT01781286|9911142|FG003|Started 3rd Intervention|Overall Study||7
8855754|NCT01781286|9911143|FG004|Started 3rd Intervention|Overall Study||6
8855755|NCT01781286|9911144|FG005|Started 3rd Intervention|Overall Study||2
8855756|NCT01781286|9911139|FG000|COMPLETED|Overall Study||5
8855757|NCT01781286|9911140|FG001|COMPLETED|Overall Study||4
8855758|NCT01781286|9911141|FG002|COMPLETED|Overall Study||7
8855759|NCT01781286|9911142|FG003|COMPLETED|Overall Study||7
8855760|NCT01781286|9911143|FG004|COMPLETED|Overall Study||6
8855761|NCT01781286|9911144|FG005|COMPLETED|Overall Study||2
8855762|NCT01781286|9911139|FG000|NOT COMPLETED|Overall Study||2
8855763|NCT01781286|9911140|FG001|NOT COMPLETED|Overall Study||0
8855764|NCT01781286|9911141|FG002|NOT COMPLETED|Overall Study||2
8855765|NCT01781286|9911142|FG003|NOT COMPLETED|Overall Study||1
8855766|NCT01781286|9911143|FG004|NOT COMPLETED|Overall Study||0
8855767|NCT01781286|9911144|FG005|NOT COMPLETED|Overall Study||1
8855768|NCT01781299|9911156|FG000|STARTED|Overall Study||4
8855769|NCT01781299|9911157|FG001|STARTED|Overall Study||5
8855770|NCT01781299|9911156|FG000|COMPLETED|Overall Study||4
8855771|NCT01781299|9911157|FG001|COMPLETED|Overall Study||4
8855772|NCT01781299|9911156|FG000|NOT COMPLETED|Overall Study||0
8855773|NCT01781299|9911157|FG001|NOT COMPLETED|Overall Study||1
8855774|NCT01781403|9911163|FG000|STARTED|Overall Study||2
8855775|NCT01781403|9911164|FG001|STARTED|Overall Study||2
8855776|NCT01781403|9911165|FG002|STARTED|Overall Study||18
8855777|NCT01781403|9911163|FG000|COMPLETED|Overall Study||2
8855778|NCT01781403|9911164|FG001|COMPLETED|Overall Study||2
8855779|NCT01781403|9911165|FG002|COMPLETED|Overall Study||18
8855780|NCT01781403|9911163|FG000|NOT COMPLETED|Overall Study||0
8855781|NCT01781403|9911164|FG001|NOT COMPLETED|Overall Study||0
8855782|NCT01781403|9911165|FG002|NOT COMPLETED|Overall Study||0
8855783|NCT01781429|9911190|FG000|STARTED|Overall Study||1
8855784|NCT01781429|9911191|FG001|STARTED|Overall Study||1
8855785|NCT01781429|9911192|FG002|STARTED|Overall Study||1
8855786|NCT01781429|9911193|FG003|STARTED|Overall Study||1
8855787|NCT01781429|9911194|FG004|STARTED|Overall Study||1
8855788|NCT01781429|9911195|FG005|STARTED|Overall Study||4
8855789|NCT01781429|9911196|FG006|STARTED|Overall Study||7
8855790|NCT01781429|9911197|FG007|STARTED|Overall Study||4
8855791|NCT01781429|9911198|FG008|STARTED|Overall Study||7
8855792|NCT01781429|9911199|FG009|STARTED|Overall Study||24
8855793|NCT01781429|9911200|FG010|STARTED|Overall Study||18
8855794|NCT01781429|9911201|FG011|STARTED|Overall Study||21
8855795|NCT01781429|9911202|FG012|STARTED|Overall Study||22
8855796|NCT01781429|9911203|FG013|STARTED|Overall Study||8
8855797|NCT01781429|9911204|FG014|STARTED|Overall Study||16
8855798|NCT01781429|9911205|FG015|STARTED|Overall Study||0
8855799|NCT01781429|9911190|FG000|COMPLETED|Overall Study||0
8855800|NCT01781429|9911191|FG001|COMPLETED|Overall Study||0
8855801|NCT01781429|9911192|FG002|COMPLETED|Overall Study||0
8855802|NCT01781429|9911193|FG003|COMPLETED|Overall Study||0
8855803|NCT01781429|9911194|FG004|COMPLETED|Overall Study||0
8855804|NCT01781429|9911195|FG005|COMPLETED|Overall Study||0
8855805|NCT01781429|9911196|FG006|COMPLETED|Overall Study||0
8855806|NCT01781429|9911197|FG007|COMPLETED|Overall Study||0
8855807|NCT01781429|9911198|FG008|COMPLETED|Overall Study||0
8855808|NCT01781429|9911199|FG009|COMPLETED|Overall Study||0
8855809|NCT01781429|9911200|FG010|COMPLETED|Overall Study||0
8855810|NCT01781429|9911201|FG011|COMPLETED|Overall Study||0
8855811|NCT01781429|9911202|FG012|COMPLETED|Overall Study||0
8855812|NCT01781429|9911203|FG013|COMPLETED|Overall Study||0
8855813|NCT01781429|9911204|FG014|COMPLETED|Overall Study||0
8855814|NCT01781429|9911205|FG015|COMPLETED|Overall Study||0
8855815|NCT01781429|9911190|FG000|NOT COMPLETED|Overall Study||1
8855816|NCT01781429|9911191|FG001|NOT COMPLETED|Overall Study||1
8855817|NCT01781429|9911192|FG002|NOT COMPLETED|Overall Study||1
8855818|NCT01781429|9911193|FG003|NOT COMPLETED|Overall Study||1
8855819|NCT01781429|9911194|FG004|NOT COMPLETED|Overall Study||1
8855820|NCT01781429|9911195|FG005|NOT COMPLETED|Overall Study||4
8855821|NCT01781429|9911196|FG006|NOT COMPLETED|Overall Study||7
8855822|NCT01781429|9911197|FG007|NOT COMPLETED|Overall Study||4
8855823|NCT01781429|9911198|FG008|NOT COMPLETED|Overall Study||7
8855824|NCT01781429|9911199|FG009|NOT COMPLETED|Overall Study||24
8855825|NCT01781429|9911200|FG010|NOT COMPLETED|Overall Study||18
8855826|NCT01781429|9911201|FG011|NOT COMPLETED|Overall Study||21
8855827|NCT01781429|9911202|FG012|NOT COMPLETED|Overall Study||22
8855828|NCT01781429|9911203|FG013|NOT COMPLETED|Overall Study||8
8855829|NCT01781429|9911204|FG014|NOT COMPLETED|Overall Study||16
8855830|NCT01781429|9911205|FG015|NOT COMPLETED|Overall Study||0
8855831|NCT01781468|9911241|FG000|STARTED|Overall Study||109
8855832|NCT01781468|9911242|FG001|STARTED|Overall Study||110
8855833|NCT01781468|9911243|FG002|STARTED|Overall Study||109
8855834|NCT01781468|9911241|FG000|COMPLETED|Overall Study||103
8855835|NCT01781468|9911242|FG001|COMPLETED|Overall Study||97
8855836|NCT01781468|9911243|FG002|COMPLETED|Overall Study||97
8855837|NCT01781468|9911241|FG000|NOT COMPLETED|Overall Study||6
8855838|NCT01781468|9911242|FG001|NOT COMPLETED|Overall Study||13
8855839|NCT01781468|9911243|FG002|NOT COMPLETED|Overall Study||12
8855840|NCT01781481|9911252|FG000|STARTED|Overall Study||148
8855841|NCT01781481|9911252|FG000|COMPLETED|Overall Study||148
8855842|NCT01781481|9911252|FG000|NOT COMPLETED|Overall Study||0
8855843|NCT01781572|9911308|FG000|STARTED|MEK162 45mg BID+LEE011 200mg||16
8855844|NCT01781572|9911309|FG001|STARTED|MEK162 45mg BID+LEE011 200mg||6
8855845|NCT01781572|9911310|FG002|STARTED|MEK162 45mg BID+LEE011 200mg||41
8855846|NCT01781572|9911308|FG000|COMPLETED|MEK162 45mg BID+LEE011 200mg||0
8855847|NCT01781572|9911309|FG001|COMPLETED|MEK162 45mg BID+LEE011 200mg||0
8855848|NCT01781572|9911310|FG002|COMPLETED|MEK162 45mg BID+LEE011 200mg||0
8855849|NCT01781572|9911308|FG000|NOT COMPLETED|MEK162 45mg BID+LEE011 200mg||16
8855850|NCT01781572|9911309|FG001|NOT COMPLETED|MEK162 45mg BID+LEE011 200mg||6
8855851|NCT01781572|9911310|FG002|NOT COMPLETED|MEK162 45mg BID+LEE011 200mg||41
8855852|NCT01781572|9911308|FG000|STARTED|MEK162 45mg BID+LEE011 250mg||3
8855853|NCT01781572|9911309|FG001|STARTED|MEK162 45mg BID+LEE011 250mg||0
8855854|NCT01781572|9911310|FG002|STARTED|MEK162 45mg BID+LEE011 250mg||0
8855855|NCT01781572|9911308|FG000|COMPLETED|MEK162 45mg BID+LEE011 250mg||0
8855856|NCT01781572|9911309|FG001|COMPLETED|MEK162 45mg BID+LEE011 250mg||0
8855857|NCT01781572|9911310|FG002|COMPLETED|MEK162 45mg BID+LEE011 250mg||0
8855858|NCT01781572|9911308|FG000|NOT COMPLETED|MEK162 45mg BID+LEE011 250mg||3
8855859|NCT01781572|9911309|FG001|NOT COMPLETED|MEK162 45mg BID+LEE011 250mg||0
8855860|NCT01781572|9911310|FG002|NOT COMPLETED|MEK162 45mg BID+LEE011 250mg||0
8855861|NCT01781572|9911308|FG000|STARTED|MEK162 30mg BID+LEE011 300mg||4
8855862|NCT01781572|9911309|FG001|STARTED|MEK162 30mg BID+LEE011 300mg||2
8855863|NCT01781572|9911310|FG002|STARTED|MEK162 30mg BID+LEE011 300mg||0
8855864|NCT01781572|9911308|FG000|COMPLETED|MEK162 30mg BID+LEE011 300mg||0
8855865|NCT01781572|9911309|FG001|COMPLETED|MEK162 30mg BID+LEE011 300mg||0
8855866|NCT01781572|9911310|FG002|COMPLETED|MEK162 30mg BID+LEE011 300mg||0
8855867|NCT01781572|9911308|FG000|NOT COMPLETED|MEK162 30mg BID+LEE011 300mg||4
8855868|NCT01781572|9911309|FG001|NOT COMPLETED|MEK162 30mg BID+LEE011 300mg||2
8855869|NCT01781572|9911310|FG002|NOT COMPLETED|MEK162 30mg BID+LEE011 300mg||0
8855870|NCT01781572|9911308|FG000|STARTED|MEK162 45mg BID+LEE011 300mg||6
8855871|NCT01781572|9911309|FG001|STARTED|MEK162 45mg BID+LEE011 300mg||4
8855872|NCT01781572|9911310|FG002|STARTED|MEK162 45mg BID+LEE011 300mg||0
8855873|NCT01781572|9911308|FG000|COMPLETED|MEK162 45mg BID+LEE011 300mg||0
8855874|NCT01781572|9911309|FG001|COMPLETED|MEK162 45mg BID+LEE011 300mg||0
8855875|NCT01781572|9911310|FG002|COMPLETED|MEK162 45mg BID+LEE011 300mg||0
8855876|NCT01781572|9911308|FG000|NOT COMPLETED|MEK162 45mg BID+LEE011 300mg||6
8855877|NCT01781572|9911309|FG001|NOT COMPLETED|MEK162 45mg BID+LEE011 300mg||4
8855878|NCT01781572|9911310|FG002|NOT COMPLETED|MEK162 45mg BID+LEE011 300mg||0
8855879|NCT01781572|9911308|FG000|STARTED|MEK162 30mg LEE011 200mg||0
8855880|NCT01781572|9911309|FG001|STARTED|MEK162 30mg LEE011 200mg||5
8855881|NCT01781572|9911310|FG002|STARTED|MEK162 30mg LEE011 200mg||0
8855882|NCT01781572|9911308|FG000|COMPLETED|MEK162 30mg LEE011 200mg||0
8855883|NCT01781572|9911309|FG001|COMPLETED|MEK162 30mg LEE011 200mg||0
8855884|NCT01781572|9911310|FG002|COMPLETED|MEK162 30mg LEE011 200mg||0
8855885|NCT01781572|9911308|FG000|NOT COMPLETED|MEK162 30mg LEE011 200mg||0
8855886|NCT01781572|9911309|FG001|NOT COMPLETED|MEK162 30mg LEE011 200mg||5
8855887|NCT01781572|9911310|FG002|NOT COMPLETED|MEK162 30mg LEE011 200mg||0
8855888|NCT01781572|9911308|FG000|STARTED|MEK162 45mg LEE011 450mg||0
8855889|NCT01781572|9911309|FG001|STARTED|MEK162 45mg LEE011 450mg||9
8855890|NCT01781572|9911310|FG002|STARTED|MEK162 45mg LEE011 450mg||0
8855891|NCT01781572|9911308|FG000|COMPLETED|MEK162 45mg LEE011 450mg||0
8855892|NCT01781572|9911309|FG001|COMPLETED|MEK162 45mg LEE011 450mg||0
8855893|NCT01781572|9911310|FG002|COMPLETED|MEK162 45mg LEE011 450mg||0
8855894|NCT01781572|9911308|FG000|NOT COMPLETED|MEK162 45mg LEE011 450mg||0
8855895|NCT01781572|9911309|FG001|NOT COMPLETED|MEK162 45mg LEE011 450mg||9
8855896|NCT01781572|9911310|FG002|NOT COMPLETED|MEK162 45mg LEE011 450mg||0
8949468|NCT02438826|10012075|FG002|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||0
8855897|NCT01781572|9911308|FG000|STARTED|MEK162 45mg LEE011 600mg||0
8855898|NCT01781572|9911309|FG001|STARTED|MEK162 45mg LEE011 600mg||6
8855899|NCT01781572|9911310|FG002|STARTED|MEK162 45mg LEE011 600mg||0
8855900|NCT01781572|9911308|FG000|COMPLETED|MEK162 45mg LEE011 600mg||0
8855901|NCT01781572|9911309|FG001|COMPLETED|MEK162 45mg LEE011 600mg||0
8855902|NCT01781572|9911310|FG002|COMPLETED|MEK162 45mg LEE011 600mg||0
8855903|NCT01781572|9911308|FG000|NOT COMPLETED|MEK162 45mg LEE011 600mg||0
8855904|NCT01781572|9911309|FG001|NOT COMPLETED|MEK162 45mg LEE011 600mg||6
8855905|NCT01781572|9911310|FG002|NOT COMPLETED|MEK162 45mg LEE011 600mg||0
8855906|NCT01781611|9911341|FG000|STARTED|Overall Study||13
8855907|NCT01781611|9911342|FG001|STARTED|Overall Study||5
8855908|NCT01781611|9911341|FG000|COMPLETED|Overall Study||9
8855909|NCT01781611|9911342|FG001|COMPLETED|Overall Study||5
8855910|NCT01781611|9911341|FG000|NOT COMPLETED|Overall Study||4
8855911|NCT01781611|9911342|FG001|NOT COMPLETED|Overall Study||0
8855912|NCT01781806|9911350|FG000|STARTED|Overall Study||297
8855913|NCT01781806|9911351|FG001|STARTED|Overall Study||4
8855914|NCT01781806|9911350|FG000|Week 0|Overall Study||297
8855915|NCT01781806|9911351|FG001|Week 0|Overall Study||4
8855916|NCT01781806|9911350|FG000|Week 4|Overall Study||284
8855917|NCT01781806|9911351|FG001|Week 4|Overall Study||4
8855918|NCT01781806|9911350|FG000|Week 8|Overall Study||278
8855919|NCT01781806|9911351|FG001|Week 8|Overall Study||4
8855920|NCT01781806|9911350|FG000|Week 12|Overall Study||272
8855921|NCT01781806|9911351|FG001|Week 12|Overall Study||2
8855922|NCT01781806|9911350|FG000|Week 24|Overall Study||260
8855923|NCT01781806|9911351|FG001|Week 24|Overall Study||1
8855924|NCT01781806|9911350|FG000|Week 36|Overall Study||247
8855925|NCT01781806|9911351|FG001|Week 36|Overall Study||1
8855926|NCT01781806|9911350|FG000|Week 48|Overall Study||222
8855927|NCT01781806|9911351|FG001|Week 48|Overall Study||1
8855928|NCT01781806|9911350|FG000|COMPLETED|Overall Study||218
8855929|NCT01781806|9911351|FG001|COMPLETED|Overall Study||1
8855930|NCT01781806|9911350|FG000|NOT COMPLETED|Overall Study||79
8855931|NCT01781806|9911351|FG001|NOT COMPLETED|Overall Study||3
8855932|NCT01781832|9911358|FG000|STARTED|Overall Study||26
8855933|NCT01781832|9911358|FG000|COMPLETED|Overall Study||25
8855934|NCT01781832|9911358|FG000|NOT COMPLETED|Overall Study||1
8855935|NCT01781962|9911362|FG000|STARTED|Overall Study||206
8855936|NCT01781962|9911362|FG000|COMPLETED|Overall Study||201
8855937|NCT01781962|9911362|FG000|NOT COMPLETED|Overall Study||5
8855938|NCT01781975|9911368|FG000|STARTED|Overall Study||45
8855939|NCT01781975|9911369|FG001|STARTED|Overall Study||22
8855940|NCT01781975|9911368|FG000|Treatment Period|Overall Study||44
8855941|NCT01781975|9911369|FG001|Treatment Period|Overall Study||22
8855942|NCT01781975|9911368|FG000|Follow-Up Period|Overall Study||43
8855943|NCT01781975|9911369|FG001|Follow-Up Period|Overall Study||21
8855944|NCT01781975|9911368|FG000|COMPLETED|Overall Study||43
8855945|NCT01781975|9911369|FG001|COMPLETED|Overall Study||21
8855946|NCT01781975|9911368|FG000|NOT COMPLETED|Overall Study||2
8855947|NCT01781975|9911369|FG001|NOT COMPLETED|Overall Study||1
8855948|NCT01782131|9911377|FG000|STARTED|Overall Study||293
8855949|NCT01782131|9911378|FG001|STARTED|Overall Study||292
8855950|NCT01782131|9911377|FG000|Treated|Overall Study||288
8855951|NCT01782131|9911378|FG001|Treated|Overall Study||287
8855952|NCT01782131|9911377|FG000|COMPLETED|Overall Study||184
8855953|NCT01782131|9911378|FG001|COMPLETED|Overall Study||177
8855954|NCT01782131|9911377|FG000|NOT COMPLETED|Overall Study||109
8855955|NCT01782131|9911378|FG001|NOT COMPLETED|Overall Study||115
8855956|NCT01782209|9911384|FG000|STARTED|Overall Study||335
8855957|NCT01782209|9911384|FG000|COMPLETED|Overall Study||225
8855958|NCT01782209|9911384|FG000|NOT COMPLETED|Overall Study||110
8855959|NCT01782222|9911391|FG000|STARTED|Overall Study||40
8855960|NCT01782222|9911392|FG001|STARTED|Overall Study||41
8855961|NCT01782222|9911393|FG002|STARTED|Overall Study||41
8855962|NCT01782222|9911391|FG000|COMPLETED|Overall Study||32
8855963|NCT01782222|9911392|FG001|COMPLETED|Overall Study||30
8855964|NCT01782222|9911393|FG002|COMPLETED|Overall Study||37
8855965|NCT01782222|9911391|FG000|NOT COMPLETED|Overall Study||8
8855966|NCT01782222|9911392|FG001|NOT COMPLETED|Overall Study||11
8855967|NCT01782222|9911393|FG002|NOT COMPLETED|Overall Study||4
8855968|NCT01782313|9911401|FG000|STARTED|Reached First Response/Completed 2 Cycle||58
8855969|NCT01782313|9911401|FG000|COMPLETED|Reached First Response/Completed 2 Cycle||52
8855970|NCT01782313|9911401|FG000|NOT COMPLETED|Reached First Response/Completed 2 Cycle||6
8855971|NCT01782313|9911401|FG000|STARTED|Treated Cycle 3||52
8855972|NCT01782313|9911401|FG000|COMPLETED|Treated Cycle 3||31
8855973|NCT01782313|9911401|FG000|NOT COMPLETED|Treated Cycle 3||21
8855974|NCT01782313|9911401|FG000|STARTED|Treated Cycle 4/Reached 16 Week Response||31
8855975|NCT01782313|9911401|FG000|COMPLETED|Treated Cycle 4/Reached 16 Week Response||25
8629906|NCT00532298|9669648|FG005|COMPLETED|Overall Study||261
8629907|NCT00532298|9669643|FG000|NOT COMPLETED|Overall Study||2
8629908|NCT00532298|9669644|FG001|NOT COMPLETED|Overall Study||1
8855976|NCT01782313|9911401|FG000|NOT COMPLETED|Treated Cycle 4/Reached 16 Week Response||6
8629909|NCT00532298|9669645|FG002|NOT COMPLETED|Overall Study||1
8855977|NCT01782313|9911401|FG000|STARTED|Continued Treatment After 16 Weeks||25
8855978|NCT01782313|9911401|FG000|COMPLETED|Continued Treatment After 16 Weeks||18
8855979|NCT01782313|9911401|FG000|NOT COMPLETED|Continued Treatment After 16 Weeks||7
8855980|NCT01782313|9911401|FG000|STARTED|Survival Follow up||58
8855981|NCT01782313|9911401|FG000|COMPLETED|Survival Follow up||57
8855982|NCT01782313|9911401|FG000|NOT COMPLETED|Survival Follow up||1
8855983|NCT01782326|9911407|FG000|STARTED|Planned Treatment Epoch||1680
8855984|NCT01782326|9911408|FG001|STARTED|Planned Treatment Epoch||1682
8855985|NCT01782326|9911407|FG000|Full Analysis Set (FAS)|Planned Treatment Epoch||1675
8855986|NCT01782326|9911408|FG001|Full Analysis Set (FAS)|Planned Treatment Epoch||1679
8855987|NCT01782326|9911407|FG000|Per-protocol Set (PPS)|Planned Treatment Epoch||1528
8855988|NCT01782326|9911408|FG001|Per-protocol Set (PPS)|Planned Treatment Epoch||1556
8855989|NCT01782326|9911407|FG000|Serial Spirometry Set|Planned Treatment Epoch||280
8855990|NCT01782326|9911408|FG001|Serial Spirometry Set|Planned Treatment Epoch||279
8855991|NCT01782326|9911407|FG000|Safety Set (SAF)|Planned Treatment Epoch||1678
8855992|NCT01782326|9911408|FG001|Safety Set (SAF)|Planned Treatment Epoch||1680
8855993|NCT01782326|9911407|FG000|Urine Cortisol Set|Planned Treatment Epoch||266
8855994|NCT01782326|9911408|FG001|Urine Cortisol Set|Planned Treatment Epoch||269
8855995|NCT01782326|9911407|FG000|COMPLETED|Planned Treatment Epoch||1478
8855996|NCT01782326|9911408|FG001|COMPLETED|Planned Treatment Epoch||1474
8855997|NCT01782326|9911407|FG000|NOT COMPLETED|Planned Treatment Epoch||202
8855998|NCT01782326|9911408|FG001|NOT COMPLETED|Planned Treatment Epoch||208
8855999|NCT01782326|9911407|FG000|STARTED|Double-blind Treatment||1678
8856000|NCT01782326|9911408|FG001|STARTED|Double-blind Treatment||1680
8856001|NCT01782326|9911407|FG000|COMPLETED|Double-blind Treatment||1400
8856002|NCT01782326|9911408|FG001|COMPLETED|Double-blind Treatment||1360
8856003|NCT01782326|9911407|FG000|NOT COMPLETED|Double-blind Treatment||278
8856004|NCT01782326|9911408|FG001|NOT COMPLETED|Double-blind Treatment||320
8856005|NCT01782378|9911416|FG000|STARTED|First Series||32
8856006|NCT01782378|9911417|FG001|STARTED|First Series||31
8856007|NCT01782378|9911416|FG000|COMPLETED|First Series||25
8856008|NCT01782378|9911417|FG001|COMPLETED|First Series||23
8856009|NCT01782378|9911416|FG000|NOT COMPLETED|First Series||7
8856010|NCT01782378|9911417|FG001|NOT COMPLETED|First Series||8
8856011|NCT01782378|9911416|FG000|STARTED|Second Series||31
8856012|NCT01782378|9911417|FG001|STARTED|Second Series||32
8856013|NCT01782378|9911416|FG000|COMPLETED|Second Series||5
8856014|NCT01782378|9911417|FG001|COMPLETED|Second Series||0
8856015|NCT01782378|9911416|FG000|NOT COMPLETED|Second Series||26
8856016|NCT01782378|9911417|FG001|NOT COMPLETED|Second Series||32
8856017|NCT01782469|9911423|FG000|STARTED|Overall Study||16
8856018|NCT01782469|9911423|FG000|COMPLETED|Overall Study||15
8856019|NCT01782469|9911423|FG000|NOT COMPLETED|Overall Study||1
8856020|NCT01782482|9911429|FG000|STARTED|Overall Study||281
8856021|NCT01782482|9911430|FG001|STARTED|Overall Study||280
8856022|NCT01782482|9911429|FG000|COMPLETED|Overall Study||271
8856023|NCT01782482|9911430|FG001|COMPLETED|Overall Study||270
8856024|NCT01782482|9911429|FG000|NOT COMPLETED|Overall Study||10
8856025|NCT01782482|9911430|FG001|NOT COMPLETED|Overall Study||10
8856026|NCT01782495|9911447|FG000|STARTED|Overall Study||34
8856027|NCT01782495|9911448|FG001|STARTED|Overall Study||27
8856028|NCT01782495|9911449|FG002|STARTED|Overall Study||13
8856029|NCT01782495|9911450|FG003|STARTED|Overall Study||4
8856030|NCT01782495|9911451|FG004|STARTED|Overall Study||2
8856031|NCT01782495|9911452|FG005|STARTED|Overall Study||22
8856032|NCT01782495|9911453|FG006|STARTED|Overall Study||12
8856033|NCT01782495|9911454|FG007|STARTED|Overall Study||9
8856034|NCT01782495|9911455|FG008|STARTED|Overall Study||3
8856035|NCT01782495|9911456|FG009|STARTED|Overall Study||2
8856036|NCT01782495|9911457|FG010|STARTED|Overall Study||1
8856037|NCT01782495|9911447|FG000|COMPLETED|Overall Study||34
8856038|NCT01782495|9911448|FG001|COMPLETED|Overall Study||26
8856039|NCT01782495|9911449|FG002|COMPLETED|Overall Study||13
8856040|NCT01782495|9911450|FG003|COMPLETED|Overall Study||4
8856041|NCT01782495|9911451|FG004|COMPLETED|Overall Study||2
8856042|NCT01782495|9911452|FG005|COMPLETED|Overall Study||22
8856043|NCT01782495|9911453|FG006|COMPLETED|Overall Study||12
8856044|NCT01782495|9911454|FG007|COMPLETED|Overall Study||6
8856045|NCT01782495|9911455|FG008|COMPLETED|Overall Study||3
8856046|NCT01782495|9911456|FG009|COMPLETED|Overall Study||2
8856047|NCT01782495|9911457|FG010|COMPLETED|Overall Study||1
8856048|NCT01782495|9911447|FG000|NOT COMPLETED|Overall Study||0
8856049|NCT01782495|9911448|FG001|NOT COMPLETED|Overall Study||1
8856050|NCT01782495|9911449|FG002|NOT COMPLETED|Overall Study||0
8856051|NCT01782495|9911450|FG003|NOT COMPLETED|Overall Study||0
8856052|NCT01782495|9911451|FG004|NOT COMPLETED|Overall Study||0
8856053|NCT01782495|9911452|FG005|NOT COMPLETED|Overall Study||0
8856054|NCT01782495|9911453|FG006|NOT COMPLETED|Overall Study||0
8856055|NCT01782495|9911454|FG007|NOT COMPLETED|Overall Study||3
8856056|NCT01782495|9911455|FG008|NOT COMPLETED|Overall Study||0
8856057|NCT01782495|9911456|FG009|NOT COMPLETED|Overall Study||0
8856058|NCT01782495|9911457|FG010|NOT COMPLETED|Overall Study||0
8856059|NCT01782664|9911487|FG000|STARTED|Overall Study||14
8856060|NCT01782664|9911488|FG001|STARTED|Overall Study||15
8856061|NCT01782664|9911489|FG002|STARTED|Overall Study||16
8856062|NCT01782664|9911490|FG003|STARTED|Overall Study||14
8856063|NCT01782664|9911491|FG004|STARTED|Overall Study||6
8856064|NCT01782664|9911492|FG005|STARTED|Overall Study||2
8856065|NCT01782664|9911487|FG000|COMPLETED|Overall Study||8
8856066|NCT01782664|9911488|FG001|COMPLETED|Overall Study||10
8856067|NCT01782664|9911489|FG002|COMPLETED|Overall Study||12
8856068|NCT01782664|9911490|FG003|COMPLETED|Overall Study||9
8856069|NCT01782664|9911491|FG004|COMPLETED|Overall Study||6
8856070|NCT01782664|9911492|FG005|COMPLETED|Overall Study||2
8856071|NCT01782664|9911487|FG000|NOT COMPLETED|Overall Study||6
8856072|NCT01782664|9911488|FG001|NOT COMPLETED|Overall Study||5
8856073|NCT01782664|9911489|FG002|NOT COMPLETED|Overall Study||4
8856074|NCT01782664|9911490|FG003|NOT COMPLETED|Overall Study||5
8856075|NCT01782664|9911491|FG004|NOT COMPLETED|Overall Study||0
8856076|NCT01782664|9911492|FG005|NOT COMPLETED|Overall Study||0
8856077|NCT01782690|9911506|FG000|STARTED|Overall Study||338
8856078|NCT01782690|9911506|FG000|COMPLETED|Overall Study||39
8856079|NCT01782690|9911506|FG000|NOT COMPLETED|Overall Study||299
8856080|NCT01782742|9911512|FG000|STARTED|Double-blind Treatment Phase||16
8856081|NCT01782742|9911513|FG001|STARTED|Double-blind Treatment Phase||4
8856082|NCT01782742|9911512|FG000|COMPLETED|Double-blind Treatment Phase||15
8856083|NCT01782742|9911513|FG001|COMPLETED|Double-blind Treatment Phase||4
8856084|NCT01782742|9911512|FG000|NOT COMPLETED|Double-blind Treatment Phase||1
8856085|NCT01782742|9911513|FG001|NOT COMPLETED|Double-blind Treatment Phase||0
8856086|NCT01782742|9911512|FG000|STARTED|Open Label Phase||19
8856087|NCT01782742|9911513|FG001|STARTED|Open Label Phase||0
8856088|NCT01782742|9911512|FG000|COMPLETED|Open Label Phase||19
8856089|NCT01782742|9911513|FG001|COMPLETED|Open Label Phase||0
8856090|NCT01782742|9911512|FG000|NOT COMPLETED|Open Label Phase||0
8856091|NCT01782742|9911513|FG001|NOT COMPLETED|Open Label Phase||0
8856092|NCT01782833|9911521|FG000|STARTED|Overall Study||3635
8856093|NCT01782833|9911521|FG000|COMPLETED|Overall Study||3365
8856094|NCT01782833|9911521|FG000|NOT COMPLETED|Overall Study||270
8856095|NCT01782859|9911527|FG000|STARTED|Overall Study||20
8856096|NCT01782859|9911528|FG001|STARTED|Overall Study||20
8856097|NCT01782859|9911527|FG000|COMPLETED|Overall Study||14
8856098|NCT01782859|9911528|FG001|COMPLETED|Overall Study||13
8856099|NCT01782859|9911527|FG000|NOT COMPLETED|Overall Study||6
8856100|NCT01782859|9911528|FG001|NOT COMPLETED|Overall Study||7
8856101|NCT01782872|9911539|FG000|STARTED|Overall Study||20
8629910|NCT00532298|9669646|FG003|NOT COMPLETED|Overall Study||0
8629911|NCT00532298|9669647|FG004|NOT COMPLETED|Overall Study||1
8856102|NCT01782872|9911540|FG001|STARTED|Overall Study||20
8856103|NCT01782872|9911541|FG002|STARTED|Overall Study||20
8856104|NCT01782872|9911542|FG003|STARTED|Overall Study||20
8856105|NCT01782872|9911539|FG000|COMPLETED|Overall Study||20
8856106|NCT01782872|9911540|FG001|COMPLETED|Overall Study||19
8856107|NCT01782872|9911541|FG002|COMPLETED|Overall Study||20
8856108|NCT01782872|9911542|FG003|COMPLETED|Overall Study||19
8856109|NCT01782872|9911539|FG000|NOT COMPLETED|Overall Study||0
8856110|NCT01782872|9911540|FG001|NOT COMPLETED|Overall Study||1
8856111|NCT01782872|9911541|FG002|NOT COMPLETED|Overall Study||0
8856112|NCT01782872|9911542|FG003|NOT COMPLETED|Overall Study||1
8856113|NCT01782885|9911554|FG000|STARTED|Overall Study||36
8856114|NCT01782885|9911555|FG001|STARTED|Overall Study||39
8856115|NCT01782885|9911554|FG000|COMPLETED|Overall Study||32
8856116|NCT01782885|9911555|FG001|COMPLETED|Overall Study||33
8856117|NCT01782885|9911554|FG000|NOT COMPLETED|Overall Study||4
8856118|NCT01782885|9911555|FG001|NOT COMPLETED|Overall Study||6
8856119|NCT01782898|9911563|FG000|STARTED|Overall Study||35
8856120|NCT01782898|9911564|FG001|STARTED|Overall Study||35
8856121|NCT01782898|9911563|FG000|COMPLETED|Overall Study||29
8856122|NCT01782898|9911564|FG001|COMPLETED|Overall Study||29
8856123|NCT01782898|9911563|FG000|NOT COMPLETED|Overall Study||6
8856124|NCT01782898|9911564|FG001|NOT COMPLETED|Overall Study||6
8856125|NCT01782963|9911570|FG000|STARTED|Overall Study||50
8856126|NCT01782963|9911570|FG000|COMPLETED|Overall Study||50
8856127|NCT01782963|9911570|FG000|NOT COMPLETED|Overall Study||0
8856128|NCT01783054|9911578|FG000|STARTED|Overall Study||2
8856129|NCT01783054|9911578|FG000|COMPLETED|Overall Study||2
8856130|NCT01783054|9911578|FG000|NOT COMPLETED|Overall Study||0
8856131|NCT01783080|9911582|FG000|STARTED|Overall Study||16
8856132|NCT01783080|9911582|FG000|COMPLETED|Overall Study||16
8856133|NCT01783080|9911582|FG000|NOT COMPLETED|Overall Study||0
8856134|NCT01783236|9911588|FG000|STARTED|Overall Study||8
8856135|NCT01783236|9911589|FG001|STARTED|Overall Study||8
8856136|NCT01783236|9911588|FG000|COMPLETED|Overall Study||6
8856137|NCT01783236|9911589|FG001|COMPLETED|Overall Study||8
8856138|NCT01783236|9911588|FG000|NOT COMPLETED|Overall Study||2
8856139|NCT01783236|9911589|FG001|NOT COMPLETED|Overall Study||0
8856140|NCT01783418|9911597|FG000|STARTED|Overall Study||8
8856141|NCT01783418|9911598|FG001|STARTED|Overall Study||6
8856142|NCT01783418|9911597|FG000|COMPLETED|Overall Study||7
8856143|NCT01783418|9911598|FG001|COMPLETED|Overall Study||6
8856144|NCT01783418|9911597|FG000|NOT COMPLETED|Overall Study||1
8856145|NCT01783418|9911598|FG001|NOT COMPLETED|Overall Study||0
8856146|NCT01783444|9911607|FG000|STARTED|Treatment Phase||104
8856147|NCT01783444|9911608|FG001|STARTED|Treatment Phase||103
8856148|NCT01783444|9911609|FG002|STARTED|Treatment Phase||102
8856149|NCT01783444|9911607|FG000|Safety Set|Treatment Phase||104
8856150|NCT01783444|9911608|FG001|Safety Set|Treatment Phase||103
8856151|NCT01783444|9911609|FG002|Safety Set|Treatment Phase||102
8856152|NCT01783444|9911607|FG000|COMPLETED|Treatment Phase||0
8856153|NCT01783444|9911608|FG001|COMPLETED|Treatment Phase||0
8856154|NCT01783444|9911609|FG002|COMPLETED|Treatment Phase||0
8856155|NCT01783444|9911607|FG000|NOT COMPLETED|Treatment Phase||104
8856156|NCT01783444|9911608|FG001|NOT COMPLETED|Treatment Phase||103
8856157|NCT01783444|9911609|FG002|NOT COMPLETED|Treatment Phase||102
8856158|NCT01783444|9911607|FG000|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Follow-Up Phase|96
8856159|NCT01783444|9911608|FG001|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Follow-Up Phase|93
8856160|NCT01783444|9911609|FG002|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Follow-Up Phase|91
8856161|NCT01783444|9911607|FG000|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
8856162|NCT01783444|9911608|FG001|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
8856163|NCT01783444|9911609|FG002|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
8856164|NCT01783444|9911607|FG000|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||96
8856165|NCT01783444|9911608|FG001|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||93
8856166|NCT01783444|9911609|FG002|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||91
8856167|NCT01783470|9911618|FG000|STARTED|Overall Study||6
8856168|NCT01783470|9911619|FG001|STARTED|Overall Study|Single-dose|6
8856169|NCT01783470|9911618|FG000|COMPLETED|Overall Study||6
8856170|NCT01783470|9911619|FG001|COMPLETED|Overall Study||6
8856171|NCT01783470|9911618|FG000|NOT COMPLETED|Overall Study||0
8856172|NCT01783470|9911619|FG001|NOT COMPLETED|Overall Study||0
8856173|NCT01783483|9911628|FG000|STARTED|Overall Study||120
8856174|NCT01783483|9911629|FG001|STARTED|Overall Study||116
8856175|NCT01783483|9911628|FG000|COMPLETED|Overall Study||100
8856176|NCT01783483|9911629|FG001|COMPLETED|Overall Study||101
8856177|NCT01783483|9911628|FG000|NOT COMPLETED|Overall Study||20
8856178|NCT01783483|9911629|FG001|NOT COMPLETED|Overall Study||15
8856179|NCT01783496|9911641|FG000|STARTED|Overall Study||10
8856180|NCT01783496|9911642|FG001|STARTED|Overall Study||10
8856181|NCT01783496|9911643|FG002|STARTED|Overall Study||10
8856182|NCT01783496|9911644|FG003|STARTED|Overall Study||10
8856183|NCT01783496|9911645|FG004|STARTED|Overall Study||5
8856184|NCT01783496|9911646|FG005|STARTED|Overall Study||5
8856185|NCT01783496|9911641|FG000|COMPLETED|Overall Study||9
8856186|NCT01783496|9911642|FG001|COMPLETED|Overall Study||10
8856187|NCT01783496|9911643|FG002|COMPLETED|Overall Study||10
8856188|NCT01783496|9911644|FG003|COMPLETED|Overall Study||8
8856189|NCT01783496|9911645|FG004|COMPLETED|Overall Study||5
8856190|NCT01783496|9911646|FG005|COMPLETED|Overall Study||4
8856191|NCT01783496|9911641|FG000|NOT COMPLETED|Overall Study||1
8856192|NCT01783496|9911642|FG001|NOT COMPLETED|Overall Study||0
8856193|NCT01783496|9911643|FG002|NOT COMPLETED|Overall Study||0
8856194|NCT01783496|9911644|FG003|NOT COMPLETED|Overall Study||2
8856195|NCT01783496|9911645|FG004|NOT COMPLETED|Overall Study||0
8856196|NCT01783496|9911646|FG005|NOT COMPLETED|Overall Study||1
8856197|NCT01783522|9911662|FG000|STARTED|Overall Study||4
8856198|NCT01783522|9911663|FG001|STARTED|Overall Study||5
8856199|NCT01783522|9911662|FG000|COMPLETED|Overall Study||4
8856200|NCT01783522|9911663|FG001|COMPLETED|Overall Study||5
8856201|NCT01783522|9911662|FG000|NOT COMPLETED|Overall Study||0
8856202|NCT01783522|9911663|FG001|NOT COMPLETED|Overall Study||0
8856203|NCT01783548|9911671|FG000|STARTED|Overall Study|Randomized|362
8856204|NCT01783548|9911672|FG001|STARTED|Overall Study|Randomized|185
8856205|NCT01783548|9911671|FG000|Full Analysis Set (FAS)|Overall Study||358
8856206|NCT01783548|9911672|FG001|Full Analysis Set (FAS)|Overall Study||184
8856207|NCT01783548|9911671|FG000|COMPLETED|Overall Study||328
8856208|NCT01783548|9911672|FG001|COMPLETED|Overall Study||167
8856209|NCT01783548|9911671|FG000|NOT COMPLETED|Overall Study||34
8856210|NCT01783548|9911672|FG001|NOT COMPLETED|Overall Study||18
8856211|NCT01783561|9911680|FG000|STARTED|Overall Study||11
8856212|NCT01783561|9911681|FG001|STARTED|Overall Study||10
8856213|NCT01783561|9911680|FG000|COMPLETED|Overall Study||11
8856214|NCT01783561|9911681|FG001|COMPLETED|Overall Study||10
8856215|NCT01783561|9911680|FG000|NOT COMPLETED|Overall Study||0
8856216|NCT01783561|9911681|FG001|NOT COMPLETED|Overall Study||0
8856217|NCT01783574|9911689|FG000|STARTED|Overall Study||51
8856218|NCT01783574|9911690|FG001|STARTED|Overall Study||50
8856219|NCT01783574|9911689|FG000|COMPLETED|Overall Study||46
8856220|NCT01783574|9911690|FG001|COMPLETED|Overall Study||41
8856221|NCT01783574|9911689|FG000|NOT COMPLETED|Overall Study||5
8856222|NCT01783574|9911690|FG001|NOT COMPLETED|Overall Study||9
8856223|NCT01783639|9911696|FG000|STARTED|Overall Study||120
8856224|NCT01783639|9911696|FG000|COMPLETED|Overall Study||120
8856225|NCT01783639|9911696|FG000|NOT COMPLETED|Overall Study||0
8856226|NCT01783678|9911706|FG000|STARTED|Overall Study||19
8856227|NCT01783678|9911707|FG001|STARTED|Overall Study||112
8856228|NCT01783678|9911708|FG002|STARTED|Overall Study||6
8856229|NCT01783678|9911709|FG003|STARTED|Overall Study||58
8856230|NCT01783678|9911710|FG004|STARTED|Overall Study||49
8856231|NCT01783678|9911711|FG005|STARTED|Overall Study||31
8856232|NCT01783678|9911706|FG000|COMPLETED|Overall Study||17
8856233|NCT01783678|9911707|FG001|COMPLETED|Overall Study||94
8856234|NCT01783678|9911708|FG002|COMPLETED|Overall Study||5
8856235|NCT01783678|9911709|FG003|COMPLETED|Overall Study||50
8856236|NCT01783678|9911710|FG004|COMPLETED|Overall Study||42
8856237|NCT01783678|9911711|FG005|COMPLETED|Overall Study||26
8856238|NCT01783678|9911706|FG000|NOT COMPLETED|Overall Study||2
8856239|NCT01783678|9911707|FG001|NOT COMPLETED|Overall Study||18
8856240|NCT01783678|9911708|FG002|NOT COMPLETED|Overall Study||1
8856241|NCT01783678|9911709|FG003|NOT COMPLETED|Overall Study||8
8856242|NCT01783678|9911710|FG004|NOT COMPLETED|Overall Study||7
8629912|NCT00532298|9669648|FG005|NOT COMPLETED|Overall Study||2
8629913|NCT00532441|9669662|FG000|STARTED|Overall Study||14
8629914|NCT00532441|9669663|FG001|STARTED|Overall Study||11
8629915|NCT00532441|9669662|FG000|COMPLETED|Overall Study||13
8856243|NCT01783678|9911711|FG005|NOT COMPLETED|Overall Study||5
8569595|NCT00098293|9601849|FG002|COMPLETED|Double-blind (DB) Phase||202
8569596|NCT00098293|9601850|FG003|COMPLETED|Double-blind (DB) Phase||0
8569597|NCT00098293|9601851|FG004|COMPLETED|Double-blind (DB) Phase||0
8569598|NCT00098293|9601847|FG000|NOT COMPLETED|Double-blind (DB) Phase||177
8569599|NCT00098293|9601848|FG001|NOT COMPLETED|Double-blind (DB) Phase||166
8569600|NCT00098293|9601849|FG002|NOT COMPLETED|Double-blind (DB) Phase||170
8569601|NCT00098293|9601850|FG003|NOT COMPLETED|Double-blind (DB) Phase||0
8569602|NCT00098293|9601851|FG004|NOT COMPLETED|Double-blind (DB) Phase||0
8569603|NCT00098293|9601847|FG000|STARTED|Between DB and OL Phase||0
8569604|NCT00098293|9601848|FG001|STARTED|Between DB and OL Phase||202
8569605|NCT00098293|9601849|FG002|STARTED|Between DB and OL Phase||202
8569606|NCT00098293|9601850|FG003|STARTED|Between DB and OL Phase||0
8569607|NCT00098293|9601851|FG004|STARTED|Between DB and OL Phase||0
8569608|NCT00098293|9601847|FG000|COMPLETED|Between DB and OL Phase||0
8569609|NCT00098293|9601848|FG001|COMPLETED|Between DB and OL Phase||202
8569610|NCT00098293|9601849|FG002|COMPLETED|Between DB and OL Phase||199
8569611|NCT00098293|9601850|FG003|COMPLETED|Between DB and OL Phase||0
8569612|NCT00098293|9601851|FG004|COMPLETED|Between DB and OL Phase||0
8569613|NCT00098293|9601847|FG000|NOT COMPLETED|Between DB and OL Phase||0
8569614|NCT00098293|9601848|FG001|NOT COMPLETED|Between DB and OL Phase||0
8856244|NCT01783730|9911726|FG000|STARTED|Overall Study||163
8856245|NCT01783730|9911726|FG000|COMPLETED|Overall Study||157
8569615|NCT00098293|9601849|FG002|NOT COMPLETED|Between DB and OL Phase||3
8569616|NCT00098293|9601850|FG003|NOT COMPLETED|Between DB and OL Phase||0
8629916|NCT00532441|9669663|FG001|COMPLETED|Overall Study||11
8856246|NCT01783730|9911726|FG000|NOT COMPLETED|Overall Study||6
8856247|NCT01783743|9911732|FG000|STARTED|Screening of Subjects by CTA During MDA||13509
8856248|NCT01783743|9911733|FG001|STARTED|Screening of Subjects by CTA During MDA||13964
8856249|NCT01783743|9911732|FG000|COMPLETED|Screening of Subjects by CTA During MDA||10082
8856250|NCT01783743|9911733|FG001|COMPLETED|Screening of Subjects by CTA During MDA||9525
8856251|NCT01783743|9911732|FG000|NOT COMPLETED|Screening of Subjects by CTA During MDA||3427
8856252|NCT01783743|9911733|FG001|NOT COMPLETED|Screening of Subjects by CTA During MDA||4439
8856253|NCT01783743|9911732|FG000|STARTED|Rescreening of Subjects by Senior Grader||13509
8856254|NCT01783743|9911733|FG001|STARTED|Rescreening of Subjects by Senior Grader||13964
8856255|NCT01783743|9911732|FG000|TT Positive Cases Screened by CTA|Rescreening of Subjects by Senior Grader||46
8856256|NCT01783743|9911733|FG001|TT Positive Cases Screened by CTA|Rescreening of Subjects by Senior Grader||409
8856257|NCT01783743|9911732|FG000|Random Sample From Non TT Cases by CTA|Rescreening of Subjects by Senior Grader||1721
8856258|NCT01783743|9911733|FG001|Random Sample From Non TT Cases by CTA|Rescreening of Subjects by Senior Grader||1786
8856259|NCT01783743|9911732|FG000|Random Sample From Subject Absent at MDA|Rescreening of Subjects by Senior Grader||846
8856260|NCT01783743|9911733|FG001|Random Sample From Subject Absent at MDA|Rescreening of Subjects by Senior Grader||849
8856261|NCT01783743|9911732|FG000|COMPLETED|Rescreening of Subjects by Senior Grader||2613
8856262|NCT01783743|9911733|FG001|COMPLETED|Rescreening of Subjects by Senior Grader||3044
8856263|NCT01783743|9911732|FG000|NOT COMPLETED|Rescreening of Subjects by Senior Grader||10896
8856264|NCT01783743|9911733|FG001|NOT COMPLETED|Rescreening of Subjects by Senior Grader||10920
8856265|NCT01783821|9911741|FG000|STARTED|Overall Study||30
8856266|NCT01783821|9911742|FG001|STARTED|Overall Study||31
8856267|NCT01783821|9911741|FG000|COMPLETED|Overall Study||29
8856268|NCT01783821|9911742|FG001|COMPLETED|Overall Study||30
8856269|NCT01783821|9911741|FG000|NOT COMPLETED|Overall Study||1
8856270|NCT01783821|9911742|FG001|NOT COMPLETED|Overall Study||1
8856271|NCT01783847|9911751|FG000|STARTED|Overall Study||85
8856272|NCT01783847|9911752|FG001|STARTED|Overall Study||16
8856273|NCT01783847|9911753|FG002|STARTED|Overall Study||16
8856274|NCT01783847|9911751|FG000|COMPLETED|Overall Study||69
8856275|NCT01783847|9911752|FG001|COMPLETED|Overall Study||15
8856276|NCT01783847|9911753|FG002|COMPLETED|Overall Study||16
8856277|NCT01783847|9911751|FG000|NOT COMPLETED|Overall Study||16
8856278|NCT01783847|9911752|FG001|NOT COMPLETED|Overall Study||1
8856279|NCT01783847|9911753|FG002|NOT COMPLETED|Overall Study||0
8856280|NCT01783860|9911766|FG000|STARTED|Overall Study||50
8856281|NCT01783860|9911767|FG001|STARTED|Overall Study||50
8856282|NCT01783860|9911766|FG000|COMPLETED|Overall Study||50
8856283|NCT01783860|9911767|FG001|COMPLETED|Overall Study||50
8856284|NCT01783860|9911766|FG000|NOT COMPLETED|Overall Study||0
8856285|NCT01783860|9911767|FG001|NOT COMPLETED|Overall Study||0
8856286|NCT01783886|9911776|FG000|STARTED|Overall Study||127
8856287|NCT01783886|9911777|FG001|STARTED|Overall Study||127
8856288|NCT01783886|9911778|FG002|STARTED|Overall Study||127
8856289|NCT01783886|9911776|FG000|Participants Received Treatment|Overall Study||127
8856290|NCT01783886|9911777|FG001|Participants Received Treatment|Overall Study||127
8856291|NCT01783886|9911778|FG002|Participants Received Treatment|Overall Study||124
8856292|NCT01783886|9911776|FG000|COMPLETED|Overall Study||122
8856293|NCT01783886|9911777|FG001|COMPLETED|Overall Study||116
8856294|NCT01783886|9911778|FG002|COMPLETED|Overall Study||117
8856295|NCT01783886|9911776|FG000|NOT COMPLETED|Overall Study||5
8856296|NCT01783886|9911777|FG001|NOT COMPLETED|Overall Study||11
8856297|NCT01783886|9911778|FG002|NOT COMPLETED|Overall Study||10
8856298|NCT01783912|9911789|FG000|STARTED|Overall Study||118
8856299|NCT01783912|9911790|FG001|STARTED|Overall Study||104
8856300|NCT01783912|9911791|FG002|STARTED|Overall Study||48
8856301|NCT01783912|9911789|FG000|COMPLETED|Overall Study||88
8949469|NCT02438826|10012076|FG003|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||0
8949470|NCT02438826|10012073|FG000|COMPLETED|Double-Blind Treatment Phase||117
8949471|NCT02438826|10012074|FG001|COMPLETED|Double-Blind Treatment Phase||113
8949472|NCT02438826|10012075|FG002|COMPLETED|Double-Blind Treatment Phase||0
8949473|NCT02438826|10012076|FG003|COMPLETED|Double-Blind Treatment Phase||0
8949474|NCT02438826|10012073|FG000|NOT COMPLETED|Double-Blind Treatment Phase||6
8949475|NCT02438826|10012074|FG001|NOT COMPLETED|Double-Blind Treatment Phase||4
8949476|NCT02438826|10012075|FG002|NOT COMPLETED|Double-Blind Treatment Phase||0
8949477|NCT02438826|10012076|FG003|NOT COMPLETED|Double-Blind Treatment Phase||0
8949478|NCT02438826|10012073|FG000|STARTED|Open-Label Treatment Phase|This period is optional phase, one participant chose not to enter the open-label phase.|116
8949479|NCT02438826|10012074|FG001|STARTED|Open-Label Treatment Phase||113
8949480|NCT02438826|10012075|FG002|STARTED|Open-Label Treatment Phase||0
8949481|NCT02438826|10012076|FG003|STARTED|Open-Label Treatment Phase||0
8949482|NCT02438826|10012073|FG000|COMPLETED|Open-Label Treatment Phase||72
8629917|NCT00532441|9669662|FG000|NOT COMPLETED|Overall Study||1
8629918|NCT00532441|9669663|FG001|NOT COMPLETED|Overall Study||0
8629919|NCT00532480|9669672|FG000|STARTED|Overall Study||10
8856302|NCT01783912|9911790|FG001|COMPLETED|Overall Study||58
8856303|NCT01783912|9911791|FG002|COMPLETED|Overall Study||25
8856304|NCT01783912|9911789|FG000|NOT COMPLETED|Overall Study||30
8856305|NCT01783912|9911790|FG001|NOT COMPLETED|Overall Study||46
8856306|NCT01783912|9911791|FG002|NOT COMPLETED|Overall Study||23
8856307|NCT01783938|9911801|FG000|STARTED|Overall Study||68
8856308|NCT01783938|9911802|FG001|STARTED|Overall Study||70
8856309|NCT01783938|9911801|FG000|COMPLETED|Overall Study||11
8856310|NCT01783938|9911802|FG001|COMPLETED|Overall Study||9
8856311|NCT01783938|9911801|FG000|NOT COMPLETED|Overall Study||57
8856312|NCT01783938|9911802|FG001|NOT COMPLETED|Overall Study||61
8949483|NCT02438826|10012074|FG001|COMPLETED|Open-Label Treatment Phase||80
8949484|NCT02438826|10012075|FG002|COMPLETED|Open-Label Treatment Phase||0
8856313|NCT01783990|9911810|FG000|STARTED|Overall Study||130
8856314|NCT01783990|9911811|FG001|STARTED|Overall Study||20
8856315|NCT01783990|9911810|FG000|COMPLETED|Overall Study||125
8856316|NCT01783990|9911811|FG001|COMPLETED|Overall Study||18
8856317|NCT01783990|9911810|FG000|NOT COMPLETED|Overall Study||5
8856318|NCT01783990|9911811|FG001|NOT COMPLETED|Overall Study||2
8856319|NCT01784029|9911822|FG000|STARTED|Overall Study||61
8856320|NCT01784029|9911823|FG001|STARTED|Overall Study||59
8856321|NCT01784029|9911824|FG002|STARTED|Overall Study||63
8856322|NCT01784029|9911822|FG000|COMPLETED|Overall Study||42
8856323|NCT01784029|9911823|FG001|COMPLETED|Overall Study||39
8856324|NCT01784029|9911824|FG002|COMPLETED|Overall Study||41
8856325|NCT01784029|9911822|FG000|NOT COMPLETED|Overall Study||19
8856326|NCT01784029|9911823|FG001|NOT COMPLETED|Overall Study||20
8856327|NCT01784029|9911824|FG002|NOT COMPLETED|Overall Study||22
8856328|NCT01784055|9911832|FG000|STARTED|Overall Study||126
8856329|NCT01784055|9911832|FG000|COMPLETED|Overall Study||100
8856330|NCT01784055|9911832|FG000|NOT COMPLETED|Overall Study||26
8856331|NCT01784068|9911836|FG000|STARTED|NTCS Phase||215
8856332|NCT01784068|9911837|FG001|STARTED|NTCS Phase||0
8856333|NCT01784068|9911836|FG000|NTRI Phase|NTCS Phase||86
8856334|NCT01784068|9911837|FG001|NTRI Phase|NTCS Phase||0
8856335|NCT01784068|9911836|FG000|NTCT Phase|NTCS Phase||13
8856336|NCT01784068|9911837|FG001|NTCT Phase|NTCS Phase||0
8856337|NCT01784068|9911836|FG000|TFR-2 Phase|NTCS Phase||8
8856338|NCT01784068|9911837|FG001|TFR-2 Phase|NTCS Phase||0
8856339|NCT01784068|9911836|FG000|NTCT-P Phase|NTCS Phase||2
8856340|NCT01784068|9911837|FG001|NTCT-P Phase|NTCS Phase||0
8856341|NCT01784068|9911836|FG000|NTRI-2|NTCS Phase||0
8856342|NCT01784068|9911837|FG001|NTRI-2|NTCS Phase||0
8856343|NCT01784068|9911836|FG000|COMPLETED|NTCS Phase||0
8856344|NCT01784068|9911837|FG001|COMPLETED|NTCS Phase||0
8856345|NCT01784068|9911836|FG000|NOT COMPLETED|NTCS Phase||215
8856346|NCT01784068|9911837|FG001|NOT COMPLETED|NTCS Phase||0
8856347|NCT01784068|9911836|FG000|STARTED|TFR Phase||0
8856348|NCT01784068|9911837|FG001|STARTED|TFR Phase||190
8856349|NCT01784068|9911836|FG000|COMPLETED|TFR Phase||0
8856350|NCT01784068|9911837|FG001|COMPLETED|TFR Phase||97
8856351|NCT01784068|9911836|FG000|NOT COMPLETED|TFR Phase||0
8856352|NCT01784068|9911837|FG001|NOT COMPLETED|TFR Phase||93
8856353|NCT01784211|9911850|FG000|STARTED|Part A (Days 1-15)||38
8856354|NCT01784211|9911851|FG001|STARTED|Part A (Days 1-15)||38
8856355|NCT01784211|9911852|FG002|STARTED|Part A (Days 1-15)||0
8856356|NCT01784211|9911853|FG003|STARTED|Part A (Days 1-15)||0
8856357|NCT01784211|9911854|FG004|STARTED|Part A (Days 1-15)||0
8856358|NCT01784211|9911855|FG005|STARTED|Part A (Days 1-15)||0
8856359|NCT01784211|9911850|FG000|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||37
8856360|NCT01784211|9911851|FG001|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||38
8856361|NCT01784211|9911852|FG002|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||0
8856362|NCT01784211|9911853|FG003|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||0
8856363|NCT01784211|9911854|FG004|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||0
8856364|NCT01784211|9911855|FG005|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||0
8856365|NCT01784211|9911850|FG000|Entered Part B|Part A (Days 1-15)|Participants who completed Part A and met certain criteria had the option of continuing to Part B.|19
8856366|NCT01784211|9911851|FG001|Entered Part B|Part A (Days 1-15)|Participants who completed Part A and met certain criteria had the option of continuing to Part B.|21
8856367|NCT01784211|9911852|FG002|Entered Part B|Part A (Days 1-15)||0
8856368|NCT01784211|9911853|FG003|Entered Part B|Part A (Days 1-15)||0
8856369|NCT01784211|9911854|FG004|Entered Part B|Part A (Days 1-15)||0
8856370|NCT01784211|9911855|FG005|Entered Part B|Part A (Days 1-15)||0
8856371|NCT01784211|9911850|FG000|COMPLETED|Part A (Days 1-15)||35
8856372|NCT01784211|9911851|FG001|COMPLETED|Part A (Days 1-15)||36
8856373|NCT01784211|9911852|FG002|COMPLETED|Part A (Days 1-15)||0
8856374|NCT01784211|9911853|FG003|COMPLETED|Part A (Days 1-15)||0
8856375|NCT01784211|9911854|FG004|COMPLETED|Part A (Days 1-15)||0
8856376|NCT01784211|9911855|FG005|COMPLETED|Part A (Days 1-15)||0
8856377|NCT01784211|9911850|FG000|NOT COMPLETED|Part A (Days 1-15)||3
8856378|NCT01784211|9911851|FG001|NOT COMPLETED|Part A (Days 1-15)||2
8856379|NCT01784211|9911852|FG002|NOT COMPLETED|Part A (Days 1-15)||0
8856380|NCT01784211|9911853|FG003|NOT COMPLETED|Part A (Days 1-15)||0
8856381|NCT01784211|9911854|FG004|NOT COMPLETED|Part A (Days 1-15)||0
8856382|NCT01784211|9911855|FG005|NOT COMPLETED|Part A (Days 1-15)||0
8856383|NCT01784211|9911850|FG000|STARTED|Part B (Days 16-21)|Participants who completed Part A and met certain criteria had the option of continuing to Part B.|0
8856384|NCT01784211|9911851|FG001|STARTED|Part B (Days 16-21)|Participants who completed Part A and met certain criteria had the option of continuing to Part B.|0
8856385|NCT01784211|9911852|FG002|STARTED|Part B (Days 16-21)||10
8856386|NCT01784211|9911853|FG003|STARTED|Part B (Days 16-21)||9
8856387|NCT01784211|9911854|FG004|STARTED|Part B (Days 16-21)||11
8856388|NCT01784211|9911855|FG005|STARTED|Part B (Days 16-21)||10
8856389|NCT01784211|9911850|FG000|COMPLETED|Part B (Days 16-21)||0
8856390|NCT01784211|9911851|FG001|COMPLETED|Part B (Days 16-21)||0
8856391|NCT01784211|9911852|FG002|COMPLETED|Part B (Days 16-21)||10
8856392|NCT01784211|9911853|FG003|COMPLETED|Part B (Days 16-21)||9
8856393|NCT01784211|9911854|FG004|COMPLETED|Part B (Days 16-21)||11
8856394|NCT01784211|9911855|FG005|COMPLETED|Part B (Days 16-21)||10
8856395|NCT01784211|9911850|FG000|NOT COMPLETED|Part B (Days 16-21)||0
8856396|NCT01784211|9911851|FG001|NOT COMPLETED|Part B (Days 16-21)||0
8856397|NCT01784211|9911852|FG002|NOT COMPLETED|Part B (Days 16-21)||0
8856398|NCT01784211|9911853|FG003|NOT COMPLETED|Part B (Days 16-21)||0
8856399|NCT01784211|9911854|FG004|NOT COMPLETED|Part B (Days 16-21)||0
8856400|NCT01784211|9911855|FG005|NOT COMPLETED|Part B (Days 16-21)||0
8856401|NCT01784419|9911867|FG000|STARTED|Overall Study||10
8856402|NCT01784419|9911867|FG000|COMPLETED|Overall Study||7
8856403|NCT01784419|9911867|FG000|NOT COMPLETED|Overall Study||3
8856404|NCT01784523|9911873|FG000|STARTED|Overall Study||7
8856405|NCT01784523|9911874|FG001|STARTED|Overall Study||4
8856406|NCT01784523|9911873|FG000|COMPLETED|Overall Study||0
8856407|NCT01784523|9911874|FG001|COMPLETED|Overall Study||0
8856408|NCT01784523|9911873|FG000|NOT COMPLETED|Overall Study||7
8856409|NCT01784523|9911874|FG001|NOT COMPLETED|Overall Study||4
8856410|NCT01784588|9911882|FG000|STARTED|Overall Study||141
8856411|NCT01784588|9911883|FG001|STARTED|Overall Study||140
8856412|NCT01784588|9911882|FG000|COMPLETED|Overall Study||104
8856413|NCT01784588|9911883|FG001|COMPLETED|Overall Study||108
8856414|NCT01784588|9911882|FG000|NOT COMPLETED|Overall Study||37
8856415|NCT01784588|9911883|FG001|NOT COMPLETED|Overall Study||32
8856416|NCT01784614|9911889|FG000|STARTED|Period 1||3
8856417|NCT01784614|9911890|FG001|STARTED|Period 1||3
8856418|NCT01784614|9911891|FG002|STARTED|Period 1||3
8856419|NCT01784614|9911892|FG003|STARTED|Period 1||3
8856420|NCT01784614|9911893|FG004|STARTED|Period 1||3
8856421|NCT01784614|9911894|FG005|STARTED|Period 1||3
8856422|NCT01784614|9911895|FG006|STARTED|Period 1||3
8856423|NCT01784614|9911896|FG007|STARTED|Period 1||3
8856424|NCT01784614|9911889|FG000|Received at Least 1 Dose of Study Drug|Period 1||3
8856425|NCT01784614|9911890|FG001|Received at Least 1 Dose of Study Drug|Period 1||3
8856426|NCT01784614|9911891|FG002|Received at Least 1 Dose of Study Drug|Period 1||3
8856427|NCT01784614|9911892|FG003|Received at Least 1 Dose of Study Drug|Period 1||3
8856428|NCT01784614|9911893|FG004|Received at Least 1 Dose of Study Drug|Period 1||3
8856429|NCT01784614|9911894|FG005|Received at Least 1 Dose of Study Drug|Period 1||3
8856430|NCT01784614|9911895|FG006|Received at Least 1 Dose of Study Drug|Period 1||3
8856431|NCT01784614|9911896|FG007|Received at Least 1 Dose of Study Drug|Period 1||3
8856432|NCT01784614|9911889|FG000|COMPLETED|Period 1||3
8856433|NCT01784614|9911890|FG001|COMPLETED|Period 1||3
8856434|NCT01784614|9911891|FG002|COMPLETED|Period 1||3
8856435|NCT01784614|9911892|FG003|COMPLETED|Period 1||3
8856436|NCT01784614|9911893|FG004|COMPLETED|Period 1||3
8856437|NCT01784614|9911894|FG005|COMPLETED|Period 1||3
8856438|NCT01784614|9911895|FG006|COMPLETED|Period 1||3
8856439|NCT01784614|9911896|FG007|COMPLETED|Period 1|One participant withdrew consent after completed Period 1 and did not enter Period 2.|3
8856440|NCT01784614|9911889|FG000|NOT COMPLETED|Period 1||0
8856441|NCT01784614|9911890|FG001|NOT COMPLETED|Period 1||0
8856442|NCT01784614|9911891|FG002|NOT COMPLETED|Period 1||0
8856443|NCT01784614|9911892|FG003|NOT COMPLETED|Period 1||0
8856444|NCT01784614|9911893|FG004|NOT COMPLETED|Period 1||0
8856445|NCT01784614|9911894|FG005|NOT COMPLETED|Period 1||0
8856446|NCT01784614|9911895|FG006|NOT COMPLETED|Period 1||0
8856447|NCT01784614|9911896|FG007|NOT COMPLETED|Period 1||0
8856448|NCT01784614|9911889|FG000|STARTED|Period 2||3
8856449|NCT01784614|9911890|FG001|STARTED|Period 2||3
8856450|NCT01784614|9911891|FG002|STARTED|Period 2||3
8856451|NCT01784614|9911892|FG003|STARTED|Period 2||3
8856452|NCT01784614|9911893|FG004|STARTED|Period 2||3
8856453|NCT01784614|9911894|FG005|STARTED|Period 2||3
8856454|NCT01784614|9911895|FG006|STARTED|Period 2||3
8856455|NCT01784614|9911896|FG007|STARTED|Period 2||2
8856456|NCT01784614|9911889|FG000|COMPLETED|Period 2||3
8856457|NCT01784614|9911890|FG001|COMPLETED|Period 2|One participant withdrew consent after completed Period 2 and did not enter Period 3.|3
8856458|NCT01784614|9911891|FG002|COMPLETED|Period 2||3
8856459|NCT01784614|9911892|FG003|COMPLETED|Period 2||3
8856460|NCT01784614|9911893|FG004|COMPLETED|Period 2||3
8856461|NCT01784614|9911894|FG005|COMPLETED|Period 2||3
8856462|NCT01784614|9911895|FG006|COMPLETED|Period 2||3
8856463|NCT01784614|9911896|FG007|COMPLETED|Period 2||2
8856464|NCT01784614|9911889|FG000|NOT COMPLETED|Period 2||0
8856465|NCT01784614|9911890|FG001|NOT COMPLETED|Period 2||0
8856466|NCT01784614|9911891|FG002|NOT COMPLETED|Period 2||0
8856467|NCT01784614|9911892|FG003|NOT COMPLETED|Period 2||0
8856468|NCT01784614|9911893|FG004|NOT COMPLETED|Period 2||0
8856469|NCT01784614|9911894|FG005|NOT COMPLETED|Period 2||0
8856470|NCT01784614|9911895|FG006|NOT COMPLETED|Period 2||0
8856471|NCT01784614|9911896|FG007|NOT COMPLETED|Period 2||0
8856472|NCT01784614|9911889|FG000|STARTED|Period 3||3
8856473|NCT01784614|9911890|FG001|STARTED|Period 3||2
8856474|NCT01784614|9911891|FG002|STARTED|Period 3||3
8856475|NCT01784614|9911892|FG003|STARTED|Period 3||3
8856476|NCT01784614|9911893|FG004|STARTED|Period 3||3
8856477|NCT01784614|9911894|FG005|STARTED|Period 3||3
8856478|NCT01784614|9911895|FG006|STARTED|Period 3||3
8856479|NCT01784614|9911896|FG007|STARTED|Period 3||2
8856480|NCT01784614|9911889|FG000|COMPLETED|Period 3||3
8856481|NCT01784614|9911890|FG001|COMPLETED|Period 3||2
8856482|NCT01784614|9911891|FG002|COMPLETED|Period 3||3
8856483|NCT01784614|9911892|FG003|COMPLETED|Period 3||3
8856484|NCT01784614|9911893|FG004|COMPLETED|Period 3||3
8856485|NCT01784614|9911894|FG005|COMPLETED|Period 3||3
8856486|NCT01784614|9911895|FG006|COMPLETED|Period 3||3
8856487|NCT01784614|9911896|FG007|COMPLETED|Period 3||2
8856488|NCT01784614|9911889|FG000|NOT COMPLETED|Period 3||0
8856489|NCT01784614|9911890|FG001|NOT COMPLETED|Period 3||0
8856490|NCT01784614|9911891|FG002|NOT COMPLETED|Period 3||0
8856491|NCT01784614|9911892|FG003|NOT COMPLETED|Period 3||0
8856492|NCT01784614|9911893|FG004|NOT COMPLETED|Period 3||0
8856493|NCT01784614|9911894|FG005|NOT COMPLETED|Period 3||0
8856494|NCT01784614|9911895|FG006|NOT COMPLETED|Period 3||0
8856495|NCT01784614|9911896|FG007|NOT COMPLETED|Period 3||0
8856496|NCT01784614|9911889|FG000|STARTED|Period 4||3
8856497|NCT01784614|9911890|FG001|STARTED|Period 4||2
8856498|NCT01784614|9911891|FG002|STARTED|Period 4||3
8856499|NCT01784614|9911892|FG003|STARTED|Period 4||3
8856500|NCT01784614|9911893|FG004|STARTED|Period 4||3
8856501|NCT01784614|9911894|FG005|STARTED|Period 4||3
8856502|NCT01784614|9911895|FG006|STARTED|Period 4||3
8856503|NCT01784614|9911896|FG007|STARTED|Period 4||2
8856504|NCT01784614|9911889|FG000|COMPLETED|Period 4||3
8856505|NCT01784614|9911890|FG001|COMPLETED|Period 4||2
8856506|NCT01784614|9911891|FG002|COMPLETED|Period 4||3
8856507|NCT01784614|9911892|FG003|COMPLETED|Period 4||3
8856508|NCT01784614|9911893|FG004|COMPLETED|Period 4||3
8856509|NCT01784614|9911894|FG005|COMPLETED|Period 4||3
8856510|NCT01784614|9911895|FG006|COMPLETED|Period 4||3
8856511|NCT01784614|9911896|FG007|COMPLETED|Period 4||2
8856512|NCT01784614|9911889|FG000|NOT COMPLETED|Period 4||0
8856513|NCT01784614|9911890|FG001|NOT COMPLETED|Period 4||0
8856514|NCT01784614|9911891|FG002|NOT COMPLETED|Period 4||0
8856515|NCT01784614|9911892|FG003|NOT COMPLETED|Period 4||0
8856516|NCT01784614|9911893|FG004|NOT COMPLETED|Period 4||0
8856517|NCT01784614|9911894|FG005|NOT COMPLETED|Period 4||0
8856518|NCT01784614|9911895|FG006|NOT COMPLETED|Period 4||0
8856519|NCT01784614|9911896|FG007|NOT COMPLETED|Period 4||0
8856520|NCT01784666|9911919|FG000|STARTED|Overall Study||1
8856521|NCT01784666|9911920|FG001|STARTED|Overall Study||0
8856522|NCT01784666|9911921|FG002|STARTED|Overall Study||1
8856523|NCT01784666|9911919|FG000|COMPLETED|Overall Study||1
8856524|NCT01784666|9911920|FG001|COMPLETED|Overall Study||0
8856525|NCT01784666|9911921|FG002|COMPLETED|Overall Study||1
8856526|NCT01784666|9911919|FG000|NOT COMPLETED|Overall Study||0
8856527|NCT01784666|9911920|FG001|NOT COMPLETED|Overall Study||0
8725299|NCT01030653|9772542|FG001|COMPLETED|Loading Dose & First Maintenance Regimen||4
8725300|NCT01030653|9772541|FG000|NOT COMPLETED|Loading Dose & First Maintenance Regimen||0
8856528|NCT01784666|9911921|FG002|NOT COMPLETED|Overall Study||0
8856529|NCT01784770|9911929|FG000|STARTED|Overall Study||21
8856530|NCT01784770|9911929|FG000|COMPLETED|Overall Study||21
8856531|NCT01784770|9911929|FG000|NOT COMPLETED|Overall Study||0
8856532|NCT01784796|9911935|FG000|STARTED|Overall Study|These are participants who provided informed consent|87
8856533|NCT01784796|9911936|FG001|STARTED|Overall Study|These are participants who provided informed consent|77
8856534|NCT01784796|9911935|FG000|Baseline Data Collected|Overall Study||75
8856535|NCT01784796|9911936|FG001|Baseline Data Collected|Overall Study||61
8856536|NCT01784796|9911935|FG000|4 Week Data Collection|Overall Study||48
8856537|NCT01784796|9911936|FG001|4 Week Data Collection|Overall Study||41
8856538|NCT01784796|9911935|FG000|8 wk Data Collection|Overall Study||50
8856539|NCT01784796|9911936|FG001|8 wk Data Collection|Overall Study||46
8856540|NCT01784796|9911935|FG000|COMPLETED|Overall Study||39
8856541|NCT01784796|9911936|FG001|COMPLETED|Overall Study||34
8949485|NCT02438826|10012076|FG003|COMPLETED|Open-Label Treatment Phase||0
8949486|NCT02438826|10012073|FG000|NOT COMPLETED|Open-Label Treatment Phase||44
8949487|NCT02438826|10012074|FG001|NOT COMPLETED|Open-Label Treatment Phase||33
8949488|NCT02438826|10012075|FG002|NOT COMPLETED|Open-Label Treatment Phase||0
8949489|NCT02438826|10012076|FG003|NOT COMPLETED|Open-Label Treatment Phase||0
8949490|NCT02438826|10012073|FG000|STARTED|Post-Treatment Phase|Participants who discontinued Open-Label Treatment also had the option to enter Post-Treatment Phase|93
8949491|NCT02438826|10012074|FG001|STARTED|Post-Treatment Phase|Participants who discontinued Open-Label Treatment also had the option to enter Post-Treatment Phase|93
8949492|NCT02438826|10012075|FG002|STARTED|Post-Treatment Phase|Participants entered from Double-Blind Treatment Phase.|2
8949493|NCT02438826|10012076|FG003|STARTED|Post-Treatment Phase|Participants entered from Double-Blind Treatment Phase.|4
8949494|NCT02438826|10012073|FG000|COMPLETED|Post-Treatment Phase||84
8949495|NCT02438826|10012074|FG001|COMPLETED|Post-Treatment Phase||92
8949496|NCT02438826|10012075|FG002|COMPLETED|Post-Treatment Phase||2
8949497|NCT02438826|10012076|FG003|COMPLETED|Post-Treatment Phase||4
8949498|NCT02438826|10012073|FG000|NOT COMPLETED|Post-Treatment Phase||9
8949499|NCT02438826|10012074|FG001|NOT COMPLETED|Post-Treatment Phase||1
8725301|NCT01030653|9772542|FG001|NOT COMPLETED|Loading Dose & First Maintenance Regimen||0
8725302|NCT01030653|9772541|FG000|STARTED|7-Day Washout Period||4
8725303|NCT01030653|9772542|FG001|STARTED|7-Day Washout Period||4
8725304|NCT01030653|9772541|FG000|COMPLETED|7-Day Washout Period||4
8725305|NCT01030653|9772542|FG001|COMPLETED|7-Day Washout Period||4
8725306|NCT01030653|9772541|FG000|NOT COMPLETED|7-Day Washout Period||0
8725307|NCT01030653|9772542|FG001|NOT COMPLETED|7-Day Washout Period||0
8725308|NCT01030653|9772541|FG000|STARTED|Loading Dose & 2nd Maintenance Regimen||4
8725309|NCT01030653|9772542|FG001|STARTED|Loading Dose & 2nd Maintenance Regimen||4
8725310|NCT01030653|9772541|FG000|COMPLETED|Loading Dose & 2nd Maintenance Regimen||4
8856542|NCT01784796|9911935|FG000|NOT COMPLETED|Overall Study||48
8856543|NCT01784796|9911936|FG001|NOT COMPLETED|Overall Study||43
8856544|NCT01784861|9911949|FG000|STARTED|Overall Study||3
8856545|NCT01784861|9911950|FG001|STARTED|Overall Study||3
8856546|NCT01784861|9911951|FG002|STARTED|Overall Study||4
8856547|NCT01784861|9911952|FG003|STARTED|Overall Study||8
8856548|NCT01784861|9911953|FG004|STARTED|Overall Study||3
8856549|NCT01784861|9911954|FG005|STARTED|Overall Study||2
8725311|NCT01030653|9772542|FG001|COMPLETED|Loading Dose & 2nd Maintenance Regimen||4
8725312|NCT01030653|9772541|FG000|NOT COMPLETED|Loading Dose & 2nd Maintenance Regimen||0
8725313|NCT01030653|9772542|FG001|NOT COMPLETED|Loading Dose & 2nd Maintenance Regimen||0
8725314|NCT01030666|9772551|FG000|STARTED|Overall Study||28
8725315|NCT01030666|9772552|FG001|STARTED|Overall Study||33
8725316|NCT01030666|9772551|FG000|COMPLETED|Overall Study||25
8856550|NCT01784861|9911949|FG000|COMPLETED|Overall Study||3
8856551|NCT01784861|9911950|FG001|COMPLETED|Overall Study||3
8856552|NCT01784861|9911951|FG002|COMPLETED|Overall Study||3
8856553|NCT01784861|9911952|FG003|COMPLETED|Overall Study||3
8856554|NCT01784861|9911953|FG004|COMPLETED|Overall Study||2
8856555|NCT01784861|9911954|FG005|COMPLETED|Overall Study||1
8856556|NCT01784861|9911949|FG000|NOT COMPLETED|Overall Study||0
8856557|NCT01784861|9911950|FG001|NOT COMPLETED|Overall Study||0
8856558|NCT01784861|9911951|FG002|NOT COMPLETED|Overall Study||1
8856559|NCT01784861|9911952|FG003|NOT COMPLETED|Overall Study||5
8856560|NCT01784861|9911953|FG004|NOT COMPLETED|Overall Study||1
8856561|NCT01784861|9911954|FG005|NOT COMPLETED|Overall Study||1
8856562|NCT01784926|9911972|FG000|STARTED|Overall Study||54
8856563|NCT01784926|9911973|FG001|STARTED|Overall Study||50
8856564|NCT01784926|9911972|FG000|COMPLETED|Overall Study||43
8856565|NCT01784926|9911973|FG001|COMPLETED|Overall Study||42
8856566|NCT01784926|9911972|FG000|NOT COMPLETED|Overall Study||11
8856567|NCT01784926|9911973|FG001|NOT COMPLETED|Overall Study||8
8856568|NCT01784965|9911981|FG000|STARTED|Overall Study||33
8856569|NCT01784965|9911982|FG001|STARTED|Overall Study||35
8856570|NCT01784965|9911981|FG000|COMPLETED|Overall Study||27
8856571|NCT01784965|9911982|FG001|COMPLETED|Overall Study||24
8856572|NCT01784965|9911981|FG000|NOT COMPLETED|Overall Study||6
8856573|NCT01784965|9911982|FG001|NOT COMPLETED|Overall Study||11
8856574|NCT01785069|9911994|FG000|STARTED|Overall Study||107
8856575|NCT01785069|9911995|FG001|STARTED|Overall Study||76
8856576|NCT01785069|9911996|FG002|STARTED|Overall Study||104
8856577|NCT01785069|9911997|FG003|STARTED|Overall Study||68
8856578|NCT01785069|9911994|FG000|COMPLETED|Overall Study||95
8856579|NCT01785069|9911995|FG001|COMPLETED|Overall Study||64
8856580|NCT01785069|9911996|FG002|COMPLETED|Overall Study||91
8856581|NCT01785069|9911997|FG003|COMPLETED|Overall Study||54
8856582|NCT01785069|9911994|FG000|NOT COMPLETED|Overall Study||12
8856583|NCT01785069|9911995|FG001|NOT COMPLETED|Overall Study||12
8856584|NCT01785069|9911996|FG002|NOT COMPLETED|Overall Study||13
8856585|NCT01785069|9911997|FG003|NOT COMPLETED|Overall Study||14
8856586|NCT01785095|9912007|FG000|STARTED|Overall Study||27
8856587|NCT01785095|9912007|FG000|COMPLETED|Overall Study||24
8856588|NCT01785095|9912007|FG000|NOT COMPLETED|Overall Study||3
8856589|NCT01785134|9912016|FG000|STARTED|Overall Study||41
8856590|NCT01785134|9912017|FG001|STARTED|Overall Study||40
8856591|NCT01785134|9912016|FG000|COMPLETED|Overall Study||29
8856592|NCT01785134|9912017|FG001|COMPLETED|Overall Study||33
8856593|NCT01785134|9912016|FG000|NOT COMPLETED|Overall Study||12
8856594|NCT01785134|9912017|FG001|NOT COMPLETED|Overall Study||7
8856595|NCT01785160|9912023|FG000|STARTED|Treatment Period 1: Raltegravir||25
8856596|NCT01785160|9912023|FG000|COMPLETED|Treatment Period 1: Raltegravir||24
8856597|NCT01785160|9912023|FG000|NOT COMPLETED|Treatment Period 1: Raltegravir||1
8856598|NCT01785160|9912023|FG000|STARTED|Washout Period of at Least 7 Days||24
8856599|NCT01785160|9912023|FG000|COMPLETED|Washout Period of at Least 7 Days||23
8856600|NCT01785160|9912023|FG000|NOT COMPLETED|Washout Period of at Least 7 Days||1
8856601|NCT01785160|9912023|FG000|STARTED|Treatment Period 2: Raltegravir + Faldap||23
8856602|NCT01785160|9912023|FG000|COMPLETED|Treatment Period 2: Raltegravir + Faldap||23
8856603|NCT01785160|9912023|FG000|NOT COMPLETED|Treatment Period 2: Raltegravir + Faldap||0
8856604|NCT01785186|9912034|FG000|STARTED|Overall Study||59
8856605|NCT01785186|9912035|FG001|STARTED|Overall Study||63
8856606|NCT01785186|9912036|FG002|STARTED|Overall Study||57
8856607|NCT01785186|9912037|FG003|STARTED|Overall Study||63
8856608|NCT01785186|9912038|FG004|STARTED|Overall Study||123
8856609|NCT01785186|9912034|FG000|COMPLETED|Overall Study||53
8856610|NCT01785186|9912035|FG001|COMPLETED|Overall Study||57
8569617|NCT00098293|9601851|FG004|NOT COMPLETED|Between DB and OL Phase||0
8725317|NCT01030666|9772552|FG001|COMPLETED|Overall Study||31
8725318|NCT01030666|9772551|FG000|NOT COMPLETED|Overall Study||3
8725319|NCT01030666|9772552|FG001|NOT COMPLETED|Overall Study||2
8725320|NCT01030718|9772562|FG000|STARTED|Studies CA180-031 and -036 Combined||30
8725321|NCT01030718|9772563|FG001|STARTED|Studies CA180-031 and -036 Combined||11
8856611|NCT01785186|9912036|FG002|COMPLETED|Overall Study||52
8856612|NCT01785186|9912037|FG003|COMPLETED|Overall Study||58
8856613|NCT01785186|9912038|FG004|COMPLETED|Overall Study||117
8856614|NCT01785186|9912034|FG000|NOT COMPLETED|Overall Study||6
8856615|NCT01785186|9912035|FG001|NOT COMPLETED|Overall Study||6
8856616|NCT01785186|9912036|FG002|NOT COMPLETED|Overall Study||5
8856617|NCT01785186|9912037|FG003|NOT COMPLETED|Overall Study||5
8856618|NCT01785186|9912038|FG004|NOT COMPLETED|Overall Study||6
8923507|NCT02240680|9984108|FG003|STARTED|Japanese Patients (Up to 52 Weeks)||52
8923508|NCT02240680|9984105|FG000|COMPLETED|Japanese Patients (Up to 52 Weeks)||0
8923509|NCT02240680|9984106|FG001|COMPLETED|Japanese Patients (Up to 52 Weeks)||0
8856619|NCT01785459|9912054|FG000|STARTED|Overall Study||11
8856620|NCT01785459|9912055|FG001|STARTED|Overall Study||12
8856621|NCT01785459|9912054|FG000|COMPLETED|Overall Study||11
8856622|NCT01785459|9912055|FG001|COMPLETED|Overall Study||12
8856623|NCT01785459|9912054|FG000|NOT COMPLETED|Overall Study||0
8856624|NCT01785459|9912055|FG001|NOT COMPLETED|Overall Study||0
8856625|NCT01785472|9912064|FG000|STARTED|Overall Study||479
8856626|NCT01785472|9912065|FG001|STARTED|Overall Study||473
8856627|NCT01785472|9912066|FG002|STARTED|Overall Study||486
8856628|NCT01785472|9912064|FG000|Full Analysis Set (FAS)|Overall Study||479
8856629|NCT01785472|9912065|FG001|Full Analysis Set (FAS)|Overall Study||472
8856630|NCT01785472|9912066|FG002|Full Analysis Set (FAS)|Overall Study||484
8856631|NCT01785472|9912064|FG000|Safety Set (SAF)|Overall Study||478
8856632|NCT01785472|9912065|FG001|Safety Set (SAF)|Overall Study||472
8856633|NCT01785472|9912066|FG002|Safety Set (SAF)|Overall Study||484
8856634|NCT01785472|9912064|FG000|COMPLETED|Overall Study||455
8856635|NCT01785472|9912065|FG001|COMPLETED|Overall Study||454
8856636|NCT01785472|9912066|FG002|COMPLETED|Overall Study||464
8856637|NCT01785472|9912064|FG000|NOT COMPLETED|Overall Study||24
8856638|NCT01785472|9912065|FG001|NOT COMPLETED|Overall Study||19
8856639|NCT01785472|9912066|FG002|NOT COMPLETED|Overall Study||22
8569618|NCT00098293|9601847|FG000|STARTED|Open-label (OL) Phase||0
8569619|NCT00098293|9601848|FG001|STARTED|Open-label (OL) Phase||202
8569620|NCT00098293|9601849|FG002|STARTED|Open-label (OL) Phase||199
8569621|NCT00098293|9601850|FG003|STARTED|Open-label (OL) Phase||130
8569622|NCT00098293|9601851|FG004|STARTED|Open-label (OL) Phase||0
8569623|NCT00098293|9601847|FG000|COMPLETED|Open-label (OL) Phase||0
8569624|NCT00098293|9601848|FG001|COMPLETED|Open-label (OL) Phase||177
8569625|NCT00098293|9601849|FG002|COMPLETED|Open-label (OL) Phase||158
8569626|NCT00098293|9601850|FG003|COMPLETED|Open-label (OL) Phase||65
8569627|NCT00098293|9601851|FG004|COMPLETED|Open-label (OL) Phase||0
8569628|NCT00098293|9601847|FG000|NOT COMPLETED|Open-label (OL) Phase||0
8569629|NCT00098293|9601848|FG001|NOT COMPLETED|Open-label (OL) Phase||25
8569630|NCT00098293|9601849|FG002|NOT COMPLETED|Open-label (OL) Phase||41
8629920|NCT00532480|9669672|FG000|COMPLETED|Overall Study||7
8856640|NCT01785524|9912078|FG000|STARTED|Overall Study||7
8856641|NCT01785524|9912079|FG001|STARTED|Overall Study||4
8856642|NCT01785524|9912078|FG000|COMPLETED|Overall Study||5
8856643|NCT01785524|9912079|FG001|COMPLETED|Overall Study||2
8856644|NCT01785524|9912078|FG000|NOT COMPLETED|Overall Study||2
8856645|NCT01785524|9912079|FG001|NOT COMPLETED|Overall Study||2
8856646|NCT01785602|9912087|FG000|STARTED|Overall Study||76
8856647|NCT01785602|9912088|FG001|STARTED|Overall Study||27
8856648|NCT01785602|9912087|FG000|COMPLETED|Overall Study||63
8856649|NCT01785602|9912088|FG001|COMPLETED|Overall Study||18
8856650|NCT01785602|9912087|FG000|NOT COMPLETED|Overall Study||13
8856651|NCT01785602|9912088|FG001|NOT COMPLETED|Overall Study||9
8856652|NCT01785615|9912097|FG000|STARTED|Dietary Phase||0
8856653|NCT01785615|9912098|FG001|STARTED|Dietary Phase||0
8856654|NCT01785615|9912099|FG002|STARTED|Dietary Phase||35
8856655|NCT01785615|9912100|FG003|STARTED|Dietary Phase||140
8856656|NCT01785615|9912097|FG000|COMPLETED|Dietary Phase||0
8856657|NCT01785615|9912098|FG001|COMPLETED|Dietary Phase||0
8629921|NCT00532480|9669672|FG000|NOT COMPLETED|Overall Study||3
8629922|NCT00532493|9669678|FG000|STARTED|Overall Study||152
8629923|NCT00532493|9669679|FG001|STARTED|Overall Study||152
8629924|NCT00532493|9669678|FG000|COMPLETED|Overall Study||122
8629925|NCT00532493|9669679|FG001|COMPLETED|Overall Study||123
8629926|NCT00532493|9669678|FG000|NOT COMPLETED|Overall Study||30
8629927|NCT00532493|9669679|FG001|NOT COMPLETED|Overall Study||29
8629928|NCT00532779|9669690|FG000|STARTED|Overall Study||578
8629929|NCT00532779|9669691|FG001|STARTED|Overall Study||583
8629930|NCT00532779|9669692|FG002|STARTED|Overall Study||581
8629931|NCT00532779|9669690|FG000|COMPLETED|Overall Study||284
8629932|NCT00532779|9669691|FG001|COMPLETED|Overall Study||296
8629933|NCT00532779|9669692|FG002|COMPLETED|Overall Study||290
8629934|NCT00532779|9669690|FG000|NOT COMPLETED|Overall Study||294
8629935|NCT00532779|9669691|FG001|NOT COMPLETED|Overall Study||287
8629936|NCT00532779|9669692|FG002|NOT COMPLETED|Overall Study||291
8629937|NCT00532844|9669702|FG000|STARTED|Treatment Period - Day 1 to Day 14|Only the 48 subjects enrolled in the final protocol are included in the participant flow.|24
8629938|NCT00532844|9669703|FG001|STARTED|Treatment Period - Day 1 to Day 14|Only the 48 subjects enrolled in the final protocol are included in the participant flow.|24
8856658|NCT01785615|9912099|FG002|COMPLETED|Dietary Phase||35
8856659|NCT01785615|9912100|FG003|COMPLETED|Dietary Phase||116
8569631|NCT00098293|9601850|FG003|NOT COMPLETED|Open-label (OL) Phase||65
8569632|NCT00098293|9601851|FG004|NOT COMPLETED|Open-label (OL) Phase||0
8629939|NCT00532844|9669702|FG000|COMPLETED|Treatment Period - Day 1 to Day 14||24
8629940|NCT00532844|9669703|FG001|COMPLETED|Treatment Period - Day 1 to Day 14||23
8629941|NCT00532844|9669702|FG000|NOT COMPLETED|Treatment Period - Day 1 to Day 14||0
8629942|NCT00532844|9669703|FG001|NOT COMPLETED|Treatment Period - Day 1 to Day 14||1
8629943|NCT00532844|9669702|FG000|STARTED|Washout (1 Day)||24
8629944|NCT00532844|9669703|FG001|STARTED|Washout (1 Day)||23
8629945|NCT00532844|9669702|FG000|COMPLETED|Washout (1 Day)||24
8629946|NCT00532844|9669703|FG001|COMPLETED|Washout (1 Day)||23
8629947|NCT00532844|9669702|FG000|NOT COMPLETED|Washout (1 Day)||0
8629948|NCT00532844|9669703|FG001|NOT COMPLETED|Washout (1 Day)||0
8629949|NCT00532844|9669702|FG000|STARTED|Treatment Period - Day 15 to Day 28||24
8856660|NCT01785615|9912097|FG000|NOT COMPLETED|Dietary Phase||0
8856661|NCT01785615|9912098|FG001|NOT COMPLETED|Dietary Phase||0
8856662|NCT01785615|9912099|FG002|NOT COMPLETED|Dietary Phase||0
8856663|NCT01785615|9912100|FG003|NOT COMPLETED|Dietary Phase||24
8856664|NCT01785615|9912097|FG000|STARTED|Atorvastatin Phase||44
8856665|NCT01785615|9912098|FG001|STARTED|Atorvastatin Phase||44
8856666|NCT01785615|9912099|FG002|STARTED|Atorvastatin Phase||0
8856667|NCT01785615|9912100|FG003|STARTED|Atorvastatin Phase||0
8856668|NCT01785615|9912097|FG000|COMPLETED|Atorvastatin Phase||44
8856669|NCT01785615|9912098|FG001|COMPLETED|Atorvastatin Phase||44
8856670|NCT01785615|9912099|FG002|COMPLETED|Atorvastatin Phase||0
8856671|NCT01785615|9912100|FG003|COMPLETED|Atorvastatin Phase||0
8856672|NCT01785615|9912097|FG000|NOT COMPLETED|Atorvastatin Phase||0
8856673|NCT01785615|9912098|FG001|NOT COMPLETED|Atorvastatin Phase||0
8856674|NCT01785615|9912099|FG002|NOT COMPLETED|Atorvastatin Phase||0
8856675|NCT01785615|9912100|FG003|NOT COMPLETED|Atorvastatin Phase||0
8856676|NCT01785628|9912114|FG000|STARTED|Overall Study||15
8856677|NCT01785628|9912115|FG001|STARTED|Overall Study||15
8856678|NCT01785628|9912114|FG000|COMPLETED|Overall Study||13
8856679|NCT01785628|9912115|FG001|COMPLETED|Overall Study||12
8856680|NCT01785628|9912114|FG000|NOT COMPLETED|Overall Study||2
8856681|NCT01785628|9912115|FG001|NOT COMPLETED|Overall Study||3
8856682|NCT01785680|9912123|FG000|STARTED|Overall Study||1100
8856683|NCT01785680|9912124|FG001|STARTED|Overall Study||857
8856684|NCT01785680|9912123|FG000|COMPLETED|Overall Study||1100
8856685|NCT01785680|9912124|FG001|COMPLETED|Overall Study||857
8856686|NCT01785680|9912123|FG000|NOT COMPLETED|Overall Study||0
8856687|NCT01785680|9912124|FG001|NOT COMPLETED|Overall Study||0
8856688|NCT01785810|9912130|FG000|STARTED|Overall Study||37
8856689|NCT01785810|9912130|FG000|COMPLETED|Overall Study||29
8856690|NCT01785810|9912130|FG000|NOT COMPLETED|Overall Study||8
8856691|NCT01785849|9912136|FG000|STARTED|Overall Study||254
8856692|NCT01785849|9912137|FG001|STARTED|Overall Study||254
8856693|NCT01785849|9912136|FG000|Received Treatment|Overall Study||254
8856694|NCT01785849|9912137|FG001|Received Treatment|Overall Study||251
8856695|NCT01785849|9912136|FG000|COMPLETED|Overall Study||193
8856696|NCT01785849|9912137|FG001|COMPLETED|Overall Study||220
8856697|NCT01785849|9912136|FG000|NOT COMPLETED|Overall Study||61
8856698|NCT01785849|9912137|FG001|NOT COMPLETED|Overall Study||34
8856699|NCT01785875|9912143|FG000|STARTED|Overall Study||384
8856700|NCT01785875|9912144|FG001|STARTED|Overall Study||384
8856701|NCT01785875|9912145|FG002|STARTED|Overall Study||123
8856702|NCT01785875|9912143|FG000|Received Etelcalcetide|Overall Study||383
8856703|NCT01785875|9912144|FG001|Received Etelcalcetide|Overall Study||384
8856704|NCT01785875|9912145|FG002|Received Etelcalcetide|Overall Study||123
8856705|NCT01785875|9912143|FG000|COMPLETED|Overall Study|Completed etelcalcetide and the 30-day safety follow-up period|90
8856706|NCT01785875|9912144|FG001|COMPLETED|Overall Study|Completed etelcalcetide and the 30-day safety follow-up period|95
8856707|NCT01785875|9912145|FG002|COMPLETED|Overall Study|Completed etelcalcetide and the 30-day safety follow-up period|16
8856708|NCT01785875|9912143|FG000|NOT COMPLETED|Overall Study||294
8856709|NCT01785875|9912144|FG001|NOT COMPLETED|Overall Study||289
8856710|NCT01785875|9912145|FG002|NOT COMPLETED|Overall Study||107
8856711|NCT01786109|9912159|FG000|STARTED|Overall Study||24
8725322|NCT01030718|9772564|FG002|STARTED|Studies CA180-031 and -036 Combined||13
8725323|NCT01030718|9772562|FG000|COMPLETED|Studies CA180-031 and -036 Combined||26
8725324|NCT01030718|9772563|FG001|COMPLETED|Studies CA180-031 and -036 Combined||2
8725325|NCT01030718|9772564|FG002|COMPLETED|Studies CA180-031 and -036 Combined||1
8725326|NCT01030718|9772562|FG000|NOT COMPLETED|Studies CA180-031 and -036 Combined||4
8725327|NCT01030718|9772563|FG001|NOT COMPLETED|Studies CA180-031 and -036 Combined||9
8856712|NCT01786109|9912160|FG001|STARTED|Overall Study||24
8856713|NCT01786109|9912161|FG002|STARTED|Overall Study||27
8856714|NCT01786109|9912159|FG000|COMPLETED|Overall Study||23
8856715|NCT01786109|9912160|FG001|COMPLETED|Overall Study||24
8856716|NCT01786109|9912161|FG002|COMPLETED|Overall Study||25
8856717|NCT01786109|9912159|FG000|NOT COMPLETED|Overall Study||1
8856718|NCT01786109|9912160|FG001|NOT COMPLETED|Overall Study||0
8725328|NCT01030718|9772564|FG002|NOT COMPLETED|Studies CA180-031 and -036 Combined||12
8725329|NCT01030718|9772562|FG000|STARTED|Study CA180-036 Only||29
8725330|NCT01030718|9772563|FG001|STARTED|Study CA180-036 Only||9
8725331|NCT01030718|9772564|FG002|STARTED|Study CA180-036 Only||6
8725332|NCT01030718|9772562|FG000|COMPLETED|Study CA180-036 Only||26
8725333|NCT01030718|9772563|FG001|COMPLETED|Study CA180-036 Only||2
8725334|NCT01030718|9772564|FG002|COMPLETED|Study CA180-036 Only||1
8725335|NCT01030718|9772562|FG000|NOT COMPLETED|Study CA180-036 Only||3
8725336|NCT01030718|9772563|FG001|NOT COMPLETED|Study CA180-036 Only||7
8725337|NCT01030718|9772564|FG002|NOT COMPLETED|Study CA180-036 Only||5
8725338|NCT01030783|9772584|FG000|STARTED|Overall Study||260
8725339|NCT01030783|9772585|FG001|STARTED|Overall Study||257
8725340|NCT01030783|9772584|FG000|COMPLETED|Overall Study||211
8856719|NCT01786109|9912161|FG002|NOT COMPLETED|Overall Study||2
8856720|NCT01786148|9912171|FG000|STARTED|Overall Study||77
8856721|NCT01786148|9912172|FG001|STARTED|Overall Study||72
8856722|NCT01786148|9912171|FG000|COMPLETED|Overall Study||55
8856723|NCT01786148|9912172|FG001|COMPLETED|Overall Study||50
8856724|NCT01786148|9912171|FG000|NOT COMPLETED|Overall Study||22
8856725|NCT01786148|9912172|FG001|NOT COMPLETED|Overall Study||22
8856726|NCT01786161|9912180|FG000|STARTED|Overall Study||22
8856727|NCT01786161|9912181|FG001|STARTED|Overall Study||22
8856728|NCT01786161|9912180|FG000|COMPLETED|Overall Study||22
8725341|NCT01030783|9772585|FG001|COMPLETED|Overall Study||231
8856729|NCT01786161|9912181|FG001|COMPLETED|Overall Study||22
8856730|NCT01786161|9912180|FG000|NOT COMPLETED|Overall Study||0
8856731|NCT01786161|9912181|FG001|NOT COMPLETED|Overall Study||0
8856732|NCT01786174|9912191|FG000|STARTED|Overall Study||18
8856733|NCT01786174|9912192|FG001|STARTED|Overall Study||10
8856734|NCT01786174|9912191|FG000|Randomized|Overall Study||19
8856735|NCT01786174|9912192|FG001|Randomized|Overall Study||11
8856736|NCT01786174|9912191|FG000|COMPLETED|Overall Study||16
8856737|NCT01786174|9912192|FG001|COMPLETED|Overall Study||10
8856738|NCT01786174|9912191|FG000|NOT COMPLETED|Overall Study||2
8856739|NCT01786174|9912192|FG001|NOT COMPLETED|Overall Study||0
8856740|NCT01786187|9912200|FG000|STARTED|Overall Study||40
8856741|NCT01786187|9912201|FG001|STARTED|Overall Study||47
8856742|NCT01786187|9912200|FG000|COMPLETED|Overall Study||35
8856743|NCT01786187|9912201|FG001|COMPLETED|Overall Study||37
8856744|NCT01786187|9912200|FG000|NOT COMPLETED|Overall Study||5
8856745|NCT01786187|9912201|FG001|NOT COMPLETED|Overall Study||10
8856746|NCT01786239|9912212|FG000|STARTED|Overall Study||25
8856747|NCT01786239|9912213|FG001|STARTED|Overall Study||25
8856748|NCT01786239|9912212|FG000|COMPLETED|Overall Study||14
8856749|NCT01786239|9912213|FG001|COMPLETED|Overall Study||14
8856750|NCT01786239|9912212|FG000|NOT COMPLETED|Overall Study||11
8856751|NCT01786239|9912213|FG001|NOT COMPLETED|Overall Study||11
8856752|NCT01786252|9912221|FG000|STARTED|Overall Study||7
8856753|NCT01786252|9912222|FG001|STARTED|Overall Study||8
8856754|NCT01786252|9912221|FG000|COMPLETED|Overall Study||7
8856755|NCT01786252|9912222|FG001|COMPLETED|Overall Study||8
8856756|NCT01786252|9912221|FG000|NOT COMPLETED|Overall Study||0
8856757|NCT01786252|9912222|FG001|NOT COMPLETED|Overall Study||0
8856758|NCT01786330|9912230|FG000|STARTED|Overall Study||30
8856759|NCT01786330|9912231|FG001|STARTED|Overall Study||30
8856760|NCT01786330|9912230|FG000|COMPLETED|Overall Study||29
8856761|NCT01786330|9912231|FG001|COMPLETED|Overall Study||27
8856762|NCT01786330|9912230|FG000|NOT COMPLETED|Overall Study||1
8856763|NCT01786330|9912231|FG001|NOT COMPLETED|Overall Study||3
8856764|NCT01786343|9912239|FG000|STARTED|Overall Study||28
8856765|NCT01786343|9912240|FG001|STARTED|Overall Study||46
8856766|NCT01786343|9912239|FG000|COMPLETED|Overall Study||28
8856767|NCT01786343|9912240|FG001|COMPLETED|Overall Study||46
8856768|NCT01786343|9912239|FG000|NOT COMPLETED|Overall Study||0
8856769|NCT01786343|9912240|FG001|NOT COMPLETED|Overall Study||0
8856770|NCT01786512|9912257|FG000|STARTED|Overall Study||11
8856771|NCT01786512|9912258|FG001|STARTED|Overall Study||11
8856772|NCT01786512|9912259|FG002|STARTED|Overall Study||14
8856773|NCT01786512|9912260|FG003|STARTED|Overall Study||13
8856774|NCT01786512|9912261|FG004|STARTED|Overall Study||10
8856775|NCT01786512|9912262|FG005|STARTED|Overall Study||11
8856776|NCT01786512|9912263|FG006|STARTED|Overall Study||12
8856777|NCT01786512|9912264|FG007|STARTED|Overall Study||14
8856778|NCT01786512|9912265|FG008|STARTED|Overall Study||149
8856779|NCT01786512|9912266|FG009|STARTED|Overall Study||150
8856780|NCT01786512|9912267|FG010|STARTED|Overall Study||149
8856781|NCT01786512|9912257|FG000|Received Study Treatment|Overall Study||11
8856782|NCT01786512|9912258|FG001|Received Study Treatment|Overall Study||10
8856783|NCT01786512|9912259|FG002|Received Study Treatment|Overall Study||14
8856784|NCT01786512|9912260|FG003|Received Study Treatment|Overall Study||13
8856785|NCT01786512|9912261|FG004|Received Study Treatment|Overall Study||10
8856786|NCT01786512|9912262|FG005|Received Study Treatment|Overall Study||11
8856787|NCT01786512|9912263|FG006|Received Study Treatment|Overall Study||11
8856788|NCT01786512|9912264|FG007|Received Study Treatment|Overall Study||14
8856789|NCT01786512|9912265|FG008|Received Study Treatment|Overall Study||149
8856790|NCT01786512|9912266|FG009|Received Study Treatment|Overall Study||150
8856791|NCT01786512|9912267|FG010|Received Study Treatment|Overall Study||146
8856792|NCT01786512|9912257|FG000|COMPLETED|Overall Study||11
8856793|NCT01786512|9912258|FG001|COMPLETED|Overall Study||10
8856794|NCT01786512|9912259|FG002|COMPLETED|Overall Study||14
8856795|NCT01786512|9912260|FG003|COMPLETED|Overall Study||13
8856796|NCT01786512|9912261|FG004|COMPLETED|Overall Study||10
8856797|NCT01786512|9912262|FG005|COMPLETED|Overall Study||11
8856798|NCT01786512|9912263|FG006|COMPLETED|Overall Study||11
8856799|NCT01786512|9912264|FG007|COMPLETED|Overall Study||14
8856800|NCT01786512|9912265|FG008|COMPLETED|Overall Study||145
8856801|NCT01786512|9912266|FG009|COMPLETED|Overall Study||145
8856802|NCT01786512|9912267|FG010|COMPLETED|Overall Study||137
8725342|NCT01030783|9772584|FG000|NOT COMPLETED|Overall Study||49
8725343|NCT01030783|9772585|FG001|NOT COMPLETED|Overall Study||26
8725344|NCT01030822|9772594|FG000|STARTED|Overall Study||100
8725345|NCT01030822|9772595|FG001|STARTED|Overall Study||95
8725346|NCT01030822|9772596|FG002|STARTED|Overall Study||87
8725347|NCT01030822|9772594|FG000|COMPLETED|Overall Study||69
8725348|NCT01030822|9772595|FG001|COMPLETED|Overall Study||71
8725349|NCT01030822|9772596|FG002|COMPLETED|Overall Study||61
8725350|NCT01030822|9772594|FG000|NOT COMPLETED|Overall Study||31
8856803|NCT01786512|9912257|FG000|NOT COMPLETED|Overall Study||0
8856804|NCT01786512|9912258|FG001|NOT COMPLETED|Overall Study||1
8856805|NCT01786512|9912259|FG002|NOT COMPLETED|Overall Study||0
8856806|NCT01786512|9912260|FG003|NOT COMPLETED|Overall Study||0
8856807|NCT01786512|9912261|FG004|NOT COMPLETED|Overall Study||0
8725351|NCT01030822|9772595|FG001|NOT COMPLETED|Overall Study||24
8856808|NCT01786512|9912262|FG005|NOT COMPLETED|Overall Study||0
8856809|NCT01786512|9912263|FG006|NOT COMPLETED|Overall Study||1
8856810|NCT01786512|9912264|FG007|NOT COMPLETED|Overall Study||0
8856811|NCT01786512|9912265|FG008|NOT COMPLETED|Overall Study||4
8856812|NCT01786512|9912266|FG009|NOT COMPLETED|Overall Study||5
8856813|NCT01786512|9912267|FG010|NOT COMPLETED|Overall Study||12
8856814|NCT01786551|9912299|FG000|STARTED|Overall Study||16
8856815|NCT01786551|9912299|FG000|COMPLETED|Overall Study||14
8856816|NCT01786551|9912299|FG000|NOT COMPLETED|Overall Study||2
8856817|NCT01786564|9912303|FG000|STARTED|Overall Study||120
8856818|NCT01786564|9912303|FG000|COMPLETED|Overall Study||56
8856819|NCT01786564|9912303|FG000|NOT COMPLETED|Overall Study||64
8856820|NCT01786603|9912309|FG000|STARTED|Overall Study||60
8856821|NCT01786603|9912310|FG001|STARTED|Overall Study||20
8856822|NCT01786603|9912309|FG000|COMPLETED|Overall Study||42
8856823|NCT01786603|9912310|FG001|COMPLETED|Overall Study||8
8856824|NCT01786603|9912309|FG000|NOT COMPLETED|Overall Study||18
8856825|NCT01786603|9912310|FG001|NOT COMPLETED|Overall Study||12
8856826|NCT01786629|9912318|FG000|STARTED|Overall Study||169
8856827|NCT01786629|9912319|FG001|STARTED|Overall Study||169
8856828|NCT01786629|9912318|FG000|COMPLETED|Overall Study||169
8856829|NCT01786629|9912319|FG001|COMPLETED|Overall Study||164
8856830|NCT01786629|9912318|FG000|NOT COMPLETED|Overall Study||0
8856831|NCT01786629|9912319|FG001|NOT COMPLETED|Overall Study||5
8856832|NCT01786668|9912329|FG000|STARTED|Overall Study||52
8856833|NCT01786668|9912330|FG001|STARTED|Overall Study||52
8856834|NCT01786668|9912331|FG002|STARTED|Overall Study||52
8856835|NCT01786668|9912332|FG003|STARTED|Overall Study||51
8856836|NCT01786668|9912329|FG000|COMPLETED|Overall Study||51
8856837|NCT01786668|9912330|FG001|COMPLETED|Overall Study||51
8856838|NCT01786668|9912331|FG002|COMPLETED|Overall Study||47
8856839|NCT01786668|9912332|FG003|COMPLETED|Overall Study||47
8856840|NCT01786668|9912329|FG000|NOT COMPLETED|Overall Study||1
8856841|NCT01786668|9912330|FG001|NOT COMPLETED|Overall Study||1
8856842|NCT01786668|9912331|FG002|NOT COMPLETED|Overall Study||5
8856843|NCT01786668|9912332|FG003|NOT COMPLETED|Overall Study||4
8725352|NCT01030822|9772596|FG002|NOT COMPLETED|Overall Study||26
8725353|NCT01030861|9772607|FG000|STARTED|Overall Study||44
8725354|NCT01030861|9772608|FG001|STARTED|Overall Study||32
8856844|NCT01786707|9912344|FG000|STARTED|Overall Study||1
8856845|NCT01786707|9912345|FG001|STARTED|Overall Study||1
8856846|NCT01786707|9912344|FG000|COMPLETED|Overall Study||0
8856847|NCT01786707|9912345|FG001|COMPLETED|Overall Study||0
8856848|NCT01786707|9912344|FG000|NOT COMPLETED|Overall Study||1
8856849|NCT01786707|9912345|FG001|NOT COMPLETED|Overall Study||1
8856850|NCT01786876|9912351|FG000|STARTED|Overall Study||6
8856851|NCT01786876|9912351|FG000|COMPLETED|Overall Study||6
8856852|NCT01786876|9912351|FG000|NOT COMPLETED|Overall Study||0
8856853|NCT01786902|9912357|FG000|STARTED|Overall Study||36
8856854|NCT01786902|9912358|FG001|STARTED|Overall Study||34
8856855|NCT01786902|9912357|FG000|COMPLETED|Overall Study||32
8856856|NCT01786902|9912358|FG001|COMPLETED|Overall Study||31
8856857|NCT01786902|9912357|FG000|NOT COMPLETED|Overall Study||4
8856858|NCT01786902|9912358|FG001|NOT COMPLETED|Overall Study||3
8856859|NCT01786954|9912364|FG000|STARTED|Overall Study||34
8949500|NCT02438826|10012075|FG002|NOT COMPLETED|Post-Treatment Phase||0
8949501|NCT02438826|10012076|FG003|NOT COMPLETED|Post-Treatment Phase||0
8725355|NCT01030861|9772607|FG000|COMPLETED|Overall Study||44
8725356|NCT01030861|9772608|FG001|COMPLETED|Overall Study||32
8725357|NCT01030861|9772607|FG000|NOT COMPLETED|Overall Study||0
8725358|NCT01030861|9772608|FG001|NOT COMPLETED|Overall Study||0
8725359|NCT01030874|9772616|FG000|STARTED|Overall Study|1 with impaired decision making capacity|178
8725360|NCT01030874|9772617|FG001|STARTED|Overall Study|1 with impaired decision making capacity|178
8725361|NCT01030874|9772616|FG000|COMPLETED|Overall Study||160
8725362|NCT01030874|9772617|FG001|COMPLETED|Overall Study||162
8725363|NCT01030874|9772616|FG000|NOT COMPLETED|Overall Study||18
8856860|NCT01786954|9912365|FG001|STARTED|Overall Study||34
8856861|NCT01786954|9912364|FG000|COMPLETED|Overall Study||34
8856862|NCT01786954|9912365|FG001|COMPLETED|Overall Study||34
8856863|NCT01786954|9912364|FG000|NOT COMPLETED|Overall Study||0
8856864|NCT01786954|9912365|FG001|NOT COMPLETED|Overall Study||0
8856865|NCT01786967|9912375|FG000|STARTED|Overall Study||61
8856866|NCT01786967|9912375|FG000|Extensive Metabolizers|Overall Study||54
8856867|NCT01786967|9912375|FG000|Poor Metabolizers|Overall Study||4
8856868|NCT01786967|9912375|FG000|Metabolizer Status Undetermined|Overall Study||3
8856869|NCT01786967|9912375|FG000|COMPLETED|Overall Study||61
8856870|NCT01786967|9912375|FG000|NOT COMPLETED|Overall Study||0
8856871|NCT01786993|9912386|FG000|STARTED|Overall Study||201
8856872|NCT01786993|9912387|FG001|STARTED|Overall Study||180
8856873|NCT01786993|9912386|FG000|Per Protocol Population at 9 Months|Overall Study||189
8856874|NCT01786993|9912387|FG001|Per Protocol Population at 9 Months|Overall Study||170
8856875|NCT01786993|9912386|FG000|COMPLETED|Overall Study||189
8856876|NCT01786993|9912387|FG001|COMPLETED|Overall Study||170
8856877|NCT01786993|9912386|FG000|NOT COMPLETED|Overall Study||12
8856878|NCT01786993|9912387|FG001|NOT COMPLETED|Overall Study||10
8856879|NCT01787006|9912396|FG000|STARTED|Overall Study||35
8856880|NCT01787006|9912397|FG001|STARTED|Overall Study||39
8856881|NCT01787006|9912396|FG000|COMPLETED|Overall Study||32
8725364|NCT01030874|9772617|FG001|NOT COMPLETED|Overall Study||16
8725365|NCT01030952|9772625|FG000|STARTED|Overall Study||51
8856882|NCT01787006|9912397|FG001|COMPLETED|Overall Study||36
8856883|NCT01787006|9912396|FG000|NOT COMPLETED|Overall Study||3
8856884|NCT01787006|9912397|FG001|NOT COMPLETED|Overall Study||3
8856885|NCT01787032|9912409|FG000|STARTED|Overall Study||3
8856886|NCT01787032|9912410|FG001|STARTED|Overall Study||3
8856887|NCT01787032|9912411|FG002|STARTED|Overall Study||3
8856888|NCT01787032|9912412|FG003|STARTED|Overall Study||3
8856889|NCT01787032|9912413|FG004|STARTED|Overall Study||4
8856890|NCT01787032|9912414|FG005|STARTED|Overall Study||4
8856891|NCT01787032|9912409|FG000|Received R|Overall Study||3
8856892|NCT01787032|9912410|FG001|Received R|Overall Study||3
8856893|NCT01787032|9912411|FG002|Received R|Overall Study||3
8856894|NCT01787032|9912412|FG003|Received R|Overall Study||3
8856895|NCT01787032|9912413|FG004|Received R|Overall Study||4
8856896|NCT01787032|9912414|FG005|Received R|Overall Study||3
8856897|NCT01787032|9912409|FG000|Received T1|Overall Study||3
8856898|NCT01787032|9912410|FG001|Received T1|Overall Study||3
8856899|NCT01787032|9912411|FG002|Received T1|Overall Study||3
8856900|NCT01787032|9912412|FG003|Received T1|Overall Study||3
8856901|NCT01787032|9912413|FG004|Received T1|Overall Study||3
8856902|NCT01787032|9912414|FG005|Received T1|Overall Study||4
8856903|NCT01787032|9912409|FG000|Received T2|Overall Study||3
8856904|NCT01787032|9912410|FG001|Received T2|Overall Study||3
8856905|NCT01787032|9912411|FG002|Received T2|Overall Study||3
8856906|NCT01787032|9912412|FG003|Received T2|Overall Study||3
8856907|NCT01787032|9912413|FG004|Received T2|Overall Study||4
8856908|NCT01787032|9912414|FG005|Received T2|Overall Study||4
8856909|NCT01787032|9912409|FG000|COMPLETED|Overall Study||3
8856910|NCT01787032|9912410|FG001|COMPLETED|Overall Study||3
8856911|NCT01787032|9912411|FG002|COMPLETED|Overall Study||3
8856912|NCT01787032|9912412|FG003|COMPLETED|Overall Study||3
8856913|NCT01787032|9912413|FG004|COMPLETED|Overall Study||3
8856914|NCT01787032|9912414|FG005|COMPLETED|Overall Study||3
8856915|NCT01787032|9912409|FG000|NOT COMPLETED|Overall Study||0
8856916|NCT01787032|9912410|FG001|NOT COMPLETED|Overall Study||0
8856917|NCT01787032|9912411|FG002|NOT COMPLETED|Overall Study||0
8856918|NCT01787032|9912412|FG003|NOT COMPLETED|Overall Study||0
8856919|NCT01787032|9912413|FG004|NOT COMPLETED|Overall Study||1
8856920|NCT01787032|9912414|FG005|NOT COMPLETED|Overall Study||1
8856921|NCT01787097|9912424|FG000|STARTED|Overall Study|Study started in 2012/2013|8
8856922|NCT01787097|9912425|FG001|STARTED|Overall Study||7
8856923|NCT01787097|9912426|FG002|STARTED|Overall Study||7
8856924|NCT01787097|9912427|FG003|STARTED|Overall Study||9
8856925|NCT01787097|9912424|FG000|COMPLETED|Overall Study|Study completed|7
8856926|NCT01787097|9912425|FG001|COMPLETED|Overall Study||7
8856927|NCT01787097|9912426|FG002|COMPLETED|Overall Study||7
8856928|NCT01787097|9912427|FG003|COMPLETED|Overall Study||9
8856929|NCT01787097|9912424|FG000|NOT COMPLETED|Overall Study||1
8856930|NCT01787097|9912425|FG001|NOT COMPLETED|Overall Study||0
8856931|NCT01787097|9912426|FG002|NOT COMPLETED|Overall Study||0
8856932|NCT01787097|9912427|FG003|NOT COMPLETED|Overall Study||0
8856933|NCT01787175|9912449|FG000|STARTED|Overall Study||30
8856934|NCT01787175|9912450|FG001|STARTED|Overall Study||28
8856935|NCT01787175|9912449|FG000|COMPLETED|Overall Study||30
8856936|NCT01787175|9912450|FG001|COMPLETED|Overall Study||28
8856937|NCT01787175|9912449|FG000|NOT COMPLETED|Overall Study||0
8856938|NCT01787175|9912450|FG001|NOT COMPLETED|Overall Study||0
8856939|NCT01787188|9912459|FG000|STARTED|Overall Study||139
8856940|NCT01787188|9912460|FG001|STARTED|Overall Study||130
8856941|NCT01787188|9912461|FG002|STARTED|Overall Study||134
8856942|NCT01787188|9912459|FG000|COMPLETED|Overall Study||122
8856943|NCT01787188|9912460|FG001|COMPLETED|Overall Study||112
8856944|NCT01787188|9912461|FG002|COMPLETED|Overall Study||116
8856945|NCT01787188|9912459|FG000|NOT COMPLETED|Overall Study||17
8856946|NCT01787188|9912460|FG001|NOT COMPLETED|Overall Study||18
8856947|NCT01787188|9912461|FG002|NOT COMPLETED|Overall Study||18
8856948|NCT01787240|9912471|FG000|STARTED|Overall Study||15
8856949|NCT01787240|9912472|FG001|STARTED|Overall Study||5
8856950|NCT01787240|9912471|FG000|COMPLETED|Overall Study||10
8856951|NCT01787240|9912472|FG001|COMPLETED|Overall Study||4
8856952|NCT01787240|9912471|FG000|NOT COMPLETED|Overall Study||5
8856953|NCT01787240|9912472|FG001|NOT COMPLETED|Overall Study||1
8856954|NCT01787279|9912481|FG000|STARTED|Overall Study||59
8856955|NCT01787279|9912481|FG000|COMPLETED|Overall Study||56
8856956|NCT01787279|9912481|FG000|NOT COMPLETED|Overall Study||3
8856957|NCT01787292|9912485|FG000|STARTED|Crossover Exercise Interventions|Participants in this group performed aerobic training prior to cross-over to balance training.|17
8856958|NCT01787292|9912486|FG001|STARTED|Crossover Exercise Interventions|Participants in this group performed balance training prior to cross-over to aerobic training.|16
8856959|NCT01787292|9912485|FG000|COMPLETED|Crossover Exercise Interventions|Participants completed the 12-week in-house program and cross-over into the balance program.|15
8856960|NCT01787292|9912486|FG001|COMPLETED|Crossover Exercise Interventions|These participants completed the 12-week in-house program and cross-over into the balance program.|14
8856961|NCT01787292|9912485|FG000|NOT COMPLETED|Crossover Exercise Interventions||2
8856962|NCT01787292|9912486|FG001|NOT COMPLETED|Crossover Exercise Interventions||2
8856963|NCT01787292|9912485|FG000|STARTED|Home Based Exercise Program||15
8856964|NCT01787292|9912486|FG001|STARTED|Home Based Exercise Program||14
8856965|NCT01787292|9912485|FG000|COMPLETED|Home Based Exercise Program||12
8856966|NCT01787292|9912486|FG001|COMPLETED|Home Based Exercise Program||13
8856967|NCT01787292|9912485|FG000|NOT COMPLETED|Home Based Exercise Program||3
8856968|NCT01787292|9912486|FG001|NOT COMPLETED|Home Based Exercise Program||1
8856969|NCT01787331|9912497|FG000|STARTED|Overall Study||21
8856970|NCT01787331|9912497|FG000|COMPLETED|Overall Study||19
8856971|NCT01787331|9912497|FG000|NOT COMPLETED|Overall Study||2
8856972|NCT01787383|9912503|FG000|STARTED|Overall Study||101
8856973|NCT01787383|9912504|FG001|STARTED|Overall Study||98
8856974|NCT01787383|9912503|FG000|COMPLETED|Overall Study||92
8856975|NCT01787383|9912504|FG001|COMPLETED|Overall Study||76
8856976|NCT01787383|9912503|FG000|NOT COMPLETED|Overall Study||9
8856977|NCT01787383|9912504|FG001|NOT COMPLETED|Overall Study||22
8856978|NCT01787461|9912520|FG000|STARTED|Overall Study||96
8856979|NCT01787461|9912521|FG001|STARTED|Overall Study||98
8856980|NCT01787461|9912520|FG000|COMPLETED|Overall Study||82
8856981|NCT01787461|9912521|FG001|COMPLETED|Overall Study||89
8856982|NCT01787461|9912520|FG000|NOT COMPLETED|Overall Study||14
8856983|NCT01787461|9912521|FG001|NOT COMPLETED|Overall Study||9
8856984|NCT01787591|9912529|FG000|STARTED|Period 1 (Cross-over Arm 1)||5
8856985|NCT01787591|9912530|FG001|STARTED|Period 1 (Cross-over Arm 1)||5
8856986|NCT01787591|9912531|FG002|STARTED|Period 1 (Cross-over Arm 1)||5
8856987|NCT01787591|9912532|FG003|STARTED|Period 1 (Cross-over Arm 1)||6
8856988|NCT01787591|9912529|FG000|COMPLETED|Period 1 (Cross-over Arm 1)||5
8856989|NCT01787591|9912530|FG001|COMPLETED|Period 1 (Cross-over Arm 1)||5
8856990|NCT01787591|9912531|FG002|COMPLETED|Period 1 (Cross-over Arm 1)||5
8856991|NCT01787591|9912532|FG003|COMPLETED|Period 1 (Cross-over Arm 1)||5
8856992|NCT01787591|9912529|FG000|NOT COMPLETED|Period 1 (Cross-over Arm 1)||0
8856993|NCT01787591|9912530|FG001|NOT COMPLETED|Period 1 (Cross-over Arm 1)||0
8856994|NCT01787591|9912531|FG002|NOT COMPLETED|Period 1 (Cross-over Arm 1)||0
8856995|NCT01787591|9912532|FG003|NOT COMPLETED|Period 1 (Cross-over Arm 1)||1
8856996|NCT01787591|9912529|FG000|STARTED|Period 2 (Cross-over Arm 2)||5
8856997|NCT01787591|9912530|FG001|STARTED|Period 2 (Cross-over Arm 2)||5
8856998|NCT01787591|9912531|FG002|STARTED|Period 2 (Cross-over Arm 2)||5
8856999|NCT01787591|9912532|FG003|STARTED|Period 2 (Cross-over Arm 2)||5
8857000|NCT01787591|9912529|FG000|COMPLETED|Period 2 (Cross-over Arm 2)||5
8857001|NCT01787591|9912530|FG001|COMPLETED|Period 2 (Cross-over Arm 2)||5
8857002|NCT01787591|9912531|FG002|COMPLETED|Period 2 (Cross-over Arm 2)||5
8857003|NCT01787591|9912532|FG003|COMPLETED|Period 2 (Cross-over Arm 2)||5
8857004|NCT01787591|9912529|FG000|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
8857005|NCT01787591|9912530|FG001|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
8857006|NCT01787591|9912531|FG002|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
8857007|NCT01787591|9912532|FG003|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
8857008|NCT01787591|9912529|FG000|STARTED|Period 3 (Cross-over Arm 3)||5
8857009|NCT01787591|9912530|FG001|STARTED|Period 3 (Cross-over Arm 3)||5
8857010|NCT01787591|9912531|FG002|STARTED|Period 3 (Cross-over Arm 3)||5
8857011|NCT01787591|9912532|FG003|STARTED|Period 3 (Cross-over Arm 3)||5
8857012|NCT01787591|9912529|FG000|COMPLETED|Period 3 (Cross-over Arm 3)||5
8857013|NCT01787591|9912530|FG001|COMPLETED|Period 3 (Cross-over Arm 3)||5
8857014|NCT01787591|9912531|FG002|COMPLETED|Period 3 (Cross-over Arm 3)||5
8857015|NCT01787591|9912532|FG003|COMPLETED|Period 3 (Cross-over Arm 3)||5
8857016|NCT01787591|9912529|FG000|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
8857017|NCT01787591|9912530|FG001|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
8857018|NCT01787591|9912531|FG002|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
8857019|NCT01787591|9912532|FG003|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
8857020|NCT01787591|9912529|FG000|STARTED|Period 4 (Cross-over Arm 4)||5
8857021|NCT01787591|9912530|FG001|STARTED|Period 4 (Cross-over Arm 4)||5
8857022|NCT01787591|9912531|FG002|STARTED|Period 4 (Cross-over Arm 4)||5
8857023|NCT01787591|9912532|FG003|STARTED|Period 4 (Cross-over Arm 4)||5
8857024|NCT01787591|9912529|FG000|COMPLETED|Period 4 (Cross-over Arm 4)||5
8857025|NCT01787591|9912530|FG001|COMPLETED|Period 4 (Cross-over Arm 4)||5
8857026|NCT01787591|9912531|FG002|COMPLETED|Period 4 (Cross-over Arm 4)||5
8857027|NCT01787591|9912532|FG003|COMPLETED|Period 4 (Cross-over Arm 4)||5
8857028|NCT01787591|9912529|FG000|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
8857029|NCT01787591|9912530|FG001|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
8857030|NCT01787591|9912531|FG002|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
8857031|NCT01787591|9912532|FG003|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
8857032|NCT01787604|9912545|FG000|STARTED|Overall Study||32
8857033|NCT01787604|9912546|FG001|STARTED|Overall Study||32
8857034|NCT01787604|9912545|FG000|COMPLETED|Overall Study||28
8857035|NCT01787604|9912546|FG001|COMPLETED|Overall Study||28
8857036|NCT01787604|9912545|FG000|NOT COMPLETED|Overall Study||4
8857037|NCT01787604|9912546|FG001|NOT COMPLETED|Overall Study||4
8857038|NCT01787760|9912555|FG000|STARTED|Overall Study||51
8857039|NCT01787760|9912556|FG001|STARTED|Overall Study||50
8857040|NCT01787760|9912557|FG002|STARTED|Overall Study||51
8857041|NCT01787760|9912555|FG000|COMPLETED|Overall Study||25
8857042|NCT01787760|9912556|FG001|COMPLETED|Overall Study||34
8857043|NCT01787760|9912557|FG002|COMPLETED|Overall Study||46
8857044|NCT01787760|9912555|FG000|NOT COMPLETED|Overall Study||26
8857045|NCT01787760|9912556|FG001|NOT COMPLETED|Overall Study||16
8857046|NCT01787760|9912557|FG002|NOT COMPLETED|Overall Study||5
8857047|NCT01787799|9912566|FG000|STARTED|Overall Study||100
8857048|NCT01787799|9912566|FG000|COMPLETED|Overall Study||100
8857049|NCT01787799|9912566|FG000|NOT COMPLETED|Overall Study||0
8857050|NCT01787825|9912570|FG000|STARTED|Overall Study||60
8857051|NCT01787825|9912571|FG001|STARTED|Overall Study||61
8857052|NCT01787825|9912570|FG000|COMPLETED|Overall Study||54
8857053|NCT01787825|9912571|FG001|COMPLETED|Overall Study||60
8857054|NCT01787825|9912570|FG000|NOT COMPLETED|Overall Study||6
8857055|NCT01787825|9912571|FG001|NOT COMPLETED|Overall Study||1
8857056|NCT01787838|9912578|FG000|STARTED|Overall Study|This is the number who met Centers for Disease Control and Prevention guidelines for vaccine.|2509
8857057|NCT01787838|9912578|FG000|COMPLETED|Overall Study|This is the number of patients successfully immunized in a one year period.|1096
8857058|NCT01787838|9912578|FG000|NOT COMPLETED|Overall Study||1413
8857059|NCT01787916|9912582|FG000|STARTED|First Intervention (24 Weeks)||8
8949502|NCT02439138|10012091|FG000|STARTED|Overall Study||5
8857060|NCT01787916|9912583|FG001|STARTED|First Intervention (24 Weeks)||7
8857061|NCT01787916|9912582|FG000|COMPLETED|First Intervention (24 Weeks)||8
8857062|NCT01787916|9912583|FG001|COMPLETED|First Intervention (24 Weeks)||7
8857063|NCT01787916|9912582|FG000|NOT COMPLETED|First Intervention (24 Weeks)||0
8857064|NCT01787916|9912583|FG001|NOT COMPLETED|First Intervention (24 Weeks)||0
8857065|NCT01787916|9912582|FG000|STARTED|Washout (4 Weeks)||8
8857066|NCT01787916|9912583|FG001|STARTED|Washout (4 Weeks)||7
8857067|NCT01787916|9912582|FG000|COMPLETED|Washout (4 Weeks)||8
8857068|NCT01787916|9912583|FG001|COMPLETED|Washout (4 Weeks)||7
8857069|NCT01787916|9912582|FG000|NOT COMPLETED|Washout (4 Weeks)||0
8857070|NCT01787916|9912583|FG001|NOT COMPLETED|Washout (4 Weeks)||0
8857071|NCT01787916|9912582|FG000|STARTED|Second Intervention (24 Weeks)||8
8857072|NCT01787916|9912583|FG001|STARTED|Second Intervention (24 Weeks)||7
8857073|NCT01787916|9912582|FG000|COMPLETED|Second Intervention (24 Weeks)||8
8857074|NCT01787916|9912583|FG001|COMPLETED|Second Intervention (24 Weeks)||7
8857075|NCT01787916|9912582|FG000|NOT COMPLETED|Second Intervention (24 Weeks)||0
8857076|NCT01787916|9912583|FG001|NOT COMPLETED|Second Intervention (24 Weeks)||0
8857077|NCT01788046|9912591|FG000|STARTED|Overall Study||260
8857078|NCT01788046|9912592|FG001|STARTED|Overall Study||255
8857079|NCT01788046|9912591|FG000|Received Treatment|Overall Study||259
8857080|NCT01788046|9912592|FG001|Received Treatment|Overall Study||252
8857081|NCT01788046|9912591|FG000|COMPLETED|Overall Study||204
8857082|NCT01788046|9912592|FG001|COMPLETED|Overall Study||218
8857083|NCT01788046|9912591|FG000|NOT COMPLETED|Overall Study||56
8857084|NCT01788046|9912592|FG001|NOT COMPLETED|Overall Study||37
8857085|NCT01788150|9912600|FG000|STARTED|Overall Study||108
8857086|NCT01788150|9912601|FG001|STARTED|Overall Study||51
8857087|NCT01788150|9912600|FG000|COMPLETED|Overall Study||95
8857088|NCT01788150|9912601|FG001|COMPLETED|Overall Study||48
8857089|NCT01788150|9912600|FG000|NOT COMPLETED|Overall Study||13
8857090|NCT01788150|9912601|FG001|NOT COMPLETED|Overall Study||3
8857091|NCT01788163|9912616|FG000|STARTED|Overall Study||1458
8857092|NCT01788163|9912617|FG001|STARTED|Overall Study||271
8857093|NCT01788163|9912618|FG002|STARTED|Overall Study||62
8857094|NCT01788163|9912619|FG003|STARTED|Overall Study||71
8857095|NCT01788163|9912620|FG004|STARTED|Overall Study||94
8857096|NCT01788163|9912621|FG005|STARTED|Overall Study||102
8857097|NCT01788163|9912622|FG006|STARTED|Overall Study||50
8857098|NCT01788163|9912623|FG007|STARTED|Overall Study||302
8857099|NCT01788163|9912624|FG008|STARTED|Overall Study||972
8857100|NCT01788163|9912616|FG000|COMPLETED|Overall Study||1403
8857101|NCT01788163|9912617|FG001|COMPLETED|Overall Study||271
8857102|NCT01788163|9912618|FG002|COMPLETED|Overall Study||62
8857103|NCT01788163|9912619|FG003|COMPLETED|Overall Study||71
8857104|NCT01788163|9912620|FG004|COMPLETED|Overall Study||94
8857105|NCT01788163|9912621|FG005|COMPLETED|Overall Study||95
8857106|NCT01788163|9912622|FG006|COMPLETED|Overall Study||49
8857107|NCT01788163|9912623|FG007|COMPLETED|Overall Study||254
8857108|NCT01788163|9912624|FG008|COMPLETED|Overall Study||956
8857109|NCT01788163|9912616|FG000|NOT COMPLETED|Overall Study||55
8857110|NCT01788163|9912617|FG001|NOT COMPLETED|Overall Study||0
8857111|NCT01788163|9912618|FG002|NOT COMPLETED|Overall Study||0
8857112|NCT01788163|9912619|FG003|NOT COMPLETED|Overall Study||0
8857113|NCT01788163|9912620|FG004|NOT COMPLETED|Overall Study||0
8857114|NCT01788163|9912621|FG005|NOT COMPLETED|Overall Study||7
8857115|NCT01788163|9912622|FG006|NOT COMPLETED|Overall Study||1
8857116|NCT01788163|9912623|FG007|NOT COMPLETED|Overall Study||48
8857117|NCT01788163|9912624|FG008|NOT COMPLETED|Overall Study||16
8857118|NCT01788215|9912705|FG000|STARTED|Overall Study||5
8857119|NCT01788215|9912706|FG001|STARTED|Overall Study||5
8857120|NCT01788215|9912705|FG000|12 Weeks of Doxycycline or Placebo|Overall Study||5
8857121|NCT01788215|9912706|FG001|12 Weeks of Doxycycline or Placebo|Overall Study||5
8857122|NCT01788215|9912705|FG000|COMPLETED|Overall Study||3
8857123|NCT01788215|9912706|FG001|COMPLETED|Overall Study||4
8857124|NCT01788215|9912705|FG000|NOT COMPLETED|Overall Study||2
8857125|NCT01788215|9912706|FG001|NOT COMPLETED|Overall Study||1
8857126|NCT01788228|9912714|FG000|STARTED|Overall Study||49
8857127|NCT01788228|9912715|FG001|STARTED|Overall Study||1
8857128|NCT01788228|9912714|FG000|COMPLETED|Overall Study||48
8857129|NCT01788228|9912715|FG001|COMPLETED|Overall Study||1
8857130|NCT01788228|9912714|FG000|NOT COMPLETED|Overall Study||1
8857131|NCT01788228|9912715|FG001|NOT COMPLETED|Overall Study||0
8857132|NCT01788358|9912724|FG000|STARTED|Overall Study||508
8857133|NCT01788358|9912724|FG000|Treated|Overall Study||508
8857134|NCT01788358|9912724|FG000|Completed Week 28|Overall Study||417
8857135|NCT01788358|9912724|FG000|Entered Extension to Week 52|Overall Study|Only the first 200 subjects who completed Week 28 visit, continued treatment up to 52 weeks.|200
8857136|NCT01788358|9912724|FG000|Completed Week 52|Overall Study||193
8857137|NCT01788358|9912724|FG000|COMPLETED|Overall Study|217 subjects completed the study at Week 28 while the remaining 193 subjects completed at Week 52|410
8857138|NCT01788358|9912724|FG000|NOT COMPLETED|Overall Study||98
8857139|NCT01788423|9912731|FG000|STARTED|Overall Study||53
8857140|NCT01788423|9912732|FG001|STARTED|Overall Study||55
8629950|NCT00532844|9669703|FG001|STARTED|Treatment Period - Day 15 to Day 28||23
8629951|NCT00532844|9669702|FG000|COMPLETED|Treatment Period - Day 15 to Day 28||20
8629952|NCT00532844|9669703|FG001|COMPLETED|Treatment Period - Day 15 to Day 28||23
8629953|NCT00532844|9669702|FG000|NOT COMPLETED|Treatment Period - Day 15 to Day 28||4
8629954|NCT00532844|9669703|FG001|NOT COMPLETED|Treatment Period - Day 15 to Day 28||0
8857141|NCT01788423|9912733|FG002|STARTED|Overall Study||55
8857142|NCT01788423|9912731|FG000|COMPLETED|Overall Study||53
8857143|NCT01788423|9912732|FG001|COMPLETED|Overall Study|Four participants were unable to self-select hearing aids.|51
8857144|NCT01788423|9912733|FG002|COMPLETED|Overall Study|Three people developed unrelated health problems and two were unable to fit/use hearing aids.|50
8857145|NCT01788423|9912731|FG000|NOT COMPLETED|Overall Study||0
8857146|NCT01788423|9912732|FG001|NOT COMPLETED|Overall Study||4
8857147|NCT01788423|9912733|FG002|NOT COMPLETED|Overall Study||5
8857148|NCT01788566|9912741|FG000|STARTED|Overall Study||61
8857149|NCT01788566|9912741|FG000|COMPLETED|Overall Study||53
8857150|NCT01788566|9912741|FG000|NOT COMPLETED|Overall Study||8
8857151|NCT01788631|9912747|FG000|STARTED|Overall Study||52
8857152|NCT01788631|9912748|FG001|STARTED|Overall Study||44
8857153|NCT01788631|9912747|FG000|Randomized|Overall Study||53
8857154|NCT01788631|9912748|FG001|Randomized|Overall Study||47
8857155|NCT01788631|9912747|FG000|COMPLETED|Overall Study||49
8857156|NCT01788631|9912748|FG001|COMPLETED|Overall Study||43
8857157|NCT01788631|9912747|FG000|NOT COMPLETED|Overall Study||3
8857158|NCT01788631|9912748|FG001|NOT COMPLETED|Overall Study||1
8857159|NCT01788943|9912756|FG000|STARTED|Overall Study|Recruitment for study began.|13
8857160|NCT01788943|9912757|FG001|STARTED|Overall Study||12
8857161|NCT01788943|9912756|FG000|COMPLETED|Overall Study|2FA-PET Brain Image Analysis Completion Date|12
8857162|NCT01788943|9912757|FG001|COMPLETED|Overall Study||12
8857163|NCT01788943|9912756|FG000|NOT COMPLETED|Overall Study||1
8857164|NCT01788943|9912757|FG001|NOT COMPLETED|Overall Study||0
8857165|NCT01789047|9912765|FG000|STARTED|Overall Study||21
8857166|NCT01789047|9912766|FG001|STARTED|Overall Study||21
8857167|NCT01789047|9912765|FG000|COMPLETED|Overall Study||17
8857168|NCT01789047|9912766|FG001|COMPLETED|Overall Study||17
8857169|NCT01789047|9912765|FG000|NOT COMPLETED|Overall Study||4
8857170|NCT01789047|9912766|FG001|NOT COMPLETED|Overall Study||4
8857171|NCT01789138|9912774|FG000|STARTED|Overall Study||254
8857172|NCT01789138|9912775|FG001|STARTED|Overall Study||258
8857173|NCT01789138|9912774|FG000|COMPLETED|Overall Study||213
8857174|NCT01789138|9912775|FG001|COMPLETED|Overall Study||206
8857175|NCT01789138|9912774|FG000|NOT COMPLETED|Overall Study||41
8857176|NCT01789138|9912775|FG001|NOT COMPLETED|Overall Study||52
8857177|NCT01789203|9912783|FG000|STARTED|Overall Study||133
8857178|NCT01789203|9912784|FG001|STARTED|Overall Study||67
8857179|NCT01789203|9912783|FG000|COMPLETED|Overall Study||124
8857180|NCT01789203|9912784|FG001|COMPLETED|Overall Study||63
8857181|NCT01789203|9912783|FG000|NOT COMPLETED|Overall Study||9
8857182|NCT01789203|9912784|FG001|NOT COMPLETED|Overall Study||4
8857183|NCT01789255|9912792|FG000|STARTED|Overall Study||12
8857184|NCT01789255|9912792|FG000|COMPLETED|Overall Study||12
8857185|NCT01789255|9912792|FG000|NOT COMPLETED|Overall Study||0
8857186|NCT01789281|9912798|FG000|STARTED|Overall Study||22
8857187|NCT01789281|9912799|FG001|STARTED|Overall Study||12
8857188|NCT01789281|9912798|FG000|COMPLETED|Overall Study||0
8857189|NCT01789281|9912799|FG001|COMPLETED|Overall Study||2
8857190|NCT01789281|9912798|FG000|NOT COMPLETED|Overall Study||22
8857191|NCT01789281|9912799|FG001|NOT COMPLETED|Overall Study||10
8857192|NCT01789320|9912806|FG000|STARTED|Overall Study||11
8857193|NCT01789320|9912806|FG000|COMPLETED|Overall Study||9
8857194|NCT01789320|9912806|FG000|NOT COMPLETED|Overall Study||2
8857195|NCT01789476|9912812|FG000|STARTED|Overall Study||34
8857196|NCT01789476|9912813|FG001|STARTED|Overall Study||17
8857197|NCT01789476|9912812|FG000|COMPLETED|Overall Study||26
8857198|NCT01789476|9912813|FG001|COMPLETED|Overall Study||15
8857199|NCT01789476|9912812|FG000|NOT COMPLETED|Overall Study||8
8857200|NCT01789476|9912813|FG001|NOT COMPLETED|Overall Study||2
8857201|NCT01789567|9912819|FG000|STARTED|Overall Study||20
8857202|NCT01789567|9912819|FG000|COMPLETED|Overall Study||14
8857203|NCT01789567|9912819|FG000|NOT COMPLETED|Overall Study||6
8857204|NCT01789606|9912825|FG000|STARTED|Overall Study||251
8857205|NCT01789606|9912826|FG001|STARTED|Overall Study||832
8857206|NCT01789606|9912825|FG000|COMPLETED|Overall Study||228
8857207|NCT01789606|9912826|FG001|COMPLETED|Overall Study||382
8857208|NCT01789606|9912825|FG000|NOT COMPLETED|Overall Study||23
8857209|NCT01789606|9912826|FG001|NOT COMPLETED|Overall Study||450
8857210|NCT01789775|9912833|FG000|STARTED|Overall Study||55
8857211|NCT01789775|9912834|FG001|STARTED|Overall Study||57
8857212|NCT01789775|9912833|FG000|COMPLETED|Overall Study||53
8857213|NCT01789775|9912834|FG001|COMPLETED|Overall Study||50
8857214|NCT01789775|9912833|FG000|NOT COMPLETED|Overall Study||2
8857215|NCT01789775|9912834|FG001|NOT COMPLETED|Overall Study||7
8857216|NCT01789814|9912842|FG000|STARTED|Overall Study||12
8857217|NCT01789814|9912843|FG001|STARTED|Overall Study||12
8857218|NCT01789814|9912842|FG000|COMPLETED|Overall Study||12
8857219|NCT01789814|9912843|FG001|COMPLETED|Overall Study||12
8857220|NCT01789814|9912842|FG000|NOT COMPLETED|Overall Study||0
8857221|NCT01789814|9912843|FG001|NOT COMPLETED|Overall Study||0
8857222|NCT01789840|9912851|FG000|STARTED|Overall Study||52
8857223|NCT01789840|9912852|FG001|STARTED|Overall Study||7
8857224|NCT01789840|9912851|FG000|COMPLETED|Overall Study||52
8857225|NCT01789840|9912852|FG001|COMPLETED|Overall Study||6
8857226|NCT01789840|9912851|FG000|NOT COMPLETED|Overall Study||0
8857227|NCT01789840|9912852|FG001|NOT COMPLETED|Overall Study||1
8857228|NCT01789905|9912860|FG000|STARTED|Overall Study||116
8857229|NCT01789905|9912860|FG000|COMPLETED|Overall Study||116
8857230|NCT01789905|9912860|FG000|NOT COMPLETED|Overall Study||0
8857231|NCT01789970|9912866|FG000|STARTED|Open-label Titration Period||625
8857232|NCT01789970|9912867|FG001|STARTED|Open-label Titration Period||0
8857233|NCT01789970|9912868|FG002|STARTED|Open-label Titration Period||0
8857234|NCT01789970|9912866|FG000|Safety Analysis Set|Open-label Titration Period|Two enrolled patients were not treated|623
8857235|NCT01789970|9912867|FG001|Safety Analysis Set|Open-label Titration Period||0
8857236|NCT01789970|9912868|FG002|Safety Analysis Set|Open-label Titration Period||0
8857237|NCT01789970|9912866|FG000|COMPLETED|Open-label Titration Period||371
8857238|NCT01789970|9912867|FG001|COMPLETED|Open-label Titration Period||0
8857239|NCT01789970|9912868|FG002|COMPLETED|Open-label Titration Period||0
8857240|NCT01789970|9912866|FG000|NOT COMPLETED|Open-label Titration Period||254
8857241|NCT01789970|9912867|FG001|NOT COMPLETED|Open-label Titration Period||0
8857242|NCT01789970|9912868|FG002|NOT COMPLETED|Open-label Titration Period||0
8857243|NCT01789970|9912866|FG000|STARTED|Double-blind Treatment Period (12 Weeks)||0
8857244|NCT01789970|9912867|FG001|STARTED|Double-blind Treatment Period (12 Weeks)||180
8857245|NCT01789970|9912868|FG002|STARTED|Double-blind Treatment Period (12 Weeks)||191
8857246|NCT01789970|9912866|FG000|Full Analysis Set and Safety Set|Double-blind Treatment Period (12 Weeks)||0
8857247|NCT01789970|9912867|FG001|Full Analysis Set and Safety Set|Double-blind Treatment Period (12 Weeks)|One participant was randomized but not treated.|179
8857248|NCT01789970|9912868|FG002|Full Analysis Set and Safety Set|Double-blind Treatment Period (12 Weeks)||191
8857249|NCT01789970|9912866|FG000|COMPLETED|Double-blind Treatment Period (12 Weeks)||0
8857250|NCT01789970|9912867|FG001|COMPLETED|Double-blind Treatment Period (12 Weeks)||130
8857251|NCT01789970|9912868|FG002|COMPLETED|Double-blind Treatment Period (12 Weeks)||147
8857252|NCT01789970|9912866|FG000|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||0
8857253|NCT01789970|9912867|FG001|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||50
8857254|NCT01789970|9912868|FG002|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||44
8857255|NCT01790048|9912884|FG000|STARTED|Overall Study||1156
8857256|NCT01790048|9912885|FG001|STARTED|Overall Study||1103
8857257|NCT01790048|9912884|FG000|COMPLETED|Overall Study||1144
8857258|NCT01790048|9912885|FG001|COMPLETED|Overall Study||1086
8857259|NCT01790048|9912884|FG000|NOT COMPLETED|Overall Study||12
8857260|NCT01790048|9912885|FG001|NOT COMPLETED|Overall Study||17
8857261|NCT01790113|9912895|FG000|STARTED|Overall Study||79
8857262|NCT01790113|9912896|FG001|STARTED|Overall Study||224
8857263|NCT01790113|9912895|FG000|COMPLETED|Overall Study||76
8857264|NCT01790113|9912896|FG001|COMPLETED|Overall Study||149
8857265|NCT01790113|9912895|FG000|NOT COMPLETED|Overall Study||3
8857266|NCT01790113|9912896|FG001|NOT COMPLETED|Overall Study||75
8857267|NCT01790126|9912905|FG000|STARTED|Overall Study||30
8857268|NCT01790126|9912906|FG001|STARTED|Overall Study||29
8857269|NCT01790126|9912907|FG002|STARTED|Overall Study||31
8857270|NCT01790126|9912905|FG000|Treated|Overall Study||29
8857271|NCT01790126|9912906|FG001|Treated|Overall Study||29
8857272|NCT01790126|9912907|FG002|Treated|Overall Study||31
8857273|NCT01790126|9912905|FG000|COMPLETED|Overall Study||0
8857274|NCT01790126|9912906|FG001|COMPLETED|Overall Study||0
8857275|NCT01790126|9912907|FG002|COMPLETED|Overall Study||0
8857276|NCT01790126|9912905|FG000|NOT COMPLETED|Overall Study||30
8857277|NCT01790126|9912906|FG001|NOT COMPLETED|Overall Study||29
8857278|NCT01790126|9912907|FG002|NOT COMPLETED|Overall Study||31
8857279|NCT01790178|9912918|FG000|STARTED|Overall Study||16
8857280|NCT01790178|9912919|FG001|STARTED|Overall Study||24
8857281|NCT01790178|9912918|FG000|COMPLETED|Overall Study||16
8857282|NCT01790178|9912919|FG001|COMPLETED|Overall Study||24
8857283|NCT01790178|9912918|FG000|NOT COMPLETED|Overall Study||0
8857284|NCT01790178|9912919|FG001|NOT COMPLETED|Overall Study||0
8857285|NCT01790243|9912927|FG000|STARTED|Overall Study||1029
8857286|NCT01790243|9912928|FG001|STARTED|Overall Study||160
8857287|NCT01790243|9912927|FG000|COMPLETED|Overall Study||739
8857288|NCT01790243|9912928|FG001|COMPLETED|Overall Study||117
8857289|NCT01790243|9912927|FG000|NOT COMPLETED|Overall Study||290
8857290|NCT01790243|9912928|FG001|NOT COMPLETED|Overall Study||43
8857291|NCT01790295|9912934|FG000|STARTED|Overall Study||21
8857292|NCT01790295|9912934|FG000|COMPLETED|Overall Study||10
8857293|NCT01790295|9912934|FG000|NOT COMPLETED|Overall Study||11
8857294|NCT01790438|9912941|FG000|STARTED|Overall Study||428
8857295|NCT01790438|9912942|FG001|STARTED|Overall Study||213
8857296|NCT01790438|9912941|FG000|Received at Least One Dose of Study Drug|Overall Study||427
8857297|NCT01790438|9912942|FG001|Received at Least One Dose of Study Drug|Overall Study||212
8857298|NCT01790438|9912941|FG000|COMPLETED|Overall Study||393
8857299|NCT01790438|9912942|FG001|COMPLETED|Overall Study||202
8857300|NCT01790438|9912941|FG000|NOT COMPLETED|Overall Study||35
8857301|NCT01790438|9912942|FG001|NOT COMPLETED|Overall Study||11
8857302|NCT01790490|9912953|FG000|STARTED|Overall Study||3
8857303|NCT01790490|9912954|FG001|STARTED|Overall Study||3
8857304|NCT01790490|9912955|FG002|STARTED|Overall Study||2
8857305|NCT01790490|9912953|FG000|COMPLETED|Overall Study||3
8857306|NCT01790490|9912954|FG001|COMPLETED|Overall Study||3
8857307|NCT01790490|9912955|FG002|COMPLETED|Overall Study||2
8857308|NCT01790490|9912953|FG000|NOT COMPLETED|Overall Study||0
8857309|NCT01790490|9912954|FG001|NOT COMPLETED|Overall Study||0
8857310|NCT01790490|9912955|FG002|NOT COMPLETED|Overall Study||0
8857311|NCT01790503|9912977|FG000|STARTED|Overall Study||3
8857312|NCT01790503|9912978|FG001|STARTED|Overall Study||1
8857313|NCT01790503|9912979|FG002|STARTED|Overall Study||1
8857314|NCT01790503|9912980|FG003|STARTED|Overall Study||2
8857315|NCT01790503|9912981|FG004|STARTED|Overall Study||5
8857316|NCT01790503|9912982|FG005|STARTED|Overall Study||5
8857317|NCT01790503|9912983|FG006|STARTED|Overall Study||1
8857318|NCT01790503|9912984|FG007|STARTED|Overall Study||1
8857319|NCT01790503|9912985|FG008|STARTED|Overall Study||3
8857320|NCT01790503|9912986|FG009|STARTED|Overall Study||27
8857321|NCT01790503|9912987|FG010|STARTED|Overall Study||16
8857322|NCT01790503|9912977|FG000|COMPLETED|Overall Study||0
8857323|NCT01790503|9912978|FG001|COMPLETED|Overall Study||0
8857324|NCT01790503|9912979|FG002|COMPLETED|Overall Study||0
8857325|NCT01790503|9912980|FG003|COMPLETED|Overall Study||0
8857326|NCT01790503|9912981|FG004|COMPLETED|Overall Study||0
8857327|NCT01790503|9912982|FG005|COMPLETED|Overall Study||0
8857328|NCT01790503|9912983|FG006|COMPLETED|Overall Study||0
8857329|NCT01790503|9912984|FG007|COMPLETED|Overall Study||0
8857330|NCT01790503|9912985|FG008|COMPLETED|Overall Study||0
8857331|NCT01790503|9912986|FG009|COMPLETED|Overall Study||1
8857332|NCT01790503|9912987|FG010|COMPLETED|Overall Study||0
8857333|NCT01790503|9912977|FG000|NOT COMPLETED|Overall Study||3
8857334|NCT01790503|9912978|FG001|NOT COMPLETED|Overall Study||1
8857335|NCT01790503|9912979|FG002|NOT COMPLETED|Overall Study||1
8857336|NCT01790503|9912980|FG003|NOT COMPLETED|Overall Study||2
8857337|NCT01790503|9912981|FG004|NOT COMPLETED|Overall Study||5
8857338|NCT01790503|9912982|FG005|NOT COMPLETED|Overall Study||5
8857339|NCT01790503|9912983|FG006|NOT COMPLETED|Overall Study||1
8857340|NCT01790503|9912984|FG007|NOT COMPLETED|Overall Study||1
8857341|NCT01790503|9912985|FG008|NOT COMPLETED|Overall Study||3
8857342|NCT01790503|9912986|FG009|NOT COMPLETED|Overall Study||26
8857343|NCT01790503|9912987|FG010|NOT COMPLETED|Overall Study||16
8857344|NCT01790516|9913026|FG000|STARTED|Overall Study||1
8857345|NCT01790516|9913027|FG001|STARTED|Overall Study||1
8857346|NCT01790516|9913026|FG000|COMPLETED|Overall Study||0
8857347|NCT01790516|9913027|FG001|COMPLETED|Overall Study||1
8857348|NCT01790516|9913026|FG000|NOT COMPLETED|Overall Study||1
8857349|NCT01790516|9913027|FG001|NOT COMPLETED|Overall Study||0
8857350|NCT01790568|9913033|FG000|STARTED|Overall Study||12
8857351|NCT01790568|9913034|FG001|STARTED|Overall Study||26
8857352|NCT01790568|9913033|FG000|COMPLETED|Overall Study||12
8857353|NCT01790568|9913034|FG001|COMPLETED|Overall Study||25
8857354|NCT01790568|9913033|FG000|NOT COMPLETED|Overall Study||0
8857355|NCT01790568|9913034|FG001|NOT COMPLETED|Overall Study||1
8857356|NCT01790581|9913040|FG000|STARTED|Overall Study||12
8857357|NCT01790581|9913041|FG001|STARTED|Overall Study||12
8857358|NCT01790581|9913040|FG000|COMPLETED|Overall Study||12
8857359|NCT01790581|9913041|FG001|COMPLETED|Overall Study||12
8857360|NCT01790581|9913040|FG000|NOT COMPLETED|Overall Study||0
8857361|NCT01790581|9913041|FG001|NOT COMPLETED|Overall Study||0
8857362|NCT01790594|9913049|FG000|STARTED|Overall Study||22
8857363|NCT01790594|9913050|FG001|STARTED|Overall Study||21
8857364|NCT01790594|9913051|FG002|STARTED|Overall Study||3
8857365|NCT01790594|9913049|FG000|COMPLETED|Overall Study||17
8857366|NCT01790594|9913050|FG001|COMPLETED|Overall Study||18
8857367|NCT01790594|9913051|FG002|COMPLETED|Overall Study||0
8857368|NCT01790594|9913049|FG000|NOT COMPLETED|Overall Study||5
8857369|NCT01790594|9913050|FG001|NOT COMPLETED|Overall Study||3
8857370|NCT01790594|9913051|FG002|NOT COMPLETED|Overall Study||3
8857371|NCT01790633|9913060|FG000|STARTED|Overall Study||163
8857372|NCT01790633|9913061|FG001|STARTED|Overall Study||164
8857373|NCT01790633|9913060|FG000|COMPLETED|Overall Study||115
8857374|NCT01790633|9913061|FG001|COMPLETED|Overall Study||159
8857375|NCT01790633|9913060|FG000|NOT COMPLETED|Overall Study||48
8857376|NCT01790633|9913061|FG001|NOT COMPLETED|Overall Study||5
8857377|NCT01790659|9913070|FG000|STARTED|Overall Study||201
8857378|NCT01790659|9913071|FG001|STARTED|Overall Study||198
8857379|NCT01790659|9913070|FG000|COMPLETED|Overall Study||195
8857380|NCT01790659|9913071|FG001|COMPLETED|Overall Study||192
8857381|NCT01790659|9913070|FG000|NOT COMPLETED|Overall Study||6
8857382|NCT01790659|9913071|FG001|NOT COMPLETED|Overall Study||6
8857383|NCT01790685|9913079|FG000|STARTED|Overall Study||23
8857384|NCT01790685|9913080|FG001|STARTED|Overall Study||17
8857385|NCT01790685|9913079|FG000|COMPLETED|Overall Study||23
8857386|NCT01790685|9913080|FG001|COMPLETED|Overall Study||17
8857387|NCT01790685|9913079|FG000|NOT COMPLETED|Overall Study||0
8857388|NCT01790685|9913080|FG001|NOT COMPLETED|Overall Study||0
8857389|NCT01790750|9913086|FG000|STARTED|Overall Study||50
8857390|NCT01790750|9913086|FG000|COMPLETED|Overall Study||50
8857391|NCT01790750|9913086|FG000|NOT COMPLETED|Overall Study||0
8857392|NCT01790828|9913091|FG000|STARTED|Overall Study||42
8857393|NCT01790828|9913091|FG000|COMPLETED|Overall Study||8
8857394|NCT01790828|9913091|FG000|NOT COMPLETED|Overall Study||34
8857395|NCT01790932|9913095|FG000|STARTED|Overall Study||50
8857396|NCT01790932|9913095|FG000|COMPLETED|Overall Study||0
8857397|NCT01790932|9913095|FG000|NOT COMPLETED|Overall Study||50
8857398|NCT01790984|9913101|FG000|STARTED|First Dietary Intervention (12 Weeks)||6
8857399|NCT01790984|9913102|FG001|STARTED|First Dietary Intervention (12 Weeks)||8
8857400|NCT01790984|9913103|FG002|STARTED|First Dietary Intervention (12 Weeks)||6
8857401|NCT01790984|9913104|FG003|STARTED|First Dietary Intervention (12 Weeks)||7
8857402|NCT01790984|9913101|FG000|COMPLETED|First Dietary Intervention (12 Weeks)||5
8857403|NCT01790984|9913102|FG001|COMPLETED|First Dietary Intervention (12 Weeks)||7
8857404|NCT01790984|9913103|FG002|COMPLETED|First Dietary Intervention (12 Weeks)||6
8857405|NCT01790984|9913104|FG003|COMPLETED|First Dietary Intervention (12 Weeks)||7
8857406|NCT01790984|9913101|FG000|NOT COMPLETED|First Dietary Intervention (12 Weeks)||1
8857407|NCT01790984|9913102|FG001|NOT COMPLETED|First Dietary Intervention (12 Weeks)||1
8857408|NCT01790984|9913103|FG002|NOT COMPLETED|First Dietary Intervention (12 Weeks)||0
8857409|NCT01790984|9913104|FG003|NOT COMPLETED|First Dietary Intervention (12 Weeks)||0
8857410|NCT01790984|9913101|FG000|STARTED|Wash-out (4 Weeks)||5
8857411|NCT01790984|9913102|FG001|STARTED|Wash-out (4 Weeks)||7
8857412|NCT01790984|9913103|FG002|STARTED|Wash-out (4 Weeks)||6
8857413|NCT01790984|9913104|FG003|STARTED|Wash-out (4 Weeks)||7
8857414|NCT01790984|9913101|FG000|COMPLETED|Wash-out (4 Weeks)||5
8857415|NCT01790984|9913102|FG001|COMPLETED|Wash-out (4 Weeks)||7
8857416|NCT01790984|9913103|FG002|COMPLETED|Wash-out (4 Weeks)||6
8857417|NCT01790984|9913104|FG003|COMPLETED|Wash-out (4 Weeks)||7
8857418|NCT01790984|9913101|FG000|NOT COMPLETED|Wash-out (4 Weeks)||0
8857419|NCT01790984|9913102|FG001|NOT COMPLETED|Wash-out (4 Weeks)||0
8857420|NCT01790984|9913103|FG002|NOT COMPLETED|Wash-out (4 Weeks)||0
8857421|NCT01790984|9913104|FG003|NOT COMPLETED|Wash-out (4 Weeks)||0
8857422|NCT01790984|9913101|FG000|STARTED|Second Dietary Intervention (12 Weeks)||5
8857423|NCT01790984|9913102|FG001|STARTED|Second Dietary Intervention (12 Weeks)||7
8857424|NCT01790984|9913103|FG002|STARTED|Second Dietary Intervention (12 Weeks)||6
8857425|NCT01790984|9913104|FG003|STARTED|Second Dietary Intervention (12 Weeks)||7
8857426|NCT01790984|9913101|FG000|COMPLETED|Second Dietary Intervention (12 Weeks)||5
8857427|NCT01790984|9913102|FG001|COMPLETED|Second Dietary Intervention (12 Weeks)||7
8857428|NCT01790984|9913103|FG002|COMPLETED|Second Dietary Intervention (12 Weeks)||6
8857429|NCT01790984|9913104|FG003|COMPLETED|Second Dietary Intervention (12 Weeks)||7
8857430|NCT01790984|9913101|FG000|NOT COMPLETED|Second Dietary Intervention (12 Weeks)||0
8857431|NCT01790984|9913102|FG001|NOT COMPLETED|Second Dietary Intervention (12 Weeks)||0
8857432|NCT01790984|9913103|FG002|NOT COMPLETED|Second Dietary Intervention (12 Weeks)||0
8857433|NCT01790984|9913104|FG003|NOT COMPLETED|Second Dietary Intervention (12 Weeks)||0
8857434|NCT01791127|9913127|FG000|STARTED|Overall Study||1758
8857435|NCT01791127|9913127|FG000|COMPLETED|Overall Study||286
8857436|NCT01791127|9913127|FG000|NOT COMPLETED|Overall Study||1472
8857437|NCT01791153|9913148|FG000|STARTED|Part 1: Blinded Period||100
8857438|NCT01791153|9913149|FG001|STARTED|Part 1: Blinded Period||49
8857439|NCT01791153|9913150|FG002|STARTED|Part 1: Blinded Period||50
8857440|NCT01791153|9913151|FG003|STARTED|Part 1: Blinded Period||51
8857441|NCT01791153|9913152|FG004|STARTED|Part 1: Blinded Period||0
8857442|NCT01791153|9913153|FG005|STARTED|Part 1: Blinded Period||0
8857443|NCT01791153|9913154|FG006|STARTED|Part 1: Blinded Period||0
8857444|NCT01791153|9913155|FG007|STARTED|Part 1: Blinded Period||0
8857445|NCT01791153|9913148|FG000|COMPLETED|Part 1: Blinded Period|Completed Study to Week 52|85
8857446|NCT01791153|9913149|FG001|COMPLETED|Part 1: Blinded Period|Completed Study to Week 52|41
8857447|NCT01791153|9913150|FG002|COMPLETED|Part 1: Blinded Period|Completed Study to Week 52|44
8857448|NCT01791153|9913151|FG003|COMPLETED|Part 1: Blinded Period|Completed Study to Week 52|46
8857449|NCT01791153|9913152|FG004|COMPLETED|Part 1: Blinded Period||0
8857450|NCT01791153|9913153|FG005|COMPLETED|Part 1: Blinded Period||0
8857451|NCT01791153|9913154|FG006|COMPLETED|Part 1: Blinded Period||0
8857452|NCT01791153|9913155|FG007|COMPLETED|Part 1: Blinded Period||0
8857453|NCT01791153|9913148|FG000|NOT COMPLETED|Part 1: Blinded Period||15
8857454|NCT01791153|9913149|FG001|NOT COMPLETED|Part 1: Blinded Period||8
8857455|NCT01791153|9913150|FG002|NOT COMPLETED|Part 1: Blinded Period||6
8857456|NCT01791153|9913151|FG003|NOT COMPLETED|Part 1: Blinded Period||5
8857457|NCT01791153|9913152|FG004|NOT COMPLETED|Part 1: Blinded Period||0
8857458|NCT01791153|9913153|FG005|NOT COMPLETED|Part 1: Blinded Period||0
8857459|NCT01791153|9913154|FG006|NOT COMPLETED|Part 1: Blinded Period||0
8857460|NCT01791153|9913155|FG007|NOT COMPLETED|Part 1: Blinded Period||0
8857461|NCT01791153|9913148|FG000|STARTED|Part 2: Open-label Period||0
8857462|NCT01791153|9913149|FG001|STARTED|Part 2: Open-label Period||0
8857463|NCT01791153|9913150|FG002|STARTED|Part 2: Open-label Period||0
8857464|NCT01791153|9913151|FG003|STARTED|Part 2: Open-label Period||0
8857465|NCT01791153|9913152|FG004|STARTED|Part 2: Open-label Period||40
8857466|NCT01791153|9913153|FG005|STARTED|Part 2: Open-label Period||58
8857467|NCT01791153|9913154|FG006|STARTED|Part 2: Open-label Period||50
8857468|NCT01791153|9913155|FG007|STARTED|Part 2: Open-label Period||67
8857469|NCT01791153|9913148|FG000|COMPLETED|Part 2: Open-label Period||0
8857470|NCT01791153|9913149|FG001|COMPLETED|Part 2: Open-label Period||0
8857471|NCT01791153|9913150|FG002|COMPLETED|Part 2: Open-label Period||0
8857472|NCT01791153|9913151|FG003|COMPLETED|Part 2: Open-label Period||0
8857473|NCT01791153|9913152|FG004|COMPLETED|Part 2: Open-label Period||38
8857474|NCT01791153|9913153|FG005|COMPLETED|Part 2: Open-label Period||54
8857475|NCT01791153|9913154|FG006|COMPLETED|Part 2: Open-label Period||44
8857476|NCT01791153|9913155|FG007|COMPLETED|Part 2: Open-label Period||61
8857477|NCT01791153|9913148|FG000|NOT COMPLETED|Part 2: Open-label Period||0
8857478|NCT01791153|9913149|FG001|NOT COMPLETED|Part 2: Open-label Period||0
8857479|NCT01791153|9913150|FG002|NOT COMPLETED|Part 2: Open-label Period||0
8857480|NCT01791153|9913151|FG003|NOT COMPLETED|Part 2: Open-label Period||0
8857481|NCT01791153|9913152|FG004|NOT COMPLETED|Part 2: Open-label Period||2
8857482|NCT01791153|9913153|FG005|NOT COMPLETED|Part 2: Open-label Period||4
8857483|NCT01791153|9913154|FG006|NOT COMPLETED|Part 2: Open-label Period||6
8857484|NCT01791153|9913155|FG007|NOT COMPLETED|Part 2: Open-label Period||6
8857485|NCT01791205|9913172|FG000|STARTED|Phase I||152
8857486|NCT01791205|9913173|FG001|STARTED|Phase I||152
8857487|NCT01791205|9913172|FG000|COMPLETED|Phase I||152
8857488|NCT01791205|9913173|FG001|COMPLETED|Phase I||152
8857489|NCT01791205|9913172|FG000|NOT COMPLETED|Phase I||0
8857490|NCT01791205|9913173|FG001|NOT COMPLETED|Phase I||0
8857491|NCT01791205|9913172|FG000|STARTED|Phase II|Participants who received tocilizumab monotherapy in Phase I was observed in Phase II.|104
8857492|NCT01791205|9913173|FG001|STARTED|Phase II||0
8857493|NCT01791205|9913172|FG000|COMPLETED|Phase II||92
8857494|NCT01791205|9913173|FG001|COMPLETED|Phase II||0
8857495|NCT01791205|9913172|FG000|NOT COMPLETED|Phase II||12
8857496|NCT01791205|9913173|FG001|NOT COMPLETED|Phase II||0
8857497|NCT01791244|9913181|FG000|STARTED|Overall Study||46
8857498|NCT01791244|9913182|FG001|STARTED|Overall Study||47
8857499|NCT01791244|9913181|FG000|Intent to Treat (ITT)|Overall Study||38
8857500|NCT01791244|9913182|FG001|Intent to Treat (ITT)|Overall Study||39
8857501|NCT01791244|9913181|FG000|COMPLETED|Overall Study||31
8857502|NCT01791244|9913182|FG001|COMPLETED|Overall Study||29
8857503|NCT01791244|9913181|FG000|NOT COMPLETED|Overall Study||15
8857504|NCT01791244|9913182|FG001|NOT COMPLETED|Overall Study||18
8857505|NCT01791413|9913192|FG000|STARTED|Overall Study||20
8857506|NCT01791413|9913193|FG001|STARTED|Overall Study||20
8857507|NCT01791413|9913192|FG000|COMPLETED|Overall Study||15
8857508|NCT01791413|9913193|FG001|COMPLETED|Overall Study||19
8857509|NCT01791413|9913192|FG000|NOT COMPLETED|Overall Study||5
8857510|NCT01791413|9913193|FG001|NOT COMPLETED|Overall Study||1
8857511|NCT01791465|9913200|FG000|STARTED|Overall Study||6
8857512|NCT01791465|9913200|FG000|COMPLETED|Overall Study||6
8857513|NCT01791465|9913200|FG000|NOT COMPLETED|Overall Study||0
8857514|NCT01791491|9913205|FG000|STARTED|Overall Study|Reasons for enrollment and non-treatment: 1 withdrew consent and 6 no longer met study criteria.|9
8857515|NCT01791491|9913205|FG000|COMPLETED|Overall Study||9
8857516|NCT01791491|9913205|FG000|NOT COMPLETED|Overall Study||0
8923510|NCT02240680|9984107|FG002|COMPLETED|Japanese Patients (Up to 52 Weeks)||42
8923511|NCT02240680|9984108|FG003|COMPLETED|Japanese Patients (Up to 52 Weeks)||45
8923512|NCT02240680|9984105|FG000|NOT COMPLETED|Japanese Patients (Up to 52 Weeks)||0
8923513|NCT02240680|9984106|FG001|NOT COMPLETED|Japanese Patients (Up to 52 Weeks)||0
8923514|NCT02240680|9984107|FG002|NOT COMPLETED|Japanese Patients (Up to 52 Weeks)||8
8923515|NCT02240680|9984108|FG003|NOT COMPLETED|Japanese Patients (Up to 52 Weeks)||7
8923516|NCT02240693|9984121|FG000|STARTED|Overall Study||22
8923517|NCT02240693|9984122|FG001|STARTED|Overall Study||21
8923518|NCT02240693|9984123|FG002|STARTED|Overall Study||21
8923519|NCT02240693|9984124|FG003|STARTED|Overall Study||21
8923520|NCT02240693|9984125|FG004|STARTED|Overall Study||43
8923521|NCT02240693|9984121|FG000|COMPLETED|Overall Study||22
8923522|NCT02240693|9984122|FG001|COMPLETED|Overall Study||21
8923523|NCT02240693|9984123|FG002|COMPLETED|Overall Study||17
8923524|NCT02240693|9984124|FG003|COMPLETED|Overall Study||20
8923525|NCT02240693|9984125|FG004|COMPLETED|Overall Study||42
8923526|NCT02240693|9984121|FG000|NOT COMPLETED|Overall Study||0
8923527|NCT02240693|9984122|FG001|NOT COMPLETED|Overall Study||0
8949503|NCT02439138|10012091|FG000|COMPLETED|Overall Study||2
8949504|NCT02439138|10012091|FG000|NOT COMPLETED|Overall Study||3
8949505|NCT02439164|10012097|FG000|STARTED|Overall Study||18
8949506|NCT02439164|10012098|FG001|STARTED|Overall Study||18
8949507|NCT02439164|10012097|FG000|COMPLETED|Overall Study||18
8949508|NCT02439164|10012098|FG001|COMPLETED|Overall Study||18
8949509|NCT02439164|10012097|FG000|NOT COMPLETED|Overall Study||0
8949510|NCT02439164|10012098|FG001|NOT COMPLETED|Overall Study||0
8949511|NCT02439281|10012107|FG000|STARTED|Overall Study||24
8949512|NCT02439281|10012108|FG001|STARTED|Overall Study||26
8949513|NCT02439281|10012107|FG000|COMPLETED|Overall Study||24
8949514|NCT02439281|10012108|FG001|COMPLETED|Overall Study||26
8629955|NCT00532883|9669726|FG000|STARTED|Overall Study||11
8629956|NCT00532883|9669727|FG001|STARTED|Overall Study||12
8629957|NCT00532883|9669728|FG002|STARTED|Overall Study||10
8629958|NCT00532883|9669729|FG003|STARTED|Overall Study||11
8629959|NCT00532883|9669726|FG000|COMPLETED|Overall Study|Study terminated early.|5
8629960|NCT00532883|9669727|FG001|COMPLETED|Overall Study|Study terminated early.|5
8629961|NCT00532883|9669728|FG002|COMPLETED|Overall Study|Study terminated early.|6
8629962|NCT00532883|9669729|FG003|COMPLETED|Overall Study|Study terminated early.|6
8629963|NCT00532883|9669726|FG000|NOT COMPLETED|Overall Study||6
8629964|NCT00532883|9669727|FG001|NOT COMPLETED|Overall Study||7
8629965|NCT00532883|9669728|FG002|NOT COMPLETED|Overall Study||4
8629966|NCT00532883|9669729|FG003|NOT COMPLETED|Overall Study||5
8629967|NCT00532935|9669741|FG000|STARTED|Overall Study|Excludes 1 patient who was randomized twice at different sites.|261
8629968|NCT00532935|9669742|FG001|STARTED|Overall Study|Excludes 1 patient who was randomized twice at different sites.|256
8629969|NCT00532935|9669741|FG000|COMPLETED|Overall Study||210
8629970|NCT00532935|9669742|FG001|COMPLETED|Overall Study||204
8629971|NCT00532935|9669741|FG000|NOT COMPLETED|Overall Study||51
8629972|NCT00532935|9669742|FG001|NOT COMPLETED|Overall Study||52
8629973|NCT00532948|9669751|FG000|STARTED|Overall Study||4
8629974|NCT00532948|9669752|FG001|STARTED|Overall Study||14
8629975|NCT00532948|9669753|FG002|STARTED|Overall Study||6
8629976|NCT00532948|9669751|FG000|COMPLETED|Overall Study||0
8629977|NCT00532948|9669752|FG001|COMPLETED|Overall Study||9
8629978|NCT00532948|9669753|FG002|COMPLETED|Overall Study||2
8629979|NCT00532948|9669751|FG000|NOT COMPLETED|Overall Study||4
8629980|NCT00532948|9669752|FG001|NOT COMPLETED|Overall Study||5
8629981|NCT00532948|9669753|FG002|NOT COMPLETED|Overall Study||4
8629982|NCT00533117|9669769|FG000|STARTED|Overall Study||18
8629983|NCT00533117|9669770|FG001|STARTED|Overall Study||19
8629984|NCT00533117|9669771|FG002|STARTED|Overall Study||20
8949515|NCT02439281|10012107|FG000|NOT COMPLETED|Overall Study||0
8949516|NCT02439281|10012108|FG001|NOT COMPLETED|Overall Study||0
8949517|NCT02439320|10012119|FG000|STARTED|Overall Study||744
8949518|NCT02439320|10012120|FG001|STARTED|Overall Study||745
8949519|NCT02439320|10012121|FG002|STARTED|Overall Study||742
8629985|NCT00533117|9669772|FG003|STARTED|Overall Study||18
8629986|NCT00533117|9669769|FG000|COMPLETED|Overall Study||14
8629987|NCT00533117|9669770|FG001|COMPLETED|Overall Study||14
8629988|NCT00533117|9669771|FG002|COMPLETED|Overall Study||14
8949520|NCT02439320|10012119|FG000|Confirmed Eligibility|Overall Study||710
8949521|NCT02439320|10012120|FG001|Confirmed Eligibility|Overall Study||695
8629989|NCT00533117|9669772|FG003|COMPLETED|Overall Study||13
8629990|NCT00533117|9669769|FG000|NOT COMPLETED|Overall Study||4
8629991|NCT00533117|9669770|FG001|NOT COMPLETED|Overall Study||5
8629992|NCT00533117|9669771|FG002|NOT COMPLETED|Overall Study||6
8923528|NCT02240693|9984123|FG002|NOT COMPLETED|Overall Study||4
8857517|NCT01791517|9913212|FG000|STARTED|Phase I: Period 1||19
8857518|NCT01791517|9913213|FG001|STARTED|Phase I: Period 1||20
8857519|NCT01791517|9913214|FG002|STARTED|Phase I: Period 1||20
8857520|NCT01791517|9913215|FG003|STARTED|Phase I: Period 1||19
8857521|NCT01791517|9913216|FG004|STARTED|Phase I: Period 1||20
8857522|NCT01791517|9913217|FG005|STARTED|Phase I: Period 1||20
8857523|NCT01791517|9913218|FG006|STARTED|Phase I: Period 1||20
8857524|NCT01791517|9913219|FG007|STARTED|Phase I: Period 1||20
8857525|NCT01791517|9913220|FG008|STARTED|Phase I: Period 1||20
8857526|NCT01791517|9913221|FG009|STARTED|Phase I: Period 1||20
8857527|NCT01791517|9913222|FG010|STARTED|Phase I: Period 1||18
8857528|NCT01791517|9913223|FG011|STARTED|Phase I: Period 1||20
8857529|NCT01791517|9913212|FG000|COMPLETED|Phase I: Period 1||18
8857530|NCT01791517|9913213|FG001|COMPLETED|Phase I: Period 1||18
8857531|NCT01791517|9913214|FG002|COMPLETED|Phase I: Period 1||18
8857532|NCT01791517|9913215|FG003|COMPLETED|Phase I: Period 1||17
8857533|NCT01791517|9913216|FG004|COMPLETED|Phase I: Period 1||19
8857534|NCT01791517|9913217|FG005|COMPLETED|Phase I: Period 1||19
8857535|NCT01791517|9913218|FG006|COMPLETED|Phase I: Period 1||19
8857536|NCT01791517|9913219|FG007|COMPLETED|Phase I: Period 1||20
8857537|NCT01791517|9913220|FG008|COMPLETED|Phase I: Period 1||19
8857538|NCT01791517|9913221|FG009|COMPLETED|Phase I: Period 1||19
8857539|NCT01791517|9913222|FG010|COMPLETED|Phase I: Period 1||18
8857540|NCT01791517|9913223|FG011|COMPLETED|Phase I: Period 1||19
8857541|NCT01791517|9913212|FG000|NOT COMPLETED|Phase I: Period 1||1
8857542|NCT01791517|9913213|FG001|NOT COMPLETED|Phase I: Period 1||2
8857543|NCT01791517|9913214|FG002|NOT COMPLETED|Phase I: Period 1||2
8857544|NCT01791517|9913215|FG003|NOT COMPLETED|Phase I: Period 1||2
8857545|NCT01791517|9913216|FG004|NOT COMPLETED|Phase I: Period 1||1
8857546|NCT01791517|9913217|FG005|NOT COMPLETED|Phase I: Period 1||1
8857547|NCT01791517|9913218|FG006|NOT COMPLETED|Phase I: Period 1||1
8857548|NCT01791517|9913219|FG007|NOT COMPLETED|Phase I: Period 1||0
8857549|NCT01791517|9913220|FG008|NOT COMPLETED|Phase I: Period 1||1
8857550|NCT01791517|9913221|FG009|NOT COMPLETED|Phase I: Period 1||1
8857551|NCT01791517|9913222|FG010|NOT COMPLETED|Phase I: Period 1||0
8857552|NCT01791517|9913223|FG011|NOT COMPLETED|Phase I: Period 1||1
8857553|NCT01791517|9913212|FG000|STARTED|Phase I: Period 2||18
8857554|NCT01791517|9913213|FG001|STARTED|Phase I: Period 2||18
8857555|NCT01791517|9913214|FG002|STARTED|Phase I: Period 2||18
8857556|NCT01791517|9913215|FG003|STARTED|Phase I: Period 2||17
8857557|NCT01791517|9913216|FG004|STARTED|Phase I: Period 2||19
8857558|NCT01791517|9913217|FG005|STARTED|Phase I: Period 2||19
8857559|NCT01791517|9913218|FG006|STARTED|Phase I: Period 2||19
8857560|NCT01791517|9913219|FG007|STARTED|Phase I: Period 2||20
8857561|NCT01791517|9913220|FG008|STARTED|Phase I: Period 2||19
8857562|NCT01791517|9913221|FG009|STARTED|Phase I: Period 2||19
8857563|NCT01791517|9913222|FG010|STARTED|Phase I: Period 2||18
8857564|NCT01791517|9913223|FG011|STARTED|Phase I: Period 2||19
8857565|NCT01791517|9913212|FG000|COMPLETED|Phase I: Period 2||17
8857566|NCT01791517|9913213|FG001|COMPLETED|Phase I: Period 2||15
8857567|NCT01791517|9913214|FG002|COMPLETED|Phase I: Period 2||16
8857568|NCT01791517|9913215|FG003|COMPLETED|Phase I: Period 2||16
8857569|NCT01791517|9913216|FG004|COMPLETED|Phase I: Period 2||19
8857570|NCT01791517|9913217|FG005|COMPLETED|Phase I: Period 2||18
8857571|NCT01791517|9913218|FG006|COMPLETED|Phase I: Period 2||19
8857572|NCT01791517|9913219|FG007|COMPLETED|Phase I: Period 2||20
8857573|NCT01791517|9913220|FG008|COMPLETED|Phase I: Period 2||19
8857574|NCT01791517|9913221|FG009|COMPLETED|Phase I: Period 2||18
8857575|NCT01791517|9913222|FG010|COMPLETED|Phase I: Period 2||16
8857576|NCT01791517|9913223|FG011|COMPLETED|Phase I: Period 2||19
8857577|NCT01791517|9913212|FG000|NOT COMPLETED|Phase I: Period 2||1
8857578|NCT01791517|9913213|FG001|NOT COMPLETED|Phase I: Period 2||3
8857579|NCT01791517|9913214|FG002|NOT COMPLETED|Phase I: Period 2||2
8857580|NCT01791517|9913215|FG003|NOT COMPLETED|Phase I: Period 2||1
8629993|NCT00533117|9669772|FG003|NOT COMPLETED|Overall Study||5
8629994|NCT00533273|9669784|FG000|STARTED|Double-blind||45
8629995|NCT00533273|9669785|FG001|STARTED|Double-blind||21
8629996|NCT00533273|9669784|FG000|COMPLETED|Double-blind||45
8857581|NCT01791517|9913216|FG004|NOT COMPLETED|Phase I: Period 2||0
8857582|NCT01791517|9913217|FG005|NOT COMPLETED|Phase I: Period 2||1
8857583|NCT01791517|9913218|FG006|NOT COMPLETED|Phase I: Period 2||0
8857584|NCT01791517|9913219|FG007|NOT COMPLETED|Phase I: Period 2||0
8857585|NCT01791517|9913220|FG008|NOT COMPLETED|Phase I: Period 2||0
8857586|NCT01791517|9913221|FG009|NOT COMPLETED|Phase I: Period 2||1
8857587|NCT01791517|9913222|FG010|NOT COMPLETED|Phase I: Period 2||2
8857588|NCT01791517|9913223|FG011|NOT COMPLETED|Phase I: Period 2||0
8857589|NCT01791517|9913212|FG000|STARTED|Phase I: Period 3||17
8857590|NCT01791517|9913213|FG001|STARTED|Phase I: Period 3||15
8857591|NCT01791517|9913214|FG002|STARTED|Phase I: Period 3||16
8857592|NCT01791517|9913215|FG003|STARTED|Phase I: Period 3||16
8629997|NCT00533273|9669785|FG001|COMPLETED|Double-blind||19
8629998|NCT00533273|9669784|FG000|NOT COMPLETED|Double-blind||0
8857593|NCT01791517|9913216|FG004|STARTED|Phase I: Period 3||19
8857594|NCT01791517|9913217|FG005|STARTED|Phase I: Period 3||18
8857595|NCT01791517|9913218|FG006|STARTED|Phase I: Period 3||19
8857596|NCT01791517|9913219|FG007|STARTED|Phase I: Period 3||20
8857597|NCT01791517|9913220|FG008|STARTED|Phase I: Period 3||19
8857598|NCT01791517|9913221|FG009|STARTED|Phase I: Period 3||18
8857599|NCT01791517|9913222|FG010|STARTED|Phase I: Period 3||16
8857600|NCT01791517|9913223|FG011|STARTED|Phase I: Period 3||19
8857601|NCT01791517|9913212|FG000|COMPLETED|Phase I: Period 3||17
8857602|NCT01791517|9913213|FG001|COMPLETED|Phase I: Period 3||14
8857603|NCT01791517|9913214|FG002|COMPLETED|Phase I: Period 3||16
8857604|NCT01791517|9913215|FG003|COMPLETED|Phase I: Period 3||15
8857605|NCT01791517|9913216|FG004|COMPLETED|Phase I: Period 3||18
8857606|NCT01791517|9913217|FG005|COMPLETED|Phase I: Period 3||18
8857607|NCT01791517|9913218|FG006|COMPLETED|Phase I: Period 3||19
8857608|NCT01791517|9913219|FG007|COMPLETED|Phase I: Period 3||20
8857609|NCT01791517|9913220|FG008|COMPLETED|Phase I: Period 3||19
8857610|NCT01791517|9913221|FG009|COMPLETED|Phase I: Period 3||18
8857611|NCT01791517|9913222|FG010|COMPLETED|Phase I: Period 3||16
8857612|NCT01791517|9913223|FG011|COMPLETED|Phase I: Period 3||18
8857613|NCT01791517|9913212|FG000|NOT COMPLETED|Phase I: Period 3||0
8857614|NCT01791517|9913213|FG001|NOT COMPLETED|Phase I: Period 3||1
8857615|NCT01791517|9913214|FG002|NOT COMPLETED|Phase I: Period 3||0
8857616|NCT01791517|9913215|FG003|NOT COMPLETED|Phase I: Period 3||1
8857617|NCT01791517|9913216|FG004|NOT COMPLETED|Phase I: Period 3||1
8857618|NCT01791517|9913217|FG005|NOT COMPLETED|Phase I: Period 3||0
8857619|NCT01791517|9913218|FG006|NOT COMPLETED|Phase I: Period 3||0
8857620|NCT01791517|9913219|FG007|NOT COMPLETED|Phase I: Period 3||0
8857621|NCT01791517|9913220|FG008|NOT COMPLETED|Phase I: Period 3||0
8857622|NCT01791517|9913221|FG009|NOT COMPLETED|Phase I: Period 3||0
8857623|NCT01791517|9913222|FG010|NOT COMPLETED|Phase I: Period 3||0
8857624|NCT01791517|9913223|FG011|NOT COMPLETED|Phase I: Period 3||1
8857625|NCT01791517|9913212|FG000|STARTED|Phase I: Period 4||17
8857626|NCT01791517|9913213|FG001|STARTED|Phase I: Period 4||14
8857627|NCT01791517|9913214|FG002|STARTED|Phase I: Period 4||16
8857628|NCT01791517|9913215|FG003|STARTED|Phase I: Period 4||15
8857629|NCT01791517|9913216|FG004|STARTED|Phase I: Period 4||18
8857630|NCT01791517|9913217|FG005|STARTED|Phase I: Period 4||18
8857631|NCT01791517|9913218|FG006|STARTED|Phase I: Period 4||19
8857632|NCT01791517|9913219|FG007|STARTED|Phase I: Period 4||20
8857633|NCT01791517|9913220|FG008|STARTED|Phase I: Period 4||19
8857634|NCT01791517|9913221|FG009|STARTED|Phase I: Period 4||18
8857635|NCT01791517|9913222|FG010|STARTED|Phase I: Period 4||16
8857636|NCT01791517|9913223|FG011|STARTED|Phase I: Period 4||18
8857637|NCT01791517|9913212|FG000|COMPLETED|Phase I: Period 4||17
8857638|NCT01791517|9913213|FG001|COMPLETED|Phase I: Period 4||14
8857639|NCT01791517|9913214|FG002|COMPLETED|Phase I: Period 4||16
8857640|NCT01791517|9913215|FG003|COMPLETED|Phase I: Period 4||15
8857641|NCT01791517|9913216|FG004|COMPLETED|Phase I: Period 4||18
8857642|NCT01791517|9913217|FG005|COMPLETED|Phase I: Period 4||18
8857643|NCT01791517|9913218|FG006|COMPLETED|Phase I: Period 4||19
8857644|NCT01791517|9913219|FG007|COMPLETED|Phase I: Period 4||20
8857645|NCT01791517|9913220|FG008|COMPLETED|Phase I: Period 4||19
8857646|NCT01791517|9913221|FG009|COMPLETED|Phase I: Period 4||18
8857647|NCT01791517|9913222|FG010|COMPLETED|Phase I: Period 4||16
8629999|NCT00533273|9669785|FG001|NOT COMPLETED|Double-blind||2
8630000|NCT00533273|9669784|FG000|STARTED|Open-label|open-label was extension of double-blind; 64 of 66 patients continued into open-label|64
8630001|NCT00533273|9669785|FG001|STARTED|Open-label|no placebo - this phase was open label|0
8857648|NCT01791517|9913223|FG011|COMPLETED|Phase I: Period 4||18
8857649|NCT01791517|9913212|FG000|NOT COMPLETED|Phase I: Period 4||0
8857650|NCT01791517|9913213|FG001|NOT COMPLETED|Phase I: Period 4||0
8569633|NCT00098293|9601847|FG000|STARTED|Supplemental Phase (SP)||0
8569634|NCT00098293|9601848|FG001|STARTED|Supplemental Phase (SP)||0
8569635|NCT00098293|9601849|FG002|STARTED|Supplemental Phase (SP)||0
8569636|NCT00098293|9601850|FG003|STARTED|Supplemental Phase (SP)||0
8569637|NCT00098293|9601851|FG004|STARTED|Supplemental Phase (SP)||127
8949522|NCT02439320|10012121|FG002|Confirmed Eligibility|Overall Study||705
8949523|NCT02439320|10012119|FG000|1st Dose (by 4 Hours Migraine Onset)|Overall Study||630
8949524|NCT02439320|10012120|FG001|1st Dose (by 4 Hours Migraine Onset)|Overall Study||609
8949525|NCT02439320|10012121|FG002|1st Dose (by 4 Hours Migraine Onset)|Overall Study||617
8949526|NCT02439320|10012119|FG000|2nd Dose (After 2 Hour Assessment)|Overall Study||289
8949527|NCT02439320|10012120|FG001|2nd Dose (After 2 Hour Assessment)|Overall Study||238
8949528|NCT02439320|10012121|FG002|2nd Dose (After 2 Hour Assessment)|Overall Study||401
8949529|NCT02439320|10012119|FG000|COMPLETED|Overall Study||648
8949530|NCT02439320|10012120|FG001|COMPLETED|Overall Study||631
8949531|NCT02439320|10012121|FG002|COMPLETED|Overall Study||643
8949532|NCT02439320|10012119|FG000|NOT COMPLETED|Overall Study||96
8949533|NCT02439320|10012120|FG001|NOT COMPLETED|Overall Study||114
8949534|NCT02439320|10012121|FG002|NOT COMPLETED|Overall Study||99
8949535|NCT02439710|10012135|FG000|STARTED|Overall Study||656
8949536|NCT02439710|10012135|FG000|COMPLETED|Overall Study||656
8949537|NCT02439710|10012135|FG000|NOT COMPLETED|Overall Study||0
8949538|NCT02439814|10012141|FG000|STARTED|Overall Study||11
8569638|NCT00098293|9601847|FG000|COMPLETED|Supplemental Phase (SP)||0
8569639|NCT00098293|9601848|FG001|COMPLETED|Supplemental Phase (SP)||0
8569640|NCT00098293|9601849|FG002|COMPLETED|Supplemental Phase (SP)||0
8569641|NCT00098293|9601850|FG003|COMPLETED|Supplemental Phase (SP)||0
8569642|NCT00098293|9601851|FG004|COMPLETED|Supplemental Phase (SP)||94
8857651|NCT01791517|9913214|FG002|NOT COMPLETED|Phase I: Period 4||0
8857652|NCT01791517|9913215|FG003|NOT COMPLETED|Phase I: Period 4||0
8857653|NCT01791517|9913216|FG004|NOT COMPLETED|Phase I: Period 4||0
8857654|NCT01791517|9913217|FG005|NOT COMPLETED|Phase I: Period 4||0
8857655|NCT01791517|9913218|FG006|NOT COMPLETED|Phase I: Period 4||0
8857656|NCT01791517|9913219|FG007|NOT COMPLETED|Phase I: Period 4||0
8857657|NCT01791517|9913220|FG008|NOT COMPLETED|Phase I: Period 4||0
8857658|NCT01791517|9913221|FG009|NOT COMPLETED|Phase I: Period 4||0
8857659|NCT01791517|9913222|FG010|NOT COMPLETED|Phase I: Period 4||0
8857660|NCT01791517|9913223|FG011|NOT COMPLETED|Phase I: Period 4||0
8857661|NCT01791517|9913212|FG000|STARTED|Phase II||17
8857662|NCT01791517|9913213|FG001|STARTED|Phase II||14
8857663|NCT01791517|9913214|FG002|STARTED|Phase II||16
8857664|NCT01791517|9913215|FG003|STARTED|Phase II||15
8857665|NCT01791517|9913216|FG004|STARTED|Phase II||18
8857666|NCT01791517|9913217|FG005|STARTED|Phase II||18
8857667|NCT01791517|9913218|FG006|STARTED|Phase II||19
8857668|NCT01791517|9913219|FG007|STARTED|Phase II||20
8857669|NCT01791517|9913220|FG008|STARTED|Phase II||19
8857670|NCT01791517|9913221|FG009|STARTED|Phase II||18
8857671|NCT01791517|9913222|FG010|STARTED|Phase II||16
8857672|NCT01791517|9913223|FG011|STARTED|Phase II||18
8857673|NCT01791517|9913212|FG000|COMPLETED|Phase II||15
8857674|NCT01791517|9913213|FG001|COMPLETED|Phase II||14
8857675|NCT01791517|9913214|FG002|COMPLETED|Phase II||15
8857676|NCT01791517|9913215|FG003|COMPLETED|Phase II||15
8857677|NCT01791517|9913216|FG004|COMPLETED|Phase II||16
8857678|NCT01791517|9913217|FG005|COMPLETED|Phase II||14
8857679|NCT01791517|9913218|FG006|COMPLETED|Phase II||17
8857680|NCT01791517|9913219|FG007|COMPLETED|Phase II||17
8857681|NCT01791517|9913220|FG008|COMPLETED|Phase II||17
8857682|NCT01791517|9913221|FG009|COMPLETED|Phase II||15
8857683|NCT01791517|9913222|FG010|COMPLETED|Phase II||15
8857684|NCT01791517|9913223|FG011|COMPLETED|Phase II||17
8857685|NCT01791517|9913212|FG000|NOT COMPLETED|Phase II||2
8857686|NCT01791517|9913213|FG001|NOT COMPLETED|Phase II||0
8857687|NCT01791517|9913214|FG002|NOT COMPLETED|Phase II||1
8857688|NCT01791517|9913215|FG003|NOT COMPLETED|Phase II||0
8857689|NCT01791517|9913216|FG004|NOT COMPLETED|Phase II||2
8857690|NCT01791517|9913217|FG005|NOT COMPLETED|Phase II||4
8857691|NCT01791517|9913218|FG006|NOT COMPLETED|Phase II||2
8857692|NCT01791517|9913219|FG007|NOT COMPLETED|Phase II||3
8857693|NCT01791517|9913220|FG008|NOT COMPLETED|Phase II||2
8857694|NCT01791517|9913221|FG009|NOT COMPLETED|Phase II||3
8857695|NCT01791517|9913222|FG010|NOT COMPLETED|Phase II||1
8857696|NCT01791517|9913223|FG011|NOT COMPLETED|Phase II||1
8857697|NCT01791725|9913244|FG000|STARTED|Overall Study||12
8857698|NCT01791725|9913245|FG001|STARTED|Overall Study||5
8857699|NCT01791725|9913246|FG002|STARTED|Overall Study||6
8857700|NCT01791725|9913244|FG000|COMPLETED|Overall Study||12
8857701|NCT01791725|9913245|FG001|COMPLETED|Overall Study||4
8857702|NCT01791725|9913246|FG002|COMPLETED|Overall Study||6
8857703|NCT01791725|9913244|FG000|NOT COMPLETED|Overall Study||0
8857704|NCT01791725|9913245|FG001|NOT COMPLETED|Overall Study||1
8857705|NCT01791725|9913246|FG002|NOT COMPLETED|Overall Study||0
8857706|NCT01791803|9913258|FG000|STARTED|Overall Study||41
8857707|NCT01791803|9913259|FG001|STARTED|Overall Study||41
8857708|NCT01791803|9913260|FG002|STARTED|Overall Study||40
8857709|NCT01791803|9913261|FG003|STARTED|Overall Study||42
8857710|NCT01791803|9913258|FG000|COMPLETED|Overall Study||41
8857711|NCT01791803|9913259|FG001|COMPLETED|Overall Study||39
8857712|NCT01791803|9913260|FG002|COMPLETED|Overall Study||38
8857713|NCT01791803|9913261|FG003|COMPLETED|Overall Study||37
8857714|NCT01791803|9913258|FG000|NOT COMPLETED|Overall Study||0
8857715|NCT01791803|9913259|FG001|NOT COMPLETED|Overall Study||2
8857716|NCT01791803|9913260|FG002|NOT COMPLETED|Overall Study||2
8857717|NCT01791803|9913261|FG003|NOT COMPLETED|Overall Study||5
8857718|NCT01791894|9913274|FG000|STARTED|Overall Study||5
8857719|NCT01791894|9913274|FG000|COMPLETED|Overall Study||4
8857720|NCT01791894|9913274|FG000|NOT COMPLETED|Overall Study||1
8857721|NCT01791972|9913281|FG000|STARTED|Overall Study||19
8857722|NCT01791972|9913282|FG001|STARTED|Overall Study||19
8857723|NCT01791972|9913281|FG000|COMPLETED|Overall Study||19
8857724|NCT01791972|9913282|FG001|COMPLETED|Overall Study||19
8949539|NCT02439814|10012142|FG001|STARTED|Overall Study||10
8949540|NCT02439814|10012141|FG000|COMPLETED|Overall Study||11
8949541|NCT02439814|10012142|FG001|COMPLETED|Overall Study||10
8949542|NCT02439814|10012141|FG000|NOT COMPLETED|Overall Study||0
8630002|NCT00533273|9669784|FG000|COMPLETED|Open-label||58
8630003|NCT00533273|9669785|FG001|COMPLETED|Open-label||0
8949543|NCT02439814|10012142|FG001|NOT COMPLETED|Overall Study||0
8949544|NCT02439879|10012150|FG000|STARTED|Overall Study||16
8949545|NCT02439879|10012151|FG001|STARTED|Overall Study||17
8949546|NCT02439879|10012150|FG000|COMPLETED|Overall Study||16
8949547|NCT02439879|10012151|FG001|COMPLETED|Overall Study||17
8949548|NCT02439879|10012150|FG000|NOT COMPLETED|Overall Study||0
8857725|NCT01791972|9913281|FG000|NOT COMPLETED|Overall Study||0
8857726|NCT01791972|9913282|FG001|NOT COMPLETED|Overall Study||0
8857727|NCT01792024|9913288|FG000|STARTED|Overall Study||27
8857728|NCT01792024|9913288|FG000|COMPLETED|Overall Study||27
8857729|NCT01792024|9913288|FG000|NOT COMPLETED|Overall Study||0
8857730|NCT01792115|9913295|FG000|STARTED|Overall Study||7
8857731|NCT01792115|9913296|FG001|STARTED|Overall Study||7
8857732|NCT01792115|9913297|FG002|STARTED|Overall Study||8
8949549|NCT02439879|10012151|FG001|NOT COMPLETED|Overall Study||0
8857733|NCT01792115|9913295|FG000|COMPLETED|Overall Study||7
8857734|NCT01792115|9913296|FG001|COMPLETED|Overall Study||6
8857735|NCT01792115|9913297|FG002|COMPLETED|Overall Study||8
8857736|NCT01792115|9913295|FG000|NOT COMPLETED|Overall Study||0
8857737|NCT01792115|9913296|FG001|NOT COMPLETED|Overall Study||1
8857738|NCT01792115|9913297|FG002|NOT COMPLETED|Overall Study||0
8857739|NCT01792284|9913305|FG000|STARTED|Lead-in Period||212
8857740|NCT01792284|9913306|FG001|STARTED|Lead-in Period||0
8857741|NCT01792284|9913307|FG002|STARTED|Lead-in Period||0
8857742|NCT01792284|9913305|FG000|COMPLETED|Lead-in Period|Participants that completed the Lead-in Period were randomized and entered Randomization Period 1.|182
8857743|NCT01792284|9913306|FG001|COMPLETED|Lead-in Period||0
8857744|NCT01792284|9913307|FG002|COMPLETED|Lead-in Period||0
8857745|NCT01792284|9913305|FG000|NOT COMPLETED|Lead-in Period||30
8857746|NCT01792284|9913306|FG001|NOT COMPLETED|Lead-in Period||0
8857747|NCT01792284|9913307|FG002|NOT COMPLETED|Lead-in Period||0
8857748|NCT01792284|9913305|FG000|STARTED|Randomization Period 1||0
8857749|NCT01792284|9913306|FG001|STARTED|Randomization Period 1||92
8857750|NCT01792284|9913307|FG002|STARTED|Randomization Period 1||90
8857751|NCT01792284|9913305|FG000|Received at Least 1 Dose of Study Drug|Randomization Period 1||0
8857752|NCT01792284|9913306|FG001|Received at Least 1 Dose of Study Drug|Randomization Period 1||92
8857753|NCT01792284|9913307|FG002|Received at Least 1 Dose of Study Drug|Randomization Period 1||90
8857754|NCT01792284|9913305|FG000|COMPLETED|Randomization Period 1||0
8857755|NCT01792284|9913306|FG001|COMPLETED|Randomization Period 1||90
8857756|NCT01792284|9913307|FG002|COMPLETED|Randomization Period 1||85
8857757|NCT01792284|9913305|FG000|NOT COMPLETED|Randomization Period 1||0
8857758|NCT01792284|9913306|FG001|NOT COMPLETED|Randomization Period 1||2
8857759|NCT01792284|9913307|FG002|NOT COMPLETED|Randomization Period 1||5
8857760|NCT01792284|9913305|FG000|STARTED|Randomization Period 2||0
8857761|NCT01792284|9913306|FG001|STARTED|Randomization Period 2||90
8857762|NCT01792284|9913307|FG002|STARTED|Randomization Period 2||85
8857763|NCT01792284|9913305|FG000|Received at Least 1 Dose of Study Drug|Randomization Period 2||0
8857764|NCT01792284|9913306|FG001|Received at Least 1 Dose of Study Drug|Randomization Period 2||90
8857765|NCT01792284|9913307|FG002|Received at Least 1 Dose of Study Drug|Randomization Period 2||85
8857766|NCT01792284|9913305|FG000|COMPLETED|Randomization Period 2||0
8857767|NCT01792284|9913306|FG001|COMPLETED|Randomization Period 2||87
8857768|NCT01792284|9913307|FG002|COMPLETED|Randomization Period 2||85
8857769|NCT01792284|9913305|FG000|NOT COMPLETED|Randomization Period 2||0
8857770|NCT01792284|9913306|FG001|NOT COMPLETED|Randomization Period 2||3
8857771|NCT01792284|9913307|FG002|NOT COMPLETED|Randomization Period 2||0
8857772|NCT01792518|9913317|FG000|STARTED|Overall Study||178
8857773|NCT01792518|9913318|FG001|STARTED|Overall Study||182
8857774|NCT01792518|9913317|FG000|COMPLETED|Overall Study||170
8857775|NCT01792518|9913318|FG001|COMPLETED|Overall Study||175
8857776|NCT01792518|9913317|FG000|NOT COMPLETED|Overall Study||8
8630004|NCT00533273|9669784|FG000|NOT COMPLETED|Open-label||6
8630005|NCT00533273|9669785|FG001|NOT COMPLETED|Open-label||0
8630006|NCT00533429|9669793|FG000|STARTED|Overall Study||20
8630007|NCT00533429|9669794|FG001|STARTED|Overall Study||20
8630008|NCT00533429|9669793|FG000|Received at Least 1 Dose of Study Drug|Overall Study||20
8630009|NCT00533429|9669794|FG001|Received at Least 1 Dose of Study Drug|Overall Study||20
8630010|NCT00533429|9669793|FG000|Entered Maintenance|Overall Study||8
8857777|NCT01792518|9913318|FG001|NOT COMPLETED|Overall Study||7
8857778|NCT01792635|9913327|FG000|STARTED|Part A||6
8857779|NCT01792635|9913328|FG001|STARTED|Part A||0
8857780|NCT01792635|9913329|FG002|STARTED|Part A||0
8857781|NCT01792635|9913327|FG000|COMPLETED|Part A||6
8857782|NCT01792635|9913328|FG001|COMPLETED|Part A||0
8857783|NCT01792635|9913329|FG002|COMPLETED|Part A||0
8857784|NCT01792635|9913327|FG000|NOT COMPLETED|Part A||0
8857785|NCT01792635|9913328|FG001|NOT COMPLETED|Part A||0
8857786|NCT01792635|9913329|FG002|NOT COMPLETED|Part A||0
8857787|NCT01792635|9913327|FG000|STARTED|Part B||0
8857788|NCT01792635|9913328|FG001|STARTED|Part B||6
8857789|NCT01792635|9913329|FG002|STARTED|Part B||7
8857790|NCT01792635|9913327|FG000|COMPLETED|Part B||0
8857791|NCT01792635|9913328|FG001|COMPLETED|Part B||2
8949550|NCT02440022|10012159|FG000|STARTED|Overall Study||141
8949551|NCT02440022|10012160|FG001|STARTED|Overall Study||144
8949552|NCT02440022|10012159|FG000|COMPLETED|Overall Study||114
8949553|NCT02440022|10012160|FG001|COMPLETED|Overall Study||131
8949554|NCT02440022|10012159|FG000|NOT COMPLETED|Overall Study||27
8949555|NCT02440022|10012160|FG001|NOT COMPLETED|Overall Study||13
8949556|NCT02440139|10012166|FG000|STARTED|Overall Study|12 radiologists read 324 CT cases|12
8949557|NCT02440139|10012166|FG000|COMPLETED|Overall Study|12 radiologists read 324 CT cases|12
8949558|NCT02440139|10012166|FG000|NOT COMPLETED|Overall Study||0
8949559|NCT02440178|10012174|FG000|STARTED|Overall Study||66
8949560|NCT02440178|10012174|FG000|COMPLETED|Overall Study||46
8949561|NCT02440178|10012174|FG000|NOT COMPLETED|Overall Study||20
8857792|NCT01792635|9913329|FG002|COMPLETED|Part B||3
8857793|NCT01792635|9913327|FG000|NOT COMPLETED|Part B||0
8857794|NCT01792635|9913328|FG001|NOT COMPLETED|Part B||4
8857795|NCT01792635|9913329|FG002|NOT COMPLETED|Part B||4
8857796|NCT01792817|9913340|FG000|STARTED|Phase 1 Double Blind Period||77
8857797|NCT01792817|9913341|FG001|STARTED|Phase 1 Double Blind Period||73
8857798|NCT01792817|9913342|FG002|STARTED|Phase 1 Double Blind Period||0
8949562|NCT02440204|10012183|FG000|STARTED|Overall Study||22
8949563|NCT02440204|10012184|FG001|STARTED|Overall Study||24
8949564|NCT02440204|10012185|FG002|STARTED|Overall Study||22
8857799|NCT01792817|9913340|FG000|COMPLETED|Phase 1 Double Blind Period||58
8857800|NCT01792817|9913341|FG001|COMPLETED|Phase 1 Double Blind Period||42
8857801|NCT01792817|9913342|FG002|COMPLETED|Phase 1 Double Blind Period||0
8857802|NCT01792817|9913340|FG000|NOT COMPLETED|Phase 1 Double Blind Period||19
8857803|NCT01792817|9913341|FG001|NOT COMPLETED|Phase 1 Double Blind Period||31
8857804|NCT01792817|9913342|FG002|NOT COMPLETED|Phase 1 Double Blind Period||0
8857805|NCT01792817|9913340|FG000|STARTED|Phase 2 Open Label||0
8857806|NCT01792817|9913341|FG001|STARTED|Phase 2 Open Label||0
8857807|NCT01792817|9913342|FG002|STARTED|Phase 2 Open Label||100
8857808|NCT01792817|9913340|FG000|COMPLETED|Phase 2 Open Label||0
8857809|NCT01792817|9913341|FG001|COMPLETED|Phase 2 Open Label||0
8857810|NCT01792817|9913342|FG002|COMPLETED|Phase 2 Open Label||74
8857811|NCT01792817|9913340|FG000|NOT COMPLETED|Phase 2 Open Label||0
8857812|NCT01792817|9913341|FG001|NOT COMPLETED|Phase 2 Open Label||0
8857813|NCT01792817|9913342|FG002|NOT COMPLETED|Phase 2 Open Label||26
8857814|NCT01792830|9913360|FG000|STARTED|Overall Study||84
8857815|NCT01792830|9913361|FG001|STARTED|Overall Study||3
8857816|NCT01792830|9913362|FG002|STARTED|Overall Study||4
8857817|NCT01792830|9913363|FG003|STARTED|Overall Study||21
8857818|NCT01792830|9913364|FG004|STARTED|Overall Study||2
8857819|NCT01792830|9913365|FG005|STARTED|Overall Study||4
8857820|NCT01792830|9913366|FG006|STARTED|Overall Study||14
8857821|NCT01792830|9913367|FG007|STARTED|Overall Study||7
8857822|NCT01792830|9913368|FG008|STARTED|Overall Study||20
8857823|NCT01792830|9913369|FG009|STARTED|Overall Study||4
8857824|NCT01792830|9913370|FG010|STARTED|Overall Study||12
8857825|NCT01792830|9913360|FG000|COMPLETED|Overall Study||59
8857826|NCT01792830|9913361|FG001|COMPLETED|Overall Study||3
8857827|NCT01792830|9913362|FG002|COMPLETED|Overall Study||4
8857828|NCT01792830|9913363|FG003|COMPLETED|Overall Study||18
8857829|NCT01792830|9913364|FG004|COMPLETED|Overall Study||1
8857830|NCT01792830|9913365|FG005|COMPLETED|Overall Study||3
8857831|NCT01792830|9913366|FG006|COMPLETED|Overall Study||12
8857832|NCT01792830|9913367|FG007|COMPLETED|Overall Study||6
8857833|NCT01792830|9913368|FG008|COMPLETED|Overall Study||11
8857834|NCT01792830|9913369|FG009|COMPLETED|Overall Study||4
8857835|NCT01792830|9913370|FG010|COMPLETED|Overall Study||9
8857836|NCT01792830|9913360|FG000|NOT COMPLETED|Overall Study||25
8857837|NCT01792830|9913361|FG001|NOT COMPLETED|Overall Study||0
8857838|NCT01792830|9913362|FG002|NOT COMPLETED|Overall Study||0
8857839|NCT01792830|9913363|FG003|NOT COMPLETED|Overall Study||3
8857840|NCT01792830|9913364|FG004|NOT COMPLETED|Overall Study||1
8857841|NCT01792830|9913365|FG005|NOT COMPLETED|Overall Study||1
8857842|NCT01792830|9913366|FG006|NOT COMPLETED|Overall Study||2
8857843|NCT01792830|9913367|FG007|NOT COMPLETED|Overall Study||1
8857844|NCT01792830|9913368|FG008|NOT COMPLETED|Overall Study||9
8857845|NCT01792830|9913369|FG009|NOT COMPLETED|Overall Study||0
8857846|NCT01792830|9913370|FG010|NOT COMPLETED|Overall Study||3
8857847|NCT01792986|9913400|FG000|STARTED|Overall Study||12
8857848|NCT01792986|9913400|FG000|COMPLETED|Overall Study||12
8857849|NCT01792986|9913400|FG000|NOT COMPLETED|Overall Study||0
8857850|NCT01793051|9913406|FG000|STARTED|Overall Study||43
8857851|NCT01793051|9913407|FG001|STARTED|Overall Study||44
8857852|NCT01793051|9913406|FG000|COMPLETED|Overall Study||33
8857853|NCT01793051|9913407|FG001|COMPLETED|Overall Study||36
8857854|NCT01793051|9913406|FG000|NOT COMPLETED|Overall Study||10
8857855|NCT01793051|9913407|FG001|NOT COMPLETED|Overall Study||8
8857856|NCT01793142|9913413|FG000|STARTED|Overall Study||3430
8857857|NCT01793142|9913413|FG000|Treated|Overall Study||3423
8857858|NCT01793142|9913413|FG000|COMPLETED|Overall Study||3423
8857859|NCT01793142|9913413|FG000|NOT COMPLETED|Overall Study||7
8857860|NCT01793285|9913417|FG000|STARTED|Overall Study||85
8857861|NCT01793285|9913417|FG000|COMPLETED|Overall Study||85
8857862|NCT01793285|9913417|FG000|NOT COMPLETED|Overall Study||0
8857863|NCT01793688|9913421|FG000|STARTED|Overall Study||982
8857864|NCT01793688|9913421|FG000|COMPLETED|Overall Study||980
8857865|NCT01793688|9913421|FG000|NOT COMPLETED|Overall Study||2
8857866|NCT01793792|9913425|FG000|STARTED|Overall Study|153 treated: 1 attempted no device implanted, 152 device implanted.|153
8857867|NCT01793792|9913425|FG000|Treated|Overall Study|153 Treated, 152 implanted with device, 1 attempted no device implanted|153
8857868|NCT01793792|9913425|FG000|COMPLETED|Overall Study||141
8857869|NCT01793792|9913425|FG000|NOT COMPLETED|Overall Study||12
8857870|NCT01793883|9913432|FG000|STARTED|Overall Study||213
8857871|NCT01793883|9913433|FG001|STARTED|Overall Study||214
8857872|NCT01793883|9913434|FG002|STARTED|Overall Study||212
8857873|NCT01793883|9913432|FG000|COMPLETED|Overall Study||201
8857874|NCT01793883|9913433|FG001|COMPLETED|Overall Study||204
8857875|NCT01793883|9913434|FG002|COMPLETED|Overall Study||204
8857876|NCT01793883|9913432|FG000|NOT COMPLETED|Overall Study||12
8569643|NCT00098293|9601847|FG000|NOT COMPLETED|Supplemental Phase (SP)||0
8569644|NCT00098293|9601848|FG001|NOT COMPLETED|Supplemental Phase (SP)||0
8857877|NCT01793883|9913433|FG001|NOT COMPLETED|Overall Study||10
8857878|NCT01793883|9913434|FG002|NOT COMPLETED|Overall Study||8
8857879|NCT01793909|9913444|FG000|STARTED|Overall Study||30
8857880|NCT01793909|9913445|FG001|STARTED|Overall Study||25
8857881|NCT01793909|9913444|FG000|COMPLETED|Overall Study||20
8857882|NCT01793909|9913445|FG001|COMPLETED|Overall Study||20
8857883|NCT01793909|9913444|FG000|NOT COMPLETED|Overall Study||10
8857884|NCT01793909|9913445|FG001|NOT COMPLETED|Overall Study||5
8857885|NCT01793935|9913453|FG000|STARTED|Overall Study||34
8857886|NCT01793935|9913454|FG001|STARTED|Overall Study||34
8857887|NCT01793935|9913453|FG000|COMPLETED|Overall Study||28
8857888|NCT01793935|9913454|FG001|COMPLETED|Overall Study||31
8857889|NCT01793935|9913453|FG000|NOT COMPLETED|Overall Study||6
8857890|NCT01793935|9913454|FG001|NOT COMPLETED|Overall Study||3
8857891|NCT01794000|9913462|FG000|STARTED|Double-Blind Phase (DBP)||171
8857892|NCT01794000|9913463|FG001|STARTED|Double-Blind Phase (DBP)||170
8857893|NCT01794000|9913462|FG000|Received at Least One Dose of Drug|Double-Blind Phase (DBP)||170
8857894|NCT01794000|9913463|FG001|Received at Least One Dose of Drug|Double-Blind Phase (DBP)||170
8857895|NCT01794000|9913462|FG000|Discontinued During Double Blind Phase|Double-Blind Phase (DBP)||169
8857896|NCT01794000|9913463|FG001|Discontinued During Double Blind Phase|Double-Blind Phase (DBP)||166
8857897|NCT01794000|9913462|FG000|COMPLETED|Double-Blind Phase (DBP)||2
8857898|NCT01794000|9913463|FG001|COMPLETED|Double-Blind Phase (DBP)||4
8857899|NCT01794000|9913462|FG000|NOT COMPLETED|Double-Blind Phase (DBP)||169
8857900|NCT01794000|9913463|FG001|NOT COMPLETED|Double-Blind Phase (DBP)||166
8857901|NCT01794000|9913462|FG000|STARTED|Open-Label Extension Phase (OLE)|Pts. who had not permanently discontinued study drug and concluded DBP were eligible to enter OLE|3
8857902|NCT01794000|9913463|FG001|STARTED|Open-Label Extension Phase (OLE)|Placebo arm was not applicable to Open-Label Extension Phase|0
8857903|NCT01794000|9913462|FG000|COMPLETED|Open-Label Extension Phase (OLE)||0
8857904|NCT01794000|9913463|FG001|COMPLETED|Open-Label Extension Phase (OLE)||0
8857905|NCT01794000|9913462|FG000|NOT COMPLETED|Open-Label Extension Phase (OLE)||3
8857906|NCT01794000|9913463|FG001|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
8857907|NCT01794039|9913472|FG000|STARTED|Overall Study||5
8857908|NCT01794039|9913473|FG001|STARTED|Overall Study||4
8857909|NCT01794039|9913472|FG000|COMPLETED|Overall Study||5
8857910|NCT01794039|9913473|FG001|COMPLETED|Overall Study||4
8857911|NCT01794039|9913472|FG000|NOT COMPLETED|Overall Study||0
8857912|NCT01794039|9913473|FG001|NOT COMPLETED|Overall Study||0
8857913|NCT01794117|9913485|FG000|STARTED|Overall Study||1
8857914|NCT01794117|9913486|FG001|STARTED|Overall Study||3
8857915|NCT01794117|9913487|FG002|STARTED|Overall Study||2
8857916|NCT01794117|9913488|FG003|STARTED|Overall Study||12
8857917|NCT01794117|9913485|FG000|COMPLETED|Overall Study||0
8857918|NCT01794117|9913486|FG001|COMPLETED|Overall Study||0
8857919|NCT01794117|9913487|FG002|COMPLETED|Overall Study||2
8857920|NCT01794117|9913488|FG003|COMPLETED|Overall Study||12
8857921|NCT01794117|9913485|FG000|NOT COMPLETED|Overall Study||1
8857922|NCT01794117|9913486|FG001|NOT COMPLETED|Overall Study||3
8857923|NCT01794117|9913487|FG002|NOT COMPLETED|Overall Study||0
8857924|NCT01794117|9913488|FG003|NOT COMPLETED|Overall Study||0
8857925|NCT01794299|9913499|FG000|STARTED|Overall Study||31
8857926|NCT01794299|9913499|FG000|COMPLETED|Overall Study||9
8857927|NCT01794299|9913499|FG000|NOT COMPLETED|Overall Study||22
8857928|NCT01794312|9913505|FG000|STARTED|Overall Study||74
8857929|NCT01794312|9913506|FG001|STARTED|Overall Study||78
8857930|NCT01794312|9913505|FG000|COMPLETED|Overall Study||68
8857931|NCT01794312|9913506|FG001|COMPLETED|Overall Study||67
8857932|NCT01794312|9913505|FG000|NOT COMPLETED|Overall Study||6
8857933|NCT01794312|9913506|FG001|NOT COMPLETED|Overall Study||11
8857934|NCT01794455|9913514|FG000|STARTED|Overall Study||0
8857935|NCT01794455|9913515|FG001|STARTED|Overall Study||1
8857936|NCT01794455|9913514|FG000|COMPLETED|Overall Study||0
8857937|NCT01794455|9913515|FG001|COMPLETED|Overall Study||1
8857938|NCT01794455|9913514|FG000|NOT COMPLETED|Overall Study||0
8857939|NCT01794455|9913515|FG001|NOT COMPLETED|Overall Study||0
8857940|NCT01794689|9913525|FG000|STARTED|Intervention 1 (2 Nights)||25
8857941|NCT01794689|9913526|FG001|STARTED|Intervention 1 (2 Nights)||29
8857942|NCT01794689|9913527|FG002|STARTED|Intervention 1 (2 Nights)||24
8857943|NCT01794689|9913528|FG003|STARTED|Intervention 1 (2 Nights)||22
8857944|NCT01794689|9913525|FG000|COMPLETED|Intervention 1 (2 Nights)||20
8857945|NCT01794689|9913526|FG001|COMPLETED|Intervention 1 (2 Nights)||27
8857946|NCT01794689|9913527|FG002|COMPLETED|Intervention 1 (2 Nights)||21
8857947|NCT01794689|9913528|FG003|COMPLETED|Intervention 1 (2 Nights)||18
8857948|NCT01794689|9913525|FG000|NOT COMPLETED|Intervention 1 (2 Nights)||5
8857949|NCT01794689|9913526|FG001|NOT COMPLETED|Intervention 1 (2 Nights)||2
8857950|NCT01794689|9913527|FG002|NOT COMPLETED|Intervention 1 (2 Nights)||3
8857951|NCT01794689|9913528|FG003|NOT COMPLETED|Intervention 1 (2 Nights)||4
8857952|NCT01794689|9913525|FG000|STARTED|Washout (2 Weeks)||20
8857953|NCT01794689|9913526|FG001|STARTED|Washout (2 Weeks)||27
8857954|NCT01794689|9913527|FG002|STARTED|Washout (2 Weeks)||21
8857955|NCT01794689|9913528|FG003|STARTED|Washout (2 Weeks)||18
8857956|NCT01794689|9913525|FG000|COMPLETED|Washout (2 Weeks)||20
8857957|NCT01794689|9913526|FG001|COMPLETED|Washout (2 Weeks)||27
8857958|NCT01794689|9913527|FG002|COMPLETED|Washout (2 Weeks)||21
8857959|NCT01794689|9913528|FG003|COMPLETED|Washout (2 Weeks)||18
8857960|NCT01794689|9913525|FG000|NOT COMPLETED|Washout (2 Weeks)||0
8857961|NCT01794689|9913526|FG001|NOT COMPLETED|Washout (2 Weeks)||0
8857962|NCT01794689|9913527|FG002|NOT COMPLETED|Washout (2 Weeks)||0
8857963|NCT01794689|9913528|FG003|NOT COMPLETED|Washout (2 Weeks)||0
8857964|NCT01794689|9913525|FG000|STARTED|Intervention 2 (2 Nights)||20
8857965|NCT01794689|9913526|FG001|STARTED|Intervention 2 (2 Nights)||27
8857966|NCT01794689|9913527|FG002|STARTED|Intervention 2 (2 Nights)||21
8857967|NCT01794689|9913528|FG003|STARTED|Intervention 2 (2 Nights)||18
8857968|NCT01794689|9913525|FG000|COMPLETED|Intervention 2 (2 Nights)||20
8857969|NCT01794689|9913526|FG001|COMPLETED|Intervention 2 (2 Nights)||27
8857970|NCT01794689|9913527|FG002|COMPLETED|Intervention 2 (2 Nights)||21
8857971|NCT01794689|9913528|FG003|COMPLETED|Intervention 2 (2 Nights)||18
8857972|NCT01794689|9913525|FG000|NOT COMPLETED|Intervention 2 (2 Nights)||0
8857973|NCT01794689|9913526|FG001|NOT COMPLETED|Intervention 2 (2 Nights)||0
8857974|NCT01794689|9913527|FG002|NOT COMPLETED|Intervention 2 (2 Nights)||0
8857975|NCT01794689|9913528|FG003|NOT COMPLETED|Intervention 2 (2 Nights)||0
8857976|NCT01794702|9913547|FG000|STARTED|Overall Study||18
8857977|NCT01794702|9913548|FG001|STARTED|Overall Study||0
8857978|NCT01794702|9913549|FG002|STARTED|Overall Study||47
8857979|NCT01794702|9913547|FG000|COMPLETED|Overall Study||18
8857980|NCT01794702|9913548|FG001|COMPLETED|Overall Study||0
8857981|NCT01794702|9913549|FG002|COMPLETED|Overall Study||47
8857982|NCT01794702|9913547|FG000|NOT COMPLETED|Overall Study||0
8857983|NCT01794702|9913548|FG001|NOT COMPLETED|Overall Study||0
8857984|NCT01794702|9913549|FG002|NOT COMPLETED|Overall Study||0
8857985|NCT01794741|9913559|FG000|STARTED|Overall Study||304
8857986|NCT01794741|9913560|FG001|STARTED|Overall Study||101
8857987|NCT01794741|9913559|FG000|COMPLETED|Overall Study||285
8857988|NCT01794741|9913560|FG001|COMPLETED|Overall Study||92
8857989|NCT01794741|9913559|FG000|NOT COMPLETED|Overall Study||19
8857990|NCT01794741|9913560|FG001|NOT COMPLETED|Overall Study||9
8857991|NCT01794780|9913574|FG000|STARTED|Overall Study||32
8857992|NCT01794780|9913575|FG001|STARTED|Overall Study||276
8857993|NCT01794780|9913576|FG002|STARTED|Overall Study||813
8857994|NCT01794780|9913577|FG003|STARTED|Overall Study||283
8857995|NCT01794780|9913578|FG004|STARTED|Overall Study||9
8857996|NCT01794780|9913579|FG005|STARTED|Overall Study||632
8857997|NCT01794780|9913580|FG006|STARTED|Overall Study||154
8857998|NCT01794780|9913581|FG007|STARTED|Overall Study||30
8857999|NCT01794780|9913574|FG000|COMPLETED|Overall Study||15
8858000|NCT01794780|9913575|FG001|COMPLETED|Overall Study||180
8858001|NCT01794780|9913576|FG002|COMPLETED|Overall Study||571
8858002|NCT01794780|9913577|FG003|COMPLETED|Overall Study||200
8858003|NCT01794780|9913578|FG004|COMPLETED|Overall Study||6
8858004|NCT01794780|9913579|FG005|COMPLETED|Overall Study||452
8858005|NCT01794780|9913580|FG006|COMPLETED|Overall Study||112
8858006|NCT01794780|9913581|FG007|COMPLETED|Overall Study||21
8858007|NCT01794780|9913574|FG000|NOT COMPLETED|Overall Study||17
8858008|NCT01794780|9913575|FG001|NOT COMPLETED|Overall Study||96
8858009|NCT01794780|9913576|FG002|NOT COMPLETED|Overall Study||242
8858010|NCT01794780|9913577|FG003|NOT COMPLETED|Overall Study||83
8858011|NCT01794780|9913578|FG004|NOT COMPLETED|Overall Study||3
8858012|NCT01794780|9913579|FG005|NOT COMPLETED|Overall Study||180
8858013|NCT01794780|9913580|FG006|NOT COMPLETED|Overall Study||42
8858014|NCT01794780|9913581|FG007|NOT COMPLETED|Overall Study||9
8858015|NCT01794806|9913608|FG000|STARTED|Overall Study||31
8858016|NCT01794806|9913609|FG001|STARTED|Overall Study||28
8858017|NCT01794806|9913608|FG000|1 Week|Overall Study||28
8858018|NCT01794806|9913609|FG001|1 Week|Overall Study||28
8858019|NCT01794806|9913608|FG000|4 Weeks|Overall Study||26
8858020|NCT01794806|9913609|FG001|4 Weeks|Overall Study||27
8858021|NCT01794806|9913608|FG000|COMPLETED|Overall Study||26
8858022|NCT01794806|9913609|FG001|COMPLETED|Overall Study||27
8858023|NCT01794806|9913608|FG000|NOT COMPLETED|Overall Study||5
8858024|NCT01794806|9913609|FG001|NOT COMPLETED|Overall Study||1
8858025|NCT01794845|9913615|FG000|STARTED|Overall Study||5
8858026|NCT01794845|9913615|FG000|COMPLETED|Overall Study||4
8858027|NCT01794845|9913615|FG000|NOT COMPLETED|Overall Study||1
8858028|NCT01794923|9913622|FG000|STARTED|Overall Study||83
8858029|NCT01794923|9913623|FG001|STARTED|Overall Study||60
8858030|NCT01794923|9913624|FG002|STARTED|Overall Study||62
8858031|NCT01794923|9913622|FG000|COMPLETED|Overall Study||83
8858032|NCT01794923|9913623|FG001|COMPLETED|Overall Study||60
8858033|NCT01794923|9913624|FG002|COMPLETED|Overall Study||61
8858034|NCT01794923|9913622|FG000|NOT COMPLETED|Overall Study||0
8858035|NCT01794923|9913623|FG001|NOT COMPLETED|Overall Study||0
8858036|NCT01794923|9913624|FG002|NOT COMPLETED|Overall Study||1
8858037|NCT01794949|9913634|FG000|STARTED|Overall Study||7
8858038|NCT01794949|9913635|FG001|STARTED|Overall Study||1
8858039|NCT01794949|9913634|FG000|6 Month Follow-up|Overall Study||6
8858040|NCT01794949|9913635|FG001|6 Month Follow-up|Overall Study||1
8858041|NCT01794949|9913634|FG000|COMPLETED|Overall Study||6
8858042|NCT01794949|9913635|FG001|COMPLETED|Overall Study||1
8858043|NCT01794949|9913634|FG000|NOT COMPLETED|Overall Study||1
8858044|NCT01794949|9913635|FG001|NOT COMPLETED|Overall Study||0
8858045|NCT01795079|9913643|FG000|STARTED|Overall Study||16
8858046|NCT01795079|9913644|FG001|STARTED|Overall Study||15
8858047|NCT01795079|9913643|FG000|COMPLETED|Overall Study||13
8858048|NCT01795079|9913644|FG001|COMPLETED|Overall Study||12
8858049|NCT01795079|9913643|FG000|NOT COMPLETED|Overall Study||3
8858050|NCT01795079|9913644|FG001|NOT COMPLETED|Overall Study||3
8858051|NCT01795105|9913650|FG000|STARTED|Overall Study||692
8858052|NCT01795105|9913650|FG000|COMPLETED|Overall Study||648
8858053|NCT01795105|9913650|FG000|NOT COMPLETED|Overall Study||44
8858054|NCT01795495|9913658|FG000|STARTED|Overall Study||20
8858055|NCT01795495|9913659|FG001|STARTED|Overall Study||22
8858056|NCT01795495|9913660|FG002|STARTED|Overall Study||21
8858057|NCT01795495|9913658|FG000|COMPLETED|Overall Study||19
8858058|NCT01795495|9913659|FG001|COMPLETED|Overall Study||22
8858059|NCT01795495|9913660|FG002|COMPLETED|Overall Study||19
8858060|NCT01795495|9913658|FG000|NOT COMPLETED|Overall Study||1
8858061|NCT01795495|9913659|FG001|NOT COMPLETED|Overall Study||0
8858062|NCT01795495|9913660|FG002|NOT COMPLETED|Overall Study||2
8858063|NCT01795534|9913668|FG000|STARTED|First Intervention (First Shot)||5
8858064|NCT01795534|9913669|FG001|STARTED|First Intervention (First Shot)||5
8858065|NCT01795534|9913668|FG000|COMPLETED|First Intervention (First Shot)||5
8858066|NCT01795534|9913669|FG001|COMPLETED|First Intervention (First Shot)||5
8858067|NCT01795534|9913668|FG000|NOT COMPLETED|First Intervention (First Shot)||0
8858068|NCT01795534|9913669|FG001|NOT COMPLETED|First Intervention (First Shot)||0
8858069|NCT01795534|9913668|FG000|STARTED|Wash Out Period (4 Days)||5
8858070|NCT01795534|9913669|FG001|STARTED|Wash Out Period (4 Days)||5
8858071|NCT01795534|9913668|FG000|COMPLETED|Wash Out Period (4 Days)||5
8858072|NCT01795534|9913669|FG001|COMPLETED|Wash Out Period (4 Days)||5
8858073|NCT01795534|9913668|FG000|NOT COMPLETED|Wash Out Period (4 Days)||0
8858074|NCT01795534|9913669|FG001|NOT COMPLETED|Wash Out Period (4 Days)||0
8858075|NCT01795534|9913668|FG000|STARTED|Second Intervention (Second Shot)||5
8858076|NCT01795534|9913669|FG001|STARTED|Second Intervention (Second Shot)||5
8858077|NCT01795534|9913668|FG000|COMPLETED|Second Intervention (Second Shot)||5
8858078|NCT01795534|9913669|FG001|COMPLETED|Second Intervention (Second Shot)||5
8858079|NCT01795534|9913668|FG000|NOT COMPLETED|Second Intervention (Second Shot)||0
8858080|NCT01795534|9913669|FG001|NOT COMPLETED|Second Intervention (Second Shot)||0
8858081|NCT01795547|9913677|FG000|STARTED|Overall Study||148
8858082|NCT01795547|9913678|FG001|STARTED|Overall Study||147
8858083|NCT01795547|9913677|FG000|COMPLETED|Overall Study||100
8858084|NCT01795547|9913678|FG001|COMPLETED|Overall Study||83
8858085|NCT01795547|9913677|FG000|NOT COMPLETED|Overall Study||48
8858086|NCT01795547|9913678|FG001|NOT COMPLETED|Overall Study||64
8858087|NCT01795638|9913688|FG000|STARTED|Overall Study||27
8858088|NCT01795638|9913689|FG001|STARTED|Overall Study||26
8858089|NCT01795638|9913688|FG000|COMPLETED|Overall Study||14
8858090|NCT01795638|9913689|FG001|COMPLETED|Overall Study||15
8858091|NCT01795638|9913688|FG000|NOT COMPLETED|Overall Study||13
8858092|NCT01795638|9913689|FG001|NOT COMPLETED|Overall Study||11
8858093|NCT01795716|9913697|FG000|STARTED|First Intervention (13 Days)||10
8858094|NCT01795716|9913698|FG001|STARTED|First Intervention (13 Days)||11
8858095|NCT01795716|9913697|FG000|COMPLETED|First Intervention (13 Days)||10
8858096|NCT01795716|9913698|FG001|COMPLETED|First Intervention (13 Days)||11
8858097|NCT01795716|9913697|FG000|NOT COMPLETED|First Intervention (13 Days)||0
8858098|NCT01795716|9913698|FG001|NOT COMPLETED|First Intervention (13 Days)||0
8858099|NCT01795716|9913697|FG000|STARTED|Washout (10 Days)||10
8858100|NCT01795716|9913698|FG001|STARTED|Washout (10 Days)||11
8858101|NCT01795716|9913697|FG000|COMPLETED|Washout (10 Days)||10
8858102|NCT01795716|9913698|FG001|COMPLETED|Washout (10 Days)||11
8858103|NCT01795716|9913697|FG000|NOT COMPLETED|Washout (10 Days)||0
8858104|NCT01795716|9913698|FG001|NOT COMPLETED|Washout (10 Days)||0
8858105|NCT01795716|9913697|FG000|STARTED|Second Intervention (13 Days)||10
8858106|NCT01795716|9913698|FG001|STARTED|Second Intervention (13 Days)||11
8858107|NCT01795716|9913697|FG000|COMPLETED|Second Intervention (13 Days)||10
8858108|NCT01795716|9913698|FG001|COMPLETED|Second Intervention (13 Days)||11
8858109|NCT01795716|9913697|FG000|NOT COMPLETED|Second Intervention (13 Days)||0
8858110|NCT01795716|9913698|FG001|NOT COMPLETED|Second Intervention (13 Days)||0
8858111|NCT01795833|9913708|FG000|STARTED|Overall Study||1031
8858112|NCT01795833|9913709|FG001|STARTED|Overall Study||1031
8858113|NCT01795833|9913708|FG000|COMPLETED|Overall Study||881
8858114|NCT01795833|9913709|FG001|COMPLETED|Overall Study||882
8858115|NCT01795833|9913708|FG000|NOT COMPLETED|Overall Study||150
8858116|NCT01795833|9913709|FG001|NOT COMPLETED|Overall Study||149
8858117|NCT01795859|9913717|FG000|STARTED|Overall Study||45
8858118|NCT01795859|9913718|FG001|STARTED|Overall Study||45
8858119|NCT01795859|9913717|FG000|COMPLETED|Overall Study||44
8858120|NCT01795859|9913718|FG001|COMPLETED|Overall Study||43
8858121|NCT01795859|9913717|FG000|NOT COMPLETED|Overall Study||1
8858122|NCT01795859|9913718|FG001|NOT COMPLETED|Overall Study||2
8858123|NCT01795898|9913724|FG000|STARTED|Overall Study||237
8858124|NCT01795898|9913724|FG000|COMPLETED|Overall Study||177
8858125|NCT01795898|9913724|FG000|NOT COMPLETED|Overall Study||60
8858126|NCT01795937|9913731|FG000|STARTED|Overall Study||18
8858127|NCT01795937|9913732|FG001|STARTED|Overall Study||16
8858128|NCT01795937|9913733|FG002|STARTED|Overall Study||17
8858129|NCT01795937|9913731|FG000|COMPLETED|Overall Study||17
8858130|NCT01795937|9913732|FG001|COMPLETED|Overall Study||15
8858131|NCT01795937|9913733|FG002|COMPLETED|Overall Study||17
8858132|NCT01795937|9913731|FG000|NOT COMPLETED|Overall Study||1
8858133|NCT01795937|9913732|FG001|NOT COMPLETED|Overall Study||1
8858134|NCT01795937|9913733|FG002|NOT COMPLETED|Overall Study||0
8858135|NCT01796236|9913751|FG000|STARTED|Overall Study||51
8858136|NCT01796236|9913752|FG001|STARTED|Overall Study||52
8858137|NCT01796236|9913751|FG000|COMPLETED|Overall Study||49
8858138|NCT01796236|9913752|FG001|COMPLETED|Overall Study||50
8858139|NCT01796236|9913751|FG000|NOT COMPLETED|Overall Study||2
8858140|NCT01796236|9913752|FG001|NOT COMPLETED|Overall Study||2
8858141|NCT01796301|9913761|FG000|STARTED|Overall Study||218
8858142|NCT01796301|9913762|FG001|STARTED|Overall Study||218
8858143|NCT01796301|9913761|FG000|Received Treatment|Overall Study||214
8858144|NCT01796301|9913762|FG001|Received Treatment|Overall Study||218
8858145|NCT01796301|9913761|FG000|COMPLETED|Overall Study||200
8858146|NCT01796301|9913762|FG001|COMPLETED|Overall Study||198
8858147|NCT01796301|9913761|FG000|NOT COMPLETED|Overall Study||18
8858148|NCT01796301|9913762|FG001|NOT COMPLETED|Overall Study||20
8858149|NCT01796392|9913770|FG000|STARTED|Overall Study||128
8858150|NCT01796392|9913771|FG001|STARTED|Overall Study||62
8858151|NCT01796392|9913770|FG000|COMPLETED|Overall Study|119 active subjects at 12-months|119
8858152|NCT01796392|9913771|FG001|COMPLETED|Overall Study|59 active subjects at 12-months|59
8858153|NCT01796392|9913770|FG000|NOT COMPLETED|Overall Study||9
8858154|NCT01796392|9913771|FG001|NOT COMPLETED|Overall Study||3
8858155|NCT01796470|9913782|FG000|STARTED|Overall Study||35
8858156|NCT01796470|9913783|FG001|STARTED|Overall Study||14
8858157|NCT01796470|9913784|FG002|STARTED|Overall Study||6
8858158|NCT01796470|9913785|FG003|STARTED|Overall Study||3
8858159|NCT01796470|9913786|FG004|STARTED|Overall Study||8
8858160|NCT01796470|9913782|FG000|Entospletinib Monotherapy|Overall Study||4
8858161|NCT01796470|9913783|FG001|Entospletinib Monotherapy|Overall Study||4
8858162|NCT01796470|9913784|FG002|Entospletinib Monotherapy|Overall Study||0
8858163|NCT01796470|9913785|FG003|Entospletinib Monotherapy|Overall Study||0
8858164|NCT01796470|9913786|FG004|Entospletinib Monotherapy|Overall Study||0
8858165|NCT01796470|9913782|FG000|COMPLETED|Overall Study||0
8858166|NCT01796470|9913783|FG001|COMPLETED|Overall Study||0
8858167|NCT01796470|9913784|FG002|COMPLETED|Overall Study||0
8858168|NCT01796470|9913785|FG003|COMPLETED|Overall Study||0
8858169|NCT01796470|9913786|FG004|COMPLETED|Overall Study||0
8858170|NCT01796470|9913782|FG000|NOT COMPLETED|Overall Study||35
8858171|NCT01796470|9913783|FG001|NOT COMPLETED|Overall Study||14
8858172|NCT01796470|9913784|FG002|NOT COMPLETED|Overall Study||6
8858173|NCT01796470|9913785|FG003|NOT COMPLETED|Overall Study||3
8858174|NCT01796470|9913786|FG004|NOT COMPLETED|Overall Study||8
8858175|NCT01796548|9913802|FG000|STARTED|Overall Study||17
8858176|NCT01796548|9913802|FG000|Treated|Overall Study||15
8858177|NCT01796548|9913802|FG000|COMPLETED|Overall Study||14
8858178|NCT01796548|9913802|FG000|NOT COMPLETED|Overall Study||3
8858179|NCT01796665|9913809|FG000|STARTED|Overall Study||474
8858180|NCT01796665|9913810|FG001|STARTED|Overall Study||469
8858181|NCT01796665|9913811|FG002|STARTED|Overall Study||237
8858182|NCT01796665|9913809|FG000|COMPLETED|Overall Study||416
8858183|NCT01796665|9913810|FG001|COMPLETED|Overall Study||396
8858184|NCT01796665|9913811|FG002|COMPLETED|Overall Study||195
8858185|NCT01796665|9913809|FG000|NOT COMPLETED|Overall Study||58
8858186|NCT01796665|9913810|FG001|NOT COMPLETED|Overall Study||73
8858187|NCT01796665|9913811|FG002|NOT COMPLETED|Overall Study||42
8858188|NCT01796860|9913819|FG000|STARTED|Overall Study||10
8858189|NCT01796860|9913819|FG000|COMPLETED|Overall Study||7
8858190|NCT01796860|9913819|FG000|NOT COMPLETED|Overall Study||3
8858191|NCT01796912|9913823|FG000|STARTED|First Intervention||10
8949565|NCT02440204|10012183|FG000|COMPLETED|Overall Study||22
8949566|NCT02440204|10012184|FG001|COMPLETED|Overall Study||24
8949567|NCT02440204|10012185|FG002|COMPLETED|Overall Study||22
8949568|NCT02440204|10012183|FG000|NOT COMPLETED|Overall Study||0
8949569|NCT02440204|10012184|FG001|NOT COMPLETED|Overall Study||0
8949570|NCT02440204|10012185|FG002|NOT COMPLETED|Overall Study||0
8949571|NCT02440308|10012193|FG000|STARTED|Overall Study||10
8949572|NCT02440308|10012193|FG000|COMPLETED|Overall Study||10
8949573|NCT02440308|10012193|FG000|NOT COMPLETED|Overall Study||0
8949574|NCT02440334|10012197|FG000|STARTED|Overall Study||53
8949575|NCT02440334|10012197|FG000|COMPLETED|Overall Study||53
8949576|NCT02440334|10012197|FG000|NOT COMPLETED|Overall Study||0
8949577|NCT02440451|10012201|FG000|STARTED|Overall Study||15
8949578|NCT02440451|10012201|FG000|COMPLETED|Overall Study||15
8949579|NCT02440451|10012201|FG000|NOT COMPLETED|Overall Study||0
8949580|NCT02440568|10012209|FG000|STARTED|Overall Study||5
8949581|NCT02440568|10012210|FG001|STARTED|Overall Study||4
8949582|NCT02440568|10012211|FG002|STARTED|Overall Study||10
8949583|NCT02440568|10012212|FG003|STARTED|Overall Study||3
8949584|NCT02440568|10012209|FG000|COMPLETED|Overall Study||1
8949585|NCT02440568|10012210|FG001|COMPLETED|Overall Study||1
8949586|NCT02440568|10012211|FG002|COMPLETED|Overall Study||5
8949587|NCT02440568|10012212|FG003|COMPLETED|Overall Study||1
8949588|NCT02440568|10012209|FG000|NOT COMPLETED|Overall Study||4
8949589|NCT02440568|10012210|FG001|NOT COMPLETED|Overall Study||3
8949590|NCT02440568|10012211|FG002|NOT COMPLETED|Overall Study||5
8949591|NCT02440568|10012212|FG003|NOT COMPLETED|Overall Study||2
8949592|NCT02440594|10012231|FG000|STARTED|Overall Study||509
8949593|NCT02440594|10012232|FG001|STARTED|Overall Study||509
8949594|NCT02440594|10012233|FG002|STARTED|Overall Study||436
8858192|NCT01796912|9913824|FG001|STARTED|First Intervention||10
8858193|NCT01796912|9913823|FG000|COMPLETED|First Intervention||10
8858194|NCT01796912|9913824|FG001|COMPLETED|First Intervention||10
8858195|NCT01796912|9913823|FG000|NOT COMPLETED|First Intervention||0
8858196|NCT01796912|9913824|FG001|NOT COMPLETED|First Intervention||0
8858197|NCT01796912|9913823|FG000|STARTED|Washout||10
8858198|NCT01796912|9913824|FG001|STARTED|Washout||10
8858199|NCT01796912|9913823|FG000|COMPLETED|Washout||10
8858200|NCT01796912|9913824|FG001|COMPLETED|Washout||10
8858201|NCT01796912|9913823|FG000|NOT COMPLETED|Washout||0
8949595|NCT02440594|10012234|FG003|STARTED|Overall Study||429
8949596|NCT02440594|10012235|FG004|STARTED|Overall Study||55
8949597|NCT02440594|10012236|FG005|STARTED|Overall Study||54
8949598|NCT02440594|10012237|FG006|STARTED|Overall Study||150
8949599|NCT02440594|10012238|FG007|STARTED|Overall Study||290
8949600|NCT02440594|10012231|FG000|COMPLETED|Overall Study||377
8949601|NCT02440594|10012232|FG001|COMPLETED|Overall Study||401
8949602|NCT02440594|10012233|FG002|COMPLETED|Overall Study||319
8949603|NCT02440594|10012234|FG003|COMPLETED|Overall Study||340
8949604|NCT02440594|10012235|FG004|COMPLETED|Overall Study||46
8949605|NCT02440594|10012236|FG005|COMPLETED|Overall Study||47
8949606|NCT02440594|10012237|FG006|COMPLETED|Overall Study||113
8949607|NCT02440594|10012238|FG007|COMPLETED|Overall Study||234
8858202|NCT01796912|9913824|FG001|NOT COMPLETED|Washout||0
8858203|NCT01796912|9913823|FG000|STARTED|Second Intervention||10
8858204|NCT01796912|9913824|FG001|STARTED|Second Intervention||10
8858205|NCT01796912|9913823|FG000|COMPLETED|Second Intervention||10
8858206|NCT01796912|9913824|FG001|COMPLETED|Second Intervention||10
8858207|NCT01796912|9913823|FG000|NOT COMPLETED|Second Intervention||0
8858208|NCT01796912|9913824|FG001|NOT COMPLETED|Second Intervention||0
8858209|NCT01796964|9913834|FG000|STARTED|Overall Study||44
8858210|NCT01796964|9913835|FG001|STARTED|Overall Study||45
8858211|NCT01796964|9913834|FG000|COMPLETED|Overall Study||41
8858212|NCT01796964|9913835|FG001|COMPLETED|Overall Study||42
8858213|NCT01796964|9913834|FG000|NOT COMPLETED|Overall Study||3
8858214|NCT01796964|9913835|FG001|NOT COMPLETED|Overall Study||3
8858215|NCT01796977|9913842|FG000|STARTED|Overall Study||27
8858216|NCT01796977|9913842|FG000|COMPLETED|Overall Study||27
8858217|NCT01796977|9913842|FG000|NOT COMPLETED|Overall Study||0
8858218|NCT01797029|9913853|FG000|STARTED|Overall Study||1174
8858219|NCT01797029|9913854|FG001|STARTED|Overall Study||587
8858220|NCT01797029|9913853|FG000|COMPLETED|Overall Study||1015
8858221|NCT01797029|9913854|FG001|COMPLETED|Overall Study||526
8858222|NCT01797029|9913853|FG000|NOT COMPLETED|Overall Study||159
8858223|NCT01797029|9913854|FG001|NOT COMPLETED|Overall Study||61
8858224|NCT01797081|9913864|FG000|STARTED|Overall Study||104
8858225|NCT01797081|9913865|FG001|STARTED|Overall Study||99
8858226|NCT01797081|9913866|FG002|STARTED|Overall Study||48
8858227|NCT01797081|9913867|FG003|STARTED|Overall Study||49
8858228|NCT01797081|9913864|FG000|COMPLETED|Overall Study||90
8858229|NCT01797081|9913865|FG001|COMPLETED|Overall Study||95
8858230|NCT01797081|9913866|FG002|COMPLETED|Overall Study||43
8858231|NCT01797081|9913867|FG003|COMPLETED|Overall Study||40
8858232|NCT01797081|9913864|FG000|NOT COMPLETED|Overall Study||14
8858233|NCT01797081|9913865|FG001|NOT COMPLETED|Overall Study||4
8858234|NCT01797081|9913866|FG002|NOT COMPLETED|Overall Study||5
8858235|NCT01797081|9913867|FG003|NOT COMPLETED|Overall Study||9
8858236|NCT01797094|9913877|FG000|STARTED|Overall Study||48
8858237|NCT01797094|9913878|FG001|STARTED|Overall Study||53
8858238|NCT01797094|9913877|FG000|COMPLETED|Overall Study||42
8858239|NCT01797094|9913878|FG001|COMPLETED|Overall Study||51
8858240|NCT01797094|9913877|FG000|NOT COMPLETED|Overall Study||6
8858241|NCT01797094|9913878|FG001|NOT COMPLETED|Overall Study||2
8858242|NCT01797120|9913886|FG000|STARTED|Overall Study||66
8858243|NCT01797120|9913887|FG001|STARTED|Overall Study||65
8858244|NCT01797120|9913886|FG000|COMPLETED|Overall Study||0
8858245|NCT01797120|9913887|FG001|COMPLETED|Overall Study||0
8858246|NCT01797120|9913886|FG000|NOT COMPLETED|Overall Study||66
8858247|NCT01797120|9913887|FG001|NOT COMPLETED|Overall Study||65
8858248|NCT01797159|9913893|FG000|STARTED|Overall Study||20
8858249|NCT01797159|9913893|FG000|COMPLETED|Overall Study||20
8858250|NCT01797159|9913893|FG000|NOT COMPLETED|Overall Study||0
8858251|NCT01797185|9913901|FG000|STARTED|Overall Study||162
8858252|NCT01797185|9913902|FG001|STARTED|Overall Study||163
8858253|NCT01797185|9913903|FG002|STARTED|Overall Study||50
8858254|NCT01797185|9913901|FG000|COMPLETED|Overall Study||134
8858255|NCT01797185|9913902|FG001|COMPLETED|Overall Study||125
8858256|NCT01797185|9913903|FG002|COMPLETED|Overall Study||38
8858257|NCT01797185|9913901|FG000|NOT COMPLETED|Overall Study||28
8858258|NCT01797185|9913902|FG001|NOT COMPLETED|Overall Study||38
8858259|NCT01797185|9913903|FG002|NOT COMPLETED|Overall Study||12
8858260|NCT01797263|9913913|FG000|STARTED|Overall Study||129
8858261|NCT01797263|9913914|FG001|STARTED|Overall Study||127
8858262|NCT01797263|9913913|FG000|1 Month|Overall Study||96
8858263|NCT01797263|9913914|FG001|1 Month|Overall Study||87
8858264|NCT01797263|9913913|FG000|3 Month|Overall Study||87
8858265|NCT01797263|9913914|FG001|3 Month|Overall Study||84
8858266|NCT01797263|9913913|FG000|6 Month|Overall Study||90
8858267|NCT01797263|9913914|FG001|6 Month|Overall Study||85
8858268|NCT01797263|9913913|FG000|9 Month|Overall Study||92
8858269|NCT01797263|9913914|FG001|9 Month|Overall Study||87
8858270|NCT01797263|9913913|FG000|COMPLETED|Overall Study||92
8858271|NCT01797263|9913914|FG001|COMPLETED|Overall Study||87
8858272|NCT01797263|9913913|FG000|NOT COMPLETED|Overall Study||37
8858273|NCT01797263|9913914|FG001|NOT COMPLETED|Overall Study||40
8858274|NCT01797302|9913923|FG000|STARTED|Overall Study||75
8858275|NCT01797302|9913924|FG001|STARTED|Overall Study||74
8858276|NCT01797302|9913925|FG002|STARTED|Overall Study||76
8858277|NCT01797302|9913923|FG000|3 Month Visit|Overall Study||60
8858278|NCT01797302|9913924|FG001|3 Month Visit|Overall Study||57
8858279|NCT01797302|9913925|FG002|3 Month Visit|Overall Study||57
8858280|NCT01797302|9913923|FG000|COMPLETED|Overall Study||58
8858281|NCT01797302|9913924|FG001|COMPLETED|Overall Study||48
8858282|NCT01797302|9913925|FG002|COMPLETED|Overall Study||50
8858283|NCT01797302|9913923|FG000|NOT COMPLETED|Overall Study||17
8858284|NCT01797302|9913924|FG001|NOT COMPLETED|Overall Study||26
8858285|NCT01797302|9913925|FG002|NOT COMPLETED|Overall Study||26
8858286|NCT01797328|9913935|FG000|STARTED|Overall Study||16
8858287|NCT01797328|9913936|FG001|STARTED|Overall Study||12
8858288|NCT01797328|9913935|FG000|COMPLETED|Overall Study||14
8858289|NCT01797328|9913936|FG001|COMPLETED|Overall Study||12
8858290|NCT01797328|9913935|FG000|NOT COMPLETED|Overall Study||2
8858291|NCT01797328|9913936|FG001|NOT COMPLETED|Overall Study||0
8858292|NCT01797432|9913942|FG000|STARTED|Overall Study||14
8858293|NCT01797432|9913942|FG000|COMPLETED|Overall Study||10
8858294|NCT01797432|9913942|FG000|NOT COMPLETED|Overall Study||4
8858295|NCT01797445|9913948|FG000|STARTED|Double-Blind Phase||435
8858296|NCT01797445|9913949|FG001|STARTED|Double-Blind Phase||437
8858297|NCT01797445|9913948|FG000|COMPLETED|Double-Blind Phase||348
8858298|NCT01797445|9913949|FG001|COMPLETED|Double-Blind Phase||348
8858299|NCT01797445|9913948|FG000|NOT COMPLETED|Double-Blind Phase||87
8858300|NCT01797445|9913949|FG001|NOT COMPLETED|Double-Blind Phase||89
8858301|NCT01797445|9913948|FG000|STARTED|Open-Label Extension Phase|207 participants completed the Double-Blind Phase, but did not enter the Open-Label Extension Phase.|141
8858302|NCT01797445|9913949|FG001|STARTED|Open-Label Extension Phase|229 participants completed the Double-Blind Phase, but did not enter the Open-Label Extension Phase.|119
8858303|NCT01797445|9913948|FG000|COMPLETED|Open-Label Extension Phase||140
8858304|NCT01797445|9913949|FG001|COMPLETED|Open-Label Extension Phase||119
8858305|NCT01797445|9913948|FG000|NOT COMPLETED|Open-Label Extension Phase||1
8858306|NCT01797445|9913949|FG001|NOT COMPLETED|Open-Label Extension Phase||0
8858307|NCT01797458|9913960|FG000|STARTED|Overall Study||52
8858308|NCT01797458|9913961|FG001|STARTED|Overall Study||52
8858309|NCT01797458|9913962|FG002|STARTED|Overall Study||65
8858310|NCT01797458|9913960|FG000|COMPLETED|Overall Study||40
8858311|NCT01797458|9913961|FG001|COMPLETED|Overall Study||43
8858312|NCT01797458|9913962|FG002|COMPLETED|Overall Study||58
8858313|NCT01797458|9913960|FG000|NOT COMPLETED|Overall Study||12
8858314|NCT01797458|9913961|FG001|NOT COMPLETED|Overall Study||9
8858315|NCT01797458|9913962|FG002|NOT COMPLETED|Overall Study||7
8858316|NCT01797471|9913979|FG000|STARTED|Overall Study||1
8858317|NCT01797471|9913979|FG000|COMPLETED|Overall Study||1
8858318|NCT01797471|9913979|FG000|NOT COMPLETED|Overall Study||0
8858319|NCT01797484|9913985|FG000|STARTED|Overall Study||10
8858320|NCT01797484|9913986|FG001|STARTED|Overall Study||10
8858321|NCT01797484|9913985|FG000|COMPLETED|Overall Study||10
8858322|NCT01797484|9913986|FG001|COMPLETED|Overall Study||10
8858323|NCT01797484|9913985|FG000|NOT COMPLETED|Overall Study||0
8858324|NCT01797484|9913986|FG001|NOT COMPLETED|Overall Study||0
8858325|NCT01797536|9913996|FG000|STARTED|Overall Study||8
8858326|NCT01797536|9913997|FG001|STARTED|Overall Study|Includes 3 participants from mild arm who were mistakenly re-enrolled and also dosed in moderate arm|11
8858327|NCT01797536|9913998|FG002|STARTED|Overall Study||7
8858328|NCT01797536|9913999|FG003|STARTED|Overall Study||8
8858329|NCT01797536|9913996|FG000|COMPLETED|Overall Study||8
8858330|NCT01797536|9913997|FG001|COMPLETED|Overall Study||10
8858331|NCT01797536|9913998|FG002|COMPLETED|Overall Study||7
8858332|NCT01797536|9913999|FG003|COMPLETED|Overall Study||8
8858333|NCT01797536|9913996|FG000|NOT COMPLETED|Overall Study||0
8858334|NCT01797536|9913997|FG001|NOT COMPLETED|Overall Study||1
8858335|NCT01797536|9913998|FG002|NOT COMPLETED|Overall Study||0
8858336|NCT01797536|9913999|FG003|NOT COMPLETED|Overall Study||0
8858337|NCT01797562|9914009|FG000|STARTED|Overall Study||116
8858338|NCT01797562|9914009|FG000|COMPLETED|Overall Study||111
8858339|NCT01797562|9914009|FG000|NOT COMPLETED|Overall Study||5
8858340|NCT01797575|9914018|FG000|STARTED|Baseline Allocation||5
8858341|NCT01797575|9914019|FG001|STARTED|Baseline Allocation||9
8858342|NCT01797575|9914020|FG002|STARTED|Baseline Allocation||9
8858343|NCT01797575|9914021|FG003|STARTED|Baseline Allocation||15
8858344|NCT01797575|9914018|FG000|COMPLETED|Baseline Allocation||4
8858345|NCT01797575|9914019|FG001|COMPLETED|Baseline Allocation||8
8858346|NCT01797575|9914020|FG002|COMPLETED|Baseline Allocation||4
8858347|NCT01797575|9914021|FG003|COMPLETED|Baseline Allocation||8
8858348|NCT01797575|9914018|FG000|NOT COMPLETED|Baseline Allocation||1
8858349|NCT01797575|9914019|FG001|NOT COMPLETED|Baseline Allocation||1
8858350|NCT01797575|9914020|FG002|NOT COMPLETED|Baseline Allocation||5
8858351|NCT01797575|9914021|FG003|NOT COMPLETED|Baseline Allocation||7
8858352|NCT01797575|9914018|FG000|STARTED|Week 8 Re-Randomization|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|4
8858353|NCT01797575|9914019|FG001|STARTED|Week 8 Re-Randomization|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|5
8858354|NCT01797575|9914020|FG002|STARTED|Week 8 Re-Randomization|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|5
8858355|NCT01797575|9914021|FG003|STARTED|Week 8 Re-Randomization|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|10
8858356|NCT01797575|9914018|FG000|COMPLETED|Week 8 Re-Randomization||4
8858357|NCT01797575|9914019|FG001|COMPLETED|Week 8 Re-Randomization||5
8858358|NCT01797575|9914020|FG002|COMPLETED|Week 8 Re-Randomization||4
8858359|NCT01797575|9914021|FG003|COMPLETED|Week 8 Re-Randomization||7
8858360|NCT01797575|9914018|FG000|NOT COMPLETED|Week 8 Re-Randomization||0
8858361|NCT01797575|9914019|FG001|NOT COMPLETED|Week 8 Re-Randomization||0
8858362|NCT01797575|9914020|FG002|NOT COMPLETED|Week 8 Re-Randomization||1
8858363|NCT01797575|9914021|FG003|NOT COMPLETED|Week 8 Re-Randomization||3
8569645|NCT00098293|9601849|FG002|NOT COMPLETED|Supplemental Phase (SP)||0
8569646|NCT00098293|9601850|FG003|NOT COMPLETED|Supplemental Phase (SP)||0
8569647|NCT00098293|9601851|FG004|NOT COMPLETED|Supplemental Phase (SP)||33
8569648|NCT00098306|9601865|FG000|STARTED|Double Blind||241
8569649|NCT00098306|9601866|FG001|STARTED|Double Blind||240
8858364|NCT01797705|9914035|FG000|STARTED|Overall Study||33
8858365|NCT01797705|9914035|FG000|COMPLETED|Overall Study||28
8858366|NCT01797705|9914035|FG000|NOT COMPLETED|Overall Study||5
8858367|NCT01797731|9914041|FG000|STARTED|Overall Study||50
8858368|NCT01797731|9914042|FG001|STARTED|Overall Study||50
8858369|NCT01797731|9914041|FG000|COMPLETED|Overall Study|3 were excluded due to not having proper radiographs for adequate follow up|47
8858370|NCT01797731|9914042|FG001|COMPLETED|Overall Study|3 excluded due to not having proper radiographs for adequate follow up|47
8858371|NCT01797731|9914041|FG000|NOT COMPLETED|Overall Study||3
8858372|NCT01797731|9914042|FG001|NOT COMPLETED|Overall Study||3
8858373|NCT01797783|9914050|FG000|STARTED|Overall Study||52
8858374|NCT01797783|9914051|FG001|STARTED|Overall Study||27
8858375|NCT01797783|9914050|FG000|COMPLETED|Overall Study||50
8858376|NCT01797783|9914051|FG001|COMPLETED|Overall Study||26
8858377|NCT01797783|9914050|FG000|NOT COMPLETED|Overall Study||2
8858378|NCT01797783|9914051|FG001|NOT COMPLETED|Overall Study||1
8858379|NCT01797822|9914065|FG000|STARTED|Overall Study||20
8858380|NCT01797822|9914065|FG000|COMPLETED|Overall Study|The protocol is now closed.|20
8858381|NCT01797822|9914065|FG000|NOT COMPLETED|Overall Study||0
8858382|NCT01797835|9914073|FG000|STARTED|Overall Study||153
8858383|NCT01797835|9914074|FG001|STARTED|Overall Study||141
8858384|NCT01797835|9914073|FG000|COMPLETED|Overall Study||122
8858385|NCT01797835|9914074|FG001|COMPLETED|Overall Study||114
8858386|NCT01797835|9914073|FG000|NOT COMPLETED|Overall Study||31
8858387|NCT01797835|9914074|FG001|NOT COMPLETED|Overall Study||27
8858388|NCT01797965|9914084|FG000|STARTED|Overall Study||597
8858389|NCT01797965|9914085|FG001|STARTED|Overall Study||607
8858390|NCT01797965|9914086|FG002|STARTED|Overall Study||70
8858391|NCT01797965|9914087|FG003|STARTED|Overall Study||227
8858392|NCT01797965|9914084|FG000|COMPLETED|Overall Study||48
8858393|NCT01797965|9914085|FG001|COMPLETED|Overall Study||38
8858394|NCT01797965|9914086|FG002|COMPLETED|Overall Study||62
8858395|NCT01797965|9914087|FG003|COMPLETED|Overall Study||154
8858396|NCT01797965|9914084|FG000|NOT COMPLETED|Overall Study||549
8858397|NCT01797965|9914085|FG001|NOT COMPLETED|Overall Study||569
8858398|NCT01797965|9914086|FG002|NOT COMPLETED|Overall Study||8
8858399|NCT01797965|9914087|FG003|NOT COMPLETED|Overall Study||73
8858400|NCT01798056|9914100|FG000|STARTED|Overall Study||117
8858401|NCT01798056|9914101|FG001|STARTED|Overall Study||115
8858402|NCT01798056|9914100|FG000|COMPLETED|Overall Study||90
8858403|NCT01798056|9914101|FG001|COMPLETED|Overall Study||90
8858404|NCT01798056|9914100|FG000|NOT COMPLETED|Overall Study||27
8858405|NCT01798056|9914101|FG001|NOT COMPLETED|Overall Study||25
8858406|NCT01798134|9914109|FG000|STARTED|Overall Study||25
8858407|NCT01798134|9914109|FG000|COMPLETED|Overall Study||9
8858408|NCT01798134|9914109|FG000|NOT COMPLETED|Overall Study||16
8858409|NCT01798186|9914117|FG000|STARTED|Overall Study||6
8858410|NCT01798186|9914118|FG001|STARTED|Overall Study||6
8858411|NCT01798186|9914119|FG002|STARTED|Overall Study||6
8858412|NCT01798186|9914120|FG003|STARTED|Overall Study||8
8858413|NCT01798186|9914117|FG000|COMPLETED|Overall Study||6
8858414|NCT01798186|9914118|FG001|COMPLETED|Overall Study||6
8858415|NCT01798186|9914119|FG002|COMPLETED|Overall Study||6
8858416|NCT01798186|9914120|FG003|COMPLETED|Overall Study||8
8858417|NCT01798186|9914117|FG000|NOT COMPLETED|Overall Study||0
8858418|NCT01798186|9914118|FG001|NOT COMPLETED|Overall Study||0
8858419|NCT01798186|9914119|FG002|NOT COMPLETED|Overall Study||0
8858420|NCT01798186|9914120|FG003|NOT COMPLETED|Overall Study||0
8858421|NCT01798225|9914135|FG000|STARTED|Overall Study||57
8858422|NCT01798225|9914136|FG001|STARTED|Overall Study||56
8858423|NCT01798225|9914135|FG000|COMPLETED|Overall Study||57
8858424|NCT01798225|9914136|FG001|COMPLETED|Overall Study||53
8858425|NCT01798225|9914135|FG000|NOT COMPLETED|Overall Study||0
8858426|NCT01798225|9914136|FG001|NOT COMPLETED|Overall Study||3
8858427|NCT01798264|9914146|FG000|STARTED|Overall Study||12
8858428|NCT01798264|9914147|FG001|STARTED|Overall Study||11
8858429|NCT01798264|9914148|FG002|STARTED|Overall Study||10
8858430|NCT01798264|9914149|FG003|STARTED|Overall Study||11
8858431|NCT01798264|9914146|FG000|COMPLETED|Overall Study||11
8858432|NCT01798264|9914147|FG001|COMPLETED|Overall Study||11
8858433|NCT01798264|9914148|FG002|COMPLETED|Overall Study||10
8858434|NCT01798264|9914149|FG003|COMPLETED|Overall Study||7
8858435|NCT01798264|9914146|FG000|NOT COMPLETED|Overall Study||1
8858436|NCT01798264|9914147|FG001|NOT COMPLETED|Overall Study||0
8858437|NCT01798264|9914148|FG002|NOT COMPLETED|Overall Study||0
8858438|NCT01798264|9914149|FG003|NOT COMPLETED|Overall Study||4
8858439|NCT01798316|9914161|FG000|STARTED|Overall Study||52
8858440|NCT01798316|9914162|FG001|STARTED|Overall Study||53
8858441|NCT01798316|9914161|FG000|COMPLETED|Overall Study||52
8858442|NCT01798316|9914162|FG001|COMPLETED|Overall Study||53
8858443|NCT01798316|9914161|FG000|NOT COMPLETED|Overall Study||0
8858444|NCT01798316|9914162|FG001|NOT COMPLETED|Overall Study||0
8858445|NCT01798394|9914172|FG000|STARTED|Overall Study||24
8858446|NCT01798394|9914173|FG001|STARTED|Overall Study||22
8858447|NCT01798394|9914172|FG000|COMPLETED|Overall Study||21
8858448|NCT01798394|9914173|FG001|COMPLETED|Overall Study||19
8858449|NCT01798394|9914172|FG000|NOT COMPLETED|Overall Study||3
8858450|NCT01798394|9914173|FG001|NOT COMPLETED|Overall Study||3
8858451|NCT01798485|9914181|FG000|STARTED|Overall Study||347
8858452|NCT01798485|9914182|FG001|STARTED|Overall Study||349
8858453|NCT01798485|9914181|FG000|Safety Population as of 23 Dec 2015|Overall Study||338
8858454|NCT01798485|9914182|FG001|Safety Population as of 23 Dec 2015|Overall Study||342
8858455|NCT01798485|9914181|FG000|Randomized as of 19 October 2015|Overall Study||335
8858456|NCT01798485|9914182|FG001|Randomized as of 19 October 2015|Overall Study||337
8858457|NCT01798485|9914181|FG000|COMPLETED|Overall Study||1
8858458|NCT01798485|9914182|FG001|COMPLETED|Overall Study||59
8858459|NCT01798485|9914181|FG000|NOT COMPLETED|Overall Study||346
8858460|NCT01798485|9914182|FG001|NOT COMPLETED|Overall Study||290
8858461|NCT01798550|9914190|FG000|STARTED|Overall Study||30
8858462|NCT01798550|9914191|FG001|STARTED|Overall Study||32
8858463|NCT01798550|9914190|FG000|COMPLETED|Overall Study||28
8858464|NCT01798550|9914191|FG001|COMPLETED|Overall Study||26
8858465|NCT01798550|9914190|FG000|NOT COMPLETED|Overall Study||2
8858466|NCT01798550|9914191|FG001|NOT COMPLETED|Overall Study||6
8858467|NCT01798589|9914197|FG000|STARTED|Overall Study||16
8858468|NCT01798589|9914197|FG000|COMPLETED|Overall Study||16
8858469|NCT01798589|9914197|FG000|NOT COMPLETED|Overall Study||0
8858470|NCT01798641|9914207|FG000|STARTED|First Intervention (6 Weeks)||19
8858471|NCT01798641|9914208|FG001|STARTED|First Intervention (6 Weeks)||19
8858472|NCT01798641|9914207|FG000|COMPLETED|First Intervention (6 Weeks)||19
8858473|NCT01798641|9914208|FG001|COMPLETED|First Intervention (6 Weeks)||19
8858474|NCT01798641|9914207|FG000|NOT COMPLETED|First Intervention (6 Weeks)||0
8858475|NCT01798641|9914208|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0
8858476|NCT01798641|9914207|FG000|STARTED|Second Intervention (6 Weeks)||19
8858477|NCT01798641|9914208|FG001|STARTED|Second Intervention (6 Weeks)||19
8858478|NCT01798641|9914207|FG000|COMPLETED|Second Intervention (6 Weeks)||19
8858479|NCT01798641|9914208|FG001|COMPLETED|Second Intervention (6 Weeks)||19
8858480|NCT01798641|9914207|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
8858481|NCT01798641|9914208|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0
8858482|NCT01798706|9914217|FG000|STARTED|Overall Study||176
8858483|NCT01798706|9914218|FG001|STARTED|Overall Study||174
8630011|NCT00533429|9669794|FG001|Entered Maintenance|Overall Study||10
8630012|NCT00533429|9669793|FG000|COMPLETED|Overall Study||1
8630013|NCT00533429|9669794|FG001|COMPLETED|Overall Study||4
8630014|NCT00533429|9669793|FG000|NOT COMPLETED|Overall Study||19
8630015|NCT00533429|9669794|FG001|NOT COMPLETED|Overall Study||16
8858484|NCT01798706|9914217|FG000|COMPLETED|Overall Study||155
8858485|NCT01798706|9914218|FG001|COMPLETED|Overall Study||153
8858486|NCT01798706|9914217|FG000|NOT COMPLETED|Overall Study||21
8858487|NCT01798706|9914218|FG001|NOT COMPLETED|Overall Study||21
8858488|NCT01798849|9914227|FG000|STARTED|Overall Study||8
8858489|NCT01798849|9914228|FG001|STARTED|Overall Study||8
8858490|NCT01798849|9914229|FG002|STARTED|Overall Study|1 participant discontinued after Period 1 and was replaced for Periods 2-4|9
8858491|NCT01798849|9914227|FG000|COMPLETED|Overall Study||8
8858492|NCT01798849|9914228|FG001|COMPLETED|Overall Study||8
8858493|NCT01798849|9914229|FG002|COMPLETED|Overall Study||8
8858494|NCT01798849|9914227|FG000|NOT COMPLETED|Overall Study||0
8858495|NCT01798849|9914228|FG001|NOT COMPLETED|Overall Study||0
8858496|NCT01798849|9914229|FG002|NOT COMPLETED|Overall Study||1
8858497|NCT01798927|9914266|FG000|STARTED|Overall Study||4
8858498|NCT01798927|9914266|FG000|COMPLETED|Overall Study||3
8858499|NCT01798927|9914266|FG000|NOT COMPLETED|Overall Study||1
8858500|NCT01798966|9914270|FG000|STARTED|Overall Study||10
8858501|NCT01798966|9914270|FG000|COMPLETED|Overall Study||10
8858502|NCT01798966|9914270|FG000|NOT COMPLETED|Overall Study||0
8858503|NCT01798992|9914279|FG000|STARTED|Overall Study||4
8858504|NCT01798992|9914280|FG001|STARTED|Overall Study||19
8858505|NCT01798992|9914281|FG002|STARTED|Overall Study||16
8858506|NCT01798992|9914282|FG003|STARTED|Overall Study||17
8858507|NCT01798992|9914279|FG000|COMPLETED|Overall Study||4
8858508|NCT01798992|9914280|FG001|COMPLETED|Overall Study||17
8858509|NCT01798992|9914281|FG002|COMPLETED|Overall Study||14
8858510|NCT01798992|9914282|FG003|COMPLETED|Overall Study||16
8858511|NCT01798992|9914279|FG000|NOT COMPLETED|Overall Study||0
8858512|NCT01798992|9914280|FG001|NOT COMPLETED|Overall Study||2
8858513|NCT01798992|9914281|FG002|NOT COMPLETED|Overall Study||2
8858514|NCT01798992|9914282|FG003|NOT COMPLETED|Overall Study||1
8858515|NCT01799135|9914291|FG000|STARTED|Overall Study||6
8858516|NCT01799135|9914291|FG000|COMPLETED|Overall Study||6
8858517|NCT01799135|9914291|FG000|NOT COMPLETED|Overall Study||0
8858518|NCT01799213|9914297|FG000|STARTED|Overall Study||180
8858519|NCT01799213|9914298|FG001|STARTED|Overall Study||184
8858520|NCT01799213|9914297|FG000|COMPLETED|Overall Study||173
8858521|NCT01799213|9914298|FG001|COMPLETED|Overall Study||178
8858522|NCT01799213|9914297|FG000|NOT COMPLETED|Overall Study||7
8630016|NCT00533442|9669804|FG000|STARTED|Allocation and Intent to Treat Analysis||86
8630017|NCT00533442|9669805|FG001|STARTED|Allocation and Intent to Treat Analysis||84
8630018|NCT00533442|9669804|FG000|COMPLETED|Allocation and Intent to Treat Analysis||86
8858523|NCT01799213|9914298|FG001|NOT COMPLETED|Overall Study||6
8858524|NCT01799226|9914312|FG000|STARTED|Overall Study||16
8858525|NCT01799226|9914313|FG001|STARTED|Overall Study||16
8858526|NCT01799226|9914312|FG000|Right Stent Side|Overall Study||8
8858527|NCT01799226|9914313|FG001|Right Stent Side|Overall Study||8
8630019|NCT00533442|9669805|FG001|COMPLETED|Allocation and Intent to Treat Analysis||84
8858528|NCT01799226|9914312|FG000|Left Stent Side|Overall Study||8
8858529|NCT01799226|9914313|FG001|Left Stent Side|Overall Study||8
8858530|NCT01799226|9914312|FG000|COMPLETED|Overall Study||14
8858531|NCT01799226|9914313|FG001|COMPLETED|Overall Study||16
8858532|NCT01799226|9914312|FG000|NOT COMPLETED|Overall Study||2
8858533|NCT01799226|9914313|FG001|NOT COMPLETED|Overall Study||0
8923529|NCT02240693|9984124|FG003|NOT COMPLETED|Overall Study||1
8923530|NCT02240693|9984125|FG004|NOT COMPLETED|Overall Study||1
8858534|NCT01799239|9914319|FG000|STARTED|Period 1 (7 Days)|It was uncertain in which order the product were tested for 1 subject. Subject is excl from analysis|15
8858535|NCT01799239|9914320|FG001|STARTED|Period 1 (7 Days)|It was uncertain in which order the product were tested for 1 subject. Subject is excl from analysis|16
8858536|NCT01799239|9914319|FG000|COMPLETED|Period 1 (7 Days)||12
8858537|NCT01799239|9914320|FG001|COMPLETED|Period 1 (7 Days)||15
8858538|NCT01799239|9914319|FG000|NOT COMPLETED|Period 1 (7 Days)||3
8858539|NCT01799239|9914320|FG001|NOT COMPLETED|Period 1 (7 Days)||1
8858540|NCT01799239|9914319|FG000|STARTED|Period 2 (7 Days)||13
8858541|NCT01799239|9914320|FG001|STARTED|Period 2 (7 Days)||15
8858542|NCT01799239|9914319|FG000|COMPLETED|Period 2 (7 Days)||11
8858543|NCT01799239|9914320|FG001|COMPLETED|Period 2 (7 Days)||14
8858544|NCT01799239|9914319|FG000|NOT COMPLETED|Period 2 (7 Days)||2
8858545|NCT01799239|9914320|FG001|NOT COMPLETED|Period 2 (7 Days)||1
8858546|NCT01799278|9914326|FG000|STARTED|Overall Study||60
8858547|NCT01799278|9914326|FG000|COMPLETED|Overall Study||60
8858548|NCT01799278|9914326|FG000|NOT COMPLETED|Overall Study||0
8923531|NCT02240706|9984144|FG000|STARTED|Overall Study||3
8923532|NCT02240706|9984145|FG001|STARTED|Overall Study||3
8923533|NCT02240706|9984146|FG002|STARTED|Overall Study||6
8630020|NCT00533442|9669804|FG000|NOT COMPLETED|Allocation and Intent to Treat Analysis||0
8630021|NCT00533442|9669805|FG001|NOT COMPLETED|Allocation and Intent to Treat Analysis||0
8630022|NCT00533442|9669804|FG000|STARTED|Follow-up|Ongoing Follow-up at 13-123 months (N=77); Lost to Follow-up (N=9, at 5-100 months).|86
8630023|NCT00533442|9669805|FG001|STARTED|Follow-up|Ongoing Follow-up at 17-124 months (N=74); Lost to Follow-up (N=10, at 5-67 months).|84
8923534|NCT02240706|9984147|FG003|STARTED|Overall Study||4
8923535|NCT02240706|9984148|FG004|STARTED|Overall Study||11
8923536|NCT02240706|9984149|FG005|STARTED|Overall Study|No patients were enrolled in the Phase II part due to strategic reasons.|0
8923537|NCT02240706|9984150|FG006|STARTED|Overall Study|No patients were enrolled in the Phase II part due to strategic reasons.|0
8923538|NCT02240706|9984144|FG000|COMPLETED|Overall Study||0
8923539|NCT02240706|9984145|FG001|COMPLETED|Overall Study||0
8923540|NCT02240706|9984146|FG002|COMPLETED|Overall Study||0
8858549|NCT01799590|9914337|FG000|STARTED|Overall Study||111
8858550|NCT01799590|9914338|FG001|STARTED|Overall Study||94
8858551|NCT01799590|9914339|FG002|STARTED|Overall Study||91
8858552|NCT01799590|9914337|FG000|COMPLETED|Overall Study||85
8858553|NCT01799590|9914338|FG001|COMPLETED|Overall Study||78
8858554|NCT01799590|9914339|FG002|COMPLETED|Overall Study||77
8858555|NCT01799590|9914337|FG000|NOT COMPLETED|Overall Study||26
8858556|NCT01799590|9914338|FG001|NOT COMPLETED|Overall Study||16
8858557|NCT01799590|9914339|FG002|NOT COMPLETED|Overall Study||14
8858558|NCT01799720|9914350|FG000|STARTED|Overall Study||20
8858559|NCT01799720|9914351|FG001|STARTED|Overall Study||18
8858560|NCT01799720|9914352|FG002|STARTED|Overall Study||19
8858561|NCT01799720|9914350|FG000|Began the Treatment|Overall Study||20
8858562|NCT01799720|9914351|FG001|Began the Treatment|Overall Study||18
8858563|NCT01799720|9914352|FG002|Began the Treatment|Overall Study||19
8858564|NCT01799720|9914350|FG000|Began the Treatment and Finished it|Overall Study||17
8858565|NCT01799720|9914351|FG001|Began the Treatment and Finished it|Overall Study||17
8858566|NCT01799720|9914352|FG002|Began the Treatment and Finished it|Overall Study||18
8858567|NCT01799720|9914350|FG000|COMPLETED|Overall Study||17
8858568|NCT01799720|9914351|FG001|COMPLETED|Overall Study||17
8858569|NCT01799720|9914352|FG002|COMPLETED|Overall Study||18
8858570|NCT01799720|9914350|FG000|NOT COMPLETED|Overall Study||3
8858571|NCT01799720|9914351|FG001|NOT COMPLETED|Overall Study||1
8858572|NCT01799720|9914352|FG002|NOT COMPLETED|Overall Study||1
8858573|NCT01799889|9914372|FG000|STARTED|Overall Study||41
8858574|NCT01799889|9914373|FG001|STARTED|Overall Study||41
8858575|NCT01799889|9914374|FG002|STARTED|Overall Study||44
8858576|NCT01799889|9914375|FG003|STARTED|Overall Study||39
8858577|NCT01799889|9914376|FG004|STARTED|Overall Study||49
8858578|NCT01799889|9914377|FG005|STARTED|Overall Study||20
8858579|NCT01799889|9914378|FG006|STARTED|Overall Study||21
8858580|NCT01799889|9914379|FG007|STARTED|Overall Study||20
8858581|NCT01799889|9914380|FG008|STARTED|Overall Study||33
8858582|NCT01799889|9914381|FG009|STARTED|Overall Study||8
8858583|NCT01799889|9914382|FG010|STARTED|Overall Study||7
8858584|NCT01799889|9914383|FG011|STARTED|Overall Study||3
8858585|NCT01799889|9914372|FG000|COMPLETED|Overall Study||0
8858586|NCT01799889|9914373|FG001|COMPLETED|Overall Study||0
8858587|NCT01799889|9914374|FG002|COMPLETED|Overall Study||0
8858588|NCT01799889|9914375|FG003|COMPLETED|Overall Study||0
8858589|NCT01799889|9914376|FG004|COMPLETED|Overall Study||0
8858590|NCT01799889|9914377|FG005|COMPLETED|Overall Study||0
8858591|NCT01799889|9914378|FG006|COMPLETED|Overall Study||0
8858592|NCT01799889|9914379|FG007|COMPLETED|Overall Study||0
8858593|NCT01799889|9914380|FG008|COMPLETED|Overall Study||0
8858594|NCT01799889|9914381|FG009|COMPLETED|Overall Study||0
8858595|NCT01799889|9914382|FG010|COMPLETED|Overall Study||0
8858596|NCT01799889|9914383|FG011|COMPLETED|Overall Study||0
8858597|NCT01799889|9914372|FG000|NOT COMPLETED|Overall Study||41
8858598|NCT01799889|9914373|FG001|NOT COMPLETED|Overall Study||41
8858599|NCT01799889|9914374|FG002|NOT COMPLETED|Overall Study||44
8858600|NCT01799889|9914375|FG003|NOT COMPLETED|Overall Study||39
8858601|NCT01799889|9914376|FG004|NOT COMPLETED|Overall Study||49
8858602|NCT01799889|9914377|FG005|NOT COMPLETED|Overall Study||20
8858603|NCT01799889|9914378|FG006|NOT COMPLETED|Overall Study||21
8858604|NCT01799889|9914379|FG007|NOT COMPLETED|Overall Study||20
8858605|NCT01799889|9914380|FG008|NOT COMPLETED|Overall Study||33
8858606|NCT01799889|9914381|FG009|NOT COMPLETED|Overall Study||8
8858607|NCT01799889|9914382|FG010|NOT COMPLETED|Overall Study||7
8858608|NCT01799889|9914383|FG011|NOT COMPLETED|Overall Study||3
8858609|NCT01799941|9914420|FG000|STARTED|Overall Study||367
8858610|NCT01799941|9914420|FG000|COMPLETED|Overall Study||271
8858611|NCT01799941|9914420|FG000|NOT COMPLETED|Overall Study||96
8858612|NCT01799993|9914432|FG000|STARTED|Overall Study||362
8858613|NCT01799993|9914433|FG001|STARTED|Overall Study||363
8858614|NCT01799993|9914432|FG000|ITT Population|Overall Study||354
8858615|NCT01799993|9914433|FG001|ITT Population|Overall Study||358
8858616|NCT01799993|9914432|FG000|mITT Population|Overall Study||255
8858617|NCT01799993|9914433|FG001|mITT Population|Overall Study||253
8858618|NCT01799993|9914432|FG000|COMPLETED|Overall Study||229
8858619|NCT01799993|9914433|FG001|COMPLETED|Overall Study||235
8858620|NCT01799993|9914432|FG000|NOT COMPLETED|Overall Study||133
8858621|NCT01799993|9914433|FG001|NOT COMPLETED|Overall Study||128
8858622|NCT01800058|9914439|FG000|STARTED|Overall Study||66
8858623|NCT01800058|9914439|FG000|COMPLETED|Overall Study||65
8858624|NCT01800058|9914439|FG000|NOT COMPLETED|Overall Study||1
8858625|NCT01800201|9914446|FG000|STARTED|Overall Study||506
8858626|NCT01800201|9914447|FG001|STARTED|Overall Study||1003
8858627|NCT01800201|9914446|FG000|COMPLETED|Overall Study||503
8858628|NCT01800201|9914447|FG001|COMPLETED|Overall Study||1000
8858629|NCT01800201|9914446|FG000|NOT COMPLETED|Overall Study||3
8858630|NCT01800201|9914447|FG001|NOT COMPLETED|Overall Study||3
8858631|NCT01800318|9914458|FG000|STARTED|Overall Study||39
8858632|NCT01800318|9914459|FG001|STARTED|Overall Study||42
8858633|NCT01800318|9914460|FG002|STARTED|Overall Study||41
8858634|NCT01800318|9914461|FG003|STARTED|Overall Study||40
8858635|NCT01800318|9914458|FG000|COMPLETED|Overall Study||37
8858636|NCT01800318|9914459|FG001|COMPLETED|Overall Study||37
8858637|NCT01800318|9914460|FG002|COMPLETED|Overall Study||40
8858638|NCT01800318|9914461|FG003|COMPLETED|Overall Study||39
8858639|NCT01800318|9914458|FG000|NOT COMPLETED|Overall Study||2
8858640|NCT01800318|9914459|FG001|NOT COMPLETED|Overall Study||5
8858641|NCT01800318|9914460|FG002|NOT COMPLETED|Overall Study||1
8858642|NCT01800318|9914461|FG003|NOT COMPLETED|Overall Study||1
8858643|NCT01800786|9914477|FG000|STARTED|Overall Study||17
8858644|NCT01800786|9914478|FG001|STARTED|Overall Study||16
8858645|NCT01800786|9914477|FG000|COMPLETED|Overall Study||15
8858646|NCT01800786|9914478|FG001|COMPLETED|Overall Study||15
8858647|NCT01800786|9914477|FG000|NOT COMPLETED|Overall Study||2
8858648|NCT01800786|9914478|FG001|NOT COMPLETED|Overall Study||1
8858649|NCT01800838|9914488|FG000|STARTED|Overall Study||1
8858650|NCT01800838|9914489|FG001|STARTED|Overall Study||1
8858651|NCT01800838|9914490|FG002|STARTED|Overall Study||7
8858652|NCT01800838|9914491|FG003|STARTED|Overall Study||2
8858653|NCT01800838|9914488|FG000|COMPLETED|Overall Study||1
8630024|NCT00533442|9669804|FG000|COMPLETED|Follow-up||77
8630025|NCT00533442|9669805|FG001|COMPLETED|Follow-up||74
8630026|NCT00533442|9669804|FG000|NOT COMPLETED|Follow-up||9
8630027|NCT00533442|9669805|FG001|NOT COMPLETED|Follow-up||10
8630028|NCT00533507|9669813|FG000|STARTED|Overall Study||230
8630029|NCT00533507|9669813|FG000|COMPLETED|Overall Study||229
8630030|NCT00533507|9669813|FG000|NOT COMPLETED|Overall Study||1
8630031|NCT00533546|9669817|FG000|STARTED|Overall Study||12
8630032|NCT00533546|9669817|FG000|COMPLETED|Overall Study||12
8630033|NCT00533546|9669817|FG000|NOT COMPLETED|Overall Study||0
8630034|NCT00533702|9669824|FG000|STARTED|Overall Study||54
8630035|NCT00533702|9669825|FG001|STARTED|Overall Study||52
8630036|NCT00533702|9669824|FG000|Received Any Quantity of Study Drug|Overall Study||52
8630037|NCT00533702|9669825|FG001|Received Any Quantity of Study Drug|Overall Study||50
8630038|NCT00533702|9669824|FG000|COMPLETED|Overall Study||49
8630039|NCT00533702|9669825|FG001|COMPLETED|Overall Study||50
8630040|NCT00533702|9669824|FG000|NOT COMPLETED|Overall Study||5
8630041|NCT00533702|9669825|FG001|NOT COMPLETED|Overall Study||2
8630042|NCT00533845|9669833|FG000|STARTED|Overall Study||15
8630043|NCT00533845|9669834|FG001|STARTED|Overall Study||15
8630044|NCT00533845|9669833|FG000|COMPLETED|Overall Study||14
8630045|NCT00533845|9669834|FG001|COMPLETED|Overall Study||15
8630046|NCT00533845|9669833|FG000|NOT COMPLETED|Overall Study||1
8630047|NCT00533845|9669834|FG001|NOT COMPLETED|Overall Study||0
8858654|NCT01800838|9914489|FG001|COMPLETED|Overall Study||1
8858655|NCT01800838|9914490|FG002|COMPLETED|Overall Study||7
8858656|NCT01800838|9914491|FG003|COMPLETED|Overall Study||2
8858657|NCT01800838|9914488|FG000|NOT COMPLETED|Overall Study||0
8858658|NCT01800838|9914489|FG001|NOT COMPLETED|Overall Study||0
8858659|NCT01800838|9914490|FG002|NOT COMPLETED|Overall Study||0
8858660|NCT01800838|9914491|FG003|NOT COMPLETED|Overall Study||0
8858661|NCT01800877|9914497|FG000|STARTED|Overall Study||60
8858662|NCT01800877|9914498|FG001|STARTED|Overall Study||60
8858663|NCT01800877|9914497|FG000|COMPLETED|Overall Study||58
8858664|NCT01800877|9914498|FG001|COMPLETED|Overall Study||60
8858665|NCT01800877|9914497|FG000|NOT COMPLETED|Overall Study||2
8858666|NCT01800877|9914498|FG001|NOT COMPLETED|Overall Study||0
8858667|NCT01800890|9914504|FG000|STARTED|Test Period 1||3
8858668|NCT01800890|9914505|FG001|STARTED|Test Period 1||3
8858669|NCT01800890|9914506|FG002|STARTED|Test Period 1||3
8858670|NCT01800890|9914507|FG003|STARTED|Test Period 1||3
8858671|NCT01800890|9914508|FG004|STARTED|Test Period 1||4
8858672|NCT01800890|9914509|FG005|STARTED|Test Period 1||4
8858673|NCT01800890|9914510|FG006|STARTED|Test Period 1||3
8858674|NCT01800890|9914511|FG007|STARTED|Test Period 1||3
8858675|NCT01800890|9914512|FG008|STARTED|Test Period 1||3
8858676|NCT01800890|9914504|FG000|COMPLETED|Test Period 1||3
8858677|NCT01800890|9914505|FG001|COMPLETED|Test Period 1||3
8858678|NCT01800890|9914506|FG002|COMPLETED|Test Period 1||3
8858679|NCT01800890|9914507|FG003|COMPLETED|Test Period 1||2
8858680|NCT01800890|9914508|FG004|COMPLETED|Test Period 1||4
8858681|NCT01800890|9914509|FG005|COMPLETED|Test Period 1||4
8858682|NCT01800890|9914510|FG006|COMPLETED|Test Period 1||3
8858683|NCT01800890|9914511|FG007|COMPLETED|Test Period 1||3
8858684|NCT01800890|9914512|FG008|COMPLETED|Test Period 1||3
8858685|NCT01800890|9914504|FG000|NOT COMPLETED|Test Period 1||0
8858686|NCT01800890|9914505|FG001|NOT COMPLETED|Test Period 1||0
8858687|NCT01800890|9914506|FG002|NOT COMPLETED|Test Period 1||0
8858688|NCT01800890|9914507|FG003|NOT COMPLETED|Test Period 1||1
8858689|NCT01800890|9914508|FG004|NOT COMPLETED|Test Period 1||0
8858690|NCT01800890|9914509|FG005|NOT COMPLETED|Test Period 1||0
8858691|NCT01800890|9914510|FG006|NOT COMPLETED|Test Period 1||0
8858692|NCT01800890|9914511|FG007|NOT COMPLETED|Test Period 1||0
8858693|NCT01800890|9914512|FG008|NOT COMPLETED|Test Period 1||0
8858694|NCT01800890|9914504|FG000|STARTED|Test Period 2||3
8858695|NCT01800890|9914505|FG001|STARTED|Test Period 2||3
8630048|NCT00533897|9669843|FG000|STARTED|Lead-in (LI) Period 1||167
8630049|NCT00533897|9669844|FG001|STARTED|Lead-in (LI) Period 1||0
8630050|NCT00533897|9669845|FG002|STARTED|Lead-in (LI) Period 1||0
8630051|NCT00533897|9669846|FG003|STARTED|Lead-in (LI) Period 1||0
8630052|NCT00533897|9669847|FG004|STARTED|Lead-in (LI) Period 1||0
8858696|NCT01800890|9914506|FG002|STARTED|Test Period 2||3
8858697|NCT01800890|9914507|FG003|STARTED|Test Period 2||2
8858698|NCT01800890|9914508|FG004|STARTED|Test Period 2||4
8858699|NCT01800890|9914509|FG005|STARTED|Test Period 2||4
8858700|NCT01800890|9914510|FG006|STARTED|Test Period 2||3
8858701|NCT01800890|9914511|FG007|STARTED|Test Period 2||3
8858702|NCT01800890|9914512|FG008|STARTED|Test Period 2||3
8630053|NCT00533897|9669848|FG005|STARTED|Lead-in (LI) Period 1||0
8630054|NCT00533897|9669849|FG006|STARTED|Lead-in (LI) Period 1||0
8630055|NCT00533897|9669850|FG007|STARTED|Lead-in (LI) Period 1||0
8630056|NCT00533897|9669843|FG000|COMPLETED|Lead-in (LI) Period 1|37 participants entered the LTE directly and did not enter the DBW Period nor receive DBW treatment.|157
8630057|NCT00533897|9669844|FG001|COMPLETED|Lead-in (LI) Period 1||0
8630058|NCT00533897|9669845|FG002|COMPLETED|Lead-in (LI) Period 1||0
8630059|NCT00533897|9669846|FG003|COMPLETED|Lead-in (LI) Period 1||0
8630060|NCT00533897|9669847|FG004|COMPLETED|Lead-in (LI) Period 1||0
8630061|NCT00533897|9669848|FG005|COMPLETED|Lead-in (LI) Period 1||0
8858703|NCT01800890|9914504|FG000|COMPLETED|Test Period 2||3
8858704|NCT01800890|9914505|FG001|COMPLETED|Test Period 2||3
8858705|NCT01800890|9914506|FG002|COMPLETED|Test Period 2||3
8858706|NCT01800890|9914507|FG003|COMPLETED|Test Period 2||2
8858707|NCT01800890|9914508|FG004|COMPLETED|Test Period 2||4
8858708|NCT01800890|9914509|FG005|COMPLETED|Test Period 2||4
8858709|NCT01800890|9914510|FG006|COMPLETED|Test Period 2||3
8858710|NCT01800890|9914511|FG007|COMPLETED|Test Period 2||3
8858711|NCT01800890|9914512|FG008|COMPLETED|Test Period 2||3
8858712|NCT01800890|9914504|FG000|NOT COMPLETED|Test Period 2||0
8858713|NCT01800890|9914505|FG001|NOT COMPLETED|Test Period 2||0
8858714|NCT01800890|9914506|FG002|NOT COMPLETED|Test Period 2||0
8858715|NCT01800890|9914507|FG003|NOT COMPLETED|Test Period 2||0
8858716|NCT01800890|9914508|FG004|NOT COMPLETED|Test Period 2||0
8858717|NCT01800890|9914509|FG005|NOT COMPLETED|Test Period 2||0
8858718|NCT01800890|9914510|FG006|NOT COMPLETED|Test Period 2||0
8858719|NCT01800890|9914511|FG007|NOT COMPLETED|Test Period 2||0
8949608|NCT02440594|10012231|FG000|NOT COMPLETED|Overall Study||132
8949609|NCT02440594|10012232|FG001|NOT COMPLETED|Overall Study||108
8949610|NCT02440594|10012233|FG002|NOT COMPLETED|Overall Study||117
8949611|NCT02440594|10012234|FG003|NOT COMPLETED|Overall Study||89
8949612|NCT02440594|10012235|FG004|NOT COMPLETED|Overall Study||9
8949613|NCT02440594|10012236|FG005|NOT COMPLETED|Overall Study||7
8949614|NCT02440594|10012237|FG006|NOT COMPLETED|Overall Study||37
8949615|NCT02440594|10012238|FG007|NOT COMPLETED|Overall Study||56
8949616|NCT02440633|10012263|FG000|STARTED|Overall Study||8
8949617|NCT02440633|10012263|FG000|COMPLETED|Overall Study||8
8949618|NCT02440633|10012263|FG000|NOT COMPLETED|Overall Study||0
8949619|NCT02440659|10012273|FG000|STARTED|Overall Study||1997
8949620|NCT02440659|10012274|FG001|STARTED|Overall Study||949
8949621|NCT02440659|10012273|FG000|COMPLETED|Overall Study||1346
8949622|NCT02440659|10012274|FG001|COMPLETED|Overall Study||614
8949623|NCT02440659|10012273|FG000|NOT COMPLETED|Overall Study||651
8949624|NCT02440659|10012274|FG001|NOT COMPLETED|Overall Study||335
8949625|NCT02440789|10012280|FG000|STARTED|Overall Study||32
8949626|NCT02440789|10012280|FG000|Initiated Sirolimus|Overall Study||30
8949627|NCT02440789|10012280|FG000|Completed 20 Weeks of Sirolimus|Overall Study||16
8949628|NCT02440789|10012280|FG000|COMPLETED|Overall Study||28
8949629|NCT02440789|10012280|FG000|NOT COMPLETED|Overall Study||4
8949630|NCT02441062|10012284|FG000|STARTED|Overall Study||122
8949631|NCT02441062|10012284|FG000|COMPLETED|Overall Study||122
8949632|NCT02441062|10012284|FG000|NOT COMPLETED|Overall Study||0
8949633|NCT02441114|10012288|FG000|STARTED|Period1||10
8949634|NCT02441114|10012288|FG000|COMPLETED|Period1||10
8630062|NCT00533897|9669849|FG006|COMPLETED|Lead-in (LI) Period 1||0
8630063|NCT00533897|9669850|FG007|COMPLETED|Lead-in (LI) Period 1||0
8630064|NCT00533897|9669843|FG000|NOT COMPLETED|Lead-in (LI) Period 1||10
8630065|NCT00533897|9669844|FG001|NOT COMPLETED|Lead-in (LI) Period 1||0
8630066|NCT00533897|9669845|FG002|NOT COMPLETED|Lead-in (LI) Period 1||0
8858720|NCT01800890|9914512|FG008|NOT COMPLETED|Test Period 2||0
8949635|NCT02441114|10012288|FG000|NOT COMPLETED|Period1||0
8949636|NCT02441114|10012288|FG000|STARTED|Washout1||10
8949637|NCT02441114|10012288|FG000|COMPLETED|Washout1||10
8949638|NCT02441114|10012288|FG000|NOT COMPLETED|Washout1||0
8949639|NCT02441114|10012288|FG000|STARTED|Period2||10
8949640|NCT02441114|10012288|FG000|COMPLETED|Period2||10
8949641|NCT02441114|10012288|FG000|NOT COMPLETED|Period2||0
8949642|NCT02441114|10012288|FG000|STARTED|Washout2||10
8949643|NCT02441114|10012288|FG000|COMPLETED|Washout2||6
8949644|NCT02441114|10012288|FG000|NOT COMPLETED|Washout2||4
8949645|NCT02441114|10012288|FG000|STARTED|Period3||6
8949646|NCT02441114|10012288|FG000|COMPLETED|Period3||6
8949647|NCT02441114|10012288|FG000|NOT COMPLETED|Period3||0
8949648|NCT02441179|10012294|FG000|STARTED|Overall Study||18
8949649|NCT02441179|10012295|FG001|STARTED|Overall Study||17
8949650|NCT02441179|10012294|FG000|COMPLETED|Overall Study||17
8949651|NCT02441179|10012295|FG001|COMPLETED|Overall Study||16
8949652|NCT02441179|10012294|FG000|NOT COMPLETED|Overall Study||1
8949653|NCT02441179|10012295|FG001|NOT COMPLETED|Overall Study||1
8949654|NCT02441218|10012304|FG000|STARTED|Overall Study||3241
8949655|NCT02441218|10012305|FG001|STARTED|Overall Study||3264
8949656|NCT02441218|10012304|FG000|COMPLETED|Overall Study||2663
8949657|NCT02441218|10012305|FG001|COMPLETED|Overall Study||2652
8949658|NCT02441218|10012304|FG000|NOT COMPLETED|Overall Study||578
8949659|NCT02441218|10012305|FG001|NOT COMPLETED|Overall Study||612
8949660|NCT02441283|10012311|FG000|STARTED|Overall Study||377
8858721|NCT01800890|9914504|FG000|STARTED|Test Period 3||3
8858722|NCT01800890|9914505|FG001|STARTED|Test Period 3||3
8858723|NCT01800890|9914506|FG002|STARTED|Test Period 3||3
8858724|NCT01800890|9914507|FG003|STARTED|Test Period 3||2
8858725|NCT01800890|9914508|FG004|STARTED|Test Period 3||4
8858726|NCT01800890|9914509|FG005|STARTED|Test Period 3||4
8858727|NCT01800890|9914510|FG006|STARTED|Test Period 3||3
8858728|NCT01800890|9914511|FG007|STARTED|Test Period 3||3
8858729|NCT01800890|9914512|FG008|STARTED|Test Period 3||3
8858730|NCT01800890|9914504|FG000|COMPLETED|Test Period 3||3
8858731|NCT01800890|9914505|FG001|COMPLETED|Test Period 3||3
8858732|NCT01800890|9914506|FG002|COMPLETED|Test Period 3||3
8858733|NCT01800890|9914507|FG003|COMPLETED|Test Period 3||2
8858734|NCT01800890|9914508|FG004|COMPLETED|Test Period 3||4
8858735|NCT01800890|9914509|FG005|COMPLETED|Test Period 3||4
8858736|NCT01800890|9914510|FG006|COMPLETED|Test Period 3||3
8858737|NCT01800890|9914511|FG007|COMPLETED|Test Period 3||3
8858738|NCT01800890|9914512|FG008|COMPLETED|Test Period 3||3
8858739|NCT01800890|9914504|FG000|NOT COMPLETED|Test Period 3||0
8858740|NCT01800890|9914505|FG001|NOT COMPLETED|Test Period 3||0
8858741|NCT01800890|9914506|FG002|NOT COMPLETED|Test Period 3||0
8858742|NCT01800890|9914507|FG003|NOT COMPLETED|Test Period 3||0
8858743|NCT01800890|9914508|FG004|NOT COMPLETED|Test Period 3||0
8858744|NCT01800890|9914509|FG005|NOT COMPLETED|Test Period 3||0
8858745|NCT01800890|9914510|FG006|NOT COMPLETED|Test Period 3||0
8858746|NCT01800890|9914511|FG007|NOT COMPLETED|Test Period 3||0
8858747|NCT01800890|9914512|FG008|NOT COMPLETED|Test Period 3||0
8858748|NCT01800903|9914522|FG000|STARTED|First Test Period||7
8858749|NCT01800903|9914523|FG001|STARTED|First Test Period||6
8858750|NCT01800903|9914524|FG002|STARTED|First Test Period||4
8858751|NCT01800903|9914525|FG003|STARTED|First Test Period||7
8858752|NCT01800903|9914526|FG004|STARTED|First Test Period||6
8858753|NCT01800903|9914527|FG005|STARTED|First Test Period||6
8858754|NCT01800903|9914522|FG000|COMPLETED|First Test Period||7
8858755|NCT01800903|9914523|FG001|COMPLETED|First Test Period||6
8858756|NCT01800903|9914524|FG002|COMPLETED|First Test Period||4
8858757|NCT01800903|9914525|FG003|COMPLETED|First Test Period||7
8858758|NCT01800903|9914526|FG004|COMPLETED|First Test Period||6
8858759|NCT01800903|9914527|FG005|COMPLETED|First Test Period||6
8858760|NCT01800903|9914522|FG000|NOT COMPLETED|First Test Period||0
8858761|NCT01800903|9914523|FG001|NOT COMPLETED|First Test Period||0
8858762|NCT01800903|9914524|FG002|NOT COMPLETED|First Test Period||0
8858763|NCT01800903|9914525|FG003|NOT COMPLETED|First Test Period||0
8858764|NCT01800903|9914526|FG004|NOT COMPLETED|First Test Period||0
8858765|NCT01800903|9914527|FG005|NOT COMPLETED|First Test Period||0
8858766|NCT01800903|9914522|FG000|STARTED|Second Test Period||7
8858767|NCT01800903|9914523|FG001|STARTED|Second Test Period||6
8858768|NCT01800903|9914524|FG002|STARTED|Second Test Period||4
8858769|NCT01800903|9914525|FG003|STARTED|Second Test Period||7
8858770|NCT01800903|9914526|FG004|STARTED|Second Test Period||6
8858771|NCT01800903|9914527|FG005|STARTED|Second Test Period||6
8858772|NCT01800903|9914522|FG000|COMPLETED|Second Test Period||6
8858773|NCT01800903|9914523|FG001|COMPLETED|Second Test Period||6
8858774|NCT01800903|9914524|FG002|COMPLETED|Second Test Period||4
8858775|NCT01800903|9914525|FG003|COMPLETED|Second Test Period||7
8858776|NCT01800903|9914526|FG004|COMPLETED|Second Test Period||6
8858777|NCT01800903|9914527|FG005|COMPLETED|Second Test Period||6
8858778|NCT01800903|9914522|FG000|NOT COMPLETED|Second Test Period||1
8858779|NCT01800903|9914523|FG001|NOT COMPLETED|Second Test Period||0
8858780|NCT01800903|9914524|FG002|NOT COMPLETED|Second Test Period||0
8858781|NCT01800903|9914525|FG003|NOT COMPLETED|Second Test Period||0
8858782|NCT01800903|9914526|FG004|NOT COMPLETED|Second Test Period||0
8858783|NCT01800903|9914527|FG005|NOT COMPLETED|Second Test Period||0
8858784|NCT01800903|9914522|FG000|STARTED|Third Test Period||6
8858785|NCT01800903|9914523|FG001|STARTED|Third Test Period||6
8858786|NCT01800903|9914524|FG002|STARTED|Third Test Period||4
8858787|NCT01800903|9914525|FG003|STARTED|Third Test Period||7
8858788|NCT01800903|9914526|FG004|STARTED|Third Test Period||6
8858789|NCT01800903|9914527|FG005|STARTED|Third Test Period||6
8858790|NCT01800903|9914522|FG000|COMPLETED|Third Test Period||6
8858791|NCT01800903|9914523|FG001|COMPLETED|Third Test Period||6
8858792|NCT01800903|9914524|FG002|COMPLETED|Third Test Period||4
8858793|NCT01800903|9914525|FG003|COMPLETED|Third Test Period||7
8858794|NCT01800903|9914526|FG004|COMPLETED|Third Test Period||6
8858795|NCT01800903|9914527|FG005|COMPLETED|Third Test Period||6
8858796|NCT01800903|9914522|FG000|NOT COMPLETED|Third Test Period||0
8858797|NCT01800903|9914523|FG001|NOT COMPLETED|Third Test Period||0
8858798|NCT01800903|9914524|FG002|NOT COMPLETED|Third Test Period||0
8858799|NCT01800903|9914525|FG003|NOT COMPLETED|Third Test Period||0
8858800|NCT01800903|9914526|FG004|NOT COMPLETED|Third Test Period||0
8858801|NCT01800903|9914527|FG005|NOT COMPLETED|Third Test Period||0
8858802|NCT01800916|9914533|FG000|STARTED|Test Period 1 (1 Week)||7
8858803|NCT01800916|9914534|FG001|STARTED|Test Period 1 (1 Week)||7
8858804|NCT01800916|9914535|FG002|STARTED|Test Period 1 (1 Week)||7
8858805|NCT01800916|9914536|FG003|STARTED|Test Period 1 (1 Week)||7
8858806|NCT01800916|9914537|FG004|STARTED|Test Period 1 (1 Week)||8
8858807|NCT01800916|9914538|FG005|STARTED|Test Period 1 (1 Week)||7
8858808|NCT01800916|9914539|FG006|STARTED|Test Period 1 (1 Week)||7
8858809|NCT01800916|9914540|FG007|STARTED|Test Period 1 (1 Week)||7
8858810|NCT01800916|9914541|FG008|STARTED|Test Period 1 (1 Week)||7
8858811|NCT01800916|9914533|FG000|COMPLETED|Test Period 1 (1 Week)||7
8858812|NCT01800916|9914534|FG001|COMPLETED|Test Period 1 (1 Week)||7
8858813|NCT01800916|9914535|FG002|COMPLETED|Test Period 1 (1 Week)||7
8858814|NCT01800916|9914536|FG003|COMPLETED|Test Period 1 (1 Week)||6
8858815|NCT01800916|9914537|FG004|COMPLETED|Test Period 1 (1 Week)||7
8858816|NCT01800916|9914538|FG005|COMPLETED|Test Period 1 (1 Week)||7
8858817|NCT01800916|9914539|FG006|COMPLETED|Test Period 1 (1 Week)||7
8858818|NCT01800916|9914540|FG007|COMPLETED|Test Period 1 (1 Week)||7
8858819|NCT01800916|9914541|FG008|COMPLETED|Test Period 1 (1 Week)||7
8858820|NCT01800916|9914533|FG000|NOT COMPLETED|Test Period 1 (1 Week)||0
8858821|NCT01800916|9914534|FG001|NOT COMPLETED|Test Period 1 (1 Week)||0
8858822|NCT01800916|9914535|FG002|NOT COMPLETED|Test Period 1 (1 Week)||0
8858823|NCT01800916|9914536|FG003|NOT COMPLETED|Test Period 1 (1 Week)||1
8858824|NCT01800916|9914537|FG004|NOT COMPLETED|Test Period 1 (1 Week)||1
8858825|NCT01800916|9914538|FG005|NOT COMPLETED|Test Period 1 (1 Week)||0
8858826|NCT01800916|9914539|FG006|NOT COMPLETED|Test Period 1 (1 Week)||0
8858827|NCT01800916|9914540|FG007|NOT COMPLETED|Test Period 1 (1 Week)||0
8858828|NCT01800916|9914541|FG008|NOT COMPLETED|Test Period 1 (1 Week)||0
8858829|NCT01800916|9914533|FG000|STARTED|Test Period 2 (1 Week)||7
8858830|NCT01800916|9914534|FG001|STARTED|Test Period 2 (1 Week)||7
8858831|NCT01800916|9914535|FG002|STARTED|Test Period 2 (1 Week)||7
8858832|NCT01800916|9914536|FG003|STARTED|Test Period 2 (1 Week)||6
8858833|NCT01800916|9914537|FG004|STARTED|Test Period 2 (1 Week)||7
8858834|NCT01800916|9914538|FG005|STARTED|Test Period 2 (1 Week)||7
8858835|NCT01800916|9914539|FG006|STARTED|Test Period 2 (1 Week)||7
8858836|NCT01800916|9914540|FG007|STARTED|Test Period 2 (1 Week)||7
8858837|NCT01800916|9914541|FG008|STARTED|Test Period 2 (1 Week)||7
8858838|NCT01800916|9914533|FG000|COMPLETED|Test Period 2 (1 Week)||7
8858839|NCT01800916|9914534|FG001|COMPLETED|Test Period 2 (1 Week)||7
8858840|NCT01800916|9914535|FG002|COMPLETED|Test Period 2 (1 Week)||7
8858841|NCT01800916|9914536|FG003|COMPLETED|Test Period 2 (1 Week)||6
8858842|NCT01800916|9914537|FG004|COMPLETED|Test Period 2 (1 Week)||7
8858843|NCT01800916|9914538|FG005|COMPLETED|Test Period 2 (1 Week)||7
8858844|NCT01800916|9914539|FG006|COMPLETED|Test Period 2 (1 Week)||7
8858845|NCT01800916|9914540|FG007|COMPLETED|Test Period 2 (1 Week)||7
8858846|NCT01800916|9914541|FG008|COMPLETED|Test Period 2 (1 Week)||7
8858847|NCT01800916|9914533|FG000|NOT COMPLETED|Test Period 2 (1 Week)||0
8858848|NCT01800916|9914534|FG001|NOT COMPLETED|Test Period 2 (1 Week)||0
8858849|NCT01800916|9914535|FG002|NOT COMPLETED|Test Period 2 (1 Week)||0
8858850|NCT01800916|9914536|FG003|NOT COMPLETED|Test Period 2 (1 Week)||0
8858851|NCT01800916|9914537|FG004|NOT COMPLETED|Test Period 2 (1 Week)||0
8858852|NCT01800916|9914538|FG005|NOT COMPLETED|Test Period 2 (1 Week)||0
8858853|NCT01800916|9914539|FG006|NOT COMPLETED|Test Period 2 (1 Week)||0
8858854|NCT01800916|9914540|FG007|NOT COMPLETED|Test Period 2 (1 Week)||0
8858855|NCT01800916|9914541|FG008|NOT COMPLETED|Test Period 2 (1 Week)||0
8858856|NCT01800916|9914533|FG000|STARTED|Test Period 3 (1 Week)||7
8858857|NCT01800916|9914534|FG001|STARTED|Test Period 3 (1 Week)||7
8858858|NCT01800916|9914535|FG002|STARTED|Test Period 3 (1 Week)||7
8858859|NCT01800916|9914536|FG003|STARTED|Test Period 3 (1 Week)||6
8858860|NCT01800916|9914537|FG004|STARTED|Test Period 3 (1 Week)||7
8858861|NCT01800916|9914538|FG005|STARTED|Test Period 3 (1 Week)||7
8858862|NCT01800916|9914539|FG006|STARTED|Test Period 3 (1 Week)||7
8858863|NCT01800916|9914540|FG007|STARTED|Test Period 3 (1 Week)||7
8858864|NCT01800916|9914541|FG008|STARTED|Test Period 3 (1 Week)||7
8858865|NCT01800916|9914533|FG000|COMPLETED|Test Period 3 (1 Week)||7
8858866|NCT01800916|9914534|FG001|COMPLETED|Test Period 3 (1 Week)||7
8858867|NCT01800916|9914535|FG002|COMPLETED|Test Period 3 (1 Week)||7
8858868|NCT01800916|9914536|FG003|COMPLETED|Test Period 3 (1 Week)||6
8858869|NCT01800916|9914537|FG004|COMPLETED|Test Period 3 (1 Week)||7
8858870|NCT01800916|9914538|FG005|COMPLETED|Test Period 3 (1 Week)||7
8858871|NCT01800916|9914539|FG006|COMPLETED|Test Period 3 (1 Week)||7
8858872|NCT01800916|9914540|FG007|COMPLETED|Test Period 3 (1 Week)||7
8858873|NCT01800916|9914541|FG008|COMPLETED|Test Period 3 (1 Week)||7
8858874|NCT01800916|9914533|FG000|NOT COMPLETED|Test Period 3 (1 Week)||0
8858875|NCT01800916|9914534|FG001|NOT COMPLETED|Test Period 3 (1 Week)||0
8858876|NCT01800916|9914535|FG002|NOT COMPLETED|Test Period 3 (1 Week)||0
8858877|NCT01800916|9914536|FG003|NOT COMPLETED|Test Period 3 (1 Week)||0
8858878|NCT01800916|9914537|FG004|NOT COMPLETED|Test Period 3 (1 Week)||0
8858879|NCT01800916|9914538|FG005|NOT COMPLETED|Test Period 3 (1 Week)||0
8858880|NCT01800916|9914539|FG006|NOT COMPLETED|Test Period 3 (1 Week)||0
8858881|NCT01800916|9914540|FG007|NOT COMPLETED|Test Period 3 (1 Week)||0
8858882|NCT01800916|9914541|FG008|NOT COMPLETED|Test Period 3 (1 Week)||0
8858883|NCT01800968|9914553|FG000|STARTED|Overall Study||154
8858884|NCT01800968|9914554|FG001|STARTED|Overall Study||146
8858885|NCT01800968|9914553|FG000|COMPLETED|Overall Study||118
8858886|NCT01800968|9914554|FG001|COMPLETED|Overall Study||114
8858887|NCT01800968|9914553|FG000|NOT COMPLETED|Overall Study||36
8858888|NCT01800968|9914554|FG001|NOT COMPLETED|Overall Study||32
8858889|NCT01801007|9914560|FG000|STARTED|Overall Study||145
8858890|NCT01801007|9914560|FG000|COMPLETED|Overall Study||134
8858891|NCT01801007|9914560|FG000|NOT COMPLETED|Overall Study||11
8858892|NCT01801111|9914564|FG000|STARTED|Overall Study||138
8858893|NCT01801111|9914564|FG000|COMPLETED|Overall Study||0
8858894|NCT01801111|9914564|FG000|NOT COMPLETED|Overall Study||138
8858895|NCT01801124|9914568|FG000|STARTED|Overall Study||13
8858896|NCT01801124|9914568|FG000|COMPLETED|Overall Study||13
8858897|NCT01801124|9914568|FG000|NOT COMPLETED|Overall Study||0
8858898|NCT01801241|9914574|FG000|STARTED|Overall Study||29
8858899|NCT01801241|9914575|FG001|STARTED|Overall Study||27
8858900|NCT01801241|9914574|FG000|COMPLETED|Overall Study||21
8858901|NCT01801241|9914575|FG001|COMPLETED|Overall Study||25
8858902|NCT01801241|9914574|FG000|NOT COMPLETED|Overall Study||8
8858903|NCT01801241|9914575|FG001|NOT COMPLETED|Overall Study||2
8858904|NCT01801280|9914585|FG000|STARTED|Period 1|Each period lasted 10-14 weeks|5
8858905|NCT01801280|9914586|FG001|STARTED|Period 1||5
8858906|NCT01801280|9914587|FG002|STARTED|Period 1||5
8858907|NCT01801280|9914588|FG003|STARTED|Period 1||5
8858908|NCT01801280|9914585|FG000|COMPLETED|Period 1||5
8858909|NCT01801280|9914586|FG001|COMPLETED|Period 1||4
8858910|NCT01801280|9914587|FG002|COMPLETED|Period 1||5
8858911|NCT01801280|9914588|FG003|COMPLETED|Period 1||5
8858912|NCT01801280|9914585|FG000|NOT COMPLETED|Period 1||0
8858913|NCT01801280|9914586|FG001|NOT COMPLETED|Period 1||1
8858914|NCT01801280|9914587|FG002|NOT COMPLETED|Period 1||0
8858915|NCT01801280|9914588|FG003|NOT COMPLETED|Period 1||0
8858916|NCT01801280|9914585|FG000|STARTED|Period 2||5
8858917|NCT01801280|9914586|FG001|STARTED|Period 2||4
8858918|NCT01801280|9914587|FG002|STARTED|Period 2||5
8858919|NCT01801280|9914588|FG003|STARTED|Period 2||5
8858920|NCT01801280|9914585|FG000|COMPLETED|Period 2||4
8858921|NCT01801280|9914586|FG001|COMPLETED|Period 2||4
8858922|NCT01801280|9914587|FG002|COMPLETED|Period 2||5
8858923|NCT01801280|9914588|FG003|COMPLETED|Period 2||5
8858924|NCT01801280|9914585|FG000|NOT COMPLETED|Period 2||1
8858925|NCT01801280|9914586|FG001|NOT COMPLETED|Period 2||0
8858926|NCT01801280|9914587|FG002|NOT COMPLETED|Period 2||0
8858927|NCT01801280|9914588|FG003|NOT COMPLETED|Period 2||0
8858928|NCT01801280|9914585|FG000|STARTED|Period 3||4
8858929|NCT01801280|9914586|FG001|STARTED|Period 3||4
8858930|NCT01801280|9914587|FG002|STARTED|Period 3||5
8858931|NCT01801280|9914588|FG003|STARTED|Period 3||5
8858932|NCT01801280|9914585|FG000|COMPLETED|Period 3||4
8858933|NCT01801280|9914586|FG001|COMPLETED|Period 3||4
8858934|NCT01801280|9914587|FG002|COMPLETED|Period 3||5
8858935|NCT01801280|9914588|FG003|COMPLETED|Period 3||5
8858936|NCT01801280|9914585|FG000|NOT COMPLETED|Period 3||0
8858937|NCT01801280|9914586|FG001|NOT COMPLETED|Period 3||0
8858938|NCT01801280|9914587|FG002|NOT COMPLETED|Period 3||0
8858939|NCT01801280|9914588|FG003|NOT COMPLETED|Period 3||0
8858940|NCT01801280|9914585|FG000|STARTED|Period 4||4
8858941|NCT01801280|9914586|FG001|STARTED|Period 4||4
8858942|NCT01801280|9914587|FG002|STARTED|Period 4||5
8569650|NCT00098306|9601867|FG002|STARTED|Double Blind||120
8569651|NCT00098306|9601868|FG003|STARTED|Double Blind||0
8569652|NCT00098306|9601869|FG004|STARTED|Double Blind||0
8569653|NCT00098306|9601870|FG005|STARTED|Double Blind||0
8569654|NCT00098306|9601871|FG006|STARTED|Double Blind||0
8858943|NCT01801280|9914588|FG003|STARTED|Period 4||5
8569655|NCT00098306|9601865|FG000|Treated|Double Blind||232
8569656|NCT00098306|9601866|FG001|Treated|Double Blind||235
8858944|NCT01801280|9914585|FG000|COMPLETED|Period 4||4
8569657|NCT00098306|9601867|FG002|Treated|Double Blind||118
8858945|NCT01801280|9914586|FG001|COMPLETED|Period 4||4
8858946|NCT01801280|9914587|FG002|COMPLETED|Period 4||4
8858947|NCT01801280|9914588|FG003|COMPLETED|Period 4||5
8858948|NCT01801280|9914585|FG000|NOT COMPLETED|Period 4||0
8858949|NCT01801280|9914586|FG001|NOT COMPLETED|Period 4||0
8858950|NCT01801280|9914587|FG002|NOT COMPLETED|Period 4||1
8858951|NCT01801280|9914588|FG003|NOT COMPLETED|Period 4||0
8858952|NCT01801358|9914604|FG000|STARTED|Overall Study||6
8858953|NCT01801358|9914605|FG001|STARTED|Overall Study||6
8858954|NCT01801358|9914606|FG002|STARTED|Overall Study||6
8858955|NCT01801358|9914607|FG003|STARTED|Overall Study||6
8858956|NCT01801358|9914608|FG004|STARTED|Overall Study||6
8858957|NCT01801358|9914609|FG005|STARTED|Overall Study||8
8858958|NCT01801358|9914604|FG000|COMPLETED|Overall Study||0
8858959|NCT01801358|9914605|FG001|COMPLETED|Overall Study||0
8858960|NCT01801358|9914606|FG002|COMPLETED|Overall Study||0
8858961|NCT01801358|9914607|FG003|COMPLETED|Overall Study||0
8858962|NCT01801358|9914608|FG004|COMPLETED|Overall Study||0
8858963|NCT01801358|9914609|FG005|COMPLETED|Overall Study||0
8858964|NCT01801358|9914604|FG000|NOT COMPLETED|Overall Study||6
8858965|NCT01801358|9914605|FG001|NOT COMPLETED|Overall Study||6
8858966|NCT01801358|9914606|FG002|NOT COMPLETED|Overall Study||6
8858967|NCT01801358|9914607|FG003|NOT COMPLETED|Overall Study||6
8858968|NCT01801358|9914608|FG004|NOT COMPLETED|Overall Study||6
8858969|NCT01801358|9914609|FG005|NOT COMPLETED|Overall Study||8
8858970|NCT01801436|9914644|FG000|STARTED|Overall Study||14
8949661|NCT02441283|10012311|FG000|COMPLETED|Overall Study||287
8949662|NCT02441283|10012311|FG000|NOT COMPLETED|Overall Study||90
8949663|NCT02441309|10012318|FG000|STARTED|Overall Study||3
8949664|NCT02441309|10012319|FG001|STARTED|Overall Study||2
8949665|NCT02441309|10012320|FG002|STARTED|Overall Study||3
8949666|NCT02441309|10012318|FG000|Received Allocated Intervention|Overall Study||1
8949667|NCT02441309|10012319|FG001|Received Allocated Intervention|Overall Study||2
8949668|NCT02441309|10012320|FG002|Received Allocated Intervention|Overall Study||3
8949669|NCT02441309|10012318|FG000|COMPLETED|Overall Study||0
8949670|NCT02441309|10012319|FG001|COMPLETED|Overall Study||0
8949671|NCT02441309|10012320|FG002|COMPLETED|Overall Study||0
8949672|NCT02441309|10012318|FG000|NOT COMPLETED|Overall Study||3
8949673|NCT02441309|10012319|FG001|NOT COMPLETED|Overall Study||2
8949674|NCT02441309|10012320|FG002|NOT COMPLETED|Overall Study||3
8949675|NCT02441517|10012331|FG000|STARTED|Overall Study||4
8949676|NCT02441517|10012331|FG000|Received Treatment|Overall Study||4
8949677|NCT02441517|10012331|FG000|COMPLETED|Overall Study||0
8949678|NCT02441517|10012331|FG000|NOT COMPLETED|Overall Study||4
8949679|NCT02441946|10012338|FG000|STARTED|Cycle 1 Period 1 (2 Weeks)||74
8949680|NCT02441946|10012339|FG001|STARTED|Cycle 1 Period 1 (2 Weeks)||76
8949681|NCT02441946|10012340|FG002|STARTED|Cycle 1 Period 1 (2 Weeks)||74
8949682|NCT02441946|10012338|FG000|Received at Least One Dose of Study Drug|Cycle 1 Period 1 (2 Weeks)||74
8949683|NCT02441946|10012339|FG001|Received at Least One Dose of Study Drug|Cycle 1 Period 1 (2 Weeks)|1 participant did not receive drug due to an error in randomization.|75
8949684|NCT02441946|10012340|FG002|Received at Least One Dose of Study Drug|Cycle 1 Period 1 (2 Weeks)||74
8949685|NCT02441946|10012338|FG000|COMPLETED|Cycle 1 Period 1 (2 Weeks)||72
8949686|NCT02441946|10012339|FG001|COMPLETED|Cycle 1 Period 1 (2 Weeks)||71
8949687|NCT02441946|10012340|FG002|COMPLETED|Cycle 1 Period 1 (2 Weeks)||74
8949688|NCT02441946|10012338|FG000|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||2
8949689|NCT02441946|10012339|FG001|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||5
8949690|NCT02441946|10012340|FG002|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
8949691|NCT02441946|10012338|FG000|STARTED|Cycle 2-5 Period 2 (14 Weeks)|All 217 participants were assigned to abemaciclib + anastrozole post cycle 1.|217
8949692|NCT02441946|10012339|FG001|STARTED|Cycle 2-5 Period 2 (14 Weeks)|All 217 participants were assigned abemaciclib + anastrozole post cycle 1.|0
8858971|NCT01801436|9914644|FG000|COMPLETED|Overall Study||5
8858972|NCT01801436|9914644|FG000|NOT COMPLETED|Overall Study||9
8858973|NCT01801449|9914648|FG000|STARTED|Overall Study||6
8949693|NCT02441946|10012340|FG002|STARTED|Cycle 2-5 Period 2 (14 Weeks)|All 217 participants were assigned abemaciclib + anastrozole post cycle 1.|0
8949694|NCT02441946|10012338|FG000|Received at Least One Dose of Study Drug|Cycle 2-5 Period 2 (14 Weeks)||217
8949695|NCT02441946|10012339|FG001|Received at Least One Dose of Study Drug|Cycle 2-5 Period 2 (14 Weeks)||0
8949696|NCT02441946|10012340|FG002|Received at Least One Dose of Study Drug|Cycle 2-5 Period 2 (14 Weeks)||0
8858974|NCT01801449|9914648|FG000|COMPLETED|Overall Study||6
8858975|NCT01801449|9914648|FG000|NOT COMPLETED|Overall Study||0
8858976|NCT01801475|9914656|FG000|STARTED|Overall Study||10
8858977|NCT01801475|9914657|FG001|STARTED|Overall Study||30
8858978|NCT01801475|9914658|FG002|STARTED|Overall Study||10
8858979|NCT01801475|9914659|FG003|STARTED|Overall Study||10
8858980|NCT01801475|9914660|FG004|STARTED|Overall Study||40
8858981|NCT01801475|9914656|FG000|COMPLETED|Overall Study||10
8858982|NCT01801475|9914657|FG001|COMPLETED|Overall Study||30
8858983|NCT01801475|9914658|FG002|COMPLETED|Overall Study||10
8858984|NCT01801475|9914659|FG003|COMPLETED|Overall Study||10
8858985|NCT01801475|9914660|FG004|COMPLETED|Overall Study||39
8858986|NCT01801475|9914656|FG000|NOT COMPLETED|Overall Study||0
8858987|NCT01801475|9914657|FG001|NOT COMPLETED|Overall Study||0
8858988|NCT01801475|9914658|FG002|NOT COMPLETED|Overall Study||0
8858989|NCT01801475|9914659|FG003|NOT COMPLETED|Overall Study||0
8858990|NCT01801475|9914660|FG004|NOT COMPLETED|Overall Study||1
8858991|NCT01801735|9914669|FG000|STARTED|Overall Study||600
8858992|NCT01801735|9914669|FG000|COMPLETED|Overall Study||390
8858993|NCT01801735|9914669|FG000|NOT COMPLETED|Overall Study||210
8858994|NCT01801865|9914673|FG000|STARTED|Overall Study||657
8858995|NCT01801865|9914673|FG000|COMPLETED|Overall Study||615
8858996|NCT01801865|9914673|FG000|NOT COMPLETED|Overall Study||42
8858997|NCT01801917|9914681|FG000|STARTED|Period 1 - Randomized||7
8858998|NCT01801917|9914682|FG001|STARTED|Period 1 - Randomized||2
8858999|NCT01801917|9914683|FG002|STARTED|Period 1 - Randomized||4
8859000|NCT01801917|9914684|FG003|STARTED|Period 1 - Randomized||1
8859001|NCT01801917|9914681|FG000|COMPLETED|Period 1 - Randomized||6
8859002|NCT01801917|9914682|FG001|COMPLETED|Period 1 - Randomized||2
8859003|NCT01801917|9914683|FG002|COMPLETED|Period 1 - Randomized||3
8859004|NCT01801917|9914684|FG003|COMPLETED|Period 1 - Randomized||1
8859005|NCT01801917|9914681|FG000|NOT COMPLETED|Period 1 - Randomized||1
8859006|NCT01801917|9914682|FG001|NOT COMPLETED|Period 1 - Randomized||0
8859007|NCT01801917|9914683|FG002|NOT COMPLETED|Period 1 - Randomized||1
8859008|NCT01801917|9914684|FG003|NOT COMPLETED|Period 1 - Randomized||0
8859009|NCT01801917|9914681|FG000|STARTED|Extension - All Active||6
8859010|NCT01801917|9914682|FG001|STARTED|Extension - All Active||0
8859011|NCT01801917|9914683|FG002|STARTED|Extension - All Active||3
8859012|NCT01801917|9914684|FG003|STARTED|Extension - All Active||0
8859013|NCT01801917|9914681|FG000|COMPLETED|Extension - All Active||6
8859014|NCT01801917|9914682|FG001|COMPLETED|Extension - All Active||0
8859015|NCT01801917|9914683|FG002|COMPLETED|Extension - All Active||3
8859016|NCT01801917|9914684|FG003|COMPLETED|Extension - All Active||0
8859017|NCT01801917|9914681|FG000|NOT COMPLETED|Extension - All Active||0
8859018|NCT01801917|9914682|FG001|NOT COMPLETED|Extension - All Active||0
8859019|NCT01801917|9914683|FG002|NOT COMPLETED|Extension - All Active||0
8859020|NCT01801917|9914684|FG003|NOT COMPLETED|Extension - All Active||0
8859021|NCT01801930|9914699|FG000|STARTED|Overall Study||6
8859022|NCT01801930|9914700|FG001|STARTED|Overall Study||6
8859023|NCT01801930|9914701|FG002|STARTED|Overall Study||6
8859024|NCT01801930|9914702|FG003|STARTED|Overall Study||6
8859025|NCT01801930|9914699|FG000|COMPLETED|Overall Study||0
8859026|NCT01801930|9914700|FG001|COMPLETED|Overall Study||0
8859027|NCT01801930|9914701|FG002|COMPLETED|Overall Study||0
8859028|NCT01801930|9914702|FG003|COMPLETED|Overall Study||0
8859029|NCT01801930|9914699|FG000|NOT COMPLETED|Overall Study||6
8859030|NCT01801930|9914700|FG001|NOT COMPLETED|Overall Study||6
8859031|NCT01801930|9914701|FG002|NOT COMPLETED|Overall Study||6
8859032|NCT01801930|9914702|FG003|NOT COMPLETED|Overall Study||6
8859033|NCT01801982|9914712|FG000|STARTED|Overall Study||1
8859034|NCT01801982|9914712|FG000|COMPLETED|Overall Study||0
8859035|NCT01801982|9914712|FG000|NOT COMPLETED|Overall Study||1
8859036|NCT01802073|9914718|FG000|STARTED|Overall Study||14
8859037|NCT01802073|9914719|FG001|STARTED|Overall Study||20
8859038|NCT01802073|9914718|FG000|COMPLETED|Overall Study||9
8859039|NCT01802073|9914719|FG001|COMPLETED|Overall Study||9
8859040|NCT01802073|9914718|FG000|NOT COMPLETED|Overall Study||5
8859041|NCT01802073|9914719|FG001|NOT COMPLETED|Overall Study||11
8859042|NCT01802151|9914729|FG000|STARTED|Overall Study||20
8859043|NCT01802151|9914730|FG001|STARTED|Overall Study||21
8859044|NCT01802151|9914731|FG002|STARTED|Overall Study||22
8949697|NCT02441946|10012338|FG000|Progressive Disease|Cycle 2-5 Period 2 (14 Weeks)||5
8949698|NCT02441946|10012339|FG001|Progressive Disease|Cycle 2-5 Period 2 (14 Weeks)||0
8859045|NCT01802151|9914732|FG003|STARTED|Overall Study||20
8859046|NCT01802151|9914729|FG000|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|20
8859047|NCT01802151|9914730|FG001|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|21
8859048|NCT01802151|9914731|FG002|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|20
8859049|NCT01802151|9914732|FG003|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|20
8859050|NCT01802151|9914729|FG000|NOT COMPLETED|Overall Study||0
8859051|NCT01802151|9914730|FG001|NOT COMPLETED|Overall Study||0
8859052|NCT01802151|9914731|FG002|NOT COMPLETED|Overall Study||2
8859053|NCT01802151|9914732|FG003|NOT COMPLETED|Overall Study||0
8859054|NCT01802216|9914744|FG000|STARTED|Baseline||17
8859055|NCT01802216|9914745|FG001|STARTED|Baseline||34
8949699|NCT02441946|10012340|FG002|Progressive Disease|Cycle 2-5 Period 2 (14 Weeks)||0
8949700|NCT02441946|10012338|FG000|COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||190
8859056|NCT01802216|9914744|FG000|COMPLETED|Baseline||17
8859057|NCT01802216|9914745|FG001|COMPLETED|Baseline||34
8859058|NCT01802216|9914744|FG000|NOT COMPLETED|Baseline||0
8859059|NCT01802216|9914745|FG001|NOT COMPLETED|Baseline||0
8859060|NCT01802216|9914744|FG000|STARTED|4 Month Visit||17
8859061|NCT01802216|9914745|FG001|STARTED|4 Month Visit||34
8859062|NCT01802216|9914744|FG000|COMPLETED|4 Month Visit||14
8859063|NCT01802216|9914745|FG001|COMPLETED|4 Month Visit||30
8859064|NCT01802216|9914744|FG000|NOT COMPLETED|4 Month Visit||3
8859065|NCT01802216|9914745|FG001|NOT COMPLETED|4 Month Visit||4
8859066|NCT01802216|9914744|FG000|STARTED|8 Month Visit||17
8859067|NCT01802216|9914745|FG001|STARTED|8 Month Visit||34
8859068|NCT01802216|9914744|FG000|COMPLETED|8 Month Visit||14
8859069|NCT01802216|9914745|FG001|COMPLETED|8 Month Visit||29
8859070|NCT01802216|9914744|FG000|NOT COMPLETED|8 Month Visit||3
8859071|NCT01802216|9914745|FG001|NOT COMPLETED|8 Month Visit||5
8859072|NCT01802216|9914744|FG000|STARTED|12 Month Visit||17
8859073|NCT01802216|9914745|FG001|STARTED|12 Month Visit||34
8859074|NCT01802216|9914744|FG000|COMPLETED|12 Month Visit||14
8859075|NCT01802216|9914745|FG001|COMPLETED|12 Month Visit||30
8859076|NCT01802216|9914744|FG000|NOT COMPLETED|12 Month Visit||3
8859077|NCT01802216|9914745|FG001|NOT COMPLETED|12 Month Visit||4
8859078|NCT01802320|9914751|FG000|STARTED|Overall Study||18
8859079|NCT01802320|9914751|FG000|COMPLETED|Overall Study||16
8859080|NCT01802320|9914751|FG000|NOT COMPLETED|Overall Study||2
8859081|NCT01802333|9914758|FG000|STARTED|Overall Study||263
8859082|NCT01802333|9914759|FG001|STARTED|Overall Study||267
8859083|NCT01802333|9914760|FG002|STARTED|Overall Study||224
8859084|NCT01802333|9914758|FG000|High Risk Patients|Overall Study||60
8859085|NCT01802333|9914759|FG001|High Risk Patients|Overall Study||61
8859086|NCT01802333|9914760|FG002|High Risk Patients|Overall Study||38
8859087|NCT01802333|9914758|FG000|High Risk Patients Achieved CR/CRi|Overall Study||38
8859088|NCT01802333|9914759|FG001|High Risk Patients Achieved CR/CRi|Overall Study||40
8859089|NCT01802333|9914760|FG002|High Risk Patients Achieved CR/CRi|Overall Study||29
8859090|NCT01802333|9914758|FG000|Known NPM1 Status at Baseline|Overall Study||169
8859091|NCT01802333|9914759|FG001|Known NPM1 Status at Baseline|Overall Study||156
8859092|NCT01802333|9914760|FG002|Known NPM1 Status at Baseline|Overall Study||142
8859093|NCT01802333|9914758|FG000|Known Cytogenetic Risk at Baseline|Overall Study||252
8859094|NCT01802333|9914759|FG001|Known Cytogenetic Risk at Baseline|Overall Study||250
8859095|NCT01802333|9914760|FG002|Known Cytogenetic Risk at Baseline|Overall Study||210
8859096|NCT01802333|9914758|FG000|COMPLETED|Overall Study||214
8859097|NCT01802333|9914759|FG001|COMPLETED|Overall Study||206
8859098|NCT01802333|9914760|FG002|COMPLETED|Overall Study||161
8859099|NCT01802333|9914758|FG000|NOT COMPLETED|Overall Study||49
8859100|NCT01802333|9914759|FG001|NOT COMPLETED|Overall Study||61
8859101|NCT01802333|9914760|FG002|NOT COMPLETED|Overall Study||63
8859102|NCT01802385|9914776|FG000|STARTED|Overall Study||231
8859103|NCT01802385|9914777|FG001|STARTED|Overall Study||229
8859104|NCT01802385|9914776|FG000|COMPLETED|Overall Study||125
8859105|NCT01802385|9914777|FG001|COMPLETED|Overall Study||109
8859106|NCT01802385|9914776|FG000|NOT COMPLETED|Overall Study||106
8859107|NCT01802385|9914777|FG001|NOT COMPLETED|Overall Study||120
8859108|NCT01802411|9914785|FG000|STARTED|Overall Study||96
8859109|NCT01802411|9914786|FG001|STARTED|Overall Study||95
8859110|NCT01802411|9914785|FG000|COMPLETED|Overall Study||82
8859111|NCT01802411|9914786|FG001|COMPLETED|Overall Study||74
8859112|NCT01802411|9914785|FG000|NOT COMPLETED|Overall Study||14
8859113|NCT01802411|9914786|FG001|NOT COMPLETED|Overall Study||21
8859114|NCT01802437|9914794|FG000|STARTED|Overall Study||20
8859115|NCT01802437|9914795|FG001|STARTED|Overall Study||20
8859116|NCT01802437|9914794|FG000|COMPLETED|Overall Study||16
8859117|NCT01802437|9914795|FG001|COMPLETED|Overall Study||16
8859118|NCT01802437|9914794|FG000|NOT COMPLETED|Overall Study||4
8859119|NCT01802437|9914795|FG001|NOT COMPLETED|Overall Study||4
8859120|NCT01802515|9914804|FG000|STARTED|Overall Study||5
8859121|NCT01802515|9914805|FG001|STARTED|Overall Study||5
8859122|NCT01802515|9914806|FG002|STARTED|Overall Study||4
8859123|NCT01802515|9914804|FG000|COMPLETED|Overall Study||2
8859124|NCT01802515|9914805|FG001|COMPLETED|Overall Study||5
8859125|NCT01802515|9914806|FG002|COMPLETED|Overall Study||4
8859126|NCT01802515|9914804|FG000|NOT COMPLETED|Overall Study||3
8859127|NCT01802515|9914805|FG001|NOT COMPLETED|Overall Study||0
8859128|NCT01802515|9914806|FG002|NOT COMPLETED|Overall Study||0
8859129|NCT01802554|9914816|FG000|STARTED|Overall Study||51
8859130|NCT01802554|9914817|FG001|STARTED|Overall Study||49
8859131|NCT01802554|9914816|FG000|COMPLETED|Overall Study||43
8859132|NCT01802554|9914817|FG001|COMPLETED|Overall Study||43
8859133|NCT01802554|9914816|FG000|NOT COMPLETED|Overall Study||8
8859134|NCT01802554|9914817|FG001|NOT COMPLETED|Overall Study||6
8859135|NCT01802580|9914825|FG000|STARTED|Overall Study||20
8859136|NCT01802580|9914826|FG001|STARTED|Overall Study||20
8859137|NCT01802580|9914825|FG000|COMPLETED|Overall Study||11
8859138|NCT01802580|9914826|FG001|COMPLETED|Overall Study||9
8859139|NCT01802580|9914825|FG000|NOT COMPLETED|Overall Study||9
8859140|NCT01802580|9914826|FG001|NOT COMPLETED|Overall Study||11
8859141|NCT01802710|9914834|FG000|STARTED|From T0 to T1||76
8859142|NCT01802710|9914835|FG001|STARTED|From T0 to T1||82
8859143|NCT01802710|9914834|FG000|COMPLETED|From T0 to T1||60
8859144|NCT01802710|9914835|FG001|COMPLETED|From T0 to T1||72
8859145|NCT01802710|9914834|FG000|NOT COMPLETED|From T0 to T1||16
8859146|NCT01802710|9914835|FG001|NOT COMPLETED|From T0 to T1||10
8859147|NCT01802710|9914834|FG000|STARTED|From T1 to T2||60
8859148|NCT01802710|9914835|FG001|STARTED|From T1 to T2||72
8859149|NCT01802710|9914834|FG000|COMPLETED|From T1 to T2||58
8859150|NCT01802710|9914835|FG001|COMPLETED|From T1 to T2||70
8859151|NCT01802710|9914834|FG000|NOT COMPLETED|From T1 to T2||2
8859152|NCT01802710|9914835|FG001|NOT COMPLETED|From T1 to T2||2
8859153|NCT01802775|9914845|FG000|STARTED|Overall Study||102
8859154|NCT01802775|9914846|FG001|STARTED|Overall Study||101
8859155|NCT01802775|9914845|FG000|Received Drug (Safety Analysis Set)|Overall Study||101
8859156|NCT01802775|9914846|FG001|Received Drug (Safety Analysis Set)|Overall Study||100
8859157|NCT01802775|9914845|FG000|COMPLETED|Overall Study||96
8859158|NCT01802775|9914846|FG001|COMPLETED|Overall Study||89
8859159|NCT01802775|9914845|FG000|NOT COMPLETED|Overall Study||6
8859160|NCT01802775|9914846|FG001|NOT COMPLETED|Overall Study||12
8859161|NCT01802879|9914852|FG000|STARTED|Overall Study||8
8859162|NCT01802879|9914852|FG000|COMPLETED|Overall Study||0
8859163|NCT01802879|9914852|FG000|NOT COMPLETED|Overall Study||8
8859164|NCT01803074|9914870|FG000|STARTED|Period 1: Part A (HIV-1 Clade B)||8
8859165|NCT01803074|9914871|FG001|STARTED|Period 1: Part A (HIV-1 Clade B)||8
8859166|NCT01803074|9914872|FG002|STARTED|Period 1: Part A (HIV-1 Clade B)||8
8859167|NCT01803074|9914873|FG003|STARTED|Period 1: Part A (HIV-1 Clade B)||8
8859168|NCT01803074|9914874|FG004|STARTED|Period 1: Part A (HIV-1 Clade B)||8
8859169|NCT01803074|9914875|FG005|STARTED|Period 1: Part A (HIV-1 Clade B)||8
8859170|NCT01803074|9914876|FG006|STARTED|Period 1: Part A (HIV-1 Clade B)||12
8859171|NCT01803074|9914877|FG007|STARTED|Period 1: Part A (HIV-1 Clade B)||0
8859172|NCT01803074|9914878|FG008|STARTED|Period 1: Part A (HIV-1 Clade B)||0
8859173|NCT01803074|9914879|FG009|STARTED|Period 1: Part A (HIV-1 Clade B)||0
8859174|NCT01803074|9914880|FG010|STARTED|Period 1: Part A (HIV-1 Clade B)||0
8859175|NCT01803074|9914881|FG011|STARTED|Period 1: Part A (HIV-1 Clade B)||0
8859176|NCT01803074|9914882|FG012|STARTED|Period 1: Part A (HIV-1 Clade B)||0
8859177|NCT01803074|9914883|FG013|STARTED|Period 1: Part A (HIV-1 Clade B)||0
8859178|NCT01803074|9914870|FG000|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
8859179|NCT01803074|9914871|FG001|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
8859180|NCT01803074|9914872|FG002|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
8859181|NCT01803074|9914873|FG003|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
8859182|NCT01803074|9914874|FG004|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
8859183|NCT01803074|9914875|FG005|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
8859184|NCT01803074|9914876|FG006|COMPLETED|Period 1: Part A (HIV-1 Clade B)||12
8859185|NCT01803074|9914877|FG007|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
8859186|NCT01803074|9914878|FG008|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
8859187|NCT01803074|9914879|FG009|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
8859188|NCT01803074|9914880|FG010|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
8859189|NCT01803074|9914881|FG011|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
8859190|NCT01803074|9914882|FG012|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
8859191|NCT01803074|9914883|FG013|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
8859192|NCT01803074|9914870|FG000|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
8859193|NCT01803074|9914871|FG001|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
8859194|NCT01803074|9914872|FG002|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
8859195|NCT01803074|9914873|FG003|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
8859196|NCT01803074|9914874|FG004|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
8859197|NCT01803074|9914875|FG005|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
8859198|NCT01803074|9914876|FG006|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
8859199|NCT01803074|9914877|FG007|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
8859200|NCT01803074|9914878|FG008|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
8859201|NCT01803074|9914879|FG009|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
8859202|NCT01803074|9914880|FG010|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
8859203|NCT01803074|9914881|FG011|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
8859204|NCT01803074|9914882|FG012|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
8859205|NCT01803074|9914883|FG013|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
8859206|NCT01803074|9914870|FG000|STARTED|Period 2: Part B (HIV-1 Clade B)||0
8859207|NCT01803074|9914871|FG001|STARTED|Period 2: Part B (HIV-1 Clade B)||0
8859208|NCT01803074|9914872|FG002|STARTED|Period 2: Part B (HIV-1 Clade B)||0
8859209|NCT01803074|9914873|FG003|STARTED|Period 2: Part B (HIV-1 Clade B)||0
8859210|NCT01803074|9914874|FG004|STARTED|Period 2: Part B (HIV-1 Clade B)||0
8859211|NCT01803074|9914875|FG005|STARTED|Period 2: Part B (HIV-1 Clade B)||0
8859212|NCT01803074|9914876|FG006|STARTED|Period 2: Part B (HIV-1 Clade B)||0
8859213|NCT01803074|9914877|FG007|STARTED|Period 2: Part B (HIV-1 Clade B)||8
8859214|NCT01803074|9914878|FG008|STARTED|Period 2: Part B (HIV-1 Clade B)||8
8859215|NCT01803074|9914879|FG009|STARTED|Period 2: Part B (HIV-1 Clade B)||4
8859216|NCT01803074|9914880|FG010|STARTED|Period 2: Part B (HIV-1 Clade B)||8
8859217|NCT01803074|9914881|FG011|STARTED|Period 2: Part B (HIV-1 Clade B)||0
8859218|NCT01803074|9914882|FG012|STARTED|Period 2: Part B (HIV-1 Clade B)||0
8859219|NCT01803074|9914883|FG013|STARTED|Period 2: Part B (HIV-1 Clade B)||0
8859220|NCT01803074|9914870|FG000|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
8859221|NCT01803074|9914871|FG001|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
8859222|NCT01803074|9914872|FG002|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
8859223|NCT01803074|9914873|FG003|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
8859224|NCT01803074|9914874|FG004|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
8859225|NCT01803074|9914875|FG005|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
8859226|NCT01803074|9914876|FG006|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
8859227|NCT01803074|9914877|FG007|COMPLETED|Period 2: Part B (HIV-1 Clade B)||8
8859228|NCT01803074|9914878|FG008|COMPLETED|Period 2: Part B (HIV-1 Clade B)||8
8859229|NCT01803074|9914879|FG009|COMPLETED|Period 2: Part B (HIV-1 Clade B)||4
8859230|NCT01803074|9914880|FG010|COMPLETED|Period 2: Part B (HIV-1 Clade B)||8
8859231|NCT01803074|9914881|FG011|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
8859232|NCT01803074|9914882|FG012|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
8859233|NCT01803074|9914883|FG013|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
8859234|NCT01803074|9914870|FG000|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
8859235|NCT01803074|9914871|FG001|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
8859236|NCT01803074|9914872|FG002|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
8859237|NCT01803074|9914873|FG003|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
8859238|NCT01803074|9914874|FG004|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
8859239|NCT01803074|9914875|FG005|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
8859240|NCT01803074|9914876|FG006|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
8859241|NCT01803074|9914877|FG007|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
8859242|NCT01803074|9914878|FG008|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
8859243|NCT01803074|9914879|FG009|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
8859244|NCT01803074|9914880|FG010|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
8859245|NCT01803074|9914881|FG011|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
8859246|NCT01803074|9914882|FG012|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
8859247|NCT01803074|9914883|FG013|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
8859248|NCT01803074|9914870|FG000|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
8859249|NCT01803074|9914871|FG001|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
8859250|NCT01803074|9914872|FG002|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
8859251|NCT01803074|9914873|FG003|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
8859252|NCT01803074|9914874|FG004|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
8859253|NCT01803074|9914875|FG005|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
8859254|NCT01803074|9914876|FG006|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
8859255|NCT01803074|9914877|FG007|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
8859256|NCT01803074|9914878|FG008|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
8859257|NCT01803074|9914879|FG009|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
8859258|NCT01803074|9914880|FG010|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
8859259|NCT01803074|9914881|FG011|STARTED|Period 3: Part C (HIV-1 Clade C Only)||8
8859260|NCT01803074|9914882|FG012|STARTED|Period 3: Part C (HIV-1 Clade C Only)||7
8859261|NCT01803074|9914883|FG013|STARTED|Period 3: Part C (HIV-1 Clade C Only)||4
8859262|NCT01803074|9914870|FG000|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8859263|NCT01803074|9914871|FG001|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8859264|NCT01803074|9914872|FG002|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8859265|NCT01803074|9914873|FG003|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8859266|NCT01803074|9914874|FG004|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8859267|NCT01803074|9914875|FG005|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8859268|NCT01803074|9914876|FG006|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8859269|NCT01803074|9914877|FG007|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8859270|NCT01803074|9914878|FG008|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8859271|NCT01803074|9914879|FG009|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8859272|NCT01803074|9914880|FG010|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8859273|NCT01803074|9914881|FG011|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||8
8859274|NCT01803074|9914882|FG012|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||7
8859275|NCT01803074|9914883|FG013|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||4
8859276|NCT01803074|9914870|FG000|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8859277|NCT01803074|9914871|FG001|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8859278|NCT01803074|9914872|FG002|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8859279|NCT01803074|9914873|FG003|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8859280|NCT01803074|9914874|FG004|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8859281|NCT01803074|9914875|FG005|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8859282|NCT01803074|9914876|FG006|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8859283|NCT01803074|9914877|FG007|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8859284|NCT01803074|9914878|FG008|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8859285|NCT01803074|9914879|FG009|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8859286|NCT01803074|9914880|FG010|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8859287|NCT01803074|9914881|FG011|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8859288|NCT01803074|9914882|FG012|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8859289|NCT01803074|9914883|FG013|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8859290|NCT01803204|9914924|FG000|STARTED|Overall Study||20
8859291|NCT01803204|9914925|FG001|STARTED|Overall Study||20
8859292|NCT01803204|9914924|FG000|COMPLETED|Overall Study||20
8859293|NCT01803204|9914925|FG001|COMPLETED|Overall Study||20
8859294|NCT01803204|9914924|FG000|NOT COMPLETED|Overall Study||0
8859295|NCT01803204|9914925|FG001|NOT COMPLETED|Overall Study||0
8859296|NCT01803269|9914934|FG000|STARTED|Overall Study||7
8859297|NCT01803269|9914935|FG001|STARTED|Overall Study||8
8859298|NCT01803269|9914936|FG002|STARTED|Overall Study||14
8859299|NCT01803269|9914934|FG000|COMPLETED|Overall Study||4
8859300|NCT01803269|9914935|FG001|COMPLETED|Overall Study||8
8859301|NCT01803269|9914936|FG002|COMPLETED|Overall Study||14
8859302|NCT01803269|9914934|FG000|NOT COMPLETED|Overall Study||3
8859303|NCT01803269|9914935|FG001|NOT COMPLETED|Overall Study||0
8859304|NCT01803269|9914936|FG002|NOT COMPLETED|Overall Study||0
8859305|NCT01803282|9914956|FG000|STARTED|Overall Study||4
8859306|NCT01803282|9914957|FG001|STARTED|Overall Study||3
8859307|NCT01803282|9914958|FG002|STARTED|Overall Study||6
8859308|NCT01803282|9914959|FG003|STARTED|Overall Study||36
8859309|NCT01803282|9914960|FG004|STARTED|Overall Study||11
8859310|NCT01803282|9914961|FG005|STARTED|Overall Study||10
8859311|NCT01803282|9914962|FG006|STARTED|Overall Study||41
8859312|NCT01803282|9914963|FG007|STARTED|Overall Study||46
8859313|NCT01803282|9914964|FG008|STARTED|Overall Study||11
8859314|NCT01803282|9914965|FG009|STARTED|Overall Study||45
8859315|NCT01803282|9914966|FG010|STARTED|Overall Study||8
8859316|NCT01803282|9914967|FG011|STARTED|Overall Study||15
8859317|NCT01803282|9914956|FG000|COMPLETED|Overall Study||0
8859318|NCT01803282|9914957|FG001|COMPLETED|Overall Study||0
8859319|NCT01803282|9914958|FG002|COMPLETED|Overall Study||0
8859320|NCT01803282|9914959|FG003|COMPLETED|Overall Study||0
8859321|NCT01803282|9914960|FG004|COMPLETED|Overall Study||0
8859322|NCT01803282|9914961|FG005|COMPLETED|Overall Study||0
8859323|NCT01803282|9914962|FG006|COMPLETED|Overall Study||0
8859324|NCT01803282|9914963|FG007|COMPLETED|Overall Study||0
8859325|NCT01803282|9914964|FG008|COMPLETED|Overall Study||0
8859326|NCT01803282|9914965|FG009|COMPLETED|Overall Study||0
8859327|NCT01803282|9914966|FG010|COMPLETED|Overall Study||0
8859328|NCT01803282|9914967|FG011|COMPLETED|Overall Study||0
8859329|NCT01803282|9914956|FG000|NOT COMPLETED|Overall Study||4
8859330|NCT01803282|9914957|FG001|NOT COMPLETED|Overall Study||3
8859331|NCT01803282|9914958|FG002|NOT COMPLETED|Overall Study||6
8859332|NCT01803282|9914959|FG003|NOT COMPLETED|Overall Study||36
8859333|NCT01803282|9914960|FG004|NOT COMPLETED|Overall Study||11
8859334|NCT01803282|9914961|FG005|NOT COMPLETED|Overall Study||10
8859335|NCT01803282|9914962|FG006|NOT COMPLETED|Overall Study||41
8859336|NCT01803282|9914963|FG007|NOT COMPLETED|Overall Study||46
8859337|NCT01803282|9914964|FG008|NOT COMPLETED|Overall Study||11
8859338|NCT01803282|9914965|FG009|NOT COMPLETED|Overall Study||45
8859339|NCT01803282|9914966|FG010|NOT COMPLETED|Overall Study||8
8859340|NCT01803282|9914967|FG011|NOT COMPLETED|Overall Study||15
8859341|NCT01803464|9914997|FG000|STARTED|Overall Study||5
8859342|NCT01803464|9914998|FG001|STARTED|Overall Study||4
8859343|NCT01803464|9914999|FG002|STARTED|Overall Study||10
8859344|NCT01803464|9915000|FG003|STARTED|Overall Study||10
8859345|NCT01803464|9914997|FG000|COMPLETED|Overall Study||4
8859346|NCT01803464|9914998|FG001|COMPLETED|Overall Study||4
8859347|NCT01803464|9914999|FG002|COMPLETED|Overall Study||6
8859348|NCT01803464|9915000|FG003|COMPLETED|Overall Study||10
8859349|NCT01803464|9914997|FG000|NOT COMPLETED|Overall Study||1
8859350|NCT01803464|9914998|FG001|NOT COMPLETED|Overall Study||0
8859351|NCT01803464|9914999|FG002|NOT COMPLETED|Overall Study||4
8859352|NCT01803464|9915000|FG003|NOT COMPLETED|Overall Study||0
8859353|NCT01803607|9915016|FG000|STARTED|Overall Study||68
8859354|NCT01803607|9915017|FG001|STARTED|Overall Study||67
8859355|NCT01803607|9915016|FG000|COMPLETED|Overall Study||0
8859356|NCT01803607|9915017|FG001|COMPLETED|Overall Study||0
8859357|NCT01803607|9915016|FG000|NOT COMPLETED|Overall Study||68
8859358|NCT01803607|9915017|FG001|NOT COMPLETED|Overall Study||67
8859359|NCT01803646|9915025|FG000|STARTED|Overall Study||204
8859360|NCT01803646|9915026|FG001|STARTED|Overall Study||139
8859361|NCT01803646|9915025|FG000|COMPLETED|Overall Study||187
8859362|NCT01803646|9915026|FG001|COMPLETED|Overall Study||129
8859363|NCT01803646|9915025|FG000|NOT COMPLETED|Overall Study||17
8859364|NCT01803646|9915026|FG001|NOT COMPLETED|Overall Study||10
8859365|NCT01803737|9915034|FG000|STARTED|Overall Study||13
8859366|NCT01803737|9915035|FG001|STARTED|Overall Study||13
8859367|NCT01803737|9915034|FG000|COMPLETED|Overall Study||12
8859368|NCT01803737|9915035|FG001|COMPLETED|Overall Study||10
8859369|NCT01803737|9915034|FG000|NOT COMPLETED|Overall Study||1
8859370|NCT01803737|9915035|FG001|NOT COMPLETED|Overall Study||3
8859371|NCT01803880|9915044|FG000|STARTED|Overall Study||19
8859372|NCT01803880|9915045|FG001|STARTED|Overall Study||28
8859373|NCT01803880|9915046|FG002|STARTED|Overall Study||29
8859374|NCT01803880|9915044|FG000|COMPLETED|Overall Study||13
8859375|NCT01803880|9915045|FG001|COMPLETED|Overall Study||18
8859376|NCT01803880|9915046|FG002|COMPLETED|Overall Study||14
8859377|NCT01803880|9915044|FG000|NOT COMPLETED|Overall Study||6
8859378|NCT01803880|9915045|FG001|NOT COMPLETED|Overall Study||10
8859379|NCT01803880|9915046|FG002|NOT COMPLETED|Overall Study||15
8859380|NCT01804036|9915058|FG000|STARTED|Overall Study||31
8859381|NCT01804036|9915059|FG001|STARTED|Overall Study||41
8859382|NCT01804036|9915058|FG000|COMPLETED|Overall Study||18
8859383|NCT01804036|9915059|FG001|COMPLETED|Overall Study||21
8859384|NCT01804036|9915058|FG000|NOT COMPLETED|Overall Study||13
8859385|NCT01804036|9915059|FG001|NOT COMPLETED|Overall Study||20
8859386|NCT01804049|9915068|FG000|STARTED|Overall Study||43
8859387|NCT01804049|9915069|FG001|STARTED|Overall Study||77
8859388|NCT01804049|9915068|FG000|COMPLETED|Overall Study||32
8859389|NCT01804049|9915069|FG001|COMPLETED|Overall Study||45
8859390|NCT01804049|9915068|FG000|NOT COMPLETED|Overall Study||11
8859391|NCT01804049|9915069|FG001|NOT COMPLETED|Overall Study||32
8859392|NCT01804062|9915077|FG000|STARTED|Overall Study||30
8859393|NCT01804062|9915077|FG000|COMPLETED|Overall Study||30
8859394|NCT01804062|9915077|FG000|NOT COMPLETED|Overall Study||0
8859395|NCT01804075|9915083|FG000|STARTED|Overall Study||15
8859396|NCT01804075|9915084|FG001|STARTED|Overall Study||16
8859397|NCT01804075|9915083|FG000|COMPLETED|Overall Study||15
8859398|NCT01804075|9915084|FG001|COMPLETED|Overall Study||16
8859399|NCT01804075|9915083|FG000|NOT COMPLETED|Overall Study||0
8630067|NCT00533897|9669846|FG003|NOT COMPLETED|Lead-in (LI) Period 1||0
8630068|NCT00533897|9669847|FG004|NOT COMPLETED|Lead-in (LI) Period 1||0
8630069|NCT00533897|9669848|FG005|NOT COMPLETED|Lead-in (LI) Period 1||0
8630070|NCT00533897|9669849|FG006|NOT COMPLETED|Lead-in (LI) Period 1||0
8630071|NCT00533897|9669850|FG007|NOT COMPLETED|Lead-in (LI) Period 1||0
8630072|NCT00533897|9669843|FG000|STARTED|Double-blind Withdrawal (DBW) Period 2||0
8630073|NCT00533897|9669844|FG001|STARTED|Double-blind Withdrawal (DBW) Period 2||40
8630074|NCT00533897|9669845|FG002|STARTED|Double-blind Withdrawal (DBW) Period 2||80
8630075|NCT00533897|9669846|FG003|STARTED|Double-blind Withdrawal (DBW) Period 2||0
8630076|NCT00533897|9669847|FG004|STARTED|Double-blind Withdrawal (DBW) Period 2||0
8630077|NCT00533897|9669848|FG005|STARTED|Double-blind Withdrawal (DBW) Period 2||0
8859400|NCT01804075|9915084|FG001|NOT COMPLETED|Overall Study||0
8859401|NCT01804101|9915094|FG000|STARTED|Overall Study||38
8859402|NCT01804101|9915095|FG001|STARTED|Overall Study||10
8859403|NCT01804101|9915094|FG000|COMPLETED|Overall Study||38
8859404|NCT01804101|9915095|FG001|COMPLETED|Overall Study||10
8859405|NCT01804101|9915094|FG000|NOT COMPLETED|Overall Study||0
8859406|NCT01804101|9915095|FG001|NOT COMPLETED|Overall Study||0
8859407|NCT01804114|9915105|FG000|STARTED|Overall Study||17
8859408|NCT01804114|9915106|FG001|STARTED|Overall Study||12
8859409|NCT01804114|9915105|FG000|COMPLETED|Overall Study||17
8859410|NCT01804114|9915106|FG001|COMPLETED|Overall Study||12
8859411|NCT01804114|9915105|FG000|NOT COMPLETED|Overall Study||0
8859412|NCT01804114|9915106|FG001|NOT COMPLETED|Overall Study||0
8859413|NCT01804140|9915112|FG000|STARTED|Overall Study|This includes all the participants who were enrolled for this study.|662
8859414|NCT01804140|9915112|FG000|COMPLETED|Overall Study|This includes all the participants with mutation results from the sampling or biopsy procedures.|548
8859415|NCT01804140|9915112|FG000|NOT COMPLETED|Overall Study||114
8859416|NCT01804257|9915116|FG000|STARTED|Overall Study||28
8859417|NCT01804257|9915116|FG000|COMPLETED|Overall Study||27
8859418|NCT01804257|9915116|FG000|NOT COMPLETED|Overall Study||1
8859419|NCT01804465|9915122|FG000|STARTED|Overall Study||24
8859420|NCT01804465|9915123|FG001|STARTED|Overall Study||26
8859421|NCT01804465|9915122|FG000|COMPLETED|Overall Study||24
8859422|NCT01804465|9915123|FG001|COMPLETED|Overall Study||26
8859423|NCT01804465|9915122|FG000|NOT COMPLETED|Overall Study||0
8859424|NCT01804465|9915123|FG001|NOT COMPLETED|Overall Study||0
8859425|NCT01804582|9915131|FG000|STARTED|Overall Study||177
8859426|NCT01804582|9915132|FG001|STARTED|Overall Study||173
8859427|NCT01804582|9915131|FG000|COMPLETED|Overall Study||128
8859428|NCT01804582|9915132|FG001|COMPLETED|Overall Study||117
8859429|NCT01804582|9915131|FG000|NOT COMPLETED|Overall Study||49
8859430|NCT01804582|9915132|FG001|NOT COMPLETED|Overall Study||56
8859431|NCT01804673|9915139|FG000|STARTED|Overall Study||174
8859432|NCT01804673|9915139|FG000|Completed Hour 24|Overall Study||170
8859433|NCT01804673|9915139|FG000|Completed Hour 48|Overall Study||79
8859434|NCT01804673|9915139|FG000|Completed Hour 72|Overall Study||36
8859435|NCT01804673|9915139|FG000|COMPLETED|Overall Study||34
8859436|NCT01804673|9915139|FG000|NOT COMPLETED|Overall Study||140
8859437|NCT01804842|9915146|FG000|STARTED|Overall Study||9
8859438|NCT01804842|9915147|FG001|STARTED|Overall Study||8
8859439|NCT01804842|9915148|FG002|STARTED|Overall Study||9
8859440|NCT01804842|9915146|FG000|Completed Treatment A|Overall Study||9
8859441|NCT01804842|9915147|FG001|Completed Treatment A|Overall Study||6
8859442|NCT01804842|9915148|FG002|Completed Treatment A|Overall Study||8
8859443|NCT01804842|9915146|FG000|Completed Treatment B|Overall Study||8
8859444|NCT01804842|9915147|FG001|Completed Treatment B|Overall Study||8
8859445|NCT01804842|9915148|FG002|Completed Treatment B|Overall Study||8
8859446|NCT01804842|9915146|FG000|Completed Treatment C|Overall Study||7
8859447|NCT01804842|9915147|FG001|Completed Treatment C|Overall Study||7
8859448|NCT01804842|9915148|FG002|Completed Treatment C|Overall Study||9
8859449|NCT01804842|9915146|FG000|COMPLETED|Overall Study||6
8859450|NCT01804842|9915147|FG001|COMPLETED|Overall Study||6
8859451|NCT01804842|9915148|FG002|COMPLETED|Overall Study||8
8859452|NCT01804842|9915146|FG000|NOT COMPLETED|Overall Study||3
8859453|NCT01804842|9915147|FG001|NOT COMPLETED|Overall Study||2
8859454|NCT01804842|9915148|FG002|NOT COMPLETED|Overall Study||1
8859455|NCT01804881|9915158|FG000|STARTED|Overall Study||16
8859456|NCT01804881|9915159|FG001|STARTED|Overall Study||14
8859457|NCT01804881|9915158|FG000|COMPLETED|Overall Study||11
8859458|NCT01804881|9915159|FG001|COMPLETED|Overall Study||10
8859459|NCT01804881|9915158|FG000|NOT COMPLETED|Overall Study||5
8630078|NCT00533897|9669849|FG006|STARTED|Double-blind Withdrawal (DBW) Period 2||0
8630079|NCT00533897|9669850|FG007|STARTED|Double-blind Withdrawal (DBW) Period 2||0
8859460|NCT01804881|9915159|FG001|NOT COMPLETED|Overall Study||4
8859461|NCT01804946|9915169|FG000|STARTED|Overall Study||81
8859462|NCT01804946|9915170|FG001|STARTED|Overall Study||80
8859463|NCT01804946|9915169|FG000|COMPLETED|Overall Study||79
8859464|NCT01804946|9915170|FG001|COMPLETED|Overall Study||76
8859465|NCT01804946|9915169|FG000|NOT COMPLETED|Overall Study||2
8859466|NCT01804946|9915170|FG001|NOT COMPLETED|Overall Study||4
8859467|NCT01805024|9915182|FG000|STARTED|Overall Study||4
8859468|NCT01805024|9915183|FG001|STARTED|Overall Study||4
8859469|NCT01805024|9915184|FG002|STARTED|Overall Study||4
8859470|NCT01805024|9915185|FG003|STARTED|Overall Study||8
8859471|NCT01805024|9915182|FG000|COMPLETED|Overall Study||4
8859472|NCT01805024|9915183|FG001|COMPLETED|Overall Study||4
8859473|NCT01805024|9915184|FG002|COMPLETED|Overall Study||4
8859474|NCT01805024|9915185|FG003|COMPLETED|Overall Study||8
8859475|NCT01805024|9915182|FG000|NOT COMPLETED|Overall Study||0
8859476|NCT01805024|9915183|FG001|NOT COMPLETED|Overall Study||0
8859477|NCT01805024|9915184|FG002|NOT COMPLETED|Overall Study||0
8859478|NCT01805024|9915185|FG003|NOT COMPLETED|Overall Study||0
8859479|NCT01805037|9915195|FG000|STARTED|Induction (4 Weeks)||0
8859480|NCT01805037|9915196|FG001|STARTED|Induction (4 Weeks)||20
8859481|NCT01805037|9915195|FG000|Received Dose of Study Drug|Induction (4 Weeks)||0
8859482|NCT01805037|9915196|FG001|Received Dose of Study Drug|Induction (4 Weeks)||20
8859483|NCT01805037|9915195|FG000|COMPLETED|Induction (4 Weeks)||0
8859484|NCT01805037|9915196|FG001|COMPLETED|Induction (4 Weeks)||20
8859485|NCT01805037|9915195|FG000|NOT COMPLETED|Induction (4 Weeks)||0
8859486|NCT01805037|9915196|FG001|NOT COMPLETED|Induction (4 Weeks)||0
8859487|NCT01805037|9915195|FG000|STARTED|Consolidation (Optional, 4 Weeks)||0
8859488|NCT01805037|9915196|FG001|STARTED|Consolidation (Optional, 4 Weeks)|Consolidation is optional for patients who have a partial or complete response during induction.|6
8859489|NCT01805037|9915195|FG000|Received Dose of Study Drug|Consolidation (Optional, 4 Weeks)||0
8859490|NCT01805037|9915196|FG001|Received Dose of Study Drug|Consolidation (Optional, 4 Weeks)||6
8859491|NCT01805037|9915195|FG000|COMPLETED|Consolidation (Optional, 4 Weeks)||0
8859492|NCT01805037|9915196|FG001|COMPLETED|Consolidation (Optional, 4 Weeks)||6
8859493|NCT01805037|9915195|FG000|NOT COMPLETED|Consolidation (Optional, 4 Weeks)||0
8859494|NCT01805037|9915196|FG001|NOT COMPLETED|Consolidation (Optional, 4 Weeks)||0
8859495|NCT01805037|9915195|FG000|STARTED|1st Cycle of Maintenance (3 Weeks)||0
8859496|NCT01805037|9915196|FG001|STARTED|1st Cycle of Maintenance (3 Weeks)|Consolidation is optional for patients who have a partial or complete response during induction|20
8859497|NCT01805037|9915195|FG000|Received Dose of Study Drug|1st Cycle of Maintenance (3 Weeks)||0
8859498|NCT01805037|9915196|FG001|Received Dose of Study Drug|1st Cycle of Maintenance (3 Weeks)||14
8859499|NCT01805037|9915195|FG000|COMPLETED|1st Cycle of Maintenance (3 Weeks)||0
8859500|NCT01805037|9915196|FG001|COMPLETED|1st Cycle of Maintenance (3 Weeks)||14
8569658|NCT00098306|9601868|FG003|Treated|Double Blind||0
8569659|NCT00098306|9601869|FG004|Treated|Double Blind||0
8569660|NCT00098306|9601870|FG005|Treated|Double Blind||0
8569661|NCT00098306|9601871|FG006|Treated|Double Blind||0
8569662|NCT00098306|9601865|FG000|COMPLETED|Double Blind||0
8569663|NCT00098306|9601866|FG001|COMPLETED|Double Blind||0
8569664|NCT00098306|9601867|FG002|COMPLETED|Double Blind||0
8569665|NCT00098306|9601868|FG003|COMPLETED|Double Blind||0
8569666|NCT00098306|9601869|FG004|COMPLETED|Double Blind||0
8569667|NCT00098306|9601870|FG005|COMPLETED|Double Blind||0
8569668|NCT00098306|9601871|FG006|COMPLETED|Double Blind||0
8569669|NCT00098306|9601865|FG000|NOT COMPLETED|Double Blind||241
8569670|NCT00098306|9601866|FG001|NOT COMPLETED|Double Blind||240
8569671|NCT00098306|9601867|FG002|NOT COMPLETED|Double Blind||120
8569672|NCT00098306|9601868|FG003|NOT COMPLETED|Double Blind||0
8569673|NCT00098306|9601869|FG004|NOT COMPLETED|Double Blind||0
8569674|NCT00098306|9601870|FG005|NOT COMPLETED|Double Blind||0
8569675|NCT00098306|9601871|FG006|NOT COMPLETED|Double Blind||0
8569676|NCT00098306|9601865|FG000|STARTED|Open Label||0
8569677|NCT00098306|9601866|FG001|STARTED|Open Label||0
8569678|NCT00098306|9601867|FG002|STARTED|Open Label||0
8569679|NCT00098306|9601868|FG003|STARTED|Open Label||327
8569680|NCT00098306|9601869|FG004|STARTED|Open Label||62
8569681|NCT00098306|9601870|FG005|STARTED|Open Label||0
8569682|NCT00098306|9601871|FG006|STARTED|Open Label||0
8569683|NCT00098306|9601865|FG000|COMPLETED|Open Label||0
8569684|NCT00098306|9601866|FG001|COMPLETED|Open Label||0
8569685|NCT00098306|9601867|FG002|COMPLETED|Open Label||0
8569686|NCT00098306|9601868|FG003|COMPLETED|Open Label||0
8569687|NCT00098306|9601869|FG004|COMPLETED|Open Label||0
8569688|NCT00098306|9601870|FG005|COMPLETED|Open Label||0
8569689|NCT00098306|9601871|FG006|COMPLETED|Open Label||0
8569690|NCT00098306|9601865|FG000|NOT COMPLETED|Open Label||0
8569691|NCT00098306|9601866|FG001|NOT COMPLETED|Open Label||0
8859501|NCT01805037|9915195|FG000|NOT COMPLETED|1st Cycle of Maintenance (3 Weeks)||0
8859502|NCT01805037|9915196|FG001|NOT COMPLETED|1st Cycle of Maintenance (3 Weeks)||6
8859503|NCT01805037|9915195|FG000|STARTED|2nd Cycle of Maintenance and Beyond||0
8859504|NCT01805037|9915196|FG001|STARTED|2nd Cycle of Maintenance and Beyond||14
8859505|NCT01805037|9915195|FG000|Received Dose of Study Drug|2nd Cycle of Maintenance and Beyond||0
8859506|NCT01805037|9915196|FG001|Received Dose of Study Drug|2nd Cycle of Maintenance and Beyond||14
8859507|NCT01805037|9915195|FG000|COMPLETED|2nd Cycle of Maintenance and Beyond||0
8859508|NCT01805037|9915196|FG001|COMPLETED|2nd Cycle of Maintenance and Beyond||2
8859509|NCT01805037|9915195|FG000|NOT COMPLETED|2nd Cycle of Maintenance and Beyond||0
8859510|NCT01805037|9915196|FG001|NOT COMPLETED|2nd Cycle of Maintenance and Beyond||12
8859511|NCT01805037|9915195|FG000|STARTED|Follow Up (up to 3 Years)||0
8859512|NCT01805037|9915196|FG001|STARTED|Follow Up (up to 3 Years)|Patients who received at least one dose of study treatment go into follow-up.|20
8859513|NCT01805037|9915195|FG000|COMPLETED|Follow Up (up to 3 Years)||0
8859514|NCT01805037|9915196|FG001|COMPLETED|Follow Up (up to 3 Years)||14
8859515|NCT01805037|9915195|FG000|NOT COMPLETED|Follow Up (up to 3 Years)||0
8859516|NCT01805037|9915196|FG001|NOT COMPLETED|Follow Up (up to 3 Years)||6
8859517|NCT01805089|9915202|FG000|STARTED|Overall Study||48
8859518|NCT01805089|9915203|FG001|STARTED|Overall Study||47
8859519|NCT01805089|9915202|FG000|COMPLETED|Overall Study||43
8859520|NCT01805089|9915203|FG001|COMPLETED|Overall Study||43
8859521|NCT01805089|9915202|FG000|NOT COMPLETED|Overall Study||5
8859522|NCT01805089|9915203|FG001|NOT COMPLETED|Overall Study||4
8859523|NCT01805154|9915209|FG000|STARTED|Overall Study||1529
8859524|NCT01805154|9915209|FG000|COMPLETED|Overall Study||1175
8859525|NCT01805154|9915209|FG000|NOT COMPLETED|Overall Study||354
8859526|NCT01805180|9915218|FG000|STARTED|Lead-in Donor Phase||7
8859527|NCT01805180|9915219|FG001|STARTED|Lead-in Donor Phase|pivotal trial subjects were not screened or enrolled in this period.|0
8859528|NCT01805180|9915220|FG002|STARTED|Lead-in Donor Phase|pivotal trial subjects were not screened or enrolled in this period.|0
8859529|NCT01805180|9915218|FG000|COMPLETED|Lead-in Donor Phase||6
8859530|NCT01805180|9915219|FG001|COMPLETED|Lead-in Donor Phase||0
8859531|NCT01805180|9915220|FG002|COMPLETED|Lead-in Donor Phase||0
8859532|NCT01805180|9915218|FG000|NOT COMPLETED|Lead-in Donor Phase||1
8859533|NCT01805180|9915219|FG001|NOT COMPLETED|Lead-in Donor Phase||0
8859534|NCT01805180|9915220|FG002|NOT COMPLETED|Lead-in Donor Phase||0
8859535|NCT01805180|9915218|FG000|STARTED|Pivotal Randomization Through Study Exit|lead-in donors were not randomized and did not participate in this period.|0
8859536|NCT01805180|9915219|FG001|STARTED|Pivotal Randomization Through Study Exit||22
8859537|NCT01805180|9915220|FG002|STARTED|Pivotal Randomization Through Study Exit||20
8859538|NCT01805180|9915218|FG000|COMPLETED|Pivotal Randomization Through Study Exit||0
8859539|NCT01805180|9915219|FG001|COMPLETED|Pivotal Randomization Through Study Exit||17
8859540|NCT01805180|9915220|FG002|COMPLETED|Pivotal Randomization Through Study Exit||15
8859541|NCT01805180|9915218|FG000|NOT COMPLETED|Pivotal Randomization Through Study Exit||0
8859542|NCT01805180|9915219|FG001|NOT COMPLETED|Pivotal Randomization Through Study Exit||5
8859543|NCT01805180|9915220|FG002|NOT COMPLETED|Pivotal Randomization Through Study Exit||5
8859544|NCT01805297|9915230|FG000|STARTED|Overall Study||6
8859545|NCT01805297|9915231|FG001|STARTED|Overall Study||6
8859546|NCT01805297|9915230|FG000|COMPLETED|Overall Study||4
8859547|NCT01805297|9915231|FG001|COMPLETED|Overall Study||3
8859548|NCT01805297|9915230|FG000|NOT COMPLETED|Overall Study||2
8859549|NCT01805297|9915231|FG001|NOT COMPLETED|Overall Study||3
8859550|NCT01805323|9915238|FG000|STARTED|Overall Study||101
8859551|NCT01805323|9915238|FG000|COMPLETED|Overall Study||101
8859552|NCT01805323|9915238|FG000|NOT COMPLETED|Overall Study||0
8859553|NCT01805440|9915245|FG000|STARTED|Overall Study||19
8859554|NCT01805440|9915246|FG001|STARTED|Overall Study||17
8859555|NCT01805440|9915247|FG002|STARTED|Overall Study||26
8859556|NCT01805440|9915245|FG000|COMPLETED|Overall Study||18
8859557|NCT01805440|9915246|FG001|COMPLETED|Overall Study||17
8859558|NCT01805440|9915247|FG002|COMPLETED|Overall Study||26
8859559|NCT01805440|9915245|FG000|NOT COMPLETED|Overall Study||1
8859560|NCT01805440|9915246|FG001|NOT COMPLETED|Overall Study||0
8859561|NCT01805440|9915247|FG002|NOT COMPLETED|Overall Study||0
8859562|NCT01805687|9915254|FG000|STARTED|Overall Study||25
8859563|NCT01805687|9915254|FG000|COMPLETED|Overall Study||25
8859564|NCT01805687|9915254|FG000|NOT COMPLETED|Overall Study||0
8859565|NCT01805791|9915261|FG000|STARTED|Overall Study||66
8859566|NCT01805791|9915262|FG001|STARTED|Overall Study||67
8859567|NCT01805791|9915263|FG002|STARTED|Overall Study||68
8859568|NCT01805791|9915261|FG000|COMPLETED|Overall Study||44
8859569|NCT01805791|9915262|FG001|COMPLETED|Overall Study||50
8859570|NCT01805791|9915263|FG002|COMPLETED|Overall Study||48
8859571|NCT01805791|9915261|FG000|NOT COMPLETED|Overall Study||22
8859572|NCT01805791|9915262|FG001|NOT COMPLETED|Overall Study||17
8859573|NCT01805791|9915263|FG002|NOT COMPLETED|Overall Study||20
8859574|NCT01805882|9915280|FG000|STARTED|Overall Study||20
8859575|NCT01805882|9915281|FG001|STARTED|Overall Study||20
8859576|NCT01805882|9915282|FG002|STARTED|Overall Study||20
8859577|NCT01805882|9915283|FG003|STARTED|Overall Study||34
8859578|NCT01805882|9915284|FG004|STARTED|Overall Study||14
8859579|NCT01805882|9915285|FG005|STARTED|Overall Study||21
8859580|NCT01805882|9915286|FG006|STARTED|Overall Study||50
8859581|NCT01805882|9915287|FG007|STARTED|Overall Study||25
8859582|NCT01805882|9915288|FG008|STARTED|Overall Study||25
8859583|NCT01805882|9915280|FG000|COMPLETED|Overall Study||20
8859584|NCT01805882|9915281|FG001|COMPLETED|Overall Study||20
8859585|NCT01805882|9915282|FG002|COMPLETED|Overall Study||19
8859586|NCT01805882|9915283|FG003|COMPLETED|Overall Study||32
8859587|NCT01805882|9915284|FG004|COMPLETED|Overall Study||14
8859588|NCT01805882|9915285|FG005|COMPLETED|Overall Study||20
8859589|NCT01805882|9915286|FG006|COMPLETED|Overall Study||48
8859590|NCT01805882|9915287|FG007|COMPLETED|Overall Study||25
8859591|NCT01805882|9915288|FG008|COMPLETED|Overall Study||24
8859592|NCT01805882|9915280|FG000|NOT COMPLETED|Overall Study||0
8859593|NCT01805882|9915281|FG001|NOT COMPLETED|Overall Study||0
8859594|NCT01805882|9915282|FG002|NOT COMPLETED|Overall Study||1
8859595|NCT01805882|9915283|FG003|NOT COMPLETED|Overall Study||2
8859596|NCT01805882|9915284|FG004|NOT COMPLETED|Overall Study||0
8859597|NCT01805882|9915285|FG005|NOT COMPLETED|Overall Study||1
8859598|NCT01805882|9915286|FG006|NOT COMPLETED|Overall Study||2
8859599|NCT01805882|9915287|FG007|NOT COMPLETED|Overall Study||0
8859600|NCT01805882|9915288|FG008|NOT COMPLETED|Overall Study||1
8859601|NCT01805895|9915310|FG000|STARTED|Overall Study||8
8859602|NCT01805895|9915311|FG001|STARTED|Overall Study||8
8859603|NCT01805895|9915310|FG000|COMPLETED|Overall Study||8
8859604|NCT01805895|9915311|FG001|COMPLETED|Overall Study||8
8859605|NCT01805895|9915310|FG000|NOT COMPLETED|Overall Study||0
8859606|NCT01805895|9915311|FG001|NOT COMPLETED|Overall Study||0
8859607|NCT01806064|9915322|FG000|STARTED|Overall Study||3
8859608|NCT01806064|9915323|FG001|STARTED|Overall Study||15
8859609|NCT01806064|9915324|FG002|STARTED|Overall Study||5
8859610|NCT01806064|9915325|FG003|STARTED|Overall Study||75
8859611|NCT01806064|9915326|FG004|STARTED|Overall Study||75
8859612|NCT01806064|9915322|FG000|COMPLETED|Overall Study||3
8859613|NCT01806064|9915323|FG001|COMPLETED|Overall Study||15
8859614|NCT01806064|9915324|FG002|COMPLETED|Overall Study||5
8859615|NCT01806064|9915325|FG003|COMPLETED|Overall Study||74
8859616|NCT01806064|9915326|FG004|COMPLETED|Overall Study||73
8859617|NCT01806064|9915322|FG000|NOT COMPLETED|Overall Study||0
8859618|NCT01806064|9915323|FG001|NOT COMPLETED|Overall Study||0
8859619|NCT01806064|9915324|FG002|NOT COMPLETED|Overall Study||0
8859620|NCT01806064|9915325|FG003|NOT COMPLETED|Overall Study||1
8859621|NCT01806064|9915326|FG004|NOT COMPLETED|Overall Study||2
8859622|NCT01806168|9915345|FG000|STARTED|Overall Study||11
8859623|NCT01806168|9915346|FG001|STARTED|Overall Study||10
8859624|NCT01806168|9915347|FG002|STARTED|Overall Study||10
8859625|NCT01806168|9915345|FG000|Received Allocated Intervention|Overall Study||11
8859626|NCT01806168|9915346|FG001|Received Allocated Intervention|Overall Study||9
8859627|NCT01806168|9915347|FG002|Received Allocated Intervention|Overall Study||9
8859628|NCT01806168|9915345|FG000|COMPLETED|Overall Study||10
8859629|NCT01806168|9915346|FG001|COMPLETED|Overall Study||9
8859630|NCT01806168|9915347|FG002|COMPLETED|Overall Study||7
8859631|NCT01806168|9915345|FG000|NOT COMPLETED|Overall Study||1
8859632|NCT01806168|9915346|FG001|NOT COMPLETED|Overall Study||1
8859633|NCT01806168|9915347|FG002|NOT COMPLETED|Overall Study||3
8859634|NCT01806259|9915360|FG000|STARTED|Overall Study||96
8859635|NCT01806259|9915361|FG001|STARTED|Overall Study||107
8859636|NCT01806259|9915360|FG000|COMPLETED|Overall Study||96
8859637|NCT01806259|9915361|FG001|COMPLETED|Overall Study||107
8859638|NCT01806259|9915360|FG000|NOT COMPLETED|Overall Study||0
8859639|NCT01806259|9915361|FG001|NOT COMPLETED|Overall Study||0
8859640|NCT01806298|9915368|FG000|STARTED|Overall Study||78
8859641|NCT01806298|9915368|FG000|COMPLETED|Overall Study||68
8859642|NCT01806298|9915368|FG000|NOT COMPLETED|Overall Study||10
8859643|NCT01806389|9915372|FG000|STARTED|Overall Study||14
8859644|NCT01806389|9915372|FG000|COMPLETED|Overall Study||10
8859645|NCT01806389|9915372|FG000|NOT COMPLETED|Overall Study||4
8859646|NCT01806506|9915388|FG000|STARTED|Overall Study||36
8859647|NCT01806506|9915389|FG001|STARTED|Overall Study||36
8859648|NCT01806506|9915388|FG000|1 Month|Overall Study||36
8859649|NCT01806506|9915389|FG001|1 Month|Overall Study||36
8859650|NCT01806506|9915388|FG000|3 Months|Overall Study|1 patient (reason - lost contact)|35
8859651|NCT01806506|9915389|FG001|3 Months|Overall Study||36
8859652|NCT01806506|9915388|FG000|6 Months|Overall Study|1 patient (reason - lost contact)|34
8859653|NCT01806506|9915389|FG001|6 Months|Overall Study||36
8859654|NCT01806506|9915388|FG000|9 Months|Overall Study||34
8859655|NCT01806506|9915389|FG001|9 Months|Overall Study|1 patient (reason - lost contact)|35
8859656|NCT01806506|9915388|FG000|COMPLETED|Overall Study||34
8859657|NCT01806506|9915389|FG001|COMPLETED|Overall Study||35
8859658|NCT01806506|9915388|FG000|NOT COMPLETED|Overall Study||2
8859659|NCT01806506|9915389|FG001|NOT COMPLETED|Overall Study||1
8859660|NCT01806545|9915397|FG000|STARTED|Overall Study||29
8859661|NCT01806545|9915398|FG001|STARTED|Overall Study||35
8859662|NCT01806545|9915397|FG000|COMPLETED|Overall Study||23
8859663|NCT01806545|9915398|FG001|COMPLETED|Overall Study||30
8859664|NCT01806545|9915397|FG000|NOT COMPLETED|Overall Study||6
8859665|NCT01806545|9915398|FG001|NOT COMPLETED|Overall Study||5
8859666|NCT01806571|9915404|FG000|STARTED|Overall Study||34
8859667|NCT01806571|9915404|FG000|COMPLETED|Overall Study||34
8859668|NCT01806571|9915404|FG000|NOT COMPLETED|Overall Study||0
8859669|NCT01806584|9915410|FG000|STARTED|Overall Study||14
8859670|NCT01806584|9915411|FG001|STARTED|Overall Study||18
8859671|NCT01806584|9915410|FG000|COMPLETED|Overall Study||0
8859672|NCT01806584|9915411|FG001|COMPLETED|Overall Study||0
8859673|NCT01806584|9915410|FG000|NOT COMPLETED|Overall Study||14
8859674|NCT01806584|9915411|FG001|NOT COMPLETED|Overall Study||18
8859675|NCT01806597|9915420|FG000|STARTED|Period 1 (Baseline to Week 16)||68
8859676|NCT01806597|9915421|FG001|STARTED|Period 1 (Baseline to Week 16)||69
8859677|NCT01806597|9915422|FG002|STARTED|Period 1 (Baseline to Week 16)||0
8859678|NCT01806597|9915423|FG003|STARTED|Period 1 (Baseline to Week 16)||0
8859679|NCT01806597|9915424|FG004|STARTED|Period 1 (Baseline to Week 16)||68
8859680|NCT01806597|9915425|FG005|STARTED|Period 1 (Baseline to Week 16)||0
8859681|NCT01806597|9915420|FG000|COMPLETED|Period 1 (Baseline to Week 16)||63
8949701|NCT02441946|10012339|FG001|COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0
8949702|NCT02441946|10012340|FG002|COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0
8949703|NCT02441946|10012338|FG000|NOT COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||27
8949704|NCT02441946|10012339|FG001|NOT COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0
8949705|NCT02441946|10012340|FG002|NOT COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0
8949706|NCT02441946|10012338|FG000|STARTED|Extension Period (8 Weeks)|All participants who did not discontinue continued to the extension period.|42
8949707|NCT02441946|10012339|FG001|STARTED|Extension Period (8 Weeks)||0
8949708|NCT02441946|10012340|FG002|STARTED|Extension Period (8 Weeks)||0
8949709|NCT02441946|10012338|FG000|COMPLETED|Extension Period (8 Weeks)||40
8949710|NCT02441946|10012339|FG001|COMPLETED|Extension Period (8 Weeks)||0
8949711|NCT02441946|10012340|FG002|COMPLETED|Extension Period (8 Weeks)||0
8949712|NCT02441946|10012338|FG000|NOT COMPLETED|Extension Period (8 Weeks)||2
8949713|NCT02441946|10012339|FG001|NOT COMPLETED|Extension Period (8 Weeks)||0
8949714|NCT02441946|10012340|FG002|NOT COMPLETED|Extension Period (8 Weeks)||0
8949715|NCT02442206|10012353|FG000|STARTED|Period 1||30
8949716|NCT02442206|10012354|FG001|STARTED|Period 1||32
8949717|NCT02442206|10012353|FG000|COMPLETED|Period 1||29
8949718|NCT02442206|10012354|FG001|COMPLETED|Period 1||29
8949719|NCT02442206|10012353|FG000|NOT COMPLETED|Period 1||1
8949720|NCT02442206|10012354|FG001|NOT COMPLETED|Period 1||3
8949721|NCT02442206|10012353|FG000|STARTED|Period 2||29
8949722|NCT02442206|10012354|FG001|STARTED|Period 2||29
8949723|NCT02442206|10012353|FG000|COMPLETED|Period 2||28
8949724|NCT02442206|10012354|FG001|COMPLETED|Period 2||29
8949725|NCT02442206|10012353|FG000|NOT COMPLETED|Period 2||1
8949726|NCT02442206|10012354|FG001|NOT COMPLETED|Period 2||0
9037455|NCT03314662|10098616|FG002|NOT COMPLETED|Overall Study||5
9037456|NCT03314753|10098634|FG000|STARTED|Overall Study||53
9037457|NCT03314753|10098635|FG001|STARTED|Overall Study||36
9037458|NCT03314753|10098634|FG000|COMPLETED|Overall Study||53
9037459|NCT03314753|10098635|FG001|COMPLETED|Overall Study||36
9037460|NCT03314753|10098634|FG000|NOT COMPLETED|Overall Study||0
9037461|NCT03314753|10098635|FG001|NOT COMPLETED|Overall Study||0
9037462|NCT03314857|10098641|FG000|STARTED|Overall Study||67
9037463|NCT03314857|10098641|FG000|Analysis Population|Overall Study||61
9037464|NCT03314857|10098641|FG000|COMPLETED|Overall Study|62/67 patients completed the 30-day primary endpoint visit.|62
9037465|NCT03314857|10098641|FG000|NOT COMPLETED|Overall Study||5
9037466|NCT03315104|10098648|FG000|STARTED|Overall Study||21
9037467|NCT03315104|10098649|FG001|STARTED|Overall Study||20
9037468|NCT03315104|10098650|FG002|STARTED|Overall Study||24
9037469|NCT03315104|10098648|FG000|Dosed (Safety Population)|Overall Study||19
9037470|NCT03315104|10098649|FG001|Dosed (Safety Population)|Overall Study||19
9037471|NCT03315104|10098650|FG002|Dosed (Safety Population)|Overall Study||22
9037472|NCT03315104|10098648|FG000|COMPLETED|Overall Study||18
9037473|NCT03315104|10098649|FG001|COMPLETED|Overall Study||16
9037474|NCT03315104|10098650|FG002|COMPLETED|Overall Study||19
9037475|NCT03315104|10098648|FG000|NOT COMPLETED|Overall Study||3
9037476|NCT03315104|10098649|FG001|NOT COMPLETED|Overall Study||4
9037477|NCT03315104|10098650|FG002|NOT COMPLETED|Overall Study||5
9037478|NCT03315208|10098660|FG000|STARTED|Overall Study||29
9037479|NCT03315208|10098661|FG001|STARTED|Overall Study||18
9037480|NCT03315208|10098660|FG000|COMPLETED|Overall Study||16
9037481|NCT03315208|10098661|FG001|COMPLETED|Overall Study||12
9037482|NCT03315208|10098660|FG000|NOT COMPLETED|Overall Study||13
9037483|NCT03315208|10098661|FG001|NOT COMPLETED|Overall Study||6
9037484|NCT03315286|10098670|FG000|STARTED|Overall Study||50
9037485|NCT03315286|10098671|FG001|STARTED|Overall Study||47
9037486|NCT03315286|10098670|FG000|COMPLETED|Overall Study||49
9037487|NCT03315286|10098671|FG001|COMPLETED|Overall Study||43
9037488|NCT03315286|10098670|FG000|NOT COMPLETED|Overall Study||1
8859682|NCT01806597|9915421|FG001|COMPLETED|Period 1 (Baseline to Week 16)||64
8859683|NCT01806597|9915422|FG002|COMPLETED|Period 1 (Baseline to Week 16)||0
8859684|NCT01806597|9915423|FG003|COMPLETED|Period 1 (Baseline to Week 16)||0
8859685|NCT01806597|9915424|FG004|COMPLETED|Period 1 (Baseline to Week 16)||63
8859686|NCT01806597|9915425|FG005|COMPLETED|Period 1 (Baseline to Week 16)||0
8859687|NCT01806597|9915420|FG000|NOT COMPLETED|Period 1 (Baseline to Week 16)||5
8859688|NCT01806597|9915421|FG001|NOT COMPLETED|Period 1 (Baseline to Week 16)||5
8859689|NCT01806597|9915422|FG002|NOT COMPLETED|Period 1 (Baseline to Week 16)||0
8859690|NCT01806597|9915423|FG003|NOT COMPLETED|Period 1 (Baseline to Week 16)||0
8859691|NCT01806597|9915424|FG004|NOT COMPLETED|Period 1 (Baseline to Week 16)||5
8859692|NCT01806597|9915425|FG005|NOT COMPLETED|Period 1 (Baseline to Week 16)||0
8859693|NCT01806597|9915420|FG000|STARTED|Treatment Period 2 (Week 16 to Week 132)||63
8859694|NCT01806597|9915421|FG001|STARTED|Treatment Period 2 (Week 16 to Week 132)||64
8859695|NCT01806597|9915422|FG002|STARTED|Treatment Period 2 (Week 16 to Week 132)||31
8859696|NCT01806597|9915423|FG003|STARTED|Treatment Period 2 (Week 16 to Week 132)||31
8859697|NCT01806597|9915424|FG004|STARTED|Treatment Period 2 (Week 16 to Week 132)||1
8859698|NCT01806597|9915425|FG005|STARTED|Treatment Period 2 (Week 16 to Week 132)||0
8859699|NCT01806597|9915420|FG000|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||24
8630080|NCT00533897|9669843|FG000|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
8691255|NCT00853840|9736490|FG001|STARTED|Period 1||9
8859700|NCT01806597|9915421|FG001|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||44
8859701|NCT01806597|9915422|FG002|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||17
8859702|NCT01806597|9915423|FG003|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||20
8859703|NCT01806597|9915424|FG004|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||0
8859704|NCT01806597|9915425|FG005|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||0
8859705|NCT01806597|9915420|FG000|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||39
8859706|NCT01806597|9915421|FG001|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||20
8859707|NCT01806597|9915422|FG002|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||14
8859708|NCT01806597|9915423|FG003|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||11
8859709|NCT01806597|9915424|FG004|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||1
8859710|NCT01806597|9915425|FG005|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||0
8949727|NCT02442271|10012361|FG000|STARTED|Overall Study||222
8949728|NCT02442271|10012361|FG000|COMPLETED|Overall Study||218
8949729|NCT02442271|10012361|FG000|NOT COMPLETED|Overall Study||4
8949730|NCT02442284|10012379|FG000|STARTED|Overall Study||99
8949731|NCT02442284|10012379|FG000|COMPLETED|Overall Study||92
8949732|NCT02442284|10012379|FG000|NOT COMPLETED|Overall Study||7
8949733|NCT02442310|10012383|FG000|STARTED|Overall Study||20
8949734|NCT02442310|10012383|FG000|COMPLETED|Overall Study||17
8949735|NCT02442310|10012383|FG000|NOT COMPLETED|Overall Study||3
8949736|NCT02442336|10012393|FG000|STARTED|Overall Study||80
8949737|NCT02442336|10012393|FG000|Developmental Phase|Overall Study||6
8949738|NCT02442336|10012393|FG000|Evaluation Phase|Overall Study||74
8949739|NCT02442336|10012393|FG000|Provided Access to Intervention|Overall Study||55
8949740|NCT02442336|10012393|FG000|COMPLETED|Overall Study||44
8949741|NCT02442336|10012393|FG000|NOT COMPLETED|Overall Study||36
8949742|NCT02442622|10012399|FG000|STARTED|Overall Study||15
8949743|NCT02442622|10012400|FG001|STARTED|Overall Study||17
8949744|NCT02442622|10012399|FG000|COMPLETED|Overall Study||12
8949745|NCT02442622|10012400|FG001|COMPLETED|Overall Study||16
8949746|NCT02442622|10012399|FG000|NOT COMPLETED|Overall Study||3
8949747|NCT02442622|10012400|FG001|NOT COMPLETED|Overall Study||1
8949748|NCT02442687|10012409|FG000|STARTED|Overall Study||21
8949749|NCT02442687|10012410|FG001|STARTED|Overall Study||22
8949750|NCT02442687|10012411|FG002|STARTED|Overall Study||22
8949751|NCT02442687|10012409|FG000|COMPLETED|Overall Study||13
8949752|NCT02442687|10012410|FG001|COMPLETED|Overall Study||11
8949753|NCT02442687|10012411|FG002|COMPLETED|Overall Study||19
8949754|NCT02442687|10012409|FG000|NOT COMPLETED|Overall Study||8
8949755|NCT02442687|10012410|FG001|NOT COMPLETED|Overall Study||11
8949756|NCT02442687|10012411|FG002|NOT COMPLETED|Overall Study||3
8949757|NCT02442700|10012422|FG000|STARTED|First 12 Weeks||12
8949758|NCT02442700|10012423|FG001|STARTED|First 12 Weeks||12
8859711|NCT01806597|9915420|FG000|STARTED|Follow-up Period (Week 132 to Week 140)||0
8859712|NCT01806597|9915421|FG001|STARTED|Follow-up Period (Week 132 to Week 140)||0
8859713|NCT01806597|9915422|FG002|STARTED|Follow-up Period (Week 132 to Week 140)||0
8859714|NCT01806597|9915423|FG003|STARTED|Follow-up Period (Week 132 to Week 140)||0
8859715|NCT01806597|9915424|FG004|STARTED|Follow-up Period (Week 132 to Week 140)||3
8949759|NCT02442700|10012422|FG000|COMPLETED|First 12 Weeks||12
8949760|NCT02442700|10012423|FG001|COMPLETED|First 12 Weeks||12
8949761|NCT02442700|10012422|FG000|NOT COMPLETED|First 12 Weeks||0
8691256|NCT00853840|9736489|FG000|Maraviroc (Days 1 - 4)|Period 1||9
8859716|NCT01806597|9915425|FG005|STARTED|Follow-up Period (Week 132 to Week 140)||161
8859717|NCT01806597|9915420|FG000|COMPLETED|Follow-up Period (Week 132 to Week 140)||0
8859718|NCT01806597|9915421|FG001|COMPLETED|Follow-up Period (Week 132 to Week 140)||0
8859719|NCT01806597|9915422|FG002|COMPLETED|Follow-up Period (Week 132 to Week 140)||0
8859720|NCT01806597|9915423|FG003|COMPLETED|Follow-up Period (Week 132 to Week 140)||0
8859721|NCT01806597|9915424|FG004|COMPLETED|Follow-up Period (Week 132 to Week 140)||3
8859722|NCT01806597|9915425|FG005|COMPLETED|Follow-up Period (Week 132 to Week 140)||149
8859723|NCT01806597|9915420|FG000|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
8859724|NCT01806597|9915421|FG001|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
8859725|NCT01806597|9915422|FG002|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
8859726|NCT01806597|9915423|FG003|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
8859727|NCT01806597|9915424|FG004|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
8859728|NCT01806597|9915425|FG005|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||12
8859729|NCT01806623|9915439|FG000|STARTED|Overall Study||157
8859730|NCT01806623|9915439|FG000|COMPLETED|Overall Study||99
8859731|NCT01806623|9915439|FG000|NOT COMPLETED|Overall Study||58
8859732|NCT01806662|9915443|FG000|STARTED|First Intervention (Weeks 0-16)||16
8859733|NCT01806662|9915444|FG001|STARTED|First Intervention (Weeks 0-16)||16
8859734|NCT01806662|9915443|FG000|Received Intervention|First Intervention (Weeks 0-16)||12
8859735|NCT01806662|9915444|FG001|Received Intervention|First Intervention (Weeks 0-16)||15
8859736|NCT01806662|9915443|FG000|COMPLETED|First Intervention (Weeks 0-16)||12
8859737|NCT01806662|9915444|FG001|COMPLETED|First Intervention (Weeks 0-16)||15
8859738|NCT01806662|9915443|FG000|NOT COMPLETED|First Intervention (Weeks 0-16)||4
8859739|NCT01806662|9915444|FG001|NOT COMPLETED|First Intervention (Weeks 0-16)||1
8859740|NCT01806662|9915443|FG000|STARTED|Second Intervention (Weeks 16-32)||12
8859741|NCT01806662|9915444|FG001|STARTED|Second Intervention (Weeks 16-32)||15
8859742|NCT01806662|9915443|FG000|COMPLETED|Second Intervention (Weeks 16-32)||10
8859743|NCT01806662|9915444|FG001|COMPLETED|Second Intervention (Weeks 16-32)||11
8859744|NCT01806662|9915443|FG000|NOT COMPLETED|Second Intervention (Weeks 16-32)||2
8859745|NCT01806662|9915444|FG001|NOT COMPLETED|Second Intervention (Weeks 16-32)||4
8859746|NCT01806675|9915453|FG000|STARTED|Overall Study||11
8859747|NCT01806675|9915454|FG001|STARTED|Overall Study||6
8859748|NCT01806675|9915455|FG002|STARTED|Overall Study||8
8859749|NCT01806675|9915453|FG000|COMPLETED|Overall Study||11
8859750|NCT01806675|9915454|FG001|COMPLETED|Overall Study||6
8859751|NCT01806675|9915455|FG002|COMPLETED|Overall Study||8
8859752|NCT01806675|9915453|FG000|NOT COMPLETED|Overall Study||0
8859753|NCT01806675|9915454|FG001|NOT COMPLETED|Overall Study||0
8859754|NCT01806675|9915455|FG002|NOT COMPLETED|Overall Study||0
8859755|NCT01806688|9915465|FG000|STARTED|First Intervention Seed Study|"Participants received one of the following:~experimental snack #1 gluten-free high protein snack a 30 g serving of buckwheat groats~placebo comparator reference product, a gluten-free snack with similar energy density but 1/2 the protein as the experimental snack, a 32g serving of corn nuts~placebo comparator non-caloric control water"|38
8859756|NCT01806688|9915466|FG001|STARTED|First Intervention Seed Study|"Participants received one of the following:~experimental snack #1 gluten-free high protein snack a 30 g serving of buckwheat groats~placebo comparator reference product, a gluten-free snack with similar energy density but 1/2 the protein as the experimental snack, a 32g serving of corn nuts~placebo comparator non-caloric control water"|0
8859757|NCT01806688|9915465|FG000|Experimental Snack #1|First Intervention Seed Study|Received experimental snack #1 at the first visit, a 30g serving of buckwheat groats|13
8859758|NCT01806688|9915466|FG001|Experimental Snack #1|First Intervention Seed Study|Received experimental snack #1 at the first visit, a 30g serving of buckwheat groats|0
8859759|NCT01806688|9915465|FG000|Placebo Comparator Reference Product #1|First Intervention Seed Study|Received the placebo comparator reference product #1 at the first visit, a 32g serving of corn nuts|13
8859760|NCT01806688|9915466|FG001|Placebo Comparator Reference Product #1|First Intervention Seed Study|Received the placebo comparator reference product #1 at the first visit, a 32g serving of corn nuts|0
8859761|NCT01806688|9915465|FG000|Placebo Comparator Non-caloric Control #1|First Intervention Seed Study|Received water, the placebo comparator non-caloric control #1 at the first visit|12
8859762|NCT01806688|9915466|FG001|Placebo Comparator Non-caloric Control #1|First Intervention Seed Study|Received water, the placebo comparator non-caloric control #1 at the first visit|0
8859763|NCT01806688|9915465|FG000|COMPLETED|First Intervention Seed Study||38
8859764|NCT01806688|9915466|FG001|COMPLETED|First Intervention Seed Study||0
8859765|NCT01806688|9915465|FG000|NOT COMPLETED|First Intervention Seed Study||0
8859766|NCT01806688|9915466|FG001|NOT COMPLETED|First Intervention Seed Study||0
8859767|NCT01806688|9915465|FG000|STARTED|Second Intervention Seed Study|"Participants received one of the following they hadn't previously received at visit 1:~experimental snack #1 gluten-free high protein snack a 30 g serving of buckwheat groats~placebo comparator reference product #1, a gluten-free snack with similar energy density but 1/2 the protein as the experimental snack, a 32g serving of corn nuts~placebo comparator non-caloric control #1, water"|38
8859768|NCT01806688|9915466|FG001|STARTED|Second Intervention Seed Study|"Participants received one of the following they hadn't previously received at visit 1:~experimental snack #1 gluten-free high protein snack a 30 g serving of buckwheat groats~placebo comparator reference product #1, a gluten-free snack with similar energy density but 1/2 the protein as the experimental snack, a 32g serving of corn nuts~placebo comparator non-caloric control #1, water"|0
8859769|NCT01806688|9915465|FG000|Experimental Snack #1|Second Intervention Seed Study|Received the experimental snack #1, a 30g serving of buckwheat groats at visit 2|13
8859770|NCT01806688|9915466|FG001|Experimental Snack #1|Second Intervention Seed Study|Received the experimental snack #1, a 30g serving of buckwheat groats at visit 2|0
8859771|NCT01806688|9915465|FG000|Placebo Comparator Reference Product #1|Second Intervention Seed Study|Received the Placebo comparator reference product #1, a 32g serving of corn nuts at visit 2|13
8859772|NCT01806688|9915466|FG001|Placebo Comparator Reference Product #1|Second Intervention Seed Study|Received the Placebo comparator reference product #1, a 32g serving of corn nuts at visit 2|0
8859773|NCT01806688|9915465|FG000|Placebo Comparator Non-caloric Control #1|Second Intervention Seed Study|Received water, the placebo comparator non-caloric control #1 at visit 2|12
8859774|NCT01806688|9915466|FG001|Placebo Comparator Non-caloric Control #1|Second Intervention Seed Study|Received water, the placebo comparator non-caloric control #1 at visit 2|0
8859775|NCT01806688|9915465|FG000|COMPLETED|Second Intervention Seed Study||38
8859776|NCT01806688|9915466|FG001|COMPLETED|Second Intervention Seed Study||0
8859777|NCT01806688|9915465|FG000|NOT COMPLETED|Second Intervention Seed Study||0
8859778|NCT01806688|9915466|FG001|NOT COMPLETED|Second Intervention Seed Study||0
8859779|NCT01806688|9915465|FG000|STARTED|Third Intervention Seed Study|"Participants received one of the following they hadn't previously received at visit 1 or visit 2:~experimental snack #1 gluten-free high protein snack a 30 g serving of buckwheat groats~placebo comparator reference product, a gluten-free snack with similar energy density but 1/2 the protein as the experimental snack, a 32g serving of corn nuts~placebo comparator non-caloric control water"|38
8859780|NCT01806688|9915466|FG001|STARTED|Third Intervention Seed Study|"Participants received one of the following they hadn't previously received at visit 1 or visit 2:~experimental snack #1 gluten-free high protein snack a 30 g serving of buckwheat groats~placebo comparator reference product, a gluten-free snack with similar energy density but 1/2 the protein as the experimental snack, a 32g serving of corn nuts~placebo comparator non-caloric control water"|0
8859781|NCT01806688|9915465|FG000|Experimental Snack #1|Third Intervention Seed Study|Received the Experimental snack #1, a 30g serving of buckwheat groats at visit 3|12
8859782|NCT01806688|9915466|FG001|Experimental Snack #1|Third Intervention Seed Study|Received the Experimental snack #1, a 30g serving of buckwheat groats at visit 3|0
8859783|NCT01806688|9915465|FG000|Placebo Comparator Reference Product #1|Third Intervention Seed Study|Received the placebo comparator reference product #1, a 32g serving of corn nuts at visit 3|12
8859784|NCT01806688|9915466|FG001|Placebo Comparator Reference Product #1|Third Intervention Seed Study|Received the placebo comparator reference product #1, a 32g serving of corn nuts at visit 3|0
8859785|NCT01806688|9915465|FG000|Placebo Comparator Non-caloric Control #1|Third Intervention Seed Study|Received water, the placebo comparator non-caloric control #1 at visit 3|14
8859786|NCT01806688|9915466|FG001|Placebo Comparator Non-caloric Control #1|Third Intervention Seed Study|Received water, the placebo comparator non-caloric control #1 at visit 3|0
8859787|NCT01806688|9915465|FG000|COMPLETED|Third Intervention Seed Study||38
8949762|NCT02442700|10012423|FG001|NOT COMPLETED|First 12 Weeks||0
8949763|NCT02442700|10012422|FG000|STARTED|Later 12 Weeks||12
8949764|NCT02442700|10012423|FG001|STARTED|Later 12 Weeks||12
8949765|NCT02442700|10012422|FG000|COMPLETED|Later 12 Weeks||12
8949766|NCT02442700|10012423|FG001|COMPLETED|Later 12 Weeks||12
8949767|NCT02442700|10012422|FG000|NOT COMPLETED|Later 12 Weeks||0
8949768|NCT02442700|10012423|FG001|NOT COMPLETED|Later 12 Weeks||0
8949769|NCT02442804|10012431|FG000|STARTED|Overall Study||8
8949770|NCT02442804|10012432|FG001|STARTED|Overall Study||8
8949771|NCT02442804|10012431|FG000|COMPLETED|Overall Study||7
8949772|NCT02442804|10012432|FG001|COMPLETED|Overall Study||7
8949773|NCT02442804|10012431|FG000|NOT COMPLETED|Overall Study||1
8949774|NCT02442804|10012432|FG001|NOT COMPLETED|Overall Study||1
8949775|NCT02442830|10012440|FG000|STARTED|Overall Study||42
8949776|NCT02442830|10012441|FG001|STARTED|Overall Study||45
8949777|NCT02442830|10012440|FG000|COMPLETED|Overall Study||42
8949778|NCT02442830|10012441|FG001|COMPLETED|Overall Study||44
8949779|NCT02442830|10012440|FG000|NOT COMPLETED|Overall Study||0
8949780|NCT02442830|10012441|FG001|NOT COMPLETED|Overall Study||1
8949781|NCT02442856|10012448|FG000|STARTED|Overall Study||21
8949782|NCT02442856|10012448|FG000|COMPLETED|Overall Study||21
8949783|NCT02442856|10012448|FG000|NOT COMPLETED|Overall Study||0
8949784|NCT02442869|10012458|FG000|STARTED|Overall Study||18
8949785|NCT02442869|10012459|FG001|STARTED|Overall Study||29
8949786|NCT02442869|10012460|FG002|STARTED|Overall Study||6
8630081|NCT00533897|9669844|FG001|COMPLETED|Double-blind Withdrawal (DBW) Period 2|One participant discontinued the DBW Period due to Lack of Efficacy to enter the RI Period early|39
8630082|NCT00533897|9669845|FG002|COMPLETED|Double-blind Withdrawal (DBW) Period 2|Two participants discontinued the DBW Period due to Lack of Efficacy to enter the RI Period early|77
8630083|NCT00533897|9669846|FG003|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
8630084|NCT00533897|9669847|FG004|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
8630085|NCT00533897|9669848|FG005|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
8630086|NCT00533897|9669849|FG006|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
8630087|NCT00533897|9669850|FG007|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
8630088|NCT00533897|9669843|FG000|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
8630089|NCT00533897|9669844|FG001|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||1
8630090|NCT00533897|9669845|FG002|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||3
8630091|NCT00533897|9669846|FG003|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
8630092|NCT00533897|9669847|FG004|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
8630093|NCT00533897|9669848|FG005|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
8630094|NCT00533897|9669849|FG006|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
8691257|NCT00853840|9736490|FG001|Maraviroc (Days 1 - 4)|Period 1||9
8949787|NCT02442869|10012461|FG003|STARTED|Overall Study||2
8949788|NCT02442869|10012462|FG004|STARTED|Overall Study||5
8949789|NCT02442869|10012463|FG005|STARTED|Overall Study||2
8949790|NCT02442869|10012458|FG000|COMPLETED|Overall Study||13
8859788|NCT01806688|9915466|FG001|COMPLETED|Third Intervention Seed Study||0
8859789|NCT01806688|9915465|FG000|NOT COMPLETED|Third Intervention Seed Study||0
8859790|NCT01806688|9915466|FG001|NOT COMPLETED|Third Intervention Seed Study||0
8859791|NCT01806688|9915465|FG000|STARTED|First Intervention Pita Study|"Participants received one of the following:~experimental snack #2 gluten-free high protein and high fibre snack a 50 g serving of buckwheat and pinto bean flour pita bread~placebo comparator reference product, a gluten-free snack with similar energy density but less protein and fibre as the experimental snack, a 50g serving of rice bread~placebo comparator non-caloric control water"|0
8859792|NCT01806688|9915466|FG001|STARTED|First Intervention Pita Study|"Participants received one of the following:~experimental snack #2 gluten-free high protein and high fibre snack a 50 g serving of buckwheat and pinto bean flour pita bread~placebo comparator reference product, a gluten-free snack with similar energy density but less protein and fibre as the experimental snack, a 50g serving of rice bread~placebo comparator non-caloric control water"|38
8859793|NCT01806688|9915465|FG000|Experimental Snack #2|First Intervention Pita Study|Received the Experimental snack #2, a 50 g serving of buckwheat and pinto bean flour pita bread at the first visit|0
8859794|NCT01806688|9915466|FG001|Experimental Snack #2|First Intervention Pita Study|Received the Experimental snack #2, a 50 g serving of buckwheat and pinto bean flour pita bread at the first visit|14
8859795|NCT01806688|9915465|FG000|Placebo Comparator Reference Product #2|First Intervention Pita Study|Received the placebo comparator reference product #2 at the first visit, a 50g serving of rice bread|0
8859796|NCT01806688|9915466|FG001|Placebo Comparator Reference Product #2|First Intervention Pita Study|Received the placebo comparator reference product #2 at the first visit, a 50g serving of rice bread|12
8859797|NCT01806688|9915465|FG000|Placebo Comparator Non-caloric Control #2|First Intervention Pita Study|Received water, the placebo comparator non-caloric control #2 at the first visit|0
8859798|NCT01806688|9915466|FG001|Placebo Comparator Non-caloric Control #2|First Intervention Pita Study|Received water, the placebo comparator non-caloric control #2 at the first visit|12
8859799|NCT01806688|9915465|FG000|COMPLETED|First Intervention Pita Study||0
8859800|NCT01806688|9915466|FG001|COMPLETED|First Intervention Pita Study||38
8859801|NCT01806688|9915465|FG000|NOT COMPLETED|First Intervention Pita Study||0
8859802|NCT01806688|9915466|FG001|NOT COMPLETED|First Intervention Pita Study||0
8859803|NCT01806688|9915465|FG000|STARTED|Second Intervention Pita Study|"Participants received one of the following:~experimental snack #2 gluten-free high protein and high fibre snack a 50 g serving of buckwheat and pinto bean flour pita bread~placebo comparator reference product, a gluten-free snack with similar energy density but less protein and fibre as the experimental snack, a 50g serving of rice bread~placebo comparator non-caloric control water"|0
8859804|NCT01806688|9915466|FG001|STARTED|Second Intervention Pita Study|"Participants received one of the following:~experimental snack #2 gluten-free high protein and high fibre snack a 50 g serving of buckwheat and pinto bean flour pita bread~placebo comparator reference product, a gluten-free snack with similar energy density but less protein and fibre as the experimental snack, a 50g serving of rice bread~placebo comparator non-caloric control water"|38
8859805|NCT01806688|9915465|FG000|Experimental Snack #2|Second Intervention Pita Study|Received the Experimental snack #2, a 50 g serving of buckwheat and pinto bean flour pita bread at the second visit|0
8859806|NCT01806688|9915466|FG001|Experimental Snack #2|Second Intervention Pita Study|Received the Experimental snack #2, a 50 g serving of buckwheat and pinto bean flour pita bread at the second visit|12
8859807|NCT01806688|9915465|FG000|Placebo Comparator Reference Product #2|Second Intervention Pita Study|Received the placebo comparator reference product #2 at the second visit, a 50g serving of rice bread|0
8859808|NCT01806688|9915466|FG001|Placebo Comparator Reference Product #2|Second Intervention Pita Study|Received the placebo comparator reference product #2 at the second visit, a 50g serving of rice bread|13
8859809|NCT01806688|9915465|FG000|Placebo Comparator Non-caloric Control #2|Second Intervention Pita Study|Received water, the placebo comparator non-caloric control #2 at the second visit|0
8859810|NCT01806688|9915466|FG001|Placebo Comparator Non-caloric Control #2|Second Intervention Pita Study|Received water, the placebo comparator non-caloric control #2 at the second visit|13
8859811|NCT01806688|9915465|FG000|COMPLETED|Second Intervention Pita Study||0
8859812|NCT01806688|9915466|FG001|COMPLETED|Second Intervention Pita Study||38
8859813|NCT01806688|9915465|FG000|NOT COMPLETED|Second Intervention Pita Study||0
8859814|NCT01806688|9915466|FG001|NOT COMPLETED|Second Intervention Pita Study||0
8923541|NCT02240706|9984147|FG003|COMPLETED|Overall Study||0
8630095|NCT00533897|9669850|FG007|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
8630096|NCT00533897|9669843|FG000|STARTED|Re-introduction (RI) Period 3||0
8630097|NCT00533897|9669844|FG001|STARTED|Re-introduction (RI) Period 3||0
8630098|NCT00533897|9669845|FG002|STARTED|Re-introduction (RI) Period 3||0
8630099|NCT00533897|9669846|FG003|STARTED|Re-introduction (RI) Period 3|1 participant discontinued the DBW Period due to Lack of Efficacy to enter RI Period early|40
8630100|NCT00533897|9669847|FG004|STARTED|Re-introduction (RI) Period 3|1 participant discontinued the DBW Period due to Lack of Efficacy to enter RI Period early|35
8630101|NCT00533897|9669848|FG005|STARTED|Re-introduction (RI) Period 3|1 participant discontinued the DBW Period due to Lack of Efficacy to enter RI Period early|44
8630102|NCT00533897|9669849|FG006|STARTED|Re-introduction (RI) Period 3||0
8630103|NCT00533897|9669850|FG007|STARTED|Re-introduction (RI) Period 3||0
8630104|NCT00533897|9669843|FG000|COMPLETED|Re-introduction (RI) Period 3||0
8630105|NCT00533897|9669844|FG001|COMPLETED|Re-introduction (RI) Period 3||0
8630106|NCT00533897|9669845|FG002|COMPLETED|Re-introduction (RI) Period 3||0
8630107|NCT00533897|9669846|FG003|COMPLETED|Re-introduction (RI) Period 3||40
8630108|NCT00533897|9669847|FG004|COMPLETED|Re-introduction (RI) Period 3||35
8630109|NCT00533897|9669848|FG005|COMPLETED|Re-introduction (RI) Period 3||42
8630110|NCT00533897|9669849|FG006|COMPLETED|Re-introduction (RI) Period 3||0
8630111|NCT00533897|9669850|FG007|COMPLETED|Re-introduction (RI) Period 3||0
8859815|NCT01806688|9915465|FG000|STARTED|Third Intervention Pita Study|"Participants received one of the following:~experimental snack #2 gluten-free high protein and high fibre snack a 50 g serving of buckwheat and pinto bean flour pita bread placebo comparator reference product, a gluten-free snack with similar energy density but less protein and fibre as the experimental snack, a 50g serving of rice bread placebo comparator non-caloric control water"|0
8859816|NCT01806688|9915466|FG001|STARTED|Third Intervention Pita Study|"Participants received one of the following:~experimental snack #2 gluten-free high protein and high fibre snack a 50 g serving of buckwheat and pinto bean flour pita bread placebo comparator reference product, a gluten-free snack with similar energy density but less protein and fibre as the experimental snack, a 50g serving of rice bread placebo comparator non-caloric control water"|38
8859817|NCT01806688|9915465|FG000|Experimental Snack #2|Third Intervention Pita Study|Received the Experimental snack #2, a 50 g serving of buckwheat and pinto bean flour pita bread at the third visit|0
8859818|NCT01806688|9915466|FG001|Experimental Snack #2|Third Intervention Pita Study|Received the Experimental snack #2, a 50 g serving of buckwheat and pinto bean flour pita bread at the third visit|12
8859819|NCT01806688|9915465|FG000|Placebo Comparator Reference Product #2|Third Intervention Pita Study|Received the placebo comparator reference product #2 at the third visit, a 50g serving of rice bread|0
8859820|NCT01806688|9915466|FG001|Placebo Comparator Reference Product #2|Third Intervention Pita Study|Received the placebo comparator reference product #2 at the third visit, a 50g serving of rice bread|13
8859821|NCT01806688|9915465|FG000|Placebo Comparator Non-caloric Control #2|Third Intervention Pita Study|Received water, the placebo comparator non-caloric control #2 at the third visit|0
8859822|NCT01806688|9915466|FG001|Placebo Comparator Non-caloric Control #2|Third Intervention Pita Study|Received water, the placebo comparator non-caloric control #2 at the third visit|13
8859823|NCT01806688|9915465|FG000|COMPLETED|Third Intervention Pita Study||0
8859824|NCT01806688|9915466|FG001|COMPLETED|Third Intervention Pita Study||38
8859825|NCT01806688|9915465|FG000|NOT COMPLETED|Third Intervention Pita Study||0
8859826|NCT01806688|9915466|FG001|NOT COMPLETED|Third Intervention Pita Study||0
8859827|NCT01806714|9915477|FG000|STARTED|Overall Study||2093
8859828|NCT01806714|9915478|FG001|STARTED|Overall Study||2089
8859829|NCT01806714|9915477|FG000|COMPLETED|Overall Study||1893
8859830|NCT01806714|9915478|FG001|COMPLETED|Overall Study||1919
8859831|NCT01806714|9915477|FG000|NOT COMPLETED|Overall Study||200
8859832|NCT01806714|9915478|FG001|NOT COMPLETED|Overall Study||170
8859833|NCT01806740|9915484|FG000|STARTED|Overall Study||37
8859834|NCT01806740|9915484|FG000|COMPLETED|Overall Study||31
8859835|NCT01806740|9915484|FG000|NOT COMPLETED|Overall Study||6
8859836|NCT01806779|9915493|FG000|STARTED|Overall Study||90
8859837|NCT01806779|9915494|FG001|STARTED|Overall Study||84
8859838|NCT01806779|9915495|FG002|STARTED|Overall Study|All 197 subjects received nicotine patches but 23 dropped before receiving other study drugs.|23
8859839|NCT01806779|9915493|FG000|Completed SE Quest. After Using Patches|Overall Study|SE quest. = Side Effects Questionnaire|90
8859840|NCT01806779|9915494|FG001|Completed SE Quest. After Using Patches|Overall Study|SE quest. = Side Effects Questionnaire|84
8859841|NCT01806779|9915495|FG002|Completed SE Quest. After Using Patches|Overall Study|SE quest. = Side Effects Questionnaire|2
8859842|NCT01806779|9915493|FG000|Randomized at Visit 2|Overall Study||90
8859843|NCT01806779|9915494|FG001|Randomized at Visit 2|Overall Study||84
8859844|NCT01806779|9915495|FG002|Randomized at Visit 2|Overall Study||0
8859845|NCT01806779|9915493|FG000|Completed SE Quest. After Randomization|Overall Study|SE quest. = Side Effects Questionnaire|87
8859846|NCT01806779|9915494|FG001|Completed SE Quest. After Randomization|Overall Study|SE quest. = Side Effects Questionnaire|83
8859847|NCT01806779|9915495|FG002|Completed SE Quest. After Randomization|Overall Study|SE quest. = Side Effects Questionnaire|0
8859848|NCT01806779|9915493|FG000|COMPLETED|Overall Study||48
8859849|NCT01806779|9915494|FG001|COMPLETED|Overall Study||40
8859850|NCT01806779|9915495|FG002|COMPLETED|Overall Study||0
8859851|NCT01806779|9915493|FG000|NOT COMPLETED|Overall Study||42
8859852|NCT01806779|9915494|FG001|NOT COMPLETED|Overall Study||44
8859853|NCT01806779|9915495|FG002|NOT COMPLETED|Overall Study||23
8859854|NCT01806857|9915502|FG000|STARTED|Overall Study||31
8859855|NCT01806857|9915503|FG001|STARTED|Overall Study||29
8859856|NCT01806857|9915502|FG000|COMPLETED|Overall Study||30
8859857|NCT01806857|9915503|FG001|COMPLETED|Overall Study||29
8949791|NCT02442869|10012459|FG001|COMPLETED|Overall Study||20
8949792|NCT02442869|10012460|FG002|COMPLETED|Overall Study||6
8949793|NCT02442869|10012461|FG003|COMPLETED|Overall Study||1
8949794|NCT02442869|10012462|FG004|COMPLETED|Overall Study||3
8949795|NCT02442869|10012463|FG005|COMPLETED|Overall Study||2
8949796|NCT02442869|10012458|FG000|NOT COMPLETED|Overall Study||5
8949797|NCT02442869|10012459|FG001|NOT COMPLETED|Overall Study||9
8949798|NCT02442869|10012460|FG002|NOT COMPLETED|Overall Study||0
8949799|NCT02442869|10012461|FG003|NOT COMPLETED|Overall Study||1
8949800|NCT02442869|10012462|FG004|NOT COMPLETED|Overall Study||2
8949801|NCT02442869|10012463|FG005|NOT COMPLETED|Overall Study||0
8949802|NCT02443103|10012487|FG000|STARTED|Overall Study||4
8949803|NCT02443103|10012487|FG000|COMPLETED|Overall Study||1
8949804|NCT02443103|10012487|FG000|NOT COMPLETED|Overall Study||3
8949805|NCT02443155|10012495|FG000|STARTED|Overall Study||77
8949806|NCT02443155|10012496|FG001|STARTED|Overall Study||77
8949807|NCT02443155|10012497|FG002|STARTED|Overall Study||76
8949808|NCT02443155|10012498|FG003|STARTED|Overall Study||77
8949809|NCT02443155|10012495|FG000|Full Analysis Set|Overall Study||77
8949810|NCT02443155|10012496|FG001|Full Analysis Set|Overall Study||77
8949811|NCT02443155|10012497|FG002|Full Analysis Set|Overall Study||76
8949812|NCT02443155|10012498|FG003|Full Analysis Set|Overall Study||77
8949813|NCT02443155|10012495|FG000|PK Analysis Set|Overall Study||21
8859858|NCT01806857|9915502|FG000|NOT COMPLETED|Overall Study||1
8859859|NCT01806857|9915503|FG001|NOT COMPLETED|Overall Study||0
8859860|NCT01806896|9915512|FG000|STARTED|Overall Study||20
8859861|NCT01806896|9915513|FG001|STARTED|Overall Study||17
8859862|NCT01806896|9915512|FG000|Received Treatment|Overall Study||19
8859863|NCT01806896|9915513|FG001|Received Treatment|Overall Study||17
8859864|NCT01806896|9915512|FG000|COMPLETED|Overall Study||17
8859865|NCT01806896|9915513|FG001|COMPLETED|Overall Study||17
8859866|NCT01806896|9915512|FG000|NOT COMPLETED|Overall Study||3
8859867|NCT01806896|9915513|FG001|NOT COMPLETED|Overall Study||0
8859868|NCT01807000|9915519|FG000|STARTED|Overall Study||6
8859869|NCT01807000|9915519|FG000|COMPLETED|Overall Study||6
8859870|NCT01807000|9915519|FG000|NOT COMPLETED|Overall Study||0
8859871|NCT01807026|9915529|FG000|STARTED|Overall Study||10
8859872|NCT01807026|9915530|FG001|STARTED|Overall Study||2
8859873|NCT01807026|9915531|FG002|STARTED|Overall Study||10
8859874|NCT01807026|9915532|FG003|STARTED|Overall Study||2
8859875|NCT01807026|9915533|FG004|STARTED|Overall Study||9
8859876|NCT01807026|9915534|FG005|STARTED|Overall Study||3
8859877|NCT01807026|9915529|FG000|Received at Least One Dose of Study Drug|Overall Study||10
8859878|NCT01807026|9915530|FG001|Received at Least One Dose of Study Drug|Overall Study||2
8859879|NCT01807026|9915531|FG002|Received at Least One Dose of Study Drug|Overall Study||10
8859880|NCT01807026|9915532|FG003|Received at Least One Dose of Study Drug|Overall Study||2
8859881|NCT01807026|9915533|FG004|Received at Least One Dose of Study Drug|Overall Study||9
8859882|NCT01807026|9915534|FG005|Received at Least One Dose of Study Drug|Overall Study||3
8859883|NCT01807026|9915529|FG000|COMPLETED|Overall Study||10
8859884|NCT01807026|9915530|FG001|COMPLETED|Overall Study||2
8859885|NCT01807026|9915531|FG002|COMPLETED|Overall Study||10
8859886|NCT01807026|9915532|FG003|COMPLETED|Overall Study||2
8859887|NCT01807026|9915533|FG004|COMPLETED|Overall Study||9
8859888|NCT01807026|9915534|FG005|COMPLETED|Overall Study||3
8859889|NCT01807026|9915529|FG000|NOT COMPLETED|Overall Study||0
8859890|NCT01807026|9915530|FG001|NOT COMPLETED|Overall Study||0
8859891|NCT01807026|9915531|FG002|NOT COMPLETED|Overall Study||0
8859892|NCT01807026|9915532|FG003|NOT COMPLETED|Overall Study||0
8859893|NCT01807026|9915533|FG004|NOT COMPLETED|Overall Study||0
8859894|NCT01807026|9915534|FG005|NOT COMPLETED|Overall Study||0
8630112|NCT00533897|9669843|FG000|NOT COMPLETED|Re-introduction (RI) Period 3||0
8630113|NCT00533897|9669844|FG001|NOT COMPLETED|Re-introduction (RI) Period 3||0
8630114|NCT00533897|9669845|FG002|NOT COMPLETED|Re-introduction (RI) Period 3||0
8630115|NCT00533897|9669846|FG003|NOT COMPLETED|Re-introduction (RI) Period 3||0
8859895|NCT01807065|9915555|FG000|STARTED|Overall Study||25
8859896|NCT01807065|9915556|FG001|STARTED|Overall Study||26
8859897|NCT01807065|9915555|FG000|COMPLETED|Overall Study||24
8859898|NCT01807065|9915556|FG001|COMPLETED|Overall Study||25
8859899|NCT01807065|9915555|FG000|NOT COMPLETED|Overall Study||1
8859900|NCT01807065|9915556|FG001|NOT COMPLETED|Overall Study||1
8923542|NCT02240706|9984148|FG004|COMPLETED|Overall Study||0
8923543|NCT02240706|9984149|FG005|COMPLETED|Overall Study||0
8923544|NCT02240706|9984150|FG006|COMPLETED|Overall Study||0
8923545|NCT02240706|9984144|FG000|NOT COMPLETED|Overall Study||3
8923546|NCT02240706|9984145|FG001|NOT COMPLETED|Overall Study||3
8923547|NCT02240706|9984146|FG002|NOT COMPLETED|Overall Study||6
8923548|NCT02240706|9984147|FG003|NOT COMPLETED|Overall Study||4
8923549|NCT02240706|9984148|FG004|NOT COMPLETED|Overall Study||11
8923550|NCT02240706|9984149|FG005|NOT COMPLETED|Overall Study||0
8923551|NCT02240706|9984150|FG006|NOT COMPLETED|Overall Study||0
8923552|NCT02240810|9984167|FG000|STARTED|Overall Study||1501
8923553|NCT02240810|9984168|FG001|STARTED|Overall Study|correct typo|2681
8923554|NCT02240810|9984167|FG000|COMPLETED|Overall Study||1441
8923555|NCT02240810|9984168|FG001|COMPLETED|Overall Study||2621
8923556|NCT02240810|9984167|FG000|NOT COMPLETED|Overall Study||60
8923557|NCT02240810|9984168|FG001|NOT COMPLETED|Overall Study||60
8923558|NCT02241486|9984175|FG000|STARTED|Overall Study||2
8923559|NCT02241486|9984175|FG000|COMPLETED|Overall Study||2
8923560|NCT02241486|9984175|FG000|NOT COMPLETED|Overall Study||0
8923561|NCT02241512|9984181|FG000|STARTED|Overall Study||30
8630116|NCT00533897|9669847|FG004|NOT COMPLETED|Re-introduction (RI) Period 3||0
8923562|NCT02241512|9984182|FG001|STARTED|Overall Study||29
8923563|NCT02241512|9984181|FG000|COMPLETED|Overall Study||29
8923564|NCT02241512|9984182|FG001|COMPLETED|Overall Study||29
8923565|NCT02241512|9984181|FG000|NOT COMPLETED|Overall Study||1
8923566|NCT02241512|9984182|FG001|NOT COMPLETED|Overall Study||0
8923567|NCT02241655|9984190|FG000|STARTED|Overall Study||614
8923568|NCT02241655|9984191|FG001|STARTED|Overall Study||618
8923569|NCT02241655|9984190|FG000|COMPLETED|Overall Study||614
8630117|NCT00533897|9669848|FG005|NOT COMPLETED|Re-introduction (RI) Period 3||2
8630118|NCT00533897|9669849|FG006|NOT COMPLETED|Re-introduction (RI) Period 3||0
8630119|NCT00533897|9669850|FG007|NOT COMPLETED|Re-introduction (RI) Period 3||0
8630120|NCT00533897|9669843|FG000|STARTED|Long Term Extension (LTE)||0
8630121|NCT00533897|9669844|FG001|STARTED|Long Term Extension (LTE)||0
8923570|NCT02241655|9984191|FG001|COMPLETED|Overall Study||618
8923571|NCT02241655|9984190|FG000|NOT COMPLETED|Overall Study||0
8923572|NCT02241655|9984191|FG001|NOT COMPLETED|Overall Study||0
8923573|NCT02241720|9984202|FG000|STARTED|Overall Study||5
8923574|NCT02241720|9984202|FG000|COMPLETED|Overall Study||1
8923575|NCT02241720|9984202|FG000|NOT COMPLETED|Overall Study||4
8923576|NCT02241733|9984208|FG000|STARTED|Overall Study||40
8923577|NCT02241733|9984209|FG001|STARTED|Overall Study||40
8859901|NCT01807091|9915562|FG000|STARTED|Overall Study||17
8859902|NCT01807091|9915562|FG000|COMPLETED|Overall Study||17
8859903|NCT01807091|9915562|FG000|NOT COMPLETED|Overall Study||0
8859904|NCT01807104|9915568|FG000|STARTED|Overall Study||43
8859905|NCT01807104|9915569|FG001|STARTED|Overall Study||44
8859906|NCT01807104|9915568|FG000|COMPLETED|Overall Study||39
8859907|NCT01807104|9915569|FG001|COMPLETED|Overall Study||40
8859908|NCT01807104|9915568|FG000|NOT COMPLETED|Overall Study||4
8859909|NCT01807104|9915569|FG001|NOT COMPLETED|Overall Study||4
8859910|NCT01807156|9915575|FG000|STARTED|Overall Study||7
8859911|NCT01807156|9915575|FG000|COMPLETED|Overall Study||6
8859912|NCT01807156|9915575|FG000|NOT COMPLETED|Overall Study||1
8859913|NCT01807221|9915585|FG000|STARTED|Overall Study||224
8859914|NCT01807221|9915586|FG001|STARTED|Overall Study||173
8859915|NCT01807221|9915587|FG002|STARTED|Overall Study||165
8859916|NCT01807221|9915588|FG003|STARTED|Overall Study||169
8859917|NCT01807221|9915589|FG004|STARTED|Overall Study||170
8859918|NCT01807221|9915590|FG005|STARTED|Overall Study||165
8859919|NCT01807221|9915585|FG000|Participants Received Study Treatment and Valid for Safety Analysis Set|Overall Study||221
8859920|NCT01807221|9915586|FG001|Participants Received Study Treatment and Valid for Safety Analysis Set|Overall Study||172
8859921|NCT01807221|9915587|FG002|Participants Received Study Treatment and Valid for Safety Analysis Set|Overall Study||163
8859922|NCT01807221|9915588|FG003|Participants Received Study Treatment and Valid for Safety Analysis Set|Overall Study||167
8859923|NCT01807221|9915589|FG004|Participants Received Study Treatment and Valid for Safety Analysis Set|Overall Study||169
8859924|NCT01807221|9915590|FG005|Participants Received Study Treatment and Valid for Safety Analysis Set|Overall Study||163
8859925|NCT01807221|9915585|FG000|COMPLETED|Overall Study||144
8859926|NCT01807221|9915586|FG001|COMPLETED|Overall Study||121
8859927|NCT01807221|9915587|FG002|COMPLETED|Overall Study||122
8859928|NCT01807221|9915588|FG003|COMPLETED|Overall Study||123
8859929|NCT01807221|9915589|FG004|COMPLETED|Overall Study||134
8859930|NCT01807221|9915590|FG005|COMPLETED|Overall Study||124
8859931|NCT01807221|9915585|FG000|NOT COMPLETED|Overall Study||80
8859932|NCT01807221|9915586|FG001|NOT COMPLETED|Overall Study||52
8859933|NCT01807221|9915587|FG002|NOT COMPLETED|Overall Study||43
8859934|NCT01807221|9915588|FG003|NOT COMPLETED|Overall Study||46
8859935|NCT01807221|9915589|FG004|NOT COMPLETED|Overall Study||36
8859936|NCT01807221|9915590|FG005|NOT COMPLETED|Overall Study||41
8859937|NCT01807234|9915610|FG000|STARTED|Overall Study||12
8859938|NCT01807234|9915611|FG001|STARTED|Overall Study||12
8859939|NCT01807234|9915612|FG002|STARTED|Overall Study||12
8859940|NCT01807234|9915613|FG003|STARTED|Overall Study||12
8859941|NCT01807234|9915614|FG004|STARTED|Overall Study||12
8859942|NCT01807234|9915615|FG005|STARTED|Overall Study||12
8859943|NCT01807234|9915610|FG000|Randomized, But Did Not Take Drug|Overall Study||3
8859944|NCT01807234|9915611|FG001|Randomized, But Did Not Take Drug|Overall Study||5
8859945|NCT01807234|9915612|FG002|Randomized, But Did Not Take Drug|Overall Study||2
8859946|NCT01807234|9915613|FG003|Randomized, But Did Not Take Drug|Overall Study||1
8859947|NCT01807234|9915614|FG004|Randomized, But Did Not Take Drug|Overall Study||4
8949814|NCT02443155|10012496|FG001|PK Analysis Set|Overall Study||21
8949815|NCT02443155|10012497|FG002|PK Analysis Set|Overall Study||22
8949816|NCT02443155|10012498|FG003|PK Analysis Set|Overall Study||20
8949817|NCT02443155|10012495|FG000|Safety Analysis Set|Overall Study||77
8949818|NCT02443155|10012496|FG001|Safety Analysis Set|Overall Study||77
8949819|NCT02443155|10012497|FG002|Safety Analysis Set|Overall Study||76
8949820|NCT02443155|10012498|FG003|Safety Analysis Set|Overall Study||77
8949821|NCT02443155|10012495|FG000|COMPLETED|Overall Study||65
8949822|NCT02443155|10012496|FG001|COMPLETED|Overall Study||63
8949823|NCT02443155|10012497|FG002|COMPLETED|Overall Study||67
8949824|NCT02443155|10012498|FG003|COMPLETED|Overall Study||61
8949825|NCT02443155|10012495|FG000|NOT COMPLETED|Overall Study||12
8949826|NCT02443155|10012496|FG001|NOT COMPLETED|Overall Study||14
8949827|NCT02443155|10012497|FG002|NOT COMPLETED|Overall Study||9
8949828|NCT02443155|10012498|FG003|NOT COMPLETED|Overall Study||16
8949829|NCT02443298|10012511|FG000|STARTED|Overall Study||105
8949830|NCT02443298|10012512|FG001|STARTED|Overall Study||109
8949831|NCT02443298|10012511|FG000|COMPLETED|Overall Study||101
8949832|NCT02443298|10012512|FG001|COMPLETED|Overall Study||104
8949833|NCT02443298|10012511|FG000|NOT COMPLETED|Overall Study||4
8949834|NCT02443298|10012512|FG001|NOT COMPLETED|Overall Study||5
8949835|NCT02443337|10012520|FG000|STARTED|Overall Study||15
8949836|NCT02443337|10012521|FG001|STARTED|Overall Study||16
8949837|NCT02443337|10012520|FG000|Received at Least One Dose of Study Drug|Overall Study||15
8949838|NCT02443337|10012521|FG001|Received at Least One Dose of Study Drug|Overall Study||16
8949839|NCT02443337|10012520|FG000|COMPLETED|Overall Study||10
8949840|NCT02443337|10012521|FG001|COMPLETED|Overall Study||14
8949841|NCT02443337|10012520|FG000|NOT COMPLETED|Overall Study||5
8949842|NCT02443337|10012521|FG001|NOT COMPLETED|Overall Study||2
8949843|NCT02443402|10012534|FG000|STARTED|Overall Study||36
8949844|NCT02443402|10012535|FG001|STARTED|Overall Study||31
8949845|NCT02443402|10012534|FG000|COMPLETED|Overall Study||32
8949846|NCT02443402|10012535|FG001|COMPLETED|Overall Study||28
8949847|NCT02443402|10012534|FG000|NOT COMPLETED|Overall Study||4
8949848|NCT02443402|10012535|FG001|NOT COMPLETED|Overall Study||3
8949849|NCT02443519|10012543|FG000|STARTED|Overall Study||31
8949850|NCT02443519|10012544|FG001|STARTED|Overall Study||29
8949851|NCT02443519|10012543|FG000|COMPLETED|Overall Study||29
8949852|NCT02443519|10012544|FG001|COMPLETED|Overall Study||26
8949853|NCT02443519|10012543|FG000|NOT COMPLETED|Overall Study||2
8859948|NCT01807234|9915615|FG005|Randomized, But Did Not Take Drug|Overall Study||3
8859949|NCT01807234|9915610|FG000|Completed Only 1 Attack|Overall Study||2
8859950|NCT01807234|9915611|FG001|Completed Only 1 Attack|Overall Study||1
8859951|NCT01807234|9915612|FG002|Completed Only 1 Attack|Overall Study||0
8859952|NCT01807234|9915613|FG003|Completed Only 1 Attack|Overall Study||1
8859953|NCT01807234|9915614|FG004|Completed Only 1 Attack|Overall Study||0
8859954|NCT01807234|9915615|FG005|Completed Only 1 Attack|Overall Study||1
8859955|NCT01807234|9915610|FG000|COMPLETED|Overall Study||7
8859956|NCT01807234|9915611|FG001|COMPLETED|Overall Study||6
8630122|NCT00533897|9669845|FG002|STARTED|Long Term Extension (LTE)||0
8630123|NCT00533897|9669846|FG003|STARTED|Long Term Extension (LTE)||0
8630124|NCT00533897|9669847|FG004|STARTED|Long Term Extension (LTE)||0
8859957|NCT01807234|9915612|FG002|COMPLETED|Overall Study||10
8859958|NCT01807234|9915613|FG003|COMPLETED|Overall Study||10
8859959|NCT01807234|9915614|FG004|COMPLETED|Overall Study||8
8859960|NCT01807234|9915615|FG005|COMPLETED|Overall Study||8
8859961|NCT01807234|9915610|FG000|NOT COMPLETED|Overall Study||5
8859962|NCT01807234|9915611|FG001|NOT COMPLETED|Overall Study||6
8859963|NCT01807234|9915612|FG002|NOT COMPLETED|Overall Study||2
8859964|NCT01807234|9915613|FG003|NOT COMPLETED|Overall Study||2
8859965|NCT01807234|9915614|FG004|NOT COMPLETED|Overall Study||4
8859966|NCT01807234|9915615|FG005|NOT COMPLETED|Overall Study||4
8859967|NCT01807299|9915629|FG000|STARTED|Overall Study||14
8859968|NCT01807299|9915630|FG001|STARTED|Overall Study||14
8859969|NCT01807299|9915631|FG002|STARTED|Overall Study||12
8859970|NCT01807299|9915632|FG003|STARTED|Overall Study||13
8859971|NCT01807299|9915629|FG000|COMPLETED|Overall Study||11
8859972|NCT01807299|9915630|FG001|COMPLETED|Overall Study||13
8859973|NCT01807299|9915631|FG002|COMPLETED|Overall Study||12
8859974|NCT01807299|9915632|FG003|COMPLETED|Overall Study||11
8859975|NCT01807299|9915629|FG000|NOT COMPLETED|Overall Study||3
8859976|NCT01807299|9915630|FG001|NOT COMPLETED|Overall Study||1
8859977|NCT01807299|9915631|FG002|NOT COMPLETED|Overall Study||0
8859978|NCT01807299|9915632|FG003|NOT COMPLETED|Overall Study||2
8859979|NCT01807455|9915642|FG000|STARTED|Overall Study||12
8859980|NCT01807455|9915642|FG000|COMPLETED|Overall Study||12
8859981|NCT01807455|9915642|FG000|NOT COMPLETED|Overall Study||0
8859982|NCT01807520|9915649|FG000|STARTED|Treatment Period 1 (0-16 Weeks)||67
8859983|NCT01807520|9915650|FG001|STARTED|Treatment Period 1 (0-16 Weeks)||66
8859984|NCT01807520|9915651|FG002|STARTED|Treatment Period 1 (0-16 Weeks)||65
8859985|NCT01807520|9915652|FG003|STARTED|Treatment Period 1 (0-16 Weeks)||0
8859986|NCT01807520|9915653|FG004|STARTED|Treatment Period 1 (0-16 Weeks)||0
8859987|NCT01807520|9915654|FG005|STARTED|Treatment Period 1 (0-16 Weeks)||0
8859988|NCT01807520|9915655|FG006|STARTED|Treatment Period 1 (0-16 Weeks)||0
8859989|NCT01807520|9915649|FG000|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||67
8859990|NCT01807520|9915650|FG001|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||66
8859991|NCT01807520|9915651|FG002|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||65
8859992|NCT01807520|9915652|FG003|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0
8859993|NCT01807520|9915653|FG004|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0
8859994|NCT01807520|9915654|FG005|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0
8859995|NCT01807520|9915655|FG006|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0
8859996|NCT01807520|9915649|FG000|Safety Set|Treatment Period 1 (0-16 Weeks)||67
8859997|NCT01807520|9915650|FG001|Safety Set|Treatment Period 1 (0-16 Weeks)||65
8859998|NCT01807520|9915651|FG002|Safety Set|Treatment Period 1 (0-16 Weeks)||65
8859999|NCT01807520|9915652|FG003|Safety Set|Treatment Period 1 (0-16 Weeks)||0
8860000|NCT01807520|9915653|FG004|Safety Set|Treatment Period 1 (0-16 Weeks)||0
8860001|NCT01807520|9915654|FG005|Safety Set|Treatment Period 1 (0-16 Weeks)||0
8860002|NCT01807520|9915655|FG006|Safety Set|Treatment Period 1 (0-16 Weeks)||0
8860003|NCT01807520|9915649|FG000|COMPLETED|Treatment Period 1 (0-16 Weeks)||63
8860004|NCT01807520|9915650|FG001|COMPLETED|Treatment Period 1 (0-16 Weeks)||65
8860005|NCT01807520|9915651|FG002|COMPLETED|Treatment Period 1 (0-16 Weeks)||58
8860006|NCT01807520|9915652|FG003|COMPLETED|Treatment Period 1 (0-16 Weeks)||0
8860007|NCT01807520|9915653|FG004|COMPLETED|Treatment Period 1 (0-16 Weeks)||0
8860008|NCT01807520|9915654|FG005|COMPLETED|Treatment Period 1 (0-16 Weeks)||0
8860009|NCT01807520|9915655|FG006|COMPLETED|Treatment Period 1 (0-16 Weeks)||0
8630125|NCT00533897|9669848|FG005|STARTED|Long Term Extension (LTE)||0
8630126|NCT00533897|9669849|FG006|STARTED|Long Term Extension (LTE)|37 non-responders in Lead-In entered the LTE directly and didn't participate in DBW or RI Periods.|37
8630127|NCT00533897|9669850|FG007|STARTED|Long Term Extension (LTE)|117 completed RI but 4 did not enter LTE: 1 lack of efficacy and 3 had their site closed.|113
8860010|NCT01807520|9915649|FG000|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||4
8860011|NCT01807520|9915650|FG001|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||1
8860012|NCT01807520|9915651|FG002|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||7
8725366|NCT01030952|9772626|FG001|STARTED|Overall Study||52
8725367|NCT01030952|9772625|FG000|COMPLETED|Overall Study||49
8860013|NCT01807520|9915652|FG003|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0
8860014|NCT01807520|9915653|FG004|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0
8860015|NCT01807520|9915654|FG005|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0
8860016|NCT01807520|9915655|FG006|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0
8860017|NCT01807520|9915649|FG000|STARTED|Treatment Period 2 (16-132 Weeks)||63
8860018|NCT01807520|9915650|FG001|STARTED|Treatment Period 2 (16-132 Weeks)||65
8630128|NCT00533897|9669843|FG000|COMPLETED|Long Term Extension (LTE)||0
8860019|NCT01807520|9915651|FG002|STARTED|Treatment Period 2 (16-132 Weeks)||0
8860020|NCT01807520|9915652|FG003|STARTED|Treatment Period 2 (16-132 Weeks)||29
8860021|NCT01807520|9915653|FG004|STARTED|Treatment Period 2 (16-132 Weeks)||29
8860022|NCT01807520|9915654|FG005|STARTED|Treatment Period 2 (16-132 Weeks)||0
8860023|NCT01807520|9915655|FG006|STARTED|Treatment Period 2 (16-132 Weeks)||0
8860024|NCT01807520|9915649|FG000|Safety Set|Treatment Period 2 (16-132 Weeks)||63
8860025|NCT01807520|9915650|FG001|Safety Set|Treatment Period 2 (16-132 Weeks)||65
8860026|NCT01807520|9915651|FG002|Safety Set|Treatment Period 2 (16-132 Weeks)||0
8860027|NCT01807520|9915652|FG003|Safety Set|Treatment Period 2 (16-132 Weeks)||29
8860028|NCT01807520|9915653|FG004|Safety Set|Treatment Period 2 (16-132 Weeks)||29
8860029|NCT01807520|9915654|FG005|Safety Set|Treatment Period 2 (16-132 Weeks)||0
8860030|NCT01807520|9915655|FG006|Safety Set|Treatment Period 2 (16-132 Weeks)||0
8860031|NCT01807520|9915649|FG000|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||67
8860032|NCT01807520|9915650|FG001|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||66
8860033|NCT01807520|9915651|FG002|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||0
8860034|NCT01807520|9915652|FG003|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||29
8860035|NCT01807520|9915653|FG004|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||29
8860036|NCT01807520|9915654|FG005|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||0
8860037|NCT01807520|9915655|FG006|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||0
8630129|NCT00533897|9669844|FG001|COMPLETED|Long Term Extension (LTE)||0
8630130|NCT00533897|9669845|FG002|COMPLETED|Long Term Extension (LTE)||0
8630131|NCT00533897|9669846|FG003|COMPLETED|Long Term Extension (LTE)||0
8630132|NCT00533897|9669847|FG004|COMPLETED|Long Term Extension (LTE)||0
8860038|NCT01807520|9915649|FG000|COMPLETED|Treatment Period 2 (16-132 Weeks)||38
8860039|NCT01807520|9915650|FG001|COMPLETED|Treatment Period 2 (16-132 Weeks)||47
8860040|NCT01807520|9915651|FG002|COMPLETED|Treatment Period 2 (16-132 Weeks)||0
8860041|NCT01807520|9915652|FG003|COMPLETED|Treatment Period 2 (16-132 Weeks)||22
8860042|NCT01807520|9915653|FG004|COMPLETED|Treatment Period 2 (16-132 Weeks)||24
8860043|NCT01807520|9915654|FG005|COMPLETED|Treatment Period 2 (16-132 Weeks)||0
8860044|NCT01807520|9915655|FG006|COMPLETED|Treatment Period 2 (16-132 Weeks)||0
8860045|NCT01807520|9915649|FG000|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||25
8860046|NCT01807520|9915650|FG001|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||18
8860047|NCT01807520|9915651|FG002|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||0
8860048|NCT01807520|9915652|FG003|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||7
8860049|NCT01807520|9915653|FG004|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||5
8860050|NCT01807520|9915654|FG005|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||0
8860051|NCT01807520|9915655|FG006|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||0
8860052|NCT01807520|9915649|FG000|STARTED|Follow-up Period (132-140 Weeks)||0
8860053|NCT01807520|9915650|FG001|STARTED|Follow-up Period (132-140 Weeks)||0
8860054|NCT01807520|9915651|FG002|STARTED|Follow-up Period (132-140 Weeks)|These participants discontinued from Treatment Period 1.|2
8860055|NCT01807520|9915652|FG003|STARTED|Follow-up Period (132-140 Weeks)||0
8860056|NCT01807520|9915653|FG004|STARTED|Follow-up Period (132-140 Weeks)||0
8860057|NCT01807520|9915654|FG005|STARTED|Follow-up Period (132-140 Weeks)|These participants received AIN457150mg during treatment period 1 and/or treatment period 2.|81
8860058|NCT01807520|9915655|FG006|STARTED|Follow-up Period (132-140 Weeks)|These participants received AIN457 300mg during treatment period 1 and/or treatment period 2.|76
8860059|NCT01807520|9915649|FG000|COMPLETED|Follow-up Period (132-140 Weeks)||0
8860060|NCT01807520|9915650|FG001|COMPLETED|Follow-up Period (132-140 Weeks)||0
8860061|NCT01807520|9915651|FG002|COMPLETED|Follow-up Period (132-140 Weeks)||2
8860062|NCT01807520|9915652|FG003|COMPLETED|Follow-up Period (132-140 Weeks)||0
8860063|NCT01807520|9915653|FG004|COMPLETED|Follow-up Period (132-140 Weeks)||0
8860064|NCT01807520|9915654|FG005|COMPLETED|Follow-up Period (132-140 Weeks)||77
8860065|NCT01807520|9915655|FG006|COMPLETED|Follow-up Period (132-140 Weeks)||75
8860066|NCT01807520|9915649|FG000|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
8860067|NCT01807520|9915650|FG001|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
8860068|NCT01807520|9915651|FG002|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
8860069|NCT01807520|9915652|FG003|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
8860070|NCT01807520|9915653|FG004|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
8860071|NCT01807520|9915654|FG005|NOT COMPLETED|Follow-up Period (132-140 Weeks)||4
8860072|NCT01807520|9915655|FG006|NOT COMPLETED|Follow-up Period (132-140 Weeks)||1
8860073|NCT01807585|9915669|FG000|STARTED|Overall Study||20
8860074|NCT01807585|9915670|FG001|STARTED|Overall Study||108
8860075|NCT01807585|9915671|FG002|STARTED|Overall Study||114
8860076|NCT01807585|9915669|FG000|3 Mos|Overall Study||20
8860077|NCT01807585|9915670|FG001|3 Mos|Overall Study||108
8860078|NCT01807585|9915671|FG002|3 Mos|Overall Study||113
8860079|NCT01807585|9915669|FG000|COMPLETED|Overall Study||19
8860080|NCT01807585|9915670|FG001|COMPLETED|Overall Study||104
8860081|NCT01807585|9915671|FG002|COMPLETED|Overall Study||108
8860082|NCT01807585|9915669|FG000|NOT COMPLETED|Overall Study||1
8860083|NCT01807585|9915670|FG001|NOT COMPLETED|Overall Study||4
8630133|NCT00533897|9669848|FG005|COMPLETED|Long Term Extension (LTE)||0
8630134|NCT00533897|9669849|FG006|COMPLETED|Long Term Extension (LTE)|Participant continued until SC ABA was available in respective country or Sponsor ended study.|24
8630135|NCT00533897|9669850|FG007|COMPLETED|Long Term Extension (LTE)|Participant continued until SC ABA was available in respective country or Sponsor ended study.|88
8630136|NCT00533897|9669843|FG000|NOT COMPLETED|Long Term Extension (LTE)||0
8630137|NCT00533897|9669844|FG001|NOT COMPLETED|Long Term Extension (LTE)||0
8630138|NCT00533897|9669845|FG002|NOT COMPLETED|Long Term Extension (LTE)||0
8630139|NCT00533897|9669846|FG003|NOT COMPLETED|Long Term Extension (LTE)||0
8630140|NCT00533897|9669847|FG004|NOT COMPLETED|Long Term Extension (LTE)||0
8630141|NCT00533897|9669848|FG005|NOT COMPLETED|Long Term Extension (LTE)||0
8630142|NCT00533897|9669849|FG006|NOT COMPLETED|Long Term Extension (LTE)||13
8630143|NCT00533897|9669850|FG007|NOT COMPLETED|Long Term Extension (LTE)||25
8630144|NCT00533910|9669883|FG000|STARTED|Overall Study||21
8630145|NCT00533910|9669884|FG001|STARTED|Overall Study||21
8630146|NCT00533910|9669883|FG000|COMPLETED|Overall Study||21
8630147|NCT00533910|9669884|FG001|COMPLETED|Overall Study||21
8630148|NCT00533910|9669883|FG000|NOT COMPLETED|Overall Study||0
8630149|NCT00533910|9669884|FG001|NOT COMPLETED|Overall Study||0
8630150|NCT00533949|9669894|FG000|STARTED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|166
8630151|NCT00533949|9669895|FG001|STARTED|Overall Study||121
8630152|NCT00533949|9669896|FG002|STARTED|Overall Study||147
8630153|NCT00533949|9669897|FG003|STARTED|Overall Study||110
8630154|NCT00533949|9669894|FG000|COMPLETED|Overall Study||151
8630155|NCT00533949|9669895|FG001|COMPLETED|Overall Study||107
8630156|NCT00533949|9669896|FG002|COMPLETED|Overall Study||137
8630157|NCT00533949|9669897|FG003|COMPLETED|Overall Study||100
8630158|NCT00533949|9669894|FG000|NOT COMPLETED|Overall Study||15
8630159|NCT00533949|9669895|FG001|NOT COMPLETED|Overall Study||14
8630160|NCT00533949|9669896|FG002|NOT COMPLETED|Overall Study||10
8630161|NCT00533949|9669897|FG003|NOT COMPLETED|Overall Study||10
8725368|NCT01030952|9772626|FG001|COMPLETED|Overall Study||49
8725369|NCT01030952|9772625|FG000|NOT COMPLETED|Overall Study||2
8860084|NCT01807585|9915671|FG002|NOT COMPLETED|Overall Study||6
8860085|NCT01807598|9915682|FG000|STARTED|Overall Study||10
8860086|NCT01807598|9915682|FG000|COMPLETED|Overall Study||4
8860087|NCT01807598|9915682|FG000|NOT COMPLETED|Overall Study||6
8860088|NCT01807624|9915686|FG000|STARTED|Overall Study||24
8860089|NCT01807624|9915686|FG000|COMPLETED|Overall Study||24
8860090|NCT01807624|9915686|FG000|NOT COMPLETED|Overall Study||0
8860091|NCT01807637|9915692|FG000|STARTED|Baseline||4
8860092|NCT01807637|9915693|FG001|STARTED|Baseline||2
8860093|NCT01807637|9915692|FG000|COMPLETED|Baseline||4
8860094|NCT01807637|9915693|FG001|COMPLETED|Baseline||2
8860095|NCT01807637|9915692|FG000|NOT COMPLETED|Baseline||0
8860096|NCT01807637|9915693|FG001|NOT COMPLETED|Baseline||0
8860097|NCT01807637|9915692|FG000|STARTED|One Week||4
8860098|NCT01807637|9915693|FG001|STARTED|One Week||2
8860099|NCT01807637|9915692|FG000|COMPLETED|One Week||4
8860100|NCT01807637|9915693|FG001|COMPLETED|One Week||2
8860101|NCT01807637|9915692|FG000|NOT COMPLETED|One Week||0
8860102|NCT01807637|9915693|FG001|NOT COMPLETED|One Week||0
8860103|NCT01807637|9915692|FG000|STARTED|One Month||4
8860104|NCT01807637|9915693|FG001|STARTED|One Month||2
8860105|NCT01807637|9915692|FG000|COMPLETED|One Month||4
8860106|NCT01807637|9915693|FG001|COMPLETED|One Month||2
8860107|NCT01807637|9915692|FG000|NOT COMPLETED|One Month||0
8860108|NCT01807637|9915693|FG001|NOT COMPLETED|One Month||0
8860109|NCT01807650|9915701|FG000|STARTED|Overall Study||112
8630162|NCT00534001|9669917|FG000|STARTED|Overall Study||48
8630163|NCT00534001|9669918|FG001|STARTED|Overall Study||47
8630164|NCT00534001|9669917|FG000|COMPLETED|Overall Study||43
8630165|NCT00534001|9669918|FG001|COMPLETED|Overall Study||43
8630166|NCT00534001|9669917|FG000|NOT COMPLETED|Overall Study||5
8630167|NCT00534001|9669918|FG001|NOT COMPLETED|Overall Study||4
8630168|NCT00534092|9669926|FG000|STARTED|Overall Study||55
8630169|NCT00534092|9669927|FG001|STARTED|Overall Study||14
8630170|NCT00534092|9669926|FG000|COMPLETED|Overall Study||53
8630171|NCT00534092|9669927|FG001|COMPLETED|Overall Study||14
8630172|NCT00534092|9669926|FG000|NOT COMPLETED|Overall Study||2
8630173|NCT00534092|9669927|FG001|NOT COMPLETED|Overall Study||0
8630174|NCT00534105|9669937|FG000|STARTED|Overall Study||47
8630175|NCT00534105|9669938|FG001|STARTED|Overall Study||59
8630176|NCT00534105|9669937|FG000|COMPLETED|Overall Study||24
8630177|NCT00534105|9669938|FG001|COMPLETED|Overall Study||20
8630178|NCT00534105|9669937|FG000|NOT COMPLETED|Overall Study||23
8630179|NCT00534105|9669938|FG001|NOT COMPLETED|Overall Study||39
8630180|NCT00534118|9669946|FG000|STARTED|Overall Study||17
8630181|NCT00534118|9669947|FG001|STARTED|Overall Study||22
8630182|NCT00534118|9669946|FG000|COMPLETED|Overall Study||17
8630183|NCT00534118|9669947|FG001|COMPLETED|Overall Study||22
8630184|NCT00534118|9669946|FG000|NOT COMPLETED|Overall Study||0
8630185|NCT00534118|9669947|FG001|NOT COMPLETED|Overall Study||0
8630186|NCT00534209|9669955|FG000|STARTED|Overall Study||1
8630187|NCT00534209|9669955|FG000|COMPLETED|Overall Study||1
8630188|NCT00534209|9669955|FG000|NOT COMPLETED|Overall Study||0
8630189|NCT00534235|9669963|FG000|STARTED|Overall Study||107
8860110|NCT01807650|9915701|FG000|COMPLETED|Overall Study||92
8630190|NCT00534235|9669964|FG001|STARTED|Overall Study||215
8630191|NCT00534235|9669963|FG000|COMPLETED|Overall Study||91
8630192|NCT00534235|9669964|FG001|COMPLETED|Overall Study||192
8860111|NCT01807650|9915701|FG000|NOT COMPLETED|Overall Study||20
8860112|NCT01807871|9915744|FG000|STARTED|Overall Study||356
8630193|NCT00534235|9669963|FG000|NOT COMPLETED|Overall Study||16
8630194|NCT00534235|9669964|FG001|NOT COMPLETED|Overall Study||23
8630195|NCT00534248|9669973|FG000|STARTED|Overall Study||11211
8630196|NCT00534248|9669974|FG001|STARTED|Overall Study||11228
8630197|NCT00534248|9669973|FG000|VACCINATED|Overall Study||11186
8630198|NCT00534248|9669974|FG001|VACCINATED|Overall Study||11210
8860113|NCT01807871|9915745|FG001|STARTED|Overall Study||345
8860114|NCT01807871|9915744|FG000|COMPLETED|Overall Study||178
8860115|NCT01807871|9915745|FG001|COMPLETED|Overall Study||127
8860116|NCT01807871|9915744|FG000|NOT COMPLETED|Overall Study||178
8860117|NCT01807871|9915745|FG001|NOT COMPLETED|Overall Study||218
8860118|NCT01807923|9915754|FG000|STARTED|Overall Study||187
8860119|NCT01807923|9915755|FG001|STARTED|Overall Study||185
8860120|NCT01807923|9915756|FG002|STARTED|Overall Study||187
8860121|NCT01807923|9915754|FG000|COMPLETED|Overall Study||182
8860122|NCT01807923|9915755|FG001|COMPLETED|Overall Study||179
8860123|NCT01807923|9915756|FG002|COMPLETED|Overall Study||176
8860124|NCT01807923|9915754|FG000|NOT COMPLETED|Overall Study||5
8860125|NCT01807923|9915755|FG001|NOT COMPLETED|Overall Study||6
8860126|NCT01807923|9915756|FG002|NOT COMPLETED|Overall Study||11
8860127|NCT01807949|9915769|FG000|STARTED|Overall Study||187
8860128|NCT01807949|9915770|FG001|STARTED|Overall Study||187
8860129|NCT01807949|9915771|FG002|STARTED|Overall Study||189
8860130|NCT01807949|9915769|FG000|COMPLETED|Overall Study||185
8860131|NCT01807949|9915770|FG001|COMPLETED|Overall Study||180
8860132|NCT01807949|9915771|FG002|COMPLETED|Overall Study||180
8860133|NCT01807949|9915769|FG000|NOT COMPLETED|Overall Study||2
8860134|NCT01807949|9915770|FG001|NOT COMPLETED|Overall Study||7
8860135|NCT01807949|9915771|FG002|NOT COMPLETED|Overall Study||9
8860136|NCT01808066|9915781|FG000|STARTED|Overall Study||21
8860137|NCT01808066|9915781|FG000|COMPLETED|Overall Study||6
8860138|NCT01808066|9915781|FG000|NOT COMPLETED|Overall Study||15
8860139|NCT01808092|9915788|FG000|STARTED|Overall Study||409
8860140|NCT01808092|9915789|FG001|STARTED|Overall Study||408
8860141|NCT01808092|9915788|FG000|COMPLETED|Overall Study||355
8860142|NCT01808092|9915789|FG001|COMPLETED|Overall Study||363
8860143|NCT01808092|9915788|FG000|NOT COMPLETED|Overall Study||54
8860144|NCT01808092|9915789|FG001|NOT COMPLETED|Overall Study||45
8860145|NCT01808118|9915795|FG000|STARTED|Period 1||673
8860146|NCT01808118|9915796|FG001|STARTED|Period 1||0
8860147|NCT01808118|9915797|FG002|STARTED|Period 1||0
8860148|NCT01808118|9915795|FG000|COMPLETED|Period 1||305
8860149|NCT01808118|9915796|FG001|COMPLETED|Period 1||0
8860150|NCT01808118|9915797|FG002|COMPLETED|Period 1||0
8860151|NCT01808118|9915795|FG000|NOT COMPLETED|Period 1||368
8860152|NCT01808118|9915796|FG001|NOT COMPLETED|Period 1||0
8860153|NCT01808118|9915797|FG002|NOT COMPLETED|Period 1||0
8860154|NCT01808118|9915795|FG000|STARTED|Period 2||0
8860155|NCT01808118|9915796|FG001|STARTED|Period 2||153
8860156|NCT01808118|9915797|FG002|STARTED|Period 2||152
8860157|NCT01808118|9915795|FG000|COMPLETED|Period 2||0
8860158|NCT01808118|9915796|FG001|COMPLETED|Period 2||140
8860159|NCT01808118|9915797|FG002|COMPLETED|Period 2||144
8860160|NCT01808118|9915795|FG000|NOT COMPLETED|Period 2||0
8860161|NCT01808118|9915796|FG001|NOT COMPLETED|Period 2||13
8860162|NCT01808118|9915797|FG002|NOT COMPLETED|Period 2||8
8860163|NCT01808144|9915813|FG000|STARTED|Overall Study||97
8860164|NCT01808144|9915814|FG001|STARTED|Overall Study||99
8860165|NCT01808144|9915813|FG000|COMPLETED|Overall Study||57
8860166|NCT01808144|9915814|FG001|COMPLETED|Overall Study||51
8860167|NCT01808144|9915813|FG000|NOT COMPLETED|Overall Study||40
8860168|NCT01808144|9915814|FG001|NOT COMPLETED|Overall Study||48
8860169|NCT01808196|9915820|FG000|STARTED|Overall Study||6
8860170|NCT01808196|9915820|FG000|COMPLETED|Overall Study||5
8860171|NCT01808196|9915820|FG000|NOT COMPLETED|Overall Study||1
8860172|NCT01808209|9915826|FG000|STARTED|Overall Study||33
8860173|NCT01808209|9915827|FG001|STARTED|Overall Study||27
8860174|NCT01808209|9915826|FG000|COMPLETED|Overall Study||33
8860175|NCT01808209|9915827|FG001|COMPLETED|Overall Study||26
8860176|NCT01808209|9915826|FG000|NOT COMPLETED|Overall Study||0
8860177|NCT01808209|9915827|FG001|NOT COMPLETED|Overall Study||1
8860178|NCT01808222|9915837|FG000|STARTED|Overall Study||25
8860179|NCT01808222|9915837|FG000|Completed Fluciclovine PET-CT Scan|Overall Study||25
8860180|NCT01808222|9915837|FG000|Completed mpMR Scan|Overall Study||24
8860181|NCT01808222|9915837|FG000|COMPLETED|Overall Study||24
8860182|NCT01808222|9915837|FG000|NOT COMPLETED|Overall Study||1
8860183|NCT01808248|9915843|FG000|STARTED|Overall Study||47
8860184|NCT01808248|9915843|FG000|Completed Posttreatment Week 12 Visit|Overall Study||45
8860185|NCT01808248|9915843|FG000|COMPLETED|Overall Study||42
8860186|NCT01808248|9915843|FG000|NOT COMPLETED|Overall Study||5
8860187|NCT01808313|9915849|FG000|STARTED|Overall Study||133
8860188|NCT01808313|9915849|FG000|COMPLETED|Overall Study||123
8860189|NCT01808313|9915849|FG000|NOT COMPLETED|Overall Study||10
8860190|NCT01808326|9915853|FG000|STARTED|Overall Study||5
8860191|NCT01808326|9915853|FG000|COMPLETED|Overall Study||5
8860192|NCT01808326|9915853|FG000|NOT COMPLETED|Overall Study||0
8860193|NCT01808339|9915857|FG000|STARTED|Treatment Period 1 (14 Days)||4
8860194|NCT01808339|9915858|FG001|STARTED|Treatment Period 1 (14 Days)||4
8860195|NCT01808339|9915859|FG002|STARTED|Treatment Period 1 (14 Days)||4
8860196|NCT01808339|9915860|FG003|STARTED|Treatment Period 1 (14 Days)||4
8860197|NCT01808339|9915861|FG004|STARTED|Treatment Period 1 (14 Days)||6
8860198|NCT01808339|9915862|FG005|STARTED|Treatment Period 1 (14 Days)||6
8860199|NCT01808339|9915857|FG000|COMPLETED|Treatment Period 1 (14 Days)||4
8860200|NCT01808339|9915858|FG001|COMPLETED|Treatment Period 1 (14 Days)||3
8860201|NCT01808339|9915859|FG002|COMPLETED|Treatment Period 1 (14 Days)||4
8860202|NCT01808339|9915860|FG003|COMPLETED|Treatment Period 1 (14 Days)||2
8860203|NCT01808339|9915861|FG004|COMPLETED|Treatment Period 1 (14 Days)||4
8860204|NCT01808339|9915862|FG005|COMPLETED|Treatment Period 1 (14 Days)||5
8860205|NCT01808339|9915857|FG000|NOT COMPLETED|Treatment Period 1 (14 Days)||0
8923578|NCT02241733|9984208|FG000|COMPLETED|Overall Study||25
8860206|NCT01808339|9915858|FG001|NOT COMPLETED|Treatment Period 1 (14 Days)||1
8860207|NCT01808339|9915859|FG002|NOT COMPLETED|Treatment Period 1 (14 Days)||0
8860208|NCT01808339|9915860|FG003|NOT COMPLETED|Treatment Period 1 (14 Days)||2
8860209|NCT01808339|9915861|FG004|NOT COMPLETED|Treatment Period 1 (14 Days)||2
8860210|NCT01808339|9915862|FG005|NOT COMPLETED|Treatment Period 1 (14 Days)||1
8860211|NCT01808339|9915857|FG000|STARTED|Washout Period 1 (14-21 Days)||4
8860212|NCT01808339|9915858|FG001|STARTED|Washout Period 1 (14-21 Days)||3
8860213|NCT01808339|9915859|FG002|STARTED|Washout Period 1 (14-21 Days)||4
8860214|NCT01808339|9915860|FG003|STARTED|Washout Period 1 (14-21 Days)||2
8860215|NCT01808339|9915861|FG004|STARTED|Washout Period 1 (14-21 Days)||4
8860216|NCT01808339|9915862|FG005|STARTED|Washout Period 1 (14-21 Days)||5
8860217|NCT01808339|9915857|FG000|COMPLETED|Washout Period 1 (14-21 Days)||4
8860218|NCT01808339|9915858|FG001|COMPLETED|Washout Period 1 (14-21 Days)||3
8860219|NCT01808339|9915859|FG002|COMPLETED|Washout Period 1 (14-21 Days)||4
8860220|NCT01808339|9915860|FG003|COMPLETED|Washout Period 1 (14-21 Days)||2
8860221|NCT01808339|9915861|FG004|COMPLETED|Washout Period 1 (14-21 Days)||4
8860222|NCT01808339|9915862|FG005|COMPLETED|Washout Period 1 (14-21 Days)||5
8860223|NCT01808339|9915857|FG000|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
8860224|NCT01808339|9915858|FG001|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
8860225|NCT01808339|9915859|FG002|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
8860226|NCT01808339|9915860|FG003|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
8860227|NCT01808339|9915861|FG004|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
8860228|NCT01808339|9915862|FG005|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
8860229|NCT01808339|9915857|FG000|STARTED|Treatment Period 2 (14 Days)||4
8860230|NCT01808339|9915858|FG001|STARTED|Treatment Period 2 (14 Days)||3
8860231|NCT01808339|9915859|FG002|STARTED|Treatment Period 2 (14 Days)||4
8860232|NCT01808339|9915860|FG003|STARTED|Treatment Period 2 (14 Days)||2
8860233|NCT01808339|9915861|FG004|STARTED|Treatment Period 2 (14 Days)||4
8860234|NCT01808339|9915862|FG005|STARTED|Treatment Period 2 (14 Days)||5
8860235|NCT01808339|9915857|FG000|COMPLETED|Treatment Period 2 (14 Days)||4
8860236|NCT01808339|9915858|FG001|COMPLETED|Treatment Period 2 (14 Days)||3
8860237|NCT01808339|9915859|FG002|COMPLETED|Treatment Period 2 (14 Days)||4
8860238|NCT01808339|9915860|FG003|COMPLETED|Treatment Period 2 (14 Days)||2
8860239|NCT01808339|9915861|FG004|COMPLETED|Treatment Period 2 (14 Days)||4
8860240|NCT01808339|9915862|FG005|COMPLETED|Treatment Period 2 (14 Days)||5
8860241|NCT01808339|9915857|FG000|NOT COMPLETED|Treatment Period 2 (14 Days)||0
8860242|NCT01808339|9915858|FG001|NOT COMPLETED|Treatment Period 2 (14 Days)||0
8860243|NCT01808339|9915859|FG002|NOT COMPLETED|Treatment Period 2 (14 Days)||0
8860244|NCT01808339|9915860|FG003|NOT COMPLETED|Treatment Period 2 (14 Days)||0
8860245|NCT01808339|9915861|FG004|NOT COMPLETED|Treatment Period 2 (14 Days)||0
8860246|NCT01808339|9915862|FG005|NOT COMPLETED|Treatment Period 2 (14 Days)||0
8860247|NCT01808339|9915857|FG000|STARTED|Washout Period 2 (14-21 Days)||4
8860248|NCT01808339|9915858|FG001|STARTED|Washout Period 2 (14-21 Days)||3
8860249|NCT01808339|9915859|FG002|STARTED|Washout Period 2 (14-21 Days)||4
8860250|NCT01808339|9915860|FG003|STARTED|Washout Period 2 (14-21 Days)||2
8860251|NCT01808339|9915861|FG004|STARTED|Washout Period 2 (14-21 Days)||4
8860252|NCT01808339|9915862|FG005|STARTED|Washout Period 2 (14-21 Days)||5
8860253|NCT01808339|9915857|FG000|COMPLETED|Washout Period 2 (14-21 Days)||4
8860254|NCT01808339|9915858|FG001|COMPLETED|Washout Period 2 (14-21 Days)||3
8860255|NCT01808339|9915859|FG002|COMPLETED|Washout Period 2 (14-21 Days)||4
8860256|NCT01808339|9915860|FG003|COMPLETED|Washout Period 2 (14-21 Days)||2
8860257|NCT01808339|9915861|FG004|COMPLETED|Washout Period 2 (14-21 Days)||4
8860258|NCT01808339|9915862|FG005|COMPLETED|Washout Period 2 (14-21 Days)||5
8860259|NCT01808339|9915857|FG000|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
8860260|NCT01808339|9915858|FG001|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
8860261|NCT01808339|9915859|FG002|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
8860262|NCT01808339|9915860|FG003|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
8860263|NCT01808339|9915861|FG004|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
8860264|NCT01808339|9915862|FG005|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
8860265|NCT01808339|9915857|FG000|STARTED|Treatment Period 3 (14 Days)||4
8860266|NCT01808339|9915858|FG001|STARTED|Treatment Period 3 (14 Days)||3
8860267|NCT01808339|9915859|FG002|STARTED|Treatment Period 3 (14 Days)||4
8860268|NCT01808339|9915860|FG003|STARTED|Treatment Period 3 (14 Days)||2
8860269|NCT01808339|9915861|FG004|STARTED|Treatment Period 3 (14 Days)||4
8860270|NCT01808339|9915862|FG005|STARTED|Treatment Period 3 (14 Days)||5
8860271|NCT01808339|9915857|FG000|COMPLETED|Treatment Period 3 (14 Days)||4
8860272|NCT01808339|9915858|FG001|COMPLETED|Treatment Period 3 (14 Days)||3
8860273|NCT01808339|9915859|FG002|COMPLETED|Treatment Period 3 (14 Days)||3
8860274|NCT01808339|9915860|FG003|COMPLETED|Treatment Period 3 (14 Days)||2
8860275|NCT01808339|9915861|FG004|COMPLETED|Treatment Period 3 (14 Days)||4
8860276|NCT01808339|9915862|FG005|COMPLETED|Treatment Period 3 (14 Days)||5
8860277|NCT01808339|9915857|FG000|NOT COMPLETED|Treatment Period 3 (14 Days)||0
8860278|NCT01808339|9915858|FG001|NOT COMPLETED|Treatment Period 3 (14 Days)||0
8860279|NCT01808339|9915859|FG002|NOT COMPLETED|Treatment Period 3 (14 Days)||1
8860280|NCT01808339|9915860|FG003|NOT COMPLETED|Treatment Period 3 (14 Days)||0
8860281|NCT01808339|9915861|FG004|NOT COMPLETED|Treatment Period 3 (14 Days)||0
8860282|NCT01808339|9915862|FG005|NOT COMPLETED|Treatment Period 3 (14 Days)||0
8860283|NCT01808508|9915873|FG000|STARTED|Overall Study||11
8860284|NCT01808508|9915874|FG001|STARTED|Overall Study||9
8860285|NCT01808508|9915875|FG002|STARTED|Overall Study||3
8860286|NCT01808508|9915873|FG000|COMPLETED|Overall Study||10
8860287|NCT01808508|9915874|FG001|COMPLETED|Overall Study||9
8860288|NCT01808508|9915875|FG002|COMPLETED|Overall Study||3
8860289|NCT01808508|9915873|FG000|NOT COMPLETED|Overall Study||1
8860290|NCT01808508|9915874|FG001|NOT COMPLETED|Overall Study||0
8860291|NCT01808508|9915875|FG002|NOT COMPLETED|Overall Study||0
8860292|NCT01808534|9915883|FG000|STARTED|Overall Study||5
8860293|NCT01808534|9915883|FG000|COMPLETED|Overall Study||1
8860294|NCT01808534|9915883|FG000|NOT COMPLETED|Overall Study||4
8860295|NCT01808547|9915889|FG000|STARTED|Overall Study||174
8860296|NCT01808547|9915890|FG001|STARTED|Overall Study||94
8860297|NCT01808547|9915889|FG000|Safety Population|Overall Study||170
8860298|NCT01808547|9915890|FG001|Safety Population|Overall Study||85
8860299|NCT01808547|9915889|FG000|mITT Population|Overall Study||168
8860300|NCT01808547|9915890|FG001|mITT Population|Overall Study||85
8860301|NCT01808547|9915889|FG000|COMPLETED|Overall Study||137
8860302|NCT01808547|9915890|FG001|COMPLETED|Overall Study||48
8860303|NCT01808547|9915889|FG000|NOT COMPLETED|Overall Study||37
8860304|NCT01808547|9915890|FG001|NOT COMPLETED|Overall Study||46
8860305|NCT01808560|9915899|FG000|STARTED|Randomization and Treatment Allocation||18
8860306|NCT01808560|9915900|FG001|STARTED|Randomization and Treatment Allocation||16
8860307|NCT01808560|9915901|FG002|STARTED|Randomization and Treatment Allocation||0
8860308|NCT01808560|9915899|FG000|COMPLETED|Randomization and Treatment Allocation||18
8860309|NCT01808560|9915900|FG001|COMPLETED|Randomization and Treatment Allocation||16
8860310|NCT01808560|9915901|FG002|COMPLETED|Randomization and Treatment Allocation||0
8860311|NCT01808560|9915899|FG000|NOT COMPLETED|Randomization and Treatment Allocation||0
8860312|NCT01808560|9915900|FG001|NOT COMPLETED|Randomization and Treatment Allocation||0
8860313|NCT01808560|9915901|FG002|NOT COMPLETED|Randomization and Treatment Allocation||0
8860314|NCT01808560|9915899|FG000|STARTED|1-Month After Cataract Surgery|ITT: 2 subjects withdrew b/c they were unable to complete cataract surgery scheduled for both eyes|16
8860315|NCT01808560|9915900|FG001|STARTED|1-Month After Cataract Surgery|ITT: 3 subjects withdrew b/c they were unable to complete cataract surgery scheduled for both eyes|13
8860316|NCT01808560|9915901|FG002|STARTED|1-Month After Cataract Surgery||0
8860317|NCT01808560|9915899|FG000|COMPLETED|1-Month After Cataract Surgery||16
8860318|NCT01808560|9915900|FG001|COMPLETED|1-Month After Cataract Surgery||13
8860319|NCT01808560|9915901|FG002|COMPLETED|1-Month After Cataract Surgery||0
8860320|NCT01808560|9915899|FG000|NOT COMPLETED|1-Month After Cataract Surgery||0
8860321|NCT01808560|9915900|FG001|NOT COMPLETED|1-Month After Cataract Surgery||0
8860322|NCT01808560|9915901|FG002|NOT COMPLETED|1-Month After Cataract Surgery||0
8860323|NCT01808560|9915899|FG000|STARTED|3-Month After Cataract Surgery||17
8860324|NCT01808560|9915900|FG001|STARTED|3-Month After Cataract Surgery||13
8860325|NCT01808560|9915901|FG002|STARTED|3-Month After Cataract Surgery||0
8860326|NCT01808560|9915899|FG000|COMPLETED|3-Month After Cataract Surgery||17
8860327|NCT01808560|9915900|FG001|COMPLETED|3-Month After Cataract Surgery||13
8860328|NCT01808560|9915901|FG002|COMPLETED|3-Month After Cataract Surgery||0
8860329|NCT01808560|9915899|FG000|NOT COMPLETED|3-Month After Cataract Surgery||0
8860330|NCT01808560|9915900|FG001|NOT COMPLETED|3-Month After Cataract Surgery||0
8860331|NCT01808560|9915901|FG002|NOT COMPLETED|3-Month After Cataract Surgery||0
8860332|NCT01808560|9915899|FG000|STARTED|Crossover Treatment||0
8860333|NCT01808560|9915900|FG001|STARTED|Crossover Treatment||0
8860334|NCT01808560|9915901|FG002|STARTED|Crossover Treatment|Post-Treatment Group Received Crossover LipiFlow treatment 3 Months after cataract surgery|13
8860335|NCT01808560|9915899|FG000|COMPLETED|Crossover Treatment||0
8860336|NCT01808560|9915900|FG001|COMPLETED|Crossover Treatment||0
8860337|NCT01808560|9915901|FG002|COMPLETED|Crossover Treatment||13
8860338|NCT01808560|9915899|FG000|NOT COMPLETED|Crossover Treatment||0
8860339|NCT01808560|9915900|FG001|NOT COMPLETED|Crossover Treatment||0
8860340|NCT01808560|9915901|FG002|NOT COMPLETED|Crossover Treatment||0
8860341|NCT01808560|9915899|FG000|STARTED|4-Month After Cataract Surgery||0
8860342|NCT01808560|9915900|FG001|STARTED|4-Month After Cataract Surgery||0
8860343|NCT01808560|9915901|FG002|STARTED|4-Month After Cataract Surgery||13
8860344|NCT01808560|9915899|FG000|COMPLETED|4-Month After Cataract Surgery||0
8860345|NCT01808560|9915900|FG001|COMPLETED|4-Month After Cataract Surgery||0
8860346|NCT01808560|9915901|FG002|COMPLETED|4-Month After Cataract Surgery||13
8860347|NCT01808560|9915899|FG000|NOT COMPLETED|4-Month After Cataract Surgery||0
8860348|NCT01808560|9915900|FG001|NOT COMPLETED|4-Month After Cataract Surgery||0
8860349|NCT01808560|9915901|FG002|NOT COMPLETED|4-Month After Cataract Surgery||0
8860350|NCT01808573|9915911|FG000|STARTED|Overall Study||307
8860351|NCT01808573|9915912|FG001|STARTED|Overall Study||314
8860352|NCT01808573|9915911|FG000|Received Treatment|Overall Study||303
8860353|NCT01808573|9915912|FG001|Received Treatment|Overall Study||311
8860354|NCT01808573|9915911|FG000|COMPLETED|Overall Study||0
8860355|NCT01808573|9915912|FG001|COMPLETED|Overall Study||0
8860356|NCT01808573|9915911|FG000|NOT COMPLETED|Overall Study||307
8860357|NCT01808573|9915912|FG001|NOT COMPLETED|Overall Study||314
8860358|NCT01808612|9915921|FG000|STARTED|Treatment Period||169
8860359|NCT01808612|9915922|FG001|STARTED|Treatment Period||84
8860360|NCT01808612|9915923|FG002|STARTED|Treatment Period||260
8860361|NCT01808612|9915921|FG000|Received at Least 1 Dose of Study Drug|Treatment Period|Only these participants were included in the study analyses (ie, Full Analysis Set).|168
8860362|NCT01808612|9915922|FG001|Received at Least 1 Dose of Study Drug|Treatment Period|Only these participants were included in the study analyses (ie, Full Analysis Set).|83
8860363|NCT01808612|9915923|FG002|Received at Least 1 Dose of Study Drug|Treatment Period|Only these participants were included in the study analyses (ie, Full Analysis Set).|259
8860364|NCT01808612|9915921|FG000|COMPLETED|Treatment Period|67 participants who completed the Treatment Period did not enter the Discontinuation Period.|154
8860365|NCT01808612|9915922|FG001|COMPLETED|Treatment Period|39 participants who completed the Treatment Period did not enter the Discontinuation Period.|77
8860366|NCT01808612|9915923|FG002|COMPLETED|Treatment Period|101 participants who completed the Treatment Period did not enter the Discontinuation Period.|246
8860367|NCT01808612|9915921|FG000|NOT COMPLETED|Treatment Period||15
8860368|NCT01808612|9915922|FG001|NOT COMPLETED|Treatment Period||7
8860369|NCT01808612|9915923|FG002|NOT COMPLETED|Treatment Period||14
8860370|NCT01808612|9915921|FG000|STARTED|Discontinuation Period||87
8860371|NCT01808612|9915922|FG001|STARTED|Discontinuation Period||38
8860372|NCT01808612|9915923|FG002|STARTED|Discontinuation Period||145
8860373|NCT01808612|9915921|FG000|COMPLETED|Discontinuation Period||85
8860374|NCT01808612|9915922|FG001|COMPLETED|Discontinuation Period||37
8860375|NCT01808612|9915923|FG002|COMPLETED|Discontinuation Period||145
8860376|NCT01808612|9915921|FG000|NOT COMPLETED|Discontinuation Period||2
8860377|NCT01808612|9915922|FG001|NOT COMPLETED|Discontinuation Period||1
8860378|NCT01808612|9915923|FG002|NOT COMPLETED|Discontinuation Period||0
8860379|NCT01808651|9915937|FG000|STARTED|Study Period 1||99
8860380|NCT01808651|9915938|FG001|STARTED|Study Period 1||65
8860381|NCT01808651|9915939|FG002|STARTED|Study Period 1||36
8860382|NCT01808651|9915937|FG000|Received at Least One Dose of Study Drug|Study Period 1||98
8860383|NCT01808651|9915938|FG001|Received at Least One Dose of Study Drug|Study Period 1||65
8860384|NCT01808651|9915939|FG002|Received at Least One Dose of Study Drug|Study Period 1||36
8860385|NCT01808651|9915937|FG000|COMPLETED|Study Period 1||73
8860386|NCT01808651|9915938|FG001|COMPLETED|Study Period 1||48
8860387|NCT01808651|9915939|FG002|COMPLETED|Study Period 1||31
8860388|NCT01808651|9915937|FG000|NOT COMPLETED|Study Period 1||26
8860389|NCT01808651|9915938|FG001|NOT COMPLETED|Study Period 1||17
8860390|NCT01808651|9915939|FG002|NOT COMPLETED|Study Period 1||5
8860391|NCT01808651|9915937|FG000|STARTED|Study Period 2||77
8860392|NCT01808651|9915938|FG001|STARTED|Study Period 2||52
8860393|NCT01808651|9915939|FG002|STARTED|Study Period 2||33
8860394|NCT01808651|9915937|FG000|COMPLETED|Study Period 2|9 Pts who DC'd from Study Period 1 and 68 Pts who completed Study Period 1 entered Study Period 2.|77
8860395|NCT01808651|9915938|FG001|COMPLETED|Study Period 2|5 Pts who DC'd from Study Period 1 and 47 Pts who completed Study Period 1 entered Study Period 2.|52
8860396|NCT01808651|9915939|FG002|COMPLETED|Study Period 2|3 Pts who DC'd from Study Period 1 and 30 pts who completed Study Period 1 entered Study Period 2.|33
8860397|NCT01808651|9915937|FG000|NOT COMPLETED|Study Period 2||0
8860398|NCT01808651|9915938|FG001|NOT COMPLETED|Study Period 2||0
8860399|NCT01808651|9915939|FG002|NOT COMPLETED|Study Period 2||0
8860400|NCT01808690|9915952|FG000|STARTED|Overall Study||25
8860401|NCT01808690|9915953|FG001|STARTED|Overall Study||23
8860402|NCT01808690|9915952|FG000|COMPLETED|Overall Study||24
8860403|NCT01808690|9915953|FG001|COMPLETED|Overall Study||21
8860404|NCT01808690|9915952|FG000|NOT COMPLETED|Overall Study||1
8630199|NCT00534248|9669973|FG000|COMPLETED|Overall Study||10550
8630200|NCT00534248|9669974|FG001|COMPLETED|Overall Study||10555
8630201|NCT00534248|9669973|FG000|NOT COMPLETED|Overall Study||661
8630202|NCT00534248|9669974|FG001|NOT COMPLETED|Overall Study||673
8630203|NCT00534313|9669984|FG000|STARTED|Short-term Period||43
8630204|NCT00534313|9669985|FG001|STARTED|Short-term Period||40
8630205|NCT00534313|9669986|FG002|STARTED|Short-term Period||45
8630206|NCT00534313|9669987|FG003|STARTED|Short-term Period||42
8630207|NCT00534313|9669984|FG000|COMPLETED|Short-term Period|Completed the short-term study|37
8630208|NCT00534313|9669985|FG001|COMPLETED|Short-term Period|Completed the short-term study|34
8630209|NCT00534313|9669986|FG002|COMPLETED|Short-term Period|Completed the short-term study|43
8630210|NCT00534313|9669987|FG003|COMPLETED|Short-term Period|Completed the short-term study|33
8860405|NCT01808690|9915953|FG001|NOT COMPLETED|Overall Study||2
8860406|NCT01808755|9915959|FG000|STARTED|Overall Study||30
8860407|NCT01808755|9915960|FG001|STARTED|Overall Study||30
8860408|NCT01808755|9915959|FG000|COMPLETED|Overall Study||30
8860409|NCT01808755|9915960|FG001|COMPLETED|Overall Study||30
8860410|NCT01808755|9915959|FG000|NOT COMPLETED|Overall Study||0
8630211|NCT00534313|9669984|FG000|NOT COMPLETED|Short-term Period||6
8630212|NCT00534313|9669985|FG001|NOT COMPLETED|Short-term Period||6
8630213|NCT00534313|9669986|FG002|NOT COMPLETED|Short-term Period||2
8630214|NCT00534313|9669987|FG003|NOT COMPLETED|Short-term Period||9
8630215|NCT00534313|9669984|FG000|STARTED|Long-term Period||37
8630216|NCT00534313|9669985|FG001|STARTED|Long-term Period||34
8860411|NCT01808755|9915960|FG001|NOT COMPLETED|Overall Study||0
8860412|NCT01808963|9915965|FG000|STARTED|Overall Study||13
8860413|NCT01808963|9915965|FG000|COMPLETED|Overall Study||13
8860414|NCT01808963|9915965|FG000|NOT COMPLETED|Overall Study||0
8860415|NCT01809054|9915971|FG000|STARTED|Overall Study||27
8860416|NCT01809054|9915972|FG001|STARTED|Overall Study||22
8860417|NCT01809054|9915971|FG000|COMPLETED|Overall Study||27
8860418|NCT01809054|9915972|FG001|COMPLETED|Overall Study||22
8860419|NCT01809054|9915971|FG000|NOT COMPLETED|Overall Study||0
8860420|NCT01809054|9915972|FG001|NOT COMPLETED|Overall Study||0
8860421|NCT01809106|9915982|FG000|STARTED|Overall Study||130
8860422|NCT01809106|9915983|FG001|STARTED|Overall Study||130
8860423|NCT01809106|9915984|FG002|STARTED|Overall Study||130
8860424|NCT01809106|9915985|FG003|STARTED|Overall Study||128
8860425|NCT01809106|9915982|FG000|COMPLETED|Overall Study||122
8630217|NCT00534313|9669986|FG002|STARTED|Long-term Period||43
8860426|NCT01809106|9915983|FG001|COMPLETED|Overall Study||125
8860427|NCT01809106|9915984|FG002|COMPLETED|Overall Study||127
8860428|NCT01809106|9915985|FG003|COMPLETED|Overall Study||124
8860429|NCT01809106|9915982|FG000|NOT COMPLETED|Overall Study||8
8860430|NCT01809106|9915983|FG001|NOT COMPLETED|Overall Study||5
8860431|NCT01809106|9915984|FG002|NOT COMPLETED|Overall Study||3
8860432|NCT01809106|9915985|FG003|NOT COMPLETED|Overall Study||4
8860433|NCT01809132|9915998|FG000|STARTED|Overall Study||53
8860434|NCT01809132|9915999|FG001|STARTED|Overall Study||50
8860435|NCT01809132|9916000|FG002|STARTED|Overall Study|Subject was consented but withdrew prior to randomization and initiation of treatment.|1
8860436|NCT01809132|9915998|FG000|COMPLETED|Overall Study||53
8860437|NCT01809132|9915999|FG001|COMPLETED|Overall Study||50
8860438|NCT01809132|9916000|FG002|COMPLETED|Overall Study||0
8860439|NCT01809132|9915998|FG000|NOT COMPLETED|Overall Study||0
8630218|NCT00534313|9669987|FG003|STARTED|Long-term Period||33
8630219|NCT00534313|9669984|FG000|COMPLETED|Long-term Period||0
8630220|NCT00534313|9669985|FG001|COMPLETED|Long-term Period||0
8630221|NCT00534313|9669986|FG002|COMPLETED|Long-term Period||0
8630222|NCT00534313|9669987|FG003|COMPLETED|Long-term Period||0
8630223|NCT00534313|9669984|FG000|NOT COMPLETED|Long-term Period||37
8630224|NCT00534313|9669985|FG001|NOT COMPLETED|Long-term Period||34
8630225|NCT00534313|9669986|FG002|NOT COMPLETED|Long-term Period||43
8630226|NCT00534313|9669987|FG003|NOT COMPLETED|Long-term Period||33
8630227|NCT00534352|9670032|FG000|STARTED|Treatment A: TMC125 + TDF/FTC||23
8630228|NCT00534352|9670032|FG000|COMPLETED|Treatment A: TMC125 + TDF/FTC||21
8630229|NCT00534352|9670032|FG000|NOT COMPLETED|Treatment A: TMC125 + TDF/FTC||2
8630230|NCT00534352|9670032|FG000|STARTED|Treatment B: TMC125 + TDF/FTC + DRV/Rtv||21
8630231|NCT00534352|9670032|FG000|COMPLETED|Treatment B: TMC125 + TDF/FTC + DRV/Rtv||21
8630232|NCT00534352|9670032|FG000|NOT COMPLETED|Treatment B: TMC125 + TDF/FTC + DRV/Rtv||0
8630233|NCT00534352|9670032|FG000|STARTED|Treatment C: DRV/Rtv + TDF/FTC||21
8630234|NCT00534352|9670032|FG000|COMPLETED|Treatment C: DRV/Rtv + TDF/FTC||20
8630235|NCT00534352|9670032|FG000|NOT COMPLETED|Treatment C: DRV/Rtv + TDF/FTC||1
8630236|NCT00534352|9670032|FG000|STARTED|Optional Extension: DRV/Rtv + TDF/FTC||18
8630237|NCT00534352|9670032|FG000|COMPLETED|Optional Extension: DRV/Rtv + TDF/FTC||14
8630238|NCT00534352|9670032|FG000|NOT COMPLETED|Optional Extension: DRV/Rtv + TDF/FTC||4
8630239|NCT00534365|9670047|FG000|STARTED|Overall Study||127
8860440|NCT01809132|9915999|FG001|NOT COMPLETED|Overall Study||0
8860441|NCT01809132|9916000|FG002|NOT COMPLETED|Overall Study||1
8860442|NCT01809197|9916010|FG000|STARTED|Overall Study||187
8860443|NCT01809197|9916011|FG001|STARTED|Overall Study||185
8860444|NCT01809197|9916010|FG000|COMPLETED|Overall Study||177
8860445|NCT01809197|9916011|FG001|COMPLETED|Overall Study||177
8860446|NCT01809197|9916010|FG000|NOT COMPLETED|Overall Study||10
8860447|NCT01809197|9916011|FG001|NOT COMPLETED|Overall Study||8
8860448|NCT01809210|9916024|FG000|STARTED|Overall Study||3
8860449|NCT01809210|9916025|FG001|STARTED|Overall Study||9
8860450|NCT01809210|9916026|FG002|STARTED|Overall Study||7
8860451|NCT01809210|9916027|FG003|STARTED|Overall Study||3
8860452|NCT01809210|9916028|FG004|STARTED|Overall Study||6
8569692|NCT00098306|9601867|FG002|NOT COMPLETED|Open Label||0
8860453|NCT01809210|9916029|FG005|STARTED|Overall Study||15
8860454|NCT01809210|9916030|FG006|STARTED|Overall Study||12
8860455|NCT01809210|9916024|FG000|COMPLETED|Overall Study||2
8860456|NCT01809210|9916025|FG001|COMPLETED|Overall Study||8
8860457|NCT01809210|9916026|FG002|COMPLETED|Overall Study||4
8860458|NCT01809210|9916027|FG003|COMPLETED|Overall Study||2
8860459|NCT01809210|9916028|FG004|COMPLETED|Overall Study||4
8860460|NCT01809210|9916029|FG005|COMPLETED|Overall Study||12
8860461|NCT01809210|9916030|FG006|COMPLETED|Overall Study||7
8860462|NCT01809210|9916024|FG000|NOT COMPLETED|Overall Study||1
8860463|NCT01809210|9916025|FG001|NOT COMPLETED|Overall Study||1
8860464|NCT01809210|9916026|FG002|NOT COMPLETED|Overall Study||3
8860465|NCT01809210|9916027|FG003|NOT COMPLETED|Overall Study||1
8860466|NCT01809210|9916028|FG004|NOT COMPLETED|Overall Study||2
8860467|NCT01809210|9916029|FG005|NOT COMPLETED|Overall Study||3
8860468|NCT01809210|9916030|FG006|NOT COMPLETED|Overall Study||5
8860469|NCT01809262|9916046|FG000|STARTED|Period 1 (First Dose + Washout)||4
8860470|NCT01809262|9916047|FG001|STARTED|Period 1 (First Dose + Washout)||4
8860471|NCT01809262|9916048|FG002|STARTED|Period 1 (First Dose + Washout)||4
8860472|NCT01809262|9916049|FG003|STARTED|Period 1 (First Dose + Washout)||3
8860473|NCT01809262|9916050|FG004|STARTED|Period 1 (First Dose + Washout)||4
8860474|NCT01809262|9916051|FG005|STARTED|Period 1 (First Dose + Washout)||3
8860475|NCT01809262|9916052|FG006|STARTED|Period 1 (First Dose + Washout)||3
8860476|NCT01809262|9916053|FG007|STARTED|Period 1 (First Dose + Washout)||4
8860477|NCT01809262|9916054|FG008|STARTED|Period 1 (First Dose + Washout)||3
8860478|NCT01809262|9916055|FG009|STARTED|Period 1 (First Dose + Washout)||4
8860479|NCT01809262|9916046|FG000|COMPLETED|Period 1 (First Dose + Washout)||4
8860480|NCT01809262|9916047|FG001|COMPLETED|Period 1 (First Dose + Washout)||4
8860481|NCT01809262|9916048|FG002|COMPLETED|Period 1 (First Dose + Washout)||4
8860482|NCT01809262|9916049|FG003|COMPLETED|Period 1 (First Dose + Washout)||3
8860483|NCT01809262|9916050|FG004|COMPLETED|Period 1 (First Dose + Washout)||3
8860484|NCT01809262|9916051|FG005|COMPLETED|Period 1 (First Dose + Washout)||3
8860485|NCT01809262|9916052|FG006|COMPLETED|Period 1 (First Dose + Washout)||3
8860486|NCT01809262|9916053|FG007|COMPLETED|Period 1 (First Dose + Washout)||4
8860487|NCT01809262|9916054|FG008|COMPLETED|Period 1 (First Dose + Washout)||3
8860488|NCT01809262|9916055|FG009|COMPLETED|Period 1 (First Dose + Washout)||4
8860489|NCT01809262|9916046|FG000|NOT COMPLETED|Period 1 (First Dose + Washout)||0
8860490|NCT01809262|9916047|FG001|NOT COMPLETED|Period 1 (First Dose + Washout)||0
8860491|NCT01809262|9916048|FG002|NOT COMPLETED|Period 1 (First Dose + Washout)||0
8860492|NCT01809262|9916049|FG003|NOT COMPLETED|Period 1 (First Dose + Washout)||0
8860493|NCT01809262|9916050|FG004|NOT COMPLETED|Period 1 (First Dose + Washout)||1
8860494|NCT01809262|9916051|FG005|NOT COMPLETED|Period 1 (First Dose + Washout)||0
8860495|NCT01809262|9916052|FG006|NOT COMPLETED|Period 1 (First Dose + Washout)||0
8860496|NCT01809262|9916053|FG007|NOT COMPLETED|Period 1 (First Dose + Washout)||0
8860497|NCT01809262|9916054|FG008|NOT COMPLETED|Period 1 (First Dose + Washout)||0
8860498|NCT01809262|9916055|FG009|NOT COMPLETED|Period 1 (First Dose + Washout)||0
8860499|NCT01809262|9916046|FG000|STARTED|Period 2 (Second Dose + Washout)||4
8860500|NCT01809262|9916047|FG001|STARTED|Period 2 (Second Dose + Washout)||4
8860501|NCT01809262|9916048|FG002|STARTED|Period 2 (Second Dose + Washout)||4
8860502|NCT01809262|9916049|FG003|STARTED|Period 2 (Second Dose + Washout)||3
8860503|NCT01809262|9916050|FG004|STARTED|Period 2 (Second Dose + Washout)||3
8860504|NCT01809262|9916051|FG005|STARTED|Period 2 (Second Dose + Washout)||3
8860505|NCT01809262|9916052|FG006|STARTED|Period 2 (Second Dose + Washout)||3
8860506|NCT01809262|9916053|FG007|STARTED|Period 2 (Second Dose + Washout)||4
8860507|NCT01809262|9916054|FG008|STARTED|Period 2 (Second Dose + Washout)||3
8860508|NCT01809262|9916055|FG009|STARTED|Period 2 (Second Dose + Washout)||4
8860509|NCT01809262|9916046|FG000|COMPLETED|Period 2 (Second Dose + Washout)||4
8860510|NCT01809262|9916047|FG001|COMPLETED|Period 2 (Second Dose + Washout)||4
8860511|NCT01809262|9916048|FG002|COMPLETED|Period 2 (Second Dose + Washout)||4
8860512|NCT01809262|9916049|FG003|COMPLETED|Period 2 (Second Dose + Washout)||3
8860513|NCT01809262|9916050|FG004|COMPLETED|Period 2 (Second Dose + Washout)||3
8860514|NCT01809262|9916051|FG005|COMPLETED|Period 2 (Second Dose + Washout)||3
8860515|NCT01809262|9916052|FG006|COMPLETED|Period 2 (Second Dose + Washout)||3
8860516|NCT01809262|9916053|FG007|COMPLETED|Period 2 (Second Dose + Washout)||4
8860517|NCT01809262|9916054|FG008|COMPLETED|Period 2 (Second Dose + Washout)||3
8860518|NCT01809262|9916055|FG009|COMPLETED|Period 2 (Second Dose + Washout)||4
8569693|NCT00098306|9601868|FG003|NOT COMPLETED|Open Label||327
8923579|NCT02241733|9984209|FG001|COMPLETED|Overall Study||30
8860519|NCT01809262|9916046|FG000|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
8860520|NCT01809262|9916047|FG001|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
8860521|NCT01809262|9916048|FG002|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
8860522|NCT01809262|9916049|FG003|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
8860523|NCT01809262|9916050|FG004|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
8860524|NCT01809262|9916051|FG005|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
8860525|NCT01809262|9916052|FG006|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
8860526|NCT01809262|9916053|FG007|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
8860527|NCT01809262|9916054|FG008|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
8860528|NCT01809262|9916055|FG009|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
8860529|NCT01809262|9916046|FG000|STARTED|Period 3 (Third Dose + Washout)||4
8860530|NCT01809262|9916047|FG001|STARTED|Period 3 (Third Dose + Washout)||4
8860531|NCT01809262|9916048|FG002|STARTED|Period 3 (Third Dose + Washout)||4
8860532|NCT01809262|9916049|FG003|STARTED|Period 3 (Third Dose + Washout)||3
8860533|NCT01809262|9916050|FG004|STARTED|Period 3 (Third Dose + Washout)||3
8860534|NCT01809262|9916051|FG005|STARTED|Period 3 (Third Dose + Washout)||3
8860535|NCT01809262|9916052|FG006|STARTED|Period 3 (Third Dose + Washout)||3
8860536|NCT01809262|9916053|FG007|STARTED|Period 3 (Third Dose + Washout)||4
8860537|NCT01809262|9916054|FG008|STARTED|Period 3 (Third Dose + Washout)||3
8860538|NCT01809262|9916055|FG009|STARTED|Period 3 (Third Dose + Washout)||4
8860539|NCT01809262|9916046|FG000|COMPLETED|Period 3 (Third Dose + Washout)||4
8860540|NCT01809262|9916047|FG001|COMPLETED|Period 3 (Third Dose + Washout)||3
8860541|NCT01809262|9916048|FG002|COMPLETED|Period 3 (Third Dose + Washout)||4
8860542|NCT01809262|9916049|FG003|COMPLETED|Period 3 (Third Dose + Washout)||3
8860543|NCT01809262|9916050|FG004|COMPLETED|Period 3 (Third Dose + Washout)||3
8860544|NCT01809262|9916051|FG005|COMPLETED|Period 3 (Third Dose + Washout)||3
8860545|NCT01809262|9916052|FG006|COMPLETED|Period 3 (Third Dose + Washout)||3
8860546|NCT01809262|9916053|FG007|COMPLETED|Period 3 (Third Dose + Washout)||4
8860547|NCT01809262|9916054|FG008|COMPLETED|Period 3 (Third Dose + Washout)||3
8860548|NCT01809262|9916055|FG009|COMPLETED|Period 3 (Third Dose + Washout)||4
8860549|NCT01809262|9916046|FG000|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
8860550|NCT01809262|9916047|FG001|NOT COMPLETED|Period 3 (Third Dose + Washout)||1
8860551|NCT01809262|9916048|FG002|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
8860552|NCT01809262|9916049|FG003|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
8860553|NCT01809262|9916050|FG004|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
8860554|NCT01809262|9916051|FG005|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
8860555|NCT01809262|9916052|FG006|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
8860556|NCT01809262|9916053|FG007|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
8860557|NCT01809262|9916054|FG008|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
8860558|NCT01809262|9916055|FG009|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
8860559|NCT01809262|9916046|FG000|STARTED|Period 4 (Fourth Dose + Washout)||4
8860560|NCT01809262|9916047|FG001|STARTED|Period 4 (Fourth Dose + Washout)||3
8860561|NCT01809262|9916048|FG002|STARTED|Period 4 (Fourth Dose + Washout)||4
8860562|NCT01809262|9916049|FG003|STARTED|Period 4 (Fourth Dose + Washout)||3
8860563|NCT01809262|9916050|FG004|STARTED|Period 4 (Fourth Dose + Washout)||3
8860564|NCT01809262|9916051|FG005|STARTED|Period 4 (Fourth Dose + Washout)||3
8860565|NCT01809262|9916052|FG006|STARTED|Period 4 (Fourth Dose + Washout)||3
8860566|NCT01809262|9916053|FG007|STARTED|Period 4 (Fourth Dose + Washout)||4
8860567|NCT01809262|9916054|FG008|STARTED|Period 4 (Fourth Dose + Washout)||3
8860568|NCT01809262|9916055|FG009|STARTED|Period 4 (Fourth Dose + Washout)||4
8860569|NCT01809262|9916046|FG000|COMPLETED|Period 4 (Fourth Dose + Washout)||4
8860570|NCT01809262|9916047|FG001|COMPLETED|Period 4 (Fourth Dose + Washout)||3
8860571|NCT01809262|9916048|FG002|COMPLETED|Period 4 (Fourth Dose + Washout)||4
8860572|NCT01809262|9916049|FG003|COMPLETED|Period 4 (Fourth Dose + Washout)||3
8860573|NCT01809262|9916050|FG004|COMPLETED|Period 4 (Fourth Dose + Washout)||3
8860574|NCT01809262|9916051|FG005|COMPLETED|Period 4 (Fourth Dose + Washout)||3
8860575|NCT01809262|9916052|FG006|COMPLETED|Period 4 (Fourth Dose + Washout)||3
8860576|NCT01809262|9916053|FG007|COMPLETED|Period 4 (Fourth Dose + Washout)||4
8860577|NCT01809262|9916054|FG008|COMPLETED|Period 4 (Fourth Dose + Washout)||3
8860578|NCT01809262|9916055|FG009|COMPLETED|Period 4 (Fourth Dose + Washout)||4
8860579|NCT01809262|9916046|FG000|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
8860580|NCT01809262|9916047|FG001|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
8860581|NCT01809262|9916048|FG002|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
8860582|NCT01809262|9916049|FG003|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
8860583|NCT01809262|9916050|FG004|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
8860584|NCT01809262|9916051|FG005|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
8860585|NCT01809262|9916052|FG006|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
8860586|NCT01809262|9916053|FG007|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
8860587|NCT01809262|9916054|FG008|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
8860588|NCT01809262|9916055|FG009|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
8860589|NCT01809262|9916046|FG000|STARTED|Period 5 (Fifth Dose + Washout)||4
8860590|NCT01809262|9916047|FG001|STARTED|Period 5 (Fifth Dose + Washout)||3
8860591|NCT01809262|9916048|FG002|STARTED|Period 5 (Fifth Dose + Washout)||4
8860592|NCT01809262|9916049|FG003|STARTED|Period 5 (Fifth Dose + Washout)||3
8860593|NCT01809262|9916050|FG004|STARTED|Period 5 (Fifth Dose + Washout)||3
8860594|NCT01809262|9916051|FG005|STARTED|Period 5 (Fifth Dose + Washout)||3
8860595|NCT01809262|9916052|FG006|STARTED|Period 5 (Fifth Dose + Washout)||3
8860596|NCT01809262|9916053|FG007|STARTED|Period 5 (Fifth Dose + Washout)||4
8860597|NCT01809262|9916054|FG008|STARTED|Period 5 (Fifth Dose + Washout)||3
8860598|NCT01809262|9916055|FG009|STARTED|Period 5 (Fifth Dose + Washout)||4
8860599|NCT01809262|9916046|FG000|COMPLETED|Period 5 (Fifth Dose + Washout)||4
8860600|NCT01809262|9916047|FG001|COMPLETED|Period 5 (Fifth Dose + Washout)||3
8860601|NCT01809262|9916048|FG002|COMPLETED|Period 5 (Fifth Dose + Washout)||4
8860602|NCT01809262|9916049|FG003|COMPLETED|Period 5 (Fifth Dose + Washout)||3
8630240|NCT00534365|9670048|FG001|STARTED|Overall Study||136
8630241|NCT00534365|9670047|FG000|Received Procedure|Overall Study||127
8630242|NCT00534365|9670048|FG001|Received Procedure|Overall Study|7 patients excluded due to receipt of sling other than mini-sling|129
8630243|NCT00534365|9670047|FG000|Any Follow up|Overall Study||126
8630244|NCT00534365|9670048|FG001|Any Follow up|Overall Study||135
8860603|NCT01809262|9916050|FG004|COMPLETED|Period 5 (Fifth Dose + Washout)||3
8860604|NCT01809262|9916051|FG005|COMPLETED|Period 5 (Fifth Dose + Washout)||3
8860605|NCT01809262|9916052|FG006|COMPLETED|Period 5 (Fifth Dose + Washout)||3
8860606|NCT01809262|9916053|FG007|COMPLETED|Period 5 (Fifth Dose + Washout)||4
8860607|NCT01809262|9916054|FG008|COMPLETED|Period 5 (Fifth Dose + Washout)||3
8860608|NCT01809262|9916055|FG009|COMPLETED|Period 5 (Fifth Dose + Washout)||4
8860609|NCT01809262|9916046|FG000|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
8860610|NCT01809262|9916047|FG001|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
8860611|NCT01809262|9916048|FG002|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
8860612|NCT01809262|9916049|FG003|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
8860613|NCT01809262|9916050|FG004|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
8860614|NCT01809262|9916051|FG005|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
8860615|NCT01809262|9916052|FG006|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
8860616|NCT01809262|9916053|FG007|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
8860617|NCT01809262|9916054|FG008|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
8860618|NCT01809262|9916055|FG009|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
8860619|NCT01809314|9916067|FG000|STARTED|Overall Study||1167
8860620|NCT01809314|9916067|FG000|COMPLETED|Overall Study||422
8860621|NCT01809314|9916067|FG000|NOT COMPLETED|Overall Study||745
8860622|NCT01809327|9916076|FG000|STARTED|Overall Study||237
8860623|NCT01809327|9916077|FG001|STARTED|Overall Study||237
8860624|NCT01809327|9916078|FG002|STARTED|Overall Study||238
8860625|NCT01809327|9916079|FG003|STARTED|Overall Study||237
8860626|NCT01809327|9916080|FG004|STARTED|Overall Study||237
8860627|NCT01809327|9916076|FG000|COMPLETED|Overall Study||205
8860628|NCT01809327|9916077|FG001|COMPLETED|Overall Study||211
8860629|NCT01809327|9916078|FG002|COMPLETED|Overall Study||216
8860630|NCT01809327|9916079|FG003|COMPLETED|Overall Study||225
8860631|NCT01809327|9916080|FG004|COMPLETED|Overall Study||212
8860632|NCT01809327|9916076|FG000|NOT COMPLETED|Overall Study||32
8860633|NCT01809327|9916077|FG001|NOT COMPLETED|Overall Study||26
8860634|NCT01809327|9916078|FG002|NOT COMPLETED|Overall Study||22
8860635|NCT01809327|9916079|FG003|NOT COMPLETED|Overall Study||12
8860636|NCT01809327|9916080|FG004|NOT COMPLETED|Overall Study||25
8860637|NCT01809639|9916094|FG000|STARTED|Overall Study||18
8860638|NCT01809639|9916095|FG001|STARTED|Overall Study||7
8860639|NCT01809639|9916094|FG000|COMPLETED|Overall Study||18
8860640|NCT01809639|9916095|FG001|COMPLETED|Overall Study||7
8860641|NCT01809639|9916094|FG000|NOT COMPLETED|Overall Study||0
8860642|NCT01809639|9916095|FG001|NOT COMPLETED|Overall Study||0
8860643|NCT01809834|9916101|FG000|STARTED|Overall Study||44
8860644|NCT01809834|9916101|FG000|COMPLETED|Overall Study||44
8860645|NCT01809834|9916101|FG000|NOT COMPLETED|Overall Study||0
8860646|NCT01809938|9916107|FG000|STARTED|First Intervention (170 Minutes)||5
8860647|NCT01809938|9916108|FG001|STARTED|First Intervention (170 Minutes)||5
8860648|NCT01809938|9916107|FG000|COMPLETED|First Intervention (170 Minutes)||5
8860649|NCT01809938|9916108|FG001|COMPLETED|First Intervention (170 Minutes)||5
8860650|NCT01809938|9916107|FG000|NOT COMPLETED|First Intervention (170 Minutes)||0
8860651|NCT01809938|9916108|FG001|NOT COMPLETED|First Intervention (170 Minutes)||0
8860652|NCT01809938|9916107|FG000|STARTED|Washout (Not Less Than 24 Hours)||5
8860653|NCT01809938|9916108|FG001|STARTED|Washout (Not Less Than 24 Hours)||5
8860654|NCT01809938|9916107|FG000|COMPLETED|Washout (Not Less Than 24 Hours)||5
8860655|NCT01809938|9916108|FG001|COMPLETED|Washout (Not Less Than 24 Hours)||5
8860656|NCT01809938|9916107|FG000|NOT COMPLETED|Washout (Not Less Than 24 Hours)||0
8860657|NCT01809938|9916108|FG001|NOT COMPLETED|Washout (Not Less Than 24 Hours)||0
8860658|NCT01809938|9916107|FG000|STARTED|Second Intervention (170 Minutes)||5
8860659|NCT01809938|9916108|FG001|STARTED|Second Intervention (170 Minutes)||5
8860660|NCT01809938|9916107|FG000|COMPLETED|Second Intervention (170 Minutes)||5
8860661|NCT01809938|9916108|FG001|COMPLETED|Second Intervention (170 Minutes)||5
8860662|NCT01809938|9916107|FG000|NOT COMPLETED|Second Intervention (170 Minutes)||0
8860663|NCT01809938|9916108|FG001|NOT COMPLETED|Second Intervention (170 Minutes)||0
8860664|NCT01810016|9916116|FG000|STARTED|Overall Study||5
8630245|NCT00534365|9670047|FG000|Follow up at 12 Months or More|Overall Study||119
8630246|NCT00534365|9670048|FG001|Follow up at 12 Months or More|Overall Study||128
8630247|NCT00534365|9670047|FG000|Included in Intent to Treat Analysis|Overall Study||127
8860665|NCT01810016|9916117|FG001|STARTED|Overall Study||2
8860666|NCT01810016|9916118|FG002|STARTED|Overall Study||1
8860667|NCT01810016|9916116|FG000|COMPLETED|Overall Study||4
8860668|NCT01810016|9916117|FG001|COMPLETED|Overall Study||1
8860669|NCT01810016|9916118|FG002|COMPLETED|Overall Study||0
8860670|NCT01810016|9916116|FG000|NOT COMPLETED|Overall Study||1
8860671|NCT01810016|9916117|FG001|NOT COMPLETED|Overall Study||1
8860672|NCT01810016|9916118|FG002|NOT COMPLETED|Overall Study||1
8860673|NCT01810042|9916126|FG000|STARTED|Overall Study||49
8860674|NCT01810042|9916126|FG000|COMPLETED|Overall Study||39
8860675|NCT01810042|9916126|FG000|NOT COMPLETED|Overall Study||10
8860676|NCT01810263|9916132|FG000|STARTED|Overall Study||16
8860677|NCT01810263|9916133|FG001|STARTED|Overall Study||18
8860678|NCT01810263|9916132|FG000|COMPLETED|Overall Study|2014 July|8
8860679|NCT01810263|9916133|FG001|COMPLETED|Overall Study||11
8860680|NCT01810263|9916132|FG000|NOT COMPLETED|Overall Study||8
8860681|NCT01810263|9916133|FG001|NOT COMPLETED|Overall Study||7
8860682|NCT01810289|9916141|FG000|STARTED|Overall Study||7277
8860683|NCT01810289|9916142|FG001|STARTED|Overall Study||4747
8860684|NCT01810289|9916141|FG000|COMPLETED|Overall Study||7277
8860685|NCT01810289|9916142|FG001|COMPLETED|Overall Study||4747
8860686|NCT01810289|9916141|FG000|NOT COMPLETED|Overall Study||0
8860687|NCT01810289|9916142|FG001|NOT COMPLETED|Overall Study||0
8860688|NCT01810380|9916151|FG000|STARTED|Overall Study||163
8860689|NCT01810380|9916152|FG001|STARTED|Overall Study||151
8860690|NCT01810380|9916153|FG002|STARTED|Overall Study||154
8860691|NCT01810380|9916151|FG000|Treated|Overall Study||161
8860692|NCT01810380|9916152|FG001|Treated|Overall Study||150
8860693|NCT01810380|9916153|FG002|Treated|Overall Study||153
8860694|NCT01810380|9916151|FG000|COMPLETED|Overall Study||108
8860695|NCT01810380|9916152|FG001|COMPLETED|Overall Study||113
8860696|NCT01810380|9916153|FG002|COMPLETED|Overall Study||122
8860697|NCT01810380|9916151|FG000|NOT COMPLETED|Overall Study||55
8860698|NCT01810380|9916152|FG001|NOT COMPLETED|Overall Study||38
8860699|NCT01810380|9916153|FG002|NOT COMPLETED|Overall Study||32
8860700|NCT01810432|9916161|FG000|STARTED|Period 1||20
8860701|NCT01810432|9916162|FG001|STARTED|Period 1||20
8860702|NCT01810432|9916161|FG000|Received at Least 1 Dose of Study Drug|Period 1||20
8860703|NCT01810432|9916162|FG001|Received at Least 1 Dose of Study Drug|Period 1||20
8860704|NCT01810432|9916161|FG000|COMPLETED|Period 1||20
8860705|NCT01810432|9916162|FG001|COMPLETED|Period 1||20
8860706|NCT01810432|9916161|FG000|NOT COMPLETED|Period 1||0
8860707|NCT01810432|9916162|FG001|NOT COMPLETED|Period 1||0
8860708|NCT01810432|9916161|FG000|STARTED|Washout||20
8860709|NCT01810432|9916162|FG001|STARTED|Washout||20
8860710|NCT01810432|9916161|FG000|COMPLETED|Washout||19
8860711|NCT01810432|9916162|FG001|COMPLETED|Washout||19
8860712|NCT01810432|9916161|FG000|NOT COMPLETED|Washout||1
8860713|NCT01810432|9916162|FG001|NOT COMPLETED|Washout||1
8860714|NCT01810432|9916161|FG000|STARTED|Period 2||19
8860715|NCT01810432|9916162|FG001|STARTED|Period 2||19
8860716|NCT01810432|9916161|FG000|Received at Least 1 Dose of Study Drug|Period 2||19
8860717|NCT01810432|9916162|FG001|Received at Least 1 Dose of Study Drug|Period 2||19
8860718|NCT01810432|9916161|FG000|COMPLETED|Period 2||15
8860719|NCT01810432|9916162|FG001|COMPLETED|Period 2||17
8860720|NCT01810432|9916161|FG000|NOT COMPLETED|Period 2||4
8860721|NCT01810432|9916162|FG001|NOT COMPLETED|Period 2||2
8860722|NCT01810666|9916168|FG000|STARTED|Overall Study||30
8860723|NCT01810666|9916168|FG000|COMPLETED|Overall Study||30
8860724|NCT01810666|9916168|FG000|NOT COMPLETED|Overall Study||0
8860725|NCT01810692|9916174|FG000|STARTED|Overall Study||77
8860726|NCT01810692|9916175|FG001|STARTED|Overall Study||77
8860727|NCT01810692|9916174|FG000|COMPLETED|Overall Study||77
8860728|NCT01810692|9916175|FG001|COMPLETED|Overall Study||77
8860729|NCT01810692|9916174|FG000|NOT COMPLETED|Overall Study||0
8860730|NCT01810692|9916175|FG001|NOT COMPLETED|Overall Study||0
8860731|NCT01810783|9916181|FG000|STARTED|Overall Study||210
8860732|NCT01810783|9916181|FG000|COMPLETED|Overall Study||101
8860733|NCT01810783|9916181|FG000|NOT COMPLETED|Overall Study||109
8860734|NCT01810939|9916185|FG000|STARTED|Part A Treatment Period||243
8860735|NCT01810939|9916186|FG001|STARTED|Part A Treatment Period||0
8860736|NCT01810939|9916187|FG002|STARTED|Part A Treatment Period||0
8860737|NCT01810939|9916185|FG000|COMPLETED|Part A Treatment Period||219
8860738|NCT01810939|9916186|FG001|COMPLETED|Part A Treatment Period||0
8860739|NCT01810939|9916187|FG002|COMPLETED|Part A Treatment Period||0
8860740|NCT01810939|9916185|FG000|NOT COMPLETED|Part A Treatment Period||24
8860741|NCT01810939|9916186|FG001|NOT COMPLETED|Part A Treatment Period||0
8860742|NCT01810939|9916187|FG002|NOT COMPLETED|Part A Treatment Period||0
8860743|NCT01810939|9916185|FG000|STARTED|Part B Placebo-Controlled Withdrawal||0
8860744|NCT01810939|9916186|FG001|STARTED|Part B Placebo-Controlled Withdrawal|Part A participants with Part A baseline serum potassium ≥ 5.5 mEq/L who responded to treatment|55
8860745|NCT01810939|9916187|FG002|STARTED|Part B Placebo-Controlled Withdrawal|Part A participants with Part A baseline serum potassium ≥ 5.5 mEq/L who responded to treatment|52
8860746|NCT01810939|9916185|FG000|COMPLETED|Part B Placebo-Controlled Withdrawal||0
8860747|NCT01810939|9916186|FG001|COMPLETED|Part B Placebo-Controlled Withdrawal||45
8860748|NCT01810939|9916187|FG002|COMPLETED|Part B Placebo-Controlled Withdrawal||30
8860749|NCT01810939|9916185|FG000|NOT COMPLETED|Part B Placebo-Controlled Withdrawal||0
8860750|NCT01810939|9916186|FG001|NOT COMPLETED|Part B Placebo-Controlled Withdrawal||10
8860751|NCT01810939|9916187|FG002|NOT COMPLETED|Part B Placebo-Controlled Withdrawal||22
8860752|NCT01810952|9916198|FG000|STARTED|Overall Study||20
8860753|NCT01810952|9916199|FG001|STARTED|Overall Study||17
8860754|NCT01810952|9916198|FG000|COMPLETED|Overall Study||20
8860755|NCT01810952|9916199|FG001|COMPLETED|Overall Study||17
8860756|NCT01810952|9916198|FG000|NOT COMPLETED|Overall Study||0
8860757|NCT01810952|9916199|FG001|NOT COMPLETED|Overall Study||0
8860758|NCT01810991|9916211|FG000|STARTED|Overall Study||19
8860759|NCT01810991|9916211|FG000|COMPLETED|Overall Study||17
8860760|NCT01810991|9916211|FG000|NOT COMPLETED|Overall Study||2
8860761|NCT01811004|9916217|FG000|STARTED|Overall Study||9
8860762|NCT01811004|9916218|FG001|STARTED|Overall Study||8
8860763|NCT01811004|9916217|FG000|COMPLETED|Overall Study||8
8860764|NCT01811004|9916218|FG001|COMPLETED|Overall Study||5
8860765|NCT01811004|9916217|FG000|NOT COMPLETED|Overall Study||1
8860766|NCT01811004|9916218|FG001|NOT COMPLETED|Overall Study||3
8860767|NCT01811030|9916226|FG000|STARTED|Overall Study||33
8860768|NCT01811030|9916226|FG000|COMPLETED|Overall Study||20
8860769|NCT01811030|9916226|FG000|NOT COMPLETED|Overall Study||13
8860770|NCT01811147|9916234|FG000|STARTED|Overall Study||51
8860771|NCT01811147|9916235|FG001|STARTED|Overall Study||56
8860772|NCT01811147|9916236|FG002|STARTED|Overall Study||49
8860773|NCT01811147|9916237|FG003|STARTED|Overall Study||33
8860774|NCT01811147|9916234|FG000|COMPLETED|Overall Study||15
8860775|NCT01811147|9916235|FG001|COMPLETED|Overall Study||11
8860776|NCT01811147|9916236|FG002|COMPLETED|Overall Study||6
8860777|NCT01811147|9916237|FG003|COMPLETED|Overall Study||4
8860778|NCT01811147|9916234|FG000|NOT COMPLETED|Overall Study||36
8860779|NCT01811147|9916235|FG001|NOT COMPLETED|Overall Study||45
8860780|NCT01811147|9916236|FG002|NOT COMPLETED|Overall Study||43
8860781|NCT01811147|9916237|FG003|NOT COMPLETED|Overall Study||29
8860782|NCT01811186|9916249|FG000|STARTED|Overall Study||132
8860783|NCT01811186|9916250|FG001|STARTED|Overall Study||126
8949854|NCT02443519|10012544|FG001|NOT COMPLETED|Overall Study||3
8949855|NCT02443571|10012553|FG000|STARTED|Overall Study||596
8949856|NCT02443571|10012554|FG001|STARTED|Overall Study||95
8949857|NCT02443571|10012555|FG002|STARTED|Overall Study||23
8949858|NCT02443571|10012553|FG000|COMPLETED|Overall Study||596
8949859|NCT02443571|10012554|FG001|COMPLETED|Overall Study||95
8949860|NCT02443571|10012555|FG002|COMPLETED|Overall Study||23
8949861|NCT02443571|10012553|FG000|NOT COMPLETED|Overall Study||0
8949862|NCT02443571|10012554|FG001|NOT COMPLETED|Overall Study||0
8949863|NCT02443571|10012555|FG002|NOT COMPLETED|Overall Study||0
8949864|NCT02443688|10012566|FG000|STARTED|Overall Study||66
8949865|NCT02443688|10012567|FG001|STARTED|Overall Study||67
8949866|NCT02443688|10012568|FG002|STARTED|Overall Study||67
8949867|NCT02443688|10012566|FG000|COMPLETED|Overall Study||54
8949868|NCT02443688|10012567|FG001|COMPLETED|Overall Study||58
8949869|NCT02443688|10012568|FG002|COMPLETED|Overall Study||55
8949870|NCT02443688|10012566|FG000|NOT COMPLETED|Overall Study||12
8949871|NCT02443688|10012567|FG001|NOT COMPLETED|Overall Study||9
8860784|NCT01811186|9916249|FG000|COMPLETED|Overall Study||61
8860785|NCT01811186|9916250|FG001|COMPLETED|Overall Study||64
8860786|NCT01811186|9916249|FG000|NOT COMPLETED|Overall Study||71
8949872|NCT02443688|10012568|FG002|NOT COMPLETED|Overall Study||12
8949873|NCT02443740|10012584|FG000|STARTED|Intervention Period 1 (3 Days)||2
8949874|NCT02443740|10012585|FG001|STARTED|Intervention Period 1 (3 Days)||2
8860787|NCT01811186|9916250|FG001|NOT COMPLETED|Overall Study||62
8860788|NCT01811212|9916260|FG000|STARTED|Overall Study||25
8860789|NCT01811212|9916260|FG000|COMPLETED|Overall Study||25
8860790|NCT01811212|9916260|FG000|NOT COMPLETED|Overall Study||0
8860791|NCT01811225|9916264|FG000|STARTED|Treatment Period 1||49
8860792|NCT01811225|9916265|FG001|STARTED|Treatment Period 1||46
8860793|NCT01811225|9916264|FG000|COMPLETED|Treatment Period 1|53 completed one arm of the cross-over and 43 completed two arms of the cross-over|24
8860794|NCT01811225|9916265|FG001|COMPLETED|Treatment Period 1||29
8860795|NCT01811225|9916264|FG000|NOT COMPLETED|Treatment Period 1||25
8860796|NCT01811225|9916265|FG001|NOT COMPLETED|Treatment Period 1||17
8860797|NCT01811225|9916264|FG000|STARTED|Treatment Period 2||24
8860798|NCT01811225|9916265|FG001|STARTED|Treatment Period 2||29
8860799|NCT01811225|9916264|FG000|COMPLETED|Treatment Period 2||20
8860800|NCT01811225|9916265|FG001|COMPLETED|Treatment Period 2||23
8860801|NCT01811225|9916264|FG000|NOT COMPLETED|Treatment Period 2||4
8860802|NCT01811225|9916265|FG001|NOT COMPLETED|Treatment Period 2||6
8860803|NCT01811238|9916271|FG000|STARTED|Overall Study|First patient was recruited on 26 Sep. 2012.|240
8860804|NCT01811238|9916271|FG000|Safety Set|Overall Study|20 subjects excluded from the safety set due to study drug not administered.|220
8860805|NCT01811238|9916271|FG000|ITT Set|Overall Study|11 subjects excluded from ITT set due to no primary efficacy assessment(5) and IC/EC violation(6).|209
8860806|NCT01811238|9916271|FG000|PP Set|Overall Study|89 subjects excluded from PP set due to various reasons.|120
8860807|NCT01811238|9916271|FG000|COMPLETED|Overall Study|159 subjects regardless PP set completed study visit.|159
8630248|NCT00534365|9670048|FG001|Included in Intent to Treat Analysis|Overall Study||136
8630249|NCT00534365|9670047|FG000|COMPLETED|Overall Study||127
8630250|NCT00534365|9670048|FG001|COMPLETED|Overall Study||129
8630251|NCT00534365|9670047|FG000|NOT COMPLETED|Overall Study||0
8630252|NCT00534365|9670048|FG001|NOT COMPLETED|Overall Study||7
8630253|NCT00534404|9670059|FG000|STARTED|Overall Study||827
8630254|NCT00534404|9670060|FG001|STARTED|Overall Study||830
8860808|NCT01811238|9916271|FG000|NOT COMPLETED|Overall Study||81
8860809|NCT01811303|9916276|FG000|STARTED|First Intervention (1 Day)||4
8860810|NCT01811303|9916277|FG001|STARTED|First Intervention (1 Day)||4
8860811|NCT01811303|9916278|FG002|STARTED|First Intervention (1 Day)||4
8860812|NCT01811303|9916279|FG003|STARTED|First Intervention (1 Day)||2
8860813|NCT01811303|9916276|FG000|COMPLETED|First Intervention (1 Day)||4
8860814|NCT01811303|9916277|FG001|COMPLETED|First Intervention (1 Day)||4
8860815|NCT01811303|9916278|FG002|COMPLETED|First Intervention (1 Day)||4
8630255|NCT00534404|9670061|FG002|STARTED|Overall Study||828
8630256|NCT00534404|9670059|FG000|Completed at Least 1 Online Session|Overall Study||781
8630257|NCT00534404|9670060|FG001|Completed at Least 1 Online Session|Overall Study||813
8860816|NCT01811303|9916279|FG003|COMPLETED|First Intervention (1 Day)||2
8860817|NCT01811303|9916276|FG000|NOT COMPLETED|First Intervention (1 Day)||0
8860818|NCT01811303|9916277|FG001|NOT COMPLETED|First Intervention (1 Day)||0
8949875|NCT02443740|10012586|FG002|STARTED|Intervention Period 1 (3 Days)||2
8949876|NCT02443740|10012587|FG003|STARTED|Intervention Period 1 (3 Days)||3
8630258|NCT00534404|9670061|FG002|Completed at Least 1 Online Session|Overall Study||658
8630259|NCT00534404|9670059|FG000|Completed First NRT Order|Overall Study||765
8630260|NCT00534404|9670060|FG001|Completed First NRT Order|Overall Study|Participants could order NRT without completing a web session|821
8630261|NCT00534404|9670061|FG002|Completed First NRT Order|Overall Study|NRT was not available for this arm|0
8630262|NCT00534404|9670059|FG000|Completed Second NRT Order|Overall Study||640
8630263|NCT00534404|9670060|FG001|Completed Second NRT Order|Overall Study||789
8630264|NCT00534404|9670061|FG002|Completed Second NRT Order|Overall Study|NRT not available for this arm.|0
8630265|NCT00534404|9670059|FG000|Completed at Least 1 Counseling Call|Overall Study||813
8630266|NCT00534404|9670060|FG001|Completed at Least 1 Counseling Call|Overall Study|There was no counseling offered in this arm|0
8693541|NCT00867100|9739049|FG007|STARTED|Overall Study||3
8693542|NCT00867100|9739050|FG008|STARTED|Overall Study||6
8693543|NCT00867100|9739051|FG009|STARTED|Overall Study||6
8693544|NCT00867100|9739052|FG010|STARTED|Overall Study||4
8693545|NCT00867100|9739053|FG011|STARTED|Overall Study||6
8693546|NCT00867100|9739054|FG012|STARTED|Overall Study||6
8693547|NCT00867100|9739042|FG000|COMPLETED|Overall Study||5
8693548|NCT00867100|9739043|FG001|COMPLETED|Overall Study||4
8693549|NCT00867100|9739044|FG002|COMPLETED|Overall Study||8
8693550|NCT00867100|9739045|FG003|COMPLETED|Overall Study||8
8693551|NCT00867100|9739046|FG004|COMPLETED|Overall Study||14
8693552|NCT00867100|9739047|FG005|COMPLETED|Overall Study||6
8693553|NCT00867100|9739048|FG006|COMPLETED|Overall Study||6
8693554|NCT00867100|9739049|FG007|COMPLETED|Overall Study||3
8693555|NCT00867100|9739050|FG008|COMPLETED|Overall Study||6
8693556|NCT00867100|9739051|FG009|COMPLETED|Overall Study||6
8693557|NCT00867100|9739052|FG010|COMPLETED|Overall Study||3
8693558|NCT00867100|9739053|FG011|COMPLETED|Overall Study||6
8693559|NCT00867100|9739054|FG012|COMPLETED|Overall Study||6
8693560|NCT00867100|9739042|FG000|NOT COMPLETED|Overall Study||0
8693561|NCT00867100|9739043|FG001|NOT COMPLETED|Overall Study||1
8693562|NCT00867100|9739044|FG002|NOT COMPLETED|Overall Study||0
8693563|NCT00867100|9739045|FG003|NOT COMPLETED|Overall Study||0
8693564|NCT00867100|9739046|FG004|NOT COMPLETED|Overall Study||0
8693565|NCT00867100|9739047|FG005|NOT COMPLETED|Overall Study||0
8693566|NCT00867100|9739048|FG006|NOT COMPLETED|Overall Study||1
8693567|NCT00867100|9739049|FG007|NOT COMPLETED|Overall Study||0
8860819|NCT01811303|9916278|FG002|NOT COMPLETED|First Intervention (1 Day)||0
8860820|NCT01811303|9916279|FG003|NOT COMPLETED|First Intervention (1 Day)||0
8860821|NCT01811303|9916276|FG000|STARTED|Washout (2 Days or More)||4
8860822|NCT01811303|9916277|FG001|STARTED|Washout (2 Days or More)||4
8860823|NCT01811303|9916278|FG002|STARTED|Washout (2 Days or More)||4
8860824|NCT01811303|9916279|FG003|STARTED|Washout (2 Days or More)||2
8860825|NCT01811303|9916276|FG000|COMPLETED|Washout (2 Days or More)||4
8860826|NCT01811303|9916277|FG001|COMPLETED|Washout (2 Days or More)||4
8860827|NCT01811303|9916278|FG002|COMPLETED|Washout (2 Days or More)||4
8860828|NCT01811303|9916279|FG003|COMPLETED|Washout (2 Days or More)||2
8860829|NCT01811303|9916276|FG000|NOT COMPLETED|Washout (2 Days or More)||0
8860830|NCT01811303|9916277|FG001|NOT COMPLETED|Washout (2 Days or More)||0
8860831|NCT01811303|9916278|FG002|NOT COMPLETED|Washout (2 Days or More)||0
8860832|NCT01811303|9916279|FG003|NOT COMPLETED|Washout (2 Days or More)||0
8860833|NCT01811303|9916276|FG000|STARTED|Second Intervention (1 Day)||4
8860834|NCT01811303|9916277|FG001|STARTED|Second Intervention (1 Day)||4
8860835|NCT01811303|9916278|FG002|STARTED|Second Intervention (1 Day)||4
8860836|NCT01811303|9916279|FG003|STARTED|Second Intervention (1 Day)||2
8860837|NCT01811303|9916276|FG000|COMPLETED|Second Intervention (1 Day)||4
8860838|NCT01811303|9916277|FG001|COMPLETED|Second Intervention (1 Day)||4
8860839|NCT01811303|9916278|FG002|COMPLETED|Second Intervention (1 Day)||4
8860840|NCT01811303|9916279|FG003|COMPLETED|Second Intervention (1 Day)||2
8860841|NCT01811303|9916276|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
8860842|NCT01811303|9916277|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
8860843|NCT01811303|9916278|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
8860844|NCT01811303|9916279|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
8860845|NCT01811303|9916276|FG000|STARTED|Washout (2 Days or More)||4
8860846|NCT01811303|9916277|FG001|STARTED|Washout (2 Days or More)||4
8860847|NCT01811303|9916278|FG002|STARTED|Washout (2 Days or More)||4
8860848|NCT01811303|9916279|FG003|STARTED|Washout (2 Days or More)||2
8860849|NCT01811303|9916276|FG000|COMPLETED|Washout (2 Days or More)||4
8860850|NCT01811303|9916277|FG001|COMPLETED|Washout (2 Days or More)||4
8860851|NCT01811303|9916278|FG002|COMPLETED|Washout (2 Days or More)||4
8860852|NCT01811303|9916279|FG003|COMPLETED|Washout (2 Days or More)||2
8860853|NCT01811303|9916276|FG000|NOT COMPLETED|Washout (2 Days or More)||0
8860854|NCT01811303|9916277|FG001|NOT COMPLETED|Washout (2 Days or More)||0
8860855|NCT01811303|9916278|FG002|NOT COMPLETED|Washout (2 Days or More)||0
8860856|NCT01811303|9916279|FG003|NOT COMPLETED|Washout (2 Days or More)||0
8860857|NCT01811303|9916276|FG000|STARTED|Third Intervention (1 Day)||4
8860858|NCT01811303|9916277|FG001|STARTED|Third Intervention (1 Day)||4
8860859|NCT01811303|9916278|FG002|STARTED|Third Intervention (1 Day)||4
8860860|NCT01811303|9916279|FG003|STARTED|Third Intervention (1 Day)||2
8860861|NCT01811303|9916276|FG000|COMPLETED|Third Intervention (1 Day)||4
8860862|NCT01811303|9916277|FG001|COMPLETED|Third Intervention (1 Day)||4
8860863|NCT01811303|9916278|FG002|COMPLETED|Third Intervention (1 Day)||4
8860864|NCT01811303|9916279|FG003|COMPLETED|Third Intervention (1 Day)||2
8860865|NCT01811303|9916276|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
8860866|NCT01811303|9916277|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
8860867|NCT01811303|9916278|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
8860868|NCT01811303|9916279|FG003|NOT COMPLETED|Third Intervention (1 Day)||0
8860869|NCT01811303|9916276|FG000|STARTED|Washout (2 Days or More)||4
8860870|NCT01811303|9916277|FG001|STARTED|Washout (2 Days or More)||4
8860871|NCT01811303|9916278|FG002|STARTED|Washout (2 Days or More)||4
8860872|NCT01811303|9916279|FG003|STARTED|Washout (2 Days or More)||2
8860873|NCT01811303|9916276|FG000|COMPLETED|Washout (2 Days or More)||4
8860874|NCT01811303|9916277|FG001|COMPLETED|Washout (2 Days or More)||4
8860875|NCT01811303|9916278|FG002|COMPLETED|Washout (2 Days or More)||4
8860876|NCT01811303|9916279|FG003|COMPLETED|Washout (2 Days or More)||2
8860877|NCT01811303|9916276|FG000|NOT COMPLETED|Washout (2 Days or More)||0
8860878|NCT01811303|9916277|FG001|NOT COMPLETED|Washout (2 Days or More)||0
8860879|NCT01811303|9916278|FG002|NOT COMPLETED|Washout (2 Days or More)||0
8860880|NCT01811303|9916279|FG003|NOT COMPLETED|Washout (2 Days or More)||0
8860881|NCT01811303|9916276|FG000|STARTED|Fourth Intervention (1 Day)||4
8860882|NCT01811303|9916277|FG001|STARTED|Fourth Intervention (1 Day)||4
8860883|NCT01811303|9916278|FG002|STARTED|Fourth Intervention (1 Day)||4
8860884|NCT01811303|9916279|FG003|STARTED|Fourth Intervention (1 Day)||2
8860885|NCT01811303|9916276|FG000|COMPLETED|Fourth Intervention (1 Day)||4
8860886|NCT01811303|9916277|FG001|COMPLETED|Fourth Intervention (1 Day)||4
8860887|NCT01811303|9916278|FG002|COMPLETED|Fourth Intervention (1 Day)||4
8860888|NCT01811303|9916279|FG003|COMPLETED|Fourth Intervention (1 Day)||2
8860889|NCT01811303|9916276|FG000|NOT COMPLETED|Fourth Intervention (1 Day)||0
8860890|NCT01811303|9916277|FG001|NOT COMPLETED|Fourth Intervention (1 Day)||0
8860891|NCT01811303|9916278|FG002|NOT COMPLETED|Fourth Intervention (1 Day)||0
8860892|NCT01811303|9916279|FG003|NOT COMPLETED|Fourth Intervention (1 Day)||0
8860893|NCT01811316|9916290|FG000|STARTED|Overall Study||21
8860894|NCT01811316|9916291|FG001|STARTED|Overall Study||22
8860895|NCT01811316|9916292|FG002|STARTED|Overall Study||19
8860896|NCT01811316|9916290|FG000|Visit 4 Weeks|Overall Study||19
8860897|NCT01811316|9916291|FG001|Visit 4 Weeks|Overall Study||22
8860898|NCT01811316|9916292|FG002|Visit 4 Weeks|Overall Study||19
8860899|NCT01811316|9916290|FG000|Visit 12 Weeks|Overall Study||18
8860900|NCT01811316|9916291|FG001|Visit 12 Weeks|Overall Study||22
8860901|NCT01811316|9916292|FG002|Visit 12 Weeks|Overall Study||19
8860902|NCT01811316|9916290|FG000|COMPLETED|Overall Study||18
8860903|NCT01811316|9916291|FG001|COMPLETED|Overall Study||22
8860904|NCT01811316|9916292|FG002|COMPLETED|Overall Study||19
8860905|NCT01811316|9916290|FG000|NOT COMPLETED|Overall Study||3
8860906|NCT01811316|9916291|FG001|NOT COMPLETED|Overall Study||0
8860907|NCT01811316|9916292|FG002|NOT COMPLETED|Overall Study||0
8860908|NCT01811355|9916300|FG000|STARTED|First Dose||11
8860909|NCT01811355|9916301|FG001|STARTED|First Dose||12
8860910|NCT01811355|9916300|FG000|COMPLETED|First Dose||9
8860911|NCT01811355|9916301|FG001|COMPLETED|First Dose||12
8860912|NCT01811355|9916300|FG000|NOT COMPLETED|First Dose||2
8860913|NCT01811355|9916301|FG001|NOT COMPLETED|First Dose||0
8860914|NCT01811355|9916300|FG000|STARTED|Washout||9
8860915|NCT01811355|9916301|FG001|STARTED|Washout||12
8860916|NCT01811355|9916300|FG000|COMPLETED|Washout||9
8860917|NCT01811355|9916301|FG001|COMPLETED|Washout||12
8860918|NCT01811355|9916300|FG000|NOT COMPLETED|Washout||0
8860919|NCT01811355|9916301|FG001|NOT COMPLETED|Washout||0
8860920|NCT01811355|9916300|FG000|STARTED|Second Dose||9
8860921|NCT01811355|9916301|FG001|STARTED|Second Dose||12
8860922|NCT01811355|9916300|FG000|COMPLETED|Second Dose||9
8860923|NCT01811355|9916301|FG001|COMPLETED|Second Dose||12
8860924|NCT01811355|9916300|FG000|NOT COMPLETED|Second Dose||0
8860925|NCT01811355|9916301|FG001|NOT COMPLETED|Second Dose||0
8860926|NCT01811472|9916312|FG000|STARTED|Overall Study||20
8860927|NCT01811472|9916313|FG001|STARTED|Overall Study||11
8860928|NCT01811472|9916314|FG002|STARTED|Overall Study||21
8860929|NCT01811472|9916312|FG000|COMPLETED|Overall Study||18
8860930|NCT01811472|9916313|FG001|COMPLETED|Overall Study||11
8860931|NCT01811472|9916314|FG002|COMPLETED|Overall Study||16
8860932|NCT01811472|9916312|FG000|NOT COMPLETED|Overall Study||2
8860933|NCT01811472|9916313|FG001|NOT COMPLETED|Overall Study||0
8860934|NCT01811472|9916314|FG002|NOT COMPLETED|Overall Study||5
8860935|NCT01811485|9916326|FG000|STARTED|Overall Study|"Started indicates randomized patients"|56
8860936|NCT01811485|9916327|FG001|STARTED|Overall Study||59
8860937|NCT01811485|9916328|FG002|STARTED|Overall Study||56
8860938|NCT01811485|9916326|FG000|COMPLETED|Overall Study||54
8860939|NCT01811485|9916327|FG001|COMPLETED|Overall Study||55
8860940|NCT01811485|9916328|FG002|COMPLETED|Overall Study||51
8860941|NCT01811485|9916326|FG000|NOT COMPLETED|Overall Study||2
8860942|NCT01811485|9916327|FG001|NOT COMPLETED|Overall Study||4
8860943|NCT01811485|9916328|FG002|NOT COMPLETED|Overall Study||5
8860944|NCT01811563|9916341|FG000|STARTED|Overall Study||25
8860945|NCT01811563|9916342|FG001|STARTED|Overall Study||23
8860946|NCT01811563|9916341|FG000|COMPLETED|Overall Study||20
8860947|NCT01811563|9916342|FG001|COMPLETED|Overall Study||20
8860948|NCT01811563|9916341|FG000|NOT COMPLETED|Overall Study||5
8860949|NCT01811563|9916342|FG001|NOT COMPLETED|Overall Study||3
8860950|NCT01811654|9916350|FG000|STARTED|Overall Study||14
8860951|NCT01811654|9916351|FG001|STARTED|Overall Study||16
8860952|NCT01811654|9916350|FG000|COMPLETED|Overall Study||14
8860953|NCT01811654|9916351|FG001|COMPLETED|Overall Study||16
8860954|NCT01811654|9916350|FG000|NOT COMPLETED|Overall Study||0
8860955|NCT01811654|9916351|FG001|NOT COMPLETED|Overall Study||0
8860956|NCT01811680|9916357|FG000|STARTED|Overall Study||10
8860957|NCT01811680|9916357|FG000|COMPLETED|Overall Study||10
8860958|NCT01811680|9916357|FG000|NOT COMPLETED|Overall Study||0
8860959|NCT01811693|9916365|FG000|STARTED|Overall Study||4
8860960|NCT01811693|9916366|FG001|STARTED|Overall Study||0
8860961|NCT01811693|9916367|FG002|STARTED|Overall Study||0
8860962|NCT01811693|9916365|FG000|COMPLETED|Overall Study||4
8860963|NCT01811693|9916366|FG001|COMPLETED|Overall Study||0
8860964|NCT01811693|9916367|FG002|COMPLETED|Overall Study||0
8860965|NCT01811693|9916365|FG000|NOT COMPLETED|Overall Study||0
8860966|NCT01811693|9916366|FG001|NOT COMPLETED|Overall Study||0
8860967|NCT01811693|9916367|FG002|NOT COMPLETED|Overall Study||0
8860968|NCT01811706|9916371|FG000|STARTED|First Intervention ( 4 Weeks)||10
8860969|NCT01811706|9916372|FG001|STARTED|First Intervention ( 4 Weeks)||10
8860970|NCT01811706|9916371|FG000|COMPLETED|First Intervention ( 4 Weeks)||9
8860971|NCT01811706|9916372|FG001|COMPLETED|First Intervention ( 4 Weeks)||10
8860972|NCT01811706|9916371|FG000|NOT COMPLETED|First Intervention ( 4 Weeks)||1
8860973|NCT01811706|9916372|FG001|NOT COMPLETED|First Intervention ( 4 Weeks)||0
8860974|NCT01811706|9916371|FG000|STARTED|Washout ( 2 Weeks)||9
8949877|NCT02443740|10012588|FG004|STARTED|Intervention Period 1 (3 Days)||2
8860975|NCT01811706|9916372|FG001|STARTED|Washout ( 2 Weeks)||10
8860976|NCT01811706|9916371|FG000|COMPLETED|Washout ( 2 Weeks)||9
8860977|NCT01811706|9916372|FG001|COMPLETED|Washout ( 2 Weeks)||10
8860978|NCT01811706|9916371|FG000|NOT COMPLETED|Washout ( 2 Weeks)||0
8860979|NCT01811706|9916372|FG001|NOT COMPLETED|Washout ( 2 Weeks)||0
8860980|NCT01811706|9916371|FG000|STARTED|Second Intervention (4 Weeks)||9
8860981|NCT01811706|9916372|FG001|STARTED|Second Intervention (4 Weeks)||10
8860982|NCT01811706|9916371|FG000|COMPLETED|Second Intervention (4 Weeks)||9
8860983|NCT01811706|9916372|FG001|COMPLETED|Second Intervention (4 Weeks)||10
8860984|NCT01811706|9916371|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0
8860985|NCT01811706|9916372|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||0
8860986|NCT01811732|9916382|FG000|STARTED|Overall Study||331
8860987|NCT01811732|9916383|FG001|STARTED|Overall Study||329
8860988|NCT01811732|9916382|FG000|COMPLETED|Overall Study||276
8860989|NCT01811732|9916383|FG001|COMPLETED|Overall Study||271
8860990|NCT01811732|9916382|FG000|NOT COMPLETED|Overall Study||55
8860991|NCT01811732|9916383|FG001|NOT COMPLETED|Overall Study||58
8860992|NCT01811875|9916390|FG000|STARTED|Overall Study||7
8860993|NCT01811875|9916390|FG000|COMPLETED|Overall Study||5
8860994|NCT01811875|9916390|FG000|NOT COMPLETED|Overall Study||2
8860995|NCT01811940|9916396|FG000|STARTED|Overall Study||64
8860996|NCT01811940|9916397|FG001|STARTED|Overall Study||63
8860997|NCT01811940|9916396|FG000|COMPLETED|Overall Study||42
8860998|NCT01811940|9916397|FG001|COMPLETED|Overall Study||37
8860999|NCT01811940|9916396|FG000|NOT COMPLETED|Overall Study||22
8861000|NCT01811940|9916397|FG001|NOT COMPLETED|Overall Study||26
8861001|NCT01811953|9916409|FG000|STARTED|Overall Study||6
8861002|NCT01811953|9916410|FG001|STARTED|Overall Study||6
8861003|NCT01811953|9916411|FG002|STARTED|Overall Study||6
8861004|NCT01811953|9916412|FG003|STARTED|Overall Study||6
8861005|NCT01811953|9916413|FG004|STARTED|Overall Study||12
8861006|NCT01811953|9916414|FG005|STARTED|Overall Study||12
8861007|NCT01811953|9916409|FG000|COMPLETED|Overall Study||6
8861008|NCT01811953|9916410|FG001|COMPLETED|Overall Study||6
8861009|NCT01811953|9916411|FG002|COMPLETED|Overall Study||6
8861010|NCT01811953|9916412|FG003|COMPLETED|Overall Study||5
8861011|NCT01811953|9916413|FG004|COMPLETED|Overall Study||11
8861012|NCT01811953|9916414|FG005|COMPLETED|Overall Study||11
8861013|NCT01811953|9916409|FG000|NOT COMPLETED|Overall Study||0
8861014|NCT01811953|9916410|FG001|NOT COMPLETED|Overall Study||0
8861015|NCT01811953|9916411|FG002|NOT COMPLETED|Overall Study||0
8861016|NCT01811953|9916412|FG003|NOT COMPLETED|Overall Study||1
8861017|NCT01811953|9916413|FG004|NOT COMPLETED|Overall Study||1
8861018|NCT01811953|9916414|FG005|NOT COMPLETED|Overall Study||1
8861019|NCT01812005|9916430|FG000|STARTED|Overall Study||1
8861020|NCT01812005|9916431|FG001|STARTED|Overall Study||13
8861021|NCT01812005|9916430|FG000|COMPLETED|Overall Study||1
8861022|NCT01812005|9916431|FG001|COMPLETED|Overall Study||13
8861023|NCT01812005|9916430|FG000|NOT COMPLETED|Overall Study||0
8861024|NCT01812005|9916431|FG001|NOT COMPLETED|Overall Study||0
8861025|NCT01812044|9916440|FG000|STARTED|Overall Study||17
8861026|NCT01812044|9916441|FG001|STARTED|Overall Study||17
8861027|NCT01812044|9916442|FG002|STARTED|Overall Study||16
8861028|NCT01812044|9916440|FG000|COMPLETED|Overall Study||17
8861029|NCT01812044|9916441|FG001|COMPLETED|Overall Study||17
8861030|NCT01812044|9916442|FG002|COMPLETED|Overall Study||16
8861031|NCT01812044|9916440|FG000|NOT COMPLETED|Overall Study||0
8861032|NCT01812044|9916441|FG001|NOT COMPLETED|Overall Study||0
8861033|NCT01812044|9916442|FG002|NOT COMPLETED|Overall Study||0
8861034|NCT01812057|9916452|FG000|STARTED|Overall Study||25
8861035|NCT01812057|9916453|FG001|STARTED|Overall Study||24
8861036|NCT01812057|9916452|FG000|COMPLETED|Overall Study||23
8861037|NCT01812057|9916453|FG001|COMPLETED|Overall Study||24
8861038|NCT01812057|9916452|FG000|NOT COMPLETED|Overall Study||2
8861039|NCT01812057|9916453|FG001|NOT COMPLETED|Overall Study||0
8861040|NCT01812109|9916463|FG000|STARTED|Overall Study||154
8861041|NCT01812109|9916463|FG000|With Torsion|Overall Study||36
8861042|NCT01812109|9916463|FG000|Without Torsion|Overall Study||85
8861043|NCT01812109|9916463|FG000|COMPLETED|Overall Study||121
8861044|NCT01812109|9916463|FG000|NOT COMPLETED|Overall Study||33
8861045|NCT01812473|9916469|FG000|STARTED|Overall Study||22
8861046|NCT01812473|9916470|FG001|STARTED|Overall Study||13
8861047|NCT01812473|9916469|FG000|COMPLETED|Overall Study||22
8861048|NCT01812473|9916470|FG001|COMPLETED|Overall Study||13
8861049|NCT01812473|9916469|FG000|NOT COMPLETED|Overall Study||0
8861050|NCT01812473|9916470|FG001|NOT COMPLETED|Overall Study||0
8861051|NCT01812655|9916479|FG000|STARTED|Overall Study|Virtual Reality-Patients used an interactive VR program during their burn wound care procedure.|9
8861052|NCT01812655|9916480|FG001|STARTED|Overall Study|Passive Distraction-Patients watched a movie during their burn wound care.|11
8861053|NCT01812655|9916481|FG002|STARTED|Overall Study|Nurses provided their usual, standard care throughout the entire burn wound care.|10
8861054|NCT01812655|9916479|FG000|COMPLETED|Overall Study||8
8861055|NCT01812655|9916480|FG001|COMPLETED|Overall Study||10
8861056|NCT01812655|9916481|FG002|COMPLETED|Overall Study||10
8861057|NCT01812655|9916479|FG000|NOT COMPLETED|Overall Study||1
8861058|NCT01812655|9916480|FG001|NOT COMPLETED|Overall Study||1
8861059|NCT01812655|9916481|FG002|NOT COMPLETED|Overall Study||0
8861060|NCT01812668|9916492|FG000|STARTED|Overall Study||20
8861061|NCT01812668|9916492|FG000|COMPLETED|Overall Study||20
8861062|NCT01812668|9916492|FG000|NOT COMPLETED|Overall Study||0
8861063|NCT01812681|9916498|FG000|STARTED|Overall Study||60
8861064|NCT01812681|9916499|FG001|STARTED|Overall Study||24
8861065|NCT01812681|9916498|FG000|COMPLETED|Overall Study||57
8861066|NCT01812681|9916499|FG001|COMPLETED|Overall Study||24
8861067|NCT01812681|9916498|FG000|NOT COMPLETED|Overall Study||3
8861068|NCT01812681|9916499|FG001|NOT COMPLETED|Overall Study||0
8861069|NCT01812707|9916509|FG000|STARTED|Overall Study||25
8861070|NCT01812707|9916510|FG001|STARTED|Overall Study||25
8861071|NCT01812707|9916511|FG002|STARTED|Overall Study||25
8861072|NCT01812707|9916512|FG003|STARTED|Overall Study||25
8949878|NCT02443740|10012589|FG005|STARTED|Intervention Period 1 (3 Days)||4
8861073|NCT01812707|9916509|FG000|Treated|Overall Study||25
8861074|NCT01812707|9916510|FG001|Treated|Overall Study||25
8861075|NCT01812707|9916511|FG002|Treated|Overall Study||25
8861076|NCT01812707|9916512|FG003|Treated|Overall Study||25
8861077|NCT01812707|9916509|FG000|COMPLETED|Overall Study||23
8861078|NCT01812707|9916510|FG001|COMPLETED|Overall Study||25
8861079|NCT01812707|9916511|FG002|COMPLETED|Overall Study||25
8861080|NCT01812707|9916512|FG003|COMPLETED|Overall Study||23
8949879|NCT02443740|10012590|FG006|STARTED|Intervention Period 1 (3 Days)||3
8861081|NCT01812707|9916509|FG000|NOT COMPLETED|Overall Study||2
8861082|NCT01812707|9916510|FG001|NOT COMPLETED|Overall Study||0
8861083|NCT01812707|9916511|FG002|NOT COMPLETED|Overall Study||0
8861084|NCT01812707|9916512|FG003|NOT COMPLETED|Overall Study||2
8861085|NCT01812759|9916526|FG000|STARTED|Overall Study||1
8861086|NCT01812759|9916527|FG001|STARTED|Overall Study||1
8861087|NCT01812759|9916528|FG002|STARTED|Overall Study||1
8861088|NCT01812759|9916526|FG000|COMPLETED|Overall Study||1
8861089|NCT01812759|9916527|FG001|COMPLETED|Overall Study||1
8861090|NCT01812759|9916528|FG002|COMPLETED|Overall Study||0
8861091|NCT01812759|9916526|FG000|NOT COMPLETED|Overall Study||0
8861092|NCT01812759|9916527|FG001|NOT COMPLETED|Overall Study||0
8861093|NCT01812759|9916528|FG002|NOT COMPLETED|Overall Study||1
8861094|NCT01812837|9916539|FG000|STARTED|Overall Study||17
8861095|NCT01812837|9916540|FG001|STARTED|Overall Study||17
8861096|NCT01812837|9916541|FG002|STARTED|Overall Study||17
8861097|NCT01812837|9916539|FG000|COMPLETED|Overall Study||15
8861098|NCT01812837|9916540|FG001|COMPLETED|Overall Study||16
8861099|NCT01812837|9916541|FG002|COMPLETED|Overall Study||17
8861100|NCT01812837|9916539|FG000|NOT COMPLETED|Overall Study||2
8861101|NCT01812837|9916540|FG001|NOT COMPLETED|Overall Study||1
8861102|NCT01812837|9916541|FG002|NOT COMPLETED|Overall Study||0
8861103|NCT01813019|9916551|FG000|STARTED|Overall Study||24
8861104|NCT01813019|9916552|FG001|STARTED|Overall Study||26
8630267|NCT00534404|9670061|FG002|Completed at Least 1 Counseling Call|Overall Study|There was no counseling offered in this arm|0
8861105|NCT01813019|9916551|FG000|COMPLETED|Overall Study||17
8861106|NCT01813019|9916552|FG001|COMPLETED|Overall Study||20
8861107|NCT01813019|9916551|FG000|NOT COMPLETED|Overall Study||7
8861108|NCT01813019|9916552|FG001|NOT COMPLETED|Overall Study||6
8861109|NCT01813058|9916560|FG000|STARTED|Overall Study||60
8861110|NCT01813058|9916561|FG001|STARTED|Overall Study||60
8861111|NCT01813058|9916560|FG000|COMPLETED|Overall Study||55
8861112|NCT01813058|9916561|FG001|COMPLETED|Overall Study||56
8861113|NCT01813058|9916560|FG000|NOT COMPLETED|Overall Study||5
8861114|NCT01813058|9916561|FG001|NOT COMPLETED|Overall Study||4
8861115|NCT01813071|9916576|FG000|STARTED|Overall Study||10
8861116|NCT01813071|9916577|FG001|STARTED|Overall Study||10
8861117|NCT01813071|9916578|FG002|STARTED|Overall Study||10
8861118|NCT01813071|9916579|FG003|STARTED|Overall Study||9
8861119|NCT01813071|9916580|FG004|STARTED|Overall Study||12
8861120|NCT01813071|9916581|FG005|STARTED|Overall Study||12
8861121|NCT01813071|9916582|FG006|STARTED|Overall Study||12
8861122|NCT01813071|9916583|FG007|STARTED|Overall Study||12
8861123|NCT01813071|9916584|FG008|STARTED|Overall Study||16
8861124|NCT01813071|9916576|FG000|COMPLETED|Overall Study||10
8861125|NCT01813071|9916577|FG001|COMPLETED|Overall Study||10
8861126|NCT01813071|9916578|FG002|COMPLETED|Overall Study||10
8861127|NCT01813071|9916579|FG003|COMPLETED|Overall Study||9
8861128|NCT01813071|9916580|FG004|COMPLETED|Overall Study||11
8861129|NCT01813071|9916581|FG005|COMPLETED|Overall Study||5
8861130|NCT01813071|9916582|FG006|COMPLETED|Overall Study||9
8861131|NCT01813071|9916583|FG007|COMPLETED|Overall Study||7
8861132|NCT01813071|9916584|FG008|COMPLETED|Overall Study||13
8861133|NCT01813071|9916576|FG000|NOT COMPLETED|Overall Study||0
8861134|NCT01813071|9916577|FG001|NOT COMPLETED|Overall Study||0
8861135|NCT01813071|9916578|FG002|NOT COMPLETED|Overall Study||0
8861136|NCT01813071|9916579|FG003|NOT COMPLETED|Overall Study||0
8861137|NCT01813071|9916580|FG004|NOT COMPLETED|Overall Study||1
8861138|NCT01813071|9916581|FG005|NOT COMPLETED|Overall Study||7
8861139|NCT01813071|9916582|FG006|NOT COMPLETED|Overall Study||3
8861140|NCT01813071|9916583|FG007|NOT COMPLETED|Overall Study||5
8861141|NCT01813071|9916584|FG008|NOT COMPLETED|Overall Study||3
8861142|NCT01813110|9916618|FG000|STARTED|Overall Study||10
8861143|NCT01813110|9916619|FG001|STARTED|Overall Study||11
8861144|NCT01813110|9916618|FG000|COMPLETED|Overall Study||10
8861145|NCT01813110|9916619|FG001|COMPLETED|Overall Study||10
8861146|NCT01813110|9916618|FG000|NOT COMPLETED|Overall Study||0
8861147|NCT01813110|9916619|FG001|NOT COMPLETED|Overall Study||1
8861148|NCT01813149|9916628|FG000|STARTED|Overall Study||90
8861149|NCT01813149|9916629|FG001|STARTED|Overall Study||38
8861150|NCT01813149|9916628|FG000|COMPLETED|Overall Study||90
8861151|NCT01813149|9916629|FG001|COMPLETED|Overall Study||38
8861152|NCT01813149|9916628|FG000|NOT COMPLETED|Overall Study||0
8861153|NCT01813149|9916629|FG001|NOT COMPLETED|Overall Study||0
8861154|NCT01813214|9916642|FG000|STARTED|Overall Study||3
8861155|NCT01813214|9916643|FG001|STARTED|Overall Study||2
8861156|NCT01813214|9916642|FG000|COMPLETED|Overall Study||3
8861157|NCT01813214|9916643|FG001|COMPLETED|Overall Study||2
8861158|NCT01813214|9916642|FG000|NOT COMPLETED|Overall Study||0
8861159|NCT01813214|9916643|FG001|NOT COMPLETED|Overall Study||0
8861160|NCT01813357|9916651|FG000|STARTED|Overall Study||40
8861161|NCT01813357|9916652|FG001|STARTED|Overall Study||44
8861162|NCT01813357|9916651|FG000|COMPLETED|Overall Study||35
8861163|NCT01813357|9916652|FG001|COMPLETED|Overall Study||38
8861164|NCT01813357|9916651|FG000|NOT COMPLETED|Overall Study||5
8861165|NCT01813357|9916652|FG001|NOT COMPLETED|Overall Study||6
8861166|NCT01813422|9916660|FG000|STARTED|Overall Study||486
8861167|NCT01813422|9916661|FG001|STARTED|Overall Study||484
8861168|NCT01813422|9916660|FG000|Received Treatment|Overall Study||484
8861169|NCT01813422|9916661|FG001|Received Treatment|Overall Study||484
8861170|NCT01813422|9916660|FG000|COMPLETED|Overall Study||466
8861171|NCT01813422|9916661|FG001|COMPLETED|Overall Study||468
8861172|NCT01813422|9916660|FG000|NOT COMPLETED|Overall Study||20
8861173|NCT01813422|9916661|FG001|NOT COMPLETED|Overall Study||16
8923580|NCT02241733|9984208|FG000|NOT COMPLETED|Overall Study||15
8923581|NCT02241733|9984209|FG001|NOT COMPLETED|Overall Study||10
8923582|NCT02241785|9984215|FG000|STARTED|Overall Study||47
8923583|NCT02241785|9984215|FG000|COMPLETED|Overall Study||0
8923584|NCT02241785|9984215|FG000|NOT COMPLETED|Overall Study||47
8923585|NCT02241889|9984219|FG000|STARTED|Overall Study||4
8923586|NCT02241889|9984220|FG001|STARTED|Overall Study||4
8923587|NCT02241889|9984221|FG002|STARTED|Overall Study||3
8923588|NCT02241889|9984222|FG003|STARTED|Overall Study||3
8923589|NCT02241889|9984223|FG004|STARTED|Overall Study||5
8923590|NCT02241889|9984224|FG005|STARTED|Overall Study||4
8923591|NCT02241889|9984219|FG000|COMPLETED|Overall Study||4
8923592|NCT02241889|9984220|FG001|COMPLETED|Overall Study||4
8923593|NCT02241889|9984221|FG002|COMPLETED|Overall Study||2
8923594|NCT02241889|9984222|FG003|COMPLETED|Overall Study||3
8923595|NCT02241889|9984223|FG004|COMPLETED|Overall Study||5
8923596|NCT02241889|9984224|FG005|COMPLETED|Overall Study||3
8923597|NCT02241889|9984219|FG000|NOT COMPLETED|Overall Study||0
8923598|NCT02241889|9984220|FG001|NOT COMPLETED|Overall Study||0
8923599|NCT02241889|9984221|FG002|NOT COMPLETED|Overall Study||1
8923600|NCT02241889|9984222|FG003|NOT COMPLETED|Overall Study||0
8923601|NCT02241889|9984223|FG004|NOT COMPLETED|Overall Study||0
8923602|NCT02241889|9984224|FG005|NOT COMPLETED|Overall Study||1
8923603|NCT02241967|9984236|FG000|STARTED|Overall Study||30
8923604|NCT02241967|9984237|FG001|STARTED|Overall Study||30
8923605|NCT02241967|9984238|FG002|STARTED|Overall Study||30
8923606|NCT02241967|9984239|FG003|STARTED|Overall Study||29
8923607|NCT02241967|9984236|FG000|COMPLETED|Overall Study||30
8923608|NCT02241967|9984237|FG001|COMPLETED|Overall Study||30
8923609|NCT02241967|9984238|FG002|COMPLETED|Overall Study||30
8569694|NCT00098306|9601869|FG004|NOT COMPLETED|Open Label||62
8569695|NCT00098306|9601870|FG005|NOT COMPLETED|Open Label||0
8569696|NCT00098306|9601871|FG006|NOT COMPLETED|Open Label||0
8569697|NCT00098306|9601865|FG000|STARTED|Observational Phase||0
8569698|NCT00098306|9601866|FG001|STARTED|Observational Phase||0
8923610|NCT02241967|9984239|FG003|COMPLETED|Overall Study||29
8923611|NCT02241967|9984236|FG000|NOT COMPLETED|Overall Study||0
8923612|NCT02241967|9984237|FG001|NOT COMPLETED|Overall Study||0
8923613|NCT02241967|9984238|FG002|NOT COMPLETED|Overall Study||0
8923614|NCT02241967|9984239|FG003|NOT COMPLETED|Overall Study||0
8923615|NCT02242019|9984249|FG000|STARTED|Overall Study||109
8923616|NCT02242019|9984249|FG000|COMPLETED|Overall Study||109
8923617|NCT02242019|9984249|FG000|NOT COMPLETED|Overall Study||0
8923618|NCT02242045|9984253|FG000|STARTED|Overall Study||6
8923619|NCT02242045|9984253|FG000|COMPLETED|Overall Study||0
8923620|NCT02242045|9984253|FG000|NOT COMPLETED|Overall Study||6
8923621|NCT02242201|9984260|FG000|STARTED|Overall Study||55
8923622|NCT02242201|9984261|FG001|STARTED|Overall Study||55
8923623|NCT02242201|9984262|FG002|STARTED|Overall Study||55
8923624|NCT02242201|9984260|FG000|COMPLETED|Overall Study||51
8923625|NCT02242201|9984261|FG001|COMPLETED|Overall Study||54
8923626|NCT02242201|9984262|FG002|COMPLETED|Overall Study||54
8923627|NCT02242201|9984260|FG000|NOT COMPLETED|Overall Study||4
8923628|NCT02242201|9984261|FG001|NOT COMPLETED|Overall Study||1
8923629|NCT02242201|9984262|FG002|NOT COMPLETED|Overall Study||1
8923630|NCT02242305|9984272|FG000|STARTED|Overall Study||151
8923631|NCT02242305|9984273|FG001|STARTED|Overall Study||151
8923632|NCT02242305|9984272|FG000|COMPLETED|Overall Study||145
8923633|NCT02242305|9984273|FG001|COMPLETED|Overall Study||141
8923634|NCT02242305|9984272|FG000|NOT COMPLETED|Overall Study||6
8923635|NCT02242305|9984273|FG001|NOT COMPLETED|Overall Study||10
8923636|NCT02242487|9984281|FG000|STARTED|Overall Study||161
8923637|NCT02242487|9984282|FG001|STARTED|Overall Study||164
8923638|NCT02242487|9984281|FG000|COMPLETED|Overall Study||99
8923639|NCT02242487|9984282|FG001|COMPLETED|Overall Study||117
8923640|NCT02242487|9984281|FG000|NOT COMPLETED|Overall Study||62
8569699|NCT00098306|9601867|FG002|STARTED|Observational Phase||0
8569700|NCT00098306|9601868|FG003|STARTED|Observational Phase||0
8569701|NCT00098306|9601869|FG004|STARTED|Observational Phase||0
8569702|NCT00098306|9601870|FG005|STARTED|Observational Phase||250
8569703|NCT00098306|9601871|FG006|STARTED|Observational Phase||81
8923641|NCT02242487|9984282|FG001|NOT COMPLETED|Overall Study||47
8923642|NCT02242630|9984294|FG000|STARTED|Overall Study||15
8923643|NCT02242630|9984295|FG001|STARTED|Overall Study||15
8923644|NCT02242630|9984296|FG002|STARTED|Overall Study||15
8923645|NCT02242630|9984297|FG003|STARTED|Overall Study||16
8923646|NCT02242630|9984294|FG000|COMPLETED|Overall Study||15
8923647|NCT02242630|9984295|FG001|COMPLETED|Overall Study||15
8923648|NCT02242630|9984296|FG002|COMPLETED|Overall Study||15
8923649|NCT02242630|9984297|FG003|COMPLETED|Overall Study||16
8923650|NCT02242630|9984294|FG000|NOT COMPLETED|Overall Study||0
8923651|NCT02242630|9984295|FG001|NOT COMPLETED|Overall Study||0
8923652|NCT02242630|9984296|FG002|NOT COMPLETED|Overall Study||0
8923653|NCT02242630|9984297|FG003|NOT COMPLETED|Overall Study||0
8923654|NCT02242643|9984309|FG000|STARTED|Overall Study||1207
8861174|NCT01813474|9916670|FG000|STARTED|Overall Study||4
8861175|NCT01813474|9916671|FG001|STARTED|Overall Study||7
8861176|NCT01813474|9916672|FG002|STARTED|Overall Study||12
8861177|NCT01813474|9916670|FG000|COMPLETED|Overall Study|ongoing study at final data cut off|1
8861178|NCT01813474|9916671|FG001|COMPLETED|Overall Study||0
8861179|NCT01813474|9916672|FG002|COMPLETED|Overall Study|ongoing study at final data cut off|1
8861180|NCT01813474|9916670|FG000|NOT COMPLETED|Overall Study||3
8861181|NCT01813474|9916671|FG001|NOT COMPLETED|Overall Study||7
8861182|NCT01813474|9916672|FG002|NOT COMPLETED|Overall Study||11
8861183|NCT01813721|9916681|FG000|STARTED|Overall Study|Indicates number of participants enrolled|1007
8861184|NCT01813721|9916681|FG000|COMPLETED|Overall Study||943
8861185|NCT01813721|9916681|FG000|NOT COMPLETED|Overall Study||64
8861186|NCT01813734|9916703|FG000|STARTED|Overall Study||9
8861187|NCT01813734|9916703|FG000|COMPLETED|Overall Study||9
8861188|NCT01813734|9916703|FG000|NOT COMPLETED|Overall Study||0
8861189|NCT01813890|9916710|FG000|STARTED|Overall Study||20
8861190|NCT01813890|9916711|FG001|STARTED|Overall Study||21
8861191|NCT01813890|9916712|FG002|STARTED|Overall Study||19
8861192|NCT01813890|9916710|FG000|COMPLETED|Overall Study||11
8861193|NCT01813890|9916711|FG001|COMPLETED|Overall Study||17
8861194|NCT01813890|9916712|FG002|COMPLETED|Overall Study||13
8861195|NCT01813890|9916710|FG000|NOT COMPLETED|Overall Study||9
8861196|NCT01813890|9916711|FG001|NOT COMPLETED|Overall Study||4
8861197|NCT01813890|9916712|FG002|NOT COMPLETED|Overall Study||6
8861198|NCT01814007|9916720|FG000|STARTED|Overall Study||35
8861199|NCT01814007|9916720|FG000|COMPLETED|Overall Study||34
8861200|NCT01814007|9916720|FG000|NOT COMPLETED|Overall Study||1
8861201|NCT01814046|9916727|FG000|STARTED|Drug Administration||22
8861202|NCT01814046|9916728|FG001|STARTED|Drug Administration||2
8861203|NCT01814046|9916729|FG002|STARTED|Drug Administration||0
8861204|NCT01814046|9916727|FG000|COMPLETED|Drug Administration||21
8861205|NCT01814046|9916728|FG001|COMPLETED|Drug Administration||2
8861206|NCT01814046|9916729|FG002|COMPLETED|Drug Administration||0
8861207|NCT01814046|9916727|FG000|NOT COMPLETED|Drug Administration||1
8861208|NCT01814046|9916728|FG001|NOT COMPLETED|Drug Administration||0
8861209|NCT01814046|9916729|FG002|NOT COMPLETED|Drug Administration||0
8861210|NCT01814046|9916727|FG000|STARTED|Retreatment||0
8861211|NCT01814046|9916728|FG001|STARTED|Retreatment||0
8861212|NCT01814046|9916729|FG002|STARTED|Retreatment||3
8861213|NCT01814046|9916727|FG000|COMPLETED|Retreatment||0
8861214|NCT01814046|9916728|FG001|COMPLETED|Retreatment||0
8861215|NCT01814046|9916729|FG002|COMPLETED|Retreatment||3
8861216|NCT01814046|9916727|FG000|NOT COMPLETED|Retreatment||0
8861217|NCT01814046|9916728|FG001|NOT COMPLETED|Retreatment||0
8861218|NCT01814046|9916729|FG002|NOT COMPLETED|Retreatment||0
8861219|NCT01814072|9916768|FG000|STARTED|Overall Study||18
8861220|NCT01814072|9916769|FG001|STARTED|Overall Study||18
8861221|NCT01814072|9916770|FG002|STARTED|Overall Study||18
8861222|NCT01814072|9916771|FG003|STARTED|Overall Study||18
8861223|NCT01814072|9916772|FG004|STARTED|Overall Study||18
8861224|NCT01814072|9916773|FG005|STARTED|Overall Study||18
8861225|NCT01814072|9916774|FG006|STARTED|Overall Study||18
8861226|NCT01814072|9916775|FG007|STARTED|Overall Study||18
8861227|NCT01814072|9916776|FG008|STARTED|Overall Study||19
8861228|NCT01814072|9916777|FG009|STARTED|Overall Study||18
8861229|NCT01814072|9916778|FG010|STARTED|Overall Study||18
8861230|NCT01814072|9916779|FG011|STARTED|Overall Study||18
8861231|NCT01814072|9916780|FG012|STARTED|Overall Study||18
8861232|NCT01814072|9916781|FG013|STARTED|Overall Study||18
8861233|NCT01814072|9916782|FG014|STARTED|Overall Study||18
8861234|NCT01814072|9916783|FG015|STARTED|Overall Study||18
8861235|NCT01814072|9916784|FG016|STARTED|Overall Study||17
8861236|NCT01814072|9916785|FG017|STARTED|Overall Study||18
8861237|NCT01814072|9916786|FG018|STARTED|Overall Study||17
8861238|NCT01814072|9916787|FG019|STARTED|Overall Study||16
8861239|NCT01814072|9916788|FG020|STARTED|Overall Study||16
8861240|NCT01814072|9916789|FG021|STARTED|Overall Study||17
8861241|NCT01814072|9916790|FG022|STARTED|Overall Study||17
8861242|NCT01814072|9916791|FG023|STARTED|Overall Study||18
8861243|NCT01814072|9916792|FG024|STARTED|Overall Study||17
8861244|NCT01814072|9916793|FG025|STARTED|Overall Study||16
8861245|NCT01814072|9916794|FG026|STARTED|Overall Study||18
8861246|NCT01814072|9916795|FG027|STARTED|Overall Study||17
8861247|NCT01814072|9916796|FG028|STARTED|Overall Study||18
8861248|NCT01814072|9916797|FG029|STARTED|Overall Study||17
8861249|NCT01814072|9916798|FG030|STARTED|Overall Study||17
8861250|NCT01814072|9916799|FG031|STARTED|Overall Study||17
8861251|NCT01814072|9916768|FG000|3-mo Visit|Overall Study||15
8861252|NCT01814072|9916769|FG001|3-mo Visit|Overall Study||18
8861253|NCT01814072|9916770|FG002|3-mo Visit|Overall Study||16
8861254|NCT01814072|9916771|FG003|3-mo Visit|Overall Study||18
8861255|NCT01814072|9916772|FG004|3-mo Visit|Overall Study||15
8861256|NCT01814072|9916773|FG005|3-mo Visit|Overall Study||15
8861257|NCT01814072|9916774|FG006|3-mo Visit|Overall Study||16
8861258|NCT01814072|9916775|FG007|3-mo Visit|Overall Study||18
8861259|NCT01814072|9916776|FG008|3-mo Visit|Overall Study||18
8861260|NCT01814072|9916777|FG009|3-mo Visit|Overall Study||15
8861261|NCT01814072|9916778|FG010|3-mo Visit|Overall Study||18
8861262|NCT01814072|9916779|FG011|3-mo Visit|Overall Study||17
8861263|NCT01814072|9916780|FG012|3-mo Visit|Overall Study||16
8861264|NCT01814072|9916781|FG013|3-mo Visit|Overall Study||16
8861265|NCT01814072|9916782|FG014|3-mo Visit|Overall Study||16
8861266|NCT01814072|9916783|FG015|3-mo Visit|Overall Study||16
8861267|NCT01814072|9916784|FG016|3-mo Visit|Overall Study||16
8861268|NCT01814072|9916785|FG017|3-mo Visit|Overall Study||16
8861269|NCT01814072|9916786|FG018|3-mo Visit|Overall Study||14
8861270|NCT01814072|9916787|FG019|3-mo Visit|Overall Study||13
8861271|NCT01814072|9916788|FG020|3-mo Visit|Overall Study||15
8861272|NCT01814072|9916789|FG021|3-mo Visit|Overall Study||17
8861273|NCT01814072|9916790|FG022|3-mo Visit|Overall Study||15
8861274|NCT01814072|9916791|FG023|3-mo Visit|Overall Study||18
8861275|NCT01814072|9916792|FG024|3-mo Visit|Overall Study||13
8861276|NCT01814072|9916793|FG025|3-mo Visit|Overall Study||14
8861277|NCT01814072|9916794|FG026|3-mo Visit|Overall Study||17
8861278|NCT01814072|9916795|FG027|3-mo Visit|Overall Study||14
8861279|NCT01814072|9916796|FG028|3-mo Visit|Overall Study||15
8861280|NCT01814072|9916797|FG029|3-mo Visit|Overall Study||16
8861281|NCT01814072|9916798|FG030|3-mo Visit|Overall Study||16
8861282|NCT01814072|9916799|FG031|3-mo Visit|Overall Study||17
8861283|NCT01814072|9916768|FG000|Intent to Treat|Overall Study||4
8861284|NCT01814072|9916769|FG001|Intent to Treat|Overall Study||2
8861285|NCT01814072|9916770|FG002|Intent to Treat|Overall Study||3
8861286|NCT01814072|9916771|FG003|Intent to Treat|Overall Study||0
8861287|NCT01814072|9916772|FG004|Intent to Treat|Overall Study||4
8861288|NCT01814072|9916773|FG005|Intent to Treat|Overall Study||6
8861289|NCT01814072|9916774|FG006|Intent to Treat|Overall Study||4
8861290|NCT01814072|9916775|FG007|Intent to Treat|Overall Study||1
8861291|NCT01814072|9916776|FG008|Intent to Treat|Overall Study||3
8861292|NCT01814072|9916777|FG009|Intent to Treat|Overall Study||5
8861293|NCT01814072|9916778|FG010|Intent to Treat|Overall Study||1
8861294|NCT01814072|9916779|FG011|Intent to Treat|Overall Study||2
8861295|NCT01814072|9916780|FG012|Intent to Treat|Overall Study||3
8861296|NCT01814072|9916781|FG013|Intent to Treat|Overall Study||2
8861297|NCT01814072|9916782|FG014|Intent to Treat|Overall Study||3
8861298|NCT01814072|9916783|FG015|Intent to Treat|Overall Study||2
8861299|NCT01814072|9916784|FG016|Intent to Treat|Overall Study||3
8861300|NCT01814072|9916785|FG017|Intent to Treat|Overall Study||1
8861301|NCT01814072|9916786|FG018|Intent to Treat|Overall Study||3
8861302|NCT01814072|9916787|FG019|Intent to Treat|Overall Study||5
8861303|NCT01814072|9916788|FG020|Intent to Treat|Overall Study||2
8861304|NCT01814072|9916789|FG021|Intent to Treat|Overall Study||1
8861305|NCT01814072|9916790|FG022|Intent to Treat|Overall Study||4
8861306|NCT01814072|9916791|FG023|Intent to Treat|Overall Study||1
8861307|NCT01814072|9916792|FG024|Intent to Treat|Overall Study||6
8861308|NCT01814072|9916793|FG025|Intent to Treat|Overall Study||2
8861309|NCT01814072|9916794|FG026|Intent to Treat|Overall Study||2
8861310|NCT01814072|9916795|FG027|Intent to Treat|Overall Study||4
8861311|NCT01814072|9916796|FG028|Intent to Treat|Overall Study||4
8861312|NCT01814072|9916797|FG029|Intent to Treat|Overall Study||3
8861313|NCT01814072|9916798|FG030|Intent to Treat|Overall Study||2
8861314|NCT01814072|9916799|FG031|Intent to Treat|Overall Study||0
8861315|NCT01814072|9916768|FG000|COMPLETED|Overall Study||14
8861316|NCT01814072|9916769|FG001|COMPLETED|Overall Study||16
8861317|NCT01814072|9916770|FG002|COMPLETED|Overall Study||15
8861318|NCT01814072|9916771|FG003|COMPLETED|Overall Study||18
8861319|NCT01814072|9916772|FG004|COMPLETED|Overall Study||14
8861320|NCT01814072|9916773|FG005|COMPLETED|Overall Study||12
8861321|NCT01814072|9916774|FG006|COMPLETED|Overall Study||14
8861322|NCT01814072|9916775|FG007|COMPLETED|Overall Study||17
8861323|NCT01814072|9916776|FG008|COMPLETED|Overall Study||16
8861324|NCT01814072|9916777|FG009|COMPLETED|Overall Study||13
8861325|NCT01814072|9916778|FG010|COMPLETED|Overall Study||17
8861326|NCT01814072|9916779|FG011|COMPLETED|Overall Study||16
8861327|NCT01814072|9916780|FG012|COMPLETED|Overall Study||15
8861328|NCT01814072|9916781|FG013|COMPLETED|Overall Study||16
8861329|NCT01814072|9916782|FG014|COMPLETED|Overall Study||15
8861330|NCT01814072|9916783|FG015|COMPLETED|Overall Study||16
8861331|NCT01814072|9916784|FG016|COMPLETED|Overall Study||14
8861332|NCT01814072|9916785|FG017|COMPLETED|Overall Study||17
8861333|NCT01814072|9916786|FG018|COMPLETED|Overall Study||14
8861334|NCT01814072|9916787|FG019|COMPLETED|Overall Study||11
8861335|NCT01814072|9916788|FG020|COMPLETED|Overall Study||14
8861336|NCT01814072|9916789|FG021|COMPLETED|Overall Study||16
8861337|NCT01814072|9916790|FG022|COMPLETED|Overall Study||13
8861338|NCT01814072|9916791|FG023|COMPLETED|Overall Study||17
8861339|NCT01814072|9916792|FG024|COMPLETED|Overall Study||11
8861340|NCT01814072|9916793|FG025|COMPLETED|Overall Study||14
8861341|NCT01814072|9916794|FG026|COMPLETED|Overall Study||16
8861342|NCT01814072|9916795|FG027|COMPLETED|Overall Study||13
8861343|NCT01814072|9916796|FG028|COMPLETED|Overall Study||14
8861344|NCT01814072|9916797|FG029|COMPLETED|Overall Study||14
8861345|NCT01814072|9916798|FG030|COMPLETED|Overall Study||15
8861346|NCT01814072|9916799|FG031|COMPLETED|Overall Study||17
8861347|NCT01814072|9916768|FG000|NOT COMPLETED|Overall Study||4
8861348|NCT01814072|9916769|FG001|NOT COMPLETED|Overall Study||2
8861349|NCT01814072|9916770|FG002|NOT COMPLETED|Overall Study||3
8861350|NCT01814072|9916771|FG003|NOT COMPLETED|Overall Study||0
8861351|NCT01814072|9916772|FG004|NOT COMPLETED|Overall Study||4
8861352|NCT01814072|9916773|FG005|NOT COMPLETED|Overall Study||6
8861353|NCT01814072|9916774|FG006|NOT COMPLETED|Overall Study||4
8861354|NCT01814072|9916775|FG007|NOT COMPLETED|Overall Study||1
8861355|NCT01814072|9916776|FG008|NOT COMPLETED|Overall Study||3
8861356|NCT01814072|9916777|FG009|NOT COMPLETED|Overall Study||5
8861357|NCT01814072|9916778|FG010|NOT COMPLETED|Overall Study||1
8861358|NCT01814072|9916779|FG011|NOT COMPLETED|Overall Study||2
8861359|NCT01814072|9916780|FG012|NOT COMPLETED|Overall Study||3
8861360|NCT01814072|9916781|FG013|NOT COMPLETED|Overall Study||2
8861361|NCT01814072|9916782|FG014|NOT COMPLETED|Overall Study||3
8861362|NCT01814072|9916783|FG015|NOT COMPLETED|Overall Study||2
8861363|NCT01814072|9916784|FG016|NOT COMPLETED|Overall Study||3
8630268|NCT00534404|9670059|FG000|1-month Follow up Completed|Overall Study||742
8630269|NCT00534404|9670060|FG001|1-month Follow up Completed|Overall Study||781
8630270|NCT00534404|9670061|FG002|1-month Follow up Completed|Overall Study||626
8861364|NCT01814072|9916785|FG017|NOT COMPLETED|Overall Study||1
8861365|NCT01814072|9916786|FG018|NOT COMPLETED|Overall Study||3
8861366|NCT01814072|9916787|FG019|NOT COMPLETED|Overall Study||5
8861367|NCT01814072|9916788|FG020|NOT COMPLETED|Overall Study||2
8861368|NCT01814072|9916789|FG021|NOT COMPLETED|Overall Study||1
8861369|NCT01814072|9916790|FG022|NOT COMPLETED|Overall Study||4
8861370|NCT01814072|9916791|FG023|NOT COMPLETED|Overall Study||1
8861371|NCT01814072|9916792|FG024|NOT COMPLETED|Overall Study||6
8861372|NCT01814072|9916793|FG025|NOT COMPLETED|Overall Study||2
8861373|NCT01814072|9916794|FG026|NOT COMPLETED|Overall Study||2
8861374|NCT01814072|9916795|FG027|NOT COMPLETED|Overall Study||4
8861375|NCT01814072|9916796|FG028|NOT COMPLETED|Overall Study||4
8861376|NCT01814072|9916797|FG029|NOT COMPLETED|Overall Study||3
8861377|NCT01814072|9916798|FG030|NOT COMPLETED|Overall Study||2
8861378|NCT01814072|9916799|FG031|NOT COMPLETED|Overall Study||0
8861379|NCT01814137|9916841|FG000|STARTED|Overall Study||20
8630271|NCT00534404|9670059|FG000|3-month Follow up Completed|Overall Study||682
8630272|NCT00534404|9670060|FG001|3-month Follow up Completed|Overall Study||731
8630273|NCT00534404|9670061|FG002|3-month Follow up Completed|Overall Study||593
8861380|NCT01814137|9916842|FG001|STARTED|Overall Study||20
8861381|NCT01814137|9916841|FG000|COMPLETED|Overall Study||15
8861382|NCT01814137|9916842|FG001|COMPLETED|Overall Study||15
8630274|NCT00534404|9670059|FG000|COMPLETED|Overall Study||647
8630275|NCT00534404|9670060|FG001|COMPLETED|Overall Study||687
8630276|NCT00534404|9670061|FG002|COMPLETED|Overall Study||586
8630277|NCT00534404|9670059|FG000|NOT COMPLETED|Overall Study||180
8630278|NCT00534404|9670060|FG001|NOT COMPLETED|Overall Study||143
8630279|NCT00534404|9670061|FG002|NOT COMPLETED|Overall Study||242
8630280|NCT00534417|9670069|FG000|STARTED|Overall Study||41
8630281|NCT00534417|9670069|FG000|COMPLETED|Overall Study||41
8630282|NCT00534417|9670069|FG000|NOT COMPLETED|Overall Study||0
8630283|NCT00534495|9670075|FG000|STARTED|Double Blind Placebo Phase Week 0-4||36
8630284|NCT00534495|9670076|FG001|STARTED|Double Blind Placebo Phase Week 0-4||35
8630285|NCT00534495|9670077|FG002|STARTED|Double Blind Placebo Phase Week 0-4||0
8630286|NCT00534495|9670075|FG000|COMPLETED|Double Blind Placebo Phase Week 0-4||36
8630287|NCT00534495|9670076|FG001|COMPLETED|Double Blind Placebo Phase Week 0-4||34
8693568|NCT00867100|9739050|FG008|NOT COMPLETED|Overall Study||0
8693569|NCT00867100|9739051|FG009|NOT COMPLETED|Overall Study||0
8693570|NCT00867100|9739052|FG010|NOT COMPLETED|Overall Study||1
8693571|NCT00867100|9739053|FG011|NOT COMPLETED|Overall Study||0
8693572|NCT00867100|9739054|FG012|NOT COMPLETED|Overall Study||0
8693573|NCT00867113|9739086|FG000|STARTED|Treatment Period||91
8693574|NCT00867113|9739086|FG000|Safety Set|Treatment Period||91
8693575|NCT00867113|9739086|FG000|Full Analysis Set (FAS)|Treatment Period||91
8693576|NCT00867113|9739086|FG000|COMPLETED|Treatment Period||46
8693577|NCT00867113|9739086|FG000|NOT COMPLETED|Treatment Period||45
8693578|NCT00867113|9739086|FG000|STARTED|Post Treatment After Survival Follow-up||68
8693579|NCT00867113|9739086|FG000|COMPLETED|Post Treatment After Survival Follow-up||57
8693580|NCT00867113|9739086|FG000|NOT COMPLETED|Post Treatment After Survival Follow-up||11
8693581|NCT00867139|9739093|FG000|STARTED|Overall Study||2
8693582|NCT00867139|9739094|FG001|STARTED|Overall Study||1
8693583|NCT00867139|9739095|FG002|STARTED|Overall Study||4
8693584|NCT00867139|9739093|FG000|COMPLETED|Overall Study||2
8693585|NCT00867139|9739094|FG001|COMPLETED|Overall Study||1
8693586|NCT00867139|9739095|FG002|COMPLETED|Overall Study|One open-labeled patient withdrew on day 5.|3
8693587|NCT00867139|9739093|FG000|NOT COMPLETED|Overall Study||0
8693588|NCT00867139|9739094|FG001|NOT COMPLETED|Overall Study||0
8693589|NCT00867139|9739095|FG002|NOT COMPLETED|Overall Study||1
8693590|NCT00867217|9739113|FG000|STARTED|Overall Study||80
8693591|NCT00867217|9739114|FG001|STARTED|Overall Study||80
8693592|NCT00867217|9739113|FG000|COMPLETED|Overall Study||77
8693593|NCT00867217|9739114|FG001|COMPLETED|Overall Study||70
8693594|NCT00867217|9739113|FG000|NOT COMPLETED|Overall Study||3
8693595|NCT00867217|9739114|FG001|NOT COMPLETED|Overall Study||10
8693596|NCT00867308|9739122|FG000|STARTED|Overall Study||9
8693597|NCT00867308|9739123|FG001|STARTED|Overall Study||18
8693598|NCT00867308|9739122|FG000|COMPLETED|Overall Study||0
8693599|NCT00867308|9739123|FG001|COMPLETED|Overall Study||0
8693600|NCT00867308|9739122|FG000|NOT COMPLETED|Overall Study||9
8693601|NCT00867308|9739123|FG001|NOT COMPLETED|Overall Study||18
8693602|NCT00867334|9739131|FG000|STARTED|Overall Study||6
8693603|NCT00867334|9739132|FG001|STARTED|Overall Study||1
8693604|NCT00867334|9739131|FG000|COMPLETED|Overall Study||4
8725370|NCT01030952|9772626|FG001|NOT COMPLETED|Overall Study||3
8725371|NCT01030965|9772638|FG000|STARTED|Overall Study||71
8725372|NCT01030965|9772639|FG001|STARTED|Overall Study||71
8725373|NCT01030965|9772640|FG002|STARTED|Overall Study||72
8725374|NCT01030965|9772641|FG003|STARTED|Overall Study||71
8725375|NCT01030965|9772638|FG000|COMPLETED|Overall Study||67
8725376|NCT01030965|9772639|FG001|COMPLETED|Overall Study||65
8725377|NCT01030965|9772640|FG002|COMPLETED|Overall Study||68
8725378|NCT01030965|9772641|FG003|COMPLETED|Overall Study||64
8725379|NCT01030965|9772638|FG000|NOT COMPLETED|Overall Study||4
8725380|NCT01030965|9772639|FG001|NOT COMPLETED|Overall Study||6
8630288|NCT00534495|9670077|FG002|COMPLETED|Double Blind Placebo Phase Week 0-4||0
8630289|NCT00534495|9670075|FG000|NOT COMPLETED|Double Blind Placebo Phase Week 0-4||0
8630290|NCT00534495|9670076|FG001|NOT COMPLETED|Double Blind Placebo Phase Week 0-4||1
8630291|NCT00534495|9670077|FG002|NOT COMPLETED|Double Blind Placebo Phase Week 0-4||0
8630292|NCT00534495|9670075|FG000|STARTED|All Active Treatment Phase Week 4-24||36
8630293|NCT00534495|9670076|FG001|STARTED|All Active Treatment Phase Week 4-24||34
8630294|NCT00534495|9670077|FG002|STARTED|All Active Treatment Phase Week 4-24||0
8630295|NCT00534495|9670075|FG000|COMPLETED|All Active Treatment Phase Week 4-24||32
8630296|NCT00534495|9670076|FG001|COMPLETED|All Active Treatment Phase Week 4-24||25
8630297|NCT00534495|9670077|FG002|COMPLETED|All Active Treatment Phase Week 4-24||0
8630298|NCT00534495|9670075|FG000|NOT COMPLETED|All Active Treatment Phase Week 4-24||4
8630299|NCT00534495|9670076|FG001|NOT COMPLETED|All Active Treatment Phase Week 4-24||9
8630300|NCT00534495|9670077|FG002|NOT COMPLETED|All Active Treatment Phase Week 4-24||0
8630301|NCT00534495|9670075|FG000|STARTED|Long Term Ext. Phase Week 24-month 21||0
8630302|NCT00534495|9670076|FG001|STARTED|Long Term Ext. Phase Week 24-month 21||0
8630303|NCT00534495|9670077|FG002|STARTED|Long Term Ext. Phase Week 24-month 21||40
8630304|NCT00534495|9670075|FG000|COMPLETED|Long Term Ext. Phase Week 24-month 21||0
8630305|NCT00534495|9670076|FG001|COMPLETED|Long Term Ext. Phase Week 24-month 21||0
8725381|NCT01030965|9772640|FG002|NOT COMPLETED|Overall Study||4
8725382|NCT01030965|9772641|FG003|NOT COMPLETED|Overall Study||7
8725383|NCT01031004|9772653|FG000|STARTED|Overall Study||25
8725384|NCT01031004|9772654|FG001|STARTED|Overall Study||25
8725385|NCT01031004|9772653|FG000|COMPLETED|Overall Study||24
8725386|NCT01031004|9772654|FG001|COMPLETED|Overall Study||24
8725387|NCT01031004|9772653|FG000|NOT COMPLETED|Overall Study||1
8725388|NCT01031004|9772654|FG001|NOT COMPLETED|Overall Study||1
8725389|NCT01031043|9772660|FG000|STARTED|Overall Study||5
8725390|NCT01031043|9772660|FG000|COMPLETED|Overall Study||4
8630306|NCT00534495|9670077|FG002|COMPLETED|Long Term Ext. Phase Week 24-month 21||29
8630307|NCT00534495|9670075|FG000|NOT COMPLETED|Long Term Ext. Phase Week 24-month 21||0
8630308|NCT00534495|9670076|FG001|NOT COMPLETED|Long Term Ext. Phase Week 24-month 21||0
8630309|NCT00534495|9670077|FG002|NOT COMPLETED|Long Term Ext. Phase Week 24-month 21||11
8630310|NCT00534599|9670090|FG000|STARTED|Overall Study|Randomized|209
8630311|NCT00534599|9670091|FG001|STARTED|Overall Study|Randomized|200
8630312|NCT00534599|9670090|FG000|COMPLETED|Overall Study||152
8630313|NCT00534599|9670091|FG001|COMPLETED|Overall Study||168
8630314|NCT00534599|9670090|FG000|NOT COMPLETED|Overall Study||57
8630315|NCT00534599|9670091|FG001|NOT COMPLETED|Overall Study||32
8630316|NCT00534638|9670099|FG000|STARTED|Overall Study||14837
8630317|NCT00534638|9670100|FG001|STARTED|Overall Study||17338
8630318|NCT00534638|9670099|FG000|COMPLETED|Overall Study||8346
8630319|NCT00534638|9670100|FG001|COMPLETED|Overall Study||5547
8725391|NCT01031043|9772660|FG000|NOT COMPLETED|Overall Study||1
8725392|NCT01031069|9772668|FG000|STARTED|Overall Study||129
8725393|NCT01031069|9772669|FG001|STARTED|Overall Study||128
8725394|NCT01031069|9772670|FG002|STARTED|Overall Study||144
8725395|NCT01031069|9772671|FG003|STARTED|Overall Study||145
8725396|NCT01031069|9772668|FG000|COMPLETED|Overall Study||117
8725397|NCT01031069|9772669|FG001|COMPLETED|Overall Study||117
8725398|NCT01031069|9772670|FG002|COMPLETED|Overall Study||103
8725399|NCT01031069|9772671|FG003|COMPLETED|Overall Study||111
8725400|NCT01031069|9772668|FG000|NOT COMPLETED|Overall Study||12
8725401|NCT01031069|9772669|FG001|NOT COMPLETED|Overall Study||11
8725402|NCT01031069|9772670|FG002|NOT COMPLETED|Overall Study||41
8725403|NCT01031069|9772671|FG003|NOT COMPLETED|Overall Study||34
8725404|NCT01031095|9772685|FG000|STARTED|Overall Study||100
8725405|NCT01031095|9772686|FG001|STARTED|Overall Study||100
8725406|NCT01031095|9772685|FG000|COMPLETED|Overall Study||100
8725407|NCT01031095|9772686|FG001|COMPLETED|Overall Study||100
8725408|NCT01031095|9772685|FG000|NOT COMPLETED|Overall Study||0
8725409|NCT01031095|9772686|FG001|NOT COMPLETED|Overall Study||0
8725410|NCT01031134|9772694|FG000|STARTED|Overall Study||114
8630320|NCT00534638|9670099|FG000|NOT COMPLETED|Overall Study||6491
8630321|NCT00534638|9670100|FG001|NOT COMPLETED|Overall Study||11791
8630322|NCT00534703|9670113|FG000|STARTED|Overall Study||4
8630323|NCT00534703|9670114|FG001|STARTED|Overall Study||1
8725411|NCT01031134|9772695|FG001|STARTED|Overall Study||88
8725412|NCT01031134|9772694|FG000|COMPLETED|Overall Study||103
8725413|NCT01031134|9772695|FG001|COMPLETED|Overall Study||78
8725414|NCT01031134|9772694|FG000|NOT COMPLETED|Overall Study||11
8725415|NCT01031134|9772695|FG001|NOT COMPLETED|Overall Study||10
8725416|NCT01031381|9772701|FG000|STARTED|Overall Study||59
8725417|NCT01031381|9772701|FG000|COMPLETED|Overall Study||50
8725418|NCT01031381|9772701|FG000|NOT COMPLETED|Overall Study||9
8725419|NCT01031420|9772706|FG000|STARTED|Overall Study||54
8725420|NCT01031420|9772706|FG000|COMPLETED|Overall Study||44
8725421|NCT01031420|9772706|FG000|NOT COMPLETED|Overall Study||10
8725422|NCT01031446|9772710|FG000|STARTED|Overall Study||55
8725423|NCT01031446|9772710|FG000|COMPLETED|Overall Study||0
8725424|NCT01031446|9772710|FG000|NOT COMPLETED|Overall Study||55
8725425|NCT01031498|9772719|FG000|STARTED|Overall Study|2 patients were not evaluable in arm 1.|49
8725426|NCT01031498|9772720|FG001|STARTED|Overall Study|3 patients were not evaluable in arm 2|51
8725427|NCT01031498|9772721|FG002|STARTED|Overall Study|2 patients were not evaluable in arm 3.|50
8725428|NCT01031498|9772719|FG000|COMPLETED|Overall Study||47
8725429|NCT01031498|9772720|FG001|COMPLETED|Overall Study||48
8725430|NCT01031498|9772721|FG002|COMPLETED|Overall Study||48
8725431|NCT01031498|9772719|FG000|NOT COMPLETED|Overall Study||2
8725432|NCT01031498|9772720|FG001|NOT COMPLETED|Overall Study||3
8725433|NCT01031498|9772721|FG002|NOT COMPLETED|Overall Study||2
8725434|NCT01031537|9772729|FG000|STARTED|Overall Study||66
8725435|NCT01031537|9772729|FG000|COMPLETED|Overall Study||34
8725436|NCT01031537|9772729|FG000|NOT COMPLETED|Overall Study||32
8725437|NCT01031680|9772735|FG000|STARTED|Overall Study|Of the 460 randomized participants only 455 were included in the full analysis set.|460
8725438|NCT01031680|9772736|FG001|STARTED|Overall Study|Of the 462 randomized participants only 459 were included in the full analysis set.|462
8725439|NCT01031680|9772735|FG000|COMPLETED|Overall Study||403
8725440|NCT01031680|9772736|FG001|COMPLETED|Overall Study||404
8725441|NCT01031680|9772735|FG000|NOT COMPLETED|Overall Study||57
8725442|NCT01031680|9772736|FG001|NOT COMPLETED|Overall Study||58
8725443|NCT01031706|9772744|FG000|STARTED|Overall Study||14
8725444|NCT01031706|9772745|FG001|STARTED|Overall Study||9
8725445|NCT01031706|9772744|FG000|COMPLETED|Overall Study||12
8725446|NCT01031706|9772745|FG001|COMPLETED|Overall Study||8
8725447|NCT01031706|9772744|FG000|NOT COMPLETED|Overall Study||2
8725448|NCT01031706|9772745|FG001|NOT COMPLETED|Overall Study||1
8725449|NCT01031810|9772751|FG000|STARTED|Overall Study||13
8725450|NCT01031810|9772751|FG000|COMPLETED|Overall Study||9
8725451|NCT01031810|9772751|FG000|NOT COMPLETED|Overall Study||4
8725452|NCT01031836|9772763|FG000|STARTED|Stage I||5
8725453|NCT01031836|9772764|FG001|STARTED|Stage I||5
8725454|NCT01031836|9772765|FG002|STARTED|Stage I||5
8725455|NCT01031836|9772766|FG003|STARTED|Stage I||5
8725456|NCT01031836|9772767|FG004|STARTED|Stage I||5
8725457|NCT01031836|9772768|FG005|STARTED|Stage I||5
8725458|NCT01031836|9772763|FG000|COMPLETED|Stage I||4
8725459|NCT01031836|9772764|FG001|COMPLETED|Stage I||3
8725460|NCT01031836|9772765|FG002|COMPLETED|Stage I||5
8725461|NCT01031836|9772766|FG003|COMPLETED|Stage I||5
8725462|NCT01031836|9772767|FG004|COMPLETED|Stage I||5
8725463|NCT01031836|9772768|FG005|COMPLETED|Stage I||4
8725464|NCT01031836|9772763|FG000|NOT COMPLETED|Stage I||1
8725465|NCT01031836|9772764|FG001|NOT COMPLETED|Stage I||2
8725466|NCT01031836|9772765|FG002|NOT COMPLETED|Stage I||0
8725467|NCT01031836|9772766|FG003|NOT COMPLETED|Stage I||0
8725468|NCT01031836|9772767|FG004|NOT COMPLETED|Stage I||0
8725469|NCT01031836|9772768|FG005|NOT COMPLETED|Stage I||1
8725470|NCT01031836|9772763|FG000|STARTED|Stage II|1 patient who completed the study treatment in Stage I did not register in Stage II.|3
8725471|NCT01031836|9772764|FG001|STARTED|Stage II|2 patient who completed the study treatment in Stage I did not register in Stage II.|1
8725472|NCT01031836|9772765|FG002|STARTED|Stage II|1 patient who completed the study treatment in Stage I did not register in Stage II.|4
8725473|NCT01031836|9772766|FG003|STARTED|Stage II|1 patient who completed the study treatment in Stage I did not register in Stage II.|4
8725474|NCT01031836|9772767|FG004|STARTED|Stage II||5
8725475|NCT01031836|9772768|FG005|STARTED|Stage II||4
8725476|NCT01031836|9772763|FG000|COMPLETED|Stage II||1
8725477|NCT01031836|9772764|FG001|COMPLETED|Stage II||1
8861383|NCT01814137|9916841|FG000|NOT COMPLETED|Overall Study||5
8861384|NCT01814137|9916842|FG001|NOT COMPLETED|Overall Study||5
8861385|NCT01814241|9916848|FG000|STARTED|Overall Study||20
8861386|NCT01814241|9916848|FG000|COMPLETED|Overall Study||16
8861387|NCT01814241|9916848|FG000|NOT COMPLETED|Overall Study||4
8861388|NCT01814332|9916855|FG000|STARTED|Overall Study||63
8949880|NCT02443740|10012591|FG007|STARTED|Intervention Period 1 (3 Days)||2
8949881|NCT02443740|10012592|FG008|STARTED|Intervention Period 1 (3 Days)||6
8949882|NCT02443740|10012593|FG009|STARTED|Intervention Period 1 (3 Days)||3
8949883|NCT02443740|10012594|FG010|STARTED|Intervention Period 1 (3 Days)||3
8949884|NCT02443740|10012584|FG000|COMPLETED|Intervention Period 1 (3 Days)||1
8949885|NCT02443740|10012585|FG001|COMPLETED|Intervention Period 1 (3 Days)||2
8949886|NCT02443740|10012586|FG002|COMPLETED|Intervention Period 1 (3 Days)||2
8949887|NCT02443740|10012587|FG003|COMPLETED|Intervention Period 1 (3 Days)||3
8725478|NCT01031836|9772765|FG002|COMPLETED|Stage II||2
8725479|NCT01031836|9772766|FG003|COMPLETED|Stage II||1
8861389|NCT01814332|9916856|FG001|STARTED|Overall Study||65
8861390|NCT01814332|9916855|FG000|COMPLETED|Overall Study||47
8861391|NCT01814332|9916856|FG001|COMPLETED|Overall Study||49
8861392|NCT01814332|9916855|FG000|NOT COMPLETED|Overall Study||16
8861393|NCT01814332|9916856|FG001|NOT COMPLETED|Overall Study||16
8861394|NCT01814371|9916864|FG000|STARTED|Overall Study||248
8861395|NCT01814371|9916865|FG001|STARTED|Overall Study||226
8861396|NCT01814371|9916864|FG000|COMPLETED|Overall Study||218
8725480|NCT01031836|9772767|FG004|COMPLETED|Stage II||3
8725481|NCT01031836|9772768|FG005|COMPLETED|Stage II||3
8861397|NCT01814371|9916865|FG001|COMPLETED|Overall Study||199
8949888|NCT02443740|10012588|FG004|COMPLETED|Intervention Period 1 (3 Days)||2
8861398|NCT01814371|9916864|FG000|NOT COMPLETED|Overall Study||30
8861399|NCT01814371|9916865|FG001|NOT COMPLETED|Overall Study||27
8861400|NCT01814397|9916874|FG000|STARTED|Overall Study||50
8861401|NCT01814397|9916874|FG000|3 Month Evaluation|Overall Study||43
8949889|NCT02443740|10012589|FG005|COMPLETED|Intervention Period 1 (3 Days)||2
8861402|NCT01814397|9916874|FG000|COMPLETED|Overall Study||36
8861403|NCT01814397|9916874|FG000|NOT COMPLETED|Overall Study||14
8861404|NCT01814553|9916880|FG000|STARTED|Overall Study||18
8861405|NCT01814553|9916881|FG001|STARTED|Overall Study||22
8861406|NCT01814553|9916880|FG000|COMPLETED|Overall Study||0
8861407|NCT01814553|9916881|FG001|COMPLETED|Overall Study||0
8861408|NCT01814553|9916880|FG000|NOT COMPLETED|Overall Study||18
8861409|NCT01814553|9916881|FG001|NOT COMPLETED|Overall Study||22
8861410|NCT01814670|9916887|FG000|STARTED|Overall Study||185
8861411|NCT01814670|9916887|FG000|COMPLETED|Overall Study||173
8861412|NCT01814670|9916887|FG000|NOT COMPLETED|Overall Study||12
8861413|NCT01814696|9916893|FG000|STARTED|Overall Study||15
8861414|NCT01814696|9916894|FG001|STARTED|Overall Study||11
8861415|NCT01814696|9916893|FG000|COMPLETED|Overall Study||13
8861416|NCT01814696|9916894|FG001|COMPLETED|Overall Study||11
8861417|NCT01814696|9916893|FG000|NOT COMPLETED|Overall Study||2
8861418|NCT01814696|9916894|FG001|NOT COMPLETED|Overall Study||0
8861419|NCT01814748|9916902|FG000|STARTED|Overall Study||102
8861420|NCT01814748|9916903|FG001|STARTED|Overall Study||101
8861421|NCT01814748|9916902|FG000|COMPLETED|Overall Study||94
8861422|NCT01814748|9916903|FG001|COMPLETED|Overall Study||94
8861423|NCT01814748|9916902|FG000|NOT COMPLETED|Overall Study||8
8861424|NCT01814748|9916903|FG001|NOT COMPLETED|Overall Study||7
8861425|NCT01814761|9916911|FG000|STARTED|Overall Study||42
8861426|NCT01814761|9916912|FG001|STARTED|Overall Study||270
8861427|NCT01814761|9916911|FG000|COMPLETED|Overall Study||34
8861428|NCT01814761|9916912|FG001|COMPLETED|Overall Study||240
8861429|NCT01814761|9916911|FG000|NOT COMPLETED|Overall Study||8
8861430|NCT01814761|9916912|FG001|NOT COMPLETED|Overall Study||30
8861431|NCT01814774|9916918|FG000|STARTED|Overall Study||48
8861432|NCT01814774|9916918|FG000|COMPLETED|Overall Study||48
8861433|NCT01814774|9916918|FG000|NOT COMPLETED|Overall Study||0
8861434|NCT01814787|9916926|FG000|STARTED|Overall Study||685
8861435|NCT01814787|9916927|FG001|STARTED|Overall Study||684
8861436|NCT01814787|9916926|FG000|COMPLETED|Overall Study||685
8861437|NCT01814787|9916927|FG001|COMPLETED|Overall Study||684
8861438|NCT01814787|9916926|FG000|NOT COMPLETED|Overall Study||0
8861439|NCT01814787|9916927|FG001|NOT COMPLETED|Overall Study||0
8861440|NCT01814800|9916933|FG000|STARTED|Overall Study||59
8861441|NCT01814800|9916933|FG000|COMPLETED|Overall Study||54
8861442|NCT01814800|9916933|FG000|NOT COMPLETED|Overall Study||5
8861443|NCT01814813|9916940|FG000|STARTED|Overall Study||29
8861444|NCT01814813|9916941|FG001|STARTED|Overall Study||30
8861445|NCT01814813|9916942|FG002|STARTED|Overall Study||31
8861446|NCT01814813|9916940|FG000|COMPLETED|Overall Study||29
8861447|NCT01814813|9916941|FG001|COMPLETED|Overall Study||30
8861448|NCT01814813|9916942|FG002|COMPLETED|Overall Study||31
8861449|NCT01814813|9916940|FG000|NOT COMPLETED|Overall Study||0
8861450|NCT01814813|9916941|FG001|NOT COMPLETED|Overall Study||0
8861451|NCT01814813|9916942|FG002|NOT COMPLETED|Overall Study||0
8861452|NCT01814878|9916952|FG000|STARTED|Overall Study||162
8861453|NCT01814878|9916953|FG001|STARTED|Overall Study||158
8861454|NCT01814878|9916952|FG000|COMPLETED|Overall Study||116
8861455|NCT01814878|9916953|FG001|COMPLETED|Overall Study||128
8861456|NCT01814878|9916952|FG000|NOT COMPLETED|Overall Study||46
8861457|NCT01814878|9916953|FG001|NOT COMPLETED|Overall Study||30
8861458|NCT01815008|9916959|FG000|STARTED|Overall Study|Had difficulty in completing enrollment|19
8861459|NCT01815008|9916959|FG000|COMPLETED|Overall Study|transcriptomic data was available on 9 participants only|15
8861460|NCT01815008|9916959|FG000|NOT COMPLETED|Overall Study||4
8861461|NCT01815099|9916965|FG000|STARTED|Overall Study||4
8861462|NCT01815099|9916965|FG000|Began rTMS Treatment|Overall Study||3
8861463|NCT01815099|9916965|FG000|COMPLETED|Overall Study||2
8861464|NCT01815099|9916965|FG000|NOT COMPLETED|Overall Study||2
8861465|NCT01815138|9916972|FG000|STARTED|Overall Study||34
8861466|NCT01815138|9916973|FG001|STARTED|Overall Study||37
8861467|NCT01815138|9916972|FG000|COMPLETED|Overall Study||26
8861468|NCT01815138|9916973|FG001|COMPLETED|Overall Study||31
8861469|NCT01815138|9916972|FG000|NOT COMPLETED|Overall Study||8
8861470|NCT01815138|9916973|FG001|NOT COMPLETED|Overall Study||6
8861471|NCT01815229|9916982|FG000|STARTED|Overall Study||13
8861472|NCT01815229|9916983|FG001|STARTED|Overall Study||18
8861473|NCT01815229|9916984|FG002|STARTED|Overall Study||51
8861474|NCT01815229|9916982|FG000|COMPLETED|Overall Study||13
8861475|NCT01815229|9916983|FG001|COMPLETED|Overall Study||18
8861476|NCT01815229|9916984|FG002|COMPLETED|Overall Study||0
8861477|NCT01815229|9916982|FG000|NOT COMPLETED|Overall Study||0
8949890|NCT02443740|10012590|FG006|COMPLETED|Intervention Period 1 (3 Days)||2
8861478|NCT01815229|9916983|FG001|NOT COMPLETED|Overall Study||0
8861479|NCT01815229|9916984|FG002|NOT COMPLETED|Overall Study||51
8861480|NCT01815333|9916991|FG000|STARTED|Overall Study||10
8861481|NCT01815333|9916991|FG000|COMPLETED|Overall Study||10
8861482|NCT01815333|9916991|FG000|NOT COMPLETED|Overall Study||0
8861483|NCT01815424|9916998|FG000|STARTED|Week 0 to 16||90
8861484|NCT01815424|9916999|FG001|STARTED|Week 0 to 16||88
8861485|NCT01815424|9917000|FG002|STARTED|Week 0 to 16||88
8861486|NCT01815424|9917001|FG003|STARTED|Week 0 to 16||0
8861487|NCT01815424|9917002|FG004|STARTED|Week 0 to 16||0
8861488|NCT01815424|9916998|FG000|COMPLETED|Week 0 to 16||83
8861489|NCT01815424|9916999|FG001|COMPLETED|Week 0 to 16||84
8861490|NCT01815424|9917000|FG002|COMPLETED|Week 0 to 16||77
8861491|NCT01815424|9917001|FG003|COMPLETED|Week 0 to 16||0
8861492|NCT01815424|9917002|FG004|COMPLETED|Week 0 to 16||0
8861493|NCT01815424|9916998|FG000|NOT COMPLETED|Week 0 to 16||7
8861494|NCT01815424|9916999|FG001|NOT COMPLETED|Week 0 to 16||4
8861495|NCT01815424|9917000|FG002|NOT COMPLETED|Week 0 to 16||11
8861496|NCT01815424|9917001|FG003|NOT COMPLETED|Week 0 to 16||0
8861497|NCT01815424|9917002|FG004|NOT COMPLETED|Week 0 to 16||0
8861498|NCT01815424|9916998|FG000|STARTED|Week 16 to 52||83
8861499|NCT01815424|9916999|FG001|STARTED|Week 16 to 52||84
8861500|NCT01815424|9917000|FG002|STARTED|Week 16 to 52||0
8861501|NCT01815424|9917001|FG003|STARTED|Week 16 to 52||38
8861502|NCT01815424|9917002|FG004|STARTED|Week 16 to 52||39
8861503|NCT01815424|9916998|FG000|COMPLETED|Week 16 to 52||81
8861504|NCT01815424|9916999|FG001|COMPLETED|Week 16 to 52||79
8861505|NCT01815424|9917000|FG002|COMPLETED|Week 16 to 52||0
8861506|NCT01815424|9917001|FG003|COMPLETED|Week 16 to 52||35
8861507|NCT01815424|9917002|FG004|COMPLETED|Week 16 to 52||36
8861508|NCT01815424|9916998|FG000|NOT COMPLETED|Week 16 to 52||2
8861509|NCT01815424|9916999|FG001|NOT COMPLETED|Week 16 to 52||5
8861510|NCT01815424|9917000|FG002|NOT COMPLETED|Week 16 to 52||0
8861511|NCT01815424|9917001|FG003|NOT COMPLETED|Week 16 to 52||3
8861512|NCT01815424|9917002|FG004|NOT COMPLETED|Week 16 to 52||3
8861513|NCT01815502|9917017|FG000|STARTED|Overall Study||10
8861514|NCT01815502|9917018|FG001|STARTED|Overall Study||10
8861515|NCT01815502|9917017|FG000|COMPLETED|Overall Study||10
8861516|NCT01815502|9917018|FG001|COMPLETED|Overall Study||10
8861517|NCT01815502|9917017|FG000|NOT COMPLETED|Overall Study||0
8861518|NCT01815502|9917018|FG001|NOT COMPLETED|Overall Study||0
8861519|NCT01815515|9917027|FG000|STARTED|Overall Study||17
8861520|NCT01815515|9917027|FG000|COMPLETED|Overall Study||17
8861521|NCT01815515|9917027|FG000|NOT COMPLETED|Overall Study||0
8861522|NCT01815645|9917033|FG000|STARTED|Overall Study||32
8861523|NCT01815645|9917034|FG001|STARTED|Overall Study||33
8861524|NCT01815645|9917033|FG000|COMPLETED|Overall Study||32
8861525|NCT01815645|9917034|FG001|COMPLETED|Overall Study||33
8861526|NCT01815645|9917033|FG000|NOT COMPLETED|Overall Study||0
8861527|NCT01815645|9917034|FG001|NOT COMPLETED|Overall Study||0
8861528|NCT01815671|9917044|FG000|STARTED|Overall Study||88
8861529|NCT01815671|9917045|FG001|STARTED|Overall Study||85
8861530|NCT01815671|9917044|FG000|COMPLETED|Overall Study||88
8861531|NCT01815671|9917045|FG001|COMPLETED|Overall Study||85
8861532|NCT01815671|9917044|FG000|NOT COMPLETED|Overall Study||0
8861533|NCT01815671|9917045|FG001|NOT COMPLETED|Overall Study||0
8861534|NCT01815736|9917053|FG000|STARTED|Randomized Treatment Phase-Up to Week 96||963
8861535|NCT01815736|9917054|FG001|STARTED|Randomized Treatment Phase-Up to Week 96||480
8861536|NCT01815736|9917053|FG000|COMPLETED|Randomized Treatment Phase-Up to Week 96||914
8861537|NCT01815736|9917054|FG001|COMPLETED|Randomized Treatment Phase-Up to Week 96||445
8861538|NCT01815736|9917053|FG000|NOT COMPLETED|Randomized Treatment Phase-Up to Week 96||49
8861539|NCT01815736|9917054|FG001|NOT COMPLETED|Randomized Treatment Phase-Up to Week 96||35
8861540|NCT01815736|9917053|FG000|STARTED|Extension Treatment Phase- After Week 96|9 participants who completed the Randomized Treatment Phase did not continue in the Extension E/C/F/TAF Treatment Phase.|905
8861541|NCT01815736|9917054|FG001|STARTED|Extension Treatment Phase- After Week 96|21 participants who completed the Randomized Treatment Phase did not continue in the Extension E/C/F/TAF Treatment Phase.|424
8861542|NCT01815736|9917053|FG000|COMPLETED|Extension Treatment Phase- After Week 96||854
8861543|NCT01815736|9917054|FG001|COMPLETED|Extension Treatment Phase- After Week 96||398
8861544|NCT01815736|9917053|FG000|NOT COMPLETED|Extension Treatment Phase- After Week 96||51
8861545|NCT01815736|9917054|FG001|NOT COMPLETED|Extension Treatment Phase- After Week 96||26
8861546|NCT01815840|9917064|FG000|STARTED|Overall Study||116
8861547|NCT01815840|9917065|FG001|STARTED|Overall Study||113
8861548|NCT01815840|9917064|FG000|COMPLETED|Overall Study||57
8861549|NCT01815840|9917065|FG001|COMPLETED|Overall Study||50
8861550|NCT01815840|9917064|FG000|NOT COMPLETED|Overall Study||59
8861551|NCT01815840|9917065|FG001|NOT COMPLETED|Overall Study||63
8861552|NCT01815918|9917073|FG000|STARTED|Overall Study||30
8861553|NCT01815918|9917074|FG001|STARTED|Overall Study||30
8861554|NCT01815918|9917073|FG000|COMPLETED|Overall Study||12
8861555|NCT01815918|9917074|FG001|COMPLETED|Overall Study||11
8861556|NCT01815918|9917073|FG000|NOT COMPLETED|Overall Study||18
8861557|NCT01815918|9917074|FG001|NOT COMPLETED|Overall Study||19
8861558|NCT01816048|9917084|FG000|STARTED|Overall Study||8
8861559|NCT01816048|9917084|FG000|COMPLETED|Overall Study||2
8861560|NCT01816048|9917084|FG000|NOT COMPLETED|Overall Study||6
8861561|NCT01816061|9917091|FG000|STARTED|Overall Study||40
8861562|NCT01816061|9917092|FG001|STARTED|Overall Study||51
8861563|NCT01816061|9917091|FG000|COMPLETED|Overall Study||27
8861564|NCT01816061|9917092|FG001|COMPLETED|Overall Study||27
8861565|NCT01816061|9917091|FG000|NOT COMPLETED|Overall Study||13
8861566|NCT01816061|9917092|FG001|NOT COMPLETED|Overall Study||24
8861567|NCT01816074|9917102|FG000|STARTED|Phase 1||11
8861568|NCT01816074|9917103|FG001|STARTED|Phase 1||9
8861569|NCT01816074|9917104|FG002|STARTED|Phase 1||11
8861570|NCT01816074|9917105|FG003|STARTED|Phase 1||10
8861571|NCT01816074|9917102|FG000|COMPLETED|Phase 1||11
8861572|NCT01816074|9917103|FG001|COMPLETED|Phase 1||9
8861573|NCT01816074|9917104|FG002|COMPLETED|Phase 1||10
8861574|NCT01816074|9917105|FG003|COMPLETED|Phase 1||10
8861575|NCT01816074|9917102|FG000|NOT COMPLETED|Phase 1||0
8861576|NCT01816074|9917103|FG001|NOT COMPLETED|Phase 1||0
8861577|NCT01816074|9917104|FG002|NOT COMPLETED|Phase 1||1
8861578|NCT01816074|9917105|FG003|NOT COMPLETED|Phase 1||0
8861579|NCT01816074|9917102|FG000|STARTED|Phase 2||11
8861580|NCT01816074|9917103|FG001|STARTED|Phase 2||9
8861581|NCT01816074|9917104|FG002|STARTED|Phase 2||10
8861582|NCT01816074|9917105|FG003|STARTED|Phase 2||10
8861583|NCT01816074|9917102|FG000|COMPLETED|Phase 2||9
8861584|NCT01816074|9917103|FG001|COMPLETED|Phase 2||7
8861585|NCT01816074|9917104|FG002|COMPLETED|Phase 2||10
8861586|NCT01816074|9917105|FG003|COMPLETED|Phase 2||9
8861587|NCT01816074|9917102|FG000|NOT COMPLETED|Phase 2||2
8861588|NCT01816074|9917103|FG001|NOT COMPLETED|Phase 2||2
8861589|NCT01816074|9917104|FG002|NOT COMPLETED|Phase 2||0
8861590|NCT01816074|9917105|FG003|NOT COMPLETED|Phase 2||1
8861591|NCT01816230|9917129|FG000|STARTED|Overall Study||36
8861592|NCT01816230|9917129|FG000|COMPLETED|Overall Study||36
8861593|NCT01816230|9917129|FG000|NOT COMPLETED|Overall Study||0
8861594|NCT01816243|9917133|FG000|STARTED|Overall Study||39
8861595|NCT01816243|9917133|FG000|COMPLETED|Overall Study||27
8861596|NCT01816243|9917133|FG000|NOT COMPLETED|Overall Study||12
8861597|NCT01816295|9917139|FG000|STARTED|Double Blind Phase||357
8861598|NCT01816295|9917140|FG001|STARTED|Double Blind Phase||358
8861599|NCT01816295|9917139|FG000|Received Study Drug|Double Blind Phase||356
8861600|NCT01816295|9917140|FG001|Received Study Drug|Double Blind Phase||354
8861601|NCT01816295|9917139|FG000|COMPLETED|Double Blind Phase||294
8861602|NCT01816295|9917140|FG001|COMPLETED|Double Blind Phase||302
8861603|NCT01816295|9917139|FG000|NOT COMPLETED|Double Blind Phase||63
8861604|NCT01816295|9917140|FG001|NOT COMPLETED|Double Blind Phase||56
8861605|NCT01816295|9917139|FG000|STARTED|OLE Phase|Participants who completed the DBP and still met eligibility criteria had option to enroll in OLE.|275
8861606|NCT01816295|9917140|FG001|STARTED|OLE Phase|Participants who completed the DBP and still met eligibility criteria had option to enroll in OLE.|283
8861607|NCT01816295|9917139|FG000|COMPLETED|OLE Phase||222
8861608|NCT01816295|9917140|FG001|COMPLETED|OLE Phase||227
8861609|NCT01816295|9917139|FG000|NOT COMPLETED|OLE Phase||53
8861610|NCT01816295|9917140|FG001|NOT COMPLETED|OLE Phase||56
8861611|NCT01816451|9917150|FG000|STARTED|Overall Study||13
8861612|NCT01816451|9917151|FG001|STARTED|Overall Study||11
8861613|NCT01816451|9917152|FG002|STARTED|Overall Study||8
8861614|NCT01816451|9917150|FG000|COMPLETED|Overall Study||13
8861615|NCT01816451|9917151|FG001|COMPLETED|Overall Study||11
8861616|NCT01816451|9917152|FG002|COMPLETED|Overall Study||8
8861617|NCT01816451|9917150|FG000|NOT COMPLETED|Overall Study||0
8861618|NCT01816451|9917151|FG001|NOT COMPLETED|Overall Study||0
8861619|NCT01816451|9917152|FG002|NOT COMPLETED|Overall Study||0
8861620|NCT01816477|9917164|FG000|STARTED|Overall Study||43
8861621|NCT01816477|9917165|FG001|STARTED|Overall Study||42
8861622|NCT01816477|9917164|FG000|COMPLETED|Overall Study||27
8861623|NCT01816477|9917165|FG001|COMPLETED|Overall Study||41
8861624|NCT01816477|9917164|FG000|NOT COMPLETED|Overall Study||16
8861625|NCT01816477|9917165|FG001|NOT COMPLETED|Overall Study||1
8861626|NCT01816594|9917173|FG000|STARTED|Overall Study||25
8861627|NCT01816594|9917174|FG001|STARTED|Overall Study||25
8861628|NCT01816594|9917173|FG000|Randomized to the wt Cohort|Overall Study|wt = PIK3CA wild-type|21
8861629|NCT01816594|9917174|FG001|Randomized to the wt Cohort|Overall Study|wt = PIK3CA wild-type|21
8861630|NCT01816594|9917173|FG000|Randomized to the mt Cohort|Overall Study|mt = PIK3CA mutant|4
8861631|NCT01816594|9917174|FG001|Randomized to the mt Cohort|Overall Study|mt = PIK3CA mutant|4
8861632|NCT01816594|9917173|FG000|COMPLETED|Overall Study||14
8861633|NCT01816594|9917174|FG001|COMPLETED|Overall Study||23
8861634|NCT01816594|9917173|FG000|NOT COMPLETED|Overall Study||11
8861635|NCT01816594|9917174|FG001|NOT COMPLETED|Overall Study||2
8861636|NCT01816685|9917188|FG000|STARTED|Overall Study||68
8861637|NCT01816685|9917189|FG001|STARTED|Overall Study||67
8861638|NCT01816685|9917188|FG000|COMPLETED|Overall Study||58
8861639|NCT01816685|9917189|FG001|COMPLETED|Overall Study||56
8861640|NCT01816685|9917188|FG000|NOT COMPLETED|Overall Study||10
8861641|NCT01816685|9917189|FG001|NOT COMPLETED|Overall Study||11
8861642|NCT01816711|9917197|FG000|STARTED|Overall Study||121
8861643|NCT01816711|9917198|FG001|STARTED|Overall Study||83
8861644|NCT01816711|9917197|FG000|COMPLETED|Overall Study||121
8861645|NCT01816711|9917198|FG001|COMPLETED|Overall Study||83
8861646|NCT01816711|9917197|FG000|NOT COMPLETED|Overall Study||0
8861647|NCT01816711|9917198|FG001|NOT COMPLETED|Overall Study||0
8861648|NCT01816763|9917207|FG000|STARTED|Overall Study||195
8861649|NCT01816763|9917208|FG001|STARTED|Overall Study||194
8861650|NCT01816763|9917209|FG002|STARTED|Overall Study||180
8861651|NCT01816763|9917207|FG000|COMPLETED|Overall Study||191
8861652|NCT01816763|9917208|FG001|COMPLETED|Overall Study||179
8861653|NCT01816763|9917209|FG002|COMPLETED|Overall Study||169
8861654|NCT01816763|9917207|FG000|NOT COMPLETED|Overall Study||4
8861655|NCT01816763|9917208|FG001|NOT COMPLETED|Overall Study||15
8861656|NCT01816763|9917209|FG002|NOT COMPLETED|Overall Study||11
8861657|NCT01816776|9917222|FG000|STARTED|Overall Study||73
8861658|NCT01816776|9917223|FG001|STARTED|Overall Study||78
8861659|NCT01816776|9917222|FG000|6 Month Primary Effectiveness Assessed|Overall Study||68
8861660|NCT01816776|9917223|FG001|6 Month Primary Effectiveness Assessed|Overall Study||73
8861661|NCT01816776|9917222|FG000|COMPLETED|Overall Study||60
8861662|NCT01816776|9917223|FG001|COMPLETED|Overall Study||70
8861663|NCT01816776|9917222|FG000|NOT COMPLETED|Overall Study||13
8861664|NCT01816776|9917223|FG001|NOT COMPLETED|Overall Study||8
8861665|NCT01816893|9917231|FG000|STARTED|Euglycemic Clamp/ Hypoglycemic Clamp||11
8861666|NCT01816893|9917232|FG001|STARTED|Euglycemic Clamp/ Hypoglycemic Clamp||11
8861667|NCT01816893|9917231|FG000|COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||11
8861668|NCT01816893|9917232|FG001|COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||11
8949891|NCT02443740|10012591|FG007|COMPLETED|Intervention Period 1 (3 Days)||2
8861669|NCT01816893|9917231|FG000|NOT COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||0
8861670|NCT01816893|9917232|FG001|NOT COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||0
8861671|NCT01816893|9917231|FG000|STARTED|Washout Period||11
8861672|NCT01816893|9917232|FG001|STARTED|Washout Period||11
8861673|NCT01816893|9917231|FG000|COMPLETED|Washout Period||9
8861674|NCT01816893|9917232|FG001|COMPLETED|Washout Period||11
8861675|NCT01816893|9917231|FG000|NOT COMPLETED|Washout Period||2
8861676|NCT01816893|9917232|FG001|NOT COMPLETED|Washout Period||0
8861677|NCT01816893|9917231|FG000|STARTED|Hypoglycemic Clamp/ Euglycemic Clamp||9
8861678|NCT01816893|9917232|FG001|STARTED|Hypoglycemic Clamp/ Euglycemic Clamp||11
8861679|NCT01816893|9917231|FG000|COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||9
8861680|NCT01816893|9917232|FG001|COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||11
8861681|NCT01816893|9917231|FG000|NOT COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||0
8861682|NCT01816893|9917232|FG001|NOT COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||0
8861683|NCT01816906|9917240|FG000|STARTED|Six Months||41
8861684|NCT01816906|9917241|FG001|STARTED|Six Months||41
8861685|NCT01816906|9917240|FG000|COMPLETED|Six Months||20
8861686|NCT01816906|9917241|FG001|COMPLETED|Six Months||19
8861687|NCT01816906|9917240|FG000|NOT COMPLETED|Six Months||21
8861688|NCT01816906|9917241|FG001|NOT COMPLETED|Six Months||22
8861689|NCT01816906|9917240|FG000|STARTED|12 Months||20
8861690|NCT01816906|9917241|FG001|STARTED|12 Months||19
8861691|NCT01816906|9917240|FG000|COMPLETED|12 Months||16
8861692|NCT01816906|9917241|FG001|COMPLETED|12 Months||14
8861693|NCT01816906|9917240|FG000|NOT COMPLETED|12 Months||4
8861694|NCT01816906|9917241|FG001|NOT COMPLETED|12 Months||5
8861695|NCT01816945|9917250|FG000|STARTED|Overall Study||23
8861696|NCT01816945|9917251|FG001|STARTED|Overall Study||24
8861697|NCT01816945|9917250|FG000|COMPLETED|Overall Study||21
8861698|NCT01816945|9917251|FG001|COMPLETED|Overall Study||19
8861699|NCT01816945|9917250|FG000|NOT COMPLETED|Overall Study||2
8861700|NCT01816945|9917251|FG001|NOT COMPLETED|Overall Study||5
8861701|NCT01816984|9917257|FG000|STARTED|Overall Study||12
8861702|NCT01816984|9917257|FG000|COMPLETED|Overall Study||11
8861703|NCT01816984|9917257|FG000|NOT COMPLETED|Overall Study||1
8861704|NCT01817075|9917263|FG000|STARTED|Overall Study||88
8861705|NCT01817075|9917264|FG001|STARTED|Overall Study||89
8861706|NCT01817075|9917263|FG000|COMPLETED|Overall Study||41
8861707|NCT01817075|9917264|FG001|COMPLETED|Overall Study||54
8861708|NCT01817075|9917263|FG000|NOT COMPLETED|Overall Study||47
8861709|NCT01817075|9917264|FG001|NOT COMPLETED|Overall Study||35
8861710|NCT01817374|9917270|FG000|STARTED|Overall Study||6
8861711|NCT01817374|9917270|FG000|COMPLETED|Overall Study||6
8861712|NCT01817374|9917270|FG000|NOT COMPLETED|Overall Study||0
8861713|NCT01817491|9917278|FG000|STARTED|Overall Study||32
8861714|NCT01817491|9917279|FG001|STARTED|Overall Study||28
8861715|NCT01817491|9917278|FG000|COMPLETED|Overall Study||28
8861716|NCT01817491|9917279|FG001|COMPLETED|Overall Study||28
8861717|NCT01817491|9917278|FG000|NOT COMPLETED|Overall Study||4
8949892|NCT02443740|10012592|FG008|COMPLETED|Intervention Period 1 (3 Days)||6
8949893|NCT02443740|10012593|FG009|COMPLETED|Intervention Period 1 (3 Days)||3
8949894|NCT02443740|10012594|FG010|COMPLETED|Intervention Period 1 (3 Days)||3
8949895|NCT02443740|10012584|FG000|NOT COMPLETED|Intervention Period 1 (3 Days)||1
8949896|NCT02443740|10012585|FG001|NOT COMPLETED|Intervention Period 1 (3 Days)||0
8949897|NCT02443740|10012586|FG002|NOT COMPLETED|Intervention Period 1 (3 Days)||0
8949898|NCT02443740|10012587|FG003|NOT COMPLETED|Intervention Period 1 (3 Days)||0
8949899|NCT02443740|10012588|FG004|NOT COMPLETED|Intervention Period 1 (3 Days)||0
8949900|NCT02443740|10012589|FG005|NOT COMPLETED|Intervention Period 1 (3 Days)||2
8949901|NCT02443740|10012590|FG006|NOT COMPLETED|Intervention Period 1 (3 Days)||1
8949902|NCT02443740|10012591|FG007|NOT COMPLETED|Intervention Period 1 (3 Days)||0
8949903|NCT02443740|10012592|FG008|NOT COMPLETED|Intervention Period 1 (3 Days)||0
8949904|NCT02443740|10012593|FG009|NOT COMPLETED|Intervention Period 1 (3 Days)||0
8949905|NCT02443740|10012594|FG010|NOT COMPLETED|Intervention Period 1 (3 Days)||0
8949906|NCT02443740|10012584|FG000|STARTED|Washout Period 1 (7 Days)||1
8949907|NCT02443740|10012585|FG001|STARTED|Washout Period 1 (7 Days)||2
8949908|NCT02443740|10012586|FG002|STARTED|Washout Period 1 (7 Days)||2
8949909|NCT02443740|10012587|FG003|STARTED|Washout Period 1 (7 Days)||3
8949910|NCT02443740|10012588|FG004|STARTED|Washout Period 1 (7 Days)||2
8949911|NCT02443740|10012589|FG005|STARTED|Washout Period 1 (7 Days)||2
8949912|NCT02443740|10012590|FG006|STARTED|Washout Period 1 (7 Days)||2
8949913|NCT02443740|10012591|FG007|STARTED|Washout Period 1 (7 Days)||2
8949914|NCT02443740|10012592|FG008|STARTED|Washout Period 1 (7 Days)||0
8949915|NCT02443740|10012593|FG009|STARTED|Washout Period 1 (7 Days)||3
8861718|NCT01817491|9917279|FG001|NOT COMPLETED|Overall Study||0
8861719|NCT01817530|9917294|FG000|STARTED|Overall Study||65
8861720|NCT01817530|9917295|FG001|STARTED|Overall Study||65
8861721|NCT01817530|9917296|FG002|STARTED|Overall Study||64
8861722|NCT01817530|9917297|FG003|STARTED|Overall Study||65
8861723|NCT01817530|9917298|FG004|STARTED|Overall Study||78
8861724|NCT01817530|9917299|FG005|STARTED|Overall Study||77
8861725|NCT01817530|9917300|FG006|STARTED|Overall Study||76
8861726|NCT01817530|9917301|FG007|STARTED|Overall Study||77
8861727|NCT01817530|9917294|FG000|COMPLETED|Overall Study||50
8861728|NCT01817530|9917295|FG001|COMPLETED|Overall Study||52
8861729|NCT01817530|9917296|FG002|COMPLETED|Overall Study||53
8861730|NCT01817530|9917297|FG003|COMPLETED|Overall Study||52
8861731|NCT01817530|9917298|FG004|COMPLETED|Overall Study||67
8861732|NCT01817530|9917299|FG005|COMPLETED|Overall Study||58
8861733|NCT01817530|9917300|FG006|COMPLETED|Overall Study||53
8861734|NCT01817530|9917301|FG007|COMPLETED|Overall Study||53
8861735|NCT01817530|9917294|FG000|NOT COMPLETED|Overall Study||15
8949916|NCT02443740|10012594|FG010|STARTED|Washout Period 1 (7 Days)||3
8949917|NCT02443740|10012584|FG000|COMPLETED|Washout Period 1 (7 Days)||1
8949918|NCT02443740|10012585|FG001|COMPLETED|Washout Period 1 (7 Days)||2
8949919|NCT02443740|10012586|FG002|COMPLETED|Washout Period 1 (7 Days)||2
8949920|NCT02443740|10012587|FG003|COMPLETED|Washout Period 1 (7 Days)||3
8949921|NCT02443740|10012588|FG004|COMPLETED|Washout Period 1 (7 Days)||2
8949922|NCT02443740|10012589|FG005|COMPLETED|Washout Period 1 (7 Days)||2
8949923|NCT02443740|10012590|FG006|COMPLETED|Washout Period 1 (7 Days)||2
8949924|NCT02443740|10012591|FG007|COMPLETED|Washout Period 1 (7 Days)||2
8949925|NCT02443740|10012592|FG008|COMPLETED|Washout Period 1 (7 Days)||0
8949926|NCT02443740|10012593|FG009|COMPLETED|Washout Period 1 (7 Days)||3
8949927|NCT02443740|10012594|FG010|COMPLETED|Washout Period 1 (7 Days)||3
8949928|NCT02443740|10012584|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
8949929|NCT02443740|10012585|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
8949930|NCT02443740|10012586|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
8949931|NCT02443740|10012587|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
8949932|NCT02443740|10012588|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||0
8949933|NCT02443740|10012589|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||0
8949934|NCT02443740|10012590|FG006|NOT COMPLETED|Washout Period 1 (7 Days)||0
8949935|NCT02443740|10012591|FG007|NOT COMPLETED|Washout Period 1 (7 Days)||0
8949936|NCT02443740|10012592|FG008|NOT COMPLETED|Washout Period 1 (7 Days)||0
8949937|NCT02443740|10012593|FG009|NOT COMPLETED|Washout Period 1 (7 Days)||0
8949938|NCT02443740|10012594|FG010|NOT COMPLETED|Washout Period 1 (7 Days)||0
8949939|NCT02443740|10012584|FG000|STARTED|Intervention Period 2 (3 Days)||1
8949940|NCT02443740|10012585|FG001|STARTED|Intervention Period 2 (3 Days)||2
8949941|NCT02443740|10012586|FG002|STARTED|Intervention Period 2 (3 Days)||2
8949942|NCT02443740|10012587|FG003|STARTED|Intervention Period 2 (3 Days)||3
8949943|NCT02443740|10012588|FG004|STARTED|Intervention Period 2 (3 Days)||2
8949944|NCT02443740|10012589|FG005|STARTED|Intervention Period 2 (3 Days)||2
8949945|NCT02443740|10012590|FG006|STARTED|Intervention Period 2 (3 Days)||2
8949946|NCT02443740|10012591|FG007|STARTED|Intervention Period 2 (3 Days)||2
8949947|NCT02443740|10012592|FG008|STARTED|Intervention Period 2 (3 Days)||0
8949948|NCT02443740|10012593|FG009|STARTED|Intervention Period 2 (3 Days)||3
8949949|NCT02443740|10012594|FG010|STARTED|Intervention Period 2 (3 Days)||3
8949950|NCT02443740|10012584|FG000|COMPLETED|Intervention Period 2 (3 Days)||1
8949951|NCT02443740|10012585|FG001|COMPLETED|Intervention Period 2 (3 Days)||2
8949952|NCT02443740|10012586|FG002|COMPLETED|Intervention Period 2 (3 Days)||2
8949953|NCT02443740|10012587|FG003|COMPLETED|Intervention Period 2 (3 Days)||3
8949954|NCT02443740|10012588|FG004|COMPLETED|Intervention Period 2 (3 Days)||2
8949955|NCT02443740|10012589|FG005|COMPLETED|Intervention Period 2 (3 Days)||2
8949956|NCT02443740|10012590|FG006|COMPLETED|Intervention Period 2 (3 Days)||2
8949957|NCT02443740|10012591|FG007|COMPLETED|Intervention Period 2 (3 Days)||2
8949958|NCT02443740|10012592|FG008|COMPLETED|Intervention Period 2 (3 Days)||0
8949959|NCT02443740|10012593|FG009|COMPLETED|Intervention Period 2 (3 Days)||3
8949960|NCT02443740|10012594|FG010|COMPLETED|Intervention Period 2 (3 Days)||3
8949961|NCT02443740|10012584|FG000|NOT COMPLETED|Intervention Period 2 (3 Days)||0
8949962|NCT02443740|10012585|FG001|NOT COMPLETED|Intervention Period 2 (3 Days)||0
8949963|NCT02443740|10012586|FG002|NOT COMPLETED|Intervention Period 2 (3 Days)||0
8949964|NCT02443740|10012587|FG003|NOT COMPLETED|Intervention Period 2 (3 Days)||0
8949965|NCT02443740|10012588|FG004|NOT COMPLETED|Intervention Period 2 (3 Days)||0
8949966|NCT02443740|10012589|FG005|NOT COMPLETED|Intervention Period 2 (3 Days)||0
8949967|NCT02443740|10012590|FG006|NOT COMPLETED|Intervention Period 2 (3 Days)||0
8949968|NCT02443740|10012591|FG007|NOT COMPLETED|Intervention Period 2 (3 Days)||0
8949969|NCT02443740|10012592|FG008|NOT COMPLETED|Intervention Period 2 (3 Days)||0
8949970|NCT02443740|10012593|FG009|NOT COMPLETED|Intervention Period 2 (3 Days)||0
8949971|NCT02443740|10012594|FG010|NOT COMPLETED|Intervention Period 2 (3 Days)||0
8949972|NCT02443740|10012584|FG000|STARTED|Washout Period 2 (7 Days)||1
8949973|NCT02443740|10012585|FG001|STARTED|Washout Period 2 (7 Days)||2
8949974|NCT02443740|10012586|FG002|STARTED|Washout Period 2 (7 Days)||2
8949975|NCT02443740|10012587|FG003|STARTED|Washout Period 2 (7 Days)||3
8949976|NCT02443740|10012588|FG004|STARTED|Washout Period 2 (7 Days)||2
8949977|NCT02443740|10012589|FG005|STARTED|Washout Period 2 (7 Days)||2
8949978|NCT02443740|10012590|FG006|STARTED|Washout Period 2 (7 Days)||2
8949979|NCT02443740|10012591|FG007|STARTED|Washout Period 2 (7 Days)||2
8949980|NCT02443740|10012592|FG008|STARTED|Washout Period 2 (7 Days)||0
8949981|NCT02443740|10012593|FG009|STARTED|Washout Period 2 (7 Days)||0
8861736|NCT01817530|9917295|FG001|NOT COMPLETED|Overall Study||13
8861737|NCT01817530|9917296|FG002|NOT COMPLETED|Overall Study||11
8949982|NCT02443740|10012594|FG010|STARTED|Washout Period 2 (7 Days)||0
8949983|NCT02443740|10012584|FG000|COMPLETED|Washout Period 2 (7 Days)||1
8949984|NCT02443740|10012585|FG001|COMPLETED|Washout Period 2 (7 Days)||2
8949985|NCT02443740|10012586|FG002|COMPLETED|Washout Period 2 (7 Days)||2
8861738|NCT01817530|9917297|FG003|NOT COMPLETED|Overall Study||13
8861739|NCT01817530|9917298|FG004|NOT COMPLETED|Overall Study||11
8861740|NCT01817530|9917299|FG005|NOT COMPLETED|Overall Study||19
8861741|NCT01817530|9917300|FG006|NOT COMPLETED|Overall Study||23
8861742|NCT01817530|9917301|FG007|NOT COMPLETED|Overall Study||24
8861743|NCT01817582|9917322|FG000|STARTED|Overall Study||33
8861744|NCT01817582|9917323|FG001|STARTED|Overall Study||36
8861745|NCT01817582|9917324|FG002|STARTED|Overall Study||33
8861746|NCT01817582|9917322|FG000|Received at Least 1 Dose of Study Drug|Overall Study||33
8861747|NCT01817582|9917323|FG001|Received at Least 1 Dose of Study Drug|Overall Study||36
8861748|NCT01817582|9917324|FG002|Received at Least 1 Dose of Study Drug|Overall Study||33
8861749|NCT01817582|9917322|FG000|COMPLETED|Overall Study||31
8861750|NCT01817582|9917323|FG001|COMPLETED|Overall Study||35
8861751|NCT01817582|9917324|FG002|COMPLETED|Overall Study||33
8861752|NCT01817582|9917322|FG000|NOT COMPLETED|Overall Study||2
8861753|NCT01817582|9917323|FG001|NOT COMPLETED|Overall Study||1
8861754|NCT01817582|9917324|FG002|NOT COMPLETED|Overall Study||0
8861755|NCT01817712|9917334|FG000|STARTED|Overall Study||271
8861756|NCT01817712|9917335|FG001|STARTED|Overall Study||270
8861757|NCT01817712|9917334|FG000|COMPLETED|Overall Study|Primary Outcome Assessed over 18 months|250
8861758|NCT01817712|9917335|FG001|COMPLETED|Overall Study|Primary Outcome assessed over 18 months|240
8861759|NCT01817712|9917334|FG000|NOT COMPLETED|Overall Study||21
8861760|NCT01817712|9917335|FG001|NOT COMPLETED|Overall Study||30
8861761|NCT01817725|9917341|FG000|STARTED|Overall Study||20
8861762|NCT01817725|9917341|FG000|COMPLETED|Overall Study||19
8861763|NCT01817725|9917341|FG000|NOT COMPLETED|Overall Study||1
8861764|NCT01817764|9917347|FG000|STARTED|Overall Study||353
8861765|NCT01817764|9917348|FG001|STARTED|Overall Study||353
8861766|NCT01817764|9917347|FG000|COMPLETED|Overall Study||319
8861767|NCT01817764|9917348|FG001|COMPLETED|Overall Study||315
8861768|NCT01817764|9917347|FG000|NOT COMPLETED|Overall Study||34
8861769|NCT01817764|9917348|FG001|NOT COMPLETED|Overall Study||38
8861770|NCT01817777|9917356|FG000|STARTED|Observational Phase (8 Weeks)||36
8861771|NCT01817777|9917357|FG001|STARTED|Observational Phase (8 Weeks)||0
8861772|NCT01817777|9917358|FG002|STARTED|Observational Phase (8 Weeks)||0
8861773|NCT01817777|9917356|FG000|COMPLETED|Observational Phase (8 Weeks)||31
8861774|NCT01817777|9917357|FG001|COMPLETED|Observational Phase (8 Weeks)||0
8861775|NCT01817777|9917358|FG002|COMPLETED|Observational Phase (8 Weeks)||0
8861776|NCT01817777|9917356|FG000|NOT COMPLETED|Observational Phase (8 Weeks)||5
8861777|NCT01817777|9917357|FG001|NOT COMPLETED|Observational Phase (8 Weeks)||0
8861778|NCT01817777|9917358|FG002|NOT COMPLETED|Observational Phase (8 Weeks)||0
8861779|NCT01817777|9917356|FG000|STARTED|Interventional Phase (20 Weeks)||0
8861780|NCT01817777|9917357|FG001|STARTED|Interventional Phase (20 Weeks)||16
8861781|NCT01817777|9917358|FG002|STARTED|Interventional Phase (20 Weeks)||15
8861782|NCT01817777|9917356|FG000|COMPLETED|Interventional Phase (20 Weeks)||0
8861783|NCT01817777|9917357|FG001|COMPLETED|Interventional Phase (20 Weeks)||11
8861784|NCT01817777|9917358|FG002|COMPLETED|Interventional Phase (20 Weeks)||10
8861785|NCT01817777|9917356|FG000|NOT COMPLETED|Interventional Phase (20 Weeks)||0
8861786|NCT01817777|9917357|FG001|NOT COMPLETED|Interventional Phase (20 Weeks)||5
8861787|NCT01817777|9917358|FG002|NOT COMPLETED|Interventional Phase (20 Weeks)||5
8861788|NCT01817790|9917366|FG000|STARTED|Overall Study||314
8861789|NCT01817790|9917367|FG001|STARTED|Overall Study||312
8861790|NCT01817790|9917366|FG000|COMPLETED|Overall Study||310
8861791|NCT01817790|9917367|FG001|COMPLETED|Overall Study||304
8861792|NCT01817790|9917366|FG000|NOT COMPLETED|Overall Study||4
8861793|NCT01817790|9917367|FG001|NOT COMPLETED|Overall Study||8
8861794|NCT01817855|9917379|FG000|STARTED|Overall Study||23
8861795|NCT01817855|9917380|FG001|STARTED|Overall Study||8
8861796|NCT01817855|9917381|FG002|STARTED|Overall Study||11
8861797|NCT01817855|9917382|FG003|STARTED|Overall Study||5
8861798|NCT01817855|9917379|FG000|COMPLETED|Overall Study||23
8861799|NCT01817855|9917380|FG001|COMPLETED|Overall Study||6
8861800|NCT01817855|9917381|FG002|COMPLETED|Overall Study||9
8861801|NCT01817855|9917382|FG003|COMPLETED|Overall Study||5
8861802|NCT01817855|9917379|FG000|NOT COMPLETED|Overall Study||0
8861803|NCT01817855|9917380|FG001|NOT COMPLETED|Overall Study||2
8861804|NCT01817855|9917381|FG002|NOT COMPLETED|Overall Study||2
8861805|NCT01817855|9917382|FG003|NOT COMPLETED|Overall Study||0
8861806|NCT01817907|9917400|FG000|STARTED|First Intervention||8
8861807|NCT01817907|9917401|FG001|STARTED|First Intervention||7
8861808|NCT01817907|9917400|FG000|COMPLETED|First Intervention||8
8861809|NCT01817907|9917401|FG001|COMPLETED|First Intervention||7
8861810|NCT01817907|9917400|FG000|NOT COMPLETED|First Intervention||0
8861811|NCT01817907|9917401|FG001|NOT COMPLETED|First Intervention||0
8861812|NCT01817907|9917400|FG000|STARTED|Washout Period||8
8861813|NCT01817907|9917401|FG001|STARTED|Washout Period||7
8861814|NCT01817907|9917400|FG000|COMPLETED|Washout Period||8
8861815|NCT01817907|9917401|FG001|COMPLETED|Washout Period||7
8861816|NCT01817907|9917400|FG000|NOT COMPLETED|Washout Period||0
8861817|NCT01817907|9917401|FG001|NOT COMPLETED|Washout Period||0
8861818|NCT01817907|9917400|FG000|STARTED|Second Intervention||8
8861819|NCT01817907|9917401|FG001|STARTED|Second Intervention||7
8861820|NCT01817907|9917400|FG000|COMPLETED|Second Intervention||8
8861821|NCT01817907|9917401|FG001|COMPLETED|Second Intervention||7
8861822|NCT01817907|9917400|FG000|NOT COMPLETED|Second Intervention||0
8861823|NCT01817907|9917401|FG001|NOT COMPLETED|Second Intervention||0
8861824|NCT01817959|9917409|FG000|STARTED|Overall Study||29
8861825|NCT01817959|9917410|FG001|STARTED|Overall Study||19
8861826|NCT01817959|9917409|FG000|COMPLETED|Overall Study||25
8861827|NCT01817959|9917410|FG001|COMPLETED|Overall Study||16
8861828|NCT01817959|9917409|FG000|NOT COMPLETED|Overall Study||4
8861829|NCT01817959|9917410|FG001|NOT COMPLETED|Overall Study||3
8861830|NCT01818063|9917418|FG000|STARTED|Overall Study||5
8861831|NCT01818063|9917419|FG001|STARTED|Overall Study||4
8861832|NCT01818063|9917418|FG000|COMPLETED|Overall Study||5
8861833|NCT01818063|9917419|FG001|COMPLETED|Overall Study||4
8861834|NCT01818063|9917418|FG000|NOT COMPLETED|Overall Study||0
8861835|NCT01818063|9917419|FG001|NOT COMPLETED|Overall Study||0
8861836|NCT01818141|9917427|FG000|STARTED|Overall Study||18
8861837|NCT01818141|9917428|FG001|STARTED|Overall Study||16
8861838|NCT01818141|9917427|FG000|COMPLETED|Overall Study||15
8861839|NCT01818141|9917428|FG001|COMPLETED|Overall Study||13
8861840|NCT01818141|9917427|FG000|NOT COMPLETED|Overall Study||3
8861841|NCT01818141|9917428|FG001|NOT COMPLETED|Overall Study||3
8861842|NCT01818245|9917436|FG000|STARTED|Intervention A||30
8861843|NCT01818245|9917437|FG001|STARTED|Intervention A|Participants didn't participate in separate interventions and received 1 dose of LY2605541 on Day 1.|22
8861844|NCT01818245|9917436|FG000|Received One Dose of Study Drug|Intervention A||30
8861845|NCT01818245|9917437|FG001|Received One Dose of Study Drug|Intervention A||22
8861846|NCT01818245|9917436|FG000|COMPLETED|Intervention A||30
8861847|NCT01818245|9917437|FG001|COMPLETED|Intervention A||22
8861848|NCT01818245|9917436|FG000|NOT COMPLETED|Intervention A||0
8861849|NCT01818245|9917437|FG001|NOT COMPLETED|Intervention A||0
8861850|NCT01818245|9917436|FG000|STARTED|Washout (16-28 Days)||30
8861851|NCT01818245|9917437|FG001|STARTED|Washout (16-28 Days)||0
8861852|NCT01818245|9917436|FG000|COMPLETED|Washout (16-28 Days)||30
8861853|NCT01818245|9917437|FG001|COMPLETED|Washout (16-28 Days)||0
8861854|NCT01818245|9917436|FG000|NOT COMPLETED|Washout (16-28 Days)||0
8861855|NCT01818245|9917437|FG001|NOT COMPLETED|Washout (16-28 Days)||0
8861856|NCT01818245|9917436|FG000|STARTED|Intervention B||30
8861857|NCT01818245|9917437|FG001|STARTED|Intervention B||0
8861858|NCT01818245|9917436|FG000|COMPLETED|Intervention B||30
8861859|NCT01818245|9917437|FG001|COMPLETED|Intervention B||0
8861860|NCT01818245|9917436|FG000|NOT COMPLETED|Intervention B||0
8861861|NCT01818245|9917437|FG001|NOT COMPLETED|Intervention B||0
8861862|NCT01818245|9917436|FG000|STARTED|Washout (16-28 Days)||30
8861863|NCT01818245|9917437|FG001|STARTED|Washout (16-28 Days)||0
8861864|NCT01818245|9917436|FG000|COMPLETED|Washout (16-28 Days)||30
8861865|NCT01818245|9917437|FG001|COMPLETED|Washout (16-28 Days)||0
8861866|NCT01818245|9917436|FG000|NOT COMPLETED|Washout (16-28 Days)||0
8861867|NCT01818245|9917437|FG001|NOT COMPLETED|Washout (16-28 Days)||0
8861868|NCT01818245|9917436|FG000|STARTED|Intervention C||30
8861869|NCT01818245|9917437|FG001|STARTED|Intervention C||0
8861870|NCT01818245|9917436|FG000|COMPLETED|Intervention C||30
8861871|NCT01818245|9917437|FG001|COMPLETED|Intervention C||0
8861872|NCT01818245|9917436|FG000|NOT COMPLETED|Intervention C||0
8861873|NCT01818245|9917437|FG001|NOT COMPLETED|Intervention C||0
8861874|NCT01818258|9917450|FG000|STARTED|Overall Study||25
8861875|NCT01818258|9917451|FG001|STARTED|Overall Study||27
8861876|NCT01818258|9917450|FG000|COMPLETED|Overall Study||22
8861877|NCT01818258|9917451|FG001|COMPLETED|Overall Study||24
8861878|NCT01818258|9917450|FG000|NOT COMPLETED|Overall Study||3
8861879|NCT01818258|9917451|FG001|NOT COMPLETED|Overall Study||3
8861880|NCT01818284|9917460|FG000|STARTED|Overall Study||11
8861881|NCT01818284|9917461|FG001|STARTED|Overall Study||11
8861882|NCT01818284|9917460|FG000|COMPLETED|Overall Study||7
8861883|NCT01818284|9917461|FG001|COMPLETED|Overall Study||5
8861884|NCT01818284|9917460|FG000|NOT COMPLETED|Overall Study||4
8861885|NCT01818284|9917461|FG001|NOT COMPLETED|Overall Study||6
8861886|NCT01818297|9917468|FG000|STARTED|Blinded Phase (Randomization - 3 Months)||32
8861887|NCT01818297|9917469|FG001|STARTED|Blinded Phase (Randomization - 3 Months)||30
8861888|NCT01818297|9917468|FG000|Week 1|Blinded Phase (Randomization - 3 Months)||32
8861889|NCT01818297|9917469|FG001|Week 1|Blinded Phase (Randomization - 3 Months)||30
8861890|NCT01818297|9917468|FG000|Week 6|Blinded Phase (Randomization - 3 Months)||32
8861891|NCT01818297|9917469|FG001|Week 6|Blinded Phase (Randomization - 3 Months)||29
8861892|NCT01818297|9917468|FG000|COMPLETED|Blinded Phase (Randomization - 3 Months)||32
8861893|NCT01818297|9917469|FG001|COMPLETED|Blinded Phase (Randomization - 3 Months)||29
8861894|NCT01818297|9917468|FG000|NOT COMPLETED|Blinded Phase (Randomization - 3 Months)||0
8861895|NCT01818297|9917469|FG001|NOT COMPLETED|Blinded Phase (Randomization - 3 Months)||1
8861896|NCT01818297|9917468|FG000|STARTED|Open Label Phase (3-12 Months)||32
8861897|NCT01818297|9917469|FG001|STARTED|Open Label Phase (3-12 Months)||29
8861898|NCT01818297|9917468|FG000|COMPLETED|Open Label Phase (3-12 Months)||14
8861899|NCT01818297|9917469|FG001|COMPLETED|Open Label Phase (3-12 Months)||19
8861900|NCT01818297|9917468|FG000|NOT COMPLETED|Open Label Phase (3-12 Months)||18
8861901|NCT01818297|9917469|FG001|NOT COMPLETED|Open Label Phase (3-12 Months)||10
8861902|NCT01818336|9917475|FG000|STARTED|Overall Study||391
8861903|NCT01818336|9917476|FG001|STARTED|Overall Study||59
8861904|NCT01818336|9917475|FG000|COMPLETED|Overall Study||391
8861905|NCT01818336|9917476|FG001|COMPLETED|Overall Study||47
8861906|NCT01818336|9917475|FG000|NOT COMPLETED|Overall Study||0
8861907|NCT01818336|9917476|FG001|NOT COMPLETED|Overall Study||12
8861908|NCT01818414|9917484|FG000|STARTED|Overall Study||14
8861909|NCT01818414|9917485|FG001|STARTED|Overall Study||15
8861910|NCT01818414|9917484|FG000|COMPLETED|Overall Study||14
8861911|NCT01818414|9917485|FG001|COMPLETED|Overall Study||15
8861912|NCT01818414|9917484|FG000|NOT COMPLETED|Overall Study||0
8861913|NCT01818414|9917485|FG001|NOT COMPLETED|Overall Study||0
8861914|NCT01818427|9917495|FG000|STARTED|Overall Study||239
8861915|NCT01818427|9917496|FG001|STARTED|Overall Study||284
8861916|NCT01818427|9917495|FG000|COMPLETED|Overall Study||230
8861917|NCT01818427|9917496|FG001|COMPLETED|Overall Study||271
8861918|NCT01818427|9917495|FG000|NOT COMPLETED|Overall Study||9
8861919|NCT01818427|9917496|FG001|NOT COMPLETED|Overall Study||13
8949986|NCT02443740|10012587|FG003|COMPLETED|Washout Period 2 (7 Days)||3
8949987|NCT02443740|10012588|FG004|COMPLETED|Washout Period 2 (7 Days)||2
8949988|NCT02443740|10012589|FG005|COMPLETED|Washout Period 2 (7 Days)||2
8949989|NCT02443740|10012590|FG006|COMPLETED|Washout Period 2 (7 Days)||2
8949990|NCT02443740|10012591|FG007|COMPLETED|Washout Period 2 (7 Days)||2
8949991|NCT02443740|10012592|FG008|COMPLETED|Washout Period 2 (7 Days)||0
8949992|NCT02443740|10012593|FG009|COMPLETED|Washout Period 2 (7 Days)||0
8949993|NCT02443740|10012594|FG010|COMPLETED|Washout Period 2 (7 Days)||0
8949994|NCT02443740|10012584|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
8949995|NCT02443740|10012585|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
8949996|NCT02443740|10012586|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
8949997|NCT02443740|10012587|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
8949998|NCT02443740|10012588|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0
8949999|NCT02443740|10012589|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0
8950000|NCT02443740|10012590|FG006|NOT COMPLETED|Washout Period 2 (7 Days)||0
8950001|NCT02443740|10012591|FG007|NOT COMPLETED|Washout Period 2 (7 Days)||0
8950002|NCT02443740|10012592|FG008|NOT COMPLETED|Washout Period 2 (7 Days)||0
8950003|NCT02443740|10012593|FG009|NOT COMPLETED|Washout Period 2 (7 Days)||0
8950004|NCT02443740|10012594|FG010|NOT COMPLETED|Washout Period 2 (7 Days)||0
8950005|NCT02443740|10012584|FG000|STARTED|Intervention Period 3 (3 Days)||1
8950006|NCT02443740|10012585|FG001|STARTED|Intervention Period 3 (3 Days)||2
8950007|NCT02443740|10012586|FG002|STARTED|Intervention Period 3 (3 Days)||2
8950008|NCT02443740|10012587|FG003|STARTED|Intervention Period 3 (3 Days)||3
8950009|NCT02443740|10012588|FG004|STARTED|Intervention Period 3 (3 Days)||2
8950010|NCT02443740|10012589|FG005|STARTED|Intervention Period 3 (3 Days)||2
8950011|NCT02443740|10012590|FG006|STARTED|Intervention Period 3 (3 Days)||2
8950012|NCT02443740|10012591|FG007|STARTED|Intervention Period 3 (3 Days)||2
8950013|NCT02443740|10012592|FG008|STARTED|Intervention Period 3 (3 Days)||0
8950014|NCT02443740|10012593|FG009|STARTED|Intervention Period 3 (3 Days)||0
8950015|NCT02443740|10012594|FG010|STARTED|Intervention Period 3 (3 Days)||0
8950016|NCT02443740|10012584|FG000|COMPLETED|Intervention Period 3 (3 Days)||1
8950017|NCT02443740|10012585|FG001|COMPLETED|Intervention Period 3 (3 Days)||2
8950018|NCT02443740|10012586|FG002|COMPLETED|Intervention Period 3 (3 Days)||2
8950019|NCT02443740|10012587|FG003|COMPLETED|Intervention Period 3 (3 Days)||3
8950020|NCT02443740|10012588|FG004|COMPLETED|Intervention Period 3 (3 Days)||2
8950021|NCT02443740|10012589|FG005|COMPLETED|Intervention Period 3 (3 Days)||2
8950022|NCT02443740|10012590|FG006|COMPLETED|Intervention Period 3 (3 Days)||2
8950023|NCT02443740|10012591|FG007|COMPLETED|Intervention Period 3 (3 Days)||2
8950024|NCT02443740|10012592|FG008|COMPLETED|Intervention Period 3 (3 Days)||0
8950025|NCT02443740|10012593|FG009|COMPLETED|Intervention Period 3 (3 Days)||0
8950026|NCT02443740|10012594|FG010|COMPLETED|Intervention Period 3 (3 Days)||0
8950027|NCT02443740|10012584|FG000|NOT COMPLETED|Intervention Period 3 (3 Days)||0
8950028|NCT02443740|10012585|FG001|NOT COMPLETED|Intervention Period 3 (3 Days)||0
8950029|NCT02443740|10012586|FG002|NOT COMPLETED|Intervention Period 3 (3 Days)||0
8950030|NCT02443740|10012587|FG003|NOT COMPLETED|Intervention Period 3 (3 Days)||0
8950031|NCT02443740|10012588|FG004|NOT COMPLETED|Intervention Period 3 (3 Days)||0
8950032|NCT02443740|10012589|FG005|NOT COMPLETED|Intervention Period 3 (3 Days)||0
8950033|NCT02443740|10012590|FG006|NOT COMPLETED|Intervention Period 3 (3 Days)||0
8950034|NCT02443740|10012591|FG007|NOT COMPLETED|Intervention Period 3 (3 Days)||0
8950035|NCT02443740|10012592|FG008|NOT COMPLETED|Intervention Period 3 (3 Days)||0
8950036|NCT02443740|10012593|FG009|NOT COMPLETED|Intervention Period 3 (3 Days)||0
8950037|NCT02443740|10012594|FG010|NOT COMPLETED|Intervention Period 3 (3 Days)||0
8950038|NCT02443740|10012584|FG000|STARTED|Washout Period 3 (7 Days)||1
8950039|NCT02443740|10012585|FG001|STARTED|Washout Period 3 (7 Days)||2
8950040|NCT02443740|10012586|FG002|STARTED|Washout Period 3 (7 Days)||2
8950041|NCT02443740|10012587|FG003|STARTED|Washout Period 3 (7 Days)||3
8950042|NCT02443740|10012588|FG004|STARTED|Washout Period 3 (7 Days)||2
8950043|NCT02443740|10012589|FG005|STARTED|Washout Period 3 (7 Days)||2
8950044|NCT02443740|10012590|FG006|STARTED|Washout Period 3 (7 Days)||2
8950045|NCT02443740|10012591|FG007|STARTED|Washout Period 3 (7 Days)||2
8950046|NCT02443740|10012592|FG008|STARTED|Washout Period 3 (7 Days)||0
8950047|NCT02443740|10012593|FG009|STARTED|Washout Period 3 (7 Days)||0
8950048|NCT02443740|10012594|FG010|STARTED|Washout Period 3 (7 Days)||0
8950049|NCT02443740|10012584|FG000|COMPLETED|Washout Period 3 (7 Days)||1
8950050|NCT02443740|10012585|FG001|COMPLETED|Washout Period 3 (7 Days)||2
8950051|NCT02443740|10012586|FG002|COMPLETED|Washout Period 3 (7 Days)||2
8950052|NCT02443740|10012587|FG003|COMPLETED|Washout Period 3 (7 Days)||3
8861920|NCT01818492|9917502|FG000|STARTED|Overall Study||45
8950053|NCT02443740|10012588|FG004|COMPLETED|Washout Period 3 (7 Days)||2
8950054|NCT02443740|10012589|FG005|COMPLETED|Washout Period 3 (7 Days)||2
8950055|NCT02443740|10012590|FG006|COMPLETED|Washout Period 3 (7 Days)||2
8950056|NCT02443740|10012591|FG007|COMPLETED|Washout Period 3 (7 Days)||2
8861921|NCT01818492|9917502|FG000|COMPLETED|Overall Study||35
8861922|NCT01818492|9917502|FG000|NOT COMPLETED|Overall Study||10
8861923|NCT01818518|9917513|FG000|STARTED|Overall Study||310
8861924|NCT01818518|9917514|FG001|STARTED|Overall Study||263
8861925|NCT01818518|9917515|FG002|STARTED|Overall Study||288
8569704|NCT00098306|9601865|FG000|COMPLETED|Observational Phase||0
8861926|NCT01818518|9917516|FG003|STARTED|Overall Study||59
8861927|NCT01818518|9917517|FG004|STARTED|Overall Study||38
8861928|NCT01818518|9917518|FG005|STARTED|Overall Study||37
8861929|NCT01818518|9917513|FG000|COMPLETED|Overall Study||310
8861930|NCT01818518|9917514|FG001|COMPLETED|Overall Study||263
8861931|NCT01818518|9917515|FG002|COMPLETED|Overall Study||288
8861932|NCT01818518|9917516|FG003|COMPLETED|Overall Study||59
8861933|NCT01818518|9917517|FG004|COMPLETED|Overall Study||38
8861934|NCT01818518|9917518|FG005|COMPLETED|Overall Study||37
8861935|NCT01818518|9917513|FG000|NOT COMPLETED|Overall Study||0
8861936|NCT01818518|9917514|FG001|NOT COMPLETED|Overall Study||0
8861937|NCT01818518|9917515|FG002|NOT COMPLETED|Overall Study||0
8861938|NCT01818518|9917516|FG003|NOT COMPLETED|Overall Study||0
8861939|NCT01818518|9917517|FG004|NOT COMPLETED|Overall Study||0
8861940|NCT01818518|9917518|FG005|NOT COMPLETED|Overall Study||0
8861941|NCT01818531|9917534|FG000|STARTED|Overall Study||75
8861942|NCT01818531|9917535|FG001|STARTED|Overall Study||75
8861943|NCT01818531|9917534|FG000|COMPLETED|Overall Study||74
8861944|NCT01818531|9917535|FG001|COMPLETED|Overall Study||73
8861945|NCT01818531|9917534|FG000|NOT COMPLETED|Overall Study||1
8861946|NCT01818531|9917535|FG001|NOT COMPLETED|Overall Study||2
8861947|NCT01818596|9917543|FG000|STARTED|Overall Study||246
8861948|NCT01818596|9917544|FG001|STARTED|Overall Study||6
8861949|NCT01818596|9917543|FG000|COMPLETED|Overall Study||215
8861950|NCT01818596|9917544|FG001|COMPLETED|Overall Study||6
8725482|NCT01031836|9772763|FG000|NOT COMPLETED|Stage II||2
8725483|NCT01031836|9772764|FG001|NOT COMPLETED|Stage II||0
8725484|NCT01031836|9772765|FG002|NOT COMPLETED|Stage II||2
8725485|NCT01031836|9772766|FG003|NOT COMPLETED|Stage II||3
8725486|NCT01031836|9772767|FG004|NOT COMPLETED|Stage II||2
8725487|NCT01031836|9772768|FG005|NOT COMPLETED|Stage II||1
8725488|NCT01031914|9772782|FG000|STARTED|Overall Study||36
8725489|NCT01031914|9772782|FG000|COMPLETED|Overall Study||36
8725490|NCT01031914|9772782|FG000|NOT COMPLETED|Overall Study||0
8725491|NCT01031953|9772786|FG000|STARTED|Overall Study||11
8725492|NCT01031953|9772786|FG000|COMPLETED|Overall Study||11
8725493|NCT01031953|9772786|FG000|NOT COMPLETED|Overall Study||0
8725494|NCT01031979|9772798|FG000|STARTED|Overall Study|To meet eligibility requirements for randomization, subjects had to reach session 3 w/o dropping.|14
8725495|NCT01031979|9772799|FG001|STARTED|Overall Study|To meet eligibility requirements for randomization, subjects had to reach session 3 w/o dropping.|12
8725496|NCT01031979|9772798|FG000|Completed Primary Outcome Measure|Overall Study||12
8725497|NCT01031979|9772799|FG001|Completed Primary Outcome Measure|Overall Study||12
8725498|NCT01031979|9772798|FG000|COMPLETED|Overall Study|These are individuals who completed treatment in the study.|9
8725499|NCT01031979|9772799|FG001|COMPLETED|Overall Study|These are individuals who completed treatment in the study.|8
8725500|NCT01031979|9772798|FG000|NOT COMPLETED|Overall Study||5
8725501|NCT01031979|9772799|FG001|NOT COMPLETED|Overall Study||4
8725502|NCT01032018|9772807|FG000|STARTED|Overall Study||77
8725503|NCT01032018|9772808|FG001|STARTED|Overall Study||73
8725504|NCT01032018|9772807|FG000|COMPLETED|Overall Study||71
8725505|NCT01032018|9772808|FG001|COMPLETED|Overall Study||67
8725506|NCT01032018|9772807|FG000|NOT COMPLETED|Overall Study||6
8725507|NCT01032018|9772808|FG001|NOT COMPLETED|Overall Study||6
8725508|NCT01032044|9772816|FG000|STARTED|Overall Study||82
8725509|NCT01032044|9772817|FG001|STARTED|Overall Study||82
8725510|NCT01032044|9772816|FG000|Procedure|Overall Study||74
8725511|NCT01032044|9772817|FG001|Procedure|Overall Study||75
8725512|NCT01032044|9772816|FG000|COMPLETED|Overall Study||57
8725513|NCT01032044|9772817|FG001|COMPLETED|Overall Study||62
8725514|NCT01032044|9772816|FG000|NOT COMPLETED|Overall Study||25
8725515|NCT01032044|9772817|FG001|NOT COMPLETED|Overall Study||20
8725516|NCT01032070|9772825|FG000|STARTED|Overall Study||13
8725517|NCT01032070|9772826|FG001|STARTED|Overall Study||12
8725518|NCT01032070|9772825|FG000|COMPLETED|Overall Study||0
8725519|NCT01032070|9772826|FG001|COMPLETED|Overall Study||0
8725520|NCT01032070|9772825|FG000|NOT COMPLETED|Overall Study||13
8725521|NCT01032070|9772826|FG001|NOT COMPLETED|Overall Study||12
8725522|NCT01032135|9772837|FG000|STARTED|2 Week Randomization||311
8725523|NCT01032135|9772838|FG001|STARTED|2 Week Randomization||93
8725524|NCT01032135|9772839|FG002|STARTED|2 Week Randomization||96
8725525|NCT01032135|9772840|FG003|STARTED|2 Week Randomization||0
8725526|NCT01032135|9772841|FG004|STARTED|2 Week Randomization||0
8725527|NCT01032135|9772842|FG005|STARTED|2 Week Randomization||0
8725528|NCT01032135|9772843|FG006|STARTED|2 Week Randomization||0
8725529|NCT01032135|9772837|FG000|COMPLETED|2 Week Randomization||311
8861951|NCT01818596|9917543|FG000|NOT COMPLETED|Overall Study||31
8861952|NCT01818596|9917544|FG001|NOT COMPLETED|Overall Study||0
8861953|NCT01818700|9917551|FG000|STARTED|Overall Study|The No. of enrolled patients|245
8861954|NCT01818700|9917551|FG000|Safety Set|Overall Study|4 subjects were not study drug administered.|241
8950057|NCT02443740|10012592|FG008|COMPLETED|Washout Period 3 (7 Days)||0
8950058|NCT02443740|10012593|FG009|COMPLETED|Washout Period 3 (7 Days)||0
8950059|NCT02443740|10012594|FG010|COMPLETED|Washout Period 3 (7 Days)||0
8950060|NCT02443740|10012584|FG000|NOT COMPLETED|Washout Period 3 (7 Days)||0
8950061|NCT02443740|10012585|FG001|NOT COMPLETED|Washout Period 3 (7 Days)||0
8950062|NCT02443740|10012586|FG002|NOT COMPLETED|Washout Period 3 (7 Days)||0
8950063|NCT02443740|10012587|FG003|NOT COMPLETED|Washout Period 3 (7 Days)||0
8950064|NCT02443740|10012588|FG004|NOT COMPLETED|Washout Period 3 (7 Days)||0
8950065|NCT02443740|10012589|FG005|NOT COMPLETED|Washout Period 3 (7 Days)||0
8950066|NCT02443740|10012590|FG006|NOT COMPLETED|Washout Period 3 (7 Days)||0
8950067|NCT02443740|10012591|FG007|NOT COMPLETED|Washout Period 3 (7 Days)||0
8950068|NCT02443740|10012592|FG008|NOT COMPLETED|Washout Period 3 (7 Days)||0
8950069|NCT02443740|10012593|FG009|NOT COMPLETED|Washout Period 3 (7 Days)||0
8950070|NCT02443740|10012594|FG010|NOT COMPLETED|Washout Period 3 (7 Days)||0
8950071|NCT02443740|10012584|FG000|STARTED|Intervention Period 4 (3 Days)||1
8950072|NCT02443740|10012585|FG001|STARTED|Intervention Period 4 (3 Days)||2
8950073|NCT02443740|10012586|FG002|STARTED|Intervention Period 4 (3 Days)||2
8630324|NCT00534703|9670113|FG000|COMPLETED|Overall Study||4
8630325|NCT00534703|9670114|FG001|COMPLETED|Overall Study||1
8630326|NCT00534703|9670113|FG000|NOT COMPLETED|Overall Study||0
8630327|NCT00534703|9670114|FG001|NOT COMPLETED|Overall Study||0
8630328|NCT00534794|9670124|FG000|STARTED|Overall Study||40
8630329|NCT00534794|9670125|FG001|STARTED|Overall Study||39
8630330|NCT00534794|9670124|FG000|COMPLETED|Overall Study||40
8630331|NCT00534794|9670125|FG001|COMPLETED|Overall Study||39
8630332|NCT00534794|9670124|FG000|NOT COMPLETED|Overall Study||0
8630333|NCT00534794|9670125|FG001|NOT COMPLETED|Overall Study||0
8950074|NCT02443740|10012587|FG003|STARTED|Intervention Period 4 (3 Days)||3
8950075|NCT02443740|10012588|FG004|STARTED|Intervention Period 4 (3 Days)||2
8950076|NCT02443740|10012589|FG005|STARTED|Intervention Period 4 (3 Days)||2
8950077|NCT02443740|10012590|FG006|STARTED|Intervention Period 4 (3 Days)||2
8950078|NCT02443740|10012591|FG007|STARTED|Intervention Period 4 (3 Days)||2
8950079|NCT02443740|10012592|FG008|STARTED|Intervention Period 4 (3 Days)||0
8950080|NCT02443740|10012593|FG009|STARTED|Intervention Period 4 (3 Days)||0
8630334|NCT00534833|9670133|FG000|STARTED|Overall Study||182
8725530|NCT01032135|9772838|FG001|COMPLETED|2 Week Randomization||93
8725531|NCT01032135|9772839|FG002|COMPLETED|2 Week Randomization||96
8725532|NCT01032135|9772840|FG003|COMPLETED|2 Week Randomization||0
8725533|NCT01032135|9772841|FG004|COMPLETED|2 Week Randomization||0
8725534|NCT01032135|9772842|FG005|COMPLETED|2 Week Randomization||0
8725535|NCT01032135|9772843|FG006|COMPLETED|2 Week Randomization||0
8725536|NCT01032135|9772837|FG000|NOT COMPLETED|2 Week Randomization||0
8725537|NCT01032135|9772838|FG001|NOT COMPLETED|2 Week Randomization||0
8725538|NCT01032135|9772839|FG002|NOT COMPLETED|2 Week Randomization||0
8725539|NCT01032135|9772840|FG003|NOT COMPLETED|2 Week Randomization||0
8725540|NCT01032135|9772841|FG004|NOT COMPLETED|2 Week Randomization||0
8725541|NCT01032135|9772842|FG005|NOT COMPLETED|2 Week Randomization||0
8725542|NCT01032135|9772843|FG006|NOT COMPLETED|2 Week Randomization||0
8725543|NCT01032135|9772837|FG000|STARTED|8 Week Randomization||227
8725544|NCT01032135|9772838|FG001|STARTED|8 Week Randomization||0
8725545|NCT01032135|9772839|FG002|STARTED|8 Week Randomization||0
8725546|NCT01032135|9772840|FG003|STARTED|8 Week Randomization||41
8725547|NCT01032135|9772841|FG004|STARTED|8 Week Randomization||43
8725548|NCT01032135|9772842|FG005|STARTED|8 Week Randomization||48
8725549|NCT01032135|9772843|FG006|STARTED|8 Week Randomization||54
8725550|NCT01032135|9772837|FG000|12 Week Follow up|8 Week Randomization|These participants were'nt included in analyses as they didn't meet criteria for study intervention.|217
8725551|NCT01032135|9772838|FG001|12 Week Follow up|8 Week Randomization||0
8725552|NCT01032135|9772839|FG002|12 Week Follow up|8 Week Randomization||0
8725553|NCT01032135|9772840|FG003|12 Week Follow up|8 Week Randomization||34
8725554|NCT01032135|9772841|FG004|12 Week Follow up|8 Week Randomization||38
8725555|NCT01032135|9772842|FG005|12 Week Follow up|8 Week Randomization||36
8725556|NCT01032135|9772843|FG006|12 Week Follow up|8 Week Randomization||41
8725557|NCT01032135|9772837|FG000|COMPLETED|8 Week Randomization|These participants were'nt included in analyses as they didn't meet criteria for study intervention.|201
8725558|NCT01032135|9772838|FG001|COMPLETED|8 Week Randomization||0
8725559|NCT01032135|9772839|FG002|COMPLETED|8 Week Randomization||0
8725560|NCT01032135|9772840|FG003|COMPLETED|8 Week Randomization||30
8725561|NCT01032135|9772841|FG004|COMPLETED|8 Week Randomization||34
8725562|NCT01032135|9772842|FG005|COMPLETED|8 Week Randomization||31
8725563|NCT01032135|9772843|FG006|COMPLETED|8 Week Randomization||36
8725564|NCT01032135|9772837|FG000|NOT COMPLETED|8 Week Randomization||26
8725565|NCT01032135|9772838|FG001|NOT COMPLETED|8 Week Randomization||0
8725566|NCT01032135|9772839|FG002|NOT COMPLETED|8 Week Randomization||0
8725567|NCT01032135|9772840|FG003|NOT COMPLETED|8 Week Randomization||11
8725568|NCT01032135|9772841|FG004|NOT COMPLETED|8 Week Randomization||9
8725569|NCT01032135|9772842|FG005|NOT COMPLETED|8 Week Randomization||17
8630335|NCT00534833|9670134|FG001|STARTED|Overall Study||180
8630336|NCT00534833|9670133|FG000|COMPLETED|Overall Study||182
8630337|NCT00534833|9670134|FG001|COMPLETED|Overall Study||180
8630338|NCT00534833|9670133|FG000|NOT COMPLETED|Overall Study||0
8630339|NCT00534833|9670134|FG001|NOT COMPLETED|Overall Study||0
8630340|NCT00534937|9670144|FG000|STARTED|Overall Study||42
8630341|NCT00534937|9670145|FG001|STARTED|Overall Study||47
8630342|NCT00534937|9670144|FG000|COMPLETED|Overall Study||34
8630343|NCT00534937|9670145|FG001|COMPLETED|Overall Study||35
8630344|NCT00534937|9670144|FG000|NOT COMPLETED|Overall Study||8
8630345|NCT00534937|9670145|FG001|NOT COMPLETED|Overall Study||12
8630346|NCT00535002|9670161|FG000|STARTED|Overall Study||19
8630347|NCT00535002|9670162|FG001|STARTED|Overall Study||12
8630348|NCT00535002|9670163|FG002|STARTED|Overall Study||13
8630349|NCT00535002|9670164|FG003|STARTED|Overall Study||14
8725570|NCT01032135|9772843|FG006|NOT COMPLETED|8 Week Randomization||18
8725571|NCT01032174|9772859|FG000|STARTED|Overall Study||63
8725572|NCT01032174|9772860|FG001|STARTED|Overall Study||60
8725573|NCT01032174|9772859|FG000|COMPLETED|Overall Study||63
8725574|NCT01032174|9772860|FG001|COMPLETED|Overall Study||59
8725575|NCT01032174|9772859|FG000|NOT COMPLETED|Overall Study||0
8725576|NCT01032174|9772860|FG001|NOT COMPLETED|Overall Study||1
8725577|NCT01032200|9772868|FG000|STARTED|Overall Study||26
8725578|NCT01032200|9772869|FG001|STARTED|Overall Study||28
8725579|NCT01032200|9772868|FG000|COMPLETED|Overall Study||22
8725580|NCT01032200|9772869|FG001|COMPLETED|Overall Study||21
8725581|NCT01032200|9772868|FG000|NOT COMPLETED|Overall Study||4
8630350|NCT00535002|9670165|FG004|STARTED|Overall Study||9
8630351|NCT00535002|9670166|FG005|STARTED|Overall Study||17
8630352|NCT00535002|9670167|FG006|STARTED|Overall Study||12
8630353|NCT00535002|9670168|FG007|STARTED|Overall Study||16
8630354|NCT00535002|9670161|FG000|COMPLETED|Overall Study||19
8725582|NCT01032200|9772869|FG001|NOT COMPLETED|Overall Study||7
8861955|NCT01818700|9917551|FG000|FAS Set|Overall Study|31 subjects excluded from FAS due to no assessment of primary efficacy(26) and IC/EC violation(5).|210
8861956|NCT01818700|9917551|FG000|PP Set|Overall Study|105 subjects excluded from PP set due to various reasons.|105
8861957|NCT01818700|9917551|FG000|COMPLETED|Overall Study|104 subjects dropped out this study prior to study completion.|141
8861958|NCT01818700|9917551|FG000|NOT COMPLETED|Overall Study||104
8861959|NCT01818726|9917559|FG000|STARTED|Overall Study||10
8861960|NCT01818726|9917560|FG001|STARTED|Overall Study||5
8861961|NCT01818726|9917559|FG000|COMPLETED|Overall Study||4
8861962|NCT01818726|9917560|FG001|COMPLETED|Overall Study||3
8861963|NCT01818726|9917559|FG000|NOT COMPLETED|Overall Study||6
8861964|NCT01818726|9917560|FG001|NOT COMPLETED|Overall Study||2
8861965|NCT01818739|9917566|FG000|STARTED|Overall Study||204
8861966|NCT01818739|9917566|FG000|COMPLETED|Overall Study||204
8861967|NCT01818739|9917566|FG000|NOT COMPLETED|Overall Study||0
8861968|NCT01818752|9917573|FG000|STARTED|Overall Study||477
8861969|NCT01818752|9917574|FG001|STARTED|Overall Study||478
8861970|NCT01818752|9917573|FG000|Received Treatment|Overall Study||470
8861971|NCT01818752|9917574|FG001|Received Treatment|Overall Study||474
8861972|NCT01818752|9917573|FG000|COMPLETED|Overall Study|Completed treatment|290
8861973|NCT01818752|9917574|FG001|COMPLETED|Overall Study|Completed treatment|280
8861974|NCT01818752|9917573|FG000|NOT COMPLETED|Overall Study||187
8861975|NCT01818752|9917574|FG001|NOT COMPLETED|Overall Study||198
8861976|NCT01818765|9917580|FG000|STARTED|Overall Study||20
8861977|NCT01818765|9917580|FG000|COMPLETED|Overall Study||18
8861978|NCT01818765|9917580|FG000|NOT COMPLETED|Overall Study||2
8861979|NCT01818804|9917587|FG000|STARTED|Overall Study||73
8861980|NCT01818804|9917588|FG001|STARTED|Overall Study||72
8861981|NCT01818804|9917587|FG000|COMPLETED|Overall Study||68
8861982|NCT01818804|9917588|FG001|COMPLETED|Overall Study||65
8861983|NCT01818804|9917587|FG000|NOT COMPLETED|Overall Study||5
8861984|NCT01818804|9917588|FG001|NOT COMPLETED|Overall Study||7
8630355|NCT00535002|9670162|FG001|COMPLETED|Overall Study||12
8861985|NCT01819129|9917596|FG000|STARTED|Overall Study||345
8861986|NCT01819129|9917597|FG001|STARTED|Overall Study||344
8861987|NCT01819129|9917596|FG000|Exposed|Overall Study||341
8861988|NCT01819129|9917597|FG001|Exposed|Overall Study||341
8861989|NCT01819129|9917596|FG000|COMPLETED|Overall Study||301
8861990|NCT01819129|9917597|FG001|COMPLETED|Overall Study||305
8861991|NCT01819129|9917596|FG000|NOT COMPLETED|Overall Study||44
8861992|NCT01819129|9917597|FG001|NOT COMPLETED|Overall Study||39
8861993|NCT01819194|9917603|FG000|STARTED|Overall Study||62
8861994|NCT01819194|9917603|FG000|COMPLETED|Overall Study||60
8861995|NCT01819194|9917603|FG000|NOT COMPLETED|Overall Study||2
8861996|NCT01819233|9917607|FG000|STARTED|Overall Study||38
8861997|NCT01819233|9917607|FG000|COMPLETED|Overall Study||32
8861998|NCT01819233|9917607|FG000|NOT COMPLETED|Overall Study||6
8861999|NCT01819272|9917617|FG000|STARTED|Overall Study||41
8862000|NCT01819272|9917618|FG001|STARTED|Overall Study||39
8862001|NCT01819272|9917619|FG002|STARTED|Overall Study||40
8862002|NCT01819272|9917620|FG003|STARTED|Overall Study||40
8862003|NCT01819272|9917621|FG004|STARTED|Overall Study||40
8862004|NCT01819272|9917622|FG005|STARTED|Overall Study||40
8862005|NCT01819272|9917617|FG000|COMPLETED|Overall Study||35
8862006|NCT01819272|9917618|FG001|COMPLETED|Overall Study||36
8862007|NCT01819272|9917619|FG002|COMPLETED|Overall Study||37
8862008|NCT01819272|9917620|FG003|COMPLETED|Overall Study||35
8862009|NCT01819272|9917621|FG004|COMPLETED|Overall Study||36
8630356|NCT00535002|9670163|FG002|COMPLETED|Overall Study||13
8630357|NCT00535002|9670164|FG003|COMPLETED|Overall Study||14
8630358|NCT00535002|9670165|FG004|COMPLETED|Overall Study||9
8630359|NCT00535002|9670166|FG005|COMPLETED|Overall Study||17
8725583|NCT01032239|9772877|FG000|STARTED|Overall Study|randomized to ITB arm|31
8725584|NCT01032239|9772878|FG001|STARTED|Overall Study|randomized to BMT arm|29
8725585|NCT01032239|9772877|FG000|Implant|Overall Study|implanted|25
8862010|NCT01819272|9917622|FG005|COMPLETED|Overall Study||33
8862011|NCT01819272|9917617|FG000|NOT COMPLETED|Overall Study||6
8862012|NCT01819272|9917618|FG001|NOT COMPLETED|Overall Study||3
8862013|NCT01819272|9917619|FG002|NOT COMPLETED|Overall Study||3
8862014|NCT01819272|9917620|FG003|NOT COMPLETED|Overall Study||5
8630360|NCT00535002|9670167|FG006|COMPLETED|Overall Study||12
8862015|NCT01819272|9917621|FG004|NOT COMPLETED|Overall Study||4
8862016|NCT01819272|9917622|FG005|NOT COMPLETED|Overall Study||7
8862017|NCT01819311|9917638|FG000|STARTED|Treatment Phase (4 Weeks)||33
8862018|NCT01819311|9917639|FG001|STARTED|Treatment Phase (4 Weeks)||31
8862019|NCT01819311|9917638|FG000|COMPLETED|Treatment Phase (4 Weeks)||31
8862020|NCT01819311|9917639|FG001|COMPLETED|Treatment Phase (4 Weeks)||30
8862021|NCT01819311|9917638|FG000|NOT COMPLETED|Treatment Phase (4 Weeks)||2
8862022|NCT01819311|9917639|FG001|NOT COMPLETED|Treatment Phase (4 Weeks)||1
8862023|NCT01819311|9917638|FG000|STARTED|Follow-up Phase (8 Weeks)||31
8862024|NCT01819311|9917639|FG001|STARTED|Follow-up Phase (8 Weeks)||30
8862025|NCT01819311|9917638|FG000|COMPLETED|Follow-up Phase (8 Weeks)||24
8862026|NCT01819311|9917639|FG001|COMPLETED|Follow-up Phase (8 Weeks)||23
8862027|NCT01819311|9917638|FG000|NOT COMPLETED|Follow-up Phase (8 Weeks)||7
8862028|NCT01819311|9917639|FG001|NOT COMPLETED|Follow-up Phase (8 Weeks)||7
8862029|NCT01819415|9917649|FG000|STARTED|Overall Study||10
8862030|NCT01819415|9917650|FG001|STARTED|Overall Study||10
8862031|NCT01819415|9917651|FG002|STARTED|Overall Study||10
8862032|NCT01819415|9917652|FG003|STARTED|Overall Study||10
8862033|NCT01819415|9917649|FG000|COMPLETED|Overall Study||7
8862034|NCT01819415|9917650|FG001|COMPLETED|Overall Study||6
8862035|NCT01819415|9917651|FG002|COMPLETED|Overall Study||9
8862036|NCT01819415|9917652|FG003|COMPLETED|Overall Study||8
8862037|NCT01819415|9917649|FG000|NOT COMPLETED|Overall Study||3
8862038|NCT01819415|9917650|FG001|NOT COMPLETED|Overall Study||4
8862039|NCT01819415|9917651|FG002|NOT COMPLETED|Overall Study||1
8862040|NCT01819415|9917652|FG003|NOT COMPLETED|Overall Study||2
8862041|NCT01819506|9917664|FG000|STARTED|Overall Study||51
8862042|NCT01819506|9917665|FG001|STARTED|Overall Study||52
8862043|NCT01819506|9917664|FG000|COMPLETED|Overall Study||43
8862044|NCT01819506|9917665|FG001|COMPLETED|Overall Study||47
8862045|NCT01819506|9917664|FG000|NOT COMPLETED|Overall Study||8
8862046|NCT01819506|9917665|FG001|NOT COMPLETED|Overall Study||5
8862047|NCT01819597|9917671|FG000|STARTED|Overall Study||52
8862048|NCT01819597|9917671|FG000|COMPLETED|Overall Study||52
8862049|NCT01819597|9917671|FG000|NOT COMPLETED|Overall Study||0
8862050|NCT01819727|9917677|FG000|STARTED|Overall Study||131
8862051|NCT01819727|9917678|FG001|STARTED|Overall Study||130
8862052|NCT01819727|9917677|FG000|COMPLETED|Overall Study||111
8862053|NCT01819727|9917678|FG001|COMPLETED|Overall Study||102
8862054|NCT01819727|9917677|FG000|NOT COMPLETED|Overall Study||20
8862055|NCT01819727|9917678|FG001|NOT COMPLETED|Overall Study||28
8862056|NCT01819844|9917684|FG000|STARTED|Overall Study||12
8862057|NCT01819844|9917684|FG000|COMPLETED|Overall Study||12
8862058|NCT01819844|9917684|FG000|NOT COMPLETED|Overall Study||0
8862059|NCT01819883|9917691|FG000|STARTED|Overall Study||20
8862060|NCT01819883|9917692|FG001|STARTED|Overall Study||20
8862061|NCT01819883|9917691|FG000|COMPLETED|Overall Study||16
8862062|NCT01819883|9917692|FG001|COMPLETED|Overall Study||20
8862063|NCT01819883|9917691|FG000|NOT COMPLETED|Overall Study||4
8862064|NCT01819883|9917692|FG001|NOT COMPLETED|Overall Study||0
8862065|NCT01819922|9917697|FG000|STARTED|First Intervention Period (1 Day)||6
8862066|NCT01819922|9917698|FG001|STARTED|First Intervention Period (1 Day)||6
8862067|NCT01819922|9917697|FG000|COMPLETED|First Intervention Period (1 Day)||6
8862068|NCT01819922|9917698|FG001|COMPLETED|First Intervention Period (1 Day)||6
8862069|NCT01819922|9917697|FG000|NOT COMPLETED|First Intervention Period (1 Day)||0
8862070|NCT01819922|9917698|FG001|NOT COMPLETED|First Intervention Period (1 Day)||0
8862071|NCT01819922|9917697|FG000|STARTED|Washout Period (at Least 7-10 Days)||6
8862072|NCT01819922|9917698|FG001|STARTED|Washout Period (at Least 7-10 Days)||6
8862073|NCT01819922|9917697|FG000|COMPLETED|Washout Period (at Least 7-10 Days)||6
8862074|NCT01819922|9917698|FG001|COMPLETED|Washout Period (at Least 7-10 Days)||6
8862075|NCT01819922|9917697|FG000|NOT COMPLETED|Washout Period (at Least 7-10 Days)||0
8862076|NCT01819922|9917698|FG001|NOT COMPLETED|Washout Period (at Least 7-10 Days)||0
8950081|NCT02443740|10012594|FG010|STARTED|Intervention Period 4 (3 Days)||0
8950082|NCT02443740|10012584|FG000|COMPLETED|Intervention Period 4 (3 Days)||1
8950083|NCT02443740|10012585|FG001|COMPLETED|Intervention Period 4 (3 Days)||2
8950084|NCT02443740|10012586|FG002|COMPLETED|Intervention Period 4 (3 Days)||2
8950085|NCT02443740|10012587|FG003|COMPLETED|Intervention Period 4 (3 Days)||3
8950086|NCT02443740|10012588|FG004|COMPLETED|Intervention Period 4 (3 Days)||2
8950087|NCT02443740|10012589|FG005|COMPLETED|Intervention Period 4 (3 Days)||2
8950088|NCT02443740|10012590|FG006|COMPLETED|Intervention Period 4 (3 Days)||2
8950089|NCT02443740|10012591|FG007|COMPLETED|Intervention Period 4 (3 Days)||2
8950090|NCT02443740|10012592|FG008|COMPLETED|Intervention Period 4 (3 Days)||0
8950091|NCT02443740|10012593|FG009|COMPLETED|Intervention Period 4 (3 Days)||0
8950092|NCT02443740|10012594|FG010|COMPLETED|Intervention Period 4 (3 Days)||0
8950093|NCT02443740|10012584|FG000|NOT COMPLETED|Intervention Period 4 (3 Days)||0
8950094|NCT02443740|10012585|FG001|NOT COMPLETED|Intervention Period 4 (3 Days)||0
8950095|NCT02443740|10012586|FG002|NOT COMPLETED|Intervention Period 4 (3 Days)||0
8950096|NCT02443740|10012587|FG003|NOT COMPLETED|Intervention Period 4 (3 Days)||0
8862077|NCT01819922|9917697|FG000|STARTED|Second Intervention Period (1 Day)||6
8950097|NCT02443740|10012588|FG004|NOT COMPLETED|Intervention Period 4 (3 Days)||0
8950098|NCT02443740|10012589|FG005|NOT COMPLETED|Intervention Period 4 (3 Days)||0
8950099|NCT02443740|10012590|FG006|NOT COMPLETED|Intervention Period 4 (3 Days)||0
8950100|NCT02443740|10012591|FG007|NOT COMPLETED|Intervention Period 4 (3 Days)||0
8950101|NCT02443740|10012592|FG008|NOT COMPLETED|Intervention Period 4 (3 Days)||0
8862078|NCT01819922|9917698|FG001|STARTED|Second Intervention Period (1 Day)||6
8862079|NCT01819922|9917697|FG000|COMPLETED|Second Intervention Period (1 Day)||6
8862080|NCT01819922|9917698|FG001|COMPLETED|Second Intervention Period (1 Day)||6
8862081|NCT01819922|9917697|FG000|NOT COMPLETED|Second Intervention Period (1 Day)||0
8862082|NCT01819922|9917698|FG001|NOT COMPLETED|Second Intervention Period (1 Day)||0
8862083|NCT01819935|9917706|FG000|STARTED|Overall Study||328
8862084|NCT01819935|9917707|FG001|STARTED|Overall Study||4943
8862085|NCT01819935|9917706|FG000|COMPLETED|Overall Study||328
8862086|NCT01819935|9917707|FG001|COMPLETED|Overall Study||4943
8862087|NCT01819935|9917706|FG000|NOT COMPLETED|Overall Study||0
8862088|NCT01819935|9917707|FG001|NOT COMPLETED|Overall Study||0
8862089|NCT01820260|9917727|FG000|STARTED|Phase 1 (Part 1)||3
8862090|NCT01820260|9917728|FG001|STARTED|Phase 1 (Part 1)||12
8862091|NCT01820260|9917729|FG002|STARTED|Phase 1 (Part 1)||10
8862092|NCT01820260|9917730|FG003|STARTED|Phase 1 (Part 1)||12
8862093|NCT01820260|9917731|FG004|STARTED|Phase 1 (Part 1)||12
8862094|NCT01820260|9917732|FG005|STARTED|Phase 1 (Part 1)||10
8862095|NCT01820260|9917733|FG006|STARTED|Phase 1 (Part 1)||12
8862096|NCT01820260|9917734|FG007|STARTED|Phase 1 (Part 1)||11
8862097|NCT01820260|9917735|FG008|STARTED|Phase 1 (Part 1)||0
8862098|NCT01820260|9917736|FG009|STARTED|Phase 1 (Part 1)||0
8862099|NCT01820260|9917737|FG010|STARTED|Phase 1 (Part 1)||0
8862100|NCT01820260|9917738|FG011|STARTED|Phase 1 (Part 1)||0
8862101|NCT01820260|9917739|FG012|STARTED|Phase 1 (Part 1)||0
8862102|NCT01820260|9917740|FG013|STARTED|Phase 1 (Part 1)||0
8862103|NCT01820260|9917727|FG000|COMPLETED|Phase 1 (Part 1)||3
8862104|NCT01820260|9917728|FG001|COMPLETED|Phase 1 (Part 1)||12
8862105|NCT01820260|9917729|FG002|COMPLETED|Phase 1 (Part 1)||10
8862106|NCT01820260|9917730|FG003|COMPLETED|Phase 1 (Part 1)||12
8862107|NCT01820260|9917731|FG004|COMPLETED|Phase 1 (Part 1)||12
8862108|NCT01820260|9917732|FG005|COMPLETED|Phase 1 (Part 1)||10
8862109|NCT01820260|9917733|FG006|COMPLETED|Phase 1 (Part 1)||11
8862110|NCT01820260|9917734|FG007|COMPLETED|Phase 1 (Part 1)||11
8862111|NCT01820260|9917735|FG008|COMPLETED|Phase 1 (Part 1)||0
8862112|NCT01820260|9917736|FG009|COMPLETED|Phase 1 (Part 1)||0
8862113|NCT01820260|9917737|FG010|COMPLETED|Phase 1 (Part 1)||0
8862114|NCT01820260|9917738|FG011|COMPLETED|Phase 1 (Part 1)||0
8862115|NCT01820260|9917739|FG012|COMPLETED|Phase 1 (Part 1)||0
8862116|NCT01820260|9917740|FG013|COMPLETED|Phase 1 (Part 1)||0
8862117|NCT01820260|9917727|FG000|NOT COMPLETED|Phase 1 (Part 1)||0
8862118|NCT01820260|9917728|FG001|NOT COMPLETED|Phase 1 (Part 1)||0
8862119|NCT01820260|9917729|FG002|NOT COMPLETED|Phase 1 (Part 1)||0
8862120|NCT01820260|9917730|FG003|NOT COMPLETED|Phase 1 (Part 1)||0
8862121|NCT01820260|9917731|FG004|NOT COMPLETED|Phase 1 (Part 1)||0
8862122|NCT01820260|9917732|FG005|NOT COMPLETED|Phase 1 (Part 1)||0
8862123|NCT01820260|9917733|FG006|NOT COMPLETED|Phase 1 (Part 1)||1
8862124|NCT01820260|9917734|FG007|NOT COMPLETED|Phase 1 (Part 1)||0
8862125|NCT01820260|9917735|FG008|NOT COMPLETED|Phase 1 (Part 1)||0
8862126|NCT01820260|9917736|FG009|NOT COMPLETED|Phase 1 (Part 1)||0
8862127|NCT01820260|9917737|FG010|NOT COMPLETED|Phase 1 (Part 1)||0
8862128|NCT01820260|9917738|FG011|NOT COMPLETED|Phase 1 (Part 1)||0
8862129|NCT01820260|9917739|FG012|NOT COMPLETED|Phase 1 (Part 1)||0
8862130|NCT01820260|9917740|FG013|NOT COMPLETED|Phase 1 (Part 1)||0
8862131|NCT01820260|9917727|FG000|STARTED|Phase 2 (Part 2)||0
8862132|NCT01820260|9917728|FG001|STARTED|Phase 2 (Part 2)||0
8862133|NCT01820260|9917729|FG002|STARTED|Phase 2 (Part 2)||0
8862134|NCT01820260|9917730|FG003|STARTED|Phase 2 (Part 2)||0
8862135|NCT01820260|9917731|FG004|STARTED|Phase 2 (Part 2)||0
8862136|NCT01820260|9917732|FG005|STARTED|Phase 2 (Part 2)||0
8862137|NCT01820260|9917733|FG006|STARTED|Phase 2 (Part 2)||0
8862138|NCT01820260|9917734|FG007|STARTED|Phase 2 (Part 2)||0
8862139|NCT01820260|9917735|FG008|STARTED|Phase 2 (Part 2)||64
8862140|NCT01820260|9917736|FG009|STARTED|Phase 2 (Part 2)||62
8862141|NCT01820260|9917737|FG010|STARTED|Phase 2 (Part 2)||61
8862142|NCT01820260|9917738|FG011|STARTED|Phase 2 (Part 2)||64
8862143|NCT01820260|9917739|FG012|STARTED|Phase 2 (Part 2)||31
8862144|NCT01820260|9917740|FG013|STARTED|Phase 2 (Part 2)||31
8862145|NCT01820260|9917727|FG000|COMPLETED|Phase 2 (Part 2)||0
8862146|NCT01820260|9917728|FG001|COMPLETED|Phase 2 (Part 2)||0
8862147|NCT01820260|9917729|FG002|COMPLETED|Phase 2 (Part 2)||0
8862148|NCT01820260|9917730|FG003|COMPLETED|Phase 2 (Part 2)||0
8862149|NCT01820260|9917731|FG004|COMPLETED|Phase 2 (Part 2)||0
8862150|NCT01820260|9917732|FG005|COMPLETED|Phase 2 (Part 2)||0
8862151|NCT01820260|9917733|FG006|COMPLETED|Phase 2 (Part 2)||0
8862152|NCT01820260|9917734|FG007|COMPLETED|Phase 2 (Part 2)||0
8862153|NCT01820260|9917735|FG008|COMPLETED|Phase 2 (Part 2)||64
8862154|NCT01820260|9917736|FG009|COMPLETED|Phase 2 (Part 2)||61
8862155|NCT01820260|9917737|FG010|COMPLETED|Phase 2 (Part 2)||61
8862156|NCT01820260|9917738|FG011|COMPLETED|Phase 2 (Part 2)||64
8862157|NCT01820260|9917739|FG012|COMPLETED|Phase 2 (Part 2)||31
8862158|NCT01820260|9917740|FG013|COMPLETED|Phase 2 (Part 2)||31
8862159|NCT01820260|9917727|FG000|NOT COMPLETED|Phase 2 (Part 2)||0
8862160|NCT01820260|9917728|FG001|NOT COMPLETED|Phase 2 (Part 2)||0
8862161|NCT01820260|9917729|FG002|NOT COMPLETED|Phase 2 (Part 2)||0
8862162|NCT01820260|9917730|FG003|NOT COMPLETED|Phase 2 (Part 2)||0
8862163|NCT01820260|9917731|FG004|NOT COMPLETED|Phase 2 (Part 2)||0
8862164|NCT01820260|9917732|FG005|NOT COMPLETED|Phase 2 (Part 2)||0
8862165|NCT01820260|9917733|FG006|NOT COMPLETED|Phase 2 (Part 2)||0
8862166|NCT01820260|9917734|FG007|NOT COMPLETED|Phase 2 (Part 2)||0
8862167|NCT01820260|9917735|FG008|NOT COMPLETED|Phase 2 (Part 2)||0
8862168|NCT01820260|9917736|FG009|NOT COMPLETED|Phase 2 (Part 2)||1
8862169|NCT01820260|9917737|FG010|NOT COMPLETED|Phase 2 (Part 2)||0
8862170|NCT01820260|9917738|FG011|NOT COMPLETED|Phase 2 (Part 2)||0
8862171|NCT01820260|9917739|FG012|NOT COMPLETED|Phase 2 (Part 2)||0
8862172|NCT01820260|9917740|FG013|NOT COMPLETED|Phase 2 (Part 2)||0
8862173|NCT01820364|9917776|FG000|STARTED|Part I: LGX818||15
8862174|NCT01820364|9917777|FG001|STARTED|Part I: LGX818||0
8862175|NCT01820364|9917776|FG000|COMPLETED|Part I: LGX818||1
8862176|NCT01820364|9917777|FG001|COMPLETED|Part I: LGX818||0
8862177|NCT01820364|9917776|FG000|NOT COMPLETED|Part I: LGX818||14
8862178|NCT01820364|9917777|FG001|NOT COMPLETED|Part I: LGX818||0
8862179|NCT01820364|9917776|FG000|STARTED|Part II: LGX818 + MEK162||0
8862180|NCT01820364|9917777|FG001|STARTED|Part II: LGX818 + MEK162||1
8862181|NCT01820364|9917776|FG000|COMPLETED|Part II: LGX818 + MEK162||0
8862182|NCT01820364|9917777|FG001|COMPLETED|Part II: LGX818 + MEK162||0
8862183|NCT01820364|9917776|FG000|NOT COMPLETED|Part II: LGX818 + MEK162||0
8862184|NCT01820364|9917777|FG001|NOT COMPLETED|Part II: LGX818 + MEK162||1
8862185|NCT01820416|9917786|FG000|STARTED|Overall Study||12
8862186|NCT01820416|9917787|FG001|STARTED|Overall Study||12
8862187|NCT01820416|9917788|FG002|STARTED|Overall Study||11
8862188|NCT01820416|9917786|FG000|COMPLETED|Overall Study||9
8862189|NCT01820416|9917787|FG001|COMPLETED|Overall Study||10
8862190|NCT01820416|9917788|FG002|COMPLETED|Overall Study||11
8862191|NCT01820416|9917786|FG000|NOT COMPLETED|Overall Study||3
8862192|NCT01820416|9917787|FG001|NOT COMPLETED|Overall Study||2
8862193|NCT01820416|9917788|FG002|NOT COMPLETED|Overall Study||0
8923655|NCT02242643|9984310|FG001|STARTED|Overall Study||1217
8923656|NCT02242643|9984309|FG000|COMPLETED|Overall Study||1132
8923657|NCT02242643|9984310|FG001|COMPLETED|Overall Study||1139
8923658|NCT02242643|9984309|FG000|NOT COMPLETED|Overall Study||75
8923659|NCT02242643|9984310|FG001|NOT COMPLETED|Overall Study||78
8923660|NCT02242903|9984325|FG000|STARTED|Overall Study||12
8923661|NCT02242903|9984326|FG001|STARTED|Overall Study||6
8923662|NCT02242903|9984327|FG002|STARTED|Overall Study||6
8923663|NCT02242903|9984328|FG003|STARTED|Overall Study||6
8923664|NCT02242903|9984329|FG004|STARTED|Overall Study||6
8923665|NCT02242903|9984330|FG005|STARTED|Overall Study||6
8923666|NCT02242903|9984331|FG006|STARTED|Overall Study||6
8923667|NCT02242903|9984325|FG000|Received at Least One Dose of Study Drug|Overall Study||12
8923668|NCT02242903|9984326|FG001|Received at Least One Dose of Study Drug|Overall Study||6
8923669|NCT02242903|9984327|FG002|Received at Least One Dose of Study Drug|Overall Study||6
8923670|NCT02242903|9984328|FG003|Received at Least One Dose of Study Drug|Overall Study||6
8923671|NCT02242903|9984329|FG004|Received at Least One Dose of Study Drug|Overall Study||6
8923672|NCT02242903|9984330|FG005|Received at Least One Dose of Study Drug|Overall Study||6
8923673|NCT02242903|9984331|FG006|Received at Least One Dose of Study Drug|Overall Study||6
8923674|NCT02242903|9984325|FG000|COMPLETED|Overall Study||11
8923675|NCT02242903|9984326|FG001|COMPLETED|Overall Study||6
8923676|NCT02242903|9984327|FG002|COMPLETED|Overall Study||6
8923677|NCT02242903|9984328|FG003|COMPLETED|Overall Study||6
8923678|NCT02242903|9984329|FG004|COMPLETED|Overall Study||6
8923679|NCT02242903|9984330|FG005|COMPLETED|Overall Study||6
8923680|NCT02242903|9984331|FG006|COMPLETED|Overall Study||6
8923681|NCT02242903|9984325|FG000|NOT COMPLETED|Overall Study||1
8923682|NCT02242903|9984326|FG001|NOT COMPLETED|Overall Study||0
8923683|NCT02242903|9984327|FG002|NOT COMPLETED|Overall Study||0
8923684|NCT02242903|9984328|FG003|NOT COMPLETED|Overall Study||0
8923685|NCT02242903|9984329|FG004|NOT COMPLETED|Overall Study||0
8923686|NCT02242903|9984330|FG005|NOT COMPLETED|Overall Study||0
8923687|NCT02242903|9984331|FG006|NOT COMPLETED|Overall Study||0
8923688|NCT02242981|9984353|FG000|STARTED|Overall Study||6
8923689|NCT02242981|9984353|FG000|Received Study Drug|Overall Study||6
8923690|NCT02242981|9984353|FG000|COMPLETED|Overall Study||5
8923691|NCT02242981|9984353|FG000|NOT COMPLETED|Overall Study||1
8950102|NCT02443740|10012593|FG009|NOT COMPLETED|Intervention Period 4 (3 Days)||0
8950103|NCT02443740|10012594|FG010|NOT COMPLETED|Intervention Period 4 (3 Days)||0
8950104|NCT02443792|10012626|FG000|STARTED|Overall Study||50
8950105|NCT02443792|10012627|FG001|STARTED|Overall Study||25
8950106|NCT02443792|10012626|FG000|COMPLETED|Overall Study||43
8950107|NCT02443792|10012627|FG001|COMPLETED|Overall Study||23
8950108|NCT02443792|10012626|FG000|NOT COMPLETED|Overall Study||7
8950109|NCT02443792|10012627|FG001|NOT COMPLETED|Overall Study||2
8950110|NCT02443805|10012635|FG000|STARTED|Overall Study||802
8950111|NCT02443805|10012636|FG001|STARTED|Overall Study||805
8950112|NCT02443805|10012635|FG000|COMPLETED|Overall Study||589
8950113|NCT02443805|10012636|FG001|COMPLETED|Overall Study||678
8950114|NCT02443805|10012635|FG000|NOT COMPLETED|Overall Study||213
8950115|NCT02443805|10012636|FG001|NOT COMPLETED|Overall Study||127
8950116|NCT02443883|10012646|FG000|STARTED|Overall Study||40
8950117|NCT02443883|10012647|FG001|STARTED|Overall Study||42
8950118|NCT02443883|10012648|FG002|STARTED|Overall Study||41
8950119|NCT02443883|10012649|FG003|STARTED|Overall Study||41
8950120|NCT02443883|10012646|FG000|Received at Least One Dose of Study Drug|Overall Study||38
8950121|NCT02443883|10012647|FG001|Received at Least One Dose of Study Drug|Overall Study||42
8950122|NCT02443883|10012648|FG002|Received at Least One Dose of Study Drug|Overall Study||41
8950123|NCT02443883|10012649|FG003|Received at Least One Dose of Study Drug|Overall Study||40
8950124|NCT02443883|10012646|FG000|COMPLETED|Overall Study||34
8862194|NCT01820559|9917799|FG000|STARTED|Overall Study||136
8862195|NCT01820559|9917800|FG001|STARTED|Overall Study||135
8862196|NCT01820559|9917801|FG002|STARTED|Overall Study||139
8862197|NCT01820559|9917799|FG000|Randomized and Treated|Overall Study||136
8862198|NCT01820559|9917800|FG001|Randomized and Treated|Overall Study||135
8862199|NCT01820559|9917801|FG002|Randomized and Treated|Overall Study||139
8862200|NCT01820559|9917799|FG000|Completed Tutration Period|Overall Study||130
8862201|NCT01820559|9917800|FG001|Completed Tutration Period|Overall Study||134
8862202|NCT01820559|9917801|FG002|Completed Tutration Period|Overall Study||131
8862203|NCT01820559|9917799|FG000|Entered Maintenance Period|Overall Study||129
8862204|NCT01820559|9917800|FG001|Entered Maintenance Period|Overall Study||133
8862205|NCT01820559|9917801|FG002|Entered Maintenance Period|Overall Study||129
8862206|NCT01820559|9917799|FG000|Completed Maintenance Period|Overall Study||122
8862207|NCT01820559|9917800|FG001|Completed Maintenance Period|Overall Study||123
8862208|NCT01820559|9917801|FG002|Completed Maintenance Period|Overall Study||110
8862209|NCT01820559|9917799|FG000|COMPLETED|Overall Study||122
8862210|NCT01820559|9917800|FG001|COMPLETED|Overall Study||122
8862211|NCT01820559|9917801|FG002|COMPLETED|Overall Study||110
8862212|NCT01820559|9917799|FG000|NOT COMPLETED|Overall Study||14
8862213|NCT01820559|9917800|FG001|NOT COMPLETED|Overall Study||13
8862214|NCT01820559|9917801|FG002|NOT COMPLETED|Overall Study||29
8862215|NCT01820572|9917811|FG000|STARTED|Randomization||223
8862216|NCT01820572|9917812|FG001|STARTED|Randomization||223
8862217|NCT01820572|9917811|FG000|COMPLETED|Randomization||221
8862218|NCT01820572|9917812|FG001|COMPLETED|Randomization||222
8862219|NCT01820572|9917811|FG000|NOT COMPLETED|Randomization||2
8862220|NCT01820572|9917812|FG001|NOT COMPLETED|Randomization||1
8862221|NCT01820572|9917811|FG000|STARTED|Treatment Period||221
8862222|NCT01820572|9917812|FG001|STARTED|Treatment Period||222
8725586|NCT01032239|9772878|FG001|Implant|Overall Study||0
8725587|NCT01032239|9772877|FG000|COMPLETED|Overall Study||24
8725588|NCT01032239|9772878|FG001|COMPLETED|Overall Study||24
8725589|NCT01032239|9772877|FG000|NOT COMPLETED|Overall Study||7
8725590|NCT01032239|9772878|FG001|NOT COMPLETED|Overall Study||5
8725591|NCT01032291|9772887|FG000|STARTED|Safety Lead-in||8
8862223|NCT01820572|9917811|FG000|COMPLETED|Treatment Period||195
8862224|NCT01820572|9917812|FG001|COMPLETED|Treatment Period||186
8862225|NCT01820572|9917811|FG000|NOT COMPLETED|Treatment Period||26
8862226|NCT01820572|9917812|FG001|NOT COMPLETED|Treatment Period||36
8862227|NCT01820585|9917822|FG000|STARTED|Overall Study||131
8862228|NCT01820585|9917823|FG001|STARTED|Overall Study||130
8862229|NCT01820585|9917824|FG002|STARTED|Overall Study||135
8862230|NCT01820585|9917825|FG003|STARTED|Overall Study||132
8950125|NCT02443883|10012647|FG001|COMPLETED|Overall Study||38
8950126|NCT02443883|10012648|FG002|COMPLETED|Overall Study||40
8950127|NCT02443883|10012649|FG003|COMPLETED|Overall Study||36
8950128|NCT02443883|10012646|FG000|NOT COMPLETED|Overall Study||6
8950129|NCT02443883|10012647|FG001|NOT COMPLETED|Overall Study||4
8950130|NCT02443883|10012648|FG002|NOT COMPLETED|Overall Study||1
8950131|NCT02443883|10012649|FG003|NOT COMPLETED|Overall Study||5
8950132|NCT02444143|10012661|FG000|STARTED|Overall Study||10
8950133|NCT02444143|10012662|FG001|STARTED|Overall Study||10
8950134|NCT02444143|10012661|FG000|COMPLETED|Overall Study||10
8950135|NCT02444143|10012662|FG001|COMPLETED|Overall Study|1 patient withdrawal|9
8950136|NCT02444143|10012661|FG000|NOT COMPLETED|Overall Study||0
8950137|NCT02444143|10012662|FG001|NOT COMPLETED|Overall Study||1
8950138|NCT02444182|10012672|FG000|STARTED|Overall Study||54
8950139|NCT02444182|10012673|FG001|STARTED|Overall Study||54
8950140|NCT02444182|10012672|FG000|COMPLETED|Overall Study||52
8950141|NCT02444182|10012673|FG001|COMPLETED|Overall Study||49
8950142|NCT02444182|10012672|FG000|NOT COMPLETED|Overall Study||2
8950143|NCT02444182|10012673|FG001|NOT COMPLETED|Overall Study||5
8950144|NCT02444234|10012679|FG000|STARTED|First Intervention (3 Days)||6
8950145|NCT02444234|10012680|FG001|STARTED|First Intervention (3 Days)||5
8950146|NCT02444234|10012679|FG000|COMPLETED|First Intervention (3 Days)||6
8950147|NCT02444234|10012680|FG001|COMPLETED|First Intervention (3 Days)||5
8950148|NCT02444234|10012679|FG000|NOT COMPLETED|First Intervention (3 Days)||0
8950149|NCT02444234|10012680|FG001|NOT COMPLETED|First Intervention (3 Days)||0
8950150|NCT02444234|10012679|FG000|STARTED|Washout (2 Day Minimum)||6
8950151|NCT02444234|10012680|FG001|STARTED|Washout (2 Day Minimum)||5
8950152|NCT02444234|10012679|FG000|COMPLETED|Washout (2 Day Minimum)||6
8950153|NCT02444234|10012680|FG001|COMPLETED|Washout (2 Day Minimum)||5
8950154|NCT02444234|10012679|FG000|NOT COMPLETED|Washout (2 Day Minimum)||0
8950155|NCT02444234|10012680|FG001|NOT COMPLETED|Washout (2 Day Minimum)||0
8950156|NCT02444234|10012679|FG000|STARTED|Second Intervention (3 Days)||6
8950157|NCT02444234|10012680|FG001|STARTED|Second Intervention (3 Days)||5
8725592|NCT01032291|9772888|FG001|STARTED|Safety Lead-in||0
8725593|NCT01032291|9772889|FG002|STARTED|Safety Lead-in||0
8862231|NCT01820585|9917822|FG000|Randomized and Treated|Overall Study||131
8862232|NCT01820585|9917823|FG001|Randomized and Treated|Overall Study||130
8862233|NCT01820585|9917824|FG002|Randomized and Treated|Overall Study||135
8862234|NCT01820585|9917825|FG003|Randomized and Treated|Overall Study||132
8862235|NCT01820585|9917822|FG000|Full Analysis Set|Overall Study||131
8862236|NCT01820585|9917823|FG001|Full Analysis Set|Overall Study||130
8862237|NCT01820585|9917824|FG002|Full Analysis Set|Overall Study||135
8862238|NCT01820585|9917825|FG003|Full Analysis Set|Overall Study||129
8862239|NCT01820585|9917822|FG000|Completed Titration Period|Overall Study||128
8862240|NCT01820585|9917823|FG001|Completed Titration Period|Overall Study||125
8862241|NCT01820585|9917824|FG002|Completed Titration Period|Overall Study||131
8862242|NCT01820585|9917825|FG003|Completed Titration Period|Overall Study||126
8862243|NCT01820585|9917822|FG000|Entered Maintenance Period|Overall Study||128
8862244|NCT01820585|9917823|FG001|Entered Maintenance Period|Overall Study||124
8862245|NCT01820585|9917824|FG002|Entered Maintenance Period|Overall Study||131
8862246|NCT01820585|9917825|FG003|Entered Maintenance Period|Overall Study||123
8862247|NCT01820585|9917822|FG000|Completed Maintenance Period|Overall Study||105
8862248|NCT01820585|9917823|FG001|Completed Maintenance Period|Overall Study||98
8862249|NCT01820585|9917824|FG002|Completed Maintenance Period|Overall Study||101
8862250|NCT01820585|9917825|FG003|Completed Maintenance Period|Overall Study||84
8862251|NCT01820585|9917822|FG000|COMPLETED|Overall Study||104
8862252|NCT01820585|9917823|FG001|COMPLETED|Overall Study||98
8862253|NCT01820585|9917824|FG002|COMPLETED|Overall Study||101
8862254|NCT01820585|9917825|FG003|COMPLETED|Overall Study||83
8862255|NCT01820585|9917822|FG000|NOT COMPLETED|Overall Study||27
8862256|NCT01820585|9917823|FG001|NOT COMPLETED|Overall Study||32
8862257|NCT01820585|9917824|FG002|NOT COMPLETED|Overall Study||34
8862258|NCT01820585|9917825|FG003|NOT COMPLETED|Overall Study||49
8862259|NCT01820637|9917835|FG000|STARTED|Overall Study||57
8862260|NCT01820637|9917835|FG000|COMPLETED|Overall Study||54
8862261|NCT01820637|9917835|FG000|NOT COMPLETED|Overall Study||3
8862262|NCT01820754|9917839|FG000|STARTED|Overall Study||24
8862263|NCT01820754|9917839|FG000|COMPLETED|Overall Study||24
8862264|NCT01820754|9917839|FG000|NOT COMPLETED|Overall Study||0
8725594|NCT01032291|9772887|FG000|COMPLETED|Safety Lead-in|Participants with disease progression|6
8725595|NCT01032291|9772888|FG001|COMPLETED|Safety Lead-in||0
8630361|NCT00535002|9670168|FG007|COMPLETED|Overall Study||16
8630362|NCT00535002|9670161|FG000|NOT COMPLETED|Overall Study||0
8630363|NCT00535002|9670162|FG001|NOT COMPLETED|Overall Study||0
8630364|NCT00535002|9670163|FG002|NOT COMPLETED|Overall Study||0
8630365|NCT00535002|9670164|FG003|NOT COMPLETED|Overall Study||0
8630366|NCT00535002|9670165|FG004|NOT COMPLETED|Overall Study||0
8630367|NCT00535002|9670166|FG005|NOT COMPLETED|Overall Study||0
8950158|NCT02444234|10012679|FG000|COMPLETED|Second Intervention (3 Days)||6
8950159|NCT02444234|10012680|FG001|COMPLETED|Second Intervention (3 Days)||5
8950160|NCT02444234|10012679|FG000|NOT COMPLETED|Second Intervention (3 Days)||0
8950161|NCT02444234|10012680|FG001|NOT COMPLETED|Second Intervention (3 Days)||0
8950162|NCT02444533|10012690|FG000|STARTED|Overall Study||17
8950163|NCT02444533|10012691|FG001|STARTED|Overall Study||22
8950164|NCT02444533|10012690|FG000|COMPLETED|Overall Study||15
8950165|NCT02444533|10012691|FG001|COMPLETED|Overall Study||18
8950166|NCT02444533|10012690|FG000|NOT COMPLETED|Overall Study||2
8950167|NCT02444533|10012691|FG001|NOT COMPLETED|Overall Study||4
8950168|NCT02444663|10012697|FG000|STARTED|Clinician Valgus||9
8950169|NCT02444663|10012697|FG000|COMPLETED|Clinician Valgus||9
8950170|NCT02444663|10012697|FG000|NOT COMPLETED|Clinician Valgus||0
8950171|NCT02444663|10012697|FG000|STARTED|Clinician Varus||9
8950172|NCT02444663|10012697|FG000|COMPLETED|Clinician Varus||9
8950173|NCT02444663|10012697|FG000|NOT COMPLETED|Clinician Varus||0
8950174|NCT02444663|10012697|FG000|STARTED|Device Valgus 0N||9
8950175|NCT02444663|10012697|FG000|COMPLETED|Device Valgus 0N||9
8950176|NCT02444663|10012697|FG000|NOT COMPLETED|Device Valgus 0N||0
8950177|NCT02444663|10012697|FG000|STARTED|Device Valgus 10N||9
8950178|NCT02444663|10012697|FG000|COMPLETED|Device Valgus 10N||9
8950179|NCT02444663|10012697|FG000|NOT COMPLETED|Device Valgus 10N||0
8950180|NCT02444663|10012697|FG000|STARTED|Device Valgus 20N||9
8950181|NCT02444663|10012697|FG000|COMPLETED|Device Valgus 20N||9
8950182|NCT02444663|10012697|FG000|NOT COMPLETED|Device Valgus 20N||0
8950183|NCT02444663|10012697|FG000|STARTED|Device Valgus 30N||9
8950184|NCT02444663|10012697|FG000|COMPLETED|Device Valgus 30N||9
8950185|NCT02444663|10012697|FG000|NOT COMPLETED|Device Valgus 30N||0
8630368|NCT00535002|9670167|FG006|NOT COMPLETED|Overall Study||0
8630369|NCT00535002|9670168|FG007|NOT COMPLETED|Overall Study||0
8630370|NCT00535132|9670184|FG000|STARTED|Randomized Population|Number of Subjects Randomized|100
8862265|NCT01821105|9917843|FG000|STARTED|Overall Study||21
8950186|NCT02444663|10012697|FG000|STARTED|Device Varus 0N||9
8950187|NCT02444663|10012697|FG000|COMPLETED|Device Varus 0N||9
8950188|NCT02444663|10012697|FG000|NOT COMPLETED|Device Varus 0N||0
8950189|NCT02444663|10012697|FG000|STARTED|Device Varus 10N||9
8630371|NCT00535132|9670185|FG001|STARTED|Randomized Population|Number of Subjects Randomized|101
8725596|NCT01032291|9772889|FG002|COMPLETED|Safety Lead-in||0
8950190|NCT02444663|10012697|FG000|COMPLETED|Device Varus 10N||9
8950191|NCT02444663|10012697|FG000|NOT COMPLETED|Device Varus 10N||0
8950192|NCT02444663|10012697|FG000|STARTED|Device Varus 20N||9
8950193|NCT02444663|10012697|FG000|COMPLETED|Device Varus 20N||9
8950194|NCT02444663|10012697|FG000|NOT COMPLETED|Device Varus 20N||0
8950195|NCT02444663|10012697|FG000|STARTED|Device Varus 30N||9
8950196|NCT02444663|10012697|FG000|COMPLETED|Device Varus 30N||9
8950197|NCT02444663|10012697|FG000|NOT COMPLETED|Device Varus 30N||0
8950198|NCT02444715|10012721|FG000|STARTED|Overall Study||46
8950199|NCT02444715|10012722|FG001|STARTED|Overall Study||48
8950200|NCT02444715|10012721|FG000|COMPLETED|Overall Study||36
8950201|NCT02444715|10012722|FG001|COMPLETED|Overall Study||32
8950202|NCT02444715|10012721|FG000|NOT COMPLETED|Overall Study||10
8950203|NCT02444715|10012722|FG001|NOT COMPLETED|Overall Study||16
8950204|NCT02444793|10012733|FG000|STARTED|Overall Study||11
8950205|NCT02444793|10012734|FG001|STARTED|Overall Study||6
8950206|NCT02444793|10012735|FG002|STARTED|Overall Study||4
8950207|NCT02444793|10012736|FG003|STARTED|Overall Study||3
8950208|NCT02444793|10012733|FG000|COMPLETED|Overall Study||0
8950209|NCT02444793|10012734|FG001|COMPLETED|Overall Study||0
8950210|NCT02444793|10012735|FG002|COMPLETED|Overall Study||0
8950211|NCT02444793|10012736|FG003|COMPLETED|Overall Study||0
8950212|NCT02444793|10012733|FG000|NOT COMPLETED|Overall Study||11
8950213|NCT02444793|10012734|FG001|NOT COMPLETED|Overall Study||6
8950214|NCT02444793|10012735|FG002|NOT COMPLETED|Overall Study||4
8950215|NCT02444793|10012736|FG003|NOT COMPLETED|Overall Study||3
8950216|NCT02444936|10012749|FG000|STARTED|Overall Study||10
8950217|NCT02444936|10012750|FG001|STARTED|Overall Study||12
8950218|NCT02444936|10012749|FG000|COMPLETED|Overall Study||10
8950219|NCT02444936|10012750|FG001|COMPLETED|Overall Study||12
8630372|NCT00535132|9670184|FG000|COMPLETED|Randomized Population||100
8630373|NCT00535132|9670185|FG001|COMPLETED|Randomized Population||101
8630374|NCT00535132|9670184|FG000|NOT COMPLETED|Randomized Population||0
8630375|NCT00535132|9670185|FG001|NOT COMPLETED|Randomized Population||0
8630376|NCT00535132|9670184|FG000|STARTED|Safety Analysis Set||100
8630377|NCT00535132|9670185|FG001|STARTED|Safety Analysis Set||101
8630378|NCT00535132|9670184|FG000|COMPLETED|Safety Analysis Set|Two patients were randomized but not treated.|98
8630379|NCT00535132|9670185|FG001|COMPLETED|Safety Analysis Set|Two patients were randomized but not treated.|99
8630380|NCT00535132|9670184|FG000|NOT COMPLETED|Safety Analysis Set||2
8630381|NCT00535132|9670185|FG001|NOT COMPLETED|Safety Analysis Set||2
8630382|NCT00535132|9670184|FG000|STARTED|Intent-to-Treat (ITT) Analysis Set||98
8630383|NCT00535132|9670185|FG001|STARTED|Intent-to-Treat (ITT) Analysis Set||99
8630384|NCT00535132|9670184|FG000|COMPLETED|Intent-to-Treat (ITT) Analysis Set|Patients who received at least one dose of study drug and have some follow-up efficacy data.|95
8950220|NCT02444936|10012749|FG000|NOT COMPLETED|Overall Study||0
8862266|NCT01821105|9917843|FG000|COMPLETED|Overall Study||21
8862267|NCT01821105|9917843|FG000|NOT COMPLETED|Overall Study||0
8862268|NCT01821118|9917849|FG000|STARTED|Overall Study||24
8862269|NCT01821118|9917850|FG001|STARTED|Overall Study||12
8862270|NCT01821118|9917849|FG000|COMPLETED|Overall Study||24
8862271|NCT01821118|9917850|FG001|COMPLETED|Overall Study||11
8862272|NCT01821118|9917849|FG000|NOT COMPLETED|Overall Study||0
8862273|NCT01821118|9917850|FG001|NOT COMPLETED|Overall Study||1
8862274|NCT01821300|9917858|FG000|STARTED|Overall Study||154
8862275|NCT01821300|9917859|FG001|STARTED|Overall Study||103
8862276|NCT01821300|9917858|FG000|COMPLETED|Overall Study||154
8862277|NCT01821300|9917859|FG001|COMPLETED|Overall Study||103
8862278|NCT01821300|9917858|FG000|NOT COMPLETED|Overall Study||0
8862279|NCT01821300|9917859|FG001|NOT COMPLETED|Overall Study||0
8862280|NCT01821326|9917871|FG000|STARTED|Overall Study||339
8862281|NCT01821326|9917871|FG000|COMPLETED|Overall Study||339
8862282|NCT01821326|9917871|FG000|NOT COMPLETED|Overall Study||0
8862283|NCT01821352|9917877|FG000|STARTED|Overall Study||28
8862284|NCT01821352|9917878|FG001|STARTED|Overall Study||25
8862285|NCT01821352|9917877|FG000|COMPLETED|Overall Study||28
8862286|NCT01821352|9917878|FG001|COMPLETED|Overall Study||25
8862287|NCT01821352|9917877|FG000|NOT COMPLETED|Overall Study||0
8862288|NCT01821352|9917878|FG001|NOT COMPLETED|Overall Study||0
8862289|NCT01821378|9917887|FG000|STARTED|Overall Study||101
8862290|NCT01821378|9917888|FG001|STARTED|Overall Study||199
8862291|NCT01821378|9917889|FG002|STARTED|Overall Study||112
8862292|NCT01821378|9917887|FG000|COMPLETED|Overall Study||74
8950221|NCT02444936|10012750|FG001|NOT COMPLETED|Overall Study||0
8950222|NCT02444988|10012758|FG000|STARTED|Overall Study||2646
8950223|NCT02444988|10012759|FG001|STARTED|Overall Study||2735
8950224|NCT02444988|10012758|FG000|COMPLETED|Overall Study||2646
8950225|NCT02444988|10012759|FG001|COMPLETED|Overall Study||2735
8950226|NCT02444988|10012758|FG000|NOT COMPLETED|Overall Study||0
8950227|NCT02444988|10012759|FG001|NOT COMPLETED|Overall Study||0
8950228|NCT02445014|10012765|FG000|STARTED|Overall Study||3
8950229|NCT02445014|10012765|FG000|COMPLETED|Overall Study||3
8950230|NCT02445014|10012765|FG000|NOT COMPLETED|Overall Study||0
8950231|NCT02445027|10012769|FG000|STARTED|Overall Study||60
8950232|NCT02445027|10012769|FG000|COMPLETED|Overall Study||45
8950233|NCT02445027|10012769|FG000|NOT COMPLETED|Overall Study||15
8950234|NCT02445196|10012775|FG000|STARTED|Overall Study||62
8950235|NCT02445196|10012776|FG001|STARTED|Overall Study||58
8862293|NCT01821378|9917888|FG001|COMPLETED|Overall Study||145
8862294|NCT01821378|9917889|FG002|COMPLETED|Overall Study||70
8862295|NCT01821378|9917887|FG000|NOT COMPLETED|Overall Study||27
8950236|NCT02445196|10012775|FG000|COMPLETED|Overall Study||51
8862296|NCT01821378|9917888|FG001|NOT COMPLETED|Overall Study||54
8950237|NCT02445196|10012776|FG001|COMPLETED|Overall Study||52
8950238|NCT02445196|10012775|FG000|NOT COMPLETED|Overall Study||11
8950239|NCT02445196|10012776|FG001|NOT COMPLETED|Overall Study||6
8950240|NCT02445287|10012784|FG000|STARTED|Overall Study||35
8950241|NCT02445287|10012785|FG001|STARTED|Overall Study||13
8862297|NCT01821378|9917889|FG002|NOT COMPLETED|Overall Study||42
8862298|NCT01821391|9917904|FG000|STARTED|Overall Study||108
8862299|NCT01821391|9917905|FG001|STARTED|Overall Study||23
8862300|NCT01821391|9917904|FG000|COMPLETED|Overall Study||107
8862301|NCT01821391|9917905|FG001|COMPLETED|Overall Study||23
8862302|NCT01821391|9917904|FG000|NOT COMPLETED|Overall Study||1
8862303|NCT01821391|9917905|FG001|NOT COMPLETED|Overall Study||0
8862304|NCT01821417|9917915|FG000|STARTED|Overall Study||37
8862305|NCT01821417|9917916|FG001|STARTED|Overall Study||31
8862306|NCT01821417|9917915|FG000|COMPLETED|Overall Study||37
8862307|NCT01821417|9917916|FG001|COMPLETED|Overall Study||31
8862308|NCT01821417|9917915|FG000|NOT COMPLETED|Overall Study||0
8862309|NCT01821417|9917916|FG001|NOT COMPLETED|Overall Study||0
8862310|NCT01821534|9917922|FG000|STARTED|Overall Study||201
8862311|NCT01821534|9917922|FG000|COMPLETED|Overall Study||201
8862312|NCT01821534|9917922|FG000|NOT COMPLETED|Overall Study||0
8862313|NCT01821560|9917928|FG000|STARTED|Overall Study||22
8862314|NCT01821560|9917929|FG001|STARTED|Overall Study||22
8862315|NCT01821560|9917928|FG000|COMPLETED|Overall Study||16
8862316|NCT01821560|9917929|FG001|COMPLETED|Overall Study||15
8862317|NCT01821560|9917928|FG000|NOT COMPLETED|Overall Study||6
8862318|NCT01821560|9917929|FG001|NOT COMPLETED|Overall Study||7
8862319|NCT01821625|9917935|FG000|STARTED|Overall Study||7
8862320|NCT01821625|9917935|FG000|COMPLETED|Overall Study||1
8862321|NCT01821625|9917935|FG000|NOT COMPLETED|Overall Study||6
8862322|NCT01821729|9917939|FG000|STARTED|Overall Study||50
8862323|NCT01821729|9917939|FG000|Received Chemoradiotherapy|Overall Study||45
8862324|NCT01821729|9917939|FG000|Underwent Attempted Surgery|Overall Study||42
8862325|NCT01821729|9917939|FG000|COMPLETED|Overall Study||49
8862326|NCT01821729|9917939|FG000|NOT COMPLETED|Overall Study||1
8862327|NCT01821807|9917945|FG000|STARTED|Overall Study||150
8862328|NCT01821807|9917946|FG001|STARTED|Overall Study||110
8862329|NCT01821807|9917945|FG000|COMPLETED|Overall Study||147
8862330|NCT01821807|9917946|FG001|COMPLETED|Overall Study||109
8862331|NCT01821807|9917945|FG000|NOT COMPLETED|Overall Study||3
8862332|NCT01821807|9917946|FG001|NOT COMPLETED|Overall Study||1
8862333|NCT01821937|9917954|FG000|STARTED|Overall Study||10
8862334|NCT01821937|9917955|FG001|STARTED|Overall Study||15
8862335|NCT01821937|9917954|FG000|COMPLETED|Overall Study||10
8862336|NCT01821937|9917955|FG001|COMPLETED|Overall Study|2 patients discontinued during Single dose period,1 Patient discontinued during Multiple dose period|12
8862337|NCT01821937|9917954|FG000|NOT COMPLETED|Overall Study||0
8862338|NCT01821937|9917955|FG001|NOT COMPLETED|Overall Study||3
8862339|NCT01822119|9917963|FG000|STARTED|Overall Study||27
8862340|NCT01822119|9917963|FG000|COMPLETED|Overall Study||27
8862341|NCT01822119|9917963|FG000|NOT COMPLETED|Overall Study||0
8862342|NCT01822132|9917969|FG000|STARTED|Overall Study||25
8862343|NCT01822132|9917970|FG001|STARTED|Overall Study||27
8862344|NCT01822132|9917969|FG000|COMPLETED|Overall Study||21
8862345|NCT01822132|9917970|FG001|COMPLETED|Overall Study||25
8862346|NCT01822132|9917969|FG000|NOT COMPLETED|Overall Study||4
8862347|NCT01822132|9917970|FG001|NOT COMPLETED|Overall Study||2
8862348|NCT01822197|9917982|FG000|STARTED|Overall Study||30
8950242|NCT02445287|10012784|FG000|COMPLETED|Overall Study||35
8950243|NCT02445287|10012785|FG001|COMPLETED|Overall Study||13
8950244|NCT02445287|10012784|FG000|NOT COMPLETED|Overall Study||0
8950245|NCT02445287|10012785|FG001|NOT COMPLETED|Overall Study||0
8950246|NCT02445326|10012798|FG000|STARTED|Overall Study||35
8950247|NCT02445326|10012799|FG001|STARTED|Overall Study||38
8950248|NCT02445326|10012798|FG000|COMPLETED|Overall Study||33
8950249|NCT02445326|10012799|FG001|COMPLETED|Overall Study||37
8950250|NCT02445326|10012798|FG000|NOT COMPLETED|Overall Study||2
8950251|NCT02445326|10012799|FG001|NOT COMPLETED|Overall Study||1
8950252|NCT02445573|10012807|FG000|STARTED|Overall Study||40
8950253|NCT02445573|10012808|FG001|STARTED|Overall Study||40
8950254|NCT02445573|10012807|FG000|COMPLETED|Overall Study||39
8950255|NCT02445573|10012808|FG001|COMPLETED|Overall Study||38
8950256|NCT02445573|10012807|FG000|NOT COMPLETED|Overall Study||1
8950257|NCT02445573|10012808|FG001|NOT COMPLETED|Overall Study||2
8950258|NCT02445586|10012814|FG000|STARTED|Overall Study||52
8950259|NCT02445586|10012814|FG000|Received at Least One Dose of Study Drug|Overall Study||52
8950260|NCT02445586|10012814|FG000|COMPLETED|Overall Study||13
8950261|NCT02445586|10012814|FG000|NOT COMPLETED|Overall Study||39
8950262|NCT02445625|10012818|FG000|STARTED|Overall Study||15
8950263|NCT02445625|10012818|FG000|COMPLETED|Overall Study||15
8950264|NCT02445625|10012818|FG000|NOT COMPLETED|Overall Study||0
9037489|NCT03315286|10098671|FG001|NOT COMPLETED|Overall Study||4
8862349|NCT01822197|9917982|FG000|COMPLETED|Overall Study||30
8862350|NCT01822197|9917982|FG000|NOT COMPLETED|Overall Study||0
8862351|NCT01822223|9917988|FG000|STARTED|Overall Study||10
8862352|NCT01822223|9917989|FG001|STARTED|Overall Study||10
8862353|NCT01822223|9917988|FG000|COMPLETED|Overall Study||10
8862354|NCT01822223|9917989|FG001|COMPLETED|Overall Study||9
8862355|NCT01822223|9917988|FG000|NOT COMPLETED|Overall Study||0
8862356|NCT01822223|9917989|FG001|NOT COMPLETED|Overall Study||1
8862357|NCT01822301|9917997|FG000|STARTED|Overall Study||5
8862358|NCT01822301|9917997|FG000|COMPLETED|Overall Study||5
8862359|NCT01822301|9917997|FG000|NOT COMPLETED|Overall Study||0
8862360|NCT01822353|9918010|FG000|STARTED|Overall Study||10
8862361|NCT01822353|9918011|FG001|STARTED|Overall Study||9
8862362|NCT01822353|9918012|FG002|STARTED|Overall Study||4
8862363|NCT01822353|9918010|FG000|COMPLETED|Overall Study||6
8862364|NCT01822353|9918011|FG001|COMPLETED|Overall Study||4
8862365|NCT01822353|9918012|FG002|COMPLETED|Overall Study||3
8862366|NCT01822353|9918010|FG000|NOT COMPLETED|Overall Study||4
8862367|NCT01822353|9918011|FG001|NOT COMPLETED|Overall Study||5
8862368|NCT01822353|9918012|FG002|NOT COMPLETED|Overall Study||1
8862369|NCT01822366|9918027|FG000|STARTED|Overall Study||320
8862370|NCT01822366|9918028|FG001|STARTED|Overall Study||320
8862371|NCT01822366|9918029|FG002|STARTED|Overall Study||320
8862372|NCT01822366|9918030|FG003|STARTED|Overall Study||320
8862373|NCT01822366|9918027|FG000|COMPLETED|Overall Study||315
8862374|NCT01822366|9918028|FG001|COMPLETED|Overall Study||298
8862375|NCT01822366|9918029|FG002|COMPLETED|Overall Study||315
8862376|NCT01822366|9918030|FG003|COMPLETED|Overall Study||298
8862377|NCT01822366|9918027|FG000|NOT COMPLETED|Overall Study||5
8862378|NCT01822366|9918028|FG001|NOT COMPLETED|Overall Study||22
8862379|NCT01822366|9918029|FG002|NOT COMPLETED|Overall Study||5
8862380|NCT01822366|9918030|FG003|NOT COMPLETED|Overall Study||22
8862381|NCT01822457|9918060|FG000|STARTED|Overall Study||20
8862382|NCT01822457|9918061|FG001|STARTED|Overall Study||17
8862383|NCT01822457|9918060|FG000|COMPLETED|Overall Study||16
8862384|NCT01822457|9918061|FG001|COMPLETED|Overall Study||12
8862385|NCT01822457|9918060|FG000|NOT COMPLETED|Overall Study||4
8862386|NCT01822457|9918061|FG001|NOT COMPLETED|Overall Study||5
8862387|NCT01822496|9918071|FG000|STARTED|Overall Study||16
8862388|NCT01822496|9918072|FG001|STARTED|Overall Study||23
8862389|NCT01822496|9918073|FG002|STARTED|Overall Study||9
8862390|NCT01822496|9918074|FG003|STARTED|Overall Study||11
8862391|NCT01822496|9918071|FG000|Eligible|Overall Study||14
8862392|NCT01822496|9918072|FG001|Eligible|Overall Study||21
8862393|NCT01822496|9918073|FG002|Eligible|Overall Study||9
8862394|NCT01822496|9918074|FG003|Eligible|Overall Study||7
8862395|NCT01822496|9918071|FG000|Eligible With Disease Assessment|Overall Study||10
8862396|NCT01822496|9918072|FG001|Eligible With Disease Assessment|Overall Study||15
8862397|NCT01822496|9918073|FG002|Eligible With Disease Assessment|Overall Study||6
8862398|NCT01822496|9918074|FG003|Eligible With Disease Assessment|Overall Study||4
8862399|NCT01822496|9918071|FG000|Eligible and Started Study Treatment|Overall Study||14
8862400|NCT01822496|9918072|FG001|Eligible and Started Study Treatment|Overall Study||20
8862401|NCT01822496|9918073|FG002|Eligible and Started Study Treatment|Overall Study||9
8862402|NCT01822496|9918074|FG003|Eligible and Started Study Treatment|Overall Study||7
8862403|NCT01822496|9918071|FG000|COMPLETED|Overall Study||14
8862404|NCT01822496|9918072|FG001|COMPLETED|Overall Study||21
8862405|NCT01822496|9918073|FG002|COMPLETED|Overall Study||9
8630385|NCT00535132|9670185|FG001|COMPLETED|Intent-to-Treat (ITT) Analysis Set|Patients who received at least one dose of study drug and have some follow-up efficacy data.|96
8630386|NCT00535132|9670184|FG000|NOT COMPLETED|Intent-to-Treat (ITT) Analysis Set||3
8630387|NCT00535132|9670185|FG001|NOT COMPLETED|Intent-to-Treat (ITT) Analysis Set||3
8630388|NCT00535145|9670193|FG000|STARTED|Phase I||114
8862406|NCT01822496|9918074|FG003|COMPLETED|Overall Study||7
8862407|NCT01822496|9918071|FG000|NOT COMPLETED|Overall Study||2
8862408|NCT01822496|9918072|FG001|NOT COMPLETED|Overall Study||2
8862409|NCT01822496|9918073|FG002|NOT COMPLETED|Overall Study||0
8862410|NCT01822496|9918074|FG003|NOT COMPLETED|Overall Study||4
8862411|NCT01822535|9918086|FG000|STARTED|Visit 1 - Tetraplegia and Able-Bodied||17
8862412|NCT01822535|9918087|FG001|STARTED|Visit 1 - Tetraplegia and Able-Bodied||13
8862413|NCT01822535|9918086|FG000|COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||11
8862414|NCT01822535|9918087|FG001|COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||11
8862415|NCT01822535|9918086|FG000|NOT COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||6
8862416|NCT01822535|9918087|FG001|NOT COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||2
8862417|NCT01822535|9918086|FG000|STARTED|Visit 2 - Tetraplegia Only - Drug|These subjects were individuals who completed Visit 1 of testing.|11
8862418|NCT01822535|9918087|FG001|STARTED|Visit 2 - Tetraplegia Only - Drug|Able-bodied subjects were not enrolled for a second visit.|0
8862419|NCT01822535|9918086|FG000|COMPLETED|Visit 2 - Tetraplegia Only - Drug||10
8862420|NCT01822535|9918087|FG001|COMPLETED|Visit 2 - Tetraplegia Only - Drug||0
8862421|NCT01822535|9918086|FG000|NOT COMPLETED|Visit 2 - Tetraplegia Only - Drug||1
8862422|NCT01822535|9918087|FG001|NOT COMPLETED|Visit 2 - Tetraplegia Only - Drug||0
8862423|NCT01822548|9918098|FG000|STARTED|Overall Study|Received allocated intervention n=38 Did not receive allocated intervention (only metformin) n=2|40
8862424|NCT01822548|9918099|FG001|STARTED|Overall Study||24
8862425|NCT01822548|9918098|FG000|Discontinued Intervention|Overall Study||0
8862426|NCT01822548|9918099|FG001|Discontinued Intervention|Overall Study||5
8862427|NCT01822548|9918098|FG000|COMPLETED|Overall Study||40
8862428|NCT01822548|9918099|FG001|COMPLETED|Overall Study||24
8862429|NCT01822548|9918098|FG000|NOT COMPLETED|Overall Study||0
8862430|NCT01822548|9918099|FG001|NOT COMPLETED|Overall Study||0
8862431|NCT01822561|9918105|FG000|STARTED|Overall Study||15
8862432|NCT01822561|9918105|FG000|COMPLETED|Overall Study||13
8862433|NCT01822561|9918105|FG000|NOT COMPLETED|Overall Study||2
8862434|NCT01822574|9918116|FG000|STARTED|Overall Study||30
8862435|NCT01822574|9918117|FG001|STARTED|Overall Study||30
8862436|NCT01822574|9918118|FG002|STARTED|Overall Study||30
8862437|NCT01822574|9918116|FG000|COMPLETED|Overall Study||30
8862438|NCT01822574|9918117|FG001|COMPLETED|Overall Study||30
8862439|NCT01822574|9918118|FG002|COMPLETED|Overall Study||30
8862440|NCT01822574|9918116|FG000|NOT COMPLETED|Overall Study||0
8862441|NCT01822574|9918117|FG001|NOT COMPLETED|Overall Study||0
8862442|NCT01822574|9918118|FG002|NOT COMPLETED|Overall Study||0
8862443|NCT01822587|9918129|FG000|STARTED|Overall Study||59
8862444|NCT01822587|9918130|FG001|STARTED|Overall Study||60
8862445|NCT01822587|9918131|FG002|STARTED|Overall Study||62
8862446|NCT01822587|9918129|FG000|COMPLETED|Overall Study||43
8862447|NCT01822587|9918130|FG001|COMPLETED|Overall Study||45
8862448|NCT01822587|9918131|FG002|COMPLETED|Overall Study||44
8862449|NCT01822587|9918129|FG000|NOT COMPLETED|Overall Study||16
8862450|NCT01822587|9918130|FG001|NOT COMPLETED|Overall Study||15
8862451|NCT01822587|9918131|FG002|NOT COMPLETED|Overall Study||18
8862452|NCT01822665|9918139|FG000|STARTED|Overall Study||28
8862453|NCT01822665|9918139|FG000|Received Ibuprofen Tablet (400 mg)|Overall Study|5 participants did not complete; Period 3(2:adverse events;1:other reason); Period 4(2:other reason)|23
8862454|NCT01822665|9918139|FG000|Received Placebo Tablet|Overall Study|5 participants did not complete; Period 2(1:other reason); Period 4(3:adverse event; 1:other reason)|23
8862455|NCT01822665|9918139|FG000|Received Ibuprofen Capsule (400 mg)|Overall Study|Two participants, each in period 3 and period 4 did not complete treatment for 'other reason'.|24
8862456|NCT01822665|9918139|FG000|Received Paracetamol Tablet (1000 mg)|Overall Study||28
8862457|NCT01822665|9918139|FG000|COMPLETED|Overall Study||20
8862458|NCT01822665|9918139|FG000|NOT COMPLETED|Overall Study||8
8862459|NCT01822678|9918160|FG000|STARTED|Overall Study||57
8862460|NCT01822678|9918161|FG001|STARTED|Overall Study||64
8862461|NCT01822678|9918162|FG002|STARTED|Overall Study||40
8862462|NCT01822678|9918160|FG000|Treated|Overall Study||57
8862463|NCT01822678|9918161|FG001|Treated|Overall Study||64
8862464|NCT01822678|9918162|FG002|Treated|Overall Study||40
8862465|NCT01822678|9918160|FG000|Safety Population|Overall Study||57
8862466|NCT01822678|9918161|FG001|Safety Population|Overall Study||64
8862467|NCT01822678|9918162|FG002|Safety Population|Overall Study||40
8862468|NCT01822678|9918160|FG000|Intention-to-Treat Population (ITT)|Overall Study||57
8862469|NCT01822678|9918161|FG001|Intention-to-Treat Population (ITT)|Overall Study|1 patient was excluded from the ITT population because he did not have post baseline efficacy data|63
8862470|NCT01822678|9918162|FG002|Intention-to-Treat Population (ITT)|Overall Study||40
8862471|NCT01822678|9918160|FG000|Per Protocol Population|Overall Study||45
8862472|NCT01822678|9918161|FG001|Per Protocol Population|Overall Study||52
8862473|NCT01822678|9918162|FG002|Per Protocol Population|Overall Study||34
8862474|NCT01822678|9918160|FG000|COMPLETED|Overall Study||45
8862475|NCT01822678|9918161|FG001|COMPLETED|Overall Study||49
8862476|NCT01822678|9918162|FG002|COMPLETED|Overall Study||29
8862477|NCT01822678|9918160|FG000|NOT COMPLETED|Overall Study||12
8862478|NCT01822678|9918161|FG001|NOT COMPLETED|Overall Study||15
8862479|NCT01822678|9918162|FG002|NOT COMPLETED|Overall Study||11
8862480|NCT01822691|9918170|FG000|STARTED|Overall Study||15
8862481|NCT01822691|9918170|FG000|COMPLETED|Overall Study||13
8862482|NCT01822691|9918170|FG000|NOT COMPLETED|Overall Study||2
8862483|NCT01822756|9918179|FG000|STARTED|Overall Study||16
8862484|NCT01822756|9918180|FG001|STARTED|Overall Study||4
8862485|NCT01822756|9918181|FG002|STARTED|Overall Study||10
8862486|NCT01822756|9918182|FG003|STARTED|Overall Study||4
8862487|NCT01822756|9918183|FG004|STARTED|Overall Study||8
8862488|NCT01822756|9918179|FG000|Discontinued From the Study|Overall Study||16
8862489|NCT01822756|9918180|FG001|Discontinued From the Study|Overall Study||4
8862490|NCT01822756|9918181|FG002|Discontinued From the Study|Overall Study||10
8862491|NCT01822756|9918182|FG003|Discontinued From the Study|Overall Study||4
8862492|NCT01822756|9918183|FG004|Discontinued From the Study|Overall Study||7
8862493|NCT01822756|9918179|FG000|COMPLETED|Overall Study||0
8862494|NCT01822756|9918180|FG001|COMPLETED|Overall Study||0
8862495|NCT01822756|9918181|FG002|COMPLETED|Overall Study||0
8862496|NCT01822756|9918182|FG003|COMPLETED|Overall Study||0
8862497|NCT01822756|9918183|FG004|COMPLETED|Overall Study||1
8862498|NCT01822756|9918179|FG000|NOT COMPLETED|Overall Study||16
8862499|NCT01822756|9918180|FG001|NOT COMPLETED|Overall Study||4
8862500|NCT01822756|9918181|FG002|NOT COMPLETED|Overall Study||10
8862501|NCT01822756|9918182|FG003|NOT COMPLETED|Overall Study||4
8862502|NCT01822756|9918183|FG004|NOT COMPLETED|Overall Study||7
8862503|NCT01822821|9918197|FG000|STARTED|Overall Study||75
8862504|NCT01822821|9918198|FG001|STARTED|Overall Study||75
8862505|NCT01822821|9918197|FG000|COMPLETED|Overall Study||73
8862506|NCT01822821|9918198|FG001|COMPLETED|Overall Study||74
8862507|NCT01822821|9918197|FG000|NOT COMPLETED|Overall Study||2
8862508|NCT01822821|9918198|FG001|NOT COMPLETED|Overall Study||1
8862509|NCT01822886|9918204|FG000|STARTED|Overall Study||20
8862510|NCT01822886|9918204|FG000|COMPLETED|Overall Study||5
8862511|NCT01822886|9918204|FG000|NOT COMPLETED|Overall Study||15
8862512|NCT01822899|9918210|FG000|STARTED|Overall Study||358
8862513|NCT01822899|9918211|FG001|STARTED|Overall Study||358
8862514|NCT01822899|9918210|FG000|COMPLETED|Overall Study||334
8862515|NCT01822899|9918211|FG001|COMPLETED|Overall Study||340
8862516|NCT01822899|9918210|FG000|NOT COMPLETED|Overall Study||24
8862517|NCT01822899|9918211|FG001|NOT COMPLETED|Overall Study||18
8862518|NCT01822925|9918221|FG000|STARTED|Overall Study||32
8862519|NCT01822925|9918222|FG001|STARTED|Overall Study||32
8862520|NCT01822925|9918223|FG002|STARTED|Overall Study||32
8862521|NCT01822925|9918224|FG003|STARTED|Overall Study||32
8862522|NCT01822925|9918221|FG000|COMPLETED|Overall Study||26
8862523|NCT01822925|9918222|FG001|COMPLETED|Overall Study||30
8862524|NCT01822925|9918223|FG002|COMPLETED|Overall Study||29
8862525|NCT01822925|9918224|FG003|COMPLETED|Overall Study||27
8862526|NCT01822925|9918221|FG000|NOT COMPLETED|Overall Study||6
8862527|NCT01822925|9918222|FG001|NOT COMPLETED|Overall Study||2
8862528|NCT01822925|9918223|FG002|NOT COMPLETED|Overall Study||3
8862529|NCT01822925|9918224|FG003|NOT COMPLETED|Overall Study||5
8862530|NCT01823107|9918234|FG000|STARTED|Overall Study||25
8862531|NCT01823107|9918234|FG000|COMPLETED|Overall Study||24
8862532|NCT01823107|9918234|FG000|NOT COMPLETED|Overall Study||1
8862533|NCT01823146|9918240|FG000|STARTED|Overall Study||55
8862534|NCT01823146|9918241|FG001|STARTED|Overall Study||51
8862535|NCT01823146|9918240|FG000|COMPLETED|Overall Study||53
8862536|NCT01823146|9918241|FG001|COMPLETED|Overall Study||49
8862537|NCT01823146|9918240|FG000|NOT COMPLETED|Overall Study||2
8862538|NCT01823146|9918241|FG001|NOT COMPLETED|Overall Study||2
8862539|NCT01823224|9918249|FG000|STARTED|Overall Study||34
8862540|NCT01823224|9918250|FG001|STARTED|Overall Study||33
8862541|NCT01823224|9918249|FG000|COMPLETED|Overall Study||28
8862542|NCT01823224|9918250|FG001|COMPLETED|Overall Study||22
8862543|NCT01823224|9918249|FG000|NOT COMPLETED|Overall Study||6
8862544|NCT01823224|9918250|FG001|NOT COMPLETED|Overall Study||11
8862545|NCT01823289|9918258|FG000|STARTED|Overall Study||71
8862546|NCT01823289|9918258|FG000|COMPLETED|Overall Study||47
8950265|NCT02445755|10012823|FG000|STARTED|Overall Study|Neonates will be tested with 3 transcutaneous (TcB) devices +/-30 minutes of routine bilirubin labs|113
8950266|NCT02445755|10012823|FG000|COMPLETED|Overall Study||100
8950267|NCT02445755|10012823|FG000|NOT COMPLETED|Overall Study||13
8950268|NCT02445794|10012834|FG000|STARTED|Overall Study||6
8950269|NCT02445794|10012835|FG001|STARTED|Overall Study||3
8950270|NCT02445794|10012836|FG002|STARTED|Overall Study||7
8950271|NCT02445794|10012837|FG003|STARTED|Overall Study||3
8950272|NCT02445794|10012834|FG000|COMPLETED|Overall Study||6
8950273|NCT02445794|10012835|FG001|COMPLETED|Overall Study||3
8950274|NCT02445794|10012836|FG002|COMPLETED|Overall Study||5
8950275|NCT02445794|10012837|FG003|COMPLETED|Overall Study||3
8950276|NCT02445794|10012834|FG000|NOT COMPLETED|Overall Study||0
8950277|NCT02445794|10012835|FG001|NOT COMPLETED|Overall Study||0
8950278|NCT02445794|10012836|FG002|NOT COMPLETED|Overall Study||2
8950279|NCT02445794|10012837|FG003|NOT COMPLETED|Overall Study||0
8950280|NCT02445807|10012854|FG000|STARTED|Overall Study||176
8950281|NCT02445807|10012855|FG001|STARTED|Overall Study||89
8950282|NCT02445807|10012854|FG000|COMPLETED|Overall Study||176
8950283|NCT02445807|10012855|FG001|COMPLETED|Overall Study||89
8950284|NCT02445807|10012854|FG000|NOT COMPLETED|Overall Study||0
8950285|NCT02445807|10012855|FG001|NOT COMPLETED|Overall Study||0
8950286|NCT02445859|10012863|FG000|STARTED|Overall Study||45
8950287|NCT02445859|10012864|FG001|STARTED|Overall Study||45
8950288|NCT02445859|10012863|FG000|COMPLETED|Overall Study||43
8950289|NCT02445859|10012864|FG001|COMPLETED|Overall Study||42
8950290|NCT02445859|10012863|FG000|NOT COMPLETED|Overall Study||2
8950291|NCT02445859|10012864|FG001|NOT COMPLETED|Overall Study||3
8950292|NCT02445911|10012874|FG000|STARTED|Overall Study||20
8950293|NCT02445911|10012875|FG001|STARTED|Overall Study||20
8950294|NCT02445911|10012876|FG002|STARTED|Overall Study||21
8950295|NCT02445911|10012877|FG003|STARTED|Overall Study||20
8950296|NCT02445911|10012874|FG000|COMPLETED|Overall Study||20
8950297|NCT02445911|10012875|FG001|COMPLETED|Overall Study||20
8950298|NCT02445911|10012876|FG002|COMPLETED|Overall Study||21
8950299|NCT02445911|10012877|FG003|COMPLETED|Overall Study||20
8950300|NCT02445911|10012874|FG000|NOT COMPLETED|Overall Study||0
8950301|NCT02445911|10012875|FG001|NOT COMPLETED|Overall Study||0
8950302|NCT02445911|10012876|FG002|NOT COMPLETED|Overall Study||0
8950303|NCT02445911|10012877|FG003|NOT COMPLETED|Overall Study||0
8950304|NCT02445963|10012891|FG000|STARTED|Overall Study||9
8950305|NCT02445963|10012892|FG001|STARTED|Overall Study||9
8950306|NCT02445963|10012893|FG002|STARTED|Overall Study||10
8950307|NCT02445963|10012894|FG003|STARTED|Overall Study||10
8950308|NCT02445963|10012891|FG000|COMPLETED|Overall Study||7
8950309|NCT02445963|10012892|FG001|COMPLETED|Overall Study||9
8950310|NCT02445963|10012893|FG002|COMPLETED|Overall Study||9
8950311|NCT02445963|10012894|FG003|COMPLETED|Overall Study||10
8950312|NCT02445963|10012891|FG000|NOT COMPLETED|Overall Study||2
8950313|NCT02445963|10012892|FG001|NOT COMPLETED|Overall Study||0
8630389|NCT00535145|9670193|FG000|COMPLETED|Phase I||85
8630390|NCT00535145|9670193|FG000|NOT COMPLETED|Phase I||29
8630391|NCT00535145|9670193|FG000|STARTED|Phase II|Of the 85 participants who completed Phase 1, 84 met the criteria to enroll into Phase 2|84
8630392|NCT00535145|9670193|FG000|COMPLETED|Phase II||69
8630393|NCT00535145|9670193|FG000|NOT COMPLETED|Phase II||15
8630394|NCT00535223|9670203|FG000|STARTED|Overall Study|Patients were randomized in cohorts of ten.|41
8630395|NCT00535223|9670204|FG001|STARTED|Overall Study|Patients were randomized in cohorts of ten.|40
8630396|NCT00535223|9670203|FG000|COMPLETED|Overall Study||37
8630397|NCT00535223|9670204|FG001|COMPLETED|Overall Study||39
8630398|NCT00535223|9670203|FG000|NOT COMPLETED|Overall Study||4
8630399|NCT00535223|9670204|FG001|NOT COMPLETED|Overall Study||1
8630400|NCT00535236|9670220|FG000|STARTED|Overall Study||40
8630401|NCT00535236|9670221|FG001|STARTED|Overall Study||10
8630402|NCT00535236|9670222|FG002|STARTED|Overall Study||41
8630403|NCT00535236|9670223|FG003|STARTED|Overall Study||10
8630404|NCT00535236|9670224|FG004|STARTED|Overall Study||59
8630405|NCT00535236|9670225|FG005|STARTED|Overall Study||20
8630406|NCT00535236|9670226|FG006|STARTED|Overall Study||62
8630407|NCT00535236|9670227|FG007|STARTED|Overall Study||19
8725597|NCT01032291|9772887|FG000|NOT COMPLETED|Safety Lead-in||2
8725598|NCT01032291|9772888|FG001|NOT COMPLETED|Safety Lead-in||0
8725599|NCT01032291|9772889|FG002|NOT COMPLETED|Safety Lead-in||0
8725600|NCT01032291|9772887|FG000|STARTED|Proof of Concept||0
8725601|NCT01032291|9772888|FG001|STARTED|Proof of Concept||22
8725602|NCT01032291|9772889|FG002|STARTED|Proof of Concept||21
8725603|NCT01032291|9772887|FG000|Intent to Treat and Safety Populations|Proof of Concept||0
8725604|NCT01032291|9772888|FG001|Intent to Treat and Safety Populations|Proof of Concept|Participants who took at least one dose of study drug|21
8725605|NCT01032291|9772889|FG002|Intent to Treat and Safety Populations|Proof of Concept|Participants who took at least one dose of study drug|21
8725606|NCT01032291|9772887|FG000|COMPLETED|Proof of Concept||0
8725607|NCT01032291|9772888|FG001|COMPLETED|Proof of Concept|Participants with disease progression|14
8950314|NCT02445963|10012893|FG002|NOT COMPLETED|Overall Study||1
8950315|NCT02445963|10012894|FG003|NOT COMPLETED|Overall Study||0
8950316|NCT02446015|10012908|FG000|STARTED|Overall Study||34
8950317|NCT02446015|10012909|FG001|STARTED|Overall Study||63
8950318|NCT02446015|10012908|FG000|COMPLETED|Overall Study||33
8950319|NCT02446015|10012909|FG001|COMPLETED|Overall Study||62
8950320|NCT02446015|10012908|FG000|NOT COMPLETED|Overall Study||1
8950321|NCT02446015|10012909|FG001|NOT COMPLETED|Overall Study||1
8630408|NCT00535236|9670228|FG008|STARTED|Overall Study||60
8862547|NCT01823289|9918258|FG000|NOT COMPLETED|Overall Study||24
8862548|NCT01823328|9918264|FG000|STARTED|Overall Study||70
8862549|NCT01823328|9918265|FG001|STARTED|Overall Study||73
8862550|NCT01823328|9918264|FG000|COMPLETED|Overall Study||62
8862551|NCT01823328|9918265|FG001|COMPLETED|Overall Study||67
8862552|NCT01823328|9918264|FG000|NOT COMPLETED|Overall Study||8
8862553|NCT01823328|9918265|FG001|NOT COMPLETED|Overall Study||6
8862554|NCT01823341|9918271|FG000|STARTED|Overall Study||97
8862555|NCT01823341|9918271|FG000|COMPLETED|Overall Study||82
8862556|NCT01823341|9918271|FG000|NOT COMPLETED|Overall Study||15
8862557|NCT01823497|9918280|FG000|STARTED|Overall Study||19
8862558|NCT01823497|9918281|FG001|STARTED|Overall Study||17
8862559|NCT01823497|9918280|FG000|COMPLETED|Overall Study||16
8862560|NCT01823497|9918281|FG001|COMPLETED|Overall Study||9
8862561|NCT01823497|9918280|FG000|NOT COMPLETED|Overall Study||3
8862562|NCT01823497|9918281|FG001|NOT COMPLETED|Overall Study||8
8862563|NCT01823510|9918287|FG000|STARTED|Days 1-7||10
8862564|NCT01823510|9918288|FG001|STARTED|Days 1-7||10
8862565|NCT01823510|9918287|FG000|COMPLETED|Days 1-7||10
8862566|NCT01823510|9918288|FG001|COMPLETED|Days 1-7||10
8862567|NCT01823510|9918287|FG000|NOT COMPLETED|Days 1-7||0
8862568|NCT01823510|9918288|FG001|NOT COMPLETED|Days 1-7||0
8862569|NCT01823510|9918287|FG000|STARTED|Days 8-21||10
8862570|NCT01823510|9918288|FG001|STARTED|Days 8-21||10
8862571|NCT01823510|9918287|FG000|COMPLETED|Days 8-21||10
8862572|NCT01823510|9918288|FG001|COMPLETED|Days 8-21||10
8862573|NCT01823510|9918287|FG000|NOT COMPLETED|Days 8-21||0
8862574|NCT01823510|9918288|FG001|NOT COMPLETED|Days 8-21||0
8862575|NCT01823510|9918287|FG000|STARTED|Days 22-28||10
8862576|NCT01823510|9918288|FG001|STARTED|Days 22-28||10
8950322|NCT02446171|10012920|FG000|STARTED|Overall Study||11
8950323|NCT02446171|10012921|FG001|STARTED|Overall Study||11
8950324|NCT02446171|10012922|FG002|STARTED|Overall Study||11
8950325|NCT02446171|10012923|FG003|STARTED|Overall Study||11
8950326|NCT02446171|10012920|FG000|COMPLETED|Overall Study||11
8950327|NCT02446171|10012921|FG001|COMPLETED|Overall Study||11
8950328|NCT02446171|10012922|FG002|COMPLETED|Overall Study||9
8950329|NCT02446171|10012923|FG003|COMPLETED|Overall Study||11
8950330|NCT02446171|10012920|FG000|NOT COMPLETED|Overall Study||0
8950331|NCT02446171|10012921|FG001|NOT COMPLETED|Overall Study||0
8950332|NCT02446171|10012922|FG002|NOT COMPLETED|Overall Study||2
8950333|NCT02446171|10012923|FG003|NOT COMPLETED|Overall Study||0
8950334|NCT02446223|10012935|FG000|STARTED|Overall Study||21
8950335|NCT02446223|10012935|FG000|COMPLETED|Overall Study||20
8950336|NCT02446223|10012935|FG000|NOT COMPLETED|Overall Study||1
8950337|NCT02446314|10012943|FG000|STARTED|Zero to Twelve Weeks.||30
8950338|NCT02446314|10012944|FG001|STARTED|Zero to Twelve Weeks.||30
8950339|NCT02446314|10012945|FG002|STARTED|Zero to Twelve Weeks.||31
8950340|NCT02446314|10012946|FG003|STARTED|Zero to Twelve Weeks.||31
8950341|NCT02446314|10012943|FG000|COMPLETED|Zero to Twelve Weeks.||27
8950342|NCT02446314|10012944|FG001|COMPLETED|Zero to Twelve Weeks.||29
8950343|NCT02446314|10012945|FG002|COMPLETED|Zero to Twelve Weeks.||31
8950344|NCT02446314|10012946|FG003|COMPLETED|Zero to Twelve Weeks.||29
8950345|NCT02446314|10012943|FG000|NOT COMPLETED|Zero to Twelve Weeks.||3
8950346|NCT02446314|10012944|FG001|NOT COMPLETED|Zero to Twelve Weeks.||1
8950347|NCT02446314|10012945|FG002|NOT COMPLETED|Zero to Twelve Weeks.||0
8950348|NCT02446314|10012946|FG003|NOT COMPLETED|Zero to Twelve Weeks.||2
8950349|NCT02446314|10012943|FG000|STARTED|Thirteen to Twenty Four Weeks||27
8950350|NCT02446314|10012944|FG001|STARTED|Thirteen to Twenty Four Weeks||29
8950351|NCT02446314|10012945|FG002|STARTED|Thirteen to Twenty Four Weeks||31
8950352|NCT02446314|10012946|FG003|STARTED|Thirteen to Twenty Four Weeks||29
8950353|NCT02446314|10012943|FG000|COMPLETED|Thirteen to Twenty Four Weeks||27
8950354|NCT02446314|10012944|FG001|COMPLETED|Thirteen to Twenty Four Weeks||28
8950355|NCT02446314|10012945|FG002|COMPLETED|Thirteen to Twenty Four Weeks||29
8950356|NCT02446314|10012946|FG003|COMPLETED|Thirteen to Twenty Four Weeks||28
8950357|NCT02446314|10012943|FG000|NOT COMPLETED|Thirteen to Twenty Four Weeks||0
8950358|NCT02446314|10012944|FG001|NOT COMPLETED|Thirteen to Twenty Four Weeks||1
8950359|NCT02446314|10012945|FG002|NOT COMPLETED|Thirteen to Twenty Four Weeks||2
8950360|NCT02446314|10012946|FG003|NOT COMPLETED|Thirteen to Twenty Four Weeks||1
8950361|NCT02446418|10012962|FG000|STARTED|Overall Study||210
8950362|NCT02446418|10012963|FG001|STARTED|Overall Study||210
8950363|NCT02446418|10012962|FG000|COMPLETED|Overall Study||192
8950364|NCT02446418|10012963|FG001|COMPLETED|Overall Study||194
8950365|NCT02446418|10012962|FG000|NOT COMPLETED|Overall Study||18
8950366|NCT02446418|10012963|FG001|NOT COMPLETED|Overall Study||16
8950367|NCT02446483|10012969|FG000|STARTED|Period 1: Intervention Period 1||30
8950368|NCT02446483|10012970|FG001|STARTED|Period 1: Intervention Period 1||30
8950369|NCT02446483|10012969|FG000|COMPLETED|Period 1: Intervention Period 1||30
8950370|NCT02446483|10012970|FG001|COMPLETED|Period 1: Intervention Period 1||30
8862577|NCT01823510|9918287|FG000|COMPLETED|Days 22-28||10
8862578|NCT01823510|9918288|FG001|COMPLETED|Days 22-28||10
8862579|NCT01823510|9918287|FG000|NOT COMPLETED|Days 22-28||0
8862580|NCT01823510|9918288|FG001|NOT COMPLETED|Days 22-28||0
8862581|NCT01823536|9918300|FG000|STARTED|Overall Study||73
8862582|NCT01823536|9918301|FG001|STARTED|Overall Study||103
8862583|NCT01823536|9918302|FG002|STARTED|Overall Study||120
8862584|NCT01823536|9918303|FG003|STARTED|Overall Study||66
8862585|NCT01823536|9918304|FG004|STARTED|Overall Study||101
8862586|NCT01823536|9918305|FG005|STARTED|Overall Study||2
8862587|NCT01823536|9918300|FG000|COMPLETED|Overall Study||71
8862588|NCT01823536|9918301|FG001|COMPLETED|Overall Study||101
8862589|NCT01823536|9918302|FG002|COMPLETED|Overall Study||119
8862590|NCT01823536|9918303|FG003|COMPLETED|Overall Study||64
8862591|NCT01823536|9918304|FG004|COMPLETED|Overall Study||99
8862592|NCT01823536|9918305|FG005|COMPLETED|Overall Study||2
8862593|NCT01823536|9918300|FG000|NOT COMPLETED|Overall Study||2
8862594|NCT01823536|9918301|FG001|NOT COMPLETED|Overall Study||2
8862595|NCT01823536|9918302|FG002|NOT COMPLETED|Overall Study||1
8862596|NCT01823536|9918303|FG003|NOT COMPLETED|Overall Study||2
8862597|NCT01823536|9918304|FG004|NOT COMPLETED|Overall Study||2
8862598|NCT01823536|9918305|FG005|NOT COMPLETED|Overall Study||0
8862599|NCT01823614|9918324|FG000|STARTED|Overall Study||179
8862600|NCT01823614|9918325|FG001|STARTED|Overall Study||140
8862601|NCT01823614|9918326|FG002|STARTED|Overall Study||176
8862602|NCT01823614|9918327|FG003|STARTED|Overall Study||122
8862603|NCT01823614|9918328|FG004|STARTED|Overall Study||172
8862604|NCT01823614|9918329|FG005|STARTED|Overall Study||154
8862605|NCT01823614|9918324|FG000|COMPLETED|Overall Study||179
8862606|NCT01823614|9918325|FG001|COMPLETED|Overall Study||140
8862607|NCT01823614|9918326|FG002|COMPLETED|Overall Study||176
8862608|NCT01823614|9918327|FG003|COMPLETED|Overall Study||122
8862609|NCT01823614|9918328|FG004|COMPLETED|Overall Study||172
8862610|NCT01823614|9918329|FG005|COMPLETED|Overall Study||154
8862611|NCT01823614|9918324|FG000|NOT COMPLETED|Overall Study||0
8862612|NCT01823614|9918325|FG001|NOT COMPLETED|Overall Study||0
8862613|NCT01823614|9918326|FG002|NOT COMPLETED|Overall Study||0
8862614|NCT01823614|9918327|FG003|NOT COMPLETED|Overall Study||0
8862615|NCT01823614|9918328|FG004|NOT COMPLETED|Overall Study||0
8862616|NCT01823614|9918329|FG005|NOT COMPLETED|Overall Study||0
8950371|NCT02446483|10012969|FG000|NOT COMPLETED|Period 1: Intervention Period 1||0
8950372|NCT02446483|10012970|FG001|NOT COMPLETED|Period 1: Intervention Period 1||0
8950373|NCT02446483|10012969|FG000|STARTED|Period 2: Washout Period (7 Days)||30
8950374|NCT02446483|10012970|FG001|STARTED|Period 2: Washout Period (7 Days)||30
8950375|NCT02446483|10012969|FG000|COMPLETED|Period 2: Washout Period (7 Days)||30
8950376|NCT02446483|10012970|FG001|COMPLETED|Period 2: Washout Period (7 Days)||30
8950377|NCT02446483|10012969|FG000|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
8950378|NCT02446483|10012970|FG001|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
8950379|NCT02446483|10012969|FG000|STARTED|Period 3: Intervention Period 2||30
8950380|NCT02446483|10012970|FG001|STARTED|Period 3: Intervention Period 2||30
8950381|NCT02446483|10012969|FG000|COMPLETED|Period 3: Intervention Period 2||30
8950382|NCT02446483|10012970|FG001|COMPLETED|Period 3: Intervention Period 2||30
8950383|NCT02446483|10012969|FG000|NOT COMPLETED|Period 3: Intervention Period 2||0
8950384|NCT02446483|10012970|FG001|NOT COMPLETED|Period 3: Intervention Period 2||0
8950385|NCT02446496|10012976|FG000|STARTED|Overall Study||24
8950386|NCT02446496|10012976|FG000|COMPLETED|Overall Study||24
8950387|NCT02446496|10012976|FG000|NOT COMPLETED|Overall Study||0
8950388|NCT02446613|10012984|FG000|STARTED|Overall Study||6
8950389|NCT02446613|10012985|FG001|STARTED|Overall Study||10
8950390|NCT02446613|10012984|FG000|COMPLETED|Overall Study||6
8950391|NCT02446613|10012985|FG001|COMPLETED|Overall Study||10
8950392|NCT02446613|10012984|FG000|NOT COMPLETED|Overall Study||0
8950393|NCT02446613|10012985|FG001|NOT COMPLETED|Overall Study||0
8950394|NCT02446691|10012995|FG000|STARTED|Overall Study||128
8950395|NCT02446691|10012995|FG000|COMPLETED|Overall Study||117
8950396|NCT02446691|10012995|FG000|NOT COMPLETED|Overall Study||11
8950397|NCT02446717|10013004|FG000|STARTED|Overall Study||6
8950398|NCT02446717|10013005|FG001|STARTED|Overall Study||22
8950399|NCT02446717|10013006|FG002|STARTED|Overall Study||22
8950400|NCT02446717|10013007|FG003|STARTED|Overall Study||44
8950401|NCT02446717|10013008|FG004|STARTED|Overall Study||47
8950402|NCT02446717|10013004|FG000|COMPLETED|Overall Study||6
8950403|NCT02446717|10013005|FG001|COMPLETED|Overall Study||21
8950404|NCT02446717|10013006|FG002|COMPLETED|Overall Study||20
8950405|NCT02446717|10013007|FG003|COMPLETED|Overall Study||43
8950406|NCT02446717|10013008|FG004|COMPLETED|Overall Study||46
8950407|NCT02446717|10013004|FG000|NOT COMPLETED|Overall Study||0
8950408|NCT02446717|10013005|FG001|NOT COMPLETED|Overall Study||1
8950409|NCT02446717|10013006|FG002|NOT COMPLETED|Overall Study||2
8950410|NCT02446717|10013007|FG003|NOT COMPLETED|Overall Study||1
8950411|NCT02446717|10013008|FG004|NOT COMPLETED|Overall Study||1
8950412|NCT02446743|10013022|FG000|STARTED|Overall Study||276
8950413|NCT02446743|10013023|FG001|STARTED|Overall Study||255
8950414|NCT02446743|10013022|FG000|COMPLETED|Overall Study||271
8862617|NCT01823653|9918349|FG000|STARTED|Overall Study||60
8862618|NCT01823653|9918349|FG000|COMPLETED|Overall Study||60
8862619|NCT01823653|9918349|FG000|NOT COMPLETED|Overall Study||0
8862620|NCT01823679|9918356|FG000|STARTED|Overall Study||2
8950415|NCT02446743|10013023|FG001|COMPLETED|Overall Study||250
8950416|NCT02446743|10013022|FG000|NOT COMPLETED|Overall Study||5
8950417|NCT02446743|10013023|FG001|NOT COMPLETED|Overall Study||5
8862621|NCT01823679|9918356|FG000|COMPLETED|Overall Study||1
8862622|NCT01823679|9918356|FG000|NOT COMPLETED|Overall Study||1
8862623|NCT01823835|9918376|FG000|STARTED|Overall Study||3
8862624|NCT01823835|9918377|FG001|STARTED|Overall Study||4
8862625|NCT01823835|9918378|FG002|STARTED|Overall Study||4
8862626|NCT01823835|9918379|FG003|STARTED|Overall Study||6
8862627|NCT01823835|9918380|FG004|STARTED|Overall Study||6
8862628|NCT01823835|9918381|FG005|STARTED|Overall Study||6
8862629|NCT01823835|9918382|FG006|STARTED|Overall Study||6
8862630|NCT01823835|9918383|FG007|STARTED|Overall Study||3
8862631|NCT01823835|9918384|FG008|STARTED|Overall Study||3
8862632|NCT01823835|9918385|FG009|STARTED|Overall Study||19
8862633|NCT01823835|9918386|FG010|STARTED|Overall Study||10
8862634|NCT01823835|9918387|FG011|STARTED|Overall Study||53
8862635|NCT01823835|9918388|FG012|STARTED|Overall Study||19
8862636|NCT01823835|9918389|FG013|STARTED|Overall Study||4
8862637|NCT01823835|9918390|FG014|STARTED|Overall Study||6
8862638|NCT01823835|9918376|FG000|COMPLETED|Overall Study||0
8862639|NCT01823835|9918377|FG001|COMPLETED|Overall Study||0
8862640|NCT01823835|9918378|FG002|COMPLETED|Overall Study||0
8862641|NCT01823835|9918379|FG003|COMPLETED|Overall Study||0
8862642|NCT01823835|9918380|FG004|COMPLETED|Overall Study||0
8862643|NCT01823835|9918381|FG005|COMPLETED|Overall Study||0
8862644|NCT01823835|9918382|FG006|COMPLETED|Overall Study||0
8862645|NCT01823835|9918383|FG007|COMPLETED|Overall Study||0
8862646|NCT01823835|9918384|FG008|COMPLETED|Overall Study||0
8862647|NCT01823835|9918385|FG009|COMPLETED|Overall Study||0
8862648|NCT01823835|9918386|FG010|COMPLETED|Overall Study||0
8862649|NCT01823835|9918387|FG011|COMPLETED|Overall Study||0
8862650|NCT01823835|9918388|FG012|COMPLETED|Overall Study||0
8862651|NCT01823835|9918389|FG013|COMPLETED|Overall Study||0
8569705|NCT00098306|9601866|FG001|COMPLETED|Observational Phase||0
8569706|NCT00098306|9601867|FG002|COMPLETED|Observational Phase||0
8569707|NCT00098306|9601868|FG003|COMPLETED|Observational Phase||0
8569708|NCT00098306|9601869|FG004|COMPLETED|Observational Phase||0
8569709|NCT00098306|9601870|FG005|COMPLETED|Observational Phase||204
8569710|NCT00098306|9601871|FG006|COMPLETED|Observational Phase||55
8569711|NCT00098306|9601865|FG000|NOT COMPLETED|Observational Phase||0
8569712|NCT00098306|9601866|FG001|NOT COMPLETED|Observational Phase||0
8569713|NCT00098306|9601867|FG002|NOT COMPLETED|Observational Phase||0
8569714|NCT00098306|9601868|FG003|NOT COMPLETED|Observational Phase||0
8569715|NCT00098306|9601869|FG004|NOT COMPLETED|Observational Phase||0
8569716|NCT00098306|9601870|FG005|NOT COMPLETED|Observational Phase||46
8569717|NCT00098306|9601871|FG006|NOT COMPLETED|Observational Phase||26
8569718|NCT00098345|9601884|FG000|STARTED|Overall Study||30
8569719|NCT00098345|9601884|FG000|COMPLETED|Overall Study|ongoing study treatment at data cut-off|17
8569720|NCT00098345|9601884|FG000|NOT COMPLETED|Overall Study||13
8569721|NCT00098371|9601888|FG000|STARTED|Overall Study||64
8569722|NCT00098371|9601888|FG000|COMPLETED|Overall Study||64
8569723|NCT00098371|9601888|FG000|NOT COMPLETED|Overall Study||0
8569724|NCT00098670|9601903|FG000|STARTED|Overall Study||102
8569725|NCT00098670|9601903|FG000|COMPLETED|Overall Study||102
8569726|NCT00098670|9601903|FG000|NOT COMPLETED|Overall Study||0
8569727|NCT00098722|9601911|FG000|STARTED|Double Blind Phase||186
8630409|NCT00535236|9670229|FG009|STARTED|Overall Study||20
8862652|NCT01823835|9918390|FG014|COMPLETED|Overall Study||0
8569728|NCT00098722|9601912|FG001|STARTED|Double Blind Phase||194
8569729|NCT00098722|9601913|FG002|STARTED|Double Blind Phase||94
8569730|NCT00098722|9601914|FG003|STARTED|Double Blind Phase||0
8569731|NCT00098722|9601915|FG004|STARTED|Double Blind Phase||0
8569732|NCT00098722|9601916|FG005|STARTED|Double Blind Phase||0
8630410|NCT00535236|9670220|FG000|Vaccination 1|Overall Study||40
8630411|NCT00535236|9670221|FG001|Vaccination 1|Overall Study||10
8862653|NCT01823835|9918376|FG000|NOT COMPLETED|Overall Study||3
8862654|NCT01823835|9918377|FG001|NOT COMPLETED|Overall Study||4
8862655|NCT01823835|9918378|FG002|NOT COMPLETED|Overall Study||4
8862656|NCT01823835|9918379|FG003|NOT COMPLETED|Overall Study||6
8862657|NCT01823835|9918380|FG004|NOT COMPLETED|Overall Study||6
8862658|NCT01823835|9918381|FG005|NOT COMPLETED|Overall Study||6
8630412|NCT00535236|9670222|FG002|Vaccination 1|Overall Study||40
8630413|NCT00535236|9670223|FG003|Vaccination 1|Overall Study||10
8630414|NCT00535236|9670224|FG004|Vaccination 1|Overall Study||58
8630415|NCT00535236|9670225|FG005|Vaccination 1|Overall Study||19
8630416|NCT00535236|9670226|FG006|Vaccination 1|Overall Study||61
8630417|NCT00535236|9670227|FG007|Vaccination 1|Overall Study||19
8862659|NCT01823835|9918382|FG006|NOT COMPLETED|Overall Study||6
8862660|NCT01823835|9918383|FG007|NOT COMPLETED|Overall Study||3
8862661|NCT01823835|9918384|FG008|NOT COMPLETED|Overall Study||3
8862662|NCT01823835|9918385|FG009|NOT COMPLETED|Overall Study||19
8862663|NCT01823835|9918386|FG010|NOT COMPLETED|Overall Study||10
8862664|NCT01823835|9918387|FG011|NOT COMPLETED|Overall Study||53
8862665|NCT01823835|9918388|FG012|NOT COMPLETED|Overall Study||19
8862666|NCT01823835|9918389|FG013|NOT COMPLETED|Overall Study||4
8862667|NCT01823835|9918390|FG014|NOT COMPLETED|Overall Study||6
8862668|NCT01823861|9918432|FG000|STARTED|4 Month Follow up||249
8862669|NCT01823861|9918433|FG001|STARTED|4 Month Follow up||251
8862670|NCT01823861|9918432|FG000|COMPLETED|4 Month Follow up||211
8862671|NCT01823861|9918433|FG001|COMPLETED|4 Month Follow up||220
8862672|NCT01823861|9918432|FG000|NOT COMPLETED|4 Month Follow up||38
8862673|NCT01823861|9918433|FG001|NOT COMPLETED|4 Month Follow up||31
8862674|NCT01823861|9918432|FG000|STARTED|12 Month Follow up||211
8862675|NCT01823861|9918433|FG001|STARTED|12 Month Follow up||220
8862676|NCT01823861|9918432|FG000|COMPLETED|12 Month Follow up||169
8862677|NCT01823861|9918433|FG001|COMPLETED|12 Month Follow up||159
8950418|NCT02446769|10013038|FG000|STARTED|Screening Period||18
8950419|NCT02446769|10013039|FG001|STARTED|Screening Period||0
8950420|NCT02446769|10013040|FG002|STARTED|Screening Period||0
8950421|NCT02446769|10013038|FG000|COMPLETED|Screening Period||7
8950422|NCT02446769|10013039|FG001|COMPLETED|Screening Period||0
8950423|NCT02446769|10013040|FG002|COMPLETED|Screening Period||0
8950424|NCT02446769|10013038|FG000|NOT COMPLETED|Screening Period||11
8950425|NCT02446769|10013039|FG001|NOT COMPLETED|Screening Period||0
8950426|NCT02446769|10013040|FG002|NOT COMPLETED|Screening Period||0
8950427|NCT02446769|10013038|FG000|STARTED|Study Period||0
8950428|NCT02446769|10013039|FG001|STARTED|Study Period||4
8950429|NCT02446769|10013040|FG002|STARTED|Study Period||3
8950430|NCT02446769|10013038|FG000|COMPLETED|Study Period||0
8950431|NCT02446769|10013039|FG001|COMPLETED|Study Period||2
8950432|NCT02446769|10013040|FG002|COMPLETED|Study Period||3
8950433|NCT02446769|10013038|FG000|NOT COMPLETED|Study Period||0
8950434|NCT02446769|10013039|FG001|NOT COMPLETED|Study Period||2
8950435|NCT02446769|10013040|FG002|NOT COMPLETED|Study Period||0
8950436|NCT02446847|10013049|FG000|STARTED|Overall Study||8
8950437|NCT02446847|10013050|FG001|STARTED|Overall Study||8
8950438|NCT02446847|10013049|FG000|COMPLETED|Overall Study||8
8950439|NCT02446847|10013050|FG001|COMPLETED|Overall Study||6
8950440|NCT02446847|10013049|FG000|NOT COMPLETED|Overall Study||0
8950441|NCT02446847|10013050|FG001|NOT COMPLETED|Overall Study||2
8950442|NCT02446886|10013058|FG000|STARTED|Overall Study||8
8950443|NCT02446886|10013059|FG001|STARTED|Overall Study||7
8950444|NCT02446886|10013058|FG000|COMPLETED|Overall Study||6
8950445|NCT02446886|10013059|FG001|COMPLETED|Overall Study||3
8950446|NCT02446886|10013058|FG000|NOT COMPLETED|Overall Study||2
8950447|NCT02446886|10013059|FG001|NOT COMPLETED|Overall Study||4
8950448|NCT02446899|10013068|FG000|STARTED|Overall Study||181
8950449|NCT02446899|10013069|FG001|STARTED|Overall Study||184
8950450|NCT02446899|10013068|FG000|Received Study Drug|Overall Study||180
8950451|NCT02446899|10013069|FG001|Received Study Drug|Overall Study||182
8950452|NCT02446899|10013068|FG000|COMPLETED|Overall Study||156
8950453|NCT02446899|10013069|FG001|COMPLETED|Overall Study||136
8950454|NCT02446899|10013068|FG000|NOT COMPLETED|Overall Study||25
8950455|NCT02446899|10013069|FG001|NOT COMPLETED|Overall Study||48
8950456|NCT02446912|10013078|FG000|STARTED|Overall Study||93
8950457|NCT02446912|10013079|FG001|STARTED|Overall Study||180
8950458|NCT02446912|10013080|FG002|STARTED|Overall Study||184
8950459|NCT02446912|10013078|FG000|Participants Who Completed Week 52|Overall Study||80
8950460|NCT02446912|10013079|FG001|Participants Who Completed Week 52|Overall Study||153
8630418|NCT00535236|9670228|FG008|Vaccination 1|Overall Study||60
8630419|NCT00535236|9670229|FG009|Vaccination 1|Overall Study||20
8862678|NCT01823861|9918432|FG000|NOT COMPLETED|12 Month Follow up||42
8950461|NCT02446912|10013080|FG002|Participants Who Completed Week 52|Overall Study||157
8950462|NCT02446912|10013078|FG000|COMPLETED|Overall Study||75
8950463|NCT02446912|10013079|FG001|COMPLETED|Overall Study||145
8950464|NCT02446912|10013080|FG002|COMPLETED|Overall Study||149
8950465|NCT02446912|10013078|FG000|NOT COMPLETED|Overall Study||18
8950466|NCT02446912|10013079|FG001|NOT COMPLETED|Overall Study||35
8950467|NCT02446912|10013080|FG002|NOT COMPLETED|Overall Study||35
8950468|NCT02446990|10013090|FG000|STARTED|Overall Study||9550
8630420|NCT00535236|9670220|FG000|Vaccination 2|Overall Study||35
8630421|NCT00535236|9670221|FG001|Vaccination 2|Overall Study||10
8630422|NCT00535236|9670222|FG002|Vaccination 2|Overall Study||37
8630423|NCT00535236|9670223|FG003|Vaccination 2|Overall Study||8
8630424|NCT00535236|9670224|FG004|Vaccination 2|Overall Study||52
8630425|NCT00535236|9670225|FG005|Vaccination 2|Overall Study||19
8630426|NCT00535236|9670226|FG006|Vaccination 2|Overall Study||58
8630427|NCT00535236|9670227|FG007|Vaccination 2|Overall Study||19
8630428|NCT00535236|9670228|FG008|Vaccination 2|Overall Study||57
8630429|NCT00535236|9670229|FG009|Vaccination 2|Overall Study||19
8630430|NCT00535236|9670220|FG000|Vaccination 3|Overall Study||34
8862679|NCT01823861|9918433|FG001|NOT COMPLETED|12 Month Follow up||61
8862680|NCT01823991|9918441|FG000|STARTED|Overall Study||18
8862681|NCT01823991|9918442|FG001|STARTED|Overall Study||18
8862682|NCT01823991|9918441|FG000|COMPLETED|Overall Study||10
8862683|NCT01823991|9918442|FG001|COMPLETED|Overall Study||13
8862684|NCT01823991|9918441|FG000|NOT COMPLETED|Overall Study||8
8862685|NCT01823991|9918442|FG001|NOT COMPLETED|Overall Study||5
8862686|NCT01824082|9918454|FG000|STARTED|Initial Treatment||71
8862687|NCT01824082|9918455|FG001|STARTED|Initial Treatment||73
8862688|NCT01824082|9918454|FG000|COMPLETED|Initial Treatment||71
8862689|NCT01824082|9918455|FG001|COMPLETED|Initial Treatment||73
8862690|NCT01824082|9918454|FG000|NOT COMPLETED|Initial Treatment||0
8862691|NCT01824082|9918455|FG001|NOT COMPLETED|Initial Treatment||0
8862692|NCT01824082|9918454|FG000|STARTED|Optional Crossover Treatment||40
8862693|NCT01824082|9918455|FG001|STARTED|Optional Crossover Treatment||25
8862694|NCT01824082|9918454|FG000|COMPLETED|Optional Crossover Treatment||40
8862695|NCT01824082|9918455|FG001|COMPLETED|Optional Crossover Treatment||25
8862696|NCT01824082|9918454|FG000|NOT COMPLETED|Optional Crossover Treatment||0
8862697|NCT01824082|9918455|FG001|NOT COMPLETED|Optional Crossover Treatment||0
8862698|NCT01824160|9918465|FG000|STARTED|Overall Study||50
8862699|NCT01824160|9918465|FG000|COMPLETED|Overall Study||50
8862700|NCT01824160|9918465|FG000|NOT COMPLETED|Overall Study||0
8862701|NCT01824290|9918471|FG000|STARTED|Period 1: Double Blind||18
8862702|NCT01824290|9918472|FG001|STARTED|Period 1: Double Blind||17
8862703|NCT01824290|9918473|FG002|STARTED|Period 1: Double Blind||0
8862704|NCT01824290|9918474|FG003|STARTED|Period 1: Double Blind||0
8862705|NCT01824290|9918471|FG000|Received at Least One Dose of Study Drug|Period 1: Double Blind||18
8862706|NCT01824290|9918472|FG001|Received at Least One Dose of Study Drug|Period 1: Double Blind||17
8862707|NCT01824290|9918473|FG002|Received at Least One Dose of Study Drug|Period 1: Double Blind||0
8862708|NCT01824290|9918474|FG003|Received at Least One Dose of Study Drug|Period 1: Double Blind||0
8862709|NCT01824290|9918471|FG000|Received 20 mg|Period 1: Double Blind||0
8862710|NCT01824290|9918472|FG001|Received 20 mg|Period 1: Double Blind||4
8862711|NCT01824290|9918473|FG002|Received 20 mg|Period 1: Double Blind||0
8862712|NCT01824290|9918474|FG003|Received 20 mg|Period 1: Double Blind||0
8862713|NCT01824290|9918471|FG000|Received 40 mg|Period 1: Double Blind||0
8862714|NCT01824290|9918472|FG001|Received 40 mg|Period 1: Double Blind||13
8862715|NCT01824290|9918473|FG002|Received 40 mg|Period 1: Double Blind||0
8862716|NCT01824290|9918474|FG003|Received 40 mg|Period 1: Double Blind||0
8862717|NCT01824290|9918471|FG000|COMPLETED|Period 1: Double Blind||15
8862718|NCT01824290|9918472|FG001|COMPLETED|Period 1: Double Blind||15
8862719|NCT01824290|9918473|FG002|COMPLETED|Period 1: Double Blind||0
8862720|NCT01824290|9918474|FG003|COMPLETED|Period 1: Double Blind||0
8862721|NCT01824290|9918471|FG000|NOT COMPLETED|Period 1: Double Blind||3
8862722|NCT01824290|9918472|FG001|NOT COMPLETED|Period 1: Double Blind||2
8862723|NCT01824290|9918473|FG002|NOT COMPLETED|Period 1: Double Blind||0
8862724|NCT01824290|9918474|FG003|NOT COMPLETED|Period 1: Double Blind||0
8862725|NCT01824290|9918471|FG000|STARTED|Period 2: Open-Label Treatment||0
8862726|NCT01824290|9918472|FG001|STARTED|Period 2: Open-Label Treatment||0
8862727|NCT01824290|9918473|FG002|STARTED|Period 2: Open-Label Treatment|As per the protocol, period 2 eligibility were participants who completed period 1 or experienced clinical worsening (CW) in period 1. 1 participant that had CW in period 1 continued to period 2.|16
8862728|NCT01824290|9918474|FG003|STARTED|Period 2: Open-Label Treatment|As per the protocol, period 2 eligibility were participants who completed period 1 or experienced clinical worsening (CW) in period 1. 1 participant that had CW in period 1 continued to period 2.|16
8862729|NCT01824290|9918471|FG000|Received 20 mg|Period 2: Open-Label Treatment||0
8862730|NCT01824290|9918472|FG001|Received 20 mg|Period 2: Open-Label Treatment||0
8862731|NCT01824290|9918473|FG002|Received 20 mg|Period 2: Open-Label Treatment||3
8862732|NCT01824290|9918474|FG003|Received 20 mg|Period 2: Open-Label Treatment||3
8862733|NCT01824290|9918471|FG000|Received 40 mg|Period 2: Open-Label Treatment||0
8862734|NCT01824290|9918472|FG001|Received 40 mg|Period 2: Open-Label Treatment||0
8862735|NCT01824290|9918473|FG002|Received 40 mg|Period 2: Open-Label Treatment||13
8862736|NCT01824290|9918474|FG003|Received 40 mg|Period 2: Open-Label Treatment||13
8862737|NCT01824290|9918471|FG000|COMPLETED|Period 2: Open-Label Treatment||0
8862738|NCT01824290|9918472|FG001|COMPLETED|Period 2: Open-Label Treatment||0
8862739|NCT01824290|9918473|FG002|COMPLETED|Period 2: Open-Label Treatment||13
8862740|NCT01824290|9918474|FG003|COMPLETED|Period 2: Open-Label Treatment||13
8862741|NCT01824290|9918471|FG000|NOT COMPLETED|Period 2: Open-Label Treatment||0
8862742|NCT01824290|9918472|FG001|NOT COMPLETED|Period 2: Open-Label Treatment||0
8862743|NCT01824290|9918473|FG002|NOT COMPLETED|Period 2: Open-Label Treatment||3
8862744|NCT01824290|9918474|FG003|NOT COMPLETED|Period 2: Open-Label Treatment||3
8862745|NCT01824303|9918488|FG000|STARTED|Randomized Study||16
8862746|NCT01824303|9918489|FG001|STARTED|Randomized Study||14
8862747|NCT01824303|9918488|FG000|COMPLETED|Randomized Study||14
8862748|NCT01824303|9918489|FG001|COMPLETED|Randomized Study||13
8862749|NCT01824303|9918488|FG000|NOT COMPLETED|Randomized Study||2
8862750|NCT01824303|9918489|FG001|NOT COMPLETED|Randomized Study||1
8862751|NCT01824303|9918488|FG000|STARTED|Open Label Extension|2 participants completed the Randomized Study but did not enter the Open Label Extension.|12
8862752|NCT01824303|9918489|FG001|STARTED|Open Label Extension|2 participants completed the Randomized Study but did not enter the Open Label Extension.|11
8862753|NCT01824303|9918488|FG000|COMPLETED|Open Label Extension||12
8862754|NCT01824303|9918489|FG001|COMPLETED|Open Label Extension||11
8862755|NCT01824303|9918488|FG000|NOT COMPLETED|Open Label Extension||0
8862756|NCT01824303|9918489|FG001|NOT COMPLETED|Open Label Extension||0
8630431|NCT00535236|9670221|FG001|Vaccination 3|Overall Study||10
8630432|NCT00535236|9670222|FG002|Vaccination 3|Overall Study||35
8630433|NCT00535236|9670223|FG003|Vaccination 3|Overall Study||8
8630434|NCT00535236|9670224|FG004|Vaccination 3|Overall Study||48
8630435|NCT00535236|9670225|FG005|Vaccination 3|Overall Study||19
8630436|NCT00535236|9670226|FG006|Vaccination 3|Overall Study||51
8630437|NCT00535236|9670227|FG007|Vaccination 3|Overall Study||18
8630438|NCT00535236|9670228|FG008|Vaccination 3|Overall Study||53
8862757|NCT01824342|9918499|FG000|STARTED|Overall Study||11
8862758|NCT01824342|9918500|FG001|STARTED|Overall Study||7
8862759|NCT01824342|9918499|FG000|COMPLETED|Overall Study||2
8862760|NCT01824342|9918500|FG001|COMPLETED|Overall Study||2
8862761|NCT01824342|9918499|FG000|NOT COMPLETED|Overall Study||9
8862762|NCT01824342|9918500|FG001|NOT COMPLETED|Overall Study||5
8862763|NCT01824355|9918506|FG000|STARTED|Overall Study||113
8862764|NCT01824355|9918506|FG000|COMPLETED|Overall Study||110
8862765|NCT01824355|9918506|FG000|NOT COMPLETED|Overall Study||3
8950469|NCT02446990|10013091|FG001|STARTED|Overall Study||9552
8950470|NCT02446990|10013090|FG000|COMPLETED|Overall Study||8830
8950471|NCT02446990|10013091|FG001|COMPLETED|Overall Study||8894
8950472|NCT02446990|10013090|FG000|NOT COMPLETED|Overall Study||720
8950473|NCT02446990|10013091|FG001|NOT COMPLETED|Overall Study||658
8950474|NCT02447003|10013099|FG000|STARTED|Overall Study||170
8950475|NCT02447003|10013100|FG001|STARTED|Overall Study||84
8950476|NCT02447003|10013099|FG000|COMPLETED|Overall Study||0
8950477|NCT02447003|10013100|FG001|COMPLETED|Overall Study||0
8950478|NCT02447003|10013099|FG000|NOT COMPLETED|Overall Study||170
8569733|NCT00098722|9601917|FG006|STARTED|Double Blind Phase||0
8569734|NCT00098722|9601911|FG000|Treated|Double Blind Phase||182
8569735|NCT00098722|9601912|FG001|Treated|Double Blind Phase||191
8569736|NCT00098722|9601913|FG002|Treated|Double Blind Phase||91
8569737|NCT00098722|9601914|FG003|Treated|Double Blind Phase||0
8569738|NCT00098722|9601915|FG004|Treated|Double Blind Phase||0
8569739|NCT00098722|9601916|FG005|Treated|Double Blind Phase||0
8569740|NCT00098722|9601917|FG006|Treated|Double Blind Phase||0
8569741|NCT00098722|9601911|FG000|COMPLETED|Double Blind Phase||0
8569742|NCT00098722|9601912|FG001|COMPLETED|Double Blind Phase||0
8630439|NCT00535236|9670229|FG009|Vaccination 3|Overall Study||18
8630440|NCT00535236|9670220|FG000|Vaccination 4|Overall Study||34
8862766|NCT01824394|9918513|FG000|STARTED|Overall Study||174
8862767|NCT01824394|9918514|FG001|STARTED|Overall Study||169
8569743|NCT00098722|9601913|FG002|COMPLETED|Double Blind Phase||0
8569744|NCT00098722|9601914|FG003|COMPLETED|Double Blind Phase||0
8569745|NCT00098722|9601915|FG004|COMPLETED|Double Blind Phase||0
8569746|NCT00098722|9601916|FG005|COMPLETED|Double Blind Phase||0
8569747|NCT00098722|9601917|FG006|COMPLETED|Double Blind Phase||0
8569748|NCT00098722|9601911|FG000|NOT COMPLETED|Double Blind Phase||186
8630441|NCT00535236|9670221|FG001|Vaccination 4|Overall Study||10
8630442|NCT00535236|9670222|FG002|Vaccination 4|Overall Study||32
8862768|NCT01824394|9918515|FG002|STARTED|Overall Study||125
8862769|NCT01824394|9918513|FG000|Intent to Treat Population|Overall Study||151
8862770|NCT01824394|9918514|FG001|Intent to Treat Population|Overall Study||149
8862771|NCT01824394|9918515|FG002|Intent to Treat Population|Overall Study|Calibration Roll-in patients are not included in the ITT|0
8862772|NCT01824394|9918513|FG000|Safety Population|Overall Study||151
8862773|NCT01824394|9918514|FG001|Safety Population|Overall Study||149
8862774|NCT01824394|9918515|FG002|Safety Population|Overall Study|Calibration Roll-in patients are included in the safety population|104
8862775|NCT01824394|9918513|FG000|Per-Protocol Population|Overall Study||150
8862776|NCT01824394|9918514|FG001|Per-Protocol Population|Overall Study||148
8862777|NCT01824394|9918515|FG002|Per-Protocol Population|Overall Study|Calibration Roll-in patients are not included in the per protocol population|0
8862778|NCT01824394|9918513|FG000|COMPLETED|Overall Study||55
8862779|NCT01824394|9918514|FG001|COMPLETED|Overall Study||53
8862780|NCT01824394|9918515|FG002|COMPLETED|Overall Study||51
8862781|NCT01824394|9918513|FG000|NOT COMPLETED|Overall Study||119
8862782|NCT01824394|9918514|FG001|NOT COMPLETED|Overall Study||116
8862783|NCT01824394|9918515|FG002|NOT COMPLETED|Overall Study||74
8862784|NCT01824446|9918523|FG000|STARTED|Overall Study||6
8862785|NCT01824446|9918523|FG000|COMPLETED|Overall Study||6
8862786|NCT01824446|9918523|FG000|NOT COMPLETED|Overall Study||0
8862787|NCT01824472|9918530|FG000|STARTED|Overall Study||17
8862788|NCT01824472|9918531|FG001|STARTED|Overall Study||13
8862789|NCT01824472|9918532|FG002|STARTED|Overall Study||15
8862790|NCT01824472|9918530|FG000|COMPLETED|Overall Study||16
8862791|NCT01824472|9918531|FG001|COMPLETED|Overall Study||6
8862792|NCT01824472|9918532|FG002|COMPLETED|Overall Study||11
8862793|NCT01824472|9918530|FG000|NOT COMPLETED|Overall Study||1
8862794|NCT01824472|9918531|FG001|NOT COMPLETED|Overall Study||7
8862795|NCT01824472|9918532|FG002|NOT COMPLETED|Overall Study||4
8862796|NCT01824498|9918546|FG000|STARTED|1st Intervention (8 Weeks)||5
8862797|NCT01824498|9918547|FG001|STARTED|1st Intervention (8 Weeks)||2
8862798|NCT01824498|9918548|FG002|STARTED|1st Intervention (8 Weeks)||6
8862799|NCT01824498|9918549|FG003|STARTED|1st Intervention (8 Weeks)||3
8862800|NCT01824498|9918550|FG004|STARTED|1st Intervention (8 Weeks)||4
8862801|NCT01824498|9918551|FG005|STARTED|1st Intervention (8 Weeks)||4
8862802|NCT01824498|9918546|FG000|COMPLETED|1st Intervention (8 Weeks)||5
8862803|NCT01824498|9918547|FG001|COMPLETED|1st Intervention (8 Weeks)||2
8862804|NCT01824498|9918548|FG002|COMPLETED|1st Intervention (8 Weeks)||6
8862805|NCT01824498|9918549|FG003|COMPLETED|1st Intervention (8 Weeks)||3
8862806|NCT01824498|9918550|FG004|COMPLETED|1st Intervention (8 Weeks)||4
8862807|NCT01824498|9918551|FG005|COMPLETED|1st Intervention (8 Weeks)||4
8862808|NCT01824498|9918546|FG000|NOT COMPLETED|1st Intervention (8 Weeks)||0
8862809|NCT01824498|9918547|FG001|NOT COMPLETED|1st Intervention (8 Weeks)||0
8862810|NCT01824498|9918548|FG002|NOT COMPLETED|1st Intervention (8 Weeks)||0
8862811|NCT01824498|9918549|FG003|NOT COMPLETED|1st Intervention (8 Weeks)||0
8862812|NCT01824498|9918550|FG004|NOT COMPLETED|1st Intervention (8 Weeks)||0
8862813|NCT01824498|9918551|FG005|NOT COMPLETED|1st Intervention (8 Weeks)||0
8862814|NCT01824498|9918546|FG000|STARTED|Washout (8 Weeks)|2 dropped out|5
8862815|NCT01824498|9918547|FG001|STARTED|Washout (8 Weeks)||2
8862816|NCT01824498|9918548|FG002|STARTED|Washout (8 Weeks)|2 dropped out|6
8862817|NCT01824498|9918549|FG003|STARTED|Washout (8 Weeks)|1 dropped out|3
8862818|NCT01824498|9918550|FG004|STARTED|Washout (8 Weeks)|1 dropped out|4
8862819|NCT01824498|9918551|FG005|STARTED|Washout (8 Weeks)||4
8862820|NCT01824498|9918546|FG000|COMPLETED|Washout (8 Weeks)||3
8862821|NCT01824498|9918547|FG001|COMPLETED|Washout (8 Weeks)||2
8862822|NCT01824498|9918548|FG002|COMPLETED|Washout (8 Weeks)||4
8862823|NCT01824498|9918549|FG003|COMPLETED|Washout (8 Weeks)||2
8862824|NCT01824498|9918550|FG004|COMPLETED|Washout (8 Weeks)||3
8862825|NCT01824498|9918551|FG005|COMPLETED|Washout (8 Weeks)||4
8862826|NCT01824498|9918546|FG000|NOT COMPLETED|Washout (8 Weeks)||2
8862827|NCT01824498|9918547|FG001|NOT COMPLETED|Washout (8 Weeks)||0
8862828|NCT01824498|9918548|FG002|NOT COMPLETED|Washout (8 Weeks)||2
8862829|NCT01824498|9918549|FG003|NOT COMPLETED|Washout (8 Weeks)||1
8862830|NCT01824498|9918550|FG004|NOT COMPLETED|Washout (8 Weeks)||1
8862831|NCT01824498|9918551|FG005|NOT COMPLETED|Washout (8 Weeks)||0
8862832|NCT01824498|9918546|FG000|STARTED|2nd Intervention (8 Weeks)||3
8862833|NCT01824498|9918547|FG001|STARTED|2nd Intervention (8 Weeks)||2
8862834|NCT01824498|9918548|FG002|STARTED|2nd Intervention (8 Weeks)||4
8862835|NCT01824498|9918549|FG003|STARTED|2nd Intervention (8 Weeks)||2
8862836|NCT01824498|9918550|FG004|STARTED|2nd Intervention (8 Weeks)||3
8862837|NCT01824498|9918551|FG005|STARTED|2nd Intervention (8 Weeks)||4
8862838|NCT01824498|9918546|FG000|COMPLETED|2nd Intervention (8 Weeks)||3
8862839|NCT01824498|9918547|FG001|COMPLETED|2nd Intervention (8 Weeks)||2
8862840|NCT01824498|9918548|FG002|COMPLETED|2nd Intervention (8 Weeks)||4
8862841|NCT01824498|9918549|FG003|COMPLETED|2nd Intervention (8 Weeks)||2
8950479|NCT02447003|10013100|FG001|NOT COMPLETED|Overall Study||84
8862842|NCT01824498|9918550|FG004|COMPLETED|2nd Intervention (8 Weeks)||3
8862843|NCT01824498|9918551|FG005|COMPLETED|2nd Intervention (8 Weeks)||4
8862844|NCT01824498|9918546|FG000|NOT COMPLETED|2nd Intervention (8 Weeks)||0
8862845|NCT01824498|9918547|FG001|NOT COMPLETED|2nd Intervention (8 Weeks)||0
8862846|NCT01824498|9918548|FG002|NOT COMPLETED|2nd Intervention (8 Weeks)||0
8862847|NCT01824498|9918549|FG003|NOT COMPLETED|2nd Intervention (8 Weeks)||0
8862848|NCT01824498|9918550|FG004|NOT COMPLETED|2nd Intervention (8 Weeks)||0
8862849|NCT01824498|9918551|FG005|NOT COMPLETED|2nd Intervention (8 Weeks)||0
8630443|NCT00535236|9670223|FG003|Vaccination 4|Overall Study||6
8630444|NCT00535236|9670224|FG004|Vaccination 4|Overall Study||47
8630445|NCT00535236|9670225|FG005|Vaccination 4|Overall Study||19
8630446|NCT00535236|9670226|FG006|Vaccination 4|Overall Study||51
8630447|NCT00535236|9670227|FG007|Vaccination 4|Overall Study||18
8630448|NCT00535236|9670228|FG008|Vaccination 4|Overall Study||50
8862850|NCT01824498|9918546|FG000|STARTED|Washout (8 Weeks)||3
8862851|NCT01824498|9918547|FG001|STARTED|Washout (8 Weeks)||2
8862852|NCT01824498|9918548|FG002|STARTED|Washout (8 Weeks)||4
8862853|NCT01824498|9918549|FG003|STARTED|Washout (8 Weeks)||2
8862854|NCT01824498|9918550|FG004|STARTED|Washout (8 Weeks)||3
8862855|NCT01824498|9918551|FG005|STARTED|Washout (8 Weeks)||4
8862856|NCT01824498|9918546|FG000|COMPLETED|Washout (8 Weeks)||3
8862857|NCT01824498|9918547|FG001|COMPLETED|Washout (8 Weeks)||2
8862858|NCT01824498|9918548|FG002|COMPLETED|Washout (8 Weeks)||4
8862859|NCT01824498|9918549|FG003|COMPLETED|Washout (8 Weeks)||2
8862860|NCT01824498|9918550|FG004|COMPLETED|Washout (8 Weeks)||3
8862861|NCT01824498|9918551|FG005|COMPLETED|Washout (8 Weeks)||4
8862862|NCT01824498|9918546|FG000|NOT COMPLETED|Washout (8 Weeks)||0
8862863|NCT01824498|9918547|FG001|NOT COMPLETED|Washout (8 Weeks)||0
8862864|NCT01824498|9918548|FG002|NOT COMPLETED|Washout (8 Weeks)||0
8862865|NCT01824498|9918549|FG003|NOT COMPLETED|Washout (8 Weeks)||0
8862866|NCT01824498|9918550|FG004|NOT COMPLETED|Washout (8 Weeks)||0
8862867|NCT01824498|9918551|FG005|NOT COMPLETED|Washout (8 Weeks)||0
8862868|NCT01824498|9918546|FG000|STARTED|3rd Intervention (8 Weeks)||3
8862869|NCT01824498|9918547|FG001|STARTED|3rd Intervention (8 Weeks)||2
8862870|NCT01824498|9918548|FG002|STARTED|3rd Intervention (8 Weeks)||4
8862871|NCT01824498|9918549|FG003|STARTED|3rd Intervention (8 Weeks)||2
8630449|NCT00535236|9670229|FG009|Vaccination 4|Overall Study||17
8630450|NCT00535236|9670220|FG000|COMPLETED|Overall Study||33
8630451|NCT00535236|9670221|FG001|COMPLETED|Overall Study||8
8862872|NCT01824498|9918550|FG004|STARTED|3rd Intervention (8 Weeks)||3
8862873|NCT01824498|9918551|FG005|STARTED|3rd Intervention (8 Weeks)||4
8862874|NCT01824498|9918546|FG000|COMPLETED|3rd Intervention (8 Weeks)||3
8862875|NCT01824498|9918547|FG001|COMPLETED|3rd Intervention (8 Weeks)||2
8630452|NCT00535236|9670222|FG002|COMPLETED|Overall Study||29
8630453|NCT00535236|9670223|FG003|COMPLETED|Overall Study||6
8630454|NCT00535236|9670224|FG004|COMPLETED|Overall Study||47
8862876|NCT01824498|9918548|FG002|COMPLETED|3rd Intervention (8 Weeks)||4
8862877|NCT01824498|9918549|FG003|COMPLETED|3rd Intervention (8 Weeks)||2
8862878|NCT01824498|9918550|FG004|COMPLETED|3rd Intervention (8 Weeks)||3
8862879|NCT01824498|9918551|FG005|COMPLETED|3rd Intervention (8 Weeks)||4
8862880|NCT01824498|9918546|FG000|NOT COMPLETED|3rd Intervention (8 Weeks)||0
8862881|NCT01824498|9918547|FG001|NOT COMPLETED|3rd Intervention (8 Weeks)||0
8862882|NCT01824498|9918548|FG002|NOT COMPLETED|3rd Intervention (8 Weeks)||0
8862883|NCT01824498|9918549|FG003|NOT COMPLETED|3rd Intervention (8 Weeks)||0
8862884|NCT01824498|9918550|FG004|NOT COMPLETED|3rd Intervention (8 Weeks)||0
8862885|NCT01824498|9918551|FG005|NOT COMPLETED|3rd Intervention (8 Weeks)||0
8862886|NCT01824576|9918559|FG000|STARTED|Overall Study||9
8862887|NCT01824576|9918559|FG000|COMPLETED|Overall Study||7
8862888|NCT01824576|9918559|FG000|NOT COMPLETED|Overall Study||2
8862889|NCT01824589|9918567|FG000|STARTED|Overall Study||1
8862890|NCT01824589|9918568|FG001|STARTED|Overall Study||0
8862891|NCT01824589|9918569|FG002|STARTED|Overall Study||0
8862892|NCT01824589|9918570|FG003|STARTED|Overall Study||0
8862893|NCT01824589|9918567|FG000|COMPLETED|Overall Study||1
8862894|NCT01824589|9918568|FG001|COMPLETED|Overall Study||0
8862895|NCT01824589|9918569|FG002|COMPLETED|Overall Study||0
8862896|NCT01824589|9918570|FG003|COMPLETED|Overall Study||0
8862897|NCT01824589|9918567|FG000|NOT COMPLETED|Overall Study||0
8862898|NCT01824589|9918568|FG001|NOT COMPLETED|Overall Study||0
8862899|NCT01824589|9918569|FG002|NOT COMPLETED|Overall Study||0
8862900|NCT01824589|9918570|FG003|NOT COMPLETED|Overall Study||0
8862901|NCT01824602|9918584|FG000|STARTED|Overall Study||11
8862902|NCT01824602|9918585|FG001|STARTED|Overall Study||8
8862903|NCT01824602|9918586|FG002|STARTED|Overall Study||9
8862904|NCT01824602|9918587|FG003|STARTED|Overall Study||10
8862905|NCT01824602|9918584|FG000|Safety Population|Overall Study||11
8862906|NCT01824602|9918585|FG001|Safety Population|Overall Study||8
8862907|NCT01824602|9918586|FG002|Safety Population|Overall Study||9
8862908|NCT01824602|9918587|FG003|Safety Population|Overall Study||10
8862909|NCT01824602|9918584|FG000|Intent-to-treat Population|Overall Study||11
8862910|NCT01824602|9918585|FG001|Intent-to-treat Population|Overall Study||8
8862911|NCT01824602|9918586|FG002|Intent-to-treat Population|Overall Study||9
8862912|NCT01824602|9918587|FG003|Intent-to-treat Population|Overall Study||9
8862913|NCT01824602|9918584|FG000|COMPLETED|Overall Study||10
8862914|NCT01824602|9918585|FG001|COMPLETED|Overall Study||8
8862915|NCT01824602|9918586|FG002|COMPLETED|Overall Study||5
8862916|NCT01824602|9918587|FG003|COMPLETED|Overall Study||5
8862917|NCT01824602|9918584|FG000|NOT COMPLETED|Overall Study||1
8862918|NCT01824602|9918585|FG001|NOT COMPLETED|Overall Study||0
8862919|NCT01824602|9918586|FG002|NOT COMPLETED|Overall Study||4
8630455|NCT00535236|9670225|FG005|COMPLETED|Overall Study||19
8630456|NCT00535236|9670226|FG006|COMPLETED|Overall Study||51
8630457|NCT00535236|9670227|FG007|COMPLETED|Overall Study||18
8862920|NCT01824602|9918587|FG003|NOT COMPLETED|Overall Study||5
8862921|NCT01824693|9918600|FG000|STARTED|Overall Study||6
8862922|NCT01824693|9918601|FG001|STARTED|Overall Study||9
8862923|NCT01824693|9918602|FG002|STARTED|Overall Study||15
8862924|NCT01824693|9918600|FG000|COMPLETED|Overall Study||5
8862925|NCT01824693|9918601|FG001|COMPLETED|Overall Study||2
8862926|NCT01824693|9918602|FG002|COMPLETED|Overall Study||0
8862927|NCT01824693|9918600|FG000|NOT COMPLETED|Overall Study||1
8862928|NCT01824693|9918601|FG001|NOT COMPLETED|Overall Study||7
8862929|NCT01824693|9918602|FG002|NOT COMPLETED|Overall Study||15
8862930|NCT01824823|9918611|FG000|STARTED|Overall Study||2
8862931|NCT01824823|9918612|FG001|STARTED|Overall Study||1
8862932|NCT01824823|9918611|FG000|COMPLETED|Overall Study||0
8862933|NCT01824823|9918612|FG001|COMPLETED|Overall Study||0
8862934|NCT01824823|9918611|FG000|NOT COMPLETED|Overall Study||2
8862935|NCT01824823|9918612|FG001|NOT COMPLETED|Overall Study||1
8862936|NCT01824901|9918618|FG000|STARTED|Overall Study||2
8862937|NCT01824901|9918619|FG001|STARTED|Overall Study||0
8862938|NCT01824901|9918620|FG002|STARTED|Overall Study||0
8862939|NCT01824901|9918621|FG003|STARTED|Overall Study||0
8862940|NCT01824901|9918618|FG000|COMPLETED|Overall Study||2
8862941|NCT01824901|9918619|FG001|COMPLETED|Overall Study||0
8862942|NCT01824901|9918620|FG002|COMPLETED|Overall Study||0
8862943|NCT01824901|9918621|FG003|COMPLETED|Overall Study||0
8862944|NCT01824901|9918618|FG000|NOT COMPLETED|Overall Study||0
8862945|NCT01824901|9918619|FG001|NOT COMPLETED|Overall Study||0
8862946|NCT01824901|9918620|FG002|NOT COMPLETED|Overall Study||0
8862947|NCT01824901|9918621|FG003|NOT COMPLETED|Overall Study||0
8862948|NCT01824979|9918627|FG000|STARTED|Overall Study||50
8862949|NCT01824979|9918628|FG001|STARTED|Overall Study||50
8862950|NCT01824979|9918627|FG000|COMPLETED|Overall Study||37
8862951|NCT01824979|9918628|FG001|COMPLETED|Overall Study||37
8862952|NCT01824979|9918627|FG000|NOT COMPLETED|Overall Study||13
8862953|NCT01824979|9918628|FG001|NOT COMPLETED|Overall Study||13
8862954|NCT01825057|9918637|FG000|STARTED|Patient Study Flow||336
8862955|NCT01825057|9918638|FG001|STARTED|Patient Study Flow||379
8862956|NCT01825057|9918639|FG002|STARTED|Patient Study Flow||458
8862957|NCT01825057|9918637|FG000|COMPLETED|Patient Study Flow||336
8862958|NCT01825057|9918638|FG001|COMPLETED|Patient Study Flow||379
8862959|NCT01825057|9918639|FG002|COMPLETED|Patient Study Flow||458
8862960|NCT01825057|9918637|FG000|NOT COMPLETED|Patient Study Flow||0
8862961|NCT01825057|9918638|FG001|NOT COMPLETED|Patient Study Flow||0
8862962|NCT01825057|9918639|FG002|NOT COMPLETED|Patient Study Flow||0
8862963|NCT01825057|9918637|FG000|STARTED|Provider Study Flow||13
8950480|NCT02447029|10013110|FG000|STARTED|Overall Study||72
8950481|NCT02447029|10013111|FG001|STARTED|Overall Study||70
8950482|NCT02447029|10013110|FG000|Treated|Overall Study||69
8862964|NCT01825057|9918638|FG001|STARTED|Provider Study Flow||12
8862965|NCT01825057|9918639|FG002|STARTED|Provider Study Flow||13
8862966|NCT01825057|9918637|FG000|COMPLETED|Provider Study Flow||13
8862967|NCT01825057|9918638|FG001|COMPLETED|Provider Study Flow||12
8862968|NCT01825057|9918639|FG002|COMPLETED|Provider Study Flow||13
8862969|NCT01825057|9918637|FG000|NOT COMPLETED|Provider Study Flow||0
8862970|NCT01825057|9918638|FG001|NOT COMPLETED|Provider Study Flow||0
8862971|NCT01825057|9918639|FG002|NOT COMPLETED|Provider Study Flow||0
8862972|NCT01825122|9918652|FG000|STARTED|Overall Study||77
8862973|NCT01825122|9918653|FG001|STARTED|Overall Study||78
8862974|NCT01825122|9918652|FG000|COMPLETED|Overall Study||67
8862975|NCT01825122|9918653|FG001|COMPLETED|Overall Study||59
8862976|NCT01825122|9918652|FG000|NOT COMPLETED|Overall Study||10
8862977|NCT01825122|9918653|FG001|NOT COMPLETED|Overall Study||19
8862978|NCT01825200|9918661|FG000|STARTED|Overall Study||1319
8862979|NCT01825200|9918662|FG001|STARTED|Overall Study||1321
8862980|NCT01825200|9918661|FG000|COMPLETED|Overall Study||1314
8862981|NCT01825200|9918662|FG001|COMPLETED|Overall Study||1314
8862982|NCT01825200|9918661|FG000|NOT COMPLETED|Overall Study||5
8862983|NCT01825200|9918662|FG001|NOT COMPLETED|Overall Study||7
8862984|NCT01825408|9918672|FG000|STARTED|Overall Study||7
8862985|NCT01825408|9918673|FG001|STARTED|Overall Study||7
8862986|NCT01825408|9918674|FG002|STARTED|Overall Study||14
8862987|NCT01825408|9918675|FG003|STARTED|Overall Study||12
8862988|NCT01825408|9918672|FG000|COMPLETED|Overall Study||7
8862989|NCT01825408|9918673|FG001|COMPLETED|Overall Study||7
8862990|NCT01825408|9918674|FG002|COMPLETED|Overall Study||14
8862991|NCT01825408|9918675|FG003|COMPLETED|Overall Study||12
8862992|NCT01825408|9918672|FG000|NOT COMPLETED|Overall Study||0
8862993|NCT01825408|9918673|FG001|NOT COMPLETED|Overall Study||0
8862994|NCT01825408|9918674|FG002|NOT COMPLETED|Overall Study||0
8862995|NCT01825408|9918675|FG003|NOT COMPLETED|Overall Study||0
8862996|NCT01825512|9918687|FG000|STARTED|Baseline||194
8862997|NCT01825512|9918688|FG001|STARTED|Baseline||199
8862998|NCT01825512|9918687|FG000|COMPLETED|Baseline||193
8862999|NCT01825512|9918688|FG001|COMPLETED|Baseline||197
8863000|NCT01825512|9918687|FG000|NOT COMPLETED|Baseline||1
8863001|NCT01825512|9918688|FG001|NOT COMPLETED|Baseline||2
8863002|NCT01825512|9918687|FG000|STARTED|Treatment||193
8863003|NCT01825512|9918688|FG001|STARTED|Treatment||197
8863004|NCT01825512|9918687|FG000|COMPLETED|Treatment||140
8863005|NCT01825512|9918688|FG001|COMPLETED|Treatment||170
8863006|NCT01825512|9918687|FG000|NOT COMPLETED|Treatment||53
8863007|NCT01825512|9918688|FG001|NOT COMPLETED|Treatment||27
8950483|NCT02447029|10013111|FG001|Treated|Overall Study||68
8950484|NCT02447029|10013110|FG000|COMPLETED|Overall Study||69
8950485|NCT02447029|10013111|FG001|COMPLETED|Overall Study||68
8950486|NCT02447029|10013110|FG000|NOT COMPLETED|Overall Study||3
8950487|NCT02447029|10013111|FG001|NOT COMPLETED|Overall Study||2
8950488|NCT02447081|10013117|FG000|STARTED|Overall Study||1088
8950489|NCT02447081|10013117|FG000|COMPLETED|Overall Study||864
8950490|NCT02447081|10013117|FG000|NOT COMPLETED|Overall Study||224
8950491|NCT02447172|10013124|FG000|STARTED|Overall Study||262
8950492|NCT02447172|10013125|FG001|STARTED|Overall Study||130
8950493|NCT02447172|10013126|FG002|STARTED|Overall Study||132
8950494|NCT02447172|10013124|FG000|COMPLETED|Overall Study||231
8950495|NCT02447172|10013125|FG001|COMPLETED|Overall Study||115
8950496|NCT02447172|10013126|FG002|COMPLETED|Overall Study||114
8950497|NCT02447172|10013124|FG000|NOT COMPLETED|Overall Study||31
8950498|NCT02447172|10013125|FG001|NOT COMPLETED|Overall Study||15
8950499|NCT02447172|10013126|FG002|NOT COMPLETED|Overall Study||18
8950500|NCT02447250|10013134|FG000|STARTED|First Dose (180 mcg Albuterol)||14
8950501|NCT02447250|10013134|FG000|COMPLETED|First Dose (180 mcg Albuterol)||14
8950502|NCT02447250|10013134|FG000|NOT COMPLETED|First Dose (180 mcg Albuterol)||0
8950503|NCT02447250|10013134|FG000|STARTED|Second Dose (270 mcg Albuterol)||14
8950504|NCT02447250|10013134|FG000|COMPLETED|Second Dose (270 mcg Albuterol)||13
8950505|NCT02447250|10013134|FG000|NOT COMPLETED|Second Dose (270 mcg Albuterol)||1
8950506|NCT02447250|10013134|FG000|STARTED|Third Dose (360 mcg Albuterol)||13
8569749|NCT00098722|9601912|FG001|NOT COMPLETED|Double Blind Phase||194
8569750|NCT00098722|9601913|FG002|NOT COMPLETED|Double Blind Phase||94
8863008|NCT01825577|9918694|FG000|STARTED|Overall Study||14
8863009|NCT01825577|9918694|FG000|COMPLETED|Overall Study||6
8863010|NCT01825577|9918694|FG000|NOT COMPLETED|Overall Study||8
8863011|NCT01825655|9918700|FG000|STARTED|Overall Study||0
8950507|NCT02447250|10013134|FG000|COMPLETED|Third Dose (360 mcg Albuterol)||8
8950508|NCT02447250|10013134|FG000|NOT COMPLETED|Third Dose (360 mcg Albuterol)||5
8950509|NCT02447302|10013142|FG000|STARTED|Overall Study||52
8950510|NCT02447302|10013143|FG001|STARTED|Overall Study||50
8950511|NCT02447302|10013144|FG002|STARTED|Overall Study||54
8950512|NCT02447302|10013142|FG000|COMPLETED|Overall Study||47
8950513|NCT02447302|10013143|FG001|COMPLETED|Overall Study||46
8950514|NCT02447302|10013144|FG002|COMPLETED|Overall Study||48
8569751|NCT00098722|9601914|FG003|NOT COMPLETED|Double Blind Phase||0
8569752|NCT00098722|9601915|FG004|NOT COMPLETED|Double Blind Phase||0
8863012|NCT01825655|9918701|FG001|STARTED|Overall Study||2
8863013|NCT01825655|9918700|FG000|COMPLETED|Overall Study||0
8950515|NCT02447302|10013142|FG000|NOT COMPLETED|Overall Study||5
8950516|NCT02447302|10013143|FG001|NOT COMPLETED|Overall Study||4
8950517|NCT02447302|10013144|FG002|NOT COMPLETED|Overall Study||6
8863014|NCT01825655|9918701|FG001|COMPLETED|Overall Study||2
8863015|NCT01825655|9918700|FG000|NOT COMPLETED|Overall Study||0
8863016|NCT01825655|9918701|FG001|NOT COMPLETED|Overall Study||0
8863017|NCT01825785|9918714|FG000|STARTED|Overall Study||12
8863018|NCT01825785|9918715|FG001|STARTED|Overall Study||6
8950518|NCT02447328|10013152|FG000|STARTED|Overall Study|Enrolment 85 Screening Failure 2 starting study drug 83|83
8950519|NCT02447328|10013152|FG000|COMPLETED|Overall Study||82
8863019|NCT01825785|9918716|FG002|STARTED|Overall Study||6
8863020|NCT01825785|9918717|FG003|STARTED|Overall Study||6
8863021|NCT01825785|9918718|FG004|STARTED|Overall Study||6
8863022|NCT01825785|9918719|FG005|STARTED|Overall Study||6
8863023|NCT01825785|9918720|FG006|STARTED|Overall Study||6
8863024|NCT01825785|9918714|FG000|COMPLETED|Overall Study||12
8863025|NCT01825785|9918715|FG001|COMPLETED|Overall Study||6
8863026|NCT01825785|9918716|FG002|COMPLETED|Overall Study||6
8863027|NCT01825785|9918717|FG003|COMPLETED|Overall Study||6
8863028|NCT01825785|9918718|FG004|COMPLETED|Overall Study||4
8863029|NCT01825785|9918719|FG005|COMPLETED|Overall Study||5
8863030|NCT01825785|9918720|FG006|COMPLETED|Overall Study||6
8863031|NCT01825785|9918714|FG000|NOT COMPLETED|Overall Study||0
8863032|NCT01825785|9918715|FG001|NOT COMPLETED|Overall Study||0
8863033|NCT01825785|9918716|FG002|NOT COMPLETED|Overall Study||0
8863034|NCT01825785|9918717|FG003|NOT COMPLETED|Overall Study||0
8863035|NCT01825785|9918718|FG004|NOT COMPLETED|Overall Study||2
8863036|NCT01825785|9918719|FG005|NOT COMPLETED|Overall Study||1
8863037|NCT01825785|9918720|FG006|NOT COMPLETED|Overall Study||0
8863038|NCT01825798|9918744|FG000|STARTED|Overall Study||32
8863039|NCT01825798|9918745|FG001|STARTED|Overall Study||28
8863040|NCT01825798|9918744|FG000|COMPLETED|Overall Study||30
8863041|NCT01825798|9918745|FG001|COMPLETED|Overall Study||23
8950520|NCT02447328|10013152|FG000|NOT COMPLETED|Overall Study||1
8950521|NCT02447432|10013158|FG000|STARTED|Epoch 001||160
8950522|NCT02447432|10013159|FG001|STARTED|Epoch 001||160
8950523|NCT02447432|10013158|FG000|COMPLETED|Epoch 001||155
8950524|NCT02447432|10013159|FG001|COMPLETED|Epoch 001||147
8950525|NCT02447432|10013158|FG000|NOT COMPLETED|Epoch 001||5
8950526|NCT02447432|10013159|FG001|NOT COMPLETED|Epoch 001||13
8950527|NCT02447432|10013158|FG000|STARTED|Epoch 002||152
8950528|NCT02447432|10013159|FG001|STARTED|Epoch 002||145
8950529|NCT02447432|10013158|FG000|COMPLETED|Epoch 002||152
8950530|NCT02447432|10013159|FG001|COMPLETED|Epoch 002||145
8950531|NCT02447432|10013158|FG000|NOT COMPLETED|Epoch 002||0
8950532|NCT02447432|10013159|FG001|NOT COMPLETED|Epoch 002||0
8950533|NCT02447458|10013171|FG000|STARTED|Overall Study||5
8950534|NCT02447458|10013172|FG001|STARTED|Overall Study||6
8950535|NCT02447458|10013173|FG002|STARTED|Overall Study||6
8950536|NCT02447458|10013174|FG003|STARTED|Overall Study||6
8950537|NCT02447458|10013175|FG004|STARTED|Overall Study||6
8950538|NCT02447458|10013176|FG005|STARTED|Overall Study||10
8950539|NCT02447458|10013171|FG000|COMPLETED|Overall Study||5
8950540|NCT02447458|10013172|FG001|COMPLETED|Overall Study||6
8950541|NCT02447458|10013173|FG002|COMPLETED|Overall Study||5
8950542|NCT02447458|10013174|FG003|COMPLETED|Overall Study||6
8950543|NCT02447458|10013175|FG004|COMPLETED|Overall Study||6
8950544|NCT02447458|10013176|FG005|COMPLETED|Overall Study||10
8950545|NCT02447458|10013171|FG000|NOT COMPLETED|Overall Study||0
8950546|NCT02447458|10013172|FG001|NOT COMPLETED|Overall Study||0
8950547|NCT02447458|10013173|FG002|NOT COMPLETED|Overall Study||1
8950548|NCT02447458|10013174|FG003|NOT COMPLETED|Overall Study||0
8950549|NCT02447458|10013175|FG004|NOT COMPLETED|Overall Study||0
8950550|NCT02447458|10013176|FG005|NOT COMPLETED|Overall Study||0
8950551|NCT02447497|10013199|FG000|STARTED|Overall Study||25
8950552|NCT02447497|10013200|FG001|STARTED|Overall Study||25
8950553|NCT02447497|10013201|FG002|STARTED|Overall Study||23
8950554|NCT02447497|10013202|FG003|STARTED|Overall Study||23
8950555|NCT02447497|10013199|FG000|COMPLETED|Overall Study||19
8950556|NCT02447497|10013200|FG001|COMPLETED|Overall Study||19
8950557|NCT02447497|10013201|FG002|COMPLETED|Overall Study||21
8950558|NCT02447497|10013202|FG003|COMPLETED|Overall Study||21
8950559|NCT02447497|10013199|FG000|NOT COMPLETED|Overall Study||6
8950560|NCT02447497|10013200|FG001|NOT COMPLETED|Overall Study||6
8950561|NCT02447497|10013201|FG002|NOT COMPLETED|Overall Study||2
8950562|NCT02447497|10013202|FG003|NOT COMPLETED|Overall Study||2
8950563|NCT02447575|10013220|FG000|STARTED|Overall Study|23 subjects were enrolled in the study: http://dx.doi.org/10.1016/j.chest.2016.08.017|23
8950564|NCT02447575|10013220|FG000|COMPLETED|Overall Study||23
8950565|NCT02447575|10013220|FG000|NOT COMPLETED|Overall Study||0
8950566|NCT02447718|10013226|FG000|STARTED|Overall Study||78
8950567|NCT02447718|10013227|FG001|STARTED|Overall Study||78
8950568|NCT02447718|10013226|FG000|Received Prevnar®13|Overall Study||74
8950569|NCT02447718|10013227|FG001|Received Prevnar®13|Overall Study|Do not receive vaccination|0
8950570|NCT02447718|10013226|FG000|Received Pediacel®|Overall Study||73
8950571|NCT02447718|10013227|FG001|Received Pediacel®|Overall Study|Do not receive vaccination|0
8950572|NCT02447718|10013226|FG000|Received Pneumovax® 23|Overall Study||73
8950573|NCT02447718|10013227|FG001|Received Pneumovax® 23|Overall Study|Do not receive vaccination|0
8950574|NCT02447718|10013226|FG000|COMPLETED|Overall Study||66
8863042|NCT01825798|9918744|FG000|NOT COMPLETED|Overall Study||2
8863043|NCT01825798|9918745|FG001|NOT COMPLETED|Overall Study||5
8863044|NCT01825837|9918755|FG000|STARTED|PART I||0
8950575|NCT02447718|10013227|FG001|COMPLETED|Overall Study||78
8950576|NCT02447718|10013226|FG000|NOT COMPLETED|Overall Study||12
8950577|NCT02447718|10013227|FG001|NOT COMPLETED|Overall Study||0
8950578|NCT02447744|10013236|FG000|STARTED|Overall Study|6 subjects are enrolled in the mindfulness program after serving on the waiting list control group|21
8950579|NCT02447744|10013237|FG001|STARTED|Overall Study||22
8863045|NCT01825837|9918756|FG001|STARTED|PART I||0
8950580|NCT02447744|10013236|FG000|COMPLETED|Overall Study||15
8950581|NCT02447744|10013237|FG001|COMPLETED|Overall Study||21
8950582|NCT02447744|10013236|FG000|NOT COMPLETED|Overall Study||6
8950583|NCT02447744|10013237|FG001|NOT COMPLETED|Overall Study||1
8863046|NCT01825837|9918757|FG002|STARTED|PART I||0
8863047|NCT01825837|9918758|FG003|STARTED|PART I||104
8863048|NCT01825837|9918755|FG000|Enrolled|PART I||0
8863049|NCT01825837|9918756|FG001|Enrolled|PART I||0
8863050|NCT01825837|9918757|FG002|Enrolled|PART I||0
8863051|NCT01825837|9918758|FG003|Enrolled|PART I||104
8863052|NCT01825837|9918755|FG000|Safety Population (Open-Label)|PART I||0
8863053|NCT01825837|9918756|FG001|Safety Population (Open-Label)|PART I||0
8863054|NCT01825837|9918757|FG002|Safety Population (Open-Label)|PART I||0
8863055|NCT01825837|9918758|FG003|Safety Population (Open-Label)|PART I||104
8863056|NCT01825837|9918755|FG000|COMPLETED|PART I||0
8863057|NCT01825837|9918756|FG001|COMPLETED|PART I||0
8863058|NCT01825837|9918757|FG002|COMPLETED|PART I||0
8863059|NCT01825837|9918758|FG003|COMPLETED|PART I||87
8863060|NCT01825837|9918755|FG000|NOT COMPLETED|PART I||0
8863061|NCT01825837|9918756|FG001|NOT COMPLETED|PART I||0
8863062|NCT01825837|9918757|FG002|NOT COMPLETED|PART I||0
8863063|NCT01825837|9918758|FG003|NOT COMPLETED|PART I||17
8863064|NCT01825837|9918755|FG000|STARTED|PART II||35
8863065|NCT01825837|9918756|FG001|STARTED|PART II||26
8863066|NCT01825837|9918757|FG002|STARTED|PART II||26
8863067|NCT01825837|9918758|FG003|STARTED|PART II||0
8863068|NCT01825837|9918755|FG000|Randomized Patients|PART II||35
8950584|NCT02447848|10013243|FG000|STARTED|Overall Study||76
8950585|NCT02447848|10013243|FG000|COMPLETED|Overall Study||65
8950586|NCT02447848|10013243|FG000|NOT COMPLETED|Overall Study||11
8950587|NCT02447926|10013247|FG000|STARTED|Overall Study||1
8950588|NCT02447926|10013247|FG000|COMPLETED|Overall Study||1
8950589|NCT02447926|10013247|FG000|NOT COMPLETED|Overall Study||0
8950590|NCT02447952|10013251|FG000|STARTED|Overall Study||25
8950591|NCT02447952|10013251|FG000|COMPLETED|Overall Study||18
8950592|NCT02447952|10013251|FG000|NOT COMPLETED|Overall Study||7
8950593|NCT02447991|10013257|FG000|STARTED|Overall Study||45
8950594|NCT02447991|10013258|FG001|STARTED|Overall Study||89
8950595|NCT02447991|10013257|FG000|COMPLETED|Overall Study||35
8950596|NCT02447991|10013258|FG001|COMPLETED|Overall Study||59
8950597|NCT02447991|10013257|FG000|NOT COMPLETED|Overall Study||10
8950598|NCT02447991|10013258|FG001|NOT COMPLETED|Overall Study||30
8950599|NCT02448043|10013270|FG000|STARTED|Overall Study||23
8950600|NCT02448043|10013271|FG001|STARTED|Overall Study||22
8950601|NCT02448043|10013270|FG000|COMPLETED|Overall Study||20
8950602|NCT02448043|10013271|FG001|COMPLETED|Overall Study||18
8950603|NCT02448043|10013270|FG000|NOT COMPLETED|Overall Study||3
8863069|NCT01825837|9918756|FG001|Randomized Patients|PART II||26
8950604|NCT02448043|10013271|FG001|NOT COMPLETED|Overall Study||4
8950605|NCT02448303|10013282|FG000|STARTED|Overall Study||38
8950606|NCT02448303|10013283|FG001|STARTED|Overall Study||36
8950607|NCT02448303|10013282|FG000|Enrolled|Overall Study||38
8950608|NCT02448303|10013283|FG001|Enrolled|Overall Study||36
8863070|NCT01825837|9918757|FG002|Randomized Patients|PART II||26
8863071|NCT01825837|9918758|FG003|Randomized Patients|PART II||0
8863072|NCT01825837|9918755|FG000|Safety Population (Double-Blind)|PART II||35
8950609|NCT02448303|10013282|FG000|Received Study Medication|Overall Study||33
8863073|NCT01825837|9918756|FG001|Safety Population (Double-Blind)|PART II||26
8863074|NCT01825837|9918757|FG002|Safety Population (Double-Blind)|PART II||26
8863075|NCT01825837|9918758|FG003|Safety Population (Double-Blind)|PART II||0
8863076|NCT01825837|9918755|FG000|Intent-to-Treat Population|PART II||34
8863077|NCT01825837|9918756|FG001|Intent-to-Treat Population|PART II||25
8863078|NCT01825837|9918757|FG002|Intent-to-Treat Population|PART II||26
8863079|NCT01825837|9918758|FG003|Intent-to-Treat Population|PART II||0
8863080|NCT01825837|9918755|FG000|Per-Protocol Population|PART II||32
8863081|NCT01825837|9918756|FG001|Per-Protocol Population|PART II||23
8863082|NCT01825837|9918757|FG002|Per-Protocol Population|PART II||24
8863083|NCT01825837|9918758|FG003|Per-Protocol Population|PART II||0
8863084|NCT01825837|9918755|FG000|COMPLETED|PART II||16
8863085|NCT01825837|9918756|FG001|COMPLETED|PART II||12
8863086|NCT01825837|9918757|FG002|COMPLETED|PART II||7
8863087|NCT01825837|9918758|FG003|COMPLETED|PART II||0
8863088|NCT01825837|9918755|FG000|NOT COMPLETED|PART II||19
8863089|NCT01825837|9918756|FG001|NOT COMPLETED|PART II||14
8863090|NCT01825837|9918757|FG002|NOT COMPLETED|PART II||19
8863091|NCT01825837|9918758|FG003|NOT COMPLETED|PART II||0
8863092|NCT01825876|9918766|FG000|STARTED|Period 1||17
8863093|NCT01825876|9918767|FG001|STARTED|Period 1||0
8863094|NCT01825876|9918766|FG000|Received 1 Dose of Study Drug|Period 1||17
8863095|NCT01825876|9918767|FG001|Received 1 Dose of Study Drug|Period 1||0
8863096|NCT01825876|9918766|FG000|COMPLETED|Period 1||17
8863097|NCT01825876|9918767|FG001|COMPLETED|Period 1||0
8863098|NCT01825876|9918766|FG000|NOT COMPLETED|Period 1||0
8863099|NCT01825876|9918767|FG001|NOT COMPLETED|Period 1||0
8863100|NCT01825876|9918766|FG000|STARTED|Period 2|Participants received a different treatment in Period 2.|0
8863101|NCT01825876|9918767|FG001|STARTED|Period 2|Participants received a different treatment in Period 1.|17
8863102|NCT01825876|9918766|FG000|Received 1 Dose of Study Drug|Period 2||0
8863103|NCT01825876|9918767|FG001|Received 1 Dose of Study Drug|Period 2||17
8863104|NCT01825876|9918766|FG000|COMPLETED|Period 2||0
8863105|NCT01825876|9918767|FG001|COMPLETED|Period 2||16
8863106|NCT01825876|9918766|FG000|NOT COMPLETED|Period 2||0
8863107|NCT01825876|9918767|FG001|NOT COMPLETED|Period 2||1
8863108|NCT01825889|9918778|FG000|STARTED|Overall Study||10
8863109|NCT01825889|9918779|FG001|STARTED|Overall Study||10
8863110|NCT01825889|9918778|FG000|Received One Dose of Study Drug|Overall Study||10
8863111|NCT01825889|9918779|FG001|Received One Dose of Study Drug|Overall Study||10
8863112|NCT01825889|9918778|FG000|COMPLETED|Overall Study||10
8863113|NCT01825889|9918779|FG001|COMPLETED|Overall Study||10
8863114|NCT01825889|9918778|FG000|NOT COMPLETED|Overall Study||0
8863115|NCT01825889|9918779|FG001|NOT COMPLETED|Overall Study||0
8863116|NCT01825941|9918787|FG000|STARTED|Overall Study||104
8863117|NCT01825941|9918788|FG001|STARTED|Overall Study||104
8863118|NCT01825941|9918787|FG000|COMPLETED|Overall Study||100
8863119|NCT01825941|9918788|FG001|COMPLETED|Overall Study||103
8863120|NCT01825941|9918787|FG000|NOT COMPLETED|Overall Study||4
8863121|NCT01825941|9918788|FG001|NOT COMPLETED|Overall Study||1
8863122|NCT01826201|9918794|FG000|STARTED|Overall Study|Subjects in each arm are same|21
8863123|NCT01826201|9918794|FG000|COMPLETED|Overall Study||17
8863124|NCT01826201|9918794|FG000|NOT COMPLETED|Overall Study||4
8863125|NCT01826214|9918802|FG000|STARTED|Overall Study||35
8863126|NCT01826214|9918803|FG001|STARTED|Overall Study|35 patients were randomized but only 34 patients received at least one dose of study drug|34
8863127|NCT01826214|9918802|FG000|Untreated|Overall Study|Untreated = did not receive study drug|0
8863128|NCT01826214|9918803|FG001|Untreated|Overall Study|Untreated = did not receive study drug|1
8863129|NCT01826214|9918802|FG000|Treated|Overall Study|Treated = received at least one dose of study drug|35
8863130|NCT01826214|9918803|FG001|Treated|Overall Study|Treated = received at least one dose of study drug|34
8863131|NCT01826214|9918802|FG000|COMPLETED|Overall Study||0
8863132|NCT01826214|9918803|FG001|COMPLETED|Overall Study||0
8863133|NCT01826214|9918802|FG000|NOT COMPLETED|Overall Study||35
8863134|NCT01826214|9918803|FG001|NOT COMPLETED|Overall Study||34
8863135|NCT01826227|9918809|FG000|STARTED|Overall Study||5
8863136|NCT01826227|9918809|FG000|COMPLETED|Overall Study||5
8863137|NCT01826227|9918809|FG000|NOT COMPLETED|Overall Study||0
8863138|NCT01826370|9918813|FG000|STARTED|Overall Study||678
8863139|NCT01826370|9918813|FG000|COMPLETED|Overall Study||658
8863140|NCT01826370|9918813|FG000|NOT COMPLETED|Overall Study||20
8863141|NCT01826422|9918819|FG000|STARTED|Overall Study||18
8863142|NCT01826422|9918820|FG001|STARTED|Overall Study||22
8863143|NCT01826422|9918819|FG000|COMPLETED|Overall Study||17
8863144|NCT01826422|9918820|FG001|COMPLETED|Overall Study||19
8863145|NCT01826422|9918819|FG000|NOT COMPLETED|Overall Study||1
8863146|NCT01826422|9918820|FG001|NOT COMPLETED|Overall Study||3
8863147|NCT01826448|9918828|FG000|STARTED|Overall Study||4
8863148|NCT01826448|9918829|FG001|STARTED|Overall Study||9
8863149|NCT01826448|9918828|FG000|COMPLETED|Overall Study||0
8863150|NCT01826448|9918829|FG001|COMPLETED|Overall Study||0
8950610|NCT02448303|10013283|FG001|Received Study Medication|Overall Study||35
8950611|NCT02448303|10013282|FG000|Discontinued Study|Overall Study||38
8950612|NCT02448303|10013283|FG001|Discontinued Study|Overall Study||36
8950613|NCT02448303|10013282|FG000|COMPLETED|Overall Study||0
8950614|NCT02448303|10013283|FG001|COMPLETED|Overall Study||0
8950615|NCT02448303|10013282|FG000|NOT COMPLETED|Overall Study||38
8950616|NCT02448303|10013283|FG001|NOT COMPLETED|Overall Study||36
8950617|NCT02448368|10013291|FG000|STARTED|Overall Study||2
8950618|NCT02448368|10013292|FG001|STARTED|Overall Study||2
8950619|NCT02448368|10013293|FG002|STARTED|Overall Study||2
8950620|NCT02448368|10013294|FG003|STARTED|Overall Study||2
8950621|NCT02448368|10013295|FG004|STARTED|Overall Study||2
8950622|NCT02448368|10013296|FG005|STARTED|Overall Study||2
8950623|NCT02448368|10013297|FG006|STARTED|Overall Study||2
8950624|NCT02448368|10013298|FG007|STARTED|Overall Study||2
8950625|NCT02448368|10013299|FG008|STARTED|Overall Study||2
8950626|NCT02448368|10013300|FG009|STARTED|Overall Study||2
8950627|NCT02448368|10013301|FG010|STARTED|Overall Study||5
8950628|NCT02448368|10013302|FG011|STARTED|Overall Study||5
8950629|NCT02448368|10013303|FG012|STARTED|Overall Study||5
8950630|NCT02448368|10013291|FG000|COMPLETED|Overall Study||2
8950631|NCT02448368|10013292|FG001|COMPLETED|Overall Study||2
8950632|NCT02448368|10013293|FG002|COMPLETED|Overall Study||2
8950633|NCT02448368|10013294|FG003|COMPLETED|Overall Study||2
8950634|NCT02448368|10013295|FG004|COMPLETED|Overall Study||2
8950635|NCT02448368|10013296|FG005|COMPLETED|Overall Study||2
8950636|NCT02448368|10013297|FG006|COMPLETED|Overall Study||2
8950637|NCT02448368|10013298|FG007|COMPLETED|Overall Study||2
8950638|NCT02448368|10013299|FG008|COMPLETED|Overall Study||2
8950639|NCT02448368|10013300|FG009|COMPLETED|Overall Study||2
8950640|NCT02448368|10013301|FG010|COMPLETED|Overall Study||5
8950641|NCT02448368|10013302|FG011|COMPLETED|Overall Study||5
8950642|NCT02448368|10013303|FG012|COMPLETED|Overall Study||5
8950643|NCT02448368|10013291|FG000|NOT COMPLETED|Overall Study||0
8950644|NCT02448368|10013292|FG001|NOT COMPLETED|Overall Study||0
8950645|NCT02448368|10013293|FG002|NOT COMPLETED|Overall Study||0
8950646|NCT02448368|10013294|FG003|NOT COMPLETED|Overall Study||0
8950647|NCT02448368|10013295|FG004|NOT COMPLETED|Overall Study||0
8950648|NCT02448368|10013296|FG005|NOT COMPLETED|Overall Study||0
8950649|NCT02448368|10013297|FG006|NOT COMPLETED|Overall Study||0
8950650|NCT02448368|10013298|FG007|NOT COMPLETED|Overall Study||0
8950651|NCT02448368|10013299|FG008|NOT COMPLETED|Overall Study||0
8950652|NCT02448368|10013300|FG009|NOT COMPLETED|Overall Study||0
8950653|NCT02448368|10013301|FG010|NOT COMPLETED|Overall Study||0
8950654|NCT02448368|10013302|FG011|NOT COMPLETED|Overall Study||0
8950655|NCT02448368|10013303|FG012|NOT COMPLETED|Overall Study||0
8950656|NCT02448446|10013330|FG000|STARTED|Overall Study||13
8950657|NCT02448446|10013331|FG001|STARTED|Overall Study||12
8950658|NCT02448446|10013330|FG000|COMPLETED|Overall Study||12
8950659|NCT02448446|10013331|FG001|COMPLETED|Overall Study||12
8950660|NCT02448446|10013330|FG000|NOT COMPLETED|Overall Study||1
8950661|NCT02448446|10013331|FG001|NOT COMPLETED|Overall Study||0
8950662|NCT02448537|10013340|FG000|STARTED|Overall Study||20
8950663|NCT02448537|10013341|FG001|STARTED|Overall Study||10
8950664|NCT02448537|10013342|FG002|STARTED|Overall Study||12
8950665|NCT02448537|10013340|FG000|COMPLETED|Overall Study||19
8950666|NCT02448537|10013341|FG001|COMPLETED|Overall Study||9
8950667|NCT02448537|10013342|FG002|COMPLETED|Overall Study||11
8950668|NCT02448537|10013340|FG000|NOT COMPLETED|Overall Study||1
8950669|NCT02448537|10013341|FG001|NOT COMPLETED|Overall Study||1
8950670|NCT02448537|10013342|FG002|NOT COMPLETED|Overall Study||1
8863151|NCT01826448|9918828|FG000|NOT COMPLETED|Overall Study||4
8863152|NCT01826448|9918829|FG001|NOT COMPLETED|Overall Study||9
8950671|NCT02448563|10013354|FG000|STARTED|Overall Study|Randomized after completing Visit 2|32
8950672|NCT02448563|10013355|FG001|STARTED|Overall Study|Randomized after completing Visit 2|30
8950673|NCT02448563|10013354|FG000|COMPLETED|Overall Study||16
8950674|NCT02448563|10013355|FG001|COMPLETED|Overall Study||19
8950675|NCT02448563|10013354|FG000|NOT COMPLETED|Overall Study||16
8950676|NCT02448563|10013355|FG001|NOT COMPLETED|Overall Study||11
8863153|NCT01826487|9918837|FG000|STARTED|Overall Study||115
8863154|NCT01826487|9918838|FG001|STARTED|Overall Study||115
8863155|NCT01826487|9918837|FG000|As-treated Population|Overall Study||115
8950677|NCT02448641|10013368|FG000|STARTED|Overall Study||55
8950678|NCT02448641|10013369|FG001|STARTED|Overall Study||56
8950679|NCT02448641|10013370|FG002|STARTED|Overall Study||52
8950680|NCT02448641|10013368|FG000|COMPLETED|Overall Study||54
8950681|NCT02448641|10013369|FG001|COMPLETED|Overall Study||51
8950682|NCT02448641|10013370|FG002|COMPLETED|Overall Study||48
8863156|NCT01826487|9918838|FG001|As-treated Population|Overall Study||115
8863157|NCT01826487|9918837|FG000|ITT Population|Overall Study||114
8863158|NCT01826487|9918838|FG001|ITT Population|Overall Study||114
8863159|NCT01826487|9918837|FG000|COMPLETED|Overall Study||111
8863160|NCT01826487|9918838|FG001|COMPLETED|Overall Study||110
8863161|NCT01826487|9918837|FG000|NOT COMPLETED|Overall Study||4
8863162|NCT01826487|9918838|FG001|NOT COMPLETED|Overall Study||5
8863163|NCT01826513|9918848|FG000|STARTED|Overall Study||5
8863164|NCT01826513|9918849|FG001|STARTED|Overall Study||10
8863165|NCT01826513|9918850|FG002|STARTED|Overall Study||10
8863166|NCT01826513|9918848|FG000|COMPLETED|Overall Study||5
8863167|NCT01826513|9918849|FG001|COMPLETED|Overall Study||10
8863168|NCT01826513|9918850|FG002|COMPLETED|Overall Study||10
8863169|NCT01826513|9918848|FG000|NOT COMPLETED|Overall Study||0
8863170|NCT01826513|9918849|FG001|NOT COMPLETED|Overall Study||0
8863171|NCT01826513|9918850|FG002|NOT COMPLETED|Overall Study||0
8863172|NCT01826604|9918859|FG000|STARTED|Overall Study||144
8863173|NCT01826604|9918860|FG001|STARTED|Overall Study||157
8863174|NCT01826604|9918859|FG000|COMPLETED|Overall Study||136
8863175|NCT01826604|9918860|FG001|COMPLETED|Overall Study||148
8863176|NCT01826604|9918859|FG000|NOT COMPLETED|Overall Study||8
8863177|NCT01826604|9918860|FG001|NOT COMPLETED|Overall Study||9
8863178|NCT01826812|9918868|FG000|STARTED|Overall Study||167
8863179|NCT01826812|9918869|FG001|STARTED|Overall Study||33
8863180|NCT01826812|9918868|FG000|COMPLETED|Overall Study||167
8863181|NCT01826812|9918869|FG001|COMPLETED|Overall Study||32
8863182|NCT01826812|9918868|FG000|NOT COMPLETED|Overall Study||0
8863183|NCT01826812|9918869|FG001|NOT COMPLETED|Overall Study||1
8863184|NCT01826825|9918879|FG000|STARTED|Overall Study||100
8863185|NCT01826825|9918880|FG001|STARTED|Overall Study||100
8863186|NCT01826825|9918879|FG000|COMPLETED|Overall Study||100
8863187|NCT01826825|9918880|FG001|COMPLETED|Overall Study||98
8863188|NCT01826825|9918879|FG000|NOT COMPLETED|Overall Study||0
8863189|NCT01826825|9918880|FG001|NOT COMPLETED|Overall Study||2
8863190|NCT01826851|9918890|FG000|STARTED|Overall Study||38
8863191|NCT01826851|9918891|FG001|STARTED|Overall Study||41
8863192|NCT01826851|9918890|FG000|COMPLETED|Overall Study||38
8863193|NCT01826851|9918891|FG001|COMPLETED|Overall Study||41
8863194|NCT01826851|9918890|FG000|NOT COMPLETED|Overall Study||0
8863195|NCT01826851|9918891|FG001|NOT COMPLETED|Overall Study||0
8863196|NCT01826981|9918912|FG000|STARTED|Overall Study||19
8863197|NCT01826981|9918913|FG001|STARTED|Overall Study||10
8863198|NCT01826981|9918914|FG002|STARTED|Overall Study||25
8863199|NCT01826981|9918915|FG003|STARTED|Overall Study||26
8863200|NCT01826981|9918916|FG004|STARTED|Overall Study||25
8863201|NCT01826981|9918917|FG005|STARTED|Overall Study||26
8863202|NCT01826981|9918918|FG006|STARTED|Overall Study||25
8863203|NCT01826981|9918919|FG007|STARTED|Overall Study||51
8863204|NCT01826981|9918920|FG008|STARTED|Overall Study||20
8863205|NCT01826981|9918921|FG009|STARTED|Overall Study||27
8863206|NCT01826981|9918922|FG010|STARTED|Overall Study||24
8863207|NCT01826981|9918923|FG011|STARTED|Overall Study||27
8863208|NCT01826981|9918924|FG012|STARTED|Overall Study||26
8863209|NCT01826981|9918925|FG013|STARTED|Overall Study||20
8863210|NCT01826981|9918926|FG014|STARTED|Overall Study||8
8863211|NCT01826981|9918912|FG000|COMPLETED|Overall Study||19
8863212|NCT01826981|9918913|FG001|COMPLETED|Overall Study||9
8863213|NCT01826981|9918914|FG002|COMPLETED|Overall Study||25
8863214|NCT01826981|9918915|FG003|COMPLETED|Overall Study||26
8863215|NCT01826981|9918916|FG004|COMPLETED|Overall Study||18
8863216|NCT01826981|9918917|FG005|COMPLETED|Overall Study||25
8863217|NCT01826981|9918918|FG006|COMPLETED|Overall Study||24
8863218|NCT01826981|9918919|FG007|COMPLETED|Overall Study||40
8863219|NCT01826981|9918920|FG008|COMPLETED|Overall Study||13
8863220|NCT01826981|9918921|FG009|COMPLETED|Overall Study||26
8863221|NCT01826981|9918922|FG010|COMPLETED|Overall Study||22
8863222|NCT01826981|9918923|FG011|COMPLETED|Overall Study||25
8863223|NCT01826981|9918924|FG012|COMPLETED|Overall Study||25
8863224|NCT01826981|9918925|FG013|COMPLETED|Overall Study||15
8863225|NCT01826981|9918926|FG014|COMPLETED|Overall Study||8
8863226|NCT01826981|9918912|FG000|NOT COMPLETED|Overall Study||0
8863227|NCT01826981|9918913|FG001|NOT COMPLETED|Overall Study||1
8863228|NCT01826981|9918914|FG002|NOT COMPLETED|Overall Study||0
8863229|NCT01826981|9918915|FG003|NOT COMPLETED|Overall Study||0
8863230|NCT01826981|9918916|FG004|NOT COMPLETED|Overall Study||7
8863231|NCT01826981|9918917|FG005|NOT COMPLETED|Overall Study||1
8863232|NCT01826981|9918918|FG006|NOT COMPLETED|Overall Study||1
8863233|NCT01826981|9918919|FG007|NOT COMPLETED|Overall Study||11
8863234|NCT01826981|9918920|FG008|NOT COMPLETED|Overall Study||7
8863235|NCT01826981|9918921|FG009|NOT COMPLETED|Overall Study||1
8863236|NCT01826981|9918922|FG010|NOT COMPLETED|Overall Study||2
8863237|NCT01826981|9918923|FG011|NOT COMPLETED|Overall Study||2
8863238|NCT01826981|9918924|FG012|NOT COMPLETED|Overall Study||1
8863239|NCT01826981|9918925|FG013|NOT COMPLETED|Overall Study||5
8863240|NCT01826981|9918926|FG014|NOT COMPLETED|Overall Study||0
8863241|NCT01827046|9918964|FG000|STARTED|Overall Study||250
8863242|NCT01827046|9918965|FG001|STARTED|Overall Study||249
8863243|NCT01827046|9918964|FG000|COMPLETED|Overall Study||249
8863244|NCT01827046|9918965|FG001|COMPLETED|Overall Study||240
8863245|NCT01827046|9918964|FG000|NOT COMPLETED|Overall Study||1
8863246|NCT01827046|9918965|FG001|NOT COMPLETED|Overall Study||9
8923692|NCT02242994|9984357|FG000|STARTED|Overall Study||5
8923693|NCT02242994|9984357|FG000|COMPLETED|Overall Study||5
8863247|NCT01827163|9918971|FG000|STARTED|Overall Study||20
8863248|NCT01827163|9918971|FG000|COMPLETED|Overall Study||9
8863249|NCT01827163|9918971|FG000|NOT COMPLETED|Overall Study||11
8863250|NCT01827254|9918975|FG000|STARTED|Overall Study||61
8863251|NCT01827254|9918975|FG000|Evaluable Population|Overall Study||52
8863252|NCT01827254|9918975|FG000|COMPLETED|Overall Study||2
8863253|NCT01827254|9918975|FG000|NOT COMPLETED|Overall Study||59
8863254|NCT01827267|9918985|FG000|STARTED|Overall Study|18 subjects were randomized but 17 received treatment.|18
8863255|NCT01827267|9918986|FG001|STARTED|Overall Study|44 subjects were randomized; 43 subjects were treated.|44
8863256|NCT01827267|9918985|FG000|Received Study Drug|Overall Study||17
8863257|NCT01827267|9918986|FG001|Received Study Drug|Overall Study||43
8863258|NCT01827267|9918985|FG000|Crossed Over to Neratinib + Temsirolimus|Overall Study||11
8863259|NCT01827267|9918986|FG001|Crossed Over to Neratinib + Temsirolimus|Overall Study||0
8863260|NCT01827267|9918985|FG000|COMPLETED|Overall Study||13
8863261|NCT01827267|9918986|FG001|COMPLETED|Overall Study||32
8863262|NCT01827267|9918985|FG000|NOT COMPLETED|Overall Study||5
8863263|NCT01827267|9918986|FG001|NOT COMPLETED|Overall Study||12
8863264|NCT01827306|9918995|FG000|STARTED|Overall Study||21
8863265|NCT01827306|9918996|FG001|STARTED|Overall Study||13
8863266|NCT01827306|9918995|FG000|COMPLETED|Overall Study||10
8863267|NCT01827306|9918996|FG001|COMPLETED|Overall Study||8
8863268|NCT01827306|9918995|FG000|NOT COMPLETED|Overall Study||11
8863269|NCT01827306|9918996|FG001|NOT COMPLETED|Overall Study||5
8863270|NCT01827319|9919002|FG000|STARTED|Overall Study||203
8863271|NCT01827319|9919002|FG000|COMPLETED|Overall Study||200
8863272|NCT01827319|9919002|FG000|NOT COMPLETED|Overall Study||3
8863273|NCT01827332|9919008|FG000|STARTED|Overall Study||8
8863274|NCT01827332|9919009|FG001|STARTED|Overall Study||8
8863275|NCT01827332|9919008|FG000|COMPLETED|Overall Study||6
8863276|NCT01827332|9919009|FG001|COMPLETED|Overall Study||7
8863277|NCT01827332|9919008|FG000|NOT COMPLETED|Overall Study||2
8863278|NCT01827332|9919009|FG001|NOT COMPLETED|Overall Study||1
8863279|NCT01827358|9919017|FG000|STARTED|Overall Study||80
8863280|NCT01827358|9919018|FG001|STARTED|Overall Study||75
8863281|NCT01827358|9919017|FG000|COMPLETED|Overall Study||45
8863282|NCT01827358|9919018|FG001|COMPLETED|Overall Study||44
8863283|NCT01827358|9919017|FG000|NOT COMPLETED|Overall Study||35
8863284|NCT01827358|9919018|FG001|NOT COMPLETED|Overall Study||31
8863285|NCT01827371|9919028|FG000|STARTED|Overall Study||115
8863286|NCT01827371|9919029|FG001|STARTED|Overall Study||96
8863287|NCT01827371|9919030|FG002|STARTED|Overall Study||104
8863288|NCT01827371|9919031|FG003|STARTED|Overall Study||120
8863289|NCT01827371|9919028|FG000|COMPLETED|Overall Study||102
8863290|NCT01827371|9919029|FG001|COMPLETED|Overall Study||89
8863291|NCT01827371|9919030|FG002|COMPLETED|Overall Study||93
8863292|NCT01827371|9919031|FG003|COMPLETED|Overall Study||97
8863293|NCT01827371|9919028|FG000|NOT COMPLETED|Overall Study||13
8863294|NCT01827371|9919029|FG001|NOT COMPLETED|Overall Study||7
8863295|NCT01827371|9919030|FG002|NOT COMPLETED|Overall Study||11
8863296|NCT01827371|9919031|FG003|NOT COMPLETED|Overall Study||23
8863297|NCT01827462|9919044|FG000|STARTED|Overall Study||59
8863298|NCT01827462|9919045|FG001|STARTED|Overall Study||37
8863299|NCT01827462|9919046|FG002|STARTED|Overall Study||40
8863300|NCT01827462|9919044|FG000|COMPLETED|Overall Study||18
8863301|NCT01827462|9919045|FG001|COMPLETED|Overall Study||19
8863302|NCT01827462|9919046|FG002|COMPLETED|Overall Study||12
8863303|NCT01827462|9919044|FG000|NOT COMPLETED|Overall Study||41
8863304|NCT01827462|9919045|FG001|NOT COMPLETED|Overall Study||18
8863305|NCT01827462|9919046|FG002|NOT COMPLETED|Overall Study||28
8863306|NCT01827475|9919060|FG000|STARTED|Overall Study||30
8863307|NCT01827475|9919061|FG001|STARTED|Overall Study||30
8863308|NCT01827475|9919062|FG002|STARTED|Overall Study||30
8863309|NCT01827475|9919060|FG000|COMPLETED|Overall Study||30
8863310|NCT01827475|9919061|FG001|COMPLETED|Overall Study||30
8863311|NCT01827475|9919062|FG002|COMPLETED|Overall Study||30
8863312|NCT01827475|9919060|FG000|NOT COMPLETED|Overall Study||0
8863313|NCT01827475|9919061|FG001|NOT COMPLETED|Overall Study||0
8863314|NCT01827475|9919062|FG002|NOT COMPLETED|Overall Study||0
8863315|NCT01827592|9919073|FG000|STARTED|Overall Study|Randomized patients.|126
8863316|NCT01827592|9919074|FG001|STARTED|Overall Study|Randomized patients.|126
8863317|NCT01827592|9919075|FG002|STARTED|Overall Study|Randomized patients.|124
8863318|NCT01827592|9919073|FG000|Safety Analysis Set|Overall Study|1 patient withdrew consent before getting the treatment.|125
8863319|NCT01827592|9919074|FG001|Safety Analysis Set|Overall Study||126
8863320|NCT01827592|9919075|FG002|Safety Analysis Set|Overall Study||124
8863321|NCT01827592|9919073|FG000|COMPLETED|Overall Study||52
8863322|NCT01827592|9919074|FG001|COMPLETED|Overall Study||46
8863323|NCT01827592|9919075|FG002|COMPLETED|Overall Study||48
8863324|NCT01827592|9919073|FG000|NOT COMPLETED|Overall Study||74
8863325|NCT01827592|9919074|FG001|NOT COMPLETED|Overall Study||80
8863326|NCT01827592|9919075|FG002|NOT COMPLETED|Overall Study||76
8863327|NCT01827670|9919085|FG000|STARTED|Overall Study||60
8863328|NCT01827670|9919086|FG001|STARTED|Overall Study||59
8863329|NCT01827670|9919085|FG000|COMPLETED|Overall Study||57
8863330|NCT01827670|9919086|FG001|COMPLETED|Overall Study||56
8863331|NCT01827670|9919085|FG000|NOT COMPLETED|Overall Study||3
8863332|NCT01827670|9919086|FG001|NOT COMPLETED|Overall Study||3
8863333|NCT01827787|9919099|FG000|STARTED|Overall Study||45
8863334|NCT01827787|9919100|FG001|STARTED|Overall Study||38
8863335|NCT01827787|9919099|FG000|COMPLETED|Overall Study||45
8863336|NCT01827787|9919100|FG001|COMPLETED|Overall Study||38
8863337|NCT01827787|9919099|FG000|NOT COMPLETED|Overall Study||0
8863338|NCT01827787|9919100|FG001|NOT COMPLETED|Overall Study||0
8863339|NCT01827839|9919109|FG000|STARTED|Overall Study||96
8863340|NCT01827839|9919109|FG000|COMPLETED|Overall Study||93
8863341|NCT01827839|9919109|FG000|NOT COMPLETED|Overall Study||3
8863342|NCT01827930|9919123|FG000|STARTED|Overall Study||24
8863343|NCT01827930|9919124|FG001|STARTED|Overall Study||25
8863344|NCT01827930|9919125|FG002|STARTED|Overall Study||19
8863345|NCT01827930|9919123|FG000|COMPLETED|Overall Study||24
8863346|NCT01827930|9919124|FG001|COMPLETED|Overall Study||25
8863347|NCT01827930|9919125|FG002|COMPLETED|Overall Study||19
8863348|NCT01827930|9919123|FG000|NOT COMPLETED|Overall Study||0
8863349|NCT01827930|9919124|FG001|NOT COMPLETED|Overall Study||0
8863350|NCT01827930|9919125|FG002|NOT COMPLETED|Overall Study||0
8863351|NCT01827943|9919133|FG000|STARTED|Overall Study||54
8863352|NCT01827943|9919133|FG000|Safety Population|Overall Study||53
8863353|NCT01827943|9919133|FG000|COMPLETED|Overall Study||45
8863354|NCT01827943|9919133|FG000|NOT COMPLETED|Overall Study||9
8863355|NCT01828034|9919141|FG000|STARTED|Overall Study||3
8863356|NCT01828034|9919142|FG001|STARTED|Overall Study||6
8863357|NCT01828034|9919143|FG002|STARTED|Overall Study||3
8863358|NCT01828034|9919144|FG003|STARTED|Overall Study||30
8863359|NCT01828034|9919141|FG000|COMPLETED|Overall Study||3
8863360|NCT01828034|9919142|FG001|COMPLETED|Overall Study||6
8863361|NCT01828034|9919143|FG002|COMPLETED|Overall Study||3
8863362|NCT01828034|9919144|FG003|COMPLETED|Overall Study||29
8863363|NCT01828034|9919141|FG000|NOT COMPLETED|Overall Study||0
8863364|NCT01828034|9919142|FG001|NOT COMPLETED|Overall Study||0
8863365|NCT01828034|9919143|FG002|NOT COMPLETED|Overall Study||0
8863366|NCT01828034|9919144|FG003|NOT COMPLETED|Overall Study||1
8863367|NCT01828073|9919153|FG000|STARTED|Overall Study||22
8863368|NCT01828073|9919154|FG001|STARTED|Overall Study||18
8863369|NCT01828073|9919153|FG000|COMPLETED|Overall Study||21
8863370|NCT01828073|9919154|FG001|COMPLETED|Overall Study||16
8863371|NCT01828073|9919153|FG000|NOT COMPLETED|Overall Study||1
8863372|NCT01828073|9919154|FG001|NOT COMPLETED|Overall Study||2
8863373|NCT01828164|9919166|FG000|STARTED|Overall Study|11 out of 60 subjects did not meet inclusion criteria after enrollment.|49
8863374|NCT01828164|9919166|FG000|COMPLETED|Overall Study||32
8863375|NCT01828164|9919166|FG000|NOT COMPLETED|Overall Study||17
8863376|NCT01828216|9919176|FG000|STARTED|Overall Study||159
8863377|NCT01828216|9919177|FG001|STARTED|Overall Study||157
8863378|NCT01828216|9919176|FG000|COMPLETED|Overall Study||159
8863379|NCT01828216|9919177|FG001|COMPLETED|Overall Study||157
8863380|NCT01828216|9919176|FG000|NOT COMPLETED|Overall Study||0
8863381|NCT01828216|9919177|FG001|NOT COMPLETED|Overall Study||0
8863382|NCT01828255|9919187|FG000|STARTED|Overall Study||20
8863383|NCT01828255|9919188|FG001|STARTED|Overall Study||20
8863384|NCT01828255|9919187|FG000|COMPLETED|Overall Study||20
8863385|NCT01828255|9919188|FG001|COMPLETED|Overall Study||20
8863386|NCT01828255|9919187|FG000|NOT COMPLETED|Overall Study||0
8863387|NCT01828255|9919188|FG001|NOT COMPLETED|Overall Study||0
8863388|NCT01828281|9919198|FG000|STARTED|Overall Study||45
8863389|NCT01828281|9919199|FG001|STARTED|Overall Study||45
8863390|NCT01828281|9919198|FG000|COMPLETED|Overall Study||44
8863391|NCT01828281|9919199|FG001|COMPLETED|Overall Study||45
8863392|NCT01828281|9919198|FG000|NOT COMPLETED|Overall Study||1
8863393|NCT01828281|9919199|FG001|NOT COMPLETED|Overall Study||0
8863394|NCT01828476|9919208|FG000|STARTED|Overall Study||13
8863395|NCT01828476|9919209|FG001|STARTED|Overall Study||0
8863396|NCT01828476|9919208|FG000|COMPLETED|Overall Study||13
8863397|NCT01828476|9919209|FG001|COMPLETED|Overall Study||0
8863398|NCT01828476|9919208|FG000|NOT COMPLETED|Overall Study||0
8863399|NCT01828476|9919209|FG001|NOT COMPLETED|Overall Study||0
8863400|NCT01828515|9919217|FG000|STARTED|First Intervention (19 Days)||13
8863401|NCT01828515|9919218|FG001|STARTED|First Intervention (19 Days)||11
8863402|NCT01828515|9919217|FG000|COMPLETED|First Intervention (19 Days)||11
8863403|NCT01828515|9919218|FG001|COMPLETED|First Intervention (19 Days)||9
8863404|NCT01828515|9919217|FG000|NOT COMPLETED|First Intervention (19 Days)||2
8863405|NCT01828515|9919218|FG001|NOT COMPLETED|First Intervention (19 Days)||2
8863406|NCT01828515|9919217|FG000|STARTED|Washout (23 Days)||11
8863407|NCT01828515|9919218|FG001|STARTED|Washout (23 Days)||9
8863408|NCT01828515|9919217|FG000|COMPLETED|Washout (23 Days)||6
8863409|NCT01828515|9919218|FG001|COMPLETED|Washout (23 Days)||8
8863410|NCT01828515|9919217|FG000|NOT COMPLETED|Washout (23 Days)||5
8863411|NCT01828515|9919218|FG001|NOT COMPLETED|Washout (23 Days)||1
8863412|NCT01828515|9919217|FG000|STARTED|Second Intervention (19 Days)||6
8863413|NCT01828515|9919218|FG001|STARTED|Second Intervention (19 Days)||8
8863414|NCT01828515|9919217|FG000|COMPLETED|Second Intervention (19 Days)||6
8863415|NCT01828515|9919218|FG001|COMPLETED|Second Intervention (19 Days)||5
8863416|NCT01828515|9919217|FG000|NOT COMPLETED|Second Intervention (19 Days)||0
8863417|NCT01828515|9919218|FG001|NOT COMPLETED|Second Intervention (19 Days)||3
8863418|NCT01828554|9919224|FG000|STARTED|Overall Study||8
8863419|NCT01828554|9919224|FG000|COMPLETED|Overall Study||8
8863420|NCT01828554|9919224|FG000|NOT COMPLETED|Overall Study||0
8863421|NCT01828567|9919230|FG000|STARTED|Overall Study||208
8863422|NCT01828567|9919231|FG001|STARTED|Overall Study||209
8863423|NCT01828567|9919230|FG000|1 Month|Overall Study||172
8863424|NCT01828567|9919231|FG001|1 Month|Overall Study||192
8950683|NCT02448641|10013368|FG000|NOT COMPLETED|Overall Study||1
8950684|NCT02448641|10013369|FG001|NOT COMPLETED|Overall Study||5
8950685|NCT02448641|10013370|FG002|NOT COMPLETED|Overall Study||4
8950686|NCT02448654|10013387|FG000|STARTED|Overall Study||19
8950687|NCT02448654|10013388|FG001|STARTED|Overall Study||17
8950688|NCT02448654|10013387|FG000|Started Pills (Tolcapone or Placebo)|Overall Study||17
8950689|NCT02448654|10013388|FG001|Started Pills (Tolcapone or Placebo)|Overall Study||15
8950690|NCT02448654|10013387|FG000|COMPLETED|Overall Study||16
8950691|NCT02448654|10013388|FG001|COMPLETED|Overall Study||13
8950692|NCT02448654|10013387|FG000|NOT COMPLETED|Overall Study||3
8950693|NCT02448654|10013388|FG001|NOT COMPLETED|Overall Study||4
8950694|NCT02448706|10013394|FG000|STARTED|Overall Study||25
8950695|NCT02448706|10013395|FG001|STARTED|Overall Study||24
8950696|NCT02448706|10013394|FG000|Withdrew for Personal Reasons|Overall Study||1
8950697|NCT02448706|10013395|FG001|Withdrew for Personal Reasons|Overall Study||1
8950698|NCT02448706|10013394|FG000|Completed Baseline Testing|Overall Study||24
8950699|NCT02448706|10013395|FG001|Completed Baseline Testing|Overall Study||23
8950700|NCT02448706|10013394|FG000|COMPLETED|Overall Study||20
8950701|NCT02448706|10013395|FG001|COMPLETED|Overall Study||20
8950702|NCT02448706|10013394|FG000|NOT COMPLETED|Overall Study||5
8950703|NCT02448706|10013395|FG001|NOT COMPLETED|Overall Study||4
8950704|NCT02448719|10013414|FG000|STARTED|Overall Study||12
8950705|NCT02448719|10013415|FG001|STARTED|Overall Study||6
8950706|NCT02448719|10013416|FG002|STARTED|Overall Study||6
8950707|NCT02448719|10013417|FG003|STARTED|Overall Study||6
8950708|NCT02448719|10013418|FG004|STARTED|Overall Study||6
8950709|NCT02448719|10013419|FG005|STARTED|Overall Study||6
8950710|NCT02448719|10013420|FG006|STARTED|Overall Study||6
8950711|NCT02448719|10013421|FG007|STARTED|Overall Study||6
8950712|NCT02448719|10013422|FG008|STARTED|Overall Study||6
8950713|NCT02448719|10013423|FG009|STARTED|Overall Study||6
8950714|NCT02448719|10013424|FG010|STARTED|Overall Study||6
8950715|NCT02448719|10013414|FG000|COMPLETED|Overall Study||12
8950716|NCT02448719|10013415|FG001|COMPLETED|Overall Study||6
8950717|NCT02448719|10013416|FG002|COMPLETED|Overall Study||6
8630458|NCT00535236|9670228|FG008|COMPLETED|Overall Study||47
8630459|NCT00535236|9670229|FG009|COMPLETED|Overall Study||16
8630460|NCT00535236|9670220|FG000|NOT COMPLETED|Overall Study||7
8630461|NCT00535236|9670221|FG001|NOT COMPLETED|Overall Study||2
8630462|NCT00535236|9670222|FG002|NOT COMPLETED|Overall Study||12
8950718|NCT02448719|10013417|FG003|COMPLETED|Overall Study||6
8630463|NCT00535236|9670223|FG003|NOT COMPLETED|Overall Study||4
8863425|NCT01828567|9919230|FG000|COMPLETED|Overall Study||177
8863426|NCT01828567|9919231|FG001|COMPLETED|Overall Study||199
8863427|NCT01828567|9919230|FG000|NOT COMPLETED|Overall Study||31
8863428|NCT01828567|9919231|FG001|NOT COMPLETED|Overall Study||10
8863429|NCT01828593|9919240|FG000|STARTED|Placebo-Controlled Phase||36
8863430|NCT01828593|9919241|FG001|STARTED|Placebo-Controlled Phase||34
8863431|NCT01828593|9919242|FG002|STARTED|Placebo-Controlled Phase||33
8863432|NCT01828593|9919240|FG000|COMPLETED|Placebo-Controlled Phase||36
8863433|NCT01828593|9919241|FG001|COMPLETED|Placebo-Controlled Phase||34
8863434|NCT01828593|9919242|FG002|COMPLETED|Placebo-Controlled Phase||32
8863435|NCT01828593|9919240|FG000|NOT COMPLETED|Placebo-Controlled Phase||0
8863436|NCT01828593|9919241|FG001|NOT COMPLETED|Placebo-Controlled Phase||0
8950719|NCT02448719|10013418|FG004|COMPLETED|Overall Study||5
8950720|NCT02448719|10013419|FG005|COMPLETED|Overall Study||6
8950721|NCT02448719|10013420|FG006|COMPLETED|Overall Study||6
8950722|NCT02448719|10013421|FG007|COMPLETED|Overall Study||6
8950723|NCT02448719|10013422|FG008|COMPLETED|Overall Study||6
8950724|NCT02448719|10013423|FG009|COMPLETED|Overall Study||6
8863437|NCT01828593|9919242|FG002|NOT COMPLETED|Placebo-Controlled Phase||1
8863438|NCT01828593|9919240|FG000|STARTED|Placebo-Free Phase|Placebo subjects took either SBI 2.5 or 5.0 g in the placebo-free phase|0
8630464|NCT00535236|9670224|FG004|NOT COMPLETED|Overall Study||12
8630465|NCT00535236|9670225|FG005|NOT COMPLETED|Overall Study||1
8630466|NCT00535236|9670226|FG006|NOT COMPLETED|Overall Study||11
8630467|NCT00535236|9670227|FG007|NOT COMPLETED|Overall Study||1
8630468|NCT00535236|9670228|FG008|NOT COMPLETED|Overall Study||13
8725608|NCT01032291|9772889|FG002|COMPLETED|Proof of Concept|Participants with disease progression|18
8863439|NCT01828593|9919241|FG001|STARTED|Placebo-Free Phase|SBI 2.5 g includes SBI 2.5 plus placebo who started taking SBI at Wk 4|55
8863440|NCT01828593|9919242|FG002|STARTED|Placebo-Free Phase|SBI 5.0 g includes SBI 5.0 plus placebo who started taking SBI at Wk 4|47
8863441|NCT01828593|9919240|FG000|COMPLETED|Placebo-Free Phase|Placebo subjects took either SBI 2.5 or 5.0 g in the placebo-free phase|0
8863442|NCT01828593|9919241|FG001|COMPLETED|Placebo-Free Phase|SBI 2.5 g includes SBI 2.5 plus placebo who started taking SBI at Wk 4|49
8863443|NCT01828593|9919242|FG002|COMPLETED|Placebo-Free Phase|SBI 5.0 g includes SBI 5.0 plus placebo who started taking SBI at Wk 4|41
8863444|NCT01828593|9919240|FG000|NOT COMPLETED|Placebo-Free Phase||0
8863445|NCT01828593|9919241|FG001|NOT COMPLETED|Placebo-Free Phase||6
8863446|NCT01828593|9919242|FG002|NOT COMPLETED|Placebo-Free Phase||6
8863447|NCT01828983|9919255|FG000|STARTED|Overall Study||80
8863448|NCT01828983|9919256|FG001|STARTED|Overall Study||81
8863449|NCT01828983|9919255|FG000|COMPLETED|Overall Study||80
8863450|NCT01828983|9919256|FG001|COMPLETED|Overall Study||81
8863451|NCT01828983|9919255|FG000|NOT COMPLETED|Overall Study||0
8863452|NCT01828983|9919256|FG001|NOT COMPLETED|Overall Study||0
8863453|NCT01829048|9919267|FG000|STARTED|Overall Study||6
8863454|NCT01829048|9919268|FG001|STARTED|Overall Study||8
8863455|NCT01829048|9919269|FG002|STARTED|Overall Study||7
8863456|NCT01829048|9919270|FG003|STARTED|Overall Study||14
8863457|NCT01829048|9919271|FG004|STARTED|Overall Study||2
8863458|NCT01829048|9919267|FG000|COMPLETED|Overall Study||6
8863459|NCT01829048|9919268|FG001|COMPLETED|Overall Study||8
8863460|NCT01829048|9919269|FG002|COMPLETED|Overall Study||7
8863461|NCT01829048|9919270|FG003|COMPLETED|Overall Study||12
8863462|NCT01829048|9919271|FG004|COMPLETED|Overall Study||2
8863463|NCT01829048|9919267|FG000|NOT COMPLETED|Overall Study||0
8863464|NCT01829048|9919268|FG001|NOT COMPLETED|Overall Study||0
8863465|NCT01829048|9919269|FG002|NOT COMPLETED|Overall Study||0
8863466|NCT01829048|9919270|FG003|NOT COMPLETED|Overall Study||2
8863467|NCT01829048|9919271|FG004|NOT COMPLETED|Overall Study||0
8863468|NCT01829113|9919286|FG000|STARTED|Overall Study|Three patients were enrolled and randomized but never received treatment.|77
8863469|NCT01829113|9919287|FG001|STARTED|Overall Study|Two patients were enrolled and randomized but never received treatment.|78
8863470|NCT01829113|9919286|FG000|COMPLETED|Overall Study||0
8863471|NCT01829113|9919287|FG001|COMPLETED|Overall Study||0
8863472|NCT01829113|9919286|FG000|NOT COMPLETED|Overall Study||77
8863473|NCT01829113|9919287|FG001|NOT COMPLETED|Overall Study||78
8863474|NCT01829165|9919297|FG000|STARTED|Overall Study||20
8725609|NCT01032291|9772887|FG000|NOT COMPLETED|Proof of Concept||0
8863475|NCT01829165|9919298|FG001|STARTED|Overall Study||13
8863476|NCT01829165|9919297|FG000|COMPLETED|Overall Study||18
8863477|NCT01829165|9919298|FG001|COMPLETED|Overall Study||13
8863478|NCT01829165|9919297|FG000|NOT COMPLETED|Overall Study||2
8863479|NCT01829165|9919298|FG001|NOT COMPLETED|Overall Study||0
8863480|NCT01829191|9919306|FG000|STARTED|Overall Study||63
8863481|NCT01829191|9919307|FG001|STARTED|Overall Study||64
8863482|NCT01829191|9919306|FG000|COMPLETED|Overall Study||56
8863483|NCT01829191|9919307|FG001|COMPLETED|Overall Study||50
8863484|NCT01829191|9919306|FG000|NOT COMPLETED|Overall Study||7
8863485|NCT01829191|9919307|FG001|NOT COMPLETED|Overall Study||14
8863486|NCT01829217|9919312|FG000|STARTED|Overall Study||13
8863487|NCT01829217|9919312|FG000|COMPLETED|Overall Study||13
8863488|NCT01829217|9919312|FG000|NOT COMPLETED|Overall Study||0
8863489|NCT01829230|9919318|FG000|STARTED|Overall Study||40
8863490|NCT01829230|9919319|FG001|STARTED|Overall Study||42
8863491|NCT01829230|9919318|FG000|COMPLETED|Overall Study||39
8863492|NCT01829230|9919319|FG001|COMPLETED|Overall Study||38
8863493|NCT01829230|9919318|FG000|NOT COMPLETED|Overall Study||1
8863494|NCT01829230|9919319|FG001|NOT COMPLETED|Overall Study||4
8863495|NCT01829243|9919325|FG000|STARTED|First Intervention||11
8863496|NCT01829243|9919326|FG001|STARTED|First Intervention||15
8863497|NCT01829243|9919325|FG000|COMPLETED|First Intervention||7
8863498|NCT01829243|9919326|FG001|COMPLETED|First Intervention||13
8863499|NCT01829243|9919325|FG000|NOT COMPLETED|First Intervention||4
8863500|NCT01829243|9919326|FG001|NOT COMPLETED|First Intervention||2
8863501|NCT01829243|9919325|FG000|STARTED|Washout Period of 1 Week||7
8863502|NCT01829243|9919326|FG001|STARTED|Washout Period of 1 Week||13
8630469|NCT00535236|9670229|FG009|NOT COMPLETED|Overall Study||4
8630470|NCT00535288|9670259|FG000|STARTED|Overall Study|2 participants randomized to receive placebo did not receive placebo|314
8630471|NCT00535288|9670260|FG001|STARTED|Overall Study||162
8630472|NCT00535288|9670261|FG002|STARTED|Overall Study||160
8630473|NCT00535288|9670262|FG003|STARTED|Overall Study||151
8630474|NCT00535288|9670263|FG004|STARTED|Overall Study|One participant randomized to receive placebo received esmirtazapine 18 mg.|158
8630475|NCT00535288|9670259|FG000|COMPLETED|Overall Study||260
8863503|NCT01829243|9919325|FG000|COMPLETED|Washout Period of 1 Week||7
8863504|NCT01829243|9919326|FG001|COMPLETED|Washout Period of 1 Week||13
8863505|NCT01829243|9919325|FG000|NOT COMPLETED|Washout Period of 1 Week||0
8863506|NCT01829243|9919326|FG001|NOT COMPLETED|Washout Period of 1 Week||0
8863507|NCT01829243|9919325|FG000|STARTED|Second Intervention||7
8863508|NCT01829243|9919326|FG001|STARTED|Second Intervention||13
8863509|NCT01829243|9919325|FG000|COMPLETED|Second Intervention||7
8863510|NCT01829243|9919326|FG001|COMPLETED|Second Intervention||13
8863511|NCT01829243|9919325|FG000|NOT COMPLETED|Second Intervention||0
8863512|NCT01829243|9919326|FG001|NOT COMPLETED|Second Intervention||0
8863513|NCT01829295|9919336|FG000|STARTED|0-6 Months||107
8863514|NCT01829295|9919337|FG001|STARTED|0-6 Months||109
8863515|NCT01829295|9919338|FG002|STARTED|0-6 Months||0
8863516|NCT01829295|9919339|FG003|STARTED|0-6 Months||0
8863517|NCT01829295|9919336|FG000|COMPLETED|0-6 Months||96
8863518|NCT01829295|9919337|FG001|COMPLETED|0-6 Months||98
8863519|NCT01829295|9919338|FG002|COMPLETED|0-6 Months||0
8863520|NCT01829295|9919339|FG003|COMPLETED|0-6 Months||0
8863521|NCT01829295|9919336|FG000|NOT COMPLETED|0-6 Months||11
8950725|NCT02448719|10013424|FG010|COMPLETED|Overall Study||6
8950726|NCT02448719|10013414|FG000|NOT COMPLETED|Overall Study||0
8950727|NCT02448719|10013415|FG001|NOT COMPLETED|Overall Study||0
8950728|NCT02448719|10013416|FG002|NOT COMPLETED|Overall Study||0
8950729|NCT02448719|10013417|FG003|NOT COMPLETED|Overall Study||0
8950730|NCT02448719|10013418|FG004|NOT COMPLETED|Overall Study||1
8950731|NCT02448719|10013419|FG005|NOT COMPLETED|Overall Study||0
8950732|NCT02448719|10013420|FG006|NOT COMPLETED|Overall Study||0
8950733|NCT02448719|10013421|FG007|NOT COMPLETED|Overall Study||0
8950734|NCT02448719|10013422|FG008|NOT COMPLETED|Overall Study||0
8950735|NCT02448719|10013423|FG009|NOT COMPLETED|Overall Study||0
8950736|NCT02448719|10013424|FG010|NOT COMPLETED|Overall Study||0
8950737|NCT02448771|10013485|FG000|STARTED|Overall Study||36
8950738|NCT02448771|10013485|FG000|COMPLETED|Overall Study||0
8950739|NCT02448771|10013485|FG000|NOT COMPLETED|Overall Study||36
8950740|NCT02448810|10013498|FG000|STARTED|Overall Study||3
8950741|NCT02448810|10013499|FG001|STARTED|Overall Study||3
8950742|NCT02448810|10013500|FG002|STARTED|Overall Study||3
8950743|NCT02448810|10013501|FG003|STARTED|Overall Study||3
8950744|NCT02448810|10013502|FG004|STARTED|Overall Study||31
8950745|NCT02448810|10013503|FG005|STARTED|Overall Study||16
8950746|NCT02448810|10013504|FG006|STARTED|Overall Study||18
8950747|NCT02448810|10013505|FG007|STARTED|Overall Study||8
8950748|NCT02448810|10013498|FG000|Treated|Overall Study||3
8950749|NCT02448810|10013499|FG001|Treated|Overall Study||3
8950750|NCT02448810|10013500|FG002|Treated|Overall Study||3
8950751|NCT02448810|10013501|FG003|Treated|Overall Study||3
8950752|NCT02448810|10013502|FG004|Treated|Overall Study||29
8950753|NCT02448810|10013503|FG005|Treated|Overall Study||13
8950754|NCT02448810|10013504|FG006|Treated|Overall Study||18
8950755|NCT02448810|10013505|FG007|Treated|Overall Study||7
8950756|NCT02448810|10013498|FG000|COMPLETED|Overall Study||0
8950757|NCT02448810|10013499|FG001|COMPLETED|Overall Study||0
8950758|NCT02448810|10013500|FG002|COMPLETED|Overall Study||0
8950759|NCT02448810|10013501|FG003|COMPLETED|Overall Study||0
8950760|NCT02448810|10013502|FG004|COMPLETED|Overall Study||0
8950761|NCT02448810|10013503|FG005|COMPLETED|Overall Study||0
8950762|NCT02448810|10013504|FG006|COMPLETED|Overall Study||0
8950763|NCT02448810|10013505|FG007|COMPLETED|Overall Study||0
8950764|NCT02448810|10013498|FG000|NOT COMPLETED|Overall Study||3
8950765|NCT02448810|10013499|FG001|NOT COMPLETED|Overall Study||3
8950766|NCT02448810|10013500|FG002|NOT COMPLETED|Overall Study||3
8950767|NCT02448810|10013501|FG003|NOT COMPLETED|Overall Study||3
8950768|NCT02448810|10013502|FG004|NOT COMPLETED|Overall Study||31
8950769|NCT02448810|10013503|FG005|NOT COMPLETED|Overall Study||16
8950770|NCT02448810|10013504|FG006|NOT COMPLETED|Overall Study||18
8950771|NCT02448810|10013505|FG007|NOT COMPLETED|Overall Study||8
8950772|NCT02448862|10013529|FG000|STARTED|Overall Study||4525
8950773|NCT02448862|10013530|FG001|STARTED|Overall Study||6050
8950774|NCT02448862|10013529|FG000|COMPLETED|Overall Study||4525
8950775|NCT02448862|10013530|FG001|COMPLETED|Overall Study||6050
8950776|NCT02448862|10013529|FG000|NOT COMPLETED|Overall Study||0
8950777|NCT02448862|10013530|FG001|NOT COMPLETED|Overall Study||0
8950778|NCT02448875|10013539|FG000|STARTED|Overall Study||60
8950779|NCT02448875|10013540|FG001|STARTED|Overall Study||21
8950780|NCT02448875|10013541|FG002|STARTED|Overall Study||61
8950781|NCT02448875|10013539|FG000|Completed Dose Selection Phase|Overall Study||20
8950782|NCT02448875|10013540|FG001|Completed Dose Selection Phase|Overall Study||21
8950783|NCT02448875|10013541|FG002|Completed Dose Selection Phase|Overall Study||20
8950784|NCT02448875|10013539|FG000|Full Analysis Set|Overall Study||60
8950785|NCT02448875|10013540|FG001|Full Analysis Set|Overall Study||21
8950786|NCT02448875|10013541|FG002|Full Analysis Set|Overall Study||61
8950787|NCT02448875|10013539|FG000|Safety Analysis Set|Overall Study||60
8950788|NCT02448875|10013540|FG001|Safety Analysis Set|Overall Study||21
8863522|NCT01829295|9919337|FG001|NOT COMPLETED|0-6 Months||11
8863523|NCT01829295|9919338|FG002|NOT COMPLETED|0-6 Months||0
8863524|NCT01829295|9919339|FG003|NOT COMPLETED|0-6 Months||0
8950789|NCT02448875|10013541|FG002|Safety Analysis Set|Overall Study||61
8950790|NCT02448875|10013539|FG000|COMPLETED|Overall Study||53
8950791|NCT02448875|10013540|FG001|COMPLETED|Overall Study||20
8950792|NCT02448875|10013541|FG002|COMPLETED|Overall Study||60
8950793|NCT02448875|10013539|FG000|NOT COMPLETED|Overall Study||7
8950794|NCT02448875|10013540|FG001|NOT COMPLETED|Overall Study||1
8863525|NCT01829295|9919336|FG000|STARTED|6-12 Months|64 patients were a treatment success on methotrexate at 6 mo and had the option to continue|64
8863526|NCT01829295|9919337|FG001|STARTED|6-12 Months|56 patients were a treatment success on mycophenolate mofetil at 6 mo and had the option to continue|56
8863527|NCT01829295|9919338|FG002|STARTED|6-12 Months|32 patients failed methotrexate within the first 6 months|32
8863528|NCT01829295|9919339|FG003|STARTED|6-12 Months|42 patients failed on mycophenolate mofetil within the first 6 months|42
8863529|NCT01829295|9919336|FG000|COMPLETED|6-12 Months||60
8863530|NCT01829295|9919337|FG001|COMPLETED|6-12 Months||54
8863531|NCT01829295|9919338|FG002|COMPLETED|6-12 Months||20
8863532|NCT01829295|9919339|FG003|COMPLETED|6-12 Months||29
8863533|NCT01829295|9919336|FG000|NOT COMPLETED|6-12 Months||4
8863534|NCT01829295|9919337|FG001|NOT COMPLETED|6-12 Months||2
8863535|NCT01829295|9919338|FG002|NOT COMPLETED|6-12 Months||12
8863536|NCT01829295|9919339|FG003|NOT COMPLETED|6-12 Months||13
8863537|NCT01829347|9919351|FG000|STARTED|VTI-210||9
8863538|NCT01829347|9919352|FG001|STARTED|VTI-210||9
8863539|NCT01829347|9919351|FG000|COMPLETED|VTI-210||3
8863540|NCT01829347|9919352|FG001|COMPLETED|VTI-210||6
8863541|NCT01829347|9919351|FG000|NOT COMPLETED|VTI-210||6
8863542|NCT01829347|9919352|FG001|NOT COMPLETED|VTI-210||3
8863543|NCT01829347|9919351|FG000|STARTED|VTI-210E||3
8863544|NCT01829347|9919352|FG001|STARTED|VTI-210E||6
8863545|NCT01829347|9919351|FG000|COMPLETED|VTI-210E||0
8863546|NCT01829347|9919352|FG001|COMPLETED|VTI-210E||0
8863547|NCT01829347|9919351|FG000|NOT COMPLETED|VTI-210E||3
8863548|NCT01829347|9919352|FG001|NOT COMPLETED|VTI-210E||6
8863549|NCT01829360|9919362|FG000|STARTED|Overall Study||8
8863550|NCT01829360|9919363|FG001|STARTED|Overall Study||9
8863551|NCT01829360|9919364|FG002|STARTED|Overall Study||10
8863552|NCT01829360|9919365|FG003|STARTED|Overall Study||8
8863553|NCT01829360|9919362|FG000|COMPLETED|Overall Study||8
8863554|NCT01829360|9919363|FG001|COMPLETED|Overall Study||9
8863555|NCT01829360|9919364|FG002|COMPLETED|Overall Study||9
8863556|NCT01829360|9919365|FG003|COMPLETED|Overall Study||8
8863557|NCT01829360|9919362|FG000|NOT COMPLETED|Overall Study||0
8863558|NCT01829360|9919363|FG001|NOT COMPLETED|Overall Study||0
8863559|NCT01829360|9919364|FG002|NOT COMPLETED|Overall Study||1
8863560|NCT01829360|9919365|FG003|NOT COMPLETED|Overall Study||0
8863561|NCT01829399|9919381|FG000|STARTED|Visit 1||12
8863562|NCT01829399|9919382|FG001|STARTED|Visit 1||12
8863563|NCT01829399|9919381|FG000|COMPLETED|Visit 1||12
8863564|NCT01829399|9919382|FG001|COMPLETED|Visit 1||12
8863565|NCT01829399|9919381|FG000|NOT COMPLETED|Visit 1||0
8863566|NCT01829399|9919382|FG001|NOT COMPLETED|Visit 1||0
8863567|NCT01829399|9919381|FG000|STARTED|Visit 2 (One Month Later)||12
8863568|NCT01829399|9919382|FG001|STARTED|Visit 2 (One Month Later)||12
8863569|NCT01829399|9919381|FG000|COMPLETED|Visit 2 (One Month Later)||12
8863570|NCT01829399|9919382|FG001|COMPLETED|Visit 2 (One Month Later)||12
8863571|NCT01829399|9919381|FG000|NOT COMPLETED|Visit 2 (One Month Later)||0
8863572|NCT01829399|9919382|FG001|NOT COMPLETED|Visit 2 (One Month Later)||0
8863573|NCT01829425|9919392|FG000|STARTED|Overall Study||78
8863574|NCT01829425|9919393|FG001|STARTED|Overall Study||74
8863575|NCT01829425|9919392|FG000|COMPLETED|Overall Study|completed primary outcome 2 month f/u N=72|72
8863576|NCT01829425|9919393|FG001|COMPLETED|Overall Study|completed primary outcome 2 month f/u N=70|70
8863577|NCT01829425|9919392|FG000|NOT COMPLETED|Overall Study||6
8863578|NCT01829425|9919393|FG001|NOT COMPLETED|Overall Study||4
8863579|NCT01829464|9919402|FG000|STARTED|Overall Study||30
8863580|NCT01829464|9919403|FG001|STARTED|Overall Study||31
8863581|NCT01829464|9919404|FG002|STARTED|Overall Study||29
8950795|NCT02448875|10013541|FG002|NOT COMPLETED|Overall Study||1
8950796|NCT02448914|10013552|FG000|STARTED|First Intervention (1 Day)||6
8950797|NCT02448914|10013553|FG001|STARTED|First Intervention (1 Day)||5
8950798|NCT02448914|10013552|FG000|COMPLETED|First Intervention (1 Day)||6
8950799|NCT02448914|10013553|FG001|COMPLETED|First Intervention (1 Day)||5
8950800|NCT02448914|10013552|FG000|NOT COMPLETED|First Intervention (1 Day)||0
8950801|NCT02448914|10013553|FG001|NOT COMPLETED|First Intervention (1 Day)||0
8950802|NCT02448914|10013552|FG000|STARTED|Second Intervention (1 Day)||6
8950803|NCT02448914|10013553|FG001|STARTED|Second Intervention (1 Day)||5
8950804|NCT02448914|10013552|FG000|COMPLETED|Second Intervention (1 Day)||6
8950805|NCT02448914|10013553|FG001|COMPLETED|Second Intervention (1 Day)||5
8950806|NCT02448914|10013552|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
8950807|NCT02448914|10013553|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
8950808|NCT02449018|10013562|FG000|STARTED|Overall Study||64
8950809|NCT02449018|10013563|FG001|STARTED|Overall Study||28
8950810|NCT02449018|10013562|FG000|COMPLETED|Overall Study||52
8950811|NCT02449018|10013563|FG001|COMPLETED|Overall Study||26
8950812|NCT02449018|10013562|FG000|NOT COMPLETED|Overall Study||12
8950813|NCT02449018|10013563|FG001|NOT COMPLETED|Overall Study||2
8950814|NCT02449044|10013569|FG000|STARTED|Overall Study||111
8950815|NCT02449044|10013569|FG000|COMPLETED|Overall Study|Participants who completed Weeks 58, 106 and 216 visit.|47
8950816|NCT02449044|10013569|FG000|NOT COMPLETED|Overall Study||64
8950817|NCT02449174|10013575|FG000|STARTED|Overall Study||36
8950818|NCT02449174|10013576|FG001|STARTED|Overall Study||32
8950819|NCT02449174|10013575|FG000|COMPLETED|Overall Study||36
8950820|NCT02449174|10013576|FG001|COMPLETED|Overall Study||32
8950821|NCT02449174|10013575|FG000|NOT COMPLETED|Overall Study||0
8950822|NCT02449174|10013576|FG001|NOT COMPLETED|Overall Study||0
8950823|NCT02449291|10013585|FG000|STARTED|Overall Study||191
8950824|NCT02449291|10013586|FG001|STARTED|Overall Study||188
8950825|NCT02449291|10013587|FG002|STARTED|Overall Study||181
8863582|NCT01829464|9919402|FG000|COMPLETED|Overall Study||2
8863583|NCT01829464|9919403|FG001|COMPLETED|Overall Study||2
8863584|NCT01829464|9919404|FG002|COMPLETED|Overall Study||3
8863585|NCT01829464|9919402|FG000|NOT COMPLETED|Overall Study||28
8863586|NCT01829464|9919403|FG001|NOT COMPLETED|Overall Study||29
8863587|NCT01829464|9919404|FG002|NOT COMPLETED|Overall Study||26
8863588|NCT01829503|9919412|FG000|STARTED|Overall Study||44
8863589|NCT01829503|9919412|FG000|COMPLETED|Overall Study||44
8863590|NCT01829503|9919412|FG000|NOT COMPLETED|Overall Study||0
8863591|NCT01829516|9919418|FG000|STARTED|First Intervention||18
8863592|NCT01829516|9919419|FG001|STARTED|First Intervention||14
8863593|NCT01829516|9919418|FG000|COMPLETED|First Intervention||18
8863594|NCT01829516|9919419|FG001|COMPLETED|First Intervention||14
8863595|NCT01829516|9919418|FG000|NOT COMPLETED|First Intervention||0
8863596|NCT01829516|9919419|FG001|NOT COMPLETED|First Intervention||0
8863597|NCT01829516|9919418|FG000|STARTED|Washout Period - 1 Week||18
8863598|NCT01829516|9919419|FG001|STARTED|Washout Period - 1 Week||14
8863599|NCT01829516|9919418|FG000|COMPLETED|Washout Period - 1 Week||18
8863600|NCT01829516|9919419|FG001|COMPLETED|Washout Period - 1 Week||14
8863601|NCT01829516|9919418|FG000|NOT COMPLETED|Washout Period - 1 Week||0
8863602|NCT01829516|9919419|FG001|NOT COMPLETED|Washout Period - 1 Week||0
8863603|NCT01829516|9919418|FG000|STARTED|2nd Intervention||18
8863604|NCT01829516|9919419|FG001|STARTED|2nd Intervention||14
8863605|NCT01829516|9919418|FG000|COMPLETED|2nd Intervention||18
8863606|NCT01829516|9919419|FG001|COMPLETED|2nd Intervention||14
8863607|NCT01829516|9919418|FG000|NOT COMPLETED|2nd Intervention||0
8863608|NCT01829516|9919419|FG001|NOT COMPLETED|2nd Intervention||0
8863609|NCT01829919|9919427|FG000|STARTED|Overall Study||24
8863610|NCT01829919|9919427|FG000|COMPLETED|Overall Study||24
8863611|NCT01829919|9919427|FG000|NOT COMPLETED|Overall Study||0
8863612|NCT01829997|9919431|FG000|STARTED|Overall Study||22
8863613|NCT01829997|9919431|FG000|COMPLETED|Overall Study||16
8863614|NCT01829997|9919431|FG000|NOT COMPLETED|Overall Study||6
8863615|NCT01830127|9919437|FG000|STARTED|Overall Study||18
8863616|NCT01830127|9919438|FG001|STARTED|Overall Study||17
8863617|NCT01830127|9919437|FG000|COMPLETED|Overall Study||13
8863618|NCT01830127|9919438|FG001|COMPLETED|Overall Study||8
8863619|NCT01830127|9919437|FG000|NOT COMPLETED|Overall Study||5
8863620|NCT01830127|9919438|FG001|NOT COMPLETED|Overall Study||9
8863621|NCT01830140|9919446|FG000|STARTED|Overall Study||233
8863622|NCT01830140|9919447|FG001|STARTED|Overall Study||233
8863623|NCT01830140|9919446|FG000|COMPLETED|Overall Study||226
8863624|NCT01830140|9919447|FG001|COMPLETED|Overall Study||229
8863625|NCT01830140|9919446|FG000|NOT COMPLETED|Overall Study||7
8863626|NCT01830140|9919447|FG001|NOT COMPLETED|Overall Study||4
8863627|NCT01830205|9919457|FG000|STARTED|Overall Study||12
8863628|NCT01830205|9919458|FG001|STARTED|Overall Study||6
8863629|NCT01830205|9919459|FG002|STARTED|Overall Study||6
8863630|NCT01830205|9919460|FG003|STARTED|Overall Study||12
8863631|NCT01830205|9919457|FG000|COMPLETED|Overall Study||12
8863632|NCT01830205|9919458|FG001|COMPLETED|Overall Study||6
8863633|NCT01830205|9919459|FG002|COMPLETED|Overall Study||6
8863634|NCT01830205|9919460|FG003|COMPLETED|Overall Study||12
8863635|NCT01830205|9919457|FG000|NOT COMPLETED|Overall Study||0
8863636|NCT01830205|9919458|FG001|NOT COMPLETED|Overall Study||0
8863637|NCT01830205|9919459|FG002|NOT COMPLETED|Overall Study||0
8863638|NCT01830205|9919460|FG003|NOT COMPLETED|Overall Study||0
8863639|NCT01830543|9919484|FG000|STARTED|Overall Study||709
8863640|NCT01830543|9919485|FG001|STARTED|Overall Study||709
8863641|NCT01830543|9919486|FG002|STARTED|Overall Study||706
8863642|NCT01830543|9919484|FG000|Treated|Overall Study||696
8863643|NCT01830543|9919485|FG001|Treated|Overall Study||706
8863644|NCT01830543|9919486|FG002|Treated|Overall Study||697
8863645|NCT01830543|9919484|FG000|COMPLETED|Overall Study||550
8863646|NCT01830543|9919485|FG001|COMPLETED|Overall Study||557
8863647|NCT01830543|9919486|FG002|COMPLETED|Overall Study||492
8863648|NCT01830543|9919484|FG000|NOT COMPLETED|Overall Study||159
8863649|NCT01830543|9919485|FG001|NOT COMPLETED|Overall Study||152
8863650|NCT01830543|9919486|FG002|NOT COMPLETED|Overall Study||214
8863651|NCT01830595|9919494|FG000|STARTED|First Period||26
8863652|NCT01830595|9919495|FG001|STARTED|First Period||28
8863653|NCT01830595|9919494|FG000|Received at Least One Dose|First Period||26
8863654|NCT01830595|9919495|FG001|Received at Least One Dose|First Period||28
8863655|NCT01830595|9919494|FG000|COMPLETED|First Period||25
8863656|NCT01830595|9919495|FG001|COMPLETED|First Period||25
8863657|NCT01830595|9919494|FG000|NOT COMPLETED|First Period||1
8863658|NCT01830595|9919495|FG001|NOT COMPLETED|First Period||3
8863659|NCT01830595|9919494|FG000|STARTED|Washout||25
8863660|NCT01830595|9919495|FG001|STARTED|Washout||25
8950826|NCT02449291|10013585|FG000|COMPLETED|Overall Study||186
8950827|NCT02449291|10013586|FG001|COMPLETED|Overall Study||186
8863661|NCT01830595|9919494|FG000|COMPLETED|Washout||23
8863662|NCT01830595|9919495|FG001|COMPLETED|Washout||23
8863663|NCT01830595|9919494|FG000|NOT COMPLETED|Washout||2
8863664|NCT01830595|9919495|FG001|NOT COMPLETED|Washout||2
8863665|NCT01830595|9919494|FG000|STARTED|Second Period||23
8863666|NCT01830595|9919495|FG001|STARTED|Second Period||23
8863667|NCT01830595|9919494|FG000|COMPLETED|Second Period||23
8863668|NCT01830595|9919495|FG001|COMPLETED|Second Period||23
8863669|NCT01830595|9919494|FG000|NOT COMPLETED|Second Period||0
8863670|NCT01830595|9919495|FG001|NOT COMPLETED|Second Period||0
8863671|NCT01830621|9919503|FG000|STARTED|Overall Study||138
8863672|NCT01830621|9919504|FG001|STARTED|Overall Study||144
8863673|NCT01830621|9919503|FG000|COMPLETED|Overall Study||138
8863674|NCT01830621|9919504|FG001|COMPLETED|Overall Study||144
8863675|NCT01830621|9919503|FG000|NOT COMPLETED|Overall Study||0
8863676|NCT01830621|9919504|FG001|NOT COMPLETED|Overall Study||0
8863677|NCT01830699|9919512|FG000|STARTED|Overall Study||13
8863678|NCT01830699|9919513|FG001|STARTED|Overall Study||20
8863679|NCT01830699|9919512|FG000|COMPLETED|Overall Study||13
8863680|NCT01830699|9919513|FG001|COMPLETED|Overall Study||20
8863681|NCT01830699|9919512|FG000|NOT COMPLETED|Overall Study||0
8863682|NCT01830699|9919513|FG001|NOT COMPLETED|Overall Study||0
8863683|NCT01830816|9919522|FG000|STARTED|Overall Study||20
8863684|NCT01830816|9919523|FG001|STARTED|Overall Study||14
8863685|NCT01830816|9919524|FG002|STARTED|Overall Study||7
8863686|NCT01830816|9919522|FG000|Pharmacokinetic-Evaluable Population|Overall Study|Participants are considered to have completed study treatment if they are PK evaluable.|18
8863687|NCT01830816|9919523|FG001|Pharmacokinetic-Evaluable Population|Overall Study||14
8863688|NCT01830816|9919524|FG002|Pharmacokinetic-Evaluable Population|Overall Study||6
8863689|NCT01830816|9919522|FG000|COMPLETED|Overall Study||0
8863690|NCT01830816|9919523|FG001|COMPLETED|Overall Study||0
8863691|NCT01830816|9919524|FG002|COMPLETED|Overall Study||0
8863692|NCT01830816|9919522|FG000|NOT COMPLETED|Overall Study||20
8863693|NCT01830816|9919523|FG001|NOT COMPLETED|Overall Study||14
8863694|NCT01830816|9919524|FG002|NOT COMPLETED|Overall Study||7
8863695|NCT01830842|9919537|FG000|STARTED|Overall Study||30
8863696|NCT01830842|9919538|FG001|STARTED|Overall Study||24
8863697|NCT01830842|9919537|FG000|COMPLETED|Overall Study||25
8863698|NCT01830842|9919538|FG001|COMPLETED|Overall Study||22
8863699|NCT01830842|9919537|FG000|NOT COMPLETED|Overall Study||5
8863700|NCT01830842|9919538|FG001|NOT COMPLETED|Overall Study||2
8863701|NCT01830855|9919548|FG000|STARTED|Overall Study||1508
8863702|NCT01830855|9919549|FG001|STARTED|Overall Study||598
8863703|NCT01830855|9919550|FG002|STARTED|Overall Study||587
8863704|NCT01830855|9919551|FG003|STARTED|Overall Study||897
8863705|NCT01830855|9919548|FG000|COMPLETED|Overall Study||1353
8863706|NCT01830855|9919549|FG001|COMPLETED|Overall Study||537
8863707|NCT01830855|9919550|FG002|COMPLETED|Overall Study||521
8863708|NCT01830855|9919551|FG003|COMPLETED|Overall Study||815
8863709|NCT01830855|9919548|FG000|NOT COMPLETED|Overall Study||155
8863710|NCT01830855|9919549|FG001|NOT COMPLETED|Overall Study||61
8863711|NCT01830855|9919550|FG002|NOT COMPLETED|Overall Study||66
8863712|NCT01830855|9919551|FG003|NOT COMPLETED|Overall Study||82
8863713|NCT01830881|9919568|FG000|STARTED|Overall Study||62
8863714|NCT01830881|9919569|FG001|STARTED|Overall Study||62
8863715|NCT01830881|9919568|FG000|COMPLETED|Overall Study||62
8863716|NCT01830881|9919569|FG001|COMPLETED|Overall Study||61
8863717|NCT01830881|9919568|FG000|NOT COMPLETED|Overall Study||0
8863718|NCT01830881|9919569|FG001|NOT COMPLETED|Overall Study||1
8950828|NCT02449291|10013587|FG002|COMPLETED|Overall Study||180
8950829|NCT02449291|10013585|FG000|NOT COMPLETED|Overall Study||5
8950830|NCT02449291|10013586|FG001|NOT COMPLETED|Overall Study||2
8950831|NCT02449291|10013587|FG002|NOT COMPLETED|Overall Study||1
8950832|NCT02449356|10013600|FG000|STARTED|Overall Study||30
8950833|NCT02449356|10013601|FG001|STARTED|Overall Study||30
8950834|NCT02449356|10013600|FG000|COMPLETED|Overall Study||30
8950835|NCT02449356|10013601|FG001|COMPLETED|Overall Study||30
8950836|NCT02449356|10013600|FG000|NOT COMPLETED|Overall Study||0
8950837|NCT02449356|10013601|FG001|NOT COMPLETED|Overall Study||0
9037490|NCT03315559|10098677|FG000|STARTED|Treatment Period 1 (8 Days)||6
9037491|NCT03315559|10098677|FG000|COMPLETED|Treatment Period 1 (8 Days)||6
9037492|NCT03315559|10098677|FG000|NOT COMPLETED|Treatment Period 1 (8 Days)||0
9037493|NCT03315559|10098677|FG000|STARTED|Washout Period (14 Days)||6
9037494|NCT03315559|10098677|FG000|COMPLETED|Washout Period (14 Days)||6
9037495|NCT03315559|10098677|FG000|NOT COMPLETED|Washout Period (14 Days)||0
9037496|NCT03315559|10098677|FG000|STARTED|Treatment Period 2 (15 Days)||6
9037497|NCT03315559|10098677|FG000|COMPLETED|Treatment Period 2 (15 Days)||6
9037498|NCT03315559|10098677|FG000|NOT COMPLETED|Treatment Period 2 (15 Days)||0
9037499|NCT03315572|10098686|FG000|STARTED|Overall Study||14
9037500|NCT03315572|10098687|FG001|STARTED|Overall Study||14
9037501|NCT03315572|10098686|FG000|COMPLETED|Overall Study||14
9037502|NCT03315572|10098687|FG001|COMPLETED|Overall Study||14
8863719|NCT01830920|9919582|FG000|STARTED|Overall Study||126
8863720|NCT01830920|9919583|FG001|STARTED|Overall Study||46
8863721|NCT01830920|9919584|FG002|STARTED|Overall Study||48
8863722|NCT01830920|9919585|FG003|STARTED|Overall Study||125
8863723|NCT01830920|9919586|FG004|STARTED|Overall Study||107
8863724|NCT01830920|9919582|FG000|Received Allocated Drug|Overall Study||115
8863725|NCT01830920|9919583|FG001|Received Allocated Drug|Overall Study||45
8863726|NCT01830920|9919584|FG002|Received Allocated Drug|Overall Study||47
8863727|NCT01830920|9919585|FG003|Received Allocated Drug|Overall Study||119
8863728|NCT01830920|9919586|FG004|Received Allocated Drug|Overall Study||105
8863729|NCT01830920|9919582|FG000|COMPLETED|Overall Study||105
8863730|NCT01830920|9919583|FG001|COMPLETED|Overall Study||40
8863731|NCT01830920|9919584|FG002|COMPLETED|Overall Study||40
9037503|NCT03315572|10098686|FG000|NOT COMPLETED|Overall Study||0
9037504|NCT03315572|10098687|FG001|NOT COMPLETED|Overall Study||0
9037505|NCT03315689|10098696|FG000|STARTED|Double-blind Period = 28 Days||4
8863732|NCT01830920|9919585|FG003|COMPLETED|Overall Study||109
8863733|NCT01830920|9919586|FG004|COMPLETED|Overall Study||99
8863734|NCT01830920|9919582|FG000|NOT COMPLETED|Overall Study||21
9037506|NCT03315689|10098697|FG001|STARTED|Double-blind Period = 28 Days||7
8863735|NCT01830920|9919583|FG001|NOT COMPLETED|Overall Study||6
8863736|NCT01830920|9919584|FG002|NOT COMPLETED|Overall Study||8
8863737|NCT01830920|9919585|FG003|NOT COMPLETED|Overall Study||16
8863738|NCT01830920|9919586|FG004|NOT COMPLETED|Overall Study||8
8863739|NCT01830933|9919600|FG000|STARTED|Overall Study||823
8863740|NCT01830933|9919601|FG001|STARTED|Overall Study||812
8863741|NCT01830933|9919600|FG000|Completed Meet-up|Overall Study||675
8863742|NCT01830933|9919601|FG001|Completed Meet-up|Overall Study||603
8863743|NCT01830933|9919600|FG000|COMPLETED|Overall Study||655
8863744|NCT01830933|9919601|FG001|COMPLETED|Overall Study||580
8863745|NCT01830933|9919600|FG000|NOT COMPLETED|Overall Study||168
8863746|NCT01830933|9919601|FG001|NOT COMPLETED|Overall Study||232
8863747|NCT01830972|9919609|FG000|STARTED|Part I||46
8863748|NCT01830972|9919610|FG001|STARTED|Part I|Not applicable; participants in this arm entered during Part 2.|0
8863749|NCT01830972|9919609|FG000|COMPLETED|Part I||46
8863750|NCT01830972|9919610|FG001|COMPLETED|Part I|Not applicable; participants in this arm entered during Part 2.|0
8863751|NCT01830972|9919609|FG000|NOT COMPLETED|Part I||0
8863752|NCT01830972|9919610|FG001|NOT COMPLETED|Part I||0
8863753|NCT01830972|9919609|FG000|STARTED|Part II||46
8863754|NCT01830972|9919610|FG001|STARTED|Part II|Entered study at Part 2|13
8863755|NCT01830972|9919609|FG000|COMPLETED|Part II||44
8863756|NCT01830972|9919610|FG001|COMPLETED|Part II||11
8863757|NCT01830972|9919609|FG000|NOT COMPLETED|Part II||2
8863758|NCT01830972|9919610|FG001|NOT COMPLETED|Part II||2
8863759|NCT01830972|9919609|FG000|STARTED|Part III|2 participants withdrew consent and did not enter Part 3|44
8863760|NCT01830972|9919610|FG001|STARTED|Part III||11
8863761|NCT01830972|9919609|FG000|COMPLETED|Part III||42
8863762|NCT01830972|9919610|FG001|COMPLETED|Part III||11
8863763|NCT01830972|9919609|FG000|NOT COMPLETED|Part III||2
8863764|NCT01830972|9919610|FG001|NOT COMPLETED|Part III||0
8863765|NCT01830972|9919609|FG000|STARTED|Part IV||42
8863766|NCT01830972|9919610|FG001|STARTED|Part IV||11
8863767|NCT01830972|9919609|FG000|COMPLETED|Part IV||39
8863768|NCT01830972|9919610|FG001|COMPLETED|Part IV||10
8863769|NCT01830972|9919609|FG000|NOT COMPLETED|Part IV||3
8863770|NCT01830972|9919610|FG001|NOT COMPLETED|Part IV||1
8863771|NCT01831089|9919632|FG000|STARTED|Cohort I: Dose Level 1||3
8863772|NCT01831089|9919633|FG001|STARTED|Cohort I: Dose Level 1||0
8863773|NCT01831089|9919634|FG002|STARTED|Cohort I: Dose Level 1||0
8863774|NCT01831089|9919635|FG003|STARTED|Cohort I: Dose Level 1||0
8863775|NCT01831089|9919636|FG004|STARTED|Cohort I: Dose Level 1||0
8863776|NCT01831089|9919637|FG005|STARTED|Cohort I: Dose Level 1||0
8863777|NCT01831089|9919632|FG000|COMPLETED|Cohort I: Dose Level 1||0
8863778|NCT01831089|9919633|FG001|COMPLETED|Cohort I: Dose Level 1||0
8863779|NCT01831089|9919634|FG002|COMPLETED|Cohort I: Dose Level 1||0
8863780|NCT01831089|9919635|FG003|COMPLETED|Cohort I: Dose Level 1||0
8863781|NCT01831089|9919636|FG004|COMPLETED|Cohort I: Dose Level 1||0
8863782|NCT01831089|9919637|FG005|COMPLETED|Cohort I: Dose Level 1||0
8863783|NCT01831089|9919632|FG000|NOT COMPLETED|Cohort I: Dose Level 1||3
8863784|NCT01831089|9919633|FG001|NOT COMPLETED|Cohort I: Dose Level 1||0
8863785|NCT01831089|9919634|FG002|NOT COMPLETED|Cohort I: Dose Level 1||0
8863786|NCT01831089|9919635|FG003|NOT COMPLETED|Cohort I: Dose Level 1||0
8863787|NCT01831089|9919636|FG004|NOT COMPLETED|Cohort I: Dose Level 1||0
8863788|NCT01831089|9919637|FG005|NOT COMPLETED|Cohort I: Dose Level 1||0
8863789|NCT01831089|9919632|FG000|STARTED|Cohort II: Dose Level 2||0
8863790|NCT01831089|9919633|FG001|STARTED|Cohort II: Dose Level 2||3
8863791|NCT01831089|9919634|FG002|STARTED|Cohort II: Dose Level 2||0
8863792|NCT01831089|9919635|FG003|STARTED|Cohort II: Dose Level 2||0
8863793|NCT01831089|9919636|FG004|STARTED|Cohort II: Dose Level 2||0
8863794|NCT01831089|9919637|FG005|STARTED|Cohort II: Dose Level 2||0
8863795|NCT01831089|9919632|FG000|COMPLETED|Cohort II: Dose Level 2||0
8863796|NCT01831089|9919633|FG001|COMPLETED|Cohort II: Dose Level 2||0
8863797|NCT01831089|9919634|FG002|COMPLETED|Cohort II: Dose Level 2||0
8863798|NCT01831089|9919635|FG003|COMPLETED|Cohort II: Dose Level 2||0
8863799|NCT01831089|9919636|FG004|COMPLETED|Cohort II: Dose Level 2||0
8863800|NCT01831089|9919637|FG005|COMPLETED|Cohort II: Dose Level 2||0
8863801|NCT01831089|9919632|FG000|NOT COMPLETED|Cohort II: Dose Level 2||0
8863802|NCT01831089|9919633|FG001|NOT COMPLETED|Cohort II: Dose Level 2||3
8863803|NCT01831089|9919634|FG002|NOT COMPLETED|Cohort II: Dose Level 2||0
8863804|NCT01831089|9919635|FG003|NOT COMPLETED|Cohort II: Dose Level 2||0
8863805|NCT01831089|9919636|FG004|NOT COMPLETED|Cohort II: Dose Level 2||0
8863806|NCT01831089|9919637|FG005|NOT COMPLETED|Cohort II: Dose Level 2||0
8863807|NCT01831089|9919632|FG000|STARTED|Cohort III: Dose Level 3||0
8863808|NCT01831089|9919633|FG001|STARTED|Cohort III: Dose Level 3||0
8863809|NCT01831089|9919634|FG002|STARTED|Cohort III: Dose Level 3||6
8863810|NCT01831089|9919635|FG003|STARTED|Cohort III: Dose Level 3||0
8863811|NCT01831089|9919636|FG004|STARTED|Cohort III: Dose Level 3||0
8863812|NCT01831089|9919637|FG005|STARTED|Cohort III: Dose Level 3||0
8863813|NCT01831089|9919632|FG000|COMPLETED|Cohort III: Dose Level 3||0
8863814|NCT01831089|9919633|FG001|COMPLETED|Cohort III: Dose Level 3||0
8863815|NCT01831089|9919634|FG002|COMPLETED|Cohort III: Dose Level 3||0
8863816|NCT01831089|9919635|FG003|COMPLETED|Cohort III: Dose Level 3||0
8863817|NCT01831089|9919636|FG004|COMPLETED|Cohort III: Dose Level 3||0
8863818|NCT01831089|9919637|FG005|COMPLETED|Cohort III: Dose Level 3||0
8863819|NCT01831089|9919632|FG000|NOT COMPLETED|Cohort III: Dose Level 3||0
8863820|NCT01831089|9919633|FG001|NOT COMPLETED|Cohort III: Dose Level 3||0
8863821|NCT01831089|9919634|FG002|NOT COMPLETED|Cohort III: Dose Level 3||6
8863822|NCT01831089|9919635|FG003|NOT COMPLETED|Cohort III: Dose Level 3||0
8863823|NCT01831089|9919636|FG004|NOT COMPLETED|Cohort III: Dose Level 3||0
8863824|NCT01831089|9919637|FG005|NOT COMPLETED|Cohort III: Dose Level 3||0
8863825|NCT01831089|9919632|FG000|STARTED|Cohort IV: Dose Level 4||0
8863826|NCT01831089|9919633|FG001|STARTED|Cohort IV: Dose Level 4||0
8863827|NCT01831089|9919634|FG002|STARTED|Cohort IV: Dose Level 4||0
8863828|NCT01831089|9919635|FG003|STARTED|Cohort IV: Dose Level 4||6
8863829|NCT01831089|9919636|FG004|STARTED|Cohort IV: Dose Level 4||0
8863830|NCT01831089|9919637|FG005|STARTED|Cohort IV: Dose Level 4||0
8863831|NCT01831089|9919632|FG000|COMPLETED|Cohort IV: Dose Level 4||0
8863832|NCT01831089|9919633|FG001|COMPLETED|Cohort IV: Dose Level 4||0
8863833|NCT01831089|9919634|FG002|COMPLETED|Cohort IV: Dose Level 4||0
8863834|NCT01831089|9919635|FG003|COMPLETED|Cohort IV: Dose Level 4||0
8863835|NCT01831089|9919636|FG004|COMPLETED|Cohort IV: Dose Level 4||0
8863836|NCT01831089|9919637|FG005|COMPLETED|Cohort IV: Dose Level 4||0
8863837|NCT01831089|9919632|FG000|NOT COMPLETED|Cohort IV: Dose Level 4||0
8863838|NCT01831089|9919633|FG001|NOT COMPLETED|Cohort IV: Dose Level 4||0
8863839|NCT01831089|9919634|FG002|NOT COMPLETED|Cohort IV: Dose Level 4||0
8863840|NCT01831089|9919635|FG003|NOT COMPLETED|Cohort IV: Dose Level 4||6
8863841|NCT01831089|9919636|FG004|NOT COMPLETED|Cohort IV: Dose Level 4||0
8863842|NCT01831089|9919637|FG005|NOT COMPLETED|Cohort IV: Dose Level 4||0
8863843|NCT01831089|9919632|FG000|STARTED|Cohort V: Dose Level 5||0
8863844|NCT01831089|9919633|FG001|STARTED|Cohort V: Dose Level 5||0
8863845|NCT01831089|9919634|FG002|STARTED|Cohort V: Dose Level 5||0
8863846|NCT01831089|9919635|FG003|STARTED|Cohort V: Dose Level 5||0
8863847|NCT01831089|9919636|FG004|STARTED|Cohort V: Dose Level 5||37
8863848|NCT01831089|9919637|FG005|STARTED|Cohort V: Dose Level 5||0
8863849|NCT01831089|9919632|FG000|COMPLETED|Cohort V: Dose Level 5||0
8863850|NCT01831089|9919633|FG001|COMPLETED|Cohort V: Dose Level 5||0
8863851|NCT01831089|9919634|FG002|COMPLETED|Cohort V: Dose Level 5||0
8863852|NCT01831089|9919635|FG003|COMPLETED|Cohort V: Dose Level 5||0
8863853|NCT01831089|9919636|FG004|COMPLETED|Cohort V: Dose Level 5||0
8863854|NCT01831089|9919637|FG005|COMPLETED|Cohort V: Dose Level 5||0
8863855|NCT01831089|9919632|FG000|NOT COMPLETED|Cohort V: Dose Level 5||0
8863856|NCT01831089|9919633|FG001|NOT COMPLETED|Cohort V: Dose Level 5||0
8863857|NCT01831089|9919634|FG002|NOT COMPLETED|Cohort V: Dose Level 5||0
8863858|NCT01831089|9919635|FG003|NOT COMPLETED|Cohort V: Dose Level 5||0
8863859|NCT01831089|9919636|FG004|NOT COMPLETED|Cohort V: Dose Level 5||37
8863860|NCT01831089|9919637|FG005|NOT COMPLETED|Cohort V: Dose Level 5||0
8863861|NCT01831089|9919632|FG000|STARTED|Cohort B: Arm B||0
8863862|NCT01831089|9919633|FG001|STARTED|Cohort B: Arm B||0
8950838|NCT02449434|10013611|FG000|STARTED|Overall Study||300
8950839|NCT02449434|10013612|FG001|STARTED|Overall Study||300
8950840|NCT02449434|10013611|FG000|COMPLETED|Overall Study||300
8950841|NCT02449434|10013612|FG001|COMPLETED|Overall Study||300
8950842|NCT02449434|10013611|FG000|NOT COMPLETED|Overall Study||0
8950843|NCT02449434|10013612|FG001|NOT COMPLETED|Overall Study||0
8950844|NCT02449473|10013620|FG000|STARTED|Overall Study||39
8950845|NCT02449473|10013621|FG001|STARTED|Overall Study||40
8950846|NCT02449473|10013620|FG000|COMPLETED|Overall Study||39
8950847|NCT02449473|10013621|FG001|COMPLETED|Overall Study||40
8950848|NCT02449473|10013620|FG000|NOT COMPLETED|Overall Study||0
8950849|NCT02449473|10013621|FG001|NOT COMPLETED|Overall Study||0
8950850|NCT02449798|10013627|FG000|STARTED|Overall Study||120
8950851|NCT02449798|10013627|FG000|COMPLETED|Overall Study||120
8950852|NCT02449798|10013627|FG000|NOT COMPLETED|Overall Study||0
8950853|NCT02449889|10013634|FG000|STARTED|Overall Study||58
8950854|NCT02449889|10013635|FG001|STARTED|Overall Study||58
8950855|NCT02449889|10013636|FG002|STARTED|Overall Study||60
8950856|NCT02449889|10013634|FG000|COMPLETED|Overall Study||57
8950857|NCT02449889|10013635|FG001|COMPLETED|Overall Study||52
8950858|NCT02449889|10013636|FG002|COMPLETED|Overall Study||59
8950859|NCT02449889|10013634|FG000|NOT COMPLETED|Overall Study||1
8950860|NCT02449889|10013635|FG001|NOT COMPLETED|Overall Study||6
8950861|NCT02449889|10013636|FG002|NOT COMPLETED|Overall Study||1
8950862|NCT02449902|10013646|FG000|STARTED|Overall Study||24
8950863|NCT02449902|10013647|FG001|STARTED|Overall Study||26
8725610|NCT01032291|9772888|FG001|NOT COMPLETED|Proof of Concept||8
8725611|NCT01032291|9772889|FG002|NOT COMPLETED|Proof of Concept||3
8863863|NCT01831089|9919634|FG002|STARTED|Cohort B: Arm B||0
8863864|NCT01831089|9919635|FG003|STARTED|Cohort B: Arm B||0
8863865|NCT01831089|9919636|FG004|STARTED|Cohort B: Arm B||0
8863866|NCT01831089|9919637|FG005|STARTED|Cohort B: Arm B||14
8863867|NCT01831089|9919632|FG000|COMPLETED|Cohort B: Arm B||0
8863868|NCT01831089|9919633|FG001|COMPLETED|Cohort B: Arm B||0
8863869|NCT01831089|9919634|FG002|COMPLETED|Cohort B: Arm B||0
8950864|NCT02449902|10013646|FG000|COMPLETED|Overall Study||24
8950865|NCT02449902|10013647|FG001|COMPLETED|Overall Study||24
8950866|NCT02449902|10013646|FG000|NOT COMPLETED|Overall Study||0
8950867|NCT02449902|10013647|FG001|NOT COMPLETED|Overall Study||2
8950868|NCT02449915|10013657|FG000|STARTED|Overall Study||35
8950869|NCT02449915|10013658|FG001|STARTED|Overall Study||35
8950870|NCT02449915|10013657|FG000|COMPLETED|Overall Study||33
8950871|NCT02449915|10013658|FG001|COMPLETED|Overall Study||31
8950872|NCT02449915|10013657|FG000|NOT COMPLETED|Overall Study||2
8863870|NCT01831089|9919635|FG003|COMPLETED|Cohort B: Arm B||0
8863871|NCT01831089|9919636|FG004|COMPLETED|Cohort B: Arm B||0
8863872|NCT01831089|9919637|FG005|COMPLETED|Cohort B: Arm B||0
8863873|NCT01831089|9919632|FG000|NOT COMPLETED|Cohort B: Arm B||0
8863874|NCT01831089|9919633|FG001|NOT COMPLETED|Cohort B: Arm B||0
8863875|NCT01831089|9919634|FG002|NOT COMPLETED|Cohort B: Arm B||0
8863876|NCT01831089|9919635|FG003|NOT COMPLETED|Cohort B: Arm B||0
8863877|NCT01831089|9919636|FG004|NOT COMPLETED|Cohort B: Arm B||0
8863878|NCT01831089|9919637|FG005|NOT COMPLETED|Cohort B: Arm B||14
8863879|NCT01831154|9919655|FG000|STARTED|Overall Study|Study Institutional Review Board (IRB) approval 11-11-2009, first subjects enrolled 6-7-2010|15
8863880|NCT01831154|9919656|FG001|STARTED|Overall Study|Study IRB approval 11-11-2009, first subjects enrolled 6-7-2010|11
8863881|NCT01831154|9919657|FG002|STARTED|Overall Study|Study IRB approval 11-11-2009, first subjects enrolled 6-7-2010|11
8863882|NCT01831154|9919655|FG000|COMPLETED|Overall Study||15
8863883|NCT01831154|9919656|FG001|COMPLETED|Overall Study||11
8863884|NCT01831154|9919657|FG002|COMPLETED|Overall Study||11
8863885|NCT01831154|9919655|FG000|NOT COMPLETED|Overall Study||0
8863886|NCT01831154|9919656|FG001|NOT COMPLETED|Overall Study||0
8863887|NCT01831154|9919657|FG002|NOT COMPLETED|Overall Study||0
8863888|NCT01831219|9919667|FG000|STARTED|Overall Study||73
8863889|NCT01831219|9919668|FG001|STARTED|Overall Study||45
8863890|NCT01831219|9919667|FG000|COMPLETED|Overall Study||40
8863891|NCT01831219|9919668|FG001|COMPLETED|Overall Study||21
8863892|NCT01831219|9919667|FG000|NOT COMPLETED|Overall Study||33
8863893|NCT01831219|9919668|FG001|NOT COMPLETED|Overall Study||24
8863894|NCT01831232|9919674|FG000|STARTED|Overall Study||24
8863895|NCT01831232|9919674|FG000|COMPLETED|Overall Study||24
8863896|NCT01831232|9919674|FG000|NOT COMPLETED|Overall Study||0
8863897|NCT01831258|9919678|FG000|STARTED|Overall Study||35
8863898|NCT01831258|9919679|FG001|STARTED|Overall Study||35
8863899|NCT01831258|9919678|FG000|COMPLETED|Overall Study||30
8863900|NCT01831258|9919679|FG001|COMPLETED|Overall Study||32
8863901|NCT01831258|9919678|FG000|NOT COMPLETED|Overall Study||5
8863902|NCT01831258|9919679|FG001|NOT COMPLETED|Overall Study||3
8863903|NCT01831427|9919698|FG000|STARTED|Overall Study||5
8863904|NCT01831427|9919699|FG001|STARTED|Overall Study||5
8863905|NCT01831427|9919700|FG002|STARTED|Overall Study||5
8863906|NCT01831427|9919701|FG003|STARTED|Overall Study||5
8863907|NCT01831427|9919702|FG004|STARTED|Overall Study||4
8863908|NCT01831427|9919703|FG005|STARTED|Overall Study||8
8863909|NCT01831427|9919704|FG006|STARTED|Overall Study||8
8863910|NCT01831427|9919705|FG007|STARTED|Overall Study||8
8863911|NCT01831427|9919706|FG008|STARTED|Overall Study||8
8863912|NCT01831427|9919707|FG009|STARTED|Overall Study||10
8863913|NCT01831427|9919708|FG010|STARTED|Overall Study||8
8863914|NCT01831427|9919698|FG000|COMPLETED|Overall Study||5
8863915|NCT01831427|9919699|FG001|COMPLETED|Overall Study||4
8863916|NCT01831427|9919700|FG002|COMPLETED|Overall Study||5
8863917|NCT01831427|9919701|FG003|COMPLETED|Overall Study||4
8863918|NCT01831427|9919702|FG004|COMPLETED|Overall Study||4
8863919|NCT01831427|9919703|FG005|COMPLETED|Overall Study||7
8863920|NCT01831427|9919704|FG006|COMPLETED|Overall Study||6
8863921|NCT01831427|9919705|FG007|COMPLETED|Overall Study||7
8863922|NCT01831427|9919706|FG008|COMPLETED|Overall Study||8
8863923|NCT01831427|9919707|FG009|COMPLETED|Overall Study||9
8863924|NCT01831427|9919708|FG010|COMPLETED|Overall Study||5
8863925|NCT01831427|9919698|FG000|NOT COMPLETED|Overall Study||0
8863926|NCT01831427|9919699|FG001|NOT COMPLETED|Overall Study||1
8863927|NCT01831427|9919700|FG002|NOT COMPLETED|Overall Study||0
8863928|NCT01831427|9919701|FG003|NOT COMPLETED|Overall Study||1
8863929|NCT01831427|9919702|FG004|NOT COMPLETED|Overall Study||0
8863930|NCT01831427|9919703|FG005|NOT COMPLETED|Overall Study||1
8863931|NCT01831427|9919704|FG006|NOT COMPLETED|Overall Study||2
8863932|NCT01831427|9919705|FG007|NOT COMPLETED|Overall Study||1
8863933|NCT01831427|9919706|FG008|NOT COMPLETED|Overall Study||0
8863934|NCT01831427|9919707|FG009|NOT COMPLETED|Overall Study||1
8863935|NCT01831427|9919708|FG010|NOT COMPLETED|Overall Study||3
8863936|NCT01831466|9919755|FG000|STARTED|Overall Study|Treated|71
8863937|NCT01831466|9919756|FG001|STARTED|Overall Study|Treated|70
8863938|NCT01831466|9919757|FG002|STARTED|Overall Study|Treated|71
8863939|NCT01831466|9919758|FG003|STARTED|Overall Study|Treated|70
8863940|NCT01831466|9919759|FG004|STARTED|Overall Study|Treated|74
8863941|NCT01831466|9919760|FG005|STARTED|Overall Study|Treated|74
8863942|NCT01831466|9919761|FG006|STARTED|Overall Study|Treated|7
8863943|NCT01831466|9919762|FG007|STARTED|Overall Study|Treated|7
8863944|NCT01831466|9919763|FG008|STARTED|Overall Study|Treated|7
8863945|NCT01831466|9919764|FG009|STARTED|Overall Study|Treated|7
8863946|NCT01831466|9919765|FG010|STARTED|Overall Study|Treated|6
8863947|NCT01831466|9919766|FG011|STARTED|Overall Study|Treated|7
8863948|NCT01831466|9919755|FG000|COMPLETED|Overall Study||55
8863949|NCT01831466|9919756|FG001|COMPLETED|Overall Study||52
8863950|NCT01831466|9919757|FG002|COMPLETED|Overall Study||48
8863951|NCT01831466|9919758|FG003|COMPLETED|Overall Study||51
8863952|NCT01831466|9919759|FG004|COMPLETED|Overall Study||57
8863953|NCT01831466|9919760|FG005|COMPLETED|Overall Study||48
8863954|NCT01831466|9919761|FG006|COMPLETED|Overall Study||6
8863955|NCT01831466|9919762|FG007|COMPLETED|Overall Study||5
8863956|NCT01831466|9919763|FG008|COMPLETED|Overall Study||4
8863957|NCT01831466|9919764|FG009|COMPLETED|Overall Study||2
8863958|NCT01831466|9919765|FG010|COMPLETED|Overall Study||4
8863959|NCT01831466|9919766|FG011|COMPLETED|Overall Study||3
8863960|NCT01831466|9919755|FG000|NOT COMPLETED|Overall Study||16
8863961|NCT01831466|9919756|FG001|NOT COMPLETED|Overall Study||18
8863962|NCT01831466|9919757|FG002|NOT COMPLETED|Overall Study||23
8863963|NCT01831466|9919758|FG003|NOT COMPLETED|Overall Study||19
8863964|NCT01831466|9919759|FG004|NOT COMPLETED|Overall Study||17
8863965|NCT01831466|9919760|FG005|NOT COMPLETED|Overall Study||26
8863966|NCT01831466|9919761|FG006|NOT COMPLETED|Overall Study||1
8863967|NCT01831466|9919762|FG007|NOT COMPLETED|Overall Study||2
8863968|NCT01831466|9919763|FG008|NOT COMPLETED|Overall Study||3
8863969|NCT01831466|9919764|FG009|NOT COMPLETED|Overall Study||5
8863970|NCT01831466|9919765|FG010|NOT COMPLETED|Overall Study||2
8863971|NCT01831466|9919766|FG011|NOT COMPLETED|Overall Study||4
8863972|NCT01831544|9919786|FG000|STARTED|Overall Study||11
8863973|NCT01831544|9919786|FG000|COMPLETED|Overall Study||8
8863974|NCT01831544|9919786|FG000|NOT COMPLETED|Overall Study||3
8863975|NCT01831726|9919790|FG000|STARTED|Overall Study||80
8863976|NCT01831726|9919790|FG000|COMPLETED|Overall Study||0
8863977|NCT01831726|9919790|FG000|NOT COMPLETED|Overall Study||80
8863978|NCT01831765|9919797|FG000|STARTED|Overall Study||381
8863979|NCT01831765|9919798|FG001|STARTED|Overall Study||382
8863980|NCT01831765|9919799|FG002|STARTED|Overall Study||380
8863981|NCT01831765|9919797|FG000|Completed 26 Weeks|Overall Study||351
8863982|NCT01831765|9919798|FG001|Completed 26 Weeks|Overall Study||355
8863983|NCT01831765|9919799|FG002|Completed 26 Weeks|Overall Study||356
8863984|NCT01831765|9919797|FG000|Completed 52 Weeks|Overall Study||337
8863985|NCT01831765|9919798|FG001|Completed 52 Weeks|Overall Study|This arm did not continue in the trial after 26 weeks ( 26 to 52 weeks).|0
8863986|NCT01831765|9919799|FG002|Completed 52 Weeks|Overall Study||338
8863987|NCT01831765|9919797|FG000|COMPLETED|Overall Study||337
8863988|NCT01831765|9919798|FG001|COMPLETED|Overall Study||355
8863989|NCT01831765|9919799|FG002|COMPLETED|Overall Study||338
8863990|NCT01831765|9919797|FG000|NOT COMPLETED|Overall Study||44
8863991|NCT01831765|9919798|FG001|NOT COMPLETED|Overall Study||27
8863992|NCT01831765|9919799|FG002|NOT COMPLETED|Overall Study||42
8863993|NCT01831791|9919809|FG000|STARTED|Overall Study||120
8863994|NCT01831791|9919809|FG000|COMPLETED|Overall Study||110
8863995|NCT01831791|9919809|FG000|NOT COMPLETED|Overall Study||10
8863996|NCT01831804|9919822|FG000|STARTED|Overall Study||4
8863997|NCT01831804|9919823|FG001|STARTED|Overall Study||3
8863998|NCT01831804|9919824|FG002|STARTED|Overall Study||9
8863999|NCT01831804|9919825|FG003|STARTED|Overall Study||5
8864000|NCT01831804|9919826|FG004|STARTED|Overall Study||5
8864001|NCT01831804|9919827|FG005|STARTED|Overall Study||3
8864002|NCT01831804|9919828|FG006|STARTED|Overall Study||4
8864003|NCT01831804|9919829|FG007|STARTED|Overall Study||26
8864004|NCT01831804|9919830|FG008|STARTED|Overall Study||4
8864005|NCT01831804|9919822|FG000|COMPLETED|Overall Study||3
8864006|NCT01831804|9919823|FG001|COMPLETED|Overall Study||1
8864007|NCT01831804|9919824|FG002|COMPLETED|Overall Study||3
8864008|NCT01831804|9919825|FG003|COMPLETED|Overall Study||5
8864009|NCT01831804|9919826|FG004|COMPLETED|Overall Study||3
8864010|NCT01831804|9919827|FG005|COMPLETED|Overall Study||3
8864011|NCT01831804|9919828|FG006|COMPLETED|Overall Study||3
8864012|NCT01831804|9919829|FG007|COMPLETED|Overall Study||23
8864013|NCT01831804|9919830|FG008|COMPLETED|Overall Study||2
8864014|NCT01831804|9919822|FG000|NOT COMPLETED|Overall Study||1
8864015|NCT01831804|9919823|FG001|NOT COMPLETED|Overall Study||2
8864016|NCT01831804|9919824|FG002|NOT COMPLETED|Overall Study||6
8864017|NCT01831804|9919825|FG003|NOT COMPLETED|Overall Study||0
8864018|NCT01831804|9919826|FG004|NOT COMPLETED|Overall Study||2
8864019|NCT01831804|9919827|FG005|NOT COMPLETED|Overall Study||0
8630476|NCT00535288|9670260|FG001|COMPLETED|Overall Study||130
8864020|NCT01831804|9919828|FG006|NOT COMPLETED|Overall Study||1
8864021|NCT01831804|9919829|FG007|NOT COMPLETED|Overall Study||3
8864022|NCT01831804|9919830|FG008|NOT COMPLETED|Overall Study||2
8864023|NCT01831817|9919863|FG000|STARTED|Overall Study||35
8864024|NCT01831817|9919864|FG001|STARTED|Overall Study||34
8864025|NCT01831817|9919865|FG002|STARTED|Overall Study||35
8864026|NCT01831817|9919866|FG003|STARTED|Overall Study||36
8864027|NCT01831817|9919863|FG000|COMPLETED|Overall Study||31
8864028|NCT01831817|9919864|FG001|COMPLETED|Overall Study||34
8864029|NCT01831817|9919865|FG002|COMPLETED|Overall Study||35
8864030|NCT01831817|9919866|FG003|COMPLETED|Overall Study||36
8864031|NCT01831817|9919863|FG000|NOT COMPLETED|Overall Study||4
8864032|NCT01831817|9919864|FG001|NOT COMPLETED|Overall Study||0
8864033|NCT01831817|9919865|FG002|NOT COMPLETED|Overall Study||0
8864034|NCT01831817|9919866|FG003|NOT COMPLETED|Overall Study||0
8864035|NCT01831856|9919878|FG000|STARTED|Overall Study||67
8864036|NCT01831856|9919879|FG001|STARTED|Overall Study||67
8864037|NCT01831856|9919878|FG000|COMPLETED|Overall Study||33
8864038|NCT01831856|9919879|FG001|COMPLETED|Overall Study||30
8864039|NCT01831856|9919878|FG000|NOT COMPLETED|Overall Study||34
8864040|NCT01831856|9919879|FG001|NOT COMPLETED|Overall Study||37
8864041|NCT01831921|9919887|FG000|STARTED|Overall Study||150
8864042|NCT01831921|9919888|FG001|STARTED|Overall Study||75
8864043|NCT01831921|9919887|FG000|6 Months|Overall Study||122
8864044|NCT01831921|9919888|FG001|6 Months|Overall Study||63
8864045|NCT01831921|9919887|FG000|12 Months|Overall Study|All participants were followed for 12 months to 24 months, depending on date of randomization.|120
8864046|NCT01831921|9919888|FG001|12 Months|Overall Study||62
8864047|NCT01831921|9919887|FG000|18 Months|Overall Study|Of 118 eligible for this visit.|90
8630477|NCT00535288|9670261|FG002|COMPLETED|Overall Study||127
8864048|NCT01831921|9919888|FG001|18 Months|Overall Study|Of 59 eligible for this visit.|49
8864049|NCT01831921|9919887|FG000|COMPLETED|Overall Study|Of 85 eligible for this visit.|66
8864050|NCT01831921|9919888|FG001|COMPLETED|Overall Study|Of 42 eligible for this visit.|36
8864051|NCT01831921|9919887|FG000|NOT COMPLETED|Overall Study||84
8864052|NCT01831921|9919888|FG001|NOT COMPLETED|Overall Study||39
8864053|NCT01831934|9919899|FG000|STARTED|Overall Study||12
8864054|NCT01831934|9919900|FG001|STARTED|Overall Study||10
8864055|NCT01831934|9919899|FG000|COMPLETED|Overall Study|Volunteer consented but not enrolled after reporting a prior bad reaction to influenza vaccine.|11
8864056|NCT01831934|9919900|FG001|COMPLETED|Overall Study||10
8864057|NCT01831934|9919899|FG000|NOT COMPLETED|Overall Study||1
8864058|NCT01831934|9919900|FG001|NOT COMPLETED|Overall Study||0
8864059|NCT01831960|9919908|FG000|STARTED|Overall Study||20
8864060|NCT01831960|9919909|FG001|STARTED|Overall Study||22
8864061|NCT01831960|9919908|FG000|COMPLETED|Overall Study||20
8864062|NCT01831960|9919909|FG001|COMPLETED|Overall Study||22
8864063|NCT01831960|9919908|FG000|NOT COMPLETED|Overall Study||0
8864064|NCT01831960|9919909|FG001|NOT COMPLETED|Overall Study||0
8864065|NCT01832038|9919916|FG000|STARTED|Overall Study||473
8864066|NCT01832038|9919916|FG000|COMPLETED|Overall Study||238
8864067|NCT01832038|9919916|FG000|NOT COMPLETED|Overall Study||235
8864068|NCT01832090|9919923|FG000|STARTED|Overall Study||89
8864069|NCT01832090|9919924|FG001|STARTED|Overall Study||29
8864070|NCT01832090|9919923|FG000|COMPLETED|Overall Study||83
8864071|NCT01832090|9919924|FG001|COMPLETED|Overall Study||28
8864072|NCT01832090|9919923|FG000|NOT COMPLETED|Overall Study||6
8864073|NCT01832090|9919924|FG001|NOT COMPLETED|Overall Study||1
8864074|NCT01832155|9919952|FG000|STARTED|Beginning of Study: Baseline at 0 Week||18
8864075|NCT01832155|9919953|FG001|STARTED|Beginning of Study: Baseline at 0 Week||18
8864076|NCT01832155|9919952|FG000|COMPLETED|Beginning of Study: Baseline at 0 Week||17
8864077|NCT01832155|9919953|FG001|COMPLETED|Beginning of Study: Baseline at 0 Week||18
8864078|NCT01832155|9919952|FG000|NOT COMPLETED|Beginning of Study: Baseline at 0 Week||1
8864079|NCT01832155|9919953|FG001|NOT COMPLETED|Beginning of Study: Baseline at 0 Week||0
8864080|NCT01832155|9919952|FG000|STARTED|Mid-point of Study: 0 - 4 Weeks||17
8864081|NCT01832155|9919953|FG001|STARTED|Mid-point of Study: 0 - 4 Weeks||18
8864082|NCT01832155|9919952|FG000|COMPLETED|Mid-point of Study: 0 - 4 Weeks||16
8864083|NCT01832155|9919953|FG001|COMPLETED|Mid-point of Study: 0 - 4 Weeks||18
8864084|NCT01832155|9919952|FG000|NOT COMPLETED|Mid-point of Study: 0 - 4 Weeks||1
8864085|NCT01832155|9919953|FG001|NOT COMPLETED|Mid-point of Study: 0 - 4 Weeks||0
8864086|NCT01832155|9919952|FG000|STARTED|End of Study: 4 - 8 Weeks||16
8864087|NCT01832155|9919953|FG001|STARTED|End of Study: 4 - 8 Weeks||18
8864088|NCT01832155|9919952|FG000|COMPLETED|End of Study: 4 - 8 Weeks||16
8864089|NCT01832155|9919953|FG001|COMPLETED|End of Study: 4 - 8 Weeks||18
8864090|NCT01832155|9919952|FG000|NOT COMPLETED|End of Study: 4 - 8 Weeks||0
8864091|NCT01832155|9919953|FG001|NOT COMPLETED|End of Study: 4 - 8 Weeks||0
8864092|NCT01832259|9919967|FG000|STARTED|Overall Study||15
8864093|NCT01832259|9919968|FG001|STARTED|Overall Study||15
8864094|NCT01832259|9919967|FG000|COMPLETED|Overall Study||15
8864095|NCT01832259|9919968|FG001|COMPLETED|Overall Study||15
8864096|NCT01832259|9919967|FG000|NOT COMPLETED|Overall Study||0
8864097|NCT01832259|9919968|FG001|NOT COMPLETED|Overall Study||0
8864098|NCT01832402|9919976|FG000|STARTED|Overall Study||19
8864099|NCT01832402|9919977|FG001|STARTED|Overall Study||16
8864100|NCT01832402|9919976|FG000|Received Allocated Medication|Overall Study||12
8864101|NCT01832402|9919977|FG001|Received Allocated Medication|Overall Study||12
8864102|NCT01832402|9919976|FG000|Completed Study With Correct Dose|Overall Study||10
8864103|NCT01832402|9919977|FG001|Completed Study With Correct Dose|Overall Study||9
8864104|NCT01832402|9919976|FG000|Completed Study With Incorrect Dose|Overall Study||2
8864105|NCT01832402|9919977|FG001|Completed Study With Incorrect Dose|Overall Study||3
8864106|NCT01832402|9919976|FG000|COMPLETED|Overall Study||12
8864107|NCT01832402|9919977|FG001|COMPLETED|Overall Study||12
8864108|NCT01832402|9919976|FG000|NOT COMPLETED|Overall Study||7
8864109|NCT01832402|9919977|FG001|NOT COMPLETED|Overall Study||4
8864110|NCT01832480|9919989|FG000|STARTED|Overall Study||311
8864111|NCT01832480|9919990|FG001|STARTED|Overall Study||312
8864112|NCT01832480|9919989|FG000|COMPLETED|Overall Study||270
8864113|NCT01832480|9919990|FG001|COMPLETED|Overall Study||270
8864114|NCT01832480|9919989|FG000|NOT COMPLETED|Overall Study||41
8864115|NCT01832480|9919990|FG001|NOT COMPLETED|Overall Study||42
8864116|NCT01832493|9919996|FG000|STARTED|Overall Study||50
8864117|NCT01832493|9919996|FG000|COMPLETED|Overall Study||42
8864118|NCT01832493|9919996|FG000|NOT COMPLETED|Overall Study||8
8864119|NCT01832506|9920003|FG000|STARTED|Overall Study||3
8864120|NCT01832506|9920004|FG001|STARTED|Overall Study||3
8864121|NCT01832506|9920005|FG002|STARTED|Overall Study||6
8864122|NCT01832506|9920003|FG000|COMPLETED|Overall Study||3
8864123|NCT01832506|9920004|FG001|COMPLETED|Overall Study||3
8864124|NCT01832506|9920005|FG002|COMPLETED|Overall Study||6
8864125|NCT01832506|9920003|FG000|NOT COMPLETED|Overall Study||0
8864126|NCT01832506|9920004|FG001|NOT COMPLETED|Overall Study||0
8864127|NCT01832506|9920005|FG002|NOT COMPLETED|Overall Study||0
8864128|NCT01832532|9920020|FG000|STARTED|Overall Study||23
8864129|NCT01832532|9920021|FG001|STARTED|Overall Study||11
8864130|NCT01832532|9920020|FG000|COMPLETED|Overall Study||18
8864131|NCT01832532|9920021|FG001|COMPLETED|Overall Study||9
8864132|NCT01832532|9920020|FG000|NOT COMPLETED|Overall Study||5
8864133|NCT01832532|9920021|FG001|NOT COMPLETED|Overall Study||2
8864134|NCT01832610|9920027|FG000|STARTED|Overall Study||101
8864135|NCT01832610|9920027|FG000|COMPLETED|Overall Study||97
8864136|NCT01832610|9920027|FG000|NOT COMPLETED|Overall Study||4
8864137|NCT01832727|9920040|FG000|STARTED|Overall Study||9
8864138|NCT01832727|9920041|FG001|STARTED|Overall Study||7
8864139|NCT01832727|9920042|FG002|STARTED|Overall Study||3
8864140|NCT01832727|9920043|FG003|STARTED|Overall Study||4
8864141|NCT01832727|9920044|FG004|STARTED|Overall Study||4
8864142|NCT01832727|9920045|FG005|STARTED|Overall Study||6
8864143|NCT01832727|9920046|FG006|STARTED|Overall Study||8
8864144|NCT01832727|9920047|FG007|STARTED|Overall Study||6
8864145|NCT01832727|9920048|FG008|STARTED|Overall Study||18
8864146|NCT01832727|9920040|FG000|COMPLETED|Overall Study||0
8864147|NCT01832727|9920041|FG001|COMPLETED|Overall Study||0
8864148|NCT01832727|9920042|FG002|COMPLETED|Overall Study||0
8864149|NCT01832727|9920043|FG003|COMPLETED|Overall Study||0
8864150|NCT01832727|9920044|FG004|COMPLETED|Overall Study||0
8864151|NCT01832727|9920045|FG005|COMPLETED|Overall Study||0
8864152|NCT01832727|9920046|FG006|COMPLETED|Overall Study||0
8864153|NCT01832727|9920047|FG007|COMPLETED|Overall Study||0
8864154|NCT01832727|9920048|FG008|COMPLETED|Overall Study||0
8864155|NCT01832727|9920040|FG000|NOT COMPLETED|Overall Study||9
8950873|NCT02449915|10013658|FG001|NOT COMPLETED|Overall Study||4
8950874|NCT02450383|10013666|FG000|STARTED|Overall Study||10
8950875|NCT02450383|10013667|FG001|STARTED|Overall Study||10
8950876|NCT02450383|10013666|FG000|COMPLETED|Overall Study||10
8950877|NCT02450383|10013667|FG001|COMPLETED|Overall Study||10
8950878|NCT02450383|10013666|FG000|NOT COMPLETED|Overall Study||0
8950879|NCT02450383|10013667|FG001|NOT COMPLETED|Overall Study||0
8950880|NCT02450487|10013673|FG000|STARTED|Overall Study||105
8950881|NCT02450487|10013673|FG000|COMPLETED|Overall Study||102
8950882|NCT02450487|10013673|FG000|NOT COMPLETED|Overall Study||3
8950883|NCT02450526|10013682|FG000|STARTED|DB Period (Cycle 1)||325
8950884|NCT02450526|10013683|FG001|STARTED|DB Period (Cycle 1)||66
8950885|NCT02450526|10013684|FG002|STARTED|DB Period (Cycle 1)||107
8950886|NCT02450526|10013685|FG003|STARTED|DB Period (Cycle 1)||22
8950887|NCT02450526|10013686|FG004|STARTED|DB Period (Cycle 1)|This arm was not included in DB Period (Cycle 1).|0
8950888|NCT02450526|10013682|FG000|Safety Population|DB Period (Cycle 1)||326
8950889|NCT02450526|10013683|FG001|Safety Population|DB Period (Cycle 1)||66
8950890|NCT02450526|10013684|FG002|Safety Population|DB Period (Cycle 1)||107
8950891|NCT02450526|10013685|FG003|Safety Population|DB Period (Cycle 1)||21
8950892|NCT02450526|10013686|FG004|Safety Population|DB Period (Cycle 1)||0
8950893|NCT02450526|10013682|FG000|COMPLETED|DB Period (Cycle 1)||294
8950894|NCT02450526|10013683|FG001|COMPLETED|DB Period (Cycle 1)||63
8950895|NCT02450526|10013684|FG002|COMPLETED|DB Period (Cycle 1)||97
8950896|NCT02450526|10013685|FG003|COMPLETED|DB Period (Cycle 1)||20
8950897|NCT02450526|10013686|FG004|COMPLETED|DB Period (Cycle 1)|This arm was not included in DB Period (Cycle 1).|0
8950898|NCT02450526|10013682|FG000|NOT COMPLETED|DB Period (Cycle 1)||31
8950899|NCT02450526|10013683|FG001|NOT COMPLETED|DB Period (Cycle 1)||3
8950900|NCT02450526|10013684|FG002|NOT COMPLETED|DB Period (Cycle 1)||10
8950901|NCT02450526|10013685|FG003|NOT COMPLETED|DB Period (Cycle 1)||2
8950902|NCT02450526|10013686|FG004|NOT COMPLETED|DB Period (Cycle 1)||0
8950903|NCT02450526|10013682|FG000|STARTED|OL Period (Cycles 2-5)|This arm was not included in OL Period (Cycles 2-5).|0
8950904|NCT02450526|10013683|FG001|STARTED|OL Period (Cycles 2-5)|This arm was not included in OL Period (Cycles 2-5).|0
8950905|NCT02450526|10013684|FG002|STARTED|OL Period (Cycles 2-5)|This arm was not included in OL Period (Cycles 2-5).|0
8950906|NCT02450526|10013685|FG003|STARTED|OL Period (Cycles 2-5)|This arm was not included in OL Period (Cycles 2-5).|0
8950907|NCT02450526|10013686|FG004|STARTED|OL Period (Cycles 2-5)|Nine subjects completed the DB Period but were not eligible for retreatment in the OL Period.|465
8950908|NCT02450526|10013682|FG000|Safety Population|OL Period (Cycles 2-5)||0
8950909|NCT02450526|10013683|FG001|Safety Population|OL Period (Cycles 2-5)||0
8950910|NCT02450526|10013684|FG002|Safety Population|OL Period (Cycles 2-5)||0
8950911|NCT02450526|10013685|FG003|Safety Population|OL Period (Cycles 2-5)||0
8950912|NCT02450526|10013686|FG004|Safety Population|OL Period (Cycles 2-5)||465
8950913|NCT02450526|10013682|FG000|Discontinued During Cycle 2|OL Period (Cycles 2-5)||0
8950914|NCT02450526|10013683|FG001|Discontinued During Cycle 2|OL Period (Cycles 2-5)||0
8950915|NCT02450526|10013684|FG002|Discontinued During Cycle 2|OL Period (Cycles 2-5)||0
8950916|NCT02450526|10013685|FG003|Discontinued During Cycle 2|OL Period (Cycles 2-5)||0
8950917|NCT02450526|10013686|FG004|Discontinued During Cycle 2|OL Period (Cycles 2-5)||28
8950918|NCT02450526|10013682|FG000|Discontinued During Cycle 3|OL Period (Cycles 2-5)||0
8950919|NCT02450526|10013683|FG001|Discontinued During Cycle 3|OL Period (Cycles 2-5)||0
8950920|NCT02450526|10013684|FG002|Discontinued During Cycle 3|OL Period (Cycles 2-5)||0
8950921|NCT02450526|10013685|FG003|Discontinued During Cycle 3|OL Period (Cycles 2-5)||0
8950922|NCT02450526|10013686|FG004|Discontinued During Cycle 3|OL Period (Cycles 2-5)||11
8950923|NCT02450526|10013682|FG000|Discontinued During Cycle 4|OL Period (Cycles 2-5)||0
8950924|NCT02450526|10013683|FG001|Discontinued During Cycle 4|OL Period (Cycles 2-5)||0
8950925|NCT02450526|10013684|FG002|Discontinued During Cycle 4|OL Period (Cycles 2-5)||0
8950926|NCT02450526|10013685|FG003|Discontinued During Cycle 4|OL Period (Cycles 2-5)||0
8950927|NCT02450526|10013686|FG004|Discontinued During Cycle 4|OL Period (Cycles 2-5)||2
8950928|NCT02450526|10013682|FG000|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0
8950929|NCT02450526|10013683|FG001|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0
8950930|NCT02450526|10013684|FG002|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0
8864156|NCT01832727|9920041|FG001|NOT COMPLETED|Overall Study||7
8864157|NCT01832727|9920042|FG002|NOT COMPLETED|Overall Study||3
8864158|NCT01832727|9920043|FG003|NOT COMPLETED|Overall Study||4
8864159|NCT01832727|9920044|FG004|NOT COMPLETED|Overall Study||4
8864160|NCT01832727|9920045|FG005|NOT COMPLETED|Overall Study||6
8864161|NCT01832727|9920046|FG006|NOT COMPLETED|Overall Study||8
8864162|NCT01832727|9920047|FG007|NOT COMPLETED|Overall Study||6
8864163|NCT01832727|9920048|FG008|NOT COMPLETED|Overall Study||18
8864164|NCT01832753|9920080|FG000|STARTED|Observation Phase (Months 0-6)||5
8864165|NCT01832753|9920081|FG001|STARTED|Observation Phase (Months 0-6)||4
8864166|NCT01832753|9920082|FG002|STARTED|Observation Phase (Months 0-6)||3
8864167|NCT01832753|9920080|FG000|COMPLETED|Observation Phase (Months 0-6)||5
8864168|NCT01832753|9920081|FG001|COMPLETED|Observation Phase (Months 0-6)||4
8864169|NCT01832753|9920082|FG002|COMPLETED|Observation Phase (Months 0-6)||1
8864170|NCT01832753|9920080|FG000|NOT COMPLETED|Observation Phase (Months 0-6)||0
8864171|NCT01832753|9920081|FG001|NOT COMPLETED|Observation Phase (Months 0-6)||0
8864172|NCT01832753|9920082|FG002|NOT COMPLETED|Observation Phase (Months 0-6)||2
8864173|NCT01832753|9920080|FG000|STARTED|Randomization Phase (Months 6-12)||5
8864174|NCT01832753|9920081|FG001|STARTED|Randomization Phase (Months 6-12)||4
8864175|NCT01832753|9920082|FG002|STARTED|Randomization Phase (Months 6-12)|1 subject was not randomized as they did not meet inclusion criteria at the end of observation phase|0
8864176|NCT01832753|9920080|FG000|COMPLETED|Randomization Phase (Months 6-12)||4
8864177|NCT01832753|9920081|FG001|COMPLETED|Randomization Phase (Months 6-12)||3
8864178|NCT01832753|9920082|FG002|COMPLETED|Randomization Phase (Months 6-12)||0
8864179|NCT01832753|9920080|FG000|NOT COMPLETED|Randomization Phase (Months 6-12)||1
8864180|NCT01832753|9920081|FG001|NOT COMPLETED|Randomization Phase (Months 6-12)||1
8864181|NCT01832753|9920082|FG002|NOT COMPLETED|Randomization Phase (Months 6-12)||0
8864182|NCT01832753|9920080|FG000|STARTED|Open Label Dose Phase (Months 12-18)||3
8864183|NCT01832753|9920081|FG001|STARTED|Open Label Dose Phase (Months 12-18)||3
8864184|NCT01832753|9920082|FG002|STARTED|Open Label Dose Phase (Months 12-18)||0
8864185|NCT01832753|9920080|FG000|COMPLETED|Open Label Dose Phase (Months 12-18)||3
8864186|NCT01832753|9920081|FG001|COMPLETED|Open Label Dose Phase (Months 12-18)||3
8864187|NCT01832753|9920082|FG002|COMPLETED|Open Label Dose Phase (Months 12-18)||0
8864188|NCT01832753|9920080|FG000|NOT COMPLETED|Open Label Dose Phase (Months 12-18)||0
8864189|NCT01832753|9920081|FG001|NOT COMPLETED|Open Label Dose Phase (Months 12-18)||0
8864190|NCT01832753|9920082|FG002|NOT COMPLETED|Open Label Dose Phase (Months 12-18)||0
8864191|NCT01832766|9920091|FG000|STARTED|First Intervention||7
8864192|NCT01832766|9920092|FG001|STARTED|First Intervention||6
8864193|NCT01832766|9920091|FG000|COMPLETED|First Intervention||7
8864194|NCT01832766|9920092|FG001|COMPLETED|First Intervention|one participant did not return for cross over visit|6
8864195|NCT01832766|9920091|FG000|NOT COMPLETED|First Intervention||0
8864196|NCT01832766|9920092|FG001|NOT COMPLETED|First Intervention||0
8864197|NCT01832766|9920091|FG000|STARTED|Washout||7
8864198|NCT01832766|9920092|FG001|STARTED|Washout||6
8864199|NCT01832766|9920091|FG000|COMPLETED|Washout||7
8864200|NCT01832766|9920092|FG001|COMPLETED|Washout||5
8864201|NCT01832766|9920091|FG000|NOT COMPLETED|Washout||0
8864202|NCT01832766|9920092|FG001|NOT COMPLETED|Washout||1
8864203|NCT01832766|9920091|FG000|STARTED|Second Intervention||7
8864204|NCT01832766|9920092|FG001|STARTED|Second Intervention||5
8864205|NCT01832766|9920091|FG000|COMPLETED|Second Intervention||7
8864206|NCT01832766|9920092|FG001|COMPLETED|Second Intervention||5
8864207|NCT01832766|9920091|FG000|NOT COMPLETED|Second Intervention||0
8864208|NCT01832766|9920092|FG001|NOT COMPLETED|Second Intervention||0
8864209|NCT01832818|9920098|FG000|STARTED|Overall Study||14
8864210|NCT01832818|9920098|FG000|COMPLETED|Overall Study||8
8864211|NCT01832818|9920098|FG000|NOT COMPLETED|Overall Study||6
8864212|NCT01832961|9920102|FG000|STARTED|First Intervention||8
8864213|NCT01832961|9920103|FG001|STARTED|First Intervention||7
8864214|NCT01832961|9920102|FG000|COMPLETED|First Intervention||8
8864215|NCT01832961|9920103|FG001|COMPLETED|First Intervention||7
8864216|NCT01832961|9920102|FG000|NOT COMPLETED|First Intervention||0
8864217|NCT01832961|9920103|FG001|NOT COMPLETED|First Intervention||0
8864218|NCT01832961|9920102|FG000|STARTED|Washout||8
8864219|NCT01832961|9920103|FG001|STARTED|Washout||7
8864220|NCT01832961|9920102|FG000|COMPLETED|Washout||8
8864221|NCT01832961|9920103|FG001|COMPLETED|Washout||7
8864222|NCT01832961|9920102|FG000|NOT COMPLETED|Washout||0
8864223|NCT01832961|9920103|FG001|NOT COMPLETED|Washout||0
8864224|NCT01832961|9920102|FG000|STARTED|Second Intervention||8
8864225|NCT01832961|9920103|FG001|STARTED|Second Intervention||7
8864226|NCT01832961|9920102|FG000|COMPLETED|Second Intervention||8
8864227|NCT01832961|9920103|FG001|COMPLETED|Second Intervention||7
8864228|NCT01832961|9920102|FG000|NOT COMPLETED|Second Intervention||0
8864229|NCT01832961|9920103|FG001|NOT COMPLETED|Second Intervention||0
8864230|NCT01832961|9920102|FG000|STARTED|Third Intervention||8
8864231|NCT01832961|9920103|FG001|STARTED|Third Intervention||7
8864232|NCT01832961|9920102|FG000|COMPLETED|Third Intervention||8
8864233|NCT01832961|9920103|FG001|COMPLETED|Third Intervention||7
8864234|NCT01832961|9920102|FG000|NOT COMPLETED|Third Intervention||0
8864235|NCT01832961|9920103|FG001|NOT COMPLETED|Third Intervention||0
8864236|NCT01833026|9920120|FG000|STARTED|Overall Study||22
8864237|NCT01833026|9920121|FG001|STARTED|Overall Study||34
8864238|NCT01833026|9920120|FG000|COMPLETED|Overall Study||22
8864239|NCT01833026|9920121|FG001|COMPLETED|Overall Study||34
8864240|NCT01833026|9920120|FG000|NOT COMPLETED|Overall Study||0
8864241|NCT01833026|9920121|FG001|NOT COMPLETED|Overall Study||0
8864242|NCT01833065|9920130|FG000|STARTED|Overall Study|Randomized patients - As treated|65
8864243|NCT01833065|9920131|FG001|STARTED|Overall Study|Randomized patients - As treated|53
8864244|NCT01833065|9920132|FG002|STARTED|Overall Study|Randomized patients - As treated|35
8864245|NCT01833065|9920133|FG003|STARTED|Overall Study|Randomized patients - As treated|50
8864246|NCT01833065|9920134|FG004|STARTED|Overall Study|Randomized patients - As treated|110
8864247|NCT01833065|9920130|FG000|Intention-to-treat Analysis Set|Overall Study|Randomized patients|50
8864248|NCT01833065|9920131|FG001|Intention-to-treat Analysis Set|Overall Study|Randomized patients|53
8864249|NCT01833065|9920132|FG002|Intention-to-treat Analysis Set|Overall Study|Randomized patients|50
8864250|NCT01833065|9920133|FG003|Intention-to-treat Analysis Set|Overall Study|Randomized patients|50
8864251|NCT01833065|9920134|FG004|Intention-to-treat Analysis Set|Overall Study|Randomized patients|111
8864252|NCT01833065|9920130|FG000|COMPLETED|Overall Study||41
8864253|NCT01833065|9920131|FG001|COMPLETED|Overall Study||40
8864254|NCT01833065|9920132|FG002|COMPLETED|Overall Study||23
8864255|NCT01833065|9920133|FG003|COMPLETED|Overall Study||41
8864256|NCT01833065|9920134|FG004|COMPLETED|Overall Study||74
8864257|NCT01833065|9920130|FG000|NOT COMPLETED|Overall Study||24
8864258|NCT01833065|9920131|FG001|NOT COMPLETED|Overall Study||13
8864259|NCT01833065|9920132|FG002|NOT COMPLETED|Overall Study||12
8864260|NCT01833065|9920133|FG003|NOT COMPLETED|Overall Study||9
8864261|NCT01833065|9920134|FG004|NOT COMPLETED|Overall Study||36
8864262|NCT01833078|9920144|FG000|STARTED|Overall Study||5
8864263|NCT01833078|9920144|FG000|COMPLETED|Overall Study||5
8864264|NCT01833078|9920144|FG000|NOT COMPLETED|Overall Study||0
8864265|NCT01833117|9920150|FG000|STARTED|Overall Study||43
8864266|NCT01833117|9920151|FG001|STARTED|Overall Study||19
8864267|NCT01833117|9920150|FG000|COMPLETED|Overall Study||43
8864268|NCT01833117|9920151|FG001|COMPLETED|Overall Study||19
8864269|NCT01833117|9920150|FG000|NOT COMPLETED|Overall Study||0
8864270|NCT01833117|9920151|FG001|NOT COMPLETED|Overall Study||0
8864271|NCT01833130|9920159|FG000|STARTED|Overall Study||25
8864272|NCT01833130|9920160|FG001|STARTED|Overall Study||27
8864273|NCT01833130|9920159|FG000|COMPLETED|Overall Study||15
8864274|NCT01833130|9920160|FG001|COMPLETED|Overall Study||8
8864275|NCT01833130|9920159|FG000|NOT COMPLETED|Overall Study||10
8864276|NCT01833130|9920160|FG001|NOT COMPLETED|Overall Study||19
8864277|NCT01833143|9920166|FG000|STARTED|Overall Study||17
8864278|NCT01833143|9920166|FG000|COMPLETED|Overall Study||16
8864279|NCT01833143|9920166|FG000|NOT COMPLETED|Overall Study||1
8864280|NCT01833169|9920170|FG000|STARTED|Overall Study||146
8864281|NCT01833169|9920170|FG000|Consented to be Followed for Survival|Overall Study||128
8864282|NCT01833169|9920170|FG000|COMPLETED|Overall Study||0
8864283|NCT01833169|9920170|FG000|NOT COMPLETED|Overall Study||146
8864284|NCT01833247|9920174|FG000|STARTED|Overall Study||12
8864285|NCT01833247|9920174|FG000|COMPLETED|Overall Study||12
8864286|NCT01833247|9920174|FG000|NOT COMPLETED|Overall Study||0
8864287|NCT01833403|9920178|FG000|STARTED|Overall Study||4
8864288|NCT01833403|9920178|FG000|COMPLETED|Overall Study||4
8864289|NCT01833403|9920178|FG000|NOT COMPLETED|Overall Study||0
8950931|NCT02450526|10013685|FG003|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0
8950932|NCT02450526|10013686|FG004|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0
8950933|NCT02450526|10013682|FG000|COMPLETED|OL Period (Cycles 2-5)||0
8950934|NCT02450526|10013683|FG001|COMPLETED|OL Period (Cycles 2-5)||0
8950935|NCT02450526|10013684|FG002|COMPLETED|OL Period (Cycles 2-5)||0
8950936|NCT02450526|10013685|FG003|COMPLETED|OL Period (Cycles 2-5)||0
8950937|NCT02450526|10013686|FG004|COMPLETED|OL Period (Cycles 2-5)||424
8950938|NCT02450526|10013682|FG000|NOT COMPLETED|OL Period (Cycles 2-5)||0
8950939|NCT02450526|10013683|FG001|NOT COMPLETED|OL Period (Cycles 2-5)||0
8950940|NCT02450526|10013684|FG002|NOT COMPLETED|OL Period (Cycles 2-5)||0
8950941|NCT02450526|10013685|FG003|NOT COMPLETED|OL Period (Cycles 2-5)||0
8950942|NCT02450526|10013686|FG004|NOT COMPLETED|OL Period (Cycles 2-5)||41
8950943|NCT02450539|10013708|FG000|STARTED|Overall Study||106
8950944|NCT02450539|10013709|FG001|STARTED|Overall Study||53
8950945|NCT02450539|10013708|FG000|Received at Least One Dose of Study Drug|Overall Study||106
8950946|NCT02450539|10013709|FG001|Received at Least One Dose of Study Drug|Overall Study||52
8950947|NCT02450539|10013708|FG000|COMPLETED|Overall Study||90
8950948|NCT02450539|10013709|FG001|COMPLETED|Overall Study||46
8950949|NCT02450539|10013708|FG000|NOT COMPLETED|Overall Study||16
8950950|NCT02450539|10013709|FG001|NOT COMPLETED|Overall Study||7
8950951|NCT02450552|10013721|FG000|STARTED|Overall Study||19
8950952|NCT02450552|10013722|FG001|STARTED|Overall Study||23
8950953|NCT02450552|10013723|FG002|STARTED|Overall Study||23
8950954|NCT02450552|10013721|FG000|COMPLETED|Overall Study||14
8923694|NCT02242994|9984357|FG000|NOT COMPLETED|Overall Study||0
8923695|NCT02243007|9984363|FG000|STARTED|Overall Study||4
8923696|NCT02243007|9984364|FG001|STARTED|Overall Study||3
8923697|NCT02243007|9984363|FG000|COMPLETED|Overall Study||4
8923698|NCT02243007|9984364|FG001|COMPLETED|Overall Study||3
8923699|NCT02243007|9984363|FG000|NOT COMPLETED|Overall Study||0
8923700|NCT02243007|9984364|FG001|NOT COMPLETED|Overall Study||0
8923701|NCT02243046|9984373|FG000|STARTED|Overall Study||55
8950955|NCT02450552|10013722|FG001|COMPLETED|Overall Study||23
8950956|NCT02450552|10013723|FG002|COMPLETED|Overall Study||18
8950957|NCT02450552|10013721|FG000|NOT COMPLETED|Overall Study||5
8950958|NCT02450552|10013722|FG001|NOT COMPLETED|Overall Study||0
8864290|NCT01833455|9920185|FG000|STARTED|Overall Study||4
8864291|NCT01833455|9920186|FG001|STARTED|Overall Study||4
8864292|NCT01833455|9920185|FG000|Completed 1st Baseline|Overall Study||4
8864293|NCT01833455|9920186|FG001|Completed 1st Baseline|Overall Study||4
8864294|NCT01833455|9920185|FG000|Completed 1st Intervention|Overall Study||3
8864295|NCT01833455|9920186|FG001|Completed 1st Intervention|Overall Study||4
8864296|NCT01833455|9920185|FG000|Completed 2nd Baseline (Washout)|Overall Study||3
8864297|NCT01833455|9920186|FG001|Completed 2nd Baseline (Washout)|Overall Study||4
8864298|NCT01833455|9920185|FG000|COMPLETED|Overall Study||3
8864299|NCT01833455|9920186|FG001|COMPLETED|Overall Study||4
8864300|NCT01833455|9920185|FG000|NOT COMPLETED|Overall Study||1
8864301|NCT01833455|9920186|FG001|NOT COMPLETED|Overall Study||0
8864302|NCT01833481|9920207|FG000|STARTED|Overall Study||10
8864303|NCT01833481|9920208|FG001|STARTED|Overall Study||10
8864304|NCT01833481|9920209|FG002|STARTED|Overall Study||10
8864305|NCT01833481|9920207|FG000|COMPLETED|Overall Study||10
8864306|NCT01833481|9920208|FG001|COMPLETED|Overall Study||10
8864307|NCT01833481|9920209|FG002|COMPLETED|Overall Study||10
8864308|NCT01833481|9920207|FG000|NOT COMPLETED|Overall Study||0
8864309|NCT01833481|9920208|FG001|NOT COMPLETED|Overall Study||0
8864310|NCT01833481|9920209|FG002|NOT COMPLETED|Overall Study||0
8864311|NCT01833494|9920217|FG000|STARTED|Overall Study||161
8864312|NCT01833494|9920217|FG000|COMPLETED|Overall Study||116
8864313|NCT01833494|9920217|FG000|NOT COMPLETED|Overall Study||45
8864314|NCT01833520|9920223|FG000|STARTED|Overall Study||3
8864315|NCT01833520|9920224|FG001|STARTED|Overall Study||3
8864316|NCT01833520|9920225|FG002|STARTED|Overall Study||9
8864317|NCT01833520|9920226|FG003|STARTED|Overall Study||3
8864318|NCT01833520|9920223|FG000|COMPLETED|Overall Study||0
8864319|NCT01833520|9920224|FG001|COMPLETED|Overall Study||0
8864320|NCT01833520|9920225|FG002|COMPLETED|Overall Study||1
8864321|NCT01833520|9920226|FG003|COMPLETED|Overall Study||0
8864322|NCT01833520|9920223|FG000|NOT COMPLETED|Overall Study||3
8864323|NCT01833520|9920224|FG001|NOT COMPLETED|Overall Study||3
8864324|NCT01833520|9920225|FG002|NOT COMPLETED|Overall Study||8
8864325|NCT01833520|9920226|FG003|NOT COMPLETED|Overall Study||3
8864326|NCT01833533|9920240|FG000|STARTED|Overall Study||100
8864327|NCT01833533|9920241|FG001|STARTED|Overall Study||205
8864328|NCT01833533|9920240|FG000|COMPLETED|Overall Study||94
8864329|NCT01833533|9920241|FG001|COMPLETED|Overall Study||184
8864330|NCT01833533|9920240|FG000|NOT COMPLETED|Overall Study||6
8864331|NCT01833533|9920241|FG001|NOT COMPLETED|Overall Study||21
8864332|NCT01833546|9920251|FG000|STARTED|Overall Study||3
8864333|NCT01833546|9920252|FG001|STARTED|Overall Study||3
8864334|NCT01833546|9920253|FG002|STARTED|Overall Study||8
8864335|NCT01833546|9920254|FG003|STARTED|Overall Study||6
8864336|NCT01833546|9920251|FG000|COMPLETED|Overall Study||3
8864337|NCT01833546|9920252|FG001|COMPLETED|Overall Study||3
8864338|NCT01833546|9920253|FG002|COMPLETED|Overall Study||8
8864339|NCT01833546|9920254|FG003|COMPLETED|Overall Study||6
8864340|NCT01833546|9920251|FG000|NOT COMPLETED|Overall Study||0
8864341|NCT01833546|9920252|FG001|NOT COMPLETED|Overall Study||0
8864342|NCT01833546|9920253|FG002|NOT COMPLETED|Overall Study||0
8864343|NCT01833546|9920254|FG003|NOT COMPLETED|Overall Study||0
8864344|NCT01833741|9920265|FG000|STARTED|Overall Study||1137
8864345|NCT01833741|9920265|FG000|COMPLETED|Overall Study||997
8864346|NCT01833741|9920265|FG000|NOT COMPLETED|Overall Study||140
8864347|NCT01833754|9920272|FG000|STARTED|Overall Study||8
8864348|NCT01833754|9920273|FG001|STARTED|Overall Study||8
8864349|NCT01833754|9920274|FG002|STARTED|Overall Study||8
8864350|NCT01833754|9920272|FG000|COMPLETED|Overall Study||8
8864351|NCT01833754|9920273|FG001|COMPLETED|Overall Study||8
8864352|NCT01833754|9920274|FG002|COMPLETED|Overall Study||8
8864353|NCT01833754|9920272|FG000|NOT COMPLETED|Overall Study||0
8864354|NCT01833754|9920273|FG001|NOT COMPLETED|Overall Study||0
8864355|NCT01833754|9920274|FG002|NOT COMPLETED|Overall Study||0
8864356|NCT01833832|9920282|FG000|STARTED|Overall Study||11
8864357|NCT01833832|9920282|FG000|COMPLETED|Overall Study||10
8864358|NCT01833832|9920282|FG000|NOT COMPLETED|Overall Study||1
8864359|NCT01833845|9920286|FG000|STARTED|Overall Study||4
8864360|NCT01833845|9920286|FG000|COMPLETED|Overall Study||4
8864361|NCT01833845|9920286|FG000|NOT COMPLETED|Overall Study||0
8864362|NCT01833897|9920290|FG000|STARTED|Overall Study||8
8864363|NCT01833897|9920290|FG000|COMPLETED|Overall Study||7
8864364|NCT01833897|9920290|FG000|NOT COMPLETED|Overall Study||1
8864365|NCT01833936|9920296|FG000|STARTED|Overall Study||20
8864366|NCT01833936|9920297|FG001|STARTED|Overall Study||20
8864367|NCT01833936|9920296|FG000|COMPLETED|Overall Study||16
8864368|NCT01833936|9920297|FG001|COMPLETED|Overall Study||18
8864369|NCT01833936|9920296|FG000|NOT COMPLETED|Overall Study||4
8864370|NCT01833936|9920297|FG001|NOT COMPLETED|Overall Study||2
8864371|NCT01833988|9920303|FG000|STARTED|Overall Study||16
8864372|NCT01833988|9920304|FG001|STARTED|Overall Study||16
8864373|NCT01833988|9920303|FG000|COMPLETED|Overall Study||16
8864374|NCT01833988|9920304|FG001|COMPLETED|Overall Study||16
8864375|NCT01833988|9920303|FG000|NOT COMPLETED|Overall Study||0
8864376|NCT01833988|9920304|FG001|NOT COMPLETED|Overall Study||0
8864377|NCT01834027|9920317|FG000|STARTED|Overall Study||28
8864378|NCT01834027|9920318|FG001|STARTED|Overall Study||28
8864379|NCT01834027|9920317|FG000|COMPLETED|Overall Study||28
8864380|NCT01834027|9920318|FG001|COMPLETED|Overall Study||28
8864381|NCT01834027|9920317|FG000|NOT COMPLETED|Overall Study||0
8864382|NCT01834027|9920318|FG001|NOT COMPLETED|Overall Study||0
8864383|NCT01834222|9920324|FG000|STARTED|Overall Study||659
8864384|NCT01834222|9920324|FG000|Treated|Overall Study||658
8864385|NCT01834222|9920324|FG000|COMPLETED|Overall Study||658
8864386|NCT01834222|9920324|FG000|NOT COMPLETED|Overall Study||1
8864387|NCT01834261|9920330|FG000|STARTED|MIT fMRI and MEG Resting State Study||11
8864388|NCT01834261|9920331|FG001|STARTED|MIT fMRI and MEG Resting State Study||10
8864389|NCT01834261|9920330|FG000|COMPLETED|MIT fMRI and MEG Resting State Study|Enrollment completed in March 2014.|10
8864390|NCT01834261|9920331|FG001|COMPLETED|MIT fMRI and MEG Resting State Study||9
8864391|NCT01834261|9920330|FG000|NOT COMPLETED|MIT fMRI and MEG Resting State Study||1
8864392|NCT01834261|9920331|FG001|NOT COMPLETED|MIT fMRI and MEG Resting State Study||1
8864393|NCT01834261|9920330|FG000|STARTED|MGH Rest + Nueroeconomic Task fMRI|Subjects who dropped out/were excluded (10), did so before they received either Oxytocin or Placebo.|10
8864394|NCT01834261|9920331|FG001|STARTED|MGH Rest + Nueroeconomic Task fMRI||10
8569753|NCT00098722|9601916|FG005|NOT COMPLETED|Double Blind Phase||0
8569754|NCT00098722|9601917|FG006|NOT COMPLETED|Double Blind Phase||0
8569755|NCT00098722|9601911|FG000|STARTED|Open Label Phase||0
8569756|NCT00098722|9601912|FG001|STARTED|Open Label Phase||0
8569757|NCT00098722|9601913|FG002|STARTED|Open Label Phase||0
8569758|NCT00098722|9601914|FG003|STARTED|Open Label Phase||272
8569759|NCT00098722|9601915|FG004|STARTED|Open Label Phase||50
8569760|NCT00098722|9601916|FG005|STARTED|Open Label Phase||0
8569761|NCT00098722|9601917|FG006|STARTED|Open Label Phase||0
8569762|NCT00098722|9601911|FG000|COMPLETED|Open Label Phase||0
8864395|NCT01834261|9920330|FG000|COMPLETED|MGH Rest + Nueroeconomic Task fMRI|Enrollment completed in May 2015.|10
8864396|NCT01834261|9920331|FG001|COMPLETED|MGH Rest + Nueroeconomic Task fMRI||10
8864397|NCT01834261|9920330|FG000|NOT COMPLETED|MGH Rest + Nueroeconomic Task fMRI||0
8864398|NCT01834261|9920331|FG001|NOT COMPLETED|MGH Rest + Nueroeconomic Task fMRI||0
8864399|NCT01834274|9920339|FG000|STARTED|Overall Study||50
8864400|NCT01834274|9920340|FG001|STARTED|Overall Study||46
8864401|NCT01834274|9920339|FG000|COMPLETED|Overall Study||3
8864402|NCT01834274|9920340|FG001|COMPLETED|Overall Study||5
8864403|NCT01834274|9920339|FG000|NOT COMPLETED|Overall Study||47
8864404|NCT01834274|9920340|FG001|NOT COMPLETED|Overall Study||41
8864405|NCT01834326|9920348|FG000|STARTED|Overall Study||10
8864406|NCT01834326|9920349|FG001|STARTED|Overall Study||8
8864407|NCT01834326|9920348|FG000|COMPLETED|Overall Study||8
8864408|NCT01834326|9920349|FG001|COMPLETED|Overall Study||2
8864409|NCT01834326|9920348|FG000|NOT COMPLETED|Overall Study||2
8864410|NCT01834326|9920349|FG001|NOT COMPLETED|Overall Study||6
8864411|NCT01834404|9920357|FG000|STARTED|Overall Study||12
8864412|NCT01834404|9920358|FG001|STARTED|Overall Study||12
8864413|NCT01834404|9920357|FG000|COMPLETED|Overall Study||12
8864414|NCT01834404|9920358|FG001|COMPLETED|Overall Study||12
8569763|NCT00098722|9601912|FG001|COMPLETED|Open Label Phase||0
8864415|NCT01834404|9920357|FG000|NOT COMPLETED|Overall Study||0
8864416|NCT01834404|9920358|FG001|NOT COMPLETED|Overall Study||0
8864417|NCT01834586|9920364|FG000|STARTED|Overall Study||30
8630478|NCT00535288|9670262|FG003|COMPLETED|Overall Study||122
8630479|NCT00535288|9670263|FG004|COMPLETED|Overall Study||116
8630480|NCT00535288|9670259|FG000|NOT COMPLETED|Overall Study||54
8864418|NCT01834586|9920364|FG000|COMPLETED|Overall Study||29
8864419|NCT01834586|9920364|FG000|NOT COMPLETED|Overall Study||1
8864420|NCT01834651|9920368|FG000|STARTED|Overall Study||17
8864421|NCT01834651|9920368|FG000|COMPLETED|Overall Study|Evaluable for primary outcome assessment at 12 weeks|16
8864422|NCT01834651|9920368|FG000|NOT COMPLETED|Overall Study||1
8864423|NCT01834716|9920376|FG000|STARTED|Overall Study||4
8864424|NCT01834716|9920377|FG001|STARTED|Overall Study||12
8864425|NCT01834716|9920376|FG000|COMPLETED|Overall Study||4
8864426|NCT01834716|9920377|FG001|COMPLETED|Overall Study||11
8864427|NCT01834716|9920376|FG000|NOT COMPLETED|Overall Study||0
8864428|NCT01834716|9920377|FG001|NOT COMPLETED|Overall Study||1
8864429|NCT01834729|9920387|FG000|STARTED|Overall Study||18
8864430|NCT01834729|9920388|FG001|STARTED|Overall Study||20
8864431|NCT01834729|9920389|FG002|STARTED|Overall Study||18
8864432|NCT01834729|9920390|FG003|STARTED|Overall Study||18
8864433|NCT01834729|9920387|FG000|COMPLETED|Overall Study||17
8864434|NCT01834729|9920388|FG001|COMPLETED|Overall Study||19
8864435|NCT01834729|9920389|FG002|COMPLETED|Overall Study||15
8864436|NCT01834729|9920390|FG003|COMPLETED|Overall Study||16
8864437|NCT01834729|9920387|FG000|NOT COMPLETED|Overall Study||1
8864438|NCT01834729|9920388|FG001|NOT COMPLETED|Overall Study||1
8864439|NCT01834729|9920389|FG002|NOT COMPLETED|Overall Study||3
8864440|NCT01834729|9920390|FG003|NOT COMPLETED|Overall Study||2
8864441|NCT01835015|9920406|FG000|STARTED|Overall Study||6
8864442|NCT01835015|9920407|FG001|STARTED|Overall Study||6
8864443|NCT01835015|9920408|FG002|STARTED|Overall Study||7
8864444|NCT01835015|9920409|FG003|STARTED|Overall Study||6
8864445|NCT01835015|9920410|FG004|STARTED|Overall Study||6
8864446|NCT01835015|9920406|FG000|COMPLETED|Overall Study||6
8864447|NCT01835015|9920407|FG001|COMPLETED|Overall Study||6
8864448|NCT01835015|9920408|FG002|COMPLETED|Overall Study||6
8864449|NCT01835015|9920409|FG003|COMPLETED|Overall Study||6
8864450|NCT01835015|9920410|FG004|COMPLETED|Overall Study||6
8630481|NCT00535288|9670260|FG001|NOT COMPLETED|Overall Study||32
8864451|NCT01835015|9920406|FG000|NOT COMPLETED|Overall Study||0
8864452|NCT01835015|9920407|FG001|NOT COMPLETED|Overall Study||0
8864453|NCT01835015|9920408|FG002|NOT COMPLETED|Overall Study||1
8864454|NCT01835015|9920409|FG003|NOT COMPLETED|Overall Study||0
8950959|NCT02450552|10013723|FG002|NOT COMPLETED|Overall Study||5
8950960|NCT02450578|10013735|FG000|STARTED|Overall Study||6
8950961|NCT02450578|10013736|FG001|STARTED|Overall Study||6
8950962|NCT02450578|10013737|FG002|STARTED|Overall Study||6
8950963|NCT02450578|10013738|FG003|STARTED|Overall Study||4
8950964|NCT02450578|10013735|FG000|COMPLETED|Overall Study||5
8950965|NCT02450578|10013736|FG001|COMPLETED|Overall Study||6
8950966|NCT02450578|10013737|FG002|COMPLETED|Overall Study||6
8950967|NCT02450578|10013738|FG003|COMPLETED|Overall Study||4
8950968|NCT02450578|10013735|FG000|NOT COMPLETED|Overall Study||1
8950969|NCT02450578|10013736|FG001|NOT COMPLETED|Overall Study||0
8950970|NCT02450578|10013737|FG002|NOT COMPLETED|Overall Study||0
8950971|NCT02450578|10013738|FG003|NOT COMPLETED|Overall Study||0
8950972|NCT02450747|10013752|FG000|STARTED|Overall Study||39
8950973|NCT02450747|10013752|FG000|COMPLETED|Overall Study||39
8950974|NCT02450747|10013752|FG000|NOT COMPLETED|Overall Study||0
8950975|NCT02450799|10013763|FG000|STARTED|Overall Study||31
8950976|NCT02450799|10013764|FG001|STARTED|Overall Study||37
8950977|NCT02450799|10013765|FG002|STARTED|Overall Study||30
8950978|NCT02450799|10013763|FG000|COMPLETED|Overall Study||31
8950979|NCT02450799|10013764|FG001|COMPLETED|Overall Study||37
8950980|NCT02450799|10013765|FG002|COMPLETED|Overall Study||30
8950981|NCT02450799|10013763|FG000|NOT COMPLETED|Overall Study||0
8950982|NCT02450799|10013764|FG001|NOT COMPLETED|Overall Study||0
8950983|NCT02450799|10013765|FG002|NOT COMPLETED|Overall Study||0
8950984|NCT02450903|10013776|FG000|STARTED|Overall Study||20
8950985|NCT02450903|10013776|FG000|Entered Post-treatment Effic. f/u Phase|Overall Study||4
8950986|NCT02450903|10013776|FG000|Entered Survival Follow-up Phase|Overall Study||15
8950987|NCT02450903|10013776|FG000|COMPLETED|Overall Study||0
8630482|NCT00535288|9670261|FG002|NOT COMPLETED|Overall Study||33
8630483|NCT00535288|9670262|FG003|NOT COMPLETED|Overall Study||29
8864455|NCT01835015|9920410|FG004|NOT COMPLETED|Overall Study||0
8864456|NCT01835132|9920423|FG000|STARTED|Initial Phase||8
8864457|NCT01835132|9920423|FG000|COMPLETED|Initial Phase||6
8864458|NCT01835132|9920423|FG000|NOT COMPLETED|Initial Phase||2
8864459|NCT01835132|9920423|FG000|STARTED|1st Extension Phase||6
8864460|NCT01835132|9920423|FG000|COMPLETED|1st Extension Phase|Completed 52 Weeks|6
8864461|NCT01835132|9920423|FG000|NOT COMPLETED|1st Extension Phase||0
8864462|NCT01835132|9920423|FG000|STARTED|2nd Extension Phase - As Needed (PRN)|PRN extension - Participants starting this phase may not equal those who completed the 1st extension|3
8864463|NCT01835132|9920423|FG000|COMPLETED|2nd Extension Phase - As Needed (PRN)||3
8864464|NCT01835132|9920423|FG000|NOT COMPLETED|2nd Extension Phase - As Needed (PRN)||0
8864465|NCT01835158|9920429|FG000|STARTED|Overall Study||79
8950988|NCT02450903|10013776|FG000|NOT COMPLETED|Overall Study||20
8950989|NCT02451007|10013780|FG000|STARTED|Overall Study||39
8950990|NCT02451007|10013780|FG000|COMPLETED|Overall Study||32
8950991|NCT02451007|10013780|FG000|NOT COMPLETED|Overall Study||7
8950992|NCT02451124|10013784|FG000|STARTED|Overall Study||156
8950993|NCT02451124|10013784|FG000|COMPLETED|Overall Study||155
8950994|NCT02451124|10013784|FG000|NOT COMPLETED|Overall Study||1
8864466|NCT01835158|9920430|FG001|STARTED|Overall Study||78
8864467|NCT01835158|9920429|FG000|COMPLETED|Overall Study||78
8864468|NCT01835158|9920430|FG001|COMPLETED|Overall Study||72
8864469|NCT01835158|9920429|FG000|NOT COMPLETED|Overall Study||1
8864470|NCT01835158|9920430|FG001|NOT COMPLETED|Overall Study||6
8864471|NCT01835223|9920438|FG000|STARTED|Overall Study||30
8864472|NCT01835223|9920439|FG001|STARTED|Overall Study||3
8864473|NCT01835223|9920438|FG000|COMPLETED|Overall Study||21
8864474|NCT01835223|9920439|FG001|COMPLETED|Overall Study||2
8864475|NCT01835223|9920438|FG000|NOT COMPLETED|Overall Study||9
8864476|NCT01835223|9920439|FG001|NOT COMPLETED|Overall Study||1
8864477|NCT01835262|9920449|FG000|STARTED|Overall Study||45
8864478|NCT01835262|9920450|FG001|STARTED|Overall Study||45
8864479|NCT01835262|9920449|FG000|COMPLETED|Overall Study||45
8950995|NCT02451137|10013794|FG000|STARTED|Overall Study||1651
8950996|NCT02451137|10013795|FG001|STARTED|Overall Study||1653
8950997|NCT02451137|10013794|FG000|Treated|Overall Study||1632
8950998|NCT02451137|10013795|FG001|Treated|Overall Study||1626
8950999|NCT02451137|10013794|FG000|Safety Population|Overall Study|4 participants received Standard of Care instead of Toujeo.|1637
8951000|NCT02451137|10013795|FG001|Safety Population|Overall Study|9 participants received Toujeo instead of Standard of Care.|1621
8951001|NCT02451137|10013794|FG000|COMPLETED|Overall Study||1405
8951002|NCT02451137|10013795|FG001|COMPLETED|Overall Study||1355
8951003|NCT02451137|10013794|FG000|NOT COMPLETED|Overall Study||246
8951004|NCT02451137|10013795|FG001|NOT COMPLETED|Overall Study||298
8951005|NCT02451150|10013803|FG000|STARTED|Overall Study||3
8951006|NCT02451150|10013804|FG001|STARTED|Overall Study||3
8951007|NCT02451150|10013803|FG000|COMPLETED|Overall Study||3
8951008|NCT02451150|10013804|FG001|COMPLETED|Overall Study||3
8951009|NCT02451150|10013803|FG000|NOT COMPLETED|Overall Study||0
8951010|NCT02451150|10013804|FG001|NOT COMPLETED|Overall Study||0
8951011|NCT02451202|10013812|FG000|STARTED|Overall Study||51
8951012|NCT02451202|10013813|FG001|STARTED|Overall Study||51
8951013|NCT02451202|10013812|FG000|COMPLETED|Overall Study||49
8951014|NCT02451202|10013813|FG001|COMPLETED|Overall Study||48
8951015|NCT02451202|10013812|FG000|NOT COMPLETED|Overall Study||2
8951016|NCT02451202|10013813|FG001|NOT COMPLETED|Overall Study||3
8951017|NCT02451488|10013823|FG000|STARTED|Overall Study||4
8951018|NCT02451488|10013824|FG001|STARTED|Overall Study||4
8951019|NCT02451488|10013823|FG000|COMPLETED|Overall Study||4
8951020|NCT02451488|10013824|FG001|COMPLETED|Overall Study||4
8951021|NCT02451488|10013823|FG000|NOT COMPLETED|Overall Study||0
8951022|NCT02451488|10013824|FG001|NOT COMPLETED|Overall Study||0
8951023|NCT02451514|10013833|FG000|STARTED|Overall Study||33
8951024|NCT02451514|10013834|FG001|STARTED|Overall Study||46
8951025|NCT02451514|10013835|FG002|STARTED|Overall Study||50
8951026|NCT02451514|10013833|FG000|COMPLETED|Overall Study||33
8951027|NCT02451514|10013834|FG001|COMPLETED|Overall Study||46
8951028|NCT02451514|10013835|FG002|COMPLETED|Overall Study||50
8951029|NCT02451514|10013833|FG000|NOT COMPLETED|Overall Study||0
8864480|NCT01835262|9920450|FG001|COMPLETED|Overall Study||45
8864481|NCT01835262|9920449|FG000|NOT COMPLETED|Overall Study||0
8864482|NCT01835262|9920450|FG001|NOT COMPLETED|Overall Study||0
8864483|NCT01835379|9920458|FG000|STARTED|Overall Study||41
8864484|NCT01835379|9920459|FG001|STARTED|Overall Study||41
8864485|NCT01835379|9920458|FG000|COMPLETED|Overall Study||41
8864486|NCT01835379|9920459|FG001|COMPLETED|Overall Study||41
8951030|NCT02451514|10013834|FG001|NOT COMPLETED|Overall Study||0
8951031|NCT02451514|10013835|FG002|NOT COMPLETED|Overall Study||0
8864487|NCT01835379|9920458|FG000|NOT COMPLETED|Overall Study||0
8864488|NCT01835379|9920459|FG001|NOT COMPLETED|Overall Study||0
8864489|NCT01835431|9920467|FG000|STARTED|Overall Study||182
8864490|NCT01835431|9920468|FG001|STARTED|Overall Study||180
8864491|NCT01835431|9920467|FG000|Exposed|Overall Study|One subject was withdrawn before exposure.|181
8951032|NCT02451670|10013853|FG000|STARTED|Overall Study||5264
8951033|NCT02451670|10013854|FG001|STARTED|Overall Study||5083
8951034|NCT02451670|10013853|FG000|COMPLETED|Overall Study||4550
8951035|NCT02451670|10013854|FG001|COMPLETED|Overall Study||4387
8951036|NCT02451670|10013853|FG000|NOT COMPLETED|Overall Study||714
8951037|NCT02451670|10013854|FG001|NOT COMPLETED|Overall Study||696
8951038|NCT02451696|10013862|FG000|STARTED|Overall Study||5
8951039|NCT02451696|10013863|FG001|STARTED|Overall Study||10
8630484|NCT00535288|9670263|FG004|NOT COMPLETED|Overall Study||42
8630485|NCT00535301|9670282|FG000|STARTED|Overall Study||38
8630486|NCT00535301|9670283|FG001|STARTED|Overall Study||38
8630487|NCT00535301|9670282|FG000|COMPLETED|Overall Study||33
8864492|NCT01835431|9920468|FG001|Exposed|Overall Study|One subject was withdrawn before exposure|179
8864493|NCT01835431|9920467|FG000|COMPLETED|Overall Study||174
8864494|NCT01835431|9920468|FG001|COMPLETED|Overall Study||168
8864495|NCT01835431|9920467|FG000|NOT COMPLETED|Overall Study||8
8864496|NCT01835431|9920468|FG001|NOT COMPLETED|Overall Study||12
8864497|NCT01835470|9920474|FG000|STARTED|Short Term Treatment Period (to Week 16)||20
8864498|NCT01835470|9920474|FG000|COMPLETED|Short Term Treatment Period (to Week 16)||20
8864499|NCT01835470|9920474|FG000|NOT COMPLETED|Short Term Treatment Period (to Week 16)||0
8864500|NCT01835470|9920474|FG000|STARTED|Long Term Treatment Period||20
8864501|NCT01835470|9920474|FG000|COMPLETED|Long Term Treatment Period|Completed LT period|16
8864502|NCT01835470|9920474|FG000|NOT COMPLETED|Long Term Treatment Period||4
8864503|NCT01835496|9920479|FG000|STARTED|Overall Study||8
8864504|NCT01835496|9920479|FG000|COMPLETED|Overall Study||8
8864505|NCT01835496|9920479|FG000|NOT COMPLETED|Overall Study||0
8864506|NCT01835548|9920485|FG000|STARTED|Screening/Washout Period||0
8864507|NCT01835548|9920486|FG001|STARTED|Screening/Washout Period||0
8864508|NCT01835548|9920487|FG002|STARTED|Screening/Washout Period||87
8864509|NCT01835548|9920485|FG000|COMPLETED|Screening/Washout Period||0
8864510|NCT01835548|9920486|FG001|COMPLETED|Screening/Washout Period||0
8864511|NCT01835548|9920487|FG002|COMPLETED|Screening/Washout Period||87
8864512|NCT01835548|9920485|FG000|NOT COMPLETED|Screening/Washout Period||0
8864513|NCT01835548|9920486|FG001|NOT COMPLETED|Screening/Washout Period||0
8864514|NCT01835548|9920487|FG002|NOT COMPLETED|Screening/Washout Period||0
8864515|NCT01835548|9920485|FG000|STARTED|Dose Optimization Period||0
8864516|NCT01835548|9920486|FG001|STARTED|Dose Optimization Period||0
8864517|NCT01835548|9920487|FG002|STARTED|Dose Optimization Period||87
8864518|NCT01835548|9920485|FG000|COMPLETED|Dose Optimization Period||0
8864519|NCT01835548|9920486|FG001|COMPLETED|Dose Optimization Period||0
8864520|NCT01835548|9920487|FG002|COMPLETED|Dose Optimization Period||85
8864521|NCT01835548|9920485|FG000|NOT COMPLETED|Dose Optimization Period||0
8864522|NCT01835548|9920486|FG001|NOT COMPLETED|Dose Optimization Period||0
8864523|NCT01835548|9920487|FG002|NOT COMPLETED|Dose Optimization Period||2
8864524|NCT01835548|9920485|FG000|STARTED|Dose Stabilization Period||0
8864525|NCT01835548|9920486|FG001|STARTED|Dose Stabilization Period||0
8864526|NCT01835548|9920487|FG002|STARTED|Dose Stabilization Period||85
8864527|NCT01835548|9920485|FG000|COMPLETED|Dose Stabilization Period||0
8864528|NCT01835548|9920486|FG001|COMPLETED|Dose Stabilization Period||0
8864529|NCT01835548|9920487|FG002|COMPLETED|Dose Stabilization Period||85
8864530|NCT01835548|9920485|FG000|NOT COMPLETED|Dose Stabilization Period||0
8864531|NCT01835548|9920486|FG001|NOT COMPLETED|Dose Stabilization Period||0
8864532|NCT01835548|9920487|FG002|NOT COMPLETED|Dose Stabilization Period||0
8864533|NCT01835548|9920485|FG000|STARTED|Double-Blind Treatment Period||44
8864534|NCT01835548|9920486|FG001|STARTED|Double-Blind Treatment Period||41
8864535|NCT01835548|9920487|FG002|STARTED|Double-Blind Treatment Period||0
8864536|NCT01835548|9920485|FG000|COMPLETED|Double-Blind Treatment Period||44
8864537|NCT01835548|9920486|FG001|COMPLETED|Double-Blind Treatment Period||39
8864538|NCT01835548|9920487|FG002|COMPLETED|Double-Blind Treatment Period||0
8864539|NCT01835548|9920485|FG000|NOT COMPLETED|Double-Blind Treatment Period||0
8864540|NCT01835548|9920486|FG001|NOT COMPLETED|Double-Blind Treatment Period||2
8864541|NCT01835548|9920487|FG002|NOT COMPLETED|Double-Blind Treatment Period||0
8864542|NCT01835587|9920503|FG000|STARTED|Overall Study||3
8864543|NCT01835587|9920504|FG001|STARTED|Overall Study||4
8864544|NCT01835587|9920505|FG002|STARTED|Overall Study||4
8864545|NCT01835587|9920506|FG003|STARTED|Overall Study||19
8864546|NCT01835587|9920503|FG000|COMPLETED|Overall Study||1
8864547|NCT01835587|9920504|FG001|COMPLETED|Overall Study||0
8864548|NCT01835587|9920505|FG002|COMPLETED|Overall Study||2
8864549|NCT01835587|9920506|FG003|COMPLETED|Overall Study||10
8864550|NCT01835587|9920503|FG000|NOT COMPLETED|Overall Study||2
8864551|NCT01835587|9920504|FG001|NOT COMPLETED|Overall Study||4
8864552|NCT01835587|9920505|FG002|NOT COMPLETED|Overall Study||2
8864553|NCT01835587|9920506|FG003|NOT COMPLETED|Overall Study||9
8864554|NCT01835626|9920523|FG000|STARTED|Overall Study||24
8864555|NCT01835626|9920523|FG000|COMPLETED|Overall Study||17
8864556|NCT01835626|9920523|FG000|NOT COMPLETED|Overall Study||7
8864557|NCT01835743|9920529|FG000|STARTED|Overall Study||37
8864558|NCT01835743|9920530|FG001|STARTED|Overall Study||32
8864559|NCT01835743|9920529|FG000|COMPLETED|Overall Study||37
8864560|NCT01835743|9920530|FG001|COMPLETED|Overall Study||32
8864561|NCT01835743|9920529|FG000|NOT COMPLETED|Overall Study||0
8864562|NCT01835743|9920530|FG001|NOT COMPLETED|Overall Study||0
8864563|NCT01835756|9920538|FG000|STARTED|Overall Study||31
8864564|NCT01835756|9920539|FG001|STARTED|Overall Study||31
8864565|NCT01835756|9920538|FG000|COMPLETED|Overall Study||31
8864566|NCT01835756|9920539|FG001|COMPLETED|Overall Study||31
8864567|NCT01835756|9920538|FG000|NOT COMPLETED|Overall Study||0
8864568|NCT01835756|9920539|FG001|NOT COMPLETED|Overall Study||0
8630488|NCT00535301|9670283|FG001|COMPLETED|Overall Study||33
8630489|NCT00535301|9670282|FG000|NOT COMPLETED|Overall Study||5
8864569|NCT01835899|9920550|FG000|STARTED|Overall Study||6
8864570|NCT01835899|9920551|FG001|STARTED|Overall Study||9
8864571|NCT01835899|9920552|FG002|STARTED|Overall Study||9
8864572|NCT01835899|9920550|FG000|COMPLETED|Overall Study||6
8864573|NCT01835899|9920551|FG001|COMPLETED|Overall Study||8
8864574|NCT01835899|9920552|FG002|COMPLETED|Overall Study||8
8864575|NCT01835899|9920550|FG000|NOT COMPLETED|Overall Study||0
8864576|NCT01835899|9920551|FG001|NOT COMPLETED|Overall Study||1
8864577|NCT01835899|9920552|FG002|NOT COMPLETED|Overall Study||1
8864578|NCT01835912|9920562|FG000|STARTED|Overall Study||10
8864579|NCT01835912|9920562|FG000|Acute|Overall Study||10
8864580|NCT01835912|9920562|FG000|Acute Placebo|Overall Study||10
8864581|NCT01835912|9920562|FG000|Chronic|Overall Study||10
8864582|NCT01835912|9920562|FG000|Chronic Placebo|Overall Study||10
8864583|NCT01835912|9920562|FG000|COMPLETED|Overall Study||10
8864584|NCT01835912|9920562|FG000|NOT COMPLETED|Overall Study||0
8864585|NCT01836029|9920574|FG000|STARTED|Overall Study||100
8864586|NCT01836029|9920575|FG001|STARTED|Overall Study||95
8864587|NCT01836029|9920574|FG000|COMPLETED|Overall Study||100
8864588|NCT01836029|9920575|FG001|COMPLETED|Overall Study||95
8864589|NCT01836029|9920574|FG000|NOT COMPLETED|Overall Study||0
8864590|NCT01836029|9920575|FG001|NOT COMPLETED|Overall Study||0
8864591|NCT01836042|9920584|FG000|STARTED|Overall Study||51
8864592|NCT01836042|9920585|FG001|STARTED|Overall Study||35
8864593|NCT01836042|9920586|FG002|STARTED|Overall Study||22
8864594|NCT01836042|9920584|FG000|COMPLETED|Overall Study||51
8864595|NCT01836042|9920585|FG001|COMPLETED|Overall Study||35
8864596|NCT01836042|9920586|FG002|COMPLETED|Overall Study||22
8864597|NCT01836042|9920584|FG000|NOT COMPLETED|Overall Study||0
8864598|NCT01836042|9920585|FG001|NOT COMPLETED|Overall Study||0
8864599|NCT01836042|9920586|FG002|NOT COMPLETED|Overall Study||0
8864600|NCT01836133|9920594|FG000|STARTED|Overall Study||70
8864601|NCT01836133|9920594|FG000|COMPLETED|Overall Study||70
8864602|NCT01836133|9920594|FG000|NOT COMPLETED|Overall Study||0
8864603|NCT01836185|9920602|FG000|STARTED|Overall Study||10
8864604|NCT01836185|9920603|FG001|STARTED|Overall Study||8
8864605|NCT01836185|9920604|FG002|STARTED|Overall Study||8
8569764|NCT00098722|9601913|FG002|COMPLETED|Open Label Phase||0
8569765|NCT00098722|9601914|FG003|COMPLETED|Open Label Phase||0
8569766|NCT00098722|9601915|FG004|COMPLETED|Open Label Phase||0
8569767|NCT00098722|9601916|FG005|COMPLETED|Open Label Phase||0
8864606|NCT01836185|9920605|FG003|STARTED|Overall Study||6
8864607|NCT01836185|9920602|FG000|Received Single Dose of Study Treatment|Overall Study||10
8864608|NCT01836185|9920603|FG001|Received Single Dose of Study Treatment|Overall Study||8
8864609|NCT01836185|9920604|FG002|Received Single Dose of Study Treatment|Overall Study||8
8864610|NCT01836185|9920605|FG003|Received Single Dose of Study Treatment|Overall Study||6
8864611|NCT01836185|9920602|FG000|COMPLETED|Overall Study||10
8864612|NCT01836185|9920603|FG001|COMPLETED|Overall Study||8
8864613|NCT01836185|9920604|FG002|COMPLETED|Overall Study||8
8864614|NCT01836185|9920605|FG003|COMPLETED|Overall Study||6
8864615|NCT01836185|9920602|FG000|NOT COMPLETED|Overall Study||0
8864616|NCT01836185|9920603|FG001|NOT COMPLETED|Overall Study||0
8864617|NCT01836185|9920604|FG002|NOT COMPLETED|Overall Study||0
8864618|NCT01836185|9920605|FG003|NOT COMPLETED|Overall Study||0
8864619|NCT01836198|9920617|FG000|STARTED|Part A, Period 1||15
8864620|NCT01836198|9920618|FG001|STARTED|Part A, Period 1||15
8864621|NCT01836198|9920619|FG002|STARTED|Part A, Period 1||0
8864622|NCT01836198|9920617|FG000|Received at Least 1 Dose of Study Drug|Part A, Period 1||15
8864623|NCT01836198|9920618|FG001|Received at Least 1 Dose of Study Drug|Part A, Period 1||15
8864624|NCT01836198|9920619|FG002|Received at Least 1 Dose of Study Drug|Part A, Period 1||0
8864625|NCT01836198|9920617|FG000|COMPLETED|Part A, Period 1||15
8864626|NCT01836198|9920618|FG001|COMPLETED|Part A, Period 1||15
8864627|NCT01836198|9920619|FG002|COMPLETED|Part A, Period 1||0
8864628|NCT01836198|9920617|FG000|NOT COMPLETED|Part A, Period 1||0
8864629|NCT01836198|9920618|FG001|NOT COMPLETED|Part A, Period 1||0
8864630|NCT01836198|9920619|FG002|NOT COMPLETED|Part A, Period 1||0
8864631|NCT01836198|9920617|FG000|STARTED|Part A, Period 2||15
8864632|NCT01836198|9920618|FG001|STARTED|Part A, Period 2||15
8864633|NCT01836198|9920619|FG002|STARTED|Part A, Period 2||0
8864634|NCT01836198|9920617|FG000|Completed Part A, Entered Part B|Part A, Period 2||6
8864635|NCT01836198|9920618|FG001|Completed Part A, Entered Part B|Part A, Period 2||6
8864636|NCT01836198|9920619|FG002|Completed Part A, Entered Part B|Part A, Period 2||0
8864637|NCT01836198|9920617|FG000|COMPLETED|Part A, Period 2||15
8864638|NCT01836198|9920618|FG001|COMPLETED|Part A, Period 2||14
8864639|NCT01836198|9920619|FG002|COMPLETED|Part A, Period 2||0
8864640|NCT01836198|9920617|FG000|NOT COMPLETED|Part A, Period 2||0
8864641|NCT01836198|9920618|FG001|NOT COMPLETED|Part A, Period 2||1
8864642|NCT01836198|9920619|FG002|NOT COMPLETED|Part A, Period 2||0
8864643|NCT01836198|9920617|FG000|STARTED|Part B||0
8864644|NCT01836198|9920618|FG001|STARTED|Part B||0
8864645|NCT01836198|9920619|FG002|STARTED|Part B||12
8864646|NCT01836198|9920617|FG000|Received at Least 1 Dose of Study Drug|Part B||0
8864647|NCT01836198|9920618|FG001|Received at Least 1 Dose of Study Drug|Part B||0
8864648|NCT01836198|9920619|FG002|Received at Least 1 Dose of Study Drug|Part B||12
8864649|NCT01836198|9920617|FG000|COMPLETED|Part B||0
8864650|NCT01836198|9920618|FG001|COMPLETED|Part B||0
8864651|NCT01836198|9920619|FG002|COMPLETED|Part B||12
8864652|NCT01836198|9920617|FG000|NOT COMPLETED|Part B||0
8864653|NCT01836198|9920618|FG001|NOT COMPLETED|Part B||0
8864654|NCT01836198|9920619|FG002|NOT COMPLETED|Part B||0
8864655|NCT01836276|9920637|FG000|STARTED|Overall Study||224
8864656|NCT01836276|9920638|FG001|STARTED|Overall Study||225
8864657|NCT01836276|9920637|FG000|Week 4|Overall Study||198
8864658|NCT01836276|9920638|FG001|Week 4|Overall Study||186
8864659|NCT01836276|9920637|FG000|Week 12|Overall Study||183
8864660|NCT01836276|9920638|FG001|Week 12|Overall Study||165
8864661|NCT01836276|9920637|FG000|COMPLETED|Overall Study||196
8630490|NCT00535301|9670283|FG001|NOT COMPLETED|Overall Study||5
8630491|NCT00535392|9670291|FG000|STARTED|Overall Study||33
8630492|NCT00535392|9670291|FG000|COMPLETED|Overall Study||33
8864662|NCT01836276|9920638|FG001|COMPLETED|Overall Study||174
8864663|NCT01836276|9920637|FG000|NOT COMPLETED|Overall Study||28
8864664|NCT01836276|9920638|FG001|NOT COMPLETED|Overall Study||51
8864665|NCT01836445|9920646|FG000|STARTED|Intervention Modules||445
8864666|NCT01836445|9920647|FG001|STARTED|Intervention Modules||456
8864667|NCT01836445|9920646|FG000|COMPLETED|Intervention Modules||375
8864668|NCT01836445|9920647|FG001|COMPLETED|Intervention Modules||434
8864669|NCT01836445|9920646|FG000|NOT COMPLETED|Intervention Modules||70
8864670|NCT01836445|9920647|FG001|NOT COMPLETED|Intervention Modules||22
8864671|NCT01836445|9920646|FG000|STARTED|3 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|445
8864672|NCT01836445|9920647|FG001|STARTED|3 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|456
8864673|NCT01836445|9920646|FG000|COMPLETED|3 Month Follow-up Assessment||348
8864674|NCT01836445|9920647|FG001|COMPLETED|3 Month Follow-up Assessment||409
8864675|NCT01836445|9920646|FG000|NOT COMPLETED|3 Month Follow-up Assessment||97
8864676|NCT01836445|9920647|FG001|NOT COMPLETED|3 Month Follow-up Assessment||47
8864677|NCT01836445|9920646|FG000|STARTED|6 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|445
8864678|NCT01836445|9920647|FG001|STARTED|6 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|455
8864679|NCT01836445|9920646|FG000|COMPLETED|6 Month Follow-up Assessment||342
8864680|NCT01836445|9920647|FG001|COMPLETED|6 Month Follow-up Assessment||380
8864681|NCT01836445|9920646|FG000|NOT COMPLETED|6 Month Follow-up Assessment||103
8630493|NCT00535392|9670291|FG000|NOT COMPLETED|Overall Study||0
8864682|NCT01836445|9920647|FG001|NOT COMPLETED|6 Month Follow-up Assessment||75
8864683|NCT01836445|9920646|FG000|STARTED|12 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|445
8864684|NCT01836445|9920647|FG001|STARTED|12 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|455
8864685|NCT01836445|9920646|FG000|COMPLETED|12 Month Follow-up Assessment||370
8864686|NCT01836445|9920647|FG001|COMPLETED|12 Month Follow-up Assessment||391
8864687|NCT01836445|9920646|FG000|NOT COMPLETED|12 Month Follow-up Assessment||75
8864688|NCT01836445|9920647|FG001|NOT COMPLETED|12 Month Follow-up Assessment||64
8864689|NCT01836445|9920646|FG000|STARTED|12 Month STI Testing|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|445
8864690|NCT01836445|9920647|FG001|STARTED|12 Month STI Testing|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|455
8864691|NCT01836445|9920646|FG000|COMPLETED|12 Month STI Testing||365
8864692|NCT01836445|9920647|FG001|COMPLETED|12 Month STI Testing||378
8864693|NCT01836445|9920646|FG000|NOT COMPLETED|12 Month STI Testing||80
8864694|NCT01836445|9920647|FG001|NOT COMPLETED|12 Month STI Testing||77
8864695|NCT01836458|9920657|FG000|STARTED|Overall Study||7
8864696|NCT01836458|9920658|FG001|STARTED|Overall Study||4
8864697|NCT01836458|9920659|FG002|STARTED|Overall Study||7
8864698|NCT01836458|9920660|FG003|STARTED|Overall Study||7
8864699|NCT01836458|9920657|FG000|COMPLETED|Overall Study||4
8864700|NCT01836458|9920658|FG001|COMPLETED|Overall Study||2
8864701|NCT01836458|9920659|FG002|COMPLETED|Overall Study||2
8864702|NCT01836458|9920660|FG003|COMPLETED|Overall Study||1
8864703|NCT01836458|9920657|FG000|NOT COMPLETED|Overall Study||3
8864704|NCT01836458|9920658|FG001|NOT COMPLETED|Overall Study||2
8864705|NCT01836458|9920659|FG002|NOT COMPLETED|Overall Study||5
8864706|NCT01836458|9920660|FG003|NOT COMPLETED|Overall Study||6
8864707|NCT01836471|9920675|FG000|STARTED|Overall Study||93
8864708|NCT01836471|9920676|FG001|STARTED|Overall Study||94
8864709|NCT01836471|9920677|FG002|STARTED|Overall Study||51
8864710|NCT01836471|9920678|FG003|STARTED|Overall Study||42
8864711|NCT01836471|9920679|FG004|STARTED|Overall Study||54
8864712|NCT01836471|9920675|FG000|COMPLETED|Overall Study||82
8864713|NCT01836471|9920676|FG001|COMPLETED|Overall Study||85
8864714|NCT01836471|9920677|FG002|COMPLETED|Overall Study||49
8864715|NCT01836471|9920678|FG003|COMPLETED|Overall Study||40
8864716|NCT01836471|9920679|FG004|COMPLETED|Overall Study||49
8864717|NCT01836471|9920675|FG000|NOT COMPLETED|Overall Study||11
8864718|NCT01836471|9920676|FG001|NOT COMPLETED|Overall Study||9
8864719|NCT01836471|9920677|FG002|NOT COMPLETED|Overall Study||2
8864720|NCT01836471|9920678|FG003|NOT COMPLETED|Overall Study||2
8864721|NCT01836471|9920679|FG004|NOT COMPLETED|Overall Study||5
8864722|NCT01836523|9920696|FG000|STARTED|Overall Study||351
8864723|NCT01836523|9920697|FG001|STARTED|Overall Study||350
8864724|NCT01836523|9920698|FG002|STARTED|Overall Study||349
8864725|NCT01836523|9920699|FG003|STARTED|Overall Study||348
8864726|NCT01836523|9920696|FG000|Exposed|Overall Study||350
8864727|NCT01836523|9920697|FG001|Exposed|Overall Study||348
8864728|NCT01836523|9920698|FG002|Exposed|Overall Study||347
8864729|NCT01836523|9920699|FG003|Exposed|Overall Study||348
8864730|NCT01836523|9920696|FG000|COMPLETED|Overall Study||300
8864731|NCT01836523|9920697|FG001|COMPLETED|Overall Study||265
8864732|NCT01836523|9920698|FG002|COMPLETED|Overall Study||258
8864733|NCT01836523|9920699|FG003|COMPLETED|Overall Study||274
8864734|NCT01836523|9920696|FG000|NOT COMPLETED|Overall Study||51
8864735|NCT01836523|9920697|FG001|NOT COMPLETED|Overall Study||85
8864736|NCT01836523|9920698|FG002|NOT COMPLETED|Overall Study||91
8864737|NCT01836523|9920699|FG003|NOT COMPLETED|Overall Study||74
8864738|NCT01836549|9920715|FG000|STARTED|Overall Study||1
8864739|NCT01836549|9920716|FG001|STARTED|Overall Study||1
8864740|NCT01836549|9920717|FG002|STARTED|Overall Study||1
8864741|NCT01836549|9920718|FG003|STARTED|Overall Study||9
8864742|NCT01836549|9920719|FG004|STARTED|Overall Study||18
8864743|NCT01836549|9920720|FG005|STARTED|Overall Study||4
8864744|NCT01836549|9920721|FG006|STARTED|Overall Study||9
8864745|NCT01836549|9920715|FG000|COMPLETED|Overall Study||1
8864746|NCT01836549|9920716|FG001|COMPLETED|Overall Study||1
8864747|NCT01836549|9920717|FG002|COMPLETED|Overall Study||0
8864748|NCT01836549|9920718|FG003|COMPLETED|Overall Study||8
8864749|NCT01836549|9920719|FG004|COMPLETED|Overall Study||18
8864750|NCT01836549|9920720|FG005|COMPLETED|Overall Study||4
8864751|NCT01836549|9920721|FG006|COMPLETED|Overall Study||8
8864752|NCT01836549|9920715|FG000|NOT COMPLETED|Overall Study||0
8864753|NCT01836549|9920716|FG001|NOT COMPLETED|Overall Study||0
8864754|NCT01836549|9920717|FG002|NOT COMPLETED|Overall Study||1
8864755|NCT01836549|9920718|FG003|NOT COMPLETED|Overall Study||1
8864756|NCT01836549|9920719|FG004|NOT COMPLETED|Overall Study||0
8864757|NCT01836549|9920720|FG005|NOT COMPLETED|Overall Study||0
8864758|NCT01836549|9920721|FG006|NOT COMPLETED|Overall Study||1
8864759|NCT01837069|9920739|FG000|STARTED|Overall Study||103
8864760|NCT01837069|9920740|FG001|STARTED|Overall Study||95
8864761|NCT01837069|9920739|FG000|COMPLETED|Overall Study||103
8864762|NCT01837069|9920740|FG001|COMPLETED|Overall Study||95
8864763|NCT01837069|9920739|FG000|NOT COMPLETED|Overall Study||0
8864764|NCT01837069|9920740|FG001|NOT COMPLETED|Overall Study||0
8864765|NCT01837524|9920748|FG000|STARTED|Overall Study||28
8864766|NCT01837524|9920749|FG001|STARTED|Overall Study||27
8864767|NCT01837524|9920748|FG000|COMPLETED|Overall Study||25
8864768|NCT01837524|9920749|FG001|COMPLETED|Overall Study||25
8864769|NCT01837524|9920748|FG000|NOT COMPLETED|Overall Study||3
8864770|NCT01837524|9920749|FG001|NOT COMPLETED|Overall Study||2
8864771|NCT01837537|9920755|FG000|STARTED|Overall Study||90
8864772|NCT01837537|9920755|FG000|COMPLETED|Overall Study||90
8864773|NCT01837537|9920755|FG000|NOT COMPLETED|Overall Study||0
8864774|NCT01837550|9920761|FG000|STARTED|T0-T1, 5 Weeks||37
8864775|NCT01837550|9920762|FG001|STARTED|T0-T1, 5 Weeks||37
8864776|NCT01837550|9920761|FG000|COMPLETED|T0-T1, 5 Weeks||37
8864777|NCT01837550|9920762|FG001|COMPLETED|T0-T1, 5 Weeks||37
8864778|NCT01837550|9920761|FG000|NOT COMPLETED|T0-T1, 5 Weeks||0
8864779|NCT01837550|9920762|FG001|NOT COMPLETED|T0-T1, 5 Weeks||0
8864780|NCT01837550|9920761|FG000|STARTED|T0-T2, 6 Months Follow-up||37
8864781|NCT01837550|9920762|FG001|STARTED|T0-T2, 6 Months Follow-up||37
8864782|NCT01837550|9920761|FG000|COMPLETED|T0-T2, 6 Months Follow-up||37
8864783|NCT01837550|9920762|FG001|COMPLETED|T0-T2, 6 Months Follow-up||37
8864784|NCT01837550|9920761|FG000|NOT COMPLETED|T0-T2, 6 Months Follow-up||0
8864785|NCT01837550|9920762|FG001|NOT COMPLETED|T0-T2, 6 Months Follow-up||0
8864786|NCT01837654|9920770|FG000|STARTED|Overall Study||11
8864787|NCT01837654|9920771|FG001|STARTED|Overall Study||11
8864788|NCT01837654|9920770|FG000|COMPLETED|Overall Study||11
8864789|NCT01837654|9920771|FG001|COMPLETED|Overall Study||11
8864790|NCT01837654|9920770|FG000|NOT COMPLETED|Overall Study||0
8864791|NCT01837654|9920771|FG001|NOT COMPLETED|Overall Study||0
8864792|NCT01837680|9920779|FG000|STARTED|Overall Study||52
8864793|NCT01837680|9920780|FG001|STARTED|Overall Study||53
8864794|NCT01837680|9920779|FG000|COMPLETED|Overall Study||42
8864795|NCT01837680|9920780|FG001|COMPLETED|Overall Study||45
8864796|NCT01837680|9920779|FG000|NOT COMPLETED|Overall Study||10
8864797|NCT01837680|9920780|FG001|NOT COMPLETED|Overall Study||8
8864798|NCT01837719|9920786|FG000|STARTED|Period 1: Days 1-7 (Treatment A or B)|Received treatment|64
8864799|NCT01837719|9920786|FG000|COMPLETED|Period 1: Days 1-7 (Treatment A or B)||64
8864800|NCT01837719|9920786|FG000|NOT COMPLETED|Period 1: Days 1-7 (Treatment A or B)||0
8864801|NCT01837719|9920786|FG000|STARTED|Period 2: Days 8-14 (Treatment B or A)||64
8864802|NCT01837719|9920786|FG000|COMPLETED|Period 2: Days 8-14 (Treatment B or A)||63
8864803|NCT01837719|9920786|FG000|NOT COMPLETED|Period 2: Days 8-14 (Treatment B or A)||1
8864804|NCT01837719|9920786|FG000|STARTED|Period 3: Days 15-21 (Treatment C or D)||63
8864805|NCT01837719|9920786|FG000|COMPLETED|Period 3: Days 15-21 (Treatment C or D)||63
8864806|NCT01837719|9920786|FG000|NOT COMPLETED|Period 3: Days 15-21 (Treatment C or D)||0
8864807|NCT01837719|9920786|FG000|STARTED|Period 4: Days 22-28 (Treatment D or C)||63
8864808|NCT01837719|9920786|FG000|COMPLETED|Period 4: Days 22-28 (Treatment D or C)|Number finishing period; 32 patients were discharged following Period 4, as per protocol|63
8864809|NCT01837719|9920786|FG000|NOT COMPLETED|Period 4: Days 22-28 (Treatment D or C)||0
8864810|NCT01837719|9920786|FG000|STARTED|Period 5: Days 29-31 (Treatment E)|Reflects the 31 patients remaining after 32 were discharged at the end of Period 4, as per protocol|31
8864811|NCT01837719|9920786|FG000|COMPLETED|Period 5: Days 29-31 (Treatment E)||30
8864812|NCT01837719|9920786|FG000|NOT COMPLETED|Period 5: Days 29-31 (Treatment E)||1
8864813|NCT01837797|9920804|FG000|STARTED|Period 1||129
8864814|NCT01837797|9920805|FG001|STARTED|Period 1||0
8864815|NCT01837797|9920806|FG002|STARTED|Period 1||0
8864816|NCT01837797|9920807|FG003|STARTED|Period 1||0
8864817|NCT01837797|9920808|FG004|STARTED|Period 1||0
8864818|NCT01837797|9920804|FG000|COMPLETED|Period 1||27
8864819|NCT01837797|9920805|FG001|COMPLETED|Period 1||0
8864820|NCT01837797|9920806|FG002|COMPLETED|Period 1||0
8864821|NCT01837797|9920807|FG003|COMPLETED|Period 1||0
8864822|NCT01837797|9920808|FG004|COMPLETED|Period 1||0
8864823|NCT01837797|9920804|FG000|NOT COMPLETED|Period 1||102
8864824|NCT01837797|9920805|FG001|NOT COMPLETED|Period 1||0
8864825|NCT01837797|9920806|FG002|NOT COMPLETED|Period 1||0
8630494|NCT00535496|9670297|FG000|STARTED|Overall Study||15
8630495|NCT00535496|9670298|FG001|STARTED|Overall Study||15
8630496|NCT00535496|9670299|FG002|STARTED|Overall Study||30
8864826|NCT01837797|9920807|FG003|NOT COMPLETED|Period 1||0
8864827|NCT01837797|9920808|FG004|NOT COMPLETED|Period 1||0
8864828|NCT01837797|9920804|FG000|STARTED|Period 2||0
8864829|NCT01837797|9920805|FG001|STARTED|Period 2||6
8864830|NCT01837797|9920806|FG002|STARTED|Period 2||3
8864831|NCT01837797|9920807|FG003|STARTED|Period 2||6
8864832|NCT01837797|9920808|FG004|STARTED|Period 2||0
8864833|NCT01837797|9920804|FG000|COMPLETED|Period 2||0
8864834|NCT01837797|9920805|FG001|COMPLETED|Period 2||1
8864835|NCT01837797|9920806|FG002|COMPLETED|Period 2||1
8864836|NCT01837797|9920807|FG003|COMPLETED|Period 2||1
8864837|NCT01837797|9920808|FG004|COMPLETED|Period 2||0
8864838|NCT01837797|9920804|FG000|NOT COMPLETED|Period 2||0
8864839|NCT01837797|9920805|FG001|NOT COMPLETED|Period 2||5
8864840|NCT01837797|9920806|FG002|NOT COMPLETED|Period 2||2
8864841|NCT01837797|9920807|FG003|NOT COMPLETED|Period 2||5
8864842|NCT01837797|9920808|FG004|NOT COMPLETED|Period 2||0
8864843|NCT01837797|9920804|FG000|STARTED|Period 3||0
8864844|NCT01837797|9920805|FG001|STARTED|Period 3||0
8864845|NCT01837797|9920806|FG002|STARTED|Period 3||0
8864846|NCT01837797|9920807|FG003|STARTED|Period 3||0
8864847|NCT01837797|9920808|FG004|STARTED|Period 3||47
8864848|NCT01837797|9920804|FG000|COMPLETED|Period 3||0
8864849|NCT01837797|9920805|FG001|COMPLETED|Period 3||0
8864850|NCT01837797|9920806|FG002|COMPLETED|Period 3||0
8864851|NCT01837797|9920807|FG003|COMPLETED|Period 3||0
8864852|NCT01837797|9920808|FG004|COMPLETED|Period 3||24
8864853|NCT01837797|9920804|FG000|NOT COMPLETED|Period 3||0
8864854|NCT01837797|9920805|FG001|NOT COMPLETED|Period 3||0
8864855|NCT01837797|9920806|FG002|NOT COMPLETED|Period 3||0
8864856|NCT01837797|9920807|FG003|NOT COMPLETED|Period 3||0
8864857|NCT01837797|9920808|FG004|NOT COMPLETED|Period 3||23
8864858|NCT01837823|9920816|FG000|STARTED|Overall Study||91
8864859|NCT01837823|9920816|FG000|COMPLETED|Overall Study||85
8864860|NCT01837823|9920816|FG000|NOT COMPLETED|Overall Study||6
8864861|NCT01837901|9920827|FG000|STARTED|Overall Study||22
8864862|NCT01837901|9920828|FG001|STARTED|Overall Study||21
8864863|NCT01837901|9920829|FG002|STARTED|Overall Study||20
8864864|NCT01837901|9920827|FG000|COMPLETED|Overall Study||20
8864865|NCT01837901|9920828|FG001|COMPLETED|Overall Study||15
8864866|NCT01837901|9920829|FG002|COMPLETED|Overall Study||17
8864867|NCT01837901|9920827|FG000|NOT COMPLETED|Overall Study||2
8864868|NCT01837901|9920828|FG001|NOT COMPLETED|Overall Study||6
8864869|NCT01837901|9920829|FG002|NOT COMPLETED|Overall Study||3
8864870|NCT01837966|9920839|FG000|STARTED|Overall Study||47
8864871|NCT01837966|9920840|FG001|STARTED|Overall Study||46
8864872|NCT01837966|9920839|FG000|COMPLETED|Overall Study||45
8864873|NCT01837966|9920840|FG001|COMPLETED|Overall Study||45
8864874|NCT01837966|9920839|FG000|NOT COMPLETED|Overall Study||2
8864875|NCT01837966|9920840|FG001|NOT COMPLETED|Overall Study||1
8864876|NCT01838044|9920848|FG000|STARTED|Overall Study||89
8864877|NCT01838044|9920849|FG001|STARTED|Overall Study||91
8864878|NCT01838044|9920848|FG000|COMPLETED|Overall Study||81
8864879|NCT01838044|9920849|FG001|COMPLETED|Overall Study||75
8864880|NCT01838044|9920848|FG000|NOT COMPLETED|Overall Study||8
8864881|NCT01838044|9920849|FG001|NOT COMPLETED|Overall Study||16
8864882|NCT01838200|9920858|FG000|STARTED|Overall Study||3
8864883|NCT01838200|9920859|FG001|STARTED|Overall Study||2
8864884|NCT01838200|9920858|FG000|COMPLETED|Overall Study||0
8864885|NCT01838200|9920859|FG001|COMPLETED|Overall Study||0
8864886|NCT01838200|9920858|FG000|NOT COMPLETED|Overall Study||3
8864887|NCT01838200|9920859|FG001|NOT COMPLETED|Overall Study||2
8864888|NCT01838213|9920867|FG000|STARTED|Overall Study||247
8864889|NCT01838213|9920868|FG001|STARTED|Overall Study||453
8864890|NCT01838213|9920867|FG000|COMPLETED|Overall Study||81
8864891|NCT01838213|9920868|FG001|COMPLETED|Overall Study||262
8864892|NCT01838213|9920867|FG000|NOT COMPLETED|Overall Study||166
8864893|NCT01838213|9920868|FG001|NOT COMPLETED|Overall Study||191
8864894|NCT01838226|9920876|FG000|STARTED|Overall Study||202
8864895|NCT01838226|9920877|FG001|STARTED|Overall Study||199
8864896|NCT01838226|9920876|FG000|COMPLETED|Overall Study||126
8864897|NCT01838226|9920877|FG001|COMPLETED|Overall Study||128
8864898|NCT01838226|9920876|FG000|NOT COMPLETED|Overall Study||76
8864899|NCT01838226|9920877|FG001|NOT COMPLETED|Overall Study||71
8864900|NCT01838304|9920885|FG000|STARTED|Overall Study||20
8864901|NCT01838304|9920886|FG001|STARTED|Overall Study||20
8864902|NCT01838304|9920885|FG000|COMPLETED|Overall Study||19
8864903|NCT01838304|9920886|FG001|COMPLETED|Overall Study||20
8864904|NCT01838304|9920885|FG000|NOT COMPLETED|Overall Study||1
8630497|NCT00535496|9670300|FG003|STARTED|Overall Study||31
8630498|NCT00535496|9670297|FG000|All-Subjects-Treated (AST) Group|Overall Study||15
8864905|NCT01838304|9920886|FG001|NOT COMPLETED|Overall Study||0
8864906|NCT01838317|9920894|FG000|STARTED|Overall Study||9
8864907|NCT01838317|9920895|FG001|STARTED|Overall Study||5
8864908|NCT01838317|9920894|FG000|COMPLETED|Overall Study||9
8864909|NCT01838317|9920895|FG001|COMPLETED|Overall Study||5
8864910|NCT01838317|9920894|FG000|NOT COMPLETED|Overall Study||0
8864911|NCT01838317|9920895|FG001|NOT COMPLETED|Overall Study||0
8864912|NCT01838447|9920903|FG000|STARTED|Overall Study||22
8864913|NCT01838447|9920904|FG001|STARTED|Overall Study||24
8864914|NCT01838447|9920903|FG000|COMPLETED|Overall Study||20
8864915|NCT01838447|9920904|FG001|COMPLETED|Overall Study||21
8864916|NCT01838447|9920903|FG000|NOT COMPLETED|Overall Study||2
8864917|NCT01838447|9920904|FG001|NOT COMPLETED|Overall Study||3
8864918|NCT01838499|9920912|FG000|STARTED|Overall Study||55
8864919|NCT01838499|9920913|FG001|STARTED|Overall Study||54
8864920|NCT01838499|9920912|FG000|COMPLETED|Overall Study||31
8864921|NCT01838499|9920913|FG001|COMPLETED|Overall Study||37
8864922|NCT01838499|9920912|FG000|NOT COMPLETED|Overall Study||24
8630499|NCT00535496|9670298|FG001|All-Subjects-Treated (AST) Group|Overall Study||14
8864923|NCT01838499|9920913|FG001|NOT COMPLETED|Overall Study||17
8864924|NCT01838551|9920919|FG000|STARTED|Overall Study|94 subjects were enrolled and received at least 1 dose of levoketoconazole|94
8864925|NCT01838551|9920919|FG000|COMPLETED|Overall Study|46 subjects completed the Extended Evaluation phase|46
8864926|NCT01838551|9920919|FG000|NOT COMPLETED|Overall Study||48
8864927|NCT01838590|9920927|FG000|STARTED|Overall Study||52
8864928|NCT01838590|9920928|FG001|STARTED|Overall Study||51
8864929|NCT01838590|9920927|FG000|COMPLETED|Overall Study||40
8864930|NCT01838590|9920928|FG001|COMPLETED|Overall Study||46
8864931|NCT01838590|9920927|FG000|NOT COMPLETED|Overall Study||12
8864932|NCT01838590|9920928|FG001|NOT COMPLETED|Overall Study||5
8630500|NCT00535496|9670299|FG002|All-Subjects-Treated (AST) Group|Overall Study||30
8864933|NCT01838616|9920940|FG000|STARTED|Titration Period||130
8864934|NCT01838616|9920941|FG001|STARTED|Titration Period||128
8864935|NCT01838616|9920940|FG000|No Post Baseline Pain Intensity Values|Titration Period||0
8864936|NCT01838616|9920941|FG001|No Post Baseline Pain Intensity Values|Titration Period||2
8864937|NCT01838616|9920940|FG000|Major Protocol Deviations|Titration Period||13
8864938|NCT01838616|9920941|FG001|Major Protocol Deviations|Titration Period||16
8864939|NCT01838616|9920940|FG000|Switched to Pick-up Arm|Titration Period||0
8864940|NCT01838616|9920941|FG001|Switched to Pick-up Arm|Titration Period||43
8864941|NCT01838616|9920940|FG000|Full Analysis Set|Titration Period||130
8864942|NCT01838616|9920941|FG001|Full Analysis Set|Titration Period||128
8864943|NCT01838616|9920940|FG000|Per Protocol Set|Titration Period||117
8864944|NCT01838616|9920941|FG001|Per Protocol Set|Titration Period||112
8864945|NCT01838616|9920940|FG000|COMPLETED|Titration Period||100
8864946|NCT01838616|9920941|FG001|COMPLETED|Titration Period||62
8864947|NCT01838616|9920940|FG000|NOT COMPLETED|Titration Period||30
8864948|NCT01838616|9920941|FG001|NOT COMPLETED|Titration Period||66
8864949|NCT01838616|9920940|FG000|STARTED|Continuation Period||100
8864950|NCT01838616|9920941|FG001|STARTED|Continuation Period||62
8864951|NCT01838616|9920940|FG000|Switched to Pick-up Arm|Continuation Period||0
8864952|NCT01838616|9920941|FG001|Switched to Pick-up Arm|Continuation Period||7
8864953|NCT01838616|9920940|FG000|COMPLETED|Continuation Period||86
8864954|NCT01838616|9920941|FG001|COMPLETED|Continuation Period||48
8864955|NCT01838616|9920940|FG000|NOT COMPLETED|Continuation Period||14
8864956|NCT01838616|9920941|FG001|NOT COMPLETED|Continuation Period||14
8864957|NCT01838616|9920940|FG000|STARTED|Pick-up Arm|Switch to Tapentadol (PR) after Oxycodone/Naloxone (PR) treatment discontinuation.|50
8864958|NCT01838616|9920941|FG001|STARTED|Pick-up Arm||0
8864959|NCT01838616|9920940|FG000|Full Analysis Set|Pick-up Arm||49
8864960|NCT01838616|9920941|FG001|Full Analysis Set|Pick-up Arm||0
8864961|NCT01838616|9920940|FG000|COMPLETED|Pick-up Arm|Participants completed the tapentadol pick-up arm after initially on oxycodone/naloxone PR treatment|35
8864962|NCT01838616|9920941|FG001|COMPLETED|Pick-up Arm||0
8864963|NCT01838616|9920940|FG000|NOT COMPLETED|Pick-up Arm||15
8864964|NCT01838616|9920941|FG001|NOT COMPLETED|Pick-up Arm||0
8864965|NCT01838642|9920952|FG000|STARTED|Overall Study||3
8864966|NCT01838642|9920952|FG000|COMPLETED|Overall Study||2
8864967|NCT01838642|9920952|FG000|NOT COMPLETED|Overall Study||1
8864968|NCT01838655|9920957|FG000|STARTED|Overall Study||5
8864969|NCT01838655|9920957|FG000|COMPLETED|Overall Study||5
8864970|NCT01838655|9920957|FG000|NOT COMPLETED|Overall Study||0
8864971|NCT01838681|9920961|FG000|STARTED|Period A||1986
8864972|NCT01838681|9920962|FG001|STARTED|Period A||0
8864973|NCT01838681|9920963|FG002|STARTED|Period A||0
8864974|NCT01838681|9920964|FG003|STARTED|Period A||0
8864975|NCT01838681|9920961|FG000|COMPLETED|Period A||1661
8864976|NCT01838681|9920962|FG001|COMPLETED|Period A||0
8864977|NCT01838681|9920963|FG002|COMPLETED|Period A||0
8864978|NCT01838681|9920964|FG003|COMPLETED|Period A||0
8864979|NCT01838681|9920961|FG000|NOT COMPLETED|Period A||325
8864980|NCT01838681|9920962|FG001|NOT COMPLETED|Period A||0
8864981|NCT01838681|9920963|FG002|NOT COMPLETED|Period A||0
8864982|NCT01838681|9920964|FG003|NOT COMPLETED|Period A||0
8864983|NCT01838681|9920961|FG000|STARTED|Period B/A+||0
8864984|NCT01838681|9920962|FG001|STARTED|Period B/A+||442
8864985|NCT01838681|9920963|FG002|STARTED|Period B/A+||444
8864986|NCT01838681|9920964|FG003|STARTED|Period B/A+||770
8864987|NCT01838681|9920961|FG000|COMPLETED|Period B/A+||0
8864988|NCT01838681|9920962|FG001|COMPLETED|Period B/A+||380
8864989|NCT01838681|9920963|FG002|COMPLETED|Period B/A+||349
8864990|NCT01838681|9920964|FG003|COMPLETED|Period B/A+||653
8864991|NCT01838681|9920961|FG000|NOT COMPLETED|Period B/A+||0
8864992|NCT01838681|9920962|FG001|NOT COMPLETED|Period B/A+||62
8864993|NCT01838681|9920963|FG002|NOT COMPLETED|Period B/A+||95
8864994|NCT01838681|9920964|FG003|NOT COMPLETED|Period B/A+||117
8864995|NCT01838694|9920972|FG000|STARTED|Overall Study||8
8864996|NCT01838694|9920973|FG001|STARTED|Overall Study||22
8864997|NCT01838694|9920972|FG000|COMPLETED|Overall Study||8
8864998|NCT01838694|9920973|FG001|COMPLETED|Overall Study||21
8864999|NCT01838694|9920972|FG000|NOT COMPLETED|Overall Study||0
8865000|NCT01838694|9920973|FG001|NOT COMPLETED|Overall Study||1
8865001|NCT01838785|9920982|FG000|STARTED|Overall Study||25
8865002|NCT01838785|9920982|FG000|COMPLETED|Overall Study||25
8865003|NCT01838785|9920982|FG000|NOT COMPLETED|Overall Study||0
8865004|NCT01838863|9920988|FG000|STARTED|Overall Study||75
8865005|NCT01838863|9920989|FG001|STARTED|Overall Study||69
8865006|NCT01838863|9920988|FG000|COMPLETED|Overall Study||65
8865007|NCT01838863|9920989|FG001|COMPLETED|Overall Study||60
8865008|NCT01838863|9920988|FG000|NOT COMPLETED|Overall Study||10
8865009|NCT01838863|9920989|FG001|NOT COMPLETED|Overall Study||9
8865010|NCT01838876|9920995|FG000|STARTED|Overall Study||442
8865011|NCT01838876|9920995|FG000|Safety Population; Received Study Drug|Overall Study||345
8865012|NCT01838876|9920995|FG000|Entered Safety Follow-up Period|Overall Study||287
8865013|NCT01838876|9920995|FG000|COMPLETED|Overall Study||209
8865014|NCT01838876|9920995|FG000|NOT COMPLETED|Overall Study||233
8865015|NCT01838941|9921001|FG000|STARTED|Overall Study||12
8865016|NCT01838941|9921001|FG000|COMPLETED|Overall Study||10
8865017|NCT01838941|9921001|FG000|NOT COMPLETED|Overall Study||2
8865018|NCT01838980|9921006|FG000|STARTED|Overall Study||15
8865019|NCT01838980|9921006|FG000|COMPLETED|Overall Study||15
8865020|NCT01838980|9921006|FG000|NOT COMPLETED|Overall Study||0
8865021|NCT01839058|9921012|FG000|STARTED|Overall Study||21
8865022|NCT01839058|9921013|FG001|STARTED|Overall Study||19
8865023|NCT01839058|9921012|FG000|COMPLETED|Overall Study||17
8865024|NCT01839058|9921013|FG001|COMPLETED|Overall Study||16
8865025|NCT01839058|9921012|FG000|NOT COMPLETED|Overall Study||4
8865026|NCT01839058|9921013|FG001|NOT COMPLETED|Overall Study||3
8865027|NCT01839110|9921022|FG000|STARTED|Overall Study||7
8865028|NCT01839110|9921023|FG001|STARTED|Overall Study||6
8865029|NCT01839110|9921024|FG002|STARTED|Overall Study||9
8865030|NCT01839110|9921022|FG000|COMPLETED|Overall Study||4
8865031|NCT01839110|9921023|FG001|COMPLETED|Overall Study||4
8865032|NCT01839110|9921024|FG002|COMPLETED|Overall Study||6
8865033|NCT01839110|9921022|FG000|NOT COMPLETED|Overall Study||3
8865034|NCT01839110|9921023|FG001|NOT COMPLETED|Overall Study||2
8865035|NCT01839110|9921024|FG002|NOT COMPLETED|Overall Study||3
8865036|NCT01839188|9921032|FG000|STARTED|Overall Study||385
8865037|NCT01839188|9921032|FG000|Treated|Overall Study||385
8865038|NCT01839188|9921032|FG000|COMPLETED|Overall Study|N=1 treated participant withdrew before receiving V3|384
8865039|NCT01839188|9921032|FG000|NOT COMPLETED|Overall Study||1
8865040|NCT01839279|9921044|FG000|STARTED|Overall Study||72
8865041|NCT01839279|9921045|FG001|STARTED|Overall Study||32
8865042|NCT01839279|9921046|FG002|STARTED|Overall Study||32
8865043|NCT01839279|9921044|FG000|QT/QTc Analysis Set|Overall Study||72
8865044|NCT01839279|9921045|FG001|QT/QTc Analysis Set|Overall Study||32
8865045|NCT01839279|9921046|FG002|QT/QTc Analysis Set|Overall Study||32
8865046|NCT01839279|9921044|FG000|PK Analysis Set|Overall Study||70
8865047|NCT01839279|9921045|FG001|PK Analysis Set|Overall Study||0
8865048|NCT01839279|9921046|FG002|PK Analysis Set|Overall Study||0
8865049|NCT01839279|9921044|FG000|Moxifloxacin/Placebo Analysis Set|Overall Study||0
8865050|NCT01839279|9921045|FG001|Moxifloxacin/Placebo Analysis Set|Overall Study||31
8865051|NCT01839279|9921046|FG002|Moxifloxacin/Placebo Analysis Set|Overall Study||30
8865052|NCT01839279|9921044|FG000|PK/QTc Analysis Set|Overall Study||70
8865053|NCT01839279|9921045|FG001|PK/QTc Analysis Set|Overall Study||0
8865054|NCT01839279|9921046|FG002|PK/QTc Analysis Set|Overall Study||0
8865055|NCT01839279|9921044|FG000|COMPLETED|Overall Study||59
8865056|NCT01839279|9921045|FG001|COMPLETED|Overall Study||30
8865057|NCT01839279|9921046|FG002|COMPLETED|Overall Study||30
8865058|NCT01839279|9921044|FG000|NOT COMPLETED|Overall Study||13
8865059|NCT01839279|9921045|FG001|NOT COMPLETED|Overall Study||2
8865060|NCT01839279|9921046|FG002|NOT COMPLETED|Overall Study||2
8865061|NCT01839318|9921061|FG000|STARTED|Period 1, First Day of Wear||4
8865062|NCT01839318|9921062|FG001|STARTED|Period 1, First Day of Wear||4
8865063|NCT01839318|9921063|FG002|STARTED|Period 1, First Day of Wear||5
8865064|NCT01839318|9921064|FG003|STARTED|Period 1, First Day of Wear||6
8865065|NCT01839318|9921065|FG004|STARTED|Period 1, First Day of Wear||7
8865066|NCT01839318|9921066|FG005|STARTED|Period 1, First Day of Wear||2
8865067|NCT01839318|9921061|FG000|COMPLETED|Period 1, First Day of Wear||4
8865068|NCT01839318|9921062|FG001|COMPLETED|Period 1, First Day of Wear||4
8865069|NCT01839318|9921063|FG002|COMPLETED|Period 1, First Day of Wear||5
8865070|NCT01839318|9921064|FG003|COMPLETED|Period 1, First Day of Wear||6
8865071|NCT01839318|9921065|FG004|COMPLETED|Period 1, First Day of Wear||7
8865072|NCT01839318|9921066|FG005|COMPLETED|Period 1, First Day of Wear||2
8865073|NCT01839318|9921061|FG000|NOT COMPLETED|Period 1, First Day of Wear||0
8865074|NCT01839318|9921062|FG001|NOT COMPLETED|Period 1, First Day of Wear||0
8865075|NCT01839318|9921063|FG002|NOT COMPLETED|Period 1, First Day of Wear||0
8865076|NCT01839318|9921064|FG003|NOT COMPLETED|Period 1, First Day of Wear||0
8865077|NCT01839318|9921065|FG004|NOT COMPLETED|Period 1, First Day of Wear||0
8865078|NCT01839318|9921066|FG005|NOT COMPLETED|Period 1, First Day of Wear||0
8865079|NCT01839318|9921061|FG000|STARTED|Period 2, Second Day of Wear||4
8865080|NCT01839318|9921062|FG001|STARTED|Period 2, Second Day of Wear||4
8865081|NCT01839318|9921063|FG002|STARTED|Period 2, Second Day of Wear||5
8865082|NCT01839318|9921064|FG003|STARTED|Period 2, Second Day of Wear||6
8865083|NCT01839318|9921065|FG004|STARTED|Period 2, Second Day of Wear||7
8865084|NCT01839318|9921066|FG005|STARTED|Period 2, Second Day of Wear||2
8865085|NCT01839318|9921061|FG000|COMPLETED|Period 2, Second Day of Wear||4
8865086|NCT01839318|9921062|FG001|COMPLETED|Period 2, Second Day of Wear||4
8865087|NCT01839318|9921063|FG002|COMPLETED|Period 2, Second Day of Wear||5
8865088|NCT01839318|9921064|FG003|COMPLETED|Period 2, Second Day of Wear||6
8865089|NCT01839318|9921065|FG004|COMPLETED|Period 2, Second Day of Wear||7
8865090|NCT01839318|9921066|FG005|COMPLETED|Period 2, Second Day of Wear||2
8865091|NCT01839318|9921061|FG000|NOT COMPLETED|Period 2, Second Day of Wear||0
8865092|NCT01839318|9921062|FG001|NOT COMPLETED|Period 2, Second Day of Wear||0
8865093|NCT01839318|9921063|FG002|NOT COMPLETED|Period 2, Second Day of Wear||0
8865094|NCT01839318|9921064|FG003|NOT COMPLETED|Period 2, Second Day of Wear||0
8865095|NCT01839318|9921065|FG004|NOT COMPLETED|Period 2, Second Day of Wear||0
8865096|NCT01839318|9921066|FG005|NOT COMPLETED|Period 2, Second Day of Wear||0
8630501|NCT00535496|9670300|FG003|All-Subjects-Treated (AST) Group|Overall Study||31
8630502|NCT00535496|9670297|FG000|COMPLETED|Overall Study||15
8630503|NCT00535496|9670298|FG001|COMPLETED|Overall Study||13
8630504|NCT00535496|9670299|FG002|COMPLETED|Overall Study||30
8865097|NCT01839318|9921061|FG000|STARTED|Period 3, Third Day of Wear||4
8865098|NCT01839318|9921062|FG001|STARTED|Period 3, Third Day of Wear||4
8865099|NCT01839318|9921063|FG002|STARTED|Period 3, Third Day of Wear||5
8865100|NCT01839318|9921064|FG003|STARTED|Period 3, Third Day of Wear||6
8865101|NCT01839318|9921065|FG004|STARTED|Period 3, Third Day of Wear||7
8865102|NCT01839318|9921066|FG005|STARTED|Period 3, Third Day of Wear||2
8865103|NCT01839318|9921061|FG000|COMPLETED|Period 3, Third Day of Wear||4
8865104|NCT01839318|9921062|FG001|COMPLETED|Period 3, Third Day of Wear||4
8865105|NCT01839318|9921063|FG002|COMPLETED|Period 3, Third Day of Wear||5
8865106|NCT01839318|9921064|FG003|COMPLETED|Period 3, Third Day of Wear||6
8865107|NCT01839318|9921065|FG004|COMPLETED|Period 3, Third Day of Wear||7
8865108|NCT01839318|9921066|FG005|COMPLETED|Period 3, Third Day of Wear||2
8951040|NCT02451696|10013862|FG000|COMPLETED|Overall Study||4
8951041|NCT02451696|10013863|FG001|COMPLETED|Overall Study||10
8951042|NCT02451696|10013862|FG000|NOT COMPLETED|Overall Study||1
8951043|NCT02451696|10013863|FG001|NOT COMPLETED|Overall Study||0
8951044|NCT02451839|10013871|FG000|STARTED|Overall Study||72
8951045|NCT02451839|10013872|FG001|STARTED|Overall Study||59
8951046|NCT02451839|10013873|FG002|STARTED|Overall Study||37
8951047|NCT02451839|10013871|FG000|Baseline WHODAS Data Recorded|Overall Study||70
8951048|NCT02451839|10013872|FG001|Baseline WHODAS Data Recorded|Overall Study||57
8951049|NCT02451839|10013873|FG002|Baseline WHODAS Data Recorded|Overall Study||37
8951050|NCT02451839|10013871|FG000|COMPLETED|Overall Study||44
8951051|NCT02451839|10013872|FG001|COMPLETED|Overall Study||40
8951052|NCT02451839|10013873|FG002|COMPLETED|Overall Study||30
8951053|NCT02451839|10013871|FG000|NOT COMPLETED|Overall Study||28
8951054|NCT02451839|10013872|FG001|NOT COMPLETED|Overall Study||19
8951055|NCT02451839|10013873|FG002|NOT COMPLETED|Overall Study||7
8951056|NCT02451917|10013883|FG000|STARTED|First Intervention (24 Weeks)||16
8951057|NCT02451917|10013884|FG001|STARTED|First Intervention (24 Weeks)||18
8951058|NCT02451917|10013883|FG000|COMPLETED|First Intervention (24 Weeks)||14
8951059|NCT02451917|10013884|FG001|COMPLETED|First Intervention (24 Weeks)||15
8951060|NCT02451917|10013883|FG000|NOT COMPLETED|First Intervention (24 Weeks)||2
8951061|NCT02451917|10013884|FG001|NOT COMPLETED|First Intervention (24 Weeks)||3
8951062|NCT02451917|10013883|FG000|STARTED|Second Intervention (24 Weeks)||14
8951063|NCT02451917|10013884|FG001|STARTED|Second Intervention (24 Weeks)||15
8951064|NCT02451917|10013883|FG000|COMPLETED|Second Intervention (24 Weeks)||14
8951065|NCT02451917|10013884|FG001|COMPLETED|Second Intervention (24 Weeks)||15
8951066|NCT02451917|10013883|FG000|NOT COMPLETED|Second Intervention (24 Weeks)||0
8951067|NCT02451917|10013884|FG001|NOT COMPLETED|Second Intervention (24 Weeks)||0
8951068|NCT02451930|10013896|FG000|STARTED|Overall Study||3
8951069|NCT02451930|10013897|FG001|STARTED|Overall Study||68
8951070|NCT02451930|10013896|FG000|Received at Least One Dose of Study Drug|Overall Study||3
8951071|NCT02451930|10013897|FG001|Received at Least One Dose of Study Drug|Overall Study||68
8951072|NCT02451930|10013896|FG000|Part A Cohort 2 Participants|Overall Study||0
8951073|NCT02451930|10013897|FG001|Part A Cohort 2 Participants|Overall Study||6
8951074|NCT02451930|10013896|FG000|Part B Participants|Overall Study||0
8951075|NCT02451930|10013897|FG001|Part B Participants|Overall Study||55
8951076|NCT02451930|10013896|FG000|Part C Participants|Overall Study||0
8951077|NCT02451930|10013897|FG001|Part C Participants|Overall Study||7
8951078|NCT02451930|10013896|FG000|COMPLETED|Overall Study||1
8951079|NCT02451930|10013897|FG001|COMPLETED|Overall Study||38
8951080|NCT02451930|10013896|FG000|NOT COMPLETED|Overall Study||2
8951081|NCT02451930|10013897|FG001|NOT COMPLETED|Overall Study||30
8951082|NCT02451995|10013915|FG000|STARTED|Overall Study||42
8951083|NCT02451995|10013916|FG001|STARTED|Overall Study||41
8951084|NCT02451995|10013915|FG000|COMPLETED|Overall Study||42
8951085|NCT02451995|10013916|FG001|COMPLETED|Overall Study||41
8951086|NCT02451995|10013915|FG000|NOT COMPLETED|Overall Study||0
8951087|NCT02451995|10013916|FG001|NOT COMPLETED|Overall Study||0
8951088|NCT02452034|10013928|FG000|STARTED|Overall Study||16
8951089|NCT02452034|10013929|FG001|STARTED|Overall Study||21
8951090|NCT02452034|10013930|FG002|STARTED|Overall Study||15
8951091|NCT02452034|10013931|FG003|STARTED|Overall Study||17
8951092|NCT02452034|10013932|FG004|STARTED|Overall Study||20
8951093|NCT02452034|10013933|FG005|STARTED|Overall Study||29
8951094|NCT02452034|10013928|FG000|Treated|Overall Study||14
8951095|NCT02452034|10013929|FG001|Treated|Overall Study||21
8951096|NCT02452034|10013930|FG002|Treated|Overall Study||15
8951097|NCT02452034|10013931|FG003|Treated|Overall Study||16
8951098|NCT02452034|10013932|FG004|Treated|Overall Study||20
8951099|NCT02452034|10013933|FG005|Treated|Overall Study||29
8951100|NCT02452034|10013928|FG000|COMPLETED|Overall Study||14
8951101|NCT02452034|10013929|FG001|COMPLETED|Overall Study||20
8951102|NCT02452034|10013930|FG002|COMPLETED|Overall Study||14
8951103|NCT02452034|10013931|FG003|COMPLETED|Overall Study||16
8951104|NCT02452034|10013932|FG004|COMPLETED|Overall Study||19
8951105|NCT02452034|10013933|FG005|COMPLETED|Overall Study||26
8951106|NCT02452034|10013928|FG000|NOT COMPLETED|Overall Study||2
8725612|NCT01032330|9772904|FG000|STARTED|Overall Study||183
8865109|NCT01839318|9921061|FG000|NOT COMPLETED|Period 3, Third Day of Wear||0
8865110|NCT01839318|9921062|FG001|NOT COMPLETED|Period 3, Third Day of Wear||0
8865111|NCT01839318|9921063|FG002|NOT COMPLETED|Period 3, Third Day of Wear||0
8865112|NCT01839318|9921064|FG003|NOT COMPLETED|Period 3, Third Day of Wear||0
8865113|NCT01839318|9921065|FG004|NOT COMPLETED|Period 3, Third Day of Wear||0
8865114|NCT01839318|9921066|FG005|NOT COMPLETED|Period 3, Third Day of Wear||0
8865115|NCT01839487|9921076|FG000|STARTED|Run-in Phase (Maximum Exposure:295 Days)||16
8865116|NCT01839487|9921077|FG001|STARTED|Run-in Phase (Maximum Exposure:295 Days)||7
8865117|NCT01839487|9921078|FG002|STARTED|Run-in Phase (Maximum Exposure:295 Days)||0
8865118|NCT01839487|9921079|FG003|STARTED|Run-in Phase (Maximum Exposure:295 Days)||0
8923702|NCT02243046|9984374|FG001|STARTED|Overall Study||54
8951107|NCT02452034|10013929|FG001|NOT COMPLETED|Overall Study||1
8951108|NCT02452034|10013930|FG002|NOT COMPLETED|Overall Study||1
8951109|NCT02452034|10013931|FG003|NOT COMPLETED|Overall Study||1
8951110|NCT02452034|10013932|FG004|NOT COMPLETED|Overall Study||1
8951111|NCT02452034|10013933|FG005|NOT COMPLETED|Overall Study||3
8951112|NCT02452047|10013950|FG000|STARTED|Overall Study||31
8865119|NCT01839487|9921080|FG004|STARTED|Run-in Phase (Maximum Exposure:295 Days)||0
8865120|NCT01839487|9921081|FG005|STARTED|Run-in Phase (Maximum Exposure:295 Days)||0
8951113|NCT02452047|10013951|FG001|STARTED|Overall Study||16
8951114|NCT02452047|10013952|FG002|STARTED|Overall Study||3
8951115|NCT02452047|10013950|FG000|COMPLETED|Overall Study||27
8951116|NCT02452047|10013951|FG001|COMPLETED|Overall Study||11
8951117|NCT02452047|10013952|FG002|COMPLETED|Overall Study||1
8951118|NCT02452047|10013950|FG000|NOT COMPLETED|Overall Study||4
8951119|NCT02452047|10013951|FG001|NOT COMPLETED|Overall Study||5
8951120|NCT02452047|10013952|FG002|NOT COMPLETED|Overall Study||2
8951121|NCT02452060|10013962|FG000|STARTED|Overall Study||46
8951122|NCT02452060|10013963|FG001|STARTED|Overall Study||44
8951123|NCT02452060|10013962|FG000|COMPLETED|Overall Study||46
8951124|NCT02452060|10013963|FG001|COMPLETED|Overall Study||44
8951125|NCT02452060|10013962|FG000|NOT COMPLETED|Overall Study||0
8951126|NCT02452060|10013963|FG001|NOT COMPLETED|Overall Study||0
8951127|NCT02452190|10013971|FG000|STARTED|Overall Study||232
8951128|NCT02452190|10013972|FG001|STARTED|Overall Study||236
8951129|NCT02452190|10013971|FG000|Intent to Treat (ITT) Population|Overall Study||230
8951130|NCT02452190|10013972|FG001|Intent to Treat (ITT) Population|Overall Study||234
8951131|NCT02452190|10013971|FG000|Safety Population|Overall Study||231
8951132|NCT02452190|10013972|FG001|Safety Population|Overall Study||237
8951133|NCT02452190|10013971|FG000|COMPLETED|Overall Study||197
8951134|NCT02452190|10013972|FG001|COMPLETED|Overall Study||212
8951135|NCT02452190|10013971|FG000|NOT COMPLETED|Overall Study||35
8951136|NCT02452190|10013972|FG001|NOT COMPLETED|Overall Study||24
8951137|NCT02452320|10013980|FG000|STARTED|Overall Study||64
8951138|NCT02452320|10013981|FG001|STARTED|Overall Study||64
8951139|NCT02452320|10013980|FG000|COMPLETED|Overall Study||64
8951140|NCT02452320|10013981|FG001|COMPLETED|Overall Study||63
8951141|NCT02452320|10013980|FG000|NOT COMPLETED|Overall Study||0
8951142|NCT02452320|10013981|FG001|NOT COMPLETED|Overall Study||1
8951143|NCT02452346|10013987|FG000|STARTED|Overall Study||12
8951144|NCT02452346|10013987|FG000|COMPLETED|Overall Study||3
8951145|NCT02452346|10013987|FG000|NOT COMPLETED|Overall Study||9
8951146|NCT02452424|10014002|FG000|STARTED|Overall Study||4
8569768|NCT00098722|9601917|FG006|COMPLETED|Open Label Phase||0
8569769|NCT00098722|9601911|FG000|NOT COMPLETED|Open Label Phase||0
8569770|NCT00098722|9601912|FG001|NOT COMPLETED|Open Label Phase||0
8569771|NCT00098722|9601913|FG002|NOT COMPLETED|Open Label Phase||0
8569772|NCT00098722|9601914|FG003|NOT COMPLETED|Open Label Phase||272
8569773|NCT00098722|9601915|FG004|NOT COMPLETED|Open Label Phase||50
8569774|NCT00098722|9601916|FG005|NOT COMPLETED|Open Label Phase||0
8569775|NCT00098722|9601917|FG006|NOT COMPLETED|Open Label Phase||0
8569776|NCT00098722|9601911|FG000|STARTED|Observation Phase||0
8569777|NCT00098722|9601912|FG001|STARTED|Observation Phase||0
8569778|NCT00098722|9601913|FG002|STARTED|Observation Phase||0
8569779|NCT00098722|9601914|FG003|STARTED|Observation Phase||0
8569780|NCT00098722|9601915|FG004|STARTED|Observation Phase||0
8569781|NCT00098722|9601916|FG005|STARTED|Observation Phase||205
8569782|NCT00098722|9601917|FG006|STARTED|Observation Phase||65
8569783|NCT00098722|9601911|FG000|COMPLETED|Observation Phase||0
8569784|NCT00098722|9601912|FG001|COMPLETED|Observation Phase||0
8569785|NCT00098722|9601913|FG002|COMPLETED|Observation Phase||0
8569786|NCT00098722|9601914|FG003|COMPLETED|Observation Phase||0
8569787|NCT00098722|9601915|FG004|COMPLETED|Observation Phase||0
8569788|NCT00098722|9601916|FG005|COMPLETED|Observation Phase||160
8569789|NCT00098722|9601917|FG006|COMPLETED|Observation Phase||48
8569790|NCT00098722|9601911|FG000|NOT COMPLETED|Observation Phase||0
8865121|NCT01839487|9921076|FG000|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
8865122|NCT01839487|9921077|FG001|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
8865123|NCT01839487|9921078|FG002|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
8951147|NCT02452424|10014003|FG001|STARTED|Overall Study||3
8951148|NCT02452424|10014004|FG002|STARTED|Overall Study||7
8951149|NCT02452424|10014005|FG003|STARTED|Overall Study||9
8865124|NCT01839487|9921079|FG003|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
8865125|NCT01839487|9921080|FG004|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
8865126|NCT01839487|9921081|FG005|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
8865127|NCT01839487|9921076|FG000|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||16
8865128|NCT01839487|9921077|FG001|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||7
8865129|NCT01839487|9921078|FG002|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
8865130|NCT01839487|9921079|FG003|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
8865131|NCT01839487|9921080|FG004|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
8951150|NCT02452424|10014006|FG004|STARTED|Overall Study||4
8951151|NCT02452424|10014007|FG005|STARTED|Overall Study||6
8951152|NCT02452424|10014008|FG006|STARTED|Overall Study||13
8951153|NCT02452424|10014009|FG007|STARTED|Overall Study||8
8951154|NCT02452424|10014010|FG008|STARTED|Overall Study||15
8951155|NCT02452424|10014011|FG009|STARTED|Overall Study||3
8951156|NCT02452424|10014012|FG010|STARTED|Overall Study||6
8865132|NCT01839487|9921081|FG005|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
8865133|NCT01839487|9921076|FG000|STARTED|Phase 2 (Maximum Exposure:935 Days)||0
8865134|NCT01839487|9921077|FG001|STARTED|Phase 2 (Maximum Exposure:935 Days)||0
8865135|NCT01839487|9921078|FG002|STARTED|Phase 2 (Maximum Exposure:935 Days)||61
8865136|NCT01839487|9921079|FG003|STARTED|Phase 2 (Maximum Exposure:935 Days)||62
8865137|NCT01839487|9921080|FG004|STARTED|Phase 2 (Maximum Exposure:935 Days)||89
8865138|NCT01839487|9921081|FG005|STARTED|Phase 2 (Maximum Exposure:935 Days)||44
8865139|NCT01839487|9921076|FG000|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
8865140|NCT01839487|9921077|FG001|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
8865141|NCT01839487|9921078|FG002|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
8865142|NCT01839487|9921079|FG003|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
8865143|NCT01839487|9921080|FG004|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||1
8865144|NCT01839487|9921081|FG005|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
8865145|NCT01839487|9921076|FG000|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
8865146|NCT01839487|9921077|FG001|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
8865147|NCT01839487|9921078|FG002|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||61
8865148|NCT01839487|9921079|FG003|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||62
8865149|NCT01839487|9921080|FG004|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||88
8865150|NCT01839487|9921081|FG005|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||44
8865151|NCT01839604|9921094|FG000|STARTED|Overall Study||6
8865152|NCT01839604|9921095|FG001|STARTED|Overall Study||6
8865153|NCT01839604|9921096|FG002|STARTED|Overall Study||7
8865154|NCT01839604|9921097|FG003|STARTED|Overall Study||5
8865155|NCT01839604|9921098|FG004|STARTED|Overall Study||15
8865156|NCT01839604|9921094|FG000|COMPLETED|Overall Study||6
8865157|NCT01839604|9921095|FG001|COMPLETED|Overall Study||6
8865158|NCT01839604|9921096|FG002|COMPLETED|Overall Study||7
8865159|NCT01839604|9921097|FG003|COMPLETED|Overall Study||5
8865160|NCT01839604|9921098|FG004|COMPLETED|Overall Study||15
8865161|NCT01839604|9921094|FG000|NOT COMPLETED|Overall Study||0
8865162|NCT01839604|9921095|FG001|NOT COMPLETED|Overall Study||0
8865163|NCT01839604|9921096|FG002|NOT COMPLETED|Overall Study||0
8865164|NCT01839604|9921097|FG003|NOT COMPLETED|Overall Study||0
8865165|NCT01839604|9921098|FG004|NOT COMPLETED|Overall Study||0
8865166|NCT01839656|9921112|FG000|STARTED|Overall Study||5
8865167|NCT01839656|9921113|FG001|STARTED|Overall Study||16
8865168|NCT01839656|9921112|FG000|Completed Loading Dose Period|Overall Study||4
8865169|NCT01839656|9921113|FG001|Completed Loading Dose Period|Overall Study||15
8865170|NCT01839656|9921112|FG000|COMPLETED|Overall Study||2
8865171|NCT01839656|9921113|FG001|COMPLETED|Overall Study||0
8865172|NCT01839656|9921112|FG000|NOT COMPLETED|Overall Study||3
8865173|NCT01839656|9921113|FG001|NOT COMPLETED|Overall Study||16
8630505|NCT00535496|9670300|FG003|COMPLETED|Overall Study||31
8630506|NCT00535496|9670297|FG000|NOT COMPLETED|Overall Study||0
8630507|NCT00535496|9670298|FG001|NOT COMPLETED|Overall Study||2
8630508|NCT00535496|9670299|FG002|NOT COMPLETED|Overall Study||0
8630509|NCT00535496|9670300|FG003|NOT COMPLETED|Overall Study||0
8630510|NCT00535587|9670311|FG000|STARTED|Overall Study||53
8630511|NCT00535587|9670312|FG001|STARTED|Overall Study||53
8630512|NCT00535587|9670313|FG002|STARTED|Overall Study||47
8865174|NCT01839695|9921119|FG000|STARTED|Overall Study||9
8865175|NCT01839695|9921119|FG000|COMPLETED|Overall Study||9
8865176|NCT01839695|9921119|FG000|NOT COMPLETED|Overall Study||0
8865177|NCT01839708|9921125|FG000|STARTED|Overall Study||387
8865178|NCT01839708|9921126|FG001|STARTED|Overall Study||182
8865179|NCT01839708|9921125|FG000|COMPLETED|Overall Study||311
8865180|NCT01839708|9921126|FG001|COMPLETED|Overall Study||115
8865181|NCT01839708|9921125|FG000|NOT COMPLETED|Overall Study||76
8865182|NCT01839708|9921126|FG001|NOT COMPLETED|Overall Study||67
8865183|NCT01839799|9921134|FG000|STARTED|Overall Study||17
8865184|NCT01839799|9921135|FG001|STARTED|Overall Study||15
8865185|NCT01839799|9921134|FG000|COMPLETED|Overall Study||17
8865186|NCT01839799|9921135|FG001|COMPLETED|Overall Study||15
8865187|NCT01839799|9921134|FG000|NOT COMPLETED|Overall Study||0
8865188|NCT01839799|9921135|FG001|NOT COMPLETED|Overall Study||0
8865189|NCT01839916|9921141|FG000|STARTED|Overall Study||77
8865190|NCT01839916|9921141|FG000|COMPLETED|Overall Study||36
8865191|NCT01839916|9921141|FG000|NOT COMPLETED|Overall Study||41
8865192|NCT01840072|9921147|FG000|STARTED|Overall Study||2038
8865193|NCT01840072|9921148|FG001|STARTED|Overall Study||2033
8865194|NCT01840072|9921147|FG000|COMPLETED|Overall Study||2031
8865195|NCT01840072|9921148|FG001|COMPLETED|Overall Study||1986
8865196|NCT01840072|9921147|FG000|NOT COMPLETED|Overall Study||7
8865197|NCT01840072|9921148|FG001|NOT COMPLETED|Overall Study||47
8865198|NCT01840163|9921158|FG000|STARTED|First Follow up -Primary Outcome||267
8865199|NCT01840163|9921159|FG001|STARTED|First Follow up -Primary Outcome||270
8865200|NCT01840163|9921158|FG000|COMPLETED|First Follow up -Primary Outcome||248
8865201|NCT01840163|9921159|FG001|COMPLETED|First Follow up -Primary Outcome||254
8865202|NCT01840163|9921158|FG000|NOT COMPLETED|First Follow up -Primary Outcome||19
8865203|NCT01840163|9921159|FG001|NOT COMPLETED|First Follow up -Primary Outcome||16
8865204|NCT01840163|9921158|FG000|STARTED|Systemic Follow Up-secondary Outcome|From primary outcome to secondary outcome prd 1 participant withdrew and 1 became deceased|265
8865205|NCT01840163|9921159|FG001|STARTED|Systemic Follow Up-secondary Outcome|4 participants became unreachable and lost to follow up before sending 9 mo follow up|266
8865206|NCT01840163|9921158|FG000|COMPLETED|Systemic Follow Up-secondary Outcome||174
8865207|NCT01840163|9921159|FG001|COMPLETED|Systemic Follow Up-secondary Outcome||191
8865208|NCT01840163|9921158|FG000|NOT COMPLETED|Systemic Follow Up-secondary Outcome||91
8865209|NCT01840163|9921159|FG001|NOT COMPLETED|Systemic Follow Up-secondary Outcome||75
8865210|NCT01840228|9921167|FG000|STARTED|Overall Study||19
8865211|NCT01840228|9921168|FG001|STARTED|Overall Study||19
8865212|NCT01840228|9921167|FG000|COMPLETED|Overall Study||18
8865213|NCT01840228|9921168|FG001|COMPLETED|Overall Study||18
8865214|NCT01840228|9921167|FG000|NOT COMPLETED|Overall Study||1
8865215|NCT01840228|9921168|FG001|NOT COMPLETED|Overall Study||1
8865216|NCT01840319|9921178|FG000|STARTED|Overall Study||156
8865217|NCT01840319|9921178|FG000|COMPLETED|Overall Study||156
8865218|NCT01840319|9921178|FG000|NOT COMPLETED|Overall Study||0
8865219|NCT01840345|9921182|FG000|STARTED|Overall Study||11
8865220|NCT01840345|9921182|FG000|COMPLETED|Overall Study||10
8865221|NCT01840345|9921182|FG000|NOT COMPLETED|Overall Study||1
8865222|NCT01840410|9921188|FG000|STARTED|Overall Study||119
8865223|NCT01840410|9921189|FG001|STARTED|Overall Study||59
8865224|NCT01840410|9921188|FG000|Safety Set|Overall Study||119
8865225|NCT01840410|9921189|FG001|Safety Set|Overall Study|52 received ranibizumab at or after Month 2;7 did not receive ranibizumab any time during the study|59
8865226|NCT01840410|9921188|FG000|Full Analysis Set|Overall Study||119
8865227|NCT01840410|9921189|FG001|Full Analysis Set|Overall Study||59
8865228|NCT01840410|9921188|FG000|COMPLETED|Overall Study||112
8865229|NCT01840410|9921189|FG001|COMPLETED|Overall Study||55
8865230|NCT01840410|9921188|FG000|NOT COMPLETED|Overall Study||7
8865231|NCT01840410|9921189|FG001|NOT COMPLETED|Overall Study||4
8865232|NCT01840579|9921207|FG000|STARTED|Overall Study||3
8865233|NCT01840579|9921208|FG001|STARTED|Overall Study||7
8865234|NCT01840579|9921209|FG002|STARTED|Overall Study||6
8865235|NCT01840579|9921210|FG003|STARTED|Overall Study||6
8865236|NCT01840579|9921211|FG004|STARTED|Overall Study||8
8865237|NCT01840579|9921212|FG005|STARTED|Overall Study||6
8865238|NCT01840579|9921213|FG006|STARTED|Overall Study||6
8865239|NCT01840579|9921214|FG007|STARTED|Overall Study||6
8865240|NCT01840579|9921215|FG008|STARTED|Overall Study||6
8865241|NCT01840579|9921216|FG009|STARTED|Overall Study||3
8865242|NCT01840579|9921207|FG000|COMPLETED|Overall Study||0
8865243|NCT01840579|9921208|FG001|COMPLETED|Overall Study||0
8865244|NCT01840579|9921209|FG002|COMPLETED|Overall Study||4
8865245|NCT01840579|9921210|FG003|COMPLETED|Overall Study||3
8865246|NCT01840579|9921211|FG004|COMPLETED|Overall Study||4
8865247|NCT01840579|9921212|FG005|COMPLETED|Overall Study||2
8951157|NCT02452424|10014002|FG000|COMPLETED|Overall Study||2
8951158|NCT02452424|10014003|FG001|COMPLETED|Overall Study||0
8951159|NCT02452424|10014004|FG002|COMPLETED|Overall Study||0
8951160|NCT02452424|10014005|FG003|COMPLETED|Overall Study||1
8951161|NCT02452424|10014006|FG004|COMPLETED|Overall Study||2
8951162|NCT02452424|10014007|FG005|COMPLETED|Overall Study||5
8951163|NCT02452424|10014008|FG006|COMPLETED|Overall Study||3
8951164|NCT02452424|10014009|FG007|COMPLETED|Overall Study||4
8865248|NCT01840579|9921213|FG006|COMPLETED|Overall Study||4
8865249|NCT01840579|9921214|FG007|COMPLETED|Overall Study||3
8865250|NCT01840579|9921215|FG008|COMPLETED|Overall Study||3
8865251|NCT01840579|9921216|FG009|COMPLETED|Overall Study||0
8951165|NCT02452424|10014010|FG008|COMPLETED|Overall Study||9
8951166|NCT02452424|10014011|FG009|COMPLETED|Overall Study||1
8951167|NCT02452424|10014012|FG010|COMPLETED|Overall Study||4
8865252|NCT01840579|9921207|FG000|NOT COMPLETED|Overall Study||3
8865253|NCT01840579|9921208|FG001|NOT COMPLETED|Overall Study||7
8865254|NCT01840579|9921209|FG002|NOT COMPLETED|Overall Study||2
8865255|NCT01840579|9921210|FG003|NOT COMPLETED|Overall Study||3
8865256|NCT01840579|9921211|FG004|NOT COMPLETED|Overall Study||4
8865257|NCT01840579|9921212|FG005|NOT COMPLETED|Overall Study||4
8865258|NCT01840579|9921213|FG006|NOT COMPLETED|Overall Study||2
8865259|NCT01840579|9921214|FG007|NOT COMPLETED|Overall Study||3
8865260|NCT01840579|9921215|FG008|NOT COMPLETED|Overall Study||3
8865261|NCT01840579|9921216|FG009|NOT COMPLETED|Overall Study||3
8923703|NCT02243046|9984375|FG002|STARTED|Overall Study||53
8923704|NCT02243046|9984373|FG000|3 Month|Overall Study|1 subject didn't return for 3 month clinic visit|54
8923705|NCT02243046|9984374|FG001|3 Month|Overall Study|1 subject didn't return for 3 month clinic visit|53
8923706|NCT02243046|9984375|FG002|3 Month|Overall Study|2 subjects didn't return for 3 month clinic visit|51
8923707|NCT02243046|9984373|FG000|6 Month|Overall Study||54
8923708|NCT02243046|9984374|FG001|6 Month|Overall Study||53
8923709|NCT02243046|9984375|FG002|6 Month|Overall Study|2 subjects didn't return for 6 month clinic visit|49
8923710|NCT02243046|9984373|FG000|COMPLETED|Overall Study||54
8923711|NCT02243046|9984374|FG001|COMPLETED|Overall Study||53
8923712|NCT02243046|9984375|FG002|COMPLETED|Overall Study||49
8923713|NCT02243046|9984373|FG000|NOT COMPLETED|Overall Study||1
8923714|NCT02243046|9984374|FG001|NOT COMPLETED|Overall Study||1
8923715|NCT02243046|9984375|FG002|NOT COMPLETED|Overall Study||4
8923716|NCT02243176|9984385|FG000|STARTED|Overall Study|3 of the randomized subjects withdrew before taking any medication|244
8923717|NCT02243176|9984386|FG001|STARTED|Overall Study||244
8923718|NCT02243176|9984385|FG000|COMPLETED|Overall Study||230
8923719|NCT02243176|9984386|FG001|COMPLETED|Overall Study||229
8923720|NCT02243176|9984385|FG000|NOT COMPLETED|Overall Study||14
8923721|NCT02243176|9984386|FG001|NOT COMPLETED|Overall Study||15
8923722|NCT02243202|9984396|FG000|STARTED|Overall Study||82
8923723|NCT02243202|9984397|FG001|STARTED|Overall Study||85
8923724|NCT02243202|9984398|FG002|STARTED|Overall Study||84
8923725|NCT02243202|9984399|FG003|STARTED|Overall Study||84
8923726|NCT02243202|9984396|FG000|Treated|Overall Study||82
8923727|NCT02243202|9984397|FG001|Treated|Overall Study||85
8923728|NCT02243202|9984398|FG002|Treated|Overall Study||84
8923729|NCT02243202|9984399|FG003|Treated|Overall Study||83
8923730|NCT02243202|9984396|FG000|COMPLETED|Overall Study||57
8923731|NCT02243202|9984397|FG001|COMPLETED|Overall Study||60
8923732|NCT02243202|9984398|FG002|COMPLETED|Overall Study||53
8923733|NCT02243202|9984399|FG003|COMPLETED|Overall Study||61
8923734|NCT02243202|9984396|FG000|NOT COMPLETED|Overall Study||25
8923735|NCT02243202|9984397|FG001|NOT COMPLETED|Overall Study||25
8923736|NCT02243202|9984398|FG002|NOT COMPLETED|Overall Study||31
8923737|NCT02243202|9984399|FG003|NOT COMPLETED|Overall Study||23
8923738|NCT02243280|9984420|FG000|STARTED|Enrolled||40
8923739|NCT02243280|9984421|FG001|STARTED|Enrolled||39
8923740|NCT02243280|9984422|FG002|STARTED|Enrolled||0
8923741|NCT02243280|9984423|FG003|STARTED|Enrolled||0
8923742|NCT02243280|9984424|FG004|STARTED|Enrolled||0
8923743|NCT02243280|9984425|FG005|STARTED|Enrolled||27
8923744|NCT02243280|9984426|FG006|STARTED|Enrolled||0
8923745|NCT02243280|9984427|FG007|STARTED|Enrolled||0
8923746|NCT02243280|9984428|FG008|STARTED|Enrolled||34
8923747|NCT02243280|9984429|FG009|STARTED|Enrolled||0
8923748|NCT02243280|9984430|FG010|STARTED|Enrolled||34
8923749|NCT02243280|9984420|FG000|COMPLETED|Enrolled||40
8923750|NCT02243280|9984421|FG001|COMPLETED|Enrolled||39
8923751|NCT02243280|9984422|FG002|COMPLETED|Enrolled||0
8923752|NCT02243280|9984423|FG003|COMPLETED|Enrolled||0
8923753|NCT02243280|9984424|FG004|COMPLETED|Enrolled||0
8923754|NCT02243280|9984425|FG005|COMPLETED|Enrolled||27
8923755|NCT02243280|9984426|FG006|COMPLETED|Enrolled||0
8923756|NCT02243280|9984427|FG007|COMPLETED|Enrolled||0
8923757|NCT02243280|9984428|FG008|COMPLETED|Enrolled||34
8923758|NCT02243280|9984429|FG009|COMPLETED|Enrolled||0
8923759|NCT02243280|9984430|FG010|COMPLETED|Enrolled||34
8923760|NCT02243280|9984420|FG000|NOT COMPLETED|Enrolled||0
8923761|NCT02243280|9984421|FG001|NOT COMPLETED|Enrolled||0
8923762|NCT02243280|9984422|FG002|NOT COMPLETED|Enrolled||0
8923763|NCT02243280|9984423|FG003|NOT COMPLETED|Enrolled||0
8923764|NCT02243280|9984424|FG004|NOT COMPLETED|Enrolled||0
8923765|NCT02243280|9984425|FG005|NOT COMPLETED|Enrolled||0
8923766|NCT02243280|9984426|FG006|NOT COMPLETED|Enrolled||0
8923767|NCT02243280|9984427|FG007|NOT COMPLETED|Enrolled||0
8630513|NCT00535587|9670314|FG003|STARTED|Overall Study||54
8865262|NCT01840605|9921252|FG000|STARTED|Overall Study||151
8865263|NCT01840605|9921253|FG001|STARTED|Overall Study||152
8865264|NCT01840605|9921252|FG000|COMPLETED|Overall Study||149
8865265|NCT01840605|9921253|FG001|COMPLETED|Overall Study||150
8865266|NCT01840605|9921252|FG000|NOT COMPLETED|Overall Study||2
8865267|NCT01840605|9921253|FG001|NOT COMPLETED|Overall Study||2
8865268|NCT01840722|9921261|FG000|STARTED|Overall Study||201
8865269|NCT01840722|9921262|FG001|STARTED|Overall Study||199
8865270|NCT01840722|9921261|FG000|COMPLETED|Overall Study||201
8865271|NCT01840722|9921262|FG001|COMPLETED|Overall Study||130
8865272|NCT01840722|9921261|FG000|NOT COMPLETED|Overall Study||0
8865273|NCT01840722|9921262|FG001|NOT COMPLETED|Overall Study||69
8865274|NCT01840943|9921270|FG000|STARTED|Overall Study||14
8865275|NCT01840943|9921271|FG001|STARTED|Overall Study||12
8865276|NCT01840943|9921270|FG000|COMPLETED|Overall Study||1
8865277|NCT01840943|9921271|FG001|COMPLETED|Overall Study||0
8865278|NCT01840943|9921270|FG000|NOT COMPLETED|Overall Study||13
8865279|NCT01840943|9921271|FG001|NOT COMPLETED|Overall Study||12
8865280|NCT01841021|9921277|FG000|STARTED|Overall Study||1
8865281|NCT01841021|9921277|FG000|COMPLETED|Overall Study||1
8865282|NCT01841021|9921277|FG000|NOT COMPLETED|Overall Study||0
8865283|NCT01841047|9921281|FG000|STARTED|Overall Study||48
8865284|NCT01841047|9921281|FG000|COMPLETED|Overall Study||48
8865285|NCT01841047|9921281|FG000|NOT COMPLETED|Overall Study||0
8865286|NCT01841060|9921285|FG000|STARTED|Overall Study||42
8865287|NCT01841060|9921285|FG000|COMPLETED|Overall Study||32
8865288|NCT01841060|9921285|FG000|NOT COMPLETED|Overall Study||10
8865289|NCT01841073|9921291|FG000|STARTED|Overall Study||22
8865290|NCT01841073|9921292|FG001|STARTED|Overall Study||22
8865291|NCT01841073|9921291|FG000|COMPLETED|Overall Study||20
8865292|NCT01841073|9921292|FG001|COMPLETED|Overall Study||19
8865293|NCT01841073|9921291|FG000|NOT COMPLETED|Overall Study||2
8865294|NCT01841073|9921292|FG001|NOT COMPLETED|Overall Study||3
8865295|NCT01841216|9921302|FG000|STARTED|Overall Study||15
8865296|NCT01841216|9921303|FG001|STARTED|Overall Study||15
8865297|NCT01841216|9921302|FG000|COMPLETED|Overall Study||15
8865298|NCT01841216|9921303|FG001|COMPLETED|Overall Study||15
8865299|NCT01841216|9921302|FG000|NOT COMPLETED|Overall Study||0
8630514|NCT00535587|9670311|FG000|COMPLETED|Overall Study||43
8630515|NCT00535587|9670312|FG001|COMPLETED|Overall Study||42
8630516|NCT00535587|9670313|FG002|COMPLETED|Overall Study||39
8630517|NCT00535587|9670314|FG003|COMPLETED|Overall Study||41
8630518|NCT00535587|9670311|FG000|NOT COMPLETED|Overall Study||10
8630519|NCT00535587|9670312|FG001|NOT COMPLETED|Overall Study||11
8630520|NCT00535587|9670313|FG002|NOT COMPLETED|Overall Study||8
8630521|NCT00535587|9670314|FG003|NOT COMPLETED|Overall Study||13
8630522|NCT00535613|9670324|FG000|STARTED|Overall Study||49
8630523|NCT00535613|9670325|FG001|STARTED|Overall Study||50
8630524|NCT00535613|9670324|FG000|COMPLETED|Overall Study||49
8630525|NCT00535613|9670325|FG001|COMPLETED|Overall Study||50
8630526|NCT00535613|9670324|FG000|NOT COMPLETED|Overall Study||0
8630527|NCT00535613|9670325|FG001|NOT COMPLETED|Overall Study||0
8630528|NCT00535626|9670331|FG000|STARTED|Overall Study||190
8630529|NCT00535626|9670331|FG000|COMPLETED|Overall Study||85
8630530|NCT00535626|9670331|FG000|NOT COMPLETED|Overall Study||105
8630531|NCT00535652|9670336|FG000|STARTED|Overall Study||23
8725613|NCT01032330|9772905|FG001|STARTED|Overall Study||175
8725614|NCT01032330|9772906|FG002|STARTED|Overall Study||97
8725615|NCT01032330|9772907|FG003|STARTED|Overall Study||104
8725616|NCT01032330|9772904|FG000|COMPLETED|Overall Study||165
8725617|NCT01032330|9772905|FG001|COMPLETED|Overall Study||151
8725618|NCT01032330|9772906|FG002|COMPLETED|Overall Study||87
8725619|NCT01032330|9772907|FG003|COMPLETED|Overall Study||90
8725620|NCT01032330|9772904|FG000|NOT COMPLETED|Overall Study||18
8725621|NCT01032330|9772905|FG001|NOT COMPLETED|Overall Study||24
8725622|NCT01032330|9772906|FG002|NOT COMPLETED|Overall Study||10
8865300|NCT01841216|9921303|FG001|NOT COMPLETED|Overall Study||0
8865301|NCT01841281|9921311|FG000|STARTED|First Intervention (12 Weeks)||11
8865302|NCT01841281|9921312|FG001|STARTED|First Intervention (12 Weeks)||12
8865303|NCT01841281|9921313|FG002|STARTED|First Intervention (12 Weeks)||13
8865304|NCT01841281|9921314|FG003|STARTED|First Intervention (12 Weeks)||14
8865305|NCT01841281|9921311|FG000|COMPLETED|First Intervention (12 Weeks)||11
8865306|NCT01841281|9921312|FG001|COMPLETED|First Intervention (12 Weeks)||12
8865307|NCT01841281|9921313|FG002|COMPLETED|First Intervention (12 Weeks)||13
8865308|NCT01841281|9921314|FG003|COMPLETED|First Intervention (12 Weeks)||14
8865309|NCT01841281|9921311|FG000|NOT COMPLETED|First Intervention (12 Weeks)||0
8865310|NCT01841281|9921312|FG001|NOT COMPLETED|First Intervention (12 Weeks)||0
8865311|NCT01841281|9921313|FG002|NOT COMPLETED|First Intervention (12 Weeks)||0
8865312|NCT01841281|9921314|FG003|NOT COMPLETED|First Intervention (12 Weeks)||0
8865313|NCT01841281|9921311|FG000|STARTED|Washout (6 Weeks)||11
8865314|NCT01841281|9921312|FG001|STARTED|Washout (6 Weeks)||12
8630532|NCT00535652|9670336|FG000|COMPLETED|Overall Study||20
8630533|NCT00535652|9670336|FG000|NOT COMPLETED|Overall Study||3
8630534|NCT00535730|9670342|FG000|STARTED|Overall Study||236
8630535|NCT00535730|9670343|FG001|STARTED|Overall Study|Two subjects were allocated but not vaccinated making the number of subjects vaccinated 235|237
8630536|NCT00535730|9670342|FG000|COMPLETED|Overall Study||234
8865315|NCT01841281|9921313|FG002|STARTED|Washout (6 Weeks)||13
8865316|NCT01841281|9921314|FG003|STARTED|Washout (6 Weeks)||14
8865317|NCT01841281|9921311|FG000|COMPLETED|Washout (6 Weeks)||9
8865318|NCT01841281|9921312|FG001|COMPLETED|Washout (6 Weeks)||9
8865319|NCT01841281|9921313|FG002|COMPLETED|Washout (6 Weeks)||10
8865320|NCT01841281|9921314|FG003|COMPLETED|Washout (6 Weeks)||13
8865321|NCT01841281|9921311|FG000|NOT COMPLETED|Washout (6 Weeks)||2
8865322|NCT01841281|9921312|FG001|NOT COMPLETED|Washout (6 Weeks)||3
8865323|NCT01841281|9921313|FG002|NOT COMPLETED|Washout (6 Weeks)||3
8865324|NCT01841281|9921314|FG003|NOT COMPLETED|Washout (6 Weeks)||1
8865325|NCT01841281|9921311|FG000|STARTED|Second Intervention (12 Weeks)||9
8865326|NCT01841281|9921312|FG001|STARTED|Second Intervention (12 Weeks)||9
8865327|NCT01841281|9921313|FG002|STARTED|Second Intervention (12 Weeks)||10
8865328|NCT01841281|9921314|FG003|STARTED|Second Intervention (12 Weeks)||13
8569791|NCT00098722|9601912|FG001|NOT COMPLETED|Observation Phase||0
8569792|NCT00098722|9601913|FG002|NOT COMPLETED|Observation Phase||0
8569793|NCT00098722|9601914|FG003|NOT COMPLETED|Observation Phase||0
8569794|NCT00098722|9601915|FG004|NOT COMPLETED|Observation Phase||0
8865329|NCT01841281|9921311|FG000|COMPLETED|Second Intervention (12 Weeks)||9
8865330|NCT01841281|9921312|FG001|COMPLETED|Second Intervention (12 Weeks)||6
8865331|NCT01841281|9921313|FG002|COMPLETED|Second Intervention (12 Weeks)||10
8865332|NCT01841281|9921314|FG003|COMPLETED|Second Intervention (12 Weeks)||13
8865333|NCT01841281|9921311|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||0
8865334|NCT01841281|9921312|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||3
8865335|NCT01841281|9921313|FG002|NOT COMPLETED|Second Intervention (12 Weeks)||0
8865336|NCT01841281|9921314|FG003|NOT COMPLETED|Second Intervention (12 Weeks)||0
8865337|NCT01841554|9921330|FG000|STARTED|Overall Study||61
8865338|NCT01841554|9921330|FG000|Implanted|Overall Study||60
8865339|NCT01841554|9921330|FG000|1 Year Follow Up|Overall Study||42
8865340|NCT01841554|9921330|FG000|COMPLETED|Overall Study||42
8865341|NCT01841554|9921330|FG000|NOT COMPLETED|Overall Study||19
8865342|NCT01841567|9921334|FG000|STARTED|Overall Study||60
8865343|NCT01841567|9921334|FG000|COMPLETED|Overall Study||57
8865344|NCT01841567|9921334|FG000|NOT COMPLETED|Overall Study||3
8865345|NCT01841593|9921340|FG000|STARTED|First Intervention (Days 1 to 7)||12
8865346|NCT01841593|9921341|FG001|STARTED|First Intervention (Days 1 to 7)||7
8865347|NCT01841593|9921340|FG000|COMPLETED|First Intervention (Days 1 to 7)||12
8865348|NCT01841593|9921341|FG001|COMPLETED|First Intervention (Days 1 to 7)||6
8865349|NCT01841593|9921340|FG000|NOT COMPLETED|First Intervention (Days 1 to 7)||0
8865350|NCT01841593|9921341|FG001|NOT COMPLETED|First Intervention (Days 1 to 7)||1
8865351|NCT01841593|9921340|FG000|STARTED|Second Intervention (Days 8 to 14)||12
8865352|NCT01841593|9921341|FG001|STARTED|Second Intervention (Days 8 to 14)||6
8865353|NCT01841593|9921340|FG000|COMPLETED|Second Intervention (Days 8 to 14)||11
8865354|NCT01841593|9921341|FG001|COMPLETED|Second Intervention (Days 8 to 14)||6
8865355|NCT01841593|9921340|FG000|NOT COMPLETED|Second Intervention (Days 8 to 14)||1
8865356|NCT01841593|9921341|FG001|NOT COMPLETED|Second Intervention (Days 8 to 14)||0
8865357|NCT01841593|9921340|FG000|STARTED|Third Intervention (Days 15 to 21)||11
8865358|NCT01841593|9921341|FG001|STARTED|Third Intervention (Days 15 to 21)||6
8865359|NCT01841593|9921340|FG000|COMPLETED|Third Intervention (Days 15 to 21)||11
8865360|NCT01841593|9921341|FG001|COMPLETED|Third Intervention (Days 15 to 21)||6
8865361|NCT01841593|9921340|FG000|NOT COMPLETED|Third Intervention (Days 15 to 21)||0
8865362|NCT01841593|9921341|FG001|NOT COMPLETED|Third Intervention (Days 15 to 21)||0
8865363|NCT01841606|9921353|FG000|STARTED|Overall Study||25
8865364|NCT01841606|9921354|FG001|STARTED|Overall Study||27
8865365|NCT01841606|9921353|FG000|COMPLETED|Overall Study||25
8865366|NCT01841606|9921354|FG001|COMPLETED|Overall Study||27
8865367|NCT01841606|9921353|FG000|NOT COMPLETED|Overall Study||0
8865368|NCT01841606|9921354|FG001|NOT COMPLETED|Overall Study||0
8865369|NCT01841619|9921360|FG000|STARTED|Overall Study||16
8865370|NCT01841619|9921360|FG000|COMPLETED|Overall Study||16
8865371|NCT01841619|9921360|FG000|NOT COMPLETED|Overall Study||0
8865372|NCT01841632|9921364|FG000|STARTED|Overall Study||3
8865373|NCT01841632|9921364|FG000|COMPLETED|Overall Study||3
8865374|NCT01841632|9921364|FG000|NOT COMPLETED|Overall Study||0
8865375|NCT01841697|9921370|FG000|STARTED|Overall Study||322
8865376|NCT01841697|9921371|FG001|STARTED|Overall Study||320
8865377|NCT01841697|9921370|FG000|COMPLETED|Overall Study||302
8865378|NCT01841697|9921371|FG001|COMPLETED|Overall Study||302
8865379|NCT01841697|9921370|FG000|NOT COMPLETED|Overall Study||20
8865380|NCT01841697|9921371|FG001|NOT COMPLETED|Overall Study||18
8865381|NCT01841762|9921377|FG000|STARTED|Screening Period||335
8865382|NCT01841762|9921377|FG000|COMPLETED|Screening Period||284
8865383|NCT01841762|9921377|FG000|NOT COMPLETED|Screening Period||51
8865384|NCT01841762|9921377|FG000|STARTED|Treatment Period||284
8865385|NCT01841762|9921377|FG000|COMPLETED|Treatment Period||252
8865386|NCT01841762|9921377|FG000|NOT COMPLETED|Treatment Period||32
8865387|NCT01841762|9921377|FG000|STARTED|Post-Treatment Safety Follow-Up Period||284
8865388|NCT01841762|9921377|FG000|COMPLETED|Post-Treatment Safety Follow-Up Period||269
8865389|NCT01841762|9921377|FG000|NOT COMPLETED|Post-Treatment Safety Follow-Up Period||15
8865390|NCT01841970|9921381|FG000|STARTED|Overall Study||20
8865391|NCT01841970|9921381|FG000|COMPLETED|Overall Study||9
8865392|NCT01841970|9921381|FG000|NOT COMPLETED|Overall Study||11
8865393|NCT01842061|9921390|FG000|STARTED|Overall Study||13
8865394|NCT01842061|9921391|FG001|STARTED|Overall Study||12
8865395|NCT01842061|9921390|FG000|COMPLETED|Overall Study||12
8865396|NCT01842061|9921391|FG001|COMPLETED|Overall Study||8
8865397|NCT01842061|9921390|FG000|NOT COMPLETED|Overall Study||1
8865398|NCT01842061|9921391|FG001|NOT COMPLETED|Overall Study||4
8951168|NCT02452424|10014002|FG000|NOT COMPLETED|Overall Study||2
8951169|NCT02452424|10014003|FG001|NOT COMPLETED|Overall Study||3
8951170|NCT02452424|10014004|FG002|NOT COMPLETED|Overall Study||7
8951171|NCT02452424|10014005|FG003|NOT COMPLETED|Overall Study||8
8951172|NCT02452424|10014006|FG004|NOT COMPLETED|Overall Study||2
8865399|NCT01842308|9921402|FG000|STARTED|Overall Study||6
8865400|NCT01842308|9921403|FG001|STARTED|Overall Study||3
8865401|NCT01842308|9921404|FG002|STARTED|Overall Study||3
8865402|NCT01842308|9921405|FG003|STARTED|Overall Study||2
8865403|NCT01842308|9921406|FG004|STARTED|Overall Study||36
8865404|NCT01842308|9921402|FG000|COMPLETED|Overall Study||6
8865405|NCT01842308|9921403|FG001|COMPLETED|Overall Study||3
8865406|NCT01842308|9921404|FG002|COMPLETED|Overall Study||3
8951173|NCT02452424|10014007|FG005|NOT COMPLETED|Overall Study||1
8865407|NCT01842308|9921405|FG003|COMPLETED|Overall Study||2
8865408|NCT01842308|9921406|FG004|COMPLETED|Overall Study||35
8865409|NCT01842308|9921402|FG000|NOT COMPLETED|Overall Study||0
8865410|NCT01842308|9921403|FG001|NOT COMPLETED|Overall Study||0
8865411|NCT01842308|9921404|FG002|NOT COMPLETED|Overall Study||0
8865412|NCT01842308|9921405|FG003|NOT COMPLETED|Overall Study||0
8865413|NCT01842308|9921406|FG004|NOT COMPLETED|Overall Study||1
8865414|NCT01842334|9921421|FG000|STARTED|Overall Study||5
8865415|NCT01842334|9921422|FG001|STARTED|Overall Study||7
8865416|NCT01842334|9921421|FG000|COMPLETED|Overall Study||2
8865417|NCT01842334|9921422|FG001|COMPLETED|Overall Study||3
8865418|NCT01842334|9921421|FG000|NOT COMPLETED|Overall Study||3
8865419|NCT01842334|9921422|FG001|NOT COMPLETED|Overall Study||4
8865420|NCT01842438|9921430|FG000|STARTED|T1: Immediately After the Intervention||42
8865421|NCT01842438|9921431|FG001|STARTED|T1: Immediately After the Intervention||44
8865422|NCT01842438|9921430|FG000|COMPLETED|T1: Immediately After the Intervention||36
8865423|NCT01842438|9921431|FG001|COMPLETED|T1: Immediately After the Intervention||36
8865424|NCT01842438|9921430|FG000|NOT COMPLETED|T1: Immediately After the Intervention||6
8865425|NCT01842438|9921431|FG001|NOT COMPLETED|T1: Immediately After the Intervention||8
8865426|NCT01842438|9921430|FG000|STARTED|T2: 6month Follow-up||36
8865427|NCT01842438|9921431|FG001|STARTED|T2: 6month Follow-up||36
8865428|NCT01842438|9921430|FG000|COMPLETED|T2: 6month Follow-up||32
8865429|NCT01842438|9921431|FG001|COMPLETED|T2: 6month Follow-up||32
8865430|NCT01842438|9921430|FG000|NOT COMPLETED|T2: 6month Follow-up||4
8865431|NCT01842438|9921431|FG001|NOT COMPLETED|T2: 6month Follow-up||4
8865432|NCT01842464|9921441|FG000|STARTED|Overall Study||44
8865433|NCT01842464|9921441|FG000|COMPLETED|Overall Study||44
8865434|NCT01842464|9921441|FG000|NOT COMPLETED|Overall Study||0
8865435|NCT01842581|9921448|FG000|STARTED|Overall Study||113
8865436|NCT01842581|9921449|FG001|STARTED|Overall Study||109
8865437|NCT01842581|9921448|FG000|Received at Least 1 Dose of Study Drug|Overall Study||113
8865438|NCT01842581|9921449|FG001|Received at Least 1 Dose of Study Drug|Overall Study||108
8865439|NCT01842581|9921448|FG000|COMPLETED|Overall Study||69
8865440|NCT01842581|9921449|FG001|COMPLETED|Overall Study||79
8865441|NCT01842581|9921448|FG000|NOT COMPLETED|Overall Study||44
8865442|NCT01842581|9921449|FG001|NOT COMPLETED|Overall Study||30
8865443|NCT01842594|9921455|FG000|STARTED|Overall Study||13
8865444|NCT01842594|9921455|FG000|COMPLETED|Overall Study||10
8865445|NCT01842594|9921455|FG000|NOT COMPLETED|Overall Study||3
8865446|NCT01842607|9921459|FG000|STARTED|Overall Study||651
8865447|NCT01842607|9921459|FG000|COMPLETED|Overall Study||585
8865448|NCT01842607|9921459|FG000|NOT COMPLETED|Overall Study||66
8865449|NCT01842620|9921463|FG000|STARTED|Period 1||13
8865450|NCT01842620|9921464|FG001|STARTED|Period 1||12
8865451|NCT01842620|9921463|FG000|COMPLETED|Period 1||12
8865452|NCT01842620|9921464|FG001|COMPLETED|Period 1||12
8865453|NCT01842620|9921463|FG000|NOT COMPLETED|Period 1||1
8865454|NCT01842620|9921464|FG001|NOT COMPLETED|Period 1||0
8865455|NCT01842620|9921463|FG000|STARTED|Washout Period||12
8865456|NCT01842620|9921464|FG001|STARTED|Washout Period||12
8865457|NCT01842620|9921463|FG000|COMPLETED|Washout Period||12
8865458|NCT01842620|9921464|FG001|COMPLETED|Washout Period||12
8865459|NCT01842620|9921463|FG000|NOT COMPLETED|Washout Period||0
8865460|NCT01842620|9921464|FG001|NOT COMPLETED|Washout Period||0
8865461|NCT01842620|9921463|FG000|STARTED|Period 2||12
8865462|NCT01842620|9921464|FG001|STARTED|Period 2||12
8865463|NCT01842620|9921463|FG000|COMPLETED|Period 2||12
8865464|NCT01842620|9921464|FG001|COMPLETED|Period 2||12
8865465|NCT01842620|9921463|FG000|NOT COMPLETED|Period 2||0
8865466|NCT01842620|9921464|FG001|NOT COMPLETED|Period 2||0
8865467|NCT01842633|9921473|FG000|STARTED|Overall Study||65
8865468|NCT01842633|9921474|FG001|STARTED|Overall Study||66
8865469|NCT01842633|9921475|FG002|STARTED|Overall Study||34
8865470|NCT01842633|9921473|FG000|COMPLETED|Overall Study||62
8865471|NCT01842633|9921474|FG001|COMPLETED|Overall Study||64
8865472|NCT01842633|9921475|FG002|COMPLETED|Overall Study||34
8865473|NCT01842633|9921473|FG000|NOT COMPLETED|Overall Study||3
8865474|NCT01842633|9921474|FG001|NOT COMPLETED|Overall Study||2
8865475|NCT01842633|9921475|FG002|NOT COMPLETED|Overall Study||0
8865476|NCT01842646|9921485|FG000|STARTED|Overall Study||35
8865477|NCT01842646|9921485|FG000|COMPLETED|Overall Study||35
8865478|NCT01842646|9921485|FG000|NOT COMPLETED|Overall Study||0
8865479|NCT01842789|9921491|FG000|STARTED|Overall Study||10
8865480|NCT01842789|9921492|FG001|STARTED|Overall Study||8
8865481|NCT01842789|9921491|FG000|COMPLETED|Overall Study||10
8865482|NCT01842789|9921492|FG001|COMPLETED|Overall Study||8
8865483|NCT01842789|9921491|FG000|NOT COMPLETED|Overall Study||0
8865484|NCT01842789|9921492|FG001|NOT COMPLETED|Overall Study||0
8865485|NCT01842815|9921499|FG000|STARTED|Overall Study||20
8865486|NCT01842815|9921499|FG000|COMPLETED|Overall Study||16
8865487|NCT01842815|9921499|FG000|NOT COMPLETED|Overall Study||4
8865488|NCT01842841|9921504|FG000|STARTED|Overall Study||5
8865489|NCT01842841|9921504|FG000|COMPLETED|Overall Study||5
8865490|NCT01842841|9921504|FG000|NOT COMPLETED|Overall Study||0
8865491|NCT01842906|9921510|FG000|STARTED|Overall Study||115
8865492|NCT01842906|9921511|FG001|STARTED|Overall Study||104
8865493|NCT01842906|9921510|FG000|COMPLETED|Overall Study||115
8865494|NCT01842906|9921511|FG001|COMPLETED|Overall Study||104
8865495|NCT01842906|9921510|FG000|NOT COMPLETED|Overall Study||0
8865496|NCT01842906|9921511|FG001|NOT COMPLETED|Overall Study||0
8865497|NCT01842958|9921519|FG000|STARTED|Overall Study||25
8865498|NCT01842958|9921520|FG001|STARTED|Overall Study||25
8923768|NCT02243280|9984428|FG008|NOT COMPLETED|Enrolled||0
8865499|NCT01842958|9921519|FG000|Randomized|Overall Study|One subject was randomized to 3.3 mm implant, but received the 4.1 mm implant.|25
8865500|NCT01842958|9921520|FG001|Randomized|Overall Study||25
8865501|NCT01842958|9921519|FG000|COMPLETED|Overall Study||24
8865502|NCT01842958|9921520|FG001|COMPLETED|Overall Study||24
8865503|NCT01842958|9921519|FG000|NOT COMPLETED|Overall Study||1
8865504|NCT01842958|9921520|FG001|NOT COMPLETED|Overall Study||1
8865505|NCT01843023|9921528|FG000|STARTED|Overall Study||144
8865506|NCT01843023|9921529|FG001|STARTED|Overall Study||144
8865507|NCT01843023|9921528|FG000|3 Months|Overall Study||110
8865508|NCT01843023|9921529|FG001|3 Months|Overall Study||114
8865509|NCT01843023|9921528|FG000|COMPLETED|Overall Study||111
8865510|NCT01843023|9921529|FG001|COMPLETED|Overall Study||109
8865511|NCT01843023|9921528|FG000|NOT COMPLETED|Overall Study||33
8865512|NCT01843023|9921529|FG001|NOT COMPLETED|Overall Study||35
8865513|NCT01843062|9921537|FG000|STARTED|Overall Study||155
8865514|NCT01843062|9921538|FG001|STARTED|Overall Study||78
8865515|NCT01843062|9921537|FG000|Intention to Treat (ITT) Analysis Set|Overall Study||155
8865516|NCT01843062|9921538|FG001|Intention to Treat (ITT) Analysis Set|Overall Study||78
8865517|NCT01843062|9921537|FG000|Safety Analysis Set|Overall Study||154
8865518|NCT01843062|9921538|FG001|Safety Analysis Set|Overall Study||77
8865519|NCT01843062|9921537|FG000|BRAF/NRAS Mutation Positive Analysis Set|Overall Study||91
8865520|NCT01843062|9921538|FG001|BRAF/NRAS Mutation Positive Analysis Set|Overall Study||51
8865521|NCT01843062|9921537|FG000|Ongoing at Primary Analysis Data Cut-off|Overall Study||134
8865522|NCT01843062|9921538|FG001|Ongoing at Primary Analysis Data Cut-off|Overall Study||71
8865523|NCT01843062|9921537|FG000|COMPLETED|Overall Study||133
8865524|NCT01843062|9921538|FG001|COMPLETED|Overall Study||69
8865525|NCT01843062|9921537|FG000|NOT COMPLETED|Overall Study||22
8865526|NCT01843062|9921538|FG001|NOT COMPLETED|Overall Study||9
8865527|NCT01843192|9921547|FG000|STARTED|Overall Study||26
8865528|NCT01843192|9921548|FG001|STARTED|Overall Study||34
8865529|NCT01843192|9921549|FG002|STARTED|Overall Study||11
8865530|NCT01843192|9921547|FG000|COMPLETED|Overall Study||24
8865531|NCT01843192|9921548|FG001|COMPLETED|Overall Study||28
8865532|NCT01843192|9921549|FG002|COMPLETED|Overall Study||9
8865533|NCT01843192|9921547|FG000|NOT COMPLETED|Overall Study||2
8865534|NCT01843192|9921548|FG001|NOT COMPLETED|Overall Study||6
8865535|NCT01843192|9921549|FG002|NOT COMPLETED|Overall Study||2
8865536|NCT01843205|9921557|FG000|STARTED|First Treatment (11 Days)||5
8865537|NCT01843205|9921558|FG001|STARTED|First Treatment (11 Days)||4
8865538|NCT01843205|9921557|FG000|COMPLETED|First Treatment (11 Days)|4 completing subjects switched to buspirone for Condition 2.|4
8865539|NCT01843205|9921558|FG001|COMPLETED|First Treatment (11 Days)|4 completing subjects switched to placebo for Condition 2.|4
8865540|NCT01843205|9921557|FG000|NOT COMPLETED|First Treatment (11 Days)||1
8865541|NCT01843205|9921558|FG001|NOT COMPLETED|First Treatment (11 Days)||0
8865542|NCT01843205|9921557|FG000|STARTED|Second Treatment (11 Days)||4
8865543|NCT01843205|9921558|FG001|STARTED|Second Treatment (11 Days)||4
8865544|NCT01843205|9921557|FG000|COMPLETED|Second Treatment (11 Days)||4
8865545|NCT01843205|9921558|FG001|COMPLETED|Second Treatment (11 Days)||4
8865546|NCT01843205|9921557|FG000|NOT COMPLETED|Second Treatment (11 Days)||0
8865547|NCT01843205|9921558|FG001|NOT COMPLETED|Second Treatment (11 Days)||0
8865548|NCT01843348|9921567|FG000|STARTED|Overall Study||205
8865549|NCT01843348|9921568|FG001|STARTED|Overall Study||208
8865550|NCT01843348|9921569|FG002|STARTED|Overall Study||199
8865551|NCT01843348|9921567|FG000|Safety Analysis Set (SAS)|Overall Study|One participant received TAC + Certican in error - analyzed with TAC + Certican arm|204
8865552|NCT01843348|9921568|FG001|Safety Analysis Set (SAS)|Overall Study|Two participants received TAC + Certican in other arms in errorr - analyzed with TAC + Certican arm|210
8865553|NCT01843348|9921569|FG002|Safety Analysis Set (SAS)|Overall Study|One participant received TAC + Certican in error - analyzed with TAC + Certican arm|198
8951174|NCT02452424|10014008|FG006|NOT COMPLETED|Overall Study||10
8951175|NCT02452424|10014009|FG007|NOT COMPLETED|Overall Study||4
8951176|NCT02452424|10014010|FG008|NOT COMPLETED|Overall Study||6
8951177|NCT02452424|10014011|FG009|NOT COMPLETED|Overall Study||2
8951178|NCT02452424|10014012|FG010|NOT COMPLETED|Overall Study||2
8951179|NCT02452463|10014041|FG000|STARTED|Overall Study||5
8951180|NCT02452463|10014042|FG001|STARTED|Overall Study||3
8951181|NCT02452463|10014043|FG002|STARTED|Overall Study|"No participants were enrolled in the Arm III (Nintedanib, Durvalumab) Arm."|0
8951182|NCT02452463|10014041|FG000|COMPLETED|Overall Study||3
8951183|NCT02452463|10014042|FG001|COMPLETED|Overall Study||1
8951184|NCT02452463|10014043|FG002|COMPLETED|Overall Study||0
8951185|NCT02452463|10014041|FG000|NOT COMPLETED|Overall Study||2
8951186|NCT02452463|10014042|FG001|NOT COMPLETED|Overall Study||2
8951187|NCT02452463|10014043|FG002|NOT COMPLETED|Overall Study||0
8951188|NCT02452476|10014053|FG000|STARTED|Overall Study||64
8951189|NCT02452476|10014054|FG001|STARTED|Overall Study||59
8630537|NCT00535730|9670343|FG001|COMPLETED|Overall Study||230
8630538|NCT00535730|9670342|FG000|NOT COMPLETED|Overall Study||2
8630539|NCT00535730|9670343|FG001|NOT COMPLETED|Overall Study||7
8630540|NCT00535743|9670374|FG000|STARTED|Overall Study||5
8951190|NCT02452476|10014053|FG000|COMPLETED|Overall Study||53
8951191|NCT02452476|10014054|FG001|COMPLETED|Overall Study||49
8630541|NCT00535743|9670375|FG001|STARTED|Overall Study||11
8630542|NCT00535743|9670376|FG002|STARTED|Overall Study||11
8951192|NCT02452476|10014053|FG000|NOT COMPLETED|Overall Study||11
8923769|NCT02243280|9984429|FG009|NOT COMPLETED|Enrolled||0
8951193|NCT02452476|10014054|FG001|NOT COMPLETED|Overall Study||10
8865554|NCT01843348|9921567|FG000|Full Analysis Set (FAS)|Overall Study|Participants in the FAS received at least one dose of study drug|205
8865555|NCT01843348|9921568|FG001|Full Analysis Set (FAS)|Overall Study|Participants in the FAS received at least one dose of study drug|208
8865556|NCT01843348|9921569|FG002|Full Analysis Set (FAS)|Overall Study|Participants in the FAS received at least one dose of study drug|199
8865557|NCT01843348|9921567|FG000|Per Protocol Set (PPS)|Overall Study|Participants in the FAS without major protocol deviations|147
8865558|NCT01843348|9921568|FG001|Per Protocol Set (PPS)|Overall Study|Participants in the FAS without major protocol deviations|111
8865559|NCT01843348|9921569|FG002|Per Protocol Set (PPS)|Overall Study|Participants in the FAS without major protocol deviations|80
8865560|NCT01843348|9921567|FG000|COMPLETED|Overall Study||182
8865561|NCT01843348|9921568|FG001|COMPLETED|Overall Study||168
8865562|NCT01843348|9921569|FG002|COMPLETED|Overall Study||158
8865563|NCT01843348|9921567|FG000|NOT COMPLETED|Overall Study||23
8865564|NCT01843348|9921568|FG001|NOT COMPLETED|Overall Study||40
8865565|NCT01843348|9921569|FG002|NOT COMPLETED|Overall Study||41
8865566|NCT01843465|9921579|FG000|STARTED|Overall Study|This study had no follow-up. It focused in the acute setting of cryoballoon ablation.|34
8865567|NCT01843465|9921579|FG000|COMPLETED|Overall Study||34
8865568|NCT01843465|9921579|FG000|NOT COMPLETED|Overall Study||0
8865569|NCT01843621|9921583|FG000|STARTED|Overall Study||7
8865570|NCT01843621|9921583|FG000|COMPLETED|Overall Study||7
8865571|NCT01843621|9921583|FG000|NOT COMPLETED|Overall Study||0
8865572|NCT01843660|9921595|FG000|STARTED|Overall Study||1059
8865573|NCT01843660|9921595|FG000|COMPLETED|Overall Study||1029
8865574|NCT01843660|9921595|FG000|NOT COMPLETED|Overall Study||30
8865575|NCT01843673|9921599|FG000|STARTED|Overall Study||16
8865576|NCT01843673|9921599|FG000|COMPLETED|Overall Study||10
8865577|NCT01843673|9921599|FG000|NOT COMPLETED|Overall Study||6
8865578|NCT01843751|9921607|FG000|STARTED|Overall Study||11
8865579|NCT01843751|9921608|FG001|STARTED|Overall Study||10
8865580|NCT01843751|9921607|FG000|COMPLETED|Overall Study||0
8865581|NCT01843751|9921608|FG001|COMPLETED|Overall Study||3
8865582|NCT01843751|9921607|FG000|NOT COMPLETED|Overall Study||11
8865583|NCT01843751|9921608|FG001|NOT COMPLETED|Overall Study||7
8865584|NCT01843777|9921616|FG000|STARTED|Overall Study|Number of participants randomized to standard-of-care.|11
8865585|NCT01843777|9921617|FG001|STARTED|Overall Study|Number of participants randomized to treatment.|10
8865586|NCT01843777|9921616|FG000|Per Protocol Population|Overall Study||11
8865587|NCT01843777|9921617|FG001|Per Protocol Population|Overall Study|A subject was randomized to treatment but received standard of care and is not in the analyses.|9
8865588|NCT01843777|9921616|FG000|COMPLETED|Overall Study|Final number of standard-of-care participants.|10
8865589|NCT01843777|9921617|FG001|COMPLETED|Overall Study|Number of subjects who received the treatment that completed collection of outcome measures|10
8865590|NCT01843777|9921616|FG000|NOT COMPLETED|Overall Study||1
8865591|NCT01843777|9921617|FG001|NOT COMPLETED|Overall Study||0
8865592|NCT01843803|9921625|FG000|STARTED|Overall Study||137
8865593|NCT01843803|9921626|FG001|STARTED|Overall Study||139
8865594|NCT01843803|9921625|FG000|COMPLETED|Overall Study||136
8865595|NCT01843803|9921626|FG001|COMPLETED|Overall Study||136
8865596|NCT01843803|9921625|FG000|NOT COMPLETED|Overall Study||1
8630543|NCT00535743|9670377|FG003|STARTED|Overall Study||11
8630544|NCT00535743|9670378|FG004|STARTED|Overall Study||11
8630545|NCT00535743|9670379|FG005|STARTED|Overall Study||10
8630546|NCT00535743|9670380|FG006|STARTED|Overall Study||3
8630547|NCT00535743|9670381|FG007|STARTED|Overall Study||5
8630548|NCT00535743|9670382|FG008|STARTED|Overall Study||5
8630549|NCT00535743|9670383|FG009|STARTED|Overall Study||5
8630550|NCT00535743|9670384|FG010|STARTED|Overall Study||5
8630551|NCT00535743|9670385|FG011|STARTED|Overall Study||5
8630552|NCT00535743|9670386|FG012|STARTED|Overall Study||5
8630553|NCT00535743|9670387|FG013|STARTED|Overall Study||10
8630554|NCT00535743|9670388|FG014|STARTED|Overall Study||9
8630555|NCT00535743|9670389|FG015|STARTED|Overall Study|N=11 randomized to Arm P. An additional N=2 (randomized to Arm O) are counted as Started in Arm P|13
8630556|NCT00535743|9670390|FG016|STARTED|Overall Study||10
8630557|NCT00535743|9670391|FG017|STARTED|Overall Study||11
8630558|NCT00535743|9670392|FG018|STARTED|Overall Study||3
8630559|NCT00535743|9670393|FG019|STARTED|Overall Study||5
8630560|NCT00535743|9670394|FG020|STARTED|Overall Study||5
8630561|NCT00535743|9670395|FG021|STARTED|Overall Study||5
8630562|NCT00535743|9670396|FG022|STARTED|Overall Study|N=5 randomized to Arm W. An additional N=1 (randomized to Arm Q) is counted as Started in Arm W|6
8630563|NCT00535743|9670397|FG023|STARTED|Overall Study||5
8630564|NCT00535743|9670374|FG000|Treated|Overall Study||5
8630565|NCT00535743|9670375|FG001|Treated|Overall Study||11
8630566|NCT00535743|9670376|FG002|Treated|Overall Study||11
8630567|NCT00535743|9670377|FG003|Treated|Overall Study||11
8630568|NCT00535743|9670378|FG004|Treated|Overall Study||11
8630569|NCT00535743|9670379|FG005|Treated|Overall Study||10
8630570|NCT00535743|9670380|FG006|Treated|Overall Study||3
8630571|NCT00535743|9670381|FG007|Treated|Overall Study||5
8865597|NCT01843803|9921626|FG001|NOT COMPLETED|Overall Study||3
8865598|NCT01843842|9921634|FG000|STARTED|Overall Study||154
8865599|NCT01843842|9921635|FG001|STARTED|Overall Study||152
8865600|NCT01843842|9921634|FG000|COMPLETED|Overall Study||153
8865601|NCT01843842|9921635|FG001|COMPLETED|Overall Study||151
8865602|NCT01843842|9921634|FG000|NOT COMPLETED|Overall Study||1
8865603|NCT01843842|9921635|FG001|NOT COMPLETED|Overall Study||1
8865604|NCT01843920|9921643|FG000|STARTED|Overall Study||12
8865605|NCT01843920|9921644|FG001|STARTED|Overall Study||9
8865606|NCT01843920|9921643|FG000|COMPLETED|Overall Study||12
8865607|NCT01843920|9921644|FG001|COMPLETED|Overall Study||9
8865608|NCT01843920|9921643|FG000|NOT COMPLETED|Overall Study||0
8865609|NCT01843920|9921644|FG001|NOT COMPLETED|Overall Study||0
8865610|NCT01843933|9921652|FG000|STARTED|Overall Study||104
8865611|NCT01843933|9921653|FG001|STARTED|Overall Study||107
8865612|NCT01843933|9921652|FG000|COMPLETED|Overall Study||98
8865613|NCT01843933|9921653|FG001|COMPLETED|Overall Study||103
8865614|NCT01843933|9921652|FG000|NOT COMPLETED|Overall Study||6
8865615|NCT01843933|9921653|FG001|NOT COMPLETED|Overall Study||4
8865616|NCT01843972|9921669|FG000|STARTED|Overall Study||13
8865617|NCT01843972|9921670|FG001|STARTED|Overall Study||6
8865618|NCT01843972|9921671|FG002|STARTED|Overall Study||5
8865619|NCT01843972|9921672|FG003|STARTED|Overall Study||6
8865620|NCT01843972|9921673|FG004|STARTED|Overall Study||6
8865621|NCT01843972|9921674|FG005|STARTED|Overall Study||6
8865622|NCT01843972|9921675|FG006|STARTED|Overall Study||5
8865623|NCT01843972|9921676|FG007|STARTED|Overall Study||5
8865624|NCT01843972|9921677|FG008|STARTED|Overall Study||17
8865625|NCT01843972|9921678|FG009|STARTED|Overall Study||12
8865626|NCT01843972|9921669|FG000|COMPLETED|Overall Study||13
8865627|NCT01843972|9921670|FG001|COMPLETED|Overall Study||6
8865628|NCT01843972|9921671|FG002|COMPLETED|Overall Study||5
8865629|NCT01843972|9921672|FG003|COMPLETED|Overall Study||6
8865630|NCT01843972|9921673|FG004|COMPLETED|Overall Study||5
8865631|NCT01843972|9921674|FG005|COMPLETED|Overall Study||6
8865632|NCT01843972|9921675|FG006|COMPLETED|Overall Study||5
8865633|NCT01843972|9921676|FG007|COMPLETED|Overall Study||5
8865634|NCT01843972|9921677|FG008|COMPLETED|Overall Study||17
8865635|NCT01843972|9921678|FG009|COMPLETED|Overall Study||12
8865636|NCT01843972|9921669|FG000|NOT COMPLETED|Overall Study||0
8865637|NCT01843972|9921670|FG001|NOT COMPLETED|Overall Study||0
8865638|NCT01843972|9921671|FG002|NOT COMPLETED|Overall Study||0
8865639|NCT01843972|9921672|FG003|NOT COMPLETED|Overall Study||0
8865640|NCT01843972|9921673|FG004|NOT COMPLETED|Overall Study||1
8865641|NCT01843972|9921674|FG005|NOT COMPLETED|Overall Study||0
8865642|NCT01843972|9921675|FG006|NOT COMPLETED|Overall Study||0
8865643|NCT01843972|9921676|FG007|NOT COMPLETED|Overall Study||0
8865644|NCT01843972|9921677|FG008|NOT COMPLETED|Overall Study||0
8865645|NCT01843972|9921678|FG009|NOT COMPLETED|Overall Study||0
8865646|NCT01844076|9921718|FG000|STARTED|Overall Study||3
8865647|NCT01844076|9921719|FG001|STARTED|Overall Study||6
8865648|NCT01844076|9921720|FG002|STARTED|Overall Study||3
8865649|NCT01844076|9921721|FG003|STARTED|Overall Study||7
8865650|NCT01844076|9921718|FG000|COMPLETED|Overall Study||1
8865651|NCT01844076|9921719|FG001|COMPLETED|Overall Study||6
8865652|NCT01844076|9921720|FG002|COMPLETED|Overall Study||3
8865653|NCT01844076|9921721|FG003|COMPLETED|Overall Study||7
8865654|NCT01844076|9921718|FG000|NOT COMPLETED|Overall Study||2
8865655|NCT01844076|9921719|FG001|NOT COMPLETED|Overall Study||0
8865656|NCT01844076|9921720|FG002|NOT COMPLETED|Overall Study||0
8865657|NCT01844076|9921721|FG003|NOT COMPLETED|Overall Study||0
8865658|NCT01844115|9921733|FG000|STARTED|Overall Study||202
8865659|NCT01844115|9921734|FG001|STARTED|Overall Study||202
8865660|NCT01844115|9921733|FG000|COMPLETED|Overall Study||163
8865661|NCT01844115|9921734|FG001|COMPLETED|Overall Study||144
8865662|NCT01844115|9921733|FG000|NOT COMPLETED|Overall Study||39
8865663|NCT01844115|9921734|FG001|NOT COMPLETED|Overall Study||58
8865664|NCT01844193|9921742|FG000|STARTED|Overall Study||19
8865665|NCT01844193|9921743|FG001|STARTED|Overall Study||21
8865666|NCT01844193|9921742|FG000|COMPLETED|Overall Study||13
8865667|NCT01844193|9921743|FG001|COMPLETED|Overall Study||15
8865668|NCT01844193|9921742|FG000|NOT COMPLETED|Overall Study||6
8865669|NCT01844193|9921743|FG001|NOT COMPLETED|Overall Study||6
8865670|NCT01844284|9921751|FG000|STARTED|Overall Study|Intent-to-treat (ITT) population|266
8865671|NCT01844284|9921752|FG001|STARTED|Overall Study|Intent-to-treat (ITT) population|134
8865672|NCT01844284|9921751|FG000|COMPLETED|Overall Study||254
8865673|NCT01844284|9921752|FG001|COMPLETED|Overall Study||127
8865674|NCT01844284|9921751|FG000|NOT COMPLETED|Overall Study||12
8865675|NCT01844284|9921752|FG001|NOT COMPLETED|Overall Study||7
8865676|NCT01844375|9921760|FG000|STARTED|Overall Study||35
8865677|NCT01844375|9921761|FG001|STARTED|Overall Study||35
8865678|NCT01844375|9921760|FG000|COMPLETED|Overall Study||34
8865679|NCT01844375|9921761|FG001|COMPLETED|Overall Study||34
8865680|NCT01844375|9921760|FG000|NOT COMPLETED|Overall Study||1
8865681|NCT01844375|9921761|FG001|NOT COMPLETED|Overall Study||1
8865682|NCT01844388|9921769|FG000|STARTED|Overall Study||244
8865683|NCT01844388|9921770|FG001|STARTED|Overall Study||121
8865684|NCT01844388|9921769|FG000|COMPLETED|Overall Study||236
8865685|NCT01844388|9921770|FG001|COMPLETED|Overall Study||114
8865686|NCT01844388|9921769|FG000|NOT COMPLETED|Overall Study||8
8865687|NCT01844388|9921770|FG001|NOT COMPLETED|Overall Study||7
8865688|NCT01844479|9921776|FG000|STARTED|First Intervention up to 30 Minutes||14
8865689|NCT01844479|9921777|FG001|STARTED|First Intervention up to 30 Minutes||13
8865690|NCT01844479|9921776|FG000|COMPLETED|First Intervention up to 30 Minutes||14
8865691|NCT01844479|9921777|FG001|COMPLETED|First Intervention up to 30 Minutes||13
8865692|NCT01844479|9921776|FG000|NOT COMPLETED|First Intervention up to 30 Minutes||0
8865693|NCT01844479|9921777|FG001|NOT COMPLETED|First Intervention up to 30 Minutes||0
8865694|NCT01844479|9921776|FG000|STARTED|Second Intervention up to 30 Minutes||14
8865695|NCT01844479|9921777|FG001|STARTED|Second Intervention up to 30 Minutes||13
8865696|NCT01844479|9921776|FG000|COMPLETED|Second Intervention up to 30 Minutes||14
8865697|NCT01844479|9921777|FG001|COMPLETED|Second Intervention up to 30 Minutes||13
8865698|NCT01844479|9921776|FG000|NOT COMPLETED|Second Intervention up to 30 Minutes||0
8865699|NCT01844479|9921777|FG001|NOT COMPLETED|Second Intervention up to 30 Minutes||0
8865700|NCT01844531|9921788|FG000|STARTED|Overall Study||6
8865701|NCT01844531|9921789|FG001|STARTED|Overall Study||6
8865702|NCT01844531|9921790|FG002|STARTED|Overall Study||6
8865703|NCT01844531|9921791|FG003|STARTED|Overall Study||6
8865704|NCT01844531|9921788|FG000|COMPLETED|Overall Study||6
8865705|NCT01844531|9921789|FG001|COMPLETED|Overall Study||5
8865706|NCT01844531|9921790|FG002|COMPLETED|Overall Study||6
8865707|NCT01844531|9921791|FG003|COMPLETED|Overall Study||6
8865708|NCT01844531|9921788|FG000|NOT COMPLETED|Overall Study||0
8865709|NCT01844531|9921789|FG001|NOT COMPLETED|Overall Study||1
8865710|NCT01844531|9921790|FG002|NOT COMPLETED|Overall Study||0
8865711|NCT01844531|9921791|FG003|NOT COMPLETED|Overall Study||0
8865712|NCT01844583|9921803|FG000|STARTED|Overall Study||26
8865713|NCT01844583|9921804|FG001|STARTED|Overall Study||29
8865714|NCT01844583|9921803|FG000|COMPLETED|Overall Study|Completed=Completed protocol-specified dosing and PK/ECG assessment.|18
8865715|NCT01844583|9921804|FG001|COMPLETED|Overall Study||19
8865716|NCT01844583|9921803|FG000|NOT COMPLETED|Overall Study||8
8865717|NCT01844583|9921804|FG001|NOT COMPLETED|Overall Study||10
8865718|NCT01844687|9921815|FG000|STARTED|Visit 1||50
8865719|NCT01844687|9921815|FG000|COMPLETED|Visit 1||42
8865720|NCT01844687|9921815|FG000|NOT COMPLETED|Visit 1||8
8865721|NCT01844687|9921815|FG000|STARTED|Visit 2||42
8865722|NCT01844687|9921815|FG000|COMPLETED|Visit 2||40
8865723|NCT01844687|9921815|FG000|NOT COMPLETED|Visit 2||2
8865724|NCT01844687|9921815|FG000|STARTED|Visit 3||40
8865725|NCT01844687|9921815|FG000|COMPLETED|Visit 3||35
8865726|NCT01844687|9921815|FG000|NOT COMPLETED|Visit 3||5
8865727|NCT01844687|9921815|FG000|STARTED|Visit 4||35
8865728|NCT01844687|9921815|FG000|COMPLETED|Visit 4||31
8865729|NCT01844687|9921815|FG000|NOT COMPLETED|Visit 4||4
8865730|NCT01844687|9921815|FG000|STARTED|Visit 5||31
8865731|NCT01844687|9921815|FG000|COMPLETED|Visit 5||31
8865732|NCT01844687|9921815|FG000|NOT COMPLETED|Visit 5||0
8865733|NCT01844687|9921815|FG000|STARTED|Visit 6||31
8865734|NCT01844687|9921815|FG000|COMPLETED|Visit 6||31
8865735|NCT01844687|9921815|FG000|NOT COMPLETED|Visit 6||0
8865736|NCT01844687|9921815|FG000|STARTED|Visit 7||31
8865737|NCT01844687|9921815|FG000|COMPLETED|Visit 7||31
8865738|NCT01844687|9921815|FG000|NOT COMPLETED|Visit 7||0
8865739|NCT01844687|9921815|FG000|STARTED|Visit 8||31
8865740|NCT01844687|9921815|FG000|COMPLETED|Visit 8||31
8865741|NCT01844687|9921815|FG000|NOT COMPLETED|Visit 8||0
8865742|NCT01844700|9921839|FG000|STARTED|Overall Study||4
8865743|NCT01844700|9921840|FG001|STARTED|Overall Study||3
8865744|NCT01844700|9921839|FG000|COMPLETED|Overall Study||1
8865745|NCT01844700|9921840|FG001|COMPLETED|Overall Study||2
8865746|NCT01844700|9921839|FG000|NOT COMPLETED|Overall Study||3
8865747|NCT01844700|9921840|FG001|NOT COMPLETED|Overall Study||1
8865748|NCT01844765|9921848|FG000|STARTED|Overall Study||34
8865749|NCT01844765|9921849|FG001|STARTED|Overall Study||25
8865750|NCT01844765|9921848|FG000|Treated|Overall Study||33
8951194|NCT02452528|10014062|FG000|STARTED|Overall Study||2
8951195|NCT02452528|10014063|FG001|STARTED|Overall Study||2
8951196|NCT02452528|10014062|FG000|COMPLETED|Overall Study||1
8951197|NCT02452528|10014063|FG001|COMPLETED|Overall Study||1
8951198|NCT02452528|10014062|FG000|NOT COMPLETED|Overall Study||1
8951199|NCT02452528|10014063|FG001|NOT COMPLETED|Overall Study||1
8951200|NCT02452762|10014071|FG000|STARTED|Overall Study||45
8951201|NCT02452762|10014072|FG001|STARTED|Overall Study||22
8951202|NCT02452762|10014071|FG000|COMPLETED|Overall Study||40
8951203|NCT02452762|10014072|FG001|COMPLETED|Overall Study||19
8951204|NCT02452762|10014071|FG000|NOT COMPLETED|Overall Study||5
8951205|NCT02452762|10014072|FG001|NOT COMPLETED|Overall Study||3
8951206|NCT02452866|10014079|FG000|STARTED|Overall Study||325
8951207|NCT02452866|10014079|FG000|COMPLETED|Overall Study||321
8865751|NCT01844765|9921849|FG001|Treated|Overall Study||25
8865752|NCT01844765|9921848|FG000|Untreated|Overall Study|Did not receive study drug due to adverse event (AE).|1
8865753|NCT01844765|9921849|FG001|Untreated|Overall Study||0
8865754|NCT01844765|9921848|FG000|COMPLETED|Overall Study||19
8865755|NCT01844765|9921849|FG001|COMPLETED|Overall Study||10
8865756|NCT01844765|9921848|FG000|NOT COMPLETED|Overall Study||15
8865757|NCT01844765|9921849|FG001|NOT COMPLETED|Overall Study||15
8865758|NCT01844778|9921863|FG000|STARTED|Overall Study||14
8865759|NCT01844778|9921864|FG001|STARTED|Overall Study||28
8951208|NCT02452866|10014079|FG000|NOT COMPLETED|Overall Study||4
8951209|NCT02452892|10014087|FG000|STARTED|Week 1 Initial Randommization||41
8951210|NCT02452892|10014088|FG001|STARTED|Week 1 Initial Randommization||40
8951211|NCT02452892|10014089|FG002|STARTED|Week 1 Initial Randommization||41
8951212|NCT02452892|10014090|FG003|STARTED|Week 1 Initial Randommization||0
8569795|NCT00098722|9601916|FG005|NOT COMPLETED|Observation Phase||45
8865760|NCT01844778|9921865|FG002|STARTED|Overall Study||18
8865761|NCT01844778|9921863|FG000|Safety Set 1 (at Least 1 Dose, Cycle 1)|Overall Study||14
8865762|NCT01844778|9921864|FG001|Safety Set 1 (at Least 1 Dose, Cycle 1)|Overall Study||28
8865763|NCT01844778|9921865|FG002|Safety Set 1 (at Least 1 Dose, Cycle 1)|Overall Study||18
8865764|NCT01844778|9921863|FG000|Safety Set 2 (at Least 1 Dose, Cycle 2)|Overall Study||12
8951213|NCT02452892|10014087|FG000|COMPLETED|Week 1 Initial Randommization||40
8951214|NCT02452892|10014088|FG001|COMPLETED|Week 1 Initial Randommization||40
8951215|NCT02452892|10014089|FG002|COMPLETED|Week 1 Initial Randommization||40
8865765|NCT01844778|9921864|FG001|Safety Set 2 (at Least 1 Dose, Cycle 2)|Overall Study||25
8865766|NCT01844778|9921865|FG002|Safety Set 2 (at Least 1 Dose, Cycle 2)|Overall Study||15
8865767|NCT01844778|9921863|FG000|COMPLETED|Overall Study||12
8865768|NCT01844778|9921864|FG001|COMPLETED|Overall Study||25
8865769|NCT01844778|9921865|FG002|COMPLETED|Overall Study||14
8865770|NCT01844778|9921863|FG000|NOT COMPLETED|Overall Study||2
8865771|NCT01844778|9921864|FG001|NOT COMPLETED|Overall Study||3
8865772|NCT01844778|9921865|FG002|NOT COMPLETED|Overall Study||4
8865773|NCT01844817|9921879|FG000|STARTED|Enrolled and Randomized||66
8865774|NCT01844817|9921880|FG001|STARTED|Enrolled and Randomized||66
8865775|NCT01844817|9921879|FG000|COMPLETED|Enrolled and Randomized||64
8865776|NCT01844817|9921880|FG001|COMPLETED|Enrolled and Randomized||63
8865777|NCT01844817|9921879|FG000|NOT COMPLETED|Enrolled and Randomized||2
8865778|NCT01844817|9921880|FG001|NOT COMPLETED|Enrolled and Randomized||3
8865779|NCT01844817|9921879|FG000|STARTED|Treatment||64
8865780|NCT01844817|9921880|FG001|STARTED|Treatment||63
8865781|NCT01844817|9921879|FG000|COMPLETED|Treatment||0
8865782|NCT01844817|9921880|FG001|COMPLETED|Treatment||0
8865783|NCT01844817|9921879|FG000|NOT COMPLETED|Treatment||64
8865784|NCT01844817|9921880|FG001|NOT COMPLETED|Treatment||63
8865785|NCT01844830|9921889|FG000|STARTED|Overall Study||60
8865786|NCT01844830|9921890|FG001|STARTED|Overall Study||30
8865787|NCT01844830|9921889|FG000|100 µL Dose|Overall Study||16
8865788|NCT01844830|9921890|FG001|100 µL Dose|Overall Study||8
8865789|NCT01844830|9921889|FG000|200 µL Dose|Overall Study||24
8865790|NCT01844830|9921890|FG001|200 µL Dose|Overall Study||12
8865791|NCT01844830|9921889|FG000|400 µL Dose|Overall Study||20
8865792|NCT01844830|9921890|FG001|400 µL Dose|Overall Study||10
8865793|NCT01844830|9921889|FG000|COMPLETED|Overall Study||59
8865794|NCT01844830|9921890|FG001|COMPLETED|Overall Study||30
8865795|NCT01844830|9921889|FG000|NOT COMPLETED|Overall Study||1
8865796|NCT01844830|9921890|FG001|NOT COMPLETED|Overall Study||0
8865797|NCT01844895|9921896|FG000|STARTED|Day 1 to Day 28 - Pre-filled Syringe||120
8865798|NCT01844895|9921896|FG000|COMPLETED|Day 1 to Day 28 - Pre-filled Syringe||117
8865799|NCT01844895|9921896|FG000|NOT COMPLETED|Day 1 to Day 28 - Pre-filled Syringe||3
8865800|NCT01844895|9921896|FG000|STARTED|Day 29 - Day113 - Autoinjector||117
8865801|NCT01844895|9921896|FG000|COMPLETED|Day 29 - Day113 - Autoinjector||111
8865802|NCT01844895|9921896|FG000|NOT COMPLETED|Day 29 - Day113 - Autoinjector||6
8865803|NCT01845025|9921911|FG000|STARTED|Overall Study||411
8865804|NCT01845025|9921912|FG001|STARTED|Overall Study||409
8865805|NCT01845025|9921911|FG000|COMPLETED|Overall Study||326
8865806|NCT01845025|9921912|FG001|COMPLETED|Overall Study||332
8865807|NCT01845025|9921911|FG000|NOT COMPLETED|Overall Study||85
8865808|NCT01845025|9921912|FG001|NOT COMPLETED|Overall Study||77
8865809|NCT01845077|9921921|FG000|STARTED|Treatment Period 1||12
8865810|NCT01845077|9921922|FG001|STARTED|Treatment Period 1||12
8865811|NCT01845077|9921923|FG002|STARTED|Treatment Period 1||12
8865812|NCT01845077|9921924|FG003|STARTED|Treatment Period 1||12
8865813|NCT01845077|9921925|FG004|STARTED|Treatment Period 1||12
8951216|NCT02452892|10014090|FG003|COMPLETED|Week 1 Initial Randommization||0
8951217|NCT02452892|10014087|FG000|NOT COMPLETED|Week 1 Initial Randommization||1
8951218|NCT02452892|10014088|FG001|NOT COMPLETED|Week 1 Initial Randommization||0
8951219|NCT02452892|10014089|FG002|NOT COMPLETED|Week 1 Initial Randommization||1
8951220|NCT02452892|10014090|FG003|NOT COMPLETED|Week 1 Initial Randommization||0
8951221|NCT02452892|10014087|FG000|STARTED|Week 2 Stratification & Re-Randomization|Week 1 Participants that started LFMS sham (27), LFMS 20min (19), and LFMS 60min (19)|65
8951222|NCT02452892|10014088|FG001|STARTED|Week 2 Stratification & Re-Randomization|Week 1 Participants that Started LFMS Sham (0), LFMS 20min (7), and LFMS 60min(0).|7
8951223|NCT02452892|10014089|FG002|STARTED|Week 2 Stratification & Re-Randomization|Week 1 Participants that Started LFMS Sham (0),LFMS 20min (0), LFMS 60min (7)|7
8951224|NCT02452892|10014090|FG003|STARTED|Week 2 Stratification & Re-Randomization|Week 1 Participants that Started LFMS Sham (13), LFMS 20min (14), and LFMS 60 min (14).|41
8951225|NCT02452892|10014087|FG000|Non-reponders|Week 2 Stratification & Re-Randomization||38
8951226|NCT02452892|10014088|FG001|Non-reponders|Week 2 Stratification & Re-Randomization||0
8951227|NCT02452892|10014089|FG002|Non-reponders|Week 2 Stratification & Re-Randomization||0
8951228|NCT02452892|10014090|FG003|Non-reponders|Week 2 Stratification & Re-Randomization||41
8951229|NCT02452892|10014087|FG000|Responders|Week 2 Stratification & Re-Randomization||27
8951230|NCT02452892|10014088|FG001|Responders|Week 2 Stratification & Re-Randomization||7
8951231|NCT02452892|10014089|FG002|Responders|Week 2 Stratification & Re-Randomization||7
8951232|NCT02452892|10014090|FG003|Responders|Week 2 Stratification & Re-Randomization||0
8951233|NCT02452892|10014087|FG000|COMPLETED|Week 2 Stratification & Re-Randomization||63
8951234|NCT02452892|10014088|FG001|COMPLETED|Week 2 Stratification & Re-Randomization||7
8951235|NCT02452892|10014089|FG002|COMPLETED|Week 2 Stratification & Re-Randomization||7
8951236|NCT02452892|10014090|FG003|COMPLETED|Week 2 Stratification & Re-Randomization||39
8951237|NCT02452892|10014087|FG000|NOT COMPLETED|Week 2 Stratification & Re-Randomization||2
8951238|NCT02452892|10014088|FG001|NOT COMPLETED|Week 2 Stratification & Re-Randomization||0
8951239|NCT02452892|10014089|FG002|NOT COMPLETED|Week 2 Stratification & Re-Randomization||0
8951240|NCT02452892|10014090|FG003|NOT COMPLETED|Week 2 Stratification & Re-Randomization||2
8951241|NCT02452892|10014087|FG000|STARTED|Follow-up||63
8951242|NCT02452892|10014088|FG001|STARTED|Follow-up||7
8951243|NCT02452892|10014089|FG002|STARTED|Follow-up||7
8865814|NCT01845077|9921926|FG005|STARTED|Treatment Period 1||12
8865815|NCT01845077|9921921|FG000|COMPLETED|Treatment Period 1||12
8865816|NCT01845077|9921922|FG001|COMPLETED|Treatment Period 1||12
8865817|NCT01845077|9921923|FG002|COMPLETED|Treatment Period 1||12
8865818|NCT01845077|9921924|FG003|COMPLETED|Treatment Period 1||12
8865819|NCT01845077|9921925|FG004|COMPLETED|Treatment Period 1||12
8865820|NCT01845077|9921926|FG005|COMPLETED|Treatment Period 1||12
8865821|NCT01845077|9921921|FG000|NOT COMPLETED|Treatment Period 1||0
8865822|NCT01845077|9921922|FG001|NOT COMPLETED|Treatment Period 1||0
8865823|NCT01845077|9921923|FG002|NOT COMPLETED|Treatment Period 1||0
8865824|NCT01845077|9921924|FG003|NOT COMPLETED|Treatment Period 1||0
8865825|NCT01845077|9921925|FG004|NOT COMPLETED|Treatment Period 1||0
8865826|NCT01845077|9921926|FG005|NOT COMPLETED|Treatment Period 1||0
8865827|NCT01845077|9921921|FG000|STARTED|Washout Period||12
8865828|NCT01845077|9921922|FG001|STARTED|Washout Period||12
8865829|NCT01845077|9921923|FG002|STARTED|Washout Period||12
8865830|NCT01845077|9921924|FG003|STARTED|Washout Period||12
8865831|NCT01845077|9921925|FG004|STARTED|Washout Period||12
8865832|NCT01845077|9921926|FG005|STARTED|Washout Period||12
8865833|NCT01845077|9921921|FG000|COMPLETED|Washout Period||11
8865834|NCT01845077|9921922|FG001|COMPLETED|Washout Period||11
8865835|NCT01845077|9921923|FG002|COMPLETED|Washout Period||11
8865836|NCT01845077|9921924|FG003|COMPLETED|Washout Period||10
8865837|NCT01845077|9921925|FG004|COMPLETED|Washout Period||11
8865838|NCT01845077|9921926|FG005|COMPLETED|Washout Period||11
8865839|NCT01845077|9921921|FG000|NOT COMPLETED|Washout Period||1
8865840|NCT01845077|9921922|FG001|NOT COMPLETED|Washout Period||1
8865841|NCT01845077|9921923|FG002|NOT COMPLETED|Washout Period||1
8865842|NCT01845077|9921924|FG003|NOT COMPLETED|Washout Period||2
8865843|NCT01845077|9921925|FG004|NOT COMPLETED|Washout Period||1
8865844|NCT01845077|9921926|FG005|NOT COMPLETED|Washout Period||1
8865845|NCT01845077|9921921|FG000|STARTED|Treatment Period 2||11
8865846|NCT01845077|9921922|FG001|STARTED|Treatment Period 2||11
8865847|NCT01845077|9921923|FG002|STARTED|Treatment Period 2||11
8865848|NCT01845077|9921924|FG003|STARTED|Treatment Period 2||10
8865849|NCT01845077|9921925|FG004|STARTED|Treatment Period 2||11
8630572|NCT00535743|9670382|FG008|Treated|Overall Study||4
8630573|NCT00535743|9670383|FG009|Treated|Overall Study||5
8630574|NCT00535743|9670384|FG010|Treated|Overall Study||5
8630575|NCT00535743|9670385|FG011|Treated|Overall Study||5
8630576|NCT00535743|9670386|FG012|Treated|Overall Study||5
8630577|NCT00535743|9670387|FG013|Treated|Overall Study||10
8630578|NCT00535743|9670388|FG014|Treated|Overall Study||9
8630579|NCT00535743|9670389|FG015|Treated|Overall Study|N=2 (randomized to Arm O) rec'd 8 mg/kg Sugammadex, 3 min after 1.2 mg/kg Esmeron®|13
8630580|NCT00535743|9670390|FG016|Treated|Overall Study||10
8630581|NCT00535743|9670391|FG017|Treated|Overall Study||11
8630582|NCT00535743|9670392|FG018|Treated|Overall Study||3
8630583|NCT00535743|9670393|FG019|Treated|Overall Study||5
8865850|NCT01845077|9921926|FG005|STARTED|Treatment Period 2||11
8865851|NCT01845077|9921921|FG000|COMPLETED|Treatment Period 2||11
8865852|NCT01845077|9921922|FG001|COMPLETED|Treatment Period 2||11
8865853|NCT01845077|9921923|FG002|COMPLETED|Treatment Period 2||11
8865854|NCT01845077|9921924|FG003|COMPLETED|Treatment Period 2||10
8865855|NCT01845077|9921925|FG004|COMPLETED|Treatment Period 2||11
8865856|NCT01845077|9921926|FG005|COMPLETED|Treatment Period 2||11
8865857|NCT01845077|9921921|FG000|NOT COMPLETED|Treatment Period 2||0
8865858|NCT01845077|9921922|FG001|NOT COMPLETED|Treatment Period 2||0
8865859|NCT01845077|9921923|FG002|NOT COMPLETED|Treatment Period 2||0
8865860|NCT01845077|9921924|FG003|NOT COMPLETED|Treatment Period 2||0
8865861|NCT01845077|9921925|FG004|NOT COMPLETED|Treatment Period 2||0
8865862|NCT01845077|9921926|FG005|NOT COMPLETED|Treatment Period 2||0
8865863|NCT01845103|9921941|FG000|STARTED|Overall Study||1
8865864|NCT01845103|9921941|FG000|COMPLETED|Overall Study||1
8865865|NCT01845103|9921941|FG000|NOT COMPLETED|Overall Study||0
8865866|NCT01845155|9921947|FG000|STARTED|Overall Study||146
8865867|NCT01845155|9921948|FG001|STARTED|Overall Study||144
8865868|NCT01845155|9921947|FG000|COMPLETED|Overall Study||145
8865869|NCT01845155|9921948|FG001|COMPLETED|Overall Study||144
8865870|NCT01845155|9921947|FG000|NOT COMPLETED|Overall Study||1
8865871|NCT01845155|9921948|FG001|NOT COMPLETED|Overall Study||0
8865872|NCT01845220|9921954|FG000|STARTED|Overall Study||30
8865873|NCT01845220|9921955|FG001|STARTED|Overall Study||30
8865874|NCT01845220|9921954|FG000|COMPLETED|Overall Study||30
8865875|NCT01845220|9921955|FG001|COMPLETED|Overall Study||30
8865876|NCT01845220|9921954|FG000|NOT COMPLETED|Overall Study||0
8865877|NCT01845220|9921955|FG001|NOT COMPLETED|Overall Study||0
8865878|NCT01845636|9921961|FG000|STARTED|Overall Study||41
8865879|NCT01845636|9921961|FG000|COMPLETED|Overall Study||37
8865880|NCT01845636|9921961|FG000|NOT COMPLETED|Overall Study||4
8865881|NCT01845792|9921967|FG000|STARTED|Overall Study||5
8865882|NCT01845792|9921968|FG001|STARTED|Overall Study||2
8630584|NCT00535743|9670394|FG020|Treated|Overall Study||5
8630585|NCT00535743|9670395|FG021|Treated|Overall Study||5
8691258|NCT00853840|9736489|FG000|Vardenafil or Placebo (Day 4)|Period 1|Administered 1 hour post Maraviroc dosing|9
8865883|NCT01845792|9921967|FG000|COMPLETED|Overall Study||5
8865884|NCT01845792|9921968|FG001|COMPLETED|Overall Study||2
8865885|NCT01845792|9921967|FG000|NOT COMPLETED|Overall Study||0
8865886|NCT01845792|9921968|FG001|NOT COMPLETED|Overall Study||0
8865887|NCT01845818|9921976|FG000|STARTED|Overall Study||126
8865888|NCT01845818|9921977|FG001|STARTED|Overall Study||57
8865889|NCT01845818|9921976|FG000|COMPLETED|Overall Study||81
8865890|NCT01845818|9921977|FG001|COMPLETED|Overall Study||40
8865891|NCT01845818|9921976|FG000|NOT COMPLETED|Overall Study||45
8865892|NCT01845818|9921977|FG001|NOT COMPLETED|Overall Study||17
8865893|NCT01845831|9921987|FG000|STARTED|Inpatient Phase||140
8865894|NCT01845831|9921988|FG001|STARTED|Inpatient Phase||139
8865895|NCT01845831|9921989|FG002|STARTED|Inpatient Phase||0
8865896|NCT01845831|9921990|FG003|STARTED|Inpatient Phase||0
8865897|NCT01845831|9921991|FG004|STARTED|Inpatient Phase||0
8865898|NCT01845831|9921987|FG000|COMPLETED|Inpatient Phase||139
8865899|NCT01845831|9921988|FG001|COMPLETED|Inpatient Phase||138
8865900|NCT01845831|9921989|FG002|COMPLETED|Inpatient Phase||0
8865901|NCT01845831|9921990|FG003|COMPLETED|Inpatient Phase||0
8865902|NCT01845831|9921991|FG004|COMPLETED|Inpatient Phase||0
8865903|NCT01845831|9921987|FG000|NOT COMPLETED|Inpatient Phase||1
8865904|NCT01845831|9921988|FG001|NOT COMPLETED|Inpatient Phase||1
8865905|NCT01845831|9921989|FG002|NOT COMPLETED|Inpatient Phase||0
8865906|NCT01845831|9921990|FG003|NOT COMPLETED|Inpatient Phase||0
8865907|NCT01845831|9921991|FG004|NOT COMPLETED|Inpatient Phase||0
8865908|NCT01845831|9921987|FG000|STARTED|Outpatient Phase||0
8865909|NCT01845831|9921988|FG001|STARTED|Outpatient Phase||0
8865910|NCT01845831|9921989|FG002|STARTED|Outpatient Phase||68
8865911|NCT01845831|9921990|FG003|STARTED|Outpatient Phase||98
8865912|NCT01845831|9921991|FG004|STARTED|Outpatient Phase||87
8865913|NCT01845831|9921987|FG000|COMPLETED|Outpatient Phase||0
8865914|NCT01845831|9921988|FG001|COMPLETED|Outpatient Phase||0
8865915|NCT01845831|9921989|FG002|COMPLETED|Outpatient Phase||68
8865916|NCT01845831|9921990|FG003|COMPLETED|Outpatient Phase||98
8865917|NCT01845831|9921991|FG004|COMPLETED|Outpatient Phase||87
8865918|NCT01845831|9921987|FG000|NOT COMPLETED|Outpatient Phase||0
8865919|NCT01845831|9921988|FG001|NOT COMPLETED|Outpatient Phase||0
8865920|NCT01845831|9921989|FG002|NOT COMPLETED|Outpatient Phase||0
8865921|NCT01845831|9921990|FG003|NOT COMPLETED|Outpatient Phase||0
8865922|NCT01845831|9921991|FG004|NOT COMPLETED|Outpatient Phase||0
8865923|NCT01845974|9922004|FG000|STARTED|Overall Study||4
8865924|NCT01845974|9922005|FG001|STARTED|Overall Study||9
8865925|NCT01845974|9922004|FG000|COMPLETED|Overall Study||3
8865926|NCT01845974|9922005|FG001|COMPLETED|Overall Study||9
8865927|NCT01845974|9922004|FG000|NOT COMPLETED|Overall Study||1
8865928|NCT01845974|9922005|FG001|NOT COMPLETED|Overall Study||0
8865929|NCT01846039|9922011|FG000|STARTED|Overall Study||29
8865930|NCT01846039|9922011|FG000|COMPLETED|Overall Study||27
8865931|NCT01846039|9922011|FG000|NOT COMPLETED|Overall Study||2
8865932|NCT01846104|9922015|FG000|STARTED|Overall Study||4
8865933|NCT01846104|9922015|FG000|COMPLETED|Overall Study||3
8865934|NCT01846104|9922015|FG000|NOT COMPLETED|Overall Study||1
8865935|NCT01846208|9922022|FG000|STARTED|Overall Study||28
8865936|NCT01846208|9922023|FG001|STARTED|Overall Study||24
8951244|NCT02452892|10014090|FG003|STARTED|Follow-up||39
8951245|NCT02452892|10014087|FG000|COMPLETED|Follow-up||62
8951246|NCT02452892|10014088|FG001|COMPLETED|Follow-up||7
8951247|NCT02452892|10014089|FG002|COMPLETED|Follow-up||7
8951248|NCT02452892|10014090|FG003|COMPLETED|Follow-up||38
8951249|NCT02452892|10014087|FG000|NOT COMPLETED|Follow-up||1
8951250|NCT02452892|10014088|FG001|NOT COMPLETED|Follow-up||0
8951251|NCT02452892|10014089|FG002|NOT COMPLETED|Follow-up||0
8951252|NCT02452892|10014090|FG003|NOT COMPLETED|Follow-up||1
8951253|NCT02452931|10014103|FG000|STARTED|Overall Study||64
8951254|NCT02452931|10014103|FG000|COMPLETED|Overall Study||60
8951255|NCT02452931|10014103|FG000|NOT COMPLETED|Overall Study||4
8951256|NCT02452944|10014109|FG000|STARTED|Overall Study||31
8951257|NCT02452944|10014110|FG001|STARTED|Overall Study||31
8951258|NCT02452944|10014109|FG000|COMPLETED|Overall Study||31
8951259|NCT02452944|10014110|FG001|COMPLETED|Overall Study||31
8951260|NCT02452944|10014109|FG000|NOT COMPLETED|Overall Study||0
8951261|NCT02452944|10014110|FG001|NOT COMPLETED|Overall Study||0
8951262|NCT02453048|10014123|FG000|STARTED|Overall Study||12
8951263|NCT02453048|10014124|FG001|STARTED|Overall Study||12
8951264|NCT02453048|10014125|FG002|STARTED|Overall Study||12
8865937|NCT01846208|9922024|FG002|STARTED|Overall Study||40
8865938|NCT01846208|9922022|FG000|Initiatiated Treatment|Overall Study||27
8865939|NCT01846208|9922023|FG001|Initiatiated Treatment|Overall Study||23
8865940|NCT01846208|9922024|FG002|Initiatiated Treatment|Overall Study||39
8865941|NCT01846208|9922022|FG000|Year 1 Desensitization OFC|Overall Study||23
8865942|NCT01846208|9922023|FG001|Year 1 Desensitization OFC|Overall Study||20
8865943|NCT01846208|9922024|FG002|Year 1 Desensitization OFC|Overall Study||34
8865944|NCT01846208|9922022|FG000|Year 2 Desensitization OFC|Overall Study||19
8865945|NCT01846208|9922023|FG001|Year 2 Desensitization OFC|Overall Study||20
8865946|NCT01846208|9922024|FG002|Year 2 Desensitization OFC|Overall Study||33
8951265|NCT02453048|10014126|FG003|STARTED|Overall Study||12
8951266|NCT02453048|10014127|FG004|STARTED|Overall Study||6
8951267|NCT02453048|10014123|FG000|6-month Follow-up|Overall Study||12
8951268|NCT02453048|10014124|FG001|6-month Follow-up|Overall Study||12
8951269|NCT02453048|10014125|FG002|6-month Follow-up|Overall Study||12
8951270|NCT02453048|10014126|FG003|6-month Follow-up|Overall Study||12
8951271|NCT02453048|10014127|FG004|6-month Follow-up|Overall Study||6
8951272|NCT02453048|10014123|FG000|COMPLETED|Overall Study||12
8951273|NCT02453048|10014124|FG001|COMPLETED|Overall Study||11
8951274|NCT02453048|10014125|FG002|COMPLETED|Overall Study||10
8951275|NCT02453048|10014126|FG003|COMPLETED|Overall Study||12
8951276|NCT02453048|10014127|FG004|COMPLETED|Overall Study||0
8951277|NCT02453048|10014123|FG000|NOT COMPLETED|Overall Study||0
8951278|NCT02453048|10014124|FG001|NOT COMPLETED|Overall Study||1
8951279|NCT02453048|10014125|FG002|NOT COMPLETED|Overall Study||2
8865947|NCT01846208|9922022|FG000|Year 2 Sustained Unresponsiveness OFC|Overall Study||4
8865948|NCT01846208|9922023|FG001|Year 2 Sustained Unresponsiveness OFC|Overall Study||18
8865949|NCT01846208|9922024|FG002|Year 2 Sustained Unresponsiveness OFC|Overall Study||21
8865950|NCT01846208|9922022|FG000|COMPLETED|Overall Study||19
8865951|NCT01846208|9922023|FG001|COMPLETED|Overall Study||20
8865952|NCT01846208|9922024|FG002|COMPLETED|Overall Study||32
8865953|NCT01846208|9922022|FG000|NOT COMPLETED|Overall Study||9
8865954|NCT01846208|9922023|FG001|NOT COMPLETED|Overall Study||4
8865955|NCT01846208|9922024|FG002|NOT COMPLETED|Overall Study||8
8865956|NCT01846221|9922034|FG000|STARTED|Overall Study||50
8865957|NCT01846221|9922035|FG001|STARTED|Overall Study||51
8865958|NCT01846221|9922034|FG000|COMPLETED|Overall Study||47
8865959|NCT01846221|9922035|FG001|COMPLETED|Overall Study||51
8865960|NCT01846221|9922034|FG000|NOT COMPLETED|Overall Study||3
8865961|NCT01846221|9922035|FG001|NOT COMPLETED|Overall Study||0
8865962|NCT01846299|9922043|FG000|STARTED|Overall Study||118
8865963|NCT01846299|9922044|FG001|STARTED|Overall Study||60
8865964|NCT01846299|9922043|FG000|Full Analysis Set|Overall Study|One participant did not receive study treatment prior to discontinuation.|117
8865965|NCT01846299|9922044|FG001|Full Analysis Set|Overall Study||60
8865966|NCT01846299|9922043|FG000|Safety Set|Overall Study|Two participants randomized to sham received ranibizumab at Month 1.|119
8865967|NCT01846299|9922044|FG001|Safety Set|Overall Study||58
8865968|NCT01846299|9922043|FG000|COMPLETED|Overall Study||106
8865969|NCT01846299|9922044|FG001|COMPLETED|Overall Study||50
8865970|NCT01846299|9922043|FG000|NOT COMPLETED|Overall Study||12
8865971|NCT01846299|9922044|FG001|NOT COMPLETED|Overall Study||10
8865972|NCT01846416|9922055|FG000|STARTED|Treatment Phase||31
8865973|NCT01846416|9922056|FG001|STARTED|Treatment Phase||93
8865974|NCT01846416|9922057|FG002|STARTED|Treatment Phase||13
8865975|NCT01846416|9922055|FG000|COMPLETED|Treatment Phase||0
8865976|NCT01846416|9922056|FG001|COMPLETED|Treatment Phase||0
8865977|NCT01846416|9922057|FG002|COMPLETED|Treatment Phase||0
8865978|NCT01846416|9922055|FG000|NOT COMPLETED|Treatment Phase||31
8865979|NCT01846416|9922056|FG001|NOT COMPLETED|Treatment Phase||93
8865980|NCT01846416|9922057|FG002|NOT COMPLETED|Treatment Phase||13
8865981|NCT01846416|9922055|FG000|STARTED|Survival Follow-up||28
8865982|NCT01846416|9922056|FG001|STARTED|Survival Follow-up||80
8865983|NCT01846416|9922057|FG002|STARTED|Survival Follow-up||12
8865984|NCT01846416|9922055|FG000|COMPLETED|Survival Follow-up||0
8865985|NCT01846416|9922056|FG001|COMPLETED|Survival Follow-up||0
8865986|NCT01846416|9922057|FG002|COMPLETED|Survival Follow-up||0
8865987|NCT01846416|9922055|FG000|NOT COMPLETED|Survival Follow-up||28
8865988|NCT01846416|9922056|FG001|NOT COMPLETED|Survival Follow-up||80
8865989|NCT01846416|9922057|FG002|NOT COMPLETED|Survival Follow-up||12
8865990|NCT01846442|9922070|FG000|STARTED|Overall Study||54
8865991|NCT01846442|9922071|FG001|STARTED|Overall Study||54
8865992|NCT01846442|9922072|FG002|STARTED|Overall Study||56
8865993|NCT01846442|9922073|FG003|STARTED|Overall Study||54
8865994|NCT01846442|9922070|FG000|Safety Population|Overall Study||54
8865995|NCT01846442|9922071|FG001|Safety Population|Overall Study||53
8865996|NCT01846442|9922072|FG002|Safety Population|Overall Study||56
8865997|NCT01846442|9922073|FG003|Safety Population|Overall Study||54
8865998|NCT01846442|9922070|FG000|ITT Population|Overall Study||53
8865999|NCT01846442|9922071|FG001|ITT Population|Overall Study||53
8866000|NCT01846442|9922072|FG002|ITT Population|Overall Study||56
8866001|NCT01846442|9922073|FG003|ITT Population|Overall Study||54
8866002|NCT01846442|9922070|FG000|COMPLETED|Overall Study||48
8866003|NCT01846442|9922071|FG001|COMPLETED|Overall Study||48
8630586|NCT00535743|9670396|FG022|Treated|Overall Study|N=1 (randomized to Arm Q) rec'd 12 mg/kg Sugammadex, 29 min after 1.2 mg/kg Esmeron®|6
8630587|NCT00535743|9670397|FG023|Treated|Overall Study||5
8630588|NCT00535743|9670374|FG000|COMPLETED|Overall Study||5
8630589|NCT00535743|9670375|FG001|COMPLETED|Overall Study||11
8630590|NCT00535743|9670376|FG002|COMPLETED|Overall Study||11
8630591|NCT00535743|9670377|FG003|COMPLETED|Overall Study||11
8630592|NCT00535743|9670378|FG004|COMPLETED|Overall Study||11
8630593|NCT00535743|9670379|FG005|COMPLETED|Overall Study||10
8630594|NCT00535743|9670380|FG006|COMPLETED|Overall Study||3
8630595|NCT00535743|9670381|FG007|COMPLETED|Overall Study||5
8630596|NCT00535743|9670382|FG008|COMPLETED|Overall Study||4
8630597|NCT00535743|9670383|FG009|COMPLETED|Overall Study||4
8630598|NCT00535743|9670384|FG010|COMPLETED|Overall Study||5
8630599|NCT00535743|9670385|FG011|COMPLETED|Overall Study||5
8866004|NCT01846442|9922072|FG002|COMPLETED|Overall Study||52
8866005|NCT01846442|9922073|FG003|COMPLETED|Overall Study||51
8866006|NCT01846442|9922070|FG000|NOT COMPLETED|Overall Study||6
8866007|NCT01846442|9922071|FG001|NOT COMPLETED|Overall Study||6
8630600|NCT00535743|9670386|FG012|COMPLETED|Overall Study||5
8630601|NCT00535743|9670387|FG013|COMPLETED|Overall Study||10
8630602|NCT00535743|9670388|FG014|COMPLETED|Overall Study||9
8630603|NCT00535743|9670389|FG015|COMPLETED|Overall Study||13
8630604|NCT00535743|9670390|FG016|COMPLETED|Overall Study||10
8866008|NCT01846442|9922072|FG002|NOT COMPLETED|Overall Study||4
8866009|NCT01846442|9922073|FG003|NOT COMPLETED|Overall Study||3
8866010|NCT01846455|9922088|FG000|STARTED|Overall Study||9
8866011|NCT01846455|9922089|FG001|STARTED|Overall Study||8
8866012|NCT01846455|9922090|FG002|STARTED|Overall Study||8
8866013|NCT01846455|9922091|FG003|STARTED|Overall Study||10
8866014|NCT01846455|9922092|FG004|STARTED|Overall Study||8
8866015|NCT01846455|9922088|FG000|PK Population|Overall Study||6
8866016|NCT01846455|9922089|FG001|PK Population|Overall Study||7
8866017|NCT01846455|9922090|FG002|PK Population|Overall Study||6
8866018|NCT01846455|9922091|FG003|PK Population|Overall Study||6
8866019|NCT01846455|9922092|FG004|PK Population|Overall Study||8
8866020|NCT01846455|9922088|FG000|COMPLETED|Overall Study||9
8866021|NCT01846455|9922089|FG001|COMPLETED|Overall Study||8
8866022|NCT01846455|9922090|FG002|COMPLETED|Overall Study||8
8866023|NCT01846455|9922091|FG003|COMPLETED|Overall Study||10
8866024|NCT01846455|9922092|FG004|COMPLETED|Overall Study||8
8866025|NCT01846455|9922088|FG000|NOT COMPLETED|Overall Study||0
8866026|NCT01846455|9922089|FG001|NOT COMPLETED|Overall Study||0
8866027|NCT01846455|9922090|FG002|NOT COMPLETED|Overall Study||0
8866028|NCT01846455|9922091|FG003|NOT COMPLETED|Overall Study||0
8866029|NCT01846455|9922092|FG004|NOT COMPLETED|Overall Study||0
8866030|NCT01846494|9922106|FG000|STARTED|Overall Study||50
8866031|NCT01846494|9922107|FG001|STARTED|Overall Study||63
8866032|NCT01846494|9922106|FG000|COMPLETED|Overall Study||20
8866033|NCT01846494|9922107|FG001|COMPLETED|Overall Study||25
8866034|NCT01846494|9922106|FG000|NOT COMPLETED|Overall Study||30
8866035|NCT01846494|9922107|FG001|NOT COMPLETED|Overall Study||38
8866036|NCT01846507|9922113|FG000|STARTED|Overall Study||32
8866037|NCT01846507|9922113|FG000|COMPLETED|Overall Study||25
8866038|NCT01846507|9922113|FG000|NOT COMPLETED|Overall Study||7
8866039|NCT01846611|9922121|FG000|STARTED|Overall Study||289
8866040|NCT01846611|9922122|FG001|STARTED|Overall Study||287
8866041|NCT01846611|9922121|FG000|Treated|Overall Study||286
8866042|NCT01846611|9922122|FG001|Treated|Overall Study||282
8866043|NCT01846611|9922121|FG000|COMPLETED|Overall Study||251
8866044|NCT01846611|9922122|FG001|COMPLETED|Overall Study||244
8866045|NCT01846611|9922121|FG000|NOT COMPLETED|Overall Study||38
8866046|NCT01846611|9922122|FG001|NOT COMPLETED|Overall Study||43
8866047|NCT01846624|9922128|FG000|STARTED|Overall Study||13
8866048|NCT01846624|9922128|FG000|COMPLETED|Overall Study||12
8866049|NCT01846624|9922128|FG000|NOT COMPLETED|Overall Study||1
8866050|NCT01846702|9922139|FG000|STARTED|Overall Study||6
8866051|NCT01846702|9922140|FG001|STARTED|Overall Study||6
8866052|NCT01846702|9922141|FG002|STARTED|Overall Study||7
8866053|NCT01846702|9922142|FG003|STARTED|Overall Study||6
8866054|NCT01846702|9922143|FG004|STARTED|Overall Study||6
8866055|NCT01846702|9922144|FG005|STARTED|Overall Study||6
8866056|NCT01846702|9922145|FG006|STARTED|Overall Study||6
8866057|NCT01846702|9922139|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
8866058|NCT01846702|9922140|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
8866059|NCT01846702|9922141|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
8866060|NCT01846702|9922142|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
8866061|NCT01846702|9922143|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6
8866062|NCT01846702|9922144|FG005|Received at Least 1 Dose of Study Drug|Overall Study||6
8866063|NCT01846702|9922145|FG006|Received at Least 1 Dose of Study Drug|Overall Study||6
8630605|NCT00535743|9670391|FG017|COMPLETED|Overall Study||11
8866064|NCT01846702|9922139|FG000|COMPLETED|Overall Study||6
8866065|NCT01846702|9922140|FG001|COMPLETED|Overall Study||6
8866066|NCT01846702|9922141|FG002|COMPLETED|Overall Study||6
8866067|NCT01846702|9922142|FG003|COMPLETED|Overall Study||6
8866068|NCT01846702|9922143|FG004|COMPLETED|Overall Study||6
8866069|NCT01846702|9922144|FG005|COMPLETED|Overall Study||6
8866070|NCT01846702|9922145|FG006|COMPLETED|Overall Study||6
8866071|NCT01846702|9922139|FG000|NOT COMPLETED|Overall Study||0
8866072|NCT01846702|9922140|FG001|NOT COMPLETED|Overall Study||0
8866073|NCT01846702|9922141|FG002|NOT COMPLETED|Overall Study||1
8866074|NCT01846702|9922142|FG003|NOT COMPLETED|Overall Study||0
8866075|NCT01846702|9922143|FG004|NOT COMPLETED|Overall Study||0
8866076|NCT01846702|9922144|FG005|NOT COMPLETED|Overall Study||0
8866077|NCT01846702|9922145|FG006|NOT COMPLETED|Overall Study||0
8866078|NCT01846728|9922169|FG000|STARTED|Overall Study||6
8866079|NCT01846728|9922169|FG000|COMPLETED|Overall Study||6
8866080|NCT01846728|9922169|FG000|NOT COMPLETED|Overall Study||0
8866081|NCT01846741|9922173|FG000|STARTED|Baseline Visit||22
8866082|NCT01846741|9922173|FG000|COMPLETED|Baseline Visit||20
8866083|NCT01846741|9922173|FG000|NOT COMPLETED|Baseline Visit||2
8866084|NCT01846741|9922173|FG000|STARTED|Implantation to 18-Month/End of Study||20
8866085|NCT01846741|9922173|FG000|COMPLETED|Implantation to 18-Month/End of Study||20
8866086|NCT01846741|9922173|FG000|NOT COMPLETED|Implantation to 18-Month/End of Study||0
8866087|NCT01846871|9922212|FG000|STARTED|Overall Study||10
8866088|NCT01846871|9922212|FG000|COMPLETED|Overall Study||10
8866089|NCT01846871|9922212|FG000|NOT COMPLETED|Overall Study||0
8866090|NCT01846988|9922223|FG000|STARTED|APAP Pressurize Comparison (4-8 Weeks)||15
8866091|NCT01846988|9922224|FG001|STARTED|APAP Pressurize Comparison (4-8 Weeks)||0
8866092|NCT01846988|9922225|FG002|STARTED|APAP Pressurize Comparison (4-8 Weeks)||0
8866093|NCT01846988|9922223|FG000|COMPLETED|APAP Pressurize Comparison (4-8 Weeks)||15
8866094|NCT01846988|9922224|FG001|COMPLETED|APAP Pressurize Comparison (4-8 Weeks)||0
8866095|NCT01846988|9922225|FG002|COMPLETED|APAP Pressurize Comparison (4-8 Weeks)||0
8866096|NCT01846988|9922223|FG000|NOT COMPLETED|APAP Pressurize Comparison (4-8 Weeks)||0
8866097|NCT01846988|9922224|FG001|NOT COMPLETED|APAP Pressurize Comparison (4-8 Weeks)||0
8866098|NCT01846988|9922225|FG002|NOT COMPLETED|APAP Pressurize Comparison (4-8 Weeks)||0
8866099|NCT01846988|9922223|FG000|STARTED|Intervention #1 - 4 Weeks||0
8866100|NCT01846988|9922224|FG001|STARTED|Intervention #1 - 4 Weeks|Only 10 of 15 participants completing Comparison period started periods 1 & 2|5
8866101|NCT01846988|9922225|FG002|STARTED|Intervention #1 - 4 Weeks||5
8866102|NCT01846988|9922223|FG000|COMPLETED|Intervention #1 - 4 Weeks||0
8866103|NCT01846988|9922224|FG001|COMPLETED|Intervention #1 - 4 Weeks||5
8866104|NCT01846988|9922225|FG002|COMPLETED|Intervention #1 - 4 Weeks||5
8866105|NCT01846988|9922223|FG000|NOT COMPLETED|Intervention #1 - 4 Weeks||0
8866106|NCT01846988|9922224|FG001|NOT COMPLETED|Intervention #1 - 4 Weeks||0
8866107|NCT01846988|9922225|FG002|NOT COMPLETED|Intervention #1 - 4 Weeks||0
8866108|NCT01846988|9922223|FG000|STARTED|Intervention #2 - 4 Weeks||0
8866109|NCT01846988|9922224|FG001|STARTED|Intervention #2 - 4 Weeks||5
8866110|NCT01846988|9922225|FG002|STARTED|Intervention #2 - 4 Weeks||5
8866111|NCT01846988|9922223|FG000|COMPLETED|Intervention #2 - 4 Weeks||0
8866112|NCT01846988|9922224|FG001|COMPLETED|Intervention #2 - 4 Weeks||5
8866113|NCT01846988|9922225|FG002|COMPLETED|Intervention #2 - 4 Weeks||5
8866114|NCT01846988|9922223|FG000|NOT COMPLETED|Intervention #2 - 4 Weeks||0
8866115|NCT01846988|9922224|FG001|NOT COMPLETED|Intervention #2 - 4 Weeks||0
8866116|NCT01846988|9922225|FG002|NOT COMPLETED|Intervention #2 - 4 Weeks||0
8866117|NCT01847001|9922242|FG000|STARTED|Overall Study||10
8866118|NCT01847001|9922242|FG000|COMPLETED|Overall Study||10
8951280|NCT02453048|10014126|FG003|NOT COMPLETED|Overall Study||0
8951281|NCT02453048|10014127|FG004|NOT COMPLETED|Overall Study||6
8951282|NCT02453113|10014139|FG000|STARTED|Overall Study||10
8951283|NCT02453113|10014139|FG000|COMPLETED|Overall Study||10
8951284|NCT02453113|10014139|FG000|NOT COMPLETED|Overall Study||0
8951285|NCT02453191|10014143|FG000|STARTED|Overall Study||30
8951286|NCT02453191|10014143|FG000|COMPLETED|Overall Study||29
8951287|NCT02453191|10014143|FG000|NOT COMPLETED|Overall Study||1
8951288|NCT02453256|10014149|FG000|STARTED|Double Blind Period||106
8630606|NCT00535743|9670392|FG018|COMPLETED|Overall Study||3
8951289|NCT02453256|10014150|FG001|STARTED|Double Blind Period||104
8951290|NCT02453256|10014149|FG000|COMPLETED|Double Blind Period||93
8951291|NCT02453256|10014150|FG001|COMPLETED|Double Blind Period||95
8951292|NCT02453256|10014149|FG000|NOT COMPLETED|Double Blind Period||13
8951293|NCT02453256|10014150|FG001|NOT COMPLETED|Double Blind Period||9
8951294|NCT02453256|10014149|FG000|STARTED|Open Label Period||89
8951295|NCT02453256|10014150|FG001|STARTED|Open Label Period||92
8951296|NCT02453256|10014149|FG000|COMPLETED|Open Label Period||82
8951297|NCT02453256|10014150|FG001|COMPLETED|Open Label Period||85
8951298|NCT02453256|10014149|FG000|NOT COMPLETED|Open Label Period||7
8951299|NCT02453256|10014150|FG001|NOT COMPLETED|Open Label Period||7
8951300|NCT02453282|10014166|FG000|STARTED|Overall Study||374
8951301|NCT02453282|10014167|FG001|STARTED|Overall Study||372
8951302|NCT02453282|10014168|FG002|STARTED|Overall Study||372
8951303|NCT02453282|10014166|FG000|Received Treatment|Overall Study||369
8951304|NCT02453282|10014167|FG001|Received Treatment|Overall Study||371
8951305|NCT02453282|10014168|FG002|Received Treatment|Overall Study||352
8951306|NCT02453282|10014166|FG000|COMPLETED|Overall Study||0
8951307|NCT02453282|10014167|FG001|COMPLETED|Overall Study||0
8951308|NCT02453282|10014168|FG002|COMPLETED|Overall Study||0
8951309|NCT02453282|10014166|FG000|NOT COMPLETED|Overall Study||374
8951310|NCT02453282|10014167|FG001|NOT COMPLETED|Overall Study||372
8951311|NCT02453282|10014168|FG002|NOT COMPLETED|Overall Study||372
8951312|NCT02453321|10014181|FG000|STARTED|Overall Study||20
8951313|NCT02453321|10014182|FG001|STARTED|Overall Study||21
8951314|NCT02453321|10014183|FG002|STARTED|Overall Study||21
8951315|NCT02453321|10014181|FG000|COMPLETED|Overall Study||19
8951316|NCT02453321|10014182|FG001|COMPLETED|Overall Study||19
8951317|NCT02453321|10014183|FG002|COMPLETED|Overall Study||19
8951318|NCT02453321|10014181|FG000|NOT COMPLETED|Overall Study||1
8951319|NCT02453321|10014182|FG001|NOT COMPLETED|Overall Study||2
8951320|NCT02453321|10014183|FG002|NOT COMPLETED|Overall Study||2
8951321|NCT02453334|10014196|FG000|STARTED|Overall Study||122
8951322|NCT02453334|10014197|FG001|STARTED|Overall Study||122
8951323|NCT02453334|10014196|FG000|COMPLETED|Overall Study||81
8951324|NCT02453334|10014197|FG001|COMPLETED|Overall Study||82
8951325|NCT02453334|10014196|FG000|NOT COMPLETED|Overall Study||41
8951326|NCT02453334|10014197|FG001|NOT COMPLETED|Overall Study||40
8951327|NCT02453347|10014203|FG000|STARTED|Overall Study||6
8951328|NCT02453347|10014203|FG000|COMPLETED|Overall Study||6
8951329|NCT02453347|10014203|FG000|NOT COMPLETED|Overall Study||0
8951330|NCT02453360|10014210|FG000|STARTED|Overall Study||20
8951331|NCT02453360|10014211|FG001|STARTED|Overall Study||20
8951332|NCT02453360|10014212|FG002|STARTED|Overall Study||20
8866119|NCT01847001|9922242|FG000|NOT COMPLETED|Overall Study||0
8951333|NCT02453360|10014210|FG000|COMPLETED|Overall Study||20
8951334|NCT02453360|10014211|FG001|COMPLETED|Overall Study||20
8951335|NCT02453360|10014212|FG002|COMPLETED|Overall Study||20
8951336|NCT02453360|10014210|FG000|NOT COMPLETED|Overall Study||0
8951337|NCT02453360|10014211|FG001|NOT COMPLETED|Overall Study||0
8630607|NCT00535743|9670393|FG019|COMPLETED|Overall Study||5
8951338|NCT02453360|10014212|FG002|NOT COMPLETED|Overall Study||0
8951339|NCT02453386|10014223|FG000|STARTED|Overall Study||151
8866120|NCT01847014|9922247|FG000|STARTED|Baseline Extension Visit||4
8866121|NCT01847014|9922247|FG000|COMPLETED|Baseline Extension Visit||4
8866122|NCT01847014|9922247|FG000|NOT COMPLETED|Baseline Extension Visit||0
8866123|NCT01847014|9922247|FG000|STARTED|Completion of Extension Study||4
8866124|NCT01847014|9922247|FG000|COMPLETED|Completion of Extension Study||0
8866125|NCT01847014|9922247|FG000|NOT COMPLETED|Completion of Extension Study||4
8866126|NCT01847027|9922253|FG000|STARTED|Overall Study||11
8866127|NCT01847027|9922254|FG001|STARTED|Overall Study||12
8866128|NCT01847027|9922253|FG000|COMPLETED|Overall Study||10
8866129|NCT01847027|9922254|FG001|COMPLETED|Overall Study||10
8866130|NCT01847027|9922253|FG000|NOT COMPLETED|Overall Study||1
8866131|NCT01847027|9922254|FG001|NOT COMPLETED|Overall Study||2
8866132|NCT01847092|9922262|FG000|STARTED|Overall Study||77
8866133|NCT01847092|9922263|FG001|STARTED|Overall Study||77
8866134|NCT01847092|9922262|FG000|COMPLETED|Overall Study||51
8866135|NCT01847092|9922263|FG001|COMPLETED|Overall Study||66
8866136|NCT01847092|9922262|FG000|NOT COMPLETED|Overall Study||26
8866137|NCT01847092|9922263|FG001|NOT COMPLETED|Overall Study||11
8866138|NCT01847131|9922271|FG000|STARTED|Overall Study||25
8866139|NCT01847131|9922272|FG001|STARTED|Overall Study||25
8866140|NCT01847131|9922271|FG000|COMPLETED|Overall Study||25
8866141|NCT01847131|9922272|FG001|COMPLETED|Overall Study||25
8866142|NCT01847131|9922271|FG000|NOT COMPLETED|Overall Study||0
8866143|NCT01847131|9922272|FG001|NOT COMPLETED|Overall Study||0
8866144|NCT01847196|9922278|FG000|STARTED|Overall Study|Includes all subjects in which Angel Catheter placement was attempted.|5
8866145|NCT01847196|9922278|FG000|COMPLETED|Overall Study||5
8866146|NCT01847196|9922278|FG000|NOT COMPLETED|Overall Study||0
8866147|NCT01847209|9922282|FG000|STARTED|Overall Study||25
8866148|NCT01847209|9922282|FG000|COMPLETED|Overall Study||23
8866149|NCT01847209|9922282|FG000|NOT COMPLETED|Overall Study||2
8923770|NCT02243280|9984430|FG010|NOT COMPLETED|Enrolled||0
8923771|NCT02243280|9984420|FG000|STARTED|Treated|Two Arm I participants received ABT-493 doses of 200 mg instead of 300 mg and are included in Arm A|42
8923772|NCT02243280|9984421|FG001|STARTED|Treated||39
8923773|NCT02243280|9984422|FG002|STARTED|Treated||0
8923774|NCT02243280|9984423|FG003|STARTED|Treated||0
8923775|NCT02243280|9984424|FG004|STARTED|Treated||0
8923776|NCT02243280|9984425|FG005|STARTED|Treated||27
8923777|NCT02243280|9984426|FG006|STARTED|Treated||0
8923778|NCT02243280|9984427|FG007|STARTED|Treated||0
8923779|NCT02243280|9984428|FG008|STARTED|Treated|Two Arm I participants received ABT-493 doses of 200 mg instead of 300 mg and are included in Arm A|32
8866150|NCT01847313|9922288|FG000|STARTED|Overall Study||10
8866151|NCT01847313|9922289|FG001|STARTED|Overall Study||10
8866152|NCT01847313|9922288|FG000|COMPLETED|Overall Study||10
8866153|NCT01847313|9922289|FG001|COMPLETED|Overall Study||8
8866154|NCT01847313|9922288|FG000|NOT COMPLETED|Overall Study||0
8866155|NCT01847313|9922289|FG001|NOT COMPLETED|Overall Study||2
8866156|NCT01847430|9922295|FG000|STARTED|Overall Study||302
8866157|NCT01847430|9922295|FG000|COMPLETED|Overall Study||302
8866158|NCT01847430|9922295|FG000|NOT COMPLETED|Overall Study||0
8866159|NCT01847443|9922299|FG000|STARTED|Study Period 1||21
8866160|NCT01847443|9922300|FG001|STARTED|Study Period 1||21
8866161|NCT01847443|9922301|FG002|STARTED|Study Period 1||21
8866162|NCT01847443|9922302|FG003|STARTED|Study Period 1||21
8866163|NCT01847443|9922299|FG000|COMPLETED|Study Period 1||21
8866164|NCT01847443|9922300|FG001|COMPLETED|Study Period 1||20
8866165|NCT01847443|9922301|FG002|COMPLETED|Study Period 1||21
8866166|NCT01847443|9922302|FG003|COMPLETED|Study Period 1||21
8866167|NCT01847443|9922299|FG000|NOT COMPLETED|Study Period 1||0
8866168|NCT01847443|9922300|FG001|NOT COMPLETED|Study Period 1||1
8866169|NCT01847443|9922301|FG002|NOT COMPLETED|Study Period 1||0
8866170|NCT01847443|9922302|FG003|NOT COMPLETED|Study Period 1||0
8866171|NCT01847443|9922299|FG000|STARTED|Washout Period Before Study Period 2||21
8866172|NCT01847443|9922300|FG001|STARTED|Washout Period Before Study Period 2||20
8866173|NCT01847443|9922301|FG002|STARTED|Washout Period Before Study Period 2||21
8866174|NCT01847443|9922302|FG003|STARTED|Washout Period Before Study Period 2||21
8866175|NCT01847443|9922299|FG000|COMPLETED|Washout Period Before Study Period 2||19
8866176|NCT01847443|9922300|FG001|COMPLETED|Washout Period Before Study Period 2||19
8866177|NCT01847443|9922301|FG002|COMPLETED|Washout Period Before Study Period 2||21
8866178|NCT01847443|9922302|FG003|COMPLETED|Washout Period Before Study Period 2||21
8866179|NCT01847443|9922299|FG000|NOT COMPLETED|Washout Period Before Study Period 2||2
8866180|NCT01847443|9922300|FG001|NOT COMPLETED|Washout Period Before Study Period 2||1
8866181|NCT01847443|9922301|FG002|NOT COMPLETED|Washout Period Before Study Period 2||0
8866182|NCT01847443|9922302|FG003|NOT COMPLETED|Washout Period Before Study Period 2||0
8866183|NCT01847443|9922299|FG000|STARTED|Study Period 2||19
8866184|NCT01847443|9922300|FG001|STARTED|Study Period 2||19
8866185|NCT01847443|9922301|FG002|STARTED|Study Period 2||21
8866186|NCT01847443|9922302|FG003|STARTED|Study Period 2||21
8866187|NCT01847443|9922299|FG000|COMPLETED|Study Period 2||19
8866188|NCT01847443|9922300|FG001|COMPLETED|Study Period 2||19
8866189|NCT01847443|9922301|FG002|COMPLETED|Study Period 2||21
8866190|NCT01847443|9922302|FG003|COMPLETED|Study Period 2||21
8866191|NCT01847443|9922299|FG000|NOT COMPLETED|Study Period 2||0
8866192|NCT01847443|9922300|FG001|NOT COMPLETED|Study Period 2||0
8866193|NCT01847443|9922301|FG002|NOT COMPLETED|Study Period 2||0
8866194|NCT01847443|9922302|FG003|NOT COMPLETED|Study Period 2||0
8866195|NCT01847443|9922299|FG000|STARTED|Washout Period Before Study Period 3||19
8866196|NCT01847443|9922300|FG001|STARTED|Washout Period Before Study Period 3||19
8866197|NCT01847443|9922301|FG002|STARTED|Washout Period Before Study Period 3||21
8866198|NCT01847443|9922302|FG003|STARTED|Washout Period Before Study Period 3||21
8866199|NCT01847443|9922299|FG000|COMPLETED|Washout Period Before Study Period 3||18
8866200|NCT01847443|9922300|FG001|COMPLETED|Washout Period Before Study Period 3||19
8866201|NCT01847443|9922301|FG002|COMPLETED|Washout Period Before Study Period 3||21
8866202|NCT01847443|9922302|FG003|COMPLETED|Washout Period Before Study Period 3||21
8866203|NCT01847443|9922299|FG000|NOT COMPLETED|Washout Period Before Study Period 3||1
8866204|NCT01847443|9922300|FG001|NOT COMPLETED|Washout Period Before Study Period 3||0
8866205|NCT01847443|9922301|FG002|NOT COMPLETED|Washout Period Before Study Period 3||0
8951340|NCT02453386|10014224|FG001|STARTED|Overall Study||149
8951341|NCT02453386|10014225|FG002|STARTED|Overall Study||149
8951342|NCT02453386|10014223|FG000|COMPLETED|Overall Study||102
8951343|NCT02453386|10014224|FG001|COMPLETED|Overall Study||100
8951344|NCT02453386|10014225|FG002|COMPLETED|Overall Study||108
8951345|NCT02453386|10014223|FG000|NOT COMPLETED|Overall Study||49
8951346|NCT02453386|10014224|FG001|NOT COMPLETED|Overall Study||49
8951347|NCT02453386|10014225|FG002|NOT COMPLETED|Overall Study||41
8951348|NCT02453555|10014242|FG000|STARTED|24-week Double-blind Treatment Period|Started are treated subjects.|182
8951349|NCT02453555|10014243|FG001|STARTED|24-week Double-blind Treatment Period|Started are treated subjects.|93
8951350|NCT02453555|10014244|FG002|STARTED|24-week Double-blind Treatment Period|This reporting group is not applicable in this period.|0
8951351|NCT02453555|10014245|FG003|STARTED|24-week Double-blind Treatment Period|This reporting group is not applicable in this period.|0
8951352|NCT02453555|10014246|FG004|STARTED|24-week Double-blind Treatment Period|This reporting group is not applicable in this period.|0
8951353|NCT02453555|10014247|FG005|STARTED|24-week Double-blind Treatment Period|This reporting group is not applicable in this period.|0
8951354|NCT02453555|10014242|FG000|COMPLETED|24-week Double-blind Treatment Period||177
8951355|NCT02453555|10014243|FG001|COMPLETED|24-week Double-blind Treatment Period||86
8951356|NCT02453555|10014244|FG002|COMPLETED|24-week Double-blind Treatment Period||0
8951357|NCT02453555|10014245|FG003|COMPLETED|24-week Double-blind Treatment Period||0
8951358|NCT02453555|10014246|FG004|COMPLETED|24-week Double-blind Treatment Period||0
8951359|NCT02453555|10014247|FG005|COMPLETED|24-week Double-blind Treatment Period||0
8951360|NCT02453555|10014242|FG000|NOT COMPLETED|24-week Double-blind Treatment Period||5
8951361|NCT02453555|10014243|FG001|NOT COMPLETED|24-week Double-blind Treatment Period||7
8951362|NCT02453555|10014244|FG002|NOT COMPLETED|24-week Double-blind Treatment Period||0
8866206|NCT01847443|9922302|FG003|NOT COMPLETED|Washout Period Before Study Period 3||0
8725623|NCT01032330|9772907|FG003|NOT COMPLETED|Overall Study||14
8866207|NCT01847443|9922299|FG000|STARTED|Study Period 3||18
8866208|NCT01847443|9922300|FG001|STARTED|Study Period 3||19
8866209|NCT01847443|9922301|FG002|STARTED|Study Period 3||21
8866210|NCT01847443|9922302|FG003|STARTED|Study Period 3||21
8866211|NCT01847443|9922299|FG000|COMPLETED|Study Period 3||18
8866212|NCT01847443|9922300|FG001|COMPLETED|Study Period 3||19
8866213|NCT01847443|9922301|FG002|COMPLETED|Study Period 3||21
8866214|NCT01847443|9922302|FG003|COMPLETED|Study Period 3||21
8866215|NCT01847443|9922299|FG000|NOT COMPLETED|Study Period 3||0
8866216|NCT01847443|9922300|FG001|NOT COMPLETED|Study Period 3||0
8866217|NCT01847443|9922301|FG002|NOT COMPLETED|Study Period 3||0
8866218|NCT01847443|9922302|FG003|NOT COMPLETED|Study Period 3||0
8866219|NCT01847443|9922299|FG000|STARTED|Washout Period Before Study Period 4||18
8866220|NCT01847443|9922300|FG001|STARTED|Washout Period Before Study Period 4||19
8866221|NCT01847443|9922301|FG002|STARTED|Washout Period Before Study Period 4||21
8866222|NCT01847443|9922302|FG003|STARTED|Washout Period Before Study Period 4||21
8866223|NCT01847443|9922299|FG000|COMPLETED|Washout Period Before Study Period 4||16
8866224|NCT01847443|9922300|FG001|COMPLETED|Washout Period Before Study Period 4||19
8866225|NCT01847443|9922301|FG002|COMPLETED|Washout Period Before Study Period 4||21
8866226|NCT01847443|9922302|FG003|COMPLETED|Washout Period Before Study Period 4||21
8866227|NCT01847443|9922299|FG000|NOT COMPLETED|Washout Period Before Study Period 4||2
8866228|NCT01847443|9922300|FG001|NOT COMPLETED|Washout Period Before Study Period 4||0
8866229|NCT01847443|9922301|FG002|NOT COMPLETED|Washout Period Before Study Period 4||0
8866230|NCT01847443|9922302|FG003|NOT COMPLETED|Washout Period Before Study Period 4||0
8866231|NCT01847443|9922299|FG000|STARTED|Study Period 4||16
8866232|NCT01847443|9922300|FG001|STARTED|Study Period 4||19
8866233|NCT01847443|9922301|FG002|STARTED|Study Period 4||21
8866234|NCT01847443|9922302|FG003|STARTED|Study Period 4||21
8866235|NCT01847443|9922299|FG000|COMPLETED|Study Period 4||16
8866236|NCT01847443|9922300|FG001|COMPLETED|Study Period 4||19
8866237|NCT01847443|9922301|FG002|COMPLETED|Study Period 4||21
8866238|NCT01847443|9922302|FG003|COMPLETED|Study Period 4||21
8866239|NCT01847443|9922299|FG000|NOT COMPLETED|Study Period 4||0
8866240|NCT01847443|9922300|FG001|NOT COMPLETED|Study Period 4||0
8866241|NCT01847443|9922301|FG002|NOT COMPLETED|Study Period 4||0
8866242|NCT01847443|9922302|FG003|NOT COMPLETED|Study Period 4||0
8866243|NCT01847469|9922316|FG000|STARTED|Overall Study||18
8866244|NCT01847469|9922317|FG001|STARTED|Overall Study||6
8866245|NCT01847469|9922316|FG000|COMPLETED|Overall Study||9
8866246|NCT01847469|9922317|FG001|COMPLETED|Overall Study||3
8866247|NCT01847469|9922316|FG000|NOT COMPLETED|Overall Study||9
8866248|NCT01847469|9922317|FG001|NOT COMPLETED|Overall Study||3
8866249|NCT01847547|9922325|FG000|STARTED|Overall Study||2991
8866250|NCT01847547|9922326|FG001|STARTED|Overall Study||2991
8866251|NCT01847547|9922325|FG000|COMPLETED|Overall Study||2991
8866252|NCT01847547|9922326|FG001|COMPLETED|Overall Study||2991
8866253|NCT01847547|9922325|FG000|NOT COMPLETED|Overall Study||0
8866254|NCT01847547|9922326|FG001|NOT COMPLETED|Overall Study||0
8866255|NCT01847560|9922343|FG000|STARTED|Overall Study||13464
8866256|NCT01847560|9922344|FG001|STARTED|Overall Study||19955
8866257|NCT01847560|9922345|FG002|STARTED|Overall Study||9731
8866258|NCT01847560|9922346|FG003|STARTED|Overall Study||56655
8866259|NCT01847560|9922347|FG004|STARTED|Overall Study||27731
8866260|NCT01847560|9922348|FG005|STARTED|Overall Study||28343
8866261|NCT01847560|9922349|FG006|STARTED|Overall Study||40971
8866262|NCT01847560|9922350|FG007|STARTED|Overall Study||19829
8866263|NCT01847560|9922351|FG008|STARTED|Overall Study||77547
8866264|NCT01847560|9922352|FG009|STARTED|Overall Study||39438
8866265|NCT01847560|9922343|FG000|COMPLETED|Overall Study||13464
8866266|NCT01847560|9922344|FG001|COMPLETED|Overall Study||19955
8866267|NCT01847560|9922345|FG002|COMPLETED|Overall Study||9731
8866268|NCT01847560|9922346|FG003|COMPLETED|Overall Study||56655
8866269|NCT01847560|9922347|FG004|COMPLETED|Overall Study||27731
8866270|NCT01847560|9922348|FG005|COMPLETED|Overall Study||28343
8866271|NCT01847560|9922349|FG006|COMPLETED|Overall Study||40971
8866272|NCT01847560|9922350|FG007|COMPLETED|Overall Study||19829
8866273|NCT01847560|9922351|FG008|COMPLETED|Overall Study||77547
8866274|NCT01847560|9922352|FG009|COMPLETED|Overall Study||39438
8866275|NCT01847560|9922343|FG000|NOT COMPLETED|Overall Study||0
8866276|NCT01847560|9922344|FG001|NOT COMPLETED|Overall Study||0
8866277|NCT01847560|9922345|FG002|NOT COMPLETED|Overall Study||0
8866278|NCT01847560|9922346|FG003|NOT COMPLETED|Overall Study||0
8866279|NCT01847560|9922347|FG004|NOT COMPLETED|Overall Study||0
8866280|NCT01847560|9922348|FG005|NOT COMPLETED|Overall Study||0
8866281|NCT01847560|9922349|FG006|NOT COMPLETED|Overall Study||0
8866282|NCT01847560|9922350|FG007|NOT COMPLETED|Overall Study||0
8866283|NCT01847560|9922351|FG008|NOT COMPLETED|Overall Study||0
8866284|NCT01847560|9922352|FG009|NOT COMPLETED|Overall Study||0
8866285|NCT01847638|9922396|FG000|STARTED|Overall Study||25
8866286|NCT01847638|9922397|FG001|STARTED|Overall Study||25
8866287|NCT01847638|9922396|FG000|COMPLETED|Overall Study||25
8866288|NCT01847638|9922397|FG001|COMPLETED|Overall Study||25
8866289|NCT01847638|9922396|FG000|NOT COMPLETED|Overall Study||0
8866290|NCT01847638|9922397|FG001|NOT COMPLETED|Overall Study||0
8866291|NCT01847755|9922403|FG000|STARTED|Overall Study||18
8866292|NCT01847755|9922403|FG000|COMPLETED|Overall Study||13
8866293|NCT01847755|9922403|FG000|NOT COMPLETED|Overall Study||5
8866294|NCT01847885|9922409|FG000|STARTED|Initial Enrollment (Consented)||88
8866295|NCT01847885|9922410|FG001|STARTED|Initial Enrollment (Consented)||0
8866296|NCT01847885|9922411|FG002|STARTED|Initial Enrollment (Consented)||0
8866297|NCT01847885|9922409|FG000|Randomized|Initial Enrollment (Consented)||46
8866298|NCT01847885|9922410|FG001|Randomized|Initial Enrollment (Consented)||0
8866299|NCT01847885|9922411|FG002|Randomized|Initial Enrollment (Consented)||0
8866300|NCT01847885|9922409|FG000|Full Analysis Set|Initial Enrollment (Consented)||43
8866301|NCT01847885|9922410|FG001|Full Analysis Set|Initial Enrollment (Consented)||0
8866302|NCT01847885|9922411|FG002|Full Analysis Set|Initial Enrollment (Consented)||0
8866303|NCT01847885|9922409|FG000|Safety Set|Initial Enrollment (Consented)||41
8866304|NCT01847885|9922410|FG001|Safety Set|Initial Enrollment (Consented)||0
8866305|NCT01847885|9922411|FG002|Safety Set|Initial Enrollment (Consented)||0
8866306|NCT01847885|9922409|FG000|Per Protocol Set|Initial Enrollment (Consented)||40
8866307|NCT01847885|9922410|FG001|Per Protocol Set|Initial Enrollment (Consented)||0
8866308|NCT01847885|9922411|FG002|Per Protocol Set|Initial Enrollment (Consented)||0
8866309|NCT01847885|9922409|FG000|COMPLETED|Initial Enrollment (Consented)||40
8866310|NCT01847885|9922410|FG001|COMPLETED|Initial Enrollment (Consented)||0
8866311|NCT01847885|9922411|FG002|COMPLETED|Initial Enrollment (Consented)||0
8866312|NCT01847885|9922409|FG000|NOT COMPLETED|Initial Enrollment (Consented)||48
8866313|NCT01847885|9922410|FG001|NOT COMPLETED|Initial Enrollment (Consented)||0
8866314|NCT01847885|9922411|FG002|NOT COMPLETED|Initial Enrollment (Consented)||0
8866315|NCT01847885|9922409|FG000|STARTED|Randomization||0
8866316|NCT01847885|9922410|FG001|STARTED|Randomization||31
8866317|NCT01847885|9922411|FG002|STARTED|Randomization||15
8866318|NCT01847885|9922409|FG000|Full Analysis Set|Randomization||0
8866319|NCT01847885|9922410|FG001|Full Analysis Set|Randomization||28
8866320|NCT01847885|9922411|FG002|Full Analysis Set|Randomization||15
8866321|NCT01847885|9922409|FG000|Safety Set|Randomization||0
8866322|NCT01847885|9922410|FG001|Safety Set|Randomization||28
8866323|NCT01847885|9922411|FG002|Safety Set|Randomization||13
8866324|NCT01847885|9922409|FG000|Per Protocol Set|Randomization||0
8866325|NCT01847885|9922410|FG001|Per Protocol Set|Randomization||27
8866326|NCT01847885|9922411|FG002|Per Protocol Set|Randomization||13
8866327|NCT01847885|9922409|FG000|COMPLETED|Randomization||0
8866328|NCT01847885|9922410|FG001|COMPLETED|Randomization||27
8866329|NCT01847885|9922411|FG002|COMPLETED|Randomization||13
8866330|NCT01847885|9922409|FG000|NOT COMPLETED|Randomization||0
8866331|NCT01847885|9922410|FG001|NOT COMPLETED|Randomization||4
8866332|NCT01847885|9922411|FG002|NOT COMPLETED|Randomization||2
8866333|NCT01848041|9922426|FG000|STARTED|Overall Study||15
8866334|NCT01848041|9922427|FG001|STARTED|Overall Study||16
8866335|NCT01848041|9922428|FG002|STARTED|Overall Study||15
8866336|NCT01848041|9922426|FG000|COMPLETED|Overall Study||15
8866337|NCT01848041|9922427|FG001|COMPLETED|Overall Study||16
8866338|NCT01848041|9922428|FG002|COMPLETED|Overall Study||15
8866339|NCT01848041|9922426|FG000|NOT COMPLETED|Overall Study||0
8866340|NCT01848041|9922427|FG001|NOT COMPLETED|Overall Study||0
8866341|NCT01848041|9922428|FG002|NOT COMPLETED|Overall Study||0
8866342|NCT01848054|9922441|FG000|STARTED|Induction Phase||155
8866343|NCT01848054|9922442|FG001|STARTED|Induction Phase||155
8866344|NCT01848054|9922441|FG000|COMPLETED|Induction Phase||132
8866345|NCT01848054|9922442|FG001|COMPLETED|Induction Phase||147
8866346|NCT01848054|9922441|FG000|NOT COMPLETED|Induction Phase||23
8866347|NCT01848054|9922442|FG001|NOT COMPLETED|Induction Phase||8
8866348|NCT01848054|9922441|FG000|STARTED|Stabilization/Maintenance||132
8866349|NCT01848054|9922442|FG001|STARTED|Stabilization/Maintenance||147
8866350|NCT01848054|9922441|FG000|COMPLETED|Stabilization/Maintenance||92
8866351|NCT01848054|9922442|FG001|COMPLETED|Stabilization/Maintenance||107
8866352|NCT01848054|9922441|FG000|NOT COMPLETED|Stabilization/Maintenance||40
8866353|NCT01848054|9922442|FG001|NOT COMPLETED|Stabilization/Maintenance||40
8866354|NCT01848067|9922452|FG000|STARTED|Overall Study||9
8866355|NCT01848067|9922452|FG000|COMPLETED|Overall Study||9
8866356|NCT01848067|9922452|FG000|NOT COMPLETED|Overall Study||0
8866357|NCT01848145|9922456|FG000|STARTED|Infusion 1: Week 1, Day 1 - 226 Minutes||34
8866358|NCT01848145|9922456|FG000|Completed Within 15min of Infusion Time|Infusion 1: Week 1, Day 1 - 226 Minutes|Number of patients who completed within 15 minutes (min) of infusion time.|1
8866359|NCT01848145|9922456|FG000|COMPLETED|Infusion 1: Week 1, Day 1 - 226 Minutes|Includes participants that completed Infusion 1 and proceeded to the next infusion, Infusion 2.|33
8923780|NCT02243280|9984429|FG009|STARTED|Treated||0
8866360|NCT01848145|9922456|FG000|NOT COMPLETED|Infusion 1: Week 1, Day 1 - 226 Minutes||1
8866361|NCT01848145|9922456|FG000|STARTED|Infusion 2: Week 1, Day 3 - 167 Minutes||33
8866362|NCT01848145|9922456|FG000|Completed Within 15min of Infusion Time|Infusion 2: Week 1, Day 3 - 167 Minutes||24
8866363|NCT01848145|9922456|FG000|COMPLETED|Infusion 2: Week 1, Day 3 - 167 Minutes|Includes participants that completed Infusion 2 and proceeded to the next infusion, Infusion 3.|31
8866364|NCT01848145|9922456|FG000|NOT COMPLETED|Infusion 2: Week 1, Day 3 - 167 Minutes||2
8866365|NCT01848145|9922456|FG000|STARTED|Infusion 3: Week 2, Day 1 - 120 Minutes||31
8923781|NCT02243280|9984430|FG010|STARTED|Treated||34
8951363|NCT02453555|10014245|FG003|NOT COMPLETED|24-week Double-blind Treatment Period||0
8951364|NCT02453555|10014246|FG004|NOT COMPLETED|24-week Double-blind Treatment Period||0
8951365|NCT02453555|10014247|FG005|NOT COMPLETED|24-week Double-blind Treatment Period||0
8951366|NCT02453555|10014242|FG000|STARTED|Extension Period|This reporting group is not applicable in this period.|0
8951367|NCT02453555|10014243|FG001|STARTED|Extension Period|This reporting group is not applicable in this period.|0
8951368|NCT02453555|10014244|FG002|STARTED|Extension Period||126
8951369|NCT02453555|10014245|FG003|STARTED|Extension Period||51
8951370|NCT02453555|10014246|FG004|STARTED|Extension Period||80
8951371|NCT02453555|10014247|FG005|STARTED|Extension Period||6
8951372|NCT02453555|10014242|FG000|COMPLETED|Extension Period||0
8951373|NCT02453555|10014243|FG001|COMPLETED|Extension Period||0
8951374|NCT02453555|10014244|FG002|COMPLETED|Extension Period||123
8951375|NCT02453555|10014245|FG003|COMPLETED|Extension Period||49
8951376|NCT02453555|10014246|FG004|COMPLETED|Extension Period||79
8951377|NCT02453555|10014247|FG005|COMPLETED|Extension Period||5
8951378|NCT02453555|10014242|FG000|NOT COMPLETED|Extension Period||0
8951379|NCT02453555|10014243|FG001|NOT COMPLETED|Extension Period||0
8951380|NCT02453555|10014244|FG002|NOT COMPLETED|Extension Period||3
8951381|NCT02453555|10014245|FG003|NOT COMPLETED|Extension Period||2
8951382|NCT02453555|10014246|FG004|NOT COMPLETED|Extension Period||1
8951383|NCT02453555|10014247|FG005|NOT COMPLETED|Extension Period||1
8951384|NCT02453581|10014257|FG000|STARTED|Overall Study||8
8951385|NCT02453581|10014258|FG001|STARTED|Overall Study||8
8951386|NCT02453581|10014259|FG002|STARTED|Overall Study||8
8951387|NCT02453581|10014257|FG000|COMPLETED|Overall Study||8
8951388|NCT02453581|10014258|FG001|COMPLETED|Overall Study||8
8951389|NCT02453581|10014259|FG002|COMPLETED|Overall Study||8
8951390|NCT02453581|10014257|FG000|NOT COMPLETED|Overall Study||0
8951391|NCT02453581|10014258|FG001|NOT COMPLETED|Overall Study||0
8951392|NCT02453581|10014259|FG002|NOT COMPLETED|Overall Study||0
8951393|NCT02453672|10014279|FG000|STARTED|Overall Study||40
8951394|NCT02453672|10014280|FG001|STARTED|Overall Study||40
8951395|NCT02453672|10014281|FG002|STARTED|Overall Study||39
8951396|NCT02453672|10014279|FG000|COMPLETED|Overall Study||37
8951397|NCT02453672|10014280|FG001|COMPLETED|Overall Study||38
8951398|NCT02453672|10014281|FG002|COMPLETED|Overall Study||38
8951399|NCT02453672|10014279|FG000|NOT COMPLETED|Overall Study||3
8951400|NCT02453672|10014280|FG001|NOT COMPLETED|Overall Study||2
8951401|NCT02453672|10014281|FG002|NOT COMPLETED|Overall Study||1
8951402|NCT02453685|10014291|FG000|STARTED|Overall Study||168
8951403|NCT02453685|10014292|FG001|STARTED|Overall Study||167
8951404|NCT02453685|10014291|FG000|Exposed|Overall Study||166
8951405|NCT02453685|10014292|FG001|Exposed|Overall Study||166
8951406|NCT02453685|10014291|FG000|COMPLETED|Overall Study||149
8951407|NCT02453685|10014292|FG001|COMPLETED|Overall Study||155
8951408|NCT02453685|10014291|FG000|NOT COMPLETED|Overall Study||19
8951409|NCT02453685|10014292|FG001|NOT COMPLETED|Overall Study||12
8951410|NCT02453711|10014307|FG000|STARTED|Overall Study||103
8951411|NCT02453711|10014308|FG001|STARTED|Overall Study||102
8951412|NCT02453711|10014309|FG002|STARTED|Overall Study||103
8951413|NCT02453711|10014310|FG003|STARTED|Overall Study||103
8951414|NCT02453711|10014311|FG004|STARTED|Overall Study||102
8951415|NCT02453711|10014312|FG005|STARTED|Overall Study||102
8951416|NCT02453711|10014313|FG006|STARTED|Overall Study||103
8951417|NCT02453711|10014314|FG007|STARTED|Overall Study||103
8951418|NCT02453711|10014315|FG008|STARTED|Overall Study||136
8951419|NCT02453711|10014307|FG000|Full Analysis Set|Overall Study||103
8951420|NCT02453711|10014308|FG001|Full Analysis Set|Overall Study||102
8951421|NCT02453711|10014309|FG002|Full Analysis Set|Overall Study||103
8951422|NCT02453711|10014310|FG003|Full Analysis Set|Overall Study||103
8951423|NCT02453711|10014311|FG004|Full Analysis Set|Overall Study||102
8951424|NCT02453711|10014312|FG005|Full Analysis Set|Overall Study||102
8951425|NCT02453711|10014313|FG006|Full Analysis Set|Overall Study||103
8951426|NCT02453711|10014314|FG007|Full Analysis Set|Overall Study||103
8951427|NCT02453711|10014315|FG008|Full Analysis Set|Overall Study||136
8951428|NCT02453711|10014307|FG000|Safety Analysis Set|Overall Study||103
8951429|NCT02453711|10014308|FG001|Safety Analysis Set|Overall Study||102
8951430|NCT02453711|10014309|FG002|Safety Analysis Set|Overall Study||103
8951431|NCT02453711|10014310|FG003|Safety Analysis Set|Overall Study||103
8951432|NCT02453711|10014311|FG004|Safety Analysis Set|Overall Study||102
8951433|NCT02453711|10014312|FG005|Safety Analysis Set|Overall Study||102
8951434|NCT02453711|10014313|FG006|Safety Analysis Set|Overall Study||103
8951435|NCT02453711|10014314|FG007|Safety Analysis Set|Overall Study||103
8951436|NCT02453711|10014315|FG008|Safety Analysis Set|Overall Study||136
8951437|NCT02453711|10014307|FG000|COMPLETED|Overall Study||92
8951438|NCT02453711|10014308|FG001|COMPLETED|Overall Study||95
8951439|NCT02453711|10014309|FG002|COMPLETED|Overall Study||94
8951440|NCT02453711|10014310|FG003|COMPLETED|Overall Study||96
8951441|NCT02453711|10014311|FG004|COMPLETED|Overall Study||100
8951442|NCT02453711|10014312|FG005|COMPLETED|Overall Study||96
8866366|NCT01848145|9922456|FG000|Completed Within 15min of Infusion Time|Infusion 3: Week 2, Day 1 - 120 Minutes||26
8866367|NCT01848145|9922456|FG000|COMPLETED|Infusion 3: Week 2, Day 1 - 120 Minutes||30
8866368|NCT01848145|9922456|FG000|NOT COMPLETED|Infusion 3: Week 2, Day 1 - 120 Minutes||1
8866369|NCT01848145|9922456|FG000|STARTED|Subsequent Infusions: Weeks 3-8||30
8866370|NCT01848145|9922456|FG000|COMPLETED|Subsequent Infusions: Weeks 3-8||20
8866371|NCT01848145|9922456|FG000|NOT COMPLETED|Subsequent Infusions: Weeks 3-8||10
8866372|NCT01848158|9922462|FG000|STARTED|Overall Study||10
8866373|NCT01848158|9922463|FG001|STARTED|Overall Study||7
8866374|NCT01848158|9922462|FG000|COMPLETED|Overall Study||10
8866375|NCT01848158|9922463|FG001|COMPLETED|Overall Study||7
8866376|NCT01848158|9922462|FG000|NOT COMPLETED|Overall Study||0
8866377|NCT01848158|9922463|FG001|NOT COMPLETED|Overall Study||0
8866378|NCT01848184|9922469|FG000|STARTED|Overall Study||126
8866379|NCT01848184|9922469|FG000|COMPLETED|Overall Study||100
8866380|NCT01848184|9922469|FG000|NOT COMPLETED|Overall Study||26
8866381|NCT01848210|9922481|FG000|STARTED|Overall Study||411
8866382|NCT01848210|9922482|FG001|STARTED|Overall Study||418
8866383|NCT01848210|9922481|FG000|Safety Population-Received Study Drug|Overall Study||394
8866384|NCT01848210|9922482|FG001|Safety Population-Received Study Drug|Overall Study||398
8866385|NCT01848210|9922481|FG000|Intent-to-Treat (ITT) Population|Overall Study||383
8866386|NCT01848210|9922482|FG001|Intent-to-Treat (ITT) Population|Overall Study||388
8951443|NCT02453711|10014313|FG006|COMPLETED|Overall Study||100
8951444|NCT02453711|10014314|FG007|COMPLETED|Overall Study||96
8951445|NCT02453711|10014315|FG008|COMPLETED|Overall Study||123
8951446|NCT02453711|10014307|FG000|NOT COMPLETED|Overall Study||11
8951447|NCT02453711|10014308|FG001|NOT COMPLETED|Overall Study||7
8951448|NCT02453711|10014309|FG002|NOT COMPLETED|Overall Study||9
8951449|NCT02453711|10014310|FG003|NOT COMPLETED|Overall Study||7
8951450|NCT02453711|10014311|FG004|NOT COMPLETED|Overall Study||2
8951451|NCT02453711|10014312|FG005|NOT COMPLETED|Overall Study||6
8951452|NCT02453711|10014313|FG006|NOT COMPLETED|Overall Study||3
8951453|NCT02453711|10014314|FG007|NOT COMPLETED|Overall Study||7
8951454|NCT02453711|10014315|FG008|NOT COMPLETED|Overall Study||13
8951455|NCT02453750|10014335|FG000|STARTED|Overall Study||21
8951456|NCT02453750|10014335|FG000|COMPLETED|Overall Study||21
8951457|NCT02453750|10014335|FG000|NOT COMPLETED|Overall Study||0
8951458|NCT02453841|10014342|FG000|STARTED|Overall Study||30
8951459|NCT02453841|10014342|FG000|COMPLETED|Overall Study||27
8951460|NCT02453841|10014342|FG000|NOT COMPLETED|Overall Study||3
8951461|NCT02454075|10014346|FG000|STARTED|Overall Study||3
8951462|NCT02454075|10014346|FG000|COMPLETED|Overall Study||3
8951463|NCT02454075|10014346|FG000|NOT COMPLETED|Overall Study||0
8951464|NCT02454101|10014354|FG000|STARTED|Overall Study||150
8951465|NCT02454101|10014355|FG001|STARTED|Overall Study||150
8951466|NCT02454101|10014354|FG000|COMPLETED|Overall Study||145
8951467|NCT02454101|10014355|FG001|COMPLETED|Overall Study||143
8951468|NCT02454101|10014354|FG000|NOT COMPLETED|Overall Study||5
8951469|NCT02454101|10014355|FG001|NOT COMPLETED|Overall Study||7
8951470|NCT02454127|10014365|FG000|STARTED|Overall Study||40
8951471|NCT02454127|10014366|FG001|STARTED|Overall Study||40
8951472|NCT02454127|10014367|FG002|STARTED|Overall Study||40
8951473|NCT02454127|10014368|FG003|STARTED|Overall Study||40
8951474|NCT02454127|10014365|FG000|COMPLETED|Overall Study||21
8951475|NCT02454127|10014366|FG001|COMPLETED|Overall Study||26
8951476|NCT02454127|10014367|FG002|COMPLETED|Overall Study||26
8951477|NCT02454127|10014368|FG003|COMPLETED|Overall Study||20
8951478|NCT02454127|10014365|FG000|NOT COMPLETED|Overall Study||19
8951479|NCT02454127|10014366|FG001|NOT COMPLETED|Overall Study||14
8951480|NCT02454127|10014367|FG002|NOT COMPLETED|Overall Study||14
8951481|NCT02454127|10014368|FG003|NOT COMPLETED|Overall Study||20
8951482|NCT02454153|10014380|FG000|STARTED|Overall Study||92
8951483|NCT02454153|10014381|FG001|STARTED|Overall Study||92
8951484|NCT02454153|10014380|FG000|COMPLETED|Overall Study||92
8951485|NCT02454153|10014381|FG001|COMPLETED|Overall Study||92
8951486|NCT02454153|10014380|FG000|NOT COMPLETED|Overall Study||0
8951487|NCT02454153|10014381|FG001|NOT COMPLETED|Overall Study||0
8951488|NCT02454179|10014390|FG000|STARTED|Overall Study||39
8951489|NCT02454179|10014391|FG001|STARTED|Overall Study||39
8951490|NCT02454179|10014390|FG000|Enrolled|Overall Study||39
8951491|NCT02454179|10014391|FG001|Enrolled|Overall Study||39
8951492|NCT02454179|10014390|FG000|Received Study Medication|Overall Study||39
8951493|NCT02454179|10014391|FG001|Received Study Medication|Overall Study||37
8951494|NCT02454179|10014390|FG000|Discontinue Study|Overall Study||39
8951495|NCT02454179|10014391|FG001|Discontinue Study|Overall Study||39
8951496|NCT02454179|10014390|FG000|COMPLETED|Overall Study||0
8951497|NCT02454179|10014391|FG001|COMPLETED|Overall Study||0
8951498|NCT02454179|10014390|FG000|NOT COMPLETED|Overall Study||39
8951499|NCT02454179|10014391|FG001|NOT COMPLETED|Overall Study||39
8951500|NCT02454283|10014399|FG000|STARTED|Overall Study||26
8951501|NCT02454283|10014400|FG001|STARTED|Overall Study||15
8866387|NCT01848210|9922481|FG000|Per Protocol Population|Overall Study||222
8866388|NCT01848210|9922482|FG001|Per Protocol Population|Overall Study||245
8866389|NCT01848210|9922481|FG000|COMPLETED|Overall Study||323
8866390|NCT01848210|9922482|FG001|COMPLETED|Overall Study||340
8866391|NCT01848210|9922481|FG000|NOT COMPLETED|Overall Study||88
8866392|NCT01848210|9922482|FG001|NOT COMPLETED|Overall Study||78
8866393|NCT01848288|9922488|FG000|STARTED|Overall Study||100
8866394|NCT01848288|9922488|FG000|COMPLETED|Overall Study|Two subjects were discontinued prior to undergoing surgery.|97
8866395|NCT01848288|9922488|FG000|NOT COMPLETED|Overall Study||3
8866396|NCT01848353|9922497|FG000|STARTED|Phase 1||38
8866397|NCT01848353|9922498|FG001|STARTED|Phase 1||43
8866398|NCT01848353|9922499|FG002|STARTED|Phase 1||20
8866399|NCT01848353|9922500|FG003|STARTED|Phase 1||19
8866400|NCT01848353|9922497|FG000|COMPLETED|Phase 1||35
8866401|NCT01848353|9922498|FG001|COMPLETED|Phase 1||42
8866402|NCT01848353|9922499|FG002|COMPLETED|Phase 1||20
8866403|NCT01848353|9922500|FG003|COMPLETED|Phase 1||19
8866404|NCT01848353|9922497|FG000|NOT COMPLETED|Phase 1||3
8866405|NCT01848353|9922498|FG001|NOT COMPLETED|Phase 1||1
8866406|NCT01848353|9922499|FG002|NOT COMPLETED|Phase 1||0
8866407|NCT01848353|9922500|FG003|NOT COMPLETED|Phase 1||0
8866408|NCT01848353|9922497|FG000|STARTED|Phase 2|26 participants from Phase 1 intervention (both groups) withdrew and did not complete Phase 2|23
8866409|NCT01848353|9922498|FG001|STARTED|Phase 2|26 participants from Phase 1 intervention (both groups) withdrew and did not complete Phase 2|28
8866410|NCT01848353|9922499|FG002|STARTED|Phase 2|Normal weight participants only completed baseline testing in Phase 1.|0
8866411|NCT01848353|9922500|FG003|STARTED|Phase 2|Normal weight participants only completed baseline testing in Phase 1.|0
8866412|NCT01848353|9922497|FG000|COMPLETED|Phase 2||20
8866413|NCT01848353|9922498|FG001|COMPLETED|Phase 2||26
8866414|NCT01848353|9922499|FG002|COMPLETED|Phase 2||0
8866415|NCT01848353|9922500|FG003|COMPLETED|Phase 2||0
8866416|NCT01848353|9922497|FG000|NOT COMPLETED|Phase 2||3
8866417|NCT01848353|9922498|FG001|NOT COMPLETED|Phase 2||2
8866418|NCT01848353|9922499|FG002|NOT COMPLETED|Phase 2||0
8866419|NCT01848353|9922500|FG003|NOT COMPLETED|Phase 2||0
8866420|NCT01848353|9922497|FG000|STARTED|Phase 3|31 participants from Phase 2 intervention (both groups) withdrew and did not complete Phase 3|5
8866421|NCT01848353|9922498|FG001|STARTED|Phase 3|31 participants from Phase 2 intervention (both groups) withdrew and did not complete Phase 3|10
8866422|NCT01848353|9922499|FG002|STARTED|Phase 3|Normal weight participants only completed baseline testing in Phase 1.|0
8866423|NCT01848353|9922500|FG003|STARTED|Phase 3|Normal weight participants only completed baseline testing in Phase 1.|0
8866424|NCT01848353|9922497|FG000|COMPLETED|Phase 3||4
8866425|NCT01848353|9922498|FG001|COMPLETED|Phase 3||9
8866426|NCT01848353|9922499|FG002|COMPLETED|Phase 3||0
8866427|NCT01848353|9922500|FG003|COMPLETED|Phase 3||0
8866428|NCT01848353|9922497|FG000|NOT COMPLETED|Phase 3||1
8866429|NCT01848353|9922498|FG001|NOT COMPLETED|Phase 3||1
8866430|NCT01848353|9922499|FG002|NOT COMPLETED|Phase 3||0
8866431|NCT01848353|9922500|FG003|NOT COMPLETED|Phase 3||0
8866432|NCT01848366|9922518|FG000|STARTED|Overall Study||8
8866433|NCT01848366|9922518|FG000|COMPLETED|Overall Study||8
8866434|NCT01848366|9922518|FG000|NOT COMPLETED|Overall Study||0
8866435|NCT01848457|9922526|FG000|STARTED|Overall Study||4
8866436|NCT01848457|9922527|FG001|STARTED|Overall Study||3
8866437|NCT01848457|9922528|FG002|STARTED|Overall Study||3
8866438|NCT01848457|9922529|FG003|STARTED|Overall Study||3
8866439|NCT01848457|9922526|FG000|Baseline|Overall Study||4
8866440|NCT01848457|9922527|FG001|Baseline|Overall Study||3
8866441|NCT01848457|9922528|FG002|Baseline|Overall Study||3
8866442|NCT01848457|9922529|FG003|Baseline|Overall Study||3
8866443|NCT01848457|9922526|FG000|Cycle 1|Overall Study||4
8866444|NCT01848457|9922527|FG001|Cycle 1|Overall Study||3
8866445|NCT01848457|9922528|FG002|Cycle 1|Overall Study||3
8866446|NCT01848457|9922529|FG003|Cycle 1|Overall Study||3
8866447|NCT01848457|9922526|FG000|Cycle 2|Overall Study||3
8866448|NCT01848457|9922527|FG001|Cycle 2|Overall Study||3
8866449|NCT01848457|9922528|FG002|Cycle 2|Overall Study||3
8866450|NCT01848457|9922529|FG003|Cycle 2|Overall Study||3
8866451|NCT01848457|9922526|FG000|Cycle 3|Overall Study||3
8866452|NCT01848457|9922527|FG001|Cycle 3|Overall Study||3
8866453|NCT01848457|9922528|FG002|Cycle 3|Overall Study||3
8866454|NCT01848457|9922529|FG003|Cycle 3|Overall Study||3
8866455|NCT01848457|9922526|FG000|Cycle 4|Overall Study||3
8866456|NCT01848457|9922527|FG001|Cycle 4|Overall Study||3
8866457|NCT01848457|9922528|FG002|Cycle 4|Overall Study||3
8866458|NCT01848457|9922529|FG003|Cycle 4|Overall Study||3
8866459|NCT01848457|9922526|FG000|COMPLETED|Overall Study||3
8866460|NCT01848457|9922527|FG001|COMPLETED|Overall Study||3
8866461|NCT01848457|9922528|FG002|COMPLETED|Overall Study||3
8866462|NCT01848457|9922529|FG003|COMPLETED|Overall Study||3
8951502|NCT02454283|10014399|FG000|COMPLETED|Overall Study||26
8866463|NCT01848457|9922526|FG000|NOT COMPLETED|Overall Study||1
8866464|NCT01848457|9922527|FG001|NOT COMPLETED|Overall Study||0
8866465|NCT01848457|9922528|FG002|NOT COMPLETED|Overall Study||0
8866466|NCT01848457|9922529|FG003|NOT COMPLETED|Overall Study||0
8866467|NCT01848483|9922549|FG000|STARTED|Overall Study||61
8866468|NCT01848483|9922550|FG001|STARTED|Overall Study||60
8866469|NCT01848483|9922549|FG000|COMPLETED|Overall Study||50
8866470|NCT01848483|9922550|FG001|COMPLETED|Overall Study||49
8866471|NCT01848483|9922549|FG000|NOT COMPLETED|Overall Study||11
8866472|NCT01848483|9922550|FG001|NOT COMPLETED|Overall Study||11
8866473|NCT01848756|9922557|FG000|STARTED|Overall Study||15
8951503|NCT02454283|10014400|FG001|COMPLETED|Overall Study||15
8866474|NCT01848756|9922557|FG000|COMPLETED|Overall Study|Cycle 1|12
8866475|NCT01848756|9922557|FG000|NOT COMPLETED|Overall Study||3
8866476|NCT01848821|9922564|FG000|STARTED|Overall Study||7
8866477|NCT01848821|9922565|FG001|STARTED|Overall Study||7
8866478|NCT01848821|9922564|FG000|COMPLETED|Overall Study||7
8866479|NCT01848821|9922565|FG001|COMPLETED|Overall Study||7
8866480|NCT01848821|9922564|FG000|NOT COMPLETED|Overall Study||0
8866481|NCT01848821|9922565|FG001|NOT COMPLETED|Overall Study||0
8866482|NCT01848834|9922576|FG000|STARTED|Overall Study||32
8866483|NCT01848834|9922577|FG001|STARTED|Overall Study||61
8866484|NCT01848834|9922578|FG002|STARTED|Overall Study||33
8866485|NCT01848834|9922579|FG003|STARTED|Overall Study||39
8866486|NCT01848834|9922580|FG004|STARTED|Overall Study||132
8866487|NCT01848834|9922576|FG000|Treated|Overall Study||32
8866488|NCT01848834|9922577|FG001|Treated|Overall Study||60
8866489|NCT01848834|9922578|FG002|Treated|Overall Study||33
8866490|NCT01848834|9922579|FG003|Treated|Overall Study||39
8866491|NCT01848834|9922580|FG004|Treated|Overall Study||132
8866492|NCT01848834|9922576|FG000|COMPLETED|Overall Study|Completed means two-year treatment completed|13
8866493|NCT01848834|9922577|FG001|COMPLETED|Overall Study|Completed means two-year treatment completed|13
8866494|NCT01848834|9922578|FG002|COMPLETED|Overall Study|Completed means two-year treatment completed|9
8866495|NCT01848834|9922579|FG003|COMPLETED|Overall Study|Completed means two-year treatment completed|13
8866496|NCT01848834|9922580|FG004|COMPLETED|Overall Study|Completed means two-year treatment completed|38
8866497|NCT01848834|9922576|FG000|NOT COMPLETED|Overall Study||19
8866498|NCT01848834|9922577|FG001|NOT COMPLETED|Overall Study||48
8866499|NCT01848834|9922578|FG002|NOT COMPLETED|Overall Study||24
8866500|NCT01848834|9922579|FG003|NOT COMPLETED|Overall Study||26
8866501|NCT01848834|9922580|FG004|NOT COMPLETED|Overall Study||94
8866502|NCT01848847|9922598|FG000|STARTED|Overall Study||51
8866503|NCT01848847|9922599|FG001|STARTED|Overall Study||51
8866504|NCT01848847|9922598|FG000|COMPLETED|Overall Study||49
8866505|NCT01848847|9922599|FG001|COMPLETED|Overall Study||48
8866506|NCT01848847|9922598|FG000|NOT COMPLETED|Overall Study||2
8866507|NCT01848847|9922599|FG001|NOT COMPLETED|Overall Study||3
8866508|NCT01848899|9922607|FG000|STARTED|Overall Study||50
8630608|NCT00535743|9670394|FG020|COMPLETED|Overall Study||5
8630609|NCT00535743|9670395|FG021|COMPLETED|Overall Study||4
8630610|NCT00535743|9670396|FG022|COMPLETED|Overall Study||6
8630611|NCT00535743|9670397|FG023|COMPLETED|Overall Study||5
8630612|NCT00535743|9670374|FG000|NOT COMPLETED|Overall Study||0
8630613|NCT00535743|9670375|FG001|NOT COMPLETED|Overall Study||0
8866509|NCT01848899|9922608|FG001|STARTED|Overall Study||50
8866510|NCT01848899|9922607|FG000|COMPLETED|Overall Study||50
8866511|NCT01848899|9922608|FG001|COMPLETED|Overall Study||50
8866512|NCT01848899|9922607|FG000|NOT COMPLETED|Overall Study||0
8866513|NCT01848899|9922608|FG001|NOT COMPLETED|Overall Study||0
8866514|NCT01848938|9922616|FG000|STARTED|Overall Study||62
8951504|NCT02454283|10014399|FG000|NOT COMPLETED|Overall Study||0
8951505|NCT02454283|10014400|FG001|NOT COMPLETED|Overall Study||0
8951506|NCT02454296|10014408|FG000|STARTED|Overall Study||20
8951507|NCT02454296|10014409|FG001|STARTED|Overall Study||21
8951508|NCT02454296|10014408|FG000|COMPLETED|Overall Study||20
8951509|NCT02454296|10014409|FG001|COMPLETED|Overall Study||21
8951510|NCT02454296|10014408|FG000|NOT COMPLETED|Overall Study||0
8951511|NCT02454296|10014409|FG001|NOT COMPLETED|Overall Study||0
8951512|NCT02454478|10014417|FG000|STARTED|Overall Study||7
8951513|NCT02454478|10014417|FG000|COMPLETED|Overall Study||6
8951514|NCT02454478|10014417|FG000|NOT COMPLETED|Overall Study||1
8951515|NCT02454530|10014423|FG000|STARTED|Overall Study||552
8951516|NCT02454530|10014424|FG001|STARTED|Overall Study||608
8951517|NCT02454530|10014423|FG000|COMPLETED|Overall Study||482
8951518|NCT02454530|10014424|FG001|COMPLETED|Overall Study||481
8951519|NCT02454530|10014423|FG000|NOT COMPLETED|Overall Study||70
8951520|NCT02454530|10014424|FG001|NOT COMPLETED|Overall Study||127
8951521|NCT02454608|10014434|FG000|STARTED|Double-Blind Period||15
8951522|NCT02454608|10014435|FG001|STARTED|Double-Blind Period||14
8951523|NCT02454608|10014436|FG002|STARTED|Double-Blind Period|This arm is not part of this period of the study|0
8951524|NCT02454608|10014434|FG000|COMPLETED|Double-Blind Period||15
8951525|NCT02454608|10014435|FG001|COMPLETED|Double-Blind Period||12
8951526|NCT02454608|10014436|FG002|COMPLETED|Double-Blind Period|This arm is not part of this period of the study|0
8630614|NCT00535743|9670376|FG002|NOT COMPLETED|Overall Study||0
8630615|NCT00535743|9670377|FG003|NOT COMPLETED|Overall Study||0
8630616|NCT00535743|9670378|FG004|NOT COMPLETED|Overall Study||0
8630617|NCT00535743|9670379|FG005|NOT COMPLETED|Overall Study||0
8630618|NCT00535743|9670380|FG006|NOT COMPLETED|Overall Study||0
8630619|NCT00535743|9670381|FG007|NOT COMPLETED|Overall Study||0
8630620|NCT00535743|9670382|FG008|NOT COMPLETED|Overall Study||1
8951527|NCT02454608|10014434|FG000|NOT COMPLETED|Double-Blind Period||0
8951528|NCT02454608|10014435|FG001|NOT COMPLETED|Double-Blind Period||2
8951529|NCT02454608|10014436|FG002|NOT COMPLETED|Double-Blind Period||0
8951530|NCT02454608|10014434|FG000|STARTED|Open Label Period|This arm is not part of this period of the study|0
8630621|NCT00535743|9670383|FG009|NOT COMPLETED|Overall Study||1
8630622|NCT00535743|9670384|FG010|NOT COMPLETED|Overall Study||0
8866515|NCT01848938|9922617|FG001|STARTED|Overall Study||61
8866516|NCT01848938|9922616|FG000|COMPLETED|Overall Study||61
8866517|NCT01848938|9922617|FG001|COMPLETED|Overall Study||60
8951531|NCT02454608|10014435|FG001|STARTED|Open Label Period|This arm is not part of this period of the study|0
8630623|NCT00535743|9670385|FG011|NOT COMPLETED|Overall Study||0
8630624|NCT00535743|9670386|FG012|NOT COMPLETED|Overall Study||0
8630625|NCT00535743|9670387|FG013|NOT COMPLETED|Overall Study||0
8630626|NCT00535743|9670388|FG014|NOT COMPLETED|Overall Study||0
8630627|NCT00535743|9670389|FG015|NOT COMPLETED|Overall Study||0
8630628|NCT00535743|9670390|FG016|NOT COMPLETED|Overall Study||0
8630629|NCT00535743|9670391|FG017|NOT COMPLETED|Overall Study||0
8630630|NCT00535743|9670392|FG018|NOT COMPLETED|Overall Study||0
8630631|NCT00535743|9670393|FG019|NOT COMPLETED|Overall Study||0
8630632|NCT00535743|9670394|FG020|NOT COMPLETED|Overall Study||0
8630633|NCT00535743|9670395|FG021|NOT COMPLETED|Overall Study||1
8866518|NCT01848938|9922616|FG000|NOT COMPLETED|Overall Study||1
8866519|NCT01848938|9922617|FG001|NOT COMPLETED|Overall Study||1
8866520|NCT01848977|9922623|FG000|STARTED|Overall Study||20
8866521|NCT01848977|9922623|FG000|COMPLETED|Overall Study||20
8866522|NCT01848977|9922623|FG000|NOT COMPLETED|Overall Study||0
8866523|NCT01848990|9922635|FG000|STARTED|Overall Study||227
8866524|NCT01848990|9922636|FG001|STARTED|Overall Study||115
8866525|NCT01848990|9922637|FG002|STARTED|Overall Study|One participant was randomized and withdrew consent before start of study treatment.|114
8866526|NCT01848990|9922635|FG000|Received at Least 1 Dose of Study Drug|Overall Study||227
8866527|NCT01848990|9922636|FG001|Received at Least 1 Dose of Study Drug|Overall Study||115
8866528|NCT01848990|9922637|FG002|Received at Least 1 Dose of Study Drug|Overall Study||113
8866529|NCT01848990|9922635|FG000|Completed Month 6|Overall Study||194
8866530|NCT01848990|9922636|FG001|Completed Month 6|Overall Study||106
8866531|NCT01848990|9922637|FG002|Completed Month 6|Overall Study||103
8866532|NCT01848990|9922635|FG000|COMPLETED|Overall Study||181
8866533|NCT01848990|9922636|FG001|COMPLETED|Overall Study||95
8866534|NCT01848990|9922637|FG002|COMPLETED|Overall Study||98
8866535|NCT01848990|9922635|FG000|NOT COMPLETED|Overall Study||46
8866536|NCT01848990|9922636|FG001|NOT COMPLETED|Overall Study||20
8866537|NCT01848990|9922637|FG002|NOT COMPLETED|Overall Study||16
8866538|NCT01849055|9922655|FG000|STARTED|Overall Study||8
8866539|NCT01849055|9922656|FG001|STARTED|Overall Study||8
8866540|NCT01849055|9922657|FG002|STARTED|Overall Study||8
8866541|NCT01849055|9922658|FG003|STARTED|Overall Study||8
8866542|NCT01849055|9922659|FG004|STARTED|Overall Study||8
8866543|NCT01849055|9922660|FG005|STARTED|Overall Study||8
8866544|NCT01849055|9922655|FG000|COMPLETED|Overall Study||8
8866545|NCT01849055|9922656|FG001|COMPLETED|Overall Study||8
8866546|NCT01849055|9922657|FG002|COMPLETED|Overall Study||7
8866547|NCT01849055|9922658|FG003|COMPLETED|Overall Study||8
8866548|NCT01849055|9922659|FG004|COMPLETED|Overall Study||8
8866549|NCT01849055|9922660|FG005|COMPLETED|Overall Study||8
8866550|NCT01849055|9922655|FG000|NOT COMPLETED|Overall Study||0
8866551|NCT01849055|9922656|FG001|NOT COMPLETED|Overall Study||0
8866552|NCT01849055|9922657|FG002|NOT COMPLETED|Overall Study||1
8866553|NCT01849055|9922658|FG003|NOT COMPLETED|Overall Study||0
8866554|NCT01849055|9922659|FG004|NOT COMPLETED|Overall Study||0
8866555|NCT01849055|9922660|FG005|NOT COMPLETED|Overall Study||0
8866556|NCT01849068|9922680|FG000|STARTED|Overall Study||10
8866557|NCT01849068|9922681|FG001|STARTED|Overall Study||10
8866558|NCT01849068|9922680|FG000|COMPLETED|Overall Study||10
8866559|NCT01849068|9922681|FG001|COMPLETED|Overall Study||10
8866560|NCT01849068|9922680|FG000|NOT COMPLETED|Overall Study||0
8866561|NCT01849068|9922681|FG001|NOT COMPLETED|Overall Study||0
8866562|NCT01849172|9922689|FG000|STARTED|Overall Study||180
8866563|NCT01849172|9922690|FG001|STARTED|Overall Study||180
8866564|NCT01849172|9922689|FG000|COMPLETED|Overall Study||173
8866565|NCT01849172|9922690|FG001|COMPLETED|Overall Study||174
8866566|NCT01849172|9922689|FG000|NOT COMPLETED|Overall Study||7
8866567|NCT01849172|9922690|FG001|NOT COMPLETED|Overall Study||6
8866568|NCT01849276|9922696|FG000|STARTED|Registered to the Study||2
8866569|NCT01849276|9922696|FG000|COMPLETED|Registered to the Study||2
8866570|NCT01849276|9922696|FG000|NOT COMPLETED|Registered to the Study||0
8866571|NCT01849276|9922696|FG000|STARTED|Completed Treatment||2
8866572|NCT01849276|9922696|FG000|COMPLETED|Completed Treatment||2
8866573|NCT01849276|9922696|FG000|NOT COMPLETED|Completed Treatment||0
8866574|NCT01849276|9922696|FG000|STARTED|Followed for Survival for 5 Years||2
8866575|NCT01849276|9922696|FG000|COMPLETED|Followed for Survival for 5 Years||0
8866576|NCT01849276|9922696|FG000|NOT COMPLETED|Followed for Survival for 5 Years||2
8866577|NCT01849289|9922702|FG000|STARTED|Overall Study||555
8866578|NCT01849289|9922703|FG001|STARTED|Overall Study||278
8866579|NCT01849289|9922702|FG000|Exposed|Overall Study|2 subjects withdrew prior to exposure of trial products|553
8630634|NCT00535743|9670396|FG022|NOT COMPLETED|Overall Study||0
8630635|NCT00535743|9670397|FG023|NOT COMPLETED|Overall Study||0
8866580|NCT01849289|9922703|FG001|Exposed|Overall Study||278
8866581|NCT01849289|9922702|FG000|COMPLETED|Overall Study||523
8866582|NCT01849289|9922703|FG001|COMPLETED|Overall Study||254
8866583|NCT01849289|9922702|FG000|NOT COMPLETED|Overall Study||32
8866584|NCT01849289|9922703|FG001|NOT COMPLETED|Overall Study||24
8866585|NCT01849419|9922709|FG000|STARTED|Overall Study||65
8866586|NCT01849419|9922709|FG000|COMPLETED|Overall Study||65
8866587|NCT01849419|9922709|FG000|NOT COMPLETED|Overall Study||0
8866588|NCT01849458|9922714|FG000|STARTED|Overall Study||50
8866589|NCT01849458|9922714|FG000|6 Months Follow-up|Overall Study||50
8630636|NCT00535769|9670449|FG000|STARTED|Overall Study||35
8866590|NCT01849458|9922714|FG000|COMPLETED|Overall Study||46
8866591|NCT01849458|9922714|FG000|NOT COMPLETED|Overall Study||4
8866592|NCT01849497|9922720|FG000|STARTED|Overall Study||75
8866593|NCT01849497|9922721|FG001|STARTED|Overall Study||74
8866594|NCT01849497|9922720|FG000|Received Treatment|Overall Study||75
8866595|NCT01849497|9922721|FG001|Received Treatment|Overall Study||74
8866596|NCT01849497|9922720|FG000|COMPLETED|Overall Study||74
8866597|NCT01849497|9922721|FG001|COMPLETED|Overall Study||70
8866598|NCT01849497|9922720|FG000|NOT COMPLETED|Overall Study||1
8866599|NCT01849497|9922721|FG001|NOT COMPLETED|Overall Study||4
8866600|NCT01849562|9922730|FG000|STARTED|Overall Study||10
8866601|NCT01849562|9922731|FG001|STARTED|Overall Study||10
8866602|NCT01849562|9922732|FG002|STARTED|Overall Study||10
8866603|NCT01849562|9922730|FG000|COMPLETED|Overall Study||8
8866604|NCT01849562|9922731|FG001|COMPLETED|Overall Study||10
8866605|NCT01849562|9922732|FG002|COMPLETED|Overall Study||10
8569796|NCT00098722|9601917|FG006|NOT COMPLETED|Observation Phase||17
8569797|NCT00098748|9601932|FG000|STARTED|Assigned to Study Treatment||63
8569798|NCT00098748|9601933|FG001|STARTED|Assigned to Study Treatment||63
8866606|NCT01849562|9922730|FG000|NOT COMPLETED|Overall Study||2
8866607|NCT01849562|9922731|FG001|NOT COMPLETED|Overall Study||0
8866608|NCT01849562|9922732|FG002|NOT COMPLETED|Overall Study||0
8866609|NCT01849575|9922743|FG000|STARTED|Overall Study||1749
8866610|NCT01849575|9922744|FG001|STARTED|Overall Study||1783
8866611|NCT01849575|9922743|FG000|COMPLETED|Overall Study||1599
8866612|NCT01849575|9922744|FG001|COMPLETED|Overall Study||1576
8866613|NCT01849575|9922743|FG000|NOT COMPLETED|Overall Study||150
8866614|NCT01849575|9922744|FG001|NOT COMPLETED|Overall Study||207
8866615|NCT01849588|9922752|FG000|STARTED|Overall Study||3
8866616|NCT01849588|9922752|FG000|COMPLETED|Overall Study||0
8866617|NCT01849588|9922752|FG000|NOT COMPLETED|Overall Study||3
8866618|NCT01849692|9922758|FG000|STARTED|Overall Study||10
8866619|NCT01849692|9922759|FG001|STARTED|Overall Study||3
8866620|NCT01849692|9922760|FG002|STARTED|Overall Study||10
8866621|NCT01849692|9922761|FG003|STARTED|Overall Study||3
8866622|NCT01849692|9922762|FG004|STARTED|Overall Study||10
8866623|NCT01849692|9922763|FG005|STARTED|Overall Study||3
8866624|NCT01849692|9922764|FG006|STARTED|Overall Study||10
8951532|NCT02454608|10014436|FG002|STARTED|Open Label Period||29
8951533|NCT02454608|10014434|FG000|COMPLETED|Open Label Period|This arm is not part of this period of the study|0
8951534|NCT02454608|10014435|FG001|COMPLETED|Open Label Period|This arm is not part of this period of the study|0
8951535|NCT02454608|10014436|FG002|COMPLETED|Open Label Period||10
8951536|NCT02454608|10014434|FG000|NOT COMPLETED|Open Label Period||0
8951537|NCT02454608|10014435|FG001|NOT COMPLETED|Open Label Period||0
8951538|NCT02454608|10014436|FG002|NOT COMPLETED|Open Label Period||19
8951539|NCT02454959|10014444|FG000|STARTED|Overall Study||79
8951540|NCT02454959|10014444|FG000|GFF MDI (PT003) With Aerochamber|Overall Study||73
8951541|NCT02454959|10014444|FG000|GFF MDI (PT003) Without Aerochamber|Overall Study||77
8951542|NCT02454959|10014444|FG000|COMPLETED|Overall Study||70
8951543|NCT02454959|10014444|FG000|NOT COMPLETED|Overall Study||9
8951544|NCT02454972|10014459|FG000|STARTED|Overall Study||19
8951545|NCT02454972|10014460|FG001|STARTED|Overall Study||19
8951546|NCT02454972|10014461|FG002|STARTED|Overall Study||76
8951547|NCT02454972|10014462|FG003|STARTED|Overall Study||29
8951548|NCT02454972|10014463|FG004|STARTED|Overall Study||24
8951549|NCT02454972|10014464|FG005|STARTED|Overall Study||15
8951550|NCT02454972|10014465|FG006|STARTED|Overall Study||21
8951551|NCT02454972|10014466|FG007|STARTED|Overall Study||32
8951552|NCT02454972|10014467|FG008|STARTED|Overall Study||110
8951553|NCT02454972|10014459|FG000|Treated|Overall Study||19
8951554|NCT02454972|10014460|FG001|Treated|Overall Study||19
8951555|NCT02454972|10014461|FG002|Treated|Overall Study||73
8951556|NCT02454972|10014462|FG003|Treated|Overall Study||28
8951557|NCT02454972|10014463|FG004|Treated|Overall Study||23
8951558|NCT02454972|10014464|FG005|Treated|Overall Study||15
8951559|NCT02454972|10014465|FG006|Treated|Overall Study||21
8951560|NCT02454972|10014466|FG007|Treated|Overall Study||32
8951561|NCT02454972|10014467|FG008|Treated|Overall Study||105
8951562|NCT02454972|10014459|FG000|COMPLETED|Overall Study||0
8951563|NCT02454972|10014460|FG001|COMPLETED|Overall Study||0
8951564|NCT02454972|10014461|FG002|COMPLETED|Overall Study||0
8951565|NCT02454972|10014462|FG003|COMPLETED|Overall Study||0
8951566|NCT02454972|10014463|FG004|COMPLETED|Overall Study||0
8951567|NCT02454972|10014464|FG005|COMPLETED|Overall Study||0
8951568|NCT02454972|10014465|FG006|COMPLETED|Overall Study||0
8951569|NCT02454972|10014466|FG007|COMPLETED|Overall Study||0
8951570|NCT02454972|10014467|FG008|COMPLETED|Overall Study||0
8951571|NCT02454972|10014459|FG000|NOT COMPLETED|Overall Study||19
8569799|NCT00098748|9601934|FG002|STARTED|Assigned to Study Treatment||64
8569800|NCT00098748|9601932|FG000|COMPLETED|Assigned to Study Treatment||63
8569801|NCT00098748|9601933|FG001|COMPLETED|Assigned to Study Treatment||61
8569802|NCT00098748|9601934|FG002|COMPLETED|Assigned to Study Treatment||62
8569803|NCT00098748|9601932|FG000|NOT COMPLETED|Assigned to Study Treatment||0
8569804|NCT00098748|9601933|FG001|NOT COMPLETED|Assigned to Study Treatment||2
8569805|NCT00098748|9601934|FG002|NOT COMPLETED|Assigned to Study Treatment||2
8569806|NCT00098748|9601932|FG000|STARTED|Received Study Treatment||63
8569807|NCT00098748|9601933|FG001|STARTED|Received Study Treatment|Due to 1 placebo subject switched to maraviroc BID, BID = 62 subjects in Adverse event tables.|61
8569808|NCT00098748|9601934|FG002|STARTED|Received Study Treatment|Due to 1 placebo subject switched to maraviroc BID, Placebo = 61 subjects in Adverse event tables.|62
8577533|NCT00159263|9610312|FG002|STARTED|Washout||2
8866625|NCT01849692|9922765|FG007|STARTED|Overall Study||3
8866626|NCT01849692|9922758|FG000|COMPLETED|Overall Study||10
8866627|NCT01849692|9922759|FG001|COMPLETED|Overall Study||3
8866628|NCT01849692|9922760|FG002|COMPLETED|Overall Study||10
8866629|NCT01849692|9922761|FG003|COMPLETED|Overall Study||3
8866630|NCT01849692|9922762|FG004|COMPLETED|Overall Study||10
8866631|NCT01849692|9922763|FG005|COMPLETED|Overall Study||3
8866632|NCT01849692|9922764|FG006|COMPLETED|Overall Study||10
8866633|NCT01849692|9922765|FG007|COMPLETED|Overall Study||3
8866634|NCT01849692|9922758|FG000|NOT COMPLETED|Overall Study||0
8866635|NCT01849692|9922759|FG001|NOT COMPLETED|Overall Study||0
8866636|NCT01849692|9922760|FG002|NOT COMPLETED|Overall Study||0
8866637|NCT01849692|9922761|FG003|NOT COMPLETED|Overall Study||0
8866638|NCT01849692|9922762|FG004|NOT COMPLETED|Overall Study||0
8866639|NCT01849692|9922763|FG005|NOT COMPLETED|Overall Study||0
8866640|NCT01849692|9922764|FG006|NOT COMPLETED|Overall Study||0
8866641|NCT01849692|9922765|FG007|NOT COMPLETED|Overall Study||0
8866642|NCT01849770|9922789|FG000|STARTED|Overall Study||20
8866643|NCT01849770|9922790|FG001|STARTED|Overall Study||19
8866644|NCT01849770|9922791|FG002|STARTED|Overall Study||20
8866645|NCT01849770|9922789|FG000|COMPLETED|Overall Study||20
8866646|NCT01849770|9922790|FG001|COMPLETED|Overall Study||15
8866647|NCT01849770|9922791|FG002|COMPLETED|Overall Study||19
8866648|NCT01849770|9922789|FG000|NOT COMPLETED|Overall Study||0
8866649|NCT01849770|9922790|FG001|NOT COMPLETED|Overall Study||4
8866650|NCT01849770|9922791|FG002|NOT COMPLETED|Overall Study||1
8866651|NCT01849822|9922801|FG000|STARTED|Overall Study||1
8866652|NCT01849822|9922801|FG000|COMPLETED|Overall Study||1
8866653|NCT01849822|9922801|FG000|NOT COMPLETED|Overall Study||0
8866654|NCT01849848|9922805|FG000|STARTED|Overall Study||17
8866655|NCT01849848|9922805|FG000|COMPLETED|Overall Study||13
8866656|NCT01849848|9922805|FG000|NOT COMPLETED|Overall Study||4
8866657|NCT01850030|9922811|FG000|STARTED|Overall Study||520
8866658|NCT01850030|9922812|FG001|STARTED|Overall Study||511
8866659|NCT01850030|9922811|FG000|COMPLETED|Overall Study||173
8866660|NCT01850030|9922812|FG001|COMPLETED|Overall Study||142
8866661|NCT01850030|9922811|FG000|NOT COMPLETED|Overall Study||347
8866662|NCT01850030|9922812|FG001|NOT COMPLETED|Overall Study||369
8866663|NCT01850394|9922821|FG000|STARTED|Overall Study||45
8866664|NCT01850394|9922822|FG001|STARTED|Overall Study||45
8866665|NCT01850394|9922823|FG002|STARTED|Overall Study||45
8866666|NCT01850394|9922821|FG000|COMPLETED|Overall Study||45
8866667|NCT01850394|9922822|FG001|COMPLETED|Overall Study||45
8866668|NCT01850394|9922823|FG002|COMPLETED|Overall Study||45
8866669|NCT01850394|9922821|FG000|NOT COMPLETED|Overall Study||0
8866670|NCT01850394|9922822|FG001|NOT COMPLETED|Overall Study||0
8866671|NCT01850394|9922823|FG002|NOT COMPLETED|Overall Study||0
8866672|NCT01850446|9922833|FG000|STARTED|Overall Study||92
8866673|NCT01850446|9922834|FG001|STARTED|Overall Study||92
8866674|NCT01850446|9922833|FG000|COMPLETED|Overall Study||87
8866675|NCT01850446|9922834|FG001|COMPLETED|Overall Study||90
8866676|NCT01850446|9922833|FG000|NOT COMPLETED|Overall Study||5
8866677|NCT01850446|9922834|FG001|NOT COMPLETED|Overall Study||2
8866678|NCT01850485|9922842|FG000|STARTED|Overall Study||9
8866679|NCT01850485|9922843|FG001|STARTED|Overall Study||13
8866680|NCT01850485|9922842|FG000|COMPLETED|Overall Study||9
8866681|NCT01850485|9922843|FG001|COMPLETED|Overall Study||13
8866682|NCT01850485|9922842|FG000|NOT COMPLETED|Overall Study||0
8866683|NCT01850485|9922843|FG001|NOT COMPLETED|Overall Study||0
8866684|NCT01850550|9922851|FG000|STARTED|Overall Study||40
8866685|NCT01850550|9922852|FG001|STARTED|Overall Study||40
8951572|NCT02454972|10014460|FG001|NOT COMPLETED|Overall Study||19
8951573|NCT02454972|10014461|FG002|NOT COMPLETED|Overall Study||76
8951574|NCT02454972|10014462|FG003|NOT COMPLETED|Overall Study||29
8951575|NCT02454972|10014463|FG004|NOT COMPLETED|Overall Study||24
8951576|NCT02454972|10014464|FG005|NOT COMPLETED|Overall Study||15
8951577|NCT02454972|10014465|FG006|NOT COMPLETED|Overall Study||21
8951578|NCT02454972|10014466|FG007|NOT COMPLETED|Overall Study||32
8951579|NCT02454972|10014467|FG008|NOT COMPLETED|Overall Study||110
8951580|NCT02455050|10014483|FG000|STARTED|Treatment Period 1||20
8951581|NCT02455050|10014484|FG001|STARTED|Treatment Period 1||19
8951582|NCT02455050|10014485|FG002|STARTED|Treatment Period 1||20
8951583|NCT02455050|10014486|FG003|STARTED|Treatment Period 1||20
8951584|NCT02455050|10014483|FG000|COMPLETED|Treatment Period 1||19
8951585|NCT02455050|10014484|FG001|COMPLETED|Treatment Period 1||18
8951586|NCT02455050|10014485|FG002|COMPLETED|Treatment Period 1||19
8951587|NCT02455050|10014486|FG003|COMPLETED|Treatment Period 1||18
8951588|NCT02455050|10014483|FG000|NOT COMPLETED|Treatment Period 1||1
8866686|NCT01850550|9922851|FG000|COMPLETED|Overall Study||40
8866687|NCT01850550|9922852|FG001|COMPLETED|Overall Study||37
8951589|NCT02455050|10014484|FG001|NOT COMPLETED|Treatment Period 1||1
8866688|NCT01850550|9922851|FG000|NOT COMPLETED|Overall Study||0
8866689|NCT01850550|9922852|FG001|NOT COMPLETED|Overall Study||3
8866690|NCT01850589|9922860|FG000|STARTED|Overall Study||22
8866691|NCT01850589|9922861|FG001|STARTED|Overall Study||22
8866692|NCT01850589|9922860|FG000|COMPLETED|Overall Study||14
8866693|NCT01850589|9922861|FG001|COMPLETED|Overall Study||22
8866694|NCT01850589|9922860|FG000|NOT COMPLETED|Overall Study||8
8866695|NCT01850589|9922861|FG001|NOT COMPLETED|Overall Study||0
8866696|NCT01850602|9922869|FG000|STARTED|Overall Study||108
8866697|NCT01850602|9922870|FG001|STARTED|Overall Study||105
8866698|NCT01850602|9922869|FG000|COMPLETED|Overall Study||94
8866699|NCT01850602|9922870|FG001|COMPLETED|Overall Study||87
8866700|NCT01850602|9922869|FG000|NOT COMPLETED|Overall Study||14
8866701|NCT01850602|9922870|FG001|NOT COMPLETED|Overall Study||18
8866702|NCT01850615|9922878|FG000|STARTED|Overall Study||116
8866703|NCT01850615|9922879|FG001|STARTED|Overall Study||120
8866704|NCT01850615|9922878|FG000|Exposed|Overall Study||115
8866705|NCT01850615|9922879|FG001|Exposed|Overall Study||120
8866706|NCT01850615|9922878|FG000|COMPLETED|Overall Study||107
8866707|NCT01850615|9922879|FG001|COMPLETED|Overall Study||115
8866708|NCT01850615|9922878|FG000|NOT COMPLETED|Overall Study||9
8866709|NCT01850615|9922879|FG001|NOT COMPLETED|Overall Study||5
8866710|NCT01850641|9922885|FG000|STARTED|Overall Study||35
8866711|NCT01850641|9922885|FG000|COMPLETED|Overall Study||30
8866712|NCT01850641|9922885|FG000|NOT COMPLETED|Overall Study||5
8866713|NCT01850745|9922892|FG000|STARTED|Overall Study||147
8866714|NCT01850745|9922893|FG001|STARTED|Overall Study||169
8866715|NCT01850745|9922894|FG002|STARTED|Overall Study||131
8866716|NCT01850745|9922892|FG000|COMPLETED|Overall Study||147
8866717|NCT01850745|9922893|FG001|COMPLETED|Overall Study||169
8866718|NCT01850745|9922894|FG002|COMPLETED|Overall Study||131
8866719|NCT01850745|9922892|FG000|NOT COMPLETED|Overall Study||0
8866720|NCT01850745|9922893|FG001|NOT COMPLETED|Overall Study||0
8866721|NCT01850745|9922894|FG002|NOT COMPLETED|Overall Study||0
8866722|NCT01850823|9922905|FG000|STARTED|Overall Study||175
8866723|NCT01850823|9922906|FG001|STARTED|Overall Study||350
8866724|NCT01850823|9922907|FG002|STARTED|Overall Study||355
8866725|NCT01850823|9922905|FG000|COMPLETED|Overall Study||172
8866726|NCT01850823|9922906|FG001|COMPLETED|Overall Study||347
8866727|NCT01850823|9922907|FG002|COMPLETED|Overall Study||345
8866728|NCT01850823|9922905|FG000|NOT COMPLETED|Overall Study||3
8866729|NCT01850823|9922906|FG001|NOT COMPLETED|Overall Study||3
8866730|NCT01850823|9922907|FG002|NOT COMPLETED|Overall Study||10
8866731|NCT01851330|9922920|FG000|STARTED|Overall Study||215
8866732|NCT01851330|9922921|FG001|STARTED|Overall Study||216
8866733|NCT01851330|9922922|FG002|STARTED|Overall Study||216
8866734|NCT01851330|9922920|FG000|COMPLETED|Overall Study||202
8866735|NCT01851330|9922921|FG001|COMPLETED|Overall Study||200
8866736|NCT01851330|9922922|FG002|COMPLETED|Overall Study||204
8866737|NCT01851330|9922920|FG000|NOT COMPLETED|Overall Study||13
8866738|NCT01851330|9922921|FG001|NOT COMPLETED|Overall Study||16
8866739|NCT01851330|9922922|FG002|NOT COMPLETED|Overall Study||12
8866740|NCT01851590|9922933|FG000|STARTED|Overall Study|In addition to clinical control visits, patients were contacted by phone during weeks 6, 13, and 29.|23
8866741|NCT01851590|9922934|FG001|STARTED|Overall Study|In addition to clinical control visits, patients were contacted by phone during weeks 6, 13, and 29.|25
8866742|NCT01851590|9922935|FG002|STARTED|Overall Study|In addition to clinical control visits, patients were contacted by phone during weeks 6, 13, and 29.|25
8866743|NCT01851590|9922933|FG000|At 3 Month: End of Terbinafine Treatment|Overall Study|Topical Resin Lacquer treatment continues ->|23
8866744|NCT01851590|9922934|FG001|At 3 Month: End of Terbinafine Treatment|Overall Study|Topical Amorolfine Lacquer Treatment continues ->|24
8866745|NCT01851590|9922935|FG002|At 3 Month: End of Terbinafine Treatment|Overall Study|End of oral Terbinafine treatment. Washout period of the Terbinafine treatment arm begins.|22
8866746|NCT01851590|9922933|FG000|At 4 Month: Follow-up Visit and Control|Overall Study|Clinical response to treatment, toenails samples and laboratory exams were controlled.|23
8866747|NCT01851590|9922934|FG001|At 4 Month: Follow-up Visit and Control|Overall Study|Clinical response to treatment, toenails samples and laboratory exams were controlled.|24
8866748|NCT01851590|9922935|FG002|At 4 Month: Follow-up Visit and Control|Overall Study|Clinical response to treatment, toenails samples and laboratory exams were controlled.|22
8866749|NCT01851590|9922933|FG000|At 9 Month: End of Topical Treatments|Overall Study|End of topical Resin Lacquer treatment. Washout period of the Resin Lacquer treatment arm begins.|23
8866750|NCT01851590|9922934|FG001|At 9 Month: End of Topical Treatments|Overall Study|End of topical Amorolfine Lacquer treatment. Washout period of the Amorolfine treatment arm begins.|24
8866751|NCT01851590|9922935|FG002|At 9 Month: End of Topical Treatments|Overall Study|Washout period of the Terbinafine treatment arm continues.|22
8866752|NCT01851590|9922933|FG000|At 10 Month: Follow-up Visit and Control|Overall Study|Study completed. Clinical response to treatment, toenails samples and lab. exams were controlled.|23
8866753|NCT01851590|9922934|FG001|At 10 Month: Follow-up Visit and Control|Overall Study|Study completed. Clinical response to treatment, toenails samples and lab. exams were controlled.|24
8866754|NCT01851590|9922935|FG002|At 10 Month: Follow-up Visit and Control|Overall Study|Study completed. Clinical response to treatment, toenails samples and lab. exams were controlled.|22
8866755|NCT01851590|9922933|FG000|COMPLETED|Overall Study|All patients (23) were included in the ITT population and final outcome analyses.|23
8866756|NCT01851590|9922934|FG001|COMPLETED|Overall Study|All patients (25) were included in the ITT population and final outcome analyses.|24
8866757|NCT01851590|9922935|FG002|COMPLETED|Overall Study|All patients (25) were included in the ITT population and final outcome analyses.|22
8866758|NCT01851590|9922933|FG000|NOT COMPLETED|Overall Study||0
8866759|NCT01851590|9922934|FG001|NOT COMPLETED|Overall Study||1
8866760|NCT01851590|9922935|FG002|NOT COMPLETED|Overall Study||3
8866761|NCT01851655|9922949|FG000|STARTED|Overall Study||12
8866762|NCT01851655|9922950|FG001|STARTED|Overall Study||12
8866763|NCT01851655|9922949|FG000|COMPLETED|Overall Study||12
8866764|NCT01851655|9922950|FG001|COMPLETED|Overall Study||12
8866765|NCT01851655|9922949|FG000|NOT COMPLETED|Overall Study||0
8866766|NCT01851655|9922950|FG001|NOT COMPLETED|Overall Study||0
8866767|NCT01851720|9922958|FG000|STARTED|Overall Study||0
8866768|NCT01851720|9922959|FG001|STARTED|Overall Study||1
8866769|NCT01851720|9922958|FG000|COMPLETED|Overall Study||0
8866770|NCT01851720|9922959|FG001|COMPLETED|Overall Study||0
8866771|NCT01851720|9922958|FG000|NOT COMPLETED|Overall Study||0
8866772|NCT01851720|9922959|FG001|NOT COMPLETED|Overall Study||1
8866773|NCT01851772|9922965|FG000|STARTED|Overall Study||3
8866774|NCT01851772|9922965|FG000|COMPLETED|Overall Study||3
8866775|NCT01851772|9922965|FG000|NOT COMPLETED|Overall Study||0
8866776|NCT01851863|9922973|FG000|STARTED|Overall Study||65
8866777|NCT01851863|9922974|FG001|STARTED|Overall Study||66
8866778|NCT01851863|9922975|FG002|STARTED|Overall Study||65
8866779|NCT01851863|9922976|FG003|STARTED|Overall Study||66
8866780|NCT01851863|9922973|FG000|COMPLETED|Overall Study||60
8866781|NCT01851863|9922974|FG001|COMPLETED|Overall Study||57
8866782|NCT01851863|9922975|FG002|COMPLETED|Overall Study||60
8866783|NCT01851863|9922976|FG003|COMPLETED|Overall Study||63
8866784|NCT01851863|9922973|FG000|NOT COMPLETED|Overall Study||5
8866785|NCT01851863|9922974|FG001|NOT COMPLETED|Overall Study||9
8866786|NCT01851863|9922975|FG002|NOT COMPLETED|Overall Study||5
8866787|NCT01851863|9922976|FG003|NOT COMPLETED|Overall Study||3
8866788|NCT01851876|9922991|FG000|STARTED|Overall Study||56
8866789|NCT01851876|9922992|FG001|STARTED|Overall Study||62
8866790|NCT01851876|9922991|FG000|COMPLETED|Overall Study||56
8866791|NCT01851876|9922992|FG001|COMPLETED|Overall Study||62
8866792|NCT01851876|9922991|FG000|NOT COMPLETED|Overall Study||0
8866793|NCT01851876|9922992|FG001|NOT COMPLETED|Overall Study||0
8866794|NCT01852019|9923000|FG000|STARTED|Day 1||3
8866795|NCT01852019|9923001|FG001|STARTED|Day 1||3
8866796|NCT01852019|9923002|FG002|STARTED|Day 1||6
8866797|NCT01852019|9923003|FG003|STARTED|Day 1||0
8866798|NCT01852019|9923004|FG004|STARTED|Day 1||0
8866799|NCT01852019|9923000|FG000|COMPLETED|Day 1||3
8866800|NCT01852019|9923001|FG001|COMPLETED|Day 1||3
8866801|NCT01852019|9923002|FG002|COMPLETED|Day 1||6
8866802|NCT01852019|9923003|FG003|COMPLETED|Day 1||0
8866803|NCT01852019|9923004|FG004|COMPLETED|Day 1||0
8866804|NCT01852019|9923000|FG000|NOT COMPLETED|Day 1||0
8866805|NCT01852019|9923001|FG001|NOT COMPLETED|Day 1||0
8866806|NCT01852019|9923002|FG002|NOT COMPLETED|Day 1||0
8866807|NCT01852019|9923003|FG003|NOT COMPLETED|Day 1||0
8866808|NCT01852019|9923004|FG004|NOT COMPLETED|Day 1||0
8866809|NCT01852019|9923000|FG000|STARTED|Day 8||0
8866810|NCT01852019|9923001|FG001|STARTED|Day 8||0
8866811|NCT01852019|9923002|FG002|STARTED|Day 8||0
8866812|NCT01852019|9923003|FG003|STARTED|Day 8||6
8866813|NCT01852019|9923004|FG004|STARTED|Day 8||6
8866814|NCT01852019|9923000|FG000|COMPLETED|Day 8||0
8866815|NCT01852019|9923001|FG001|COMPLETED|Day 8||0
8866816|NCT01852019|9923002|FG002|COMPLETED|Day 8||0
8866817|NCT01852019|9923003|FG003|COMPLETED|Day 8||6
8866818|NCT01852019|9923004|FG004|COMPLETED|Day 8||6
8866819|NCT01852019|9923000|FG000|NOT COMPLETED|Day 8||0
8866820|NCT01852019|9923001|FG001|NOT COMPLETED|Day 8||0
8866821|NCT01852019|9923002|FG002|NOT COMPLETED|Day 8||0
8866822|NCT01852019|9923003|FG003|NOT COMPLETED|Day 8||0
8866823|NCT01852019|9923004|FG004|NOT COMPLETED|Day 8||0
8866824|NCT01852032|9923017|FG000|STARTED|Overall Study||23
8866825|NCT01852032|9923017|FG000|COMPLETED|Overall Study||23
8866826|NCT01852032|9923017|FG000|NOT COMPLETED|Overall Study||0
8866827|NCT01852045|9923024|FG000|STARTED|Overall Study||39
8866828|NCT01852045|9923025|FG001|STARTED|Overall Study||45
8866829|NCT01852045|9923026|FG002|STARTED|Overall Study||30
8866830|NCT01852045|9923024|FG000|mITT Population|Overall Study||38
8866831|NCT01852045|9923025|FG001|mITT Population|Overall Study||45
8866832|NCT01852045|9923026|FG002|mITT Population|Overall Study||30
8866833|NCT01852045|9923024|FG000|Safety Population|Overall Study||38
8866834|NCT01852045|9923025|FG001|Safety Population|Overall Study||45
8866835|NCT01852045|9923026|FG002|Safety Population|Overall Study||30
8866836|NCT01852045|9923024|FG000|COMPLETED|Overall Study||33
8866837|NCT01852045|9923025|FG001|COMPLETED|Overall Study||41
8866838|NCT01852045|9923026|FG002|COMPLETED|Overall Study||26
8866839|NCT01852045|9923024|FG000|NOT COMPLETED|Overall Study||6
8866840|NCT01852045|9923025|FG001|NOT COMPLETED|Overall Study||4
8866841|NCT01852045|9923026|FG002|NOT COMPLETED|Overall Study||4
8866842|NCT01852058|9923037|FG000|STARTED|Treatment Cycle 1, Occurred in Study 120||31
8630637|NCT00535769|9670450|FG001|STARTED|Overall Study||35
8630638|NCT00535769|9670449|FG000|COMPLETED|Overall Study||35
8951590|NCT02455050|10014485|FG002|NOT COMPLETED|Treatment Period 1||1
8630639|NCT00535769|9670450|FG001|COMPLETED|Overall Study||35
8866843|NCT01852058|9923038|FG001|STARTED|Treatment Cycle 1, Occurred in Study 120||39
8866844|NCT01852058|9923039|FG002|STARTED|Treatment Cycle 1, Occurred in Study 120||25
8866845|NCT01852058|9923040|FG003|STARTED|Treatment Cycle 1, Occurred in Study 120||0
8866846|NCT01852058|9923041|FG004|STARTED|Treatment Cycle 1, Occurred in Study 120||0
8866847|NCT01852058|9923042|FG005|STARTED|Treatment Cycle 1, Occurred in Study 120||0
8866848|NCT01852058|9923043|FG006|STARTED|Treatment Cycle 1, Occurred in Study 120||0
8866849|NCT01852058|9923044|FG007|STARTED|Treatment Cycle 1, Occurred in Study 120||0
8866850|NCT01852058|9923045|FG008|STARTED|Treatment Cycle 1, Occurred in Study 120||0
8866851|NCT01852058|9923046|FG009|STARTED|Treatment Cycle 1, Occurred in Study 120||0
8866852|NCT01852058|9923047|FG010|STARTED|Treatment Cycle 1, Occurred in Study 120||0
8866853|NCT01852058|9923048|FG011|STARTED|Treatment Cycle 1, Occurred in Study 120||0
8866854|NCT01852058|9923037|FG000|COMPLETED|Treatment Cycle 1, Occurred in Study 120||30
8866855|NCT01852058|9923038|FG001|COMPLETED|Treatment Cycle 1, Occurred in Study 120||39
8866856|NCT01852058|9923039|FG002|COMPLETED|Treatment Cycle 1, Occurred in Study 120||25
8866857|NCT01852058|9923040|FG003|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
8866858|NCT01852058|9923041|FG004|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
8866859|NCT01852058|9923042|FG005|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
8866860|NCT01852058|9923043|FG006|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
8866861|NCT01852058|9923044|FG007|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
8866862|NCT01852058|9923045|FG008|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
8866863|NCT01852058|9923046|FG009|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
8866864|NCT01852058|9923047|FG010|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
8866865|NCT01852058|9923048|FG011|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
8866866|NCT01852058|9923037|FG000|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||1
8866867|NCT01852058|9923038|FG001|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
8866868|NCT01852058|9923039|FG002|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
8866869|NCT01852058|9923040|FG003|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
8866870|NCT01852058|9923041|FG004|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
8866871|NCT01852058|9923042|FG005|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
8866872|NCT01852058|9923043|FG006|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
8866873|NCT01852058|9923044|FG007|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
8866874|NCT01852058|9923045|FG008|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
8866875|NCT01852058|9923046|FG009|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
8866876|NCT01852058|9923047|FG010|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
8866877|NCT01852058|9923048|FG011|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
8866878|NCT01852058|9923037|FG000|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
8866879|NCT01852058|9923038|FG001|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
8866880|NCT01852058|9923039|FG002|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
8866881|NCT01852058|9923040|FG003|STARTED|Treatment Cycle2:Retreatment 1,Study 121||9
8866882|NCT01852058|9923041|FG004|STARTED|Treatment Cycle2:Retreatment 1,Study 121||45
8866883|NCT01852058|9923042|FG005|STARTED|Treatment Cycle2:Retreatment 1,Study 121||36
8866884|NCT01852058|9923043|FG006|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
8866885|NCT01852058|9923044|FG007|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
8866886|NCT01852058|9923045|FG008|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
8866887|NCT01852058|9923046|FG009|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
8866888|NCT01852058|9923047|FG010|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
8866889|NCT01852058|9923048|FG011|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
8866890|NCT01852058|9923037|FG000|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
8866891|NCT01852058|9923038|FG001|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
8866892|NCT01852058|9923039|FG002|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
8866893|NCT01852058|9923040|FG003|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||8
8866894|NCT01852058|9923041|FG004|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||38
8866895|NCT01852058|9923042|FG005|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||27
8866896|NCT01852058|9923043|FG006|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
8866897|NCT01852058|9923044|FG007|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
8866898|NCT01852058|9923045|FG008|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
8866899|NCT01852058|9923046|FG009|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
8866900|NCT01852058|9923047|FG010|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
8866901|NCT01852058|9923048|FG011|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
8866902|NCT01852058|9923037|FG000|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
8866903|NCT01852058|9923038|FG001|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
8866904|NCT01852058|9923039|FG002|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
8866905|NCT01852058|9923040|FG003|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||1
8866906|NCT01852058|9923041|FG004|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||7
8866907|NCT01852058|9923042|FG005|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||9
8866908|NCT01852058|9923043|FG006|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
8866909|NCT01852058|9923044|FG007|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
8866910|NCT01852058|9923045|FG008|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
8866911|NCT01852058|9923046|FG009|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
8866912|NCT01852058|9923047|FG010|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
8866913|NCT01852058|9923048|FG011|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
8866914|NCT01852058|9923037|FG000|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
8866915|NCT01852058|9923038|FG001|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
8866916|NCT01852058|9923039|FG002|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
8866917|NCT01852058|9923040|FG003|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
8866918|NCT01852058|9923041|FG004|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
8866919|NCT01852058|9923042|FG005|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
8866920|NCT01852058|9923043|FG006|STARTED|Treatment Cycle3:Retreatment 2,Study 121||5
8866921|NCT01852058|9923044|FG007|STARTED|Treatment Cycle3:Retreatment 2,Study 121||16
8577534|NCT00159263|9610313|FG003|STARTED|Washout||2
8923782|NCT02243280|9984420|FG000|Completed Treatment|Treated||42
8866922|NCT01852058|9923045|FG008|STARTED|Treatment Cycle3:Retreatment 2,Study 121||34
8866923|NCT01852058|9923046|FG009|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
8866924|NCT01852058|9923047|FG010|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
8866925|NCT01852058|9923048|FG011|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
8866926|NCT01852058|9923037|FG000|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
8866927|NCT01852058|9923038|FG001|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
8866928|NCT01852058|9923039|FG002|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
8866929|NCT01852058|9923040|FG003|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
8866930|NCT01852058|9923041|FG004|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
8866931|NCT01852058|9923042|FG005|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
8866932|NCT01852058|9923043|FG006|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||5
8951591|NCT02455050|10014486|FG003|NOT COMPLETED|Treatment Period 1||2
8951592|NCT02455050|10014483|FG000|STARTED|Treatment Period 2||19
8951593|NCT02455050|10014484|FG001|STARTED|Treatment Period 2||18
8951594|NCT02455050|10014485|FG002|STARTED|Treatment Period 2||19
8951595|NCT02455050|10014486|FG003|STARTED|Treatment Period 2||18
8951596|NCT02455050|10014483|FG000|COMPLETED|Treatment Period 2||18
8951597|NCT02455050|10014484|FG001|COMPLETED|Treatment Period 2||18
8951598|NCT02455050|10014485|FG002|COMPLETED|Treatment Period 2||17
8951599|NCT02455050|10014486|FG003|COMPLETED|Treatment Period 2||17
8951600|NCT02455050|10014483|FG000|NOT COMPLETED|Treatment Period 2||1
8951601|NCT02455050|10014484|FG001|NOT COMPLETED|Treatment Period 2||0
8951602|NCT02455050|10014485|FG002|NOT COMPLETED|Treatment Period 2||2
8951603|NCT02455050|10014486|FG003|NOT COMPLETED|Treatment Period 2||1
8951604|NCT02455076|10014511|FG000|STARTED|Inpatient||47
8951605|NCT02455076|10014512|FG001|STARTED|Inpatient||51
8951606|NCT02455076|10014513|FG002|STARTED|Inpatient||52
8951607|NCT02455076|10014514|FG003|STARTED|Inpatient||0
8951608|NCT02455076|10014515|FG004|STARTED|Inpatient||0
8951609|NCT02455076|10014511|FG000|COMPLETED|Inpatient||43
8951610|NCT02455076|10014512|FG001|COMPLETED|Inpatient||50
8951611|NCT02455076|10014513|FG002|COMPLETED|Inpatient||52
8951612|NCT02455076|10014514|FG003|COMPLETED|Inpatient||0
8951613|NCT02455076|10014515|FG004|COMPLETED|Inpatient||0
8951614|NCT02455076|10014511|FG000|NOT COMPLETED|Inpatient||4
8951615|NCT02455076|10014512|FG001|NOT COMPLETED|Inpatient||1
8951616|NCT02455076|10014513|FG002|NOT COMPLETED|Inpatient||0
8951617|NCT02455076|10014514|FG003|NOT COMPLETED|Inpatient||0
8951618|NCT02455076|10014515|FG004|NOT COMPLETED|Inpatient||0
8951619|NCT02455076|10014511|FG000|STARTED|Outpatient||0
8951620|NCT02455076|10014512|FG001|STARTED|Outpatient||0
8951621|NCT02455076|10014513|FG002|STARTED|Outpatient||0
8951622|NCT02455076|10014514|FG003|STARTED|Outpatient||48
8951623|NCT02455076|10014515|FG004|STARTED|Outpatient||55
8951624|NCT02455076|10014511|FG000|COMPLETED|Outpatient||0
8951625|NCT02455076|10014512|FG001|COMPLETED|Outpatient||0
8951626|NCT02455076|10014513|FG002|COMPLETED|Outpatient||0
8951627|NCT02455076|10014514|FG003|COMPLETED|Outpatient||42
8951628|NCT02455076|10014515|FG004|COMPLETED|Outpatient||43
8951629|NCT02455076|10014511|FG000|NOT COMPLETED|Outpatient||0
8951630|NCT02455076|10014512|FG001|NOT COMPLETED|Outpatient||0
8951631|NCT02455076|10014513|FG002|NOT COMPLETED|Outpatient||0
8951632|NCT02455076|10014514|FG003|NOT COMPLETED|Outpatient||6
8951633|NCT02455076|10014515|FG004|NOT COMPLETED|Outpatient||12
8951634|NCT02455167|10014527|FG000|STARTED|Overall Study||4
8951635|NCT02455167|10014527|FG000|COMPLETED|Overall Study||4
8951636|NCT02455167|10014527|FG000|NOT COMPLETED|Overall Study||0
8951637|NCT02455336|10014533|FG000|STARTED|Overall Study||15
8951638|NCT02455336|10014534|FG001|STARTED|Overall Study||8
8951639|NCT02455336|10014533|FG000|COMPLETED|Overall Study||10
8951640|NCT02455336|10014534|FG001|COMPLETED|Overall Study||6
8951641|NCT02455336|10014533|FG000|NOT COMPLETED|Overall Study||5
8951642|NCT02455336|10014534|FG001|NOT COMPLETED|Overall Study||2
8951643|NCT02455388|10014542|FG000|STARTED|Overall Study||18
8951644|NCT02455388|10014543|FG001|STARTED|Overall Study||15
8951645|NCT02455388|10014544|FG002|STARTED|Overall Study||337
8951646|NCT02455388|10014542|FG000|COMPLETED|Overall Study||17
8951647|NCT02455388|10014543|FG001|COMPLETED|Overall Study||15
8951648|NCT02455388|10014544|FG002|COMPLETED|Overall Study||326
8951649|NCT02455388|10014542|FG000|NOT COMPLETED|Overall Study||1
8951650|NCT02455388|10014543|FG001|NOT COMPLETED|Overall Study||0
8951651|NCT02455388|10014544|FG002|NOT COMPLETED|Overall Study||11
8951652|NCT02455453|10014552|FG000|STARTED|Overall Study||47
8951653|NCT02455453|10014552|FG000|COMPLETED|Overall Study||47
8951654|NCT02455453|10014552|FG000|NOT COMPLETED|Overall Study||0
8951655|NCT02455518|10014560|FG000|STARTED|Overall Study||104
8951656|NCT02455518|10014561|FG001|STARTED|Overall Study||104
8951657|NCT02455518|10014562|FG002|STARTED|Overall Study||104
8866933|NCT01852058|9923044|FG007|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||15
8866934|NCT01852058|9923045|FG008|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||33
8923783|NCT02243280|9984421|FG001|Completed Treatment|Treated||38
8951658|NCT02455518|10014563|FG003|STARTED|Overall Study||104
8951659|NCT02455518|10014560|FG000|COMPLETED|Overall Study||104
8951660|NCT02455518|10014561|FG001|COMPLETED|Overall Study||103
8951661|NCT02455518|10014562|FG002|COMPLETED|Overall Study||103
8951662|NCT02455518|10014563|FG003|COMPLETED|Overall Study||101
8951663|NCT02455518|10014560|FG000|NOT COMPLETED|Overall Study||0
8951664|NCT02455518|10014561|FG001|NOT COMPLETED|Overall Study||1
8951665|NCT02455518|10014562|FG002|NOT COMPLETED|Overall Study||1
8951666|NCT02455518|10014563|FG003|NOT COMPLETED|Overall Study||3
8866935|NCT01852058|9923046|FG009|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
8866936|NCT01852058|9923047|FG010|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
8866937|NCT01852058|9923048|FG011|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
8866938|NCT01852058|9923037|FG000|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
8866939|NCT01852058|9923038|FG001|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
8866940|NCT01852058|9923039|FG002|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
8866941|NCT01852058|9923040|FG003|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
8866942|NCT01852058|9923041|FG004|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
8866943|NCT01852058|9923042|FG005|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
8866944|NCT01852058|9923043|FG006|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
8866945|NCT01852058|9923044|FG007|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||1
8866946|NCT01852058|9923045|FG008|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||1
8866947|NCT01852058|9923046|FG009|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
8866948|NCT01852058|9923047|FG010|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
8866949|NCT01852058|9923048|FG011|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
8866950|NCT01852058|9923037|FG000|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
8866951|NCT01852058|9923038|FG001|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
8866952|NCT01852058|9923039|FG002|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
8866953|NCT01852058|9923040|FG003|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
8866954|NCT01852058|9923041|FG004|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
8866955|NCT01852058|9923042|FG005|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
8866956|NCT01852058|9923043|FG006|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
8866957|NCT01852058|9923044|FG007|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
8866958|NCT01852058|9923045|FG008|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
8866959|NCT01852058|9923046|FG009|STARTED|Treatment Cycle4:Retreatment 3,Study 121||3
8866960|NCT01852058|9923047|FG010|STARTED|Treatment Cycle4:Retreatment 3,Study 121||4
8866961|NCT01852058|9923048|FG011|STARTED|Treatment Cycle4:Retreatment 3,Study 121||4
8866962|NCT01852058|9923037|FG000|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
8866963|NCT01852058|9923038|FG001|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
8866964|NCT01852058|9923039|FG002|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
8866965|NCT01852058|9923040|FG003|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
8866966|NCT01852058|9923041|FG004|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
8866967|NCT01852058|9923042|FG005|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
8866968|NCT01852058|9923043|FG006|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
8866969|NCT01852058|9923044|FG007|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
8866970|NCT01852058|9923045|FG008|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
8866971|NCT01852058|9923046|FG009|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||3
8866972|NCT01852058|9923047|FG010|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||4
8866973|NCT01852058|9923048|FG011|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||4
8866974|NCT01852058|9923037|FG000|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
8866975|NCT01852058|9923038|FG001|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
8866976|NCT01852058|9923039|FG002|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
8866977|NCT01852058|9923040|FG003|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
8866978|NCT01852058|9923041|FG004|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
8866979|NCT01852058|9923042|FG005|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
8866980|NCT01852058|9923043|FG006|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
8866981|NCT01852058|9923044|FG007|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
8866982|NCT01852058|9923045|FG008|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
8866983|NCT01852058|9923046|FG009|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
8866984|NCT01852058|9923047|FG010|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
8866985|NCT01852058|9923048|FG011|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
8866986|NCT01852071|9923085|FG000|STARTED|Overall Study||20
8866987|NCT01852071|9923086|FG001|STARTED|Overall Study||26
8866988|NCT01852071|9923085|FG000|COMPLETED|Overall Study||20
8866989|NCT01852071|9923086|FG001|COMPLETED|Overall Study||26
8866990|NCT01852071|9923085|FG000|NOT COMPLETED|Overall Study||0
8866991|NCT01852071|9923086|FG001|NOT COMPLETED|Overall Study||0
8866992|NCT01852084|9923102|FG000|STARTED|Overall Study||79
8866993|NCT01852084|9923103|FG001|STARTED|Overall Study||80
8866994|NCT01852084|9923104|FG002|STARTED|Overall Study||20
8866995|NCT01852084|9923105|FG003|STARTED|Overall Study||12
8866996|NCT01852084|9923102|FG000|COMPLETED|Overall Study||79
8866997|NCT01852084|9923103|FG001|COMPLETED|Overall Study||80
8866998|NCT01852084|9923104|FG002|COMPLETED|Overall Study||18
8866999|NCT01852084|9923105|FG003|COMPLETED|Overall Study||12
8867000|NCT01852084|9923102|FG000|NOT COMPLETED|Overall Study||0
8867001|NCT01852084|9923103|FG001|NOT COMPLETED|Overall Study||0
8867002|NCT01852084|9923104|FG002|NOT COMPLETED|Overall Study||2
8867003|NCT01852084|9923105|FG003|NOT COMPLETED|Overall Study||0
8867004|NCT01852110|9923117|FG000|STARTED|Overall Study||120
8867005|NCT01852110|9923118|FG001|STARTED|Overall Study||120
8867006|NCT01852110|9923119|FG002|STARTED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
8867007|NCT01852110|9923120|FG003|STARTED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
8867008|NCT01852110|9923121|FG004|STARTED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
8867009|NCT01852110|9923122|FG005|STARTED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
8867010|NCT01852110|9923117|FG000|Treated|Overall Study||119
8867011|NCT01852110|9923118|FG001|Treated|Overall Study||120
8867012|NCT01852110|9923119|FG002|Treated|Overall Study||0
8867013|NCT01852110|9923120|FG003|Treated|Overall Study||0
8867014|NCT01852110|9923121|FG004|Treated|Overall Study||0
8867015|NCT01852110|9923122|FG005|Treated|Overall Study||0
8867016|NCT01852110|9923117|FG000|COMPLETED|Overall Study||70
8867017|NCT01852110|9923118|FG001|COMPLETED|Overall Study||74
8867018|NCT01852110|9923119|FG002|COMPLETED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
8867019|NCT01852110|9923120|FG003|COMPLETED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
8867020|NCT01852110|9923121|FG004|COMPLETED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
8867021|NCT01852110|9923122|FG005|COMPLETED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
8867022|NCT01852110|9923117|FG000|NOT COMPLETED|Overall Study||50
8951667|NCT02456103|10014573|FG000|STARTED|Overall Study||246
8951668|NCT02456103|10014573|FG000|As-Treated Population|Overall Study||245
8951669|NCT02456103|10014573|FG000|Intent-to-treat (ITT) Population|Overall Study||244
8951670|NCT02456103|10014573|FG000|COMPLETED|Overall Study||0
8951671|NCT02456103|10014573|FG000|NOT COMPLETED|Overall Study||246
8951672|NCT02456636|10014580|FG000|STARTED|Overall Study||478
8951673|NCT02456636|10014581|FG001|STARTED|Overall Study||479
8951674|NCT02456636|10014582|FG002|STARTED|Overall Study||475
8951675|NCT02456636|10014580|FG000|6 Month|Overall Study||474
8951676|NCT02456636|10014581|FG001|6 Month|Overall Study||474
8951677|NCT02456636|10014582|FG002|6 Month|Overall Study||468
8951678|NCT02456636|10014580|FG000|18 Month|Overall Study||467
8951679|NCT02456636|10014581|FG001|18 Month|Overall Study||463
8951680|NCT02456636|10014582|FG002|18 Month|Overall Study||461
8951681|NCT02456636|10014580|FG000|COMPLETED|Overall Study||410
8951682|NCT02456636|10014581|FG001|COMPLETED|Overall Study||410
8951683|NCT02456636|10014582|FG002|COMPLETED|Overall Study||400
8951684|NCT02456636|10014580|FG000|NOT COMPLETED|Overall Study||68
8951685|NCT02456636|10014581|FG001|NOT COMPLETED|Overall Study||69
8951686|NCT02456636|10014582|FG002|NOT COMPLETED|Overall Study||75
8951687|NCT02456662|10014592|FG000|STARTED|Overall Study||159
8951688|NCT02456662|10014593|FG001|STARTED|Overall Study||160
8951689|NCT02456662|10014592|FG000|COMPLETED|Overall Study||157
8951690|NCT02456662|10014593|FG001|COMPLETED|Overall Study||159
8951691|NCT02456662|10014592|FG000|NOT COMPLETED|Overall Study||2
8951692|NCT02456662|10014593|FG001|NOT COMPLETED|Overall Study||1
8951693|NCT02456727|10014601|FG000|STARTED|Overall Study||389
8951694|NCT02456727|10014602|FG001|STARTED|Overall Study||390
8951695|NCT02456727|10014601|FG000|Initiated Treatment|Overall Study||346
8951696|NCT02456727|10014602|FG001|Initiated Treatment|Overall Study||360
8951697|NCT02456727|10014601|FG000|6 Week|Overall Study||298
8951698|NCT02456727|10014602|FG001|6 Week|Overall Study||320
8951699|NCT02456727|10014601|FG000|12 Week|Overall Study||295
8951700|NCT02456727|10014602|FG001|12 Week|Overall Study||310
8951701|NCT02456727|10014601|FG000|24 Week|Overall Study||280
8951702|NCT02456727|10014602|FG001|24 Week|Overall Study||284
8951703|NCT02456727|10014601|FG000|COMPLETED|Overall Study||280
8951704|NCT02456727|10014602|FG001|COMPLETED|Overall Study||284
8951705|NCT02456727|10014601|FG000|NOT COMPLETED|Overall Study||109
8951706|NCT02456727|10014602|FG001|NOT COMPLETED|Overall Study||106
8951707|NCT02456896|10014626|FG000|STARTED|Overall Study||25
8951708|NCT02456896|10014627|FG001|STARTED|Overall Study||25
8951709|NCT02456896|10014626|FG000|COMPLETED|Overall Study||19
8951710|NCT02456896|10014627|FG001|COMPLETED|Overall Study||21
8951711|NCT02456896|10014626|FG000|NOT COMPLETED|Overall Study||6
8951712|NCT02456896|10014627|FG001|NOT COMPLETED|Overall Study||4
8951713|NCT02456909|10014635|FG000|STARTED|Overall Study||88
8951714|NCT02456909|10014636|FG001|STARTED|Overall Study||88
8951715|NCT02456909|10014635|FG000|COMPLETED|Overall Study||64
8951716|NCT02456909|10014636|FG001|COMPLETED|Overall Study||61
8951717|NCT02456909|10014635|FG000|NOT COMPLETED|Overall Study||24
8951718|NCT02456909|10014636|FG001|NOT COMPLETED|Overall Study||27
8951719|NCT02457065|10014644|FG000|STARTED|Overall Study||27
8951720|NCT02457065|10014645|FG001|STARTED|Overall Study||27
8951721|NCT02457065|10014644|FG000|COMPLETED|Overall Study||18
8867023|NCT01852110|9923118|FG001|NOT COMPLETED|Overall Study||46
8867024|NCT01852110|9923119|FG002|NOT COMPLETED|Overall Study||0
8867025|NCT01852110|9923120|FG003|NOT COMPLETED|Overall Study||0
8867026|NCT01852110|9923121|FG004|NOT COMPLETED|Overall Study||0
8867027|NCT01852110|9923122|FG005|NOT COMPLETED|Overall Study||0
8867028|NCT01852162|9923138|FG000|STARTED|Overall Study||18
8867029|NCT01852162|9923139|FG001|STARTED|Overall Study||17
8867030|NCT01852162|9923138|FG000|COMPLETED|Overall Study||14
8867031|NCT01852162|9923139|FG001|COMPLETED|Overall Study||16
8867032|NCT01852162|9923138|FG000|NOT COMPLETED|Overall Study||4
8867033|NCT01852162|9923139|FG001|NOT COMPLETED|Overall Study||1
8867034|NCT01852175|9923147|FG000|STARTED|Overall Study||55
8867035|NCT01852175|9923148|FG001|STARTED|Overall Study||55
8867036|NCT01852175|9923147|FG000|COMPLETED|Overall Study||55
8867037|NCT01852175|9923148|FG001|COMPLETED|Overall Study||55
8867038|NCT01852175|9923147|FG000|NOT COMPLETED|Overall Study||0
8867039|NCT01852175|9923148|FG001|NOT COMPLETED|Overall Study||0
8867040|NCT01852201|9923156|FG000|STARTED|Overall Study||21
8867041|NCT01852201|9923157|FG001|STARTED|Overall Study||12
8867042|NCT01852201|9923156|FG000|COMPLETED|Overall Study||21
8867043|NCT01852201|9923157|FG001|COMPLETED|Overall Study||12
8867044|NCT01852201|9923156|FG000|NOT COMPLETED|Overall Study||0
8867045|NCT01852201|9923157|FG001|NOT COMPLETED|Overall Study||0
8867046|NCT01852214|9923164|FG000|STARTED|Period 1||26
8867047|NCT01852214|9923165|FG001|STARTED|Period 1||24
8867048|NCT01852214|9923164|FG000|COMPLETED|Period 1||25
8867049|NCT01852214|9923165|FG001|COMPLETED|Period 1||21
8867050|NCT01852214|9923164|FG000|NOT COMPLETED|Period 1||1
8867051|NCT01852214|9923165|FG001|NOT COMPLETED|Period 1||3
8867052|NCT01852214|9923164|FG000|STARTED|Washout Period||25
8867053|NCT01852214|9923165|FG001|STARTED|Washout Period||21
8867054|NCT01852214|9923164|FG000|COMPLETED|Washout Period||25
8867055|NCT01852214|9923165|FG001|COMPLETED|Washout Period||20
8867056|NCT01852214|9923164|FG000|NOT COMPLETED|Washout Period||0
8867057|NCT01852214|9923165|FG001|NOT COMPLETED|Washout Period||1
8867058|NCT01852214|9923164|FG000|STARTED|Period 2||25
8867059|NCT01852214|9923165|FG001|STARTED|Period 2||20
8867060|NCT01852214|9923164|FG000|COMPLETED|Period 2||25
8867061|NCT01852214|9923165|FG001|COMPLETED|Period 2||20
8867062|NCT01852214|9923164|FG000|NOT COMPLETED|Period 2||0
8867063|NCT01852214|9923165|FG001|NOT COMPLETED|Period 2||0
8867064|NCT01852292|9923174|FG000|STARTED|Overall Study||79
8867065|NCT01852292|9923175|FG001|STARTED|Overall Study||79
8867066|NCT01852292|9923174|FG000|COMPLETED|Overall Study|Completed = participants who were ongoing and did not discontinue study treatment per protocol|0
8867067|NCT01852292|9923175|FG001|COMPLETED|Overall Study|Completed = participants who were ongoing and did not discontinue study treatment per protocol|0
8867068|NCT01852292|9923174|FG000|NOT COMPLETED|Overall Study||79
8867069|NCT01852292|9923175|FG001|NOT COMPLETED|Overall Study||79
8867070|NCT01852344|9923185|FG000|STARTED|Overall Study||27
8867071|NCT01852344|9923186|FG001|STARTED|Overall Study||27
8867072|NCT01852344|9923187|FG002|STARTED|Overall Study||27
8867073|NCT01852344|9923188|FG003|STARTED|Overall Study||27
8867074|NCT01852344|9923185|FG000|Actual Participation in First Assignment|Overall Study||27
8867075|NCT01852344|9923186|FG001|Actual Participation in First Assignment|Overall Study||27
8630640|NCT00535769|9670449|FG000|NOT COMPLETED|Overall Study||0
8630641|NCT00535769|9670450|FG001|NOT COMPLETED|Overall Study||0
8691259|NCT00853840|9736490|FG001|Vardenafil or Placebo (Day 4)|Period 1|Administered 1 hour post Maraviroc dosing|9
8691260|NCT00853840|9736489|FG000|COMPLETED|Period 1||9
8691261|NCT00853840|9736490|FG001|COMPLETED|Period 1||9
8691262|NCT00853840|9736489|FG000|NOT COMPLETED|Period 1||0
8691263|NCT00853840|9736490|FG001|NOT COMPLETED|Period 1||0
8867076|NCT01852344|9923187|FG002|Actual Participation in First Assignment|Overall Study||27
8867077|NCT01852344|9923188|FG003|Actual Participation in First Assignment|Overall Study||27
8867078|NCT01852344|9923185|FG000|COMPLETED|Overall Study||27
8867079|NCT01852344|9923186|FG001|COMPLETED|Overall Study||27
8867080|NCT01852344|9923187|FG002|COMPLETED|Overall Study||27
8867081|NCT01852344|9923188|FG003|COMPLETED|Overall Study||27
8867082|NCT01852344|9923185|FG000|NOT COMPLETED|Overall Study||0
8867083|NCT01852344|9923186|FG001|NOT COMPLETED|Overall Study||0
8867084|NCT01852344|9923187|FG002|NOT COMPLETED|Overall Study||0
8867085|NCT01852344|9923188|FG003|NOT COMPLETED|Overall Study||0
8867086|NCT01852383|9923199|FG000|STARTED|Overall Study||30
8867087|NCT01852383|9923199|FG000|COMPLETED|Overall Study||19
8867088|NCT01852383|9923199|FG000|NOT COMPLETED|Overall Study||11
8867089|NCT01852513|9923206|FG000|STARTED|Overall Study||20
8867090|NCT01852513|9923207|FG001|STARTED|Overall Study||19
8691264|NCT00853840|9736489|FG000|STARTED|Period 2||9
8691265|NCT00853840|9736490|FG001|STARTED|Period 2||9
8691266|NCT00853840|9736489|FG000|Maraviroc (Days 1 - 3)|Period 2||9
8691267|NCT00853840|9736490|FG001|Maraviroc (Days 1 - 3)|Period 2||9
8691268|NCT00853840|9736489|FG000|Vardenafil or Placebo (Day 3)|Period 2|Administered 1 hour post Maraviroc dosing|9
8867091|NCT01852513|9923206|FG000|COMPLETED|Overall Study||20
8867092|NCT01852513|9923207|FG001|COMPLETED|Overall Study||19
8867093|NCT01852513|9923206|FG000|NOT COMPLETED|Overall Study||0
8867094|NCT01852513|9923207|FG001|NOT COMPLETED|Overall Study||0
8867095|NCT01852591|9923213|FG000|STARTED|Overall Study||8
8867096|NCT01852591|9923213|FG000|COMPLETED|Overall Study||5
8867097|NCT01852591|9923213|FG000|NOT COMPLETED|Overall Study||3
8867098|NCT01852669|9923219|FG000|STARTED|Overall Study||71
8867099|NCT01852669|9923220|FG001|STARTED|Overall Study||69
8867100|NCT01852669|9923219|FG000|COMPLETED|Overall Study||71
8867101|NCT01852669|9923220|FG001|COMPLETED|Overall Study|Randomisation error. Patient has protocol violation which necessitated exclusion from analysis|68
8867102|NCT01852669|9923219|FG000|NOT COMPLETED|Overall Study||0
8867103|NCT01852669|9923220|FG001|NOT COMPLETED|Overall Study||1
8867104|NCT01852799|9923226|FG000|STARTED|Overall Study||18
8867105|NCT01852799|9923226|FG000|COMPLETED|Overall Study||0
8867106|NCT01852799|9923226|FG000|NOT COMPLETED|Overall Study||18
8867107|NCT01852825|9923233|FG000|STARTED|Overall Study||16
8867108|NCT01852825|9923234|FG001|STARTED|Overall Study||7
8867109|NCT01852825|9923235|FG002|STARTED|Overall Study||3
8867110|NCT01852825|9923233|FG000|COMPLETED|Overall Study||14
8867111|NCT01852825|9923234|FG001|COMPLETED|Overall Study||7
8867112|NCT01852825|9923235|FG002|COMPLETED|Overall Study||3
8867113|NCT01852825|9923233|FG000|NOT COMPLETED|Overall Study||2
8867114|NCT01852825|9923234|FG001|NOT COMPLETED|Overall Study||0
8867115|NCT01852825|9923235|FG002|NOT COMPLETED|Overall Study||0
8867116|NCT01852942|9923245|FG000|STARTED|Overall Study||25
8867117|NCT01852942|9923246|FG001|STARTED|Overall Study||27
8867118|NCT01852942|9923245|FG000|COMPLETED|Overall Study||20
8867119|NCT01852942|9923246|FG001|COMPLETED|Overall Study||21
8867120|NCT01852942|9923245|FG000|NOT COMPLETED|Overall Study||5
8867121|NCT01852942|9923246|FG001|NOT COMPLETED|Overall Study||6
8867122|NCT01852955|9923255|FG000|STARTED|Overall Study||35
8867123|NCT01852955|9923256|FG001|STARTED|Overall Study||35
8867124|NCT01852955|9923255|FG000|COMPLETED|Overall Study||33
8867125|NCT01852955|9923256|FG001|COMPLETED|Overall Study||32
8867126|NCT01852955|9923255|FG000|NOT COMPLETED|Overall Study||2
8867127|NCT01852955|9923256|FG001|NOT COMPLETED|Overall Study||3
8867128|NCT01853046|9923264|FG000|STARTED|Overall Study||18
8867129|NCT01853046|9923265|FG001|STARTED|Overall Study||6
8867130|NCT01853046|9923264|FG000|Received Treatment|Overall Study||18
8867131|NCT01853046|9923265|FG001|Received Treatment|Overall Study||6
8867132|NCT01853046|9923264|FG000|COMPLETED|Overall Study||0
8867133|NCT01853046|9923265|FG001|COMPLETED|Overall Study||0
8867134|NCT01853046|9923264|FG000|NOT COMPLETED|Overall Study||18
8867135|NCT01853046|9923265|FG001|NOT COMPLETED|Overall Study||6
8867136|NCT01853072|9923274|FG000|STARTED|Overall Study||308
8867137|NCT01853072|9923275|FG001|STARTED|Overall Study||307
8867138|NCT01853072|9923274|FG000|Randomized|Overall Study||308
8867139|NCT01853072|9923275|FG001|Randomized|Overall Study||307
8867140|NCT01853072|9923274|FG000|Treated (Safety Analysis Set)|Overall Study||301
8867141|NCT01853072|9923275|FG001|Treated (Safety Analysis Set)|Overall Study||302
8867142|NCT01853072|9923274|FG000|Full Analysis Set|Overall Study||298
8867143|NCT01853072|9923275|FG001|Full Analysis Set|Overall Study||300
8867144|NCT01853072|9923274|FG000|COMPLETED|Overall Study||296
8867145|NCT01853072|9923275|FG001|COMPLETED|Overall Study||286
8867146|NCT01853072|9923274|FG000|NOT COMPLETED|Overall Study||12
8867147|NCT01853072|9923275|FG001|NOT COMPLETED|Overall Study||21
8867148|NCT01853085|9923283|FG000|STARTED|Overall Study||1830
8867149|NCT01853085|9923283|FG000|COMPLETED|Overall Study||1595
8867150|NCT01853085|9923283|FG000|NOT COMPLETED|Overall Study||235
8867151|NCT01853137|9923289|FG000|STARTED|Overall Study||25
8867152|NCT01853137|9923290|FG001|STARTED|Overall Study||18
8867153|NCT01853137|9923289|FG000|COMPLETED|Overall Study||21
8867154|NCT01853137|9923290|FG001|COMPLETED|Overall Study||17
8867155|NCT01853137|9923289|FG000|NOT COMPLETED|Overall Study||4
8867156|NCT01853137|9923290|FG001|NOT COMPLETED|Overall Study||1
8867157|NCT01853215|9923297|FG000|STARTED|Overall Study||24
8867158|NCT01853215|9923297|FG000|COMPLETED|Overall Study||24
8867159|NCT01853215|9923297|FG000|NOT COMPLETED|Overall Study||0
8867160|NCT01853228|9923302|FG000|STARTED|Phase 1||9
8867161|NCT01853228|9923303|FG001|STARTED|Phase 1||7
8867162|NCT01853228|9923302|FG000|COMPLETED|Phase 1||0
8867163|NCT01853228|9923303|FG001|COMPLETED|Phase 1|Participants who completed Phase 1 moved to Phase 2.|7
8867164|NCT01853228|9923302|FG000|NOT COMPLETED|Phase 1||9
8867165|NCT01853228|9923303|FG001|NOT COMPLETED|Phase 1||0
8867166|NCT01853228|9923302|FG000|STARTED|Phase 2||0
8867167|NCT01853228|9923303|FG001|STARTED|Phase 2|1 additional participant was enrolled, making total of 8 participants evaluable in Phase 2.|8
8867168|NCT01853228|9923302|FG000|COMPLETED|Phase 2||0
8867169|NCT01853228|9923303|FG001|COMPLETED|Phase 2||0
8867170|NCT01853228|9923302|FG000|NOT COMPLETED|Phase 2||0
8867171|NCT01853228|9923303|FG001|NOT COMPLETED|Phase 2||8
8867172|NCT01853254|9923308|FG000|STARTED|Overall Study||272
8867173|NCT01853254|9923308|FG000|COMPLETED|Overall Study||168
8867174|NCT01853254|9923308|FG000|NOT COMPLETED|Overall Study||104
8867175|NCT01853280|9923314|FG000|STARTED|Overall Study||22
8867176|NCT01853280|9923315|FG001|STARTED|Overall Study||22
8867177|NCT01853280|9923314|FG000|COMPLETED|Overall Study||20
8867178|NCT01853280|9923315|FG001|COMPLETED|Overall Study||16
8867179|NCT01853280|9923314|FG000|NOT COMPLETED|Overall Study||2
8867180|NCT01853280|9923315|FG001|NOT COMPLETED|Overall Study||6
8867181|NCT01853332|9923321|FG000|STARTED|Overall Study||210
8867182|NCT01853332|9923321|FG000|COMPLETED|Overall Study||151
8867183|NCT01853332|9923321|FG000|NOT COMPLETED|Overall Study||59
8867184|NCT01853371|9923328|FG000|STARTED|Overall Study||10
8867185|NCT01853371|9923329|FG001|STARTED|Overall Study||10
8867186|NCT01853371|9923328|FG000|COMPLETED|Overall Study||10
8867187|NCT01853371|9923329|FG001|COMPLETED|Overall Study||8
8867188|NCT01853371|9923328|FG000|NOT COMPLETED|Overall Study||0
8867189|NCT01853371|9923329|FG001|NOT COMPLETED|Overall Study||2
8867190|NCT01853384|9923337|FG000|STARTED|Randomized||131
8867191|NCT01853384|9923338|FG001|STARTED|Randomized||121
8867192|NCT01853384|9923337|FG000|COMPLETED|Randomized||69
8867193|NCT01853384|9923338|FG001|COMPLETED|Randomized||75
8867194|NCT01853384|9923337|FG000|NOT COMPLETED|Randomized||62
8867195|NCT01853384|9923338|FG001|NOT COMPLETED|Randomized||46
8867196|NCT01853384|9923337|FG000|STARTED|Enrolled in Follow up Period||96
8867197|NCT01853384|9923338|FG001|STARTED|Enrolled in Follow up Period||94
8867198|NCT01853384|9923337|FG000|Not Enrolled in Follow-up|Enrolled in Follow up Period||35
8867199|NCT01853384|9923338|FG001|Not Enrolled in Follow-up|Enrolled in Follow up Period||27
8867200|NCT01853384|9923337|FG000|COMPLETED|Enrolled in Follow up Period||96
8867201|NCT01853384|9923338|FG001|COMPLETED|Enrolled in Follow up Period||94
8867202|NCT01853384|9923337|FG000|NOT COMPLETED|Enrolled in Follow up Period||0
8867203|NCT01853384|9923338|FG001|NOT COMPLETED|Enrolled in Follow up Period||0
8867204|NCT01853384|9923337|FG000|STARTED|Completed Follow up Visit 1||96
8867205|NCT01853384|9923338|FG001|STARTED|Completed Follow up Visit 1||94
8630642|NCT00535782|9670459|FG000|STARTED|Part 1: 24-Week Double-blind Period||69
8725624|NCT01032382|9772927|FG000|STARTED|Overall Study||16
8725625|NCT01032382|9772928|FG001|STARTED|Overall Study||14
8725626|NCT01032382|9772927|FG000|COMPLETED|Overall Study||11
8725627|NCT01032382|9772928|FG001|COMPLETED|Overall Study||9
8725628|NCT01032382|9772927|FG000|NOT COMPLETED|Overall Study||5
8725629|NCT01032382|9772928|FG001|NOT COMPLETED|Overall Study||5
8725630|NCT01032538|9772934|FG000|STARTED|Overall Study|Knees|99
8725631|NCT01032538|9772934|FG000|COMPLETED|Overall Study|Knees|99
8725632|NCT01032538|9772934|FG000|NOT COMPLETED|Overall Study||0
8725633|NCT01032629|9772943|FG000|STARTED|Overall Study||1442
8725634|NCT01032629|9772944|FG001|STARTED|Overall Study||1445
8725635|NCT01032629|9772945|FG002|STARTED|Overall Study||1443
8725636|NCT01032629|9772943|FG000|Treated|Overall Study||1441
8725637|NCT01032629|9772944|FG001|Treated|Overall Study||1445
8725638|NCT01032629|9772945|FG002|Treated|Overall Study||1441
8725639|NCT01032629|9772943|FG000|COMPLETED|Overall Study|Participants who died on trial were considered completed|1297
8725640|NCT01032629|9772944|FG001|COMPLETED|Overall Study|Participants who died on trial were considered completed|1344
8725641|NCT01032629|9772945|FG002|COMPLETED|Overall Study|Participants who died on trial were considered completed|1355
8725642|NCT01032629|9772943|FG000|NOT COMPLETED|Overall Study||145
8725643|NCT01032629|9772944|FG001|NOT COMPLETED|Overall Study||101
8725644|NCT01032629|9772945|FG002|NOT COMPLETED|Overall Study||88
8806516|NCT01477853|9858733|FG000|COMPLETED|Phase B||0
8806517|NCT01477853|9858734|FG001|COMPLETED|Phase B||0
8806518|NCT01477853|9858735|FG002|COMPLETED|Phase B||0
8806519|NCT01477853|9858733|FG000|NOT COMPLETED|Phase B||12
8806520|NCT01477853|9858734|FG001|NOT COMPLETED|Phase B||11
8806521|NCT01477853|9858735|FG002|NOT COMPLETED|Phase B||11
8806522|NCT01477892|9858745|FG000|STARTED|Overall Study||7
8806523|NCT01477892|9858746|FG001|STARTED|Overall Study||7
8806524|NCT01477892|9858745|FG000|COMPLETED|Overall Study||7
8806525|NCT01477892|9858746|FG001|COMPLETED|Overall Study||5
8806526|NCT01477892|9858745|FG000|NOT COMPLETED|Overall Study||0
8806527|NCT01477892|9858746|FG001|NOT COMPLETED|Overall Study||2
8806528|NCT01478009|9858754|FG000|STARTED|Overall Study||50
8806529|NCT01478009|9858755|FG001|STARTED|Overall Study||50
8806530|NCT01478009|9858754|FG000|COMPLETED|Overall Study||49
8806531|NCT01478009|9858755|FG001|COMPLETED|Overall Study||49
8806532|NCT01478009|9858754|FG000|NOT COMPLETED|Overall Study||1
8806533|NCT01478009|9858755|FG001|NOT COMPLETED|Overall Study||1
8806534|NCT01478048|9858763|FG000|STARTED|Overall Study||77
8806535|NCT01478048|9858764|FG001|STARTED|Overall Study||75
8806536|NCT01478048|9858763|FG000|Received Treatment|Overall Study|1 randomized to E-Bd but received Bd. Included in E-Bd group for efficacy and Bd group for safety|76
8806537|NCT01478048|9858764|FG001|Received Treatment|Overall Study|1 randomized to E-Bd but received Bd. Included in E-Bd group for efficacy and Bd group for safety|74
8806538|NCT01478048|9858763|FG000|COMPLETED|Overall Study||0
8806539|NCT01478048|9858764|FG001|COMPLETED|Overall Study||0
8806540|NCT01478048|9858763|FG000|NOT COMPLETED|Overall Study||77
8806541|NCT01478048|9858764|FG001|NOT COMPLETED|Overall Study||75
8806542|NCT01478087|9858770|FG000|STARTED|Overall Study||3
8806543|NCT01478087|9858770|FG000|COMPLETED|Overall Study||2
8806544|NCT01478087|9858770|FG000|NOT COMPLETED|Overall Study||1
8867206|NCT01853384|9923337|FG000|COMPLETED|Completed Follow up Visit 1||82
8867207|NCT01853384|9923338|FG001|COMPLETED|Completed Follow up Visit 1||85
8867208|NCT01853384|9923337|FG000|NOT COMPLETED|Completed Follow up Visit 1||14
8867209|NCT01853384|9923338|FG001|NOT COMPLETED|Completed Follow up Visit 1||9
8867210|NCT01853384|9923337|FG000|STARTED|Completed Follow up Visit 2||96
8867211|NCT01853384|9923338|FG001|STARTED|Completed Follow up Visit 2||94
8867212|NCT01853384|9923337|FG000|COMPLETED|Completed Follow up Visit 2||93
8867213|NCT01853384|9923338|FG001|COMPLETED|Completed Follow up Visit 2||91
8630643|NCT00535782|9670460|FG001|STARTED|Part 1: 24-Week Double-blind Period||63
8630644|NCT00535782|9670461|FG002|STARTED|Part 1: 24-Week Double-blind Period||0
8630645|NCT00535782|9670459|FG000|Treated With TCZ + MTX|Part 1: 24-Week Double-blind Period||69
8630646|NCT00535782|9670460|FG001|Treated With TCZ + MTX|Part 1: 24-Week Double-blind Period|1 misrandomized patient received the TCZ in error, and 1 patient received TCZ as rescue therapy.|2
8630647|NCT00535782|9670461|FG002|Treated With TCZ + MTX|Part 1: 24-Week Double-blind Period||0
8630648|NCT00535782|9670459|FG000|Treated With Placebo + MTX|Part 1: 24-Week Double-blind Period||0
8630649|NCT00535782|9670460|FG001|Treated With Placebo + MTX|Part 1: 24-Week Double-blind Period||62
8867214|NCT01853384|9923337|FG000|NOT COMPLETED|Completed Follow up Visit 2||3
8867215|NCT01853384|9923338|FG001|NOT COMPLETED|Completed Follow up Visit 2||3
8867216|NCT01853397|9923348|FG000|STARTED|Overall Study||18
8867217|NCT01853397|9923349|FG001|STARTED|Overall Study||20
8867218|NCT01853397|9923350|FG002|STARTED|Overall Study||17
8867219|NCT01853397|9923351|FG003|STARTED|Overall Study||17
8867220|NCT01853397|9923348|FG000|COMPLETED|Overall Study||18
8867221|NCT01853397|9923349|FG001|COMPLETED|Overall Study||20
8867222|NCT01853397|9923350|FG002|COMPLETED|Overall Study||17
8867223|NCT01853397|9923351|FG003|COMPLETED|Overall Study||15
8867224|NCT01853397|9923348|FG000|NOT COMPLETED|Overall Study||0
8867225|NCT01853397|9923349|FG001|NOT COMPLETED|Overall Study||0
8867226|NCT01853397|9923350|FG002|NOT COMPLETED|Overall Study||0
8867227|NCT01853397|9923351|FG003|NOT COMPLETED|Overall Study||2
8867228|NCT01853462|9923363|FG000|STARTED|Overall Study||11
8867229|NCT01853462|9923364|FG001|STARTED|Overall Study||11
8867230|NCT01853462|9923363|FG000|COMPLETED|Overall Study||10
8867231|NCT01853462|9923364|FG001|COMPLETED|Overall Study||10
8867232|NCT01853462|9923363|FG000|NOT COMPLETED|Overall Study||1
8867233|NCT01853462|9923364|FG001|NOT COMPLETED|Overall Study||1
8867234|NCT01853475|9923375|FG000|STARTED|Overall Study||8
8867235|NCT01853475|9923376|FG001|STARTED|Overall Study||8
8867236|NCT01853475|9923377|FG002|STARTED|Overall Study||8
8867237|NCT01853475|9923375|FG000|COMPLETED|Overall Study||8
8867238|NCT01853475|9923376|FG001|COMPLETED|Overall Study||7
8867239|NCT01853475|9923377|FG002|COMPLETED|Overall Study||8
8867240|NCT01853475|9923375|FG000|NOT COMPLETED|Overall Study||0
8867241|NCT01853475|9923376|FG001|NOT COMPLETED|Overall Study||1
8867242|NCT01853475|9923377|FG002|NOT COMPLETED|Overall Study||0
8867243|NCT01853553|9923387|FG000|STARTED|Overall Study||29
8867244|NCT01853553|9923388|FG001|STARTED|Overall Study||32
8867245|NCT01853553|9923387|FG000|COMPLETED|Overall Study||28
8951722|NCT02457065|10014645|FG001|COMPLETED|Overall Study||16
8693605|NCT00867334|9739132|FG001|COMPLETED|Overall Study||0
8951723|NCT02457065|10014644|FG000|NOT COMPLETED|Overall Study||9
8951724|NCT02457065|10014645|FG001|NOT COMPLETED|Overall Study||11
8951725|NCT02457182|10014653|FG000|STARTED|Overall Study||9
8951726|NCT02457182|10014654|FG001|STARTED|Overall Study||11
8951727|NCT02457182|10014653|FG000|COMPLETED|Overall Study||8
8951728|NCT02457182|10014654|FG001|COMPLETED|Overall Study||11
8951729|NCT02457182|10014653|FG000|NOT COMPLETED|Overall Study||1
8951730|NCT02457182|10014654|FG001|NOT COMPLETED|Overall Study||0
8951731|NCT02457195|10014660|FG000|STARTED|Overall Study||50
8951732|NCT02457195|10014660|FG000|COMPLETED|Overall Study||41
8951733|NCT02457195|10014660|FG000|NOT COMPLETED|Overall Study||9
8951734|NCT02457247|10014668|FG000|STARTED|Period 1||68
8951735|NCT02457247|10014669|FG001|STARTED|Period 1||70
8951736|NCT02457247|10014670|FG002|STARTED|Period 1||68
8951737|NCT02457247|10014671|FG003|STARTED|Period 1||70
8951738|NCT02457247|10014668|FG000|COMPLETED|Period 1||66
8951739|NCT02457247|10014669|FG001|COMPLETED|Period 1||68
8951740|NCT02457247|10014670|FG002|COMPLETED|Period 1||68
8951741|NCT02457247|10014671|FG003|COMPLETED|Period 1||70
8951742|NCT02457247|10014668|FG000|NOT COMPLETED|Period 1||2
8951743|NCT02457247|10014669|FG001|NOT COMPLETED|Period 1||2
8951744|NCT02457247|10014670|FG002|NOT COMPLETED|Period 1||0
8951745|NCT02457247|10014671|FG003|NOT COMPLETED|Period 1||0
8951746|NCT02457247|10014668|FG000|STARTED|Period 2||66
8951747|NCT02457247|10014669|FG001|STARTED|Period 2||68
8951748|NCT02457247|10014670|FG002|STARTED|Period 2||68
8951749|NCT02457247|10014671|FG003|STARTED|Period 2||70
8951750|NCT02457247|10014668|FG000|COMPLETED|Period 2||64
8951751|NCT02457247|10014669|FG001|COMPLETED|Period 2||65
8951752|NCT02457247|10014670|FG002|COMPLETED|Period 2||68
8951753|NCT02457247|10014671|FG003|COMPLETED|Period 2||70
8951754|NCT02457247|10014668|FG000|NOT COMPLETED|Period 2||2
8951755|NCT02457247|10014669|FG001|NOT COMPLETED|Period 2||3
8951756|NCT02457247|10014670|FG002|NOT COMPLETED|Period 2||0
8951757|NCT02457247|10014671|FG003|NOT COMPLETED|Period 2||0
8951758|NCT02457260|10014690|FG000|STARTED|Overall Study||12
8951759|NCT02457260|10014691|FG001|STARTED|Overall Study||7
8951760|NCT02457260|10014692|FG002|STARTED|Overall Study||2
8951761|NCT02457260|10014690|FG000|COMPLETED|Overall Study||10
8951762|NCT02457260|10014691|FG001|COMPLETED|Overall Study||4
8951763|NCT02457260|10014692|FG002|COMPLETED|Overall Study||1
8951764|NCT02457260|10014690|FG000|NOT COMPLETED|Overall Study||2
8951765|NCT02457260|10014691|FG001|NOT COMPLETED|Overall Study||3
8951766|NCT02457260|10014692|FG002|NOT COMPLETED|Overall Study||1
8867246|NCT01853553|9923388|FG001|COMPLETED|Overall Study||32
8867247|NCT01853553|9923387|FG000|NOT COMPLETED|Overall Study||1
8867248|NCT01853553|9923388|FG001|NOT COMPLETED|Overall Study||0
8867249|NCT01853605|9923398|FG000|STARTED|Overall Study||1939
8867250|NCT01853605|9923399|FG001|STARTED|Overall Study||693
8867251|NCT01853605|9923400|FG002|STARTED|Overall Study||751
8867252|NCT01853605|9923401|FG003|STARTED|Overall Study||428
8867253|NCT01853605|9923398|FG000|COMPLETED|Overall Study||1939
8867254|NCT01853605|9923399|FG001|COMPLETED|Overall Study||693
8867255|NCT01853605|9923400|FG002|COMPLETED|Overall Study||751
8951767|NCT02457325|10014703|FG000|STARTED|First Intervention (1 Day)||25
8951768|NCT02457325|10014704|FG001|STARTED|First Intervention (1 Day)||25
8951769|NCT02457325|10014703|FG000|COMPLETED|First Intervention (1 Day)||23
8951770|NCT02457325|10014704|FG001|COMPLETED|First Intervention (1 Day)||23
8951771|NCT02457325|10014703|FG000|NOT COMPLETED|First Intervention (1 Day)||2
8951772|NCT02457325|10014704|FG001|NOT COMPLETED|First Intervention (1 Day)||2
8951773|NCT02457325|10014703|FG000|STARTED|Washout (1-2 Months)||23
8867256|NCT01853605|9923401|FG003|COMPLETED|Overall Study||428
8867257|NCT01853605|9923398|FG000|NOT COMPLETED|Overall Study||0
8867258|NCT01853605|9923399|FG001|NOT COMPLETED|Overall Study||0
8867259|NCT01853605|9923400|FG002|NOT COMPLETED|Overall Study||0
8867260|NCT01853605|9923401|FG003|NOT COMPLETED|Overall Study||0
8867261|NCT01853618|9923416|FG000|STARTED|Overall Study||8
8867262|NCT01853618|9923417|FG001|STARTED|Overall Study||12
8867263|NCT01853618|9923418|FG002|STARTED|Overall Study||12
8867264|NCT01853618|9923419|FG003|STARTED|Overall Study||9
8867265|NCT01853618|9923420|FG004|STARTED|Overall Study||20
8867266|NCT01853618|9923416|FG000|COMPLETED|Overall Study||6
8867267|NCT01853618|9923417|FG001|COMPLETED|Overall Study||10
8867268|NCT01853618|9923418|FG002|COMPLETED|Overall Study||10
8867269|NCT01853618|9923419|FG003|COMPLETED|Overall Study||8
8867270|NCT01853618|9923420|FG004|COMPLETED|Overall Study||17
8867271|NCT01853618|9923416|FG000|NOT COMPLETED|Overall Study||2
8867272|NCT01853618|9923417|FG001|NOT COMPLETED|Overall Study||2
8867273|NCT01853618|9923418|FG002|NOT COMPLETED|Overall Study||2
8867274|NCT01853618|9923419|FG003|NOT COMPLETED|Overall Study||1
8867275|NCT01853618|9923420|FG004|NOT COMPLETED|Overall Study||3
8923784|NCT02243280|9984422|FG002|Completed Treatment|Treated||0
8923785|NCT02243280|9984423|FG003|Completed Treatment|Treated||0
8923786|NCT02243280|9984424|FG004|Completed Treatment|Treated||0
8923787|NCT02243280|9984425|FG005|Completed Treatment|Treated||27
8923788|NCT02243280|9984426|FG006|Completed Treatment|Treated||0
8923789|NCT02243280|9984427|FG007|Completed Treatment|Treated||0
8923790|NCT02243280|9984428|FG008|Completed Treatment|Treated||32
8951774|NCT02457325|10014704|FG001|STARTED|Washout (1-2 Months)||23
8951775|NCT02457325|10014703|FG000|COMPLETED|Washout (1-2 Months)||23
8951776|NCT02457325|10014704|FG001|COMPLETED|Washout (1-2 Months)||23
8951777|NCT02457325|10014703|FG000|NOT COMPLETED|Washout (1-2 Months)||0
8951778|NCT02457325|10014704|FG001|NOT COMPLETED|Washout (1-2 Months)||0
8951779|NCT02457325|10014703|FG000|STARTED|Second Intervention (1 Day)||23
8951780|NCT02457325|10014704|FG001|STARTED|Second Intervention (1 Day)||23
8951781|NCT02457325|10014703|FG000|COMPLETED|Second Intervention (1 Day)||23
8951782|NCT02457325|10014704|FG001|COMPLETED|Second Intervention (1 Day)||23
8951783|NCT02457325|10014703|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
8951784|NCT02457325|10014704|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
8951785|NCT02457403|10014712|FG000|STARTED|Overall Study|34 participants|34
8951786|NCT02457403|10014713|FG001|STARTED|Overall Study|34 historic controls|34
8951787|NCT02457403|10014712|FG000|COMPLETED|Overall Study||34
8951788|NCT02457403|10014713|FG001|COMPLETED|Overall Study||34
8951789|NCT02457403|10014712|FG000|NOT COMPLETED|Overall Study||0
8951790|NCT02457403|10014713|FG001|NOT COMPLETED|Overall Study||0
8951791|NCT02457520|10014721|FG000|STARTED|Active Treatment Phase|All subjects received treatment according to the same regimen.|201
8951792|NCT02457520|10014721|FG000|COMPLETED|Active Treatment Phase||167
8951793|NCT02457520|10014721|FG000|NOT COMPLETED|Active Treatment Phase||34
8951794|NCT02457520|10014721|FG000|STARTED|Post-treatment Period||167
8951795|NCT02457520|10014721|FG000|COMPLETED|Post-treatment Period||119
8951796|NCT02457520|10014721|FG000|NOT COMPLETED|Post-treatment Period||48
8951797|NCT02457546|10014753|FG000|STARTED|Overall Study||114
8951798|NCT02457546|10014754|FG001|STARTED|Overall Study||120
8951799|NCT02457546|10014753|FG000|COMPLETED|Overall Study||105
8951800|NCT02457546|10014754|FG001|COMPLETED|Overall Study||116
8951801|NCT02457546|10014753|FG000|NOT COMPLETED|Overall Study||9
8951802|NCT02457546|10014754|FG001|NOT COMPLETED|Overall Study||4
8951803|NCT02457611|10014760|FG000|STARTED|Overall Study||26
8951804|NCT02457611|10014760|FG000|COMPLETED|Overall Study||23
8951805|NCT02457611|10014760|FG000|NOT COMPLETED|Overall Study||3
8951806|NCT02457637|10014764|FG000|STARTED|Recruitment|2600 is the number of inpatients who met our eligibility.|2600
8951807|NCT02457637|10014764|FG000|COMPLETED|Recruitment|2361 patients were excluded according to our exclusion criteria,2600 patients remained.|2600
8951808|NCT02457637|10014764|FG000|NOT COMPLETED|Recruitment||0
8951809|NCT02457637|10014764|FG000|STARTED|28-Days Hospitalization and Observation||2600
8951810|NCT02457637|10014764|FG000|Liver Transplantation|28-Days Hospitalization and Observation||124
8951811|NCT02457637|10014764|FG000|Death|28-Days Hospitalization and Observation||74
8951812|NCT02457637|10014764|FG000|COMPLETED|28-Days Hospitalization and Observation|Death and receiving Liver transplantation are two end points of our observation.|2600
8951813|NCT02457637|10014764|FG000|NOT COMPLETED|28-Days Hospitalization and Observation||0
8951814|NCT02457637|10014764|FG000|STARTED|Clinic or Telephone Follow-up||2600
8951815|NCT02457637|10014764|FG000|One-year Liver Transplantation|Clinic or Telephone Follow-up||182
8951816|NCT02457637|10014764|FG000|One-year Death|Clinic or Telephone Follow-up||475
8951817|NCT02457637|10014764|FG000|COMPLETED|Clinic or Telephone Follow-up||2529
8951818|NCT02457637|10014764|FG000|NOT COMPLETED|Clinic or Telephone Follow-up||71
8951819|NCT02457728|10014769|FG000|STARTED|Overall Study||34
8951820|NCT02457728|10014769|FG000|COMPLETED|Overall Study||34
8951821|NCT02457728|10014769|FG000|NOT COMPLETED|Overall Study||0
8923791|NCT02243280|9984429|FG009|Completed Treatment|Treated||0
8923792|NCT02243280|9984430|FG010|Completed Treatment|Treated||33
8923793|NCT02243280|9984420|FG000|COMPLETED|Treated||41
8923794|NCT02243280|9984421|FG001|COMPLETED|Treated||39
8923795|NCT02243280|9984422|FG002|COMPLETED|Treated||0
8923796|NCT02243280|9984423|FG003|COMPLETED|Treated||0
8923797|NCT02243280|9984424|FG004|COMPLETED|Treated||0
8923798|NCT02243280|9984425|FG005|COMPLETED|Treated||27
8951822|NCT02457793|10014779|FG000|STARTED|Overall Study||1
8951823|NCT02457793|10014780|FG001|STARTED|Overall Study||5
8867276|NCT01853644|9923433|FG000|STARTED|Registration and Treatment Start||31
8867277|NCT01853644|9923433|FG000|Registered|Registration and Treatment Start||31
8867278|NCT01853644|9923433|FG000|Started Treatment|Registration and Treatment Start||30
8867279|NCT01853644|9923433|FG000|COMPLETED|Registration and Treatment Start||30
8867280|NCT01853644|9923433|FG000|NOT COMPLETED|Registration and Treatment Start||1
8867281|NCT01853644|9923433|FG000|STARTED|Reached First Response/Complete 2 Cycles||30
8867282|NCT01853644|9923433|FG000|COMPLETED|Reached First Response/Complete 2 Cycles||24
8867283|NCT01853644|9923433|FG000|NOT COMPLETED|Reached First Response/Complete 2 Cycles||6
8867284|NCT01853644|9923433|FG000|STARTED|Continued Treatment After First Response||24
8867285|NCT01853644|9923433|FG000|COMPLETED|Continued Treatment After First Response||12
8867286|NCT01853644|9923433|FG000|NOT COMPLETED|Continued Treatment After First Response||12
8867287|NCT01853644|9923433|FG000|STARTED|Follow up for 3 Years or Until Death|All patients that are treated on the study go into the follow up period|30
8867288|NCT01853644|9923433|FG000|COMPLETED|Follow up for 3 Years or Until Death||30
8867289|NCT01853644|9923433|FG000|NOT COMPLETED|Follow up for 3 Years or Until Death||0
8867290|NCT01853696|9923439|FG000|STARTED|Overall Study||84
8867291|NCT01853696|9923440|FG001|STARTED|Overall Study||83
8867292|NCT01853696|9923439|FG000|COMPLETED|Overall Study||78
8867293|NCT01853696|9923440|FG001|COMPLETED|Overall Study||78
8867294|NCT01853696|9923439|FG000|NOT COMPLETED|Overall Study||6
8867295|NCT01853696|9923440|FG001|NOT COMPLETED|Overall Study||5
8951824|NCT02457793|10014781|FG002|STARTED|Overall Study||3
8951825|NCT02457793|10014782|FG003|STARTED|Overall Study||5
8951826|NCT02457793|10014783|FG004|STARTED|Overall Study||4
8951827|NCT02457793|10014784|FG005|STARTED|Overall Study||6
8951828|NCT02457793|10014779|FG000|COMPLETED|Overall Study||0
8951829|NCT02457793|10014780|FG001|COMPLETED|Overall Study||1
8951830|NCT02457793|10014781|FG002|COMPLETED|Overall Study||0
8951831|NCT02457793|10014782|FG003|COMPLETED|Overall Study||0
8951832|NCT02457793|10014783|FG004|COMPLETED|Overall Study||0
8951833|NCT02457793|10014784|FG005|COMPLETED|Overall Study||0
8951834|NCT02457793|10014779|FG000|NOT COMPLETED|Overall Study||1
8951835|NCT02457793|10014780|FG001|NOT COMPLETED|Overall Study||4
8951836|NCT02457793|10014781|FG002|NOT COMPLETED|Overall Study||3
8951837|NCT02457793|10014782|FG003|NOT COMPLETED|Overall Study||5
8951838|NCT02457793|10014783|FG004|NOT COMPLETED|Overall Study||4
8951839|NCT02457793|10014784|FG005|NOT COMPLETED|Overall Study||6
8951840|NCT02457819|10014799|FG000|STARTED|Overall Study||237
8951841|NCT02457819|10014799|FG000|Safety Population|Overall Study||236
8951842|NCT02457819|10014799|FG000|COMPLETED|Overall Study||138
8951843|NCT02457819|10014799|FG000|NOT COMPLETED|Overall Study||99
8951844|NCT02457897|10014803|FG000|STARTED|Part 1 Short-term (2 Weeks) Study||7
8951845|NCT02457897|10014803|FG000|COMPLETED|Part 1 Short-term (2 Weeks) Study||7
8951846|NCT02457897|10014803|FG000|NOT COMPLETED|Part 1 Short-term (2 Weeks) Study||0
8951847|NCT02457897|10014803|FG000|STARTED|Part 2 Long-term (6 Month) Study|Two patients were not eligible for Part 2 study because their HbA1c was less than 7.|5
8951848|NCT02457897|10014803|FG000|COMPLETED|Part 2 Long-term (6 Month) Study||5
8951849|NCT02457897|10014803|FG000|NOT COMPLETED|Part 2 Long-term (6 Month) Study||0
9037507|NCT03315689|10098696|FG000|COMPLETED|Double-blind Period = 28 Days||3
9037508|NCT03315689|10098697|FG001|COMPLETED|Double-blind Period = 28 Days||7
9037509|NCT03315689|10098696|FG000|NOT COMPLETED|Double-blind Period = 28 Days||1
9037510|NCT03315689|10098697|FG001|NOT COMPLETED|Double-blind Period = 28 Days||0
9037511|NCT03315689|10098696|FG000|STARTED|Open Label Extension = 52 Weeks||0
9037512|NCT03315689|10098697|FG001|STARTED|Open Label Extension = 52 Weeks||10
9037513|NCT03315689|10098696|FG000|COMPLETED|Open Label Extension = 52 Weeks||0
9037514|NCT03315689|10098697|FG001|COMPLETED|Open Label Extension = 52 Weeks||7
9037515|NCT03315689|10098696|FG000|NOT COMPLETED|Open Label Extension = 52 Weeks||0
9037516|NCT03315689|10098697|FG001|NOT COMPLETED|Open Label Extension = 52 Weeks||3
9037517|NCT03315702|10098705|FG000|STARTED|Overall Study||52
9037518|NCT03315702|10098705|FG000|COMPLETED|Overall Study||52
9037519|NCT03315702|10098705|FG000|NOT COMPLETED|Overall Study||0
9037520|NCT03315780|10098710|FG000|STARTED|Period 1||6
9037521|NCT03315780|10098711|FG001|STARTED|Period 1||6
9037522|NCT03315780|10098710|FG000|Received One Dose of Study Drug|Period 1||6
9037523|NCT03315780|10098711|FG001|Received One Dose of Study Drug|Period 1||6
9037524|NCT03315780|10098710|FG000|COMPLETED|Period 1||6
9037525|NCT03315780|10098711|FG001|COMPLETED|Period 1||6
9037526|NCT03315780|10098710|FG000|NOT COMPLETED|Period 1||0
9037527|NCT03315780|10098711|FG001|NOT COMPLETED|Period 1||0
9037528|NCT03315780|10098710|FG000|STARTED|Period 2||6
9037529|NCT03315780|10098711|FG001|STARTED|Period 2||6
9037530|NCT03315780|10098710|FG000|COMPLETED|Period 2||6
8569809|NCT00098748|9601932|FG000|Dual-tropic Subjects by Phenotype Assay|Received Study Treatment|Dual-tropic: Virus capable of using both CCR5 and CXCR4 coreceptors for cell entry.|57
8569810|NCT00098748|9601933|FG001|Dual-tropic Subjects by Phenotype Assay|Received Study Treatment||52
9037531|NCT03315780|10098711|FG001|COMPLETED|Period 2||6
9037532|NCT03315780|10098710|FG000|NOT COMPLETED|Period 2||0
9037533|NCT03315780|10098711|FG001|NOT COMPLETED|Period 2||0
9037534|NCT03315793|10098719|FG000|STARTED|Overall Study||75
8569811|NCT00098748|9601934|FG002|Dual-tropic Subjects by Phenotype Assay|Received Study Treatment||58
8569812|NCT00098748|9601932|FG000|COMPLETED|Received Study Treatment||15
9037535|NCT03315793|10098720|FG001|STARTED|Overall Study||74
8569813|NCT00098748|9601933|FG001|COMPLETED|Received Study Treatment||25
8867296|NCT01853774|9923448|FG000|STARTED|Overall Study||257
8867297|NCT01853774|9923449|FG001|STARTED|Overall Study||162
8867298|NCT01853774|9923448|FG000|COMPLETED|Overall Study||211
8867299|NCT01853774|9923449|FG001|COMPLETED|Overall Study||134
8867300|NCT01853774|9923448|FG000|NOT COMPLETED|Overall Study||46
8867301|NCT01853774|9923449|FG001|NOT COMPLETED|Overall Study||28
8867302|NCT01853839|9923457|FG000|STARTED|Overall Study||2092
8867303|NCT01853839|9923457|FG000|COMPLETED|Overall Study||1663
8867304|NCT01853839|9923457|FG000|NOT COMPLETED|Overall Study||429
8867305|NCT01853878|9923467|FG000|STARTED|Overall Study||86
8867306|NCT01853878|9923468|FG001|STARTED|Overall Study||47
8867307|NCT01853878|9923467|FG000|COMPLETED|Overall Study||23
8867308|NCT01853878|9923468|FG001|COMPLETED|Overall Study||3
8867309|NCT01853878|9923467|FG000|NOT COMPLETED|Overall Study||63
8867310|NCT01853878|9923468|FG001|NOT COMPLETED|Overall Study||44
8867311|NCT01853930|9923476|FG000|STARTED|Overall Study||25
8867312|NCT01853930|9923477|FG001|STARTED|Overall Study||8
8867313|NCT01853930|9923476|FG000|COMPLETED|Overall Study||25
8867314|NCT01853930|9923477|FG001|COMPLETED|Overall Study||8
8867315|NCT01853930|9923476|FG000|NOT COMPLETED|Overall Study||0
8867316|NCT01853930|9923477|FG001|NOT COMPLETED|Overall Study||0
8867317|NCT01854034|9923483|FG000|STARTED|Overall Study||29
8867318|NCT01854034|9923483|FG000|COMPLETED|Overall Study||29
8867319|NCT01854034|9923483|FG000|NOT COMPLETED|Overall Study||0
8867320|NCT01854047|9923492|FG000|STARTED|Overall Study||158
8867321|NCT01854047|9923493|FG001|STARTED|Overall Study||157
8867322|NCT01854047|9923494|FG002|STARTED|Overall Study||150
8867323|NCT01854047|9923495|FG003|STARTED|Overall Study||157
8951850|NCT02458092|10014809|FG000|STARTED|Overall Study||20
8951851|NCT02458092|10014810|FG001|STARTED|Overall Study||10
8951852|NCT02458092|10014809|FG000|COMPLETED|Overall Study||19
8951853|NCT02458092|10014810|FG001|COMPLETED|Overall Study||10
8951854|NCT02458092|10014809|FG000|NOT COMPLETED|Overall Study||1
8951855|NCT02458092|10014810|FG001|NOT COMPLETED|Overall Study||0
8951856|NCT02458235|10014817|FG000|STARTED|Overall Study||17
8951857|NCT02458235|10014817|FG000|COMPLETED|Overall Study||17
8951858|NCT02458235|10014817|FG000|NOT COMPLETED|Overall Study||0
8951859|NCT02458287|10014825|FG000|STARTED|Overall Study||50
8951860|NCT02458287|10014826|FG001|STARTED|Overall Study||100
8951861|NCT02458287|10014827|FG002|STARTED|Overall Study||49
8951862|NCT02458287|10014828|FG003|STARTED|Overall Study||100
8951863|NCT02458287|10014825|FG000|COMPLETED|Overall Study||50
8951864|NCT02458287|10014826|FG001|COMPLETED|Overall Study||96
8951865|NCT02458287|10014827|FG002|COMPLETED|Overall Study||46
8951866|NCT02458287|10014828|FG003|COMPLETED|Overall Study||97
8951867|NCT02458287|10014825|FG000|NOT COMPLETED|Overall Study||0
8951868|NCT02458287|10014826|FG001|NOT COMPLETED|Overall Study||4
8951869|NCT02458287|10014827|FG002|NOT COMPLETED|Overall Study||3
8951870|NCT02458287|10014828|FG003|NOT COMPLETED|Overall Study||3
8951871|NCT02458352|10014844|FG000|STARTED|Overall Study||105
8951872|NCT02458352|10014844|FG000|COMPLETED|Overall Study||105
8951873|NCT02458352|10014844|FG000|NOT COMPLETED|Overall Study||0
8951874|NCT02458365|10014852|FG000|STARTED|Overall Study||2000
8951875|NCT02458365|10014853|FG001|STARTED|Overall Study||1901
8951876|NCT02458365|10014852|FG000|COMPLETED|Overall Study||1723
8951877|NCT02458365|10014853|FG001|COMPLETED|Overall Study||1607
8951878|NCT02458365|10014852|FG000|NOT COMPLETED|Overall Study||277
8951879|NCT02458365|10014853|FG001|NOT COMPLETED|Overall Study||294
8951880|NCT02458469|10014860|FG000|STARTED|First Intervention (2 Weeks)||3
8951881|NCT02458469|10014861|FG001|STARTED|First Intervention (2 Weeks)||2
8951882|NCT02458469|10014862|FG002|STARTED|First Intervention (2 Weeks)||3
8951883|NCT02458469|10014863|FG003|STARTED|First Intervention (2 Weeks)||0
8951884|NCT02458469|10014864|FG004|STARTED|First Intervention (2 Weeks)||1
8951885|NCT02458469|10014865|FG005|STARTED|First Intervention (2 Weeks)||2
8951886|NCT02458469|10014860|FG000|COMPLETED|First Intervention (2 Weeks)||2
8951887|NCT02458469|10014861|FG001|COMPLETED|First Intervention (2 Weeks)||2
8951888|NCT02458469|10014862|FG002|COMPLETED|First Intervention (2 Weeks)||2
8951889|NCT02458469|10014863|FG003|COMPLETED|First Intervention (2 Weeks)||0
8951890|NCT02458469|10014864|FG004|COMPLETED|First Intervention (2 Weeks)||1
8569814|NCT00098748|9601934|FG002|COMPLETED|Received Study Treatment||18
8867324|NCT01854047|9923496|FG004|STARTED|Overall Study||154
8867325|NCT01854047|9923492|FG000|Treated|Overall Study||158
8867326|NCT01854047|9923493|FG001|Treated|Overall Study||156
8867327|NCT01854047|9923494|FG002|Treated|Overall Study||148
8867328|NCT01854047|9923495|FG003|Treated|Overall Study||157
8867329|NCT01854047|9923496|FG004|Treated|Overall Study||150
8867330|NCT01854047|9923492|FG000|Completed 12-week Study Treatment|Overall Study||153
8867331|NCT01854047|9923493|FG001|Completed 12-week Study Treatment|Overall Study||149
8951891|NCT02458469|10014865|FG005|COMPLETED|First Intervention (2 Weeks)||2
8951892|NCT02458469|10014860|FG000|NOT COMPLETED|First Intervention (2 Weeks)||1
8951893|NCT02458469|10014861|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0
8951894|NCT02458469|10014862|FG002|NOT COMPLETED|First Intervention (2 Weeks)||1
8867332|NCT01854047|9923494|FG002|Completed 12-week Study Treatment|Overall Study||141
8867333|NCT01854047|9923495|FG003|Completed 12-week Study Treatment|Overall Study||146
8867334|NCT01854047|9923496|FG004|Completed 12-week Study Treatment|Overall Study||143
8867335|NCT01854047|9923492|FG000|COMPLETED|Overall Study||146
8867336|NCT01854047|9923493|FG001|COMPLETED|Overall Study||149
8867337|NCT01854047|9923494|FG002|COMPLETED|Overall Study||137
8867338|NCT01854047|9923495|FG003|COMPLETED|Overall Study||142
8867339|NCT01854047|9923496|FG004|COMPLETED|Overall Study||135
8867340|NCT01854047|9923492|FG000|NOT COMPLETED|Overall Study||12
8867341|NCT01854047|9923493|FG001|NOT COMPLETED|Overall Study||8
8867342|NCT01854047|9923494|FG002|NOT COMPLETED|Overall Study||13
8867343|NCT01854047|9923495|FG003|NOT COMPLETED|Overall Study||15
8867344|NCT01854047|9923496|FG004|NOT COMPLETED|Overall Study||19
8867345|NCT01854138|9923510|FG000|STARTED|Overall Study|historical control with waiver of authorization; no informed consent signed|400
8867346|NCT01854138|9923511|FG001|STARTED|Overall Study||248
8867347|NCT01854138|9923510|FG000|COMPLETED|Overall Study||400
8867348|NCT01854138|9923511|FG001|COMPLETED|Overall Study||196
8867349|NCT01854138|9923510|FG000|NOT COMPLETED|Overall Study||0
8867350|NCT01854138|9923511|FG001|NOT COMPLETED|Overall Study||52
8867351|NCT01854177|9923518|FG000|STARTED|Overall Study||10
8867352|NCT01854177|9923518|FG000|COMPLETED|Overall Study||10
8867353|NCT01854177|9923518|FG000|NOT COMPLETED|Overall Study||0
8867354|NCT01854242|9923524|FG000|STARTED|Overall Study||50
8867355|NCT01854242|9923524|FG000|COMPLETED|Overall Study||50
8867356|NCT01854242|9923524|FG000|NOT COMPLETED|Overall Study||0
8867357|NCT01854281|9923532|FG000|STARTED|Overall Study||15
8867358|NCT01854281|9923533|FG001|STARTED|Overall Study||19
8867359|NCT01854281|9923534|FG002|STARTED|Overall Study||5
8867360|NCT01854281|9923535|FG003|STARTED|Overall Study||8
8867361|NCT01854281|9923532|FG000|COMPLETED|Overall Study||15
8867362|NCT01854281|9923533|FG001|COMPLETED|Overall Study||19
8867363|NCT01854281|9923534|FG002|COMPLETED|Overall Study||5
8867364|NCT01854281|9923535|FG003|COMPLETED|Overall Study||8
8867365|NCT01854281|9923532|FG000|NOT COMPLETED|Overall Study||0
8867366|NCT01854281|9923533|FG001|NOT COMPLETED|Overall Study||0
8867367|NCT01854281|9923534|FG002|NOT COMPLETED|Overall Study||0
8867368|NCT01854281|9923535|FG003|NOT COMPLETED|Overall Study||0
8867369|NCT01854359|9923547|FG000|STARTED|Overall Study||31
8867370|NCT01854359|9923548|FG001|STARTED|Overall Study||30
8867371|NCT01854359|9923547|FG000|COMPLETED|Overall Study||26
8867372|NCT01854359|9923548|FG001|COMPLETED|Overall Study||22
8867373|NCT01854359|9923547|FG000|NOT COMPLETED|Overall Study||5
8867374|NCT01854359|9923548|FG001|NOT COMPLETED|Overall Study||8
8867375|NCT01854528|9923564|FG000|STARTED|Overall Study||101
8867376|NCT01854528|9923565|FG001|STARTED|Overall Study||47
8867377|NCT01854528|9923564|FG000|COMPLETED|Overall Study||101
8867378|NCT01854528|9923565|FG001|COMPLETED|Overall Study||32
8867379|NCT01854528|9923564|FG000|NOT COMPLETED|Overall Study||0
8867380|NCT01854528|9923565|FG001|NOT COMPLETED|Overall Study||15
8867381|NCT01854593|9923573|FG000|STARTED|Overall Study||34
8867382|NCT01854593|9923574|FG001|STARTED|Overall Study||35
8867383|NCT01854593|9923573|FG000|COMPLETED|Overall Study||32
8867384|NCT01854593|9923574|FG001|COMPLETED|Overall Study||34
8867385|NCT01854593|9923573|FG000|NOT COMPLETED|Overall Study||2
8867386|NCT01854593|9923574|FG001|NOT COMPLETED|Overall Study||1
8867387|NCT01854632|9923583|FG000|STARTED|Overall Study||1174
8867388|NCT01854632|9923584|FG001|STARTED|Overall Study||587
8867389|NCT01854632|9923583|FG000|COMPLETED|Overall Study||1148
8867390|NCT01854632|9923584|FG001|COMPLETED|Overall Study||574
8867391|NCT01854632|9923583|FG000|NOT COMPLETED|Overall Study||26
8867392|NCT01854632|9923584|FG001|NOT COMPLETED|Overall Study||13
8867393|NCT01854645|9923595|FG000|STARTED|Overall Study||527
8867394|NCT01854645|9923596|FG001|STARTED|Overall Study||451
8867395|NCT01854645|9923597|FG002|STARTED|Overall Study||452
8867396|NCT01854645|9923598|FG003|STARTED|Overall Study||453
8867397|NCT01854645|9923599|FG004|STARTED|Overall Study||220
8867398|NCT01854645|9923595|FG000|COMPLETED|Overall Study||429
8867399|NCT01854645|9923596|FG001|COMPLETED|Overall Study||345
8867400|NCT01854645|9923597|FG002|COMPLETED|Overall Study||370
8867401|NCT01854645|9923598|FG003|COMPLETED|Overall Study||391
8867402|NCT01854645|9923599|FG004|COMPLETED|Overall Study||160
8867403|NCT01854645|9923595|FG000|NOT COMPLETED|Overall Study||98
8867404|NCT01854645|9923596|FG001|NOT COMPLETED|Overall Study||106
8867405|NCT01854645|9923597|FG002|NOT COMPLETED|Overall Study||82
8867406|NCT01854645|9923598|FG003|NOT COMPLETED|Overall Study||62
8867407|NCT01854645|9923599|FG004|NOT COMPLETED|Overall Study||60
8867408|NCT01854658|9923615|FG000|STARTED|Overall Study||439
8867409|NCT01854658|9923616|FG001|STARTED|Overall Study||440
8867410|NCT01854658|9923617|FG002|STARTED|Overall Study||512
8867411|NCT01854658|9923618|FG003|STARTED|Overall Study||224
8867412|NCT01854658|9923615|FG000|COMPLETED|Overall Study||346
8867413|NCT01854658|9923616|FG001|COMPLETED|Overall Study||365
8867414|NCT01854658|9923617|FG002|COMPLETED|Overall Study||432
8867415|NCT01854658|9923618|FG003|COMPLETED|Overall Study||165
8867416|NCT01854658|9923615|FG000|NOT COMPLETED|Overall Study||93
8867417|NCT01854658|9923616|FG001|NOT COMPLETED|Overall Study||75
8867418|NCT01854658|9923617|FG002|NOT COMPLETED|Overall Study||80
8867419|NCT01854658|9923618|FG003|NOT COMPLETED|Overall Study||59
8867420|NCT01854697|9923633|FG000|STARTED|Overall Study||69
8867421|NCT01854697|9923634|FG001|STARTED|Overall Study||34
8867422|NCT01854697|9923635|FG002|STARTED|Overall Study||84
8867423|NCT01854697|9923636|FG003|STARTED|Overall Study||83
8867424|NCT01854697|9923637|FG004|STARTED|Overall Study||41
8867425|NCT01854697|9923633|FG000|COMPLETED|Overall Study||63
8867426|NCT01854697|9923634|FG001|COMPLETED|Overall Study||31
8867427|NCT01854697|9923635|FG002|COMPLETED|Overall Study||82
8867428|NCT01854697|9923636|FG003|COMPLETED|Overall Study||80
8867429|NCT01854697|9923637|FG004|COMPLETED|Overall Study||39
8867430|NCT01854697|9923633|FG000|NOT COMPLETED|Overall Study||6
8867431|NCT01854697|9923634|FG001|NOT COMPLETED|Overall Study||3
8867432|NCT01854697|9923635|FG002|NOT COMPLETED|Overall Study||2
8867433|NCT01854697|9923636|FG003|NOT COMPLETED|Overall Study||3
8867434|NCT01854697|9923637|FG004|NOT COMPLETED|Overall Study||2
8867435|NCT01854710|9923647|FG000|STARTED|Overall Study||10
8867436|NCT01854710|9923648|FG001|STARTED|Overall Study||10
8867437|NCT01854710|9923649|FG002|STARTED|Overall Study||10
8630650|NCT00535782|9670461|FG002|Treated With Placebo + MTX|Part 1: 24-Week Double-blind Period||0
8630651|NCT00535782|9670459|FG000|COMPLETED|Part 1: 24-Week Double-blind Period||65
8630652|NCT00535782|9670460|FG001|COMPLETED|Part 1: 24-Week Double-blind Period||59
8867438|NCT01854710|9923650|FG003|STARTED|Overall Study||10
8867439|NCT01854710|9923651|FG004|STARTED|Overall Study||10
8867440|NCT01854710|9923652|FG005|STARTED|Overall Study||10
8867441|NCT01854710|9923647|FG000|COMPLETED|Overall Study||6
8867442|NCT01854710|9923648|FG001|COMPLETED|Overall Study||7
8867443|NCT01854710|9923649|FG002|COMPLETED|Overall Study||8
8867444|NCT01854710|9923650|FG003|COMPLETED|Overall Study||8
8867445|NCT01854710|9923651|FG004|COMPLETED|Overall Study||8
8867446|NCT01854710|9923652|FG005|COMPLETED|Overall Study||8
8630653|NCT00535782|9670461|FG002|COMPLETED|Part 1: 24-Week Double-blind Period||0
8630654|NCT00535782|9670459|FG000|NOT COMPLETED|Part 1: 24-Week Double-blind Period||4
8630655|NCT00535782|9670460|FG001|NOT COMPLETED|Part 1: 24-Week Double-blind Period||4
8630656|NCT00535782|9670461|FG002|NOT COMPLETED|Part 1: 24-Week Double-blind Period||0
8630657|NCT00535782|9670459|FG000|STARTED|Part 2: 80-Week Open-label Period||0
8630658|NCT00535782|9670460|FG001|STARTED|Part 2: 80-Week Open-label Period||0
8630659|NCT00535782|9670461|FG002|STARTED|Part 2: 80-Week Open-label Period||124
8630660|NCT00535782|9670459|FG000|COMPLETED|Part 2: 80-Week Open-label Period||0
8630661|NCT00535782|9670460|FG001|COMPLETED|Part 2: 80-Week Open-label Period||0
8630662|NCT00535782|9670461|FG002|COMPLETED|Part 2: 80-Week Open-label Period||98
8630663|NCT00535782|9670459|FG000|NOT COMPLETED|Part 2: 80-Week Open-label Period||0
8630664|NCT00535782|9670460|FG001|NOT COMPLETED|Part 2: 80-Week Open-label Period||0
8867447|NCT01854710|9923647|FG000|NOT COMPLETED|Overall Study||4
8867448|NCT01854710|9923648|FG001|NOT COMPLETED|Overall Study||3
8867449|NCT01854710|9923649|FG002|NOT COMPLETED|Overall Study||2
8867450|NCT01854710|9923650|FG003|NOT COMPLETED|Overall Study||2
8867451|NCT01854710|9923651|FG004|NOT COMPLETED|Overall Study||2
8867452|NCT01854710|9923652|FG005|NOT COMPLETED|Overall Study||2
8867453|NCT01854775|9923665|FG000|STARTED|Treatment Phase (48 Weeks)||50
8867454|NCT01854775|9923666|FG001|STARTED|Treatment Phase (48 Weeks)||52
8867455|NCT01854775|9923667|FG002|STARTED|Treatment Phase (48 Weeks)||27
8867456|NCT01854775|9923665|FG000|COMPLETED|Treatment Phase (48 Weeks)||48
8867457|NCT01854775|9923666|FG001|COMPLETED|Treatment Phase (48 Weeks)||51
8867458|NCT01854775|9923667|FG002|COMPLETED|Treatment Phase (48 Weeks)||18
8867459|NCT01854775|9923665|FG000|NOT COMPLETED|Treatment Phase (48 Weeks)||2
8867460|NCT01854775|9923666|FG001|NOT COMPLETED|Treatment Phase (48 Weeks)||1
8867461|NCT01854775|9923667|FG002|NOT COMPLETED|Treatment Phase (48 Weeks)||9
8867462|NCT01854775|9923665|FG000|STARTED|Extension Phase||48
8867463|NCT01854775|9923666|FG001|STARTED|Extension Phase||50
8867464|NCT01854775|9923667|FG002|STARTED|Extension Phase||18
8867465|NCT01854775|9923665|FG000|COMPLETED|Extension Phase||9
8867466|NCT01854775|9923666|FG001|COMPLETED|Extension Phase||3
8867467|NCT01854775|9923667|FG002|COMPLETED|Extension Phase||0
8867468|NCT01854775|9923665|FG000|NOT COMPLETED|Extension Phase||39
8867469|NCT01854775|9923666|FG001|NOT COMPLETED|Extension Phase||47
8630665|NCT00535782|9670461|FG002|NOT COMPLETED|Part 2: 80-Week Open-label Period||26
8630666|NCT00535821|9670470|FG000|STARTED|Overall Study||2
8867470|NCT01854775|9923667|FG002|NOT COMPLETED|Extension Phase||18
8951895|NCT02458469|10014863|FG003|NOT COMPLETED|First Intervention (2 Weeks)||0
8951896|NCT02458469|10014864|FG004|NOT COMPLETED|First Intervention (2 Weeks)||0
8951897|NCT02458469|10014865|FG005|NOT COMPLETED|First Intervention (2 Weeks)||0
8951898|NCT02458469|10014860|FG000|STARTED|First Washout (2 Weeks)||2
8951899|NCT02458469|10014861|FG001|STARTED|First Washout (2 Weeks)||2
8951900|NCT02458469|10014862|FG002|STARTED|First Washout (2 Weeks)||2
8951901|NCT02458469|10014863|FG003|STARTED|First Washout (2 Weeks)||0
8630667|NCT00535821|9670471|FG001|STARTED|Overall Study||3
8867471|NCT01854827|9923675|FG000|STARTED|Overall Study||30
8867472|NCT01854827|9923675|FG000|COMPLETED|Overall Study||29
8867473|NCT01854827|9923675|FG000|NOT COMPLETED|Overall Study||1
8867474|NCT01854879|9923679|FG000|STARTED|Overall Study|97 consented|97
8867475|NCT01854879|9923679|FG000|COMPLETED|Overall Study|92 had matched endpoint data|92
8867476|NCT01854879|9923679|FG000|NOT COMPLETED|Overall Study||5
8867477|NCT01854905|9923683|FG000|STARTED|Overall Study||400
8867478|NCT01854905|9923683|FG000|COMPLETED|Overall Study||400
8867479|NCT01854905|9923683|FG000|NOT COMPLETED|Overall Study||0
8867480|NCT01854918|9923689|FG000|STARTED|SOC-controlled Period (Year 1)||1227
8867481|NCT01854918|9923690|FG001|STARTED|SOC-controlled Period (Year 1)||2454
8867482|NCT01854918|9923689|FG000|Received Evolocumab|SOC-controlled Period (Year 1)|5 participants received evolocumab in error|5
8867483|NCT01854918|9923690|FG001|Received Evolocumab|SOC-controlled Period (Year 1)||2452
8867484|NCT01854918|9923689|FG000|COMPLETED|SOC-controlled Period (Year 1)||1197
8867485|NCT01854918|9923690|FG001|COMPLETED|SOC-controlled Period (Year 1)||2391
8867486|NCT01854918|9923689|FG000|NOT COMPLETED|SOC-controlled Period (Year 1)||30
8867487|NCT01854918|9923690|FG001|NOT COMPLETED|SOC-controlled Period (Year 1)||63
8867488|NCT01854918|9923689|FG000|STARTED|All-IP Period (Years 2 and 3)||1197
8867489|NCT01854918|9923690|FG001|STARTED|All-IP Period (Years 2 and 3)||2391
8867490|NCT01854918|9923689|FG000|Received Evolocumab|All-IP Period (Years 2 and 3)||1152
8867491|NCT01854918|9923690|FG001|Received Evolocumab|All-IP Period (Years 2 and 3)||2291
8867492|NCT01854918|9923689|FG000|COMPLETED|All-IP Period (Years 2 and 3)||1079
8867493|NCT01854918|9923690|FG001|COMPLETED|All-IP Period (Years 2 and 3)||2196
8867494|NCT01854918|9923689|FG000|NOT COMPLETED|All-IP Period (Years 2 and 3)||118
8951902|NCT02458469|10014864|FG004|STARTED|First Washout (2 Weeks)||1
8951903|NCT02458469|10014865|FG005|STARTED|First Washout (2 Weeks)||2
8951904|NCT02458469|10014860|FG000|COMPLETED|First Washout (2 Weeks)||2
8951905|NCT02458469|10014861|FG001|COMPLETED|First Washout (2 Weeks)||2
8951906|NCT02458469|10014862|FG002|COMPLETED|First Washout (2 Weeks)||2
8951907|NCT02458469|10014863|FG003|COMPLETED|First Washout (2 Weeks)||0
8951908|NCT02458469|10014864|FG004|COMPLETED|First Washout (2 Weeks)||1
8951909|NCT02458469|10014865|FG005|COMPLETED|First Washout (2 Weeks)||2
8951910|NCT02458469|10014860|FG000|NOT COMPLETED|First Washout (2 Weeks)||0
8951911|NCT02458469|10014861|FG001|NOT COMPLETED|First Washout (2 Weeks)||0
8951912|NCT02458469|10014862|FG002|NOT COMPLETED|First Washout (2 Weeks)||0
8951913|NCT02458469|10014863|FG003|NOT COMPLETED|First Washout (2 Weeks)||0
8951914|NCT02458469|10014864|FG004|NOT COMPLETED|First Washout (2 Weeks)||0
8951915|NCT02458469|10014865|FG005|NOT COMPLETED|First Washout (2 Weeks)||0
8951916|NCT02458469|10014860|FG000|STARTED|Second Intervention (2 Weeks)||2
8951917|NCT02458469|10014861|FG001|STARTED|Second Intervention (2 Weeks)||2
8951918|NCT02458469|10014862|FG002|STARTED|Second Intervention (2 Weeks)||2
8951919|NCT02458469|10014863|FG003|STARTED|Second Intervention (2 Weeks)||0
8951920|NCT02458469|10014864|FG004|STARTED|Second Intervention (2 Weeks)||1
8951921|NCT02458469|10014865|FG005|STARTED|Second Intervention (2 Weeks)||2
8951922|NCT02458469|10014860|FG000|COMPLETED|Second Intervention (2 Weeks)||2
8951923|NCT02458469|10014861|FG001|COMPLETED|Second Intervention (2 Weeks)||2
8951924|NCT02458469|10014862|FG002|COMPLETED|Second Intervention (2 Weeks)||2
8951925|NCT02458469|10014863|FG003|COMPLETED|Second Intervention (2 Weeks)||0
8951926|NCT02458469|10014864|FG004|COMPLETED|Second Intervention (2 Weeks)||1
8951927|NCT02458469|10014865|FG005|COMPLETED|Second Intervention (2 Weeks)||1
8951928|NCT02458469|10014860|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0
8951929|NCT02458469|10014861|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0
8951930|NCT02458469|10014862|FG002|NOT COMPLETED|Second Intervention (2 Weeks)||0
8951931|NCT02458469|10014863|FG003|NOT COMPLETED|Second Intervention (2 Weeks)||0
8951932|NCT02458469|10014864|FG004|NOT COMPLETED|Second Intervention (2 Weeks)||0
8951933|NCT02458469|10014865|FG005|NOT COMPLETED|Second Intervention (2 Weeks)||1
8951934|NCT02458469|10014860|FG000|STARTED|Second Washout (2 Weeks)||2
8951935|NCT02458469|10014861|FG001|STARTED|Second Washout (2 Weeks)||2
8951936|NCT02458469|10014862|FG002|STARTED|Second Washout (2 Weeks)||2
8951937|NCT02458469|10014863|FG003|STARTED|Second Washout (2 Weeks)||0
8951938|NCT02458469|10014864|FG004|STARTED|Second Washout (2 Weeks)||1
8951939|NCT02458469|10014865|FG005|STARTED|Second Washout (2 Weeks)||1
8951940|NCT02458469|10014860|FG000|COMPLETED|Second Washout (2 Weeks)||2
8951941|NCT02458469|10014861|FG001|COMPLETED|Second Washout (2 Weeks)||2
8951942|NCT02458469|10014862|FG002|COMPLETED|Second Washout (2 Weeks)||2
8951943|NCT02458469|10014863|FG003|COMPLETED|Second Washout (2 Weeks)||0
8951944|NCT02458469|10014864|FG004|COMPLETED|Second Washout (2 Weeks)||1
8951945|NCT02458469|10014865|FG005|COMPLETED|Second Washout (2 Weeks)||1
8951946|NCT02458469|10014860|FG000|NOT COMPLETED|Second Washout (2 Weeks)||0
8951947|NCT02458469|10014861|FG001|NOT COMPLETED|Second Washout (2 Weeks)||0
8951948|NCT02458469|10014862|FG002|NOT COMPLETED|Second Washout (2 Weeks)||0
8630668|NCT00535821|9670470|FG000|COMPLETED|Overall Study||2
8630669|NCT00535821|9670471|FG001|COMPLETED|Overall Study||3
8630670|NCT00535821|9670470|FG000|NOT COMPLETED|Overall Study||0
8630671|NCT00535821|9670471|FG001|NOT COMPLETED|Overall Study||0
8630672|NCT00535847|9670480|FG000|STARTED|Overall Study||81
8630673|NCT00535847|9670481|FG001|STARTED|Overall Study||34
8630674|NCT00535847|9670482|FG002|STARTED|Overall Study||2
8630675|NCT00535847|9670480|FG000|COMPLETED|Overall Study||59
8630676|NCT00535847|9670481|FG001|COMPLETED|Overall Study||20
8630677|NCT00535847|9670482|FG002|COMPLETED|Overall Study||0
8630678|NCT00535847|9670480|FG000|NOT COMPLETED|Overall Study||22
8630679|NCT00535847|9670481|FG001|NOT COMPLETED|Overall Study||14
8630680|NCT00535847|9670482|FG002|NOT COMPLETED|Overall Study||2
8630681|NCT00535873|9670494|FG000|STARTED|Overall Study||60
8630682|NCT00535873|9670494|FG000|COMPLETED|Overall Study||60
8630683|NCT00535873|9670494|FG000|NOT COMPLETED|Overall Study||0
8630684|NCT00535925|9670500|FG000|STARTED|Overall Study||188
8630685|NCT00535925|9670501|FG001|STARTED|Overall Study||207
8630686|NCT00535925|9670500|FG000|COMPLETED|Overall Study||169
8630687|NCT00535925|9670501|FG001|COMPLETED|Overall Study||199
8630688|NCT00535925|9670500|FG000|NOT COMPLETED|Overall Study||19
8630689|NCT00535925|9670501|FG001|NOT COMPLETED|Overall Study||8
8630690|NCT00535938|9670511|FG000|STARTED|Overall Study||506
8630691|NCT00535938|9670512|FG001|STARTED|Overall Study||866
8867495|NCT01854918|9923690|FG001|NOT COMPLETED|All-IP Period (Years 2 and 3)||195
8630692|NCT00535938|9670511|FG000|COMPLETED|Overall Study||115
8630693|NCT00535938|9670512|FG001|COMPLETED|Overall Study||404
8630694|NCT00535938|9670511|FG000|NOT COMPLETED|Overall Study||391
8630695|NCT00535938|9670512|FG001|NOT COMPLETED|Overall Study||462
8630696|NCT00536107|9670520|FG000|STARTED|Overall Study||8
8630697|NCT00536107|9670521|FG001|STARTED|Overall Study||6
8630698|NCT00536107|9670520|FG000|COMPLETED|Overall Study||0
8630699|NCT00536107|9670521|FG001|COMPLETED|Overall Study||0
8630700|NCT00536107|9670520|FG000|NOT COMPLETED|Overall Study||8
8630701|NCT00536107|9670521|FG001|NOT COMPLETED|Overall Study||6
8630702|NCT00536120|9670529|FG000|STARTED|Overall Study||30
8630703|NCT00536120|9670530|FG001|STARTED|Overall Study||30
8630704|NCT00536120|9670529|FG000|COMPLETED|Overall Study||24
8630705|NCT00536120|9670530|FG001|COMPLETED|Overall Study||27
8630706|NCT00536120|9670529|FG000|NOT COMPLETED|Overall Study||6
8630707|NCT00536120|9670530|FG001|NOT COMPLETED|Overall Study||3
8630708|NCT00536172|9670538|FG000|STARTED|Overall Study||74
8630709|NCT00536172|9670539|FG001|STARTED|Overall Study||74
8630710|NCT00536172|9670538|FG000|COMPLETED|Overall Study||60
8630711|NCT00536172|9670539|FG001|COMPLETED|Overall Study||65
8630712|NCT00536172|9670538|FG000|NOT COMPLETED|Overall Study||14
8630713|NCT00536172|9670539|FG001|NOT COMPLETED|Overall Study||9
8630714|NCT00536198|9670547|FG000|STARTED|Overall Study||125
8630715|NCT00536198|9670548|FG001|STARTED|Overall Study||127
8630716|NCT00536198|9670547|FG000|Cycle 1|Overall Study||110
8630717|NCT00536198|9670548|FG001|Cycle 1|Overall Study||123
8630718|NCT00536198|9670547|FG000|Cycle 2|Overall Study||104
8630719|NCT00536198|9670548|FG001|Cycle 2|Overall Study||112
8630720|NCT00536198|9670547|FG000|Cycle 3|Overall Study||100
8630721|NCT00536198|9670548|FG001|Cycle 3|Overall Study||101
8630722|NCT00536198|9670547|FG000|Cycle 4|Overall Study||95
8630723|NCT00536198|9670548|FG001|Cycle 4|Overall Study||98
8630724|NCT00536198|9670547|FG000|Cycle 5|Overall Study||88
8630725|NCT00536198|9670548|FG001|Cycle 5|Overall Study||85
8630726|NCT00536198|9670547|FG000|Cycle 6|Overall Study||88
8630727|NCT00536198|9670548|FG001|Cycle 6|Overall Study||88
8630728|NCT00536198|9670547|FG000|COMPLETED|Overall Study||88
8630729|NCT00536198|9670548|FG001|COMPLETED|Overall Study||88
8630730|NCT00536198|9670547|FG000|NOT COMPLETED|Overall Study||37
8630731|NCT00536198|9670548|FG001|NOT COMPLETED|Overall Study||39
8630732|NCT00536263|9670559|FG000|STARTED|Overall Study||225
8630733|NCT00536263|9670560|FG001|STARTED|Overall Study||221
8630734|NCT00536263|9670561|FG002|STARTED|Overall Study|One (1) participant withdrawn from study for non-compliance.|225
8630735|NCT00536263|9670559|FG000|COMPLETED|Overall Study||214
8630736|NCT00536263|9670560|FG001|COMPLETED|Overall Study||207
8630737|NCT00536263|9670561|FG002|COMPLETED|Overall Study||204
8630738|NCT00536263|9670559|FG000|NOT COMPLETED|Overall Study||11
8630739|NCT00536263|9670560|FG001|NOT COMPLETED|Overall Study||14
8630740|NCT00536263|9670561|FG002|NOT COMPLETED|Overall Study||21
8630741|NCT00536341|9670571|FG000|STARTED|Overall Study||10
8630742|NCT00536341|9670572|FG001|STARTED|Overall Study||54
8630743|NCT00536341|9670571|FG000|COMPLETED|Overall Study||5
8630744|NCT00536341|9670572|FG001|COMPLETED|Overall Study||43
8630745|NCT00536341|9670571|FG000|NOT COMPLETED|Overall Study||5
8630746|NCT00536341|9670572|FG001|NOT COMPLETED|Overall Study||11
8630747|NCT00536471|9670583|FG000|STARTED|Overall Study||257
8630748|NCT00536471|9670584|FG001|STARTED|Overall Study||127
8630749|NCT00536471|9670585|FG002|STARTED|Overall Study||261
8630750|NCT00536471|9670586|FG003|STARTED|Overall Study||131
8630751|NCT00536471|9670583|FG000|COMPLETED|Overall Study||101
8630752|NCT00536471|9670584|FG001|COMPLETED|Overall Study||43
8867496|NCT01854944|9923706|FG000|STARTED|Overall Study||4
8867497|NCT01854944|9923707|FG001|STARTED|Overall Study||4
8867498|NCT01854944|9923708|FG002|STARTED|Overall Study||4
8867499|NCT01854944|9923706|FG000|COMPLETED|Overall Study||4
8867500|NCT01854944|9923707|FG001|COMPLETED|Overall Study||4
8867501|NCT01854944|9923708|FG002|COMPLETED|Overall Study||3
8867502|NCT01854944|9923706|FG000|NOT COMPLETED|Overall Study||0
8867503|NCT01854944|9923707|FG001|NOT COMPLETED|Overall Study||0
8867504|NCT01854944|9923708|FG002|NOT COMPLETED|Overall Study||1
8867505|NCT01855048|9923736|FG000|STARTED|Overall Study||9
8630753|NCT00536471|9670585|FG002|COMPLETED|Overall Study||122
8630754|NCT00536471|9670586|FG003|COMPLETED|Overall Study||57
8630755|NCT00536471|9670583|FG000|NOT COMPLETED|Overall Study||156
8630756|NCT00536471|9670584|FG001|NOT COMPLETED|Overall Study||84
8951949|NCT02458469|10014863|FG003|NOT COMPLETED|Second Washout (2 Weeks)||0
8951950|NCT02458469|10014864|FG004|NOT COMPLETED|Second Washout (2 Weeks)||0
8867506|NCT01855048|9923737|FG001|STARTED|Overall Study||3
8630757|NCT00536471|9670585|FG002|NOT COMPLETED|Overall Study||139
8630758|NCT00536471|9670586|FG003|NOT COMPLETED|Overall Study||74
8630759|NCT00536484|9670605|FG000|STARTED|Overall Study|448 participants randomised; 3 not treated|445
8630760|NCT00536484|9670606|FG001|STARTED|Overall Study|448 participants randomised; 10 not treated|438
8630761|NCT00536484|9670605|FG000|COMPLETED|Overall Study|88 completed on matched 4mg dose and 297 on matched 8mg dose|385
8630762|NCT00536484|9670606|FG001|COMPLETED|Overall Study|134 completed on 4mg dose and 248 on 8mg dose|382
8630763|NCT00536484|9670605|FG000|NOT COMPLETED|Overall Study||60
8630764|NCT00536484|9670606|FG001|NOT COMPLETED|Overall Study||56
8630765|NCT00536510|9670614|FG000|STARTED|Overall Study||322
8630766|NCT00536510|9670615|FG001|STARTED|Overall Study||324
8867507|NCT01855048|9923738|FG002|STARTED|Overall Study||6
8867508|NCT01855048|9923739|FG003|STARTED|Overall Study||6
8867509|NCT01855048|9923740|FG004|STARTED|Overall Study||6
8630767|NCT00536510|9670614|FG000|COMPLETED|Overall Study||240
8630768|NCT00536510|9670615|FG001|COMPLETED|Overall Study||295
8630769|NCT00536510|9670614|FG000|NOT COMPLETED|Overall Study||82
8630770|NCT00536510|9670615|FG001|NOT COMPLETED|Overall Study||29
8630771|NCT00536575|9670621|FG000|STARTED|Overall Study||13
8630772|NCT00536575|9670621|FG000|COMPLETED|Overall Study||11
8630773|NCT00536575|9670621|FG000|NOT COMPLETED|Overall Study||2
8630774|NCT00536601|9670630|FG000|STARTED|Overall Study||6
8630775|NCT00536601|9670631|FG001|STARTED|Overall Study||21
8630776|NCT00536601|9670632|FG002|STARTED|Overall Study||71
8630777|NCT00536601|9670633|FG003|STARTED|Overall Study||65
8630778|NCT00536601|9670634|FG004|STARTED|Overall Study||11
8630779|NCT00536601|9670630|FG000|COMPLETED|Overall Study||6
8630780|NCT00536601|9670631|FG001|COMPLETED|Overall Study||21
8630781|NCT00536601|9670632|FG002|COMPLETED|Overall Study||71
8630782|NCT00536601|9670633|FG003|COMPLETED|Overall Study||65
8630783|NCT00536601|9670634|FG004|COMPLETED|Overall Study||11
8630784|NCT00536601|9670630|FG000|NOT COMPLETED|Overall Study||0
8630785|NCT00536601|9670631|FG001|NOT COMPLETED|Overall Study||0
8630786|NCT00536601|9670632|FG002|NOT COMPLETED|Overall Study||0
8630787|NCT00536601|9670633|FG003|NOT COMPLETED|Overall Study||0
8630788|NCT00536601|9670634|FG004|NOT COMPLETED|Overall Study||0
8630789|NCT00536731|9670649|FG000|STARTED|Overall Study||253
8630790|NCT00536731|9670650|FG001|STARTED|Overall Study||246
8630791|NCT00536731|9670651|FG002|STARTED|Overall Study||243
8630792|NCT00536731|9670649|FG000|COMPLETED|Overall Study||249
8630793|NCT00536731|9670650|FG001|COMPLETED|Overall Study||241
8630794|NCT00536731|9670651|FG002|COMPLETED|Overall Study||238
8630795|NCT00536731|9670649|FG000|NOT COMPLETED|Overall Study||4
8630796|NCT00536731|9670650|FG001|NOT COMPLETED|Overall Study||5
8630797|NCT00536731|9670651|FG002|NOT COMPLETED|Overall Study||5
8630798|NCT00536744|9670661|FG000|STARTED|Overall Study||107
8630799|NCT00536744|9670662|FG001|STARTED|Overall Study||99
8630800|NCT00536744|9670661|FG000|COMPLETED|Overall Study||78
8630801|NCT00536744|9670662|FG001|COMPLETED|Overall Study||71
8630802|NCT00536744|9670661|FG000|NOT COMPLETED|Overall Study||29
8630803|NCT00536744|9670662|FG001|NOT COMPLETED|Overall Study||28
8630804|NCT00536809|9670668|FG000|STARTED|Phase I (Dose-finding Phase)||10
8630805|NCT00536809|9670668|FG000|COMPLETED|Phase I (Dose-finding Phase)||10
8630806|NCT00536809|9670668|FG000|NOT COMPLETED|Phase I (Dose-finding Phase)||0
8630807|NCT00536809|9670668|FG000|STARTED|Phase II||2
8630808|NCT00536809|9670668|FG000|COMPLETED|Phase II||0
8630809|NCT00536809|9670668|FG000|NOT COMPLETED|Phase II||2
8630810|NCT00536874|9670672|FG000|STARTED|Overall Study||39
8630811|NCT00536874|9670672|FG000|COMPLETED|Overall Study||35
8630812|NCT00536874|9670672|FG000|NOT COMPLETED|Overall Study||4
8630813|NCT00536913|9670678|FG000|STARTED|Overall Study||55
8630814|NCT00536913|9670679|FG001|STARTED|Overall Study||52
8630815|NCT00536913|9670678|FG000|COMPLETED|Overall Study||55
8630816|NCT00536913|9670679|FG001|COMPLETED|Overall Study||52
8630817|NCT00536913|9670678|FG000|NOT COMPLETED|Overall Study||0
8630818|NCT00536913|9670679|FG001|NOT COMPLETED|Overall Study||0
8630819|NCT00536939|9670685|FG000|STARTED|Overall Study||2
8630820|NCT00536939|9670686|FG001|STARTED|Overall Study||0
8630821|NCT00536939|9670685|FG000|Entered Safety lead-in|Overall Study||2
8630822|NCT00536939|9670686|FG001|Entered Safety lead-in|Overall Study||0
8630823|NCT00536939|9670685|FG000|Randomized|Overall Study||0
8630824|NCT00536939|9670686|FG001|Randomized|Overall Study||0
8630825|NCT00536939|9670685|FG000|COMPLETED|Overall Study||0
8630826|NCT00536939|9670686|FG001|COMPLETED|Overall Study||0
8630827|NCT00536939|9670685|FG000|NOT COMPLETED|Overall Study||2
8630828|NCT00536939|9670686|FG001|NOT COMPLETED|Overall Study||0
8630829|NCT00536991|9670691|FG000|STARTED|Overall Study||51
8630830|NCT00536991|9670691|FG000|COMPLETED|Overall Study||38
8630831|NCT00536991|9670691|FG000|NOT COMPLETED|Overall Study||13
8630832|NCT00537017|9670696|FG000|STARTED|Treatment Phase||140
8630833|NCT00537017|9670696|FG000|COMPLETED|Treatment Phase||106
8630834|NCT00537017|9670696|FG000|NOT COMPLETED|Treatment Phase||34
8630835|NCT00537017|9670696|FG000|STARTED|Follow-up Phase|All TP participants were eligible for FUP entry. 5 participants completing TP did not enter FUP.|135
8630836|NCT00537017|9670696|FG000|COMPLETED|Follow-up Phase||126
8630837|NCT00537017|9670696|FG000|NOT COMPLETED|Follow-up Phase||9
8630838|NCT00537030|9670700|FG000|STARTED|Overall Study||59
8630839|NCT00537030|9670700|FG000|COMPLETED|Overall Study||43
8630840|NCT00537030|9670700|FG000|NOT COMPLETED|Overall Study||16
8630841|NCT00537056|9670704|FG000|STARTED|Baseline PET/CT||17
8630842|NCT00537056|9670704|FG000|COMPLETED|Baseline PET/CT||17
8630843|NCT00537056|9670704|FG000|NOT COMPLETED|Baseline PET/CT||0
8630844|NCT00537056|9670704|FG000|STARTED|Interim PET/CT||17
8630845|NCT00537056|9670704|FG000|COMPLETED|Interim PET/CT||12
8630846|NCT00537056|9670704|FG000|NOT COMPLETED|Interim PET/CT||5
8630847|NCT00537056|9670704|FG000|STARTED|12-month Follow-up||17
8630848|NCT00537056|9670704|FG000|COMPLETED|12-month Follow-up||17
8630849|NCT00537056|9670704|FG000|NOT COMPLETED|12-month Follow-up||0
8630850|NCT00537082|9670713|FG000|STARTED|Overall Study||57
8630851|NCT00537082|9670714|FG001|STARTED|Overall Study||57
8630852|NCT00537082|9670715|FG002|STARTED|Overall Study||57
8630853|NCT00537082|9670713|FG000|COMPLETED|Overall Study||48
8630854|NCT00537082|9670714|FG001|COMPLETED|Overall Study||48
8630855|NCT00537082|9670715|FG002|COMPLETED|Overall Study||51
8630856|NCT00537082|9670713|FG000|NOT COMPLETED|Overall Study||9
8630857|NCT00537082|9670714|FG001|NOT COMPLETED|Overall Study||9
8630858|NCT00537082|9670715|FG002|NOT COMPLETED|Overall Study||6
8630859|NCT00537095|9670725|FG000|STARTED|Overall Study||72
8630860|NCT00537095|9670726|FG001|STARTED|Overall Study||73
8630861|NCT00537095|9670725|FG000|COMPLETED|Overall Study||21
8630862|NCT00537095|9670726|FG001|COMPLETED|Overall Study||16
8630863|NCT00537095|9670725|FG000|NOT COMPLETED|Overall Study||51
8630864|NCT00537095|9670726|FG001|NOT COMPLETED|Overall Study||57
8630865|NCT00537238|9670734|FG000|STARTED|Overall Study||254
8630866|NCT00537238|9670735|FG001|STARTED|Overall Study||255
8630867|NCT00537238|9670734|FG000|Completed Titration Phase|Overall Study||226
8630868|NCT00537238|9670735|FG001|Completed Titration Phase|Overall Study||236
8630869|NCT00537238|9670734|FG000|Completed Maintenance Phase|Overall Study|Primary analysis drawn from the population in the maintenance phase.|208
8630870|NCT00537238|9670735|FG001|Completed Maintenance Phase|Overall Study|Primary analysis drawn from the population in the maintenance phase.|210
8630871|NCT00537238|9670734|FG000|Entered Opt Blinded Continuation Phase|Overall Study|Participants who had clinical benefit were eligible to progress into opt blinded continuation phase.|185
8630872|NCT00537238|9670735|FG001|Entered Opt Blinded Continuation Phase|Overall Study|Participants who had clinical benefit were eligible to progress into opt blinded continuation phase.|195
8630873|NCT00537238|9670734|FG000|COMPLETED|Overall Study|Completed designates participants who completed the opt blinded continuation phase.|80
8630874|NCT00537238|9670735|FG001|COMPLETED|Overall Study|Completed designates participants who completed the opt blinded continuation phase.|82
8630875|NCT00537238|9670734|FG000|NOT COMPLETED|Overall Study||174
8630876|NCT00537238|9670735|FG001|NOT COMPLETED|Overall Study||173
8630877|NCT00537277|9670741|FG000|STARTED|Overall Study||161
8630878|NCT00537277|9670741|FG000|Exposed to Trial Drug|Overall Study|One subject not exposed to trial drug, and thus not included in full analysis set (FAS)|160
8630879|NCT00537277|9670741|FG000|COMPLETED|Overall Study||112
8630880|NCT00537277|9670741|FG000|NOT COMPLETED|Overall Study||49
8630881|NCT00537290|9670745|FG000|STARTED|Overall Study||19
8630882|NCT00537290|9670745|FG000|COMPLETED|Overall Study||19
8630883|NCT00537290|9670745|FG000|NOT COMPLETED|Overall Study||0
8630884|NCT00537303|9670751|FG000|STARTED|Overall Study||146
8630885|NCT00537303|9670752|FG001|STARTED|Overall Study||150
8630886|NCT00537303|9670751|FG000|COMPLETED|Overall Study||120
8630887|NCT00537303|9670752|FG001|COMPLETED|Overall Study||125
8630888|NCT00537303|9670751|FG000|NOT COMPLETED|Overall Study||26
8630889|NCT00537303|9670752|FG001|NOT COMPLETED|Overall Study||25
8630890|NCT00537316|9670764|FG000|STARTED|Part 1||79
8630891|NCT00537316|9670765|FG001|STARTED|Part 1||80
8630892|NCT00537316|9670766|FG002|STARTED|Part 1||80
8867510|NCT01855048|9923741|FG005|STARTED|Overall Study||6
8867511|NCT01855048|9923736|FG000|COMPLETED|Overall Study||9
8867512|NCT01855048|9923737|FG001|COMPLETED|Overall Study||2
8867513|NCT01855048|9923738|FG002|COMPLETED|Overall Study||6
8867514|NCT01855048|9923739|FG003|COMPLETED|Overall Study||6
8867515|NCT01855048|9923740|FG004|COMPLETED|Overall Study||5
8867516|NCT01855048|9923741|FG005|COMPLETED|Overall Study||6
8867517|NCT01855048|9923736|FG000|NOT COMPLETED|Overall Study||0
8867518|NCT01855048|9923737|FG001|NOT COMPLETED|Overall Study||1
8867519|NCT01855048|9923738|FG002|NOT COMPLETED|Overall Study||0
8867520|NCT01855048|9923739|FG003|NOT COMPLETED|Overall Study||0
8867521|NCT01855048|9923740|FG004|NOT COMPLETED|Overall Study||1
8867522|NCT01855048|9923741|FG005|NOT COMPLETED|Overall Study||0
8867523|NCT01855074|9923765|FG000|STARTED|Overall Study||80
8867524|NCT01855074|9923765|FG000|Treated|Overall Study||79
8867525|NCT01855074|9923765|FG000|COMPLETED|Overall Study||66
8867526|NCT01855074|9923765|FG000|NOT COMPLETED|Overall Study||14
8867527|NCT01855126|9923771|FG000|STARTED|First Intervention (8 Weeks)||24
8867528|NCT01855126|9923772|FG001|STARTED|First Intervention (8 Weeks)||22
8867529|NCT01855126|9923771|FG000|COMPLETED|First Intervention (8 Weeks)||20
8867530|NCT01855126|9923772|FG001|COMPLETED|First Intervention (8 Weeks)||16
8867531|NCT01855126|9923771|FG000|NOT COMPLETED|First Intervention (8 Weeks)||4
8867532|NCT01855126|9923772|FG001|NOT COMPLETED|First Intervention (8 Weeks)||6
8867533|NCT01855126|9923771|FG000|STARTED|Washout Period (2 Weeks)||20
8867534|NCT01855126|9923772|FG001|STARTED|Washout Period (2 Weeks)||16
8867535|NCT01855126|9923771|FG000|COMPLETED|Washout Period (2 Weeks)||20
8867536|NCT01855126|9923772|FG001|COMPLETED|Washout Period (2 Weeks)||16
8867537|NCT01855126|9923771|FG000|NOT COMPLETED|Washout Period (2 Weeks)||0
8867538|NCT01855126|9923772|FG001|NOT COMPLETED|Washout Period (2 Weeks)||0
8867539|NCT01855126|9923771|FG000|STARTED|Second Intervention (8 Weeks)||20
8867540|NCT01855126|9923772|FG001|STARTED|Second Intervention (8 Weeks)||16
8867541|NCT01855126|9923771|FG000|COMPLETED|Second Intervention (8 Weeks)||18
8867542|NCT01855126|9923772|FG001|COMPLETED|Second Intervention (8 Weeks)||14
8867543|NCT01855126|9923771|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||2
8630893|NCT00537316|9670767|FG003|STARTED|Part 1||0
8630894|NCT00537316|9670768|FG004|STARTED|Part 1||0
8630895|NCT00537316|9670769|FG005|STARTED|Part 1||0
8630896|NCT00537316|9670770|FG006|STARTED|Part 1||0
8630897|NCT00537316|9670764|FG000|COMPLETED|Part 1||65
8630898|NCT00537316|9670765|FG001|COMPLETED|Part 1||53
8867544|NCT01855126|9923772|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||2
8867545|NCT01855243|9923785|FG000|STARTED|Overall Study||20
8867546|NCT01855243|9923786|FG001|STARTED|Overall Study||21
8867547|NCT01855243|9923787|FG002|STARTED|Overall Study||22
8867548|NCT01855243|9923785|FG000|COMPLETED|Overall Study||19
8867549|NCT01855243|9923786|FG001|COMPLETED|Overall Study||21
8867550|NCT01855243|9923787|FG002|COMPLETED|Overall Study||22
8867551|NCT01855243|9923785|FG000|NOT COMPLETED|Overall Study||1
8867552|NCT01855243|9923786|FG001|NOT COMPLETED|Overall Study||0
8630899|NCT00537316|9670766|FG002|COMPLETED|Part 1||63
8630900|NCT00537316|9670767|FG003|COMPLETED|Part 1||0
8630901|NCT00537316|9670768|FG004|COMPLETED|Part 1||0
8630902|NCT00537316|9670769|FG005|COMPLETED|Part 1||0
8630903|NCT00537316|9670770|FG006|COMPLETED|Part 1||0
8630904|NCT00537316|9670764|FG000|NOT COMPLETED|Part 1||14
8630905|NCT00537316|9670765|FG001|NOT COMPLETED|Part 1||27
8630906|NCT00537316|9670766|FG002|NOT COMPLETED|Part 1||17
8630907|NCT00537316|9670767|FG003|NOT COMPLETED|Part 1||0
8630908|NCT00537316|9670768|FG004|NOT COMPLETED|Part 1||0
8630909|NCT00537316|9670769|FG005|NOT COMPLETED|Part 1||0
8630910|NCT00537316|9670770|FG006|NOT COMPLETED|Part 1||0
8630911|NCT00537316|9670764|FG000|STARTED|Part 2||37
8630912|NCT00537316|9670765|FG001|STARTED|Part 2||10
8725645|NCT01032694|9772956|FG000|STARTED|Overall Study||20
8725646|NCT01032694|9772957|FG001|STARTED|Overall Study||10
8867553|NCT01855243|9923787|FG002|NOT COMPLETED|Overall Study||0
8867554|NCT01855360|9923795|FG000|STARTED|Overall Study||40
8867555|NCT01855360|9923795|FG000|COMPLETED|Overall Study||30
8867556|NCT01855360|9923795|FG000|NOT COMPLETED|Overall Study||10
8867557|NCT01855399|9923801|FG000|STARTED|6 Month||146
8867558|NCT01855399|9923802|FG001|STARTED|6 Month||144
8867559|NCT01855399|9923801|FG000|COMPLETED|6 Month||126
8867560|NCT01855399|9923802|FG001|COMPLETED|6 Month||129
8867561|NCT01855399|9923801|FG000|NOT COMPLETED|6 Month||20
8867562|NCT01855399|9923802|FG001|NOT COMPLETED|6 Month||15
8867563|NCT01855399|9923801|FG000|STARTED|12 Month||126
8867564|NCT01855399|9923802|FG001|STARTED|12 Month||129
8867565|NCT01855399|9923801|FG000|COMPLETED|12 Month||119
8867566|NCT01855399|9923802|FG001|COMPLETED|12 Month||118
8867567|NCT01855399|9923801|FG000|NOT COMPLETED|12 Month||7
8867568|NCT01855399|9923802|FG001|NOT COMPLETED|12 Month||11
8867569|NCT01855425|9923808|FG000|STARTED|Overall Study||96
8867570|NCT01855425|9923808|FG000|COMPLETED|Overall Study||76
8867571|NCT01855425|9923808|FG000|NOT COMPLETED|Overall Study||20
8867572|NCT01855750|9923814|FG000|STARTED|Overall Study||419
8867573|NCT01855750|9923815|FG001|STARTED|Overall Study||419
8867574|NCT01855750|9923814|FG000|Treated|Overall Study|3 participants not treated:2 withdrew consent and 1 not treated per Sponsor/investigator's decision.|416
8867575|NCT01855750|9923815|FG001|Treated|Overall Study|1 participant not treated: withdrew consent.|418
8867576|NCT01855750|9923814|FG000|COMPLETED|Overall Study||0
8867577|NCT01855750|9923815|FG001|COMPLETED|Overall Study||0
8867578|NCT01855750|9923814|FG000|NOT COMPLETED|Overall Study||419
8867579|NCT01855750|9923815|FG001|NOT COMPLETED|Overall Study||419
8867580|NCT01855789|9923821|FG000|STARTED|1) Baseline up to Week 24||718
8867581|NCT01855789|9923822|FG001|STARTED|1) Baseline up to Week 24||0
8867582|NCT01855789|9923823|FG002|STARTED|1) Baseline up to Week 24||0
8867583|NCT01855789|9923824|FG003|STARTED|1) Baseline up to Week 24||0
8867584|NCT01855789|9923821|FG000|COMPLETED|1) Baseline up to Week 24||602
8867585|NCT01855789|9923822|FG001|COMPLETED|1) Baseline up to Week 24||0
8867586|NCT01855789|9923823|FG002|COMPLETED|1) Baseline up to Week 24||0
8867587|NCT01855789|9923824|FG003|COMPLETED|1) Baseline up to Week 24||0
8867588|NCT01855789|9923821|FG000|NOT COMPLETED|1) Baseline up to Week 24||116
8867589|NCT01855789|9923822|FG001|NOT COMPLETED|1) Baseline up to Week 24||0
8867590|NCT01855789|9923823|FG002|NOT COMPLETED|1) Baseline up to Week 24||0
8867591|NCT01855789|9923824|FG003|NOT COMPLETED|1) Baseline up to Week 24||0
8867592|NCT01855789|9923821|FG000|STARTED|2) Week 24 up to End of Study||0
8867593|NCT01855789|9923822|FG001|STARTED|2) Week 24 up to End of Study||147
8867594|NCT01855789|9923823|FG002|STARTED|2) Week 24 up to End of Study||147
8867595|NCT01855789|9923824|FG003|STARTED|2) Week 24 up to End of Study||308
8867596|NCT01855789|9923821|FG000|COMPLETED|2) Week 24 up to End of Study||0
8867597|NCT01855789|9923822|FG001|COMPLETED|2) Week 24 up to End of Study||132
8867598|NCT01855789|9923823|FG002|COMPLETED|2) Week 24 up to End of Study||129
8867599|NCT01855789|9923824|FG003|COMPLETED|2) Week 24 up to End of Study||250
8867600|NCT01855789|9923821|FG000|NOT COMPLETED|2) Week 24 up to End of Study||0
8867601|NCT01855789|9923822|FG001|NOT COMPLETED|2) Week 24 up to End of Study||15
8867602|NCT01855789|9923823|FG002|NOT COMPLETED|2) Week 24 up to End of Study||18
8867603|NCT01855789|9923824|FG003|NOT COMPLETED|2) Week 24 up to End of Study||58
8867604|NCT01855828|9923830|FG000|STARTED|Overall Study||50
8867605|NCT01855828|9923830|FG000|COMPLETED|Overall Study||48
8867606|NCT01855828|9923830|FG000|NOT COMPLETED|Overall Study||2
8867607|NCT01855919|9923841|FG000|STARTED|Overall Study||232
8867608|NCT01855919|9923842|FG001|STARTED|Overall Study||226
8630913|NCT00537316|9670766|FG002|STARTED|Part 2||48
8630914|NCT00537316|9670767|FG003|STARTED|Part 2||5
8630915|NCT00537316|9670768|FG004|STARTED|Part 2||2
8630916|NCT00537316|9670769|FG005|STARTED|Part 2||4
8630917|NCT00537316|9670770|FG006|STARTED|Part 2||2
8725647|NCT01032694|9772956|FG000|COMPLETED|Overall Study||20
8867609|NCT01855919|9923841|FG000|Received at Least 1 Dose of Study Drug|Overall Study||232
8867610|NCT01855919|9923842|FG001|Received at Least 1 Dose of Study Drug|Overall Study||226
8867611|NCT01855919|9923841|FG000|COMPLETED|Overall Study||209
8630918|NCT00537316|9670764|FG000|COMPLETED|Part 2||11
8630919|NCT00537316|9670765|FG001|COMPLETED|Part 2||1
8630920|NCT00537316|9670766|FG002|COMPLETED|Part 2||16
8867612|NCT01855919|9923842|FG001|COMPLETED|Overall Study||200
8867613|NCT01855919|9923841|FG000|NOT COMPLETED|Overall Study||23
8867614|NCT01855919|9923842|FG001|NOT COMPLETED|Overall Study||26
8867615|NCT01855945|9923861|FG000|STARTED|Overall Study||54
8867616|NCT01855945|9923862|FG001|STARTED|Overall Study||55
8867617|NCT01855945|9923863|FG002|STARTED|Overall Study||51
8867618|NCT01855945|9923864|FG003|STARTED|Overall Study||53
8867619|NCT01855945|9923865|FG004|STARTED|Overall Study||51
8867620|NCT01855945|9923866|FG005|STARTED|Overall Study||53
8867621|NCT01855945|9923867|FG006|STARTED|Overall Study||53
8867622|NCT01855945|9923868|FG007|STARTED|Overall Study||55
8867623|NCT01855945|9923869|FG008|STARTED|Overall Study||48
8867624|NCT01855945|9923870|FG009|STARTED|Overall Study||51
8867625|NCT01855945|9923871|FG010|STARTED|Overall Study||51
8867626|NCT01855945|9923872|FG011|STARTED|Overall Study||52
8867627|NCT01855945|9923861|FG000|COMPLETED|Overall Study||38
8867628|NCT01855945|9923862|FG001|COMPLETED|Overall Study||44
8867629|NCT01855945|9923863|FG002|COMPLETED|Overall Study||39
8867630|NCT01855945|9923864|FG003|COMPLETED|Overall Study||49
8867631|NCT01855945|9923865|FG004|COMPLETED|Overall Study||50
8867632|NCT01855945|9923866|FG005|COMPLETED|Overall Study||50
8867633|NCT01855945|9923867|FG006|COMPLETED|Overall Study||43
8867634|NCT01855945|9923868|FG007|COMPLETED|Overall Study||47
8867635|NCT01855945|9923869|FG008|COMPLETED|Overall Study||46
8867636|NCT01855945|9923870|FG009|COMPLETED|Overall Study||49
8867637|NCT01855945|9923871|FG010|COMPLETED|Overall Study||46
8867638|NCT01855945|9923872|FG011|COMPLETED|Overall Study||49
8867639|NCT01855945|9923861|FG000|NOT COMPLETED|Overall Study||16
8867640|NCT01855945|9923862|FG001|NOT COMPLETED|Overall Study||11
8867641|NCT01855945|9923863|FG002|NOT COMPLETED|Overall Study||12
8867642|NCT01855945|9923864|FG003|NOT COMPLETED|Overall Study||4
8867643|NCT01855945|9923865|FG004|NOT COMPLETED|Overall Study||1
8867644|NCT01855945|9923866|FG005|NOT COMPLETED|Overall Study||3
8867645|NCT01855945|9923867|FG006|NOT COMPLETED|Overall Study||10
8867646|NCT01855945|9923868|FG007|NOT COMPLETED|Overall Study||8
8867647|NCT01855945|9923869|FG008|NOT COMPLETED|Overall Study||2
8867648|NCT01855945|9923870|FG009|NOT COMPLETED|Overall Study||2
8867649|NCT01855945|9923871|FG010|NOT COMPLETED|Overall Study||5
8867650|NCT01855945|9923872|FG011|NOT COMPLETED|Overall Study||3
8867651|NCT01855958|9923937|FG000|STARTED|Overall Study||13
8867652|NCT01855958|9923938|FG001|STARTED|Overall Study||13
8867653|NCT01855958|9923937|FG000|COMPLETED|Overall Study||12
8867654|NCT01855958|9923938|FG001|COMPLETED|Overall Study||13
8867655|NCT01855958|9923937|FG000|NOT COMPLETED|Overall Study||1
8867656|NCT01855958|9923938|FG001|NOT COMPLETED|Overall Study||0
8867657|NCT01855997|9923946|FG000|STARTED|Overall Study||1669
8867658|NCT01855997|9923946|FG000|COMPLETED|Overall Study||1669
8867659|NCT01855997|9923946|FG000|NOT COMPLETED|Overall Study||0
8867660|NCT01856114|9923960|FG000|STARTED|Overall Study||11
8867661|NCT01856114|9923961|FG001|STARTED|Overall Study||11
8867662|NCT01856114|9923960|FG000|COMPLETED|Overall Study||9
8867663|NCT01856114|9923961|FG001|COMPLETED|Overall Study||11
8867664|NCT01856114|9923960|FG000|NOT COMPLETED|Overall Study||2
8867665|NCT01856114|9923961|FG001|NOT COMPLETED|Overall Study||0
8867666|NCT01856218|9923967|FG000|STARTED|First Phase||3
8867667|NCT01856218|9923967|FG000|COMPLETED|First Phase||3
8867668|NCT01856218|9923967|FG000|NOT COMPLETED|First Phase||0
8867669|NCT01856218|9923967|FG000|STARTED|Long-Term Extension Phase||3
8867670|NCT01856218|9923967|FG000|COMPLETED|Long-Term Extension Phase||3
8867671|NCT01856218|9923967|FG000|NOT COMPLETED|Long-Term Extension Phase||0
8867672|NCT01856257|9923974|FG000|STARTED|Overall Study||29
8867673|NCT01856257|9923975|FG001|STARTED|Overall Study||29
8867674|NCT01856257|9923976|FG002|STARTED|Overall Study||11
8867675|NCT01856257|9923977|FG003|STARTED|Overall Study||2
8867676|NCT01856257|9923974|FG000|COMPLETED|Overall Study||26
8867677|NCT01856257|9923975|FG001|COMPLETED|Overall Study||28
8867678|NCT01856257|9923976|FG002|COMPLETED|Overall Study||11
8867679|NCT01856257|9923977|FG003|COMPLETED|Overall Study||0
8867680|NCT01856257|9923974|FG000|NOT COMPLETED|Overall Study||3
8867681|NCT01856257|9923975|FG001|NOT COMPLETED|Overall Study||1
8867682|NCT01856257|9923976|FG002|NOT COMPLETED|Overall Study||0
8867683|NCT01856257|9923977|FG003|NOT COMPLETED|Overall Study||2
8867684|NCT01856309|9923990|FG000|STARTED|Overall Study||305
8867685|NCT01856309|9923991|FG001|STARTED|Overall Study||291
8867686|NCT01856309|9923992|FG002|STARTED|Overall Study||606
8867687|NCT01856309|9923993|FG003|STARTED|Overall Study||618
8867688|NCT01856309|9923990|FG000|Participants From Study CNTO136ARA3002|Overall Study||197
8867689|NCT01856309|9923991|FG001|Participants From Study CNTO136ARA3002|Overall Study||187
8867690|NCT01856309|9923992|FG002|Participants From Study CNTO136ARA3002|Overall Study||405
8867691|NCT01856309|9923993|FG003|Participants From Study CNTO136ARA3002|Overall Study||412
8867692|NCT01856309|9923990|FG000|Participants From Study CNTO136ARA3003|Overall Study||108
8867693|NCT01856309|9923991|FG001|Participants From Study CNTO136ARA3003|Overall Study||104
8867694|NCT01856309|9923992|FG002|Participants From Study CNTO136ARA3003|Overall Study||201
8867695|NCT01856309|9923993|FG003|Participants From Study CNTO136ARA3003|Overall Study||206
8867696|NCT01856309|9923990|FG000|Treated Partcipants|Overall Study||305
8867697|NCT01856309|9923991|FG001|Treated Partcipants|Overall Study||290
8867698|NCT01856309|9923992|FG002|Treated Partcipants|Overall Study||605
8867699|NCT01856309|9923993|FG003|Treated Partcipants|Overall Study||618
8867700|NCT01856309|9923990|FG000|COMPLETED|Overall Study||6
8867701|NCT01856309|9923991|FG001|COMPLETED|Overall Study||3
8867702|NCT01856309|9923992|FG002|COMPLETED|Overall Study||11
8867703|NCT01856309|9923993|FG003|COMPLETED|Overall Study||9
8867704|NCT01856309|9923990|FG000|NOT COMPLETED|Overall Study||299
8867705|NCT01856309|9923991|FG001|NOT COMPLETED|Overall Study||288
8867706|NCT01856309|9923992|FG002|NOT COMPLETED|Overall Study||595
8867707|NCT01856309|9923993|FG003|NOT COMPLETED|Overall Study||609
8867708|NCT01856491|9924003|FG000|STARTED|Overall Study||167
8867709|NCT01856491|9924003|FG000|COMPLETED|Overall Study||152
8867710|NCT01856491|9924003|FG000|NOT COMPLETED|Overall Study||15
8867711|NCT01856530|9924009|FG000|STARTED|Overall Study||27
8867712|NCT01856530|9924010|FG001|STARTED|Overall Study||27
8867713|NCT01856530|9924009|FG000|COMPLETED|Overall Study||27
8867714|NCT01856530|9924010|FG001|COMPLETED|Overall Study||27
8867715|NCT01856530|9924009|FG000|NOT COMPLETED|Overall Study||0
8867716|NCT01856530|9924010|FG001|NOT COMPLETED|Overall Study||0
8867717|NCT01856543|9924018|FG000|STARTED|Overall Study||73
8867718|NCT01856543|9924019|FG001|STARTED|Overall Study||70
8867719|NCT01856543|9924018|FG000|COMPLETED|Overall Study||60
8867720|NCT01856543|9924019|FG001|COMPLETED|Overall Study||64
8867721|NCT01856543|9924018|FG000|NOT COMPLETED|Overall Study||13
8867722|NCT01856543|9924019|FG001|NOT COMPLETED|Overall Study||6
8923799|NCT02243280|9984426|FG006|COMPLETED|Treated||0
8923800|NCT02243280|9984427|FG007|COMPLETED|Treated||0
8923801|NCT02243280|9984428|FG008|COMPLETED|Treated||31
8923802|NCT02243280|9984429|FG009|COMPLETED|Treated||0
8951951|NCT02458469|10014865|FG005|NOT COMPLETED|Second Washout (2 Weeks)||0
8951952|NCT02458469|10014860|FG000|STARTED|Third Intervention (2 Weeks)||2
8951953|NCT02458469|10014861|FG001|STARTED|Third Intervention (2 Weeks)||2
8951954|NCT02458469|10014862|FG002|STARTED|Third Intervention (2 Weeks)||2
8951955|NCT02458469|10014863|FG003|STARTED|Third Intervention (2 Weeks)||0
8951956|NCT02458469|10014864|FG004|STARTED|Third Intervention (2 Weeks)||1
8951957|NCT02458469|10014865|FG005|STARTED|Third Intervention (2 Weeks)||1
8951958|NCT02458469|10014860|FG000|COMPLETED|Third Intervention (2 Weeks)||2
8951959|NCT02458469|10014861|FG001|COMPLETED|Third Intervention (2 Weeks)||2
8951960|NCT02458469|10014862|FG002|COMPLETED|Third Intervention (2 Weeks)||2
8951961|NCT02458469|10014863|FG003|COMPLETED|Third Intervention (2 Weeks)||0
8951962|NCT02458469|10014864|FG004|COMPLETED|Third Intervention (2 Weeks)||1
8951963|NCT02458469|10014865|FG005|COMPLETED|Third Intervention (2 Weeks)||1
8951964|NCT02458469|10014860|FG000|NOT COMPLETED|Third Intervention (2 Weeks)||0
8951965|NCT02458469|10014861|FG001|NOT COMPLETED|Third Intervention (2 Weeks)||0
8951966|NCT02458469|10014862|FG002|NOT COMPLETED|Third Intervention (2 Weeks)||0
8951967|NCT02458469|10014863|FG003|NOT COMPLETED|Third Intervention (2 Weeks)||0
8951968|NCT02458469|10014864|FG004|NOT COMPLETED|Third Intervention (2 Weeks)||0
8951969|NCT02458469|10014865|FG005|NOT COMPLETED|Third Intervention (2 Weeks)||0
8951970|NCT02458638|10014873|FG000|STARTED|Overall Study||474
8951971|NCT02458638|10014873|FG000|COMPLETED|Overall Study||15
8951972|NCT02458638|10014873|FG000|NOT COMPLETED|Overall Study||459
8951973|NCT02458690|10014879|FG000|STARTED|Overall Study||107
8951974|NCT02458690|10014880|FG001|STARTED|Overall Study||109
8951975|NCT02458690|10014879|FG000|COMPLETED|Overall Study||99
8951976|NCT02458690|10014880|FG001|COMPLETED|Overall Study||100
8630921|NCT00537316|9670767|FG003|COMPLETED|Part 2||2
8630922|NCT00537316|9670768|FG004|COMPLETED|Part 2||1
8630923|NCT00537316|9670769|FG005|COMPLETED|Part 2||0
8630924|NCT00537316|9670770|FG006|COMPLETED|Part 2||0
8630925|NCT00537316|9670764|FG000|NOT COMPLETED|Part 2||26
8630926|NCT00537316|9670765|FG001|NOT COMPLETED|Part 2||9
8630927|NCT00537316|9670766|FG002|NOT COMPLETED|Part 2||32
8630928|NCT00537316|9670767|FG003|NOT COMPLETED|Part 2||3
8630929|NCT00537316|9670768|FG004|NOT COMPLETED|Part 2||1
8630930|NCT00537316|9670769|FG005|NOT COMPLETED|Part 2||4
8630931|NCT00537316|9670770|FG006|NOT COMPLETED|Part 2||2
8630932|NCT00537329|9670789|FG000|STARTED|Overall Study||43
8951977|NCT02458690|10014879|FG000|NOT COMPLETED|Overall Study||8
8951978|NCT02458690|10014880|FG001|NOT COMPLETED|Overall Study||9
8951979|NCT02458768|10014888|FG000|STARTED|Overall Study||57
8951980|NCT02458768|10014889|FG001|STARTED|Overall Study||55
8951981|NCT02458768|10014888|FG000|COMPLETED|Overall Study||50
8951982|NCT02458768|10014889|FG001|COMPLETED|Overall Study||50
8951983|NCT02458768|10014888|FG000|NOT COMPLETED|Overall Study||7
8951984|NCT02458768|10014889|FG001|NOT COMPLETED|Overall Study||5
8951985|NCT02459093|10014897|FG000|STARTED|Overall Study||275
8951986|NCT02459093|10014898|FG001|STARTED|Overall Study||275
8951987|NCT02459093|10014897|FG000|COMPLETED|Overall Study||263
8951988|NCT02459093|10014898|FG001|COMPLETED|Overall Study||257
8951989|NCT02459093|10014897|FG000|NOT COMPLETED|Overall Study||12
8951990|NCT02459093|10014898|FG001|NOT COMPLETED|Overall Study||18
8630933|NCT00537329|9670789|FG000|COMPLETED|Overall Study||17
8630934|NCT00537329|9670789|FG000|NOT COMPLETED|Overall Study||26
8630935|NCT00537381|9670795|FG000|STARTED|Overall Study|11 Participants after disease progression switched to intetumumab alone (2) or D+P+ Intetumumab (9).|65
8630936|NCT00537381|9670796|FG001|STARTED|Overall Study||66
8630937|NCT00537381|9670795|FG000|COMPLETED|Overall Study||9
8630938|NCT00537381|9670796|FG001|COMPLETED|Overall Study||4
8923803|NCT02243280|9984430|FG010|COMPLETED|Treated||31
8923804|NCT02243280|9984420|FG000|NOT COMPLETED|Treated||1
8923805|NCT02243280|9984421|FG001|NOT COMPLETED|Treated||0
8923806|NCT02243280|9984422|FG002|NOT COMPLETED|Treated||0
8923807|NCT02243280|9984423|FG003|NOT COMPLETED|Treated||0
8923808|NCT02243280|9984424|FG004|NOT COMPLETED|Treated||0
8923809|NCT02243280|9984425|FG005|NOT COMPLETED|Treated||0
8923810|NCT02243280|9984426|FG006|NOT COMPLETED|Treated||0
8923811|NCT02243280|9984427|FG007|NOT COMPLETED|Treated||0
8951991|NCT02459119|10014904|FG000|STARTED|Overall Study||17
8951992|NCT02459119|10014904|FG000|COMPLETED|Overall Study||17
8951993|NCT02459119|10014904|FG000|NOT COMPLETED|Overall Study||0
8951994|NCT02459197|10014910|FG000|STARTED|Overall Study||58
8867723|NCT01856569|9924026|FG000|STARTED|Overall Study||152
8867724|NCT01856569|9924026|FG000|Full Analysis Set|Overall Study||144
8867725|NCT01856569|9924026|FG000|COMPLETED|Overall Study||139
8867726|NCT01856569|9924026|FG000|NOT COMPLETED|Overall Study||13
8867727|NCT01856582|9924030|FG000|STARTED|Overall Study||23
8867728|NCT01856582|9924030|FG000|COMPLETED|Overall Study||22
8867729|NCT01856582|9924030|FG000|NOT COMPLETED|Overall Study||1
8867730|NCT01856595|9924043|FG000|STARTED|Overall Study||18
8867731|NCT01856595|9924044|FG001|STARTED|Overall Study||12
8867732|NCT01856595|9924045|FG002|STARTED|Overall Study||12
8867733|NCT01856595|9924046|FG003|STARTED|Overall Study||12
8867734|NCT01856595|9924047|FG004|STARTED|Overall Study||14
8867735|NCT01856595|9924048|FG005|STARTED|Overall Study||12
8867736|NCT01856595|9924049|FG006|STARTED|Overall Study||13
8867737|NCT01856595|9924050|FG007|STARTED|Overall Study||10
8867738|NCT01856595|9924051|FG008|STARTED|Overall Study||14
8867739|NCT01856595|9924043|FG000|COMPLETED|Overall Study||18
8867740|NCT01856595|9924044|FG001|COMPLETED|Overall Study||11
8867741|NCT01856595|9924045|FG002|COMPLETED|Overall Study||12
8867742|NCT01856595|9924046|FG003|COMPLETED|Overall Study||12
8867743|NCT01856595|9924047|FG004|COMPLETED|Overall Study||14
8867744|NCT01856595|9924048|FG005|COMPLETED|Overall Study||12
8867745|NCT01856595|9924049|FG006|COMPLETED|Overall Study||12
8867746|NCT01856595|9924050|FG007|COMPLETED|Overall Study||10
8867747|NCT01856595|9924051|FG008|COMPLETED|Overall Study||14
8867748|NCT01856595|9924043|FG000|NOT COMPLETED|Overall Study||0
8867749|NCT01856595|9924044|FG001|NOT COMPLETED|Overall Study||1
8867750|NCT01856595|9924045|FG002|NOT COMPLETED|Overall Study||0
8867751|NCT01856595|9924046|FG003|NOT COMPLETED|Overall Study||0
8867752|NCT01856595|9924047|FG004|NOT COMPLETED|Overall Study||0
8867753|NCT01856595|9924048|FG005|NOT COMPLETED|Overall Study||0
8867754|NCT01856595|9924049|FG006|NOT COMPLETED|Overall Study||1
8867755|NCT01856595|9924050|FG007|NOT COMPLETED|Overall Study||0
8867756|NCT01856595|9924051|FG008|NOT COMPLETED|Overall Study||0
8867757|NCT01856673|9924089|FG000|STARTED|Overall Study||175
8867758|NCT01856673|9924090|FG001|STARTED|Overall Study||175
8867759|NCT01856673|9924091|FG002|STARTED|Overall Study||171
8867760|NCT01856673|9924089|FG000|Buenaventura Participants|Overall Study||92
8867761|NCT01856673|9924090|FG001|Buenaventura Participants|Overall Study||89
8867762|NCT01856673|9924091|FG002|Buenaventura Participants|Overall Study||88
8867763|NCT01856673|9924089|FG000|Quibdó Participants|Overall Study||83
8867764|NCT01856673|9924090|FG001|Quibdó Participants|Overall Study||86
8867765|NCT01856673|9924091|FG002|Quibdó Participants|Overall Study||83
8867766|NCT01856673|9924089|FG000|COMPLETED|Overall Study|A percentage of 75.1% completed the follow-up (exit survey)|80
8867767|NCT01856673|9924090|FG001|COMPLETED|Overall Study|A percentage of 80.9% completed the follow-up (exit survey)|90
8867768|NCT01856673|9924091|FG002|COMPLETED|Overall Study||137
8867769|NCT01856673|9924089|FG000|NOT COMPLETED|Overall Study||95
8867770|NCT01856673|9924090|FG001|NOT COMPLETED|Overall Study||85
8867771|NCT01856673|9924091|FG002|NOT COMPLETED|Overall Study||34
8867772|NCT01856686|9924101|FG000|STARTED|Overall Study||31
8867773|NCT01856686|9924102|FG001|STARTED|Overall Study||33
8867774|NCT01856686|9924101|FG000|COMPLETED|Overall Study||26
8867775|NCT01856686|9924102|FG001|COMPLETED|Overall Study||22
8867776|NCT01856686|9924101|FG000|NOT COMPLETED|Overall Study||5
8867777|NCT01856686|9924102|FG001|NOT COMPLETED|Overall Study||11
8867778|NCT01856712|9924110|FG000|STARTED|Overall Study||23
8867779|NCT01856712|9924111|FG001|STARTED|Overall Study|1 received oral in error thus randomized.|22
8867780|NCT01856712|9924110|FG000|Lost to 14 Day Follow up|Overall Study||6
8867781|NCT01856712|9924111|FG001|Lost to 14 Day Follow up|Overall Study||2
8867782|NCT01856712|9924110|FG000|Lost to 45 Day Follow up|Overall Study||1
8867783|NCT01856712|9924111|FG001|Lost to 45 Day Follow up|Overall Study||1
8867784|NCT01856712|9924110|FG000|COMPLETED|Overall Study||16
8867785|NCT01856712|9924111|FG001|COMPLETED|Overall Study||19
8867786|NCT01856712|9924110|FG000|NOT COMPLETED|Overall Study||7
8867787|NCT01856712|9924111|FG001|NOT COMPLETED|Overall Study||3
8867788|NCT01856764|9924123|FG000|STARTED|Overall Study||20
8867789|NCT01856764|9924124|FG001|STARTED|Overall Study||20
8867790|NCT01856764|9924123|FG000|COMPLETED|Overall Study||20
8867791|NCT01856764|9924124|FG001|COMPLETED|Overall Study||20
8867792|NCT01856764|9924123|FG000|NOT COMPLETED|Overall Study||0
8867793|NCT01856764|9924124|FG001|NOT COMPLETED|Overall Study||0
8867794|NCT01856790|9924130|FG000|STARTED|Closed Loop Control||15
8867795|NCT01856790|9924130|FG000|COMPLETED|Closed Loop Control||13
8867796|NCT01856790|9924130|FG000|NOT COMPLETED|Closed Loop Control||2
8867797|NCT01856790|9924130|FG000|STARTED|Closed Loop Control + Liraglutide||13
8867798|NCT01856790|9924130|FG000|COMPLETED|Closed Loop Control + Liraglutide||11
8867799|NCT01856790|9924130|FG000|NOT COMPLETED|Closed Loop Control + Liraglutide||2
8867800|NCT01856907|9924144|FG000|STARTED|Overall Study||12
8867801|NCT01856907|9924145|FG001|STARTED|Overall Study||12
8867802|NCT01856907|9924146|FG002|STARTED|Overall Study||12
8867803|NCT01856907|9924144|FG000|COMPLETED|Overall Study||12
8867804|NCT01856907|9924145|FG001|COMPLETED|Overall Study||9
8867805|NCT01856907|9924146|FG002|COMPLETED|Overall Study||12
8867806|NCT01856907|9924144|FG000|NOT COMPLETED|Overall Study||0
8867807|NCT01856907|9924145|FG001|NOT COMPLETED|Overall Study||3
8867808|NCT01856907|9924146|FG002|NOT COMPLETED|Overall Study||0
8867809|NCT01856933|9924157|FG000|STARTED|Overall Study||6
8867810|NCT01856933|9924157|FG000|COMPLETED|Overall Study||6
8867811|NCT01856933|9924157|FG000|NOT COMPLETED|Overall Study||0
8867812|NCT01857102|9924161|FG000|STARTED|Period 1||58
8867813|NCT01857102|9924162|FG001|STARTED|Period 1||56
8867814|NCT01857102|9924161|FG000|Habitual Users|Period 1||51
8867815|NCT01857102|9924162|FG001|Habitual Users|Period 1||52
8867816|NCT01857102|9924161|FG000|Neophtyes|Period 1||7
8867817|NCT01857102|9924162|FG001|Neophtyes|Period 1||4
8867818|NCT01857102|9924161|FG000|COMPLETED|Period 1||55
8867819|NCT01857102|9924162|FG001|COMPLETED|Period 1||51
8867820|NCT01857102|9924161|FG000|NOT COMPLETED|Period 1||3
8867821|NCT01857102|9924162|FG001|NOT COMPLETED|Period 1||5
8867822|NCT01857102|9924161|FG000|STARTED|Period 2||55
8867823|NCT01857102|9924162|FG001|STARTED|Period 2||51
8867824|NCT01857102|9924161|FG000|Habitual Users|Period 2||48
8867825|NCT01857102|9924162|FG001|Habitual Users|Period 2||47
8867826|NCT01857102|9924161|FG000|Neophytes|Period 2||7
8867827|NCT01857102|9924162|FG001|Neophytes|Period 2||4
8867828|NCT01857102|9924161|FG000|COMPLETED|Period 2||53
8867829|NCT01857102|9924162|FG001|COMPLETED|Period 2||51
8867830|NCT01857102|9924161|FG000|NOT COMPLETED|Period 2||2
8867831|NCT01857102|9924162|FG001|NOT COMPLETED|Period 2||0
8867832|NCT01857206|9924172|FG000|STARTED|Overall Study||1372
8867833|NCT01857206|9924173|FG001|STARTED|Overall Study||683
8867834|NCT01857206|9924172|FG000|COMPLETED|Overall Study||1359
8867835|NCT01857206|9924173|FG001|COMPLETED|Overall Study||673
8867836|NCT01857206|9924172|FG000|NOT COMPLETED|Overall Study||13
8867837|NCT01857206|9924173|FG001|NOT COMPLETED|Overall Study||10
8867838|NCT01857232|9924188|FG000|STARTED|Overall Study||69
8867839|NCT01857232|9924189|FG001|STARTED|Overall Study||67
8867840|NCT01857232|9924190|FG002|STARTED|Overall Study||67
8867841|NCT01857232|9924191|FG003|STARTED|Overall Study||70
8867842|NCT01857232|9924192|FG004|STARTED|Overall Study||69
8867843|NCT01857232|9924188|FG000|Evaluable ITT|Overall Study||66
8867844|NCT01857232|9924189|FG001|Evaluable ITT|Overall Study||66
8867845|NCT01857232|9924190|FG002|Evaluable ITT|Overall Study||63
8951995|NCT02459197|10014911|FG001|STARTED|Overall Study||56
8951996|NCT02459197|10014910|FG000|COMPLETED|Overall Study||58
8951997|NCT02459197|10014911|FG001|COMPLETED|Overall Study||55
8951998|NCT02459197|10014910|FG000|NOT COMPLETED|Overall Study||0
8951999|NCT02459197|10014911|FG001|NOT COMPLETED|Overall Study||1
8952000|NCT02459262|10014928|FG000|STARTED|Overall Study||8
8952001|NCT02459262|10014929|FG001|STARTED|Overall Study||8
8952002|NCT02459262|10014930|FG002|STARTED|Overall Study||8
8952003|NCT02459262|10014931|FG003|STARTED|Overall Study||8
8952004|NCT02459262|10014932|FG004|STARTED|Overall Study||8
8952005|NCT02459262|10014933|FG005|STARTED|Overall Study||8
8867846|NCT01857232|9924191|FG003|Evaluable ITT|Overall Study||68
8867847|NCT01857232|9924192|FG004|Evaluable ITT|Overall Study||65
8867848|NCT01857232|9924188|FG000|COMPLETED|Overall Study||61
8867849|NCT01857232|9924189|FG001|COMPLETED|Overall Study||65
8867850|NCT01857232|9924190|FG002|COMPLETED|Overall Study||63
8952006|NCT02459262|10014934|FG006|STARTED|Overall Study||12
8952007|NCT02459262|10014935|FG007|STARTED|Overall Study||45
8952008|NCT02459262|10014936|FG008|STARTED|Overall Study||45
8952009|NCT02459262|10014937|FG009|STARTED|Overall Study||45
8952010|NCT02459262|10014938|FG010|STARTED|Overall Study||45
8867851|NCT01857232|9924191|FG003|COMPLETED|Overall Study||68
8867852|NCT01857232|9924192|FG004|COMPLETED|Overall Study||63
8867853|NCT01857232|9924188|FG000|NOT COMPLETED|Overall Study||8
8867854|NCT01857232|9924189|FG001|NOT COMPLETED|Overall Study||2
8867855|NCT01857232|9924190|FG002|NOT COMPLETED|Overall Study||4
8867856|NCT01857232|9924191|FG003|NOT COMPLETED|Overall Study||2
8867857|NCT01857232|9924192|FG004|NOT COMPLETED|Overall Study||6
8867858|NCT01857258|9924207|FG000|STARTED|First Intervention (3 h Postprandially)||8
8867859|NCT01857258|9924208|FG001|STARTED|First Intervention (3 h Postprandially)||7
8867860|NCT01857258|9924207|FG000|COMPLETED|First Intervention (3 h Postprandially)||8
8867861|NCT01857258|9924208|FG001|COMPLETED|First Intervention (3 h Postprandially)||7
8867862|NCT01857258|9924207|FG000|NOT COMPLETED|First Intervention (3 h Postprandially)||0
8867863|NCT01857258|9924208|FG001|NOT COMPLETED|First Intervention (3 h Postprandially)||0
8867864|NCT01857258|9924207|FG000|STARTED|Wash-out Period (7 Days)||8
8952011|NCT02459262|10014928|FG000|COMPLETED|Overall Study||8
8952012|NCT02459262|10014929|FG001|COMPLETED|Overall Study||8
8630939|NCT00537381|9670795|FG000|NOT COMPLETED|Overall Study||56
8630940|NCT00537381|9670796|FG001|NOT COMPLETED|Overall Study||62
8630941|NCT00537394|9670807|FG000|STARTED|First Year of Follow-up||181
8630942|NCT00537394|9670808|FG001|STARTED|First Year of Follow-up||179
8630943|NCT00537394|9670809|FG002|STARTED|First Year of Follow-up||53
8630944|NCT00537394|9670807|FG000|COMPLETED|First Year of Follow-up|Completed refers to completing first 48 weeks of follow-up.|169
8630945|NCT00537394|9670808|FG001|COMPLETED|First Year of Follow-up|Completed refers to completing first 48 weeks of follow-up.|168
8630946|NCT00537394|9670809|FG002|COMPLETED|First Year of Follow-up||50
8630947|NCT00537394|9670807|FG000|NOT COMPLETED|First Year of Follow-up||12
8630948|NCT00537394|9670808|FG001|NOT COMPLETED|First Year of Follow-up||11
8630949|NCT00537394|9670809|FG002|NOT COMPLETED|First Year of Follow-up||3
8867865|NCT01857258|9924208|FG001|STARTED|Wash-out Period (7 Days)||7
8867866|NCT01857258|9924207|FG000|COMPLETED|Wash-out Period (7 Days)||8
8867867|NCT01857258|9924208|FG001|COMPLETED|Wash-out Period (7 Days)||7
8867868|NCT01857258|9924207|FG000|NOT COMPLETED|Wash-out Period (7 Days)||0
8867869|NCT01857258|9924208|FG001|NOT COMPLETED|Wash-out Period (7 Days)||0
8867870|NCT01857258|9924207|FG000|STARTED|Second Intervention (3 h Postprandially)||8
8867871|NCT01857258|9924208|FG001|STARTED|Second Intervention (3 h Postprandially)||7
8867872|NCT01857258|9924207|FG000|COMPLETED|Second Intervention (3 h Postprandially)||8
8867873|NCT01857258|9924208|FG001|COMPLETED|Second Intervention (3 h Postprandially)||7
8867874|NCT01857258|9924207|FG000|NOT COMPLETED|Second Intervention (3 h Postprandially)||0
8867875|NCT01857258|9924208|FG001|NOT COMPLETED|Second Intervention (3 h Postprandially)||0
8867876|NCT01857297|9924218|FG000|STARTED|Overall Study||60
8867877|NCT01857297|9924219|FG001|STARTED|Overall Study||60
8867878|NCT01857297|9924218|FG000|COMPLETED|Overall Study||60
8867879|NCT01857297|9924219|FG001|COMPLETED|Overall Study||60
8867880|NCT01857297|9924218|FG000|NOT COMPLETED|Overall Study||0
8867881|NCT01857297|9924219|FG001|NOT COMPLETED|Overall Study||0
8867882|NCT01857310|9924227|FG000|STARTED|Primary Analysis: Live Birth|Male partner|1185
8867883|NCT01857310|9924228|FG001|STARTED|Primary Analysis: Live Birth|Male partner|1185
8867884|NCT01857310|9924227|FG000|COMPLETED|Primary Analysis: Live Birth|Chart abstraction of whether live birth occurred|1185
8867885|NCT01857310|9924228|FG001|COMPLETED|Primary Analysis: Live Birth|Chart abstraction of whether live birth occurred|1185
8867886|NCT01857310|9924227|FG000|NOT COMPLETED|Primary Analysis: Live Birth||0
8867887|NCT01857310|9924228|FG001|NOT COMPLETED|Primary Analysis: Live Birth||0
8867888|NCT01857310|9924227|FG000|STARTED|Secondary Analysis: Semen Quality at 6m|Male partner|1185
8867889|NCT01857310|9924228|FG001|STARTED|Secondary Analysis: Semen Quality at 6m|Male partner|1185
8867890|NCT01857310|9924227|FG000|COMPLETED|Secondary Analysis: Semen Quality at 6m|Completed 6-month study visit|870
8867891|NCT01857310|9924228|FG001|COMPLETED|Secondary Analysis: Semen Quality at 6m|Completed 6-month study visit|903
8867892|NCT01857310|9924227|FG000|NOT COMPLETED|Secondary Analysis: Semen Quality at 6m||315
8867893|NCT01857310|9924228|FG001|NOT COMPLETED|Secondary Analysis: Semen Quality at 6m||282
8867894|NCT01857323|9924234|FG000|STARTED|Overall Study|36 day treatment cohort: 45 participants 50 day treatment cohort: 272 participants|317
8867895|NCT01857323|9924234|FG000|Safety Population|Overall Study|One enrolled participant was lost to follow-up.|316
8867896|NCT01857323|9924234|FG000|COMPLETED|Overall Study||253
8867897|NCT01857323|9924234|FG000|NOT COMPLETED|Overall Study||64
8867898|NCT01857362|9924238|FG000|STARTED|Overall Study||6
8867899|NCT01857362|9924239|FG001|STARTED|Overall Study||6
8867900|NCT01857362|9924238|FG000|COMPLETED|Overall Study||6
8867901|NCT01857362|9924239|FG001|COMPLETED|Overall Study||6
8867902|NCT01857362|9924238|FG000|NOT COMPLETED|Overall Study||0
8867903|NCT01857362|9924239|FG001|NOT COMPLETED|Overall Study||0
8867904|NCT01857531|9924245|FG000|STARTED|Overall Study||16
8867905|NCT01857531|9924245|FG000|COMPLETED|Overall Study||12
8867906|NCT01857531|9924245|FG000|NOT COMPLETED|Overall Study||4
8867907|NCT01857583|9924253|FG000|STARTED|Overall Study||30
8867908|NCT01857583|9924254|FG001|STARTED|Overall Study||7
8867909|NCT01857583|9924255|FG002|STARTED|Overall Study||22
8867910|NCT01857583|9924256|FG003|STARTED|Overall Study||21
8867911|NCT01857583|9924253|FG000|Safety Analysis Population|Overall Study||30
8867912|NCT01857583|9924254|FG001|Safety Analysis Population|Overall Study||7
8867913|NCT01857583|9924255|FG002|Safety Analysis Population|Overall Study||22
8867914|NCT01857583|9924256|FG003|Safety Analysis Population|Overall Study||20
8867915|NCT01857583|9924253|FG000|COMPLETED|Overall Study||29
8867916|NCT01857583|9924254|FG001|COMPLETED|Overall Study||6
8867917|NCT01857583|9924255|FG002|COMPLETED|Overall Study||19
8867918|NCT01857583|9924256|FG003|COMPLETED|Overall Study||17
8867919|NCT01857583|9924253|FG000|NOT COMPLETED|Overall Study||1
8867920|NCT01857583|9924254|FG001|NOT COMPLETED|Overall Study||1
8630950|NCT00537394|9670807|FG000|STARTED|2nd Year of Follow-up||169
8630951|NCT00537394|9670808|FG001|STARTED|2nd Year of Follow-up||168
8867921|NCT01857583|9924255|FG002|NOT COMPLETED|Overall Study||3
8867922|NCT01857583|9924256|FG003|NOT COMPLETED|Overall Study||4
8867923|NCT01857622|9924269|FG000|STARTED|Overall Study||50
8867924|NCT01857622|9924270|FG001|STARTED|Overall Study||22
8867925|NCT01857622|9924271|FG002|STARTED|Overall Study||21
8867926|NCT01857622|9924269|FG000|COMPLETED|Overall Study||39
8867927|NCT01857622|9924270|FG001|COMPLETED|Overall Study||21
8867928|NCT01857622|9924271|FG002|COMPLETED|Overall Study||19
8867929|NCT01857622|9924269|FG000|NOT COMPLETED|Overall Study||11
8867930|NCT01857622|9924270|FG001|NOT COMPLETED|Overall Study||1
8867931|NCT01857622|9924271|FG002|NOT COMPLETED|Overall Study||2
8867932|NCT01857713|9924279|FG000|STARTED|Overall Study||95
8867933|NCT01857713|9924279|FG000|COMPLETED|Overall Study||89
8867934|NCT01857713|9924279|FG000|NOT COMPLETED|Overall Study||6
8867935|NCT01857869|9924295|FG000|STARTED|Primary/Challenge Phase||34
8867936|NCT01857869|9924296|FG001|STARTED|Primary/Challenge Phase||17
8867937|NCT01857869|9924297|FG002|STARTED|Primary/Challenge Phase||12
8867938|NCT01857869|9924298|FG003|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
8867939|NCT01857869|9924299|FG004|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
8867940|NCT01857869|9924300|FG005|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
8867941|NCT01857869|9924301|FG006|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
8867942|NCT01857869|9924302|FG007|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
8867943|NCT01857869|9924303|FG008|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
8867944|NCT01857869|9924304|FG009|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
8867945|NCT01857869|9924295|FG000|COMPLETED|Primary/Challenge Phase||29
8867946|NCT01857869|9924296|FG001|COMPLETED|Primary/Challenge Phase||16
8867947|NCT01857869|9924297|FG002|COMPLETED|Primary/Challenge Phase||12
8867948|NCT01857869|9924298|FG003|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
8867949|NCT01857869|9924299|FG004|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
8867950|NCT01857869|9924300|FG005|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
8867951|NCT01857869|9924301|FG006|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
8867952|NCT01857869|9924302|FG007|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
8867953|NCT01857869|9924303|FG008|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
8867954|NCT01857869|9924304|FG009|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
8867955|NCT01857869|9924295|FG000|NOT COMPLETED|Primary/Challenge Phase||5
8867956|NCT01857869|9924296|FG001|NOT COMPLETED|Primary/Challenge Phase||1
8867957|NCT01857869|9924297|FG002|NOT COMPLETED|Primary/Challenge Phase||0
8867958|NCT01857869|9924298|FG003|NOT COMPLETED|Primary/Challenge Phase||0
8867959|NCT01857869|9924299|FG004|NOT COMPLETED|Primary/Challenge Phase||0
8867960|NCT01857869|9924300|FG005|NOT COMPLETED|Primary/Challenge Phase||0
8867961|NCT01857869|9924301|FG006|NOT COMPLETED|Primary/Challenge Phase||0
8867962|NCT01857869|9924302|FG007|NOT COMPLETED|Primary/Challenge Phase||0
8867963|NCT01857869|9924303|FG008|NOT COMPLETED|Primary/Challenge Phase||0
8867964|NCT01857869|9924304|FG009|NOT COMPLETED|Primary/Challenge Phase||0
8867965|NCT01857869|9924295|FG000|STARTED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
8867966|NCT01857869|9924296|FG001|STARTED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
8867967|NCT01857869|9924297|FG002|STARTED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
8867968|NCT01857869|9924298|FG003|STARTED|Booster/Rechallenge Phase||9
8867969|NCT01857869|9924299|FG004|STARTED|Booster/Rechallenge Phase||10
8867970|NCT01857869|9924300|FG005|STARTED|Booster/Rechallenge Phase||2
8867971|NCT01857869|9924301|FG006|STARTED|Booster/Rechallenge Phase||5
8867972|NCT01857869|9924302|FG007|STARTED|Booster/Rechallenge Phase||4
8867973|NCT01857869|9924303|FG008|STARTED|Booster/Rechallenge Phase||3
8867974|NCT01857869|9924304|FG009|STARTED|Booster/Rechallenge Phase||6
8867975|NCT01857869|9924295|FG000|COMPLETED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
8867976|NCT01857869|9924296|FG001|COMPLETED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
8867977|NCT01857869|9924297|FG002|COMPLETED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
8867978|NCT01857869|9924298|FG003|COMPLETED|Booster/Rechallenge Phase||7
8867979|NCT01857869|9924299|FG004|COMPLETED|Booster/Rechallenge Phase||10
8867980|NCT01857869|9924300|FG005|COMPLETED|Booster/Rechallenge Phase||2
8867981|NCT01857869|9924301|FG006|COMPLETED|Booster/Rechallenge Phase||5
8867982|NCT01857869|9924302|FG007|COMPLETED|Booster/Rechallenge Phase||4
8867983|NCT01857869|9924303|FG008|COMPLETED|Booster/Rechallenge Phase||3
8867984|NCT01857869|9924304|FG009|COMPLETED|Booster/Rechallenge Phase||6
8867985|NCT01857869|9924295|FG000|NOT COMPLETED|Booster/Rechallenge Phase||0
8867986|NCT01857869|9924296|FG001|NOT COMPLETED|Booster/Rechallenge Phase||0
8867987|NCT01857869|9924297|FG002|NOT COMPLETED|Booster/Rechallenge Phase||0
8867988|NCT01857869|9924298|FG003|NOT COMPLETED|Booster/Rechallenge Phase||2
8867989|NCT01857869|9924299|FG004|NOT COMPLETED|Booster/Rechallenge Phase||0
8867990|NCT01857869|9924300|FG005|NOT COMPLETED|Booster/Rechallenge Phase||0
8867991|NCT01857869|9924301|FG006|NOT COMPLETED|Booster/Rechallenge Phase||0
8867992|NCT01857869|9924302|FG007|NOT COMPLETED|Booster/Rechallenge Phase||0
8867993|NCT01857869|9924303|FG008|NOT COMPLETED|Booster/Rechallenge Phase||0
8867994|NCT01857869|9924304|FG009|NOT COMPLETED|Booster/Rechallenge Phase||0
8867995|NCT01857882|9924329|FG000|STARTED|Overall Study||21
8867996|NCT01857882|9924330|FG001|STARTED|Overall Study||20
8867997|NCT01857882|9924329|FG000|COMPLETED|Overall Study||21
8867998|NCT01857882|9924330|FG001|COMPLETED|Overall Study||20
8867999|NCT01857882|9924329|FG000|NOT COMPLETED|Overall Study||0
8868000|NCT01857882|9924330|FG001|NOT COMPLETED|Overall Study||0
8868001|NCT01857973|9924336|FG000|STARTED|Overall Study||78
8868002|NCT01857973|9924336|FG000|Exploratory A Phase|Overall Study||9
8868003|NCT01857973|9924336|FG000|Xploratory B Phase|Overall Study||9
8868004|NCT01857973|9924336|FG000|Phase 1|Overall Study||17
8868005|NCT01857973|9924336|FG000|Phase 2|Overall Study||14
8868006|NCT01857973|9924336|FG000|Phase 3|Overall Study||10
8868007|NCT01857973|9924336|FG000|Phase 4|Overall Study||10
8868008|NCT01857973|9924336|FG000|Phase 6|Overall Study||4
8868009|NCT01857973|9924336|FG000|Phase 7|Overall Study||4
8868010|NCT01857973|9924336|FG000|COMPLETED|Overall Study||73
8868011|NCT01857973|9924336|FG000|NOT COMPLETED|Overall Study||5
8868012|NCT01857986|9924342|FG000|STARTED|Overall Study||39
8868013|NCT01857986|9924343|FG001|STARTED|Overall Study||37
8868014|NCT01857986|9924342|FG000|COMPLETED|Overall Study||34
8868015|NCT01857986|9924343|FG001|COMPLETED|Overall Study||30
8868016|NCT01857986|9924342|FG000|NOT COMPLETED|Overall Study||5
8868017|NCT01857986|9924343|FG001|NOT COMPLETED|Overall Study||7
8868018|NCT01858194|9924351|FG000|STARTED|Overall Study||8
8868019|NCT01858194|9924352|FG001|STARTED|Overall Study||9
8868020|NCT01858194|9924351|FG000|COMPLETED|Overall Study|All patients in Control arm completed.|8
8868021|NCT01858194|9924352|FG001|COMPLETED|Overall Study||7
8868022|NCT01858194|9924351|FG000|NOT COMPLETED|Overall Study||0
8868023|NCT01858194|9924352|FG001|NOT COMPLETED|Overall Study||2
8868024|NCT01858363|9924362|FG000|STARTED|Overall Study||222
8868025|NCT01858363|9924363|FG001|STARTED|Overall Study||72
8868026|NCT01858363|9924362|FG000|Pre-discharge Visit|Overall Study||219
8868027|NCT01858363|9924363|FG001|Pre-discharge Visit|Overall Study||72
8868028|NCT01858363|9924362|FG000|1-month Visit|Overall Study||214
8868029|NCT01858363|9924363|FG001|1-month Visit|Overall Study||68
8868030|NCT01858363|9924362|FG000|6-month Visit|Overall Study||208
8868031|NCT01858363|9924363|FG001|6-month Visit|Overall Study||64
8868032|NCT01858363|9924362|FG000|12-month Vist|Overall Study||205
8868033|NCT01858363|9924363|FG001|12-month Vist|Overall Study||61
8868034|NCT01858363|9924362|FG000|24-month Visit|Overall Study||184
8868035|NCT01858363|9924363|FG001|24-month Visit|Overall Study||58
8868036|NCT01858363|9924362|FG000|36-month Visit|Overall Study||169
8868037|NCT01858363|9924363|FG001|36-month Visit|Overall Study||53
8868038|NCT01858363|9924362|FG000|48-month Visit|Overall Study||157
8868039|NCT01858363|9924363|FG001|48-month Visit|Overall Study||53
8868040|NCT01858363|9924362|FG000|COMPLETED|Overall Study||146
8868041|NCT01858363|9924363|FG001|COMPLETED|Overall Study||46
8868042|NCT01858363|9924362|FG000|NOT COMPLETED|Overall Study||76
8868043|NCT01858363|9924363|FG001|NOT COMPLETED|Overall Study||26
8868044|NCT01858376|9924369|FG000|STARTED|Overall Study||24
8868045|NCT01858376|9924369|FG000|COMPLETED|Overall Study||20
8868046|NCT01858376|9924369|FG000|NOT COMPLETED|Overall Study||4
8868047|NCT01858389|9924375|FG000|STARTED|Overall Study|Enrolled|16
8868048|NCT01858389|9924376|FG001|STARTED|Overall Study|Enrolled|25
8868049|NCT01858389|9924375|FG000|Received Treatment|Overall Study||16
8868050|NCT01858389|9924376|FG001|Received Treatment|Overall Study||22
8868051|NCT01858389|9924375|FG000|COMPLETED|Overall Study||0
8868052|NCT01858389|9924376|FG001|COMPLETED|Overall Study||0
8868053|NCT01858389|9924375|FG000|NOT COMPLETED|Overall Study||16
8868054|NCT01858389|9924376|FG001|NOT COMPLETED|Overall Study||25
8868055|NCT01858428|9924386|FG000|STARTED|Overall Study|EverCross™ Balloon Catheter now a product of Medtronic|100
8868056|NCT01858428|9924387|FG001|STARTED|Overall Study||200
8868057|NCT01858428|9924386|FG000|COMPLETED|Overall Study||99
8868058|NCT01858428|9924387|FG001|COMPLETED|Overall Study||190
8868059|NCT01858428|9924386|FG000|NOT COMPLETED|Overall Study||1
8868060|NCT01858428|9924387|FG001|NOT COMPLETED|Overall Study||10
8868061|NCT01858532|9924397|FG000|STARTED|Overall Study||1325
8868062|NCT01858532|9924398|FG001|STARTED|Overall Study||1323
8868063|NCT01858532|9924399|FG002|STARTED|Overall Study||509
8868064|NCT01858532|9924400|FG003|STARTED|Overall Study||511
8868065|NCT01858532|9924397|FG000|COMPLETED|Overall Study||1144
8868066|NCT01858532|9924398|FG001|COMPLETED|Overall Study||1131
8868067|NCT01858532|9924399|FG002|COMPLETED|Overall Study||411
8868068|NCT01858532|9924400|FG003|COMPLETED|Overall Study||418
8868069|NCT01858532|9924397|FG000|NOT COMPLETED|Overall Study||181
8868070|NCT01858532|9924398|FG001|NOT COMPLETED|Overall Study||192
8868071|NCT01858532|9924399|FG002|NOT COMPLETED|Overall Study||98
8868072|NCT01858532|9924400|FG003|NOT COMPLETED|Overall Study||93
8868073|NCT01858545|9924412|FG000|STARTED|Overall Study||27
8868074|NCT01858545|9924413|FG001|STARTED|Overall Study||29
8868075|NCT01858545|9924412|FG000|COMPLETED|Overall Study||23
8868076|NCT01858545|9924413|FG001|COMPLETED|Overall Study||23
8868077|NCT01858545|9924412|FG000|NOT COMPLETED|Overall Study||4
8868078|NCT01858545|9924413|FG001|NOT COMPLETED|Overall Study||6
8868079|NCT01858558|9924421|FG000|STARTED|Overall Study||70
8868080|NCT01858558|9924422|FG001|STARTED|Overall Study||31
8868081|NCT01858558|9924421|FG000|COMPLETED|Overall Study||61
8868082|NCT01858558|9924422|FG001|COMPLETED|Overall Study||29
8868083|NCT01858558|9924421|FG000|NOT COMPLETED|Overall Study||9
8868084|NCT01858558|9924422|FG001|NOT COMPLETED|Overall Study||2
8868085|NCT01858636|9924428|FG000|STARTED|Overall Study|Subjects consented|235
8868086|NCT01858636|9924428|FG000|Device Deployment|Overall Study||211
8868087|NCT01858636|9924428|FG000|COMPLETED|Overall Study||207
8868088|NCT01858636|9924428|FG000|NOT COMPLETED|Overall Study||28
8868089|NCT01858701|9924433|FG000|STARTED|Period 1, First 30 Days of Wear||20
8868090|NCT01858701|9924434|FG001|STARTED|Period 1, First 30 Days of Wear||20
8868091|NCT01858701|9924433|FG000|COMPLETED|Period 1, First 30 Days of Wear||20
8868092|NCT01858701|9924434|FG001|COMPLETED|Period 1, First 30 Days of Wear||19
8868093|NCT01858701|9924433|FG000|NOT COMPLETED|Period 1, First 30 Days of Wear||0
8868094|NCT01858701|9924434|FG001|NOT COMPLETED|Period 1, First 30 Days of Wear||1
8868095|NCT01858701|9924433|FG000|STARTED|Washout Period, 1-13 Days||20
8868096|NCT01858701|9924434|FG001|STARTED|Washout Period, 1-13 Days||19
8868097|NCT01858701|9924433|FG000|COMPLETED|Washout Period, 1-13 Days||18
8868098|NCT01858701|9924434|FG001|COMPLETED|Washout Period, 1-13 Days||17
8868099|NCT01858701|9924433|FG000|NOT COMPLETED|Washout Period, 1-13 Days||2
8868100|NCT01858701|9924434|FG001|NOT COMPLETED|Washout Period, 1-13 Days||2
8868101|NCT01858701|9924433|FG000|STARTED|Period 2, Second 30 Days of Wear||18
8868102|NCT01858701|9924434|FG001|STARTED|Period 2, Second 30 Days of Wear||17
8868103|NCT01858701|9924433|FG000|COMPLETED|Period 2, Second 30 Days of Wear||18
8868104|NCT01858701|9924434|FG001|COMPLETED|Period 2, Second 30 Days of Wear||16
8868105|NCT01858701|9924433|FG000|NOT COMPLETED|Period 2, Second 30 Days of Wear||0
8868106|NCT01858701|9924434|FG001|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
8868107|NCT01858753|9924442|FG000|STARTED|Overall Study||5
8868108|NCT01858753|9924443|FG001|STARTED|Overall Study||0
8868109|NCT01858753|9924442|FG000|COMPLETED|Overall Study||0
8868110|NCT01858753|9924443|FG001|COMPLETED|Overall Study||0
8868111|NCT01858753|9924442|FG000|NOT COMPLETED|Overall Study||5
8868112|NCT01858753|9924443|FG001|NOT COMPLETED|Overall Study||0
8868113|NCT01858766|9924468|FG000|STARTED|Overall Study||27
8868114|NCT01858766|9924469|FG001|STARTED|Overall Study||28
8868115|NCT01858766|9924470|FG002|STARTED|Overall Study||11
8868116|NCT01858766|9924471|FG003|STARTED|Overall Study||10
8868117|NCT01858766|9924472|FG004|STARTED|Overall Study||27
8868118|NCT01858766|9924473|FG005|STARTED|Overall Study||28
8868119|NCT01858766|9924474|FG006|STARTED|Overall Study||7
8868120|NCT01858766|9924475|FG007|STARTED|Overall Study||7
8868121|NCT01858766|9924476|FG008|STARTED|Overall Study||1
8868122|NCT01858766|9924477|FG009|STARTED|Overall Study||4
8868123|NCT01858766|9924478|FG010|STARTED|Overall Study||5
8868124|NCT01858766|9924479|FG011|STARTED|Overall Study||30
8868125|NCT01858766|9924480|FG012|STARTED|Overall Study||30
8868126|NCT01858766|9924481|FG013|STARTED|Overall Study||29
8868127|NCT01858766|9924482|FG014|STARTED|Overall Study||31
8868128|NCT01858766|9924483|FG015|STARTED|Overall Study||26
8868129|NCT01858766|9924484|FG016|STARTED|Overall Study||25
8868130|NCT01858766|9924485|FG017|STARTED|Overall Study||27
8868131|NCT01858766|9924486|FG018|STARTED|Overall Study||26
8868132|NCT01858766|9924468|FG000|COMPLETED|Overall Study||26
8868133|NCT01858766|9924469|FG001|COMPLETED|Overall Study||28
8868134|NCT01858766|9924470|FG002|COMPLETED|Overall Study||10
8868135|NCT01858766|9924471|FG003|COMPLETED|Overall Study||10
8630952|NCT00537394|9670809|FG002|STARTED|2nd Year of Follow-up||50
8630953|NCT00537394|9670807|FG000|COMPLETED|2nd Year of Follow-up||158
8868136|NCT01858766|9924472|FG004|COMPLETED|Overall Study||26
8868137|NCT01858766|9924473|FG005|COMPLETED|Overall Study||24
8868138|NCT01858766|9924474|FG006|COMPLETED|Overall Study||7
8868139|NCT01858766|9924475|FG007|COMPLETED|Overall Study||5
8868140|NCT01858766|9924476|FG008|COMPLETED|Overall Study||1
8868141|NCT01858766|9924477|FG009|COMPLETED|Overall Study||4
8868142|NCT01858766|9924478|FG010|COMPLETED|Overall Study||5
8868143|NCT01858766|9924479|FG011|COMPLETED|Overall Study||25
8868144|NCT01858766|9924480|FG012|COMPLETED|Overall Study||25
8868145|NCT01858766|9924481|FG013|COMPLETED|Overall Study||26
8868146|NCT01858766|9924482|FG014|COMPLETED|Overall Study||23
8868147|NCT01858766|9924483|FG015|COMPLETED|Overall Study||20
8868148|NCT01858766|9924484|FG016|COMPLETED|Overall Study||22
8868149|NCT01858766|9924485|FG017|COMPLETED|Overall Study||23
8868150|NCT01858766|9924486|FG018|COMPLETED|Overall Study||22
8868151|NCT01858766|9924468|FG000|NOT COMPLETED|Overall Study||1
8868152|NCT01858766|9924469|FG001|NOT COMPLETED|Overall Study||0
8868153|NCT01858766|9924470|FG002|NOT COMPLETED|Overall Study||1
8868154|NCT01858766|9924471|FG003|NOT COMPLETED|Overall Study||0
8868155|NCT01858766|9924472|FG004|NOT COMPLETED|Overall Study||1
8868156|NCT01858766|9924473|FG005|NOT COMPLETED|Overall Study||4
8630954|NCT00537394|9670808|FG001|COMPLETED|2nd Year of Follow-up||159
8868157|NCT01858766|9924474|FG006|NOT COMPLETED|Overall Study||0
8868158|NCT01858766|9924475|FG007|NOT COMPLETED|Overall Study||2
8868159|NCT01858766|9924476|FG008|NOT COMPLETED|Overall Study||0
8868160|NCT01858766|9924477|FG009|NOT COMPLETED|Overall Study||0
8868161|NCT01858766|9924478|FG010|NOT COMPLETED|Overall Study||0
8868162|NCT01858766|9924479|FG011|NOT COMPLETED|Overall Study||5
8868163|NCT01858766|9924480|FG012|NOT COMPLETED|Overall Study||5
8868164|NCT01858766|9924481|FG013|NOT COMPLETED|Overall Study||3
8868165|NCT01858766|9924482|FG014|NOT COMPLETED|Overall Study||8
8868166|NCT01858766|9924483|FG015|NOT COMPLETED|Overall Study||6
8868167|NCT01858766|9924484|FG016|NOT COMPLETED|Overall Study||3
8868168|NCT01858766|9924485|FG017|NOT COMPLETED|Overall Study||4
8868169|NCT01858766|9924486|FG018|NOT COMPLETED|Overall Study||4
8868170|NCT01859013|9924521|FG000|STARTED|Overall Study||16
8868171|NCT01859013|9924522|FG001|STARTED|Overall Study||14
8868172|NCT01859013|9924521|FG000|COMPLETED|Overall Study||12
8868173|NCT01859013|9924522|FG001|COMPLETED|Overall Study||9
8868174|NCT01859013|9924521|FG000|NOT COMPLETED|Overall Study||4
8868175|NCT01859013|9924522|FG001|NOT COMPLETED|Overall Study||5
8868176|NCT01859078|9924528|FG000|STARTED|Overall Study||28
8868177|NCT01859078|9924528|FG000|COMPLETED|Overall Study||28
8868178|NCT01859078|9924528|FG000|NOT COMPLETED|Overall Study||0
8868179|NCT01859143|9924536|FG000|STARTED|Overall Study||240
8868180|NCT01859143|9924537|FG001|STARTED|Overall Study|One participant in this group received trivalent influenza vaccine on Day 1.|60
8868181|NCT01859143|9924536|FG000|COMPLETED|Overall Study||238
8868182|NCT01859143|9924537|FG001|COMPLETED|Overall Study||60
8868183|NCT01859143|9924536|FG000|NOT COMPLETED|Overall Study||2
8868184|NCT01859143|9924537|FG001|NOT COMPLETED|Overall Study||0
8868185|NCT01859195|9924546|FG000|STARTED|Overall Study||24
8868186|NCT01859195|9924547|FG001|STARTED|Overall Study||12
8868187|NCT01859195|9924546|FG000|COMPLETED|Overall Study||24
8868188|NCT01859195|9924547|FG001|COMPLETED|Overall Study||12
8868189|NCT01859195|9924546|FG000|NOT COMPLETED|Overall Study||0
8868190|NCT01859195|9924547|FG001|NOT COMPLETED|Overall Study||0
8868191|NCT01859247|9924563|FG000|STARTED|Overall Study||1
8868192|NCT01859247|9924564|FG001|STARTED|Overall Study||1
8868193|NCT01859247|9924565|FG002|STARTED|Overall Study||1
8868194|NCT01859247|9924566|FG003|STARTED|Overall Study||1
8868195|NCT01859247|9924567|FG004|STARTED|Overall Study||1
8868196|NCT01859247|9924568|FG005|STARTED|Overall Study||1
8868197|NCT01859247|9924569|FG006|STARTED|Overall Study||1
8868198|NCT01859247|9924570|FG007|STARTED|Overall Study||1
8868199|NCT01859247|9924563|FG000|COMPLETED|Overall Study||1
8868200|NCT01859247|9924564|FG001|COMPLETED|Overall Study||1
8868201|NCT01859247|9924565|FG002|COMPLETED|Overall Study||1
8868202|NCT01859247|9924566|FG003|COMPLETED|Overall Study||1
8868203|NCT01859247|9924567|FG004|COMPLETED|Overall Study||1
8868204|NCT01859247|9924568|FG005|COMPLETED|Overall Study||1
8868205|NCT01859247|9924569|FG006|COMPLETED|Overall Study||1
8868206|NCT01859247|9924570|FG007|COMPLETED|Overall Study||1
8868207|NCT01859247|9924563|FG000|NOT COMPLETED|Overall Study||0
8868208|NCT01859247|9924564|FG001|NOT COMPLETED|Overall Study||0
8868209|NCT01859247|9924565|FG002|NOT COMPLETED|Overall Study||0
8868210|NCT01859247|9924566|FG003|NOT COMPLETED|Overall Study||0
8868211|NCT01859247|9924567|FG004|NOT COMPLETED|Overall Study||0
8868212|NCT01859247|9924568|FG005|NOT COMPLETED|Overall Study||0
8868213|NCT01859247|9924569|FG006|NOT COMPLETED|Overall Study||0
8868214|NCT01859247|9924570|FG007|NOT COMPLETED|Overall Study||0
8868215|NCT01859312|9924589|FG000|STARTED|Overall Study||8
8868216|NCT01859312|9924589|FG000|COMPLETED|Overall Study|Based on medication & supply accountability, one participant was found to be partially non-compliant|8
8868217|NCT01859312|9924589|FG000|NOT COMPLETED|Overall Study||0
8868218|NCT01859325|9924596|FG000|STARTED|Overall Study||15
8868219|NCT01859325|9924597|FG001|STARTED|Overall Study||16
8868220|NCT01859325|9924598|FG002|STARTED|Overall Study||2
8868221|NCT01859325|9924596|FG000|COMPLETED|Overall Study||12
8868222|NCT01859325|9924597|FG001|COMPLETED|Overall Study||12
8868223|NCT01859325|9924598|FG002|COMPLETED|Overall Study||2
8868224|NCT01859325|9924596|FG000|NOT COMPLETED|Overall Study||3
8868225|NCT01859325|9924597|FG001|NOT COMPLETED|Overall Study||4
8868226|NCT01859325|9924598|FG002|NOT COMPLETED|Overall Study||0
8868227|NCT01859390|9924606|FG000|STARTED|Overall Study||36
8868228|NCT01859390|9924607|FG001|STARTED|Overall Study||37
8868229|NCT01859390|9924606|FG000|Withdrawals|Overall Study||2
8868230|NCT01859390|9924607|FG001|Withdrawals|Overall Study||2
8868231|NCT01859390|9924606|FG000|COMPLETED|Overall Study||35
8868232|NCT01859390|9924607|FG001|COMPLETED|Overall Study||30
8868233|NCT01859390|9924606|FG000|NOT COMPLETED|Overall Study||1
8868234|NCT01859390|9924607|FG001|NOT COMPLETED|Overall Study||7
8868235|NCT01859403|9924615|FG000|STARTED|Primary Endpoint Measure||21
8868236|NCT01859403|9924616|FG001|STARTED|Primary Endpoint Measure||30
8868237|NCT01859403|9924615|FG000|COMPLETED|Primary Endpoint Measure||20
8868238|NCT01859403|9924616|FG001|COMPLETED|Primary Endpoint Measure||26
8868239|NCT01859403|9924615|FG000|NOT COMPLETED|Primary Endpoint Measure||1
8868240|NCT01859403|9924616|FG001|NOT COMPLETED|Primary Endpoint Measure||4
8868241|NCT01859403|9924615|FG000|STARTED|Secondary Endpoint Measure||20
8868242|NCT01859403|9924616|FG001|STARTED|Secondary Endpoint Measure||26
8868243|NCT01859403|9924615|FG000|COMPLETED|Secondary Endpoint Measure||14
8868244|NCT01859403|9924616|FG001|COMPLETED|Secondary Endpoint Measure||18
8868245|NCT01859403|9924615|FG000|NOT COMPLETED|Secondary Endpoint Measure||6
8868246|NCT01859403|9924616|FG001|NOT COMPLETED|Secondary Endpoint Measure||8
8952013|NCT02459262|10014930|FG002|COMPLETED|Overall Study||8
8952014|NCT02459262|10014931|FG003|COMPLETED|Overall Study||8
8952015|NCT02459262|10014932|FG004|COMPLETED|Overall Study||8
8952016|NCT02459262|10014933|FG005|COMPLETED|Overall Study||8
8952017|NCT02459262|10014934|FG006|COMPLETED|Overall Study||12
8952018|NCT02459262|10014935|FG007|COMPLETED|Overall Study||45
8952019|NCT02459262|10014936|FG008|COMPLETED|Overall Study||45
8952020|NCT02459262|10014937|FG009|COMPLETED|Overall Study||44
8952021|NCT02459262|10014938|FG010|COMPLETED|Overall Study||45
8952022|NCT02459262|10014928|FG000|NOT COMPLETED|Overall Study||0
8952023|NCT02459262|10014929|FG001|NOT COMPLETED|Overall Study||0
8952024|NCT02459262|10014930|FG002|NOT COMPLETED|Overall Study||0
8952025|NCT02459262|10014931|FG003|NOT COMPLETED|Overall Study||0
8952026|NCT02459262|10014932|FG004|NOT COMPLETED|Overall Study||0
8952027|NCT02459262|10014933|FG005|NOT COMPLETED|Overall Study||0
8952028|NCT02459262|10014934|FG006|NOT COMPLETED|Overall Study||0
8952029|NCT02459262|10014935|FG007|NOT COMPLETED|Overall Study||0
8952030|NCT02459262|10014936|FG008|NOT COMPLETED|Overall Study||0
8952031|NCT02459262|10014937|FG009|NOT COMPLETED|Overall Study||1
8952032|NCT02459262|10014938|FG010|NOT COMPLETED|Overall Study||0
8952033|NCT02459275|10014964|FG000|STARTED|Overall Study||19
8952034|NCT02459275|10014965|FG001|STARTED|Overall Study||17
8952035|NCT02459275|10014964|FG000|COMPLETED|Overall Study||19
8952036|NCT02459275|10014965|FG001|COMPLETED|Overall Study||17
8952037|NCT02459275|10014964|FG000|NOT COMPLETED|Overall Study||0
8952038|NCT02459275|10014965|FG001|NOT COMPLETED|Overall Study||0
8952039|NCT02459418|10014973|FG000|STARTED|Overall Study||21
8952040|NCT02459418|10014974|FG001|STARTED|Overall Study||21
8952041|NCT02459418|10014973|FG000|Received First Treatment|Overall Study||21
8952042|NCT02459418|10014974|FG001|Received First Treatment|Overall Study||21
8952043|NCT02459418|10014973|FG000|Received Second Treatment|Overall Study||13
8952044|NCT02459418|10014974|FG001|Received Second Treatment|Overall Study||15
8952045|NCT02459418|10014973|FG000|COMPLETED|Overall Study||13
8952046|NCT02459418|10014974|FG001|COMPLETED|Overall Study||15
8952047|NCT02459418|10014973|FG000|NOT COMPLETED|Overall Study||8
8952048|NCT02459418|10014974|FG001|NOT COMPLETED|Overall Study||6
8952049|NCT02459587|10014985|FG000|STARTED|3-Month Follow-up Assessment||157
8952050|NCT02459587|10014986|FG001|STARTED|3-Month Follow-up Assessment||150
8952051|NCT02459587|10014985|FG000|COMPLETED|3-Month Follow-up Assessment||125
8952052|NCT02459587|10014986|FG001|COMPLETED|3-Month Follow-up Assessment||119
8868247|NCT01859494|9924622|FG000|STARTED|Overall Study||219
8868248|NCT01859494|9924622|FG000|COMPLETED|Overall Study||218
8868249|NCT01859494|9924622|FG000|NOT COMPLETED|Overall Study||1
8868250|NCT01859507|9924626|FG000|STARTED|Overall Study||32
8868251|NCT01859507|9924626|FG000|COMPLETED|Overall Study||28
8868252|NCT01859507|9924626|FG000|NOT COMPLETED|Overall Study||4
8868253|NCT01859598|9924631|FG000|STARTED|Visit 2 at 3 Months|At visit 1, patients remained at baseline, N=18995|18995
8952053|NCT02459587|10014985|FG000|NOT COMPLETED|3-Month Follow-up Assessment||32
8952054|NCT02459587|10014986|FG001|NOT COMPLETED|3-Month Follow-up Assessment||31
8952055|NCT02459587|10014985|FG000|STARTED|6-month Follow-up Assessment|Total excludes participants who withdrew participation or were deceased prior to follow-up.|152
8952056|NCT02459587|10014986|FG001|STARTED|6-month Follow-up Assessment|Total excludes participants who withdrew participation or were deceased prior to follow-up.|141
8868254|NCT01859598|9924631|FG000|COMPLETED|Visit 2 at 3 Months||17253
8868255|NCT01859598|9924631|FG000|NOT COMPLETED|Visit 2 at 3 Months||1742
8868256|NCT01859598|9924631|FG000|STARTED|Visit 3 at 6 Months||17253
8868257|NCT01859598|9924631|FG000|COMPLETED|Visit 3 at 6 Months|Loss to follow-up, N=1517; Come back at visit 3, N=605;|16341
8868258|NCT01859598|9924631|FG000|NOT COMPLETED|Visit 3 at 6 Months||912
8868259|NCT01859611|9924637|FG000|STARTED|Overall Study||51
8868260|NCT01859611|9924637|FG000|COMPLETED|Overall Study||43
8868261|NCT01859611|9924637|FG000|NOT COMPLETED|Overall Study||8
8868262|NCT01859637|9924641|FG000|STARTED|Overall Study||6
8868263|NCT01859637|9924641|FG000|COMPLETED|Overall Study||6
8868264|NCT01859637|9924641|FG000|NOT COMPLETED|Overall Study||0
8868265|NCT01859702|9924645|FG000|STARTED|Overall Study||36
8868266|NCT01859702|9924645|FG000|COMPLETED|Overall Study||31
8868267|NCT01859702|9924645|FG000|NOT COMPLETED|Overall Study||5
8923812|NCT02243280|9984428|FG008|NOT COMPLETED|Treated||1
8923813|NCT02243280|9984429|FG009|NOT COMPLETED|Treated||0
8923814|NCT02243280|9984430|FG010|NOT COMPLETED|Treated||3
8923815|NCT02243293|9984465|FG000|STARTED|Overall Study||25
8923816|NCT02243293|9984466|FG001|STARTED|Overall Study||24
8923817|NCT02243293|9984467|FG002|STARTED|Overall Study||25
8923818|NCT02243293|9984468|FG003|STARTED|Overall Study||30
8923819|NCT02243293|9984469|FG004|STARTED|Overall Study||31
8923820|NCT02243293|9984470|FG005|STARTED|Overall Study||31
8923821|NCT02243293|9984471|FG006|STARTED|Overall Study||30
8923822|NCT02243293|9984472|FG007|STARTED|Overall Study||0
8923823|NCT02243293|9984473|FG008|STARTED|Overall Study||0
8923824|NCT02243293|9984474|FG009|STARTED|Overall Study||55
8923825|NCT02243293|9984475|FG010|STARTED|Overall Study||0
8923826|NCT02243293|9984476|FG011|STARTED|Overall Study||53
8923827|NCT02243293|9984477|FG012|STARTED|Overall Study||0
8923828|NCT02243293|9984478|FG013|STARTED|Overall Study||0
8630955|NCT00537394|9670809|FG002|COMPLETED|2nd Year of Follow-up||44
8630956|NCT00537394|9670807|FG000|NOT COMPLETED|2nd Year of Follow-up||11
8630957|NCT00537394|9670808|FG001|NOT COMPLETED|2nd Year of Follow-up||9
8868268|NCT01859715|9924652|FG000|STARTED|Overall Study||141
8952057|NCT02459587|10014985|FG000|COMPLETED|6-month Follow-up Assessment||128
8952058|NCT02459587|10014986|FG001|COMPLETED|6-month Follow-up Assessment||116
8952059|NCT02459587|10014985|FG000|NOT COMPLETED|6-month Follow-up Assessment||24
8952060|NCT02459587|10014986|FG001|NOT COMPLETED|6-month Follow-up Assessment||25
8952061|NCT02459587|10014985|FG000|STARTED|12-month Follow-up Assessment|Total excludes participants who withdrew participation or were deceased prior to follow-up.|149
8952062|NCT02459587|10014986|FG001|STARTED|12-month Follow-up Assessment|Total excludes participants who withdrew participation or were deceased prior to follow-up.|138
8952063|NCT02459587|10014985|FG000|COMPLETED|12-month Follow-up Assessment||127
8952064|NCT02459587|10014986|FG001|COMPLETED|12-month Follow-up Assessment||111
8952065|NCT02459587|10014985|FG000|NOT COMPLETED|12-month Follow-up Assessment||22
8952066|NCT02459587|10014986|FG001|NOT COMPLETED|12-month Follow-up Assessment||27
8952067|NCT02459665|10014997|FG000|STARTED|Overall Study||17
8952068|NCT02459665|10014998|FG001|STARTED|Overall Study||17
8952069|NCT02459665|10014999|FG002|STARTED|Overall Study||17
8952070|NCT02459665|10015000|FG003|STARTED|Overall Study||17
8952071|NCT02459665|10014997|FG000|Day 7 Visit|Overall Study||17
8952072|NCT02459665|10014998|FG001|Day 7 Visit|Overall Study||17
8952073|NCT02459665|10014999|FG002|Day 7 Visit|Overall Study||17
8952074|NCT02459665|10015000|FG003|Day 7 Visit|Overall Study||16
8952075|NCT02459665|10014997|FG000|Month 1 Visit|Overall Study||17
8952076|NCT02459665|10014998|FG001|Month 1 Visit|Overall Study||17
8952077|NCT02459665|10014999|FG002|Month 1 Visit|Overall Study||17
8952078|NCT02459665|10015000|FG003|Month 1 Visit|Overall Study||16
8952079|NCT02459665|10014997|FG000|Month 2 Visit|Overall Study||17
8952080|NCT02459665|10014998|FG001|Month 2 Visit|Overall Study||16
8952081|NCT02459665|10014999|FG002|Month 2 Visit|Overall Study||17
8952082|NCT02459665|10015000|FG003|Month 2 Visit|Overall Study||16
8952083|NCT02459665|10014997|FG000|Month 6 Visit|Overall Study||17
8952084|NCT02459665|10014998|FG001|Month 6 Visit|Overall Study||16
8952085|NCT02459665|10014999|FG002|Month 6 Visit|Overall Study||16
8952086|NCT02459665|10015000|FG003|Month 6 Visit|Overall Study||15
8952087|NCT02459665|10014997|FG000|COMPLETED|Overall Study||17
8952088|NCT02459665|10014998|FG001|COMPLETED|Overall Study||16
8952089|NCT02459665|10014999|FG002|COMPLETED|Overall Study||16
8952090|NCT02459665|10015000|FG003|COMPLETED|Overall Study||15
8952091|NCT02459665|10014997|FG000|NOT COMPLETED|Overall Study||0
8952092|NCT02459665|10014998|FG001|NOT COMPLETED|Overall Study||1
8952093|NCT02459665|10014999|FG002|NOT COMPLETED|Overall Study||1
8952094|NCT02459665|10015000|FG003|NOT COMPLETED|Overall Study||2
8952095|NCT02459795|10015020|FG000|STARTED|Overall Study||187
8952096|NCT02459795|10015021|FG001|STARTED|Overall Study||189
8952097|NCT02459795|10015022|FG002|STARTED|Overall Study||93
8952098|NCT02459795|10015020|FG000|COMPLETED|Overall Study||181
8952099|NCT02459795|10015021|FG001|COMPLETED|Overall Study||186
8952100|NCT02459795|10015022|FG002|COMPLETED|Overall Study||92
8952101|NCT02459795|10015020|FG000|NOT COMPLETED|Overall Study||6
8952102|NCT02459795|10015021|FG001|NOT COMPLETED|Overall Study||3
8952103|NCT02459795|10015022|FG002|NOT COMPLETED|Overall Study||1
8952104|NCT02459899|10015034|FG000|STARTED|Overall Study||36
8952105|NCT02459899|10015035|FG001|STARTED|Overall Study||35
8952106|NCT02459899|10015036|FG002|STARTED|Overall Study||35
8952107|NCT02459899|10015037|FG003|STARTED|Overall Study||35
8952108|NCT02459899|10015034|FG000|COMPLETED|Overall Study||33
8952109|NCT02459899|10015035|FG001|COMPLETED|Overall Study||29
8952110|NCT02459899|10015036|FG002|COMPLETED|Overall Study||35
8952111|NCT02459899|10015037|FG003|COMPLETED|Overall Study||33
8952112|NCT02459899|10015034|FG000|NOT COMPLETED|Overall Study||3
8952113|NCT02459899|10015035|FG001|NOT COMPLETED|Overall Study||6
8952114|NCT02459899|10015036|FG002|NOT COMPLETED|Overall Study||0
8952115|NCT02459899|10015037|FG003|NOT COMPLETED|Overall Study||2
8952116|NCT02459951|10015047|FG000|STARTED|Overall Study||10
8952117|NCT02459951|10015047|FG000|COMPLETED|Overall Study||9
8952118|NCT02459951|10015047|FG000|NOT COMPLETED|Overall Study||1
8952119|NCT02459964|10015055|FG000|STARTED|Overall Study||42
8952120|NCT02459964|10015056|FG001|STARTED|Overall Study||40
8952121|NCT02459964|10015057|FG002|STARTED|Overall Study||2
8630958|NCT00537394|9670809|FG002|NOT COMPLETED|2nd Year of Follow-up||6
8952122|NCT02459964|10015055|FG000|COMPLETED|Overall Study||42
8952123|NCT02459964|10015056|FG001|COMPLETED|Overall Study||40
8952124|NCT02459964|10015057|FG002|COMPLETED|Overall Study||0
8868269|NCT01859715|9924653|FG001|STARTED|Overall Study||91
8868270|NCT01859715|9924654|FG002|STARTED|Overall Study||116
8868271|NCT01859715|9924652|FG000|COMPLETED|Overall Study||125
8868272|NCT01859715|9924653|FG001|COMPLETED|Overall Study||83
8868273|NCT01859715|9924654|FG002|COMPLETED|Overall Study||93
8868274|NCT01859715|9924652|FG000|NOT COMPLETED|Overall Study||16
8868275|NCT01859715|9924653|FG001|NOT COMPLETED|Overall Study||8
8868276|NCT01859715|9924654|FG002|NOT COMPLETED|Overall Study||23
8868277|NCT01859741|9924672|FG000|STARTED|Overall Study||3
8868278|NCT01859741|9924673|FG001|STARTED|Overall Study||3
8952125|NCT02459964|10015055|FG000|NOT COMPLETED|Overall Study||0
8952126|NCT02459964|10015056|FG001|NOT COMPLETED|Overall Study||0
8952127|NCT02459964|10015057|FG002|NOT COMPLETED|Overall Study||2
8952128|NCT02460172|10015064|FG000|STARTED|Overall Study||25
8952129|NCT02460172|10015064|FG000|COMPLETED|Overall Study||25
8630959|NCT00537407|9670820|FG000|STARTED|Part 1 Weeks 1-4||10
8868279|NCT01859741|9924674|FG002|STARTED|Overall Study||6
8868280|NCT01859741|9924675|FG003|STARTED|Overall Study||3
8725648|NCT01032694|9772957|FG001|COMPLETED|Overall Study||10
8725649|NCT01032694|9772956|FG000|NOT COMPLETED|Overall Study||0
8725650|NCT01032694|9772957|FG001|NOT COMPLETED|Overall Study||0
8725651|NCT01032733|9772965|FG000|STARTED|Overall Study||17
8868281|NCT01859741|9924676|FG004|STARTED|Overall Study||6
8868282|NCT01859741|9924677|FG005|STARTED|Overall Study||6
8868283|NCT01859741|9924678|FG006|STARTED|Overall Study||72
8868284|NCT01859741|9924679|FG007|STARTED|Overall Study||73
8868285|NCT01859741|9924672|FG000|COMPLETED|Overall Study||0
8868286|NCT01859741|9924673|FG001|COMPLETED|Overall Study||0
8868287|NCT01859741|9924674|FG002|COMPLETED|Overall Study||0
8868288|NCT01859741|9924675|FG003|COMPLETED|Overall Study||0
8868289|NCT01859741|9924676|FG004|COMPLETED|Overall Study||0
8868290|NCT01859741|9924677|FG005|COMPLETED|Overall Study||0
8868291|NCT01859741|9924678|FG006|COMPLETED|Overall Study||2
8868292|NCT01859741|9924679|FG007|COMPLETED|Overall Study||3
8868293|NCT01859741|9924672|FG000|NOT COMPLETED|Overall Study||3
8868294|NCT01859741|9924673|FG001|NOT COMPLETED|Overall Study||3
8868295|NCT01859741|9924674|FG002|NOT COMPLETED|Overall Study||6
8868296|NCT01859741|9924675|FG003|NOT COMPLETED|Overall Study||3
8868297|NCT01859741|9924676|FG004|NOT COMPLETED|Overall Study||6
8868298|NCT01859741|9924677|FG005|NOT COMPLETED|Overall Study||6
8868299|NCT01859741|9924678|FG006|NOT COMPLETED|Overall Study||70
8868300|NCT01859741|9924679|FG007|NOT COMPLETED|Overall Study||70
8868301|NCT01859793|9924699|FG000|STARTED|First Intervention (8 Weeks)||20
8868302|NCT01859793|9924700|FG001|STARTED|First Intervention (8 Weeks)||18
8868303|NCT01859793|9924699|FG000|COMPLETED|First Intervention (8 Weeks)||15
8868304|NCT01859793|9924700|FG001|COMPLETED|First Intervention (8 Weeks)||17
8868305|NCT01859793|9924699|FG000|NOT COMPLETED|First Intervention (8 Weeks)||5
8868306|NCT01859793|9924700|FG001|NOT COMPLETED|First Intervention (8 Weeks)||1
8868307|NCT01859793|9924699|FG000|STARTED|Washout Period (4 Weeks)||15
8868308|NCT01859793|9924700|FG001|STARTED|Washout Period (4 Weeks)||17
8868309|NCT01859793|9924699|FG000|COMPLETED|Washout Period (4 Weeks)||14
8868310|NCT01859793|9924700|FG001|COMPLETED|Washout Period (4 Weeks)||16
8868311|NCT01859793|9924699|FG000|NOT COMPLETED|Washout Period (4 Weeks)||1
8868312|NCT01859793|9924700|FG001|NOT COMPLETED|Washout Period (4 Weeks)||1
8868313|NCT01859793|9924699|FG000|STARTED|2nd Intervention Period||14
8868314|NCT01859793|9924700|FG001|STARTED|2nd Intervention Period||16
8868315|NCT01859793|9924699|FG000|COMPLETED|2nd Intervention Period||14
8868316|NCT01859793|9924700|FG001|COMPLETED|2nd Intervention Period||16
8868317|NCT01859793|9924699|FG000|NOT COMPLETED|2nd Intervention Period||0
8868318|NCT01859793|9924700|FG001|NOT COMPLETED|2nd Intervention Period||0
8868319|NCT01859923|9924710|FG000|STARTED|Overall Study||7
8868320|NCT01859923|9924711|FG001|STARTED|Overall Study||6
8868321|NCT01859923|9924712|FG002|STARTED|Overall Study||12
8868322|NCT01859923|9924713|FG003|STARTED|Overall Study||12
8868323|NCT01859923|9924710|FG000|COMPLETED|Overall Study||7
8868324|NCT01859923|9924711|FG001|COMPLETED|Overall Study||6
8868325|NCT01859923|9924712|FG002|COMPLETED|Overall Study||11
8868326|NCT01859923|9924713|FG003|COMPLETED|Overall Study||11
8868327|NCT01859923|9924710|FG000|NOT COMPLETED|Overall Study||0
8868328|NCT01859923|9924711|FG001|NOT COMPLETED|Overall Study||0
8868329|NCT01859923|9924712|FG002|NOT COMPLETED|Overall Study||1
8868330|NCT01859923|9924713|FG003|NOT COMPLETED|Overall Study||1
8868331|NCT01859949|9924728|FG000|STARTED|Overall Study|Treated participants|29
8868332|NCT01859949|9924729|FG001|STARTED|Overall Study|Treated participants|32
8868333|NCT01859949|9924728|FG000|COMPLETED|Overall Study||15
8868334|NCT01859949|9924729|FG001|COMPLETED|Overall Study||15
8868335|NCT01859949|9924728|FG000|NOT COMPLETED|Overall Study||14
8868336|NCT01859949|9924729|FG001|NOT COMPLETED|Overall Study||17
8868337|NCT01859988|9924741|FG000|STARTED|Overall Study||63
8868338|NCT01859988|9924742|FG001|STARTED|Overall Study||64
8868339|NCT01859988|9924743|FG002|STARTED|Overall Study||62
8868340|NCT01859988|9924744|FG003|STARTED|Overall Study||65
8868341|NCT01859988|9924745|FG004|STARTED|Overall Study||65
8868342|NCT01859988|9924746|FG005|STARTED|Overall Study||61
8868343|NCT01859988|9924741|FG000|Treated|Overall Study||63
8868344|NCT01859988|9924742|FG001|Treated|Overall Study||64
8868345|NCT01859988|9924743|FG002|Treated|Overall Study||61
8868346|NCT01859988|9924744|FG003|Treated|Overall Study||65
8868347|NCT01859988|9924745|FG004|Treated|Overall Study||65
8868348|NCT01859988|9924746|FG005|Treated|Overall Study||61
8868349|NCT01859988|9924741|FG000|COMPLETED|Overall Study||52
8868350|NCT01859988|9924742|FG001|COMPLETED|Overall Study||52
8868351|NCT01859988|9924743|FG002|COMPLETED|Overall Study||34
8868352|NCT01859988|9924744|FG003|COMPLETED|Overall Study||55
8868353|NCT01859988|9924745|FG004|COMPLETED|Overall Study||42
8868354|NCT01859988|9924746|FG005|COMPLETED|Overall Study||42
8868355|NCT01859988|9924741|FG000|NOT COMPLETED|Overall Study||11
8952130|NCT02460172|10015064|FG000|NOT COMPLETED|Overall Study||0
8725652|NCT01032733|9772966|FG001|STARTED|Overall Study||17
8868356|NCT01859988|9924742|FG001|NOT COMPLETED|Overall Study||12
8868357|NCT01859988|9924743|FG002|NOT COMPLETED|Overall Study||28
8868358|NCT01859988|9924744|FG003|NOT COMPLETED|Overall Study||10
8868359|NCT01859988|9924745|FG004|NOT COMPLETED|Overall Study||23
8868360|NCT01859988|9924746|FG005|NOT COMPLETED|Overall Study||19
8868361|NCT01860079|9924762|FG000|STARTED|Overall Study||384
8868362|NCT01860079|9924763|FG001|STARTED|Overall Study||385
8868363|NCT01860079|9924762|FG000|COMPLETED|Overall Study||370
8868364|NCT01860079|9924763|FG001|COMPLETED|Overall Study||363
8868365|NCT01860079|9924762|FG000|NOT COMPLETED|Overall Study||14
8868366|NCT01860079|9924763|FG001|NOT COMPLETED|Overall Study||22
8868367|NCT01860170|9924772|FG000|STARTED|Overall Study||3
8868368|NCT01860170|9924773|FG001|STARTED|Overall Study||3
8868369|NCT01860170|9924774|FG002|STARTED|Overall Study||22
8868370|NCT01860170|9924772|FG000|COMPLETED|Overall Study||3
8868371|NCT01860170|9924773|FG001|COMPLETED|Overall Study||3
8868372|NCT01860170|9924774|FG002|COMPLETED|Overall Study||22
8868373|NCT01860170|9924772|FG000|NOT COMPLETED|Overall Study||0
8868374|NCT01860170|9924773|FG001|NOT COMPLETED|Overall Study||0
8868375|NCT01860170|9924774|FG002|NOT COMPLETED|Overall Study||0
8868376|NCT01860287|9924785|FG000|STARTED|Overall Study||18
8868377|NCT01860287|9924786|FG001|STARTED|Overall Study||15
8868378|NCT01860287|9924787|FG002|STARTED|Overall Study||15
8868379|NCT01860287|9924785|FG000|COMPLETED|Overall Study||18
8630960|NCT00537407|9670821|FG001|STARTED|Part 1 Weeks 1-4||9
8630961|NCT00537407|9670822|FG002|STARTED|Part 1 Weeks 1-4||11
8630962|NCT00537407|9670823|FG003|STARTED|Part 1 Weeks 1-4||10
8630963|NCT00537407|9670824|FG004|STARTED|Part 1 Weeks 1-4||10
8868380|NCT01860287|9924786|FG001|COMPLETED|Overall Study||15
8868381|NCT01860287|9924787|FG002|COMPLETED|Overall Study||15
8868382|NCT01860287|9924785|FG000|NOT COMPLETED|Overall Study||0
8868383|NCT01860287|9924786|FG001|NOT COMPLETED|Overall Study||0
8868384|NCT01860287|9924787|FG002|NOT COMPLETED|Overall Study||0
8868385|NCT01860521|9924797|FG000|STARTED|Overall Study|September 2011|52
8868386|NCT01860521|9924798|FG001|STARTED|Overall Study|September 2011|52
8868387|NCT01860521|9924797|FG000|COMPLETED|Overall Study|June 2013|52
8868388|NCT01860521|9924798|FG001|COMPLETED|Overall Study|June 2013|52
8868389|NCT01860521|9924797|FG000|NOT COMPLETED|Overall Study||0
8868390|NCT01860521|9924798|FG001|NOT COMPLETED|Overall Study||0
8868391|NCT01860534|9924806|FG000|STARTED|ROP #1||14
8868392|NCT01860534|9924807|FG001|STARTED|ROP #1||14
8868393|NCT01860534|9924806|FG000|COMPLETED|ROP #1||14
8868394|NCT01860534|9924807|FG001|COMPLETED|ROP #1||13
8868395|NCT01860534|9924806|FG000|NOT COMPLETED|ROP #1||0
8868396|NCT01860534|9924807|FG001|NOT COMPLETED|ROP #1||1
8868397|NCT01860534|9924806|FG000|STARTED|ROP #2||14
8868398|NCT01860534|9924807|FG001|STARTED|ROP #2||13
8868399|NCT01860534|9924806|FG000|COMPLETED|ROP #2||13
8868400|NCT01860534|9924807|FG001|COMPLETED|ROP #2||13
8868401|NCT01860534|9924806|FG000|NOT COMPLETED|ROP #2||1
8868402|NCT01860534|9924807|FG001|NOT COMPLETED|ROP #2||0
8868403|NCT01860573|9924817|FG000|STARTED|Overall Study||83
8868404|NCT01860573|9924818|FG001|STARTED|Overall Study||85
8868405|NCT01860573|9924817|FG000|COMPLETED|Overall Study||83
8868406|NCT01860573|9924818|FG001|COMPLETED|Overall Study||85
8868407|NCT01860573|9924817|FG000|NOT COMPLETED|Overall Study||0
8868408|NCT01860573|9924818|FG001|NOT COMPLETED|Overall Study||0
8868409|NCT01860586|9924824|FG000|STARTED|Overall Study||20
8868410|NCT01860586|9924824|FG000|COMPLETED|Overall Study||20
8868411|NCT01860586|9924824|FG000|NOT COMPLETED|Overall Study||0
8868412|NCT01860651|9924831|FG000|STARTED|Overall Study||56
8868413|NCT01860651|9924832|FG001|STARTED|Overall Study||47
8868414|NCT01860651|9924831|FG000|COMPLETED|Overall Study||31
8868415|NCT01860651|9924832|FG001|COMPLETED|Overall Study||39
8868416|NCT01860651|9924831|FG000|NOT COMPLETED|Overall Study||25
8868417|NCT01860651|9924832|FG001|NOT COMPLETED|Overall Study||8
8868418|NCT01860677|9924844|FG000|STARTED|First Intervention (1 Day)||8
8868419|NCT01860677|9924845|FG001|STARTED|First Intervention (1 Day)||0
8868420|NCT01860677|9924844|FG000|COMPLETED|First Intervention (1 Day)||8
8868421|NCT01860677|9924845|FG001|COMPLETED|First Intervention (1 Day)||0
8868422|NCT01860677|9924844|FG000|NOT COMPLETED|First Intervention (1 Day)||0
8868423|NCT01860677|9924845|FG001|NOT COMPLETED|First Intervention (1 Day)||0
8868424|NCT01860677|9924844|FG000|STARTED|Second Intervention (1 Day)||8
8868425|NCT01860677|9924845|FG001|STARTED|Second Intervention (1 Day)||0
8868426|NCT01860677|9924844|FG000|COMPLETED|Second Intervention (1 Day)||1
8868427|NCT01860677|9924845|FG001|COMPLETED|Second Intervention (1 Day)||0
8868428|NCT01860677|9924844|FG000|NOT COMPLETED|Second Intervention (1 Day)||7
8868429|NCT01860677|9924845|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
8868430|NCT01860703|9924852|FG000|STARTED|Overall Study||13
8868431|NCT01860703|9924853|FG001|STARTED|Overall Study||13
8868432|NCT01860703|9924854|FG002|STARTED|Overall Study||12
8868433|NCT01860703|9924855|FG003|STARTED|Overall Study||12
8868434|NCT01860703|9924852|FG000|COMPLETED|Overall Study||11
8868435|NCT01860703|9924853|FG001|COMPLETED|Overall Study||8
8868436|NCT01860703|9924854|FG002|COMPLETED|Overall Study||11
8868437|NCT01860703|9924855|FG003|COMPLETED|Overall Study||10
8868438|NCT01860703|9924852|FG000|NOT COMPLETED|Overall Study||2
8868439|NCT01860703|9924853|FG001|NOT COMPLETED|Overall Study||5
8868440|NCT01860703|9924854|FG002|NOT COMPLETED|Overall Study||1
8868441|NCT01860703|9924855|FG003|NOT COMPLETED|Overall Study||2
8868442|NCT01860807|9924873|FG000|STARTED|Overall Study||64
8630964|NCT00537407|9670820|FG000|COMPLETED|Part 1 Weeks 1-4||10
8630965|NCT00537407|9670821|FG001|COMPLETED|Part 1 Weeks 1-4||9
8868443|NCT01860807|9924874|FG001|STARTED|Overall Study||61
8868444|NCT01860807|9924873|FG000|COMPLETED|Overall Study||34
8868445|NCT01860807|9924874|FG001|COMPLETED|Overall Study||32
8868446|NCT01860807|9924873|FG000|NOT COMPLETED|Overall Study||30
8868447|NCT01860807|9924874|FG001|NOT COMPLETED|Overall Study||29
8868448|NCT01860846|9924880|FG000|STARTED|Overall Study||106
8868449|NCT01860846|9924880|FG000|Month 1|Overall Study||97
8868450|NCT01860846|9924880|FG000|Month 2|Overall Study||83
8868451|NCT01860846|9924880|FG000|Month 4|Overall Study||82
8868452|NCT01860846|9924880|FG000|Month 6|Overall Study||85
8868453|NCT01860846|9924880|FG000|Month 12|Overall Study||73
8868454|NCT01860846|9924880|FG000|COMPLETED|Overall Study||73
8868455|NCT01860846|9924880|FG000|NOT COMPLETED|Overall Study||33
8868456|NCT01860950|9924890|FG000|STARTED|Overall Study||14
8868457|NCT01860950|9924891|FG001|STARTED|Overall Study||15
8868458|NCT01860950|9924892|FG002|STARTED|Overall Study||10
8868459|NCT01860950|9924893|FG003|STARTED|Overall Study||13
8868460|NCT01860950|9924894|FG004|STARTED|Overall Study||14
8868461|NCT01860950|9924895|FG005|STARTED|Overall Study||13
8868462|NCT01860950|9924890|FG000|COMPLETED|Overall Study||14
8868463|NCT01860950|9924891|FG001|COMPLETED|Overall Study||15
8868464|NCT01860950|9924892|FG002|COMPLETED|Overall Study||10
8868465|NCT01860950|9924893|FG003|COMPLETED|Overall Study||13
8868466|NCT01860950|9924894|FG004|COMPLETED|Overall Study||14
8868467|NCT01860950|9924895|FG005|COMPLETED|Overall Study||13
8868468|NCT01860950|9924890|FG000|NOT COMPLETED|Overall Study||0
8868469|NCT01860950|9924891|FG001|NOT COMPLETED|Overall Study||0
8868470|NCT01860950|9924892|FG002|NOT COMPLETED|Overall Study||0
8868471|NCT01860950|9924893|FG003|NOT COMPLETED|Overall Study||0
8868472|NCT01860950|9924894|FG004|NOT COMPLETED|Overall Study||0
8868473|NCT01860950|9924895|FG005|NOT COMPLETED|Overall Study||0
8868474|NCT01860989|9924910|FG000|STARTED|Overall Study||11
8868475|NCT01860989|9924910|FG000|COMPLETED|Overall Study||6
8868476|NCT01860989|9924910|FG000|NOT COMPLETED|Overall Study||5
8868477|NCT01861002|9924914|FG000|STARTED|Overall Study||15
8868478|NCT01861002|9924914|FG000|COMPLETED|Overall Study||14
8868479|NCT01861002|9924914|FG000|NOT COMPLETED|Overall Study||1
8868480|NCT01861028|9924922|FG000|STARTED|Overall Study||44
8868481|NCT01861028|9924922|FG000|COMPLETED|Overall Study||44
8868482|NCT01861028|9924922|FG000|NOT COMPLETED|Overall Study||0
8868483|NCT01861054|9924929|FG000|STARTED|Overall Study||18
8868484|NCT01861054|9924930|FG001|STARTED|Overall Study||2
8868485|NCT01861054|9924929|FG000|Safety Population|Overall Study||18
8868486|NCT01861054|9924930|FG001|Safety Population|Overall Study||2
8868487|NCT01861054|9924929|FG000|PK Population|Overall Study||4
8868488|NCT01861054|9924930|FG001|PK Population|Overall Study||2
8868489|NCT01861054|9924929|FG000|COMPLETED|Overall Study||18
8868490|NCT01861054|9924930|FG001|COMPLETED|Overall Study||2
8868491|NCT01861054|9924929|FG000|NOT COMPLETED|Overall Study||0
8868492|NCT01861054|9924930|FG001|NOT COMPLETED|Overall Study||0
8868493|NCT01861301|9924939|FG000|STARTED|Overall Study||18
8868494|NCT01861301|9924939|FG000|COMPLETED|Overall Study||18
8868495|NCT01861301|9924939|FG000|NOT COMPLETED|Overall Study||0
8868496|NCT01861457|9924946|FG000|STARTED|Overall Study||20
8868497|NCT01861457|9924947|FG001|STARTED|Overall Study||19
8868498|NCT01861457|9924946|FG000|COMPLETED|Overall Study||20
8868499|NCT01861457|9924947|FG001|COMPLETED|Overall Study||19
8868500|NCT01861457|9924946|FG000|NOT COMPLETED|Overall Study||0
8868501|NCT01861457|9924947|FG001|NOT COMPLETED|Overall Study||0
8868502|NCT01861522|9924955|FG000|STARTED|Overall Study||240
8868503|NCT01861522|9924956|FG001|STARTED|Overall Study|One subject who did not receive any study drug was excluded from the FAS and the Safety Analysis Set|232
8868504|NCT01861522|9924955|FG000|COMPLETED|Overall Study||237
8868505|NCT01861522|9924956|FG001|COMPLETED|Overall Study||232
8868506|NCT01861522|9924955|FG000|NOT COMPLETED|Overall Study||3
8868507|NCT01861522|9924956|FG001|NOT COMPLETED|Overall Study||0
8868508|NCT01861574|9924966|FG000|STARTED|Overall Study||28
8868509|NCT01861574|9924967|FG001|STARTED|Overall Study||25
8868510|NCT01861574|9924968|FG002|STARTED|Overall Study||27
8868511|NCT01861574|9924969|FG003|STARTED|Overall Study||28
8868512|NCT01861574|9924966|FG000|COMPLETED|Overall Study||28
8868513|NCT01861574|9924967|FG001|COMPLETED|Overall Study||25
8868514|NCT01861574|9924968|FG002|COMPLETED|Overall Study||27
8868515|NCT01861574|9924969|FG003|COMPLETED|Overall Study||28
8868516|NCT01861574|9924966|FG000|NOT COMPLETED|Overall Study||0
8868517|NCT01861574|9924967|FG001|NOT COMPLETED|Overall Study||0
8868518|NCT01861574|9924968|FG002|NOT COMPLETED|Overall Study||0
8868519|NCT01861574|9924969|FG003|NOT COMPLETED|Overall Study||0
8868520|NCT01861587|9924984|FG000|STARTED|Overall Study||14
8868521|NCT01861587|9924985|FG001|STARTED|Overall Study||13
8868522|NCT01861587|9924984|FG000|COMPLETED|Overall Study||14
8868523|NCT01861587|9924985|FG001|COMPLETED|Overall Study||13
8952131|NCT02460263|10015070|FG000|STARTED|In-Center Period||30
8952132|NCT02460263|10015070|FG000|COMPLETED|In-Center Period||30
8868524|NCT01861587|9924984|FG000|NOT COMPLETED|Overall Study||0
8868525|NCT01861587|9924985|FG001|NOT COMPLETED|Overall Study||0
8868526|NCT01861665|9924997|FG000|STARTED|Overall Study||10
8868527|NCT01861665|9924998|FG001|STARTED|Overall Study||17
8868528|NCT01861665|9924997|FG000|COMPLETED|Overall Study||10
8868529|NCT01861665|9924998|FG001|COMPLETED|Overall Study||17
8868530|NCT01861665|9924997|FG000|NOT COMPLETED|Overall Study||0
8868531|NCT01861665|9924998|FG001|NOT COMPLETED|Overall Study||0
8868532|NCT01861704|9925006|FG000|STARTED|Overall Study||70
8868533|NCT01861704|9925007|FG001|STARTED|Overall Study||107
8868534|NCT01861704|9925006|FG000|COMPLETED|Overall Study||67
8868535|NCT01861704|9925007|FG001|COMPLETED|Overall Study||104
8868536|NCT01861704|9925006|FG000|NOT COMPLETED|Overall Study||3
8868537|NCT01861704|9925007|FG001|NOT COMPLETED|Overall Study||3
8868538|NCT01861756|9925015|FG000|STARTED|Overall Study||101
8868539|NCT01861756|9925016|FG001|STARTED|Overall Study||103
8868540|NCT01861756|9925015|FG000|COMPLETED|Overall Study||88
8868541|NCT01861756|9925016|FG001|COMPLETED|Overall Study||85
8868542|NCT01861756|9925015|FG000|NOT COMPLETED|Overall Study||13
8868543|NCT01861756|9925016|FG001|NOT COMPLETED|Overall Study||18
8868544|NCT01861925|9925025|FG000|STARTED|Overall Study||34
8868545|NCT01861925|9925026|FG001|STARTED|Overall Study||8
8868546|NCT01861925|9925027|FG002|STARTED|Overall Study||8
8868547|NCT01861925|9925025|FG000|COMPLETED|Overall Study||34
8868548|NCT01861925|9925026|FG001|COMPLETED|Overall Study||8
8868549|NCT01861925|9925027|FG002|COMPLETED|Overall Study||8
8868550|NCT01861925|9925025|FG000|NOT COMPLETED|Overall Study||0
8868551|NCT01861925|9925026|FG001|NOT COMPLETED|Overall Study||0
8868552|NCT01861925|9925027|FG002|NOT COMPLETED|Overall Study||0
8868553|NCT01862029|9925036|FG000|STARTED|Overall Study||9
8868554|NCT01862029|9925036|FG000|COMPLETED|Overall Study||8
8868555|NCT01862029|9925036|FG000|NOT COMPLETED|Overall Study||1
8868556|NCT01862133|9925041|FG000|STARTED|Overall Study||105
8868557|NCT01862133|9925042|FG001|STARTED|Overall Study||31
8868558|NCT01862133|9925041|FG000|Returned During 6 mo Study|Overall Study||92
8868559|NCT01862133|9925042|FG001|Returned During 6 mo Study|Overall Study||31
8868560|NCT01862133|9925041|FG000|COMPLETED|Overall Study|All 105 patients recorded preferences; 92 (88%) returned to the study clinic during the 6 mo. study|105
8868561|NCT01862133|9925042|FG001|COMPLETED|Overall Study||31
8868562|NCT01862133|9925041|FG000|NOT COMPLETED|Overall Study||0
8868563|NCT01862133|9925042|FG001|NOT COMPLETED|Overall Study||0
8952133|NCT02460263|10015070|FG000|NOT COMPLETED|In-Center Period||0
8952134|NCT02460263|10015070|FG000|STARTED|Transition Period||30
8952135|NCT02460263|10015070|FG000|COMPLETED|Transition Period||28
8952136|NCT02460263|10015070|FG000|NOT COMPLETED|Transition Period||2
8952137|NCT02460263|10015070|FG000|STARTED|In-Home Period||28
8952138|NCT02460263|10015070|FG000|COMPLETED|In-Home Period||28
8952139|NCT02460263|10015070|FG000|NOT COMPLETED|In-Home Period||0
8952140|NCT02460380|10015080|FG000|STARTED|Overall Study||45
8952141|NCT02460380|10015081|FG001|STARTED|Overall Study||23
8952142|NCT02460380|10015080|FG000|COMPLETED|Overall Study||35
8952143|NCT02460380|10015081|FG001|COMPLETED|Overall Study||18
8952144|NCT02460380|10015080|FG000|NOT COMPLETED|Overall Study||10
8952145|NCT02460380|10015081|FG001|NOT COMPLETED|Overall Study||5
8952146|NCT02460562|10015090|FG000|STARTED|Overall Study||74
8952147|NCT02460562|10015091|FG001|STARTED|Overall Study||76
8952148|NCT02460562|10015090|FG000|COMPLETED|Overall Study||59
8952149|NCT02460562|10015091|FG001|COMPLETED|Overall Study||60
8952150|NCT02460562|10015090|FG000|NOT COMPLETED|Overall Study||15
8952151|NCT02460562|10015091|FG001|NOT COMPLETED|Overall Study||16
8952152|NCT02460575|10015099|FG000|STARTED|Overall Study||40
8952153|NCT02460575|10015100|FG001|STARTED|Overall Study||20
8952154|NCT02460575|10015099|FG000|COMPLETED|Overall Study||39
8952155|NCT02460575|10015100|FG001|COMPLETED|Overall Study||20
8952156|NCT02460575|10015099|FG000|NOT COMPLETED|Overall Study||1
8952157|NCT02460575|10015100|FG001|NOT COMPLETED|Overall Study||0
8952158|NCT02460666|10015108|FG000|STARTED|Overall Study||89
8952159|NCT02460666|10015109|FG001|STARTED|Overall Study||89
8952160|NCT02460666|10015108|FG000|COMPLETED|Overall Study||62
8952161|NCT02460666|10015109|FG001|COMPLETED|Overall Study||63
8952162|NCT02460666|10015108|FG000|NOT COMPLETED|Overall Study||27
8952163|NCT02460666|10015109|FG001|NOT COMPLETED|Overall Study||26
8952164|NCT02460679|10015115|FG000|STARTED|Overall Study||19
8952165|NCT02460679|10015115|FG000|Received at Least 1 Dose of Study Drug|Overall Study||19
8952166|NCT02460679|10015115|FG000|COMPLETED|Overall Study||14
8952167|NCT02460679|10015115|FG000|NOT COMPLETED|Overall Study||5
8952168|NCT02460822|10015119|FG000|STARTED|Overall Study||16
8952169|NCT02460822|10015119|FG000|COMPLETED|Overall Study||15
8952170|NCT02460822|10015119|FG000|NOT COMPLETED|Overall Study||1
8569815|NCT00098748|9601932|FG000|NOT COMPLETED|Received Study Treatment||48
8569816|NCT00098748|9601933|FG001|NOT COMPLETED|Received Study Treatment||36
8569817|NCT00098748|9601934|FG002|NOT COMPLETED|Received Study Treatment||44
8569818|NCT00098748|9601932|FG000|STARTED|Continued on Open-Label Treatment||15
8569819|NCT00098748|9601933|FG001|STARTED|Continued on Open-Label Treatment||25
8577535|NCT00159263|9610314|FG004|STARTED|Washout||2
8868564|NCT01862159|9925048|FG000|STARTED|Overall Study||25038
8868565|NCT01862159|9925048|FG000|COMPLETED|Overall Study||25038
8868566|NCT01862159|9925048|FG000|NOT COMPLETED|Overall Study||0
8868567|NCT01862250|9925052|FG000|STARTED|Overall Study||12
8952171|NCT02460978|10015126|FG000|STARTED|Overall Study||271
8952172|NCT02460978|10015127|FG001|STARTED|Overall Study||270
8952173|NCT02460978|10015128|FG002|STARTED|Overall Study||272
8952174|NCT02460978|10015126|FG000|COMPLETED|Overall Study||244
8952175|NCT02460978|10015127|FG001|COMPLETED|Overall Study||245
8868568|NCT01862250|9925052|FG000|COMPLETED|Overall Study||8
8868569|NCT01862250|9925052|FG000|NOT COMPLETED|Overall Study||4
8868570|NCT01862328|9925063|FG000|STARTED|Overall Study||4
8868571|NCT01862328|9925064|FG001|STARTED|Overall Study||18
8868572|NCT01862328|9925065|FG002|STARTED|Overall Study||6
8868573|NCT01862328|9925066|FG003|STARTED|Overall Study||7
8868574|NCT01862328|9925067|FG004|STARTED|Overall Study||12
8868575|NCT01862328|9925068|FG005|STARTED|Overall Study||7
8868576|NCT01862328|9925069|FG006|STARTED|Overall Study||10
8868577|NCT01862328|9925063|FG000|COMPLETED|Overall Study||0
8868578|NCT01862328|9925064|FG001|COMPLETED|Overall Study||0
8868579|NCT01862328|9925065|FG002|COMPLETED|Overall Study||0
8868580|NCT01862328|9925066|FG003|COMPLETED|Overall Study||0
8868581|NCT01862328|9925067|FG004|COMPLETED|Overall Study||0
8868582|NCT01862328|9925068|FG005|COMPLETED|Overall Study||0
8868583|NCT01862328|9925069|FG006|COMPLETED|Overall Study||0
8868584|NCT01862328|9925063|FG000|NOT COMPLETED|Overall Study||4
8868585|NCT01862328|9925064|FG001|NOT COMPLETED|Overall Study||18
8868586|NCT01862328|9925065|FG002|NOT COMPLETED|Overall Study||6
8868587|NCT01862328|9925066|FG003|NOT COMPLETED|Overall Study||7
8868588|NCT01862328|9925067|FG004|NOT COMPLETED|Overall Study||12
8868589|NCT01862328|9925068|FG005|NOT COMPLETED|Overall Study||7
8868590|NCT01862328|9925069|FG006|NOT COMPLETED|Overall Study||10
8868591|NCT01862419|9925093|FG000|STARTED|Overall Study||1201
8868592|NCT01862419|9925094|FG001|STARTED|Overall Study||1192
8868593|NCT01862419|9925093|FG000|COMPLETED|Overall Study||1201
8868594|NCT01862419|9925094|FG001|COMPLETED|Overall Study||1192
8868595|NCT01862419|9925093|FG000|NOT COMPLETED|Overall Study||0
8868596|NCT01862419|9925094|FG001|NOT COMPLETED|Overall Study||0
8868597|NCT01862484|9925102|FG000|STARTED|Overall Study||15
8868598|NCT01862484|9925103|FG001|STARTED|Overall Study||14
8868599|NCT01862484|9925102|FG000|COMPLETED|Overall Study||13
8868600|NCT01862484|9925103|FG001|COMPLETED|Overall Study||6
8868601|NCT01862484|9925102|FG000|NOT COMPLETED|Overall Study||2
8868602|NCT01862484|9925103|FG001|NOT COMPLETED|Overall Study||8
8868603|NCT01862536|9925111|FG000|STARTED|Overall Study||13
8868604|NCT01862536|9925112|FG001|STARTED|Overall Study||23
8868605|NCT01862536|9925111|FG000|COMPLETED|Overall Study||10
8868606|NCT01862536|9925112|FG001|COMPLETED|Overall Study||16
8868607|NCT01862536|9925111|FG000|NOT COMPLETED|Overall Study||3
8868608|NCT01862536|9925112|FG001|NOT COMPLETED|Overall Study||7
8868609|NCT01862614|9925120|FG000|STARTED|First Appointment.|Received articaine injection at first appointment.|40
8868610|NCT01862614|9925121|FG001|STARTED|First Appointment.|Received buffered articaine at first appointment.|40
8868611|NCT01862614|9925120|FG000|COMPLETED|First Appointment.||40
8868612|NCT01862614|9925121|FG001|COMPLETED|First Appointment.||40
8868613|NCT01862614|9925120|FG000|NOT COMPLETED|First Appointment.||0
8868614|NCT01862614|9925121|FG001|NOT COMPLETED|First Appointment.||0
8868615|NCT01862614|9925120|FG000|STARTED|2 Week Washout Period.||40
8868616|NCT01862614|9925121|FG001|STARTED|2 Week Washout Period.||40
8868617|NCT01862614|9925120|FG000|COMPLETED|2 Week Washout Period.||40
8868618|NCT01862614|9925121|FG001|COMPLETED|2 Week Washout Period.||40
8868619|NCT01862614|9925120|FG000|NOT COMPLETED|2 Week Washout Period.||0
8868620|NCT01862614|9925121|FG001|NOT COMPLETED|2 Week Washout Period.||0
8868621|NCT01862614|9925120|FG000|STARTED|Second Appointment.|Received buffered articaine at second appointment.|40
8868622|NCT01862614|9925121|FG001|STARTED|Second Appointment.|Received articaine at second appointment.|40
8868623|NCT01862614|9925120|FG000|COMPLETED|Second Appointment.||40
8868624|NCT01862614|9925121|FG001|COMPLETED|Second Appointment.||40
8868625|NCT01862614|9925120|FG000|NOT COMPLETED|Second Appointment.||0
8868626|NCT01862614|9925121|FG001|NOT COMPLETED|Second Appointment.||0
8868627|NCT01862640|9925131|FG000|STARTED|Overall Study||20
8868628|NCT01862640|9925132|FG001|STARTED|Overall Study||137
8868629|NCT01862640|9925133|FG002|STARTED|Overall Study||140
8868630|NCT01862640|9925134|FG003|STARTED|Overall Study||136
8868631|NCT01862640|9925131|FG000|COMPLETED|Overall Study||13
8868632|NCT01862640|9925132|FG001|COMPLETED|Overall Study||121
8868633|NCT01862640|9925133|FG002|COMPLETED|Overall Study||122
8868634|NCT01862640|9925134|FG003|COMPLETED|Overall Study||121
8868635|NCT01862640|9925131|FG000|NOT COMPLETED|Overall Study||7
8868636|NCT01862640|9925132|FG001|NOT COMPLETED|Overall Study||16
8868637|NCT01862640|9925133|FG002|NOT COMPLETED|Overall Study||18
8868638|NCT01862640|9925134|FG003|NOT COMPLETED|Overall Study||15
8868639|NCT01862796|9925146|FG000|STARTED|Overall Study||19
8868640|NCT01862796|9925147|FG001|STARTED|Overall Study||18
8868641|NCT01862796|9925148|FG002|STARTED|Overall Study||24
8868642|NCT01862796|9925146|FG000|COMPLETED|Overall Study||19
8868643|NCT01862796|9925147|FG001|COMPLETED|Overall Study||18
8868644|NCT01862796|9925148|FG002|COMPLETED|Overall Study||23
8868645|NCT01862796|9925146|FG000|NOT COMPLETED|Overall Study||0
8868646|NCT01862796|9925147|FG001|NOT COMPLETED|Overall Study||0
8868647|NCT01862796|9925148|FG002|NOT COMPLETED|Overall Study||1
8868648|NCT01862874|9925158|FG000|STARTED|Overall Study|Randomized participants|562
8868649|NCT01862874|9925159|FG001|STARTED|Overall Study|Randomized participants|562
8868650|NCT01862874|9925158|FG000|Vaccination 1|Overall Study||561
8868651|NCT01862874|9925159|FG001|Vaccination 1|Overall Study||562
8868652|NCT01862874|9925158|FG000|Vaccination 2|Overall Study||539
8868653|NCT01862874|9925159|FG001|Vaccination 2|Overall Study||542
8868654|NCT01862874|9925158|FG000|Vaccination 3|Overall Study||530
8868655|NCT01862874|9925159|FG001|Vaccination 3|Overall Study||532
8868656|NCT01862874|9925158|FG000|COMPLETED|Overall Study||483
8868657|NCT01862874|9925159|FG001|COMPLETED|Overall Study||485
8868658|NCT01862874|9925158|FG000|NOT COMPLETED|Overall Study||79
8868659|NCT01862874|9925159|FG001|NOT COMPLETED|Overall Study||77
8868660|NCT01862991|9925168|FG000|STARTED|Overall Study||24
8868661|NCT01862991|9925169|FG001|STARTED|Overall Study||28
8868662|NCT01862991|9925170|FG002|STARTED|Overall Study||28
8868663|NCT01862991|9925168|FG000|COMPLETED|Overall Study||21
8868664|NCT01862991|9925169|FG001|COMPLETED|Overall Study||27
8868665|NCT01862991|9925170|FG002|COMPLETED|Overall Study||27
8868666|NCT01862991|9925168|FG000|NOT COMPLETED|Overall Study||3
8868667|NCT01862991|9925169|FG001|NOT COMPLETED|Overall Study||1
8868668|NCT01862991|9925170|FG002|NOT COMPLETED|Overall Study||1
8868669|NCT01863017|9925180|FG000|STARTED|Overall Study||12
8868670|NCT01863017|9925181|FG001|STARTED|Overall Study||19
8868671|NCT01863017|9925180|FG000|Normal Weight Participants|Overall Study||5
8868672|NCT01863017|9925181|FG001|Normal Weight Participants|Overall Study||5
8868673|NCT01863017|9925180|FG000|Obese Participants|Overall Study||4
8868674|NCT01863017|9925181|FG001|Obese Participants|Overall Study||7
8868675|NCT01863017|9925180|FG000|Participants With PWS|Overall Study||3
8868676|NCT01863017|9925181|FG001|Participants With PWS|Overall Study||7
8868677|NCT01863017|9925180|FG000|COMPLETED|Overall Study||12
8868678|NCT01863017|9925181|FG001|COMPLETED|Overall Study||19
8868679|NCT01863017|9925180|FG000|NOT COMPLETED|Overall Study||0
8868680|NCT01863017|9925181|FG001|NOT COMPLETED|Overall Study||0
8868681|NCT01863030|9925187|FG000|STARTED|Baseline||31
8868682|NCT01863030|9925187|FG000|COMPLETED|Baseline||31
8868683|NCT01863030|9925187|FG000|NOT COMPLETED|Baseline||0
8868684|NCT01863030|9925187|FG000|STARTED|Follow up||31
8868685|NCT01863030|9925187|FG000|2 Weeks|Follow up||31
8868686|NCT01863030|9925187|FG000|3 Months|Follow up||28
8868687|NCT01863030|9925187|FG000|6 Months|Follow up||29
8868688|NCT01863030|9925187|FG000|12 Months|Follow up||26
8868689|NCT01863030|9925187|FG000|24 Months|Follow up||13
8868690|NCT01863030|9925187|FG000|COMPLETED|Follow up||13
8868691|NCT01863030|9925187|FG000|NOT COMPLETED|Follow up||18
8868692|NCT01863134|9925194|FG000|STARTED|Overall Study||72
8868693|NCT01863134|9925195|FG001|STARTED|Overall Study||68
8868694|NCT01863134|9925194|FG000|COMPLETED|Overall Study||72
8868695|NCT01863134|9925195|FG001|COMPLETED|Overall Study||68
8868696|NCT01863134|9925194|FG000|NOT COMPLETED|Overall Study||0
8868697|NCT01863134|9925195|FG001|NOT COMPLETED|Overall Study||0
8868698|NCT01863368|9925203|FG000|STARTED|Phase I, Day 0 to Day 35||46
8868699|NCT01863368|9925204|FG001|STARTED|Phase I, Day 0 to Day 35||48
8868700|NCT01863368|9925203|FG000|Treated|Phase I, Day 0 to Day 35||46
8868701|NCT01863368|9925204|FG001|Treated|Phase I, Day 0 to Day 35||47
8952176|NCT02460978|10015128|FG002|COMPLETED|Overall Study||239
8952177|NCT02460978|10015126|FG000|NOT COMPLETED|Overall Study||27
8952178|NCT02460978|10015127|FG001|NOT COMPLETED|Overall Study||25
8952179|NCT02460978|10015128|FG002|NOT COMPLETED|Overall Study||33
8952180|NCT02460991|10015138|FG000|STARTED|Overall Study||0
8952181|NCT02460991|10015139|FG001|STARTED|Overall Study||2
8952182|NCT02460991|10015138|FG000|COMPLETED|Overall Study||0
8952183|NCT02460991|10015139|FG001|COMPLETED|Overall Study||0
8952184|NCT02460991|10015138|FG000|NOT COMPLETED|Overall Study||0
8952185|NCT02460991|10015139|FG001|NOT COMPLETED|Overall Study||2
8952186|NCT02461134|10015150|FG000|STARTED|Overall Study||1
8952187|NCT02461134|10015150|FG000|COMPLETED|Overall Study||0
8952188|NCT02461134|10015150|FG000|NOT COMPLETED|Overall Study||1
8952189|NCT02461160|10015167|FG000|STARTED|Overall Study||8
8952190|NCT02461160|10015168|FG001|STARTED|Overall Study||6
8952191|NCT02461160|10015169|FG002|STARTED|Overall Study||6
8952192|NCT02461160|10015170|FG003|STARTED|Overall Study||12
8952193|NCT02461160|10015171|FG004|STARTED|Overall Study||6
8952194|NCT02461160|10015172|FG005|STARTED|Overall Study||6
8952195|NCT02461160|10015173|FG006|STARTED|Overall Study||6
8952196|NCT02461160|10015174|FG007|STARTED|Overall Study||6
8952197|NCT02461160|10015175|FG008|STARTED|Overall Study||12
8952198|NCT02461160|10015176|FG009|STARTED|Overall Study||4
8952199|NCT02461160|10015177|FG010|STARTED|Overall Study||4
8952200|NCT02461160|10015178|FG011|STARTED|Overall Study||4
8952201|NCT02461160|10015179|FG012|STARTED|Overall Study||8
8952202|NCT02461160|10015167|FG000|COMPLETED|Overall Study||8
8952203|NCT02461160|10015168|FG001|COMPLETED|Overall Study||6
8952204|NCT02461160|10015169|FG002|COMPLETED|Overall Study||6
8952205|NCT02461160|10015170|FG003|COMPLETED|Overall Study||12
8952206|NCT02461160|10015171|FG004|COMPLETED|Overall Study||6
8952207|NCT02461160|10015172|FG005|COMPLETED|Overall Study||6
8952208|NCT02461160|10015173|FG006|COMPLETED|Overall Study||6
8952209|NCT02461160|10015174|FG007|COMPLETED|Overall Study||5
8952210|NCT02461160|10015175|FG008|COMPLETED|Overall Study||12
8952211|NCT02461160|10015176|FG009|COMPLETED|Overall Study||4
8952212|NCT02461160|10015177|FG010|COMPLETED|Overall Study||4
8952213|NCT02461160|10015178|FG011|COMPLETED|Overall Study||4
8952214|NCT02461160|10015179|FG012|COMPLETED|Overall Study||8
8868702|NCT01863368|9925203|FG000|COMPLETED|Phase I, Day 0 to Day 35||43
8868703|NCT01863368|9925204|FG001|COMPLETED|Phase I, Day 0 to Day 35||41
8868704|NCT01863368|9925203|FG000|NOT COMPLETED|Phase I, Day 0 to Day 35||3
8868705|NCT01863368|9925204|FG001|NOT COMPLETED|Phase I, Day 0 to Day 35||7
8868706|NCT01863368|9925203|FG000|STARTED|Phase II, Day 35 to Day 90||43
8952215|NCT02461160|10015167|FG000|NOT COMPLETED|Overall Study||0
8952216|NCT02461160|10015168|FG001|NOT COMPLETED|Overall Study||0
8952217|NCT02461160|10015169|FG002|NOT COMPLETED|Overall Study||0
8952218|NCT02461160|10015170|FG003|NOT COMPLETED|Overall Study||0
8868707|NCT01863368|9925204|FG001|STARTED|Phase II, Day 35 to Day 90||41
8868708|NCT01863368|9925203|FG000|COMPLETED|Phase II, Day 35 to Day 90||41
8868709|NCT01863368|9925204|FG001|COMPLETED|Phase II, Day 35 to Day 90||41
8868710|NCT01863368|9925203|FG000|NOT COMPLETED|Phase II, Day 35 to Day 90||2
8868711|NCT01863368|9925204|FG001|NOT COMPLETED|Phase II, Day 35 to Day 90||0
8868712|NCT01863433|9925211|FG000|STARTED|Overall Study||120
8868713|NCT01863433|9925211|FG000|COMPLETED|Overall Study|1 subject was withdrawn from the study due to evidence of substance abuse.|119
8868714|NCT01863433|9925211|FG000|NOT COMPLETED|Overall Study||1
8868715|NCT01863498|9925217|FG000|STARTED|Overall Study||33
8868716|NCT01863498|9925218|FG001|STARTED|Overall Study||32
8868717|NCT01863498|9925217|FG000|COMPLETED|Overall Study||33
8868718|NCT01863498|9925218|FG001|COMPLETED|Overall Study||32
8868719|NCT01863498|9925217|FG000|NOT COMPLETED|Overall Study||0
8868720|NCT01863498|9925218|FG001|NOT COMPLETED|Overall Study||0
8868721|NCT01863563|9925224|FG000|STARTED|Overall Study||100
8952219|NCT02461160|10015171|FG004|NOT COMPLETED|Overall Study||0
8952220|NCT02461160|10015172|FG005|NOT COMPLETED|Overall Study||0
8952221|NCT02461160|10015173|FG006|NOT COMPLETED|Overall Study||0
8952222|NCT02461160|10015174|FG007|NOT COMPLETED|Overall Study||1
8952223|NCT02461160|10015175|FG008|NOT COMPLETED|Overall Study||0
8952224|NCT02461160|10015176|FG009|NOT COMPLETED|Overall Study||0
8952225|NCT02461160|10015177|FG010|NOT COMPLETED|Overall Study||0
8952226|NCT02461160|10015178|FG011|NOT COMPLETED|Overall Study||0
8868722|NCT01863563|9925224|FG000|COMPLETED|Overall Study||100
8868723|NCT01863563|9925224|FG000|NOT COMPLETED|Overall Study||0
8868724|NCT01863667|9925230|FG000|STARTED|Overall Study||33
8868725|NCT01863667|9925231|FG001|STARTED|Overall Study||32
8868726|NCT01863667|9925230|FG000|COMPLETED|Overall Study||0
8868727|NCT01863667|9925231|FG001|COMPLETED|Overall Study||0
8868728|NCT01863667|9925230|FG000|NOT COMPLETED|Overall Study||33
8868729|NCT01863667|9925231|FG001|NOT COMPLETED|Overall Study||32
8868730|NCT01863680|9925237|FG000|STARTED|Overall Study||178
8868731|NCT01863680|9925237|FG000|Subjects Started COS Treatment|Overall Study||169
8868732|NCT01863680|9925237|FG000|Subjects Received hCG Injection|Overall Study||162
8868733|NCT01863680|9925237|FG000|Subjects Received Study Drug|Overall Study||149
8868734|NCT01863680|9925237|FG000|Subjects Who Have Undergone IVF/ET|Overall Study||123
8868735|NCT01863680|9925237|FG000|COMPLETED|Overall Study||121
8868736|NCT01863680|9925237|FG000|NOT COMPLETED|Overall Study||57
8868737|NCT01863732|9925245|FG000|STARTED|Overall Study||100
8868738|NCT01863732|9925246|FG001|STARTED|Overall Study||87
8868739|NCT01863732|9925247|FG002|STARTED|Overall Study||46
8868740|NCT01863732|9925248|FG003|STARTED|Overall Study||41
8868741|NCT01863732|9925245|FG000|COMPLETED|Overall Study||87
8868742|NCT01863732|9925246|FG001|COMPLETED|Overall Study||75
8868743|NCT01863732|9925247|FG002|COMPLETED|Overall Study||35
8868744|NCT01863732|9925248|FG003|COMPLETED|Overall Study||33
8868745|NCT01863732|9925245|FG000|NOT COMPLETED|Overall Study||13
8868746|NCT01863732|9925246|FG001|NOT COMPLETED|Overall Study||12
8868747|NCT01863732|9925247|FG002|NOT COMPLETED|Overall Study||11
8868748|NCT01863732|9925248|FG003|NOT COMPLETED|Overall Study||8
8868749|NCT01863758|9925257|FG000|STARTED|Pharmacokinetic Assessment||66
8868750|NCT01863758|9925257|FG000|COMPLETED|Pharmacokinetic Assessment||66
8868751|NCT01863758|9925257|FG000|NOT COMPLETED|Pharmacokinetic Assessment||0
8868752|NCT01863758|9925257|FG000|STARTED|Prophylactic Treatment-Phase I||66
8868753|NCT01863758|9925257|FG000|COMPLETED|Prophylactic Treatment-Phase I||66
8868754|NCT01863758|9925257|FG000|NOT COMPLETED|Prophylactic Treatment-Phase I||0
8868755|NCT01863758|9925257|FG000|STARTED|Prophylactic Treatment-Phase II||66
8868756|NCT01863758|9925257|FG000|COMPLETED|Prophylactic Treatment-Phase II||64
8868757|NCT01863758|9925257|FG000|NOT COMPLETED|Prophylactic Treatment-Phase II||2
8868758|NCT01863771|9925261|FG000|STARTED|Induction Phase||144
8868759|NCT01863771|9925262|FG001|STARTED|Induction Phase||0
8868760|NCT01863771|9925263|FG002|STARTED|Induction Phase||0
8868761|NCT01863771|9925264|FG003|STARTED|Induction Phase||0
8868762|NCT01863771|9925261|FG000|COMPLETED|Induction Phase|Same participants who completed the induction phase participated in the maintenance phase.|123
8868763|NCT01863771|9925262|FG001|COMPLETED|Induction Phase||0
8868764|NCT01863771|9925263|FG002|COMPLETED|Induction Phase||0
8868765|NCT01863771|9925264|FG003|COMPLETED|Induction Phase||0
8868766|NCT01863771|9925261|FG000|NOT COMPLETED|Induction Phase||21
8868767|NCT01863771|9925262|FG001|NOT COMPLETED|Induction Phase||0
8868768|NCT01863771|9925263|FG002|NOT COMPLETED|Induction Phase||0
8868769|NCT01863771|9925264|FG003|NOT COMPLETED|Induction Phase||0
8868770|NCT01863771|9925261|FG000|STARTED|Maintenance Phase||0
8868771|NCT01863771|9925262|FG001|STARTED|Maintenance Phase||32
8868772|NCT01863771|9925263|FG002|STARTED|Maintenance Phase||31
8868773|NCT01863771|9925264|FG003|STARTED|Maintenance Phase||60
8868774|NCT01863771|9925261|FG000|COMPLETED|Maintenance Phase||0
8868775|NCT01863771|9925262|FG001|COMPLETED|Maintenance Phase||27
8868776|NCT01863771|9925263|FG002|COMPLETED|Maintenance Phase||19
8868777|NCT01863771|9925264|FG003|COMPLETED|Maintenance Phase||17
8868778|NCT01863771|9925261|FG000|NOT COMPLETED|Maintenance Phase||0
8868779|NCT01863771|9925262|FG001|NOT COMPLETED|Maintenance Phase||5
8868780|NCT01863771|9925263|FG002|NOT COMPLETED|Maintenance Phase||12
8868781|NCT01863771|9925264|FG003|NOT COMPLETED|Maintenance Phase||43
8868782|NCT01863849|9925274|FG000|STARTED|Overall Study||60
8868783|NCT01863849|9925275|FG001|STARTED|Overall Study||60
8868784|NCT01863849|9925274|FG000|COMPLETED|Overall Study||59
8868785|NCT01863849|9925275|FG001|COMPLETED|Overall Study||60
8868786|NCT01863849|9925274|FG000|NOT COMPLETED|Overall Study||1
8868787|NCT01863849|9925275|FG001|NOT COMPLETED|Overall Study||0
8868788|NCT01863953|9925285|FG000|STARTED|Overall Study||38
8868789|NCT01863953|9925286|FG001|STARTED|Overall Study||36
8868790|NCT01863953|9925287|FG002|STARTED|Overall Study||38
8868791|NCT01863953|9925285|FG000|COMPLETED|Overall Study||38
8868792|NCT01863953|9925286|FG001|COMPLETED|Overall Study||36
8868793|NCT01863953|9925287|FG002|COMPLETED|Overall Study||37
8868794|NCT01863953|9925285|FG000|NOT COMPLETED|Overall Study||0
8868795|NCT01863953|9925286|FG001|NOT COMPLETED|Overall Study||0
8868796|NCT01863953|9925287|FG002|NOT COMPLETED|Overall Study||1
8868797|NCT01864005|9925297|FG000|STARTED|Overall Study||29
8868798|NCT01864005|9925298|FG001|STARTED|Overall Study||31
8868799|NCT01864005|9925297|FG000|COMPLETED|Overall Study||26
8868800|NCT01864005|9925298|FG001|COMPLETED|Overall Study||25
8868801|NCT01864005|9925297|FG000|NOT COMPLETED|Overall Study||3
8868802|NCT01864005|9925298|FG001|NOT COMPLETED|Overall Study||6
8868803|NCT01864148|9925309|FG000|STARTED|Overall Study||93
8868804|NCT01864148|9925310|FG001|STARTED|Overall Study||45
8868805|NCT01864148|9925311|FG002|STARTED|Overall Study||95
8868806|NCT01864148|9925312|FG003|STARTED|Overall Study||94
8868807|NCT01864148|9925313|FG004|STARTED|Overall Study||92
8868808|NCT01864148|9925309|FG000|Randomized and Dosed|Overall Study||93
8868809|NCT01864148|9925310|FG001|Randomized and Dosed|Overall Study||45
8868810|NCT01864148|9925311|FG002|Randomized and Dosed|Overall Study||95
8868811|NCT01864148|9925312|FG003|Randomized and Dosed|Overall Study||93
8868812|NCT01864148|9925313|FG004|Randomized and Dosed|Overall Study||92
8868813|NCT01864148|9925309|FG000|COMPLETED|Overall Study||73
8868814|NCT01864148|9925310|FG001|COMPLETED|Overall Study||40
8868815|NCT01864148|9925311|FG002|COMPLETED|Overall Study||84
8868816|NCT01864148|9925312|FG003|COMPLETED|Overall Study||68
8868817|NCT01864148|9925313|FG004|COMPLETED|Overall Study||69
8868818|NCT01864148|9925309|FG000|NOT COMPLETED|Overall Study||20
8868819|NCT01864148|9925310|FG001|NOT COMPLETED|Overall Study||5
8868820|NCT01864148|9925311|FG002|NOT COMPLETED|Overall Study||11
8868821|NCT01864148|9925312|FG003|NOT COMPLETED|Overall Study||26
8868822|NCT01864148|9925313|FG004|NOT COMPLETED|Overall Study||23
8868823|NCT01864174|9925332|FG000|STARTED|Double Blind Treatment - All Treated||283
8868824|NCT01864174|9925333|FG001|STARTED|Double Blind Treatment - All Treated||285
8868825|NCT01864174|9925332|FG000|COMPLETED|Double Blind Treatment - All Treated||268
8868826|NCT01864174|9925333|FG001|COMPLETED|Double Blind Treatment - All Treated||271
8868827|NCT01864174|9925332|FG000|NOT COMPLETED|Double Blind Treatment - All Treated||15
8868828|NCT01864174|9925333|FG001|NOT COMPLETED|Double Blind Treatment - All Treated||14
8868829|NCT01864174|9925332|FG000|STARTED|Double Blind - Compliant Randomized||268
8868830|NCT01864174|9925333|FG001|STARTED|Double Blind - Compliant Randomized||271
8868831|NCT01864174|9925332|FG000|COMPLETED|Double Blind - Compliant Randomized||245
8868832|NCT01864174|9925333|FG001|COMPLETED|Double Blind - Compliant Randomized||245
8868833|NCT01864174|9925332|FG000|NOT COMPLETED|Double Blind - Compliant Randomized||23
8868834|NCT01864174|9925333|FG001|NOT COMPLETED|Double Blind - Compliant Randomized||26
8868835|NCT01864174|9925332|FG000|STARTED|Off Treatment Follow-Up||9
8868836|NCT01864174|9925333|FG001|STARTED|Off Treatment Follow-Up||1
8868837|NCT01864174|9925332|FG000|COMPLETED|Off Treatment Follow-Up||6
8868838|NCT01864174|9925333|FG001|COMPLETED|Off Treatment Follow-Up||1
8868839|NCT01864174|9925332|FG000|NOT COMPLETED|Off Treatment Follow-Up||3
8868840|NCT01864174|9925333|FG001|NOT COMPLETED|Off Treatment Follow-Up||0
8868841|NCT01864200|9925341|FG000|STARTED|Overall Study||45
8868842|NCT01864200|9925342|FG001|STARTED|Overall Study||29
8868843|NCT01864200|9925341|FG000|COMPLETED|Overall Study||43
8868844|NCT01864200|9925342|FG001|COMPLETED|Overall Study||26
8868845|NCT01864200|9925341|FG000|NOT COMPLETED|Overall Study||2
8868846|NCT01864200|9925342|FG001|NOT COMPLETED|Overall Study||3
8868847|NCT01864291|9925348|FG000|STARTED|Overall Study||9
8868848|NCT01864291|9925348|FG000|COMPLETED|Overall Study|7/9 subjects had a minimum of one year followup since enrollment.|7
8868849|NCT01864291|9925348|FG000|NOT COMPLETED|Overall Study||2
8868850|NCT01864434|9925354|FG000|STARTED|Overall Study||25
8868851|NCT01864434|9925355|FG001|STARTED|Overall Study||25
8868852|NCT01864434|9925354|FG000|COMPLETED|Overall Study||25
8868853|NCT01864434|9925355|FG001|COMPLETED|Overall Study||25
8868854|NCT01864434|9925354|FG000|NOT COMPLETED|Overall Study||0
8868855|NCT01864434|9925355|FG001|NOT COMPLETED|Overall Study||0
8868856|NCT01864525|9925363|FG000|STARTED|Overall Study||10
8868857|NCT01864525|9925364|FG001|STARTED|Overall Study||7
8868858|NCT01864525|9925363|FG000|COMPLETED|Overall Study||9
8868859|NCT01864525|9925364|FG001|COMPLETED|Overall Study||7
8868860|NCT01864525|9925363|FG000|NOT COMPLETED|Overall Study||1
8868861|NCT01864525|9925364|FG001|NOT COMPLETED|Overall Study||0
8868862|NCT01864538|9925370|FG000|STARTED|Overall Study||11
8868863|NCT01864538|9925370|FG000|COMPLETED|Overall Study||0
8868864|NCT01864538|9925370|FG000|NOT COMPLETED|Overall Study||11
8868865|NCT01864564|9925376|FG000|STARTED|Overall Study||480
8868866|NCT01864564|9925377|FG001|STARTED|Overall Study||482
8868867|NCT01864564|9925376|FG000|COMPLETED|Overall Study||443
8868868|NCT01864564|9925377|FG001|COMPLETED|Overall Study||387
8868869|NCT01864564|9925376|FG000|NOT COMPLETED|Overall Study||37
8868870|NCT01864564|9925377|FG001|NOT COMPLETED|Overall Study||95
8868871|NCT01865084|9925386|FG000|STARTED|Double Blind Period (DB)||116
8868872|NCT01865084|9925387|FG001|STARTED|Double Blind Period (DB)||102
8868873|NCT01865084|9925388|FG002|STARTED|Double Blind Period (DB)||113
8868874|NCT01865084|9925386|FG000|Received at Least One Dose of Study Drug|Double Blind Period (DB)||116
8868875|NCT01865084|9925387|FG001|Received at Least One Dose of Study Drug|Double Blind Period (DB)||102
8868876|NCT01865084|9925388|FG002|Received at Least One Dose of Study Drug|Double Blind Period (DB)||112
8868877|NCT01865084|9925386|FG000|COMPLETED|Double Blind Period (DB)||111
8868878|NCT01865084|9925387|FG001|COMPLETED|Double Blind Period (DB)|One participant stopped therapy during the DB period but remained in the study for follow-up.|98
8868879|NCT01865084|9925388|FG002|COMPLETED|Double Blind Period (DB)||107
8868880|NCT01865084|9925386|FG000|NOT COMPLETED|Double Blind Period (DB)||5
8952227|NCT02461160|10015179|FG012|NOT COMPLETED|Overall Study||0
8952228|NCT02461290|10015228|FG000|STARTED|Overall Study||99
8569820|NCT00098748|9601934|FG002|STARTED|Continued on Open-Label Treatment|Placebo group not offered open-label maraviroc due to study not reaching primary endpoint at Week 24|0
8569821|NCT00098748|9601932|FG000|COMPLETED|Continued on Open-Label Treatment||7
8569822|NCT00098748|9601933|FG001|COMPLETED|Continued on Open-Label Treatment||10
8569823|NCT00098748|9601934|FG002|COMPLETED|Continued on Open-Label Treatment||0
8569824|NCT00098748|9601932|FG000|NOT COMPLETED|Continued on Open-Label Treatment||8
8569825|NCT00098748|9601933|FG001|NOT COMPLETED|Continued on Open-Label Treatment||15
8569826|NCT00098748|9601934|FG002|NOT COMPLETED|Continued on Open-Label Treatment||0
8569827|NCT00098774|9601942|FG000|STARTED|Overall Study||44
8569828|NCT00098774|9601942|FG000|COMPLETED|Overall Study||26
8569829|NCT00098774|9601942|FG000|NOT COMPLETED|Overall Study||18
8569830|NCT00098787|9601949|FG000|STARTED|Overall Study||73
8569831|NCT00098787|9601950|FG001|STARTED|Overall Study||75
8569832|NCT00098787|9601951|FG002|STARTED|Overall Study||63
8569833|NCT00098787|9601949|FG000|Treated|Overall Study||70
8569834|NCT00098787|9601950|FG001|Treated|Overall Study||73
8569835|NCT00098787|9601951|FG002|Treated|Overall Study||62
8569836|NCT00098787|9601949|FG000|Eligible and Treated|Overall Study||61
8569837|NCT00098787|9601950|FG001|Eligible and Treated|Overall Study||66
8569838|NCT00098787|9601951|FG002|Eligible and Treated|Overall Study||59
8569839|NCT00098787|9601949|FG000|COMPLETED|Overall Study||0
8569840|NCT00098787|9601950|FG001|COMPLETED|Overall Study||0
8569841|NCT00098787|9601951|FG002|COMPLETED|Overall Study||0
8569842|NCT00098787|9601949|FG000|NOT COMPLETED|Overall Study||73
8569843|NCT00098787|9601950|FG001|NOT COMPLETED|Overall Study||75
8569844|NCT00098787|9601951|FG002|NOT COMPLETED|Overall Study||63
8577536|NCT00159263|9610315|FG005|STARTED|Washout||2
8577537|NCT00159263|9610310|FG000|COMPLETED|Washout||1
8577538|NCT00159263|9610311|FG001|COMPLETED|Washout||1
8577539|NCT00159263|9610312|FG002|COMPLETED|Washout||2
8577540|NCT00159263|9610313|FG003|COMPLETED|Washout||2
8577541|NCT00159263|9610314|FG004|COMPLETED|Washout||2
8577542|NCT00159263|9610315|FG005|COMPLETED|Washout||2
8577543|NCT00159263|9610310|FG000|NOT COMPLETED|Washout||0
8577544|NCT00159263|9610311|FG001|NOT COMPLETED|Washout||0
8577545|NCT00159263|9610312|FG002|NOT COMPLETED|Washout||0
8577546|NCT00159263|9610313|FG003|NOT COMPLETED|Washout||0
8577547|NCT00159263|9610314|FG004|NOT COMPLETED|Washout||0
8577548|NCT00159263|9610315|FG005|NOT COMPLETED|Washout||0
8577549|NCT00159263|9610310|FG000|STARTED|Sixth Intervention||1
8577550|NCT00159263|9610311|FG001|STARTED|Sixth Intervention||1
8577551|NCT00159263|9610312|FG002|STARTED|Sixth Intervention||2
8577552|NCT00159263|9610313|FG003|STARTED|Sixth Intervention||2
8577553|NCT00159263|9610314|FG004|STARTED|Sixth Intervention||2
8577554|NCT00159263|9610315|FG005|STARTED|Sixth Intervention||2
8577555|NCT00159263|9610310|FG000|COMPLETED|Sixth Intervention||1
8577556|NCT00159263|9610311|FG001|COMPLETED|Sixth Intervention||1
8577557|NCT00159263|9610312|FG002|COMPLETED|Sixth Intervention||2
8577558|NCT00159263|9610313|FG003|COMPLETED|Sixth Intervention||2
8577559|NCT00159263|9610314|FG004|COMPLETED|Sixth Intervention||2
8577560|NCT00159263|9610315|FG005|COMPLETED|Sixth Intervention||2
8577561|NCT00159263|9610310|FG000|NOT COMPLETED|Sixth Intervention||0
8577562|NCT00159263|9610311|FG001|NOT COMPLETED|Sixth Intervention||0
8577563|NCT00159263|9610312|FG002|NOT COMPLETED|Sixth Intervention||0
8868881|NCT01865084|9925387|FG001|NOT COMPLETED|Double Blind Period (DB)||4
8868882|NCT01865084|9925388|FG002|NOT COMPLETED|Double Blind Period (DB)||6
8868883|NCT01865084|9925386|FG000|STARTED|Open Label Extension (OLE) Period|Participants who were on Placebo during the double blind period were assigned tadalafil during OLE.|0
8868884|NCT01865084|9925387|FG001|STARTED|Open Label Extension (OLE) Period|Participants who were on Placebo during the double blind period were assigned tadalafil during OLE.|150
8868885|NCT01865084|9925388|FG002|STARTED|Open Label Extension (OLE) Period|Participants who were on Placebo during the double blind period were assigned tadalafil during OLE.|165
8868886|NCT01865084|9925386|FG000|COMPLETED|Open Label Extension (OLE) Period||0
8868887|NCT01865084|9925387|FG001|COMPLETED|Open Label Extension (OLE) Period||139
8868888|NCT01865084|9925388|FG002|COMPLETED|Open Label Extension (OLE) Period||158
8868889|NCT01865084|9925386|FG000|NOT COMPLETED|Open Label Extension (OLE) Period||0
8868890|NCT01865084|9925387|FG001|NOT COMPLETED|Open Label Extension (OLE) Period||11
8868891|NCT01865084|9925388|FG002|NOT COMPLETED|Open Label Extension (OLE) Period||7
8868892|NCT01865448|9925402|FG000|STARTED|Overall Study||17
8868893|NCT01865448|9925403|FG001|STARTED|Overall Study||17
8868894|NCT01865448|9925402|FG000|COMPLETED|Overall Study||15
8868895|NCT01865448|9925403|FG001|COMPLETED|Overall Study||14
8868896|NCT01865448|9925402|FG000|NOT COMPLETED|Overall Study||2
8868897|NCT01865448|9925403|FG001|NOT COMPLETED|Overall Study||3
8868898|NCT01865487|9925416|FG000|STARTED|Overall Study||15
8868899|NCT01865487|9925417|FG001|STARTED|Overall Study||15
8868900|NCT01865487|9925418|FG002|STARTED|Overall Study||15
8868901|NCT01865487|9925419|FG003|STARTED|Overall Study||5
8868902|NCT01865487|9925420|FG004|STARTED|Overall Study||12
8868903|NCT01865487|9925421|FG005|STARTED|Overall Study||4
8868904|NCT01865487|9925422|FG006|STARTED|Overall Study||12
8868905|NCT01865487|9925423|FG007|STARTED|Overall Study||4
8868906|NCT01865487|9925424|FG008|STARTED|Overall Study||12
8868907|NCT01865487|9925425|FG009|STARTED|Overall Study||4
8868908|NCT01865487|9925416|FG000|COMPLETED|Overall Study||15
8868909|NCT01865487|9925417|FG001|COMPLETED|Overall Study||15
8952229|NCT02461290|10015228|FG000|COMPLETED|Overall Study||89
8952230|NCT02461290|10015228|FG000|NOT COMPLETED|Overall Study||10
8952231|NCT02461433|10015234|FG000|STARTED|Overall Study||1
8952232|NCT02461433|10015235|FG001|STARTED|Overall Study||1
8952233|NCT02461433|10015234|FG000|COMPLETED|Overall Study||1
8952234|NCT02461433|10015235|FG001|COMPLETED|Overall Study||1
8952235|NCT02461433|10015234|FG000|NOT COMPLETED|Overall Study||0
8952236|NCT02461433|10015235|FG001|NOT COMPLETED|Overall Study||0
8952237|NCT02461563|10015245|FG000|STARTED|Overall Study||3
8952238|NCT02461563|10015246|FG001|STARTED|Overall Study||3
8952239|NCT02461563|10015247|FG002|STARTED|Overall Study||3
8952240|NCT02461563|10015248|FG003|STARTED|Overall Study||3
8952241|NCT02461563|10015245|FG000|COMPLETED|Overall Study||3
8952242|NCT02461563|10015246|FG001|COMPLETED|Overall Study||3
8952243|NCT02461563|10015247|FG002|COMPLETED|Overall Study||3
8952244|NCT02461563|10015248|FG003|COMPLETED|Overall Study||3
8952245|NCT02461563|10015245|FG000|NOT COMPLETED|Overall Study||0
8952246|NCT02461563|10015246|FG001|NOT COMPLETED|Overall Study||0
8952247|NCT02461563|10015247|FG002|NOT COMPLETED|Overall Study||0
8952248|NCT02461563|10015248|FG003|NOT COMPLETED|Overall Study||0
8952249|NCT02461589|10015274|FG000|STARTED|Overall Study||64
8952250|NCT02461589|10015275|FG001|STARTED|Overall Study||63
8952251|NCT02461589|10015276|FG002|STARTED|Overall Study||65
8952252|NCT02461589|10015277|FG003|STARTED|Overall Study||63
8952253|NCT02461589|10015278|FG004|STARTED|Overall Study||64
8952254|NCT02461589|10015279|FG005|STARTED|Overall Study||64
8952255|NCT02461589|10015280|FG006|STARTED|Overall Study||64
8952256|NCT02461589|10015281|FG007|STARTED|Overall Study||65
8952257|NCT02461589|10015282|FG008|STARTED|Overall Study||129
8952258|NCT02461589|10015283|FG009|STARTED|Overall Study||65
8952259|NCT02461589|10015274|FG000|Exposed|Overall Study||64
8952260|NCT02461589|10015275|FG001|Exposed|Overall Study||63
8952261|NCT02461589|10015276|FG002|Exposed|Overall Study||65
8952262|NCT02461589|10015277|FG003|Exposed|Overall Study||63
8952263|NCT02461589|10015278|FG004|Exposed|Overall Study||64
8952264|NCT02461589|10015279|FG005|Exposed|Overall Study||64
8952265|NCT02461589|10015280|FG006|Exposed|Overall Study||64
8952266|NCT02461589|10015281|FG007|Exposed|Overall Study||65
8952267|NCT02461589|10015282|FG008|Exposed|Overall Study||129
8952268|NCT02461589|10015283|FG009|Exposed|Overall Study||64
8952269|NCT02461589|10015274|FG000|COMPLETED|Overall Study||58
8952270|NCT02461589|10015275|FG001|COMPLETED|Overall Study||61
8952271|NCT02461589|10015276|FG002|COMPLETED|Overall Study||60
8952272|NCT02461589|10015277|FG003|COMPLETED|Overall Study||58
8952273|NCT02461589|10015278|FG004|COMPLETED|Overall Study||62
8952274|NCT02461589|10015279|FG005|COMPLETED|Overall Study||61
8952275|NCT02461589|10015280|FG006|COMPLETED|Overall Study||58
8952276|NCT02461589|10015281|FG007|COMPLETED|Overall Study||60
8952277|NCT02461589|10015282|FG008|COMPLETED|Overall Study||123
8952278|NCT02461589|10015283|FG009|COMPLETED|Overall Study||60
8952279|NCT02461589|10015274|FG000|NOT COMPLETED|Overall Study||6
8952280|NCT02461589|10015275|FG001|NOT COMPLETED|Overall Study||2
8952281|NCT02461589|10015276|FG002|NOT COMPLETED|Overall Study||5
8952282|NCT02461589|10015277|FG003|NOT COMPLETED|Overall Study||5
8952283|NCT02461589|10015278|FG004|NOT COMPLETED|Overall Study||2
8569845|NCT00098813|9601959|FG000|STARTED|Overall Study||20
8952284|NCT02461589|10015279|FG005|NOT COMPLETED|Overall Study||3
8952285|NCT02461589|10015280|FG006|NOT COMPLETED|Overall Study||6
8952286|NCT02461589|10015281|FG007|NOT COMPLETED|Overall Study||5
8868910|NCT01865487|9925418|FG002|COMPLETED|Overall Study||15
8868911|NCT01865487|9925419|FG003|COMPLETED|Overall Study||4
8868912|NCT01865487|9925420|FG004|COMPLETED|Overall Study||11
8868913|NCT01865487|9925421|FG005|COMPLETED|Overall Study||4
8868914|NCT01865487|9925422|FG006|COMPLETED|Overall Study||11
8868915|NCT01865487|9925423|FG007|COMPLETED|Overall Study||4
8868916|NCT01865487|9925424|FG008|COMPLETED|Overall Study||12
8868917|NCT01865487|9925425|FG009|COMPLETED|Overall Study||4
8868918|NCT01865487|9925416|FG000|NOT COMPLETED|Overall Study||0
8952287|NCT02461589|10015282|FG008|NOT COMPLETED|Overall Study||6
8952288|NCT02461589|10015283|FG009|NOT COMPLETED|Overall Study||5
8952289|NCT02461628|10015307|FG000|STARTED|Overall Study||3733
8952290|NCT02461628|10015308|FG001|STARTED|Overall Study||3632
8952291|NCT02461628|10015307|FG000|Baseline Survey|Overall Study||1038
8952292|NCT02461628|10015308|FG001|Baseline Survey|Overall Study||974
8952293|NCT02461628|10015307|FG000|6 Month Survey|Overall Study||814
8952294|NCT02461628|10015308|FG001|6 Month Survey|Overall Study||832
8952295|NCT02461628|10015307|FG000|12 Month Survey|Overall Study||882
8952296|NCT02461628|10015308|FG001|12 Month Survey|Overall Study||914
8952297|NCT02461628|10015307|FG000|18 Month Survey|Overall Study||995
8952298|NCT02461628|10015308|FG001|18 Month Survey|Overall Study||905
8952299|NCT02461628|10015307|FG000|COMPLETED|Overall Study||3729
8952300|NCT02461628|10015308|FG001|COMPLETED|Overall Study||3625
8952301|NCT02461628|10015307|FG000|NOT COMPLETED|Overall Study||4
8952302|NCT02461628|10015308|FG001|NOT COMPLETED|Overall Study||7
8952303|NCT02461693|10015316|FG000|STARTED|Overall Study||103
8952304|NCT02461693|10015317|FG001|STARTED|Overall Study||102
8952305|NCT02461693|10015316|FG000|COMPLETED|Overall Study||103
8952306|NCT02461693|10015317|FG001|COMPLETED|Overall Study||102
8952307|NCT02461693|10015316|FG000|NOT COMPLETED|Overall Study||0
8952308|NCT02461693|10015317|FG001|NOT COMPLETED|Overall Study||0
8952309|NCT02461745|10015325|FG000|STARTED|Overall Study||130
8952310|NCT02461745|10015326|FG001|STARTED|Overall Study||70
8952311|NCT02461745|10015325|FG000|COMPLETED|Overall Study||116
8952312|NCT02461745|10015326|FG001|COMPLETED|Overall Study||66
8952313|NCT02461745|10015325|FG000|NOT COMPLETED|Overall Study||14
8952314|NCT02461745|10015326|FG001|NOT COMPLETED|Overall Study||4
8952315|NCT02461758|10015338|FG000|STARTED|Overall Study||20
8952316|NCT02461758|10015339|FG001|STARTED|Overall Study||20
8952317|NCT02461758|10015340|FG002|STARTED|Overall Study||26
8952318|NCT02461758|10015341|FG003|STARTED|Overall Study||15
8952319|NCT02461758|10015338|FG000|COMPLETED|Overall Study||20
8952320|NCT02461758|10015339|FG001|COMPLETED|Overall Study||19
8952321|NCT02461758|10015340|FG002|COMPLETED|Overall Study||25
8952322|NCT02461758|10015341|FG003|COMPLETED|Overall Study||15
8952323|NCT02461758|10015338|FG000|NOT COMPLETED|Overall Study||0
8952324|NCT02461758|10015339|FG001|NOT COMPLETED|Overall Study||1
8952325|NCT02461758|10015340|FG002|NOT COMPLETED|Overall Study||1
8952326|NCT02461758|10015341|FG003|NOT COMPLETED|Overall Study||0
8952327|NCT02461771|10015357|FG000|STARTED|Overall Study||3
8952328|NCT02461771|10015358|FG001|STARTED|Overall Study||3
8952329|NCT02461771|10015359|FG002|STARTED|Overall Study||7
8952330|NCT02461771|10015357|FG000|COMPLETED|Overall Study||3
8952331|NCT02461771|10015358|FG001|COMPLETED|Overall Study||3
8952332|NCT02461771|10015359|FG002|COMPLETED|Overall Study||7
8952333|NCT02461771|10015357|FG000|NOT COMPLETED|Overall Study||0
8952334|NCT02461771|10015358|FG001|NOT COMPLETED|Overall Study||0
8952335|NCT02461771|10015359|FG002|NOT COMPLETED|Overall Study||0
8952336|NCT02461966|10015370|FG000|STARTED|Overall Study||160
8952337|NCT02461966|10015371|FG001|STARTED|Overall Study||80
8952338|NCT02461966|10015372|FG002|STARTED|Overall Study||60
8952339|NCT02461966|10015370|FG000|COMPLETED|Overall Study||160
8952340|NCT02461966|10015371|FG001|COMPLETED|Overall Study||80
8952341|NCT02461966|10015372|FG002|COMPLETED|Overall Study||60
8952342|NCT02461966|10015370|FG000|NOT COMPLETED|Overall Study||0
8952343|NCT02461966|10015371|FG001|NOT COMPLETED|Overall Study||0
8952344|NCT02461966|10015372|FG002|NOT COMPLETED|Overall Study||0
8952345|NCT02461992|10015380|FG000|STARTED|Overall Study||13
8952346|NCT02461992|10015380|FG000|COMPLETED|Overall Study||13
8952347|NCT02461992|10015380|FG000|NOT COMPLETED|Overall Study||0
8952348|NCT02462057|10015389|FG000|STARTED|Overall Study||791
8952349|NCT02462057|10015390|FG001|STARTED|Overall Study||793
8952350|NCT02462057|10015391|FG002|STARTED|Overall Study||812
8952351|NCT02462057|10015392|FG003|STARTED|Overall Study||752
8952352|NCT02462057|10015393|FG004|STARTED|Overall Study||758
8952353|NCT02462057|10015389|FG000|COMPLETED|Overall Study||737
8952354|NCT02462057|10015390|FG001|COMPLETED|Overall Study||753
8630966|NCT00537407|9670822|FG002|COMPLETED|Part 1 Weeks 1-4||11
8630967|NCT00537407|9670823|FG003|COMPLETED|Part 1 Weeks 1-4||10
8630968|NCT00537407|9670824|FG004|COMPLETED|Part 1 Weeks 1-4||10
8630969|NCT00537407|9670820|FG000|NOT COMPLETED|Part 1 Weeks 1-4||0
8630970|NCT00537407|9670821|FG001|NOT COMPLETED|Part 1 Weeks 1-4||0
8868919|NCT01865487|9925417|FG001|NOT COMPLETED|Overall Study||0
8952355|NCT02462057|10015391|FG002|COMPLETED|Overall Study||766
8952356|NCT02462057|10015392|FG003|COMPLETED|Overall Study||701
8952357|NCT02462057|10015393|FG004|COMPLETED|Overall Study||708
8952358|NCT02462057|10015389|FG000|NOT COMPLETED|Overall Study||54
8952359|NCT02462057|10015390|FG001|NOT COMPLETED|Overall Study||40
8952360|NCT02462057|10015391|FG002|NOT COMPLETED|Overall Study||46
8868920|NCT01865487|9925418|FG002|NOT COMPLETED|Overall Study||0
8868921|NCT01865487|9925419|FG003|NOT COMPLETED|Overall Study||1
8952361|NCT02462057|10015392|FG003|NOT COMPLETED|Overall Study||51
8868922|NCT01865487|9925420|FG004|NOT COMPLETED|Overall Study||1
8868923|NCT01865487|9925421|FG005|NOT COMPLETED|Overall Study||0
8868924|NCT01865487|9925422|FG006|NOT COMPLETED|Overall Study||1
8868925|NCT01865487|9925423|FG007|NOT COMPLETED|Overall Study||0
8868926|NCT01865487|9925424|FG008|NOT COMPLETED|Overall Study||0
8868927|NCT01865487|9925425|FG009|NOT COMPLETED|Overall Study||0
8868928|NCT01865552|9925459|FG000|STARTED|Period 1||23
8868929|NCT01865552|9925460|FG001|STARTED|Period 1||23
8868930|NCT01865552|9925461|FG002|STARTED|Period 1||23
8868931|NCT01865552|9925462|FG003|STARTED|Period 1||23
8868932|NCT01865552|9925463|FG004|STARTED|Period 1||23
8868933|NCT01865552|9925464|FG005|STARTED|Period 1||23
8868934|NCT01865552|9925459|FG000|Discontinued From Period 1|Period 1||1
8868935|NCT01865552|9925460|FG001|Discontinued From Period 1|Period 1||0
8868936|NCT01865552|9925461|FG002|Discontinued From Period 1|Period 1||0
8868937|NCT01865552|9925462|FG003|Discontinued From Period 1|Period 1||1
8868938|NCT01865552|9925463|FG004|Discontinued From Period 1|Period 1||3
8868939|NCT01865552|9925464|FG005|Discontinued From Period 1|Period 1||1
8868940|NCT01865552|9925459|FG000|COMPLETED|Period 1||22
8868941|NCT01865552|9925460|FG001|COMPLETED|Period 1||23
8868942|NCT01865552|9925461|FG002|COMPLETED|Period 1||23
8868943|NCT01865552|9925462|FG003|COMPLETED|Period 1||22
8868944|NCT01865552|9925463|FG004|COMPLETED|Period 1||20
8868945|NCT01865552|9925464|FG005|COMPLETED|Period 1||22
8868946|NCT01865552|9925459|FG000|NOT COMPLETED|Period 1||1
8868947|NCT01865552|9925460|FG001|NOT COMPLETED|Period 1||0
8868948|NCT01865552|9925461|FG002|NOT COMPLETED|Period 1||0
8868949|NCT01865552|9925462|FG003|NOT COMPLETED|Period 1||1
8868950|NCT01865552|9925463|FG004|NOT COMPLETED|Period 1||3
8868951|NCT01865552|9925464|FG005|NOT COMPLETED|Period 1||1
8868952|NCT01865552|9925459|FG000|STARTED|Period 2||22
8868953|NCT01865552|9925460|FG001|STARTED|Period 2||23
8868954|NCT01865552|9925461|FG002|STARTED|Period 2||23
8868955|NCT01865552|9925462|FG003|STARTED|Period 2||22
8868956|NCT01865552|9925463|FG004|STARTED|Period 2||20
8868957|NCT01865552|9925464|FG005|STARTED|Period 2||22
8868958|NCT01865552|9925459|FG000|COMPLETED|Period 2||22
8868959|NCT01865552|9925460|FG001|COMPLETED|Period 2||23
8868960|NCT01865552|9925461|FG002|COMPLETED|Period 2||23
8868961|NCT01865552|9925462|FG003|COMPLETED|Period 2||22
8868962|NCT01865552|9925463|FG004|COMPLETED|Period 2||20
8868963|NCT01865552|9925464|FG005|COMPLETED|Period 2||22
8868964|NCT01865552|9925459|FG000|NOT COMPLETED|Period 2||0
8868965|NCT01865552|9925460|FG001|NOT COMPLETED|Period 2||0
8868966|NCT01865552|9925461|FG002|NOT COMPLETED|Period 2||0
8868967|NCT01865552|9925462|FG003|NOT COMPLETED|Period 2||0
8868968|NCT01865552|9925463|FG004|NOT COMPLETED|Period 2||0
8868969|NCT01865552|9925464|FG005|NOT COMPLETED|Period 2||0
8868970|NCT01865708|9925478|FG000|STARTED|Overall Study||10
8868971|NCT01865708|9925478|FG000|COMPLETED|Overall Study||10
8868972|NCT01865708|9925478|FG000|NOT COMPLETED|Overall Study||0
8868973|NCT01865747|9925484|FG000|STARTED|Overall Study (ITT)||330
8868974|NCT01865747|9925485|FG001|STARTED|Overall Study (ITT)||328
8868975|NCT01865747|9925484|FG000|COMPLETED|Overall Study (ITT)|One subject randomized to everolimus arm received cabozantinib discontd due to clin. deterioration|132
8868976|NCT01865747|9925485|FG001|COMPLETED|Overall Study (ITT)|Five subjects were randomized but not treated|73
8868977|NCT01865747|9925484|FG000|NOT COMPLETED|Overall Study (ITT)||198
8868978|NCT01865747|9925485|FG001|NOT COMPLETED|Overall Study (ITT)||255
8868979|NCT01865747|9925484|FG000|STARTED|Primary Intent to Treat (PITT)||187
8868980|NCT01865747|9925485|FG001|STARTED|Primary Intent to Treat (PITT)|Three subjects in the everolimus arm were randomized but not treated.|188
8868981|NCT01865747|9925484|FG000|COMPLETED|Primary Intent to Treat (PITT)||56
8868982|NCT01865747|9925485|FG001|COMPLETED|Primary Intent to Treat (PITT)||36
8868983|NCT01865747|9925484|FG000|NOT COMPLETED|Primary Intent to Treat (PITT)||131
8868984|NCT01865747|9925485|FG001|NOT COMPLETED|Primary Intent to Treat (PITT)||152
8868985|NCT01865812|9925491|FG000|STARTED|Overall Study||26
8868986|NCT01865812|9925491|FG000|COMPLETED|Overall Study||24
8868987|NCT01865812|9925491|FG000|NOT COMPLETED|Overall Study||2
8868988|NCT01866098|9925498|FG000|STARTED|Overall Study||51
8868989|NCT01866098|9925499|FG001|STARTED|Overall Study||47
8868990|NCT01866098|9925500|FG002|STARTED|Overall Study||46
8868991|NCT01866098|9925498|FG000|COMPLETED|Overall Study||32
8868992|NCT01866098|9925499|FG001|COMPLETED|Overall Study||20
8868993|NCT01866098|9925500|FG002|COMPLETED|Overall Study||25
8868994|NCT01866098|9925498|FG000|NOT COMPLETED|Overall Study||19
8868995|NCT01866098|9925499|FG001|NOT COMPLETED|Overall Study||27
8630971|NCT00537407|9670822|FG002|NOT COMPLETED|Part 1 Weeks 1-4||0
8630972|NCT00537407|9670823|FG003|NOT COMPLETED|Part 1 Weeks 1-4||0
8630973|NCT00537407|9670824|FG004|NOT COMPLETED|Part 1 Weeks 1-4||0
8630974|NCT00537407|9670820|FG000|STARTED|Part 2 Weeks 5-48 or 72||10
8868996|NCT01866098|9925500|FG002|NOT COMPLETED|Overall Study||21
8868997|NCT01866150|9925508|FG000|STARTED|Overall Study||450
8868998|NCT01866150|9925508|FG000|COMPLETED|Overall Study||450
8868999|NCT01866150|9925508|FG000|NOT COMPLETED|Overall Study||0
8869000|NCT01866163|9925517|FG000|STARTED|Overall Study||323
8869001|NCT01866163|9925518|FG001|STARTED|Overall Study||103
8869002|NCT01866163|9925517|FG000|COMPLETED|Overall Study||313
8869003|NCT01866163|9925518|FG001|COMPLETED|Overall Study||99
8869004|NCT01866163|9925517|FG000|NOT COMPLETED|Overall Study||10
8869005|NCT01866163|9925518|FG001|NOT COMPLETED|Overall Study||4
8869006|NCT01866293|9925524|FG000|STARTED|Overall Study||11
8869007|NCT01866293|9925524|FG000|COMPLETED|Overall Study||9
8869008|NCT01866293|9925524|FG000|NOT COMPLETED|Overall Study||2
8869009|NCT01866306|9925535|FG000|STARTED|Overall Study||6
8869010|NCT01866306|9925536|FG001|STARTED|Overall Study||6
8630975|NCT00537407|9670821|FG001|STARTED|Part 2 Weeks 5-48 or 72||9
8869011|NCT01866306|9925537|FG002|STARTED|Overall Study||6
8869012|NCT01866306|9925538|FG003|STARTED|Overall Study||6
8869013|NCT01866306|9925539|FG004|STARTED|Overall Study||6
8869014|NCT01866306|9925540|FG005|STARTED|Overall Study||6
8869015|NCT01866306|9925541|FG006|STARTED|Overall Study||23
8869016|NCT01866306|9925535|FG000|COMPLETED|Overall Study||6
8630976|NCT00537407|9670822|FG002|STARTED|Part 2 Weeks 5-48 or 72||11
8630977|NCT00537407|9670823|FG003|STARTED|Part 2 Weeks 5-48 or 72||10
8630978|NCT00537407|9670824|FG004|STARTED|Part 2 Weeks 5-48 or 72||10
8630979|NCT00537407|9670820|FG000|COMPLETED|Part 2 Weeks 5-48 or 72||2
8630980|NCT00537407|9670821|FG001|COMPLETED|Part 2 Weeks 5-48 or 72||1
8630981|NCT00537407|9670822|FG002|COMPLETED|Part 2 Weeks 5-48 or 72||2
8630982|NCT00537407|9670823|FG003|COMPLETED|Part 2 Weeks 5-48 or 72||4
8869017|NCT01866306|9925536|FG001|COMPLETED|Overall Study||6
8869018|NCT01866306|9925537|FG002|COMPLETED|Overall Study||6
8869019|NCT01866306|9925538|FG003|COMPLETED|Overall Study||6
8869020|NCT01866306|9925539|FG004|COMPLETED|Overall Study||6
8869021|NCT01866306|9925540|FG005|COMPLETED|Overall Study||6
8869022|NCT01866306|9925541|FG006|COMPLETED|Overall Study||23
8869023|NCT01866306|9925535|FG000|NOT COMPLETED|Overall Study||0
8869024|NCT01866306|9925536|FG001|NOT COMPLETED|Overall Study||0
8869025|NCT01866306|9925537|FG002|NOT COMPLETED|Overall Study||0
8869026|NCT01866306|9925538|FG003|NOT COMPLETED|Overall Study||0
8869027|NCT01866306|9925539|FG004|NOT COMPLETED|Overall Study||0
8869028|NCT01866306|9925540|FG005|NOT COMPLETED|Overall Study||0
8869029|NCT01866306|9925541|FG006|NOT COMPLETED|Overall Study||0
8869030|NCT01866319|9925560|FG000|STARTED|Overall Study||278
8869031|NCT01866319|9925561|FG001|STARTED|Overall Study||279
8869032|NCT01866319|9925562|FG002|STARTED|Overall Study||277
8869033|NCT01866319|9925560|FG000|Treated|Overall Study||256
8869034|NCT01866319|9925561|FG001|Treated|Overall Study||278
8869035|NCT01866319|9925562|FG002|Treated|Overall Study||277
8869036|NCT01866319|9925560|FG000|COMPLETED|Overall Study||71
8869037|NCT01866319|9925561|FG001|COMPLETED|Overall Study||101
8869038|NCT01866319|9925562|FG002|COMPLETED|Overall Study||97
8869039|NCT01866319|9925560|FG000|NOT COMPLETED|Overall Study||207
8869040|NCT01866319|9925561|FG001|NOT COMPLETED|Overall Study||178
8869041|NCT01866319|9925562|FG002|NOT COMPLETED|Overall Study||180
8869042|NCT01866410|9925570|FG000|STARTED|Overall Study||37
8869043|NCT01866410|9925570|FG000|COMPLETED|Overall Study||37
8869044|NCT01866410|9925570|FG000|NOT COMPLETED|Overall Study||0
8869045|NCT01866423|9925577|FG000|STARTED|Overall Study||4
8869046|NCT01866423|9925577|FG000|COMPLETED|Overall Study||0
8869047|NCT01866423|9925577|FG000|NOT COMPLETED|Overall Study||4
8869048|NCT01866592|9925581|FG000|STARTED|Overall Study||81
8869049|NCT01866592|9925581|FG000|COMPLETED|Overall Study||58
8869050|NCT01866592|9925581|FG000|NOT COMPLETED|Overall Study||23
8869051|NCT01866826|9925585|FG000|STARTED|Phase I -Initial Randomization - 4 Weeks||23
8869052|NCT01866826|9925586|FG001|STARTED|Phase I -Initial Randomization - 4 Weeks||23
8869053|NCT01866826|9925585|FG000|COMPLETED|Phase I -Initial Randomization - 4 Weeks||22
8869054|NCT01866826|9925586|FG001|COMPLETED|Phase I -Initial Randomization - 4 Weeks||23
8869055|NCT01866826|9925585|FG000|NOT COMPLETED|Phase I -Initial Randomization - 4 Weeks||1
8869056|NCT01866826|9925586|FG001|NOT COMPLETED|Phase I -Initial Randomization - 4 Weeks||0
8869057|NCT01866826|9925585|FG000|STARTED|Wash-Out Period - 4 -6 Weeks||22
8869058|NCT01866826|9925586|FG001|STARTED|Wash-Out Period - 4 -6 Weeks||23
8869059|NCT01866826|9925585|FG000|COMPLETED|Wash-Out Period - 4 -6 Weeks||22
8869060|NCT01866826|9925586|FG001|COMPLETED|Wash-Out Period - 4 -6 Weeks||20
8869061|NCT01866826|9925585|FG000|NOT COMPLETED|Wash-Out Period - 4 -6 Weeks||0
8869062|NCT01866826|9925586|FG001|NOT COMPLETED|Wash-Out Period - 4 -6 Weeks||3
8869063|NCT01866826|9925585|FG000|STARTED|Second Intervention - 4 Weeks||22
8869064|NCT01866826|9925586|FG001|STARTED|Second Intervention - 4 Weeks||20
8869065|NCT01866826|9925585|FG000|COMPLETED|Second Intervention - 4 Weeks||22
8869066|NCT01866826|9925586|FG001|COMPLETED|Second Intervention - 4 Weeks||20
8869067|NCT01866826|9925585|FG000|NOT COMPLETED|Second Intervention - 4 Weeks||0
8869068|NCT01866826|9925586|FG001|NOT COMPLETED|Second Intervention - 4 Weeks||0
8869069|NCT01866839|9925592|FG000|STARTED|Overall Study||40
8869070|NCT01866839|9925592|FG000|COMPLETED|Overall Study||30
8869071|NCT01866839|9925592|FG000|NOT COMPLETED|Overall Study||10
8869072|NCT01866917|9925598|FG000|STARTED|Overall Study||17
8869073|NCT01866917|9925599|FG001|STARTED|Overall Study||18
8869074|NCT01866917|9925598|FG000|COMPLETED|Overall Study||13
8869075|NCT01866917|9925599|FG001|COMPLETED|Overall Study||12
8869076|NCT01866917|9925598|FG000|NOT COMPLETED|Overall Study||4
8869077|NCT01866917|9925599|FG001|NOT COMPLETED|Overall Study||6
8869078|NCT01866943|9925607|FG000|STARTED|Overall Study||19
8869079|NCT01866943|9925608|FG001|STARTED|Overall Study||22
8869080|NCT01866943|9925607|FG000|COMPLETED|Overall Study|Unknown - the only spreadsheet available is de-identified and blinded.|0
8869081|NCT01866943|9925608|FG001|COMPLETED|Overall Study|Unknown - the only spreadsheet available is de-identified and blinded.|0
8869082|NCT01866943|9925607|FG000|NOT COMPLETED|Overall Study||19
8869083|NCT01866943|9925608|FG001|NOT COMPLETED|Overall Study||22
8869084|NCT01867008|9925617|FG000|STARTED|Overall Study||55
8869085|NCT01867008|9925617|FG000|COMPLETED|Overall Study||54
8869086|NCT01867008|9925617|FG000|NOT COMPLETED|Overall Study||1
8869087|NCT01867021|9925623|FG000|STARTED|Overall Study||1452
8869088|NCT01867021|9925624|FG001|STARTED|Overall Study||1450
8869089|NCT01867021|9925623|FG000|COMPLETED|Overall Study||1450
8869090|NCT01867021|9925624|FG001|COMPLETED|Overall Study||1440
8869091|NCT01867021|9925623|FG000|NOT COMPLETED|Overall Study||2
8869092|NCT01867021|9925624|FG001|NOT COMPLETED|Overall Study||10
8869093|NCT01867047|9925637|FG000|STARTED|Overall Study||31
8869094|NCT01867047|9925638|FG001|STARTED|Overall Study||28
8869095|NCT01867047|9925637|FG000|COMPLETED|Overall Study||23
8869096|NCT01867047|9925638|FG001|COMPLETED|Overall Study||23
8869097|NCT01867047|9925637|FG000|NOT COMPLETED|Overall Study||8
8869098|NCT01867047|9925638|FG001|NOT COMPLETED|Overall Study||5
8869099|NCT01867086|9925648|FG000|STARTED|Overall Study||1
8869100|NCT01867086|9925648|FG000|COMPLETED|Overall Study|"Completed means subject had been given all manufactured doses."|0
8869101|NCT01867086|9925648|FG000|NOT COMPLETED|Overall Study||1
8869102|NCT01867164|9925654|FG000|STARTED|Overall Study||81
8869103|NCT01867164|9925655|FG001|STARTED|Overall Study||79
8869104|NCT01867164|9925654|FG000|COMPLETED|Overall Study||81
8869105|NCT01867164|9925655|FG001|COMPLETED|Overall Study||79
8869106|NCT01867164|9925654|FG000|NOT COMPLETED|Overall Study||0
8869107|NCT01867164|9925655|FG001|NOT COMPLETED|Overall Study||0
8869108|NCT01867216|9925668|FG000|STARTED|Overall Study||16
8869109|NCT01867216|9925669|FG001|STARTED|Overall Study||8
8869110|NCT01867216|9925670|FG002|STARTED|Overall Study||8
8869111|NCT01867216|9925671|FG003|STARTED|Overall Study||8
8869112|NCT01867216|9925672|FG004|STARTED|Overall Study||9
8869113|NCT01867216|9925673|FG005|STARTED|Overall Study||8
8869114|NCT01867216|9925674|FG006|STARTED|Overall Study||9
8869115|NCT01867216|9925668|FG000|Received Study Drug|Overall Study||14
8869116|NCT01867216|9925669|FG001|Received Study Drug|Overall Study||8
8869117|NCT01867216|9925670|FG002|Received Study Drug|Overall Study||8
8869118|NCT01867216|9925671|FG003|Received Study Drug|Overall Study||8
8869119|NCT01867216|9925672|FG004|Received Study Drug|Overall Study||9
8869120|NCT01867216|9925673|FG005|Received Study Drug|Overall Study||8
8869121|NCT01867216|9925674|FG006|Received Study Drug|Overall Study||9
8869122|NCT01867216|9925668|FG000|COMPLETED|Overall Study||12
8869123|NCT01867216|9925669|FG001|COMPLETED|Overall Study||8
8869124|NCT01867216|9925670|FG002|COMPLETED|Overall Study||8
8869125|NCT01867216|9925671|FG003|COMPLETED|Overall Study||8
8869126|NCT01867216|9925672|FG004|COMPLETED|Overall Study||8
8952362|NCT02462057|10015393|FG004|NOT COMPLETED|Overall Study||50
8952363|NCT02462070|10015407|FG000|STARTED|Overall Study||135
8952364|NCT02462070|10015408|FG001|STARTED|Overall Study||68
8952365|NCT02462070|10015407|FG000|COMPLETED|Overall Study||112
8952366|NCT02462070|10015408|FG001|COMPLETED|Overall Study||57
8952367|NCT02462070|10015407|FG000|NOT COMPLETED|Overall Study||23
8952368|NCT02462070|10015408|FG001|NOT COMPLETED|Overall Study||11
8952369|NCT02462083|10015414|FG000|STARTED|Overall Study||555
8952370|NCT02462083|10015414|FG000|Safety Population|Overall Study||550
8952371|NCT02462083|10015414|FG000|COMPLETED|Overall Study||136
8952372|NCT02462083|10015414|FG000|NOT COMPLETED|Overall Study||419
8952373|NCT02462122|10015420|FG000|STARTED|Overall Study||141
8952374|NCT02462122|10015421|FG001|STARTED|Overall Study||74
8952375|NCT02462122|10015420|FG000|COMPLETED|Overall Study||120
8952376|NCT02462122|10015421|FG001|COMPLETED|Overall Study||61
8952377|NCT02462122|10015420|FG000|NOT COMPLETED|Overall Study||21
8952378|NCT02462122|10015421|FG001|NOT COMPLETED|Overall Study||13
8952379|NCT02462148|10015430|FG000|STARTED|Overall Study||37
8952380|NCT02462148|10015431|FG001|STARTED|Overall Study||36
8952381|NCT02462148|10015432|FG002|STARTED|Overall Study||12
8952382|NCT02462148|10015430|FG000|COMPLETED|Overall Study||36
8952383|NCT02462148|10015431|FG001|COMPLETED|Overall Study||36
8952384|NCT02462148|10015432|FG002|COMPLETED|Overall Study||12
8952385|NCT02462148|10015430|FG000|NOT COMPLETED|Overall Study||1
8952386|NCT02462148|10015431|FG001|NOT COMPLETED|Overall Study||0
8952387|NCT02462148|10015432|FG002|NOT COMPLETED|Overall Study||0
8869127|NCT01867216|9925673|FG005|COMPLETED|Overall Study||8
8869128|NCT01867216|9925674|FG006|COMPLETED|Overall Study||8
8869129|NCT01867216|9925668|FG000|NOT COMPLETED|Overall Study||4
8952388|NCT02462291|10015445|FG000|STARTED|Overall Study||82
8952389|NCT02462291|10015446|FG001|STARTED|Overall Study||81
8952390|NCT02462291|10015445|FG000|COMPLETED|Overall Study||77
8952391|NCT02462291|10015446|FG001|COMPLETED|Overall Study||75
8952392|NCT02462291|10015445|FG000|NOT COMPLETED|Overall Study||5
8869130|NCT01867216|9925669|FG001|NOT COMPLETED|Overall Study||0
8869131|NCT01867216|9925670|FG002|NOT COMPLETED|Overall Study||0
8869132|NCT01867216|9925671|FG003|NOT COMPLETED|Overall Study||0
8869133|NCT01867216|9925672|FG004|NOT COMPLETED|Overall Study||1
8869134|NCT01867216|9925673|FG005|NOT COMPLETED|Overall Study||0
8869135|NCT01867216|9925674|FG006|NOT COMPLETED|Overall Study||1
8869136|NCT01867294|9925700|FG000|STARTED|Overall Study||9
8869137|NCT01867294|9925701|FG001|STARTED|Overall Study||10
8869138|NCT01867294|9925702|FG002|STARTED|Overall Study||0
8569846|NCT00098813|9601959|FG000|COMPLETED|Overall Study||1
8869139|NCT01867294|9925703|FG003|STARTED|Overall Study||0
8869140|NCT01867294|9925700|FG000|COMPLETED|Overall Study||8
8869141|NCT01867294|9925701|FG001|COMPLETED|Overall Study||9
8869142|NCT01867294|9925702|FG002|COMPLETED|Overall Study||0
8869143|NCT01867294|9925703|FG003|COMPLETED|Overall Study||0
8869144|NCT01867294|9925700|FG000|NOT COMPLETED|Overall Study||1
8869145|NCT01867294|9925701|FG001|NOT COMPLETED|Overall Study||1
8869146|NCT01867294|9925702|FG002|NOT COMPLETED|Overall Study||0
8869147|NCT01867294|9925703|FG003|NOT COMPLETED|Overall Study||0
8869148|NCT01867307|9925713|FG000|STARTED|Overall Study|Started are the treated patients|18
8869149|NCT01867307|9925714|FG001|STARTED|Overall Study|Started are the treated patients|19
8869150|NCT01867307|9925713|FG000|COMPLETED|Overall Study||15
8869151|NCT01867307|9925714|FG001|COMPLETED|Overall Study||16
8869152|NCT01867307|9925713|FG000|NOT COMPLETED|Overall Study||3
8869153|NCT01867307|9925714|FG001|NOT COMPLETED|Overall Study||3
8869154|NCT01867424|9925722|FG000|STARTED|Overall Study||12
8869155|NCT01867424|9925723|FG001|STARTED|Overall Study||12
8869156|NCT01867424|9925722|FG000|COMPLETED|Overall Study||10
8869157|NCT01867424|9925723|FG001|COMPLETED|Overall Study||11
8869158|NCT01867424|9925722|FG000|NOT COMPLETED|Overall Study||2
8869159|NCT01867424|9925723|FG001|NOT COMPLETED|Overall Study||1
8869160|NCT01867515|9925732|FG000|STARTED|Overall Study||13
8869161|NCT01867515|9925733|FG001|STARTED|Overall Study||12
8869162|NCT01867515|9925734|FG002|STARTED|Overall Study||25
8869163|NCT01867515|9925732|FG000|COMPLETED|Overall Study||13
8569847|NCT00098813|9601959|FG000|NOT COMPLETED|Overall Study||19
8569848|NCT00098839|9601965|FG000|STARTED|Overall Study||56
8569849|NCT00098839|9601966|FG001|STARTED|Overall Study||60
8569850|NCT00098839|9601965|FG000|COMPLETED|Overall Study||24
8569851|NCT00098839|9601966|FG001|COMPLETED|Overall Study||27
8869164|NCT01867515|9925733|FG001|COMPLETED|Overall Study||11
8869165|NCT01867515|9925734|FG002|COMPLETED|Overall Study||14
8869166|NCT01867515|9925732|FG000|NOT COMPLETED|Overall Study||0
8869167|NCT01867515|9925733|FG001|NOT COMPLETED|Overall Study||1
8869168|NCT01867515|9925734|FG002|NOT COMPLETED|Overall Study||11
8869169|NCT01867580|9925744|FG000|STARTED|Overall Study||93
8869170|NCT01867580|9925745|FG001|STARTED|Overall Study||88
8869171|NCT01867580|9925744|FG000|COMPLETED|Overall Study||65
8869172|NCT01867580|9925745|FG001|COMPLETED|Overall Study||64
8869173|NCT01867580|9925744|FG000|NOT COMPLETED|Overall Study||28
8869174|NCT01867580|9925745|FG001|NOT COMPLETED|Overall Study||24
8869175|NCT01867632|9925753|FG000|STARTED|Overall Study||65
8869176|NCT01867632|9925754|FG001|STARTED|Overall Study||66
8869177|NCT01867632|9925753|FG000|COMPLETED|Overall Study||65
8869178|NCT01867632|9925754|FG001|COMPLETED|Overall Study||66
8869179|NCT01867632|9925753|FG000|NOT COMPLETED|Overall Study||0
8869180|NCT01867632|9925754|FG001|NOT COMPLETED|Overall Study||0
8923829|NCT02243293|9984479|FG014|STARTED|Overall Study||28
8923830|NCT02243293|9984480|FG015|STARTED|Overall Study||27
8923831|NCT02243293|9984481|FG016|STARTED|Overall Study||40
8923832|NCT02243293|9984482|FG017|STARTED|Overall Study||22
8923833|NCT02243293|9984483|FG018|STARTED|Overall Study||22
8923834|NCT02243293|9984484|FG019|STARTED|Overall Study||48
8923835|NCT02243293|9984485|FG020|STARTED|Overall Study||145
8923836|NCT02243293|9984486|FG021|STARTED|Overall Study||58
8923837|NCT02243293|9984465|FG000|COMPLETED|Overall Study||23
8923838|NCT02243293|9984466|FG001|COMPLETED|Overall Study||23
8923839|NCT02243293|9984467|FG002|COMPLETED|Overall Study||24
8923840|NCT02243293|9984468|FG003|COMPLETED|Overall Study||29
8569852|NCT00098839|9601965|FG000|NOT COMPLETED|Overall Study||32
8569853|NCT00098839|9601966|FG001|NOT COMPLETED|Overall Study||33
8569854|NCT00098865|9601973|FG000|STARTED|Overall Study||15
8569855|NCT00098865|9601973|FG000|COMPLETED|Overall Study||6
8569856|NCT00098865|9601973|FG000|NOT COMPLETED|Overall Study||9
8569857|NCT00098956|9601977|FG000|STARTED|Overall Study||19
8569858|NCT00098956|9601977|FG000|COMPLETED|Overall Study||19
8569859|NCT00098956|9601977|FG000|NOT COMPLETED|Overall Study||0
8569860|NCT00099021|9601981|FG000|STARTED|Overall Study||21
8569861|NCT00099021|9601981|FG000|COMPLETED|Overall Study||21
8569862|NCT00099021|9601981|FG000|NOT COMPLETED|Overall Study||0
8569863|NCT00099047|9601987|FG000|STARTED|Overall Study||11
8569864|NCT00099047|9601988|FG001|STARTED|Overall Study||12
8569865|NCT00099047|9601987|FG000|COMPLETED|Overall Study||11
8569866|NCT00099047|9601988|FG001|COMPLETED|Overall Study||12
8569867|NCT00099047|9601987|FG000|NOT COMPLETED|Overall Study||0
8569868|NCT00099047|9601988|FG001|NOT COMPLETED|Overall Study||0
8569869|NCT00099268|9601996|FG000|STARTED|Overall Study||374
8569870|NCT00099268|9601997|FG001|STARTED|Overall Study||373
8569871|NCT00099268|9601996|FG000|Intent-to-Treat|Overall Study|One patient from each group discontinued without receiving a single dose of study drug.|373
8569872|NCT00099268|9601997|FG001|Intent-to-Treat|Overall Study||372
8569873|NCT00099268|9601996|FG000|COMPLETED|Overall Study|Plus 1 death in the carbidopa/levodopa/entacapone group within 30 days of treatment discontinuation|282
8569874|NCT00099268|9601997|FG001|COMPLETED|Overall Study|Plus 1 death in the carbidopa/levodopa group within 30 days of treatment discontinuation|291
8569875|NCT00099268|9601996|FG000|NOT COMPLETED|Overall Study||92
8569876|NCT00099268|9601997|FG001|NOT COMPLETED|Overall Study||82
8569877|NCT00099359|9602006|FG000|STARTED|Overall Study||581
8569878|NCT00099359|9602007|FG001|STARTED|Overall Study||580
8569879|NCT00099359|9602008|FG002|STARTED|Overall Study||574
8569880|NCT00099359|9602006|FG000|COMPLETED|Overall Study||527
8569881|NCT00099359|9602007|FG001|COMPLETED|Overall Study||515
8569882|NCT00099359|9602008|FG002|COMPLETED|Overall Study||506
8569883|NCT00099359|9602006|FG000|NOT COMPLETED|Overall Study||54
8569884|NCT00099359|9602007|FG001|NOT COMPLETED|Overall Study||65
8569885|NCT00099359|9602008|FG002|NOT COMPLETED|Overall Study||68
8923841|NCT02243293|9984469|FG004|COMPLETED|Overall Study||30
8923842|NCT02243293|9984470|FG005|COMPLETED|Overall Study||31
8923843|NCT02243293|9984471|FG006|COMPLETED|Overall Study||27
8923844|NCT02243293|9984472|FG007|COMPLETED|Overall Study||0
8923845|NCT02243293|9984473|FG008|COMPLETED|Overall Study||0
8923846|NCT02243293|9984474|FG009|COMPLETED|Overall Study||53
8923847|NCT02243293|9984475|FG010|COMPLETED|Overall Study||0
8923848|NCT02243293|9984476|FG011|COMPLETED|Overall Study||50
8923849|NCT02243293|9984477|FG012|COMPLETED|Overall Study||0
8923850|NCT02243293|9984478|FG013|COMPLETED|Overall Study||0
8923851|NCT02243293|9984479|FG014|COMPLETED|Overall Study||27
8569886|NCT00099372|9602028|FG000|STARTED|Enrolled in Extended CARE Trial||104
8569887|NCT00099372|9602029|FG001|STARTED|Enrolled in Extended CARE Trial||111
8569888|NCT00099372|9602028|FG000|COMPLETED|Enrolled in Extended CARE Trial||104
8923852|NCT02243293|9984480|FG015|COMPLETED|Overall Study||26
8869181|NCT01867658|9925760|FG000|STARTED|Overall Study||112
8869182|NCT01867658|9925760|FG000|COMPLETED|Overall Study||103
8869183|NCT01867658|9925760|FG000|NOT COMPLETED|Overall Study||9
8869184|NCT01867671|9925766|FG000|STARTED|Overall Study||96
8869185|NCT01867671|9925767|FG001|STARTED|Overall Study||50
8869186|NCT01867671|9925766|FG000|COMPLETED|Overall Study||67
8869187|NCT01867671|9925767|FG001|COMPLETED|Overall Study||22
8869188|NCT01867671|9925766|FG000|NOT COMPLETED|Overall Study||29
8869189|NCT01867671|9925767|FG001|NOT COMPLETED|Overall Study||28
8869190|NCT01867710|9925777|FG000|STARTED|Overall Study||41
8869191|NCT01867710|9925778|FG001|STARTED|Overall Study||41
8869192|NCT01867710|9925779|FG002|STARTED|Overall Study||40
8952393|NCT02462291|10015446|FG001|NOT COMPLETED|Overall Study||6
8952394|NCT02462382|10015456|FG000|STARTED|Overall Study||24
8952395|NCT02462382|10015457|FG001|STARTED|Overall Study||27
8952396|NCT02462382|10015456|FG000|COMPLETED|Overall Study||24
8952397|NCT02462382|10015457|FG001|COMPLETED|Overall Study||27
8952398|NCT02462382|10015456|FG000|NOT COMPLETED|Overall Study||0
8952399|NCT02462382|10015457|FG001|NOT COMPLETED|Overall Study||0
8952400|NCT02462473|10015463|FG000|STARTED|Overall Study||9
8952401|NCT02462473|10015463|FG000|COMPLETED|Overall Study||5
8952402|NCT02462473|10015463|FG000|NOT COMPLETED|Overall Study||4
8952403|NCT02462486|10015470|FG000|STARTED|Overall Study||316
8952404|NCT02462486|10015471|FG001|STARTED|Overall Study||315
8952405|NCT02462486|10015472|FG002|STARTED|Overall Study||318
8952406|NCT02462486|10015470|FG000|COMPLETED|Overall Study||222
8952407|NCT02462486|10015471|FG001|COMPLETED|Overall Study||223
8952408|NCT02462486|10015472|FG002|COMPLETED|Overall Study||266
8569889|NCT00099372|9602029|FG001|COMPLETED|Enrolled in Extended CARE Trial||111
8569890|NCT00099372|9602028|FG000|NOT COMPLETED|Enrolled in Extended CARE Trial||0
8569891|NCT00099372|9602029|FG001|NOT COMPLETED|Enrolled in Extended CARE Trial||0
8569892|NCT00099372|9602028|FG000|STARTED|Followed up 5 Years After Index Surgery||104
8569893|NCT00099372|9602029|FG001|STARTED|Followed up 5 Years After Index Surgery||111
8569894|NCT00099372|9602028|FG000|COMPLETED|Followed up 5 Years After Index Surgery||89
8569895|NCT00099372|9602029|FG001|COMPLETED|Followed up 5 Years After Index Surgery||92
8569896|NCT00099372|9602028|FG000|NOT COMPLETED|Followed up 5 Years After Index Surgery||15
8569897|NCT00099372|9602029|FG001|NOT COMPLETED|Followed up 5 Years After Index Surgery||19
8569898|NCT00099372|9602028|FG000|STARTED|Followed up 7 Years After Index Surgery||89
8569899|NCT00099372|9602029|FG001|STARTED|Followed up 7 Years After Index Surgery||92
8569900|NCT00099372|9602028|FG000|COMPLETED|Followed up 7 Years After Index Surgery||66
8569901|NCT00099372|9602029|FG001|COMPLETED|Followed up 7 Years After Index Surgery||60
8569902|NCT00099372|9602028|FG000|NOT COMPLETED|Followed up 7 Years After Index Surgery||23
8569903|NCT00099372|9602029|FG001|NOT COMPLETED|Followed up 7 Years After Index Surgery||32
8569904|NCT00099632|9602043|FG000|STARTED|Overall Study||73
8569905|NCT00099632|9602044|FG001|STARTED|Overall Study||68
8569906|NCT00099632|9602045|FG002|STARTED|Overall Study||75
8569907|NCT00099632|9602046|FG003|STARTED|Overall Study||67
8569908|NCT00099632|9602047|FG004|STARTED|Overall Study||71
8569909|NCT00099632|9602048|FG005|STARTED|Overall Study||68
8569910|NCT00099632|9602043|FG000|COMPLETED|Overall Study||72
8952409|NCT02462486|10015470|FG000|NOT COMPLETED|Overall Study||94
8952410|NCT02462486|10015471|FG001|NOT COMPLETED|Overall Study||92
8952411|NCT02462486|10015472|FG002|NOT COMPLETED|Overall Study||52
8569911|NCT00099632|9602044|FG001|COMPLETED|Overall Study||67
8569912|NCT00099632|9602045|FG002|COMPLETED|Overall Study||72
8569913|NCT00099632|9602046|FG003|COMPLETED|Overall Study||66
8569914|NCT00099632|9602047|FG004|COMPLETED|Overall Study||70
8569915|NCT00099632|9602048|FG005|COMPLETED|Overall Study||66
8569916|NCT00099632|9602043|FG000|NOT COMPLETED|Overall Study||1
8569917|NCT00099632|9602044|FG001|NOT COMPLETED|Overall Study||1
8569918|NCT00099632|9602045|FG002|NOT COMPLETED|Overall Study||3
8569919|NCT00099632|9602046|FG003|NOT COMPLETED|Overall Study||1
8569920|NCT00099632|9602047|FG004|NOT COMPLETED|Overall Study||1
8569921|NCT00099632|9602048|FG005|NOT COMPLETED|Overall Study||2
8569922|NCT00099983|9602064|FG000|STARTED|Overall Study||147
8569923|NCT00099983|9602065|FG001|STARTED|Overall Study||149
8569924|NCT00099983|9602064|FG000|COMPLETED|Overall Study||123
8569925|NCT00099983|9602065|FG001|COMPLETED|Overall Study||124
8569926|NCT00099983|9602064|FG000|NOT COMPLETED|Overall Study||24
8869193|NCT01867710|9925780|FG003|STARTED|Overall Study||42
8952412|NCT02462720|10015480|FG000|STARTED|Part 1||18
8952413|NCT02462720|10015481|FG001|STARTED|Part 1||17
8952414|NCT02462720|10015480|FG000|COMPLETED|Part 1||18
8952415|NCT02462720|10015481|FG001|COMPLETED|Part 1||17
8952416|NCT02462720|10015480|FG000|NOT COMPLETED|Part 1||0
8952417|NCT02462720|10015481|FG001|NOT COMPLETED|Part 1||0
8952418|NCT02462720|10015480|FG000|STARTED|Part 2||18
8869194|NCT01867710|9925777|FG000|Treated|Overall Study||41
8869195|NCT01867710|9925778|FG001|Treated|Overall Study||41
8869196|NCT01867710|9925779|FG002|Treated|Overall Study||39
8952419|NCT02462720|10015481|FG001|STARTED|Part 2||17
8952420|NCT02462720|10015480|FG000|COMPLETED|Part 2||17
8952421|NCT02462720|10015481|FG001|COMPLETED|Part 2||16
8952422|NCT02462720|10015480|FG000|NOT COMPLETED|Part 2||1
8952423|NCT02462720|10015481|FG001|NOT COMPLETED|Part 2||1
8952424|NCT02462759|10015491|FG000|STARTED|Part 1: Double Blind||7
8952425|NCT02462759|10015492|FG001|STARTED|Part 1: Double Blind||14
8952426|NCT02462759|10015493|FG002|STARTED|Part 1: Double Blind||0
8952427|NCT02462759|10015491|FG000|COMPLETED|Part 1: Double Blind||6
8952428|NCT02462759|10015492|FG001|COMPLETED|Part 1: Double Blind||14
8569927|NCT00099983|9602065|FG001|NOT COMPLETED|Overall Study||25
8569928|NCT00100048|9602076|FG000|STARTED|Cohort I-Monotherapy Phase 10 Days||7
8569929|NCT00100048|9602077|FG001|STARTED|Cohort I-Monotherapy Phase 10 Days||7
8569930|NCT00100048|9602078|FG002|STARTED|Cohort I-Monotherapy Phase 10 Days||6
8569931|NCT00100048|9602079|FG003|STARTED|Cohort I-Monotherapy Phase 10 Days||8
8569932|NCT00100048|9602080|FG004|STARTED|Cohort I-Monotherapy Phase 10 Days||7
8569933|NCT00100048|9602081|FG005|STARTED|Cohort I-Monotherapy Phase 10 Days|participants only assigned Efavirenz 600 mg q.h.s in Cohort II Combined-Combination Therapy Phase|0
8569934|NCT00100048|9602076|FG000|Treated|Cohort I-Monotherapy Phase 10 Days||7
8569935|NCT00100048|9602077|FG001|Treated|Cohort I-Monotherapy Phase 10 Days||7
8569936|NCT00100048|9602078|FG002|Treated|Cohort I-Monotherapy Phase 10 Days||6
8569937|NCT00100048|9602079|FG003|Treated|Cohort I-Monotherapy Phase 10 Days||8
8569938|NCT00100048|9602080|FG004|Treated|Cohort I-Monotherapy Phase 10 Days||7
8569939|NCT00100048|9602081|FG005|Treated|Cohort I-Monotherapy Phase 10 Days||0
8577564|NCT00159263|9610313|FG003|NOT COMPLETED|Sixth Intervention||0
8630983|NCT00537407|9670824|FG004|COMPLETED|Part 2 Weeks 5-48 or 72||3
8630984|NCT00537407|9670820|FG000|NOT COMPLETED|Part 2 Weeks 5-48 or 72||8
8869197|NCT01867710|9925780|FG003|Treated|Overall Study||42
8952429|NCT02462759|10015493|FG002|COMPLETED|Part 1: Double Blind||0
8952430|NCT02462759|10015491|FG000|NOT COMPLETED|Part 1: Double Blind||1
8869198|NCT01867710|9925777|FG000|COMPLETED|Overall Study||0
8869199|NCT01867710|9925778|FG001|COMPLETED|Overall Study||0
8869200|NCT01867710|9925779|FG002|COMPLETED|Overall Study||0
8869201|NCT01867710|9925780|FG003|COMPLETED|Overall Study||0
8869202|NCT01867710|9925777|FG000|NOT COMPLETED|Overall Study||41
8869203|NCT01867710|9925778|FG001|NOT COMPLETED|Overall Study||41
8869204|NCT01867710|9925779|FG002|NOT COMPLETED|Overall Study||40
8869205|NCT01867710|9925780|FG003|NOT COMPLETED|Overall Study||42
8869206|NCT01868009|9925790|FG000|STARTED|Period 1 (5-9 Days)||143
8869207|NCT01868009|9925791|FG001|STARTED|Period 1 (5-9 Days)||144
8869208|NCT01868009|9925790|FG000|COMPLETED|Period 1 (5-9 Days)||143
8869209|NCT01868009|9925791|FG001|COMPLETED|Period 1 (5-9 Days)||142
8869210|NCT01868009|9925790|FG000|NOT COMPLETED|Period 1 (5-9 Days)||0
8869211|NCT01868009|9925791|FG001|NOT COMPLETED|Period 1 (5-9 Days)||2
8869212|NCT01868009|9925790|FG000|STARTED|Period 2 (5-9 Days)||143
8869213|NCT01868009|9925791|FG001|STARTED|Period 2 (5-9 Days)||142
8869214|NCT01868009|9925790|FG000|COMPLETED|Period 2 (5-9 Days)||141
8869215|NCT01868009|9925791|FG001|COMPLETED|Period 2 (5-9 Days)||142
8869216|NCT01868009|9925790|FG000|NOT COMPLETED|Period 2 (5-9 Days)||2
8869217|NCT01868009|9925791|FG001|NOT COMPLETED|Period 2 (5-9 Days)||0
8869218|NCT01868022|9925806|FG000|STARTED|Overall Study||3
8869219|NCT01868022|9925807|FG001|STARTED|Overall Study||3
8869220|NCT01868022|9925808|FG002|STARTED|Overall Study||14
8869221|NCT01868022|9925809|FG003|STARTED|Overall Study||3
8869222|NCT01868022|9925810|FG004|STARTED|Overall Study||3
8869223|NCT01868022|9925811|FG005|STARTED|Overall Study||3
8869224|NCT01868022|9925812|FG006|STARTED|Overall Study||3
8869225|NCT01868022|9925813|FG007|STARTED|Overall Study||25
8869226|NCT01868022|9925814|FG008|STARTED|Overall Study||8
8869227|NCT01868022|9925806|FG000|COMPLETED|Overall Study||3
8869228|NCT01868022|9925807|FG001|COMPLETED|Overall Study||3
8869229|NCT01868022|9925808|FG002|COMPLETED|Overall Study||13
8869230|NCT01868022|9925809|FG003|COMPLETED|Overall Study||2
8869231|NCT01868022|9925810|FG004|COMPLETED|Overall Study||1
8869232|NCT01868022|9925811|FG005|COMPLETED|Overall Study||2
8869233|NCT01868022|9925812|FG006|COMPLETED|Overall Study||3
8869234|NCT01868022|9925813|FG007|COMPLETED|Overall Study||16
8869235|NCT01868022|9925814|FG008|COMPLETED|Overall Study||6
8869236|NCT01868022|9925806|FG000|NOT COMPLETED|Overall Study||0
8869237|NCT01868022|9925807|FG001|NOT COMPLETED|Overall Study||0
8869238|NCT01868022|9925808|FG002|NOT COMPLETED|Overall Study||1
8869239|NCT01868022|9925809|FG003|NOT COMPLETED|Overall Study||1
8869240|NCT01868022|9925810|FG004|NOT COMPLETED|Overall Study||2
8869241|NCT01868022|9925811|FG005|NOT COMPLETED|Overall Study||1
8869242|NCT01868022|9925812|FG006|NOT COMPLETED|Overall Study||0
8952431|NCT02462759|10015492|FG001|NOT COMPLETED|Part 1: Double Blind||0
8869243|NCT01868022|9925813|FG007|NOT COMPLETED|Overall Study||9
8869244|NCT01868022|9925814|FG008|NOT COMPLETED|Overall Study||2
8869245|NCT01868035|9925840|FG000|STARTED|Overall Study||15
8630985|NCT00537407|9670821|FG001|NOT COMPLETED|Part 2 Weeks 5-48 or 72||8
8630986|NCT00537407|9670822|FG002|NOT COMPLETED|Part 2 Weeks 5-48 or 72||9
8630987|NCT00537407|9670823|FG003|NOT COMPLETED|Part 2 Weeks 5-48 or 72||6
8630988|NCT00537407|9670824|FG004|NOT COMPLETED|Part 2 Weeks 5-48 or 72||7
8630989|NCT00537485|9670842|FG000|STARTED|Overall Study||90
8630990|NCT00537485|9670843|FG001|STARTED|Overall Study||90
8630991|NCT00537485|9670842|FG000|COMPLETED|Overall Study||75
8630992|NCT00537485|9670843|FG001|COMPLETED|Overall Study||80
8630993|NCT00537485|9670842|FG000|NOT COMPLETED|Overall Study||15
8630994|NCT00537485|9670843|FG001|NOT COMPLETED|Overall Study||10
8630995|NCT00537511|9670849|FG000|STARTED|Treatment Period (Combination)||22
8630996|NCT00537511|9670849|FG000|Intent-to-Treat (ITT) Populaton|Treatment Period (Combination)|ITT = all participants enrolled in the study.|22
8630997|NCT00537511|9670849|FG000|Safety Population|Treatment Period (Combination)|Safety = All participants who took ≥1 dose of study treatment.|22
8630998|NCT00537511|9670849|FG000|COMPLETED|Treatment Period (Combination)||17
8630999|NCT00537511|9670849|FG000|NOT COMPLETED|Treatment Period (Combination)||5
8631000|NCT00537511|9670849|FG000|STARTED|Extension Period (Combination)||17
8631001|NCT00537511|9670849|FG000|COMPLETED|Extension Period (Combination)||11
8631002|NCT00537511|9670849|FG000|NOT COMPLETED|Extension Period (Combination)||6
8631003|NCT00537511|9670849|FG000|STARTED|Recovery Period (Monotherapy)||11
8725653|NCT01032733|9772965|FG000|COMPLETED|Overall Study||16
8869246|NCT01868035|9925840|FG000|COMPLETED|Overall Study|These participants completed 10 years of follow-up.|8
8869247|NCT01868035|9925840|FG000|NOT COMPLETED|Overall Study||7
8869248|NCT01868074|9925846|FG000|STARTED|Overall Study||36
8869249|NCT01868074|9925847|FG001|STARTED|Overall Study||36
8869250|NCT01868074|9925846|FG000|COMPLETED|Overall Study||29
8869251|NCT01868074|9925847|FG001|COMPLETED|Overall Study||32
8869252|NCT01868074|9925846|FG000|NOT COMPLETED|Overall Study||7
8869253|NCT01868074|9925847|FG001|NOT COMPLETED|Overall Study||4
8869254|NCT01868165|9925853|FG000|STARTED|Overall Study||337
8869255|NCT01868165|9925853|FG000|COMPLETED|Overall Study||292
8869256|NCT01868165|9925853|FG000|NOT COMPLETED|Overall Study||45
8869257|NCT01868243|9925859|FG000|STARTED|Overall Study||15
8869258|NCT01868243|9925860|FG001|STARTED|Overall Study||12
8869259|NCT01868243|9925859|FG000|COMPLETED|Overall Study||15
8869260|NCT01868243|9925860|FG001|COMPLETED|Overall Study||11
8869261|NCT01868243|9925859|FG000|NOT COMPLETED|Overall Study||0
8869262|NCT01868243|9925860|FG001|NOT COMPLETED|Overall Study||1
8869263|NCT01868334|9925870|FG000|STARTED|Year 1 RCCT Study||13186
8869264|NCT01868334|9925871|FG001|STARTED|Year 1 RCCT Study||17185
8869265|NCT01868334|9925872|FG002|STARTED|Year 1 RCCT Study||19274
8869266|NCT01868334|9925873|FG003|STARTED|Year 1 RCCT Study||20904
8869267|NCT01868334|9925870|FG000|COMPLETED|Year 1 RCCT Study||13186
8869268|NCT01868334|9925871|FG001|COMPLETED|Year 1 RCCT Study||17185
8869269|NCT01868334|9925872|FG002|COMPLETED|Year 1 RCCT Study||19274
8869270|NCT01868334|9925873|FG003|COMPLETED|Year 1 RCCT Study||20904
8869271|NCT01868334|9925870|FG000|NOT COMPLETED|Year 1 RCCT Study||0
8869272|NCT01868334|9925871|FG001|NOT COMPLETED|Year 1 RCCT Study||0
8869273|NCT01868334|9925872|FG002|NOT COMPLETED|Year 1 RCCT Study||0
8869274|NCT01868334|9925873|FG003|NOT COMPLETED|Year 1 RCCT Study||0
8869275|NCT01868334|9925870|FG000|STARTED|Year 2 Pre-post Study|Reflects: control sites from Year 1 (N=8) and Year 1 Intervention sites who continued in Y2 (N=4)|22324
8869276|NCT01868334|9925871|FG001|STARTED|Year 2 Pre-post Study|Reflects: the six Year 1 Intervention sites who chose not to actively engage Year 2|8047
8869277|NCT01868334|9925872|FG002|STARTED|Year 2 Pre-post Study|Reflects: Year 1 Control sites who became active in the intervention during Year 2|20904
8869278|NCT01868334|9925873|FG003|STARTED|Year 2 Pre-post Study|Reflects: Year 1 Intervention sites who chose not to actively engage Year 2|19274
8869279|NCT01868334|9925870|FG000|COMPLETED|Year 2 Pre-post Study||22324
8869280|NCT01868334|9925871|FG001|COMPLETED|Year 2 Pre-post Study||8047
8869281|NCT01868334|9925872|FG002|COMPLETED|Year 2 Pre-post Study||20904
8869282|NCT01868334|9925873|FG003|COMPLETED|Year 2 Pre-post Study||19274
8869283|NCT01868334|9925870|FG000|NOT COMPLETED|Year 2 Pre-post Study||0
8869284|NCT01868334|9925871|FG001|NOT COMPLETED|Year 2 Pre-post Study||0
8869285|NCT01868334|9925872|FG002|NOT COMPLETED|Year 2 Pre-post Study||0
8869286|NCT01868334|9925873|FG003|NOT COMPLETED|Year 2 Pre-post Study||0
8869287|NCT01868425|9925913|FG000|STARTED|Overall Study||55
8952432|NCT02462759|10015493|FG002|NOT COMPLETED|Part 1: Double Blind||0
8952433|NCT02462759|10015491|FG000|STARTED|Part 2: Open-Label Phase||0
8952434|NCT02462759|10015492|FG001|STARTED|Part 2: Open-Label Phase||0
8952435|NCT02462759|10015493|FG002|STARTED|Part 2: Open-Label Phase||20
8952436|NCT02462759|10015491|FG000|COMPLETED|Part 2: Open-Label Phase||0
8952437|NCT02462759|10015492|FG001|COMPLETED|Part 2: Open-Label Phase||0
8952438|NCT02462759|10015493|FG002|COMPLETED|Part 2: Open-Label Phase||20
8952439|NCT02462759|10015491|FG000|NOT COMPLETED|Part 2: Open-Label Phase||0
8952440|NCT02462759|10015492|FG001|NOT COMPLETED|Part 2: Open-Label Phase||0
8952441|NCT02462759|10015493|FG002|NOT COMPLETED|Part 2: Open-Label Phase||0
8952442|NCT02462928|10015507|FG000|STARTED|Overall Study||314
8952443|NCT02462928|10015508|FG001|STARTED|Overall Study||313
8725654|NCT01032733|9772966|FG001|COMPLETED|Overall Study||16
8952444|NCT02462928|10015509|FG002|STARTED|Overall Study||312
8952445|NCT02462928|10015507|FG000|COMPLETED|Overall Study||224
8952446|NCT02462928|10015508|FG001|COMPLETED|Overall Study||221
8952447|NCT02462928|10015509|FG002|COMPLETED|Overall Study||255
8952448|NCT02462928|10015507|FG000|NOT COMPLETED|Overall Study||90
8631004|NCT00537511|9670849|FG000|COMPLETED|Recovery Period (Monotherapy)||3
8631005|NCT00537511|9670849|FG000|NOT COMPLETED|Recovery Period (Monotherapy)||8
8869288|NCT01868425|9925914|FG001|STARTED|Overall Study||57
8869289|NCT01868425|9925913|FG000|COMPLETED|Overall Study||55
8869290|NCT01868425|9925914|FG001|COMPLETED|Overall Study||57
8869291|NCT01868425|9925913|FG000|NOT COMPLETED|Overall Study||0
8631006|NCT00537511|9670849|FG000|STARTED|Maintenance Phase (Monotherapy)||8
8631007|NCT00537511|9670849|FG000|COMPLETED|Maintenance Phase (Monotherapy)||0
8631008|NCT00537511|9670849|FG000|NOT COMPLETED|Maintenance Phase (Monotherapy)||8
8631009|NCT00537576|9670872|FG000|STARTED|Overall Study||3
8631010|NCT00537576|9670873|FG001|STARTED|Overall Study||3
8869292|NCT01868425|9925914|FG001|NOT COMPLETED|Overall Study||0
8869293|NCT01868477|9925922|FG000|STARTED|Overall Study||12
8869294|NCT01868477|9925923|FG001|STARTED|Overall Study||11
8869295|NCT01868477|9925922|FG000|Switched to EPO+DFX|Overall Study||5
8869296|NCT01868477|9925923|FG001|Switched to EPO+DFX|Overall Study||0
8869297|NCT01868477|9925922|FG000|Not Switched to EPO+DFX|Overall Study||7
8869298|NCT01868477|9925923|FG001|Not Switched to EPO+DFX|Overall Study||0
8869299|NCT01868477|9925922|FG000|COMPLETED|Overall Study||8
8869300|NCT01868477|9925923|FG001|COMPLETED|Overall Study||6
8869301|NCT01868477|9925922|FG000|NOT COMPLETED|Overall Study||4
8869302|NCT01868477|9925923|FG001|NOT COMPLETED|Overall Study||5
8869303|NCT01868503|9925936|FG000|STARTED|Overall Study||7
8869304|NCT01868503|9925936|FG000|COMPLETED|Overall Study||5
8869305|NCT01868503|9925936|FG000|NOT COMPLETED|Overall Study||2
8869306|NCT01868542|9925944|FG000|STARTED|Overall Study||23
8869307|NCT01868542|9925945|FG001|STARTED|Overall Study||23
8869308|NCT01868542|9925944|FG000|COMPLETED|Overall Study||23
8869309|NCT01868542|9925945|FG001|COMPLETED|Overall Study||21
8869310|NCT01868542|9925944|FG000|NOT COMPLETED|Overall Study||0
8869311|NCT01868542|9925945|FG001|NOT COMPLETED|Overall Study||2
8869312|NCT01868594|9925953|FG000|STARTED|Overall Study||76
8869313|NCT01868594|9925954|FG001|STARTED|Overall Study||75
8869314|NCT01868594|9925953|FG000|COMPLETED|Overall Study||72
8869315|NCT01868594|9925954|FG001|COMPLETED|Overall Study||72
8869316|NCT01868594|9925953|FG000|NOT COMPLETED|Overall Study||4
8869317|NCT01868594|9925954|FG001|NOT COMPLETED|Overall Study||3
8869318|NCT01868633|9925964|FG000|STARTED|Overall Study||26
8869319|NCT01868633|9925965|FG001|STARTED|Overall Study||26
8869320|NCT01868633|9925964|FG000|COMPLETED|Overall Study||26
8869321|NCT01868633|9925965|FG001|COMPLETED|Overall Study||26
8869322|NCT01868633|9925964|FG000|NOT COMPLETED|Overall Study||0
8869323|NCT01868633|9925965|FG001|NOT COMPLETED|Overall Study||0
8869324|NCT01868646|9925973|FG000|STARTED|Overall Study||76
8869325|NCT01868646|9925974|FG001|STARTED|Overall Study||72
8869326|NCT01868646|9925973|FG000|COMPLETED|Overall Study||73
8869327|NCT01868646|9925974|FG001|COMPLETED|Overall Study||67
8869328|NCT01868646|9925973|FG000|NOT COMPLETED|Overall Study||3
8869329|NCT01868646|9925974|FG001|NOT COMPLETED|Overall Study||5
8869330|NCT01868776|9925982|FG000|STARTED|Overall Study||50
8869331|NCT01868776|9925983|FG001|STARTED|Overall Study||50
8869332|NCT01868776|9925982|FG000|COMPLETED|Overall Study||50
8869333|NCT01868776|9925983|FG001|COMPLETED|Overall Study||50
8869334|NCT01868776|9925982|FG000|NOT COMPLETED|Overall Study||0
8869335|NCT01868776|9925983|FG001|NOT COMPLETED|Overall Study||0
8869336|NCT01868789|9925991|FG000|STARTED|Overall Study||9
8869337|NCT01868789|9925992|FG001|STARTED|Overall Study||14
8869338|NCT01868789|9925991|FG000|COMPLETED|Overall Study||7
8869339|NCT01868789|9925992|FG001|COMPLETED|Overall Study||12
8869340|NCT01868789|9925991|FG000|NOT COMPLETED|Overall Study||2
8869341|NCT01868789|9925992|FG001|NOT COMPLETED|Overall Study||2
8869342|NCT01868893|9925998|FG000|STARTED|Overall Study||20
8869343|NCT01868893|9925998|FG000|COMPLETED|Overall Study||0
8869344|NCT01868893|9925998|FG000|NOT COMPLETED|Overall Study||20
8869345|NCT01868997|9926006|FG000|STARTED|Overall Study|randomized and treated|45
8869346|NCT01868997|9926007|FG001|STARTED|Overall Study|randomized and treated|42
8869347|NCT01868997|9926006|FG000|COMPLETED|Overall Study||38
8869348|NCT01868997|9926007|FG001|COMPLETED|Overall Study||36
8869349|NCT01868997|9926006|FG000|NOT COMPLETED|Overall Study||7
8869350|NCT01868997|9926007|FG001|NOT COMPLETED|Overall Study||6
8869351|NCT01869075|9926019|FG000|STARTED|Phase 0 (Baseline)|Phase 0 was the baseline phase. No intervention had been started.|0
8869352|NCT01869075|9926020|FG001|STARTED|Phase 0 (Baseline)||418
8869353|NCT01869075|9926021|FG002|STARTED|Phase 0 (Baseline)|Phase 0 was the baseline phase. No intervention had been started.|0
8869354|NCT01869075|9926022|FG003|STARTED|Phase 0 (Baseline)||416
8869355|NCT01869075|9926023|FG004|STARTED|Phase 0 (Baseline)|Phase 0 was the baseline phase. No intervention had been started.|0
8869356|NCT01869075|9926024|FG005|STARTED|Phase 0 (Baseline)||341
8869357|NCT01869075|9926019|FG000|COMPLETED|Phase 0 (Baseline)||0
8869358|NCT01869075|9926020|FG001|COMPLETED|Phase 0 (Baseline)||418
8869359|NCT01869075|9926021|FG002|COMPLETED|Phase 0 (Baseline)||0
8869360|NCT01869075|9926022|FG003|COMPLETED|Phase 0 (Baseline)||416
8869361|NCT01869075|9926023|FG004|COMPLETED|Phase 0 (Baseline)||0
8869362|NCT01869075|9926024|FG005|COMPLETED|Phase 0 (Baseline)||341
8631011|NCT00537576|9670874|FG002|STARTED|Overall Study||3
8631012|NCT00537576|9670875|FG003|STARTED|Overall Study||1
8869363|NCT01869075|9926019|FG000|NOT COMPLETED|Phase 0 (Baseline)||0
8869364|NCT01869075|9926020|FG001|NOT COMPLETED|Phase 0 (Baseline)||0
8869365|NCT01869075|9926021|FG002|NOT COMPLETED|Phase 0 (Baseline)||0
8869366|NCT01869075|9926022|FG003|NOT COMPLETED|Phase 0 (Baseline)||0
8869367|NCT01869075|9926023|FG004|NOT COMPLETED|Phase 0 (Baseline)||0
8869368|NCT01869075|9926024|FG005|NOT COMPLETED|Phase 0 (Baseline)||0
8923853|NCT02243293|9984481|FG016|COMPLETED|Overall Study||37
8869369|NCT01869075|9926019|FG000|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|45
8869370|NCT01869075|9926020|FG001|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|75
8869371|NCT01869075|9926021|FG002|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|45
8869372|NCT01869075|9926022|FG003|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|75
8869373|NCT01869075|9926023|FG004|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|30
8869374|NCT01869075|9926024|FG005|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|90
8869375|NCT01869075|9926019|FG000|COMPLETED|Phase 1||45
8869376|NCT01869075|9926020|FG001|COMPLETED|Phase 1||75
8869377|NCT01869075|9926021|FG002|COMPLETED|Phase 1||45
8869378|NCT01869075|9926022|FG003|COMPLETED|Phase 1||75
8869379|NCT01869075|9926023|FG004|COMPLETED|Phase 1||30
8869380|NCT01869075|9926024|FG005|COMPLETED|Phase 1||90
8869381|NCT01869075|9926019|FG000|NOT COMPLETED|Phase 1||0
8869382|NCT01869075|9926020|FG001|NOT COMPLETED|Phase 1||0
8869383|NCT01869075|9926021|FG002|NOT COMPLETED|Phase 1||0
8869384|NCT01869075|9926022|FG003|NOT COMPLETED|Phase 1||0
8869385|NCT01869075|9926023|FG004|NOT COMPLETED|Phase 1||0
8869386|NCT01869075|9926024|FG005|NOT COMPLETED|Phase 1||0
8869387|NCT01869075|9926019|FG000|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|90
8869388|NCT01869075|9926020|FG001|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|30
8869389|NCT01869075|9926021|FG002|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|75
8869390|NCT01869075|9926022|FG003|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|45
8869391|NCT01869075|9926023|FG004|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|75
8869392|NCT01869075|9926024|FG005|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|45
8869393|NCT01869075|9926019|FG000|COMPLETED|Phase 2||90
8869394|NCT01869075|9926020|FG001|COMPLETED|Phase 2||30
8869395|NCT01869075|9926021|FG002|COMPLETED|Phase 2||75
8869396|NCT01869075|9926022|FG003|COMPLETED|Phase 2||45
8869397|NCT01869075|9926023|FG004|COMPLETED|Phase 2||75
8869398|NCT01869075|9926024|FG005|COMPLETED|Phase 2||45
8869399|NCT01869075|9926019|FG000|NOT COMPLETED|Phase 2||0
8869400|NCT01869075|9926020|FG001|NOT COMPLETED|Phase 2||0
8869401|NCT01869075|9926021|FG002|NOT COMPLETED|Phase 2||0
8869402|NCT01869075|9926022|FG003|NOT COMPLETED|Phase 2||0
8869403|NCT01869075|9926023|FG004|NOT COMPLETED|Phase 2||0
8869404|NCT01869075|9926024|FG005|NOT COMPLETED|Phase 2||0
8869405|NCT01869192|9926040|FG000|STARTED|Preoperative Chemotherapy to Surgery||37
8869406|NCT01869192|9926041|FG001|STARTED|Preoperative Chemotherapy to Surgery||35
8869407|NCT01869192|9926040|FG000|COMPLETED|Preoperative Chemotherapy to Surgery||35
8869408|NCT01869192|9926041|FG001|COMPLETED|Preoperative Chemotherapy to Surgery|one never got treatment on study|34
8869409|NCT01869192|9926040|FG000|NOT COMPLETED|Preoperative Chemotherapy to Surgery||2
8869410|NCT01869192|9926041|FG001|NOT COMPLETED|Preoperative Chemotherapy to Surgery||1
8869411|NCT01869192|9926040|FG000|STARTED|Postoperative Chemotherapy|3 did not start postop chemotherapy|32
8869412|NCT01869192|9926041|FG001|STARTED|Postoperative Chemotherapy||33
8869413|NCT01869192|9926040|FG000|COMPLETED|Postoperative Chemotherapy||32
8869414|NCT01869192|9926041|FG001|COMPLETED|Postoperative Chemotherapy||31
8869415|NCT01869192|9926040|FG000|NOT COMPLETED|Postoperative Chemotherapy||0
8869416|NCT01869192|9926041|FG001|NOT COMPLETED|Postoperative Chemotherapy||2
8869417|NCT01869348|9926049|FG000|STARTED|Overall Study||20
8869418|NCT01869348|9926050|FG001|STARTED|Overall Study||20
8869419|NCT01869348|9926049|FG000|COMPLETED|Overall Study||19
8869420|NCT01869348|9926050|FG001|COMPLETED|Overall Study||19
8869421|NCT01869348|9926049|FG000|NOT COMPLETED|Overall Study||1
8869422|NCT01869348|9926050|FG001|NOT COMPLETED|Overall Study||1
8869423|NCT01869374|9926058|FG000|STARTED|Overall Study||9
8869424|NCT01869374|9926059|FG001|STARTED|Overall Study||9
8869425|NCT01869374|9926058|FG000|COMPLETED|Overall Study||9
8569940|NCT00100048|9602076|FG000|COMPLETED|Cohort I-Monotherapy Phase 10 Days|7 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|7
8569941|NCT00100048|9602077|FG001|COMPLETED|Cohort I-Monotherapy Phase 10 Days|7 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|7
8869426|NCT01869374|9926059|FG001|COMPLETED|Overall Study||8
8869427|NCT01869374|9926058|FG000|NOT COMPLETED|Overall Study||0
8869428|NCT01869374|9926059|FG001|NOT COMPLETED|Overall Study||1
8869429|NCT01869439|9926065|FG000|STARTED|Overall Study||40
8869430|NCT01869439|9926065|FG000|COMPLETED|Overall Study||40
8869431|NCT01869439|9926065|FG000|NOT COMPLETED|Overall Study||0
8869432|NCT01869634|9926071|FG000|STARTED|Overall Study||20
8869433|NCT01869634|9926072|FG001|STARTED|Overall Study||17
8869434|NCT01869634|9926071|FG000|COMPLETED|Overall Study||18
8869435|NCT01869634|9926072|FG001|COMPLETED|Overall Study||17
8869436|NCT01869634|9926071|FG000|NOT COMPLETED|Overall Study||2
8869437|NCT01869634|9926072|FG001|NOT COMPLETED|Overall Study||0
8869438|NCT01869647|9926081|FG000|STARTED|Overall Study||66
8869439|NCT01869647|9926082|FG001|STARTED|Overall Study||136
8869440|NCT01869647|9926083|FG002|STARTED|Overall Study||62
8869441|NCT01869647|9926081|FG000|COMPLETED|Overall Study||65
8869442|NCT01869647|9926082|FG001|COMPLETED|Overall Study||130
8869443|NCT01869647|9926083|FG002|COMPLETED|Overall Study||62
8869444|NCT01869647|9926081|FG000|NOT COMPLETED|Overall Study||1
8869445|NCT01869647|9926082|FG001|NOT COMPLETED|Overall Study||6
8869446|NCT01869647|9926083|FG002|NOT COMPLETED|Overall Study||0
8869447|NCT01869686|9926091|FG000|STARTED|Overall Study||12
8869448|NCT01869686|9926091|FG000|COMPLETED|Overall Study||12
8869449|NCT01869686|9926091|FG000|NOT COMPLETED|Overall Study||0
8869450|NCT01869699|9926097|FG000|STARTED|Overall Study||21
8869451|NCT01869699|9926098|FG001|STARTED|Overall Study||20
8869452|NCT01869699|9926097|FG000|COMPLETED|Overall Study||20
8869453|NCT01869699|9926098|FG001|COMPLETED|Overall Study||20
8869454|NCT01869699|9926097|FG000|NOT COMPLETED|Overall Study||1
8869455|NCT01869699|9926098|FG001|NOT COMPLETED|Overall Study||0
8869456|NCT01869725|9926104|FG000|STARTED|Overall Study||68
8869457|NCT01869725|9926104|FG000|COMPLETED|Overall Study||64
8869458|NCT01869725|9926104|FG000|NOT COMPLETED|Overall Study||4
8869459|NCT01869764|9926110|FG000|STARTED|Overall Study||28
8869460|NCT01869764|9926111|FG001|STARTED|Overall Study||29
8869461|NCT01869764|9926110|FG000|COMPLETED|Overall Study||28
8869462|NCT01869764|9926111|FG001|COMPLETED|Overall Study||27
8869463|NCT01869764|9926110|FG000|NOT COMPLETED|Overall Study||0
8869464|NCT01869764|9926111|FG001|NOT COMPLETED|Overall Study||2
8869465|NCT01869777|9926117|FG000|STARTED|Overall Study||102
8869466|NCT01869777|9926117|FG000|COMPLETED|Overall Study||101
8869467|NCT01869777|9926117|FG000|NOT COMPLETED|Overall Study||1
8869468|NCT01869959|9926125|FG000|STARTED|Randomization Period||0
8869469|NCT01869959|9926126|FG001|STARTED|Randomization Period||0
8869470|NCT01869959|9926127|FG002|STARTED|Randomization Period||0
8869471|NCT01869959|9926128|FG003|STARTED|Randomization Period||0
8869472|NCT01869959|9926129|FG004|STARTED|Randomization Period||47
8869473|NCT01869959|9926125|FG000|COMPLETED|Randomization Period||0
8869474|NCT01869959|9926126|FG001|COMPLETED|Randomization Period||0
8869475|NCT01869959|9926127|FG002|COMPLETED|Randomization Period||0
8869476|NCT01869959|9926128|FG003|COMPLETED|Randomization Period||0
8869477|NCT01869959|9926129|FG004|COMPLETED|Randomization Period|One participant discontinued after randomization but did not receive study drug.|46
8869478|NCT01869959|9926125|FG000|NOT COMPLETED|Randomization Period||0
8869479|NCT01869959|9926126|FG001|NOT COMPLETED|Randomization Period||0
8869480|NCT01869959|9926127|FG002|NOT COMPLETED|Randomization Period||0
8869481|NCT01869959|9926128|FG003|NOT COMPLETED|Randomization Period||0
8869482|NCT01869959|9926129|FG004|NOT COMPLETED|Randomization Period||1
8869483|NCT01869959|9926125|FG000|STARTED|Treatment Period||11
8869484|NCT01869959|9926126|FG001|STARTED|Treatment Period||10
8869485|NCT01869959|9926127|FG002|STARTED|Treatment Period||15
8869486|NCT01869959|9926128|FG003|STARTED|Treatment Period||10
8869487|NCT01869959|9926129|FG004|STARTED|Treatment Period|Participants were randomized to treatment groups for the Treatment Period.|0
8869488|NCT01869959|9926125|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||11
8869489|NCT01869959|9926126|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||10
8869490|NCT01869959|9926127|FG002|Received at Least 1 Dose of Study Drug|Treatment Period||15
8869491|NCT01869959|9926128|FG003|Received at Least 1 Dose of Study Drug|Treatment Period||10
8869492|NCT01869959|9926129|FG004|Received at Least 1 Dose of Study Drug|Treatment Period||0
8869493|NCT01869959|9926125|FG000|COMPLETED|Treatment Period||10
8869494|NCT01869959|9926126|FG001|COMPLETED|Treatment Period||8
8869495|NCT01869959|9926127|FG002|COMPLETED|Treatment Period||12
8869496|NCT01869959|9926128|FG003|COMPLETED|Treatment Period||8
8869497|NCT01869959|9926129|FG004|COMPLETED|Treatment Period||0
8869498|NCT01869959|9926125|FG000|NOT COMPLETED|Treatment Period||1
8869499|NCT01869959|9926126|FG001|NOT COMPLETED|Treatment Period||2
8869500|NCT01869959|9926127|FG002|NOT COMPLETED|Treatment Period||3
8869501|NCT01869959|9926128|FG003|NOT COMPLETED|Treatment Period||2
8869502|NCT01869959|9926129|FG004|NOT COMPLETED|Treatment Period||0
8869503|NCT01870076|9926143|FG000|STARTED|Overall Study||10
8869504|NCT01870076|9926144|FG001|STARTED|Overall Study||12
8869505|NCT01870076|9926145|FG002|STARTED|Overall Study||8
8869506|NCT01870076|9926146|FG003|STARTED|Overall Study||11
8869507|NCT01870076|9926143|FG000|COMPLETED|Overall Study||9
8869508|NCT01870076|9926144|FG001|COMPLETED|Overall Study||12
8869509|NCT01870076|9926145|FG002|COMPLETED|Overall Study||7
8869510|NCT01870076|9926146|FG003|COMPLETED|Overall Study||11
8869511|NCT01870076|9926143|FG000|NOT COMPLETED|Overall Study||1
8869512|NCT01870076|9926144|FG001|NOT COMPLETED|Overall Study||0
8869513|NCT01870076|9926145|FG002|NOT COMPLETED|Overall Study||1
8869514|NCT01870076|9926146|FG003|NOT COMPLETED|Overall Study||0
8869515|NCT01870297|9926163|FG000|STARTED|Overall Study||11
8869516|NCT01870297|9926164|FG001|STARTED|Overall Study||15
8869517|NCT01870297|9926165|FG002|STARTED|Overall Study||8
8869518|NCT01870297|9926166|FG003|STARTED|Overall Study||9
8869519|NCT01870297|9926167|FG004|STARTED|Overall Study||10
8869520|NCT01870297|9926168|FG005|STARTED|Overall Study||9
8869521|NCT01870297|9926169|FG006|STARTED|Overall Study||10
8869522|NCT01870297|9926163|FG000|COMPLETED|Overall Study||11
8869523|NCT01870297|9926164|FG001|COMPLETED|Overall Study||8
8869524|NCT01870297|9926165|FG002|COMPLETED|Overall Study||7
8869525|NCT01870297|9926166|FG003|COMPLETED|Overall Study||9
8869526|NCT01870297|9926167|FG004|COMPLETED|Overall Study||7
8869527|NCT01870297|9926168|FG005|COMPLETED|Overall Study||8
8869528|NCT01870297|9926169|FG006|COMPLETED|Overall Study||8
8869529|NCT01870297|9926163|FG000|NOT COMPLETED|Overall Study||0
8869530|NCT01870297|9926164|FG001|NOT COMPLETED|Overall Study||7
8869531|NCT01870297|9926165|FG002|NOT COMPLETED|Overall Study||1
8869532|NCT01870297|9926166|FG003|NOT COMPLETED|Overall Study||0
8869533|NCT01870297|9926167|FG004|NOT COMPLETED|Overall Study||3
8869534|NCT01870297|9926168|FG005|NOT COMPLETED|Overall Study||1
8869535|NCT01870297|9926169|FG006|NOT COMPLETED|Overall Study||2
8869536|NCT01870388|9926196|FG000|STARTED|Overall Study||8
8869537|NCT01870388|9926197|FG001|STARTED|Overall Study||8
8869538|NCT01870388|9926196|FG000|Received 1 Dose of Study Drug|Overall Study||8
8869539|NCT01870388|9926197|FG001|Received 1 Dose of Study Drug|Overall Study||8
8869540|NCT01870388|9926196|FG000|COMPLETED|Overall Study||8
8869541|NCT01870388|9926197|FG001|COMPLETED|Overall Study||8
8569942|NCT00100048|9602078|FG002|COMPLETED|Cohort I-Monotherapy Phase 10 Days|6 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|6
8569943|NCT00100048|9602079|FG003|COMPLETED|Cohort I-Monotherapy Phase 10 Days|6 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|8
8869542|NCT01870388|9926196|FG000|NOT COMPLETED|Overall Study||0
8869543|NCT01870388|9926197|FG001|NOT COMPLETED|Overall Study||0
8869544|NCT01870583|9926208|FG000|STARTED|Overall Study||467
8869545|NCT01870583|9926209|FG001|STARTED|Overall Study||474
8869546|NCT01870583|9926210|FG002|STARTED|Overall Study||463
8869547|NCT01870583|9926208|FG000|COMPLETED|Overall Study||456
8869548|NCT01870583|9926209|FG001|COMPLETED|Overall Study||456
8869549|NCT01870583|9926210|FG002|COMPLETED|Overall Study||455
8869550|NCT01870583|9926208|FG000|NOT COMPLETED|Overall Study||11
8869551|NCT01870583|9926209|FG001|NOT COMPLETED|Overall Study||18
8869552|NCT01870583|9926210|FG002|NOT COMPLETED|Overall Study||8
8869553|NCT01870596|9926220|FG000|STARTED|Overall Study||14
8869554|NCT01870596|9926221|FG001|STARTED|Overall Study||18
8869555|NCT01870596|9926220|FG000|COMPLETED|Overall Study||14
8869556|NCT01870596|9926221|FG001|COMPLETED|Overall Study||18
8869557|NCT01870596|9926220|FG000|NOT COMPLETED|Overall Study||0
8869558|NCT01870596|9926221|FG001|NOT COMPLETED|Overall Study||0
8869559|NCT01870726|9926234|FG000|STARTED|Overall Study||5
8869560|NCT01870726|9926235|FG001|STARTED|Overall Study||6
8869561|NCT01870726|9926236|FG002|STARTED|Overall Study||4
8869562|NCT01870726|9926237|FG003|STARTED|Overall Study||6
8869563|NCT01870726|9926238|FG004|STARTED|Overall Study||7
8869564|NCT01870726|9926239|FG005|STARTED|Overall Study||5
8869565|NCT01870726|9926240|FG006|STARTED|Overall Study||10
8869566|NCT01870726|9926234|FG000|COMPLETED|Overall Study||0
8869567|NCT01870726|9926235|FG001|COMPLETED|Overall Study||0
8869568|NCT01870726|9926236|FG002|COMPLETED|Overall Study||0
8869569|NCT01870726|9926237|FG003|COMPLETED|Overall Study||0
8869570|NCT01870726|9926238|FG004|COMPLETED|Overall Study||0
8869571|NCT01870726|9926239|FG005|COMPLETED|Overall Study||0
8869572|NCT01870726|9926240|FG006|COMPLETED|Overall Study||0
8869573|NCT01870726|9926234|FG000|NOT COMPLETED|Overall Study||5
8869574|NCT01870726|9926235|FG001|NOT COMPLETED|Overall Study||6
8869575|NCT01870726|9926236|FG002|NOT COMPLETED|Overall Study||4
8869576|NCT01870726|9926237|FG003|NOT COMPLETED|Overall Study||6
8869577|NCT01870726|9926238|FG004|NOT COMPLETED|Overall Study||7
8869578|NCT01870726|9926239|FG005|NOT COMPLETED|Overall Study||5
8869579|NCT01870726|9926240|FG006|NOT COMPLETED|Overall Study||10
8869580|NCT01870739|9926267|FG000|STARTED|Single Drug Treatment (12 Weeks)|"Start = Safety/Pharmacokinetic/Pharmacodynamic analysis set"|57
8869581|NCT01870739|9926268|FG001|STARTED|Single Drug Treatment (12 Weeks)||57
8869582|NCT01870739|9926267|FG000|Initiation Dose Completed|Single Drug Treatment (12 Weeks)||57
8869583|NCT01870739|9926268|FG001|Initiation Dose Completed|Single Drug Treatment (12 Weeks)||56
8869584|NCT01870739|9926267|FG000|Maintenance Dose Started|Single Drug Treatment (12 Weeks)||57
8869585|NCT01870739|9926268|FG001|Maintenance Dose Started|Single Drug Treatment (12 Weeks)||56
8869586|NCT01870739|9926267|FG000|COMPLETED|Single Drug Treatment (12 Weeks)|"Completed indicates maintenance dose complete"|54
8869587|NCT01870739|9926268|FG001|COMPLETED|Single Drug Treatment (12 Weeks)||53
8869588|NCT01870739|9926267|FG000|NOT COMPLETED|Single Drug Treatment (12 Weeks)||3
8869589|NCT01870739|9926268|FG001|NOT COMPLETED|Single Drug Treatment (12 Weeks)||4
8869590|NCT01870739|9926267|FG000|STARTED|Add-on Period (40 Weeks)||54
8869591|NCT01870739|9926268|FG001|STARTED|Add-on Period (40 Weeks)||53
8869592|NCT01870739|9926267|FG000|COMPLETED|Add-on Period (40 Weeks)||51
8869593|NCT01870739|9926268|FG001|COMPLETED|Add-on Period (40 Weeks)||51
8869594|NCT01870739|9926267|FG000|NOT COMPLETED|Add-on Period (40 Weeks)||3
8869595|NCT01870739|9926268|FG001|NOT COMPLETED|Add-on Period (40 Weeks)||2
8869596|NCT01870778|9926286|FG000|STARTED|Overall Study||3274
8869597|NCT01870778|9926287|FG001|STARTED|Overall Study||3271
8869598|NCT01870778|9926286|FG000|Safety Set|Overall Study||3257
8869599|NCT01870778|9926287|FG001|Safety Set|Overall Study||3248
8869600|NCT01870778|9926286|FG000|Full Analysis Set|Overall Study||3274
8869601|NCT01870778|9926287|FG001|Full Analysis Set|Overall Study||3271
8869602|NCT01870778|9926286|FG000|Biomarker Analysis Set|Overall Study||521
8869603|NCT01870778|9926287|FG001|Biomarker Analysis Set|Overall Study||510
8869604|NCT01870778|9926286|FG000|COMPLETED|Overall Study||3266
8869605|NCT01870778|9926287|FG001|COMPLETED|Overall Study||3262
8869606|NCT01870778|9926286|FG000|NOT COMPLETED|Overall Study||8
8869607|NCT01870778|9926287|FG001|NOT COMPLETED|Overall Study||9
8869608|NCT01870843|9926293|FG000|STARTED|Overall Study||261
8869609|NCT01870843|9926293|FG000|COMPLETED|Overall Study||208
8869610|NCT01870843|9926293|FG000|NOT COMPLETED|Overall Study||53
8869611|NCT01870856|9926299|FG000|STARTED|Overall Study||25
8869612|NCT01870856|9926300|FG001|STARTED|Overall Study||27
8869613|NCT01870856|9926299|FG000|COMPLETED|Overall Study||25
8869614|NCT01870856|9926300|FG001|COMPLETED|Overall Study||27
8869615|NCT01870856|9926299|FG000|NOT COMPLETED|Overall Study||0
8869616|NCT01870856|9926300|FG001|NOT COMPLETED|Overall Study||0
8869617|NCT01870869|9926312|FG000|STARTED|Overall Study||288
8869618|NCT01870869|9926313|FG001|STARTED|Overall Study||206
8869619|NCT01870869|9926314|FG002|STARTED|Overall Study||1222
8869620|NCT01870869|9926315|FG003|STARTED|Overall Study||235
8869621|NCT01870869|9926312|FG000|COMPLETED|Overall Study||260
8869622|NCT01870869|9926313|FG001|COMPLETED|Overall Study||192
8869623|NCT01870869|9926314|FG002|COMPLETED|Overall Study||1092
8869624|NCT01870869|9926315|FG003|COMPLETED|Overall Study||205
8869625|NCT01870869|9926312|FG000|NOT COMPLETED|Overall Study||28
8869626|NCT01870869|9926313|FG001|NOT COMPLETED|Overall Study||14
8869627|NCT01870869|9926314|FG002|NOT COMPLETED|Overall Study||130
8869628|NCT01870869|9926315|FG003|NOT COMPLETED|Overall Study||30
8869629|NCT01870921|9926325|FG000|STARTED|Overall Study||2004
8869630|NCT01870921|9926325|FG000|COMPLETED|Overall Study||1914
8869631|NCT01870921|9926325|FG000|NOT COMPLETED|Overall Study||90
8869632|NCT01870973|9926331|FG000|STARTED|Overall Study||56
8869633|NCT01870973|9926332|FG001|STARTED|Overall Study||52
8869634|NCT01870973|9926331|FG000|COMPLETED|Overall Study||46
8869635|NCT01870973|9926332|FG001|COMPLETED|Overall Study||49
8869636|NCT01870973|9926331|FG000|NOT COMPLETED|Overall Study||10
8869637|NCT01870973|9926332|FG001|NOT COMPLETED|Overall Study||3
8869638|NCT01870999|9926341|FG000|STARTED|Overall Study||14
8869639|NCT01870999|9926342|FG001|STARTED|Overall Study||16
8869640|NCT01870999|9926343|FG002|STARTED|Overall Study||11
8869641|NCT01870999|9926341|FG000|Safety Population; Received Study Drug|Overall Study||14
8869642|NCT01870999|9926342|FG001|Safety Population; Received Study Drug|Overall Study||15
8869643|NCT01870999|9926343|FG002|Safety Population; Received Study Drug|Overall Study||10
8869644|NCT01870999|9926341|FG000|COMPLETED|Overall Study||10
8869645|NCT01870999|9926342|FG001|COMPLETED|Overall Study||8
8869646|NCT01870999|9926343|FG002|COMPLETED|Overall Study||4
8869647|NCT01870999|9926341|FG000|NOT COMPLETED|Overall Study||4
8869648|NCT01870999|9926342|FG001|NOT COMPLETED|Overall Study||8
8952449|NCT02462928|10015508|FG001|NOT COMPLETED|Overall Study||92
8952450|NCT02462928|10015509|FG002|NOT COMPLETED|Overall Study||57
8952451|NCT02462967|10015520|FG000|STARTED|Overall Study||54
8952452|NCT02462967|10015521|FG001|STARTED|Overall Study||54
8952453|NCT02462967|10015522|FG002|STARTED|Overall Study||54
8952454|NCT02462967|10015520|FG000|COMPLETED|Overall Study||52
8952455|NCT02462967|10015521|FG001|COMPLETED|Overall Study||48
8952456|NCT02462967|10015522|FG002|COMPLETED|Overall Study||51
8952457|NCT02462967|10015520|FG000|NOT COMPLETED|Overall Study||2
8952458|NCT02462967|10015521|FG001|NOT COMPLETED|Overall Study||6
8952459|NCT02462967|10015522|FG002|NOT COMPLETED|Overall Study||3
8952460|NCT02463032|10015532|FG000|STARTED|Overall Study||72
8952461|NCT02463032|10015533|FG001|STARTED|Overall Study||64
8952462|NCT02463032|10015532|FG000|COMPLETED|Overall Study||1
8952463|NCT02463032|10015533|FG001|COMPLETED|Overall Study||0
8952464|NCT02463032|10015532|FG000|NOT COMPLETED|Overall Study||71
8952465|NCT02463032|10015533|FG001|NOT COMPLETED|Overall Study||64
8952466|NCT02463071|10015542|FG000|STARTED|Overall Study||152
8952467|NCT02463071|10015543|FG001|STARTED|Overall Study||154
8952468|NCT02463071|10015544|FG002|STARTED|Overall Study||77
8569944|NCT00100048|9602080|FG004|COMPLETED|Cohort I-Monotherapy Phase 10 Days|4 Subjects Continued to Cohort II, as part of the Efavirenz 600 mg q.d. arm|7
8569945|NCT00100048|9602081|FG005|COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
8869649|NCT01870999|9926343|FG002|NOT COMPLETED|Overall Study||7
8952469|NCT02463071|10015542|FG000|COMPLETED|Overall Study||140
8952470|NCT02463071|10015543|FG001|COMPLETED|Overall Study||138
8952471|NCT02463071|10015544|FG002|COMPLETED|Overall Study||71
8952472|NCT02463071|10015542|FG000|NOT COMPLETED|Overall Study||12
8952473|NCT02463071|10015543|FG001|NOT COMPLETED|Overall Study||16
8952474|NCT02463071|10015544|FG002|NOT COMPLETED|Overall Study||6
8952475|NCT02463097|10015552|FG000|STARTED|Overall Study||124
8952476|NCT02463097|10015552|FG000|COMPLETED|Overall Study||123
8952477|NCT02463097|10015552|FG000|NOT COMPLETED|Overall Study||1
8952478|NCT02463227|10015556|FG000|STARTED|Overall Study||14
8952479|NCT02463227|10015556|FG000|COMPLETED|Overall Study||14
8952480|NCT02463227|10015556|FG000|NOT COMPLETED|Overall Study||0
8952481|NCT02463331|10015562|FG000|STARTED|Overall Study||26
8952482|NCT02463331|10015563|FG001|STARTED|Overall Study||31
8952483|NCT02463331|10015562|FG000|COMPLETED|Overall Study||10
8952484|NCT02463331|10015563|FG001|COMPLETED|Overall Study||25
8952485|NCT02463331|10015562|FG000|NOT COMPLETED|Overall Study||16
8952486|NCT02463331|10015563|FG001|NOT COMPLETED|Overall Study||6
8952487|NCT02463357|10015574|FG000|STARTED|Overall Study||20
8952488|NCT02463357|10015575|FG001|STARTED|Overall Study||20
8952489|NCT02463357|10015576|FG002|STARTED|Overall Study||20
8952490|NCT02463357|10015577|FG003|STARTED|Overall Study||19
8952491|NCT02463357|10015578|FG004|STARTED|Overall Study||20
8952492|NCT02463357|10015574|FG000|COMPLETED|Overall Study||19
8952493|NCT02463357|10015575|FG001|COMPLETED|Overall Study||20
8952494|NCT02463357|10015576|FG002|COMPLETED|Overall Study||20
8952495|NCT02463357|10015577|FG003|COMPLETED|Overall Study||19
8952496|NCT02463357|10015578|FG004|COMPLETED|Overall Study||19
8952497|NCT02463357|10015574|FG000|NOT COMPLETED|Overall Study||1
8952498|NCT02463357|10015575|FG001|NOT COMPLETED|Overall Study||0
8952499|NCT02463357|10015576|FG002|NOT COMPLETED|Overall Study||0
8952500|NCT02463357|10015577|FG003|NOT COMPLETED|Overall Study||0
8952501|NCT02463357|10015578|FG004|NOT COMPLETED|Overall Study||1
8952502|NCT02463409|10015590|FG000|STARTED|Overall Study||6
8952503|NCT02463409|10015590|FG000|COMPLETED|Overall Study||4
8952504|NCT02463409|10015590|FG000|NOT COMPLETED|Overall Study||2
8952505|NCT02463487|10015596|FG000|STARTED|Overall Study||75
8952506|NCT02463487|10015597|FG001|STARTED|Overall Study||75
8952507|NCT02463487|10015596|FG000|COMPLETED|Overall Study||65
8952508|NCT02463487|10015597|FG001|COMPLETED|Overall Study||65
8952509|NCT02463487|10015596|FG000|NOT COMPLETED|Overall Study||10
8952510|NCT02463487|10015597|FG001|NOT COMPLETED|Overall Study||10
8952511|NCT02463799|10015605|FG000|STARTED|Overall Study||16
8952512|NCT02463799|10015606|FG001|STARTED|Overall Study||16
8952513|NCT02463799|10015605|FG000|COMPLETED|Overall Study||16
8952514|NCT02463799|10015606|FG001|COMPLETED|Overall Study||16
8952515|NCT02463799|10015605|FG000|NOT COMPLETED|Overall Study||0
8952516|NCT02463799|10015606|FG001|NOT COMPLETED|Overall Study||0
8952517|NCT02464033|10015612|FG000|STARTED|Overall Study||20
8952518|NCT02464033|10015612|FG000|COMPLETED|Overall Study||20
8952519|NCT02464033|10015612|FG000|NOT COMPLETED|Overall Study||0
8952520|NCT02464059|10015617|FG000|STARTED|Overall Study||23
8952521|NCT02464059|10015617|FG000|COMPLETED|Overall Study||17
8952522|NCT02464059|10015617|FG000|NOT COMPLETED|Overall Study||6
8952523|NCT02464163|10015625|FG000|STARTED|Overall Study||102
8952524|NCT02464163|10015626|FG001|STARTED|Overall Study||102
8952525|NCT02464163|10015627|FG002|STARTED|Overall Study||102
8869650|NCT01871077|9926351|FG000|STARTED|Overall Study||30
8869651|NCT01871077|9926351|FG000|COMPLETED|Overall Study||30
8869652|NCT01871077|9926351|FG000|NOT COMPLETED|Overall Study||0
8869653|NCT01871090|9926357|FG000|STARTED|Overall Study||35
8869654|NCT01871090|9926358|FG001|STARTED|Overall Study||48
8869655|NCT01871090|9926357|FG000|COMPLETED|Overall Study||33
8869656|NCT01871090|9926358|FG001|COMPLETED|Overall Study||25
8869657|NCT01871090|9926357|FG000|NOT COMPLETED|Overall Study||2
8869658|NCT01871090|9926358|FG001|NOT COMPLETED|Overall Study||23
8869659|NCT01871142|9926364|FG000|STARTED|Overall Study||12
8869660|NCT01871142|9926364|FG000|Received Placebo + Normoixa|Overall Study||11
8869661|NCT01871142|9926364|FG000|Received Placebo + Hypoxia|Overall Study||12
8869662|NCT01871142|9926364|FG000|Received 1000mg Aes 103+ Hypoxia|Overall Study||11
8869663|NCT01871142|9926364|FG000|Received 3000mg Aes-103 + Hypoxia|Overall Study||12
8869664|NCT01871142|9926364|FG000|COMPLETED|Overall Study||11
8869665|NCT01871142|9926364|FG000|NOT COMPLETED|Overall Study||1
8869666|NCT01871285|9926380|FG000|STARTED|First Intervention (1 Day)||18
8869667|NCT01871285|9926381|FG001|STARTED|First Intervention (1 Day)||15
8869668|NCT01871285|9926382|FG002|STARTED|First Intervention (1 Day)||4
8869669|NCT01871285|9926383|FG003|STARTED|First Intervention (1 Day)||2
8869670|NCT01871285|9926380|FG000|COMPLETED|First Intervention (1 Day)||17
8869671|NCT01871285|9926381|FG001|COMPLETED|First Intervention (1 Day)||14
8869672|NCT01871285|9926382|FG002|COMPLETED|First Intervention (1 Day)||3
8869673|NCT01871285|9926383|FG003|COMPLETED|First Intervention (1 Day)||2
8869674|NCT01871285|9926380|FG000|NOT COMPLETED|First Intervention (1 Day)||1
8869675|NCT01871285|9926381|FG001|NOT COMPLETED|First Intervention (1 Day)||1
8869676|NCT01871285|9926382|FG002|NOT COMPLETED|First Intervention (1 Day)||1
8869677|NCT01871285|9926383|FG003|NOT COMPLETED|First Intervention (1 Day)||0
8869678|NCT01871285|9926380|FG000|STARTED|Second Intervention (1 Day)||17
8869679|NCT01871285|9926381|FG001|STARTED|Second Intervention (1 Day)||14
8869680|NCT01871285|9926382|FG002|STARTED|Second Intervention (1 Day)||3
8869681|NCT01871285|9926383|FG003|STARTED|Second Intervention (1 Day)||2
8869682|NCT01871285|9926380|FG000|COMPLETED|Second Intervention (1 Day)||17
8869683|NCT01871285|9926381|FG001|COMPLETED|Second Intervention (1 Day)||14
8869684|NCT01871285|9926382|FG002|COMPLETED|Second Intervention (1 Day)||3
8869685|NCT01871285|9926383|FG003|COMPLETED|Second Intervention (1 Day)||2
8869686|NCT01871285|9926380|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
8869687|NCT01871285|9926381|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
8869688|NCT01871285|9926382|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
8869689|NCT01871285|9926383|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
8869690|NCT01871402|9926395|FG000|STARTED|Overall Study||110
8869691|NCT01871402|9926396|FG001|STARTED|Overall Study||111
8869692|NCT01871402|9926395|FG000|COMPLETED|Overall Study||109
8869693|NCT01871402|9926396|FG001|COMPLETED|Overall Study||108
8869694|NCT01871402|9926395|FG000|NOT COMPLETED|Overall Study||1
8869695|NCT01871402|9926396|FG001|NOT COMPLETED|Overall Study||3
8869696|NCT01871441|9926402|FG000|STARTED|Overall Study||4
8869697|NCT01871441|9926402|FG000|COMPLETED|Overall Study||4
8869698|NCT01871441|9926402|FG000|NOT COMPLETED|Overall Study||0
8869699|NCT01871506|9926409|FG000|STARTED|Overall Study||150
8869700|NCT01871506|9926410|FG001|STARTED|Overall Study||153
8869701|NCT01871506|9926409|FG000|COMPLETED|Overall Study||150
8869702|NCT01871506|9926410|FG001|COMPLETED|Overall Study||153
8869703|NCT01871506|9926409|FG000|NOT COMPLETED|Overall Study||0
8869704|NCT01871506|9926410|FG001|NOT COMPLETED|Overall Study||0
8869705|NCT01871519|9926429|FG000|STARTED|Overall Study||350
8869706|NCT01871519|9926429|FG000|COMPLETED|Overall Study||260
8869707|NCT01871519|9926429|FG000|NOT COMPLETED|Overall Study||90
8869708|NCT01871532|9926436|FG000|STARTED|Overall Study||12
8869709|NCT01871532|9926437|FG001|STARTED|Overall Study||12
8869710|NCT01871532|9926436|FG000|Subjects Received hCG Treatment|Overall Study||11
8869711|NCT01871532|9926437|FG001|Subjects Received hCG Treatment|Overall Study||9
8869712|NCT01871532|9926436|FG000|COMPLETED|Overall Study||11
8869713|NCT01871532|9926437|FG001|COMPLETED|Overall Study||10
8869714|NCT01871532|9926436|FG000|NOT COMPLETED|Overall Study||1
8869715|NCT01871532|9926437|FG001|NOT COMPLETED|Overall Study||2
8869716|NCT01871545|9926445|FG000|STARTED|Overall Study||73
8869717|NCT01871545|9926446|FG001|STARTED|Overall Study||11
8869718|NCT01871545|9926445|FG000|COMPLETED|Overall Study||56
8869719|NCT01871545|9926446|FG001|COMPLETED|Overall Study||8
8869720|NCT01871545|9926445|FG000|NOT COMPLETED|Overall Study||17
8569946|NCT00100048|9602076|FG000|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
8569947|NCT00100048|9602077|FG001|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
8869721|NCT01871545|9926446|FG001|NOT COMPLETED|Overall Study||3
8869722|NCT01871558|9926457|FG000|STARTED|Overall Study||21
8569948|NCT00100048|9602078|FG002|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
8569949|NCT00100048|9602079|FG003|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
8869723|NCT01871558|9926458|FG001|STARTED|Overall Study||21
8869724|NCT01871558|9926457|FG000|COMPLETED|Overall Study||18
8869725|NCT01871558|9926458|FG001|COMPLETED|Overall Study||19
8869726|NCT01871558|9926457|FG000|NOT COMPLETED|Overall Study||3
8869727|NCT01871558|9926458|FG001|NOT COMPLETED|Overall Study||2
8869728|NCT01871805|9926470|FG000|STARTED|Phase I||7
8869729|NCT01871805|9926471|FG001|STARTED|Phase I||7
8869730|NCT01871805|9926472|FG002|STARTED|Phase I||13
8869731|NCT01871805|9926473|FG003|STARTED|Phase I||7
8869732|NCT01871805|9926474|FG004|STARTED|Phase I||13
8869733|NCT01871805|9926475|FG005|STARTED|Phase I||0
8869734|NCT01871805|9926470|FG000|COMPLETED|Phase I||0
8869735|NCT01871805|9926471|FG001|COMPLETED|Phase I||0
8869736|NCT01871805|9926472|FG002|COMPLETED|Phase I||0
8869737|NCT01871805|9926473|FG003|COMPLETED|Phase I||0
8869738|NCT01871805|9926474|FG004|COMPLETED|Phase I||0
8869739|NCT01871805|9926475|FG005|COMPLETED|Phase I||0
8869740|NCT01871805|9926470|FG000|NOT COMPLETED|Phase I||7
8869741|NCT01871805|9926471|FG001|NOT COMPLETED|Phase I||7
8869742|NCT01871805|9926472|FG002|NOT COMPLETED|Phase I||13
8869743|NCT01871805|9926473|FG003|NOT COMPLETED|Phase I||7
8869744|NCT01871805|9926474|FG004|NOT COMPLETED|Phase I||13
8869745|NCT01871805|9926475|FG005|NOT COMPLETED|Phase I||0
8869746|NCT01871805|9926470|FG000|STARTED|Phase II||0
8869747|NCT01871805|9926471|FG001|STARTED|Phase II||0
8869748|NCT01871805|9926472|FG002|STARTED|Phase II||0
8869749|NCT01871805|9926473|FG003|STARTED|Phase II||0
8869750|NCT01871805|9926474|FG004|STARTED|Phase II||0
8869751|NCT01871805|9926475|FG005|STARTED|Phase II||87
8869752|NCT01871805|9926470|FG000|COMPLETED|Phase II||0
8869753|NCT01871805|9926471|FG001|COMPLETED|Phase II||0
8869754|NCT01871805|9926472|FG002|COMPLETED|Phase II||0
8869755|NCT01871805|9926473|FG003|COMPLETED|Phase II||0
8869756|NCT01871805|9926474|FG004|COMPLETED|Phase II||0
8869757|NCT01871805|9926475|FG005|COMPLETED|Phase II||0
8869758|NCT01871805|9926470|FG000|NOT COMPLETED|Phase II||0
8869759|NCT01871805|9926471|FG001|NOT COMPLETED|Phase II||0
8869760|NCT01871805|9926472|FG002|NOT COMPLETED|Phase II||0
8869761|NCT01871805|9926473|FG003|NOT COMPLETED|Phase II||0
8869762|NCT01871805|9926474|FG004|NOT COMPLETED|Phase II||0
8869763|NCT01871805|9926475|FG005|NOT COMPLETED|Phase II||87
8869764|NCT01871870|9926506|FG000|STARTED|Overall Study||20
8869765|NCT01871870|9926506|FG000|COMPLETED|Overall Study||11
8869766|NCT01871870|9926506|FG000|NOT COMPLETED|Overall Study||9
8869767|NCT01872078|9926514|FG000|STARTED|Overall Study||16
8869768|NCT01872078|9926515|FG001|STARTED|Overall Study||15
8869769|NCT01872078|9926516|FG002|STARTED|Overall Study||17
8869770|NCT01872078|9926517|FG003|STARTED|Overall Study||17
8869771|NCT01872078|9926514|FG000|COMPLETED|Overall Study||16
8869772|NCT01872078|9926515|FG001|COMPLETED|Overall Study||15
8869773|NCT01872078|9926516|FG002|COMPLETED|Overall Study||14
8869774|NCT01872078|9926517|FG003|COMPLETED|Overall Study||15
8869775|NCT01872078|9926514|FG000|NOT COMPLETED|Overall Study||0
8869776|NCT01872078|9926515|FG001|NOT COMPLETED|Overall Study||0
8869777|NCT01872078|9926516|FG002|NOT COMPLETED|Overall Study||3
8869778|NCT01872078|9926517|FG003|NOT COMPLETED|Overall Study||2
8869779|NCT01872325|9926529|FG000|STARTED|Overall Study||689
8869780|NCT01872325|9926530|FG001|STARTED|Overall Study||387
8869781|NCT01872325|9926529|FG000|COMPLETED|Overall Study||689
8869782|NCT01872325|9926530|FG001|COMPLETED|Overall Study||387
8869783|NCT01872325|9926529|FG000|NOT COMPLETED|Overall Study||0
8869784|NCT01872325|9926530|FG001|NOT COMPLETED|Overall Study||0
8869785|NCT01872338|9926538|FG000|STARTED|Overall Study||66
8869786|NCT01872338|9926539|FG001|STARTED|Overall Study||69
8869787|NCT01872338|9926538|FG000|COMPLETED|Overall Study||46
8869788|NCT01872338|9926539|FG001|COMPLETED|Overall Study||69
8869789|NCT01872338|9926538|FG000|NOT COMPLETED|Overall Study||20
8869790|NCT01872338|9926539|FG001|NOT COMPLETED|Overall Study||0
8869791|NCT01872611|9926547|FG000|STARTED|Overall Study||301
8869792|NCT01872611|9926548|FG001|STARTED|Overall Study||304
8869793|NCT01872611|9926547|FG000|Randomized|Overall Study||301
8869794|NCT01872611|9926548|FG001|Randomized|Overall Study||304
8869795|NCT01872611|9926547|FG000|Treated (Safety Analysis Set)|Overall Study||293
8869796|NCT01872611|9926548|FG001|Treated (Safety Analysis Set)|Overall Study||295
8869797|NCT01872611|9926547|FG000|Full Analysis Set|Overall Study||289
8869798|NCT01872611|9926548|FG001|Full Analysis Set|Overall Study||293
8869799|NCT01872611|9926547|FG000|COMPLETED|Overall Study||277
8869800|NCT01872611|9926548|FG001|COMPLETED|Overall Study||292
8869801|NCT01872611|9926547|FG000|NOT COMPLETED|Overall Study||24
8869802|NCT01872611|9926548|FG001|NOT COMPLETED|Overall Study||12
8869803|NCT01872689|9926560|FG000|STARTED|Double-Blind/Placebo-Controlled Period||76
8869804|NCT01872689|9926561|FG001|STARTED|Double-Blind/Placebo-Controlled Period||78
8869805|NCT01872689|9926562|FG002|STARTED|Double-Blind/Placebo-Controlled Period||177
8869806|NCT01872689|9926563|FG003|STARTED|Double-Blind/Placebo-Controlled Period||174
8869807|NCT01872689|9926560|FG000|COMPLETED|Double-Blind/Placebo-Controlled Period||56
8869808|NCT01872689|9926561|FG001|COMPLETED|Double-Blind/Placebo-Controlled Period||58
8869809|NCT01872689|9926562|FG002|COMPLETED|Double-Blind/Placebo-Controlled Period||129
8869810|NCT01872689|9926563|FG003|COMPLETED|Double-Blind/Placebo-Controlled Period||136
8869811|NCT01872689|9926560|FG000|NOT COMPLETED|Double-Blind/Placebo-Controlled Period||20
8869812|NCT01872689|9926561|FG001|NOT COMPLETED|Double-Blind/Placebo-Controlled Period||20
8869813|NCT01872689|9926562|FG002|NOT COMPLETED|Double-Blind/Placebo-Controlled Period||48
8869814|NCT01872689|9926563|FG003|NOT COMPLETED|Double-Blind/Placebo-Controlled Period||38
8869815|NCT01872689|9926560|FG000|STARTED|Open-Label Period (Only For Monotherapy)|Of the 56 participants who completed Period 1, only 52 started Period 2.|52
8869816|NCT01872689|9926561|FG001|STARTED|Open-Label Period (Only For Monotherapy)|Of the 58 participants who completed Period 1, only 56 started Period 2.|56
8869817|NCT01872689|9926562|FG002|STARTED|Open-Label Period (Only For Monotherapy)|As per study design, Period 2 was not intended for this arm.|0
8869818|NCT01872689|9926563|FG003|STARTED|Open-Label Period (Only For Monotherapy)|As per study design, Period 2 was not intended for this arm.|0
8869819|NCT01872689|9926560|FG000|COMPLETED|Open-Label Period (Only For Monotherapy)||31
8869820|NCT01872689|9926561|FG001|COMPLETED|Open-Label Period (Only For Monotherapy)||33
8869821|NCT01872689|9926562|FG002|COMPLETED|Open-Label Period (Only For Monotherapy)||0
8869822|NCT01872689|9926563|FG003|COMPLETED|Open-Label Period (Only For Monotherapy)||0
8869823|NCT01872689|9926560|FG000|NOT COMPLETED|Open-Label Period (Only For Monotherapy)||21
8869824|NCT01872689|9926561|FG001|NOT COMPLETED|Open-Label Period (Only For Monotherapy)||23
8869825|NCT01872689|9926562|FG002|NOT COMPLETED|Open-Label Period (Only For Monotherapy)||0
8869826|NCT01872689|9926563|FG003|NOT COMPLETED|Open-Label Period (Only For Monotherapy)||0
8869827|NCT01872715|9926576|FG000|STARTED|Overall Study||24
8869828|NCT01872715|9926576|FG000|COMPLETED|Overall Study||20
8869829|NCT01872715|9926576|FG000|NOT COMPLETED|Overall Study||4
8869830|NCT01872819|9926590|FG000|STARTED|Overall Study||14
8869831|NCT01872819|9926590|FG000|COMPLETED|Overall Study||14
8869832|NCT01872819|9926590|FG000|NOT COMPLETED|Overall Study||0
8869833|NCT01872910|9926601|FG000|STARTED|Overall Study||30
8869834|NCT01872910|9926602|FG001|STARTED|Overall Study||31
8869835|NCT01872910|9926603|FG002|STARTED|Overall Study||30
8869836|NCT01872910|9926604|FG003|STARTED|Overall Study||15
8869837|NCT01872910|9926605|FG004|STARTED|Overall Study||15
8869838|NCT01872910|9926606|FG005|STARTED|Overall Study||3
8869839|NCT01872910|9926601|FG000|Received Any Study Drug|Overall Study||30
8869840|NCT01872910|9926602|FG001|Received Any Study Drug|Overall Study||31
8869841|NCT01872910|9926603|FG002|Received Any Study Drug|Overall Study||30
8869842|NCT01872910|9926604|FG003|Received Any Study Drug|Overall Study||15
8869843|NCT01872910|9926605|FG004|Received Any Study Drug|Overall Study||15
8869844|NCT01872910|9926606|FG005|Received Any Study Drug|Overall Study||3
8869845|NCT01872910|9926601|FG000|COMPLETED|Overall Study||28
8869846|NCT01872910|9926602|FG001|COMPLETED|Overall Study||31
8869847|NCT01872910|9926603|FG002|COMPLETED|Overall Study||28
8869848|NCT01872910|9926604|FG003|COMPLETED|Overall Study||15
8869849|NCT01872910|9926605|FG004|COMPLETED|Overall Study||15
8869850|NCT01872910|9926606|FG005|COMPLETED|Overall Study||3
8869851|NCT01872910|9926601|FG000|NOT COMPLETED|Overall Study||2
8869852|NCT01872910|9926602|FG001|NOT COMPLETED|Overall Study||0
8869853|NCT01872910|9926603|FG002|NOT COMPLETED|Overall Study||2
8869854|NCT01872910|9926604|FG003|NOT COMPLETED|Overall Study||0
8869855|NCT01872910|9926605|FG004|NOT COMPLETED|Overall Study||0
8869856|NCT01872910|9926606|FG005|NOT COMPLETED|Overall Study||0
8869857|NCT01873287|9926621|FG000|STARTED|Overall Study||2006
8869858|NCT01873287|9926622|FG001|STARTED|Overall Study||1057
8869859|NCT01873287|9926621|FG000|COMPLETED|Overall Study||1701
8869860|NCT01873287|9926622|FG001|COMPLETED|Overall Study||883
8869861|NCT01873287|9926621|FG000|NOT COMPLETED|Overall Study||305
8869862|NCT01873287|9926622|FG001|NOT COMPLETED|Overall Study||174
8869863|NCT01873417|9926630|FG000|STARTED|Overall Study||237
8869864|NCT01873417|9926630|FG000|Safety Population|Overall Study|Participants who received at least 1 dose of dimethyl fumarate (DMF), recorded in diary data.|233
8869865|NCT01873417|9926630|FG000|COMPLETED|Overall Study||202
8869866|NCT01873417|9926630|FG000|NOT COMPLETED|Overall Study||35
8869867|NCT01873495|9926634|FG000|STARTED|Overall Study||7
8869868|NCT01873495|9926634|FG000|COMPLETED|Overall Study||0
8869869|NCT01873495|9926634|FG000|NOT COMPLETED|Overall Study||7
8869870|NCT01873586|9926638|FG000|STARTED|Overall Study||29
8869871|NCT01873586|9926638|FG000|COMPLETED|Overall Study||26
8869872|NCT01873586|9926638|FG000|NOT COMPLETED|Overall Study||3
8869873|NCT01873729|9926645|FG000|STARTED|Overall Study||3
8869874|NCT01873729|9926645|FG000|COMPLETED|Overall Study||2
8869875|NCT01873729|9926645|FG000|NOT COMPLETED|Overall Study||1
8869876|NCT01873742|9926651|FG000|STARTED|Overall Study||165
8869877|NCT01873742|9926652|FG001|STARTED|Overall Study||163
8869878|NCT01873742|9926651|FG000|COMPLETED|Overall Study||97
8869879|NCT01873742|9926652|FG001|COMPLETED|Overall Study||87
8869880|NCT01873742|9926651|FG000|NOT COMPLETED|Overall Study||68
8869881|NCT01873742|9926652|FG001|NOT COMPLETED|Overall Study||76
8869882|NCT01873846|9926658|FG000|STARTED|Overall Study||400
8869883|NCT01873846|9926658|FG000|Eligble Participants Dispensed Lenses|Overall Study||396
8869884|NCT01873846|9926658|FG000|COMPLETED|Overall Study||388
8869885|NCT01873846|9926658|FG000|NOT COMPLETED|Overall Study||12
8869886|NCT01873859|9926664|FG000|STARTED|Overall Study||83
8869887|NCT01873859|9926665|FG001|STARTED|Overall Study||83
8869888|NCT01873859|9926664|FG000|COMPLETED|Overall Study||83
8869889|NCT01873859|9926665|FG001|COMPLETED|Overall Study||79
8869890|NCT01873859|9926664|FG000|NOT COMPLETED|Overall Study||0
8869891|NCT01873859|9926665|FG001|NOT COMPLETED|Overall Study||4
8869892|NCT01873950|9926672|FG000|STARTED|Period 1||5
8869893|NCT01873950|9926673|FG001|STARTED|Period 1||4
8869894|NCT01873950|9926674|FG002|STARTED|Period 1||5
8869895|NCT01873950|9926675|FG003|STARTED|Period 1||4
8869896|NCT01873950|9926676|FG004|STARTED|Period 1||4
8869897|NCT01873950|9926672|FG000|COMPLETED|Period 1||5
8869898|NCT01873950|9926673|FG001|COMPLETED|Period 1||4
8869899|NCT01873950|9926674|FG002|COMPLETED|Period 1||5
8869900|NCT01873950|9926675|FG003|COMPLETED|Period 1||4
8869901|NCT01873950|9926676|FG004|COMPLETED|Period 1||4
8869902|NCT01873950|9926672|FG000|NOT COMPLETED|Period 1||0
8869903|NCT01873950|9926673|FG001|NOT COMPLETED|Period 1||0
8869904|NCT01873950|9926674|FG002|NOT COMPLETED|Period 1||0
8869905|NCT01873950|9926675|FG003|NOT COMPLETED|Period 1||0
8869906|NCT01873950|9926676|FG004|NOT COMPLETED|Period 1||0
8869907|NCT01873950|9926672|FG000|STARTED|Period 2||5
8869908|NCT01873950|9926673|FG001|STARTED|Period 2||4
8869909|NCT01873950|9926674|FG002|STARTED|Period 2||4
8869910|NCT01873950|9926675|FG003|STARTED|Period 2||4
8869911|NCT01873950|9926676|FG004|STARTED|Period 2||5
8952526|NCT02464163|10015628|FG003|STARTED|Overall Study||101
8952527|NCT02464163|10015625|FG000|COMPLETED|Overall Study||99
8952528|NCT02464163|10015626|FG001|COMPLETED|Overall Study||94
8952529|NCT02464163|10015627|FG002|COMPLETED|Overall Study||97
8952530|NCT02464163|10015628|FG003|COMPLETED|Overall Study||96
8952531|NCT02464163|10015625|FG000|NOT COMPLETED|Overall Study||3
8952532|NCT02464163|10015626|FG001|NOT COMPLETED|Overall Study||8
8952533|NCT02464163|10015627|FG002|NOT COMPLETED|Overall Study||5
8952534|NCT02464163|10015628|FG003|NOT COMPLETED|Overall Study||5
8952535|NCT02464176|10015641|FG000|STARTED|Overall Study||50
8952536|NCT02464176|10015642|FG001|STARTED|Overall Study||50
8952537|NCT02464176|10015643|FG002|STARTED|Overall Study||15
8869912|NCT01873950|9926672|FG000|COMPLETED|Period 2||5
8869913|NCT01873950|9926673|FG001|COMPLETED|Period 2||4
8869914|NCT01873950|9926674|FG002|COMPLETED|Period 2||4
8869915|NCT01873950|9926675|FG003|COMPLETED|Period 2||4
8869916|NCT01873950|9926676|FG004|COMPLETED|Period 2||5
8869917|NCT01873950|9926672|FG000|NOT COMPLETED|Period 2||0
8869918|NCT01873950|9926673|FG001|NOT COMPLETED|Period 2||0
8869919|NCT01873950|9926674|FG002|NOT COMPLETED|Period 2||0
8869920|NCT01873950|9926675|FG003|NOT COMPLETED|Period 2||0
8869921|NCT01873950|9926676|FG004|NOT COMPLETED|Period 2||0
8869922|NCT01873950|9926672|FG000|STARTED|Period 3||4
8869923|NCT01873950|9926673|FG001|STARTED|Period 3||4
8869924|NCT01873950|9926674|FG002|STARTED|Period 3||5
8869925|NCT01873950|9926675|FG003|STARTED|Period 3||5
8869926|NCT01873950|9926676|FG004|STARTED|Period 3||4
8869927|NCT01873950|9926672|FG000|COMPLETED|Period 3||4
8869928|NCT01873950|9926673|FG001|COMPLETED|Period 3||4
8869929|NCT01873950|9926674|FG002|COMPLETED|Period 3||5
8869930|NCT01873950|9926675|FG003|COMPLETED|Period 3||5
8869931|NCT01873950|9926676|FG004|COMPLETED|Period 3||4
8869932|NCT01873950|9926672|FG000|NOT COMPLETED|Period 3||0
8869933|NCT01873950|9926673|FG001|NOT COMPLETED|Period 3||0
8869934|NCT01873950|9926674|FG002|NOT COMPLETED|Period 3||0
8869935|NCT01873950|9926675|FG003|NOT COMPLETED|Period 3||0
8869936|NCT01873950|9926676|FG004|NOT COMPLETED|Period 3||0
8952538|NCT02464176|10015641|FG000|COMPLETED|Overall Study||50
8952539|NCT02464176|10015642|FG001|COMPLETED|Overall Study||50
8952540|NCT02464176|10015643|FG002|COMPLETED|Overall Study||15
8952541|NCT02464176|10015641|FG000|NOT COMPLETED|Overall Study||0
8952542|NCT02464176|10015642|FG001|NOT COMPLETED|Overall Study||0
8952543|NCT02464176|10015643|FG002|NOT COMPLETED|Overall Study||0
8952544|NCT02464449|10015653|FG000|STARTED|Overall Study||166
8952545|NCT02464449|10015654|FG001|STARTED|Overall Study||112
8952546|NCT02464449|10015653|FG000|COMPLETED|Overall Study||151
8952547|NCT02464449|10015654|FG001|COMPLETED|Overall Study||100
8952548|NCT02464449|10015653|FG000|NOT COMPLETED|Overall Study||15
8952549|NCT02464449|10015654|FG001|NOT COMPLETED|Overall Study||12
8952550|NCT02464540|10015660|FG000|STARTED|Overall Study||11
8952551|NCT02464540|10015661|FG001|STARTED|Overall Study||11
8952552|NCT02464540|10015660|FG000|COMPLETED|Overall Study||11
8952553|NCT02464540|10015661|FG001|COMPLETED|Overall Study||11
8952554|NCT02464540|10015660|FG000|NOT COMPLETED|Overall Study||0
8952555|NCT02464540|10015661|FG001|NOT COMPLETED|Overall Study||0
8952556|NCT02464657|10015670|FG000|STARTED|Overall Study||3
8952557|NCT02464657|10015671|FG001|STARTED|Overall Study||2
8952558|NCT02464657|10015672|FG002|STARTED|Overall Study||39
8952559|NCT02464657|10015670|FG000|COMPLETED|Overall Study||3
8952560|NCT02464657|10015671|FG001|COMPLETED|Overall Study||2
8952561|NCT02464657|10015672|FG002|COMPLETED|Overall Study||39
8952562|NCT02464657|10015670|FG000|NOT COMPLETED|Overall Study||0
8952563|NCT02464657|10015671|FG001|NOT COMPLETED|Overall Study||0
8952564|NCT02464657|10015672|FG002|NOT COMPLETED|Overall Study||0
8952565|NCT02464917|10015683|FG000|STARTED|Overall Study||35
8869937|NCT01873950|9926672|FG000|STARTED|Period 4||4
8869938|NCT01873950|9926673|FG001|STARTED|Period 4||5
8869939|NCT01873950|9926674|FG002|STARTED|Period 4||4
8869940|NCT01873950|9926675|FG003|STARTED|Period 4||4
8869941|NCT01873950|9926676|FG004|STARTED|Period 4||5
8869942|NCT01873950|9926672|FG000|COMPLETED|Period 4||4
8952566|NCT02464917|10015684|FG001|STARTED|Overall Study||35
8952567|NCT02464917|10015683|FG000|COMPLETED|Overall Study||35
8869943|NCT01873950|9926673|FG001|COMPLETED|Period 4||5
8869944|NCT01873950|9926674|FG002|COMPLETED|Period 4||4
8869945|NCT01873950|9926675|FG003|COMPLETED|Period 4||4
8952568|NCT02464917|10015684|FG001|COMPLETED|Overall Study||35
8952569|NCT02464917|10015683|FG000|NOT COMPLETED|Overall Study||0
8869946|NCT01873950|9926676|FG004|COMPLETED|Period 4||5
8869947|NCT01873950|9926672|FG000|NOT COMPLETED|Period 4||0
8869948|NCT01873950|9926673|FG001|NOT COMPLETED|Period 4||0
8869949|NCT01873950|9926674|FG002|NOT COMPLETED|Period 4||0
8869950|NCT01873950|9926675|FG003|NOT COMPLETED|Period 4||0
8869951|NCT01873950|9926676|FG004|NOT COMPLETED|Period 4||0
8869952|NCT01873950|9926672|FG000|STARTED|Period 5||4
8952570|NCT02464917|10015684|FG001|NOT COMPLETED|Overall Study||0
8952571|NCT02465034|10015692|FG000|STARTED|Overall Study||19
8952572|NCT02465034|10015693|FG001|STARTED|Overall Study||26
8952573|NCT02465034|10015692|FG000|Started PAS|Overall Study||12
8952574|NCT02465034|10015693|FG001|Started PAS|Overall Study||21
8952575|NCT02465034|10015692|FG000|Completed PAS|Overall Study||9
8869953|NCT01873950|9926673|FG001|STARTED|Period 5||5
8869954|NCT01873950|9926674|FG002|STARTED|Period 5||4
8869955|NCT01873950|9926675|FG003|STARTED|Period 5||4
8869956|NCT01873950|9926676|FG004|STARTED|Period 5||4
8869957|NCT01873950|9926672|FG000|COMPLETED|Period 5||4
8869958|NCT01873950|9926673|FG001|COMPLETED|Period 5||5
8869959|NCT01873950|9926674|FG002|COMPLETED|Period 5||4
8869960|NCT01873950|9926675|FG003|COMPLETED|Period 5||3
8869961|NCT01873950|9926676|FG004|COMPLETED|Period 5||4
8869962|NCT01873950|9926672|FG000|NOT COMPLETED|Period 5||0
8869963|NCT01873950|9926673|FG001|NOT COMPLETED|Period 5||0
8869964|NCT01873950|9926674|FG002|NOT COMPLETED|Period 5||0
8869965|NCT01873950|9926675|FG003|NOT COMPLETED|Period 5||1
8869966|NCT01873950|9926676|FG004|NOT COMPLETED|Period 5||0
8869967|NCT01873989|9926692|FG000|STARTED|Overall Study||8
8869968|NCT01873989|9926693|FG001|STARTED|Overall Study||7
8869969|NCT01873989|9926692|FG000|COMPLETED|Overall Study||7
8869970|NCT01873989|9926693|FG001|COMPLETED|Overall Study||6
8869971|NCT01873989|9926692|FG000|NOT COMPLETED|Overall Study||1
8869972|NCT01873989|9926693|FG001|NOT COMPLETED|Overall Study||1
8869973|NCT01874054|9926699|FG000|STARTED|Overall Study||55
8869974|NCT01874054|9926699|FG000|Completed ≥2 Cycles of Combo Treatment|Overall Study||53
8869975|NCT01874054|9926699|FG000|Completed 16 Cycles of BV Treatment|Overall Study||17
8869976|NCT01874054|9926699|FG000|COMPLETED|Overall Study||0
8952576|NCT02465034|10015693|FG001|Completed PAS|Overall Study||20
8952577|NCT02465034|10015692|FG000|Started CC-PAS|Overall Study||16
8952578|NCT02465034|10015693|FG001|Started CC-PAS|Overall Study||0
8952579|NCT02465034|10015692|FG000|Completed CC-PAS|Overall Study||16
8952580|NCT02465034|10015693|FG001|Completed CC-PAS|Overall Study||0
8952581|NCT02465034|10015692|FG000|COMPLETED|Overall Study||16
8869977|NCT01874054|9926699|FG000|NOT COMPLETED|Overall Study||55
8869978|NCT01874119|9926703|FG000|STARTED|First Intervention (6 Days)||8
8869979|NCT01874119|9926704|FG001|STARTED|First Intervention (6 Days)||5
8869980|NCT01874119|9926703|FG000|COMPLETED|First Intervention (6 Days)||7
8869981|NCT01874119|9926704|FG001|COMPLETED|First Intervention (6 Days)||5
8869982|NCT01874119|9926703|FG000|NOT COMPLETED|First Intervention (6 Days)||1
8869983|NCT01874119|9926704|FG001|NOT COMPLETED|First Intervention (6 Days)||0
8869984|NCT01874119|9926703|FG000|STARTED|Washout (7 Days)||7
8869985|NCT01874119|9926704|FG001|STARTED|Washout (7 Days)||5
8869986|NCT01874119|9926703|FG000|COMPLETED|Washout (7 Days)||4
8869987|NCT01874119|9926704|FG001|COMPLETED|Washout (7 Days)||3
8869988|NCT01874119|9926703|FG000|NOT COMPLETED|Washout (7 Days)||3
8869989|NCT01874119|9926704|FG001|NOT COMPLETED|Washout (7 Days)||2
8869990|NCT01874119|9926703|FG000|STARTED|Second Intervention (6 Days)||4
8869991|NCT01874119|9926704|FG001|STARTED|Second Intervention (6 Days)||3
8869992|NCT01874119|9926703|FG000|COMPLETED|Second Intervention (6 Days)||4
8869993|NCT01874119|9926704|FG001|COMPLETED|Second Intervention (6 Days)||3
8869994|NCT01874119|9926703|FG000|NOT COMPLETED|Second Intervention (6 Days)||0
8869995|NCT01874119|9926704|FG001|NOT COMPLETED|Second Intervention (6 Days)||0
8869996|NCT01874132|9926713|FG000|STARTED|Overall Study||22
8869997|NCT01874132|9926714|FG001|STARTED|Overall Study||22
8952582|NCT02465034|10015693|FG001|COMPLETED|Overall Study||20
8952583|NCT02465034|10015692|FG000|NOT COMPLETED|Overall Study||3
8952584|NCT02465034|10015693|FG001|NOT COMPLETED|Overall Study||6
8952585|NCT02465073|10015710|FG000|STARTED|Overall Study||17
8869998|NCT01874132|9926715|FG002|STARTED|Overall Study||22
8869999|NCT01874132|9926713|FG000|COMPLETED|Overall Study||18
8870000|NCT01874132|9926714|FG001|COMPLETED|Overall Study||18
8870001|NCT01874132|9926715|FG002|COMPLETED|Overall Study||19
8870002|NCT01874132|9926713|FG000|NOT COMPLETED|Overall Study||4
8870003|NCT01874132|9926714|FG001|NOT COMPLETED|Overall Study||4
8870004|NCT01874132|9926715|FG002|NOT COMPLETED|Overall Study||3
8870005|NCT01874145|9926725|FG000|STARTED|Core Period||101
8870006|NCT01874145|9926726|FG001|STARTED|Core Period||108
8870007|NCT01874145|9926725|FG000|Full Analysis Set|Core Period||100
8870008|NCT01874145|9926726|FG001|Full Analysis Set|Core Period||108
8870009|NCT01874145|9926725|FG000|COMPLETED|Core Period||98
8870010|NCT01874145|9926726|FG001|COMPLETED|Core Period||101
8870011|NCT01874145|9926725|FG000|NOT COMPLETED|Core Period||3
8870012|NCT01874145|9926726|FG001|NOT COMPLETED|Core Period||7
8870013|NCT01874145|9926725|FG000|STARTED|Extension Period|Switchers|97
8870014|NCT01874145|9926726|FG001|STARTED|Extension Period|Non-Switchers|101
8870015|NCT01874145|9926725|FG000|Full Analysis Set|Extension Period||95
8870016|NCT01874145|9926726|FG001|Full Analysis Set|Extension Period||101
8870017|NCT01874145|9926725|FG000|COMPLETED|Extension Period||91
8870018|NCT01874145|9926726|FG001|COMPLETED|Extension Period||97
8952586|NCT02465073|10015711|FG001|STARTED|Overall Study||16
8952587|NCT02465073|10015712|FG002|STARTED|Overall Study||16
8870019|NCT01874145|9926725|FG000|NOT COMPLETED|Extension Period||6
8870020|NCT01874145|9926726|FG001|NOT COMPLETED|Extension Period||4
8870021|NCT01874262|9926738|FG000|STARTED|Overall Study||91
8870022|NCT01874262|9926739|FG001|STARTED|Overall Study||83
8870023|NCT01874262|9926738|FG000|Not Correctly Randomised|Overall Study||2
8870024|NCT01874262|9926739|FG001|Not Correctly Randomised|Overall Study||0
8870025|NCT01874262|9926738|FG000|Not Included Due to Tehnical Issues|Overall Study||3
8870026|NCT01874262|9926739|FG001|Not Included Due to Tehnical Issues|Overall Study||3
8870027|NCT01874262|9926738|FG000|COMPLETED|Overall Study||86
8870028|NCT01874262|9926739|FG001|COMPLETED|Overall Study||80
8870029|NCT01874262|9926738|FG000|NOT COMPLETED|Overall Study||5
8870030|NCT01874262|9926739|FG001|NOT COMPLETED|Overall Study||3
8870031|NCT01874275|9926747|FG000|STARTED|Overall Study||4
8870032|NCT01874275|9926748|FG001|STARTED|Overall Study||2
8870033|NCT01874275|9926747|FG000|COMPLETED|Overall Study||3
8870034|NCT01874275|9926748|FG001|COMPLETED|Overall Study||2
8870035|NCT01874275|9926747|FG000|NOT COMPLETED|Overall Study||1
8870036|NCT01874275|9926748|FG001|NOT COMPLETED|Overall Study||0
8870037|NCT01874288|9926765|FG000|STARTED|Overall Study||3
8870038|NCT01874288|9926766|FG001|STARTED|Overall Study||3
8870039|NCT01874288|9926767|FG002|STARTED|Overall Study||9
8870040|NCT01874288|9926768|FG003|STARTED|Overall Study||7
8870041|NCT01874288|9926769|FG004|STARTED|Overall Study||2
8870042|NCT01874288|9926765|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
8870043|NCT01874288|9926766|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
8870044|NCT01874288|9926767|FG002|Received at Least 1 Dose of Study Drug|Overall Study||9
8870045|NCT01874288|9926768|FG003|Received at Least 1 Dose of Study Drug|Overall Study||7
8870046|NCT01874288|9926769|FG004|Received at Least 1 Dose of Study Drug|Overall Study||2
8870047|NCT01874288|9926765|FG000|COMPLETED|Overall Study||0
8870048|NCT01874288|9926766|FG001|COMPLETED|Overall Study||3
8870049|NCT01874288|9926767|FG002|COMPLETED|Overall Study||4
8952588|NCT02465073|10015710|FG000|COMPLETED|Overall Study||15
8952589|NCT02465073|10015711|FG001|COMPLETED|Overall Study||15
8952590|NCT02465073|10015712|FG002|COMPLETED|Overall Study||15
8952591|NCT02465073|10015710|FG000|NOT COMPLETED|Overall Study||2
8952592|NCT02465073|10015711|FG001|NOT COMPLETED|Overall Study||1
8952593|NCT02465073|10015712|FG002|NOT COMPLETED|Overall Study||1
8952594|NCT02465099|10015722|FG000|STARTED|Overall Study||45
8952595|NCT02465099|10015723|FG001|STARTED|Overall Study||19
8952596|NCT02465099|10015722|FG000|COMPLETED|Overall Study||45
8952597|NCT02465099|10015723|FG001|COMPLETED|Overall Study||19
8952598|NCT02465099|10015722|FG000|NOT COMPLETED|Overall Study||0
8952599|NCT02465099|10015723|FG001|NOT COMPLETED|Overall Study||0
8952600|NCT02465203|10015732|FG000|STARTED|Overall Study||56
8952601|NCT02465203|10015733|FG001|STARTED|Overall Study||36
8952602|NCT02465203|10015734|FG002|STARTED|Overall Study||13
8952603|NCT02465203|10015732|FG000|COMPLETED|Overall Study||0
8952604|NCT02465203|10015733|FG001|COMPLETED|Overall Study||0
8952605|NCT02465203|10015734|FG002|COMPLETED|Overall Study||0
8952606|NCT02465203|10015732|FG000|NOT COMPLETED|Overall Study||56
8952607|NCT02465203|10015733|FG001|NOT COMPLETED|Overall Study||36
8952608|NCT02465203|10015734|FG002|NOT COMPLETED|Overall Study||13
8952609|NCT02465216|10015746|FG000|STARTED|Overall Study||15
8952610|NCT02465216|10015747|FG001|STARTED|Overall Study||5
8952611|NCT02465216|10015748|FG002|STARTED|Overall Study||14
8952612|NCT02465216|10015749|FG003|STARTED|Overall Study||14
8952613|NCT02465216|10015750|FG004|STARTED|Overall Study||12
8952614|NCT02465216|10015746|FG000|COMPLETED|Overall Study||12
8952615|NCT02465216|10015747|FG001|COMPLETED|Overall Study||5
8952616|NCT02465216|10015748|FG002|COMPLETED|Overall Study||13
8952617|NCT02465216|10015749|FG003|COMPLETED|Overall Study||12
8952618|NCT02465216|10015750|FG004|COMPLETED|Overall Study||9
8952619|NCT02465216|10015746|FG000|NOT COMPLETED|Overall Study||3
8952620|NCT02465216|10015747|FG001|NOT COMPLETED|Overall Study||0
8952621|NCT02465216|10015748|FG002|NOT COMPLETED|Overall Study||1
8952622|NCT02465216|10015749|FG003|NOT COMPLETED|Overall Study||2
8952623|NCT02465216|10015750|FG004|NOT COMPLETED|Overall Study||3
8952624|NCT02465372|10015764|FG000|STARTED|Overall Study||349
8952625|NCT02465372|10015765|FG001|STARTED|Overall Study||250
8952626|NCT02465372|10015764|FG000|COMPLETED|Overall Study||227
8952627|NCT02465372|10015765|FG001|COMPLETED|Overall Study||153
8631013|NCT00537576|9670876|FG004|STARTED|Overall Study||1
8631014|NCT00537576|9670877|FG005|STARTED|Overall Study||1
8631015|NCT00537576|9670872|FG000|COMPLETED|Overall Study||3
8631016|NCT00537576|9670873|FG001|COMPLETED|Overall Study||3
8631017|NCT00537576|9670874|FG002|COMPLETED|Overall Study||3
8631018|NCT00537576|9670875|FG003|COMPLETED|Overall Study||1
8631019|NCT00537576|9670876|FG004|COMPLETED|Overall Study||1
8631020|NCT00537576|9670877|FG005|COMPLETED|Overall Study||1
8631021|NCT00537576|9670872|FG000|NOT COMPLETED|Overall Study||0
8870050|NCT01874288|9926768|FG003|COMPLETED|Overall Study||0
8870051|NCT01874288|9926769|FG004|COMPLETED|Overall Study||0
8870052|NCT01874288|9926765|FG000|NOT COMPLETED|Overall Study||3
8870053|NCT01874288|9926766|FG001|NOT COMPLETED|Overall Study||0
8870054|NCT01874288|9926767|FG002|NOT COMPLETED|Overall Study||5
8870055|NCT01874288|9926768|FG003|NOT COMPLETED|Overall Study||7
8870056|NCT01874288|9926769|FG004|NOT COMPLETED|Overall Study||2
8870057|NCT01874340|9926786|FG000|STARTED|Overall Study||6
8952628|NCT02465372|10015764|FG000|NOT COMPLETED|Overall Study||122
8952629|NCT02465372|10015765|FG001|NOT COMPLETED|Overall Study||97
8952630|NCT02465437|10015775|FG000|STARTED|Overall Study||9
8870058|NCT01874340|9926787|FG001|STARTED|Overall Study||8
8870059|NCT01874340|9926788|FG002|STARTED|Overall Study||8
8870060|NCT01874340|9926789|FG003|STARTED|Overall Study||6
8870061|NCT01874340|9926786|FG000|COMPLETED|Overall Study||0
8870062|NCT01874340|9926787|FG001|COMPLETED|Overall Study||0
8870063|NCT01874340|9926788|FG002|COMPLETED|Overall Study||0
8870064|NCT01874340|9926789|FG003|COMPLETED|Overall Study||1
8870065|NCT01874340|9926786|FG000|NOT COMPLETED|Overall Study||6
8870066|NCT01874340|9926787|FG001|NOT COMPLETED|Overall Study||8
8870067|NCT01874340|9926788|FG002|NOT COMPLETED|Overall Study||8
8870068|NCT01874340|9926789|FG003|NOT COMPLETED|Overall Study||5
8870069|NCT01874392|9926799|FG000|STARTED|Overall Study||9
8870070|NCT01874392|9926799|FG000|COMPLETED|Overall Study||9
8870071|NCT01874392|9926799|FG000|NOT COMPLETED|Overall Study||0
8870072|NCT01874431|9926811|FG000|STARTED|Overall Study||96
8870073|NCT01874431|9926812|FG001|STARTED|Overall Study||92
8870074|NCT01874431|9926813|FG002|STARTED|Overall Study||100
8870075|NCT01874431|9926814|FG003|STARTED|Overall Study||98
8870076|NCT01874431|9926815|FG004|STARTED|Overall Study||98
8870077|NCT01874431|9926816|FG005|STARTED|Overall Study||125
8870078|NCT01874431|9926817|FG006|STARTED|Overall Study||120
8870079|NCT01874431|9926818|FG007|STARTED|Overall Study||94
8870080|NCT01874431|9926811|FG000|Participants Received Treatment|Overall Study||96
8870081|NCT01874431|9926812|FG001|Participants Received Treatment|Overall Study||92
8870082|NCT01874431|9926813|FG002|Participants Received Treatment|Overall Study||100
8870083|NCT01874431|9926814|FG003|Participants Received Treatment|Overall Study||97
8870084|NCT01874431|9926815|FG004|Participants Received Treatment|Overall Study||98
8870085|NCT01874431|9926816|FG005|Participants Received Treatment|Overall Study||125
8870086|NCT01874431|9926817|FG006|Participants Received Treatment|Overall Study||119
8870087|NCT01874431|9926818|FG007|Participants Received Treatment|Overall Study||94
8870088|NCT01874431|9926811|FG000|COMPLETED|Overall Study||90
8870089|NCT01874431|9926812|FG001|COMPLETED|Overall Study||87
8870090|NCT01874431|9926813|FG002|COMPLETED|Overall Study||90
8870091|NCT01874431|9926814|FG003|COMPLETED|Overall Study||91
8870092|NCT01874431|9926815|FG004|COMPLETED|Overall Study||90
8870093|NCT01874431|9926816|FG005|COMPLETED|Overall Study||114
8870094|NCT01874431|9926817|FG006|COMPLETED|Overall Study||112
8870095|NCT01874431|9926818|FG007|COMPLETED|Overall Study||90
8870096|NCT01874431|9926811|FG000|NOT COMPLETED|Overall Study||6
8870097|NCT01874431|9926812|FG001|NOT COMPLETED|Overall Study||5
8870098|NCT01874431|9926813|FG002|NOT COMPLETED|Overall Study||10
8870099|NCT01874431|9926814|FG003|NOT COMPLETED|Overall Study||7
8870100|NCT01874431|9926815|FG004|NOT COMPLETED|Overall Study||8
8870101|NCT01874431|9926816|FG005|NOT COMPLETED|Overall Study||11
8870102|NCT01874431|9926817|FG006|NOT COMPLETED|Overall Study||8
8870103|NCT01874431|9926818|FG007|NOT COMPLETED|Overall Study||4
8870104|NCT01874535|9926838|FG000|STARTED|Overall Study||207
8870105|NCT01874535|9926839|FG001|STARTED|Overall Study||201
8870106|NCT01874535|9926838|FG000|COMPLETED|Overall Study||152
8870107|NCT01874535|9926839|FG001|COMPLETED|Overall Study||157
8870108|NCT01874535|9926838|FG000|NOT COMPLETED|Overall Study||55
8870109|NCT01874535|9926839|FG001|NOT COMPLETED|Overall Study||44
8870110|NCT01874665|9926847|FG000|STARTED|Overall Study||30
8870111|NCT01874665|9926848|FG001|STARTED|Overall Study||15
8870112|NCT01874665|9926847|FG000|COMPLETED|Overall Study||0
8870113|NCT01874665|9926848|FG001|COMPLETED|Overall Study||0
8870114|NCT01874665|9926847|FG000|NOT COMPLETED|Overall Study||30
8870115|NCT01874665|9926848|FG001|NOT COMPLETED|Overall Study||15
8870116|NCT01874756|9926859|FG000|STARTED|Overall Study||29
8870117|NCT01874756|9926860|FG001|STARTED|Overall Study||10
8870118|NCT01874756|9926861|FG002|STARTED|Overall Study||29
8870119|NCT01874756|9926862|FG003|STARTED|Overall Study||27
8870120|NCT01874756|9926859|FG000|COMPLETED|Overall Study||28
8870121|NCT01874756|9926860|FG001|COMPLETED|Overall Study||10
8870122|NCT01874756|9926861|FG002|COMPLETED|Overall Study||27
8870123|NCT01874756|9926862|FG003|COMPLETED|Overall Study||21
8870124|NCT01874756|9926859|FG000|NOT COMPLETED|Overall Study||1
8870125|NCT01874756|9926860|FG001|NOT COMPLETED|Overall Study||0
8870126|NCT01874756|9926861|FG002|NOT COMPLETED|Overall Study||2
8870127|NCT01874756|9926862|FG003|NOT COMPLETED|Overall Study||6
8870128|NCT01874951|9926874|FG000|STARTED|Overall Study||6
8870129|NCT01874951|9926875|FG001|STARTED|Overall Study||6
8870130|NCT01874951|9926874|FG000|COMPLETED|Overall Study||6
8870131|NCT01874951|9926875|FG001|COMPLETED|Overall Study||6
8870132|NCT01874951|9926874|FG000|NOT COMPLETED|Overall Study||0
8870133|NCT01874951|9926875|FG001|NOT COMPLETED|Overall Study||0
8569950|NCT00100048|9602080|FG004|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
8569951|NCT00100048|9602081|FG005|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
8870134|NCT01875159|9926886|FG000|STARTED|Overall Study||45
8870135|NCT01875159|9926887|FG001|STARTED|Overall Study||53
8870136|NCT01875159|9926886|FG000|COMPLETED|Overall Study||42
8870137|NCT01875159|9926887|FG001|COMPLETED|Overall Study||53
8870138|NCT01875159|9926886|FG000|NOT COMPLETED|Overall Study||3
8870139|NCT01875159|9926887|FG001|NOT COMPLETED|Overall Study||0
8870140|NCT01875237|9926895|FG000|STARTED|Overall Study||2
8870141|NCT01875237|9926896|FG001|STARTED|Overall Study||1
8870142|NCT01875237|9926895|FG000|COMPLETED|Overall Study||0
8870143|NCT01875237|9926896|FG001|COMPLETED|Overall Study||1
8870144|NCT01875237|9926895|FG000|NOT COMPLETED|Overall Study||2
8870145|NCT01875237|9926896|FG001|NOT COMPLETED|Overall Study||0
8870146|NCT01875250|9926906|FG000|STARTED|Overall Study||19
8870147|NCT01875250|9926907|FG001|STARTED|Overall Study||19
8870148|NCT01875250|9926906|FG000|COMPLETED|Overall Study||17
8870149|NCT01875250|9926907|FG001|COMPLETED|Overall Study||19
8870150|NCT01875250|9926906|FG000|NOT COMPLETED|Overall Study||2
8870151|NCT01875250|9926907|FG001|NOT COMPLETED|Overall Study||0
8870152|NCT01875367|9926917|FG000|STARTED|Overall Study||81
8870153|NCT01875367|9926918|FG001|STARTED|Overall Study||85
8870154|NCT01875367|9926917|FG000|COMPLETED|Overall Study||76
8870155|NCT01875367|9926918|FG001|COMPLETED|Overall Study||83
8870156|NCT01875367|9926917|FG000|NOT COMPLETED|Overall Study||5
8870157|NCT01875367|9926918|FG001|NOT COMPLETED|Overall Study||2
8870158|NCT01875445|9926930|FG000|STARTED|Overall Study||19
8870159|NCT01875445|9926931|FG001|STARTED|Overall Study||19
8870160|NCT01875445|9926930|FG000|COMPLETED|Overall Study||12
8870161|NCT01875445|9926931|FG001|COMPLETED|Overall Study||19
8870162|NCT01875445|9926930|FG000|NOT COMPLETED|Overall Study||7
8870163|NCT01875445|9926931|FG001|NOT COMPLETED|Overall Study||0
8870164|NCT01875471|9926939|FG000|STARTED|Overall Study||137
8870165|NCT01875471|9926940|FG001|STARTED|Overall Study||138
8870166|NCT01875471|9926939|FG000|Completed Per Protocol|Overall Study||127
8870167|NCT01875471|9926940|FG001|Completed Per Protocol|Overall Study||123
8870168|NCT01875471|9926939|FG000|COMPLETED|Overall Study||136
8870169|NCT01875471|9926940|FG001|COMPLETED|Overall Study||137
8631022|NCT00537576|9670873|FG001|NOT COMPLETED|Overall Study||0
8870170|NCT01875471|9926939|FG000|NOT COMPLETED|Overall Study||1
8870171|NCT01875471|9926940|FG001|NOT COMPLETED|Overall Study||1
8870172|NCT01875510|9926948|FG000|STARTED|Overall Study||40
8870173|NCT01875510|9926949|FG001|STARTED|Overall Study||40
8870174|NCT01875510|9926948|FG000|COMPLETED|Overall Study||40
8870175|NCT01875510|9926949|FG001|COMPLETED|Overall Study||40
8870176|NCT01875510|9926948|FG000|NOT COMPLETED|Overall Study||0
8870177|NCT01875510|9926949|FG001|NOT COMPLETED|Overall Study||0
8923854|NCT02243293|9984482|FG017|COMPLETED|Overall Study||21
8923855|NCT02243293|9984483|FG018|COMPLETED|Overall Study||22
8923856|NCT02243293|9984484|FG019|COMPLETED|Overall Study||47
8923857|NCT02243293|9984485|FG020|COMPLETED|Overall Study||143
8923858|NCT02243293|9984486|FG021|COMPLETED|Overall Study||55
8923859|NCT02243293|9984465|FG000|NOT COMPLETED|Overall Study||2
8923860|NCT02243293|9984466|FG001|NOT COMPLETED|Overall Study||1
8923861|NCT02243293|9984467|FG002|NOT COMPLETED|Overall Study||1
8923862|NCT02243293|9984468|FG003|NOT COMPLETED|Overall Study||1
8923863|NCT02243293|9984469|FG004|NOT COMPLETED|Overall Study||1
8923864|NCT02243293|9984470|FG005|NOT COMPLETED|Overall Study||0
8923865|NCT02243293|9984471|FG006|NOT COMPLETED|Overall Study||3
8923866|NCT02243293|9984472|FG007|NOT COMPLETED|Overall Study||0
8923867|NCT02243293|9984473|FG008|NOT COMPLETED|Overall Study||0
8923868|NCT02243293|9984474|FG009|NOT COMPLETED|Overall Study||2
8923869|NCT02243293|9984475|FG010|NOT COMPLETED|Overall Study||0
8923870|NCT02243293|9984476|FG011|NOT COMPLETED|Overall Study||3
8923871|NCT02243293|9984477|FG012|NOT COMPLETED|Overall Study||0
8923872|NCT02243293|9984478|FG013|NOT COMPLETED|Overall Study||0
8923873|NCT02243293|9984479|FG014|NOT COMPLETED|Overall Study||1
8923874|NCT02243293|9984480|FG015|NOT COMPLETED|Overall Study||1
8923875|NCT02243293|9984481|FG016|NOT COMPLETED|Overall Study||3
8923876|NCT02243293|9984482|FG017|NOT COMPLETED|Overall Study||1
8923877|NCT02243293|9984483|FG018|NOT COMPLETED|Overall Study||0
8923878|NCT02243293|9984484|FG019|NOT COMPLETED|Overall Study||1
8923879|NCT02243293|9984485|FG020|NOT COMPLETED|Overall Study||2
8923880|NCT02243293|9984486|FG021|NOT COMPLETED|Overall Study||3
8923881|NCT02243371|9984525|FG000|STARTED|Overall Study||51
8923882|NCT02243371|9984526|FG001|STARTED|Overall Study||42
8923883|NCT02243371|9984525|FG000|COMPLETED|Overall Study||14
8923884|NCT02243371|9984526|FG001|COMPLETED|Overall Study||10
8923885|NCT02243371|9984525|FG000|NOT COMPLETED|Overall Study||37
8923886|NCT02243371|9984526|FG001|NOT COMPLETED|Overall Study||32
8923887|NCT02243527|9984534|FG000|STARTED|Overall Study||12
8923888|NCT02243527|9984535|FG001|STARTED|Overall Study||13
8923889|NCT02243527|9984534|FG000|COMPLETED|Overall Study||12
8923890|NCT02243527|9984535|FG001|COMPLETED|Overall Study||13
8923891|NCT02243527|9984534|FG000|NOT COMPLETED|Overall Study||0
8923892|NCT02243527|9984535|FG001|NOT COMPLETED|Overall Study||0
8923893|NCT02243579|9984541|FG000|STARTED|Overall Study||24
8923894|NCT02243579|9984541|FG000|COMPLETED|Overall Study||4
8923895|NCT02243579|9984541|FG000|NOT COMPLETED|Overall Study||20
8923896|NCT02243696|9984545|FG000|STARTED|Overall Study||1694
8923897|NCT02243696|9984545|FG000|COMPLETED|Overall Study||0
8923898|NCT02243696|9984545|FG000|NOT COMPLETED|Overall Study||1694
8923899|NCT02243865|9984551|FG000|STARTED|Overall Study||44
8923900|NCT02243865|9984552|FG001|STARTED|Overall Study||43
8631023|NCT00537576|9670874|FG002|NOT COMPLETED|Overall Study||0
8923901|NCT02243865|9984551|FG000|COMPLETED|Overall Study||40
8923902|NCT02243865|9984552|FG001|COMPLETED|Overall Study||38
8923903|NCT02243865|9984551|FG000|NOT COMPLETED|Overall Study||4
8923904|NCT02243865|9984552|FG001|NOT COMPLETED|Overall Study||5
8923905|NCT02243943|9984562|FG000|STARTED|Overall Study||50
8923906|NCT02243943|9984563|FG001|STARTED|Overall Study||50
8923907|NCT02243943|9984562|FG000|COMPLETED|Overall Study||50
8923908|NCT02243943|9984563|FG001|COMPLETED|Overall Study||50
8923909|NCT02243943|9984562|FG000|NOT COMPLETED|Overall Study||0
8923910|NCT02243943|9984563|FG001|NOT COMPLETED|Overall Study||0
8952631|NCT02465437|10015776|FG001|STARTED|Overall Study||9
8952632|NCT02465437|10015777|FG002|STARTED|Overall Study||9
8870178|NCT01875731|9926957|FG000|STARTED|Overall Study||34
8870179|NCT01875731|9926958|FG001|STARTED|Overall Study||32
8870180|NCT01875731|9926957|FG000|COMPLETED|Overall Study||33
8870181|NCT01875731|9926958|FG001|COMPLETED|Overall Study||32
8870182|NCT01875731|9926957|FG000|NOT COMPLETED|Overall Study||1
8870183|NCT01875731|9926958|FG001|NOT COMPLETED|Overall Study||0
8870184|NCT01875783|9926964|FG000|STARTED|Overall Study||385
8870185|NCT01875783|9926964|FG000|COMPLETED|Overall Study||385
8870186|NCT01875783|9926964|FG000|NOT COMPLETED|Overall Study||0
8870187|NCT01875848|9926972|FG000|STARTED|Overall Study|3 patients were enrolled in the Buprenorphine arm of the study|3
8870188|NCT01875848|9926973|FG001|STARTED|Overall Study|4 patients were enrolled in the opioid dose escalation arm of the study|4
8870189|NCT01875848|9926972|FG000|COMPLETED|Overall Study|1 patient completed the Buprenorphine arm of the study. 2 patients withdrew|1
8870190|NCT01875848|9926973|FG001|COMPLETED|Overall Study|4 patients completed the opioid dose escalation arm of the study|4
8870191|NCT01875848|9926972|FG000|NOT COMPLETED|Overall Study||2
8870192|NCT01875848|9926973|FG001|NOT COMPLETED|Overall Study||0
8870193|NCT01875861|9926981|FG000|STARTED|Pre-implementation||4779
8870194|NCT01875861|9926982|FG001|STARTED|Pre-implementation||3714
8870195|NCT01875861|9926981|FG000|COMPLETED|Pre-implementation||4779
8870196|NCT01875861|9926982|FG001|COMPLETED|Pre-implementation||3714
8870197|NCT01875861|9926981|FG000|NOT COMPLETED|Pre-implementation||0
8870198|NCT01875861|9926982|FG001|NOT COMPLETED|Pre-implementation||0
8631024|NCT00537576|9670875|FG003|NOT COMPLETED|Overall Study||0
8631025|NCT00537576|9670876|FG004|NOT COMPLETED|Overall Study||0
8631026|NCT00537576|9670877|FG005|NOT COMPLETED|Overall Study||0
8631027|NCT00537680|9670894|FG000|STARTED|Overall Study||22
8631028|NCT00537680|9670895|FG001|STARTED|Overall Study||24
8631029|NCT00537680|9670896|FG002|STARTED|Overall Study||24
8870199|NCT01875861|9926981|FG000|STARTED|Implementation||4546
8870200|NCT01875861|9926982|FG001|STARTED|Implementation||3444
8870201|NCT01875861|9926981|FG000|COMPLETED|Implementation||4546
8870202|NCT01875861|9926982|FG001|COMPLETED|Implementation||3444
8870203|NCT01875861|9926981|FG000|NOT COMPLETED|Implementation||0
8870204|NCT01875861|9926982|FG001|NOT COMPLETED|Implementation||0
8870205|NCT01875861|9926981|FG000|STARTED|Sustainability||4306
8870206|NCT01875861|9926982|FG001|STARTED|Sustainability||3444
8870207|NCT01875861|9926981|FG000|COMPLETED|Sustainability||4306
8870208|NCT01875861|9926982|FG001|COMPLETED|Sustainability||3444
8870209|NCT01875861|9926981|FG000|NOT COMPLETED|Sustainability||0
8870210|NCT01875861|9926982|FG001|NOT COMPLETED|Sustainability||0
8870211|NCT01875874|9926989|FG000|STARTED|Overall Study||8
8631030|NCT00537680|9670894|FG000|COMPLETED|Overall Study||22
8631031|NCT00537680|9670895|FG001|COMPLETED|Overall Study||22
8631032|NCT00537680|9670896|FG002|COMPLETED|Overall Study||24
8631033|NCT00537680|9670894|FG000|NOT COMPLETED|Overall Study||0
8631034|NCT00537680|9670895|FG001|NOT COMPLETED|Overall Study||2
8631035|NCT00537680|9670896|FG002|NOT COMPLETED|Overall Study||0
8631036|NCT00537745|9670904|FG000|STARTED|Overall Study|There were three screen fails and two early terminations.|14
8631037|NCT00537745|9670904|FG000|Began Intervention|Overall Study||11
8631038|NCT00537745|9670904|FG000|COMPLETED|Overall Study||9
8631039|NCT00537745|9670904|FG000|NOT COMPLETED|Overall Study||5
8631040|NCT00537771|9670911|FG000|STARTED|Overall Study||178
8631041|NCT00537771|9670912|FG001|STARTED|Overall Study||175
8631042|NCT00537771|9670911|FG000|COMPLETED|Overall Study||149
8631043|NCT00537771|9670912|FG001|COMPLETED|Overall Study||114
8631044|NCT00537771|9670911|FG000|NOT COMPLETED|Overall Study||29
8631045|NCT00537771|9670912|FG001|NOT COMPLETED|Overall Study||61
8631046|NCT00537810|9670922|FG000|STARTED|Overall Study||26
8631047|NCT00537810|9670923|FG001|STARTED|Overall Study||27
8631048|NCT00537810|9670924|FG002|STARTED|Overall Study||25
8631049|NCT00537810|9670925|FG003|STARTED|Overall Study||26
8631050|NCT00537810|9670922|FG000|COMPLETED|Overall Study||20
8631051|NCT00537810|9670923|FG001|COMPLETED|Overall Study||14
8631052|NCT00537810|9670924|FG002|COMPLETED|Overall Study||21
8631053|NCT00537810|9670925|FG003|COMPLETED|Overall Study||22
8631054|NCT00537810|9670922|FG000|NOT COMPLETED|Overall Study||6
8631055|NCT00537810|9670923|FG001|NOT COMPLETED|Overall Study||13
8631056|NCT00537810|9670924|FG002|NOT COMPLETED|Overall Study||4
8631057|NCT00537810|9670925|FG003|NOT COMPLETED|Overall Study||4
8631058|NCT00537823|9670937|FG000|STARTED|Overall Study||7
8631059|NCT00537823|9670938|FG001|STARTED|Overall Study||2
8631060|NCT00537823|9670937|FG000|COMPLETED|Overall Study||5
8631061|NCT00537823|9670938|FG001|COMPLETED|Overall Study||2
8870212|NCT01875874|9926989|FG000|COMPLETED|Overall Study||5
8870213|NCT01875874|9926989|FG000|NOT COMPLETED|Overall Study||3
8870214|NCT01875978|9926996|FG000|STARTED|Study 4weeks||20
8631062|NCT00537823|9670937|FG000|NOT COMPLETED|Overall Study||2
8631063|NCT00537823|9670938|FG001|NOT COMPLETED|Overall Study||0
8631064|NCT00537940|9670947|FG000|STARTED|Overall Study||241
8631065|NCT00537940|9670948|FG001|STARTED|Overall Study||241
8631066|NCT00537940|9670947|FG000|Completed Titration Phase|Overall Study||213
8631067|NCT00537940|9670948|FG001|Completed Titration Phase|Overall Study||210
8631068|NCT00537940|9670947|FG000|Completed Maintenance Phase|Overall Study||187
8631069|NCT00537940|9670948|FG001|Completed Maintenance Phase|Overall Study||172
8870215|NCT01875978|9926997|FG001|STARTED|Study 4weeks||20
8870216|NCT01875978|9926996|FG000|COMPLETED|Study 4weeks||20
8870217|NCT01875978|9926997|FG001|COMPLETED|Study 4weeks||20
8631070|NCT00537940|9670947|FG000|Entered Opt Blinded Continuation Phase|Overall Study||140
8693606|NCT00867334|9739131|FG000|NOT COMPLETED|Overall Study||2
8870218|NCT01875978|9926996|FG000|NOT COMPLETED|Study 4weeks||0
8870219|NCT01875978|9926997|FG001|NOT COMPLETED|Study 4weeks||0
8870220|NCT01875978|9926996|FG000|STARTED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
8870221|NCT01875978|9926997|FG001|STARTED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
8870222|NCT01875978|9926996|FG000|COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
8870223|NCT01875978|9926997|FG001|COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
8870224|NCT01875978|9926996|FG000|NOT COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||0
8870225|NCT01875978|9926997|FG001|NOT COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||0
8870226|NCT01875991|9927007|FG000|STARTED|Overall Study||108
8870227|NCT01875991|9927008|FG001|STARTED|Overall Study||109
8870228|NCT01875991|9927007|FG000|Received Etanercept in Period 1|Overall Study||108
8870229|NCT01875991|9927008|FG001|Received Etanercept in Period 1|Overall Study||108
8870230|NCT01875991|9927007|FG000|Received Etanercept in Period 2|Overall Study||102
8870231|NCT01875991|9927008|FG001|Received Etanercept in Period 2|Overall Study||103
8870232|NCT01875991|9927007|FG000|COMPLETED|Overall Study||101
8870233|NCT01875991|9927008|FG001|COMPLETED|Overall Study||103
8870234|NCT01875991|9927007|FG000|NOT COMPLETED|Overall Study||7
8870235|NCT01875991|9927008|FG001|NOT COMPLETED|Overall Study||6
8870236|NCT01876043|9927017|FG000|STARTED|Overall Study||24
8870237|NCT01876043|9927017|FG000|Interim Analysis Population|Overall Study||17
8870238|NCT01876043|9927017|FG000|COMPLETED|Overall Study||22
8870239|NCT01876043|9927017|FG000|NOT COMPLETED|Overall Study||2
8870240|NCT01876082|9927023|FG000|STARTED|Overall Study||48
8870241|NCT01876082|9927024|FG001|STARTED|Overall Study||24
8870242|NCT01876082|9927023|FG000|Safety Population|Overall Study||48
8870243|NCT01876082|9927024|FG001|Safety Population|Overall Study|2 patients did not start control treatment|22
8870244|NCT01876082|9927023|FG000|COMPLETED|Overall Study||46
8870245|NCT01876082|9927024|FG001|COMPLETED|Overall Study||20
8870246|NCT01876082|9927023|FG000|NOT COMPLETED|Overall Study||2
8870247|NCT01876082|9927024|FG001|NOT COMPLETED|Overall Study||4
8870248|NCT01876212|9927032|FG000|STARTED|Overall Study||9
8870249|NCT01876212|9927033|FG001|STARTED|Overall Study||6
8870250|NCT01876212|9927032|FG000|COMPLETED|Overall Study||9
8870251|NCT01876212|9927033|FG001|COMPLETED|Overall Study||6
8870252|NCT01876212|9927032|FG000|NOT COMPLETED|Overall Study||0
8870253|NCT01876212|9927033|FG001|NOT COMPLETED|Overall Study||0
8870254|NCT01876251|9927042|FG000|STARTED|Overall Study||15
8870255|NCT01876251|9927043|FG001|STARTED|Overall Study||3
8870256|NCT01876251|9927044|FG002|STARTED|Overall Study||11
8870257|NCT01876251|9927042|FG000|COMPLETED|Overall Study||0
8870258|NCT01876251|9927043|FG001|COMPLETED|Overall Study||0
8870259|NCT01876251|9927044|FG002|COMPLETED|Overall Study||0
8870260|NCT01876251|9927042|FG000|NOT COMPLETED|Overall Study||15
8870261|NCT01876251|9927043|FG001|NOT COMPLETED|Overall Study||3
8870262|NCT01876251|9927044|FG002|NOT COMPLETED|Overall Study||11
8870263|NCT01876329|9927056|FG000|STARTED|Overall Study||45
8870264|NCT01876329|9927057|FG001|STARTED|Overall Study||36
8870265|NCT01876329|9927058|FG002|STARTED|Overall Study||44
8870266|NCT01876329|9927056|FG000|COMPLETED|Overall Study||45
8870267|NCT01876329|9927057|FG001|COMPLETED|Overall Study||36
8870268|NCT01876329|9927058|FG002|COMPLETED|Overall Study||44
8870269|NCT01876329|9927056|FG000|NOT COMPLETED|Overall Study||0
8870270|NCT01876329|9927057|FG001|NOT COMPLETED|Overall Study||0
8870271|NCT01876329|9927058|FG002|NOT COMPLETED|Overall Study||0
8870272|NCT01876368|9927068|FG000|STARTED|Overall Study||188
8870273|NCT01876368|9927069|FG001|STARTED|Overall Study||188
8870274|NCT01876368|9927068|FG000|Full Analysis Set (FAS)|Overall Study||188
8870275|NCT01876368|9927069|FG001|Full Analysis Set (FAS)|Overall Study|One patient was not included in the SAF and FAS due to mis-randomization.|187
8870276|NCT01876368|9927068|FG000|Safety Set (SAF)|Overall Study||188
8870277|NCT01876368|9927069|FG001|Safety Set (SAF)|Overall Study||187
8870278|NCT01876368|9927068|FG000|COMPLETED|Overall Study||179
8870279|NCT01876368|9927069|FG001|COMPLETED|Overall Study||175
8870280|NCT01876368|9927068|FG000|NOT COMPLETED|Overall Study||9
8870281|NCT01876368|9927069|FG001|NOT COMPLETED|Overall Study||13
8870282|NCT01876381|9927075|FG000|STARTED|Overall Study||23
8870283|NCT01876381|9927075|FG000|COMPLETED|Overall Study||16
8870284|NCT01876381|9927075|FG000|NOT COMPLETED|Overall Study||7
8870285|NCT01876420|9927079|FG000|STARTED|Overall Study||60
8870286|NCT01876420|9927079|FG000|COMPLETED|Overall Study||59
8870287|NCT01876420|9927079|FG000|NOT COMPLETED|Overall Study||1
8870288|NCT01876446|9927085|FG000|STARTED|Overall Study||20
8870289|NCT01876446|9927086|FG001|STARTED|Overall Study||18
8870290|NCT01876446|9927085|FG000|COMPLETED|Overall Study||18
8870291|NCT01876446|9927086|FG001|COMPLETED|Overall Study||12
8870292|NCT01876446|9927085|FG000|NOT COMPLETED|Overall Study||2
8870293|NCT01876446|9927086|FG001|NOT COMPLETED|Overall Study||6
8870294|NCT01876485|9927094|FG000|STARTED|Overall Study||140
8870295|NCT01876485|9927095|FG001|STARTED|Overall Study||140
8870296|NCT01876485|9927094|FG000|Post-Intervention|Overall Study||125
8870297|NCT01876485|9927095|FG001|Post-Intervention|Overall Study||129
8870298|NCT01876485|9927094|FG000|Maintenance|Overall Study||116
8870299|NCT01876485|9927095|FG001|Maintenance|Overall Study||114
8870300|NCT01876485|9927094|FG000|COMPLETED|Overall Study||116
8870301|NCT01876485|9927095|FG001|COMPLETED|Overall Study||114
8870302|NCT01876485|9927094|FG000|NOT COMPLETED|Overall Study||24
8870303|NCT01876485|9927095|FG001|NOT COMPLETED|Overall Study||26
8870304|NCT01876511|9927104|FG000|STARTED|Overall Study||41
8870305|NCT01876511|9927105|FG001|STARTED|Overall Study||25
8870306|NCT01876511|9927106|FG002|STARTED|Overall Study||47
8870307|NCT01876511|9927104|FG000|Stages 1 and 2|Overall Study||24
8870308|NCT01876511|9927105|FG001|Stages 1 and 2|Overall Study||25
8870309|NCT01876511|9927106|FG002|Stages 1 and 2|Overall Study||21
8870310|NCT01876511|9927104|FG000|COMPLETED|Overall Study||18
8870311|NCT01876511|9927105|FG001|COMPLETED|Overall Study||0
8870312|NCT01876511|9927106|FG002|COMPLETED|Overall Study||16
8870313|NCT01876511|9927104|FG000|NOT COMPLETED|Overall Study||23
8870314|NCT01876511|9927105|FG001|NOT COMPLETED|Overall Study||25
8870315|NCT01876511|9927106|FG002|NOT COMPLETED|Overall Study||31
8870316|NCT01876706|9927116|FG000|STARTED|Overall Study||51
8870317|NCT01876706|9927116|FG000|1 Month|Overall Study||51
8870318|NCT01876706|9927116|FG000|3 Months|Overall Study||51
8870319|NCT01876706|9927116|FG000|6 Months|Overall Study||46
8870320|NCT01876706|9927116|FG000|12 Months|Overall Study||42
8870321|NCT01876706|9927116|FG000|24 Months|Overall Study||35
8870322|NCT01876706|9927116|FG000|36 Months|Overall Study||32
8870323|NCT01876706|9927116|FG000|48 Months|Overall Study||31
8870324|NCT01876706|9927116|FG000|60 Months|Overall Study||26
8870325|NCT01876706|9927116|FG000|COMPLETED|Overall Study||26
8870326|NCT01876706|9927116|FG000|NOT COMPLETED|Overall Study||25
8870327|NCT01876732|9927120|FG000|STARTED|Overall Study||132
8870328|NCT01876732|9927120|FG000|COMPLETED|Overall Study||57
8870329|NCT01876732|9927120|FG000|NOT COMPLETED|Overall Study||75
8870330|NCT01876784|9927127|FG000|STARTED|Overall Study||119
8870331|NCT01876784|9927128|FG001|STARTED|Overall Study||119
8870332|NCT01876784|9927127|FG000|Treated|Overall Study||117
8870333|NCT01876784|9927128|FG001|Treated|Overall Study||118
8870334|NCT01876784|9927127|FG000|COMPLETED|Overall Study||0
8870335|NCT01876784|9927128|FG001|COMPLETED|Overall Study||0
8870336|NCT01876784|9927127|FG000|NOT COMPLETED|Overall Study||119
8870337|NCT01876784|9927128|FG001|NOT COMPLETED|Overall Study||119
8870338|NCT01876810|9927134|FG000|STARTED|Overall Study||14
8870339|NCT01876810|9927135|FG001|STARTED|Overall Study||14
8870340|NCT01876810|9927134|FG000|COMPLETED|Overall Study||14
8870341|NCT01876810|9927135|FG001|COMPLETED|Overall Study||13
8870342|NCT01876810|9927134|FG000|NOT COMPLETED|Overall Study||0
8870343|NCT01876810|9927135|FG001|NOT COMPLETED|Overall Study||1
8870344|NCT01876823|9927144|FG000|STARTED|Overall Study||35
8870345|NCT01876823|9927144|FG000|COMPLETED|Overall Study||26
8870346|NCT01876823|9927144|FG000|NOT COMPLETED|Overall Study||9
8870347|NCT01876901|9927150|FG000|STARTED|Overall Study||65
8870348|NCT01876901|9927151|FG001|STARTED|Overall Study||59
8870349|NCT01876901|9927150|FG000|COMPLETED|Overall Study||48
8870350|NCT01876901|9927151|FG001|COMPLETED|Overall Study||52
8870351|NCT01876901|9927150|FG000|NOT COMPLETED|Overall Study||17
8870352|NCT01876901|9927151|FG001|NOT COMPLETED|Overall Study||7
8870353|NCT01876979|9927160|FG000|STARTED|Overall Study||2
8870354|NCT01876979|9927161|FG001|STARTED|Overall Study||3
8870355|NCT01876979|9927160|FG000|COMPLETED|Overall Study||0
8870356|NCT01876979|9927161|FG001|COMPLETED|Overall Study||0
8870357|NCT01876979|9927160|FG000|NOT COMPLETED|Overall Study||2
8870358|NCT01876979|9927161|FG001|NOT COMPLETED|Overall Study||3
8870359|NCT01876992|9927169|FG000|STARTED|Overall Study||5
8631071|NCT00537940|9670948|FG001|Entered Opt Blinded Continuation Phase|Overall Study||139
8631072|NCT00537940|9670947|FG000|COMPLETED|Overall Study|2 participants had both treatment related and non-treatment related AE leading to discontinuation.|58
8631073|NCT00537940|9670948|FG001|COMPLETED|Overall Study||62
8631074|NCT00537940|9670947|FG000|NOT COMPLETED|Overall Study||183
8870360|NCT01876992|9927170|FG001|STARTED|Overall Study||5
8870361|NCT01876992|9927169|FG000|COMPLETED|Overall Study||5
8870362|NCT01876992|9927170|FG001|COMPLETED|Overall Study||5
8870363|NCT01876992|9927169|FG000|NOT COMPLETED|Overall Study||0
8870364|NCT01876992|9927170|FG001|NOT COMPLETED|Overall Study||0
8870365|NCT01877083|9927177|FG000|STARTED|Treatment Phase||25
8870366|NCT01877083|9927177|FG000|COMPLETED|Treatment Phase||5
8870367|NCT01877083|9927177|FG000|NOT COMPLETED|Treatment Phase||20
8870368|NCT01877083|9927177|FG000|STARTED|Extension Phase||5
8870369|NCT01877083|9927177|FG000|COMPLETED|Extension Phase||0
8870370|NCT01877083|9927177|FG000|NOT COMPLETED|Extension Phase||5
8870371|NCT01877148|9927183|FG000|STARTED|Overall Study||6
8870372|NCT01877148|9927184|FG001|STARTED|Overall Study||6
8870373|NCT01877148|9927183|FG000|COMPLETED|Overall Study||5
8870374|NCT01877148|9927184|FG001|COMPLETED|Overall Study||5
8870375|NCT01877148|9927183|FG000|NOT COMPLETED|Overall Study||1
8870376|NCT01877148|9927184|FG001|NOT COMPLETED|Overall Study||1
8870377|NCT01877161|9927190|FG000|STARTED|First Session of Stimulation||12
8870378|NCT01877161|9927190|FG000|COMPLETED|First Session of Stimulation||12
8870379|NCT01877161|9927190|FG000|NOT COMPLETED|First Session of Stimulation||0
8870380|NCT01877161|9927190|FG000|STARTED|Washout (at Least 3 Days)||12
8870381|NCT01877161|9927190|FG000|COMPLETED|Washout (at Least 3 Days)||12
8870382|NCT01877161|9927190|FG000|NOT COMPLETED|Washout (at Least 3 Days)||0
8870383|NCT01877161|9927190|FG000|STARTED|Second Session of Stimulation||12
8870384|NCT01877161|9927190|FG000|COMPLETED|Second Session of Stimulation||12
8870385|NCT01877161|9927190|FG000|NOT COMPLETED|Second Session of Stimulation||0
8870386|NCT01877161|9927190|FG000|STARTED|Washout (at Least 3 Days)||12
8870387|NCT01877161|9927190|FG000|COMPLETED|Washout (at Least 3 Days)||12
8870388|NCT01877161|9927190|FG000|NOT COMPLETED|Washout (at Least 3 Days)||0
8870389|NCT01877161|9927190|FG000|STARTED|Third Session of Stimulation||12
8870390|NCT01877161|9927190|FG000|COMPLETED|Third Session of Stimulation||12
8870391|NCT01877161|9927190|FG000|NOT COMPLETED|Third Session of Stimulation||0
8870392|NCT01877187|9927198|FG000|STARTED|Overall Study|21 HCC, 18 non-HCC|39
8870393|NCT01877187|9927198|FG000|Completed 30 Day f/u|Overall Study|18 HCC, 17 non-HCC|35
8870394|NCT01877187|9927198|FG000|Completed 90 Day f/u|Overall Study|11 HCC, 9 non-HCC|20
8870395|NCT01877187|9927198|FG000|COMPLETED|Overall Study|10 HCC, 7 non-HCC|17
8870396|NCT01877187|9927198|FG000|NOT COMPLETED|Overall Study||22
8870397|NCT01877239|9927205|FG000|STARTED|Overall Study||111
8870398|NCT01877239|9927205|FG000|Treated|Overall Study||76
8870399|NCT01877239|9927205|FG000|COMPLETED|Overall Study||61
8870400|NCT01877239|9927205|FG000|NOT COMPLETED|Overall Study||50
8870401|NCT01877265|9927209|FG000|STARTED|Treatment Period 1||3
8870402|NCT01877265|9927210|FG001|STARTED|Treatment Period 1||3
8870403|NCT01877265|9927211|FG002|STARTED|Treatment Period 1||3
8870404|NCT01877265|9927212|FG003|STARTED|Treatment Period 1||3
8870405|NCT01877265|9927213|FG004|STARTED|Treatment Period 1||3
8870406|NCT01877265|9927214|FG005|STARTED|Treatment Period 1||3
8870407|NCT01877265|9927209|FG000|Received at Least One Dose of Study Drug|Treatment Period 1||3
8870408|NCT01877265|9927210|FG001|Received at Least One Dose of Study Drug|Treatment Period 1||3
8870409|NCT01877265|9927211|FG002|Received at Least One Dose of Study Drug|Treatment Period 1||3
8870410|NCT01877265|9927212|FG003|Received at Least One Dose of Study Drug|Treatment Period 1||3
8870411|NCT01877265|9927213|FG004|Received at Least One Dose of Study Drug|Treatment Period 1||3
8870412|NCT01877265|9927214|FG005|Received at Least One Dose of Study Drug|Treatment Period 1||3
8870413|NCT01877265|9927209|FG000|COMPLETED|Treatment Period 1||3
8870414|NCT01877265|9927210|FG001|COMPLETED|Treatment Period 1||3
8870415|NCT01877265|9927211|FG002|COMPLETED|Treatment Period 1||2
8870416|NCT01877265|9927212|FG003|COMPLETED|Treatment Period 1||3
8870417|NCT01877265|9927213|FG004|COMPLETED|Treatment Period 1||3
8870418|NCT01877265|9927214|FG005|COMPLETED|Treatment Period 1||3
8870419|NCT01877265|9927209|FG000|NOT COMPLETED|Treatment Period 1||0
8870420|NCT01877265|9927210|FG001|NOT COMPLETED|Treatment Period 1||0
8870421|NCT01877265|9927211|FG002|NOT COMPLETED|Treatment Period 1||1
8870422|NCT01877265|9927212|FG003|NOT COMPLETED|Treatment Period 1||0
8870423|NCT01877265|9927213|FG004|NOT COMPLETED|Treatment Period 1||0
8870424|NCT01877265|9927214|FG005|NOT COMPLETED|Treatment Period 1||0
8870425|NCT01877265|9927209|FG000|STARTED|Washout Period 1 (at Least 14 Days)||3
8870426|NCT01877265|9927210|FG001|STARTED|Washout Period 1 (at Least 14 Days)||3
8870427|NCT01877265|9927211|FG002|STARTED|Washout Period 1 (at Least 14 Days)||2
8870428|NCT01877265|9927212|FG003|STARTED|Washout Period 1 (at Least 14 Days)||3
8870429|NCT01877265|9927213|FG004|STARTED|Washout Period 1 (at Least 14 Days)||3
8870430|NCT01877265|9927214|FG005|STARTED|Washout Period 1 (at Least 14 Days)||3
8870431|NCT01877265|9927209|FG000|COMPLETED|Washout Period 1 (at Least 14 Days)||3
8870432|NCT01877265|9927210|FG001|COMPLETED|Washout Period 1 (at Least 14 Days)||3
8870433|NCT01877265|9927211|FG002|COMPLETED|Washout Period 1 (at Least 14 Days)||2
8870434|NCT01877265|9927212|FG003|COMPLETED|Washout Period 1 (at Least 14 Days)||3
8870435|NCT01877265|9927213|FG004|COMPLETED|Washout Period 1 (at Least 14 Days)||3
8870436|NCT01877265|9927214|FG005|COMPLETED|Washout Period 1 (at Least 14 Days)||3
8870437|NCT01877265|9927209|FG000|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
8870438|NCT01877265|9927210|FG001|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
8870439|NCT01877265|9927211|FG002|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
8870440|NCT01877265|9927212|FG003|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
8870441|NCT01877265|9927213|FG004|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
8870442|NCT01877265|9927214|FG005|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
8870443|NCT01877265|9927209|FG000|STARTED|Treatment Period 2||3
8870444|NCT01877265|9927210|FG001|STARTED|Treatment Period 2||3
8870445|NCT01877265|9927211|FG002|STARTED|Treatment Period 2||2
8870446|NCT01877265|9927212|FG003|STARTED|Treatment Period 2||3
8870447|NCT01877265|9927213|FG004|STARTED|Treatment Period 2||3
8870448|NCT01877265|9927214|FG005|STARTED|Treatment Period 2||3
8870449|NCT01877265|9927209|FG000|Received at Least One Dose of Study Drug|Treatment Period 2||3
8870450|NCT01877265|9927210|FG001|Received at Least One Dose of Study Drug|Treatment Period 2||3
8870451|NCT01877265|9927211|FG002|Received at Least One Dose of Study Drug|Treatment Period 2||2
8870452|NCT01877265|9927212|FG003|Received at Least One Dose of Study Drug|Treatment Period 2||3
8870453|NCT01877265|9927213|FG004|Received at Least One Dose of Study Drug|Treatment Period 2||3
8870454|NCT01877265|9927214|FG005|Received at Least One Dose of Study Drug|Treatment Period 2||3
8870455|NCT01877265|9927209|FG000|COMPLETED|Treatment Period 2||3
8870456|NCT01877265|9927210|FG001|COMPLETED|Treatment Period 2||3
8870457|NCT01877265|9927211|FG002|COMPLETED|Treatment Period 2||2
8870458|NCT01877265|9927212|FG003|COMPLETED|Treatment Period 2||3
8870459|NCT01877265|9927213|FG004|COMPLETED|Treatment Period 2||3
8870460|NCT01877265|9927214|FG005|COMPLETED|Treatment Period 2||3
8870461|NCT01877265|9927209|FG000|NOT COMPLETED|Treatment Period 2||0
8870462|NCT01877265|9927210|FG001|NOT COMPLETED|Treatment Period 2||0
8870463|NCT01877265|9927211|FG002|NOT COMPLETED|Treatment Period 2||0
8870464|NCT01877265|9927212|FG003|NOT COMPLETED|Treatment Period 2||0
8870465|NCT01877265|9927213|FG004|NOT COMPLETED|Treatment Period 2||0
8870466|NCT01877265|9927214|FG005|NOT COMPLETED|Treatment Period 2||0
8870467|NCT01877265|9927209|FG000|STARTED|Washout Period 2 (at Least 14 Days)||3
8870468|NCT01877265|9927210|FG001|STARTED|Washout Period 2 (at Least 14 Days)||3
8870469|NCT01877265|9927211|FG002|STARTED|Washout Period 2 (at Least 14 Days)||2
8870470|NCT01877265|9927212|FG003|STARTED|Washout Period 2 (at Least 14 Days)||3
8870471|NCT01877265|9927213|FG004|STARTED|Washout Period 2 (at Least 14 Days)||3
8870472|NCT01877265|9927214|FG005|STARTED|Washout Period 2 (at Least 14 Days)||3
8870473|NCT01877265|9927209|FG000|COMPLETED|Washout Period 2 (at Least 14 Days)||3
8870474|NCT01877265|9927210|FG001|COMPLETED|Washout Period 2 (at Least 14 Days)||3
8870475|NCT01877265|9927211|FG002|COMPLETED|Washout Period 2 (at Least 14 Days)||2
8870476|NCT01877265|9927212|FG003|COMPLETED|Washout Period 2 (at Least 14 Days)||3
8870477|NCT01877265|9927213|FG004|COMPLETED|Washout Period 2 (at Least 14 Days)||3
8870478|NCT01877265|9927214|FG005|COMPLETED|Washout Period 2 (at Least 14 Days)||2
8870479|NCT01877265|9927209|FG000|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
8870480|NCT01877265|9927210|FG001|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
8870481|NCT01877265|9927211|FG002|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
8870482|NCT01877265|9927212|FG003|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
8870483|NCT01877265|9927213|FG004|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
8870484|NCT01877265|9927214|FG005|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||1
8870485|NCT01877265|9927209|FG000|STARTED|Treatment Period 3||3
8870486|NCT01877265|9927210|FG001|STARTED|Treatment Period 3||3
8870487|NCT01877265|9927211|FG002|STARTED|Treatment Period 3||2
8870488|NCT01877265|9927212|FG003|STARTED|Treatment Period 3||3
8870489|NCT01877265|9927213|FG004|STARTED|Treatment Period 3||3
8870490|NCT01877265|9927214|FG005|STARTED|Treatment Period 3||2
8870491|NCT01877265|9927209|FG000|Received at Least One Dose of Study Drug|Treatment Period 3||3
8870492|NCT01877265|9927210|FG001|Received at Least One Dose of Study Drug|Treatment Period 3||3
8870493|NCT01877265|9927211|FG002|Received at Least One Dose of Study Drug|Treatment Period 3||2
8870494|NCT01877265|9927212|FG003|Received at Least One Dose of Study Drug|Treatment Period 3||3
8870495|NCT01877265|9927213|FG004|Received at Least One Dose of Study Drug|Treatment Period 3||3
8870496|NCT01877265|9927214|FG005|Received at Least One Dose of Study Drug|Treatment Period 3||2
8870497|NCT01877265|9927209|FG000|COMPLETED|Treatment Period 3||2
8870498|NCT01877265|9927210|FG001|COMPLETED|Treatment Period 3||3
8870499|NCT01877265|9927211|FG002|COMPLETED|Treatment Period 3||2
8870500|NCT01877265|9927212|FG003|COMPLETED|Treatment Period 3||3
8870501|NCT01877265|9927213|FG004|COMPLETED|Treatment Period 3||3
8870502|NCT01877265|9927214|FG005|COMPLETED|Treatment Period 3||2
8870503|NCT01877265|9927209|FG000|NOT COMPLETED|Treatment Period 3||1
8870504|NCT01877265|9927210|FG001|NOT COMPLETED|Treatment Period 3||0
8870505|NCT01877265|9927211|FG002|NOT COMPLETED|Treatment Period 3||0
8631075|NCT00537940|9670948|FG001|NOT COMPLETED|Overall Study||179
8631076|NCT00537979|9670956|FG000|STARTED|Overall Study||38
8631077|NCT00537979|9670957|FG001|STARTED|Overall Study||109
8631078|NCT00537979|9670956|FG000|COMPLETED|Overall Study||32
8631079|NCT00537979|9670957|FG001|COMPLETED|Overall Study||89
8870506|NCT01877265|9927212|FG003|NOT COMPLETED|Treatment Period 3||0
8870507|NCT01877265|9927213|FG004|NOT COMPLETED|Treatment Period 3||0
8870508|NCT01877265|9927214|FG005|NOT COMPLETED|Treatment Period 3||0
8870509|NCT01877278|9927227|FG000|STARTED|Overall Study||33
8870510|NCT01877278|9927228|FG001|STARTED|Overall Study||33
8870511|NCT01877278|9927227|FG000|COMPLETED|Overall Study||30
8870512|NCT01877278|9927228|FG001|COMPLETED|Overall Study||30
8870513|NCT01877278|9927227|FG000|NOT COMPLETED|Overall Study||3
8870514|NCT01877278|9927228|FG001|NOT COMPLETED|Overall Study||3
8870515|NCT01877408|9927236|FG000|STARTED|Overall Study||50
8870516|NCT01877408|9927237|FG001|STARTED|Overall Study||100
8870517|NCT01877408|9927236|FG000|COMPLETED|Overall Study|Completed follow up visit 28 days after procedure|50
8870518|NCT01877408|9927237|FG001|COMPLETED|Overall Study|Completed follow up visit 28 days after procedure|98
8870519|NCT01877408|9927236|FG000|NOT COMPLETED|Overall Study||0
8870520|NCT01877408|9927237|FG001|NOT COMPLETED|Overall Study||2
8870521|NCT01877421|9927276|FG000|STARTED|Phase 1||2
8870522|NCT01877421|9927277|FG001|STARTED|Phase 1||1
8870523|NCT01877421|9927278|FG002|STARTED|Phase 1||4
8870524|NCT01877421|9927279|FG003|STARTED|Phase 1||2
8870525|NCT01877421|9927280|FG004|STARTED|Phase 1||4
8870526|NCT01877421|9927281|FG005|STARTED|Phase 1||2
8870527|NCT01877421|9927282|FG006|STARTED|Phase 1||4
8870528|NCT01877421|9927283|FG007|STARTED|Phase 1||2
8870529|NCT01877421|9927284|FG008|STARTED|Phase 1||7
8870530|NCT01877421|9927285|FG009|STARTED|Phase 1||3
8870531|NCT01877421|9927286|FG010|STARTED|Phase 1||7
8870532|NCT01877421|9927287|FG011|STARTED|Phase 1||3
8870533|NCT01877421|9927288|FG012|STARTED|Phase 1||7
8870534|NCT01877421|9927289|FG013|STARTED|Phase 1||3
8870535|NCT01877421|9927290|FG014|STARTED|Phase 1||7
8870536|NCT01877421|9927291|FG015|STARTED|Phase 1||3
8870537|NCT01877421|9927292|FG016|STARTED|Phase 1||7
8631080|NCT00537979|9670956|FG000|NOT COMPLETED|Overall Study||6
8631081|NCT00537979|9670957|FG001|NOT COMPLETED|Overall Study||20
8870538|NCT01877421|9927293|FG017|STARTED|Phase 1||3
8870539|NCT01877421|9927276|FG000|COMPLETED|Phase 1||2
8870540|NCT01877421|9927277|FG001|COMPLETED|Phase 1||1
8870541|NCT01877421|9927278|FG002|COMPLETED|Phase 1||4
8870542|NCT01877421|9927279|FG003|COMPLETED|Phase 1||2
8870543|NCT01877421|9927280|FG004|COMPLETED|Phase 1||4
8870544|NCT01877421|9927281|FG005|COMPLETED|Phase 1||2
8631082|NCT00538213|9670967|FG000|STARTED|Overall Study||55
8870545|NCT01877421|9927282|FG006|COMPLETED|Phase 1||4
8870546|NCT01877421|9927283|FG007|COMPLETED|Phase 1||2
8870547|NCT01877421|9927284|FG008|COMPLETED|Phase 1||7
8870548|NCT01877421|9927285|FG009|COMPLETED|Phase 1||3
8870549|NCT01877421|9927286|FG010|COMPLETED|Phase 1||7
8870550|NCT01877421|9927287|FG011|COMPLETED|Phase 1||3
8870551|NCT01877421|9927288|FG012|COMPLETED|Phase 1||7
8870552|NCT01877421|9927289|FG013|COMPLETED|Phase 1||3
8870553|NCT01877421|9927290|FG014|COMPLETED|Phase 1||7
8870554|NCT01877421|9927291|FG015|COMPLETED|Phase 1||3
8870555|NCT01877421|9927292|FG016|COMPLETED|Phase 1||7
8870556|NCT01877421|9927293|FG017|COMPLETED|Phase 1||3
8870557|NCT01877421|9927276|FG000|NOT COMPLETED|Phase 1||0
8870558|NCT01877421|9927277|FG001|NOT COMPLETED|Phase 1||0
8870559|NCT01877421|9927278|FG002|NOT COMPLETED|Phase 1||0
8870560|NCT01877421|9927279|FG003|NOT COMPLETED|Phase 1||0
8870561|NCT01877421|9927280|FG004|NOT COMPLETED|Phase 1||0
8870562|NCT01877421|9927281|FG005|NOT COMPLETED|Phase 1||0
8870563|NCT01877421|9927282|FG006|NOT COMPLETED|Phase 1||0
8870564|NCT01877421|9927283|FG007|NOT COMPLETED|Phase 1||0
8870565|NCT01877421|9927284|FG008|NOT COMPLETED|Phase 1||0
8870566|NCT01877421|9927285|FG009|NOT COMPLETED|Phase 1||0
8870567|NCT01877421|9927286|FG010|NOT COMPLETED|Phase 1||0
8870568|NCT01877421|9927287|FG011|NOT COMPLETED|Phase 1||0
8870569|NCT01877421|9927288|FG012|NOT COMPLETED|Phase 1||0
8870570|NCT01877421|9927289|FG013|NOT COMPLETED|Phase 1||0
8870571|NCT01877421|9927290|FG014|NOT COMPLETED|Phase 1||0
8870572|NCT01877421|9927291|FG015|NOT COMPLETED|Phase 1||0
8870573|NCT01877421|9927292|FG016|NOT COMPLETED|Phase 1||0
8870574|NCT01877421|9927293|FG017|NOT COMPLETED|Phase 1||0
8870575|NCT01877421|9927276|FG000|STARTED|Phase 2||0
8870576|NCT01877421|9927277|FG001|STARTED|Phase 2||0
8870577|NCT01877421|9927278|FG002|STARTED|Phase 2||4
8870578|NCT01877421|9927279|FG003|STARTED|Phase 2||2
8870579|NCT01877421|9927280|FG004|STARTED|Phase 2||7
8870580|NCT01877421|9927281|FG005|STARTED|Phase 2||3
8870581|NCT01877421|9927282|FG006|STARTED|Phase 2||7
8870582|NCT01877421|9927283|FG007|STARTED|Phase 2||2
8569952|NCT00100048|9602076|FG000|STARTED|Cohort I & II-Combination Therapy Phase|7 subjects from the Monotherapy Phase and 34 new subjects|41
8569953|NCT00100048|9602077|FG001|STARTED|Cohort I & II-Combination Therapy Phase|7 subjects from the Monotherapy Phase and 33 new subjects|40
8569954|NCT00100048|9602078|FG002|STARTED|Cohort I & II-Combination Therapy Phase|6 subjects from the Monotherapy Phase and 35 new subjects|41
8569955|NCT00100048|9602079|FG003|STARTED|Cohort I & II-Combination Therapy Phase|8 subjects from the Monotherapy Phase and 32 new subjects|40
8569956|NCT00100048|9602080|FG004|STARTED|Cohort I & II-Combination Therapy Phase|participants only assigned Placebo in Cohort I-Monotherapy Phase.|0
8569957|NCT00100048|9602081|FG005|STARTED|Cohort I & II-Combination Therapy Phase|4 subjects from the Monotherapy Phase (Placebo)and 35 new subjects|39
8569958|NCT00100048|9602076|FG000|Treated|Cohort I & II-Combination Therapy Phase||39
8569959|NCT00100048|9602077|FG001|Treated|Cohort I & II-Combination Therapy Phase||40
8569960|NCT00100048|9602078|FG002|Treated|Cohort I & II-Combination Therapy Phase||41
8569961|NCT00100048|9602079|FG003|Treated|Cohort I & II-Combination Therapy Phase||40
8569962|NCT00100048|9602080|FG004|Treated|Cohort I & II-Combination Therapy Phase||0
8569963|NCT00100048|9602081|FG005|Treated|Cohort I & II-Combination Therapy Phase||38
8569964|NCT00100048|9602076|FG000|Never Treated|Cohort I & II-Combination Therapy Phase|Randomised in Cohort II did not start Period|2
8569965|NCT00100048|9602077|FG001|Never Treated|Cohort I & II-Combination Therapy Phase||0
8569966|NCT00100048|9602078|FG002|Never Treated|Cohort I & II-Combination Therapy Phase||0
8569967|NCT00100048|9602079|FG003|Never Treated|Cohort I & II-Combination Therapy Phase||0
8569968|NCT00100048|9602080|FG004|Never Treated|Cohort I & II-Combination Therapy Phase||0
8569969|NCT00100048|9602081|FG005|Never Treated|Cohort I & II-Combination Therapy Phase|Randomised in Cohort II did not start Period|1
8569970|NCT00100048|9602076|FG000|COMPLETED|Cohort I & II-Combination Therapy Phase||27
8569971|NCT00100048|9602077|FG001|COMPLETED|Cohort I & II-Combination Therapy Phase||31
8577565|NCT00159263|9610314|FG004|NOT COMPLETED|Sixth Intervention||0
8870583|NCT01877421|9927284|FG008|STARTED|Phase 2||6
8870584|NCT01877421|9927285|FG009|STARTED|Phase 2||3
8870585|NCT01877421|9927286|FG010|STARTED|Phase 2||7
8870586|NCT01877421|9927287|FG011|STARTED|Phase 2||3
8870587|NCT01877421|9927288|FG012|STARTED|Phase 2||7
8870588|NCT01877421|9927289|FG013|STARTED|Phase 2||3
8870589|NCT01877421|9927290|FG014|STARTED|Phase 2||7
8870590|NCT01877421|9927291|FG015|STARTED|Phase 2||3
8870591|NCT01877421|9927292|FG016|STARTED|Phase 2||0
8870592|NCT01877421|9927293|FG017|STARTED|Phase 2||0
8870593|NCT01877421|9927276|FG000|COMPLETED|Phase 2||0
8870594|NCT01877421|9927277|FG001|COMPLETED|Phase 2||0
8870595|NCT01877421|9927278|FG002|COMPLETED|Phase 2||4
8870596|NCT01877421|9927279|FG003|COMPLETED|Phase 2||2
8870597|NCT01877421|9927280|FG004|COMPLETED|Phase 2||7
8870598|NCT01877421|9927281|FG005|COMPLETED|Phase 2||3
8870599|NCT01877421|9927282|FG006|COMPLETED|Phase 2||6
8870600|NCT01877421|9927283|FG007|COMPLETED|Phase 2||2
8870601|NCT01877421|9927284|FG008|COMPLETED|Phase 2||5
8870602|NCT01877421|9927285|FG009|COMPLETED|Phase 2||3
8870603|NCT01877421|9927286|FG010|COMPLETED|Phase 2||5
8870604|NCT01877421|9927287|FG011|COMPLETED|Phase 2||3
8870605|NCT01877421|9927288|FG012|COMPLETED|Phase 2||6
8870606|NCT01877421|9927289|FG013|COMPLETED|Phase 2||3
8870607|NCT01877421|9927290|FG014|COMPLETED|Phase 2||7
8870608|NCT01877421|9927291|FG015|COMPLETED|Phase 2||2
8870609|NCT01877421|9927292|FG016|COMPLETED|Phase 2||0
8870610|NCT01877421|9927293|FG017|COMPLETED|Phase 2||0
8870611|NCT01877421|9927276|FG000|NOT COMPLETED|Phase 2||0
8870612|NCT01877421|9927277|FG001|NOT COMPLETED|Phase 2||0
8870613|NCT01877421|9927278|FG002|NOT COMPLETED|Phase 2||0
8870614|NCT01877421|9927279|FG003|NOT COMPLETED|Phase 2||0
8870615|NCT01877421|9927280|FG004|NOT COMPLETED|Phase 2||0
8870616|NCT01877421|9927281|FG005|NOT COMPLETED|Phase 2||0
8870617|NCT01877421|9927282|FG006|NOT COMPLETED|Phase 2||1
8870618|NCT01877421|9927283|FG007|NOT COMPLETED|Phase 2||0
8870619|NCT01877421|9927284|FG008|NOT COMPLETED|Phase 2||1
8870620|NCT01877421|9927285|FG009|NOT COMPLETED|Phase 2||0
8870621|NCT01877421|9927286|FG010|NOT COMPLETED|Phase 2||2
8870622|NCT01877421|9927287|FG011|NOT COMPLETED|Phase 2||0
8870623|NCT01877421|9927288|FG012|NOT COMPLETED|Phase 2||1
8870624|NCT01877421|9927289|FG013|NOT COMPLETED|Phase 2||0
8870625|NCT01877421|9927290|FG014|NOT COMPLETED|Phase 2||0
8870626|NCT01877421|9927291|FG015|NOT COMPLETED|Phase 2||1
8870627|NCT01877421|9927292|FG016|NOT COMPLETED|Phase 2||0
8870628|NCT01877421|9927293|FG017|NOT COMPLETED|Phase 2||0
8870629|NCT01877538|9927373|FG000|STARTED|Overall Study||7
8870630|NCT01877538|9927373|FG000|COMPLETED|Overall Study||7
8870631|NCT01877538|9927373|FG000|NOT COMPLETED|Overall Study||0
8870632|NCT01877551|9927379|FG000|STARTED|Overall Study||13
8870633|NCT01877551|9927380|FG001|STARTED|Overall Study||14
8870634|NCT01877551|9927379|FG000|COMPLETED|Overall Study||13
8870635|NCT01877551|9927380|FG001|COMPLETED|Overall Study||13
8870636|NCT01877551|9927379|FG000|NOT COMPLETED|Overall Study||0
8870637|NCT01877551|9927380|FG001|NOT COMPLETED|Overall Study||1
8870638|NCT01877642|9927388|FG000|STARTED|Overall Study||4
8870639|NCT01877642|9927389|FG001|STARTED|Overall Study||3
8870640|NCT01877642|9927390|FG002|STARTED|Overall Study||3
8870641|NCT01877642|9927391|FG003|STARTED|Overall Study||3
8870642|NCT01877642|9927392|FG004|STARTED|Overall Study||3
8870643|NCT01877642|9927393|FG005|STARTED|Overall Study||3
8870644|NCT01877642|9927394|FG006|STARTED|Overall Study||3
8870645|NCT01877642|9927388|FG000|COMPLETED|Overall Study||4
8870646|NCT01877642|9927389|FG001|COMPLETED|Overall Study||3
8870647|NCT01877642|9927390|FG002|COMPLETED|Overall Study||3
8870648|NCT01877642|9927391|FG003|COMPLETED|Overall Study||3
8870649|NCT01877642|9927392|FG004|COMPLETED|Overall Study||3
8870650|NCT01877642|9927393|FG005|COMPLETED|Overall Study||3
8952633|NCT02465437|10015778|FG003|STARTED|Overall Study||15
8952634|NCT02465437|10015775|FG000|COMPLETED|Overall Study||8
8952635|NCT02465437|10015776|FG001|COMPLETED|Overall Study||8
8952636|NCT02465437|10015777|FG002|COMPLETED|Overall Study||8
8952637|NCT02465437|10015778|FG003|COMPLETED|Overall Study||14
8952638|NCT02465437|10015775|FG000|NOT COMPLETED|Overall Study||1
8952639|NCT02465437|10015776|FG001|NOT COMPLETED|Overall Study||1
8952640|NCT02465437|10015777|FG002|NOT COMPLETED|Overall Study||1
8952641|NCT02465437|10015778|FG003|NOT COMPLETED|Overall Study||1
8952642|NCT02465450|10015789|FG000|STARTED|Treatment Period 1||26
8952643|NCT02465450|10015790|FG001|STARTED|Treatment Period 1||24
8952644|NCT02465450|10015791|FG002|STARTED|Treatment Period 1||35
8952645|NCT02465450|10015792|FG003|STARTED|Treatment Period 1||0
8952646|NCT02465450|10015793|FG004|STARTED|Treatment Period 1||0
8952647|NCT02465450|10015794|FG005|STARTED|Treatment Period 1||0
8952648|NCT02465450|10015789|FG000|COMPLETED|Treatment Period 1||24
8952649|NCT02465450|10015790|FG001|COMPLETED|Treatment Period 1||23
8952650|NCT02465450|10015791|FG002|COMPLETED|Treatment Period 1||34
8952651|NCT02465450|10015792|FG003|COMPLETED|Treatment Period 1||0
8952652|NCT02465450|10015793|FG004|COMPLETED|Treatment Period 1||0
8952653|NCT02465450|10015794|FG005|COMPLETED|Treatment Period 1||0
8952654|NCT02465450|10015789|FG000|NOT COMPLETED|Treatment Period 1||2
8870651|NCT01877642|9927394|FG006|COMPLETED|Overall Study||3
8870652|NCT01877642|9927388|FG000|NOT COMPLETED|Overall Study||0
8870653|NCT01877642|9927389|FG001|NOT COMPLETED|Overall Study||0
8870654|NCT01877642|9927390|FG002|NOT COMPLETED|Overall Study||0
8870655|NCT01877642|9927391|FG003|NOT COMPLETED|Overall Study||0
8870656|NCT01877642|9927392|FG004|NOT COMPLETED|Overall Study||0
8870657|NCT01877642|9927393|FG005|NOT COMPLETED|Overall Study||0
8870658|NCT01877642|9927394|FG006|NOT COMPLETED|Overall Study||0
8870659|NCT01877668|9927408|FG000|STARTED|Overall Study|Received treatment|107
8870660|NCT01877668|9927409|FG001|STARTED|Overall Study|Received treatment|104
8870661|NCT01877668|9927410|FG002|STARTED|Overall Study|Received treatment|106
8870662|NCT01877668|9927411|FG003|STARTED|Overall Study|Received treatment|52
8870663|NCT01877668|9927412|FG004|STARTED|Overall Study|Received treatment|53
8870664|NCT01877668|9927408|FG000|COMPLETED|Overall Study||96
8870665|NCT01877668|9927409|FG001|COMPLETED|Overall Study||96
8870666|NCT01877668|9927410|FG002|COMPLETED|Overall Study||94
8870667|NCT01877668|9927411|FG003|COMPLETED|Overall Study||44
8870668|NCT01877668|9927412|FG004|COMPLETED|Overall Study||43
8870669|NCT01877668|9927408|FG000|NOT COMPLETED|Overall Study||11
8870670|NCT01877668|9927409|FG001|NOT COMPLETED|Overall Study||8
8870671|NCT01877668|9927410|FG002|NOT COMPLETED|Overall Study||12
8870672|NCT01877668|9927411|FG003|NOT COMPLETED|Overall Study||8
8870673|NCT01877668|9927412|FG004|NOT COMPLETED|Overall Study||10
8870674|NCT01877720|9927428|FG000|STARTED|Overall Study||8
8870675|NCT01877720|9927429|FG001|STARTED|Overall Study||8
8870676|NCT01877720|9927428|FG000|1st Intervention|Overall Study||7
8870677|NCT01877720|9927429|FG001|1st Intervention|Overall Study||8
8870678|NCT01877720|9927428|FG000|2nd Intervention|Overall Study||7
8870679|NCT01877720|9927429|FG001|2nd Intervention|Overall Study||8
8870680|NCT01877720|9927428|FG000|COMPLETED|Overall Study||7
8870681|NCT01877720|9927429|FG001|COMPLETED|Overall Study||8
8870682|NCT01877720|9927428|FG000|NOT COMPLETED|Overall Study||1
8870683|NCT01877720|9927429|FG001|NOT COMPLETED|Overall Study||0
8870684|NCT01877915|9927437|FG000|STARTED|Overall Study||2507
8870685|NCT01877915|9927438|FG001|STARTED|Overall Study||2515
8870686|NCT01877915|9927437|FG000|COMPLETED|Overall Study||2453
8870687|NCT01877915|9927438|FG001|COMPLETED|Overall Study||2447
8870688|NCT01877915|9927437|FG000|NOT COMPLETED|Overall Study||54
8870689|NCT01877915|9927438|FG001|NOT COMPLETED|Overall Study||68
8870690|NCT01877941|9927444|FG000|STARTED|Overall Study||39
8870691|NCT01877941|9927444|FG000|COMPLETED|Overall Study||39
8870692|NCT01877941|9927444|FG000|NOT COMPLETED|Overall Study||0
8870693|NCT01878006|9927449|FG000|STARTED|Study Session 1||5
8870694|NCT01878006|9927450|FG001|STARTED|Study Session 1||5
8870695|NCT01878006|9927449|FG000|COMPLETED|Study Session 1||5
8870696|NCT01878006|9927450|FG001|COMPLETED|Study Session 1||5
8952655|NCT02465450|10015790|FG001|NOT COMPLETED|Treatment Period 1||1
8952656|NCT02465450|10015791|FG002|NOT COMPLETED|Treatment Period 1||1
8952657|NCT02465450|10015792|FG003|NOT COMPLETED|Treatment Period 1||0
8952658|NCT02465450|10015793|FG004|NOT COMPLETED|Treatment Period 1||0
8952659|NCT02465450|10015794|FG005|NOT COMPLETED|Treatment Period 1||0
8952660|NCT02465450|10015789|FG000|STARTED|Treatment Period 2||0
8952661|NCT02465450|10015790|FG001|STARTED|Treatment Period 2||0
8952662|NCT02465450|10015791|FG002|STARTED|Treatment Period 2||0
8952663|NCT02465450|10015792|FG003|STARTED|Treatment Period 2||30
8952664|NCT02465450|10015793|FG004|STARTED|Treatment Period 2||28
8952665|NCT02465450|10015794|FG005|STARTED|Treatment Period 2||23
8952666|NCT02465450|10015789|FG000|COMPLETED|Treatment Period 2||0
8952667|NCT02465450|10015790|FG001|COMPLETED|Treatment Period 2||0
8952668|NCT02465450|10015791|FG002|COMPLETED|Treatment Period 2||0
8952669|NCT02465450|10015792|FG003|COMPLETED|Treatment Period 2||27
8952670|NCT02465450|10015793|FG004|COMPLETED|Treatment Period 2||24
8952671|NCT02465450|10015794|FG005|COMPLETED|Treatment Period 2||23
8952672|NCT02465450|10015789|FG000|NOT COMPLETED|Treatment Period 2||0
8952673|NCT02465450|10015790|FG001|NOT COMPLETED|Treatment Period 2||0
8952674|NCT02465450|10015791|FG002|NOT COMPLETED|Treatment Period 2||0
8952675|NCT02465450|10015792|FG003|NOT COMPLETED|Treatment Period 2||3
8952676|NCT02465450|10015793|FG004|NOT COMPLETED|Treatment Period 2||4
8952677|NCT02465450|10015794|FG005|NOT COMPLETED|Treatment Period 2||0
8952678|NCT02465463|10015814|FG000|STARTED|Overall Study||8
8952679|NCT02465463|10015815|FG001|STARTED|Overall Study||5
8952680|NCT02465463|10015814|FG000|COMPLETED|Overall Study||4
8952681|NCT02465463|10015815|FG001|COMPLETED|Overall Study||4
8952682|NCT02465463|10015814|FG000|NOT COMPLETED|Overall Study||4
8952683|NCT02465463|10015815|FG001|NOT COMPLETED|Overall Study||1
8952684|NCT02465489|10015822|FG000|STARTED|Overall Study||20
8952685|NCT02465489|10015822|FG000|COMPLETED|Overall Study||15
8952686|NCT02465489|10015822|FG000|NOT COMPLETED|Overall Study||5
8952687|NCT02465515|10015836|FG000|STARTED|Overall Study||4732
8952688|NCT02465515|10015837|FG001|STARTED|Overall Study||4731
8952689|NCT02465515|10015836|FG000|COMPLETED|Overall Study||4578
8952690|NCT02465515|10015837|FG001|COMPLETED|Overall Study||4620
8952691|NCT02465515|10015836|FG000|NOT COMPLETED|Overall Study||154
8952692|NCT02465515|10015837|FG001|NOT COMPLETED|Overall Study||111
8952693|NCT02465528|10015847|FG000|STARTED|Overall Study||1
8952694|NCT02465528|10015848|FG001|STARTED|Overall Study||4
8952695|NCT02465528|10015849|FG002|STARTED|Overall Study||12
8952696|NCT02465528|10015850|FG003|STARTED|Overall Study||5
8952697|NCT02465528|10015847|FG000|COMPLETED|Overall Study||0
8952698|NCT02465528|10015848|FG001|COMPLETED|Overall Study||0
8952699|NCT02465528|10015849|FG002|COMPLETED|Overall Study||0
8952700|NCT02465528|10015850|FG003|COMPLETED|Overall Study||0
8952701|NCT02465528|10015847|FG000|NOT COMPLETED|Overall Study||1
8952702|NCT02465528|10015848|FG001|NOT COMPLETED|Overall Study||4
8952703|NCT02465528|10015849|FG002|NOT COMPLETED|Overall Study||12
8952704|NCT02465528|10015850|FG003|NOT COMPLETED|Overall Study||5
8952705|NCT02465567|10015866|FG000|STARTED|Overall Study||2157
8952706|NCT02465567|10015867|FG001|STARTED|Overall Study||2137
8952707|NCT02465567|10015868|FG002|STARTED|Overall Study||2143
8952708|NCT02465567|10015869|FG003|STARTED|Overall Study||2151
8952709|NCT02465567|10015866|FG000|COMPLETED|Overall Study||1708
8952710|NCT02465567|10015867|FG001|COMPLETED|Overall Study||1713
8952711|NCT02465567|10015868|FG002|COMPLETED|Overall Study||1580
8870697|NCT01878006|9927449|FG000|NOT COMPLETED|Study Session 1||0
8870698|NCT01878006|9927450|FG001|NOT COMPLETED|Study Session 1||0
8870699|NCT01878006|9927449|FG000|STARTED|Study Session 2||5
8870700|NCT01878006|9927450|FG001|STARTED|Study Session 2||5
8870701|NCT01878006|9927449|FG000|COMPLETED|Study Session 2||5
8870702|NCT01878006|9927450|FG001|COMPLETED|Study Session 2||5
8870703|NCT01878006|9927449|FG000|NOT COMPLETED|Study Session 2||0
8870704|NCT01878006|9927450|FG001|NOT COMPLETED|Study Session 2||0
8870705|NCT01878084|9927456|FG000|STARTED|Overall Study||9
8631083|NCT00538213|9670968|FG001|STARTED|Overall Study||40
8631084|NCT00538213|9670969|FG002|STARTED|Overall Study||38
8631085|NCT00538213|9670967|FG000|COMPLETED|Overall Study||55
8631086|NCT00538213|9670968|FG001|COMPLETED|Overall Study||40
8631087|NCT00538213|9670969|FG002|COMPLETED|Overall Study||38
8631088|NCT00538213|9670967|FG000|NOT COMPLETED|Overall Study||0
8631089|NCT00538213|9670968|FG001|NOT COMPLETED|Overall Study||0
8631090|NCT00538213|9670969|FG002|NOT COMPLETED|Overall Study||0
8631091|NCT00538291|9670978|FG000|STARTED|Overall Study||13
8631092|NCT00538291|9670978|FG000|COMPLETED|Overall Study||10
8870706|NCT01878084|9927456|FG000|Test(Received TAMP Bioglass) s|Overall Study||7
8870707|NCT01878084|9927456|FG000|Control (Sockets Were Left Empty)|Overall Study||7
8870708|NCT01878084|9927456|FG000|COMPLETED|Overall Study||7
8870709|NCT01878084|9927456|FG000|NOT COMPLETED|Overall Study||2
8870710|NCT01878097|9927463|FG000|STARTED|Baseline|number of students in 13 intervention schools completing anonymous surveys with non missing data|10725
8870711|NCT01878097|9927464|FG001|STARTED|Baseline|number of students in 13 control schools completing anonymous surveys with non missing data|10081
8870712|NCT01878097|9927463|FG000|COMPLETED|Baseline|Anonymous surveys so only last year data provided as annual completed.|8228
8870713|NCT01878097|9927464|FG001|COMPLETED|Baseline|Anonymous surveys; sum of all completed surveys.|8281
8870714|NCT01878097|9927463|FG000|NOT COMPLETED|Baseline||2497
8870715|NCT01878097|9927464|FG001|NOT COMPLETED|Baseline||1800
8870716|NCT01878097|9927463|FG000|STARTED|Implementation Year 1||11742
8870717|NCT01878097|9927464|FG001|STARTED|Implementation Year 1||9866
8870718|NCT01878097|9927463|FG000|COMPLETED|Implementation Year 1||8540
8870719|NCT01878097|9927464|FG001|COMPLETED|Implementation Year 1||7317
8870720|NCT01878097|9927463|FG000|NOT COMPLETED|Implementation Year 1||3202
8870721|NCT01878097|9927464|FG001|NOT COMPLETED|Implementation Year 1||2549
8870722|NCT01878097|9927463|FG000|STARTED|Implementation Year 2||11567
8870723|NCT01878097|9927464|FG001|STARTED|Implementation Year 2||9611
8870724|NCT01878097|9927463|FG000|COMPLETED|Implementation Year 2||8286
8870725|NCT01878097|9927464|FG001|COMPLETED|Implementation Year 2||6770
8870726|NCT01878097|9927463|FG000|NOT COMPLETED|Implementation Year 2||3281
8870727|NCT01878097|9927464|FG001|NOT COMPLETED|Implementation Year 2||2841
8870728|NCT01878097|9927463|FG000|STARTED|Implementation Year 3||10540
8870729|NCT01878097|9927464|FG001|STARTED|Implementation Year 3||9750
8870730|NCT01878097|9927463|FG000|COMPLETED|Implementation Year 3||7046
8870731|NCT01878097|9927464|FG001|COMPLETED|Implementation Year 3||6770
8870732|NCT01878097|9927463|FG000|NOT COMPLETED|Implementation Year 3||3494
8870733|NCT01878097|9927464|FG001|NOT COMPLETED|Implementation Year 3||2980
8870734|NCT01878097|9927463|FG000|STARTED|Implementation Year 4||10585
8870735|NCT01878097|9927464|FG001|STARTED|Implementation Year 4||9614
8870736|NCT01878097|9927463|FG000|COMPLETED|Implementation Year 4||6981
8870737|NCT01878097|9927464|FG001|COMPLETED|Implementation Year 4||6607
8870738|NCT01878097|9927463|FG000|NOT COMPLETED|Implementation Year 4||3604
8870739|NCT01878097|9927464|FG001|NOT COMPLETED|Implementation Year 4||3007
8870740|NCT01878149|9927472|FG000|STARTED|Overall Study||21
8870741|NCT01878149|9927473|FG001|STARTED|Overall Study||17
8870742|NCT01878149|9927472|FG000|COMPLETED|Overall Study||19
8870743|NCT01878149|9927473|FG001|COMPLETED|Overall Study||15
8870744|NCT01878149|9927472|FG000|NOT COMPLETED|Overall Study||2
8870745|NCT01878149|9927473|FG001|NOT COMPLETED|Overall Study||2
8870746|NCT01878175|9927479|FG000|STARTED|Overall Study||15
8870747|NCT01878175|9927479|FG000|COMPLETED|Overall Study||13
8870748|NCT01878175|9927479|FG000|NOT COMPLETED|Overall Study||2
8870749|NCT01878214|9927486|FG000|STARTED|Overall Study||223
8870750|NCT01878214|9927487|FG001|STARTED|Overall Study||219
8870751|NCT01878214|9927486|FG000|COMPLETED|Overall Study||170
8870752|NCT01878214|9927487|FG001|COMPLETED|Overall Study||175
8870753|NCT01878214|9927486|FG000|NOT COMPLETED|Overall Study||53
8870754|NCT01878214|9927487|FG001|NOT COMPLETED|Overall Study||44
8870755|NCT01878253|9927493|FG000|STARTED|Overall Study||95
8870756|NCT01878253|9927493|FG000|Pre-Operative|Overall Study||95
8870757|NCT01878253|9927493|FG000|6 Weeks|Overall Study||95
8870758|NCT01878253|9927493|FG000|6 Months|Overall Study||90
8870759|NCT01878253|9927493|FG000|1 Year|Overall Study||88
8870760|NCT01878253|9927493|FG000|2 Year|Overall Study||86
8870761|NCT01878253|9927493|FG000|COMPLETED|Overall Study||86
8870762|NCT01878253|9927493|FG000|NOT COMPLETED|Overall Study||9
8870763|NCT01878292|9927505|FG000|STARTED|Randomized||174
8870764|NCT01878292|9927506|FG001|STARTED|Randomized||175
8870765|NCT01878292|9927507|FG002|STARTED|Randomized||180
8631093|NCT00538291|9670978|FG000|NOT COMPLETED|Overall Study||3
8870766|NCT01878292|9927505|FG000|COMPLETED|Randomized||171
8870767|NCT01878292|9927506|FG001|COMPLETED|Randomized||175
8870768|NCT01878292|9927507|FG002|COMPLETED|Randomized||180
8870769|NCT01878292|9927505|FG000|NOT COMPLETED|Randomized||3
8870770|NCT01878292|9927506|FG001|NOT COMPLETED|Randomized||0
8870771|NCT01878292|9927507|FG002|NOT COMPLETED|Randomized||0
8870772|NCT01878292|9927505|FG000|STARTED|Double-blind Treatment Period||171
8870773|NCT01878292|9927506|FG001|STARTED|Double-blind Treatment Period||175
8870774|NCT01878292|9927507|FG002|STARTED|Double-blind Treatment Period||180
8631094|NCT00538304|9670984|FG000|STARTED|Overall Study||151
8870775|NCT01878292|9927505|FG000|COMPLETED|Double-blind Treatment Period||142
8870776|NCT01878292|9927506|FG001|COMPLETED|Double-blind Treatment Period||149
8870777|NCT01878292|9927507|FG002|COMPLETED|Double-blind Treatment Period||161
8870778|NCT01878292|9927505|FG000|NOT COMPLETED|Double-blind Treatment Period||29
8870779|NCT01878292|9927506|FG001|NOT COMPLETED|Double-blind Treatment Period||26
8870780|NCT01878292|9927507|FG002|NOT COMPLETED|Double-blind Treatment Period||19
8870781|NCT01878292|9927505|FG000|STARTED|Double-blind Down-Taper Period||127
8870782|NCT01878292|9927506|FG001|STARTED|Double-blind Down-Taper Period||140
8870783|NCT01878292|9927507|FG002|STARTED|Double-blind Down-Taper Period||146
8870784|NCT01878292|9927505|FG000|COMPLETED|Double-blind Down-Taper Period||122
8870785|NCT01878292|9927506|FG001|COMPLETED|Double-blind Down-Taper Period||132
8870786|NCT01878292|9927507|FG002|COMPLETED|Double-blind Down-Taper Period||142
8870787|NCT01878292|9927505|FG000|NOT COMPLETED|Double-blind Down-Taper Period||5
8870788|NCT01878292|9927506|FG001|NOT COMPLETED|Double-blind Down-Taper Period||8
8870789|NCT01878292|9927507|FG002|NOT COMPLETED|Double-blind Down-Taper Period||4
8870790|NCT01878383|9927517|FG000|STARTED|Overall Study||50
8870791|NCT01878383|9927518|FG001|STARTED|Overall Study||12500
8870792|NCT01878383|9927517|FG000|COMPLETED|Overall Study||50
8870793|NCT01878383|9927518|FG001|COMPLETED|Overall Study||11001
8870794|NCT01878383|9927517|FG000|NOT COMPLETED|Overall Study||0
8870795|NCT01878383|9927518|FG001|NOT COMPLETED|Overall Study||1499
8870796|NCT01878526|9927526|FG000|STARTED|Overall Study||40
8870797|NCT01878526|9927527|FG001|STARTED|Overall Study||40
8870798|NCT01878526|9927526|FG000|COMPLETED|Overall Study||37
8870799|NCT01878526|9927527|FG001|COMPLETED|Overall Study||38
8870800|NCT01878526|9927526|FG000|NOT COMPLETED|Overall Study||3
8870801|NCT01878526|9927527|FG001|NOT COMPLETED|Overall Study||2
8870802|NCT01878604|9927534|FG000|STARTED|Overall Study||5
8870803|NCT01878604|9927534|FG000|COMPLETED|Overall Study||5
8870804|NCT01878604|9927534|FG000|NOT COMPLETED|Overall Study||0
8870805|NCT01878656|9927541|FG000|STARTED|Overall Study||72
8870806|NCT01878656|9927542|FG001|STARTED|Overall Study||72
8870807|NCT01878656|9927541|FG000|COMPLETED|Overall Study||72
8870808|NCT01878656|9927542|FG001|COMPLETED|Overall Study||72
8870809|NCT01878656|9927541|FG000|NOT COMPLETED|Overall Study||0
8870810|NCT01878656|9927542|FG001|NOT COMPLETED|Overall Study||0
8870811|NCT01878799|9927550|FG000|STARTED|Overall Study||37
8870812|NCT01878799|9927551|FG001|STARTED|Overall Study||13
8870813|NCT01878799|9927550|FG000|COMPLETED|Overall Study||36
8870814|NCT01878799|9927551|FG001|COMPLETED|Overall Study||13
8870815|NCT01878799|9927550|FG000|NOT COMPLETED|Overall Study||1
8870816|NCT01878799|9927551|FG001|NOT COMPLETED|Overall Study||0
8870817|NCT01878812|9927559|FG000|STARTED|Overall Study||60
8870818|NCT01878812|9927560|FG001|STARTED|Overall Study||57
8870819|NCT01878812|9927559|FG000|COMPLETED|Overall Study||60
8870820|NCT01878812|9927560|FG001|COMPLETED|Overall Study||57
8870821|NCT01878812|9927559|FG000|NOT COMPLETED|Overall Study||0
8870822|NCT01878812|9927560|FG001|NOT COMPLETED|Overall Study||0
8870823|NCT01878825|9927568|FG000|STARTED|Overall Study||60
8870824|NCT01878825|9927569|FG001|STARTED|Overall Study||60
8870825|NCT01878825|9927568|FG000|COMPLETED|Overall Study||60
8870826|NCT01878825|9927569|FG001|COMPLETED|Overall Study||60
8870827|NCT01878825|9927568|FG000|NOT COMPLETED|Overall Study||0
8870828|NCT01878825|9927569|FG001|NOT COMPLETED|Overall Study||0
8870829|NCT01878890|9927588|FG000|STARTED|Overall Study||5
8870830|NCT01878890|9927589|FG001|STARTED|Overall Study||11
8870831|NCT01878890|9927590|FG002|STARTED|Overall Study||4
8870832|NCT01878890|9927591|FG003|STARTED|Overall Study||5
8870833|NCT01878890|9927588|FG000|COMPLETED|Overall Study||5
8870834|NCT01878890|9927589|FG001|COMPLETED|Overall Study||10
8870835|NCT01878890|9927590|FG002|COMPLETED|Overall Study||4
8870836|NCT01878890|9927591|FG003|COMPLETED|Overall Study||5
8870837|NCT01878890|9927588|FG000|NOT COMPLETED|Overall Study||0
8870838|NCT01878890|9927589|FG001|NOT COMPLETED|Overall Study||1
8870839|NCT01878890|9927590|FG002|NOT COMPLETED|Overall Study||0
8870840|NCT01878890|9927591|FG003|NOT COMPLETED|Overall Study||0
8870841|NCT01879059|9927602|FG000|STARTED|Overall Study||13
8870842|NCT01879059|9927602|FG000|COMPLETED|Overall Study||13
8870843|NCT01879059|9927602|FG000|NOT COMPLETED|Overall Study||0
8870844|NCT01879072|9927606|FG000|STARTED|Overall Study||1860
8870845|NCT01879072|9927606|FG000|COMPLETED|Overall Study||1709
8870846|NCT01879072|9927606|FG000|NOT COMPLETED|Overall Study||151
8870847|NCT01879176|9927612|FG000|STARTED|Overall Study||24
8870848|NCT01879176|9927613|FG001|STARTED|Overall Study||22
8870849|NCT01879176|9927612|FG000|COMPLETED|Overall Study||16
8870850|NCT01879176|9927613|FG001|COMPLETED|Overall Study||16
8870851|NCT01879176|9927612|FG000|NOT COMPLETED|Overall Study||8
8870852|NCT01879176|9927613|FG001|NOT COMPLETED|Overall Study||6
8870853|NCT01879319|9927621|FG000|STARTED|Overall Study||82
8870854|NCT01879319|9927622|FG001|STARTED|Overall Study||82
8870855|NCT01879319|9927621|FG000|Received Treatment|Overall Study||82
8870856|NCT01879319|9927622|FG001|Received Treatment|Overall Study||82
8870857|NCT01879319|9927621|FG000|COMPLETED|Overall Study||80
8870858|NCT01879319|9927622|FG001|COMPLETED|Overall Study||77
8870859|NCT01879319|9927621|FG000|NOT COMPLETED|Overall Study||2
8870860|NCT01879319|9927622|FG001|NOT COMPLETED|Overall Study||5
8870861|NCT01879332|9927631|FG000|STARTED|Overall Study||6
8870862|NCT01879332|9927632|FG001|STARTED|Overall Study||6
8870863|NCT01879332|9927633|FG002|STARTED|Overall Study||4
8870864|NCT01879332|9927631|FG000|COMPLETED|Overall Study||0
8870865|NCT01879332|9927632|FG001|COMPLETED|Overall Study||0
8870866|NCT01879332|9927633|FG002|COMPLETED|Overall Study||0
8870867|NCT01879332|9927631|FG000|NOT COMPLETED|Overall Study||6
8870868|NCT01879332|9927632|FG001|NOT COMPLETED|Overall Study||6
8870869|NCT01879332|9927633|FG002|NOT COMPLETED|Overall Study||4
8870870|NCT01879345|9927644|FG000|STARTED|Single-dose Period||6
8870871|NCT01879345|9927645|FG001|STARTED|Single-dose Period||6
8870872|NCT01879345|9927646|FG002|STARTED|Single-dose Period||6
8870873|NCT01879345|9927644|FG000|COMPLETED|Single-dose Period||6
8870874|NCT01879345|9927645|FG001|COMPLETED|Single-dose Period||6
8870875|NCT01879345|9927646|FG002|COMPLETED|Single-dose Period||6
8870876|NCT01879345|9927644|FG000|NOT COMPLETED|Single-dose Period||0
8952712|NCT02465567|10015869|FG003|COMPLETED|Overall Study||1643
8952713|NCT02465567|10015866|FG000|NOT COMPLETED|Overall Study||449
8952714|NCT02465567|10015867|FG001|NOT COMPLETED|Overall Study||424
8952715|NCT02465567|10015868|FG002|NOT COMPLETED|Overall Study||563
8952716|NCT02465567|10015869|FG003|NOT COMPLETED|Overall Study||508
8952717|NCT02465632|10015882|FG000|STARTED|Overall Study||440
8952718|NCT02465632|10015883|FG001|STARTED|Overall Study||440
8952719|NCT02465632|10015884|FG002|STARTED|Overall Study||220
8952720|NCT02465632|10015882|FG000|COMPLETED|Overall Study||409
8952721|NCT02465632|10015883|FG001|COMPLETED|Overall Study||417
8952722|NCT02465632|10015884|FG002|COMPLETED|Overall Study||203
8952723|NCT02465632|10015882|FG000|NOT COMPLETED|Overall Study||31
8952724|NCT02465632|10015883|FG001|NOT COMPLETED|Overall Study||23
8952725|NCT02465632|10015884|FG002|NOT COMPLETED|Overall Study||17
8952726|NCT02465866|10015893|FG000|STARTED|Period 1||5
8952727|NCT02465866|10015894|FG001|STARTED|Period 1||5
8952728|NCT02465866|10015895|FG002|STARTED|Period 1||5
8952729|NCT02465866|10015896|FG003|STARTED|Period 1||5
8952730|NCT02465866|10015893|FG000|COMPLETED|Period 1||5
8952731|NCT02465866|10015894|FG001|COMPLETED|Period 1||5
8952732|NCT02465866|10015895|FG002|COMPLETED|Period 1||5
8952733|NCT02465866|10015896|FG003|COMPLETED|Period 1||5
8952734|NCT02465866|10015893|FG000|NOT COMPLETED|Period 1||0
8952735|NCT02465866|10015894|FG001|NOT COMPLETED|Period 1||0
8952736|NCT02465866|10015895|FG002|NOT COMPLETED|Period 1||0
8952737|NCT02465866|10015896|FG003|NOT COMPLETED|Period 1||0
8952738|NCT02465866|10015893|FG000|STARTED|Period 1: Washout (14 Days)||5
8952739|NCT02465866|10015894|FG001|STARTED|Period 1: Washout (14 Days)||5
8952740|NCT02465866|10015895|FG002|STARTED|Period 1: Washout (14 Days)||5
8952741|NCT02465866|10015896|FG003|STARTED|Period 1: Washout (14 Days)||5
8952742|NCT02465866|10015893|FG000|COMPLETED|Period 1: Washout (14 Days)||5
8952743|NCT02465866|10015894|FG001|COMPLETED|Period 1: Washout (14 Days)||5
8952744|NCT02465866|10015895|FG002|COMPLETED|Period 1: Washout (14 Days)||5
8952745|NCT02465866|10015896|FG003|COMPLETED|Period 1: Washout (14 Days)||5
8952746|NCT02465866|10015893|FG000|NOT COMPLETED|Period 1: Washout (14 Days)||0
8952747|NCT02465866|10015894|FG001|NOT COMPLETED|Period 1: Washout (14 Days)||0
8952748|NCT02465866|10015895|FG002|NOT COMPLETED|Period 1: Washout (14 Days)||0
8952749|NCT02465866|10015896|FG003|NOT COMPLETED|Period 1: Washout (14 Days)||0
8952750|NCT02465866|10015893|FG000|STARTED|Period 2||5
8952751|NCT02465866|10015894|FG001|STARTED|Period 2||5
8952752|NCT02465866|10015895|FG002|STARTED|Period 2||5
8952753|NCT02465866|10015896|FG003|STARTED|Period 2||5
8952754|NCT02465866|10015893|FG000|COMPLETED|Period 2||5
8952755|NCT02465866|10015894|FG001|COMPLETED|Period 2||5
8952756|NCT02465866|10015895|FG002|COMPLETED|Period 2||5
8952757|NCT02465866|10015896|FG003|COMPLETED|Period 2||5
8952758|NCT02465866|10015893|FG000|NOT COMPLETED|Period 2||0
8952759|NCT02465866|10015894|FG001|NOT COMPLETED|Period 2||0
8952760|NCT02465866|10015895|FG002|NOT COMPLETED|Period 2||0
8952761|NCT02465866|10015896|FG003|NOT COMPLETED|Period 2||0
8952762|NCT02465866|10015893|FG000|STARTED|Period 2: Washout (14 Days)||5
8952763|NCT02465866|10015894|FG001|STARTED|Period 2: Washout (14 Days)||5
8952764|NCT02465866|10015895|FG002|STARTED|Period 2: Washout (14 Days)||5
8952765|NCT02465866|10015896|FG003|STARTED|Period 2: Washout (14 Days)||5
8952766|NCT02465866|10015893|FG000|COMPLETED|Period 2: Washout (14 Days)||5
8952767|NCT02465866|10015894|FG001|COMPLETED|Period 2: Washout (14 Days)||5
8952768|NCT02465866|10015895|FG002|COMPLETED|Period 2: Washout (14 Days)||5
8952769|NCT02465866|10015896|FG003|COMPLETED|Period 2: Washout (14 Days)||5
8952770|NCT02465866|10015893|FG000|NOT COMPLETED|Period 2: Washout (14 Days)||0
8952771|NCT02465866|10015894|FG001|NOT COMPLETED|Period 2: Washout (14 Days)||0
8952772|NCT02465866|10015895|FG002|NOT COMPLETED|Period 2: Washout (14 Days)||0
8952773|NCT02465866|10015896|FG003|NOT COMPLETED|Period 2: Washout (14 Days)||0
8952774|NCT02465866|10015893|FG000|STARTED|Period 3||5
8952775|NCT02465866|10015894|FG001|STARTED|Period 3||5
8952776|NCT02465866|10015895|FG002|STARTED|Period 3||5
8952777|NCT02465866|10015896|FG003|STARTED|Period 3||5
8952778|NCT02465866|10015893|FG000|COMPLETED|Period 3||5
8952779|NCT02465866|10015894|FG001|COMPLETED|Period 3||4
8952780|NCT02465866|10015895|FG002|COMPLETED|Period 3||5
8952781|NCT02465866|10015896|FG003|COMPLETED|Period 3||5
8952782|NCT02465866|10015893|FG000|NOT COMPLETED|Period 3||0
8952783|NCT02465866|10015894|FG001|NOT COMPLETED|Period 3||1
8952784|NCT02465866|10015895|FG002|NOT COMPLETED|Period 3||0
8870877|NCT01879345|9927645|FG001|NOT COMPLETED|Single-dose Period||0
8952785|NCT02465866|10015896|FG003|NOT COMPLETED|Period 3||0
8952786|NCT02465866|10015893|FG000|STARTED|Period 3: Washout (14 Days)||5
8952787|NCT02465866|10015894|FG001|STARTED|Period 3: Washout (14 Days)||4
8952788|NCT02465866|10015895|FG002|STARTED|Period 3: Washout (14 Days)||5
8952789|NCT02465866|10015896|FG003|STARTED|Period 3: Washout (14 Days)||5
8952790|NCT02465866|10015893|FG000|COMPLETED|Period 3: Washout (14 Days)||5
8870878|NCT01879345|9927646|FG002|NOT COMPLETED|Single-dose Period||0
8870879|NCT01879345|9927644|FG000|STARTED|7-day Multiple-dose Period||6
8870880|NCT01879345|9927645|FG001|STARTED|7-day Multiple-dose Period||6
8870881|NCT01879345|9927646|FG002|STARTED|7-day Multiple-dose Period||6
8870882|NCT01879345|9927644|FG000|COMPLETED|7-day Multiple-dose Period||6
8870883|NCT01879345|9927645|FG001|COMPLETED|7-day Multiple-dose Period||6
8870884|NCT01879345|9927646|FG002|COMPLETED|7-day Multiple-dose Period||6
8870885|NCT01879345|9927644|FG000|NOT COMPLETED|7-day Multiple-dose Period||0
8870886|NCT01879345|9927645|FG001|NOT COMPLETED|7-day Multiple-dose Period||0
8870887|NCT01879345|9927646|FG002|NOT COMPLETED|7-day Multiple-dose Period||0
8870888|NCT01879371|9927662|FG000|STARTED|Overall Study||6
8870889|NCT01879371|9927663|FG001|STARTED|Overall Study||6
8870890|NCT01879371|9927664|FG002|STARTED|Overall Study||6
8870891|NCT01879371|9927665|FG003|STARTED|Overall Study||6
8870892|NCT01879371|9927666|FG004|STARTED|Overall Study||6
8870893|NCT01879371|9927667|FG005|STARTED|Overall Study||6
8870894|NCT01879371|9927662|FG000|COMPLETED|Overall Study||6
8870895|NCT01879371|9927663|FG001|COMPLETED|Overall Study||6
8870896|NCT01879371|9927664|FG002|COMPLETED|Overall Study||6
8870897|NCT01879371|9927665|FG003|COMPLETED|Overall Study||6
8870898|NCT01879371|9927666|FG004|COMPLETED|Overall Study||6
8870899|NCT01879371|9927667|FG005|COMPLETED|Overall Study||6
8870900|NCT01879371|9927662|FG000|NOT COMPLETED|Overall Study||0
8870901|NCT01879371|9927663|FG001|NOT COMPLETED|Overall Study||0
8870902|NCT01879371|9927664|FG002|NOT COMPLETED|Overall Study||0
8870903|NCT01879371|9927665|FG003|NOT COMPLETED|Overall Study||0
8870904|NCT01879371|9927666|FG004|NOT COMPLETED|Overall Study||0
8870905|NCT01879371|9927667|FG005|NOT COMPLETED|Overall Study||0
8870906|NCT01879410|9927677|FG000|STARTED|Overall Study||350
8870907|NCT01879410|9927678|FG001|STARTED|Overall Study||350
8870908|NCT01879410|9927677|FG000|Intent-to-Treat Population|Overall Study||349
8870909|NCT01879410|9927678|FG001|Intent-to-Treat Population|Overall Study||348
8870910|NCT01879410|9927677|FG000|COMPLETED|Overall Study||326
8870911|NCT01879410|9927678|FG001|COMPLETED|Overall Study||312
8870912|NCT01879410|9927677|FG000|NOT COMPLETED|Overall Study||24
8870913|NCT01879410|9927678|FG001|NOT COMPLETED|Overall Study||38
8870914|NCT01879540|9927684|FG000|STARTED|Overall Study||63
8870915|NCT01879540|9927684|FG000|COMPLETED|Overall Study||63
8870916|NCT01879540|9927684|FG000|NOT COMPLETED|Overall Study||0
8870917|NCT01879553|9927690|FG000|STARTED|Overall Study||63
8870918|NCT01879553|9927691|FG001|STARTED|Overall Study||63
8870919|NCT01879553|9927690|FG000|COMPLETED|Overall Study||62
8870920|NCT01879553|9927691|FG001|COMPLETED|Overall Study||63
8870921|NCT01879553|9927690|FG000|NOT COMPLETED|Overall Study||1
8870922|NCT01879553|9927691|FG001|NOT COMPLETED|Overall Study||0
8870923|NCT01879579|9927700|FG000|STARTED|Overall Study||33
8870924|NCT01879579|9927701|FG001|STARTED|Overall Study||28
8870925|NCT01879579|9927700|FG000|COMPLETED|Overall Study||28
8870926|NCT01879579|9927701|FG001|COMPLETED|Overall Study||26
8870927|NCT01879579|9927700|FG000|NOT COMPLETED|Overall Study||5
8870928|NCT01879579|9927701|FG001|NOT COMPLETED|Overall Study||2
8870929|NCT01879618|9927710|FG000|STARTED|Overall Study||152
8870930|NCT01879618|9927710|FG000|COMPLETED|Overall Study||131
8870931|NCT01879618|9927710|FG000|NOT COMPLETED|Overall Study||21
8870932|NCT01879683|9927714|FG000|STARTED|Overall Study||10
8870933|NCT01879683|9927714|FG000|COMPLETED|Overall Study||9
8870934|NCT01879683|9927714|FG000|NOT COMPLETED|Overall Study||1
8870935|NCT01879722|9927728|FG000|STARTED|Overall Study||7
8870936|NCT01879722|9927729|FG001|STARTED|Overall Study||8
8870937|NCT01879722|9927730|FG002|STARTED|Overall Study||7
8870938|NCT01879722|9927731|FG003|STARTED|Overall Study||8
8870939|NCT01879722|9927732|FG004|STARTED|Overall Study||8
8870940|NCT01879722|9927733|FG005|STARTED|Overall Study||9
8870941|NCT01879722|9927734|FG006|STARTED|Overall Study||8
8870942|NCT01879722|9927735|FG007|STARTED|Overall Study||8
8870943|NCT01879722|9927736|FG008|STARTED|Overall Study||8
8870944|NCT01879722|9927737|FG009|STARTED|Overall Study||6
8870945|NCT01879722|9927728|FG000|COMPLETED|Overall Study||7
8870946|NCT01879722|9927729|FG001|COMPLETED|Overall Study||7
8870947|NCT01879722|9927730|FG002|COMPLETED|Overall Study||7
8870948|NCT01879722|9927731|FG003|COMPLETED|Overall Study||7
8870949|NCT01879722|9927732|FG004|COMPLETED|Overall Study||7
8870950|NCT01879722|9927733|FG005|COMPLETED|Overall Study||9
8870951|NCT01879722|9927734|FG006|COMPLETED|Overall Study||8
8870952|NCT01879722|9927735|FG007|COMPLETED|Overall Study||7
8870953|NCT01879722|9927736|FG008|COMPLETED|Overall Study||6
8870954|NCT01879722|9927737|FG009|COMPLETED|Overall Study||6
8870955|NCT01879722|9927728|FG000|NOT COMPLETED|Overall Study||0
8870956|NCT01879722|9927729|FG001|NOT COMPLETED|Overall Study||1
8870957|NCT01879722|9927730|FG002|NOT COMPLETED|Overall Study||0
8870958|NCT01879722|9927731|FG003|NOT COMPLETED|Overall Study||1
8870959|NCT01879722|9927732|FG004|NOT COMPLETED|Overall Study||1
8870960|NCT01879722|9927733|FG005|NOT COMPLETED|Overall Study||0
8870961|NCT01879722|9927734|FG006|NOT COMPLETED|Overall Study||0
8870962|NCT01879722|9927735|FG007|NOT COMPLETED|Overall Study||1
8870963|NCT01879722|9927736|FG008|NOT COMPLETED|Overall Study||2
8870964|NCT01879722|9927737|FG009|NOT COMPLETED|Overall Study||0
8952791|NCT02465866|10015894|FG001|COMPLETED|Period 3: Washout (14 Days)||4
8923911|NCT02244424|9984571|FG000|STARTED|Overall Study|Teens were the participants who received the intervention. Data were collected on the infants.|102
8923912|NCT02244424|9984572|FG001|STARTED|Overall Study|Teen participants received the MIHP standard care. Data were collected on infants.|62
8870965|NCT04838054|9927764|FG000|STARTED|Overall Study||29
8870966|NCT04838054|9927765|FG001|STARTED|Overall Study||28
8870967|NCT04838054|9927764|FG000|COMPLETED|Overall Study||27
8870968|NCT04838054|9927765|FG001|COMPLETED|Overall Study||28
8870969|NCT04838054|9927764|FG000|NOT COMPLETED|Overall Study||2
8870970|NCT04838054|9927765|FG001|NOT COMPLETED|Overall Study||0
8870971|NCT04495829|9927771|FG000|STARTED|Overall Study||70
8870972|NCT04495829|9927771|FG000|COMPLETED|Overall Study||65
8870973|NCT04495829|9927771|FG000|NOT COMPLETED|Overall Study||5
8870974|NCT03861052|9927779|FG000|STARTED|Overall Study||159
8870975|NCT03861052|9927780|FG001|STARTED|Overall Study||158
8870976|NCT03861052|9927781|FG002|STARTED|Overall Study||160
8870977|NCT03861052|9927782|FG003|STARTED|Overall Study||159
8870978|NCT03861052|9927779|FG000|Received at Least One Dose of Study Drug|Overall Study||159
8870979|NCT03861052|9927780|FG001|Received at Least One Dose of Study Drug|Overall Study||158
8870980|NCT03861052|9927781|FG002|Received at Least One Dose of Study Drug|Overall Study||160
8870981|NCT03861052|9927782|FG003|Received at Least One Dose of Study Drug|Overall Study||159
8870982|NCT03861052|9927779|FG000|COMPLETED|Overall Study||155
8870983|NCT03861052|9927780|FG001|COMPLETED|Overall Study||151
8870984|NCT03861052|9927781|FG002|COMPLETED|Overall Study||155
8870985|NCT03861052|9927782|FG003|COMPLETED|Overall Study||154
8870986|NCT03861052|9927779|FG000|NOT COMPLETED|Overall Study||4
8870987|NCT03861052|9927780|FG001|NOT COMPLETED|Overall Study||7
8870988|NCT03861052|9927781|FG002|NOT COMPLETED|Overall Study||5
8870989|NCT03861052|9927782|FG003|NOT COMPLETED|Overall Study||5
8870990|NCT03846453|9927799|FG000|STARTED|Placebo Run-in (14 Days)||1108
8870991|NCT03846453|9927800|FG001|STARTED|Placebo Run-in (14 Days)|Participants in this group were randomized after they completed the placebo run-in period.|0
8870992|NCT03846453|9927801|FG002|STARTED|Placebo Run-in (14 Days)|Participants in this group were randomized after they completed the placebo run-in period.|0
8870993|NCT03846453|9927799|FG000|COMPLETED|Placebo Run-in (14 Days)||637
8870994|NCT03846453|9927800|FG001|COMPLETED|Placebo Run-in (14 Days)||0
8870995|NCT03846453|9927801|FG002|COMPLETED|Placebo Run-in (14 Days)||0
8870996|NCT03846453|9927799|FG000|NOT COMPLETED|Placebo Run-in (14 Days)||471
8870997|NCT03846453|9927800|FG001|NOT COMPLETED|Placebo Run-in (14 Days)||0
8870998|NCT03846453|9927801|FG002|NOT COMPLETED|Placebo Run-in (14 Days)||0
8870999|NCT03846453|9927799|FG000|STARTED|Randomized Treatment Period (Days 57±3)|All participants who completed the placebo run-in period and qualified were randomized to either 0.25% HL036 Ophthalmic Solution group or placebo group.|0
8871000|NCT03846453|9927800|FG001|STARTED|Randomized Treatment Period (Days 57±3)||318
8871001|NCT03846453|9927801|FG002|STARTED|Randomized Treatment Period (Days 57±3)||319
8871002|NCT03846453|9927799|FG000|COMPLETED|Randomized Treatment Period (Days 57±3)||0
8871003|NCT03846453|9927800|FG001|COMPLETED|Randomized Treatment Period (Days 57±3)||291
8871004|NCT03846453|9927801|FG002|COMPLETED|Randomized Treatment Period (Days 57±3)||294
8871005|NCT03846453|9927799|FG000|NOT COMPLETED|Randomized Treatment Period (Days 57±3)||0
8871006|NCT03846453|9927800|FG001|NOT COMPLETED|Randomized Treatment Period (Days 57±3)||27
8871007|NCT03846453|9927801|FG002|NOT COMPLETED|Randomized Treatment Period (Days 57±3)||25
8871014|NCT03605862|9927820|FG000|STARTED|Overall Study||872
8871015|NCT03605862|9927821|FG001|STARTED|Overall Study||884
8871016|NCT03605862|9927820|FG000|COMPLETED|Overall Study||844
8871017|NCT03605862|9927821|FG001|COMPLETED|Overall Study||858
8871018|NCT03605862|9927820|FG000|NOT COMPLETED|Overall Study||28
8871019|NCT03605862|9927821|FG001|NOT COMPLETED|Overall Study||26
8871020|NCT03541252|9927828|FG000|STARTED|Overall Study||20
8871021|NCT03541252|9927828|FG000|COMPLETED|Overall Study||19
8871022|NCT03541252|9927828|FG000|NOT COMPLETED|Overall Study||1
8871023|NCT03401112|9927837|FG000|STARTED|Overall Study||15
8871024|NCT03401112|9927838|FG001|STARTED|Overall Study||26
8871025|NCT03401112|9927839|FG002|STARTED|Overall Study||22
8871026|NCT03401112|9927840|FG003|STARTED|Overall Study||27
8871027|NCT03401112|9927841|FG004|STARTED|Overall Study||10
8871028|NCT03401112|9927837|FG000|Received at Least 1 Dose of Study Drug|Overall Study||12
8871029|NCT03401112|9927838|FG001|Received at Least 1 Dose of Study Drug|Overall Study||26
8871030|NCT03401112|9927839|FG002|Received at Least 1 Dose of Study Drug|Overall Study||20
8871031|NCT03401112|9927840|FG003|Received at Least 1 Dose of Study Drug|Overall Study||25
8871032|NCT03401112|9927841|FG004|Received at Least 1 Dose of Study Drug|Overall Study||10
8871033|NCT03401112|9927837|FG000|COMPLETED|Overall Study||10
8871034|NCT03401112|9927838|FG001|COMPLETED|Overall Study||19
8871035|NCT03401112|9927839|FG002|COMPLETED|Overall Study||11
8871036|NCT03401112|9927840|FG003|COMPLETED|Overall Study||21
8871037|NCT03401112|9927841|FG004|COMPLETED|Overall Study||10
8871038|NCT03401112|9927837|FG000|NOT COMPLETED|Overall Study||5
8871039|NCT03401112|9927838|FG001|NOT COMPLETED|Overall Study||7
8871040|NCT03401112|9927839|FG002|NOT COMPLETED|Overall Study||11
8871041|NCT03401112|9927840|FG003|NOT COMPLETED|Overall Study||6
8871042|NCT03401112|9927841|FG004|NOT COMPLETED|Overall Study||0
8871043|NCT03383666|9927868|FG000|STARTED|Overall Study||21
8871044|NCT03383666|9927868|FG000|Implanted With Pulse Rider|Overall Study||18
8871045|NCT03383666|9927868|FG000|Attempted But Unsuccessful Implantation|Overall Study||3
8871046|NCT03383666|9927868|FG000|COMPLETED|Overall Study||17
8871047|NCT03383666|9927868|FG000|NOT COMPLETED|Overall Study||4
8871048|NCT03362112|9927872|FG000|STARTED|Overall Study||1713
8871049|NCT03362112|9927872|FG000|COMPLETED|Overall Study||1622
8871050|NCT03362112|9927872|FG000|NOT COMPLETED|Overall Study||91
8923913|NCT02244424|9984571|FG000|Infants|Overall Study|Infants of participants included in the study for collection of demographic and weight data.|51
8923914|NCT02244424|9984572|FG001|Infants|Overall Study|Infants of participants included in the study for collection of demographic and weight data.|31
8923915|NCT02244424|9984571|FG000|Mothers|Overall Study||51
8923916|NCT02244424|9984572|FG001|Mothers|Overall Study||31
8923917|NCT02244424|9984571|FG000|COMPLETED|Overall Study|Data were collected on all of the infants of the teen moms (n = 41).|82
8923918|NCT02244424|9984572|FG001|COMPLETED|Overall Study|Data were collected on all of the infants of teen moms (n = 26).|52
8923919|NCT02244424|9984571|FG000|NOT COMPLETED|Overall Study||20
8923920|NCT02244424|9984572|FG001|NOT COMPLETED|Overall Study||10
8923921|NCT02244580|9984578|FG000|STARTED|Overall Study||1010
8923922|NCT02244580|9984578|FG000|COMPLETED|Overall Study|An RT-qPCR assay was performed from breast cancer tissues of 769 out of the 1010 patients.|769
8923923|NCT02244580|9984578|FG000|NOT COMPLETED|Overall Study||241
8923924|NCT02244619|9984588|FG000|STARTED|Overall Study||249
8923925|NCT02244619|9984589|FG001|STARTED|Overall Study||266
8923926|NCT02244619|9984588|FG000|COMPLETED|Overall Study||241
8923927|NCT02244619|9984589|FG001|COMPLETED|Overall Study||245
8923928|NCT02244619|9984588|FG000|NOT COMPLETED|Overall Study||8
8923929|NCT02244619|9984589|FG001|NOT COMPLETED|Overall Study||21
8923930|NCT02244840|9984595|FG000|STARTED|Overall Study||40
8923931|NCT02244840|9984595|FG000|COMPLETED|Overall Study||40
8923932|NCT02244840|9984595|FG000|NOT COMPLETED|Overall Study||0
8923933|NCT02244918|9984601|FG000|STARTED|Overall Study||185
8923934|NCT02244918|9984602|FG001|STARTED|Overall Study||93
8923935|NCT02244918|9984601|FG000|Week 12|Overall Study||160
8923936|NCT02244918|9984602|FG001|Week 12|Overall Study||83
8923937|NCT02244918|9984601|FG000|COMPLETED|Overall Study||185
8923938|NCT02244918|9984602|FG001|COMPLETED|Overall Study||93
8923939|NCT02244918|9984601|FG000|NOT COMPLETED|Overall Study||0
8923940|NCT02244918|9984602|FG001|NOT COMPLETED|Overall Study||0
8923941|NCT02244957|9984611|FG000|STARTED|Overall Study||7
8923942|NCT02244957|9984612|FG001|STARTED|Overall Study||16
8923943|NCT02244957|9984611|FG000|COMPLETED|Overall Study||6
8923944|NCT02244957|9984612|FG001|COMPLETED|Overall Study||16
8923945|NCT02244957|9984611|FG000|NOT COMPLETED|Overall Study||1
8923946|NCT02244957|9984612|FG001|NOT COMPLETED|Overall Study||0
8923947|NCT02244996|9984622|FG000|STARTED|Overall Study||25
8923948|NCT02244996|9984623|FG001|STARTED|Overall Study||25
8923949|NCT02244996|9984622|FG000|COMPLETED|Overall Study||23
8923950|NCT02244996|9984623|FG001|COMPLETED|Overall Study||19
8923951|NCT02244996|9984622|FG000|NOT COMPLETED|Overall Study||2
8923952|NCT02244996|9984623|FG001|NOT COMPLETED|Overall Study||6
8923953|NCT02245217|9984629|FG000|STARTED|Overall Study||9
8923954|NCT02245217|9984629|FG000|COMPLETED|Overall Study||7
8923955|NCT02245217|9984629|FG000|NOT COMPLETED|Overall Study||2
8923956|NCT02245360|9984635|FG000|STARTED|Overall Study||53
8923957|NCT02245360|9984636|FG001|STARTED|Overall Study||54
8923958|NCT02245360|9984635|FG000|COMPLETED|Overall Study||48
8923959|NCT02245360|9984636|FG001|COMPLETED|Overall Study||52
8923960|NCT02245360|9984635|FG000|NOT COMPLETED|Overall Study||5
8923961|NCT02245360|9984636|FG001|NOT COMPLETED|Overall Study||2
8923962|NCT02245412|9984645|FG000|STARTED|Treatment Period||17
8923963|NCT02245412|9984646|FG001|STARTED|Treatment Period||6
8923964|NCT02245412|9984647|FG002|STARTED|Treatment Period||2
8923965|NCT02245412|9984645|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||17
8952792|NCT02465866|10015895|FG002|COMPLETED|Period 3: Washout (14 Days)||5
8952793|NCT02465866|10015896|FG003|COMPLETED|Period 3: Washout (14 Days)||5
8952794|NCT02465866|10015893|FG000|NOT COMPLETED|Period 3: Washout (14 Days)||0
8952795|NCT02465866|10015894|FG001|NOT COMPLETED|Period 3: Washout (14 Days)||0
8952796|NCT02465866|10015895|FG002|NOT COMPLETED|Period 3: Washout (14 Days)||0
8952797|NCT02465866|10015896|FG003|NOT COMPLETED|Period 3: Washout (14 Days)||0
8952798|NCT02465866|10015893|FG000|STARTED|Period 4||5
8952799|NCT02465866|10015894|FG001|STARTED|Period 4||4
8952800|NCT02465866|10015895|FG002|STARTED|Period 4||5
8952801|NCT02465866|10015896|FG003|STARTED|Period 4||5
8952802|NCT02465866|10015893|FG000|COMPLETED|Period 4||5
8952803|NCT02465866|10015894|FG001|COMPLETED|Period 4||4
8952804|NCT02465866|10015895|FG002|COMPLETED|Period 4||5
8952805|NCT02465866|10015896|FG003|COMPLETED|Period 4||5
8952806|NCT02465866|10015893|FG000|NOT COMPLETED|Period 4||0
8952807|NCT02465866|10015894|FG001|NOT COMPLETED|Period 4||0
8952808|NCT02465866|10015895|FG002|NOT COMPLETED|Period 4||0
8952809|NCT02465866|10015896|FG003|NOT COMPLETED|Period 4||0
8952810|NCT02465866|10015893|FG000|STARTED|Period 4: Washout (14 Days)||5
8952811|NCT02465866|10015894|FG001|STARTED|Period 4: Washout (14 Days)||4
8952812|NCT02465866|10015895|FG002|STARTED|Period 4: Washout (14 Days)||5
8952813|NCT02465866|10015896|FG003|STARTED|Period 4: Washout (14 Days)||5
8952814|NCT02465866|10015893|FG000|COMPLETED|Period 4: Washout (14 Days)||5
8952815|NCT02465866|10015894|FG001|COMPLETED|Period 4: Washout (14 Days)||4
8952816|NCT02465866|10015895|FG002|COMPLETED|Period 4: Washout (14 Days)||5
8952817|NCT02465866|10015896|FG003|COMPLETED|Period 4: Washout (14 Days)||5
8952818|NCT02465866|10015893|FG000|NOT COMPLETED|Period 4: Washout (14 Days)||0
8952819|NCT02465866|10015894|FG001|NOT COMPLETED|Period 4: Washout (14 Days)||0
8952820|NCT02465866|10015895|FG002|NOT COMPLETED|Period 4: Washout (14 Days)||0
8871051|NCT03158298|9927876|FG000|STARTED|Overall Study||82
8871052|NCT03158298|9927876|FG000|COMPLETED|Overall Study||82
8871053|NCT03158298|9927876|FG000|NOT COMPLETED|Overall Study||0
8871054|NCT03041701|9927883|FG000|STARTED|Ph I: Dose Level 1 and 2 Dose Escalation||7
8871055|NCT03041701|9927884|FG001|STARTED|Ph I: Dose Level 1 and 2 Dose Escalation||6
8871056|NCT03041701|9927885|FG002|STARTED|Ph I: Dose Level 1 and 2 Dose Escalation||0
8871057|NCT03041701|9927883|FG000|COMPLETED|Ph I: Dose Level 1 and 2 Dose Escalation||6
8871058|NCT03041701|9927884|FG001|COMPLETED|Ph I: Dose Level 1 and 2 Dose Escalation||5
8871059|NCT03041701|9927885|FG002|COMPLETED|Ph I: Dose Level 1 and 2 Dose Escalation||0
8871060|NCT03041701|9927883|FG000|NOT COMPLETED|Ph I: Dose Level 1 and 2 Dose Escalation||1
8871061|NCT03041701|9927884|FG001|NOT COMPLETED|Ph I: Dose Level 1 and 2 Dose Escalation||1
8871062|NCT03041701|9927885|FG002|NOT COMPLETED|Ph I: Dose Level 1 and 2 Dose Escalation||0
8871063|NCT03041701|9927883|FG000|STARTED|Ph 2:Dose Level 1 Maximum Tolerated Dose||0
8871064|NCT03041701|9927884|FG001|STARTED|Ph 2:Dose Level 1 Maximum Tolerated Dose||0
8871065|NCT03041701|9927885|FG002|STARTED|Ph 2:Dose Level 1 Maximum Tolerated Dose||1
8871066|NCT03041701|9927883|FG000|COMPLETED|Ph 2:Dose Level 1 Maximum Tolerated Dose||0
8871067|NCT03041701|9927884|FG001|COMPLETED|Ph 2:Dose Level 1 Maximum Tolerated Dose||0
8871068|NCT03041701|9927885|FG002|COMPLETED|Ph 2:Dose Level 1 Maximum Tolerated Dose||0
8871069|NCT03041701|9927883|FG000|NOT COMPLETED|Ph 2:Dose Level 1 Maximum Tolerated Dose||0
8871070|NCT03041701|9927884|FG001|NOT COMPLETED|Ph 2:Dose Level 1 Maximum Tolerated Dose||0
8871071|NCT03041701|9927885|FG002|NOT COMPLETED|Ph 2:Dose Level 1 Maximum Tolerated Dose||1
8871072|NCT03000179|9927896|FG000|STARTED|Overall Study||8
8871073|NCT03000179|9927896|FG000|COMPLETED|Overall Study||6
8871074|NCT03000179|9927896|FG000|NOT COMPLETED|Overall Study||2
8871075|NCT02876835|9927902|FG000|STARTED|Run-in Period: Placebo (Week-4 to Day 1)||1937
8871076|NCT02876835|9927903|FG001|STARTED|Run-in Period: Placebo (Week-4 to Day 1)||1935
8871077|NCT02876835|9927902|FG000|COMPLETED|Run-in Period: Placebo (Week-4 to Day 1)||1937
8871078|NCT02876835|9927903|FG001|COMPLETED|Run-in Period: Placebo (Week-4 to Day 1)||1935
8871079|NCT02876835|9927902|FG000|NOT COMPLETED|Run-in Period: Placebo (Week-4 to Day 1)||0
8871080|NCT02876835|9927903|FG001|NOT COMPLETED|Run-in Period: Placebo (Week-4 to Day 1)||0
8871081|NCT02876835|9927902|FG000|STARTED|Treatment Period (51.1 Month)||1937
8871082|NCT02876835|9927903|FG001|STARTED|Treatment Period (51.1 Month)||1935
8871083|NCT02876835|9927902|FG000|COMPLETED|Treatment Period (51.1 Month)||1873
8871084|NCT02876835|9927903|FG001|COMPLETED|Treatment Period (51.1 Month)||1870
8871085|NCT02876835|9927902|FG000|NOT COMPLETED|Treatment Period (51.1 Month)||64
8871086|NCT02876835|9927903|FG001|NOT COMPLETED|Treatment Period (51.1 Month)||65
8871087|NCT02860039|9927912|FG000|STARTED|Overall Study||84
8871088|NCT02860039|9927913|FG001|STARTED|Overall Study||86
8871089|NCT02860039|9927912|FG000|Visit 1|Overall Study||84
8871090|NCT02860039|9927913|FG001|Visit 1|Overall Study||86
8871091|NCT02860039|9927912|FG000|Visit 2|Overall Study||83
8871092|NCT02860039|9927913|FG001|Visit 2|Overall Study||84
8871093|NCT02860039|9927912|FG000|Visit 3|Overall Study||77
8871094|NCT02860039|9927913|FG001|Visit 3|Overall Study||84
8871095|NCT02860039|9927912|FG000|Visit 4|Overall Study||73
8871096|NCT02860039|9927913|FG001|Visit 4|Overall Study||82
8871097|NCT02860039|9927912|FG000|Visit 1 Repeat|Overall Study||31
8871098|NCT02860039|9927913|FG001|Visit 1 Repeat|Overall Study||35
8871099|NCT02860039|9927912|FG000|Visit 2 Repeat|Overall Study||30
8871100|NCT02860039|9927913|FG001|Visit 2 Repeat|Overall Study||35
8871101|NCT02860039|9927912|FG000|Visit 3 Repeat|Overall Study||29
8871102|NCT02860039|9927913|FG001|Visit 3 Repeat|Overall Study||35
8871103|NCT02860039|9927912|FG000|Visit 4 Repeat|Overall Study||26
8871104|NCT02860039|9927913|FG001|Visit 4 Repeat|Overall Study||22
8871105|NCT02860039|9927912|FG000|COMPLETED|Overall Study||73
8871106|NCT02860039|9927913|FG001|COMPLETED|Overall Study||82
8871107|NCT02860039|9927912|FG000|NOT COMPLETED|Overall Study||11
8871108|NCT02860039|9927913|FG001|NOT COMPLETED|Overall Study||4
8871109|NCT02743728|9927919|FG000|STARTED|Overall Study||20
8871110|NCT02743728|9927919|FG000|COMPLETED|Overall Study||20
8871111|NCT02743728|9927919|FG000|NOT COMPLETED|Overall Study||0
8871112|NCT02482389|9927923|FG000|STARTED|Overall Study||3
8871113|NCT02482389|9927923|FG000|COMPLETED|Overall Study||3
8871114|NCT02482389|9927923|FG000|NOT COMPLETED|Overall Study||0
8871115|NCT02232282|9927929|FG000|STARTED|Overall Study||10
8871116|NCT02232282|9927930|FG001|STARTED|Overall Study||12
8871117|NCT02232282|9927929|FG000|COMPLETED|Overall Study||10
8871118|NCT02232282|9927930|FG001|COMPLETED|Overall Study||11
8871119|NCT02232282|9927929|FG000|NOT COMPLETED|Overall Study||0
8871120|NCT02232282|9927930|FG001|NOT COMPLETED|Overall Study||1
8923966|NCT02245412|9984646|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||6
8923967|NCT02245412|9984647|FG002|Received at Least 1 Dose of Study Drug|Treatment Period||2
8923968|NCT02245412|9984645|FG000|Modified Full Analysis Set (mFAS)|Treatment Period||16
8923969|NCT02245412|9984646|FG001|Modified Full Analysis Set (mFAS)|Treatment Period||6
8923970|NCT02245412|9984647|FG002|Modified Full Analysis Set (mFAS)|Treatment Period||2
8923971|NCT02245412|9984645|FG000|COMPLETED|Treatment Period||12
8923972|NCT02245412|9984646|FG001|COMPLETED|Treatment Period||3
8923973|NCT02245412|9984647|FG002|COMPLETED|Treatment Period||2
8923974|NCT02245412|9984645|FG000|NOT COMPLETED|Treatment Period||5
8923975|NCT02245412|9984646|FG001|NOT COMPLETED|Treatment Period||3
8923976|NCT02245412|9984647|FG002|NOT COMPLETED|Treatment Period||0
8952821|NCT02465866|10015896|FG003|NOT COMPLETED|Period 4: Washout (14 Days)||0
8871121|NCT01492361|9927942|FG000|STARTED|Overall Study||4089
8871122|NCT01492361|9927943|FG001|STARTED|Overall Study||4090
8631095|NCT00538304|9670985|FG001|STARTED|Overall Study||71
8631096|NCT00538304|9670984|FG000|COMPLETED|Overall Study||144
8871123|NCT01492361|9927942|FG000|Completed Final Visit|Overall Study||3419
8871124|NCT01492361|9927943|FG001|Completed Final Visit|Overall Study||3335
8871125|NCT01492361|9927942|FG000|Death Before Final Visit|Overall Study||265
8871126|NCT01492361|9927943|FG001|Death Before Final Visit|Overall Study||295
8871127|NCT01492361|9927942|FG000|COMPLETED|Overall Study||3684
8871128|NCT01492361|9927943|FG001|COMPLETED|Overall Study||3630
8871129|NCT01492361|9927942|FG000|NOT COMPLETED|Overall Study||405
8871130|NCT01492361|9927943|FG001|NOT COMPLETED|Overall Study||460
8871131|NCT01296711|9927957|FG000|STARTED|Overall Study||20
8871132|NCT01296711|9927958|FG001|STARTED|Overall Study||20
8871133|NCT01296711|9927959|FG002|STARTED|Overall Study||21
8871134|NCT01296711|9927960|FG003|STARTED|Overall Study||20
8871135|NCT01296711|9927961|FG004|STARTED|Overall Study||17
8871136|NCT01296711|9927962|FG005|STARTED|Overall Study||16
8871137|NCT01296711|9927963|FG006|STARTED|Overall Study||40
8871138|NCT01296711|9927964|FG007|STARTED|Overall Study||36
8871139|NCT01296711|9927957|FG000|COMPLETED|Overall Study||4
8871140|NCT01296711|9927958|FG001|COMPLETED|Overall Study||12
8871141|NCT01296711|9927959|FG002|COMPLETED|Overall Study||8
8871142|NCT01296711|9927960|FG003|COMPLETED|Overall Study||7
8871143|NCT01296711|9927961|FG004|COMPLETED|Overall Study||7
8871144|NCT01296711|9927962|FG005|COMPLETED|Overall Study||5
8871145|NCT01296711|9927963|FG006|COMPLETED|Overall Study||9
8871146|NCT01296711|9927964|FG007|COMPLETED|Overall Study||15
8871147|NCT01296711|9927957|FG000|NOT COMPLETED|Overall Study||16
8871148|NCT01296711|9927958|FG001|NOT COMPLETED|Overall Study||8
8871149|NCT01296711|9927959|FG002|NOT COMPLETED|Overall Study||13
8871150|NCT01296711|9927960|FG003|NOT COMPLETED|Overall Study||13
8871151|NCT01296711|9927961|FG004|NOT COMPLETED|Overall Study||10
8871152|NCT01296711|9927962|FG005|NOT COMPLETED|Overall Study||11
8871153|NCT01296711|9927963|FG006|NOT COMPLETED|Overall Study||31
8871154|NCT01296711|9927964|FG007|NOT COMPLETED|Overall Study||21
8871155|NCT00084656|9927985|FG000|STARTED|Overall Study||25
8871156|NCT00084656|9927986|FG001|STARTED|Overall Study||25
8871157|NCT00084656|9927987|FG002|STARTED|Overall Study||26
8871158|NCT00084656|9927985|FG000|COMPLETED|Overall Study||0
8871159|NCT00084656|9927986|FG001|COMPLETED|Overall Study||0
8871160|NCT00084656|9927987|FG002|COMPLETED|Overall Study||0
8871161|NCT00084656|9927985|FG000|NOT COMPLETED|Overall Study||25
8871162|NCT00084656|9927986|FG001|NOT COMPLETED|Overall Study||25
8871163|NCT00084656|9927987|FG002|NOT COMPLETED|Overall Study||26
8871164|NCT01879735|9927999|FG000|STARTED|Overall Study||6
8871165|NCT01879735|9928000|FG001|STARTED|Overall Study||16
8871166|NCT01879735|9927999|FG000|COMPLETED|Overall Study||6
8871167|NCT01879735|9928000|FG001|COMPLETED|Overall Study||16
8871168|NCT01879735|9927999|FG000|NOT COMPLETED|Overall Study||0
8871169|NCT01879735|9928000|FG001|NOT COMPLETED|Overall Study||0
8871170|NCT01879800|9928008|FG000|STARTED|Overall Study||14
8871171|NCT01879800|9928009|FG001|STARTED|Overall Study||30
8871172|NCT01879800|9928008|FG000|COMPLETED|Overall Study||14
8871173|NCT01879800|9928009|FG001|COMPLETED|Overall Study||26
8871174|NCT01879800|9928008|FG000|NOT COMPLETED|Overall Study||0
8871175|NCT01879800|9928009|FG001|NOT COMPLETED|Overall Study||4
8631097|NCT00538304|9670985|FG001|COMPLETED|Overall Study||66
8631098|NCT00538304|9670984|FG000|NOT COMPLETED|Overall Study||7
8871176|NCT01879826|9928017|FG000|STARTED|Overall Study||41
8871177|NCT01879826|9928018|FG001|STARTED|Overall Study||40
8871178|NCT01879826|9928017|FG000|COMPLETED|Overall Study||41
8871179|NCT01879826|9928018|FG001|COMPLETED|Overall Study||40
8871180|NCT01879826|9928017|FG000|NOT COMPLETED|Overall Study||0
8871181|NCT01879826|9928018|FG001|NOT COMPLETED|Overall Study||0
8871182|NCT01879852|9928026|FG000|STARTED|Overall Study||14
8871183|NCT01879852|9928027|FG001|STARTED|Overall Study||13
8871184|NCT01879852|9928026|FG000|COMPLETED|Overall Study||12
8871185|NCT01879852|9928027|FG001|COMPLETED|Overall Study||13
8631099|NCT00538304|9670985|FG001|NOT COMPLETED|Overall Study||5
8871186|NCT01879852|9928026|FG000|NOT COMPLETED|Overall Study||2
8871187|NCT01879852|9928027|FG001|NOT COMPLETED|Overall Study||0
8871188|NCT01880047|9928037|FG000|STARTED|Weeks 0-2||17
8871189|NCT01880047|9928038|FG001|STARTED|Weeks 0-2||9
8871190|NCT01880047|9928039|FG002|STARTED|Weeks 0-2||5
8871191|NCT01880047|9928040|FG003|STARTED|Weeks 0-2||3
8871192|NCT01880047|9928037|FG000|COMPLETED|Weeks 0-2||17
8871193|NCT01880047|9928038|FG001|COMPLETED|Weeks 0-2||8
8871194|NCT01880047|9928039|FG002|COMPLETED|Weeks 0-2||4
8871195|NCT01880047|9928040|FG003|COMPLETED|Weeks 0-2||2
8871196|NCT01880047|9928037|FG000|NOT COMPLETED|Weeks 0-2||0
8871197|NCT01880047|9928038|FG001|NOT COMPLETED|Weeks 0-2||1
8871198|NCT01880047|9928039|FG002|NOT COMPLETED|Weeks 0-2||1
8871199|NCT01880047|9928040|FG003|NOT COMPLETED|Weeks 0-2||1
8871200|NCT01880047|9928037|FG000|STARTED|Weeks 3-4||17
8871201|NCT01880047|9928038|FG001|STARTED|Weeks 3-4||8
8871202|NCT01880047|9928039|FG002|STARTED|Weeks 3-4||4
8871203|NCT01880047|9928040|FG003|STARTED|Weeks 3-4||2
8871204|NCT01880047|9928037|FG000|COMPLETED|Weeks 3-4||17
8871205|NCT01880047|9928038|FG001|COMPLETED|Weeks 3-4||7
8871206|NCT01880047|9928039|FG002|COMPLETED|Weeks 3-4||4
8871207|NCT01880047|9928040|FG003|COMPLETED|Weeks 3-4||2
8871208|NCT01880047|9928037|FG000|NOT COMPLETED|Weeks 3-4||0
8871209|NCT01880047|9928038|FG001|NOT COMPLETED|Weeks 3-4||1
8871210|NCT01880047|9928039|FG002|NOT COMPLETED|Weeks 3-4||0
8871211|NCT01880047|9928040|FG003|NOT COMPLETED|Weeks 3-4||0
8871212|NCT01880047|9928037|FG000|STARTED|Weeks 5-8||17
8871213|NCT01880047|9928038|FG001|STARTED|Weeks 5-8||7
8871214|NCT01880047|9928039|FG002|STARTED|Weeks 5-8||4
8871215|NCT01880047|9928040|FG003|STARTED|Weeks 5-8||2
8871216|NCT01880047|9928037|FG000|COMPLETED|Weeks 5-8||15
8871217|NCT01880047|9928038|FG001|COMPLETED|Weeks 5-8||6
8871218|NCT01880047|9928039|FG002|COMPLETED|Weeks 5-8||4
8871219|NCT01880047|9928040|FG003|COMPLETED|Weeks 5-8||2
8871220|NCT01880047|9928037|FG000|NOT COMPLETED|Weeks 5-8||2
8871221|NCT01880047|9928038|FG001|NOT COMPLETED|Weeks 5-8||1
8871222|NCT01880047|9928039|FG002|NOT COMPLETED|Weeks 5-8||0
8871223|NCT01880047|9928040|FG003|NOT COMPLETED|Weeks 5-8||0
8871224|NCT01880047|9928037|FG000|STARTED|Extension Phase - 18 Months|15 subjects went into extension phase, were followed for variable periods of time|15
8871225|NCT01880047|9928038|FG001|STARTED|Extension Phase - 18 Months|6 subjects went into extension phase, were followed for variable periods of time|6
8871226|NCT01880047|9928039|FG002|STARTED|Extension Phase - 18 Months|4 subjects went into extension phase, were followed for variable periods of time|4
8871227|NCT01880047|9928040|FG003|STARTED|Extension Phase - 18 Months|2 subjects went into extension phase, were followed for variable periods of time|2
8871228|NCT01880047|9928037|FG000|COMPLETED|Extension Phase - 18 Months||6
8871229|NCT01880047|9928038|FG001|COMPLETED|Extension Phase - 18 Months||3
8871230|NCT01880047|9928039|FG002|COMPLETED|Extension Phase - 18 Months||3
8871231|NCT01880047|9928040|FG003|COMPLETED|Extension Phase - 18 Months||0
8871232|NCT01880047|9928037|FG000|NOT COMPLETED|Extension Phase - 18 Months||9
8871233|NCT01880047|9928038|FG001|NOT COMPLETED|Extension Phase - 18 Months||3
8871234|NCT01880047|9928039|FG002|NOT COMPLETED|Extension Phase - 18 Months||1
8871235|NCT01880047|9928040|FG003|NOT COMPLETED|Extension Phase - 18 Months||2
8871236|NCT01880073|9928057|FG000|STARTED|Overall Study||24
8871237|NCT01880073|9928057|FG000|COMPLETED|Overall Study||24
8871238|NCT01880073|9928057|FG000|NOT COMPLETED|Overall Study||0
8871239|NCT01880086|9928063|FG000|STARTED|Overall Study||6
8871240|NCT01880086|9928064|FG001|STARTED|Overall Study||7
8871241|NCT01880086|9928063|FG000|COMPLETED|Overall Study||5
8871242|NCT01880086|9928064|FG001|COMPLETED|Overall Study||6
8871243|NCT01880086|9928063|FG000|NOT COMPLETED|Overall Study||1
8871244|NCT01880086|9928064|FG001|NOT COMPLETED|Overall Study||1
8871245|NCT01880099|9928073|FG000|STARTED|Overall Study||17
8871246|NCT01880099|9928074|FG001|STARTED|Overall Study||21
8871247|NCT01880099|9928075|FG002|STARTED|Overall Study||22
8871248|NCT01880099|9928073|FG000|COMPLETED|Overall Study||9
8871249|NCT01880099|9928074|FG001|COMPLETED|Overall Study||11
8871250|NCT01880099|9928075|FG002|COMPLETED|Overall Study||15
8871251|NCT01880099|9928073|FG000|NOT COMPLETED|Overall Study||8
8871252|NCT01880099|9928074|FG001|NOT COMPLETED|Overall Study||10
8871253|NCT01880099|9928075|FG002|NOT COMPLETED|Overall Study||7
8871254|NCT01880320|9928086|FG000|STARTED|Overall Study||217
8871255|NCT01880320|9928087|FG001|STARTED|Overall Study||217
8871256|NCT01880320|9928088|FG002|STARTED|Overall Study||69
8871257|NCT01880320|9928086|FG000|COMPLETED|Overall Study||197
8871258|NCT01880320|9928087|FG001|COMPLETED|Overall Study||192
8871259|NCT01880320|9928088|FG002|COMPLETED|Overall Study||61
8871260|NCT01880320|9928086|FG000|NOT COMPLETED|Overall Study||20
8871261|NCT01880320|9928087|FG001|NOT COMPLETED|Overall Study||25
8871262|NCT01880320|9928088|FG002|NOT COMPLETED|Overall Study||8
8871263|NCT01880424|9928098|FG000|STARTED|Overall Study||417
8871264|NCT01880424|9928099|FG001|STARTED|Overall Study||422
8952822|NCT02465931|10015908|FG000|STARTED|Overall Study||55
8952823|NCT02465931|10015909|FG001|STARTED|Overall Study||56
8952824|NCT02465931|10015908|FG000|COMPLETED|Overall Study||44
8952825|NCT02465931|10015909|FG001|COMPLETED|Overall Study||45
8871265|NCT01880424|9928098|FG000|COMPLETED|Overall Study||384
8871266|NCT01880424|9928099|FG001|COMPLETED|Overall Study||367
8871267|NCT01880424|9928098|FG000|NOT COMPLETED|Overall Study||33
8871268|NCT01880424|9928099|FG001|NOT COMPLETED|Overall Study||55
8871269|NCT01880437|9928108|FG000|STARTED|Overall Study||15
8871270|NCT01880437|9928109|FG001|STARTED|Overall Study||4
8871271|NCT01880437|9928110|FG002|STARTED|Overall Study||19
8871272|NCT01880437|9928108|FG000|COMPLETED|Overall Study||0
8871273|NCT01880437|9928109|FG001|COMPLETED|Overall Study||0
8871274|NCT01880437|9928110|FG002|COMPLETED|Overall Study||0
8871275|NCT01880437|9928108|FG000|NOT COMPLETED|Overall Study||15
8871276|NCT01880437|9928109|FG001|NOT COMPLETED|Overall Study||4
8871277|NCT01880437|9928110|FG002|NOT COMPLETED|Overall Study||19
8871278|NCT01880515|9928122|FG000|STARTED|Overall Study||53
8871279|NCT01880515|9928123|FG001|STARTED|Overall Study||54
8871280|NCT01880515|9928122|FG000|COMPLETED|Overall Study||45
8871281|NCT01880515|9928123|FG001|COMPLETED|Overall Study||45
8871282|NCT01880515|9928122|FG000|NOT COMPLETED|Overall Study||8
8871283|NCT01880515|9928123|FG001|NOT COMPLETED|Overall Study||9
8871284|NCT01880528|9928132|FG000|STARTED|Overall Study||12
8871285|NCT01880528|9928133|FG001|STARTED|Overall Study||11
8871286|NCT01880528|9928132|FG000|COMPLETED|Overall Study||11
8871287|NCT01880528|9928133|FG001|COMPLETED|Overall Study||10
8871288|NCT01880528|9928132|FG000|NOT COMPLETED|Overall Study||1
8871289|NCT01880528|9928133|FG001|NOT COMPLETED|Overall Study||1
8871290|NCT01880554|9928139|FG000|STARTED|Overall Study|Patients enrolled in the study|68
8871291|NCT01880554|9928139|FG000|Population Eligible|Overall Study||58
8871292|NCT01880554|9928139|FG000|Population Eligible and Assessable|Overall Study||54
8871293|NCT01880554|9928139|FG000|COMPLETED|Overall Study|Patients eligible and assessable according to two-stage Simon's design (primary outcome)|52
8871294|NCT01880554|9928139|FG000|NOT COMPLETED|Overall Study||16
8871295|NCT01880593|9928146|FG000|STARTED|Overall Study||18
8871296|NCT01880593|9928147|FG001|STARTED|Overall Study||16
8871297|NCT01880593|9928146|FG000|COMPLETED|Overall Study||10
8871298|NCT01880593|9928147|FG001|COMPLETED|Overall Study||10
8871299|NCT01880593|9928146|FG000|NOT COMPLETED|Overall Study||8
8871300|NCT01880593|9928147|FG001|NOT COMPLETED|Overall Study||6
8871301|NCT01880697|9928155|FG000|STARTED|Overall Study||63
8871302|NCT01880697|9928156|FG001|STARTED|Overall Study||63
8871303|NCT01880697|9928155|FG000|COMPLETED|Overall Study||63
8871304|NCT01880697|9928156|FG001|COMPLETED|Overall Study||62
8871305|NCT01880697|9928155|FG000|NOT COMPLETED|Overall Study||0
8871306|NCT01880697|9928156|FG001|NOT COMPLETED|Overall Study||1
8871307|NCT01880723|9928164|FG000|STARTED|Overall Study||16
8871308|NCT01880723|9928165|FG001|STARTED|Overall Study||16
8871309|NCT01880723|9928164|FG000|COMPLETED|Overall Study||16
8871310|NCT01880723|9928165|FG001|COMPLETED|Overall Study||16
8871311|NCT01880723|9928164|FG000|NOT COMPLETED|Overall Study||0
8631100|NCT00538434|9670995|FG000|STARTED|Overall Study||56
8631101|NCT00538434|9670996|FG001|STARTED|Overall Study||57
8871312|NCT01880723|9928165|FG001|NOT COMPLETED|Overall Study||0
8871313|NCT01880736|9928175|FG000|STARTED|Overall Study||114
8871314|NCT01880736|9928176|FG001|STARTED|Overall Study||115
8871315|NCT01880736|9928177|FG002|STARTED|Overall Study||115
8871316|NCT01880736|9928178|FG003|STARTED|Overall Study||114
8871317|NCT01880736|9928175|FG000|COMPLETED|Overall Study||113
8871318|NCT01880736|9928176|FG001|COMPLETED|Overall Study||113
8871319|NCT01880736|9928177|FG002|COMPLETED|Overall Study||114
8871320|NCT01880736|9928178|FG003|COMPLETED|Overall Study||108
8871321|NCT01880736|9928175|FG000|NOT COMPLETED|Overall Study||1
8871322|NCT01880736|9928176|FG001|NOT COMPLETED|Overall Study||2
8871323|NCT01880736|9928177|FG002|NOT COMPLETED|Overall Study||1
8871324|NCT01880736|9928178|FG003|NOT COMPLETED|Overall Study||6
8871325|NCT01880840|9928190|FG000|STARTED|Overall Study||95
8871326|NCT01880840|9928191|FG001|STARTED|Overall Study||96
8871327|NCT01880840|9928190|FG000|COMPLETED|Overall Study||87
8871328|NCT01880840|9928191|FG001|COMPLETED|Overall Study||91
8871329|NCT01880840|9928190|FG000|NOT COMPLETED|Overall Study||8
8871330|NCT01880840|9928191|FG001|NOT COMPLETED|Overall Study||5
8871331|NCT01881009|9928199|FG000|STARTED|Inpatient Safety Testing (22 Hours)||16
8871332|NCT01881009|9928200|FG001|STARTED|Inpatient Safety Testing (22 Hours)||0
8871333|NCT01881009|9928199|FG000|COMPLETED|Inpatient Safety Testing (22 Hours)||16
8871334|NCT01881009|9928200|FG001|COMPLETED|Inpatient Safety Testing (22 Hours)||0
8871335|NCT01881009|9928199|FG000|NOT COMPLETED|Inpatient Safety Testing (22 Hours)||0
8871336|NCT01881009|9928200|FG001|NOT COMPLETED|Inpatient Safety Testing (22 Hours)||0
8871337|NCT01881009|9928199|FG000|STARTED|Summer Camp Session (6 Days)||0
8871338|NCT01881009|9928200|FG001|STARTED|Summer Camp Session (6 Days)||22
8871339|NCT01881009|9928199|FG000|COMPLETED|Summer Camp Session (6 Days)||0
8871340|NCT01881009|9928200|FG001|COMPLETED|Summer Camp Session (6 Days)||21
8871341|NCT01881009|9928199|FG000|NOT COMPLETED|Summer Camp Session (6 Days)||0
8871342|NCT01881009|9928200|FG001|NOT COMPLETED|Summer Camp Session (6 Days)||1
8871343|NCT01881087|9928210|FG000|STARTED|Overall Study||60
8871344|NCT01881087|9928211|FG001|STARTED|Overall Study||61
8952826|NCT02465931|10015908|FG000|NOT COMPLETED|Overall Study||11
8631102|NCT00538434|9670997|FG002|STARTED|Overall Study||57
8871345|NCT01881087|9928212|FG002|STARTED|Overall Study||62
8871346|NCT01881087|9928210|FG000|COMPLETED|Overall Study||59
8871347|NCT01881087|9928211|FG001|COMPLETED|Overall Study||61
8871348|NCT01881087|9928212|FG002|COMPLETED|Overall Study||60
8631103|NCT00538434|9670998|FG003|STARTED|Overall Study||57
8871349|NCT01881087|9928210|FG000|NOT COMPLETED|Overall Study||1
8871350|NCT01881087|9928211|FG001|NOT COMPLETED|Overall Study||0
8871351|NCT01881087|9928212|FG002|NOT COMPLETED|Overall Study||2
8871352|NCT01881113|9928222|FG000|STARTED|Overall Study||51
8871353|NCT01881113|9928223|FG001|STARTED|Overall Study||50
8871354|NCT01881113|9928222|FG000|COMPLETED|Overall Study||43
8871355|NCT01881113|9928223|FG001|COMPLETED|Overall Study||44
8631104|NCT00538434|9670995|FG000|Intent-to-treat (ITT) Population|Overall Study|1 participant was randomized but not treated|55
8871356|NCT01881113|9928222|FG000|NOT COMPLETED|Overall Study||8
8871357|NCT01881113|9928223|FG001|NOT COMPLETED|Overall Study||6
8871358|NCT01881126|9928231|FG000|STARTED|Overall Study||47
8871359|NCT01881126|9928232|FG001|STARTED|Overall Study||46
8871360|NCT01881126|9928231|FG000|COMPLETED|Overall Study||46
8871361|NCT01881126|9928232|FG001|COMPLETED|Overall Study||44
8871362|NCT01881126|9928231|FG000|NOT COMPLETED|Overall Study||1
8871363|NCT01881126|9928232|FG001|NOT COMPLETED|Overall Study||2
8871364|NCT01881230|9928241|FG000|STARTED|Overall Study||61
8871365|NCT01881230|9928242|FG001|STARTED|Overall Study||64
8871366|NCT01881230|9928243|FG002|STARTED|Overall Study||66
8871367|NCT01881230|9928241|FG000|Safety Population|Overall Study|Safety Population = randomized who received at least 1 dose of Investigational Product (IP)|60
8871368|NCT01881230|9928242|FG001|Safety Population|Overall Study|Safety Population = randomized who received at least 1 dose of IP|64
8871369|NCT01881230|9928243|FG002|Safety Population|Overall Study|Safety Population = randomized who received at least 1 dose of IP|64
8871370|NCT01881230|9928241|FG000|Treatment Discontinued|Overall Study|Treatment Duration=PD, toxicity, radiation/removal of lesions, consent withdrawal, doctor decision|60
8871371|NCT01881230|9928242|FG001|Treatment Discontinued|Overall Study|Treatment Duration=PD, toxicity, radiation/removal of lesions, consent withdrawal, doctor decision|64
8871372|NCT01881230|9928243|FG002|Treatment Discontinued|Overall Study|Treatment Duration=PD, toxicity, radiation/removal of lesions, consent withdrawal, doctor decision|64
8871373|NCT01881230|9928241|FG000|COMPLETED|Overall Study|Not applicable according to the study design|0
8871374|NCT01881230|9928242|FG001|COMPLETED|Overall Study|Not applicable according to the study design|0
8871375|NCT01881230|9928243|FG002|COMPLETED|Overall Study|Not applicable according to the study design|0
8871376|NCT01881230|9928241|FG000|NOT COMPLETED|Overall Study||61
8871377|NCT01881230|9928242|FG001|NOT COMPLETED|Overall Study||64
8871378|NCT01881230|9928243|FG002|NOT COMPLETED|Overall Study||66
8871379|NCT01881373|9928254|FG000|STARTED|Baseline|Cross-sectional sample|1517
8871380|NCT01881373|9928255|FG001|STARTED|Baseline|Cross-sectional sample|1491
8871381|NCT01881373|9928256|FG002|STARTED|Baseline|Cross-sectional sample|1321
8871382|NCT01881373|9928254|FG000|COMPLETED|Baseline|Cross-sectional sample|1517
8871383|NCT01881373|9928255|FG001|COMPLETED|Baseline|Cross-sectional sample|1491
8871384|NCT01881373|9928256|FG002|COMPLETED|Baseline|Cross-sectional sample|1321
8871385|NCT01881373|9928254|FG000|NOT COMPLETED|Baseline||0
8871386|NCT01881373|9928255|FG001|NOT COMPLETED|Baseline||0
8871387|NCT01881373|9928256|FG002|NOT COMPLETED|Baseline||0
8871388|NCT01881373|9928254|FG000|STARTED|24 Months|Cross-sectional sample, independent of sample at baseline|1342
8871389|NCT01881373|9928255|FG001|STARTED|24 Months|Cross-sectional sample, independent of sample at baseline|1295
8871390|NCT01881373|9928256|FG002|STARTED|24 Months|Cross-sectional sample, independent of sample at baseline|1405
8952827|NCT02465931|10015909|FG001|NOT COMPLETED|Overall Study||11
8952828|NCT02466009|10015915|FG000|STARTED|Overall Study||27
8952829|NCT02466009|10015915|FG000|COMPLETED|Overall Study||27
8952830|NCT02466009|10015915|FG000|NOT COMPLETED|Overall Study||0
8952831|NCT02466087|10015919|FG000|STARTED|First Intervention: Weeks 1-6||62
8952832|NCT02466087|10015920|FG001|STARTED|First Intervention: Weeks 1-6||64
8952833|NCT02466087|10015919|FG000|COMPLETED|First Intervention: Weeks 1-6||55
8952834|NCT02466087|10015920|FG001|COMPLETED|First Intervention: Weeks 1-6||57
8952835|NCT02466087|10015919|FG000|NOT COMPLETED|First Intervention: Weeks 1-6||7
8952836|NCT02466087|10015920|FG001|NOT COMPLETED|First Intervention: Weeks 1-6||7
8952837|NCT02466087|10015919|FG000|STARTED|Second Intervention: Weeks 7-12||55
8952838|NCT02466087|10015920|FG001|STARTED|Second Intervention: Weeks 7-12||57
8952839|NCT02466087|10015919|FG000|COMPLETED|Second Intervention: Weeks 7-12||55
8952840|NCT02466087|10015920|FG001|COMPLETED|Second Intervention: Weeks 7-12||57
8952841|NCT02466087|10015919|FG000|NOT COMPLETED|Second Intervention: Weeks 7-12||0
8952842|NCT02466087|10015920|FG001|NOT COMPLETED|Second Intervention: Weeks 7-12||0
8952843|NCT02466126|10015929|FG000|STARTED|Baseline||109
8952844|NCT02466126|10015930|FG001|STARTED|Baseline||80
8952845|NCT02466126|10015929|FG000|COMPLETED|Baseline||109
8952846|NCT02466126|10015930|FG001|COMPLETED|Baseline||80
8952847|NCT02466126|10015929|FG000|NOT COMPLETED|Baseline||0
8952848|NCT02466126|10015930|FG001|NOT COMPLETED|Baseline||0
8952849|NCT02466126|10015929|FG000|STARTED|4 Month Assessment||109
8952850|NCT02466126|10015930|FG001|STARTED|4 Month Assessment||80
8952851|NCT02466126|10015929|FG000|COMPLETED|4 Month Assessment||93
8952852|NCT02466126|10015930|FG001|COMPLETED|4 Month Assessment||71
8952853|NCT02466126|10015929|FG000|NOT COMPLETED|4 Month Assessment||16
8952854|NCT02466126|10015930|FG001|NOT COMPLETED|4 Month Assessment||9
8952855|NCT02466126|10015929|FG000|STARTED|8 Month Assessment||93
8952856|NCT02466126|10015930|FG001|STARTED|8 Month Assessment||71
8952857|NCT02466126|10015929|FG000|COMPLETED|8 Month Assessment||86
8952858|NCT02466126|10015930|FG001|COMPLETED|8 Month Assessment||68
8569972|NCT00100048|9602078|FG002|COMPLETED|Cohort I & II-Combination Therapy Phase||28
8569973|NCT00100048|9602079|FG003|COMPLETED|Cohort I & II-Combination Therapy Phase||30
8569974|NCT00100048|9602080|FG004|COMPLETED|Cohort I & II-Combination Therapy Phase||0
8569975|NCT00100048|9602081|FG005|COMPLETED|Cohort I & II-Combination Therapy Phase||26
8569976|NCT00100048|9602076|FG000|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||14
8569977|NCT00100048|9602077|FG001|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||9
8569978|NCT00100048|9602078|FG002|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||13
8569979|NCT00100048|9602079|FG003|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||10
8569980|NCT00100048|9602080|FG004|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||0
8569981|NCT00100048|9602081|FG005|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||13
8569982|NCT00100165|9602109|FG000|STARTED|Baseline||10
8871391|NCT01881373|9928254|FG000|COMPLETED|24 Months|Cross-sectional sample, independent of sample at baseline|1342
8871392|NCT01881373|9928255|FG001|COMPLETED|24 Months|Cross-sectional sample, independent of sample at baseline|1295
8871393|NCT01881373|9928256|FG002|COMPLETED|24 Months|Cross-sectional sample, independent of sample at baseline|1405
8871394|NCT01881373|9928254|FG000|NOT COMPLETED|24 Months||0
8871395|NCT01881373|9928255|FG001|NOT COMPLETED|24 Months||0
8871396|NCT01881373|9928256|FG002|NOT COMPLETED|24 Months||0
8871397|NCT01881412|9928270|FG000|STARTED|Overall Study||59
8871398|NCT01881412|9928271|FG001|STARTED|Overall Study||59
8871399|NCT01881412|9928270|FG000|COMPLETED|Overall Study||49
8871400|NCT01881412|9928271|FG001|COMPLETED|Overall Study||57
8871401|NCT01881412|9928270|FG000|NOT COMPLETED|Overall Study||10
8871402|NCT01881412|9928271|FG001|NOT COMPLETED|Overall Study||2
8871403|NCT01881620|9928277|FG000|STARTED|Overall Study||109
8871404|NCT01881620|9928277|FG000|COMPLETED|Overall Study|Eligible patients with PET-CT scanner performed AND interpretation of 2 pairs of observors available|105
8871405|NCT01881620|9928277|FG000|NOT COMPLETED|Overall Study||4
8871406|NCT01881737|9928281|FG000|STARTED|Overall Study|This is a pilot study|15
8871407|NCT01881737|9928281|FG000|Number Screened|Overall Study||15
8871408|NCT01881737|9928281|FG000|COMPLETED|Overall Study||10
8871409|NCT01881737|9928281|FG000|NOT COMPLETED|Overall Study||5
8871410|NCT01881750|9928289|FG000|STARTED|Overall Study||27
8871411|NCT01881750|9928290|FG001|STARTED|Overall Study||26
8871412|NCT01881750|9928289|FG000|COMPLETED|Overall Study||25
8871413|NCT01881750|9928290|FG001|COMPLETED|Overall Study||22
8871414|NCT01881750|9928289|FG000|NOT COMPLETED|Overall Study||2
8871415|NCT01881750|9928290|FG001|NOT COMPLETED|Overall Study||4
8871416|NCT01881776|9928301|FG000|STARTED|Overall Study||24
8871417|NCT01881776|9928302|FG001|STARTED|Overall Study||24
8871418|NCT01881776|9928303|FG002|STARTED|Overall Study||22
8871419|NCT01881776|9928301|FG000|COMPLETED|Overall Study||23
8871420|NCT01881776|9928302|FG001|COMPLETED|Overall Study||20
8871421|NCT01881776|9928303|FG002|COMPLETED|Overall Study||20
8871422|NCT01881776|9928301|FG000|NOT COMPLETED|Overall Study||1
8871423|NCT01881776|9928302|FG001|NOT COMPLETED|Overall Study||4
8871424|NCT01881776|9928303|FG002|NOT COMPLETED|Overall Study||2
8871425|NCT01881789|9928317|FG000|STARTED|Overall Study||3
8871426|NCT01881789|9928318|FG001|STARTED|Overall Study||7
8871427|NCT01881789|9928319|FG002|STARTED|Overall Study||3
8871428|NCT01881789|9928320|FG003|STARTED|Overall Study||3
8871429|NCT01881789|9928321|FG004|STARTED|Overall Study||2
8871430|NCT01881789|9928322|FG005|STARTED|Overall Study||3
8871431|NCT01881789|9928317|FG000|COMPLETED|Overall Study||0
8871432|NCT01881789|9928318|FG001|COMPLETED|Overall Study||0
8871433|NCT01881789|9928319|FG002|COMPLETED|Overall Study||0
8871434|NCT01881789|9928320|FG003|COMPLETED|Overall Study||0
8871435|NCT01881789|9928321|FG004|COMPLETED|Overall Study||0
8871436|NCT01881789|9928322|FG005|COMPLETED|Overall Study||0
8871437|NCT01881789|9928317|FG000|NOT COMPLETED|Overall Study||3
8871438|NCT01881789|9928318|FG001|NOT COMPLETED|Overall Study||7
8871439|NCT01881789|9928319|FG002|NOT COMPLETED|Overall Study||3
8871440|NCT01881789|9928320|FG003|NOT COMPLETED|Overall Study||3
8871441|NCT01881789|9928321|FG004|NOT COMPLETED|Overall Study||2
8871442|NCT01881789|9928322|FG005|NOT COMPLETED|Overall Study||3
8871443|NCT01881828|9928339|FG000|STARTED|Overall Study|23 excluded at randomization from enrollment|71
8871444|NCT01881828|9928340|FG001|STARTED|Overall Study|23 excluded from randomization from enrollment|69
8871445|NCT01881828|9928339|FG000|COMPLETED|Overall Study||71
8871446|NCT01881828|9928340|FG001|COMPLETED|Overall Study||69
8871447|NCT01881828|9928339|FG000|NOT COMPLETED|Overall Study||0
8871448|NCT01881828|9928340|FG001|NOT COMPLETED|Overall Study||0
8871449|NCT01881867|9928348|FG000|STARTED|Overall Study||26
8871450|NCT01881867|9928349|FG001|STARTED|Overall Study||28
8871451|NCT01881867|9928348|FG000|COMPLETED|Overall Study||14
8871452|NCT01881867|9928349|FG001|COMPLETED|Overall Study||15
8871453|NCT01881867|9928348|FG000|NOT COMPLETED|Overall Study||12
8871454|NCT01881867|9928349|FG001|NOT COMPLETED|Overall Study||13
8871455|NCT01882062|9928357|FG000|STARTED|Overall Study|16th of may 2013|10
8871456|NCT01882062|9928357|FG000|COMPLETED|Overall Study|18th of july 2013|10
8871457|NCT01882062|9928357|FG000|NOT COMPLETED|Overall Study||0
8871458|NCT01882088|9928361|FG000|STARTED|Overall Study|35 patients were provided with psyllium in 5.0 sachets, 3 sachets per day for 10 days|35
8871459|NCT01882088|9928361|FG000|COMPLETED|Overall Study||30
8871460|NCT01882088|9928361|FG000|NOT COMPLETED|Overall Study||5
8871461|NCT01882257|9928368|FG000|STARTED|Study Origination to Beginning Therapy||11
8871462|NCT01882257|9928369|FG001|STARTED|Study Origination to Beginning Therapy||40
8871463|NCT01882257|9928370|FG002|STARTED|Study Origination to Beginning Therapy||23
8871464|NCT01882257|9928368|FG000|Started Therapy Using Device|Study Origination to Beginning Therapy||11
8871465|NCT01882257|9928369|FG001|Started Therapy Using Device|Study Origination to Beginning Therapy|Of the 40 who were given the device, 2 chose not to begin the actual therapy|38
8871466|NCT01882257|9928370|FG002|Started Therapy Using Device|Study Origination to Beginning Therapy|Of the 23 who were given the device, 1 chose not to begin the actual therapy|22
8631105|NCT00538434|9670996|FG001|Intent-to-treat (ITT) Population|Overall Study||57
8631106|NCT00538434|9670997|FG002|Intent-to-treat (ITT) Population|Overall Study||57
8631107|NCT00538434|9670998|FG003|Intent-to-treat (ITT) Population|Overall Study||57
8871467|NCT01882257|9928368|FG000|COMPLETED|Study Origination to Beginning Therapy||11
8871468|NCT01882257|9928369|FG001|COMPLETED|Study Origination to Beginning Therapy||38
8871469|NCT01882257|9928370|FG002|COMPLETED|Study Origination to Beginning Therapy||22
8871470|NCT01882257|9928368|FG000|NOT COMPLETED|Study Origination to Beginning Therapy||0
8871471|NCT01882257|9928369|FG001|NOT COMPLETED|Study Origination to Beginning Therapy||2
8871472|NCT01882257|9928370|FG002|NOT COMPLETED|Study Origination to Beginning Therapy||1
8871473|NCT01882257|9928368|FG000|STARTED|Therapy Portion of Study (12 Months)||11
8871474|NCT01882257|9928369|FG001|STARTED|Therapy Portion of Study (12 Months)||38
8871475|NCT01882257|9928370|FG002|STARTED|Therapy Portion of Study (12 Months)||22
8871476|NCT01882257|9928368|FG000|COMPLETED|Therapy Portion of Study (12 Months)||11
8871477|NCT01882257|9928369|FG001|COMPLETED|Therapy Portion of Study (12 Months)||27
8631108|NCT00538434|9670995|FG000|COMPLETED|Overall Study|Completed all scheduled study visits|47
8871478|NCT01882257|9928370|FG002|COMPLETED|Therapy Portion of Study (12 Months)||18
8871479|NCT01882257|9928368|FG000|NOT COMPLETED|Therapy Portion of Study (12 Months)||0
8871480|NCT01882257|9928369|FG001|NOT COMPLETED|Therapy Portion of Study (12 Months)||11
8871481|NCT01882257|9928370|FG002|NOT COMPLETED|Therapy Portion of Study (12 Months)||4
8871482|NCT01882413|9928377|FG000|STARTED|Overall Study||204
8871483|NCT01882413|9928377|FG000|COMPLETED|Overall Study||204
8871484|NCT01882413|9928377|FG000|NOT COMPLETED|Overall Study||0
8871485|NCT01882439|9928385|FG000|STARTED|Overall Study|Received treatment|131
8871486|NCT01882439|9928386|FG001|STARTED|Overall Study|Received treatment|132
8871487|NCT01882439|9928387|FG002|STARTED|Overall Study|Received treatment|66
8871488|NCT01882439|9928388|FG003|STARTED|Overall Study|Received treatment|65
8871489|NCT01882439|9928385|FG000|COMPLETED|Overall Study||122
8871490|NCT01882439|9928386|FG001|COMPLETED|Overall Study||111
8871491|NCT01882439|9928387|FG002|COMPLETED|Overall Study||56
8871492|NCT01882439|9928388|FG003|COMPLETED|Overall Study||56
8871493|NCT01882439|9928385|FG000|NOT COMPLETED|Overall Study||9
8871494|NCT01882439|9928386|FG001|NOT COMPLETED|Overall Study||21
8871495|NCT01882439|9928387|FG002|NOT COMPLETED|Overall Study||10
8871496|NCT01882439|9928388|FG003|NOT COMPLETED|Overall Study||9
8871497|NCT01882465|9928403|FG000|STARTED|Period 1||6
8871498|NCT01882465|9928404|FG001|STARTED|Period 1||6
8871499|NCT01882465|9928405|FG002|STARTED|Period 1||5
8871500|NCT01882465|9928406|FG003|STARTED|Period 1||6
8871501|NCT01882465|9928407|FG004|STARTED|Period 1||5
8871502|NCT01882465|9928408|FG005|STARTED|Period 1||5
8871503|NCT01882465|9928409|FG006|STARTED|Period 1||1
8871504|NCT01882465|9928403|FG000|COMPLETED|Period 1||6
8871505|NCT01882465|9928404|FG001|COMPLETED|Period 1||6
8871506|NCT01882465|9928405|FG002|COMPLETED|Period 1||5
8871507|NCT01882465|9928406|FG003|COMPLETED|Period 1||5
8871508|NCT01882465|9928407|FG004|COMPLETED|Period 1||5
8871509|NCT01882465|9928408|FG005|COMPLETED|Period 1||5
8871510|NCT01882465|9928409|FG006|COMPLETED|Period 1||0
8871511|NCT01882465|9928403|FG000|NOT COMPLETED|Period 1||0
8871512|NCT01882465|9928404|FG001|NOT COMPLETED|Period 1||0
8871513|NCT01882465|9928405|FG002|NOT COMPLETED|Period 1||0
8871514|NCT01882465|9928406|FG003|NOT COMPLETED|Period 1||1
8871515|NCT01882465|9928407|FG004|NOT COMPLETED|Period 1||0
8871516|NCT01882465|9928408|FG005|NOT COMPLETED|Period 1||0
8871517|NCT01882465|9928409|FG006|NOT COMPLETED|Period 1||1
8871518|NCT01882465|9928403|FG000|STARTED|Period 2||6
8871519|NCT01882465|9928404|FG001|STARTED|Period 2||6
8871520|NCT01882465|9928405|FG002|STARTED|Period 2||5
8871521|NCT01882465|9928406|FG003|STARTED|Period 2||5
8871522|NCT01882465|9928407|FG004|STARTED|Period 2||5
8871523|NCT01882465|9928408|FG005|STARTED|Period 2||5
8871524|NCT01882465|9928409|FG006|STARTED|Period 2||0
8871525|NCT01882465|9928403|FG000|COMPLETED|Period 2||6
8871526|NCT01882465|9928404|FG001|COMPLETED|Period 2||6
8871527|NCT01882465|9928405|FG002|COMPLETED|Period 2||5
8871528|NCT01882465|9928406|FG003|COMPLETED|Period 2||5
8871529|NCT01882465|9928407|FG004|COMPLETED|Period 2||4
8871530|NCT01882465|9928408|FG005|COMPLETED|Period 2||5
8871531|NCT01882465|9928409|FG006|COMPLETED|Period 2||0
8871532|NCT01882465|9928403|FG000|NOT COMPLETED|Period 2||0
8871533|NCT01882465|9928404|FG001|NOT COMPLETED|Period 2||0
8871534|NCT01882465|9928405|FG002|NOT COMPLETED|Period 2||0
8871535|NCT01882465|9928406|FG003|NOT COMPLETED|Period 2||0
8631109|NCT00538434|9670996|FG001|COMPLETED|Overall Study|Completed all scheduled study visits|46
8871536|NCT01882465|9928407|FG004|NOT COMPLETED|Period 2||1
8871537|NCT01882465|9928408|FG005|NOT COMPLETED|Period 2||0
8871538|NCT01882465|9928409|FG006|NOT COMPLETED|Period 2||0
8871539|NCT01882465|9928403|FG000|STARTED|Period 3||6
8871540|NCT01882465|9928404|FG001|STARTED|Period 3||6
8871541|NCT01882465|9928405|FG002|STARTED|Period 3||5
8871542|NCT01882465|9928406|FG003|STARTED|Period 3||5
8871543|NCT01882465|9928407|FG004|STARTED|Period 3||4
8871544|NCT01882465|9928408|FG005|STARTED|Period 3||5
8871545|NCT01882465|9928409|FG006|STARTED|Period 3||0
8871546|NCT01882465|9928403|FG000|COMPLETED|Period 3||6
8871547|NCT01882465|9928404|FG001|COMPLETED|Period 3||6
8871548|NCT01882465|9928405|FG002|COMPLETED|Period 3||5
8871549|NCT01882465|9928406|FG003|COMPLETED|Period 3||5
8871550|NCT01882465|9928407|FG004|COMPLETED|Period 3||4
8871551|NCT01882465|9928408|FG005|COMPLETED|Period 3||5
8871552|NCT01882465|9928409|FG006|COMPLETED|Period 3||0
8871553|NCT01882465|9928403|FG000|NOT COMPLETED|Period 3||0
8871554|NCT01882465|9928404|FG001|NOT COMPLETED|Period 3||0
8871555|NCT01882465|9928405|FG002|NOT COMPLETED|Period 3||0
8871556|NCT01882465|9928406|FG003|NOT COMPLETED|Period 3||0
8871557|NCT01882465|9928407|FG004|NOT COMPLETED|Period 3||0
8871558|NCT01882465|9928408|FG005|NOT COMPLETED|Period 3||0
8871559|NCT01882465|9928409|FG006|NOT COMPLETED|Period 3||0
8871560|NCT01882543|9928419|FG000|STARTED|Overall Study||37
8871561|NCT01882543|9928420|FG001|STARTED|Overall Study||32
8871562|NCT01882543|9928419|FG000|COMPLETED|Overall Study||33
8871563|NCT01882543|9928420|FG001|COMPLETED|Overall Study||29
8871564|NCT01882543|9928419|FG000|NOT COMPLETED|Overall Study||4
8871565|NCT01882543|9928420|FG001|NOT COMPLETED|Overall Study||3
8871566|NCT01882647|9928429|FG000|STARTED|Overall Study||110
8871567|NCT01882647|9928430|FG001|STARTED|Overall Study||112
8871568|NCT01882647|9928429|FG000|COMPLETED|Overall Study||108
8871569|NCT01882647|9928430|FG001|COMPLETED|Overall Study||106
8871570|NCT01882647|9928429|FG000|NOT COMPLETED|Overall Study||2
8871571|NCT01882647|9928430|FG001|NOT COMPLETED|Overall Study||6
8871572|NCT01882725|9928436|FG000|STARTED|Overall Study||14
8871573|NCT01882725|9928436|FG000|COMPLETED|Overall Study||14
8871574|NCT01882725|9928436|FG000|NOT COMPLETED|Overall Study||0
8871575|NCT01882764|9928442|FG000|STARTED|Overall Study||47
8871576|NCT01882764|9928443|FG001|STARTED|Overall Study||19
8871577|NCT01882764|9928442|FG000|COMPLETED|Overall Study||0
8871578|NCT01882764|9928443|FG001|COMPLETED|Overall Study||1
8871579|NCT01882764|9928442|FG000|NOT COMPLETED|Overall Study||47
8871580|NCT01882764|9928443|FG001|NOT COMPLETED|Overall Study||18
8871581|NCT01882803|9928449|FG000|STARTED|Overall Study||129
8871582|NCT01882803|9928449|FG000|COMPLETED|Overall Study|Subject received treatment in 28-day cycles until disease progression or unacceptable toxicity.|35
8871583|NCT01882803|9928449|FG000|NOT COMPLETED|Overall Study||94
8871584|NCT01882829|9928454|FG000|STARTED|Overall Study||20
8871585|NCT01882829|9928454|FG000|COMPLETED|Overall Study||14
8871586|NCT01882829|9928454|FG000|NOT COMPLETED|Overall Study||6
8871587|NCT01882868|9928458|FG000|STARTED|Overall Study||62
8871588|NCT01882868|9928458|FG000|COMPLETED|Overall Study||62
8871589|NCT01882868|9928458|FG000|NOT COMPLETED|Overall Study||0
8871590|NCT01882907|9928464|FG000|STARTED|Overall Study||117
8871591|NCT01882907|9928465|FG001|STARTED|Overall Study||111
8871592|NCT01882907|9928464|FG000|COMPLETED|Overall Study||103
8871593|NCT01882907|9928465|FG001|COMPLETED|Overall Study||83
8871594|NCT01882907|9928464|FG000|NOT COMPLETED|Overall Study||14
8871595|NCT01882907|9928465|FG001|NOT COMPLETED|Overall Study||28
8871596|NCT01882985|9928473|FG000|STARTED|Overall Study||14
8871597|NCT01882985|9928473|FG000|COMPLETED|Overall Study||12
8871598|NCT01882985|9928473|FG000|NOT COMPLETED|Overall Study||2
8871599|NCT01883141|9928477|FG000|STARTED|Overall Study||31
8871600|NCT01883141|9928477|FG000|Passing Eligibility|Overall Study||30
8871601|NCT01883141|9928477|FG000|EP Study Performed|Overall Study||30
8871602|NCT01883141|9928477|FG000|Usable EP Data|Overall Study||26
8871603|NCT01883141|9928477|FG000|BiV Pacing-Distal|Overall Study||24
8871604|NCT01883141|9928477|FG000|BiV Pacing-Mid|Overall Study||25
8871605|NCT01883141|9928477|FG000|BiV Pacing-Standard Therapy|Overall Study||26
8871606|NCT01883141|9928477|FG000|Multispot-pacing|Overall Study||24
8871607|NCT01883141|9928477|FG000|BiV Pacing-Anterior|Overall Study||23
8871608|NCT01883141|9928477|FG000|Biv Pacing-Posterior|Overall Study||22
8871609|NCT01883141|9928477|FG000|Multivein|Overall Study||23
8871610|NCT01883141|9928477|FG000|COMPLETED|Overall Study|Exit form with exit reason available|31
8871611|NCT01883141|9928477|FG000|NOT COMPLETED|Overall Study||0
8871612|NCT01883362|9928483|FG000|STARTED|Treatment||30
8871613|NCT01883362|9928484|FG001|STARTED|Treatment||30
8871614|NCT01883362|9928483|FG000|COMPLETED|Treatment||14
8871615|NCT01883362|9928484|FG001|COMPLETED|Treatment||16
8871616|NCT01883362|9928483|FG000|NOT COMPLETED|Treatment||16
8871617|NCT01883362|9928484|FG001|NOT COMPLETED|Treatment||14
8871618|NCT01883362|9928483|FG000|STARTED|Post Treatment Follow-up||26
8871619|NCT01883362|9928484|FG001|STARTED|Post Treatment Follow-up||27
8871620|NCT01883362|9928483|FG000|COMPLETED|Post Treatment Follow-up||10
8871621|NCT01883362|9928484|FG001|COMPLETED|Post Treatment Follow-up||13
8871622|NCT01883362|9928483|FG000|NOT COMPLETED|Post Treatment Follow-up||16
8871623|NCT01883362|9928484|FG001|NOT COMPLETED|Post Treatment Follow-up||14
8871624|NCT01883427|9928496|FG000|STARTED|Overall Study||20
8871625|NCT01883427|9928497|FG001|STARTED|Overall Study||20
8871626|NCT01883427|9928496|FG000|COMPLETED|Overall Study||20
8871627|NCT01883427|9928497|FG001|COMPLETED|Overall Study||20
8871628|NCT01883427|9928496|FG000|NOT COMPLETED|Overall Study||0
8871629|NCT01883427|9928497|FG001|NOT COMPLETED|Overall Study||0
8871630|NCT01883440|9928505|FG000|STARTED|Overall Study||45
8871631|NCT01883440|9928506|FG001|STARTED|Overall Study||45
8871632|NCT01883440|9928505|FG000|COMPLETED|Overall Study||42
8871633|NCT01883440|9928506|FG001|COMPLETED|Overall Study||45
8871634|NCT01883440|9928505|FG000|NOT COMPLETED|Overall Study||3
8871635|NCT01883440|9928506|FG001|NOT COMPLETED|Overall Study||0
8871636|NCT01883453|9928515|FG000|STARTED|Overall Study||73
8871637|NCT01883453|9928516|FG001|STARTED|Overall Study||73
8871638|NCT01883453|9928515|FG000|COMPLETED|Overall Study||48
8871639|NCT01883453|9928516|FG001|COMPLETED|Overall Study||50
8871640|NCT01883453|9928515|FG000|NOT COMPLETED|Overall Study||25
8871641|NCT01883453|9928516|FG001|NOT COMPLETED|Overall Study||23
8871642|NCT01883492|9928524|FG000|STARTED|Overall Study||75
8871643|NCT01883492|9928525|FG001|STARTED|Overall Study||78
8871644|NCT01883492|9928524|FG000|COMPLETED|Overall Study||62
8871645|NCT01883492|9928525|FG001|COMPLETED|Overall Study||67
8871646|NCT01883492|9928524|FG000|NOT COMPLETED|Overall Study||13
8952859|NCT02466126|10015929|FG000|NOT COMPLETED|8 Month Assessment||7
8952860|NCT02466126|10015930|FG001|NOT COMPLETED|8 Month Assessment||3
8952861|NCT02466126|10015929|FG000|STARTED|12 Month Assessment||86
8952862|NCT02466126|10015930|FG001|STARTED|12 Month Assessment||68
8952863|NCT02466126|10015929|FG000|COMPLETED|12 Month Assessment||85
8952864|NCT02466126|10015930|FG001|COMPLETED|12 Month Assessment||66
8952865|NCT02466126|10015929|FG000|NOT COMPLETED|12 Month Assessment||1
8952866|NCT02466126|10015930|FG001|NOT COMPLETED|12 Month Assessment||2
8952867|NCT02466230|10015936|FG000|STARTED|Overall Study||28
8952868|NCT02466230|10015936|FG000|COMPLETED|Overall Study||28
8952869|NCT02466230|10015936|FG000|NOT COMPLETED|Overall Study||0
8952870|NCT02466386|10015940|FG000|STARTED|Overall Study||113
8952871|NCT02466386|10015940|FG000|COMPLETED|Overall Study||69
8952872|NCT02466386|10015940|FG000|NOT COMPLETED|Overall Study||44
8952873|NCT02466399|10015946|FG000|STARTED|Overall Study||53
8952874|NCT02466399|10015947|FG001|STARTED|Overall Study||27
8952875|NCT02466399|10015946|FG000|COMPLETED|Overall Study||51
8952876|NCT02466399|10015947|FG001|COMPLETED|Overall Study||27
8952877|NCT02466399|10015946|FG000|NOT COMPLETED|Overall Study||2
8952878|NCT02466399|10015947|FG001|NOT COMPLETED|Overall Study||0
8952879|NCT02466412|10015955|FG000|STARTED|Washout Period of 1 Day (Day -1)||24
8952880|NCT02466412|10015956|FG001|STARTED|Washout Period of 1 Day (Day -1)||24
8952881|NCT02466412|10015955|FG000|COMPLETED|Washout Period of 1 Day (Day -1)||24
8952882|NCT02466412|10015956|FG001|COMPLETED|Washout Period of 1 Day (Day -1)||24
8952883|NCT02466412|10015955|FG000|NOT COMPLETED|Washout Period of 1 Day (Day -1)||0
8952884|NCT02466412|10015956|FG001|NOT COMPLETED|Washout Period of 1 Day (Day -1)||0
8952885|NCT02466412|10015955|FG000|STARTED|First Intervention (Day 1)||24
8952886|NCT02466412|10015956|FG001|STARTED|First Intervention (Day 1)||24
8952887|NCT02466412|10015955|FG000|COMPLETED|First Intervention (Day 1)||24
8952888|NCT02466412|10015956|FG001|COMPLETED|First Intervention (Day 1)||24
8952889|NCT02466412|10015955|FG000|NOT COMPLETED|First Intervention (Day 1)||0
8952890|NCT02466412|10015956|FG001|NOT COMPLETED|First Intervention (Day 1)||0
8952891|NCT02466412|10015955|FG000|STARTED|Washout Period of 1 Day (Day 2)||24
8952892|NCT02466412|10015956|FG001|STARTED|Washout Period of 1 Day (Day 2)||24
8952893|NCT02466412|10015955|FG000|COMPLETED|Washout Period of 1 Day (Day 2)||24
8952894|NCT02466412|10015956|FG001|COMPLETED|Washout Period of 1 Day (Day 2)||24
8952895|NCT02466412|10015955|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
8952896|NCT02466412|10015956|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
8952897|NCT02466412|10015955|FG000|STARTED|Second Intervention (Day 3)||24
8952898|NCT02466412|10015956|FG001|STARTED|Second Intervention (Day 3)||24
8952899|NCT02466412|10015955|FG000|COMPLETED|Second Intervention (Day 3)||24
8952900|NCT02466412|10015956|FG001|COMPLETED|Second Intervention (Day 3)||24
8952901|NCT02466412|10015955|FG000|NOT COMPLETED|Second Intervention (Day 3)||0
8952902|NCT02466412|10015956|FG001|NOT COMPLETED|Second Intervention (Day 3)||0
8952903|NCT02466425|10015965|FG000|STARTED|Overall Study||132
8952904|NCT02466425|10015966|FG001|STARTED|Overall Study||132
8952905|NCT02466425|10015965|FG000|Treated|Overall Study||131
8952906|NCT02466425|10015966|FG001|Treated|Overall Study||132
8952907|NCT02466425|10015965|FG000|COMPLETED|Overall Study||118
8952908|NCT02466425|10015966|FG001|COMPLETED|Overall Study||116
8952909|NCT02466425|10015965|FG000|NOT COMPLETED|Overall Study||14
8952910|NCT02466425|10015966|FG001|NOT COMPLETED|Overall Study||16
8952911|NCT02466516|10015977|FG000|STARTED|Overall Study||20
8952912|NCT02466516|10015978|FG001|STARTED|Overall Study||22
8952913|NCT02466516|10015979|FG002|STARTED|Overall Study||10
8952914|NCT02466516|10015980|FG003|STARTED|Overall Study||10
8952915|NCT02466516|10015981|FG004|STARTED|Overall Study||10
8952916|NCT02466516|10015977|FG000|COMPLETED|Overall Study||16
8952917|NCT02466516|10015978|FG001|COMPLETED|Overall Study||21
8952918|NCT02466516|10015979|FG002|COMPLETED|Overall Study||9
8952919|NCT02466516|10015980|FG003|COMPLETED|Overall Study||10
8952920|NCT02466516|10015981|FG004|COMPLETED|Overall Study||10
8952921|NCT02466516|10015977|FG000|NOT COMPLETED|Overall Study||4
8952922|NCT02466516|10015978|FG001|NOT COMPLETED|Overall Study||1
8952923|NCT02466516|10015979|FG002|NOT COMPLETED|Overall Study||1
8952924|NCT02466516|10015980|FG003|NOT COMPLETED|Overall Study||0
8952925|NCT02466516|10015981|FG004|NOT COMPLETED|Overall Study||0
8952926|NCT02466555|10015993|FG000|STARTED|Overall Study||30
8952927|NCT02466555|10015993|FG000|COMPLETED|Overall Study||28
8952928|NCT02466555|10015993|FG000|NOT COMPLETED|Overall Study||2
9037536|NCT03315793|10098719|FG000|Received at Least 1 Dose of Study Drug|Overall Study||75
9037537|NCT03315793|10098720|FG001|Received at Least 1 Dose of Study Drug|Overall Study||74
9037538|NCT03315793|10098719|FG000|COMPLETED|Overall Study||70
9037539|NCT03315793|10098720|FG001|COMPLETED|Overall Study||71
9037540|NCT03315793|10098719|FG000|NOT COMPLETED|Overall Study||5
9037541|NCT03315793|10098720|FG001|NOT COMPLETED|Overall Study||3
9037542|NCT03315949|10098730|FG000|STARTED|Overall Study||176
9037543|NCT03315949|10098731|FG001|STARTED|Overall Study||176
9037544|NCT03315949|10098730|FG000|COMPLETED|Overall Study||171
9037545|NCT03315949|10098731|FG001|COMPLETED|Overall Study||166
9037546|NCT03315949|10098730|FG000|NOT COMPLETED|Overall Study||5
9037547|NCT03315949|10098731|FG001|NOT COMPLETED|Overall Study||10
9037548|NCT03316131|10098737|FG000|STARTED|Treatment Period 1||18
9037549|NCT03316131|10098738|FG001|STARTED|Treatment Period 1||18
9037550|NCT03316131|10098737|FG000|COMPLETED|Treatment Period 1||18
9037551|NCT03316131|10098738|FG001|COMPLETED|Treatment Period 1||18
9037552|NCT03316131|10098737|FG000|NOT COMPLETED|Treatment Period 1||0
9037553|NCT03316131|10098738|FG001|NOT COMPLETED|Treatment Period 1||0
8871647|NCT01883492|9928525|FG001|NOT COMPLETED|Overall Study||11
8871648|NCT01883635|9928533|FG000|STARTED|Overall Study||24
8871649|NCT01883635|9928534|FG001|STARTED|Overall Study||20
8871650|NCT01883635|9928533|FG000|COMPLETED|Overall Study||20
8871651|NCT01883635|9928534|FG001|COMPLETED|Overall Study||20
8871652|NCT01883635|9928533|FG000|NOT COMPLETED|Overall Study||4
8871653|NCT01883635|9928534|FG001|NOT COMPLETED|Overall Study||0
8631110|NCT00538434|9670997|FG002|COMPLETED|Overall Study|Completed all scheduled study visits|50
8631111|NCT00538434|9670998|FG003|COMPLETED|Overall Study|Completed all scheduled study visits|51
8631112|NCT00538434|9670995|FG000|NOT COMPLETED|Overall Study||9
8631113|NCT00538434|9670996|FG001|NOT COMPLETED|Overall Study||11
8631114|NCT00538434|9670997|FG002|NOT COMPLETED|Overall Study||7
8631115|NCT00538434|9670998|FG003|NOT COMPLETED|Overall Study||6
8631116|NCT00538473|9671011|FG000|STARTED|Overall Study||33
8631117|NCT00538473|9671012|FG001|STARTED|Overall Study||35
8631118|NCT00538473|9671011|FG000|COMPLETED|Overall Study||32
8871654|NCT01883856|9928544|FG000|STARTED|Overall Study||26
8871655|NCT01883856|9928545|FG001|STARTED|Overall Study||26
8871656|NCT01883856|9928544|FG000|COMPLETED|Overall Study||26
8871657|NCT01883856|9928545|FG001|COMPLETED|Overall Study||26
8871658|NCT01883856|9928544|FG000|NOT COMPLETED|Overall Study||0
8871659|NCT01883856|9928545|FG001|NOT COMPLETED|Overall Study||0
8871660|NCT01883895|9928551|FG000|STARTED|Overall Study||34
8871661|NCT01883895|9928551|FG000|COMPLETED|Overall Study||32
8871662|NCT01883895|9928551|FG000|NOT COMPLETED|Overall Study||2
8871663|NCT01883986|9928557|FG000|STARTED|Overall Study|Allocated to intervention arm|20
8871664|NCT01883986|9928558|FG001|STARTED|Overall Study|Allocated to usual care arm|20
8871665|NCT01883986|9928557|FG000|Did Not Complete Study|Overall Study||3
8871666|NCT01883986|9928558|FG001|Did Not Complete Study|Overall Study|Did not completed study|1
8871667|NCT01883986|9928557|FG000|COMPLETED|Overall Study|Received allocated intervention|17
8871668|NCT01883986|9928558|FG001|COMPLETED|Overall Study|Completed study|19
8871669|NCT01883986|9928557|FG000|NOT COMPLETED|Overall Study||3
8871670|NCT01883986|9928558|FG001|NOT COMPLETED|Overall Study||1
8871671|NCT01883999|9928564|FG000|STARTED|Overall Study||64
8871672|NCT01883999|9928564|FG000|COMPLETED|Overall Study||61
8871673|NCT01883999|9928564|FG000|NOT COMPLETED|Overall Study||3
8871674|NCT01884025|9928570|FG000|STARTED|Overall Study||13
8871675|NCT01884025|9928571|FG001|STARTED|Overall Study||14
8871676|NCT01884025|9928570|FG000|COMPLETED|Overall Study||10
8871677|NCT01884025|9928571|FG001|COMPLETED|Overall Study||10
8871678|NCT01884025|9928570|FG000|NOT COMPLETED|Overall Study||3
8871679|NCT01884025|9928571|FG001|NOT COMPLETED|Overall Study||4
8871680|NCT01884064|9928579|FG000|STARTED|Overall Study||12
8871681|NCT01884064|9928580|FG001|STARTED|Overall Study||5
8871682|NCT01884064|9928579|FG000|COMPLETED|Overall Study||12
8871683|NCT01884064|9928580|FG001|COMPLETED|Overall Study||5
8871684|NCT01884064|9928579|FG000|NOT COMPLETED|Overall Study||0
8871685|NCT01884064|9928580|FG001|NOT COMPLETED|Overall Study||0
8871686|NCT01884311|9928586|FG000|STARTED|Overall Study||38
8871687|NCT01884311|9928586|FG000|COMPLETED|Overall Study||33
8871688|NCT01884311|9928586|FG000|NOT COMPLETED|Overall Study||5
8871689|NCT01884337|9928595|FG000|STARTED|Treatment||326
8871690|NCT01884337|9928596|FG001|STARTED|Treatment||172
8871691|NCT01884337|9928595|FG000|Continuing Into Follow-up Period|Treatment||324
8871692|NCT01884337|9928596|FG001|Continuing Into Follow-up Period|Treatment||171
8871693|NCT01884337|9928595|FG000|COMPLETED|Treatment||322
8871694|NCT01884337|9928596|FG001|COMPLETED|Treatment||170
8871695|NCT01884337|9928595|FG000|NOT COMPLETED|Treatment||4
8871696|NCT01884337|9928596|FG001|NOT COMPLETED|Treatment||2
8871697|NCT01884337|9928595|FG000|STARTED|Follow-up Period||324
8871698|NCT01884337|9928596|FG001|STARTED|Follow-up Period||171
8871699|NCT01884337|9928595|FG000|COMPLETED|Follow-up Period||323
8871700|NCT01884337|9928596|FG001|COMPLETED|Follow-up Period||170
8871701|NCT01884337|9928595|FG000|NOT COMPLETED|Follow-up Period||1
8871702|NCT01884337|9928596|FG001|NOT COMPLETED|Follow-up Period||1
8871703|NCT01884350|9928604|FG000|STARTED|Primary Efficacy Analysis Set (24 Weeks)||583
8871704|NCT01884350|9928605|FG001|STARTED|Primary Efficacy Analysis Set (24 Weeks)||579
8871705|NCT01884350|9928606|FG002|STARTED|Primary Efficacy Analysis Set (24 Weeks)|Participants were not randomized to this arm until after initial 24-week period|0
8871706|NCT01884350|9928604|FG000|Safety Analysis Set|Primary Efficacy Analysis Set (24 Weeks)||604
8871707|NCT01884350|9928605|FG001|Safety Analysis Set|Primary Efficacy Analysis Set (24 Weeks)||558
8871708|NCT01884350|9928606|FG002|Safety Analysis Set|Primary Efficacy Analysis Set (24 Weeks)||0
8871709|NCT01884350|9928604|FG000|COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||529
8871710|NCT01884350|9928605|FG001|COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||525
8871711|NCT01884350|9928606|FG002|COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||0
8871712|NCT01884350|9928604|FG000|NOT COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||54
8871713|NCT01884350|9928605|FG001|NOT COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||54
8871714|NCT01884350|9928606|FG002|NOT COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||0
8871715|NCT01884350|9928604|FG000|STARTED|Primary Efficacy Analysis Set (48 Weeks)||583
8871716|NCT01884350|9928605|FG001|STARTED|Primary Efficacy Analysis Set (48 Weeks)|After 24 weeks participants were randomized to continue AEP or stop AEP and revert to SOC.|263
8952929|NCT02466646|10016001|FG000|STARTED|Overall Study||14
8952930|NCT02466646|10016002|FG001|STARTED|Overall Study||14
8631119|NCT00538473|9671012|FG001|COMPLETED|Overall Study||35
8631120|NCT00538473|9671011|FG000|NOT COMPLETED|Overall Study||1
8631121|NCT00538473|9671012|FG001|NOT COMPLETED|Overall Study||0
8631122|NCT00538512|9671021|FG000|STARTED|Overall Study||814
8631123|NCT00538512|9671022|FG001|STARTED|Overall Study||813
8871717|NCT01884350|9928606|FG002|STARTED|Primary Efficacy Analysis Set (48 Weeks)|After 24 weeks participants were randomized to continue AEP or stop AEP and revert to SOC.|261
8871718|NCT01884350|9928604|FG000|Safety Analysis Set|Primary Efficacy Analysis Set (48 Weeks)||604
8871719|NCT01884350|9928605|FG001|Safety Analysis Set|Primary Efficacy Analysis Set (48 Weeks)||308
8871720|NCT01884350|9928606|FG002|Safety Analysis Set|Primary Efficacy Analysis Set (48 Weeks)||223
8871721|NCT01884350|9928604|FG000|COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||503
8952931|NCT02466646|10016003|FG002|STARTED|Overall Study||14
8631124|NCT00538512|9671023|FG002|STARTED|Overall Study||325
8631125|NCT00538512|9671021|FG000|COMPLETED|Overall Study||787
8631126|NCT00538512|9671022|FG001|COMPLETED|Overall Study||783
8631127|NCT00538512|9671023|FG002|COMPLETED|Overall Study||312
8631128|NCT00538512|9671021|FG000|NOT COMPLETED|Overall Study||27
8631129|NCT00538512|9671022|FG001|NOT COMPLETED|Overall Study||30
8631130|NCT00538512|9671023|FG002|NOT COMPLETED|Overall Study||13
8631131|NCT00538590|9671033|FG000|STARTED|Overall Study||10
8631132|NCT00538590|9671034|FG001|STARTED|Overall Study||10
8631133|NCT00538590|9671033|FG000|COMPLETED|Overall Study|Deceased 8 months after surgery due to known cardiovascular co-morbidity.|9
8631134|NCT00538590|9671034|FG001|COMPLETED|Overall Study||10
8631135|NCT00538590|9671033|FG000|NOT COMPLETED|Overall Study||1
8631136|NCT00538590|9671034|FG001|NOT COMPLETED|Overall Study||0
8631137|NCT00538616|9671042|FG000|STARTED|Overall Study||5
8631138|NCT00538616|9671043|FG001|STARTED|Overall Study||3
8631139|NCT00538616|9671042|FG000|COMPLETED|Overall Study||5
8631140|NCT00538616|9671043|FG001|COMPLETED|Overall Study||3
8631141|NCT00538616|9671042|FG000|NOT COMPLETED|Overall Study||0
8631142|NCT00538616|9671043|FG001|NOT COMPLETED|Overall Study||0
8631143|NCT00538629|9671049|FG000|STARTED|Overall Study||471
8631144|NCT00538629|9671049|FG000|COMPLETED|Overall Study||449
8631145|NCT00538629|9671049|FG000|NOT COMPLETED|Overall Study||22
8631146|NCT00538642|9671055|FG000|STARTED|Overall Study||10
8631147|NCT00538642|9671056|FG001|STARTED|Overall Study||14
8631148|NCT00538642|9671055|FG000|COMPLETED|Overall Study||9
8631149|NCT00538642|9671056|FG001|COMPLETED|Overall Study||9
8631150|NCT00538642|9671055|FG000|NOT COMPLETED|Overall Study||1
8631151|NCT00538642|9671056|FG001|NOT COMPLETED|Overall Study||5
8631152|NCT00538681|9671067|FG000|STARTED|Overall Study||9
8631153|NCT00538681|9671068|FG001|STARTED|Overall Study||4
8631154|NCT00538681|9671069|FG002|STARTED|Overall Study||11
8631155|NCT00538681|9671070|FG003|STARTED|Overall Study|One (1) participant received pemetrexed and cisplatin only before the study was closed.|11
8631156|NCT00538681|9671067|FG000|Received ≥1 Dose of Any Study Drug|Overall Study||9
8631157|NCT00538681|9671068|FG001|Received ≥1 Dose of Any Study Drug|Overall Study||4
8631158|NCT00538681|9671069|FG002|Received ≥1 Dose of Any Study Drug|Overall Study||11
8631159|NCT00538681|9671070|FG003|Received ≥1 Dose of Any Study Drug|Overall Study||11
8631160|NCT00538681|9671067|FG000|COMPLETED|Overall Study||0
8631161|NCT00538681|9671068|FG001|COMPLETED|Overall Study||0
8631162|NCT00538681|9671069|FG002|COMPLETED|Overall Study||0
8631163|NCT00538681|9671070|FG003|COMPLETED|Overall Study||0
8631164|NCT00538681|9671067|FG000|NOT COMPLETED|Overall Study||9
8631165|NCT00538681|9671068|FG001|NOT COMPLETED|Overall Study||4
8631166|NCT00538681|9671069|FG002|NOT COMPLETED|Overall Study||11
8631167|NCT00538681|9671070|FG003|NOT COMPLETED|Overall Study||11
8631168|NCT00538733|9671081|FG000|STARTED|Overall Study||26
8631169|NCT00538733|9671081|FG000|Removed Due to Progression of Disease|Overall Study||1
8631170|NCT00538733|9671081|FG000|Removed to Pursue a Stem Cell Transplant|Overall Study||11
8631171|NCT00538733|9671081|FG000|Removed to Pursue Alternative Theray|Overall Study||2
8631172|NCT00538733|9671081|FG000|COMPLETED|Overall Study||14
8631173|NCT00538733|9671081|FG000|NOT COMPLETED|Overall Study||12
8631174|NCT00538759|9671090|FG000|STARTED|Overall Study||13
8631175|NCT00538759|9671091|FG001|STARTED|Overall Study||8
8631176|NCT00538759|9671090|FG000|COMPLETED|Overall Study||13
8631177|NCT00538759|9671091|FG001|COMPLETED|Overall Study||8
8631178|NCT00538759|9671090|FG000|NOT COMPLETED|Overall Study||0
8631179|NCT00538759|9671091|FG001|NOT COMPLETED|Overall Study||0
8631180|NCT00538785|9671099|FG000|STARTED|Overall Study|A subject was randomized without appropriate consent in France and is not included in the results.|623
8631181|NCT00538785|9671100|FG001|STARTED|Overall Study||612
8631182|NCT00538785|9671099|FG000|COMPLETED|Overall Study||604
8631183|NCT00538785|9671100|FG001|COMPLETED|Overall Study||595
8631184|NCT00538785|9671099|FG000|NOT COMPLETED|Overall Study||19
8631185|NCT00538785|9671100|FG001|NOT COMPLETED|Overall Study||17
8631186|NCT00538824|9671106|FG000|STARTED|Overall Study||5
8631187|NCT00538824|9671106|FG000|Progression of Disease|Overall Study||2
8631188|NCT00538824|9671106|FG000|COMPLETED|Overall Study||5
8631189|NCT00538824|9671106|FG000|NOT COMPLETED|Overall Study||0
8631190|NCT00538850|9671110|FG000|STARTED|Titration Period||130
8631191|NCT00538850|9671111|FG001|STARTED|Titration Period|There were no participants in this reporting group in the titration period.|0
8631192|NCT00538850|9671112|FG002|STARTED|Titration Period|There were no participants in this reporting group in the titration period.|0
8631193|NCT00538850|9671110|FG000|COMPLETED|Titration Period||98
8631194|NCT00538850|9671111|FG001|COMPLETED|Titration Period||0
8631195|NCT00538850|9671112|FG002|COMPLETED|Titration Period||0
8631196|NCT00538850|9671110|FG000|NOT COMPLETED|Titration Period||32
8631197|NCT00538850|9671111|FG001|NOT COMPLETED|Titration Period||0
8631198|NCT00538850|9671112|FG002|NOT COMPLETED|Titration Period||0
8631199|NCT00538850|9671110|FG000|STARTED|Fentanyl Sublingual Spray - Double-blind|There were no participants in this reporting group in the double-blind period.|0
8631200|NCT00538850|9671111|FG001|STARTED|Fentanyl Sublingual Spray - Double-blind||98
8631201|NCT00538850|9671112|FG002|STARTED|Fentanyl Sublingual Spray - Double-blind|There were no participants in this reporting group in the double-blind period.|0
8693607|NCT00867334|9739132|FG001|NOT COMPLETED|Overall Study||1
8871722|NCT01884350|9928605|FG001|COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||250
8871723|NCT01884350|9928606|FG002|COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||250
8871724|NCT01884350|9928604|FG000|NOT COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||80
8871725|NCT01884350|9928605|FG001|NOT COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||13
8871726|NCT01884350|9928606|FG002|NOT COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||11
8871727|NCT01884519|9928618|FG000|STARTED|Overall Study||60
8871728|NCT01884519|9928619|FG001|STARTED|Overall Study||60
8871729|NCT01884519|9928618|FG000|COMPLETED|Overall Study||60
8871730|NCT01884519|9928619|FG001|COMPLETED|Overall Study||60
8871731|NCT01884519|9928618|FG000|NOT COMPLETED|Overall Study||0
8871732|NCT01884519|9928619|FG001|NOT COMPLETED|Overall Study||0
8871733|NCT01884545|9928637|FG000|STARTED|Overall Study||50
8871734|NCT01884545|9928638|FG001|STARTED|Overall Study||49
8871735|NCT01884545|9928639|FG002|STARTED|Overall Study||49
8871736|NCT01884545|9928640|FG003|STARTED|Overall Study||52
8871737|NCT01884545|9928637|FG000|COMPLETED|Overall Study||37
8871738|NCT01884545|9928638|FG001|COMPLETED|Overall Study||31
8871739|NCT01884545|9928639|FG002|COMPLETED|Overall Study||35
8871740|NCT01884545|9928640|FG003|COMPLETED|Overall Study||43
8871741|NCT01884545|9928637|FG000|NOT COMPLETED|Overall Study||13
8871742|NCT01884545|9928638|FG001|NOT COMPLETED|Overall Study||18
8871743|NCT01884545|9928639|FG002|NOT COMPLETED|Overall Study||14
8871744|NCT01884545|9928640|FG003|NOT COMPLETED|Overall Study||9
8871745|NCT01884571|9928650|FG000|STARTED|Overall Study||31
8871746|NCT01884571|9928650|FG000|COMPLETED|Overall Study||23
8871747|NCT01884571|9928650|FG000|NOT COMPLETED|Overall Study||8
8871748|NCT01884597|9928657|FG000|STARTED|Overall Study||5
8871749|NCT01884597|9928658|FG001|STARTED|Overall Study||3
8871750|NCT01884597|9928659|FG002|STARTED|Overall Study||16
8871751|NCT01884597|9928657|FG000|COMPLETED|Overall Study||4
8871752|NCT01884597|9928658|FG001|COMPLETED|Overall Study||2
8871753|NCT01884597|9928659|FG002|COMPLETED|Overall Study||15
8693608|NCT00867360|9739140|FG000|STARTED|Overall Study||4
8693609|NCT00867360|9739141|FG001|STARTED|Overall Study||6
8871754|NCT01884597|9928657|FG000|NOT COMPLETED|Overall Study||1
8871755|NCT01884597|9928658|FG001|NOT COMPLETED|Overall Study||1
8871756|NCT01884597|9928659|FG002|NOT COMPLETED|Overall Study||1
8871757|NCT01884675|9928675|FG000|STARTED|Overall Study||16
8871758|NCT01884675|9928676|FG001|STARTED|Overall Study||17
8871759|NCT01884675|9928675|FG000|COMPLETED|Overall Study||13
8871760|NCT01884675|9928676|FG001|COMPLETED|Overall Study||15
8871761|NCT01884675|9928675|FG000|NOT COMPLETED|Overall Study||3
8871762|NCT01884675|9928676|FG001|NOT COMPLETED|Overall Study||2
8871763|NCT01884688|9928684|FG000|STARTED|Overall Study||3
8871764|NCT01884688|9928684|FG000|COMPLETED|Overall Study||1
8871765|NCT01884688|9928684|FG000|NOT COMPLETED|Overall Study||2
8871766|NCT01884844|9928690|FG000|STARTED|Overall Study||16
8871767|NCT01884844|9928691|FG001|STARTED|Overall Study||17
8871768|NCT01884844|9928690|FG000|COMPLETED|Overall Study||13
8871769|NCT01884844|9928691|FG001|COMPLETED|Overall Study||12
8693610|NCT00867360|9739140|FG000|COMPLETED|Overall Study||3
8693611|NCT00867360|9739141|FG001|COMPLETED|Overall Study||5
8693612|NCT00867360|9739140|FG000|NOT COMPLETED|Overall Study||1
8693613|NCT00867360|9739141|FG001|NOT COMPLETED|Overall Study||1
8693614|NCT00867451|9739150|FG000|STARTED|Overall Study||4
8693615|NCT00867451|9739151|FG001|STARTED|Overall Study||4
8693616|NCT00867451|9739150|FG000|COMPLETED|Overall Study||4
8693617|NCT00867451|9739151|FG001|COMPLETED|Overall Study||4
8693618|NCT00867451|9739150|FG000|NOT COMPLETED|Overall Study||0
8693619|NCT00867451|9739151|FG001|NOT COMPLETED|Overall Study||0
8693620|NCT00867490|9739161|FG000|STARTED|Phase 1 - Candesartan+HCTZ||186
8693621|NCT00867490|9739161|FG000|COMPLETED|Phase 1 - Candesartan+HCTZ||176
8693622|NCT00867490|9739161|FG000|NOT COMPLETED|Phase 1 - Candesartan+HCTZ||10
8693623|NCT00867490|9739161|FG000|STARTED|Phase 2 - Aliskiren+HCTZ|Only patients with mean sitting diastolic BP ≥ 90 mmHg at the end of Phase 1 entered this phase.|123
8693624|NCT00867490|9739161|FG000|COMPLETED|Phase 2 - Aliskiren+HCTZ||120
8693625|NCT00867490|9739161|FG000|NOT COMPLETED|Phase 2 - Aliskiren+HCTZ||3
8693626|NCT00867490|9739161|FG000|STARTED|Phase 3 - Aliskiren+HCTZ+Amlodipine|The first 60 patients with systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg entered this phase.|61
8693627|NCT00867490|9739161|FG000|COMPLETED|Phase 3 - Aliskiren+HCTZ+Amlodipine||61
8693628|NCT00867490|9739161|FG000|NOT COMPLETED|Phase 3 - Aliskiren+HCTZ+Amlodipine||0
8693629|NCT00867503|9739168|FG000|STARTED|Overall Study||10
8693630|NCT00867503|9739168|FG000|COMPLETED|Overall Study||9
8693631|NCT00867503|9739168|FG000|NOT COMPLETED|Overall Study||1
8693632|NCT00867529|9739174|FG000|STARTED|Overall Study||63
8693633|NCT00867529|9739174|FG000|COMPLETED|Overall Study||63
8693634|NCT00867529|9739174|FG000|NOT COMPLETED|Overall Study||0
8693635|NCT00867659|9739178|FG000|STARTED|Overall Study|October 2009|20
8693636|NCT00867659|9739178|FG000|COMPLETED|Overall Study|January 2010|20
8871770|NCT01884844|9928690|FG000|NOT COMPLETED|Overall Study||3
8871771|NCT01884844|9928691|FG001|NOT COMPLETED|Overall Study||5
8871772|NCT01885000|9928699|FG000|STARTED|Overall Study||48
8871773|NCT01885000|9928700|FG001|STARTED|Overall Study||44
8871774|NCT01885000|9928699|FG000|COMPLETED|Overall Study||46
8871775|NCT01885000|9928700|FG001|COMPLETED|Overall Study||42
8871776|NCT01885000|9928699|FG000|NOT COMPLETED|Overall Study||2
8871777|NCT01885000|9928700|FG001|NOT COMPLETED|Overall Study||2
8871778|NCT01885104|9928708|FG000|STARTED|Overall Study||31
8871779|NCT01885104|9928709|FG001|STARTED|Overall Study||34
8871780|NCT01885104|9928708|FG000|COMPLETED|Overall Study||29
8871781|NCT01885104|9928709|FG001|COMPLETED|Overall Study||33
8871782|NCT01885104|9928708|FG000|NOT COMPLETED|Overall Study||2
8871783|NCT01885104|9928709|FG001|NOT COMPLETED|Overall Study||1
8871784|NCT01885117|9928717|FG000|STARTED|Overall Study||61
8871785|NCT01885117|9928718|FG001|STARTED|Overall Study||64
8871786|NCT01885117|9928717|FG000|COMPLETED|Overall Study||61
8871787|NCT01885117|9928718|FG001|COMPLETED|Overall Study||64
8871788|NCT01885117|9928717|FG000|NOT COMPLETED|Overall Study||0
8871789|NCT01885117|9928718|FG001|NOT COMPLETED|Overall Study||0
8871790|NCT01885182|9928726|FG000|STARTED|Overall Study||117
8871791|NCT01885182|9928727|FG001|STARTED|Overall Study||115
8871792|NCT01885182|9928726|FG000|Safety Population|Overall Study||114
8871793|NCT01885182|9928727|FG001|Safety Population|Overall Study||111
8871794|NCT01885182|9928726|FG000|FAP Population|Overall Study||107
8871795|NCT01885182|9928727|FG001|FAP Population|Overall Study||106
8871796|NCT01885182|9928726|FG000|COMPLETED|Overall Study||83
8871797|NCT01885182|9928727|FG001|COMPLETED|Overall Study||93
8871798|NCT01885182|9928726|FG000|NOT COMPLETED|Overall Study||34
8871799|NCT01885182|9928727|FG001|NOT COMPLETED|Overall Study||22
8871800|NCT01885195|9928735|FG000|STARTED|Overall Study||110
8871801|NCT01885195|9928735|FG000|COMPLETED|Overall Study||0
8871802|NCT01885195|9928735|FG000|NOT COMPLETED|Overall Study||110
8871803|NCT01885208|9928741|FG000|STARTED|Overall Study||406
8871804|NCT01885208|9928742|FG001|STARTED|Overall Study||407
8871805|NCT01885208|9928741|FG000|Exposed|Overall Study||404
8871806|NCT01885208|9928742|FG001|Exposed|Overall Study||405
8871807|NCT01885208|9928741|FG000|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial.|82
8871808|NCT01885208|9928742|FG001|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial.|85
8871809|NCT01885208|9928741|FG000|COMPLETED|Overall Study||374
8871810|NCT01885208|9928742|FG001|COMPLETED|Overall Study||369
8871811|NCT01885208|9928741|FG000|NOT COMPLETED|Overall Study||32
8871812|NCT01885208|9928742|FG001|NOT COMPLETED|Overall Study||38
8871813|NCT01885559|9928750|FG000|STARTED|Overall Study||242
8871814|NCT01885559|9928751|FG001|STARTED|Overall Study||244
8871815|NCT01885559|9928750|FG000|COMPLETED|Overall Study||218
8871816|NCT01885559|9928751|FG001|COMPLETED|Overall Study||208
8871817|NCT01885559|9928750|FG000|NOT COMPLETED|Overall Study||24
8871818|NCT01885559|9928751|FG001|NOT COMPLETED|Overall Study||36
8871819|NCT01885871|9928757|FG000|STARTED|Overall Study||20
8952932|NCT02466646|10016001|FG000|COMPLETED|Overall Study||14
8952933|NCT02466646|10016002|FG001|COMPLETED|Overall Study||14
8952934|NCT02466646|10016003|FG002|COMPLETED|Overall Study||14
8952935|NCT02466646|10016001|FG000|NOT COMPLETED|Overall Study||0
8952936|NCT02466646|10016002|FG001|NOT COMPLETED|Overall Study||0
8952937|NCT02466646|10016003|FG002|NOT COMPLETED|Overall Study||0
8952938|NCT02466659|10016016|FG000|STARTED|Overall Study||5
8952939|NCT02466659|10016017|FG001|STARTED|Overall Study||3
8952940|NCT02466659|10016016|FG000|COMPLETED|Overall Study||0
8952941|NCT02466659|10016017|FG001|COMPLETED|Overall Study||1
8952942|NCT02466659|10016016|FG000|NOT COMPLETED|Overall Study||5
8952943|NCT02466659|10016017|FG001|NOT COMPLETED|Overall Study||2
8952944|NCT02466958|10016025|FG000|STARTED|Overall Study||17
8952945|NCT02466958|10016026|FG001|STARTED|Overall Study||12
8952946|NCT02466958|10016025|FG000|COMPLETED|Overall Study||7
8952947|NCT02466958|10016026|FG001|COMPLETED|Overall Study||9
8952948|NCT02466958|10016025|FG000|NOT COMPLETED|Overall Study||10
8952949|NCT02466958|10016026|FG001|NOT COMPLETED|Overall Study||3
8952950|NCT02467075|10016034|FG000|STARTED|Initial CT Scan||0
8952951|NCT02467075|10016035|FG001|STARTED|Initial CT Scan||1
8952952|NCT02467075|10016034|FG000|COMPLETED|Initial CT Scan||0
8952953|NCT02467075|10016035|FG001|COMPLETED|Initial CT Scan||1
8952954|NCT02467075|10016034|FG000|NOT COMPLETED|Initial CT Scan||0
8952955|NCT02467075|10016035|FG001|NOT COMPLETED|Initial CT Scan||0
8952956|NCT02467075|10016034|FG000|STARTED|48 Hour Follow-up||0
8952957|NCT02467075|10016035|FG001|STARTED|48 Hour Follow-up||1
8952958|NCT02467075|10016034|FG000|COMPLETED|48 Hour Follow-up||0
8952959|NCT02467075|10016035|FG001|COMPLETED|48 Hour Follow-up||1
8952960|NCT02467075|10016034|FG000|NOT COMPLETED|48 Hour Follow-up||0
8952961|NCT02467075|10016035|FG001|NOT COMPLETED|48 Hour Follow-up||0
8952962|NCT02467075|10016034|FG000|STARTED|72 Hour Follow-up||0
8952963|NCT02467075|10016035|FG001|STARTED|72 Hour Follow-up||1
8952964|NCT02467075|10016034|FG000|COMPLETED|72 Hour Follow-up||0
8952965|NCT02467075|10016035|FG001|COMPLETED|72 Hour Follow-up||1
8952966|NCT02467075|10016034|FG000|NOT COMPLETED|72 Hour Follow-up||0
8952967|NCT02467075|10016035|FG001|NOT COMPLETED|72 Hour Follow-up||0
8952968|NCT02467075|10016034|FG000|STARTED|30 Day Follow-up||0
8952969|NCT02467075|10016035|FG001|STARTED|30 Day Follow-up||1
8952970|NCT02467075|10016034|FG000|COMPLETED|30 Day Follow-up||0
8871820|NCT01885871|9928757|FG000|COMPLETED|Overall Study||20
8871821|NCT01885871|9928757|FG000|NOT COMPLETED|Overall Study||0
8871822|NCT01885897|9928767|FG000|STARTED|Overall Study||6
8871823|NCT01885897|9928768|FG001|STARTED|Overall Study||3
8871824|NCT01885897|9928769|FG002|STARTED|Overall Study||4
8871825|NCT01885897|9928770|FG003|STARTED|Overall Study||3
8871826|NCT01885897|9928771|FG004|STARTED|Overall Study||8
8871827|NCT01885897|9928772|FG005|STARTED|Overall Study||9
8871828|NCT01885897|9928767|FG000|COMPLETED|Overall Study||6
8871829|NCT01885897|9928768|FG001|COMPLETED|Overall Study||3
8871830|NCT01885897|9928769|FG002|COMPLETED|Overall Study||4
8871831|NCT01885897|9928770|FG003|COMPLETED|Overall Study||3
8871832|NCT01885897|9928771|FG004|COMPLETED|Overall Study||8
8871833|NCT01885897|9928772|FG005|COMPLETED|Overall Study||9
8871834|NCT01885897|9928767|FG000|NOT COMPLETED|Overall Study||0
8871835|NCT01885897|9928768|FG001|NOT COMPLETED|Overall Study||0
8871836|NCT01885897|9928769|FG002|NOT COMPLETED|Overall Study||0
8871837|NCT01885897|9928770|FG003|NOT COMPLETED|Overall Study||0
8871838|NCT01885897|9928771|FG004|NOT COMPLETED|Overall Study||0
8871839|NCT01885897|9928772|FG005|NOT COMPLETED|Overall Study||0
8871840|NCT01885910|9928786|FG000|STARTED|Overall Study||32
8871841|NCT01885910|9928786|FG000|COMPLETED|Overall Study||24
8871842|NCT01885910|9928786|FG000|NOT COMPLETED|Overall Study||8
8871843|NCT01885936|9928794|FG000|STARTED|Overall Study||8
8871844|NCT01885936|9928795|FG001|STARTED|Overall Study||5
8871845|NCT01885936|9928794|FG000|COMPLETED|Overall Study||7
8871846|NCT01885936|9928795|FG001|COMPLETED|Overall Study||5
8871847|NCT01885936|9928794|FG000|NOT COMPLETED|Overall Study||1
8871848|NCT01885936|9928795|FG001|NOT COMPLETED|Overall Study||0
8871849|NCT01886105|9928801|FG000|STARTED|Overall Study||4
8871850|NCT01886105|9928801|FG000|COMPLETED|Overall Study||1
8871851|NCT01886105|9928801|FG000|NOT COMPLETED|Overall Study||3
8871852|NCT01886235|9928806|FG000|STARTED|Overall Study||10
8871853|NCT01886235|9928806|FG000|COMPLETED|Overall Study||10
8871854|NCT01886235|9928806|FG000|NOT COMPLETED|Overall Study||0
8871855|NCT01886287|9928810|FG000|STARTED|Overall Study||2
8871856|NCT01886287|9928810|FG000|COMPLETED|Overall Study||0
8871857|NCT01886287|9928810|FG000|NOT COMPLETED|Overall Study||2
8923977|NCT02245412|9984645|FG000|STARTED|Follow-Up Period|One participant who discontinued Study Drug in Treatment Period continued to Follow-Up Period.|13
8923978|NCT02245412|9984646|FG001|STARTED|Follow-Up Period|One participant who discontinued Study Drug in Treatment Period continued to Follow-Up Period.|4
8923979|NCT02245412|9984647|FG002|STARTED|Follow-Up Period||2
8923980|NCT02245412|9984645|FG000|COMPLETED|Follow-Up Period||8
8923981|NCT02245412|9984646|FG001|COMPLETED|Follow-Up Period||2
8923982|NCT02245412|9984647|FG002|COMPLETED|Follow-Up Period||0
8923983|NCT02245412|9984645|FG000|NOT COMPLETED|Follow-Up Period||5
8923984|NCT02245412|9984646|FG001|NOT COMPLETED|Follow-Up Period||2
8923985|NCT02245412|9984647|FG002|NOT COMPLETED|Follow-Up Period||2
8923986|NCT02245516|9984657|FG000|STARTED|Overall Study||9
8923987|NCT02245516|9984658|FG001|STARTED|Overall Study||7
8923988|NCT02245516|9984657|FG000|COMPLETED|Overall Study||9
8923989|NCT02245516|9984658|FG001|COMPLETED|Overall Study||4
8923990|NCT02245516|9984657|FG000|NOT COMPLETED|Overall Study||0
8923991|NCT02245516|9984658|FG001|NOT COMPLETED|Overall Study||3
8923992|NCT02245568|9984664|FG000|STARTED|Overall Study||913
8923993|NCT02245568|9984664|FG000|COMPLETED|Overall Study||60
8923994|NCT02245568|9984664|FG000|NOT COMPLETED|Overall Study||853
8923995|NCT02245620|9984670|FG000|STARTED|Overall Study||20
8923996|NCT02245620|9984671|FG001|STARTED|Overall Study||21
8923997|NCT02245620|9984670|FG000|COMPLETED|Overall Study||19
8923998|NCT02245620|9984671|FG001|COMPLETED|Overall Study||20
8923999|NCT02245620|9984670|FG000|NOT COMPLETED|Overall Study||1
8924000|NCT02245620|9984671|FG001|NOT COMPLETED|Overall Study||1
8924001|NCT02245737|9984680|FG000|STARTED|Overall Study||740
8924002|NCT02245737|9984681|FG001|STARTED|Overall Study||739
8924003|NCT02245737|9984682|FG002|STARTED|Overall Study||739
8924004|NCT02245737|9984680|FG000|Received at Least 1 Dose of Study Drug|Overall Study||738
8924005|NCT02245737|9984681|FG001|Received at Least 1 Dose of Study Drug|Overall Study||736
8924006|NCT02245737|9984682|FG002|Received at Least 1 Dose of Study Drug|Overall Study||735
8924007|NCT02245737|9984680|FG000|COMPLETED|Overall Study||187
8924008|NCT02245737|9984681|FG001|COMPLETED|Overall Study||184
8924009|NCT02245737|9984682|FG002|COMPLETED|Overall Study||168
8924010|NCT02245737|9984680|FG000|NOT COMPLETED|Overall Study||553
8924011|NCT02245737|9984681|FG001|NOT COMPLETED|Overall Study||555
8924012|NCT02245737|9984682|FG002|NOT COMPLETED|Overall Study||571
8924013|NCT02245815|9984694|FG000|STARTED|Overall Study||45
8924014|NCT02245815|9984695|FG001|STARTED|Overall Study||45
8924015|NCT02245815|9984694|FG000|COMPLETED|Overall Study||45
8924016|NCT02245815|9984695|FG001|COMPLETED|Overall Study||45
8924017|NCT02245815|9984694|FG000|NOT COMPLETED|Overall Study||0
8924018|NCT02245815|9984695|FG001|NOT COMPLETED|Overall Study||0
8924019|NCT02246010|9984705|FG000|STARTED|Overall Study||4
8924020|NCT02246010|9984706|FG001|STARTED|Overall Study||2
8924021|NCT02246010|9984705|FG000|COMPLETED|Overall Study||4
8924022|NCT02246010|9984706|FG001|COMPLETED|Overall Study||2
8924023|NCT02246010|9984705|FG000|NOT COMPLETED|Overall Study||0
8924024|NCT02246010|9984706|FG001|NOT COMPLETED|Overall Study||0
8924025|NCT02246062|9984716|FG000|STARTED|Overall Study||21
8924026|NCT02246062|9984717|FG001|STARTED|Overall Study||21
8924027|NCT02246062|9984718|FG002|STARTED|Overall Study||21
8924028|NCT02246062|9984719|FG003|STARTED|Overall Study||21
8871858|NCT01886300|9928814|FG000|STARTED|Overall Study||16
8871859|NCT01886300|9928814|FG000|COMPLETED|Overall Study||0
8952971|NCT02467075|10016035|FG001|COMPLETED|30 Day Follow-up||1
8952972|NCT02467075|10016034|FG000|NOT COMPLETED|30 Day Follow-up||0
8952973|NCT02467075|10016035|FG001|NOT COMPLETED|30 Day Follow-up||0
8952974|NCT02467166|10016043|FG000|STARTED|Overall Study||36
8952975|NCT02467166|10016043|FG000|COMPLETED|Overall Study||36
8952976|NCT02467166|10016043|FG000|NOT COMPLETED|Overall Study||0
8952977|NCT02467179|10016049|FG000|STARTED|Overall Study||25
8952978|NCT02467179|10016050|FG001|STARTED|Overall Study||25
8952979|NCT02467179|10016049|FG000|COMPLETED|Overall Study||25
8952980|NCT02467179|10016050|FG001|COMPLETED|Overall Study||25
8952981|NCT02467179|10016049|FG000|NOT COMPLETED|Overall Study||0
8952982|NCT02467179|10016050|FG001|NOT COMPLETED|Overall Study||0
8871860|NCT01886300|9928814|FG000|NOT COMPLETED|Overall Study||16
8871861|NCT01886313|9928820|FG000|STARTED|Overall Study||6
8871862|NCT01886313|9928821|FG001|STARTED|Overall Study||5
8871863|NCT01886313|9928820|FG000|COMPLETED|Overall Study||5
8871864|NCT01886313|9928821|FG001|COMPLETED|Overall Study||4
8871865|NCT01886313|9928820|FG000|NOT COMPLETED|Overall Study||1
8871866|NCT01886313|9928821|FG001|NOT COMPLETED|Overall Study||1
8871867|NCT01886378|9928827|FG000|STARTED|Overall Study||29
8871868|NCT01886378|9928827|FG000|Completed 24 Weeks of UX007 Treatment|Overall Study||25
8871869|NCT01886378|9928827|FG000|COMPLETED|Overall Study||24
8871870|NCT01886378|9928827|FG000|NOT COMPLETED|Overall Study||5
8871871|NCT01886690|9928833|FG000|STARTED|Overall Study||75
8871872|NCT01886690|9928834|FG001|STARTED|Overall Study||73
8871873|NCT01886690|9928833|FG000|COMPLETED|Overall Study||75
8871874|NCT01886690|9928834|FG001|COMPLETED|Overall Study||71
8871875|NCT01886690|9928833|FG000|NOT COMPLETED|Overall Study||0
8871876|NCT01886690|9928834|FG001|NOT COMPLETED|Overall Study||2
8871877|NCT01886716|9928844|FG000|STARTED|Week 1||24
8871878|NCT01886716|9928845|FG001|STARTED|Week 1||20
8871879|NCT01886716|9928846|FG002|STARTED|Week 1||22
8871880|NCT01886716|9928847|FG003|STARTED|Week 1||20
8871881|NCT01886716|9928844|FG000|COMPLETED|Week 1||24
8871882|NCT01886716|9928845|FG001|COMPLETED|Week 1||20
8871883|NCT01886716|9928846|FG002|COMPLETED|Week 1||20
8871884|NCT01886716|9928847|FG003|COMPLETED|Week 1||18
8871885|NCT01886716|9928844|FG000|NOT COMPLETED|Week 1||0
8871886|NCT01886716|9928845|FG001|NOT COMPLETED|Week 1||0
8871887|NCT01886716|9928846|FG002|NOT COMPLETED|Week 1||2
8871888|NCT01886716|9928847|FG003|NOT COMPLETED|Week 1||2
8871889|NCT01886716|9928844|FG000|STARTED|Week 2||24
8569983|NCT00100165|9602110|FG001|STARTED|Baseline||10
8569984|NCT00100165|9602111|FG002|STARTED|Baseline||9
8871890|NCT01886716|9928845|FG001|STARTED|Week 2||20
8871891|NCT01886716|9928846|FG002|STARTED|Week 2||20
8871892|NCT01886716|9928847|FG003|STARTED|Week 2||18
8871893|NCT01886716|9928844|FG000|COMPLETED|Week 2||21
8871894|NCT01886716|9928845|FG001|COMPLETED|Week 2||18
8871895|NCT01886716|9928846|FG002|COMPLETED|Week 2||19
8871896|NCT01886716|9928847|FG003|COMPLETED|Week 2||15
8871897|NCT01886716|9928844|FG000|NOT COMPLETED|Week 2||3
8871898|NCT01886716|9928845|FG001|NOT COMPLETED|Week 2||2
8871899|NCT01886716|9928846|FG002|NOT COMPLETED|Week 2||1
8871900|NCT01886716|9928847|FG003|NOT COMPLETED|Week 2||3
8871901|NCT01886716|9928844|FG000|STARTED|Week 3||21
8871902|NCT01886716|9928845|FG001|STARTED|Week 3||18
8871903|NCT01886716|9928846|FG002|STARTED|Week 3||19
8871904|NCT01886716|9928847|FG003|STARTED|Week 3||15
8871905|NCT01886716|9928844|FG000|COMPLETED|Week 3||20
8871906|NCT01886716|9928845|FG001|COMPLETED|Week 3||17
8871907|NCT01886716|9928846|FG002|COMPLETED|Week 3||19
8871908|NCT01886716|9928847|FG003|COMPLETED|Week 3||14
8871909|NCT01886716|9928844|FG000|NOT COMPLETED|Week 3||1
8871910|NCT01886716|9928845|FG001|NOT COMPLETED|Week 3||1
8871911|NCT01886716|9928846|FG002|NOT COMPLETED|Week 3||0
8871912|NCT01886716|9928847|FG003|NOT COMPLETED|Week 3||1
8871913|NCT01886716|9928844|FG000|STARTED|Week 4||20
8871914|NCT01886716|9928845|FG001|STARTED|Week 4||17
8871915|NCT01886716|9928846|FG002|STARTED|Week 4||19
8871916|NCT01886716|9928847|FG003|STARTED|Week 4||14
8871917|NCT01886716|9928844|FG000|COMPLETED|Week 4||20
8871918|NCT01886716|9928845|FG001|COMPLETED|Week 4||17
8871919|NCT01886716|9928846|FG002|COMPLETED|Week 4||19
8871920|NCT01886716|9928847|FG003|COMPLETED|Week 4||14
8871921|NCT01886716|9928844|FG000|NOT COMPLETED|Week 4||0
8871922|NCT01886716|9928845|FG001|NOT COMPLETED|Week 4||0
8871923|NCT01886716|9928846|FG002|NOT COMPLETED|Week 4||0
8952983|NCT02467192|10016056|FG000|STARTED|Overall Study||203
8952984|NCT02467192|10016056|FG000|COMPLETED|Overall Study||200
8952985|NCT02467192|10016056|FG000|NOT COMPLETED|Overall Study||3
8952986|NCT02467387|10016064|FG000|STARTED|First Intervention||11
8569985|NCT00100165|9602109|FG000|COMPLETED|Baseline||10
8569986|NCT00100165|9602110|FG001|COMPLETED|Baseline||10
8871924|NCT01886716|9928847|FG003|NOT COMPLETED|Week 4||0
8871925|NCT01886716|9928844|FG000|STARTED|1-Week Post Follow-Up||20
8871926|NCT01886716|9928845|FG001|STARTED|1-Week Post Follow-Up||17
8871927|NCT01886716|9928846|FG002|STARTED|1-Week Post Follow-Up||19
8871928|NCT01886716|9928847|FG003|STARTED|1-Week Post Follow-Up||14
8871929|NCT01886716|9928844|FG000|COMPLETED|1-Week Post Follow-Up||20
8871930|NCT01886716|9928845|FG001|COMPLETED|1-Week Post Follow-Up||17
8871931|NCT01886716|9928846|FG002|COMPLETED|1-Week Post Follow-Up||19
8871932|NCT01886716|9928847|FG003|COMPLETED|1-Week Post Follow-Up||14
8952987|NCT02467387|10016065|FG001|STARTED|First Intervention||12
8952988|NCT02467387|10016064|FG000|Received Treatment as Randomized|First Intervention||10
8871933|NCT01886716|9928844|FG000|NOT COMPLETED|1-Week Post Follow-Up||0
8871934|NCT01886716|9928845|FG001|NOT COMPLETED|1-Week Post Follow-Up||0
8871935|NCT01886716|9928846|FG002|NOT COMPLETED|1-Week Post Follow-Up||0
8871936|NCT01886716|9928847|FG003|NOT COMPLETED|1-Week Post Follow-Up||0
8871937|NCT01886716|9928844|FG000|STARTED|1-Month Post Follow-Up||20
8871938|NCT01886716|9928845|FG001|STARTED|1-Month Post Follow-Up||17
8871939|NCT01886716|9928846|FG002|STARTED|1-Month Post Follow-Up||19
8871940|NCT01886716|9928847|FG003|STARTED|1-Month Post Follow-Up||14
8871941|NCT01886716|9928844|FG000|COMPLETED|1-Month Post Follow-Up||20
8871942|NCT01886716|9928845|FG001|COMPLETED|1-Month Post Follow-Up||17
8871943|NCT01886716|9928846|FG002|COMPLETED|1-Month Post Follow-Up||19
8871944|NCT01886716|9928847|FG003|COMPLETED|1-Month Post Follow-Up||14
8871945|NCT01886716|9928844|FG000|NOT COMPLETED|1-Month Post Follow-Up||0
8871946|NCT01886716|9928845|FG001|NOT COMPLETED|1-Month Post Follow-Up||0
8871947|NCT01886716|9928846|FG002|NOT COMPLETED|1-Month Post Follow-Up||0
8871948|NCT01886716|9928847|FG003|NOT COMPLETED|1-Month Post Follow-Up||0
8871949|NCT01886781|9928859|FG000|STARTED|Overall Study||54
8871950|NCT01886781|9928860|FG001|STARTED|Overall Study||27
8871951|NCT01886781|9928859|FG000|COMPLETED|Overall Study||40
8871952|NCT01886781|9928860|FG001|COMPLETED|Overall Study||25
8871953|NCT01886781|9928859|FG000|NOT COMPLETED|Overall Study||14
8871954|NCT01886781|9928860|FG001|NOT COMPLETED|Overall Study||2
8631202|NCT00538850|9671110|FG000|COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
8631203|NCT00538850|9671111|FG001|COMPLETED|Fentanyl Sublingual Spray - Double-blind||95
8871955|NCT01886807|9928869|FG000|STARTED|Overall Study||164
8871956|NCT01886807|9928870|FG001|STARTED|Overall Study||155
8871957|NCT01886807|9928871|FG002|STARTED|Overall Study||163
8871958|NCT01886807|9928869|FG000|COMPLETED|Overall Study||159
8952989|NCT02467387|10016065|FG001|Received Treatment as Randomized|First Intervention||12
8952990|NCT02467387|10016064|FG000|COMPLETED|First Intervention||10
8952991|NCT02467387|10016065|FG001|COMPLETED|First Intervention||12
8952992|NCT02467387|10016064|FG000|NOT COMPLETED|First Intervention||1
8952993|NCT02467387|10016065|FG001|NOT COMPLETED|First Intervention||0
8952994|NCT02467387|10016064|FG000|STARTED|Second Intervention||10
8952995|NCT02467387|10016065|FG001|STARTED|Second Intervention||12
8952996|NCT02467387|10016064|FG000|COMPLETED|Second Intervention||7
8952997|NCT02467387|10016065|FG001|COMPLETED|Second Intervention||12
8952998|NCT02467387|10016064|FG000|NOT COMPLETED|Second Intervention||3
8871959|NCT01886807|9928870|FG001|COMPLETED|Overall Study||145
8871960|NCT01886807|9928871|FG002|COMPLETED|Overall Study||153
8871961|NCT01886807|9928869|FG000|NOT COMPLETED|Overall Study||5
8871962|NCT01886807|9928870|FG001|NOT COMPLETED|Overall Study||10
8871963|NCT01886807|9928871|FG002|NOT COMPLETED|Overall Study||10
8871964|NCT01886833|9928882|FG000|STARTED|Overall Study||420
8952999|NCT02467387|10016065|FG001|NOT COMPLETED|Second Intervention||0
8953000|NCT02467465|10016075|FG000|STARTED|Overall Study||15
8953001|NCT02467465|10016076|FG001|STARTED|Overall Study||15
8953002|NCT02467465|10016075|FG000|COMPLETED|Overall Study||15
8953003|NCT02467465|10016076|FG001|COMPLETED|Overall Study||15
8953004|NCT02467465|10016075|FG000|NOT COMPLETED|Overall Study||0
8953005|NCT02467465|10016076|FG001|NOT COMPLETED|Overall Study||0
8953006|NCT02467491|10016084|FG000|STARTED|Overall Study||12
8953007|NCT02467491|10016084|FG000|COMPLETED|Overall Study||12
8953008|NCT02467491|10016084|FG000|NOT COMPLETED|Overall Study||0
8953009|NCT02467504|10016090|FG000|STARTED|Overall Study||23
8953010|NCT02467504|10016091|FG001|STARTED|Overall Study||24
8953011|NCT02467504|10016090|FG000|COMPLETED|Overall Study||17
8953012|NCT02467504|10016091|FG001|COMPLETED|Overall Study||23
8953013|NCT02467504|10016090|FG000|NOT COMPLETED|Overall Study||6
8953014|NCT02467504|10016091|FG001|NOT COMPLETED|Overall Study||1
8953015|NCT02467621|10016099|FG000|STARTED|Overall Study||1645
8953016|NCT02467621|10016100|FG001|STARTED|Overall Study||1653
8953017|NCT02467621|10016099|FG000|COMPLETED|Overall Study||1644
8953018|NCT02467621|10016100|FG001|COMPLETED|Overall Study||1647
8953019|NCT02467621|10016099|FG000|NOT COMPLETED|Overall Study||1
8953020|NCT02467621|10016100|FG001|NOT COMPLETED|Overall Study||6
8953021|NCT02467777|10016108|FG000|STARTED|Overall Study||23
8953022|NCT02467777|10016109|FG001|STARTED|Overall Study||27
8631204|NCT00538850|9671112|FG002|COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
8631205|NCT00538850|9671110|FG000|NOT COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
8871965|NCT01886833|9928882|FG000|COMPLETED|Overall Study||216
8871966|NCT01886833|9928882|FG000|NOT COMPLETED|Overall Study||204
8871967|NCT01886937|9928891|FG000|STARTED|Overall Study||7
8871968|NCT01886937|9928892|FG001|STARTED|Overall Study||6
8953023|NCT02467777|10016108|FG000|COMPLETED|Overall Study||23
8953024|NCT02467777|10016109|FG001|COMPLETED|Overall Study||27
8953025|NCT02467777|10016108|FG000|NOT COMPLETED|Overall Study||0
8953026|NCT02467777|10016109|FG001|NOT COMPLETED|Overall Study||0
8953027|NCT02467842|10016118|FG000|STARTED|Overall Study||752
8953028|NCT02467842|10016119|FG001|STARTED|Overall Study||373
8953029|NCT02467842|10016120|FG002|STARTED|Overall Study||378
8953030|NCT02467842|10016118|FG000|COMPLETED|Overall Study||752
8953031|NCT02467842|10016119|FG001|COMPLETED|Overall Study||373
8953032|NCT02467842|10016120|FG002|COMPLETED|Overall Study||378
8953033|NCT02467842|10016118|FG000|NOT COMPLETED|Overall Study||0
8871969|NCT01886937|9928891|FG000|COMPLETED|Overall Study||7
8953034|NCT02467842|10016119|FG001|NOT COMPLETED|Overall Study||0
8953035|NCT02467842|10016120|FG002|NOT COMPLETED|Overall Study||0
8953036|NCT02468154|10016132|FG000|STARTED|Overall Study||29
8871970|NCT01886937|9928892|FG001|COMPLETED|Overall Study||6
8871971|NCT01886937|9928891|FG000|NOT COMPLETED|Overall Study||0
8871972|NCT01886937|9928892|FG001|NOT COMPLETED|Overall Study||0
8871973|NCT01887132|9928898|FG000|STARTED|Overall Study||4
8871974|NCT01887132|9928898|FG000|COMPLETED|Overall Study||4
8871975|NCT01887132|9928898|FG000|NOT COMPLETED|Overall Study||0
8871976|NCT01887171|9928904|FG000|STARTED|Overall Study||43
8871977|NCT01887171|9928905|FG001|STARTED|Overall Study||43
8871978|NCT01887171|9928904|FG000|COMPLETED|Overall Study||43
8871979|NCT01887171|9928905|FG001|COMPLETED|Overall Study||43
8871980|NCT01887171|9928904|FG000|NOT COMPLETED|Overall Study||0
8871981|NCT01887171|9928905|FG001|NOT COMPLETED|Overall Study||0
8871982|NCT01887210|9928913|FG000|STARTED|Overall Study||33
8871983|NCT01887210|9928914|FG001|STARTED|Overall Study||33
8871984|NCT01887210|9928913|FG000|COMPLETED|Overall Study||32
8871985|NCT01887210|9928914|FG001|COMPLETED|Overall Study||29
8871986|NCT01887210|9928913|FG000|NOT COMPLETED|Overall Study||1
8871987|NCT01887210|9928914|FG001|NOT COMPLETED|Overall Study||4
8871988|NCT01887327|9928923|FG000|STARTED|Overall Study||30
8871989|NCT01887327|9928924|FG001|STARTED|Overall Study||31
8871990|NCT01887327|9928925|FG002|STARTED|Overall Study||30
8871991|NCT01887327|9928923|FG000|COMPLETED|Overall Study||29
8871992|NCT01887327|9928924|FG001|COMPLETED|Overall Study||27
8871993|NCT01887327|9928925|FG002|COMPLETED|Overall Study||27
8871994|NCT01887327|9928923|FG000|NOT COMPLETED|Overall Study||1
8871995|NCT01887327|9928924|FG001|NOT COMPLETED|Overall Study||4
8871996|NCT01887327|9928925|FG002|NOT COMPLETED|Overall Study||3
8871997|NCT01887353|9928936|FG000|STARTED|Overall Study||4
8871998|NCT01887353|9928937|FG001|STARTED|Overall Study||4
8871999|NCT01887353|9928936|FG000|COMPLETED|Overall Study|Study was stopped early because of difficulty recruiting.|0
8872000|NCT01887353|9928937|FG001|COMPLETED|Overall Study|Study was stopped early because of difficulty recruiting.|1
8872001|NCT01887353|9928936|FG000|NOT COMPLETED|Overall Study||4
8872002|NCT01887353|9928937|FG001|NOT COMPLETED|Overall Study||3
8872003|NCT01887418|9928946|FG000|STARTED|Overall Study||15
8872004|NCT01887418|9928947|FG001|STARTED|Overall Study||14
8872005|NCT01887418|9928948|FG002|STARTED|Overall Study||10
8872006|NCT01887418|9928946|FG000|COMPLETED|Overall Study||15
8872007|NCT01887418|9928947|FG001|COMPLETED|Overall Study||14
8872008|NCT01887418|9928948|FG002|COMPLETED|Overall Study||9
8872009|NCT01887418|9928946|FG000|NOT COMPLETED|Overall Study||0
8872010|NCT01887418|9928947|FG001|NOT COMPLETED|Overall Study||0
8872011|NCT01887418|9928948|FG002|NOT COMPLETED|Overall Study||1
8872012|NCT01887470|9928960|FG000|STARTED|Overall Study||10
8872013|NCT01887470|9928961|FG001|STARTED|Overall Study||10
8872014|NCT01887470|9928962|FG002|STARTED|Overall Study||10
8872015|NCT01887470|9928963|FG003|STARTED|Overall Study||10
8872016|NCT01887470|9928960|FG000|COMPLETED|Overall Study||10
8872017|NCT01887470|9928961|FG001|COMPLETED|Overall Study||10
8872018|NCT01887470|9928962|FG002|COMPLETED|Overall Study||10
8872019|NCT01887470|9928963|FG003|COMPLETED|Overall Study||10
8872020|NCT01887470|9928960|FG000|NOT COMPLETED|Overall Study||0
8872021|NCT01887470|9928961|FG001|NOT COMPLETED|Overall Study||0
8872022|NCT01887470|9928962|FG002|NOT COMPLETED|Overall Study||0
8872023|NCT01887470|9928963|FG003|NOT COMPLETED|Overall Study||0
8872024|NCT01887587|9928973|FG000|STARTED|Overall Study||5
8872025|NCT01887587|9928973|FG000|COMPLETED|Overall Study||5
8872026|NCT01887587|9928973|FG000|NOT COMPLETED|Overall Study||0
8872027|NCT01887600|9928980|FG000|STARTED|Overall Study||391
8872028|NCT01887600|9928981|FG001|STARTED|Overall Study||203
8872029|NCT01887600|9928980|FG000|Treatment Received|Overall Study||391
8872030|NCT01887600|9928981|FG001|Treatment Received|Overall Study||203
8872031|NCT01887600|9928980|FG000|COMPLETED|Overall Study||245
8872032|NCT01887600|9928981|FG001|COMPLETED|Overall Study||89
8872033|NCT01887600|9928980|FG000|NOT COMPLETED|Overall Study||146
8872034|NCT01887600|9928981|FG001|NOT COMPLETED|Overall Study||114
8872035|NCT01887678|9928990|FG000|STARTED|Overall Study||119
8872036|NCT01887678|9928991|FG001|STARTED|Overall Study||113
8872037|NCT01887678|9928990|FG000|COMPLETED|Overall Study||102
8872038|NCT01887678|9928991|FG001|COMPLETED|Overall Study||85
8872039|NCT01887678|9928990|FG000|NOT COMPLETED|Overall Study||17
8872040|NCT01887678|9928991|FG001|NOT COMPLETED|Overall Study||28
8872041|NCT01887717|9928999|FG000|STARTED|Overall Study||17
8872042|NCT01887717|9929000|FG001|STARTED|Overall Study||19
8872043|NCT01887717|9928999|FG000|Received at Least 1 Dose of Study Drug|Overall Study||15
8872044|NCT01887717|9929000|FG001|Received at Least 1 Dose of Study Drug|Overall Study||16
8872045|NCT01887717|9928999|FG000|COMPLETED|Overall Study||11
8872046|NCT01887717|9929000|FG001|COMPLETED|Overall Study||8
8872047|NCT01887717|9928999|FG000|NOT COMPLETED|Overall Study||6
8872048|NCT01887717|9929000|FG001|NOT COMPLETED|Overall Study||11
8872049|NCT01887990|9929010|FG000|STARTED|Overall Study||7
8872050|NCT01887990|9929011|FG001|STARTED|Overall Study||7
8872051|NCT01887990|9929012|FG002|STARTED|Overall Study||2
8872052|NCT01887990|9929013|FG003|STARTED|Overall Study||2
8872053|NCT01887990|9929010|FG000|COMPLETED|Overall Study||7
8872054|NCT01887990|9929011|FG001|COMPLETED|Overall Study||7
8872055|NCT01887990|9929012|FG002|COMPLETED|Overall Study||2
8872056|NCT01887990|9929013|FG003|COMPLETED|Overall Study||2
8872057|NCT01887990|9929010|FG000|NOT COMPLETED|Overall Study||0
8872058|NCT01887990|9929011|FG001|NOT COMPLETED|Overall Study||0
8872059|NCT01887990|9929012|FG002|NOT COMPLETED|Overall Study||0
8872060|NCT01887990|9929013|FG003|NOT COMPLETED|Overall Study||0
8872061|NCT01888003|9929028|FG000|STARTED|Overall Study||5
8872062|NCT01888003|9929029|FG001|STARTED|Overall Study||6
8872063|NCT01888003|9929030|FG002|STARTED|Overall Study||40
8872064|NCT01888003|9929028|FG000|COMPLETED|Overall Study||0
8872065|NCT01888003|9929029|FG001|COMPLETED|Overall Study||0
8872066|NCT01888003|9929030|FG002|COMPLETED|Overall Study||0
8872067|NCT01888003|9929028|FG000|NOT COMPLETED|Overall Study||5
8872068|NCT01888003|9929029|FG001|NOT COMPLETED|Overall Study||6
8872069|NCT01888003|9929030|FG002|NOT COMPLETED|Overall Study||40
8872070|NCT01888367|9929041|FG000|STARTED|Overall Study||296
8872071|NCT01888367|9929042|FG001|STARTED|Overall Study||71
8872072|NCT01888367|9929043|FG002|STARTED|Overall Study||78
8872073|NCT01888367|9929041|FG000|COMPLETED|Overall Study||288
8872074|NCT01888367|9929042|FG001|COMPLETED|Overall Study||66
8872075|NCT01888367|9929043|FG002|COMPLETED|Overall Study||73
8872076|NCT01888367|9929041|FG000|NOT COMPLETED|Overall Study||8
8872077|NCT01888367|9929042|FG001|NOT COMPLETED|Overall Study||5
8872078|NCT01888367|9929043|FG002|NOT COMPLETED|Overall Study||5
8872079|NCT01888432|9929053|FG000|STARTED|12-month Analysis (FAS)||142
8872080|NCT01888432|9929054|FG001|STARTED|12-month Analysis (FAS)||142
8872081|NCT01888432|9929053|FG000|COMPLETED|12-month Analysis (FAS)||131
8872082|NCT01888432|9929054|FG001|COMPLETED|12-month Analysis (FAS)||133
8872083|NCT01888432|9929053|FG000|NOT COMPLETED|12-month Analysis (FAS)||11
8872084|NCT01888432|9929054|FG001|NOT COMPLETED|12-month Analysis (FAS)||9
8872085|NCT01888432|9929053|FG000|STARTED|24-month Analysis (FAS)||142
8872086|NCT01888432|9929054|FG001|STARTED|24-month Analysis (FAS)||142
8872087|NCT01888432|9929053|FG000|COMPLETED|24-month Analysis (FAS)||125
8872088|NCT01888432|9929054|FG001|COMPLETED|24-month Analysis (FAS)||125
8872089|NCT01888432|9929053|FG000|NOT COMPLETED|24-month Analysis (FAS)||17
8872090|NCT01888432|9929054|FG001|NOT COMPLETED|24-month Analysis (FAS)||17
8872091|NCT01888432|9929053|FG000|STARTED|36-month Analysis (Extension)||13
8872092|NCT01888432|9929054|FG001|STARTED|36-month Analysis (Extension)||5
8872093|NCT01888432|9929053|FG000|COMPLETED|36-month Analysis (Extension)||12
8872094|NCT01888432|9929054|FG001|COMPLETED|36-month Analysis (Extension)||5
8872095|NCT01888432|9929053|FG000|NOT COMPLETED|36-month Analysis (Extension)||1
8872096|NCT01888432|9929054|FG001|NOT COMPLETED|36-month Analysis (Extension)||0
8872097|NCT01888484|9929062|FG000|STARTED|Overall Study||12
8872098|NCT01888484|9929063|FG001|STARTED|Overall Study||14
8872099|NCT01888484|9929064|FG002|STARTED|Overall Study||12
8953037|NCT02468154|10016133|FG001|STARTED|Overall Study||28
8953038|NCT02468154|10016132|FG000|COMPLETED|Overall Study||29
8953039|NCT02468154|10016133|FG001|COMPLETED|Overall Study||28
8953040|NCT02468154|10016132|FG000|NOT COMPLETED|Overall Study||0
8953041|NCT02468154|10016133|FG001|NOT COMPLETED|Overall Study||0
8953042|NCT02468193|10016139|FG000|STARTED|Overall Study||9
8953043|NCT02468193|10016139|FG000|Completed Week-12 (Study Period I)|Overall Study||7
8953044|NCT02468193|10016139|FG000|Discontinued at or Prior to Week-12|Overall Study||2
8953045|NCT02468193|10016139|FG000|Completed Week-12, Did Not Enter Per. II|Overall Study||3
8872100|NCT01888484|9929065|FG003|STARTED|Overall Study||37
8872101|NCT01888484|9929062|FG000|COMPLETED|Overall Study||12
8872102|NCT01888484|9929063|FG001|COMPLETED|Overall Study||14
8872103|NCT01888484|9929064|FG002|COMPLETED|Overall Study||8
8872104|NCT01888484|9929065|FG003|COMPLETED|Overall Study||34
8872105|NCT01888484|9929062|FG000|NOT COMPLETED|Overall Study||0
8872106|NCT01888484|9929063|FG001|NOT COMPLETED|Overall Study||0
8872107|NCT01888484|9929064|FG002|NOT COMPLETED|Overall Study||4
8872108|NCT01888484|9929065|FG003|NOT COMPLETED|Overall Study||3
8872109|NCT01888497|9929070|FG000|STARTED|First Intervention Period||13
8872110|NCT01888497|9929071|FG001|STARTED|First Intervention Period||14
8872111|NCT01888497|9929072|FG002|STARTED|First Intervention Period||15
8953046|NCT02468193|10016139|FG000|Completed Week-12, Entered Study Per. II|Overall Study||4
8953047|NCT02468193|10016139|FG000|Completed Week-48 (Study Period II)|Overall Study||2
8953048|NCT02468193|10016139|FG000|Discontinued at or Prior to Week48|Overall Study||2
8872112|NCT01888497|9929073|FG003|STARTED|First Intervention Period||17
8872113|NCT01888497|9929070|FG000|COMPLETED|First Intervention Period||13
8872114|NCT01888497|9929071|FG001|COMPLETED|First Intervention Period||14
8872115|NCT01888497|9929072|FG002|COMPLETED|First Intervention Period||15
8872116|NCT01888497|9929073|FG003|COMPLETED|First Intervention Period||17
8872117|NCT01888497|9929070|FG000|NOT COMPLETED|First Intervention Period||0
8872118|NCT01888497|9929071|FG001|NOT COMPLETED|First Intervention Period||0
8872119|NCT01888497|9929072|FG002|NOT COMPLETED|First Intervention Period||0
8872120|NCT01888497|9929073|FG003|NOT COMPLETED|First Intervention Period||0
8872121|NCT01888497|9929070|FG000|STARTED|Washout Period 1||13
8872122|NCT01888497|9929071|FG001|STARTED|Washout Period 1||14
8872123|NCT01888497|9929072|FG002|STARTED|Washout Period 1||15
8872124|NCT01888497|9929073|FG003|STARTED|Washout Period 1||17
8872125|NCT01888497|9929070|FG000|COMPLETED|Washout Period 1||13
8872126|NCT01888497|9929071|FG001|COMPLETED|Washout Period 1||14
8872127|NCT01888497|9929072|FG002|COMPLETED|Washout Period 1||14
8872128|NCT01888497|9929073|FG003|COMPLETED|Washout Period 1||16
8872129|NCT01888497|9929070|FG000|NOT COMPLETED|Washout Period 1||0
8872130|NCT01888497|9929071|FG001|NOT COMPLETED|Washout Period 1||0
8872131|NCT01888497|9929072|FG002|NOT COMPLETED|Washout Period 1||1
8872132|NCT01888497|9929073|FG003|NOT COMPLETED|Washout Period 1||1
8872133|NCT01888497|9929070|FG000|STARTED|Second Intervention Period||13
8872134|NCT01888497|9929071|FG001|STARTED|Second Intervention Period||14
8872135|NCT01888497|9929072|FG002|STARTED|Second Intervention Period||14
8872136|NCT01888497|9929073|FG003|STARTED|Second Intervention Period||16
8872137|NCT01888497|9929070|FG000|COMPLETED|Second Intervention Period||13
8872138|NCT01888497|9929071|FG001|COMPLETED|Second Intervention Period||14
8872139|NCT01888497|9929072|FG002|COMPLETED|Second Intervention Period||14
8872140|NCT01888497|9929073|FG003|COMPLETED|Second Intervention Period||16
8872141|NCT01888497|9929070|FG000|NOT COMPLETED|Second Intervention Period||0
8872142|NCT01888497|9929071|FG001|NOT COMPLETED|Second Intervention Period||0
8872143|NCT01888497|9929072|FG002|NOT COMPLETED|Second Intervention Period||0
8872144|NCT01888497|9929073|FG003|NOT COMPLETED|Second Intervention Period||0
8872145|NCT01888497|9929070|FG000|STARTED|Washout Period 2||13
8872146|NCT01888497|9929071|FG001|STARTED|Washout Period 2||14
8872147|NCT01888497|9929072|FG002|STARTED|Washout Period 2||14
8872148|NCT01888497|9929073|FG003|STARTED|Washout Period 2||16
8872149|NCT01888497|9929070|FG000|COMPLETED|Washout Period 2||13
8872150|NCT01888497|9929071|FG001|COMPLETED|Washout Period 2||14
8872151|NCT01888497|9929072|FG002|COMPLETED|Washout Period 2||14
8872152|NCT01888497|9929073|FG003|COMPLETED|Washout Period 2||14
8872153|NCT01888497|9929070|FG000|NOT COMPLETED|Washout Period 2||0
8872154|NCT01888497|9929071|FG001|NOT COMPLETED|Washout Period 2||0
8872155|NCT01888497|9929072|FG002|NOT COMPLETED|Washout Period 2||0
8872156|NCT01888497|9929073|FG003|NOT COMPLETED|Washout Period 2||2
8872157|NCT01888497|9929070|FG000|STARTED|Third Intervention Period||13
8872158|NCT01888497|9929071|FG001|STARTED|Third Intervention Period||14
8872159|NCT01888497|9929072|FG002|STARTED|Third Intervention Period||14
8872160|NCT01888497|9929073|FG003|STARTED|Third Intervention Period||14
8872161|NCT01888497|9929070|FG000|COMPLETED|Third Intervention Period||13
8872162|NCT01888497|9929071|FG001|COMPLETED|Third Intervention Period||14
8872163|NCT01888497|9929072|FG002|COMPLETED|Third Intervention Period||14
8872164|NCT01888497|9929073|FG003|COMPLETED|Third Intervention Period||14
8872165|NCT01888497|9929070|FG000|NOT COMPLETED|Third Intervention Period||0
8872166|NCT01888497|9929071|FG001|NOT COMPLETED|Third Intervention Period||0
8872167|NCT01888497|9929072|FG002|NOT COMPLETED|Third Intervention Period||0
8872168|NCT01888497|9929073|FG003|NOT COMPLETED|Third Intervention Period||0
8872169|NCT01888497|9929070|FG000|STARTED|Washout Period 3||13
8872170|NCT01888497|9929071|FG001|STARTED|Washout Period 3||14
8872171|NCT01888497|9929072|FG002|STARTED|Washout Period 3||14
8872172|NCT01888497|9929073|FG003|STARTED|Washout Period 3||14
8872173|NCT01888497|9929070|FG000|COMPLETED|Washout Period 3||13
8872174|NCT01888497|9929071|FG001|COMPLETED|Washout Period 3||14
8872175|NCT01888497|9929072|FG002|COMPLETED|Washout Period 3||14
8872176|NCT01888497|9929073|FG003|COMPLETED|Washout Period 3||14
8872177|NCT01888497|9929070|FG000|NOT COMPLETED|Washout Period 3||0
8872178|NCT01888497|9929071|FG001|NOT COMPLETED|Washout Period 3||0
8872179|NCT01888497|9929072|FG002|NOT COMPLETED|Washout Period 3||0
8872180|NCT01888497|9929073|FG003|NOT COMPLETED|Washout Period 3||0
8872181|NCT01888497|9929070|FG000|STARTED|Fourth Intervention Period||13
8872182|NCT01888497|9929071|FG001|STARTED|Fourth Intervention Period||14
8872183|NCT01888497|9929072|FG002|STARTED|Fourth Intervention Period||14
8872184|NCT01888497|9929073|FG003|STARTED|Fourth Intervention Period||14
8872185|NCT01888497|9929070|FG000|COMPLETED|Fourth Intervention Period||13
8872186|NCT01888497|9929071|FG001|COMPLETED|Fourth Intervention Period||14
8872187|NCT01888497|9929072|FG002|COMPLETED|Fourth Intervention Period||14
8872188|NCT01888497|9929073|FG003|COMPLETED|Fourth Intervention Period||14
8872189|NCT01888497|9929070|FG000|NOT COMPLETED|Fourth Intervention Period||0
8872190|NCT01888497|9929071|FG001|NOT COMPLETED|Fourth Intervention Period||0
8872191|NCT01888497|9929072|FG002|NOT COMPLETED|Fourth Intervention Period||0
8872192|NCT01888497|9929073|FG003|NOT COMPLETED|Fourth Intervention Period||0
8872193|NCT01888640|9929086|FG000|STARTED|Overall Study||103
8872194|NCT01888640|9929087|FG001|STARTED|Overall Study||99
8872195|NCT01888640|9929088|FG002|STARTED|Overall Study||99
8872196|NCT01888640|9929086|FG000|COMPLETED|Overall Study||76
8872197|NCT01888640|9929087|FG001|COMPLETED|Overall Study||68
8872198|NCT01888640|9929088|FG002|COMPLETED|Overall Study||94
8872199|NCT01888640|9929086|FG000|NOT COMPLETED|Overall Study||27
8872200|NCT01888640|9929087|FG001|NOT COMPLETED|Overall Study||31
8872201|NCT01888640|9929088|FG002|NOT COMPLETED|Overall Study||5
8872202|NCT01888874|9929106|FG000|STARTED|Period 1 (Baseline up to Week 12)||86
8872203|NCT01888874|9929107|FG001|STARTED|Period 1 (Baseline up to Week 12)||82
8872204|NCT01888874|9929108|FG002|STARTED|Period 1 (Baseline up to Week 12)||85
8872205|NCT01888874|9929109|FG003|STARTED|Period 1 (Baseline up to Week 12)||86
8872206|NCT01888874|9929110|FG004|STARTED|Period 1 (Baseline up to Week 12)||86
8872207|NCT01888874|9929111|FG005|STARTED|Period 1 (Baseline up to Week 12)||85
8872208|NCT01888874|9929112|FG006|STARTED|Period 1 (Baseline up to Week 12)||84
8872209|NCT01888874|9929106|FG000|COMPLETED|Period 1 (Baseline up to Week 12)||83
8872210|NCT01888874|9929107|FG001|COMPLETED|Period 1 (Baseline up to Week 12)||76
8872211|NCT01888874|9929108|FG002|COMPLETED|Period 1 (Baseline up to Week 12)||78
8872212|NCT01888874|9929109|FG003|COMPLETED|Period 1 (Baseline up to Week 12)||80
8872213|NCT01888874|9929110|FG004|COMPLETED|Period 1 (Baseline up to Week 12)||77
8872214|NCT01888874|9929111|FG005|COMPLETED|Period 1 (Baseline up to Week 12)||80
8872215|NCT01888874|9929112|FG006|COMPLETED|Period 1 (Baseline up to Week 12)||83
8872216|NCT01888874|9929106|FG000|NOT COMPLETED|Period 1 (Baseline up to Week 12)||3
8872217|NCT01888874|9929107|FG001|NOT COMPLETED|Period 1 (Baseline up to Week 12)||6
8872218|NCT01888874|9929108|FG002|NOT COMPLETED|Period 1 (Baseline up to Week 12)||7
8872219|NCT01888874|9929109|FG003|NOT COMPLETED|Period 1 (Baseline up to Week 12)||6
8872220|NCT01888874|9929110|FG004|NOT COMPLETED|Period 1 (Baseline up to Week 12)||9
8872221|NCT01888874|9929111|FG005|NOT COMPLETED|Period 1 (Baseline up to Week 12)||5
8872222|NCT01888874|9929112|FG006|NOT COMPLETED|Period 1 (Baseline up to Week 12)||1
8872223|NCT01888874|9929106|FG000|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from Placebo group moved to 100 mg QD(15 participants) and 50 mg BID(15 participants).|53
8872224|NCT01888874|9929107|FG001|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from 50 mg QD group moved to 100 mg QD group (19 participants).|57
8872225|NCT01888874|9929108|FG002|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from Placebo(15 participants) and 50 mg QD (19 participants) moved to 100 mg QD group.|112
8872226|NCT01888874|9929109|FG003|STARTED|Period 2 (Week 13 to Week 24)||80
8872227|NCT01888874|9929110|FG004|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from 25 mg BID group moved to 50 mg BID group (17 participants).|60
8872228|NCT01888874|9929111|FG005|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from Placebo(15 participants) and 25 mg BID(17 participants) moved to 50 mg BID group.|112
8872229|NCT01888874|9929112|FG006|STARTED|Period 2 (Week 13 to Week 24)||83
8872230|NCT01888874|9929106|FG000|COMPLETED|Period 2 (Week 13 to Week 24)||50
8872231|NCT01888874|9929107|FG001|COMPLETED|Period 2 (Week 13 to Week 24)||55
8872232|NCT01888874|9929108|FG002|COMPLETED|Period 2 (Week 13 to Week 24)||104
8872233|NCT01888874|9929109|FG003|COMPLETED|Period 2 (Week 13 to Week 24)||78
8953049|NCT02468193|10016139|FG000|Compl. Wk-48, Didn't Enter Opt. Ext. Per|Overall Study||0
8953050|NCT02468193|10016139|FG000|Compl. Wk-48, Entered Opt. Ext. Period|Overall Study||2
8953051|NCT02468193|10016139|FG000|Completed Optional Extension Period|Overall Study||0
8953052|NCT02468193|10016139|FG000|Discontinued Study in Optional Ext. Per.|Overall Study||2
8953053|NCT02468193|10016139|FG000|COMPLETED|Overall Study||3
8953054|NCT02468193|10016139|FG000|NOT COMPLETED|Overall Study||6
8953055|NCT02468557|10016159|FG000|STARTED|Overall Study||16
8953056|NCT02468557|10016159|FG000|COMPLETED|Overall Study||0
8953057|NCT02468557|10016159|FG000|NOT COMPLETED|Overall Study||16
8953058|NCT02468570|10016169|FG000|STARTED|Overall Study||6
8953059|NCT02468570|10016170|FG001|STARTED|Overall Study||3
8953060|NCT02468570|10016169|FG000|COMPLETED|Overall Study||6
8953061|NCT02468570|10016170|FG001|COMPLETED|Overall Study||3
8953062|NCT02468570|10016169|FG000|NOT COMPLETED|Overall Study||0
8953063|NCT02468570|10016170|FG001|NOT COMPLETED|Overall Study||0
8953064|NCT02468648|10016176|FG000|STARTED|Overall Study||72
8953065|NCT02468648|10016176|FG000|COMPLETED|Overall Study||71
8953066|NCT02468648|10016176|FG000|NOT COMPLETED|Overall Study||1
8953067|NCT02468674|10016189|FG000|STARTED|Overall Study||5
8953068|NCT02468674|10016190|FG001|STARTED|Overall Study||5
8953069|NCT02468674|10016191|FG002|STARTED|Overall Study||5
8953070|NCT02468674|10016192|FG003|STARTED|Overall Study||4
8953071|NCT02468674|10016193|FG004|STARTED|Overall Study||7
8953072|NCT02468674|10016194|FG005|STARTED|Overall Study||7
8953073|NCT02468674|10016195|FG006|STARTED|Overall Study||15
8953074|NCT02468674|10016196|FG007|STARTED|Overall Study||69
8953075|NCT02468674|10016197|FG008|STARTED|Overall Study||43
8953076|NCT02468674|10016189|FG000|COMPLETED|Overall Study||4
8953077|NCT02468674|10016190|FG001|COMPLETED|Overall Study||5
8953078|NCT02468674|10016191|FG002|COMPLETED|Overall Study||5
8953079|NCT02468674|10016192|FG003|COMPLETED|Overall Study||3
8953080|NCT02468674|10016193|FG004|COMPLETED|Overall Study||6
8953081|NCT02468674|10016194|FG005|COMPLETED|Overall Study||6
8953082|NCT02468674|10016195|FG006|COMPLETED|Overall Study||14
8953083|NCT02468674|10016196|FG007|COMPLETED|Overall Study||65
8953084|NCT02468674|10016197|FG008|COMPLETED|Overall Study||40
8953085|NCT02468674|10016189|FG000|NOT COMPLETED|Overall Study||1
8953086|NCT02468674|10016190|FG001|NOT COMPLETED|Overall Study||0
8953087|NCT02468674|10016191|FG002|NOT COMPLETED|Overall Study||0
8953088|NCT02468674|10016192|FG003|NOT COMPLETED|Overall Study||1
8953089|NCT02468674|10016193|FG004|NOT COMPLETED|Overall Study||1
8953090|NCT02468674|10016194|FG005|NOT COMPLETED|Overall Study||1
8953091|NCT02468674|10016195|FG006|NOT COMPLETED|Overall Study||1
8953092|NCT02468674|10016196|FG007|NOT COMPLETED|Overall Study||4
8953093|NCT02468674|10016197|FG008|NOT COMPLETED|Overall Study||3
8953094|NCT02468700|10016219|FG000|STARTED|Overall Study||22
8953095|NCT02468700|10016220|FG001|STARTED|Overall Study||21
8953096|NCT02468700|10016219|FG000|COMPLETED|Overall Study||20
8872234|NCT01888874|9929110|FG004|COMPLETED|Period 2 (Week 13 to Week 24)||57
8872235|NCT01888874|9929111|FG005|COMPLETED|Period 2 (Week 13 to Week 24)||109
8872236|NCT01888874|9929112|FG006|COMPLETED|Period 2 (Week 13 to Week 24)||80
8872237|NCT01888874|9929106|FG000|NOT COMPLETED|Period 2 (Week 13 to Week 24)||3
8872238|NCT01888874|9929107|FG001|NOT COMPLETED|Period 2 (Week 13 to Week 24)||2
8872239|NCT01888874|9929108|FG002|NOT COMPLETED|Period 2 (Week 13 to Week 24)||8
8872240|NCT01888874|9929109|FG003|NOT COMPLETED|Period 2 (Week 13 to Week 24)||2
8872241|NCT01888874|9929110|FG004|NOT COMPLETED|Period 2 (Week 13 to Week 24)||3
8872242|NCT01888874|9929111|FG005|NOT COMPLETED|Period 2 (Week 13 to Week 24)||3
8872243|NCT01888874|9929112|FG006|NOT COMPLETED|Period 2 (Week 13 to Week 24)||3
8872244|NCT01888900|9929131|FG000|STARTED|Overall Study||22
8872245|NCT01888900|9929132|FG001|STARTED|Overall Study||13
8872246|NCT01888900|9929131|FG000|COMPLETED|Overall Study||22
8872247|NCT01888900|9929132|FG001|COMPLETED|Overall Study||11
8872248|NCT01888900|9929131|FG000|NOT COMPLETED|Overall Study||0
8872249|NCT01888900|9929132|FG001|NOT COMPLETED|Overall Study||2
8872250|NCT01888952|9929140|FG000|STARTED|Overall Study||10
8872251|NCT01888952|9929140|FG000|COMPLETED|Overall Study||10
8872252|NCT01888952|9929140|FG000|NOT COMPLETED|Overall Study||0
8872253|NCT01888965|9929144|FG000|STARTED|Overall Study||9
8872254|NCT01888965|9929144|FG000|COMPLETED|Overall Study||0
8872255|NCT01888965|9929144|FG000|NOT COMPLETED|Overall Study||9
8872256|NCT01889069|9929150|FG000|STARTED|Overall Study||158
8872257|NCT01889069|9929150|FG000|COMPLETED|Overall Study||113
8872258|NCT01889069|9929150|FG000|NOT COMPLETED|Overall Study||45
8872259|NCT01889238|9929160|FG000|STARTED|Overall Study||118
8872260|NCT01889238|9929160|FG000|COMPLETED|Overall Study|DP, AE, death, treatment withdrawal were considered completed (defined in protocol).|109
8872261|NCT01889238|9929160|FG000|NOT COMPLETED|Overall Study||9
8872262|NCT01889251|9929166|FG000|STARTED|Overall Study||115
8872263|NCT01889251|9929167|FG001|STARTED|Overall Study||57
8872264|NCT01889251|9929166|FG000|COMPLETED|Overall Study||114
8872265|NCT01889251|9929167|FG001|COMPLETED|Overall Study||57
8872266|NCT01889251|9929166|FG000|NOT COMPLETED|Overall Study||1
8872267|NCT01889251|9929167|FG001|NOT COMPLETED|Overall Study||0
8872268|NCT01889355|9929173|FG000|STARTED|Overall Study||115
8872269|NCT01889355|9929173|FG000|COMPLETED|Overall Study||113
8872270|NCT01889355|9929173|FG000|NOT COMPLETED|Overall Study||2
8872271|NCT01889563|9929179|FG000|STARTED|Overall Study||17
8872272|NCT01889563|9929180|FG001|STARTED|Overall Study||15
8872273|NCT01889563|9929179|FG000|COMPLETED|Overall Study||10
8872274|NCT01889563|9929180|FG001|COMPLETED|Overall Study||10
8872275|NCT01889563|9929179|FG000|NOT COMPLETED|Overall Study||7
8872276|NCT01889563|9929180|FG001|NOT COMPLETED|Overall Study||5
8872277|NCT01889602|9929189|FG000|STARTED|First Intervention||20
8872278|NCT01889602|9929190|FG001|STARTED|First Intervention||20
8872279|NCT01889602|9929191|FG002|STARTED|First Intervention||20
8872280|NCT01889602|9929189|FG000|COMPLETED|First Intervention||19
8872281|NCT01889602|9929190|FG001|COMPLETED|First Intervention||17
8872282|NCT01889602|9929191|FG002|COMPLETED|First Intervention||18
8872283|NCT01889602|9929189|FG000|NOT COMPLETED|First Intervention||1
8872284|NCT01889602|9929190|FG001|NOT COMPLETED|First Intervention||3
8872285|NCT01889602|9929191|FG002|NOT COMPLETED|First Intervention||2
8872286|NCT01889602|9929189|FG000|STARTED|First Washout Period of at Least 2 Weeks||19
8872287|NCT01889602|9929190|FG001|STARTED|First Washout Period of at Least 2 Weeks||17
8872288|NCT01889602|9929191|FG002|STARTED|First Washout Period of at Least 2 Weeks||18
8872289|NCT01889602|9929189|FG000|COMPLETED|First Washout Period of at Least 2 Weeks||19
8872290|NCT01889602|9929190|FG001|COMPLETED|First Washout Period of at Least 2 Weeks||17
8872291|NCT01889602|9929191|FG002|COMPLETED|First Washout Period of at Least 2 Weeks||18
8872292|NCT01889602|9929189|FG000|NOT COMPLETED|First Washout Period of at Least 2 Weeks||0
8872293|NCT01889602|9929190|FG001|NOT COMPLETED|First Washout Period of at Least 2 Weeks||0
8872294|NCT01889602|9929191|FG002|NOT COMPLETED|First Washout Period of at Least 2 Weeks||0
8872295|NCT01889602|9929189|FG000|STARTED|Second Intervention||19
8872296|NCT01889602|9929190|FG001|STARTED|Second Intervention||17
8872297|NCT01889602|9929191|FG002|STARTED|Second Intervention||18
8872298|NCT01889602|9929189|FG000|COMPLETED|Second Intervention||18
8872299|NCT01889602|9929190|FG001|COMPLETED|Second Intervention||17
8872300|NCT01889602|9929191|FG002|COMPLETED|Second Intervention||16
8872301|NCT01889602|9929189|FG000|NOT COMPLETED|Second Intervention||1
8872302|NCT01889602|9929190|FG001|NOT COMPLETED|Second Intervention||0
8872303|NCT01889602|9929191|FG002|NOT COMPLETED|Second Intervention||2
8872304|NCT01889602|9929189|FG000|STARTED|Second Washout Period of at Least 2 Week||18
8872305|NCT01889602|9929190|FG001|STARTED|Second Washout Period of at Least 2 Week||17
8872306|NCT01889602|9929191|FG002|STARTED|Second Washout Period of at Least 2 Week||16
8953097|NCT02468700|10016220|FG001|COMPLETED|Overall Study||19
8872307|NCT01889602|9929189|FG000|COMPLETED|Second Washout Period of at Least 2 Week||18
8872308|NCT01889602|9929190|FG001|COMPLETED|Second Washout Period of at Least 2 Week||17
8872309|NCT01889602|9929191|FG002|COMPLETED|Second Washout Period of at Least 2 Week||16
8872310|NCT01889602|9929189|FG000|NOT COMPLETED|Second Washout Period of at Least 2 Week||0
8872311|NCT01889602|9929190|FG001|NOT COMPLETED|Second Washout Period of at Least 2 Week||0
8872312|NCT01889602|9929191|FG002|NOT COMPLETED|Second Washout Period of at Least 2 Week||0
8872313|NCT01889602|9929189|FG000|STARTED|Third Intervention||18
8872314|NCT01889602|9929190|FG001|STARTED|Third Intervention||17
8872315|NCT01889602|9929191|FG002|STARTED|Third Intervention||16
8872316|NCT01889602|9929189|FG000|COMPLETED|Third Intervention||15
8872317|NCT01889602|9929190|FG001|COMPLETED|Third Intervention||15
8872318|NCT01889602|9929191|FG002|COMPLETED|Third Intervention||16
8872319|NCT01889602|9929189|FG000|NOT COMPLETED|Third Intervention||3
8953098|NCT02468700|10016219|FG000|NOT COMPLETED|Overall Study||2
8953099|NCT02468700|10016220|FG001|NOT COMPLETED|Overall Study||2
8953100|NCT02468804|10016228|FG000|STARTED|Overall Study||37
8953101|NCT02468804|10016229|FG001|STARTED|Overall Study||58
8953102|NCT02468804|10016228|FG000|COMPLETED|Overall Study||36
8953103|NCT02468804|10016229|FG001|COMPLETED|Overall Study||50
8953104|NCT02468804|10016228|FG000|NOT COMPLETED|Overall Study||1
8953105|NCT02468804|10016229|FG001|NOT COMPLETED|Overall Study||8
8953106|NCT02468830|10016235|FG000|STARTED|Overall Study||58
8953107|NCT02468830|10016235|FG000|COMPLETED|Overall Study||55
8953108|NCT02468830|10016235|FG000|NOT COMPLETED|Overall Study||3
8953109|NCT02468934|10016239|FG000|STARTED|Overall Study||27
8953110|NCT02468934|10016239|FG000|Enrolled/Received Leads|Overall Study||24
8953111|NCT02468934|10016239|FG000|Underwent Total Knee Arthroplasty|Overall Study||20
8953112|NCT02468934|10016239|FG000|COMPLETED|Overall Study||20
8953113|NCT02468934|10016239|FG000|NOT COMPLETED|Overall Study||7
8953114|NCT02469038|10016247|FG000|STARTED|Overall Study||26
8953115|NCT02469038|10016248|FG001|STARTED|Overall Study||24
8953116|NCT02469038|10016247|FG000|COMPLETED|Overall Study||22
8953117|NCT02469038|10016248|FG001|COMPLETED|Overall Study||19
8953118|NCT02469038|10016247|FG000|NOT COMPLETED|Overall Study||4
8953119|NCT02469038|10016248|FG001|NOT COMPLETED|Overall Study||5
8631206|NCT00538850|9671111|FG001|NOT COMPLETED|Fentanyl Sublingual Spray - Double-blind||3
8631207|NCT00538850|9671112|FG002|NOT COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
8691269|NCT00853840|9736490|FG001|Vardenafil or Placebo (Day 3)|Period 2|Administered 1 hour post Maraviroc dosing|9
8953120|NCT02469064|10016256|FG000|STARTED|Overall Study||64
8953121|NCT02469064|10016257|FG001|STARTED|Overall Study||62
8953122|NCT02469064|10016256|FG000|COMPLETED|Overall Study||63
8953123|NCT02469064|10016257|FG001|COMPLETED|Overall Study||59
8953124|NCT02469064|10016256|FG000|NOT COMPLETED|Overall Study||1
8953125|NCT02469064|10016257|FG001|NOT COMPLETED|Overall Study||3
8953126|NCT02469077|10016265|FG000|STARTED|Pre Randomization - Pre Intervention||44
8953127|NCT02469077|10016266|FG001|STARTED|Pre Randomization - Pre Intervention||49
8953128|NCT02469077|10016265|FG000|Pre Intervention Placebo|Pre Randomization - Pre Intervention||44
8953129|NCT02469077|10016266|FG001|Pre Intervention Placebo|Pre Randomization - Pre Intervention||49
8953130|NCT02469077|10016265|FG000|Pre Intervention Morpine|Pre Randomization - Pre Intervention||44
8953131|NCT02469077|10016266|FG001|Pre Intervention Morpine|Pre Randomization - Pre Intervention||49
8953132|NCT02469077|10016265|FG000|Pre Intervention Naloxone|Pre Randomization - Pre Intervention||44
8953133|NCT02469077|10016266|FG001|Pre Intervention Naloxone|Pre Randomization - Pre Intervention||49
8953134|NCT02469077|10016265|FG000|COMPLETED|Pre Randomization - Pre Intervention||44
8953135|NCT02469077|10016266|FG001|COMPLETED|Pre Randomization - Pre Intervention||49
8953136|NCT02469077|10016265|FG000|NOT COMPLETED|Pre Randomization - Pre Intervention||0
8953137|NCT02469077|10016266|FG001|NOT COMPLETED|Pre Randomization - Pre Intervention||0
8953138|NCT02469077|10016265|FG000|STARTED|Post Randomization/Intervention Period||44
8953139|NCT02469077|10016266|FG001|STARTED|Post Randomization/Intervention Period||49
8953140|NCT02469077|10016265|FG000|COMPLETED|Post Randomization/Intervention Period||40
8953141|NCT02469077|10016266|FG001|COMPLETED|Post Randomization/Intervention Period||45
8953142|NCT02469077|10016265|FG000|NOT COMPLETED|Post Randomization/Intervention Period||4
8953143|NCT02469077|10016266|FG001|NOT COMPLETED|Post Randomization/Intervention Period||4
8953144|NCT02469077|10016265|FG000|STARTED|Post Intervention /Followup||40
8953145|NCT02469077|10016266|FG001|STARTED|Post Intervention /Followup||45
8953146|NCT02469077|10016265|FG000|Post Intervention Placebo|Post Intervention /Followup||39
8953147|NCT02469077|10016266|FG001|Post Intervention Placebo|Post Intervention /Followup||45
8953148|NCT02469077|10016265|FG000|Post Intervention Morphine|Post Intervention /Followup||40
8953149|NCT02469077|10016266|FG001|Post Intervention Morphine|Post Intervention /Followup||45
8953150|NCT02469077|10016265|FG000|Post Intervention Naloxone|Post Intervention /Followup||39
8953151|NCT02469077|10016266|FG001|Post Intervention Naloxone|Post Intervention /Followup||44
8953152|NCT02469077|10016265|FG000|COMPLETED|Post Intervention /Followup||38
8953153|NCT02469077|10016266|FG001|COMPLETED|Post Intervention /Followup||44
8953154|NCT02469077|10016265|FG000|NOT COMPLETED|Post Intervention /Followup||2
8872320|NCT01889602|9929190|FG001|NOT COMPLETED|Third Intervention||2
8953155|NCT02469077|10016266|FG001|NOT COMPLETED|Post Intervention /Followup||1
8953156|NCT02469090|10016278|FG000|STARTED|Period 1: Dose Titration Phase||141
8953157|NCT02469090|10016279|FG001|STARTED|Period 1: Dose Titration Phase||0
8953158|NCT02469090|10016280|FG002|STARTED|Period 1: Dose Titration Phase||0
8953159|NCT02469090|10016278|FG000|COMPLETED|Period 1: Dose Titration Phase||109
8953160|NCT02469090|10016279|FG001|COMPLETED|Period 1: Dose Titration Phase||0
8953161|NCT02469090|10016280|FG002|COMPLETED|Period 1: Dose Titration Phase||0
8953162|NCT02469090|10016278|FG000|NOT COMPLETED|Period 1: Dose Titration Phase||32
8953163|NCT02469090|10016279|FG001|NOT COMPLETED|Period 1: Dose Titration Phase||0
8953164|NCT02469090|10016280|FG002|NOT COMPLETED|Period 1: Dose Titration Phase||0
8872321|NCT01889602|9929191|FG002|NOT COMPLETED|Third Intervention||0
8872322|NCT01889602|9929189|FG000|STARTED|Third Washout Period of at Least 2 Weeks||15
8872323|NCT01889602|9929190|FG001|STARTED|Third Washout Period of at Least 2 Weeks||15
8872324|NCT01889602|9929191|FG002|STARTED|Third Washout Period of at Least 2 Weeks||16
8872325|NCT01889602|9929189|FG000|COMPLETED|Third Washout Period of at Least 2 Weeks||15
8872326|NCT01889602|9929190|FG001|COMPLETED|Third Washout Period of at Least 2 Weeks||15
8872327|NCT01889602|9929191|FG002|COMPLETED|Third Washout Period of at Least 2 Weeks||16
8872328|NCT01889602|9929189|FG000|NOT COMPLETED|Third Washout Period of at Least 2 Weeks||0
8872329|NCT01889602|9929190|FG001|NOT COMPLETED|Third Washout Period of at Least 2 Weeks||0
8953165|NCT02469090|10016278|FG000|STARTED|Period 2: Maintenance Treatment Phase|Subjects who completed the Titration Phase were eligible to proceed to Maintenance Treatment Phase|0
8953166|NCT02469090|10016279|FG001|STARTED|Period 2: Maintenance Treatment Phase|subjects who completed the Titration Phase and were randomized to Placebo in the Maintenance Phase|55
8953167|NCT02469090|10016280|FG002|STARTED|Period 2: Maintenance Treatment Phase|subjects who completed the Titration Phase and were randomized to APL-130277 Maintenance Phase|54
8953168|NCT02469090|10016278|FG000|COMPLETED|Period 2: Maintenance Treatment Phase||0
8953169|NCT02469090|10016279|FG001|COMPLETED|Period 2: Maintenance Treatment Phase||46
8953170|NCT02469090|10016280|FG002|COMPLETED|Period 2: Maintenance Treatment Phase||34
8953171|NCT02469090|10016278|FG000|NOT COMPLETED|Period 2: Maintenance Treatment Phase||0
8953172|NCT02469090|10016279|FG001|NOT COMPLETED|Period 2: Maintenance Treatment Phase||9
8953173|NCT02469090|10016280|FG002|NOT COMPLETED|Period 2: Maintenance Treatment Phase||20
8953174|NCT02469116|10016287|FG000|STARTED|Overall Study||18
8953175|NCT02469116|10016287|FG000|COMPLETED|Overall Study||18
8953176|NCT02469116|10016287|FG000|NOT COMPLETED|Overall Study||0
8953177|NCT02469168|10016293|FG000|STARTED|Overall Study||1
8953178|NCT02469168|10016294|FG001|STARTED|Overall Study||0
8953179|NCT02469168|10016293|FG000|COMPLETED|Overall Study||0
8953180|NCT02469168|10016294|FG001|COMPLETED|Overall Study||0
8953181|NCT02469168|10016293|FG000|NOT COMPLETED|Overall Study||1
8953182|NCT02469168|10016294|FG001|NOT COMPLETED|Overall Study||0
8953183|NCT02469246|10016302|FG000|STARTED|Double-Blind Phase||285
8953184|NCT02469246|10016303|FG001|STARTED|Double-Blind Phase||282
8953185|NCT02469246|10016302|FG000|COMPLETED|Double-Blind Phase||218
8953186|NCT02469246|10016303|FG001|COMPLETED|Double-Blind Phase||226
8953187|NCT02469246|10016302|FG000|NOT COMPLETED|Double-Blind Phase||67
8953188|NCT02469246|10016303|FG001|NOT COMPLETED|Double-Blind Phase||56
8953189|NCT02469246|10016302|FG000|STARTED|Open-Label Extension (OLE)|Only participants in countries where F/TAF was not commercially available were eligible for the OLE.|6
8953190|NCT02469246|10016303|FG001|STARTED|Open-Label Extension (OLE)|Only participants in countries where F/TAF was not commercially available were eligible for the OLE.|5
8953191|NCT02469246|10016302|FG000|COMPLETED|Open-Label Extension (OLE)||6
8953192|NCT02469246|10016303|FG001|COMPLETED|Open-Label Extension (OLE)||5
8953193|NCT02469246|10016302|FG000|NOT COMPLETED|Open-Label Extension (OLE)||0
8953194|NCT02469246|10016303|FG001|NOT COMPLETED|Open-Label Extension (OLE)||0
8953195|NCT02469298|10016315|FG000|STARTED|Overall Study||15
8953196|NCT02469298|10016316|FG001|STARTED|Overall Study||7
8953197|NCT02469298|10016317|FG002|STARTED|Overall Study||16
8953198|NCT02469298|10016318|FG003|STARTED|Overall Study||7
8953199|NCT02469298|10016315|FG000|COMPLETED|Overall Study||14
8569987|NCT00100165|9602111|FG002|COMPLETED|Baseline||9
8569988|NCT00100165|9602109|FG000|NOT COMPLETED|Baseline||0
8569989|NCT00100165|9602110|FG001|NOT COMPLETED|Baseline||0
8569990|NCT00100165|9602111|FG002|NOT COMPLETED|Baseline||0
8569991|NCT00100165|9602109|FG000|STARTED|First Intervention (4 Weeks)||10
8569992|NCT00100165|9602110|FG001|STARTED|First Intervention (4 Weeks)||10
8569993|NCT00100165|9602111|FG002|STARTED|First Intervention (4 Weeks)||9
8569994|NCT00100165|9602109|FG000|COMPLETED|First Intervention (4 Weeks)||10
8569995|NCT00100165|9602110|FG001|COMPLETED|First Intervention (4 Weeks)||10
8569996|NCT00100165|9602111|FG002|COMPLETED|First Intervention (4 Weeks)||9
8872330|NCT01889602|9929191|FG002|NOT COMPLETED|Third Washout Period of at Least 2 Weeks||0
8872331|NCT01889667|9929210|FG000|STARTED|Overall Study||10
8872332|NCT01889667|9929211|FG001|STARTED|Overall Study||10
8872333|NCT01889667|9929212|FG002|STARTED|Overall Study||10
8872334|NCT01889667|9929210|FG000|COMPLETED|Overall Study||10
8872335|NCT01889667|9929211|FG001|COMPLETED|Overall Study||10
8872336|NCT01889667|9929212|FG002|COMPLETED|Overall Study||10
8872337|NCT01889667|9929210|FG000|NOT COMPLETED|Overall Study||0
8872338|NCT01889667|9929211|FG001|NOT COMPLETED|Overall Study||0
8872339|NCT01889667|9929212|FG002|NOT COMPLETED|Overall Study||0
8872340|NCT01889797|9929224|FG000|STARTED|Overall Study||16
8872341|NCT01889797|9929225|FG001|STARTED|Overall Study||16
8872342|NCT01889797|9929224|FG000|COMPLETED|Overall Study||16
8872343|NCT01889797|9929225|FG001|COMPLETED|Overall Study||16
8872344|NCT01889797|9929224|FG000|NOT COMPLETED|Overall Study||0
8872345|NCT01889797|9929225|FG001|NOT COMPLETED|Overall Study||0
8872346|NCT01889862|9929231|FG000|STARTED|Part 1 (Up to 13 Weeks)||86
8872347|NCT01889862|9929232|FG001|STARTED|Part 1 (Up to 13 Weeks)||0
8872348|NCT01889862|9929233|FG002|STARTED|Part 1 (Up to 13 Weeks)||78
8872349|NCT01889862|9929234|FG003|STARTED|Part 1 (Up to 13 Weeks)||0
8872350|NCT01889862|9929235|FG004|STARTED|Part 1 (Up to 13 Weeks)||0
8872351|NCT01889862|9929231|FG000|COMPLETED|Part 1 (Up to 13 Weeks)|Out of 164, total 12 subjects have not completed Part 1.|74
8872352|NCT01889862|9929232|FG001|COMPLETED|Part 1 (Up to 13 Weeks)||0
8872353|NCT01889862|9929233|FG002|COMPLETED|Part 1 (Up to 13 Weeks)||78
8872354|NCT01889862|9929234|FG003|COMPLETED|Part 1 (Up to 13 Weeks)||0
8872355|NCT01889862|9929235|FG004|COMPLETED|Part 1 (Up to 13 Weeks)||0
8872356|NCT01889862|9929231|FG000|NOT COMPLETED|Part 1 (Up to 13 Weeks)||12
8872357|NCT01889862|9929232|FG001|NOT COMPLETED|Part 1 (Up to 13 Weeks)||0
8872358|NCT01889862|9929233|FG002|NOT COMPLETED|Part 1 (Up to 13 Weeks)||0
8872359|NCT01889862|9929234|FG003|NOT COMPLETED|Part 1 (Up to 13 Weeks)||0
8872360|NCT01889862|9929235|FG004|NOT COMPLETED|Part 1 (Up to 13 Weeks)||0
8872361|NCT01889862|9929231|FG000|STARTED|Part 2 (8 Weeks)|Subjects ≥20% reduction in blood Phe from naïve baseline levels are randomized in Part 2.|34
8872362|NCT01889862|9929232|FG001|STARTED|Part 2 (8 Weeks)|Subjects ≥20% reduction in blood Phe from naïve baseline levels are randomized in Part 2.|15
8872363|NCT01889862|9929233|FG002|STARTED|Part 2 (8 Weeks)|Subjects ≥20% reduction in blood Phe from naïve baseline levels are randomized in Part 2.|32
8872364|NCT01889862|9929234|FG003|STARTED|Part 2 (8 Weeks)|Subjects ≥20% reduction in blood Phe from naïve baseline levels are randomized in Part 2.|14
8872365|NCT01889862|9929235|FG004|STARTED|Part 2 (8 Weeks)||0
8872366|NCT01889862|9929231|FG000|Per Amendment #2 of the Protocol|Part 2 (8 Weeks)||29
8872367|NCT01889862|9929232|FG001|Per Amendment #2 of the Protocol|Part 2 (8 Weeks)||14
8872368|NCT01889862|9929233|FG002|Per Amendment #2 of the Protocol|Part 2 (8 Weeks)||29
8872369|NCT01889862|9929234|FG003|Per Amendment #2 of the Protocol|Part 2 (8 Weeks)||14
8872370|NCT01889862|9929235|FG004|Per Amendment #2 of the Protocol|Part 2 (8 Weeks)||0
8872371|NCT01889862|9929231|FG000|COMPLETED|Part 2 (8 Weeks)||34
8872372|NCT01889862|9929232|FG001|COMPLETED|Part 2 (8 Weeks)||15
8872373|NCT01889862|9929233|FG002|COMPLETED|Part 2 (8 Weeks)||31
8872374|NCT01889862|9929234|FG003|COMPLETED|Part 2 (8 Weeks)||14
8872375|NCT01889862|9929235|FG004|COMPLETED|Part 2 (8 Weeks)||0
8872376|NCT01889862|9929231|FG000|NOT COMPLETED|Part 2 (8 Weeks)||0
8872377|NCT01889862|9929232|FG001|NOT COMPLETED|Part 2 (8 Weeks)||0
8872378|NCT01889862|9929233|FG002|NOT COMPLETED|Part 2 (8 Weeks)||1
8872379|NCT01889862|9929234|FG003|NOT COMPLETED|Part 2 (8 Weeks)||0
8872380|NCT01889862|9929235|FG004|NOT COMPLETED|Part 2 (8 Weeks)||0
8872381|NCT01889862|9929231|FG000|STARTED|Part 3A/B (6 Week)|Subjects switch from placebo to active 20mg/kg.|48
8872382|NCT01889862|9929232|FG001|STARTED|Part 3A/B (6 Week)|Subjects switch from placebo to active 20mg/kg.|0
8872383|NCT01889862|9929233|FG002|STARTED|Part 3A/B (6 Week)|Subjects switch from placebo to active 40mg/kg.|41
8872384|NCT01889862|9929234|FG003|STARTED|Part 3A/B (6 Week)|Subjects switch from placebo to active 40mg/kg.|0
8872385|NCT01889862|9929235|FG004|STARTED|Part 3A/B (6 Week)||0
8872386|NCT01889862|9929231|FG000|Per Amendment #2 of the Protocol|Part 3A/B (6 Week)||34
8872387|NCT01889862|9929232|FG001|Per Amendment #2 of the Protocol|Part 3A/B (6 Week)||0
8872388|NCT01889862|9929233|FG002|Per Amendment #2 of the Protocol|Part 3A/B (6 Week)||26
8872389|NCT01889862|9929234|FG003|Per Amendment #2 of the Protocol|Part 3A/B (6 Week)||0
8872390|NCT01889862|9929235|FG004|Per Amendment #2 of the Protocol|Part 3A/B (6 Week)||0
8872391|NCT01889862|9929231|FG000|COMPLETED|Part 3A/B (6 Week)||48
8872392|NCT01889862|9929232|FG001|COMPLETED|Part 3A/B (6 Week)||0
8872393|NCT01889862|9929233|FG002|COMPLETED|Part 3A/B (6 Week)||41
8872394|NCT01889862|9929234|FG003|COMPLETED|Part 3A/B (6 Week)||0
8872395|NCT01889862|9929235|FG004|COMPLETED|Part 3A/B (6 Week)||0
8872396|NCT01889862|9929231|FG000|NOT COMPLETED|Part 3A/B (6 Week)||0
8872397|NCT01889862|9929232|FG001|NOT COMPLETED|Part 3A/B (6 Week)||0
8872398|NCT01889862|9929233|FG002|NOT COMPLETED|Part 3A/B (6 Week)||0
8872399|NCT01889862|9929234|FG003|NOT COMPLETED|Part 3A/B (6 Week)||0
8872400|NCT01889862|9929235|FG004|NOT COMPLETED|Part 3A/B (6 Week)||0
8872401|NCT01889862|9929231|FG000|STARTED|Part 4 (Up to 274 Weeks)|51, 57, 5 and 89 subjects from 165-301, 165-302 Part 1, 2 & 3 entered 165-302 Part 4 respectively.|0
8872402|NCT01889862|9929232|FG001|STARTED|Part 4 (Up to 274 Weeks)||0
8872403|NCT01889862|9929233|FG002|STARTED|Part 4 (Up to 274 Weeks)|51, 57, 5 and 89 subjects from 165-301, 165-302 Part 1, 2 & 3 entered 165-302 Part 4 respectively.|0
8872404|NCT01889862|9929234|FG003|STARTED|Part 4 (Up to 274 Weeks)||0
8872405|NCT01889862|9929235|FG004|STARTED|Part 4 (Up to 274 Weeks)|Total of 202 subjects from 165-301, Part 1, 2, 3 entered Part 4 to receive dose of up to 60mg/kg.|202
8872406|NCT01889862|9929231|FG000|COMPLETED|Part 4 (Up to 274 Weeks)||0
8872407|NCT01889862|9929232|FG001|COMPLETED|Part 4 (Up to 274 Weeks)||0
8872408|NCT01889862|9929233|FG002|COMPLETED|Part 4 (Up to 274 Weeks)||0
8872409|NCT01889862|9929234|FG003|COMPLETED|Part 4 (Up to 274 Weeks)||0
8872410|NCT01889862|9929235|FG004|COMPLETED|Part 4 (Up to 274 Weeks)||172
8872411|NCT01889862|9929231|FG000|NOT COMPLETED|Part 4 (Up to 274 Weeks)||0
8872412|NCT01889862|9929232|FG001|NOT COMPLETED|Part 4 (Up to 274 Weeks)||0
8872413|NCT01889862|9929233|FG002|NOT COMPLETED|Part 4 (Up to 274 Weeks)||0
8872414|NCT01889862|9929234|FG003|NOT COMPLETED|Part 4 (Up to 274 Weeks)||0
8872415|NCT01889862|9929235|FG004|NOT COMPLETED|Part 4 (Up to 274 Weeks)||30
8872416|NCT01890031|9929265|FG000|STARTED|Overall Study||50
8872417|NCT01890031|9929266|FG001|STARTED|Overall Study||50
8872418|NCT01890031|9929267|FG002|STARTED|Overall Study||12
8872419|NCT01890031|9929268|FG003|STARTED|Overall Study||11
8872420|NCT01890031|9929269|FG004|STARTED|Overall Study||8
8872421|NCT01890031|9929265|FG000|COMPLETED|Overall Study||50
8872422|NCT01890031|9929266|FG001|COMPLETED|Overall Study||50
8872423|NCT01890031|9929267|FG002|COMPLETED|Overall Study||12
8872424|NCT01890031|9929268|FG003|COMPLETED|Overall Study||11
8872425|NCT01890031|9929269|FG004|COMPLETED|Overall Study||8
8872426|NCT01890031|9929265|FG000|NOT COMPLETED|Overall Study||0
8872427|NCT01890031|9929266|FG001|NOT COMPLETED|Overall Study||0
8872428|NCT01890031|9929267|FG002|NOT COMPLETED|Overall Study||0
8872429|NCT01890031|9929268|FG003|NOT COMPLETED|Overall Study||0
8872430|NCT01890031|9929269|FG004|NOT COMPLETED|Overall Study||0
8872431|NCT01890109|9929283|FG000|STARTED|Overall Study||52
8872432|NCT01890109|9929284|FG001|STARTED|Overall Study||51
8872433|NCT01890109|9929283|FG000|Received Study Treatment|Overall Study||52
8872434|NCT01890109|9929284|FG001|Received Study Treatment|Overall Study||50
8872435|NCT01890109|9929283|FG000|COMPLETED|Overall Study||51
8872436|NCT01890109|9929284|FG001|COMPLETED|Overall Study||46
8872437|NCT01890109|9929283|FG000|NOT COMPLETED|Overall Study||1
8872438|NCT01890109|9929284|FG001|NOT COMPLETED|Overall Study||5
8872439|NCT01890122|9929295|FG000|STARTED|Overall Study|Started = Enrolled set which included all participants who signed informed consent.|162
8872440|NCT01890122|9929296|FG001|STARTED|Overall Study||163
8872441|NCT01890122|9929297|FG002|STARTED|Overall Study||159
8872442|NCT01890122|9929298|FG003|STARTED|Overall Study||163
8872443|NCT01890122|9929295|FG000|Treated|Overall Study|Treated = Randomized participants who received at least one dose of study drug.|161
8872444|NCT01890122|9929296|FG001|Treated|Overall Study||162
8872445|NCT01890122|9929297|FG002|Treated|Overall Study||159
8872446|NCT01890122|9929298|FG003|Treated|Overall Study||163
8872447|NCT01890122|9929295|FG000|COMPLETED|Overall Study||135
8872448|NCT01890122|9929296|FG001|COMPLETED|Overall Study||126
8872449|NCT01890122|9929297|FG002|COMPLETED|Overall Study||146
8872450|NCT01890122|9929298|FG003|COMPLETED|Overall Study||104
8872451|NCT01890122|9929295|FG000|NOT COMPLETED|Overall Study||27
8872452|NCT01890122|9929296|FG001|NOT COMPLETED|Overall Study||37
8872453|NCT01890122|9929297|FG002|NOT COMPLETED|Overall Study||13
8872454|NCT01890122|9929298|FG003|NOT COMPLETED|Overall Study||59
8872455|NCT01890148|9929308|FG000|STARTED|Overall Study||5
8872456|NCT01890148|9929308|FG000|COMPLETED|Overall Study||4
8872457|NCT01890148|9929308|FG000|NOT COMPLETED|Overall Study||1
8872458|NCT01890226|9929314|FG000|STARTED|Overall Study||155
8872459|NCT01890226|9929315|FG001|STARTED|Overall Study||156
8872460|NCT01890226|9929314|FG000|COMPLETED|Overall Study||155
8872461|NCT01890226|9929315|FG001|COMPLETED|Overall Study||156
8872462|NCT01890226|9929314|FG000|NOT COMPLETED|Overall Study||0
8872463|NCT01890226|9929315|FG001|NOT COMPLETED|Overall Study||0
8872464|NCT01890265|9929327|FG000|STARTED|Overall Study||50
8872465|NCT01890265|9929328|FG001|STARTED|Overall Study||53
8872466|NCT01890265|9929329|FG002|STARTED|Overall Study||24
8872467|NCT01890265|9929330|FG003|STARTED|Overall Study||12
8872468|NCT01890265|9929331|FG004|STARTED|Overall Study||15
8872469|NCT01890265|9929332|FG005|STARTED|Overall Study||6
8872470|NCT01890265|9929327|FG000|Safety Population|Overall Study||50
8872471|NCT01890265|9929328|FG001|Safety Population|Overall Study||53
8872472|NCT01890265|9929329|FG002|Safety Population|Overall Study||24
8872473|NCT01890265|9929330|FG003|Safety Population|Overall Study||12
8872474|NCT01890265|9929331|FG004|Safety Population|Overall Study||15
8872475|NCT01890265|9929332|FG005|Safety Population|Overall Study||6
8872476|NCT01890265|9929327|FG000|Intent-to-Treat (ITT) Population|Overall Study||50
8872477|NCT01890265|9929328|FG001|Intent-to-Treat (ITT) Population|Overall Study||51
8872478|NCT01890265|9929329|FG002|Intent-to-Treat (ITT) Population|Overall Study||24
8872479|NCT01890265|9929330|FG003|Intent-to-Treat (ITT) Population|Overall Study||12
8872480|NCT01890265|9929331|FG004|Intent-to-Treat (ITT) Population|Overall Study||15
8953200|NCT02469298|10016316|FG001|COMPLETED|Overall Study||6
8872481|NCT01890265|9929332|FG005|Intent-to-Treat (ITT) Population|Overall Study||6
8872482|NCT01890265|9929327|FG000|COMPLETED|Overall Study||40
8872483|NCT01890265|9929328|FG001|COMPLETED|Overall Study||40
8872484|NCT01890265|9929329|FG002|COMPLETED|Overall Study||20
8872485|NCT01890265|9929330|FG003|COMPLETED|Overall Study||12
8872486|NCT01890265|9929331|FG004|COMPLETED|Overall Study||13
8872487|NCT01890265|9929332|FG005|COMPLETED|Overall Study||6
8872488|NCT01890265|9929327|FG000|NOT COMPLETED|Overall Study||10
8872489|NCT01890265|9929328|FG001|NOT COMPLETED|Overall Study||13
8872490|NCT01890265|9929329|FG002|NOT COMPLETED|Overall Study||4
8872491|NCT01890265|9929330|FG003|NOT COMPLETED|Overall Study||0
8872492|NCT01890265|9929331|FG004|NOT COMPLETED|Overall Study||2
8872493|NCT01890265|9929332|FG005|NOT COMPLETED|Overall Study||0
8872494|NCT01890343|9929345|FG000|STARTED|Overall Study||8
8872495|NCT01890343|9929346|FG001|STARTED|Overall Study||10
8872496|NCT01890343|9929347|FG002|STARTED|Overall Study||10
8872497|NCT01890343|9929345|FG000|COMPLETED|Overall Study||8
8872498|NCT01890343|9929346|FG001|COMPLETED|Overall Study||10
8872499|NCT01890343|9929347|FG002|COMPLETED|Overall Study||10
8872500|NCT01890343|9929345|FG000|NOT COMPLETED|Overall Study||0
8872501|NCT01890343|9929346|FG001|NOT COMPLETED|Overall Study||0
8872502|NCT01890343|9929347|FG002|NOT COMPLETED|Overall Study||0
8872503|NCT01890421|9929355|FG000|STARTED|Overall Study||426
8872504|NCT01890421|9929355|FG000|COMPLETED|Overall Study||415
8872505|NCT01890421|9929355|FG000|NOT COMPLETED|Overall Study||11
8872506|NCT01890434|9929359|FG000|STARTED|Overall Study||478
8872507|NCT01890434|9929359|FG000|Evaluated for Efficacy|Overall Study||389
8872508|NCT01890434|9929359|FG000|COMPLETED|Overall Study||458
8872509|NCT01890434|9929359|FG000|NOT COMPLETED|Overall Study||20
8872510|NCT01890473|9929365|FG000|STARTED|Overall Study||111
8872511|NCT01890473|9929366|FG001|STARTED|Overall Study||113
8872512|NCT01890473|9929365|FG000|COMPLETED|Overall Study||109
8872513|NCT01890473|9929366|FG001|COMPLETED|Overall Study||113
8872514|NCT01890473|9929365|FG000|NOT COMPLETED|Overall Study||2
8872515|NCT01890473|9929366|FG001|NOT COMPLETED|Overall Study||0
8872516|NCT01890512|9929374|FG000|STARTED|Overall Study||20
8872517|NCT01890512|9929374|FG000|COMPLETED|Overall Study||17
8872518|NCT01890512|9929374|FG000|NOT COMPLETED|Overall Study||3
8872519|NCT01890642|9929381|FG000|STARTED|Overall Study||56
8872520|NCT01890642|9929382|FG001|STARTED|Overall Study||53
8872521|NCT01890642|9929383|FG002|STARTED|Overall Study||96
8872522|NCT01890642|9929381|FG000|COMPLETED|Overall Study||56
8872523|NCT01890642|9929382|FG001|COMPLETED|Overall Study||53
8872524|NCT01890642|9929383|FG002|COMPLETED|Overall Study||96
8872525|NCT01890642|9929381|FG000|NOT COMPLETED|Overall Study||0
8872526|NCT01890642|9929382|FG001|NOT COMPLETED|Overall Study||0
8872527|NCT01890642|9929383|FG002|NOT COMPLETED|Overall Study||0
8872528|NCT01890707|9929393|FG000|STARTED|Overall Study||11
8872529|NCT01890707|9929394|FG001|STARTED|Overall Study||8
8872530|NCT01890707|9929393|FG000|COMPLETED|Overall Study||10
8872531|NCT01890707|9929394|FG001|COMPLETED|Overall Study||7
8872532|NCT01890707|9929393|FG000|NOT COMPLETED|Overall Study||1
8872533|NCT01890707|9929394|FG001|NOT COMPLETED|Overall Study||1
8872534|NCT01890746|9929402|FG000|STARTED|Overall Study||74
8872535|NCT01890746|9929403|FG001|STARTED|Overall Study||74
8872536|NCT01890746|9929402|FG000|COMPLETED|Overall Study||22
8872537|NCT01890746|9929403|FG001|COMPLETED|Overall Study||33
8872538|NCT01890746|9929402|FG000|NOT COMPLETED|Overall Study||52
8872539|NCT01890746|9929403|FG001|NOT COMPLETED|Overall Study||41
8872540|NCT01890785|9929415|FG000|STARTED|First Intervention||5
8872541|NCT01890785|9929416|FG001|STARTED|First Intervention||5
8872542|NCT01890785|9929417|FG002|STARTED|First Intervention||5
8872543|NCT01890785|9929418|FG003|STARTED|First Intervention||5
8872544|NCT01890785|9929419|FG004|STARTED|First Intervention||5
8872545|NCT01890785|9929420|FG005|STARTED|First Intervention||5
8872546|NCT01890785|9929415|FG000|COMPLETED|First Intervention||5
8872547|NCT01890785|9929416|FG001|COMPLETED|First Intervention||5
8872548|NCT01890785|9929417|FG002|COMPLETED|First Intervention||5
8872549|NCT01890785|9929418|FG003|COMPLETED|First Intervention||5
8872550|NCT01890785|9929419|FG004|COMPLETED|First Intervention||5
8872551|NCT01890785|9929420|FG005|COMPLETED|First Intervention||5
8872552|NCT01890785|9929415|FG000|NOT COMPLETED|First Intervention||0
8872553|NCT01890785|9929416|FG001|NOT COMPLETED|First Intervention||0
8872554|NCT01890785|9929417|FG002|NOT COMPLETED|First Intervention||0
8872555|NCT01890785|9929418|FG003|NOT COMPLETED|First Intervention||0
8872556|NCT01890785|9929419|FG004|NOT COMPLETED|First Intervention||0
8872557|NCT01890785|9929420|FG005|NOT COMPLETED|First Intervention||0
8872558|NCT01890785|9929415|FG000|STARTED|Second Intervention||5
8872559|NCT01890785|9929416|FG001|STARTED|Second Intervention||5
8872560|NCT01890785|9929417|FG002|STARTED|Second Intervention||5
8872561|NCT01890785|9929418|FG003|STARTED|Second Intervention||5
8872562|NCT01890785|9929419|FG004|STARTED|Second Intervention||5
8872563|NCT01890785|9929420|FG005|STARTED|Second Intervention||5
8872564|NCT01890785|9929415|FG000|COMPLETED|Second Intervention||5
8872565|NCT01890785|9929416|FG001|COMPLETED|Second Intervention||5
8872566|NCT01890785|9929417|FG002|COMPLETED|Second Intervention||5
8872567|NCT01890785|9929418|FG003|COMPLETED|Second Intervention||5
8872568|NCT01890785|9929419|FG004|COMPLETED|Second Intervention||5
8872569|NCT01890785|9929420|FG005|COMPLETED|Second Intervention||5
8872570|NCT01890785|9929415|FG000|NOT COMPLETED|Second Intervention||0
8872571|NCT01890785|9929416|FG001|NOT COMPLETED|Second Intervention||0
8872572|NCT01890785|9929417|FG002|NOT COMPLETED|Second Intervention||0
8872573|NCT01890785|9929418|FG003|NOT COMPLETED|Second Intervention||0
8872574|NCT01890785|9929419|FG004|NOT COMPLETED|Second Intervention||0
8872575|NCT01890785|9929420|FG005|NOT COMPLETED|Second Intervention||0
8872576|NCT01890785|9929415|FG000|STARTED|Third Intervention||5
8872577|NCT01890785|9929416|FG001|STARTED|Third Intervention||5
8872578|NCT01890785|9929417|FG002|STARTED|Third Intervention||5
8872579|NCT01890785|9929418|FG003|STARTED|Third Intervention||5
8872580|NCT01890785|9929419|FG004|STARTED|Third Intervention||5
8872581|NCT01890785|9929420|FG005|STARTED|Third Intervention||5
8872582|NCT01890785|9929415|FG000|COMPLETED|Third Intervention||5
8872583|NCT01890785|9929416|FG001|COMPLETED|Third Intervention||4
8872584|NCT01890785|9929417|FG002|COMPLETED|Third Intervention||5
8872585|NCT01890785|9929418|FG003|COMPLETED|Third Intervention||5
8872586|NCT01890785|9929419|FG004|COMPLETED|Third Intervention||5
8872587|NCT01890785|9929420|FG005|COMPLETED|Third Intervention||5
8872588|NCT01890785|9929415|FG000|NOT COMPLETED|Third Intervention||0
8872589|NCT01890785|9929416|FG001|NOT COMPLETED|Third Intervention||1
8872590|NCT01890785|9929417|FG002|NOT COMPLETED|Third Intervention||0
8872591|NCT01890785|9929418|FG003|NOT COMPLETED|Third Intervention||0
8872592|NCT01890785|9929419|FG004|NOT COMPLETED|Third Intervention||0
8872593|NCT01890785|9929420|FG005|NOT COMPLETED|Third Intervention||0
8872594|NCT01890915|9929431|FG000|STARTED|Overall Study||11
8872595|NCT01890915|9929432|FG001|STARTED|Overall Study||10
8953201|NCT02469298|10016317|FG002|COMPLETED|Overall Study||14
8953202|NCT02469298|10016318|FG003|COMPLETED|Overall Study||5
8953203|NCT02469298|10016315|FG000|NOT COMPLETED|Overall Study||1
8953204|NCT02469298|10016316|FG001|NOT COMPLETED|Overall Study||1
8953205|NCT02469298|10016317|FG002|NOT COMPLETED|Overall Study||2
8953206|NCT02469298|10016318|FG003|NOT COMPLETED|Overall Study||2
8953207|NCT02469389|10016337|FG000|STARTED|Overall Study||53
8953208|NCT02469389|10016338|FG001|STARTED|Overall Study||52
8953209|NCT02469389|10016337|FG000|Completed 12-week Assessment|Overall Study|13 lost to contact or refused|40
8953210|NCT02469389|10016338|FG001|Completed 12-week Assessment|Overall Study|8 lost to contact or refused|44
8953211|NCT02469389|10016337|FG000|Completed 24-week Assessment|Overall Study|16 lost to contact or refused|37
8953212|NCT02469389|10016338|FG001|Completed 24-week Assessment|Overall Study|6 lost to contact or refused|46
8953213|NCT02469389|10016337|FG000|COMPLETED|Overall Study||37
8953214|NCT02469389|10016338|FG001|COMPLETED|Overall Study||44
8953215|NCT02469389|10016337|FG000|NOT COMPLETED|Overall Study||16
8953216|NCT02469389|10016338|FG001|NOT COMPLETED|Overall Study||8
8953217|NCT02469597|10016346|FG000|STARTED|Overall Study||22
8953218|NCT02469597|10016347|FG001|STARTED|Overall Study||24
8953219|NCT02469597|10016346|FG000|COMPLETED|Overall Study||22
8953220|NCT02469597|10016347|FG001|COMPLETED|Overall Study||24
8953221|NCT02469597|10016346|FG000|NOT COMPLETED|Overall Study||0
8953222|NCT02469597|10016347|FG001|NOT COMPLETED|Overall Study||0
8953223|NCT02469610|10016355|FG000|STARTED|Overall Study||34
8953224|NCT02469610|10016356|FG001|STARTED|Overall Study||31
8953225|NCT02469610|10016355|FG000|COMPLETED|Overall Study||30
8953226|NCT02469610|10016356|FG001|COMPLETED|Overall Study||30
8953227|NCT02469610|10016355|FG000|NOT COMPLETED|Overall Study||4
8953228|NCT02469610|10016356|FG001|NOT COMPLETED|Overall Study||1
8953229|NCT02469623|10016362|FG000|STARTED|Overall Study||85
8953230|NCT02469623|10016362|FG000|COMPLETED|Overall Study||72
8953231|NCT02469623|10016362|FG000|NOT COMPLETED|Overall Study||13
8953232|NCT02469701|10016367|FG000|STARTED|Overall Study||10
8953233|NCT02469701|10016367|FG000|COMPLETED|Overall Study||10
8953234|NCT02469701|10016367|FG000|NOT COMPLETED|Overall Study||0
8953235|NCT02469714|10016373|FG000|STARTED|Overall Study||55
8953236|NCT02469714|10016374|FG001|STARTED|Overall Study||55
8953237|NCT02469714|10016373|FG000|4 Month Follow-Up|Overall Study||50
8953238|NCT02469714|10016374|FG001|4 Month Follow-Up|Overall Study||51
8953239|NCT02469714|10016373|FG000|8 Month Follow-Up|Overall Study||49
8953240|NCT02469714|10016374|FG001|8 Month Follow-Up|Overall Study||50
8953241|NCT02469714|10016373|FG000|COMPLETED|Overall Study||47
8953242|NCT02469714|10016374|FG001|COMPLETED|Overall Study||50
8953243|NCT02469714|10016373|FG000|NOT COMPLETED|Overall Study||8
8953244|NCT02469714|10016374|FG001|NOT COMPLETED|Overall Study||5
8953245|NCT02469857|10016382|FG000|STARTED|Overall Study||143
8953246|NCT02469857|10016383|FG001|STARTED|Overall Study||147
8953247|NCT02469857|10016382|FG000|COMPLETED|Overall Study||118
8953248|NCT02469857|10016383|FG001|COMPLETED|Overall Study||115
8953249|NCT02469857|10016382|FG000|NOT COMPLETED|Overall Study||25
8953250|NCT02469857|10016383|FG001|NOT COMPLETED|Overall Study||32
8953251|NCT02469870|10016393|FG000|STARTED|Overall Study||77
8953252|NCT02469870|10016394|FG001|STARTED|Overall Study||79
8953253|NCT02469870|10016393|FG000|COMPLETED|Overall Study||73
8953254|NCT02469870|10016394|FG001|COMPLETED|Overall Study||72
8953255|NCT02469870|10016393|FG000|NOT COMPLETED|Overall Study||4
8953256|NCT02469870|10016394|FG001|NOT COMPLETED|Overall Study||7
8953257|NCT02469896|10016405|FG000|STARTED|Overall Study||8
8953258|NCT02469896|10016406|FG001|STARTED|Overall Study||14
8953259|NCT02469896|10016405|FG000|COMPLETED|Overall Study||6
8953260|NCT02469896|10016406|FG001|COMPLETED|Overall Study||14
8953261|NCT02469896|10016405|FG000|NOT COMPLETED|Overall Study||2
8953262|NCT02469896|10016406|FG001|NOT COMPLETED|Overall Study||0
8953263|NCT02469961|10016418|FG000|STARTED|Overall Study||25
8953264|NCT02469961|10016419|FG001|STARTED|Overall Study||25
8953265|NCT02469961|10016418|FG000|COMPLETED|Overall Study||21
8953266|NCT02469961|10016419|FG001|COMPLETED|Overall Study||24
8953267|NCT02469961|10016418|FG000|NOT COMPLETED|Overall Study||4
8953268|NCT02469961|10016419|FG001|NOT COMPLETED|Overall Study||1
8953269|NCT02470234|10016433|FG000|STARTED|Overall Study||5
8953270|NCT02470234|10016434|FG001|STARTED|Overall Study||3
8953271|NCT02470234|10016435|FG002|STARTED|Overall Study||2
8953272|NCT02470234|10016433|FG000|COMPLETED|Overall Study||5
8953273|NCT02470234|10016434|FG001|COMPLETED|Overall Study||3
8872596|NCT01890915|9929431|FG000|COMPLETED|Overall Study||8
8872597|NCT01890915|9929432|FG001|COMPLETED|Overall Study||9
8872598|NCT01890915|9929431|FG000|NOT COMPLETED|Overall Study||3
8872599|NCT01890915|9929432|FG001|NOT COMPLETED|Overall Study||1
8872600|NCT01890954|9929440|FG000|STARTED|Overall Study||9
8872601|NCT01890954|9929441|FG001|STARTED|Overall Study||8
8872602|NCT01890954|9929440|FG000|COMPLETED|Overall Study||8
8872603|NCT01890954|9929441|FG001|COMPLETED|Overall Study||8
8872604|NCT01890954|9929440|FG000|NOT COMPLETED|Overall Study||1
8953274|NCT02470234|10016435|FG002|COMPLETED|Overall Study||2
8953275|NCT02470234|10016433|FG000|NOT COMPLETED|Overall Study||0
8953276|NCT02470234|10016434|FG001|NOT COMPLETED|Overall Study||0
8953277|NCT02470234|10016435|FG002|NOT COMPLETED|Overall Study||0
8953278|NCT02470312|10016450|FG000|STARTED|Overall Study||147
8953279|NCT02470312|10016451|FG001|STARTED|Overall Study||431
8953280|NCT02470312|10016450|FG000|COMPLETED|Overall Study||142
8953281|NCT02470312|10016451|FG001|COMPLETED|Overall Study||419
8953282|NCT02470312|10016450|FG000|NOT COMPLETED|Overall Study||5
8953283|NCT02470312|10016451|FG001|NOT COMPLETED|Overall Study||12
8953284|NCT02470390|10016459|FG000|STARTED|Overall Study||6
8953285|NCT02470390|10016460|FG001|STARTED|Overall Study||7
8953286|NCT02470390|10016459|FG000|COMPLETED|Overall Study||6
8953287|NCT02470390|10016460|FG001|COMPLETED|Overall Study||6
8953288|NCT02470390|10016459|FG000|NOT COMPLETED|Overall Study||0
8953289|NCT02470390|10016460|FG001|NOT COMPLETED|Overall Study||1
8953290|NCT02470403|10016473|FG000|STARTED|Overall Study||44
8953291|NCT02470403|10016474|FG001|STARTED|Overall Study||44
8953292|NCT02470403|10016475|FG002|STARTED|Overall Study||40
8953293|NCT02470403|10016476|FG003|STARTED|Overall Study||43
8953294|NCT02470403|10016477|FG004|STARTED|Overall Study||10
8953295|NCT02470403|10016473|FG000|Dysglycemic|Overall Study||24
8953296|NCT02470403|10016474|FG001|Dysglycemic|Overall Study||24
8953297|NCT02470403|10016475|FG002|Dysglycemic|Overall Study||20
8953298|NCT02470403|10016476|FG003|Dysglycemic|Overall Study||20
8953299|NCT02470403|10016477|FG004|Dysglycemic|Overall Study||5
8953300|NCT02470403|10016473|FG000|Normoglycemic|Overall Study||20
8953301|NCT02470403|10016474|FG001|Normoglycemic|Overall Study||20
8953302|NCT02470403|10016475|FG002|Normoglycemic|Overall Study||20
8953303|NCT02470403|10016476|FG003|Normoglycemic|Overall Study||23
8953304|NCT02470403|10016477|FG004|Normoglycemic|Overall Study||5
8953305|NCT02470403|10016473|FG000|COMPLETED|Overall Study||42
8953306|NCT02470403|10016474|FG001|COMPLETED|Overall Study||43
8953307|NCT02470403|10016475|FG002|COMPLETED|Overall Study||40
8953308|NCT02470403|10016476|FG003|COMPLETED|Overall Study||39
8953309|NCT02470403|10016477|FG004|COMPLETED|Overall Study||10
8953310|NCT02470403|10016473|FG000|NOT COMPLETED|Overall Study||2
8953311|NCT02470403|10016474|FG001|NOT COMPLETED|Overall Study||1
8953312|NCT02470403|10016475|FG002|NOT COMPLETED|Overall Study||0
8953313|NCT02470403|10016476|FG003|NOT COMPLETED|Overall Study||4
8953314|NCT02470403|10016477|FG004|NOT COMPLETED|Overall Study||0
8953315|NCT02470429|10016494|FG000|STARTED|Overall Study||50
8953316|NCT02470429|10016495|FG001|STARTED|Overall Study||49
8953317|NCT02470429|10016494|FG000|COMPLETED|Overall Study||48
8953318|NCT02470429|10016495|FG001|COMPLETED|Overall Study||49
8953319|NCT02470429|10016494|FG000|NOT COMPLETED|Overall Study||2
8953320|NCT02470429|10016495|FG001|NOT COMPLETED|Overall Study||0
8953321|NCT02470494|10016502|FG000|STARTED|Overall Study||46
8953322|NCT02470494|10016502|FG000|COMPLETED|Overall Study||41
8953323|NCT02470494|10016502|FG000|NOT COMPLETED|Overall Study||5
8953324|NCT02470585|10016509|FG000|STARTED|Overall Study||375
8953325|NCT02470585|10016510|FG001|STARTED|Overall Study||383
8953326|NCT02470585|10016511|FG002|STARTED|Overall Study||382
8953327|NCT02470585|10016509|FG000|Received Study Drug|Overall Study||371
8953328|NCT02470585|10016510|FG001|Received Study Drug|Overall Study||376
8953329|NCT02470585|10016511|FG002|Received Study Drug|Overall Study||377
8953330|NCT02470585|10016509|FG000|COMPLETED|Overall Study||268
8953331|NCT02470585|10016510|FG001|COMPLETED|Overall Study||266
8953332|NCT02470585|10016511|FG002|COMPLETED|Overall Study||257
8953333|NCT02470585|10016509|FG000|NOT COMPLETED|Overall Study||107
8953334|NCT02470585|10016510|FG001|NOT COMPLETED|Overall Study||117
8953335|NCT02470585|10016511|FG002|NOT COMPLETED|Overall Study||125
8953336|NCT02470741|10016521|FG000|STARTED|Overall Study||6
8953337|NCT02470741|10016522|FG001|STARTED|Overall Study||6
8953338|NCT02470741|10016521|FG000|COMPLETED|Overall Study||3
8953339|NCT02470741|10016522|FG001|COMPLETED|Overall Study||4
8953340|NCT02470741|10016521|FG000|NOT COMPLETED|Overall Study||3
8953341|NCT02470741|10016522|FG001|NOT COMPLETED|Overall Study||2
8953342|NCT02470754|10016528|FG000|STARTED|Overall Study||19
8953343|NCT02470754|10016529|FG001|STARTED|Overall Study||19
8953344|NCT02470754|10016528|FG000|COMPLETED|Overall Study||17
8953345|NCT02470754|10016529|FG001|COMPLETED|Overall Study||19
8953346|NCT02470754|10016528|FG000|NOT COMPLETED|Overall Study||2
8953347|NCT02470754|10016529|FG001|NOT COMPLETED|Overall Study||0
8953348|NCT02470806|10016537|FG000|STARTED|Overall Study||80
8953349|NCT02470806|10016538|FG001|STARTED|Overall Study|The Safety analysis included 164, ITT was 161, and Per Protocol was 115 subjects (total both arms).|84
8953350|NCT02470806|10016537|FG000|COMPLETED|Overall Study||62
8953351|NCT02470806|10016538|FG001|COMPLETED|Overall Study||42
8953352|NCT02470806|10016537|FG000|NOT COMPLETED|Overall Study||18
8953353|NCT02470806|10016538|FG001|NOT COMPLETED|Overall Study||42
8872605|NCT01890954|9929441|FG001|NOT COMPLETED|Overall Study||0
8872606|NCT01890967|9929453|FG000|STARTED|Overall Study||88
8872607|NCT01890967|9929454|FG001|STARTED|Overall Study||88
8569997|NCT00100165|9602109|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0
8569998|NCT00100165|9602110|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0
8569999|NCT00100165|9602111|FG002|NOT COMPLETED|First Intervention (4 Weeks)||0
8570000|NCT00100165|9602109|FG000|STARTED|Washout (1 Week)||10
8725655|NCT01032733|9772965|FG000|NOT COMPLETED|Overall Study||1
8872608|NCT01890967|9929455|FG002|STARTED|Overall Study||88
8872609|NCT01890967|9929456|FG003|STARTED|Overall Study||88
8872610|NCT01890967|9929457|FG004|STARTED|Overall Study||87
8872611|NCT01890967|9929458|FG005|STARTED|Overall Study||88
8872612|NCT01890967|9929453|FG000|Received at Least One Dose of Study Drug|Overall Study||87
8872613|NCT01890967|9929454|FG001|Received at Least One Dose of Study Drug|Overall Study||87
8872614|NCT01890967|9929455|FG002|Received at Least One Dose of Study Drug|Overall Study||86
8872615|NCT01890967|9929456|FG003|Received at Least One Dose of Study Drug|Overall Study||86
8872616|NCT01890967|9929457|FG004|Received at Least One Dose of Study Drug|Overall Study||86
8872617|NCT01890967|9929458|FG005|Received at Least One Dose of Study Drug|Overall Study||87
8872618|NCT01890967|9929453|FG000|COMPLETED|Overall Study||78
8872619|NCT01890967|9929454|FG001|COMPLETED|Overall Study||77
8872620|NCT01890967|9929455|FG002|COMPLETED|Overall Study||78
8872621|NCT01890967|9929456|FG003|COMPLETED|Overall Study||77
8872622|NCT01890967|9929457|FG004|COMPLETED|Overall Study||77
8872623|NCT01890967|9929458|FG005|COMPLETED|Overall Study||75
8872624|NCT01890967|9929453|FG000|NOT COMPLETED|Overall Study||10
8872625|NCT01890967|9929454|FG001|NOT COMPLETED|Overall Study||11
8872626|NCT01890967|9929455|FG002|NOT COMPLETED|Overall Study||10
8872627|NCT01890967|9929456|FG003|NOT COMPLETED|Overall Study||11
8872628|NCT01890967|9929457|FG004|NOT COMPLETED|Overall Study||10
8872629|NCT01890967|9929458|FG005|NOT COMPLETED|Overall Study||13
8872630|NCT01891305|9929481|FG000|STARTED|Overall Study||12
8872631|NCT01891305|9929482|FG001|STARTED|Overall Study||12
8872632|NCT01891305|9929483|FG002|STARTED|Overall Study||14
8872633|NCT01891305|9929484|FG003|STARTED|Overall Study||12
8872634|NCT01891305|9929481|FG000|COMPLETED|Overall Study||9
8872635|NCT01891305|9929482|FG001|COMPLETED|Overall Study||11
8872636|NCT01891305|9929483|FG002|COMPLETED|Overall Study||11
8872637|NCT01891305|9929484|FG003|COMPLETED|Overall Study||12
8872638|NCT01891305|9929481|FG000|NOT COMPLETED|Overall Study||3
8872639|NCT01891305|9929482|FG001|NOT COMPLETED|Overall Study||1
8872640|NCT01891305|9929483|FG002|NOT COMPLETED|Overall Study||3
8872641|NCT01891305|9929484|FG003|NOT COMPLETED|Overall Study||0
8872642|NCT01891331|9929498|FG000|STARTED|Overall Study||14
8872643|NCT01891331|9929499|FG001|STARTED|Overall Study||12
8872644|NCT01891331|9929500|FG002|STARTED|Overall Study||14
8872645|NCT01891331|9929501|FG003|STARTED|Overall Study||15
8872646|NCT01891331|9929498|FG000|COMPLETED|Overall Study||12
8872647|NCT01891331|9929499|FG001|COMPLETED|Overall Study||10
8872648|NCT01891331|9929500|FG002|COMPLETED|Overall Study||13
8872649|NCT01891331|9929501|FG003|COMPLETED|Overall Study||13
8872650|NCT01891331|9929498|FG000|NOT COMPLETED|Overall Study||2
8872651|NCT01891331|9929499|FG001|NOT COMPLETED|Overall Study||2
8872652|NCT01891331|9929500|FG002|NOT COMPLETED|Overall Study||1
8872653|NCT01891331|9929501|FG003|NOT COMPLETED|Overall Study||2
8872654|NCT01891357|9929511|FG000|STARTED|Overall Study||64
8872655|NCT01891357|9929511|FG000|COMPLETED|Overall Study||61
8872656|NCT01891357|9929511|FG000|NOT COMPLETED|Overall Study||3
8872657|NCT01891669|9929525|FG000|STARTED|Overall Study||2
8872658|NCT01891669|9929526|FG001|STARTED|Overall Study||2
8872659|NCT01891669|9929527|FG002|STARTED|Overall Study||2
8872660|NCT01891669|9929528|FG003|STARTED|Overall Study||2
8872661|NCT01891669|9929529|FG004|STARTED|Overall Study||2
8872662|NCT01891669|9929530|FG005|STARTED|Overall Study||2
8872663|NCT01891669|9929531|FG006|STARTED|Overall Study||2
8872664|NCT01891669|9929532|FG007|STARTED|Overall Study||6
8872665|NCT01891669|9929533|FG008|STARTED|Overall Study||3
8872666|NCT01891669|9929534|FG009|STARTED|Overall Study||3
8872667|NCT01891669|9929525|FG000|COMPLETED|Overall Study||0
8872668|NCT01891669|9929526|FG001|COMPLETED|Overall Study||1
8872669|NCT01891669|9929527|FG002|COMPLETED|Overall Study||2
8872670|NCT01891669|9929528|FG003|COMPLETED|Overall Study||2
8872671|NCT01891669|9929529|FG004|COMPLETED|Overall Study||2
8872672|NCT01891669|9929530|FG005|COMPLETED|Overall Study||2
8872673|NCT01891669|9929531|FG006|COMPLETED|Overall Study||1
8872674|NCT01891669|9929532|FG007|COMPLETED|Overall Study||2
8872675|NCT01891669|9929533|FG008|COMPLETED|Overall Study||2
8872676|NCT01891669|9929534|FG009|COMPLETED|Overall Study||1
8872677|NCT01891669|9929525|FG000|NOT COMPLETED|Overall Study||2
8872678|NCT01891669|9929526|FG001|NOT COMPLETED|Overall Study||1
8872679|NCT01891669|9929527|FG002|NOT COMPLETED|Overall Study||0
8872680|NCT01891669|9929528|FG003|NOT COMPLETED|Overall Study||0
8872681|NCT01891669|9929529|FG004|NOT COMPLETED|Overall Study||0
8872682|NCT01891669|9929530|FG005|NOT COMPLETED|Overall Study||0
8570001|NCT00100165|9602110|FG001|STARTED|Washout (1 Week)||10
8872683|NCT01891669|9929531|FG006|NOT COMPLETED|Overall Study||1
8872684|NCT01891669|9929532|FG007|NOT COMPLETED|Overall Study||4
8872685|NCT01891669|9929533|FG008|NOT COMPLETED|Overall Study||1
8872686|NCT01891669|9929534|FG009|NOT COMPLETED|Overall Study||2
8872687|NCT01891721|9929568|FG000|STARTED|Overall Study||39
8872688|NCT01891721|9929569|FG001|STARTED|Overall Study||40
8872689|NCT01891721|9929570|FG002|STARTED|Overall Study||20
8872690|NCT01891721|9929568|FG000|COMPLETED|Overall Study||29
8570002|NCT00100165|9602111|FG002|STARTED|Washout (1 Week)||9
8570003|NCT00100165|9602109|FG000|COMPLETED|Washout (1 Week)||10
8872691|NCT01891721|9929569|FG001|COMPLETED|Overall Study||35
8872692|NCT01891721|9929570|FG002|COMPLETED|Overall Study||19
8872693|NCT01891721|9929568|FG000|NOT COMPLETED|Overall Study||10
8872694|NCT01891721|9929569|FG001|NOT COMPLETED|Overall Study||5
8872695|NCT01891721|9929570|FG002|NOT COMPLETED|Overall Study||1
8872696|NCT01891734|9929580|FG000|STARTED|Overall Study||17
8872697|NCT01891734|9929581|FG001|STARTED|Overall Study||16
8872698|NCT01891734|9929580|FG000|COMPLETED|Overall Study||14
8872699|NCT01891734|9929581|FG001|COMPLETED|Overall Study||13
8872700|NCT01891734|9929580|FG000|NOT COMPLETED|Overall Study||3
8872701|NCT01891734|9929581|FG001|NOT COMPLETED|Overall Study||3
8872702|NCT01891864|9929591|FG000|STARTED|Treatment Period 1||264
8872703|NCT01891864|9929592|FG001|STARTED|Treatment Period 1||267
8872704|NCT01891864|9929593|FG002|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
8872705|NCT01891864|9929594|FG003|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
8872706|NCT01891864|9929595|FG004|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
8872707|NCT01891864|9929596|FG005|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
8872708|NCT01891864|9929591|FG000|COMPLETED|Treatment Period 1|6 patients discontinued after completion of Treatment Period 1 and did NOT start Treatment Period 2|256
8872709|NCT01891864|9929592|FG001|COMPLETED|Treatment Period 1|8 patients discontinued after completion of Treatment Period 1 and did NOT start Treatment Period 2|255
8872710|NCT01891864|9929593|FG002|COMPLETED|Treatment Period 1||0
8872711|NCT01891864|9929594|FG003|COMPLETED|Treatment Period 1||0
8872712|NCT01891864|9929595|FG004|COMPLETED|Treatment Period 1||0
8872713|NCT01891864|9929596|FG005|COMPLETED|Treatment Period 1||0
8872714|NCT01891864|9929591|FG000|NOT COMPLETED|Treatment Period 1||8
8872715|NCT01891864|9929592|FG001|NOT COMPLETED|Treatment Period 1||12
8872716|NCT01891864|9929593|FG002|NOT COMPLETED|Treatment Period 1||0
8872717|NCT01891864|9929594|FG003|NOT COMPLETED|Treatment Period 1||0
8872718|NCT01891864|9929595|FG004|NOT COMPLETED|Treatment Period 1||0
8872719|NCT01891864|9929596|FG005|NOT COMPLETED|Treatment Period 1||0
8872720|NCT01891864|9929591|FG000|STARTED|Treatment Period 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
8872721|NCT01891864|9929592|FG001|STARTED|Treatment Period 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
8872722|NCT01891864|9929593|FG002|STARTED|Treatment Period 2|"Part of the patients re-randomized from GP2015 Etanercept treatment arm in Treatment Period 1"|150
8872723|NCT01891864|9929594|FG003|STARTED|Treatment Period 2|"Part of the patients re-randomized from Enbrel ® Etanercept treatment arm in Treatment Period 1"|151
8872724|NCT01891864|9929595|FG004|STARTED|Treatment Period 2|"Part of the patients re-randomized from GP2015 Etanercept treatment arm in Treatment Period 1"|100
8872725|NCT01891864|9929596|FG005|STARTED|Treatment Period 2|"Part of the patients re-randomized from Enbrel ® Etanercept treatment arm in Treatment Period 1"|96
8872726|NCT01891864|9929591|FG000|COMPLETED|Treatment Period 2||0
8872727|NCT01891864|9929592|FG001|COMPLETED|Treatment Period 2||0
8872728|NCT01891864|9929593|FG002|COMPLETED|Treatment Period 2||143
8872729|NCT01891864|9929594|FG003|COMPLETED|Treatment Period 2||142
8872730|NCT01891864|9929595|FG004|COMPLETED|Treatment Period 2||96
8953354|NCT02470910|10016544|FG000|STARTED|Overall Study||15
8953355|NCT02470910|10016544|FG000|COMPLETED|Overall Study||15
8953356|NCT02470910|10016544|FG000|NOT COMPLETED|Overall Study||0
8953357|NCT02470949|10016551|FG000|STARTED|First Intervention||4
8953358|NCT02470949|10016552|FG001|STARTED|First Intervention||5
8953359|NCT02470949|10016551|FG000|COMPLETED|First Intervention||4
8953360|NCT02470949|10016552|FG001|COMPLETED|First Intervention||5
8953361|NCT02470949|10016551|FG000|NOT COMPLETED|First Intervention||0
8953362|NCT02470949|10016552|FG001|NOT COMPLETED|First Intervention||0
8953363|NCT02470949|10016551|FG000|STARTED|Washout Period for a Minimum of 4 Weeks||4
8953364|NCT02470949|10016552|FG001|STARTED|Washout Period for a Minimum of 4 Weeks||5
8953365|NCT02470949|10016551|FG000|COMPLETED|Washout Period for a Minimum of 4 Weeks||4
8570004|NCT00100165|9602110|FG001|COMPLETED|Washout (1 Week)||10
8570005|NCT00100165|9602111|FG002|COMPLETED|Washout (1 Week)||9
8570006|NCT00100165|9602109|FG000|NOT COMPLETED|Washout (1 Week)||0
8953366|NCT02470949|10016552|FG001|COMPLETED|Washout Period for a Minimum of 4 Weeks||5
8872731|NCT01891864|9929596|FG005|COMPLETED|Treatment Period 2||91
8872732|NCT01891864|9929591|FG000|NOT COMPLETED|Treatment Period 2||0
8872733|NCT01891864|9929592|FG001|NOT COMPLETED|Treatment Period 2||0
8872734|NCT01891864|9929593|FG002|NOT COMPLETED|Treatment Period 2||7
8872735|NCT01891864|9929594|FG003|NOT COMPLETED|Treatment Period 2||9
8872736|NCT01891864|9929595|FG004|NOT COMPLETED|Treatment Period 2||4
8872737|NCT01891864|9929596|FG005|NOT COMPLETED|Treatment Period 2||5
8872738|NCT01891864|9929591|FG000|STARTED|Extension Period||0
8872739|NCT01891864|9929592|FG001|STARTED|Extension Period||0
8872740|NCT01891864|9929593|FG002|STARTED|Extension Period|2 patients withdrew consent 1 patient lost to FU between Treatment Period 2 and the Extension period|140
8872741|NCT01891864|9929594|FG003|STARTED|Extension Period||142
8872742|NCT01891864|9929595|FG004|STARTED|Extension Period|1 patient discontinued between Treatment Period 2 and Extension Period due to lack of efficacy|95
8872743|NCT01891864|9929596|FG005|STARTED|Extension Period|1 patient discontinued between Treatment Period 2 and Extension Period due to an adverse event|90
8872744|NCT01891864|9929591|FG000|COMPLETED|Extension Period||0
8872745|NCT01891864|9929592|FG001|COMPLETED|Extension Period||0
8872746|NCT01891864|9929593|FG002|COMPLETED|Extension Period||132
8872747|NCT01891864|9929594|FG003|COMPLETED|Extension Period||137
8872748|NCT01891864|9929595|FG004|COMPLETED|Extension Period||88
8872749|NCT01891864|9929596|FG005|COMPLETED|Extension Period||90
8872750|NCT01891864|9929591|FG000|NOT COMPLETED|Extension Period||0
8872751|NCT01891864|9929592|FG001|NOT COMPLETED|Extension Period||0
8872752|NCT01891864|9929593|FG002|NOT COMPLETED|Extension Period||8
8872753|NCT01891864|9929594|FG003|NOT COMPLETED|Extension Period||5
8872754|NCT01891864|9929595|FG004|NOT COMPLETED|Extension Period||7
8872755|NCT01891864|9929596|FG005|NOT COMPLETED|Extension Period||0
8872756|NCT01891890|9929611|FG000|STARTED|Overall Study||24
8872757|NCT01891890|9929612|FG001|STARTED|Overall Study||27
8872758|NCT01891890|9929613|FG002|STARTED|Overall Study||21
8872759|NCT01891890|9929611|FG000|COMPLETED|Overall Study||17
8872760|NCT01891890|9929612|FG001|COMPLETED|Overall Study||24
8872761|NCT01891890|9929613|FG002|COMPLETED|Overall Study||14
8872762|NCT01891890|9929611|FG000|NOT COMPLETED|Overall Study||7
8872763|NCT01891890|9929612|FG001|NOT COMPLETED|Overall Study||3
8872764|NCT01891890|9929613|FG002|NOT COMPLETED|Overall Study||7
8872765|NCT01891968|9929621|FG000|STARTED|Overall Study||15
8872766|NCT01891968|9929621|FG000|COMPLETED|Overall Study||15
8872767|NCT01891968|9929621|FG000|NOT COMPLETED|Overall Study||0
8872768|NCT01892007|9929627|FG000|STARTED|Overall Study||27
8872769|NCT01892007|9929628|FG001|STARTED|Overall Study||30
8872770|NCT01892007|9929627|FG000|COMPLETED|Overall Study||27
8872771|NCT01892007|9929628|FG001|COMPLETED|Overall Study||30
8872772|NCT01892007|9929627|FG000|NOT COMPLETED|Overall Study||0
8872773|NCT01892007|9929628|FG001|NOT COMPLETED|Overall Study||0
8872774|NCT01892020|9929634|FG000|STARTED|Period 1||81
8872775|NCT01892020|9929635|FG001|STARTED|Period 1||80
8872776|NCT01892020|9929634|FG000|COMPLETED|Period 1||78
8872777|NCT01892020|9929635|FG001|COMPLETED|Period 1||74
8872778|NCT01892020|9929634|FG000|NOT COMPLETED|Period 1||3
8872779|NCT01892020|9929635|FG001|NOT COMPLETED|Period 1||6
8872780|NCT01892020|9929634|FG000|STARTED|Period 2||78
8872781|NCT01892020|9929635|FG001|STARTED|Period 2||74
8872782|NCT01892020|9929634|FG000|COMPLETED|Period 2||77
8872783|NCT01892020|9929635|FG001|COMPLETED|Period 2||74
8872784|NCT01892020|9929634|FG000|NOT COMPLETED|Period 2||1
8872785|NCT01892020|9929635|FG001|NOT COMPLETED|Period 2||0
8872786|NCT01892163|9929643|FG000|STARTED|Overall Study||50
8872787|NCT01892163|9929644|FG001|STARTED|Overall Study||50
8872788|NCT01892163|9929643|FG000|COMPLETED|Overall Study||48
8872789|NCT01892163|9929644|FG001|COMPLETED|Overall Study||49
8872790|NCT01892163|9929643|FG000|NOT COMPLETED|Overall Study||2
8872791|NCT01892163|9929644|FG001|NOT COMPLETED|Overall Study||1
8872792|NCT01892189|9929659|FG000|STARTED|First Intervention Period (1 Day)||3
8872793|NCT01892189|9929660|FG001|STARTED|First Intervention Period (1 Day)||3
8872794|NCT01892189|9929661|FG002|STARTED|First Intervention Period (1 Day)||3
8872795|NCT01892189|9929662|FG003|STARTED|First Intervention Period (1 Day)||3
8872796|NCT01892189|9929663|FG004|STARTED|First Intervention Period (1 Day)||3
8872797|NCT01892189|9929664|FG005|STARTED|First Intervention Period (1 Day)||3
8872798|NCT01892189|9929665|FG006|STARTED|First Intervention Period (1 Day)||3
8872799|NCT01892189|9929666|FG007|STARTED|First Intervention Period (1 Day)||3
8872800|NCT01892189|9929667|FG008|STARTED|First Intervention Period (1 Day)||3
8872801|NCT01892189|9929659|FG000|COMPLETED|First Intervention Period (1 Day)||3
8872802|NCT01892189|9929660|FG001|COMPLETED|First Intervention Period (1 Day)||3
8872803|NCT01892189|9929661|FG002|COMPLETED|First Intervention Period (1 Day)||3
8872804|NCT01892189|9929662|FG003|COMPLETED|First Intervention Period (1 Day)||3
8872805|NCT01892189|9929663|FG004|COMPLETED|First Intervention Period (1 Day)||3
8872806|NCT01892189|9929664|FG005|COMPLETED|First Intervention Period (1 Day)||3
8872807|NCT01892189|9929665|FG006|COMPLETED|First Intervention Period (1 Day)||3
8872808|NCT01892189|9929666|FG007|COMPLETED|First Intervention Period (1 Day)||3
8872809|NCT01892189|9929667|FG008|COMPLETED|First Intervention Period (1 Day)||3
8872810|NCT01892189|9929659|FG000|NOT COMPLETED|First Intervention Period (1 Day)||0
8872811|NCT01892189|9929660|FG001|NOT COMPLETED|First Intervention Period (1 Day)||0
8872812|NCT01892189|9929661|FG002|NOT COMPLETED|First Intervention Period (1 Day)||0
8872813|NCT01892189|9929662|FG003|NOT COMPLETED|First Intervention Period (1 Day)||0
8872814|NCT01892189|9929663|FG004|NOT COMPLETED|First Intervention Period (1 Day)||0
8924029|NCT02246062|9984716|FG000|COMPLETED|Overall Study||21
8872815|NCT01892189|9929664|FG005|NOT COMPLETED|First Intervention Period (1 Day)||0
8872816|NCT01892189|9929665|FG006|NOT COMPLETED|First Intervention Period (1 Day)||0
8872817|NCT01892189|9929666|FG007|NOT COMPLETED|First Intervention Period (1 Day)||0
8872818|NCT01892189|9929667|FG008|NOT COMPLETED|First Intervention Period (1 Day)||0
8872819|NCT01892189|9929659|FG000|STARTED|Washout Period 1 (7 Days)||3
8872820|NCT01892189|9929660|FG001|STARTED|Washout Period 1 (7 Days)||3
8872821|NCT01892189|9929661|FG002|STARTED|Washout Period 1 (7 Days)||3
8872822|NCT01892189|9929662|FG003|STARTED|Washout Period 1 (7 Days)||3
8872823|NCT01892189|9929663|FG004|STARTED|Washout Period 1 (7 Days)||3
8872824|NCT01892189|9929664|FG005|STARTED|Washout Period 1 (7 Days)||3
8872825|NCT01892189|9929665|FG006|STARTED|Washout Period 1 (7 Days)||3
8872826|NCT01892189|9929666|FG007|STARTED|Washout Period 1 (7 Days)||3
8872827|NCT01892189|9929667|FG008|STARTED|Washout Period 1 (7 Days)||3
8872828|NCT01892189|9929659|FG000|COMPLETED|Washout Period 1 (7 Days)||3
8872829|NCT01892189|9929660|FG001|COMPLETED|Washout Period 1 (7 Days)||3
8872830|NCT01892189|9929661|FG002|COMPLETED|Washout Period 1 (7 Days)||1
8872831|NCT01892189|9929662|FG003|COMPLETED|Washout Period 1 (7 Days)||2
8872832|NCT01892189|9929663|FG004|COMPLETED|Washout Period 1 (7 Days)||3
8872833|NCT01892189|9929664|FG005|COMPLETED|Washout Period 1 (7 Days)||2
8872834|NCT01892189|9929665|FG006|COMPLETED|Washout Period 1 (7 Days)||2
8872835|NCT01892189|9929666|FG007|COMPLETED|Washout Period 1 (7 Days)||3
8872836|NCT01892189|9929667|FG008|COMPLETED|Washout Period 1 (7 Days)||1
8872837|NCT01892189|9929659|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
8872838|NCT01892189|9929660|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
8872839|NCT01892189|9929661|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||2
8872840|NCT01892189|9929662|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||1
8872841|NCT01892189|9929663|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||0
8872842|NCT01892189|9929664|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||1
8872843|NCT01892189|9929665|FG006|NOT COMPLETED|Washout Period 1 (7 Days)||1
8872844|NCT01892189|9929666|FG007|NOT COMPLETED|Washout Period 1 (7 Days)||0
8872845|NCT01892189|9929667|FG008|NOT COMPLETED|Washout Period 1 (7 Days)||2
8872846|NCT01892189|9929659|FG000|STARTED|Second Intervention Period (1 Day)||3
8872847|NCT01892189|9929660|FG001|STARTED|Second Intervention Period (1 Day)||3
8872848|NCT01892189|9929661|FG002|STARTED|Second Intervention Period (1 Day)||1
8872849|NCT01892189|9929662|FG003|STARTED|Second Intervention Period (1 Day)||2
8872850|NCT01892189|9929663|FG004|STARTED|Second Intervention Period (1 Day)||3
8872851|NCT01892189|9929664|FG005|STARTED|Second Intervention Period (1 Day)||2
8872852|NCT01892189|9929665|FG006|STARTED|Second Intervention Period (1 Day)||2
8872853|NCT01892189|9929666|FG007|STARTED|Second Intervention Period (1 Day)||3
8872854|NCT01892189|9929667|FG008|STARTED|Second Intervention Period (1 Day)||1
8872855|NCT01892189|9929659|FG000|COMPLETED|Second Intervention Period (1 Day)||3
8872856|NCT01892189|9929660|FG001|COMPLETED|Second Intervention Period (1 Day)||3
8872857|NCT01892189|9929661|FG002|COMPLETED|Second Intervention Period (1 Day)||1
8872858|NCT01892189|9929662|FG003|COMPLETED|Second Intervention Period (1 Day)||2
8872859|NCT01892189|9929663|FG004|COMPLETED|Second Intervention Period (1 Day)||3
8872860|NCT01892189|9929664|FG005|COMPLETED|Second Intervention Period (1 Day)||2
8872861|NCT01892189|9929665|FG006|COMPLETED|Second Intervention Period (1 Day)||2
8872862|NCT01892189|9929666|FG007|COMPLETED|Second Intervention Period (1 Day)||3
8872863|NCT01892189|9929667|FG008|COMPLETED|Second Intervention Period (1 Day)||1
8872864|NCT01892189|9929659|FG000|NOT COMPLETED|Second Intervention Period (1 Day)||0
8872865|NCT01892189|9929660|FG001|NOT COMPLETED|Second Intervention Period (1 Day)||0
8872866|NCT01892189|9929661|FG002|NOT COMPLETED|Second Intervention Period (1 Day)||0
8872867|NCT01892189|9929662|FG003|NOT COMPLETED|Second Intervention Period (1 Day)||0
8872868|NCT01892189|9929663|FG004|NOT COMPLETED|Second Intervention Period (1 Day)||0
8872869|NCT01892189|9929664|FG005|NOT COMPLETED|Second Intervention Period (1 Day)||0
8872870|NCT01892189|9929665|FG006|NOT COMPLETED|Second Intervention Period (1 Day)||0
8872871|NCT01892189|9929666|FG007|NOT COMPLETED|Second Intervention Period (1 Day)||0
8872872|NCT01892189|9929667|FG008|NOT COMPLETED|Second Intervention Period (1 Day)||0
8872873|NCT01892189|9929659|FG000|STARTED|Washout Period 2 (7 Days)||3
8872874|NCT01892189|9929660|FG001|STARTED|Washout Period 2 (7 Days)||3
8872875|NCT01892189|9929661|FG002|STARTED|Washout Period 2 (7 Days)||1
8872876|NCT01892189|9929662|FG003|STARTED|Washout Period 2 (7 Days)||2
8872877|NCT01892189|9929663|FG004|STARTED|Washout Period 2 (7 Days)||3
8872878|NCT01892189|9929664|FG005|STARTED|Washout Period 2 (7 Days)||2
8872879|NCT01892189|9929665|FG006|STARTED|Washout Period 2 (7 Days)||2
8872880|NCT01892189|9929666|FG007|STARTED|Washout Period 2 (7 Days)||3
8872881|NCT01892189|9929667|FG008|STARTED|Washout Period 2 (7 Days)||1
8872882|NCT01892189|9929659|FG000|COMPLETED|Washout Period 2 (7 Days)||3
8872883|NCT01892189|9929660|FG001|COMPLETED|Washout Period 2 (7 Days)||3
8872884|NCT01892189|9929661|FG002|COMPLETED|Washout Period 2 (7 Days)||1
8872885|NCT01892189|9929662|FG003|COMPLETED|Washout Period 2 (7 Days)||2
8872886|NCT01892189|9929663|FG004|COMPLETED|Washout Period 2 (7 Days)||3
8872887|NCT01892189|9929664|FG005|COMPLETED|Washout Period 2 (7 Days)||2
8872888|NCT01892189|9929665|FG006|COMPLETED|Washout Period 2 (7 Days)||2
8872889|NCT01892189|9929666|FG007|COMPLETED|Washout Period 2 (7 Days)||3
8872890|NCT01892189|9929667|FG008|COMPLETED|Washout Period 2 (7 Days)||1
8872891|NCT01892189|9929659|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
8872892|NCT01892189|9929660|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
8872893|NCT01892189|9929661|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
8872894|NCT01892189|9929662|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
8872895|NCT01892189|9929663|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0
8872896|NCT01892189|9929664|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0
8872897|NCT01892189|9929665|FG006|NOT COMPLETED|Washout Period 2 (7 Days)||0
8872898|NCT01892189|9929666|FG007|NOT COMPLETED|Washout Period 2 (7 Days)||0
8872899|NCT01892189|9929667|FG008|NOT COMPLETED|Washout Period 2 (7 Days)||0
8872900|NCT01892189|9929659|FG000|STARTED|Third Intervention Period (1 Day)||3
8872901|NCT01892189|9929660|FG001|STARTED|Third Intervention Period (1 Day)||3
8872902|NCT01892189|9929661|FG002|STARTED|Third Intervention Period (1 Day)||1
8872903|NCT01892189|9929662|FG003|STARTED|Third Intervention Period (1 Day)||2
8872904|NCT01892189|9929663|FG004|STARTED|Third Intervention Period (1 Day)||3
8872905|NCT01892189|9929664|FG005|STARTED|Third Intervention Period (1 Day)||2
8872906|NCT01892189|9929665|FG006|STARTED|Third Intervention Period (1 Day)||2
8872907|NCT01892189|9929666|FG007|STARTED|Third Intervention Period (1 Day)||3
8872908|NCT01892189|9929667|FG008|STARTED|Third Intervention Period (1 Day)||1
8872909|NCT01892189|9929659|FG000|COMPLETED|Third Intervention Period (1 Day)||3
8872910|NCT01892189|9929660|FG001|COMPLETED|Third Intervention Period (1 Day)||3
8872911|NCT01892189|9929661|FG002|COMPLETED|Third Intervention Period (1 Day)||1
8872912|NCT01892189|9929662|FG003|COMPLETED|Third Intervention Period (1 Day)||2
8872913|NCT01892189|9929663|FG004|COMPLETED|Third Intervention Period (1 Day)||3
8872914|NCT01892189|9929664|FG005|COMPLETED|Third Intervention Period (1 Day)||2
8872915|NCT01892189|9929665|FG006|COMPLETED|Third Intervention Period (1 Day)||2
8872916|NCT01892189|9929666|FG007|COMPLETED|Third Intervention Period (1 Day)||3
8872917|NCT01892189|9929667|FG008|COMPLETED|Third Intervention Period (1 Day)||1
8872918|NCT01892189|9929659|FG000|NOT COMPLETED|Third Intervention Period (1 Day)||0
8872919|NCT01892189|9929660|FG001|NOT COMPLETED|Third Intervention Period (1 Day)||0
8872920|NCT01892189|9929661|FG002|NOT COMPLETED|Third Intervention Period (1 Day)||0
8872921|NCT01892189|9929662|FG003|NOT COMPLETED|Third Intervention Period (1 Day)||0
8872922|NCT01892189|9929663|FG004|NOT COMPLETED|Third Intervention Period (1 Day)||0
8872923|NCT01892189|9929664|FG005|NOT COMPLETED|Third Intervention Period (1 Day)||0
8872924|NCT01892189|9929665|FG006|NOT COMPLETED|Third Intervention Period (1 Day)||0
8872925|NCT01892189|9929666|FG007|NOT COMPLETED|Third Intervention Period (1 Day)||0
8872926|NCT01892189|9929667|FG008|NOT COMPLETED|Third Intervention Period (1 Day)||0
8872927|NCT01892267|9929684|FG000|STARTED|Overall Study||9
8872928|NCT01892267|9929685|FG001|STARTED|Overall Study||10
8872929|NCT01892267|9929684|FG000|COMPLETED|Overall Study||9
8872930|NCT01892267|9929685|FG001|COMPLETED|Overall Study||10
8872931|NCT01892267|9929684|FG000|NOT COMPLETED|Overall Study||0
8872932|NCT01892267|9929685|FG001|NOT COMPLETED|Overall Study||0
8872933|NCT01892293|9929691|FG000|STARTED|Overall Study||6
8872934|NCT01892293|9929691|FG000|Received T-cell|Overall Study||2
8872935|NCT01892293|9929691|FG000|COMPLETED|Overall Study||2
8872936|NCT01892293|9929691|FG000|NOT COMPLETED|Overall Study||4
8872937|NCT01892306|9929697|FG000|STARTED|Overall Study||13
8872938|NCT01892306|9929698|FG001|STARTED|Overall Study||16
8872939|NCT01892306|9929697|FG000|COMPLETED|Overall Study||8
8872940|NCT01892306|9929698|FG001|COMPLETED|Overall Study||10
8872941|NCT01892306|9929697|FG000|NOT COMPLETED|Overall Study||5
8872942|NCT01892306|9929698|FG001|NOT COMPLETED|Overall Study||6
8872943|NCT01892345|9929706|FG000|STARTED|Overall Study||96
8872944|NCT01892345|9929707|FG001|STARTED|Overall Study||47
8872945|NCT01892345|9929706|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||96
8872946|NCT01892345|9929707|FG001|Received At Least 1 Dose Of Study Drug|Overall Study||47
8872947|NCT01892345|9929706|FG000|COMPLETED|Overall Study||80
8872948|NCT01892345|9929707|FG001|COMPLETED|Overall Study||44
8872949|NCT01892345|9929706|FG000|NOT COMPLETED|Overall Study||16
8872950|NCT01892345|9929707|FG001|NOT COMPLETED|Overall Study||3
8872951|NCT01892436|9929717|FG000|STARTED|Overall Study||147
8872952|NCT01892436|9929718|FG001|STARTED|Overall Study||161
8872953|NCT01892436|9929719|FG002|STARTED|Overall Study||74
8872954|NCT01892436|9929720|FG003|STARTED|Overall Study||75
8872955|NCT01892436|9929717|FG000|COMPLETED|Overall Study||124
8872956|NCT01892436|9929718|FG001|COMPLETED|Overall Study||132
8872957|NCT01892436|9929719|FG002|COMPLETED|Overall Study||63
8872958|NCT01892436|9929720|FG003|COMPLETED|Overall Study||61
8872959|NCT01892436|9929717|FG000|NOT COMPLETED|Overall Study||23
8872960|NCT01892436|9929718|FG001|NOT COMPLETED|Overall Study||29
8872961|NCT01892436|9929719|FG002|NOT COMPLETED|Overall Study||11
8872962|NCT01892436|9929720|FG003|NOT COMPLETED|Overall Study||14
8872963|NCT01892501|9929730|FG000|STARTED|Overall Study||75
8872964|NCT01892501|9929730|FG000|Group A : Biopsy Surgically Possible|Overall Study||72
8872965|NCT01892501|9929730|FG000|Group B : Biopsy Not Surgically Possible|Overall Study||3
8953367|NCT02470949|10016551|FG000|NOT COMPLETED|Washout Period for a Minimum of 4 Weeks||0
8872966|NCT01892501|9929730|FG000|COMPLETED|Overall Study||47
8872967|NCT01892501|9929730|FG000|NOT COMPLETED|Overall Study||28
8872968|NCT01892540|9929737|FG000|STARTED|Overall Study||15
8872969|NCT01892540|9929738|FG001|STARTED|Overall Study||0
8872970|NCT01892540|9929739|FG002|STARTED|Overall Study||28
8872971|NCT01892540|9929737|FG000|COMPLETED|Overall Study||15
8872972|NCT01892540|9929738|FG001|COMPLETED|Overall Study||0
8872973|NCT01892540|9929739|FG002|COMPLETED|Overall Study||25
8872974|NCT01892540|9929737|FG000|NOT COMPLETED|Overall Study||0
8872975|NCT01892540|9929738|FG001|NOT COMPLETED|Overall Study||0
8872976|NCT01892540|9929739|FG002|NOT COMPLETED|Overall Study||3
8872977|NCT01892657|9929747|FG000|STARTED|Overall Study||128
8872978|NCT01892657|9929747|FG000|COMPLETED|Overall Study||110
8872979|NCT01892657|9929747|FG000|NOT COMPLETED|Overall Study||18
8872980|NCT01892709|9929763|FG000|STARTED|Overall Study||215
8872981|NCT01892709|9929763|FG000|COMPLETED|Overall Study||215
8872982|NCT01892709|9929763|FG000|NOT COMPLETED|Overall Study||0
8872983|NCT01892865|9929773|FG000|STARTED|Overall Study|107 operative days scheduled with the Historical Means method were included|356
8872984|NCT01892865|9929774|FG001|STARTED|Overall Study|100 operative days scheduled with the Predictive Modeling System method were included|379
8872985|NCT01892865|9929773|FG000|COMPLETED|Overall Study||356
8872986|NCT01892865|9929774|FG001|COMPLETED|Overall Study||379
8872987|NCT01892865|9929773|FG000|NOT COMPLETED|Overall Study||0
8872988|NCT01892865|9929774|FG001|NOT COMPLETED|Overall Study||0
8872989|NCT01893203|9929780|FG000|STARTED|Overall Study||14
8872990|NCT01893203|9929780|FG000|COMPLETED|Overall Study||13
8872991|NCT01893203|9929780|FG000|NOT COMPLETED|Overall Study||1
8872992|NCT01893281|9929784|FG000|STARTED|Overall Study||78
8872993|NCT01893281|9929784|FG000|Received at Least 1 Dose of Study Drug|Overall Study||78
8872994|NCT01893281|9929784|FG000|COMPLETED|Overall Study||75
8872995|NCT01893281|9929784|FG000|NOT COMPLETED|Overall Study||3
8872996|NCT01893346|9929792|FG000|STARTED|Overall Study||11
8872997|NCT01893346|9929793|FG001|STARTED|Overall Study||8
8872998|NCT01893346|9929794|FG002|STARTED|Overall Study||8
8872999|NCT01893346|9929795|FG003|STARTED|Overall Study||8
8873000|NCT01893346|9929792|FG000|Patients Who Received Full Infusion|Overall Study||8
8873001|NCT01893346|9929793|FG001|Patients Who Received Full Infusion|Overall Study||8
8873002|NCT01893346|9929794|FG002|Patients Who Received Full Infusion|Overall Study||8
8873003|NCT01893346|9929795|FG003|Patients Who Received Full Infusion|Overall Study||8
8873004|NCT01893346|9929792|FG000|COMPLETED|Overall Study||8
8873005|NCT01893346|9929793|FG001|COMPLETED|Overall Study||7
8873006|NCT01893346|9929794|FG002|COMPLETED|Overall Study||8
8873007|NCT01893346|9929795|FG003|COMPLETED|Overall Study||8
8873008|NCT01893346|9929792|FG000|NOT COMPLETED|Overall Study||3
8873009|NCT01893346|9929793|FG001|NOT COMPLETED|Overall Study||1
8873010|NCT01893346|9929794|FG002|NOT COMPLETED|Overall Study||0
8873011|NCT01893346|9929795|FG003|NOT COMPLETED|Overall Study||0
8873012|NCT01893372|9929807|FG000|STARTED|Overall Study||7
8873013|NCT01893372|9929808|FG001|STARTED|Overall Study||22
8873014|NCT01893372|9929807|FG000|COMPLETED|Overall Study||7
8873015|NCT01893372|9929808|FG001|COMPLETED|Overall Study||22
8873016|NCT01893372|9929807|FG000|NOT COMPLETED|Overall Study||0
8873017|NCT01893372|9929808|FG001|NOT COMPLETED|Overall Study||0
8873018|NCT01893411|9929817|FG000|STARTED|Overall Study||156
8873019|NCT01893411|9929818|FG001|STARTED|Overall Study||77
8873020|NCT01893411|9929819|FG002|STARTED|Overall Study||78
8873021|NCT01893411|9929817|FG000|COMPLETED|Overall Study||139
8873022|NCT01893411|9929818|FG001|COMPLETED|Overall Study||70
8873023|NCT01893411|9929819|FG002|COMPLETED|Overall Study||69
8873024|NCT01893411|9929817|FG000|NOT COMPLETED|Overall Study||17
8873025|NCT01893411|9929818|FG001|NOT COMPLETED|Overall Study||7
8873026|NCT01893411|9929819|FG002|NOT COMPLETED|Overall Study||9
8873027|NCT01893567|9929827|FG000|STARTED|Overall Study||28
8873028|NCT01893567|9929827|FG000|COMPLETED|Overall Study||28
8873029|NCT01893567|9929827|FG000|NOT COMPLETED|Overall Study||0
8873030|NCT01893632|9929833|FG000|STARTED|Overall Study||1
8873031|NCT01893632|9929834|FG001|STARTED|Overall Study||1
8873032|NCT01893632|9929833|FG000|COMPLETED|Overall Study||1
8873033|NCT01893632|9929834|FG001|COMPLETED|Overall Study||1
8873034|NCT01893632|9929833|FG000|NOT COMPLETED|Overall Study||0
8873035|NCT01893632|9929834|FG001|NOT COMPLETED|Overall Study||0
8873036|NCT01893801|9929840|FG000|STARTED|Overall Study||25
8873037|NCT01893801|9929840|FG000|COMPLETED|Overall Study||25
8873038|NCT01893801|9929840|FG000|NOT COMPLETED|Overall Study||0
8873039|NCT01893827|9929848|FG000|STARTED|Overall Study||117
8873040|NCT01893827|9929849|FG001|STARTED|Overall Study||120
8873041|NCT01893827|9929848|FG000|COMPLETED|Overall Study||98
8873042|NCT01893827|9929849|FG001|COMPLETED|Overall Study||94
8873043|NCT01893827|9929848|FG000|NOT COMPLETED|Overall Study||19
8873044|NCT01893827|9929849|FG001|NOT COMPLETED|Overall Study||26
8873045|NCT01893879|9929857|FG000|STARTED|Overall Study||7
8873046|NCT01893879|9929858|FG001|STARTED|Overall Study||7
8873047|NCT01893879|9929857|FG000|COMPLETED|Overall Study||5
8873048|NCT01893879|9929858|FG001|COMPLETED|Overall Study||4
8873049|NCT01893879|9929857|FG000|NOT COMPLETED|Overall Study||2
8873050|NCT01893879|9929858|FG001|NOT COMPLETED|Overall Study||3
8873051|NCT01893905|9929866|FG000|STARTED|Overall Study||80
8873052|NCT01893905|9929867|FG001|STARTED|Overall Study||78
8953368|NCT02470949|10016552|FG001|NOT COMPLETED|Washout Period for a Minimum of 4 Weeks||0
8953369|NCT02470949|10016551|FG000|STARTED|Second Intervention||4
8873053|NCT01893905|9929866|FG000|COMPLETED|Overall Study||55
8873054|NCT01893905|9929867|FG001|COMPLETED|Overall Study||64
8873055|NCT01893905|9929866|FG000|NOT COMPLETED|Overall Study||25
8953370|NCT02470949|10016552|FG001|STARTED|Second Intervention||2
8873056|NCT01893905|9929867|FG001|NOT COMPLETED|Overall Study||14
8873057|NCT01893983|9929875|FG000|STARTED|Overall Study||140
8873058|NCT01893983|9929876|FG001|STARTED|Overall Study||140
8873059|NCT01893983|9929875|FG000|COMPLETED|Overall Study||130
8873060|NCT01893983|9929876|FG001|COMPLETED|Overall Study||134
8873061|NCT01893983|9929875|FG000|NOT COMPLETED|Overall Study||10
8873062|NCT01893983|9929876|FG001|NOT COMPLETED|Overall Study||6
8873063|NCT01894022|9929884|FG000|STARTED|Overall Study||9
8873064|NCT01894022|9929885|FG001|STARTED|Overall Study||10
8873065|NCT01894022|9929884|FG000|COMPLETED|Overall Study||0
8873066|NCT01894022|9929885|FG001|COMPLETED|Overall Study||0
8873067|NCT01894022|9929884|FG000|NOT COMPLETED|Overall Study||9
8873068|NCT01894022|9929885|FG001|NOT COMPLETED|Overall Study||10
8873069|NCT01894087|9929894|FG000|STARTED|Overall Study||102
8873070|NCT01894087|9929895|FG001|STARTED|Overall Study||102
8873071|NCT01894087|9929894|FG000|COMPLETED|Overall Study||96
8873072|NCT01894087|9929895|FG001|COMPLETED|Overall Study||102
8873073|NCT01894087|9929894|FG000|NOT COMPLETED|Overall Study||6
8873074|NCT01894087|9929895|FG001|NOT COMPLETED|Overall Study||0
8873075|NCT01894100|9929903|FG000|STARTED|Overall Study||15
8873076|NCT01894100|9929904|FG001|STARTED|Overall Study||15
8873077|NCT01894100|9929903|FG000|COMPLETED|Overall Study||12
8873078|NCT01894100|9929904|FG001|COMPLETED|Overall Study||14
8873079|NCT01894100|9929903|FG000|NOT COMPLETED|Overall Study||3
8873080|NCT01894100|9929904|FG001|NOT COMPLETED|Overall Study||1
8873081|NCT01894152|9929910|FG000|STARTED|Overall Study||2002
8873082|NCT01894152|9929910|FG000|COMPLETED|Overall Study||1851
8873083|NCT01894152|9929910|FG000|NOT COMPLETED|Overall Study||151
8873084|NCT01894178|9929916|FG000|STARTED|Overall Study||30
8873085|NCT01894178|9929917|FG001|STARTED|Overall Study||30
8873086|NCT01894178|9929916|FG000|COMPLETED|Overall Study||30
8873087|NCT01894178|9929917|FG001|COMPLETED|Overall Study||30
8873088|NCT01894178|9929916|FG000|NOT COMPLETED|Overall Study||0
8873089|NCT01894178|9929917|FG001|NOT COMPLETED|Overall Study||0
8873090|NCT01894230|9929925|FG000|STARTED|Overall Study||83
8873091|NCT01894230|9929926|FG001|STARTED|Overall Study||76
8873092|NCT01894230|9929925|FG000|COMPLETED|Overall Study||76
8873093|NCT01894230|9929926|FG001|COMPLETED|Overall Study||69
8873094|NCT01894230|9929925|FG000|NOT COMPLETED|Overall Study||7
8873095|NCT01894230|9929926|FG001|NOT COMPLETED|Overall Study||7
8873096|NCT01894243|9929935|FG000|STARTED|Overall Study||13
8873097|NCT01894243|9929936|FG001|STARTED|Overall Study||10
8873098|NCT01894243|9929937|FG002|STARTED|Overall Study||8
8873099|NCT01894243|9929935|FG000|Completed Treatment in Part A|Overall Study||13
8873100|NCT01894243|9929936|FG001|Completed Treatment in Part A|Overall Study||10
8873101|NCT01894243|9929937|FG002|Completed Treatment in Part A|Overall Study||8
8873102|NCT01894243|9929935|FG000|Ongoing Into Part B|Overall Study||13
8873103|NCT01894243|9929936|FG001|Ongoing Into Part B|Overall Study||10
8873104|NCT01894243|9929937|FG002|Ongoing Into Part B|Overall Study||8
8873105|NCT01894243|9929935|FG000|COMPLETED|Overall Study||0
8873106|NCT01894243|9929936|FG001|COMPLETED|Overall Study||0
8873107|NCT01894243|9929937|FG002|COMPLETED|Overall Study||0
8873108|NCT01894243|9929935|FG000|NOT COMPLETED|Overall Study||13
8873109|NCT01894243|9929936|FG001|NOT COMPLETED|Overall Study||10
8873110|NCT01894243|9929937|FG002|NOT COMPLETED|Overall Study||8
8924030|NCT02246062|9984717|FG001|COMPLETED|Overall Study||21
8924031|NCT02246062|9984718|FG002|COMPLETED|Overall Study||21
8924032|NCT02246062|9984719|FG003|COMPLETED|Overall Study||21
8924033|NCT02246062|9984716|FG000|NOT COMPLETED|Overall Study||0
8924034|NCT02246062|9984717|FG001|NOT COMPLETED|Overall Study||0
8924035|NCT02246062|9984718|FG002|NOT COMPLETED|Overall Study||0
8924036|NCT02246062|9984719|FG003|NOT COMPLETED|Overall Study||0
8924037|NCT02246166|9984731|FG000|STARTED|Overall Study||26
8924038|NCT02246166|9984732|FG001|STARTED|Overall Study||27
8924039|NCT02246166|9984731|FG000|COMPLETED|Overall Study||25
8924040|NCT02246166|9984732|FG001|COMPLETED|Overall Study||27
8924041|NCT02246166|9984731|FG000|NOT COMPLETED|Overall Study||1
8924042|NCT02246166|9984732|FG001|NOT COMPLETED|Overall Study||0
8924043|NCT02246218|9984740|FG000|STARTED|Overall Study||10
8924044|NCT02246218|9984741|FG001|STARTED|Overall Study||16
8924045|NCT02246218|9984740|FG000|COMPLETED|Overall Study||6
8924046|NCT02246218|9984741|FG001|COMPLETED|Overall Study||10
8924047|NCT02246218|9984740|FG000|NOT COMPLETED|Overall Study||4
8924048|NCT02246218|9984741|FG001|NOT COMPLETED|Overall Study||6
8924049|NCT02246309|9984749|FG000|STARTED|Overall Study|16 patients going through Time Lapse System and 15 through Standard Embryo Culture.|16
8924050|NCT02246309|9984750|FG001|STARTED|Overall Study||15
8924051|NCT02246309|9984749|FG000|COMPLETED|Overall Study||16
8924052|NCT02246309|9984750|FG001|COMPLETED|Overall Study||15
8924053|NCT02246309|9984749|FG000|NOT COMPLETED|Overall Study||0
8924054|NCT02246309|9984750|FG001|NOT COMPLETED|Overall Study||0
8924055|NCT02246413|9984758|FG000|STARTED|12-months (Primary Outcome)||204
8924056|NCT02246413|9984759|FG001|STARTED|12-months (Primary Outcome)||205
8924057|NCT02246413|9984758|FG000|COMPLETED|12-months (Primary Outcome)||169
8924058|NCT02246413|9984759|FG001|COMPLETED|12-months (Primary Outcome)||175
8924059|NCT02246413|9984758|FG000|NOT COMPLETED|12-months (Primary Outcome)||35
8924060|NCT02246413|9984759|FG001|NOT COMPLETED|12-months (Primary Outcome)||30
8924061|NCT02246413|9984758|FG000|STARTED|24-months (Secondary Outcome)||204
8924062|NCT02246413|9984759|FG001|STARTED|24-months (Secondary Outcome)||205
8873111|NCT01894256|9929955|FG000|STARTED|Part A||15
8873112|NCT01894256|9929956|FG001|STARTED|Part A||15
8873113|NCT01894256|9929957|FG002|STARTED|Part A||14
8873114|NCT01894256|9929955|FG000|COMPLETED|Part A||15
8873115|NCT01894256|9929956|FG001|COMPLETED|Part A||14
8873116|NCT01894256|9929957|FG002|COMPLETED|Part A||14
8873117|NCT01894256|9929955|FG000|NOT COMPLETED|Part A||0
8873118|NCT01894256|9929956|FG001|NOT COMPLETED|Part A||1
8873119|NCT01894256|9929957|FG002|NOT COMPLETED|Part A||0
8873120|NCT01894256|9929955|FG000|STARTED|Part B||15
8873121|NCT01894256|9929956|FG001|STARTED|Part B||14
8873122|NCT01894256|9929957|FG002|STARTED|Part B||14
8873123|NCT01894256|9929955|FG000|COMPLETED|Part B||0
8873124|NCT01894256|9929956|FG001|COMPLETED|Part B||0
8873125|NCT01894256|9929957|FG002|COMPLETED|Part B||0
8873126|NCT01894256|9929955|FG000|NOT COMPLETED|Part B||15
8873127|NCT01894256|9929956|FG001|NOT COMPLETED|Part B||14
8873128|NCT01894256|9929957|FG002|NOT COMPLETED|Part B||14
8873129|NCT01894477|9929970|FG000|STARTED|Overall Study||35
8873130|NCT01894477|9929971|FG001|STARTED|Overall Study||67
8873131|NCT01894477|9929970|FG000|COMPLETED|Overall Study||35
8873132|NCT01894477|9929971|FG001|COMPLETED|Overall Study||65
8873133|NCT01894477|9929970|FG000|NOT COMPLETED|Overall Study||0
8873134|NCT01894477|9929971|FG001|NOT COMPLETED|Overall Study||2
8873135|NCT01894503|9929977|FG000|STARTED|Overall Study||5
8873136|NCT01894503|9929977|FG000|COMPLETED|Overall Study||5
8873137|NCT01894503|9929977|FG000|NOT COMPLETED|Overall Study||0
8873138|NCT01894516|9929986|FG000|STARTED|Period 1 (Baseline up to Week 12)||72
8873139|NCT01894516|9929987|FG001|STARTED|Period 1 (Baseline up to Week 12)||72
8873140|NCT01894516|9929988|FG002|STARTED|Period 1 (Baseline up to Week 12)||70
8873141|NCT01894516|9929989|FG003|STARTED|Period 1 (Baseline up to Week 12)||69
8873142|NCT01894516|9929986|FG000|COMPLETED|Period 1 (Baseline up to Week 12)||65
8873143|NCT01894516|9929987|FG001|COMPLETED|Period 1 (Baseline up to Week 12)||67
8873144|NCT01894516|9929988|FG002|COMPLETED|Period 1 (Baseline up to Week 12)||67
8873145|NCT01894516|9929989|FG003|COMPLETED|Period 1 (Baseline up to Week 12)||66
8873146|NCT01894516|9929986|FG000|NOT COMPLETED|Period 1 (Baseline up to Week 12)||7
8873147|NCT01894516|9929987|FG001|NOT COMPLETED|Period 1 (Baseline up to Week 12)||5
8873148|NCT01894516|9929988|FG002|NOT COMPLETED|Period 1 (Baseline up to Week 12)||3
8873149|NCT01894516|9929989|FG003|NOT COMPLETED|Period 1 (Baseline up to Week 12)||3
8873150|NCT01894516|9929986|FG000|STARTED|Period 2 (Week 13 to Week 24)|All participants from Placebo moved to 100 mg QD (65 participants) group.|0
8873151|NCT01894516|9929987|FG001|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from 50 mg QD group moved to 100 mg QD group (15 participants).|52
8873152|NCT01894516|9929988|FG002|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from Placebo(65 participants) and 50 mg QD (15 participants) moved to 100 mg QD group.|147
8873153|NCT01894516|9929989|FG003|STARTED|Period 2 (Week 13 to Week 24)||66
8873154|NCT01894516|9929986|FG000|COMPLETED|Period 2 (Week 13 to Week 24)||0
8873155|NCT01894516|9929987|FG001|COMPLETED|Period 2 (Week 13 to Week 24)||50
8873156|NCT01894516|9929988|FG002|COMPLETED|Period 2 (Week 13 to Week 24)||142
8873157|NCT01894516|9929989|FG003|COMPLETED|Period 2 (Week 13 to Week 24)||65
8873158|NCT01894516|9929986|FG000|NOT COMPLETED|Period 2 (Week 13 to Week 24)||0
8873159|NCT01894516|9929987|FG001|NOT COMPLETED|Period 2 (Week 13 to Week 24)||2
8873160|NCT01894516|9929988|FG002|NOT COMPLETED|Period 2 (Week 13 to Week 24)||5
8873161|NCT01894516|9929989|FG003|NOT COMPLETED|Period 2 (Week 13 to Week 24)||1
8873162|NCT01894555|9930003|FG000|STARTED|Overall Study||33
8873163|NCT01894555|9930003|FG000|COMPLETED|Overall Study||33
8873164|NCT01894555|9930003|FG000|NOT COMPLETED|Overall Study||0
8873165|NCT01894568|9930009|FG000|STARTED|Overall Study||192
8873166|NCT01894568|9930010|FG001|STARTED|Overall Study||196
8873167|NCT01894568|9930009|FG000|Received at Least 1 Dose of Study Drug|Overall Study||192
8873168|NCT01894568|9930010|FG001|Received at Least 1 Dose of Study Drug|Overall Study||196
8873169|NCT01894568|9930009|FG000|COMPLETED|Overall Study||182
8873170|NCT01894568|9930010|FG001|COMPLETED|Overall Study||186
8873171|NCT01894568|9930009|FG000|NOT COMPLETED|Overall Study||10
8873172|NCT01894568|9930010|FG001|NOT COMPLETED|Overall Study||10
8873173|NCT01894581|9930019|FG000|STARTED|Overall Study||20
8873174|NCT01894581|9930020|FG001|STARTED|Overall Study||19
8873175|NCT01894581|9930019|FG000|COMPLETED|Overall Study||15
8873176|NCT01894581|9930020|FG001|COMPLETED|Overall Study||12
8873177|NCT01894581|9930019|FG000|NOT COMPLETED|Overall Study||5
8873178|NCT01894581|9930020|FG001|NOT COMPLETED|Overall Study||7
8873179|NCT01894607|9930026|FG000|STARTED|Overall Study||11
8873180|NCT01894607|9930026|FG000|COMPLETED|Overall Study||10
8873181|NCT01894607|9930026|FG000|NOT COMPLETED|Overall Study||1
8873182|NCT01894620|9930032|FG000|STARTED|Overall Study||6
8873183|NCT01894620|9930033|FG001|STARTED|Overall Study||5
8873184|NCT01894620|9930032|FG000|COMPLETED|Overall Study||6
8873185|NCT01894620|9930033|FG001|COMPLETED|Overall Study||4
8873186|NCT01894620|9930032|FG000|NOT COMPLETED|Overall Study||0
8873187|NCT01894620|9930033|FG001|NOT COMPLETED|Overall Study||1
8873188|NCT01894672|9930041|FG000|STARTED|Overall Study||7
8873189|NCT01894672|9930041|FG000|COMPLETED|Overall Study||7
8873190|NCT01894672|9930041|FG000|NOT COMPLETED|Overall Study||0
8873191|NCT01894776|9930046|FG000|STARTED|Overall Study||15
8873192|NCT01894776|9930046|FG000|COMPLETED|Overall Study||14
8873193|NCT01894776|9930046|FG000|NOT COMPLETED|Overall Study||1
8873194|NCT01894841|9930052|FG000|STARTED|Overall Study||52
8873195|NCT01894841|9930053|FG001|STARTED|Overall Study||53
8873196|NCT01894841|9930052|FG000|COMPLETED|Overall Study||34
8873197|NCT01894841|9930053|FG001|COMPLETED|Overall Study||44
8873198|NCT01894841|9930052|FG000|NOT COMPLETED|Overall Study||18
8873199|NCT01894841|9930053|FG001|NOT COMPLETED|Overall Study||9
8873200|NCT01894906|9930065|FG000|STARTED|Overall Study||6
8873201|NCT01894906|9930066|FG001|STARTED|Overall Study||6
8873202|NCT01894906|9930065|FG000|Treatment A|Overall Study||6
8873203|NCT01894906|9930066|FG001|Treatment A|Overall Study||6
8873204|NCT01894906|9930065|FG000|Treatment B|Overall Study||6
8873205|NCT01894906|9930066|FG001|Treatment B|Overall Study||6
8873206|NCT01894906|9930065|FG000|Treatment C|Overall Study||6
8873207|NCT01894906|9930066|FG001|Treatment C|Overall Study||6
8873208|NCT01894906|9930065|FG000|Treatment D|Overall Study||6
8873209|NCT01894906|9930066|FG001|Treatment D|Overall Study||6
8873210|NCT01894906|9930065|FG000|Treatment E|Overall Study||6
8873211|NCT01894906|9930066|FG001|Treatment E|Overall Study||6
8873212|NCT01894906|9930065|FG000|Treatment F|Overall Study||6
8873213|NCT01894906|9930066|FG001|Treatment F|Overall Study||6
8873214|NCT01894906|9930065|FG000|COMPLETED|Overall Study||6
8873215|NCT01894906|9930066|FG001|COMPLETED|Overall Study||6
8873216|NCT01894906|9930065|FG000|NOT COMPLETED|Overall Study||0
8873217|NCT01894906|9930066|FG001|NOT COMPLETED|Overall Study||0
8873218|NCT01894919|9930097|FG000|STARTED|Overall Study||98
8873219|NCT01894919|9930098|FG001|STARTED|Overall Study||47
8873220|NCT01894919|9930099|FG002|STARTED|Overall Study||89
8873221|NCT01894919|9930100|FG003|STARTED|Overall Study||43
8873222|NCT01894919|9930101|FG004|STARTED|Overall Study||81
8953371|NCT02470949|10016551|FG000|COMPLETED|Second Intervention||4
8953372|NCT02470949|10016552|FG001|COMPLETED|Second Intervention||2
8953373|NCT02470949|10016551|FG000|NOT COMPLETED|Second Intervention||0
8953374|NCT02470949|10016552|FG001|NOT COMPLETED|Second Intervention||0
8953375|NCT02471014|10016562|FG000|STARTED|Overall Study||25
8953376|NCT02471014|10016563|FG001|STARTED|Overall Study||25
8953377|NCT02471014|10016562|FG000|COMPLETED|Overall Study||23
8953378|NCT02471014|10016563|FG001|COMPLETED|Overall Study||23
8953379|NCT02471014|10016562|FG000|NOT COMPLETED|Overall Study||2
8953380|NCT02471014|10016563|FG001|NOT COMPLETED|Overall Study||2
8953381|NCT02471183|10016569|FG000|STARTED|Main Treatment Period||34
8953382|NCT02471183|10016569|FG000|COMPLETED|Main Treatment Period||32
8953383|NCT02471183|10016569|FG000|NOT COMPLETED|Main Treatment Period||2
8953384|NCT02471183|10016569|FG000|STARTED|Extended Treatment Period||32
8953385|NCT02471183|10016569|FG000|COMPLETED|Extended Treatment Period||31
8953386|NCT02471183|10016569|FG000|NOT COMPLETED|Extended Treatment Period||1
8953387|NCT02471313|10016573|FG000|STARTED|Overall Study||3
8953388|NCT02471313|10016573|FG000|COMPLETED|Overall Study||3
8953389|NCT02471313|10016573|FG000|NOT COMPLETED|Overall Study||0
8953390|NCT02471326|10016577|FG000|STARTED|Overall Study||10
8953391|NCT02471326|10016577|FG000|COMPLETED|Overall Study||9
8953392|NCT02471326|10016577|FG000|NOT COMPLETED|Overall Study||1
8953393|NCT02471404|10016584|FG000|STARTED|Overall Study||314
8953394|NCT02471404|10016585|FG001|STARTED|Overall Study||312
8953395|NCT02471404|10016586|FG002|STARTED|Overall Study||313
8953396|NCT02471404|10016584|FG000|COMPLETED|Overall Study||281
8953397|NCT02471404|10016585|FG001|COMPLETED|Overall Study||298
8953398|NCT02471404|10016586|FG002|COMPLETED|Overall Study||288
8691270|NCT00853840|9736489|FG000|COMPLETED|Period 2||9
8953399|NCT02471404|10016584|FG000|NOT COMPLETED|Overall Study||33
8953400|NCT02471404|10016585|FG001|NOT COMPLETED|Overall Study||14
8953401|NCT02471404|10016586|FG002|NOT COMPLETED|Overall Study||25
8953402|NCT02471521|10016596|FG000|STARTED|Overall Study||60
8953403|NCT02471521|10016597|FG001|STARTED|Overall Study||60
8953404|NCT02471521|10016596|FG000|COMPLETED|Overall Study||60
8953405|NCT02471521|10016597|FG001|COMPLETED|Overall Study||52
8953406|NCT02471521|10016596|FG000|NOT COMPLETED|Overall Study||0
8953407|NCT02471521|10016597|FG001|NOT COMPLETED|Overall Study||8
8953408|NCT02471586|10016606|FG000|STARTED|Overall Study||158
8873223|NCT01894919|9930102|FG005|STARTED|Overall Study||39
8873224|NCT01894919|9930103|FG006|STARTED|Overall Study||32
8873225|NCT01894919|9930104|FG007|STARTED|Overall Study||36
8873226|NCT01894919|9930105|FG008|STARTED|Overall Study||91
8873227|NCT01894919|9930106|FG009|STARTED|Overall Study||90
8873228|NCT01894919|9930107|FG010|STARTED|Overall Study||100
8953409|NCT02471586|10016607|FG001|STARTED|Overall Study||146
8953410|NCT02471586|10016608|FG002|STARTED|Overall Study||146
8953411|NCT02471586|10016606|FG000|COMPLETED|Overall Study||153
8953412|NCT02471586|10016607|FG001|COMPLETED|Overall Study||136
8953413|NCT02471586|10016608|FG002|COMPLETED|Overall Study||142
8953414|NCT02471586|10016606|FG000|NOT COMPLETED|Overall Study||5
8953415|NCT02471586|10016607|FG001|NOT COMPLETED|Overall Study||10
8953416|NCT02471586|10016608|FG002|NOT COMPLETED|Overall Study||4
8953417|NCT02471612|10016618|FG000|STARTED|Overall Study||159
8873229|NCT01894919|9930108|FG011|STARTED|Overall Study||55
8873230|NCT01894919|9930109|FG012|STARTED|Overall Study||50
8873231|NCT01894919|9930097|FG000|COMPLETED|Overall Study||96
8873232|NCT01894919|9930098|FG001|COMPLETED|Overall Study||47
8873233|NCT01894919|9930099|FG002|COMPLETED|Overall Study||89
8873234|NCT01894919|9930100|FG003|COMPLETED|Overall Study||43
8873235|NCT01894919|9930101|FG004|COMPLETED|Overall Study||78
8873236|NCT01894919|9930102|FG005|COMPLETED|Overall Study||39
8873237|NCT01894919|9930103|FG006|COMPLETED|Overall Study||32
8873238|NCT01894919|9930104|FG007|COMPLETED|Overall Study||36
8873239|NCT01894919|9930105|FG008|COMPLETED|Overall Study||91
8873240|NCT01894919|9930106|FG009|COMPLETED|Overall Study||89
8873241|NCT01894919|9930107|FG010|COMPLETED|Overall Study||98
8873242|NCT01894919|9930108|FG011|COMPLETED|Overall Study||55
8873243|NCT01894919|9930109|FG012|COMPLETED|Overall Study||50
8873244|NCT01894919|9930097|FG000|NOT COMPLETED|Overall Study||2
8873245|NCT01894919|9930098|FG001|NOT COMPLETED|Overall Study||0
8873246|NCT01894919|9930099|FG002|NOT COMPLETED|Overall Study||0
8873247|NCT01894919|9930100|FG003|NOT COMPLETED|Overall Study||0
8873248|NCT01894919|9930101|FG004|NOT COMPLETED|Overall Study||3
8873249|NCT01894919|9930102|FG005|NOT COMPLETED|Overall Study||0
8873250|NCT01894919|9930103|FG006|NOT COMPLETED|Overall Study||0
8873251|NCT01894919|9930104|FG007|NOT COMPLETED|Overall Study||0
8873252|NCT01894919|9930105|FG008|NOT COMPLETED|Overall Study||0
8873253|NCT01894919|9930106|FG009|NOT COMPLETED|Overall Study||1
8873254|NCT01894919|9930107|FG010|NOT COMPLETED|Overall Study||2
8873255|NCT01894919|9930108|FG011|NOT COMPLETED|Overall Study||0
8873256|NCT01894919|9930109|FG012|NOT COMPLETED|Overall Study||0
8873257|NCT01894984|9930153|FG000|STARTED|Overall Study||396
8873258|NCT01894984|9930154|FG001|STARTED|Overall Study||244
8873259|NCT01894984|9930153|FG000|COMPLETED|Overall Study||82
8873260|NCT01894984|9930154|FG001|COMPLETED|Overall Study||69
8873261|NCT01894984|9930153|FG000|NOT COMPLETED|Overall Study||314
8873262|NCT01894984|9930154|FG001|NOT COMPLETED|Overall Study||175
8873263|NCT01895036|9930160|FG000|STARTED|Overall Study||6
8873264|NCT01895036|9930160|FG000|COMPLETED|Overall Study||6
8873265|NCT01895036|9930160|FG000|NOT COMPLETED|Overall Study||0
8873266|NCT01895062|9930166|FG000|STARTED|Overall Study||30
8873267|NCT01895062|9930167|FG001|STARTED|Overall Study||24
8873268|NCT01895062|9930166|FG000|COMPLETED|Overall Study||30
8873269|NCT01895062|9930167|FG001|COMPLETED|Overall Study||24
8873270|NCT01895062|9930166|FG000|NOT COMPLETED|Overall Study||0
8873271|NCT01895062|9930167|FG001|NOT COMPLETED|Overall Study||0
8873272|NCT01895088|9930173|FG000|STARTED|Overall Study|1 subject consented for monitoring after device removal (not included in cohort), per FDA request.|271
8873273|NCT01895088|9930173|FG000|COMPLETED|Overall Study||253
8873274|NCT01895088|9930173|FG000|NOT COMPLETED|Overall Study||18
8873275|NCT01895101|9930180|FG000|STARTED|Overall Study||250
8873276|NCT01895101|9930181|FG001|STARTED|Overall Study||250
8873277|NCT01895101|9930182|FG002|STARTED|Overall Study||250
8873278|NCT01895101|9930180|FG000|COMPLETED|Overall Study||249
8873279|NCT01895101|9930181|FG001|COMPLETED|Overall Study||245
8873280|NCT01895101|9930182|FG002|COMPLETED|Overall Study||245
8873281|NCT01895101|9930180|FG000|NOT COMPLETED|Overall Study||1
8873282|NCT01895101|9930181|FG001|NOT COMPLETED|Overall Study||5
8873283|NCT01895101|9930182|FG002|NOT COMPLETED|Overall Study||5
8873284|NCT01895127|9930192|FG000|STARTED|Screening||4
8873285|NCT01895127|9930193|FG001|STARTED|Screening||7
8873286|NCT01895127|9930192|FG000|COMPLETED|Screening|One subject was found to be pregnant at screening so was withdrawn from the study prior to treatment|4
8873287|NCT01895127|9930193|FG001|COMPLETED|Screening||7
8873288|NCT01895127|9930192|FG000|NOT COMPLETED|Screening||0
8873289|NCT01895127|9930193|FG001|NOT COMPLETED|Screening||0
8873290|NCT01895127|9930192|FG000|STARTED|Treatment Period (Week 0-Month 3)||3
8873291|NCT01895127|9930193|FG001|STARTED|Treatment Period (Week 0-Month 3)||7
8873292|NCT01895127|9930192|FG000|COMPLETED|Treatment Period (Week 0-Month 3)||3
8873293|NCT01895127|9930193|FG001|COMPLETED|Treatment Period (Week 0-Month 3)||7
8873294|NCT01895127|9930192|FG000|NOT COMPLETED|Treatment Period (Week 0-Month 3)||0
8873295|NCT01895127|9930193|FG001|NOT COMPLETED|Treatment Period (Week 0-Month 3)||0
8873296|NCT01895127|9930192|FG000|STARTED|Month 3 Follow-up & Biopsy||3
8873297|NCT01895127|9930193|FG001|STARTED|Month 3 Follow-up & Biopsy||7
8873298|NCT01895127|9930192|FG000|COMPLETED|Month 3 Follow-up & Biopsy||3
8873299|NCT01895127|9930193|FG001|COMPLETED|Month 3 Follow-up & Biopsy||7
8873300|NCT01895127|9930192|FG000|NOT COMPLETED|Month 3 Follow-up & Biopsy||0
8873301|NCT01895127|9930193|FG001|NOT COMPLETED|Month 3 Follow-up & Biopsy||0
8873302|NCT01895127|9930192|FG000|STARTED|Long Term Follow-up (Month 3-12)||3
8873303|NCT01895127|9930193|FG001|STARTED|Long Term Follow-up (Month 3-12)||7
8873304|NCT01895127|9930192|FG000|COMPLETED|Long Term Follow-up (Month 3-12)||1
8873305|NCT01895127|9930193|FG001|COMPLETED|Long Term Follow-up (Month 3-12)||4
8873306|NCT01895127|9930192|FG000|NOT COMPLETED|Long Term Follow-up (Month 3-12)||2
8873307|NCT01895127|9930193|FG001|NOT COMPLETED|Long Term Follow-up (Month 3-12)||3
8873308|NCT01895270|9930202|FG000|STARTED|Study Medications Induction (W1-4)||11
8873309|NCT01895270|9930203|FG001|STARTED|Study Medications Induction (W1-4)||14
8873310|NCT01895270|9930202|FG000|COMPLETED|Study Medications Induction (W1-4)||5
8873311|NCT01895270|9930203|FG001|COMPLETED|Study Medications Induction (W1-4)||8
8873312|NCT01895270|9930202|FG000|NOT COMPLETED|Study Medications Induction (W1-4)||6
8873313|NCT01895270|9930203|FG001|NOT COMPLETED|Study Medications Induction (W1-4)||6
8873314|NCT01895270|9930202|FG000|STARTED|Buprenorphine Taper (W5 to W6D3)||5
8873315|NCT01895270|9930203|FG001|STARTED|Buprenorphine Taper (W5 to W6D3)|1 subject missed meds prior to bup taper so did not start this phase|7
8873316|NCT01895270|9930202|FG000|COMPLETED|Buprenorphine Taper (W5 to W6D3)||2
8873317|NCT01895270|9930203|FG001|COMPLETED|Buprenorphine Taper (W5 to W6D3)||2
8873318|NCT01895270|9930202|FG000|NOT COMPLETED|Buprenorphine Taper (W5 to W6D3)||3
8873319|NCT01895270|9930203|FG001|NOT COMPLETED|Buprenorphine Taper (W5 to W6D3)||5
8631208|NCT00538850|9671110|FG000|STARTED|Placebo - Double-blind|There were no participants in this reporting group in the double-blind period.|0
8631209|NCT00538850|9671111|FG001|STARTED|Placebo - Double-blind|There were no participants in this reporting group in the double-blind period.|0
8631210|NCT00538850|9671112|FG002|STARTED|Placebo - Double-blind||98
8873320|NCT01895270|9930202|FG000|STARTED|Isradipine Taper (W7-8)||2
8873321|NCT01895270|9930203|FG001|STARTED|Isradipine Taper (W7-8)||2
8873322|NCT01895270|9930202|FG000|COMPLETED|Isradipine Taper (W7-8)||2
8873323|NCT01895270|9930203|FG001|COMPLETED|Isradipine Taper (W7-8)||0
8873324|NCT01895270|9930202|FG000|NOT COMPLETED|Isradipine Taper (W7-8)||0
8873325|NCT01895270|9930203|FG001|NOT COMPLETED|Isradipine Taper (W7-8)||2
8873326|NCT01895309|9930211|FG000|STARTED|Overall Study||299
8873327|NCT01895309|9930212|FG001|STARTED|Overall Study||297
8873328|NCT01895309|9930211|FG000|COMPLETED|Overall Study||259
8873329|NCT01895309|9930212|FG001|COMPLETED|Overall Study||246
8873330|NCT01895309|9930211|FG000|NOT COMPLETED|Overall Study||40
8873331|NCT01895309|9930212|FG001|NOT COMPLETED|Overall Study||51
8873332|NCT01895322|9930222|FG000|STARTED|Overall Study||20
8873333|NCT01895322|9930222|FG000|COMPLETED|Overall Study||7
8873334|NCT01895322|9930222|FG000|NOT COMPLETED|Overall Study||13
8873335|NCT01895335|9930227|FG000|STARTED|Overall Study||1001
8873336|NCT01895335|9930227|FG000|Treated|Overall Study||1000
8873337|NCT01895335|9930227|FG000|COMPLETED|Overall Study||786
8873338|NCT01895335|9930227|FG000|NOT COMPLETED|Overall Study||215
8873339|NCT01895361|9930234|FG000|STARTED|Overall Study||67
8873340|NCT01895361|9930235|FG001|STARTED|Overall Study||66
8873341|NCT01895361|9930236|FG002|STARTED|Overall Study||65
8873342|NCT01895361|9930234|FG000|COMPLETED|Overall Study||43
8953418|NCT02471612|10016618|FG000|COMPLETED|Overall Study||157
8953419|NCT02471612|10016618|FG000|NOT COMPLETED|Overall Study||2
8953420|NCT02471651|10016637|FG000|STARTED|Overall Study||20
8953421|NCT02471651|10016638|FG001|STARTED|Overall Study||20
8953422|NCT02471651|10016637|FG000|COMPLETED|Overall Study||15
8953423|NCT02471651|10016638|FG001|COMPLETED|Overall Study||15
8953424|NCT02471651|10016637|FG000|NOT COMPLETED|Overall Study||5
8953425|NCT02471651|10016638|FG001|NOT COMPLETED|Overall Study||5
8953426|NCT02471716|10016649|FG000|STARTED|Overall Study||3
8953427|NCT02471716|10016650|FG001|STARTED|Overall Study||3
8953428|NCT02471716|10016651|FG002|STARTED|Overall Study||3
8953429|NCT02471716|10016652|FG003|STARTED|Overall Study||33
8631211|NCT00538850|9671110|FG000|COMPLETED|Placebo - Double-blind||0
8953430|NCT02471716|10016653|FG004|STARTED|Overall Study||24
8953431|NCT02471716|10016649|FG000|COMPLETED|Overall Study||3
8953432|NCT02471716|10016650|FG001|COMPLETED|Overall Study||2
8953433|NCT02471716|10016651|FG002|COMPLETED|Overall Study||3
8953434|NCT02471716|10016652|FG003|COMPLETED|Overall Study||18
8953435|NCT02471716|10016653|FG004|COMPLETED|Overall Study||8
8953436|NCT02471716|10016649|FG000|NOT COMPLETED|Overall Study||0
8953437|NCT02471716|10016650|FG001|NOT COMPLETED|Overall Study||1
8953438|NCT02471716|10016651|FG002|NOT COMPLETED|Overall Study||0
8953439|NCT02471716|10016652|FG003|NOT COMPLETED|Overall Study||15
8953440|NCT02471716|10016653|FG004|NOT COMPLETED|Overall Study||16
8953441|NCT02471755|10016669|FG000|STARTED|Overall Study||45
8953442|NCT02471755|10016670|FG001|STARTED|Overall Study||45
8953443|NCT02471755|10016669|FG000|COMPLETED|Overall Study||44
8953444|NCT02471755|10016670|FG001|COMPLETED|Overall Study||44
8953445|NCT02471755|10016669|FG000|NOT COMPLETED|Overall Study||1
8953446|NCT02471755|10016670|FG001|NOT COMPLETED|Overall Study||1
8953447|NCT02472145|10016679|FG000|STARTED|Overall Study||10
8953448|NCT02472145|10016680|FG001|STARTED|Overall Study||159
8953449|NCT02472145|10016681|FG002|STARTED|Overall Study||157
8953450|NCT02472145|10016679|FG000|Treated|Overall Study||10
8953451|NCT02472145|10016680|FG001|Treated|Overall Study||156
8953452|NCT02472145|10016681|FG002|Treated|Overall Study||156
8953453|NCT02472145|10016679|FG000|Safety|Overall Study||10
8953454|NCT02472145|10016680|FG001|Safety|Overall Study|9 participants who received decitabine,not JNJ-56022473 included,3 untreated participant excluded.|165
8953455|NCT02472145|10016681|FG002|Safety|Overall Study|1 participant who was not treated and 9 participants who received only decitabine were excluded.|147
8953456|NCT02472145|10016679|FG000|COMPLETED|Overall Study||0
8953457|NCT02472145|10016680|FG001|COMPLETED|Overall Study||0
8953458|NCT02472145|10016681|FG002|COMPLETED|Overall Study||0
8953459|NCT02472145|10016679|FG000|NOT COMPLETED|Overall Study||10
8953460|NCT02472145|10016680|FG001|NOT COMPLETED|Overall Study||159
8953461|NCT02472145|10016681|FG002|NOT COMPLETED|Overall Study||157
8953462|NCT02472223|10016690|FG000|STARTED|Overall Study||16
8953463|NCT02472223|10016691|FG001|STARTED|Overall Study||12
8953464|NCT02472223|10016690|FG000|COMPLETED|Overall Study||10
8953465|NCT02472223|10016691|FG001|COMPLETED|Overall Study||7
8953466|NCT02472223|10016690|FG000|NOT COMPLETED|Overall Study||6
8631212|NCT00538850|9671111|FG001|COMPLETED|Placebo - Double-blind||0
8631213|NCT00538850|9671112|FG002|COMPLETED|Placebo - Double-blind||95
8631214|NCT00538850|9671110|FG000|NOT COMPLETED|Placebo - Double-blind||0
8873343|NCT01895361|9930235|FG001|COMPLETED|Overall Study||45
8873344|NCT01895361|9930236|FG002|COMPLETED|Overall Study||41
8873345|NCT01895361|9930234|FG000|NOT COMPLETED|Overall Study||24
8873346|NCT01895361|9930235|FG001|NOT COMPLETED|Overall Study||21
8873347|NCT01895361|9930236|FG002|NOT COMPLETED|Overall Study||24
8953467|NCT02472223|10016691|FG001|NOT COMPLETED|Overall Study||5
8953468|NCT02472262|10016700|FG000|STARTED|Overall Study||117
8953469|NCT02472262|10016701|FG001|STARTED|Overall Study||120
8873348|NCT01895452|9930246|FG000|STARTED|Overall Study||65
8873349|NCT01895452|9930247|FG001|STARTED|Overall Study||226
8873350|NCT01895452|9930246|FG000|COMPLETED|Overall Study||61
8873351|NCT01895452|9930247|FG001|COMPLETED|Overall Study||198
8873352|NCT01895452|9930246|FG000|NOT COMPLETED|Overall Study||4
8873353|NCT01895452|9930247|FG001|NOT COMPLETED|Overall Study||28
8873354|NCT01895543|9930253|FG000|STARTED|Overall Study||411
8873355|NCT01895543|9930253|FG000|Safety Analysis Set|Overall Study|Set included all enrolled patients who took at least one dose of Investigational Medicinal Product.|409
8873356|NCT01895543|9930253|FG000|Per Protocol Analysis Set|Overall Study|Set included all enrolled patients who had no major protocol deviations.|380
8873357|NCT01895543|9930253|FG000|COMPLETED|Overall Study||282
8873358|NCT01895543|9930253|FG000|NOT COMPLETED|Overall Study||129
8873359|NCT01895608|9930261|FG000|STARTED|Overall Study||10
8873360|NCT01895608|9930262|FG001|STARTED|Overall Study||7
8873361|NCT01895608|9930263|FG002|STARTED|Overall Study||11
8873362|NCT01895608|9930264|FG003|STARTED|Overall Study||6
8873363|NCT01895608|9930261|FG000|COMPLETED|Overall Study||10
8953470|NCT02472262|10016702|FG002|STARTED|Overall Study||118
8953471|NCT02472262|10016700|FG000|COMPLETED|Overall Study||99
8953472|NCT02472262|10016701|FG001|COMPLETED|Overall Study||99
8953473|NCT02472262|10016702|FG002|COMPLETED|Overall Study||93
8953474|NCT02472262|10016700|FG000|NOT COMPLETED|Overall Study||18
8953475|NCT02472262|10016701|FG001|NOT COMPLETED|Overall Study||21
8953476|NCT02472262|10016702|FG002|NOT COMPLETED|Overall Study||25
8953477|NCT02472314|10016712|FG000|STARTED|Overall Study||34
8953478|NCT02472314|10016713|FG001|STARTED|Overall Study||36
8953479|NCT02472314|10016712|FG000|COMPLETED|Overall Study||34
8953480|NCT02472314|10016713|FG001|COMPLETED|Overall Study||36
8953481|NCT02472314|10016712|FG000|NOT COMPLETED|Overall Study||0
8953482|NCT02472314|10016713|FG001|NOT COMPLETED|Overall Study||0
8953483|NCT02472353|10016721|FG000|STARTED|Overall Study||14
8953484|NCT02472353|10016722|FG001|STARTED|Overall Study||16
8953485|NCT02472353|10016721|FG000|COMPLETED|Overall Study||10
8953486|NCT02472353|10016722|FG001|COMPLETED|Overall Study||10
8953487|NCT02472353|10016721|FG000|NOT COMPLETED|Overall Study||4
8953488|NCT02472353|10016722|FG001|NOT COMPLETED|Overall Study||6
8953489|NCT02472366|10016730|FG000|STARTED|Overall Study|6 subjects receiving ILUVIEN, 7 eyes receiving ILUVIEN|6
8953490|NCT02472366|10016731|FG001|STARTED|Overall Study||10
8953491|NCT02472366|10016730|FG000|COMPLETED|Overall Study||5
8953492|NCT02472366|10016731|FG001|COMPLETED|Overall Study||10
8953493|NCT02472366|10016730|FG000|NOT COMPLETED|Overall Study||1
8953494|NCT02472366|10016731|FG001|NOT COMPLETED|Overall Study||0
8953495|NCT02472405|10016737|FG000|STARTED|Overall Study||18
8953496|NCT02472405|10016737|FG000|COMPLETED|Overall Study||8
8953497|NCT02472405|10016737|FG000|NOT COMPLETED|Overall Study||10
8953498|NCT02472457|10016745|FG000|STARTED|Overall Study|1 subject followed the Specific Carbohydrate Diet|8
8953499|NCT02472457|10016746|FG001|STARTED|Overall Study||11
8953500|NCT02472457|10016745|FG000|COMPLETED|Overall Study||8
8953501|NCT02472457|10016746|FG001|COMPLETED|Overall Study||10
8953502|NCT02472457|10016745|FG000|NOT COMPLETED|Overall Study||0
8953503|NCT02472457|10016746|FG001|NOT COMPLETED|Overall Study||1
8953504|NCT02472522|10016754|FG000|STARTED|Overall Study||50
8953505|NCT02472522|10016755|FG001|STARTED|Overall Study||50
8953506|NCT02472522|10016754|FG000|COMPLETED|Overall Study||50
8953507|NCT02472522|10016755|FG001|COMPLETED|Overall Study||50
8953508|NCT02472522|10016754|FG000|NOT COMPLETED|Overall Study||0
8953509|NCT02472522|10016755|FG001|NOT COMPLETED|Overall Study||0
8953510|NCT02472652|10016763|FG000|STARTED|Overall Study||2
8953511|NCT02472652|10016763|FG000|COMPLETED|Overall Study||1
8953512|NCT02472652|10016763|FG000|NOT COMPLETED|Overall Study||1
8953513|NCT02472730|10016769|FG000|STARTED|Overall Study||110
8953514|NCT02472730|10016770|FG001|STARTED|Overall Study||109
8953515|NCT02472730|10016769|FG000|COMPLETED|Overall Study||101
8953516|NCT02472730|10016770|FG001|COMPLETED|Overall Study||102
8953517|NCT02472730|10016769|FG000|NOT COMPLETED|Overall Study||9
8953518|NCT02472730|10016770|FG001|NOT COMPLETED|Overall Study||7
8953519|NCT02472756|10016776|FG000|STARTED|Induction (Approximately 6 Months)||41
8953520|NCT02472756|10016776|FG000|Treated|Induction (Approximately 6 Months)||40
8953521|NCT02472756|10016776|FG000|COMPLETED|Induction (Approximately 6 Months)||39
8953522|NCT02472756|10016776|FG000|NOT COMPLETED|Induction (Approximately 6 Months)||2
8873364|NCT01895608|9930262|FG001|COMPLETED|Overall Study||6
8873365|NCT01895608|9930263|FG002|COMPLETED|Overall Study||8
8873366|NCT01895608|9930264|FG003|COMPLETED|Overall Study||6
8873367|NCT01895608|9930261|FG000|NOT COMPLETED|Overall Study||0
8873368|NCT01895608|9930262|FG001|NOT COMPLETED|Overall Study||1
8873369|NCT01895608|9930263|FG002|NOT COMPLETED|Overall Study||3
8953523|NCT02472756|10016776|FG000|STARTED|Maintenance (Approximately 2 Years)|Out of 39 participants who completed induction period, 19 did not continue in maintenance period.|20
8953524|NCT02472756|10016776|FG000|COMPLETED|Maintenance (Approximately 2 Years)||10
8953525|NCT02472756|10016776|FG000|NOT COMPLETED|Maintenance (Approximately 2 Years)||10
8953526|NCT02472795|10016785|FG000|STARTED|Overall Study||12
8873370|NCT01895608|9930264|FG003|NOT COMPLETED|Overall Study||0
8953527|NCT02472795|10016786|FG001|STARTED|Overall Study||12
8953528|NCT02472795|10016787|FG002|STARTED|Overall Study||13
8953529|NCT02472795|10016788|FG003|STARTED|Overall Study||13
8953530|NCT02472795|10016789|FG004|STARTED|Overall Study||17
8953531|NCT02472795|10016785|FG000|Pharmacodynamic Set|Overall Study||12
8873371|NCT01895634|9930274|FG000|STARTED|Overall Study||49
8873372|NCT01895634|9930274|FG000|COMPLETED|Overall Study||46
8873373|NCT01895634|9930274|FG000|NOT COMPLETED|Overall Study||3
8873374|NCT01895647|9930281|FG000|STARTED|Overall Study||8
8873375|NCT01895647|9930282|FG001|STARTED|Overall Study||10
8873376|NCT01895647|9930283|FG002|STARTED|Overall Study||7
8873377|NCT01895647|9930281|FG000|COMPLETED|Overall Study||8
8873378|NCT01895647|9930282|FG001|COMPLETED|Overall Study||10
8873379|NCT01895647|9930283|FG002|COMPLETED|Overall Study||7
8873380|NCT01895647|9930281|FG000|NOT COMPLETED|Overall Study||0
8873381|NCT01895647|9930282|FG001|NOT COMPLETED|Overall Study||0
8873382|NCT01895647|9930283|FG002|NOT COMPLETED|Overall Study||0
8873383|NCT01895777|9930293|FG000|STARTED|Overall Study||177
8873384|NCT01895777|9930294|FG001|STARTED|Overall Study||90
8873385|NCT01895777|9930293|FG000|Treated|Overall Study||176
8873386|NCT01895777|9930294|FG001|Treated|Overall Study||90
8873387|NCT01895777|9930293|FG000|COMPLETED|Overall Study||168
8873388|NCT01895777|9930294|FG001|COMPLETED|Overall Study||85
8873389|NCT01895777|9930293|FG000|NOT COMPLETED|Overall Study||9
8873390|NCT01895777|9930294|FG001|NOT COMPLETED|Overall Study||5
8873391|NCT01895855|9930305|FG000|STARTED|Overall Study||95
8873392|NCT01895855|9930306|FG001|STARTED|Overall Study||102
8873393|NCT01895855|9930305|FG000|COMPLETED|Overall Study||95
8873394|NCT01895855|9930306|FG001|COMPLETED|Overall Study||102
8873395|NCT01895855|9930305|FG000|NOT COMPLETED|Overall Study||0
8873396|NCT01895855|9930306|FG001|NOT COMPLETED|Overall Study||0
8873397|NCT01895946|9930318|FG000|STARTED|Overall Study||18
8873398|NCT01895946|9930319|FG001|STARTED|Overall Study||12
8873399|NCT01895946|9930318|FG000|COMPLETED|Overall Study||18
8873400|NCT01895946|9930319|FG001|COMPLETED|Overall Study||12
8873401|NCT01895946|9930318|FG000|NOT COMPLETED|Overall Study||0
8873402|NCT01895946|9930319|FG001|NOT COMPLETED|Overall Study||0
8873403|NCT01895972|9930325|FG000|STARTED|Overall Study||130
8873404|NCT01895972|9930325|FG000|COMPLETED|Overall Study||121
8873405|NCT01895972|9930325|FG000|NOT COMPLETED|Overall Study||9
8873406|NCT01896050|9930331|FG000|STARTED|Overall Study||93
8873407|NCT01896050|9930332|FG001|STARTED|Overall Study||22
8873408|NCT01896050|9930331|FG000|COMPLETED|Overall Study|This includes only patients who remained on the same aromatase inhibitor medication for 12 months|55
8873409|NCT01896050|9930332|FG001|COMPLETED|Overall Study||20
8873410|NCT01896050|9930331|FG000|NOT COMPLETED|Overall Study||38
8873411|NCT01896050|9930332|FG001|NOT COMPLETED|Overall Study||2
8873412|NCT01896115|9930342|FG000|STARTED|Overall Study||16
8873413|NCT01896115|9930343|FG001|STARTED|Overall Study||24
8873414|NCT01896115|9930342|FG000|Phase 1 Short PW|Overall Study||15
8873415|NCT01896115|9930343|FG001|Phase 1 Short PW|Overall Study||0
8873416|NCT01896115|9930342|FG000|Phase 1 Conventional PW|Overall Study||15
8873417|NCT01896115|9930343|FG001|Phase 1 Conventional PW|Overall Study||0
8873418|NCT01896115|9930342|FG000|Phase 1 Dorsal Steering|Overall Study||15
8873419|NCT01896115|9930343|FG001|Phase 1 Dorsal Steering|Overall Study||0
8873420|NCT01896115|9930342|FG000|Phase 1 Ventral Steering|Overall Study||15
8873421|NCT01896115|9930343|FG001|Phase 1 Ventral Steering|Overall Study||0
8873422|NCT01896115|9930342|FG000|Phase 2 Single Contact|Overall Study||0
8873423|NCT01896115|9930343|FG001|Phase 2 Single Contact|Overall Study||24
8873424|NCT01896115|9930342|FG000|Phase 2 Steering|Overall Study||0
8873425|NCT01896115|9930343|FG001|Phase 2 Steering|Overall Study||24
8873426|NCT01896115|9930342|FG000|COMPLETED|Overall Study||15
8873427|NCT01896115|9930343|FG001|COMPLETED|Overall Study||24
8873428|NCT01896115|9930342|FG000|NOT COMPLETED|Overall Study||1
8873429|NCT01896115|9930343|FG001|NOT COMPLETED|Overall Study||0
8873430|NCT01896128|9930356|FG000|STARTED|Overall Study||8
8873431|NCT01896128|9930357|FG001|STARTED|Overall Study||11
8873432|NCT01896128|9930356|FG000|COMPLETED|Overall Study||5
8873433|NCT01896128|9930357|FG001|COMPLETED|Overall Study||8
8873434|NCT01896128|9930356|FG000|NOT COMPLETED|Overall Study||3
8873435|NCT01896128|9930357|FG001|NOT COMPLETED|Overall Study||3
8873436|NCT01896193|9930367|FG000|STARTED|Overall Study||62
8873437|NCT01896193|9930368|FG001|STARTED|Overall Study||65
8873438|NCT01896193|9930367|FG000|COMPLETED|Overall Study||41
8873439|NCT01896193|9930368|FG001|COMPLETED|Overall Study||53
8873440|NCT01896193|9930367|FG000|NOT COMPLETED|Overall Study||21
8953532|NCT02472795|10016786|FG001|Pharmacodynamic Set|Overall Study||10
8953533|NCT02472795|10016787|FG002|Pharmacodynamic Set|Overall Study||13
8953534|NCT02472795|10016788|FG003|Pharmacodynamic Set|Overall Study||13
8953535|NCT02472795|10016789|FG004|Pharmacodynamic Set|Overall Study||16
8953536|NCT02472795|10016785|FG000|Modified Pharmacodynamic Analysis Set|Overall Study||12
8953537|NCT02472795|10016786|FG001|Modified Pharmacodynamic Analysis Set|Overall Study||10
8953538|NCT02472795|10016787|FG002|Modified Pharmacodynamic Analysis Set|Overall Study||13
8953539|NCT02472795|10016788|FG003|Modified Pharmacodynamic Analysis Set|Overall Study||9
8953540|NCT02472795|10016789|FG004|Modified Pharmacodynamic Analysis Set|Overall Study||16
8953541|NCT02472795|10016785|FG000|COMPLETED|Overall Study||12
8953542|NCT02472795|10016786|FG001|COMPLETED|Overall Study||11
8873441|NCT01896193|9930368|FG001|NOT COMPLETED|Overall Study||12
8873442|NCT01896206|9930376|FG000|STARTED|Overall Study||21
8873443|NCT01896206|9930376|FG000|COMPLETED|Overall Study||21
8873444|NCT01896206|9930376|FG000|NOT COMPLETED|Overall Study||0
8873445|NCT01896232|9930382|FG000|STARTED|Overall Study||343
8873446|NCT01896232|9930383|FG001|STARTED|Overall Study||340
8873447|NCT01896232|9930382|FG000|Received Treatment|Overall Study||341
8873448|NCT01896232|9930383|FG001|Received Treatment|Overall Study||338
8873449|NCT01896232|9930382|FG000|COMPLETED|Overall Study||294
8953543|NCT02472795|10016787|FG002|COMPLETED|Overall Study||13
8873450|NCT01896232|9930383|FG001|COMPLETED|Overall Study||287
8873451|NCT01896232|9930382|FG000|NOT COMPLETED|Overall Study||49
8873452|NCT01896232|9930383|FG001|NOT COMPLETED|Overall Study||53
8873453|NCT01896271|9930389|FG000|STARTED|Overall Study||30
8873454|NCT01896271|9930389|FG000|COMPLETED|Overall Study||20
8873455|NCT01896271|9930389|FG000|NOT COMPLETED|Overall Study||10
8873456|NCT01896297|9930393|FG000|STARTED|Overall Study||60
8873457|NCT01896297|9930393|FG000|COMPLETED|Overall Study||59
8873458|NCT01896297|9930393|FG000|NOT COMPLETED|Overall Study||1
8873459|NCT01896544|9930400|FG000|STARTED|Overall Study||10
8873460|NCT01896544|9930401|FG001|STARTED|Overall Study||10
8873461|NCT01896544|9930402|FG002|STARTED|Overall Study||10
8873462|NCT01896544|9930400|FG000|COMPLETED|Overall Study||10
8873463|NCT01896544|9930401|FG001|COMPLETED|Overall Study||10
8873464|NCT01896544|9930402|FG002|COMPLETED|Overall Study||10
8873465|NCT01896544|9930400|FG000|NOT COMPLETED|Overall Study||0
8873466|NCT01896544|9930401|FG001|NOT COMPLETED|Overall Study||0
8873467|NCT01896544|9930402|FG002|NOT COMPLETED|Overall Study||0
8873468|NCT01896557|9930415|FG000|STARTED|Clopidogrel Alone||44
8873469|NCT01896557|9930416|FG001|STARTED|Clopidogrel Alone||48
8873470|NCT01896557|9930415|FG000|COMPLETED|Clopidogrel Alone||43
8873471|NCT01896557|9930416|FG001|COMPLETED|Clopidogrel Alone||48
8873472|NCT01896557|9930415|FG000|NOT COMPLETED|Clopidogrel Alone||1
8873473|NCT01896557|9930416|FG001|NOT COMPLETED|Clopidogrel Alone||0
8873474|NCT01896557|9930415|FG000|STARTED|Clopidogrel + GI Protector||43
8873475|NCT01896557|9930416|FG001|STARTED|Clopidogrel + GI Protector||48
8873476|NCT01896557|9930415|FG000|COMPLETED|Clopidogrel + GI Protector||41
8873477|NCT01896557|9930416|FG001|COMPLETED|Clopidogrel + GI Protector||44
8873478|NCT01896557|9930415|FG000|NOT COMPLETED|Clopidogrel + GI Protector||2
8873479|NCT01896557|9930416|FG001|NOT COMPLETED|Clopidogrel + GI Protector||4
8873480|NCT01896687|9930424|FG000|STARTED|Overall Study||15
8873481|NCT01896687|9930425|FG001|STARTED|Overall Study||15
8873482|NCT01896687|9930424|FG000|COMPLETED|Overall Study||15
8873483|NCT01896687|9930425|FG001|COMPLETED|Overall Study||15
8873484|NCT01896687|9930424|FG000|NOT COMPLETED|Overall Study||0
8873485|NCT01896687|9930425|FG001|NOT COMPLETED|Overall Study||0
8873486|NCT01896700|9930433|FG000|STARTED|Overall Study||12
8953544|NCT02472795|10016788|FG003|COMPLETED|Overall Study||13
8953545|NCT02472795|10016789|FG004|COMPLETED|Overall Study||14
8953546|NCT02472795|10016785|FG000|NOT COMPLETED|Overall Study||0
8953547|NCT02472795|10016786|FG001|NOT COMPLETED|Overall Study||1
8953548|NCT02472795|10016787|FG002|NOT COMPLETED|Overall Study||0
8953549|NCT02472795|10016788|FG003|NOT COMPLETED|Overall Study||0
8953550|NCT02472795|10016789|FG004|NOT COMPLETED|Overall Study||3
8953551|NCT02472847|10016803|FG000|STARTED|Overall Study||24
8953552|NCT02472847|10016804|FG001|STARTED|Overall Study||26
8953553|NCT02472847|10016803|FG000|COMPLETED|Overall Study||23
8953554|NCT02472847|10016804|FG001|COMPLETED|Overall Study||21
8953555|NCT02472847|10016803|FG000|NOT COMPLETED|Overall Study||1
8953556|NCT02472847|10016804|FG001|NOT COMPLETED|Overall Study||5
8953557|NCT02472886|10016813|FG000|STARTED|Overall Study||67
8953558|NCT02472886|10016814|FG001|STARTED|Overall Study||59
8953559|NCT02472886|10016815|FG002|STARTED|Overall Study||27
8953560|NCT02472886|10016813|FG000|COMPLETED|Overall Study||67
8953561|NCT02472886|10016814|FG001|COMPLETED|Overall Study||57
8953562|NCT02472886|10016815|FG002|COMPLETED|Overall Study||26
8953563|NCT02472886|10016813|FG000|NOT COMPLETED|Overall Study||0
8953564|NCT02472886|10016814|FG001|NOT COMPLETED|Overall Study||2
8953565|NCT02472886|10016815|FG002|NOT COMPLETED|Overall Study||1
8953566|NCT02472977|10016831|FG000|STARTED|Overall Study||6
8953567|NCT02472977|10016832|FG001|STARTED|Overall Study||27
8953568|NCT02472977|10016833|FG002|STARTED|Overall Study||8
8953569|NCT02472977|10016831|FG000|COMPLETED|Overall Study||0
8953570|NCT02472977|10016832|FG001|COMPLETED|Overall Study||0
8953571|NCT02472977|10016833|FG002|COMPLETED|Overall Study||0
8953572|NCT02472977|10016831|FG000|NOT COMPLETED|Overall Study||6
8953573|NCT02472977|10016832|FG001|NOT COMPLETED|Overall Study||27
8953574|NCT02472977|10016833|FG002|NOT COMPLETED|Overall Study||8
8953575|NCT02473250|10016841|FG000|STARTED|Overall Study||40
8953576|NCT02473250|10016841|FG000|COMPLETED|Overall Study||20
8953577|NCT02473250|10016841|FG000|NOT COMPLETED|Overall Study||20
8953578|NCT02473289|10016848|FG000|STARTED|Overall Study||99
8953579|NCT02473289|10016849|FG001|STARTED|Overall Study||94
8953580|NCT02473289|10016848|FG000|COMPLETED|Overall Study||88
8953581|NCT02473289|10016849|FG001|COMPLETED|Overall Study||81
8953582|NCT02473289|10016848|FG000|NOT COMPLETED|Overall Study||11
8873487|NCT01896700|9930434|FG001|STARTED|Overall Study||12
8873488|NCT01896700|9930433|FG000|COMPLETED|Overall Study||8
8873489|NCT01896700|9930434|FG001|COMPLETED|Overall Study||6
8873490|NCT01896700|9930433|FG000|NOT COMPLETED|Overall Study||4
8873491|NCT01896700|9930434|FG001|NOT COMPLETED|Overall Study||6
8873492|NCT01896726|9930440|FG000|STARTED|Treatment Period 1 (Days 1-22)||20
8873493|NCT01896726|9930440|FG000|Received Microgynon|Treatment Period 1 (Days 1-22)||20
8953583|NCT02473289|10016849|FG001|NOT COMPLETED|Overall Study||13
8953584|NCT02473367|10016855|FG000|STARTED|Period 1||20
8953585|NCT02473367|10016855|FG000|COMPLETED|Period 1||20
8873494|NCT01896726|9930440|FG000|COMPLETED|Treatment Period 1 (Days 1-22)||20
8873495|NCT01896726|9930440|FG000|NOT COMPLETED|Treatment Period 1 (Days 1-22)||0
8873496|NCT01896726|9930440|FG000|STARTED|Treatment Period 2 (Days 23-31)||20
8953586|NCT02473367|10016855|FG000|NOT COMPLETED|Period 1||0
8953587|NCT02473367|10016855|FG000|STARTED|Wait 1||20
8873497|NCT01896726|9930440|FG000|Received at Least 1 Dose of Baricitinib|Treatment Period 2 (Days 23-31)||20
8873498|NCT01896726|9930440|FG000|Received Microgynon|Treatment Period 2 (Days 23-31)||18
8873499|NCT01896726|9930440|FG000|COMPLETED|Treatment Period 2 (Days 23-31)||18
8873500|NCT01896726|9930440|FG000|NOT COMPLETED|Treatment Period 2 (Days 23-31)||2
8873501|NCT01896856|9930453|FG000|STARTED|Overall Study||6
8873502|NCT01896856|9930454|FG001|STARTED|Overall Study||3
8873503|NCT01896856|9930455|FG002|STARTED|Overall Study||7
8873504|NCT01896856|9930456|FG003|STARTED|Overall Study||6
8873505|NCT01896856|9930457|FG004|STARTED|Overall Study||62
8873506|NCT01896856|9930458|FG005|STARTED|Overall Study||34
8873507|NCT01896856|9930453|FG000|COMPLETED|Overall Study||6
8873508|NCT01896856|9930454|FG001|COMPLETED|Overall Study||3
8873509|NCT01896856|9930455|FG002|COMPLETED|Overall Study||6
8873510|NCT01896856|9930456|FG003|COMPLETED|Overall Study||6
8873511|NCT01896856|9930457|FG004|COMPLETED|Overall Study||62
8873512|NCT01896856|9930458|FG005|COMPLETED|Overall Study||34
8873513|NCT01896856|9930453|FG000|NOT COMPLETED|Overall Study||0
8873514|NCT01896856|9930454|FG001|NOT COMPLETED|Overall Study||0
8873515|NCT01896856|9930455|FG002|NOT COMPLETED|Overall Study||1
8873516|NCT01896856|9930456|FG003|NOT COMPLETED|Overall Study||0
8873517|NCT01896856|9930457|FG004|NOT COMPLETED|Overall Study||0
8873518|NCT01896856|9930458|FG005|NOT COMPLETED|Overall Study||0
8873519|NCT01896869|9930475|FG000|STARTED|Overall Study||41
8873520|NCT01896869|9930476|FG001|STARTED|Overall Study||42
8873521|NCT01896869|9930475|FG000|COMPLETED|Overall Study||40
8873522|NCT01896869|9930476|FG001|COMPLETED|Overall Study||36
8873523|NCT01896869|9930475|FG000|NOT COMPLETED|Overall Study||1
8873524|NCT01896869|9930476|FG001|NOT COMPLETED|Overall Study||6
8873525|NCT01896895|9930487|FG000|STARTED|Double-blind MP||20
8873526|NCT01896895|9930488|FG001|STARTED|Double-blind MP||22
8873527|NCT01896895|9930489|FG002|STARTED|Double-blind MP||19
8873528|NCT01896895|9930490|FG003|STARTED|Double-blind MP||0
8873529|NCT01896895|9930487|FG000|COMPLETED|Double-blind MP||19
8873530|NCT01896895|9930488|FG001|COMPLETED|Double-blind MP||20
8873531|NCT01896895|9930489|FG002|COMPLETED|Double-blind MP||16
8873532|NCT01896895|9930490|FG003|COMPLETED|Double-blind MP||0
8873533|NCT01896895|9930487|FG000|NOT COMPLETED|Double-blind MP||1
8873534|NCT01896895|9930488|FG001|NOT COMPLETED|Double-blind MP||2
8873535|NCT01896895|9930489|FG002|NOT COMPLETED|Double-blind MP||3
8873536|NCT01896895|9930490|FG003|NOT COMPLETED|Double-blind MP||0
8873537|NCT01896895|9930487|FG000|STARTED|OLEX Period||0
8873538|NCT01896895|9930488|FG001|STARTED|OLEX Period||0
8873539|NCT01896895|9930489|FG002|STARTED|OLEX Period||0
8873540|NCT01896895|9930490|FG003|STARTED|OLEX Period|Not all participants who completed double-blind MP fulfilled the inclusion criteria for OLEX period.|39
8873541|NCT01896895|9930487|FG000|COMPLETED|OLEX Period||0
8873542|NCT01896895|9930488|FG001|COMPLETED|OLEX Period||0
8873543|NCT01896895|9930489|FG002|COMPLETED|OLEX Period||0
8873544|NCT01896895|9930490|FG003|COMPLETED|OLEX Period||39
8873545|NCT01896895|9930487|FG000|NOT COMPLETED|OLEX Period||0
8873546|NCT01896895|9930488|FG001|NOT COMPLETED|OLEX Period||0
8873547|NCT01896895|9930489|FG002|NOT COMPLETED|OLEX Period||0
8873548|NCT01896895|9930490|FG003|NOT COMPLETED|OLEX Period||0
8873549|NCT01896921|9930499|FG000|STARTED|Overall Study||7
8953588|NCT02473367|10016855|FG000|COMPLETED|Wait 1||19
8631215|NCT00538850|9671111|FG001|NOT COMPLETED|Placebo - Double-blind||0
8873550|NCT01896921|9930499|FG000|COMPLETED|Overall Study||5
8873551|NCT01896921|9930499|FG000|NOT COMPLETED|Overall Study||2
8873552|NCT01896934|9930503|FG000|STARTED|Overall Study||21
8873553|NCT01896934|9930503|FG000|COMPLETED|Overall Study||19
8873554|NCT01896934|9930503|FG000|NOT COMPLETED|Overall Study||2
8873555|NCT01896986|9930509|FG000|STARTED|Overall Study||14
8873556|NCT01896986|9930510|FG001|STARTED|Overall Study||23
8873557|NCT01896986|9930509|FG000|COMPLETED|Overall Study||0
8873558|NCT01896986|9930510|FG001|COMPLETED|Overall Study||0
8873559|NCT01896986|9930509|FG000|NOT COMPLETED|Overall Study||14
8873560|NCT01896986|9930510|FG001|NOT COMPLETED|Overall Study||23
8873561|NCT01897025|9930518|FG000|STARTED|Overall Study||10
8873562|NCT01897025|9930519|FG001|STARTED|Overall Study||9
8873563|NCT01897025|9930518|FG000|COMPLETED|Overall Study||10
8873564|NCT01897025|9930519|FG001|COMPLETED|Overall Study||9
8873565|NCT01897025|9930518|FG000|NOT COMPLETED|Overall Study||0
8873566|NCT01897025|9930519|FG001|NOT COMPLETED|Overall Study||0
8873567|NCT01897077|9930527|FG000|STARTED|Overall Study||0
8873568|NCT01897077|9930528|FG001|STARTED|Overall Study||5
8873569|NCT01897077|9930527|FG000|COMPLETED|Overall Study||0
8873570|NCT01897077|9930528|FG001|COMPLETED|Overall Study||5
8873571|NCT01897077|9930527|FG000|NOT COMPLETED|Overall Study||0
8873572|NCT01897077|9930528|FG001|NOT COMPLETED|Overall Study||0
8873573|NCT01897233|9930534|FG000|STARTED|Part A (14 Days)||10
8873574|NCT01897233|9930534|FG000|Part A Cohort 1 (6 to 8 Years)|Part A (14 Days)||5
8873575|NCT01897233|9930534|FG000|Part A Cohort 2 (9 to 11 Years)|Part A (14 Days)||5
8873576|NCT01897233|9930534|FG000|COMPLETED|Part A (14 Days)||10
8873577|NCT01897233|9930534|FG000|NOT COMPLETED|Part A (14 Days)||0
8873578|NCT01897233|9930534|FG000|STARTED|Part B (24 Weeks)|6 participants from Part A also participated in Part B of the study.|58
8873579|NCT01897233|9930534|FG000|COMPLETED|Part B (24 Weeks)||54
8873580|NCT01897233|9930534|FG000|NOT COMPLETED|Part B (24 Weeks)||4
8873581|NCT01897285|9930542|FG000|STARTED|Overall Study|All 20 participants received original AND test adhesive dressings on upper arms and lower back.|20
8873582|NCT01897285|9930542|FG000|COMPLETED|Overall Study||20
8873583|NCT01897285|9930542|FG000|NOT COMPLETED|Overall Study||0
8873584|NCT01897402|9930550|FG000|STARTED|Overall Study||265
8873585|NCT01897402|9930551|FG001|STARTED|Overall Study||260
8873586|NCT01897402|9930550|FG000|COMPLETED|Overall Study||246
8873587|NCT01897402|9930551|FG001|COMPLETED|Overall Study||244
8873588|NCT01897402|9930550|FG000|NOT COMPLETED|Overall Study||19
8873589|NCT01897402|9930551|FG001|NOT COMPLETED|Overall Study||16
8873590|NCT01897493|9930563|FG000|STARTED|Period 1 (Day 1 Through Day 6 Predose)||16
8873591|NCT01897493|9930563|FG000|Received at Least 1 Dose of Study Drug|Period 1 (Day 1 Through Day 6 Predose)||16
8873592|NCT01897493|9930563|FG000|COMPLETED|Period 1 (Day 1 Through Day 6 Predose)||15
8873593|NCT01897493|9930563|FG000|NOT COMPLETED|Period 1 (Day 1 Through Day 6 Predose)||1
8873594|NCT01897493|9930563|FG000|STARTED|Period 2 (Day 6 Postdose Through Day 20)||15
8873595|NCT01897493|9930563|FG000|Received at Least 1 Dose of Study Drug|Period 2 (Day 6 Postdose Through Day 20)||15
8873596|NCT01897493|9930563|FG000|COMPLETED|Period 2 (Day 6 Postdose Through Day 20)||15
8873597|NCT01897493|9930563|FG000|NOT COMPLETED|Period 2 (Day 6 Postdose Through Day 20)||0
8873598|NCT01897532|9930572|FG000|STARTED|Discontinuation From Treatment||3492
8873599|NCT01897532|9930573|FG001|STARTED|Discontinuation From Treatment||3499
8873600|NCT01897532|9930572|FG000|Treated|Discontinuation From Treatment||3485
8873601|NCT01897532|9930573|FG001|Treated|Discontinuation From Treatment||3494
8873602|NCT01897532|9930572|FG000|COMPLETED|Discontinuation From Treatment||2530
8873603|NCT01897532|9930573|FG001|COMPLETED|Discontinuation From Treatment||2660
8873604|NCT01897532|9930572|FG000|NOT COMPLETED|Discontinuation From Treatment||962
8873605|NCT01897532|9930573|FG001|NOT COMPLETED|Discontinuation From Treatment||839
8873606|NCT01897532|9930572|FG000|STARTED|Discontinuation From Trial||3492
8873607|NCT01897532|9930573|FG001|STARTED|Discontinuation From Trial||3499
8873608|NCT01897532|9930572|FG000|Treated|Discontinuation From Trial||3485
8873609|NCT01897532|9930573|FG001|Treated|Discontinuation From Trial||3494
8873610|NCT01897532|9930572|FG000|COMPLETED|Discontinuation From Trial||3430
8873611|NCT01897532|9930573|FG001|COMPLETED|Discontinuation From Trial||3458
8873612|NCT01897532|9930572|FG000|NOT COMPLETED|Discontinuation From Trial||62
8873613|NCT01897532|9930573|FG001|NOT COMPLETED|Discontinuation From Trial||41
8873614|NCT01897714|9930585|FG000|STARTED|Phase I (Dose Escalation)||4
8873615|NCT01897714|9930586|FG001|STARTED|Phase I (Dose Escalation)||7
8873616|NCT01897714|9930587|FG002|STARTED|Phase I (Dose Escalation)||6
8873617|NCT01897714|9930588|FG003|STARTED|Phase I (Dose Escalation)||6
8873618|NCT01897714|9930589|FG004|STARTED|Phase I (Dose Escalation)||0
8873619|NCT01897714|9930590|FG005|STARTED|Phase I (Dose Escalation)||0
8873620|NCT01897714|9930585|FG000|COMPLETED|Phase I (Dose Escalation)||1
8873621|NCT01897714|9930586|FG001|COMPLETED|Phase I (Dose Escalation)||0
8873622|NCT01897714|9930587|FG002|COMPLETED|Phase I (Dose Escalation)||1
8873623|NCT01897714|9930588|FG003|COMPLETED|Phase I (Dose Escalation)||0
8873624|NCT01897714|9930589|FG004|COMPLETED|Phase I (Dose Escalation)||0
8873625|NCT01897714|9930590|FG005|COMPLETED|Phase I (Dose Escalation)||0
8873626|NCT01897714|9930585|FG000|NOT COMPLETED|Phase I (Dose Escalation)||3
8873627|NCT01897714|9930586|FG001|NOT COMPLETED|Phase I (Dose Escalation)||7
8873628|NCT01897714|9930587|FG002|NOT COMPLETED|Phase I (Dose Escalation)||5
8873629|NCT01897714|9930588|FG003|NOT COMPLETED|Phase I (Dose Escalation)||6
8873630|NCT01897714|9930589|FG004|NOT COMPLETED|Phase I (Dose Escalation)||0
8873631|NCT01897714|9930590|FG005|NOT COMPLETED|Phase I (Dose Escalation)||0
8873632|NCT01897714|9930585|FG000|STARTED|Phase II (MTD)||0
8873633|NCT01897714|9930586|FG001|STARTED|Phase II (MTD)||0
8873634|NCT01897714|9930587|FG002|STARTED|Phase II (MTD)||0
8873635|NCT01897714|9930588|FG003|STARTED|Phase II (MTD)||0
8873636|NCT01897714|9930589|FG004|STARTED|Phase II (MTD)|6 patients were entered from the Phase I: Melflufen 40 mg + Dexamethasone arm.|45
8873637|NCT01897714|9930590|FG005|STARTED|Phase II (MTD)||13
8873638|NCT01897714|9930585|FG000|COMPLETED|Phase II (MTD)||0
8873639|NCT01897714|9930586|FG001|COMPLETED|Phase II (MTD)||0
8873640|NCT01897714|9930587|FG002|COMPLETED|Phase II (MTD)||0
8873641|NCT01897714|9930588|FG003|COMPLETED|Phase II (MTD)||0
8873642|NCT01897714|9930589|FG004|COMPLETED|Phase II (MTD)||15
8873643|NCT01897714|9930590|FG005|COMPLETED|Phase II (MTD)||2
8873644|NCT01897714|9930585|FG000|NOT COMPLETED|Phase II (MTD)||0
8873645|NCT01897714|9930586|FG001|NOT COMPLETED|Phase II (MTD)||0
8873646|NCT01897714|9930587|FG002|NOT COMPLETED|Phase II (MTD)||0
8873647|NCT01897714|9930588|FG003|NOT COMPLETED|Phase II (MTD)||0
8873648|NCT01897714|9930589|FG004|NOT COMPLETED|Phase II (MTD)||30
8873649|NCT01897714|9930590|FG005|NOT COMPLETED|Phase II (MTD)||11
8873650|NCT01897727|9930608|FG000|STARTED|Overall Study||8
8873651|NCT01897727|9930609|FG001|STARTED|Overall Study||9
8873652|NCT01897727|9930608|FG000|COMPLETED|Overall Study||8
8873653|NCT01897727|9930609|FG001|COMPLETED|Overall Study||8
8873654|NCT01897727|9930608|FG000|NOT COMPLETED|Overall Study||0
8873655|NCT01897727|9930609|FG001|NOT COMPLETED|Overall Study||1
8873656|NCT01897766|9930615|FG000|STARTED|Overall Study||482
8873657|NCT01897766|9930615|FG000|COMPLETED|Overall Study||482
8873658|NCT01897766|9930615|FG000|NOT COMPLETED|Overall Study||0
8873659|NCT01897792|9930621|FG000|STARTED|Overall Study||6
8873660|NCT01897792|9930622|FG001|STARTED|Overall Study||5
8873661|NCT01897792|9930621|FG000|COMPLETED|Overall Study||6
8873662|NCT01897792|9930622|FG001|COMPLETED|Overall Study||5
8873663|NCT01897792|9930621|FG000|NOT COMPLETED|Overall Study||0
8873664|NCT01897792|9930622|FG001|NOT COMPLETED|Overall Study||0
8873665|NCT01897896|9930634|FG000|STARTED|Overall Study||82
8873666|NCT01897896|9930635|FG001|STARTED|Overall Study||37
8873667|NCT01897896|9930634|FG000|COMPLETED|Overall Study||56
8873668|NCT01897896|9930635|FG001|COMPLETED|Overall Study||25
8873669|NCT01897896|9930634|FG000|NOT COMPLETED|Overall Study||26
8873670|NCT01897896|9930635|FG001|NOT COMPLETED|Overall Study||12
8873671|NCT01898013|9930645|FG000|STARTED|Visit 3 (Randomization Visit)||45
8873672|NCT01898013|9930646|FG001|STARTED|Visit 3 (Randomization Visit)||49
8873673|NCT01898013|9930645|FG000|COMPLETED|Visit 3 (Randomization Visit)||45
8873674|NCT01898013|9930646|FG001|COMPLETED|Visit 3 (Randomization Visit)||49
8873675|NCT01898013|9930645|FG000|NOT COMPLETED|Visit 3 (Randomization Visit)||0
8873676|NCT01898013|9930646|FG001|NOT COMPLETED|Visit 3 (Randomization Visit)||0
8873677|NCT01898013|9930645|FG000|STARTED|Visit 4||45
8873678|NCT01898013|9930646|FG001|STARTED|Visit 4||49
8873679|NCT01898013|9930645|FG000|COMPLETED|Visit 4||45
8873680|NCT01898013|9930646|FG001|COMPLETED|Visit 4||48
8873681|NCT01898013|9930645|FG000|NOT COMPLETED|Visit 4||0
8873682|NCT01898013|9930646|FG001|NOT COMPLETED|Visit 4||1
8873683|NCT01898013|9930645|FG000|STARTED|Visit 5||45
8873684|NCT01898013|9930646|FG001|STARTED|Visit 5||48
8873685|NCT01898013|9930645|FG000|COMPLETED|Visit 5||44
8873686|NCT01898013|9930646|FG001|COMPLETED|Visit 5||47
8873687|NCT01898013|9930645|FG000|NOT COMPLETED|Visit 5||1
8873688|NCT01898013|9930646|FG001|NOT COMPLETED|Visit 5||1
8873689|NCT01898013|9930645|FG000|STARTED|Visit 6||44
8873690|NCT01898013|9930646|FG001|STARTED|Visit 6||47
8873691|NCT01898013|9930645|FG000|COMPLETED|Visit 6||41
8873692|NCT01898013|9930646|FG001|COMPLETED|Visit 6||42
8873693|NCT01898013|9930645|FG000|NOT COMPLETED|Visit 6||3
8873694|NCT01898013|9930646|FG001|NOT COMPLETED|Visit 6||5
8873695|NCT01898078|9930654|FG000|STARTED|Overall Study||13
8873696|NCT01898078|9930655|FG001|STARTED|Overall Study||13
8873697|NCT01898078|9930654|FG000|COMPLETED|Overall Study|Completed treatment|7
8873698|NCT01898078|9930655|FG001|COMPLETED|Overall Study|Completed treatment|5
8873699|NCT01898078|9930654|FG000|NOT COMPLETED|Overall Study||6
8873700|NCT01898078|9930655|FG001|NOT COMPLETED|Overall Study||8
8873701|NCT01898091|9930665|FG000|STARTED|Overall Study|Allocated to intervention. All allocated received intervention.|25
8873702|NCT01898091|9930666|FG001|STARTED|Overall Study|Allocated to intervention. All allocated received intervention.|25
8873703|NCT01898091|9930665|FG000|COMPLETED|Overall Study||23
8873704|NCT01898091|9930666|FG001|COMPLETED|Overall Study||19
8873705|NCT01898091|9930665|FG000|NOT COMPLETED|Overall Study||2
8873706|NCT01898091|9930666|FG001|NOT COMPLETED|Overall Study||6
8873707|NCT01898130|9930672|FG000|STARTED|Treatment||27
8873708|NCT01898130|9930672|FG000|Reached 1st Response/2 Cycles|Treatment||24
8873709|NCT01898130|9930672|FG000|Went on to Start Cycle 3|Treatment||21
8873710|NCT01898130|9930672|FG000|COMPLETED|Treatment||21
8873711|NCT01898130|9930672|FG000|NOT COMPLETED|Treatment||6
8873712|NCT01898130|9930672|FG000|STARTED|Follow up Until PD or Death|All patients treated on study go into follow up period for survival data.|27
8873713|NCT01898130|9930672|FG000|COMPLETED|Follow up Until PD or Death||26
8873714|NCT01898130|9930672|FG000|NOT COMPLETED|Follow up Until PD or Death||1
8873715|NCT01898195|9930679|FG000|STARTED|Varenicline Adherence||53
8873716|NCT01898195|9930680|FG001|STARTED|Varenicline Adherence||54
8873717|NCT01898195|9930681|FG002|STARTED|Varenicline Adherence||51
8873718|NCT01898195|9930679|FG000|COMPLETED|Varenicline Adherence||18
8873719|NCT01898195|9930680|FG001|COMPLETED|Varenicline Adherence||16
8873720|NCT01898195|9930681|FG002|COMPLETED|Varenicline Adherence||15
8873721|NCT01898195|9930679|FG000|NOT COMPLETED|Varenicline Adherence||35
8873722|NCT01898195|9930680|FG001|NOT COMPLETED|Varenicline Adherence||38
8873723|NCT01898195|9930681|FG002|NOT COMPLETED|Varenicline Adherence||36
8873724|NCT01898195|9930679|FG000|STARTED|Smoking Abstinence||53
8873725|NCT01898195|9930680|FG001|STARTED|Smoking Abstinence||54
8873726|NCT01898195|9930681|FG002|STARTED|Smoking Abstinence||51
8873727|NCT01898195|9930679|FG000|COMPLETED|Smoking Abstinence||18
8873728|NCT01898195|9930680|FG001|COMPLETED|Smoking Abstinence||16
8873729|NCT01898195|9930681|FG002|COMPLETED|Smoking Abstinence||15
8873730|NCT01898195|9930679|FG000|NOT COMPLETED|Smoking Abstinence||35
8873731|NCT01898195|9930680|FG001|NOT COMPLETED|Smoking Abstinence||38
8873732|NCT01898195|9930681|FG002|NOT COMPLETED|Smoking Abstinence||36
8873733|NCT01898208|9930692|FG000|STARTED|Overall Study||247
8873734|NCT01898208|9930693|FG001|STARTED|Overall Study||247
8873735|NCT01898208|9930694|FG002|STARTED|Overall Study||249
8873736|NCT01898208|9930692|FG000|COMPLETED|Overall Study||207
8873737|NCT01898208|9930693|FG001|COMPLETED|Overall Study||198
8873738|NCT01898208|9930694|FG002|COMPLETED|Overall Study||212
8873739|NCT01898208|9930692|FG000|NOT COMPLETED|Overall Study||40
8873740|NCT01898208|9930693|FG001|NOT COMPLETED|Overall Study||49
8873741|NCT01898208|9930694|FG002|NOT COMPLETED|Overall Study||37
8873742|NCT01898286|9930702|FG000|STARTED|Overall Study||38
8924063|NCT02246413|9984758|FG000|COMPLETED|24-months (Secondary Outcome)||153
8873743|NCT01898286|9930702|FG000|COMPLETED|Overall Study|"For this study completed is defined as completing the Early Termination visit"|35
8873744|NCT01898286|9930702|FG000|NOT COMPLETED|Overall Study||3
8873745|NCT01898299|9930708|FG000|STARTED|Post Treatment (One Week)||47
8873746|NCT01898299|9930709|FG001|STARTED|Post Treatment (One Week)||42
8873747|NCT01898299|9930708|FG000|COMPLETED|Post Treatment (One Week)||47
8873748|NCT01898299|9930709|FG001|COMPLETED|Post Treatment (One Week)||42
8873749|NCT01898299|9930708|FG000|NOT COMPLETED|Post Treatment (One Week)||0
8873750|NCT01898299|9930709|FG001|NOT COMPLETED|Post Treatment (One Week)||0
8873751|NCT01898299|9930708|FG000|STARTED|Post Treatment (One Month)||47
8873752|NCT01898299|9930709|FG001|STARTED|Post Treatment (One Month)||42
8873753|NCT01898299|9930708|FG000|COMPLETED|Post Treatment (One Month)||44
8873754|NCT01898299|9930709|FG001|COMPLETED|Post Treatment (One Month)||38
8873755|NCT01898299|9930708|FG000|NOT COMPLETED|Post Treatment (One Month)||3
8873756|NCT01898299|9930709|FG001|NOT COMPLETED|Post Treatment (One Month)||4
8873757|NCT01898403|9930715|FG000|STARTED|Overall Study||50
8873758|NCT01898403|9930715|FG000|COMPLETED|Overall Study||50
8873759|NCT01898403|9930715|FG000|NOT COMPLETED|Overall Study||0
8873760|NCT01898429|9930721|FG000|STARTED|Phase 1||5
8873761|NCT01898429|9930722|FG001|STARTED|Phase 1||0
8873762|NCT01898429|9930723|FG002|STARTED|Phase 1||0
8873763|NCT01898429|9930721|FG000|COMPLETED|Phase 1||5
8873764|NCT01898429|9930722|FG001|COMPLETED|Phase 1||0
8873765|NCT01898429|9930723|FG002|COMPLETED|Phase 1||0
8873766|NCT01898429|9930721|FG000|NOT COMPLETED|Phase 1||0
8873767|NCT01898429|9930722|FG001|NOT COMPLETED|Phase 1||0
8873768|NCT01898429|9930723|FG002|NOT COMPLETED|Phase 1||0
8873769|NCT01898429|9930721|FG000|STARTED|Phase 2||0
8873770|NCT01898429|9930722|FG001|STARTED|Phase 2||5
8873771|NCT01898429|9930723|FG002|STARTED|Phase 2||0
8873772|NCT01898429|9930721|FG000|COMPLETED|Phase 2||0
8873773|NCT01898429|9930722|FG001|COMPLETED|Phase 2||5
8873774|NCT01898429|9930723|FG002|COMPLETED|Phase 2||0
8873775|NCT01898429|9930721|FG000|NOT COMPLETED|Phase 2||0
8873776|NCT01898429|9930722|FG001|NOT COMPLETED|Phase 2||0
8873777|NCT01898429|9930723|FG002|NOT COMPLETED|Phase 2||0
8873778|NCT01898429|9930721|FG000|STARTED|Phase 3||0
8873779|NCT01898429|9930722|FG001|STARTED|Phase 3||0
8873780|NCT01898429|9930723|FG002|STARTED|Phase 3||5
8873781|NCT01898429|9930721|FG000|COMPLETED|Phase 3||0
8873782|NCT01898429|9930722|FG001|COMPLETED|Phase 3||0
8873783|NCT01898429|9930723|FG002|COMPLETED|Phase 3||5
8873784|NCT01898429|9930721|FG000|NOT COMPLETED|Phase 3||0
8873785|NCT01898429|9930722|FG001|NOT COMPLETED|Phase 3||0
8873786|NCT01898429|9930723|FG002|NOT COMPLETED|Phase 3||0
8873787|NCT01898442|9930730|FG000|STARTED|Overall Study||17
8873788|NCT01898442|9930731|FG001|STARTED|Overall Study||17
8873789|NCT01898442|9930732|FG002|STARTED|Overall Study||18
8873790|NCT01898442|9930730|FG000|COMPLETED|Overall Study||16
8873791|NCT01898442|9930731|FG001|COMPLETED|Overall Study||15
8873792|NCT01898442|9930732|FG002|COMPLETED|Overall Study||15
8873793|NCT01898442|9930730|FG000|NOT COMPLETED|Overall Study||1
8873794|NCT01898442|9930731|FG001|NOT COMPLETED|Overall Study||2
8873795|NCT01898442|9930732|FG002|NOT COMPLETED|Overall Study||3
8873796|NCT01898598|9930742|FG000|STARTED|Overall Study||12
8873797|NCT01898598|9930743|FG001|STARTED|Overall Study||6
8873798|NCT01898598|9930742|FG000|Treated|Overall Study||11
8873799|NCT01898598|9930743|FG001|Treated|Overall Study||5
8873800|NCT01898598|9930742|FG000|COMPLETED|Overall Study||8
8873801|NCT01898598|9930743|FG001|COMPLETED|Overall Study||4
8873802|NCT01898598|9930742|FG000|NOT COMPLETED|Overall Study||4
8873803|NCT01898598|9930743|FG001|NOT COMPLETED|Overall Study||2
8873804|NCT01898611|9930751|FG000|STARTED|Overall Study||5
8873805|NCT01898611|9930752|FG001|STARTED|Overall Study||11
8873806|NCT01898611|9930751|FG000|COMPLETED|Overall Study||5
8873807|NCT01898611|9930752|FG001|COMPLETED|Overall Study||10
8873808|NCT01898611|9930751|FG000|NOT COMPLETED|Overall Study||0
8873809|NCT01898611|9930752|FG001|NOT COMPLETED|Overall Study||1
8873810|NCT01898689|9930760|FG000|STARTED|Overall Study||10
8873811|NCT01898689|9930761|FG001|STARTED|Overall Study||14
8873812|NCT01898689|9930760|FG000|COMPLETED|Overall Study||10
8873813|NCT01898689|9930761|FG001|COMPLETED|Overall Study||14
8873814|NCT01898689|9930760|FG000|NOT COMPLETED|Overall Study||0
8873815|NCT01898689|9930761|FG001|NOT COMPLETED|Overall Study||0
8873816|NCT01898754|9930771|FG000|STARTED|Overall Study||494
8873817|NCT01898754|9930772|FG001|STARTED|Overall Study||497
8873818|NCT01898754|9930771|FG000|COMPLETED|Overall Study||400
8873819|NCT01898754|9930772|FG001|COMPLETED|Overall Study||403
8873820|NCT01898754|9930771|FG000|NOT COMPLETED|Overall Study||94
8873821|NCT01898754|9930772|FG001|NOT COMPLETED|Overall Study||94
8873822|NCT01898806|9930778|FG000|STARTED|Overall Study||11
8873823|NCT01898806|9930778|FG000|COMPLETED|Overall Study||8
8873824|NCT01898806|9930778|FG000|NOT COMPLETED|Overall Study||3
8873825|NCT01898884|9930787|FG000|STARTED|Single Dose Period||8
8873826|NCT01898884|9930788|FG001|STARTED|Single Dose Period||6
8873827|NCT01898884|9930789|FG002|STARTED|Single Dose Period||6
8873828|NCT01898884|9930790|FG003|STARTED|Single Dose Period||6
8873829|NCT01898884|9930791|FG004|STARTED|Single Dose Period||6
8873830|NCT01898884|9930792|FG005|STARTED|Single Dose Period||0
8873831|NCT01898884|9930793|FG006|STARTED|Single Dose Period||0
8873832|NCT01898884|9930794|FG007|STARTED|Single Dose Period||0
8873833|NCT01898884|9930795|FG008|STARTED|Single Dose Period||0
8873834|NCT01898884|9930787|FG000|COMPLETED|Single Dose Period||8
8873835|NCT01898884|9930788|FG001|COMPLETED|Single Dose Period||6
8873836|NCT01898884|9930789|FG002|COMPLETED|Single Dose Period||6
8873837|NCT01898884|9930790|FG003|COMPLETED|Single Dose Period||6
8873838|NCT01898884|9930791|FG004|COMPLETED|Single Dose Period||6
8873839|NCT01898884|9930792|FG005|COMPLETED|Single Dose Period||0
8873840|NCT01898884|9930793|FG006|COMPLETED|Single Dose Period||0
8873841|NCT01898884|9930794|FG007|COMPLETED|Single Dose Period||0
8873842|NCT01898884|9930795|FG008|COMPLETED|Single Dose Period||0
8873843|NCT01898884|9930787|FG000|NOT COMPLETED|Single Dose Period||0
8873844|NCT01898884|9930788|FG001|NOT COMPLETED|Single Dose Period||0
8873845|NCT01898884|9930789|FG002|NOT COMPLETED|Single Dose Period||0
8873846|NCT01898884|9930790|FG003|NOT COMPLETED|Single Dose Period||0
8873847|NCT01898884|9930791|FG004|NOT COMPLETED|Single Dose Period||0
8873848|NCT01898884|9930792|FG005|NOT COMPLETED|Single Dose Period||0
8873849|NCT01898884|9930793|FG006|NOT COMPLETED|Single Dose Period||0
8873850|NCT01898884|9930794|FG007|NOT COMPLETED|Single Dose Period||0
8873851|NCT01898884|9930795|FG008|NOT COMPLETED|Single Dose Period||0
8873852|NCT01898884|9930787|FG000|STARTED|Multiple Dose Period||0
8873853|NCT01898884|9930788|FG001|STARTED|Multiple Dose Period||0
8873854|NCT01898884|9930789|FG002|STARTED|Multiple Dose Period||0
8873855|NCT01898884|9930790|FG003|STARTED|Multiple Dose Period||0
8873856|NCT01898884|9930791|FG004|STARTED|Multiple Dose Period||0
8873857|NCT01898884|9930792|FG005|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
8873858|NCT01898884|9930793|FG006|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
8873859|NCT01898884|9930794|FG007|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
8873860|NCT01898884|9930795|FG008|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
8873861|NCT01898884|9930787|FG000|Treated|Multiple Dose Period||0
8873862|NCT01898884|9930788|FG001|Treated|Multiple Dose Period||0
8873863|NCT01898884|9930789|FG002|Treated|Multiple Dose Period||0
8873864|NCT01898884|9930790|FG003|Treated|Multiple Dose Period||0
8873865|NCT01898884|9930791|FG004|Treated|Multiple Dose Period||0
8873866|NCT01898884|9930792|FG005|Treated|Multiple Dose Period||6
8873867|NCT01898884|9930793|FG006|Treated|Multiple Dose Period||6
8873868|NCT01898884|9930794|FG007|Treated|Multiple Dose Period||6
8873869|NCT01898884|9930795|FG008|Treated|Multiple Dose Period||5
8873870|NCT01898884|9930787|FG000|COMPLETED|Multiple Dose Period||0
8873871|NCT01898884|9930788|FG001|COMPLETED|Multiple Dose Period||0
8873872|NCT01898884|9930789|FG002|COMPLETED|Multiple Dose Period||0
8873873|NCT01898884|9930790|FG003|COMPLETED|Multiple Dose Period||0
8873874|NCT01898884|9930791|FG004|COMPLETED|Multiple Dose Period||0
8873875|NCT01898884|9930792|FG005|COMPLETED|Multiple Dose Period||6
8873876|NCT01898884|9930793|FG006|COMPLETED|Multiple Dose Period||5
8873877|NCT01898884|9930794|FG007|COMPLETED|Multiple Dose Period||6
8873878|NCT01898884|9930795|FG008|COMPLETED|Multiple Dose Period||5
8873879|NCT01898884|9930787|FG000|NOT COMPLETED|Multiple Dose Period||0
8873880|NCT01898884|9930788|FG001|NOT COMPLETED|Multiple Dose Period||0
8873881|NCT01898884|9930789|FG002|NOT COMPLETED|Multiple Dose Period||0
8873882|NCT01898884|9930790|FG003|NOT COMPLETED|Multiple Dose Period||0
8873883|NCT01898884|9930791|FG004|NOT COMPLETED|Multiple Dose Period||0
8873884|NCT01898884|9930792|FG005|NOT COMPLETED|Multiple Dose Period||0
8873885|NCT01898884|9930793|FG006|NOT COMPLETED|Multiple Dose Period||1
8873886|NCT01898884|9930794|FG007|NOT COMPLETED|Multiple Dose Period||0
8873887|NCT01898884|9930795|FG008|NOT COMPLETED|Multiple Dose Period||1
8873888|NCT01898923|9930833|FG000|STARTED|Overall Study||122
8873889|NCT01898923|9930834|FG001|STARTED|Overall Study||114
8873890|NCT01898923|9930833|FG000|COMPLETED|Overall Study||106
8873891|NCT01898923|9930834|FG001|COMPLETED|Overall Study||93
8873892|NCT01898923|9930833|FG000|NOT COMPLETED|Overall Study||16
8873893|NCT01898923|9930834|FG001|NOT COMPLETED|Overall Study||21
8873894|NCT01899053|9930854|FG000|STARTED|Overall Study||7
8873895|NCT01899053|9930855|FG001|STARTED|Overall Study||3
8873896|NCT01899053|9930856|FG002|STARTED|Overall Study||7
8873897|NCT01899053|9930857|FG003|STARTED|Overall Study||3
8873898|NCT01899053|9930858|FG004|STARTED|Overall Study||6
8873899|NCT01899053|9930859|FG005|STARTED|Overall Study||3
8873900|NCT01899053|9930860|FG006|STARTED|Overall Study||3
8873901|NCT01899053|9930861|FG007|STARTED|Overall Study||3
8873902|NCT01899053|9930862|FG008|STARTED|Overall Study||6
8873903|NCT01899053|9930863|FG009|STARTED|Overall Study||3
8873904|NCT01899053|9930864|FG010|STARTED|Overall Study||16
8873905|NCT01899053|9930865|FG011|STARTED|Overall Study||7
8873906|NCT01899053|9930866|FG012|STARTED|Overall Study||14
8873907|NCT01899053|9930867|FG013|STARTED|Overall Study||20
8873908|NCT01899053|9930854|FG000|COMPLETED|Overall Study||0
8873909|NCT01899053|9930855|FG001|COMPLETED|Overall Study||0
8873910|NCT01899053|9930856|FG002|COMPLETED|Overall Study||0
8873911|NCT01899053|9930857|FG003|COMPLETED|Overall Study||0
8873912|NCT01899053|9930858|FG004|COMPLETED|Overall Study||0
8873913|NCT01899053|9930859|FG005|COMPLETED|Overall Study||0
8873914|NCT01899053|9930860|FG006|COMPLETED|Overall Study||0
8873915|NCT01899053|9930861|FG007|COMPLETED|Overall Study||0
8873916|NCT01899053|9930862|FG008|COMPLETED|Overall Study||0
8873917|NCT01899053|9930863|FG009|COMPLETED|Overall Study||0
8873918|NCT01899053|9930864|FG010|COMPLETED|Overall Study||0
8873919|NCT01899053|9930865|FG011|COMPLETED|Overall Study||0
8873920|NCT01899053|9930866|FG012|COMPLETED|Overall Study||0
8873921|NCT01899053|9930867|FG013|COMPLETED|Overall Study||0
8873922|NCT01899053|9930854|FG000|NOT COMPLETED|Overall Study||7
8873923|NCT01899053|9930855|FG001|NOT COMPLETED|Overall Study||3
8873924|NCT01899053|9930856|FG002|NOT COMPLETED|Overall Study||7
8873925|NCT01899053|9930857|FG003|NOT COMPLETED|Overall Study||3
8873926|NCT01899053|9930858|FG004|NOT COMPLETED|Overall Study||6
8873927|NCT01899053|9930859|FG005|NOT COMPLETED|Overall Study||3
8873928|NCT01899053|9930860|FG006|NOT COMPLETED|Overall Study||3
8873929|NCT01899053|9930861|FG007|NOT COMPLETED|Overall Study||3
8873930|NCT01899053|9930862|FG008|NOT COMPLETED|Overall Study||6
8873931|NCT01899053|9930863|FG009|NOT COMPLETED|Overall Study||3
8873932|NCT01899053|9930864|FG010|NOT COMPLETED|Overall Study||16
8873933|NCT01899053|9930865|FG011|NOT COMPLETED|Overall Study||7
8873934|NCT01899053|9930866|FG012|NOT COMPLETED|Overall Study||14
8873935|NCT01899053|9930867|FG013|NOT COMPLETED|Overall Study||20
8873936|NCT01899300|9930899|FG000|STARTED|Overall Study||1
8873937|NCT01899300|9930900|FG001|STARTED|Overall Study||0
8873938|NCT01899300|9930899|FG000|COMPLETED|Overall Study||1
8873939|NCT01899300|9930900|FG001|COMPLETED|Overall Study||0
8873940|NCT01899300|9930899|FG000|NOT COMPLETED|Overall Study||0
8873941|NCT01899300|9930900|FG001|NOT COMPLETED|Overall Study||0
8873942|NCT01899677|9930908|FG000|STARTED|Overall Study||35
8873943|NCT01899677|9930909|FG001|STARTED|Overall Study||35
8873944|NCT01899677|9930908|FG000|COMPLETED|Overall Study||25
8873945|NCT01899677|9930909|FG001|COMPLETED|Overall Study||28
8873946|NCT01899677|9930908|FG000|NOT COMPLETED|Overall Study||10
8873947|NCT01899677|9930909|FG001|NOT COMPLETED|Overall Study||7
8873948|NCT01899742|9930917|FG000|STARTED|Overall Study||247
8873949|NCT01899742|9930918|FG001|STARTED|Overall Study||247
8873950|NCT01899742|9930917|FG000|COMPLETED|Overall Study||230
8873951|NCT01899742|9930918|FG001|COMPLETED|Overall Study||231
8873952|NCT01899742|9930917|FG000|NOT COMPLETED|Overall Study||17
8873953|NCT01899742|9930918|FG001|NOT COMPLETED|Overall Study||16
8873954|NCT01899768|9930924|FG000|STARTED|Part A||16
8873955|NCT01899768|9930924|FG000|COMPLETED|Part A||13
8873956|NCT01899768|9930924|FG000|NOT COMPLETED|Part A||3
8873957|NCT01899768|9930924|FG000|STARTED|Part B||13
8873958|NCT01899768|9930924|FG000|COMPLETED|Part B||11
8873959|NCT01899768|9930924|FG000|NOT COMPLETED|Part B||2
8873960|NCT01899768|9930924|FG000|STARTED|Part C||11
8873961|NCT01899768|9930924|FG000|COMPLETED|Part C||11
8873962|NCT01899768|9930924|FG000|NOT COMPLETED|Part C||0
8873963|NCT01899911|9930932|FG000|STARTED|Overall Study||12
8873964|NCT01899911|9930932|FG000|COMPLETED|Overall Study||12
8873965|NCT01899911|9930932|FG000|NOT COMPLETED|Overall Study||0
8873966|NCT01900054|9930936|FG000|STARTED|Overall Study||58
8873967|NCT01900054|9930936|FG000|COMPLETED|Overall Study||56
8873968|NCT01900054|9930936|FG000|NOT COMPLETED|Overall Study||2
8873969|NCT01900067|9930942|FG000|STARTED|Overall Study||134
8873970|NCT01900067|9930943|FG001|STARTED|Overall Study||137
8873971|NCT01900067|9930942|FG000|COMPLETED|Overall Study||122
8873972|NCT01900067|9930943|FG001|COMPLETED|Overall Study||124
8873973|NCT01900067|9930942|FG000|NOT COMPLETED|Overall Study||12
8873974|NCT01900067|9930943|FG001|NOT COMPLETED|Overall Study||13
8873975|NCT01900249|9930952|FG000|STARTED|Overall Study||67
8873976|NCT01900249|9930953|FG001|STARTED|Overall Study||68
8873977|NCT01900249|9930954|FG002|STARTED|Overall Study||69
8873978|NCT01900249|9930952|FG000|COMPLETED|Overall Study||64
8873979|NCT01900249|9930953|FG001|COMPLETED|Overall Study||63
8873980|NCT01900249|9930954|FG002|COMPLETED|Overall Study||65
8873981|NCT01900249|9930952|FG000|NOT COMPLETED|Overall Study||3
8873982|NCT01900249|9930953|FG001|NOT COMPLETED|Overall Study||5
8873983|NCT01900249|9930954|FG002|NOT COMPLETED|Overall Study||4
8873984|NCT01900314|9930964|FG000|STARTED|Overall Study||20
8873985|NCT01900314|9930965|FG001|STARTED|Overall Study||20
8873986|NCT01900314|9930964|FG000|Completed MRI#1|Overall Study|2 withdrew consent prior to MRI, 1 had MRI technical failure|17
8873987|NCT01900314|9930965|FG001|Completed MRI#1|Overall Study|2 withdrew consent, 1 patient was unable to tolerate MRI|17
8873988|NCT01900314|9930964|FG000|COMPLETED|Overall Study|1 patient had MRI, then moved away after 5 TMS treatments|16
8873989|NCT01900314|9930965|FG001|COMPLETED|Overall Study|1 patient had 4 TMS Tx, but missed too many for protocol requirements,|16
8873990|NCT01900314|9930964|FG000|NOT COMPLETED|Overall Study||4
8873991|NCT01900314|9930965|FG001|NOT COMPLETED|Overall Study||4
8873992|NCT01900392|9930975|FG000|STARTED|Overall Study||39
8873993|NCT01900392|9930976|FG001|STARTED|Overall Study||75
8873994|NCT01900392|9930977|FG002|STARTED|Overall Study||77
8873995|NCT01900392|9930975|FG000|COMPLETED|Overall Study||38
8873996|NCT01900392|9930976|FG001|COMPLETED|Overall Study||74
8873997|NCT01900392|9930977|FG002|COMPLETED|Overall Study||77
8873998|NCT01900392|9930975|FG000|NOT COMPLETED|Overall Study||1
8873999|NCT01900392|9930976|FG001|NOT COMPLETED|Overall Study||1
8874000|NCT01900392|9930977|FG002|NOT COMPLETED|Overall Study||0
8874001|NCT01900431|9930987|FG000|STARTED|Principal Treatment Period (Part A)||20
8874002|NCT01900431|9930988|FG001|STARTED|Principal Treatment Period (Part A)||38
8874003|NCT01900431|9930989|FG002|STARTED|Principal Treatment Period (Part A)||0
8874004|NCT01900431|9930987|FG000|COMPLETED|Principal Treatment Period (Part A)|8 responders entered Part B and 5 non-responders entered Part C.|13
8874005|NCT01900431|9930988|FG001|COMPLETED|Principal Treatment Period (Part A)|22 responders entered Part B, 5 non-responders entered Part C, 1 discontinued the study.|28
8874006|NCT01900431|9930989|FG002|COMPLETED|Principal Treatment Period (Part A)||0
8874007|NCT01900431|9930987|FG000|NOT COMPLETED|Principal Treatment Period (Part A)||7
8874008|NCT01900431|9930988|FG001|NOT COMPLETED|Principal Treatment Period (Part A)||10
8874009|NCT01900431|9930989|FG002|NOT COMPLETED|Principal Treatment Period (Part A)||0
8874010|NCT01900431|9930987|FG000|STARTED|Extended Treatment Period (Part B)||8
8874011|NCT01900431|9930988|FG001|STARTED|Extended Treatment Period (Part B)||22
8874012|NCT01900431|9930989|FG002|STARTED|Extended Treatment Period (Part B)||0
8874013|NCT01900431|9930987|FG000|COMPLETED|Extended Treatment Period (Part B)||7
8874014|NCT01900431|9930988|FG001|COMPLETED|Extended Treatment Period (Part B)||12
8874015|NCT01900431|9930989|FG002|COMPLETED|Extended Treatment Period (Part B)||0
8874016|NCT01900431|9930987|FG000|NOT COMPLETED|Extended Treatment Period (Part B)||1
8874017|NCT01900431|9930988|FG001|NOT COMPLETED|Extended Treatment Period (Part B)||10
8874018|NCT01900431|9930989|FG002|NOT COMPLETED|Extended Treatment Period (Part B)||0
8874019|NCT01900431|9930987|FG000|STARTED|Open-Label Treatment Period (Part C)||0
8874020|NCT01900431|9930988|FG001|STARTED|Open-Label Treatment Period (Part C)||0
8874021|NCT01900431|9930989|FG002|STARTED|Open-Label Treatment Period (Part C)|10 non-responders (5 Placebo, 5 Sarilumab) & 11 non-completers (6 Placebo, 5 Sarilumab) from Part A.|21
8874022|NCT01900431|9930987|FG000|COMPLETED|Open-Label Treatment Period (Part C)||0
8874023|NCT01900431|9930988|FG001|COMPLETED|Open-Label Treatment Period (Part C)||0
8874024|NCT01900431|9930989|FG002|COMPLETED|Open-Label Treatment Period (Part C)||13
8874025|NCT01900431|9930987|FG000|NOT COMPLETED|Open-Label Treatment Period (Part C)||0
8874026|NCT01900431|9930988|FG001|NOT COMPLETED|Open-Label Treatment Period (Part C)||0
8874027|NCT01900431|9930989|FG002|NOT COMPLETED|Open-Label Treatment Period (Part C)||8
8874028|NCT01900561|9930999|FG000|STARTED|Overall Study||278
8874029|NCT01900561|9931000|FG001|STARTED|Overall Study||278
8874030|NCT01900561|9930999|FG000|COMPLETED|Overall Study||261
8874031|NCT01900561|9931000|FG001|COMPLETED|Overall Study||269
8874032|NCT01900561|9930999|FG000|NOT COMPLETED|Overall Study||17
8874033|NCT01900561|9931000|FG001|NOT COMPLETED|Overall Study||9
8874034|NCT01900652|9931008|FG000|STARTED|Overall Study||83
8874035|NCT01900652|9931009|FG001|STARTED|Overall Study||28
8874036|NCT01900652|9931008|FG000|Post-Erlotinib Progression Tumor Sample|Overall Study||66
8874037|NCT01900652|9931009|FG001|Post-Erlotinib Progression Tumor Sample|Overall Study||23
8874038|NCT01900652|9931008|FG000|COMPLETED|Overall Study||75
8874039|NCT01900652|9931009|FG001|COMPLETED|Overall Study||25
8874040|NCT01900652|9931008|FG000|NOT COMPLETED|Overall Study||8
8874041|NCT01900652|9931009|FG001|NOT COMPLETED|Overall Study||3
8874042|NCT01900665|9931022|FG000|STARTED|Placebo Controlled Period||1057
8874043|NCT01900665|9931023|FG001|STARTED|Placebo Controlled Period||1072
8874044|NCT01900665|9931022|FG000|Received at Least 1 Dose of Study Drug|Placebo Controlled Period||1054
8874045|NCT01900665|9931023|FG001|Received at Least 1 Dose of Study Drug|Placebo Controlled Period||1067
8874046|NCT01900665|9931022|FG000|COMPLETED|Placebo Controlled Period||914
8874047|NCT01900665|9931023|FG001|COMPLETED|Placebo Controlled Period||908
8874048|NCT01900665|9931022|FG000|NOT COMPLETED|Placebo Controlled Period||143
8874049|NCT01900665|9931023|FG001|NOT COMPLETED|Placebo Controlled Period||164
8874050|NCT01900665|9931022|FG000|STARTED|Open Label Period|Patients from Placebo Controlled Period were not required to enter into Open Label Period.|881
8874051|NCT01900665|9931023|FG001|STARTED|Open Label Period|Patients from Placebo Controlled Period were not required to enter into Open Label Period.|859
8874052|NCT01900665|9931022|FG000|COMPLETED|Open Label Period||0
8874053|NCT01900665|9931023|FG001|COMPLETED|Open Label Period||0
8874054|NCT01900665|9931022|FG000|NOT COMPLETED|Open Label Period||881
8874055|NCT01900665|9931023|FG001|NOT COMPLETED|Open Label Period||859
8874056|NCT01900704|9931035|FG000|STARTED|Overall Study||270
8874057|NCT01900704|9931036|FG001|STARTED|Overall Study||270
8874058|NCT01900704|9931037|FG002|STARTED|Overall Study||270
8874059|NCT01900704|9931035|FG000|COMPLETED|Overall Study||229
8874060|NCT01900704|9931036|FG001|COMPLETED|Overall Study||235
8874061|NCT01900704|9931037|FG002|COMPLETED|Overall Study||237
8874062|NCT01900704|9931035|FG000|NOT COMPLETED|Overall Study||41
8874063|NCT01900704|9931036|FG001|NOT COMPLETED|Overall Study||35
8874064|NCT01900704|9931037|FG002|NOT COMPLETED|Overall Study||33
8874065|NCT01900899|9931048|FG000|STARTED|Overall Study||159
8874066|NCT01900899|9931049|FG001|STARTED|Overall Study||25
8874067|NCT01900899|9931048|FG000|COMPLETED|Overall Study||150
8874068|NCT01900899|9931049|FG001|COMPLETED|Overall Study||24
8874069|NCT01900899|9931048|FG000|NOT COMPLETED|Overall Study||9
8874070|NCT01900899|9931049|FG001|NOT COMPLETED|Overall Study||1
8924064|NCT02246413|9984759|FG001|COMPLETED|24-months (Secondary Outcome)||173
8924065|NCT02246413|9984758|FG000|NOT COMPLETED|24-months (Secondary Outcome)||51
8924066|NCT02246413|9984759|FG001|NOT COMPLETED|24-months (Secondary Outcome)||32
8924067|NCT02246439|9984767|FG000|STARTED|Overall Study|6 participants that enrolled in the study did not receive allocated intervention.|192
8924068|NCT02246439|9984768|FG001|STARTED|Overall Study|3 participants that enrolled in the study did not receive allocated intervention.|129
8924069|NCT02246439|9984767|FG000|Randomized|Overall Study||198
8924070|NCT02246439|9984768|FG001|Randomized|Overall Study||132
8924071|NCT02246439|9984767|FG000|COMPLETED|Overall Study||180
8924072|NCT02246439|9984768|FG001|COMPLETED|Overall Study||118
8924073|NCT02246439|9984767|FG000|NOT COMPLETED|Overall Study||12
8924074|NCT02246439|9984768|FG001|NOT COMPLETED|Overall Study||11
8924075|NCT02246478|9984778|FG000|STARTED|Single-dose Phase||6
8924076|NCT02246478|9984779|FG001|STARTED|Single-dose Phase||5
8924077|NCT02246478|9984780|FG002|STARTED|Single-dose Phase||5
8924078|NCT02246478|9984781|FG003|STARTED|Single-dose Phase||5
8924079|NCT02246478|9984778|FG000|COMPLETED|Single-dose Phase||6
8924080|NCT02246478|9984779|FG001|COMPLETED|Single-dose Phase||5
8924081|NCT02246478|9984780|FG002|COMPLETED|Single-dose Phase||5
8874071|NCT01901055|9931057|FG000|STARTED|Randomization But Not Titrated||49
8874072|NCT01901055|9931058|FG001|STARTED|Randomization But Not Titrated||49
8874073|NCT01901055|9931057|FG000|COMPLETED|Randomization But Not Titrated||48
8874074|NCT01901055|9931058|FG001|COMPLETED|Randomization But Not Titrated||47
8874075|NCT01901055|9931057|FG000|NOT COMPLETED|Randomization But Not Titrated||1
8874076|NCT01901055|9931058|FG001|NOT COMPLETED|Randomization But Not Titrated||2
8874077|NCT01901055|9931057|FG000|STARTED|Started Protocol to Week 6||48
8874078|NCT01901055|9931058|FG001|STARTED|Started Protocol to Week 6||47
8874079|NCT01901055|9931057|FG000|COMPLETED|Started Protocol to Week 6||45
8874080|NCT01901055|9931058|FG001|COMPLETED|Started Protocol to Week 6||43
8874081|NCT01901055|9931057|FG000|NOT COMPLETED|Started Protocol to Week 6||3
8874082|NCT01901055|9931058|FG001|NOT COMPLETED|Started Protocol to Week 6||4
8874083|NCT01901055|9931057|FG000|STARTED|Week 12 Assessment||45
8874084|NCT01901055|9931058|FG001|STARTED|Week 12 Assessment||43
8874085|NCT01901055|9931057|FG000|COMPLETED|Week 12 Assessment||44
8874086|NCT01901055|9931058|FG001|COMPLETED|Week 12 Assessment||39
8874087|NCT01901055|9931057|FG000|NOT COMPLETED|Week 12 Assessment||1
8874088|NCT01901055|9931058|FG001|NOT COMPLETED|Week 12 Assessment||4
8874089|NCT01901055|9931057|FG000|STARTED|Week 24||44
8874090|NCT01901055|9931058|FG001|STARTED|Week 24||39
8874091|NCT01901055|9931057|FG000|COMPLETED|Week 24||30
8874092|NCT01901055|9931058|FG001|COMPLETED|Week 24||20
8874093|NCT01901055|9931057|FG000|NOT COMPLETED|Week 24||14
8874094|NCT01901055|9931058|FG001|NOT COMPLETED|Week 24||19
8874095|NCT01901055|9931057|FG000|STARTED|Week 36||30
8874096|NCT01901055|9931058|FG001|STARTED|Week 36||20
8874097|NCT01901055|9931057|FG000|COMPLETED|Week 36||30
8874098|NCT01901055|9931058|FG001|COMPLETED|Week 36||15
8874099|NCT01901055|9931057|FG000|NOT COMPLETED|Week 36||0
8874100|NCT01901055|9931058|FG001|NOT COMPLETED|Week 36||5
8874101|NCT01901146|9931069|FG000|STARTED|Neoadjuvant Phase||364
8874102|NCT01901146|9931070|FG001|STARTED|Neoadjuvant Phase||361
8874103|NCT01901146|9931071|FG002|STARTED|Neoadjuvant Phase||0
8874104|NCT01901146|9931072|FG003|STARTED|Neoadjuvant Phase||0
8874105|NCT01901146|9931073|FG004|STARTED|Neoadjuvant Phase||0
8874106|NCT01901146|9931069|FG000|COMPLETED|Neoadjuvant Phase|Indicates participants who completed surgery|358
8874107|NCT01901146|9931070|FG001|COMPLETED|Neoadjuvant Phase|Indicates participants who completed surgery|347
8874108|NCT01901146|9931071|FG002|COMPLETED|Neoadjuvant Phase||0
8874109|NCT01901146|9931072|FG003|COMPLETED|Neoadjuvant Phase||0
8874110|NCT01901146|9931073|FG004|COMPLETED|Neoadjuvant Phase||0
8874111|NCT01901146|9931069|FG000|NOT COMPLETED|Neoadjuvant Phase||6
8874112|NCT01901146|9931070|FG001|NOT COMPLETED|Neoadjuvant Phase||14
8874113|NCT01901146|9931071|FG002|NOT COMPLETED|Neoadjuvant Phase||0
8874114|NCT01901146|9931072|FG003|NOT COMPLETED|Neoadjuvant Phase||0
8874115|NCT01901146|9931073|FG004|NOT COMPLETED|Neoadjuvant Phase||0
8631216|NCT00538850|9671112|FG002|NOT COMPLETED|Placebo - Double-blind||3
8631217|NCT00538863|9671118|FG000|STARTED|Open-label Titration||229
8874116|NCT01901146|9931069|FG000|STARTED|Adjuvant Phase||0
8874117|NCT01901146|9931070|FG001|STARTED|Adjuvant Phase||0
8874118|NCT01901146|9931071|FG002|STARTED|Adjuvant Phase|Nine participants discontinued the study after surgery but before entering adjuvant phase.|349
8874119|NCT01901146|9931072|FG003|STARTED|Adjuvant Phase|Two participants discontinued the study after surgery but before entering adjuvant phase.|171
8874120|NCT01901146|9931073|FG004|STARTED|Adjuvant Phase|Three participants discontinued the study after surgery but before entering adjuvant phase.|171
8874121|NCT01901146|9931069|FG000|COMPLETED|Adjuvant Phase||0
8874122|NCT01901146|9931070|FG001|COMPLETED|Adjuvant Phase||0
8874123|NCT01901146|9931071|FG002|COMPLETED|Adjuvant Phase||323
8874124|NCT01901146|9931072|FG003|COMPLETED|Adjuvant Phase||164
8874125|NCT01901146|9931073|FG004|COMPLETED|Adjuvant Phase||157
8874126|NCT01901146|9931069|FG000|NOT COMPLETED|Adjuvant Phase||0
8874127|NCT01901146|9931070|FG001|NOT COMPLETED|Adjuvant Phase||0
8874128|NCT01901146|9931071|FG002|NOT COMPLETED|Adjuvant Phase||26
8874129|NCT01901146|9931072|FG003|NOT COMPLETED|Adjuvant Phase||7
8874130|NCT01901146|9931073|FG004|NOT COMPLETED|Adjuvant Phase||14
8874131|NCT01901185|9931082|FG000|STARTED|Overall Study||77
8874132|NCT01901185|9931082|FG000|Received Etanercept With Autoinjector A|Overall Study||75
8874133|NCT01901185|9931082|FG000|COMPLETED|Overall Study||75
8874134|NCT01901185|9931082|FG000|NOT COMPLETED|Overall Study||2
8953589|NCT02473367|10016855|FG000|NOT COMPLETED|Wait 1||1
8953590|NCT02473367|10016855|FG000|STARTED|Period 2||19
8631218|NCT00538863|9671118|FG000|COMPLETED|Open-label Titration||184
8953591|NCT02473367|10016855|FG000|COMPLETED|Period 2||19
8953592|NCT02473367|10016855|FG000|NOT COMPLETED|Period 2||0
8953593|NCT02473367|10016855|FG000|STARTED|Wait 2||19
8953594|NCT02473367|10016855|FG000|COMPLETED|Wait 2||19
8631219|NCT00538863|9671118|FG000|NOT COMPLETED|Open-label Titration||45
8953595|NCT02473367|10016855|FG000|NOT COMPLETED|Wait 2||0
8953596|NCT02473367|10016855|FG000|STARTED|Period 3||19
8953597|NCT02473367|10016855|FG000|COMPLETED|Period 3||19
8953598|NCT02473367|10016855|FG000|NOT COMPLETED|Period 3||0
8953599|NCT02473367|10016855|FG000|STARTED|Wait 3||19
8953600|NCT02473367|10016855|FG000|COMPLETED|Wait 3||19
8953601|NCT02473367|10016855|FG000|NOT COMPLETED|Wait 3||0
8953602|NCT02473367|10016855|FG000|STARTED|Period 4||19
8953603|NCT02473367|10016855|FG000|COMPLETED|Period 4||18
8953604|NCT02473367|10016855|FG000|NOT COMPLETED|Period 4||1
8953605|NCT02473393|10016869|FG000|STARTED|Overall Study||5
8874135|NCT01901211|9931088|FG000|STARTED|First Ten-week Period||6
8953606|NCT02473393|10016870|FG001|STARTED|Overall Study||12
8953607|NCT02473393|10016871|FG002|STARTED|Overall Study||13
8874136|NCT01901211|9931089|FG001|STARTED|First Ten-week Period||5
8874137|NCT01901211|9931088|FG000|COMPLETED|First Ten-week Period||6
8874138|NCT01901211|9931089|FG001|COMPLETED|First Ten-week Period||5
8874139|NCT01901211|9931088|FG000|NOT COMPLETED|First Ten-week Period||0
8874140|NCT01901211|9931089|FG001|NOT COMPLETED|First Ten-week Period||0
8874141|NCT01901211|9931088|FG000|STARTED|Washout (6 Weeks)||6
8874142|NCT01901211|9931089|FG001|STARTED|Washout (6 Weeks)||5
8874143|NCT01901211|9931088|FG000|COMPLETED|Washout (6 Weeks)||6
8874144|NCT01901211|9931089|FG001|COMPLETED|Washout (6 Weeks)||5
8874145|NCT01901211|9931088|FG000|NOT COMPLETED|Washout (6 Weeks)||0
8874146|NCT01901211|9931089|FG001|NOT COMPLETED|Washout (6 Weeks)||0
8874147|NCT01901211|9931088|FG000|STARTED|Second Ten-week Period||6
8874148|NCT01901211|9931089|FG001|STARTED|Second Ten-week Period||5
8874149|NCT01901211|9931088|FG000|COMPLETED|Second Ten-week Period||6
8874150|NCT01901211|9931089|FG001|COMPLETED|Second Ten-week Period||5
8874151|NCT01901211|9931088|FG000|NOT COMPLETED|Second Ten-week Period||0
8874152|NCT01901211|9931089|FG001|NOT COMPLETED|Second Ten-week Period||0
8874153|NCT01901250|9931097|FG000|STARTED|Overall Study||260
8874154|NCT01901250|9931098|FG001|STARTED|Overall Study||265
8874155|NCT01901250|9931097|FG000|End of Kidergarten|Overall Study||215
8953608|NCT02473393|10016872|FG003|STARTED|Overall Study||13
8953609|NCT02473393|10016869|FG000|COMPLETED|Overall Study||5
8953610|NCT02473393|10016870|FG001|COMPLETED|Overall Study||12
8953611|NCT02473393|10016871|FG002|COMPLETED|Overall Study||11
8953612|NCT02473393|10016872|FG003|COMPLETED|Overall Study||12
8953613|NCT02473393|10016869|FG000|NOT COMPLETED|Overall Study||0
8953614|NCT02473393|10016870|FG001|NOT COMPLETED|Overall Study||0
8953615|NCT02473393|10016871|FG002|NOT COMPLETED|Overall Study||2
8953616|NCT02473393|10016872|FG003|NOT COMPLETED|Overall Study||1
8874156|NCT01901250|9931098|FG001|End of Kidergarten|Overall Study||212
8874157|NCT01901250|9931097|FG000|Start of 1st Grade|Overall Study||173
8874158|NCT01901250|9931098|FG001|Start of 1st Grade|Overall Study||176
8874159|NCT01901250|9931097|FG000|End of 1st Grade|Overall Study||143
8874160|NCT01901250|9931098|FG001|End of 1st Grade|Overall Study||151
8874161|NCT01901250|9931097|FG000|COMPLETED|Overall Study||122
8874162|NCT01901250|9931098|FG001|COMPLETED|Overall Study||139
8874163|NCT01901250|9931097|FG000|NOT COMPLETED|Overall Study||138
8874164|NCT01901250|9931098|FG001|NOT COMPLETED|Overall Study||126
8874165|NCT01901302|9931106|FG000|STARTED|Overall Study||31
8874166|NCT01901302|9931107|FG001|STARTED|Overall Study||30
8874167|NCT01901302|9931106|FG000|Received at Least 1 Dose of Study Drug|Overall Study||31
8874168|NCT01901302|9931107|FG001|Received at Least 1 Dose of Study Drug|Overall Study||30
8874169|NCT01901302|9931106|FG000|COMPLETED|Overall Study||4
8874170|NCT01901302|9931107|FG001|COMPLETED|Overall Study||7
8874171|NCT01901302|9931106|FG000|NOT COMPLETED|Overall Study||27
8874172|NCT01901302|9931107|FG001|NOT COMPLETED|Overall Study||23
8874173|NCT01901328|9931115|FG000|STARTED|Overall Study||26
8874174|NCT01901328|9931116|FG001|STARTED|Overall Study||23
8874175|NCT01901328|9931115|FG000|Received at Least 1 Dose of Study Drug|Overall Study||26
8874176|NCT01901328|9931116|FG001|Received at Least 1 Dose of Study Drug|Overall Study||23
8874177|NCT01901328|9931115|FG000|COMPLETED|Overall Study||4
8874178|NCT01901328|9931116|FG001|COMPLETED|Overall Study||2
8874179|NCT01901328|9931115|FG000|NOT COMPLETED|Overall Study||22
8874180|NCT01901328|9931116|FG001|NOT COMPLETED|Overall Study||21
8874181|NCT01901341|9931125|FG000|STARTED|Overall Study||22
8874182|NCT01901341|9931126|FG001|STARTED|Overall Study||22
8874183|NCT01901341|9931125|FG000|Received at Least 1 Dose of Study Drug|Overall Study||22
8874184|NCT01901341|9931126|FG001|Received at Least 1 Dose of Study Drug|Overall Study||22
8874185|NCT01901341|9931125|FG000|COMPLETED|Overall Study||2
8874186|NCT01901341|9931126|FG001|COMPLETED|Overall Study||1
8874187|NCT01901341|9931125|FG000|NOT COMPLETED|Overall Study||20
8874188|NCT01901341|9931126|FG001|NOT COMPLETED|Overall Study||21
8874189|NCT01901393|9931135|FG000|STARTED|Overall Study||51
8874190|NCT01901393|9931136|FG001|STARTED|Overall Study||49
8874191|NCT01901393|9931135|FG000|COMPLETED|Overall Study||50
8874192|NCT01901393|9931136|FG001|COMPLETED|Overall Study||49
8874193|NCT01901393|9931135|FG000|NOT COMPLETED|Overall Study||1
8874194|NCT01901393|9931136|FG001|NOT COMPLETED|Overall Study||0
8874195|NCT01901419|9931144|FG000|STARTED|Overall Study||40
8874196|NCT01901419|9931145|FG001|STARTED|Overall Study||40
8874197|NCT01901419|9931144|FG000|COMPLETED|Overall Study||32
8874198|NCT01901419|9931145|FG001|COMPLETED|Overall Study||31
8874199|NCT01901419|9931144|FG000|NOT COMPLETED|Overall Study||8
8874200|NCT01901419|9931145|FG001|NOT COMPLETED|Overall Study||9
8874201|NCT01901575|9931151|FG000|STARTED|Overall Study|enrolled patients with PVC's present prior to sedation with remifentanil IVPCA|16
8874202|NCT01901575|9931151|FG000|COMPLETED|Overall Study||16
8874203|NCT01901575|9931151|FG000|NOT COMPLETED|Overall Study||0
8874204|NCT01901588|9931158|FG000|STARTED|Overall Study||32
8874205|NCT01901588|9931159|FG001|STARTED|Overall Study||31
8874206|NCT01901588|9931158|FG000|COMPLETED|Overall Study||32
8874207|NCT01901588|9931159|FG001|COMPLETED|Overall Study||31
8874208|NCT01901588|9931158|FG000|NOT COMPLETED|Overall Study||0
8874209|NCT01901588|9931159|FG001|NOT COMPLETED|Overall Study||0
8874210|NCT01901614|9931167|FG000|STARTED|Overall Study||3
8874211|NCT01901614|9931168|FG001|STARTED|Overall Study||2
8874212|NCT01901614|9931167|FG000|COMPLETED|Overall Study||1
8953617|NCT02473471|10016882|FG000|STARTED|Overall Study||35
8874213|NCT01901614|9931168|FG001|COMPLETED|Overall Study||1
8953618|NCT02473471|10016882|FG000|Received Allocated Intervention|Overall Study||33
8874214|NCT01901614|9931167|FG000|NOT COMPLETED|Overall Study||2
8874215|NCT01901614|9931168|FG001|NOT COMPLETED|Overall Study||1
8874216|NCT01901653|9931187|FG000|STARTED|Overall Study||3
8874217|NCT01901653|9931188|FG001|STARTED|Overall Study||1
8874218|NCT01901653|9931189|FG002|STARTED|Overall Study||11
8874219|NCT01901653|9931190|FG003|STARTED|Overall Study||3
8874220|NCT01901653|9931191|FG004|STARTED|Overall Study||2
8874221|NCT01901653|9931192|FG005|STARTED|Overall Study||3
8874222|NCT01901653|9931193|FG006|STARTED|Overall Study||7
8874223|NCT01901653|9931194|FG007|STARTED|Overall Study||10
8874224|NCT01901653|9931195|FG008|STARTED|Overall Study||1
8874225|NCT01901653|9931196|FG009|STARTED|Overall Study||18
8874226|NCT01901653|9931197|FG010|STARTED|Overall Study||2
8874227|NCT01901653|9931198|FG011|STARTED|Overall Study||16
8874228|NCT01901653|9931199|FG012|STARTED|Overall Study||5
8874229|NCT01901653|9931187|FG000|COMPLETED|Overall Study||0
8874230|NCT01901653|9931188|FG001|COMPLETED|Overall Study||0
8874231|NCT01901653|9931189|FG002|COMPLETED|Overall Study||0
8874232|NCT01901653|9931190|FG003|COMPLETED|Overall Study||0
8874233|NCT01901653|9931191|FG004|COMPLETED|Overall Study||0
8874234|NCT01901653|9931192|FG005|COMPLETED|Overall Study||0
8874235|NCT01901653|9931193|FG006|COMPLETED|Overall Study||0
8874236|NCT01901653|9931194|FG007|COMPLETED|Overall Study||0
8874237|NCT01901653|9931195|FG008|COMPLETED|Overall Study||0
8874238|NCT01901653|9931196|FG009|COMPLETED|Overall Study||0
8874239|NCT01901653|9931197|FG010|COMPLETED|Overall Study||0
8874240|NCT01901653|9931198|FG011|COMPLETED|Overall Study||0
8874241|NCT01901653|9931199|FG012|COMPLETED|Overall Study||0
8874242|NCT01901653|9931187|FG000|NOT COMPLETED|Overall Study||3
8874243|NCT01901653|9931188|FG001|NOT COMPLETED|Overall Study||1
8874244|NCT01901653|9931189|FG002|NOT COMPLETED|Overall Study||11
8874245|NCT01901653|9931190|FG003|NOT COMPLETED|Overall Study||3
8874246|NCT01901653|9931191|FG004|NOT COMPLETED|Overall Study||2
8874247|NCT01901653|9931192|FG005|NOT COMPLETED|Overall Study||3
8874248|NCT01901653|9931193|FG006|NOT COMPLETED|Overall Study||7
8874249|NCT01901653|9931194|FG007|NOT COMPLETED|Overall Study||10
8874250|NCT01901653|9931195|FG008|NOT COMPLETED|Overall Study||1
8874251|NCT01901653|9931196|FG009|NOT COMPLETED|Overall Study||18
8874252|NCT01901653|9931197|FG010|NOT COMPLETED|Overall Study||2
8874253|NCT01901653|9931198|FG011|NOT COMPLETED|Overall Study||16
8874254|NCT01901653|9931199|FG012|NOT COMPLETED|Overall Study||5
8874255|NCT01901809|9931229|FG000|STARTED|Overall Study||19
8874256|NCT01901809|9931230|FG001|STARTED|Overall Study||23
8874257|NCT01901809|9931231|FG002|STARTED|Overall Study||24
8874258|NCT01901809|9931232|FG003|STARTED|Overall Study||24
8874259|NCT01901809|9931229|FG000|COMPLETED|Overall Study||19
8874260|NCT01901809|9931230|FG001|COMPLETED|Overall Study||23
8874261|NCT01901809|9931231|FG002|COMPLETED|Overall Study||21
8874262|NCT01901809|9931232|FG003|COMPLETED|Overall Study||22
8874263|NCT01901809|9931229|FG000|NOT COMPLETED|Overall Study||0
8874264|NCT01901809|9931230|FG001|NOT COMPLETED|Overall Study||0
8874265|NCT01901809|9931231|FG002|NOT COMPLETED|Overall Study||3
8874266|NCT01901809|9931232|FG003|NOT COMPLETED|Overall Study||2
8874267|NCT01901848|9931248|FG000|STARTED|Randomized and Treated||25
8874268|NCT01901848|9931249|FG001|STARTED|Randomized and Treated||25
8874269|NCT01901848|9931248|FG000|COMPLETED|Randomized and Treated|Ten cases were practice cases used to establish fidelity to CPT, and were removed from analyses.|22
8874270|NCT01901848|9931249|FG001|COMPLETED|Randomized and Treated||19
8874271|NCT01901848|9931248|FG000|NOT COMPLETED|Randomized and Treated||3
8874272|NCT01901848|9931249|FG001|NOT COMPLETED|Randomized and Treated||6
8874273|NCT01901848|9931248|FG000|STARTED|Removed From Analyses||22
8874274|NCT01901848|9931249|FG001|STARTED|Removed From Analyses||19
8874275|NCT01901848|9931248|FG000|COMPLETED|Removed From Analyses||12
8874276|NCT01901848|9931249|FG001|COMPLETED|Removed From Analyses||19
8874277|NCT01901848|9931248|FG000|NOT COMPLETED|Removed From Analyses||10
8874278|NCT01901848|9931249|FG001|NOT COMPLETED|Removed From Analyses||0
8874279|NCT01901874|9931255|FG000|STARTED|Procedure||312
8874280|NCT01901874|9931255|FG000|COMPLETED|Procedure||312
8874281|NCT01901874|9931255|FG000|NOT COMPLETED|Procedure||0
8874282|NCT01901874|9931255|FG000|STARTED|Screening Committee Retrospective Review||312
8874283|NCT01901874|9931255|FG000|COMPLETED|Screening Committee Retrospective Review||265
8874284|NCT01901874|9931255|FG000|NOT COMPLETED|Screening Committee Retrospective Review||47
8874285|NCT01901874|9931255|FG000|STARTED|30-Day MAE Evaluation||265
8874286|NCT01901874|9931255|FG000|COMPLETED|30-Day MAE Evaluation||264
8874287|NCT01901874|9931255|FG000|NOT COMPLETED|30-Day MAE Evaluation||1
8874288|NCT01901874|9931255|FG000|STARTED|1-Year (365-Day) MAE Evaluation||264
8874289|NCT01901874|9931255|FG000|COMPLETED|1-Year (365-Day) MAE Evaluation||244
8874290|NCT01901874|9931255|FG000|NOT COMPLETED|1-Year (365-Day) MAE Evaluation||20
8874291|NCT01902004|9931261|FG000|STARTED|Overall Study||48
8874292|NCT01902004|9931262|FG001|STARTED|Overall Study||47
8874293|NCT01902004|9931261|FG000|COMPLETED|Overall Study||33
8874294|NCT01902004|9931262|FG001|COMPLETED|Overall Study||29
8874295|NCT01902004|9931261|FG000|NOT COMPLETED|Overall Study||15
8874296|NCT01902004|9931262|FG001|NOT COMPLETED|Overall Study||18
8874297|NCT01902134|9931274|FG000|STARTED|Overall Study||159
8874298|NCT01902134|9931275|FG001|STARTED|Overall Study||161
8874299|NCT01902134|9931276|FG002|STARTED|Overall Study||160
8874300|NCT01902134|9931277|FG003|STARTED|Overall Study||54
8874301|NCT01902134|9931278|FG004|STARTED|Overall Study||53
8874302|NCT01902134|9931279|FG005|STARTED|Overall Study||54
8874303|NCT01902134|9931274|FG000|Single-dose Phase|Overall Study||159
8874304|NCT01902134|9931275|FG001|Single-dose Phase|Overall Study||161
8874305|NCT01902134|9931276|FG002|Single-dose Phase|Overall Study||160
8874306|NCT01902134|9931277|FG003|Single-dose Phase|Overall Study||54
8874307|NCT01902134|9931278|FG004|Single-dose Phase|Overall Study||53
8874308|NCT01902134|9931279|FG005|Single-dose Phase|Overall Study||54
8874309|NCT01902134|9931274|FG000|Multiple-dose Phase|Overall Study||159
8874310|NCT01902134|9931275|FG001|Multiple-dose Phase|Overall Study||160
8874311|NCT01902134|9931276|FG002|Multiple-dose Phase|Overall Study||160
8874312|NCT01902134|9931277|FG003|Multiple-dose Phase|Overall Study||54
8874313|NCT01902134|9931278|FG004|Multiple-dose Phase|Overall Study||53
8874314|NCT01902134|9931279|FG005|Multiple-dose Phase|Overall Study||52
8874315|NCT01902134|9931274|FG000|COMPLETED|Overall Study||151
8874316|NCT01902134|9931275|FG001|COMPLETED|Overall Study||150
8874317|NCT01902134|9931276|FG002|COMPLETED|Overall Study||145
8570007|NCT00100165|9602110|FG001|NOT COMPLETED|Washout (1 Week)||0
8570008|NCT00100165|9602111|FG002|NOT COMPLETED|Washout (1 Week)||0
8570009|NCT00100165|9602109|FG000|STARTED|Second Intervention (4 Weeks)||10
8570010|NCT00100165|9602110|FG001|STARTED|Second Intervention (4 Weeks)||10
8570011|NCT00100165|9602111|FG002|STARTED|Second Intervention (4 Weeks)||9
8570012|NCT00100165|9602109|FG000|COMPLETED|Second Intervention (4 Weeks)||10
8570013|NCT00100165|9602110|FG001|COMPLETED|Second Intervention (4 Weeks)||10
8570014|NCT00100165|9602111|FG002|COMPLETED|Second Intervention (4 Weeks)||9
8570015|NCT00100165|9602109|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0
8570016|NCT00100165|9602110|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||0
8570017|NCT00100165|9602111|FG002|NOT COMPLETED|Second Intervention (4 Weeks)||0
8570018|NCT00100165|9602109|FG000|STARTED|Washout (1 Week)||10
8570019|NCT00100165|9602110|FG001|STARTED|Washout (1 Week)||10
8570020|NCT00100165|9602111|FG002|STARTED|Washout (1 Week)||9
8570021|NCT00100165|9602109|FG000|COMPLETED|Washout (1 Week)||10
8570022|NCT00100165|9602110|FG001|COMPLETED|Washout (1 Week)||10
8570023|NCT00100165|9602111|FG002|COMPLETED|Washout (1 Week)||9
8570024|NCT00100165|9602109|FG000|NOT COMPLETED|Washout (1 Week)||0
8570025|NCT00100165|9602110|FG001|NOT COMPLETED|Washout (1 Week)||0
8570026|NCT00100165|9602111|FG002|NOT COMPLETED|Washout (1 Week)||0
8570027|NCT00100165|9602109|FG000|STARTED|Third Intervention (4 Weeks)||10
8570028|NCT00100165|9602110|FG001|STARTED|Third Intervention (4 Weeks)||10
8570029|NCT00100165|9602111|FG002|STARTED|Third Intervention (4 Weeks)||9
8570030|NCT00100165|9602109|FG000|COMPLETED|Third Intervention (4 Weeks)||10
8570031|NCT00100165|9602110|FG001|COMPLETED|Third Intervention (4 Weeks)||10
8570032|NCT00100165|9602111|FG002|COMPLETED|Third Intervention (4 Weeks)||9
8570033|NCT00100165|9602109|FG000|NOT COMPLETED|Third Intervention (4 Weeks)||0
8570034|NCT00100165|9602110|FG001|NOT COMPLETED|Third Intervention (4 Weeks)||0
8570035|NCT00100165|9602111|FG002|NOT COMPLETED|Third Intervention (4 Weeks)||0
8570036|NCT00100178|9602125|FG000|STARTED|Overall Study||41
8570037|NCT00100178|9602126|FG001|STARTED|Overall Study|12 subjects randomized to the MMF alone group were excluded from analysis due to randomization error|31
8570038|NCT00100178|9602127|FG002|STARTED|Overall Study||42
8570039|NCT00100178|9602125|FG000|COMPLETED|Overall Study||32
8570040|NCT00100178|9602126|FG001|COMPLETED|Overall Study||21
8570041|NCT00100178|9602127|FG002|COMPLETED|Overall Study||32
8570042|NCT00100178|9602125|FG000|NOT COMPLETED|Overall Study||9
8570043|NCT00100178|9602126|FG001|NOT COMPLETED|Overall Study||10
8570044|NCT00100178|9602127|FG002|NOT COMPLETED|Overall Study||10
8570045|NCT00100230|9602137|FG000|STARTED|Overall Study||41
8570046|NCT00100230|9602138|FG001|STARTED|Overall Study||37
8570047|NCT00100230|9602137|FG000|COMPLETED|Overall Study||29
8570048|NCT00100230|9602138|FG001|COMPLETED|Overall Study||22
8570049|NCT00100230|9602137|FG000|NOT COMPLETED|Overall Study||12
8570050|NCT00100230|9602138|FG001|NOT COMPLETED|Overall Study||15
8570051|NCT00100659|9602148|FG000|STARTED|Overall Study||55
8570052|NCT00100659|9602149|FG001|STARTED|Overall Study||59
8570053|NCT00100659|9602148|FG000|COMPLETED|Overall Study||52
8570054|NCT00100659|9602149|FG001|COMPLETED|Overall Study||57
8570055|NCT00100659|9602148|FG000|NOT COMPLETED|Overall Study||3
8570056|NCT00100659|9602149|FG001|NOT COMPLETED|Overall Study||2
8570057|NCT00100698|9602159|FG000|STARTED|Overall Study||27
8570058|NCT00100698|9602160|FG001|STARTED|Overall Study||29
8570059|NCT00100698|9602159|FG000|COMPLETED|Overall Study||21
8874318|NCT01902134|9931277|FG003|COMPLETED|Overall Study||52
8874319|NCT01902134|9931278|FG004|COMPLETED|Overall Study||46
8570060|NCT00100698|9602160|FG001|COMPLETED|Overall Study||27
8874320|NCT01902134|9931279|FG005|COMPLETED|Overall Study||45
8874321|NCT01902134|9931274|FG000|NOT COMPLETED|Overall Study||8
8874322|NCT01902134|9931275|FG001|NOT COMPLETED|Overall Study||11
8874323|NCT01902134|9931276|FG002|NOT COMPLETED|Overall Study||15
8874324|NCT01902134|9931277|FG003|NOT COMPLETED|Overall Study||2
8874325|NCT01902134|9931278|FG004|NOT COMPLETED|Overall Study||7
8874326|NCT01902134|9931279|FG005|NOT COMPLETED|Overall Study||9
8874327|NCT01902303|9931297|FG000|STARTED|Overall Study|Allocated to placebo|77
8874328|NCT01902303|9931298|FG001|STARTED|Overall Study|Allocated to active treatment|81
8924082|NCT02246478|9984781|FG003|COMPLETED|Single-dose Phase||5
8924083|NCT02246478|9984778|FG000|NOT COMPLETED|Single-dose Phase||0
8924084|NCT02246478|9984779|FG001|NOT COMPLETED|Single-dose Phase||0
8924085|NCT02246478|9984780|FG002|NOT COMPLETED|Single-dose Phase||0
8924086|NCT02246478|9984781|FG003|NOT COMPLETED|Single-dose Phase||0
8924087|NCT02246478|9984778|FG000|STARTED|Multiple-dose Phase||6
8924088|NCT02246478|9984779|FG001|STARTED|Multiple-dose Phase||5
8924089|NCT02246478|9984780|FG002|STARTED|Multiple-dose Phase||5
8924090|NCT02246478|9984781|FG003|STARTED|Multiple-dose Phase||5
8924091|NCT02246478|9984778|FG000|COMPLETED|Multiple-dose Phase||5
8924092|NCT02246478|9984779|FG001|COMPLETED|Multiple-dose Phase||5
8924093|NCT02246478|9984780|FG002|COMPLETED|Multiple-dose Phase||5
8924094|NCT02246478|9984781|FG003|COMPLETED|Multiple-dose Phase||4
8924095|NCT02246478|9984778|FG000|NOT COMPLETED|Multiple-dose Phase||1
8924096|NCT02246478|9984779|FG001|NOT COMPLETED|Multiple-dose Phase||0
8924097|NCT02246478|9984780|FG002|NOT COMPLETED|Multiple-dose Phase||0
8924098|NCT02246478|9984781|FG003|NOT COMPLETED|Multiple-dose Phase||1
8924099|NCT02246582|9984798|FG000|STARTED|Overall Study||44
8924100|NCT02246582|9984799|FG001|STARTED|Overall Study||45
8924101|NCT02246582|9984798|FG000|COMPLETED|Overall Study||41
8924102|NCT02246582|9984799|FG001|COMPLETED|Overall Study||41
8924103|NCT02246582|9984798|FG000|NOT COMPLETED|Overall Study||3
8924104|NCT02246582|9984799|FG001|NOT COMPLETED|Overall Study||4
8924105|NCT02246608|9984805|FG000|STARTED|Overall Study||22
8924106|NCT02246608|9984806|FG001|STARTED|Overall Study||21
8924107|NCT02246608|9984805|FG000|COMPLETED|Overall Study||10
8924108|NCT02246608|9984806|FG001|COMPLETED|Overall Study||11
8924109|NCT02246608|9984805|FG000|NOT COMPLETED|Overall Study||12
8924110|NCT02246608|9984806|FG001|NOT COMPLETED|Overall Study||10
8924111|NCT02246647|9984814|FG000|STARTED|Overall Study||19
8924112|NCT02246647|9984815|FG001|STARTED|Overall Study||20
8924113|NCT02246647|9984814|FG000|COMPLETED|Overall Study||18
8924114|NCT02246647|9984815|FG001|COMPLETED|Overall Study||19
8924115|NCT02246647|9984814|FG000|NOT COMPLETED|Overall Study||1
8924116|NCT02246647|9984815|FG001|NOT COMPLETED|Overall Study||1
8924117|NCT02246660|9984838|FG000|STARTED|Overall Study||23
8924118|NCT02246660|9984839|FG001|STARTED|Overall Study||21
8924119|NCT02246660|9984840|FG002|STARTED|Overall Study||22
8924120|NCT02246660|9984838|FG000|COMPLETED|Overall Study||23
8924121|NCT02246660|9984839|FG001|COMPLETED|Overall Study||20
8924122|NCT02246660|9984840|FG002|COMPLETED|Overall Study||21
8924123|NCT02246660|9984838|FG000|NOT COMPLETED|Overall Study||0
8924124|NCT02246660|9984839|FG001|NOT COMPLETED|Overall Study||1
8924125|NCT02246660|9984840|FG002|NOT COMPLETED|Overall Study||1
8924126|NCT02246673|9984853|FG000|STARTED|Overall Study||14
8924127|NCT02246673|9984854|FG001|STARTED|Overall Study||12
8924128|NCT02246673|9984855|FG002|STARTED|Overall Study||12
8924129|NCT02246673|9984856|FG003|STARTED|Overall Study||14
8924130|NCT02246673|9984857|FG004|STARTED|Overall Study||12
8924131|NCT02246673|9984853|FG000|COMPLETED|Overall Study||13
8924132|NCT02246673|9984854|FG001|COMPLETED|Overall Study||12
8924133|NCT02246673|9984855|FG002|COMPLETED|Overall Study||12
8924134|NCT02246673|9984856|FG003|COMPLETED|Overall Study||12
8924135|NCT02246673|9984857|FG004|COMPLETED|Overall Study||11
8924136|NCT02246673|9984853|FG000|NOT COMPLETED|Overall Study||1
8924137|NCT02246673|9984854|FG001|NOT COMPLETED|Overall Study||0
8924138|NCT02246673|9984855|FG002|NOT COMPLETED|Overall Study||0
8924139|NCT02246673|9984856|FG003|NOT COMPLETED|Overall Study||2
8924140|NCT02246673|9984857|FG004|NOT COMPLETED|Overall Study||1
8924141|NCT02246764|9984902|FG000|STARTED|Overall Study||34
8924142|NCT02246764|9984903|FG001|STARTED|Overall Study||36
8924143|NCT02246764|9984904|FG002|STARTED|Overall Study||23
8924144|NCT02246764|9984902|FG000|COMPLETED|Overall Study||16
8924145|NCT02246764|9984903|FG001|COMPLETED|Overall Study||4
8924146|NCT02246764|9984904|FG002|COMPLETED|Overall Study||19
8924147|NCT02246764|9984902|FG000|NOT COMPLETED|Overall Study||18
8924148|NCT02246764|9984903|FG001|NOT COMPLETED|Overall Study||32
8924149|NCT02246764|9984904|FG002|NOT COMPLETED|Overall Study||4
8924150|NCT02246777|9984912|FG000|STARTED|Overall Study||32
8924151|NCT02246777|9984912|FG000|COMPLETED|Overall Study||29
8924152|NCT02246777|9984912|FG000|NOT COMPLETED|Overall Study||3
8924153|NCT02246998|9984925|FG000|STARTED|Overall Study||18
8924154|NCT02246998|9984926|FG001|STARTED|Overall Study||18
8924155|NCT02246998|9984927|FG002|STARTED|Overall Study||18
8924156|NCT02246998|9984928|FG003|STARTED|Overall Study||18
8924157|NCT02246998|9984925|FG000|COMPLETED|Overall Study||16
8924158|NCT02246998|9984926|FG001|COMPLETED|Overall Study||15
8924159|NCT02246998|9984927|FG002|COMPLETED|Overall Study||15
8924160|NCT02246998|9984928|FG003|COMPLETED|Overall Study||16
8874329|NCT01902303|9931297|FG000|Number of Participants|Overall Study|Number of randomized participants who developed a cold sore and used the assigned treatment.|56
8874330|NCT01902303|9931298|FG001|Number of Participants|Overall Study|Number of randomized participants who developed a cold sore and used the assigned treatment.|62
8874331|NCT01902303|9931297|FG000|COMPLETED|Overall Study|21 not treated - did not use placebo medication as they did not develop cold sore|54
8953619|NCT02473471|10016882|FG000|Randomized Not Treated|Overall Study||2
8953620|NCT02473471|10016882|FG000|COMPLETED|Overall Study||32
8953621|NCT02473471|10016882|FG000|NOT COMPLETED|Overall Study||3
8953622|NCT02473510|10016894|FG000|STARTED|Overall Study||60
8953623|NCT02473510|10016895|FG001|STARTED|Overall Study||240
8874332|NCT01902303|9931298|FG001|COMPLETED|Overall Study|19 not treated /did not use medication as they did not develop a cold sore|57
8874333|NCT01902303|9931297|FG000|NOT COMPLETED|Overall Study||23
8874334|NCT01902303|9931298|FG001|NOT COMPLETED|Overall Study||24
8874335|NCT01902459|9931308|FG000|STARTED|Overall Study||75
8874336|NCT01902459|9931309|FG001|STARTED|Overall Study||75
8874337|NCT01902459|9931308|FG000|COMPLETED|Overall Study||75
8874338|NCT01902459|9931309|FG001|COMPLETED|Overall Study||75
8874339|NCT01902459|9931308|FG000|NOT COMPLETED|Overall Study||0
8874340|NCT01902459|9931309|FG001|NOT COMPLETED|Overall Study||0
8874341|NCT01902628|9931315|FG000|STARTED|Overall Study||437
8874342|NCT01902628|9931315|FG000|COMPLETED|Overall Study||354
8874343|NCT01902628|9931315|FG000|NOT COMPLETED|Overall Study||83
8874344|NCT01902758|9931321|FG000|STARTED|Overall Study||14
8874345|NCT01902758|9931322|FG001|STARTED|Overall Study||14
8874346|NCT01902758|9931321|FG000|COMPLETED|Overall Study||14
8953624|NCT02473510|10016894|FG000|COMPLETED|Overall Study||59
8953625|NCT02473510|10016895|FG001|COMPLETED|Overall Study||238
8953626|NCT02473510|10016894|FG000|NOT COMPLETED|Overall Study||1
8953627|NCT02473510|10016895|FG001|NOT COMPLETED|Overall Study||2
8953628|NCT02473614|10016901|FG000|STARTED|First Intervention (3 Weeks)||6
8953629|NCT02473614|10016902|FG001|STARTED|First Intervention (3 Weeks)||5
8953630|NCT02473614|10016901|FG000|COMPLETED|First Intervention (3 Weeks)||5
8631220|NCT00538863|9671118|FG000|STARTED|Open-label Maintenance|Five participants who completed the titration period did not start the maintenance period.|269
8631221|NCT00538863|9671118|FG000|COMPLETED|Open-label Maintenance||163
8631222|NCT00538863|9671118|FG000|NOT COMPLETED|Open-label Maintenance||106
8953631|NCT02473614|10016902|FG001|COMPLETED|First Intervention (3 Weeks)||5
8953632|NCT02473614|10016901|FG000|NOT COMPLETED|First Intervention (3 Weeks)||1
8953633|NCT02473614|10016902|FG001|NOT COMPLETED|First Intervention (3 Weeks)||0
8570061|NCT00100698|9602159|FG000|NOT COMPLETED|Overall Study||6
8570062|NCT00100698|9602160|FG001|NOT COMPLETED|Overall Study||2
8570063|NCT00100789|9602166|FG000|STARTED|Overall Study||67
8570064|NCT00100789|9602166|FG000|Eligible|Overall Study||64
8570065|NCT00100789|9602166|FG000|Eligible and Began Protocol Therapy|Overall Study||63
8570066|NCT00100789|9602166|FG000|COMPLETED|Overall Study||3
8570067|NCT00100789|9602166|FG000|NOT COMPLETED|Overall Study||64
8570068|NCT00100802|9602171|FG000|STARTED|Overall Study||118
8874347|NCT01902758|9931322|FG001|COMPLETED|Overall Study||14
8874348|NCT01902758|9931321|FG000|NOT COMPLETED|Overall Study||0
8953634|NCT02473614|10016901|FG000|STARTED|Wash Out Period (3 Weeks)||5
8953635|NCT02473614|10016902|FG001|STARTED|Wash Out Period (3 Weeks)||5
8953636|NCT02473614|10016901|FG000|COMPLETED|Wash Out Period (3 Weeks)||5
8570069|NCT00100802|9602171|FG000|COMPLETED|Overall Study||38
8570070|NCT00100802|9602171|FG000|NOT COMPLETED|Overall Study||80
8570071|NCT00100815|9602175|FG000|STARTED|Overall Study||50
8874349|NCT01902758|9931322|FG001|NOT COMPLETED|Overall Study||0
8874350|NCT01902901|9931330|FG000|STARTED|Overall Study||180
8953637|NCT02473614|10016902|FG001|COMPLETED|Wash Out Period (3 Weeks)||5
8953638|NCT02473614|10016901|FG000|NOT COMPLETED|Wash Out Period (3 Weeks)||0
8953639|NCT02473614|10016902|FG001|NOT COMPLETED|Wash Out Period (3 Weeks)||0
8874351|NCT01902901|9931331|FG001|STARTED|Overall Study||203
8874352|NCT01902901|9931330|FG000|COMPLETED|Overall Study||180
8874353|NCT01902901|9931331|FG001|COMPLETED|Overall Study||201
8874354|NCT01902901|9931330|FG000|NOT COMPLETED|Overall Study||0
8874355|NCT01902901|9931331|FG001|NOT COMPLETED|Overall Study||2
8874356|NCT01902953|9931337|FG000|STARTED|Overall Study||16
8874357|NCT01902953|9931337|FG000|COMPLETED|Overall Study||16
8874358|NCT01902953|9931337|FG000|NOT COMPLETED|Overall Study||0
8874359|NCT01903005|9931343|FG000|STARTED|Overall Study|Primary study OX219-006 (n=475); Primary study OX219-007 (n=190)|665
8874360|NCT01903005|9931343|FG000|COMPLETED|Overall Study|Primary study OX219-006 (n=194); Primary study OX219-007 (n=98)|292
8874361|NCT01903005|9931343|FG000|NOT COMPLETED|Overall Study||373
8874362|NCT01903031|9931351|FG000|STARTED|Overall Study||27
8874363|NCT01903031|9931352|FG001|STARTED|Overall Study||28
8874364|NCT01903031|9931353|FG002|STARTED|Overall Study||29
8874365|NCT01903031|9931351|FG000|COMPLETED|Overall Study||25
8874366|NCT01903031|9931352|FG001|COMPLETED|Overall Study||25
8874367|NCT01903031|9931353|FG002|COMPLETED|Overall Study||24
8874368|NCT01903031|9931351|FG000|NOT COMPLETED|Overall Study||2
8874369|NCT01903031|9931352|FG001|NOT COMPLETED|Overall Study||3
8874370|NCT01903031|9931353|FG002|NOT COMPLETED|Overall Study||5
8874371|NCT01903148|9931366|FG000|STARTED|Overall Study||441
8874372|NCT01903148|9931366|FG000|COMPLETED|Overall Study||441
8874373|NCT01903148|9931366|FG000|NOT COMPLETED|Overall Study||0
8874374|NCT01903187|9931374|FG000|STARTED|Procedure||2
8874375|NCT01903187|9931375|FG001|STARTED|Procedure||2
8874376|NCT01903187|9931374|FG000|COMPLETED|Procedure||2
8874377|NCT01903187|9931375|FG001|COMPLETED|Procedure||2
8874378|NCT01903187|9931374|FG000|NOT COMPLETED|Procedure||0
8874379|NCT01903187|9931375|FG001|NOT COMPLETED|Procedure||0
8874380|NCT01903187|9931374|FG000|STARTED|1 Month||2
8874381|NCT01903187|9931375|FG001|STARTED|1 Month||2
8874382|NCT01903187|9931374|FG000|COMPLETED|1 Month||2
8874383|NCT01903187|9931375|FG001|COMPLETED|1 Month||2
8874384|NCT01903187|9931374|FG000|NOT COMPLETED|1 Month||0
8874385|NCT01903187|9931375|FG001|NOT COMPLETED|1 Month||0
8953640|NCT02473614|10016901|FG000|STARTED|Second Intervention (3 Weeks)||5
8953641|NCT02473614|10016902|FG001|STARTED|Second Intervention (3 Weeks)||5
8953642|NCT02473614|10016901|FG000|COMPLETED|Second Intervention (3 Weeks)||5
8953643|NCT02473614|10016902|FG001|COMPLETED|Second Intervention (3 Weeks)||5
8570072|NCT00100815|9602175|FG000|COMPLETED|Overall Study||1
8570073|NCT00100815|9602175|FG000|NOT COMPLETED|Overall Study||49
8570074|NCT00100841|9602179|FG000|STARTED|Overall Study||66
8570075|NCT00100841|9602179|FG000|COMPLETED|Overall Study||66
8570076|NCT00100841|9602179|FG000|NOT COMPLETED|Overall Study||0
8570077|NCT00100932|9602185|FG000|STARTED|Overall Study|Represents all enrolled pts; counts in demographic section represents ITT/Safety Population.|78
8570078|NCT00100932|9602186|FG001|STARTED|Overall Study|Represents all enrolled pts; counts in demographic section represents ITT/Safety Population.|28
8570079|NCT00100932|9602185|FG000|COMPLETED|Overall Study||5
8570080|NCT00100932|9602186|FG001|COMPLETED|Overall Study||1
8570081|NCT00100932|9602185|FG000|NOT COMPLETED|Overall Study||73
8570082|NCT00100932|9602186|FG001|NOT COMPLETED|Overall Study||27
8570083|NCT00101010|9602192|FG000|STARTED|Overall Study||80
8570084|NCT00101010|9602192|FG000|COMPLETED|Overall Study||79
8570085|NCT00101010|9602192|FG000|NOT COMPLETED|Overall Study||1
8570086|NCT00101036|9602198|FG000|STARTED|Overall Study||17
8570087|NCT00101036|9602199|FG001|STARTED|Overall Study||40
8570088|NCT00101036|9602198|FG000|COMPLETED|Overall Study||17
8570089|NCT00101036|9602199|FG001|COMPLETED|Overall Study||40
8570090|NCT00101036|9602198|FG000|NOT COMPLETED|Overall Study||0
8570091|NCT00101036|9602199|FG001|NOT COMPLETED|Overall Study||0
8570092|NCT00101101|9602205|FG000|STARTED|Overall Study||43
8570093|NCT00101101|9602205|FG000|COMPLETED|Overall Study|Participants who received at least one vaccine injection.|23
8570094|NCT00101101|9602205|FG000|NOT COMPLETED|Overall Study||20
8570095|NCT00101166|9602209|FG000|STARTED|Overall Study||28
8570096|NCT00101166|9602209|FG000|COMPLETED|Overall Study||18
8570097|NCT00101166|9602209|FG000|NOT COMPLETED|Overall Study||10
8570098|NCT00101192|9602213|FG000|STARTED|Overall Study||76
8570099|NCT00101192|9602213|FG000|COMPLETED|Overall Study||69
8570100|NCT00101192|9602213|FG000|NOT COMPLETED|Overall Study||7
8570101|NCT00101283|9602219|FG000|STARTED|Overall Study||16
8874386|NCT01903187|9931374|FG000|STARTED|3 Month||2
8874387|NCT01903187|9931375|FG001|STARTED|3 Month||0
8874388|NCT01903187|9931374|FG000|COMPLETED|3 Month||2
8570102|NCT00101283|9602220|FG001|STARTED|Overall Study||16
8570103|NCT00101283|9602219|FG000|Began Treatment|Overall Study||16
8570104|NCT00101283|9602220|FG001|Began Treatment|Overall Study||13
8570105|NCT00101283|9602219|FG000|COMPLETED|Overall Study||16
8570106|NCT00101283|9602220|FG001|COMPLETED|Overall Study||13
8874389|NCT01903187|9931375|FG001|COMPLETED|3 Month||0
8874390|NCT01903187|9931374|FG000|NOT COMPLETED|3 Month||0
8874391|NCT01903187|9931375|FG001|NOT COMPLETED|3 Month||0
8874392|NCT01903187|9931374|FG000|STARTED|6 Month||2
8570107|NCT00101283|9602219|FG000|NOT COMPLETED|Overall Study||0
8570108|NCT00101283|9602220|FG001|NOT COMPLETED|Overall Study||3
8570109|NCT00101361|9602228|FG000|STARTED|Overall Study||108
8570110|NCT00101361|9602229|FG001|STARTED|Overall Study||104
8874393|NCT01903187|9931375|FG001|STARTED|6 Month||0
8874394|NCT01903187|9931374|FG000|COMPLETED|6 Month||2
8874395|NCT01903187|9931375|FG001|COMPLETED|6 Month||0
8874396|NCT01903187|9931374|FG000|NOT COMPLETED|6 Month||0
8874397|NCT01903187|9931375|FG001|NOT COMPLETED|6 Month||0
8874398|NCT01903187|9931374|FG000|STARTED|12 Month||2
8874399|NCT01903187|9931375|FG001|STARTED|12 Month||0
8874400|NCT01903187|9931374|FG000|COMPLETED|12 Month||2
8874401|NCT01903187|9931375|FG001|COMPLETED|12 Month||0
8874402|NCT01903187|9931374|FG000|NOT COMPLETED|12 Month||0
8874403|NCT01903187|9931375|FG001|NOT COMPLETED|12 Month||0
8874404|NCT01903252|9931384|FG000|STARTED|Double-Blind Induction||409
8874405|NCT01903252|9931385|FG001|STARTED|Double-Blind Induction||408
8874406|NCT01903252|9931386|FG002|STARTED|Double-Blind Induction||0
8874407|NCT01903252|9931387|FG003|STARTED|Double-Blind Induction||0
8874408|NCT01903252|9931388|FG004|STARTED|Double-Blind Induction||0
8874409|NCT01903252|9931389|FG005|STARTED|Double-Blind Induction||0
8874410|NCT01903252|9931384|FG000|COMPLETED|Double-Blind Induction||370
8874411|NCT01903252|9931385|FG001|COMPLETED|Double-Blind Induction||367
8874412|NCT01903252|9931386|FG002|COMPLETED|Double-Blind Induction||0
8874413|NCT01903252|9931387|FG003|COMPLETED|Double-Blind Induction||0
8874414|NCT01903252|9931388|FG004|COMPLETED|Double-Blind Induction||0
8874415|NCT01903252|9931389|FG005|COMPLETED|Double-Blind Induction||0
8874416|NCT01903252|9931384|FG000|NOT COMPLETED|Double-Blind Induction||39
8874417|NCT01903252|9931385|FG001|NOT COMPLETED|Double-Blind Induction||41
8874418|NCT01903252|9931386|FG002|NOT COMPLETED|Double-Blind Induction||0
8874419|NCT01903252|9931387|FG003|NOT COMPLETED|Double-Blind Induction||0
8874420|NCT01903252|9931388|FG004|NOT COMPLETED|Double-Blind Induction||0
8874421|NCT01903252|9931389|FG005|NOT COMPLETED|Double-Blind Induction||0
8874422|NCT01903252|9931384|FG000|STARTED|Extended Induction, Open-Label||0
8874423|NCT01903252|9931385|FG001|STARTED|Extended Induction, Open-Label|This treatment arm was only used in Period 1, double-blind induction phase.|0
8874424|NCT01903252|9931386|FG002|STARTED|Extended Induction, Open-Label|The subjects in this phase were non-responders at week 8 and discontinued the double-blind phase.|243
8874425|NCT01903252|9931387|FG003|STARTED|Extended Induction, Open-Label||0
8874426|NCT01903252|9931388|FG004|STARTED|Extended Induction, Open-Label||0
8874427|NCT01903252|9931389|FG005|STARTED|Extended Induction, Open-Label||0
8874428|NCT01903252|9931384|FG000|COMPLETED|Extended Induction, Open-Label||0
8874429|NCT01903252|9931385|FG001|COMPLETED|Extended Induction, Open-Label||0
8874430|NCT01903252|9931386|FG002|COMPLETED|Extended Induction, Open-Label||220
8874431|NCT01903252|9931387|FG003|COMPLETED|Extended Induction, Open-Label||0
8874432|NCT01903252|9931388|FG004|COMPLETED|Extended Induction, Open-Label||0
8874433|NCT01903252|9931389|FG005|COMPLETED|Extended Induction, Open-Label||0
8874434|NCT01903252|9931384|FG000|NOT COMPLETED|Extended Induction, Open-Label||0
8874435|NCT01903252|9931385|FG001|NOT COMPLETED|Extended Induction, Open-Label||0
8874436|NCT01903252|9931386|FG002|NOT COMPLETED|Extended Induction, Open-Label||23
8874437|NCT01903252|9931387|FG003|NOT COMPLETED|Extended Induction, Open-Label||0
8874438|NCT01903252|9931388|FG004|NOT COMPLETED|Extended Induction, Open-Label||0
8874439|NCT01903252|9931389|FG005|NOT COMPLETED|Extended Induction, Open-Label||0
8874440|NCT01903252|9931384|FG000|STARTED|Maintenance, Open-Label||0
8874441|NCT01903252|9931385|FG001|STARTED|Maintenance, Open-Label||0
8874442|NCT01903252|9931386|FG002|STARTED|Maintenance, Open-Label|Period 2 (extended induction) is completed, subjects are newly allocated to Period 3, maintenance.|0
8874443|NCT01903252|9931387|FG003|STARTED|Maintenance, Open-Label|This is period 3, Open-Label Maintenance following on from period 1, the double-blind induction.|202
8874444|NCT01903252|9931388|FG004|STARTED|Maintenance, Open-Label|This is period 3, Open-Label Maintenance following on from period 1, the double-blind induction.|274
8874445|NCT01903252|9931389|FG005|STARTED|Maintenance, Open-Label|This is period 3, Open-Label Maintenance following on from period 1, the double-blind induction.|199
8874446|NCT01903252|9931384|FG000|COMPLETED|Maintenance, Open-Label||0
8874447|NCT01903252|9931385|FG001|COMPLETED|Maintenance, Open-Label||0
8874448|NCT01903252|9931386|FG002|COMPLETED|Maintenance, Open-Label||0
8874449|NCT01903252|9931387|FG003|COMPLETED|Maintenance, Open-Label||196
8874450|NCT01903252|9931388|FG004|COMPLETED|Maintenance, Open-Label||253
8874451|NCT01903252|9931389|FG005|COMPLETED|Maintenance, Open-Label||181
8874452|NCT01903252|9931384|FG000|NOT COMPLETED|Maintenance, Open-Label||0
8874453|NCT01903252|9931385|FG001|NOT COMPLETED|Maintenance, Open-Label||0
8874454|NCT01903252|9931386|FG002|NOT COMPLETED|Maintenance, Open-Label||0
8874455|NCT01903252|9931387|FG003|NOT COMPLETED|Maintenance, Open-Label||6
8874456|NCT01903252|9931388|FG004|NOT COMPLETED|Maintenance, Open-Label||21
8874457|NCT01903252|9931389|FG005|NOT COMPLETED|Maintenance, Open-Label||18
8874458|NCT01903265|9931409|FG000|STARTED|Overall Study||103
8874459|NCT01903265|9931410|FG001|STARTED|Overall Study||102
8874460|NCT01903265|9931409|FG000|COMPLETED|Overall Study||89
8874461|NCT01903265|9931410|FG001|COMPLETED|Overall Study||85
8874462|NCT01903265|9931409|FG000|NOT COMPLETED|Overall Study||14
8874463|NCT01903265|9931410|FG001|NOT COMPLETED|Overall Study||17
8874464|NCT01903356|9931416|FG000|STARTED|Overall Study||724
8874465|NCT01903356|9931416|FG000|COMPLETED|Overall Study||709
8874466|NCT01903356|9931416|FG000|NOT COMPLETED|Overall Study||15
8874467|NCT01903434|9931420|FG000|STARTED|Treatment Period 1||30
8874468|NCT01903434|9931421|FG001|STARTED|Treatment Period 1||30
8874469|NCT01903434|9931420|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1||30
8874470|NCT01903434|9931421|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1||30
8874471|NCT01903434|9931420|FG000|COMPLETED|Treatment Period 1||30
8874472|NCT01903434|9931421|FG001|COMPLETED|Treatment Period 1||30
8874473|NCT01903434|9931420|FG000|NOT COMPLETED|Treatment Period 1||0
8874474|NCT01903434|9931421|FG001|NOT COMPLETED|Treatment Period 1||0
8874475|NCT01903434|9931420|FG000|STARTED|Washout Period 1 (at Least 14 Days)||30
8874476|NCT01903434|9931421|FG001|STARTED|Washout Period 1 (at Least 14 Days)||30
8874477|NCT01903434|9931420|FG000|COMPLETED|Washout Period 1 (at Least 14 Days)||29
8874478|NCT01903434|9931421|FG001|COMPLETED|Washout Period 1 (at Least 14 Days)||28
8874479|NCT01903434|9931420|FG000|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||1
8874480|NCT01903434|9931421|FG001|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||2
8874481|NCT01903434|9931420|FG000|STARTED|Treatment Period 2||29
8874482|NCT01903434|9931421|FG001|STARTED|Treatment Period 2||28
8874483|NCT01903434|9931420|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 2||29
8874484|NCT01903434|9931421|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 2||28
8874485|NCT01903434|9931420|FG000|COMPLETED|Treatment Period 2||29
8874486|NCT01903434|9931421|FG001|COMPLETED|Treatment Period 2||28
8874487|NCT01903434|9931420|FG000|NOT COMPLETED|Treatment Period 2||0
8874488|NCT01903434|9931421|FG001|NOT COMPLETED|Treatment Period 2||0
8874489|NCT01903434|9931420|FG000|STARTED|Washout Period 1 (at Least 14 Days)||29
8874490|NCT01903434|9931421|FG001|STARTED|Washout Period 1 (at Least 14 Days)||28
8874491|NCT01903434|9931420|FG000|COMPLETED|Washout Period 1 (at Least 14 Days)||29
8874492|NCT01903434|9931421|FG001|COMPLETED|Washout Period 1 (at Least 14 Days)||28
8874493|NCT01903434|9931420|FG000|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
8874494|NCT01903434|9931421|FG001|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
8874495|NCT01903434|9931420|FG000|STARTED|Treatment Period 3||29
8874496|NCT01903434|9931421|FG001|STARTED|Treatment Period 3||28
8874497|NCT01903434|9931420|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 3||29
8874498|NCT01903434|9931421|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 3||28
8874499|NCT01903434|9931420|FG000|COMPLETED|Treatment Period 3||29
8874500|NCT01903434|9931421|FG001|COMPLETED|Treatment Period 3||28
8874501|NCT01903434|9931420|FG000|NOT COMPLETED|Treatment Period 3||0
8874502|NCT01903434|9931421|FG001|NOT COMPLETED|Treatment Period 3||0
8874503|NCT01903460|9931431|FG000|STARTED|Overall Study||6
8874504|NCT01903460|9931432|FG001|STARTED|Overall Study||8
8874505|NCT01903460|9931433|FG002|STARTED|Overall Study||3
8874506|NCT01903460|9931434|FG003|STARTED|Overall Study||3
8874507|NCT01903460|9931431|FG000|COMPLETED|Overall Study||6
8874508|NCT01903460|9931432|FG001|COMPLETED|Overall Study||8
8874509|NCT01903460|9931433|FG002|COMPLETED|Overall Study||3
8874510|NCT01903460|9931434|FG003|COMPLETED|Overall Study||2
8874511|NCT01903460|9931431|FG000|NOT COMPLETED|Overall Study||0
8874512|NCT01903460|9931432|FG001|NOT COMPLETED|Overall Study||0
8874513|NCT01903460|9931433|FG002|NOT COMPLETED|Overall Study||0
8874514|NCT01903460|9931434|FG003|NOT COMPLETED|Overall Study||1
8874515|NCT01903525|9931445|FG000|STARTED|Overall Study||20
8874516|NCT01903525|9931446|FG001|STARTED|Overall Study||20
8874517|NCT01903525|9931445|FG000|COMPLETED|Overall Study||15
8874518|NCT01903525|9931446|FG001|COMPLETED|Overall Study||10
8874519|NCT01903525|9931445|FG000|NOT COMPLETED|Overall Study||5
8874520|NCT01903525|9931446|FG001|NOT COMPLETED|Overall Study||10
8874521|NCT01903564|9931454|FG000|STARTED|Overall Study||10
8874522|NCT01903564|9931455|FG001|STARTED|Overall Study||29
8874523|NCT01903564|9931454|FG000|COMPLETED|Overall Study||10
8874524|NCT01903564|9931455|FG001|COMPLETED|Overall Study||29
8874525|NCT01903564|9931454|FG000|NOT COMPLETED|Overall Study||0
8874526|NCT01903564|9931455|FG001|NOT COMPLETED|Overall Study||0
8874527|NCT01903720|9931461|FG000|STARTED|Overall Study||71
8874528|NCT01903720|9931461|FG000|COMPLETED|Overall Study||59
8874529|NCT01903720|9931461|FG000|NOT COMPLETED|Overall Study||12
8874530|NCT01903733|9931469|FG000|STARTED|Overall Study||250
8874531|NCT01903733|9931470|FG001|STARTED|Overall Study||284
8874532|NCT01903733|9931471|FG002|STARTED|Overall Study||119
8874533|NCT01903733|9931472|FG003|STARTED|Overall Study||167
8874534|NCT01903733|9931469|FG000|Full Analysis Set|Overall Study||250
8874535|NCT01903733|9931470|FG001|Full Analysis Set|Overall Study||284
8874536|NCT01903733|9931471|FG002|Full Analysis Set|Overall Study||119
8874537|NCT01903733|9931472|FG003|Full Analysis Set|Overall Study||167
8874538|NCT01903733|9931469|FG000|Safety Analysis Set|Overall Study||248
8874539|NCT01903733|9931470|FG001|Safety Analysis Set|Overall Study||284
8874540|NCT01903733|9931471|FG002|Safety Analysis Set|Overall Study||119
8874541|NCT01903733|9931472|FG003|Safety Analysis Set|Overall Study||167
8874542|NCT01903733|9931469|FG000|Enrolled in B1871040|Overall Study||124
8874543|NCT01903733|9931470|FG001|Enrolled in B1871040|Overall Study||90
8874544|NCT01903733|9931471|FG002|Enrolled in B1871040|Overall Study||28
8874545|NCT01903733|9931472|FG003|Enrolled in B1871040|Overall Study||18
8874546|NCT01903733|9931469|FG000|Treated in B1871040|Overall Study||98
8874547|NCT01903733|9931470|FG001|Treated in B1871040|Overall Study||69
8874548|NCT01903733|9931471|FG002|Treated in B1871040|Overall Study||13
8874549|NCT01903733|9931472|FG003|Treated in B1871040|Overall Study||8
8874550|NCT01903733|9931469|FG000|COMPLETED|Overall Study||144
8874551|NCT01903733|9931470|FG001|COMPLETED|Overall Study||158
8874552|NCT01903733|9931471|FG002|COMPLETED|Overall Study||58
8874553|NCT01903733|9931472|FG003|COMPLETED|Overall Study||48
8874554|NCT01903733|9931469|FG000|NOT COMPLETED|Overall Study||106
8874555|NCT01903733|9931470|FG001|NOT COMPLETED|Overall Study||126
8874556|NCT01903733|9931471|FG002|NOT COMPLETED|Overall Study||61
8874557|NCT01903733|9931472|FG003|NOT COMPLETED|Overall Study||119
8874558|NCT01903798|9931496|FG000|STARTED|Overall Study||2
8874559|NCT01903798|9931497|FG001|STARTED|Overall Study||0
8874560|NCT01903798|9931498|FG002|STARTED|Overall Study||1
8874561|NCT01903798|9931499|FG003|STARTED|Overall Study||1
8874562|NCT01903798|9931496|FG000|COMPLETED|Overall Study||2
8874563|NCT01903798|9931497|FG001|COMPLETED|Overall Study||0
8874564|NCT01903798|9931498|FG002|COMPLETED|Overall Study||1
8874565|NCT01903798|9931499|FG003|COMPLETED|Overall Study||1
8874566|NCT01903798|9931496|FG000|NOT COMPLETED|Overall Study||0
8874567|NCT01903798|9931497|FG001|NOT COMPLETED|Overall Study||0
8874568|NCT01903798|9931498|FG002|NOT COMPLETED|Overall Study||0
8874569|NCT01903798|9931499|FG003|NOT COMPLETED|Overall Study||0
8874570|NCT01903811|9931511|FG000|STARTED|Overall Study||72
8874571|NCT01903811|9931512|FG001|STARTED|Overall Study||71
8874572|NCT01903811|9931511|FG000|Crossover to Arm II|Overall Study|Following disease progression on Arm I. Note: these patients are also counted in 'Completed'.|16
8874573|NCT01903811|9931512|FG001|Crossover to Arm II|Overall Study||0
8874574|NCT01903811|9931511|FG000|COMPLETED|Overall Study||64
8874575|NCT01903811|9931512|FG001|COMPLETED|Overall Study||57
8874576|NCT01903811|9931511|FG000|NOT COMPLETED|Overall Study||8
8874577|NCT01903811|9931512|FG001|NOT COMPLETED|Overall Study||14
8874578|NCT01903837|9931525|FG000|STARTED|Part A||75
8874579|NCT01903837|9931526|FG001|STARTED|Part A||80
8874580|NCT01903837|9931527|FG002|STARTED|Part A||86
8874581|NCT01903837|9931528|FG003|STARTED|Part A||68
8874582|NCT01903837|9931525|FG000|COMPLETED|Part A||56
8874583|NCT01903837|9931526|FG001|COMPLETED|Part A||52
8874584|NCT01903837|9931527|FG002|COMPLETED|Part A||58
8874585|NCT01903837|9931528|FG003|COMPLETED|Part A||55
8874586|NCT01903837|9931525|FG000|NOT COMPLETED|Part A||19
8874587|NCT01903837|9931526|FG001|NOT COMPLETED|Part A||28
8874588|NCT01903837|9931527|FG002|NOT COMPLETED|Part A||28
8874589|NCT01903837|9931528|FG003|NOT COMPLETED|Part A||13
8874590|NCT01903837|9931525|FG000|STARTED|Part B||54
8874591|NCT01903837|9931526|FG001|STARTED|Part B||52
8874592|NCT01903837|9931527|FG002|STARTED|Part B||57
8874593|NCT01903837|9931528|FG003|STARTED|Part B||55
8874594|NCT01903837|9931525|FG000|COMPLETED|Part B||45
8874595|NCT01903837|9931526|FG001|COMPLETED|Part B||46
8874596|NCT01903837|9931527|FG002|COMPLETED|Part B||52
8874597|NCT01903837|9931528|FG003|COMPLETED|Part B||44
8874598|NCT01903837|9931525|FG000|NOT COMPLETED|Part B||9
8874599|NCT01903837|9931526|FG001|NOT COMPLETED|Part B||6
8874600|NCT01903837|9931527|FG002|NOT COMPLETED|Part B||5
8874601|NCT01903837|9931528|FG003|NOT COMPLETED|Part B||11
8874602|NCT01903863|9931561|FG000|STARTED|Overall Study||15
8874603|NCT01903863|9931562|FG001|STARTED|Overall Study||16
8874604|NCT01903863|9931561|FG000|COMPLETED|Overall Study||13
8874605|NCT01903863|9931562|FG001|COMPLETED|Overall Study||16
8874606|NCT01903863|9931561|FG000|NOT COMPLETED|Overall Study||2
8874607|NCT01903863|9931562|FG001|NOT COMPLETED|Overall Study||0
8874608|NCT01903876|9931570|FG000|STARTED|Baseline to Post-Intervention Period||367
8874609|NCT01903876|9931571|FG001|STARTED|Baseline to Post-Intervention Period||376
8874610|NCT01903876|9931570|FG000|COMPLETED|Baseline to Post-Intervention Period||183
8874611|NCT01903876|9931571|FG001|COMPLETED|Baseline to Post-Intervention Period||268
8874612|NCT01903876|9931570|FG000|NOT COMPLETED|Baseline to Post-Intervention Period||184
8874613|NCT01903876|9931571|FG001|NOT COMPLETED|Baseline to Post-Intervention Period||108
8874614|NCT01903876|9931570|FG000|STARTED|Six-Month Follow-up Period||183
8874615|NCT01903876|9931571|FG001|STARTED|Six-Month Follow-up Period||268
8874616|NCT01903876|9931570|FG000|COMPLETED|Six-Month Follow-up Period||92
8874617|NCT01903876|9931571|FG001|COMPLETED|Six-Month Follow-up Period||123
8874618|NCT01903876|9931570|FG000|NOT COMPLETED|Six-Month Follow-up Period||91
8874619|NCT01903876|9931571|FG001|NOT COMPLETED|Six-Month Follow-up Period||145
8874620|NCT01903993|9931579|FG000|STARTED|Overall Study||143
8874621|NCT01903993|9931580|FG001|STARTED|Overall Study||144
8874622|NCT01903993|9931579|FG000|Received Treatment|Overall Study||135
8874623|NCT01903993|9931580|FG001|Received Treatment|Overall Study||142
8874624|NCT01903993|9931579|FG000|COMPLETED|Overall Study||0
8874625|NCT01903993|9931580|FG001|COMPLETED|Overall Study||0
8874626|NCT01903993|9931579|FG000|NOT COMPLETED|Overall Study||143
8874627|NCT01903993|9931580|FG001|NOT COMPLETED|Overall Study||144
8874628|NCT01904019|9931587|FG000|STARTED|Pre-operative||95
8874629|NCT01904019|9931587|FG000|COMPLETED|Pre-operative||95
8874630|NCT01904019|9931587|FG000|NOT COMPLETED|Pre-operative||0
8874631|NCT01904019|9931587|FG000|STARTED|1 Year Follow-up||95
8874632|NCT01904019|9931587|FG000|COMPLETED|1 Year Follow-up||86
8874633|NCT01904019|9931587|FG000|NOT COMPLETED|1 Year Follow-up||9
8874634|NCT01904019|9931587|FG000|STARTED|3 Year Follow-up||86
8874635|NCT01904019|9931587|FG000|COMPLETED|3 Year Follow-up||71
8874636|NCT01904019|9931587|FG000|NOT COMPLETED|3 Year Follow-up||15
8874637|NCT01904019|9931587|FG000|STARTED|5 Year Follow-up||71
8874638|NCT01904019|9931587|FG000|COMPLETED|5 Year Follow-up||65
8874639|NCT01904019|9931587|FG000|NOT COMPLETED|5 Year Follow-up||6
8874640|NCT01904058|9931595|FG000|STARTED|Overall Study||21
8874641|NCT01904058|9931596|FG001|STARTED|Overall Study||21
8874642|NCT01904058|9931597|FG002|STARTED|Overall Study||11
8874643|NCT01904058|9931598|FG003|STARTED|Overall Study||13
8874644|NCT01904058|9931595|FG000|COMPLETED|Overall Study||18
8874645|NCT01904058|9931596|FG001|COMPLETED|Overall Study||21
8874646|NCT01904058|9931597|FG002|COMPLETED|Overall Study||10
8874647|NCT01904058|9931598|FG003|COMPLETED|Overall Study||12
8874648|NCT01904058|9931595|FG000|NOT COMPLETED|Overall Study||3
8874649|NCT01904058|9931596|FG001|NOT COMPLETED|Overall Study||0
8874650|NCT01904058|9931597|FG002|NOT COMPLETED|Overall Study||1
8874651|NCT01904058|9931598|FG003|NOT COMPLETED|Overall Study||1
8874652|NCT01904071|9931617|FG000|STARTED|Overall Study||24
8874653|NCT01904071|9931618|FG001|STARTED|Overall Study||20
8874654|NCT01904071|9931619|FG002|STARTED|Overall Study||20
8874655|NCT01904071|9931617|FG000|COMPLETED|Overall Study||24
8874656|NCT01904071|9931618|FG001|COMPLETED|Overall Study||20
8874657|NCT01904071|9931619|FG002|COMPLETED|Overall Study||20
8874658|NCT01904071|9931617|FG000|NOT COMPLETED|Overall Study||0
8874659|NCT01904071|9931618|FG001|NOT COMPLETED|Overall Study||0
8874660|NCT01904071|9931619|FG002|NOT COMPLETED|Overall Study||0
8874661|NCT01904149|9931633|FG000|STARTED|Overall Study||152
8874662|NCT01904149|9931634|FG001|STARTED|Overall Study||151
8874663|NCT01904149|9931635|FG002|STARTED|Overall Study||150
8874664|NCT01904149|9931636|FG003|STARTED|Overall Study||51
8874665|NCT01904149|9931637|FG004|STARTED|Overall Study||51
8874666|NCT01904149|9931638|FG005|STARTED|Overall Study||51
8874667|NCT01904149|9931633|FG000|Single-dose Phase|Overall Study||152
8874668|NCT01904149|9931634|FG001|Single-dose Phase|Overall Study||151
8874669|NCT01904149|9931635|FG002|Single-dose Phase|Overall Study||150
8874670|NCT01904149|9931636|FG003|Single-dose Phase|Overall Study||51
8874671|NCT01904149|9931637|FG004|Single-dose Phase|Overall Study||51
8874672|NCT01904149|9931638|FG005|Single-dose Phase|Overall Study||51
8874673|NCT01904149|9931633|FG000|Multiple-dose Phase|Overall Study||150
8874674|NCT01904149|9931634|FG001|Multiple-dose Phase|Overall Study||146
8874675|NCT01904149|9931635|FG002|Multiple-dose Phase|Overall Study||149
8874676|NCT01904149|9931636|FG003|Multiple-dose Phase|Overall Study||48
8874677|NCT01904149|9931637|FG004|Multiple-dose Phase|Overall Study||48
8874678|NCT01904149|9931638|FG005|Multiple-dose Phase|Overall Study||49
8874679|NCT01904149|9931633|FG000|COMPLETED|Overall Study||147
8874680|NCT01904149|9931634|FG001|COMPLETED|Overall Study||140
8953644|NCT02473614|10016901|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0
8953645|NCT02473614|10016902|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
8953646|NCT02473640|10016909|FG000|STARTED|Treatment Period 1||15
8953647|NCT02473640|10016909|FG000|COMPLETED|Treatment Period 1||14
8953648|NCT02473640|10016909|FG000|NOT COMPLETED|Treatment Period 1||1
8631223|NCT00538902|9671127|FG000|STARTED|DB Wk 0 Through 12 (Primary D/C Reasons)||60
8631224|NCT00538902|9671128|FG001|STARTED|DB Wk 0 Through 12 (Primary D/C Reasons)||121
8631225|NCT00538902|9671129|FG002|STARTED|DB Wk 0 Through 12 (Primary D/C Reasons)||121
8631226|NCT00538902|9671127|FG000|COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||59
8631227|NCT00538902|9671128|FG001|COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||119
8631228|NCT00538902|9671129|FG002|COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||116
8631229|NCT00538902|9671127|FG000|NOT COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||1
8874681|NCT01904149|9931635|FG002|COMPLETED|Overall Study||148
8953649|NCT02473640|10016909|FG000|STARTED|Run-in Phase||14
8953650|NCT02473640|10016909|FG000|COMPLETED|Run-in Phase||14
8953651|NCT02473640|10016909|FG000|NOT COMPLETED|Run-in Phase||0
8953652|NCT02473640|10016909|FG000|STARTED|Treatment Period 2||14
8953653|NCT02473640|10016909|FG000|COMPLETED|Treatment Period 2||14
8953654|NCT02473640|10016909|FG000|NOT COMPLETED|Treatment Period 2||0
8953655|NCT02473718|10016918|FG000|STARTED|Overall Study||41
8953656|NCT02473718|10016919|FG001|STARTED|Overall Study||41
8953657|NCT02473718|10016918|FG000|COMPLETED|Overall Study||41
8953658|NCT02473718|10016919|FG001|COMPLETED|Overall Study||41
8953659|NCT02473718|10016918|FG000|NOT COMPLETED|Overall Study||0
8953660|NCT02473718|10016919|FG001|NOT COMPLETED|Overall Study||0
8953661|NCT02473783|10016927|FG000|STARTED|Overall Study||20
8953662|NCT02473783|10016928|FG001|STARTED|Overall Study||17
8953663|NCT02473783|10016927|FG000|COMPLETED|Overall Study||20
8953664|NCT02473783|10016928|FG001|COMPLETED|Overall Study||17
8953665|NCT02473783|10016927|FG000|NOT COMPLETED|Overall Study||0
8953666|NCT02473783|10016928|FG001|NOT COMPLETED|Overall Study||0
8953667|NCT02473913|10016937|FG000|STARTED|Overall Study||11
8953668|NCT02473913|10016938|FG001|STARTED|Overall Study||11
8953669|NCT02473913|10016937|FG000|COMPLETED|Overall Study||8
8953670|NCT02473913|10016938|FG001|COMPLETED|Overall Study||8
8953671|NCT02473913|10016937|FG000|NOT COMPLETED|Overall Study||3
8953672|NCT02473913|10016938|FG001|NOT COMPLETED|Overall Study||3
8953673|NCT02473952|10016946|FG000|STARTED|Overall Study||30
8953674|NCT02473952|10016947|FG001|STARTED|Overall Study||32
8953675|NCT02473952|10016946|FG000|COMPLETED|Overall Study||28
8953676|NCT02473952|10016947|FG001|COMPLETED|Overall Study||24
8953677|NCT02473952|10016946|FG000|NOT COMPLETED|Overall Study||2
8874682|NCT01904149|9931636|FG003|COMPLETED|Overall Study||47
8953678|NCT02473952|10016947|FG001|NOT COMPLETED|Overall Study||8
8874683|NCT01904149|9931637|FG004|COMPLETED|Overall Study||46
8874684|NCT01904149|9931638|FG005|COMPLETED|Overall Study||48
8953679|NCT02473965|10016955|FG000|STARTED|Overall Study||30
8953680|NCT02473965|10016956|FG001|STARTED|Overall Study||30
8953681|NCT02473965|10016955|FG000|COMPLETED|Overall Study||18
8953682|NCT02473965|10016956|FG001|COMPLETED|Overall Study||20
8874685|NCT01904149|9931633|FG000|NOT COMPLETED|Overall Study||5
8874686|NCT01904149|9931634|FG001|NOT COMPLETED|Overall Study||11
8874687|NCT01904149|9931635|FG002|NOT COMPLETED|Overall Study||2
8874688|NCT01904149|9931636|FG003|NOT COMPLETED|Overall Study||4
8953683|NCT02473965|10016955|FG000|NOT COMPLETED|Overall Study||12
8953684|NCT02473965|10016956|FG001|NOT COMPLETED|Overall Study||10
8953685|NCT02473991|10016962|FG000|STARTED|Overall Study||395
8953686|NCT02473991|10016962|FG000|COMPLETED|Overall Study||395
8953687|NCT02473991|10016962|FG000|NOT COMPLETED|Overall Study||0
8953688|NCT02474069|10016966|FG000|STARTED|Selection Phase (SP)||772
8953689|NCT02474069|10016967|FG001|STARTED|Selection Phase (SP)||0
8953690|NCT02474069|10016968|FG002|STARTED|Selection Phase (SP)||0
8953691|NCT02474069|10016966|FG000|COMPLETED|Selection Phase (SP)||749
8953692|NCT02474069|10016967|FG001|COMPLETED|Selection Phase (SP)||0
8953693|NCT02474069|10016968|FG002|COMPLETED|Selection Phase (SP)||0
8953694|NCT02474069|10016966|FG000|NOT COMPLETED|Selection Phase (SP)||23
8953695|NCT02474069|10016967|FG001|NOT COMPLETED|Selection Phase (SP)||0
8953696|NCT02474069|10016968|FG002|NOT COMPLETED|Selection Phase (SP)||0
8953697|NCT02474069|10016966|FG000|STARTED|Comparative Dosing Phase (CDP)||0
8953698|NCT02474069|10016967|FG001|STARTED|Comparative Dosing Phase (CDP)||162
8874689|NCT01904149|9931637|FG004|NOT COMPLETED|Overall Study||5
8874690|NCT01904149|9931638|FG005|NOT COMPLETED|Overall Study||3
8874691|NCT01904383|9931654|FG000|STARTED|Overall Study||4057
8874692|NCT01904383|9931654|FG000|Treated|Overall Study||3940
8874693|NCT01904383|9931654|FG000|COMPLETED|Overall Study||2283
8953699|NCT02474069|10016968|FG002|STARTED|Comparative Dosing Phase (CDP)||163
8953700|NCT02474069|10016966|FG000|COMPLETED|Comparative Dosing Phase (CDP)||0
8953701|NCT02474069|10016967|FG001|COMPLETED|Comparative Dosing Phase (CDP)||153
8953702|NCT02474069|10016968|FG002|COMPLETED|Comparative Dosing Phase (CDP)||157
8953703|NCT02474069|10016966|FG000|NOT COMPLETED|Comparative Dosing Phase (CDP)||0
8953704|NCT02474069|10016967|FG001|NOT COMPLETED|Comparative Dosing Phase (CDP)||9
8953705|NCT02474069|10016968|FG002|NOT COMPLETED|Comparative Dosing Phase (CDP)||6
8953706|NCT02474082|10016980|FG000|STARTED|Overall Study||105
8953707|NCT02474082|10016981|FG001|STARTED|Overall Study||97
8953708|NCT02474082|10016980|FG000|Full Analysis Set (FAS)|Overall Study||105
8953709|NCT02474082|10016981|FG001|Full Analysis Set (FAS)|Overall Study||95
8953710|NCT02474082|10016980|FG000|COMPLETED|Overall Study||99
8953711|NCT02474082|10016981|FG001|COMPLETED|Overall Study||43
8953712|NCT02474082|10016980|FG000|NOT COMPLETED|Overall Study||6
8953713|NCT02474082|10016981|FG001|NOT COMPLETED|Overall Study||54
8953714|NCT02474199|10016989|FG000|STARTED|Overall Study||5
8953715|NCT02474199|10016990|FG001|STARTED|Overall Study|Insufficient numbers of darTregs for infusion (4 of these 5 participants)|5
8953716|NCT02474199|10016991|FG002|STARTED|Overall Study||2
8953717|NCT02474199|10016992|FG003|STARTED|Overall Study||3
8953718|NCT02474199|10016989|FG000|COMPLETED|Overall Study||3
8953719|NCT02474199|10016990|FG001|COMPLETED|Overall Study||2
8953720|NCT02474199|10016991|FG002|COMPLETED|Overall Study||0
8953721|NCT02474199|10016992|FG003|COMPLETED|Overall Study||0
8953722|NCT02474199|10016989|FG000|NOT COMPLETED|Overall Study||2
8953723|NCT02474199|10016990|FG001|NOT COMPLETED|Overall Study||3
8953724|NCT02474199|10016991|FG002|NOT COMPLETED|Overall Study||2
8953725|NCT02474199|10016992|FG003|NOT COMPLETED|Overall Study||3
8953726|NCT02474355|10016999|FG000|STARTED|Overall Study||3014
8953727|NCT02474355|10016999|FG000|COMPLETED|Overall Study||1386
8953728|NCT02474355|10016999|FG000|NOT COMPLETED|Overall Study||1628
8953729|NCT02474407|10017003|FG000|STARTED|First Intervention (14 Days)||39
8953730|NCT02474407|10017004|FG001|STARTED|First Intervention (14 Days)||39
8953731|NCT02474407|10017003|FG000|COMPLETED|First Intervention (14 Days)||39
8953732|NCT02474407|10017004|FG001|COMPLETED|First Intervention (14 Days)||39
8953733|NCT02474407|10017003|FG000|NOT COMPLETED|First Intervention (14 Days)||0
8953734|NCT02474407|10017004|FG001|NOT COMPLETED|First Intervention (14 Days)||0
8953735|NCT02474407|10017003|FG000|STARTED|Washout (14 Days)||39
8953736|NCT02474407|10017004|FG001|STARTED|Washout (14 Days)||39
8953737|NCT02474407|10017003|FG000|COMPLETED|Washout (14 Days)||39
8953738|NCT02474407|10017004|FG001|COMPLETED|Washout (14 Days)||39
8953739|NCT02474407|10017003|FG000|NOT COMPLETED|Washout (14 Days)||0
8953740|NCT02474407|10017004|FG001|NOT COMPLETED|Washout (14 Days)||0
8953741|NCT02474407|10017003|FG000|STARTED|Second Intervention (14 Days)||39
8953742|NCT02474407|10017004|FG001|STARTED|Second Intervention (14 Days)||39
8953743|NCT02474407|10017003|FG000|COMPLETED|Second Intervention (14 Days)||39
8874694|NCT01904383|9931654|FG000|NOT COMPLETED|Overall Study||1774
8874695|NCT01904448|9931658|FG000|STARTED|Overall Study||5
8874696|NCT01904448|9931658|FG000|COMPLETED|Overall Study||5
8874697|NCT01904448|9931658|FG000|NOT COMPLETED|Overall Study||0
8874698|NCT01904526|9931663|FG000|STARTED|Overall Study||5
8874699|NCT01904526|9931663|FG000|COMPLETED|Overall Study||5
8953744|NCT02474407|10017004|FG001|COMPLETED|Second Intervention (14 Days)||39
8953745|NCT02474407|10017003|FG000|NOT COMPLETED|Second Intervention (14 Days)||0
8953746|NCT02474407|10017004|FG001|NOT COMPLETED|Second Intervention (14 Days)||0
9037554|NCT03316131|10098737|FG000|STARTED|Treatment Period 2||18
9037555|NCT03316131|10098738|FG001|STARTED|Treatment Period 2||18
9037556|NCT03316131|10098737|FG000|COMPLETED|Treatment Period 2||17
9037557|NCT03316131|10098738|FG001|COMPLETED|Treatment Period 2||18
9037558|NCT03316131|10098737|FG000|NOT COMPLETED|Treatment Period 2||1
9037559|NCT03316131|10098738|FG001|NOT COMPLETED|Treatment Period 2||0
9037560|NCT03316170|10098746|FG000|STARTED|Overall Study||24
9037561|NCT03316170|10098747|FG001|STARTED|Overall Study||25
9037562|NCT03316170|10098746|FG000|COMPLETED|Overall Study||17
8874700|NCT01904526|9931663|FG000|NOT COMPLETED|Overall Study||0
9037563|NCT03316170|10098747|FG001|COMPLETED|Overall Study||18
8953747|NCT02474498|10017033|FG000|STARTED|Overall Study||13
8953748|NCT02474498|10017034|FG001|STARTED|Overall Study||14
8953749|NCT02474498|10017035|FG002|STARTED|Overall Study||14
8953750|NCT02474498|10017033|FG000|COMPLETED|Overall Study||13
8953751|NCT02474498|10017034|FG001|COMPLETED|Overall Study||14
8953752|NCT02474498|10017035|FG002|COMPLETED|Overall Study||14
8953753|NCT02474498|10017033|FG000|NOT COMPLETED|Overall Study||0
8953754|NCT02474498|10017034|FG001|NOT COMPLETED|Overall Study||0
8953755|NCT02474498|10017035|FG002|NOT COMPLETED|Overall Study||0
8953756|NCT02474589|10017049|FG000|STARTED|Overall Study||359
8953757|NCT02474589|10017050|FG001|STARTED|Overall Study||90
8953758|NCT02474589|10017049|FG000|COMPLETED|Overall Study||334
8953759|NCT02474589|10017050|FG001|COMPLETED|Overall Study||85
8953760|NCT02474589|10017049|FG000|NOT COMPLETED|Overall Study||25
8953761|NCT02474589|10017050|FG001|NOT COMPLETED|Overall Study||5
8953762|NCT02474901|10017058|FG000|STARTED|Overall Study||45
8953763|NCT02474901|10017059|FG001|STARTED|Overall Study||56
8953764|NCT02474901|10017058|FG000|COMPLETED|Overall Study||44
8953765|NCT02474901|10017059|FG001|COMPLETED|Overall Study||56
8953766|NCT02474901|10017058|FG000|NOT COMPLETED|Overall Study||1
8953767|NCT02474901|10017059|FG001|NOT COMPLETED|Overall Study||0
8953768|NCT02475031|10017067|FG000|STARTED|Overall Study||35
8953769|NCT02475031|10017068|FG001|STARTED|Overall Study||35
8953770|NCT02475031|10017067|FG000|COMPLETED|Overall Study||35
8953771|NCT02475031|10017068|FG001|COMPLETED|Overall Study||35
8953772|NCT02475031|10017067|FG000|NOT COMPLETED|Overall Study||0
8953773|NCT02475031|10017068|FG001|NOT COMPLETED|Overall Study||0
8953774|NCT02475070|10017078|FG000|STARTED|Overall Study||17
8953775|NCT02475070|10017079|FG001|STARTED|Overall Study||11
8953776|NCT02475070|10017078|FG000|COMPLETED|Overall Study||17
8953777|NCT02475070|10017079|FG001|COMPLETED|Overall Study||11
8953778|NCT02475070|10017078|FG000|NOT COMPLETED|Overall Study||0
8953779|NCT02475070|10017079|FG001|NOT COMPLETED|Overall Study||0
8953780|NCT02475265|10017086|FG000|STARTED|Overall Study||11
8953781|NCT02475265|10017086|FG000|COMPLETED|Overall Study||8
8953782|NCT02475265|10017086|FG000|NOT COMPLETED|Overall Study||3
8953783|NCT02475278|10017090|FG000|STARTED|Overall Study||50
8953784|NCT02475278|10017090|FG000|COMPLETED|Overall Study||48
8953785|NCT02475278|10017090|FG000|NOT COMPLETED|Overall Study||2
8953786|NCT02475369|10017094|FG000|STARTED|Run-in Washout Period #1 (7 Days)||10
8953787|NCT02475369|10017095|FG001|STARTED|Run-in Washout Period #1 (7 Days)||11
8953788|NCT02475369|10017094|FG000|COMPLETED|Run-in Washout Period #1 (7 Days)||3
8953789|NCT02475369|10017095|FG001|COMPLETED|Run-in Washout Period #1 (7 Days)||9
8953790|NCT02475369|10017094|FG000|NOT COMPLETED|Run-in Washout Period #1 (7 Days)||7
8953791|NCT02475369|10017095|FG001|NOT COMPLETED|Run-in Washout Period #1 (7 Days)||2
8953792|NCT02475369|10017094|FG000|STARTED|Treatment Period #1 (10 Days)||3
8953793|NCT02475369|10017095|FG001|STARTED|Treatment Period #1 (10 Days)||9
8953794|NCT02475369|10017094|FG000|COMPLETED|Treatment Period #1 (10 Days)||3
8953795|NCT02475369|10017095|FG001|COMPLETED|Treatment Period #1 (10 Days)||9
8953796|NCT02475369|10017094|FG000|NOT COMPLETED|Treatment Period #1 (10 Days)||0
8953797|NCT02475369|10017095|FG001|NOT COMPLETED|Treatment Period #1 (10 Days)||0
8953798|NCT02475369|10017094|FG000|STARTED|Run-in Washout Period #2 (7 Days)||3
8953799|NCT02475369|10017095|FG001|STARTED|Run-in Washout Period #2 (7 Days)||9
8953800|NCT02475369|10017094|FG000|COMPLETED|Run-in Washout Period #2 (7 Days)||3
8953801|NCT02475369|10017095|FG001|COMPLETED|Run-in Washout Period #2 (7 Days)||9
8953802|NCT02475369|10017094|FG000|NOT COMPLETED|Run-in Washout Period #2 (7 Days)||0
8953803|NCT02475369|10017095|FG001|NOT COMPLETED|Run-in Washout Period #2 (7 Days)||0
8953804|NCT02475369|10017094|FG000|STARTED|Treatment Period #2 (10 Days)||3
8953805|NCT02475369|10017095|FG001|STARTED|Treatment Period #2 (10 Days)||9
8953806|NCT02475369|10017094|FG000|COMPLETED|Treatment Period #2 (10 Days)||3
8953807|NCT02475369|10017095|FG001|COMPLETED|Treatment Period #2 (10 Days)||9
8953808|NCT02475369|10017094|FG000|NOT COMPLETED|Treatment Period #2 (10 Days)||0
8953809|NCT02475369|10017095|FG001|NOT COMPLETED|Treatment Period #2 (10 Days)||0
8953810|NCT02475395|10017108|FG000|STARTED|Overall Study||258
8953811|NCT02475395|10017109|FG001|STARTED|Overall Study||14
8953812|NCT02475395|10017108|FG000|COMPLETED|Overall Study||228
8953813|NCT02475395|10017109|FG001|COMPLETED|Overall Study||11
8953814|NCT02475395|10017108|FG000|NOT COMPLETED|Overall Study||30
8953815|NCT02475395|10017109|FG001|NOT COMPLETED|Overall Study||3
8953816|NCT02475564|10017117|FG000|STARTED|Overall Study||22
8953817|NCT02475564|10017118|FG001|STARTED|Overall Study||22
8953818|NCT02475564|10017117|FG000|COMPLETED|Overall Study||18
8953819|NCT02475564|10017118|FG001|COMPLETED|Overall Study||21
8953820|NCT02475564|10017117|FG000|NOT COMPLETED|Overall Study||4
8953821|NCT02475564|10017118|FG001|NOT COMPLETED|Overall Study||1
8953822|NCT02475629|10017124|FG000|STARTED|Overall Study||40
8953823|NCT02475629|10017124|FG000|COMPLETED|Overall Study||31
8953824|NCT02475629|10017124|FG000|NOT COMPLETED|Overall Study||9
8953825|NCT02475655|10017130|FG000|STARTED|Overall Study||40
8953826|NCT02475655|10017131|FG001|STARTED|Overall Study||20
8953827|NCT02475655|10017130|FG000|COMPLETED|Overall Study||40
8953828|NCT02475655|10017131|FG001|COMPLETED|Overall Study||19
8953829|NCT02475655|10017130|FG000|NOT COMPLETED|Overall Study||0
8953830|NCT02475655|10017131|FG001|NOT COMPLETED|Overall Study||1
8953831|NCT02475733|10017139|FG000|STARTED|Overall Study||61
8953832|NCT02475733|10017140|FG001|STARTED|Overall Study||22
8953833|NCT02475733|10017139|FG000|COMPLETED|Overall Study||59
8953834|NCT02475733|10017140|FG001|COMPLETED|Overall Study||22
8953835|NCT02475733|10017139|FG000|NOT COMPLETED|Overall Study||2
8953836|NCT02475733|10017140|FG001|NOT COMPLETED|Overall Study||0
8953837|NCT02475837|10017148|FG000|STARTED|Overall Study||6
8953838|NCT02475837|10017149|FG001|STARTED|Overall Study||7
8953839|NCT02475837|10017148|FG000|COMPLETED|Overall Study||6
8953840|NCT02475837|10017149|FG001|COMPLETED|Overall Study||7
8953841|NCT02475837|10017148|FG000|NOT COMPLETED|Overall Study||0
8953842|NCT02475837|10017149|FG001|NOT COMPLETED|Overall Study||0
8953843|NCT02475850|10017157|FG000|STARTED|Overall Study||2802
8953844|NCT02475850|10017158|FG001|STARTED|Overall Study||2649
8953845|NCT02475850|10017157|FG000|COMPLETED|Overall Study||2209
8953846|NCT02475850|10017158|FG001|COMPLETED|Overall Study||2165
8953847|NCT02475850|10017157|FG000|NOT COMPLETED|Overall Study||593
8953848|NCT02475850|10017158|FG001|NOT COMPLETED|Overall Study||484
8953849|NCT02475954|10017167|FG000|STARTED|Overall Study||87
8953850|NCT02475954|10017168|FG001|STARTED|Overall Study||87
8953851|NCT02475954|10017167|FG000|COMPLETED|Overall Study||73
8953852|NCT02475954|10017168|FG001|COMPLETED|Overall Study||75
8953853|NCT02475954|10017167|FG000|NOT COMPLETED|Overall Study||14
8953854|NCT02475954|10017168|FG001|NOT COMPLETED|Overall Study||12
8953855|NCT02475980|10017175|FG000|STARTED|Overall Study||13
8953856|NCT02475980|10017175|FG000|COMPLETED|Overall Study||8
8953857|NCT02475980|10017175|FG000|NOT COMPLETED|Overall Study||5
8953858|NCT02476032|10017182|FG000|STARTED|Overall Study||20
8953859|NCT02476032|10017183|FG001|STARTED|Overall Study||20
8953860|NCT02476032|10017184|FG002|STARTED|Overall Study||20
8953861|NCT02476032|10017182|FG000|COMPLETED|Overall Study||20
8953862|NCT02476032|10017183|FG001|COMPLETED|Overall Study||19
8953863|NCT02476032|10017184|FG002|COMPLETED|Overall Study||19
8953864|NCT02476032|10017182|FG000|NOT COMPLETED|Overall Study||0
8953865|NCT02476032|10017183|FG001|NOT COMPLETED|Overall Study||1
8953866|NCT02476032|10017184|FG002|NOT COMPLETED|Overall Study||1
8953867|NCT02476175|10017195|FG000|STARTED|Overall Study||35
8953868|NCT02476175|10017195|FG000|COMPLETED|Overall Study||33
8570111|NCT00101361|9602228|FG000|COMPLETED|Overall Study||108
8953869|NCT02476175|10017195|FG000|NOT COMPLETED|Overall Study||2
8953870|NCT02476357|10017201|FG000|STARTED|Overall Study||40
8953871|NCT02476357|10017202|FG001|STARTED|Overall Study||40
8953872|NCT02476357|10017201|FG000|COMPLETED|Overall Study||40
8953873|NCT02476357|10017202|FG001|COMPLETED|Overall Study||40
8953874|NCT02476357|10017201|FG000|NOT COMPLETED|Overall Study||0
8953875|NCT02476357|10017202|FG001|NOT COMPLETED|Overall Study||0
8953876|NCT02476422|10017212|FG000|STARTED|Overall Study|"started = Randomized Set/Full analysis set/Safety set"|166
8953877|NCT02476422|10017213|FG001|STARTED|Overall Study||162
8953878|NCT02476422|10017212|FG000|COMPLETED|Overall Study||166
8953879|NCT02476422|10017213|FG001|COMPLETED|Overall Study||161
8953880|NCT02476422|10017212|FG000|NOT COMPLETED|Overall Study||0
8953881|NCT02476422|10017213|FG001|NOT COMPLETED|Overall Study||1
9037564|NCT03316170|10098746|FG000|NOT COMPLETED|Overall Study||7
8631230|NCT00538902|9671128|FG001|NOT COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||2
8631231|NCT00538902|9671129|FG002|NOT COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||5
8631232|NCT00538902|9671127|FG000|STARTED|OL Wk 24 to End (Primary D/C Reasons)||59
8631233|NCT00538902|9671128|FG001|STARTED|OL Wk 24 to End (Primary D/C Reasons)||119
8953882|NCT02476448|10017223|FG000|STARTED|Overall Study|one given phenazopyridine pre-op and was analyzed in her randomization group per intention to treat|44
8631234|NCT00538902|9671129|FG002|STARTED|OL Wk 24 to End (Primary D/C Reasons)||116
8631235|NCT00538902|9671127|FG000|COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||23
8953883|NCT02476448|10017224|FG001|STARTED|Overall Study||44
8631236|NCT00538902|9671128|FG001|COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||55
8631237|NCT00538902|9671129|FG002|COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||52
8631238|NCT00538902|9671127|FG000|NOT COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||36
8631239|NCT00538902|9671128|FG001|NOT COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||64
8631240|NCT00538902|9671129|FG002|NOT COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||64
8631241|NCT00538915|9671139|FG000|STARTED|Overall Study||63
8631242|NCT00538915|9671139|FG000|COMPLETED|Overall Study||52
8631243|NCT00538915|9671139|FG000|NOT COMPLETED|Overall Study||11
8631244|NCT00539006|9671147|FG000|STARTED|Pre-treatment||96
8631245|NCT00539006|9671148|FG001|STARTED|Pre-treatment||95
8631246|NCT00539006|9671149|FG002|STARTED|Pre-treatment||95
8631247|NCT00539006|9671150|FG003|STARTED|Pre-treatment||91
8631248|NCT00539006|9671147|FG000|COMPLETED|Pre-treatment||96
8631249|NCT00539006|9671148|FG001|COMPLETED|Pre-treatment||94
8953884|NCT02476448|10017225|FG002|STARTED|Overall Study||44
8953885|NCT02476448|10017226|FG003|STARTED|Overall Study||44
8953886|NCT02476448|10017223|FG000|COMPLETED|Overall Study||44
8953887|NCT02476448|10017224|FG001|COMPLETED|Overall Study||44
8953888|NCT02476448|10017225|FG002|COMPLETED|Overall Study||44
8953889|NCT02476448|10017226|FG003|COMPLETED|Overall Study||44
8953890|NCT02476448|10017223|FG000|NOT COMPLETED|Overall Study||0
8953891|NCT02476448|10017224|FG001|NOT COMPLETED|Overall Study||0
8953892|NCT02476448|10017225|FG002|NOT COMPLETED|Overall Study||0
8953893|NCT02476448|10017226|FG003|NOT COMPLETED|Overall Study||0
8953894|NCT02476565|10017238|FG000|STARTED|Overall Study||20
8953895|NCT02476565|10017239|FG001|STARTED|Overall Study||19
8953896|NCT02476565|10017238|FG000|COMPLETED|Overall Study||20
8953897|NCT02476565|10017239|FG001|COMPLETED|Overall Study||19
8953898|NCT02476565|10017238|FG000|NOT COMPLETED|Overall Study||0
8953899|NCT02476565|10017239|FG001|NOT COMPLETED|Overall Study||0
8953900|NCT02476578|10017247|FG000|STARTED|Overall Study||4310
8953901|NCT02476578|10017248|FG001|STARTED|Overall Study||4274
8953902|NCT02476578|10017247|FG000|Died Before Email Was Sent|Overall Study||35
8953903|NCT02476578|10017248|FG001|Died Before Email Was Sent|Overall Study||43
8953904|NCT02476578|10017247|FG000|Left Before End of Trial|Overall Study||6
8953905|NCT02476578|10017248|FG001|Left Before End of Trial|Overall Study||13
8953906|NCT02476578|10017247|FG000|COMPLETED|Overall Study||4269
8953907|NCT02476578|10017248|FG001|COMPLETED|Overall Study||4218
8953908|NCT02476578|10017247|FG000|NOT COMPLETED|Overall Study||41
8953909|NCT02476578|10017248|FG001|NOT COMPLETED|Overall Study||56
8953910|NCT02476617|10017254|FG000|STARTED|Overall Study||25
8953911|NCT02476617|10017254|FG000|COMPLETED|Overall Study||23
8953912|NCT02476617|10017254|FG000|NOT COMPLETED|Overall Study||2
8953913|NCT02476890|10017262|FG000|STARTED|Overall Study|Crossover study|6
8953914|NCT02476890|10017263|FG001|STARTED|Overall Study|Crossover study|6
8953915|NCT02476890|10017264|FG002|STARTED|Overall Study|Crossover study|12
8953916|NCT02476890|10017265|FG003|STARTED|Overall Study|Crossover study|12
8953917|NCT02476890|10017262|FG000|Washout|Overall Study||6
8953918|NCT02476890|10017263|FG001|Washout|Overall Study||6
8953919|NCT02476890|10017264|FG002|Washout|Overall Study||12
8953920|NCT02476890|10017265|FG003|Washout|Overall Study||12
8953921|NCT02476890|10017262|FG000|COMPLETED|Overall Study||6
8953922|NCT02476890|10017263|FG001|COMPLETED|Overall Study||6
8953923|NCT02476890|10017264|FG002|COMPLETED|Overall Study||12
8953924|NCT02476890|10017265|FG003|COMPLETED|Overall Study||12
8953925|NCT02476890|10017262|FG000|NOT COMPLETED|Overall Study||0
8953926|NCT02476890|10017263|FG001|NOT COMPLETED|Overall Study||0
8953927|NCT02476890|10017264|FG002|NOT COMPLETED|Overall Study||0
8953928|NCT02476890|10017265|FG003|NOT COMPLETED|Overall Study||0
8953929|NCT02477020|10017279|FG000|STARTED|Overall Study||81
8953930|NCT02477020|10017280|FG001|STARTED|Overall Study||83
8953931|NCT02477020|10017279|FG000|COMPLETED|Overall Study|Completed = participants who completed study treatment.|51
8953932|NCT02477020|10017280|FG001|COMPLETED|Overall Study|Completed = participants who completed study treatment.|55
8953933|NCT02477020|10017279|FG000|NOT COMPLETED|Overall Study||30
8953934|NCT02477020|10017280|FG001|NOT COMPLETED|Overall Study||28
8953935|NCT02477111|10017286|FG000|STARTED|Overall Study||150
8953936|NCT02477111|10017286|FG000|COMPLETED|Overall Study|All participants who were assessed for one year|139
8953937|NCT02477111|10017286|FG000|NOT COMPLETED|Overall Study||11
8953938|NCT02477215|10017296|FG000|STARTED|Dose Escalation Phase||4
8953939|NCT02477215|10017297|FG001|STARTED|Dose Escalation Phase||8
8953940|NCT02477215|10017298|FG002|STARTED|Dose Escalation Phase||6
8953941|NCT02477215|10017296|FG000|COMPLETED|Dose Escalation Phase||3
8953942|NCT02477215|10017297|FG001|COMPLETED|Dose Escalation Phase||6
8953943|NCT02477215|10017298|FG002|COMPLETED|Dose Escalation Phase||6
8953944|NCT02477215|10017296|FG000|NOT COMPLETED|Dose Escalation Phase||1
8953945|NCT02477215|10017297|FG001|NOT COMPLETED|Dose Escalation Phase||2
8953946|NCT02477215|10017298|FG002|NOT COMPLETED|Dose Escalation Phase||0
8953947|NCT02477215|10017296|FG000|STARTED|Fixed Dose Phase|No subjects were started in this group as it was not the optimal dose.|0
8953948|NCT02477215|10017297|FG001|STARTED|Fixed Dose Phase|Subjects in Period 1 did not continue into Period 2. This is a new subject population.|20
8953949|NCT02477215|10017298|FG002|STARTED|Fixed Dose Phase|No subjects were started in this group as it was not the optimal dose.|0
8953950|NCT02477215|10017296|FG000|COMPLETED|Fixed Dose Phase||0
8953951|NCT02477215|10017297|FG001|COMPLETED|Fixed Dose Phase||13
8953952|NCT02477215|10017298|FG002|COMPLETED|Fixed Dose Phase||0
8953953|NCT02477215|10017296|FG000|NOT COMPLETED|Fixed Dose Phase||0
8953954|NCT02477215|10017297|FG001|NOT COMPLETED|Fixed Dose Phase||7
8953955|NCT02477215|10017298|FG002|NOT COMPLETED|Fixed Dose Phase||0
8953956|NCT02477319|10017313|FG000|STARTED|Overall Study||55
8953957|NCT02477319|10017314|FG001|STARTED|Overall Study||40
8953958|NCT02477319|10017315|FG002|STARTED|Overall Study||164
8953959|NCT02477319|10017316|FG003|STARTED|Overall Study||193
8953960|NCT02477319|10017313|FG000|COMPLETED|Overall Study||55
8953961|NCT02477319|10017314|FG001|COMPLETED|Overall Study||37
8953962|NCT02477319|10017315|FG002|COMPLETED|Overall Study||149
8953963|NCT02477319|10017316|FG003|COMPLETED|Overall Study||171
8953964|NCT02477319|10017313|FG000|NOT COMPLETED|Overall Study||0
8953965|NCT02477319|10017314|FG001|NOT COMPLETED|Overall Study||3
8953966|NCT02477319|10017315|FG002|NOT COMPLETED|Overall Study||15
8953967|NCT02477319|10017316|FG003|NOT COMPLETED|Overall Study||22
8953968|NCT02477332|10017329|FG000|STARTED|Overall Study||43
8953969|NCT02477332|10017330|FG001|STARTED|Overall Study||84
8953970|NCT02477332|10017331|FG002|STARTED|Overall Study||85
8953971|NCT02477332|10017332|FG003|STARTED|Overall Study||85
8953972|NCT02477332|10017333|FG004|STARTED|Overall Study||43
8953973|NCT02477332|10017334|FG005|STARTED|Overall Study||42
8953974|NCT02477332|10017329|FG000|COMPLETED|Overall Study||40
8953975|NCT02477332|10017330|FG001|COMPLETED|Overall Study||77
8953976|NCT02477332|10017331|FG002|COMPLETED|Overall Study||73
8953977|NCT02477332|10017332|FG003|COMPLETED|Overall Study||72
8953978|NCT02477332|10017333|FG004|COMPLETED|Overall Study||39
8953979|NCT02477332|10017334|FG005|COMPLETED|Overall Study||37
8953980|NCT02477332|10017329|FG000|NOT COMPLETED|Overall Study||3
8953981|NCT02477332|10017330|FG001|NOT COMPLETED|Overall Study||7
8953982|NCT02477332|10017331|FG002|NOT COMPLETED|Overall Study||12
8953983|NCT02477332|10017332|FG003|NOT COMPLETED|Overall Study||13
8953984|NCT02477332|10017333|FG004|NOT COMPLETED|Overall Study||4
8953985|NCT02477332|10017334|FG005|NOT COMPLETED|Overall Study||5
8953986|NCT02477423|10017352|FG000|STARTED|Overall Study||12
8953987|NCT02477423|10017353|FG001|STARTED|Overall Study||15
8953988|NCT02477423|10017352|FG000|COMPLETED|Overall Study||11
8953989|NCT02477423|10017353|FG001|COMPLETED|Overall Study||11
8953990|NCT02477423|10017352|FG000|NOT COMPLETED|Overall Study||1
8953991|NCT02477423|10017353|FG001|NOT COMPLETED|Overall Study||4
8953992|NCT02477527|10017359|FG000|STARTED|Overall Study||27
8953993|NCT02477527|10017359|FG000|COMPLETED|Overall Study||21
8953994|NCT02477527|10017359|FG000|NOT COMPLETED|Overall Study||6
8953995|NCT02477553|10017365|FG000|STARTED|Overall Study||364
8953996|NCT02477553|10017366|FG001|STARTED|Overall Study||364
8953997|NCT02477553|10017365|FG000|COMPLETED|Overall Study||344
8953998|NCT02477553|10017366|FG001|COMPLETED|Overall Study||344
8953999|NCT02477553|10017365|FG000|NOT COMPLETED|Overall Study||20
8954000|NCT02477553|10017366|FG001|NOT COMPLETED|Overall Study||20
8954001|NCT02477605|10017374|FG000|STARTED|Overall Study||68
8954002|NCT02477605|10017375|FG001|STARTED|Overall Study||68
8954003|NCT02477605|10017374|FG000|Randomized and Treated|Overall Study||67
8954004|NCT02477605|10017375|FG001|Randomized and Treated|Overall Study||68
8954005|NCT02477605|10017374|FG000|COMPLETED|Overall Study||67
8954006|NCT02477605|10017375|FG001|COMPLETED|Overall Study||64
8954007|NCT02477605|10017374|FG000|NOT COMPLETED|Overall Study||1
8954008|NCT02477605|10017375|FG001|NOT COMPLETED|Overall Study||4
8954009|NCT02477670|10017387|FG000|STARTED|Stage 1||47
8954010|NCT02477670|10017388|FG001|STARTED|Stage 1||80
8954011|NCT02477670|10017389|FG002|STARTED|Stage 1||0
8954012|NCT02477670|10017390|FG003|STARTED|Stage 1||0
8954013|NCT02477670|10017391|FG004|STARTED|Stage 1||0
8954014|NCT02477670|10017392|FG005|STARTED|Stage 1||0
8954015|NCT02477670|10017393|FG006|STARTED|Stage 1||0
8954016|NCT02477670|10017387|FG000|COMPLETED|Stage 1||43
8954017|NCT02477670|10017388|FG001|COMPLETED|Stage 1||67
8954018|NCT02477670|10017389|FG002|COMPLETED|Stage 1||0
8954019|NCT02477670|10017390|FG003|COMPLETED|Stage 1||0
8954020|NCT02477670|10017391|FG004|COMPLETED|Stage 1||0
8954021|NCT02477670|10017392|FG005|COMPLETED|Stage 1||0
8954022|NCT02477670|10017393|FG006|COMPLETED|Stage 1||0
8954023|NCT02477670|10017387|FG000|NOT COMPLETED|Stage 1||4
8954024|NCT02477670|10017388|FG001|NOT COMPLETED|Stage 1||13
8954025|NCT02477670|10017389|FG002|NOT COMPLETED|Stage 1||0
8954026|NCT02477670|10017390|FG003|NOT COMPLETED|Stage 1||0
8954027|NCT02477670|10017391|FG004|NOT COMPLETED|Stage 1||0
8954028|NCT02477670|10017392|FG005|NOT COMPLETED|Stage 1||0
8954029|NCT02477670|10017393|FG006|NOT COMPLETED|Stage 1||0
8954030|NCT02477670|10017387|FG000|STARTED|Stage 2||0
8954031|NCT02477670|10017388|FG001|STARTED|Stage 2||0
8954032|NCT02477670|10017389|FG002|STARTED|Stage 2||30
8954033|NCT02477670|10017390|FG003|STARTED|Stage 2||33
8954034|NCT02477670|10017391|FG004|STARTED|Stage 2||2
8954035|NCT02477670|10017392|FG005|STARTED|Stage 2||1
8954036|NCT02477670|10017393|FG006|STARTED|Stage 2||42
8954037|NCT02477670|10017387|FG000|COMPLETED|Stage 2||0
8954038|NCT02477670|10017388|FG001|COMPLETED|Stage 2||0
8954039|NCT02477670|10017389|FG002|COMPLETED|Stage 2||28
8954040|NCT02477670|10017390|FG003|COMPLETED|Stage 2||32
8954041|NCT02477670|10017391|FG004|COMPLETED|Stage 2||2
8954042|NCT02477670|10017392|FG005|COMPLETED|Stage 2||1
8954043|NCT02477670|10017393|FG006|COMPLETED|Stage 2||42
8954044|NCT02477670|10017387|FG000|NOT COMPLETED|Stage 2||0
8954045|NCT02477670|10017388|FG001|NOT COMPLETED|Stage 2||0
8954046|NCT02477670|10017389|FG002|NOT COMPLETED|Stage 2||2
8954047|NCT02477670|10017390|FG003|NOT COMPLETED|Stage 2||1
8954048|NCT02477670|10017391|FG004|NOT COMPLETED|Stage 2||0
8954049|NCT02477670|10017392|FG005|NOT COMPLETED|Stage 2||0
8954050|NCT02477670|10017393|FG006|NOT COMPLETED|Stage 2||0
8954051|NCT02477709|10017404|FG000|STARTED|Overall Study||6
8954052|NCT02477709|10017404|FG000|COMPLETED|Overall Study||6
8954053|NCT02477709|10017404|FG000|NOT COMPLETED|Overall Study||0
8954054|NCT02477800|10017411|FG000|STARTED|Placebo-Controlled Period||545
8954055|NCT02477800|10017412|FG001|STARTED|Placebo-Controlled Period||547
8954056|NCT02477800|10017413|FG002|STARTED|Placebo-Controlled Period||555
8954057|NCT02477800|10017414|FG003|STARTED|Placebo-Controlled Period||0
8954058|NCT02477800|10017415|FG004|STARTED|Placebo-Controlled Period||0
8954059|NCT02477800|10017416|FG005|STARTED|Placebo-Controlled Period||0
8954060|NCT02477800|10017417|FG006|STARTED|Placebo-Controlled Period||0
8954061|NCT02477800|10017411|FG000|COMPLETED|Placebo-Controlled Period||325
8954062|NCT02477800|10017412|FG001|COMPLETED|Placebo-Controlled Period||325
8954063|NCT02477800|10017413|FG002|COMPLETED|Placebo-Controlled Period||288
8954064|NCT02477800|10017414|FG003|COMPLETED|Placebo-Controlled Period||0
8954065|NCT02477800|10017415|FG004|COMPLETED|Placebo-Controlled Period||0
8954066|NCT02477800|10017416|FG005|COMPLETED|Placebo-Controlled Period||0
8954067|NCT02477800|10017417|FG006|COMPLETED|Placebo-Controlled Period||0
8954068|NCT02477800|10017411|FG000|NOT COMPLETED|Placebo-Controlled Period||220
8954069|NCT02477800|10017412|FG001|NOT COMPLETED|Placebo-Controlled Period||222
8954070|NCT02477800|10017413|FG002|NOT COMPLETED|Placebo-Controlled Period||267
8954071|NCT02477800|10017414|FG003|NOT COMPLETED|Placebo-Controlled Period||0
8954072|NCT02477800|10017415|FG004|NOT COMPLETED|Placebo-Controlled Period||0
8954073|NCT02477800|10017416|FG005|NOT COMPLETED|Placebo-Controlled Period||0
8954074|NCT02477800|10017417|FG006|NOT COMPLETED|Placebo-Controlled Period||0
8954075|NCT02477800|10017411|FG000|STARTED|Long Term Extension Period||0
8954076|NCT02477800|10017412|FG001|STARTED|Long Term Extension Period||0
8954077|NCT02477800|10017413|FG002|STARTED|Long Term Extension Period||0
8954078|NCT02477800|10017414|FG003|STARTED|Long Term Extension Period|12 PC completers did not enter LTE.|150
8954079|NCT02477800|10017415|FG004|STARTED|Long Term Extension Period|11 PC completers did not enter LTE.|152
8954080|NCT02477800|10017416|FG005|STARTED|Long Term Extension Period|26 PC completers did not enter LTE.|299
8954081|NCT02477800|10017417|FG006|STARTED|Long Term Extension Period|37 PC completers did not enter LTE.|251
8954082|NCT02477800|10017411|FG000|COMPLETED|Long Term Extension Period||0
8954083|NCT02477800|10017412|FG001|COMPLETED|Long Term Extension Period||0
8954084|NCT02477800|10017413|FG002|COMPLETED|Long Term Extension Period||0
8954085|NCT02477800|10017414|FG003|COMPLETED|Long Term Extension Period||0
8954086|NCT02477800|10017415|FG004|COMPLETED|Long Term Extension Period||0
8954087|NCT02477800|10017416|FG005|COMPLETED|Long Term Extension Period||0
8954088|NCT02477800|10017417|FG006|COMPLETED|Long Term Extension Period||0
8954089|NCT02477800|10017411|FG000|NOT COMPLETED|Long Term Extension Period||0
8954090|NCT02477800|10017412|FG001|NOT COMPLETED|Long Term Extension Period||0
8954091|NCT02477800|10017413|FG002|NOT COMPLETED|Long Term Extension Period||0
8954092|NCT02477800|10017414|FG003|NOT COMPLETED|Long Term Extension Period||150
8954093|NCT02477800|10017415|FG004|NOT COMPLETED|Long Term Extension Period||152
8954094|NCT02477800|10017416|FG005|NOT COMPLETED|Long Term Extension Period||299
8954095|NCT02477800|10017417|FG006|NOT COMPLETED|Long Term Extension Period||251
8954096|NCT02477839|10017431|FG000|STARTED|Overall Study||127
8954097|NCT02477839|10017432|FG001|STARTED|Overall Study||128
8954098|NCT02477839|10017431|FG000|Completed Transition Period|Overall Study||124
8954099|NCT02477839|10017432|FG001|Completed Transition Period|Overall Study||117
8954100|NCT02477839|10017431|FG000|Completed Taper After Maintenance|Overall Study||0
8954101|NCT02477839|10017432|FG001|Completed Taper After Maintenance|Overall Study||1
8954102|NCT02477839|10017431|FG000|COMPLETED|Overall Study||124
8954103|NCT02477839|10017432|FG001|COMPLETED|Overall Study||118
8954104|NCT02477839|10017431|FG000|NOT COMPLETED|Overall Study||3
8954105|NCT02477839|10017432|FG001|NOT COMPLETED|Overall Study||10
8954106|NCT02478164|10017440|FG000|STARTED|Overall Study|17 participants enrolled. 15 of 17 received ponatinib as 2 participants withdrew prior to ponatinib.|15
8954107|NCT02478164|10017440|FG000|COMPLETED|Overall Study||0
8954108|NCT02478164|10017440|FG000|NOT COMPLETED|Overall Study||15
8954109|NCT02478359|10017446|FG000|STARTED|Overall Study||1349
8954110|NCT02478359|10017447|FG001|STARTED|Overall Study||1358
8954111|NCT02478359|10017446|FG000|Intention-to-treat Population Month 12|Overall Study|Disenrolled from health plan: 106|1243
8954112|NCT02478359|10017447|FG001|Intention-to-treat Population Month 12|Overall Study|Disenrolled from health plan: 65|1293
8954113|NCT02478359|10017446|FG000|COMPLETED|Overall Study||1243
8954114|NCT02478359|10017447|FG001|COMPLETED|Overall Study||1293
8954115|NCT02478359|10017446|FG000|NOT COMPLETED|Overall Study||106
8631250|NCT00539006|9671149|FG002|COMPLETED|Pre-treatment||95
8631251|NCT00539006|9671150|FG003|COMPLETED|Pre-treatment||91
8631252|NCT00539006|9671147|FG000|NOT COMPLETED|Pre-treatment||0
8954116|NCT02478359|10017447|FG001|NOT COMPLETED|Overall Study||65
8954117|NCT02478372|10017457|FG000|STARTED|Overall Study||121
8954118|NCT02478372|10017458|FG001|STARTED|Overall Study||121
8631253|NCT00539006|9671148|FG001|NOT COMPLETED|Pre-treatment||1
8631254|NCT00539006|9671149|FG002|NOT COMPLETED|Pre-treatment||0
8954119|NCT02478372|10017457|FG000|Recieved Allocation Intervention|Overall Study||109
8954120|NCT02478372|10017458|FG001|Recieved Allocation Intervention|Overall Study||113
9037565|NCT03316170|10098747|FG001|NOT COMPLETED|Overall Study||7
8954121|NCT02478372|10017457|FG000|Reviewed at Six Weeks|Overall Study|Routine follow up at six weeks - one patient refused to attend|108
8954122|NCT02478372|10017458|FG001|Reviewed at Six Weeks|Overall Study|Routine follow up at six weeks|113
8954123|NCT02478372|10017457|FG000|Reviewed at One Year|Overall Study|Routine follow up at one year|108
8954124|NCT02478372|10017458|FG001|Reviewed at One Year|Overall Study|Routine folow up at one year - four patients did not attend, two patients died|107
8954125|NCT02478372|10017457|FG000|COMPLETED|Overall Study||108
8954126|NCT02478372|10017458|FG001|COMPLETED|Overall Study||107
8954127|NCT02478372|10017457|FG000|NOT COMPLETED|Overall Study||13
8954128|NCT02478372|10017458|FG001|NOT COMPLETED|Overall Study||14
8954129|NCT02478398|10017466|FG000|STARTED|Overall Study||513
8954130|NCT02478398|10017467|FG001|STARTED|Overall Study||512
8954131|NCT02478398|10017466|FG000|Treated|Overall Study||512
8954132|NCT02478398|10017467|FG001|Treated|Overall Study||510
8954133|NCT02478398|10017466|FG000|COMPLETED|Overall Study||461
8954134|NCT02478398|10017467|FG001|COMPLETED|Overall Study||491
8874701|NCT01904604|9931674|FG000|STARTED|Overall Study||25
8874702|NCT01904604|9931675|FG001|STARTED|Overall Study||25
8874703|NCT01904604|9931676|FG002|STARTED|Overall Study||25
8874704|NCT01904604|9931674|FG000|Completed Week 52 OFC|Overall Study||22
8874705|NCT01904604|9931675|FG001|Completed Week 52 OFC|Overall Study||21
8874706|NCT01904604|9931676|FG002|Completed Week 52 OFC|Overall Study||25
8874707|NCT01904604|9931674|FG000|Began Crossover Treatment|Overall Study|2 participants who completed the Week 52 OFC did not crossover; 1 passed the OFC and 1 relocated.|20
8874708|NCT01904604|9931675|FG001|Began Crossover Treatment|Overall Study||21
8874709|NCT01904604|9931676|FG002|Began Crossover Treatment|Overall Study|Per protocol, this treatment group did not crossover.|0
8954135|NCT02478398|10017466|FG000|NOT COMPLETED|Overall Study||52
8954136|NCT02478398|10017467|FG001|NOT COMPLETED|Overall Study||21
8954137|NCT02478463|10017474|FG000|STARTED|Treatment Period 1 (Up to Day 29)||19
8954138|NCT02478463|10017474|FG000|COMPLETED|Treatment Period 1 (Up to Day 29)||18
8954139|NCT02478463|10017474|FG000|NOT COMPLETED|Treatment Period 1 (Up to Day 29)||1
8954140|NCT02478463|10017474|FG000|STARTED|Washout Period (Up to 42 Days)||18
8954141|NCT02478463|10017474|FG000|COMPLETED|Washout Period (Up to 42 Days)||17
8954142|NCT02478463|10017474|FG000|NOT COMPLETED|Washout Period (Up to 42 Days)||1
8954143|NCT02478463|10017474|FG000|STARTED|Treatment Period 2 (Up to 52 Weeks)||17
8954144|NCT02478463|10017474|FG000|COMPLETED|Treatment Period 2 (Up to 52 Weeks)||16
8954145|NCT02478463|10017474|FG000|NOT COMPLETED|Treatment Period 2 (Up to 52 Weeks)||1
8954146|NCT02478489|10017482|FG000|STARTED|Overall Study||123
8954147|NCT02478489|10017483|FG001|STARTED|Overall Study||125
8954148|NCT02478489|10017482|FG000|COMPLETED|Overall Study||108
8954149|NCT02478489|10017483|FG001|COMPLETED|Overall Study||109
8954150|NCT02478489|10017482|FG000|NOT COMPLETED|Overall Study||15
8954151|NCT02478489|10017483|FG001|NOT COMPLETED|Overall Study||16
8954152|NCT02478580|10017491|FG000|STARTED|Overall Study||34
8954153|NCT02478580|10017492|FG001|STARTED|Overall Study||33
8954154|NCT02478580|10017491|FG000|COMPLETED|Overall Study||34
8954155|NCT02478580|10017492|FG001|COMPLETED|Overall Study||33
8954156|NCT02478580|10017491|FG000|NOT COMPLETED|Overall Study||0
8954157|NCT02478580|10017492|FG001|NOT COMPLETED|Overall Study||0
8954158|NCT02478632|10017502|FG000|STARTED|Early Switch Phase (Up to Week 52)||53
8954159|NCT02478632|10017503|FG001|STARTED|Early Switch Phase (Up to Week 52)||49
8954160|NCT02478632|10017502|FG000|COMPLETED|Early Switch Phase (Up to Week 52)||49
8954161|NCT02478632|10017503|FG001|COMPLETED|Early Switch Phase (Up to Week 52)||44
8954162|NCT02478632|10017502|FG000|NOT COMPLETED|Early Switch Phase (Up to Week 52)||4
8954163|NCT02478632|10017503|FG001|NOT COMPLETED|Early Switch Phase (Up to Week 52)||5
8954164|NCT02478632|10017502|FG000|STARTED|Late Switch Phase (Week 52 to Week 148)||49
8954165|NCT02478632|10017503|FG001|STARTED|Late Switch Phase (Week 52 to Week 148)||44
8954166|NCT02478632|10017502|FG000|COMPLETED|Late Switch Phase (Week 52 to Week 148)||42
8954167|NCT02478632|10017503|FG001|COMPLETED|Late Switch Phase (Week 52 to Week 148)||40
8954168|NCT02478632|10017502|FG000|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||7
8954169|NCT02478632|10017503|FG001|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||4
8954170|NCT02478671|10017512|FG000|STARTED|Overall Study||4
8954171|NCT02478671|10017512|FG000|COMPLETED|Overall Study||4
8954172|NCT02478671|10017512|FG000|NOT COMPLETED|Overall Study||0
8954173|NCT02479139|10017523|FG000|STARTED|Overall Study||27
8954174|NCT02479139|10017524|FG001|STARTED|Overall Study||22
8954175|NCT02479139|10017525|FG002|STARTED|Overall Study||28
8954176|NCT02479139|10017526|FG003|STARTED|Overall Study||21
8954177|NCT02479139|10017527|FG004|STARTED|Overall Study||22
8954178|NCT02479139|10017528|FG005|STARTED|Overall Study||25
8954179|NCT02479139|10017523|FG000|COMPLETED|Overall Study||19
8954180|NCT02479139|10017524|FG001|COMPLETED|Overall Study||12
8954181|NCT02479139|10017525|FG002|COMPLETED|Overall Study||21
8954182|NCT02479139|10017526|FG003|COMPLETED|Overall Study||14
8954183|NCT02479139|10017527|FG004|COMPLETED|Overall Study||17
8954184|NCT02479139|10017528|FG005|COMPLETED|Overall Study||19
8954185|NCT02479139|10017523|FG000|NOT COMPLETED|Overall Study||8
8954186|NCT02479139|10017524|FG001|NOT COMPLETED|Overall Study||10
8954187|NCT02479139|10017525|FG002|NOT COMPLETED|Overall Study||7
8954188|NCT02479139|10017526|FG003|NOT COMPLETED|Overall Study||7
8954189|NCT02479139|10017527|FG004|NOT COMPLETED|Overall Study||5
8954190|NCT02479139|10017528|FG005|NOT COMPLETED|Overall Study||6
8954191|NCT02479412|10017551|FG000|STARTED|Overall Study||6
8874710|NCT01904604|9931674|FG000|Completed Week 130 OFC|Overall Study||18
8954192|NCT02479412|10017552|FG001|STARTED|Overall Study||6
8954193|NCT02479412|10017553|FG002|STARTED|Overall Study||6
8954194|NCT02479412|10017554|FG003|STARTED|Overall Study||7
8954195|NCT02479412|10017555|FG004|STARTED|Overall Study||6
8954196|NCT02479412|10017556|FG005|STARTED|Overall Study||5
8954197|NCT02479412|10017557|FG006|STARTED|Overall Study||6
8954198|NCT02479412|10017558|FG007|STARTED|Overall Study||5
8954199|NCT02479412|10017559|FG008|STARTED|Overall Study||7
8954200|NCT02479412|10017551|FG000|COMPLETED|Overall Study||6
8954201|NCT02479412|10017552|FG001|COMPLETED|Overall Study||6
8954202|NCT02479412|10017553|FG002|COMPLETED|Overall Study||4
8631255|NCT00539006|9671150|FG003|NOT COMPLETED|Pre-treatment||0
8631256|NCT00539006|9671147|FG000|STARTED|Treatment Period 1||96
8631257|NCT00539006|9671148|FG001|STARTED|Treatment Period 1||94
8631258|NCT00539006|9671149|FG002|STARTED|Treatment Period 1||95
8570112|NCT00101361|9602229|FG001|COMPLETED|Overall Study||104
8570113|NCT00101361|9602228|FG000|NOT COMPLETED|Overall Study||0
8570114|NCT00101361|9602229|FG001|NOT COMPLETED|Overall Study||0
8570115|NCT00101400|9602235|FG000|STARTED|Treatment|Treated until disease progression, unacceptable sorafenib-related toxicity or withdrawal of consent.|54
8570116|NCT00101400|9602235|FG000|COMPLETED|Treatment|Reasons for treatment termination: 4 Adverse Events, 3 Deaths, 46 Progression, 1 Withdrawal.|54
8570117|NCT00101400|9602235|FG000|NOT COMPLETED|Treatment||0
8570118|NCT00101400|9602235|FG000|STARTED|Survival Follow-Up|3 subjects died during previous period (completion as defined in protocol)|51
8570119|NCT00101400|9602235|FG000|COMPLETED|Survival Follow-Up|44 subjects reached endpoint (death); 7 subjects were still alive|44
8570120|NCT00101400|9602235|FG000|NOT COMPLETED|Survival Follow-Up||7
8631259|NCT00539006|9671150|FG003|STARTED|Treatment Period 1||91
8631260|NCT00539006|9671147|FG000|COMPLETED|Treatment Period 1||96
8631261|NCT00539006|9671148|FG001|COMPLETED|Treatment Period 1||94
8631262|NCT00539006|9671149|FG002|COMPLETED|Treatment Period 1||93
8954203|NCT02479412|10017554|FG003|COMPLETED|Overall Study||6
8954204|NCT02479412|10017555|FG004|COMPLETED|Overall Study||5
8954205|NCT02479412|10017556|FG005|COMPLETED|Overall Study||5
8954206|NCT02479412|10017557|FG006|COMPLETED|Overall Study||6
8954207|NCT02479412|10017558|FG007|COMPLETED|Overall Study||4
8954208|NCT02479412|10017559|FG008|COMPLETED|Overall Study||6
8954209|NCT02479412|10017551|FG000|NOT COMPLETED|Overall Study||0
8954210|NCT02479412|10017552|FG001|NOT COMPLETED|Overall Study||0
8954211|NCT02479412|10017553|FG002|NOT COMPLETED|Overall Study||2
8954212|NCT02479412|10017554|FG003|NOT COMPLETED|Overall Study||1
8954213|NCT02479412|10017555|FG004|NOT COMPLETED|Overall Study||1
8954214|NCT02479412|10017556|FG005|NOT COMPLETED|Overall Study||0
8954215|NCT02479412|10017557|FG006|NOT COMPLETED|Overall Study||0
8954216|NCT02479412|10017558|FG007|NOT COMPLETED|Overall Study||1
8954217|NCT02479412|10017559|FG008|NOT COMPLETED|Overall Study||1
8954218|NCT02479763|10017577|FG000|STARTED|Overall Study||53
8954219|NCT02479763|10017578|FG001|STARTED|Overall Study||53
8954220|NCT02479763|10017577|FG000|COMPLETED|Overall Study||50
8954221|NCT02479763|10017578|FG001|COMPLETED|Overall Study||50
8954222|NCT02479763|10017577|FG000|NOT COMPLETED|Overall Study||3
8954223|NCT02479763|10017578|FG001|NOT COMPLETED|Overall Study||3
8954224|NCT02479802|10017584|FG000|STARTED|Overall Study||13
8954225|NCT02479802|10017584|FG000|COMPLETED|Overall Study||11
8954226|NCT02479802|10017584|FG000|NOT COMPLETED|Overall Study||2
8954227|NCT02479880|10017590|FG000|STARTED|Overall Study||15
8954228|NCT02479880|10017591|FG001|STARTED|Overall Study||15
8954229|NCT02479880|10017590|FG000|COMPLETED|Overall Study||2
8954230|NCT02479880|10017591|FG001|COMPLETED|Overall Study||2
8954231|NCT02479880|10017590|FG000|NOT COMPLETED|Overall Study||13
8954232|NCT02479880|10017591|FG001|NOT COMPLETED|Overall Study||13
8954233|NCT02480010|10017599|FG000|STARTED|Overall Study||35
8954234|NCT02480010|10017600|FG001|STARTED|Overall Study||33
8954235|NCT02480010|10017599|FG000|COMPLETED|Overall Study||0
8954236|NCT02480010|10017600|FG001|COMPLETED|Overall Study||0
8954237|NCT02480010|10017599|FG000|NOT COMPLETED|Overall Study||35
8954238|NCT02480010|10017600|FG001|NOT COMPLETED|Overall Study||33
8954239|NCT02480114|10017608|FG000|STARTED|Overall Study||41
8954240|NCT02480114|10017609|FG001|STARTED|Overall Study||38
8954241|NCT02480114|10017608|FG000|COMPLETED|Overall Study||32
8954242|NCT02480114|10017609|FG001|COMPLETED|Overall Study||30
8954243|NCT02480114|10017608|FG000|NOT COMPLETED|Overall Study||9
8954244|NCT02480114|10017609|FG001|NOT COMPLETED|Overall Study||8
8954245|NCT02480153|10017617|FG000|STARTED|Period 1: First Dose to Week 26 Pre-dose||297
8954246|NCT02480153|10017618|FG001|STARTED|Period 1: First Dose to Week 26 Pre-dose||300
8954247|NCT02480153|10017619|FG002|STARTED|Period 1: First Dose to Week 26 Pre-dose||0
8954248|NCT02480153|10017617|FG000|Received Treatment|Period 1: First Dose to Week 26 Pre-dose||297
8954249|NCT02480153|10017618|FG001|Received Treatment|Period 1: First Dose to Week 26 Pre-dose||299
8954250|NCT02480153|10017619|FG002|Received Treatment|Period 1: First Dose to Week 26 Pre-dose||0
8954251|NCT02480153|10017617|FG000|COMPLETED|Period 1: First Dose to Week 26 Pre-dose||293
8954252|NCT02480153|10017618|FG001|COMPLETED|Period 1: First Dose to Week 26 Pre-dose||284
8954253|NCT02480153|10017619|FG002|COMPLETED|Period 1: First Dose to Week 26 Pre-dose||0
8954254|NCT02480153|10017617|FG000|NOT COMPLETED|Period 1: First Dose to Week 26 Pre-dose||4
8954255|NCT02480153|10017618|FG001|NOT COMPLETED|Period 1: First Dose to Week 26 Pre-dose||16
8954256|NCT02480153|10017619|FG002|NOT COMPLETED|Period 1: First Dose to Week 26 Pre-dose||0
8954257|NCT02480153|10017617|FG000|STARTED|Period 2: Week 26 to Week 52 Pre-dose||283
8954258|NCT02480153|10017618|FG001|STARTED|Period 2: Week 26 to Week 52 Pre-dose||135
8954259|NCT02480153|10017619|FG002|STARTED|Period 2: Week 26 to Week 52 Pre-dose||134
8631263|NCT00539006|9671150|FG003|COMPLETED|Treatment Period 1||90
8631264|NCT00539006|9671147|FG000|NOT COMPLETED|Treatment Period 1||0
8954260|NCT02480153|10017617|FG000|Received Treatment|Period 2: Week 26 to Week 52 Pre-dose||283
8954261|NCT02480153|10017618|FG001|Received Treatment|Period 2: Week 26 to Week 52 Pre-dose||135
8954262|NCT02480153|10017619|FG002|Received Treatment|Period 2: Week 26 to Week 52 Pre-dose||133
8954263|NCT02480153|10017617|FG000|COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||263
8954264|NCT02480153|10017618|FG001|COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||122
8954265|NCT02480153|10017619|FG002|COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||127
8954266|NCT02480153|10017617|FG000|NOT COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||20
8954267|NCT02480153|10017618|FG001|NOT COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||13
8954268|NCT02480153|10017619|FG002|NOT COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||7
8954269|NCT02480153|10017617|FG000|STARTED|Period 3: Week 52 Dosing to Week 78||259
8954270|NCT02480153|10017618|FG001|STARTED|Period 3: Week 52 Dosing to Week 78||121
8954271|NCT02480153|10017619|FG002|STARTED|Period 3: Week 52 Dosing to Week 78||127
8954272|NCT02480153|10017617|FG000|Received Treatment|Period 3: Week 52 Dosing to Week 78||258
8954273|NCT02480153|10017618|FG001|Received Treatment|Period 3: Week 52 Dosing to Week 78||120
8954274|NCT02480153|10017619|FG002|Received Treatment|Period 3: Week 52 Dosing to Week 78||127
8954275|NCT02480153|10017617|FG000|COMPLETED|Period 3: Week 52 Dosing to Week 78||252
8954276|NCT02480153|10017618|FG001|COMPLETED|Period 3: Week 52 Dosing to Week 78||118
8954277|NCT02480153|10017619|FG002|COMPLETED|Period 3: Week 52 Dosing to Week 78||123
8954278|NCT02480153|10017617|FG000|NOT COMPLETED|Period 3: Week 52 Dosing to Week 78||7
8954279|NCT02480153|10017618|FG001|NOT COMPLETED|Period 3: Week 52 Dosing to Week 78||3
8954280|NCT02480153|10017619|FG002|NOT COMPLETED|Period 3: Week 52 Dosing to Week 78||4
8954281|NCT02480166|10017645|FG000|STARTED|Overall Study||20
8954282|NCT02480166|10017646|FG001|STARTED|Overall Study||36
8954283|NCT02480166|10017647|FG002|STARTED|Overall Study||4
8954284|NCT02480166|10017645|FG000|COMPLETED|Overall Study||20
8631265|NCT00539006|9671148|FG001|NOT COMPLETED|Treatment Period 1||0
8631266|NCT00539006|9671149|FG002|NOT COMPLETED|Treatment Period 1||2
8954285|NCT02480166|10017646|FG001|COMPLETED|Overall Study||36
8954286|NCT02480166|10017647|FG002|COMPLETED|Overall Study||4
8954287|NCT02480166|10017645|FG000|NOT COMPLETED|Overall Study||0
8954288|NCT02480166|10017646|FG001|NOT COMPLETED|Overall Study||0
8954289|NCT02480166|10017647|FG002|NOT COMPLETED|Overall Study||0
8954290|NCT02480439|10017659|FG000|STARTED|Treatment Period 1||8
8954291|NCT02480439|10017660|FG001|STARTED|Treatment Period 1||8
8954292|NCT02480439|10017661|FG002|STARTED|Treatment Period 1||8
8954293|NCT02480439|10017659|FG000|COMPLETED|Treatment Period 1||8
8954294|NCT02480439|10017660|FG001|COMPLETED|Treatment Period 1||8
8954295|NCT02480439|10017661|FG002|COMPLETED|Treatment Period 1||8
8954296|NCT02480439|10017659|FG000|NOT COMPLETED|Treatment Period 1||0
8954297|NCT02480439|10017660|FG001|NOT COMPLETED|Treatment Period 1||0
8954298|NCT02480439|10017661|FG002|NOT COMPLETED|Treatment Period 1||0
8954299|NCT02480439|10017659|FG000|STARTED|Treatment Period 2||8
8954300|NCT02480439|10017660|FG001|STARTED|Treatment Period 2|1 Participant was withdrawn due to an Adverse Event after completing Period 1.|7
8954301|NCT02480439|10017661|FG002|STARTED|Treatment Period 2||8
8954302|NCT02480439|10017659|FG000|COMPLETED|Treatment Period 2||8
8954303|NCT02480439|10017660|FG001|COMPLETED|Treatment Period 2||7
8954304|NCT02480439|10017661|FG002|COMPLETED|Treatment Period 2||8
8954305|NCT02480439|10017659|FG000|NOT COMPLETED|Treatment Period 2||0
8954306|NCT02480439|10017660|FG001|NOT COMPLETED|Treatment Period 2||0
8954307|NCT02480439|10017661|FG002|NOT COMPLETED|Treatment Period 2||0
8954308|NCT02480439|10017659|FG000|STARTED|Treatment Period 3||8
8954309|NCT02480439|10017660|FG001|STARTED|Treatment Period 3||7
8954310|NCT02480439|10017661|FG002|STARTED|Treatment Period 3|1 Participant was withdrawn due to an Adverse Event after completing Period 2.|7
8954311|NCT02480439|10017659|FG000|COMPLETED|Treatment Period 3||8
8954312|NCT02480439|10017660|FG001|COMPLETED|Treatment Period 3||7
8954313|NCT02480439|10017661|FG002|COMPLETED|Treatment Period 3||7
8954314|NCT02480439|10017659|FG000|NOT COMPLETED|Treatment Period 3||0
8954315|NCT02480439|10017660|FG001|NOT COMPLETED|Treatment Period 3||0
8954316|NCT02480439|10017661|FG002|NOT COMPLETED|Treatment Period 3||0
8954317|NCT02480582|10017669|FG000|STARTED|Overall Study||7
8954318|NCT02480582|10017670|FG001|STARTED|Overall Study||7
8954319|NCT02480582|10017671|FG002|STARTED|Overall Study||7
8954320|NCT02480582|10017672|FG003|STARTED|Overall Study||7
8954321|NCT02480582|10017673|FG004|STARTED|Overall Study||7
8954322|NCT02480582|10017674|FG005|STARTED|Overall Study||7
8954323|NCT02480582|10017669|FG000|COMPLETED|Overall Study||7
8954324|NCT02480582|10017670|FG001|COMPLETED|Overall Study||7
8954325|NCT02480582|10017671|FG002|COMPLETED|Overall Study||7
8954326|NCT02480582|10017672|FG003|COMPLETED|Overall Study||7
8954327|NCT02480582|10017673|FG004|COMPLETED|Overall Study||7
8954328|NCT02480582|10017674|FG005|COMPLETED|Overall Study||7
8954329|NCT02480582|10017669|FG000|NOT COMPLETED|Overall Study||0
8954330|NCT02480582|10017670|FG001|NOT COMPLETED|Overall Study||0
8954331|NCT02480582|10017671|FG002|NOT COMPLETED|Overall Study||0
8954332|NCT02480582|10017672|FG003|NOT COMPLETED|Overall Study||0
8954333|NCT02480582|10017673|FG004|NOT COMPLETED|Overall Study||0
8954334|NCT02480582|10017674|FG005|NOT COMPLETED|Overall Study||0
8954335|NCT02480621|10017689|FG000|STARTED|Randomization||44
8954336|NCT02480621|10017690|FG001|STARTED|Randomization||40
8954337|NCT02480621|10017689|FG000|COMPLETED|Randomization||43
8954338|NCT02480621|10017690|FG001|COMPLETED|Randomization||39
8954339|NCT02480621|10017689|FG000|NOT COMPLETED|Randomization||1
8954340|NCT02480621|10017690|FG001|NOT COMPLETED|Randomization||1
8954341|NCT02480621|10017689|FG000|STARTED|Follow Up||43
8954342|NCT02480621|10017690|FG001|STARTED|Follow Up||39
8954343|NCT02480621|10017689|FG000|COMPLETED|Follow Up||39
8954344|NCT02480621|10017690|FG001|COMPLETED|Follow Up||37
8954345|NCT02480621|10017689|FG000|NOT COMPLETED|Follow Up||4
8954346|NCT02480621|10017690|FG001|NOT COMPLETED|Follow Up||2
8954347|NCT02480712|10017696|FG000|STARTED|Overall Study||107
8954348|NCT02480712|10017696|FG000|COMPLETED|Overall Study||96
8954349|NCT02480712|10017696|FG000|NOT COMPLETED|Overall Study||11
8954350|NCT02480764|10017709|FG000|STARTED|Overall Study||199
8954351|NCT02480764|10017710|FG001|STARTED|Overall Study||209
8954352|NCT02480764|10017711|FG002|STARTED|Overall Study||204
8954353|NCT02480764|10017709|FG000|COMPLETED|Overall Study||189
8954354|NCT02480764|10017710|FG001|COMPLETED|Overall Study||189
8954355|NCT02480764|10017711|FG002|COMPLETED|Overall Study||183
8954356|NCT02480764|10017709|FG000|NOT COMPLETED|Overall Study||10
8954357|NCT02480764|10017710|FG001|NOT COMPLETED|Overall Study||20
8954358|NCT02480764|10017711|FG002|NOT COMPLETED|Overall Study||21
8954359|NCT02480920|10017719|FG000|STARTED|Overall Study||2738
8954360|NCT02480920|10017719|FG000|COMPLETED|Overall Study||2738
8954361|NCT02480920|10017719|FG000|NOT COMPLETED|Overall Study||0
8954362|NCT02480998|10017725|FG000|STARTED|Overall Study||56
8954363|NCT02480998|10017726|FG001|STARTED|Overall Study||28
8954364|NCT02480998|10017725|FG000|COMPLETED|Overall Study||56
8954365|NCT02480998|10017726|FG001|COMPLETED|Overall Study||28
8954366|NCT02480998|10017725|FG000|NOT COMPLETED|Overall Study||0
8954367|NCT02480998|10017726|FG001|NOT COMPLETED|Overall Study||0
8954368|NCT02481050|10017734|FG000|STARTED|Overall Study||58
8954369|NCT02481050|10017734|FG000|COMPLETED|Overall Study||0
8954370|NCT02481050|10017734|FG000|NOT COMPLETED|Overall Study||58
8954371|NCT02481141|10017740|FG000|STARTED|Overall Study||35
8954372|NCT02481141|10017741|FG001|STARTED|Overall Study||18
8954373|NCT02481141|10017740|FG000|COMPLETED|Overall Study||26
8954374|NCT02481141|10017741|FG001|COMPLETED|Overall Study||13
8954375|NCT02481141|10017740|FG000|NOT COMPLETED|Overall Study||9
8954376|NCT02481141|10017741|FG001|NOT COMPLETED|Overall Study||5
8954377|NCT02481206|10017770|FG000|STARTED|Overall Study||34
8954378|NCT02481206|10017771|FG001|STARTED|Overall Study||32
8954379|NCT02481206|10017770|FG000|COMPLETED|Overall Study||29
8954380|NCT02481206|10017771|FG001|COMPLETED|Overall Study||31
8954381|NCT02481206|10017770|FG000|NOT COMPLETED|Overall Study||5
8954382|NCT02481206|10017771|FG001|NOT COMPLETED|Overall Study||1
8954383|NCT02481219|10017781|FG000|STARTED|Overall Study||60
8954384|NCT02481219|10017782|FG001|STARTED|Overall Study||62
8954385|NCT02481219|10017781|FG000|COMPLETED|Overall Study||58
8954386|NCT02481219|10017782|FG001|COMPLETED|Overall Study||61
8954387|NCT02481219|10017781|FG000|NOT COMPLETED|Overall Study||2
8954388|NCT02481219|10017782|FG001|NOT COMPLETED|Overall Study||1
8954389|NCT02481258|10017794|FG000|STARTED|Overall Study||12
8954390|NCT02481258|10017795|FG001|STARTED|Overall Study||11
8954391|NCT02481258|10017794|FG000|COMPLETED|Overall Study||12
8954392|NCT02481258|10017795|FG001|COMPLETED|Overall Study||11
8954393|NCT02481258|10017794|FG000|NOT COMPLETED|Overall Study||0
8954394|NCT02481258|10017795|FG001|NOT COMPLETED|Overall Study||0
8954395|NCT02481297|10017805|FG000|STARTED|Overall Study||1
8954396|NCT02481297|10017806|FG001|STARTED|Overall Study||6
8954397|NCT02481297|10017805|FG000|COMPLETED|Overall Study||1
8954398|NCT02481297|10017806|FG001|COMPLETED|Overall Study||6
8954399|NCT02481297|10017805|FG000|NOT COMPLETED|Overall Study||0
8954400|NCT02481297|10017806|FG001|NOT COMPLETED|Overall Study||0
8954401|NCT02481375|10017816|FG000|STARTED|Overall Study||206
8954402|NCT02481375|10017817|FG001|STARTED|Overall Study||202
8954403|NCT02481375|10017818|FG002|STARTED|Overall Study||201
8954404|NCT02481375|10017819|FG003|STARTED|Overall Study||200
8954405|NCT02481375|10017816|FG000|COMPLETED|Overall Study||192
8954406|NCT02481375|10017817|FG001|COMPLETED|Overall Study||191
8954407|NCT02481375|10017818|FG002|COMPLETED|Overall Study||191
8954408|NCT02481375|10017819|FG003|COMPLETED|Overall Study||186
8954409|NCT02481375|10017816|FG000|NOT COMPLETED|Overall Study||14
8954410|NCT02481375|10017817|FG001|NOT COMPLETED|Overall Study||11
8954411|NCT02481375|10017818|FG002|NOT COMPLETED|Overall Study||10
8954412|NCT02481375|10017819|FG003|NOT COMPLETED|Overall Study||14
8954413|NCT02481440|10017829|FG000|STARTED|Overall Study||102
8954414|NCT02481440|10017829|FG000|COMPLETED|Overall Study||41
8954415|NCT02481440|10017829|FG000|NOT COMPLETED|Overall Study||61
8954416|NCT02481505|10017836|FG000|STARTED|Overall Study||15
8954417|NCT02481505|10017837|FG001|STARTED|Overall Study||15
8954418|NCT02481505|10017838|FG002|STARTED|Overall Study||15
8954419|NCT02481505|10017836|FG000|COMPLETED|Overall Study||15
8954420|NCT02481505|10017837|FG001|COMPLETED|Overall Study||15
8954421|NCT02481505|10017838|FG002|COMPLETED|Overall Study||15
8954422|NCT02481505|10017836|FG000|NOT COMPLETED|Overall Study||0
8954423|NCT02481505|10017837|FG001|NOT COMPLETED|Overall Study||0
8954424|NCT02481505|10017838|FG002|NOT COMPLETED|Overall Study||0
8954425|NCT02481557|10017848|FG000|STARTED|Overall Study||17
8954426|NCT02481557|10017849|FG001|STARTED|Overall Study||19
8954427|NCT02481557|10017848|FG000|COMPLETED|Overall Study||17
8954428|NCT02481557|10017849|FG001|COMPLETED|Overall Study||19
8954429|NCT02481557|10017848|FG000|NOT COMPLETED|Overall Study||0
8954430|NCT02481557|10017849|FG001|NOT COMPLETED|Overall Study||0
8954431|NCT02481596|10017858|FG000|STARTED|Overall Study||126
8954432|NCT02481596|10017859|FG001|STARTED|Overall Study||127
8954433|NCT02481596|10017860|FG002|STARTED|Overall Study||253
8954434|NCT02481596|10017858|FG000|COMPLETED|Overall Study||123
8954435|NCT02481596|10017859|FG001|COMPLETED|Overall Study||126
8954436|NCT02481596|10017860|FG002|COMPLETED|Overall Study||245
8954437|NCT02481596|10017858|FG000|NOT COMPLETED|Overall Study||3
8954438|NCT02481596|10017859|FG001|NOT COMPLETED|Overall Study||1
8954439|NCT02481596|10017860|FG002|NOT COMPLETED|Overall Study||8
8954440|NCT02481713|10017870|FG000|STARTED|Overall Study||56
8954441|NCT02481713|10017871|FG001|STARTED|Overall Study||58
8954442|NCT02481713|10017870|FG000|COMPLETED|Overall Study||40
8954443|NCT02481713|10017871|FG001|COMPLETED|Overall Study||42
8954444|NCT02481713|10017870|FG000|NOT COMPLETED|Overall Study||16
8954445|NCT02481713|10017871|FG001|NOT COMPLETED|Overall Study||16
8954446|NCT02481869|10017879|FG000|STARTED|Overall Study||5
8954447|NCT02481869|10017880|FG001|STARTED|Overall Study||6
8954448|NCT02481869|10017879|FG000|COMPLETED|Overall Study||0
8954449|NCT02481869|10017880|FG001|COMPLETED|Overall Study||2
8954450|NCT02481869|10017879|FG000|NOT COMPLETED|Overall Study||5
8954451|NCT02481869|10017880|FG001|NOT COMPLETED|Overall Study||4
8954452|NCT02481934|10017887|FG000|STARTED|Overall Study||5
8954453|NCT02481934|10017887|FG000|COMPLETED|Overall Study||3
8954454|NCT02481934|10017887|FG000|NOT COMPLETED|Overall Study||2
8954455|NCT02481947|10017893|FG000|STARTED|Overall Study||230
8954456|NCT02481947|10017894|FG001|STARTED|Overall Study||229
8954457|NCT02481947|10017893|FG000|COMPLETED|Overall Study||184
8954458|NCT02481947|10017894|FG001|COMPLETED|Overall Study||193
8954459|NCT02481947|10017893|FG000|NOT COMPLETED|Overall Study||46
8954460|NCT02481947|10017894|FG001|NOT COMPLETED|Overall Study||36
8954461|NCT02482025|10017902|FG000|STARTED|Overall Study||122
8954462|NCT02482025|10017903|FG001|STARTED|Overall Study||118
8954463|NCT02482025|10017902|FG000|COMPLETED|Overall Study||122
8954464|NCT02482025|10017903|FG001|COMPLETED|Overall Study||118
8954465|NCT02482025|10017902|FG000|NOT COMPLETED|Overall Study||0
8954466|NCT02482025|10017903|FG001|NOT COMPLETED|Overall Study||0
8954467|NCT02482129|10017911|FG000|STARTED|Overall Study||32
8954468|NCT02482129|10017912|FG001|STARTED|Overall Study||11
8954469|NCT02482129|10017911|FG000|Treated, as Randomized|Overall Study||30
8954470|NCT02482129|10017912|FG001|Treated, as Randomized|Overall Study||9
8954471|NCT02482129|10017911|FG000|COMPLETED|Overall Study||26
8954472|NCT02482129|10017912|FG001|COMPLETED|Overall Study||9
8954473|NCT02482129|10017911|FG000|NOT COMPLETED|Overall Study||6
8954474|NCT02482129|10017912|FG001|NOT COMPLETED|Overall Study||2
8954475|NCT02482298|10017923|FG000|STARTED|Overall Study||30
8954476|NCT02482298|10017924|FG001|STARTED|Overall Study||27
8954477|NCT02482298|10017925|FG002|STARTED|Overall Study||30
8954478|NCT02482298|10017923|FG000|COMPLETED|Overall Study||28
8954479|NCT02482298|10017924|FG001|COMPLETED|Overall Study||24
8954480|NCT02482298|10017925|FG002|COMPLETED|Overall Study||27
8954481|NCT02482298|10017923|FG000|NOT COMPLETED|Overall Study||2
8954482|NCT02482298|10017924|FG001|NOT COMPLETED|Overall Study||3
8954483|NCT02482298|10017925|FG002|NOT COMPLETED|Overall Study||3
8954484|NCT02482428|10017938|FG000|STARTED|Overall Study||24
8954485|NCT02482428|10017939|FG001|STARTED|Overall Study||22
8954486|NCT02482428|10017940|FG002|STARTED|Overall Study||10
8954487|NCT02482428|10017941|FG003|STARTED|Overall Study||10
8954488|NCT02482428|10017942|FG004|STARTED|Overall Study||22
8954489|NCT02482428|10017938|FG000|COMPLETED|Overall Study||15
8954490|NCT02482428|10017939|FG001|COMPLETED|Overall Study||10
8954491|NCT02482428|10017940|FG002|COMPLETED|Overall Study||9
8954492|NCT02482428|10017941|FG003|COMPLETED|Overall Study||8
8954493|NCT02482428|10017942|FG004|COMPLETED|Overall Study||15
8954494|NCT02482428|10017938|FG000|NOT COMPLETED|Overall Study||9
8954495|NCT02482428|10017939|FG001|NOT COMPLETED|Overall Study||12
8954496|NCT02482428|10017940|FG002|NOT COMPLETED|Overall Study||1
8954497|NCT02482428|10017941|FG003|NOT COMPLETED|Overall Study||2
8954498|NCT02482428|10017942|FG004|NOT COMPLETED|Overall Study||7
8954499|NCT02482571|10017956|FG000|STARTED|Overall Study||25
8954500|NCT02482571|10017956|FG000|COMPLETED|Overall Study||17
8954501|NCT02482571|10017956|FG000|NOT COMPLETED|Overall Study||8
8954502|NCT02482610|10017961|FG000|STARTED|Overall Study||4
8954503|NCT02482610|10017962|FG001|STARTED|Overall Study||5
8954504|NCT02482610|10017963|FG002|STARTED|Overall Study||2
8954505|NCT02482610|10017964|FG003|STARTED|Overall Study||3
8954506|NCT02482610|10017965|FG004|STARTED|Overall Study||3
8954507|NCT02482610|10017966|FG005|STARTED|Overall Study||5
8954508|NCT02482610|10017961|FG000|COMPLETED|Overall Study||4
8954509|NCT02482610|10017962|FG001|COMPLETED|Overall Study||5
8954510|NCT02482610|10017963|FG002|COMPLETED|Overall Study||2
8954511|NCT02482610|10017964|FG003|COMPLETED|Overall Study||3
8954512|NCT02482610|10017965|FG004|COMPLETED|Overall Study||3
8954513|NCT02482610|10017966|FG005|COMPLETED|Overall Study||5
8954514|NCT02482610|10017961|FG000|NOT COMPLETED|Overall Study||0
8954515|NCT02482610|10017962|FG001|NOT COMPLETED|Overall Study||0
8954516|NCT02482610|10017963|FG002|NOT COMPLETED|Overall Study||0
8954517|NCT02482610|10017964|FG003|NOT COMPLETED|Overall Study||0
8954518|NCT02482610|10017965|FG004|NOT COMPLETED|Overall Study||0
8954519|NCT02482610|10017966|FG005|NOT COMPLETED|Overall Study||0
8954520|NCT02482675|10017977|FG000|STARTED|Overall Study||1
8954521|NCT02482675|10017978|FG001|STARTED|Overall Study||1
8954522|NCT02482675|10017979|FG002|STARTED|Overall Study||1
8954523|NCT02482675|10017980|FG003|STARTED|Overall Study||1
8954524|NCT02482675|10017981|FG004|STARTED|Overall Study||1
8954525|NCT02482675|10017982|FG005|STARTED|Overall Study||1
8954526|NCT02482675|10017983|FG006|STARTED|Overall Study||1
8954527|NCT02482675|10017984|FG007|STARTED|Overall Study||1
8954528|NCT02482675|10017985|FG008|STARTED|Overall Study||1
8954529|NCT02482675|10017986|FG009|STARTED|Overall Study||1
8954530|NCT02482675|10017987|FG010|STARTED|Overall Study||1
8954531|NCT02482675|10017988|FG011|STARTED|Overall Study||1
8954532|NCT02482675|10017989|FG012|STARTED|Overall Study||1
8954533|NCT02482675|10017990|FG013|STARTED|Overall Study||1
8954534|NCT02482675|10017991|FG014|STARTED|Overall Study||1
8954535|NCT02482675|10017992|FG015|STARTED|Overall Study||1
8954536|NCT02482675|10017993|FG016|STARTED|Overall Study||1
8954537|NCT02482675|10017994|FG017|STARTED|Overall Study||1
8954538|NCT02482675|10017995|FG018|STARTED|Overall Study||1
8954539|NCT02482675|10017996|FG019|STARTED|Overall Study||1
8954540|NCT02482675|10017997|FG020|STARTED|Overall Study||1
8954541|NCT02482675|10017998|FG021|STARTED|Overall Study||1
8954542|NCT02482675|10017999|FG022|STARTED|Overall Study||1
8954543|NCT02482675|10017977|FG000|COMPLETED|Overall Study||1
8954544|NCT02482675|10017978|FG001|COMPLETED|Overall Study||1
8954545|NCT02482675|10017979|FG002|COMPLETED|Overall Study||1
8954546|NCT02482675|10017980|FG003|COMPLETED|Overall Study||1
8954547|NCT02482675|10017981|FG004|COMPLETED|Overall Study||1
8954548|NCT02482675|10017982|FG005|COMPLETED|Overall Study||1
8954549|NCT02482675|10017983|FG006|COMPLETED|Overall Study||1
8954550|NCT02482675|10017984|FG007|COMPLETED|Overall Study||1
8954551|NCT02482675|10017985|FG008|COMPLETED|Overall Study||1
8954552|NCT02482675|10017986|FG009|COMPLETED|Overall Study||1
8954553|NCT02482675|10017987|FG010|COMPLETED|Overall Study||1
8954554|NCT02482675|10017988|FG011|COMPLETED|Overall Study||1
8954555|NCT02482675|10017989|FG012|COMPLETED|Overall Study||1
8954556|NCT02482675|10017990|FG013|COMPLETED|Overall Study||1
8954557|NCT02482675|10017991|FG014|COMPLETED|Overall Study||1
8954558|NCT02482675|10017992|FG015|COMPLETED|Overall Study||1
8954559|NCT02482675|10017993|FG016|COMPLETED|Overall Study||1
8954560|NCT02482675|10017994|FG017|COMPLETED|Overall Study||1
8954561|NCT02482675|10017995|FG018|COMPLETED|Overall Study||1
8954562|NCT02482675|10017996|FG019|COMPLETED|Overall Study||1
8954563|NCT02482675|10017997|FG020|COMPLETED|Overall Study||1
8954564|NCT02482675|10017998|FG021|COMPLETED|Overall Study||1
8954565|NCT02482675|10017999|FG022|COMPLETED|Overall Study||1
8954566|NCT02482675|10017977|FG000|NOT COMPLETED|Overall Study||0
8954567|NCT02482675|10017978|FG001|NOT COMPLETED|Overall Study||0
8954568|NCT02482675|10017979|FG002|NOT COMPLETED|Overall Study||0
8954569|NCT02482675|10017980|FG003|NOT COMPLETED|Overall Study||0
8954570|NCT02482675|10017981|FG004|NOT COMPLETED|Overall Study||0
8954571|NCT02482675|10017982|FG005|NOT COMPLETED|Overall Study||0
8631267|NCT00539006|9671150|FG003|NOT COMPLETED|Treatment Period 1||1
8631268|NCT00539006|9671147|FG000|STARTED|Washout||96
8631269|NCT00539006|9671148|FG001|STARTED|Washout||94
8954572|NCT02482675|10017983|FG006|NOT COMPLETED|Overall Study||0
8954573|NCT02482675|10017984|FG007|NOT COMPLETED|Overall Study||0
8954574|NCT02482675|10017985|FG008|NOT COMPLETED|Overall Study||0
8954575|NCT02482675|10017986|FG009|NOT COMPLETED|Overall Study||0
8954576|NCT02482675|10017987|FG010|NOT COMPLETED|Overall Study||0
8954577|NCT02482675|10017988|FG011|NOT COMPLETED|Overall Study||0
8954578|NCT02482675|10017989|FG012|NOT COMPLETED|Overall Study||0
8954579|NCT02482675|10017990|FG013|NOT COMPLETED|Overall Study||0
8954580|NCT02482675|10017991|FG014|NOT COMPLETED|Overall Study||0
8954581|NCT02482675|10017992|FG015|NOT COMPLETED|Overall Study||0
8954582|NCT02482675|10017993|FG016|NOT COMPLETED|Overall Study||0
8631270|NCT00539006|9671149|FG002|STARTED|Washout||93
8631271|NCT00539006|9671150|FG003|STARTED|Washout||90
8631272|NCT00539006|9671147|FG000|COMPLETED|Washout||76
8631273|NCT00539006|9671148|FG001|COMPLETED|Washout||84
8954583|NCT02482675|10017994|FG017|NOT COMPLETED|Overall Study||0
8954584|NCT02482675|10017995|FG018|NOT COMPLETED|Overall Study||0
8954585|NCT02482675|10017996|FG019|NOT COMPLETED|Overall Study||0
8954586|NCT02482675|10017997|FG020|NOT COMPLETED|Overall Study||0
8954587|NCT02482675|10017998|FG021|NOT COMPLETED|Overall Study||0
8954588|NCT02482675|10017999|FG022|NOT COMPLETED|Overall Study||0
8954589|NCT02482805|10018012|FG000|STARTED|Overall Study||26
8874711|NCT01904604|9931675|FG001|Completed Week 130 OFC|Overall Study||18
8874712|NCT01904604|9931676|FG002|Completed Week 130 OFC|Overall Study||23
8874713|NCT01904604|9931674|FG000|COMPLETED|Overall Study|COMPLETED: Completed the Week 130 Oral Food Challenge (OFC).|18
8874714|NCT01904604|9931675|FG001|COMPLETED|Overall Study|COMPLETED: Completed the Week 130 Oral Food Challenge (OFC).|18
8874715|NCT01904604|9931676|FG002|COMPLETED|Overall Study|COMPLETED: Completed the Week 130 Oral Food Challenge (OFC).|23
8874716|NCT01904604|9931674|FG000|NOT COMPLETED|Overall Study||7
8954590|NCT02482805|10018013|FG001|STARTED|Overall Study||27
8954591|NCT02482805|10018014|FG002|STARTED|Overall Study||20
8954592|NCT02482805|10018012|FG000|COMPLETED|Overall Study||22
8954593|NCT02482805|10018013|FG001|COMPLETED|Overall Study||23
8954594|NCT02482805|10018014|FG002|COMPLETED|Overall Study||20
8954595|NCT02482805|10018012|FG000|NOT COMPLETED|Overall Study||4
8954596|NCT02482805|10018013|FG001|NOT COMPLETED|Overall Study||4
8954597|NCT02482805|10018014|FG002|NOT COMPLETED|Overall Study||0
8954598|NCT02482870|10018022|FG000|STARTED|Period 1 - First 60 Patients||30
8954599|NCT02482870|10018023|FG001|STARTED|Period 1 - First 60 Patients||30
8954600|NCT02482870|10018022|FG000|COMPLETED|Period 1 - First 60 Patients||30
8954601|NCT02482870|10018023|FG001|COMPLETED|Period 1 - First 60 Patients||30
8954602|NCT02482870|10018022|FG000|NOT COMPLETED|Period 1 - First 60 Patients||0
8954603|NCT02482870|10018023|FG001|NOT COMPLETED|Period 1 - First 60 Patients||0
8954604|NCT02482870|10018022|FG000|STARTED|Period 2 - Rest of the Study||186
8954605|NCT02482870|10018023|FG001|STARTED|Period 2 - Rest of the Study||202
8954606|NCT02482870|10018022|FG000|COMPLETED|Period 2 - Rest of the Study||186
8954607|NCT02482870|10018023|FG001|COMPLETED|Period 2 - Rest of the Study||202
8954608|NCT02482870|10018022|FG000|NOT COMPLETED|Period 2 - Rest of the Study||0
8954609|NCT02482870|10018023|FG001|NOT COMPLETED|Period 2 - Rest of the Study||0
8954610|NCT02482935|10018037|FG000|STARTED|Period 1||15
8954611|NCT02482935|10018038|FG001|STARTED|Period 1||15
8954612|NCT02482935|10018037|FG000|Received Abemaciclib|Period 1||15
8954613|NCT02482935|10018038|FG001|Received Abemaciclib|Period 1||15
8954614|NCT02482935|10018037|FG000|Washout|Period 1||15
8954615|NCT02482935|10018038|FG001|Washout|Period 1||15
8954616|NCT02482935|10018037|FG000|COMPLETED|Period 1||14
8954617|NCT02482935|10018038|FG001|COMPLETED|Period 1||15
8954618|NCT02482935|10018037|FG000|NOT COMPLETED|Period 1||1
8954619|NCT02482935|10018038|FG001|NOT COMPLETED|Period 1||0
8954620|NCT02482935|10018037|FG000|STARTED|Period 2||14
8954621|NCT02482935|10018038|FG001|STARTED|Period 2||15
8954622|NCT02482935|10018037|FG000|Received Abemaciclib|Period 2||14
8954623|NCT02482935|10018038|FG001|Received Abemaciclib|Period 2||15
8954624|NCT02482935|10018037|FG000|Follow-up|Period 2||14
8954625|NCT02482935|10018038|FG001|Follow-up|Period 2||15
8954626|NCT02482935|10018037|FG000|COMPLETED|Period 2||14
8954627|NCT02482935|10018038|FG001|COMPLETED|Period 2||15
8954628|NCT02482935|10018037|FG000|NOT COMPLETED|Period 2||0
8954629|NCT02482935|10018038|FG001|NOT COMPLETED|Period 2||0
8954630|NCT02483000|10018044|FG000|STARTED|Overall Study||3
8954631|NCT02483000|10018044|FG000|COMPLETED|Overall Study||3
8954632|NCT02483000|10018044|FG000|NOT COMPLETED|Overall Study||0
8954633|NCT02483416|10018053|FG000|STARTED|Overall Study||21
8954634|NCT02483416|10018054|FG001|STARTED|Overall Study||7
8954635|NCT02483416|10018053|FG000|COMPLETED|Overall Study||18
8954636|NCT02483416|10018054|FG001|COMPLETED|Overall Study||6
8954637|NCT02483416|10018053|FG000|NOT COMPLETED|Overall Study||3
8954638|NCT02483416|10018054|FG001|NOT COMPLETED|Overall Study||1
8631274|NCT00539006|9671149|FG002|COMPLETED|Washout||77
8631275|NCT00539006|9671150|FG003|COMPLETED|Washout||81
8631276|NCT00539006|9671147|FG000|NOT COMPLETED|Washout||20
8631277|NCT00539006|9671148|FG001|NOT COMPLETED|Washout||10
8631278|NCT00539006|9671149|FG002|NOT COMPLETED|Washout||16
8631279|NCT00539006|9671150|FG003|NOT COMPLETED|Washout||9
8631280|NCT00539006|9671147|FG000|STARTED|Treatment Period 2||76
8631281|NCT00539006|9671148|FG001|STARTED|Treatment Period 2||84
8631282|NCT00539006|9671149|FG002|STARTED|Treatment Period 2||77
8631283|NCT00539006|9671150|FG003|STARTED|Treatment Period 2||81
8631284|NCT00539006|9671147|FG000|COMPLETED|Treatment Period 2||75
8631285|NCT00539006|9671148|FG001|COMPLETED|Treatment Period 2||83
8631286|NCT00539006|9671149|FG002|COMPLETED|Treatment Period 2||77
8631287|NCT00539006|9671150|FG003|COMPLETED|Treatment Period 2||81
8874717|NCT01904604|9931675|FG001|NOT COMPLETED|Overall Study||7
8874718|NCT01904604|9931676|FG002|NOT COMPLETED|Overall Study||2
8954639|NCT02483520|10018063|FG000|STARTED|Overall Study||92
8954640|NCT02483520|10018064|FG001|STARTED|Overall Study||97
8954641|NCT02483520|10018063|FG000|Caregivers|Overall Study||50
8954642|NCT02483520|10018064|FG001|Caregivers|Overall Study||56
8954643|NCT02483520|10018063|FG000|Persons With Dementia|Overall Study||42
8954644|NCT02483520|10018064|FG001|Persons With Dementia|Overall Study||41
8954645|NCT02483520|10018063|FG000|COMPLETED|Overall Study||81
8954646|NCT02483520|10018064|FG001|COMPLETED|Overall Study||73
8954647|NCT02483520|10018063|FG000|NOT COMPLETED|Overall Study||11
8954648|NCT02483520|10018064|FG001|NOT COMPLETED|Overall Study||24
8954649|NCT02483572|10018072|FG000|STARTED|Overall Study||2
8954650|NCT02483572|10018073|FG001|STARTED|Overall Study||2
8954651|NCT02483572|10018072|FG000|COMPLETED|Overall Study||0
8954652|NCT02483572|10018073|FG001|COMPLETED|Overall Study||1
8954653|NCT02483572|10018072|FG000|NOT COMPLETED|Overall Study||2
8954654|NCT02483572|10018073|FG001|NOT COMPLETED|Overall Study||1
8954655|NCT02483611|10018082|FG000|STARTED|Overall Study||16
8954656|NCT02483611|10018083|FG001|STARTED|Overall Study||16
8954657|NCT02483611|10018084|FG002|STARTED|Overall Study||16
8954658|NCT02483611|10018082|FG000|COMPLETED|Overall Study||16
8954659|NCT02483611|10018083|FG001|COMPLETED|Overall Study||16
8954660|NCT02483611|10018084|FG002|COMPLETED|Overall Study|One patient required decurarization|15
8954661|NCT02483611|10018082|FG000|NOT COMPLETED|Overall Study||0
8954662|NCT02483611|10018083|FG001|NOT COMPLETED|Overall Study||0
8954663|NCT02483611|10018084|FG002|NOT COMPLETED|Overall Study||1
8954664|NCT02483676|10018094|FG000|STARTED|Overall Study||23
8954665|NCT02483676|10018095|FG001|STARTED|Overall Study||22
8954666|NCT02483676|10018094|FG000|COMPLETED|Overall Study||17
8954667|NCT02483676|10018095|FG001|COMPLETED|Overall Study||17
8954668|NCT02483676|10018094|FG000|NOT COMPLETED|Overall Study||6
8954669|NCT02483676|10018095|FG001|NOT COMPLETED|Overall Study||5
8954670|NCT02483975|10018103|FG000|STARTED|Overall Study||56
8954671|NCT02483975|10018104|FG001|STARTED|Overall Study||55
8954672|NCT02483975|10018103|FG000|COMPLETED|Overall Study||54
8954673|NCT02483975|10018104|FG001|COMPLETED|Overall Study|Subject reported as not completed due to AE was discontinued due to exacerbation, was not an AE/SAE|53
8954674|NCT02483975|10018103|FG000|NOT COMPLETED|Overall Study||2
8954675|NCT02483975|10018104|FG001|NOT COMPLETED|Overall Study||2
8954676|NCT02484092|10018113|FG000|STARTED|Overall Study||15
8954677|NCT02484092|10018113|FG000|COMPLETED|Overall Study||15
8954678|NCT02484092|10018113|FG000|NOT COMPLETED|Overall Study||0
8954679|NCT02484222|10018117|FG000|STARTED|Overall Study||80
8954680|NCT02484222|10018117|FG000|COMPLETED|Overall Study||77
8954681|NCT02484222|10018117|FG000|NOT COMPLETED|Overall Study||3
8954682|NCT02484547|10018126|FG000|STARTED|Placebo-Controlled Period||548
8954683|NCT02484547|10018127|FG001|STARTED|Placebo-Controlled Period||543
8954684|NCT02484547|10018128|FG002|STARTED|Placebo-Controlled Period||547
8954685|NCT02484547|10018129|FG003|STARTED|Placebo-Controlled Period||0
8954686|NCT02484547|10018130|FG004|STARTED|Placebo-Controlled Period||0
8954687|NCT02484547|10018131|FG005|STARTED|Placebo-Controlled Period||0
8954688|NCT02484547|10018132|FG006|STARTED|Placebo-Controlled Period||0
8954689|NCT02484547|10018126|FG000|COMPLETED|Placebo-Controlled Period||288
8954690|NCT02484547|10018127|FG001|COMPLETED|Placebo-Controlled Period||291
8954691|NCT02484547|10018128|FG002|COMPLETED|Placebo-Controlled Period||295
8954692|NCT02484547|10018129|FG003|COMPLETED|Placebo-Controlled Period||0
8631288|NCT00539006|9671147|FG000|NOT COMPLETED|Treatment Period 2||1
8631289|NCT00539006|9671148|FG001|NOT COMPLETED|Treatment Period 2||1
8631290|NCT00539006|9671149|FG002|NOT COMPLETED|Treatment Period 2||0
8631291|NCT00539006|9671150|FG003|NOT COMPLETED|Treatment Period 2||0
8954693|NCT02484547|10018130|FG004|COMPLETED|Placebo-Controlled Period||0
8954694|NCT02484547|10018131|FG005|COMPLETED|Placebo-Controlled Period||0
8954695|NCT02484547|10018132|FG006|COMPLETED|Placebo-Controlled Period||0
8954696|NCT02484547|10018126|FG000|NOT COMPLETED|Placebo-Controlled Period||260
8954697|NCT02484547|10018127|FG001|NOT COMPLETED|Placebo-Controlled Period||252
8954698|NCT02484547|10018128|FG002|NOT COMPLETED|Placebo-Controlled Period||252
8954699|NCT02484547|10018129|FG003|NOT COMPLETED|Placebo-Controlled Period||0
8954700|NCT02484547|10018130|FG004|NOT COMPLETED|Placebo-Controlled Period||0
8954701|NCT02484547|10018131|FG005|NOT COMPLETED|Placebo-Controlled Period||0
8954702|NCT02484547|10018132|FG006|NOT COMPLETED|Placebo-Controlled Period||0
8954703|NCT02484547|10018126|FG000|STARTED|Long-Term Extension Period||0
8954704|NCT02484547|10018127|FG001|STARTED|Long-Term Extension Period||0
8954705|NCT02484547|10018128|FG002|STARTED|Long-Term Extension Period||0
8954706|NCT02484547|10018129|FG003|STARTED|Long-Term Extension Period|11 PC completers did not enter LTE.|131
8631292|NCT00539006|9671147|FG000|STARTED|Post-Study||75
8631293|NCT00539006|9671148|FG001|STARTED|Post-Study||83
8631294|NCT00539006|9671149|FG002|STARTED|Post-Study||77
8631295|NCT00539006|9671150|FG003|STARTED|Post-Study||81
8631296|NCT00539006|9671147|FG000|COMPLETED|Post-Study||75
8954707|NCT02484547|10018130|FG004|STARTED|Long-Term Extension Period|14 PC completers did not enter LTE.|132
8954708|NCT02484547|10018131|FG005|STARTED|Long-Term Extension Period|40 PC completers did not enter LTE.|251
8954709|NCT02484547|10018132|FG006|STARTED|Long-Term Extension Period|38 PC completers did not enter LTE.|257
8954710|NCT02484547|10018126|FG000|COMPLETED|Long-Term Extension Period||0
8954711|NCT02484547|10018127|FG001|COMPLETED|Long-Term Extension Period||0
8954712|NCT02484547|10018128|FG002|COMPLETED|Long-Term Extension Period||0
8954713|NCT02484547|10018129|FG003|COMPLETED|Long-Term Extension Period||0
8954714|NCT02484547|10018130|FG004|COMPLETED|Long-Term Extension Period||0
8954715|NCT02484547|10018131|FG005|COMPLETED|Long-Term Extension Period||0
8954716|NCT02484547|10018132|FG006|COMPLETED|Long-Term Extension Period||0
8954717|NCT02484547|10018126|FG000|NOT COMPLETED|Long-Term Extension Period||0
8954718|NCT02484547|10018127|FG001|NOT COMPLETED|Long-Term Extension Period||0
8954719|NCT02484547|10018128|FG002|NOT COMPLETED|Long-Term Extension Period||0
8954720|NCT02484547|10018129|FG003|NOT COMPLETED|Long-Term Extension Period||131
8954721|NCT02484547|10018130|FG004|NOT COMPLETED|Long-Term Extension Period||132
8954722|NCT02484547|10018131|FG005|NOT COMPLETED|Long-Term Extension Period||251
8954723|NCT02484547|10018132|FG006|NOT COMPLETED|Long-Term Extension Period||257
8954724|NCT02484651|10018146|FG000|STARTED|Overall Study|35 patients were randomized|35
8954725|NCT02484651|10018147|FG001|STARTED|Overall Study|35 patients were randomized|35
8954726|NCT02484651|10018146|FG000|End of Clinical Study|Overall Study||35
8954727|NCT02484651|10018147|FG001|End of Clinical Study|Overall Study||35
8954728|NCT02484651|10018146|FG000|Data Analysis|Overall Study||32
8954729|NCT02484651|10018147|FG001|Data Analysis|Overall Study||31
8954730|NCT02484651|10018146|FG000|COMPLETED|Overall Study||32
8954731|NCT02484651|10018147|FG001|COMPLETED|Overall Study||31
8954732|NCT02484651|10018146|FG000|NOT COMPLETED|Overall Study||3
8954733|NCT02484651|10018147|FG001|NOT COMPLETED|Overall Study||4
9037566|NCT03316378|10098756|FG000|STARTED|Overall Study||23
9037567|NCT03316378|10098757|FG001|STARTED|Overall Study||23
9037568|NCT03316378|10098756|FG000|COMPLETED|Overall Study||23
9037569|NCT03316378|10098757|FG001|COMPLETED|Overall Study||23
9037570|NCT03316378|10098756|FG000|NOT COMPLETED|Overall Study||0
9037571|NCT03316378|10098757|FG001|NOT COMPLETED|Overall Study||0
9037572|NCT03316547|10098766|FG000|STARTED|Overall Study||39
9037573|NCT03316547|10098767|FG001|STARTED|Overall Study||31
9037574|NCT03316547|10098766|FG000|COMPLETED|Overall Study||21
9037575|NCT03316547|10098767|FG001|COMPLETED|Overall Study||18
9037576|NCT03316547|10098766|FG000|NOT COMPLETED|Overall Study||18
9037577|NCT03316547|10098767|FG001|NOT COMPLETED|Overall Study||13
9037578|NCT03316911|10098777|FG000|STARTED|Overall Study|2 did not complete baseline survey|122
9037579|NCT03316911|10098778|FG001|STARTED|Overall Study|3 did not complete baseline survey|139
9037580|NCT03316911|10098777|FG000|3-Month Follow-up Survey|Overall Study||93
9037581|NCT03316911|10098778|FG001|3-Month Follow-up Survey|Overall Study||112
9037582|NCT03316911|10098777|FG000|5-Month Follow-up Survey|Overall Study||89
9037583|NCT03316911|10098778|FG001|5-Month Follow-up Survey|Overall Study||110
9037584|NCT03316911|10098777|FG000|COMPLETED|Overall Study||89
9037585|NCT03316911|10098778|FG001|COMPLETED|Overall Study||110
9037586|NCT03316911|10098777|FG000|NOT COMPLETED|Overall Study||33
9037587|NCT03316911|10098778|FG001|NOT COMPLETED|Overall Study||29
9037588|NCT03316976|10098786|FG000|STARTED|Overall Study||20
9037589|NCT03316976|10098787|FG001|STARTED|Overall Study||20
9037590|NCT03316976|10098786|FG000|COMPLETED|Overall Study||20
9037591|NCT03316976|10098787|FG001|COMPLETED|Overall Study||20
9037592|NCT03316976|10098786|FG000|NOT COMPLETED|Overall Study||0
9037593|NCT03316976|10098787|FG001|NOT COMPLETED|Overall Study||0
9037594|NCT03317002|10098796|FG000|STARTED|Overall Study||52
9037595|NCT03317002|10098797|FG001|STARTED|Overall Study||25
9037596|NCT03317002|10098798|FG002|STARTED|Overall Study||52
9037597|NCT03317002|10098796|FG000|COMPLETED|Overall Study||50
9037598|NCT03317002|10098797|FG001|COMPLETED|Overall Study||24
9037599|NCT03317002|10098798|FG002|COMPLETED|Overall Study||51
9037600|NCT03317002|10098796|FG000|NOT COMPLETED|Overall Study||2
9037601|NCT03317002|10098797|FG001|NOT COMPLETED|Overall Study||1
9037602|NCT03317002|10098798|FG002|NOT COMPLETED|Overall Study||1
8631297|NCT00539006|9671148|FG001|COMPLETED|Post-Study||83
9037603|NCT03317288|10098806|FG000|STARTED|Overall Study||15
8631298|NCT00539006|9671149|FG002|COMPLETED|Post-Study||77
8725656|NCT01032733|9772966|FG001|NOT COMPLETED|Overall Study||1
8725657|NCT01032759|9772975|FG000|STARTED|Overall Study||32
8725658|NCT01032759|9772976|FG001|STARTED|Overall Study||31
8725659|NCT01032759|9772975|FG000|Completed 24 Hour Assessment|Overall Study||32
8725660|NCT01032759|9772976|FG001|Completed 24 Hour Assessment|Overall Study||30
8725661|NCT01032759|9772975|FG000|Completed 48 Hour Assessment|Overall Study||31
8725662|NCT01032759|9772976|FG001|Completed 48 Hour Assessment|Overall Study||28
8725663|NCT01032759|9772975|FG000|COMPLETED|Overall Study||31
8954734|NCT02484690|10018159|FG000|STARTED|Overall Study||68
8954735|NCT02484690|10018160|FG001|STARTED|Overall Study||46
8954736|NCT02484690|10018161|FG002|STARTED|Overall Study||39
8954737|NCT02484690|10018162|FG003|STARTED|Overall Study||46
8954738|NCT02484690|10018163|FG004|STARTED|Overall Study||64
8954739|NCT02484690|10018159|FG000|Received at Least One Dose of Study Drug|Overall Study||67
8954740|NCT02484690|10018160|FG001|Received at Least One Dose of Study Drug|Overall Study||46
8954741|NCT02484690|10018161|FG002|Received at Least One Dose of Study Drug|Overall Study||39
8954742|NCT02484690|10018162|FG003|Received at Least One Dose of Study Drug|Overall Study||46
8954743|NCT02484690|10018163|FG004|Received at Least One Dose of Study Drug|Overall Study||64
8954744|NCT02484690|10018159|FG000|COMPLETED|Overall Study||64
8954745|NCT02484690|10018160|FG001|COMPLETED|Overall Study||40
8954746|NCT02484690|10018161|FG002|COMPLETED|Overall Study||36
8954747|NCT02484690|10018162|FG003|COMPLETED|Overall Study||44
8954748|NCT02484690|10018163|FG004|COMPLETED|Overall Study||58
8954749|NCT02484690|10018159|FG000|NOT COMPLETED|Overall Study||4
8954750|NCT02484690|10018160|FG001|NOT COMPLETED|Overall Study||6
8954751|NCT02484690|10018161|FG002|NOT COMPLETED|Overall Study||3
8954752|NCT02484690|10018162|FG003|NOT COMPLETED|Overall Study||2
8954753|NCT02484690|10018163|FG004|NOT COMPLETED|Overall Study||6
9037604|NCT03317288|10098806|FG000|COMPLETED|Overall Study||15
9037605|NCT03317288|10098806|FG000|NOT COMPLETED|Overall Study||0
9037606|NCT03317379|10098827|FG000|STARTED|Overall Study||20
9037607|NCT03317379|10098828|FG001|STARTED|Overall Study||18
9037608|NCT03317379|10098829|FG002|STARTED|Overall Study||22
9037609|NCT03317379|10098827|FG000|Completed Intervention|Overall Study||16
9037610|NCT03317379|10098828|FG001|Completed Intervention|Overall Study||6
9037611|NCT03317379|10098829|FG002|Completed Intervention|Overall Study||0
9037612|NCT03317379|10098827|FG000|COMPLETED|Overall Study||20
9037613|NCT03317379|10098828|FG001|COMPLETED|Overall Study||15
9037614|NCT03317379|10098829|FG002|COMPLETED|Overall Study||20
9037615|NCT03317379|10098827|FG000|NOT COMPLETED|Overall Study||0
9037616|NCT03317379|10098828|FG001|NOT COMPLETED|Overall Study||3
9037617|NCT03317379|10098829|FG002|NOT COMPLETED|Overall Study||2
9037618|NCT03317431|10098837|FG000|STARTED|Overall Study||46
9037619|NCT03317431|10098837|FG000|COMPLETED|Overall Study||46
9037620|NCT03317431|10098837|FG000|NOT COMPLETED|Overall Study||0
9037621|NCT03317444|10098843|FG000|STARTED|Overall Study||124
9037622|NCT03317444|10098844|FG001|STARTED|Overall Study||93
9037623|NCT03317444|10098843|FG000|COMPLETED|Overall Study||119
9037624|NCT03317444|10098844|FG001|COMPLETED|Overall Study||89
9037625|NCT03317444|10098843|FG000|NOT COMPLETED|Overall Study||5
9037626|NCT03317444|10098844|FG001|NOT COMPLETED|Overall Study||4
9037627|NCT03318315|10098853|FG000|STARTED|Overall Study||62
9037628|NCT03318315|10098854|FG001|STARTED|Overall Study||53
9037629|NCT03318315|10098855|FG002|STARTED|Overall Study||34
9037630|NCT03318315|10098853|FG000|Received First Vaccination|Overall Study||62
9037631|NCT03318315|10098854|FG001|Received First Vaccination|Overall Study||53
9037632|NCT03318315|10098855|FG002|Received First Vaccination|Overall Study||34
9037633|NCT03318315|10098853|FG000|Received Second Vaccination|Overall Study||59
9037634|NCT03318315|10098854|FG001|Received Second Vaccination|Overall Study||48
9037635|NCT03318315|10098855|FG002|Received Second Vaccination|Overall Study||0
9037636|NCT03318315|10098853|FG000|Received Third Vaccination|Overall Study||0
9037637|NCT03318315|10098854|FG001|Received Third Vaccination|Overall Study||46
9037638|NCT03318315|10098855|FG002|Received Third Vaccination|Overall Study||0
9037639|NCT03318315|10098853|FG000|COMPLETED|Overall Study||58
9037640|NCT03318315|10098854|FG001|COMPLETED|Overall Study||50
9037641|NCT03318315|10098855|FG002|COMPLETED|Overall Study||30
9037642|NCT03318315|10098853|FG000|NOT COMPLETED|Overall Study||4
9037643|NCT03318315|10098854|FG001|NOT COMPLETED|Overall Study||3
9037644|NCT03318315|10098855|FG002|NOT COMPLETED|Overall Study||4
9037645|NCT03318341|10098866|FG000|STARTED|Month 1||13
9037646|NCT03318341|10098867|FG001|STARTED|Month 1||13
9037647|NCT03318341|10098866|FG000|COMPLETED|Month 1||13
9037648|NCT03318341|10098867|FG001|COMPLETED|Month 1||12
9037649|NCT03318341|10098866|FG000|NOT COMPLETED|Month 1||0
9037650|NCT03318341|10098867|FG001|NOT COMPLETED|Month 1||1
9037651|NCT03318341|10098866|FG000|STARTED|Month 2||13
9037652|NCT03318341|10098867|FG001|STARTED|Month 2||12
9037653|NCT03318341|10098866|FG000|COMPLETED|Month 2||13
9037654|NCT03318341|10098867|FG001|COMPLETED|Month 2||12
9037655|NCT03318341|10098866|FG000|NOT COMPLETED|Month 2||0
9037656|NCT03318341|10098867|FG001|NOT COMPLETED|Month 2||0
9037657|NCT03318783|10098877|FG000|STARTED|Overall Study||10
9037658|NCT03318783|10098878|FG001|STARTED|Overall Study||10
9037659|NCT03318783|10098877|FG000|COMPLETED|Overall Study||10
9037660|NCT03318783|10098878|FG001|COMPLETED|Overall Study||8
9037661|NCT03318783|10098877|FG000|NOT COMPLETED|Overall Study||0
9037662|NCT03318783|10098878|FG001|NOT COMPLETED|Overall Study||2
9037663|NCT03318809|10098886|FG000|STARTED|Overall Study||6
9037664|NCT03318809|10098887|FG001|STARTED|Overall Study||6
9037665|NCT03318809|10098886|FG000|COMPLETED|Overall Study||6
8954754|NCT02484729|10018186|FG000|STARTED|Overall Study||16
8954755|NCT02484729|10018187|FG001|STARTED|Overall Study||6
8954756|NCT02484729|10018188|FG002|STARTED|Overall Study||6
8954757|NCT02484729|10018189|FG003|STARTED|Overall Study||6
8954758|NCT02484729|10018190|FG004|STARTED|Overall Study||5
8954759|NCT02484729|10018191|FG005|STARTED|Overall Study||6
8954760|NCT02484729|10018192|FG006|STARTED|Overall Study||5
8954761|NCT02484729|10018193|FG007|STARTED|Overall Study||6
8954762|NCT02484729|10018194|FG008|STARTED|Overall Study||6
8954763|NCT02484729|10018195|FG009|STARTED|Overall Study||8
8954764|NCT02484729|10018186|FG000|COMPLETED|Overall Study||16
8954765|NCT02484729|10018187|FG001|COMPLETED|Overall Study||6
8954766|NCT02484729|10018188|FG002|COMPLETED|Overall Study||6
8954767|NCT02484729|10018189|FG003|COMPLETED|Overall Study||6
8954768|NCT02484729|10018190|FG004|COMPLETED|Overall Study||5
8954769|NCT02484729|10018191|FG005|COMPLETED|Overall Study||6
8954770|NCT02484729|10018192|FG006|COMPLETED|Overall Study||5
8954771|NCT02484729|10018193|FG007|COMPLETED|Overall Study||6
8954772|NCT02484729|10018194|FG008|COMPLETED|Overall Study||6
8954773|NCT02484729|10018195|FG009|COMPLETED|Overall Study||7
8954774|NCT02484729|10018186|FG000|NOT COMPLETED|Overall Study||0
8954775|NCT02484729|10018187|FG001|NOT COMPLETED|Overall Study||0
8954776|NCT02484729|10018188|FG002|NOT COMPLETED|Overall Study||0
8954777|NCT02484729|10018189|FG003|NOT COMPLETED|Overall Study||0
8954778|NCT02484729|10018190|FG004|NOT COMPLETED|Overall Study||0
8954779|NCT02484729|10018191|FG005|NOT COMPLETED|Overall Study||0
8954780|NCT02484729|10018192|FG006|NOT COMPLETED|Overall Study||0
8954781|NCT02484729|10018193|FG007|NOT COMPLETED|Overall Study||0
8954782|NCT02484729|10018194|FG008|NOT COMPLETED|Overall Study||0
8954783|NCT02484729|10018195|FG009|NOT COMPLETED|Overall Study||1
8954784|NCT02484807|10018235|FG000|STARTED|Overall Study||39
8954785|NCT02484807|10018236|FG001|STARTED|Overall Study||7
8954786|NCT02484807|10018237|FG002|STARTED|Overall Study||19
8631299|NCT00539006|9671150|FG003|COMPLETED|Post-Study||81
8954787|NCT02484807|10018238|FG003|STARTED|Overall Study||21
8954788|NCT02484807|10018239|FG004|STARTED|Overall Study||33
8954789|NCT02484807|10018240|FG005|STARTED|Overall Study||6
8954790|NCT02484807|10018235|FG000|COMPLETED|Overall Study||39
8954791|NCT02484807|10018236|FG001|COMPLETED|Overall Study||7
8954792|NCT02484807|10018237|FG002|COMPLETED|Overall Study||19
8954793|NCT02484807|10018238|FG003|COMPLETED|Overall Study||21
8954794|NCT02484807|10018239|FG004|COMPLETED|Overall Study||33
8954795|NCT02484807|10018240|FG005|COMPLETED|Overall Study||6
8954796|NCT02484807|10018235|FG000|NOT COMPLETED|Overall Study||0
8954797|NCT02484807|10018236|FG001|NOT COMPLETED|Overall Study||0
8954798|NCT02484807|10018237|FG002|NOT COMPLETED|Overall Study||0
8954799|NCT02484807|10018238|FG003|NOT COMPLETED|Overall Study||0
8954800|NCT02484807|10018239|FG004|NOT COMPLETED|Overall Study||0
8954801|NCT02484807|10018240|FG005|NOT COMPLETED|Overall Study||0
8954802|NCT02484859|10018257|FG000|STARTED|Overall Study||44
8954803|NCT02484859|10018258|FG001|STARTED|Overall Study||44
8954804|NCT02484859|10018257|FG000|COMPLETED|Overall Study||44
8954805|NCT02484859|10018258|FG001|COMPLETED|Overall Study||44
8954806|NCT02484859|10018257|FG000|NOT COMPLETED|Overall Study||0
8954807|NCT02484859|10018258|FG001|NOT COMPLETED|Overall Study||0
8954808|NCT02484898|10018266|FG000|STARTED|Overall Study||200
8954809|NCT02484898|10018266|FG000|COMPLETED|Overall Study||182
8954810|NCT02484898|10018266|FG000|NOT COMPLETED|Overall Study||18
8954811|NCT02484911|10018272|FG000|STARTED|Overall Study||60
8954812|NCT02484911|10018273|FG001|STARTED|Overall Study||60
8954813|NCT02484911|10018272|FG000|COMPLETED|Overall Study||56
8954814|NCT02484911|10018273|FG001|COMPLETED|Overall Study||58
8954815|NCT02484911|10018272|FG000|NOT COMPLETED|Overall Study||4
8954816|NCT02484911|10018273|FG001|NOT COMPLETED|Overall Study||2
8954817|NCT02485158|10018280|FG000|STARTED|Overall Study||28
8631300|NCT00539006|9671147|FG000|NOT COMPLETED|Post-Study||0
8631301|NCT00539006|9671148|FG001|NOT COMPLETED|Post-Study||0
8631302|NCT00539006|9671149|FG002|NOT COMPLETED|Post-Study||0
8954818|NCT02485158|10018280|FG000|COMPLETED|Overall Study||24
8954819|NCT02485158|10018280|FG000|NOT COMPLETED|Overall Study||4
8954820|NCT02485301|10018291|FG000|STARTED|Overall Study||1509
8954821|NCT02485301|10018292|FG001|STARTED|Overall Study||1504
8954822|NCT02485301|10018291|FG000|COMPLETED|Overall Study||1471
8954823|NCT02485301|10018292|FG001|COMPLETED|Overall Study||1455
8631303|NCT00539006|9671150|FG003|NOT COMPLETED|Post-Study||0
8631304|NCT00539032|9671168|FG000|STARTED|Overall Study||153
8631305|NCT00539032|9671169|FG001|STARTED|Overall Study||85
8954824|NCT02485301|10018291|FG000|NOT COMPLETED|Overall Study||38
8954825|NCT02485301|10018292|FG001|NOT COMPLETED|Overall Study||49
8954826|NCT02485353|10018298|FG000|STARTED|Overall Study||2
8954827|NCT02485353|10018298|FG000|COMPLETED|Overall Study||0
8954828|NCT02485353|10018298|FG000|NOT COMPLETED|Overall Study||2
8954829|NCT02485483|10018304|FG000|STARTED|Overall Study||277
8954830|NCT02485483|10018305|FG001|STARTED|Overall Study||1015
8954831|NCT02485483|10018304|FG000|COMPLETED|Overall Study||223
8954832|NCT02485483|10018305|FG001|COMPLETED|Overall Study||1015
8954833|NCT02485483|10018304|FG000|NOT COMPLETED|Overall Study||54
8954834|NCT02485483|10018305|FG001|NOT COMPLETED|Overall Study||0
8954835|NCT02485561|10018314|FG000|STARTED|Overall Study||161
8954836|NCT02485561|10018315|FG001|STARTED|Overall Study||157
8954837|NCT02485561|10018316|FG002|STARTED|Overall Study||159
8954838|NCT02485561|10018314|FG000|Completed 1 mo Survey|Overall Study||145
8954839|NCT02485561|10018315|FG001|Completed 1 mo Survey|Overall Study||138
8954840|NCT02485561|10018316|FG002|Completed 1 mo Survey|Overall Study||144
8954841|NCT02485561|10018314|FG000|COMPLETED|Overall Study||133
8954842|NCT02485561|10018315|FG001|COMPLETED|Overall Study||118
8954843|NCT02485561|10018316|FG002|COMPLETED|Overall Study||136
8631306|NCT00539032|9671168|FG000|COMPLETED|Overall Study||151
8631307|NCT00539032|9671169|FG001|COMPLETED|Overall Study||84
8631308|NCT00539032|9671168|FG000|NOT COMPLETED|Overall Study||2
8631309|NCT00539032|9671169|FG001|NOT COMPLETED|Overall Study||1
8631310|NCT00539110|9671177|FG000|STARTED|Overall Study||5
8631311|NCT00539110|9671178|FG001|STARTED|Overall Study||5
8631312|NCT00539110|9671177|FG000|COMPLETED|Overall Study||5
8954844|NCT02485561|10018314|FG000|NOT COMPLETED|Overall Study||28
8954845|NCT02485561|10018315|FG001|NOT COMPLETED|Overall Study||39
8631313|NCT00539110|9671178|FG001|COMPLETED|Overall Study||5
8631314|NCT00539110|9671177|FG000|NOT COMPLETED|Overall Study||0
8631315|NCT00539110|9671178|FG001|NOT COMPLETED|Overall Study||0
8631316|NCT00539188|9671186|FG000|STARTED|Overall Study||4
8631317|NCT00539188|9671187|FG001|STARTED|Overall Study||2
8954846|NCT02485561|10018316|FG002|NOT COMPLETED|Overall Study||23
8954847|NCT02485704|10018326|FG000|STARTED|Overall Study||154
8954848|NCT02485704|10018327|FG001|STARTED|Overall Study||126
8954849|NCT02485704|10018326|FG000|COMPLETED|Overall Study||149
8954850|NCT02485704|10018327|FG001|COMPLETED|Overall Study||118
8954851|NCT02485704|10018326|FG000|NOT COMPLETED|Overall Study||5
8954852|NCT02485704|10018327|FG001|NOT COMPLETED|Overall Study||8
8954853|NCT02485717|10018336|FG000|STARTED|Overall Study||142
8954854|NCT02485717|10018337|FG001|STARTED|Overall Study||129
8954855|NCT02485717|10018338|FG002|STARTED|Overall Study||20
8954856|NCT02485717|10018336|FG000|COMPLETED|Overall Study||136
8954857|NCT02485717|10018337|FG001|COMPLETED|Overall Study||127
8954858|NCT02485717|10018338|FG002|COMPLETED|Overall Study||19
8954859|NCT02485717|10018336|FG000|NOT COMPLETED|Overall Study||6
8954860|NCT02485717|10018337|FG001|NOT COMPLETED|Overall Study||2
8954861|NCT02485717|10018338|FG002|NOT COMPLETED|Overall Study||1
8954862|NCT02485834|10018346|FG000|STARTED|Overall Study||3
8954863|NCT02485834|10018347|FG001|STARTED|Overall Study||2
8954864|NCT02485834|10018346|FG000|COMPLETED|Overall Study||3
8954865|NCT02485834|10018347|FG001|COMPLETED|Overall Study||2
8954866|NCT02485834|10018346|FG000|NOT COMPLETED|Overall Study||0
8954867|NCT02485834|10018347|FG001|NOT COMPLETED|Overall Study||0
8954868|NCT02485912|10018354|FG000|STARTED|Overall Study||20
8954869|NCT02485912|10018355|FG001|STARTED|Overall Study||20
8954870|NCT02485912|10018354|FG000|COMPLETED|Overall Study||20
8954871|NCT02485912|10018355|FG001|COMPLETED|Overall Study||20
8954872|NCT02485912|10018354|FG000|NOT COMPLETED|Overall Study||0
8954873|NCT02485912|10018355|FG001|NOT COMPLETED|Overall Study||0
8954874|NCT02485925|10018361|FG000|STARTED|Overall Study||200
8954875|NCT02485925|10018361|FG000|Safety Population|Overall Study||200
8954876|NCT02485925|10018361|FG000|Intent to Treat (ITT) Population|Overall Study||193
8954877|NCT02485925|10018361|FG000|Per-Protocol Population|Overall Study||166
8954878|NCT02485925|10018361|FG000|COMPLETED|Overall Study||185
8954879|NCT02485925|10018361|FG000|NOT COMPLETED|Overall Study||15
8954880|NCT02485964|10018365|FG000|STARTED|Overall Study||10
8954881|NCT02485964|10018365|FG000|COMPLETED|Overall Study||10
8954882|NCT02485964|10018365|FG000|NOT COMPLETED|Overall Study||0
8954883|NCT02486016|10018369|FG000|STARTED|Overall Study|Same 10 volunteers completed Apotex, Duragesic and Mylan arms of the study; crossover study.|10
8954884|NCT02486016|10018369|FG000|COMPLETED|Overall Study||10
8954885|NCT02486016|10018369|FG000|NOT COMPLETED|Overall Study||0
8954886|NCT02486211|10018379|FG000|STARTED|Overall Study||7
8954887|NCT02486211|10018380|FG001|STARTED|Overall Study||7
8954888|NCT02486211|10018379|FG000|COMPLETED|Overall Study||6
8954889|NCT02486211|10018380|FG001|COMPLETED|Overall Study||7
8954890|NCT02486211|10018379|FG000|NOT COMPLETED|Overall Study||1
8954891|NCT02486211|10018380|FG001|NOT COMPLETED|Overall Study||0
8954892|NCT02486263|10018389|FG000|STARTED|Overall Study||40
8954893|NCT02486263|10018390|FG001|STARTED|Overall Study||36
8954894|NCT02486263|10018389|FG000|COMPLETED|Overall Study||37
8954895|NCT02486263|10018390|FG001|COMPLETED|Overall Study||35
8954896|NCT02486263|10018389|FG000|NOT COMPLETED|Overall Study||3
8954897|NCT02486263|10018390|FG001|NOT COMPLETED|Overall Study||1
8954898|NCT02486302|10018398|FG000|STARTED|Overall Study||1534
8954899|NCT02486302|10018398|FG000|Treated|Overall Study||1523
8954900|NCT02486302|10018398|FG000|COMPLETED|Overall Study||858
8954901|NCT02486302|10018398|FG000|NOT COMPLETED|Overall Study||676
8954902|NCT02486328|10018413|FG000|STARTED|Overall Study||52
8954903|NCT02486328|10018414|FG001|STARTED|Overall Study||51
8954904|NCT02486328|10018413|FG000|COMPLETED|Overall Study||50
8954905|NCT02486328|10018414|FG001|COMPLETED|Overall Study||50
8954906|NCT02486328|10018413|FG000|NOT COMPLETED|Overall Study||2
8954907|NCT02486328|10018414|FG001|NOT COMPLETED|Overall Study||1
8954908|NCT02486406|10018424|FG000|STARTED|Overall Study||12
8954909|NCT02486406|10018425|FG001|STARTED|Overall Study||26
8954910|NCT02486406|10018426|FG002|STARTED|Overall Study||12
8954911|NCT02486406|10018427|FG003|STARTED|Overall Study||14
8954912|NCT02486406|10018424|FG000|COMPLETED|Overall Study||10
8631318|NCT00539188|9671186|FG000|Received Allocated Intervention|Overall Study||3
8631319|NCT00539188|9671187|FG001|Received Allocated Intervention|Overall Study||2
8631320|NCT00539188|9671186|FG000|COMPLETED|Overall Study||1
8631321|NCT00539188|9671187|FG001|COMPLETED|Overall Study||1
8631322|NCT00539188|9671186|FG000|NOT COMPLETED|Overall Study||3
8954913|NCT02486406|10018425|FG001|COMPLETED|Overall Study||23
8954914|NCT02486406|10018426|FG002|COMPLETED|Overall Study||10
8954915|NCT02486406|10018427|FG003|COMPLETED|Overall Study||10
8954916|NCT02486406|10018424|FG000|NOT COMPLETED|Overall Study||2
8954917|NCT02486406|10018425|FG001|NOT COMPLETED|Overall Study||3
8954918|NCT02486406|10018426|FG002|NOT COMPLETED|Overall Study||2
8954919|NCT02486406|10018427|FG003|NOT COMPLETED|Overall Study||4
8631323|NCT00539188|9671187|FG001|NOT COMPLETED|Overall Study||1
8631324|NCT00539240|9671196|FG000|STARTED|Overall Study||59
8631325|NCT00539240|9671197|FG001|STARTED|Overall Study||55
8631326|NCT00539240|9671198|FG002|STARTED|Overall Study||54
8631327|NCT00539240|9671196|FG000|COMPLETED|Overall Study||53
8631328|NCT00539240|9671197|FG001|COMPLETED|Overall Study||48
8631329|NCT00539240|9671198|FG002|COMPLETED|Overall Study||39
8631330|NCT00539240|9671196|FG000|NOT COMPLETED|Overall Study||6
8954920|NCT02486588|10018465|FG000|STARTED|Overall Study||1188
8954921|NCT02486588|10018466|FG001|STARTED|Overall Study||1252
8954922|NCT02486588|10018467|FG002|STARTED|Overall Study||1220
8954923|NCT02486588|10018468|FG003|STARTED|Overall Study||1206
8954924|NCT02486588|10018469|FG004|STARTED|Overall Study||1243
8954925|NCT02486588|10018470|FG005|STARTED|Overall Study||1205
8954926|NCT02486588|10018465|FG000|COMPLETED|Overall Study||450
8954927|NCT02486588|10018466|FG001|COMPLETED|Overall Study||502
8954928|NCT02486588|10018467|FG002|COMPLETED|Overall Study||465
8954929|NCT02486588|10018468|FG003|COMPLETED|Overall Study||468
8954930|NCT02486588|10018469|FG004|COMPLETED|Overall Study||497
8954931|NCT02486588|10018470|FG005|COMPLETED|Overall Study||459
8954932|NCT02486588|10018465|FG000|NOT COMPLETED|Overall Study||738
8954933|NCT02486588|10018466|FG001|NOT COMPLETED|Overall Study||750
8954934|NCT02486588|10018467|FG002|NOT COMPLETED|Overall Study||755
8954935|NCT02486588|10018468|FG003|NOT COMPLETED|Overall Study||738
8954936|NCT02486588|10018469|FG004|NOT COMPLETED|Overall Study||746
8954937|NCT02486588|10018470|FG005|NOT COMPLETED|Overall Study||746
8954938|NCT02486627|10018491|FG000|STARTED|Overall Study||306
8954939|NCT02486627|10018492|FG001|STARTED|Overall Study||303
8954940|NCT02486627|10018491|FG000|COMPLETED|Overall Study||299
8954941|NCT02486627|10018492|FG001|COMPLETED|Overall Study||294
8954942|NCT02486627|10018491|FG000|NOT COMPLETED|Overall Study||7
8954943|NCT02486627|10018492|FG001|NOT COMPLETED|Overall Study||9
8954944|NCT02486653|10018500|FG000|STARTED|Overall Study||76
8954945|NCT02486653|10018501|FG001|STARTED|Overall Study||75
8954946|NCT02486653|10018500|FG000|COMPLETED|Overall Study||70
8954947|NCT02486653|10018501|FG001|COMPLETED|Overall Study||71
8954948|NCT02486653|10018500|FG000|NOT COMPLETED|Overall Study||6
8954949|NCT02486653|10018501|FG001|NOT COMPLETED|Overall Study||4
8954950|NCT02486692|10018509|FG000|STARTED|Overall Study||30
8954951|NCT02486692|10018510|FG001|STARTED|Overall Study||30
8954952|NCT02486692|10018509|FG000|COMPLETED|Overall Study||26
8954953|NCT02486692|10018510|FG001|COMPLETED|Overall Study||23
8954954|NCT02486692|10018509|FG000|NOT COMPLETED|Overall Study||4
8954955|NCT02486692|10018510|FG001|NOT COMPLETED|Overall Study||7
8954956|NCT02486757|10018516|FG000|STARTED|Overall Study||6
8954957|NCT02486757|10018516|FG000|COMPLETED|Overall Study||5
8954958|NCT02486757|10018516|FG000|NOT COMPLETED|Overall Study||1
8954959|NCT02486796|10018522|FG000|STARTED|Overall Study||3
8954960|NCT02486796|10018523|FG001|STARTED|Overall Study||2
8954961|NCT02486796|10018522|FG000|COMPLETED|Overall Study||1
8954962|NCT02486796|10018523|FG001|COMPLETED|Overall Study||1
8954963|NCT02486796|10018522|FG000|NOT COMPLETED|Overall Study||2
8954964|NCT02486796|10018523|FG001|NOT COMPLETED|Overall Study||1
8954965|NCT02486939|10018531|FG000|STARTED|Overall Study||225
8954966|NCT02486939|10018532|FG001|STARTED|Overall Study||134
8954967|NCT02486939|10018531|FG000|COMPLETED|Overall Study||224
8954968|NCT02486939|10018532|FG001|COMPLETED|Overall Study||132
8954969|NCT02486939|10018531|FG000|NOT COMPLETED|Overall Study||1
8954970|NCT02486939|10018532|FG001|NOT COMPLETED|Overall Study||2
8954971|NCT02486952|10018538|FG000|STARTED|Overall Study||154
8954972|NCT02486952|10018538|FG000|Started Induction Therapy|Overall Study||151
8954973|NCT02486952|10018538|FG000|COMPLETED|Overall Study||104
8954974|NCT02486952|10018538|FG000|NOT COMPLETED|Overall Study||50
8954975|NCT02487030|10018549|FG000|STARTED|Overall Study||43
8954976|NCT02487030|10018550|FG001|STARTED|Overall Study||42
8954977|NCT02487030|10018551|FG002|STARTED|Overall Study||43
8954978|NCT02487030|10018552|FG003|STARTED|Overall Study||42
8954979|NCT02487030|10018553|FG004|STARTED|Overall Study||36
8954980|NCT02487030|10018554|FG005|STARTED|Overall Study||38
8954981|NCT02487030|10018555|FG006|STARTED|Overall Study||11
8954982|NCT02487030|10018549|FG000|COMPLETED|Overall Study||41
8954983|NCT02487030|10018550|FG001|COMPLETED|Overall Study||38
8954984|NCT02487030|10018551|FG002|COMPLETED|Overall Study||41
8954985|NCT02487030|10018552|FG003|COMPLETED|Overall Study||40
8954986|NCT02487030|10018553|FG004|COMPLETED|Overall Study||34
8954987|NCT02487030|10018554|FG005|COMPLETED|Overall Study||37
8954988|NCT02487030|10018555|FG006|COMPLETED|Overall Study||11
8954989|NCT02487030|10018549|FG000|NOT COMPLETED|Overall Study||2
8954990|NCT02487030|10018550|FG001|NOT COMPLETED|Overall Study||4
8954991|NCT02487030|10018551|FG002|NOT COMPLETED|Overall Study||2
8954992|NCT02487030|10018552|FG003|NOT COMPLETED|Overall Study||2
8954993|NCT02487030|10018553|FG004|NOT COMPLETED|Overall Study||2
8874719|NCT01904721|9931694|FG000|STARTED|Overall Study||13
8874720|NCT01904721|9931695|FG001|STARTED|Overall Study||13
8874721|NCT01904721|9931696|FG002|STARTED|Overall Study||12
8874722|NCT01904721|9931697|FG003|STARTED|Overall Study||12
8874723|NCT01904721|9931698|FG004|STARTED|Overall Study||65
8874724|NCT01904721|9931699|FG005|STARTED|Overall Study||65
8874725|NCT01904721|9931700|FG006|STARTED|Overall Study||64
8874726|NCT01904721|9931694|FG000|COMPLETED|Overall Study||13
8874727|NCT01904721|9931695|FG001|COMPLETED|Overall Study||13
8874728|NCT01904721|9931696|FG002|COMPLETED|Overall Study||11
8874729|NCT01904721|9931697|FG003|COMPLETED|Overall Study||11
8954994|NCT02487030|10018554|FG005|NOT COMPLETED|Overall Study||1
8954995|NCT02487030|10018555|FG006|NOT COMPLETED|Overall Study||0
8954996|NCT02487056|10018572|FG000|STARTED|Overall Study||1622
8954997|NCT02487056|10018572|FG000|COMPLETED|Overall Study||1606
8954998|NCT02487056|10018572|FG000|NOT COMPLETED|Overall Study||16
8954999|NCT02487199|10018579|FG000|STARTED|Overall Study||13
8955000|NCT02487199|10018580|FG001|STARTED|Overall Study||5
8955001|NCT02487199|10018579|FG000|COMPLETED|Overall Study||13
8955002|NCT02487199|10018580|FG001|COMPLETED|Overall Study||4
8955003|NCT02487199|10018579|FG000|NOT COMPLETED|Overall Study||0
8955004|NCT02487199|10018580|FG001|NOT COMPLETED|Overall Study||1
8955005|NCT02487225|10018588|FG000|STARTED|Overall Study||45
8955006|NCT02487225|10018589|FG001|STARTED|Overall Study||38
8955007|NCT02487225|10018588|FG000|COMPLETED|Overall Study||18
8955008|NCT02487225|10018589|FG001|COMPLETED|Overall Study||8
8955009|NCT02487225|10018588|FG000|NOT COMPLETED|Overall Study||27
8955010|NCT02487225|10018589|FG001|NOT COMPLETED|Overall Study||30
8874730|NCT01904721|9931698|FG004|COMPLETED|Overall Study||57
8874731|NCT01904721|9931699|FG005|COMPLETED|Overall Study||56
8874732|NCT01904721|9931700|FG006|COMPLETED|Overall Study||57
8955011|NCT02487303|10018598|FG000|STARTED|Overall Study||49
8955012|NCT02487303|10018599|FG001|STARTED|Overall Study||51
8955013|NCT02487303|10018600|FG002|STARTED|Overall Study||48
8955014|NCT02487303|10018598|FG000|COMPLETED|Overall Study||47
8955015|NCT02487303|10018599|FG001|COMPLETED|Overall Study||47
8955016|NCT02487303|10018600|FG002|COMPLETED|Overall Study||47
8955017|NCT02487303|10018598|FG000|NOT COMPLETED|Overall Study||2
8955018|NCT02487303|10018599|FG001|NOT COMPLETED|Overall Study||4
8955019|NCT02487303|10018600|FG002|NOT COMPLETED|Overall Study||1
8955020|NCT02487446|10018611|FG000|STARTED|Period 1||178
8955021|NCT02487446|10018612|FG001|STARTED|Period 1||179
8955022|NCT02487446|10018611|FG000|COMPLETED|Period 1||165
8955023|NCT02487446|10018612|FG001|COMPLETED|Period 1||171
8955024|NCT02487446|10018611|FG000|NOT COMPLETED|Period 1||13
8955025|NCT02487446|10018612|FG001|NOT COMPLETED|Period 1||8
8955026|NCT02487446|10018611|FG000|STARTED|Washout||165
8955027|NCT02487446|10018612|FG001|STARTED|Washout||171
8955028|NCT02487446|10018611|FG000|COMPLETED|Washout||162
8955029|NCT02487446|10018612|FG001|COMPLETED|Washout||163
8955030|NCT02487446|10018611|FG000|NOT COMPLETED|Washout||3
8955031|NCT02487446|10018612|FG001|NOT COMPLETED|Washout||8
8955032|NCT02487446|10018611|FG000|STARTED|Period 2||162
8955033|NCT02487446|10018612|FG001|STARTED|Period 2||163
8955034|NCT02487446|10018611|FG000|COMPLETED|Period 2||154
8955035|NCT02487446|10018612|FG001|COMPLETED|Period 2||158
8955036|NCT02487446|10018611|FG000|NOT COMPLETED|Period 2||8
8955037|NCT02487446|10018612|FG001|NOT COMPLETED|Period 2||5
8955038|NCT02487472|10018619|FG000|STARTED|Overall Study||101
8955039|NCT02487472|10018619|FG000|COMPLETED|Overall Study||90
8955040|NCT02487472|10018619|FG000|NOT COMPLETED|Overall Study||11
8955041|NCT02487485|10018627|FG000|STARTED|Overall Study||12
8955042|NCT02487485|10018628|FG001|STARTED|Overall Study||11
8955043|NCT02487485|10018627|FG000|COMPLETED|Overall Study||9
8955044|NCT02487485|10018628|FG001|COMPLETED|Overall Study||8
8955045|NCT02487485|10018627|FG000|NOT COMPLETED|Overall Study||3
8955046|NCT02487485|10018628|FG001|NOT COMPLETED|Overall Study||3
8955047|NCT02487498|10018634|FG000|STARTED|Period: Period 1||178
8955048|NCT02487498|10018635|FG001|STARTED|Period: Period 1||177
8955049|NCT02487498|10018634|FG000|COMPLETED|Period: Period 1||172
8955050|NCT02487498|10018635|FG001|COMPLETED|Period: Period 1||166
8955051|NCT02487498|10018634|FG000|NOT COMPLETED|Period: Period 1||6
8955052|NCT02487498|10018635|FG001|NOT COMPLETED|Period: Period 1||11
8955053|NCT02487498|10018634|FG000|STARTED|Period: Washout||172
8955054|NCT02487498|10018635|FG001|STARTED|Period: Washout||166
8955055|NCT02487498|10018634|FG000|COMPLETED|Period: Washout||170
8955056|NCT02487498|10018635|FG001|COMPLETED|Period: Washout||159
8955057|NCT02487498|10018634|FG000|NOT COMPLETED|Period: Washout||2
8955058|NCT02487498|10018635|FG001|NOT COMPLETED|Period: Washout||7
8955059|NCT02487498|10018634|FG000|STARTED|Period: Period 2||170
8955060|NCT02487498|10018635|FG001|STARTED|Period: Period 2||159
8955061|NCT02487498|10018634|FG000|COMPLETED|Period: Period 2||164
8955062|NCT02487498|10018635|FG001|COMPLETED|Period: Period 2||154
8955063|NCT02487498|10018634|FG000|NOT COMPLETED|Period: Period 2||6
8955064|NCT02487498|10018635|FG001|NOT COMPLETED|Period: Period 2||5
8955065|NCT02487563|10018645|FG000|STARTED|Overall Study||32
8955066|NCT02487563|10018646|FG001|STARTED|Overall Study||33
8955067|NCT02487563|10018647|FG002|STARTED|Overall Study||32
8955068|NCT02487563|10018645|FG000|COMPLETED|Overall Study||30
8955069|NCT02487563|10018646|FG001|COMPLETED|Overall Study||30
8955070|NCT02487563|10018647|FG002|COMPLETED|Overall Study||31
8874733|NCT01904721|9931694|FG000|NOT COMPLETED|Overall Study||0
8874734|NCT01904721|9931695|FG001|NOT COMPLETED|Overall Study||0
8874735|NCT01904721|9931696|FG002|NOT COMPLETED|Overall Study||1
8874736|NCT01904721|9931697|FG003|NOT COMPLETED|Overall Study||1
8955071|NCT02487563|10018645|FG000|NOT COMPLETED|Overall Study||2
8955072|NCT02487563|10018646|FG001|NOT COMPLETED|Overall Study||3
8955073|NCT02487563|10018647|FG002|NOT COMPLETED|Overall Study||1
8955074|NCT02487771|10018660|FG000|STARTED|Overall Study||91
8955075|NCT02487771|10018661|FG001|STARTED|Overall Study||99
8955076|NCT02487771|10018660|FG000|COMPLETED|Overall Study||81
8874737|NCT01904721|9931698|FG004|NOT COMPLETED|Overall Study||8
8955077|NCT02487771|10018661|FG001|COMPLETED|Overall Study||85
8955078|NCT02487771|10018660|FG000|NOT COMPLETED|Overall Study||10
8955079|NCT02487771|10018661|FG001|NOT COMPLETED|Overall Study||14
8955080|NCT02487810|10018669|FG000|STARTED|Overall Study||98
8955081|NCT02487810|10018670|FG001|STARTED|Overall Study||102
8874738|NCT01904721|9931699|FG005|NOT COMPLETED|Overall Study||9
8874739|NCT01904721|9931700|FG006|NOT COMPLETED|Overall Study||7
8874740|NCT01904760|9931714|FG000|STARTED|Overall Study||40
8874741|NCT01904760|9931715|FG001|STARTED|Overall Study||40
8874742|NCT01904760|9931714|FG000|COMPLETED|Overall Study||39
8955082|NCT02487810|10018669|FG000|COMPLETED|Overall Study||97
8955083|NCT02487810|10018670|FG001|COMPLETED|Overall Study||102
8955084|NCT02487810|10018669|FG000|NOT COMPLETED|Overall Study||1
8955085|NCT02487810|10018670|FG001|NOT COMPLETED|Overall Study||0
8955086|NCT02487966|10018680|FG000|STARTED|Overall Study||29
8874743|NCT01904760|9931715|FG001|COMPLETED|Overall Study||40
8955087|NCT02487966|10018681|FG001|STARTED|Overall Study||28
8955088|NCT02487966|10018682|FG002|STARTED|Overall Study||28
8955089|NCT02487966|10018683|FG003|STARTED|Overall Study||27
8955090|NCT02487966|10018680|FG000|COMPLETED|Overall Study||28
8955091|NCT02487966|10018681|FG001|COMPLETED|Overall Study||24
8955092|NCT02487966|10018682|FG002|COMPLETED|Overall Study||26
8955093|NCT02487966|10018683|FG003|COMPLETED|Overall Study||25
8955094|NCT02487966|10018680|FG000|NOT COMPLETED|Overall Study||1
8955095|NCT02487966|10018681|FG001|NOT COMPLETED|Overall Study||4
8955096|NCT02487966|10018682|FG002|NOT COMPLETED|Overall Study||2
8955097|NCT02487966|10018683|FG003|NOT COMPLETED|Overall Study||2
8955098|NCT02488005|10018693|FG000|STARTED|Overall Study||15
8955099|NCT02488005|10018693|FG000|COMPLETED|Overall Study||13
8955100|NCT02488005|10018693|FG000|NOT COMPLETED|Overall Study||2
8955101|NCT02488018|10018697|FG000|STARTED|Overall Study||10
8955102|NCT02488018|10018697|FG000|COMPLETED|Overall Study||10
8955103|NCT02488018|10018697|FG000|NOT COMPLETED|Overall Study||0
8955104|NCT02488070|10018701|FG000|STARTED|Overall Study||10
8955105|NCT02488070|10018701|FG000|COMPLETED|Overall Study||10
8955106|NCT02488070|10018701|FG000|NOT COMPLETED|Overall Study||0
8955107|NCT02488109|10018708|FG000|STARTED|Treatment in Hospital||60
8955108|NCT02488109|10018709|FG001|STARTED|Treatment in Hospital||56
8955109|NCT02488109|10018708|FG000|Received Treatment|Treatment in Hospital||60
8955110|NCT02488109|10018709|FG001|Received Treatment|Treatment in Hospital||51
8955111|NCT02488109|10018708|FG000|Included in mITT Analysis|Treatment in Hospital||60
8955112|NCT02488109|10018709|FG001|Included in mITT Analysis|Treatment in Hospital||51
8955113|NCT02488109|10018708|FG000|COMPLETED|Treatment in Hospital||60
8955114|NCT02488109|10018709|FG001|COMPLETED|Treatment in Hospital||51
8955115|NCT02488109|10018708|FG000|NOT COMPLETED|Treatment in Hospital||0
8955116|NCT02488109|10018709|FG001|NOT COMPLETED|Treatment in Hospital||5
8955117|NCT02488109|10018708|FG000|STARTED|12-month Follow-Up||60
8955118|NCT02488109|10018709|FG001|STARTED|12-month Follow-Up||51
8955119|NCT02488109|10018708|FG000|Included in mITT Analysis|12-month Follow-Up||60
8955120|NCT02488109|10018709|FG001|Included in mITT Analysis|12-month Follow-Up||51
8955121|NCT02488109|10018708|FG000|COMPLETED|12-month Follow-Up||56
8955122|NCT02488109|10018709|FG001|COMPLETED|12-month Follow-Up||44
8955123|NCT02488109|10018708|FG000|NOT COMPLETED|12-month Follow-Up||4
8955124|NCT02488109|10018709|FG001|NOT COMPLETED|12-month Follow-Up||7
8955125|NCT02488239|10018717|FG000|STARTED|Overall Study||64
8955126|NCT02488239|10018717|FG000|COMPLETED|Overall Study||54
8955127|NCT02488239|10018717|FG000|NOT COMPLETED|Overall Study||10
8955128|NCT02488317|10018724|FG000|STARTED|Overall Study||117
8955129|NCT02488317|10018725|FG001|STARTED|Overall Study||117
8955130|NCT02488317|10018724|FG000|COMPLETED|Overall Study||63
8955131|NCT02488317|10018725|FG001|COMPLETED|Overall Study||70
8955132|NCT02488317|10018724|FG000|NOT COMPLETED|Overall Study||54
8955133|NCT02488317|10018725|FG001|NOT COMPLETED|Overall Study||47
8631331|NCT00539240|9671197|FG001|NOT COMPLETED|Overall Study||7
8955134|NCT02488330|10018735|FG000|STARTED|Overall Study||12
8955135|NCT02488330|10018735|FG000|COMPLETED|Overall Study||0
8955136|NCT02488330|10018735|FG000|NOT COMPLETED|Overall Study||12
8955137|NCT02488681|10018739|FG000|STARTED|Overall Study|Patients with Micra implant attempt|276
8955138|NCT02488681|10018739|FG000|COMPLETED|Overall Study|Patients successfully implanted with Micra|269
8955139|NCT02488681|10018739|FG000|NOT COMPLETED|Overall Study||7
8955140|NCT02488824|10018745|FG000|STARTED|Overall Study||21
8955141|NCT02488824|10018746|FG001|STARTED|Overall Study||20
8955142|NCT02488824|10018745|FG000|COMPLETED|Overall Study||20
8955143|NCT02488824|10018746|FG001|COMPLETED|Overall Study||19
8955144|NCT02488824|10018745|FG000|NOT COMPLETED|Overall Study||1
8955145|NCT02488824|10018746|FG001|NOT COMPLETED|Overall Study||1
8955146|NCT02488915|10018752|FG000|STARTED|Overall Study||228
8955147|NCT02488915|10018752|FG000|COMPLETED|Overall Study||202
8955148|NCT02488915|10018752|FG000|NOT COMPLETED|Overall Study||26
8955149|NCT02488980|10018759|FG000|STARTED|Overall Study||104
8955150|NCT02488980|10018760|FG001|STARTED|Overall Study||101
8955151|NCT02488980|10018761|FG002|STARTED|Overall Study||101
8955152|NCT02488980|10018759|FG000|COMPLETED|Overall Study||102
8955153|NCT02488980|10018760|FG001|COMPLETED|Overall Study||99
8955154|NCT02488980|10018761|FG002|COMPLETED|Overall Study||99
8955155|NCT02488980|10018759|FG000|NOT COMPLETED|Overall Study||2
8955156|NCT02488980|10018760|FG001|NOT COMPLETED|Overall Study||2
8955157|NCT02488980|10018761|FG002|NOT COMPLETED|Overall Study||2
8955158|NCT02489045|10018769|FG000|STARTED|Overall Study||178
8955159|NCT02489045|10018769|FG000|COMPLETED|Overall Study||125
8955160|NCT02489045|10018769|FG000|NOT COMPLETED|Overall Study||53
8955161|NCT02489045|10018769|FG000|STARTED|Follow-up|"Only subjects with portal hypertension in overall study were eligible to progress to follow-up"|21
8955162|NCT02489045|10018769|FG000|COMPLETED|Follow-up||11
8955163|NCT02489045|10018769|FG000|NOT COMPLETED|Follow-up||10
8955164|NCT02489110|10018775|FG000|STARTED|Overall Study||75
8955165|NCT02489110|10018776|FG001|STARTED|Overall Study||75
8955166|NCT02489110|10018775|FG000|COMPLETED|Overall Study||48
8955167|NCT02489110|10018776|FG001|COMPLETED|Overall Study||50
8955168|NCT02489110|10018775|FG000|NOT COMPLETED|Overall Study||27
8955169|NCT02489110|10018776|FG001|NOT COMPLETED|Overall Study||25
8955170|NCT02489123|10018782|FG000|STARTED|Overall Study||8
8955171|NCT02489123|10018782|FG000|COMPLETED|Overall Study||8
8955172|NCT02489123|10018782|FG000|NOT COMPLETED|Overall Study||0
8955173|NCT02489227|10018789|FG000|STARTED|Overall Study||274
8955174|NCT02489227|10018790|FG001|STARTED|Overall Study||135
8955175|NCT02489227|10018791|FG002|STARTED|Overall Study||136
8631332|NCT00539240|9671198|FG002|NOT COMPLETED|Overall Study||15
8631333|NCT00539253|9671206|FG000|STARTED|Overall Study||45
8955176|NCT02489227|10018789|FG000|COMPLETED|Overall Study||220
8955177|NCT02489227|10018790|FG001|COMPLETED|Overall Study||101
8955178|NCT02489227|10018791|FG002|COMPLETED|Overall Study||117
8631334|NCT00539253|9671206|FG000|COMPLETED|Overall Study||19
8631335|NCT00539253|9671206|FG000|NOT COMPLETED|Overall Study||26
8631336|NCT00539279|9671212|FG000|STARTED|Treatment||41
8874744|NCT01904760|9931714|FG000|NOT COMPLETED|Overall Study||1
8874745|NCT01904760|9931715|FG001|NOT COMPLETED|Overall Study||0
8874746|NCT01904773|9931721|FG000|STARTED|Screen||28
8874747|NCT01904773|9931722|FG001|STARTED|Screen||0
8874748|NCT01904773|9931723|FG002|STARTED|Screen||0
8874749|NCT01904773|9931724|FG003|STARTED|Screen||0
8874750|NCT01904773|9931725|FG004|STARTED|Screen||0
8874751|NCT01904773|9931726|FG005|STARTED|Screen||0
8874752|NCT01904773|9931727|FG006|STARTED|Screen||0
8874753|NCT01904773|9931728|FG007|STARTED|Screen||0
8874754|NCT01904773|9931729|FG008|STARTED|Screen||0
8874755|NCT01904773|9931721|FG000|COMPLETED|Screen||24
8874756|NCT01904773|9931722|FG001|COMPLETED|Screen||0
8874757|NCT01904773|9931723|FG002|COMPLETED|Screen||0
8874758|NCT01904773|9931724|FG003|COMPLETED|Screen||0
8874759|NCT01904773|9931725|FG004|COMPLETED|Screen||0
8874760|NCT01904773|9931726|FG005|COMPLETED|Screen||0
8874761|NCT01904773|9931727|FG006|COMPLETED|Screen||0
8874762|NCT01904773|9931728|FG007|COMPLETED|Screen||0
8874763|NCT01904773|9931729|FG008|COMPLETED|Screen||0
8874764|NCT01904773|9931721|FG000|NOT COMPLETED|Screen||4
8874765|NCT01904773|9931722|FG001|NOT COMPLETED|Screen||0
8874766|NCT01904773|9931723|FG002|NOT COMPLETED|Screen||0
8874767|NCT01904773|9931724|FG003|NOT COMPLETED|Screen||0
8874768|NCT01904773|9931725|FG004|NOT COMPLETED|Screen||0
8874769|NCT01904773|9931726|FG005|NOT COMPLETED|Screen||0
8955179|NCT02489227|10018789|FG000|NOT COMPLETED|Overall Study||54
8955180|NCT02489227|10018790|FG001|NOT COMPLETED|Overall Study||34
8955181|NCT02489227|10018791|FG002|NOT COMPLETED|Overall Study||19
8955182|NCT02489279|10018803|FG000|STARTED|Overall Study||44
8955183|NCT02489279|10018804|FG001|STARTED|Overall Study||41
8955184|NCT02489279|10018803|FG000|COMPLETED|Overall Study||32
8955185|NCT02489279|10018804|FG001|COMPLETED|Overall Study||31
8955186|NCT02489279|10018803|FG000|NOT COMPLETED|Overall Study||12
8955187|NCT02489279|10018804|FG001|NOT COMPLETED|Overall Study||10
8955188|NCT02489344|10018810|FG000|STARTED|ACT13739 (Initial Study): 26 Weeks||11
8955189|NCT02489344|10018810|FG000|COMPLETED|ACT13739 (Initial Study): 26 Weeks||9
8955190|NCT02489344|10018810|FG000|NOT COMPLETED|ACT13739 (Initial Study): 26 Weeks||2
8955191|NCT02489344|10018810|FG000|STARTED|LTS14116 (Extension Study): 31 Months||8
8955192|NCT02489344|10018810|FG000|COMPLETED|LTS14116 (Extension Study): 31 Months||5
8955193|NCT02489344|10018810|FG000|NOT COMPLETED|LTS14116 (Extension Study): 31 Months||3
8955194|NCT02489357|10018814|FG000|STARTED|Overall Study||12
8955195|NCT02489357|10018814|FG000|COMPLETED|Overall Study||12
8955196|NCT02489357|10018814|FG000|NOT COMPLETED|Overall Study||0
8955197|NCT02489500|10018820|FG000|STARTED|Overall Study||2
8955198|NCT02489500|10018821|FG001|STARTED|Overall Study||1
8955199|NCT02489500|10018820|FG000|COMPLETED|Overall Study||1
8955200|NCT02489500|10018821|FG001|COMPLETED|Overall Study||0
8955201|NCT02489500|10018820|FG000|NOT COMPLETED|Overall Study||1
8955202|NCT02489500|10018821|FG001|NOT COMPLETED|Overall Study||1
8955203|NCT02489630|10018829|FG000|STARTED|Overall Study||53
8955204|NCT02489630|10018830|FG001|STARTED|Overall Study||63
8955205|NCT02489630|10018829|FG000|COMPLETED|Overall Study||51
8955206|NCT02489630|10018830|FG001|COMPLETED|Overall Study||61
8955207|NCT02489630|10018829|FG000|NOT COMPLETED|Overall Study||2
8955208|NCT02489630|10018830|FG001|NOT COMPLETED|Overall Study||2
8955209|NCT02489734|10018838|FG000|STARTED|Overall Study||56
8955210|NCT02489734|10018839|FG001|STARTED|Overall Study||53
8955211|NCT02489734|10018838|FG000|COMPLETED|Overall Study||39
8955212|NCT02489734|10018839|FG001|COMPLETED|Overall Study||53
8955213|NCT02489734|10018838|FG000|NOT COMPLETED|Overall Study||17
8955214|NCT02489734|10018839|FG001|NOT COMPLETED|Overall Study||0
8955215|NCT02489773|10018847|FG000|STARTED|Overall Study||98
8955216|NCT02489773|10018848|FG001|STARTED|Overall Study||52
8955217|NCT02489773|10018847|FG000|COMPLETED|Overall Study||91
8955218|NCT02489773|10018848|FG001|COMPLETED|Overall Study||50
8955219|NCT02489773|10018847|FG000|NOT COMPLETED|Overall Study||7
8955220|NCT02489773|10018848|FG001|NOT COMPLETED|Overall Study||2
8955221|NCT02489799|10018856|FG000|STARTED|Overall Study||45
8955222|NCT02489799|10018857|FG001|STARTED|Overall Study||47
8955223|NCT02489799|10018856|FG000|Presurgical Consent Visit (V2)|Overall Study||40
8955224|NCT02489799|10018857|FG001|Presurgical Consent Visit (V2)|Overall Study||39
8955225|NCT02489799|10018856|FG000|Postsurgical One Week Visit (V3)|Overall Study||40
8955226|NCT02489799|10018857|FG001|Postsurgical One Week Visit (V3)|Overall Study||39
8955227|NCT02489799|10018856|FG000|COMPLETED|Overall Study||36
8955228|NCT02489799|10018857|FG001|COMPLETED|Overall Study||38
8631337|NCT00539279|9671213|FG001|STARTED|Treatment||46
8631338|NCT00539279|9671212|FG000|COMPLETED|Treatment||30
8631339|NCT00539279|9671213|FG001|COMPLETED|Treatment||38
8874770|NCT01904773|9931727|FG006|NOT COMPLETED|Screen||0
8874771|NCT01904773|9931728|FG007|NOT COMPLETED|Screen||0
8874772|NCT01904773|9931729|FG008|NOT COMPLETED|Screen||0
8874773|NCT01904773|9931721|FG000|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||24
8874774|NCT01904773|9931722|FG001|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8874775|NCT01904773|9931723|FG002|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8631340|NCT00539279|9671212|FG000|NOT COMPLETED|Treatment||11
8874776|NCT01904773|9931724|FG003|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8955229|NCT02489799|10018856|FG000|NOT COMPLETED|Overall Study||9
8955230|NCT02489799|10018857|FG001|NOT COMPLETED|Overall Study||9
8955231|NCT02489968|10018865|FG000|STARTED|Open-label Treatment Period||439
8955232|NCT02489968|10018866|FG001|STARTED|Open-label Treatment Period|1 subject did not receive treatment and hence excluded. Started represents treated numbers.|440
8955233|NCT02489968|10018867|FG002|STARTED|Open-label Treatment Period||0
8955234|NCT02489968|10018868|FG003|STARTED|Open-label Treatment Period||0
8955235|NCT02489968|10018869|FG004|STARTED|Open-label Treatment Period||0
8955236|NCT02489968|10018870|FG005|STARTED|Open-label Treatment Period||0
8955237|NCT02489968|10018865|FG000|COMPLETED|Open-label Treatment Period||215
8955238|NCT02489968|10018866|FG001|COMPLETED|Open-label Treatment Period||232
8955239|NCT02489968|10018867|FG002|COMPLETED|Open-label Treatment Period||0
8955240|NCT02489968|10018868|FG003|COMPLETED|Open-label Treatment Period||0
8955241|NCT02489968|10018869|FG004|COMPLETED|Open-label Treatment Period||0
8955242|NCT02489968|10018870|FG005|COMPLETED|Open-label Treatment Period||0
8955243|NCT02489968|10018865|FG000|NOT COMPLETED|Open-label Treatment Period||224
8955244|NCT02489968|10018866|FG001|NOT COMPLETED|Open-label Treatment Period||208
8955245|NCT02489968|10018867|FG002|NOT COMPLETED|Open-label Treatment Period||0
8955246|NCT02489968|10018868|FG003|NOT COMPLETED|Open-label Treatment Period||0
8955247|NCT02489968|10018869|FG004|NOT COMPLETED|Open-label Treatment Period||0
8955248|NCT02489968|10018870|FG005|NOT COMPLETED|Open-label Treatment Period||0
8955249|NCT02489968|10018865|FG000|STARTED|Double-blind Treatment Period||0
8955250|NCT02489968|10018866|FG001|STARTED|Double-blind Treatment Period||0
8955251|NCT02489968|10018867|FG002|STARTED|Double-blind Treatment Period||107
8955252|NCT02489968|10018868|FG003|STARTED|Double-blind Treatment Period||108
8955253|NCT02489968|10018869|FG004|STARTED|Double-blind Treatment Period||116
8955254|NCT02489968|10018870|FG005|STARTED|Double-blind Treatment Period||116
8955255|NCT02489968|10018865|FG000|COMPLETED|Double-blind Treatment Period||0
8955256|NCT02489968|10018866|FG001|COMPLETED|Double-blind Treatment Period||0
8955257|NCT02489968|10018867|FG002|COMPLETED|Double-blind Treatment Period||105
8725664|NCT01032759|9772976|FG001|COMPLETED|Overall Study||28
8725665|NCT01032759|9772975|FG000|NOT COMPLETED|Overall Study||1
8725666|NCT01032759|9772976|FG001|NOT COMPLETED|Overall Study||3
8955258|NCT02489968|10018868|FG003|COMPLETED|Double-blind Treatment Period||100
8955259|NCT02489968|10018869|FG004|COMPLETED|Double-blind Treatment Period||110
8955260|NCT02489968|10018870|FG005|COMPLETED|Double-blind Treatment Period||108
8955261|NCT02489968|10018865|FG000|NOT COMPLETED|Double-blind Treatment Period||0
8955262|NCT02489968|10018866|FG001|NOT COMPLETED|Double-blind Treatment Period||0
8955263|NCT02489968|10018867|FG002|NOT COMPLETED|Double-blind Treatment Period||2
8955264|NCT02489968|10018868|FG003|NOT COMPLETED|Double-blind Treatment Period||8
8955265|NCT02489968|10018869|FG004|NOT COMPLETED|Double-blind Treatment Period||6
8955266|NCT02489968|10018870|FG005|NOT COMPLETED|Double-blind Treatment Period||8
8955267|NCT02489981|10018882|FG000|STARTED|Overall Study||340
8955268|NCT02489981|10018882|FG000|COMPLETED|Overall Study||213
8955269|NCT02489981|10018882|FG000|NOT COMPLETED|Overall Study||127
8955270|NCT02490293|10018888|FG000|STARTED|Overall Study||96
8955271|NCT02490293|10018889|FG001|STARTED|Overall Study||102
8955272|NCT02490293|10018888|FG000|COMPLETED|Overall Study||94
8955273|NCT02490293|10018889|FG001|COMPLETED|Overall Study||99
8955274|NCT02490293|10018888|FG000|NOT COMPLETED|Overall Study||2
8955275|NCT02490293|10018889|FG001|NOT COMPLETED|Overall Study||3
8955276|NCT02490371|10018897|FG000|STARTED|Overall Study||12
8955277|NCT02490371|10018898|FG001|STARTED|Overall Study||12
8955278|NCT02490371|10018897|FG000|COMPLETED|Overall Study||11
8955279|NCT02490371|10018898|FG001|COMPLETED|Overall Study||11
8955280|NCT02490371|10018897|FG000|NOT COMPLETED|Overall Study||1
8955281|NCT02490371|10018898|FG001|NOT COMPLETED|Overall Study||1
8955282|NCT02490475|10018908|FG000|STARTED|Period 1: First 6 Cycles||6
8955283|NCT02490475|10018909|FG001|STARTED|Period 1: First 6 Cycles||2
8955284|NCT02490475|10018910|FG002|STARTED|Period 1: First 6 Cycles||6
8955285|NCT02490475|10018911|FG003|STARTED|Period 1: First 6 Cycles||5
8955286|NCT02490475|10018908|FG000|COMPLETED|Period 1: First 6 Cycles||0
8955287|NCT02490475|10018909|FG001|COMPLETED|Period 1: First 6 Cycles||0
8955288|NCT02490475|10018910|FG002|COMPLETED|Period 1: First 6 Cycles||0
8955289|NCT02490475|10018911|FG003|COMPLETED|Period 1: First 6 Cycles||0
8955290|NCT02490475|10018908|FG000|NOT COMPLETED|Period 1: First 6 Cycles||6
8955291|NCT02490475|10018909|FG001|NOT COMPLETED|Period 1: First 6 Cycles||2
8955292|NCT02490475|10018910|FG002|NOT COMPLETED|Period 1: First 6 Cycles||6
8955293|NCT02490475|10018911|FG003|NOT COMPLETED|Period 1: First 6 Cycles||5
8955294|NCT02490475|10018908|FG000|STARTED|Period 2: Extension Phase||1
8955295|NCT02490475|10018909|FG001|STARTED|Period 2: Extension Phase||0
8955296|NCT02490475|10018910|FG002|STARTED|Period 2: Extension Phase||3
8955297|NCT02490475|10018911|FG003|STARTED|Period 2: Extension Phase||1
8955298|NCT02490475|10018908|FG000|COMPLETED|Period 2: Extension Phase||0
8955299|NCT02490475|10018909|FG001|COMPLETED|Period 2: Extension Phase||0
8955300|NCT02490475|10018910|FG002|COMPLETED|Period 2: Extension Phase||0
8955301|NCT02490475|10018911|FG003|COMPLETED|Period 2: Extension Phase||0
8955302|NCT02490475|10018908|FG000|NOT COMPLETED|Period 2: Extension Phase||1
8955303|NCT02490475|10018909|FG001|NOT COMPLETED|Period 2: Extension Phase||0
8955304|NCT02490475|10018910|FG002|NOT COMPLETED|Period 2: Extension Phase||3
8955305|NCT02490475|10018911|FG003|NOT COMPLETED|Period 2: Extension Phase||1
8955306|NCT02490631|10018934|FG000|STARTED|Overall Study||79
8725667|NCT01032837|9772986|FG000|STARTED|Overall Study||26
8955307|NCT02490631|10018935|FG001|STARTED|Overall Study||78
8955308|NCT02490631|10018934|FG000|COMPLETED|Overall Study||76
8955309|NCT02490631|10018935|FG001|COMPLETED|Overall Study||75
8955310|NCT02490631|10018934|FG000|NOT COMPLETED|Overall Study||3
8955311|NCT02490631|10018935|FG001|NOT COMPLETED|Overall Study||3
8955312|NCT02490670|10018943|FG000|STARTED|Period 1 (19 Days)||14
8955313|NCT02490670|10018944|FG001|STARTED|Period 1 (19 Days)||14
8955314|NCT02490670|10018943|FG000|COMPLETED|Period 1 (19 Days)||14
8955315|NCT02490670|10018944|FG001|COMPLETED|Period 1 (19 Days)||14
8955316|NCT02490670|10018943|FG000|NOT COMPLETED|Period 1 (19 Days)||0
8955317|NCT02490670|10018944|FG001|NOT COMPLETED|Period 1 (19 Days)||0
8955318|NCT02490670|10018943|FG000|STARTED|Washout Period (7 Days)||14
8955319|NCT02490670|10018944|FG001|STARTED|Washout Period (7 Days)||14
8955320|NCT02490670|10018943|FG000|COMPLETED|Washout Period (7 Days)||14
8955321|NCT02490670|10018944|FG001|COMPLETED|Washout Period (7 Days)||14
8955322|NCT02490670|10018943|FG000|NOT COMPLETED|Washout Period (7 Days)||0
8955323|NCT02490670|10018944|FG001|NOT COMPLETED|Washout Period (7 Days)||0
8955324|NCT02490670|10018943|FG000|STARTED|Period 2 (19 Days)||14
8955325|NCT02490670|10018944|FG001|STARTED|Period 2 (19 Days)||14
8955326|NCT02490670|10018943|FG000|COMPLETED|Period 2 (19 Days)||14
8955327|NCT02490670|10018944|FG001|COMPLETED|Period 2 (19 Days)||14
8955328|NCT02490670|10018943|FG000|NOT COMPLETED|Period 2 (19 Days)||0
8955329|NCT02490670|10018944|FG001|NOT COMPLETED|Period 2 (19 Days)||0
8955330|NCT02490878|10018952|FG000|STARTED|Overall Study||10
8955331|NCT02490878|10018953|FG001|STARTED|Overall Study||9
8955332|NCT02490878|10018952|FG000|Eligible Participants|Overall Study||10
8955333|NCT02490878|10018953|FG001|Eligible Participants|Overall Study||8
8955334|NCT02490878|10018952|FG000|COMPLETED|Overall Study||10
8955335|NCT02490878|10018953|FG001|COMPLETED|Overall Study||6
8955336|NCT02490878|10018952|FG000|NOT COMPLETED|Overall Study||0
8955337|NCT02490878|10018953|FG001|NOT COMPLETED|Overall Study||3
8955338|NCT02491073|10018961|FG000|STARTED|Overall Study||37
8955339|NCT02491073|10018962|FG001|STARTED|Overall Study||34
8955340|NCT02491073|10018961|FG000|COMPLETED|Overall Study||36
8955341|NCT02491073|10018962|FG001|COMPLETED|Overall Study||34
8955342|NCT02491073|10018961|FG000|NOT COMPLETED|Overall Study||1
8955343|NCT02491073|10018962|FG001|NOT COMPLETED|Overall Study||0
8955344|NCT02491359|10018984|FG000|STARTED|Overall Study||20
8955345|NCT02491359|10018984|FG000|COMPLETED|Overall Study||4
8955346|NCT02491359|10018984|FG000|NOT COMPLETED|Overall Study||16
8955347|NCT02491437|10018992|FG000|STARTED|Overall Study||520
8955348|NCT02491437|10018993|FG001|STARTED|Overall Study||514
8955349|NCT02491437|10018992|FG000|Safety Sample|Overall Study||518
8955350|NCT02491437|10018993|FG001|Safety Sample|Overall Study||512
8955351|NCT02491437|10018992|FG000|Full Analysis Sample|Overall Study||494
8955352|NCT02491437|10018993|FG001|Full Analysis Sample|Overall Study||489
8955353|NCT02491437|10018992|FG000|COMPLETED|Overall Study||168
8955354|NCT02491437|10018993|FG001|COMPLETED|Overall Study||157
8955355|NCT02491437|10018992|FG000|NOT COMPLETED|Overall Study||352
8955356|NCT02491437|10018993|FG001|NOT COMPLETED|Overall Study||357
8955357|NCT02491463|10019005|FG000|STARTED|Overall Study||7
8955358|NCT02491463|10019006|FG001|STARTED|Overall Study||31
8955359|NCT02491463|10019007|FG002|STARTED|Overall Study||19
8955360|NCT02491463|10019008|FG003|STARTED|Overall Study||15
8955361|NCT02491463|10019005|FG000|COMPLETED|Overall Study||5
8955362|NCT02491463|10019006|FG001|COMPLETED|Overall Study||21
8955363|NCT02491463|10019007|FG002|COMPLETED|Overall Study||15
8955364|NCT02491463|10019008|FG003|COMPLETED|Overall Study||14
8955365|NCT02491463|10019005|FG000|NOT COMPLETED|Overall Study||2
8955366|NCT02491463|10019006|FG001|NOT COMPLETED|Overall Study||10
8955367|NCT02491463|10019007|FG002|NOT COMPLETED|Overall Study||4
8955368|NCT02491463|10019008|FG003|NOT COMPLETED|Overall Study||1
8955369|NCT02491671|10019020|FG000|STARTED|Overall Study||129
8725668|NCT01032837|9772987|FG001|STARTED|Overall Study||26
8725669|NCT01032837|9772988|FG002|STARTED|Overall Study||25
8725670|NCT01032837|9772989|FG003|STARTED|Overall Study||25
8725671|NCT01032837|9772986|FG000|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|26
8725672|NCT01032837|9772987|FG001|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|26
8725673|NCT01032837|9772988|FG002|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|25
8955370|NCT02491671|10019021|FG001|STARTED|Overall Study||131
8955371|NCT02491671|10019020|FG000|COMPLETED|Overall Study||118
8955372|NCT02491671|10019021|FG001|COMPLETED|Overall Study||118
8955373|NCT02491671|10019020|FG000|NOT COMPLETED|Overall Study||11
8955374|NCT02491671|10019021|FG001|NOT COMPLETED|Overall Study||13
8725674|NCT01032837|9772989|FG003|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|24
8725675|NCT01032837|9772986|FG000|COMPLETED|Overall Study|Represents patients who completed treatment.|26
8725676|NCT01032837|9772987|FG001|COMPLETED|Overall Study|Represents patients who completed treatment.|23
8725677|NCT01032837|9772988|FG002|COMPLETED|Overall Study|Represents patients who completed treatment.|24
8725678|NCT01032837|9772989|FG003|COMPLETED|Overall Study|Represents patients who completed treatment.|22
8725679|NCT01032837|9772986|FG000|NOT COMPLETED|Overall Study||0
8955375|NCT02491684|10019029|FG000|STARTED|Pre-treatment Phase||61
8955376|NCT02491684|10019030|FG001|STARTED|Pre-treatment Phase||60
8955377|NCT02491684|10019029|FG000|COMPLETED|Pre-treatment Phase||61
8955378|NCT02491684|10019030|FG001|COMPLETED|Pre-treatment Phase||60
8955379|NCT02491684|10019029|FG000|NOT COMPLETED|Pre-treatment Phase||0
8955380|NCT02491684|10019030|FG001|NOT COMPLETED|Pre-treatment Phase||0
8955381|NCT02491684|10019029|FG000|STARTED|Treatment Phase||61
8955382|NCT02491684|10019030|FG001|STARTED|Treatment Phase||60
8955383|NCT02491684|10019029|FG000|COMPLETED|Treatment Phase||58
8955384|NCT02491684|10019030|FG001|COMPLETED|Treatment Phase||57
8955385|NCT02491684|10019029|FG000|NOT COMPLETED|Treatment Phase||3
8955386|NCT02491684|10019030|FG001|NOT COMPLETED|Treatment Phase||3
8955387|NCT02491788|10019038|FG000|STARTED|Overall Study||8
8955388|NCT02491788|10019039|FG001|STARTED|Overall Study||11
8955389|NCT02491788|10019038|FG000|COMPLETED|Overall Study||8
8955390|NCT02491788|10019039|FG001|COMPLETED|Overall Study||11
8955391|NCT02491788|10019038|FG000|NOT COMPLETED|Overall Study||0
8955392|NCT02491788|10019039|FG001|NOT COMPLETED|Overall Study||0
8955393|NCT02491892|10019047|FG000|STARTED|Overall Study||41
8955394|NCT02491892|10019048|FG001|STARTED|Overall Study||38
8955395|NCT02491892|10019047|FG000|Treated|Overall Study||41
8955396|NCT02491892|10019048|FG001|Treated|Overall Study|One participant was randomized but died before receiving study medication.|37
8955397|NCT02491892|10019047|FG000|COMPLETED|Overall Study||0
8955398|NCT02491892|10019048|FG001|COMPLETED|Overall Study||0
8955399|NCT02491892|10019047|FG000|NOT COMPLETED|Overall Study||41
8955400|NCT02491892|10019048|FG001|NOT COMPLETED|Overall Study||38
8874777|NCT01904773|9931725|FG004|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8874778|NCT01904773|9931726|FG005|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8874779|NCT01904773|9931727|FG006|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8874780|NCT01904773|9931728|FG007|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8874781|NCT01904773|9931729|FG008|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8874782|NCT01904773|9931721|FG000|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||24
8874783|NCT01904773|9931722|FG001|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8874784|NCT01904773|9931723|FG002|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8874785|NCT01904773|9931724|FG003|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8874786|NCT01904773|9931725|FG004|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8955401|NCT02491944|10019054|FG000|STARTED|Overall Study||10
8955402|NCT02491944|10019054|FG000|COMPLETED|Overall Study||10
8955403|NCT02491944|10019054|FG000|NOT COMPLETED|Overall Study||0
8955404|NCT02492100|10019058|FG000|STARTED|Overall Study||47
8955405|NCT02492100|10019058|FG000|COMPLETED|Overall Study||46
8955406|NCT02492100|10019058|FG000|NOT COMPLETED|Overall Study||1
8955407|NCT02492451|10019066|FG000|STARTED|Overall Study||40
8955408|NCT02492451|10019067|FG001|STARTED|Overall Study||39
8955409|NCT02492451|10019068|FG002|STARTED|Overall Study||39
8955410|NCT02492451|10019066|FG000|COMPLETED|Overall Study||40
8955411|NCT02492451|10019067|FG001|COMPLETED|Overall Study||39
8955412|NCT02492451|10019068|FG002|COMPLETED|Overall Study||39
8955413|NCT02492451|10019066|FG000|NOT COMPLETED|Overall Study||0
8955414|NCT02492451|10019067|FG001|NOT COMPLETED|Overall Study||0
8955415|NCT02492451|10019068|FG002|NOT COMPLETED|Overall Study||0
8955416|NCT02492750|10019079|FG000|STARTED|Overall Study||4
8955417|NCT02492750|10019080|FG001|STARTED|Overall Study||4
8955418|NCT02492750|10019081|FG002|STARTED|Overall Study||6
8955419|NCT02492750|10019079|FG000|COMPLETED|Overall Study||4
8955420|NCT02492750|10019080|FG001|COMPLETED|Overall Study||4
8955421|NCT02492750|10019081|FG002|COMPLETED|Overall Study||6
8955422|NCT02492750|10019079|FG000|NOT COMPLETED|Overall Study||0
8955423|NCT02492750|10019080|FG001|NOT COMPLETED|Overall Study||0
8955424|NCT02492750|10019081|FG002|NOT COMPLETED|Overall Study||0
8955425|NCT02492763|10019093|FG000|STARTED|Overall Study||46
8955426|NCT02492763|10019094|FG001|STARTED|Overall Study||44
8955427|NCT02492763|10019095|FG002|STARTED|Overall Study||43
8955428|NCT02492763|10019096|FG003|STARTED|Overall Study||43
8955429|NCT02492763|10019093|FG000|Treated|Overall Study||46
8955430|NCT02492763|10019094|FG001|Treated|Overall Study||44
8955431|NCT02492763|10019095|FG002|Treated|Overall Study||43
8955432|NCT02492763|10019096|FG003|Treated|Overall Study||42
8955433|NCT02492763|10019093|FG000|COMPLETED|Overall Study||30
8955434|NCT02492763|10019094|FG001|COMPLETED|Overall Study||29
8955435|NCT02492763|10019095|FG002|COMPLETED|Overall Study||33
8955436|NCT02492763|10019096|FG003|COMPLETED|Overall Study||30
8955437|NCT02492763|10019093|FG000|NOT COMPLETED|Overall Study||16
8874787|NCT01904773|9931726|FG005|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8874788|NCT01904773|9931727|FG006|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8874789|NCT01904773|9931728|FG007|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8874790|NCT01904773|9931729|FG008|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8874791|NCT01904773|9931721|FG000|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8874792|NCT01904773|9931722|FG001|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8874793|NCT01904773|9931723|FG002|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8874794|NCT01904773|9931724|FG003|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8874795|NCT01904773|9931725|FG004|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8874796|NCT01904773|9931726|FG005|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8874797|NCT01904773|9931727|FG006|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8874798|NCT01904773|9931728|FG007|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8874799|NCT01904773|9931729|FG008|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8874800|NCT01904773|9931721|FG000|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||24
8955438|NCT02492763|10019094|FG001|NOT COMPLETED|Overall Study||15
8955439|NCT02492763|10019095|FG002|NOT COMPLETED|Overall Study||10
8955440|NCT02492763|10019096|FG003|NOT COMPLETED|Overall Study||13
8955441|NCT02492802|10019106|FG000|STARTED|Overall Study||64
8955442|NCT02492802|10019106|FG000|COMPLETED|Overall Study||64
8955443|NCT02492802|10019106|FG000|NOT COMPLETED|Overall Study||0
8955444|NCT02492841|10019113|FG000|STARTED|Overall Study||56
8955445|NCT02492841|10019114|FG001|STARTED|Overall Study||53
8955446|NCT02492841|10019115|FG002|STARTED|Overall Study||60
8955447|NCT02492841|10019113|FG000|COMPLETED|Overall Study||22
8955448|NCT02492841|10019114|FG001|COMPLETED|Overall Study||22
8955449|NCT02492841|10019115|FG002|COMPLETED|Overall Study||25
8955450|NCT02492841|10019113|FG000|NOT COMPLETED|Overall Study||34
8955451|NCT02492841|10019114|FG001|NOT COMPLETED|Overall Study||31
8955452|NCT02492841|10019115|FG002|NOT COMPLETED|Overall Study||35
8955453|NCT02492854|10019128|FG000|STARTED|Overall Study||5
8955454|NCT02492854|10019129|FG001|STARTED|Overall Study||3
8955455|NCT02492854|10019128|FG000|COMPLETED|Overall Study||5
8955456|NCT02492854|10019129|FG001|COMPLETED|Overall Study||3
8955457|NCT02492854|10019128|FG000|NOT COMPLETED|Overall Study||0
8955458|NCT02492854|10019129|FG001|NOT COMPLETED|Overall Study||0
8955459|NCT02492880|10019135|FG000|STARTED|Overall Study||15
8955460|NCT02492880|10019135|FG000|COMPLETED|Overall Study||13
8955461|NCT02492880|10019135|FG000|NOT COMPLETED|Overall Study||2
8955462|NCT02492958|10019143|FG000|STARTED|Overall Study||34
8955463|NCT02492958|10019144|FG001|STARTED|Overall Study||34
8955464|NCT02492958|10019145|FG002|STARTED|Overall Study||34
8570121|NCT00101413|9602239|FG000|STARTED|Overall Study||52
8570122|NCT00101413|9602239|FG000|COMPLETED|Overall Study|Safety data collected for 4 subjects after 30 Jun 2005 until 11 Apr 2008.|52
8570123|NCT00101413|9602239|FG000|NOT COMPLETED|Overall Study||0
8570124|NCT00101452|9602246|FG000|STARTED|Overall Study||65
8570125|NCT00101452|9602247|FG001|STARTED|Overall Study||69
8570126|NCT00101452|9602248|FG002|STARTED|Overall Study||65
8570127|NCT00101452|9602246|FG000|COMPLETED|Overall Study||21
8570128|NCT00101452|9602247|FG001|COMPLETED|Overall Study||26
8570129|NCT00101452|9602248|FG002|COMPLETED|Overall Study||22
8570130|NCT00101452|9602246|FG000|NOT COMPLETED|Overall Study||44
8570131|NCT00101452|9602247|FG001|NOT COMPLETED|Overall Study||43
8570132|NCT00101452|9602248|FG002|NOT COMPLETED|Overall Study||43
8570133|NCT00101582|9602262|FG000|STARTED|Overall Study||94
8570134|NCT00101582|9602263|FG001|STARTED|Overall Study||94
8570135|NCT00101582|9602262|FG000|Received Study Drug|Overall Study||91
8570136|NCT00101582|9602263|FG001|Received Study Drug|Overall Study||94
8570137|NCT00101582|9602262|FG000|COMPLETED|Overall Study|Participants who completed the acute oral mucositis evaluation phase|83
8570138|NCT00101582|9602263|FG001|COMPLETED|Overall Study|Participants who completed the acute oral mucositis evaluation phase|79
8570139|NCT00101582|9602262|FG000|NOT COMPLETED|Overall Study||11
8570140|NCT00101582|9602263|FG001|NOT COMPLETED|Overall Study||15
8570141|NCT00101647|9602271|FG000|STARTED|Overall Study|Randomized|13
8570142|NCT00101647|9602272|FG001|STARTED|Overall Study|Randomized|161
8570143|NCT00101647|9602271|FG000|COMPLETED|Overall Study||13
8570144|NCT00101647|9602272|FG001|COMPLETED|Overall Study||161
8570145|NCT00101647|9602271|FG000|NOT COMPLETED|Overall Study||0
8570146|NCT00101647|9602272|FG001|NOT COMPLETED|Overall Study||0
8570147|NCT00101660|9602290|FG000|STARTED|Overall Study||99
8570148|NCT00101660|9602291|FG001|STARTED|Overall Study||288
8570149|NCT00101660|9602290|FG000|COMPLETED|Overall Study||99
8570150|NCT00101660|9602291|FG001|COMPLETED|Overall Study||288
8570151|NCT00101660|9602290|FG000|NOT COMPLETED|Overall Study||0
8570152|NCT00101660|9602291|FG001|NOT COMPLETED|Overall Study||0
8570153|NCT00101686|9602313|FG000|STARTED|Overall Study||71
8570154|NCT00101686|9602314|FG001|STARTED|Overall Study||73
8570155|NCT00101686|9602315|FG002|STARTED|Overall Study||69
8570156|NCT00101686|9602316|FG003|STARTED|Overall Study||72
8570157|NCT00101686|9602317|FG004|STARTED|Overall Study||73
8570158|NCT00101686|9602318|FG005|STARTED|Overall Study||72
8570159|NCT00101686|9602319|FG006|STARTED|Overall Study||27
8570160|NCT00101686|9602320|FG007|STARTED|Overall Study||30
8570161|NCT00101686|9602321|FG008|STARTED|Overall Study||30
8570162|NCT00101686|9602322|FG009|STARTED|Overall Study||30
8570163|NCT00101686|9602313|FG000|Received Treatment|Overall Study||70
8570164|NCT00101686|9602314|FG001|Received Treatment|Overall Study||67
8570165|NCT00101686|9602315|FG002|Received Treatment|Overall Study||67
8570166|NCT00101686|9602316|FG003|Received Treatment|Overall Study||70
8570167|NCT00101686|9602317|FG004|Received Treatment|Overall Study||71
8570168|NCT00101686|9602318|FG005|Received Treatment|Overall Study||70
8570169|NCT00101686|9602319|FG006|Received Treatment|Overall Study||27
8570170|NCT00101686|9602320|FG007|Received Treatment|Overall Study||29
8570171|NCT00101686|9602321|FG008|Received Treatment|Overall Study||30
8570172|NCT00101686|9602322|FG009|Received Treatment|Overall Study||29
8570173|NCT00101686|9602313|FG000|COMPLETED|Overall Study|Patients treated until disease progression.|0
8570174|NCT00101686|9602314|FG001|COMPLETED|Overall Study|Patients treated until disease progression.|0
8577566|NCT00159263|9610315|FG005|NOT COMPLETED|Sixth Intervention||0
8955465|NCT02492958|10019146|FG003|STARTED|Overall Study||34
8955466|NCT02492958|10019143|FG000|COMPLETED|Overall Study||33
8955467|NCT02492958|10019144|FG001|COMPLETED|Overall Study||34
8955468|NCT02492958|10019145|FG002|COMPLETED|Overall Study||32
8955469|NCT02492958|10019146|FG003|COMPLETED|Overall Study||34
8955470|NCT02492958|10019143|FG000|NOT COMPLETED|Overall Study||1
8955471|NCT02492958|10019144|FG001|NOT COMPLETED|Overall Study||0
8955472|NCT02492958|10019145|FG002|NOT COMPLETED|Overall Study||2
8955473|NCT02492958|10019146|FG003|NOT COMPLETED|Overall Study||0
8955474|NCT02492984|10019158|FG000|STARTED|Overall Study||73
8955475|NCT02492984|10019159|FG001|STARTED|Overall Study||14
8955476|NCT02492984|10019158|FG000|COMPLETED|Overall Study||70
8955477|NCT02492984|10019159|FG001|COMPLETED|Overall Study||14
8955478|NCT02492984|10019158|FG000|NOT COMPLETED|Overall Study||3
8955479|NCT02492984|10019159|FG001|NOT COMPLETED|Overall Study||0
8955480|NCT02492997|10019170|FG000|STARTED|Overall Study||21
8955481|NCT02492997|10019171|FG001|STARTED|Overall Study||21
8955482|NCT02492997|10019170|FG000|COMPLETED|Overall Study||19
8955483|NCT02492997|10019171|FG001|COMPLETED|Overall Study||20
8955484|NCT02492997|10019170|FG000|NOT COMPLETED|Overall Study||2
8955485|NCT02492997|10019171|FG001|NOT COMPLETED|Overall Study||1
8955486|NCT02493036|10019180|FG000|STARTED|Overall Study||17
8955487|NCT02493036|10019181|FG001|STARTED|Overall Study||20
8955488|NCT02493036|10019182|FG002|STARTED|Overall Study||17
8955489|NCT02493036|10019180|FG000|COMPLETED|Overall Study||16
8955490|NCT02493036|10019181|FG001|COMPLETED|Overall Study||18
8955491|NCT02493036|10019182|FG002|COMPLETED|Overall Study||15
8955492|NCT02493036|10019180|FG000|NOT COMPLETED|Overall Study||1
8955493|NCT02493036|10019181|FG001|NOT COMPLETED|Overall Study||2
8955494|NCT02493036|10019182|FG002|NOT COMPLETED|Overall Study||2
8955495|NCT02493062|10019190|FG000|STARTED|Overall Study||35
8955496|NCT02493062|10019190|FG000|COMPLETED|Overall Study||23
8955497|NCT02493062|10019190|FG000|NOT COMPLETED|Overall Study||12
8955498|NCT02493088|10019194|FG000|STARTED|Overall Study||11
8955499|NCT02493088|10019194|FG000|COMPLETED|Overall Study||11
8955500|NCT02493088|10019194|FG000|NOT COMPLETED|Overall Study||0
8955501|NCT02493127|10019200|FG000|STARTED|Overall Study||61
8955502|NCT02493127|10019201|FG001|STARTED|Overall Study||61
8955503|NCT02493127|10019200|FG000|COMPLETED|Overall Study||60
8955504|NCT02493127|10019201|FG001|COMPLETED|Overall Study||60
8955505|NCT02493127|10019200|FG000|NOT COMPLETED|Overall Study||1
8955506|NCT02493127|10019201|FG001|NOT COMPLETED|Overall Study||1
8955507|NCT02493257|10019211|FG000|STARTED|Overall Study||11
8955508|NCT02493257|10019212|FG001|STARTED|Overall Study||11
8955509|NCT02493257|10019211|FG000|4 Week Follow up|Overall Study||11
8955510|NCT02493257|10019212|FG001|4 Week Follow up|Overall Study||11
8955511|NCT02493257|10019211|FG000|12 Week Follow up|Overall Study||10
8955512|NCT02493257|10019212|FG001|12 Week Follow up|Overall Study||10
8955513|NCT02493257|10019211|FG000|COMPLETED|Overall Study||10
8955514|NCT02493257|10019212|FG001|COMPLETED|Overall Study||10
8955515|NCT02493257|10019211|FG000|NOT COMPLETED|Overall Study||1
8955516|NCT02493257|10019212|FG001|NOT COMPLETED|Overall Study||1
9037666|NCT03318809|10098887|FG001|COMPLETED|Overall Study||6
9037667|NCT03318809|10098886|FG000|NOT COMPLETED|Overall Study||0
9037668|NCT03318809|10098887|FG001|NOT COMPLETED|Overall Study||0
9037669|NCT03319134|10098896|FG000|STARTED|Overall Study||15
9037670|NCT03319134|10098897|FG001|STARTED|Overall Study||15
9037671|NCT03319134|10098898|FG002|STARTED|Overall Study||15
9037672|NCT03319134|10098896|FG000|COMPLETED|Overall Study||15
9037673|NCT03319134|10098897|FG001|COMPLETED|Overall Study||15
9037674|NCT03319134|10098898|FG002|COMPLETED|Overall Study||15
9037675|NCT03319134|10098896|FG000|NOT COMPLETED|Overall Study||0
9037676|NCT03319134|10098897|FG001|NOT COMPLETED|Overall Study||0
9037677|NCT03319134|10098898|FG002|NOT COMPLETED|Overall Study||0
9037678|NCT03319173|10098908|FG000|STARTED|Overall Study||48
9037679|NCT03319173|10098909|FG001|STARTED|Overall Study||50
9037680|NCT03319173|10098908|FG000|COMPLETED|Overall Study||48
9037681|NCT03319173|10098909|FG001|COMPLETED|Overall Study||50
9037682|NCT03319173|10098908|FG000|NOT COMPLETED|Overall Study||0
9037683|NCT03319173|10098909|FG001|NOT COMPLETED|Overall Study||0
9037684|NCT03319212|10098921|FG000|STARTED|Overall Study||29
9037685|NCT03319212|10098922|FG001|STARTED|Overall Study||52
9037686|NCT03319212|10098921|FG000|COMPLETED|Overall Study||26
9037687|NCT03319212|10098922|FG001|COMPLETED|Overall Study||47
9037688|NCT03319212|10098921|FG000|NOT COMPLETED|Overall Study||3
9037689|NCT03319212|10098922|FG001|NOT COMPLETED|Overall Study||5
9037690|NCT03319277|10098929|FG000|STARTED|Overall Study||59
9037691|NCT03319277|10098930|FG001|STARTED|Overall Study||59
9037692|NCT03319277|10098929|FG000|COMPLETED|Overall Study||59
9037693|NCT03319277|10098930|FG001|COMPLETED|Overall Study||59
9037694|NCT03319277|10098929|FG000|NOT COMPLETED|Overall Study||0
9037695|NCT03319277|10098930|FG001|NOT COMPLETED|Overall Study||0
9037696|NCT03319719|10098936|FG000|STARTED|Overall Study||52
9037697|NCT03319719|10098936|FG000|COMPLETED|Overall Study||51
9037698|NCT03319719|10098936|FG000|NOT COMPLETED|Overall Study||1
9037699|NCT03319810|10098942|FG000|STARTED|Overall Study||5
9037700|NCT03319810|10098942|FG000|COMPLETED|Overall Study||5
9037701|NCT03319810|10098942|FG000|NOT COMPLETED|Overall Study||0
9037702|NCT03319953|10098950|FG000|STARTED|Period 1 (Day 1 to 14)||3
9037703|NCT03319953|10098951|FG001|STARTED|Period 1 (Day 1 to 14)||4
9037704|NCT03319953|10098952|FG002|STARTED|Period 1 (Day 1 to 14)||9
9037705|NCT03319953|10098953|FG003|STARTED|Period 1 (Day 1 to 14)||7
9037706|NCT03319953|10098950|FG000|COMPLETED|Period 1 (Day 1 to 14)||3
9037707|NCT03319953|10098951|FG001|COMPLETED|Period 1 (Day 1 to 14)||4
9037708|NCT03319953|10098952|FG002|COMPLETED|Period 1 (Day 1 to 14)||9
8955517|NCT02493361|10019218|FG000|STARTED|Overall Study||24
8955518|NCT02493361|10019218|FG000|Week 24 Assessment|Overall Study||21
8955519|NCT02493361|10019218|FG000|COMPLETED|Overall Study||21
8955520|NCT02493361|10019218|FG000|NOT COMPLETED|Overall Study||3
8955521|NCT02493452|10019225|FG000|STARTED|Overall Study||379
8955522|NCT02493452|10019226|FG001|STARTED|Overall Study||377
8955523|NCT02493452|10019227|FG002|STARTED|Overall Study||379
8955524|NCT02493452|10019225|FG000|COMPLETED|Overall Study||329
8955525|NCT02493452|10019226|FG001|COMPLETED|Overall Study||328
8955526|NCT02493452|10019227|FG002|COMPLETED|Overall Study||325
8955527|NCT02493452|10019225|FG000|NOT COMPLETED|Overall Study||50
8955528|NCT02493452|10019226|FG001|NOT COMPLETED|Overall Study||49
8955529|NCT02493452|10019227|FG002|NOT COMPLETED|Overall Study||54
8955530|NCT02493517|10019237|FG000|STARTED|Overall Study||64
8955531|NCT02493517|10019238|FG001|STARTED|Overall Study||64
8955532|NCT02493517|10019237|FG000|COMPLETED|Overall Study||62
8955533|NCT02493517|10019238|FG001|COMPLETED|Overall Study||57
8955534|NCT02493517|10019237|FG000|NOT COMPLETED|Overall Study||2
8955535|NCT02493517|10019238|FG001|NOT COMPLETED|Overall Study||7
8955536|NCT02493608|10019248|FG000|STARTED|Overall Study||48
8955537|NCT02493608|10019249|FG001|STARTED|Overall Study||48
8955538|NCT02493608|10019248|FG000|COMPLETED|Overall Study||48
8955539|NCT02493608|10019249|FG001|COMPLETED|Overall Study||48
8955540|NCT02493608|10019248|FG000|NOT COMPLETED|Overall Study||0
8955541|NCT02493608|10019249|FG001|NOT COMPLETED|Overall Study||0
8955542|NCT02493621|10019257|FG000|STARTED|Overall Study||58
8955543|NCT02493621|10019258|FG001|STARTED|Overall Study||58
8955544|NCT02493621|10019257|FG000|COMPLETED|Overall Study||58
8955545|NCT02493621|10019258|FG001|COMPLETED|Overall Study||58
8955546|NCT02493621|10019257|FG000|NOT COMPLETED|Overall Study||0
8955547|NCT02493621|10019258|FG001|NOT COMPLETED|Overall Study||0
8955548|NCT02493660|10019266|FG000|STARTED|Overall Study|ITT|93
8955549|NCT02493660|10019267|FG001|STARTED|Overall Study|ITT|91
8955550|NCT02493660|10019266|FG000|COMPLETED|Overall Study||93
8955551|NCT02493660|10019267|FG001|COMPLETED|Overall Study|Investigator requested subject be discontinued prior to any post-procedure efficacy assessments.|90
8955552|NCT02493660|10019266|FG000|NOT COMPLETED|Overall Study||0
8955553|NCT02493660|10019267|FG001|NOT COMPLETED|Overall Study||1
8955554|NCT02493712|10019276|FG000|STARTED|Overall Study||16
8955555|NCT02493712|10019277|FG001|STARTED|Overall Study||18
8955556|NCT02493712|10019278|FG002|STARTED|Overall Study||17
8955557|NCT02493712|10019276|FG000|COMPLETED|Overall Study||14
8955558|NCT02493712|10019277|FG001|COMPLETED|Overall Study||12
8955559|NCT02493712|10019278|FG002|COMPLETED|Overall Study||11
8955560|NCT02493712|10019276|FG000|NOT COMPLETED|Overall Study||2
8955561|NCT02493712|10019277|FG001|NOT COMPLETED|Overall Study||6
8955562|NCT02493712|10019278|FG002|NOT COMPLETED|Overall Study||6
8955563|NCT02493764|10019288|FG000|STARTED|Overall Study||268
8955564|NCT02493764|10019289|FG001|STARTED|Overall Study||269
8955565|NCT02493764|10019288|FG000|COMPLETED|Overall Study||185
8955566|NCT02493764|10019289|FG001|COMPLETED|Overall Study||187
8955567|NCT02493764|10019288|FG000|NOT COMPLETED|Overall Study||83
8955568|NCT02493764|10019289|FG001|NOT COMPLETED|Overall Study||82
8955569|NCT02493777|10019297|FG000|STARTED|Overall Study||65
8955570|NCT02493777|10019298|FG001|STARTED|Overall Study||54
8955571|NCT02493777|10019297|FG000|COMPLETED|Overall Study||65
8955572|NCT02493777|10019298|FG001|COMPLETED|Overall Study||53
8955573|NCT02493777|10019297|FG000|NOT COMPLETED|Overall Study||0
8955574|NCT02493777|10019298|FG001|NOT COMPLETED|Overall Study||1
8955575|NCT02493855|10019307|FG000|STARTED|Overall Study||21
8955576|NCT02493855|10019308|FG001|STARTED|Overall Study||19
8955577|NCT02493855|10019309|FG002|STARTED|Overall Study||6
8955578|NCT02493855|10019307|FG000|COMPLETED|Overall Study||19
8955579|NCT02493855|10019308|FG001|COMPLETED|Overall Study||18
8955580|NCT02493855|10019309|FG002|COMPLETED|Overall Study||6
8955581|NCT02493855|10019307|FG000|NOT COMPLETED|Overall Study||2
8955582|NCT02493855|10019308|FG001|NOT COMPLETED|Overall Study||1
8955583|NCT02493855|10019309|FG002|NOT COMPLETED|Overall Study||0
8955584|NCT02493868|10019317|FG000|STARTED|Induction Phase: DE Participants||437
8955585|NCT02493868|10019318|FG001|STARTED|Induction Phase: DE Participants||0
8955586|NCT02493868|10019317|FG000|COMPLETED|Induction Phase: DE Participants|Participants who completed and met predefined response criteria continued to OP phase.|273
8955587|NCT02493868|10019318|FG001|COMPLETED|Induction Phase: DE Participants||0
8955588|NCT02493868|10019317|FG000|NOT COMPLETED|Induction Phase: DE Participants||164
8955589|NCT02493868|10019318|FG001|NOT COMPLETED|Induction Phase: DE Participants||0
8955590|NCT02493868|10019317|FG000|STARTED|Optimization Phase: DE+TE Participants|Total participants: direct-entry (273) + esketamine-treated transferred-entry participants (182).|455
8955591|NCT02493868|10019318|FG001|STARTED|Optimization Phase: DE+TE Participants|Placebo treated transferred-entry participant.|86
8955592|NCT02493868|10019317|FG000|COMPLETED|Optimization Phase: DE+TE Participants|Participants who completed and met predefined remission/response criteria randomized to MA phase|297
8955593|NCT02493868|10019318|FG001|COMPLETED|Optimization Phase: DE+TE Participants|Participants who completed and met predefined remission/response criteria continued to MA phase.|54
8955594|NCT02493868|10019317|FG000|NOT COMPLETED|Optimization Phase: DE+TE Participants||158
8955595|NCT02493868|10019318|FG001|NOT COMPLETED|Optimization Phase: DE+TE Participants||32
8955596|NCT02493868|10019317|FG000|STARTED|Maintenance Phase: DE+TE Participants|152 participants randomized from intranasal esketamine arm after OP phase: DE (90) + TE (62)|152
9037709|NCT03319953|10098953|FG003|COMPLETED|Period 1 (Day 1 to 14)||7
8955597|NCT02493868|10019318|FG001|STARTED|Maintenance Phase: DE+TE Participants|145 participants randomized from intranasal esketamine arm after OP phase+54 continued from OP phase|199
8955598|NCT02493868|10019317|FG000|Stable Remitters|Maintenance Phase: DE+TE Participants||90
8955599|NCT02493868|10019318|FG001|Stable Remitters|Maintenance Phase: DE+TE Participants||86
8955600|NCT02493868|10019317|FG000|Stable Responders|Maintenance Phase: DE+TE Participants||62
8955601|NCT02493868|10019318|FG001|Stable Responders|Maintenance Phase: DE+TE Participants||59
8955602|NCT02493868|10019317|FG000|COMPLETED|Maintenance Phase: DE+TE Participants||139
8955603|NCT02493868|10019318|FG001|COMPLETED|Maintenance Phase: DE+TE Participants||177
8955604|NCT02493868|10019317|FG000|NOT COMPLETED|Maintenance Phase: DE+TE Participants||13
8955605|NCT02493868|10019318|FG001|NOT COMPLETED|Maintenance Phase: DE+TE Participants||22
8955606|NCT02493868|10019317|FG000|STARTED|Follow-up Phase||481
8955607|NCT02493868|10019318|FG001|STARTED|Follow-up Phase||64
8955608|NCT02493868|10019317|FG000|COMPLETED|Follow-up Phase||470
8955609|NCT02493868|10019318|FG001|COMPLETED|Follow-up Phase||62
8955610|NCT02493868|10019317|FG000|NOT COMPLETED|Follow-up Phase||11
8955611|NCT02493868|10019318|FG001|NOT COMPLETED|Follow-up Phase||2
8955612|NCT02493946|10019333|FG000|STARTED|DB Period||126
8955613|NCT02493946|10019334|FG001|STARTED|DB Period||64
8955614|NCT02493946|10019335|FG002|STARTED|DB Period||0
8955615|NCT02493946|10019333|FG000|COMPLETED|DB Period||118
8955616|NCT02493946|10019334|FG001|COMPLETED|DB Period||59
8955617|NCT02493946|10019335|FG002|COMPLETED|DB Period||0
8955618|NCT02493946|10019333|FG000|NOT COMPLETED|DB Period||8
8955619|NCT02493946|10019334|FG001|NOT COMPLETED|DB Period||5
8955620|NCT02493946|10019335|FG002|NOT COMPLETED|DB Period||0
8955621|NCT02493946|10019333|FG000|STARTED|Open Label Period|Only the BTX-A-HAC Solution 50 U - LT Analyses arm is applicable for this period.|0
8955622|NCT02493946|10019334|FG001|STARTED|Open Label Period|Only the BTX-A-HAC Solution 50 U - LT Analyses arm is applicable for this period.|0
8955623|NCT02493946|10019335|FG002|STARTED|Open Label Period|The previous period relates to DB period only, this period relates to OL treatment only.|595
8955624|NCT02493946|10019333|FG000|COMPLETED|Open Label Period||0
8955625|NCT02493946|10019334|FG001|COMPLETED|Open Label Period||0
8955626|NCT02493946|10019335|FG002|COMPLETED|Open Label Period||509
8955627|NCT02493946|10019333|FG000|NOT COMPLETED|Open Label Period||0
8955628|NCT02493946|10019334|FG001|NOT COMPLETED|Open Label Period||0
8955629|NCT02493946|10019335|FG002|NOT COMPLETED|Open Label Period||86
8955630|NCT02494076|10019345|FG000|STARTED|Overall Study||26
8955631|NCT02494076|10019346|FG001|STARTED|Overall Study||26
8955632|NCT02494076|10019345|FG000|COMPLETED|Overall Study||26
8955633|NCT02494076|10019346|FG001|COMPLETED|Overall Study||26
8955634|NCT02494076|10019345|FG000|NOT COMPLETED|Overall Study||0
8955635|NCT02494076|10019346|FG001|NOT COMPLETED|Overall Study||0
8955636|NCT02494102|10019354|FG000|STARTED|Overall Study||42
8955637|NCT02494102|10019355|FG001|STARTED|Overall Study||47
8955638|NCT02494102|10019354|FG000|COMPLETED|Overall Study||42
8955639|NCT02494102|10019355|FG001|COMPLETED|Overall Study||47
8955640|NCT02494102|10019354|FG000|NOT COMPLETED|Overall Study||0
8955641|NCT02494102|10019355|FG001|NOT COMPLETED|Overall Study||0
8955642|NCT02494180|10019363|FG000|STARTED|Overall Study||85
8955643|NCT02494180|10019364|FG001|STARTED|Overall Study||85
8955644|NCT02494180|10019363|FG000|COMPLETED|Overall Study||85
8955645|NCT02494180|10019364|FG001|COMPLETED|Overall Study||85
8955646|NCT02494180|10019363|FG000|NOT COMPLETED|Overall Study||0
8955647|NCT02494180|10019364|FG001|NOT COMPLETED|Overall Study||0
8955648|NCT02494297|10019370|FG000|STARTED|Overall Study||1597
8955649|NCT02494297|10019370|FG000|COMPLETED|Overall Study|As there was no Follow-Up in this study, participation equals completion|1597
8955650|NCT02494297|10019370|FG000|NOT COMPLETED|Overall Study||0
8955651|NCT02494323|10019374|FG000|STARTED|Overall Study||70
8955652|NCT02494323|10019374|FG000|COMPLETED|Overall Study||70
8955653|NCT02494323|10019374|FG000|NOT COMPLETED|Overall Study||0
8955654|NCT02494336|10019380|FG000|STARTED|Overall Study||24
8955655|NCT02494336|10019381|FG001|STARTED|Overall Study||24
8955656|NCT02494336|10019380|FG000|COMPLETED|Overall Study||24
8955657|NCT02494336|10019381|FG001|COMPLETED|Overall Study||24
8955658|NCT02494336|10019380|FG000|NOT COMPLETED|Overall Study||0
8955659|NCT02494336|10019381|FG001|NOT COMPLETED|Overall Study||0
8955660|NCT02494401|10019389|FG000|STARTED|Overall Study||134
8955661|NCT02494401|10019390|FG001|STARTED|Overall Study||133
8955662|NCT02494401|10019389|FG000|Week 16|Overall Study||123
8955663|NCT02494401|10019390|FG001|Week 16|Overall Study||124
8955664|NCT02494401|10019389|FG000|6 Month Follow up|Overall Study||109
8955665|NCT02494401|10019390|FG001|6 Month Follow up|Overall Study||106
8955666|NCT02494401|10019389|FG000|COMPLETED|Overall Study||109
8955667|NCT02494401|10019390|FG001|COMPLETED|Overall Study||106
8955668|NCT02494401|10019389|FG000|NOT COMPLETED|Overall Study||25
8955669|NCT02494401|10019390|FG001|NOT COMPLETED|Overall Study||27
8955670|NCT02494440|10019396|FG000|STARTED|Overall Study||90
8955671|NCT02494440|10019396|FG000|COMPLETED|Overall Study||90
8955672|NCT02494440|10019396|FG000|NOT COMPLETED|Overall Study||0
8955673|NCT02494518|10019403|FG000|STARTED|Overall Study||11
8955674|NCT02494518|10019404|FG001|STARTED|Overall Study||12
8955675|NCT02494518|10019405|FG002|STARTED|Overall Study||11
8955676|NCT02494518|10019403|FG000|COMPLETED|Overall Study||10
8955677|NCT02494518|10019404|FG001|COMPLETED|Overall Study||10
8955678|NCT02494518|10019405|FG002|COMPLETED|Overall Study||8
8955679|NCT02494518|10019403|FG000|NOT COMPLETED|Overall Study||1
8955680|NCT02494518|10019404|FG001|NOT COMPLETED|Overall Study||2
8955681|NCT02494518|10019405|FG002|NOT COMPLETED|Overall Study||3
8955682|NCT02494583|10019416|FG000|STARTED|Overall Study||256
8955683|NCT02494583|10019417|FG001|STARTED|Overall Study||257
8955684|NCT02494583|10019418|FG002|STARTED|Overall Study||250
8955685|NCT02494583|10019416|FG000|Treated|Overall Study|1 participant randomized to the pembro combo arm received pembrolizumab monotherapy by mistake.|254
8955686|NCT02494583|10019417|FG001|Treated|Overall Study||250
8955687|NCT02494583|10019418|FG002|Treated|Overall Study||244
8955688|NCT02494583|10019416|FG000|COMPLETED|Overall Study||0
8955689|NCT02494583|10019417|FG001|COMPLETED|Overall Study||0
8955690|NCT02494583|10019418|FG002|COMPLETED|Overall Study||0
8955691|NCT02494583|10019416|FG000|NOT COMPLETED|Overall Study||256
8955692|NCT02494583|10019417|FG001|NOT COMPLETED|Overall Study||257
8955693|NCT02494583|10019418|FG002|NOT COMPLETED|Overall Study||250
8955694|NCT02494596|10019426|FG000|STARTED|Overall Study||5
8955695|NCT02494596|10019427|FG001|STARTED|Overall Study||7
8955696|NCT02494596|10019428|FG002|STARTED|Overall Study||7
8955697|NCT02494596|10019426|FG000|COMPLETED|Overall Study||2
8955698|NCT02494596|10019427|FG001|COMPLETED|Overall Study||2
8955699|NCT02494596|10019428|FG002|COMPLETED|Overall Study||6
8955700|NCT02494596|10019426|FG000|NOT COMPLETED|Overall Study||3
8955701|NCT02494596|10019427|FG001|NOT COMPLETED|Overall Study||5
8955702|NCT02494596|10019428|FG002|NOT COMPLETED|Overall Study||1
8955703|NCT02494713|10019439|FG000|STARTED|Overall Study||4
8955704|NCT02494713|10019439|FG000|COMPLETED|Overall Study||4
8955705|NCT02494713|10019439|FG000|NOT COMPLETED|Overall Study||0
8955706|NCT02494778|10019443|FG000|STARTED|Overall Study||248
8955707|NCT02494778|10019443|FG000|COMPLETED|Overall Study||27
8955708|NCT02494778|10019443|FG000|NOT COMPLETED|Overall Study||221
8955709|NCT02494817|10019449|FG000|STARTED|Overall Study|representing 81 couples|162
8955710|NCT02494817|10019450|FG001|STARTED|Overall Study|representing 68 couples|136
8955711|NCT02494817|10019449|FG000|3 Month Assessment|Overall Study|represents 59 couples and 7 partnered men|125
8955712|NCT02494817|10019450|FG001|3 Month Assessment|Overall Study|represents 44 couples and 4 partnered men|92
8955713|NCT02494817|10019449|FG000|6 Month Assessment|Overall Study|represents 52 couples and 11 partnered men|115
8955714|NCT02494817|10019450|FG001|6 Month Assessment|Overall Study|represents 45 couples and 8 partnered men|98
8955715|NCT02494817|10019449|FG000|COMPLETED|Overall Study|49 couples and 9 partnered men completed all 3 assessments (baseline, 3- and 6-month)|107
8955716|NCT02494817|10019450|FG001|COMPLETED|Overall Study|41 couples and 5 partnered men completed all 3 assessments (baseline, 3- and 6-month)|87
8955717|NCT02494817|10019449|FG000|NOT COMPLETED|Overall Study||55
8955718|NCT02494817|10019450|FG001|NOT COMPLETED|Overall Study||49
8955719|NCT02495025|10019458|FG000|STARTED|Overall Study||77
8955720|NCT02495025|10019459|FG001|STARTED|Overall Study||75
8955721|NCT02495025|10019458|FG000|COMPLETED|Overall Study||51
8955722|NCT02495025|10019459|FG001|COMPLETED|Overall Study||61
8955723|NCT02495025|10019458|FG000|NOT COMPLETED|Overall Study||26
8955724|NCT02495025|10019459|FG001|NOT COMPLETED|Overall Study||14
8955725|NCT02495038|10019468|FG000|STARTED|Overall Study||27
8955726|NCT02495038|10019469|FG001|STARTED|Overall Study||27
8955727|NCT02495038|10019470|FG002|STARTED|Overall Study||27
8955728|NCT02495038|10019468|FG000|COMPLETED|Overall Study||27
8955729|NCT02495038|10019469|FG001|COMPLETED|Overall Study||27
8955730|NCT02495038|10019470|FG002|COMPLETED|Overall Study||27
8955731|NCT02495038|10019468|FG000|NOT COMPLETED|Overall Study||0
8955732|NCT02495038|10019469|FG001|NOT COMPLETED|Overall Study||0
8955733|NCT02495038|10019470|FG002|NOT COMPLETED|Overall Study||0
8955734|NCT02495103|10019480|FG000|STARTED|Overall Study||3
8955735|NCT02495103|10019481|FG001|STARTED|Overall Study||4
8955736|NCT02495103|10019480|FG000|COMPLETED|Overall Study||3
8955737|NCT02495103|10019481|FG001|COMPLETED|Overall Study||4
8955738|NCT02495103|10019480|FG000|NOT COMPLETED|Overall Study||0
8955739|NCT02495103|10019481|FG001|NOT COMPLETED|Overall Study||0
8955740|NCT02495168|10019492|FG000|STARTED|Overall Study||504
8955741|NCT02495168|10019493|FG001|STARTED|Overall Study||516
8955742|NCT02495168|10019494|FG002|STARTED|Overall Study||127
8955743|NCT02495168|10019492|FG000|Safety Population|Overall Study||501
8955744|NCT02495168|10019493|FG001|Safety Population|Overall Study||514
8955745|NCT02495168|10019494|FG002|Safety Population|Overall Study||126
8955746|NCT02495168|10019492|FG000|Modified Intent-to-Treat Population|Overall Study||468
8955747|NCT02495168|10019493|FG001|Modified Intent-to-Treat Population|Overall Study||478
8955748|NCT02495168|10019494|FG002|Modified Intent-to-Treat Population|Overall Study||111
8955749|NCT02495168|10019492|FG000|Day1 Per-protocol Set (D1PPS) Population|Overall Study||437
8955750|NCT02495168|10019493|FG001|Day1 Per-protocol Set (D1PPS) Population|Overall Study||437
8955751|NCT02495168|10019494|FG002|Day1 Per-protocol Set (D1PPS) Population|Overall Study||99
8955752|NCT02495168|10019492|FG000|Day 42 (D42PPS) Population|Overall Study||382
8955753|NCT02495168|10019493|FG001|Day 42 (D42PPS) Population|Overall Study||383
8955754|NCT02495168|10019494|FG002|Day 42 (D42PPS) Population|Overall Study||88
8955755|NCT02495168|10019492|FG000|COMPLETED|Overall Study||466
8955756|NCT02495168|10019493|FG001|COMPLETED|Overall Study||462
8955757|NCT02495168|10019494|FG002|COMPLETED|Overall Study||110
8955758|NCT02495168|10019492|FG000|NOT COMPLETED|Overall Study||38
8955759|NCT02495168|10019493|FG001|NOT COMPLETED|Overall Study||54
8955760|NCT02495168|10019494|FG002|NOT COMPLETED|Overall Study||17
8955761|NCT02495233|10019504|FG000|STARTED|Overall Study||3
8955762|NCT02495233|10019505|FG001|STARTED|Overall Study||7
8955763|NCT02495233|10019504|FG000|COMPLETED|Overall Study||3
8955764|NCT02495233|10019505|FG001|COMPLETED|Overall Study||6
8955765|NCT02495233|10019504|FG000|NOT COMPLETED|Overall Study||0
8955766|NCT02495233|10019505|FG001|NOT COMPLETED|Overall Study||1
8955767|NCT02495259|10019514|FG000|STARTED|Overall Study||7
8955768|NCT02495259|10019515|FG001|STARTED|Overall Study||4
8955769|NCT02495259|10019516|FG002|STARTED|Overall Study||8
8955770|NCT02495259|10019514|FG000|COMPLETED|Overall Study||7
8955771|NCT02495259|10019515|FG001|COMPLETED|Overall Study||3
8955772|NCT02495259|10019516|FG002|COMPLETED|Overall Study||8
8955773|NCT02495259|10019514|FG000|NOT COMPLETED|Overall Study||0
8955774|NCT02495259|10019515|FG001|NOT COMPLETED|Overall Study||1
8955775|NCT02495259|10019516|FG002|NOT COMPLETED|Overall Study||0
8955776|NCT02495389|10019524|FG000|STARTED|Overall Study||84
8955777|NCT02495389|10019524|FG000|COMPLETED|Overall Study||44
8955778|NCT02495389|10019524|FG000|NOT COMPLETED|Overall Study||40
8955779|NCT02495454|10019528|FG000|STARTED|Overall Study||34
8955780|NCT02495454|10019528|FG000|COMPLETED|Overall Study|One case excluded for violation of inclusion criteria (transformed lymphoma)|33
8955781|NCT02495454|10019528|FG000|NOT COMPLETED|Overall Study||1
8955782|NCT02495467|10019535|FG000|STARTED|First Intervention (4 Weeks)||114
8955783|NCT02495467|10019536|FG001|STARTED|First Intervention (4 Weeks)||118
8955784|NCT02495467|10019535|FG000|COMPLETED|First Intervention (4 Weeks)||114
8955785|NCT02495467|10019536|FG001|COMPLETED|First Intervention (4 Weeks)|One subject completed visits in treatment Period 1 but never used treatment|118
8955786|NCT02495467|10019535|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0
8955787|NCT02495467|10019536|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0
8955788|NCT02495467|10019535|FG000|STARTED|Washout (1 Week)||114
8955789|NCT02495467|10019536|FG001|STARTED|Washout (1 Week)||118
8955790|NCT02495467|10019535|FG000|COMPLETED|Washout (1 Week)||112
8955791|NCT02495467|10019536|FG001|COMPLETED|Washout (1 Week)||116
8955792|NCT02495467|10019535|FG000|NOT COMPLETED|Washout (1 Week)||2
8955793|NCT02495467|10019536|FG001|NOT COMPLETED|Washout (1 Week)||2
8955794|NCT02495467|10019535|FG000|STARTED|Second Intervention (4 Weeks)||112
8955795|NCT02495467|10019536|FG001|STARTED|Second Intervention (4 Weeks)||116
8955796|NCT02495467|10019535|FG000|COMPLETED|Second Intervention (4 Weeks)||112
8955797|NCT02495467|10019536|FG001|COMPLETED|Second Intervention (4 Weeks)||113
8955798|NCT02495467|10019535|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0
8955799|NCT02495467|10019536|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||3
8955800|NCT02495623|10019545|FG000|STARTED|Overall Study||25
8955801|NCT02495623|10019546|FG001|STARTED|Overall Study||26
8955802|NCT02495623|10019547|FG002|STARTED|Overall Study||28
8955803|NCT02495623|10019545|FG000|Dosed|Overall Study||22
8955804|NCT02495623|10019546|FG001|Dosed|Overall Study||19
8955805|NCT02495623|10019547|FG002|Dosed|Overall Study||22
8955806|NCT02495623|10019545|FG000|COMPLETED|Overall Study||20
8955807|NCT02495623|10019546|FG001|COMPLETED|Overall Study||17
8955808|NCT02495623|10019547|FG002|COMPLETED|Overall Study||20
8955809|NCT02495623|10019545|FG000|NOT COMPLETED|Overall Study||5
8955810|NCT02495623|10019546|FG001|NOT COMPLETED|Overall Study||9
8955811|NCT02495623|10019547|FG002|NOT COMPLETED|Overall Study||8
8955812|NCT02495779|10019555|FG000|STARTED|Overall Study||54
8955813|NCT02495779|10019555|FG000|COMPLETED|Overall Study||48
8955814|NCT02495779|10019555|FG000|NOT COMPLETED|Overall Study||6
8955815|NCT02495831|10019559|FG000|STARTED|First Intervention||13
8955816|NCT02495831|10019560|FG001|STARTED|First Intervention||10
8955817|NCT02495831|10019559|FG000|COMPLETED|First Intervention||13
8955818|NCT02495831|10019560|FG001|COMPLETED|First Intervention||10
8955819|NCT02495831|10019559|FG000|NOT COMPLETED|First Intervention||0
8955820|NCT02495831|10019560|FG001|NOT COMPLETED|First Intervention||0
8955821|NCT02495831|10019559|FG000|STARTED|Second Intervention|One participant withdrew at the end of period 1|12
8955822|NCT02495831|10019560|FG001|STARTED|Second Intervention||10
8955823|NCT02495831|10019559|FG000|COMPLETED|Second Intervention||12
8955824|NCT02495831|10019560|FG001|COMPLETED|Second Intervention||10
8955825|NCT02495831|10019559|FG000|NOT COMPLETED|Second Intervention||0
8955826|NCT02495831|10019560|FG001|NOT COMPLETED|Second Intervention||0
8955827|NCT02495844|10019568|FG000|STARTED|Overall Study||27
8874801|NCT01904773|9931722|FG001|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8874802|NCT01904773|9931723|FG002|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8874803|NCT01904773|9931724|FG003|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8874804|NCT01904773|9931725|FG004|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8874805|NCT01904773|9931726|FG005|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8874806|NCT01904773|9931727|FG006|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8874807|NCT01904773|9931728|FG007|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8874808|NCT01904773|9931729|FG008|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8955828|NCT02495844|10019569|FG001|STARTED|Overall Study||28
8955829|NCT02495844|10019568|FG000|COMPLETED|Overall Study||26
8955830|NCT02495844|10019569|FG001|COMPLETED|Overall Study||24
8955831|NCT02495844|10019568|FG000|NOT COMPLETED|Overall Study||1
8955832|NCT02495844|10019569|FG001|NOT COMPLETED|Overall Study||4
8955833|NCT02495857|10019580|FG000|STARTED|Overall Study||200
8955834|NCT02495857|10019581|FG001|STARTED|Overall Study||200
8955835|NCT02495857|10019582|FG002|STARTED|Overall Study||199
8955836|NCT02495857|10019580|FG000|COMPLETED|Overall Study||178
8955837|NCT02495857|10019581|FG001|COMPLETED|Overall Study||184
8955838|NCT02495857|10019582|FG002|COMPLETED|Overall Study||181
8955839|NCT02495857|10019580|FG000|NOT COMPLETED|Overall Study||22
8955840|NCT02495857|10019581|FG001|NOT COMPLETED|Overall Study||16
8955841|NCT02495857|10019582|FG002|NOT COMPLETED|Overall Study||18
8955842|NCT02495883|10019592|FG000|STARTED|Overall Study||32
8955843|NCT02495883|10019593|FG001|STARTED|Overall Study||24
8955844|NCT02495883|10019592|FG000|COMPLETED|Overall Study||31
8955845|NCT02495883|10019593|FG001|COMPLETED|Overall Study||24
8955846|NCT02495883|10019592|FG000|NOT COMPLETED|Overall Study||1
8955847|NCT02495883|10019593|FG001|NOT COMPLETED|Overall Study||0
8955848|NCT02495948|10019598|FG000|STARTED|Period 1, First 30 Days of Wear||83
8955849|NCT02495948|10019599|FG001|STARTED|Period 1, First 30 Days of Wear||84
8955850|NCT02495948|10019598|FG000|COMPLETED|Period 1, First 30 Days of Wear||83
8955851|NCT02495948|10019599|FG001|COMPLETED|Period 1, First 30 Days of Wear||83
8955852|NCT02495948|10019598|FG000|NOT COMPLETED|Period 1, First 30 Days of Wear||0
8955853|NCT02495948|10019599|FG001|NOT COMPLETED|Period 1, First 30 Days of Wear||1
8955854|NCT02495948|10019598|FG000|STARTED|Period 2, Second 30 Days of Wear||83
8955855|NCT02495948|10019599|FG001|STARTED|Period 2, Second 30 Days of Wear||83
8955856|NCT02495948|10019598|FG000|COMPLETED|Period 2, Second 30 Days of Wear||82
8955857|NCT02495948|10019599|FG001|COMPLETED|Period 2, Second 30 Days of Wear||82
8955858|NCT02495948|10019598|FG000|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
8955859|NCT02495948|10019599|FG001|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
8955860|NCT02496000|10019609|FG000|STARTED|Overall Study||64
8955861|NCT02496000|10019610|FG001|STARTED|Overall Study||61
8955862|NCT02496000|10019611|FG002|STARTED|Overall Study||63
8955863|NCT02496000|10019609|FG000|COMPLETED|Overall Study||62
8955864|NCT02496000|10019610|FG001|COMPLETED|Overall Study||56
8955865|NCT02496000|10019611|FG002|COMPLETED|Overall Study||61
8955866|NCT02496000|10019609|FG000|NOT COMPLETED|Overall Study||2
8955867|NCT02496000|10019610|FG001|NOT COMPLETED|Overall Study||5
8955868|NCT02496000|10019611|FG002|NOT COMPLETED|Overall Study||2
8955869|NCT02496091|10019620|FG000|STARTED|Overall Study||144
8955870|NCT02496091|10019620|FG000|COMPLETED|Overall Study||142
8955871|NCT02496091|10019620|FG000|NOT COMPLETED|Overall Study||2
8955872|NCT02496221|10019625|FG000|STARTED|Treatment Period 1 - 4 Days||10
8955873|NCT02496221|10019626|FG001|STARTED|Treatment Period 1 - 4 Days||10
8955874|NCT02496221|10019625|FG000|COMPLETED|Treatment Period 1 - 4 Days||10
8955875|NCT02496221|10019626|FG001|COMPLETED|Treatment Period 1 - 4 Days||10
8955876|NCT02496221|10019625|FG000|NOT COMPLETED|Treatment Period 1 - 4 Days||0
8955877|NCT02496221|10019626|FG001|NOT COMPLETED|Treatment Period 1 - 4 Days||0
8955878|NCT02496221|10019625|FG000|STARTED|Treatment Period 2 - 4 Days||10
8955879|NCT02496221|10019626|FG001|STARTED|Treatment Period 2 - 4 Days||10
8955880|NCT02496221|10019625|FG000|COMPLETED|Treatment Period 2 - 4 Days||8
8955881|NCT02496221|10019626|FG001|COMPLETED|Treatment Period 2 - 4 Days||9
8955882|NCT02496221|10019625|FG000|NOT COMPLETED|Treatment Period 2 - 4 Days||2
8955883|NCT02496221|10019626|FG001|NOT COMPLETED|Treatment Period 2 - 4 Days||1
8955884|NCT02496533|10019636|FG000|STARTED|Overall Study||105
8955885|NCT02496533|10019637|FG001|STARTED|Overall Study||112
8955886|NCT02496533|10019636|FG000|COMPLETED|Overall Study||102
8955887|NCT02496533|10019637|FG001|COMPLETED|Overall Study||106
8955888|NCT02496533|10019636|FG000|NOT COMPLETED|Overall Study||3
8955889|NCT02496533|10019637|FG001|NOT COMPLETED|Overall Study||6
8955890|NCT02496702|10019645|FG000|STARTED|Overall Study||30
8955891|NCT02496702|10019646|FG001|STARTED|Overall Study||30
8955892|NCT02496702|10019645|FG000|Received Allocated Intervention|Overall Study||21
8955893|NCT02496702|10019646|FG001|Received Allocated Intervention|Overall Study||0
8955894|NCT02496702|10019645|FG000|Did Not Receive Allocated Intervention|Overall Study||9
8955895|NCT02496702|10019646|FG001|Did Not Receive Allocated Intervention|Overall Study||0
8955896|NCT02496702|10019645|FG000|COMPLETED|Overall Study||22
8955897|NCT02496702|10019646|FG001|COMPLETED|Overall Study||22
8955898|NCT02496702|10019645|FG000|NOT COMPLETED|Overall Study||8
8955899|NCT02496702|10019646|FG001|NOT COMPLETED|Overall Study||8
8955900|NCT02496767|10019656|FG000|STARTED|Open-label Lead-in Phase||744
8955901|NCT02496767|10019657|FG001|STARTED|Open-label Lead-in Phase||0
8955902|NCT02496767|10019658|FG002|STARTED|Open-label Lead-in Phase||0
8955903|NCT02496767|10019659|FG003|STARTED|Open-label Lead-in Phase||0
8955904|NCT02496767|10019660|FG004|STARTED|Open-label Lead-in Phase||0
8955905|NCT02496767|10019661|FG005|STARTED|Open-label Lead-in Phase||0
8955906|NCT02496767|10019662|FG006|STARTED|Open-label Lead-in Phase||0
8955907|NCT02496767|10019663|FG007|STARTED|Open-label Lead-in Phase||0
8955908|NCT02496767|10019656|FG000|COMPLETED|Open-label Lead-in Phase||565
8955909|NCT02496767|10019657|FG001|COMPLETED|Open-label Lead-in Phase||0
8955910|NCT02496767|10019658|FG002|COMPLETED|Open-label Lead-in Phase||0
8955911|NCT02496767|10019659|FG003|COMPLETED|Open-label Lead-in Phase||0
8955912|NCT02496767|10019660|FG004|COMPLETED|Open-label Lead-in Phase||0
8955913|NCT02496767|10019661|FG005|COMPLETED|Open-label Lead-in Phase||0
8955914|NCT02496767|10019662|FG006|COMPLETED|Open-label Lead-in Phase||0
8955915|NCT02496767|10019663|FG007|COMPLETED|Open-label Lead-in Phase||0
8955916|NCT02496767|10019656|FG000|NOT COMPLETED|Open-label Lead-in Phase||179
8955917|NCT02496767|10019657|FG001|NOT COMPLETED|Open-label Lead-in Phase||0
8955918|NCT02496767|10019658|FG002|NOT COMPLETED|Open-label Lead-in Phase||0
8955919|NCT02496767|10019659|FG003|NOT COMPLETED|Open-label Lead-in Phase||0
8955920|NCT02496767|10019660|FG004|NOT COMPLETED|Open-label Lead-in Phase||0
8955921|NCT02496767|10019661|FG005|NOT COMPLETED|Open-label Lead-in Phase||0
8955922|NCT02496767|10019662|FG006|NOT COMPLETED|Open-label Lead-in Phase||0
8955923|NCT02496767|10019663|FG007|NOT COMPLETED|Open-label Lead-in Phase||0
8955924|NCT02496767|10019656|FG000|STARTED|Double-blind, Placebo-controlled Phase||0
8955925|NCT02496767|10019657|FG001|STARTED|Double-blind, Placebo-controlled Phase||188
8955926|NCT02496767|10019658|FG002|STARTED|Double-blind, Placebo-controlled Phase||126
8955927|NCT02496767|10019659|FG003|STARTED|Double-blind, Placebo-controlled Phase||126
8955928|NCT02496767|10019660|FG004|STARTED|Double-blind, Placebo-controlled Phase||125
8955929|NCT02496767|10019661|FG005|STARTED|Double-blind, Placebo-controlled Phase||0
8955930|NCT02496767|10019662|FG006|STARTED|Double-blind, Placebo-controlled Phase||0
8955931|NCT02496767|10019663|FG007|STARTED|Double-blind, Placebo-controlled Phase||0
8955932|NCT02496767|10019656|FG000|COMPLETED|Double-blind, Placebo-controlled Phase||0
8955933|NCT02496767|10019657|FG001|COMPLETED|Double-blind, Placebo-controlled Phase||132
8955934|NCT02496767|10019658|FG002|COMPLETED|Double-blind, Placebo-controlled Phase||80
8955935|NCT02496767|10019659|FG003|COMPLETED|Double-blind, Placebo-controlled Phase||65
8955936|NCT02496767|10019660|FG004|COMPLETED|Double-blind, Placebo-controlled Phase||59
8955937|NCT02496767|10019661|FG005|COMPLETED|Double-blind, Placebo-controlled Phase||0
8955938|NCT02496767|10019662|FG006|COMPLETED|Double-blind, Placebo-controlled Phase||0
8955939|NCT02496767|10019663|FG007|COMPLETED|Double-blind, Placebo-controlled Phase||0
8955940|NCT02496767|10019656|FG000|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
8955941|NCT02496767|10019657|FG001|NOT COMPLETED|Double-blind, Placebo-controlled Phase||56
8955942|NCT02496767|10019658|FG002|NOT COMPLETED|Double-blind, Placebo-controlled Phase||46
8955943|NCT02496767|10019659|FG003|NOT COMPLETED|Double-blind, Placebo-controlled Phase||61
8955944|NCT02496767|10019660|FG004|NOT COMPLETED|Double-blind, Placebo-controlled Phase||66
8955945|NCT02496767|10019661|FG005|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
8955946|NCT02496767|10019662|FG006|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
8955947|NCT02496767|10019663|FG007|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
8955948|NCT02496767|10019656|FG000|STARTED|Double-blind, Withdrawal Phase||0
8955949|NCT02496767|10019657|FG001|STARTED|Double-blind, Withdrawal Phase||0
8955950|NCT02496767|10019658|FG002|STARTED|Double-blind, Withdrawal Phase||0
8955951|NCT02496767|10019659|FG003|STARTED|Double-blind, Withdrawal Phase||0
8955952|NCT02496767|10019660|FG004|STARTED|Double-blind, Withdrawal Phase||0
8955953|NCT02496767|10019661|FG005|STARTED|Double-blind, Withdrawal Phase||132
8955954|NCT02496767|10019662|FG006|STARTED|Double-blind, Withdrawal Phase||103
8955955|NCT02496767|10019663|FG007|STARTED|Double-blind, Withdrawal Phase||101
8955956|NCT02496767|10019656|FG000|COMPLETED|Double-blind, Withdrawal Phase||0
8955957|NCT02496767|10019657|FG001|COMPLETED|Double-blind, Withdrawal Phase||0
8955958|NCT02496767|10019658|FG002|COMPLETED|Double-blind, Withdrawal Phase||0
8955959|NCT02496767|10019659|FG003|COMPLETED|Double-blind, Withdrawal Phase||0
8955960|NCT02496767|10019660|FG004|COMPLETED|Double-blind, Withdrawal Phase||0
8955961|NCT02496767|10019661|FG005|COMPLETED|Double-blind, Withdrawal Phase||126
8955962|NCT02496767|10019662|FG006|COMPLETED|Double-blind, Withdrawal Phase||99
8955963|NCT02496767|10019663|FG007|COMPLETED|Double-blind, Withdrawal Phase||96
8955964|NCT02496767|10019656|FG000|NOT COMPLETED|Double-blind, Withdrawal Phase||0
8955965|NCT02496767|10019657|FG001|NOT COMPLETED|Double-blind, Withdrawal Phase||0
8955966|NCT02496767|10019658|FG002|NOT COMPLETED|Double-blind, Withdrawal Phase||0
8955967|NCT02496767|10019659|FG003|NOT COMPLETED|Double-blind, Withdrawal Phase||0
8955968|NCT02496767|10019660|FG004|NOT COMPLETED|Double-blind, Withdrawal Phase||0
8955969|NCT02496767|10019661|FG005|NOT COMPLETED|Double-blind, Withdrawal Phase||6
8955970|NCT02496767|10019662|FG006|NOT COMPLETED|Double-blind, Withdrawal Phase||4
8955971|NCT02496767|10019663|FG007|NOT COMPLETED|Double-blind, Withdrawal Phase||5
8955972|NCT02496884|10019681|FG000|STARTED|Overall Study||17
8955973|NCT02496884|10019682|FG001|STARTED|Overall Study||34
8955974|NCT02496884|10019683|FG002|STARTED|Overall Study||1
8955975|NCT02496884|10019684|FG003|STARTED|Overall Study||4
8955976|NCT02496884|10019681|FG000|Safety Analysis Set|Overall Study||17
8955977|NCT02496884|10019682|FG001|Safety Analysis Set|Overall Study||34
8955978|NCT02496884|10019683|FG002|Safety Analysis Set|Overall Study||1
8955979|NCT02496884|10019684|FG003|Safety Analysis Set|Overall Study||4
8955980|NCT02496884|10019681|FG000|Modified Intent to Treat Set (mITT)|Overall Study||17
8955981|NCT02496884|10019682|FG001|Modified Intent to Treat Set (mITT)|Overall Study||34
8955982|NCT02496884|10019683|FG002|Modified Intent to Treat Set (mITT)|Overall Study||1
8955983|NCT02496884|10019684|FG003|Modified Intent to Treat Set (mITT)|Overall Study||4
8955984|NCT02496884|10019681|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||0
8955985|NCT02496884|10019682|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||33
8955986|NCT02496884|10019683|FG002|Pharmacokinetic (PK) Analysis Set|Overall Study||0
8955987|NCT02496884|10019684|FG003|Pharmacokinetic (PK) Analysis Set|Overall Study||4
8955988|NCT02496884|10019681|FG000|Completed Treatment Per Protocol|Overall Study||16
8955989|NCT02496884|10019682|FG001|Completed Treatment Per Protocol|Overall Study||27
8955990|NCT02496884|10019683|FG002|Completed Treatment Per Protocol|Overall Study||1
8955991|NCT02496884|10019684|FG003|Completed Treatment Per Protocol|Overall Study||3
8955992|NCT02496884|10019681|FG000|COMPLETED|Overall Study||15
8955993|NCT02496884|10019682|FG001|COMPLETED|Overall Study||31
8955994|NCT02496884|10019683|FG002|COMPLETED|Overall Study||1
8955995|NCT02496884|10019684|FG003|COMPLETED|Overall Study||4
8955996|NCT02496884|10019681|FG000|NOT COMPLETED|Overall Study||2
8955997|NCT02496884|10019682|FG001|NOT COMPLETED|Overall Study||3
8955998|NCT02496884|10019683|FG002|NOT COMPLETED|Overall Study||0
8955999|NCT02496884|10019684|FG003|NOT COMPLETED|Overall Study||0
8956000|NCT02497001|10019698|FG000|STARTED|Overall Study||640
8956001|NCT02497001|10019699|FG001|STARTED|Overall Study||627
8956002|NCT02497001|10019700|FG002|STARTED|Overall Study||316
8956003|NCT02497001|10019701|FG003|STARTED|Overall Study||319
8956004|NCT02497001|10019698|FG000|COMPLETED|Overall Study||566
8956005|NCT02497001|10019699|FG001|COMPLETED|Overall Study||524
8956006|NCT02497001|10019700|FG002|COMPLETED|Overall Study||266
8956007|NCT02497001|10019701|FG003|COMPLETED|Overall Study||278
8956008|NCT02497001|10019698|FG000|NOT COMPLETED|Overall Study||74
8956009|NCT02497001|10019699|FG001|NOT COMPLETED|Overall Study||103
8956010|NCT02497001|10019700|FG002|NOT COMPLETED|Overall Study||50
8956011|NCT02497001|10019701|FG003|NOT COMPLETED|Overall Study||41
8956012|NCT02497040|10019717|FG000|STARTED|Overall Study||30
8956013|NCT02497040|10019718|FG001|STARTED|Overall Study||30
8956014|NCT02497040|10019719|FG002|STARTED|Overall Study||30
8956015|NCT02497040|10019717|FG000|COMPLETED|Overall Study||30
8956016|NCT02497040|10019718|FG001|COMPLETED|Overall Study||30
8956017|NCT02497040|10019719|FG002|COMPLETED|Overall Study||30
8956018|NCT02497040|10019717|FG000|NOT COMPLETED|Overall Study||0
8956019|NCT02497040|10019718|FG001|NOT COMPLETED|Overall Study||0
8956020|NCT02497040|10019719|FG002|NOT COMPLETED|Overall Study||0
8956021|NCT02497235|10019732|FG000|STARTED|Overall Study||2
8956022|NCT02497235|10019733|FG001|STARTED|Overall Study||2
8956023|NCT02497235|10019734|FG002|STARTED|Overall Study||2
8956024|NCT02497235|10019735|FG003|STARTED|Overall Study||2
8956025|NCT02497235|10019736|FG004|STARTED|Overall Study||3
8956026|NCT02497235|10019732|FG000|COMPLETED|Overall Study||2
8956027|NCT02497235|10019733|FG001|COMPLETED|Overall Study||2
8956028|NCT02497235|10019734|FG002|COMPLETED|Overall Study||2
8956029|NCT02497235|10019735|FG003|COMPLETED|Overall Study||2
8956030|NCT02497235|10019736|FG004|COMPLETED|Overall Study||3
8956031|NCT02497235|10019732|FG000|NOT COMPLETED|Overall Study||0
8956032|NCT02497235|10019733|FG001|NOT COMPLETED|Overall Study||0
8956033|NCT02497235|10019734|FG002|NOT COMPLETED|Overall Study||0
8956034|NCT02497235|10019735|FG003|NOT COMPLETED|Overall Study||0
8956035|NCT02497235|10019736|FG004|NOT COMPLETED|Overall Study||0
8956036|NCT02497287|10019751|FG000|STARTED|Induction Phase (4 Weeks)|Included DE participants (691) and non-responders from TRD3005 (88).|779
8956037|NCT02497287|10019751|FG000|COMPLETED|Induction Phase (4 Weeks)||580
8956038|NCT02497287|10019751|FG000|NOT COMPLETED|Induction Phase (4 Weeks)||199
8956039|NCT02497287|10019751|FG000|STARTED|Optimization/Maintenance (48 Weeks)|Included who completed IND phase (580) + responders from TRD3005 (23).|603
8956040|NCT02497287|10019751|FG000|COMPLETED|Optimization/Maintenance (48 Weeks)||150
8956041|NCT02497287|10019751|FG000|NOT COMPLETED|Optimization/Maintenance (48 Weeks)||453
8956042|NCT02497287|10019751|FG000|STARTED|Follow-up Phase (4 Week)|Included non-responders (IND phase) or discontinued treatment phase or completed OP/MA phase.|357
8956043|NCT02497287|10019751|FG000|COMPLETED|Follow-up Phase (4 Week)||326
8956044|NCT02497287|10019751|FG000|NOT COMPLETED|Follow-up Phase (4 Week)||31
8956045|NCT02497391|10019757|FG000|STARTED|Period 1 (14 Days)||16
8956046|NCT02497391|10019758|FG001|STARTED|Period 1 (14 Days)||15
8956047|NCT02497391|10019759|FG002|STARTED|Period 1 (14 Days)||16
8956048|NCT02497391|10019760|FG003|STARTED|Period 1 (14 Days)||16
8956049|NCT02497391|10019761|FG004|STARTED|Period 1 (14 Days)||16
8956050|NCT02497391|10019762|FG005|STARTED|Period 1 (14 Days)||16
8956051|NCT02497391|10019757|FG000|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
8956052|NCT02497391|10019758|FG001|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||15
8956053|NCT02497391|10019759|FG002|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
8956054|NCT02497391|10019760|FG003|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
8956055|NCT02497391|10019761|FG004|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
8956056|NCT02497391|10019762|FG005|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
8956057|NCT02497391|10019757|FG000|COMPLETED|Period 1 (14 Days)||16
8956058|NCT02497391|10019758|FG001|COMPLETED|Period 1 (14 Days)||15
8956059|NCT02497391|10019759|FG002|COMPLETED|Period 1 (14 Days)||16
8956060|NCT02497391|10019760|FG003|COMPLETED|Period 1 (14 Days)||16
8956061|NCT02497391|10019761|FG004|COMPLETED|Period 1 (14 Days)||16
8956062|NCT02497391|10019762|FG005|COMPLETED|Period 1 (14 Days)||16
8956063|NCT02497391|10019757|FG000|NOT COMPLETED|Period 1 (14 Days)||0
8956064|NCT02497391|10019758|FG001|NOT COMPLETED|Period 1 (14 Days)||0
8956065|NCT02497391|10019759|FG002|NOT COMPLETED|Period 1 (14 Days)||0
8956066|NCT02497391|10019760|FG003|NOT COMPLETED|Period 1 (14 Days)||0
8956067|NCT02497391|10019761|FG004|NOT COMPLETED|Period 1 (14 Days)||0
8956068|NCT02497391|10019762|FG005|NOT COMPLETED|Period 1 (14 Days)||0
8956069|NCT02497391|10019757|FG000|STARTED|Period 2 (14 Days)||16
8956070|NCT02497391|10019758|FG001|STARTED|Period 2 (14 Days)||15
8956071|NCT02497391|10019759|FG002|STARTED|Period 2 (14 Days)||16
8956072|NCT02497391|10019760|FG003|STARTED|Period 2 (14 Days)||16
8956073|NCT02497391|10019761|FG004|STARTED|Period 2 (14 Days)||16
8956074|NCT02497391|10019762|FG005|STARTED|Period 2 (14 Days)||16
8956075|NCT02497391|10019757|FG000|COMPLETED|Period 2 (14 Days)||12
8956076|NCT02497391|10019758|FG001|COMPLETED|Period 2 (14 Days)||14
8956077|NCT02497391|10019759|FG002|COMPLETED|Period 2 (14 Days)||13
8956078|NCT02497391|10019760|FG003|COMPLETED|Period 2 (14 Days)||13
8956079|NCT02497391|10019761|FG004|COMPLETED|Period 2 (14 Days)||14
8956080|NCT02497391|10019762|FG005|COMPLETED|Period 2 (14 Days)||13
8956081|NCT02497391|10019757|FG000|NOT COMPLETED|Period 2 (14 Days)||4
8956082|NCT02497391|10019758|FG001|NOT COMPLETED|Period 2 (14 Days)||1
8956083|NCT02497391|10019759|FG002|NOT COMPLETED|Period 2 (14 Days)||3
8956084|NCT02497391|10019760|FG003|NOT COMPLETED|Period 2 (14 Days)||3
8956085|NCT02497391|10019761|FG004|NOT COMPLETED|Period 2 (14 Days)||2
8956086|NCT02497391|10019762|FG005|NOT COMPLETED|Period 2 (14 Days)||3
8956087|NCT02497391|10019757|FG000|STARTED|Period 3 (14 Days)||12
8956088|NCT02497391|10019758|FG001|STARTED|Period 3 (14 Days)||14
8956089|NCT02497391|10019759|FG002|STARTED|Period 3 (14 Days)||13
8956090|NCT02497391|10019760|FG003|STARTED|Period 3 (14 Days)||13
8956091|NCT02497391|10019761|FG004|STARTED|Period 3 (14 Days)||14
8956092|NCT02497391|10019762|FG005|STARTED|Period 3 (14 Days)||13
8956093|NCT02497391|10019757|FG000|COMPLETED|Period 3 (14 Days)||12
8956094|NCT02497391|10019758|FG001|COMPLETED|Period 3 (14 Days)||13
8956095|NCT02497391|10019759|FG002|COMPLETED|Period 3 (14 Days)||12
8956096|NCT02497391|10019760|FG003|COMPLETED|Period 3 (14 Days)||13
8956097|NCT02497391|10019761|FG004|COMPLETED|Period 3 (14 Days)||13
8956098|NCT02497391|10019762|FG005|COMPLETED|Period 3 (14 Days)||13
8956099|NCT02497391|10019757|FG000|NOT COMPLETED|Period 3 (14 Days)||0
8956100|NCT02497391|10019758|FG001|NOT COMPLETED|Period 3 (14 Days)||1
8956101|NCT02497391|10019759|FG002|NOT COMPLETED|Period 3 (14 Days)||1
8956102|NCT02497391|10019760|FG003|NOT COMPLETED|Period 3 (14 Days)||0
8956103|NCT02497391|10019761|FG004|NOT COMPLETED|Period 3 (14 Days)||1
8956104|NCT02497391|10019762|FG005|NOT COMPLETED|Period 3 (14 Days)||0
8956105|NCT02497404|10019770|FG000|STARTED|Overall Study||40
8956106|NCT02497404|10019770|FG000|COMPLETED|Overall Study||39
8956107|NCT02497404|10019770|FG000|NOT COMPLETED|Overall Study||1
8956108|NCT02497469|10019776|FG000|STARTED|Overall Study||386
8956109|NCT02497469|10019777|FG001|STARTED|Overall Study||385
8956110|NCT02497469|10019776|FG000|Safety Analysis Set|Overall Study||386
8956111|NCT02497469|10019777|FG001|Safety Analysis Set|Overall Study||383
8956112|NCT02497469|10019776|FG000|COMPLETED|Overall Study||217
8956113|NCT02497469|10019777|FG001|COMPLETED|Overall Study||270
8956114|NCT02497469|10019776|FG000|NOT COMPLETED|Overall Study||169
8956115|NCT02497469|10019777|FG001|NOT COMPLETED|Overall Study||115
8956116|NCT02497755|10019785|FG000|STARTED|Overall Study||18
8956117|NCT02497755|10019786|FG001|STARTED|Overall Study||1
8956118|NCT02497755|10019785|FG000|COMPLETED|Overall Study||17
8956119|NCT02497755|10019786|FG001|COMPLETED|Overall Study||1
8956120|NCT02497755|10019785|FG000|NOT COMPLETED|Overall Study||1
8956121|NCT02497755|10019786|FG001|NOT COMPLETED|Overall Study||0
8956122|NCT02497781|10019795|FG000|STARTED|Overall Study||68
8956123|NCT02497781|10019796|FG001|STARTED|Overall Study||29
8956124|NCT02497781|10019795|FG000|Treated|Overall Study||67
8956125|NCT02497781|10019796|FG001|Treated|Overall Study||28
8956126|NCT02497781|10019795|FG000|COMPLETED|Overall Study||64
8956127|NCT02497781|10019796|FG001|COMPLETED|Overall Study||26
8956128|NCT02497781|10019795|FG000|NOT COMPLETED|Overall Study||4
8956129|NCT02497781|10019796|FG001|NOT COMPLETED|Overall Study||3
8956130|NCT02497937|10019802|FG000|STARTED|Period 1 (Up to 7 Days)||6
8956131|NCT02497937|10019803|FG001|STARTED|Period 1 (Up to 7 Days)||5
8956132|NCT02497937|10019802|FG000|COMPLETED|Period 1 (Up to 7 Days)||6
8956133|NCT02497937|10019803|FG001|COMPLETED|Period 1 (Up to 7 Days)||5
8956134|NCT02497937|10019802|FG000|NOT COMPLETED|Period 1 (Up to 7 Days)||0
8956135|NCT02497937|10019803|FG001|NOT COMPLETED|Period 1 (Up to 7 Days)||0
8956136|NCT02497937|10019802|FG000|STARTED|Washout Period (Up to 14 Days)||6
8956137|NCT02497937|10019803|FG001|STARTED|Washout Period (Up to 14 Days)||5
8956138|NCT02497937|10019802|FG000|COMPLETED|Washout Period (Up to 14 Days)||6
8956139|NCT02497937|10019803|FG001|COMPLETED|Washout Period (Up to 14 Days)||5
8956140|NCT02497937|10019802|FG000|NOT COMPLETED|Washout Period (Up to 14 Days)||0
8956141|NCT02497937|10019803|FG001|NOT COMPLETED|Washout Period (Up to 14 Days)||0
8956142|NCT02497937|10019802|FG000|STARTED|Period 2 (Up to 7 Days)||6
8956143|NCT02497937|10019803|FG001|STARTED|Period 2 (Up to 7 Days)||5
8956144|NCT02497937|10019802|FG000|COMPLETED|Period 2 (Up to 7 Days)||6
8956145|NCT02497937|10019803|FG001|COMPLETED|Period 2 (Up to 7 Days)||5
8956146|NCT02497937|10019802|FG000|NOT COMPLETED|Period 2 (Up to 7 Days)||0
8956147|NCT02497937|10019803|FG001|NOT COMPLETED|Period 2 (Up to 7 Days)||0
8956148|NCT02497976|10019812|FG000|STARTED|Overall Study||28
8956149|NCT02497976|10019813|FG001|STARTED|Overall Study||14
8956150|NCT02497976|10019812|FG000|COMPLETED|Overall Study||26
8956151|NCT02497976|10019813|FG001|COMPLETED|Overall Study||13
8956152|NCT02497976|10019812|FG000|NOT COMPLETED|Overall Study||2
8956153|NCT02497976|10019813|FG001|NOT COMPLETED|Overall Study||1
8956154|NCT02498067|10019819|FG000|STARTED|Overall Study||104
8956155|NCT02498067|10019819|FG000|COMPLETED|Overall Study||71
8956156|NCT02498067|10019819|FG000|NOT COMPLETED|Overall Study||33
8956157|NCT02498236|10019833|FG000|STARTED|Overall Study||6
8956158|NCT02498236|10019834|FG001|STARTED|Overall Study||6
8956159|NCT02498236|10019835|FG002|STARTED|Overall Study||6
8956160|NCT02498236|10019836|FG003|STARTED|Overall Study||6
8956161|NCT02498236|10019837|FG004|STARTED|Overall Study||7
8956162|NCT02498236|10019838|FG005|STARTED|Overall Study||6
8956163|NCT02498236|10019839|FG006|STARTED|Overall Study||7
8956164|NCT02498236|10019840|FG007|STARTED|Overall Study||7
8956165|NCT02498236|10019833|FG000|Randomized|Overall Study||6
8956166|NCT02498236|10019834|FG001|Randomized|Overall Study||6
8956167|NCT02498236|10019835|FG002|Randomized|Overall Study||6
8956168|NCT02498236|10019836|FG003|Randomized|Overall Study||6
8956169|NCT02498236|10019837|FG004|Randomized|Overall Study||7
8956170|NCT02498236|10019838|FG005|Randomized|Overall Study||6
8956171|NCT02498236|10019839|FG006|Randomized|Overall Study||7
8956172|NCT02498236|10019840|FG007|Randomized|Overall Study||7
8956173|NCT02498236|10019833|FG000|COMPLETED|Overall Study||5
8956174|NCT02498236|10019834|FG001|COMPLETED|Overall Study||6
8956175|NCT02498236|10019835|FG002|COMPLETED|Overall Study||6
8956176|NCT02498236|10019836|FG003|COMPLETED|Overall Study||6
8956177|NCT02498236|10019837|FG004|COMPLETED|Overall Study||6
8956178|NCT02498236|10019838|FG005|COMPLETED|Overall Study||6
8956179|NCT02498236|10019839|FG006|COMPLETED|Overall Study||6
8956180|NCT02498236|10019840|FG007|COMPLETED|Overall Study||6
8956181|NCT02498236|10019833|FG000|NOT COMPLETED|Overall Study||1
8956182|NCT02498236|10019834|FG001|NOT COMPLETED|Overall Study||0
8956183|NCT02498236|10019835|FG002|NOT COMPLETED|Overall Study||0
8956184|NCT02498236|10019836|FG003|NOT COMPLETED|Overall Study||0
8956185|NCT02498236|10019837|FG004|NOT COMPLETED|Overall Study||1
8956186|NCT02498236|10019838|FG005|NOT COMPLETED|Overall Study||0
8956187|NCT02498236|10019839|FG006|NOT COMPLETED|Overall Study||1
8956188|NCT02498236|10019840|FG007|NOT COMPLETED|Overall Study||1
8956189|NCT02498418|10019864|FG000|STARTED|Overall Study||247
8956190|NCT02498418|10019865|FG001|STARTED|Overall Study||248
8956191|NCT02498418|10019866|FG002|STARTED|Overall Study||244
8956192|NCT02498418|10019864|FG000|Safety Population|Overall Study||246
8570175|NCT00101686|9602315|FG002|COMPLETED|Overall Study|Patients treated until disease progression.|0
8956193|NCT02498418|10019865|FG001|Safety Population|Overall Study||247
8956194|NCT02498418|10019866|FG002|Safety Population|Overall Study||244
8956195|NCT02498418|10019864|FG000|Modified Intent-to-treat Population|Overall Study||183
8956196|NCT02498418|10019865|FG001|Modified Intent-to-treat Population|Overall Study||186
8956197|NCT02498418|10019866|FG002|Modified Intent-to-treat Population|Overall Study||180
8956198|NCT02498418|10019864|FG000|Per-protocol Analysis Set|Overall Study||182
8956199|NCT02498418|10019865|FG001|Per-protocol Analysis Set|Overall Study||181
8956200|NCT02498418|10019866|FG002|Per-protocol Analysis Set|Overall Study||176
8956201|NCT02498418|10019864|FG000|COMPLETED|Overall Study||245
8956202|NCT02498418|10019865|FG001|COMPLETED|Overall Study||246
8956203|NCT02498418|10019866|FG002|COMPLETED|Overall Study||238
8956204|NCT02498418|10019864|FG000|NOT COMPLETED|Overall Study||2
8956205|NCT02498418|10019865|FG001|NOT COMPLETED|Overall Study||2
8956206|NCT02498418|10019866|FG002|NOT COMPLETED|Overall Study||6
8956207|NCT02498483|10019876|FG000|STARTED|Overall Study||6
8956208|NCT02498483|10019877|FG001|STARTED|Overall Study||5
8956209|NCT02498483|10019876|FG000|COMPLETED|Overall Study||6
8956210|NCT02498483|10019877|FG001|COMPLETED|Overall Study||5
8956211|NCT02498483|10019876|FG000|NOT COMPLETED|Overall Study||0
8956212|NCT02498483|10019877|FG001|NOT COMPLETED|Overall Study||0
8956213|NCT02498522|10019885|FG000|STARTED|Overall Study||85
8956214|NCT02498522|10019886|FG001|STARTED|Overall Study||85
8956215|NCT02498522|10019885|FG000|COMPLETED|Overall Study||83
8956216|NCT02498522|10019886|FG001|COMPLETED|Overall Study||83
8956217|NCT02498522|10019885|FG000|NOT COMPLETED|Overall Study||2
8956218|NCT02498522|10019886|FG001|NOT COMPLETED|Overall Study||2
8956219|NCT02498652|10019894|FG000|STARTED|Overall Study||20
8956220|NCT02498652|10019895|FG001|STARTED|Overall Study||21
8956221|NCT02498652|10019894|FG000|COMPLETED|Overall Study||20
8956222|NCT02498652|10019895|FG001|COMPLETED|Overall Study|One subject was withdrawn due to noncompliance/protocol violation|20
8956223|NCT02498652|10019894|FG000|NOT COMPLETED|Overall Study||0
8956224|NCT02498652|10019895|FG001|NOT COMPLETED|Overall Study||1
8956225|NCT02498678|10019921|FG000|STARTED|Overall Study||25
8956226|NCT02498678|10019922|FG001|STARTED|Overall Study||25
8956227|NCT02498678|10019921|FG000|COMPLETED|Overall Study||25
8956228|NCT02498678|10019922|FG001|COMPLETED|Overall Study||23
8956229|NCT02498678|10019921|FG000|NOT COMPLETED|Overall Study||0
8956230|NCT02498678|10019922|FG001|NOT COMPLETED|Overall Study||2
8956231|NCT02498769|10019930|FG000|STARTED|Overall Study||63
8956232|NCT02498769|10019931|FG001|STARTED|Overall Study||67
8956233|NCT02498769|10019930|FG000|COMPLETED|Overall Study||63
8956234|NCT02498769|10019931|FG001|COMPLETED|Overall Study||67
8956235|NCT02498769|10019930|FG000|NOT COMPLETED|Overall Study||0
8956236|NCT02498769|10019931|FG001|NOT COMPLETED|Overall Study||0
8956237|NCT02498821|10019939|FG000|STARTED|Overall Study||63
8956238|NCT02498821|10019940|FG001|STARTED|Overall Study||65
8956239|NCT02498821|10019939|FG000|COMPLETED|Overall Study||60
8956240|NCT02498821|10019940|FG001|COMPLETED|Overall Study||60
8956241|NCT02498821|10019939|FG000|NOT COMPLETED|Overall Study||3
8956242|NCT02498821|10019940|FG001|NOT COMPLETED|Overall Study||5
8956243|NCT02498834|10019948|FG000|STARTED|Overall Study||185
8956244|NCT02498834|10019949|FG001|STARTED|Overall Study||174
8956245|NCT02498834|10019948|FG000|COMPLETED|Overall Study||175
8956246|NCT02498834|10019949|FG001|COMPLETED|Overall Study||164
8956247|NCT02498834|10019948|FG000|NOT COMPLETED|Overall Study||10
8956248|NCT02498834|10019949|FG001|NOT COMPLETED|Overall Study||10
8956249|NCT02499029|10019957|FG000|STARTED|Overall Study||18
8956250|NCT02499029|10019958|FG001|STARTED|Overall Study||17
8956251|NCT02499029|10019957|FG000|COMPLETED|Overall Study||13
8956252|NCT02499029|10019958|FG001|COMPLETED|Overall Study||14
8956253|NCT02499029|10019957|FG000|NOT COMPLETED|Overall Study||5
8956254|NCT02499029|10019958|FG001|NOT COMPLETED|Overall Study||3
8956255|NCT02499081|10019964|FG000|STARTED|Overall Study||20
8956256|NCT02499081|10019964|FG000|COMPLETED|Overall Study||1
8956257|NCT02499081|10019964|FG000|NOT COMPLETED|Overall Study||19
8956258|NCT02499120|10019970|FG000|STARTED|Overall Study||65
8956259|NCT02499120|10019971|FG001|STARTED|Overall Study||60
8956260|NCT02499120|10019970|FG000|Received Treatment|Overall Study||64
8956261|NCT02499120|10019971|FG001|Received Treatment|Overall Study||60
8956262|NCT02499120|10019970|FG000|COMPLETED|Overall Study||0
8956263|NCT02499120|10019971|FG001|COMPLETED|Overall Study||0
8956264|NCT02499120|10019970|FG000|NOT COMPLETED|Overall Study||65
8956265|NCT02499120|10019971|FG001|NOT COMPLETED|Overall Study||60
8956266|NCT02499146|10019977|FG000|STARTED|Overall Study||26
8956267|NCT02499146|10019977|FG000|COMPLETED|Overall Study||0
8956268|NCT02499146|10019977|FG000|NOT COMPLETED|Overall Study||26
8956269|NCT02499159|10019983|FG000|STARTED|Randomization||50
8956270|NCT02499159|10019984|FG001|STARTED|Randomization||50
8956271|NCT02499159|10019983|FG000|COMPLETED|Randomization||49
8956272|NCT02499159|10019984|FG001|COMPLETED|Randomization||49
8956273|NCT02499159|10019983|FG000|NOT COMPLETED|Randomization||1
8956274|NCT02499159|10019984|FG001|NOT COMPLETED|Randomization||1
8956275|NCT02499159|10019983|FG000|STARTED|30-Day Follow-Up Phone Call||49
8956276|NCT02499159|10019984|FG001|STARTED|30-Day Follow-Up Phone Call||49
8956277|NCT02499159|10019983|FG000|COMPLETED|30-Day Follow-Up Phone Call||42
8956278|NCT02499159|10019984|FG001|COMPLETED|30-Day Follow-Up Phone Call||47
8956279|NCT02499159|10019983|FG000|NOT COMPLETED|30-Day Follow-Up Phone Call||7
8956280|NCT02499159|10019984|FG001|NOT COMPLETED|30-Day Follow-Up Phone Call||2
8956281|NCT02499172|10019994|FG000|STARTED|Overall Study||900
8956282|NCT02499172|10019995|FG001|STARTED|Overall Study||899
8956283|NCT02499172|10019996|FG002|STARTED|Overall Study||523
8956284|NCT02499172|10019997|FG003|STARTED|Overall Study||436
8956285|NCT02499172|10019994|FG000|COMPLETED|Overall Study||835
8956286|NCT02499172|10019995|FG001|COMPLETED|Overall Study||835
8956287|NCT02499172|10019996|FG002|COMPLETED|Overall Study||0
8956288|NCT02499172|10019997|FG003|COMPLETED|Overall Study||0
8956289|NCT02499172|10019994|FG000|NOT COMPLETED|Overall Study||65
8956290|NCT02499172|10019995|FG001|NOT COMPLETED|Overall Study||64
8956291|NCT02499172|10019996|FG002|NOT COMPLETED|Overall Study||523
8956292|NCT02499172|10019997|FG003|NOT COMPLETED|Overall Study||436
8956293|NCT02499263|10020007|FG000|STARTED|Overall Study||146
8956294|NCT02499263|10020007|FG000|COMPLETED|Overall Study||84
8956295|NCT02499263|10020007|FG000|NOT COMPLETED|Overall Study||62
8956296|NCT02499380|10020011|FG000|STARTED|Overall Study||20
8956297|NCT02499380|10020011|FG000|COMPLETED|Overall Study||17
8956298|NCT02499380|10020011|FG000|NOT COMPLETED|Overall Study||3
8956299|NCT02499406|10020015|FG000|STARTED|Overall Study||17
8956300|NCT02499406|10020015|FG000|COMPLETED|Overall Study||13
8956301|NCT02499406|10020015|FG000|NOT COMPLETED|Overall Study||4
8956302|NCT02499497|10020023|FG000|STARTED|Overall Study||36
8956303|NCT02499497|10020024|FG001|STARTED|Overall Study||28
8956304|NCT02499497|10020025|FG002|STARTED|Overall Study||36
8956305|NCT02499497|10020026|FG003|STARTED|Overall Study||14
8956306|NCT02499497|10020023|FG000|COMPLETED|Overall Study||32
8956307|NCT02499497|10020024|FG001|COMPLETED|Overall Study||22
8956308|NCT02499497|10020025|FG002|COMPLETED|Overall Study||35
8956309|NCT02499497|10020026|FG003|COMPLETED|Overall Study||13
8956310|NCT02499497|10020023|FG000|NOT COMPLETED|Overall Study||4
8956311|NCT02499497|10020024|FG001|NOT COMPLETED|Overall Study||6
8956312|NCT02499497|10020025|FG002|NOT COMPLETED|Overall Study||1
8956313|NCT02499497|10020026|FG003|NOT COMPLETED|Overall Study||1
8956314|NCT02499575|10020038|FG000|STARTED|Overall Study||1
8956315|NCT02499575|10020039|FG001|STARTED|Overall Study||1
8956316|NCT02499575|10020038|FG000|COMPLETED|Overall Study||1
8956317|NCT02499575|10020039|FG001|COMPLETED|Overall Study||0
8956318|NCT02499575|10020038|FG000|NOT COMPLETED|Overall Study||0
8956319|NCT02499575|10020039|FG001|NOT COMPLETED|Overall Study||1
8956320|NCT02499692|10020045|FG000|STARTED|Overall Study||103
8956321|NCT02499692|10020045|FG000|COMPLETED|Overall Study||103
8956322|NCT02499692|10020045|FG000|NOT COMPLETED|Overall Study||0
8956323|NCT02499770|10020051|FG000|STARTED|Overall Study||19
8956324|NCT02499770|10020052|FG001|STARTED|Overall Study||77
8956325|NCT02499770|10020051|FG000|COMPLETED|Overall Study||0
8956326|NCT02499770|10020052|FG001|COMPLETED|Overall Study||0
8956327|NCT02499770|10020051|FG000|NOT COMPLETED|Overall Study||19
8956328|NCT02499770|10020052|FG001|NOT COMPLETED|Overall Study||77
8956329|NCT02499783|10020066|FG000|STARTED|DB Period/Placebo-Controlled: Weeks 0-4||102
8956330|NCT02499783|10020067|FG001|STARTED|DB Period/Placebo-Controlled: Weeks 0-4||103
8956331|NCT02499783|10020068|FG002|STARTED|DB Period/Placebo-Controlled: Weeks 0-4||0
8956332|NCT02499783|10020066|FG000|COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||98
8956333|NCT02499783|10020067|FG001|COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||98
8956334|NCT02499783|10020068|FG002|COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||0
8956335|NCT02499783|10020066|FG000|NOT COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||4
8956336|NCT02499783|10020067|FG001|NOT COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||5
8956337|NCT02499783|10020068|FG002|NOT COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||0
8956338|NCT02499783|10020066|FG000|STARTED|DB Period: Weeks 0-8||102
8956339|NCT02499783|10020067|FG001|STARTED|DB Period: Weeks 0-8||103
8956340|NCT02499783|10020068|FG002|STARTED|DB Period: Weeks 0-8||0
8956341|NCT02499783|10020066|FG000|COMPLETED|DB Period: Weeks 0-8||92
8956342|NCT02499783|10020067|FG001|COMPLETED|DB Period: Weeks 0-8||96
8956343|NCT02499783|10020068|FG002|COMPLETED|DB Period: Weeks 0-8||0
8956344|NCT02499783|10020066|FG000|NOT COMPLETED|DB Period: Weeks 0-8||10
8956345|NCT02499783|10020067|FG001|NOT COMPLETED|DB Period: Weeks 0-8||7
8956346|NCT02499783|10020068|FG002|NOT COMPLETED|DB Period: Weeks 0-8||0
8956347|NCT02499783|10020066|FG000|STARTED|Open Label Period: Weeks 8 to 26||0
8956348|NCT02499783|10020067|FG001|STARTED|Open Label Period: Weeks 8 to 26||0
8956349|NCT02499783|10020068|FG002|STARTED|Open Label Period: Weeks 8 to 26||188
8956350|NCT02499783|10020066|FG000|COMPLETED|Open Label Period: Weeks 8 to 26||0
8956351|NCT02499783|10020067|FG001|COMPLETED|Open Label Period: Weeks 8 to 26||0
8956352|NCT02499783|10020068|FG002|COMPLETED|Open Label Period: Weeks 8 to 26||159
8956353|NCT02499783|10020066|FG000|NOT COMPLETED|Open Label Period: Weeks 8 to 26||0
8956354|NCT02499783|10020067|FG001|NOT COMPLETED|Open Label Period: Weeks 8 to 26||0
8570176|NCT00101686|9602316|FG003|COMPLETED|Overall Study|Patients treated until disease progression.|0
8725680|NCT01032837|9772987|FG001|NOT COMPLETED|Overall Study||3
8725681|NCT01032837|9772988|FG002|NOT COMPLETED|Overall Study||1
8725682|NCT01032837|9772989|FG003|NOT COMPLETED|Overall Study||3
8725683|NCT01032850|9772999|FG000|STARTED|Overall Study||15
8725684|NCT01032850|9772999|FG000|COMPLETED|Overall Study||13
8725685|NCT01032850|9772999|FG000|NOT COMPLETED|Overall Study||2
8725686|NCT01032889|9773006|FG000|STARTED|Overall Study||41
8725687|NCT01032889|9773007|FG001|STARTED|Overall Study||43
8725688|NCT01032889|9773008|FG002|STARTED|Overall Study||45
8956355|NCT02499783|10020068|FG002|NOT COMPLETED|Open Label Period: Weeks 8 to 26||29
8956356|NCT02499952|10020078|FG000|STARTED|Overall Study||12
8956357|NCT02499952|10020078|FG000|COMPLETED|Overall Study||2
8725689|NCT01032889|9773006|FG000|Received Treatment|Overall Study||41
8956358|NCT02499952|10020078|FG000|NOT COMPLETED|Overall Study||10
8956359|NCT02500043|10020084|FG000|STARTED|Overall Study||337
8956360|NCT02500043|10020085|FG001|STARTED|Overall Study||170
8956361|NCT02500043|10020084|FG000|As-Treated (AT) Population|Overall Study||335
8956362|NCT02500043|10020085|FG001|As-Treated (AT) Population|Overall Study||168
8956363|NCT02500043|10020084|FG000|COMPLETED|Overall Study||0
8631341|NCT00539279|9671213|FG001|NOT COMPLETED|Treatment||8
8631342|NCT00539279|9671212|FG000|STARTED|Post-Treatment Assessment|Individuals eligible for post-treatment assessment (includes all individuals randomized to PE)|30
8631343|NCT00539279|9671213|FG001|STARTED|Post-Treatment Assessment|Individuals eligible for post-treatment assessment (includes all individuals randomized to RT)|38
8631344|NCT00539279|9671212|FG000|COMPLETED|Post-Treatment Assessment||18
8631345|NCT00539279|9671213|FG001|COMPLETED|Post-Treatment Assessment||29
8956364|NCT02500043|10020085|FG001|COMPLETED|Overall Study||0
8956365|NCT02500043|10020084|FG000|NOT COMPLETED|Overall Study||337
8956366|NCT02500043|10020085|FG001|NOT COMPLETED|Overall Study||170
8956367|NCT02500056|10020093|FG000|STARTED|Overall Study||70
8956368|NCT02500056|10020094|FG001|STARTED|Overall Study||73
8956369|NCT02500056|10020093|FG000|COMPLETED|Overall Study||63
8956370|NCT02500056|10020094|FG001|COMPLETED|Overall Study||65
8956371|NCT02500056|10020093|FG000|NOT COMPLETED|Overall Study||7
8956372|NCT02500056|10020094|FG001|NOT COMPLETED|Overall Study||8
8956373|NCT02500368|10020100|FG000|STARTED|First Intervention (1 Week)||20
8956374|NCT02500368|10020101|FG001|STARTED|First Intervention (1 Week)||20
8956375|NCT02500368|10020100|FG000|COMPLETED|First Intervention (1 Week)||20
8956376|NCT02500368|10020101|FG001|COMPLETED|First Intervention (1 Week)||20
8956377|NCT02500368|10020100|FG000|NOT COMPLETED|First Intervention (1 Week)||0
8956378|NCT02500368|10020101|FG001|NOT COMPLETED|First Intervention (1 Week)||0
8956379|NCT02500368|10020100|FG000|STARTED|Second Intervention (1 Week)||20
8956380|NCT02500368|10020101|FG001|STARTED|Second Intervention (1 Week)||20
8956381|NCT02500368|10020100|FG000|COMPLETED|Second Intervention (1 Week)||20
8956382|NCT02500368|10020101|FG001|COMPLETED|Second Intervention (1 Week)||20
8956383|NCT02500368|10020100|FG000|NOT COMPLETED|Second Intervention (1 Week)||0
8956384|NCT02500368|10020101|FG001|NOT COMPLETED|Second Intervention (1 Week)||0
8956385|NCT02500537|10020109|FG000|STARTED|Overall Study||60
8956386|NCT02500537|10020110|FG001|STARTED|Overall Study||40
8956387|NCT02500537|10020109|FG000|COMPLETED|Overall Study||57
8956388|NCT02500537|10020110|FG001|COMPLETED|Overall Study||39
8956389|NCT02500537|10020109|FG000|NOT COMPLETED|Overall Study||3
8956390|NCT02500537|10020110|FG001|NOT COMPLETED|Overall Study||1
8956391|NCT02500550|10020117|FG000|STARTED|Overall Study||15
8956392|NCT02500550|10020117|FG000|COMPLETED|Overall Study||8
8956393|NCT02500550|10020117|FG000|NOT COMPLETED|Overall Study||7
8956394|NCT02500602|10020123|FG000|STARTED|Treatment Phase||74
8956395|NCT02500602|10020124|FG001|STARTED|Treatment Phase||70
8956396|NCT02500602|10020123|FG000|COMPLETED|Treatment Phase||68
8956397|NCT02500602|10020124|FG001|COMPLETED|Treatment Phase||69
8956398|NCT02500602|10020123|FG000|NOT COMPLETED|Treatment Phase||6
8956399|NCT02500602|10020124|FG001|NOT COMPLETED|Treatment Phase||1
8956400|NCT02500602|10020123|FG000|STARTED|Follow Up Phase||68
8956401|NCT02500602|10020124|FG001|STARTED|Follow Up Phase||69
8956402|NCT02500602|10020123|FG000|COMPLETED|Follow Up Phase||53
8956403|NCT02500602|10020124|FG001|COMPLETED|Follow Up Phase||47
8956404|NCT02500602|10020123|FG000|NOT COMPLETED|Follow Up Phase||15
8956405|NCT02500602|10020124|FG001|NOT COMPLETED|Follow Up Phase||22
8956406|NCT02500628|10020134|FG000|STARTED|Overall Study||38
8956407|NCT02500628|10020135|FG001|STARTED|Overall Study||23
8956408|NCT02500628|10020134|FG000|COMPLETED|Overall Study||38
8956409|NCT02500628|10020135|FG001|COMPLETED|Overall Study||23
8956410|NCT02500628|10020134|FG000|NOT COMPLETED|Overall Study||0
8956411|NCT02500628|10020135|FG001|NOT COMPLETED|Overall Study||0
8956412|NCT02500641|10020145|FG000|STARTED|Overall Study||98
8956413|NCT02500641|10020146|FG001|STARTED|Overall Study||98
8956414|NCT02500641|10020145|FG000|COMPLETED|Overall Study||88
8956415|NCT02500641|10020146|FG001|COMPLETED|Overall Study||86
8956416|NCT02500641|10020145|FG000|NOT COMPLETED|Overall Study||10
8956417|NCT02500641|10020146|FG001|NOT COMPLETED|Overall Study||12
8956418|NCT02500706|10020155|FG000|STARTED|Overall Study||342
8956419|NCT02500706|10020156|FG001|STARTED|Overall Study||341
8956420|NCT02500706|10020157|FG002|STARTED|Overall Study||342
8956421|NCT02500706|10020155|FG000|Exposed|Overall Study||342
8956422|NCT02500706|10020156|FG001|Exposed|Overall Study||341
8956423|NCT02500706|10020157|FG002|Exposed|Overall Study||342
8956424|NCT02500706|10020155|FG000|COMPLETED|Overall Study||338
8956425|NCT02500706|10020156|FG001|COMPLETED|Overall Study||334
8956426|NCT02500706|10020157|FG002|COMPLETED|Overall Study||335
8956427|NCT02500706|10020155|FG000|NOT COMPLETED|Overall Study||4
8956428|NCT02500706|10020156|FG001|NOT COMPLETED|Overall Study||7
8956429|NCT02500706|10020157|FG002|NOT COMPLETED|Overall Study||7
8956430|NCT02500719|10020167|FG000|STARTED|Overall Study||14
8956431|NCT02500719|10020168|FG001|STARTED|Overall Study||16
8631346|NCT00539279|9671212|FG000|NOT COMPLETED|Post-Treatment Assessment||12
8631347|NCT00539279|9671213|FG001|NOT COMPLETED|Post-Treatment Assessment||9
8956432|NCT02500719|10020167|FG000|COMPLETED|Overall Study||11
8956433|NCT02500719|10020168|FG001|COMPLETED|Overall Study||9
8956434|NCT02500719|10020167|FG000|NOT COMPLETED|Overall Study||3
8956435|NCT02500719|10020168|FG001|NOT COMPLETED|Overall Study||7
8956436|NCT02500732|10020176|FG000|STARTED|Overall Study||27
8956437|NCT02500732|10020177|FG001|STARTED|Overall Study||30
8956438|NCT02500732|10020176|FG000|COMPLETED|Overall Study||27
8956439|NCT02500732|10020177|FG001|COMPLETED|Overall Study|Not true event in 1 participant (pseudosyncope)|29
8956440|NCT02500732|10020176|FG000|NOT COMPLETED|Overall Study||0
8956441|NCT02500732|10020177|FG001|NOT COMPLETED|Overall Study||1
8956442|NCT02500758|10020185|FG000|STARTED|First Intervention (2 Minutes)||15
8956443|NCT02500758|10020186|FG001|STARTED|First Intervention (2 Minutes)||15
8956444|NCT02500758|10020185|FG000|COMPLETED|First Intervention (2 Minutes)||15
8956445|NCT02500758|10020186|FG001|COMPLETED|First Intervention (2 Minutes)||14
8956446|NCT02500758|10020185|FG000|NOT COMPLETED|First Intervention (2 Minutes)||0
8956447|NCT02500758|10020186|FG001|NOT COMPLETED|First Intervention (2 Minutes)||1
8956448|NCT02500758|10020185|FG000|STARTED|Washout (1 Week)||15
8956449|NCT02500758|10020186|FG001|STARTED|Washout (1 Week)||14
8956450|NCT02500758|10020185|FG000|COMPLETED|Washout (1 Week)||13
8956451|NCT02500758|10020186|FG001|COMPLETED|Washout (1 Week)||12
8956452|NCT02500758|10020185|FG000|NOT COMPLETED|Washout (1 Week)||2
8956453|NCT02500758|10020186|FG001|NOT COMPLETED|Washout (1 Week)||2
8956454|NCT02500758|10020185|FG000|STARTED|Second Intervention (2 Minutes)||13
8956455|NCT02500758|10020186|FG001|STARTED|Second Intervention (2 Minutes)||12
8956456|NCT02500758|10020185|FG000|COMPLETED|Second Intervention (2 Minutes)||10
8956457|NCT02500758|10020186|FG001|COMPLETED|Second Intervention (2 Minutes)||10
8956458|NCT02500758|10020185|FG000|NOT COMPLETED|Second Intervention (2 Minutes)||3
8956459|NCT02500758|10020186|FG001|NOT COMPLETED|Second Intervention (2 Minutes)||2
8956460|NCT02500836|10020196|FG000|STARTED|Overall Study||259
8956461|NCT02500836|10020197|FG001|STARTED|Overall Study||259
8956462|NCT02500836|10020198|FG002|STARTED|Overall Study||128
8956463|NCT02500836|10020196|FG000|COMPLETED|Overall Study||256
8956464|NCT02500836|10020197|FG001|COMPLETED|Overall Study||254
8956465|NCT02500836|10020198|FG002|COMPLETED|Overall Study||127
8956466|NCT02500836|10020196|FG000|NOT COMPLETED|Overall Study||3
8956467|NCT02500836|10020197|FG001|NOT COMPLETED|Overall Study||5
8570177|NCT00101686|9602317|FG004|COMPLETED|Overall Study|Patients treated until disease progression.|0
8956468|NCT02500836|10020198|FG002|NOT COMPLETED|Overall Study||1
8956469|NCT02500979|10020208|FG000|STARTED|Period 1||16
8956470|NCT02500979|10020209|FG001|STARTED|Period 1||17
8956471|NCT02500979|10020208|FG000|COMPLETED|Period 1||12
8956472|NCT02500979|10020209|FG001|COMPLETED|Period 1||16
8956473|NCT02500979|10020208|FG000|NOT COMPLETED|Period 1||4
8956474|NCT02500979|10020209|FG001|NOT COMPLETED|Period 1||1
8956475|NCT02500979|10020208|FG000|STARTED|Period 2||12
8956476|NCT02500979|10020209|FG001|STARTED|Period 2||16
8956477|NCT02500979|10020208|FG000|COMPLETED|Period 2||11
8956478|NCT02500979|10020209|FG001|COMPLETED|Period 2||16
8956479|NCT02500979|10020208|FG000|NOT COMPLETED|Period 2||1
8956480|NCT02500979|10020209|FG001|NOT COMPLETED|Period 2||0
8956481|NCT02501135|10020215|FG000|STARTED|Overall Study||281
8956482|NCT02501135|10020215|FG000|COMPLETED|Overall Study||281
8956483|NCT02501135|10020215|FG000|NOT COMPLETED|Overall Study||0
9037710|NCT03319953|10098950|FG000|NOT COMPLETED|Period 1 (Day 1 to 14)||0
9037711|NCT03319953|10098951|FG001|NOT COMPLETED|Period 1 (Day 1 to 14)||0
9037712|NCT03319953|10098952|FG002|NOT COMPLETED|Period 1 (Day 1 to 14)||0
9037713|NCT03319953|10098953|FG003|NOT COMPLETED|Period 1 (Day 1 to 14)||0
9037714|NCT03319953|10098950|FG000|STARTED|Washout Period (Day 15 to 49)||3
9037715|NCT03319953|10098951|FG001|STARTED|Washout Period (Day 15 to 49)||4
9037716|NCT03319953|10098952|FG002|STARTED|Washout Period (Day 15 to 49)||9
9037717|NCT03319953|10098953|FG003|STARTED|Washout Period (Day 15 to 49)||7
9037718|NCT03319953|10098950|FG000|COMPLETED|Washout Period (Day 15 to 49)||3
9037719|NCT03319953|10098951|FG001|COMPLETED|Washout Period (Day 15 to 49)||4
9037720|NCT03319953|10098952|FG002|COMPLETED|Washout Period (Day 15 to 49)||9
9037721|NCT03319953|10098953|FG003|COMPLETED|Washout Period (Day 15 to 49)||7
9037722|NCT03319953|10098950|FG000|NOT COMPLETED|Washout Period (Day 15 to 49)||0
9037723|NCT03319953|10098951|FG001|NOT COMPLETED|Washout Period (Day 15 to 49)||0
9037724|NCT03319953|10098952|FG002|NOT COMPLETED|Washout Period (Day 15 to 49)||0
9037725|NCT03319953|10098953|FG003|NOT COMPLETED|Washout Period (Day 15 to 49)||0
9037726|NCT03319953|10098950|FG000|STARTED|Period 2 (Day 49 to 154)||3
9037727|NCT03319953|10098951|FG001|STARTED|Period 2 (Day 49 to 154)||4
9037728|NCT03319953|10098952|FG002|STARTED|Period 2 (Day 49 to 154)||9
9037729|NCT03319953|10098953|FG003|STARTED|Period 2 (Day 49 to 154)||7
9037730|NCT03319953|10098950|FG000|Treated|Period 2 (Day 49 to 154)||2
9037731|NCT03319953|10098951|FG001|Treated|Period 2 (Day 49 to 154)||4
9037732|NCT03319953|10098952|FG002|Treated|Period 2 (Day 49 to 154)||8
8570178|NCT00101686|9602318|FG005|COMPLETED|Overall Study|Patients treated until disease progression.|0
8956484|NCT02501161|10020227|FG000|STARTED|Overall Study||506
8956485|NCT02501161|10020228|FG001|STARTED|Overall Study||506
8956486|NCT02501161|10020227|FG000|Exposed|Overall Study||506
8956487|NCT02501161|10020228|FG001|Exposed|Overall Study||504
8956488|NCT02501161|10020227|FG000|COMPLETED|Overall Study||484
8956489|NCT02501161|10020228|FG001|COMPLETED|Overall Study||481
8956490|NCT02501161|10020227|FG000|NOT COMPLETED|Overall Study||22
8956491|NCT02501161|10020228|FG001|NOT COMPLETED|Overall Study||25
8956492|NCT02501265|10020238|FG000|STARTED|Overall Study||63
8956493|NCT02501265|10020239|FG001|STARTED|Overall Study||30
8956494|NCT02501265|10020240|FG002|STARTED|Overall Study||64
8956495|NCT02501265|10020241|FG003|STARTED|Overall Study||31
8956496|NCT02501265|10020238|FG000|COMPLETED|Overall Study||46
8956497|NCT02501265|10020239|FG001|COMPLETED|Overall Study||21
8956498|NCT02501265|10020240|FG002|COMPLETED|Overall Study||46
8956499|NCT02501265|10020241|FG003|COMPLETED|Overall Study||23
8956500|NCT02501265|10020238|FG000|NOT COMPLETED|Overall Study||17
8956501|NCT02501265|10020239|FG001|NOT COMPLETED|Overall Study||9
8956502|NCT02501265|10020240|FG002|NOT COMPLETED|Overall Study||18
8956503|NCT02501265|10020241|FG003|NOT COMPLETED|Overall Study||8
8956504|NCT02501473|10020258|FG000|STARTED|Overall Study||3
8956505|NCT02501473|10020259|FG001|STARTED|Overall Study||3
8956506|NCT02501473|10020260|FG002|STARTED|Overall Study||13
8956507|NCT02501473|10020261|FG003|STARTED|Overall Study||14
8956508|NCT02501473|10020262|FG004|STARTED|Overall Study||4
8956509|NCT02501473|10020263|FG005|STARTED|Overall Study||14
8956510|NCT02501473|10020264|FG006|STARTED|Overall Study||1
8956511|NCT02501473|10020265|FG007|STARTED|Overall Study||0
8956512|NCT02501473|10020258|FG000|Treated|Overall Study||3
8956513|NCT02501473|10020259|FG001|Treated|Overall Study||3
8956514|NCT02501473|10020260|FG002|Treated|Overall Study||13
8956515|NCT02501473|10020261|FG003|Treated|Overall Study||13
8956516|NCT02501473|10020262|FG004|Treated|Overall Study||4
8956517|NCT02501473|10020263|FG005|Treated|Overall Study||14
8956518|NCT02501473|10020264|FG006|Treated|Overall Study||1
8956519|NCT02501473|10020265|FG007|Treated|Overall Study||0
8956520|NCT02501473|10020258|FG000|COMPLETED|Overall Study||0
8956521|NCT02501473|10020259|FG001|COMPLETED|Overall Study||0
8956522|NCT02501473|10020260|FG002|COMPLETED|Overall Study||0
8956523|NCT02501473|10020261|FG003|COMPLETED|Overall Study||0
8956524|NCT02501473|10020262|FG004|COMPLETED|Overall Study||0
8956525|NCT02501473|10020263|FG005|COMPLETED|Overall Study||0
8956526|NCT02501473|10020264|FG006|COMPLETED|Overall Study||0
8956527|NCT02501473|10020265|FG007|COMPLETED|Overall Study||0
8956528|NCT02501473|10020258|FG000|NOT COMPLETED|Overall Study||3
8956529|NCT02501473|10020259|FG001|NOT COMPLETED|Overall Study||3
8956530|NCT02501473|10020260|FG002|NOT COMPLETED|Overall Study||13
8956531|NCT02501473|10020261|FG003|NOT COMPLETED|Overall Study||14
8956532|NCT02501473|10020262|FG004|NOT COMPLETED|Overall Study||4
8956533|NCT02501473|10020263|FG005|NOT COMPLETED|Overall Study||14
8956534|NCT02501473|10020264|FG006|NOT COMPLETED|Overall Study||1
8956535|NCT02501473|10020265|FG007|NOT COMPLETED|Overall Study||0
8956536|NCT02501538|10020281|FG000|STARTED|Overall Study||23
8956537|NCT02501538|10020281|FG000|COMPLETED|Overall Study||20
8956538|NCT02501538|10020281|FG000|NOT COMPLETED|Overall Study||3
8956539|NCT02501590|10020290|FG000|STARTED|Overall Study||13
8956540|NCT02501590|10020291|FG001|STARTED|Overall Study||35
8956541|NCT02501590|10020290|FG000|COMPLETED|Overall Study||13
8956542|NCT02501590|10020291|FG001|COMPLETED|Overall Study||35
8956543|NCT02501590|10020290|FG000|NOT COMPLETED|Overall Study||0
8956544|NCT02501590|10020291|FG001|NOT COMPLETED|Overall Study||0
8956545|NCT02501629|10020299|FG000|STARTED|Overall Study||89
8956546|NCT02501629|10020300|FG001|STARTED|Overall Study||88
8956547|NCT02501629|10020299|FG000|COMPLETED|Overall Study||84
8956548|NCT02501629|10020300|FG001|COMPLETED|Overall Study||81
8956549|NCT02501629|10020299|FG000|NOT COMPLETED|Overall Study||5
8956550|NCT02501629|10020300|FG001|NOT COMPLETED|Overall Study||7
8956551|NCT02501642|10020308|FG000|STARTED|Overall Study|Start of study: 10.1.2014|238
8956552|NCT02501642|10020309|FG001|STARTED|Overall Study|Start of study: 10.1.2014|241
8956553|NCT02501642|10020308|FG000|COMPLETED|Overall Study|Study ended 9.30.2018|231
8956554|NCT02501642|10020309|FG001|COMPLETED|Overall Study|Study ended 9.30.2018|230
8956555|NCT02501642|10020308|FG000|NOT COMPLETED|Overall Study||7
8956556|NCT02501642|10020309|FG001|NOT COMPLETED|Overall Study||11
8956557|NCT02501811|10020319|FG000|STARTED|Overall Study||33
8956558|NCT02501811|10020320|FG001|STARTED|Overall Study||29
8956559|NCT02501811|10020321|FG002|STARTED|Overall Study||31
8956560|NCT02501811|10020322|FG003|STARTED|Overall Study||32
8956561|NCT02501811|10020319|FG000|COMPLETED|Overall Study|includes 1 participant who completed final study visit but died within 30 days after final visit.|29
8956562|NCT02501811|10020320|FG001|COMPLETED|Overall Study||23
8956563|NCT02501811|10020321|FG002|COMPLETED|Overall Study||25
8956564|NCT02501811|10020322|FG003|COMPLETED|Overall Study|includes 1 participant who completed final study visit but died within 30 days after final visit.|25
8956565|NCT02501811|10020319|FG000|NOT COMPLETED|Overall Study||4
8956566|NCT02501811|10020320|FG001|NOT COMPLETED|Overall Study||6
8956567|NCT02501811|10020321|FG002|NOT COMPLETED|Overall Study||6
8956568|NCT02501811|10020322|FG003|NOT COMPLETED|Overall Study||7
8956569|NCT02501902|10020340|FG000|STARTED|Overall Study||3
8956570|NCT02501902|10020341|FG001|STARTED|Overall Study||7
8956571|NCT02501902|10020342|FG002|STARTED|Overall Study||4
8956572|NCT02501902|10020343|FG003|STARTED|Overall Study||11
8956573|NCT02501902|10020344|FG004|STARTED|Overall Study||11
8956574|NCT02501902|10020345|FG005|STARTED|Overall Study||11
8956575|NCT02501902|10020346|FG006|STARTED|Overall Study||9
8956576|NCT02501902|10020347|FG007|STARTED|Overall Study||20
8956577|NCT02501902|10020340|FG000|COMPLETED|Overall Study||0
8956578|NCT02501902|10020341|FG001|COMPLETED|Overall Study||0
8956579|NCT02501902|10020342|FG002|COMPLETED|Overall Study||0
8956580|NCT02501902|10020343|FG003|COMPLETED|Overall Study||0
8956581|NCT02501902|10020344|FG004|COMPLETED|Overall Study||0
8631348|NCT00539279|9671212|FG000|STARTED|6-Month Follow-Up Assessment|Individuals eligible for 6-month assessment (includes all individuals randomized to PE)|18
8631349|NCT00539279|9671213|FG001|STARTED|6-Month Follow-Up Assessment|Individuals eligible for 6-month assessment (includes all individuals randomized to RT)|29
8631350|NCT00539279|9671212|FG000|COMPLETED|6-Month Follow-Up Assessment||17
8631351|NCT00539279|9671213|FG001|COMPLETED|6-Month Follow-Up Assessment||22
8631352|NCT00539279|9671212|FG000|NOT COMPLETED|6-Month Follow-Up Assessment||1
8956582|NCT02501902|10020345|FG005|COMPLETED|Overall Study||0
8956583|NCT02501902|10020346|FG006|COMPLETED|Overall Study||0
8956584|NCT02501902|10020347|FG007|COMPLETED|Overall Study||0
8956585|NCT02501902|10020340|FG000|NOT COMPLETED|Overall Study||3
8956586|NCT02501902|10020341|FG001|NOT COMPLETED|Overall Study||7
8956587|NCT02501902|10020342|FG002|NOT COMPLETED|Overall Study||4
8956588|NCT02501902|10020343|FG003|NOT COMPLETED|Overall Study||11
8956589|NCT02501902|10020344|FG004|NOT COMPLETED|Overall Study||11
8956590|NCT02501902|10020345|FG005|NOT COMPLETED|Overall Study||11
8956591|NCT02501902|10020346|FG006|NOT COMPLETED|Overall Study||9
8956592|NCT02501902|10020347|FG007|NOT COMPLETED|Overall Study||20
8956593|NCT02501928|10020373|FG000|STARTED|Overall Study|No participant was assigned to this arm, in this LTE study.|0
8956594|NCT02501928|10020374|FG001|STARTED|Overall Study||2
8956595|NCT02501928|10020375|FG002|STARTED|Overall Study|No participant was assigned to this arm, in this LTE study.|0
8956596|NCT02501928|10020376|FG003|STARTED|Overall Study|No participant was assigned to this arm, in this LTE study.|0
8956597|NCT02501928|10020377|FG004|STARTED|Overall Study||7
8956598|NCT02501928|10020378|FG005|STARTED|Overall Study||3
8956599|NCT02501928|10020373|FG000|COMPLETED|Overall Study||0
8956600|NCT02501928|10020374|FG001|COMPLETED|Overall Study||2
8956601|NCT02501928|10020375|FG002|COMPLETED|Overall Study||0
8956602|NCT02501928|10020376|FG003|COMPLETED|Overall Study||0
8956603|NCT02501928|10020377|FG004|COMPLETED|Overall Study||6
8956604|NCT02501928|10020378|FG005|COMPLETED|Overall Study||3
8956605|NCT02501928|10020373|FG000|NOT COMPLETED|Overall Study||0
8956606|NCT02501928|10020374|FG001|NOT COMPLETED|Overall Study||0
8956607|NCT02501928|10020375|FG002|NOT COMPLETED|Overall Study||0
8956608|NCT02501928|10020376|FG003|NOT COMPLETED|Overall Study||0
8956609|NCT02501928|10020377|FG004|NOT COMPLETED|Overall Study||1
8956610|NCT02501928|10020378|FG005|NOT COMPLETED|Overall Study||0
8956611|NCT02502019|10020395|FG000|STARTED|Overall Study||27
8956612|NCT02502019|10020395|FG000|COMPLETED|Overall Study||27
8956613|NCT02502019|10020395|FG000|NOT COMPLETED|Overall Study||0
8956614|NCT02502097|10020403|FG000|STARTED|Period 1||4
8956615|NCT02502097|10020404|FG001|STARTED|Period 1||3
8956616|NCT02502097|10020405|FG002|STARTED|Period 1||22
8956617|NCT02502097|10020406|FG003|STARTED|Period 1||22
8956618|NCT02502097|10020403|FG000|COMPLETED|Period 1||4
8956619|NCT02502097|10020404|FG001|COMPLETED|Period 1||3
8956620|NCT02502097|10020405|FG002|COMPLETED|Period 1||21
8956621|NCT02502097|10020406|FG003|COMPLETED|Period 1||22
8956622|NCT02502097|10020403|FG000|NOT COMPLETED|Period 1||0
8956623|NCT02502097|10020404|FG001|NOT COMPLETED|Period 1||0
8956624|NCT02502097|10020405|FG002|NOT COMPLETED|Period 1||1
8956625|NCT02502097|10020406|FG003|NOT COMPLETED|Period 1||0
8956626|NCT02502097|10020403|FG000|STARTED|Wash Out Period||4
8956627|NCT02502097|10020404|FG001|STARTED|Wash Out Period||3
8956628|NCT02502097|10020405|FG002|STARTED|Wash Out Period||21
8956629|NCT02502097|10020406|FG003|STARTED|Wash Out Period||22
8956630|NCT02502097|10020403|FG000|COMPLETED|Wash Out Period||4
8956631|NCT02502097|10020404|FG001|COMPLETED|Wash Out Period||2
8956632|NCT02502097|10020405|FG002|COMPLETED|Wash Out Period||20
8956633|NCT02502097|10020406|FG003|COMPLETED|Wash Out Period||21
8956634|NCT02502097|10020403|FG000|NOT COMPLETED|Wash Out Period||0
8956635|NCT02502097|10020404|FG001|NOT COMPLETED|Wash Out Period||1
8956636|NCT02502097|10020405|FG002|NOT COMPLETED|Wash Out Period||1
8956637|NCT02502097|10020406|FG003|NOT COMPLETED|Wash Out Period||1
8956638|NCT02502097|10020403|FG000|STARTED|Period 2||4
8956639|NCT02502097|10020404|FG001|STARTED|Period 2||2
8956640|NCT02502097|10020405|FG002|STARTED|Period 2||20
8956641|NCT02502097|10020406|FG003|STARTED|Period 2||21
8956642|NCT02502097|10020403|FG000|COMPLETED|Period 2||4
8956643|NCT02502097|10020404|FG001|COMPLETED|Period 2||2
8956644|NCT02502097|10020405|FG002|COMPLETED|Period 2||19
8956645|NCT02502097|10020406|FG003|COMPLETED|Period 2||21
8956646|NCT02502097|10020403|FG000|NOT COMPLETED|Period 2||0
8956647|NCT02502097|10020404|FG001|NOT COMPLETED|Period 2||0
8956648|NCT02502097|10020405|FG002|NOT COMPLETED|Period 2||1
8956649|NCT02502097|10020406|FG003|NOT COMPLETED|Period 2||0
8956650|NCT02502149|10020413|FG000|STARTED|PK1 Assessment Period||24
8956651|NCT02502149|10020414|FG001|STARTED|PK1 Assessment Period||0
8956652|NCT02502149|10020415|FG002|STARTED|PK1 Assessment Period||0
8956653|NCT02502149|10020416|FG003|STARTED|PK1 Assessment Period||0
8956654|NCT02502149|10020417|FG004|STARTED|PK1 Assessment Period||0
8956655|NCT02502149|10020413|FG000|COMPLETED|PK1 Assessment Period||24
8956656|NCT02502149|10020414|FG001|COMPLETED|PK1 Assessment Period||0
8956657|NCT02502149|10020415|FG002|COMPLETED|PK1 Assessment Period||0
8956658|NCT02502149|10020416|FG003|COMPLETED|PK1 Assessment Period||0
8956659|NCT02502149|10020417|FG004|COMPLETED|PK1 Assessment Period||0
8956660|NCT02502149|10020413|FG000|NOT COMPLETED|PK1 Assessment Period||0
8956661|NCT02502149|10020414|FG001|NOT COMPLETED|PK1 Assessment Period||0
8956662|NCT02502149|10020415|FG002|NOT COMPLETED|PK1 Assessment Period||0
8956663|NCT02502149|10020416|FG003|NOT COMPLETED|PK1 Assessment Period||0
8956664|NCT02502149|10020417|FG004|NOT COMPLETED|PK1 Assessment Period||0
8956665|NCT02502149|10020413|FG000|STARTED|Intermediate||24
8956666|NCT02502149|10020414|FG001|STARTED|Intermediate||0
8956667|NCT02502149|10020415|FG002|STARTED|Intermediate||0
8956668|NCT02502149|10020416|FG003|STARTED|Intermediate||0
8956669|NCT02502149|10020417|FG004|STARTED|Intermediate||0
8956670|NCT02502149|10020413|FG000|COMPLETED|Intermediate||23
8956671|NCT02502149|10020414|FG001|COMPLETED|Intermediate||0
8956672|NCT02502149|10020415|FG002|COMPLETED|Intermediate||0
8956673|NCT02502149|10020416|FG003|COMPLETED|Intermediate||0
8956674|NCT02502149|10020417|FG004|COMPLETED|Intermediate||0
8956675|NCT02502149|10020413|FG000|NOT COMPLETED|Intermediate||1
8956676|NCT02502149|10020414|FG001|NOT COMPLETED|Intermediate||0
8956677|NCT02502149|10020415|FG002|NOT COMPLETED|Intermediate||0
8956678|NCT02502149|10020416|FG003|NOT COMPLETED|Intermediate||0
8956679|NCT02502149|10020417|FG004|NOT COMPLETED|Intermediate||0
8956680|NCT02502149|10020413|FG000|STARTED|PK2 Assessment Period||0
8956681|NCT02502149|10020414|FG001|STARTED|PK2 Assessment Period||11
8956682|NCT02502149|10020415|FG002|STARTED|PK2 Assessment Period||12
8956683|NCT02502149|10020416|FG003|STARTED|PK2 Assessment Period||0
8956684|NCT02502149|10020417|FG004|STARTED|PK2 Assessment Period||0
8956685|NCT02502149|10020413|FG000|COMPLETED|PK2 Assessment Period||0
8956686|NCT02502149|10020414|FG001|COMPLETED|PK2 Assessment Period||11
8956687|NCT02502149|10020415|FG002|COMPLETED|PK2 Assessment Period||12
8956688|NCT02502149|10020416|FG003|COMPLETED|PK2 Assessment Period||0
8956689|NCT02502149|10020417|FG004|COMPLETED|PK2 Assessment Period||0
8956690|NCT02502149|10020413|FG000|NOT COMPLETED|PK2 Assessment Period||0
8956691|NCT02502149|10020414|FG001|NOT COMPLETED|PK2 Assessment Period||0
8956692|NCT02502149|10020415|FG002|NOT COMPLETED|PK2 Assessment Period||0
8956693|NCT02502149|10020416|FG003|NOT COMPLETED|PK2 Assessment Period||0
8956694|NCT02502149|10020417|FG004|NOT COMPLETED|PK2 Assessment Period||0
8956695|NCT02502149|10020413|FG000|STARTED|Treatment Period||0
8956696|NCT02502149|10020414|FG001|STARTED|Treatment Period||0
8956697|NCT02502149|10020415|FG002|STARTED|Treatment Period||0
8956698|NCT02502149|10020416|FG003|STARTED|Treatment Period||11
8956699|NCT02502149|10020417|FG004|STARTED|Treatment Period||12
8956700|NCT02502149|10020413|FG000|COMPLETED|Treatment Period||0
8956701|NCT02502149|10020414|FG001|COMPLETED|Treatment Period||0
8956702|NCT02502149|10020415|FG002|COMPLETED|Treatment Period||0
8956703|NCT02502149|10020416|FG003|COMPLETED|Treatment Period||11
8956704|NCT02502149|10020417|FG004|COMPLETED|Treatment Period||12
8956705|NCT02502149|10020413|FG000|NOT COMPLETED|Treatment Period||0
8570179|NCT00101686|9602319|FG006|COMPLETED|Overall Study|Patients treated until disease progression.|0
8570180|NCT00101686|9602320|FG007|COMPLETED|Overall Study|Patients treated until disease progression.|0
8570181|NCT00101686|9602321|FG008|COMPLETED|Overall Study|Patients treated until disease progression.|0
8570182|NCT00101686|9602322|FG009|COMPLETED|Overall Study|Patients treated until disease progression.|0
8570183|NCT00101686|9602313|FG000|NOT COMPLETED|Overall Study||71
8874809|NCT01904773|9931721|FG000|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||20
8956706|NCT02502149|10020414|FG001|NOT COMPLETED|Treatment Period||0
8956707|NCT02502149|10020415|FG002|NOT COMPLETED|Treatment Period||0
8956708|NCT02502149|10020416|FG003|NOT COMPLETED|Treatment Period||0
8956709|NCT02502149|10020417|FG004|NOT COMPLETED|Treatment Period||0
8956710|NCT02502461|10020436|FG000|STARTED|Overall Study||46
8956711|NCT02502461|10020437|FG001|STARTED|Overall Study||44
8956712|NCT02502461|10020436|FG000|COMPLETED|Overall Study||46
8956713|NCT02502461|10020437|FG001|COMPLETED|Overall Study||44
8956714|NCT02502461|10020436|FG000|NOT COMPLETED|Overall Study||0
8956715|NCT02502461|10020437|FG001|NOT COMPLETED|Overall Study||0
8956716|NCT02502487|10020446|FG000|STARTED|Overall Study||86
8956717|NCT02502487|10020447|FG001|STARTED|Overall Study||86
8956718|NCT02502487|10020448|FG002|STARTED|Overall Study||86
8956719|NCT02502487|10020446|FG000|COMPLETED|Overall Study||86
8956720|NCT02502487|10020447|FG001|COMPLETED|Overall Study||86
8956721|NCT02502487|10020448|FG002|COMPLETED|Overall Study||86
8956722|NCT02502487|10020446|FG000|NOT COMPLETED|Overall Study||0
8956723|NCT02502487|10020447|FG001|NOT COMPLETED|Overall Study||0
8956724|NCT02502487|10020448|FG002|NOT COMPLETED|Overall Study||0
8956725|NCT02502526|10020459|FG000|STARTED|Overall Study||62
8956726|NCT02502526|10020460|FG001|STARTED|Overall Study||59
8956727|NCT02502526|10020461|FG002|STARTED|Overall Study||61
8956728|NCT02502526|10020459|FG000|Intent-to-Treat (ITT)|Overall Study||57
8956729|NCT02502526|10020460|FG001|Intent-to-Treat (ITT)|Overall Study||57
8956730|NCT02502526|10020461|FG002|Intent-to-Treat (ITT)|Overall Study||59
8956731|NCT02502526|10020459|FG000|COMPLETED|Overall Study||56
8956732|NCT02502526|10020460|FG001|COMPLETED|Overall Study||55
8956733|NCT02502526|10020461|FG002|COMPLETED|Overall Study||55
8956734|NCT02502526|10020459|FG000|NOT COMPLETED|Overall Study||6
8956735|NCT02502526|10020460|FG001|NOT COMPLETED|Overall Study||4
8956736|NCT02502526|10020461|FG002|NOT COMPLETED|Overall Study||6
8956737|NCT02502734|10020470|FG000|STARTED|Double-blind Treatment Period 1||30
8956738|NCT02502734|10020471|FG001|STARTED|Double-blind Treatment Period 1||30
8956739|NCT02502734|10020470|FG000|COMPLETED|Double-blind Treatment Period 1||29
8956740|NCT02502734|10020471|FG001|COMPLETED|Double-blind Treatment Period 1||30
8956741|NCT02502734|10020470|FG000|NOT COMPLETED|Double-blind Treatment Period 1||1
8956742|NCT02502734|10020471|FG001|NOT COMPLETED|Double-blind Treatment Period 1||0
8956743|NCT02502734|10020470|FG000|STARTED|Washout Period||29
8956744|NCT02502734|10020471|FG001|STARTED|Washout Period||30
8956745|NCT02502734|10020470|FG000|COMPLETED|Washout Period||28
8956746|NCT02502734|10020471|FG001|COMPLETED|Washout Period||30
8956747|NCT02502734|10020470|FG000|NOT COMPLETED|Washout Period||1
8956748|NCT02502734|10020471|FG001|NOT COMPLETED|Washout Period||0
8956749|NCT02502734|10020470|FG000|STARTED|Double-blind Treatment Period 2||28
8956750|NCT02502734|10020471|FG001|STARTED|Double-blind Treatment Period 2||30
8956751|NCT02502734|10020470|FG000|COMPLETED|Double-blind Treatment Period 2||28
8956752|NCT02502734|10020471|FG001|COMPLETED|Double-blind Treatment Period 2||30
8956753|NCT02502734|10020470|FG000|NOT COMPLETED|Double-blind Treatment Period 2||0
8956754|NCT02502734|10020471|FG001|NOT COMPLETED|Double-blind Treatment Period 2||0
8956755|NCT02502864|10020479|FG000|STARTED|Overall Study||9
8956756|NCT02502864|10020479|FG000|COMPLETED|Overall Study||8
8956757|NCT02502864|10020479|FG000|NOT COMPLETED|Overall Study||1
8956758|NCT02503085|10020483|FG000|STARTED|Period 1||7
8956759|NCT02503085|10020484|FG001|STARTED|Period 1||7
8956760|NCT02503085|10020485|FG002|STARTED|Period 1||7
8956761|NCT02503085|10020486|FG003|STARTED|Period 1||7
8956762|NCT02503085|10020483|FG000|COMPLETED|Period 1||7
8956763|NCT02503085|10020484|FG001|COMPLETED|Period 1||7
8956764|NCT02503085|10020485|FG002|COMPLETED|Period 1||7
8956765|NCT02503085|10020486|FG003|COMPLETED|Period 1||7
8956766|NCT02503085|10020483|FG000|NOT COMPLETED|Period 1||0
8956767|NCT02503085|10020484|FG001|NOT COMPLETED|Period 1||0
8956768|NCT02503085|10020485|FG002|NOT COMPLETED|Period 1||0
8874810|NCT01904773|9931722|FG001|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8874811|NCT01904773|9931723|FG002|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8874812|NCT01904773|9931724|FG003|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8874813|NCT01904773|9931725|FG004|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8874814|NCT01904773|9931726|FG005|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8874815|NCT01904773|9931727|FG006|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8874816|NCT01904773|9931728|FG007|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8956769|NCT02503085|10020486|FG003|NOT COMPLETED|Period 1||0
8956770|NCT02503085|10020483|FG000|STARTED|Period 1: Washout (3 to 7 Days)||7
8956771|NCT02503085|10020484|FG001|STARTED|Period 1: Washout (3 to 7 Days)||7
8956772|NCT02503085|10020485|FG002|STARTED|Period 1: Washout (3 to 7 Days)||7
8956773|NCT02503085|10020486|FG003|STARTED|Period 1: Washout (3 to 7 Days)||7
8956774|NCT02503085|10020483|FG000|COMPLETED|Period 1: Washout (3 to 7 Days)||7
8956775|NCT02503085|10020484|FG001|COMPLETED|Period 1: Washout (3 to 7 Days)||7
8956776|NCT02503085|10020485|FG002|COMPLETED|Period 1: Washout (3 to 7 Days)||7
8956777|NCT02503085|10020486|FG003|COMPLETED|Period 1: Washout (3 to 7 Days)||7
8956778|NCT02503085|10020483|FG000|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
8956779|NCT02503085|10020484|FG001|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
8956780|NCT02503085|10020485|FG002|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
8956781|NCT02503085|10020486|FG003|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
8956782|NCT02503085|10020483|FG000|STARTED|Period 2||7
8956783|NCT02503085|10020484|FG001|STARTED|Period 2||7
8956784|NCT02503085|10020485|FG002|STARTED|Period 2||7
8956785|NCT02503085|10020486|FG003|STARTED|Period 2||7
8956786|NCT02503085|10020483|FG000|COMPLETED|Period 2||7
8956787|NCT02503085|10020484|FG001|COMPLETED|Period 2||7
8956788|NCT02503085|10020485|FG002|COMPLETED|Period 2||7
8956789|NCT02503085|10020486|FG003|COMPLETED|Period 2||7
8956790|NCT02503085|10020483|FG000|NOT COMPLETED|Period 2||0
8956791|NCT02503085|10020484|FG001|NOT COMPLETED|Period 2||0
8956792|NCT02503085|10020485|FG002|NOT COMPLETED|Period 2||0
8956793|NCT02503085|10020486|FG003|NOT COMPLETED|Period 2||0
8956794|NCT02503085|10020483|FG000|STARTED|Period 2: Washout (3 to 7 Days)||7
8956795|NCT02503085|10020484|FG001|STARTED|Period 2: Washout (3 to 7 Days)||7
8956796|NCT02503085|10020485|FG002|STARTED|Period 2: Washout (3 to 7 Days)||7
8956797|NCT02503085|10020486|FG003|STARTED|Period 2: Washout (3 to 7 Days)||7
8956798|NCT02503085|10020483|FG000|COMPLETED|Period 2: Washout (3 to 7 Days)||6
8631353|NCT00539279|9671213|FG001|NOT COMPLETED|6-Month Follow-Up Assessment||7
8631354|NCT00539305|9671221|FG000|STARTED|Overall Study||10
8631355|NCT00539305|9671222|FG001|STARTED|Overall Study||12
8956799|NCT02503085|10020484|FG001|COMPLETED|Period 2: Washout (3 to 7 Days)||7
8956800|NCT02503085|10020485|FG002|COMPLETED|Period 2: Washout (3 to 7 Days)||6
8956801|NCT02503085|10020486|FG003|COMPLETED|Period 2: Washout (3 to 7 Days)||7
8956802|NCT02503085|10020483|FG000|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||1
8956803|NCT02503085|10020484|FG001|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
8956804|NCT02503085|10020485|FG002|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||1
8956805|NCT02503085|10020486|FG003|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
8956806|NCT02503085|10020483|FG000|STARTED|Period 3||6
8956807|NCT02503085|10020484|FG001|STARTED|Period 3||7
8956808|NCT02503085|10020485|FG002|STARTED|Period 3||6
8956809|NCT02503085|10020486|FG003|STARTED|Period 3||7
8956810|NCT02503085|10020483|FG000|COMPLETED|Period 3||6
8956811|NCT02503085|10020484|FG001|COMPLETED|Period 3||7
8956812|NCT02503085|10020485|FG002|COMPLETED|Period 3||6
8956813|NCT02503085|10020486|FG003|COMPLETED|Period 3||7
8956814|NCT02503085|10020483|FG000|NOT COMPLETED|Period 3||0
8956815|NCT02503085|10020484|FG001|NOT COMPLETED|Period 3||0
8956816|NCT02503085|10020485|FG002|NOT COMPLETED|Period 3||0
8956817|NCT02503085|10020486|FG003|NOT COMPLETED|Period 3||0
8956818|NCT02503085|10020483|FG000|STARTED|Period 3: Washout (3 to 7 Days)||6
8956819|NCT02503085|10020484|FG001|STARTED|Period 3: Washout (3 to 7 Days)||7
8956820|NCT02503085|10020485|FG002|STARTED|Period 3: Washout (3 to 7 Days)||6
8956821|NCT02503085|10020486|FG003|STARTED|Period 3: Washout (3 to 7 Days)||7
8956822|NCT02503085|10020483|FG000|COMPLETED|Period 3: Washout (3 to 7 Days)||6
8956823|NCT02503085|10020484|FG001|COMPLETED|Period 3: Washout (3 to 7 Days)||7
8956824|NCT02503085|10020485|FG002|COMPLETED|Period 3: Washout (3 to 7 Days)||6
8956825|NCT02503085|10020486|FG003|COMPLETED|Period 3: Washout (3 to 7 Days)||7
8956826|NCT02503085|10020483|FG000|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
8956827|NCT02503085|10020484|FG001|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
8956828|NCT02503085|10020485|FG002|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
8956829|NCT02503085|10020486|FG003|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
8956830|NCT02503085|10020483|FG000|STARTED|Period 4||6
8956831|NCT02503085|10020484|FG001|STARTED|Period 4||7
8956832|NCT02503085|10020485|FG002|STARTED|Period 4||6
8956833|NCT02503085|10020486|FG003|STARTED|Period 4||7
8956834|NCT02503085|10020483|FG000|COMPLETED|Period 4||6
8956835|NCT02503085|10020484|FG001|COMPLETED|Period 4||7
8956836|NCT02503085|10020485|FG002|COMPLETED|Period 4||6
8956837|NCT02503085|10020486|FG003|COMPLETED|Period 4||7
8956838|NCT02503085|10020483|FG000|NOT COMPLETED|Period 4||0
8956839|NCT02503085|10020484|FG001|NOT COMPLETED|Period 4||0
8956840|NCT02503085|10020485|FG002|NOT COMPLETED|Period 4||0
8956841|NCT02503085|10020486|FG003|NOT COMPLETED|Period 4||0
8956842|NCT02503202|10020498|FG000|STARTED|Base Study: Up to Month 6||266
8956843|NCT02503202|10020499|FG001|STARTED|Base Study: Up to Month 6||265
8956844|NCT02503202|10020500|FG002|STARTED|Base Study: Up to Month 6||267
8956845|NCT02503202|10020501|FG003|STARTED|Base Study: Up to Month 6||266
8956846|NCT02503202|10020502|FG004|STARTED|Base Study: Up to Month 6||133
8956847|NCT02503202|10020498|FG000|Vaccinated|Base Study: Up to Month 6||266
8956848|NCT02503202|10020499|FG001|Vaccinated|Base Study: Up to Month 6||265
8956849|NCT02503202|10020500|FG002|Vaccinated|Base Study: Up to Month 6||266
8956850|NCT02503202|10020501|FG003|Vaccinated|Base Study: Up to Month 6||264
8956851|NCT02503202|10020502|FG004|Vaccinated|Base Study: Up to Month 6||133
8956852|NCT02503202|10020498|FG000|COMPLETED|Base Study: Up to Month 6||248
8956853|NCT02503202|10020499|FG001|COMPLETED|Base Study: Up to Month 6||253
8956854|NCT02503202|10020500|FG002|COMPLETED|Base Study: Up to Month 6||252
8956855|NCT02503202|10020501|FG003|COMPLETED|Base Study: Up to Month 6||255
8956856|NCT02503202|10020502|FG004|COMPLETED|Base Study: Up to Month 6||130
8956857|NCT02503202|10020498|FG000|NOT COMPLETED|Base Study: Up to Month 6||18
8956858|NCT02503202|10020499|FG001|NOT COMPLETED|Base Study: Up to Month 6||12
8956859|NCT02503202|10020500|FG002|NOT COMPLETED|Base Study: Up to Month 6||15
8956860|NCT02503202|10020501|FG003|NOT COMPLETED|Base Study: Up to Month 6||11
8956861|NCT02503202|10020502|FG004|NOT COMPLETED|Base Study: Up to Month 6||3
8956862|NCT02503202|10020498|FG000|STARTED|Extension: Month 6 to 24||119
8956863|NCT02503202|10020499|FG001|STARTED|Extension: Month 6 to 24||130
8956864|NCT02503202|10020500|FG002|STARTED|Extension: Month 6 to 24||112
8631356|NCT00539305|9671221|FG000|COMPLETED|Overall Study||9
8631357|NCT00539305|9671222|FG001|COMPLETED|Overall Study||10
8956865|NCT02503202|10020501|FG003|STARTED|Extension: Month 6 to 24||137
8956866|NCT02503202|10020502|FG004|STARTED|Extension: Month 6 to 24||68
8956867|NCT02503202|10020498|FG000|COMPLETED|Extension: Month 6 to 24||108
8956868|NCT02503202|10020499|FG001|COMPLETED|Extension: Month 6 to 24||114
8956869|NCT02503202|10020500|FG002|COMPLETED|Extension: Month 6 to 24||103
8956870|NCT02503202|10020501|FG003|COMPLETED|Extension: Month 6 to 24||119
8956871|NCT02503202|10020502|FG004|COMPLETED|Extension: Month 6 to 24||67
8956872|NCT02503202|10020498|FG000|NOT COMPLETED|Extension: Month 6 to 24||11
8956873|NCT02503202|10020499|FG001|NOT COMPLETED|Extension: Month 6 to 24||16
8956874|NCT02503202|10020500|FG002|NOT COMPLETED|Extension: Month 6 to 24||9
8956875|NCT02503202|10020501|FG003|NOT COMPLETED|Extension: Month 6 to 24||18
8956876|NCT02503202|10020502|FG004|NOT COMPLETED|Extension: Month 6 to 24||1
8956877|NCT02503215|10020514|FG000|STARTED|Overall Study||17
8956878|NCT02503215|10020514|FG000|COMPLETED|Overall Study||14
8956879|NCT02503215|10020514|FG000|NOT COMPLETED|Overall Study||3
8956880|NCT02503254|10020520|FG000|STARTED|Overall Study||41
8956881|NCT02503254|10020521|FG001|STARTED|Overall Study||39
8956882|NCT02503254|10020520|FG000|COMPLETED|Overall Study||41
8956883|NCT02503254|10020521|FG001|COMPLETED|Overall Study||39
8956884|NCT02503254|10020520|FG000|NOT COMPLETED|Overall Study||0
8956885|NCT02503254|10020521|FG001|NOT COMPLETED|Overall Study||0
8956886|NCT02503332|10020531|FG000|STARTED|Overall Study||86
8956887|NCT02503332|10020532|FG001|STARTED|Overall Study||79
8956888|NCT02503332|10020533|FG002|STARTED|Overall Study||41
8956889|NCT02503332|10020534|FG003|STARTED|Overall Study||40
8956890|NCT02503332|10020531|FG000|COMPLETED|Overall Study||52
8956891|NCT02503332|10020532|FG001|COMPLETED|Overall Study||60
8956892|NCT02503332|10020533|FG002|COMPLETED|Overall Study||33
8956893|NCT02503332|10020534|FG003|COMPLETED|Overall Study||36
8956894|NCT02503332|10020531|FG000|NOT COMPLETED|Overall Study||34
8956895|NCT02503332|10020532|FG001|NOT COMPLETED|Overall Study||19
8956896|NCT02503332|10020533|FG002|NOT COMPLETED|Overall Study||8
8956897|NCT02503332|10020534|FG003|NOT COMPLETED|Overall Study||4
8956898|NCT02503410|10020550|FG000|STARTED|Overall Study||4
8956899|NCT02503410|10020551|FG001|STARTED|Overall Study||3
8956900|NCT02503410|10020550|FG000|COMPLETED|Overall Study||4
8956901|NCT02503410|10020551|FG001|COMPLETED|Overall Study||3
8956902|NCT02503410|10020550|FG000|NOT COMPLETED|Overall Study||0
8956903|NCT02503410|10020551|FG001|NOT COMPLETED|Overall Study||0
8956904|NCT02503501|10020564|FG000|STARTED|Overall Study||19
8956905|NCT02503501|10020565|FG001|STARTED|Overall Study||16
8956906|NCT02503501|10020564|FG000|COMPLETED|Overall Study||18
8956907|NCT02503501|10020565|FG001|COMPLETED|Overall Study||13
8956908|NCT02503501|10020564|FG000|NOT COMPLETED|Overall Study||1
8956909|NCT02503501|10020565|FG001|NOT COMPLETED|Overall Study||3
8570184|NCT00101686|9602314|FG001|NOT COMPLETED|Overall Study||73
8570185|NCT00101686|9602315|FG002|NOT COMPLETED|Overall Study||69
8570186|NCT00101686|9602316|FG003|NOT COMPLETED|Overall Study||72
8570187|NCT00101686|9602317|FG004|NOT COMPLETED|Overall Study||73
8570188|NCT00101686|9602318|FG005|NOT COMPLETED|Overall Study||72
8570189|NCT00101686|9602319|FG006|NOT COMPLETED|Overall Study||27
8570190|NCT00101686|9602320|FG007|NOT COMPLETED|Overall Study||30
8570191|NCT00101686|9602321|FG008|NOT COMPLETED|Overall Study||30
8570192|NCT00101686|9602322|FG009|NOT COMPLETED|Overall Study||30
8570193|NCT00101816|9602341|FG000|STARTED|Overall Study||10
8570194|NCT00101816|9602342|FG001|STARTED|Overall Study||99
8570195|NCT00101816|9602341|FG000|COMPLETED|Overall Study||10
8631358|NCT00539305|9671221|FG000|NOT COMPLETED|Overall Study||1
8874817|NCT01904773|9931729|FG008|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8874818|NCT01904773|9931721|FG000|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||4
8874819|NCT01904773|9931722|FG001|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8874820|NCT01904773|9931723|FG002|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8874821|NCT01904773|9931724|FG003|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8874822|NCT01904773|9931725|FG004|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8874823|NCT01904773|9931726|FG005|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8956910|NCT02503540|10020571|FG000|STARTED|Overall Study||31
8956911|NCT02503540|10020571|FG000|COMPLETED|Overall Study||28
8956912|NCT02503540|10020571|FG000|NOT COMPLETED|Overall Study||3
8956913|NCT02503735|10020575|FG000|STARTED|Overall Study||10
8570196|NCT00101816|9602342|FG001|COMPLETED|Overall Study||99
8631359|NCT00539305|9671222|FG001|NOT COMPLETED|Overall Study||2
8956914|NCT02503735|10020575|FG000|SVR 12 (12week Post Treatment RNA Neg)|Overall Study||8
8956915|NCT02503735|10020575|FG000|COMPLETED|Overall Study||10
8956916|NCT02503735|10020575|FG000|NOT COMPLETED|Overall Study||0
8956917|NCT02503787|10020585|FG000|STARTED|Enrollment||64
8956918|NCT02503787|10020585|FG000|COMPLETED|Enrollment||44
8956919|NCT02503787|10020585|FG000|NOT COMPLETED|Enrollment||20
8956920|NCT02503787|10020585|FG000|STARTED|Device Trial (HD Programming Trial)||44
8956921|NCT02503787|10020585|FG000|COMPLETED|Device Trial (HD Programming Trial)||37
8956922|NCT02503787|10020585|FG000|NOT COMPLETED|Device Trial (HD Programming Trial)||7
8956923|NCT02503787|10020585|FG000|STARTED|Successful Trial (≥50% Pain Relief)||37
8956924|NCT02503787|10020585|FG000|COMPLETED|Successful Trial (≥50% Pain Relief)||32
8956925|NCT02503787|10020585|FG000|NOT COMPLETED|Successful Trial (≥50% Pain Relief)||5
8956926|NCT02503787|10020585|FG000|STARTED|Implant to 3 Month Endpoint||32
8956927|NCT02503787|10020585|FG000|COMPLETED|Implant to 3 Month Endpoint||29
8956928|NCT02503787|10020585|FG000|NOT COMPLETED|Implant to 3 Month Endpoint||3
8956929|NCT02503852|10020593|FG000|STARTED|Overall Study||16
8956930|NCT02503852|10020594|FG001|STARTED|Overall Study||22
8956931|NCT02503852|10020595|FG002|STARTED|Overall Study||24
8956932|NCT02503852|10020596|FG003|STARTED|Overall Study||9
8956933|NCT02503852|10020593|FG000|COMPLETED|Overall Study||12
8956934|NCT02503852|10020594|FG001|COMPLETED|Overall Study||19
8956935|NCT02503852|10020595|FG002|COMPLETED|Overall Study||21
8956936|NCT02503852|10020596|FG003|COMPLETED|Overall Study||8
8956937|NCT02503852|10020593|FG000|NOT COMPLETED|Overall Study||4
8956938|NCT02503852|10020594|FG001|NOT COMPLETED|Overall Study||3
8956939|NCT02503852|10020595|FG002|NOT COMPLETED|Overall Study||3
8956940|NCT02503852|10020596|FG003|NOT COMPLETED|Overall Study||1
8956941|NCT02503865|10020609|FG000|STARTED|Overall Study||70
8956942|NCT02503865|10020610|FG001|STARTED|Overall Study||269
8956943|NCT02503865|10020611|FG002|STARTED|Overall Study||66
8956944|NCT02503865|10020609|FG000|COMPLETED|Overall Study||65
8956945|NCT02503865|10020610|FG001|COMPLETED|Overall Study||222
8956946|NCT02503865|10020611|FG002|COMPLETED|Overall Study||64
8956947|NCT02503865|10020609|FG000|NOT COMPLETED|Overall Study||5
8956948|NCT02503865|10020610|FG001|NOT COMPLETED|Overall Study||47
8956949|NCT02503865|10020611|FG002|NOT COMPLETED|Overall Study||2
8956950|NCT02503982|10020620|FG000|STARTED|Overall Study||13
8956951|NCT02503982|10020620|FG000|COMPLETED|Overall Study||13
8956952|NCT02503982|10020620|FG000|NOT COMPLETED|Overall Study||0
8956953|NCT02504073|10020624|FG000|STARTED|Overall Study||54
8956954|NCT02504073|10020624|FG000|COMPLETED|Overall Study||54
8956955|NCT02504073|10020624|FG000|NOT COMPLETED|Overall Study||0
8956956|NCT02504216|10020631|FG000|STARTED|Overall Study||3286
8956957|NCT02504216|10020632|FG001|STARTED|Overall Study||3278
8956958|NCT02504216|10020631|FG000|Received Treatment|Overall Study||3256
8956959|NCT02504216|10020632|FG001|Received Treatment|Overall Study||3248
8956960|NCT02504216|10020631|FG000|COMPLETED|Overall Study||3275
8956961|NCT02504216|10020632|FG001|COMPLETED|Overall Study||3263
8956962|NCT02504216|10020631|FG000|NOT COMPLETED|Overall Study||11
8956963|NCT02504216|10020632|FG001|NOT COMPLETED|Overall Study||15
8956964|NCT02504268|10020641|FG000|STARTED|Overall Study||451
8956965|NCT02504268|10020642|FG001|STARTED|Overall Study||301
8956966|NCT02504268|10020643|FG002|STARTED|Overall Study||242
8956967|NCT02504268|10020644|FG003|STARTED|Overall Study||0
8956968|NCT02504268|10020645|FG004|STARTED|Overall Study||0
8956969|NCT02504268|10020646|FG005|STARTED|Overall Study||0
8956970|NCT02504268|10020647|FG006|STARTED|Overall Study||0
8956971|NCT02504268|10020648|FG007|STARTED|Overall Study||0
8956972|NCT02504268|10020649|FG008|STARTED|Overall Study||0
8956973|NCT02504268|10020641|FG000|Induction to Open Label|Overall Study||289
8956974|NCT02504268|10020642|FG001|Induction to Open Label|Overall Study||196
8956975|NCT02504268|10020643|FG002|Induction to Open Label|Overall Study||147
8956976|NCT02504268|10020644|FG003|Induction to Open Label|Overall Study||0
8956977|NCT02504268|10020645|FG004|Induction to Open Label|Overall Study||0
8956978|NCT02504268|10020646|FG005|Induction to Open Label|Overall Study||0
8956979|NCT02504268|10020647|FG006|Induction to Open Label|Overall Study||0
8956980|NCT02504268|10020648|FG007|Induction to Open Label|Overall Study||0
8956981|NCT02504268|10020649|FG008|Induction to Open Label|Overall Study||0
8956982|NCT02504268|10020641|FG000|Early Escaped to Open Label|Overall Study||10
8956983|NCT02504268|10020642|FG001|Early Escaped to Open Label|Overall Study||21
8956984|NCT02504268|10020643|FG002|Early Escaped to Open Label|Overall Study||8
8956985|NCT02504268|10020644|FG003|Early Escaped to Open Label|Overall Study||0
8956986|NCT02504268|10020645|FG004|Early Escaped to Open Label|Overall Study||0
8956987|NCT02504268|10020646|FG005|Early Escaped to Open Label|Overall Study||0
8956988|NCT02504268|10020647|FG006|Early Escaped to Open Label|Overall Study||0
8956989|NCT02504268|10020648|FG007|Early Escaped to Open Label|Overall Study||0
8956990|NCT02504268|10020649|FG008|Early Escaped to Open Label|Overall Study||0
8956991|NCT02504268|10020641|FG000|Induction to De-Escalation|Overall Study||94
8956992|NCT02504268|10020642|FG001|Induction to De-Escalation|Overall Study||37
8956993|NCT02504268|10020643|FG002|Induction to De-Escalation|Overall Study||53
8956994|NCT02504268|10020644|FG003|Induction to De-Escalation|Overall Study||0
8956995|NCT02504268|10020645|FG004|Induction to De-Escalation|Overall Study||0
8956996|NCT02504268|10020646|FG005|Induction to De-Escalation|Overall Study||0
8956997|NCT02504268|10020647|FG006|Induction to De-Escalation|Overall Study||0
8956998|NCT02504268|10020648|FG007|Induction to De-Escalation|Overall Study||0
8956999|NCT02504268|10020649|FG008|Induction to De-Escalation|Overall Study||0
8957000|NCT02504268|10020641|FG000|Randomized in De-Escalation Period|Overall Study||0
8957001|NCT02504268|10020642|FG001|Randomized in De-Escalation Period|Overall Study||0
8957002|NCT02504268|10020643|FG002|Randomized in De-Escalation Period|Overall Study||0
8957003|NCT02504268|10020644|FG003|Randomized in De-Escalation Period|Overall Study||50
8957004|NCT02504268|10020645|FG004|Randomized in De-Escalation Period|Overall Study||50
8957005|NCT02504268|10020646|FG005|Randomized in De-Escalation Period|Overall Study||47
8957006|NCT02504268|10020647|FG006|Randomized in De-Escalation Period|Overall Study||37
8957007|NCT02504268|10020648|FG007|Randomized in De-Escalation Period|Overall Study||0
8957008|NCT02504268|10020649|FG008|Randomized in De-Escalation Period|Overall Study||0
8957009|NCT02504268|10020641|FG000|De-Escalation to Open Label Extension|Overall Study||0
8957010|NCT02504268|10020642|FG001|De-Escalation to Open Label Extension|Overall Study||0
8957011|NCT02504268|10020643|FG002|De-Escalation to Open Label Extension|Overall Study||0
8957012|NCT02504268|10020644|FG003|De-Escalation to Open Label Extension|Overall Study||36
8957013|NCT02504268|10020645|FG004|De-Escalation to Open Label Extension|Overall Study||30
8957014|NCT02504268|10020646|FG005|De-Escalation to Open Label Extension|Overall Study||32
8957015|NCT02504268|10020647|FG006|De-Escalation to Open Label Extension|Overall Study||22
8957016|NCT02504268|10020648|FG007|De-Escalation to Open Label Extension|Overall Study||0
8957017|NCT02504268|10020649|FG008|De-Escalation to Open Label Extension|Overall Study||0
8957018|NCT02504268|10020641|FG000|Early Escaped De-Escalation to Open Label Period|Overall Study||0
8957019|NCT02504268|10020642|FG001|Early Escaped De-Escalation to Open Label Period|Overall Study||0
8957020|NCT02504268|10020643|FG002|Early Escaped De-Escalation to Open Label Period|Overall Study||0
8957021|NCT02504268|10020644|FG003|Early Escaped De-Escalation to Open Label Period|Overall Study||2
8957022|NCT02504268|10020645|FG004|Early Escaped De-Escalation to Open Label Period|Overall Study||5
8957023|NCT02504268|10020646|FG005|Early Escaped De-Escalation to Open Label Period|Overall Study||4
8957024|NCT02504268|10020647|FG006|Early Escaped De-Escalation to Open Label Period|Overall Study||3
8957025|NCT02504268|10020648|FG007|Early Escaped De-Escalation to Open Label Period|Overall Study||0
8957026|NCT02504268|10020649|FG008|Early Escaped De-Escalation to Open Label Period|Overall Study||0
8957027|NCT02504268|10020641|FG000|Open Label and Open Label Extension Period|Overall Study||0
8957028|NCT02504268|10020642|FG001|Open Label and Open Label Extension Period|Overall Study||0
8957029|NCT02504268|10020643|FG002|Open Label and Open Label Extension Period|Overall Study||0
8957030|NCT02504268|10020644|FG003|Open Label and Open Label Extension Period|Overall Study||0
8957031|NCT02504268|10020645|FG004|Open Label and Open Label Extension Period|Overall Study||0
8957032|NCT02504268|10020646|FG005|Open Label and Open Label Extension Period|Overall Study||0
8957033|NCT02504268|10020647|FG006|Open Label and Open Label Extension Period|Overall Study||0
8957034|NCT02504268|10020648|FG007|Open Label and Open Label Extension Period|Overall Study||685
8957035|NCT02504268|10020649|FG008|Open Label and Open Label Extension Period|Overall Study||120
8957036|NCT02504268|10020641|FG000|COMPLETED|Overall Study||388
8957037|NCT02504268|10020642|FG001|COMPLETED|Overall Study||233
8957038|NCT02504268|10020643|FG002|COMPLETED|Overall Study||201
8957039|NCT02504268|10020644|FG003|COMPLETED|Overall Study||0
8957040|NCT02504268|10020645|FG004|COMPLETED|Overall Study||0
8957041|NCT02504268|10020646|FG005|COMPLETED|Overall Study||0
8957042|NCT02504268|10020647|FG006|COMPLETED|Overall Study||0
8957043|NCT02504268|10020648|FG007|COMPLETED|Overall Study||0
8957044|NCT02504268|10020649|FG008|COMPLETED|Overall Study||0
8957045|NCT02504268|10020641|FG000|NOT COMPLETED|Overall Study||63
8957046|NCT02504268|10020642|FG001|NOT COMPLETED|Overall Study||68
8957047|NCT02504268|10020643|FG002|NOT COMPLETED|Overall Study||41
8957048|NCT02504268|10020644|FG003|NOT COMPLETED|Overall Study||0
8957049|NCT02504268|10020645|FG004|NOT COMPLETED|Overall Study||0
8957050|NCT02504268|10020646|FG005|NOT COMPLETED|Overall Study||0
8957051|NCT02504268|10020647|FG006|NOT COMPLETED|Overall Study||0
8957052|NCT02504268|10020648|FG007|NOT COMPLETED|Overall Study||0
8957053|NCT02504268|10020649|FG008|NOT COMPLETED|Overall Study||0
8957054|NCT02504294|10020671|FG000|STARTED|Overall Study||212
8957055|NCT02504294|10020672|FG001|STARTED|Overall Study||206
8957056|NCT02504294|10020671|FG000|COMPLETED|Overall Study||156
8957057|NCT02504294|10020672|FG001|COMPLETED|Overall Study||158
8957058|NCT02504294|10020671|FG000|NOT COMPLETED|Overall Study||56
8957059|NCT02504294|10020672|FG001|NOT COMPLETED|Overall Study||48
8957060|NCT02504320|10020682|FG000|STARTED|Treatment Period 1||19
8957061|NCT02504320|10020683|FG001|STARTED|Treatment Period 1||19
8957062|NCT02504320|10020684|FG002|STARTED|Treatment Period 1||20
8957063|NCT02504320|10020685|FG003|STARTED|Treatment Period 1||20
8957064|NCT02504320|10020682|FG000|COMPLETED|Treatment Period 1||19
8957065|NCT02504320|10020683|FG001|COMPLETED|Treatment Period 1||19
8957066|NCT02504320|10020684|FG002|COMPLETED|Treatment Period 1||19
8957067|NCT02504320|10020685|FG003|COMPLETED|Treatment Period 1||20
8957068|NCT02504320|10020682|FG000|NOT COMPLETED|Treatment Period 1||0
8957069|NCT02504320|10020683|FG001|NOT COMPLETED|Treatment Period 1||0
8957070|NCT02504320|10020684|FG002|NOT COMPLETED|Treatment Period 1||1
8957071|NCT02504320|10020685|FG003|NOT COMPLETED|Treatment Period 1||0
8957072|NCT02504320|10020682|FG000|STARTED|Treatment Period 2||19
8957073|NCT02504320|10020683|FG001|STARTED|Treatment Period 2||19
8957074|NCT02504320|10020684|FG002|STARTED|Treatment Period 2||19
8957075|NCT02504320|10020685|FG003|STARTED|Treatment Period 2||20
8957076|NCT02504320|10020682|FG000|COMPLETED|Treatment Period 2||19
8957077|NCT02504320|10020683|FG001|COMPLETED|Treatment Period 2||18
8957078|NCT02504320|10020684|FG002|COMPLETED|Treatment Period 2||19
8957079|NCT02504320|10020685|FG003|COMPLETED|Treatment Period 2||20
8957080|NCT02504320|10020682|FG000|NOT COMPLETED|Treatment Period 2||0
8957081|NCT02504320|10020683|FG001|NOT COMPLETED|Treatment Period 2||1
8957082|NCT02504320|10020684|FG002|NOT COMPLETED|Treatment Period 2||0
8957083|NCT02504320|10020685|FG003|NOT COMPLETED|Treatment Period 2||0
8957084|NCT02504320|10020682|FG000|STARTED|Treatment Period 3||19
8957085|NCT02504320|10020683|FG001|STARTED|Treatment Period 3||18
8957086|NCT02504320|10020684|FG002|STARTED|Treatment Period 3||19
8957087|NCT02504320|10020685|FG003|STARTED|Treatment Period 3||20
8957088|NCT02504320|10020682|FG000|COMPLETED|Treatment Period 3||19
8957089|NCT02504320|10020683|FG001|COMPLETED|Treatment Period 3||18
8957090|NCT02504320|10020684|FG002|COMPLETED|Treatment Period 3||18
8957091|NCT02504320|10020685|FG003|COMPLETED|Treatment Period 3||19
8957092|NCT02504320|10020682|FG000|NOT COMPLETED|Treatment Period 3||0
8957093|NCT02504320|10020683|FG001|NOT COMPLETED|Treatment Period 3||0
8957094|NCT02504320|10020684|FG002|NOT COMPLETED|Treatment Period 3||1
8957095|NCT02504320|10020685|FG003|NOT COMPLETED|Treatment Period 3||1
8957096|NCT02504320|10020682|FG000|STARTED|Treatment Period 4||19
8957097|NCT02504320|10020683|FG001|STARTED|Treatment Period 4||18
8957098|NCT02504320|10020684|FG002|STARTED|Treatment Period 4||18
8957099|NCT02504320|10020685|FG003|STARTED|Treatment Period 4||19
8957100|NCT02504320|10020682|FG000|COMPLETED|Treatment Period 4||19
8957101|NCT02504320|10020683|FG001|COMPLETED|Treatment Period 4||18
8957102|NCT02504320|10020684|FG002|COMPLETED|Treatment Period 4||18
8957103|NCT02504320|10020685|FG003|COMPLETED|Treatment Period 4||19
8957104|NCT02504320|10020682|FG000|NOT COMPLETED|Treatment Period 4||0
8957105|NCT02504320|10020683|FG001|NOT COMPLETED|Treatment Period 4||0
8957106|NCT02504320|10020684|FG002|NOT COMPLETED|Treatment Period 4||0
8957107|NCT02504320|10020685|FG003|NOT COMPLETED|Treatment Period 4||0
8957108|NCT02504424|10020695|FG000|STARTED|Overall Study||50
8957109|NCT02504424|10020695|FG000|COMPLETED|Overall Study||48
8957110|NCT02504424|10020695|FG000|NOT COMPLETED|Overall Study||2
8957111|NCT02504502|10020702|FG000|STARTED|Routine Care vs. Enhanced Report||24
8957112|NCT02504502|10020703|FG001|STARTED|Routine Care vs. Enhanced Report||28
8957113|NCT02504502|10020702|FG000|COMPLETED|Routine Care vs. Enhanced Report||20
8957114|NCT02504502|10020703|FG001|COMPLETED|Routine Care vs. Enhanced Report||21
8957115|NCT02504502|10020702|FG000|NOT COMPLETED|Routine Care vs. Enhanced Report||4
8957116|NCT02504502|10020703|FG001|NOT COMPLETED|Routine Care vs. Enhanced Report||7
8957117|NCT02504502|10020702|FG000|STARTED|Crossover to Enhanced Report||20
8957118|NCT02504502|10020703|FG001|STARTED|Crossover to Enhanced Report|The enhanced report arm was completed in first period and does not carry forward to period 2.|0
8957119|NCT02504502|10020702|FG000|COMPLETED|Crossover to Enhanced Report||15
8957120|NCT02504502|10020703|FG001|COMPLETED|Crossover to Enhanced Report|the enhanced report arm was completed in first period and does not carry forward to period 2|0
8957121|NCT02504502|10020702|FG000|NOT COMPLETED|Crossover to Enhanced Report||5
8957122|NCT02504502|10020703|FG001|NOT COMPLETED|Crossover to Enhanced Report||0
8957123|NCT02504541|10020709|FG000|STARTED|Overall Study||133
8957124|NCT02504541|10020709|FG000|COMPLETED|Overall Study||113
8957125|NCT02504541|10020709|FG000|NOT COMPLETED|Overall Study||20
8957126|NCT02504554|10020715|FG000|STARTED|Overall Study|1 participant was switched from the oral group to the rectal group due to nausea/vomiting.|12
8570197|NCT00101816|9602341|FG000|NOT COMPLETED|Overall Study||0
8570198|NCT00101816|9602342|FG001|NOT COMPLETED|Overall Study||0
8570199|NCT00101868|9602358|FG000|STARTED|Overall Study|35 hospital physicians allocated to discharge software|316
8570200|NCT00101868|9602359|FG001|STARTED|Overall Study|35 hospital physicians allocated to usual care discharge|315
8570201|NCT00101868|9602358|FG000|COMPLETED|Overall Study|1 hospital physician with zero patients lost to follow up|287
8570202|NCT00101868|9602359|FG001|COMPLETED|Overall Study|zero hospital physician with zero patients lost to follow up|283
8570203|NCT00101868|9602358|FG000|NOT COMPLETED|Overall Study||29
8570204|NCT00101868|9602359|FG001|NOT COMPLETED|Overall Study||32
8570205|NCT00101907|9602373|FG000|STARTED|Overall Study||8
8957127|NCT02504554|10020716|FG001|STARTED|Overall Study||6
8957128|NCT02504554|10020715|FG000|COMPLETED|Overall Study||12
8957129|NCT02504554|10020716|FG001|COMPLETED|Overall Study||6
8957130|NCT02504554|10020715|FG000|NOT COMPLETED|Overall Study||0
8957131|NCT02504554|10020716|FG001|NOT COMPLETED|Overall Study||0
8957132|NCT02504619|10020722|FG000|STARTED|Overall Study||1
8957133|NCT02504619|10020722|FG000|COMPLETED|Overall Study||1
8957134|NCT02504619|10020722|FG000|NOT COMPLETED|Overall Study||0
8957135|NCT02504645|10020729|FG000|STARTED|Overall Study||101
8957136|NCT02504645|10020730|FG001|STARTED|Overall Study||101
8957137|NCT02504645|10020729|FG000|COMPLETED|Overall Study||77
8957138|NCT02504645|10020730|FG001|COMPLETED|Overall Study||76
8957139|NCT02504645|10020729|FG000|NOT COMPLETED|Overall Study||24
8957140|NCT02504645|10020730|FG001|NOT COMPLETED|Overall Study||25
8957141|NCT02504671|10020742|FG000|STARTED|Overall Study||37
8957142|NCT02504671|10020743|FG001|STARTED|Overall Study||37
8957143|NCT02504671|10020744|FG002|STARTED|Overall Study||37
8957144|NCT02504671|10020745|FG003|STARTED|Overall Study||37
8957145|NCT02504671|10020746|FG004|STARTED|Overall Study||37
8957146|NCT02504671|10020747|FG005|STARTED|Overall Study||37
8957147|NCT02504671|10020742|FG000|COMPLETED|Overall Study||25
8957148|NCT02504671|10020743|FG001|COMPLETED|Overall Study||23
8957149|NCT02504671|10020744|FG002|COMPLETED|Overall Study||27
8957150|NCT02504671|10020745|FG003|COMPLETED|Overall Study||27
8957151|NCT02504671|10020746|FG004|COMPLETED|Overall Study||25
8957152|NCT02504671|10020747|FG005|COMPLETED|Overall Study||23
8957153|NCT02504671|10020742|FG000|NOT COMPLETED|Overall Study||12
8957154|NCT02504671|10020743|FG001|NOT COMPLETED|Overall Study||14
8957155|NCT02504671|10020744|FG002|NOT COMPLETED|Overall Study||10
8957156|NCT02504671|10020745|FG003|NOT COMPLETED|Overall Study||10
8957157|NCT02504671|10020746|FG004|NOT COMPLETED|Overall Study||12
8957158|NCT02504671|10020747|FG005|NOT COMPLETED|Overall Study||14
8957159|NCT02504723|10020763|FG000|STARTED|Overall Study||60
8957160|NCT02504723|10020764|FG001|STARTED|Overall Study||61
8957161|NCT02504723|10020763|FG000|COMPLETED|Overall Study||60
8957162|NCT02504723|10020764|FG001|COMPLETED|Overall Study||61
8957163|NCT02504723|10020763|FG000|NOT COMPLETED|Overall Study||0
8957164|NCT02504723|10020764|FG001|NOT COMPLETED|Overall Study||0
8957165|NCT02504775|10020770|FG000|STARTED|Period 1||14
8957166|NCT02504775|10020771|FG001|STARTED|Period 1||14
8957167|NCT02504775|10020770|FG000|COMPLETED|Period 1||14
8957168|NCT02504775|10020771|FG001|COMPLETED|Period 1||14
8957169|NCT02504775|10020770|FG000|NOT COMPLETED|Period 1||0
8957170|NCT02504775|10020771|FG001|NOT COMPLETED|Period 1||0
8957171|NCT02504775|10020770|FG000|STARTED|Washout||14
8957172|NCT02504775|10020771|FG001|STARTED|Washout||14
8957173|NCT02504775|10020770|FG000|COMPLETED|Washout||14
8957174|NCT02504775|10020771|FG001|COMPLETED|Washout||14
8957175|NCT02504775|10020770|FG000|NOT COMPLETED|Washout||0
8957176|NCT02504775|10020771|FG001|NOT COMPLETED|Washout||0
8957177|NCT02504775|10020770|FG000|STARTED|Period 2||14
8957178|NCT02504775|10020771|FG001|STARTED|Period 2||14
8957179|NCT02504775|10020770|FG000|COMPLETED|Period 2||14
8957180|NCT02504775|10020771|FG001|COMPLETED|Period 2||14
8957181|NCT02504775|10020770|FG000|NOT COMPLETED|Period 2||0
8957182|NCT02504775|10020771|FG001|NOT COMPLETED|Period 2||0
8957183|NCT02504827|10020779|FG000|STARTED|Overall Study||12
8957184|NCT02504827|10020779|FG000|COMPLETED|Overall Study||11
8957185|NCT02504827|10020779|FG000|NOT COMPLETED|Overall Study||1
8957186|NCT02504892|10020783|FG000|STARTED|Overall Study||3
8957187|NCT02504892|10020783|FG000|COMPLETED|Overall Study||1
8957188|NCT02504892|10020783|FG000|NOT COMPLETED|Overall Study||2
8957189|NCT02504931|10020789|FG000|STARTED|Overall Study||26
8957190|NCT02504931|10020790|FG001|STARTED|Overall Study||23
8957191|NCT02504931|10020789|FG000|COMPLETED|Overall Study||14
8957192|NCT02504931|10020790|FG001|COMPLETED|Overall Study||13
8957193|NCT02504931|10020789|FG000|NOT COMPLETED|Overall Study||12
8957194|NCT02504931|10020790|FG001|NOT COMPLETED|Overall Study||10
8957195|NCT02505217|10020798|FG000|STARTED|Overall Study||105
8957196|NCT02505217|10020799|FG001|STARTED|Overall Study||95
8957197|NCT02505217|10020798|FG000|COMPLETED|Overall Study||104
8957198|NCT02505217|10020799|FG001|COMPLETED|Overall Study||93
8957199|NCT02505217|10020798|FG000|NOT COMPLETED|Overall Study||1
8957200|NCT02505217|10020799|FG001|NOT COMPLETED|Overall Study||2
8957201|NCT02505269|10020805|FG000|STARTED|Overall Study||34
8957202|NCT02505269|10020805|FG000|COMPLETED|Overall Study||34
8957203|NCT02505269|10020805|FG000|NOT COMPLETED|Overall Study||0
8957204|NCT02505334|10020811|FG000|STARTED|Main Treatment Period||233
8957205|NCT02505334|10020812|FG001|STARTED|Main Treatment Period||233
8957206|NCT02505334|10020811|FG000|COMPLETED|Main Treatment Period||218
8957207|NCT02505334|10020812|FG001|COMPLETED|Main Treatment Period||194
8957208|NCT02505334|10020811|FG000|NOT COMPLETED|Main Treatment Period||15
8957209|NCT02505334|10020812|FG001|NOT COMPLETED|Main Treatment Period||39
8957210|NCT02505334|10020811|FG000|STARTED|Extension Treatment Period|6 subjects withdrew from the trial after the main period and prior to entering the extension period|212
8957211|NCT02505334|10020812|FG001|STARTED|Extension Treatment Period|This treatment arm is not considered for this period as the subjects were treated for 26 weeks|0
8957212|NCT02505334|10020811|FG000|COMPLETED|Extension Treatment Period||194
8957213|NCT02505334|10020812|FG001|COMPLETED|Extension Treatment Period||0
8957214|NCT02505334|10020811|FG000|NOT COMPLETED|Extension Treatment Period||18
8957215|NCT02505334|10020812|FG001|NOT COMPLETED|Extension Treatment Period||0
8957216|NCT02505542|10020818|FG000|STARTED|Part A: Open-Label Period||736
8957217|NCT02505542|10020819|FG001|STARTED|Part A: Open-Label Period||0
8957218|NCT02505542|10020820|FG002|STARTED|Part A: Open-Label Period||0
8957219|NCT02505542|10020821|FG003|STARTED|Part A: Open-Label Period||0
8957220|NCT02505542|10020818|FG000|COMPLETED|Part A: Open-Label Period||659
8957221|NCT02505542|10020819|FG001|COMPLETED|Part A: Open-Label Period||0
8957222|NCT02505542|10020820|FG002|COMPLETED|Part A: Open-Label Period||0
8957223|NCT02505542|10020821|FG003|COMPLETED|Part A: Open-Label Period||0
8957224|NCT02505542|10020818|FG000|NOT COMPLETED|Part A: Open-Label Period||77
8957225|NCT02505542|10020819|FG001|NOT COMPLETED|Part A: Open-Label Period||0
8957226|NCT02505542|10020820|FG002|NOT COMPLETED|Part A: Open-Label Period||0
8957227|NCT02505542|10020821|FG003|NOT COMPLETED|Part A: Open-Label Period||0
8957228|NCT02505542|10020818|FG000|STARTED|Completed Part A, Did Not Enter Part B||659
8957229|NCT02505542|10020819|FG001|STARTED|Completed Part A, Did Not Enter Part B||0
8957230|NCT02505542|10020820|FG002|STARTED|Completed Part A, Did Not Enter Part B||0
8957231|NCT02505542|10020821|FG003|STARTED|Completed Part A, Did Not Enter Part B||0
8957232|NCT02505542|10020818|FG000|COMPLETED|Completed Part A, Did Not Enter Part B||313
8957233|NCT02505542|10020819|FG001|COMPLETED|Completed Part A, Did Not Enter Part B||0
8957234|NCT02505542|10020820|FG002|COMPLETED|Completed Part A, Did Not Enter Part B||0
8957235|NCT02505542|10020821|FG003|COMPLETED|Completed Part A, Did Not Enter Part B||0
8957236|NCT02505542|10020818|FG000|NOT COMPLETED|Completed Part A, Did Not Enter Part B||346
8957237|NCT02505542|10020819|FG001|NOT COMPLETED|Completed Part A, Did Not Enter Part B||0
8957238|NCT02505542|10020820|FG002|NOT COMPLETED|Completed Part A, Did Not Enter Part B||0
8957239|NCT02505542|10020821|FG003|NOT COMPLETED|Completed Part A, Did Not Enter Part B||0
8957240|NCT02505542|10020818|FG000|STARTED|Part B: Double-Blind Period||0
8957241|NCT02505542|10020819|FG001|STARTED|Part B: Double-Blind Period||104
8957242|NCT02505542|10020820|FG002|STARTED|Part B: Double-Blind Period||104
8957243|NCT02505542|10020821|FG003|STARTED|Part B: Double-Blind Period||105
8957244|NCT02505542|10020818|FG000|Started Escape Period|Part B: Double-Blind Period||0
8957245|NCT02505542|10020819|FG001|Started Escape Period|Part B: Double-Blind Period||73
8957246|NCT02505542|10020820|FG002|Started Escape Period|Part B: Double-Blind Period||7
8957247|NCT02505542|10020821|FG003|Started Escape Period|Part B: Double-Blind Period||15
8957248|NCT02505542|10020818|FG000|COMPLETED|Part B: Double-Blind Period||0
8957249|NCT02505542|10020819|FG001|COMPLETED|Part B: Double-Blind Period||92
8957250|NCT02505542|10020820|FG002|COMPLETED|Part B: Double-Blind Period||95
8957251|NCT02505542|10020821|FG003|COMPLETED|Part B: Double-Blind Period||98
8957252|NCT02505542|10020818|FG000|NOT COMPLETED|Part B: Double-Blind Period||0
8957253|NCT02505542|10020819|FG001|NOT COMPLETED|Part B: Double-Blind Period||12
8957254|NCT02505542|10020820|FG002|NOT COMPLETED|Part B: Double-Blind Period||9
8957255|NCT02505542|10020821|FG003|NOT COMPLETED|Part B: Double-Blind Period||7
8957256|NCT02505867|10020849|FG000|STARTED|Overall Study||6
8957257|NCT02505867|10020850|FG001|STARTED|Overall Study||6
8957258|NCT02505867|10020849|FG000|COMPLETED|Overall Study||0
8957259|NCT02505867|10020850|FG001|COMPLETED|Overall Study||0
8957260|NCT02505867|10020849|FG000|NOT COMPLETED|Overall Study||6
8957261|NCT02505867|10020850|FG001|NOT COMPLETED|Overall Study||6
8957262|NCT02505919|10020858|FG000|STARTED|Treatment||117
8957263|NCT02505919|10020859|FG001|STARTED|Treatment||67
8957264|NCT02505919|10020858|FG000|COMPLETED|Treatment||116
8957265|NCT02505919|10020859|FG001|COMPLETED|Treatment||65
8957266|NCT02505919|10020858|FG000|NOT COMPLETED|Treatment||1
8957267|NCT02505919|10020859|FG001|NOT COMPLETED|Treatment||2
8957268|NCT02505919|10020858|FG000|STARTED|1 Week Follow-Up||116
8957269|NCT02505919|10020859|FG001|STARTED|1 Week Follow-Up||65
8957270|NCT02505919|10020858|FG000|COMPLETED|1 Week Follow-Up||116
8957271|NCT02505919|10020859|FG001|COMPLETED|1 Week Follow-Up||65
8957272|NCT02505919|10020858|FG000|NOT COMPLETED|1 Week Follow-Up||0
8957273|NCT02505919|10020859|FG001|NOT COMPLETED|1 Week Follow-Up||0
8957274|NCT02505919|10020858|FG000|STARTED|1 Month Follow-Up||116
8957275|NCT02505919|10020859|FG001|STARTED|1 Month Follow-Up||65
8957276|NCT02505919|10020858|FG000|COMPLETED|1 Month Follow-Up||116
8957277|NCT02505919|10020859|FG001|COMPLETED|1 Month Follow-Up||65
8957278|NCT02505919|10020858|FG000|NOT COMPLETED|1 Month Follow-Up||0
8957279|NCT02505919|10020859|FG001|NOT COMPLETED|1 Month Follow-Up||0
8957280|NCT02505919|10020858|FG000|STARTED|3 Months Follow-Up||116
8957281|NCT02505919|10020859|FG001|STARTED|3 Months Follow-Up||65
8957282|NCT02505919|10020858|FG000|COMPLETED|3 Months Follow-Up||116
8957283|NCT02505919|10020859|FG001|COMPLETED|3 Months Follow-Up||65
8957284|NCT02505919|10020858|FG000|NOT COMPLETED|3 Months Follow-Up||0
8957285|NCT02505919|10020859|FG001|NOT COMPLETED|3 Months Follow-Up||0
8957286|NCT02505919|10020858|FG000|STARTED|6 Months Follow-Up||116
8957287|NCT02505919|10020859|FG001|STARTED|6 Months Follow-Up||65
8957288|NCT02505919|10020858|FG000|COMPLETED|6 Months Follow-Up||116
8957289|NCT02505919|10020859|FG001|COMPLETED|6 Months Follow-Up||63
8957290|NCT02505919|10020858|FG000|NOT COMPLETED|6 Months Follow-Up||0
8957291|NCT02505919|10020859|FG001|NOT COMPLETED|6 Months Follow-Up||2
8957292|NCT02505919|10020858|FG000|STARTED|12 Months Follow-Up||116
8957293|NCT02505919|10020859|FG001|STARTED|12 Months Follow-Up||63
8957294|NCT02505919|10020858|FG000|COMPLETED|12 Months Follow-Up||115
8957295|NCT02505919|10020859|FG001|COMPLETED|12 Months Follow-Up||61
8957296|NCT02505919|10020858|FG000|NOT COMPLETED|12 Months Follow-Up||1
8957297|NCT02505919|10020859|FG001|NOT COMPLETED|12 Months Follow-Up||2
8957298|NCT02505919|10020858|FG000|STARTED|24 Months Follow-Up||115
8957299|NCT02505919|10020859|FG001|STARTED|24 Months Follow-Up||61
8957300|NCT02505919|10020858|FG000|COMPLETED|24 Months Follow-Up||112
8957301|NCT02505919|10020859|FG001|COMPLETED|24 Months Follow-Up||60
8957302|NCT02505919|10020858|FG000|NOT COMPLETED|24 Months Follow-Up||3
8957303|NCT02505919|10020859|FG001|NOT COMPLETED|24 Months Follow-Up||1
8957304|NCT02505919|10020858|FG000|STARTED|36 Months Follow-Up||112
8957305|NCT02505919|10020859|FG001|STARTED|36 Months Follow-Up||60
8957306|NCT02505919|10020858|FG000|COMPLETED|36 Months Follow-Up||97
8957307|NCT02505919|10020859|FG001|COMPLETED|36 Months Follow-Up||55
8957308|NCT02505919|10020858|FG000|NOT COMPLETED|36 Months Follow-Up||15
8957309|NCT02505919|10020859|FG001|NOT COMPLETED|36 Months Follow-Up||5
8957310|NCT02505945|10020867|FG000|STARTED|Overall Study||102
8957311|NCT02505945|10020868|FG001|STARTED|Overall Study||50
8957312|NCT02505945|10020867|FG000|COMPLETED|Overall Study||80
8957313|NCT02505945|10020868|FG001|COMPLETED|Overall Study||46
8957314|NCT02505945|10020867|FG000|NOT COMPLETED|Overall Study||22
8957315|NCT02505945|10020868|FG001|NOT COMPLETED|Overall Study||4
8957316|NCT02506036|10020876|FG000|STARTED|First Intervention (4-6 Weeks)||3
8957317|NCT02506036|10020877|FG001|STARTED|First Intervention (4-6 Weeks)||3
8957318|NCT02506036|10020876|FG000|COMPLETED|First Intervention (4-6 Weeks)||2
8957319|NCT02506036|10020877|FG001|COMPLETED|First Intervention (4-6 Weeks)||1
8957320|NCT02506036|10020876|FG000|NOT COMPLETED|First Intervention (4-6 Weeks)||1
8957321|NCT02506036|10020877|FG001|NOT COMPLETED|First Intervention (4-6 Weeks)||2
8957322|NCT02506036|10020876|FG000|STARTED|Washout (1-2 Weeks)||2
8957323|NCT02506036|10020877|FG001|STARTED|Washout (1-2 Weeks)||1
8957324|NCT02506036|10020876|FG000|COMPLETED|Washout (1-2 Weeks)||2
8957325|NCT02506036|10020877|FG001|COMPLETED|Washout (1-2 Weeks)||1
8957326|NCT02506036|10020876|FG000|NOT COMPLETED|Washout (1-2 Weeks)||0
8957327|NCT02506036|10020877|FG001|NOT COMPLETED|Washout (1-2 Weeks)||0
8957328|NCT02506036|10020876|FG000|STARTED|Second Intervention (4-6 Weeks)||2
8957329|NCT02506036|10020877|FG001|STARTED|Second Intervention (4-6 Weeks)||1
8957330|NCT02506036|10020876|FG000|COMPLETED|Second Intervention (4-6 Weeks)||2
8957331|NCT02506036|10020877|FG001|COMPLETED|Second Intervention (4-6 Weeks)||1
8957332|NCT02506036|10020876|FG000|NOT COMPLETED|Second Intervention (4-6 Weeks)||0
8957333|NCT02506036|10020877|FG001|NOT COMPLETED|Second Intervention (4-6 Weeks)||0
8957334|NCT02506114|10020886|FG000|STARTED|Overall Study||5
8957335|NCT02506114|10020887|FG001|STARTED|Overall Study||4
8957336|NCT02506114|10020888|FG002|STARTED|Overall Study||6
8957337|NCT02506114|10020886|FG000|COMPLETED|Overall Study||5
8957338|NCT02506114|10020887|FG001|COMPLETED|Overall Study||4
8957339|NCT02506114|10020888|FG002|COMPLETED|Overall Study||6
8957340|NCT02506114|10020886|FG000|NOT COMPLETED|Overall Study||0
8957341|NCT02506114|10020887|FG001|NOT COMPLETED|Overall Study||0
8957342|NCT02506114|10020888|FG002|NOT COMPLETED|Overall Study||0
8957343|NCT02506257|10020900|FG000|STARTED|Overall Study||26
8957344|NCT02506257|10020901|FG001|STARTED|Overall Study||28
8957345|NCT02506257|10020902|FG002|STARTED|Overall Study||27
8957346|NCT02506257|10020903|FG003|STARTED|Overall Study||9
8957347|NCT02506257|10020900|FG000|COMPLETED|Overall Study||26
8957348|NCT02506257|10020901|FG001|COMPLETED|Overall Study||26
8957349|NCT02506257|10020902|FG002|COMPLETED|Overall Study||23
8957350|NCT02506257|10020903|FG003|COMPLETED|Overall Study||9
8957351|NCT02506257|10020900|FG000|NOT COMPLETED|Overall Study||0
8957352|NCT02506257|10020901|FG001|NOT COMPLETED|Overall Study||2
8957353|NCT02506257|10020902|FG002|NOT COMPLETED|Overall Study||4
8957354|NCT02506257|10020903|FG003|NOT COMPLETED|Overall Study||0
8957355|NCT02506309|10020915|FG000|STARTED|Overall Study||84
8957356|NCT02506309|10020916|FG001|STARTED|Overall Study||84
8957357|NCT02506309|10020915|FG000|COMPLETED|Overall Study||66
8957358|NCT02506309|10020916|FG001|COMPLETED|Overall Study||64
8957359|NCT02506309|10020915|FG000|NOT COMPLETED|Overall Study||18
8957360|NCT02506309|10020916|FG001|NOT COMPLETED|Overall Study||20
8957361|NCT02506634|10020930|FG000|STARTED|Overall Study||374
8957362|NCT02506634|10020930|FG000|Participants Who Were Diagnosed as GERD|Overall Study||154
8957363|NCT02506634|10020930|FG000|Participants Who Received PPI Treatment|Overall Study||357
8957364|NCT02506634|10020930|FG000|Participants Who Finished GERDQ|Overall Study||342
8957365|NCT02506634|10020930|FG000|COMPLETED|Overall Study||357
8957366|NCT02506634|10020930|FG000|NOT COMPLETED|Overall Study||17
8957367|NCT02506660|10020970|FG000|STARTED|Overall Study||64
8957368|NCT02506660|10020971|FG001|STARTED|Overall Study||64
8957369|NCT02506660|10020970|FG000|COMPLETED|Overall Study||62
8957370|NCT02506660|10020971|FG001|COMPLETED|Overall Study||63
8957371|NCT02506660|10020970|FG000|NOT COMPLETED|Overall Study||2
8957372|NCT02506660|10020971|FG001|NOT COMPLETED|Overall Study||1
8957373|NCT02506673|10020979|FG000|STARTED|Overall Study||13
8957374|NCT02506673|10020980|FG001|STARTED|Overall Study||13
8957375|NCT02506673|10020979|FG000|COMPLETED|Overall Study||13
8957376|NCT02506673|10020980|FG001|COMPLETED|Overall Study||13
8957377|NCT02506673|10020979|FG000|NOT COMPLETED|Overall Study||0
8957378|NCT02506673|10020980|FG001|NOT COMPLETED|Overall Study||0
8957379|NCT02506816|10020986|FG000|STARTED|Overall Study||36
8957380|NCT02506816|10020986|FG000|Samples Availability|Overall Study|31 of 36 patients had valid samples for analysis of biomarkers (primary and secondary analysis)|31
8957381|NCT02506816|10020986|FG000|COMPLETED|Overall Study||33
8957382|NCT02506816|10020986|FG000|NOT COMPLETED|Overall Study||3
8957383|NCT02506868|10020992|FG000|STARTED|Main Period of Study (24 Weeks)||98
8957384|NCT02506868|10020993|FG001|STARTED|Main Period of Study (24 Weeks)||98
8957385|NCT02506868|10020992|FG000|mITT Population|Main Period of Study (24 Weeks)||98
8957386|NCT02506868|10020993|FG001|mITT Population|Main Period of Study (24 Weeks)|One patient from Aranesp group was excluded prior to the first administration|97
8957387|NCT02506868|10020992|FG000|Per Protocol Population|Main Period of Study (24 Weeks)||86
8957388|NCT02506868|10020993|FG001|Per Protocol Population|Main Period of Study (24 Weeks)||90
8957389|NCT02506868|10020992|FG000|COMPLETED|Main Period of Study (24 Weeks)||86
8957390|NCT02506868|10020993|FG001|COMPLETED|Main Period of Study (24 Weeks)||90
8957391|NCT02506868|10020992|FG000|NOT COMPLETED|Main Period of Study (24 Weeks)||12
8957392|NCT02506868|10020993|FG001|NOT COMPLETED|Main Period of Study (24 Weeks)||8
8957393|NCT02506868|10020992|FG000|STARTED|Additional Period of Study (Until 52W)||86
8957394|NCT02506868|10020993|FG001|STARTED|Additional Period of Study (Until 52W)||90
8957395|NCT02506868|10020992|FG000|COMPLETED|Additional Period of Study (Until 52W)||83
8957396|NCT02506868|10020993|FG001|COMPLETED|Additional Period of Study (Until 52W)||85
8957397|NCT02506868|10020992|FG000|NOT COMPLETED|Additional Period of Study (Until 52W)||3
8957398|NCT02506868|10020993|FG001|NOT COMPLETED|Additional Period of Study (Until 52W)||5
8957399|NCT02506881|10021007|FG000|STARTED|First Intervention (Day 1)||13
8957400|NCT02506881|10021008|FG001|STARTED|First Intervention (Day 1)||12
8957401|NCT02506881|10021009|FG002|STARTED|First Intervention (Day 1)||25
8957402|NCT02506881|10021010|FG003|STARTED|First Intervention (Day 1)||24
8957403|NCT02506881|10021007|FG000|COMPLETED|First Intervention (Day 1)||12
8957404|NCT02506881|10021008|FG001|COMPLETED|First Intervention (Day 1)||12
8957405|NCT02506881|10021009|FG002|COMPLETED|First Intervention (Day 1)||12
8957406|NCT02506881|10021010|FG003|COMPLETED|First Intervention (Day 1)||12
8957407|NCT02506881|10021007|FG000|NOT COMPLETED|First Intervention (Day 1)||1
8957408|NCT02506881|10021008|FG001|NOT COMPLETED|First Intervention (Day 1)||0
8957409|NCT02506881|10021009|FG002|NOT COMPLETED|First Intervention (Day 1)||13
8957410|NCT02506881|10021010|FG003|NOT COMPLETED|First Intervention (Day 1)||12
8957411|NCT02506881|10021007|FG000|STARTED|Washout (at Least 25 Days)||12
8957412|NCT02506881|10021008|FG001|STARTED|Washout (at Least 25 Days)||12
8957413|NCT02506881|10021009|FG002|STARTED|Washout (at Least 25 Days)||12
8957414|NCT02506881|10021010|FG003|STARTED|Washout (at Least 25 Days)||12
8957415|NCT02506881|10021007|FG000|COMPLETED|Washout (at Least 25 Days)||12
8957416|NCT02506881|10021008|FG001|COMPLETED|Washout (at Least 25 Days)||12
8957417|NCT02506881|10021009|FG002|COMPLETED|Washout (at Least 25 Days)||12
8957418|NCT02506881|10021010|FG003|COMPLETED|Washout (at Least 25 Days)||12
8957419|NCT02506881|10021007|FG000|NOT COMPLETED|Washout (at Least 25 Days)||0
8957420|NCT02506881|10021008|FG001|NOT COMPLETED|Washout (at Least 25 Days)||0
8957421|NCT02506881|10021009|FG002|NOT COMPLETED|Washout (at Least 25 Days)||0
8957422|NCT02506881|10021010|FG003|NOT COMPLETED|Washout (at Least 25 Days)||0
8957423|NCT02506881|10021007|FG000|STARTED|Second Intervention (Day 1)||12
8957424|NCT02506881|10021008|FG001|STARTED|Second Intervention (Day 1)||12
8957425|NCT02506881|10021009|FG002|STARTED|Second Intervention (Day 1)||12
8957426|NCT02506881|10021010|FG003|STARTED|Second Intervention (Day 1)||12
8631360|NCT00539500|9671228|FG000|STARTED|Overall Study||3
8631361|NCT00539500|9671228|FG000|COMPLETED|Overall Study||0
8631362|NCT00539500|9671228|FG000|NOT COMPLETED|Overall Study||3
8631363|NCT00539513|9671234|FG000|STARTED|Overall Study||5
8631364|NCT00539513|9671235|FG001|STARTED|Overall Study||5
8631365|NCT00539513|9671234|FG000|Received Allocated Intervention|Overall Study||3
8631366|NCT00539513|9671235|FG001|Received Allocated Intervention|Overall Study||4
8631367|NCT00539513|9671234|FG000|COMPLETED|Overall Study||3
8631368|NCT00539513|9671235|FG001|COMPLETED|Overall Study||3
8631369|NCT00539513|9671234|FG000|NOT COMPLETED|Overall Study||2
8631370|NCT00539513|9671235|FG001|NOT COMPLETED|Overall Study||2
8631371|NCT00539526|9671244|FG000|STARTED|Overall Study||35
8631372|NCT00539526|9671245|FG001|STARTED|Overall Study||33
8631373|NCT00539526|9671246|FG002|STARTED|Overall Study||38
8631374|NCT00539526|9671244|FG000|COMPLETED|Overall Study||32
8957427|NCT02506881|10021007|FG000|COMPLETED|Second Intervention (Day 1)||12
8957428|NCT02506881|10021008|FG001|COMPLETED|Second Intervention (Day 1)||12
8957429|NCT02506881|10021009|FG002|COMPLETED|Second Intervention (Day 1)||12
8957430|NCT02506881|10021010|FG003|COMPLETED|Second Intervention (Day 1)||12
8957431|NCT02506881|10021007|FG000|NOT COMPLETED|Second Intervention (Day 1)||0
8631375|NCT00539526|9671245|FG001|COMPLETED|Overall Study||31
8957432|NCT02506881|10021008|FG001|NOT COMPLETED|Second Intervention (Day 1)||0
8957433|NCT02506881|10021009|FG002|NOT COMPLETED|Second Intervention (Day 1)||0
8957434|NCT02506881|10021010|FG003|NOT COMPLETED|Second Intervention (Day 1)||0
8957435|NCT02507011|10021030|FG000|STARTED|First Intervention||1
8957436|NCT02507011|10021031|FG001|STARTED|First Intervention||1
8957437|NCT02507011|10021030|FG000|COMPLETED|First Intervention||1
8957438|NCT02507011|10021031|FG001|COMPLETED|First Intervention||1
8957439|NCT02507011|10021030|FG000|NOT COMPLETED|First Intervention||0
8957440|NCT02507011|10021031|FG001|NOT COMPLETED|First Intervention||0
8957441|NCT02507011|10021030|FG000|STARTED|Second Intervention||1
8957442|NCT02507011|10021031|FG001|STARTED|Second Intervention||1
8957443|NCT02507011|10021030|FG000|COMPLETED|Second Intervention||1
8957444|NCT02507011|10021031|FG001|COMPLETED|Second Intervention||1
8957445|NCT02507011|10021030|FG000|NOT COMPLETED|Second Intervention||0
8957446|NCT02507011|10021031|FG001|NOT COMPLETED|Second Intervention||0
8957447|NCT02507219|10021037|FG000|STARTED|Overall Study||5
8957448|NCT02507219|10021038|FG001|STARTED|Overall Study||4
8957449|NCT02507219|10021039|FG002|STARTED|Overall Study||3
8957450|NCT02507219|10021040|FG003|STARTED|Overall Study||3
8957451|NCT02507219|10021041|FG004|STARTED|Overall Study||4
8957452|NCT02507219|10021042|FG005|STARTED|Overall Study||3
8957453|NCT02507219|10021037|FG000|COMPLETED|Overall Study||4
8957454|NCT02507219|10021038|FG001|COMPLETED|Overall Study||4
8957455|NCT02507219|10021039|FG002|COMPLETED|Overall Study||3
8957456|NCT02507219|10021040|FG003|COMPLETED|Overall Study||3
8957457|NCT02507219|10021041|FG004|COMPLETED|Overall Study||3
8957458|NCT02507219|10021042|FG005|COMPLETED|Overall Study||3
8957459|NCT02507219|10021037|FG000|NOT COMPLETED|Overall Study||1
8957460|NCT02507219|10021038|FG001|NOT COMPLETED|Overall Study||0
8957461|NCT02507219|10021039|FG002|NOT COMPLETED|Overall Study||0
8957462|NCT02507219|10021040|FG003|NOT COMPLETED|Overall Study||0
8957463|NCT02507219|10021041|FG004|NOT COMPLETED|Overall Study||1
8631376|NCT00539526|9671246|FG002|COMPLETED|Overall Study||36
8631377|NCT00539526|9671244|FG000|NOT COMPLETED|Overall Study||3
8957464|NCT02507219|10021042|FG005|NOT COMPLETED|Overall Study||0
8957465|NCT02507297|10021052|FG000|STARTED|Overall Study||16
8957466|NCT02507297|10021053|FG001|STARTED|Overall Study||13
8957467|NCT02507297|10021052|FG000|COMPLETED|Overall Study||15
8957468|NCT02507297|10021053|FG001|COMPLETED|Overall Study||12
8957469|NCT02507297|10021052|FG000|NOT COMPLETED|Overall Study||1
8957470|NCT02507297|10021053|FG001|NOT COMPLETED|Overall Study||1
8957471|NCT02507349|10021061|FG000|STARTED|Overall Study||1232
8957472|NCT02507349|10021062|FG001|STARTED|Overall Study||1211
8957473|NCT02507349|10021061|FG000|COMPLETED|Overall Study||1045
8957474|NCT02507349|10021062|FG001|COMPLETED|Overall Study||1050
8957475|NCT02507349|10021061|FG000|NOT COMPLETED|Overall Study||187
8957476|NCT02507349|10021062|FG001|NOT COMPLETED|Overall Study||161
8957477|NCT02507375|10021070|FG000|STARTED|Overall Study||6
8957478|NCT02507375|10021071|FG001|STARTED|Overall Study|Two patients in cohort 2 did not begin treatment in Cycle 1 so were not included in the analysis set|9
8957479|NCT02507375|10021070|FG000|Cycle 1|Overall Study||6
8957480|NCT02507375|10021071|FG001|Cycle 1|Overall Study||9
8957481|NCT02507375|10021070|FG000|Received Pertuzumab|Overall Study||6
8957482|NCT02507375|10021071|FG001|Received Pertuzumab|Overall Study||6
8957483|NCT02507375|10021070|FG000|Cycle 2|Overall Study||5
8957484|NCT02507375|10021071|FG001|Cycle 2|Overall Study||5
8957485|NCT02507375|10021070|FG000|Cycle 3|Overall Study||4
8957486|NCT02507375|10021071|FG001|Cycle 3|Overall Study||5
8957487|NCT02507375|10021070|FG000|Cycle 4|Overall Study||4
8957488|NCT02507375|10021071|FG001|Cycle 4|Overall Study||2
8957489|NCT02507375|10021070|FG000|Cycle 5|Overall Study||3
8957490|NCT02507375|10021071|FG001|Cycle 5|Overall Study||1
8957491|NCT02507375|10021070|FG000|Cycle 6|Overall Study||3
8957492|NCT02507375|10021071|FG001|Cycle 6|Overall Study||1
8957493|NCT02507375|10021070|FG000|Extension Period|Overall Study||2
8957494|NCT02507375|10021071|FG001|Extension Period|Overall Study||1
8957495|NCT02507375|10021070|FG000|COMPLETED|Overall Study||2
8957496|NCT02507375|10021071|FG001|COMPLETED|Overall Study||1
8957497|NCT02507375|10021070|FG000|NOT COMPLETED|Overall Study||4
8957498|NCT02507375|10021071|FG001|NOT COMPLETED|Overall Study||8
8957499|NCT02507388|10021083|FG000|STARTED|Overall Study||25
8957500|NCT02507388|10021084|FG001|STARTED|Overall Study||25
8957501|NCT02507388|10021083|FG000|COMPLETED|Overall Study||25
8957502|NCT02507388|10021084|FG001|COMPLETED|Overall Study||25
8957503|NCT02507388|10021083|FG000|NOT COMPLETED|Overall Study||0
8957504|NCT02507388|10021084|FG001|NOT COMPLETED|Overall Study||0
8957505|NCT02507752|10021091|FG000|STARTED|Overall Study||72
8957506|NCT02507752|10021091|FG000|COMPLETED|Overall Study||55
8957507|NCT02507752|10021091|FG000|NOT COMPLETED|Overall Study||17
8957508|NCT02508077|10021095|FG000|STARTED|Overall Study||1
8957509|NCT02508077|10021095|FG000|COMPLETED|Overall Study||1
8957510|NCT02508077|10021095|FG000|NOT COMPLETED|Overall Study||0
8957511|NCT02508103|10021101|FG000|STARTED|Overall Study||5
8957512|NCT02508103|10021102|FG001|STARTED|Overall Study||5
8957513|NCT02508103|10021101|FG000|COMPLETED|Overall Study||5
8957514|NCT02508103|10021102|FG001|COMPLETED|Overall Study||5
8957515|NCT02508103|10021101|FG000|NOT COMPLETED|Overall Study||0
8957516|NCT02508103|10021102|FG001|NOT COMPLETED|Overall Study||0
8957517|NCT02508116|10021110|FG000|STARTED|Overall Study||252
8957518|NCT02508116|10021111|FG001|STARTED|Overall Study||257
8957519|NCT02508116|10021110|FG000|Received Intervention as Randomized|Overall Study||249
8957520|NCT02508116|10021111|FG001|Received Intervention as Randomized|Overall Study||255
8957521|NCT02508116|10021110|FG000|COMPLETED|Overall Study||244
8957522|NCT02508116|10021111|FG001|COMPLETED|Overall Study||250
8957523|NCT02508116|10021110|FG000|NOT COMPLETED|Overall Study||8
8957524|NCT02508116|10021111|FG001|NOT COMPLETED|Overall Study||7
8957525|NCT02508194|10021119|FG000|STARTED|Overall Study||949
8957526|NCT02508194|10021120|FG001|STARTED|Overall Study||951
8957527|NCT02508194|10021119|FG000|COMPLETED|Overall Study||897
8957528|NCT02508194|10021120|FG001|COMPLETED|Overall Study||907
8957529|NCT02508194|10021119|FG000|NOT COMPLETED|Overall Study||52
8957530|NCT02508194|10021120|FG001|NOT COMPLETED|Overall Study||44
8957531|NCT02508207|10021128|FG000|STARTED|Overall Study||7
8957532|NCT02508207|10021129|FG001|STARTED|Overall Study||27
8957533|NCT02508207|10021128|FG000|COMPLETED|Overall Study||7
8957534|NCT02508207|10021129|FG001|COMPLETED|Overall Study||27
8957535|NCT02508207|10021128|FG000|NOT COMPLETED|Overall Study||0
8957536|NCT02508207|10021129|FG001|NOT COMPLETED|Overall Study||0
8957537|NCT02508259|10021137|FG000|STARTED|Overall Study||5
8957538|NCT02508259|10021138|FG001|STARTED|Overall Study||5
8957539|NCT02508259|10021137|FG000|COMPLETED|Overall Study||5
8957540|NCT02508259|10021138|FG001|COMPLETED|Overall Study||5
8957541|NCT02508259|10021137|FG000|NOT COMPLETED|Overall Study||0
8957542|NCT02508259|10021138|FG001|NOT COMPLETED|Overall Study||0
8957543|NCT02508389|10021147|FG000|STARTED|Overall Study||73
8957544|NCT02508389|10021148|FG001|STARTED|Overall Study||76
8957545|NCT02508389|10021149|FG002|STARTED|Overall Study||74
8570206|NCT00101907|9602374|FG001|STARTED|Overall Study||8
8957546|NCT02508389|10021147|FG000|COMPLETED|Overall Study||45
8957547|NCT02508389|10021148|FG001|COMPLETED|Overall Study||45
8957548|NCT02508389|10021149|FG002|COMPLETED|Overall Study||42
8957549|NCT02508389|10021147|FG000|NOT COMPLETED|Overall Study||28
8957550|NCT02508389|10021148|FG001|NOT COMPLETED|Overall Study||31
8957551|NCT02508389|10021149|FG002|NOT COMPLETED|Overall Study||32
8957552|NCT02508428|10021159|FG000|STARTED|Overall Study||114
8957553|NCT02508428|10021160|FG001|STARTED|Overall Study||111
8957554|NCT02508428|10021159|FG000|COMPLETED|Overall Study||62
8957555|NCT02508428|10021160|FG001|COMPLETED|Overall Study||44
8957556|NCT02508428|10021159|FG000|NOT COMPLETED|Overall Study||52
8957557|NCT02508428|10021160|FG001|NOT COMPLETED|Overall Study||67
8957558|NCT02508480|10021168|FG000|STARTED|Overall Study||95
8957559|NCT02508480|10021169|FG001|STARTED|Overall Study||97
8957560|NCT02508480|10021168|FG000|Post-Treatment Assessment|Overall Study||87
8957561|NCT02508480|10021169|FG001|Post-Treatment Assessment|Overall Study||89
8957562|NCT02508480|10021168|FG000|Three Month Follow-up|Overall Study||84
8957563|NCT02508480|10021169|FG001|Three Month Follow-up|Overall Study||86
8957564|NCT02508480|10021168|FG000|Six-Month Follow-Up|Overall Study||84
8957565|NCT02508480|10021169|FG001|Six-Month Follow-Up|Overall Study||86
8957566|NCT02508480|10021168|FG000|COMPLETED|Overall Study||90
8957567|NCT02508480|10021169|FG001|COMPLETED|Overall Study||93
8957568|NCT02508480|10021168|FG000|NOT COMPLETED|Overall Study||5
8957569|NCT02508480|10021169|FG001|NOT COMPLETED|Overall Study||4
8957570|NCT02508532|10021182|FG000|STARTED|Part 1 - Dose Determining Period||6
8874824|NCT01904773|9931727|FG006|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8874825|NCT01904773|9931728|FG007|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8874826|NCT01904773|9931729|FG008|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8874827|NCT01904773|9931721|FG000|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||23
8874828|NCT01904773|9931722|FG001|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8874829|NCT01904773|9931723|FG002|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8874830|NCT01904773|9931724|FG003|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8957571|NCT02508532|10021183|FG001|STARTED|Part 1 - Dose Determining Period||6
8957572|NCT02508532|10021184|FG002|STARTED|Part 1 - Dose Determining Period||6
8957573|NCT02508532|10021185|FG003|STARTED|Part 1 - Dose Determining Period||6
8957574|NCT02508532|10021186|FG004|STARTED|Part 1 - Dose Determining Period||6
8957575|NCT02508532|10021187|FG005|STARTED|Part 1 - Dose Determining Period||6
8957576|NCT02508532|10021188|FG006|STARTED|Part 1 - Dose Determining Period||7
8957577|NCT02508532|10021189|FG007|STARTED|Part 1 - Dose Determining Period||3
8957578|NCT02508532|10021190|FG008|STARTED|Part 1 - Dose Determining Period|This group includes patients enrolled in Part 1 and Part 2 at a starting dose of 300 or 400 mg QD. This group was not used to determine the MTD in Part 1|0
8957579|NCT02508532|10021182|FG000|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||0
8957580|NCT02508532|10021183|FG001|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||0
8957581|NCT02508532|10021184|FG002|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||0
8957582|NCT02508532|10021185|FG003|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||0
8957583|NCT02508532|10021186|FG004|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||0
8957584|NCT02508532|10021187|FG005|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||6
8957585|NCT02508532|10021188|FG006|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||7
8957586|NCT02508532|10021189|FG007|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||0
8957587|NCT02508532|10021190|FG008|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||0
8957588|NCT02508532|10021182|FG000|COMPLETED|Part 1 - Dose Determining Period||6
8957589|NCT02508532|10021183|FG001|COMPLETED|Part 1 - Dose Determining Period||6
8957590|NCT02508532|10021184|FG002|COMPLETED|Part 1 - Dose Determining Period||6
8957591|NCT02508532|10021185|FG003|COMPLETED|Part 1 - Dose Determining Period||6
8957592|NCT02508532|10021186|FG004|COMPLETED|Part 1 - Dose Determining Period||6
8957593|NCT02508532|10021187|FG005|COMPLETED|Part 1 - Dose Determining Period||6
8957594|NCT02508532|10021188|FG006|COMPLETED|Part 1 - Dose Determining Period||6
8957595|NCT02508532|10021189|FG007|COMPLETED|Part 1 - Dose Determining Period||2
8874831|NCT01904773|9931725|FG004|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8957596|NCT02508532|10021190|FG008|COMPLETED|Part 1 - Dose Determining Period||0
8957597|NCT02508532|10021182|FG000|NOT COMPLETED|Part 1 - Dose Determining Period||0
8957598|NCT02508532|10021183|FG001|NOT COMPLETED|Part 1 - Dose Determining Period||0
8957599|NCT02508532|10021184|FG002|NOT COMPLETED|Part 1 - Dose Determining Period||0
8957600|NCT02508532|10021185|FG003|NOT COMPLETED|Part 1 - Dose Determining Period||0
8957601|NCT02508532|10021186|FG004|NOT COMPLETED|Part 1 - Dose Determining Period||0
8957602|NCT02508532|10021187|FG005|NOT COMPLETED|Part 1 - Dose Determining Period||0
8957603|NCT02508532|10021188|FG006|NOT COMPLETED|Part 1 - Dose Determining Period||1
8957604|NCT02508532|10021189|FG007|NOT COMPLETED|Part 1 - Dose Determining Period||1
8957605|NCT02508532|10021190|FG008|NOT COMPLETED|Part 1 - Dose Determining Period||0
8957606|NCT02508532|10021182|FG000|STARTED|Part 2 - Treatment|These patients are not included in Part 2 analyses|0
8957607|NCT02508532|10021183|FG001|STARTED|Part 2 - Treatment|These patients are not included in Part 2 analyses|0
8957608|NCT02508532|10021184|FG002|STARTED|Part 2 - Treatment|These patients are not included in Part 2 analyses|0
8957609|NCT02508532|10021185|FG003|STARTED|Part 2 - Treatment|These patients are not included in Part 2 analyses|0
8957610|NCT02508532|10021186|FG004|STARTED|Part 2 - Treatment|These patients are not included in Part 2 analyses|0
8957611|NCT02508532|10021187|FG005|STARTED|Part 2 - Treatment|"Part 1 Only:~6 Patients from this group are included in the 300 or 400 mg QD group."|0
8957612|NCT02508532|10021188|FG006|STARTED|Part 2 - Treatment|"Part 1 Only:~7 Patients from this group are included in the 300 or 400 mg QD group."|0
8957613|NCT02508532|10021189|FG007|STARTED|Part 2 - Treatment|These patients are not included in Part 2 analyses|0
8957614|NCT02508532|10021190|FG008|STARTED|Part 2 - Treatment|Includes 13 patients enrolled in Part 1 at a starting dose of 300 mg (n = 6) or 400 mg (n = 7) QD.|217
8957615|NCT02508532|10021182|FG000|COMPLETED|Part 2 - Treatment||0
8957616|NCT02508532|10021183|FG001|COMPLETED|Part 2 - Treatment||0
8957617|NCT02508532|10021184|FG002|COMPLETED|Part 2 - Treatment||0
8957618|NCT02508532|10021185|FG003|COMPLETED|Part 2 - Treatment||0
8957619|NCT02508532|10021186|FG004|COMPLETED|Part 2 - Treatment||0
8957620|NCT02508532|10021187|FG005|COMPLETED|Part 2 - Treatment||0
8957621|NCT02508532|10021188|FG006|COMPLETED|Part 2 - Treatment||0
8957622|NCT02508532|10021189|FG007|COMPLETED|Part 2 - Treatment||0
8957623|NCT02508532|10021190|FG008|COMPLETED|Part 2 - Treatment||0
8957624|NCT02508532|10021182|FG000|NOT COMPLETED|Part 2 - Treatment||0
8957625|NCT02508532|10021183|FG001|NOT COMPLETED|Part 2 - Treatment||0
8957626|NCT02508532|10021184|FG002|NOT COMPLETED|Part 2 - Treatment||0
8957627|NCT02508532|10021185|FG003|NOT COMPLETED|Part 2 - Treatment||0
8957628|NCT02508532|10021186|FG004|NOT COMPLETED|Part 2 - Treatment||0
8957629|NCT02508532|10021187|FG005|NOT COMPLETED|Part 2 - Treatment||0
8957630|NCT02508532|10021188|FG006|NOT COMPLETED|Part 2 - Treatment||0
8957631|NCT02508532|10021189|FG007|NOT COMPLETED|Part 2 - Treatment||0
8957632|NCT02508532|10021190|FG008|NOT COMPLETED|Part 2 - Treatment||217
8957633|NCT02508532|10021182|FG000|STARTED|Part 1 and Part 2 End of Study||6
8957634|NCT02508532|10021183|FG001|STARTED|Part 1 and Part 2 End of Study||6
8957635|NCT02508532|10021184|FG002|STARTED|Part 1 and Part 2 End of Study||6
8957636|NCT02508532|10021185|FG003|STARTED|Part 1 and Part 2 End of Study||6
8957637|NCT02508532|10021186|FG004|STARTED|Part 1 and Part 2 End of Study||6
8957638|NCT02508532|10021187|FG005|STARTED|Part 1 and Part 2 End of Study|These 6 patients are included in the 300 or 400 mg QD dose group|0
8957639|NCT02508532|10021188|FG006|STARTED|Part 1 and Part 2 End of Study|These 7 patients are included in the 300 or 400 mg QD dose group|0
8957640|NCT02508532|10021189|FG007|STARTED|Part 1 and Part 2 End of Study||3
8957641|NCT02508532|10021190|FG008|STARTED|Part 1 and Part 2 End of Study|Includes 13 patients enrolled in Part 1 at a starting dose of 300 mg (n = 6) or 400 mg (n = 7) QD.|217
8957642|NCT02508532|10021182|FG000|COMPLETED|Part 1 and Part 2 End of Study||0
8957643|NCT02508532|10021183|FG001|COMPLETED|Part 1 and Part 2 End of Study||0
8957644|NCT02508532|10021184|FG002|COMPLETED|Part 1 and Part 2 End of Study||0
8957645|NCT02508532|10021185|FG003|COMPLETED|Part 1 and Part 2 End of Study||0
8957646|NCT02508532|10021186|FG004|COMPLETED|Part 1 and Part 2 End of Study||0
8957647|NCT02508532|10021187|FG005|COMPLETED|Part 1 and Part 2 End of Study||0
8957648|NCT02508532|10021188|FG006|COMPLETED|Part 1 and Part 2 End of Study||0
8957649|NCT02508532|10021189|FG007|COMPLETED|Part 1 and Part 2 End of Study||0
8957650|NCT02508532|10021190|FG008|COMPLETED|Part 1 and Part 2 End of Study||0
8957651|NCT02508532|10021182|FG000|NOT COMPLETED|Part 1 and Part 2 End of Study||6
8957652|NCT02508532|10021183|FG001|NOT COMPLETED|Part 1 and Part 2 End of Study||6
8957653|NCT02508532|10021184|FG002|NOT COMPLETED|Part 1 and Part 2 End of Study||6
8957654|NCT02508532|10021185|FG003|NOT COMPLETED|Part 1 and Part 2 End of Study||6
8957655|NCT02508532|10021186|FG004|NOT COMPLETED|Part 1 and Part 2 End of Study||6
8957656|NCT02508532|10021187|FG005|NOT COMPLETED|Part 1 and Part 2 End of Study||0
8957657|NCT02508532|10021188|FG006|NOT COMPLETED|Part 1 and Part 2 End of Study||0
8957658|NCT02508532|10021189|FG007|NOT COMPLETED|Part 1 and Part 2 End of Study||3
8957659|NCT02508532|10021190|FG008|NOT COMPLETED|Part 1 and Part 2 End of Study||217
8957660|NCT02508636|10021219|FG000|STARTED|Overall Study||11
8957661|NCT02508636|10021219|FG000|COMPLETED|Overall Study||11
8957662|NCT02508636|10021219|FG000|NOT COMPLETED|Overall Study||0
8957663|NCT02508649|10021227|FG000|STARTED|Overall Study||283
8957664|NCT02508649|10021228|FG001|STARTED|Overall Study||197
8957665|NCT02508649|10021229|FG002|STARTED|Overall Study||189
8957666|NCT02508649|10021230|FG003|STARTED|Overall Study||199
8957667|NCT02508649|10021227|FG000|Dosed|Overall Study||266
8957668|NCT02508649|10021228|FG001|Dosed|Overall Study||191
8957669|NCT02508649|10021229|FG002|Dosed|Overall Study||177
8957670|NCT02508649|10021230|FG003|Dosed|Overall Study||194
8957671|NCT02508649|10021227|FG000|COMPLETED|Overall Study||265
8957672|NCT02508649|10021228|FG001|COMPLETED|Overall Study||184
8957673|NCT02508649|10021229|FG002|COMPLETED|Overall Study||174
8957674|NCT02508649|10021230|FG003|COMPLETED|Overall Study||189
8957675|NCT02508649|10021227|FG000|NOT COMPLETED|Overall Study||18
8957676|NCT02508649|10021228|FG001|NOT COMPLETED|Overall Study||13
8957677|NCT02508649|10021229|FG002|NOT COMPLETED|Overall Study||15
8957678|NCT02508649|10021230|FG003|NOT COMPLETED|Overall Study||10
8957679|NCT02508701|10021247|FG000|STARTED|Overall Study||9
8957680|NCT02508701|10021248|FG001|STARTED|Overall Study||6
8957681|NCT02508701|10021249|FG002|STARTED|Overall Study||5
8957682|NCT02508701|10021250|FG003|STARTED|Overall Study||4
8957683|NCT02508701|10021247|FG000|COMPLETED|Overall Study||0
8957684|NCT02508701|10021248|FG001|COMPLETED|Overall Study||1
8957685|NCT02508701|10021249|FG002|COMPLETED|Overall Study||0
8957686|NCT02508701|10021250|FG003|COMPLETED|Overall Study||1
8957687|NCT02508701|10021247|FG000|NOT COMPLETED|Overall Study||9
8957688|NCT02508701|10021248|FG001|NOT COMPLETED|Overall Study||5
8957689|NCT02508701|10021249|FG002|NOT COMPLETED|Overall Study||5
8957690|NCT02508701|10021250|FG003|NOT COMPLETED|Overall Study||3
8957691|NCT02508935|10021264|FG000|STARTED|Overall Study||23
8957692|NCT02508935|10021264|FG000|COMPLETED|Overall Study||0
8957693|NCT02508935|10021264|FG000|NOT COMPLETED|Overall Study||23
8957694|NCT02509026|10021270|FG000|STARTED|Induction Period (24 Weeks)||210
8957695|NCT02509026|10021270|FG000|Treated|Induction Period (24 Weeks)||209
8957696|NCT02509026|10021270|FG000|COMPLETED|Induction Period (24 Weeks)||188
8957697|NCT02509026|10021270|FG000|NOT COMPLETED|Induction Period (24 Weeks)||22
8957698|NCT02509026|10021270|FG000|STARTED|Withdrawal Period (40 Weeks)|Participants who completed Period 1 and achieved ASDAS-CRP<1.3 were eligible to enter into Period 2|119
8957699|NCT02509026|10021270|FG000|COMPLETED|Withdrawal Period (40 Weeks)||112
8957700|NCT02509026|10021270|FG000|NOT COMPLETED|Withdrawal Period (40 Weeks)||7
8957701|NCT02509026|10021270|FG000|STARTED|Retreatment Period (12 Weeks)|Participants who completed Period 2 and achieved ASDAS-ESR>=2.1 were eligible to enter into Period 3|88
8957702|NCT02509026|10021270|FG000|Treated|Retreatment Period (12 Weeks)||87
8957703|NCT02509026|10021270|FG000|COMPLETED|Retreatment Period (12 Weeks)||84
8957704|NCT02509026|10021270|FG000|NOT COMPLETED|Retreatment Period (12 Weeks)||4
8957705|NCT02509065|10021279|FG000|STARTED|Overall Study||1
8957706|NCT02509065|10021280|FG001|STARTED|Overall Study||1
8957707|NCT02509065|10021281|FG002|STARTED|Overall Study||2
8957708|NCT02509065|10021282|FG003|STARTED|Overall Study||1
8957709|NCT02509065|10021283|FG004|STARTED|Overall Study||1
8957710|NCT02509065|10021284|FG005|STARTED|Overall Study||1
8957711|NCT02509065|10021285|FG006|STARTED|Overall Study||1
8957712|NCT02509065|10021286|FG007|STARTED|Overall Study||1
8957713|NCT02509065|10021287|FG008|STARTED|Overall Study||1
8957714|NCT02509065|10021288|FG009|STARTED|Overall Study||1
8957715|NCT02509065|10021289|FG010|STARTED|Overall Study||1
8957716|NCT02509065|10021290|FG011|STARTED|Overall Study||1
8957717|NCT02509065|10021291|FG012|STARTED|Overall Study||1
8957718|NCT02509065|10021292|FG013|STARTED|Overall Study||1
8957719|NCT02509065|10021293|FG014|STARTED|Overall Study||1
8957720|NCT02509065|10021294|FG015|STARTED|Overall Study||1
8957721|NCT02509065|10021295|FG016|STARTED|Overall Study||1
8957722|NCT02509065|10021296|FG017|STARTED|Overall Study||1
8957723|NCT02509065|10021297|FG018|STARTED|Overall Study||1
8957724|NCT02509065|10021298|FG019|STARTED|Overall Study||1
8957725|NCT02509065|10021299|FG020|STARTED|Overall Study||1
8957726|NCT02509065|10021300|FG021|STARTED|Overall Study||1
8957727|NCT02509065|10021301|FG022|STARTED|Overall Study||1
8957728|NCT02509065|10021279|FG000|COMPLETED|Overall Study||1
8957729|NCT02509065|10021280|FG001|COMPLETED|Overall Study||1
8957730|NCT02509065|10021281|FG002|COMPLETED|Overall Study||2
8957731|NCT02509065|10021282|FG003|COMPLETED|Overall Study||1
8957732|NCT02509065|10021283|FG004|COMPLETED|Overall Study||1
8957733|NCT02509065|10021284|FG005|COMPLETED|Overall Study||1
8957734|NCT02509065|10021285|FG006|COMPLETED|Overall Study||1
8957735|NCT02509065|10021286|FG007|COMPLETED|Overall Study||1
8957736|NCT02509065|10021287|FG008|COMPLETED|Overall Study||1
8957737|NCT02509065|10021288|FG009|COMPLETED|Overall Study||1
8957738|NCT02509065|10021289|FG010|COMPLETED|Overall Study||1
8957739|NCT02509065|10021290|FG011|COMPLETED|Overall Study||1
8957740|NCT02509065|10021291|FG012|COMPLETED|Overall Study||1
8957741|NCT02509065|10021292|FG013|COMPLETED|Overall Study||1
8957742|NCT02509065|10021293|FG014|COMPLETED|Overall Study||1
8957743|NCT02509065|10021294|FG015|COMPLETED|Overall Study||1
8957744|NCT02509065|10021295|FG016|COMPLETED|Overall Study||1
8957745|NCT02509065|10021296|FG017|COMPLETED|Overall Study||1
8957746|NCT02509065|10021297|FG018|COMPLETED|Overall Study||1
8957747|NCT02509065|10021298|FG019|COMPLETED|Overall Study||1
8957748|NCT02509065|10021299|FG020|COMPLETED|Overall Study||1
8957749|NCT02509065|10021300|FG021|COMPLETED|Overall Study||1
8957750|NCT02509065|10021301|FG022|COMPLETED|Overall Study||1
8957751|NCT02509065|10021279|FG000|NOT COMPLETED|Overall Study||0
8957752|NCT02509065|10021280|FG001|NOT COMPLETED|Overall Study||0
8957753|NCT02509065|10021281|FG002|NOT COMPLETED|Overall Study||0
8957754|NCT02509065|10021282|FG003|NOT COMPLETED|Overall Study||0
8957755|NCT02509065|10021283|FG004|NOT COMPLETED|Overall Study||0
8957756|NCT02509065|10021284|FG005|NOT COMPLETED|Overall Study||0
8957757|NCT02509065|10021285|FG006|NOT COMPLETED|Overall Study||0
8957758|NCT02509065|10021286|FG007|NOT COMPLETED|Overall Study||0
8957759|NCT02509065|10021287|FG008|NOT COMPLETED|Overall Study||0
8957760|NCT02509065|10021288|FG009|NOT COMPLETED|Overall Study||0
8957761|NCT02509065|10021289|FG010|NOT COMPLETED|Overall Study||0
8957762|NCT02509065|10021290|FG011|NOT COMPLETED|Overall Study||0
8957763|NCT02509065|10021291|FG012|NOT COMPLETED|Overall Study||0
8957764|NCT02509065|10021292|FG013|NOT COMPLETED|Overall Study||0
8957765|NCT02509065|10021293|FG014|NOT COMPLETED|Overall Study||0
8957766|NCT02509065|10021294|FG015|NOT COMPLETED|Overall Study||0
8957767|NCT02509065|10021295|FG016|NOT COMPLETED|Overall Study||0
8957768|NCT02509065|10021296|FG017|NOT COMPLETED|Overall Study||0
8957769|NCT02509065|10021297|FG018|NOT COMPLETED|Overall Study||0
8957770|NCT02509065|10021298|FG019|NOT COMPLETED|Overall Study||0
8957771|NCT02509065|10021299|FG020|NOT COMPLETED|Overall Study||0
8570207|NCT00101907|9602375|FG002|STARTED|Overall Study||6
8570208|NCT00101907|9602376|FG003|STARTED|Overall Study||6
8570209|NCT00101907|9602377|FG004|STARTED|Overall Study||11
8570210|NCT00101907|9602378|FG005|STARTED|Overall Study||2
8570211|NCT00101907|9602373|FG000|COMPLETED|Overall Study||6
8570212|NCT00101907|9602374|FG001|COMPLETED|Overall Study||7
8570213|NCT00101907|9602375|FG002|COMPLETED|Overall Study||5
8570214|NCT00101907|9602376|FG003|COMPLETED|Overall Study||5
8570215|NCT00101907|9602377|FG004|COMPLETED|Overall Study||6
8570216|NCT00101907|9602378|FG005|COMPLETED|Overall Study||2
8570217|NCT00101907|9602373|FG000|NOT COMPLETED|Overall Study||2
8570218|NCT00101907|9602374|FG001|NOT COMPLETED|Overall Study||1
8570219|NCT00101907|9602375|FG002|NOT COMPLETED|Overall Study||1
8570220|NCT00101907|9602376|FG003|NOT COMPLETED|Overall Study||1
8570221|NCT00101907|9602377|FG004|NOT COMPLETED|Overall Study||5
8570222|NCT00101907|9602378|FG005|NOT COMPLETED|Overall Study||0
8570223|NCT00101933|9602401|FG000|STARTED|Overall Study||54
8570224|NCT00101933|9602402|FG001|STARTED|Overall Study||55
8570225|NCT00101933|9602401|FG000|COMPLETED|Overall Study||54
8570226|NCT00101933|9602402|FG001|COMPLETED|Overall Study||55
8570227|NCT00101933|9602401|FG000|NOT COMPLETED|Overall Study||0
8570228|NCT00101933|9602402|FG001|NOT COMPLETED|Overall Study||0
8570229|NCT00102063|9602412|FG000|STARTED|Overall Study||100
8570230|NCT00102063|9602413|FG001|STARTED|Overall Study||102
8570231|NCT00102063|9602414|FG002|STARTED|Overall Study||100
8570232|NCT00102063|9602412|FG000|COMPLETED|Overall Study||84
8570233|NCT00102063|9602413|FG001|COMPLETED|Overall Study||84
8957772|NCT02509065|10021300|FG021|NOT COMPLETED|Overall Study||0
8957773|NCT02509065|10021301|FG022|NOT COMPLETED|Overall Study||0
8957774|NCT02509078|10021319|FG000|STARTED|Overall Study||502
8570234|NCT00102063|9602414|FG002|COMPLETED|Overall Study||90
8570235|NCT00102063|9602412|FG000|NOT COMPLETED|Overall Study||16
8570236|NCT00102063|9602413|FG001|NOT COMPLETED|Overall Study||18
8570237|NCT00102063|9602414|FG002|NOT COMPLETED|Overall Study||10
8570238|NCT00102440|9602425|FG000|STARTED|Overall Study||256
8957775|NCT02509078|10021320|FG001|STARTED|Overall Study||506
8957776|NCT02509078|10021319|FG000|COMPLETED|Overall Study||501
8957777|NCT02509078|10021320|FG001|COMPLETED|Overall Study||505
8957778|NCT02509078|10021319|FG000|NOT COMPLETED|Overall Study||1
8957779|NCT02509078|10021320|FG001|NOT COMPLETED|Overall Study||1
8957780|NCT02509117|10021338|FG000|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||2
8957781|NCT02509117|10021339|FG001|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||2
8957782|NCT02509117|10021340|FG002|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||2
8957783|NCT02509117|10021341|FG003|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||2
8957784|NCT02509117|10021342|FG004|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||8
8957785|NCT02509117|10021343|FG005|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||8
8957786|NCT02509117|10021344|FG006|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||8
8957787|NCT02509117|10021345|FG007|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||8
8957788|NCT02509117|10021346|FG008|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||4
8957789|NCT02509117|10021347|FG009|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||10
8957790|NCT02509117|10021338|FG000|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||2
8957791|NCT02509117|10021339|FG001|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||1
8957792|NCT02509117|10021340|FG002|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||2
8957793|NCT02509117|10021341|FG003|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||2
8957794|NCT02509117|10021342|FG004|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||8
8957795|NCT02509117|10021343|FG005|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||8
8957796|NCT02509117|10021344|FG006|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||8
8957797|NCT02509117|10021345|FG007|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||8
8957798|NCT02509117|10021346|FG008|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||4
8957799|NCT02509117|10021347|FG009|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||10
8874832|NCT01904773|9931726|FG005|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8874833|NCT01904773|9931727|FG006|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8874834|NCT01904773|9931728|FG007|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8874835|NCT01904773|9931729|FG008|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8874836|NCT01904773|9931721|FG000|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||1
8874837|NCT01904773|9931722|FG001|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8874838|NCT01904773|9931723|FG002|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8874839|NCT01904773|9931724|FG003|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8874840|NCT01904773|9931725|FG004|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8874841|NCT01904773|9931726|FG005|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8874842|NCT01904773|9931727|FG006|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8874843|NCT01904773|9931728|FG007|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8874844|NCT01904773|9931729|FG008|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8874845|NCT01904773|9931721|FG000|STARTED|First Intervention||0
8874846|NCT01904773|9931722|FG001|STARTED|First Intervention||2
8874847|NCT01904773|9931723|FG002|STARTED|First Intervention||1
8874848|NCT01904773|9931724|FG003|STARTED|First Intervention||2
8874849|NCT01904773|9931725|FG004|STARTED|First Intervention||3
8874850|NCT01904773|9931726|FG005|STARTED|First Intervention||4
8874851|NCT01904773|9931727|FG006|STARTED|First Intervention||4
8874852|NCT01904773|9931728|FG007|STARTED|First Intervention||3
8874853|NCT01904773|9931729|FG008|STARTED|First Intervention||4
8874854|NCT01904773|9931721|FG000|COMPLETED|First Intervention||0
8874855|NCT01904773|9931722|FG001|COMPLETED|First Intervention||2
8874856|NCT01904773|9931723|FG002|COMPLETED|First Intervention||1
8874857|NCT01904773|9931724|FG003|COMPLETED|First Intervention||2
8874858|NCT01904773|9931725|FG004|COMPLETED|First Intervention||3
8874859|NCT01904773|9931726|FG005|COMPLETED|First Intervention||4
8874860|NCT01904773|9931727|FG006|COMPLETED|First Intervention||3
8874861|NCT01904773|9931728|FG007|COMPLETED|First Intervention||3
8874862|NCT01904773|9931729|FG008|COMPLETED|First Intervention||4
8874863|NCT01904773|9931721|FG000|NOT COMPLETED|First Intervention||0
8874864|NCT01904773|9931722|FG001|NOT COMPLETED|First Intervention||0
8874865|NCT01904773|9931723|FG002|NOT COMPLETED|First Intervention||0
8874866|NCT01904773|9931724|FG003|NOT COMPLETED|First Intervention||0
8874867|NCT01904773|9931725|FG004|NOT COMPLETED|First Intervention||0
8874868|NCT01904773|9931726|FG005|NOT COMPLETED|First Intervention||0
8874869|NCT01904773|9931727|FG006|NOT COMPLETED|First Intervention||1
8874870|NCT01904773|9931728|FG007|NOT COMPLETED|First Intervention||0
8874871|NCT01904773|9931729|FG008|NOT COMPLETED|First Intervention||0
8874872|NCT01904773|9931721|FG000|STARTED|Placebo Washout First Intervention||0
8874873|NCT01904773|9931722|FG001|STARTED|Placebo Washout First Intervention||2
8874874|NCT01904773|9931723|FG002|STARTED|Placebo Washout First Intervention||1
8874875|NCT01904773|9931724|FG003|STARTED|Placebo Washout First Intervention||2
8874876|NCT01904773|9931725|FG004|STARTED|Placebo Washout First Intervention||3
8874877|NCT01904773|9931726|FG005|STARTED|Placebo Washout First Intervention||4
8874878|NCT01904773|9931727|FG006|STARTED|Placebo Washout First Intervention||3
8957800|NCT02509117|10021338|FG000|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||2
8957801|NCT02509117|10021339|FG001|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||1
8957802|NCT02509117|10021340|FG002|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||2
8957803|NCT02509117|10021341|FG003|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||2
8957804|NCT02509117|10021342|FG004|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
8957805|NCT02509117|10021343|FG005|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
8957806|NCT02509117|10021344|FG006|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
8957807|NCT02509117|10021345|FG007|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
8957808|NCT02509117|10021346|FG008|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||4
8957809|NCT02509117|10021347|FG009|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
8957810|NCT02509117|10021338|FG000|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
8957811|NCT02509117|10021339|FG001|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||1
8957812|NCT02509117|10021340|FG002|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
8957813|NCT02509117|10021341|FG003|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
8957814|NCT02509117|10021342|FG004|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
8957815|NCT02509117|10021343|FG005|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
8957816|NCT02509117|10021344|FG006|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
8957817|NCT02509117|10021345|FG007|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
8631378|NCT00539526|9671245|FG001|NOT COMPLETED|Overall Study||2
8631379|NCT00539526|9671246|FG002|NOT COMPLETED|Overall Study||2
8631380|NCT00539539|9671256|FG000|STARTED|Overall Study||815
8631381|NCT00539539|9671257|FG001|STARTED|Overall Study||771
8631382|NCT00539539|9671256|FG000|COMPLETED|Overall Study||815
8631383|NCT00539539|9671257|FG001|COMPLETED|Overall Study||771
8631384|NCT00539539|9671256|FG000|NOT COMPLETED|Overall Study||0
8631385|NCT00539539|9671257|FG001|NOT COMPLETED|Overall Study||0
8725690|NCT01032889|9773007|FG001|Received Treatment|Overall Study||43
8874879|NCT01904773|9931728|FG007|STARTED|Placebo Washout First Intervention||3
8874880|NCT01904773|9931729|FG008|STARTED|Placebo Washout First Intervention||4
8874881|NCT01904773|9931721|FG000|COMPLETED|Placebo Washout First Intervention||0
8874882|NCT01904773|9931722|FG001|COMPLETED|Placebo Washout First Intervention||1
8874883|NCT01904773|9931723|FG002|COMPLETED|Placebo Washout First Intervention||1
8874884|NCT01904773|9931724|FG003|COMPLETED|Placebo Washout First Intervention||2
8874885|NCT01904773|9931725|FG004|COMPLETED|Placebo Washout First Intervention||3
8874886|NCT01904773|9931726|FG005|COMPLETED|Placebo Washout First Intervention||4
8874887|NCT01904773|9931727|FG006|COMPLETED|Placebo Washout First Intervention||3
8874888|NCT01904773|9931728|FG007|COMPLETED|Placebo Washout First Intervention||3
8874889|NCT01904773|9931729|FG008|COMPLETED|Placebo Washout First Intervention||4
8874890|NCT01904773|9931721|FG000|NOT COMPLETED|Placebo Washout First Intervention||0
8874891|NCT01904773|9931722|FG001|NOT COMPLETED|Placebo Washout First Intervention||1
8874892|NCT01904773|9931723|FG002|NOT COMPLETED|Placebo Washout First Intervention||0
8874893|NCT01904773|9931724|FG003|NOT COMPLETED|Placebo Washout First Intervention||0
8874894|NCT01904773|9931725|FG004|NOT COMPLETED|Placebo Washout First Intervention||0
8874895|NCT01904773|9931726|FG005|NOT COMPLETED|Placebo Washout First Intervention||0
8874896|NCT01904773|9931727|FG006|NOT COMPLETED|Placebo Washout First Intervention||0
8874897|NCT01904773|9931728|FG007|NOT COMPLETED|Placebo Washout First Intervention||0
8874898|NCT01904773|9931729|FG008|NOT COMPLETED|Placebo Washout First Intervention||0
8874899|NCT01904773|9931721|FG000|STARTED|Second Intervention||0
8874900|NCT01904773|9931722|FG001|STARTED|Second Intervention||1
8874901|NCT01904773|9931723|FG002|STARTED|Second Intervention||1
8874902|NCT01904773|9931724|FG003|STARTED|Second Intervention||2
8874903|NCT01904773|9931725|FG004|STARTED|Second Intervention||3
8874904|NCT01904773|9931726|FG005|STARTED|Second Intervention||4
8874905|NCT01904773|9931727|FG006|STARTED|Second Intervention||3
8874906|NCT01904773|9931728|FG007|STARTED|Second Intervention||3
8874907|NCT01904773|9931729|FG008|STARTED|Second Intervention||4
8874908|NCT01904773|9931721|FG000|COMPLETED|Second Intervention||0
8957818|NCT02509117|10021346|FG008|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
8957819|NCT02509117|10021347|FG009|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||2
8957820|NCT02509117|10021338|FG000|STARTED|Washout Period 1 (Part A: 7 Days)||2
8957821|NCT02509117|10021339|FG001|STARTED|Washout Period 1 (Part A: 7 Days)||1
8631386|NCT00539656|9671263|FG000|STARTED|Overall Study||3
8725691|NCT01032889|9773008|FG002|Received Treatment|Overall Study||45
8725692|NCT01032889|9773006|FG000|COMPLETED|Overall Study||33
8725693|NCT01032889|9773007|FG001|COMPLETED|Overall Study||28
8725694|NCT01032889|9773008|FG002|COMPLETED|Overall Study||42
8725695|NCT01032889|9773006|FG000|NOT COMPLETED|Overall Study||8
8725696|NCT01032889|9773007|FG001|NOT COMPLETED|Overall Study||15
8725697|NCT01032889|9773008|FG002|NOT COMPLETED|Overall Study||3
8725698|NCT01032915|9773020|FG000|STARTED|Overall Study||29
8725699|NCT01032915|9773021|FG001|STARTED|Overall Study||31
8725700|NCT01032915|9773022|FG002|STARTED|Overall Study||31
8725701|NCT01032915|9773023|FG003|STARTED|Overall Study||34
8725702|NCT01032915|9773020|FG000|COMPLETED|Overall Study||21
8725703|NCT01032915|9773021|FG001|COMPLETED|Overall Study||20
8725704|NCT01032915|9773022|FG002|COMPLETED|Overall Study||24
8725705|NCT01032915|9773023|FG003|COMPLETED|Overall Study||27
8725706|NCT01032915|9773020|FG000|NOT COMPLETED|Overall Study||8
8725707|NCT01032915|9773021|FG001|NOT COMPLETED|Overall Study||11
8725708|NCT01032915|9773022|FG002|NOT COMPLETED|Overall Study||7
8725709|NCT01032915|9773023|FG003|NOT COMPLETED|Overall Study||7
8725710|NCT01032928|9773033|FG000|STARTED|Overall Study||30
8725711|NCT01032928|9773033|FG000|COMPLETED|Overall Study||30
8570239|NCT00102440|9602426|FG001|STARTED|Overall Study||251
8570240|NCT00102440|9602427|FG002|STARTED|Overall Study||253
8570241|NCT00102440|9602425|FG000|COMPLETED|Overall Study||168
8570242|NCT00102440|9602426|FG001|COMPLETED|Overall Study||153
8570243|NCT00102440|9602427|FG002|COMPLETED|Overall Study||187
8570244|NCT00102440|9602425|FG000|NOT COMPLETED|Overall Study||88
8570245|NCT00102440|9602426|FG001|NOT COMPLETED|Overall Study||98
8570246|NCT00102440|9602427|FG002|NOT COMPLETED|Overall Study||66
8570247|NCT00102518|9602435|FG000|STARTED|Overall Study||325
8570248|NCT00102518|9602435|FG000|COMPLETED|Overall Study||238
8631387|NCT00539656|9671263|FG000|COMPLETED|Overall Study||3
8631388|NCT00539656|9671263|FG000|NOT COMPLETED|Overall Study||0
8631389|NCT00539695|9671267|FG000|STARTED|Overall Study||25
8631390|NCT00539695|9671267|FG000|Evaluable Patients|Overall Study|Patients who received IL-2.|22
8631391|NCT00539695|9671267|FG000|COMPLETED|Overall Study||12
8631392|NCT00539695|9671267|FG000|NOT COMPLETED|Overall Study||13
8874909|NCT01904773|9931722|FG001|COMPLETED|Second Intervention||1
8874910|NCT01904773|9931723|FG002|COMPLETED|Second Intervention||1
8874911|NCT01904773|9931724|FG003|COMPLETED|Second Intervention||2
8874912|NCT01904773|9931725|FG004|COMPLETED|Second Intervention||3
8874913|NCT01904773|9931726|FG005|COMPLETED|Second Intervention||4
8874914|NCT01904773|9931727|FG006|COMPLETED|Second Intervention||3
8874915|NCT01904773|9931728|FG007|COMPLETED|Second Intervention||3
8874916|NCT01904773|9931729|FG008|COMPLETED|Second Intervention||4
8874917|NCT01904773|9931721|FG000|NOT COMPLETED|Second Intervention||0
8874918|NCT01904773|9931722|FG001|NOT COMPLETED|Second Intervention||0
8874919|NCT01904773|9931723|FG002|NOT COMPLETED|Second Intervention||0
8874920|NCT01904773|9931724|FG003|NOT COMPLETED|Second Intervention||0
8874921|NCT01904773|9931725|FG004|NOT COMPLETED|Second Intervention||0
8874922|NCT01904773|9931726|FG005|NOT COMPLETED|Second Intervention||0
8874923|NCT01904773|9931727|FG006|NOT COMPLETED|Second Intervention||0
8874924|NCT01904773|9931728|FG007|NOT COMPLETED|Second Intervention||0
8874925|NCT01904773|9931729|FG008|NOT COMPLETED|Second Intervention||0
8874926|NCT01904773|9931721|FG000|STARTED|Placebo Washout Second Intervention||0
8874927|NCT01904773|9931722|FG001|STARTED|Placebo Washout Second Intervention||1
8874928|NCT01904773|9931723|FG002|STARTED|Placebo Washout Second Intervention||1
8874929|NCT01904773|9931724|FG003|STARTED|Placebo Washout Second Intervention||2
8874930|NCT01904773|9931725|FG004|STARTED|Placebo Washout Second Intervention||3
8874931|NCT01904773|9931726|FG005|STARTED|Placebo Washout Second Intervention||4
8874932|NCT01904773|9931727|FG006|STARTED|Placebo Washout Second Intervention||3
8874933|NCT01904773|9931728|FG007|STARTED|Placebo Washout Second Intervention||3
8874934|NCT01904773|9931729|FG008|STARTED|Placebo Washout Second Intervention||4
8874935|NCT01904773|9931721|FG000|COMPLETED|Placebo Washout Second Intervention||0
8874936|NCT01904773|9931722|FG001|COMPLETED|Placebo Washout Second Intervention||1
8874937|NCT01904773|9931723|FG002|COMPLETED|Placebo Washout Second Intervention||1
8874938|NCT01904773|9931724|FG003|COMPLETED|Placebo Washout Second Intervention||2
8874939|NCT01904773|9931725|FG004|COMPLETED|Placebo Washout Second Intervention||3
8874940|NCT01904773|9931726|FG005|COMPLETED|Placebo Washout Second Intervention||4
8874941|NCT01904773|9931727|FG006|COMPLETED|Placebo Washout Second Intervention||3
8874942|NCT01904773|9931728|FG007|COMPLETED|Placebo Washout Second Intervention||3
8874943|NCT01904773|9931729|FG008|COMPLETED|Placebo Washout Second Intervention||4
8874944|NCT01904773|9931721|FG000|NOT COMPLETED|Placebo Washout Second Intervention||0
8874945|NCT01904773|9931722|FG001|NOT COMPLETED|Placebo Washout Second Intervention||0
8874946|NCT01904773|9931723|FG002|NOT COMPLETED|Placebo Washout Second Intervention||0
8874947|NCT01904773|9931724|FG003|NOT COMPLETED|Placebo Washout Second Intervention||0
8874948|NCT01904773|9931725|FG004|NOT COMPLETED|Placebo Washout Second Intervention||0
8874949|NCT01904773|9931726|FG005|NOT COMPLETED|Placebo Washout Second Intervention||0
8874950|NCT01904773|9931727|FG006|NOT COMPLETED|Placebo Washout Second Intervention||0
8874951|NCT01904773|9931728|FG007|NOT COMPLETED|Placebo Washout Second Intervention||0
8874952|NCT01904773|9931729|FG008|NOT COMPLETED|Placebo Washout Second Intervention||0
8874953|NCT01904773|9931721|FG000|STARTED|Third Intervention||0
8874954|NCT01904773|9931722|FG001|STARTED|Third Intervention||1
8874955|NCT01904773|9931723|FG002|STARTED|Third Intervention||1
8874956|NCT01904773|9931724|FG003|STARTED|Third Intervention||2
8874957|NCT01904773|9931725|FG004|STARTED|Third Intervention||3
8874958|NCT01904773|9931726|FG005|STARTED|Third Intervention||4
8874959|NCT01904773|9931727|FG006|STARTED|Third Intervention||3
8874960|NCT01904773|9931728|FG007|STARTED|Third Intervention||3
8874961|NCT01904773|9931729|FG008|STARTED|Third Intervention||4
8874962|NCT01904773|9931721|FG000|COMPLETED|Third Intervention||0
8874963|NCT01904773|9931722|FG001|COMPLETED|Third Intervention||1
8570249|NCT00102518|9602435|FG000|NOT COMPLETED|Overall Study||87
8874964|NCT01904773|9931723|FG002|COMPLETED|Third Intervention||1
8957822|NCT02509117|10021340|FG002|STARTED|Washout Period 1 (Part A: 7 Days)||2
8957823|NCT02509117|10021341|FG003|STARTED|Washout Period 1 (Part A: 7 Days)||2
8957824|NCT02509117|10021342|FG004|STARTED|Washout Period 1 (Part A: 7 Days)||0
8957825|NCT02509117|10021343|FG005|STARTED|Washout Period 1 (Part A: 7 Days)||0
8957826|NCT02509117|10021344|FG006|STARTED|Washout Period 1 (Part A: 7 Days)||0
8957827|NCT02509117|10021345|FG007|STARTED|Washout Period 1 (Part A: 7 Days)||0
8957828|NCT02509117|10021346|FG008|STARTED|Washout Period 1 (Part A: 7 Days)||0
8957829|NCT02509117|10021347|FG009|STARTED|Washout Period 1 (Part A: 7 Days)||0
8957830|NCT02509117|10021338|FG000|COMPLETED|Washout Period 1 (Part A: 7 Days)||2
8957831|NCT02509117|10021339|FG001|COMPLETED|Washout Period 1 (Part A: 7 Days)||1
8957832|NCT02509117|10021340|FG002|COMPLETED|Washout Period 1 (Part A: 7 Days)||2
8957833|NCT02509117|10021341|FG003|COMPLETED|Washout Period 1 (Part A: 7 Days)||2
8957834|NCT02509117|10021342|FG004|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
8957835|NCT02509117|10021343|FG005|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
8957836|NCT02509117|10021344|FG006|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
8957837|NCT02509117|10021345|FG007|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
8957838|NCT02509117|10021346|FG008|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
8957839|NCT02509117|10021347|FG009|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
8957840|NCT02509117|10021338|FG000|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
8957841|NCT02509117|10021339|FG001|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
8957842|NCT02509117|10021340|FG002|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
8957843|NCT02509117|10021341|FG003|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
8957844|NCT02509117|10021342|FG004|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
8957845|NCT02509117|10021343|FG005|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
8957846|NCT02509117|10021344|FG006|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
8957847|NCT02509117|10021345|FG007|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
8957848|NCT02509117|10021346|FG008|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
8957849|NCT02509117|10021347|FG009|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
8957850|NCT02509117|10021338|FG000|STARTED|Period 2 -Part A: 4 Days||2
8957851|NCT02509117|10021339|FG001|STARTED|Period 2 -Part A: 4 Days|1 participant was added in intervention period 2|2
8957852|NCT02509117|10021340|FG002|STARTED|Period 2 -Part A: 4 Days||2
8957853|NCT02509117|10021341|FG003|STARTED|Period 2 -Part A: 4 Days||2
8957854|NCT02509117|10021342|FG004|STARTED|Period 2 -Part A: 4 Days||0
8957855|NCT02509117|10021343|FG005|STARTED|Period 2 -Part A: 4 Days||0
8957856|NCT02509117|10021344|FG006|STARTED|Period 2 -Part A: 4 Days||0
8957857|NCT02509117|10021345|FG007|STARTED|Period 2 -Part A: 4 Days||0
8957858|NCT02509117|10021346|FG008|STARTED|Period 2 -Part A: 4 Days||0
8957859|NCT02509117|10021347|FG009|STARTED|Period 2 -Part A: 4 Days||0
8957860|NCT02509117|10021338|FG000|Treated|Period 2 -Part A: 4 Days||2
8957861|NCT02509117|10021339|FG001|Treated|Period 2 -Part A: 4 Days||2
8957862|NCT02509117|10021340|FG002|Treated|Period 2 -Part A: 4 Days||2
8957863|NCT02509117|10021341|FG003|Treated|Period 2 -Part A: 4 Days||2
8957864|NCT02509117|10021342|FG004|Treated|Period 2 -Part A: 4 Days||0
8957865|NCT02509117|10021343|FG005|Treated|Period 2 -Part A: 4 Days||0
8957866|NCT02509117|10021344|FG006|Treated|Period 2 -Part A: 4 Days||0
8957867|NCT02509117|10021345|FG007|Treated|Period 2 -Part A: 4 Days||0
8957868|NCT02509117|10021346|FG008|Treated|Period 2 -Part A: 4 Days||0
8957869|NCT02509117|10021347|FG009|Treated|Period 2 -Part A: 4 Days||0
8957870|NCT02509117|10021338|FG000|COMPLETED|Period 2 -Part A: 4 Days||2
8957871|NCT02509117|10021339|FG001|COMPLETED|Period 2 -Part A: 4 Days||2
8957872|NCT02509117|10021340|FG002|COMPLETED|Period 2 -Part A: 4 Days||2
8957873|NCT02509117|10021341|FG003|COMPLETED|Period 2 -Part A: 4 Days||2
8957874|NCT02509117|10021342|FG004|COMPLETED|Period 2 -Part A: 4 Days||0
8957875|NCT02509117|10021343|FG005|COMPLETED|Period 2 -Part A: 4 Days||0
8957876|NCT02509117|10021344|FG006|COMPLETED|Period 2 -Part A: 4 Days||0
8631393|NCT00539734|9671271|FG000|STARTED|Overall Study||26
8631394|NCT00539734|9671271|FG000|COMPLETED|Overall Study||25
8631395|NCT00539734|9671271|FG000|NOT COMPLETED|Overall Study||1
8631396|NCT00539864|9671277|FG000|STARTED|Overall Study||300
8631397|NCT00539864|9671278|FG001|STARTED|Overall Study||302
8957877|NCT02509117|10021345|FG007|COMPLETED|Period 2 -Part A: 4 Days||0
8957878|NCT02509117|10021346|FG008|COMPLETED|Period 2 -Part A: 4 Days||0
8957879|NCT02509117|10021347|FG009|COMPLETED|Period 2 -Part A: 4 Days||0
8957880|NCT02509117|10021338|FG000|NOT COMPLETED|Period 2 -Part A: 4 Days||0
8957881|NCT02509117|10021339|FG001|NOT COMPLETED|Period 2 -Part A: 4 Days||0
8957882|NCT02509117|10021340|FG002|NOT COMPLETED|Period 2 -Part A: 4 Days||0
8957883|NCT02509117|10021341|FG003|NOT COMPLETED|Period 2 -Part A: 4 Days||0
8957884|NCT02509117|10021342|FG004|NOT COMPLETED|Period 2 -Part A: 4 Days||0
8957885|NCT02509117|10021343|FG005|NOT COMPLETED|Period 2 -Part A: 4 Days||0
8631398|NCT00539864|9671277|FG000|COMPLETED|Overall Study||299
8957886|NCT02509117|10021344|FG006|NOT COMPLETED|Period 2 -Part A: 4 Days||0
8957887|NCT02509117|10021345|FG007|NOT COMPLETED|Period 2 -Part A: 4 Days||0
8957888|NCT02509117|10021346|FG008|NOT COMPLETED|Period 2 -Part A: 4 Days||0
8957889|NCT02509117|10021347|FG009|NOT COMPLETED|Period 2 -Part A: 4 Days||0
8631399|NCT00539864|9671278|FG001|COMPLETED|Overall Study||300
8957890|NCT02509117|10021338|FG000|STARTED|Washout Period 2 (Part A: 7 Days)||2
8957891|NCT02509117|10021339|FG001|STARTED|Washout Period 2 (Part A: 7 Days)||2
8957892|NCT02509117|10021340|FG002|STARTED|Washout Period 2 (Part A: 7 Days)||2
8957893|NCT02509117|10021341|FG003|STARTED|Washout Period 2 (Part A: 7 Days)||2
8957894|NCT02509117|10021342|FG004|STARTED|Washout Period 2 (Part A: 7 Days)||0
8957895|NCT02509117|10021343|FG005|STARTED|Washout Period 2 (Part A: 7 Days)||0
8957896|NCT02509117|10021344|FG006|STARTED|Washout Period 2 (Part A: 7 Days)||0
8957897|NCT02509117|10021345|FG007|STARTED|Washout Period 2 (Part A: 7 Days)||0
8957898|NCT02509117|10021346|FG008|STARTED|Washout Period 2 (Part A: 7 Days)||0
8957899|NCT02509117|10021347|FG009|STARTED|Washout Period 2 (Part A: 7 Days)||0
8957900|NCT02509117|10021338|FG000|COMPLETED|Washout Period 2 (Part A: 7 Days)||2
8957901|NCT02509117|10021339|FG001|COMPLETED|Washout Period 2 (Part A: 7 Days)||2
8957902|NCT02509117|10021340|FG002|COMPLETED|Washout Period 2 (Part A: 7 Days)||2
8957903|NCT02509117|10021341|FG003|COMPLETED|Washout Period 2 (Part A: 7 Days)||2
8957904|NCT02509117|10021342|FG004|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
8957905|NCT02509117|10021343|FG005|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
8957906|NCT02509117|10021344|FG006|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
8957907|NCT02509117|10021345|FG007|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
8957908|NCT02509117|10021346|FG008|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
8957909|NCT02509117|10021347|FG009|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
8957910|NCT02509117|10021338|FG000|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
8957911|NCT02509117|10021339|FG001|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
8957912|NCT02509117|10021340|FG002|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
8957913|NCT02509117|10021341|FG003|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
8957914|NCT02509117|10021342|FG004|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
8957915|NCT02509117|10021343|FG005|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
8957916|NCT02509117|10021344|FG006|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
8957917|NCT02509117|10021345|FG007|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
8957918|NCT02509117|10021346|FG008|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
8957919|NCT02509117|10021347|FG009|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
8957920|NCT02509117|10021338|FG000|STARTED|Period 3 -Part A: 4 Days||2
8957921|NCT02509117|10021339|FG001|STARTED|Period 3 -Part A: 4 Days||2
8957922|NCT02509117|10021340|FG002|STARTED|Period 3 -Part A: 4 Days||2
8957923|NCT02509117|10021341|FG003|STARTED|Period 3 -Part A: 4 Days||2
8957924|NCT02509117|10021342|FG004|STARTED|Period 3 -Part A: 4 Days||0
8957925|NCT02509117|10021343|FG005|STARTED|Period 3 -Part A: 4 Days||0
8957926|NCT02509117|10021344|FG006|STARTED|Period 3 -Part A: 4 Days||0
8957927|NCT02509117|10021345|FG007|STARTED|Period 3 -Part A: 4 Days||0
8957928|NCT02509117|10021346|FG008|STARTED|Period 3 -Part A: 4 Days||0
8957929|NCT02509117|10021347|FG009|STARTED|Period 3 -Part A: 4 Days||0
8957930|NCT02509117|10021338|FG000|COMPLETED|Period 3 -Part A: 4 Days||2
8957931|NCT02509117|10021339|FG001|COMPLETED|Period 3 -Part A: 4 Days||2
8957932|NCT02509117|10021340|FG002|COMPLETED|Period 3 -Part A: 4 Days||2
8957933|NCT02509117|10021341|FG003|COMPLETED|Period 3 -Part A: 4 Days||2
8957934|NCT02509117|10021342|FG004|COMPLETED|Period 3 -Part A: 4 Days||0
8957935|NCT02509117|10021343|FG005|COMPLETED|Period 3 -Part A: 4 Days||0
8957936|NCT02509117|10021344|FG006|COMPLETED|Period 3 -Part A: 4 Days||0
8957937|NCT02509117|10021345|FG007|COMPLETED|Period 3 -Part A: 4 Days||0
8957938|NCT02509117|10021346|FG008|COMPLETED|Period 3 -Part A: 4 Days||0
8957939|NCT02509117|10021347|FG009|COMPLETED|Period 3 -Part A: 4 Days||0
8957940|NCT02509117|10021338|FG000|NOT COMPLETED|Period 3 -Part A: 4 Days||0
8957941|NCT02509117|10021339|FG001|NOT COMPLETED|Period 3 -Part A: 4 Days||0
8957942|NCT02509117|10021340|FG002|NOT COMPLETED|Period 3 -Part A: 4 Days||0
8957943|NCT02509117|10021341|FG003|NOT COMPLETED|Period 3 -Part A: 4 Days||0
8957944|NCT02509117|10021342|FG004|NOT COMPLETED|Period 3 -Part A: 4 Days||0
8957945|NCT02509117|10021343|FG005|NOT COMPLETED|Period 3 -Part A: 4 Days||0
8957946|NCT02509117|10021344|FG006|NOT COMPLETED|Period 3 -Part A: 4 Days||0
8957947|NCT02509117|10021345|FG007|NOT COMPLETED|Period 3 -Part A: 4 Days||0
8957948|NCT02509117|10021346|FG008|NOT COMPLETED|Period 3 -Part A: 4 Days||0
8957949|NCT02509117|10021347|FG009|NOT COMPLETED|Period 3 -Part A: 4 Days||0
8957950|NCT02509117|10021338|FG000|STARTED|Washout Period 3 (Part A: 7 Days)||2
8957951|NCT02509117|10021339|FG001|STARTED|Washout Period 3 (Part A: 7 Days)||2
8957952|NCT02509117|10021340|FG002|STARTED|Washout Period 3 (Part A: 7 Days)||2
8957953|NCT02509117|10021341|FG003|STARTED|Washout Period 3 (Part A: 7 Days)||2
8957954|NCT02509117|10021342|FG004|STARTED|Washout Period 3 (Part A: 7 Days)||0
8957955|NCT02509117|10021343|FG005|STARTED|Washout Period 3 (Part A: 7 Days)||0
8957956|NCT02509117|10021344|FG006|STARTED|Washout Period 3 (Part A: 7 Days)||0
8957957|NCT02509117|10021345|FG007|STARTED|Washout Period 3 (Part A: 7 Days)||0
8957958|NCT02509117|10021346|FG008|STARTED|Washout Period 3 (Part A: 7 Days)||0
8957959|NCT02509117|10021347|FG009|STARTED|Washout Period 3 (Part A: 7 Days)||0
8957960|NCT02509117|10021338|FG000|COMPLETED|Washout Period 3 (Part A: 7 Days)||2
8957961|NCT02509117|10021339|FG001|COMPLETED|Washout Period 3 (Part A: 7 Days)||2
8957962|NCT02509117|10021340|FG002|COMPLETED|Washout Period 3 (Part A: 7 Days)||2
8957963|NCT02509117|10021341|FG003|COMPLETED|Washout Period 3 (Part A: 7 Days)||2
8957964|NCT02509117|10021342|FG004|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
8957965|NCT02509117|10021343|FG005|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
8957966|NCT02509117|10021344|FG006|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
8957967|NCT02509117|10021345|FG007|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
8957968|NCT02509117|10021346|FG008|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
8957969|NCT02509117|10021347|FG009|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
8957970|NCT02509117|10021338|FG000|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
8957971|NCT02509117|10021339|FG001|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
8957972|NCT02509117|10021340|FG002|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
8957973|NCT02509117|10021341|FG003|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
8957974|NCT02509117|10021342|FG004|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
8957975|NCT02509117|10021343|FG005|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
8957976|NCT02509117|10021344|FG006|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
8957977|NCT02509117|10021345|FG007|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
8957978|NCT02509117|10021346|FG008|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
8957979|NCT02509117|10021347|FG009|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
8957980|NCT02509117|10021338|FG000|STARTED|Period 4 -Part A: 4 Days||2
8957981|NCT02509117|10021339|FG001|STARTED|Period 4 -Part A: 4 Days||2
8957982|NCT02509117|10021340|FG002|STARTED|Period 4 -Part A: 4 Days||2
8957983|NCT02509117|10021341|FG003|STARTED|Period 4 -Part A: 4 Days||2
8957984|NCT02509117|10021342|FG004|STARTED|Period 4 -Part A: 4 Days||0
8957985|NCT02509117|10021343|FG005|STARTED|Period 4 -Part A: 4 Days||0
8957986|NCT02509117|10021344|FG006|STARTED|Period 4 -Part A: 4 Days||0
8957987|NCT02509117|10021345|FG007|STARTED|Period 4 -Part A: 4 Days||0
8957988|NCT02509117|10021346|FG008|STARTED|Period 4 -Part A: 4 Days||0
8957989|NCT02509117|10021347|FG009|STARTED|Period 4 -Part A: 4 Days||0
8957990|NCT02509117|10021338|FG000|COMPLETED|Period 4 -Part A: 4 Days||2
8957991|NCT02509117|10021339|FG001|COMPLETED|Period 4 -Part A: 4 Days||2
8957992|NCT02509117|10021340|FG002|COMPLETED|Period 4 -Part A: 4 Days||2
8957993|NCT02509117|10021341|FG003|COMPLETED|Period 4 -Part A: 4 Days||2
8957994|NCT02509117|10021342|FG004|COMPLETED|Period 4 -Part A: 4 Days||0
8957995|NCT02509117|10021343|FG005|COMPLETED|Period 4 -Part A: 4 Days||0
8957996|NCT02509117|10021344|FG006|COMPLETED|Period 4 -Part A: 4 Days||0
8957997|NCT02509117|10021345|FG007|COMPLETED|Period 4 -Part A: 4 Days||0
8957998|NCT02509117|10021346|FG008|COMPLETED|Period 4 -Part A: 4 Days||0
8957999|NCT02509117|10021347|FG009|COMPLETED|Period 4 -Part A: 4 Days||0
8958000|NCT02509117|10021338|FG000|NOT COMPLETED|Period 4 -Part A: 4 Days||0
8958001|NCT02509117|10021339|FG001|NOT COMPLETED|Period 4 -Part A: 4 Days||0
8958002|NCT02509117|10021340|FG002|NOT COMPLETED|Period 4 -Part A: 4 Days||0
8958003|NCT02509117|10021341|FG003|NOT COMPLETED|Period 4 -Part A: 4 Days||0
8958004|NCT02509117|10021342|FG004|NOT COMPLETED|Period 4 -Part A: 4 Days||0
8958005|NCT02509117|10021343|FG005|NOT COMPLETED|Period 4 -Part A: 4 Days||0
8958006|NCT02509117|10021344|FG006|NOT COMPLETED|Period 4 -Part A: 4 Days||0
8958007|NCT02509117|10021345|FG007|NOT COMPLETED|Period 4 -Part A: 4 Days||0
8958008|NCT02509117|10021346|FG008|NOT COMPLETED|Period 4 -Part A: 4 Days||0
8958009|NCT02509117|10021347|FG009|NOT COMPLETED|Period 4 -Part A: 4 Days||0
8958010|NCT02509156|10021387|FG000|STARTED|Open-Label Lead-In Phase||6
8958011|NCT02509156|10021388|FG001|STARTED|Open-Label Lead-In Phase||0
8958012|NCT02509156|10021387|FG000|COMPLETED|Open-Label Lead-In Phase||6
8958013|NCT02509156|10021388|FG001|COMPLETED|Open-Label Lead-In Phase||0
8958014|NCT02509156|10021387|FG000|NOT COMPLETED|Open-Label Lead-In Phase||0
8958015|NCT02509156|10021388|FG001|NOT COMPLETED|Open-Label Lead-In Phase||0
8958016|NCT02509156|10021387|FG000|STARTED|Randomized Phase|Includes randomized participants only|14
8958017|NCT02509156|10021388|FG001|STARTED|Randomized Phase||17
8958018|NCT02509156|10021387|FG000|COMPLETED|Randomized Phase||12
8958019|NCT02509156|10021388|FG001|COMPLETED|Randomized Phase||16
8958020|NCT02509156|10021387|FG000|NOT COMPLETED|Randomized Phase||2
8958021|NCT02509156|10021388|FG001|NOT COMPLETED|Randomized Phase||1
8958022|NCT02509481|10021396|FG000|STARTED|Overall Study||1265
8958023|NCT02509481|10021397|FG001|STARTED|Overall Study||1447
8958024|NCT02509481|10021396|FG000|COMPLETED|Overall Study||1265
8958025|NCT02509481|10021397|FG001|COMPLETED|Overall Study||1447
8958026|NCT02509481|10021396|FG000|NOT COMPLETED|Overall Study||0
8958027|NCT02509481|10021397|FG001|NOT COMPLETED|Overall Study||0
8958028|NCT02509585|10021403|FG000|STARTED|Overall Study||18
8958029|NCT02509585|10021403|FG000|COMPLETED|Overall Study||18
8958030|NCT02509585|10021403|FG000|NOT COMPLETED|Overall Study||0
8958031|NCT02509624|10021412|FG000|STARTED|Overall Study||10
8958032|NCT02509624|10021413|FG001|STARTED|Overall Study||10
8958033|NCT02509624|10021414|FG002|STARTED|Overall Study||10
8958034|NCT02509624|10021415|FG003|STARTED|Overall Study||22
8958035|NCT02509624|10021412|FG000|COMPLETED|Overall Study||10
8958036|NCT02509624|10021413|FG001|COMPLETED|Overall Study||10
8958037|NCT02509624|10021414|FG002|COMPLETED|Overall Study||10
8958038|NCT02509624|10021415|FG003|COMPLETED|Overall Study||22
8958039|NCT02509624|10021412|FG000|NOT COMPLETED|Overall Study||0
8958040|NCT02509624|10021413|FG001|NOT COMPLETED|Overall Study||0
8958041|NCT02509624|10021414|FG002|NOT COMPLETED|Overall Study||0
8958042|NCT02509624|10021415|FG003|NOT COMPLETED|Overall Study||0
8958043|NCT02509767|10021430|FG000|STARTED|Overall Study||201
8958044|NCT02509767|10021431|FG001|STARTED|Overall Study||200
8958045|NCT02509767|10021430|FG000|COMPLETED|Overall Study||157
8958046|NCT02509767|10021431|FG001|COMPLETED|Overall Study||159
8958047|NCT02509767|10021430|FG000|NOT COMPLETED|Overall Study||44
8958048|NCT02509767|10021431|FG001|NOT COMPLETED|Overall Study||41
8958049|NCT02509936|10021442|FG000|STARTED|Overall Study||163
8958050|NCT02509936|10021443|FG001|STARTED|Overall Study||161
8958051|NCT02509936|10021442|FG000|COMPLETED|Overall Study||151
8958052|NCT02509936|10021443|FG001|COMPLETED|Overall Study||145
8958053|NCT02509936|10021442|FG000|NOT COMPLETED|Overall Study||12
8958054|NCT02509936|10021443|FG001|NOT COMPLETED|Overall Study||16
8958055|NCT02510001|10021457|FG000|STARTED|Overall Study||6
8958056|NCT02510001|10021458|FG001|STARTED|Overall Study||5
8958057|NCT02510001|10021459|FG002|STARTED|Overall Study||6
8958058|NCT02510001|10021460|FG003|STARTED|Overall Study||8
8958059|NCT02510001|10021461|FG004|STARTED|Overall Study||8
8958060|NCT02510001|10021462|FG005|STARTED|Overall Study||7
8958061|NCT02510001|10021463|FG006|STARTED|Overall Study||5
8958062|NCT02510001|10021464|FG007|STARTED|Overall Study||37
8958063|NCT02510001|10021457|FG000|COMPLETED|Overall Study||6
8958064|NCT02510001|10021458|FG001|COMPLETED|Overall Study||5
8958065|NCT02510001|10021459|FG002|COMPLETED|Overall Study||6
8958066|NCT02510001|10021460|FG003|COMPLETED|Overall Study||6
8958067|NCT02510001|10021461|FG004|COMPLETED|Overall Study||4
8958068|NCT02510001|10021462|FG005|COMPLETED|Overall Study||5
8958069|NCT02510001|10021463|FG006|COMPLETED|Overall Study||3
8958070|NCT02510001|10021464|FG007|COMPLETED|Overall Study||30
8958071|NCT02510001|10021457|FG000|NOT COMPLETED|Overall Study||0
8958072|NCT02510001|10021458|FG001|NOT COMPLETED|Overall Study||0
8958073|NCT02510001|10021459|FG002|NOT COMPLETED|Overall Study||0
8958074|NCT02510001|10021460|FG003|NOT COMPLETED|Overall Study||2
8958075|NCT02510001|10021461|FG004|NOT COMPLETED|Overall Study||4
8958076|NCT02510001|10021462|FG005|NOT COMPLETED|Overall Study||2
8958077|NCT02510001|10021463|FG006|NOT COMPLETED|Overall Study||2
8958078|NCT02510001|10021464|FG007|NOT COMPLETED|Overall Study||7
8958079|NCT02510014|10021502|FG000|STARTED|Run-In Period (Days -14 to Day -1)||508
8958080|NCT02510014|10021503|FG001|STARTED|Run-In Period (Days -14 to Day -1)||267
8958081|NCT02510014|10021502|FG000|COMPLETED|Run-In Period (Days -14 to Day -1)||412
8958082|NCT02510014|10021503|FG001|COMPLETED|Run-In Period (Days -14 to Day -1)||257
8958083|NCT02510014|10021502|FG000|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||96
8958084|NCT02510014|10021503|FG001|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||10
8958085|NCT02510014|10021502|FG000|STARTED|Treatment Period||412
8958086|NCT02510014|10021503|FG001|STARTED|Treatment Period||257
8958087|NCT02510014|10021502|FG000|COMPLETED|Treatment Period||206
8958088|NCT02510014|10021503|FG001|COMPLETED|Treatment Period||200
8958089|NCT02510014|10021502|FG000|NOT COMPLETED|Treatment Period||206
8958090|NCT02510014|10021503|FG001|NOT COMPLETED|Treatment Period||57
8958091|NCT02510144|10021511|FG000|STARTED|Overall Study||39
8958092|NCT02510144|10021512|FG001|STARTED|Overall Study||41
8958093|NCT02510144|10021511|FG000|COMPLETED|Overall Study||39
8958094|NCT02510144|10021512|FG001|COMPLETED|Overall Study||41
8958095|NCT02510144|10021511|FG000|NOT COMPLETED|Overall Study||0
8958096|NCT02510144|10021512|FG001|NOT COMPLETED|Overall Study||0
8958097|NCT02510664|10021521|FG000|STARTED|Overall Study||84
8958098|NCT02510664|10021522|FG001|STARTED|Overall Study||84
8958099|NCT02510664|10021523|FG002|STARTED|Overall Study||4
8958100|NCT02510664|10021521|FG000|COMPLETED|Overall Study||64
8958101|NCT02510664|10021522|FG001|COMPLETED|Overall Study||64
8958102|NCT02510664|10021523|FG002|COMPLETED|Overall Study||4
8958103|NCT02510664|10021521|FG000|NOT COMPLETED|Overall Study||20
8958104|NCT02510664|10021522|FG001|NOT COMPLETED|Overall Study||20
8958105|NCT02510664|10021523|FG002|NOT COMPLETED|Overall Study||0
9037733|NCT03319953|10098953|FG003|Treated|Period 2 (Day 49 to 154)||6
9037734|NCT03319953|10098950|FG000|COMPLETED|Period 2 (Day 49 to 154)||2
9037735|NCT03319953|10098951|FG001|COMPLETED|Period 2 (Day 49 to 154)||4
9037736|NCT03319953|10098952|FG002|COMPLETED|Period 2 (Day 49 to 154)||8
9037737|NCT03319953|10098953|FG003|COMPLETED|Period 2 (Day 49 to 154)||6
9037738|NCT03319953|10098950|FG000|NOT COMPLETED|Period 2 (Day 49 to 154)||1
9037739|NCT03319953|10098951|FG001|NOT COMPLETED|Period 2 (Day 49 to 154)||0
9037740|NCT03319953|10098952|FG002|NOT COMPLETED|Period 2 (Day 49 to 154)||1
9037741|NCT03319953|10098953|FG003|NOT COMPLETED|Period 2 (Day 49 to 154)||1
9037742|NCT03320057|10098961|FG000|STARTED|Overall Study||266
9037743|NCT03320057|10098962|FG001|STARTED|Overall Study|Includes pharmacists at study pharmacies that consented to training on mifepristone dispensing.|60
9037744|NCT03320057|10098961|FG000|Patient's Clinical Outcome Information Obtained|Overall Study||262
9037745|NCT03320057|10098962|FG001|Patient's Clinical Outcome Information Obtained|Overall Study|Clinical outcome data were not collected for pharmacists - this milestone does not apply|0
9037746|NCT03320057|10098961|FG000|Received Pharmacist Training|Overall Study||0
9037747|NCT03320057|10098962|FG001|Received Pharmacist Training|Overall Study||56
9037748|NCT03320057|10098961|FG000|Pharmacists Completed Baseline Survey|Overall Study||0
9037749|NCT03320057|10098962|FG001|Pharmacists Completed Baseline Survey|Overall Study||47
9037750|NCT03320057|10098961|FG000|COMPLETED|Overall Study||260
9037751|NCT03320057|10098962|FG001|COMPLETED|Overall Study|This includes pharmacists who completed the endline survey. Only trained pharmacists (n=56) were eligible.|43
9037752|NCT03320057|10098961|FG000|NOT COMPLETED|Overall Study||6
9037753|NCT03320057|10098962|FG001|NOT COMPLETED|Overall Study||17
9037754|NCT03320096|10098968|FG000|STARTED|Overall Study||20
9037755|NCT03320096|10098968|FG000|COMPLETED|Overall Study||20
9037756|NCT03320096|10098968|FG000|NOT COMPLETED|Overall Study||0
9037757|NCT03320369|10098972|FG000|STARTED|Overall Study||18
9037758|NCT03320369|10098972|FG000|COMPLETED|Overall Study||15
9037759|NCT03320369|10098972|FG000|NOT COMPLETED|Overall Study||3
9037760|NCT03320824|10098978|FG000|STARTED|Overall Study||184
9037761|NCT03320824|10098979|FG001|STARTED|Overall Study||89
9037762|NCT03320824|10098978|FG000|COMPLETED|Overall Study||166
9037763|NCT03320824|10098979|FG001|COMPLETED|Overall Study||85
9037764|NCT03320824|10098978|FG000|NOT COMPLETED|Overall Study||18
9037765|NCT03320824|10098979|FG001|NOT COMPLETED|Overall Study||4
9037766|NCT03320850|10098995|FG000|STARTED|Overall Study||18
9037767|NCT03320850|10098996|FG001|STARTED|Overall Study||12
9037768|NCT03320850|10098997|FG002|STARTED|Overall Study||18
9037769|NCT03320850|10098998|FG003|STARTED|Overall Study||22
9037770|NCT03320850|10098999|FG004|STARTED|Overall Study||19
9037771|NCT03320850|10099000|FG005|STARTED|Overall Study||58
9037772|NCT03320850|10099001|FG006|STARTED|Overall Study||57
9037773|NCT03320850|10099002|FG007|STARTED|Overall Study||60
8958106|NCT02510794|10021540|FG000|STARTED|Overall Study||59
8958107|NCT02510794|10021541|FG001|STARTED|Overall Study||62
8958108|NCT02510794|10021542|FG002|STARTED|Overall Study||63
8958109|NCT02510794|10021543|FG003|STARTED|Overall Study||41
8958110|NCT02510794|10021540|FG000|COMPLETED|Overall Study||51
8958111|NCT02510794|10021541|FG001|COMPLETED|Overall Study||56
8958112|NCT02510794|10021542|FG002|COMPLETED|Overall Study||56
8958113|NCT02510794|10021543|FG003|COMPLETED|Overall Study||36
8958114|NCT02510794|10021540|FG000|NOT COMPLETED|Overall Study||8
8958115|NCT02510794|10021541|FG001|NOT COMPLETED|Overall Study||6
8958116|NCT02510794|10021542|FG002|NOT COMPLETED|Overall Study||7
8958117|NCT02510794|10021543|FG003|NOT COMPLETED|Overall Study||5
8958118|NCT02510820|10021555|FG000|STARTED|First Intervention (4 Weeks)||21
8958119|NCT02510820|10021556|FG001|STARTED|First Intervention (4 Weeks)||27
8958120|NCT02510820|10021555|FG000|COMPLETED|First Intervention (4 Weeks)||21
8958121|NCT02510820|10021556|FG001|COMPLETED|First Intervention (4 Weeks)||26
8958122|NCT02510820|10021555|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0
8958123|NCT02510820|10021556|FG001|NOT COMPLETED|First Intervention (4 Weeks)||1
8958124|NCT02510820|10021555|FG000|STARTED|Washout (1 Week)||21
8958125|NCT02510820|10021556|FG001|STARTED|Washout (1 Week)||26
8958126|NCT02510820|10021555|FG000|COMPLETED|Washout (1 Week)||21
8958127|NCT02510820|10021556|FG001|COMPLETED|Washout (1 Week)||26
8958128|NCT02510820|10021555|FG000|NOT COMPLETED|Washout (1 Week)||0
8958129|NCT02510820|10021556|FG001|NOT COMPLETED|Washout (1 Week)||0
8958130|NCT02510820|10021555|FG000|STARTED|Second Intervention (4 Weeks)||21
8958131|NCT02510820|10021556|FG001|STARTED|Second Intervention (4 Weeks)||26
8958132|NCT02510820|10021555|FG000|COMPLETED|Second Intervention (4 Weeks)||20
8958133|NCT02510820|10021556|FG001|COMPLETED|Second Intervention (4 Weeks)||26
8958134|NCT02510820|10021555|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||1
8958135|NCT02510820|10021556|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||0
8958136|NCT02511184|10021565|FG000|STARTED|Overall Study||2
8958137|NCT02511184|10021566|FG001|STARTED|Overall Study||7
8958138|NCT02511184|10021565|FG000|COMPLETED|Overall Study||0
8958139|NCT02511184|10021566|FG001|COMPLETED|Overall Study||0
8958140|NCT02511184|10021565|FG000|NOT COMPLETED|Overall Study||2
8958141|NCT02511184|10021566|FG001|NOT COMPLETED|Overall Study||7
8958142|NCT02511236|10021575|FG000|STARTED|Overall Study||165
8958143|NCT02511236|10021576|FG001|STARTED|Overall Study||191
8958144|NCT02511236|10021575|FG000|COMPLETED|Overall Study||125
8958145|NCT02511236|10021576|FG001|COMPLETED|Overall Study||146
8958146|NCT02511236|10021575|FG000|NOT COMPLETED|Overall Study||40
8958147|NCT02511236|10021576|FG001|NOT COMPLETED|Overall Study||45
8958148|NCT02511379|10021582|FG000|STARTED|Overall Study||14
8958149|NCT02511379|10021582|FG000|COMPLETED|Overall Study||14
8958150|NCT02511379|10021582|FG000|NOT COMPLETED|Overall Study||0
8958151|NCT02511431|10021592|FG000|STARTED|Treatment||4
8958152|NCT02511431|10021593|FG001|STARTED|Treatment||4
8958153|NCT02511431|10021594|FG002|STARTED|Treatment||4
8958154|NCT02511431|10021595|FG003|STARTED|Treatment||3
8958155|NCT02511431|10021596|FG004|STARTED|Treatment||3
8958156|NCT02511431|10021597|FG005|STARTED|Treatment||3
8958157|NCT02511431|10021592|FG000|COMPLETED|Treatment||4
8958158|NCT02511431|10021593|FG001|COMPLETED|Treatment||4
8958159|NCT02511431|10021594|FG002|COMPLETED|Treatment||3
8958160|NCT02511431|10021595|FG003|COMPLETED|Treatment||3
8958161|NCT02511431|10021596|FG004|COMPLETED|Treatment||3
8958162|NCT02511431|10021597|FG005|COMPLETED|Treatment||2
8958163|NCT02511431|10021592|FG000|NOT COMPLETED|Treatment||0
8958164|NCT02511431|10021593|FG001|NOT COMPLETED|Treatment||0
8958165|NCT02511431|10021594|FG002|NOT COMPLETED|Treatment||1
8958166|NCT02511431|10021595|FG003|NOT COMPLETED|Treatment||0
8958167|NCT02511431|10021596|FG004|NOT COMPLETED|Treatment||0
8958168|NCT02511431|10021597|FG005|NOT COMPLETED|Treatment||1
8958169|NCT02511431|10021592|FG000|STARTED|Post-treatment Follow-up||4
8958170|NCT02511431|10021593|FG001|STARTED|Post-treatment Follow-up||4
8958171|NCT02511431|10021594|FG002|STARTED|Post-treatment Follow-up||3
8958172|NCT02511431|10021595|FG003|STARTED|Post-treatment Follow-up||3
8958173|NCT02511431|10021596|FG004|STARTED|Post-treatment Follow-up||3
8958174|NCT02511431|10021597|FG005|STARTED|Post-treatment Follow-up||2
8958175|NCT02511431|10021592|FG000|COMPLETED|Post-treatment Follow-up||4
8958176|NCT02511431|10021593|FG001|COMPLETED|Post-treatment Follow-up||4
8958177|NCT02511431|10021594|FG002|COMPLETED|Post-treatment Follow-up||3
8958178|NCT02511431|10021595|FG003|COMPLETED|Post-treatment Follow-up||3
8958179|NCT02511431|10021596|FG004|COMPLETED|Post-treatment Follow-up||3
8958180|NCT02511431|10021597|FG005|COMPLETED|Post-treatment Follow-up||2
8958181|NCT02511431|10021592|FG000|NOT COMPLETED|Post-treatment Follow-up||0
8958182|NCT02511431|10021593|FG001|NOT COMPLETED|Post-treatment Follow-up||0
8958183|NCT02511431|10021594|FG002|NOT COMPLETED|Post-treatment Follow-up||0
8958184|NCT02511431|10021595|FG003|NOT COMPLETED|Post-treatment Follow-up||0
8958185|NCT02511431|10021596|FG004|NOT COMPLETED|Post-treatment Follow-up||0
8958186|NCT02511431|10021597|FG005|NOT COMPLETED|Post-treatment Follow-up||0
8958187|NCT02511535|10021615|FG000|STARTED|Overall Study||49
8958188|NCT02511535|10021616|FG001|STARTED|Overall Study||21
8958189|NCT02511535|10021617|FG002|STARTED|Overall Study||49
8958190|NCT02511535|10021615|FG000|COMPLETED|Overall Study||49
8958191|NCT02511535|10021616|FG001|COMPLETED|Overall Study||21
8958192|NCT02511535|10021617|FG002|COMPLETED|Overall Study||49
8958193|NCT02511535|10021615|FG000|NOT COMPLETED|Overall Study||0
8958194|NCT02511535|10021616|FG001|NOT COMPLETED|Overall Study||0
8958195|NCT02511535|10021617|FG002|NOT COMPLETED|Overall Study||0
8958196|NCT02511561|10021628|FG000|STARTED|Overall Study||25
8958197|NCT02511561|10021629|FG001|STARTED|Overall Study||25
8958198|NCT02511561|10021630|FG002|STARTED|Overall Study||25
8958199|NCT02511561|10021628|FG000|COMPLETED|Overall Study||25
8958200|NCT02511561|10021629|FG001|COMPLETED|Overall Study||25
8958201|NCT02511561|10021630|FG002|COMPLETED|Overall Study||25
8958202|NCT02511561|10021628|FG000|NOT COMPLETED|Overall Study||0
8958203|NCT02511561|10021629|FG001|NOT COMPLETED|Overall Study||0
8958204|NCT02511561|10021630|FG002|NOT COMPLETED|Overall Study||0
8958205|NCT02511587|10021641|FG000|STARTED|Overall Study||58
8958206|NCT02511587|10021642|FG001|STARTED|Overall Study||58
8958207|NCT02511587|10021641|FG000|COMPLETED|Overall Study||58
8958208|NCT02511587|10021642|FG001|COMPLETED|Overall Study||58
8958209|NCT02511587|10021641|FG000|NOT COMPLETED|Overall Study||0
8958210|NCT02511587|10021642|FG001|NOT COMPLETED|Overall Study||0
8958211|NCT02511678|10021648|FG000|STARTED|Overall Study||73
8958212|NCT02511678|10021648|FG000|Intent-to-Treat (ITT) Population|Overall Study|Participants for whom cryoablation via Galil Medical cryoablation system was attempted or performed.|66
8958213|NCT02511678|10021648|FG000|Participants Discontinued Pre-Treatment|Overall Study||7
8958214|NCT02511678|10021648|FG000|Safety Population|Overall Study|Participants for whom received the complete study cryoablation procedure.|65
8958215|NCT02511678|10021648|FG000|COMPLETED|Overall Study||37
8958216|NCT02511678|10021648|FG000|NOT COMPLETED|Overall Study||36
8958217|NCT02511717|10021655|FG000|STARTED|Overall Study||10
8958218|NCT02511717|10021656|FG001|STARTED|Overall Study||10
8958219|NCT02511717|10021655|FG000|COMPLETED|Overall Study||8
8570250|NCT00102531|9602441|FG000|STARTED|Overall Study||7
8570251|NCT00102531|9602442|FG001|STARTED|Overall Study||12
8570252|NCT00102531|9602441|FG000|COMPLETED|Overall Study||2
8570253|NCT00102531|9602442|FG001|COMPLETED|Overall Study||1
8570254|NCT00102531|9602441|FG000|NOT COMPLETED|Overall Study||5
8570255|NCT00102531|9602442|FG001|NOT COMPLETED|Overall Study||11
8570256|NCT00102596|9602448|FG000|STARTED|Part A||11
8570257|NCT00102596|9602449|FG001|STARTED|Part A||0
8570258|NCT00102596|9602448|FG000|Participants Assigned Treatment|Part A||5
8570259|NCT00102596|9602449|FG001|Participants Assigned Treatment|Part A||0
8570260|NCT00102596|9602448|FG000|COMPLETED|Part A||4
8570261|NCT00102596|9602449|FG001|COMPLETED|Part A||0
8570262|NCT00102596|9602448|FG000|NOT COMPLETED|Part A||7
8570263|NCT00102596|9602449|FG001|NOT COMPLETED|Part A||0
8570264|NCT00102596|9602448|FG000|STARTED|Part B|Participants from Part A did not continue to Part B|0
8570265|NCT00102596|9602449|FG001|STARTED|Part B||10
8570266|NCT00102596|9602448|FG000|COMPLETED|Part B||0
8570267|NCT00102596|9602449|FG001|COMPLETED|Part B||10
8570268|NCT00102596|9602448|FG000|NOT COMPLETED|Part B||0
8570269|NCT00102596|9602449|FG001|NOT COMPLETED|Part B||0
8570270|NCT00102596|9602448|FG000|STARTED|Part C||0
8570271|NCT00102596|9602449|FG001|STARTED|Part C|Only 2 patients participated in Part C|2
8570272|NCT00102596|9602448|FG000|COMPLETED|Part C||0
8570273|NCT00102596|9602449|FG001|COMPLETED|Part C||2
8570274|NCT00102596|9602448|FG000|NOT COMPLETED|Part C||0
8570275|NCT00102596|9602449|FG001|NOT COMPLETED|Part C||0
8570276|NCT00102687|9602459|FG000|STARTED|Initial Period||50
8570277|NCT00102687|9602460|FG001|STARTED|Initial Period||50
8570278|NCT00102687|9602461|FG002|STARTED|Initial Period|3 randomized participants did not receive treatment.|51
8570279|NCT00102687|9602462|FG003|STARTED|Initial Period||0
8570280|NCT00102687|9602463|FG004|STARTED|Initial Period||0
8570281|NCT00102687|9602459|FG000|COMPLETED|Initial Period||32
8631400|NCT00539864|9671277|FG000|NOT COMPLETED|Overall Study||1
8570282|NCT00102687|9602460|FG001|COMPLETED|Initial Period||22
8570283|NCT00102687|9602461|FG002|COMPLETED|Initial Period||25
8570284|NCT00102687|9602462|FG003|COMPLETED|Initial Period||0
8570285|NCT00102687|9602463|FG004|COMPLETED|Initial Period||0
8570286|NCT00102687|9602459|FG000|NOT COMPLETED|Initial Period||18
8570287|NCT00102687|9602460|FG001|NOT COMPLETED|Initial Period||28
8570288|NCT00102687|9602461|FG002|NOT COMPLETED|Initial Period||26
8570289|NCT00102687|9602462|FG003|NOT COMPLETED|Initial Period||0
8570290|NCT00102687|9602463|FG004|NOT COMPLETED|Initial Period||0
8570291|NCT00102687|9602459|FG000|STARTED|Maintenance Period|Remained on initial treatment in the maintenance period.|13
8570292|NCT00102687|9602460|FG001|STARTED|Maintenance Period|Remained on initial treatment in the maintenance period.|6
8958220|NCT02511717|10021656|FG001|COMPLETED|Overall Study||10
8958221|NCT02511717|10021655|FG000|NOT COMPLETED|Overall Study||2
8958222|NCT02511717|10021656|FG001|NOT COMPLETED|Overall Study||0
8958223|NCT02511730|10021662|FG000|STARTED|First Reading Session||50
8958224|NCT02511730|10021663|FG001|STARTED|First Reading Session||50
8958225|NCT02511730|10021662|FG000|COMPLETED|First Reading Session||50
8958226|NCT02511730|10021663|FG001|COMPLETED|First Reading Session||50
8958227|NCT02511730|10021662|FG000|NOT COMPLETED|First Reading Session||0
8958228|NCT02511730|10021663|FG001|NOT COMPLETED|First Reading Session||0
8958229|NCT02511730|10021662|FG000|STARTED|4 Week Memory Washout Period||50
8958230|NCT02511730|10021663|FG001|STARTED|4 Week Memory Washout Period||50
8958231|NCT02511730|10021662|FG000|COMPLETED|4 Week Memory Washout Period||50
8958232|NCT02511730|10021663|FG001|COMPLETED|4 Week Memory Washout Period||50
8958233|NCT02511730|10021662|FG000|NOT COMPLETED|4 Week Memory Washout Period||0
8958234|NCT02511730|10021663|FG001|NOT COMPLETED|4 Week Memory Washout Period||0
8958235|NCT02511730|10021662|FG000|STARTED|Session Reading Session||50
8958236|NCT02511730|10021663|FG001|STARTED|Session Reading Session||50
8958237|NCT02511730|10021662|FG000|COMPLETED|Session Reading Session||50
8958238|NCT02511730|10021663|FG001|COMPLETED|Session Reading Session||50
8958239|NCT02511730|10021662|FG000|NOT COMPLETED|Session Reading Session||0
8958240|NCT02511730|10021663|FG001|NOT COMPLETED|Session Reading Session||0
8958241|NCT02511782|10021672|FG000|STARTED|Overall Study||51
8958242|NCT02511782|10021673|FG001|STARTED|Overall Study||2
8958243|NCT02511782|10021674|FG002|STARTED|Overall Study||10
8958244|NCT02511782|10021672|FG000|COMPLETED|Overall Study||50
8958245|NCT02511782|10021673|FG001|COMPLETED|Overall Study||2
8958246|NCT02511782|10021674|FG002|COMPLETED|Overall Study||10
8958247|NCT02511782|10021672|FG000|NOT COMPLETED|Overall Study||1
8958248|NCT02511782|10021673|FG001|NOT COMPLETED|Overall Study||0
8958249|NCT02511782|10021674|FG002|NOT COMPLETED|Overall Study||0
8958250|NCT02512042|10021684|FG000|STARTED|Overall Study||495
8958251|NCT02512042|10021685|FG001|STARTED|Overall Study||478
8958252|NCT02512042|10021684|FG000|COMPLETED|Overall Study||472
8958253|NCT02512042|10021685|FG001|COMPLETED|Overall Study||453
8958254|NCT02512042|10021684|FG000|NOT COMPLETED|Overall Study||23
8958255|NCT02512042|10021685|FG001|NOT COMPLETED|Overall Study||25
8958256|NCT02512068|10021693|FG000|STARTED|Overall Study||55
8958257|NCT02512068|10021694|FG001|STARTED|Overall Study||52
8958258|NCT02512068|10021693|FG000|COMPLETED|Overall Study||43
8958259|NCT02512068|10021694|FG001|COMPLETED|Overall Study||39
8958260|NCT02512068|10021693|FG000|NOT COMPLETED|Overall Study||12
8958261|NCT02512068|10021694|FG001|NOT COMPLETED|Overall Study||13
8958262|NCT02512094|10021700|FG000|STARTED|Overall Study||53
8958263|NCT02512094|10021700|FG000|COMPLETED|Overall Study||53
8958264|NCT02512094|10021700|FG000|NOT COMPLETED|Overall Study||0
8958265|NCT02512224|10021706|FG000|STARTED|Overall Study||2912
8631401|NCT00539864|9671278|FG001|NOT COMPLETED|Overall Study||2
8958266|NCT02512224|10021707|FG001|STARTED|Overall Study||2912
8631402|NCT00539942|9671286|FG000|STARTED|Overall Study||4
8958267|NCT02512224|10021706|FG000|COMPLETED|Overall Study||2912
8958268|NCT02512224|10021707|FG001|COMPLETED|Overall Study||2912
8958269|NCT02512224|10021706|FG000|NOT COMPLETED|Overall Study||0
8958270|NCT02512224|10021707|FG001|NOT COMPLETED|Overall Study||0
8958271|NCT02512276|10021715|FG000|STARTED|Overall Study||2038
8958272|NCT02512276|10021716|FG001|STARTED|Overall Study||2040
8958273|NCT02512276|10021715|FG000|COMPLETED|Overall Study||2030
8958274|NCT02512276|10021716|FG001|COMPLETED|Overall Study||2029
8958275|NCT02512276|10021715|FG000|NOT COMPLETED|Overall Study||8
8958276|NCT02512276|10021716|FG001|NOT COMPLETED|Overall Study||11
8958277|NCT02512302|10021722|FG000|STARTED|Period 1||3
8958278|NCT02512302|10021723|FG001|STARTED|Period 1||3
8958279|NCT02512302|10021724|FG002|STARTED|Period 1||4
8958280|NCT02512302|10021725|FG003|STARTED|Period 1||3
8958281|NCT02512302|10021726|FG004|STARTED|Period 1||3
8958282|NCT02512302|10021727|FG005|STARTED|Period 1||3
8958283|NCT02512302|10021728|FG006|STARTED|Period 1||2
8958284|NCT02512302|10021729|FG007|STARTED|Period 1||3
8958285|NCT02512302|10021730|FG008|STARTED|Period 1||3
8958286|NCT02512302|10021731|FG009|STARTED|Period 1||3
8958287|NCT02512302|10021722|FG000|COMPLETED|Period 1||3
8958288|NCT02512302|10021723|FG001|COMPLETED|Period 1||2
8958289|NCT02512302|10021724|FG002|COMPLETED|Period 1||4
8958290|NCT02512302|10021725|FG003|COMPLETED|Period 1||3
8958291|NCT02512302|10021726|FG004|COMPLETED|Period 1||3
8958292|NCT02512302|10021727|FG005|COMPLETED|Period 1||3
8958293|NCT02512302|10021728|FG006|COMPLETED|Period 1||2
8958294|NCT02512302|10021729|FG007|COMPLETED|Period 1||3
8958295|NCT02512302|10021730|FG008|COMPLETED|Period 1||3
8958296|NCT02512302|10021731|FG009|COMPLETED|Period 1||3
8958297|NCT02512302|10021722|FG000|NOT COMPLETED|Period 1||0
8958298|NCT02512302|10021723|FG001|NOT COMPLETED|Period 1||1
8958299|NCT02512302|10021724|FG002|NOT COMPLETED|Period 1||0
8958300|NCT02512302|10021725|FG003|NOT COMPLETED|Period 1||0
8958301|NCT02512302|10021726|FG004|NOT COMPLETED|Period 1||0
8958302|NCT02512302|10021727|FG005|NOT COMPLETED|Period 1||0
8958303|NCT02512302|10021728|FG006|NOT COMPLETED|Period 1||0
8958304|NCT02512302|10021729|FG007|NOT COMPLETED|Period 1||0
8958305|NCT02512302|10021730|FG008|NOT COMPLETED|Period 1||0
8958306|NCT02512302|10021731|FG009|NOT COMPLETED|Period 1||0
8958307|NCT02512302|10021722|FG000|STARTED|Period 2||3
8958308|NCT02512302|10021723|FG001|STARTED|Period 2||2
8958309|NCT02512302|10021724|FG002|STARTED|Period 2||4
8958310|NCT02512302|10021725|FG003|STARTED|Period 2||3
8958311|NCT02512302|10021726|FG004|STARTED|Period 2||3
8958312|NCT02512302|10021727|FG005|STARTED|Period 2||3
8958313|NCT02512302|10021728|FG006|STARTED|Period 2||2
8958314|NCT02512302|10021729|FG007|STARTED|Period 2||3
8958315|NCT02512302|10021730|FG008|STARTED|Period 2||3
8958316|NCT02512302|10021731|FG009|STARTED|Period 2||3
8958317|NCT02512302|10021722|FG000|COMPLETED|Period 2||3
8958318|NCT02512302|10021723|FG001|COMPLETED|Period 2||2
8958319|NCT02512302|10021724|FG002|COMPLETED|Period 2||4
8958320|NCT02512302|10021725|FG003|COMPLETED|Period 2||3
8958321|NCT02512302|10021726|FG004|COMPLETED|Period 2||3
8958322|NCT02512302|10021727|FG005|COMPLETED|Period 2||3
8958323|NCT02512302|10021728|FG006|COMPLETED|Period 2||2
8958324|NCT02512302|10021729|FG007|COMPLETED|Period 2||3
8958325|NCT02512302|10021730|FG008|COMPLETED|Period 2||3
8958326|NCT02512302|10021731|FG009|COMPLETED|Period 2||2
8958327|NCT02512302|10021722|FG000|NOT COMPLETED|Period 2||0
8958328|NCT02512302|10021723|FG001|NOT COMPLETED|Period 2||0
8958329|NCT02512302|10021724|FG002|NOT COMPLETED|Period 2||0
8958330|NCT02512302|10021725|FG003|NOT COMPLETED|Period 2||0
8958331|NCT02512302|10021726|FG004|NOT COMPLETED|Period 2||0
8958332|NCT02512302|10021727|FG005|NOT COMPLETED|Period 2||0
8958333|NCT02512302|10021728|FG006|NOT COMPLETED|Period 2||0
8958334|NCT02512302|10021729|FG007|NOT COMPLETED|Period 2||0
8958335|NCT02512302|10021730|FG008|NOT COMPLETED|Period 2||0
8958336|NCT02512302|10021731|FG009|NOT COMPLETED|Period 2||1
8958337|NCT02512302|10021722|FG000|STARTED|Period 3||3
8958338|NCT02512302|10021723|FG001|STARTED|Period 3||2
8958339|NCT02512302|10021724|FG002|STARTED|Period 3||4
8958340|NCT02512302|10021725|FG003|STARTED|Period 3||3
8958341|NCT02512302|10021726|FG004|STARTED|Period 3||3
8958342|NCT02512302|10021727|FG005|STARTED|Period 3||3
8958343|NCT02512302|10021728|FG006|STARTED|Period 3||2
8958344|NCT02512302|10021729|FG007|STARTED|Period 3||3
8958345|NCT02512302|10021730|FG008|STARTED|Period 3||3
8958346|NCT02512302|10021731|FG009|STARTED|Period 3||2
8958347|NCT02512302|10021722|FG000|COMPLETED|Period 3||3
8958348|NCT02512302|10021723|FG001|COMPLETED|Period 3||2
8958349|NCT02512302|10021724|FG002|COMPLETED|Period 3||3
8958350|NCT02512302|10021725|FG003|COMPLETED|Period 3||3
8958351|NCT02512302|10021726|FG004|COMPLETED|Period 3||3
8958352|NCT02512302|10021727|FG005|COMPLETED|Period 3||3
8958353|NCT02512302|10021728|FG006|COMPLETED|Period 3||2
8958354|NCT02512302|10021729|FG007|COMPLETED|Period 3||3
8958355|NCT02512302|10021730|FG008|COMPLETED|Period 3||3
8958356|NCT02512302|10021731|FG009|COMPLETED|Period 3||2
8958357|NCT02512302|10021722|FG000|NOT COMPLETED|Period 3||0
8958358|NCT02512302|10021723|FG001|NOT COMPLETED|Period 3||0
8958359|NCT02512302|10021724|FG002|NOT COMPLETED|Period 3||1
8958360|NCT02512302|10021725|FG003|NOT COMPLETED|Period 3||0
8958361|NCT02512302|10021726|FG004|NOT COMPLETED|Period 3||0
8958362|NCT02512302|10021727|FG005|NOT COMPLETED|Period 3||0
8958363|NCT02512302|10021728|FG006|NOT COMPLETED|Period 3||0
8958364|NCT02512302|10021729|FG007|NOT COMPLETED|Period 3||0
8958365|NCT02512302|10021730|FG008|NOT COMPLETED|Period 3||0
8958366|NCT02512302|10021731|FG009|NOT COMPLETED|Period 3||0
8958367|NCT02512302|10021722|FG000|STARTED|Period 4||3
8958368|NCT02512302|10021723|FG001|STARTED|Period 4||2
8958369|NCT02512302|10021724|FG002|STARTED|Period 4||3
8958370|NCT02512302|10021725|FG003|STARTED|Period 4||3
8958371|NCT02512302|10021726|FG004|STARTED|Period 4||3
8958372|NCT02512302|10021727|FG005|STARTED|Period 4||3
8958373|NCT02512302|10021728|FG006|STARTED|Period 4||2
8958374|NCT02512302|10021729|FG007|STARTED|Period 4||3
8958375|NCT02512302|10021730|FG008|STARTED|Period 4||3
8958376|NCT02512302|10021731|FG009|STARTED|Period 4||2
8958377|NCT02512302|10021722|FG000|COMPLETED|Period 4||3
8958378|NCT02512302|10021723|FG001|COMPLETED|Period 4||2
8958379|NCT02512302|10021724|FG002|COMPLETED|Period 4||3
8958380|NCT02512302|10021725|FG003|COMPLETED|Period 4||3
8958381|NCT02512302|10021726|FG004|COMPLETED|Period 4||3
8958382|NCT02512302|10021727|FG005|COMPLETED|Period 4||3
8958383|NCT02512302|10021728|FG006|COMPLETED|Period 4||1
8958384|NCT02512302|10021729|FG007|COMPLETED|Period 4||3
8958385|NCT02512302|10021730|FG008|COMPLETED|Period 4||3
8631403|NCT00539942|9671287|FG001|STARTED|Overall Study||3
8631404|NCT00539942|9671286|FG000|COMPLETED|Overall Study||4
8631405|NCT00539942|9671287|FG001|COMPLETED|Overall Study||3
8631406|NCT00539942|9671286|FG000|NOT COMPLETED|Overall Study||0
8958386|NCT02512302|10021731|FG009|COMPLETED|Period 4||2
8958387|NCT02512302|10021722|FG000|NOT COMPLETED|Period 4||0
8958388|NCT02512302|10021723|FG001|NOT COMPLETED|Period 4||0
8958389|NCT02512302|10021724|FG002|NOT COMPLETED|Period 4||0
8958390|NCT02512302|10021725|FG003|NOT COMPLETED|Period 4||0
8958391|NCT02512302|10021726|FG004|NOT COMPLETED|Period 4||0
8958392|NCT02512302|10021727|FG005|NOT COMPLETED|Period 4||0
8958393|NCT02512302|10021728|FG006|NOT COMPLETED|Period 4||1
8958394|NCT02512302|10021729|FG007|NOT COMPLETED|Period 4||0
8958395|NCT02512302|10021730|FG008|NOT COMPLETED|Period 4||0
8958396|NCT02512302|10021731|FG009|NOT COMPLETED|Period 4||0
8958397|NCT02512302|10021722|FG000|STARTED|Period 5||3
8958398|NCT02512302|10021723|FG001|STARTED|Period 5||2
8958399|NCT02512302|10021724|FG002|STARTED|Period 5||3
8958400|NCT02512302|10021725|FG003|STARTED|Period 5||3
8958401|NCT02512302|10021726|FG004|STARTED|Period 5||3
8958402|NCT02512302|10021727|FG005|STARTED|Period 5||3
8958403|NCT02512302|10021728|FG006|STARTED|Period 5||1
8958404|NCT02512302|10021729|FG007|STARTED|Period 5||3
8958405|NCT02512302|10021730|FG008|STARTED|Period 5||3
8958406|NCT02512302|10021731|FG009|STARTED|Period 5||2
8958407|NCT02512302|10021722|FG000|COMPLETED|Period 5||3
8958408|NCT02512302|10021723|FG001|COMPLETED|Period 5||2
8958409|NCT02512302|10021724|FG002|COMPLETED|Period 5||3
8958410|NCT02512302|10021725|FG003|COMPLETED|Period 5||3
8958411|NCT02512302|10021726|FG004|COMPLETED|Period 5||3
8958412|NCT02512302|10021727|FG005|COMPLETED|Period 5||3
8958413|NCT02512302|10021728|FG006|COMPLETED|Period 5||1
8958414|NCT02512302|10021729|FG007|COMPLETED|Period 5||3
8958415|NCT02512302|10021730|FG008|COMPLETED|Period 5||3
8958416|NCT02512302|10021731|FG009|COMPLETED|Period 5||2
8958417|NCT02512302|10021722|FG000|NOT COMPLETED|Period 5||0
8958418|NCT02512302|10021723|FG001|NOT COMPLETED|Period 5||0
8958419|NCT02512302|10021724|FG002|NOT COMPLETED|Period 5||0
8958420|NCT02512302|10021725|FG003|NOT COMPLETED|Period 5||0
8958421|NCT02512302|10021726|FG004|NOT COMPLETED|Period 5||0
8958422|NCT02512302|10021727|FG005|NOT COMPLETED|Period 5||0
8958423|NCT02512302|10021728|FG006|NOT COMPLETED|Period 5||0
8958424|NCT02512302|10021729|FG007|NOT COMPLETED|Period 5||0
8958425|NCT02512302|10021730|FG008|NOT COMPLETED|Period 5||0
8958426|NCT02512302|10021731|FG009|NOT COMPLETED|Period 5||0
8958427|NCT02512393|10021746|FG000|STARTED|Overall Study||21
8958428|NCT02512393|10021747|FG001|STARTED|Overall Study||20
8958429|NCT02512393|10021746|FG000|COMPLETED|Overall Study||20
8958430|NCT02512393|10021747|FG001|COMPLETED|Overall Study||20
8958431|NCT02512393|10021746|FG000|NOT COMPLETED|Overall Study||1
8958432|NCT02512393|10021747|FG001|NOT COMPLETED|Overall Study||0
8958433|NCT02512419|10021755|FG000|STARTED|Overall Study||24
8958434|NCT02512419|10021756|FG001|STARTED|Overall Study||24
8958435|NCT02512419|10021755|FG000|COMPLETED|Overall Study|2 participants became ineligible after enrolling therefore were not included in analysis.|22
8958436|NCT02512419|10021756|FG001|COMPLETED|Overall Study||24
8958437|NCT02512419|10021755|FG000|NOT COMPLETED|Overall Study||2
8958438|NCT02512419|10021756|FG001|NOT COMPLETED|Overall Study||0
8958439|NCT02512575|10021772|FG000|STARTED|Overall Study||6
8958440|NCT02512575|10021773|FG001|STARTED|Overall Study||6
8958441|NCT02512575|10021774|FG002|STARTED|Overall Study||6
8958442|NCT02512575|10021775|FG003|STARTED|Overall Study||6
8958443|NCT02512575|10021776|FG004|STARTED|Overall Study||6
8958444|NCT02512575|10021777|FG005|STARTED|Overall Study||6
8958445|NCT02512575|10021778|FG006|STARTED|Overall Study||6
8958446|NCT02512575|10021779|FG007|STARTED|Overall Study||6
8958447|NCT02512575|10021780|FG008|STARTED|Overall Study||6
8958448|NCT02512575|10021781|FG009|STARTED|Overall Study||18
8958449|NCT02512575|10021772|FG000|COMPLETED|Overall Study||6
8958450|NCT02512575|10021773|FG001|COMPLETED|Overall Study||6
8958451|NCT02512575|10021774|FG002|COMPLETED|Overall Study||6
8958452|NCT02512575|10021775|FG003|COMPLETED|Overall Study||6
8958453|NCT02512575|10021776|FG004|COMPLETED|Overall Study||6
8958454|NCT02512575|10021777|FG005|COMPLETED|Overall Study||6
8958455|NCT02512575|10021778|FG006|COMPLETED|Overall Study||6
8631407|NCT00539942|9671287|FG001|NOT COMPLETED|Overall Study||0
8631408|NCT00539994|9671296|FG000|STARTED|Overall Study||23
8958456|NCT02512575|10021779|FG007|COMPLETED|Overall Study||6
8958457|NCT02512575|10021780|FG008|COMPLETED|Overall Study||6
8958458|NCT02512575|10021781|FG009|COMPLETED|Overall Study||18
8958459|NCT02512575|10021772|FG000|NOT COMPLETED|Overall Study||0
8958460|NCT02512575|10021773|FG001|NOT COMPLETED|Overall Study||0
8958461|NCT02512575|10021774|FG002|NOT COMPLETED|Overall Study||0
8958462|NCT02512575|10021775|FG003|NOT COMPLETED|Overall Study||0
8958463|NCT02512575|10021776|FG004|NOT COMPLETED|Overall Study||0
8958464|NCT02512575|10021777|FG005|NOT COMPLETED|Overall Study||0
8958465|NCT02512575|10021778|FG006|NOT COMPLETED|Overall Study||0
8958466|NCT02512575|10021779|FG007|NOT COMPLETED|Overall Study||0
8958467|NCT02512575|10021780|FG008|NOT COMPLETED|Overall Study||0
8958468|NCT02512575|10021781|FG009|NOT COMPLETED|Overall Study||0
8958469|NCT02512679|10021803|FG000|STARTED|Overall Study||20
8958470|NCT02512679|10021804|FG001|STARTED|Overall Study||0
8958471|NCT02512679|10021803|FG000|COMPLETED|Overall Study||20
8958472|NCT02512679|10021804|FG001|COMPLETED|Overall Study||0
8958473|NCT02512679|10021803|FG000|NOT COMPLETED|Overall Study||0
8958474|NCT02512679|10021804|FG001|NOT COMPLETED|Overall Study||0
8958475|NCT02512783|10021810|FG000|STARTED|Overall Study||96
8958476|NCT02512783|10021811|FG001|STARTED|Overall Study||75
8958477|NCT02512783|10021810|FG000|COMPLETED|Overall Study||96
8958478|NCT02512783|10021811|FG001|COMPLETED|Overall Study||75
8958479|NCT02512783|10021810|FG000|NOT COMPLETED|Overall Study||0
8958480|NCT02512783|10021811|FG001|NOT COMPLETED|Overall Study||0
8958481|NCT02512809|10021820|FG000|STARTED|Overall Study||25
8958482|NCT02512809|10021820|FG000|COMPLETED|Overall Study||25
8958483|NCT02512809|10021820|FG000|NOT COMPLETED|Overall Study||0
8958484|NCT02512861|10021826|FG000|STARTED|Overall Study||44
8958485|NCT02512861|10021827|FG001|STARTED|Overall Study||49
8958486|NCT02512861|10021826|FG000|COMPLETED|Overall Study||38
8958487|NCT02512861|10021827|FG001|COMPLETED|Overall Study||40
8958488|NCT02512861|10021826|FG000|NOT COMPLETED|Overall Study||6
8958489|NCT02512861|10021827|FG001|NOT COMPLETED|Overall Study||9
8958490|NCT02512874|10021833|FG000|STARTED|Overall Study||65
8958491|NCT02512874|10021833|FG000|COMPLETED|Overall Study||63
8958492|NCT02512874|10021833|FG000|NOT COMPLETED|Overall Study||2
8958493|NCT02512900|10021839|FG000|STARTED|Overall Study||11
8958494|NCT02512900|10021840|FG001|STARTED|Overall Study||10
8958495|NCT02512900|10021839|FG000|COMPLETED|Overall Study||11
8958496|NCT02512900|10021840|FG001|COMPLETED|Overall Study||10
8958497|NCT02512900|10021839|FG000|NOT COMPLETED|Overall Study||0
8958498|NCT02512900|10021840|FG001|NOT COMPLETED|Overall Study||0
8958499|NCT02512965|10021849|FG000|STARTED|Overall Study||115
8958500|NCT02512965|10021850|FG001|STARTED|Overall Study||114
8958501|NCT02512965|10021849|FG000|COMPLETED|Overall Study||115
8958502|NCT02512965|10021850|FG001|COMPLETED|Overall Study|4 patients did not receive any dose of the assigned treatment.|110
8958503|NCT02512965|10021849|FG000|NOT COMPLETED|Overall Study||0
8958504|NCT02512965|10021850|FG001|NOT COMPLETED|Overall Study||4
8958505|NCT02513095|10021858|FG000|STARTED|Overall Study||17
8958506|NCT02513095|10021859|FG001|STARTED|Overall Study||17
8958507|NCT02513095|10021858|FG000|Treatment Phase - Up to 120 Minutes|Overall Study||17
8958508|NCT02513095|10021859|FG001|Treatment Phase - Up to 120 Minutes|Overall Study||17
8958509|NCT02513095|10021858|FG000|COMPLETED|Overall Study||17
8958510|NCT02513095|10021859|FG001|COMPLETED|Overall Study||17
8958511|NCT02513095|10021858|FG000|NOT COMPLETED|Overall Study||0
8958512|NCT02513095|10021859|FG001|NOT COMPLETED|Overall Study||0
8958513|NCT02513121|10021867|FG000|STARTED|Overall Study||20
8958514|NCT02513121|10021868|FG001|STARTED|Overall Study||20
8958515|NCT02513121|10021867|FG000|COMPLETED|Overall Study||20
8958516|NCT02513121|10021868|FG001|COMPLETED|Overall Study||20
8958517|NCT02513121|10021867|FG000|NOT COMPLETED|Overall Study||0
8958518|NCT02513121|10021868|FG001|NOT COMPLETED|Overall Study||0
8958519|NCT02513160|10021880|FG000|STARTED|Run-In Period (Days -14 to Day -1)|Enrolled|713
8958520|NCT02513160|10021881|FG001|STARTED|Run-In Period (Days -14 to Day -1)||0
8958521|NCT02513160|10021882|FG002|STARTED|Run-In Period (Days -14 to Day -1)||0
8958522|NCT02513160|10021883|FG003|STARTED|Run-In Period (Days -14 to Day -1)||0
8958523|NCT02513160|10021880|FG000|COMPLETED|Run-In Period (Days -14 to Day -1)||425
8958524|NCT02513160|10021881|FG001|COMPLETED|Run-In Period (Days -14 to Day -1)||0
8958525|NCT02513160|10021882|FG002|COMPLETED|Run-In Period (Days -14 to Day -1)||0
8958526|NCT02513160|10021883|FG003|COMPLETED|Run-In Period (Days -14 to Day -1)||0
8958527|NCT02513160|10021880|FG000|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||288
8958528|NCT02513160|10021881|FG001|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
8958529|NCT02513160|10021882|FG002|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
8958530|NCT02513160|10021883|FG003|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
8958531|NCT02513160|10021880|FG000|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|107
8958532|NCT02513160|10021881|FG001|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|108
8958533|NCT02513160|10021882|FG002|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|105
8958534|NCT02513160|10021883|FG003|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|105
8958535|NCT02513160|10021880|FG000|COMPLETED|Treatment Period (Day 0 to Week 6)||101
8958536|NCT02513160|10021881|FG001|COMPLETED|Treatment Period (Day 0 to Week 6)||104
8958537|NCT02513160|10021882|FG002|COMPLETED|Treatment Period (Day 0 to Week 6)||104
8958538|NCT02513160|10021883|FG003|COMPLETED|Treatment Period (Day 0 to Week 6)||103
8958539|NCT02513160|10021880|FG000|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||6
8958540|NCT02513160|10021881|FG001|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||4
8958541|NCT02513160|10021882|FG002|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||1
8958542|NCT02513160|10021883|FG003|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||2
8958543|NCT02513212|10021896|FG000|STARTED|Overall Study||12
8958544|NCT02513212|10021897|FG001|STARTED|Overall Study||12
8958545|NCT02513212|10021896|FG000|COMPLETED|Overall Study||11
8958546|NCT02513212|10021897|FG001|COMPLETED|Overall Study||12
8958547|NCT02513212|10021896|FG000|NOT COMPLETED|Overall Study||1
8958548|NCT02513212|10021897|FG001|NOT COMPLETED|Overall Study||0
8958549|NCT02513446|10021905|FG000|STARTED|Period 1||8
8958550|NCT02513446|10021906|FG001|STARTED|Period 1||8
8958551|NCT02513446|10021905|FG000|COMPLETED|Period 1||8
8958552|NCT02513446|10021906|FG001|COMPLETED|Period 1||8
8958553|NCT02513446|10021905|FG000|NOT COMPLETED|Period 1||0
8958554|NCT02513446|10021906|FG001|NOT COMPLETED|Period 1||0
8958555|NCT02513446|10021905|FG000|STARTED|Washout Period of 10 Days||8
8958556|NCT02513446|10021906|FG001|STARTED|Washout Period of 10 Days||8
8958557|NCT02513446|10021905|FG000|COMPLETED|Washout Period of 10 Days||8
8958558|NCT02513446|10021906|FG001|COMPLETED|Washout Period of 10 Days||8
8958559|NCT02513446|10021905|FG000|NOT COMPLETED|Washout Period of 10 Days||0
8958560|NCT02513446|10021906|FG001|NOT COMPLETED|Washout Period of 10 Days||0
8958561|NCT02513446|10021905|FG000|STARTED|Period 2||8
8958562|NCT02513446|10021906|FG001|STARTED|Period 2||8
8958563|NCT02513446|10021905|FG000|COMPLETED|Period 2||8
8958564|NCT02513446|10021906|FG001|COMPLETED|Period 2||8
8958565|NCT02513446|10021905|FG000|NOT COMPLETED|Period 2||0
8958566|NCT02513446|10021906|FG001|NOT COMPLETED|Period 2||0
8958567|NCT02513459|10021913|FG000|STARTED|Overall Study||65
8958568|NCT02513459|10021913|FG000|COMPLETED|Overall Study||44
8958569|NCT02513459|10021913|FG000|NOT COMPLETED|Overall Study||21
8958570|NCT02513498|10021922|FG000|STARTED|Overall Study||50
8958571|NCT02513498|10021922|FG000|COMPLETED|Overall Study||26
8958572|NCT02513498|10021922|FG000|NOT COMPLETED|Overall Study||24
8958573|NCT02513550|10021934|FG000|STARTED|Double Blind Treatment Period||310
8958574|NCT02513550|10021935|FG001|STARTED|Double Blind Treatment Period||306
8958575|NCT02513550|10021936|FG002|STARTED|Double Blind Treatment Period||611
8958576|NCT02513550|10021937|FG003|STARTED|Double Blind Treatment Period||9
8958577|NCT02513550|10021938|FG004|STARTED|Double Blind Treatment Period||5
8958578|NCT02513550|10021939|FG005|STARTED|Double Blind Treatment Period||16
8958579|NCT02513550|10021934|FG000|Received at Least One Dose of Study Drug|Double Blind Treatment Period||310
8958580|NCT02513550|10021935|FG001|Received at Least One Dose of Study Drug|Double Blind Treatment Period||306
8958581|NCT02513550|10021936|FG002|Received at Least One Dose of Study Drug|Double Blind Treatment Period||609
8958582|NCT02513550|10021937|FG003|Received at Least One Dose of Study Drug|Double Blind Treatment Period||9
8958583|NCT02513550|10021938|FG004|Received at Least One Dose of Study Drug|Double Blind Treatment Period||5
8958584|NCT02513550|10021939|FG005|Received at Least One Dose of Study Drug|Double Blind Treatment Period||16
8958585|NCT02513550|10021934|FG000|COMPLETED|Double Blind Treatment Period||274
8958586|NCT02513550|10021935|FG001|COMPLETED|Double Blind Treatment Period||268
8958587|NCT02513550|10021936|FG002|COMPLETED|Double Blind Treatment Period||537
8958588|NCT02513550|10021937|FG003|COMPLETED|Double Blind Treatment Period||9
8958589|NCT02513550|10021938|FG004|COMPLETED|Double Blind Treatment Period||4
8958590|NCT02513550|10021939|FG005|COMPLETED|Double Blind Treatment Period||15
8958591|NCT02513550|10021934|FG000|NOT COMPLETED|Double Blind Treatment Period||36
8958592|NCT02513550|10021935|FG001|NOT COMPLETED|Double Blind Treatment Period||38
8958593|NCT02513550|10021936|FG002|NOT COMPLETED|Double Blind Treatment Period||74
8958594|NCT02513550|10021937|FG003|NOT COMPLETED|Double Blind Treatment Period||0
8958595|NCT02513550|10021938|FG004|NOT COMPLETED|Double Blind Treatment Period||1
8958596|NCT02513550|10021939|FG005|NOT COMPLETED|Double Blind Treatment Period||1
8958597|NCT02513550|10021934|FG000|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|285
8958598|NCT02513550|10021935|FG001|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|283
8958599|NCT02513550|10021936|FG002|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|559
8958600|NCT02513550|10021937|FG003|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|9
8958601|NCT02513550|10021938|FG004|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|4
8958602|NCT02513550|10021939|FG005|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|15
8958603|NCT02513550|10021934|FG000|COMPLETED|Post-Treatment Follow-up Period||254
8958604|NCT02513550|10021935|FG001|COMPLETED|Post-Treatment Follow-up Period||244
8958605|NCT02513550|10021936|FG002|COMPLETED|Post-Treatment Follow-up Period||496
8958606|NCT02513550|10021937|FG003|COMPLETED|Post-Treatment Follow-up Period||9
8958607|NCT02513550|10021938|FG004|COMPLETED|Post-Treatment Follow-up Period||4
8958608|NCT02513550|10021939|FG005|COMPLETED|Post-Treatment Follow-up Period||15
8958609|NCT02513550|10021934|FG000|NOT COMPLETED|Post-Treatment Follow-up Period||31
8958610|NCT02513550|10021935|FG001|NOT COMPLETED|Post-Treatment Follow-up Period||39
8958611|NCT02513550|10021936|FG002|NOT COMPLETED|Post-Treatment Follow-up Period||63
8958612|NCT02513550|10021937|FG003|NOT COMPLETED|Post-Treatment Follow-up Period||0
8958613|NCT02513550|10021938|FG004|NOT COMPLETED|Post-Treatment Follow-up Period||0
8958614|NCT02513550|10021939|FG005|NOT COMPLETED|Post-Treatment Follow-up Period||0
8958615|NCT02513641|10021961|FG000|STARTED|Overall Study||8
8577567|NCT00159419|9610331|FG000|STARTED|Overall Study||9
8958616|NCT02513641|10021961|FG000|COMPLETED|Overall Study||8
8958617|NCT02513641|10021961|FG000|NOT COMPLETED|Overall Study||0
8958618|NCT02513719|10021965|FG000|STARTED|At 8 Months Clinical Follow-up||312
8958619|NCT02513719|10021965|FG000|COMPLETED|At 8 Months Clinical Follow-up||312
8958620|NCT02513719|10021965|FG000|NOT COMPLETED|At 8 Months Clinical Follow-up||0
8958621|NCT02513719|10021965|FG000|STARTED|At 1 Year Clinical Follow-up||312
8958622|NCT02513719|10021965|FG000|COMPLETED|At 1 Year Clinical Follow-up||305
8958623|NCT02513719|10021965|FG000|NOT COMPLETED|At 1 Year Clinical Follow-up||7
8958624|NCT02513719|10021965|FG000|STARTED|At 2 Years Clinical Follow-up||305
8958625|NCT02513719|10021965|FG000|COMPLETED|At 2 Years Clinical Follow-up||300
8958626|NCT02513719|10021965|FG000|NOT COMPLETED|At 2 Years Clinical Follow-up||5
8958627|NCT02513719|10021965|FG000|STARTED|At 3 Years Clinical Follow-up||300
8958628|NCT02513719|10021965|FG000|COMPLETED|At 3 Years Clinical Follow-up||289
8958629|NCT02513719|10021965|FG000|NOT COMPLETED|At 3 Years Clinical Follow-up||11
8958630|NCT02513719|10021965|FG000|STARTED|At 4 Years Clinical Follow-up||289
8958631|NCT02513719|10021965|FG000|COMPLETED|At 4 Years Clinical Follow-up||273
8958632|NCT02513719|10021965|FG000|NOT COMPLETED|At 4 Years Clinical Follow-up||16
8958633|NCT02513719|10021965|FG000|STARTED|At 5 Years Clinical Follow-up||273
8958634|NCT02513719|10021965|FG000|COMPLETED|At 5 Years Clinical Follow-up||254
8958635|NCT02513719|10021965|FG000|NOT COMPLETED|At 5 Years Clinical Follow-up||19
8958636|NCT02513732|10021969|FG000|STARTED|Overall Study||100
8958637|NCT02513732|10021969|FG000|COMPLETED|Overall Study||78
8958638|NCT02513732|10021969|FG000|NOT COMPLETED|Overall Study||22
8958639|NCT02513745|10021975|FG000|STARTED|Overall Study||42
8958640|NCT02513745|10021976|FG001|STARTED|Overall Study||42
8958641|NCT02513745|10021975|FG000|COMPLETED|Overall Study||39
8958642|NCT02513745|10021976|FG001|COMPLETED|Overall Study||39
8958643|NCT02513745|10021975|FG000|NOT COMPLETED|Overall Study||3
8958644|NCT02513745|10021976|FG001|NOT COMPLETED|Overall Study||3
8958645|NCT02513771|10021984|FG000|STARTED|Overall Study||45
8958646|NCT02513771|10021985|FG001|STARTED|Overall Study||45
8958647|NCT02513771|10021984|FG000|COMPLETED|Overall Study||43
8958648|NCT02513771|10021985|FG001|COMPLETED|Overall Study||44
8958649|NCT02513771|10021984|FG000|NOT COMPLETED|Overall Study||2
8958650|NCT02513771|10021985|FG001|NOT COMPLETED|Overall Study||1
8958651|NCT02513823|10021991|FG000|STARTED|Overall Study||27
8958652|NCT02513823|10021991|FG000|COMPLETED|Overall Study||22
8958653|NCT02513823|10021991|FG000|NOT COMPLETED|Overall Study||5
8958654|NCT02513940|10021995|FG000|STARTED|Overall Study|This was a crossover study, with a total n=14. All 14 subjects completed each phase of the study|2
8958655|NCT02513940|10021996|FG001|STARTED|Overall Study||3
8958656|NCT02513940|10021997|FG002|STARTED|Overall Study||2
8958657|NCT02513940|10021998|FG003|STARTED|Overall Study||2
8958658|NCT02513940|10021999|FG004|STARTED|Overall Study||2
8958659|NCT02513940|10022000|FG005|STARTED|Overall Study||3
8958660|NCT02513940|10021995|FG000|COMPLETED|Overall Study||2
8958661|NCT02513940|10021996|FG001|COMPLETED|Overall Study||3
8958662|NCT02513940|10021997|FG002|COMPLETED|Overall Study||2
8958663|NCT02513940|10021998|FG003|COMPLETED|Overall Study||2
8958664|NCT02513940|10021999|FG004|COMPLETED|Overall Study||2
8958665|NCT02513940|10022000|FG005|COMPLETED|Overall Study||3
8958666|NCT02513940|10021995|FG000|NOT COMPLETED|Overall Study||0
8958667|NCT02513940|10021996|FG001|NOT COMPLETED|Overall Study||0
8958668|NCT02513940|10021997|FG002|NOT COMPLETED|Overall Study||0
8958669|NCT02513940|10021998|FG003|NOT COMPLETED|Overall Study||0
8958670|NCT02513940|10021999|FG004|NOT COMPLETED|Overall Study||0
8958671|NCT02513940|10022000|FG005|NOT COMPLETED|Overall Study||0
8958672|NCT02514044|10022010|FG000|STARTED|Dexedrine+tDCS+Speech Therapy (1 Day)||10
8958673|NCT02514044|10022010|FG000|COMPLETED|Dexedrine+tDCS+Speech Therapy (1 Day)||10
8958674|NCT02514044|10022010|FG000|NOT COMPLETED|Dexedrine+tDCS+Speech Therapy (1 Day)||0
8958675|NCT02514044|10022010|FG000|STARTED|Washout (1 Week)||10
8958676|NCT02514044|10022010|FG000|COMPLETED|Washout (1 Week)||10
8958677|NCT02514044|10022010|FG000|NOT COMPLETED|Washout (1 Week)||0
8958678|NCT02514044|10022010|FG000|STARTED|Placebo+tDCS+Speech Therapy (1 Day)||10
8958679|NCT02514044|10022010|FG000|COMPLETED|Placebo+tDCS+Speech Therapy (1 Day)||10
8958680|NCT02514044|10022010|FG000|NOT COMPLETED|Placebo+tDCS+Speech Therapy (1 Day)||0
8958681|NCT02514070|10022020|FG000|STARTED|Weeks 0 to Week 6||19
8958682|NCT02514070|10022021|FG001|STARTED|Weeks 0 to Week 6||20
8958683|NCT02514070|10022020|FG000|COMPLETED|Weeks 0 to Week 6||17
8958684|NCT02514070|10022021|FG001|COMPLETED|Weeks 0 to Week 6||16
8958685|NCT02514070|10022020|FG000|NOT COMPLETED|Weeks 0 to Week 6||2
8958686|NCT02514070|10022021|FG001|NOT COMPLETED|Weeks 0 to Week 6||4
8958687|NCT02514070|10022020|FG000|STARTED|Week 6 to Week 14 - Washout Period||17
8958688|NCT02514070|10022021|FG001|STARTED|Week 6 to Week 14 - Washout Period||16
8958689|NCT02514070|10022020|FG000|COMPLETED|Week 6 to Week 14 - Washout Period||17
8958690|NCT02514070|10022021|FG001|COMPLETED|Week 6 to Week 14 - Washout Period||16
8958691|NCT02514070|10022020|FG000|NOT COMPLETED|Week 6 to Week 14 - Washout Period||0
8958692|NCT02514070|10022021|FG001|NOT COMPLETED|Week 6 to Week 14 - Washout Period||0
8958693|NCT02514070|10022020|FG000|STARTED|Week 14 to Week 20||17
8958694|NCT02514070|10022021|FG001|STARTED|Week 14 to Week 20||16
8958695|NCT02514070|10022020|FG000|COMPLETED|Week 14 to Week 20||16
8958696|NCT02514070|10022021|FG001|COMPLETED|Week 14 to Week 20||14
8958697|NCT02514070|10022020|FG000|NOT COMPLETED|Week 14 to Week 20||1
8958698|NCT02514070|10022021|FG001|NOT COMPLETED|Week 14 to Week 20||2
8958699|NCT02514122|10022033|FG000|STARTED|Overall Study||32
8958700|NCT02514122|10022034|FG001|STARTED|Overall Study||29
8958701|NCT02514122|10022033|FG000|COMPLETED|Overall Study|one participant dropped out for religious reasons; one for needle phobia|30
8958702|NCT02514122|10022034|FG001|COMPLETED|Overall Study||29
8958703|NCT02514122|10022033|FG000|NOT COMPLETED|Overall Study||2
8958704|NCT02514122|10022034|FG001|NOT COMPLETED|Overall Study||0
8958705|NCT02514174|10022040|FG000|STARTED|Overall Study||25
8958706|NCT02514174|10022040|FG000|COMPLETED|Overall Study||0
8958707|NCT02514174|10022040|FG000|NOT COMPLETED|Overall Study||25
8958708|NCT02514473|10022046|FG000|STARTED|Overall Study||101
8958709|NCT02514473|10022047|FG001|STARTED|Overall Study||103
8958710|NCT02514473|10022046|FG000|COMPLETED|Overall Study||98
8958711|NCT02514473|10022047|FG001|COMPLETED|Overall Study||98
8958712|NCT02514473|10022046|FG000|NOT COMPLETED|Overall Study||3
8958713|NCT02514473|10022047|FG001|NOT COMPLETED|Overall Study||5
8958714|NCT02514551|10022056|FG000|STARTED|Overall Study||123
8958715|NCT02514551|10022057|FG001|STARTED|Overall Study||122
8958716|NCT02514551|10022056|FG000|Received at Least One Dose of Study Drug|Overall Study||123
8958717|NCT02514551|10022057|FG001|Received at Least One Dose of Study Drug|Overall Study||120
8958718|NCT02514551|10022056|FG000|COMPLETED|Overall Study||123
8958719|NCT02514551|10022057|FG001|COMPLETED|Overall Study||119
8958720|NCT02514551|10022056|FG000|NOT COMPLETED|Overall Study||0
8958721|NCT02514551|10022057|FG001|NOT COMPLETED|Overall Study||3
8958722|NCT02514577|10022066|FG000|STARTED|Overall Study||143
8958723|NCT02514577|10022067|FG001|STARTED|Overall Study||74
8958724|NCT02514577|10022066|FG000|Intent-to-Treat (ITT) Population|Overall Study||143
8958725|NCT02514577|10022067|FG001|Intent-to-Treat (ITT) Population|Overall Study||74
8958726|NCT02514577|10022066|FG000|Safety Population|Overall Study||142
8958727|NCT02514577|10022067|FG001|Safety Population|Overall Study||72
8958728|NCT02514577|10022066|FG000|COMPLETED|Overall Study||129
8958729|NCT02514577|10022067|FG001|COMPLETED|Overall Study||61
8958730|NCT02514577|10022066|FG000|NOT COMPLETED|Overall Study||14
8958731|NCT02514577|10022067|FG001|NOT COMPLETED|Overall Study||13
8958732|NCT02514746|10022075|FG000|STARTED|Overall Study||437
8958733|NCT02514746|10022076|FG001|STARTED|Overall Study||124
8958734|NCT02514746|10022075|FG000|Valid Serology 3 Years Post Primary Dose|Overall Study||437
8958735|NCT02514746|10022076|FG001|Valid Serology 3 Years Post Primary Dose|Overall Study||123
8958736|NCT02514746|10022075|FG000|Valid Serology 4 Years Post Primary Dose|Overall Study||424
8958737|NCT02514746|10022076|FG001|Valid Serology 4 Years Post Primary Dose|Overall Study||109
8958738|NCT02514746|10022075|FG000|Received CD-JEV Booster Vaccine|Overall Study||424
8958739|NCT02514746|10022076|FG001|Received CD-JEV Booster Vaccine|Overall Study||109
8958740|NCT02514746|10022075|FG000|COMPLETED|Overall Study||415
8958741|NCT02514746|10022076|FG001|COMPLETED|Overall Study||109
8958742|NCT02514746|10022075|FG000|NOT COMPLETED|Overall Study||22
8958743|NCT02514746|10022076|FG001|NOT COMPLETED|Overall Study||15
8958744|NCT02514772|10022086|FG000|STARTED|Overall Study||53
8958745|NCT02514772|10022087|FG001|STARTED|Overall Study||54
8958746|NCT02514772|10022086|FG000|COMPLETED|Overall Study||50
8958747|NCT02514772|10022087|FG001|COMPLETED|Overall Study||52
8958748|NCT02514772|10022086|FG000|NOT COMPLETED|Overall Study||3
8958749|NCT02514772|10022087|FG001|NOT COMPLETED|Overall Study||2
8958750|NCT02514824|10022097|FG000|STARTED|Overall Study||4
8958751|NCT02514824|10022098|FG001|STARTED|Overall Study||5
8958752|NCT02514824|10022099|FG002|STARTED|Overall Study||0
8958753|NCT02514824|10022100|FG003|STARTED|Overall Study||0
8958754|NCT02514824|10022097|FG000|Evaluable for Dose-limiting Toxicity|Overall Study||3
8958755|NCT02514824|10022098|FG001|Evaluable for Dose-limiting Toxicity|Overall Study||5
8958756|NCT02514824|10022099|FG002|Evaluable for Dose-limiting Toxicity|Overall Study||0
8958757|NCT02514824|10022100|FG003|Evaluable for Dose-limiting Toxicity|Overall Study||0
8958758|NCT02514824|10022097|FG000|COMPLETED|Overall Study||3
8958759|NCT02514824|10022098|FG001|COMPLETED|Overall Study||4
8958760|NCT02514824|10022099|FG002|COMPLETED|Overall Study||0
8958761|NCT02514824|10022100|FG003|COMPLETED|Overall Study||0
8958762|NCT02514824|10022097|FG000|NOT COMPLETED|Overall Study||1
8958763|NCT02514824|10022098|FG001|NOT COMPLETED|Overall Study||1
8958764|NCT02514824|10022099|FG002|NOT COMPLETED|Overall Study||0
8958765|NCT02514824|10022100|FG003|NOT COMPLETED|Overall Study||0
8958766|NCT02514889|10022109|FG000|STARTED|Randomization/Allocation to Condition||131
8958767|NCT02514889|10022110|FG001|STARTED|Randomization/Allocation to Condition||130
8958768|NCT02514889|10022109|FG000|COMPLETED|Randomization/Allocation to Condition||111
8958769|NCT02514889|10022110|FG001|COMPLETED|Randomization/Allocation to Condition||106
8958770|NCT02514889|10022109|FG000|NOT COMPLETED|Randomization/Allocation to Condition||20
8958771|NCT02514889|10022110|FG001|NOT COMPLETED|Randomization/Allocation to Condition||24
8958772|NCT02514889|10022109|FG000|STARTED|Intervention Participation||111
8958773|NCT02514889|10022110|FG001|STARTED|Intervention Participation||106
8958774|NCT02514889|10022109|FG000|COMPLETED|Intervention Participation||102
8958775|NCT02514889|10022110|FG001|COMPLETED|Intervention Participation||98
8958776|NCT02514889|10022109|FG000|NOT COMPLETED|Intervention Participation||9
8958777|NCT02514889|10022110|FG001|NOT COMPLETED|Intervention Participation||8
8958778|NCT02514889|10022109|FG000|STARTED|Follow-up Assessment Participation||102
8958779|NCT02514889|10022110|FG001|STARTED|Follow-up Assessment Participation||98
8958780|NCT02514889|10022109|FG000|COMPLETED|Follow-up Assessment Participation||92
8958781|NCT02514889|10022110|FG001|COMPLETED|Follow-up Assessment Participation||86
8958782|NCT02514889|10022109|FG000|NOT COMPLETED|Follow-up Assessment Participation||10
8958783|NCT02514889|10022110|FG001|NOT COMPLETED|Follow-up Assessment Participation||12
8958784|NCT02515045|10022118|FG000|STARTED|Overall Study||29
8958785|NCT02515045|10022119|FG001|STARTED|Overall Study||30
8958786|NCT02515045|10022120|FG002|STARTED|Overall Study||59
8958787|NCT02515045|10022118|FG000|COMPLETED|Overall Study||29
8958788|NCT02515045|10022119|FG001|COMPLETED|Overall Study||26
8958789|NCT02515045|10022120|FG002|COMPLETED|Overall Study||55
8958790|NCT02515045|10022118|FG000|NOT COMPLETED|Overall Study||0
8958791|NCT02515045|10022119|FG001|NOT COMPLETED|Overall Study||4
8958792|NCT02515045|10022120|FG002|NOT COMPLETED|Overall Study||4
8958793|NCT02515058|10022130|FG000|STARTED|Overall Study||21
8958794|NCT02515058|10022131|FG001|STARTED|Overall Study||22
8958795|NCT02515058|10022130|FG000|COMPLETED|Overall Study||18
8958796|NCT02515058|10022131|FG001|COMPLETED|Overall Study||20
8958797|NCT02515058|10022130|FG000|NOT COMPLETED|Overall Study||3
8958798|NCT02515058|10022131|FG001|NOT COMPLETED|Overall Study||2
8958799|NCT02515097|10022139|FG000|STARTED|Overall Study||142
8958800|NCT02515097|10022140|FG001|STARTED|Overall Study||71
8958801|NCT02515097|10022139|FG000|Intent-to-Treat (ITT) Population|Overall Study||142
8958802|NCT02515097|10022140|FG001|Intent-to-Treat (ITT) Population|Overall Study||71
8958803|NCT02515097|10022139|FG000|Safety Population|Overall Study||142
8958804|NCT02515097|10022140|FG001|Safety Population|Overall Study||70
8958805|NCT02515097|10022139|FG000|COMPLETED|Overall Study||135
8958806|NCT02515097|10022140|FG001|COMPLETED|Overall Study||65
8958807|NCT02515097|10022139|FG000|NOT COMPLETED|Overall Study||7
8958808|NCT02515097|10022140|FG001|NOT COMPLETED|Overall Study||6
8958809|NCT02515253|10022148|FG000|STARTED|Overall Study||17
8958810|NCT02515253|10022149|FG001|STARTED|Overall Study||16
8958811|NCT02515253|10022148|FG000|COMPLETED|Overall Study||10
8958812|NCT02515253|10022149|FG001|COMPLETED|Overall Study||8
8958813|NCT02515253|10022148|FG000|NOT COMPLETED|Overall Study||7
8958814|NCT02515253|10022149|FG001|NOT COMPLETED|Overall Study||8
8958815|NCT02515279|10022155|FG000|STARTED|Overall Study||463
8958816|NCT02515279|10022155|FG000|COMPLETED|Overall Study||359
8958817|NCT02515279|10022155|FG000|NOT COMPLETED|Overall Study||104
8958818|NCT02515305|10022162|FG000|STARTED|Overall Study||385
8958819|NCT02515305|10022163|FG001|STARTED|Overall Study||378
8958820|NCT02515305|10022164|FG002|STARTED|Overall Study||127
8958821|NCT02515305|10022162|FG000|COMPLETED|Overall Study||356
8958822|NCT02515305|10022163|FG001|COMPLETED|Overall Study||343
8958823|NCT02515305|10022164|FG002|COMPLETED|Overall Study||113
8958824|NCT02515305|10022162|FG000|NOT COMPLETED|Overall Study||29
8958825|NCT02515305|10022163|FG001|NOT COMPLETED|Overall Study||35
8958826|NCT02515305|10022164|FG002|NOT COMPLETED|Overall Study||14
8958827|NCT02515331|10022175|FG000|STARTED|Overall Study||17
8958828|NCT02515331|10022176|FG001|STARTED|Overall Study||15
8958829|NCT02515331|10022177|FG002|STARTED|Overall Study||32
8958830|NCT02515331|10022175|FG000|Primary Pharmacodynamic Analysis Set|Overall Study||15
8958831|NCT02515331|10022176|FG001|Primary Pharmacodynamic Analysis Set|Overall Study||14
8958832|NCT02515331|10022177|FG002|Primary Pharmacodynamic Analysis Set|Overall Study||29
8958833|NCT02515331|10022175|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||17
8958834|NCT02515331|10022176|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||15
8958835|NCT02515331|10022177|FG002|Pharmacokinetic (PK) Analysis Set|Overall Study||0
8958836|NCT02515331|10022175|FG000|COMPLETED|Overall Study||15
8958837|NCT02515331|10022176|FG001|COMPLETED|Overall Study||15
8958838|NCT02515331|10022177|FG002|COMPLETED|Overall Study||28
8958839|NCT02515331|10022175|FG000|NOT COMPLETED|Overall Study||2
8958840|NCT02515331|10022176|FG001|NOT COMPLETED|Overall Study||0
8958841|NCT02515331|10022177|FG002|NOT COMPLETED|Overall Study||4
8958842|NCT02515630|10022187|FG000|STARTED|Overall Study||41
8958843|NCT02515630|10022187|FG000|COMPLETED|Overall Study||25
8958844|NCT02515630|10022187|FG000|NOT COMPLETED|Overall Study||16
8958845|NCT02515656|10022196|FG000|STARTED|Overall Study||326
8958846|NCT02515656|10022197|FG001|STARTED|Overall Study||332
8958847|NCT02515656|10022196|FG000|Full Analysis Set (FAS)|Overall Study||302
8958848|NCT02515656|10022197|FG001|Full Analysis Set (FAS)|Overall Study||309
8958849|NCT02515656|10022196|FG000|Per Protocol Set (PPS)|Overall Study||277
8958850|NCT02515656|10022197|FG001|Per Protocol Set (PPS)|Overall Study||275
8958851|NCT02515656|10022196|FG000|Safety Population|Overall Study||325
8958852|NCT02515656|10022197|FG001|Safety Population|Overall Study||328
8958853|NCT02515656|10022196|FG000|COMPLETED|Overall Study||270
8958854|NCT02515656|10022197|FG001|COMPLETED|Overall Study||261
8958855|NCT02515656|10022196|FG000|NOT COMPLETED|Overall Study||56
8958856|NCT02515656|10022197|FG001|NOT COMPLETED|Overall Study||71
8958857|NCT02515669|10022207|FG000|STARTED|24 Week Double-Blind Phase||11
8958858|NCT02515669|10022208|FG001|STARTED|24 Week Double-Blind Phase||7
8958859|NCT02515669|10022209|FG002|STARTED|24 Week Double-Blind Phase||6
8958860|NCT02515669|10022210|FG003|STARTED|24 Week Double-Blind Phase||19
8958861|NCT02515669|10022207|FG000|COMPLETED|24 Week Double-Blind Phase||11
8958862|NCT02515669|10022208|FG001|COMPLETED|24 Week Double-Blind Phase||7
8958863|NCT02515669|10022209|FG002|COMPLETED|24 Week Double-Blind Phase||6
8958864|NCT02515669|10022210|FG003|COMPLETED|24 Week Double-Blind Phase||19
8958865|NCT02515669|10022207|FG000|NOT COMPLETED|24 Week Double-Blind Phase||0
8958866|NCT02515669|10022208|FG001|NOT COMPLETED|24 Week Double-Blind Phase||0
8958867|NCT02515669|10022209|FG002|NOT COMPLETED|24 Week Double-Blind Phase||0
8958868|NCT02515669|10022210|FG003|NOT COMPLETED|24 Week Double-Blind Phase||0
8958869|NCT02515669|10022207|FG000|STARTED|228 Week Open-Label Phase|Double-blind (DB) placebo participants switched to RO7239361 (RO) for the open label phase.|0
8958870|NCT02515669|10022208|FG001|STARTED|228 Week Open-Label Phase|2 DB placebo participants switched to the Panel 1 RO cohort for the open-label phase.|9
8958871|NCT02515669|10022209|FG002|STARTED|228 Week Open-Label Phase|2 DB placebo participants switched to the Panel 2 RO cohort for the open-label phase.|8
8958872|NCT02515669|10022210|FG003|STARTED|228 Week Open-Label Phase|7 DB placebo participants switched to the Panel 3/Expansion RO cohort for the open-label phase.|26
8958873|NCT02515669|10022207|FG000|COMPLETED|228 Week Open-Label Phase||0
8958874|NCT02515669|10022208|FG001|COMPLETED|228 Week Open-Label Phase||0
8958875|NCT02515669|10022209|FG002|COMPLETED|228 Week Open-Label Phase||0
8958876|NCT02515669|10022210|FG003|COMPLETED|228 Week Open-Label Phase||0
8958877|NCT02515669|10022207|FG000|NOT COMPLETED|228 Week Open-Label Phase||0
8958878|NCT02515669|10022208|FG001|NOT COMPLETED|228 Week Open-Label Phase||9
8958879|NCT02515669|10022209|FG002|NOT COMPLETED|228 Week Open-Label Phase||8
8958880|NCT02515669|10022210|FG003|NOT COMPLETED|228 Week Open-Label Phase||26
8958881|NCT02515825|10022242|FG000|STARTED|Overall Study||70
8958882|NCT02515825|10022243|FG001|STARTED|Overall Study||31
8958883|NCT02515825|10022242|FG000|COMPLETED|Overall Study||70
8958884|NCT02515825|10022243|FG001|COMPLETED|Overall Study||31
8958885|NCT02515825|10022242|FG000|NOT COMPLETED|Overall Study||0
8958886|NCT02515825|10022243|FG001|NOT COMPLETED|Overall Study||0
8958887|NCT02515890|10022255|FG000|STARTED|Overall Study||7
8958888|NCT02515890|10022256|FG001|STARTED|Overall Study||4
8958889|NCT02515890|10022257|FG002|STARTED|Overall Study||5
8958890|NCT02515890|10022258|FG003|STARTED|Overall Study||8
8958891|NCT02515890|10022259|FG004|STARTED|Overall Study||8
8958892|NCT02515890|10022255|FG000|COMPLETED|Overall Study||7
8958893|NCT02515890|10022256|FG001|COMPLETED|Overall Study||4
8958894|NCT02515890|10022257|FG002|COMPLETED|Overall Study||5
8958895|NCT02515890|10022258|FG003|COMPLETED|Overall Study||8
8958896|NCT02515890|10022259|FG004|COMPLETED|Overall Study||8
8958897|NCT02515890|10022255|FG000|NOT COMPLETED|Overall Study||0
8958898|NCT02515890|10022256|FG001|NOT COMPLETED|Overall Study||0
8958899|NCT02515890|10022257|FG002|NOT COMPLETED|Overall Study||0
8958900|NCT02515890|10022258|FG003|NOT COMPLETED|Overall Study||0
8958901|NCT02515890|10022259|FG004|NOT COMPLETED|Overall Study||0
8958902|NCT02515942|10022273|FG000|STARTED|Overall Study||36
8958903|NCT02515942|10022274|FG001|STARTED|Overall Study||39
8958904|NCT02515942|10022275|FG002|STARTED|Overall Study||39
8631409|NCT00539994|9671297|FG001|STARTED|Overall Study||19
8631410|NCT00539994|9671298|FG002|STARTED|Overall Study||15
8631411|NCT00539994|9671296|FG000|COMPLETED|Overall Study||20
8958905|NCT02515942|10022273|FG000|Safety Analysis Set|Overall Study||36
8958906|NCT02515942|10022274|FG001|Safety Analysis Set|Overall Study||39
8958907|NCT02515942|10022275|FG002|Safety Analysis Set|Overall Study||39
8958908|NCT02515942|10022273|FG000|Full Analysis Set (FAS)|Overall Study||35
8958909|NCT02515942|10022274|FG001|Full Analysis Set (FAS)|Overall Study||37
8958910|NCT02515942|10022275|FG002|Full Analysis Set (FAS)|Overall Study||38
8958911|NCT02515942|10022273|FG000|Per Protocol Analysis Set (PPS)|Overall Study||30
8958912|NCT02515942|10022274|FG001|Per Protocol Analysis Set (PPS)|Overall Study||35
8958913|NCT02515942|10022275|FG002|Per Protocol Analysis Set (PPS)|Overall Study||34
8958914|NCT02515942|10022273|FG000|Pharmacokinetics (PK) Analysis Set|Overall Study||36
8958915|NCT02515942|10022274|FG001|Pharmacokinetics (PK) Analysis Set|Overall Study||39
8958916|NCT02515942|10022275|FG002|Pharmacokinetics (PK) Analysis Set|Overall Study||0
8958917|NCT02515942|10022273|FG000|Completed Day 85|Overall Study||35
8958918|NCT02515942|10022274|FG001|Completed Day 85|Overall Study||38
8958919|NCT02515942|10022275|FG002|Completed Day 85|Overall Study||37
8958920|NCT02515942|10022273|FG000|Completed Day 169|Overall Study||32
8958921|NCT02515942|10022274|FG001|Completed Day 169|Overall Study||37
8958922|NCT02515942|10022275|FG002|Completed Day 169|Overall Study||37
8958923|NCT02515942|10022273|FG000|Completed Day 253|Overall Study|One subject missed Day 253 visit|29
8958924|NCT02515942|10022274|FG001|Completed Day 253|Overall Study||37
8958925|NCT02515942|10022275|FG002|Completed Day 253|Overall Study||36
8958926|NCT02515942|10022273|FG000|Completed Day 337|Overall Study||30
8958927|NCT02515942|10022274|FG001|Completed Day 337|Overall Study||36
8958928|NCT02515942|10022275|FG002|Completed Day 337|Overall Study||35
8958929|NCT02515942|10022273|FG000|COMPLETED|Overall Study||29
8958930|NCT02515942|10022274|FG001|COMPLETED|Overall Study||36
8958931|NCT02515942|10022275|FG002|COMPLETED|Overall Study||35
8958932|NCT02515942|10022273|FG000|NOT COMPLETED|Overall Study||7
8958933|NCT02515942|10022274|FG001|NOT COMPLETED|Overall Study||3
8958934|NCT02515942|10022275|FG002|NOT COMPLETED|Overall Study||4
8958935|NCT02515994|10022287|FG000|STARTED|Overall Study||109
8958936|NCT02515994|10022288|FG001|STARTED|Overall Study||112
8958937|NCT02515994|10022287|FG000|COMPLETED|Overall Study||99
8958938|NCT02515994|10022288|FG001|COMPLETED|Overall Study||105
8958939|NCT02515994|10022287|FG000|NOT COMPLETED|Overall Study||10
8958940|NCT02515994|10022288|FG001|NOT COMPLETED|Overall Study||7
8958941|NCT02516046|10022294|FG000|STARTED|Overall Study|Total number of subjects scanned|156
8958942|NCT02516046|10022294|FG000|Died While on Study|Overall Study||73
8958943|NCT02516046|10022294|FG000|Valid Autopsy Results and PET Scan|Overall Study|includes 3 front-runners|67
8958944|NCT02516046|10022294|FG000|COMPLETED|Overall Study|Completed = included in autopsy cohort|64
8958945|NCT02516046|10022294|FG000|NOT COMPLETED|Overall Study||92
8958946|NCT02516098|10022310|FG000|STARTED|Period 1||28
8958947|NCT02516098|10022311|FG001|STARTED|Period 1||28
8958948|NCT02516098|10022310|FG000|COMPLETED|Period 1||27
8958949|NCT02516098|10022311|FG001|COMPLETED|Period 1||28
8958950|NCT02516098|10022310|FG000|NOT COMPLETED|Period 1||1
8958951|NCT02516098|10022311|FG001|NOT COMPLETED|Period 1||0
8958952|NCT02516098|10022310|FG000|STARTED|Washout After Period 1||27
8958953|NCT02516098|10022311|FG001|STARTED|Washout After Period 1||28
8958954|NCT02516098|10022310|FG000|COMPLETED|Washout After Period 1||27
8958955|NCT02516098|10022311|FG001|COMPLETED|Washout After Period 1||27
8958956|NCT02516098|10022310|FG000|NOT COMPLETED|Washout After Period 1||0
8958957|NCT02516098|10022311|FG001|NOT COMPLETED|Washout After Period 1||1
8958958|NCT02516098|10022310|FG000|STARTED|Period 2||27
8958959|NCT02516098|10022311|FG001|STARTED|Period 2||27
8958960|NCT02516098|10022310|FG000|COMPLETED|Period 2||27
8958961|NCT02516098|10022311|FG001|COMPLETED|Period 2||26
8958962|NCT02516098|10022310|FG000|NOT COMPLETED|Period 2||0
8958963|NCT02516098|10022311|FG001|NOT COMPLETED|Period 2||1
8958964|NCT02516098|10022310|FG000|STARTED|Washout After Period 2||27
8958965|NCT02516098|10022311|FG001|STARTED|Washout After Period 2||26
8958966|NCT02516098|10022310|FG000|COMPLETED|Washout After Period 2||27
8958967|NCT02516098|10022311|FG001|COMPLETED|Washout After Period 2||26
8958968|NCT02516098|10022310|FG000|NOT COMPLETED|Washout After Period 2||0
8958969|NCT02516098|10022311|FG001|NOT COMPLETED|Washout After Period 2||0
8958970|NCT02516150|10022317|FG000|STARTED|Overall Study||15
8958971|NCT02516150|10022317|FG000|COMPLETED|Overall Study||15
8958972|NCT02516150|10022317|FG000|NOT COMPLETED|Overall Study||0
8958973|NCT02516163|10022323|FG000|STARTED|Overall Study||52
8958974|NCT02516163|10022323|FG000|COMPLETED|Overall Study||24
8958975|NCT02516163|10022323|FG000|NOT COMPLETED|Overall Study||28
8958976|NCT02516202|10022330|FG000|STARTED|Overall Study||102
8958977|NCT02516202|10022331|FG001|STARTED|Overall Study||100
8958978|NCT02516202|10022332|FG002|STARTED|Overall Study||100
8958979|NCT02516202|10022330|FG000|COMPLETED|Overall Study||100
8958980|NCT02516202|10022331|FG001|COMPLETED|Overall Study||99
8958981|NCT02516202|10022332|FG002|COMPLETED|Overall Study||97
8958982|NCT02516202|10022330|FG000|NOT COMPLETED|Overall Study||2
8958983|NCT02516202|10022331|FG001|NOT COMPLETED|Overall Study||1
8958984|NCT02516202|10022332|FG002|NOT COMPLETED|Overall Study||3
8958985|NCT02516306|10022342|FG000|STARTED|Period 1: Day 1 - 7||50
8958986|NCT02516306|10022343|FG001|STARTED|Period 1: Day 1 - 7||25
8958987|NCT02516306|10022342|FG000|COMPLETED|Period 1: Day 1 - 7||50
8958988|NCT02516306|10022343|FG001|COMPLETED|Period 1: Day 1 - 7||25
8958989|NCT02516306|10022342|FG000|NOT COMPLETED|Period 1: Day 1 - 7||0
8958990|NCT02516306|10022343|FG001|NOT COMPLETED|Period 1: Day 1 - 7||0
8958991|NCT02516306|10022342|FG000|STARTED|Period 2: Day 8 - 91||50
8958992|NCT02516306|10022343|FG001|STARTED|Period 2: Day 8 - 91||25
8958993|NCT02516306|10022342|FG000|COMPLETED|Period 2: Day 8 - 91||49
8958994|NCT02516306|10022343|FG001|COMPLETED|Period 2: Day 8 - 91||23
8958995|NCT02516306|10022342|FG000|NOT COMPLETED|Period 2: Day 8 - 91||1
8958996|NCT02516306|10022343|FG001|NOT COMPLETED|Period 2: Day 8 - 91||2
8958997|NCT02516332|10022352|FG000|STARTED|Overall Study||52
8958998|NCT02516332|10022353|FG001|STARTED|Overall Study||53
8958999|NCT02516332|10022354|FG002|STARTED|Overall Study||23
8959000|NCT02516332|10022352|FG000|COMPLETED|Overall Study||50
8959001|NCT02516332|10022353|FG001|COMPLETED|Overall Study||52
8959002|NCT02516332|10022354|FG002|COMPLETED|Overall Study||21
8959003|NCT02516332|10022352|FG000|NOT COMPLETED|Overall Study||2
8959004|NCT02516332|10022353|FG001|NOT COMPLETED|Overall Study||1
8959005|NCT02516332|10022354|FG002|NOT COMPLETED|Overall Study||2
8959006|NCT02516410|10022364|FG000|STARTED|Overall Study||85
8959007|NCT02516410|10022365|FG001|STARTED|Overall Study||83
8959008|NCT02516410|10022364|FG000|COMPLETED|Overall Study||85
8959009|NCT02516410|10022365|FG001|COMPLETED|Overall Study||81
8959010|NCT02516410|10022364|FG000|NOT COMPLETED|Overall Study||0
8959011|NCT02516410|10022365|FG001|NOT COMPLETED|Overall Study||2
8959012|NCT02516579|10022372|FG000|STARTED|Overall Study||1906
8959013|NCT02516579|10022372|FG000|COMPLETED|Overall Study||1906
8959014|NCT02516579|10022372|FG000|NOT COMPLETED|Overall Study||0
8959015|NCT02516592|10022378|FG000|STARTED|Overall Study||251
8959016|NCT02516592|10022379|FG001|STARTED|Overall Study||251
8959017|NCT02516592|10022378|FG000|Full Analysis Set|Overall Study||248
8959018|NCT02516592|10022379|FG001|Full Analysis Set|Overall Study||250
8959019|NCT02516592|10022378|FG000|COMPLETED|Overall Study||235
8959020|NCT02516592|10022379|FG001|COMPLETED|Overall Study||238
8959021|NCT02516592|10022378|FG000|NOT COMPLETED|Overall Study||16
8959022|NCT02516592|10022379|FG001|NOT COMPLETED|Overall Study||13
8959023|NCT02516605|10022390|FG000|STARTED|Overall Study||11
8959024|NCT02516605|10022391|FG001|STARTED|Overall Study||9
8959025|NCT02516605|10022392|FG002|STARTED|Overall Study||12
8959026|NCT02516605|10022393|FG003|STARTED|Overall Study||8
8959027|NCT02516605|10022394|FG004|STARTED|Overall Study||21
8959028|NCT02516605|10022390|FG000|COMPLETED|Overall Study||11
8959029|NCT02516605|10022391|FG001|COMPLETED|Overall Study||9
8959030|NCT02516605|10022392|FG002|COMPLETED|Overall Study||12
8959031|NCT02516605|10022393|FG003|COMPLETED|Overall Study||7
8959032|NCT02516605|10022394|FG004|COMPLETED|Overall Study||20
8959033|NCT02516605|10022390|FG000|NOT COMPLETED|Overall Study||0
8959034|NCT02516605|10022391|FG001|NOT COMPLETED|Overall Study||0
8959035|NCT02516605|10022392|FG002|NOT COMPLETED|Overall Study||0
8959036|NCT02516605|10022393|FG003|NOT COMPLETED|Overall Study||1
8959037|NCT02516605|10022394|FG004|NOT COMPLETED|Overall Study||1
8959038|NCT02516982|10022414|FG000|STARTED|Overall Study||305
8959039|NCT02516982|10022415|FG001|STARTED|Overall Study||292
8959040|NCT02516982|10022416|FG002|STARTED|Overall Study||174
8959041|NCT02516982|10022417|FG003|STARTED|Overall Study||175
8959042|NCT02516982|10022414|FG000|COMPLETED|Overall Study||273
8959043|NCT02516982|10022415|FG001|COMPLETED|Overall Study||257
8959044|NCT02516982|10022416|FG002|COMPLETED|Overall Study||126
8959045|NCT02516982|10022417|FG003|COMPLETED|Overall Study||125
8959046|NCT02516982|10022414|FG000|NOT COMPLETED|Overall Study||32
8959047|NCT02516982|10022415|FG001|NOT COMPLETED|Overall Study||35
8959048|NCT02516982|10022416|FG002|NOT COMPLETED|Overall Study||48
8959049|NCT02516982|10022417|FG003|NOT COMPLETED|Overall Study||50
8959050|NCT02517021|10022429|FG000|STARTED|Overall Study||203
8959051|NCT02517021|10022430|FG001|STARTED|Overall Study||202
8959052|NCT02517021|10022429|FG000|COMPLETED|Overall Study||120
8959053|NCT02517021|10022430|FG001|COMPLETED|Overall Study||117
8959054|NCT02517021|10022429|FG000|NOT COMPLETED|Overall Study||83
8959055|NCT02517021|10022430|FG001|NOT COMPLETED|Overall Study||85
8959056|NCT02517047|10022436|FG000|STARTED|Overall Study||26
8959057|NCT02517047|10022436|FG000|COMPLETED|Overall Study||24
8959058|NCT02517047|10022436|FG000|NOT COMPLETED|Overall Study||2
8959059|NCT02517268|10022443|FG000|STARTED|Overall Study||40
8959060|NCT02517268|10022444|FG001|STARTED|Overall Study||37
8959061|NCT02517268|10022443|FG000|COMPLETED|Overall Study||39
8959062|NCT02517268|10022444|FG001|COMPLETED|Overall Study||37
8959063|NCT02517268|10022443|FG000|NOT COMPLETED|Overall Study||1
8959064|NCT02517268|10022444|FG001|NOT COMPLETED|Overall Study||0
8959065|NCT02517463|10022452|FG000|STARTED|Overall Study||369
8959066|NCT02517463|10022453|FG001|STARTED|Overall Study||331
8959067|NCT02517463|10022452|FG000|COMPLETED|Overall Study||364
8959068|NCT02517463|10022453|FG001|COMPLETED|Overall Study||329
8959069|NCT02517463|10022452|FG000|NOT COMPLETED|Overall Study||5
8959070|NCT02517463|10022453|FG001|NOT COMPLETED|Overall Study||2
8959071|NCT02517515|10022461|FG000|STARTED|Overall Study||325
8959072|NCT02517515|10022462|FG001|STARTED|Overall Study||325
8959073|NCT02517515|10022461|FG000|COMPLETED|Overall Study||323
8959074|NCT02517515|10022462|FG001|COMPLETED|Overall Study||323
8959075|NCT02517515|10022461|FG000|NOT COMPLETED|Overall Study||2
8959076|NCT02517515|10022462|FG001|NOT COMPLETED|Overall Study||2
8959077|NCT02517528|10022469|FG000|STARTED|Overall Study||104
8959078|NCT02517528|10022469|FG000|COMPLETED|Overall Study||103
8959079|NCT02517528|10022469|FG000|NOT COMPLETED|Overall Study||1
8959080|NCT02517541|10022473|FG000|STARTED|Baseline Period (Own Product)||74
8959081|NCT02517541|10022473|FG000|COMPLETED|Baseline Period (Own Product)||73
8959082|NCT02517541|10022473|FG000|NOT COMPLETED|Baseline Period (Own Product)||1
8959083|NCT02517541|10022473|FG000|STARTED|Test Period (SenSura Mio Convex Soft)||73
8959084|NCT02517541|10022473|FG000|COMPLETED|Test Period (SenSura Mio Convex Soft)||61
8959085|NCT02517541|10022473|FG000|NOT COMPLETED|Test Period (SenSura Mio Convex Soft)||12
8959086|NCT02517567|10022479|FG000|STARTED|First Exposure (8 Hours)||6
8959087|NCT02517567|10022480|FG001|STARTED|First Exposure (8 Hours)||8
8959088|NCT02517567|10022481|FG002|STARTED|First Exposure (8 Hours)||7
8959089|NCT02517567|10022482|FG003|STARTED|First Exposure (8 Hours)||8
8959090|NCT02517567|10022479|FG000|COMPLETED|First Exposure (8 Hours)||6
8959091|NCT02517567|10022480|FG001|COMPLETED|First Exposure (8 Hours)||8
8959092|NCT02517567|10022481|FG002|COMPLETED|First Exposure (8 Hours)||7
8959093|NCT02517567|10022482|FG003|COMPLETED|First Exposure (8 Hours)||8
8959094|NCT02517567|10022479|FG000|NOT COMPLETED|First Exposure (8 Hours)||0
8959095|NCT02517567|10022480|FG001|NOT COMPLETED|First Exposure (8 Hours)||0
8959096|NCT02517567|10022481|FG002|NOT COMPLETED|First Exposure (8 Hours)||0
8959097|NCT02517567|10022482|FG003|NOT COMPLETED|First Exposure (8 Hours)||0
8959098|NCT02517567|10022479|FG000|STARTED|Second Exposure (8 Hours)||6
8959099|NCT02517567|10022480|FG001|STARTED|Second Exposure (8 Hours)||8
8959100|NCT02517567|10022481|FG002|STARTED|Second Exposure (8 Hours)||7
8959101|NCT02517567|10022482|FG003|STARTED|Second Exposure (8 Hours)||8
8959102|NCT02517567|10022479|FG000|COMPLETED|Second Exposure (8 Hours)||6
8959103|NCT02517567|10022480|FG001|COMPLETED|Second Exposure (8 Hours)||8
8959104|NCT02517567|10022481|FG002|COMPLETED|Second Exposure (8 Hours)||7
8959105|NCT02517567|10022482|FG003|COMPLETED|Second Exposure (8 Hours)||8
8959106|NCT02517567|10022479|FG000|NOT COMPLETED|Second Exposure (8 Hours)||0
8959107|NCT02517567|10022480|FG001|NOT COMPLETED|Second Exposure (8 Hours)||0
8959108|NCT02517567|10022481|FG002|NOT COMPLETED|Second Exposure (8 Hours)||0
8959109|NCT02517567|10022482|FG003|NOT COMPLETED|Second Exposure (8 Hours)||0
8959110|NCT02517567|10022479|FG000|STARTED|Third Exposure (8 Hours)||6
8959111|NCT02517567|10022480|FG001|STARTED|Third Exposure (8 Hours)||8
8959112|NCT02517567|10022481|FG002|STARTED|Third Exposure (8 Hours)||7
8959113|NCT02517567|10022482|FG003|STARTED|Third Exposure (8 Hours)||8
8959114|NCT02517567|10022479|FG000|COMPLETED|Third Exposure (8 Hours)||6
8959115|NCT02517567|10022480|FG001|COMPLETED|Third Exposure (8 Hours)||8
8959116|NCT02517567|10022481|FG002|COMPLETED|Third Exposure (8 Hours)||7
8959117|NCT02517567|10022482|FG003|COMPLETED|Third Exposure (8 Hours)||8
8959118|NCT02517567|10022479|FG000|NOT COMPLETED|Third Exposure (8 Hours)||0
8577568|NCT00159419|9610332|FG001|STARTED|Overall Study||9
8959119|NCT02517567|10022480|FG001|NOT COMPLETED|Third Exposure (8 Hours)||0
8959120|NCT02517567|10022481|FG002|NOT COMPLETED|Third Exposure (8 Hours)||0
8959121|NCT02517567|10022482|FG003|NOT COMPLETED|Third Exposure (8 Hours)||0
8959122|NCT02517567|10022479|FG000|STARTED|Fourth Exposure (8 Hours)||6
8959123|NCT02517567|10022480|FG001|STARTED|Fourth Exposure (8 Hours)||8
8959124|NCT02517567|10022481|FG002|STARTED|Fourth Exposure (8 Hours)|One subject discontinued between Period 3 and Period 4 (withdrawal by subject)|6
8959125|NCT02517567|10022482|FG003|STARTED|Fourth Exposure (8 Hours)||8
8959126|NCT02517567|10022479|FG000|COMPLETED|Fourth Exposure (8 Hours)||6
8959127|NCT02517567|10022480|FG001|COMPLETED|Fourth Exposure (8 Hours)||8
8959128|NCT02517567|10022481|FG002|COMPLETED|Fourth Exposure (8 Hours)||6
8959129|NCT02517567|10022482|FG003|COMPLETED|Fourth Exposure (8 Hours)||8
8924200|NCT02247336|9984987|FG000|STARTED|Overall Study||252
8924201|NCT02247336|9984988|FG001|STARTED|Overall Study||253
8924202|NCT02247336|9984987|FG000|COMPLETED|Overall Study||252
8924203|NCT02247336|9984988|FG001|COMPLETED|Overall Study||253
8924204|NCT02247336|9984987|FG000|NOT COMPLETED|Overall Study||0
8924205|NCT02247336|9984988|FG001|NOT COMPLETED|Overall Study||0
8924206|NCT02247401|9984997|FG000|STARTED|Overall Study||100
8924207|NCT02247401|9984998|FG001|STARTED|Overall Study||31
8924208|NCT02247401|9984999|FG002|STARTED|Overall Study||29
8924209|NCT02247401|9984997|FG000|COMPLETED|Overall Study||94
8924210|NCT02247401|9984998|FG001|COMPLETED|Overall Study||29
8924211|NCT02247401|9984999|FG002|COMPLETED|Overall Study||27
8924212|NCT02247401|9984997|FG000|NOT COMPLETED|Overall Study||6
8924213|NCT02247401|9984998|FG001|NOT COMPLETED|Overall Study||2
8924214|NCT02247401|9984999|FG002|NOT COMPLETED|Overall Study||2
8924215|NCT02247440|9985008|FG000|STARTED|Overall Study||18
8874965|NCT01904773|9931724|FG003|COMPLETED|Third Intervention||2
8874966|NCT01904773|9931725|FG004|COMPLETED|Third Intervention||3
8874967|NCT01904773|9931726|FG005|COMPLETED|Third Intervention||4
8874968|NCT01904773|9931727|FG006|COMPLETED|Third Intervention||3
8874969|NCT01904773|9931728|FG007|COMPLETED|Third Intervention||3
8874970|NCT01904773|9931729|FG008|COMPLETED|Third Intervention||4
8874971|NCT01904773|9931721|FG000|NOT COMPLETED|Third Intervention||0
8874972|NCT01904773|9931722|FG001|NOT COMPLETED|Third Intervention||0
8874973|NCT01904773|9931723|FG002|NOT COMPLETED|Third Intervention||0
8874974|NCT01904773|9931724|FG003|NOT COMPLETED|Third Intervention||0
8874975|NCT01904773|9931725|FG004|NOT COMPLETED|Third Intervention||0
8874976|NCT01904773|9931726|FG005|NOT COMPLETED|Third Intervention||0
8874977|NCT01904773|9931727|FG006|NOT COMPLETED|Third Intervention||0
8874978|NCT01904773|9931728|FG007|NOT COMPLETED|Third Intervention||0
8874979|NCT01904773|9931729|FG008|NOT COMPLETED|Third Intervention||0
8874980|NCT01904773|9931721|FG000|STARTED|Placebo Washout Third Intervention||0
8874981|NCT01904773|9931722|FG001|STARTED|Placebo Washout Third Intervention||1
8874982|NCT01904773|9931723|FG002|STARTED|Placebo Washout Third Intervention||1
8874983|NCT01904773|9931724|FG003|STARTED|Placebo Washout Third Intervention||2
8874984|NCT01904773|9931725|FG004|STARTED|Placebo Washout Third Intervention||3
8874985|NCT01904773|9931726|FG005|STARTED|Placebo Washout Third Intervention||4
8874986|NCT01904773|9931727|FG006|STARTED|Placebo Washout Third Intervention||3
8874987|NCT01904773|9931728|FG007|STARTED|Placebo Washout Third Intervention||3
8874988|NCT01904773|9931729|FG008|STARTED|Placebo Washout Third Intervention||4
8874989|NCT01904773|9931721|FG000|COMPLETED|Placebo Washout Third Intervention||0
8874990|NCT01904773|9931722|FG001|COMPLETED|Placebo Washout Third Intervention||1
8874991|NCT01904773|9931723|FG002|COMPLETED|Placebo Washout Third Intervention||1
8874992|NCT01904773|9931724|FG003|COMPLETED|Placebo Washout Third Intervention||2
8874993|NCT01904773|9931725|FG004|COMPLETED|Placebo Washout Third Intervention||3
8874994|NCT01904773|9931726|FG005|COMPLETED|Placebo Washout Third Intervention||4
8924161|NCT02246998|9984925|FG000|NOT COMPLETED|Overall Study||2
8924162|NCT02246998|9984926|FG001|NOT COMPLETED|Overall Study||3
8924163|NCT02246998|9984927|FG002|NOT COMPLETED|Overall Study||3
8924164|NCT02246998|9984928|FG003|NOT COMPLETED|Overall Study||2
8924165|NCT02247011|9984943|FG000|STARTED|Overall Study||1100
8924166|NCT02247011|9984943|FG000|COMPLETED|Overall Study||975
8924167|NCT02247011|9984943|FG000|NOT COMPLETED|Overall Study||125
8924168|NCT02247063|9984952|FG000|STARTED|Overall Study||12
8924169|NCT02247063|9984953|FG001|STARTED|Overall Study||12
8924170|NCT02247063|9984952|FG000|COMPLETED|Overall Study||12
8924171|NCT02247063|9984953|FG001|COMPLETED|Overall Study||12
8924172|NCT02247063|9984952|FG000|NOT COMPLETED|Overall Study||0
8924173|NCT02247063|9984953|FG001|NOT COMPLETED|Overall Study||0
8924174|NCT02247193|9984961|FG000|STARTED|Overall Study||15
8924175|NCT02247193|9984962|FG001|STARTED|Overall Study||15
8924176|NCT02247193|9984961|FG000|Number Who Underwent Cleft Lip Repair Surgery|Overall Study||15
8924177|NCT02247193|9984962|FG001|Number Who Underwent Cleft Lip Repair Surgery|Overall Study||15
8924178|NCT02247193|9984961|FG000|Number Who Received Botox or Placebo|Overall Study||15
8924179|NCT02247193|9984962|FG001|Number Who Received Botox or Placebo|Overall Study||15
8924180|NCT02247193|9984961|FG000|Number Who Completed the 6-month Follow up|Overall Study||15
8924181|NCT02247193|9984962|FG001|Number Who Completed the 6-month Follow up|Overall Study||15
8924182|NCT02247193|9984961|FG000|Number Who Completed the 12-month Follow up|Overall Study||15
8924183|NCT02247193|9984962|FG001|Number Who Completed the 12-month Follow up|Overall Study||15
8924184|NCT02247193|9984961|FG000|COMPLETED|Overall Study||15
8924185|NCT02247193|9984962|FG001|COMPLETED|Overall Study||15
8924186|NCT02247193|9984961|FG000|NOT COMPLETED|Overall Study||0
8924187|NCT02247193|9984962|FG001|NOT COMPLETED|Overall Study||0
8924188|NCT02247245|9984972|FG000|STARTED|Overall Study||13
8924189|NCT02247245|9984973|FG001|STARTED|Overall Study||13
8924190|NCT02247245|9984974|FG002|STARTED|Overall Study||7
8924191|NCT02247245|9984975|FG003|STARTED|Overall Study||7
8924192|NCT02247245|9984972|FG000|COMPLETED|Overall Study||13
8924193|NCT02247245|9984973|FG001|COMPLETED|Overall Study||13
8924194|NCT02247245|9984974|FG002|COMPLETED|Overall Study||7
8924195|NCT02247245|9984975|FG003|COMPLETED|Overall Study||7
8924196|NCT02247245|9984972|FG000|NOT COMPLETED|Overall Study||0
8924197|NCT02247245|9984973|FG001|NOT COMPLETED|Overall Study||0
8924198|NCT02247245|9984974|FG002|NOT COMPLETED|Overall Study||0
8924199|NCT02247245|9984975|FG003|NOT COMPLETED|Overall Study||0
8924216|NCT02247440|9985008|FG000|COMPLETED|Overall Study||14
8924217|NCT02247440|9985008|FG000|NOT COMPLETED|Overall Study||4
8924218|NCT02247466|9985014|FG000|STARTED|Overall Study||19
8924219|NCT02247466|9985015|FG001|STARTED|Overall Study||18
8924220|NCT02247466|9985014|FG000|COMPLETED|Overall Study||19
8924221|NCT02247466|9985015|FG001|COMPLETED|Overall Study||15
8924222|NCT02247466|9985014|FG000|NOT COMPLETED|Overall Study||0
8924223|NCT02247466|9985015|FG001|NOT COMPLETED|Overall Study||3
8959130|NCT02517567|10022479|FG000|NOT COMPLETED|Fourth Exposure (8 Hours)||0
8959131|NCT02517567|10022480|FG001|NOT COMPLETED|Fourth Exposure (8 Hours)||0
8959132|NCT02517567|10022481|FG002|NOT COMPLETED|Fourth Exposure (8 Hours)||0
8959133|NCT02517567|10022482|FG003|NOT COMPLETED|Fourth Exposure (8 Hours)||0
8959134|NCT02517580|10022491|FG000|STARTED|Overall Study||60
8959135|NCT02517580|10022491|FG000|COMPLETED|Overall Study||56
8959136|NCT02517580|10022491|FG000|NOT COMPLETED|Overall Study||4
8959137|NCT02517658|10022498|FG000|STARTED|Overall Study||33
8959138|NCT02517658|10022499|FG001|STARTED|Overall Study||33
8959139|NCT02517658|10022500|FG002|STARTED|Overall Study||33
8959140|NCT02517658|10022498|FG000|COMPLETED|Overall Study||33
8959141|NCT02517658|10022499|FG001|COMPLETED|Overall Study||33
8959142|NCT02517658|10022500|FG002|COMPLETED|Overall Study||33
8959143|NCT02517658|10022498|FG000|NOT COMPLETED|Overall Study||0
8959144|NCT02517658|10022499|FG001|NOT COMPLETED|Overall Study||0
8959145|NCT02517658|10022500|FG002|NOT COMPLETED|Overall Study||0
8959146|NCT02517866|10022508|FG000|STARTED|Overall Study||289
8959147|NCT02517866|10022509|FG001|STARTED|Overall Study||90
8959148|NCT02517866|10022510|FG002|STARTED|Overall Study||1
8959149|NCT02517866|10022508|FG000|COMPLETED|Overall Study||269
8959150|NCT02517866|10022509|FG001|COMPLETED|Overall Study||84
8959151|NCT02517866|10022510|FG002|COMPLETED|Overall Study||1
8959152|NCT02517866|10022508|FG000|NOT COMPLETED|Overall Study||20
8959153|NCT02517866|10022509|FG001|NOT COMPLETED|Overall Study||6
8959154|NCT02517866|10022510|FG002|NOT COMPLETED|Overall Study||0
8959155|NCT02517905|10022522|FG000|STARTED|Overall Study||107
8959156|NCT02517905|10022523|FG001|STARTED|Overall Study||59
8959157|NCT02517905|10022522|FG000|COMPLETED|Overall Study||97
8959158|NCT02517905|10022523|FG001|COMPLETED|Overall Study||57
8959159|NCT02517905|10022522|FG000|NOT COMPLETED|Overall Study||10
8959160|NCT02517905|10022523|FG001|NOT COMPLETED|Overall Study||2
8959161|NCT02517996|10022531|FG000|STARTED|Overall Study||8
8959162|NCT02517996|10022532|FG001|STARTED|Overall Study||9
8959163|NCT02517996|10022531|FG000|COMPLETED|Overall Study||8
8959164|NCT02517996|10022532|FG001|COMPLETED|Overall Study||9
8959165|NCT02517996|10022531|FG000|NOT COMPLETED|Overall Study||0
8959166|NCT02517996|10022532|FG001|NOT COMPLETED|Overall Study||0
8959167|NCT02518048|10022538|FG000|STARTED|Overall Study||35
8959168|NCT02518048|10022538|FG000|COMPLETED|Overall Study||34
8959169|NCT02518048|10022538|FG000|NOT COMPLETED|Overall Study||1
8959170|NCT02518113|10022547|FG000|STARTED|Overall Study||6
8959171|NCT02518113|10022548|FG001|STARTED|Overall Study||12
8959172|NCT02518113|10022549|FG002|STARTED|Overall Study||15
8959173|NCT02518113|10022550|FG003|STARTED|Overall Study||3
8959174|NCT02518113|10022547|FG000|COMPLETED|Overall Study||3
8959175|NCT02518113|10022548|FG001|COMPLETED|Overall Study||7
8959176|NCT02518113|10022549|FG002|COMPLETED|Overall Study||11
8959177|NCT02518113|10022550|FG003|COMPLETED|Overall Study||3
8959178|NCT02518113|10022547|FG000|NOT COMPLETED|Overall Study||3
8959179|NCT02518113|10022548|FG001|NOT COMPLETED|Overall Study||5
8959180|NCT02518113|10022549|FG002|NOT COMPLETED|Overall Study||4
8959181|NCT02518113|10022550|FG003|NOT COMPLETED|Overall Study||0
8959182|NCT02518191|10022565|FG000|STARTED|Overall Study||171
8959183|NCT02518191|10022566|FG001|STARTED|Overall Study||174
8959184|NCT02518191|10022565|FG000|COMPLETED|Overall Study||165
8959185|NCT02518191|10022566|FG001|COMPLETED|Overall Study||165
8959186|NCT02518191|10022565|FG000|NOT COMPLETED|Overall Study||6
8959187|NCT02518191|10022566|FG001|NOT COMPLETED|Overall Study||9
8959188|NCT02518230|10022576|FG000|STARTED|Overall Study||11
8959189|NCT02518230|10022577|FG001|STARTED|Overall Study||11
8959190|NCT02518230|10022576|FG000|COMPLETED|Overall Study||11
8959191|NCT02518230|10022577|FG001|COMPLETED|Overall Study||11
8959192|NCT02518230|10022576|FG000|NOT COMPLETED|Overall Study||0
8959193|NCT02518230|10022577|FG001|NOT COMPLETED|Overall Study||0
8959194|NCT02518464|10022584|FG000|STARTED|Overall Study||40
8959195|NCT02518464|10022584|FG000|COMPLETED|Overall Study||38
8959196|NCT02518464|10022584|FG000|NOT COMPLETED|Overall Study||2
8959197|NCT02518490|10022588|FG000|STARTED|Overall Study||18
8959198|NCT02518490|10022589|FG001|STARTED|Overall Study||18
8959199|NCT02518490|10022588|FG000|COMPLETED|Overall Study||17
8959200|NCT02518490|10022589|FG001|COMPLETED|Overall Study||17
8959201|NCT02518490|10022588|FG000|NOT COMPLETED|Overall Study||1
8959202|NCT02518490|10022589|FG001|NOT COMPLETED|Overall Study||1
9037774|NCT03320850|10099003|FG008|STARTED|Overall Study||60
9037775|NCT03320850|10099004|FG009|STARTED|Overall Study||59
9037776|NCT03320850|10098995|FG000|Safety Population|Overall Study||18
9037777|NCT03320850|10098996|FG001|Safety Population|Overall Study||12
9037778|NCT03320850|10098997|FG002|Safety Population|Overall Study||18
9037779|NCT03320850|10098998|FG003|Safety Population|Overall Study||22
9037780|NCT03320850|10098999|FG004|Safety Population|Overall Study||19
9037781|NCT03320850|10099000|FG005|Safety Population|Overall Study||57
9037782|NCT03320850|10099001|FG006|Safety Population|Overall Study||57
9037783|NCT03320850|10099002|FG007|Safety Population|Overall Study||60
9037784|NCT03320850|10099003|FG008|Safety Population|Overall Study||60
8959203|NCT02518620|10022598|FG000|STARTED|Overall Study||257
8959204|NCT02518620|10022599|FG001|STARTED|Overall Study||149
8959205|NCT02518620|10022598|FG000|COMPLETED|Overall Study||205
8959206|NCT02518620|10022599|FG001|COMPLETED|Overall Study||123
8570293|NCT00102687|9602461|FG002|STARTED|Maintenance Period|Remained on initial treatment in the maintenance period.|8
8570294|NCT00102687|9602462|FG003|STARTED|Maintenance Period|Second randomization to one of two maintenance regimens|22
8570295|NCT00102687|9602463|FG004|STARTED|Maintenance Period|Second randomization to one of two maintenance regimens|21
8570296|NCT00102687|9602459|FG000|COMPLETED|Maintenance Period||6
8570297|NCT00102687|9602460|FG001|COMPLETED|Maintenance Period||2
8570298|NCT00102687|9602461|FG002|COMPLETED|Maintenance Period||2
8570299|NCT00102687|9602462|FG003|COMPLETED|Maintenance Period||12
8570300|NCT00102687|9602463|FG004|COMPLETED|Maintenance Period||8
8570301|NCT00102687|9602459|FG000|NOT COMPLETED|Maintenance Period||7
8570302|NCT00102687|9602460|FG001|NOT COMPLETED|Maintenance Period||4
8570303|NCT00102687|9602461|FG002|NOT COMPLETED|Maintenance Period||6
8570304|NCT00102687|9602462|FG003|NOT COMPLETED|Maintenance Period||10
8570305|NCT00102687|9602463|FG004|NOT COMPLETED|Maintenance Period||13
8570306|NCT00102804|9602481|FG000|STARTED|Overall Study||441
8570307|NCT00102804|9602482|FG001|STARTED|Overall Study||222
8570308|NCT00102804|9602481|FG000|Received at Least 1 Dose of Study Drug|Overall Study||434
8570309|NCT00102804|9602482|FG001|Received at Least 1 Dose of Study Drug|Overall Study|Four participants randomized to placebo received pemetrexed.|222
8570310|NCT00102804|9602481|FG000|COMPLETED|Overall Study||0
8570311|NCT00102804|9602482|FG001|COMPLETED|Overall Study||0
8570312|NCT00102804|9602481|FG000|NOT COMPLETED|Overall Study||441
8570313|NCT00102804|9602482|FG001|NOT COMPLETED|Overall Study||222
8570314|NCT00102960|9602491|FG000|STARTED|Overall Study||125
8570315|NCT00102960|9602492|FG001|STARTED|Overall Study||126
8570316|NCT00102960|9602493|FG002|STARTED|Overall Study||126
8570317|NCT00102960|9602491|FG000|COMPLETED|Overall Study||95
8570318|NCT00102960|9602492|FG001|COMPLETED|Overall Study||103
8570319|NCT00102960|9602493|FG002|COMPLETED|Overall Study||98
8570320|NCT00102960|9602491|FG000|NOT COMPLETED|Overall Study||30
8570321|NCT00102960|9602492|FG001|NOT COMPLETED|Overall Study||23
8570322|NCT00102960|9602493|FG002|NOT COMPLETED|Overall Study||28
8570323|NCT00103012|9602508|FG000|STARTED|Overall Study||17
8570324|NCT00103012|9602509|FG001|STARTED|Overall Study||14
8570325|NCT00103012|9602510|FG002|STARTED|Overall Study||16
8570326|NCT00103012|9602508|FG000|COMPLETED|Overall Study||14
8570327|NCT00103012|9602509|FG001|COMPLETED|Overall Study||13
8570328|NCT00103012|9602510|FG002|COMPLETED|Overall Study||12
8570329|NCT00103012|9602508|FG000|NOT COMPLETED|Overall Study||3
8570330|NCT00103012|9602509|FG001|NOT COMPLETED|Overall Study||1
8570331|NCT00103012|9602510|FG002|NOT COMPLETED|Overall Study||4
8570332|NCT00103116|9602518|FG000|STARTED|Overall Study||32
8570333|NCT00103116|9602518|FG000|COMPLETED|Overall Study||32
8570334|NCT00103116|9602518|FG000|NOT COMPLETED|Overall Study||0
8570335|NCT00103142|9602524|FG000|STARTED|Overall Study||36
8570336|NCT00103142|9602525|FG001|STARTED|Overall Study||37
8570337|NCT00103142|9602524|FG000|COMPLETED|Overall Study||33
8570338|NCT00103142|9602525|FG001|COMPLETED|Overall Study||36
8631412|NCT00539994|9671297|FG001|COMPLETED|Overall Study||18
8631413|NCT00539994|9671298|FG002|COMPLETED|Overall Study||13
8631414|NCT00539994|9671296|FG000|NOT COMPLETED|Overall Study||3
8631415|NCT00539994|9671297|FG001|NOT COMPLETED|Overall Study||1
8631416|NCT00539994|9671298|FG002|NOT COMPLETED|Overall Study||2
8631417|NCT00540007|9671315|FG000|STARTED|Overall Study||38
8631418|NCT00540007|9671316|FG001|STARTED|Overall Study||42
8631419|NCT00540007|9671315|FG000|COMPLETED|Overall Study||38
8631420|NCT00540007|9671316|FG001|COMPLETED|Overall Study||42
8631421|NCT00540007|9671315|FG000|NOT COMPLETED|Overall Study||0
8631422|NCT00540007|9671316|FG001|NOT COMPLETED|Overall Study||0
8631423|NCT00540046|9671325|FG000|STARTED|Overall Study||104
8631424|NCT00540046|9671326|FG001|STARTED|Overall Study||111
8631425|NCT00540046|9671325|FG000|COMPLETED|Overall Study||71
8631426|NCT00540046|9671326|FG001|COMPLETED|Overall Study||88
8959207|NCT02518620|10022598|FG000|NOT COMPLETED|Overall Study||52
8631427|NCT00540046|9671325|FG000|NOT COMPLETED|Overall Study||33
8631428|NCT00540046|9671326|FG001|NOT COMPLETED|Overall Study||23
8631429|NCT00540124|9671337|FG000|STARTED|Overall Study||51
8631430|NCT00540124|9671338|FG001|STARTED|Overall Study||51
8631431|NCT00540124|9671339|FG002|STARTED|Overall Study||49
8959208|NCT02518620|10022599|FG001|NOT COMPLETED|Overall Study||26
8570339|NCT00103142|9602524|FG000|NOT COMPLETED|Overall Study||3
8570340|NCT00103142|9602525|FG001|NOT COMPLETED|Overall Study||1
8570341|NCT00103194|9602533|FG000|STARTED|Overall Study||49
8570342|NCT00103194|9602533|FG000|Treated|Overall Study||49
8570343|NCT00103194|9602533|FG000|Eligible|Overall Study||35
8631432|NCT00540124|9671337|FG000|COMPLETED|Overall Study||47
8959209|NCT02518685|10022609|FG000|STARTED|Overall Study||213
8959210|NCT02518685|10022610|FG001|STARTED|Overall Study||89
8959211|NCT02518685|10022609|FG000|Safety Cohort|Overall Study|Randomized to and successfully received TPS (171) + Open-Label TPS-treated Subjects (32)|203
8959212|NCT02518685|10022610|FG001|Safety Cohort|Overall Study||89
8959213|NCT02518685|10022609|FG000|Randomized Cohort|Overall Study||181
8959214|NCT02518685|10022610|FG001|Randomized Cohort|Overall Study||89
8959215|NCT02518685|10022609|FG000|Enrolled|Overall Study|Includes 171 Successful device deployments, 10 unsuccessful delivery attempts and 32 Open-Label|213
8959216|NCT02518685|10022610|FG001|Enrolled|Overall Study||89
8959217|NCT02518685|10022609|FG000|Per Protocol Analysis|Overall Study|Three TPS-treated subjects were inadvertently unblinded, excluding them from efficacy analyses.|168
8959218|NCT02518685|10022610|FG001|Per Protocol Analysis|Overall Study||89
8959219|NCT02518685|10022609|FG000|COMPLETED|Overall Study|Randomized Completers (139) plus Open-Label Completers (25)|164
8631433|NCT00540124|9671338|FG001|COMPLETED|Overall Study||48
8631434|NCT00540124|9671339|FG002|COMPLETED|Overall Study||48
8631435|NCT00540124|9671337|FG000|NOT COMPLETED|Overall Study||4
8959220|NCT02518685|10022610|FG001|COMPLETED|Overall Study||79
8959221|NCT02518685|10022609|FG000|NOT COMPLETED|Overall Study||49
8959222|NCT02518685|10022610|FG001|NOT COMPLETED|Overall Study||10
8959223|NCT02518919|10022620|FG000|STARTED|Overall Study||21
8959224|NCT02518919|10022621|FG001|STARTED|Overall Study||21
8959225|NCT02518919|10022622|FG002|STARTED|Overall Study||21
8959226|NCT02518919|10022620|FG000|COMPLETED|Overall Study||20
8959227|NCT02518919|10022621|FG001|COMPLETED|Overall Study||20
8959228|NCT02518919|10022622|FG002|COMPLETED|Overall Study||19
8959229|NCT02518919|10022620|FG000|NOT COMPLETED|Overall Study||1
8959230|NCT02518919|10022621|FG001|NOT COMPLETED|Overall Study||1
8959231|NCT02518919|10022622|FG002|NOT COMPLETED|Overall Study||2
8959232|NCT02518971|10022632|FG000|STARTED|Overall Study||87
8959233|NCT02518971|10022633|FG001|STARTED|Overall Study||87
8959234|NCT02518971|10022632|FG000|COMPLETED|Overall Study||64
8959235|NCT02518971|10022633|FG001|COMPLETED|Overall Study||67
8959236|NCT02518971|10022632|FG000|NOT COMPLETED|Overall Study||23
8959237|NCT02518971|10022633|FG001|NOT COMPLETED|Overall Study||20
8959238|NCT02518997|10022640|FG000|STARTED|Overall Study||18
8959239|NCT02518997|10022640|FG000|COMPLETED|Overall Study||18
8959240|NCT02518997|10022640|FG000|NOT COMPLETED|Overall Study||0
8959241|NCT02519023|10022649|FG000|STARTED|Overall Study||49
8631436|NCT00540124|9671338|FG001|NOT COMPLETED|Overall Study||3
8631437|NCT00540124|9671339|FG002|NOT COMPLETED|Overall Study||1
8631438|NCT00540228|9671352|FG000|STARTED|Overall Study||200
8631439|NCT00540228|9671353|FG001|STARTED|Overall Study||198
8631440|NCT00540228|9671354|FG002|STARTED|Overall Study||204
8631441|NCT00540228|9671355|FG003|STARTED|Overall Study||202
8631442|NCT00540228|9671356|FG004|STARTED|Overall Study||202
8631443|NCT00540228|9671352|FG000|COMPLETED|Overall Study||197
8631444|NCT00540228|9671353|FG001|COMPLETED|Overall Study||197
8631445|NCT00540228|9671354|FG002|COMPLETED|Overall Study||204
8631446|NCT00540228|9671355|FG003|COMPLETED|Overall Study||202
8631447|NCT00540228|9671356|FG004|COMPLETED|Overall Study||202
8631448|NCT00540228|9671352|FG000|NOT COMPLETED|Overall Study||3
8631449|NCT00540228|9671353|FG001|NOT COMPLETED|Overall Study||1
8631450|NCT00540228|9671354|FG002|NOT COMPLETED|Overall Study||0
8631451|NCT00540228|9671355|FG003|NOT COMPLETED|Overall Study||0
8631452|NCT00540228|9671356|FG004|NOT COMPLETED|Overall Study||0
8631453|NCT00540293|9671368|FG000|STARTED|Overall Study||425
8631454|NCT00540293|9671368|FG000|COMPLETED|Overall Study||390
8631455|NCT00540293|9671368|FG000|NOT COMPLETED|Overall Study||35
8631456|NCT00540423|9671380|FG000|STARTED|Double-Blind Treatment Period||8
8631457|NCT00540423|9671381|FG001|STARTED|Double-Blind Treatment Period||15
8631458|NCT00540423|9671382|FG002|STARTED|Double-Blind Treatment Period||0
8631459|NCT00540423|9671380|FG000|COMPLETED|Double-Blind Treatment Period||8
8631460|NCT00540423|9671381|FG001|COMPLETED|Double-Blind Treatment Period||14
8631461|NCT00540423|9671382|FG002|COMPLETED|Double-Blind Treatment Period||0
8631462|NCT00540423|9671380|FG000|NOT COMPLETED|Double-Blind Treatment Period||0
8631463|NCT00540423|9671381|FG001|NOT COMPLETED|Double-Blind Treatment Period||1
8631464|NCT00540423|9671382|FG002|NOT COMPLETED|Double-Blind Treatment Period||0
8631465|NCT00540423|9671380|FG000|STARTED|Open-Label Treatment Period||0
8631466|NCT00540423|9671381|FG001|STARTED|Open-Label Treatment Period||0
8631467|NCT00540423|9671382|FG002|STARTED|Open-Label Treatment Period||22
8631468|NCT00540423|9671380|FG000|COMPLETED|Open-Label Treatment Period||0
8631469|NCT00540423|9671381|FG001|COMPLETED|Open-Label Treatment Period||0
8959242|NCT02519023|10022650|FG001|STARTED|Overall Study||38
8959243|NCT02519023|10022649|FG000|COMPLETED|Overall Study||31
8959244|NCT02519023|10022650|FG001|COMPLETED|Overall Study||31
8959245|NCT02519023|10022649|FG000|NOT COMPLETED|Overall Study||18
8959246|NCT02519023|10022650|FG001|NOT COMPLETED|Overall Study||7
8959247|NCT02519036|10022662|FG000|STARTED|Overall Study||12
8959248|NCT02519036|10022663|FG001|STARTED|Overall Study||3
8959249|NCT02519036|10022664|FG002|STARTED|Overall Study||6
8959250|NCT02519036|10022665|FG003|STARTED|Overall Study||6
8959251|NCT02519036|10022666|FG004|STARTED|Overall Study||9
8959252|NCT02519036|10022667|FG005|STARTED|Overall Study||10
8959253|NCT02519036|10022662|FG000|COMPLETED|Overall Study||12
8959254|NCT02519036|10022663|FG001|COMPLETED|Overall Study||3
8959255|NCT02519036|10022664|FG002|COMPLETED|Overall Study||6
8959256|NCT02519036|10022665|FG003|COMPLETED|Overall Study||6
8959257|NCT02519036|10022666|FG004|COMPLETED|Overall Study||9
8959258|NCT02519036|10022667|FG005|COMPLETED|Overall Study||10
8959259|NCT02519036|10022662|FG000|NOT COMPLETED|Overall Study||0
8959260|NCT02519036|10022663|FG001|NOT COMPLETED|Overall Study||0
8959261|NCT02519036|10022664|FG002|NOT COMPLETED|Overall Study||0
8959262|NCT02519036|10022665|FG003|NOT COMPLETED|Overall Study||0
8959263|NCT02519036|10022666|FG004|NOT COMPLETED|Overall Study||0
8959264|NCT02519036|10022667|FG005|NOT COMPLETED|Overall Study||0
8959265|NCT02519231|10022688|FG000|STARTED|Overall Study||14
8959266|NCT02519231|10022689|FG001|STARTED|Overall Study||14
8959267|NCT02519231|10022688|FG000|COMPLETED|Overall Study|One was lost to follow up and never took the treatment. another never turned in bleeding diary.|12
8959268|NCT02519231|10022689|FG001|COMPLETED|Overall Study|Six participants never turned in their bleeding diaries.|8
8959269|NCT02519231|10022688|FG000|NOT COMPLETED|Overall Study||2
8959270|NCT02519231|10022689|FG001|NOT COMPLETED|Overall Study||6
8959271|NCT02519244|10022697|FG000|STARTED|Overall Study||10
8959272|NCT02519244|10022697|FG000|COMPLETED|Overall Study||10
8959273|NCT02519244|10022697|FG000|NOT COMPLETED|Overall Study||0
8959274|NCT02519387|10022701|FG000|STARTED|Overall Study||78
8959275|NCT02519387|10022701|FG000|COMPLETED|Overall Study||56
8959276|NCT02519387|10022701|FG000|NOT COMPLETED|Overall Study||22
8959277|NCT02519491|10022707|FG000|STARTED|Overall Study||219
8959278|NCT02519491|10022708|FG001|STARTED|Overall Study||219
8959279|NCT02519491|10022707|FG000|COMPLETED|Overall Study||219
8959280|NCT02519491|10022708|FG001|COMPLETED|Overall Study||219
8959281|NCT02519491|10022707|FG000|NOT COMPLETED|Overall Study||0
8959282|NCT02519491|10022708|FG001|NOT COMPLETED|Overall Study||0
8959283|NCT02519504|10022716|FG000|STARTED|Overall Study||319
8959284|NCT02519504|10022717|FG001|STARTED|Overall Study||247
8959285|NCT02519504|10022716|FG000|Attended Direct Testing|Overall Study||212
8959286|NCT02519504|10022717|FG001|Attended Direct Testing|Overall Study||149
8959287|NCT02519504|10022716|FG000|COMPLETED|Overall Study||206
8959288|NCT02519504|10022717|FG001|COMPLETED|Overall Study||144
8959289|NCT02519504|10022716|FG000|NOT COMPLETED|Overall Study||113
8959290|NCT02519504|10022717|FG001|NOT COMPLETED|Overall Study||103
8959291|NCT02519595|10022726|FG000|STARTED|Overall Study||58
8959292|NCT02519595|10022727|FG001|STARTED|Overall Study||57
8959293|NCT02519595|10022728|FG002|STARTED|Overall Study||56
8959294|NCT02519595|10022726|FG000|COMPLETED|Overall Study||50
8959295|NCT02519595|10022727|FG001|COMPLETED|Overall Study||35
8959296|NCT02519595|10022728|FG002|COMPLETED|Overall Study||40
8959297|NCT02519595|10022726|FG000|NOT COMPLETED|Overall Study||8
8959298|NCT02519595|10022727|FG001|NOT COMPLETED|Overall Study||22
8959299|NCT02519595|10022728|FG002|NOT COMPLETED|Overall Study||16
8959300|NCT02519621|10022739|FG000|STARTED|Overall Study||30
8959301|NCT02519621|10022740|FG001|STARTED|Overall Study||30
8959302|NCT02519621|10022741|FG002|STARTED|Overall Study||30
8959303|NCT02519621|10022739|FG000|COMPLETED|Overall Study||30
8959304|NCT02519621|10022740|FG001|COMPLETED|Overall Study||30
8959305|NCT02519621|10022741|FG002|COMPLETED|Overall Study||30
8959306|NCT02519621|10022739|FG000|NOT COMPLETED|Overall Study||0
8959307|NCT02519621|10022740|FG001|NOT COMPLETED|Overall Study||0
8959308|NCT02519621|10022741|FG002|NOT COMPLETED|Overall Study||0
8959309|NCT02519842|10022751|FG000|STARTED|Base Study: Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6.|38
8959310|NCT02519842|10022752|FG001|STARTED|Base Study: Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6.|37
8959311|NCT02519842|10022753|FG002|STARTED|Base Study: Cycle 1||0
8959312|NCT02519842|10022751|FG000|Treated|Base Study: Cycle 1||37
8959313|NCT02519842|10022752|FG001|Treated|Base Study: Cycle 1||34
8959314|NCT02519842|10022753|FG002|Treated|Base Study: Cycle 1||0
8959315|NCT02519842|10022751|FG000|COMPLETED|Base Study: Cycle 1||36
8959316|NCT02519842|10022752|FG001|COMPLETED|Base Study: Cycle 1||34
8959317|NCT02519842|10022753|FG002|COMPLETED|Base Study: Cycle 1||0
8959318|NCT02519842|10022751|FG000|NOT COMPLETED|Base Study: Cycle 1||2
8959319|NCT02519842|10022752|FG001|NOT COMPLETED|Base Study: Cycle 1||3
8959320|NCT02519842|10022753|FG002|NOT COMPLETED|Base Study: Cycle 1||0
8959321|NCT02519842|10022751|FG000|STARTED|Optional Extension: Cycles 2-6|27 participants from this arm in Cycle 1 entered optional Cycles 2-6|0
8959322|NCT02519842|10022752|FG001|STARTED|Optional Extension: Cycles 2-6|28 participants from this arm in Cycle 1 entered optional Cycles 2-6|0
8959323|NCT02519842|10022753|FG002|STARTED|Optional Extension: Cycles 2-6|Enrollment in Cycles 2-6 was optional.|55
8959324|NCT02519842|10022751|FG000|Treated|Optional Extension: Cycles 2-6||0
8959325|NCT02519842|10022752|FG001|Treated|Optional Extension: Cycles 2-6||0
8959326|NCT02519842|10022753|FG002|Treated|Optional Extension: Cycles 2-6||55
8959327|NCT02519842|10022751|FG000|COMPLETED|Optional Extension: Cycles 2-6||0
8959328|NCT02519842|10022752|FG001|COMPLETED|Optional Extension: Cycles 2-6||0
8959329|NCT02519842|10022753|FG002|COMPLETED|Optional Extension: Cycles 2-6||26
8959330|NCT02519842|10022751|FG000|NOT COMPLETED|Optional Extension: Cycles 2-6||0
8959331|NCT02519842|10022752|FG001|NOT COMPLETED|Optional Extension: Cycles 2-6||0
8959332|NCT02519842|10022753|FG002|NOT COMPLETED|Optional Extension: Cycles 2-6||29
8959333|NCT02519855|10022763|FG000|STARTED|Overall Study|Participants are included as treated|441
8959334|NCT02519855|10022764|FG001|STARTED|Overall Study|Participants are included as treated|441
8959335|NCT02519855|10022763|FG000|Vaccinated on Day 1|Overall Study||440
8959336|NCT02519855|10022764|FG001|Vaccinated on Day 1|Overall Study||441
8959337|NCT02519855|10022763|FG000|Vaccinated at Week 4|Overall Study||432
8959338|NCT02519855|10022764|FG001|Vaccinated at Week 4|Overall Study||424
8959339|NCT02519855|10022763|FG000|COMPLETED|Overall Study||438
8959340|NCT02519855|10022764|FG001|COMPLETED|Overall Study||437
8959341|NCT02519855|10022763|FG000|NOT COMPLETED|Overall Study||3
8959342|NCT02519855|10022764|FG001|NOT COMPLETED|Overall Study||4
8959343|NCT02520089|10022772|FG000|STARTED|Overall Study||12
8959344|NCT02520089|10022773|FG001|STARTED|Overall Study||11
8959345|NCT02520089|10022772|FG000|COMPLETED|Overall Study||9
8959346|NCT02520089|10022773|FG001|COMPLETED|Overall Study||7
8959347|NCT02520089|10022772|FG000|NOT COMPLETED|Overall Study||3
8959348|NCT02520089|10022773|FG001|NOT COMPLETED|Overall Study||4
8959349|NCT02520284|10022782|FG000|STARTED|Blinded Induction Phase: Up to Week 8||54
8959350|NCT02520284|10022783|FG001|STARTED|Blinded Induction Phase: Up to Week 8||56
8959351|NCT02520284|10022784|FG002|STARTED|Blinded Induction Phase: Up to Week 8||55
8959352|NCT02520284|10022782|FG000|COMPLETED|Blinded Induction Phase: Up to Week 8||52
8959353|NCT02520284|10022783|FG001|COMPLETED|Blinded Induction Phase: Up to Week 8|1 Participant completed Blinded Induction Phase but did not continue further in study.|52
8959354|NCT02520284|10022784|FG002|COMPLETED|Blinded Induction Phase: Up to Week 8|1 Participant completed Blinded Induction Phase but did not continue further in study.|53
8959355|NCT02520284|10022782|FG000|NOT COMPLETED|Blinded Induction Phase: Up to Week 8||2
8959356|NCT02520284|10022783|FG001|NOT COMPLETED|Blinded Induction Phase: Up to Week 8||4
8959357|NCT02520284|10022784|FG002|NOT COMPLETED|Blinded Induction Phase: Up to Week 8||2
8959358|NCT02520284|10022782|FG000|STARTED|Blinded Maintenance Phase: Up to Week 51|Participants achieving EBS remission and/or MCS response continued in Blinded Maintenance Phase.|20
8959359|NCT02520284|10022783|FG001|STARTED|Blinded Maintenance Phase: Up to Week 51|Participants achieving EBS remission and/or MCS response continued in Blinded Maintenance Phase.|16
8959360|NCT02520284|10022784|FG002|STARTED|Blinded Maintenance Phase: Up to Week 51|Participants achieving EBS remission and/or MCS response continued in Blinded Maintenance Phase.|18
8959361|NCT02520284|10022782|FG000|COMPLETED|Blinded Maintenance Phase: Up to Week 51||0
8959362|NCT02520284|10022783|FG001|COMPLETED|Blinded Maintenance Phase: Up to Week 51||0
8959363|NCT02520284|10022784|FG002|COMPLETED|Blinded Maintenance Phase: Up to Week 51||0
8959364|NCT02520284|10022782|FG000|NOT COMPLETED|Blinded Maintenance Phase: Up to Week 51||20
8959365|NCT02520284|10022783|FG001|NOT COMPLETED|Blinded Maintenance Phase: Up to Week 51||16
8959366|NCT02520284|10022784|FG002|NOT COMPLETED|Blinded Maintenance Phase: Up to Week 51||18
8959367|NCT02520284|10022782|FG000|STARTED|Open-Label MaintenancePhase: Upto Week51|Participants achieving neither EBS remission nor MCS response entered Open-Label Maintenance Phase.|32
8959368|NCT02520284|10022783|FG001|STARTED|Open-Label MaintenancePhase: Upto Week51|Participants achieving neither EBS remission nor MCS response entered Open-Label Maintenance Phase.|35
8959369|NCT02520284|10022784|FG002|STARTED|Open-Label MaintenancePhase: Upto Week51|Participants achieving neither EBS remission nor MCS response entered Open-Label Maintenance Phase.|34
8959370|NCT02520284|10022782|FG000|COMPLETED|Open-Label MaintenancePhase: Upto Week51||0
8959371|NCT02520284|10022783|FG001|COMPLETED|Open-Label MaintenancePhase: Upto Week51||0
8959372|NCT02520284|10022784|FG002|COMPLETED|Open-Label MaintenancePhase: Upto Week51||0
8959373|NCT02520284|10022782|FG000|NOT COMPLETED|Open-Label MaintenancePhase: Upto Week51||32
8959374|NCT02520284|10022783|FG001|NOT COMPLETED|Open-Label MaintenancePhase: Upto Week51||35
8959375|NCT02520284|10022784|FG002|NOT COMPLETED|Open-Label MaintenancePhase: Upto Week51||34
8959376|NCT02520310|10022798|FG000|STARTED|At 30 Days Clinical Follow-up||30
8959377|NCT02520310|10022798|FG000|COMPLETED|At 30 Days Clinical Follow-up||30
8959378|NCT02520310|10022798|FG000|NOT COMPLETED|At 30 Days Clinical Follow-up||0
8959379|NCT02520310|10022798|FG000|STARTED|At 6 Months Clinical Follow-up||30
8959380|NCT02520310|10022798|FG000|COMPLETED|At 6 Months Clinical Follow-up||29
8959381|NCT02520310|10022798|FG000|NOT COMPLETED|At 6 Months Clinical Follow-up||1
8959382|NCT02520310|10022798|FG000|STARTED|At 1 Year Clinical Follow-up||29
8959383|NCT02520310|10022798|FG000|COMPLETED|At 1 Year Clinical Follow-up||28
8959384|NCT02520310|10022798|FG000|NOT COMPLETED|At 1 Year Clinical Follow-up||1
8959385|NCT02520310|10022798|FG000|STARTED|At 2 Year Clinical Follow-up||28
8631470|NCT00540423|9671382|FG002|COMPLETED|Open-Label Treatment Period||20
8959386|NCT02520310|10022798|FG000|COMPLETED|At 2 Year Clinical Follow-up||28
8959387|NCT02520310|10022798|FG000|NOT COMPLETED|At 2 Year Clinical Follow-up||0
8959388|NCT02520310|10022798|FG000|STARTED|AT 3 Year Clinical Follow-up||28
8959389|NCT02520310|10022798|FG000|COMPLETED|AT 3 Year Clinical Follow-up||24
8959390|NCT02520310|10022798|FG000|NOT COMPLETED|AT 3 Year Clinical Follow-up||4
8959391|NCT02520310|10022798|FG000|STARTED|AT 4 Year Clinical Follow-up||24
8959392|NCT02520310|10022798|FG000|COMPLETED|AT 4 Year Clinical Follow-up||22
8959393|NCT02520310|10022798|FG000|NOT COMPLETED|AT 4 Year Clinical Follow-up||2
8959394|NCT02520388|10022806|FG000|STARTED|Overall Study||82
8959395|NCT02520388|10022807|FG001|STARTED|Overall Study||81
8959396|NCT02520388|10022806|FG000|Treated|Overall Study||81
8959397|NCT02520388|10022807|FG001|Treated|Overall Study||80
8959398|NCT02520388|10022806|FG000|COMPLETED|Overall Study||73
8959399|NCT02520388|10022807|FG001|COMPLETED|Overall Study||65
8959400|NCT02520388|10022806|FG000|NOT COMPLETED|Overall Study||9
8959401|NCT02520388|10022807|FG001|NOT COMPLETED|Overall Study||16
8959402|NCT02520414|10022813|FG000|STARTED|Overall Study||10
8959403|NCT02520414|10022813|FG000|COMPLETED|Overall Study||10
8959404|NCT02520414|10022813|FG000|NOT COMPLETED|Overall Study||0
8959405|NCT02520518|10022821|FG000|STARTED|Overall Study||3
8959406|NCT02520518|10022822|FG001|STARTED|Overall Study||1
8959407|NCT02520518|10022823|FG002|STARTED|Overall Study||3
8959408|NCT02520518|10022824|FG003|STARTED|Overall Study||2
8959409|NCT02520518|10022821|FG000|COMPLETED|Overall Study||3
8959410|NCT02520518|10022822|FG001|COMPLETED|Overall Study||1
8959411|NCT02520518|10022823|FG002|COMPLETED|Overall Study||1
8959412|NCT02520518|10022824|FG003|COMPLETED|Overall Study||1
8959413|NCT02520518|10022821|FG000|NOT COMPLETED|Overall Study||0
8959414|NCT02520518|10022822|FG001|NOT COMPLETED|Overall Study||0
8959415|NCT02520518|10022823|FG002|NOT COMPLETED|Overall Study||2
8959416|NCT02520518|10022824|FG003|NOT COMPLETED|Overall Study||1
8959417|NCT02520531|10022838|FG000|STARTED|Overall Study||42
8959418|NCT02520531|10022839|FG001|STARTED|Overall Study||42
8959419|NCT02520531|10022838|FG000|COMPLETED|Overall Study||36
8959420|NCT02520531|10022839|FG001|COMPLETED|Overall Study||36
8959421|NCT02520531|10022838|FG000|NOT COMPLETED|Overall Study||6
8959422|NCT02520531|10022839|FG001|NOT COMPLETED|Overall Study||6
8959423|NCT02521181|10022848|FG000|STARTED|Overall Study||52
8959424|NCT02521181|10022849|FG001|STARTED|Overall Study||90
8959425|NCT02521181|10022850|FG002|STARTED|Overall Study||52
8959426|NCT02521181|10022848|FG000|COMPLETED|Overall Study|All patients included in primary analysis|52
8959427|NCT02521181|10022849|FG001|COMPLETED|Overall Study|All patients included in primary analysis|90
8959428|NCT02521181|10022850|FG002|COMPLETED|Overall Study|All patients included in primary analysis|52
8959429|NCT02521181|10022848|FG000|NOT COMPLETED|Overall Study||0
8959430|NCT02521181|10022849|FG001|NOT COMPLETED|Overall Study||0
8959431|NCT02521181|10022850|FG002|NOT COMPLETED|Overall Study||0
8959432|NCT02521259|10022860|FG000|STARTED|Overall Study||35
8959433|NCT02521259|10022861|FG001|STARTED|Overall Study||33
8959434|NCT02521259|10022860|FG000|COMPLETED|Overall Study||34
8959435|NCT02521259|10022861|FG001|COMPLETED|Overall Study||28
8959436|NCT02521259|10022860|FG000|NOT COMPLETED|Overall Study||1
8959437|NCT02521259|10022861|FG001|NOT COMPLETED|Overall Study||5
8959438|NCT02521376|10022871|FG000|STARTED|Overall Study||8
8959439|NCT02521376|10022872|FG001|STARTED|Overall Study||18
8959440|NCT02521376|10022873|FG002|STARTED|Overall Study||10
8959441|NCT02521376|10022874|FG003|STARTED|Overall Study||20
8959442|NCT02521376|10022871|FG000|COMPLETED|Overall Study||7
8959443|NCT02521376|10022872|FG001|COMPLETED|Overall Study||18
8959444|NCT02521376|10022873|FG002|COMPLETED|Overall Study||10
8959445|NCT02521376|10022874|FG003|COMPLETED|Overall Study||20
8959446|NCT02521376|10022871|FG000|NOT COMPLETED|Overall Study||1
8959447|NCT02521376|10022872|FG001|NOT COMPLETED|Overall Study||0
8959448|NCT02521376|10022873|FG002|NOT COMPLETED|Overall Study||0
8959449|NCT02521376|10022874|FG003|NOT COMPLETED|Overall Study||0
8959450|NCT02521766|10022894|FG000|STARTED|Overall Study||49
8959451|NCT02521766|10022895|FG001|STARTED|Overall Study||65
8959452|NCT02521766|10022894|FG000|Per Protocol|Overall Study||47
8959453|NCT02521766|10022895|FG001|Per Protocol|Overall Study||65
8959454|NCT02521766|10022894|FG000|COMPLETED|Overall Study||44
8959455|NCT02521766|10022895|FG001|COMPLETED|Overall Study||62
8959456|NCT02521766|10022894|FG000|NOT COMPLETED|Overall Study||5
8959457|NCT02521766|10022895|FG001|NOT COMPLETED|Overall Study||3
8959458|NCT02521792|10022912|FG000|STARTED|Overall Study||6
8959459|NCT02521792|10022912|FG000|Received Treatment|Overall Study||4
8959460|NCT02521792|10022912|FG000|COMPLETED|Overall Study||0
8959461|NCT02521792|10022912|FG000|NOT COMPLETED|Overall Study||6
8959462|NCT02521870|10022924|FG000|STARTED|Phase 1: Dose Escalation||6
8959463|NCT02521870|10022925|FG001|STARTED|Phase 1: Dose Escalation||5
8959464|NCT02521870|10022926|FG002|STARTED|Phase 1: Dose Escalation||5
8959465|NCT02521870|10022927|FG003|STARTED|Phase 1: Dose Escalation||6
8959466|NCT02521870|10022928|FG004|STARTED|Phase 1: Dose Escalation||0
8959467|NCT02521870|10022929|FG005|STARTED|Phase 1: Dose Escalation||0
8959468|NCT02521870|10022930|FG006|STARTED|Phase 1: Dose Escalation||0
8959469|NCT02521870|10022931|FG007|STARTED|Phase 1: Dose Escalation||0
8959470|NCT02521870|10022932|FG008|STARTED|Phase 1: Dose Escalation||0
8959471|NCT02521870|10022933|FG009|STARTED|Phase 1: Dose Escalation||0
8959472|NCT02521870|10022934|FG010|STARTED|Phase 1: Dose Escalation||0
8959473|NCT02521870|10022935|FG011|STARTED|Phase 1: Dose Escalation||0
8959474|NCT02521870|10022924|FG000|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||3
8959475|NCT02521870|10022925|FG001|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||3
8959476|NCT02521870|10022926|FG002|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0
8959477|NCT02521870|10022927|FG003|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||1
8959478|NCT02521870|10022928|FG004|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0
8959479|NCT02521870|10022929|FG005|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0
8959480|NCT02521870|10022930|FG006|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0
8959481|NCT02521870|10022931|FG007|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0
8959482|NCT02521870|10022932|FG008|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0
8959483|NCT02521870|10022933|FG009|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0
8959484|NCT02521870|10022934|FG010|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0
8959485|NCT02521870|10022935|FG011|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0
8959486|NCT02521870|10022924|FG000|COMPLETED|Phase 1: Dose Escalation||1
8959487|NCT02521870|10022925|FG001|COMPLETED|Phase 1: Dose Escalation||1
8959488|NCT02521870|10022926|FG002|COMPLETED|Phase 1: Dose Escalation||1
8959489|NCT02521870|10022927|FG003|COMPLETED|Phase 1: Dose Escalation||0
8959490|NCT02521870|10022928|FG004|COMPLETED|Phase 1: Dose Escalation||0
8959491|NCT02521870|10022929|FG005|COMPLETED|Phase 1: Dose Escalation||0
8959492|NCT02521870|10022930|FG006|COMPLETED|Phase 1: Dose Escalation||0
8959493|NCT02521870|10022931|FG007|COMPLETED|Phase 1: Dose Escalation||0
8959494|NCT02521870|10022932|FG008|COMPLETED|Phase 1: Dose Escalation||0
8959495|NCT02521870|10022933|FG009|COMPLETED|Phase 1: Dose Escalation||0
8959496|NCT02521870|10022934|FG010|COMPLETED|Phase 1: Dose Escalation||0
8959497|NCT02521870|10022935|FG011|COMPLETED|Phase 1: Dose Escalation||0
8959498|NCT02521870|10022924|FG000|NOT COMPLETED|Phase 1: Dose Escalation||5
8959499|NCT02521870|10022925|FG001|NOT COMPLETED|Phase 1: Dose Escalation||4
8959500|NCT02521870|10022926|FG002|NOT COMPLETED|Phase 1: Dose Escalation||4
8959501|NCT02521870|10022927|FG003|NOT COMPLETED|Phase 1: Dose Escalation||6
8959502|NCT02521870|10022928|FG004|NOT COMPLETED|Phase 1: Dose Escalation||0
8959503|NCT02521870|10022929|FG005|NOT COMPLETED|Phase 1: Dose Escalation||0
8959504|NCT02521870|10022930|FG006|NOT COMPLETED|Phase 1: Dose Escalation||0
8959505|NCT02521870|10022931|FG007|NOT COMPLETED|Phase 1: Dose Escalation||0
8959506|NCT02521870|10022932|FG008|NOT COMPLETED|Phase 1: Dose Escalation||0
8959507|NCT02521870|10022933|FG009|NOT COMPLETED|Phase 1: Dose Escalation||0
8959508|NCT02521870|10022934|FG010|NOT COMPLETED|Phase 1: Dose Escalation||0
8959509|NCT02521870|10022935|FG011|NOT COMPLETED|Phase 1: Dose Escalation||0
8959510|NCT02521870|10022924|FG000|STARTED|Phase 2: Dose Expansion||0
8959511|NCT02521870|10022925|FG001|STARTED|Phase 2: Dose Expansion||0
8959512|NCT02521870|10022926|FG002|STARTED|Phase 2: Dose Expansion||0
8959513|NCT02521870|10022927|FG003|STARTED|Phase 2: Dose Expansion||0
8959514|NCT02521870|10022928|FG004|STARTED|Phase 2: Dose Expansion||57
8959515|NCT02521870|10022929|FG005|STARTED|Phase 2: Dose Expansion||25
8959516|NCT02521870|10022930|FG006|STARTED|Phase 2: Dose Expansion||23
8959517|NCT02521870|10022931|FG007|STARTED|Phase 2: Dose Expansion||9
8959518|NCT02521870|10022932|FG008|STARTED|Phase 2: Dose Expansion||24
8959519|NCT02521870|10022933|FG009|STARTED|Phase 2: Dose Expansion||28
8959520|NCT02521870|10022934|FG010|STARTED|Phase 2: Dose Expansion||23
8959521|NCT02521870|10022935|FG011|STARTED|Phase 2: Dose Expansion||30
8959522|NCT02521870|10022924|FG000|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||0
8959523|NCT02521870|10022925|FG001|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||0
8959524|NCT02521870|10022926|FG002|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||0
8959525|NCT02521870|10022927|FG003|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||0
8959526|NCT02521870|10022928|FG004|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||25
8959527|NCT02521870|10022929|FG005|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||7
8959528|NCT02521870|10022930|FG006|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||3
8959529|NCT02521870|10022931|FG007|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||2
8959530|NCT02521870|10022932|FG008|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||9
8959531|NCT02521870|10022933|FG009|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||5
8959532|NCT02521870|10022934|FG010|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||1
8959533|NCT02521870|10022935|FG011|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||11
8959534|NCT02521870|10022924|FG000|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
8959535|NCT02521870|10022925|FG001|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
8959536|NCT02521870|10022926|FG002|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
8959537|NCT02521870|10022927|FG003|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
8959538|NCT02521870|10022928|FG004|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||7
8959539|NCT02521870|10022929|FG005|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||1
8959540|NCT02521870|10022930|FG006|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
8959541|NCT02521870|10022931|FG007|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
8959542|NCT02521870|10022932|FG008|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
8959543|NCT02521870|10022933|FG009|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
8959544|NCT02521870|10022934|FG010|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
8959545|NCT02521870|10022935|FG011|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
8959546|NCT02521870|10022924|FG000|COMPLETED|Phase 2: Dose Expansion||0
8959547|NCT02521870|10022925|FG001|COMPLETED|Phase 2: Dose Expansion||0
8959548|NCT02521870|10022926|FG002|COMPLETED|Phase 2: Dose Expansion||0
8959549|NCT02521870|10022927|FG003|COMPLETED|Phase 2: Dose Expansion||0
8959550|NCT02521870|10022928|FG004|COMPLETED|Phase 2: Dose Expansion||5
8959551|NCT02521870|10022929|FG005|COMPLETED|Phase 2: Dose Expansion||0
8959552|NCT02521870|10022930|FG006|COMPLETED|Phase 2: Dose Expansion||0
8959553|NCT02521870|10022931|FG007|COMPLETED|Phase 2: Dose Expansion||0
8959554|NCT02521870|10022932|FG008|COMPLETED|Phase 2: Dose Expansion|4 participants completed pembrolizumab treatment (up to 35 cycles).|2
8959555|NCT02521870|10022933|FG009|COMPLETED|Phase 2: Dose Expansion||0
8959556|NCT02521870|10022934|FG010|COMPLETED|Phase 2: Dose Expansion||0
8959557|NCT02521870|10022935|FG011|COMPLETED|Phase 2: Dose Expansion||0
8959558|NCT02521870|10022924|FG000|NOT COMPLETED|Phase 2: Dose Expansion||0
8959559|NCT02521870|10022925|FG001|NOT COMPLETED|Phase 2: Dose Expansion||0
8959560|NCT02521870|10022926|FG002|NOT COMPLETED|Phase 2: Dose Expansion||0
8959561|NCT02521870|10022927|FG003|NOT COMPLETED|Phase 2: Dose Expansion||0
8959562|NCT02521870|10022928|FG004|NOT COMPLETED|Phase 2: Dose Expansion||52
8959563|NCT02521870|10022929|FG005|NOT COMPLETED|Phase 2: Dose Expansion||25
8959564|NCT02521870|10022930|FG006|NOT COMPLETED|Phase 2: Dose Expansion||23
8959565|NCT02521870|10022931|FG007|NOT COMPLETED|Phase 2: Dose Expansion||9
8959566|NCT02521870|10022932|FG008|NOT COMPLETED|Phase 2: Dose Expansion||22
8959567|NCT02521870|10022933|FG009|NOT COMPLETED|Phase 2: Dose Expansion||28
8959568|NCT02521870|10022934|FG010|NOT COMPLETED|Phase 2: Dose Expansion||23
8959569|NCT02521870|10022935|FG011|NOT COMPLETED|Phase 2: Dose Expansion||30
8959570|NCT02521948|10022965|FG000|STARTED|Overall Study||50
8959571|NCT02521948|10022965|FG000|COMPLETED|Overall Study||37
8959572|NCT02521948|10022965|FG000|NOT COMPLETED|Overall Study||13
8959573|NCT02521974|10022974|FG000|STARTED|Overall Study||50
8959574|NCT02521974|10022975|FG001|STARTED|Overall Study||114
8959575|NCT02521974|10022974|FG000|COMPLETED|Overall Study||47
8959576|NCT02521974|10022975|FG001|COMPLETED|Overall Study||110
8959577|NCT02521974|10022974|FG000|NOT COMPLETED|Overall Study||3
8959578|NCT02521974|10022975|FG001|NOT COMPLETED|Overall Study||4
8959579|NCT02522104|10022985|FG000|STARTED|Overall Study||13
8959580|NCT02522104|10022986|FG001|STARTED|Overall Study||15
8959581|NCT02522104|10022987|FG002|STARTED|Overall Study||12
8959582|NCT02522104|10022985|FG000|COMPLETED|Overall Study||10
8959583|NCT02522104|10022986|FG001|COMPLETED|Overall Study||12
8959584|NCT02522104|10022987|FG002|COMPLETED|Overall Study||5
8959585|NCT02522104|10022985|FG000|NOT COMPLETED|Overall Study||3
8959586|NCT02522104|10022986|FG001|NOT COMPLETED|Overall Study||3
8959587|NCT02522104|10022987|FG002|NOT COMPLETED|Overall Study||7
8959588|NCT02522286|10023002|FG000|STARTED|Overall Study||78
8959589|NCT02522286|10023003|FG001|STARTED|Overall Study||75
8959590|NCT02522286|10023004|FG002|STARTED|Overall Study||75
8959591|NCT02522286|10023005|FG003|STARTED|Overall Study||78
8959592|NCT02522286|10023002|FG000|COMPLETED|Overall Study||75
8959593|NCT02522286|10023003|FG001|COMPLETED|Overall Study||75
8959594|NCT02522286|10023004|FG002|COMPLETED|Overall Study||75
8959595|NCT02522286|10023005|FG003|COMPLETED|Overall Study||75
8959596|NCT02522286|10023002|FG000|NOT COMPLETED|Overall Study||3
8959597|NCT02522286|10023003|FG001|NOT COMPLETED|Overall Study||0
8959598|NCT02522286|10023004|FG002|NOT COMPLETED|Overall Study||0
8959599|NCT02522286|10023005|FG003|NOT COMPLETED|Overall Study||3
8959600|NCT02522299|10023017|FG000|STARTED|Overall Study||22
8959601|NCT02522299|10023018|FG001|STARTED|Overall Study||22
8959602|NCT02522299|10023017|FG000|COMPLETED|Overall Study||18
8959603|NCT02522299|10023018|FG001|COMPLETED|Overall Study||21
8959604|NCT02522299|10023017|FG000|NOT COMPLETED|Overall Study||4
8959605|NCT02522299|10023018|FG001|NOT COMPLETED|Overall Study||1
8959606|NCT02522325|10023038|FG000|STARTED|Overall Study||15
8959607|NCT02522325|10023039|FG001|STARTED|Overall Study||15
8959608|NCT02522325|10023038|FG000|COMPLETED|Overall Study||15
8959609|NCT02522325|10023039|FG001|COMPLETED|Overall Study||14
8959610|NCT02522325|10023038|FG000|NOT COMPLETED|Overall Study||0
8959611|NCT02522325|10023039|FG001|NOT COMPLETED|Overall Study||1
8959612|NCT02522377|10023047|FG000|STARTED|Overall Study||7
8959613|NCT02522377|10023048|FG001|STARTED|Overall Study||5
8959614|NCT02522377|10023047|FG000|COMPLETED|Overall Study||3
8959615|NCT02522377|10023048|FG001|COMPLETED|Overall Study||5
8959616|NCT02522377|10023047|FG000|NOT COMPLETED|Overall Study||4
8959617|NCT02522377|10023048|FG001|NOT COMPLETED|Overall Study||0
8959618|NCT02522403|10023056|FG000|STARTED|Overall Study||17
8959619|NCT02522403|10023057|FG001|STARTED|Overall Study||19
8959620|NCT02522403|10023056|FG000|COMPLETED|Overall Study||13
8959621|NCT02522403|10023057|FG001|COMPLETED|Overall Study||13
8959622|NCT02522403|10023056|FG000|NOT COMPLETED|Overall Study||4
8959623|NCT02522403|10023057|FG001|NOT COMPLETED|Overall Study||6
8959624|NCT02522442|10023065|FG000|STARTED|Overall Study||26
8959625|NCT02522442|10023066|FG001|STARTED|Overall Study||22
8959626|NCT02522442|10023065|FG000|COMPLETED|Overall Study||26
8959627|NCT02522442|10023066|FG001|COMPLETED|Overall Study||22
8959628|NCT02522442|10023065|FG000|NOT COMPLETED|Overall Study||0
8959629|NCT02522442|10023066|FG001|NOT COMPLETED|Overall Study||0
8959630|NCT02522481|10023072|FG000|STARTED|Overall Study||175
8959631|NCT02522481|10023072|FG000|COMPLETED|Overall Study||172
8959632|NCT02522481|10023072|FG000|NOT COMPLETED|Overall Study||3
8959633|NCT02522494|10023085|FG000|STARTED|Overall Study||51
8959634|NCT02522494|10023086|FG001|STARTED|Overall Study||51
8959635|NCT02522494|10023085|FG000|Post-CVT Visit Interview|Overall Study||37
8959636|NCT02522494|10023086|FG001|Post-CVT Visit Interview|Overall Study||48
8959637|NCT02522494|10023085|FG000|4-Week Follow Up|Overall Study||37
8959638|NCT02522494|10023086|FG001|4-Week Follow Up|Overall Study||46
8959639|NCT02522494|10023085|FG000|COMPLETED|Overall Study||37
8959640|NCT02522494|10023086|FG001|COMPLETED|Overall Study||46
8959641|NCT02522494|10023085|FG000|NOT COMPLETED|Overall Study||14
8959642|NCT02522494|10023086|FG001|NOT COMPLETED|Overall Study||5
8959643|NCT02522624|10023094|FG000|STARTED|Overall Study||165
8959644|NCT02522624|10023095|FG001|STARTED|Overall Study||163
8959645|NCT02522624|10023094|FG000|COMPLETED|Overall Study|Discontinued intervention due to technical failure (n=1)|164
8959646|NCT02522624|10023095|FG001|COMPLETED|Overall Study||163
8959647|NCT02522624|10023094|FG000|NOT COMPLETED|Overall Study||1
8959648|NCT02522624|10023095|FG001|NOT COMPLETED|Overall Study||0
8959649|NCT02522728|10023103|FG000|STARTED|Overall Study||28
8959650|NCT02522728|10023104|FG001|STARTED|Overall Study||30
8959651|NCT02522728|10023103|FG000|COMPLETED|Overall Study||16
8959652|NCT02522728|10023104|FG001|COMPLETED|Overall Study||19
8959653|NCT02522728|10023103|FG000|NOT COMPLETED|Overall Study||12
8959654|NCT02522728|10023104|FG001|NOT COMPLETED|Overall Study||11
8959655|NCT02522767|10023112|FG000|STARTED|Double-blind||114
8959656|NCT02522767|10023113|FG001|STARTED|Double-blind||114
8959657|NCT02522767|10023112|FG000|COMPLETED|Double-blind||103
8959658|NCT02522767|10023113|FG001|COMPLETED|Double-blind||90
8959659|NCT02522767|10023112|FG000|NOT COMPLETED|Double-blind||11
8959660|NCT02522767|10023113|FG001|NOT COMPLETED|Double-blind||24
8959661|NCT02522767|10023112|FG000|STARTED|Open-label|Subjects provided their consent to receive additional 8 weeks open-label treatment with mesalamine.|88
8959662|NCT02522767|10023113|FG001|STARTED|Open-label|Subjects provided their consent to receive additional 8 weeks open-label treatment with mesalamine.|82
8959663|NCT02522767|10023112|FG000|COMPLETED|Open-label||83
8959664|NCT02522767|10023113|FG001|COMPLETED|Open-label||75
8959665|NCT02522767|10023112|FG000|NOT COMPLETED|Open-label||5
8959666|NCT02522767|10023113|FG001|NOT COMPLETED|Open-label||7
8959667|NCT02522780|10023123|FG000|STARTED|Overall Study||138
8959668|NCT02522780|10023124|FG001|STARTED|Overall Study||138
8959669|NCT02522780|10023123|FG000|Treated|Overall Study||137
8959670|NCT02522780|10023124|FG001|Treated|Overall Study||135
8959671|NCT02522780|10023123|FG000|Intention-to-treat (ITT) Population|Overall Study||136
8959672|NCT02522780|10023124|FG001|Intention-to-treat (ITT) Population|Overall Study||136
8959673|NCT02522780|10023123|FG000|COMPLETED|Overall Study||121
8959674|NCT02522780|10023124|FG001|COMPLETED|Overall Study||111
8959675|NCT02522780|10023123|FG000|NOT COMPLETED|Overall Study||17
8959676|NCT02522780|10023124|FG001|NOT COMPLETED|Overall Study||27
8959677|NCT02522845|10023133|FG000|STARTED|Overall Study||100
8959678|NCT02522845|10023134|FG001|STARTED|Overall Study||104
8959679|NCT02522845|10023133|FG000|COMPLETED|Overall Study||63
8959680|NCT02522845|10023134|FG001|COMPLETED|Overall Study||69
8959681|NCT02522845|10023133|FG000|NOT COMPLETED|Overall Study||37
8959682|NCT02522845|10023134|FG001|NOT COMPLETED|Overall Study||35
8959683|NCT02522884|10023140|FG000|STARTED|Overall Study|Intent to Treat (ITT) population.|213
8959684|NCT02522884|10023140|FG000|COMPLETED|Overall Study|Completed 12-month follow-up.|195
8959685|NCT02522884|10023140|FG000|NOT COMPLETED|Overall Study||18
8959686|NCT02523196|10023144|FG000|STARTED|Overall Study||20
8959687|NCT02523196|10023144|FG000|Received HVPG|Overall Study||20
8959688|NCT02523196|10023144|FG000|Received HQ Shunt|Overall Study||20
8959689|NCT02523196|10023144|FG000|COMPLETED|Overall Study||20
8959690|NCT02523196|10023144|FG000|NOT COMPLETED|Overall Study||0
8959691|NCT02523235|10023155|FG000|STARTED|Overall Study||56
8959692|NCT02523235|10023156|FG001|STARTED|Overall Study||58
8959693|NCT02523235|10023155|FG000|COMPLETED|Overall Study||56
8959694|NCT02523235|10023156|FG001|COMPLETED|Overall Study||58
8959695|NCT02523235|10023155|FG000|NOT COMPLETED|Overall Study||0
8959696|NCT02523235|10023156|FG001|NOT COMPLETED|Overall Study||0
8959697|NCT02523586|10023163|FG000|STARTED|Overall Study||14
8959698|NCT02523586|10023163|FG000|COMPLETED|Overall Study||10
8959699|NCT02523586|10023163|FG000|NOT COMPLETED|Overall Study||4
8959700|NCT02523599|10023176|FG000|STARTED|Overall Study||204
8959701|NCT02523599|10023177|FG001|STARTED|Overall Study||101
8959702|NCT02523599|10023176|FG000|Randomized But Not Treated|Overall Study||1
8959703|NCT02523599|10023177|FG001|Randomized But Not Treated|Overall Study||0
8959704|NCT02523599|10023176|FG000|COMPLETED|Overall Study||196
8959705|NCT02523599|10023177|FG001|COMPLETED|Overall Study||100
8959706|NCT02523599|10023176|FG000|NOT COMPLETED|Overall Study||8
8959707|NCT02523599|10023177|FG001|NOT COMPLETED|Overall Study||1
8959708|NCT02523690|10023185|FG000|STARTED|Overall Study||3
8959709|NCT02523690|10023186|FG001|STARTED|Overall Study||2
8959710|NCT02523690|10023185|FG000|COMPLETED|Overall Study||3
8959711|NCT02523690|10023186|FG001|COMPLETED|Overall Study||2
8959712|NCT02523690|10023185|FG000|NOT COMPLETED|Overall Study||0
8959713|NCT02523690|10023186|FG001|NOT COMPLETED|Overall Study||0
8959714|NCT02523924|10023192|FG000|STARTED|Overall Study||31
8959715|NCT02523924|10023192|FG000|COMPLETED|Overall Study||31
8959716|NCT02523924|10023192|FG000|NOT COMPLETED|Overall Study||0
8959717|NCT02524054|10023198|FG000|STARTED|Overall Study||7
8959718|NCT02524054|10023199|FG001|STARTED|Overall Study||9
8959719|NCT02524054|10023200|FG002|STARTED|Overall Study||8
8959720|NCT02524054|10023198|FG000|COMPLETED|Overall Study||7
8959721|NCT02524054|10023199|FG001|COMPLETED|Overall Study||9
8959722|NCT02524054|10023200|FG002|COMPLETED|Overall Study||8
8959723|NCT02524054|10023198|FG000|NOT COMPLETED|Overall Study||0
8959724|NCT02524054|10023199|FG001|NOT COMPLETED|Overall Study||0
8959725|NCT02524054|10023200|FG002|NOT COMPLETED|Overall Study||0
8959726|NCT02524106|10023212|FG000|STARTED|Overall Study||6
8959727|NCT02524106|10023213|FG001|STARTED|Overall Study||5
8959728|NCT02524106|10023212|FG000|COMPLETED|Overall Study||6
8959729|NCT02524106|10023213|FG001|COMPLETED|Overall Study||5
8959730|NCT02524106|10023212|FG000|NOT COMPLETED|Overall Study||0
8959731|NCT02524106|10023213|FG001|NOT COMPLETED|Overall Study||0
8959732|NCT02524119|10023219|FG000|STARTED|Overall Study||5
8959733|NCT02524119|10023219|FG000|COMPLETED|Overall Study||5
8959734|NCT02524119|10023219|FG000|NOT COMPLETED|Overall Study||0
8959735|NCT02524145|10023226|FG000|STARTED|Overall Study||15
8959736|NCT02524145|10023227|FG001|STARTED|Overall Study||15
8959737|NCT02524145|10023228|FG002|STARTED|Overall Study||10
8959738|NCT02524145|10023226|FG000|COMPLETED|Overall Study||13
8959739|NCT02524145|10023227|FG001|COMPLETED|Overall Study||13
8959740|NCT02524145|10023228|FG002|COMPLETED|Overall Study||7
8959741|NCT02524145|10023226|FG000|NOT COMPLETED|Overall Study||2
8959742|NCT02524145|10023227|FG001|NOT COMPLETED|Overall Study||2
8959743|NCT02524145|10023228|FG002|NOT COMPLETED|Overall Study||3
8959744|NCT02524158|10023238|FG000|STARTED|12-weeks Assessment||76
8959745|NCT02524158|10023239|FG001|STARTED|12-weeks Assessment||76
8959746|NCT02524158|10023238|FG000|COMPLETED|12-weeks Assessment||57
8959747|NCT02524158|10023239|FG001|COMPLETED|12-weeks Assessment||63
8959748|NCT02524158|10023238|FG000|NOT COMPLETED|12-weeks Assessment||19
8959749|NCT02524158|10023239|FG001|NOT COMPLETED|12-weeks Assessment||13
8959750|NCT02524158|10023238|FG000|STARTED|6-month Assessment||76
8959751|NCT02524158|10023239|FG001|STARTED|6-month Assessment||76
8959752|NCT02524158|10023238|FG000|COMPLETED|6-month Assessment||54
8959753|NCT02524158|10023239|FG001|COMPLETED|6-month Assessment||55
8959754|NCT02524158|10023238|FG000|NOT COMPLETED|6-month Assessment||22
8959755|NCT02524158|10023239|FG001|NOT COMPLETED|6-month Assessment||21
8959756|NCT02524418|10023248|FG000|STARTED|Overall Study||88
8959757|NCT02524418|10023248|FG000|COMPLETED|Overall Study||75
8959758|NCT02524418|10023248|FG000|NOT COMPLETED|Overall Study||13
8959759|NCT02524561|10023258|FG000|STARTED|Baseline: Pre-randomization Mammogram|Consented to MDBHAS|168
8959760|NCT02524561|10023259|FG001|STARTED|Baseline: Pre-randomization Mammogram|Consented to MDBHAS|162
8959761|NCT02524561|10023260|FG002|STARTED|Baseline: Pre-randomization Mammogram|Consented to MDBHAS.|187
8959762|NCT02524561|10023258|FG000|Obtained Baseline Mammogram|Baseline: Pre-randomization Mammogram||137
8959763|NCT02524561|10023259|FG001|Obtained Baseline Mammogram|Baseline: Pre-randomization Mammogram||133
8959764|NCT02524561|10023260|FG002|Obtained Baseline Mammogram|Baseline: Pre-randomization Mammogram||151
8959765|NCT02524561|10023258|FG000|COMPLETED|Baseline: Pre-randomization Mammogram||168
8959766|NCT02524561|10023259|FG001|COMPLETED|Baseline: Pre-randomization Mammogram||162
8959767|NCT02524561|10023260|FG002|COMPLETED|Baseline: Pre-randomization Mammogram||187
8959768|NCT02524561|10023258|FG000|NOT COMPLETED|Baseline: Pre-randomization Mammogram||0
8959769|NCT02524561|10023259|FG001|NOT COMPLETED|Baseline: Pre-randomization Mammogram||0
8959770|NCT02524561|10023260|FG002|NOT COMPLETED|Baseline: Pre-randomization Mammogram||0
8959771|NCT02524561|10023258|FG000|STARTED|Year 1: Post Randomization Mammograms|Consented to MDBHAS|168
8959772|NCT02524561|10023259|FG001|STARTED|Year 1: Post Randomization Mammograms|Consented to MDBHAS|162
8959773|NCT02524561|10023260|FG002|STARTED|Year 1: Post Randomization Mammograms|Consented to MDBHAS|187
8959774|NCT02524561|10023258|FG000|Obtained Mammogam|Year 1: Post Randomization Mammograms|Obtained post-randomization mammogram|136
8959775|NCT02524561|10023259|FG001|Obtained Mammogam|Year 1: Post Randomization Mammograms|Obtained post randomization mammogram|123
8959776|NCT02524561|10023260|FG002|Obtained Mammogam|Year 1: Post Randomization Mammograms|Obtained post randomization mammogram|148
8959777|NCT02524561|10023258|FG000|COMPLETED|Year 1: Post Randomization Mammograms||168
8959778|NCT02524561|10023259|FG001|COMPLETED|Year 1: Post Randomization Mammograms||162
8959779|NCT02524561|10023260|FG002|COMPLETED|Year 1: Post Randomization Mammograms||187
8959780|NCT02524561|10023258|FG000|NOT COMPLETED|Year 1: Post Randomization Mammograms||0
8959781|NCT02524561|10023259|FG001|NOT COMPLETED|Year 1: Post Randomization Mammograms||0
8959782|NCT02524561|10023260|FG002|NOT COMPLETED|Year 1: Post Randomization Mammograms||0
8959783|NCT02524561|10023258|FG000|STARTED|Final: Year 3 or 4 Post-randomization|Consented to MDBHAS|168
8959784|NCT02524561|10023259|FG001|STARTED|Final: Year 3 or 4 Post-randomization|Consented to MDBHAS|162
8959785|NCT02524561|10023260|FG002|STARTED|Final: Year 3 or 4 Post-randomization|Consented to MDBHAS|187
8959786|NCT02524561|10023258|FG000|Obtained Year 3 or 4 Mammogram|Final: Year 3 or 4 Post-randomization||143
8959787|NCT02524561|10023259|FG001|Obtained Year 3 or 4 Mammogram|Final: Year 3 or 4 Post-randomization||139
8959788|NCT02524561|10023260|FG002|Obtained Year 3 or 4 Mammogram|Final: Year 3 or 4 Post-randomization||151
8959789|NCT02524561|10023258|FG000|COMPLETED|Final: Year 3 or 4 Post-randomization||168
8959790|NCT02524561|10023259|FG001|COMPLETED|Final: Year 3 or 4 Post-randomization||162
8959791|NCT02524561|10023260|FG002|COMPLETED|Final: Year 3 or 4 Post-randomization||187
8959792|NCT02524561|10023258|FG000|NOT COMPLETED|Final: Year 3 or 4 Post-randomization||0
8959793|NCT02524561|10023259|FG001|NOT COMPLETED|Final: Year 3 or 4 Post-randomization||0
8959794|NCT02524561|10023260|FG002|NOT COMPLETED|Final: Year 3 or 4 Post-randomization||0
8959795|NCT02524665|10023268|FG000|STARTED|Overall Study||20
8959796|NCT02524665|10023268|FG000|COMPLETED|Overall Study||19
8959797|NCT02524665|10023268|FG000|NOT COMPLETED|Overall Study||1
8959798|NCT02524730|10023273|FG000|STARTED|Overall Study||205
8959799|NCT02524730|10023273|FG000|COMPLETED|Overall Study||159
8959800|NCT02524730|10023273|FG000|NOT COMPLETED|Overall Study||46
8959801|NCT02524769|10023277|FG000|STARTED|Overall Study||27
8959802|NCT02524769|10023277|FG000|COMPLETED|Overall Study||17
8959803|NCT02524769|10023277|FG000|NOT COMPLETED|Overall Study||10
8959804|NCT02524847|10023281|FG000|STARTED|Overall Study||29
8959805|NCT02524847|10023281|FG000|Completed Treatment Up to Week 12|Overall Study||14
8959806|NCT02524847|10023281|FG000|Started Second Line Treatment|Overall Study||5
8959807|NCT02524847|10023281|FG000|COMPLETED|Overall Study||15
8959808|NCT02524847|10023281|FG000|NOT COMPLETED|Overall Study||14
8959809|NCT02524977|10023288|FG000|STARTED|Overall Study||738
8959810|NCT02524977|10023289|FG001|STARTED|Overall Study||846
8959811|NCT02524977|10023288|FG000|COMPLETED|Overall Study||692
8959812|NCT02524977|10023289|FG001|COMPLETED|Overall Study||801
8959813|NCT02524977|10023288|FG000|NOT COMPLETED|Overall Study||46
8959814|NCT02524977|10023289|FG001|NOT COMPLETED|Overall Study||45
8959815|NCT02525055|10023303|FG000|STARTED|Overall Study||6
8959816|NCT02525055|10023304|FG001|STARTED|Overall Study||6
8959817|NCT02525055|10023305|FG002|STARTED|Overall Study||6
8959818|NCT02525055|10023306|FG003|STARTED|Overall Study||6
8959819|NCT02525055|10023307|FG004|STARTED|Overall Study||6
8959820|NCT02525055|10023308|FG005|STARTED|Overall Study||16
8959821|NCT02525055|10023303|FG000|COMPLETED|Overall Study||6
8959822|NCT02525055|10023304|FG001|COMPLETED|Overall Study||6
8959823|NCT02525055|10023305|FG002|COMPLETED|Overall Study||6
8959824|NCT02525055|10023306|FG003|COMPLETED|Overall Study||6
8959825|NCT02525055|10023307|FG004|COMPLETED|Overall Study||6
8959826|NCT02525055|10023308|FG005|COMPLETED|Overall Study||16
8959827|NCT02525055|10023303|FG000|NOT COMPLETED|Overall Study||0
8959828|NCT02525055|10023304|FG001|NOT COMPLETED|Overall Study||0
8959829|NCT02525055|10023305|FG002|NOT COMPLETED|Overall Study||0
8959830|NCT02525055|10023306|FG003|NOT COMPLETED|Overall Study||0
8959831|NCT02525055|10023307|FG004|NOT COMPLETED|Overall Study||0
8959832|NCT02525055|10023308|FG005|NOT COMPLETED|Overall Study||0
8959833|NCT02525094|10023324|FG000|STARTED|Overall Study||57
8959834|NCT02525094|10023325|FG001|STARTED|Overall Study||56
8959835|NCT02525094|10023324|FG000|Treated|Overall Study||56
8959836|NCT02525094|10023325|FG001|Treated|Overall Study||55
8959837|NCT02525094|10023324|FG000|COMPLETED|Overall Study||49
8959838|NCT02525094|10023325|FG001|COMPLETED|Overall Study||48
8959839|NCT02525094|10023324|FG000|NOT COMPLETED|Overall Study||8
8959840|NCT02525094|10023325|FG001|NOT COMPLETED|Overall Study||8
8959841|NCT02525133|10023334|FG000|STARTED|Overall Study||213
8959842|NCT02525133|10023335|FG001|STARTED|Overall Study||106
8959843|NCT02525133|10023334|FG000|Randomized But Not Treated|Overall Study||4
8959844|NCT02525133|10023335|FG001|Randomized But Not Treated|Overall Study||0
8959845|NCT02525133|10023334|FG000|COMPLETED|Overall Study||203
8959846|NCT02525133|10023335|FG001|COMPLETED|Overall Study||103
8959847|NCT02525133|10023334|FG000|NOT COMPLETED|Overall Study||10
8959848|NCT02525133|10023335|FG001|NOT COMPLETED|Overall Study||3
8959849|NCT02525263|10023341|FG000|STARTED|Overall Study|The single patient in this trial was enrolled on 18 July 2016.|1
8959850|NCT02525263|10023341|FG000|COMPLETED|Overall Study|The trial was completed when the patient reached the specified endpoint of starting hemodialysis.|1
8959851|NCT02525263|10023341|FG000|NOT COMPLETED|Overall Study||0
8959852|NCT02525471|10023347|FG000|STARTED|Overall Study||24
8959853|NCT02525471|10023347|FG000|Randomized/Treated|Overall Study||16
8959854|NCT02525471|10023347|FG000|COMPLETED|Overall Study||13
8959855|NCT02525471|10023347|FG000|NOT COMPLETED|Overall Study||11
8959856|NCT02525523|10023354|FG000|STARTED|Overall Study||69
8959857|NCT02525523|10023355|FG001|STARTED|Overall Study||69
8959858|NCT02525523|10023354|FG000|COMPLETED|Overall Study||46
8959859|NCT02525523|10023355|FG001|COMPLETED|Overall Study||44
8959860|NCT02525523|10023354|FG000|NOT COMPLETED|Overall Study||23
8959861|NCT02525523|10023355|FG001|NOT COMPLETED|Overall Study||25
8959862|NCT02525536|10023364|FG000|STARTED|Overall Study||6
8959863|NCT02525536|10023365|FG001|STARTED|Overall Study||6
8959864|NCT02525536|10023366|FG002|STARTED|Overall Study||6
8959865|NCT02525536|10023364|FG000|COMPLETED|Overall Study||6
8959866|NCT02525536|10023365|FG001|COMPLETED|Overall Study||6
8959867|NCT02525536|10023366|FG002|COMPLETED|Overall Study||6
8959868|NCT02525536|10023364|FG000|NOT COMPLETED|Overall Study||0
8959869|NCT02525536|10023365|FG001|NOT COMPLETED|Overall Study||0
8959870|NCT02525536|10023366|FG002|NOT COMPLETED|Overall Study||0
8959871|NCT02525549|10023377|FG000|STARTED|Overall Study||365
8959872|NCT02525549|10023378|FG001|STARTED|Overall Study||360
8959873|NCT02525549|10023379|FG002|STARTED|Overall Study||178
8959874|NCT02525549|10023377|FG000|COMPLETED|Overall Study||330
8959875|NCT02525549|10023378|FG001|COMPLETED|Overall Study||307
8959876|NCT02525549|10023379|FG002|COMPLETED|Overall Study||159
8959877|NCT02525549|10023377|FG000|NOT COMPLETED|Overall Study||35
8959878|NCT02525549|10023378|FG001|NOT COMPLETED|Overall Study||53
8959879|NCT02525549|10023379|FG002|NOT COMPLETED|Overall Study||19
8959880|NCT02525575|10023387|FG000|STARTED|Overall Study||37
8959881|NCT02525575|10023387|FG000|COMPLETED|Overall Study||22
8959882|NCT02525575|10023387|FG000|NOT COMPLETED|Overall Study||15
8959883|NCT02525588|10023393|FG000|STARTED|Overall Study||48
8959884|NCT02525588|10023394|FG001|STARTED|Overall Study||48
8959885|NCT02525588|10023393|FG000|COMPLETED|Overall Study||42
8959886|NCT02525588|10023394|FG001|COMPLETED|Overall Study||45
8959887|NCT02525588|10023393|FG000|NOT COMPLETED|Overall Study||6
8959888|NCT02525588|10023394|FG001|NOT COMPLETED|Overall Study||3
8959889|NCT02525627|10023402|FG000|STARTED|Overall Study||16
8959890|NCT02525627|10023403|FG001|STARTED|Overall Study||18
8959891|NCT02525627|10023402|FG000|COMPLETED|Overall Study||2
8959892|NCT02525627|10023403|FG001|COMPLETED|Overall Study||5
8959893|NCT02525627|10023402|FG000|NOT COMPLETED|Overall Study||14
8959894|NCT02525627|10023403|FG001|NOT COMPLETED|Overall Study||13
8959895|NCT02525653|10023409|FG000|STARTED|Overall Study||40
8959896|NCT02525653|10023409|FG000|COMPLETED|Overall Study||40
8959897|NCT02525653|10023409|FG000|NOT COMPLETED|Overall Study||0
8631471|NCT00540423|9671380|FG000|NOT COMPLETED|Open-Label Treatment Period||0
8631472|NCT00540423|9671381|FG001|NOT COMPLETED|Open-Label Treatment Period||0
8959898|NCT02525718|10023415|FG000|STARTED|Overall Study||23
8959899|NCT02525718|10023416|FG001|STARTED|Overall Study||24
8959900|NCT02525718|10023415|FG000|COMPLETED|Overall Study||22
8959901|NCT02525718|10023416|FG001|COMPLETED|Overall Study||23
8959902|NCT02525718|10023415|FG000|NOT COMPLETED|Overall Study||1
8959903|NCT02525718|10023416|FG001|NOT COMPLETED|Overall Study||1
8959904|NCT02525744|10023422|FG000|STARTED|Period 1||6
8959905|NCT02525744|10023423|FG001|STARTED|Period 1||6
8959906|NCT02525744|10023424|FG002|STARTED|Period 1||6
8959907|NCT02525744|10023425|FG003|STARTED|Period 1||6
8959908|NCT02525744|10023422|FG000|Received at Least 1 Dose of Study Drug|Period 1||6
8959909|NCT02525744|10023423|FG001|Received at Least 1 Dose of Study Drug|Period 1||6
8959910|NCT02525744|10023424|FG002|Received at Least 1 Dose of Study Drug|Period 1||5
8959911|NCT02525744|10023425|FG003|Received at Least 1 Dose of Study Drug|Period 1||6
8959912|NCT02525744|10023422|FG000|COMPLETED|Period 1||6
8959913|NCT02525744|10023423|FG001|COMPLETED|Period 1||6
8959914|NCT02525744|10023424|FG002|COMPLETED|Period 1||5
8959915|NCT02525744|10023425|FG003|COMPLETED|Period 1||6
8959916|NCT02525744|10023422|FG000|NOT COMPLETED|Period 1||0
8959917|NCT02525744|10023423|FG001|NOT COMPLETED|Period 1||0
8959918|NCT02525744|10023424|FG002|NOT COMPLETED|Period 1||1
8959919|NCT02525744|10023425|FG003|NOT COMPLETED|Period 1||0
8959920|NCT02525744|10023422|FG000|STARTED|Period 2||6
8959921|NCT02525744|10023423|FG001|STARTED|Period 2||6
8959922|NCT02525744|10023424|FG002|STARTED|Period 2||5
8959923|NCT02525744|10023425|FG003|STARTED|Period 2||6
8959924|NCT02525744|10023422|FG000|Received at Least 1 Dose of Study Drug|Period 2||6
8874995|NCT01904773|9931727|FG006|COMPLETED|Placebo Washout Third Intervention||3
8874996|NCT01904773|9931728|FG007|COMPLETED|Placebo Washout Third Intervention||3
8874997|NCT01904773|9931729|FG008|COMPLETED|Placebo Washout Third Intervention||4
8874998|NCT01904773|9931721|FG000|NOT COMPLETED|Placebo Washout Third Intervention||0
8874999|NCT01904773|9931722|FG001|NOT COMPLETED|Placebo Washout Third Intervention||0
8875000|NCT01904773|9931723|FG002|NOT COMPLETED|Placebo Washout Third Intervention||0
8875001|NCT01904773|9931724|FG003|NOT COMPLETED|Placebo Washout Third Intervention||0
8875002|NCT01904773|9931725|FG004|NOT COMPLETED|Placebo Washout Third Intervention||0
8875003|NCT01904773|9931726|FG005|NOT COMPLETED|Placebo Washout Third Intervention||0
8875004|NCT01904773|9931727|FG006|NOT COMPLETED|Placebo Washout Third Intervention||0
8875005|NCT01904773|9931728|FG007|NOT COMPLETED|Placebo Washout Third Intervention||0
8875006|NCT01904773|9931729|FG008|NOT COMPLETED|Placebo Washout Third Intervention||0
8875007|NCT01904773|9931721|FG000|STARTED|Fourth Intervention||0
8875008|NCT01904773|9931722|FG001|STARTED|Fourth Intervention||1
8875009|NCT01904773|9931723|FG002|STARTED|Fourth Intervention||1
8875010|NCT01904773|9931724|FG003|STARTED|Fourth Intervention||2
8875011|NCT01904773|9931725|FG004|STARTED|Fourth Intervention||3
8875012|NCT01904773|9931726|FG005|STARTED|Fourth Intervention||4
8875013|NCT01904773|9931727|FG006|STARTED|Fourth Intervention||3
8875014|NCT01904773|9931728|FG007|STARTED|Fourth Intervention||3
8875015|NCT01904773|9931729|FG008|STARTED|Fourth Intervention||4
8875016|NCT01904773|9931721|FG000|COMPLETED|Fourth Intervention||0
8875017|NCT01904773|9931722|FG001|COMPLETED|Fourth Intervention||1
8875018|NCT01904773|9931723|FG002|COMPLETED|Fourth Intervention||1
8875019|NCT01904773|9931724|FG003|COMPLETED|Fourth Intervention||2
8875020|NCT01904773|9931725|FG004|COMPLETED|Fourth Intervention||3
8875021|NCT01904773|9931726|FG005|COMPLETED|Fourth Intervention||4
8875022|NCT01904773|9931727|FG006|COMPLETED|Fourth Intervention||3
8875023|NCT01904773|9931728|FG007|COMPLETED|Fourth Intervention||3
8875024|NCT01904773|9931729|FG008|COMPLETED|Fourth Intervention||4
8875025|NCT01904773|9931721|FG000|NOT COMPLETED|Fourth Intervention||0
8875026|NCT01904773|9931722|FG001|NOT COMPLETED|Fourth Intervention||0
8875027|NCT01904773|9931723|FG002|NOT COMPLETED|Fourth Intervention||0
8875028|NCT01904773|9931724|FG003|NOT COMPLETED|Fourth Intervention||0
8875029|NCT01904773|9931725|FG004|NOT COMPLETED|Fourth Intervention||0
8875030|NCT01904773|9931726|FG005|NOT COMPLETED|Fourth Intervention||0
8875031|NCT01904773|9931727|FG006|NOT COMPLETED|Fourth Intervention||0
8959925|NCT02525744|10023423|FG001|Received at Least 1 Dose of Study Drug|Period 2||6
8959926|NCT02525744|10023424|FG002|Received at Least 1 Dose of Study Drug|Period 2||5
8959927|NCT02525744|10023425|FG003|Received at Least 1 Dose of Study Drug|Period 2||6
8959928|NCT02525744|10023422|FG000|COMPLETED|Period 2||6
8959929|NCT02525744|10023423|FG001|COMPLETED|Period 2||6
8959930|NCT02525744|10023424|FG002|COMPLETED|Period 2||5
8959931|NCT02525744|10023425|FG003|COMPLETED|Period 2||6
8959932|NCT02525744|10023422|FG000|NOT COMPLETED|Period 2||0
8959933|NCT02525744|10023423|FG001|NOT COMPLETED|Period 2||0
8959934|NCT02525744|10023424|FG002|NOT COMPLETED|Period 2||0
8959935|NCT02525744|10023425|FG003|NOT COMPLETED|Period 2||0
8959936|NCT02525744|10023422|FG000|STARTED|Period 3||6
8959937|NCT02525744|10023423|FG001|STARTED|Period 3||6
8959938|NCT02525744|10023424|FG002|STARTED|Period 3||5
8959939|NCT02525744|10023425|FG003|STARTED|Period 3||6
8959940|NCT02525744|10023422|FG000|Received at Least 1 Dose of Study Drug|Period 3||6
8959941|NCT02525744|10023423|FG001|Received at Least 1 Dose of Study Drug|Period 3||6
8959942|NCT02525744|10023424|FG002|Received at Least 1 Dose of Study Drug|Period 3||5
8959943|NCT02525744|10023425|FG003|Received at Least 1 Dose of Study Drug|Period 3||6
8959944|NCT02525744|10023422|FG000|COMPLETED|Period 3||6
8959945|NCT02525744|10023423|FG001|COMPLETED|Period 3||5
8959946|NCT02525744|10023424|FG002|COMPLETED|Period 3||5
8959947|NCT02525744|10023425|FG003|COMPLETED|Period 3||6
8959948|NCT02525744|10023422|FG000|NOT COMPLETED|Period 3||0
8959949|NCT02525744|10023423|FG001|NOT COMPLETED|Period 3||1
8875032|NCT01904773|9931728|FG007|NOT COMPLETED|Fourth Intervention||0
8875033|NCT01904773|9931729|FG008|NOT COMPLETED|Fourth Intervention||0
8875034|NCT01904773|9931721|FG000|STARTED|Placebo Washout Fourth Intervention||0
8875035|NCT01904773|9931722|FG001|STARTED|Placebo Washout Fourth Intervention||1
8875036|NCT01904773|9931723|FG002|STARTED|Placebo Washout Fourth Intervention||1
8875037|NCT01904773|9931724|FG003|STARTED|Placebo Washout Fourth Intervention||2
8875038|NCT01904773|9931725|FG004|STARTED|Placebo Washout Fourth Intervention||3
8875039|NCT01904773|9931726|FG005|STARTED|Placebo Washout Fourth Intervention||4
8959950|NCT02525744|10023424|FG002|NOT COMPLETED|Period 3||0
8959951|NCT02525744|10023425|FG003|NOT COMPLETED|Period 3||0
8959952|NCT02525744|10023422|FG000|STARTED|Period 4||6
8959953|NCT02525744|10023423|FG001|STARTED|Period 4||5
8959954|NCT02525744|10023424|FG002|STARTED|Period 4||5
8959955|NCT02525744|10023425|FG003|STARTED|Period 4||6
8959956|NCT02525744|10023422|FG000|Received at Least 1 Dose of Study Drug|Period 4||6
8959957|NCT02525744|10023423|FG001|Received at Least 1 Dose of Study Drug|Period 4||5
8959958|NCT02525744|10023424|FG002|Received at Least 1 Dose of Study Drug|Period 4||5
8959959|NCT02525744|10023425|FG003|Received at Least 1 Dose of Study Drug|Period 4||6
8959960|NCT02525744|10023422|FG000|COMPLETED|Period 4||5
8959961|NCT02525744|10023423|FG001|COMPLETED|Period 4||5
8959962|NCT02525744|10023424|FG002|COMPLETED|Period 4||5
8959963|NCT02525744|10023425|FG003|COMPLETED|Period 4||6
8959964|NCT02525744|10023422|FG000|NOT COMPLETED|Period 4||1
8959965|NCT02525744|10023423|FG001|NOT COMPLETED|Period 4||0
8959966|NCT02525744|10023424|FG002|NOT COMPLETED|Period 4||0
8959967|NCT02525744|10023425|FG003|NOT COMPLETED|Period 4||0
8959968|NCT02525744|10023422|FG000|STARTED|Period 5||5
8959969|NCT02525744|10023423|FG001|STARTED|Period 5||5
8959970|NCT02525744|10023424|FG002|STARTED|Period 5||5
8959971|NCT02525744|10023425|FG003|STARTED|Period 5||6
8959972|NCT02525744|10023422|FG000|Received at Least 1 Dose of Study Drug|Period 5||4
8959973|NCT02525744|10023423|FG001|Received at Least 1 Dose of Study Drug|Period 5||5
8959974|NCT02525744|10023424|FG002|Received at Least 1 Dose of Study Drug|Period 5||5
8959975|NCT02525744|10023425|FG003|Received at Least 1 Dose of Study Drug|Period 5||6
8959976|NCT02525744|10023422|FG000|COMPLETED|Period 5||4
8959977|NCT02525744|10023423|FG001|COMPLETED|Period 5||5
8959978|NCT02525744|10023424|FG002|COMPLETED|Period 5||5
8959979|NCT02525744|10023425|FG003|COMPLETED|Period 5||6
8959980|NCT02525744|10023422|FG000|NOT COMPLETED|Period 5||1
8959981|NCT02525744|10023423|FG001|NOT COMPLETED|Period 5||0
8959982|NCT02525744|10023424|FG002|NOT COMPLETED|Period 5||0
8959983|NCT02525744|10023425|FG003|NOT COMPLETED|Period 5||0
8959984|NCT02525861|10023437|FG000|STARTED|Overall Study||18
8959985|NCT02525861|10023438|FG001|STARTED|Overall Study||16
8959986|NCT02525861|10023437|FG000|COMPLETED|Overall Study||17
8959987|NCT02525861|10023438|FG001|COMPLETED|Overall Study||14
8959988|NCT02525861|10023437|FG000|NOT COMPLETED|Overall Study||1
8959989|NCT02525861|10023438|FG001|NOT COMPLETED|Overall Study||2
8959990|NCT02525874|10023446|FG000|STARTED|Overall Study||218
8959991|NCT02525874|10023446|FG000|COMPLETED|Overall Study||158
8959992|NCT02525874|10023446|FG000|NOT COMPLETED|Overall Study||60
8959993|NCT02526160|10023452|FG000|STARTED|Double-Blind (Placebo-Controlled) Period||66
8959994|NCT02526160|10023453|FG001|STARTED|Double-Blind (Placebo-Controlled) Period||68
8959995|NCT02526160|10023452|FG000|COMPLETED|Double-Blind (Placebo-Controlled) Period||66
8959996|NCT02526160|10023453|FG001|COMPLETED|Double-Blind (Placebo-Controlled) Period||67
8959997|NCT02526160|10023452|FG000|NOT COMPLETED|Double-Blind (Placebo-Controlled) Period||0
8959998|NCT02526160|10023453|FG001|NOT COMPLETED|Double-Blind (Placebo-Controlled) Period||1
8959999|NCT02526160|10023452|FG000|STARTED|Open-label Treatment Continuation Period||66
8960000|NCT02526160|10023453|FG001|STARTED|Open-label Treatment Continuation Period||67
8960001|NCT02526160|10023452|FG000|COMPLETED|Open-label Treatment Continuation Period||63
8960002|NCT02526160|10023453|FG001|COMPLETED|Open-label Treatment Continuation Period||63
8960003|NCT02526160|10023452|FG000|NOT COMPLETED|Open-label Treatment Continuation Period||3
8960004|NCT02526160|10023453|FG001|NOT COMPLETED|Open-label Treatment Continuation Period||4
8960005|NCT02526160|10023452|FG000|STARTED|Open-Label Treatment Extension Period I||63
8960006|NCT02526160|10023453|FG001|STARTED|Open-Label Treatment Extension Period I||63
8960007|NCT02526160|10023452|FG000|COMPLETED|Open-Label Treatment Extension Period I||60
8960008|NCT02526160|10023453|FG001|COMPLETED|Open-Label Treatment Extension Period I||59
8960009|NCT02526160|10023452|FG000|NOT COMPLETED|Open-Label Treatment Extension Period I||3
8960010|NCT02526160|10023453|FG001|NOT COMPLETED|Open-Label Treatment Extension Period I||4
8960011|NCT02526160|10023452|FG000|STARTED|Open-Label Treatment Extension Period II||52
8960012|NCT02526160|10023453|FG001|STARTED|Open-Label Treatment Extension Period II||49
8960013|NCT02526160|10023452|FG000|COMPLETED|Open-Label Treatment Extension Period II||51
8960014|NCT02526160|10023453|FG001|COMPLETED|Open-Label Treatment Extension Period II||49
8960015|NCT02526160|10023452|FG000|NOT COMPLETED|Open-Label Treatment Extension Period II||1
8960016|NCT02526160|10023453|FG001|NOT COMPLETED|Open-Label Treatment Extension Period II||0
8960017|NCT02526212|10023466|FG000|STARTED|Overall Study||10
8960018|NCT02526212|10023467|FG001|STARTED|Overall Study||8
8960019|NCT02526212|10023466|FG000|COMPLETED|Overall Study||8
8960020|NCT02526212|10023467|FG001|COMPLETED|Overall Study||7
8960021|NCT02526212|10023466|FG000|NOT COMPLETED|Overall Study||2
8960022|NCT02526212|10023467|FG001|NOT COMPLETED|Overall Study||1
8960023|NCT02526277|10023477|FG000|STARTED|Overall Study||8
8960024|NCT02526277|10023478|FG001|STARTED|Overall Study||6
8960025|NCT02526277|10023479|FG002|STARTED|Overall Study||7
8960026|NCT02526277|10023480|FG003|STARTED|Overall Study||7
8960027|NCT02526277|10023477|FG000|COMPLETED|Overall Study||8
8960028|NCT02526277|10023478|FG001|COMPLETED|Overall Study||6
8960029|NCT02526277|10023479|FG002|COMPLETED|Overall Study||7
8960030|NCT02526277|10023480|FG003|COMPLETED|Overall Study||7
8960031|NCT02526277|10023477|FG000|NOT COMPLETED|Overall Study||0
8960032|NCT02526277|10023478|FG001|NOT COMPLETED|Overall Study||0
8960033|NCT02526277|10023479|FG002|NOT COMPLETED|Overall Study||0
8960034|NCT02526277|10023480|FG003|NOT COMPLETED|Overall Study||0
8960035|NCT02526290|10023493|FG000|STARTED|Overall Study||97
8960036|NCT02526290|10023493|FG000|COMPLETED|Overall Study||89
8960037|NCT02526290|10023493|FG000|NOT COMPLETED|Overall Study||8
8960038|NCT02526524|10023503|FG000|STARTED|Overall Study||94
8960039|NCT02526524|10023504|FG001|STARTED|Overall Study||95
8960040|NCT02526524|10023505|FG002|STARTED|Overall Study||96
8960041|NCT02526524|10023506|FG003|STARTED|Overall Study||96
8960042|NCT02526524|10023507|FG004|STARTED|Overall Study||96
8960043|NCT02526524|10023508|FG005|STARTED|Overall Study||94
8960044|NCT02526524|10023503|FG000|COMPLETED|Overall Study||82
8960045|NCT02526524|10023504|FG001|COMPLETED|Overall Study||86
8960046|NCT02526524|10023505|FG002|COMPLETED|Overall Study||70
8960047|NCT02526524|10023506|FG003|COMPLETED|Overall Study||89
8960048|NCT02526524|10023507|FG004|COMPLETED|Overall Study||72
8960049|NCT02526524|10023508|FG005|COMPLETED|Overall Study||73
8960050|NCT02526524|10023503|FG000|NOT COMPLETED|Overall Study||12
8960051|NCT02526524|10023504|FG001|NOT COMPLETED|Overall Study||9
8960052|NCT02526524|10023505|FG002|NOT COMPLETED|Overall Study||26
8960053|NCT02526524|10023506|FG003|NOT COMPLETED|Overall Study||7
8960054|NCT02526524|10023507|FG004|NOT COMPLETED|Overall Study||24
8960055|NCT02526524|10023508|FG005|NOT COMPLETED|Overall Study||21
8960056|NCT02526550|10023522|FG000|STARTED|Overall Study||50
8960057|NCT02526550|10023522|FG000|COMPLETED|Overall Study||49
8960058|NCT02526550|10023522|FG000|NOT COMPLETED|Overall Study||1
8960059|NCT02526654|10023528|FG000|STARTED|Overall Study||79
8960060|NCT02526654|10023529|FG001|STARTED|Overall Study||36
8960061|NCT02526654|10023528|FG000|COMPLETED|Overall Study||79
8960062|NCT02526654|10023529|FG001|COMPLETED|Overall Study||36
8960063|NCT02526654|10023528|FG000|NOT COMPLETED|Overall Study||0
8960064|NCT02526654|10023529|FG001|NOT COMPLETED|Overall Study||0
8960065|NCT02526667|10023538|FG000|STARTED|Abdomen||284
8960066|NCT02526667|10023539|FG001|STARTED|Abdomen||56
8960067|NCT02526667|10023540|FG002|STARTED|Abdomen||281
8960068|NCT02526667|10023538|FG000|COMPLETED|Abdomen||284
8960069|NCT02526667|10023539|FG001|COMPLETED|Abdomen||56
8960070|NCT02526667|10023540|FG002|COMPLETED|Abdomen||281
8960071|NCT02526667|10023538|FG000|NOT COMPLETED|Abdomen||0
8960072|NCT02526667|10023539|FG001|NOT COMPLETED|Abdomen||0
8960073|NCT02526667|10023540|FG002|NOT COMPLETED|Abdomen||0
8631473|NCT00540423|9671382|FG002|NOT COMPLETED|Open-Label Treatment Period||2
8631474|NCT00540436|9671400|FG000|STARTED|First 12-Week Treatment Period||25
8631475|NCT00540436|9671400|FG000|COMPLETED|First 12-Week Treatment Period||22
8960074|NCT02526667|10023538|FG000|STARTED|Groin||290
8960075|NCT02526667|10023539|FG001|STARTED|Groin||56
8960076|NCT02526667|10023540|FG002|STARTED|Groin||294
8960077|NCT02526667|10023538|FG000|COMPLETED|Groin||290
8960078|NCT02526667|10023539|FG001|COMPLETED|Groin||56
8960079|NCT02526667|10023540|FG002|COMPLETED|Groin||294
8960080|NCT02526667|10023538|FG000|NOT COMPLETED|Groin||0
8960081|NCT02526667|10023539|FG001|NOT COMPLETED|Groin||0
8960082|NCT02526667|10023540|FG002|NOT COMPLETED|Groin||0
8960083|NCT02526680|10023554|FG000|STARTED|Overall Study||27
8960084|NCT02526680|10023554|FG000|COMPLETED|Overall Study||27
8960085|NCT02526680|10023554|FG000|NOT COMPLETED|Overall Study||0
8960086|NCT02526693|10023561|FG000|STARTED|Overall Study||53
8960087|NCT02526693|10023562|FG001|STARTED|Overall Study||51
8960088|NCT02526693|10023561|FG000|COMPLETED|Overall Study||50
8960089|NCT02526693|10023562|FG001|COMPLETED|Overall Study||50
8960090|NCT02526693|10023561|FG000|NOT COMPLETED|Overall Study||3
8960091|NCT02526693|10023562|FG001|NOT COMPLETED|Overall Study||1
8960092|NCT02527148|10023574|FG000|STARTED|Overall Study||50
8960093|NCT02527148|10023575|FG001|STARTED|Overall Study||50
8960094|NCT02527148|10023574|FG000|COMPLETED|Overall Study||49
8960095|NCT02527148|10023575|FG001|COMPLETED|Overall Study||50
8960096|NCT02527148|10023574|FG000|NOT COMPLETED|Overall Study||1
8960097|NCT02527148|10023575|FG001|NOT COMPLETED|Overall Study||0
8960098|NCT02527161|10023583|FG000|STARTED|Overall Study|All results are reported by knee throughout record. Participant=knee.|205
8960099|NCT02527161|10023583|FG000|COMPLETED|Overall Study|Completed/Not completed counts are for knees at the 5 year outcome interval.|73
8960100|NCT02527161|10023583|FG000|NOT COMPLETED|Overall Study||132
8631476|NCT00540436|9671400|FG000|NOT COMPLETED|First 12-Week Treatment Period||3
8960101|NCT02527265|10023590|FG000|STARTED|Overall Study||15
8960102|NCT02527265|10023591|FG001|STARTED|Overall Study||15
8960103|NCT02527265|10023590|FG000|COMPLETED|Overall Study||13
8960104|NCT02527265|10023591|FG001|COMPLETED|Overall Study||11
8960105|NCT02527265|10023590|FG000|NOT COMPLETED|Overall Study||2
8960106|NCT02527265|10023591|FG001|NOT COMPLETED|Overall Study||4
8960107|NCT02527343|10023599|FG000|STARTED|RT Period: Weeks 1 to 52||19
8960108|NCT02527343|10023600|FG001|STARTED|RT Period: Weeks 1 to 52||21
8960109|NCT02527343|10023601|FG002|STARTED|RT Period: Weeks 1 to 52||0
8960110|NCT02527343|10023602|FG003|STARTED|RT Period: Weeks 1 to 52||0
8960111|NCT02527343|10023603|FG004|STARTED|RT Period: Weeks 1 to 52||0
8960112|NCT02527343|10023604|FG005|STARTED|RT Period: Weeks 1 to 52||0
8960113|NCT02527343|10023599|FG000|COMPLETED|RT Period: Weeks 1 to 52||13
8960114|NCT02527343|10023600|FG001|COMPLETED|RT Period: Weeks 1 to 52||14
8960115|NCT02527343|10023601|FG002|COMPLETED|RT Period: Weeks 1 to 52||0
8960116|NCT02527343|10023602|FG003|COMPLETED|RT Period: Weeks 1 to 52||0
8875040|NCT01904773|9931727|FG006|STARTED|Placebo Washout Fourth Intervention||3
8875041|NCT01904773|9931728|FG007|STARTED|Placebo Washout Fourth Intervention||3
8875042|NCT01904773|9931729|FG008|STARTED|Placebo Washout Fourth Intervention||4
8875043|NCT01904773|9931721|FG000|COMPLETED|Placebo Washout Fourth Intervention||0
8960117|NCT02527343|10023603|FG004|COMPLETED|RT Period: Weeks 1 to 52||0
8960118|NCT02527343|10023604|FG005|COMPLETED|RT Period: Weeks 1 to 52||0
8960119|NCT02527343|10023599|FG000|NOT COMPLETED|RT Period: Weeks 1 to 52||6
8960120|NCT02527343|10023600|FG001|NOT COMPLETED|RT Period: Weeks 1 to 52||7
8960121|NCT02527343|10023601|FG002|NOT COMPLETED|RT Period: Weeks 1 to 52||0
8960122|NCT02527343|10023602|FG003|NOT COMPLETED|RT Period: Weeks 1 to 52||0
8960123|NCT02527343|10023603|FG004|NOT COMPLETED|RT Period: Weeks 1 to 52||0
8960124|NCT02527343|10023604|FG005|NOT COMPLETED|RT Period: Weeks 1 to 52||0
8960125|NCT02527343|10023599|FG000|STARTED|RT Post Treatment Follow-up: Weeks 54-65||0
8960126|NCT02527343|10023600|FG001|STARTED|RT Post Treatment Follow-up: Weeks 54-65||0
8960127|NCT02527343|10023601|FG002|STARTED|RT Post Treatment Follow-up: Weeks 54-65|Only those participants who were entered in the 13-week post-treatment follow-up period after the randomized treatment period.|7
8960128|NCT02527343|10023602|FG003|STARTED|RT Post Treatment Follow-up: Weeks 54-65|Only those participants who were entered in the 13-week post-treatment follow-up period after the randomized treatment period.|9
8960129|NCT02527343|10023603|FG004|STARTED|RT Post Treatment Follow-up: Weeks 54-65||0
8960130|NCT02527343|10023604|FG005|STARTED|RT Post Treatment Follow-up: Weeks 54-65||0
8960131|NCT02527343|10023599|FG000|COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||0
8960132|NCT02527343|10023600|FG001|COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||0
8960133|NCT02527343|10023601|FG002|COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||6
8960134|NCT02527343|10023602|FG003|COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||7
8960135|NCT02527343|10023603|FG004|COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||0
8960136|NCT02527343|10023604|FG005|COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||0
8960137|NCT02527343|10023599|FG000|NOT COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||0
8960138|NCT02527343|10023600|FG001|NOT COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||0
8960139|NCT02527343|10023601|FG002|NOT COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||1
8960140|NCT02527343|10023602|FG003|NOT COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||2
8960141|NCT02527343|10023603|FG004|NOT COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||0
8960142|NCT02527343|10023604|FG005|NOT COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||0
8960143|NCT02527343|10023599|FG000|STARTED|OLE Period-Year 1: Week 53 to 104||0
8960144|NCT02527343|10023600|FG001|STARTED|OLE Period-Year 1: Week 53 to 104||0
8960145|NCT02527343|10023601|FG002|STARTED|OLE Period-Year 1: Week 53 to 104||0
8960146|NCT02527343|10023602|FG003|STARTED|OLE Period-Year 1: Week 53 to 104||0
8960147|NCT02527343|10023603|FG004|STARTED|OLE Period-Year 1: Week 53 to 104|Only those participants who were entered the in the OLE period (first OLE period) after the randomized treatment period.|12
8960148|NCT02527343|10023604|FG005|STARTED|OLE Period-Year 1: Week 53 to 104|Only those participants who were entered the in the OLE period (first OLE period) after the randomized treatment period.|12
8960149|NCT02527343|10023599|FG000|COMPLETED|OLE Period-Year 1: Week 53 to 104||0
8960150|NCT02527343|10023600|FG001|COMPLETED|OLE Period-Year 1: Week 53 to 104||0
8960151|NCT02527343|10023601|FG002|COMPLETED|OLE Period-Year 1: Week 53 to 104||0
8960152|NCT02527343|10023602|FG003|COMPLETED|OLE Period-Year 1: Week 53 to 104||0
8960153|NCT02527343|10023603|FG004|COMPLETED|OLE Period-Year 1: Week 53 to 104||1
8631477|NCT00540436|9671400|FG000|STARTED|Second 12-Week Treatment Period||22
8631478|NCT00540436|9671400|FG000|COMPLETED|Second 12-Week Treatment Period||21
8631479|NCT00540436|9671400|FG000|NOT COMPLETED|Second 12-Week Treatment Period||1
8631480|NCT00540449|9671406|FG000|STARTED|Overall Study||346
8631481|NCT00540449|9671407|FG001|STARTED|Overall Study||344
8631482|NCT00540449|9671406|FG000|COMPLETED|Overall Study||262
8631483|NCT00540449|9671407|FG001|COMPLETED|Overall Study||266
8631484|NCT00540449|9671406|FG000|NOT COMPLETED|Overall Study||84
8631485|NCT00540449|9671407|FG001|NOT COMPLETED|Overall Study||78
8691271|NCT00853840|9736490|FG001|COMPLETED|Period 2||9
8875044|NCT01904773|9931722|FG001|COMPLETED|Placebo Washout Fourth Intervention||1
8875045|NCT01904773|9931723|FG002|COMPLETED|Placebo Washout Fourth Intervention||1
8875046|NCT01904773|9931724|FG003|COMPLETED|Placebo Washout Fourth Intervention||2
8875047|NCT01904773|9931725|FG004|COMPLETED|Placebo Washout Fourth Intervention||3
8875048|NCT01904773|9931726|FG005|COMPLETED|Placebo Washout Fourth Intervention||4
8875049|NCT01904773|9931727|FG006|COMPLETED|Placebo Washout Fourth Intervention||3
8875050|NCT01904773|9931728|FG007|COMPLETED|Placebo Washout Fourth Intervention||3
8875051|NCT01904773|9931729|FG008|COMPLETED|Placebo Washout Fourth Intervention||4
8875052|NCT01904773|9931721|FG000|NOT COMPLETED|Placebo Washout Fourth Intervention||0
8875053|NCT01904773|9931722|FG001|NOT COMPLETED|Placebo Washout Fourth Intervention||0
8875054|NCT01904773|9931723|FG002|NOT COMPLETED|Placebo Washout Fourth Intervention||0
8875055|NCT01904773|9931724|FG003|NOT COMPLETED|Placebo Washout Fourth Intervention||0
8875056|NCT01904773|9931725|FG004|NOT COMPLETED|Placebo Washout Fourth Intervention||0
8875057|NCT01904773|9931726|FG005|NOT COMPLETED|Placebo Washout Fourth Intervention||0
8875058|NCT01904773|9931727|FG006|NOT COMPLETED|Placebo Washout Fourth Intervention||0
8875059|NCT01904773|9931728|FG007|NOT COMPLETED|Placebo Washout Fourth Intervention||0
8875060|NCT01904773|9931729|FG008|NOT COMPLETED|Placebo Washout Fourth Intervention||0
8960154|NCT02527343|10023604|FG005|COMPLETED|OLE Period-Year 1: Week 53 to 104||3
8960155|NCT02527343|10023599|FG000|NOT COMPLETED|OLE Period-Year 1: Week 53 to 104||0
8960156|NCT02527343|10023600|FG001|NOT COMPLETED|OLE Period-Year 1: Week 53 to 104||0
8960157|NCT02527343|10023601|FG002|NOT COMPLETED|OLE Period-Year 1: Week 53 to 104||0
8960158|NCT02527343|10023602|FG003|NOT COMPLETED|OLE Period-Year 1: Week 53 to 104||0
8960159|NCT02527343|10023603|FG004|NOT COMPLETED|OLE Period-Year 1: Week 53 to 104||11
8960160|NCT02527343|10023604|FG005|NOT COMPLETED|OLE Period-Year 1: Week 53 to 104||9
8960161|NCT02527343|10023599|FG000|STARTED|OLE Period-Year 2: Week 105 to 156||0
8960162|NCT02527343|10023600|FG001|STARTED|OLE Period-Year 2: Week 105 to 156||0
8960163|NCT02527343|10023601|FG002|STARTED|OLE Period-Year 2: Week 105 to 156||0
8960164|NCT02527343|10023602|FG003|STARTED|OLE Period-Year 2: Week 105 to 156||0
8960165|NCT02527343|10023603|FG004|STARTED|OLE Period-Year 2: Week 105 to 156|Only those participants who were continuing the dosing for up to an additional 52 weeks in the second OLE period.|1
8960166|NCT02527343|10023604|FG005|STARTED|OLE Period-Year 2: Week 105 to 156|Only those participants who were continuing the dosing for up to an additional 52 weeks in the second OLE period.|2
8960167|NCT02527343|10023599|FG000|COMPLETED|OLE Period-Year 2: Week 105 to 156||0
8960168|NCT02527343|10023600|FG001|COMPLETED|OLE Period-Year 2: Week 105 to 156||0
8960169|NCT02527343|10023601|FG002|COMPLETED|OLE Period-Year 2: Week 105 to 156||0
8960170|NCT02527343|10023602|FG003|COMPLETED|OLE Period-Year 2: Week 105 to 156||0
8960171|NCT02527343|10023603|FG004|COMPLETED|OLE Period-Year 2: Week 105 to 156||0
8960172|NCT02527343|10023604|FG005|COMPLETED|OLE Period-Year 2: Week 105 to 156||0
8960173|NCT02527343|10023599|FG000|NOT COMPLETED|OLE Period-Year 2: Week 105 to 156||0
8960174|NCT02527343|10023600|FG001|NOT COMPLETED|OLE Period-Year 2: Week 105 to 156||0
8960175|NCT02527343|10023601|FG002|NOT COMPLETED|OLE Period-Year 2: Week 105 to 156||0
8960176|NCT02527343|10023602|FG003|NOT COMPLETED|OLE Period-Year 2: Week 105 to 156||0
8960177|NCT02527343|10023603|FG004|NOT COMPLETED|OLE Period-Year 2: Week 105 to 156||1
8960178|NCT02527343|10023604|FG005|NOT COMPLETED|OLE Period-Year 2: Week 105 to 156||2
8960179|NCT02527343|10023599|FG000|STARTED|PT Follow-up: Weeks 104 to 169||0
8960180|NCT02527343|10023600|FG001|STARTED|PT Follow-up: Weeks 104 to 169||0
8960181|NCT02527343|10023601|FG002|STARTED|PT Follow-up: Weeks 104 to 169||0
8960182|NCT02527343|10023602|FG003|STARTED|PT Follow-up: Weeks 104 to 169||0
8960183|NCT02527343|10023603|FG004|STARTED|PT Follow-up: Weeks 104 to 169|Participants who were entered in the post-treatment follow-up after the OLE Period.|12
8960184|NCT02527343|10023604|FG005|STARTED|PT Follow-up: Weeks 104 to 169|Participants who were entered in the post-treatment follow-up after the OLE Period.|12
8960185|NCT02527343|10023599|FG000|COMPLETED|PT Follow-up: Weeks 104 to 169||0
8960186|NCT02527343|10023600|FG001|COMPLETED|PT Follow-up: Weeks 104 to 169||0
8631486|NCT00540514|9671415|FG000|STARTED|Overall Study|Intent-to-treat Population: all randomized patients regardless of treatment received.|521
8631487|NCT00540514|9671416|FG001|STARTED|Overall Study|Intent-to-treat Population: all randomized patients regardless of treatment received.|531
8631488|NCT00540514|9671415|FG000|Treated|Overall Study||514
8631489|NCT00540514|9671416|FG001|Treated|Overall Study||524
8631490|NCT00540514|9671415|FG000|Biomarker Population|Overall Study||35
8631491|NCT00540514|9671416|FG001|Biomarker Population|Overall Study||36
8631492|NCT00540514|9671415|FG000|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease|275
8631493|NCT00540514|9671416|FG001|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease|265
8631494|NCT00540514|9671415|FG000|NOT COMPLETED|Overall Study||246
8631495|NCT00540514|9671416|FG001|NOT COMPLETED|Overall Study||266
8631496|NCT00540579|9671423|FG000|STARTED|Overall Study||23
8631497|NCT00540579|9671423|FG000|COMPLETED|Overall Study||23
8631498|NCT00540579|9671423|FG000|NOT COMPLETED|Overall Study||0
8631499|NCT00540592|9671437|FG000|STARTED|Overall Study||204
8960187|NCT02527343|10023601|FG002|COMPLETED|PT Follow-up: Weeks 104 to 169||0
8960188|NCT02527343|10023602|FG003|COMPLETED|PT Follow-up: Weeks 104 to 169||0
8960189|NCT02527343|10023603|FG004|COMPLETED|PT Follow-up: Weeks 104 to 169||11
8960190|NCT02527343|10023604|FG005|COMPLETED|PT Follow-up: Weeks 104 to 169||11
8960191|NCT02527343|10023599|FG000|NOT COMPLETED|PT Follow-up: Weeks 104 to 169||0
8960192|NCT02527343|10023600|FG001|NOT COMPLETED|PT Follow-up: Weeks 104 to 169||0
8960193|NCT02527343|10023601|FG002|NOT COMPLETED|PT Follow-up: Weeks 104 to 169||0
8960194|NCT02527343|10023602|FG003|NOT COMPLETED|PT Follow-up: Weeks 104 to 169||0
8960195|NCT02527343|10023603|FG004|NOT COMPLETED|PT Follow-up: Weeks 104 to 169||1
8960196|NCT02527343|10023604|FG005|NOT COMPLETED|PT Follow-up: Weeks 104 to 169||1
8960197|NCT02527421|10023621|FG000|STARTED|Overall Study||2
8960198|NCT02527421|10023622|FG001|STARTED|Overall Study||1
8960199|NCT02527421|10023621|FG000|COMPLETED|Overall Study||1
8960200|NCT02527421|10023622|FG001|COMPLETED|Overall Study||1
8960201|NCT02527421|10023621|FG000|NOT COMPLETED|Overall Study||1
8960202|NCT02527421|10023622|FG001|NOT COMPLETED|Overall Study||0
8960203|NCT02527512|10023630|FG000|STARTED|Overall Study||85
8960204|NCT02527512|10023631|FG001|STARTED|Overall Study||82
8960205|NCT02527512|10023630|FG000|COMPLETED|Overall Study||77
8960206|NCT02527512|10023631|FG001|COMPLETED|Overall Study||76
8960207|NCT02527512|10023630|FG000|NOT COMPLETED|Overall Study||8
8960208|NCT02527512|10023631|FG001|NOT COMPLETED|Overall Study||6
8960209|NCT02527694|10023643|FG000|STARTED|Overall Study||20
8631500|NCT00540592|9671438|FG001|STARTED|Overall Study||202
8631501|NCT00540592|9671439|FG002|STARTED|Overall Study||202
8960210|NCT02527694|10023644|FG001|STARTED|Overall Study||29
8960211|NCT02527694|10023643|FG000|COMPLETED|Overall Study||10
8631502|NCT00540592|9671440|FG003|STARTED|Overall Study||202
8631503|NCT00540592|9671441|FG004|STARTED|Overall Study||199
8631504|NCT00540592|9671442|FG005|STARTED|Overall Study||198
8631505|NCT00540592|9671443|FG006|STARTED|Overall Study||198
8631506|NCT00540592|9671444|FG007|STARTED|Overall Study||199
8631507|NCT00540592|9671445|FG008|STARTED|Overall Study||200
8631508|NCT00540592|9671446|FG009|STARTED|Overall Study||203
8631509|NCT00540592|9671437|FG000|Completed at Day 180|Overall Study||200
8631510|NCT00540592|9671438|FG001|Completed at Day 180|Overall Study||201
8960212|NCT02527694|10023644|FG001|COMPLETED|Overall Study||21
8960213|NCT02527694|10023643|FG000|NOT COMPLETED|Overall Study||10
8960214|NCT02527694|10023644|FG001|NOT COMPLETED|Overall Study||8
8960215|NCT02528188|10023655|FG000|STARTED|Overall Study||1008
8960216|NCT02528188|10023656|FG001|STARTED|Overall Study||1005
8960217|NCT02528188|10023657|FG002|STARTED|Overall Study||1008
8960218|NCT02528188|10023655|FG000|Treated|Overall Study||1002
8960219|NCT02528188|10023656|FG001|Treated|Overall Study||998
8960220|NCT02528188|10023657|FG002|Treated|Overall Study||996
8960221|NCT02528188|10023655|FG000|COMPLETED|Overall Study||741
8960222|NCT02528188|10023656|FG001|COMPLETED|Overall Study||729
8960223|NCT02528188|10023657|FG002|COMPLETED|Overall Study||757
8960224|NCT02528188|10023655|FG000|NOT COMPLETED|Overall Study||267
8960225|NCT02528188|10023656|FG001|NOT COMPLETED|Overall Study||276
8960226|NCT02528188|10023657|FG002|NOT COMPLETED|Overall Study||251
8960227|NCT02528214|10023667|FG000|STARTED|Overall Study||107
8960228|NCT02528214|10023668|FG001|STARTED|Overall Study||103
8960229|NCT02528214|10023667|FG000|Treated|Overall Study||107
8960230|NCT02528214|10023668|FG001|Treated|Overall Study||103
8960231|NCT02528214|10023667|FG000|COMPLETED|Overall Study||107
8960232|NCT02528214|10023668|FG001|COMPLETED|Overall Study||100
8960233|NCT02528214|10023667|FG000|NOT COMPLETED|Overall Study||0
8960234|NCT02528214|10023668|FG001|NOT COMPLETED|Overall Study||3
8960235|NCT02528253|10023680|FG000|STARTED|Overall Study||205
8960236|NCT02528253|10023681|FG001|STARTED|Overall Study||204
8960237|NCT02528253|10023682|FG002|STARTED|Overall Study||407
8960238|NCT02528253|10023683|FG003|STARTED|Overall Study||407
8960239|NCT02528253|10023684|FG004|STARTED|Overall Study||602
8960240|NCT02528253|10023680|FG000|Intent to Treat Population|Overall Study||202
8960241|NCT02528253|10023681|FG001|Intent to Treat Population|Overall Study||204
8960242|NCT02528253|10023682|FG002|Intent to Treat Population|Overall Study||407
8960243|NCT02528253|10023683|FG003|Intent to Treat Population|Overall Study||407
8960244|NCT02528253|10023684|FG004|Intent to Treat Population|Overall Study|3 participants randomized to placebo arm received tramadol during the course of study|605
8960245|NCT02528253|10023680|FG000|Treated at Week 16|Overall Study||99
8960246|NCT02528253|10023681|FG001|Treated at Week 16|Overall Study||95
8960247|NCT02528253|10023682|FG002|Treated at Week 16|Overall Study||236
8960248|NCT02528253|10023683|FG003|Treated at Week 16|Overall Study||242
8960249|NCT02528253|10023684|FG004|Treated at Week 16|Overall Study||307
8960250|NCT02528253|10023680|FG000|COMPLETED|Overall Study||130
8960251|NCT02528253|10023681|FG001|COMPLETED|Overall Study||134
8960252|NCT02528253|10023682|FG002|COMPLETED|Overall Study||267
8960253|NCT02528253|10023683|FG003|COMPLETED|Overall Study||271
8960254|NCT02528253|10023684|FG004|COMPLETED|Overall Study||379
8960255|NCT02528253|10023680|FG000|NOT COMPLETED|Overall Study||75
8960256|NCT02528253|10023681|FG001|NOT COMPLETED|Overall Study||70
8960257|NCT02528253|10023682|FG002|NOT COMPLETED|Overall Study||140
8960258|NCT02528253|10023683|FG003|NOT COMPLETED|Overall Study||136
8960259|NCT02528253|10023684|FG004|NOT COMPLETED|Overall Study||223
8631511|NCT00540592|9671439|FG002|Completed at Day 180|Overall Study||197
8631512|NCT00540592|9671440|FG003|Completed at Day 180|Overall Study||197
8631513|NCT00540592|9671441|FG004|Completed at Day 180|Overall Study||195
9037785|NCT03320850|10099004|FG009|Safety Population|Overall Study||58
9037786|NCT03320850|10098995|FG000|COMPLETED|Overall Study||18
9037787|NCT03320850|10098996|FG001|COMPLETED|Overall Study||12
9037788|NCT03320850|10098997|FG002|COMPLETED|Overall Study||18
9037789|NCT03320850|10098998|FG003|COMPLETED|Overall Study||21
9037790|NCT03320850|10098999|FG004|COMPLETED|Overall Study||17
9037791|NCT03320850|10099000|FG005|COMPLETED|Overall Study||49
9037792|NCT03320850|10099001|FG006|COMPLETED|Overall Study||50
8960260|NCT02528305|10023715|FG000|STARTED|Overall Study||12
8960261|NCT02528305|10023715|FG000|End of Control Period Assessment|Overall Study||11
8960262|NCT02528305|10023715|FG000|End of Intervention Period Assessment|Overall Study||9
8960263|NCT02528305|10023715|FG000|COMPLETED|Overall Study||9
8960264|NCT02528305|10023715|FG000|NOT COMPLETED|Overall Study||3
8960265|NCT02528318|10023726|FG000|STARTED|Overall Study||8
8960266|NCT02528318|10023727|FG001|STARTED|Overall Study||8
8960267|NCT02528318|10023728|FG002|STARTED|Overall Study||8
8960268|NCT02528318|10023729|FG003|STARTED|Overall Study|Study was terminated prior to initiation of this intervention|0
8960269|NCT02528318|10023730|FG004|STARTED|Overall Study||24
8960270|NCT02528318|10023726|FG000|COMPLETED|Overall Study||8
8960271|NCT02528318|10023727|FG001|COMPLETED|Overall Study||8
8960272|NCT02528318|10023728|FG002|COMPLETED|Overall Study||8
8960273|NCT02528318|10023729|FG003|COMPLETED|Overall Study||0
8960274|NCT02528318|10023730|FG004|COMPLETED|Overall Study||24
8960275|NCT02528318|10023726|FG000|NOT COMPLETED|Overall Study||0
8631514|NCT00540592|9671442|FG005|Completed at Day 180|Overall Study||198
8631515|NCT00540592|9671443|FG006|Completed at Day 180|Overall Study||196
8631516|NCT00540592|9671444|FG007|Completed at Day 180|Overall Study||193
8631517|NCT00540592|9671445|FG008|Completed at Day 180|Overall Study||198
8631518|NCT00540592|9671446|FG009|Completed at Day 180|Overall Study||189
8631519|NCT00540592|9671437|FG000|COMPLETED|Overall Study||202
8631520|NCT00540592|9671438|FG001|COMPLETED|Overall Study||201
8631521|NCT00540592|9671439|FG002|COMPLETED|Overall Study||201
8631522|NCT00540592|9671440|FG003|COMPLETED|Overall Study||201
8631523|NCT00540592|9671441|FG004|COMPLETED|Overall Study||198
8631524|NCT00540592|9671442|FG005|COMPLETED|Overall Study||198
8631525|NCT00540592|9671443|FG006|COMPLETED|Overall Study||198
8960276|NCT02528318|10023727|FG001|NOT COMPLETED|Overall Study||0
8960277|NCT02528318|10023728|FG002|NOT COMPLETED|Overall Study||0
8960278|NCT02528318|10023729|FG003|NOT COMPLETED|Overall Study||0
8960279|NCT02528318|10023730|FG004|NOT COMPLETED|Overall Study||0
8960280|NCT02528331|10023742|FG000|STARTED|Overall Study||2
8960281|NCT02528331|10023742|FG000|COMPLETED|Overall Study||0
8960282|NCT02528331|10023742|FG000|NOT COMPLETED|Overall Study||2
8960283|NCT02528357|10023765|FG000|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||1
8960284|NCT02528357|10023766|FG001|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||1
8960285|NCT02528357|10023767|FG002|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||8
8960286|NCT02528357|10023768|FG003|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||10
8960287|NCT02528357|10023769|FG004|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||10
8960288|NCT02528357|10023770|FG005|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||4
8960289|NCT02528357|10023771|FG006|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||7
8960290|NCT02528357|10023772|FG007|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||4
8960291|NCT02528357|10023773|FG008|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
8960292|NCT02528357|10023774|FG009|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
8960293|NCT02528357|10023775|FG010|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
8960294|NCT02528357|10023776|FG011|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
8960295|NCT02528357|10023777|FG012|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
8960296|NCT02528357|10023778|FG013|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
8960297|NCT02528357|10023779|FG014|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
8960298|NCT02528357|10023780|FG015|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
8960299|NCT02528357|10023781|FG016|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
8960300|NCT02528357|10023782|FG017|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
8960301|NCT02528357|10023783|FG018|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
8960302|NCT02528357|10023765|FG000|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||1
8960303|NCT02528357|10023766|FG001|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
8960304|NCT02528357|10023767|FG002|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||6
8960305|NCT02528357|10023768|FG003|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||9
8960306|NCT02528357|10023769|FG004|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||6
8960307|NCT02528357|10023770|FG005|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||2
8960308|NCT02528357|10023771|FG006|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||5
8960309|NCT02528357|10023772|FG007|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||2
8960310|NCT02528357|10023773|FG008|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
8960311|NCT02528357|10023774|FG009|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
8960312|NCT02528357|10023775|FG010|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
8960313|NCT02528357|10023776|FG011|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
8960314|NCT02528357|10023777|FG012|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
8960315|NCT02528357|10023778|FG013|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
8960316|NCT02528357|10023779|FG014|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
8960317|NCT02528357|10023780|FG015|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
8960318|NCT02528357|10023781|FG016|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
8960319|NCT02528357|10023782|FG017|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
8960320|NCT02528357|10023783|FG018|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
8960321|NCT02528357|10023765|FG000|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
8960322|NCT02528357|10023766|FG001|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||1
8960323|NCT02528357|10023767|FG002|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||2
8960324|NCT02528357|10023768|FG003|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||1
8960325|NCT02528357|10023769|FG004|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||4
8960326|NCT02528357|10023770|FG005|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||2
8960327|NCT02528357|10023771|FG006|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||2
8960328|NCT02528357|10023772|FG007|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||2
8960329|NCT02528357|10023773|FG008|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
8960330|NCT02528357|10023774|FG009|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
8960331|NCT02528357|10023775|FG010|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
8960332|NCT02528357|10023776|FG011|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
8960333|NCT02528357|10023777|FG012|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
8960334|NCT02528357|10023778|FG013|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
8960335|NCT02528357|10023779|FG014|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
8960336|NCT02528357|10023780|FG015|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
8960337|NCT02528357|10023781|FG016|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
8960338|NCT02528357|10023782|FG017|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
8960339|NCT02528357|10023783|FG018|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
8960340|NCT02528357|10023765|FG000|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
8960341|NCT02528357|10023766|FG001|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
8960342|NCT02528357|10023767|FG002|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
8960343|NCT02528357|10023768|FG003|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
8960344|NCT02528357|10023769|FG004|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
8960345|NCT02528357|10023770|FG005|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
8960346|NCT02528357|10023771|FG006|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
8960347|NCT02528357|10023772|FG007|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
8631526|NCT00540592|9671444|FG007|COMPLETED|Overall Study||198
8631527|NCT00540592|9671445|FG008|COMPLETED|Overall Study||199
8960348|NCT02528357|10023773|FG008|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||5
8960349|NCT02528357|10023774|FG009|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||5
8960350|NCT02528357|10023775|FG010|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||10
8960351|NCT02528357|10023776|FG011|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||12
8960352|NCT02528357|10023777|FG012|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||14
8960353|NCT02528357|10023778|FG013|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||12
8960354|NCT02528357|10023779|FG014|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||12
8875061|NCT01904773|9931721|FG000|STARTED|Fifth Intervention||0
8875062|NCT01904773|9931722|FG001|STARTED|Fifth Intervention||1
8875063|NCT01904773|9931723|FG002|STARTED|Fifth Intervention||1
8875064|NCT01904773|9931724|FG003|STARTED|Fifth Intervention||2
8875065|NCT01904773|9931725|FG004|STARTED|Fifth Intervention||3
8960355|NCT02528357|10023780|FG015|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||4
8960356|NCT02528357|10023781|FG016|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
8960357|NCT02528357|10023782|FG017|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
8960358|NCT02528357|10023783|FG018|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
8960359|NCT02528357|10023765|FG000|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
8960360|NCT02528357|10023766|FG001|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
8960361|NCT02528357|10023767|FG002|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
8570344|NCT00103194|9602533|FG000|Eligible and Treated|Overall Study||35
8570345|NCT00103194|9602533|FG000|COMPLETED|Overall Study||18
8570346|NCT00103194|9602533|FG000|NOT COMPLETED|Overall Study||31
8570347|NCT00103207|9602537|FG000|STARTED|Overall Study||72
8570348|NCT00103207|9602537|FG000|Eligible Patients w/ Confirmed Diagnosis|Overall Study||41
8570349|NCT00103207|9602537|FG000|Eligible Patients w/ Smoking Status Data|Overall Study||37
8570350|NCT00103207|9602537|FG000|COMPLETED|Overall Study||34
8570351|NCT00103207|9602537|FG000|NOT COMPLETED|Overall Study||38
8570352|NCT00103259|9602545|FG000|STARTED|Overall Study||27
8570353|NCT00103259|9602546|FG001|STARTED|Overall Study||44
8570354|NCT00103259|9602545|FG000|Eligible|Overall Study||27
8875066|NCT01904773|9931726|FG005|STARTED|Fifth Intervention||4
8875067|NCT01904773|9931727|FG006|STARTED|Fifth Intervention||3
8570355|NCT00103259|9602546|FG001|Eligible|Overall Study||41
8875068|NCT01904773|9931728|FG007|STARTED|Fifth Intervention||3
8875069|NCT01904773|9931729|FG008|STARTED|Fifth Intervention||4
8875070|NCT01904773|9931721|FG000|COMPLETED|Fifth Intervention||0
8875071|NCT01904773|9931722|FG001|COMPLETED|Fifth Intervention||1
8875072|NCT01904773|9931723|FG002|COMPLETED|Fifth Intervention||1
8875073|NCT01904773|9931724|FG003|COMPLETED|Fifth Intervention||2
8875074|NCT01904773|9931725|FG004|COMPLETED|Fifth Intervention||3
8875075|NCT01904773|9931726|FG005|COMPLETED|Fifth Intervention||4
8875076|NCT01904773|9931727|FG006|COMPLETED|Fifth Intervention||3
8875077|NCT01904773|9931728|FG007|COMPLETED|Fifth Intervention||2
8875078|NCT01904773|9931729|FG008|COMPLETED|Fifth Intervention||4
8875079|NCT01904773|9931721|FG000|NOT COMPLETED|Fifth Intervention||0
8875080|NCT01904773|9931722|FG001|NOT COMPLETED|Fifth Intervention||0
8875081|NCT01904773|9931723|FG002|NOT COMPLETED|Fifth Intervention||0
8960362|NCT02528357|10023768|FG003|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
8960363|NCT02528357|10023769|FG004|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
8960364|NCT02528357|10023770|FG005|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
8960365|NCT02528357|10023771|FG006|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
8960366|NCT02528357|10023772|FG007|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
8960367|NCT02528357|10023773|FG008|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||4
8960368|NCT02528357|10023774|FG009|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||4
8960369|NCT02528357|10023775|FG010|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||7
8960370|NCT02528357|10023776|FG011|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||9
8960371|NCT02528357|10023777|FG012|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||9
8960372|NCT02528357|10023778|FG013|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||6
8960373|NCT02528357|10023779|FG014|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||5
8960374|NCT02528357|10023780|FG015|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||4
8960375|NCT02528357|10023781|FG016|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
8960376|NCT02528357|10023782|FG017|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
8960377|NCT02528357|10023783|FG018|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
8960378|NCT02528357|10023765|FG000|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
8960379|NCT02528357|10023766|FG001|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
8960380|NCT02528357|10023767|FG002|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
8960381|NCT02528357|10023768|FG003|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
8960382|NCT02528357|10023769|FG004|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
8960383|NCT02528357|10023770|FG005|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
8960384|NCT02528357|10023771|FG006|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
8960385|NCT02528357|10023772|FG007|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
8960386|NCT02528357|10023773|FG008|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||1
8960387|NCT02528357|10023774|FG009|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||1
8960388|NCT02528357|10023775|FG010|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||3
8960389|NCT02528357|10023776|FG011|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||3
8960390|NCT02528357|10023777|FG012|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||5
8960391|NCT02528357|10023778|FG013|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||6
8960392|NCT02528357|10023779|FG014|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||7
8960393|NCT02528357|10023780|FG015|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
8960394|NCT02528357|10023781|FG016|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
8960395|NCT02528357|10023782|FG017|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
8960396|NCT02528357|10023783|FG018|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
8960397|NCT02528357|10023765|FG000|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8960398|NCT02528357|10023766|FG001|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8960399|NCT02528357|10023767|FG002|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8960400|NCT02528357|10023768|FG003|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8960401|NCT02528357|10023769|FG004|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8960402|NCT02528357|10023770|FG005|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8960403|NCT02528357|10023771|FG006|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8960404|NCT02528357|10023772|FG007|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8960405|NCT02528357|10023773|FG008|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8960406|NCT02528357|10023774|FG009|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8960407|NCT02528357|10023775|FG010|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8960408|NCT02528357|10023776|FG011|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8960409|NCT02528357|10023777|FG012|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8960410|NCT02528357|10023778|FG013|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8960411|NCT02528357|10023779|FG014|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8960412|NCT02528357|10023780|FG015|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8960413|NCT02528357|10023781|FG016|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||9
8960414|NCT02528357|10023782|FG017|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||8
8960415|NCT02528357|10023783|FG018|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||5
8960416|NCT02528357|10023765|FG000|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8960417|NCT02528357|10023766|FG001|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8960418|NCT02528357|10023767|FG002|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8960419|NCT02528357|10023768|FG003|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8960420|NCT02528357|10023769|FG004|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8960421|NCT02528357|10023770|FG005|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8960422|NCT02528357|10023771|FG006|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8960423|NCT02528357|10023772|FG007|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8960424|NCT02528357|10023773|FG008|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8960425|NCT02528357|10023774|FG009|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8960426|NCT02528357|10023775|FG010|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8960427|NCT02528357|10023776|FG011|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8960428|NCT02528357|10023777|FG012|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8960429|NCT02528357|10023778|FG013|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8960430|NCT02528357|10023779|FG014|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8960431|NCT02528357|10023780|FG015|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8960432|NCT02528357|10023781|FG016|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||6
8960433|NCT02528357|10023782|FG017|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||4
8960434|NCT02528357|10023783|FG018|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||2
8960435|NCT02528357|10023765|FG000|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8960436|NCT02528357|10023766|FG001|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8960437|NCT02528357|10023767|FG002|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8960438|NCT02528357|10023768|FG003|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8960439|NCT02528357|10023769|FG004|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8960440|NCT02528357|10023770|FG005|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8631528|NCT00540592|9671446|FG009|COMPLETED|Overall Study||201
8631529|NCT00540592|9671437|FG000|NOT COMPLETED|Overall Study||2
8631530|NCT00540592|9671438|FG001|NOT COMPLETED|Overall Study||1
8631531|NCT00540592|9671439|FG002|NOT COMPLETED|Overall Study||1
8631532|NCT00540592|9671440|FG003|NOT COMPLETED|Overall Study||1
8631533|NCT00540592|9671441|FG004|NOT COMPLETED|Overall Study||1
8631534|NCT00540592|9671442|FG005|NOT COMPLETED|Overall Study||0
8631535|NCT00540592|9671443|FG006|NOT COMPLETED|Overall Study||0
8631536|NCT00540592|9671444|FG007|NOT COMPLETED|Overall Study||1
8960441|NCT02528357|10023771|FG006|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8960442|NCT02528357|10023772|FG007|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8960443|NCT02528357|10023773|FG008|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8960444|NCT02528357|10023774|FG009|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8960445|NCT02528357|10023775|FG010|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8960446|NCT02528357|10023776|FG011|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8960447|NCT02528357|10023777|FG012|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8960448|NCT02528357|10023778|FG013|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8960449|NCT02528357|10023779|FG014|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8960450|NCT02528357|10023780|FG015|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8960451|NCT02528357|10023781|FG016|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||3
8960452|NCT02528357|10023782|FG017|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||4
8960453|NCT02528357|10023783|FG018|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||3
8960454|NCT02528370|10023825|FG000|STARTED|Overall Study||119
8960455|NCT02528370|10023826|FG001|STARTED|Overall Study||78
8960456|NCT02528370|10023825|FG000|COMPLETED|Overall Study||102
8960457|NCT02528370|10023826|FG001|COMPLETED|Overall Study||77
8960458|NCT02528370|10023825|FG000|NOT COMPLETED|Overall Study||17
8960459|NCT02528370|10023826|FG001|NOT COMPLETED|Overall Study||1
8960460|NCT02528409|10023834|FG000|STARTED|Overall Study||40
8960461|NCT02528409|10023835|FG001|STARTED|Overall Study||40
8960462|NCT02528409|10023834|FG000|COMPLETED|Overall Study||18
8960463|NCT02528409|10023835|FG001|COMPLETED|Overall Study||24
8960464|NCT02528409|10023834|FG000|NOT COMPLETED|Overall Study||22
8960465|NCT02528409|10023835|FG001|NOT COMPLETED|Overall Study||16
8960466|NCT02528721|10023843|FG000|STARTED|Overall Study||203
8960467|NCT02528721|10023844|FG001|STARTED|Overall Study||79
8960468|NCT02528721|10023843|FG000|COMPLETED|Overall Study||196
8960469|NCT02528721|10023844|FG001|COMPLETED|Overall Study||76
8960470|NCT02528721|10023843|FG000|NOT COMPLETED|Overall Study||7
8960471|NCT02528721|10023844|FG001|NOT COMPLETED|Overall Study||3
8960472|NCT02528786|10023850|FG000|STARTED|Overall Study||8
8960473|NCT02528786|10023850|FG000|COMPLETED|Overall Study||8
8960474|NCT02528786|10023850|FG000|NOT COMPLETED|Overall Study||0
8960475|NCT02528942|10023854|FG000|STARTED|Overall Study||101
8960476|NCT02528942|10023854|FG000|COMPLETED|Overall Study||67
8960477|NCT02528942|10023854|FG000|NOT COMPLETED|Overall Study||34
8960478|NCT02529072|10023860|FG000|STARTED|Overall Study||3
8960479|NCT02529072|10023861|FG001|STARTED|Overall Study||3
8960480|NCT02529072|10023860|FG000|COMPLETED|Overall Study||3
8960481|NCT02529072|10023861|FG001|COMPLETED|Overall Study||3
8960482|NCT02529072|10023860|FG000|NOT COMPLETED|Overall Study||0
8960483|NCT02529072|10023861|FG001|NOT COMPLETED|Overall Study||0
8960484|NCT02529137|10023867|FG000|STARTED|Overall Study||2000
8960485|NCT02529137|10023867|FG000|COMPLETED|Overall Study||1992
8960486|NCT02529137|10023867|FG000|NOT COMPLETED|Overall Study||8
8960487|NCT02529488|10023872|FG000|STARTED|Overall Study||149
8960488|NCT02529488|10023872|FG000|COMPLETED|Overall Study||145
8960489|NCT02529488|10023872|FG000|NOT COMPLETED|Overall Study||4
8960490|NCT02529553|10023889|FG000|STARTED|Overall Study||1
8960491|NCT02529553|10023890|FG001|STARTED|Overall Study||1
8960492|NCT02529553|10023891|FG002|STARTED|Overall Study||1
8960493|NCT02529553|10023892|FG003|STARTED|Overall Study||3
8960494|NCT02529553|10023893|FG004|STARTED|Overall Study||3
8960495|NCT02529553|10023894|FG005|STARTED|Overall Study||4
8960496|NCT02529553|10023895|FG006|STARTED|Overall Study||3
8960497|NCT02529553|10023896|FG007|STARTED|Overall Study||6
8960498|NCT02529553|10023897|FG008|STARTED|Overall Study||3
8960499|NCT02529553|10023889|FG000|COMPLETED|Overall Study||0
8960500|NCT02529553|10023890|FG001|COMPLETED|Overall Study||0
8960501|NCT02529553|10023891|FG002|COMPLETED|Overall Study||0
8960502|NCT02529553|10023892|FG003|COMPLETED|Overall Study||0
8960503|NCT02529553|10023893|FG004|COMPLETED|Overall Study||0
8960504|NCT02529553|10023894|FG005|COMPLETED|Overall Study||0
8960505|NCT02529553|10023895|FG006|COMPLETED|Overall Study||0
8960506|NCT02529553|10023896|FG007|COMPLETED|Overall Study||0
8960507|NCT02529553|10023897|FG008|COMPLETED|Overall Study||0
8960508|NCT02529553|10023889|FG000|NOT COMPLETED|Overall Study||1
8960509|NCT02529553|10023890|FG001|NOT COMPLETED|Overall Study||1
8960510|NCT02529553|10023891|FG002|NOT COMPLETED|Overall Study||1
8960511|NCT02529553|10023892|FG003|NOT COMPLETED|Overall Study||3
8960512|NCT02529553|10023893|FG004|NOT COMPLETED|Overall Study||3
8960513|NCT02529553|10023894|FG005|NOT COMPLETED|Overall Study||4
8960514|NCT02529553|10023895|FG006|NOT COMPLETED|Overall Study||3
8960515|NCT02529553|10023896|FG007|NOT COMPLETED|Overall Study||6
8960516|NCT02529553|10023897|FG008|NOT COMPLETED|Overall Study||3
8960517|NCT02529995|10023920|FG000|STARTED|Part A||15
8960518|NCT02529995|10023921|FG001|STARTED|Part A||16
8960519|NCT02529995|10023920|FG000|COMPLETED|Part A|'Completed' means 'Completed the Study', i.e. zero patient completed the study in part A.|0
8960520|NCT02529995|10023921|FG001|COMPLETED|Part A|'Completed' means 'Completed the Study', i.e. zero patient completed the study in part A.|0
8960521|NCT02529995|10023920|FG000|NOT COMPLETED|Part A||15
8960522|NCT02529995|10023921|FG001|NOT COMPLETED|Part A||16
8960523|NCT02529995|10023920|FG000|STARTED|Part B||15
8960524|NCT02529995|10023921|FG001|STARTED|Part B||16
8960525|NCT02529995|10023920|FG000|COMPLETED|Part B||9
8960526|NCT02529995|10023921|FG001|COMPLETED|Part B||4
8960527|NCT02529995|10023920|FG000|NOT COMPLETED|Part B||6
8960528|NCT02529995|10023921|FG001|NOT COMPLETED|Part B||12
8960529|NCT02530125|10023927|FG000|STARTED|Completed Treatment||4
8960530|NCT02530125|10023927|FG000|COMPLETED|Completed Treatment||3
8960531|NCT02530125|10023927|FG000|NOT COMPLETED|Completed Treatment||1
8960532|NCT02530125|10023927|FG000|STARTED|Followed for Survival for 2 Years||3
8960533|NCT02530125|10023927|FG000|COMPLETED|Followed for Survival for 2 Years||0
8960534|NCT02530125|10023927|FG000|NOT COMPLETED|Followed for Survival for 2 Years||3
8960535|NCT02530151|10023933|FG000|STARTED|Overall Study||37
8960536|NCT02530151|10023934|FG001|STARTED|Overall Study||33
8960537|NCT02530151|10023933|FG000|COMPLETED|Overall Study||16
8960538|NCT02530151|10023934|FG001|COMPLETED|Overall Study||17
8960539|NCT02530151|10023933|FG000|NOT COMPLETED|Overall Study||21
8960540|NCT02530151|10023934|FG001|NOT COMPLETED|Overall Study||16
8960541|NCT02530242|10023942|FG000|STARTED|Overall Study||16
8960542|NCT02530242|10023943|FG001|STARTED|Overall Study||16
8960543|NCT02530242|10023942|FG000|COMPLETED|Overall Study||16
8960544|NCT02530242|10023943|FG001|COMPLETED|Overall Study||15
8960545|NCT02530242|10023942|FG000|NOT COMPLETED|Overall Study||0
8960546|NCT02530242|10023943|FG001|NOT COMPLETED|Overall Study||1
8960547|NCT02530281|10023951|FG000|STARTED|Overall Study||229
8960548|NCT02530281|10023952|FG001|STARTED|Overall Study||115
8960549|NCT02530281|10023951|FG000|COMPLETED|Overall Study||208
8960550|NCT02530281|10023952|FG001|COMPLETED|Overall Study||112
8960551|NCT02530281|10023951|FG000|NOT COMPLETED|Overall Study||21
8960552|NCT02530281|10023952|FG001|NOT COMPLETED|Overall Study||3
8960553|NCT02530294|10023962|FG000|STARTED|Overall Study||234
8960554|NCT02530294|10023963|FG001|STARTED|Overall Study||119
8960555|NCT02530294|10023962|FG000|COMPLETED|Overall Study||218
8960556|NCT02530294|10023963|FG001|COMPLETED|Overall Study||113
8960557|NCT02530294|10023962|FG000|NOT COMPLETED|Overall Study||16
8960558|NCT02530294|10023963|FG001|NOT COMPLETED|Overall Study||6
8960559|NCT02530385|10023971|FG000|STARTED|Overall Study||12
8960560|NCT02530385|10023972|FG001|STARTED|Overall Study||12
8960561|NCT02530385|10023971|FG000|COMPLETED|Overall Study||12
8960562|NCT02530385|10023972|FG001|COMPLETED|Overall Study||11
8960563|NCT02530385|10023971|FG000|NOT COMPLETED|Overall Study||0
8960564|NCT02530385|10023972|FG001|NOT COMPLETED|Overall Study||1
8960565|NCT02530450|10023980|FG000|STARTED|Overall Study||16
8960566|NCT02530450|10023981|FG001|STARTED|Overall Study||14
8960567|NCT02530450|10023980|FG000|COMPLETED|Overall Study||10
8960568|NCT02530450|10023981|FG001|COMPLETED|Overall Study||9
8960569|NCT02530450|10023980|FG000|NOT COMPLETED|Overall Study||6
8960570|NCT02530450|10023981|FG001|NOT COMPLETED|Overall Study||5
8960571|NCT02530476|10023991|FG000|STARTED|Overall Study||4
8960572|NCT02530476|10023992|FG001|STARTED|Overall Study||3
8960573|NCT02530476|10023993|FG002|STARTED|Overall Study||7
8960574|NCT02530476|10023994|FG003|STARTED|Overall Study||3
8960575|NCT02530476|10023991|FG000|COMPLETED|Overall Study||4
8960576|NCT02530476|10023992|FG001|COMPLETED|Overall Study||3
8960577|NCT02530476|10023993|FG002|COMPLETED|Overall Study||7
8960578|NCT02530476|10023994|FG003|COMPLETED|Overall Study||3
8960579|NCT02530476|10023991|FG000|NOT COMPLETED|Overall Study||0
8960580|NCT02530476|10023992|FG001|NOT COMPLETED|Overall Study||0
8960581|NCT02530476|10023993|FG002|NOT COMPLETED|Overall Study||0
8960582|NCT02530476|10023994|FG003|NOT COMPLETED|Overall Study||0
8960583|NCT02530515|10024007|FG000|STARTED|Overall Study||0
8960584|NCT02530515|10024008|FG001|STARTED|Overall Study||0
8960585|NCT02530515|10024009|FG002|STARTED|Overall Study||8
8960586|NCT02530515|10024007|FG000|COMPLETED|Overall Study||0
8960587|NCT02530515|10024008|FG001|COMPLETED|Overall Study||0
8960588|NCT02530515|10024009|FG002|COMPLETED|Overall Study||8
8960589|NCT02530515|10024007|FG000|NOT COMPLETED|Overall Study||0
8960590|NCT02530515|10024008|FG001|NOT COMPLETED|Overall Study||0
8960591|NCT02530515|10024009|FG002|NOT COMPLETED|Overall Study||0
8960592|NCT02530528|10024017|FG000|STARTED|Overall Study||13
8960593|NCT02530528|10024018|FG001|STARTED|Overall Study||13
8960594|NCT02530528|10024019|FG002|STARTED|Overall Study||14
8960595|NCT02530528|10024020|FG003|STARTED|Overall Study||14
8960596|NCT02530528|10024021|FG004|STARTED|Overall Study||13
8960597|NCT02530528|10024022|FG005|STARTED|Overall Study||13
8960598|NCT02530528|10024023|FG006|STARTED|Overall Study||14
8960599|NCT02530528|10024024|FG007|STARTED|Overall Study||14
8960600|NCT02530528|10024017|FG000|COMPLETED|Overall Study|13 participants received CHG Cloth|12
8960601|NCT02530528|10024018|FG001|COMPLETED|Overall Study||12
8960602|NCT02530528|10024019|FG002|COMPLETED|Overall Study|14 participants received CHG cloth|12
8960603|NCT02530528|10024020|FG003|COMPLETED|Overall Study||12
8960604|NCT02530528|10024021|FG004|COMPLETED|Overall Study|13 participants received CHG cloth|12
8960605|NCT02530528|10024022|FG005|COMPLETED|Overall Study||12
8960606|NCT02530528|10024023|FG006|COMPLETED|Overall Study|14 participants received comparator CHG.|12
8960607|NCT02530528|10024024|FG007|COMPLETED|Overall Study||12
8960608|NCT02530528|10024017|FG000|NOT COMPLETED|Overall Study||1
8960609|NCT02530528|10024018|FG001|NOT COMPLETED|Overall Study||1
8960610|NCT02530528|10024019|FG002|NOT COMPLETED|Overall Study||2
8960611|NCT02530528|10024020|FG003|NOT COMPLETED|Overall Study||2
8960612|NCT02530528|10024021|FG004|NOT COMPLETED|Overall Study||1
8960613|NCT02530528|10024022|FG005|NOT COMPLETED|Overall Study||1
8960614|NCT02530528|10024023|FG006|NOT COMPLETED|Overall Study||2
8960615|NCT02530528|10024024|FG007|NOT COMPLETED|Overall Study||2
8960616|NCT02530541|10024038|FG000|STARTED|Overall Study||21
8960617|NCT02530541|10024039|FG001|STARTED|Overall Study||23
8960618|NCT02530541|10024040|FG002|STARTED|Overall Study||22
8960619|NCT02530541|10024041|FG003|STARTED|Overall Study||21
8960620|NCT02530541|10024042|FG004|STARTED|Overall Study||20
8960621|NCT02530541|10024043|FG005|STARTED|Overall Study||19
8960622|NCT02530541|10024038|FG000|COMPLETED|Overall Study||14
8960623|NCT02530541|10024039|FG001|COMPLETED|Overall Study||15
8960624|NCT02530541|10024040|FG002|COMPLETED|Overall Study||14
8960625|NCT02530541|10024041|FG003|COMPLETED|Overall Study||15
8960626|NCT02530541|10024042|FG004|COMPLETED|Overall Study||15
8960627|NCT02530541|10024043|FG005|COMPLETED|Overall Study||14
8960628|NCT02530541|10024038|FG000|NOT COMPLETED|Overall Study||7
8960629|NCT02530541|10024039|FG001|NOT COMPLETED|Overall Study||8
8960630|NCT02530541|10024040|FG002|NOT COMPLETED|Overall Study||8
8960631|NCT02530541|10024041|FG003|NOT COMPLETED|Overall Study||6
8960632|NCT02530541|10024042|FG004|NOT COMPLETED|Overall Study||5
8960633|NCT02530541|10024043|FG005|NOT COMPLETED|Overall Study||5
8960634|NCT02530554|10024052|FG000|STARTED|Overall Study||12
8960635|NCT02530554|10024053|FG001|STARTED|Overall Study||14
8960636|NCT02530554|10024054|FG002|STARTED|Overall Study||12
8960637|NCT02530554|10024055|FG003|STARTED|Overall Study||14
8960638|NCT02530554|10024052|FG000|COMPLETED|Overall Study||12
8960639|NCT02530554|10024053|FG001|COMPLETED|Overall Study||14
8960640|NCT02530554|10024054|FG002|COMPLETED|Overall Study||12
8960641|NCT02530554|10024055|FG003|COMPLETED|Overall Study||14
8960642|NCT02530554|10024052|FG000|NOT COMPLETED|Overall Study||0
8960643|NCT02530554|10024053|FG001|NOT COMPLETED|Overall Study||0
8960644|NCT02530554|10024054|FG002|NOT COMPLETED|Overall Study||0
8960645|NCT02530554|10024055|FG003|NOT COMPLETED|Overall Study||0
8960646|NCT02530619|10024062|FG000|STARTED|Registered for Study||26
8960647|NCT02530619|10024062|FG000|Registered|Registered for Study||26
8960648|NCT02530619|10024062|FG000|Received 1st Dose of Alisertib|Registered for Study||24
8960649|NCT02530619|10024062|FG000|COMPLETED|Registered for Study||24
8960650|NCT02530619|10024062|FG000|NOT COMPLETED|Registered for Study||2
8960651|NCT02530619|10024062|FG000|STARTED|Completed 1st Cycle of Treatment||24
8960652|NCT02530619|10024062|FG000|COMPLETED|Completed 1st Cycle of Treatment||24
8960653|NCT02530619|10024062|FG000|NOT COMPLETED|Completed 1st Cycle of Treatment||0
8960654|NCT02530619|10024062|FG000|STARTED|Continued Treatment Cycles 2 Through 6||24
8960655|NCT02530619|10024062|FG000|COMPLETED|Continued Treatment Cycles 2 Through 6||14
8960656|NCT02530619|10024062|FG000|NOT COMPLETED|Continued Treatment Cycles 2 Through 6||10
8960657|NCT02530619|10024062|FG000|STARTED|Continued Treatment Cycle 7+||14
8960658|NCT02530619|10024062|FG000|COMPLETED|Continued Treatment Cycle 7+||14
8960659|NCT02530619|10024062|FG000|NOT COMPLETED|Continued Treatment Cycle 7+||0
8960660|NCT02530619|10024062|FG000|STARTED|Follow-up Period (6 Months)|Patients who received at least one dose of study drug go into follow-up.|21
8960661|NCT02530619|10024062|FG000|COMPLETED|Follow-up Period (6 Months)||10
8960662|NCT02530619|10024062|FG000|NOT COMPLETED|Follow-up Period (6 Months)||11
8960663|NCT02530671|10024068|FG000|STARTED|Overall Study||55
8960664|NCT02530671|10024069|FG001|STARTED|Overall Study||55
8960665|NCT02530671|10024068|FG000|COMPLETED|Overall Study||52
8960666|NCT02530671|10024069|FG001|COMPLETED|Overall Study||55
8960667|NCT02530671|10024068|FG000|NOT COMPLETED|Overall Study||3
8960668|NCT02530671|10024069|FG001|NOT COMPLETED|Overall Study||0
8960669|NCT02530905|10024077|FG000|STARTED|Double-Blind Period (12 Weeks)||4
8960670|NCT02530905|10024078|FG001|STARTED|Double-Blind Period (12 Weeks)||8
8960671|NCT02530905|10024079|FG002|STARTED|Double-Blind Period (12 Weeks)||0
8960672|NCT02530905|10024077|FG000|Received 4 mg/kg|Double-Blind Period (12 Weeks)||0
8960673|NCT02530905|10024078|FG001|Received 4 mg/kg|Double-Blind Period (12 Weeks)||8
8960674|NCT02530905|10024079|FG002|Received 4 mg/kg|Double-Blind Period (12 Weeks)||0
8960675|NCT02530905|10024077|FG000|Received 10 mg/kg|Double-Blind Period (12 Weeks)||0
8960676|NCT02530905|10024078|FG001|Received 10 mg/kg|Double-Blind Period (12 Weeks)||8
8960677|NCT02530905|10024079|FG002|Received 10 mg/kg|Double-Blind Period (12 Weeks)||0
8960678|NCT02530905|10024077|FG000|Received 20 mg/kg|Double-Blind Period (12 Weeks)||0
8960679|NCT02530905|10024078|FG001|Received 20 mg/kg|Double-Blind Period (12 Weeks)||8
8960680|NCT02530905|10024079|FG002|Received 20 mg/kg|Double-Blind Period (12 Weeks)||0
8960681|NCT02530905|10024077|FG000|Received 30 mg/kg|Double-Blind Period (12 Weeks)||0
8960682|NCT02530905|10024078|FG001|Received 30 mg/kg|Double-Blind Period (12 Weeks)||8
8960683|NCT02530905|10024079|FG002|Received 30 mg/kg|Double-Blind Period (12 Weeks)||0
8960684|NCT02530905|10024077|FG000|COMPLETED|Double-Blind Period (12 Weeks)||4
8960685|NCT02530905|10024078|FG001|COMPLETED|Double-Blind Period (12 Weeks)||8
8960686|NCT02530905|10024079|FG002|COMPLETED|Double-Blind Period (12 Weeks)||0
8960687|NCT02530905|10024077|FG000|NOT COMPLETED|Double-Blind Period (12 Weeks)||0
8960688|NCT02530905|10024078|FG001|NOT COMPLETED|Double-Blind Period (12 Weeks)||0
8960689|NCT02530905|10024079|FG002|NOT COMPLETED|Double-Blind Period (12 Weeks)||0
8570356|NCT00103259|9602545|FG000|Treated|Overall Study||23
8570357|NCT00103259|9602546|FG001|Treated|Overall Study||41
8570358|NCT00103259|9602545|FG000|Eligible and Treated|Overall Study||23
8960690|NCT02530905|10024077|FG000|STARTED|Open Label Extension Period (132 Weeks)||0
8960691|NCT02530905|10024078|FG001|STARTED|Open Label Extension Period (132 Weeks)||0
8960692|NCT02530905|10024079|FG002|STARTED|Open Label Extension Period (132 Weeks)|All participants from the double-blind period amenable to exon 45 skipping were enrolled to open-label extension period.|12
8960693|NCT02530905|10024077|FG000|COMPLETED|Open Label Extension Period (132 Weeks)||0
8960694|NCT02530905|10024078|FG001|COMPLETED|Open Label Extension Period (132 Weeks)||0
8960695|NCT02530905|10024079|FG002|COMPLETED|Open Label Extension Period (132 Weeks)||11
8570359|NCT00103259|9602546|FG001|Eligible and Treated|Overall Study||38
8570360|NCT00103259|9602545|FG000|Cross Over to the Other Arm|Overall Study||0
8577569|NCT00159419|9610331|FG000|COMPLETED|Overall Study||9
8960696|NCT02530905|10024077|FG000|NOT COMPLETED|Open Label Extension Period (132 Weeks)||0
8960697|NCT02530905|10024078|FG001|NOT COMPLETED|Open Label Extension Period (132 Weeks)||0
8960698|NCT02530905|10024079|FG002|NOT COMPLETED|Open Label Extension Period (132 Weeks)||1
8960699|NCT02530970|10024101|FG000|STARTED|Overall Study||1025
8960700|NCT02530970|10024101|FG000|COMPLETED|Overall Study||891
8960701|NCT02530970|10024101|FG000|NOT COMPLETED|Overall Study||134
8960702|NCT02530996|10024105|FG000|STARTED|First Intervention||6
8960703|NCT02530996|10024106|FG001|STARTED|First Intervention||6
8960704|NCT02530996|10024105|FG000|COMPLETED|First Intervention||6
8960705|NCT02530996|10024106|FG001|COMPLETED|First Intervention||6
8960706|NCT02530996|10024105|FG000|NOT COMPLETED|First Intervention||0
8960707|NCT02530996|10024106|FG001|NOT COMPLETED|First Intervention||0
8960708|NCT02530996|10024105|FG000|STARTED|Washout (5 Days)||6
8960709|NCT02530996|10024106|FG001|STARTED|Washout (5 Days)||6
8960710|NCT02530996|10024105|FG000|COMPLETED|Washout (5 Days)||6
8960711|NCT02530996|10024106|FG001|COMPLETED|Washout (5 Days)||6
8960712|NCT02530996|10024105|FG000|NOT COMPLETED|Washout (5 Days)||0
8960713|NCT02530996|10024106|FG001|NOT COMPLETED|Washout (5 Days)||0
8960714|NCT02530996|10024105|FG000|STARTED|Second Intervention||6
8960715|NCT02530996|10024106|FG001|STARTED|Second Intervention||6
8960716|NCT02530996|10024105|FG000|COMPLETED|Second Intervention||6
8960717|NCT02530996|10024106|FG001|COMPLETED|Second Intervention||6
8960718|NCT02530996|10024105|FG000|NOT COMPLETED|Second Intervention||0
8960719|NCT02530996|10024106|FG001|NOT COMPLETED|Second Intervention||0
8960720|NCT02531022|10024118|FG000|STARTED|Overall Study||55
8960721|NCT02531022|10024119|FG001|STARTED|Overall Study||50
8960722|NCT02531022|10024118|FG000|COMPLETED|Overall Study||55
8960723|NCT02531022|10024119|FG001|COMPLETED|Overall Study||48
8960724|NCT02531022|10024118|FG000|NOT COMPLETED|Overall Study||0
8960725|NCT02531022|10024119|FG001|NOT COMPLETED|Overall Study||2
8960726|NCT02531035|10024127|FG000|STARTED|Overall Study||705
8960727|NCT02531035|10024128|FG001|STARTED|Overall Study||700
8960728|NCT02531035|10024127|FG000|Treated|Overall Study||703
8960729|NCT02531035|10024128|FG001|Treated|Overall Study||699
8960730|NCT02531035|10024127|FG000|COMPLETED|Overall Study||624
8960731|NCT02531035|10024128|FG001|COMPLETED|Overall Study||605
8960732|NCT02531035|10024127|FG000|NOT COMPLETED|Overall Study||81
8960733|NCT02531035|10024128|FG001|NOT COMPLETED|Overall Study||95
8960734|NCT02531113|10024134|FG000|STARTED|Induction Period: Week 0 to 12||69
8960735|NCT02531113|10024134|FG000|COMPLETED|Induction Period: Week 0 to 12||58
8960736|NCT02531113|10024134|FG000|NOT COMPLETED|Induction Period: Week 0 to 12||11
8960737|NCT02531113|10024134|FG000|STARTED|Extension Period: Week 12 up to Week 160|6 participants completed induction; did not advance to extension due to lack efficacy.|52
8960738|NCT02531113|10024134|FG000|COMPLETED|Extension Period: Week 12 up to Week 160||14
8960739|NCT02531113|10024134|FG000|NOT COMPLETED|Extension Period: Week 12 up to Week 160||38
8960740|NCT02531321|10024140|FG000|STARTED|Overall Study||7
8960741|NCT02531321|10024141|FG001|STARTED|Overall Study||10
8960742|NCT02531321|10024140|FG000|COMPLETED|Overall Study||5
8960743|NCT02531321|10024141|FG001|COMPLETED|Overall Study||10
8960744|NCT02531321|10024140|FG000|NOT COMPLETED|Overall Study||2
8960745|NCT02531321|10024141|FG001|NOT COMPLETED|Overall Study||0
8960746|NCT02531373|10024156|FG000|STARTED|Overall Study||20
8960747|NCT02531373|10024157|FG001|STARTED|Overall Study||20
8960748|NCT02531373|10024158|FG002|STARTED|Overall Study||20
8960749|NCT02531373|10024159|FG003|STARTED|Overall Study||20
8960750|NCT02531373|10024160|FG004|STARTED|Overall Study||51
8960751|NCT02531373|10024161|FG005|STARTED|Overall Study||51
8960752|NCT02531373|10024162|FG006|STARTED|Overall Study||52
8960753|NCT02531373|10024163|FG007|STARTED|Overall Study||52
8960754|NCT02531373|10024164|FG008|STARTED|Overall Study||52
8960755|NCT02531373|10024156|FG000|Vaccination 1|Overall Study||20
8960756|NCT02531373|10024157|FG001|Vaccination 1|Overall Study||20
8960757|NCT02531373|10024158|FG002|Vaccination 1|Overall Study||20
8960758|NCT02531373|10024159|FG003|Vaccination 1|Overall Study||20
8960759|NCT02531373|10024160|FG004|Vaccination 1|Overall Study||50
8960760|NCT02531373|10024161|FG005|Vaccination 1|Overall Study||50
8960761|NCT02531373|10024162|FG006|Vaccination 1|Overall Study||52
8960762|NCT02531373|10024163|FG007|Vaccination 1|Overall Study||52
8960763|NCT02531373|10024164|FG008|Vaccination 1|Overall Study||52
8960764|NCT02531373|10024156|FG000|Vaccination 2|Overall Study||0
8960765|NCT02531373|10024157|FG001|Vaccination 2|Overall Study||0
8960766|NCT02531373|10024158|FG002|Vaccination 2|Overall Study||0
8960767|NCT02531373|10024159|FG003|Vaccination 2|Overall Study||0
8960768|NCT02531373|10024160|FG004|Vaccination 2|Overall Study||49
8960769|NCT02531373|10024161|FG005|Vaccination 2|Overall Study||48
8960770|NCT02531373|10024162|FG006|Vaccination 2|Overall Study||50
8960771|NCT02531373|10024163|FG007|Vaccination 2|Overall Study||51
8960772|NCT02531373|10024164|FG008|Vaccination 2|Overall Study||51
8960773|NCT02531373|10024156|FG000|Vaccination 3|Overall Study||0
8960774|NCT02531373|10024157|FG001|Vaccination 3|Overall Study||0
8960775|NCT02531373|10024158|FG002|Vaccination 3|Overall Study||0
8960776|NCT02531373|10024159|FG003|Vaccination 3|Overall Study||0
8960777|NCT02531373|10024160|FG004|Vaccination 3|Overall Study||48
8960778|NCT02531373|10024161|FG005|Vaccination 3|Overall Study||47
8960779|NCT02531373|10024162|FG006|Vaccination 3|Overall Study||49
8960780|NCT02531373|10024163|FG007|Vaccination 3|Overall Study||51
8960781|NCT02531373|10024164|FG008|Vaccination 3|Overall Study||49
8960782|NCT02531373|10024156|FG000|Vaccination 4|Overall Study||0
8960783|NCT02531373|10024157|FG001|Vaccination 4|Overall Study||0
8960784|NCT02531373|10024158|FG002|Vaccination 4|Overall Study||0
8960785|NCT02531373|10024159|FG003|Vaccination 4|Overall Study||0
8960786|NCT02531373|10024160|FG004|Vaccination 4|Overall Study||44
8960787|NCT02531373|10024161|FG005|Vaccination 4|Overall Study||43
8960788|NCT02531373|10024162|FG006|Vaccination 4|Overall Study||43
8960789|NCT02531373|10024163|FG007|Vaccination 4|Overall Study||43
8960790|NCT02531373|10024164|FG008|Vaccination 4|Overall Study||43
8960791|NCT02531373|10024156|FG000|COMPLETED|Overall Study||20
8960792|NCT02531373|10024157|FG001|COMPLETED|Overall Study||20
8960793|NCT02531373|10024158|FG002|COMPLETED|Overall Study||20
8960794|NCT02531373|10024159|FG003|COMPLETED|Overall Study||20
8960795|NCT02531373|10024160|FG004|COMPLETED|Overall Study||43
8960796|NCT02531373|10024161|FG005|COMPLETED|Overall Study||42
8960797|NCT02531373|10024162|FG006|COMPLETED|Overall Study||41
8960798|NCT02531373|10024163|FG007|COMPLETED|Overall Study||43
8960799|NCT02531373|10024164|FG008|COMPLETED|Overall Study||43
8960800|NCT02531373|10024156|FG000|NOT COMPLETED|Overall Study||0
8960801|NCT02531373|10024157|FG001|NOT COMPLETED|Overall Study||0
8960802|NCT02531373|10024158|FG002|NOT COMPLETED|Overall Study||0
8960803|NCT02531373|10024159|FG003|NOT COMPLETED|Overall Study||0
8960804|NCT02531373|10024160|FG004|NOT COMPLETED|Overall Study||8
8960805|NCT02531373|10024161|FG005|NOT COMPLETED|Overall Study||9
8960806|NCT02531373|10024162|FG006|NOT COMPLETED|Overall Study||11
8960807|NCT02531373|10024163|FG007|NOT COMPLETED|Overall Study||9
8960808|NCT02531373|10024164|FG008|NOT COMPLETED|Overall Study||9
8960809|NCT02531438|10024187|FG000|STARTED|Overall Study||386
8960810|NCT02531438|10024188|FG001|STARTED|Overall Study||388
8960811|NCT02531438|10024187|FG000|COMPLETED|Overall Study||356
8960812|NCT02531438|10024188|FG001|COMPLETED|Overall Study||362
8960813|NCT02531438|10024187|FG000|NOT COMPLETED|Overall Study||30
8960814|NCT02531438|10024188|FG001|NOT COMPLETED|Overall Study||26
8960815|NCT02531633|10024199|FG000|STARTED|Part A (52 Weeks)||42
8960816|NCT02531633|10024200|FG001|STARTED|Part A (52 Weeks)||39
8960817|NCT02531633|10024201|FG002|STARTED|Part A (52 Weeks)||26
8960818|NCT02531633|10024202|FG003|STARTED|Part A (52 Weeks)||27
8960819|NCT02531633|10024203|FG004|STARTED|Part A (52 Weeks)||27
8960820|NCT02531633|10024204|FG005|STARTED|Part A (52 Weeks)||0
8960821|NCT02531633|10024205|FG006|STARTED|Part A (52 Weeks)||0
8960822|NCT02531633|10024206|FG007|STARTED|Part A (52 Weeks)||0
8960823|NCT02531633|10024207|FG008|STARTED|Part A (52 Weeks)||0
8960824|NCT02531633|10024208|FG009|STARTED|Part A (52 Weeks)||0
8960825|NCT02531633|10024199|FG000|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||1
8960826|NCT02531633|10024200|FG001|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
8960827|NCT02531633|10024201|FG002|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||1
8960828|NCT02531633|10024202|FG003|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
8960829|NCT02531633|10024203|FG004|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
8960830|NCT02531633|10024204|FG005|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
8960831|NCT02531633|10024205|FG006|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
8960832|NCT02531633|10024206|FG007|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
8960833|NCT02531633|10024207|FG008|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
8960834|NCT02531633|10024208|FG009|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
8960835|NCT02531633|10024199|FG000|COMPLETED|Part A (52 Weeks)||8
8960836|NCT02531633|10024200|FG001|COMPLETED|Part A (52 Weeks)||5
8960837|NCT02531633|10024201|FG002|COMPLETED|Part A (52 Weeks)||4
8960838|NCT02531633|10024202|FG003|COMPLETED|Part A (52 Weeks)||5
8960839|NCT02531633|10024203|FG004|COMPLETED|Part A (52 Weeks)||4
8960840|NCT02531633|10024204|FG005|COMPLETED|Part A (52 Weeks)||0
8960841|NCT02531633|10024205|FG006|COMPLETED|Part A (52 Weeks)||0
8960842|NCT02531633|10024206|FG007|COMPLETED|Part A (52 Weeks)||0
8960843|NCT02531633|10024207|FG008|COMPLETED|Part A (52 Weeks)||0
8960844|NCT02531633|10024208|FG009|COMPLETED|Part A (52 Weeks)||0
8960845|NCT02531633|10024199|FG000|NOT COMPLETED|Part A (52 Weeks)||34
8960846|NCT02531633|10024200|FG001|NOT COMPLETED|Part A (52 Weeks)||34
8960847|NCT02531633|10024201|FG002|NOT COMPLETED|Part A (52 Weeks)||22
8960848|NCT02531633|10024202|FG003|NOT COMPLETED|Part A (52 Weeks)||22
8960849|NCT02531633|10024203|FG004|NOT COMPLETED|Part A (52 Weeks)||23
8960850|NCT02531633|10024204|FG005|NOT COMPLETED|Part A (52 Weeks)||0
8960851|NCT02531633|10024205|FG006|NOT COMPLETED|Part A (52 Weeks)||0
8960852|NCT02531633|10024206|FG007|NOT COMPLETED|Part A (52 Weeks)||0
8960853|NCT02531633|10024207|FG008|NOT COMPLETED|Part A (52 Weeks)||0
8960854|NCT02531633|10024208|FG009|NOT COMPLETED|Part A (52 Weeks)||0
8960855|NCT02531633|10024199|FG000|STARTED|Part B (104 Weeks)||0
8960856|NCT02531633|10024200|FG001|STARTED|Part B (104 Weeks)||0
8960857|NCT02531633|10024201|FG002|STARTED|Part B (104 Weeks)||0
8960858|NCT02531633|10024202|FG003|STARTED|Part B (104 Weeks)||0
8960859|NCT02531633|10024203|FG004|STARTED|Part B (104 Weeks)||0
8960860|NCT02531633|10024204|FG005|STARTED|Part B (104 Weeks)||8
8960861|NCT02531633|10024205|FG006|STARTED|Part B (104 Weeks)||5
8960862|NCT02531633|10024206|FG007|STARTED|Part B (104 Weeks)||4
8960863|NCT02531633|10024207|FG008|STARTED|Part B (104 Weeks)||5
8960864|NCT02531633|10024208|FG009|STARTED|Part B (104 Weeks)||4
8960865|NCT02531633|10024199|FG000|COMPLETED|Part B (104 Weeks)||0
8960866|NCT02531633|10024200|FG001|COMPLETED|Part B (104 Weeks)||0
8960867|NCT02531633|10024201|FG002|COMPLETED|Part B (104 Weeks)||0
8960868|NCT02531633|10024202|FG003|COMPLETED|Part B (104 Weeks)||0
8960869|NCT02531633|10024203|FG004|COMPLETED|Part B (104 Weeks)||0
8960870|NCT02531633|10024204|FG005|COMPLETED|Part B (104 Weeks)||0
8960871|NCT02531633|10024205|FG006|COMPLETED|Part B (104 Weeks)||0
8960872|NCT02531633|10024206|FG007|COMPLETED|Part B (104 Weeks)||0
8960873|NCT02531633|10024207|FG008|COMPLETED|Part B (104 Weeks)||0
8960874|NCT02531633|10024208|FG009|COMPLETED|Part B (104 Weeks)||0
8960875|NCT02531633|10024199|FG000|NOT COMPLETED|Part B (104 Weeks)||0
8960876|NCT02531633|10024200|FG001|NOT COMPLETED|Part B (104 Weeks)||0
8960877|NCT02531633|10024201|FG002|NOT COMPLETED|Part B (104 Weeks)||0
8960878|NCT02531633|10024202|FG003|NOT COMPLETED|Part B (104 Weeks)||0
8960879|NCT02531633|10024203|FG004|NOT COMPLETED|Part B (104 Weeks)||0
8960880|NCT02531633|10024204|FG005|NOT COMPLETED|Part B (104 Weeks)||8
8960881|NCT02531633|10024205|FG006|NOT COMPLETED|Part B (104 Weeks)||5
8960882|NCT02531633|10024206|FG007|NOT COMPLETED|Part B (104 Weeks)||4
8960883|NCT02531633|10024207|FG008|NOT COMPLETED|Part B (104 Weeks)||5
8960884|NCT02531633|10024208|FG009|NOT COMPLETED|Part B (104 Weeks)||4
8960885|NCT02531646|10024251|FG000|STARTED|Overall Study||37
8960886|NCT02531646|10024252|FG001|STARTED|Overall Study||18
8960887|NCT02531646|10024253|FG002|STARTED|Overall Study||11
8960888|NCT02531646|10024251|FG000|COMPLETED|Overall Study||32
8631537|NCT00540592|9671445|FG008|NOT COMPLETED|Overall Study||1
8631538|NCT00540592|9671446|FG009|NOT COMPLETED|Overall Study||2
8631539|NCT00540644|9671470|FG000|STARTED|Overall Study||48
8631540|NCT00540644|9671471|FG001|STARTED|Overall Study||22
8631541|NCT00540644|9671470|FG000|COMPLETED|Overall Study||39
8631542|NCT00540644|9671471|FG001|COMPLETED|Overall Study||13
8960889|NCT02531646|10024252|FG001|COMPLETED|Overall Study||17
8960890|NCT02531646|10024253|FG002|COMPLETED|Overall Study||11
8960891|NCT02531646|10024251|FG000|NOT COMPLETED|Overall Study||5
8960892|NCT02531646|10024252|FG001|NOT COMPLETED|Overall Study||1
8960893|NCT02531646|10024253|FG002|NOT COMPLETED|Overall Study||0
8960894|NCT02531698|10024263|FG000|STARTED|Overall Study||294
8960895|NCT02531698|10024264|FG001|STARTED|Overall Study||106
8960896|NCT02531698|10024263|FG000|COMPLETED|Overall Study||283
8960897|NCT02531698|10024264|FG001|COMPLETED|Overall Study||104
8960898|NCT02531698|10024263|FG000|NOT COMPLETED|Overall Study||11
8960899|NCT02531698|10024264|FG001|NOT COMPLETED|Overall Study||2
8960900|NCT02531802|10024300|FG000|STARTED|Received Vaccination 1||15
8960901|NCT02531802|10024301|FG001|STARTED|Received Vaccination 1||15
8960902|NCT02531802|10024302|FG002|STARTED|Received Vaccination 1||15
8960903|NCT02531802|10024303|FG003|STARTED|Received Vaccination 1||15
8960904|NCT02531802|10024304|FG004|STARTED|Received Vaccination 1||15
8960905|NCT02531802|10024305|FG005|STARTED|Received Vaccination 1||3
8960906|NCT02531802|10024306|FG006|STARTED|Received Vaccination 1||15
8960907|NCT02531802|10024307|FG007|STARTED|Received Vaccination 1||15
8960908|NCT02531802|10024308|FG008|STARTED|Received Vaccination 1||15
8960909|NCT02531802|10024309|FG009|STARTED|Received Vaccination 1||52
8960910|NCT02531802|10024310|FG010|STARTED|Received Vaccination 1||15
8960911|NCT02531802|10024311|FG011|STARTED|Received Vaccination 1||15
8960912|NCT02531802|10024312|FG012|STARTED|Received Vaccination 1||15
8631543|NCT00540644|9671470|FG000|NOT COMPLETED|Overall Study||9
8631544|NCT00540644|9671471|FG001|NOT COMPLETED|Overall Study||9
8631545|NCT00540722|9671477|FG000|STARTED|Overall Study||56
8960913|NCT02531802|10024313|FG013|STARTED|Received Vaccination 1||15
8960914|NCT02531802|10024314|FG014|STARTED|Received Vaccination 1||40
8960915|NCT02531802|10024315|FG015|STARTED|Received Vaccination 1||30
8960916|NCT02531802|10024316|FG016|STARTED|Received Vaccination 1||30
8960917|NCT02531802|10024317|FG017|STARTED|Received Vaccination 1||30
8960918|NCT02531802|10024318|FG018|STARTED|Received Vaccination 1||30
8960919|NCT02531802|10024319|FG019|STARTED|Received Vaccination 1||30
8960920|NCT02531802|10024320|FG020|STARTED|Received Vaccination 1||50
8960921|NCT02531802|10024300|FG000|COMPLETED|Received Vaccination 1||15
8960922|NCT02531802|10024301|FG001|COMPLETED|Received Vaccination 1||15
8960923|NCT02531802|10024302|FG002|COMPLETED|Received Vaccination 1||15
8960924|NCT02531802|10024303|FG003|COMPLETED|Received Vaccination 1||15
8960925|NCT02531802|10024304|FG004|COMPLETED|Received Vaccination 1||15
8960926|NCT02531802|10024305|FG005|COMPLETED|Received Vaccination 1||3
8960927|NCT02531802|10024306|FG006|COMPLETED|Received Vaccination 1||15
8960928|NCT02531802|10024307|FG007|COMPLETED|Received Vaccination 1||15
8960929|NCT02531802|10024308|FG008|COMPLETED|Received Vaccination 1||15
8960930|NCT02531802|10024309|FG009|COMPLETED|Received Vaccination 1||52
8960931|NCT02531802|10024310|FG010|COMPLETED|Received Vaccination 1||15
8960932|NCT02531802|10024311|FG011|COMPLETED|Received Vaccination 1||15
8960933|NCT02531802|10024312|FG012|COMPLETED|Received Vaccination 1||15
8960934|NCT02531802|10024313|FG013|COMPLETED|Received Vaccination 1||15
8960935|NCT02531802|10024314|FG014|COMPLETED|Received Vaccination 1||40
8960936|NCT02531802|10024315|FG015|COMPLETED|Received Vaccination 1||30
8960937|NCT02531802|10024316|FG016|COMPLETED|Received Vaccination 1||30
8631546|NCT00540722|9671477|FG000|COMPLETED|Overall Study||56
8631547|NCT00540722|9671477|FG000|NOT COMPLETED|Overall Study||0
8631548|NCT00540982|9671482|FG000|STARTED|Overall Study||47
8631549|NCT00540982|9671482|FG000|Normal Liver Function|Overall Study||11
8960938|NCT02531802|10024317|FG017|COMPLETED|Received Vaccination 1||30
8960939|NCT02531802|10024318|FG018|COMPLETED|Received Vaccination 1||30
8960940|NCT02531802|10024319|FG019|COMPLETED|Received Vaccination 1||30
8960941|NCT02531802|10024320|FG020|COMPLETED|Received Vaccination 1||50
8960942|NCT02531802|10024300|FG000|NOT COMPLETED|Received Vaccination 1||0
8960943|NCT02531802|10024301|FG001|NOT COMPLETED|Received Vaccination 1||0
8960944|NCT02531802|10024302|FG002|NOT COMPLETED|Received Vaccination 1||0
8960945|NCT02531802|10024303|FG003|NOT COMPLETED|Received Vaccination 1||0
8960946|NCT02531802|10024304|FG004|NOT COMPLETED|Received Vaccination 1||0
8960947|NCT02531802|10024305|FG005|NOT COMPLETED|Received Vaccination 1||0
8960948|NCT02531802|10024306|FG006|NOT COMPLETED|Received Vaccination 1||0
8960949|NCT02531802|10024307|FG007|NOT COMPLETED|Received Vaccination 1||0
8960950|NCT02531802|10024308|FG008|NOT COMPLETED|Received Vaccination 1||0
8960951|NCT02531802|10024309|FG009|NOT COMPLETED|Received Vaccination 1||0
8960952|NCT02531802|10024310|FG010|NOT COMPLETED|Received Vaccination 1||0
8960953|NCT02531802|10024311|FG011|NOT COMPLETED|Received Vaccination 1||0
8960954|NCT02531802|10024312|FG012|NOT COMPLETED|Received Vaccination 1||0
8960955|NCT02531802|10024313|FG013|NOT COMPLETED|Received Vaccination 1||0
8960956|NCT02531802|10024314|FG014|NOT COMPLETED|Received Vaccination 1||0
8960957|NCT02531802|10024315|FG015|NOT COMPLETED|Received Vaccination 1||0
8960958|NCT02531802|10024316|FG016|NOT COMPLETED|Received Vaccination 1||0
8960959|NCT02531802|10024317|FG017|NOT COMPLETED|Received Vaccination 1||0
8960960|NCT02531802|10024318|FG018|NOT COMPLETED|Received Vaccination 1||0
8960961|NCT02531802|10024319|FG019|NOT COMPLETED|Received Vaccination 1||0
8960962|NCT02531802|10024320|FG020|NOT COMPLETED|Received Vaccination 1||0
8960963|NCT02531802|10024300|FG000|STARTED|Received Vaccination 2||15
8960964|NCT02531802|10024301|FG001|STARTED|Received Vaccination 2||15
8960965|NCT02531802|10024302|FG002|STARTED|Received Vaccination 2||15
8960966|NCT02531802|10024303|FG003|STARTED|Received Vaccination 2||15
8960967|NCT02531802|10024304|FG004|STARTED|Received Vaccination 2||15
8960968|NCT02531802|10024305|FG005|STARTED|Received Vaccination 2||3
8960969|NCT02531802|10024306|FG006|STARTED|Received Vaccination 2||15
8960970|NCT02531802|10024307|FG007|STARTED|Received Vaccination 2||15
8960971|NCT02531802|10024308|FG008|STARTED|Received Vaccination 2||15
8960972|NCT02531802|10024309|FG009|STARTED|Received Vaccination 2||52
8960973|NCT02531802|10024310|FG010|STARTED|Received Vaccination 2||15
8960974|NCT02531802|10024311|FG011|STARTED|Received Vaccination 2||15
8960975|NCT02531802|10024312|FG012|STARTED|Received Vaccination 2||15
8960976|NCT02531802|10024313|FG013|STARTED|Received Vaccination 2||15
8960977|NCT02531802|10024314|FG014|STARTED|Received Vaccination 2||40
8960978|NCT02531802|10024315|FG015|STARTED|Received Vaccination 2||30
8960979|NCT02531802|10024316|FG016|STARTED|Received Vaccination 2||30
8960980|NCT02531802|10024317|FG017|STARTED|Received Vaccination 2||30
8960981|NCT02531802|10024318|FG018|STARTED|Received Vaccination 2||30
8960982|NCT02531802|10024319|FG019|STARTED|Received Vaccination 2||30
8960983|NCT02531802|10024320|FG020|STARTED|Received Vaccination 2||50
8960984|NCT02531802|10024300|FG000|COMPLETED|Received Vaccination 2||15
8960985|NCT02531802|10024301|FG001|COMPLETED|Received Vaccination 2||15
8960986|NCT02531802|10024302|FG002|COMPLETED|Received Vaccination 2||14
8960987|NCT02531802|10024303|FG003|COMPLETED|Received Vaccination 2||15
8960988|NCT02531802|10024304|FG004|COMPLETED|Received Vaccination 2||15
8631550|NCT00540982|9671482|FG000|Mild Liver Dysfunction|Overall Study||6
8960989|NCT02531802|10024305|FG005|COMPLETED|Received Vaccination 2||0
8960990|NCT02531802|10024306|FG006|COMPLETED|Received Vaccination 2||15
8960991|NCT02531802|10024307|FG007|COMPLETED|Received Vaccination 2||15
8631551|NCT00540982|9671482|FG000|Moderate Liver Dysfunction|Overall Study||18
8631552|NCT00540982|9671482|FG000|Severe Liver Dysfunction|Overall Study||12
8960992|NCT02531802|10024308|FG008|COMPLETED|Received Vaccination 2||15
8960993|NCT02531802|10024309|FG009|COMPLETED|Received Vaccination 2||49
8960994|NCT02531802|10024310|FG010|COMPLETED|Received Vaccination 2||13
8960995|NCT02531802|10024311|FG011|COMPLETED|Received Vaccination 2||15
8960996|NCT02531802|10024312|FG012|COMPLETED|Received Vaccination 2||13
8960997|NCT02531802|10024313|FG013|COMPLETED|Received Vaccination 2||13
8960998|NCT02531802|10024314|FG014|COMPLETED|Received Vaccination 2||39
8960999|NCT02531802|10024315|FG015|COMPLETED|Received Vaccination 2||30
8961000|NCT02531802|10024316|FG016|COMPLETED|Received Vaccination 2||30
8961001|NCT02531802|10024317|FG017|COMPLETED|Received Vaccination 2||26
8961002|NCT02531802|10024318|FG018|COMPLETED|Received Vaccination 2||27
8961003|NCT02531802|10024319|FG019|COMPLETED|Received Vaccination 2||29
8961004|NCT02531802|10024320|FG020|COMPLETED|Received Vaccination 2||49
8961005|NCT02531802|10024300|FG000|NOT COMPLETED|Received Vaccination 2||0
8961006|NCT02531802|10024301|FG001|NOT COMPLETED|Received Vaccination 2||0
8961007|NCT02531802|10024302|FG002|NOT COMPLETED|Received Vaccination 2||1
8961008|NCT02531802|10024303|FG003|NOT COMPLETED|Received Vaccination 2||0
8961009|NCT02531802|10024304|FG004|NOT COMPLETED|Received Vaccination 2||0
8961010|NCT02531802|10024305|FG005|NOT COMPLETED|Received Vaccination 2||3
8961011|NCT02531802|10024306|FG006|NOT COMPLETED|Received Vaccination 2||0
8961012|NCT02531802|10024307|FG007|NOT COMPLETED|Received Vaccination 2||0
8961013|NCT02531802|10024308|FG008|NOT COMPLETED|Received Vaccination 2||0
8961014|NCT02531802|10024309|FG009|NOT COMPLETED|Received Vaccination 2||3
8961015|NCT02531802|10024310|FG010|NOT COMPLETED|Received Vaccination 2||2
8961016|NCT02531802|10024311|FG011|NOT COMPLETED|Received Vaccination 2||0
8961017|NCT02531802|10024312|FG012|NOT COMPLETED|Received Vaccination 2||2
8961018|NCT02531802|10024313|FG013|NOT COMPLETED|Received Vaccination 2||2
8631553|NCT00540982|9671482|FG000|COMPLETED|Overall Study||47
8631554|NCT00540982|9671482|FG000|NOT COMPLETED|Overall Study||0
8631555|NCT00541034|9671504|FG000|STARTED|Overall Study||49
8961019|NCT02531802|10024314|FG014|NOT COMPLETED|Received Vaccination 2||1
8961020|NCT02531802|10024315|FG015|NOT COMPLETED|Received Vaccination 2||0
8961021|NCT02531802|10024316|FG016|NOT COMPLETED|Received Vaccination 2||0
8961022|NCT02531802|10024317|FG017|NOT COMPLETED|Received Vaccination 2||4
8961023|NCT02531802|10024318|FG018|NOT COMPLETED|Received Vaccination 2||3
8961024|NCT02531802|10024319|FG019|NOT COMPLETED|Received Vaccination 2||1
8961025|NCT02531802|10024320|FG020|NOT COMPLETED|Received Vaccination 2||1
8961026|NCT02531867|10024393|FG000|STARTED|Overall Study||13
8961027|NCT02531867|10024393|FG000|COMPLETED|Overall Study||13
8961028|NCT02531867|10024393|FG000|NOT COMPLETED|Overall Study||0
8961029|NCT02531971|10024399|FG000|STARTED|Overall Study||11
8961030|NCT02531971|10024400|FG001|STARTED|Overall Study||13
8961031|NCT02531971|10024399|FG000|COMPLETED|Overall Study||11
8961032|NCT02531971|10024400|FG001|COMPLETED|Overall Study||13
8961033|NCT02531971|10024399|FG000|NOT COMPLETED|Overall Study||0
8961034|NCT02531971|10024400|FG001|NOT COMPLETED|Overall Study||0
8961035|NCT02532010|10024409|FG000|STARTED|Overall Study||9
8961036|NCT02532010|10024410|FG001|STARTED|Overall Study||4
8961037|NCT02532010|10024409|FG000|COMPLETED|Overall Study||0
8961038|NCT02532010|10024410|FG001|COMPLETED|Overall Study||0
8961039|NCT02532010|10024409|FG000|NOT COMPLETED|Overall Study||9
8961040|NCT02532010|10024410|FG001|NOT COMPLETED|Overall Study||4
8961041|NCT02532036|10024416|FG000|STARTED|Overall Study||2
8961042|NCT02532036|10024417|FG001|STARTED|Overall Study||0
8961043|NCT02532036|10024416|FG000|COMPLETED|Overall Study||2
8961044|NCT02532036|10024417|FG001|COMPLETED|Overall Study||0
8961045|NCT02532036|10024416|FG000|NOT COMPLETED|Overall Study||0
8961046|NCT02532036|10024417|FG001|NOT COMPLETED|Overall Study||0
8961047|NCT02532179|10024421|FG000|STARTED|Overall Study||12
8961048|NCT02532179|10024421|FG000|COMPLETED|Overall Study||9
8961049|NCT02532179|10024421|FG000|NOT COMPLETED|Overall Study||3
8961050|NCT02532283|10024427|FG000|STARTED|Overall Study||64
8961051|NCT02532283|10024428|FG001|STARTED|Overall Study||35
8961052|NCT02532283|10024427|FG000|Full Analysis Set|Overall Study||63
8961053|NCT02532283|10024428|FG001|Full Analysis Set|Overall Study||32
8961054|NCT02532283|10024427|FG000|COMPLETED|Overall Study||55
8961055|NCT02532283|10024428|FG001|COMPLETED|Overall Study||30
8961056|NCT02532283|10024427|FG000|NOT COMPLETED|Overall Study||9
8961057|NCT02532283|10024428|FG001|NOT COMPLETED|Overall Study||5
8961058|NCT02532374|10024436|FG000|STARTED|Overall Study||16
8961059|NCT02532374|10024436|FG000|Nicorette Inhalator (Visit 3)|Overall Study||15
8961060|NCT02532374|10024436|FG000|P3L 50 μg/Puff (Visit 4)|Overall Study||15
8961061|NCT02532374|10024436|FG000|P3L 80 μg/Puff (Visit 5)|Overall Study||14
8961062|NCT02532374|10024436|FG000|P3L150 μg/Puff (Visit 6)|Overall Study||14
8961063|NCT02532374|10024436|FG000|COMPLETED|Overall Study||14
8961064|NCT02532374|10024436|FG000|NOT COMPLETED|Overall Study||2
8961065|NCT02532465|10024450|FG000|STARTED|Overall Study||25
8961066|NCT02532465|10024451|FG001|STARTED|Overall Study||25
8570361|NCT00103259|9602546|FG001|Cross Over to the Other Arm|Overall Study|11 patients who progressed on bortezomib crossed over to Arm I. 10 of them were eligible|11
8570362|NCT00103259|9602545|FG000|Eligible Patients Who Cross Over|Overall Study||0
8570363|NCT00103259|9602546|FG001|Eligible Patients Who Cross Over|Overall Study||10
8570364|NCT00103259|9602545|FG000|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity.|15
8570365|NCT00103259|9602546|FG001|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity.This number is for stage I.|32
8570366|NCT00103259|9602545|FG000|NOT COMPLETED|Overall Study||12
8570367|NCT00103259|9602546|FG001|NOT COMPLETED|Overall Study||12
8570368|NCT00103285|9602554|FG000|STARTED|Induction||5377
8570369|NCT00103285|9602555|FG001|STARTED|Induction||0
8570370|NCT00103285|9602556|FG002|STARTED|Induction||0
8570371|NCT00103285|9602557|FG003|STARTED|Induction||0
8570372|NCT00103285|9602558|FG004|STARTED|Induction||0
8570373|NCT00103285|9602559|FG005|STARTED|Induction||0
8961067|NCT02532465|10024450|FG000|COMPLETED|Overall Study||24
8961068|NCT02532465|10024451|FG001|COMPLETED|Overall Study||24
8961069|NCT02532465|10024450|FG000|NOT COMPLETED|Overall Study||1
8961070|NCT02532465|10024451|FG001|NOT COMPLETED|Overall Study||1
8961071|NCT02532517|10024457|FG000|STARTED|Overall Study||45
8961072|NCT02532517|10024457|FG000|mITT Analysis Set|Overall Study||44
8961073|NCT02532517|10024457|FG000|COMPLETED|Overall Study||28
8961074|NCT02532517|10024457|FG000|NOT COMPLETED|Overall Study||17
8961075|NCT02532543|10024465|FG000|STARTED|Overall Study||3
8961076|NCT02532543|10024466|FG001|STARTED|Overall Study||4
8961077|NCT02532543|10024467|FG002|STARTED|Overall Study||5
8961078|NCT02532543|10024468|FG003|STARTED|Overall Study||4
8961079|NCT02532543|10024465|FG000|COMPLETED|Overall Study||3
8961080|NCT02532543|10024466|FG001|COMPLETED|Overall Study||4
8961081|NCT02532543|10024467|FG002|COMPLETED|Overall Study||4
8961082|NCT02532543|10024468|FG003|COMPLETED|Overall Study||4
8961083|NCT02532543|10024465|FG000|NOT COMPLETED|Overall Study||0
8961084|NCT02532543|10024466|FG001|NOT COMPLETED|Overall Study||0
8961085|NCT02532543|10024467|FG002|NOT COMPLETED|Overall Study||1
8961086|NCT02532543|10024468|FG003|NOT COMPLETED|Overall Study||0
8961087|NCT02532556|10024478|FG000|STARTED|Overall Study||12
8961088|NCT02532556|10024478|FG000|COMPLETED|Overall Study||12
8961089|NCT02532556|10024478|FG000|NOT COMPLETED|Overall Study||0
8961090|NCT02532647|10024491|FG000|STARTED|Overall Study||32
8961091|NCT02532647|10024492|FG001|STARTED|Overall Study||16
8961092|NCT02532647|10024493|FG002|STARTED|Overall Study||31
8961093|NCT02532647|10024491|FG000|Safety Population|Overall Study||31
8961094|NCT02532647|10024492|FG001|Safety Population|Overall Study||16
8961095|NCT02532647|10024493|FG002|Safety Population|Overall Study||30
8961096|NCT02532647|10024491|FG000|COMPLETED|Overall Study||31
8961097|NCT02532647|10024492|FG001|COMPLETED|Overall Study||16
8961098|NCT02532647|10024493|FG002|COMPLETED|Overall Study||30
8961099|NCT02532647|10024491|FG000|NOT COMPLETED|Overall Study||1
8961100|NCT02532647|10024492|FG001|NOT COMPLETED|Overall Study||0
8961101|NCT02532647|10024493|FG002|NOT COMPLETED|Overall Study||1
8961102|NCT02532764|10024511|FG000|STARTED|Single Ascending Dose (SAD) Cohorts||6
8961103|NCT02532764|10024512|FG001|STARTED|Single Ascending Dose (SAD) Cohorts||6
8961104|NCT02532764|10024513|FG002|STARTED|Single Ascending Dose (SAD) Cohorts||9
8961105|NCT02532764|10024514|FG003|STARTED|Single Ascending Dose (SAD) Cohorts||6
8961106|NCT02532764|10024515|FG004|STARTED|Single Ascending Dose (SAD) Cohorts||9
8961107|NCT02532764|10024516|FG005|STARTED|Single Ascending Dose (SAD) Cohorts||0
8961108|NCT02532764|10024517|FG006|STARTED|Single Ascending Dose (SAD) Cohorts||0
8961109|NCT02532764|10024518|FG007|STARTED|Single Ascending Dose (SAD) Cohorts||0
8961110|NCT02532764|10024519|FG008|STARTED|Single Ascending Dose (SAD) Cohorts||0
8961111|NCT02532764|10024520|FG009|STARTED|Single Ascending Dose (SAD) Cohorts||0
8961112|NCT02532764|10024511|FG000|COMPLETED|Single Ascending Dose (SAD) Cohorts||6
8961113|NCT02532764|10024512|FG001|COMPLETED|Single Ascending Dose (SAD) Cohorts||6
8961114|NCT02532764|10024513|FG002|COMPLETED|Single Ascending Dose (SAD) Cohorts||9
8961115|NCT02532764|10024514|FG003|COMPLETED|Single Ascending Dose (SAD) Cohorts||6
8961116|NCT02532764|10024515|FG004|COMPLETED|Single Ascending Dose (SAD) Cohorts||9
8961117|NCT02532764|10024516|FG005|COMPLETED|Single Ascending Dose (SAD) Cohorts||0
8961118|NCT02532764|10024517|FG006|COMPLETED|Single Ascending Dose (SAD) Cohorts||0
8961119|NCT02532764|10024518|FG007|COMPLETED|Single Ascending Dose (SAD) Cohorts||0
8961120|NCT02532764|10024519|FG008|COMPLETED|Single Ascending Dose (SAD) Cohorts||0
8961121|NCT02532764|10024520|FG009|COMPLETED|Single Ascending Dose (SAD) Cohorts||0
8961122|NCT02532764|10024511|FG000|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
8961123|NCT02532764|10024512|FG001|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
8961124|NCT02532764|10024513|FG002|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
8961125|NCT02532764|10024514|FG003|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
8961126|NCT02532764|10024515|FG004|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
8961127|NCT02532764|10024516|FG005|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
8961128|NCT02532764|10024517|FG006|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
8961129|NCT02532764|10024518|FG007|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
8961130|NCT02532764|10024519|FG008|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
8961131|NCT02532764|10024520|FG009|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
8961132|NCT02532764|10024511|FG000|STARTED|Multiple Ascending Dose (MAD) Cohorst||0
8961133|NCT02532764|10024512|FG001|STARTED|Multiple Ascending Dose (MAD) Cohorst||0
8961134|NCT02532764|10024513|FG002|STARTED|Multiple Ascending Dose (MAD) Cohorst||0
8961135|NCT02532764|10024514|FG003|STARTED|Multiple Ascending Dose (MAD) Cohorst||0
8961136|NCT02532764|10024515|FG004|STARTED|Multiple Ascending Dose (MAD) Cohorst||0
8961137|NCT02532764|10024516|FG005|STARTED|Multiple Ascending Dose (MAD) Cohorst||6
8961138|NCT02532764|10024517|FG006|STARTED|Multiple Ascending Dose (MAD) Cohorst||6
8961139|NCT02532764|10024518|FG007|STARTED|Multiple Ascending Dose (MAD) Cohorst||7
8961140|NCT02532764|10024519|FG008|STARTED|Multiple Ascending Dose (MAD) Cohorst||6
8961141|NCT02532764|10024520|FG009|STARTED|Multiple Ascending Dose (MAD) Cohorst||9
8961142|NCT02532764|10024511|FG000|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
8961143|NCT02532764|10024512|FG001|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
8961144|NCT02532764|10024513|FG002|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
8961145|NCT02532764|10024514|FG003|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
8961146|NCT02532764|10024515|FG004|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
8961147|NCT02532764|10024516|FG005|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||6
8961148|NCT02532764|10024517|FG006|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||6
8961149|NCT02532764|10024518|FG007|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||6
8961150|NCT02532764|10024519|FG008|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||5
8961151|NCT02532764|10024520|FG009|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||8
8961152|NCT02532764|10024511|FG000|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
8961153|NCT02532764|10024512|FG001|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
8961154|NCT02532764|10024513|FG002|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
8961155|NCT02532764|10024514|FG003|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
8961156|NCT02532764|10024515|FG004|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
8961157|NCT02532764|10024516|FG005|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
8961158|NCT02532764|10024517|FG006|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
8961159|NCT02532764|10024518|FG007|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||1
8961160|NCT02532764|10024519|FG008|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||1
8961161|NCT02532764|10024520|FG009|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||1
8961162|NCT02532855|10024549|FG000|STARTED|Overall Study||307
8961163|NCT02532855|10024550|FG001|STARTED|Overall Study||307
8961164|NCT02532855|10024549|FG000|Treated|Overall Study||307
8961165|NCT02532855|10024550|FG001|Treated|Overall Study|One participant had a protocol violation, was randomized but did not take study medication.|306
8961166|NCT02532855|10024549|FG000|COMPLETED|Overall Study||299
8961167|NCT02532855|10024550|FG001|COMPLETED|Overall Study||296
8961168|NCT02532855|10024549|FG000|NOT COMPLETED|Overall Study||8
8961169|NCT02532855|10024550|FG001|NOT COMPLETED|Overall Study||11
8961170|NCT02532933|10024558|FG000|STARTED|Overall Study||22
8961171|NCT02532933|10024559|FG001|STARTED|Overall Study||22
8961172|NCT02532933|10024558|FG000|COMPLETED|Overall Study||16
8961173|NCT02532933|10024559|FG001|COMPLETED|Overall Study||16
8961174|NCT02532933|10024558|FG000|NOT COMPLETED|Overall Study||6
8961175|NCT02532933|10024559|FG001|NOT COMPLETED|Overall Study||6
8961176|NCT02532972|10024565|FG000|STARTED|Overall Study||11
8961177|NCT02532972|10024565|FG000|COMPLETED|Overall Study||10
8961178|NCT02532972|10024565|FG000|NOT COMPLETED|Overall Study||1
8961179|NCT02532998|10024569|FG000|STARTED|Overall Study||23
8961180|NCT02532998|10024569|FG000|COMPLETED|Overall Study||23
8961181|NCT02532998|10024569|FG000|NOT COMPLETED|Overall Study||0
8631556|NCT00541034|9671504|FG000|COMPLETED|Overall Study||46
8631557|NCT00541034|9671504|FG000|NOT COMPLETED|Overall Study||3
8691272|NCT00853840|9736489|FG000|NOT COMPLETED|Period 2||0
8691273|NCT00853840|9736490|FG001|NOT COMPLETED|Period 2||0
8961182|NCT02533063|10024585|FG000|STARTED|Intervention 1 (8 Weeks)||16
8961183|NCT02533063|10024586|FG001|STARTED|Intervention 1 (8 Weeks)||16
8961184|NCT02533063|10024585|FG000|COMPLETED|Intervention 1 (8 Weeks)||14
8961185|NCT02533063|10024586|FG001|COMPLETED|Intervention 1 (8 Weeks)||11
8961186|NCT02533063|10024585|FG000|NOT COMPLETED|Intervention 1 (8 Weeks)||2
8961187|NCT02533063|10024586|FG001|NOT COMPLETED|Intervention 1 (8 Weeks)||5
8961188|NCT02533063|10024585|FG000|STARTED|Washout (4 Weeks)||14
8961189|NCT02533063|10024586|FG001|STARTED|Washout (4 Weeks)||11
8961190|NCT02533063|10024585|FG000|COMPLETED|Washout (4 Weeks)||14
8961191|NCT02533063|10024586|FG001|COMPLETED|Washout (4 Weeks)||11
8961192|NCT02533063|10024585|FG000|NOT COMPLETED|Washout (4 Weeks)||0
8961193|NCT02533063|10024586|FG001|NOT COMPLETED|Washout (4 Weeks)||0
8961194|NCT02533063|10024585|FG000|STARTED|Intervention 2 (8 Weeks)||14
8961195|NCT02533063|10024586|FG001|STARTED|Intervention 2 (8 Weeks)||11
8961196|NCT02533063|10024585|FG000|COMPLETED|Intervention 2 (8 Weeks)||14
8961197|NCT02533063|10024586|FG001|COMPLETED|Intervention 2 (8 Weeks)||11
8961198|NCT02533063|10024585|FG000|NOT COMPLETED|Intervention 2 (8 Weeks)||0
8961199|NCT02533063|10024586|FG001|NOT COMPLETED|Intervention 2 (8 Weeks)||0
8961200|NCT02533089|10024595|FG000|STARTED|Overall Study||605
8961201|NCT02533089|10024596|FG001|STARTED|Overall Study||548
8961202|NCT02533089|10024595|FG000|COMPLETED|Overall Study|4 HC accrued no eligable patients 11 HC no patients with outcome data 241 cases missing outcome|364
8961203|NCT02533089|10024596|FG001|COMPLETED|Overall Study|6 HC accrued no eligible patients 8 HC no patients with outcome data 114 cases missing outcome|434
8961204|NCT02533089|10024595|FG000|NOT COMPLETED|Overall Study||241
8691274|NCT00853905|9736499|FG000|STARTED|Overall Study||37
8691275|NCT00853905|9736500|FG001|STARTED|Overall Study||40
8961205|NCT02533089|10024596|FG001|NOT COMPLETED|Overall Study||114
8961206|NCT02533167|10024602|FG000|STARTED|Overall Study||70
8961207|NCT02533167|10024602|FG000|COMPLETED|Overall Study||55
8961208|NCT02533167|10024602|FG000|NOT COMPLETED|Overall Study||15
8961209|NCT02533180|10024609|FG000|STARTED|Overall Study||39
8961210|NCT02533180|10024610|FG001|STARTED|Overall Study||61
8961211|NCT02533180|10024609|FG000|COMPLETED|Overall Study||0
8961212|NCT02533180|10024610|FG001|COMPLETED|Overall Study||14
8691276|NCT00853905|9736499|FG000|COMPLETED|Overall Study||35
8961213|NCT02533180|10024609|FG000|NOT COMPLETED|Overall Study||39
8961214|NCT02533180|10024610|FG001|NOT COMPLETED|Overall Study||47
8961215|NCT02533258|10024615|FG000|STARTED|Overall Study||13
8961216|NCT02533258|10024615|FG000|COMPLETED|Overall Study||5
8961217|NCT02533258|10024615|FG000|NOT COMPLETED|Overall Study||8
8961218|NCT02533375|10024619|FG000|STARTED|Overall Study||10
8961219|NCT02533375|10024619|FG000|COMPLETED|Overall Study||5
8961220|NCT02533375|10024619|FG000|NOT COMPLETED|Overall Study||5
8961221|NCT02533401|10024623|FG000|STARTED|Overall Study||34
8961222|NCT02533401|10024623|FG000|COMPLETED|Overall Study||23
8961223|NCT02533401|10024623|FG000|NOT COMPLETED|Overall Study||11
8961224|NCT02533427|10024627|FG000|STARTED|Overall Study||15
8961225|NCT02533427|10024627|FG000|COMPLETED|Overall Study||15
8961226|NCT02533427|10024627|FG000|NOT COMPLETED|Overall Study||0
8961227|NCT02533453|10024634|FG000|STARTED|Overall Study||110
8961228|NCT02533453|10024634|FG000|COMPLETED|Overall Study||101
8961229|NCT02533453|10024634|FG000|NOT COMPLETED|Overall Study||9
8961230|NCT02533466|10024640|FG000|STARTED|Overall Study||16
8961231|NCT02533466|10024641|FG001|STARTED|Overall Study||14
8961232|NCT02533466|10024640|FG000|COMPLETED|Overall Study||16
8961233|NCT02533466|10024641|FG001|COMPLETED|Overall Study||14
8961234|NCT02533466|10024640|FG000|NOT COMPLETED|Overall Study||0
8961235|NCT02533466|10024641|FG001|NOT COMPLETED|Overall Study||0
8961236|NCT02533505|10024649|FG000|STARTED|Overall Study||26
8961237|NCT02533505|10024650|FG001|STARTED|Overall Study||25
8961238|NCT02533505|10024649|FG000|COMPLETED|Overall Study||23
8961239|NCT02533505|10024650|FG001|COMPLETED|Overall Study||24
8961240|NCT02533505|10024649|FG000|NOT COMPLETED|Overall Study||3
8961241|NCT02533505|10024650|FG001|NOT COMPLETED|Overall Study||1
8961242|NCT02533570|10024659|FG000|STARTED|Overall Study||4
8961243|NCT02533570|10024660|FG001|STARTED|Overall Study||8
8961244|NCT02533570|10024661|FG002|STARTED|Overall Study||8
8961245|NCT02533570|10024659|FG000|COMPLETED|Overall Study||4
8961246|NCT02533570|10024660|FG001|COMPLETED|Overall Study||7
8961247|NCT02533570|10024661|FG002|COMPLETED|Overall Study||7
8961248|NCT02533570|10024659|FG000|NOT COMPLETED|Overall Study||0
8961249|NCT02533570|10024660|FG001|NOT COMPLETED|Overall Study||1
8961250|NCT02533570|10024661|FG002|NOT COMPLETED|Overall Study||1
8961251|NCT02533674|10024677|FG000|STARTED|Dose Level I||5
8961252|NCT02533674|10024678|FG001|STARTED|Dose Level I||0
8961253|NCT02533674|10024679|FG002|STARTED|Dose Level I||0
8961254|NCT02533674|10024680|FG003|STARTED|Dose Level I||0
8961255|NCT02533674|10024681|FG004|STARTED|Dose Level I||0
8961256|NCT02533674|10024682|FG005|STARTED|Dose Level I||0
8961257|NCT02533674|10024683|FG006|STARTED|Dose Level I||0
8961258|NCT02533674|10024684|FG007|STARTED|Dose Level I||0
8961259|NCT02533674|10024677|FG000|COMPLETED|Dose Level I||0
8961260|NCT02533674|10024678|FG001|COMPLETED|Dose Level I||0
8961261|NCT02533674|10024679|FG002|COMPLETED|Dose Level I||0
8961262|NCT02533674|10024680|FG003|COMPLETED|Dose Level I||0
8961263|NCT02533674|10024681|FG004|COMPLETED|Dose Level I||0
8961264|NCT02533674|10024682|FG005|COMPLETED|Dose Level I||0
8961265|NCT02533674|10024683|FG006|COMPLETED|Dose Level I||0
8961266|NCT02533674|10024684|FG007|COMPLETED|Dose Level I||0
8961267|NCT02533674|10024677|FG000|NOT COMPLETED|Dose Level I||5
8961268|NCT02533674|10024678|FG001|NOT COMPLETED|Dose Level I||0
8961269|NCT02533674|10024679|FG002|NOT COMPLETED|Dose Level I||0
8961270|NCT02533674|10024680|FG003|NOT COMPLETED|Dose Level I||0
8961271|NCT02533674|10024681|FG004|NOT COMPLETED|Dose Level I||0
8961272|NCT02533674|10024682|FG005|NOT COMPLETED|Dose Level I||0
8961273|NCT02533674|10024683|FG006|NOT COMPLETED|Dose Level I||0
8961274|NCT02533674|10024684|FG007|NOT COMPLETED|Dose Level I||0
8961275|NCT02533674|10024677|FG000|STARTED|Dose Level II||0
8961276|NCT02533674|10024678|FG001|STARTED|Dose Level II||7
8961277|NCT02533674|10024679|FG002|STARTED|Dose Level II||0
8961278|NCT02533674|10024680|FG003|STARTED|Dose Level II||0
8961279|NCT02533674|10024681|FG004|STARTED|Dose Level II||0
8961280|NCT02533674|10024682|FG005|STARTED|Dose Level II||0
8961281|NCT02533674|10024683|FG006|STARTED|Dose Level II||0
8961282|NCT02533674|10024684|FG007|STARTED|Dose Level II||0
8961283|NCT02533674|10024677|FG000|COMPLETED|Dose Level II||0
8961284|NCT02533674|10024678|FG001|COMPLETED|Dose Level II||0
8961285|NCT02533674|10024679|FG002|COMPLETED|Dose Level II||0
8961286|NCT02533674|10024680|FG003|COMPLETED|Dose Level II||0
8961287|NCT02533674|10024681|FG004|COMPLETED|Dose Level II||0
8961288|NCT02533674|10024682|FG005|COMPLETED|Dose Level II||0
8961289|NCT02533674|10024683|FG006|COMPLETED|Dose Level II||0
8961290|NCT02533674|10024684|FG007|COMPLETED|Dose Level II||0
8961291|NCT02533674|10024677|FG000|NOT COMPLETED|Dose Level II||0
8961292|NCT02533674|10024678|FG001|NOT COMPLETED|Dose Level II||7
8961293|NCT02533674|10024679|FG002|NOT COMPLETED|Dose Level II||0
8961294|NCT02533674|10024680|FG003|NOT COMPLETED|Dose Level II||0
8961295|NCT02533674|10024681|FG004|NOT COMPLETED|Dose Level II||0
8961296|NCT02533674|10024682|FG005|NOT COMPLETED|Dose Level II||0
8961297|NCT02533674|10024683|FG006|NOT COMPLETED|Dose Level II||0
8961298|NCT02533674|10024684|FG007|NOT COMPLETED|Dose Level II||0
8961299|NCT02533674|10024677|FG000|STARTED|Dose Level III||0
8631558|NCT00541099|9671508|FG000|STARTED|Overall Study||11
8631559|NCT00541099|9671508|FG000|COMPLETED|Overall Study||8
8631560|NCT00541099|9671508|FG000|NOT COMPLETED|Overall Study||3
8961300|NCT02533674|10024678|FG001|STARTED|Dose Level III||0
8961301|NCT02533674|10024679|FG002|STARTED|Dose Level III||4
8961302|NCT02533674|10024680|FG003|STARTED|Dose Level III||0
8961303|NCT02533674|10024681|FG004|STARTED|Dose Level III||0
8961304|NCT02533674|10024682|FG005|STARTED|Dose Level III||0
8961305|NCT02533674|10024683|FG006|STARTED|Dose Level III||0
8961306|NCT02533674|10024684|FG007|STARTED|Dose Level III||0
8961307|NCT02533674|10024677|FG000|COMPLETED|Dose Level III||0
8961308|NCT02533674|10024678|FG001|COMPLETED|Dose Level III||0
8631561|NCT00541190|9671514|FG000|STARTED|Overall Study||10
8961309|NCT02533674|10024679|FG002|COMPLETED|Dose Level III||0
8961310|NCT02533674|10024680|FG003|COMPLETED|Dose Level III||0
8961311|NCT02533674|10024681|FG004|COMPLETED|Dose Level III||0
8961312|NCT02533674|10024682|FG005|COMPLETED|Dose Level III||0
8961313|NCT02533674|10024683|FG006|COMPLETED|Dose Level III||0
8961314|NCT02533674|10024684|FG007|COMPLETED|Dose Level III||0
8961315|NCT02533674|10024677|FG000|NOT COMPLETED|Dose Level III||0
8961316|NCT02533674|10024678|FG001|NOT COMPLETED|Dose Level III||0
8961317|NCT02533674|10024679|FG002|NOT COMPLETED|Dose Level III||4
8961318|NCT02533674|10024680|FG003|NOT COMPLETED|Dose Level III||0
8961319|NCT02533674|10024681|FG004|NOT COMPLETED|Dose Level III||0
8961320|NCT02533674|10024682|FG005|NOT COMPLETED|Dose Level III||0
8961321|NCT02533674|10024683|FG006|NOT COMPLETED|Dose Level III||0
8961322|NCT02533674|10024684|FG007|NOT COMPLETED|Dose Level III||0
8961323|NCT02533674|10024677|FG000|STARTED|Dose Level IV||0
8961324|NCT02533674|10024678|FG001|STARTED|Dose Level IV||0
8961325|NCT02533674|10024679|FG002|STARTED|Dose Level IV||0
8961326|NCT02533674|10024680|FG003|STARTED|Dose Level IV||5
8961327|NCT02533674|10024681|FG004|STARTED|Dose Level IV||0
8961328|NCT02533674|10024682|FG005|STARTED|Dose Level IV||0
8961329|NCT02533674|10024683|FG006|STARTED|Dose Level IV||0
8961330|NCT02533674|10024684|FG007|STARTED|Dose Level IV||0
8961331|NCT02533674|10024677|FG000|COMPLETED|Dose Level IV||0
8961332|NCT02533674|10024678|FG001|COMPLETED|Dose Level IV||0
8961333|NCT02533674|10024679|FG002|COMPLETED|Dose Level IV||0
8961334|NCT02533674|10024680|FG003|COMPLETED|Dose Level IV||0
8961335|NCT02533674|10024681|FG004|COMPLETED|Dose Level IV||0
8961336|NCT02533674|10024682|FG005|COMPLETED|Dose Level IV||0
8961337|NCT02533674|10024683|FG006|COMPLETED|Dose Level IV||0
8961338|NCT02533674|10024684|FG007|COMPLETED|Dose Level IV||0
8961339|NCT02533674|10024677|FG000|NOT COMPLETED|Dose Level IV||0
8961340|NCT02533674|10024678|FG001|NOT COMPLETED|Dose Level IV||0
8961341|NCT02533674|10024679|FG002|NOT COMPLETED|Dose Level IV||0
8961342|NCT02533674|10024680|FG003|NOT COMPLETED|Dose Level IV||5
8961343|NCT02533674|10024681|FG004|NOT COMPLETED|Dose Level IV||0
8961344|NCT02533674|10024682|FG005|NOT COMPLETED|Dose Level IV||0
8961345|NCT02533674|10024683|FG006|NOT COMPLETED|Dose Level IV||0
8961346|NCT02533674|10024684|FG007|NOT COMPLETED|Dose Level IV||0
8961347|NCT02533674|10024677|FG000|STARTED|Dose Level V||0
8961348|NCT02533674|10024678|FG001|STARTED|Dose Level V||0
8961349|NCT02533674|10024679|FG002|STARTED|Dose Level V||0
8961350|NCT02533674|10024680|FG003|STARTED|Dose Level V||0
8961351|NCT02533674|10024681|FG004|STARTED|Dose Level V||5
8961352|NCT02533674|10024682|FG005|STARTED|Dose Level V||0
8961353|NCT02533674|10024683|FG006|STARTED|Dose Level V||0
8961354|NCT02533674|10024684|FG007|STARTED|Dose Level V||0
8961355|NCT02533674|10024677|FG000|COMPLETED|Dose Level V||0
8961356|NCT02533674|10024678|FG001|COMPLETED|Dose Level V||0
8961357|NCT02533674|10024679|FG002|COMPLETED|Dose Level V||0
8961358|NCT02533674|10024680|FG003|COMPLETED|Dose Level V||0
8961359|NCT02533674|10024681|FG004|COMPLETED|Dose Level V||0
8961360|NCT02533674|10024682|FG005|COMPLETED|Dose Level V||0
8961361|NCT02533674|10024683|FG006|COMPLETED|Dose Level V||0
8961362|NCT02533674|10024684|FG007|COMPLETED|Dose Level V||0
8961363|NCT02533674|10024677|FG000|NOT COMPLETED|Dose Level V||0
8961364|NCT02533674|10024678|FG001|NOT COMPLETED|Dose Level V||0
8961365|NCT02533674|10024679|FG002|NOT COMPLETED|Dose Level V||0
8961366|NCT02533674|10024680|FG003|NOT COMPLETED|Dose Level V||0
8961367|NCT02533674|10024681|FG004|NOT COMPLETED|Dose Level V||5
8961368|NCT02533674|10024682|FG005|NOT COMPLETED|Dose Level V||0
8961369|NCT02533674|10024683|FG006|NOT COMPLETED|Dose Level V||0
8961370|NCT02533674|10024684|FG007|NOT COMPLETED|Dose Level V||0
8961371|NCT02533674|10024677|FG000|STARTED|Dose Level VI||0
8961372|NCT02533674|10024678|FG001|STARTED|Dose Level VI||0
8961373|NCT02533674|10024679|FG002|STARTED|Dose Level VI||0
8631562|NCT00541190|9671515|FG001|STARTED|Overall Study||11
8961374|NCT02533674|10024680|FG003|STARTED|Dose Level VI||0
8961375|NCT02533674|10024681|FG004|STARTED|Dose Level VI||0
8961376|NCT02533674|10024682|FG005|STARTED|Dose Level VI||9
8961377|NCT02533674|10024683|FG006|STARTED|Dose Level VI||0
8961378|NCT02533674|10024684|FG007|STARTED|Dose Level VI||0
8961379|NCT02533674|10024677|FG000|COMPLETED|Dose Level VI||0
8961380|NCT02533674|10024678|FG001|COMPLETED|Dose Level VI||0
8961381|NCT02533674|10024679|FG002|COMPLETED|Dose Level VI||0
8961382|NCT02533674|10024680|FG003|COMPLETED|Dose Level VI||0
8875082|NCT01904773|9931724|FG003|NOT COMPLETED|Fifth Intervention||0
8961383|NCT02533674|10024681|FG004|COMPLETED|Dose Level VI||0
8961384|NCT02533674|10024682|FG005|COMPLETED|Dose Level VI||0
8961385|NCT02533674|10024683|FG006|COMPLETED|Dose Level VI||0
8961386|NCT02533674|10024684|FG007|COMPLETED|Dose Level VI||0
8961387|NCT02533674|10024677|FG000|NOT COMPLETED|Dose Level VI||0
8961388|NCT02533674|10024678|FG001|NOT COMPLETED|Dose Level VI||0
8961389|NCT02533674|10024679|FG002|NOT COMPLETED|Dose Level VI||0
8961390|NCT02533674|10024680|FG003|NOT COMPLETED|Dose Level VI||0
8961391|NCT02533674|10024681|FG004|NOT COMPLETED|Dose Level VI||0
8961392|NCT02533674|10024682|FG005|NOT COMPLETED|Dose Level VI||9
8961393|NCT02533674|10024683|FG006|NOT COMPLETED|Dose Level VI||0
8631563|NCT00541190|9671514|FG000|COMPLETED|Overall Study||10
8631564|NCT00541190|9671515|FG001|COMPLETED|Overall Study||11
8631565|NCT00541190|9671514|FG000|NOT COMPLETED|Overall Study||0
8631566|NCT00541190|9671515|FG001|NOT COMPLETED|Overall Study||0
8631567|NCT00541229|9671529|FG000|STARTED|Treatment Period I (Week 1)||17
8631568|NCT00541229|9671530|FG001|STARTED|Treatment Period I (Week 1)||16
8875083|NCT01904773|9931725|FG004|NOT COMPLETED|Fifth Intervention||0
8875084|NCT01904773|9931726|FG005|NOT COMPLETED|Fifth Intervention||0
8875085|NCT01904773|9931727|FG006|NOT COMPLETED|Fifth Intervention||0
8875086|NCT01904773|9931728|FG007|NOT COMPLETED|Fifth Intervention||1
8875087|NCT01904773|9931729|FG008|NOT COMPLETED|Fifth Intervention||0
8875088|NCT01904773|9931721|FG000|STARTED|Placebo Washout Fifth Intervention||0
8875089|NCT01904773|9931722|FG001|STARTED|Placebo Washout Fifth Intervention||1
8875090|NCT01904773|9931723|FG002|STARTED|Placebo Washout Fifth Intervention||1
8875091|NCT01904773|9931724|FG003|STARTED|Placebo Washout Fifth Intervention||2
8875092|NCT01904773|9931725|FG004|STARTED|Placebo Washout Fifth Intervention||3
8875093|NCT01904773|9931726|FG005|STARTED|Placebo Washout Fifth Intervention||4
8875094|NCT01904773|9931727|FG006|STARTED|Placebo Washout Fifth Intervention||3
8875095|NCT01904773|9931728|FG007|STARTED|Placebo Washout Fifth Intervention||2
8875096|NCT01904773|9931729|FG008|STARTED|Placebo Washout Fifth Intervention||4
8875097|NCT01904773|9931721|FG000|COMPLETED|Placebo Washout Fifth Intervention||0
8875098|NCT01904773|9931722|FG001|COMPLETED|Placebo Washout Fifth Intervention||0
8875099|NCT01904773|9931723|FG002|COMPLETED|Placebo Washout Fifth Intervention||1
8875100|NCT01904773|9931724|FG003|COMPLETED|Placebo Washout Fifth Intervention||2
8875101|NCT01904773|9931725|FG004|COMPLETED|Placebo Washout Fifth Intervention||3
8875102|NCT01904773|9931726|FG005|COMPLETED|Placebo Washout Fifth Intervention||4
8875103|NCT01904773|9931727|FG006|COMPLETED|Placebo Washout Fifth Intervention||3
8875104|NCT01904773|9931728|FG007|COMPLETED|Placebo Washout Fifth Intervention||2
8875105|NCT01904773|9931729|FG008|COMPLETED|Placebo Washout Fifth Intervention||4
8875106|NCT01904773|9931721|FG000|NOT COMPLETED|Placebo Washout Fifth Intervention||0
8875107|NCT01904773|9931722|FG001|NOT COMPLETED|Placebo Washout Fifth Intervention||1
8875108|NCT01904773|9931723|FG002|NOT COMPLETED|Placebo Washout Fifth Intervention||0
8875109|NCT01904773|9931724|FG003|NOT COMPLETED|Placebo Washout Fifth Intervention||0
8875110|NCT01904773|9931725|FG004|NOT COMPLETED|Placebo Washout Fifth Intervention||0
8961394|NCT02533674|10024684|FG007|NOT COMPLETED|Dose Level VI||0
8961395|NCT02533674|10024677|FG000|STARTED|Dose Level VII||0
8961396|NCT02533674|10024678|FG001|STARTED|Dose Level VII||0
8961397|NCT02533674|10024679|FG002|STARTED|Dose Level VII||0
8961398|NCT02533674|10024680|FG003|STARTED|Dose Level VII||0
8961399|NCT02533674|10024681|FG004|STARTED|Dose Level VII||0
8961400|NCT02533674|10024682|FG005|STARTED|Dose Level VII||0
8961401|NCT02533674|10024683|FG006|STARTED|Dose Level VII||16
8961402|NCT02533674|10024684|FG007|STARTED|Dose Level VII||0
8961403|NCT02533674|10024677|FG000|COMPLETED|Dose Level VII||0
8961404|NCT02533674|10024678|FG001|COMPLETED|Dose Level VII||0
8961405|NCT02533674|10024679|FG002|COMPLETED|Dose Level VII||0
8961406|NCT02533674|10024680|FG003|COMPLETED|Dose Level VII||0
8961407|NCT02533674|10024681|FG004|COMPLETED|Dose Level VII||0
8961408|NCT02533674|10024682|FG005|COMPLETED|Dose Level VII||0
8961409|NCT02533674|10024683|FG006|COMPLETED|Dose Level VII||0
8961410|NCT02533674|10024684|FG007|COMPLETED|Dose Level VII||0
8961411|NCT02533674|10024677|FG000|NOT COMPLETED|Dose Level VII||0
8961412|NCT02533674|10024678|FG001|NOT COMPLETED|Dose Level VII||0
8961413|NCT02533674|10024679|FG002|NOT COMPLETED|Dose Level VII||0
8961414|NCT02533674|10024680|FG003|NOT COMPLETED|Dose Level VII||0
8961415|NCT02533674|10024681|FG004|NOT COMPLETED|Dose Level VII||0
8961416|NCT02533674|10024682|FG005|NOT COMPLETED|Dose Level VII||0
8961417|NCT02533674|10024683|FG006|NOT COMPLETED|Dose Level VII||16
8961418|NCT02533674|10024684|FG007|NOT COMPLETED|Dose Level VII||0
8961419|NCT02533674|10024677|FG000|STARTED|Dose Level VIII||0
8961420|NCT02533674|10024678|FG001|STARTED|Dose Level VIII||0
8961421|NCT02533674|10024679|FG002|STARTED|Dose Level VIII||0
8961422|NCT02533674|10024680|FG003|STARTED|Dose Level VIII||0
8961423|NCT02533674|10024681|FG004|STARTED|Dose Level VIII||0
8961424|NCT02533674|10024682|FG005|STARTED|Dose Level VIII||0
8961425|NCT02533674|10024683|FG006|STARTED|Dose Level VIII||0
8961426|NCT02533674|10024684|FG007|STARTED|Dose Level VIII||6
8961427|NCT02533674|10024677|FG000|COMPLETED|Dose Level VIII||0
8961428|NCT02533674|10024678|FG001|COMPLETED|Dose Level VIII||0
8961429|NCT02533674|10024679|FG002|COMPLETED|Dose Level VIII||0
8961430|NCT02533674|10024680|FG003|COMPLETED|Dose Level VIII||0
8961431|NCT02533674|10024681|FG004|COMPLETED|Dose Level VIII||0
8961432|NCT02533674|10024682|FG005|COMPLETED|Dose Level VIII||0
8961433|NCT02533674|10024683|FG006|COMPLETED|Dose Level VIII||0
8961434|NCT02533674|10024684|FG007|COMPLETED|Dose Level VIII||0
8961435|NCT02533674|10024677|FG000|NOT COMPLETED|Dose Level VIII||0
8961436|NCT02533674|10024678|FG001|NOT COMPLETED|Dose Level VIII||0
8961437|NCT02533674|10024679|FG002|NOT COMPLETED|Dose Level VIII||0
8961438|NCT02533674|10024680|FG003|NOT COMPLETED|Dose Level VIII||0
8961439|NCT02533674|10024681|FG004|NOT COMPLETED|Dose Level VIII||0
8961440|NCT02533674|10024682|FG005|NOT COMPLETED|Dose Level VIII||0
8961441|NCT02533674|10024683|FG006|NOT COMPLETED|Dose Level VIII||0
8961442|NCT02533674|10024684|FG007|NOT COMPLETED|Dose Level VIII||6
8961443|NCT02533726|10024704|FG000|STARTED|Initial Allocation||659
8961444|NCT02533726|10024705|FG001|STARTED|Initial Allocation||653
8961445|NCT02533726|10024704|FG000|COMPLETED|Initial Allocation||659
8961446|NCT02533726|10024705|FG001|COMPLETED|Initial Allocation||653
8961447|NCT02533726|10024704|FG000|NOT COMPLETED|Initial Allocation||0
8961448|NCT02533726|10024705|FG001|NOT COMPLETED|Initial Allocation||0
8961449|NCT02533726|10024704|FG000|STARTED|Treatment|54 participants allocated to Standard Care actually received Optimal Turning|709
8961450|NCT02533726|10024705|FG001|STARTED|Treatment|4 participants allocated to Optimal Turning actually received Standard Care|603
8961451|NCT02533726|10024704|FG000|Per Protocol Population|Treatment||671
8961452|NCT02533726|10024705|FG001|Per Protocol Population|Treatment||555
8961453|NCT02533726|10024704|FG000|COMPLETED|Treatment||709
8961454|NCT02533726|10024705|FG001|COMPLETED|Treatment||603
8961455|NCT02533726|10024704|FG000|NOT COMPLETED|Treatment||0
8961456|NCT02533726|10024705|FG001|NOT COMPLETED|Treatment||0
8961457|NCT02533921|10024713|FG000|STARTED|Overall Study||104
8961458|NCT02533921|10024714|FG001|STARTED|Overall Study||106
8961459|NCT02533921|10024713|FG000|COMPLETED|Overall Study||88
8961460|NCT02533921|10024714|FG001|COMPLETED|Overall Study||95
8961461|NCT02533921|10024713|FG000|NOT COMPLETED|Overall Study||16
8961462|NCT02533921|10024714|FG001|NOT COMPLETED|Overall Study||11
8961463|NCT02533934|10024722|FG000|STARTED|Overall Study||42
8961464|NCT02533934|10024723|FG001|STARTED|Overall Study||26
8961465|NCT02533934|10024722|FG000|COMPLETED|Overall Study||42
8961466|NCT02533934|10024723|FG001|COMPLETED|Overall Study||26
8961467|NCT02533934|10024722|FG000|NOT COMPLETED|Overall Study||0
8961468|NCT02533934|10024723|FG001|NOT COMPLETED|Overall Study||0
8961469|NCT02533999|10024731|FG000|STARTED|Overall Study||38
8570374|NCT00103285|9602560|FG006|STARTED|Induction||0
8570375|NCT00103285|9602561|FG007|STARTED|Induction||0
8961470|NCT02533999|10024732|FG001|STARTED|Overall Study||37
8961471|NCT02533999|10024731|FG000|COMPLETED|Overall Study||32
8961472|NCT02533999|10024732|FG001|COMPLETED|Overall Study||30
8961473|NCT02533999|10024731|FG000|NOT COMPLETED|Overall Study||6
8961474|NCT02533999|10024732|FG001|NOT COMPLETED|Overall Study||7
8961475|NCT02534129|10024738|FG000|STARTED|Overall Study||13
8961476|NCT02534129|10024739|FG001|STARTED|Overall Study||13
8961477|NCT02534129|10024738|FG000|COMPLETED|Overall Study||13
8961478|NCT02534129|10024739|FG001|COMPLETED|Overall Study||13
8961479|NCT02534129|10024738|FG000|NOT COMPLETED|Overall Study||0
8961480|NCT02534129|10024739|FG001|NOT COMPLETED|Overall Study||0
8570376|NCT00103285|9602554|FG000|COMPLETED|Induction||4028
8570377|NCT00103285|9602555|FG001|COMPLETED|Induction||0
8570378|NCT00103285|9602556|FG002|COMPLETED|Induction||0
8570379|NCT00103285|9602557|FG003|COMPLETED|Induction||0
8961481|NCT02534285|10024747|FG000|STARTED|Overall Study||50
8961482|NCT02534285|10024748|FG001|STARTED|Overall Study||50
8961483|NCT02534285|10024747|FG000|COMPLETED|Overall Study||50
8961484|NCT02534285|10024748|FG001|COMPLETED|Overall Study||50
8961485|NCT02534285|10024747|FG000|NOT COMPLETED|Overall Study||0
8961486|NCT02534285|10024748|FG001|NOT COMPLETED|Overall Study||0
8961487|NCT02534324|10024756|FG000|STARTED|Overall Study||98
8961488|NCT02534324|10024757|FG001|STARTED|Overall Study||48
8961489|NCT02534324|10024756|FG000|COMPLETED|Overall Study||73
8961490|NCT02534324|10024757|FG001|COMPLETED|Overall Study||40
8961491|NCT02534324|10024756|FG000|NOT COMPLETED|Overall Study||25
8961492|NCT02534324|10024757|FG001|NOT COMPLETED|Overall Study||8
8961493|NCT02534350|10024765|FG000|STARTED|Overall Study||41
8961494|NCT02534350|10024766|FG001|STARTED|Overall Study||20
8961495|NCT02534350|10024765|FG000|COMPLETED|Overall Study||37
8961496|NCT02534350|10024766|FG001|COMPLETED|Overall Study||20
8961497|NCT02534350|10024765|FG000|NOT COMPLETED|Overall Study||4
8961498|NCT02534350|10024766|FG001|NOT COMPLETED|Overall Study||0
8961499|NCT02534493|10024772|FG000|STARTED|Overall Study||13
8961500|NCT02534493|10024772|FG000|COMPLETED|Overall Study||11
8961501|NCT02534493|10024772|FG000|NOT COMPLETED|Overall Study||2
8961502|NCT02534883|10024780|FG000|STARTED|Overall Study||8
8961503|NCT02534883|10024781|FG001|STARTED|Overall Study||3
8961504|NCT02534883|10024780|FG000|COMPLETED|Overall Study||0
8961505|NCT02534883|10024781|FG001|COMPLETED|Overall Study||0
8961506|NCT02534883|10024780|FG000|NOT COMPLETED|Overall Study||8
8961507|NCT02534883|10024781|FG001|NOT COMPLETED|Overall Study||3
8961508|NCT02534896|10024790|FG000|STARTED|Overall Study||49
8961509|NCT02534896|10024791|FG001|STARTED|Overall Study||52
8961510|NCT02534896|10024792|FG002|STARTED|Overall Study||49
8961511|NCT02534896|10024790|FG000|COMPLETED|Overall Study||45
8961512|NCT02534896|10024791|FG001|COMPLETED|Overall Study||51
8961513|NCT02534896|10024792|FG002|COMPLETED|Overall Study||48
8961514|NCT02534896|10024790|FG000|NOT COMPLETED|Overall Study||4
8961515|NCT02534896|10024791|FG001|NOT COMPLETED|Overall Study||1
8961516|NCT02534896|10024792|FG002|NOT COMPLETED|Overall Study||1
8961517|NCT02534935|10024803|FG000|STARTED|Stage 1: 24 Months||44
8961518|NCT02534935|10024804|FG001|STARTED|Stage 1: 24 Months||220
8961519|NCT02534935|10024805|FG002|STARTED|Stage 1: 24 Months||132
8961520|NCT02534935|10024803|FG000|COMPLETED|Stage 1: 24 Months||44
8961521|NCT02534935|10024804|FG001|COMPLETED|Stage 1: 24 Months||210
8961522|NCT02534935|10024805|FG002|COMPLETED|Stage 1: 24 Months||127
8961523|NCT02534935|10024803|FG000|NOT COMPLETED|Stage 1: 24 Months||0
8961524|NCT02534935|10024804|FG001|NOT COMPLETED|Stage 1: 24 Months||10
8961525|NCT02534935|10024805|FG002|NOT COMPLETED|Stage 1: 24 Months||5
8961526|NCT02534935|10024803|FG000|STARTED|Stage 2: 8 Months|Participants entered into Stage 2.|40
8961527|NCT02534935|10024804|FG001|STARTED|Stage 2: 8 Months|Participants who received all 3 doses and entered Stage 2.|174
8961528|NCT02534935|10024805|FG002|STARTED|Stage 2: 8 Months|Participants of HAV/Saline were not eligible for Stage 2.|0
8961529|NCT02534935|10024803|FG000|COMPLETED|Stage 2: 8 Months||40
8961530|NCT02534935|10024804|FG001|COMPLETED|Stage 2: 8 Months||170
8961531|NCT02534935|10024805|FG002|COMPLETED|Stage 2: 8 Months||0
8961532|NCT02534935|10024803|FG000|NOT COMPLETED|Stage 2: 8 Months||0
8961533|NCT02534935|10024804|FG001|NOT COMPLETED|Stage 2: 8 Months||4
8961534|NCT02534935|10024805|FG002|NOT COMPLETED|Stage 2: 8 Months||0
8961535|NCT02534935|10024803|FG000|STARTED|Stage 2: Booster Phase (6 Months)|Participants were not eligible for Booster vaccination in Stage 2.|0
8961536|NCT02534935|10024804|FG001|STARTED|Stage 2: Booster Phase (6 Months)|Participants who received 3 doses of bivalent rLP2086 in Stage 1 and gave consent for booster vaccination.|148
8961537|NCT02534935|10024805|FG002|STARTED|Stage 2: Booster Phase (6 Months)|Participants of HAV/Saline were not eligible for Stage 2.|0
8961538|NCT02534935|10024803|FG000|COMPLETED|Stage 2: Booster Phase (6 Months)||0
8961539|NCT02534935|10024804|FG001|COMPLETED|Stage 2: Booster Phase (6 Months)||147
8961540|NCT02534935|10024805|FG002|COMPLETED|Stage 2: Booster Phase (6 Months)||0
8961541|NCT02534935|10024803|FG000|NOT COMPLETED|Stage 2: Booster Phase (6 Months)||0
8961542|NCT02534935|10024804|FG001|NOT COMPLETED|Stage 2: Booster Phase (6 Months)||1
8961543|NCT02534935|10024805|FG002|NOT COMPLETED|Stage 2: Booster Phase (6 Months)||0
8961544|NCT02535000|10024833|FG000|STARTED|Overall Study||30
8961545|NCT02535000|10024834|FG001|STARTED|Overall Study||30
8961546|NCT02535000|10024833|FG000|COMPLETED|Overall Study||29
8961547|NCT02535000|10024834|FG001|COMPLETED|Overall Study||28
8961548|NCT02535000|10024833|FG000|NOT COMPLETED|Overall Study||1
8961549|NCT02535000|10024834|FG001|NOT COMPLETED|Overall Study||2
8961550|NCT02535026|10024840|FG000|STARTED|Overall Study||580
8961551|NCT02535026|10024840|FG000|COMPLETED|Overall Study||580
8961552|NCT02535026|10024840|FG000|NOT COMPLETED|Overall Study||0
8961553|NCT02535364|10024854|FG000|STARTED|Part A Screening Through Leukapheresis||82
8961554|NCT02535364|10024854|FG000|COMPLETED|Part A Screening Through Leukapheresis||57
8961555|NCT02535364|10024854|FG000|NOT COMPLETED|Part A Screening Through Leukapheresis||25
8961556|NCT02535364|10024854|FG000|STARTED|Part B Screening||57
8961557|NCT02535364|10024854|FG000|COMPLETED|Part B Screening||40
8961558|NCT02535364|10024854|FG000|NOT COMPLETED|Part B Screening||17
8961559|NCT02535364|10024854|FG000|STARTED|Study Treatment||40
8961560|NCT02535364|10024854|FG000|COMPLETED|Study Treatment||38
8961561|NCT02535364|10024854|FG000|NOT COMPLETED|Study Treatment||2
8961562|NCT02535364|10024854|FG000|STARTED|12-Month Follow-up Period||38
8961563|NCT02535364|10024854|FG000|COMPLETED|12-Month Follow-up Period||3
8961564|NCT02535364|10024854|FG000|NOT COMPLETED|12-Month Follow-up Period||35
8961565|NCT02535416|10024867|FG000|STARTED|Overall Study||4
8961566|NCT02535416|10024868|FG001|STARTED|Overall Study||2
8961567|NCT02535416|10024869|FG002|STARTED|Overall Study||4
8961568|NCT02535416|10024870|FG003|STARTED|Overall Study||4
8961569|NCT02535416|10024871|FG004|STARTED|Overall Study||4
8961570|NCT02535416|10024872|FG005|STARTED|Overall Study||4
8961571|NCT02535416|10024873|FG006|STARTED|Overall Study||6
8961572|NCT02535416|10024874|FG007|STARTED|Overall Study||6
8961573|NCT02535416|10024875|FG008|STARTED|Overall Study||6
8961574|NCT02535416|10024867|FG000|COMPLETED|Overall Study||3
8961575|NCT02535416|10024868|FG001|COMPLETED|Overall Study||2
8961576|NCT02535416|10024869|FG002|COMPLETED|Overall Study||4
8961577|NCT02535416|10024870|FG003|COMPLETED|Overall Study||4
8961578|NCT02535416|10024871|FG004|COMPLETED|Overall Study||4
8961579|NCT02535416|10024872|FG005|COMPLETED|Overall Study||4
8961580|NCT02535416|10024873|FG006|COMPLETED|Overall Study||6
8961581|NCT02535416|10024874|FG007|COMPLETED|Overall Study||6
8961582|NCT02535416|10024875|FG008|COMPLETED|Overall Study||6
8961583|NCT02535416|10024867|FG000|NOT COMPLETED|Overall Study||1
8961584|NCT02535416|10024868|FG001|NOT COMPLETED|Overall Study||0
8961585|NCT02535416|10024869|FG002|NOT COMPLETED|Overall Study||0
8961586|NCT02535416|10024870|FG003|NOT COMPLETED|Overall Study||0
8961587|NCT02535416|10024871|FG004|NOT COMPLETED|Overall Study||0
8961588|NCT02535416|10024872|FG005|NOT COMPLETED|Overall Study||0
8961589|NCT02535416|10024873|FG006|NOT COMPLETED|Overall Study||0
8961590|NCT02535416|10024874|FG007|NOT COMPLETED|Overall Study||0
8961591|NCT02535416|10024875|FG008|NOT COMPLETED|Overall Study||0
8961592|NCT02535481|10024901|FG000|STARTED|Overall Study||22
8961593|NCT02535481|10024902|FG001|STARTED|Overall Study||22
8961594|NCT02535481|10024901|FG000|COMPLETED|Overall Study||22
8961595|NCT02535481|10024902|FG001|COMPLETED|Overall Study||22
8961596|NCT02535481|10024901|FG000|NOT COMPLETED|Overall Study||0
8961597|NCT02535481|10024902|FG001|NOT COMPLETED|Overall Study||0
8961598|NCT02535572|10024910|FG000|STARTED|Overall Study||21
8961599|NCT02535572|10024911|FG001|STARTED|Overall Study||20
8961600|NCT02535572|10024910|FG000|COMPLETED|Overall Study||17
8961601|NCT02535572|10024911|FG001|COMPLETED|Overall Study||17
8961602|NCT02535572|10024910|FG000|NOT COMPLETED|Overall Study||4
8961603|NCT02535572|10024911|FG001|NOT COMPLETED|Overall Study||3
8961604|NCT02535611|10024920|FG000|STARTED|Overall Study||27
8961605|NCT02535611|10024921|FG001|STARTED|Overall Study||20
8961606|NCT02535611|10024920|FG000|COMPLETED|Overall Study||27
8961607|NCT02535611|10024921|FG001|COMPLETED|Overall Study||20
8961608|NCT02535611|10024920|FG000|NOT COMPLETED|Overall Study||0
8961609|NCT02535611|10024921|FG001|NOT COMPLETED|Overall Study||0
8961610|NCT02535715|10024927|FG000|STARTED|Overall Study||4
8961611|NCT02535715|10024928|FG001|STARTED|Overall Study||4
8961612|NCT02535715|10024929|FG002|STARTED|Overall Study||3
8961613|NCT02535715|10024927|FG000|COMPLETED|Overall Study||4
8961614|NCT02535715|10024928|FG001|COMPLETED|Overall Study||4
8961615|NCT02535715|10024929|FG002|COMPLETED|Overall Study||2
8961616|NCT02535715|10024927|FG000|NOT COMPLETED|Overall Study||0
8961617|NCT02535715|10024928|FG001|NOT COMPLETED|Overall Study||0
8961618|NCT02535715|10024929|FG002|NOT COMPLETED|Overall Study||1
8961619|NCT02535741|10024940|FG000|STARTED|Overall Study||168
8961620|NCT02535741|10024940|FG000|COMPLETED|Overall Study|Completed cases at 2 years follow-up|136
8961621|NCT02535741|10024940|FG000|NOT COMPLETED|Overall Study||32
8961622|NCT02535806|10024945|FG000|STARTED|Overall Study||2
8961623|NCT02535806|10024945|FG000|COMPLETED|Overall Study||2
8961624|NCT02535806|10024945|FG000|NOT COMPLETED|Overall Study||0
8961625|NCT02535949|10024952|FG000|STARTED|Overall Study||50
8961626|NCT02535949|10024953|FG001|STARTED|Overall Study||50
8961627|NCT02535949|10024954|FG002|STARTED|Overall Study||50
8961628|NCT02535949|10024952|FG000|COMPLETED|Overall Study||49
8961629|NCT02535949|10024953|FG001|COMPLETED|Overall Study||50
8961630|NCT02535949|10024954|FG002|COMPLETED|Overall Study||50
8961631|NCT02535949|10024952|FG000|NOT COMPLETED|Overall Study||1
8961632|NCT02535949|10024953|FG001|NOT COMPLETED|Overall Study||0
8961633|NCT02535949|10024954|FG002|NOT COMPLETED|Overall Study||0
8961634|NCT02536040|10024965|FG000|STARTED|Overall Study||30
8961635|NCT02536040|10024966|FG001|STARTED|Overall Study||36
8961636|NCT02536040|10024965|FG000|COMPLETED|Overall Study||29
8961637|NCT02536040|10024966|FG001|COMPLETED|Overall Study||35
8961638|NCT02536040|10024965|FG000|NOT COMPLETED|Overall Study||1
8961639|NCT02536040|10024966|FG001|NOT COMPLETED|Overall Study||1
8961640|NCT02536105|10024972|FG000|STARTED|Concerta Open Label||80
8961641|NCT02536105|10024972|FG000|Completion of Phase|Concerta Open Label||76
8961642|NCT02536105|10024972|FG000|COMPLETED|Concerta Open Label||72
8961643|NCT02536105|10024972|FG000|NOT COMPLETED|Concerta Open Label||8
8961644|NCT02536105|10024972|FG000|STARTED|Placebo||74
8961645|NCT02536105|10024972|FG000|Completion of Placebo Day|Placebo||74
8961646|NCT02536105|10024972|FG000|COMPLETED|Placebo||72
8961647|NCT02536105|10024972|FG000|NOT COMPLETED|Placebo||2
8961648|NCT02536105|10024972|FG000|STARTED|Methylphenidate HCl ER Tablet 1||72
8961649|NCT02536105|10024972|FG000|Completion of MPH HCl ER Tab 1 Day|Methylphenidate HCl ER Tablet 1||72
8961650|NCT02536105|10024972|FG000|COMPLETED|Methylphenidate HCl ER Tablet 1||72
8961651|NCT02536105|10024972|FG000|NOT COMPLETED|Methylphenidate HCl ER Tablet 1||0
8961652|NCT02536105|10024972|FG000|STARTED|Methylphenidate HCl ER Tablet 2||73
8961653|NCT02536105|10024972|FG000|Completion of MPH HCl ER Tablet 2 Phase|Methylphenidate HCl ER Tablet 2||73
8961654|NCT02536105|10024972|FG000|COMPLETED|Methylphenidate HCl ER Tablet 2||72
8961655|NCT02536105|10024972|FG000|NOT COMPLETED|Methylphenidate HCl ER Tablet 2||1
8961656|NCT02536105|10024972|FG000|STARTED|Methylphenidate HCl ER Suspension||74
8961657|NCT02536105|10024972|FG000|Completion of MPH HCl ER Susp Phase|Methylphenidate HCl ER Suspension||74
8961658|NCT02536105|10024972|FG000|COMPLETED|Methylphenidate HCl ER Suspension||72
8961659|NCT02536105|10024972|FG000|NOT COMPLETED|Methylphenidate HCl ER Suspension||2
8961660|NCT02536196|10024985|FG000|STARTED|Overall Study||262
8961661|NCT02536196|10024986|FG001|STARTED|Overall Study||121
8961662|NCT02536196|10024987|FG002|STARTED|Overall Study||95
8961663|NCT02536196|10024985|FG000|COMPLETED|Overall Study||233
8961664|NCT02536196|10024986|FG001|COMPLETED|Overall Study||107
8961665|NCT02536196|10024987|FG002|COMPLETED|Overall Study||95
8961666|NCT02536196|10024985|FG000|NOT COMPLETED|Overall Study||29
8961667|NCT02536196|10024986|FG001|NOT COMPLETED|Overall Study||14
8961668|NCT02536196|10024987|FG002|NOT COMPLETED|Overall Study||0
8961669|NCT02536248|10024996|FG000|STARTED|First Intervention (6 Weeks)||10
8961670|NCT02536248|10024997|FG001|STARTED|First Intervention (6 Weeks)||10
8961671|NCT02536248|10024996|FG000|COMPLETED|First Intervention (6 Weeks)||10
8961672|NCT02536248|10024997|FG001|COMPLETED|First Intervention (6 Weeks)||10
8961673|NCT02536248|10024996|FG000|NOT COMPLETED|First Intervention (6 Weeks)||0
8961674|NCT02536248|10024997|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0
8961675|NCT02536248|10024996|FG000|STARTED|Wash-out (14 Days)||10
8961676|NCT02536248|10024997|FG001|STARTED|Wash-out (14 Days)||10
8961677|NCT02536248|10024996|FG000|COMPLETED|Wash-out (14 Days)||10
8961678|NCT02536248|10024997|FG001|COMPLETED|Wash-out (14 Days)||10
8961679|NCT02536248|10024996|FG000|NOT COMPLETED|Wash-out (14 Days)||0
8961680|NCT02536248|10024997|FG001|NOT COMPLETED|Wash-out (14 Days)||0
8961681|NCT02536248|10024996|FG000|STARTED|Second Intervention (6 Weeks)||10
8961682|NCT02536248|10024997|FG001|STARTED|Second Intervention (6 Weeks)||10
8961683|NCT02536248|10024996|FG000|COMPLETED|Second Intervention (6 Weeks)||10
8961684|NCT02536248|10024997|FG001|COMPLETED|Second Intervention (6 Weeks)||10
8961685|NCT02536248|10024996|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
8961686|NCT02536248|10024997|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0
8961687|NCT02536313|10025005|FG000|STARTED|Overall Study||24
8961688|NCT02536313|10025006|FG001|STARTED|Overall Study||25
8961689|NCT02536313|10025005|FG000|COMPLETED|Overall Study||24
8961690|NCT02536313|10025006|FG001|COMPLETED|Overall Study||24
8961691|NCT02536313|10025005|FG000|NOT COMPLETED|Overall Study||0
8961692|NCT02536313|10025006|FG001|NOT COMPLETED|Overall Study||1
8961693|NCT02536378|10025016|FG000|STARTED|Overall Study||632
8961694|NCT02536378|10025017|FG001|STARTED|Overall Study||60
8961695|NCT02536378|10025016|FG000|COMPLETED|Overall Study||625
8961696|NCT02536378|10025017|FG001|COMPLETED|Overall Study||53
8961697|NCT02536378|10025016|FG000|NOT COMPLETED|Overall Study||7
8961698|NCT02536378|10025017|FG001|NOT COMPLETED|Overall Study||7
9037793|NCT03320850|10099002|FG007|COMPLETED|Overall Study||53
9037794|NCT03320850|10099003|FG008|COMPLETED|Overall Study||50
9037795|NCT03320850|10099004|FG009|COMPLETED|Overall Study||50
9037796|NCT03320850|10098995|FG000|NOT COMPLETED|Overall Study||0
9037797|NCT03320850|10098996|FG001|NOT COMPLETED|Overall Study||0
9037798|NCT03320850|10098997|FG002|NOT COMPLETED|Overall Study||0
9037799|NCT03320850|10098998|FG003|NOT COMPLETED|Overall Study||1
9037800|NCT03320850|10098999|FG004|NOT COMPLETED|Overall Study||2
9037801|NCT03320850|10099000|FG005|NOT COMPLETED|Overall Study||9
9037802|NCT03320850|10099001|FG006|NOT COMPLETED|Overall Study||7
9037803|NCT03320850|10099002|FG007|NOT COMPLETED|Overall Study||7
9037804|NCT03320850|10099003|FG008|NOT COMPLETED|Overall Study||10
9037805|NCT03320850|10099004|FG009|NOT COMPLETED|Overall Study||9
9037806|NCT03320941|10099036|FG000|STARTED|Overall Study||19
9037807|NCT03320941|10099037|FG001|STARTED|Overall Study||19
9037808|NCT03320941|10099038|FG002|STARTED|Overall Study||28
9037809|NCT03320941|10099039|FG003|STARTED|Overall Study||31
9037810|NCT03320941|10099040|FG004|STARTED|Overall Study||29
9037811|NCT03320941|10099036|FG000|COMPLETED|Overall Study||19
9037812|NCT03320941|10099037|FG001|COMPLETED|Overall Study||19
8875111|NCT01904773|9931726|FG005|NOT COMPLETED|Placebo Washout Fifth Intervention||0
8875112|NCT01904773|9931727|FG006|NOT COMPLETED|Placebo Washout Fifth Intervention||0
8875113|NCT01904773|9931728|FG007|NOT COMPLETED|Placebo Washout Fifth Intervention||0
8875114|NCT01904773|9931729|FG008|NOT COMPLETED|Placebo Washout Fifth Intervention||0
8875115|NCT01904773|9931721|FG000|STARTED|Sixth Intervention||0
8875116|NCT01904773|9931722|FG001|STARTED|Sixth Intervention||0
8875117|NCT01904773|9931723|FG002|STARTED|Sixth Intervention||1
8875118|NCT01904773|9931724|FG003|STARTED|Sixth Intervention||2
9037813|NCT03320941|10099038|FG002|COMPLETED|Overall Study||28
9037814|NCT03320941|10099039|FG003|COMPLETED|Overall Study||30
9037815|NCT03320941|10099040|FG004|COMPLETED|Overall Study||29
9037816|NCT03320941|10099036|FG000|NOT COMPLETED|Overall Study||0
9037817|NCT03320941|10099037|FG001|NOT COMPLETED|Overall Study||0
9037818|NCT03320941|10099038|FG002|NOT COMPLETED|Overall Study||0
9037819|NCT03320941|10099039|FG003|NOT COMPLETED|Overall Study||1
9037820|NCT03320941|10099040|FG004|NOT COMPLETED|Overall Study||0
9037821|NCT03321006|10099054|FG000|STARTED|Overall Study||14
9037822|NCT03321006|10099055|FG001|STARTED|Overall Study||11
8875119|NCT01904773|9931725|FG004|STARTED|Sixth Intervention||3
9037823|NCT03321006|10099054|FG000|COMPLETED|Overall Study||12
9037824|NCT03321006|10099055|FG001|COMPLETED|Overall Study||11
9037825|NCT03321006|10099054|FG000|NOT COMPLETED|Overall Study||2
8875120|NCT01904773|9931726|FG005|STARTED|Sixth Intervention||4
9037826|NCT03321006|10099055|FG001|NOT COMPLETED|Overall Study||0
9037827|NCT03321097|10099063|FG000|STARTED|Overall Study||18
8961699|NCT02536404|10025027|FG000|STARTED|Overall Study||112
8961700|NCT02536404|10025028|FG001|STARTED|Overall Study||6
8961701|NCT02536404|10025027|FG000|COMPLETED|Overall Study||92
8961702|NCT02536404|10025028|FG001|COMPLETED|Overall Study||5
8961703|NCT02536404|10025027|FG000|NOT COMPLETED|Overall Study||20
8961704|NCT02536404|10025028|FG001|NOT COMPLETED|Overall Study||1
8961705|NCT02536508|10025037|FG000|STARTED|Overall Study||194
8961706|NCT02536508|10025038|FG001|STARTED|Overall Study||174
8961707|NCT02536508|10025039|FG002|STARTED|Overall Study||88
8961708|NCT02536508|10025037|FG000|COMPLETED|Overall Study||142
8961709|NCT02536508|10025038|FG001|COMPLETED|Overall Study||130
8961710|NCT02536508|10025039|FG002|COMPLETED|Overall Study||65
8961711|NCT02536508|10025037|FG000|NOT COMPLETED|Overall Study||52
8961712|NCT02536508|10025038|FG001|NOT COMPLETED|Overall Study||44
8961713|NCT02536508|10025039|FG002|NOT COMPLETED|Overall Study||23
8961714|NCT02536664|10025049|FG000|STARTED|Overall Study||312
8961715|NCT02536664|10025050|FG001|STARTED|Overall Study||177
8961716|NCT02536664|10025049|FG000|COMPLETED|Overall Study||205
8961717|NCT02536664|10025050|FG001|COMPLETED|Overall Study||97
8961718|NCT02536664|10025049|FG000|NOT COMPLETED|Overall Study||107
8961719|NCT02536664|10025050|FG001|NOT COMPLETED|Overall Study||80
8961720|NCT02536781|10025058|FG000|STARTED|Overall Study||36
8961721|NCT02536781|10025059|FG001|STARTED|Overall Study||34
8961722|NCT02536781|10025058|FG000|COMPLETED|Overall Study||34
8875121|NCT01904773|9931727|FG006|STARTED|Sixth Intervention||3
8875122|NCT01904773|9931728|FG007|STARTED|Sixth Intervention||2
8875123|NCT01904773|9931729|FG008|STARTED|Sixth Intervention||4
8875124|NCT01904773|9931721|FG000|COMPLETED|Sixth Intervention||0
8875125|NCT01904773|9931722|FG001|COMPLETED|Sixth Intervention||0
8875126|NCT01904773|9931723|FG002|COMPLETED|Sixth Intervention||1
8875127|NCT01904773|9931724|FG003|COMPLETED|Sixth Intervention||2
8875128|NCT01904773|9931725|FG004|COMPLETED|Sixth Intervention||3
8875129|NCT01904773|9931726|FG005|COMPLETED|Sixth Intervention||4
8961723|NCT02536781|10025059|FG001|COMPLETED|Overall Study||34
8961724|NCT02536781|10025058|FG000|NOT COMPLETED|Overall Study||2
8961725|NCT02536781|10025059|FG001|NOT COMPLETED|Overall Study||0
8961726|NCT02536833|10025069|FG000|STARTED|Overall Study||112
8961727|NCT02536833|10025070|FG001|STARTED|Overall Study||117
8961728|NCT02536833|10025071|FG002|STARTED|Overall Study||110
8961729|NCT02536833|10025072|FG003|STARTED|Overall Study||116
8961730|NCT02536833|10025069|FG000|COMPLETED|Overall Study||103
8961731|NCT02536833|10025070|FG001|COMPLETED|Overall Study||107
8961732|NCT02536833|10025071|FG002|COMPLETED|Overall Study||95
8961733|NCT02536833|10025072|FG003|COMPLETED|Overall Study||97
8961734|NCT02536833|10025069|FG000|NOT COMPLETED|Overall Study||9
8961735|NCT02536833|10025070|FG001|NOT COMPLETED|Overall Study||10
8961736|NCT02536833|10025071|FG002|NOT COMPLETED|Overall Study||15
8961737|NCT02536833|10025072|FG003|NOT COMPLETED|Overall Study||19
8961738|NCT02536846|10025083|FG000|STARTED|Overall Study||10
8961739|NCT02536846|10025083|FG000|COMPLETED|Overall Study||9
8961740|NCT02536846|10025083|FG000|NOT COMPLETED|Overall Study||1
8961741|NCT02536963|10025088|FG000|STARTED|Overall Study||318
8961742|NCT02536963|10025088|FG000|COMPLETED|Overall Study||300
8961743|NCT02536963|10025088|FG000|NOT COMPLETED|Overall Study||18
8875130|NCT01904773|9931727|FG006|COMPLETED|Sixth Intervention||3
8875131|NCT01904773|9931728|FG007|COMPLETED|Sixth Intervention||2
8875132|NCT01904773|9931729|FG008|COMPLETED|Sixth Intervention||4
8875133|NCT01904773|9931721|FG000|NOT COMPLETED|Sixth Intervention||0
8875134|NCT01904773|9931722|FG001|NOT COMPLETED|Sixth Intervention||0
8875135|NCT01904773|9931723|FG002|NOT COMPLETED|Sixth Intervention||0
8875136|NCT01904773|9931724|FG003|NOT COMPLETED|Sixth Intervention||0
8875137|NCT01904773|9931725|FG004|NOT COMPLETED|Sixth Intervention||0
8875138|NCT01904773|9931726|FG005|NOT COMPLETED|Sixth Intervention||0
8875139|NCT01904773|9931727|FG006|NOT COMPLETED|Sixth Intervention||0
8875140|NCT01904773|9931728|FG007|NOT COMPLETED|Sixth Intervention||0
8875141|NCT01904773|9931729|FG008|NOT COMPLETED|Sixth Intervention||0
8875142|NCT01904864|9931743|FG000|STARTED|Overall Study||40
8875143|NCT01904864|9931744|FG001|STARTED|Overall Study||40
8875144|NCT01904864|9931743|FG000|COMPLETED|Overall Study||31
8875145|NCT01904864|9931744|FG001|COMPLETED|Overall Study||28
8875146|NCT01904864|9931743|FG000|NOT COMPLETED|Overall Study||9
8961744|NCT02536976|10025094|FG000|STARTED|Overall Study|2 weeks single blind placebo run-in|3
8961745|NCT02536976|10025095|FG001|STARTED|Overall Study|2 weeks single blind placebo run-in. 1 participant terminated due to unrelated failing health|2
8961746|NCT02536976|10025094|FG000|Randomization|Overall Study|2 weeks double blind mirabegron|3
8961747|NCT02536976|10025095|FG001|Randomization|Overall Study|2 weeks double blind placebo matching mirabegron|1
8961748|NCT02536976|10025094|FG000|Dose Escalation and Maintenance|Overall Study|10 weeks double blind mirabegron|3
8961749|NCT02536976|10025095|FG001|Dose Escalation and Maintenance|Overall Study|10 weeks double blind placebo matching mirabegron|1
8961750|NCT02536976|10025094|FG000|Washout|Overall Study||3
8961751|NCT02536976|10025095|FG001|Washout|Overall Study||1
8961752|NCT02536976|10025094|FG000|COMPLETED|Overall Study||3
8961753|NCT02536976|10025095|FG001|COMPLETED|Overall Study||1
8961754|NCT02536976|10025094|FG000|NOT COMPLETED|Overall Study||0
8961755|NCT02536976|10025095|FG001|NOT COMPLETED|Overall Study||1
8875147|NCT01904864|9931744|FG001|NOT COMPLETED|Overall Study||12
8875148|NCT01905241|9931750|FG000|STARTED|Overall Study||20
8875149|NCT01905241|9931750|FG000|COMPLETED|Overall Study||20
8875150|NCT01905241|9931750|FG000|NOT COMPLETED|Overall Study||0
8875151|NCT01905254|9931754|FG000|STARTED|Overall Study||34
8961756|NCT02537015|10025103|FG000|STARTED|Overall Study||81
8961757|NCT02537015|10025103|FG000|COMPLETED|Overall Study||75
8961758|NCT02537015|10025103|FG000|NOT COMPLETED|Overall Study||6
8961759|NCT02537431|10025107|FG000|STARTED|Open-Label Period (Week 0 to Week 48)|Screened and received at least 1 dose of study drug.|14
8961760|NCT02537431|10025107|FG000|COMPLETED|Open-Label Period (Week 0 to Week 48)|Completed Open-Label Period (Week 0 - Week 48)|13
8961761|NCT02537431|10025107|FG000|NOT COMPLETED|Open-Label Period (Week 0 to Week 48)||1
8961762|NCT02537431|10025107|FG000|STARTED|Treatment Extension Period I||13
8961763|NCT02537431|10025107|FG000|COMPLETED|Treatment Extension Period I||13
8961764|NCT02537431|10025107|FG000|NOT COMPLETED|Treatment Extension Period I||0
8961765|NCT02537431|10025107|FG000|STARTED|Treatment Extension Period II|5 participants completing Treatment Extension Period I did not enter Treatment Extension Period II|8
8961766|NCT02537431|10025107|FG000|COMPLETED|Treatment Extension Period II||8
8961767|NCT02537431|10025107|FG000|NOT COMPLETED|Treatment Extension Period II||0
8961768|NCT02537444|10025113|FG000|STARTED|Overall Study||39
8961769|NCT02537444|10025114|FG001|STARTED|Overall Study||39
8961770|NCT02537444|10025113|FG000|Enrolled|Overall Study||39
8961771|NCT02537444|10025114|FG001|Enrolled|Overall Study||39
8961772|NCT02537444|10025113|FG000|Received Study Medication|Overall Study||38
8961773|NCT02537444|10025114|FG001|Received Study Medication|Overall Study||39
8961774|NCT02537444|10025113|FG000|Discontinued Study|Overall Study||39
8961775|NCT02537444|10025114|FG001|Discontinued Study|Overall Study||39
8961776|NCT02537444|10025113|FG000|COMPLETED|Overall Study||0
8961777|NCT02537444|10025114|FG001|COMPLETED|Overall Study||0
8961778|NCT02537444|10025113|FG000|NOT COMPLETED|Overall Study||39
8961779|NCT02537444|10025114|FG001|NOT COMPLETED|Overall Study||39
8961780|NCT02537522|10025120|FG000|STARTED|Phase I - Contralateral||34
8961781|NCT02537522|10025121|FG001|STARTED|Phase I - Contralateral||37
8961782|NCT02537522|10025122|FG002|STARTED|Phase I - Contralateral||0
8961783|NCT02537522|10025123|FG003|STARTED|Phase I - Contralateral||0
8961784|NCT02537522|10025120|FG000|COMPLETED|Phase I - Contralateral||19
8961785|NCT02537522|10025121|FG001|COMPLETED|Phase I - Contralateral||27
8961786|NCT02537522|10025122|FG002|COMPLETED|Phase I - Contralateral||0
8725712|NCT01032928|9773033|FG000|NOT COMPLETED|Overall Study||0
8961787|NCT02537522|10025123|FG003|COMPLETED|Phase I - Contralateral||0
8961788|NCT02537522|10025120|FG000|NOT COMPLETED|Phase I - Contralateral||15
8961789|NCT02537522|10025121|FG001|NOT COMPLETED|Phase I - Contralateral||10
8961790|NCT02537522|10025122|FG002|NOT COMPLETED|Phase I - Contralateral||0
8961791|NCT02537522|10025123|FG003|NOT COMPLETED|Phase I - Contralateral||0
8961792|NCT02537522|10025120|FG000|STARTED|Phase II - Period 1 Bilateral||0
8961793|NCT02537522|10025121|FG001|STARTED|Phase II - Period 1 Bilateral||0
8961794|NCT02537522|10025122|FG002|STARTED|Phase II - Period 1 Bilateral||23
8961795|NCT02537522|10025123|FG003|STARTED|Phase II - Period 1 Bilateral||23
8961796|NCT02537522|10025120|FG000|COMPLETED|Phase II - Period 1 Bilateral||0
8961797|NCT02537522|10025121|FG001|COMPLETED|Phase II - Period 1 Bilateral||0
8961798|NCT02537522|10025122|FG002|COMPLETED|Phase II - Period 1 Bilateral||23
8961799|NCT02537522|10025123|FG003|COMPLETED|Phase II - Period 1 Bilateral||22
8961800|NCT02537522|10025120|FG000|NOT COMPLETED|Phase II - Period 1 Bilateral||0
8961801|NCT02537522|10025121|FG001|NOT COMPLETED|Phase II - Period 1 Bilateral||0
8961802|NCT02537522|10025122|FG002|NOT COMPLETED|Phase II - Period 1 Bilateral||0
8961803|NCT02537522|10025123|FG003|NOT COMPLETED|Phase II - Period 1 Bilateral||1
8961804|NCT02537522|10025120|FG000|STARTED|Phase II - Period 2 Bilateral||0
8961805|NCT02537522|10025121|FG001|STARTED|Phase II - Period 2 Bilateral||0
8961806|NCT02537522|10025122|FG002|STARTED|Phase II - Period 2 Bilateral||23
8961807|NCT02537522|10025123|FG003|STARTED|Phase II - Period 2 Bilateral||22
8961808|NCT02537522|10025120|FG000|COMPLETED|Phase II - Period 2 Bilateral||0
8961809|NCT02537522|10025121|FG001|COMPLETED|Phase II - Period 2 Bilateral||0
8961810|NCT02537522|10025122|FG002|COMPLETED|Phase II - Period 2 Bilateral||23
8961811|NCT02537522|10025123|FG003|COMPLETED|Phase II - Period 2 Bilateral||22
8961812|NCT02537522|10025120|FG000|NOT COMPLETED|Phase II - Period 2 Bilateral||0
8961813|NCT02537522|10025121|FG001|NOT COMPLETED|Phase II - Period 2 Bilateral||0
8961814|NCT02537522|10025122|FG002|NOT COMPLETED|Phase II - Period 2 Bilateral||0
8961815|NCT02537522|10025123|FG003|NOT COMPLETED|Phase II - Period 2 Bilateral||0
8961816|NCT02537574|10025132|FG000|STARTED|Overall Study||126
8961817|NCT02537574|10025133|FG001|STARTED|Overall Study||126
8961818|NCT02537574|10025134|FG002|STARTED|Overall Study||126
8961819|NCT02537574|10025132|FG000|COMPLETED|Overall Study||27
8961820|NCT02537574|10025133|FG001|COMPLETED|Overall Study||23
8961821|NCT02537574|10025134|FG002|COMPLETED|Overall Study||18
8961822|NCT02537574|10025132|FG000|NOT COMPLETED|Overall Study||99
8725713|NCT01032954|9773044|FG000|STARTED|Overall Study||30
8961823|NCT02537574|10025133|FG001|NOT COMPLETED|Overall Study||103
8961824|NCT02537574|10025134|FG002|NOT COMPLETED|Overall Study||108
8961825|NCT02537717|10025142|FG000|STARTED|Overall Study||17
8961826|NCT02537717|10025142|FG000|COMPLETED|Overall Study||17
8961827|NCT02537717|10025142|FG000|NOT COMPLETED|Overall Study||0
8961828|NCT02537730|10025149|FG000|STARTED|First Intervention (7 Days)||17
8961829|NCT02537730|10025150|FG001|STARTED|First Intervention (7 Days)||16
8961830|NCT02537730|10025149|FG000|COMPLETED|First Intervention (7 Days)||17
8961831|NCT02537730|10025150|FG001|COMPLETED|First Intervention (7 Days)||16
8961832|NCT02537730|10025149|FG000|NOT COMPLETED|First Intervention (7 Days)||0
8631569|NCT00541229|9671531|FG002|STARTED|Treatment Period I (Week 1)||20
8631570|NCT00541229|9671532|FG003|STARTED|Treatment Period I (Week 1)||18
8961833|NCT02537730|10025150|FG001|NOT COMPLETED|First Intervention (7 Days)||0
8961834|NCT02537730|10025149|FG000|STARTED|Second Intervention (7 Days)||17
8961835|NCT02537730|10025150|FG001|STARTED|Second Intervention (7 Days)||16
8961836|NCT02537730|10025149|FG000|COMPLETED|Second Intervention (7 Days)||17
8961837|NCT02537730|10025150|FG001|COMPLETED|Second Intervention (7 Days)||16
8961838|NCT02537730|10025149|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
8961839|NCT02537730|10025150|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
8961840|NCT02537873|10025158|FG000|STARTED|Overall Study||17
8961841|NCT02537873|10025159|FG001|STARTED|Overall Study||8
8961842|NCT02537873|10025158|FG000|COMPLETED|Overall Study||9
8961843|NCT02537873|10025159|FG001|COMPLETED|Overall Study||4
8961844|NCT02537873|10025158|FG000|NOT COMPLETED|Overall Study||8
8961845|NCT02537873|10025159|FG001|NOT COMPLETED|Overall Study||4
8961846|NCT02537951|10025166|FG000|STARTED|Overall Study||10
8961847|NCT02537951|10025166|FG000|COMPLETED|Overall Study||10
8961848|NCT02537951|10025166|FG000|NOT COMPLETED|Overall Study||0
8961849|NCT02538016|10025174|FG000|STARTED|Overall Study||4
8961850|NCT02538016|10025174|FG000|COMPLETED|Overall Study||4
8961851|NCT02538016|10025174|FG000|NOT COMPLETED|Overall Study||0
8961852|NCT02538029|10025181|FG000|STARTED|Overall Study||24
8961853|NCT02538029|10025182|FG001|STARTED|Overall Study||10
8961854|NCT02538029|10025183|FG002|STARTED|Overall Study||11
8961855|NCT02538029|10025181|FG000|COMPLETED|Overall Study||23
8961856|NCT02538029|10025182|FG001|COMPLETED|Overall Study||10
8961857|NCT02538029|10025183|FG002|COMPLETED|Overall Study||10
8961858|NCT02538029|10025181|FG000|NOT COMPLETED|Overall Study||1
8961859|NCT02538029|10025182|FG001|NOT COMPLETED|Overall Study||0
8961860|NCT02538029|10025183|FG002|NOT COMPLETED|Overall Study||1
8961861|NCT02538042|10025195|FG000|STARTED|Overall Study||17
8961862|NCT02538042|10025196|FG001|STARTED|Overall Study||17
8961863|NCT02538042|10025195|FG000|Completed All MCE Sessions|Overall Study||15
8961864|NCT02538042|10025196|FG001|Completed All MCE Sessions|Overall Study||15
8961865|NCT02538042|10025195|FG000|Attended Post-Quit Visit|Overall Study||15
8961866|NCT02538042|10025196|FG001|Attended Post-Quit Visit|Overall Study||14
8961867|NCT02538042|10025195|FG000|Completed All Post-Quit Visits|Overall Study||12
8961868|NCT02538042|10025196|FG001|Completed All Post-Quit Visits|Overall Study||12
8961869|NCT02538042|10025195|FG000|COMPLETED|Overall Study||6
8961870|NCT02538042|10025196|FG001|COMPLETED|Overall Study||6
8961871|NCT02538042|10025195|FG000|NOT COMPLETED|Overall Study||11
8961872|NCT02538042|10025196|FG001|NOT COMPLETED|Overall Study||11
8961873|NCT02538094|10025204|FG000|STARTED|Intervention 1 (5 Days Per Participant)||2
8961874|NCT02538094|10025205|FG001|STARTED|Intervention 1 (5 Days Per Participant)||5
8961875|NCT02538094|10025204|FG000|COMPLETED|Intervention 1 (5 Days Per Participant)||2
8961876|NCT02538094|10025205|FG001|COMPLETED|Intervention 1 (5 Days Per Participant)||4
8961877|NCT02538094|10025204|FG000|NOT COMPLETED|Intervention 1 (5 Days Per Participant)||0
8961878|NCT02538094|10025205|FG001|NOT COMPLETED|Intervention 1 (5 Days Per Participant)||1
8961879|NCT02538094|10025204|FG000|STARTED|Washout (4 Weeks)||2
8961880|NCT02538094|10025205|FG001|STARTED|Washout (4 Weeks)||4
8961881|NCT02538094|10025204|FG000|COMPLETED|Washout (4 Weeks)||2
8961882|NCT02538094|10025205|FG001|COMPLETED|Washout (4 Weeks)||3
8961883|NCT02538094|10025204|FG000|NOT COMPLETED|Washout (4 Weeks)||0
8961884|NCT02538094|10025205|FG001|NOT COMPLETED|Washout (4 Weeks)||1
8961885|NCT02538094|10025204|FG000|STARTED|Intervention 2 (5 Days Per Participant)||2
8961886|NCT02538094|10025205|FG001|STARTED|Intervention 2 (5 Days Per Participant)||3
8961887|NCT02538094|10025204|FG000|COMPLETED|Intervention 2 (5 Days Per Participant)||2
8961888|NCT02538094|10025205|FG001|COMPLETED|Intervention 2 (5 Days Per Participant)||3
8961889|NCT02538094|10025204|FG000|NOT COMPLETED|Intervention 2 (5 Days Per Participant)||0
8961890|NCT02538094|10025205|FG001|NOT COMPLETED|Intervention 2 (5 Days Per Participant)||0
8961891|NCT02538107|10025211|FG000|STARTED|Overall Study||290
8961892|NCT02538107|10025211|FG000|COMPLETED|Overall Study||180
8961893|NCT02538107|10025211|FG000|NOT COMPLETED|Overall Study||110
8961894|NCT02538341|10025227|FG000|STARTED|Overall Study||310
8961895|NCT02538341|10025228|FG001|STARTED|Overall Study||307
8961896|NCT02538341|10025227|FG000|Week 6 (Primary Outcome)|Overall Study||303
8961897|NCT02538341|10025228|FG001|Week 6 (Primary Outcome)|Overall Study||299
8961898|NCT02538341|10025227|FG000|Month 6 (Safety Outcome)|Overall Study||276
8961899|NCT02538341|10025228|FG001|Month 6 (Safety Outcome)|Overall Study||260
8961900|NCT02538341|10025227|FG000|1 Year Visit|Overall Study||254
8961901|NCT02538341|10025228|FG001|1 Year Visit|Overall Study||0
8961902|NCT02538341|10025227|FG000|COMPLETED|Overall Study||254
8961903|NCT02538341|10025228|FG001|COMPLETED|Overall Study||260
8961904|NCT02538341|10025227|FG000|NOT COMPLETED|Overall Study||56
8631571|NCT00541229|9671533|FG004|STARTED|Treatment Period I (Week 1)||14
8961905|NCT02538341|10025228|FG001|NOT COMPLETED|Overall Study||47
8961906|NCT02538354|10025236|FG000|STARTED|Overall Study||40
8961907|NCT02538354|10025237|FG001|STARTED|Overall Study||30
8961908|NCT02538354|10025236|FG000|COMPLETED|Overall Study||40
8961909|NCT02538354|10025237|FG001|COMPLETED|Overall Study||30
8961910|NCT02538354|10025236|FG000|NOT COMPLETED|Overall Study||0
8961911|NCT02538354|10025237|FG001|NOT COMPLETED|Overall Study||0
8961912|NCT02538419|10025245|FG000|STARTED|Overall Study||20
8961913|NCT02538419|10025246|FG001|STARTED|Overall Study||20
8961914|NCT02538419|10025245|FG000|COMPLETED|Overall Study||20
8961915|NCT02538419|10025246|FG001|COMPLETED|Overall Study||20
8961916|NCT02538419|10025245|FG000|NOT COMPLETED|Overall Study||0
8961917|NCT02538419|10025246|FG001|NOT COMPLETED|Overall Study||0
8961918|NCT02538471|10025252|FG000|STARTED|Overall Study||3
8961919|NCT02538471|10025252|FG000|COMPLETED|Overall Study||1
8961920|NCT02538471|10025252|FG000|NOT COMPLETED|Overall Study||2
8961921|NCT02538523|10025258|FG000|STARTED|Overall Study||29
8961922|NCT02538523|10025259|FG001|STARTED|Overall Study||29
8961923|NCT02538523|10025258|FG000|COMPLETED|Overall Study||29
8961924|NCT02538523|10025259|FG001|COMPLETED|Overall Study||29
8961925|NCT02538523|10025258|FG000|NOT COMPLETED|Overall Study||0
8961926|NCT02538523|10025259|FG001|NOT COMPLETED|Overall Study||0
8961927|NCT02538614|10025265|FG000|STARTED|Overall Study||2
8961928|NCT02538614|10025265|FG000|COMPLETED|Overall Study||0
8961929|NCT02538614|10025265|FG000|NOT COMPLETED|Overall Study||2
8961930|NCT02538679|10025274|FG000|STARTED|Overall Study||24
8961931|NCT02538679|10025275|FG001|STARTED|Overall Study||54
8961932|NCT02538679|10025276|FG002|STARTED|Overall Study||49
8961933|NCT02538679|10025274|FG000|COMPLETED|Overall Study||21
8961934|NCT02538679|10025275|FG001|COMPLETED|Overall Study||45
8961935|NCT02538679|10025276|FG002|COMPLETED|Overall Study||41
8961936|NCT02538679|10025274|FG000|NOT COMPLETED|Overall Study||3
8961937|NCT02538679|10025275|FG001|NOT COMPLETED|Overall Study||9
8961938|NCT02538679|10025276|FG002|NOT COMPLETED|Overall Study||8
8961939|NCT02538783|10025286|FG000|STARTED|Overall Study||130
8961940|NCT02538783|10025287|FG001|STARTED|Overall Study||129
8961941|NCT02538783|10025286|FG000|COMPLETED|Overall Study||130
8961942|NCT02538783|10025287|FG001|COMPLETED|Overall Study||128
8961943|NCT02538783|10025286|FG000|NOT COMPLETED|Overall Study||0
8961944|NCT02538783|10025287|FG001|NOT COMPLETED|Overall Study||1
8961945|NCT02538900|10025296|FG000|STARTED|Overall Study||116
8961946|NCT02538900|10025297|FG001|STARTED|Overall Study||124
8961947|NCT02538900|10025298|FG002|STARTED|Overall Study||65
8961948|NCT02538900|10025296|FG000|COMPLETED|Overall Study||96
8961949|NCT02538900|10025297|FG001|COMPLETED|Overall Study||106
8961950|NCT02538900|10025298|FG002|COMPLETED|Overall Study||48
8961951|NCT02538900|10025296|FG000|NOT COMPLETED|Overall Study||20
8961952|NCT02538900|10025297|FG001|NOT COMPLETED|Overall Study||18
8961953|NCT02538900|10025298|FG002|NOT COMPLETED|Overall Study||17
8961954|NCT02538965|10025306|FG000|STARTED|Treatment Period||17
8961955|NCT02538965|10025306|FG000|COMPLETED|Treatment Period||0
8961956|NCT02538965|10025306|FG000|NOT COMPLETED|Treatment Period||17
8961957|NCT02538965|10025306|FG000|STARTED|Follow-Up Period||17
8961958|NCT02538965|10025306|FG000|COMPLETED|Follow-Up Period||0
8961959|NCT02538965|10025306|FG000|NOT COMPLETED|Follow-Up Period||17
8961960|NCT02539108|10025312|FG000|STARTED|Overall Study||30
8961961|NCT02539108|10025313|FG001|STARTED|Overall Study||30
8961962|NCT02539108|10025312|FG000|COMPLETED|Overall Study||30
8961963|NCT02539108|10025313|FG001|COMPLETED|Overall Study||30
8961964|NCT02539108|10025312|FG000|NOT COMPLETED|Overall Study||0
8961965|NCT02539108|10025313|FG001|NOT COMPLETED|Overall Study||0
8961966|NCT02539134|10025325|FG000|STARTED|Overall Study||10
8961967|NCT02539134|10025326|FG001|STARTED|Overall Study||6
8961968|NCT02539134|10025327|FG002|STARTED|Overall Study||6
8961969|NCT02539134|10025328|FG003|STARTED|Overall Study||6
8961970|NCT02539134|10025329|FG004|STARTED|Overall Study||6
8961971|NCT02539134|10025330|FG005|STARTED|Overall Study||6
8961972|NCT02539134|10025325|FG000|COMPLETED|Overall Study||9
8961973|NCT02539134|10025326|FG001|COMPLETED|Overall Study||6
8961974|NCT02539134|10025327|FG002|COMPLETED|Overall Study||6
8961975|NCT02539134|10025328|FG003|COMPLETED|Overall Study||6
8961976|NCT02539134|10025329|FG004|COMPLETED|Overall Study||6
8961977|NCT02539134|10025330|FG005|COMPLETED|Overall Study||6
8961978|NCT02539134|10025325|FG000|NOT COMPLETED|Overall Study||1
8961979|NCT02539134|10025326|FG001|NOT COMPLETED|Overall Study||0
8961980|NCT02539134|10025327|FG002|NOT COMPLETED|Overall Study||0
8961981|NCT02539134|10025328|FG003|NOT COMPLETED|Overall Study||0
8961982|NCT02539134|10025329|FG004|NOT COMPLETED|Overall Study||0
8961983|NCT02539134|10025330|FG005|NOT COMPLETED|Overall Study||0
8961984|NCT02539342|10025351|FG000|STARTED|Overall Study||1
8961985|NCT02539342|10025352|FG001|STARTED|Overall Study||0
8961986|NCT02539342|10025351|FG000|COMPLETED|Overall Study||1
8961987|NCT02539342|10025352|FG001|COMPLETED|Overall Study||0
8961988|NCT02539342|10025351|FG000|NOT COMPLETED|Overall Study||0
8961989|NCT02539342|10025352|FG001|NOT COMPLETED|Overall Study||0
8961990|NCT02539368|10025363|FG000|STARTED|Overall Study||1522
8961991|NCT02539368|10025364|FG001|STARTED|Overall Study||494
8961992|NCT02539368|10025365|FG002|STARTED|Overall Study||358
8961993|NCT02539368|10025366|FG003|STARTED|Overall Study||67
8961994|NCT02539368|10025367|FG004|STARTED|Overall Study||102
8961995|NCT02539368|10025363|FG000|COMPLETED|Overall Study||1117
8961996|NCT02539368|10025364|FG001|COMPLETED|Overall Study||393
8961997|NCT02539368|10025365|FG002|COMPLETED|Overall Study||291
8961998|NCT02539368|10025366|FG003|COMPLETED|Overall Study||60
8961999|NCT02539368|10025367|FG004|COMPLETED|Overall Study||88
8962000|NCT02539368|10025363|FG000|NOT COMPLETED|Overall Study||405
8962001|NCT02539368|10025364|FG001|NOT COMPLETED|Overall Study||101
8962002|NCT02539368|10025365|FG002|NOT COMPLETED|Overall Study||67
8962003|NCT02539368|10025366|FG003|NOT COMPLETED|Overall Study||7
8962004|NCT02539368|10025367|FG004|NOT COMPLETED|Overall Study||14
8962005|NCT02539459|10025382|FG000|STARTED|Overall Study||20
8962006|NCT02539459|10025382|FG000|COMPLETED|Overall Study||18
8962007|NCT02539459|10025382|FG000|NOT COMPLETED|Overall Study||2
8962008|NCT02539511|10025388|FG000|STARTED|Overall Study||23
8962009|NCT02539511|10025389|FG001|STARTED|Overall Study||17
8962010|NCT02539511|10025388|FG000|COMPLETED|Overall Study||17
8962011|NCT02539511|10025389|FG001|COMPLETED|Overall Study||17
8962012|NCT02539511|10025388|FG000|NOT COMPLETED|Overall Study||6
8962013|NCT02539511|10025389|FG001|NOT COMPLETED|Overall Study||0
8962014|NCT02539654|10025395|FG000|STARTED|Overall Study||14
8962015|NCT02539654|10025395|FG000|COMPLETED|Overall Study||14
8962016|NCT02539654|10025395|FG000|NOT COMPLETED|Overall Study||0
8962017|NCT02539797|10025400|FG000|STARTED|Overall Study||12
8962018|NCT02539797|10025401|FG001|STARTED|Overall Study||13
8962019|NCT02539797|10025402|FG002|STARTED|Overall Study||13
8962020|NCT02539797|10025400|FG000|COMPLETED|Overall Study||12
8962021|NCT02539797|10025401|FG001|COMPLETED|Overall Study||12
8962022|NCT02539797|10025402|FG002|COMPLETED|Overall Study||13
8962023|NCT02539797|10025400|FG000|NOT COMPLETED|Overall Study||0
8962024|NCT02539797|10025401|FG001|NOT COMPLETED|Overall Study||1
8962025|NCT02539797|10025402|FG002|NOT COMPLETED|Overall Study||0
8962026|NCT02539992|10025413|FG000|STARTED|Overall Study||15
8962027|NCT02539992|10025414|FG001|STARTED|Overall Study||11
8962028|NCT02539992|10025415|FG002|STARTED|Overall Study||18
8962029|NCT02539992|10025413|FG000|COMPLETED|Overall Study||15
8962030|NCT02539992|10025414|FG001|COMPLETED|Overall Study||7
8962031|NCT02539992|10025415|FG002|COMPLETED|Overall Study||14
8962032|NCT02539992|10025413|FG000|NOT COMPLETED|Overall Study||0
8962033|NCT02539992|10025414|FG001|NOT COMPLETED|Overall Study||4
8962034|NCT02539992|10025415|FG002|NOT COMPLETED|Overall Study||4
8962035|NCT02540083|10025425|FG000|STARTED|Overall Study||94
8962036|NCT02540083|10025425|FG000|COMPLETED|Overall Study||78
8962037|NCT02540083|10025425|FG000|NOT COMPLETED|Overall Study||16
8962038|NCT02540161|10025433|FG000|STARTED|Overall Study||20
8962039|NCT02540161|10025434|FG001|STARTED|Overall Study||7
8962040|NCT02540161|10025435|FG002|STARTED|Overall Study||5
8962041|NCT02540161|10025436|FG003|STARTED|Overall Study||7
8962042|NCT02540161|10025433|FG000|COMPLETED|Overall Study||20
8962043|NCT02540161|10025434|FG001|COMPLETED|Overall Study||7
8962044|NCT02540161|10025435|FG002|COMPLETED|Overall Study||5
8962045|NCT02540161|10025436|FG003|COMPLETED|Overall Study||7
8962046|NCT02540161|10025433|FG000|NOT COMPLETED|Overall Study||0
8962047|NCT02540161|10025434|FG001|NOT COMPLETED|Overall Study||0
8962048|NCT02540161|10025435|FG002|NOT COMPLETED|Overall Study||0
8962049|NCT02540161|10025436|FG003|NOT COMPLETED|Overall Study||0
8962050|NCT02540213|10025446|FG000|STARTED|Overall Study||240
8962051|NCT02540213|10025446|FG000|COMPLETED|Overall Study||201
8962052|NCT02540213|10025446|FG000|NOT COMPLETED|Overall Study||39
8962053|NCT02540226|10025452|FG000|STARTED|Overall Study||33
8962054|NCT02540226|10025453|FG001|STARTED|Overall Study||33
8962055|NCT02540226|10025452|FG000|COMPLETED|Overall Study||31
8962056|NCT02540226|10025453|FG001|COMPLETED|Overall Study||32
8962057|NCT02540226|10025452|FG000|NOT COMPLETED|Overall Study||2
8962058|NCT02540226|10025453|FG001|NOT COMPLETED|Overall Study||1
8962059|NCT02540265|10025462|FG000|STARTED|Overall Study||20
8962060|NCT02540265|10025463|FG001|STARTED|Overall Study||20
8962061|NCT02540265|10025464|FG002|STARTED|Overall Study||19
8962062|NCT02540265|10025462|FG000|Treatment Completion|Overall Study||20
8962063|NCT02540265|10025463|FG001|Treatment Completion|Overall Study||19
8962064|NCT02540265|10025464|FG002|Treatment Completion|Overall Study||18
8962065|NCT02540265|10025462|FG000|COMPLETED|Overall Study||20
8962066|NCT02540265|10025463|FG001|COMPLETED|Overall Study||20
8962067|NCT02540265|10025464|FG002|COMPLETED|Overall Study||18
8962068|NCT02540265|10025462|FG000|NOT COMPLETED|Overall Study||0
8962069|NCT02540265|10025463|FG001|NOT COMPLETED|Overall Study||0
8962070|NCT02540265|10025464|FG002|NOT COMPLETED|Overall Study||1
8962071|NCT02540291|10025476|FG000|STARTED|Overall Study||8
8962072|NCT02540291|10025477|FG001|STARTED|Overall Study||8
8962073|NCT02540291|10025478|FG002|STARTED|Overall Study||7
8962074|NCT02540291|10025479|FG003|STARTED|Overall Study||7
8962075|NCT02540291|10025476|FG000|COMPLETED|Overall Study||0
8962076|NCT02540291|10025477|FG001|COMPLETED|Overall Study||0
8962077|NCT02540291|10025478|FG002|COMPLETED|Overall Study||0
8962078|NCT02540291|10025479|FG003|COMPLETED|Overall Study||0
8962079|NCT02540291|10025476|FG000|NOT COMPLETED|Overall Study||8
8570380|NCT00103285|9602558|FG004|COMPLETED|Induction||0
8570381|NCT00103285|9602559|FG005|COMPLETED|Induction||0
8570382|NCT00103285|9602560|FG006|COMPLETED|Induction||0
8570383|NCT00103285|9602561|FG007|COMPLETED|Induction||0
8962080|NCT02540291|10025477|FG001|NOT COMPLETED|Overall Study||8
8962081|NCT02540291|10025478|FG002|NOT COMPLETED|Overall Study||7
8962082|NCT02540291|10025479|FG003|NOT COMPLETED|Overall Study||7
8962083|NCT02540356|10025493|FG000|STARTED|Overall Study||1
8962084|NCT02540356|10025494|FG001|STARTED|Overall Study||0
8962085|NCT02540356|10025493|FG000|COMPLETED|Overall Study||0
8962086|NCT02540356|10025494|FG001|COMPLETED|Overall Study||0
8962087|NCT02540356|10025493|FG000|NOT COMPLETED|Overall Study||1
8962088|NCT02540356|10025494|FG001|NOT COMPLETED|Overall Study||0
8962089|NCT02540447|10025501|FG000|STARTED|Overall Study||40
8962090|NCT02540447|10025502|FG001|STARTED|Overall Study||40
8962091|NCT02540447|10025501|FG000|COMPLETED|Overall Study||40
8962092|NCT02540447|10025502|FG001|COMPLETED|Overall Study||40
8962093|NCT02540447|10025501|FG000|NOT COMPLETED|Overall Study||0
8962094|NCT02540447|10025502|FG001|NOT COMPLETED|Overall Study||0
8962095|NCT02540538|10025511|FG000|STARTED|Overall Study||12
8962096|NCT02540538|10025512|FG001|STARTED|Overall Study||12
8962097|NCT02540538|10025513|FG002|STARTED|Overall Study||10
8962098|NCT02540538|10025511|FG000|COMPLETED|Overall Study||12
8962099|NCT02540538|10025512|FG001|COMPLETED|Overall Study||11
8962100|NCT02540538|10025513|FG002|COMPLETED|Overall Study||10
8962101|NCT02540538|10025511|FG000|NOT COMPLETED|Overall Study||0
8962102|NCT02540538|10025512|FG001|NOT COMPLETED|Overall Study||1
8962103|NCT02540538|10025513|FG002|NOT COMPLETED|Overall Study||0
8962104|NCT02540629|10025523|FG000|STARTED|Overall Study||6201
8962105|NCT02540629|10025524|FG001|STARTED|Overall Study||6469
8962106|NCT02540629|10025523|FG000|COMPLETED|Overall Study||6201
8962107|NCT02540629|10025524|FG001|COMPLETED|Overall Study||6469
8962108|NCT02540629|10025523|FG000|NOT COMPLETED|Overall Study||0
8962109|NCT02540629|10025524|FG001|NOT COMPLETED|Overall Study||0
8962110|NCT02540668|10025531|FG000|STARTED|Period 1 - Warfarin Single Dose||15
8962111|NCT02540668|10025532|FG001|STARTED|Period 1 - Warfarin Single Dose||0
8962112|NCT02540668|10025531|FG000|Received at Least One Dose of Study Drug|Period 1 - Warfarin Single Dose||15
8962113|NCT02540668|10025532|FG001|Received at Least One Dose of Study Drug|Period 1 - Warfarin Single Dose||0
8962114|NCT02540668|10025531|FG000|COMPLETED|Period 1 - Warfarin Single Dose||15
8962115|NCT02540668|10025532|FG001|COMPLETED|Period 1 - Warfarin Single Dose||0
8962116|NCT02540668|10025531|FG000|NOT COMPLETED|Period 1 - Warfarin Single Dose||0
8962117|NCT02540668|10025532|FG001|NOT COMPLETED|Period 1 - Warfarin Single Dose||0
8962118|NCT02540668|10025531|FG000|STARTED|Period 2 - LY3314814 and Warfarin|Warfarin was administered alone only in Period 1.|0
8962119|NCT02540668|10025532|FG001|STARTED|Period 2 - LY3314814 and Warfarin|Warfarin was co-administered with LY3314814 only in Period 2.|15
8962120|NCT02540668|10025531|FG000|COMPLETED|Period 2 - LY3314814 and Warfarin||0
8962121|NCT02540668|10025532|FG001|COMPLETED|Period 2 - LY3314814 and Warfarin||14
8962122|NCT02540668|10025531|FG000|NOT COMPLETED|Period 2 - LY3314814 and Warfarin||0
8962123|NCT02540668|10025532|FG001|NOT COMPLETED|Period 2 - LY3314814 and Warfarin||1
8631572|NCT00541229|9671534|FG005|STARTED|Treatment Period I (Week 1)||18
8875152|NCT01905254|9931754|FG000|COMPLETED|Overall Study||34
8875153|NCT01905254|9931754|FG000|NOT COMPLETED|Overall Study||0
8875154|NCT01905267|9931760|FG000|STARTED|Overall Study||17
8875155|NCT01905267|9931761|FG001|STARTED|Overall Study||16
8875156|NCT01905267|9931760|FG000|COMPLETED|Overall Study||15
8875157|NCT01905267|9931761|FG001|COMPLETED|Overall Study||14
8875158|NCT01905267|9931760|FG000|NOT COMPLETED|Overall Study||2
8875159|NCT01905267|9931761|FG001|NOT COMPLETED|Overall Study||2
8875160|NCT01905423|9931772|FG000|STARTED|Overall Study||4456
8875161|NCT01905423|9931773|FG001|STARTED|Overall Study||3297
8875162|NCT01905423|9931774|FG002|STARTED|Overall Study||4111
8875163|NCT01905423|9931775|FG003|STARTED|Overall Study||2757
8875164|NCT01905423|9931776|FG004|STARTED|Overall Study||2487
8875165|NCT01905423|9931772|FG000|Baseline|Overall Study||1443
8875166|NCT01905423|9931773|FG001|Baseline|Overall Study||722
8875167|NCT01905423|9931774|FG002|Baseline|Overall Study||1033
8875168|NCT01905423|9931775|FG003|Baseline|Overall Study||1482
8875169|NCT01905423|9931776|FG004|Baseline|Overall Study||1326
8875170|NCT01905423|9931772|FG000|Year 1 Follow-up|Overall Study||994
8875171|NCT01905423|9931773|FG001|Year 1 Follow-up|Overall Study||846
8875172|NCT01905423|9931774|FG002|Year 1 Follow-up|Overall Study||1007
8875173|NCT01905423|9931775|FG003|Year 1 Follow-up|Overall Study||1275
8875174|NCT01905423|9931776|FG004|Year 1 Follow-up|Overall Study||1161
8875175|NCT01905423|9931772|FG000|Year 2 Follow-up|Overall Study||1114
8875176|NCT01905423|9931773|FG001|Year 2 Follow-up|Overall Study||858
8875177|NCT01905423|9931774|FG002|Year 2 Follow-up|Overall Study||1043
8875178|NCT01905423|9931775|FG003|Year 2 Follow-up|Overall Study||0
8875179|NCT01905423|9931776|FG004|Year 2 Follow-up|Overall Study||0
8875180|NCT01905423|9931772|FG000|Year 3 Follow-up|Overall Study||905
8875181|NCT01905423|9931773|FG001|Year 3 Follow-up|Overall Study||871
8875182|NCT01905423|9931774|FG002|Year 3 Follow-up|Overall Study||1028
8962124|NCT02540772|10025541|FG000|STARTED|Overall Study||10
8962125|NCT02540772|10025542|FG001|STARTED|Overall Study||10
8962126|NCT02540772|10025541|FG000|COMPLETED|Overall Study||10
8962127|NCT02540772|10025542|FG001|COMPLETED|Overall Study||10
8962128|NCT02540772|10025541|FG000|NOT COMPLETED|Overall Study||0
8631573|NCT00541229|9671529|FG000|COMPLETED|Treatment Period I (Week 1)||17
8875183|NCT01905423|9931775|FG003|Year 3 Follow-up|Overall Study||0
8962129|NCT02540772|10025542|FG001|NOT COMPLETED|Overall Study||0
8875184|NCT01905423|9931776|FG004|Year 3 Follow-up|Overall Study||0
8875185|NCT01905423|9931772|FG000|COMPLETED|Overall Study||4456
8875186|NCT01905423|9931773|FG001|COMPLETED|Overall Study||3297
8875187|NCT01905423|9931774|FG002|COMPLETED|Overall Study||4111
8875188|NCT01905423|9931775|FG003|COMPLETED|Overall Study||2757
8875189|NCT01905423|9931776|FG004|COMPLETED|Overall Study||2487
8875190|NCT01905423|9931772|FG000|NOT COMPLETED|Overall Study||0
8875191|NCT01905423|9931773|FG001|NOT COMPLETED|Overall Study||0
8875192|NCT01905423|9931774|FG002|NOT COMPLETED|Overall Study||0
8875193|NCT01905423|9931775|FG003|NOT COMPLETED|Overall Study||0
8875194|NCT01905423|9931776|FG004|NOT COMPLETED|Overall Study||0
8875195|NCT01905540|9931792|FG000|STARTED|Period 1||7
8875196|NCT01905540|9931793|FG001|STARTED|Period 1||7
8875197|NCT01905540|9931794|FG002|STARTED|Period 1||7
8875198|NCT01905540|9931795|FG003|STARTED|Period 1||7
8962130|NCT02540850|10025551|FG000|STARTED|Overall Study||360
8962131|NCT02540850|10025552|FG001|STARTED|Overall Study||396
8962132|NCT02540850|10025553|FG002|STARTED|Overall Study||444
8962133|NCT02540850|10025551|FG000|COMPLETED|Overall Study||291
8962134|NCT02540850|10025552|FG001|COMPLETED|Overall Study||330
8962135|NCT02540850|10025553|FG002|COMPLETED|Overall Study||410
8631574|NCT00541229|9671530|FG001|COMPLETED|Treatment Period I (Week 1)||15
8631575|NCT00541229|9671531|FG002|COMPLETED|Treatment Period I (Week 1)||17
8631576|NCT00541229|9671532|FG003|COMPLETED|Treatment Period I (Week 1)||17
8875199|NCT01905540|9931792|FG000|COMPLETED|Period 1||7
8875200|NCT01905540|9931793|FG001|COMPLETED|Period 1||7
8875201|NCT01905540|9931794|FG002|COMPLETED|Period 1||7
8962136|NCT02540850|10025551|FG000|NOT COMPLETED|Overall Study||69
8962137|NCT02540850|10025552|FG001|NOT COMPLETED|Overall Study||66
8962138|NCT02540850|10025553|FG002|NOT COMPLETED|Overall Study||34
8962139|NCT02540954|10025563|FG000|STARTED|Overall Study||168
8962140|NCT02540954|10025564|FG001|STARTED|Overall Study||168
8962141|NCT02540954|10025563|FG000|Treated|Overall Study||167
8962142|NCT02540954|10025564|FG001|Treated|Overall Study||168
8962143|NCT02540954|10025563|FG000|Post-baseline BCVA Assessment|Overall Study|FAS|165
8962144|NCT02540954|10025564|FG001|Post-baseline BCVA Assessment|Overall Study|FAS|167
8962145|NCT02540954|10025563|FG000|COMPLETED|Overall Study|Completed treatment|149
8962146|NCT02540954|10025564|FG001|COMPLETED|Overall Study|Completed treatment|154
8962147|NCT02540954|10025563|FG000|NOT COMPLETED|Overall Study||19
8962148|NCT02540954|10025564|FG001|NOT COMPLETED|Overall Study||14
8962149|NCT02540993|10025572|FG000|STARTED|Overall Study||2866
8962150|NCT02540993|10025573|FG001|STARTED|Overall Study||2868
8962151|NCT02540993|10025572|FG000|Included in FAS|Overall Study||2833
8962152|NCT02540993|10025573|FG001|Included in FAS|Overall Study||2841
8962153|NCT02540993|10025572|FG000|Treated|Overall Study||2827
8962154|NCT02540993|10025573|FG001|Treated|Overall Study||2831
8962155|NCT02540993|10025572|FG000|COMPLETED|Overall Study||2824
8962156|NCT02540993|10025573|FG001|COMPLETED|Overall Study||2832
8962157|NCT02540993|10025572|FG000|NOT COMPLETED|Overall Study||42
8962158|NCT02540993|10025573|FG001|NOT COMPLETED|Overall Study||36
8962159|NCT02541409|10025581|FG000|STARTED|Overall Study||25
8962160|NCT02541409|10025582|FG001|STARTED|Overall Study||25
8962161|NCT02541409|10025581|FG000|COMPLETED|Overall Study||22
8962162|NCT02541409|10025582|FG001|COMPLETED|Overall Study||22
8962163|NCT02541409|10025581|FG000|NOT COMPLETED|Overall Study||3
8962164|NCT02541409|10025582|FG001|NOT COMPLETED|Overall Study||3
8962165|NCT02541422|10025588|FG000|STARTED|First Intervention||23
8962166|NCT02541422|10025589|FG001|STARTED|First Intervention||26
8962167|NCT02541422|10025588|FG000|COMPLETED|First Intervention||23
8962168|NCT02541422|10025589|FG001|COMPLETED|First Intervention||26
8962169|NCT02541422|10025588|FG000|NOT COMPLETED|First Intervention||0
8962170|NCT02541422|10025589|FG001|NOT COMPLETED|First Intervention||0
8962171|NCT02541422|10025588|FG000|STARTED|Second Intervention||23
8962172|NCT02541422|10025589|FG001|STARTED|Second Intervention||26
8962173|NCT02541422|10025588|FG000|COMPLETED|Second Intervention||23
8962174|NCT02541422|10025589|FG001|COMPLETED|Second Intervention||26
8962175|NCT02541422|10025588|FG000|NOT COMPLETED|Second Intervention||0
8962176|NCT02541422|10025589|FG001|NOT COMPLETED|Second Intervention||0
8962177|NCT02541565|10025595|FG000|STARTED|Overall Study||30
8962178|NCT02541565|10025595|FG000|COMPLETED|Overall Study||27
8962179|NCT02541565|10025595|FG000|NOT COMPLETED|Overall Study||3
8962180|NCT02541604|10025611|FG000|STARTED|Overall Study||11
8875202|NCT01905540|9931795|FG003|COMPLETED|Period 1||7
8875203|NCT01905540|9931792|FG000|NOT COMPLETED|Period 1||0
8875204|NCT01905540|9931793|FG001|NOT COMPLETED|Period 1||0
8875205|NCT01905540|9931794|FG002|NOT COMPLETED|Period 1||0
8875206|NCT01905540|9931795|FG003|NOT COMPLETED|Period 1||0
8875207|NCT01905540|9931792|FG000|STARTED|Period 2||7
8875208|NCT01905540|9931793|FG001|STARTED|Period 2||7
8875209|NCT01905540|9931794|FG002|STARTED|Period 2||7
8962181|NCT02541604|10025612|FG001|STARTED|Overall Study||9
8962182|NCT02541604|10025613|FG002|STARTED|Overall Study||11
8962183|NCT02541604|10025614|FG003|STARTED|Overall Study||3
8962184|NCT02541604|10025615|FG004|STARTED|Overall Study||10
8962185|NCT02541604|10025616|FG005|STARTED|Overall Study||10
8962186|NCT02541604|10025617|FG006|STARTED|Overall Study||10
8962187|NCT02541604|10025618|FG007|STARTED|Overall Study||10
8962188|NCT02541604|10025619|FG008|STARTED|Overall Study||4
8962189|NCT02541604|10025620|FG009|STARTED|Overall Study||4
8875210|NCT01905540|9931795|FG003|STARTED|Period 2||7
8875211|NCT01905540|9931792|FG000|COMPLETED|Period 2||7
8875212|NCT01905540|9931793|FG001|COMPLETED|Period 2||7
8875213|NCT01905540|9931794|FG002|COMPLETED|Period 2||7
8875214|NCT01905540|9931795|FG003|COMPLETED|Period 2||7
8875215|NCT01905540|9931792|FG000|NOT COMPLETED|Period 2||0
8875216|NCT01905540|9931793|FG001|NOT COMPLETED|Period 2||0
8875217|NCT01905540|9931794|FG002|NOT COMPLETED|Period 2||0
8875218|NCT01905540|9931795|FG003|NOT COMPLETED|Period 2||0
8962190|NCT02541604|10025621|FG010|STARTED|Overall Study||2
8962191|NCT02541604|10025622|FG011|STARTED|Overall Study||3
8962192|NCT02541604|10025611|FG000|COMPLETED|Overall Study||0
8962193|NCT02541604|10025612|FG001|COMPLETED|Overall Study||0
8631577|NCT00541229|9671533|FG004|COMPLETED|Treatment Period I (Week 1)||14
8631578|NCT00541229|9671534|FG005|COMPLETED|Treatment Period I (Week 1)||16
8631579|NCT00541229|9671529|FG000|NOT COMPLETED|Treatment Period I (Week 1)||0
8631580|NCT00541229|9671530|FG001|NOT COMPLETED|Treatment Period I (Week 1)||1
8875219|NCT01905540|9931792|FG000|STARTED|Period 3||7
8875220|NCT01905540|9931793|FG001|STARTED|Period 3||7
8875221|NCT01905540|9931794|FG002|STARTED|Period 3||7
8631581|NCT00541229|9671531|FG002|NOT COMPLETED|Treatment Period I (Week 1)||3
8875222|NCT01905540|9931795|FG003|STARTED|Period 3||7
8875223|NCT01905540|9931792|FG000|COMPLETED|Period 3||6
8875224|NCT01905540|9931793|FG001|COMPLETED|Period 3||7
8875225|NCT01905540|9931794|FG002|COMPLETED|Period 3||6
8875226|NCT01905540|9931795|FG003|COMPLETED|Period 3||6
8875227|NCT01905540|9931792|FG000|NOT COMPLETED|Period 3||1
8875228|NCT01905540|9931793|FG001|NOT COMPLETED|Period 3||0
8875229|NCT01905540|9931794|FG002|NOT COMPLETED|Period 3||1
8875230|NCT01905540|9931795|FG003|NOT COMPLETED|Period 3||1
8875231|NCT01905553|9931807|FG000|STARTED|Period 1||5
8875232|NCT01905553|9931808|FG001|STARTED|Period 1||4
8875233|NCT01905553|9931807|FG000|COMPLETED|Period 1||5
8875234|NCT01905553|9931808|FG001|COMPLETED|Period 1||4
8875235|NCT01905553|9931807|FG000|NOT COMPLETED|Period 1||0
8875236|NCT01905553|9931808|FG001|NOT COMPLETED|Period 1||0
8875237|NCT01905553|9931807|FG000|STARTED|Period 2||5
8875238|NCT01905553|9931808|FG001|STARTED|Period 2||4
8875239|NCT01905553|9931807|FG000|COMPLETED|Period 2||4
8875240|NCT01905553|9931808|FG001|COMPLETED|Period 2||4
8875241|NCT01905553|9931807|FG000|NOT COMPLETED|Period 2||1
8875242|NCT01905553|9931808|FG001|NOT COMPLETED|Period 2||0
8875243|NCT01905592|9931816|FG000|STARTED|Overall Study||71
8875244|NCT01905592|9931817|FG001|STARTED|Overall Study||135
8875245|NCT01905592|9931816|FG000|COMPLETED|Overall Study||0
8875246|NCT01905592|9931817|FG001|COMPLETED|Overall Study||0
8875247|NCT01905592|9931816|FG000|NOT COMPLETED|Overall Study||71
8875248|NCT01905592|9931817|FG001|NOT COMPLETED|Overall Study||135
8875249|NCT01905657|9931826|FG000|STARTED|Overall Study||345
8875250|NCT01905657|9931827|FG001|STARTED|Overall Study||346
8875251|NCT01905657|9931828|FG002|STARTED|Overall Study||343
8875252|NCT01905657|9931826|FG000|Treated|Overall Study||339
8875253|NCT01905657|9931827|FG001|Treated|Overall Study||343
8875254|NCT01905657|9931828|FG002|Treated|Overall Study||309
8962194|NCT02541604|10025613|FG002|COMPLETED|Overall Study||0
8962195|NCT02541604|10025614|FG003|COMPLETED|Overall Study||0
8962196|NCT02541604|10025615|FG004|COMPLETED|Overall Study||0
8962197|NCT02541604|10025616|FG005|COMPLETED|Overall Study||0
8962198|NCT02541604|10025617|FG006|COMPLETED|Overall Study||0
8962199|NCT02541604|10025618|FG007|COMPLETED|Overall Study||0
8962200|NCT02541604|10025619|FG008|COMPLETED|Overall Study||0
8570384|NCT00103285|9602554|FG000|NOT COMPLETED|Induction||1349
8570385|NCT00103285|9602555|FG001|NOT COMPLETED|Induction||0
8631582|NCT00541229|9671532|FG003|NOT COMPLETED|Treatment Period I (Week 1)||1
8631583|NCT00541229|9671533|FG004|NOT COMPLETED|Treatment Period I (Week 1)||0
8631584|NCT00541229|9671534|FG005|NOT COMPLETED|Treatment Period I (Week 1)||2
8631585|NCT00541229|9671529|FG000|STARTED|Washout Period I (Week 2-5)||17
8631586|NCT00541229|9671530|FG001|STARTED|Washout Period I (Week 2-5)||15
8631587|NCT00541229|9671531|FG002|STARTED|Washout Period I (Week 2-5)||17
8631588|NCT00541229|9671532|FG003|STARTED|Washout Period I (Week 2-5)||17
8631589|NCT00541229|9671533|FG004|STARTED|Washout Period I (Week 2-5)||14
8631590|NCT00541229|9671534|FG005|STARTED|Washout Period I (Week 2-5)||16
8631591|NCT00541229|9671529|FG000|COMPLETED|Washout Period I (Week 2-5)||13
8631592|NCT00541229|9671530|FG001|COMPLETED|Washout Period I (Week 2-5)||13
8631593|NCT00541229|9671531|FG002|COMPLETED|Washout Period I (Week 2-5)||13
8631594|NCT00541229|9671532|FG003|COMPLETED|Washout Period I (Week 2-5)||13
8631595|NCT00541229|9671533|FG004|COMPLETED|Washout Period I (Week 2-5)||13
8631596|NCT00541229|9671534|FG005|COMPLETED|Washout Period I (Week 2-5)||11
8631597|NCT00541229|9671529|FG000|NOT COMPLETED|Washout Period I (Week 2-5)||4
8631598|NCT00541229|9671530|FG001|NOT COMPLETED|Washout Period I (Week 2-5)||2
8631599|NCT00541229|9671531|FG002|NOT COMPLETED|Washout Period I (Week 2-5)||4
8631600|NCT00541229|9671532|FG003|NOT COMPLETED|Washout Period I (Week 2-5)||4
8875255|NCT01905657|9931826|FG000|Received Second Course of Pembrolizumab|Overall Study||14
8875256|NCT01905657|9931827|FG001|Received Second Course of Pembrolizumab|Overall Study||7
8875257|NCT01905657|9931828|FG002|Received Second Course of Pembrolizumab|Overall Study||0
8875258|NCT01905657|9931826|FG000|Switched Over to Pembrolizumab|Overall Study||0
8875259|NCT01905657|9931827|FG001|Switched Over to Pembrolizumab|Overall Study||0
8875260|NCT01905657|9931828|FG002|Switched Over to Pembrolizumab|Overall Study||8
8875261|NCT01905657|9931826|FG000|COMPLETED|Overall Study||142
8875262|NCT01905657|9931827|FG001|COMPLETED|Overall Study||159
8962201|NCT02541604|10025620|FG009|COMPLETED|Overall Study||0
8570386|NCT00103285|9602556|FG002|NOT COMPLETED|Induction||0
8570387|NCT00103285|9602557|FG003|NOT COMPLETED|Induction||0
8570388|NCT00103285|9602558|FG004|NOT COMPLETED|Induction||0
8570389|NCT00103285|9602559|FG005|NOT COMPLETED|Induction||0
8570390|NCT00103285|9602560|FG006|NOT COMPLETED|Induction||0
8570391|NCT00103285|9602561|FG007|NOT COMPLETED|Induction||0
8570392|NCT00103285|9602554|FG000|STARTED|Response Assignment||0
8570393|NCT00103285|9602555|FG001|STARTED|Response Assignment||939
8570394|NCT00103285|9602556|FG002|STARTED|Response Assignment||937
8570395|NCT00103285|9602557|FG003|STARTED|Response Assignment||503
8570396|NCT00103285|9602558|FG004|STARTED|Response Assignment||509
8570397|NCT00103285|9602559|FG005|STARTED|Response Assignment||249
8570398|NCT00103285|9602560|FG006|STARTED|Response Assignment||248
8570399|NCT00103285|9602561|FG007|STARTED|Response Assignment||643
8570400|NCT00103285|9602554|FG000|COMPLETED|Response Assignment||0
8570401|NCT00103285|9602555|FG001|COMPLETED|Response Assignment||807
8570402|NCT00103285|9602556|FG002|COMPLETED|Response Assignment||853
8570403|NCT00103285|9602557|FG003|COMPLETED|Response Assignment||441
8570404|NCT00103285|9602558|FG004|COMPLETED|Response Assignment||425
8570405|NCT00103285|9602559|FG005|COMPLETED|Response Assignment||201
8570406|NCT00103285|9602560|FG006|COMPLETED|Response Assignment||199
8570407|NCT00103285|9602561|FG007|COMPLETED|Response Assignment||523
8570408|NCT00103285|9602554|FG000|NOT COMPLETED|Response Assignment||0
8570409|NCT00103285|9602555|FG001|NOT COMPLETED|Response Assignment||132
8570410|NCT00103285|9602556|FG002|NOT COMPLETED|Response Assignment||84
8570411|NCT00103285|9602557|FG003|NOT COMPLETED|Response Assignment||62
8570412|NCT00103285|9602558|FG004|NOT COMPLETED|Response Assignment||84
8570413|NCT00103285|9602559|FG005|NOT COMPLETED|Response Assignment||48
8570414|NCT00103285|9602560|FG006|NOT COMPLETED|Response Assignment||49
8570415|NCT00103285|9602561|FG007|NOT COMPLETED|Response Assignment||120
8570416|NCT00103311|9602588|FG000|STARTED|Overall Study||33
8570417|NCT00103311|9602589|FG001|STARTED|Overall Study||31
8570418|NCT00103311|9602588|FG000|COMPLETED|Overall Study||29
8570419|NCT00103311|9602589|FG001|COMPLETED|Overall Study||30
8570420|NCT00103311|9602588|FG000|NOT COMPLETED|Overall Study||4
8570421|NCT00103311|9602589|FG001|NOT COMPLETED|Overall Study||1
8570422|NCT00103376|9602598|FG000|STARTED|Overall Study||8
8570423|NCT00103376|9602599|FG001|STARTED|Overall Study||7
8570424|NCT00103376|9602600|FG002|STARTED|Overall Study||8
8570425|NCT00103376|9602598|FG000|COMPLETED|Overall Study||8
8570426|NCT00103376|9602599|FG001|COMPLETED|Overall Study||7
8570427|NCT00103376|9602600|FG002|COMPLETED|Overall Study||8
8570428|NCT00103376|9602598|FG000|NOT COMPLETED|Overall Study||0
8570429|NCT00103376|9602599|FG001|NOT COMPLETED|Overall Study||0
8631601|NCT00541229|9671533|FG004|NOT COMPLETED|Washout Period I (Week 2-5)||1
8875263|NCT01905657|9931828|FG002|COMPLETED|Overall Study||143
8570430|NCT00103376|9602600|FG002|NOT COMPLETED|Overall Study||0
8962202|NCT02541604|10025621|FG010|COMPLETED|Overall Study||0
8570431|NCT00103402|9602616|FG000|STARTED|Overall Study||138
8570432|NCT00103402|9602617|FG001|STARTED|Overall Study||134
8570433|NCT00103402|9602616|FG000|COMPLETED|Overall Study||116
8570434|NCT00103402|9602617|FG001|COMPLETED|Overall Study||117
8570435|NCT00103402|9602616|FG000|NOT COMPLETED|Overall Study||22
8570436|NCT00103402|9602617|FG001|NOT COMPLETED|Overall Study||17
8570437|NCT00103506|9602625|FG000|STARTED|Overall Study||322
8570438|NCT00103506|9602626|FG001|STARTED|Overall Study||324
8570439|NCT00103506|9602625|FG000|COMPLETED|Overall Study||0
8570440|NCT00103506|9602626|FG001|COMPLETED|Overall Study||0
8570441|NCT00103506|9602625|FG000|NOT COMPLETED|Overall Study||322
8570442|NCT00103506|9602626|FG001|NOT COMPLETED|Overall Study||324
8570443|NCT00103610|9602634|FG000|STARTED|Overall Study||150
8570444|NCT00103610|9602635|FG001|STARTED|Overall Study||148
8570445|NCT00103610|9602634|FG000|COMPLETED|Overall Study||112
8570446|NCT00103610|9602635|FG001|COMPLETED|Overall Study||68
8570447|NCT00103610|9602634|FG000|NOT COMPLETED|Overall Study||38
8570448|NCT00103610|9602635|FG001|NOT COMPLETED|Overall Study||80
8570449|NCT00103662|9602644|FG000|STARTED|Overall Study||148
8570450|NCT00103662|9602645|FG001|STARTED|Overall Study||154
8570451|NCT00103662|9602644|FG000|COMPLETED|Overall Study|1 participant was wrongly terminated due to 'other'; the participant stayed on study until death.|129
8570452|NCT00103662|9602645|FG001|COMPLETED|Overall Study|1 participant was wrongly terminated due to 'other'; the participant stayed on study until death.|121
8570453|NCT00103662|9602644|FG000|NOT COMPLETED|Overall Study||19
8570454|NCT00103662|9602645|FG001|NOT COMPLETED|Overall Study||33
8570455|NCT00103740|9602653|FG000|STARTED|Period 1 - Core||92
8570456|NCT00103740|9602654|FG001|STARTED|Period 1 - Core||93
8570457|NCT00103740|9602653|FG000|COMPLETED|Period 1 - Core||85
8570458|NCT00103740|9602654|FG001|COMPLETED|Period 1 - Core||89
8570459|NCT00103740|9602653|FG000|NOT COMPLETED|Period 1 - Core||7
8570460|NCT00103740|9602654|FG001|NOT COMPLETED|Period 1 - Core||4
8570461|NCT00103740|9602653|FG000|STARTED|Period 2 - Extended Observation Period||78
8631602|NCT00541229|9671534|FG005|NOT COMPLETED|Washout Period I (Week 2-5)||5
8570462|NCT00103740|9602654|FG001|STARTED|Period 2 - Extended Observation Period||63
8570463|NCT00103740|9602653|FG000|COMPLETED|Period 2 - Extended Observation Period|Includes patients retreated for Paget's disease and patients discontinued when sponsor ended study|9
8631603|NCT00541229|9671529|FG000|STARTED|Treatment Period II (Week 6)||13
8631604|NCT00541229|9671530|FG001|STARTED|Treatment Period II (Week 6)||13
8631605|NCT00541229|9671531|FG002|STARTED|Treatment Period II (Week 6)||13
8631606|NCT00541229|9671532|FG003|STARTED|Treatment Period II (Week 6)||13
8631607|NCT00541229|9671533|FG004|STARTED|Treatment Period II (Week 6)||13
8570464|NCT00103740|9602654|FG001|COMPLETED|Period 2 - Extended Observation Period|Includes patients retreated for Paget's disease and patients discontinued when sponsor ended study|27
8570465|NCT00103740|9602653|FG000|NOT COMPLETED|Period 2 - Extended Observation Period||69
8570466|NCT00103740|9602654|FG001|NOT COMPLETED|Period 2 - Extended Observation Period||36
8570467|NCT00103844|9602662|FG000|STARTED|Overall Study||101
8570468|NCT00103844|9602663|FG001|STARTED|Overall Study||49
8570469|NCT00103844|9602662|FG000|Crossed Over|Overall Study|22 participants from the dasatinib arm crossed over to imatinib|22
8570470|NCT00103844|9602663|FG001|Crossed Over|Overall Study|40 participants from the imatinib arm crossed over the dasatinib|40
8570471|NCT00103844|9602662|FG000|COMPLETED|Overall Study|Completed=no longer on treatment.Treatment continued until disease progression/intolerable toxicity.|101
8570472|NCT00103844|9602663|FG001|COMPLETED|Overall Study|Completed=no longer on treatment.Treatment continued until disease progression/intolerable toxicity.|49
8570473|NCT00103844|9602662|FG000|NOT COMPLETED|Overall Study||0
8962203|NCT02541604|10025622|FG011|COMPLETED|Overall Study||0
8962204|NCT02541604|10025611|FG000|NOT COMPLETED|Overall Study||11
8962205|NCT02541604|10025612|FG001|NOT COMPLETED|Overall Study||9
8962206|NCT02541604|10025613|FG002|NOT COMPLETED|Overall Study||11
8962207|NCT02541604|10025614|FG003|NOT COMPLETED|Overall Study||3
8962208|NCT02541604|10025615|FG004|NOT COMPLETED|Overall Study||10
8962209|NCT02541604|10025616|FG005|NOT COMPLETED|Overall Study||10
8962210|NCT02541604|10025617|FG006|NOT COMPLETED|Overall Study||10
8962211|NCT02541604|10025618|FG007|NOT COMPLETED|Overall Study||10
8962212|NCT02541604|10025619|FG008|NOT COMPLETED|Overall Study||4
8962213|NCT02541604|10025620|FG009|NOT COMPLETED|Overall Study||4
8962214|NCT02541604|10025621|FG010|NOT COMPLETED|Overall Study||2
8962215|NCT02541604|10025622|FG011|NOT COMPLETED|Overall Study||3
8962216|NCT02541669|10025676|FG000|STARTED|Open Label Treatment Period||8
8962217|NCT02541669|10025677|FG001|STARTED|Open Label Treatment Period||8
8962218|NCT02541669|10025678|FG002|STARTED|Open Label Treatment Period||0
8962219|NCT02541669|10025679|FG003|STARTED|Open Label Treatment Period||0
8962220|NCT02541669|10025680|FG004|STARTED|Open Label Treatment Period||0
8962221|NCT02541669|10025676|FG000|COMPLETED|Open Label Treatment Period||8
8962222|NCT02541669|10025677|FG001|COMPLETED|Open Label Treatment Period||8
8962223|NCT02541669|10025678|FG002|COMPLETED|Open Label Treatment Period||0
8962224|NCT02541669|10025679|FG003|COMPLETED|Open Label Treatment Period||0
8962225|NCT02541669|10025680|FG004|COMPLETED|Open Label Treatment Period||0
8962226|NCT02541669|10025676|FG000|NOT COMPLETED|Open Label Treatment Period||0
8962227|NCT02541669|10025677|FG001|NOT COMPLETED|Open Label Treatment Period||0
8962228|NCT02541669|10025678|FG002|NOT COMPLETED|Open Label Treatment Period||0
8962229|NCT02541669|10025679|FG003|NOT COMPLETED|Open Label Treatment Period||0
8962230|NCT02541669|10025680|FG004|NOT COMPLETED|Open Label Treatment Period||0
8962231|NCT02541669|10025676|FG000|STARTED|Double-Blinded Treatment Period||0
8962232|NCT02541669|10025677|FG001|STARTED|Double-Blinded Treatment Period||0
8962233|NCT02541669|10025678|FG002|STARTED|Double-Blinded Treatment Period||16
8962234|NCT02541669|10025679|FG003|STARTED|Double-Blinded Treatment Period||16
8962235|NCT02541669|10025680|FG004|STARTED|Double-Blinded Treatment Period||16
8962236|NCT02541669|10025676|FG000|COMPLETED|Double-Blinded Treatment Period||0
8962237|NCT02541669|10025677|FG001|COMPLETED|Double-Blinded Treatment Period||0
8962238|NCT02541669|10025678|FG002|COMPLETED|Double-Blinded Treatment Period||15
8962239|NCT02541669|10025679|FG003|COMPLETED|Double-Blinded Treatment Period||16
8962240|NCT02541669|10025680|FG004|COMPLETED|Double-Blinded Treatment Period||15
8962241|NCT02541669|10025676|FG000|NOT COMPLETED|Double-Blinded Treatment Period||0
8962242|NCT02541669|10025677|FG001|NOT COMPLETED|Double-Blinded Treatment Period||0
8962243|NCT02541669|10025678|FG002|NOT COMPLETED|Double-Blinded Treatment Period||1
8962244|NCT02541669|10025679|FG003|NOT COMPLETED|Double-Blinded Treatment Period||0
8962245|NCT02541669|10025680|FG004|NOT COMPLETED|Double-Blinded Treatment Period||1
8962246|NCT02541812|10025693|FG000|STARTED|Overall Study||10
8962247|NCT02541812|10025694|FG001|STARTED|Overall Study||10
8962248|NCT02541812|10025693|FG000|COMPLETED|Overall Study||10
8962249|NCT02541812|10025694|FG001|COMPLETED|Overall Study||10
8962250|NCT02541812|10025693|FG000|NOT COMPLETED|Overall Study||0
8962251|NCT02541812|10025694|FG001|NOT COMPLETED|Overall Study||0
8962252|NCT02541864|10025703|FG000|STARTED|Overall Study||164
8962253|NCT02541864|10025704|FG001|STARTED|Overall Study||166
8962254|NCT02541864|10025703|FG000|COMPLETED|Overall Study||164
8962255|NCT02541864|10025704|FG001|COMPLETED|Overall Study||166
8962256|NCT02541864|10025703|FG000|NOT COMPLETED|Overall Study||0
8962257|NCT02541864|10025704|FG001|NOT COMPLETED|Overall Study||0
8962258|NCT02541903|10025710|FG000|STARTED|Overall Study||8
8962259|NCT02541903|10025710|FG000|COMPLETED|Overall Study||7
8962260|NCT02541903|10025710|FG000|NOT COMPLETED|Overall Study||1
8962261|NCT02541942|10025714|FG000|STARTED|Overall Study||19
8962262|NCT02541942|10025714|FG000|COMPLETED|Overall Study||19
8962263|NCT02541942|10025714|FG000|NOT COMPLETED|Overall Study||0
8962264|NCT02542046|10025721|FG000|STARTED|Overall Study||300
8962265|NCT02542046|10025722|FG001|STARTED|Overall Study||300
8962266|NCT02542046|10025723|FG002|STARTED|Overall Study||300
8962267|NCT02542046|10025721|FG000|COMPLETED|Overall Study||300
8962268|NCT02542046|10025722|FG001|COMPLETED|Overall Study||300
8962269|NCT02542046|10025723|FG002|COMPLETED|Overall Study||300
8962270|NCT02542046|10025721|FG000|NOT COMPLETED|Overall Study||0
8962271|NCT02542046|10025722|FG001|NOT COMPLETED|Overall Study||0
8962272|NCT02542046|10025723|FG002|NOT COMPLETED|Overall Study||0
8962273|NCT02542072|10025733|FG000|STARTED|First Intervention (1 Month)||44
8962274|NCT02542072|10025734|FG001|STARTED|First Intervention (1 Month)||46
8962275|NCT02542072|10025733|FG000|COMPLETED|First Intervention (1 Month)||39
8962276|NCT02542072|10025734|FG001|COMPLETED|First Intervention (1 Month)||43
8962277|NCT02542072|10025733|FG000|NOT COMPLETED|First Intervention (1 Month)||5
8962278|NCT02542072|10025734|FG001|NOT COMPLETED|First Intervention (1 Month)||3
8962279|NCT02542072|10025733|FG000|STARTED|Second Intervention (1 Month)||39
8962280|NCT02542072|10025734|FG001|STARTED|Second Intervention (1 Month)||43
8962281|NCT02542072|10025733|FG000|COMPLETED|Second Intervention (1 Month)||37
8962282|NCT02542072|10025734|FG001|COMPLETED|Second Intervention (1 Month)||43
8631608|NCT00541229|9671534|FG005|STARTED|Treatment Period II (Week 6)||11
8631609|NCT00541229|9671529|FG000|COMPLETED|Treatment Period II (Week 6)||11
8631610|NCT00541229|9671530|FG001|COMPLETED|Treatment Period II (Week 6)||12
8631611|NCT00541229|9671531|FG002|COMPLETED|Treatment Period II (Week 6)||12
8631612|NCT00541229|9671532|FG003|COMPLETED|Treatment Period II (Week 6)||12
8631613|NCT00541229|9671533|FG004|COMPLETED|Treatment Period II (Week 6)||11
8962283|NCT02542072|10025733|FG000|NOT COMPLETED|Second Intervention (1 Month)||2
8962284|NCT02542072|10025734|FG001|NOT COMPLETED|Second Intervention (1 Month)||0
8962285|NCT02542150|10025762|FG000|STARTED|Overall Study||12
8962286|NCT02542150|10025763|FG001|STARTED|Overall Study||12
8962287|NCT02542150|10025762|FG000|Completed Placebo|Overall Study||12
8962288|NCT02542150|10025763|FG001|Completed Placebo|Overall Study||12
8962289|NCT02542150|10025762|FG000|Started Intervention|Overall Study||12
8962290|NCT02542150|10025763|FG001|Started Intervention|Overall Study||12
8962291|NCT02542150|10025762|FG000|COMPLETED|Overall Study||12
8962292|NCT02542150|10025763|FG001|COMPLETED|Overall Study||12
8962293|NCT02542150|10025762|FG000|NOT COMPLETED|Overall Study||0
8962294|NCT02542150|10025763|FG001|NOT COMPLETED|Overall Study||0
8962295|NCT02542280|10025775|FG000|STARTED|Overall Study||174
8962296|NCT02542280|10025776|FG001|STARTED|Overall Study||175
8962297|NCT02542280|10025775|FG000|COMPLETED|Overall Study||162
8962298|NCT02542280|10025776|FG001|COMPLETED|Overall Study||167
8962299|NCT02542280|10025775|FG000|NOT COMPLETED|Overall Study||12
8962300|NCT02542280|10025776|FG001|NOT COMPLETED|Overall Study||8
8962301|NCT02542410|10025784|FG000|STARTED|Overall Study||5
8962302|NCT02542410|10025785|FG001|STARTED|Overall Study||5
8962303|NCT02542410|10025784|FG000|COMPLETED|Overall Study||3
8962304|NCT02542410|10025785|FG001|COMPLETED|Overall Study||4
8962305|NCT02542410|10025784|FG000|NOT COMPLETED|Overall Study||2
8962306|NCT02542410|10025785|FG001|NOT COMPLETED|Overall Study||1
8962307|NCT02542462|10025795|FG000|STARTED|Overall Study||25
8962308|NCT02542462|10025796|FG001|STARTED|Overall Study||25
8962309|NCT02542462|10025797|FG002|STARTED|Overall Study||25
8962310|NCT02542462|10025798|FG003|STARTED|Overall Study||26
8962311|NCT02542462|10025795|FG000|COMPLETED|Overall Study||25
8962312|NCT02542462|10025796|FG001|COMPLETED|Overall Study||25
8962313|NCT02542462|10025797|FG002|COMPLETED|Overall Study||25
8962314|NCT02542462|10025798|FG003|COMPLETED|Overall Study||25
8962315|NCT02542462|10025795|FG000|NOT COMPLETED|Overall Study||0
8962316|NCT02542462|10025796|FG001|NOT COMPLETED|Overall Study||0
8962317|NCT02542462|10025797|FG002|NOT COMPLETED|Overall Study||0
8962318|NCT02542462|10025798|FG003|NOT COMPLETED|Overall Study||1
8631614|NCT00541229|9671534|FG005|COMPLETED|Treatment Period II (Week 6)||8
8631615|NCT00541229|9671529|FG000|NOT COMPLETED|Treatment Period II (Week 6)||2
8875264|NCT01905657|9931826|FG000|NOT COMPLETED|Overall Study||203
8875265|NCT01905657|9931827|FG001|NOT COMPLETED|Overall Study||187
8875266|NCT01905657|9931828|FG002|NOT COMPLETED|Overall Study||200
8875267|NCT01905683|9931839|FG000|STARTED|Overall Study||370
8962319|NCT02542605|10025809|FG000|STARTED|Part A: PACAP-38 Dose Selection Phase||12
8962320|NCT02542605|10025810|FG001|STARTED|Part A: PACAP-38 Dose Selection Phase||0
8962321|NCT02542605|10025811|FG002|STARTED|Part A: PACAP-38 Dose Selection Phase||0
8962322|NCT02542605|10025809|FG000|Received PACAP-38|Part A: PACAP-38 Dose Selection Phase||12
8962323|NCT02542605|10025810|FG001|Received PACAP-38|Part A: PACAP-38 Dose Selection Phase||0
8962324|NCT02542605|10025811|FG002|Received PACAP-38|Part A: PACAP-38 Dose Selection Phase||0
8962325|NCT02542605|10025809|FG000|Proceeded to Part B Randomization Phase|Part A: PACAP-38 Dose Selection Phase||2
8962326|NCT02542605|10025810|FG001|Proceeded to Part B Randomization Phase|Part A: PACAP-38 Dose Selection Phase||0
8962327|NCT02542605|10025811|FG002|Proceeded to Part B Randomization Phase|Part A: PACAP-38 Dose Selection Phase||0
8962328|NCT02542605|10025809|FG000|COMPLETED|Part A: PACAP-38 Dose Selection Phase||12
8631616|NCT00541229|9671530|FG001|NOT COMPLETED|Treatment Period II (Week 6)||1
8875268|NCT01905683|9931839|FG000|COMPLETED|Overall Study||319
8875269|NCT01905683|9931839|FG000|NOT COMPLETED|Overall Study||51
8875270|NCT01905943|9931843|FG000|STARTED|Overall Study||972
8875271|NCT01905943|9931843|FG000|COMPLETED|Overall Study|All patients provide reason at final analysis|658
8875272|NCT01905943|9931843|FG000|NOT COMPLETED|Overall Study||314
8875273|NCT01905956|9931864|FG000|STARTED|Overall Study|Randomized|60
8875274|NCT01905956|9931865|FG001|STARTED|Overall Study|Randomized|59
8962329|NCT02542605|10025810|FG001|COMPLETED|Part A: PACAP-38 Dose Selection Phase||0
8962330|NCT02542605|10025811|FG002|COMPLETED|Part A: PACAP-38 Dose Selection Phase||0
8962331|NCT02542605|10025809|FG000|NOT COMPLETED|Part A: PACAP-38 Dose Selection Phase||0
8962332|NCT02542605|10025810|FG001|NOT COMPLETED|Part A: PACAP-38 Dose Selection Phase||0
8962333|NCT02542605|10025811|FG002|NOT COMPLETED|Part A: PACAP-38 Dose Selection Phase||0
8875275|NCT01905956|9931864|FG000|Intention-to-treat Population|Overall Study|Intention-to-treat population|57
8875276|NCT01905956|9931865|FG001|Intention-to-treat Population|Overall Study|Intention-to-treat population|54
8962334|NCT02542605|10025809|FG000|STARTED|Part B: Challenge Phase||23
8962335|NCT02542605|10025810|FG001|STARTED|Part B: Challenge Phase||0
8962336|NCT02542605|10025811|FG002|STARTED|Part B: Challenge Phase||0
8962337|NCT02542605|10025809|FG000|Received PACAP-38|Part B: Challenge Phase||23
8962338|NCT02542605|10025810|FG001|Received PACAP-38|Part B: Challenge Phase||0
8962339|NCT02542605|10025811|FG002|Received PACAP-38|Part B: Challenge Phase||0
8962340|NCT02542605|10025809|FG000|Proceeded to Randomization Phase|Part B: Challenge Phase||15
8962341|NCT02542605|10025810|FG001|Proceeded to Randomization Phase|Part B: Challenge Phase||0
8962342|NCT02542605|10025811|FG002|Proceeded to Randomization Phase|Part B: Challenge Phase||0
8962343|NCT02542605|10025809|FG000|COMPLETED|Part B: Challenge Phase||22
8962344|NCT02542605|10025810|FG001|COMPLETED|Part B: Challenge Phase||0
8962345|NCT02542605|10025811|FG002|COMPLETED|Part B: Challenge Phase||0
8962346|NCT02542605|10025809|FG000|NOT COMPLETED|Part B: Challenge Phase||1
8962347|NCT02542605|10025810|FG001|NOT COMPLETED|Part B: Challenge Phase||0
8962348|NCT02542605|10025811|FG002|NOT COMPLETED|Part B: Challenge Phase||0
8962349|NCT02542605|10025809|FG000|STARTED|Part B: Randomization Phase||0
8962350|NCT02542605|10025810|FG001|STARTED|Part B: Randomization Phase||9
8962351|NCT02542605|10025811|FG002|STARTED|Part B: Randomization Phase||8
8962352|NCT02542605|10025809|FG000|Not PACAP-38 naïve Participants|Part B: Randomization Phase||0
8962353|NCT02542605|10025810|FG001|Not PACAP-38 naïve Participants|Part B: Randomization Phase||2
8962354|NCT02542605|10025811|FG002|Not PACAP-38 naïve Participants|Part B: Randomization Phase||0
8962355|NCT02542605|10025809|FG000|PACAP-38 naïve Participants|Part B: Randomization Phase||0
8962356|NCT02542605|10025810|FG001|PACAP-38 naïve Participants|Part B: Randomization Phase||7
8962357|NCT02542605|10025811|FG002|PACAP-38 naïve Participants|Part B: Randomization Phase||8
8962358|NCT02542605|10025809|FG000|Received Placebo/Erenumab|Part B: Randomization Phase||0
8962359|NCT02542605|10025810|FG001|Received Placebo/Erenumab|Part B: Randomization Phase||9
8962360|NCT02542605|10025811|FG002|Received Placebo/Erenumab|Part B: Randomization Phase||7
8962361|NCT02542605|10025809|FG000|COMPLETED|Part B: Randomization Phase||0
8962362|NCT02542605|10025810|FG001|COMPLETED|Part B: Randomization Phase||9
8962363|NCT02542605|10025811|FG002|COMPLETED|Part B: Randomization Phase||7
8962364|NCT02542605|10025809|FG000|NOT COMPLETED|Part B: Randomization Phase||0
8962365|NCT02542605|10025810|FG001|NOT COMPLETED|Part B: Randomization Phase||0
8962366|NCT02542605|10025811|FG002|NOT COMPLETED|Part B: Randomization Phase||1
8962367|NCT02542631|10025822|FG000|STARTED|Overall Study||139
8962368|NCT02542631|10025823|FG001|STARTED|Overall Study||139
8962369|NCT02542631|10025822|FG000|COMPLETED|Overall Study||108
8962370|NCT02542631|10025823|FG001|COMPLETED|Overall Study||108
8962371|NCT02542631|10025822|FG000|NOT COMPLETED|Overall Study||31
8962372|NCT02542631|10025823|FG001|NOT COMPLETED|Overall Study||31
8962373|NCT02542761|10025829|FG000|STARTED|Acclimation Period 1||5
8962374|NCT02542761|10025830|FG001|STARTED|Acclimation Period 1||5
8962375|NCT02542761|10025829|FG000|COMPLETED|Acclimation Period 1||5
8962376|NCT02542761|10025830|FG001|COMPLETED|Acclimation Period 1||5
8962377|NCT02542761|10025829|FG000|NOT COMPLETED|Acclimation Period 1||0
8962378|NCT02542761|10025830|FG001|NOT COMPLETED|Acclimation Period 1||0
8962379|NCT02542761|10025829|FG000|STARTED|First Intervention||5
8962380|NCT02542761|10025830|FG001|STARTED|First Intervention||5
8962381|NCT02542761|10025829|FG000|COMPLETED|First Intervention||5
8962382|NCT02542761|10025830|FG001|COMPLETED|First Intervention||5
8962383|NCT02542761|10025829|FG000|NOT COMPLETED|First Intervention||0
8875277|NCT01905956|9931864|FG000|COMPLETED|Overall Study|Per-protocol population|54
8875278|NCT01905956|9931865|FG001|COMPLETED|Overall Study|Per-protocol population|48
8875279|NCT01905956|9931864|FG000|NOT COMPLETED|Overall Study||6
8875280|NCT01905956|9931865|FG001|NOT COMPLETED|Overall Study||11
8875281|NCT01906008|9931873|FG000|STARTED|Overall Study||59
8875282|NCT01906008|9931874|FG001|STARTED|Overall Study||61
8875283|NCT01906008|9931873|FG000|COMPLETED|Overall Study||32
8875284|NCT01906008|9931874|FG001|COMPLETED|Overall Study||34
8875285|NCT01906008|9931873|FG000|NOT COMPLETED|Overall Study||27
8875286|NCT01906008|9931874|FG001|NOT COMPLETED|Overall Study||27
8875287|NCT01906346|9931880|FG000|STARTED|Overall Study||9
8875288|NCT01906346|9931880|FG000|COMPLETED|Overall Study||8
8875289|NCT01906346|9931880|FG000|NOT COMPLETED|Overall Study||1
8875290|NCT01906372|9931886|FG000|STARTED|Overall Study||12
8875291|NCT01906372|9931886|FG000|Visit 7: Treatment Phase Completed|Overall Study||10
8875292|NCT01906372|9931886|FG000|Visit 10: Follow up Phase Completed|Overall Study||8
8875293|NCT01906372|9931886|FG000|COMPLETED|Overall Study||10
8875294|NCT01906372|9931886|FG000|NOT COMPLETED|Overall Study||2
8875295|NCT01906476|9931893|FG000|STARTED|Overall Study||157
8875296|NCT01906476|9931894|FG001|STARTED|Overall Study||155
8962384|NCT02542761|10025830|FG001|NOT COMPLETED|First Intervention||0
8962385|NCT02542761|10025829|FG000|STARTED|Acclimation Period 2||5
8962386|NCT02542761|10025830|FG001|STARTED|Acclimation Period 2||5
8962387|NCT02542761|10025829|FG000|COMPLETED|Acclimation Period 2||5
8962388|NCT02542761|10025830|FG001|COMPLETED|Acclimation Period 2||5
8962389|NCT02542761|10025829|FG000|NOT COMPLETED|Acclimation Period 2||0
8875297|NCT01906476|9931893|FG000|COMPLETED|Overall Study||140
8875298|NCT01906476|9931894|FG001|COMPLETED|Overall Study||139
8875299|NCT01906476|9931893|FG000|NOT COMPLETED|Overall Study||17
8875300|NCT01906476|9931894|FG001|NOT COMPLETED|Overall Study||16
8875301|NCT01906515|9931902|FG000|STARTED|Overall Study||45
8962390|NCT02542761|10025830|FG001|NOT COMPLETED|Acclimation Period 2||0
8962391|NCT02542761|10025829|FG000|STARTED|Second Intervention||5
8962392|NCT02542761|10025830|FG001|STARTED|Second Intervention||5
8962393|NCT02542761|10025829|FG000|COMPLETED|Second Intervention||5
8962394|NCT02542761|10025830|FG001|COMPLETED|Second Intervention||5
8962395|NCT02542761|10025829|FG000|NOT COMPLETED|Second Intervention||0
8962396|NCT02542761|10025830|FG001|NOT COMPLETED|Second Intervention||0
8962397|NCT02542865|10025838|FG000|STARTED|Overall Study||462
8962398|NCT02542865|10025839|FG001|STARTED|Overall Study||462
8962399|NCT02542865|10025838|FG000|Treated|Overall Study||460
8962400|NCT02542865|10025839|FG001|Treated|Overall Study||462
8962401|NCT02542865|10025838|FG000|COMPLETED|Overall Study||445
8962402|NCT02542865|10025839|FG001|COMPLETED|Overall Study||462
8962403|NCT02542865|10025838|FG000|NOT COMPLETED|Overall Study||17
8962404|NCT02542865|10025839|FG001|NOT COMPLETED|Overall Study||0
8962405|NCT02542943|10025848|FG000|STARTED|Overall Study||79
8962406|NCT02542943|10025849|FG001|STARTED|Overall Study||80
8962407|NCT02542943|10025850|FG002|STARTED|Overall Study||81
8962408|NCT02542943|10025848|FG000|COMPLETED|Overall Study||78
8962409|NCT02542943|10025849|FG001|COMPLETED|Overall Study||79
8962410|NCT02542943|10025850|FG002|COMPLETED|Overall Study||81
8962411|NCT02542943|10025848|FG000|NOT COMPLETED|Overall Study||1
8962412|NCT02542943|10025849|FG001|NOT COMPLETED|Overall Study||1
8962413|NCT02542943|10025850|FG002|NOT COMPLETED|Overall Study||0
8962414|NCT02543203|10025861|FG000|STARTED|Overall Study||13
8962415|NCT02543203|10025862|FG001|STARTED|Overall Study||15
8962416|NCT02543203|10025861|FG000|COMPLETED|Overall Study||7
8962417|NCT02543203|10025862|FG001|COMPLETED|Overall Study||10
8962418|NCT02543203|10025861|FG000|NOT COMPLETED|Overall Study||6
8962419|NCT02543203|10025862|FG001|NOT COMPLETED|Overall Study||5
8962420|NCT02543294|10025876|FG000|STARTED|Overall Study||20
8962421|NCT02543294|10025876|FG000|COMPLETED|Overall Study||8
8962422|NCT02543294|10025876|FG000|NOT COMPLETED|Overall Study||12
8962423|NCT02543346|10025881|FG000|STARTED|First Priming Visit||26
8725714|NCT01032954|9773045|FG001|STARTED|Overall Study||30
8962424|NCT02543346|10025882|FG001|STARTED|First Priming Visit||25
8962425|NCT02543346|10025883|FG002|STARTED|First Priming Visit||24
8962426|NCT02543346|10025884|FG003|STARTED|First Priming Visit||23
8962427|NCT02543346|10025881|FG000|COMPLETED|First Priming Visit||26
8631617|NCT00541229|9671531|FG002|NOT COMPLETED|Treatment Period II (Week 6)||1
8631618|NCT00541229|9671532|FG003|NOT COMPLETED|Treatment Period II (Week 6)||1
8631619|NCT00541229|9671533|FG004|NOT COMPLETED|Treatment Period II (Week 6)||2
8631620|NCT00541229|9671534|FG005|NOT COMPLETED|Treatment Period II (Week 6)||3
8631621|NCT00541229|9671529|FG000|STARTED|Washout Period II (Week 7-10)||11
8631622|NCT00541229|9671530|FG001|STARTED|Washout Period II (Week 7-10)||12
8631623|NCT00541229|9671531|FG002|STARTED|Washout Period II (Week 7-10)||12
8631624|NCT00541229|9671532|FG003|STARTED|Washout Period II (Week 7-10)||12
8631625|NCT00541229|9671533|FG004|STARTED|Washout Period II (Week 7-10)||11
8631626|NCT00541229|9671534|FG005|STARTED|Washout Period II (Week 7-10)||8
8631627|NCT00541229|9671529|FG000|COMPLETED|Washout Period II (Week 7-10)||7
8631628|NCT00541229|9671530|FG001|COMPLETED|Washout Period II (Week 7-10)||8
8962428|NCT02543346|10025882|FG001|COMPLETED|First Priming Visit||25
8962429|NCT02543346|10025883|FG002|COMPLETED|First Priming Visit||24
8962430|NCT02543346|10025884|FG003|COMPLETED|First Priming Visit||23
8962431|NCT02543346|10025881|FG000|NOT COMPLETED|First Priming Visit||0
8962432|NCT02543346|10025882|FG001|NOT COMPLETED|First Priming Visit||0
8962433|NCT02543346|10025883|FG002|NOT COMPLETED|First Priming Visit||0
8962434|NCT02543346|10025884|FG003|NOT COMPLETED|First Priming Visit||0
8962435|NCT02543346|10025881|FG000|STARTED|First Treatment Visit||26
8962436|NCT02543346|10025882|FG001|STARTED|First Treatment Visit||25
8962437|NCT02543346|10025883|FG002|STARTED|First Treatment Visit||24
8962438|NCT02543346|10025884|FG003|STARTED|First Treatment Visit||23
8962439|NCT02543346|10025881|FG000|COMPLETED|First Treatment Visit||26
8962440|NCT02543346|10025882|FG001|COMPLETED|First Treatment Visit||25
8962441|NCT02543346|10025883|FG002|COMPLETED|First Treatment Visit||24
8962442|NCT02543346|10025884|FG003|COMPLETED|First Treatment Visit||23
8962443|NCT02543346|10025881|FG000|NOT COMPLETED|First Treatment Visit||0
8962444|NCT02543346|10025882|FG001|NOT COMPLETED|First Treatment Visit||0
8962445|NCT02543346|10025883|FG002|NOT COMPLETED|First Treatment Visit||0
8962446|NCT02543346|10025884|FG003|NOT COMPLETED|First Treatment Visit||0
8962447|NCT02543346|10025881|FG000|STARTED|Washout (at Least 14 Days)||26
8962448|NCT02543346|10025882|FG001|STARTED|Washout (at Least 14 Days)||25
8962449|NCT02543346|10025883|FG002|STARTED|Washout (at Least 14 Days)||24
8962450|NCT02543346|10025884|FG003|STARTED|Washout (at Least 14 Days)||23
8962451|NCT02543346|10025881|FG000|COMPLETED|Washout (at Least 14 Days)||26
8962452|NCT02543346|10025882|FG001|COMPLETED|Washout (at Least 14 Days)||25
8962453|NCT02543346|10025883|FG002|COMPLETED|Washout (at Least 14 Days)||24
8962454|NCT02543346|10025884|FG003|COMPLETED|Washout (at Least 14 Days)||23
8962455|NCT02543346|10025881|FG000|NOT COMPLETED|Washout (at Least 14 Days)||0
8962456|NCT02543346|10025882|FG001|NOT COMPLETED|Washout (at Least 14 Days)||0
8962457|NCT02543346|10025883|FG002|NOT COMPLETED|Washout (at Least 14 Days)||0
8962458|NCT02543346|10025884|FG003|NOT COMPLETED|Washout (at Least 14 Days)||0
8962459|NCT02543346|10025881|FG000|STARTED|Second Priming Visit||26
8962460|NCT02543346|10025882|FG001|STARTED|Second Priming Visit||25
8962461|NCT02543346|10025883|FG002|STARTED|Second Priming Visit||24
8962462|NCT02543346|10025884|FG003|STARTED|Second Priming Visit||23
8962463|NCT02543346|10025881|FG000|COMPLETED|Second Priming Visit||25
8962464|NCT02543346|10025882|FG001|COMPLETED|Second Priming Visit||23
8962465|NCT02543346|10025883|FG002|COMPLETED|Second Priming Visit||22
8962466|NCT02543346|10025884|FG003|COMPLETED|Second Priming Visit||21
8962467|NCT02543346|10025881|FG000|NOT COMPLETED|Second Priming Visit||1
8962468|NCT02543346|10025882|FG001|NOT COMPLETED|Second Priming Visit||2
8962469|NCT02543346|10025883|FG002|NOT COMPLETED|Second Priming Visit||2
8962470|NCT02543346|10025884|FG003|NOT COMPLETED|Second Priming Visit||2
8962471|NCT02543346|10025881|FG000|STARTED|Second Treatment Visit||25
8962472|NCT02543346|10025882|FG001|STARTED|Second Treatment Visit||23
8962473|NCT02543346|10025883|FG002|STARTED|Second Treatment Visit||22
8962474|NCT02543346|10025884|FG003|STARTED|Second Treatment Visit||21
8962475|NCT02543346|10025881|FG000|COMPLETED|Second Treatment Visit||25
8962476|NCT02543346|10025882|FG001|COMPLETED|Second Treatment Visit||23
8962477|NCT02543346|10025883|FG002|COMPLETED|Second Treatment Visit||22
8962478|NCT02543346|10025884|FG003|COMPLETED|Second Treatment Visit||21
8962479|NCT02543346|10025881|FG000|NOT COMPLETED|Second Treatment Visit||0
8962480|NCT02543346|10025882|FG001|NOT COMPLETED|Second Treatment Visit||0
8875302|NCT01906515|9931903|FG001|STARTED|Overall Study||61
8875303|NCT01906515|9931902|FG000|COMPLETED|Overall Study||45
8875304|NCT01906515|9931903|FG001|COMPLETED|Overall Study||61
8875305|NCT01906515|9931902|FG000|NOT COMPLETED|Overall Study||0
8875306|NCT01906515|9931903|FG001|NOT COMPLETED|Overall Study||0
8875307|NCT01906658|9931914|FG000|STARTED|Overall Study||11
8875308|NCT01906658|9931915|FG001|STARTED|Overall Study||11
8875309|NCT01906658|9931916|FG002|STARTED|Overall Study||10
8875310|NCT01906658|9931917|FG003|STARTED|Overall Study||11
8875311|NCT01906658|9931914|FG000|COMPLETED|Overall Study||9
8875312|NCT01906658|9931915|FG001|COMPLETED|Overall Study||10
8875313|NCT01906658|9931916|FG002|COMPLETED|Overall Study||7
8875314|NCT01906658|9931917|FG003|COMPLETED|Overall Study||11
8875315|NCT01906658|9931914|FG000|NOT COMPLETED|Overall Study||2
8875316|NCT01906658|9931915|FG001|NOT COMPLETED|Overall Study||1
8875317|NCT01906658|9931916|FG002|NOT COMPLETED|Overall Study||3
8875318|NCT01906658|9931917|FG003|NOT COMPLETED|Overall Study||0
8875319|NCT01906866|9931929|FG000|STARTED|Overall Study||60
8875320|NCT01906866|9931930|FG001|STARTED|Overall Study||65
8875321|NCT01906866|9931929|FG000|COMPLETED|Overall Study||51
8875322|NCT01906866|9931930|FG001|COMPLETED|Overall Study||44
8875323|NCT01906866|9931929|FG000|NOT COMPLETED|Overall Study||9
8875324|NCT01906866|9931930|FG001|NOT COMPLETED|Overall Study||21
8875325|NCT01907087|9931939|FG000|STARTED|Overall Study||24
8875326|NCT01907087|9931939|FG000|COMPLETED|Overall Study||23
8875327|NCT01907087|9931939|FG000|NOT COMPLETED|Overall Study||1
8962481|NCT02543346|10025883|FG002|NOT COMPLETED|Second Treatment Visit||0
8962482|NCT02543346|10025884|FG003|NOT COMPLETED|Second Treatment Visit||0
8875328|NCT01907100|9931947|FG000|STARTED|Overall Study||43
8875329|NCT01907100|9931948|FG001|STARTED|Overall Study||44
8875330|NCT01907100|9931949|FG002|STARTED|Overall Study||229
8875331|NCT01907100|9931950|FG003|STARTED|Overall Study||229
8875332|NCT01907100|9931947|FG000|Treated Patients|Overall Study||41
8875333|NCT01907100|9931948|FG001|Treated Patients|Overall Study||44
8875334|NCT01907100|9931949|FG002|Treated Patients|Overall Study||228
8875335|NCT01907100|9931950|FG003|Treated Patients|Overall Study||227
8875336|NCT01907100|9931947|FG000|COMPLETED|Overall Study||1
8962483|NCT02543398|10025896|FG000|STARTED|Overall Study||20
8962484|NCT02543398|10025897|FG001|STARTED|Overall Study||20
8962485|NCT02543398|10025896|FG000|COMPLETED|Overall Study||20
8962486|NCT02543398|10025897|FG001|COMPLETED|Overall Study||20
8962487|NCT02543398|10025896|FG000|NOT COMPLETED|Overall Study||0
8962488|NCT02543398|10025897|FG001|NOT COMPLETED|Overall Study||0
8962489|NCT02543437|10025903|FG000|STARTED|Overall Study||117
8962490|NCT02543437|10025903|FG000|COMPLETED|Overall Study||117
8962491|NCT02543437|10025903|FG000|NOT COMPLETED|Overall Study||0
8962492|NCT02543528|10025907|FG000|STARTED|Adaptation Period||0
8962493|NCT02543528|10025908|FG001|STARTED|Adaptation Period||0
8962494|NCT02543528|10025909|FG002|STARTED|Adaptation Period||0
8962495|NCT02543528|10025910|FG003|STARTED|Adaptation Period||0
8962496|NCT02543528|10025911|FG004|STARTED|Adaptation Period||168
8962497|NCT02543528|10025907|FG000|COMPLETED|Adaptation Period||0
8962498|NCT02543528|10025908|FG001|COMPLETED|Adaptation Period||0
8962499|NCT02543528|10025909|FG002|COMPLETED|Adaptation Period||0
8962500|NCT02543528|10025910|FG003|COMPLETED|Adaptation Period||0
8962501|NCT02543528|10025911|FG004|COMPLETED|Adaptation Period||142
8962502|NCT02543528|10025907|FG000|NOT COMPLETED|Adaptation Period||0
8962503|NCT02543528|10025908|FG001|NOT COMPLETED|Adaptation Period||0
8875337|NCT01907100|9931948|FG001|COMPLETED|Overall Study||4
8875338|NCT01907100|9931949|FG002|COMPLETED|Overall Study||82
8875339|NCT01907100|9931950|FG003|COMPLETED|Overall Study||83
8962504|NCT02543528|10025909|FG002|NOT COMPLETED|Adaptation Period||0
8962505|NCT02543528|10025910|FG003|NOT COMPLETED|Adaptation Period||0
8962506|NCT02543528|10025911|FG004|NOT COMPLETED|Adaptation Period||26
8962507|NCT02543528|10025907|FG000|STARTED|Extended Wear Period||36
8962508|NCT02543528|10025908|FG001|STARTED|Extended Wear Period||35
8725715|NCT01032954|9773046|FG002|STARTED|Overall Study||30
8875340|NCT01907100|9931947|FG000|NOT COMPLETED|Overall Study||42
8875341|NCT01907100|9931948|FG001|NOT COMPLETED|Overall Study||40
8875342|NCT01907100|9931949|FG002|NOT COMPLETED|Overall Study||147
8875343|NCT01907100|9931950|FG003|NOT COMPLETED|Overall Study||146
8875344|NCT01907113|9931963|FG000|STARTED|Overall Study||8
8875345|NCT01907113|9931964|FG001|STARTED|Overall Study||9
8875346|NCT01907113|9931965|FG002|STARTED|Overall Study||7
8875347|NCT01907113|9931966|FG003|STARTED|Overall Study||8
8875348|NCT01907113|9931967|FG004|STARTED|Overall Study||8
8875349|NCT01907113|9931963|FG000|COMPLETED|Overall Study||8
8875350|NCT01907113|9931964|FG001|COMPLETED|Overall Study||9
8875351|NCT01907113|9931965|FG002|COMPLETED|Overall Study||7
8875352|NCT01907113|9931966|FG003|COMPLETED|Overall Study||8
8875353|NCT01907113|9931967|FG004|COMPLETED|Overall Study||8
8875354|NCT01907113|9931963|FG000|NOT COMPLETED|Overall Study||0
8875355|NCT01907113|9931964|FG001|NOT COMPLETED|Overall Study||0
8875356|NCT01907113|9931965|FG002|NOT COMPLETED|Overall Study||0
8875357|NCT01907113|9931966|FG003|NOT COMPLETED|Overall Study||0
8875358|NCT01907113|9931967|FG004|NOT COMPLETED|Overall Study||0
8875359|NCT01907217|9931981|FG000|STARTED|Overall Study||69
8875360|NCT01907217|9931982|FG001|STARTED|Overall Study||69
8875361|NCT01907217|9931981|FG000|COMPLETED|Overall Study||69
8875362|NCT01907217|9931982|FG001|COMPLETED|Overall Study||67
8875363|NCT01907217|9931981|FG000|NOT COMPLETED|Overall Study||0
8875364|NCT01907217|9931982|FG001|NOT COMPLETED|Overall Study||2
8875365|NCT01907269|9931992|FG000|STARTED|6 Month Outcome Measures Post-interventi||1342
8875366|NCT01907269|9931993|FG001|STARTED|6 Month Outcome Measures Post-interventi||1342
8875367|NCT01907269|9931992|FG000|COMPLETED|6 Month Outcome Measures Post-interventi||953
8875368|NCT01907269|9931993|FG001|COMPLETED|6 Month Outcome Measures Post-interventi||1053
8875369|NCT01907269|9931992|FG000|NOT COMPLETED|6 Month Outcome Measures Post-interventi||389
8875370|NCT01907269|9931993|FG001|NOT COMPLETED|6 Month Outcome Measures Post-interventi||289
8875371|NCT01907269|9931992|FG000|STARTED|18 Month Outcome Measures Post-intervent||1178
8962509|NCT02543528|10025909|FG002|STARTED|Extended Wear Period||36
8962510|NCT02543528|10025910|FG003|STARTED|Extended Wear Period||35
8962511|NCT02543528|10025911|FG004|STARTED|Extended Wear Period||0
8962512|NCT02543528|10025907|FG000|COMPLETED|Extended Wear Period||8
8962513|NCT02543528|10025908|FG001|COMPLETED|Extended Wear Period||14
8962514|NCT02543528|10025909|FG002|COMPLETED|Extended Wear Period||13
8962515|NCT02543528|10025910|FG003|COMPLETED|Extended Wear Period||23
8962516|NCT02543528|10025911|FG004|COMPLETED|Extended Wear Period||0
8725716|NCT01032954|9773044|FG000|COMPLETED|Overall Study||26
8725717|NCT01032954|9773045|FG001|COMPLETED|Overall Study||29
8725718|NCT01032954|9773046|FG002|COMPLETED|Overall Study||30
8725719|NCT01032954|9773044|FG000|NOT COMPLETED|Overall Study||4
8725720|NCT01032954|9773045|FG001|NOT COMPLETED|Overall Study||1
8725721|NCT01032954|9773046|FG002|NOT COMPLETED|Overall Study||0
8725722|NCT01032993|9773056|FG000|STARTED|Overall Study||19
8725723|NCT01032993|9773057|FG001|STARTED|Overall Study||20
8725724|NCT01032993|9773056|FG000|COMPLETED|Overall Study||19
8725725|NCT01032993|9773057|FG001|COMPLETED|Overall Study||20
8725726|NCT01032993|9773056|FG000|NOT COMPLETED|Overall Study||0
8725727|NCT01032993|9773057|FG001|NOT COMPLETED|Overall Study||0
8725728|NCT01033019|9773065|FG000|STARTED|Overall Study||16
8725729|NCT01033019|9773066|FG001|STARTED|Overall Study||8
8725730|NCT01033019|9773065|FG000|COMPLETED|Overall Study||15
8725731|NCT01033019|9773066|FG001|COMPLETED|Overall Study||8
8725732|NCT01033019|9773065|FG000|NOT COMPLETED|Overall Study||1
8875372|NCT01907269|9931993|FG001|STARTED|18 Month Outcome Measures Post-intervent||1250
8875373|NCT01907269|9931992|FG000|COMPLETED|18 Month Outcome Measures Post-intervent||859
8875374|NCT01907269|9931993|FG001|COMPLETED|18 Month Outcome Measures Post-intervent||970
8875375|NCT01907269|9931992|FG000|NOT COMPLETED|18 Month Outcome Measures Post-intervent||319
8962517|NCT02543528|10025907|FG000|NOT COMPLETED|Extended Wear Period||28
8962518|NCT02543528|10025908|FG001|NOT COMPLETED|Extended Wear Period||21
8962519|NCT02543528|10025909|FG002|NOT COMPLETED|Extended Wear Period||23
8962520|NCT02543528|10025910|FG003|NOT COMPLETED|Extended Wear Period||12
8962521|NCT02543528|10025911|FG004|NOT COMPLETED|Extended Wear Period||0
8962522|NCT02543554|10025927|FG000|STARTED|Overall Study||1192
8962523|NCT02543554|10025928|FG001|STARTED|Overall Study||513
8962524|NCT02543554|10025927|FG000|COMPLETED|Overall Study||1192
8962525|NCT02543554|10025928|FG001|COMPLETED|Overall Study||513
8962526|NCT02543554|10025927|FG000|NOT COMPLETED|Overall Study||0
8962527|NCT02543554|10025928|FG001|NOT COMPLETED|Overall Study||0
8962528|NCT02543658|10025936|FG000|STARTED|Overall Study||40
8962529|NCT02543658|10025937|FG001|STARTED|Overall Study||40
8962530|NCT02543658|10025936|FG000|COMPLETED|Overall Study||40
8962531|NCT02543658|10025937|FG001|COMPLETED|Overall Study||36
8962532|NCT02543658|10025936|FG000|NOT COMPLETED|Overall Study||0
8962533|NCT02543658|10025937|FG001|NOT COMPLETED|Overall Study||4
8875376|NCT01907269|9931993|FG001|NOT COMPLETED|18 Month Outcome Measures Post-intervent||280
8875377|NCT01907321|9931999|FG000|STARTED|Overall Study||14
8875378|NCT01907321|9931999|FG000|COMPLETED|Overall Study||12
8875379|NCT01907321|9931999|FG000|NOT COMPLETED|Overall Study||2
8875380|NCT01907334|9932003|FG000|STARTED|Overall Study||6
8875381|NCT01907334|9932004|FG001|STARTED|Overall Study||4
8875382|NCT01907334|9932003|FG000|COMPLETED|Overall Study||6
8875383|NCT01907334|9932004|FG001|COMPLETED|Overall Study||4
8875384|NCT01907334|9932003|FG000|NOT COMPLETED|Overall Study||0
8875385|NCT01907334|9932004|FG001|NOT COMPLETED|Overall Study||0
8875386|NCT01907490|9932009|FG000|STARTED|Overall Study||38
8875387|NCT01907490|9932009|FG000|COMPLETED|Overall Study||38
8875388|NCT01907490|9932009|FG000|NOT COMPLETED|Overall Study||0
8875389|NCT01907516|9932016|FG000|STARTED|First Intervention (3 Weeks)||50
8875390|NCT01907516|9932017|FG001|STARTED|First Intervention (3 Weeks)||50
8875391|NCT01907516|9932016|FG000|COMPLETED|First Intervention (3 Weeks)||40
8875392|NCT01907516|9932017|FG001|COMPLETED|First Intervention (3 Weeks)||34
8875393|NCT01907516|9932016|FG000|NOT COMPLETED|First Intervention (3 Weeks)||10
8875394|NCT01907516|9932017|FG001|NOT COMPLETED|First Intervention (3 Weeks)||16
8875395|NCT01907516|9932016|FG000|STARTED|Second Intervention (3 Weeks)||40
8875396|NCT01907516|9932017|FG001|STARTED|Second Intervention (3 Weeks)||34
8875397|NCT01907516|9932016|FG000|COMPLETED|Second Intervention (3 Weeks)||40
8875398|NCT01907516|9932017|FG001|COMPLETED|Second Intervention (3 Weeks)||34
8875399|NCT01907516|9932016|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0
8875400|NCT01907516|9932017|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
8875401|NCT01907607|9932024|FG000|STARTED|Overall Study||29
8875402|NCT01907607|9932024|FG000|COMPLETED|Overall Study||29
8875403|NCT01907607|9932024|FG000|NOT COMPLETED|Overall Study||0
8875404|NCT01907737|9932028|FG000|STARTED|Overall Study||22
8875405|NCT01907737|9932028|FG000|COMPLETED|Overall Study||21
8875406|NCT01907737|9932028|FG000|NOT COMPLETED|Overall Study||1
8875407|NCT01907815|9932040|FG000|STARTED|Overall Study||17
8875408|NCT01907815|9932041|FG001|STARTED|Overall Study||7
8875409|NCT01907815|9932040|FG000|COMPLETED|Overall Study||16
8875410|NCT01907815|9932041|FG001|COMPLETED|Overall Study||7
8875411|NCT01907815|9932040|FG000|NOT COMPLETED|Overall Study||1
8875412|NCT01907815|9932041|FG001|NOT COMPLETED|Overall Study||0
8875413|NCT01907828|9932051|FG000|STARTED|Overall Study||39
8875414|NCT01907828|9932052|FG001|STARTED|Overall Study||22
8875415|NCT01907828|9932051|FG000|Underwent Procedure|Overall Study||39
8875416|NCT01907828|9932052|FG001|Underwent Procedure|Overall Study|2 participants terminated early|20
8875417|NCT01907828|9932051|FG000|1-month Follow-up|Overall Study|2 participants terminated early|37
8875418|NCT01907828|9932052|FG001|1-month Follow-up|Overall Study|3 participants terminated early|17
8875419|NCT01907828|9932051|FG000|3-month Follow-up|Overall Study|1 participant terminated early|36
8875420|NCT01907828|9932052|FG001|3-month Follow-up|Overall Study|1 participant terminated early|16
8875421|NCT01907828|9932051|FG000|6-month Follow-up|Overall Study|1 participant terminated early|35
8875422|NCT01907828|9932052|FG001|6-month Follow-up|Overall Study||16
8875423|NCT01907828|9932051|FG000|12-month Follow-up|Overall Study|1 participant terminated early|34
8875424|NCT01907828|9932052|FG001|12-month Follow-up|Overall Study||16
8875425|NCT01907828|9932051|FG000|24-month Follow-up|Overall Study|2 participants terminated early|32
8875426|NCT01907828|9932052|FG001|24-month Follow-up|Overall Study||16
8875427|NCT01907828|9932051|FG000|COMPLETED|Overall Study||32
8875428|NCT01907828|9932052|FG001|COMPLETED|Overall Study||16
8875429|NCT01907828|9932051|FG000|NOT COMPLETED|Overall Study||7
8875430|NCT01907828|9932052|FG001|NOT COMPLETED|Overall Study||6
8875431|NCT01907854|9932060|FG000|STARTED|Overall Study||203
8962534|NCT02543723|10025946|FG000|STARTED|Overall Study||65
8962535|NCT02543723|10025947|FG001|STARTED|Overall Study||63
8962536|NCT02543723|10025946|FG000|COMPLETED|Overall Study||65
8962537|NCT02543723|10025947|FG001|COMPLETED|Overall Study||63
8962538|NCT02543723|10025946|FG000|NOT COMPLETED|Overall Study||0
8875432|NCT01907854|9932061|FG001|STARTED|Overall Study||204
8875433|NCT01907854|9932060|FG000|Exposed|Overall Study|One subject in lira arm was not exposed (Reason: withdrawal by subject)|202
8875434|NCT01907854|9932061|FG001|Exposed|Overall Study||204
8875435|NCT01907854|9932060|FG000|COMPLETED|Overall Study||187
8875436|NCT01907854|9932061|FG001|COMPLETED|Overall Study||191
8875437|NCT01907854|9932060|FG000|NOT COMPLETED|Overall Study||16
8875438|NCT01907854|9932061|FG001|NOT COMPLETED|Overall Study||13
8962539|NCT02543723|10025947|FG001|NOT COMPLETED|Overall Study||0
8962540|NCT02543801|10025959|FG000|STARTED|Overall Study||61
8962541|NCT02543801|10025960|FG001|STARTED|Overall Study||60
8962542|NCT02543801|10025961|FG002|STARTED|Overall Study||59
8962543|NCT02543801|10025962|FG003|STARTED|Overall Study||59
8962544|NCT02543801|10025959|FG000|COMPLETED|Overall Study||60
8962545|NCT02543801|10025960|FG001|COMPLETED|Overall Study||58
8962546|NCT02543801|10025961|FG002|COMPLETED|Overall Study||59
8962547|NCT02543801|10025962|FG003|COMPLETED|Overall Study||59
8962548|NCT02543801|10025959|FG000|NOT COMPLETED|Overall Study||1
8962549|NCT02543801|10025960|FG001|NOT COMPLETED|Overall Study||2
8962550|NCT02543801|10025961|FG002|NOT COMPLETED|Overall Study||0
8962551|NCT02543801|10025962|FG003|NOT COMPLETED|Overall Study||0
8962552|NCT02543840|10025974|FG000|STARTED|Overall Study|This is a quasi-experimental design, not a RCT. 1050 veterans did 1436 interviews at 3 time points.|1050
8962553|NCT02543840|10025975|FG001|STARTED|Overall Study||62
8962554|NCT02543840|10025974|FG000|0 Month Timepoint (t0)|Overall Study||593
8962555|NCT02543840|10025975|FG001|0 Month Timepoint (t0)|Overall Study||40
8962556|NCT02543840|10025974|FG000|6 Month Timepoint (t6)|Overall Study|593 participants started at 0 months; 188 repeated and 66 participants added at 6 months timepoint.|66
8962557|NCT02543840|10025975|FG001|6 Month Timepoint (t6)|Overall Study||0
8962558|NCT02543840|10025974|FG000|12 Month Timepoint (t12)|Overall Study|91 continued from 0 months (t0), 16 from 6 months (t6), 91 from t0 & t6; 391 added at 12 months.|391
8962559|NCT02543840|10025975|FG001|12 Month Timepoint (t12)|Overall Study|22 new providers completed at 12 months; 21 completed at both 0 and 12 months. 19 completed only T0.|22
8962560|NCT02543840|10025974|FG000|COMPLETED|Overall Study||1050
8962561|NCT02543840|10025975|FG001|COMPLETED|Overall Study||62
8962562|NCT02543840|10025974|FG000|NOT COMPLETED|Overall Study||0
8962563|NCT02543840|10025975|FG001|NOT COMPLETED|Overall Study||0
8962564|NCT02543892|10025990|FG000|STARTED|Received Vaccination 1||12
8962565|NCT02543892|10025991|FG001|STARTED|Received Vaccination 1||12
8962566|NCT02543892|10025992|FG002|STARTED|Received Vaccination 1||12
8962567|NCT02543892|10025993|FG003|STARTED|Received Vaccination 1||12
8962568|NCT02543892|10025994|FG004|STARTED|Received Vaccination 1||50
8962569|NCT02543892|10025995|FG005|STARTED|Received Vaccination 1||50
8962570|NCT02543892|10025996|FG006|STARTED|Received Vaccination 1||50
8962571|NCT02543892|10025997|FG007|STARTED|Received Vaccination 1||50
8962572|NCT02543892|10025990|FG000|COMPLETED|Received Vaccination 1||12
8962573|NCT02543892|10025991|FG001|COMPLETED|Received Vaccination 1||12
8962574|NCT02543892|10025992|FG002|COMPLETED|Received Vaccination 1||12
8962575|NCT02543892|10025993|FG003|COMPLETED|Received Vaccination 1||12
8962576|NCT02543892|10025994|FG004|COMPLETED|Received Vaccination 1||50
8962577|NCT02543892|10025995|FG005|COMPLETED|Received Vaccination 1||50
8962578|NCT02543892|10025996|FG006|COMPLETED|Received Vaccination 1||50
8962579|NCT02543892|10025997|FG007|COMPLETED|Received Vaccination 1||50
8962580|NCT02543892|10025990|FG000|NOT COMPLETED|Received Vaccination 1||0
8962581|NCT02543892|10025991|FG001|NOT COMPLETED|Received Vaccination 1||0
8962582|NCT02543892|10025992|FG002|NOT COMPLETED|Received Vaccination 1||0
8962583|NCT02543892|10025993|FG003|NOT COMPLETED|Received Vaccination 1||0
8962584|NCT02543892|10025994|FG004|NOT COMPLETED|Received Vaccination 1||0
8962585|NCT02543892|10025995|FG005|NOT COMPLETED|Received Vaccination 1||0
8962586|NCT02543892|10025996|FG006|NOT COMPLETED|Received Vaccination 1||0
8962587|NCT02543892|10025997|FG007|NOT COMPLETED|Received Vaccination 1||0
8962588|NCT02543892|10025990|FG000|STARTED|Received Vaccination 2||12
8962589|NCT02543892|10025991|FG001|STARTED|Received Vaccination 2||12
8962590|NCT02543892|10025992|FG002|STARTED|Received Vaccination 2||12
8962591|NCT02543892|10025993|FG003|STARTED|Received Vaccination 2||12
8962592|NCT02543892|10025994|FG004|STARTED|Received Vaccination 2||50
8962593|NCT02543892|10025995|FG005|STARTED|Received Vaccination 2||50
8962594|NCT02543892|10025996|FG006|STARTED|Received Vaccination 2||50
8962595|NCT02543892|10025997|FG007|STARTED|Received Vaccination 2||50
8962596|NCT02543892|10025990|FG000|COMPLETED|Received Vaccination 2||11
8962597|NCT02543892|10025991|FG001|COMPLETED|Received Vaccination 2||11
8962598|NCT02543892|10025992|FG002|COMPLETED|Received Vaccination 2||12
8962599|NCT02543892|10025993|FG003|COMPLETED|Received Vaccination 2||12
8962600|NCT02543892|10025994|FG004|COMPLETED|Received Vaccination 2||50
8962601|NCT02543892|10025995|FG005|COMPLETED|Received Vaccination 2||49
8962602|NCT02543892|10025996|FG006|COMPLETED|Received Vaccination 2||50
8962603|NCT02543892|10025997|FG007|COMPLETED|Received Vaccination 2||49
8962604|NCT02543892|10025990|FG000|NOT COMPLETED|Received Vaccination 2||1
8962605|NCT02543892|10025991|FG001|NOT COMPLETED|Received Vaccination 2||1
8962606|NCT02543892|10025992|FG002|NOT COMPLETED|Received Vaccination 2||0
8962607|NCT02543892|10025993|FG003|NOT COMPLETED|Received Vaccination 2||0
8875439|NCT01907906|9932069|FG000|STARTED|Overall Study||16
8875440|NCT01907906|9932070|FG001|STARTED|Overall Study||13
8875441|NCT01907906|9932069|FG000|COMPLETED|Overall Study||12
8875442|NCT01907906|9932070|FG001|COMPLETED|Overall Study||12
8875443|NCT01907906|9932069|FG000|NOT COMPLETED|Overall Study||4
8875444|NCT01907906|9932070|FG001|NOT COMPLETED|Overall Study||1
8875445|NCT01908062|9932080|FG000|STARTED|Overall Study||26
8875446|NCT01908062|9932081|FG001|STARTED|Overall Study||25
8875447|NCT01908062|9932080|FG000|COMPLETED|Overall Study||24
8962608|NCT02543892|10025994|FG004|NOT COMPLETED|Received Vaccination 2||0
8962609|NCT02543892|10025995|FG005|NOT COMPLETED|Received Vaccination 2||1
8962610|NCT02543892|10025996|FG006|NOT COMPLETED|Received Vaccination 2||0
8875448|NCT01908062|9932081|FG001|COMPLETED|Overall Study||22
8875449|NCT01908062|9932080|FG000|NOT COMPLETED|Overall Study||2
8875450|NCT01908062|9932081|FG001|NOT COMPLETED|Overall Study||3
8631629|NCT00541229|9671531|FG002|COMPLETED|Washout Period II (Week 7-10)||10
8631630|NCT00541229|9671532|FG003|COMPLETED|Washout Period II (Week 7-10)||8
8631631|NCT00541229|9671533|FG004|COMPLETED|Washout Period II (Week 7-10)||7
8631632|NCT00541229|9671534|FG005|COMPLETED|Washout Period II (Week 7-10)||5
8725733|NCT01033019|9773066|FG001|NOT COMPLETED|Overall Study||0
8725734|NCT01033071|9773076|FG000|STARTED|Overall Study||355
8725735|NCT01033071|9773077|FG001|STARTED|Overall Study||352
8725736|NCT01033071|9773078|FG002|STARTED|Overall Study||364
8725737|NCT01033071|9773076|FG000|COMPLETED|Overall Study||300
8725738|NCT01033071|9773077|FG001|COMPLETED|Overall Study||275
8725739|NCT01033071|9773078|FG002|COMPLETED|Overall Study||317
8725740|NCT01033071|9773076|FG000|NOT COMPLETED|Overall Study||55
8725741|NCT01033071|9773077|FG001|NOT COMPLETED|Overall Study||77
8725742|NCT01033071|9773078|FG002|NOT COMPLETED|Overall Study||47
8725743|NCT01033136|9773088|FG000|STARTED|Baseline Assessment||36
8725744|NCT01033136|9773089|FG001|STARTED|Baseline Assessment||32
8725745|NCT01033136|9773088|FG000|COMPLETED|Baseline Assessment||30
8725746|NCT01033136|9773089|FG001|COMPLETED|Baseline Assessment||26
8725747|NCT01033136|9773088|FG000|NOT COMPLETED|Baseline Assessment||6
8725748|NCT01033136|9773089|FG001|NOT COMPLETED|Baseline Assessment||6
8725749|NCT01033136|9773088|FG000|STARTED|Post-Treatment (1 Week)||30
8725750|NCT01033136|9773089|FG001|STARTED|Post-Treatment (1 Week)||26
8725751|NCT01033136|9773088|FG000|COMPLETED|Post-Treatment (1 Week)||16
8725752|NCT01033136|9773089|FG001|COMPLETED|Post-Treatment (1 Week)||15
8725753|NCT01033136|9773088|FG000|NOT COMPLETED|Post-Treatment (1 Week)||14
8725754|NCT01033136|9773089|FG001|NOT COMPLETED|Post-Treatment (1 Week)||11
8875451|NCT01908101|9932090|FG000|STARTED|Overall Study||68
8875452|NCT01908101|9932090|FG000|COMPLETED|Overall Study||59
8875453|NCT01908101|9932090|FG000|NOT COMPLETED|Overall Study||9
8875454|NCT01908127|9932096|FG000|STARTED|Overall Study||23
8875455|NCT01908127|9932097|FG001|STARTED|Overall Study||23
8875456|NCT01908127|9932096|FG000|COMPLETED|Overall Study||22
8875457|NCT01908127|9932097|FG001|COMPLETED|Overall Study||23
8875458|NCT01908127|9932096|FG000|NOT COMPLETED|Overall Study||1
8875459|NCT01908127|9932097|FG001|NOT COMPLETED|Overall Study||0
8875460|NCT01908140|9932105|FG000|STARTED|Overall Study||468
8875461|NCT01908140|9932106|FG001|STARTED|Overall Study||465
8875462|NCT01908140|9932105|FG000|COMPLETED|Overall Study||402
8875463|NCT01908140|9932106|FG001|COMPLETED|Overall Study||386
8875464|NCT01908140|9932105|FG000|NOT COMPLETED|Overall Study||66
8875465|NCT01908140|9932106|FG001|NOT COMPLETED|Overall Study||79
8875466|NCT01908205|9932114|FG000|STARTED|Overall Study||30
8875467|NCT01908205|9932115|FG001|STARTED|Overall Study||30
8875468|NCT01908205|9932114|FG000|COMPLETED|Overall Study||25
8875469|NCT01908205|9932115|FG001|COMPLETED|Overall Study||29
8875470|NCT01908205|9932114|FG000|NOT COMPLETED|Overall Study||5
8875471|NCT01908205|9932115|FG001|NOT COMPLETED|Overall Study||1
8875472|NCT01908426|9932136|FG000|STARTED|Overall Study||470
8875473|NCT01908426|9932137|FG001|STARTED|Overall Study||237
8875474|NCT01908426|9932136|FG000|COMPLETED|Overall Study||73
8875475|NCT01908426|9932137|FG001|COMPLETED|Overall Study||26
8875476|NCT01908426|9932136|FG000|NOT COMPLETED|Overall Study||397
8875477|NCT01908426|9932137|FG001|NOT COMPLETED|Overall Study||211
8875478|NCT01908530|9932146|FG000|STARTED|Overall Study||8
8875479|NCT01908530|9932147|FG001|STARTED|Overall Study||8
8875480|NCT01908530|9932148|FG002|STARTED|Overall Study||10
8875481|NCT01908530|9932146|FG000|COMPLETED|Overall Study||8
8875482|NCT01908530|9932147|FG001|COMPLETED|Overall Study||8
8875483|NCT01908530|9932148|FG002|COMPLETED|Overall Study||10
8875484|NCT01908530|9932146|FG000|NOT COMPLETED|Overall Study||0
8875485|NCT01908530|9932147|FG001|NOT COMPLETED|Overall Study||0
8875486|NCT01908530|9932148|FG002|NOT COMPLETED|Overall Study||0
8631633|NCT00541229|9671529|FG000|NOT COMPLETED|Washout Period II (Week 7-10)||4
8631634|NCT00541229|9671530|FG001|NOT COMPLETED|Washout Period II (Week 7-10)||4
8631635|NCT00541229|9671531|FG002|NOT COMPLETED|Washout Period II (Week 7-10)||2
8631636|NCT00541229|9671532|FG003|NOT COMPLETED|Washout Period II (Week 7-10)||4
8631637|NCT00541229|9671533|FG004|NOT COMPLETED|Washout Period II (Week 7-10)||4
8631638|NCT00541229|9671534|FG005|NOT COMPLETED|Washout Period II (Week 7-10)||3
8631639|NCT00541229|9671529|FG000|STARTED|Treatment Period III (Week 11)||7
8631640|NCT00541229|9671530|FG001|STARTED|Treatment Period III (Week 11)||8
8631641|NCT00541229|9671531|FG002|STARTED|Treatment Period III (Week 11)||10
8631642|NCT00541229|9671532|FG003|STARTED|Treatment Period III (Week 11)||8
8631643|NCT00541229|9671533|FG004|STARTED|Treatment Period III (Week 11)||7
8631644|NCT00541229|9671534|FG005|STARTED|Treatment Period III (Week 11)||5
8631645|NCT00541229|9671529|FG000|COMPLETED|Treatment Period III (Week 11)||7
8631646|NCT00541229|9671530|FG001|COMPLETED|Treatment Period III (Week 11)||8
8631647|NCT00541229|9671531|FG002|COMPLETED|Treatment Period III (Week 11)||9
8631648|NCT00541229|9671532|FG003|COMPLETED|Treatment Period III (Week 11)||8
8631649|NCT00541229|9671533|FG004|COMPLETED|Treatment Period III (Week 11)||6
8725755|NCT01033136|9773088|FG000|STARTED|Follow-Up (3 Month)||16
8725756|NCT01033136|9773089|FG001|STARTED|Follow-Up (3 Month)||15
8725757|NCT01033136|9773088|FG000|COMPLETED|Follow-Up (3 Month)||14
8725758|NCT01033136|9773089|FG001|COMPLETED|Follow-Up (3 Month)||13
8875487|NCT01908582|9932159|FG000|STARTED|Period 1||26
8875488|NCT01908582|9932159|FG000|Received at Least One Dose of Study Drug|Period 1||26
8875489|NCT01908582|9932159|FG000|COMPLETED|Period 1||26
8962611|NCT02543892|10025997|FG007|NOT COMPLETED|Received Vaccination 2||1
8962612|NCT02543892|10025990|FG000|STARTED|Had Immunology Data||11
8962613|NCT02543892|10025991|FG001|STARTED|Had Immunology Data||11
8962614|NCT02543892|10025992|FG002|STARTED|Had Immunology Data||12
8962615|NCT02543892|10025993|FG003|STARTED|Had Immunology Data||12
8962616|NCT02543892|10025994|FG004|STARTED|Had Immunology Data||50
8962617|NCT02543892|10025995|FG005|STARTED|Had Immunology Data||49
8962618|NCT02543892|10025996|FG006|STARTED|Had Immunology Data||50
8962619|NCT02543892|10025997|FG007|STARTED|Had Immunology Data||49
8962620|NCT02543892|10025990|FG000|COMPLETED|Had Immunology Data||11
8962621|NCT02543892|10025991|FG001|COMPLETED|Had Immunology Data||11
8962622|NCT02543892|10025992|FG002|COMPLETED|Had Immunology Data||12
8962623|NCT02543892|10025993|FG003|COMPLETED|Had Immunology Data||12
8962624|NCT02543892|10025994|FG004|COMPLETED|Had Immunology Data||50
8962625|NCT02543892|10025995|FG005|COMPLETED|Had Immunology Data||49
8962626|NCT02543892|10025996|FG006|COMPLETED|Had Immunology Data|Subject received both vaccinations and attended last visit, but withdrew consent afterwards.|49
8962627|NCT02543892|10025997|FG007|COMPLETED|Had Immunology Data||49
8962628|NCT02543892|10025990|FG000|NOT COMPLETED|Had Immunology Data||0
8875490|NCT01908582|9932159|FG000|NOT COMPLETED|Period 1||0
8875491|NCT01908582|9932159|FG000|STARTED|Period 2||26
8875492|NCT01908582|9932159|FG000|COMPLETED|Period 2||24
8875493|NCT01908582|9932159|FG000|NOT COMPLETED|Period 2||2
8875494|NCT01908634|9932166|FG000|STARTED|Milk-based Strawberry Beverage With Meal||10
8875495|NCT01908634|9932166|FG000|COMPLETED|Milk-based Strawberry Beverage With Meal||10
8875496|NCT01908634|9932166|FG000|NOT COMPLETED|Milk-based Strawberry Beverage With Meal||0
8875497|NCT01908634|9932166|FG000|STARTED|Water-based Strawberry Beverage Wit Meal||10
8875498|NCT01908634|9932166|FG000|COMPLETED|Water-based Strawberry Beverage Wit Meal||9
8875499|NCT01908634|9932166|FG000|NOT COMPLETED|Water-based Strawberry Beverage Wit Meal||1
8875500|NCT01908634|9932166|FG000|STARTED|Milk-based Strawberry Beverage w/o Meal||9
8875501|NCT01908634|9932166|FG000|COMPLETED|Milk-based Strawberry Beverage w/o Meal||4
8875502|NCT01908634|9932166|FG000|NOT COMPLETED|Milk-based Strawberry Beverage w/o Meal||5
8875503|NCT01908634|9932166|FG000|STARTED|Water-based Strawberry Beverage w/o Meal||4
8875504|NCT01908634|9932166|FG000|COMPLETED|Water-based Strawberry Beverage w/o Meal||4
8875505|NCT01908634|9932166|FG000|NOT COMPLETED|Water-based Strawberry Beverage w/o Meal||0
8875506|NCT01908699|9932176|FG000|STARTED|Overall Study||137
8875507|NCT01908699|9932177|FG001|STARTED|Overall Study||136
8875508|NCT01908699|9932176|FG000|Received at Least 1 Dose of Study Drug|Overall Study||136
8875509|NCT01908699|9932177|FG001|Received at Least 1 Dose of Study Drug|Overall Study||135
8875510|NCT01908699|9932176|FG000|COMPLETED|Overall Study||62
8875511|NCT01908699|9932177|FG001|COMPLETED|Overall Study||58
8875512|NCT01908699|9932176|FG000|NOT COMPLETED|Overall Study||75
8875513|NCT01908699|9932177|FG001|NOT COMPLETED|Overall Study||78
8875514|NCT01908751|9932187|FG000|STARTED|Overall Study||22
8875515|NCT01908751|9932188|FG001|STARTED|Overall Study||23
8875516|NCT01908751|9932189|FG002|STARTED|Overall Study||21
8875517|NCT01908751|9932190|FG003|STARTED|Overall Study||20
8875518|NCT01908751|9932187|FG000|COMPLETED|Overall Study||17
8875519|NCT01908751|9932188|FG001|COMPLETED|Overall Study||18
8875520|NCT01908751|9932189|FG002|COMPLETED|Overall Study||16
8875521|NCT01908751|9932190|FG003|COMPLETED|Overall Study||16
8875522|NCT01908751|9932187|FG000|NOT COMPLETED|Overall Study||5
8875523|NCT01908751|9932188|FG001|NOT COMPLETED|Overall Study||5
8875524|NCT01908751|9932189|FG002|NOT COMPLETED|Overall Study||5
8875525|NCT01908751|9932190|FG003|NOT COMPLETED|Overall Study||4
8962629|NCT02543892|10025991|FG001|NOT COMPLETED|Had Immunology Data||0
8962630|NCT02543892|10025992|FG002|NOT COMPLETED|Had Immunology Data||0
8962631|NCT02543892|10025993|FG003|NOT COMPLETED|Had Immunology Data||0
8962632|NCT02543892|10025994|FG004|NOT COMPLETED|Had Immunology Data||0
8962633|NCT02543892|10025995|FG005|NOT COMPLETED|Had Immunology Data||0
8962634|NCT02543892|10025996|FG006|NOT COMPLETED|Had Immunology Data||1
8962635|NCT02543892|10025997|FG007|NOT COMPLETED|Had Immunology Data||0
8962636|NCT02543918|10026022|FG000|STARTED|Overall Study||41
8962637|NCT02543918|10026023|FG001|STARTED|Overall Study||43
8962638|NCT02543918|10026022|FG000|Received at Least 1 Dose of Study Drug|Overall Study||41
8962639|NCT02543918|10026023|FG001|Received at Least 1 Dose of Study Drug|Overall Study||42
8962640|NCT02543918|10026022|FG000|COMPLETED|Overall Study||38
8962641|NCT02543918|10026023|FG001|COMPLETED|Overall Study||39
8962642|NCT02543918|10026022|FG000|NOT COMPLETED|Overall Study||3
8962643|NCT02543918|10026023|FG001|NOT COMPLETED|Overall Study||4
8962644|NCT02544113|10026031|FG000|STARTED|Overall Study||55
8962645|NCT02544113|10026032|FG001|STARTED|Overall Study||55
8962646|NCT02544113|10026031|FG000|COMPLETED|Overall Study||52
8962647|NCT02544113|10026032|FG001|COMPLETED|Overall Study||51
8962648|NCT02544113|10026031|FG000|NOT COMPLETED|Overall Study||3
8962649|NCT02544113|10026032|FG001|NOT COMPLETED|Overall Study||4
8962650|NCT02544152|10026040|FG000|STARTED|Overall Study||34
8962651|NCT02544152|10026041|FG001|STARTED|Overall Study||37
8962652|NCT02544152|10026040|FG000|Modified Intent to Treat (mITT)|Overall Study||34
8962653|NCT02544152|10026041|FG001|Modified Intent to Treat (mITT)|Overall Study||37
8962654|NCT02544152|10026040|FG000|Safety Analysis Set (SAS)|Overall Study||34
8962655|NCT02544152|10026041|FG001|Safety Analysis Set (SAS)|Overall Study||37
8962656|NCT02544152|10026040|FG000|COMPLETED|Overall Study||33
8962657|NCT02544152|10026041|FG001|COMPLETED|Overall Study||30
8962658|NCT02544152|10026040|FG000|NOT COMPLETED|Overall Study||1
8962659|NCT02544152|10026041|FG001|NOT COMPLETED|Overall Study||7
8962660|NCT02544217|10026053|FG000|STARTED|Overall Study||7
8962661|NCT02544217|10026054|FG001|STARTED|Overall Study||7
8962662|NCT02544217|10026055|FG002|STARTED|Overall Study||4
8962663|NCT02544217|10026056|FG003|STARTED|Overall Study||4
8962664|NCT02544217|10026057|FG004|STARTED|Overall Study||4
8962665|NCT02544217|10026058|FG005|STARTED|Overall Study||6
8962666|NCT02544217|10026053|FG000|COMPLETED|Overall Study||6
8962667|NCT02544217|10026054|FG001|COMPLETED|Overall Study|Two subjects prematurely withdrew from the study for non-medical reasons and were replaced.|6
8962668|NCT02544217|10026055|FG002|COMPLETED|Overall Study||4
8962669|NCT02544217|10026056|FG003|COMPLETED|Overall Study||4
8962670|NCT02544217|10026057|FG004|COMPLETED|Overall Study||4
8962671|NCT02544217|10026058|FG005|COMPLETED|Overall Study||6
8962672|NCT02544217|10026053|FG000|NOT COMPLETED|Overall Study||1
8962673|NCT02544217|10026054|FG001|NOT COMPLETED|Overall Study||1
8962674|NCT02544217|10026055|FG002|NOT COMPLETED|Overall Study||0
8962675|NCT02544217|10026056|FG003|NOT COMPLETED|Overall Study||0
8962676|NCT02544217|10026057|FG004|NOT COMPLETED|Overall Study||0
8962677|NCT02544217|10026058|FG005|NOT COMPLETED|Overall Study||0
8962678|NCT02544321|10026127|FG000|STARTED|Overall Study||43
8875526|NCT01908803|9932202|FG000|STARTED|Overall Study||46
8875527|NCT01908803|9932203|FG001|STARTED|Overall Study||24
8875528|NCT01908803|9932202|FG000|Treated|Overall Study|Two randomized subjects discontinued prior to receiving investigational product.|44
8875529|NCT01908803|9932203|FG001|Treated|Overall Study||24
8875530|NCT01908803|9932202|FG000|COMPLETED|Overall Study||42
8875531|NCT01908803|9932203|FG001|COMPLETED|Overall Study||23
8875532|NCT01908803|9932202|FG000|NOT COMPLETED|Overall Study||4
8875533|NCT01908803|9932203|FG001|NOT COMPLETED|Overall Study||1
8875534|NCT01908816|9932214|FG000|STARTED|Overall Study||93
8875535|NCT01908816|9932215|FG001|STARTED|Overall Study||84
8875536|NCT01908816|9932216|FG002|STARTED|Overall Study||58
8875537|NCT01908816|9932217|FG003|STARTED|Overall Study||35
8875538|NCT01908816|9932214|FG000|COMPLETED|Overall Study||0
8875539|NCT01908816|9932215|FG001|COMPLETED|Overall Study||0
8875540|NCT01908816|9932216|FG002|COMPLETED|Overall Study||0
8875541|NCT01908816|9932217|FG003|COMPLETED|Overall Study||0
8875542|NCT01908816|9932214|FG000|NOT COMPLETED|Overall Study||93
8875543|NCT01908816|9932215|FG001|NOT COMPLETED|Overall Study||84
8875544|NCT01908816|9932216|FG002|NOT COMPLETED|Overall Study||58
8875545|NCT01908816|9932217|FG003|NOT COMPLETED|Overall Study||35
8875546|NCT01908829|9932233|FG000|STARTED|Overall Study||727
8875547|NCT01908829|9932234|FG001|STARTED|Overall Study||728
8875548|NCT01908829|9932235|FG002|STARTED|Overall Study||719
8875549|NCT01908829|9932233|FG000|Treated With Double-blind Drug|Overall Study||725
8875550|NCT01908829|9932234|FG001|Treated With Double-blind Drug|Overall Study||728
8875551|NCT01908829|9932235|FG002|Treated With Double-blind Drug|Overall Study||719
8875552|NCT01908829|9932233|FG000|COMPLETED|Overall Study||678
8875553|NCT01908829|9932234|FG001|COMPLETED|Overall Study||679
8875554|NCT01908829|9932235|FG002|COMPLETED|Overall Study||680
8875555|NCT01908829|9932233|FG000|NOT COMPLETED|Overall Study||49
8875556|NCT01908829|9932234|FG001|NOT COMPLETED|Overall Study||49
8875557|NCT01908829|9932235|FG002|NOT COMPLETED|Overall Study||39
8875558|NCT01908842|9932245|FG000|STARTED|Induction||383
8875559|NCT01908842|9932246|FG001|STARTED|Induction||375
8875560|NCT01908842|9932245|FG000|COMPLETED|Induction||357
8875561|NCT01908842|9932246|FG001|COMPLETED|Induction||344
8875562|NCT01908842|9932245|FG000|NOT COMPLETED|Induction||26
8875563|NCT01908842|9932246|FG001|NOT COMPLETED|Induction||31
8875564|NCT01908842|9932245|FG000|STARTED|Switch to Other BNX Formulation (Day 15)||357
8875565|NCT01908842|9932246|FG001|STARTED|Switch to Other BNX Formulation (Day 15)||344
8875566|NCT01908842|9932245|FG000|COMPLETED|Switch to Other BNX Formulation (Day 15)||287
8875567|NCT01908842|9932246|FG001|COMPLETED|Switch to Other BNX Formulation (Day 15)||279
8875568|NCT01908842|9932245|FG000|NOT COMPLETED|Switch to Other BNX Formulation (Day 15)||70
8875569|NCT01908842|9932246|FG001|NOT COMPLETED|Switch to Other BNX Formulation (Day 15)||65
8875570|NCT01908842|9932245|FG000|STARTED|Day 22: Film (Col 1); Tablets (Col 2)||287
8875571|NCT01908842|9932246|FG001|STARTED|Day 22: Film (Col 1); Tablets (Col 2)||279
8875572|NCT01908842|9932245|FG000|COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||262
8875573|NCT01908842|9932246|FG001|COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||262
8875574|NCT01908842|9932245|FG000|NOT COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||25
8875575|NCT01908842|9932246|FG001|NOT COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||17
8875576|NCT01908907|9932254|FG000|STARTED|Overall Study||31
8962679|NCT02544321|10026128|FG001|STARTED|Overall Study||43
8875577|NCT01908907|9932255|FG001|STARTED|Overall Study||29
8962680|NCT02544321|10026127|FG000|Completed First Treatment|Overall Study||43
8962681|NCT02544321|10026128|FG001|Completed First Treatment|Overall Study||41
8962682|NCT02544321|10026127|FG000|Completed Washout|Overall Study||43
8962683|NCT02544321|10026128|FG001|Completed Washout|Overall Study||41
8962684|NCT02544321|10026127|FG000|Started Second Treatment|Overall Study||42
8962685|NCT02544321|10026128|FG001|Started Second Treatment|Overall Study||40
8962686|NCT02544321|10026127|FG000|COMPLETED|Overall Study||41
8962687|NCT02544321|10026128|FG001|COMPLETED|Overall Study||39
8962688|NCT02544321|10026127|FG000|NOT COMPLETED|Overall Study||2
8962689|NCT02544321|10026128|FG001|NOT COMPLETED|Overall Study||4
8962690|NCT02544451|10026146|FG000|STARTED|Treatment Period 1 (96 Weeks)||143
8962691|NCT02544451|10026147|FG001|STARTED|Treatment Period 1 (96 Weeks)||96
8962692|NCT02544451|10026148|FG002|STARTED|Treatment Period 1 (96 Weeks)||6
8962693|NCT02544451|10026149|FG003|STARTED|Treatment Period 1 (96 Weeks)||0
8962694|NCT02544451|10026146|FG000|COMPLETED|Treatment Period 1 (96 Weeks)||129
8962695|NCT02544451|10026147|FG001|COMPLETED|Treatment Period 1 (96 Weeks)||84
8962696|NCT02544451|10026148|FG002|COMPLETED|Treatment Period 1 (96 Weeks)||5
8962697|NCT02544451|10026149|FG003|COMPLETED|Treatment Period 1 (96 Weeks)||0
8962698|NCT02544451|10026146|FG000|NOT COMPLETED|Treatment Period 1 (96 Weeks)||14
8962699|NCT02544451|10026147|FG001|NOT COMPLETED|Treatment Period 1 (96 Weeks)||12
8962700|NCT02544451|10026148|FG002|NOT COMPLETED|Treatment Period 1 (96 Weeks)||1
8962701|NCT02544451|10026149|FG003|NOT COMPLETED|Treatment Period 1 (96 Weeks)||0
8962702|NCT02544451|10026146|FG000|STARTED|Treatment Period 2 (168 Weeks)||0
8962703|NCT02544451|10026147|FG001|STARTED|Treatment Period 2 (168 Weeks)||0
8962704|NCT02544451|10026148|FG002|STARTED|Treatment Period 2 (168 Weeks)||0
8962705|NCT02544451|10026149|FG003|STARTED|Treatment Period 2 (168 Weeks)||10
8962706|NCT02544451|10026146|FG000|COMPLETED|Treatment Period 2 (168 Weeks)||0
8962707|NCT02544451|10026147|FG001|COMPLETED|Treatment Period 2 (168 Weeks)||0
8962708|NCT02544451|10026148|FG002|COMPLETED|Treatment Period 2 (168 Weeks)||0
8962709|NCT02544451|10026149|FG003|COMPLETED|Treatment Period 2 (168 Weeks)||0
8962710|NCT02544451|10026146|FG000|NOT COMPLETED|Treatment Period 2 (168 Weeks)||0
8962711|NCT02544451|10026147|FG001|NOT COMPLETED|Treatment Period 2 (168 Weeks)||0
8962712|NCT02544451|10026148|FG002|NOT COMPLETED|Treatment Period 2 (168 Weeks)||0
8962713|NCT02544451|10026149|FG003|NOT COMPLETED|Treatment Period 2 (168 Weeks)||10
8962714|NCT02544607|10026167|FG000|STARTED|Overall Study||16
8962715|NCT02544607|10026167|FG000|COMPLETED|Overall Study||16
8962716|NCT02544607|10026167|FG000|NOT COMPLETED|Overall Study||0
8962717|NCT02544633|10026176|FG000|STARTED|Treatment Period||28
8962718|NCT02544633|10026177|FG001|STARTED|Treatment Period||20
8962719|NCT02544633|10026178|FG002|STARTED|Treatment Period||8
8962720|NCT02544633|10026179|FG003|STARTED|Treatment Period||12
8962721|NCT02544633|10026176|FG000|COMPLETED|Treatment Period||0
8962722|NCT02544633|10026177|FG001|COMPLETED|Treatment Period||0
8962723|NCT02544633|10026178|FG002|COMPLETED|Treatment Period||0
8962724|NCT02544633|10026179|FG003|COMPLETED|Treatment Period||0
8962725|NCT02544633|10026176|FG000|NOT COMPLETED|Treatment Period||28
8962726|NCT02544633|10026177|FG001|NOT COMPLETED|Treatment Period||20
8962727|NCT02544633|10026178|FG002|NOT COMPLETED|Treatment Period||8
8962728|NCT02544633|10026179|FG003|NOT COMPLETED|Treatment Period||12
8962729|NCT02544633|10026176|FG000|STARTED|Survival Follow-up Period||28
8962730|NCT02544633|10026177|FG001|STARTED|Survival Follow-up Period||19
8962731|NCT02544633|10026178|FG002|STARTED|Survival Follow-up Period||7
8962732|NCT02544633|10026179|FG003|STARTED|Survival Follow-up Period||12
8962733|NCT02544633|10026176|FG000|COMPLETED|Survival Follow-up Period||0
8962734|NCT02544633|10026177|FG001|COMPLETED|Survival Follow-up Period||0
8962735|NCT02544633|10026178|FG002|COMPLETED|Survival Follow-up Period||0
8962736|NCT02544633|10026179|FG003|COMPLETED|Survival Follow-up Period||0
8875578|NCT01908907|9932254|FG000|COMPLETED|Overall Study||29
8875579|NCT01908907|9932255|FG001|COMPLETED|Overall Study||29
8875580|NCT01908907|9932254|FG000|NOT COMPLETED|Overall Study||2
8875581|NCT01908907|9932255|FG001|NOT COMPLETED|Overall Study||0
8875582|NCT01908972|9932267|FG000|STARTED|Overall Study||17
8875583|NCT01908972|9932268|FG001|STARTED|Overall Study||17
8875584|NCT01908972|9932267|FG000|COMPLETED|Overall Study||15
8875585|NCT01908972|9932268|FG001|COMPLETED|Overall Study||17
8875586|NCT01908972|9932267|FG000|NOT COMPLETED|Overall Study||2
8875587|NCT01908972|9932268|FG001|NOT COMPLETED|Overall Study||0
8875588|NCT01909011|9932276|FG000|STARTED|Overall Study||7
8875589|NCT01909011|9932277|FG001|STARTED|Overall Study||9
8875590|NCT01909011|9932276|FG000|COMPLETED|Overall Study||7
8875591|NCT01909011|9932277|FG001|COMPLETED|Overall Study||9
8875592|NCT01909011|9932276|FG000|NOT COMPLETED|Overall Study||0
8875593|NCT01909011|9932277|FG001|NOT COMPLETED|Overall Study||0
8875594|NCT01909141|9932285|FG000|STARTED|Overall Study||50
8875595|NCT01909141|9932286|FG001|STARTED|Overall Study||50
8962737|NCT02544633|10026176|FG000|NOT COMPLETED|Survival Follow-up Period||28
8962738|NCT02544633|10026177|FG001|NOT COMPLETED|Survival Follow-up Period||19
8962739|NCT02544633|10026178|FG002|NOT COMPLETED|Survival Follow-up Period||7
8962740|NCT02544633|10026179|FG003|NOT COMPLETED|Survival Follow-up Period||12
8962741|NCT02544763|10026204|FG000|STARTED|Overall Study||75
8962742|NCT02544763|10026205|FG001|STARTED|Overall Study||73
8875596|NCT01909141|9932285|FG000|COMPLETED|Overall Study||50
8875597|NCT01909141|9932286|FG001|COMPLETED|Overall Study||50
8875598|NCT01909141|9932285|FG000|NOT COMPLETED|Overall Study||0
8875599|NCT01909141|9932286|FG001|NOT COMPLETED|Overall Study||0
8875600|NCT01909154|9932294|FG000|STARTED|Overall Study||12
8962743|NCT02544763|10026206|FG002|STARTED|Overall Study||76
8962744|NCT02544763|10026204|FG000|COMPLETED|Overall Study||65
8962745|NCT02544763|10026205|FG001|COMPLETED|Overall Study||61
8962746|NCT02544763|10026206|FG002|COMPLETED|Overall Study||75
8962747|NCT02544763|10026204|FG000|NOT COMPLETED|Overall Study||10
8962748|NCT02544763|10026205|FG001|NOT COMPLETED|Overall Study||12
8962749|NCT02544763|10026206|FG002|NOT COMPLETED|Overall Study||1
8962750|NCT02544984|10026216|FG000|STARTED|Overall Study||30
8962751|NCT02544984|10026217|FG001|STARTED|Overall Study||30
8962752|NCT02544984|10026216|FG000|COMPLETED|Overall Study||28
8962753|NCT02544984|10026217|FG001|COMPLETED|Overall Study||28
8962754|NCT02544984|10026216|FG000|NOT COMPLETED|Overall Study||2
8962755|NCT02544984|10026217|FG001|NOT COMPLETED|Overall Study||2
8962756|NCT02545075|10026225|FG000|STARTED|Randomization||122
8962757|NCT02545075|10026226|FG001|STARTED|Randomization||60
8962758|NCT02545075|10026225|FG000|COMPLETED|Randomization||122
8962759|NCT02545075|10026226|FG001|COMPLETED|Randomization||53
8962760|NCT02545075|10026225|FG000|NOT COMPLETED|Randomization||0
8962761|NCT02545075|10026226|FG001|NOT COMPLETED|Randomization||7
8962762|NCT02545075|10026225|FG000|STARTED|Treatment||122
8962763|NCT02545075|10026226|FG001|STARTED|Treatment||53
8962764|NCT02545075|10026225|FG000|COMPLETED|Treatment||0
8962765|NCT02545075|10026226|FG001|COMPLETED|Treatment||0
8962766|NCT02545075|10026225|FG000|NOT COMPLETED|Treatment||122
8962767|NCT02545075|10026226|FG001|NOT COMPLETED|Treatment||53
8962768|NCT02545101|10026232|FG000|STARTED|Overall Study||100
8962769|NCT02545101|10026232|FG000|COMPLETED|Overall Study||100
8962770|NCT02545101|10026232|FG000|NOT COMPLETED|Overall Study||0
9037828|NCT03321097|10099064|FG001|STARTED|Overall Study||18
9037829|NCT03321097|10099063|FG000|COMPLETED|Overall Study||18
9037830|NCT03321097|10099064|FG001|COMPLETED|Overall Study||18
9037831|NCT03321097|10099063|FG000|NOT COMPLETED|Overall Study||0
9037832|NCT03321097|10099064|FG001|NOT COMPLETED|Overall Study||0
9037833|NCT03321253|10099070|FG000|STARTED|Overall Study||38
9037834|NCT03321253|10099070|FG000|COMPLETED|Overall Study||38
9037835|NCT03321253|10099070|FG000|NOT COMPLETED|Overall Study||0
9037836|NCT03321396|10099074|FG000|STARTED|Overall Study||13
9037837|NCT03321396|10099074|FG000|COMPLETED|Overall Study||12
9037838|NCT03321396|10099074|FG000|NOT COMPLETED|Overall Study||1
9037839|NCT03321721|10099081|FG000|STARTED|Overall Study||4
9037840|NCT03321721|10099082|FG001|STARTED|Overall Study||10
9037841|NCT03321721|10099083|FG002|STARTED|Overall Study||12
9037842|NCT03321721|10099081|FG000|COMPLETED|Overall Study||0
9037843|NCT03321721|10099082|FG001|COMPLETED|Overall Study||2
9037844|NCT03321721|10099083|FG002|COMPLETED|Overall Study||1
9037845|NCT03321721|10099081|FG000|NOT COMPLETED|Overall Study||4
9037846|NCT03321721|10099082|FG001|NOT COMPLETED|Overall Study||8
9037847|NCT03321721|10099083|FG002|NOT COMPLETED|Overall Study||11
9037848|NCT03322423|10099092|FG000|STARTED|Period 1||38
9037849|NCT03322423|10099093|FG001|STARTED|Period 1||40
9037850|NCT03322423|10099092|FG000|COMPLETED|Period 1||36
9037851|NCT03322423|10099093|FG001|COMPLETED|Period 1||38
9037852|NCT03322423|10099092|FG000|NOT COMPLETED|Period 1||2
9037853|NCT03322423|10099093|FG001|NOT COMPLETED|Period 1||2
9037854|NCT03322423|10099092|FG000|STARTED|Period 2||36
9037855|NCT03322423|10099093|FG001|STARTED|Period 2||38
9037856|NCT03322423|10099092|FG000|COMPLETED|Period 2||35
9037857|NCT03322423|10099093|FG001|COMPLETED|Period 2||36
9037858|NCT03322423|10099092|FG000|NOT COMPLETED|Period 2||1
9037859|NCT03322423|10099093|FG001|NOT COMPLETED|Period 2||2
9037860|NCT03322462|10099099|FG000|STARTED|Overall Study||155
9037861|NCT03322462|10099099|FG000|Flortaucipir PET Scan|Overall Study||155
9037862|NCT03322462|10099099|FG000|COMPLETED|Overall Study||152
9037863|NCT03322462|10099099|FG000|NOT COMPLETED|Overall Study||3
9037864|NCT03322514|10099107|FG000|STARTED|Overall Study||6
9037865|NCT03322514|10099108|FG001|STARTED|Overall Study||6
9037866|NCT03322514|10099107|FG000|COMPLETED|Overall Study||5
9037867|NCT03322514|10099108|FG001|COMPLETED|Overall Study||5
9037868|NCT03322514|10099107|FG000|NOT COMPLETED|Overall Study||1
9037869|NCT03322514|10099108|FG001|NOT COMPLETED|Overall Study||1
8570474|NCT00103844|9602663|FG001|NOT COMPLETED|Overall Study||0
8570475|NCT00103857|9602676|FG000|STARTED|54-Week Base Study||179
8570476|NCT00103857|9602677|FG001|STARTED|54-Week Base Study||182
8570477|NCT00103857|9602678|FG002|STARTED|54-Week Base Study||182
8570478|NCT00103857|9602679|FG003|STARTED|54-Week Base Study||190
8570479|NCT00103857|9602680|FG004|STARTED|54-Week Base Study||182
9037870|NCT03322657|10099116|FG000|STARTED|Overall Study||34
9037871|NCT03322657|10099117|FG001|STARTED|Overall Study||35
9037872|NCT03322657|10099116|FG000|COMPLETED|Overall Study||33
9037873|NCT03322657|10099117|FG001|COMPLETED|Overall Study||35
9037874|NCT03322657|10099116|FG000|NOT COMPLETED|Overall Study||1
9037875|NCT03322657|10099117|FG001|NOT COMPLETED|Overall Study||0
9037876|NCT03322930|10099125|FG000|STARTED|Overall Study|recruitment of 20 patients with retinitis pigmentosa|20
9037877|NCT03322930|10099126|FG001|STARTED|Overall Study|recruitment of 20 patients with macular degeneration|20
9037878|NCT03322930|10099125|FG000|COMPLETED|Overall Study||20
9037879|NCT03322930|10099126|FG001|COMPLETED|Overall Study||20
9037880|NCT03322930|10099125|FG000|NOT COMPLETED|Overall Study||0
9037881|NCT03322930|10099126|FG001|NOT COMPLETED|Overall Study||0
9037882|NCT03323086|10099134|FG000|STARTED|Overall Study||26
9037883|NCT03323086|10099135|FG001|STARTED|Overall Study||22
9037884|NCT03323086|10099134|FG000|COMPLETED|Overall Study||23
9037885|NCT03323086|10099135|FG001|COMPLETED|Overall Study||20
9037886|NCT03323086|10099134|FG000|NOT COMPLETED|Overall Study||3
9037887|NCT03323086|10099135|FG001|NOT COMPLETED|Overall Study||2
8962771|NCT02545270|10026239|FG000|STARTED|Overall Study||6
8962772|NCT02545270|10026240|FG001|STARTED|Overall Study||5
8962773|NCT02545270|10026241|FG002|STARTED|Overall Study||5
8962774|NCT02545270|10026239|FG000|COMPLETED|Overall Study||6
8962775|NCT02545270|10026240|FG001|COMPLETED|Overall Study||4
8962776|NCT02545270|10026241|FG002|COMPLETED|Overall Study||3
8962777|NCT02545270|10026239|FG000|NOT COMPLETED|Overall Study||0
8962778|NCT02545270|10026240|FG001|NOT COMPLETED|Overall Study||1
8962779|NCT02545270|10026241|FG002|NOT COMPLETED|Overall Study||2
8962780|NCT02545322|10026250|FG000|STARTED|Overall Study||18
8962781|NCT02545322|10026250|FG000|COMPLETED|Overall Study||15
8962782|NCT02545322|10026250|FG000|NOT COMPLETED|Overall Study||3
8962783|NCT02545504|10026256|FG000|STARTED|Overall Study||218
8962784|NCT02545504|10026257|FG001|STARTED|Overall Study||214
8962785|NCT02545504|10026256|FG000|COMPLETED|Overall Study||0
8962786|NCT02545504|10026257|FG001|COMPLETED|Overall Study||0
8962787|NCT02545504|10026256|FG000|NOT COMPLETED|Overall Study||218
8962788|NCT02545504|10026257|FG001|NOT COMPLETED|Overall Study||214
8962789|NCT02545543|10026269|FG000|STARTED|Overall Study||1709
8962790|NCT02545543|10026270|FG001|STARTED|Overall Study||569
8962791|NCT02545543|10026269|FG000|COMPLETED|Overall Study||1628
8962792|NCT02545543|10026270|FG001|COMPLETED|Overall Study||535
8962793|NCT02545543|10026269|FG000|NOT COMPLETED|Overall Study||81
8962794|NCT02545543|10026270|FG001|NOT COMPLETED|Overall Study||34
8962795|NCT02545608|10026280|FG000|STARTED|Overall Study||9
8962796|NCT02545608|10026281|FG001|STARTED|Overall Study|Split hand study design. Total no. of subjects in Randomised group and No-treatment control is 100.|100
8962797|NCT02545608|10026280|FG000|COMPLETED|Overall Study||9
8725759|NCT01033136|9773088|FG000|NOT COMPLETED|Follow-Up (3 Month)||2
8725760|NCT01033136|9773089|FG001|NOT COMPLETED|Follow-Up (3 Month)||2
8725761|NCT01033227|9773099|FG000|STARTED|Overall Study||3
8725762|NCT01033227|9773100|FG001|STARTED|Overall Study||2
8725763|NCT01033227|9773099|FG000|COMPLETED|Overall Study||3
8875601|NCT01909154|9932294|FG000|COMPLETED|Overall Study||12
8875602|NCT01909154|9932294|FG000|NOT COMPLETED|Overall Study||0
8875603|NCT01909180|9932298|FG000|STARTED|Overall Study||49
8875604|NCT01909180|9932298|FG000|COMPLETED|Overall Study||49
8875605|NCT01909180|9932298|FG000|NOT COMPLETED|Overall Study||0
8875606|NCT01909336|9932307|FG000|STARTED|Overall Study||53
8875607|NCT01909336|9932308|FG001|STARTED|Overall Study||53
8875608|NCT01909336|9932309|FG002|STARTED|Overall Study||55
8875609|NCT01909336|9932307|FG000|COMPLETED|Overall Study||49
8875610|NCT01909336|9932308|FG001|COMPLETED|Overall Study||50
8875611|NCT01909336|9932309|FG002|COMPLETED|Overall Study||52
8875612|NCT01909336|9932307|FG000|NOT COMPLETED|Overall Study||4
8875613|NCT01909336|9932308|FG001|NOT COMPLETED|Overall Study||3
8875614|NCT01909336|9932309|FG002|NOT COMPLETED|Overall Study||3
8875615|NCT01909466|9932317|FG000|STARTED|Overall Study||68
8875616|NCT01909466|9932318|FG001|STARTED|Overall Study||73
8875617|NCT01909466|9932317|FG000|COMPLETED|Overall Study||46
8875618|NCT01909466|9932318|FG001|COMPLETED|Overall Study||50
8875619|NCT01909466|9932317|FG000|NOT COMPLETED|Overall Study||22
8875620|NCT01909466|9932318|FG001|NOT COMPLETED|Overall Study||23
8875621|NCT01909674|9932324|FG000|STARTED|Overall Study||12
8875622|NCT01909674|9932325|FG001|STARTED|Overall Study||9
8875623|NCT01909674|9932324|FG000|COMPLETED|Overall Study||7
8875624|NCT01909674|9932325|FG001|COMPLETED|Overall Study||7
8875625|NCT01909674|9932324|FG000|NOT COMPLETED|Overall Study||5
8875626|NCT01909674|9932325|FG001|NOT COMPLETED|Overall Study||2
8875627|NCT01909713|9932331|FG000|STARTED|Overall Study||35
8875628|NCT01909713|9932331|FG000|COMPLETED|Overall Study||35
8875629|NCT01909713|9932331|FG000|NOT COMPLETED|Overall Study||0
8875630|NCT01909778|9932356|FG000|STARTED|Overall Study||2
8875631|NCT01909778|9932356|FG000|COMPLETED|Overall Study||1
8875632|NCT01909778|9932356|FG000|NOT COMPLETED|Overall Study||1
8875633|NCT01909791|9932365|FG000|STARTED|Overall Study||226
8875634|NCT01909791|9932366|FG001|STARTED|Overall Study||240
8875635|NCT01909791|9932367|FG002|STARTED|Overall Study||236
8875636|NCT01909791|9932365|FG000|COMPLETED|Overall Study||205
8875637|NCT01909791|9932366|FG001|COMPLETED|Overall Study||212
8875638|NCT01909791|9932367|FG002|COMPLETED|Overall Study||208
8875639|NCT01909791|9932365|FG000|NOT COMPLETED|Overall Study||21
8875640|NCT01909791|9932366|FG001|NOT COMPLETED|Overall Study||28
8725764|NCT01033227|9773100|FG001|COMPLETED|Overall Study||2
8725765|NCT01033227|9773099|FG000|NOT COMPLETED|Overall Study||0
8875641|NCT01909791|9932367|FG002|NOT COMPLETED|Overall Study||28
8875642|NCT01909804|9932392|FG000|STARTED|Overall Study||26
8875643|NCT01909804|9932393|FG001|STARTED|Overall Study||28
8875644|NCT01909804|9932394|FG002|STARTED|Overall Study||27
8875645|NCT01909804|9932395|FG003|STARTED|Overall Study||26
8875646|NCT01909804|9932396|FG004|STARTED|Overall Study||26
8875647|NCT01909804|9932397|FG005|STARTED|Overall Study||25
8875648|NCT01909804|9932398|FG006|STARTED|Overall Study||27
8875649|NCT01909804|9932399|FG007|STARTED|Overall Study||26
8875650|NCT01909804|9932400|FG008|STARTED|Overall Study||27
8875651|NCT01909804|9932401|FG009|STARTED|Overall Study||29
8962798|NCT02545608|10026281|FG001|COMPLETED|Overall Study||93
8962799|NCT02545608|10026280|FG000|NOT COMPLETED|Overall Study||0
8962800|NCT02545608|10026281|FG001|NOT COMPLETED|Overall Study||7
8962801|NCT02545907|10026290|FG000|STARTED|Overall Study||3
8962802|NCT02545907|10026291|FG001|STARTED|Overall Study||3
8962803|NCT02545907|10026292|FG002|STARTED|Overall Study||4
8962804|NCT02545907|10026290|FG000|COMPLETED|Overall Study||3
8962805|NCT02545907|10026291|FG001|COMPLETED|Overall Study||3
8962806|NCT02545907|10026292|FG002|COMPLETED|Overall Study||4
8962807|NCT02545907|10026290|FG000|NOT COMPLETED|Overall Study||0
8962808|NCT02545907|10026291|FG001|NOT COMPLETED|Overall Study||0
8962809|NCT02545907|10026292|FG002|NOT COMPLETED|Overall Study||0
8962810|NCT02545933|10026304|FG000|STARTED|Overall Study||44
8962811|NCT02545933|10026305|FG001|STARTED|Overall Study||43
8962812|NCT02545933|10026306|FG002|STARTED|Overall Study||43
8962813|NCT02545933|10026304|FG000|COMPLETED|Overall Study||38
8962814|NCT02545933|10026305|FG001|COMPLETED|Overall Study||40
8962815|NCT02545933|10026306|FG002|COMPLETED|Overall Study||39
8962816|NCT02545933|10026304|FG000|NOT COMPLETED|Overall Study||6
8962817|NCT02545933|10026305|FG001|NOT COMPLETED|Overall Study||3
8962818|NCT02545933|10026306|FG002|NOT COMPLETED|Overall Study||4
8962819|NCT02546193|10026316|FG000|STARTED|Overall Study||10
8962820|NCT02546193|10026317|FG001|STARTED|Overall Study||10
8962821|NCT02546193|10026318|FG002|STARTED|Overall Study|Enrolled independently (Prospective study). Not counted in Outpatient Foley Catheter Arm.|2
8962822|NCT02546193|10026319|FG003|STARTED|Overall Study||0
8962823|NCT02546193|10026316|FG000|COMPLETED|Overall Study||4
8962824|NCT02546193|10026317|FG001|COMPLETED|Overall Study||4
8962825|NCT02546193|10026318|FG002|COMPLETED|Overall Study||0
8962826|NCT02546193|10026319|FG003|COMPLETED|Overall Study||0
8962827|NCT02546193|10026316|FG000|NOT COMPLETED|Overall Study||6
8962828|NCT02546193|10026317|FG001|NOT COMPLETED|Overall Study||6
8962829|NCT02546193|10026318|FG002|NOT COMPLETED|Overall Study||2
8962830|NCT02546193|10026319|FG003|NOT COMPLETED|Overall Study||0
8962831|NCT02546323|10026327|FG000|STARTED|Overall Study||272
8962832|NCT02546323|10026328|FG001|STARTED|Overall Study||271
8962833|NCT02546323|10026327|FG000|Received Treatment|Overall Study||272
8962834|NCT02546323|10026328|FG001|Received Treatment|Overall Study||268
8962835|NCT02546323|10026327|FG000|COMPLETED|Overall Study||212
8962836|NCT02546323|10026328|FG001|COMPLETED|Overall Study||205
8962837|NCT02546323|10026327|FG000|NOT COMPLETED|Overall Study||60
8962838|NCT02546323|10026328|FG001|NOT COMPLETED|Overall Study||66
8962839|NCT02546362|10026334|FG000|STARTED|4-week Treatment Period||50
8962840|NCT02546362|10026334|FG000|COMPLETED|4-week Treatment Period||47
8962841|NCT02546362|10026334|FG000|NOT COMPLETED|4-week Treatment Period||3
8962842|NCT02546362|10026334|FG000|STARTED|12-week Treatment Period||47
8962843|NCT02546362|10026334|FG000|COMPLETED|12-week Treatment Period||38
8962844|NCT02546362|10026334|FG000|NOT COMPLETED|12-week Treatment Period||9
8962845|NCT02546375|10026338|FG000|STARTED|Overall Study||87
8962846|NCT02546375|10026338|FG000|COMPLETED|Overall Study||87
8962847|NCT02546375|10026338|FG000|NOT COMPLETED|Overall Study||0
8962848|NCT02546388|10026344|FG000|STARTED|Overall Study||4
8962849|NCT02546388|10026345|FG001|STARTED|Overall Study||13
8962850|NCT02546388|10026344|FG000|COMPLETED|Overall Study||4
8962851|NCT02546388|10026345|FG001|COMPLETED|Overall Study||13
8962852|NCT02546388|10026344|FG000|NOT COMPLETED|Overall Study||0
8962853|NCT02546388|10026345|FG001|NOT COMPLETED|Overall Study||0
8962854|NCT02546544|10026352|FG000|STARTED|Overall Study||16
8962855|NCT02546544|10026352|FG000|Received Allocated Intervention|Overall Study||16
8962856|NCT02546544|10026352|FG000|COMPLETED|Overall Study||0
8962857|NCT02546544|10026352|FG000|NOT COMPLETED|Overall Study||16
8962858|NCT02546570|10026358|FG000|STARTED|Overall Study||9
8962859|NCT02546570|10026359|FG001|STARTED|Overall Study||2
8962860|NCT02546570|10026358|FG000|Crossover Order: Oxytocin, Placebo|Overall Study||6
8962861|NCT02546570|10026359|FG001|Crossover Order: Oxytocin, Placebo|Overall Study||2
8962862|NCT02546570|10026358|FG000|Crossover Order: Placebo, Oxytocin|Overall Study||3
8962863|NCT02546570|10026359|FG001|Crossover Order: Placebo, Oxytocin|Overall Study||0
8962864|NCT02546570|10026358|FG000|COMPLETED|Overall Study||9
8962865|NCT02546570|10026359|FG001|COMPLETED|Overall Study||2
8962866|NCT02546570|10026358|FG000|NOT COMPLETED|Overall Study||0
8962867|NCT02546570|10026359|FG001|NOT COMPLETED|Overall Study||0
8962868|NCT02546609|10026372|FG000|STARTED|Overall Study||24
8962869|NCT02546609|10026373|FG001|STARTED|Overall Study||35
8962870|NCT02546609|10026374|FG002|STARTED|Overall Study||32
8962871|NCT02546609|10026372|FG000|COMPLETED|Overall Study||22
8962872|NCT02546609|10026373|FG001|COMPLETED|Overall Study||24
8962873|NCT02546609|10026374|FG002|COMPLETED|Overall Study||25
8962874|NCT02546609|10026372|FG000|NOT COMPLETED|Overall Study||2
8962875|NCT02546609|10026373|FG001|NOT COMPLETED|Overall Study||11
8962876|NCT02546609|10026374|FG002|NOT COMPLETED|Overall Study||7
8962877|NCT02546765|10026386|FG000|STARTED|Overall Study||31
8962878|NCT02546765|10026387|FG001|STARTED|Overall Study||30
8962879|NCT02546765|10026388|FG002|STARTED|Overall Study||30
8962880|NCT02546765|10026389|FG003|STARTED|Overall Study||30
8962881|NCT02546765|10026386|FG000|COMPLETED|Overall Study||31
8962882|NCT02546765|10026387|FG001|COMPLETED|Overall Study|29 Received study drug; 1 withdrew before surgery and after randomization|29
8962883|NCT02546765|10026388|FG002|COMPLETED|Overall Study||30
8962884|NCT02546765|10026389|FG003|COMPLETED|Overall Study||30
8962885|NCT02546765|10026386|FG000|NOT COMPLETED|Overall Study||0
8962886|NCT02546765|10026387|FG001|NOT COMPLETED|Overall Study||1
8962887|NCT02546765|10026388|FG002|NOT COMPLETED|Overall Study||0
8962888|NCT02546765|10026389|FG003|NOT COMPLETED|Overall Study||0
8962889|NCT02546856|10026412|FG000|STARTED|4 Months Evaluation||164
8962890|NCT02546856|10026413|FG001|STARTED|4 Months Evaluation||156
8962891|NCT02546856|10026412|FG000|COMPLETED|4 Months Evaluation||144
8962892|NCT02546856|10026413|FG001|COMPLETED|4 Months Evaluation||145
8962893|NCT02546856|10026412|FG000|NOT COMPLETED|4 Months Evaluation||20
8962894|NCT02546856|10026413|FG001|NOT COMPLETED|4 Months Evaluation||11
8962895|NCT02546856|10026412|FG000|STARTED|6 Months Evaluation||144
8962896|NCT02546856|10026413|FG001|STARTED|6 Months Evaluation||145
8962897|NCT02546856|10026412|FG000|COMPLETED|6 Months Evaluation||136
8962898|NCT02546856|10026413|FG001|COMPLETED|6 Months Evaluation||138
8962899|NCT02546856|10026412|FG000|NOT COMPLETED|6 Months Evaluation||8
8962900|NCT02546856|10026413|FG001|NOT COMPLETED|6 Months Evaluation||7
8962901|NCT02547012|10026433|FG000|STARTED|Overall Study||24
8962902|NCT02547012|10026434|FG001|STARTED|Overall Study||27
8962903|NCT02547012|10026433|FG000|COMPLETED|Overall Study||24
8962904|NCT02547012|10026434|FG001|COMPLETED|Overall Study||27
8962905|NCT02547012|10026433|FG000|NOT COMPLETED|Overall Study||0
8962906|NCT02547012|10026434|FG001|NOT COMPLETED|Overall Study||0
8962907|NCT02547038|10026442|FG000|STARTED|Overall Study||176
8962908|NCT02547038|10026443|FG001|STARTED|Overall Study||176
8962909|NCT02547038|10026442|FG000|COMPLETED|Overall Study||173
8962910|NCT02547038|10026443|FG001|COMPLETED|Overall Study||174
8962911|NCT02547038|10026442|FG000|NOT COMPLETED|Overall Study||3
8962912|NCT02547038|10026443|FG001|NOT COMPLETED|Overall Study||2
8962913|NCT02547064|10026451|FG000|STARTED|Overall Study||81
8962914|NCT02547064|10026452|FG001|STARTED|Overall Study||81
8962915|NCT02547064|10026451|FG000|COMPLETED|Overall Study||78
8962916|NCT02547064|10026452|FG001|COMPLETED|Overall Study||79
8962917|NCT02547064|10026451|FG000|NOT COMPLETED|Overall Study||3
8962918|NCT02547064|10026452|FG001|NOT COMPLETED|Overall Study||2
8962919|NCT02547220|10026460|FG000|STARTED|Overall Study||19
8962920|NCT02547220|10026461|FG001|STARTED|Overall Study||20
8962921|NCT02547220|10026460|FG000|COMPLETED|Overall Study||0
8962922|NCT02547220|10026461|FG001|COMPLETED|Overall Study||0
8962923|NCT02547220|10026460|FG000|NOT COMPLETED|Overall Study||19
8962924|NCT02547220|10026461|FG001|NOT COMPLETED|Overall Study||20
8962925|NCT02547233|10026469|FG000|STARTED|3-day Treatment and 8-week Follow-up||205
8962926|NCT02547233|10026470|FG001|STARTED|3-day Treatment and 8-week Follow-up||102
8962927|NCT02547233|10026469|FG000|Treated|3-day Treatment and 8-week Follow-up||205
8962928|NCT02547233|10026470|FG001|Treated|3-day Treatment and 8-week Follow-up||100
8962929|NCT02547233|10026469|FG000|COMPLETED|3-day Treatment and 8-week Follow-up||203
8962930|NCT02547233|10026470|FG001|COMPLETED|3-day Treatment and 8-week Follow-up||92
8962931|NCT02547233|10026469|FG000|NOT COMPLETED|3-day Treatment and 8-week Follow-up||2
8962932|NCT02547233|10026470|FG001|NOT COMPLETED|3-day Treatment and 8-week Follow-up||10
8962933|NCT02547233|10026469|FG000|STARTED|12-month Follow-up||199
8962934|NCT02547233|10026470|FG001|STARTED|12-month Follow-up||84
8962935|NCT02547233|10026469|FG000|COMPLETED|12-month Follow-up||185
8962936|NCT02547233|10026470|FG001|COMPLETED|12-month Follow-up||67
8962937|NCT02547233|10026469|FG000|NOT COMPLETED|12-month Follow-up||14
8962938|NCT02547233|10026470|FG001|NOT COMPLETED|12-month Follow-up||17
8962939|NCT02547363|10026480|FG000|STARTED|3-day Treatment and 8-week Follow-up||211
8962940|NCT02547363|10026481|FG001|STARTED|3-day Treatment and 8-week Follow-up||105
8962941|NCT02547363|10026480|FG000|Treated|3-day Treatment and 8-week Follow-up||209
8962942|NCT02547363|10026481|FG001|Treated|3-day Treatment and 8-week Follow-up||104
8962943|NCT02547363|10026480|FG000|COMPLETED|3-day Treatment and 8-week Follow-up||207
8962944|NCT02547363|10026481|FG001|COMPLETED|3-day Treatment and 8-week Follow-up||94
8962945|NCT02547363|10026480|FG000|NOT COMPLETED|3-day Treatment and 8-week Follow-up||4
8962946|NCT02547363|10026481|FG001|NOT COMPLETED|3-day Treatment and 8-week Follow-up||11
8962947|NCT02547363|10026480|FG000|STARTED|12-month Follow-up||204
8962948|NCT02547363|10026481|FG001|STARTED|12-month Follow-up||86
8962949|NCT02547363|10026480|FG000|COMPLETED|12-month Follow-up||194
8962950|NCT02547363|10026481|FG001|COMPLETED|12-month Follow-up||81
8962951|NCT02547363|10026480|FG000|NOT COMPLETED|12-month Follow-up||10
8962952|NCT02547363|10026481|FG001|NOT COMPLETED|12-month Follow-up||5
8962953|NCT02547428|10026491|FG000|STARTED|Period 1- Treatment Sequence 1 (3 Weeks)||42
8962954|NCT02547428|10026492|FG001|STARTED|Period 1- Treatment Sequence 1 (3 Weeks)||43
8962955|NCT02547428|10026491|FG000|Received at Least 1 Dose of Study Drug|Period 1- Treatment Sequence 1 (3 Weeks)||42
8962956|NCT02547428|10026492|FG001|Received at Least 1 Dose of Study Drug|Period 1- Treatment Sequence 1 (3 Weeks)||43
8962957|NCT02547428|10026491|FG000|COMPLETED|Period 1- Treatment Sequence 1 (3 Weeks)||31
8962958|NCT02547428|10026492|FG001|COMPLETED|Period 1- Treatment Sequence 1 (3 Weeks)||37
8962959|NCT02547428|10026491|FG000|NOT COMPLETED|Period 1- Treatment Sequence 1 (3 Weeks)||11
8962960|NCT02547428|10026492|FG001|NOT COMPLETED|Period 1- Treatment Sequence 1 (3 Weeks)||6
8962961|NCT02547428|10026491|FG000|STARTED|Period 2- Treatment Sequence 2 (3 Weeks)||31
8962962|NCT02547428|10026492|FG001|STARTED|Period 2- Treatment Sequence 2 (3 Weeks)||37
8962963|NCT02547428|10026491|FG000|COMPLETED|Period 2- Treatment Sequence 2 (3 Weeks)||30
8962964|NCT02547428|10026492|FG001|COMPLETED|Period 2- Treatment Sequence 2 (3 Weeks)||30
8962965|NCT02547428|10026491|FG000|NOT COMPLETED|Period 2- Treatment Sequence 2 (3 Weeks)||1
8962966|NCT02547428|10026492|FG001|NOT COMPLETED|Period 2- Treatment Sequence 2 (3 Weeks)||7
8962967|NCT02547454|10026505|FG000|STARTED|Overall Study||393
8962968|NCT02547454|10026505|FG000|COMPLETED|Overall Study||221
8962969|NCT02547454|10026505|FG000|NOT COMPLETED|Overall Study||172
8962970|NCT02547623|10026511|FG000|STARTED|Overall Study||126
8962971|NCT02547623|10026512|FG001|STARTED|Overall Study||55
8962972|NCT02547623|10026511|FG000|COMPLETED|Overall Study||122
8962973|NCT02547623|10026512|FG001|COMPLETED|Overall Study||52
8962974|NCT02547623|10026511|FG000|NOT COMPLETED|Overall Study||4
8962975|NCT02547623|10026512|FG001|NOT COMPLETED|Overall Study||3
8962976|NCT02547649|10026521|FG000|STARTED|Overall Study||231
8962977|NCT02547649|10026522|FG001|STARTED|Overall Study||231
8962978|NCT02547649|10026523|FG002|STARTED|Overall Study||228
8962979|NCT02547649|10026521|FG000|Vaccinated|Overall Study||231
8962980|NCT02547649|10026522|FG001|Vaccinated|Overall Study||231
8962981|NCT02547649|10026523|FG002|Vaccinated|Overall Study||227
8962982|NCT02547649|10026521|FG000|COMPLETED|Overall Study||228
8962983|NCT02547649|10026522|FG001|COMPLETED|Overall Study||226
8962984|NCT02547649|10026523|FG002|COMPLETED|Overall Study||224
8631650|NCT00541229|9671534|FG005|COMPLETED|Treatment Period III (Week 11)||4
8631651|NCT00541229|9671529|FG000|NOT COMPLETED|Treatment Period III (Week 11)||0
8875652|NCT01909804|9932402|FG010|STARTED|Overall Study||27
8962985|NCT02547649|10026521|FG000|NOT COMPLETED|Overall Study||3
8962986|NCT02547649|10026522|FG001|NOT COMPLETED|Overall Study||5
8962987|NCT02547649|10026523|FG002|NOT COMPLETED|Overall Study||4
8962988|NCT02547714|10026531|FG000|STARTED|Overall Study||34
8962989|NCT02547714|10026531|FG000|COMPLETED|Overall Study||34
8962990|NCT02547714|10026531|FG000|NOT COMPLETED|Overall Study||0
8962991|NCT02547766|10026536|FG000|STARTED|Overall Study||10
8962992|NCT02547766|10026536|FG000|COMPLETED|Overall Study||9
8962993|NCT02547766|10026536|FG000|NOT COMPLETED|Overall Study||1
8962994|NCT02547779|10026542|FG000|STARTED|Overall Study||5214
8962995|NCT02547779|10026543|FG001|STARTED|Overall Study||5207
8962996|NCT02547779|10026542|FG000|COMPLETED|Overall Study||5214
8962997|NCT02547779|10026543|FG001|COMPLETED|Overall Study||5207
8875653|NCT01909804|9932403|FG011|STARTED|Overall Study||29
8875654|NCT01909804|9932392|FG000|COMPLETED|Overall Study||22
8875655|NCT01909804|9932393|FG001|COMPLETED|Overall Study||27
8875656|NCT01909804|9932394|FG002|COMPLETED|Overall Study||27
8875657|NCT01909804|9932395|FG003|COMPLETED|Overall Study||26
8875658|NCT01909804|9932396|FG004|COMPLETED|Overall Study||18
8875659|NCT01909804|9932397|FG005|COMPLETED|Overall Study||21
8875660|NCT01909804|9932398|FG006|COMPLETED|Overall Study||25
8875661|NCT01909804|9932399|FG007|COMPLETED|Overall Study||25
8875662|NCT01909804|9932400|FG008|COMPLETED|Overall Study||27
8875663|NCT01909804|9932401|FG009|COMPLETED|Overall Study||28
8875664|NCT01909804|9932402|FG010|COMPLETED|Overall Study||26
8875665|NCT01909804|9932403|FG011|COMPLETED|Overall Study||26
8875666|NCT01909804|9932392|FG000|NOT COMPLETED|Overall Study||4
8875667|NCT01909804|9932393|FG001|NOT COMPLETED|Overall Study||1
8875668|NCT01909804|9932394|FG002|NOT COMPLETED|Overall Study||0
8875669|NCT01909804|9932395|FG003|NOT COMPLETED|Overall Study||0
8875670|NCT01909804|9932396|FG004|NOT COMPLETED|Overall Study||8
8875671|NCT01909804|9932397|FG005|NOT COMPLETED|Overall Study||4
8875672|NCT01909804|9932398|FG006|NOT COMPLETED|Overall Study||2
8875673|NCT01909804|9932399|FG007|NOT COMPLETED|Overall Study||1
8875674|NCT01909804|9932400|FG008|NOT COMPLETED|Overall Study||0
8875675|NCT01909804|9932401|FG009|NOT COMPLETED|Overall Study||1
8875676|NCT01909804|9932402|FG010|NOT COMPLETED|Overall Study||1
8875677|NCT01909804|9932403|FG011|NOT COMPLETED|Overall Study||3
8875678|NCT01909973|9932427|FG000|STARTED|Overall Study||8
8875679|NCT01909973|9932428|FG001|STARTED|Overall Study||7
8875680|NCT01909973|9932427|FG000|COMPLETED|Overall Study||7
8875681|NCT01909973|9932428|FG001|COMPLETED|Overall Study||7
8875682|NCT01909973|9932427|FG000|NOT COMPLETED|Overall Study||1
8875683|NCT01909973|9932428|FG001|NOT COMPLETED|Overall Study||0
8875684|NCT01910064|9932434|FG000|STARTED|Overall Study||436
8875685|NCT01910064|9932434|FG000|COMPLETED|Overall Study||391
8875686|NCT01910064|9932434|FG000|NOT COMPLETED|Overall Study||45
8875687|NCT01910116|9932440|FG000|STARTED|Overall Study||110
8875688|NCT01910116|9932441|FG001|STARTED|Overall Study||110
8875689|NCT01910116|9932440|FG000|Week 4|Overall Study||106
8875690|NCT01910116|9932441|FG001|Week 4|Overall Study||102
8875691|NCT01910116|9932440|FG000|Week 8|Overall Study||98
8875692|NCT01910116|9932441|FG001|Week 8|Overall Study||99
8875693|NCT01910116|9932440|FG000|Week 12|Overall Study||97
8962998|NCT02547779|10026542|FG000|NOT COMPLETED|Overall Study||0
8962999|NCT02547779|10026543|FG001|NOT COMPLETED|Overall Study||0
8631652|NCT00541229|9671530|FG001|NOT COMPLETED|Treatment Period III (Week 11)||0
8631653|NCT00541229|9671531|FG002|NOT COMPLETED|Treatment Period III (Week 11)||1
8631654|NCT00541229|9671532|FG003|NOT COMPLETED|Treatment Period III (Week 11)||0
8875694|NCT01910116|9932441|FG001|Week 12|Overall Study||96
8875695|NCT01910116|9932440|FG000|Week 16|Overall Study||96
8875696|NCT01910116|9932441|FG001|Week 16|Overall Study||94
8875697|NCT01910116|9932440|FG000|COMPLETED|Overall Study||96
8875698|NCT01910116|9932441|FG001|COMPLETED|Overall Study||94
8875699|NCT01910116|9932440|FG000|NOT COMPLETED|Overall Study||14
8875700|NCT01910116|9932441|FG001|NOT COMPLETED|Overall Study||16
8875701|NCT01910129|9932449|FG000|STARTED|Run-in Period Phase 1||0
8875702|NCT01910129|9932450|FG001|STARTED|Run-in Period Phase 1||0
8963000|NCT02547922|10026552|FG000|STARTED|Overall Study||46
8963001|NCT02547922|10026553|FG001|STARTED|Overall Study||52
8963002|NCT02547922|10026554|FG002|STARTED|Overall Study||49
8963003|NCT02547922|10026552|FG000|FAS (Full Analysis Set)|Overall Study||45
8963004|NCT02547922|10026553|FG001|FAS (Full Analysis Set)|Overall Study||51
8963005|NCT02547922|10026554|FG002|FAS (Full Analysis Set)|Overall Study||49
8963006|NCT02547922|10026552|FG000|COMPLETED|Overall Study||18
8963007|NCT02547922|10026553|FG001|COMPLETED|Overall Study||28
8963008|NCT02547922|10026554|FG002|COMPLETED|Overall Study||20
8963009|NCT02547922|10026552|FG000|NOT COMPLETED|Overall Study||28
8963010|NCT02547922|10026553|FG001|NOT COMPLETED|Overall Study||24
8963011|NCT02547922|10026554|FG002|NOT COMPLETED|Overall Study||29
8963012|NCT02547935|10026571|FG000|STARTED|Overall Study||155
8963013|NCT02547935|10026572|FG001|STARTED|Overall Study||145
8963014|NCT02547935|10026573|FG002|STARTED|Overall Study||148
8963015|NCT02547935|10026571|FG000|Received Treatment|Overall Study||152
8963016|NCT02547935|10026572|FG001|Received Treatment|Overall Study||145
8963017|NCT02547935|10026573|FG002|Received Treatment|Overall Study||148
8963018|NCT02547935|10026571|FG000|Full Analysis Set|Overall Study||152
8963019|NCT02547935|10026572|FG001|Full Analysis Set|Overall Study||144
8963020|NCT02547935|10026573|FG002|Full Analysis Set|Overall Study||148
8963021|NCT02547935|10026571|FG000|Safety Analysis Set|Overall Study||152
8963022|NCT02547935|10026572|FG001|Safety Analysis Set|Overall Study||145
8963023|NCT02547935|10026573|FG002|Safety Analysis Set|Overall Study||148
8631655|NCT00541229|9671533|FG004|NOT COMPLETED|Treatment Period III (Week 11)||1
8631656|NCT00541229|9671534|FG005|NOT COMPLETED|Treatment Period III (Week 11)||1
8631657|NCT00541242|9671544|FG000|STARTED|Treatment Period 1||0
8875703|NCT01910129|9932451|FG002|STARTED|Run-in Period Phase 1||13
8875704|NCT01910129|9932449|FG000|COMPLETED|Run-in Period Phase 1||0
8875705|NCT01910129|9932450|FG001|COMPLETED|Run-in Period Phase 1||0
8631658|NCT00541242|9671545|FG001|STARTED|Treatment Period 1|586 patients were enrolled and received open-label latanoprost for 6 weeks|586
8875706|NCT01910129|9932451|FG002|COMPLETED|Run-in Period Phase 1||13
8875707|NCT01910129|9932449|FG000|NOT COMPLETED|Run-in Period Phase 1||0
8875708|NCT01910129|9932450|FG001|NOT COMPLETED|Run-in Period Phase 1||0
8875709|NCT01910129|9932451|FG002|NOT COMPLETED|Run-in Period Phase 1||0
8875710|NCT01910129|9932449|FG000|STARTED|Randomized Phase 2||7
8875711|NCT01910129|9932450|FG001|STARTED|Randomized Phase 2||6
8875712|NCT01910129|9932451|FG002|STARTED|Randomized Phase 2||0
8875713|NCT01910129|9932449|FG000|COMPLETED|Randomized Phase 2||5
8875714|NCT01910129|9932450|FG001|COMPLETED|Randomized Phase 2||5
8875715|NCT01910129|9932451|FG002|COMPLETED|Randomized Phase 2||0
8875716|NCT01910129|9932449|FG000|NOT COMPLETED|Randomized Phase 2||2
8875717|NCT01910129|9932450|FG001|NOT COMPLETED|Randomized Phase 2||1
8875718|NCT01910129|9932451|FG002|NOT COMPLETED|Randomized Phase 2||0
8875719|NCT01910129|9932449|FG000|STARTED|Randomized Phase 3||5
8875720|NCT01910129|9932450|FG001|STARTED|Randomized Phase 3||5
8875721|NCT01910129|9932451|FG002|STARTED|Randomized Phase 3||0
8875722|NCT01910129|9932449|FG000|COMPLETED|Randomized Phase 3||5
8875723|NCT01910129|9932450|FG001|COMPLETED|Randomized Phase 3||4
8875724|NCT01910129|9932451|FG002|COMPLETED|Randomized Phase 3||0
8875725|NCT01910129|9932449|FG000|NOT COMPLETED|Randomized Phase 3||0
8875726|NCT01910129|9932450|FG001|NOT COMPLETED|Randomized Phase 3||1
8875727|NCT01910129|9932451|FG002|NOT COMPLETED|Randomized Phase 3||0
8875728|NCT01910181|9932469|FG000|STARTED|Overall Study||46
8875729|NCT01910181|9932469|FG000|PK Cohort|Overall Study||20
8875730|NCT01910181|9932469|FG000|Expansion Cohort|Overall Study||26
8875731|NCT01910181|9932469|FG000|COMPLETED|Overall Study||0
8875732|NCT01910181|9932469|FG000|NOT COMPLETED|Overall Study||46
8875733|NCT01910298|9932476|FG000|STARTED|Overall Study||76
8875734|NCT01910298|9932477|FG001|STARTED|Overall Study||55
8875735|NCT01910298|9932476|FG000|Safety Set|Overall Study||76
8875736|NCT01910298|9932477|FG001|Safety Set|Overall Study|4 participants did not have first surgery date and were not included in Safety Set.|51
8875737|NCT01910298|9932476|FG000|COMPLETED|Overall Study||71
8875738|NCT01910298|9932477|FG001|COMPLETED|Overall Study||23
8875739|NCT01910298|9932476|FG000|NOT COMPLETED|Overall Study||5
8875740|NCT01910298|9932477|FG001|NOT COMPLETED|Overall Study||32
8875741|NCT01910311|9932483|FG000|STARTED|Period 1 (Days 1-2)||18
8875742|NCT01910311|9932483|FG000|Received Baricitinib|Period 1 (Days 1-2)||18
8875743|NCT01910311|9932483|FG000|COMPLETED|Period 1 (Days 1-2)||18
8875744|NCT01910311|9932483|FG000|NOT COMPLETED|Period 1 (Days 1-2)||0
8875745|NCT01910311|9932483|FG000|STARTED|Period 2 (Days 3-32)||18
8875746|NCT01910311|9932483|FG000|Received Baricitinib|Period 2 (Days 3-32)||18
8875747|NCT01910311|9932483|FG000|Received At Least 1 Dose of Rifampicin|Period 2 (Days 3-32)||18
8875748|NCT01910311|9932483|FG000|COMPLETED|Period 2 (Days 3-32)||18
8875749|NCT01910311|9932483|FG000|NOT COMPLETED|Period 2 (Days 3-32)||0
8875750|NCT01910519|9932493|FG000|STARTED|Overall Study||35
8875751|NCT01910519|9932494|FG001|STARTED|Overall Study||15
8875752|NCT01910519|9932493|FG000|COMPLETED|Overall Study||31
8875753|NCT01910519|9932494|FG001|COMPLETED|Overall Study||15
8875754|NCT01910519|9932493|FG000|NOT COMPLETED|Overall Study||4
8875755|NCT01910519|9932494|FG001|NOT COMPLETED|Overall Study||0
8875756|NCT01910636|9932502|FG000|STARTED|Overall Study||90
8875757|NCT01910636|9932503|FG001|STARTED|Overall Study||63
8875758|NCT01910636|9932502|FG000|COMPLETED|Overall Study||90
8875759|NCT01910636|9932503|FG001|COMPLETED|Overall Study||63
8875760|NCT01910636|9932502|FG000|NOT COMPLETED|Overall Study||0
8875761|NCT01910636|9932503|FG001|NOT COMPLETED|Overall Study||0
8963024|NCT02547935|10026571|FG000|COMPLETED|Overall Study||150
8963025|NCT02547935|10026572|FG001|COMPLETED|Overall Study||137
8963026|NCT02547935|10026573|FG002|COMPLETED|Overall Study||143
8963027|NCT02547935|10026571|FG000|NOT COMPLETED|Overall Study||5
8963028|NCT02547935|10026572|FG001|NOT COMPLETED|Overall Study||8
8963029|NCT02547935|10026573|FG002|NOT COMPLETED|Overall Study||5
8963030|NCT02547974|10026587|FG000|STARTED|Overall Study||15
8963031|NCT02547974|10026588|FG001|STARTED|Overall Study||31
8963032|NCT02547974|10026589|FG002|STARTED|Overall Study||30
8963033|NCT02547974|10026590|FG003|STARTED|Overall Study||44
8963034|NCT02547974|10026587|FG000|COMPLETED|Overall Study||14
8963035|NCT02547974|10026588|FG001|COMPLETED|Overall Study||31
8963036|NCT02547974|10026589|FG002|COMPLETED|Overall Study||30
8963037|NCT02547974|10026590|FG003|COMPLETED|Overall Study||44
8963038|NCT02547974|10026587|FG000|NOT COMPLETED|Overall Study||1
8963039|NCT02547974|10026588|FG001|NOT COMPLETED|Overall Study||0
8963040|NCT02547974|10026589|FG002|NOT COMPLETED|Overall Study||0
8963041|NCT02547974|10026590|FG003|NOT COMPLETED|Overall Study||0
8963042|NCT02547987|10026603|FG000|STARTED|Overall Study||25
8963043|NCT02547987|10026603|FG000|COMPLETED|Overall Study||22
8963044|NCT02547987|10026603|FG000|NOT COMPLETED|Overall Study||3
8570480|NCT00103857|9602681|FG005|STARTED|54-Week Base Study||176
8570481|NCT00103857|9602682|FG006|STARTED|54-Week Base Study|Results for the OLC are through Week 24. Results for the 6 randomized groups are through Week 54.|117
8570482|NCT00103857|9602676|FG000|COMPLETED|54-Week Base Study||122
8570483|NCT00103857|9602677|FG001|COMPLETED|54-Week Base Study||126
8570484|NCT00103857|9602678|FG002|COMPLETED|54-Week Base Study||135
8570485|NCT00103857|9602679|FG003|COMPLETED|54-Week Base Study||148
8875762|NCT01910688|9932509|FG000|STARTED|Overall Study||25
8875763|NCT01910688|9932509|FG000|3.5month|Overall Study||25
8875764|NCT01910688|9932509|FG000|2nd RFA Treatment|Overall Study||22
8875765|NCT01910688|9932509|FG000|7.5months|Overall Study||24
8875766|NCT01910688|9932509|FG000|3rd RFA Treatment|Overall Study||18
8875767|NCT01910688|9932509|FG000|12months|Overall Study||22
8875768|NCT01910688|9932509|FG000|COMPLETED|Overall Study||20
8875769|NCT01910688|9932509|FG000|NOT COMPLETED|Overall Study||5
8875770|NCT01910792|9932515|FG000|STARTED|Overall Study||9
8875771|NCT01910792|9932516|FG001|STARTED|Overall Study||10
8875772|NCT01910792|9932515|FG000|COMPLETED|Overall Study||9
8875773|NCT01910792|9932516|FG001|COMPLETED|Overall Study||10
8875774|NCT01910792|9932515|FG000|NOT COMPLETED|Overall Study||0
8875775|NCT01910792|9932516|FG001|NOT COMPLETED|Overall Study||0
8875776|NCT01910831|9932522|FG000|STARTED|Overall Study||20
8875777|NCT01910831|9932522|FG000|COMPLETED|Overall Study||19
8875778|NCT01910831|9932522|FG000|NOT COMPLETED|Overall Study||1
8875779|NCT01911065|9932529|FG000|STARTED|Overall Study||45
8875780|NCT01911065|9932530|FG001|STARTED|Overall Study||9
8875781|NCT01911065|9932529|FG000|COMPLETED|Overall Study||45
8875782|NCT01911065|9932530|FG001|COMPLETED|Overall Study||9
8875783|NCT01911065|9932529|FG000|NOT COMPLETED|Overall Study||0
8875784|NCT01911065|9932530|FG001|NOT COMPLETED|Overall Study||0
8875785|NCT01911169|9932538|FG000|STARTED|Overall Study||6
8875786|NCT01911169|9932539|FG001|STARTED|Overall Study||3
8875787|NCT01911169|9932538|FG000|COMPLETED|Overall Study||6
8875788|NCT01911169|9932539|FG001|COMPLETED|Overall Study||3
8875789|NCT01911169|9932538|FG000|NOT COMPLETED|Overall Study||0
8875790|NCT01911169|9932539|FG001|NOT COMPLETED|Overall Study||0
8875791|NCT01911221|9932545|FG000|STARTED|Overall Study||13
8875792|NCT01911221|9932545|FG000|COMPLETED|Overall Study||13
8875793|NCT01911221|9932545|FG000|NOT COMPLETED|Overall Study||0
8875794|NCT01911260|9932553|FG000|STARTED|Supplementation Period||50
8875795|NCT01911260|9932554|FG001|STARTED|Supplementation Period||50
8875796|NCT01911260|9932555|FG002|STARTED|Supplementation Period||49
8875797|NCT01911260|9932556|FG003|STARTED|Supplementation Period||50
8875798|NCT01911260|9932553|FG000|COMPLETED|Supplementation Period||40
8875799|NCT01911260|9932554|FG001|COMPLETED|Supplementation Period||38
8875800|NCT01911260|9932555|FG002|COMPLETED|Supplementation Period||39
8875801|NCT01911260|9932556|FG003|COMPLETED|Supplementation Period||42
8875802|NCT01911260|9932553|FG000|NOT COMPLETED|Supplementation Period||10
8875803|NCT01911260|9932554|FG001|NOT COMPLETED|Supplementation Period||12
8875804|NCT01911260|9932555|FG002|NOT COMPLETED|Supplementation Period||10
8963045|NCT02548078|10026609|FG000|STARTED|Overall Study||300
8963046|NCT02548078|10026610|FG001|STARTED|Overall Study||300
8963047|NCT02548078|10026609|FG000|COMPLETED|Overall Study||295
8570486|NCT00103857|9602680|FG004|COMPLETED|54-Week Base Study||141
8570487|NCT00103857|9602681|FG005|COMPLETED|54-Week Base Study||115
8570488|NCT00103857|9602682|FG006|COMPLETED|54-Week Base Study||79
8875805|NCT01911260|9932556|FG003|NOT COMPLETED|Supplementation Period||8
8875806|NCT01911260|9932553|FG000|STARTED|Follow-up Period||40
8875807|NCT01911260|9932554|FG001|STARTED|Follow-up Period||38
8875808|NCT01911260|9932555|FG002|STARTED|Follow-up Period||39
8875809|NCT01911260|9932556|FG003|STARTED|Follow-up Period||42
8875810|NCT01911260|9932553|FG000|COMPLETED|Follow-up Period||27
8875811|NCT01911260|9932554|FG001|COMPLETED|Follow-up Period||18
8875812|NCT01911260|9932555|FG002|COMPLETED|Follow-up Period||24
8963048|NCT02548078|10026610|FG001|COMPLETED|Overall Study||294
8963049|NCT02548078|10026609|FG000|NOT COMPLETED|Overall Study||5
8963050|NCT02548078|10026610|FG001|NOT COMPLETED|Overall Study||6
8963051|NCT02548156|10026623|FG000|STARTED|Period 1||5
8963052|NCT02548156|10026624|FG001|STARTED|Period 1||5
8963053|NCT02548156|10026625|FG002|STARTED|Period 1||4
8963054|NCT02548156|10026626|FG003|STARTED|Period 1||5
8963055|NCT02548156|10026627|FG004|STARTED|Period 1||5
8963056|NCT02548156|10026628|FG005|STARTED|Period 1||5
8963057|NCT02548156|10026623|FG000|COMPLETED|Period 1||5
8963058|NCT02548156|10026624|FG001|COMPLETED|Period 1||5
8963059|NCT02548156|10026625|FG002|COMPLETED|Period 1||4
8963060|NCT02548156|10026626|FG003|COMPLETED|Period 1||5
8963061|NCT02548156|10026627|FG004|COMPLETED|Period 1||5
8963062|NCT02548156|10026628|FG005|COMPLETED|Period 1||5
8963063|NCT02548156|10026623|FG000|NOT COMPLETED|Period 1||0
8963064|NCT02548156|10026624|FG001|NOT COMPLETED|Period 1||0
8963065|NCT02548156|10026625|FG002|NOT COMPLETED|Period 1||0
8963066|NCT02548156|10026626|FG003|NOT COMPLETED|Period 1||0
8963067|NCT02548156|10026627|FG004|NOT COMPLETED|Period 1||0
8963068|NCT02548156|10026628|FG005|NOT COMPLETED|Period 1||0
8963069|NCT02548156|10026623|FG000|STARTED|Washout Period 1||5
8963070|NCT02548156|10026624|FG001|STARTED|Washout Period 1||5
8875813|NCT01911260|9932556|FG003|COMPLETED|Follow-up Period||30
8875814|NCT01911260|9932553|FG000|NOT COMPLETED|Follow-up Period||13
8875815|NCT01911260|9932554|FG001|NOT COMPLETED|Follow-up Period||20
8875816|NCT01911260|9932555|FG002|NOT COMPLETED|Follow-up Period||15
8875817|NCT01911260|9932556|FG003|NOT COMPLETED|Follow-up Period||12
8875818|NCT01911273|9932568|FG000|STARTED|Overall Study||1
8875819|NCT01911273|9932569|FG001|STARTED|Overall Study||2
8875820|NCT01911273|9932568|FG000|COMPLETED|Overall Study||0
8875821|NCT01911273|9932569|FG001|COMPLETED|Overall Study||0
8875822|NCT01911273|9932568|FG000|NOT COMPLETED|Overall Study||1
8875823|NCT01911273|9932569|FG001|NOT COMPLETED|Overall Study||2
8875824|NCT01911351|9932577|FG000|STARTED|Overall Study||39
8875825|NCT01911351|9932578|FG001|STARTED|Overall Study||43
8875826|NCT01911351|9932577|FG000|COMPLETED|Overall Study||39
8875827|NCT01911351|9932578|FG001|COMPLETED|Overall Study||43
8875828|NCT01911351|9932577|FG000|NOT COMPLETED|Overall Study||0
8875829|NCT01911351|9932578|FG001|NOT COMPLETED|Overall Study||0
8875830|NCT01911390|9932588|FG000|STARTED|Overall Study||10
8963071|NCT02548156|10026625|FG002|STARTED|Washout Period 1||4
8963072|NCT02548156|10026626|FG003|STARTED|Washout Period 1||5
8963073|NCT02548156|10026627|FG004|STARTED|Washout Period 1||5
8963074|NCT02548156|10026628|FG005|STARTED|Washout Period 1||5
8963075|NCT02548156|10026623|FG000|COMPLETED|Washout Period 1||5
8963076|NCT02548156|10026624|FG001|COMPLETED|Washout Period 1||5
8963077|NCT02548156|10026625|FG002|COMPLETED|Washout Period 1||4
8963078|NCT02548156|10026626|FG003|COMPLETED|Washout Period 1||5
8963079|NCT02548156|10026627|FG004|COMPLETED|Washout Period 1||4
8963080|NCT02548156|10026628|FG005|COMPLETED|Washout Period 1||5
8963081|NCT02548156|10026623|FG000|NOT COMPLETED|Washout Period 1||0
8963082|NCT02548156|10026624|FG001|NOT COMPLETED|Washout Period 1||0
8963083|NCT02548156|10026625|FG002|NOT COMPLETED|Washout Period 1||0
8963084|NCT02548156|10026626|FG003|NOT COMPLETED|Washout Period 1||0
8963085|NCT02548156|10026627|FG004|NOT COMPLETED|Washout Period 1||1
8963086|NCT02548156|10026628|FG005|NOT COMPLETED|Washout Period 1||0
8963087|NCT02548156|10026623|FG000|STARTED|Period 2||5
8963088|NCT02548156|10026624|FG001|STARTED|Period 2||5
8963089|NCT02548156|10026625|FG002|STARTED|Period 2||4
8963090|NCT02548156|10026626|FG003|STARTED|Period 2||5
8963091|NCT02548156|10026627|FG004|STARTED|Period 2||4
8963092|NCT02548156|10026628|FG005|STARTED|Period 2||5
8963093|NCT02548156|10026623|FG000|COMPLETED|Period 2||5
8963094|NCT02548156|10026624|FG001|COMPLETED|Period 2||5
8963095|NCT02548156|10026625|FG002|COMPLETED|Period 2||4
8963096|NCT02548156|10026626|FG003|COMPLETED|Period 2||5
8963097|NCT02548156|10026627|FG004|COMPLETED|Period 2||4
8963098|NCT02548156|10026628|FG005|COMPLETED|Period 2||5
8963099|NCT02548156|10026623|FG000|NOT COMPLETED|Period 2||0
8963100|NCT02548156|10026624|FG001|NOT COMPLETED|Period 2||0
8963101|NCT02548156|10026625|FG002|NOT COMPLETED|Period 2||0
8963102|NCT02548156|10026626|FG003|NOT COMPLETED|Period 2||0
8963103|NCT02548156|10026627|FG004|NOT COMPLETED|Period 2||0
8963104|NCT02548156|10026628|FG005|NOT COMPLETED|Period 2||0
8963105|NCT02548156|10026623|FG000|STARTED|Washout Period 2||5
8963106|NCT02548156|10026624|FG001|STARTED|Washout Period 2||5
8963107|NCT02548156|10026625|FG002|STARTED|Washout Period 2||4
8963108|NCT02548156|10026626|FG003|STARTED|Washout Period 2||5
8875831|NCT01911390|9932589|FG001|STARTED|Overall Study||10
8875832|NCT01911390|9932590|FG002|STARTED|Overall Study||10
8875833|NCT01911390|9932591|FG003|STARTED|Overall Study||11
8875834|NCT01911390|9932588|FG000|COMPLETED|Overall Study||9
8875835|NCT01911390|9932589|FG001|COMPLETED|Overall Study||10
8963109|NCT02548156|10026627|FG004|STARTED|Washout Period 2||4
8963110|NCT02548156|10026628|FG005|STARTED|Washout Period 2||5
8963111|NCT02548156|10026623|FG000|COMPLETED|Washout Period 2||5
8963112|NCT02548156|10026624|FG001|COMPLETED|Washout Period 2||5
8963113|NCT02548156|10026625|FG002|COMPLETED|Washout Period 2||4
8963114|NCT02548156|10026626|FG003|COMPLETED|Washout Period 2||5
8963115|NCT02548156|10026627|FG004|COMPLETED|Washout Period 2||4
8963116|NCT02548156|10026628|FG005|COMPLETED|Washout Period 2||5
8963117|NCT02548156|10026623|FG000|NOT COMPLETED|Washout Period 2||0
8963118|NCT02548156|10026624|FG001|NOT COMPLETED|Washout Period 2||0
8963119|NCT02548156|10026625|FG002|NOT COMPLETED|Washout Period 2||0
8963120|NCT02548156|10026626|FG003|NOT COMPLETED|Washout Period 2||0
8963121|NCT02548156|10026627|FG004|NOT COMPLETED|Washout Period 2||0
8963122|NCT02548156|10026628|FG005|NOT COMPLETED|Washout Period 2||0
8963123|NCT02548156|10026623|FG000|STARTED|Period 3||5
8963124|NCT02548156|10026624|FG001|STARTED|Period 3||5
8963125|NCT02548156|10026625|FG002|STARTED|Period 3||4
8963126|NCT02548156|10026626|FG003|STARTED|Period 3||5
8963127|NCT02548156|10026627|FG004|STARTED|Period 3||4
8963128|NCT02548156|10026628|FG005|STARTED|Period 3||5
8963129|NCT02548156|10026623|FG000|COMPLETED|Period 3||5
8963130|NCT02548156|10026624|FG001|COMPLETED|Period 3||5
8963131|NCT02548156|10026625|FG002|COMPLETED|Period 3||4
8875836|NCT01911390|9932590|FG002|COMPLETED|Overall Study||9
8875837|NCT01911390|9932591|FG003|COMPLETED|Overall Study||10
8875838|NCT01911390|9932588|FG000|NOT COMPLETED|Overall Study||1
8875839|NCT01911390|9932589|FG001|NOT COMPLETED|Overall Study||0
8875840|NCT01911390|9932590|FG002|NOT COMPLETED|Overall Study||1
8875841|NCT01911390|9932591|FG003|NOT COMPLETED|Overall Study||1
8875842|NCT01911403|9932603|FG000|STARTED|Overall Study||61
8875843|NCT01911403|9932604|FG001|STARTED|Overall Study||62
8875844|NCT01911403|9932603|FG000|COMPLETED|Overall Study||52
8875845|NCT01911403|9932604|FG001|COMPLETED|Overall Study||59
8875846|NCT01911403|9932603|FG000|NOT COMPLETED|Overall Study||9
8875847|NCT01911403|9932604|FG001|NOT COMPLETED|Overall Study||3
8875848|NCT01911429|9932613|FG000|STARTED|Overall Study||108
8875849|NCT01911429|9932614|FG001|STARTED|Overall Study|Subjects received lurasidone 40/mg day from Days 1-3, and 80mg/day from days 4 to Week 6 visit|106
8875850|NCT01911429|9932615|FG002|STARTED|Overall Study|one subject randomized to Placebo group was never dosed for study medication, making the total 112|113
8875851|NCT01911429|9932613|FG000|COMPLETED|Overall Study||96
8875852|NCT01911429|9932614|FG001|COMPLETED|Overall Study||96
8875853|NCT01911429|9932615|FG002|COMPLETED|Overall Study||93
8875854|NCT01911429|9932613|FG000|NOT COMPLETED|Overall Study||12
8875855|NCT01911429|9932614|FG001|NOT COMPLETED|Overall Study||10
8875856|NCT01911429|9932615|FG002|NOT COMPLETED|Overall Study||20
8875857|NCT01911442|9932626|FG000|STARTED|Overall Study||49
8875858|NCT01911442|9932627|FG001|STARTED|Overall Study||51
8875859|NCT01911442|9932628|FG002|STARTED|Overall Study||50
8875860|NCT01911442|9932626|FG000|COMPLETED|Overall Study||43
8875861|NCT01911442|9932627|FG001|COMPLETED|Overall Study||47
8875862|NCT01911442|9932628|FG002|COMPLETED|Overall Study||38
8875863|NCT01911442|9932626|FG000|NOT COMPLETED|Overall Study||6
8875864|NCT01911442|9932627|FG001|NOT COMPLETED|Overall Study||4
8875865|NCT01911442|9932628|FG002|NOT COMPLETED|Overall Study||12
8875866|NCT01911546|9932640|FG000|STARTED|Overall Study||20
8875867|NCT01911546|9932640|FG000|COMPLETED|Overall Study||14
8875868|NCT01911546|9932640|FG000|NOT COMPLETED|Overall Study||6
8875869|NCT01911689|9932646|FG000|STARTED|Overall Study||117
8875870|NCT01911689|9932647|FG001|STARTED|Overall Study||51
8875871|NCT01911689|9932646|FG000|COMPLETED|Overall Study||117
8875872|NCT01911689|9932647|FG001|COMPLETED|Overall Study||51
8875873|NCT01911689|9932646|FG000|NOT COMPLETED|Overall Study||0
8875874|NCT01911689|9932647|FG001|NOT COMPLETED|Overall Study||0
8875875|NCT01911780|9932662|FG000|STARTED|Double-blind Period (8 Weeks)||68
8875876|NCT01911780|9932663|FG001|STARTED|Double-blind Period (8 Weeks)||64
8875877|NCT01911780|9932662|FG000|COMPLETED|Double-blind Period (8 Weeks)||65
8875878|NCT01911780|9932663|FG001|COMPLETED|Double-blind Period (8 Weeks)||61
8875879|NCT01911780|9932662|FG000|NOT COMPLETED|Double-blind Period (8 Weeks)||3
8875880|NCT01911780|9932663|FG001|NOT COMPLETED|Double-blind Period (8 Weeks)||3
8875881|NCT01911780|9932662|FG000|STARTED|Extension Period (52 Weeks)||65
8875882|NCT01911780|9932663|FG001|STARTED|Extension Period (52 Weeks)||61
8875883|NCT01911780|9932662|FG000|COMPLETED|Extension Period (52 Weeks)||61
8875884|NCT01911780|9932663|FG001|COMPLETED|Extension Period (52 Weeks)||58
8875885|NCT01911780|9932662|FG000|NOT COMPLETED|Extension Period (52 Weeks)||4
8875886|NCT01911780|9932663|FG001|NOT COMPLETED|Extension Period (52 Weeks)||3
8875887|NCT01911819|9932676|FG000|STARTED|Overall Study||10
8875888|NCT01911819|9932677|FG001|STARTED|Overall Study|One of 10 sinuses was replaced to another sinus due to infection.|11
8875889|NCT01911819|9932678|FG002|STARTED|Overall Study||10
8875890|NCT01911819|9932676|FG000|COMPLETED|Overall Study||9
8875891|NCT01911819|9932677|FG001|COMPLETED|Overall Study||9
8875892|NCT01911819|9932678|FG002|COMPLETED|Overall Study||10
8875893|NCT01911819|9932676|FG000|NOT COMPLETED|Overall Study||1
8875894|NCT01911819|9932677|FG001|NOT COMPLETED|Overall Study||2
8875895|NCT01911819|9932678|FG002|NOT COMPLETED|Overall Study||0
8875896|NCT01911845|9932686|FG000|STARTED|Overall Study||38
8875897|NCT01911845|9932686|FG000|Completed Study Drug|Overall Study||37
8875898|NCT01911845|9932686|FG000|COMPLETED|Overall Study||32
8875899|NCT01911845|9932686|FG000|NOT COMPLETED|Overall Study||6
8875900|NCT01911910|9932694|FG000|STARTED|Overall Study||197
8875901|NCT01911910|9932695|FG001|STARTED|Overall Study||205
8875902|NCT01911910|9932694|FG000|COMPLETED|Overall Study||184
8875903|NCT01911910|9932695|FG001|COMPLETED|Overall Study||194
8875904|NCT01911910|9932694|FG000|NOT COMPLETED|Overall Study||13
8875905|NCT01911910|9932695|FG001|NOT COMPLETED|Overall Study||11
8963132|NCT02548156|10026626|FG003|COMPLETED|Period 3||5
8963133|NCT02548156|10026627|FG004|COMPLETED|Period 3||4
8963134|NCT02548156|10026628|FG005|COMPLETED|Period 3||5
8963135|NCT02548156|10026623|FG000|NOT COMPLETED|Period 3||0
8963136|NCT02548156|10026624|FG001|NOT COMPLETED|Period 3||0
8963137|NCT02548156|10026625|FG002|NOT COMPLETED|Period 3||0
8963138|NCT02548156|10026626|FG003|NOT COMPLETED|Period 3||0
8963139|NCT02548156|10026627|FG004|NOT COMPLETED|Period 3||0
8963140|NCT02548156|10026628|FG005|NOT COMPLETED|Period 3||0
8963141|NCT02548312|10026644|FG000|STARTED|Overall Study||133
8963142|NCT02548312|10026645|FG001|STARTED|Overall Study||133
8963143|NCT02548312|10026646|FG002|STARTED|Overall Study||134
8963144|NCT02548312|10026647|FG003|STARTED|Overall Study||133
8963145|NCT02548312|10026648|FG004|STARTED|Overall Study||133
8963146|NCT02548312|10026649|FG005|STARTED|Overall Study||133
8963147|NCT02548312|10026650|FG006|STARTED|Overall Study||133
8963148|NCT02548312|10026651|FG007|STARTED|Overall Study||133
8963149|NCT02548312|10026644|FG000|COMPLETED|Overall Study||100
8963150|NCT02548312|10026645|FG001|COMPLETED|Overall Study||90
8963151|NCT02548312|10026646|FG002|COMPLETED|Overall Study||96
8963152|NCT02548312|10026647|FG003|COMPLETED|Overall Study||87
8963153|NCT02548312|10026648|FG004|COMPLETED|Overall Study||99
8963154|NCT02548312|10026649|FG005|COMPLETED|Overall Study||93
8963155|NCT02548312|10026650|FG006|COMPLETED|Overall Study||93
8963156|NCT02548312|10026651|FG007|COMPLETED|Overall Study||91
8963157|NCT02548312|10026644|FG000|NOT COMPLETED|Overall Study||33
8963158|NCT02548312|10026645|FG001|NOT COMPLETED|Overall Study||43
8963159|NCT02548312|10026646|FG002|NOT COMPLETED|Overall Study||38
8963160|NCT02548312|10026647|FG003|NOT COMPLETED|Overall Study||46
8963161|NCT02548312|10026648|FG004|NOT COMPLETED|Overall Study||34
8963162|NCT02548312|10026649|FG005|NOT COMPLETED|Overall Study||40
8963163|NCT02548312|10026650|FG006|NOT COMPLETED|Overall Study||40
8963164|NCT02548312|10026651|FG007|NOT COMPLETED|Overall Study||42
8963165|NCT02548455|10026669|FG000|STARTED|Overall Study|A total of 499 subjects were enrolled at 31 investigational sites.|499
8963166|NCT02548455|10026669|FG000|Completed Pre-Discharge|Overall Study||484
8963167|NCT02548455|10026669|FG000|Completed 6-Month Follow-up|Overall Study||259
8963168|NCT02548455|10026669|FG000|Completed 12-Month Follow-up|Overall Study|Study completed prior to all subjects reaching the 6- and 12-month visits.|61
8963169|NCT02548455|10026669|FG000|COMPLETED|Overall Study|Completed 6-Month Follow-up|259
8963170|NCT02548455|10026669|FG000|NOT COMPLETED|Overall Study||240
8963171|NCT02548585|10026680|FG000|STARTED|Overall Study||45
8875906|NCT01912222|9932704|FG000|STARTED|Part A: Pharmacokinetic Period||13
8875907|NCT01912222|9932705|FG001|STARTED|Part A: Pharmacokinetic Period||15
8875908|NCT01912222|9932706|FG002|STARTED|Part A: Pharmacokinetic Period||20
8875909|NCT01912222|9932704|FG000|COMPLETED|Part A: Pharmacokinetic Period||12
8875910|NCT01912222|9932705|FG001|COMPLETED|Part A: Pharmacokinetic Period||13
8875911|NCT01912222|9932706|FG002|COMPLETED|Part A: Pharmacokinetic Period||18
8875912|NCT01912222|9932704|FG000|NOT COMPLETED|Part A: Pharmacokinetic Period||1
8875913|NCT01912222|9932705|FG001|NOT COMPLETED|Part A: Pharmacokinetic Period||2
8875914|NCT01912222|9932706|FG002|NOT COMPLETED|Part A: Pharmacokinetic Period||2
8963172|NCT02548585|10026681|FG001|STARTED|Overall Study||6
8963173|NCT02548585|10026682|FG002|STARTED|Overall Study||6
8963174|NCT02548585|10026683|FG003|STARTED|Overall Study||7
8963175|NCT02548585|10026684|FG004|STARTED|Overall Study||25
8963176|NCT02548585|10026685|FG005|STARTED|Overall Study||12
8963177|NCT02548585|10026686|FG006|STARTED|Overall Study||12
8963178|NCT02548585|10026680|FG000|Treated|Overall Study||45
8963179|NCT02548585|10026681|FG001|Treated|Overall Study||6
8963180|NCT02548585|10026682|FG002|Treated|Overall Study||6
8963181|NCT02548585|10026683|FG003|Treated|Overall Study||7
8963182|NCT02548585|10026684|FG004|Treated|Overall Study||25
8963183|NCT02548585|10026685|FG005|Treated|Overall Study||11
8963184|NCT02548585|10026686|FG006|Treated|Overall Study||12
8963185|NCT02548585|10026680|FG000|COMPLETED|Overall Study||43
8963186|NCT02548585|10026681|FG001|COMPLETED|Overall Study||6
8963187|NCT02548585|10026682|FG002|COMPLETED|Overall Study||6
8963188|NCT02548585|10026683|FG003|COMPLETED|Overall Study||5
8963189|NCT02548585|10026684|FG004|COMPLETED|Overall Study||22
8963190|NCT02548585|10026685|FG005|COMPLETED|Overall Study||10
8963191|NCT02548585|10026686|FG006|COMPLETED|Overall Study||11
8963192|NCT02548585|10026680|FG000|NOT COMPLETED|Overall Study||2
8963193|NCT02548585|10026681|FG001|NOT COMPLETED|Overall Study||0
8963194|NCT02548585|10026682|FG002|NOT COMPLETED|Overall Study||0
8963195|NCT02548585|10026683|FG003|NOT COMPLETED|Overall Study||2
8963196|NCT02548585|10026684|FG004|NOT COMPLETED|Overall Study||3
8963197|NCT02548585|10026685|FG005|NOT COMPLETED|Overall Study||2
8963198|NCT02548585|10026686|FG006|NOT COMPLETED|Overall Study||1
8963199|NCT02548650|10026729|FG000|STARTED|Triple Therapy||30
8963200|NCT02548650|10026730|FG001|STARTED|Triple Therapy||36
8963201|NCT02548650|10026729|FG000|COMPLETED|Triple Therapy||29
8963202|NCT02548650|10026730|FG001|COMPLETED|Triple Therapy||32
8963203|NCT02548650|10026729|FG000|NOT COMPLETED|Triple Therapy||1
8963204|NCT02548650|10026730|FG001|NOT COMPLETED|Triple Therapy||4
8963205|NCT02548650|10026729|FG000|STARTED|Double Therapy||29
8963206|NCT02548650|10026730|FG001|STARTED|Double Therapy||32
8963207|NCT02548650|10026729|FG000|COMPLETED|Double Therapy||28
8963208|NCT02548650|10026730|FG001|COMPLETED|Double Therapy||30
8963209|NCT02548650|10026729|FG000|NOT COMPLETED|Double Therapy||1
8963210|NCT02548650|10026730|FG001|NOT COMPLETED|Double Therapy||2
8963211|NCT02548728|10026738|FG000|STARTED|Overall Study||6
8963212|NCT02548728|10026739|FG001|STARTED|Overall Study||6
8963213|NCT02548728|10026738|FG000|COMPLETED|Overall Study||6
8963214|NCT02548728|10026739|FG001|COMPLETED|Overall Study||6
8963215|NCT02548728|10026738|FG000|NOT COMPLETED|Overall Study||0
8963216|NCT02548728|10026739|FG001|NOT COMPLETED|Overall Study||0
8963217|NCT02548845|10026745|FG000|STARTED|Overall Study||70
8963218|NCT02548845|10026745|FG000|COMPLETED|Overall Study||70
8963219|NCT02548845|10026745|FG000|NOT COMPLETED|Overall Study||0
8963220|NCT02548910|10026755|FG000|STARTED|Overall Study||31
8963221|NCT02548910|10026756|FG001|STARTED|Overall Study||31
8963222|NCT02548910|10026755|FG000|COMPLETED|Overall Study||31
8963223|NCT02548910|10026756|FG001|COMPLETED|Overall Study||31
8963224|NCT02548910|10026755|FG000|NOT COMPLETED|Overall Study||0
8963225|NCT02548910|10026756|FG001|NOT COMPLETED|Overall Study||0
8963226|NCT02548949|10026763|FG000|STARTED|Overall Study||700
8963227|NCT02548949|10026763|FG000|COMPLETED|Overall Study||700
8963228|NCT02548949|10026763|FG000|NOT COMPLETED|Overall Study||0
8963229|NCT02548962|10026769|FG000|STARTED|Overall Study||8
8963230|NCT02548962|10026770|FG001|STARTED|Overall Study||3
8963231|NCT02548962|10026769|FG000|COMPLETED|Overall Study||7
8963232|NCT02548962|10026770|FG001|COMPLETED|Overall Study||3
8963233|NCT02548962|10026769|FG000|NOT COMPLETED|Overall Study||1
8963234|NCT02548962|10026770|FG001|NOT COMPLETED|Overall Study||0
8963235|NCT02549014|10026780|FG000|STARTED|Overall Study||8
8963236|NCT02549014|10026781|FG001|STARTED|Overall Study||8
8963237|NCT02549014|10026780|FG000|COMPLETED|Overall Study||8
8963238|NCT02549014|10026781|FG001|COMPLETED|Overall Study||8
8963239|NCT02549014|10026780|FG000|NOT COMPLETED|Overall Study||0
8963240|NCT02549014|10026781|FG001|NOT COMPLETED|Overall Study||0
8963241|NCT02549027|10026805|FG000|STARTED|Period 1 - MK-1064 or Placebo||5
8963242|NCT02549027|10026806|FG001|STARTED|Period 1 - MK-1064 or Placebo||5
8963243|NCT02549027|10026807|FG002|STARTED|Period 1 - MK-1064 or Placebo||5
8963244|NCT02549027|10026808|FG003|STARTED|Period 1 - MK-1064 or Placebo||5
8963245|NCT02549027|10026809|FG004|STARTED|Period 1 - MK-1064 or Placebo||0
8963246|NCT02549027|10026810|FG005|STARTED|Period 1 - MK-1064 or Placebo||0
8963247|NCT02549027|10026805|FG000|COMPLETED|Period 1 - MK-1064 or Placebo||5
8963248|NCT02549027|10026806|FG001|COMPLETED|Period 1 - MK-1064 or Placebo||5
8963249|NCT02549027|10026807|FG002|COMPLETED|Period 1 - MK-1064 or Placebo||5
8963250|NCT02549027|10026808|FG003|COMPLETED|Period 1 - MK-1064 or Placebo||5
8963251|NCT02549027|10026809|FG004|COMPLETED|Period 1 - MK-1064 or Placebo||0
8963252|NCT02549027|10026810|FG005|COMPLETED|Period 1 - MK-1064 or Placebo||0
8963253|NCT02549027|10026805|FG000|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
8963254|NCT02549027|10026806|FG001|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
8963255|NCT02549027|10026807|FG002|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
8963256|NCT02549027|10026808|FG003|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
8963257|NCT02549027|10026809|FG004|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
8963258|NCT02549027|10026810|FG005|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
8963259|NCT02549027|10026805|FG000|STARTED|Washout After Period 1||5
8963260|NCT02549027|10026806|FG001|STARTED|Washout After Period 1||5
8963261|NCT02549027|10026807|FG002|STARTED|Washout After Period 1||5
8963262|NCT02549027|10026808|FG003|STARTED|Washout After Period 1||5
8963263|NCT02549027|10026809|FG004|STARTED|Washout After Period 1||0
8963264|NCT02549027|10026810|FG005|STARTED|Washout After Period 1||0
8963265|NCT02549027|10026805|FG000|COMPLETED|Washout After Period 1||5
8963266|NCT02549027|10026806|FG001|COMPLETED|Washout After Period 1||5
8963267|NCT02549027|10026807|FG002|COMPLETED|Washout After Period 1||5
8963268|NCT02549027|10026808|FG003|COMPLETED|Washout After Period 1||5
8963269|NCT02549027|10026809|FG004|COMPLETED|Washout After Period 1||0
8963270|NCT02549027|10026810|FG005|COMPLETED|Washout After Period 1||0
8963271|NCT02549027|10026805|FG000|NOT COMPLETED|Washout After Period 1||0
8963272|NCT02549027|10026806|FG001|NOT COMPLETED|Washout After Period 1||0
8963273|NCT02549027|10026807|FG002|NOT COMPLETED|Washout After Period 1||0
8963274|NCT02549027|10026808|FG003|NOT COMPLETED|Washout After Period 1||0
8963275|NCT02549027|10026809|FG004|NOT COMPLETED|Washout After Period 1||0
8963276|NCT02549027|10026810|FG005|NOT COMPLETED|Washout After Period 1||0
8963277|NCT02549027|10026805|FG000|STARTED|Period 2 - MK-1064 or Placebo||5
8963278|NCT02549027|10026806|FG001|STARTED|Period 2 - MK-1064 or Placebo||5
8963279|NCT02549027|10026807|FG002|STARTED|Period 2 - MK-1064 or Placebo||5
8963280|NCT02549027|10026808|FG003|STARTED|Period 2 - MK-1064 or Placebo||5
8963281|NCT02549027|10026809|FG004|STARTED|Period 2 - MK-1064 or Placebo||0
8963282|NCT02549027|10026810|FG005|STARTED|Period 2 - MK-1064 or Placebo||0
8963283|NCT02549027|10026805|FG000|COMPLETED|Period 2 - MK-1064 or Placebo||5
8963284|NCT02549027|10026806|FG001|COMPLETED|Period 2 - MK-1064 or Placebo||5
8963285|NCT02549027|10026807|FG002|COMPLETED|Period 2 - MK-1064 or Placebo||5
8963286|NCT02549027|10026808|FG003|COMPLETED|Period 2 - MK-1064 or Placebo||5
8963287|NCT02549027|10026809|FG004|COMPLETED|Period 2 - MK-1064 or Placebo||0
8963288|NCT02549027|10026810|FG005|COMPLETED|Period 2 - MK-1064 or Placebo||0
8963289|NCT02549027|10026805|FG000|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
8963290|NCT02549027|10026806|FG001|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
8963291|NCT02549027|10026807|FG002|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
8963292|NCT02549027|10026808|FG003|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
8963293|NCT02549027|10026809|FG004|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
8963294|NCT02549027|10026810|FG005|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
8963295|NCT02549027|10026805|FG000|STARTED|Washout After Period 2||5
8963296|NCT02549027|10026806|FG001|STARTED|Washout After Period 2||5
8875915|NCT01912222|9932704|FG000|STARTED|Part B: Treatment Period||13
8875916|NCT01912222|9932705|FG001|STARTED|Part B: Treatment Period||15
8875917|NCT01912222|9932706|FG002|STARTED|Part B: Treatment Period||20
8875918|NCT01912222|9932704|FG000|COMPLETED|Part B: Treatment Period||0
8875919|NCT01912222|9932705|FG001|COMPLETED|Part B: Treatment Period||0
8963297|NCT02549027|10026807|FG002|STARTED|Washout After Period 2||5
8963298|NCT02549027|10026808|FG003|STARTED|Washout After Period 2||5
8963299|NCT02549027|10026809|FG004|STARTED|Washout After Period 2||0
8963300|NCT02549027|10026810|FG005|STARTED|Washout After Period 2||0
8963301|NCT02549027|10026805|FG000|COMPLETED|Washout After Period 2||5
8963302|NCT02549027|10026806|FG001|COMPLETED|Washout After Period 2||5
8963303|NCT02549027|10026807|FG002|COMPLETED|Washout After Period 2||5
8963304|NCT02549027|10026808|FG003|COMPLETED|Washout After Period 2||5
8963305|NCT02549027|10026809|FG004|COMPLETED|Washout After Period 2||0
8963306|NCT02549027|10026810|FG005|COMPLETED|Washout After Period 2||0
8963307|NCT02549027|10026805|FG000|NOT COMPLETED|Washout After Period 2||0
8963308|NCT02549027|10026806|FG001|NOT COMPLETED|Washout After Period 2||0
8963309|NCT02549027|10026807|FG002|NOT COMPLETED|Washout After Period 2||0
8963310|NCT02549027|10026808|FG003|NOT COMPLETED|Washout After Period 2||0
8875920|NCT01912222|9932706|FG002|COMPLETED|Part B: Treatment Period||0
8875921|NCT01912222|9932704|FG000|NOT COMPLETED|Part B: Treatment Period||13
8875922|NCT01912222|9932705|FG001|NOT COMPLETED|Part B: Treatment Period||15
8875923|NCT01912222|9932706|FG002|NOT COMPLETED|Part B: Treatment Period||20
8875924|NCT01912274|9932715|FG000|STARTED|Overall Study||50
8875925|NCT01912274|9932715|FG000|COMPLETED|Overall Study||50
8875926|NCT01912274|9932715|FG000|NOT COMPLETED|Overall Study||0
8875927|NCT01912287|9932722|FG000|STARTED|Overall Study||93
8875928|NCT01912287|9932723|FG001|STARTED|Overall Study||90
8875929|NCT01912287|9932724|FG002|STARTED|Overall Study||43
8875930|NCT01912287|9932722|FG000|COMPLETED|Overall Study||60
8875931|NCT01912287|9932723|FG001|COMPLETED|Overall Study||67
8875932|NCT01912287|9932724|FG002|COMPLETED|Overall Study||28
8875933|NCT01912287|9932722|FG000|NOT COMPLETED|Overall Study||33
8875934|NCT01912287|9932723|FG001|NOT COMPLETED|Overall Study||23
8875935|NCT01912287|9932724|FG002|NOT COMPLETED|Overall Study||15
8875936|NCT01912339|9932734|FG000|STARTED|Blinded (0 to 3 Months)||136
8875937|NCT01912339|9932735|FG001|STARTED|Blinded (0 to 3 Months)||61
8875938|NCT01912339|9932736|FG002|STARTED|Blinded (0 to 3 Months)||0
8875939|NCT01912339|9932734|FG000|COMPLETED|Blinded (0 to 3 Months)||134
8875940|NCT01912339|9932735|FG001|COMPLETED|Blinded (0 to 3 Months)||61
8875941|NCT01912339|9932736|FG002|COMPLETED|Blinded (0 to 3 Months)||0
8875942|NCT01912339|9932734|FG000|NOT COMPLETED|Blinded (0 to 3 Months)||2
8875943|NCT01912339|9932735|FG001|NOT COMPLETED|Blinded (0 to 3 Months)||0
8875944|NCT01912339|9932736|FG002|NOT COMPLETED|Blinded (0 to 3 Months)||0
8875945|NCT01912339|9932734|FG000|STARTED|Unblinded (3 to 6 Months/Crossover)||134
8875946|NCT01912339|9932735|FG001|STARTED|Unblinded (3 to 6 Months/Crossover)||61
8875947|NCT01912339|9932736|FG002|STARTED|Unblinded (3 to 6 Months/Crossover)||0
8875948|NCT01912339|9932734|FG000|COMPLETED|Unblinded (3 to 6 Months/Crossover)|Still in study|133
8875949|NCT01912339|9932735|FG001|COMPLETED|Unblinded (3 to 6 Months/Crossover)|Of the 61 subjects, there were 53 crossover subjects and 8 that completed their study participation.|61
8875950|NCT01912339|9932736|FG002|COMPLETED|Unblinded (3 to 6 Months/Crossover)|Still in study|0
8875951|NCT01912339|9932734|FG000|NOT COMPLETED|Unblinded (3 to 6 Months/Crossover)||1
8875952|NCT01912339|9932735|FG001|NOT COMPLETED|Unblinded (3 to 6 Months/Crossover)||0
8875953|NCT01912339|9932736|FG002|NOT COMPLETED|Unblinded (3 to 6 Months/Crossover)||0
8875954|NCT01912339|9932734|FG000|STARTED|Unblinded (6 Months/Crossover to 5 Yrs)||133
8875955|NCT01912339|9932735|FG001|STARTED|Unblinded (6 Months/Crossover to 5 Yrs)|All subjects for the control group either completed study or crossed over.|0
8875956|NCT01912339|9932736|FG002|STARTED|Unblinded (6 Months/Crossover to 5 Yrs)|Control subjects that have crossed over.|53
8963311|NCT02549027|10026809|FG004|NOT COMPLETED|Washout After Period 2||0
8963312|NCT02549027|10026810|FG005|NOT COMPLETED|Washout After Period 2||0
8963313|NCT02549027|10026805|FG000|STARTED|Period 3 - MK-1064 or Placebo||5
8963314|NCT02549027|10026806|FG001|STARTED|Period 3 - MK-1064 or Placebo||5
8963315|NCT02549027|10026807|FG002|STARTED|Period 3 - MK-1064 or Placebo||5
8963316|NCT02549027|10026808|FG003|STARTED|Period 3 - MK-1064 or Placebo||5
8963317|NCT02549027|10026809|FG004|STARTED|Period 3 - MK-1064 or Placebo||0
8963318|NCT02549027|10026810|FG005|STARTED|Period 3 - MK-1064 or Placebo||0
8963319|NCT02549027|10026805|FG000|COMPLETED|Period 3 - MK-1064 or Placebo||5
8963320|NCT02549027|10026806|FG001|COMPLETED|Period 3 - MK-1064 or Placebo||5
8963321|NCT02549027|10026807|FG002|COMPLETED|Period 3 - MK-1064 or Placebo||5
8963322|NCT02549027|10026808|FG003|COMPLETED|Period 3 - MK-1064 or Placebo||5
8963323|NCT02549027|10026809|FG004|COMPLETED|Period 3 - MK-1064 or Placebo||0
8963324|NCT02549027|10026810|FG005|COMPLETED|Period 3 - MK-1064 or Placebo||0
8963325|NCT02549027|10026805|FG000|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
8963326|NCT02549027|10026806|FG001|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
8875957|NCT01912339|9932734|FG000|COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
8875958|NCT01912339|9932735|FG001|COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
8875959|NCT01912339|9932736|FG002|COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
8875960|NCT01912339|9932734|FG000|NOT COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||133
8875961|NCT01912339|9932735|FG001|NOT COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
8875962|NCT01912339|9932736|FG002|NOT COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||53
8875963|NCT01912352|9932742|FG000|STARTED|Overall Study||83
8875964|NCT01912352|9932742|FG000|COMPLETED|Overall Study||78
8875965|NCT01912352|9932742|FG000|NOT COMPLETED|Overall Study||5
8875966|NCT01912456|9932748|FG000|STARTED|Period 1||22
8875967|NCT01912456|9932749|FG001|STARTED|Period 1||23
8875968|NCT01912456|9932750|FG002|STARTED|Period 1||23
8875969|NCT01912456|9932751|FG003|STARTED|Period 1||22
8875970|NCT01912456|9932748|FG000|COMPLETED|Period 1||20
8875971|NCT01912456|9932749|FG001|COMPLETED|Period 1||22
8875972|NCT01912456|9932750|FG002|COMPLETED|Period 1||21
8875973|NCT01912456|9932751|FG003|COMPLETED|Period 1||19
8963327|NCT02549027|10026807|FG002|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
8963328|NCT02549027|10026808|FG003|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
8963329|NCT02549027|10026809|FG004|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
8963330|NCT02549027|10026810|FG005|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
8963331|NCT02549027|10026805|FG000|STARTED|Washout After Period 3||5
8963332|NCT02549027|10026806|FG001|STARTED|Washout After Period 3||5
8963333|NCT02549027|10026807|FG002|STARTED|Washout After Period 3||5
8963334|NCT02549027|10026808|FG003|STARTED|Washout After Period 3||5
8963335|NCT02549027|10026809|FG004|STARTED|Washout After Period 3||0
8963336|NCT02549027|10026810|FG005|STARTED|Washout After Period 3||0
8963337|NCT02549027|10026805|FG000|COMPLETED|Washout After Period 3||5
8963338|NCT02549027|10026806|FG001|COMPLETED|Washout After Period 3||5
8963339|NCT02549027|10026807|FG002|COMPLETED|Washout After Period 3||5
8963340|NCT02549027|10026808|FG003|COMPLETED|Washout After Period 3||5
8963341|NCT02549027|10026809|FG004|COMPLETED|Washout After Period 3||0
8963342|NCT02549027|10026810|FG005|COMPLETED|Washout After Period 3||0
8963343|NCT02549027|10026805|FG000|NOT COMPLETED|Washout After Period 3||0
8963344|NCT02549027|10026806|FG001|NOT COMPLETED|Washout After Period 3||0
8963345|NCT02549027|10026807|FG002|NOT COMPLETED|Washout After Period 3||0
8963346|NCT02549027|10026808|FG003|NOT COMPLETED|Washout After Period 3||0
8963347|NCT02549027|10026809|FG004|NOT COMPLETED|Washout After Period 3||0
8963348|NCT02549027|10026810|FG005|NOT COMPLETED|Washout After Period 3||0
8963349|NCT02549027|10026805|FG000|STARTED|Period 4 - MK-1064 or Placebo||5
8963350|NCT02549027|10026806|FG001|STARTED|Period 4 - MK-1064 or Placebo||5
8963351|NCT02549027|10026807|FG002|STARTED|Period 4 - MK-1064 or Placebo||5
8963352|NCT02549027|10026808|FG003|STARTED|Period 4 - MK-1064 or Placebo||5
8963353|NCT02549027|10026809|FG004|STARTED|Period 4 - MK-1064 or Placebo||0
8963354|NCT02549027|10026810|FG005|STARTED|Period 4 - MK-1064 or Placebo||0
8963355|NCT02549027|10026805|FG000|COMPLETED|Period 4 - MK-1064 or Placebo||5
8963356|NCT02549027|10026806|FG001|COMPLETED|Period 4 - MK-1064 or Placebo||5
8963357|NCT02549027|10026807|FG002|COMPLETED|Period 4 - MK-1064 or Placebo||5
8963358|NCT02549027|10026808|FG003|COMPLETED|Period 4 - MK-1064 or Placebo||5
8963359|NCT02549027|10026809|FG004|COMPLETED|Period 4 - MK-1064 or Placebo||0
8963360|NCT02549027|10026810|FG005|COMPLETED|Period 4 - MK-1064 or Placebo||0
8963361|NCT02549027|10026805|FG000|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
8963362|NCT02549027|10026806|FG001|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
8963363|NCT02549027|10026807|FG002|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
8963364|NCT02549027|10026808|FG003|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
8963365|NCT02549027|10026809|FG004|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
8963366|NCT02549027|10026810|FG005|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
8963367|NCT02549027|10026805|FG000|STARTED|Washout After Period 4||5
8963368|NCT02549027|10026806|FG001|STARTED|Washout After Period 4||5
8963369|NCT02549027|10026807|FG002|STARTED|Washout After Period 4||5
8963370|NCT02549027|10026808|FG003|STARTED|Washout After Period 4||5
8963371|NCT02549027|10026809|FG004|STARTED|Washout After Period 4||0
8963372|NCT02549027|10026810|FG005|STARTED|Washout After Period 4||0
8963373|NCT02549027|10026805|FG000|COMPLETED|Washout After Period 4||5
8963374|NCT02549027|10026806|FG001|COMPLETED|Washout After Period 4||4
8963375|NCT02549027|10026807|FG002|COMPLETED|Washout After Period 4||4
8875974|NCT01912456|9932748|FG000|NOT COMPLETED|Period 1||2
8875975|NCT01912456|9932749|FG001|NOT COMPLETED|Period 1||1
8963376|NCT02549027|10026808|FG003|COMPLETED|Washout After Period 4||4
8963377|NCT02549027|10026809|FG004|COMPLETED|Washout After Period 4||0
8963378|NCT02549027|10026810|FG005|COMPLETED|Washout After Period 4||0
8963379|NCT02549027|10026805|FG000|NOT COMPLETED|Washout After Period 4||0
8963380|NCT02549027|10026806|FG001|NOT COMPLETED|Washout After Period 4||1
8963381|NCT02549027|10026807|FG002|NOT COMPLETED|Washout After Period 4||1
8963382|NCT02549027|10026808|FG003|NOT COMPLETED|Washout After Period 4||1
8963383|NCT02549027|10026809|FG004|NOT COMPLETED|Washout After Period 4||0
8963384|NCT02549027|10026810|FG005|NOT COMPLETED|Washout After Period 4||0
8963385|NCT02549027|10026805|FG000|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg/Placebo (Period 5) arms|0
8963386|NCT02549027|10026806|FG001|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg (Period 5) arm|0
8963387|NCT02549027|10026807|FG002|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg (Period 5) arm|0
8963388|NCT02549027|10026808|FG003|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg (Period 5) arm|0
8963389|NCT02549027|10026809|FG004|STARTED|Period 5 - MK-6096 or Placebo|Participants entering Period 5 were previously in MK-1064/Placebo (Period 1-4) arms|16
8963390|NCT02549027|10026810|FG005|STARTED|Period 5 - MK-6096 or Placebo|Participants entering Period 5 were previously in MK-1064/Placebo (Period 1-4) arms|1
8963391|NCT02549027|10026805|FG000|COMPLETED|Period 5 - MK-6096 or Placebo||0
8963392|NCT02549027|10026806|FG001|COMPLETED|Period 5 - MK-6096 or Placebo||0
8963393|NCT02549027|10026807|FG002|COMPLETED|Period 5 - MK-6096 or Placebo||0
8963394|NCT02549027|10026808|FG003|COMPLETED|Period 5 - MK-6096 or Placebo||0
8963395|NCT02549027|10026809|FG004|COMPLETED|Period 5 - MK-6096 or Placebo|The 2 participants who did not complete Period 5 did not receive study drug in Period 5|14
8963396|NCT02549027|10026810|FG005|COMPLETED|Period 5 - MK-6096 or Placebo||1
8875976|NCT01912456|9932750|FG002|NOT COMPLETED|Period 1||2
8875977|NCT01912456|9932751|FG003|NOT COMPLETED|Period 1||3
8875978|NCT01912456|9932748|FG000|STARTED|Period 2||20
8875979|NCT01912456|9932749|FG001|STARTED|Period 2||22
8875980|NCT01912456|9932750|FG002|STARTED|Period 2||21
8875981|NCT01912456|9932751|FG003|STARTED|Period 2||19
8875982|NCT01912456|9932748|FG000|COMPLETED|Period 2||20
8875983|NCT01912456|9932749|FG001|COMPLETED|Period 2||20
8875984|NCT01912456|9932750|FG002|COMPLETED|Period 2||21
8875985|NCT01912456|9932751|FG003|COMPLETED|Period 2||18
8875986|NCT01912456|9932748|FG000|NOT COMPLETED|Period 2||0
8875987|NCT01912456|9932749|FG001|NOT COMPLETED|Period 2||2
8875988|NCT01912456|9932750|FG002|NOT COMPLETED|Period 2||0
8875989|NCT01912456|9932751|FG003|NOT COMPLETED|Period 2||1
8875990|NCT01912495|9932761|FG000|STARTED|Overall Study|8 patients had only screening visit, total enrollment: 65|57
8875991|NCT01912495|9932761|FG000|COMPLETED|Overall Study||57
8875992|NCT01912495|9932761|FG000|NOT COMPLETED|Overall Study||0
8875993|NCT01912599|9932770|FG000|STARTED|Overall Study||20
8875994|NCT01912599|9932771|FG001|STARTED|Overall Study||16
8875995|NCT01912599|9932770|FG000|COMPLETED|Overall Study||20
8875996|NCT01912599|9932771|FG001|COMPLETED|Overall Study||15
8875997|NCT01912599|9932770|FG000|NOT COMPLETED|Overall Study||0
8875998|NCT01912599|9932771|FG001|NOT COMPLETED|Overall Study||1
8875999|NCT01912612|9932779|FG000|STARTED|Overall Study||36
8876000|NCT01912612|9932780|FG001|STARTED|Overall Study||40
8876001|NCT01912612|9932781|FG002|STARTED|Overall Study||3
8876002|NCT01912612|9932779|FG000|COMPLETED|Overall Study||31
8876003|NCT01912612|9932780|FG001|COMPLETED|Overall Study||40
8876004|NCT01912612|9932781|FG002|COMPLETED|Overall Study||0
8876005|NCT01912612|9932779|FG000|NOT COMPLETED|Overall Study||5
8876006|NCT01912612|9932780|FG001|NOT COMPLETED|Overall Study||0
8876007|NCT01912612|9932781|FG002|NOT COMPLETED|Overall Study||3
8876008|NCT01912716|9932789|FG000|STARTED|Overall Study|receipt of 1st dose of indomethacin|522
8876009|NCT01912716|9932790|FG001|STARTED|Overall Study||515
8876010|NCT01912716|9932789|FG000|Receipt of 2nd Dose|Overall Study||511
8876011|NCT01912716|9932790|FG001|Receipt of 2nd Dose|Overall Study||503
8876012|NCT01912716|9932789|FG000|5-day Follow-up|Overall Study||522
8876013|NCT01912716|9932790|FG001|5-day Follow-up|Overall Study||515
8876014|NCT01912716|9932789|FG000|3-day Follow-up|Overall Study||521
8876015|NCT01912716|9932790|FG001|3-day Follow-up|Overall Study||513
8876016|NCT01912716|9932789|FG000|COMPLETED|Overall Study||522
8876017|NCT01912716|9932790|FG001|COMPLETED|Overall Study||515
8876018|NCT01912716|9932789|FG000|NOT COMPLETED|Overall Study||0
8876019|NCT01912716|9932790|FG001|NOT COMPLETED|Overall Study||0
8876020|NCT01912729|9932800|FG000|STARTED|Overall Study||20
8876021|NCT01912729|9932801|FG001|STARTED|Overall Study||20
8876022|NCT01912729|9932800|FG000|COMPLETED|Overall Study||20
8876023|NCT01912729|9932801|FG001|COMPLETED|Overall Study||19
8876024|NCT01912729|9932800|FG000|NOT COMPLETED|Overall Study||0
8876025|NCT01912729|9932801|FG001|NOT COMPLETED|Overall Study||1
8963397|NCT02549027|10026805|FG000|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
8963398|NCT02549027|10026806|FG001|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
8963399|NCT02549027|10026807|FG002|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
8963400|NCT02549027|10026808|FG003|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
8963401|NCT02549027|10026809|FG004|NOT COMPLETED|Period 5 - MK-6096 or Placebo||2
8963402|NCT02549027|10026810|FG005|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
8963403|NCT02549040|10026825|FG000|STARTED|Period 1||16
8876026|NCT01912768|9932809|FG000|STARTED|Overall Study||239
8876027|NCT01912768|9932810|FG001|STARTED|Overall Study||113
8876028|NCT01912768|9932809|FG000|COMPLETED|Overall Study||229
8963404|NCT02549040|10026825|FG000|COMPLETED|Period 1||16
8631659|NCT00541242|9671544|FG000|COMPLETED|Treatment Period 1||0
8631660|NCT00541242|9671545|FG001|COMPLETED|Treatment Period 1|43 of the 586 patients did not enter Treatment Period 2 (Randomized at Week 6)|586
8876029|NCT01912768|9932810|FG001|COMPLETED|Overall Study||109
8876030|NCT01912768|9932809|FG000|NOT COMPLETED|Overall Study||10
8876031|NCT01912768|9932810|FG001|NOT COMPLETED|Overall Study||4
8876032|NCT01912781|9932819|FG000|STARTED|Overall Study||71
8876033|NCT01912781|9932820|FG001|STARTED|Overall Study||35
8876034|NCT01912781|9932819|FG000|COMPLETED|Overall Study||69
8876035|NCT01912781|9932820|FG001|COMPLETED|Overall Study||35
8876036|NCT01912781|9932819|FG000|NOT COMPLETED|Overall Study||2
8876037|NCT01912781|9932820|FG001|NOT COMPLETED|Overall Study||0
8876038|NCT01912807|9932829|FG000|STARTED|Overall Study|Enrolment phase: Recruiting of participants started December 11, 2013|150
8876039|NCT01912807|9932830|FG001|STARTED|Overall Study|Enrolment phase: Recruitment of participants started December 11, 2013|150
8876040|NCT01912807|9932829|FG000|Randomized|Overall Study||144
8876041|NCT01912807|9932830|FG001|Randomized|Overall Study||146
8876042|NCT01912807|9932829|FG000|COMPLETED|Overall Study|"n=108 completed study and immediate follow up~n=36 participants were lost to follow up at 24 hr"|108
8876043|NCT01912807|9932830|FG001|COMPLETED|Overall Study|"n=109 completed study and immediate follow up~n=37 participants were lost to follow up at 24 hr"|109
8876044|NCT01912807|9932829|FG000|NOT COMPLETED|Overall Study||42
8876045|NCT01912807|9932830|FG001|NOT COMPLETED|Overall Study||41
8876046|NCT01912872|9932840|FG000|STARTED|Overall Study||16
8876047|NCT01912872|9932841|FG001|STARTED|Overall Study||17
8876048|NCT01912872|9932842|FG002|STARTED|Overall Study||40
8876049|NCT01912872|9932843|FG003|STARTED|Overall Study||39
8876050|NCT01912872|9932840|FG000|Completed Study Treatment at Month 12|Overall Study||11
8876051|NCT01912872|9932841|FG001|Completed Study Treatment at Month 12|Overall Study||13
8876052|NCT01912872|9932842|FG002|Completed Study Treatment at Month 12|Overall Study||30
8876053|NCT01912872|9932843|FG003|Completed Study Treatment at Month 12|Overall Study||27
8876054|NCT01912872|9932840|FG000|Discontinued Treatment Prior to Month 12|Overall Study||5
8876055|NCT01912872|9932841|FG001|Discontinued Treatment Prior to Month 12|Overall Study||4
8876056|NCT01912872|9932842|FG002|Discontinued Treatment Prior to Month 12|Overall Study||10
8876057|NCT01912872|9932843|FG003|Discontinued Treatment Prior to Month 12|Overall Study||11
8876058|NCT01912872|9932840|FG000|COMPLETED|Overall Study||11
8876059|NCT01912872|9932841|FG001|COMPLETED|Overall Study||13
8876060|NCT01912872|9932842|FG002|COMPLETED|Overall Study||30
8876061|NCT01912872|9932843|FG003|COMPLETED|Overall Study||27
8876062|NCT01912872|9932840|FG000|NOT COMPLETED|Overall Study||5
8876063|NCT01912872|9932841|FG001|NOT COMPLETED|Overall Study||4
8876064|NCT01912872|9932842|FG002|NOT COMPLETED|Overall Study||10
8876065|NCT01912872|9932843|FG003|NOT COMPLETED|Overall Study||12
8876066|NCT01912963|9932857|FG000|STARTED|Overall Study||6
8876067|NCT01912963|9932858|FG001|STARTED|Overall Study||19
8876068|NCT01912963|9932859|FG002|STARTED|Overall Study||7
8876069|NCT01912963|9932857|FG000|COMPLETED|Overall Study||0
8876070|NCT01912963|9932858|FG001|COMPLETED|Overall Study||0
8876071|NCT01912963|9932859|FG002|COMPLETED|Overall Study||0
8876072|NCT01912963|9932857|FG000|NOT COMPLETED|Overall Study||6
8876073|NCT01912963|9932858|FG001|NOT COMPLETED|Overall Study||19
8876074|NCT01912963|9932859|FG002|NOT COMPLETED|Overall Study||7
8876075|NCT01913041|9932867|FG000|STARTED|Overall Study||869
8876076|NCT01913041|9932867|FG000|COMPLETED|Overall Study||830
8876077|NCT01913041|9932867|FG000|NOT COMPLETED|Overall Study||39
8876078|NCT01913314|9932871|FG000|STARTED|Overall Study||6
8876079|NCT01913314|9932871|FG000|Received Study Drug|Overall Study||6
8876080|NCT01913314|9932871|FG000|COMPLETED|Overall Study||6
8876081|NCT01913314|9932871|FG000|NOT COMPLETED|Overall Study||0
8876082|NCT01913340|9932877|FG000|STARTED|Overall Study|22 (92%) received all 5 doses, 1 (4%) received 4 doses, and 1 (4%) only received 1 dose.|24
8876083|NCT01913340|9932878|FG001|STARTED|Overall Study||26
8876084|NCT01913340|9932877|FG000|COMPLETED|Overall Study||21
8876085|NCT01913340|9932878|FG001|COMPLETED|Overall Study||20
8876086|NCT01913340|9932877|FG000|NOT COMPLETED|Overall Study||3
8876087|NCT01913340|9932878|FG001|NOT COMPLETED|Overall Study||6
8876088|NCT01913353|9932886|FG000|STARTED|Overall Study||221
8876089|NCT01913353|9932887|FG001|STARTED|Overall Study||219
8876090|NCT01913353|9932886|FG000|COMPLETED|Overall Study||189
8876091|NCT01913353|9932887|FG001|COMPLETED|Overall Study||204
8876092|NCT01913353|9932886|FG000|NOT COMPLETED|Overall Study||32
8876093|NCT01913353|9932887|FG001|NOT COMPLETED|Overall Study||15
8876094|NCT01913405|9932900|FG000|STARTED|Overall Study||22
8876095|NCT01913405|9932900|FG000|COMPLETED|Overall Study||20
8876096|NCT01913405|9932900|FG000|NOT COMPLETED|Overall Study||2
8876097|NCT01913470|9932919|FG000|STARTED|Overall Study||5
8876098|NCT01913470|9932920|FG001|STARTED|Overall Study||7
8876099|NCT01913470|9932919|FG000|COMPLETED|Overall Study||5
8876100|NCT01913470|9932920|FG001|COMPLETED|Overall Study||4
8876101|NCT01913470|9932919|FG000|NOT COMPLETED|Overall Study||0
8876102|NCT01913470|9932920|FG001|NOT COMPLETED|Overall Study||3
8876103|NCT01913483|9932929|FG000|STARTED|Overall Study||367
8876104|NCT01913483|9932930|FG001|STARTED|Overall Study||365
8876105|NCT01913483|9932929|FG000|Received at Least 1 Dose of Study Drug|Overall Study||335
8876106|NCT01913483|9932930|FG001|Received at Least 1 Dose of Study Drug|Overall Study||321
8876107|NCT01913483|9932929|FG000|COMPLETED|Overall Study||346
8876108|NCT01913483|9932930|FG001|COMPLETED|Overall Study||343
8963405|NCT02549040|10026825|FG000|NOT COMPLETED|Period 1||0
8963406|NCT02549040|10026825|FG000|STARTED|Period 2||16
8963407|NCT02549040|10026825|FG000|COMPLETED|Period 2||16
8963408|NCT02549040|10026825|FG000|NOT COMPLETED|Period 2||0
8963409|NCT02549040|10026825|FG000|STARTED|Period 3||16
8570489|NCT00103857|9602676|FG000|NOT COMPLETED|54-Week Base Study||57
8570490|NCT00103857|9602677|FG001|NOT COMPLETED|54-Week Base Study||56
8570491|NCT00103857|9602678|FG002|NOT COMPLETED|54-Week Base Study||47
8570492|NCT00103857|9602679|FG003|NOT COMPLETED|54-Week Base Study||42
8570493|NCT00103857|9602680|FG004|NOT COMPLETED|54-Week Base Study||41
8570494|NCT00103857|9602681|FG005|NOT COMPLETED|54-Week Base Study||61
8570495|NCT00103857|9602682|FG006|NOT COMPLETED|54-Week Base Study||38
8570496|NCT00103857|9602676|FG000|STARTED|50-Week Extension Study|19 randomized patients completed Period 1 but did not enter Period 2.|103
8570497|NCT00103857|9602677|FG001|STARTED|50-Week Extension Study|19 randomized patients completed Period 1 but did not enter Period 2.|107
8570498|NCT00103857|9602678|FG002|STARTED|50-Week Extension Study|14 randomized patients completed Period 1 but did not enter Period 2.|121
8570499|NCT00103857|9602679|FG003|STARTED|50-Week Extension Study|14 randomized patients completed Period 1 but did not enter Period 2.|134
8570500|NCT00103857|9602680|FG004|STARTED|50-Week Extension Study|19 randomized patients completed Period 1 but did not enter Period 2.|122
8570501|NCT00103857|9602681|FG005|STARTED|50-Week Extension Study|17 randomized patients completed Period 1 but did not enter Period 2.|98
8570502|NCT00103857|9602682|FG006|STARTED|50-Week Extension Study||0
8570503|NCT00103857|9602676|FG000|COMPLETED|50-Week Extension Study||65
8570504|NCT00103857|9602677|FG001|COMPLETED|50-Week Extension Study||80
8570505|NCT00103857|9602678|FG002|COMPLETED|50-Week Extension Study||95
8570506|NCT00103857|9602679|FG003|COMPLETED|50-Week Extension Study||98
8570507|NCT00103857|9602680|FG004|COMPLETED|50-Week Extension Study||101
8570508|NCT00103857|9602681|FG005|COMPLETED|50-Week Extension Study||78
8570509|NCT00103857|9602682|FG006|COMPLETED|50-Week Extension Study||0
8570510|NCT00103857|9602676|FG000|NOT COMPLETED|50-Week Extension Study||38
8570511|NCT00103857|9602677|FG001|NOT COMPLETED|50-Week Extension Study||27
8570512|NCT00103857|9602678|FG002|NOT COMPLETED|50-Week Extension Study||26
8570513|NCT00103857|9602679|FG003|NOT COMPLETED|50-Week Extension Study||36
8570514|NCT00103857|9602680|FG004|NOT COMPLETED|50-Week Extension Study||21
8570515|NCT00103857|9602681|FG005|NOT COMPLETED|50-Week Extension Study||20
8570516|NCT00103857|9602682|FG006|NOT COMPLETED|50-Week Extension Study||0
8570517|NCT00104052|9602697|FG000|STARTED|Overall Study||107
8570518|NCT00104052|9602697|FG000|COMPLETED|Overall Study||78
8570519|NCT00104052|9602697|FG000|NOT COMPLETED|Overall Study||29
8570520|NCT00104104|9602703|FG000|STARTED|Overall Study|2 Participants in the 15-minute infusion group did not receive study drug.|90
8570521|NCT00104104|9602704|FG001|STARTED|Overall Study|1 Participants in the 30-minute infusion group did not receive study drug.|89
8631661|NCT00541242|9671544|FG000|NOT COMPLETED|Treatment Period 1||0
8631662|NCT00541242|9671545|FG001|NOT COMPLETED|Treatment Period 1||0
8876109|NCT01913483|9932929|FG000|NOT COMPLETED|Overall Study||21
8876110|NCT01913483|9932930|FG001|NOT COMPLETED|Overall Study||22
8876111|NCT01913535|9932941|FG000|STARTED|Phase 1 (Days 0-2)||2
8876112|NCT01913535|9932942|FG001|STARTED|Phase 1 (Days 0-2)||2
8876113|NCT01913535|9932943|FG002|STARTED|Phase 1 (Days 0-2)||1
8876114|NCT01913535|9932944|FG003|STARTED|Phase 1 (Days 0-2)||2
8876115|NCT01913535|9932945|FG004|STARTED|Phase 1 (Days 0-2)||1
8876116|NCT01913535|9932941|FG000|COMPLETED|Phase 1 (Days 0-2)||2
8876117|NCT01913535|9932942|FG001|COMPLETED|Phase 1 (Days 0-2)||2
8876118|NCT01913535|9932943|FG002|COMPLETED|Phase 1 (Days 0-2)||1
8876119|NCT01913535|9932944|FG003|COMPLETED|Phase 1 (Days 0-2)||2
8876120|NCT01913535|9932945|FG004|COMPLETED|Phase 1 (Days 0-2)||1
8876121|NCT01913535|9932941|FG000|NOT COMPLETED|Phase 1 (Days 0-2)||0
8876122|NCT01913535|9932942|FG001|NOT COMPLETED|Phase 1 (Days 0-2)||0
8876123|NCT01913535|9932943|FG002|NOT COMPLETED|Phase 1 (Days 0-2)||0
8876124|NCT01913535|9932944|FG003|NOT COMPLETED|Phase 1 (Days 0-2)||0
8876125|NCT01913535|9932945|FG004|NOT COMPLETED|Phase 1 (Days 0-2)||0
8876126|NCT01913535|9932941|FG000|STARTED|Phase 2 (Days 3-5)||2
8876127|NCT01913535|9932942|FG001|STARTED|Phase 2 (Days 3-5)||2
8876128|NCT01913535|9932943|FG002|STARTED|Phase 2 (Days 3-5)||1
8963410|NCT02549040|10026825|FG000|COMPLETED|Period 3||16
8963411|NCT02549040|10026825|FG000|NOT COMPLETED|Period 3||0
8963412|NCT02549040|10026825|FG000|STARTED|Period 4||16
8963413|NCT02549040|10026825|FG000|COMPLETED|Period 4||16
8876129|NCT01913535|9932944|FG003|STARTED|Phase 2 (Days 3-5)||2
8963414|NCT02549040|10026825|FG000|NOT COMPLETED|Period 4||0
8963415|NCT02549040|10026825|FG000|STARTED|Period 5||16
8963416|NCT02549040|10026825|FG000|COMPLETED|Period 5||16
8963417|NCT02549040|10026825|FG000|NOT COMPLETED|Period 5||0
8963418|NCT02549196|10026841|FG000|STARTED|Overall Study||8
8963419|NCT02549196|10026842|FG001|STARTED|Overall Study||1
8963420|NCT02549196|10026843|FG002|STARTED|Overall Study||6
8963421|NCT02549196|10026844|FG003|STARTED|Overall Study||13
8963422|NCT02549196|10026841|FG000|COMPLETED|Overall Study||7
8963423|NCT02549196|10026842|FG001|COMPLETED|Overall Study||1
8963424|NCT02549196|10026843|FG002|COMPLETED|Overall Study||5
8963425|NCT02549196|10026844|FG003|COMPLETED|Overall Study||12
8963426|NCT02549196|10026841|FG000|NOT COMPLETED|Overall Study||1
8963427|NCT02549196|10026842|FG001|NOT COMPLETED|Overall Study||0
8876130|NCT01913535|9932945|FG004|STARTED|Phase 2 (Days 3-5)||1
8876131|NCT01913535|9932941|FG000|COMPLETED|Phase 2 (Days 3-5)||2
8876132|NCT01913535|9932942|FG001|COMPLETED|Phase 2 (Days 3-5)||2
8876133|NCT01913535|9932943|FG002|COMPLETED|Phase 2 (Days 3-5)||1
8876134|NCT01913535|9932944|FG003|COMPLETED|Phase 2 (Days 3-5)||2
8876135|NCT01913535|9932945|FG004|COMPLETED|Phase 2 (Days 3-5)||1
8876136|NCT01913535|9932941|FG000|NOT COMPLETED|Phase 2 (Days 3-5)||0
8876137|NCT01913535|9932942|FG001|NOT COMPLETED|Phase 2 (Days 3-5)||0
8876138|NCT01913535|9932943|FG002|NOT COMPLETED|Phase 2 (Days 3-5)||0
8876139|NCT01913535|9932944|FG003|NOT COMPLETED|Phase 2 (Days 3-5)||0
8876140|NCT01913535|9932945|FG004|NOT COMPLETED|Phase 2 (Days 3-5)||0
8876141|NCT01913600|9932958|FG000|STARTED|Overall Study||56
8876142|NCT01913600|9932958|FG000|COMPLETED|Overall Study||55
8876143|NCT01913600|9932958|FG000|NOT COMPLETED|Overall Study||1
8876144|NCT01913639|9932962|FG000|STARTED|Overall Study||39
8876145|NCT01913639|9932962|FG000|COMPLETED|Overall Study||36
8876146|NCT01913639|9932962|FG000|NOT COMPLETED|Overall Study||3
8876147|NCT01913795|9932970|FG000|STARTED|Overall Study||4
8876148|NCT01913795|9932971|FG001|STARTED|Overall Study||10
8876149|NCT01913795|9932972|FG002|STARTED|Overall Study||9
8876150|NCT01913795|9932973|FG003|STARTED|Overall Study||6
8876151|NCT01913795|9932970|FG000|COMPLETED|Overall Study||4
8876152|NCT01913795|9932971|FG001|COMPLETED|Overall Study||7
8876153|NCT01913795|9932972|FG002|COMPLETED|Overall Study||9
8876154|NCT01913795|9932973|FG003|COMPLETED|Overall Study||5
8876155|NCT01913795|9932970|FG000|NOT COMPLETED|Overall Study||0
8876156|NCT01913795|9932971|FG001|NOT COMPLETED|Overall Study||3
8876157|NCT01913795|9932972|FG002|NOT COMPLETED|Overall Study||0
8876158|NCT01913795|9932973|FG003|NOT COMPLETED|Overall Study||1
8876159|NCT01914003|9932985|FG000|STARTED|Overall Study||27
8876160|NCT01914003|9932986|FG001|STARTED|Overall Study||26
8876161|NCT01914003|9932985|FG000|COMPLETED|Overall Study|Number of subjects who completed through study and qualify as evaluable|19
8876162|NCT01914003|9932986|FG001|COMPLETED|Overall Study|Number of subjects who completed through study and qualify as evaluable|14
8876163|NCT01914003|9932985|FG000|NOT COMPLETED|Overall Study||8
8876164|NCT01914003|9932986|FG001|NOT COMPLETED|Overall Study||12
8876165|NCT01914159|9932992|FG000|STARTED|Overall Study||24
8876166|NCT01914159|9932992|FG000|COMPLETED|Overall Study||21
8876167|NCT01914159|9932992|FG000|NOT COMPLETED|Overall Study||3
8876168|NCT01914393|9932999|FG000|STARTED|Overall Study||271
8876169|NCT01914393|9933000|FG001|STARTED|Overall Study||125
8876170|NCT01914393|9933001|FG002|STARTED|Overall Study||306
8876171|NCT01914393|9932999|FG000|COMPLETED|Overall Study||156
8876172|NCT01914393|9933000|FG001|COMPLETED|Overall Study||54
8876173|NCT01914393|9933001|FG002|COMPLETED|Overall Study||168
8876174|NCT01914393|9932999|FG000|NOT COMPLETED|Overall Study||115
8876175|NCT01914393|9933000|FG001|NOT COMPLETED|Overall Study||71
8876176|NCT01914393|9933001|FG002|NOT COMPLETED|Overall Study||138
8876177|NCT01914510|9933013|FG000|STARTED|Overall Study||40
8876178|NCT01914510|9933013|FG000|COMPLETED|Overall Study||38
8876179|NCT01914510|9933013|FG000|NOT COMPLETED|Overall Study||2
8876180|NCT01914666|9933021|FG000|STARTED|Treatment Period||68
8876181|NCT01914666|9933022|FG001|STARTED|Treatment Period||42
8876182|NCT01914666|9933023|FG002|STARTED|Treatment Period||41
8876183|NCT01914666|9933021|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||68
8876184|NCT01914666|9933022|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||42
8876185|NCT01914666|9933023|FG002|Received at Least 1 Dose of Study Drug|Treatment Period||41
8876186|NCT01914666|9933021|FG000|COMPLETED|Treatment Period||55
8876187|NCT01914666|9933022|FG001|COMPLETED|Treatment Period||36
8876188|NCT01914666|9933023|FG002|COMPLETED|Treatment Period||33
8876189|NCT01914666|9933021|FG000|NOT COMPLETED|Treatment Period||13
8876190|NCT01914666|9933022|FG001|NOT COMPLETED|Treatment Period||6
8876191|NCT01914666|9933023|FG002|NOT COMPLETED|Treatment Period||8
8876192|NCT01914666|9933021|FG000|STARTED|Tapering Period|4 Pts who discontinued, and 55 Pts who completed Treatment Period entered Tapering Period.|59
8876193|NCT01914666|9933022|FG001|STARTED|Tapering Period|3 Pts who discontinued, and 36 Pts who completed Treatment Period entered Tapering Period.|39
8876194|NCT01914666|9933023|FG002|STARTED|Tapering Period|7 Pts who discontinued, and 33 Pts who completed Treatment Period entered Tapering Period.|40
8876195|NCT01914666|9933021|FG000|COMPLETED|Tapering Period||59
8876196|NCT01914666|9933022|FG001|COMPLETED|Tapering Period||39
8876197|NCT01914666|9933023|FG002|COMPLETED|Tapering Period||40
8876198|NCT01914666|9933021|FG000|NOT COMPLETED|Tapering Period||0
8876199|NCT01914666|9933022|FG001|NOT COMPLETED|Tapering Period||0
8876200|NCT01914666|9933023|FG002|NOT COMPLETED|Tapering Period||0
8876201|NCT01914679|9933029|FG000|STARTED|Overall Study||17
8876202|NCT01914679|9933029|FG000|Began 12 Week Actual RINCE Treatment|Overall Study||17
8876203|NCT01914679|9933029|FG000|COMPLETED|Overall Study||12
8876204|NCT01914679|9933029|FG000|NOT COMPLETED|Overall Study||5
8876205|NCT01914757|9933036|FG000|STARTED|Overall Study||425
8876206|NCT01914757|9933037|FG001|STARTED|Overall Study||441
8876207|NCT01914757|9933038|FG002|STARTED|Overall Study||440
8876208|NCT01914757|9933036|FG000|COMPLETED|Overall Study||389
8876209|NCT01914757|9933037|FG001|COMPLETED|Overall Study||390
8963428|NCT02549196|10026843|FG002|NOT COMPLETED|Overall Study||1
8963429|NCT02549196|10026844|FG003|NOT COMPLETED|Overall Study||1
8963430|NCT02549287|10026856|FG000|STARTED|Overall Study||193
8963431|NCT02549287|10026857|FG001|STARTED|Overall Study||96
8963432|NCT02549287|10026856|FG000|COMPLETED|Overall Study||113
8963433|NCT02549287|10026857|FG001|COMPLETED|Overall Study||64
8963434|NCT02549287|10026856|FG000|NOT COMPLETED|Overall Study||80
8963435|NCT02549287|10026857|FG001|NOT COMPLETED|Overall Study||32
8963436|NCT02549339|10026865|FG000|STARTED|3-day Treatment and 8-week Follow-up||205
8963437|NCT02549339|10026866|FG001|STARTED|3-day Treatment and 8-week Follow-up||104
8963438|NCT02549339|10026865|FG000|Treated|3-day Treatment and 8-week Follow-up||202
8963439|NCT02549339|10026866|FG001|Treated|3-day Treatment and 8-week Follow-up||104
8963440|NCT02549339|10026865|FG000|COMPLETED|3-day Treatment and 8-week Follow-up||201
8963441|NCT02549339|10026866|FG001|COMPLETED|3-day Treatment and 8-week Follow-up||99
8963442|NCT02549339|10026865|FG000|NOT COMPLETED|3-day Treatment and 8-week Follow-up||4
8963443|NCT02549339|10026866|FG001|NOT COMPLETED|3-day Treatment and 8-week Follow-up||5
8963444|NCT02549339|10026865|FG000|STARTED|12-month Follow-up||201
8963445|NCT02549339|10026866|FG001|STARTED|12-month Follow-up||98
8963446|NCT02549339|10026865|FG000|COMPLETED|12-month Follow-up||192
8963447|NCT02549339|10026866|FG001|COMPLETED|12-month Follow-up||87
8963448|NCT02549339|10026865|FG000|NOT COMPLETED|12-month Follow-up||9
8963449|NCT02549339|10026866|FG001|NOT COMPLETED|12-month Follow-up||11
8963450|NCT02549352|10026876|FG000|STARTED|3-day Treatment and 8-week Follow-up||209
8963451|NCT02549352|10026877|FG001|STARTED|3-day Treatment and 8-week Follow-up||102
8963452|NCT02549352|10026876|FG000|Treated|3-day Treatment and 8-week Follow-up||209
8963453|NCT02549352|10026877|FG001|Treated|3-day Treatment and 8-week Follow-up|1 participant was included in 0.037% in the safety analysis set as they received both IMPs in error|101
8963454|NCT02549352|10026876|FG000|COMPLETED|3-day Treatment and 8-week Follow-up||207
8963455|NCT02549352|10026877|FG001|COMPLETED|3-day Treatment and 8-week Follow-up||96
8963456|NCT02549352|10026876|FG000|NOT COMPLETED|3-day Treatment and 8-week Follow-up||2
8963457|NCT02549352|10026877|FG001|NOT COMPLETED|3-day Treatment and 8-week Follow-up||6
8963458|NCT02549352|10026876|FG000|STARTED|12-month Follow-up||207
8963459|NCT02549352|10026877|FG001|STARTED|12-month Follow-up||93
8963460|NCT02549352|10026876|FG000|COMPLETED|12-month Follow-up||199
8963461|NCT02549352|10026877|FG001|COMPLETED|12-month Follow-up||81
8963462|NCT02549352|10026876|FG000|NOT COMPLETED|12-month Follow-up||8
8963463|NCT02549352|10026877|FG001|NOT COMPLETED|12-month Follow-up||12
8963464|NCT02549365|10026887|FG000|STARTED|Overall Study||164
8963465|NCT02549365|10026888|FG001|STARTED|Overall Study||112
8963466|NCT02549365|10026887|FG000|COMPLETED|Overall Study||164
8963467|NCT02549365|10026888|FG001|COMPLETED|Overall Study||112
8963468|NCT02549365|10026887|FG000|NOT COMPLETED|Overall Study||0
8963469|NCT02549365|10026888|FG001|NOT COMPLETED|Overall Study||0
8963470|NCT02549508|10026896|FG000|STARTED|Overall Study||47
8963471|NCT02549508|10026897|FG001|STARTED|Overall Study||38
8963472|NCT02549508|10026896|FG000|COMPLETED|Overall Study||33
8963473|NCT02549508|10026897|FG001|COMPLETED|Overall Study||21
8963474|NCT02549508|10026896|FG000|NOT COMPLETED|Overall Study||14
8963475|NCT02549508|10026897|FG001|NOT COMPLETED|Overall Study||17
8963476|NCT02549573|10026907|FG000|STARTED|Overall Study||6
8963477|NCT02549573|10026908|FG001|STARTED|Overall Study||7
8963478|NCT02549573|10026907|FG000|COMPLETED|Overall Study||6
8963479|NCT02549573|10026908|FG001|COMPLETED|Overall Study||4
8963480|NCT02549573|10026907|FG000|NOT COMPLETED|Overall Study||0
8963481|NCT02549573|10026908|FG001|NOT COMPLETED|Overall Study||3
8963482|NCT02549859|10026914|FG000|STARTED|Visit 1||11
8963483|NCT02549859|10026914|FG000|COMPLETED|Visit 1||11
8963484|NCT02549859|10026914|FG000|NOT COMPLETED|Visit 1||0
8963485|NCT02549859|10026914|FG000|STARTED|Long-term 60 Hz DBS||11
8963486|NCT02549859|10026914|FG000|COMPLETED|Long-term 60 Hz DBS||10
8963487|NCT02549859|10026914|FG000|NOT COMPLETED|Long-term 60 Hz DBS||1
8963488|NCT02549859|10026914|FG000|STARTED|Visit 2||10
8963489|NCT02549859|10026914|FG000|COMPLETED|Visit 2||10
8963490|NCT02549859|10026914|FG000|NOT COMPLETED|Visit 2||0
8963491|NCT02550106|10026922|FG000|STARTED|Overall Study||136
8963492|NCT02550106|10026922|FG000|COMPLETED|Overall Study||124
8963493|NCT02550106|10026922|FG000|NOT COMPLETED|Overall Study||12
8963494|NCT02550132|10026928|FG000|STARTED|Overall Study||25
8570522|NCT00104104|9602703|FG000|Safety Population (Including Site 74)|Overall Study||88
8963495|NCT02550132|10026928|FG000|COMPLETED|Overall Study||25
8570523|NCT00104104|9602704|FG001|Safety Population (Including Site 74)|Overall Study||88
8963496|NCT02550132|10026928|FG000|NOT COMPLETED|Overall Study||0
8963497|NCT02550210|10026932|FG000|STARTED|Overall Study||23
8963498|NCT02550210|10026932|FG000|COMPLETED|Overall Study||19
8963499|NCT02550210|10026932|FG000|NOT COMPLETED|Overall Study||4
8963500|NCT02550743|10026940|FG000|STARTED|Overall Study||3
8963501|NCT02550743|10026941|FG001|STARTED|Overall Study||3
8963502|NCT02550743|10026942|FG002|STARTED|Overall Study||1
8876210|NCT01914757|9933038|FG002|COMPLETED|Overall Study||402
8876211|NCT01914757|9933036|FG000|NOT COMPLETED|Overall Study||36
8876212|NCT01914757|9933037|FG001|NOT COMPLETED|Overall Study||51
8876213|NCT01914757|9933038|FG002|NOT COMPLETED|Overall Study||38
8876214|NCT01914926|9933048|FG000|STARTED|Overall Study||29
8876215|NCT01914926|9933049|FG001|STARTED|Overall Study||25
8876216|NCT01914926|9933048|FG000|COMPLETED|Overall Study||28
8876217|NCT01914926|9933049|FG001|COMPLETED|Overall Study||24
8876218|NCT01914926|9933048|FG000|NOT COMPLETED|Overall Study||1
8876219|NCT01914926|9933049|FG001|NOT COMPLETED|Overall Study||1
8876220|NCT01915095|9933062|FG000|STARTED|Overall Study||10
8876221|NCT01915095|9933063|FG001|STARTED|Overall Study||10
8876222|NCT01915095|9933064|FG002|STARTED|Overall Study||5
8876223|NCT01915095|9933065|FG003|STARTED|Overall Study||8
8876224|NCT01915095|9933066|FG004|STARTED|Overall Study||9
8876225|NCT01915095|9933062|FG000|SCI|Overall Study||5
8876226|NCT01915095|9933063|FG001|SCI|Overall Study||5
8876227|NCT01915095|9933064|FG002|SCI|Overall Study||5
8876228|NCT01915095|9933065|FG003|SCI|Overall Study||8
8876229|NCT01915095|9933066|FG004|SCI|Overall Study||9
8876230|NCT01915095|9933062|FG000|Control|Overall Study||5
8876231|NCT01915095|9933063|FG001|Control|Overall Study||5
8876232|NCT01915095|9933064|FG002|Control|Overall Study||0
8876233|NCT01915095|9933065|FG003|Control|Overall Study||0
8876234|NCT01915095|9933066|FG004|Control|Overall Study||0
8876235|NCT01915095|9933062|FG000|COMPLETED|Overall Study||10
8876236|NCT01915095|9933063|FG001|COMPLETED|Overall Study||10
8876237|NCT01915095|9933064|FG002|COMPLETED|Overall Study||5
8876238|NCT01915095|9933065|FG003|COMPLETED|Overall Study||4
8876239|NCT01915095|9933066|FG004|COMPLETED|Overall Study||3
8876240|NCT01915095|9933062|FG000|NOT COMPLETED|Overall Study||0
8876241|NCT01915095|9933063|FG001|NOT COMPLETED|Overall Study||0
8876242|NCT01915095|9933064|FG002|NOT COMPLETED|Overall Study||0
8876243|NCT01915095|9933065|FG003|NOT COMPLETED|Overall Study||4
8876244|NCT01915095|9933066|FG004|NOT COMPLETED|Overall Study||6
8876245|NCT01915108|9933091|FG000|STARTED|Overall Study||32
8876246|NCT01915108|9933092|FG001|STARTED|Overall Study||32
8876247|NCT01915108|9933093|FG002|STARTED|Overall Study||32
8876248|NCT01915108|9933094|FG003|STARTED|Overall Study||32
8876249|NCT01915108|9933091|FG000|COMPLETED|Overall Study|two patients were excluded from the study|30
8876250|NCT01915108|9933092|FG001|COMPLETED|Overall Study|three patients were excluded from the study|29
8876251|NCT01915108|9933093|FG002|COMPLETED|Overall Study|one patients were excluded from the study|31
8876252|NCT01915108|9933094|FG003|COMPLETED|Overall Study|two patients were excluded from the study|30
8876253|NCT01915108|9933091|FG000|NOT COMPLETED|Overall Study||2
8876254|NCT01915108|9933092|FG001|NOT COMPLETED|Overall Study||3
8876255|NCT01915108|9933093|FG002|NOT COMPLETED|Overall Study||1
8876256|NCT01915108|9933094|FG003|NOT COMPLETED|Overall Study||2
8876257|NCT01915173|9933108|FG000|STARTED|Overall Study||6
8876258|NCT01915173|9933109|FG001|STARTED|Overall Study||6
8876259|NCT01915173|9933110|FG002|STARTED|Overall Study||6
8876260|NCT01915173|9933111|FG003|STARTED|Overall Study||6
8876261|NCT01915173|9933108|FG000|COMPLETED|Overall Study||6
8876262|NCT01915173|9933109|FG001|COMPLETED|Overall Study||6
8876263|NCT01915173|9933110|FG002|COMPLETED|Overall Study||6
8876264|NCT01915173|9933111|FG003|COMPLETED|Overall Study||6
8876265|NCT01915173|9933108|FG000|NOT COMPLETED|Overall Study||0
8876266|NCT01915173|9933109|FG001|NOT COMPLETED|Overall Study||0
8876267|NCT01915173|9933110|FG002|NOT COMPLETED|Overall Study||0
8876268|NCT01915173|9933111|FG003|NOT COMPLETED|Overall Study||0
8876269|NCT01915303|9933121|FG000|STARTED|Core Phase||68
8876270|NCT01915303|9933121|FG000|COMPLETED|Core Phase||52
8876271|NCT01915303|9933121|FG000|NOT COMPLETED|Core Phase||16
8876272|NCT01915303|9933121|FG000|STARTED|Extension Phase||29
8876273|NCT01915303|9933121|FG000|COMPLETED|Extension Phase||12
8876274|NCT01915303|9933121|FG000|NOT COMPLETED|Extension Phase||17
8876275|NCT01915563|9933127|FG000|STARTED|Overall Study||243
8876276|NCT01915563|9933128|FG001|STARTED|Overall Study||227
8876277|NCT01915563|9933127|FG000|COMPLETED|Overall Study||243
8876278|NCT01915563|9933128|FG001|COMPLETED|Overall Study||227
8963503|NCT02550743|10026943|FG003|STARTED|Overall Study||0
8963504|NCT02550743|10026940|FG000|COMPLETED|Overall Study||3
8963505|NCT02550743|10026941|FG001|COMPLETED|Overall Study||3
8963506|NCT02550743|10026942|FG002|COMPLETED|Overall Study||1
8963507|NCT02550743|10026943|FG003|COMPLETED|Overall Study||0
8963508|NCT02550743|10026940|FG000|NOT COMPLETED|Overall Study||0
8876279|NCT01915563|9933127|FG000|NOT COMPLETED|Overall Study||0
8876280|NCT01915563|9933128|FG001|NOT COMPLETED|Overall Study||0
8876281|NCT01915732|9933136|FG000|STARTED|Overall Study||500
8876282|NCT01915732|9933137|FG001|STARTED|Overall Study||516
8876283|NCT01915732|9933136|FG000|COMPLETED|Overall Study||430
8876284|NCT01915732|9933137|FG001|COMPLETED|Overall Study||445
8876285|NCT01915732|9933136|FG000|NOT COMPLETED|Overall Study||70
8876286|NCT01915732|9933137|FG001|NOT COMPLETED|Overall Study||71
8876287|NCT01915771|9933143|FG000|STARTED|Day 1||15
8876288|NCT01915771|9933143|FG000|COMPLETED|Day 1||14
8876289|NCT01915771|9933143|FG000|NOT COMPLETED|Day 1||1
8963509|NCT02550743|10026941|FG001|NOT COMPLETED|Overall Study||0
8963510|NCT02550743|10026942|FG002|NOT COMPLETED|Overall Study||0
8963511|NCT02550743|10026943|FG003|NOT COMPLETED|Overall Study||0
8963512|NCT02550795|10026957|FG000|STARTED|Overall Study||50
8963513|NCT02550795|10026958|FG001|STARTED|Overall Study||50
8963514|NCT02550795|10026959|FG002|STARTED|Overall Study||50
8963515|NCT02550795|10026957|FG000|COMPLETED|Overall Study||50
8876290|NCT01915771|9933143|FG000|STARTED|Day 15||14
8876291|NCT01915771|9933143|FG000|COMPLETED|Day 15||13
8876292|NCT01915771|9933143|FG000|NOT COMPLETED|Day 15||1
8876293|NCT01915823|9933153|FG000|STARTED|Overall Study||173
8876294|NCT01915823|9933154|FG001|STARTED|Overall Study||175
8876295|NCT01915823|9933153|FG000|COMPLETED|Overall Study||171
8876296|NCT01915823|9933154|FG001|COMPLETED|Overall Study||173
8876297|NCT01915823|9933153|FG000|NOT COMPLETED|Overall Study||2
8876298|NCT01915823|9933154|FG001|NOT COMPLETED|Overall Study||2
8876299|NCT01915849|9933164|FG000|STARTED|Treatment Period 1 (4 Days)||5
8876300|NCT01915849|9933165|FG001|STARTED|Treatment Period 1 (4 Days)||3
8876301|NCT01915849|9933166|FG002|STARTED|Treatment Period 1 (4 Days)||3
8876302|NCT01915849|9933167|FG003|STARTED|Treatment Period 1 (4 Days)||3
8876303|NCT01915849|9933164|FG000|COMPLETED|Treatment Period 1 (4 Days)||3
8876304|NCT01915849|9933165|FG001|COMPLETED|Treatment Period 1 (4 Days)||3
8876305|NCT01915849|9933166|FG002|COMPLETED|Treatment Period 1 (4 Days)||3
8876306|NCT01915849|9933167|FG003|COMPLETED|Treatment Period 1 (4 Days)||3
8876307|NCT01915849|9933164|FG000|NOT COMPLETED|Treatment Period 1 (4 Days)||2
8876308|NCT01915849|9933165|FG001|NOT COMPLETED|Treatment Period 1 (4 Days)||0
8876309|NCT01915849|9933166|FG002|NOT COMPLETED|Treatment Period 1 (4 Days)||0
8876310|NCT01915849|9933167|FG003|NOT COMPLETED|Treatment Period 1 (4 Days)||0
8876311|NCT01915849|9933164|FG000|STARTED|Treatment Period 2 (4 Days)||3
8876312|NCT01915849|9933165|FG001|STARTED|Treatment Period 2 (4 Days)||3
8876313|NCT01915849|9933166|FG002|STARTED|Treatment Period 2 (4 Days)||3
8876314|NCT01915849|9933167|FG003|STARTED|Treatment Period 2 (4 Days)||3
8876315|NCT01915849|9933164|FG000|COMPLETED|Treatment Period 2 (4 Days)||3
8876316|NCT01915849|9933165|FG001|COMPLETED|Treatment Period 2 (4 Days)||3
8876317|NCT01915849|9933166|FG002|COMPLETED|Treatment Period 2 (4 Days)||3
8876318|NCT01915849|9933167|FG003|COMPLETED|Treatment Period 2 (4 Days)||3
8876319|NCT01915849|9933164|FG000|NOT COMPLETED|Treatment Period 2 (4 Days)||0
8876320|NCT01915849|9933165|FG001|NOT COMPLETED|Treatment Period 2 (4 Days)||0
8876321|NCT01915849|9933166|FG002|NOT COMPLETED|Treatment Period 2 (4 Days)||0
8876322|NCT01915849|9933167|FG003|NOT COMPLETED|Treatment Period 2 (4 Days)||0
8876323|NCT01915849|9933164|FG000|STARTED|Treatment Period 3 (4 Days)||3
8876324|NCT01915849|9933165|FG001|STARTED|Treatment Period 3 (4 Days)||3
8876325|NCT01915849|9933166|FG002|STARTED|Treatment Period 3 (4 Days)||3
8876326|NCT01915849|9933167|FG003|STARTED|Treatment Period 3 (4 Days)||3
8876327|NCT01915849|9933164|FG000|COMPLETED|Treatment Period 3 (4 Days)||3
8876328|NCT01915849|9933165|FG001|COMPLETED|Treatment Period 3 (4 Days)||3
8876329|NCT01915849|9933166|FG002|COMPLETED|Treatment Period 3 (4 Days)||3
8876330|NCT01915849|9933167|FG003|COMPLETED|Treatment Period 3 (4 Days)||3
8876331|NCT01915849|9933164|FG000|NOT COMPLETED|Treatment Period 3 (4 Days)||0
8876332|NCT01915849|9933165|FG001|NOT COMPLETED|Treatment Period 3 (4 Days)||0
8876333|NCT01915849|9933166|FG002|NOT COMPLETED|Treatment Period 3 (4 Days)||0
8876334|NCT01915849|9933167|FG003|NOT COMPLETED|Treatment Period 3 (4 Days)||0
8876335|NCT01915849|9933164|FG000|STARTED|Treatment Period 4 (4 Days)||3
8876336|NCT01915849|9933165|FG001|STARTED|Treatment Period 4 (4 Days)||3
8876337|NCT01915849|9933166|FG002|STARTED|Treatment Period 4 (4 Days)||3
8876338|NCT01915849|9933167|FG003|STARTED|Treatment Period 4 (4 Days)||3
8876339|NCT01915849|9933164|FG000|COMPLETED|Treatment Period 4 (4 Days)||3
8876340|NCT01915849|9933165|FG001|COMPLETED|Treatment Period 4 (4 Days)||3
8876341|NCT01915849|9933166|FG002|COMPLETED|Treatment Period 4 (4 Days)||3
8876342|NCT01915849|9933167|FG003|COMPLETED|Treatment Period 4 (4 Days)||3
8876343|NCT01915849|9933164|FG000|NOT COMPLETED|Treatment Period 4 (4 Days)||0
8876344|NCT01915849|9933165|FG001|NOT COMPLETED|Treatment Period 4 (4 Days)||0
8876345|NCT01915849|9933166|FG002|NOT COMPLETED|Treatment Period 4 (4 Days)||0
8876346|NCT01915849|9933167|FG003|NOT COMPLETED|Treatment Period 4 (4 Days)||0
8876347|NCT01915914|9933177|FG000|STARTED|Acute Phase||123
8876348|NCT01915914|9933178|FG001|STARTED|Acute Phase||0
8876349|NCT01915914|9933179|FG002|STARTED|Acute Phase||0
8876350|NCT01915914|9933180|FG003|STARTED|Acute Phase||0
8876351|NCT01915914|9933177|FG000|Completed-Not Entered Maintenance Phase|Acute Phase||4
8876352|NCT01915914|9933178|FG001|Completed-Not Entered Maintenance Phase|Acute Phase||0
8876353|NCT01915914|9933179|FG002|Completed-Not Entered Maintenance Phase|Acute Phase||0
8876354|NCT01915914|9933180|FG003|Completed-Not Entered Maintenance Phase|Acute Phase||0
8876355|NCT01915914|9933177|FG000|COMPLETED|Acute Phase||111
8876356|NCT01915914|9933178|FG001|COMPLETED|Acute Phase||0
8876357|NCT01915914|9933179|FG002|COMPLETED|Acute Phase||0
8876358|NCT01915914|9933180|FG003|COMPLETED|Acute Phase||0
8876359|NCT01915914|9933177|FG000|NOT COMPLETED|Acute Phase||12
8876360|NCT01915914|9933178|FG001|NOT COMPLETED|Acute Phase||0
8963516|NCT02550795|10026958|FG001|COMPLETED|Overall Study||49
8963517|NCT02550795|10026959|FG002|COMPLETED|Overall Study||50
8876361|NCT01915914|9933179|FG002|NOT COMPLETED|Acute Phase||0
8876362|NCT01915914|9933180|FG003|NOT COMPLETED|Acute Phase||0
8876363|NCT01915914|9933177|FG000|STARTED|Maintenance Phase||0
8876364|NCT01915914|9933178|FG001|STARTED|Maintenance Phase||54
8876365|NCT01915914|9933179|FG002|STARTED|Maintenance Phase||53
8963518|NCT02550795|10026957|FG000|NOT COMPLETED|Overall Study||0
8876366|NCT01915914|9933180|FG003|STARTED|Maintenance Phase||0
8876367|NCT01915914|9933177|FG000|COMPLETED|Maintenance Phase||0
8876368|NCT01915914|9933178|FG001|COMPLETED|Maintenance Phase||48
8876369|NCT01915914|9933179|FG002|COMPLETED|Maintenance Phase||51
8876370|NCT01915914|9933180|FG003|COMPLETED|Maintenance Phase||0
8876371|NCT01915914|9933177|FG000|NOT COMPLETED|Maintenance Phase||0
8876372|NCT01915914|9933178|FG001|NOT COMPLETED|Maintenance Phase||6
8876373|NCT01915914|9933179|FG002|NOT COMPLETED|Maintenance Phase||2
8876374|NCT01915914|9933180|FG003|NOT COMPLETED|Maintenance Phase||0
8876375|NCT01915914|9933177|FG000|STARTED|Follow-up Phase||0
8876376|NCT01915914|9933178|FG001|STARTED|Follow-up Phase||0
8876377|NCT01915914|9933179|FG002|STARTED|Follow-up Phase||0
8876378|NCT01915914|9933180|FG003|STARTED|Follow-up Phase||66
8876379|NCT01915914|9933177|FG000|COMPLETED|Follow-up Phase||0
8876380|NCT01915914|9933178|FG001|COMPLETED|Follow-up Phase||0
8876381|NCT01915914|9933179|FG002|COMPLETED|Follow-up Phase||0
8876382|NCT01915914|9933180|FG003|COMPLETED|Follow-up Phase||64
8876383|NCT01915914|9933177|FG000|NOT COMPLETED|Follow-up Phase||0
8876384|NCT01915914|9933178|FG001|NOT COMPLETED|Follow-up Phase||0
8876385|NCT01915914|9933179|FG002|NOT COMPLETED|Follow-up Phase||0
8876386|NCT01915914|9933180|FG003|NOT COMPLETED|Follow-up Phase||2
8876387|NCT01915940|9933200|FG000|STARTED|Pre-randomization Washout Period||169
8876388|NCT01915940|9933201|FG001|STARTED|Pre-randomization Washout Period||0
8876389|NCT01915940|9933202|FG002|STARTED|Pre-randomization Washout Period||0
8876390|NCT01915940|9933200|FG000|COMPLETED|Pre-randomization Washout Period||130
8876391|NCT01915940|9933201|FG001|COMPLETED|Pre-randomization Washout Period||0
8876392|NCT01915940|9933202|FG002|COMPLETED|Pre-randomization Washout Period||0
8876393|NCT01915940|9933200|FG000|NOT COMPLETED|Pre-randomization Washout Period||39
8876394|NCT01915940|9933201|FG001|NOT COMPLETED|Pre-randomization Washout Period||0
8876395|NCT01915940|9933202|FG002|NOT COMPLETED|Pre-randomization Washout Period||0
8876396|NCT01915940|9933200|FG000|STARTED|Treatment Period||0
8876397|NCT01915940|9933201|FG001|STARTED|Treatment Period||64
8876398|NCT01915940|9933202|FG002|STARTED|Treatment Period||66
8876399|NCT01915940|9933200|FG000|COMPLETED|Treatment Period||0
8963519|NCT02550795|10026958|FG001|NOT COMPLETED|Overall Study||1
8963520|NCT02550795|10026959|FG002|NOT COMPLETED|Overall Study||0
8963521|NCT02550938|10026971|FG000|STARTED|Overall Study||44
8963522|NCT02550938|10026972|FG001|STARTED|Overall Study||85
8963523|NCT02550938|10026973|FG002|STARTED|Overall Study||43
8963524|NCT02550938|10026974|FG003|STARTED|Overall Study||81
8963525|NCT02550938|10026971|FG000|COMPLETED|Overall Study||36
8963526|NCT02550938|10026972|FG001|COMPLETED|Overall Study||78
8963527|NCT02550938|10026973|FG002|COMPLETED|Overall Study||31
8963528|NCT02550938|10026974|FG003|COMPLETED|Overall Study||70
8963529|NCT02550938|10026971|FG000|NOT COMPLETED|Overall Study||8
8963530|NCT02550938|10026972|FG001|NOT COMPLETED|Overall Study||7
8963531|NCT02550938|10026973|FG002|NOT COMPLETED|Overall Study||12
8963532|NCT02550938|10026974|FG003|NOT COMPLETED|Overall Study||11
8963533|NCT02551055|10026991|FG000|STARTED|Overall Study||4
8963534|NCT02551055|10026992|FG001|STARTED|Overall Study||6
8963535|NCT02551055|10026993|FG002|STARTED|Overall Study||3
8963536|NCT02551055|10026994|FG003|STARTED|Overall Study||6
8963537|NCT02551055|10026995|FG004|STARTED|Overall Study||7
8963538|NCT02551055|10026996|FG005|STARTED|Overall Study||2
8963539|NCT02551055|10026997|FG006|STARTED|Overall Study||4
8963540|NCT02551055|10026998|FG007|STARTED|Overall Study||0
8963541|NCT02551055|10026991|FG000|COMPLETED|Overall Study||0
8963542|NCT02551055|10026992|FG001|COMPLETED|Overall Study||0
8963543|NCT02551055|10026993|FG002|COMPLETED|Overall Study||1
8963544|NCT02551055|10026994|FG003|COMPLETED|Overall Study||1
8570524|NCT00104104|9602703|FG000|Safety Population (Excluding Site 74)|Overall Study|Because of GCP violations at Site 74, post-baseline data for 3 patients in this arm were excluded.|85
8570525|NCT00104104|9602704|FG001|Safety Population (Excluding Site 74)|Overall Study|Because of GCP violations at Site 74, post-baseline data for 4 patients in this arm were excluded.|84
8570526|NCT00104104|9602703|FG000|COMPLETED|Overall Study||15
8570527|NCT00104104|9602704|FG001|COMPLETED|Overall Study||17
8570528|NCT00104104|9602703|FG000|NOT COMPLETED|Overall Study||75
8570529|NCT00104104|9602704|FG001|NOT COMPLETED|Overall Study||72
8570530|NCT00104234|9602712|FG000|STARTED|Overall Study||19
8570531|NCT00104234|9602713|FG001|STARTED|Overall Study||20
8570532|NCT00104234|9602712|FG000|COMPLETED|Overall Study||19
8963545|NCT02551055|10026995|FG004|COMPLETED|Overall Study||0
8963546|NCT02551055|10026996|FG005|COMPLETED|Overall Study||1
8963547|NCT02551055|10026997|FG006|COMPLETED|Overall Study||1
8963548|NCT02551055|10026998|FG007|COMPLETED|Overall Study||0
8963549|NCT02551055|10026991|FG000|NOT COMPLETED|Overall Study||4
8963550|NCT02551055|10026992|FG001|NOT COMPLETED|Overall Study||6
8963551|NCT02551055|10026993|FG002|NOT COMPLETED|Overall Study||2
8963552|NCT02551055|10026994|FG003|NOT COMPLETED|Overall Study||5
8963553|NCT02551055|10026995|FG004|NOT COMPLETED|Overall Study||7
8570533|NCT00104234|9602713|FG001|COMPLETED|Overall Study||19
8876400|NCT01915940|9933201|FG001|COMPLETED|Treatment Period||53
8963554|NCT02551055|10026996|FG005|NOT COMPLETED|Overall Study||1
8876401|NCT01915940|9933202|FG002|COMPLETED|Treatment Period||62
8876402|NCT01915940|9933200|FG000|NOT COMPLETED|Treatment Period||0
8876403|NCT01915940|9933201|FG001|NOT COMPLETED|Treatment Period||11
8876404|NCT01915940|9933202|FG002|NOT COMPLETED|Treatment Period||4
8963555|NCT02551055|10026997|FG006|NOT COMPLETED|Overall Study||3
8963556|NCT02551055|10026998|FG007|NOT COMPLETED|Overall Study||0
8963557|NCT02551094|10027018|FG000|STARTED|Overall Study||2366
8876405|NCT01916109|9933208|FG000|STARTED|Overall Study||4
8876406|NCT01916109|9933208|FG000|COMPLETED|Overall Study||3
8876407|NCT01916109|9933208|FG000|NOT COMPLETED|Overall Study||1
8876408|NCT01916226|9933216|FG000|STARTED|Overall Study||170
8876409|NCT01916226|9933217|FG001|STARTED|Overall Study||170
8876410|NCT01916226|9933218|FG002|STARTED|Overall Study||171
8876411|NCT01916226|9933219|FG003|STARTED|Overall Study||171
8876412|NCT01916226|9933216|FG000|COMPLETED|Overall Study||169
8876413|NCT01916226|9933217|FG001|COMPLETED|Overall Study||169
8876414|NCT01916226|9933218|FG002|COMPLETED|Overall Study||168
8876415|NCT01916226|9933219|FG003|COMPLETED|Overall Study||167
8876416|NCT01916226|9933216|FG000|NOT COMPLETED|Overall Study||1
8876417|NCT01916226|9933217|FG001|NOT COMPLETED|Overall Study||1
8876418|NCT01916226|9933218|FG002|NOT COMPLETED|Overall Study||3
8876419|NCT01916226|9933219|FG003|NOT COMPLETED|Overall Study||4
8876420|NCT01916304|9933230|FG000|STARTED|Overall Study||101
8876421|NCT01916304|9933230|FG000|Safety Set|Overall Study||101
8876422|NCT01916304|9933230|FG000|Intent-to-Treat Set|Overall Study||84
8876423|NCT01916304|9933230|FG000|COMPLETED|Overall Study||84
8876424|NCT01916304|9933230|FG000|NOT COMPLETED|Overall Study||17
8876425|NCT01916629|9933236|FG000|STARTED|Overall Study||7
8876426|NCT01916629|9933237|FG001|STARTED|Overall Study||5
8876427|NCT01916629|9933236|FG000|COMPLETED|Overall Study||7
8876428|NCT01916629|9933237|FG001|COMPLETED|Overall Study||5
8876429|NCT01916629|9933236|FG000|NOT COMPLETED|Overall Study||0
8876430|NCT01916629|9933237|FG001|NOT COMPLETED|Overall Study||0
8876431|NCT01916655|9933246|FG000|STARTED|Overall Study||131
8876432|NCT01916655|9933247|FG001|STARTED|Overall Study||109
8876433|NCT01916655|9933248|FG002|STARTED|Overall Study||120
8876434|NCT01916655|9933246|FG000|COMPLETED|Overall Study||116
8876435|NCT01916655|9933247|FG001|COMPLETED|Overall Study||89
8876436|NCT01916655|9933248|FG002|COMPLETED|Overall Study||91
8876437|NCT01916655|9933246|FG000|NOT COMPLETED|Overall Study||15
8876438|NCT01916655|9933247|FG001|NOT COMPLETED|Overall Study||20
8876439|NCT01916655|9933248|FG002|NOT COMPLETED|Overall Study||29
8876440|NCT01916681|9933260|FG000|STARTED|Overall Study||123
8876441|NCT01916681|9933261|FG001|STARTED|Overall Study||120
8876442|NCT01916681|9933262|FG002|STARTED|Overall Study||123
8876443|NCT01916681|9933263|FG003|STARTED|Overall Study||125
8876444|NCT01916681|9933260|FG000|COMPLETED|Overall Study||123
8876445|NCT01916681|9933261|FG001|COMPLETED|Overall Study||120
8876446|NCT01916681|9933262|FG002|COMPLETED|Overall Study||123
8876447|NCT01916681|9933263|FG003|COMPLETED|Overall Study||125
8876448|NCT01916681|9933260|FG000|NOT COMPLETED|Overall Study||0
8876449|NCT01916681|9933261|FG001|NOT COMPLETED|Overall Study||0
8876450|NCT01916681|9933262|FG002|NOT COMPLETED|Overall Study||0
8876451|NCT01916681|9933263|FG003|NOT COMPLETED|Overall Study||0
8876452|NCT01916824|9933276|FG000|STARTED|Overall Study||24
8876453|NCT01916824|9933277|FG001|STARTED|Overall Study||29
8876454|NCT01916824|9933276|FG000|COMPLETED|Overall Study||17
8876455|NCT01916824|9933277|FG001|COMPLETED|Overall Study||20
8876456|NCT01916824|9933276|FG000|NOT COMPLETED|Overall Study||7
8876457|NCT01916824|9933277|FG001|NOT COMPLETED|Overall Study||9
8876458|NCT01916928|9933283|FG000|STARTED|Overall Study||50
8876459|NCT01916928|9933283|FG000|COMPLETED|Overall Study||50
8876460|NCT01916928|9933283|FG000|NOT COMPLETED|Overall Study||0
8876461|NCT01916941|9933289|FG000|STARTED|Overall Study||18
8876462|NCT01916941|9933290|FG001|STARTED|Overall Study||18
8876463|NCT01916941|9933289|FG000|COMPLETED|Overall Study||13
8876464|NCT01916941|9933290|FG001|COMPLETED|Overall Study||14
8876465|NCT01916941|9933289|FG000|NOT COMPLETED|Overall Study||5
8876466|NCT01916941|9933290|FG001|NOT COMPLETED|Overall Study||4
8963558|NCT02551094|10027019|FG001|STARTED|Overall Study||2379
8963559|NCT02551094|10027018|FG000|COMPLETED|Overall Study||2226
8963560|NCT02551094|10027019|FG001|COMPLETED|Overall Study||2232
8963561|NCT02551094|10027018|FG000|NOT COMPLETED|Overall Study||140
8963562|NCT02551094|10027019|FG001|NOT COMPLETED|Overall Study||147
8963563|NCT02551159|10027028|FG000|STARTED|Overall Study||413
8963564|NCT02551159|10027029|FG001|STARTED|Overall Study||204
8963565|NCT02551159|10027030|FG002|STARTED|Overall Study||206
8963566|NCT02551159|10027028|FG000|Full Analysis Set|Overall Study||413
8963567|NCT02551159|10027029|FG001|Full Analysis Set|Overall Study||204
8963568|NCT02551159|10027030|FG002|Full Analysis Set|Overall Study||206
8963569|NCT02551159|10027028|FG000|Safety Analysis Set|Overall Study||408
8963570|NCT02551159|10027029|FG001|Safety Analysis Set|Overall Study||202
8963571|NCT02551159|10027030|FG002|Safety Analysis Set|Overall Study||196
8963572|NCT02551159|10027028|FG000|PD-L1 TC/IC High Subgroup Analysis Set|Overall Study||190
8963573|NCT02551159|10027029|FG001|PD-L1 TC/IC High Subgroup Analysis Set|Overall Study||99
8963574|NCT02551159|10027030|FG002|PD-L1 TC/IC High Subgroup Analysis Set|Overall Study||94
8963575|NCT02551159|10027028|FG000|COMPLETED|Overall Study||0
8963576|NCT02551159|10027029|FG001|COMPLETED|Overall Study||0
8963577|NCT02551159|10027030|FG002|COMPLETED|Overall Study||0
8963578|NCT02551159|10027028|FG000|NOT COMPLETED|Overall Study||413
8963579|NCT02551159|10027029|FG001|NOT COMPLETED|Overall Study||204
8963580|NCT02551159|10027030|FG002|NOT COMPLETED|Overall Study||206
8963581|NCT02551224|10027038|FG000|STARTED|First Intervention||50
8963582|NCT02551224|10027039|FG001|STARTED|First Intervention||50
8963583|NCT02551224|10027038|FG000|COMPLETED|First Intervention||50
8963584|NCT02551224|10027039|FG001|COMPLETED|First Intervention||50
8963585|NCT02551224|10027038|FG000|NOT COMPLETED|First Intervention||0
8963586|NCT02551224|10027039|FG001|NOT COMPLETED|First Intervention||0
8963587|NCT02551224|10027038|FG000|STARTED|Second Intervention (5 Min After First )||50
8963588|NCT02551224|10027039|FG001|STARTED|Second Intervention (5 Min After First )||50
8963589|NCT02551224|10027038|FG000|COMPLETED|Second Intervention (5 Min After First )||50
8963590|NCT02551224|10027039|FG001|COMPLETED|Second Intervention (5 Min After First )||50
8963591|NCT02551224|10027038|FG000|NOT COMPLETED|Second Intervention (5 Min After First )||0
8963592|NCT02551224|10027039|FG001|NOT COMPLETED|Second Intervention (5 Min After First )||0
8963593|NCT02551432|10027045|FG000|STARTED|Overall Study||26
8963594|NCT02551432|10027045|FG000|COMPLETED|Overall Study||26
8963595|NCT02551432|10027045|FG000|NOT COMPLETED|Overall Study||0
8963596|NCT02551653|10027051|FG000|STARTED|Overall Study||5
8963597|NCT02551653|10027052|FG001|STARTED|Overall Study||5
8963598|NCT02551653|10027051|FG000|COMPLETED|Overall Study||5
8963599|NCT02551653|10027052|FG001|COMPLETED|Overall Study||5
8963600|NCT02551653|10027051|FG000|NOT COMPLETED|Overall Study||0
8963601|NCT02551653|10027052|FG001|NOT COMPLETED|Overall Study||0
8963602|NCT02551666|10027060|FG000|STARTED|Overall Study||16
8631663|NCT00541242|9671544|FG000|STARTED|Treatment Period 2||270
8963603|NCT02551666|10027061|FG001|STARTED|Overall Study||19
8631664|NCT00541242|9671545|FG001|STARTED|Treatment Period 2||273
8631665|NCT00541242|9671544|FG000|COMPLETED|Treatment Period 2||261
8963604|NCT02551666|10027060|FG000|COMPLETED|Overall Study||15
8963605|NCT02551666|10027061|FG001|COMPLETED|Overall Study||16
8963606|NCT02551666|10027060|FG000|NOT COMPLETED|Overall Study||1
8963607|NCT02551666|10027061|FG001|NOT COMPLETED|Overall Study||3
8963608|NCT02551692|10027070|FG000|STARTED|Overall Study||31
8963609|NCT02551692|10027071|FG001|STARTED|Overall Study||27
8963610|NCT02551692|10027072|FG002|STARTED|Overall Study||30
8963611|NCT02551692|10027070|FG000|COMPLETED|Overall Study||30
8963612|NCT02551692|10027071|FG001|COMPLETED|Overall Study||26
8963613|NCT02551692|10027072|FG002|COMPLETED|Overall Study||25
8963614|NCT02551692|10027070|FG000|NOT COMPLETED|Overall Study||1
8963615|NCT02551692|10027071|FG001|NOT COMPLETED|Overall Study||1
8963616|NCT02551692|10027072|FG002|NOT COMPLETED|Overall Study||5
8963617|NCT02551731|10027080|FG000|STARTED|Overall Study||9
8963618|NCT02551731|10027080|FG000|COMPLETED|Overall Study||7
8963619|NCT02551731|10027080|FG000|NOT COMPLETED|Overall Study||2
8631666|NCT00541242|9671545|FG001|COMPLETED|Treatment Period 2||266
8631667|NCT00541242|9671544|FG000|NOT COMPLETED|Treatment Period 2||9
8631668|NCT00541242|9671545|FG001|NOT COMPLETED|Treatment Period 2||7
8631669|NCT00541307|9671551|FG000|STARTED|Overall Study||119
8631670|NCT00541307|9671551|FG000|COMPLETED|Overall Study||95
8631671|NCT00541307|9671551|FG000|NOT COMPLETED|Overall Study||24
8631672|NCT00541346|9671555|FG000|STARTED|Baseline||16
8631673|NCT00541346|9671555|FG000|COMPLETED|Baseline||16
8963620|NCT02551744|10027086|FG000|STARTED|Overall Study||50
8963621|NCT02551744|10027087|FG001|STARTED|Overall Study||51
8963622|NCT02551744|10027086|FG000|COMPLETED|Overall Study||50
8963623|NCT02551744|10027087|FG001|COMPLETED|Overall Study||51
8963624|NCT02551744|10027086|FG000|NOT COMPLETED|Overall Study||0
8963625|NCT02551744|10027087|FG001|NOT COMPLETED|Overall Study||0
8963626|NCT02551757|10027095|FG000|STARTED|Overall Study||20
8963627|NCT02551757|10027096|FG001|STARTED|Overall Study||20
8963628|NCT02551757|10027095|FG000|COMPLETED|Overall Study||13
8963629|NCT02551757|10027096|FG001|COMPLETED|Overall Study||17
8963630|NCT02551757|10027095|FG000|NOT COMPLETED|Overall Study||7
8963631|NCT02551757|10027096|FG001|NOT COMPLETED|Overall Study||3
8963632|NCT02551770|10027106|FG000|STARTED|Overall Study||51
8963633|NCT02551770|10027107|FG001|STARTED|Overall Study||51
8963634|NCT02551770|10027106|FG000|COMPLETED|Overall Study||48
8963635|NCT02551770|10027107|FG001|COMPLETED|Overall Study||48
8963636|NCT02551770|10027106|FG000|NOT COMPLETED|Overall Study||3
8963637|NCT02551770|10027107|FG001|NOT COMPLETED|Overall Study||3
8963638|NCT02551809|10027115|FG000|STARTED|Overall Study||14
8963639|NCT02551809|10027116|FG001|STARTED|Overall Study||15
8963640|NCT02551809|10027117|FG002|STARTED|Overall Study||14
8963641|NCT02551809|10027115|FG000|COMPLETED|Overall Study||14
8963642|NCT02551809|10027116|FG001|COMPLETED|Overall Study||14
8963643|NCT02551809|10027117|FG002|COMPLETED|Overall Study||13
8963644|NCT02551809|10027115|FG000|NOT COMPLETED|Overall Study||0
8963645|NCT02551809|10027116|FG001|NOT COMPLETED|Overall Study||1
8963646|NCT02551809|10027117|FG002|NOT COMPLETED|Overall Study||1
8963647|NCT02551822|10027127|FG000|STARTED|Overall Study||11
8963648|NCT02551822|10027128|FG001|STARTED|Overall Study||12
8963649|NCT02551822|10027127|FG000|COMPLETED|Overall Study||9
8963650|NCT02551822|10027128|FG001|COMPLETED|Overall Study||10
8963651|NCT02551822|10027127|FG000|NOT COMPLETED|Overall Study||2
8963652|NCT02551822|10027128|FG001|NOT COMPLETED|Overall Study||2
8963653|NCT02551874|10027136|FG000|STARTED|Overall Study||324
8963654|NCT02551874|10027137|FG001|STARTED|Overall Study||326
8963655|NCT02551874|10027136|FG000|Received Treatment in Short-term Study|Overall Study||324
8631674|NCT00541346|9671555|FG000|NOT COMPLETED|Baseline||0
8631675|NCT00541346|9671555|FG000|STARTED|Follow-up||16
8631676|NCT00541346|9671555|FG000|COMPLETED|Follow-up||15
8963656|NCT02551874|10027137|FG001|Received Treatment in Short-term Study|Overall Study||319
8963657|NCT02551874|10027136|FG000|Entered Long-term Study|Overall Study||306
8963658|NCT02551874|10027137|FG001|Entered Long-term Study|Overall Study||294
8963659|NCT02551874|10027136|FG000|Received Treatment in Long-term Study|Overall Study||295
8963660|NCT02551874|10027137|FG001|Received Treatment in Long-term Study|Overall Study||284
8963661|NCT02551874|10027136|FG000|COMPLETED|Overall Study||296
8963662|NCT02551874|10027137|FG001|COMPLETED|Overall Study||287
8963663|NCT02551874|10027136|FG000|NOT COMPLETED|Overall Study||28
8963664|NCT02551874|10027137|FG001|NOT COMPLETED|Overall Study||39
8963665|NCT02551887|10027146|FG000|STARTED|Overall Study||301
8963666|NCT02551887|10027147|FG001|STARTED|Overall Study||124
8963667|NCT02551887|10027148|FG002|STARTED|Overall Study||222
8631677|NCT00541346|9671555|FG000|NOT COMPLETED|Follow-up||1
8631678|NCT00541385|9671561|FG000|STARTED|Overall Study||355
8963668|NCT02551887|10027146|FG000|COMPLETED|Overall Study||301
8963669|NCT02551887|10027147|FG001|COMPLETED|Overall Study||124
8963670|NCT02551887|10027148|FG002|COMPLETED|Overall Study||222
8963671|NCT02551887|10027146|FG000|NOT COMPLETED|Overall Study||0
8963672|NCT02551887|10027147|FG001|NOT COMPLETED|Overall Study||0
8963673|NCT02551887|10027148|FG002|NOT COMPLETED|Overall Study||0
8963674|NCT02552121|10027164|FG000|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||3
8963675|NCT02552121|10027165|FG001|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
8963676|NCT02552121|10027166|FG002|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
8963677|NCT02552121|10027167|FG003|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
8963678|NCT02552121|10027168|FG004|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
8963679|NCT02552121|10027169|FG005|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
8963680|NCT02552121|10027170|FG006|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
8963681|NCT02552121|10027171|FG007|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
8963682|NCT02552121|10027164|FG000|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
8963683|NCT02552121|10027165|FG001|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
8963684|NCT02552121|10027166|FG002|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
8963685|NCT02552121|10027167|FG003|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
8963686|NCT02552121|10027168|FG004|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
8963687|NCT02552121|10027169|FG005|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
8963688|NCT02552121|10027170|FG006|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
8963689|NCT02552121|10027171|FG007|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
8963690|NCT02552121|10027164|FG000|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||3
8963691|NCT02552121|10027165|FG001|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
8963692|NCT02552121|10027166|FG002|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
8963693|NCT02552121|10027167|FG003|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
8963694|NCT02552121|10027168|FG004|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
8963695|NCT02552121|10027169|FG005|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
8963696|NCT02552121|10027170|FG006|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
8963697|NCT02552121|10027171|FG007|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
8963698|NCT02552121|10027164|FG000|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
8963699|NCT02552121|10027165|FG001|STARTED|Part 1: Dose Level 2 (Week 17-48)||6
8963700|NCT02552121|10027166|FG002|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
8963701|NCT02552121|10027167|FG003|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
8963702|NCT02552121|10027168|FG004|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
8963703|NCT02552121|10027169|FG005|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
8963704|NCT02552121|10027170|FG006|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
8963705|NCT02552121|10027171|FG007|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
8963706|NCT02552121|10027164|FG000|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
8963707|NCT02552121|10027165|FG001|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
8963708|NCT02552121|10027166|FG002|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
8963709|NCT02552121|10027167|FG003|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
8963710|NCT02552121|10027168|FG004|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
8963711|NCT02552121|10027169|FG005|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
8963712|NCT02552121|10027170|FG006|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
8963713|NCT02552121|10027171|FG007|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
8963714|NCT02552121|10027164|FG000|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
8963715|NCT02552121|10027165|FG001|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||6
8963716|NCT02552121|10027166|FG002|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
8963717|NCT02552121|10027167|FG003|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
8963718|NCT02552121|10027168|FG004|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
8963719|NCT02552121|10027169|FG005|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
8963720|NCT02552121|10027170|FG006|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
8963721|NCT02552121|10027171|FG007|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
8963722|NCT02552121|10027164|FG000|STARTED|Part 2: Cohort Expansion||0
8963723|NCT02552121|10027165|FG001|STARTED|Part 2: Cohort Expansion||0
8963724|NCT02552121|10027166|FG002|STARTED|Part 2: Cohort Expansion||11
8963725|NCT02552121|10027167|FG003|STARTED|Part 2: Cohort Expansion||3
8963726|NCT02552121|10027168|FG004|STARTED|Part 2: Cohort Expansion||1
8963727|NCT02552121|10027169|FG005|STARTED|Part 2: Cohort Expansion||5
8963728|NCT02552121|10027170|FG006|STARTED|Part 2: Cohort Expansion||1
8963729|NCT02552121|10027171|FG007|STARTED|Part 2: Cohort Expansion||3
8963730|NCT02552121|10027164|FG000|COMPLETED|Part 2: Cohort Expansion||0
8963731|NCT02552121|10027165|FG001|COMPLETED|Part 2: Cohort Expansion||0
8963732|NCT02552121|10027166|FG002|COMPLETED|Part 2: Cohort Expansion||0
8963733|NCT02552121|10027167|FG003|COMPLETED|Part 2: Cohort Expansion||0
8963734|NCT02552121|10027168|FG004|COMPLETED|Part 2: Cohort Expansion||0
8963735|NCT02552121|10027169|FG005|COMPLETED|Part 2: Cohort Expansion||1
8963736|NCT02552121|10027170|FG006|COMPLETED|Part 2: Cohort Expansion||0
8963737|NCT02552121|10027171|FG007|COMPLETED|Part 2: Cohort Expansion||0
8963738|NCT02552121|10027164|FG000|NOT COMPLETED|Part 2: Cohort Expansion||0
8963739|NCT02552121|10027165|FG001|NOT COMPLETED|Part 2: Cohort Expansion||0
8963740|NCT02552121|10027166|FG002|NOT COMPLETED|Part 2: Cohort Expansion||11
8963741|NCT02552121|10027167|FG003|NOT COMPLETED|Part 2: Cohort Expansion||3
8963742|NCT02552121|10027168|FG004|NOT COMPLETED|Part 2: Cohort Expansion||1
8963743|NCT02552121|10027169|FG005|NOT COMPLETED|Part 2: Cohort Expansion||4
8963744|NCT02552121|10027170|FG006|NOT COMPLETED|Part 2: Cohort Expansion||1
8963745|NCT02552121|10027171|FG007|NOT COMPLETED|Part 2: Cohort Expansion||3
8963746|NCT02552147|10027203|FG000|STARTED|First Intervention (7 Days)||4
8963747|NCT02552147|10027204|FG001|STARTED|First Intervention (7 Days)||4
8963748|NCT02552147|10027203|FG000|COMPLETED|First Intervention (7 Days)||3
8963749|NCT02552147|10027204|FG001|COMPLETED|First Intervention (7 Days)||4
8963750|NCT02552147|10027203|FG000|NOT COMPLETED|First Intervention (7 Days)||1
8963751|NCT02552147|10027204|FG001|NOT COMPLETED|First Intervention (7 Days)||0
8963752|NCT02552147|10027203|FG000|STARTED|Washout (7 Days)||3
8963753|NCT02552147|10027204|FG001|STARTED|Washout (7 Days)||4
8963754|NCT02552147|10027203|FG000|COMPLETED|Washout (7 Days)||3
8963755|NCT02552147|10027204|FG001|COMPLETED|Washout (7 Days)||4
8963756|NCT02552147|10027203|FG000|NOT COMPLETED|Washout (7 Days)||0
8963757|NCT02552147|10027204|FG001|NOT COMPLETED|Washout (7 Days)||0
8963758|NCT02552147|10027203|FG000|STARTED|Second Intervention (7 Days)||3
8963759|NCT02552147|10027204|FG001|STARTED|Second Intervention (7 Days)||4
8963760|NCT02552147|10027203|FG000|COMPLETED|Second Intervention (7 Days)||1
8963761|NCT02552147|10027204|FG001|COMPLETED|Second Intervention (7 Days)||4
8963762|NCT02552147|10027203|FG000|NOT COMPLETED|Second Intervention (7 Days)||2
8963763|NCT02552147|10027204|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
8963764|NCT02552225|10027212|FG000|STARTED|Overall Study||3
8963765|NCT02552225|10027213|FG001|STARTED|Overall Study||3
8963766|NCT02552225|10027212|FG000|COMPLETED|Overall Study||2
8963767|NCT02552225|10027213|FG001|COMPLETED|Overall Study||3
8963768|NCT02552225|10027212|FG000|NOT COMPLETED|Overall Study||1
8963769|NCT02552225|10027213|FG001|NOT COMPLETED|Overall Study||0
8963770|NCT02552238|10027219|FG000|STARTED|Overall Study||174
8963771|NCT02552238|10027219|FG000|COMPLETED|Overall Study|Of the 174 subjects enrolled in the study, 2 withdrew consent prior to administration of investigational product and 2 discontinued due to post-dose adverse event. Therefore, 170 subjects completed the study.|170
8963772|NCT02552238|10027219|FG000|NOT COMPLETED|Overall Study||4
8963773|NCT02552303|10027234|FG000|STARTED|Allocation||10
8963774|NCT02552303|10027235|FG001|STARTED|Allocation||10
8963775|NCT02552303|10027236|FG002|STARTED|Allocation||8
8963776|NCT02552303|10027237|FG003|STARTED|Allocation||11
8963777|NCT02552303|10027234|FG000|COMPLETED|Allocation||7
8963778|NCT02552303|10027235|FG001|COMPLETED|Allocation||8
8963779|NCT02552303|10027236|FG002|COMPLETED|Allocation||7
8963780|NCT02552303|10027237|FG003|COMPLETED|Allocation||10
8963781|NCT02552303|10027234|FG000|NOT COMPLETED|Allocation||3
8963782|NCT02552303|10027235|FG001|NOT COMPLETED|Allocation||2
8963783|NCT02552303|10027236|FG002|NOT COMPLETED|Allocation||1
8963784|NCT02552303|10027237|FG003|NOT COMPLETED|Allocation||1
8963785|NCT02552303|10027234|FG000|STARTED|Follow-Up||7
8963786|NCT02552303|10027235|FG001|STARTED|Follow-Up||8
8963787|NCT02552303|10027236|FG002|STARTED|Follow-Up||7
8963788|NCT02552303|10027237|FG003|STARTED|Follow-Up||10
8963789|NCT02552303|10027234|FG000|COMPLETED|Follow-Up||7
8963790|NCT02552303|10027235|FG001|COMPLETED|Follow-Up||6
8963791|NCT02552303|10027236|FG002|COMPLETED|Follow-Up||6
8963792|NCT02552303|10027237|FG003|COMPLETED|Follow-Up||10
8963793|NCT02552303|10027234|FG000|NOT COMPLETED|Follow-Up||0
8963794|NCT02552303|10027235|FG001|NOT COMPLETED|Follow-Up||2
8963795|NCT02552303|10027236|FG002|NOT COMPLETED|Follow-Up||1
8963796|NCT02552303|10027237|FG003|NOT COMPLETED|Follow-Up||0
8963797|NCT02552316|10027247|FG000|STARTED|Overall Study||34
8963798|NCT02552316|10027247|FG000|COMPLETED|Overall Study||32
8963799|NCT02552316|10027247|FG000|NOT COMPLETED|Overall Study||2
8963800|NCT02552355|10027299|FG000|STARTED|Overall Study||14
8963801|NCT02552355|10027300|FG001|STARTED|Overall Study||13
8963802|NCT02552355|10027301|FG002|STARTED|Overall Study||14
8963803|NCT02552355|10027302|FG003|STARTED|Overall Study||15
8963804|NCT02552355|10027299|FG000|COMPLETED|Overall Study||14
8963805|NCT02552355|10027300|FG001|COMPLETED|Overall Study||11
8963806|NCT02552355|10027301|FG002|COMPLETED|Overall Study||12
8963807|NCT02552355|10027302|FG003|COMPLETED|Overall Study||14
8963808|NCT02552355|10027299|FG000|NOT COMPLETED|Overall Study||0
8963809|NCT02552355|10027300|FG001|NOT COMPLETED|Overall Study||2
8963810|NCT02552355|10027301|FG002|NOT COMPLETED|Overall Study||2
8963811|NCT02552355|10027302|FG003|NOT COMPLETED|Overall Study||1
8963812|NCT02552368|10027312|FG000|STARTED|Overall Study||23
8963813|NCT02552368|10027312|FG000|COMPLETED|Overall Study||10
8963814|NCT02552368|10027312|FG000|NOT COMPLETED|Overall Study||13
8963815|NCT02552732|10027317|FG000|STARTED|Overall Study||29
8963816|NCT02552732|10027317|FG000|Used Device|Overall Study||23
8963817|NCT02552732|10027317|FG000|Completed Week 1|Overall Study||21
8963818|NCT02552732|10027317|FG000|Completed Week 2|Overall Study||20
8963819|NCT02552732|10027317|FG000|Completed Week 3|Overall Study||19
8963820|NCT02552732|10027317|FG000|Completed Week 4|Overall Study||19
8963821|NCT02552732|10027317|FG000|Completed Day 1 and Day 31 Spirometry|Overall Study||12
8963822|NCT02552732|10027317|FG000|COMPLETED|Overall Study||19
8963823|NCT02552732|10027317|FG000|NOT COMPLETED|Overall Study||10
8963824|NCT02552810|10027324|FG000|STARTED|Overall Study||15
8963825|NCT02552810|10027325|FG001|STARTED|Overall Study||15
8963826|NCT02552810|10027324|FG000|COMPLETED|Overall Study||15
8963827|NCT02552810|10027325|FG001|COMPLETED|Overall Study||15
8963828|NCT02552810|10027324|FG000|NOT COMPLETED|Overall Study||0
8963829|NCT02552810|10027325|FG001|NOT COMPLETED|Overall Study||0
8963830|NCT02552888|10027333|FG000|STARTED|Overall Study|35 participants were enrolled.|35
8963831|NCT02552888|10027334|FG001|STARTED|Overall Study|35 participants were enrolled.|35
8963832|NCT02552888|10027333|FG000|COMPLETED|Overall Study|34 participants completed the study.|34
8963833|NCT02552888|10027334|FG001|COMPLETED|Overall Study|34 participants completed the study|34
8963834|NCT02552888|10027333|FG000|NOT COMPLETED|Overall Study||1
8963835|NCT02552888|10027334|FG001|NOT COMPLETED|Overall Study||1
8963836|NCT02552966|10027344|FG000|STARTED|Overall Study||20
8963837|NCT02552966|10027344|FG000|COMPLETED|Overall Study||15
8963838|NCT02552966|10027344|FG000|NOT COMPLETED|Overall Study||5
8963839|NCT02553135|10027348|FG000|STARTED|Overall Study||6
8963840|NCT02553135|10027348|FG000|COMPLETED|Overall Study||6
8963841|NCT02553135|10027348|FG000|NOT COMPLETED|Overall Study||0
8963842|NCT02553317|10027354|FG000|STARTED|Overall Treatment Period + Follow-up||72
8963843|NCT02553317|10027355|FG001|STARTED|Overall Treatment Period + Follow-up||73
8963844|NCT02553317|10027354|FG000|Received Study Drug|Overall Treatment Period + Follow-up||71
8963845|NCT02553317|10027355|FG001|Received Study Drug|Overall Treatment Period + Follow-up||73
8963846|NCT02553317|10027354|FG000|COMPLETED|Overall Treatment Period + Follow-up||58
8963847|NCT02553317|10027355|FG001|COMPLETED|Overall Treatment Period + Follow-up||50
8963848|NCT02553317|10027354|FG000|NOT COMPLETED|Overall Treatment Period + Follow-up||14
8963849|NCT02553317|10027355|FG001|NOT COMPLETED|Overall Treatment Period + Follow-up||23
8963850|NCT02553317|10027354|FG000|STARTED|Double-blind (DB) Treatment Period|One patient withdrew consent prior to first dosing and did not start the DB treatment period.|71
8963851|NCT02553317|10027355|FG001|STARTED|Double-blind (DB) Treatment Period||73
8963852|NCT02553317|10027354|FG000|COMPLETED|Double-blind (DB) Treatment Period||68
8963853|NCT02553317|10027355|FG001|COMPLETED|Double-blind (DB) Treatment Period||65
8963854|NCT02553317|10027354|FG000|NOT COMPLETED|Double-blind (DB) Treatment Period||3
8963855|NCT02553317|10027355|FG001|NOT COMPLETED|Double-blind (DB) Treatment Period||8
8963856|NCT02553317|10027354|FG000|STARTED|Open-label (OL) Treatment Period|2 patients on caplacizumab had a recurrence of TTP during the DB period and started OL treatment.|2
8963857|NCT02553317|10027355|FG001|STARTED|Open-label (OL) Treatment Period|26 patients on placebo had a recurrence of TTP during the DB period and started OL treatment.|26
8963858|NCT02553317|10027354|FG000|COMPLETED|Open-label (OL) Treatment Period||2
8963859|NCT02553317|10027355|FG001|COMPLETED|Open-label (OL) Treatment Period||22
8963860|NCT02553317|10027354|FG000|NOT COMPLETED|Open-label (OL) Treatment Period||0
8963861|NCT02553317|10027355|FG001|NOT COMPLETED|Open-label (OL) Treatment Period||4
8963862|NCT02553330|10027365|FG000|STARTED|Overall Study||12
8963863|NCT02553330|10027366|FG001|STARTED|Overall Study||39
8963864|NCT02553330|10027367|FG002|STARTED|Overall Study||39
8963865|NCT02553330|10027365|FG000|COMPLETED|Overall Study||7
8963866|NCT02553330|10027366|FG001|COMPLETED|Overall Study||0
8963867|NCT02553330|10027367|FG002|COMPLETED|Overall Study||2
8963868|NCT02553330|10027365|FG000|NOT COMPLETED|Overall Study||5
8963869|NCT02553330|10027366|FG001|NOT COMPLETED|Overall Study||39
8963870|NCT02553330|10027367|FG002|NOT COMPLETED|Overall Study||37
8963871|NCT02553395|10027378|FG000|STARTED|First Intervention||12
8963872|NCT02553395|10027379|FG001|STARTED|First Intervention||18
8963873|NCT02553395|10027378|FG000|COMPLETED|First Intervention||12
8963874|NCT02553395|10027379|FG001|COMPLETED|First Intervention||18
8963875|NCT02553395|10027378|FG000|NOT COMPLETED|First Intervention||0
8963876|NCT02553395|10027379|FG001|NOT COMPLETED|First Intervention||0
8963877|NCT02553395|10027378|FG000|STARTED|Second Intervention||12
8963878|NCT02553395|10027379|FG001|STARTED|Second Intervention||18
8963879|NCT02553395|10027378|FG000|COMPLETED|Second Intervention||12
8963880|NCT02553395|10027379|FG001|COMPLETED|Second Intervention||18
8963881|NCT02553395|10027378|FG000|NOT COMPLETED|Second Intervention||0
8963882|NCT02553395|10027379|FG001|NOT COMPLETED|Second Intervention||0
8963883|NCT02553421|10027388|FG000|STARTED|Overall Study||185
8963884|NCT02553421|10027389|FG001|STARTED|Overall Study||58
8963885|NCT02553421|10027388|FG000|COMPLETED|Overall Study||156
8963886|NCT02553421|10027389|FG001|COMPLETED|Overall Study||57
8963887|NCT02553421|10027388|FG000|NOT COMPLETED|Overall Study||29
8963888|NCT02553421|10027389|FG001|NOT COMPLETED|Overall Study||1
8963889|NCT02553499|10027410|FG000|STARTED|Overall Study||2
8963890|NCT02553499|10027411|FG001|STARTED|Overall Study||2
8963891|NCT02553499|10027412|FG002|STARTED|Overall Study||2
8963892|NCT02553499|10027413|FG003|STARTED|Overall Study||2
8963893|NCT02553499|10027414|FG004|STARTED|Overall Study||3
8963894|NCT02553499|10027415|FG005|STARTED|Overall Study||3
8963895|NCT02553499|10027416|FG006|STARTED|Overall Study||3
8963896|NCT02553499|10027417|FG007|STARTED|Overall Study||3
8963897|NCT02553499|10027418|FG008|STARTED|Overall Study||3
8963898|NCT02553499|10027419|FG009|STARTED|Overall Study||3
8963899|NCT02553499|10027420|FG010|STARTED|Overall Study||3
8963900|NCT02553499|10027421|FG011|STARTED|Overall Study||3
8963901|NCT02553499|10027422|FG012|STARTED|Overall Study||3
8963902|NCT02553499|10027423|FG013|STARTED|Overall Study||2
8963903|NCT02553499|10027410|FG000|COMPLETED|Overall Study||0
8963904|NCT02553499|10027411|FG001|COMPLETED|Overall Study||0
8963905|NCT02553499|10027412|FG002|COMPLETED|Overall Study||0
8963906|NCT02553499|10027413|FG003|COMPLETED|Overall Study||0
8963907|NCT02553499|10027414|FG004|COMPLETED|Overall Study||0
8963908|NCT02553499|10027415|FG005|COMPLETED|Overall Study||0
8963909|NCT02553499|10027416|FG006|COMPLETED|Overall Study||0
8963910|NCT02553499|10027417|FG007|COMPLETED|Overall Study||0
8963911|NCT02553499|10027418|FG008|COMPLETED|Overall Study||0
8963912|NCT02553499|10027419|FG009|COMPLETED|Overall Study||0
8963913|NCT02553499|10027420|FG010|COMPLETED|Overall Study||0
8963914|NCT02553499|10027421|FG011|COMPLETED|Overall Study||0
8963915|NCT02553499|10027422|FG012|COMPLETED|Overall Study||0
8963916|NCT02553499|10027423|FG013|COMPLETED|Overall Study||0
8963917|NCT02553499|10027410|FG000|NOT COMPLETED|Overall Study||2
8963918|NCT02553499|10027411|FG001|NOT COMPLETED|Overall Study||2
8963919|NCT02553499|10027412|FG002|NOT COMPLETED|Overall Study||2
8963920|NCT02553499|10027413|FG003|NOT COMPLETED|Overall Study||2
8963921|NCT02553499|10027414|FG004|NOT COMPLETED|Overall Study||3
8963922|NCT02553499|10027415|FG005|NOT COMPLETED|Overall Study||3
8963923|NCT02553499|10027416|FG006|NOT COMPLETED|Overall Study||3
8963924|NCT02553499|10027417|FG007|NOT COMPLETED|Overall Study||3
8963925|NCT02553499|10027418|FG008|NOT COMPLETED|Overall Study||3
8963926|NCT02553499|10027419|FG009|NOT COMPLETED|Overall Study||3
8963927|NCT02553499|10027420|FG010|NOT COMPLETED|Overall Study||3
8963928|NCT02553499|10027421|FG011|NOT COMPLETED|Overall Study||3
8963929|NCT02553499|10027422|FG012|NOT COMPLETED|Overall Study||3
8963930|NCT02553499|10027423|FG013|NOT COMPLETED|Overall Study||2
8963931|NCT02553512|10027454|FG000|STARTED|Overall Study||167
8963932|NCT02553512|10027454|FG000|COMPLETED|Overall Study||144
8963933|NCT02553512|10027454|FG000|NOT COMPLETED|Overall Study||23
8963934|NCT02553538|10027460|FG000|STARTED|Overall Study||792
8631679|NCT00541385|9671562|FG001|STARTED|Overall Study||180
8631680|NCT00541385|9671561|FG000|COMPLETED|Overall Study||274
8963935|NCT02553538|10027461|FG001|STARTED|Overall Study||820
8963936|NCT02553538|10027460|FG000|COMPLETED|Overall Study||605
8963937|NCT02553538|10027461|FG001|COMPLETED|Overall Study||764
8963938|NCT02553538|10027460|FG000|NOT COMPLETED|Overall Study||187
8963939|NCT02553538|10027461|FG001|NOT COMPLETED|Overall Study||56
8963940|NCT02553629|10027469|FG000|STARTED|Overall Study||53
8963941|NCT02553629|10027470|FG001|STARTED|Overall Study||56
8963942|NCT02553629|10027469|FG000|COMPLETED|Overall Study||50
8963943|NCT02553629|10027470|FG001|COMPLETED|Overall Study||50
8963944|NCT02553629|10027469|FG000|NOT COMPLETED|Overall Study||3
8963945|NCT02553629|10027470|FG001|NOT COMPLETED|Overall Study||6
8963946|NCT02553746|10027478|FG000|STARTED|Overall Study||80
8963947|NCT02553746|10027479|FG001|STARTED|Overall Study||66
8963948|NCT02553746|10027478|FG000|COMPLETED|Overall Study||77
8570534|NCT00104234|9602712|FG000|NOT COMPLETED|Overall Study||0
8570535|NCT00104234|9602713|FG001|NOT COMPLETED|Overall Study||1
8570536|NCT00104247|9602721|FG000|STARTED|Overall Study||42
8570537|NCT00104247|9602722|FG001|STARTED|Overall Study||47
8570538|NCT00104247|9602721|FG000|COMPLETED|Overall Study|Subject withdrew prior to dosing|41
8963949|NCT02553746|10027479|FG001|COMPLETED|Overall Study||64
8963950|NCT02553746|10027478|FG000|NOT COMPLETED|Overall Study||3
8963951|NCT02553746|10027479|FG001|NOT COMPLETED|Overall Study||2
9037888|NCT03323164|10099143|FG000|STARTED|Overall Study||18
9037889|NCT03323164|10099144|FG001|STARTED|Overall Study||17
9037890|NCT03323164|10099143|FG000|COMPLETED|Overall Study||16
8570539|NCT00104247|9602722|FG001|COMPLETED|Overall Study|One subject withdrew at Week 4, but is included in the data analysis|46
8570540|NCT00104247|9602721|FG000|NOT COMPLETED|Overall Study||1
8570541|NCT00104247|9602722|FG001|NOT COMPLETED|Overall Study||1
8570542|NCT00104299|9602730|FG000|STARTED|Overall Study||99
8570543|NCT00104299|9602731|FG001|STARTED|Overall Study||98
9037891|NCT03323164|10099144|FG001|COMPLETED|Overall Study||15
9037892|NCT03323164|10099143|FG000|NOT COMPLETED|Overall Study||2
9037893|NCT03323164|10099144|FG001|NOT COMPLETED|Overall Study||2
9037894|NCT03323307|10099154|FG000|STARTED|Overall Study||70
8570544|NCT00104299|9602730|FG000|COMPLETED|Overall Study|Number of participants who completed 18 months post-randomization|90
9037895|NCT03323307|10099154|FG000|COMPLETED|Overall Study||70
8570545|NCT00104299|9602731|FG001|COMPLETED|Overall Study|Number of participants who completed 18 months post-randomization|88
8570546|NCT00104299|9602730|FG000|NOT COMPLETED|Overall Study||9
9037896|NCT03323307|10099154|FG000|NOT COMPLETED|Overall Study||0
9037897|NCT03323723|10099158|FG000|STARTED|Screening||73
8963952|NCT02553772|10027487|FG000|STARTED|Overall Study||120
8963953|NCT02553772|10027488|FG001|STARTED|Overall Study||122
8963954|NCT02553772|10027487|FG000|COMPLETED|Overall Study||114
8963955|NCT02553772|10027488|FG001|COMPLETED|Overall Study||116
8963956|NCT02553772|10027487|FG000|NOT COMPLETED|Overall Study||6
8963957|NCT02553772|10027488|FG001|NOT COMPLETED|Overall Study||6
8963958|NCT02553798|10027494|FG000|STARTED|Overall Study||564
8963959|NCT02553798|10027494|FG000|COMPLETED|Overall Study||226
8963960|NCT02553798|10027494|FG000|NOT COMPLETED|Overall Study||338
8963961|NCT02553928|10027500|FG000|STARTED|Overall Study||30
8963962|NCT02553928|10027501|FG001|STARTED|Overall Study||32
8963963|NCT02553928|10027500|FG000|COMPLETED|Overall Study||28
8963964|NCT02553928|10027501|FG001|COMPLETED|Overall Study||29
8963965|NCT02553928|10027500|FG000|NOT COMPLETED|Overall Study||2
8963966|NCT02553928|10027501|FG001|NOT COMPLETED|Overall Study||3
8963967|NCT02554019|10027511|FG000|STARTED|Overall Study||12
8963968|NCT02554019|10027512|FG001|STARTED|Overall Study||12
8963969|NCT02554019|10027513|FG002|STARTED|Overall Study||12
8963970|NCT02554019|10027511|FG000|COMPLETED|Overall Study||10
8963971|NCT02554019|10027512|FG001|COMPLETED|Overall Study||12
8963972|NCT02554019|10027513|FG002|COMPLETED|Overall Study||10
8963973|NCT02554019|10027511|FG000|NOT COMPLETED|Overall Study||2
8963974|NCT02554019|10027512|FG001|NOT COMPLETED|Overall Study||0
8963975|NCT02554019|10027513|FG002|NOT COMPLETED|Overall Study||2
8963976|NCT02554279|10027523|FG000|STARTED|Overall Study||311
8963977|NCT02554279|10027524|FG001|STARTED|Overall Study||309
8963978|NCT02554279|10027523|FG000|Treated|Overall Study||310
8963979|NCT02554279|10027524|FG001|Treated|Overall Study||309
8963980|NCT02554279|10027523|FG000|Completed Day 6 of Stimulation|Overall Study||308
8963981|NCT02554279|10027524|FG001|Completed Day 6 of Stimulation|Overall Study||309
8963982|NCT02554279|10027523|FG000|Received Trigger|Overall Study||293
8963983|NCT02554279|10027524|FG001|Received Trigger|Overall Study||307
8963984|NCT02554279|10027523|FG000|Completed Oocyte Retrieval|Overall Study||292
8963985|NCT02554279|10027524|FG001|Completed Oocyte Retrieval|Overall Study||306
8963986|NCT02554279|10027523|FG000|Completed Fresh Blastocyst Transfer|Overall Study||201
8963987|NCT02554279|10027524|FG001|Completed Fresh Blastocyst Transfer|Overall Study||191
8963988|NCT02554279|10027523|FG000|COMPLETED|Overall Study||279
8963989|NCT02554279|10027524|FG001|COMPLETED|Overall Study||291
8963990|NCT02554279|10027523|FG000|NOT COMPLETED|Overall Study||32
8963991|NCT02554279|10027524|FG001|NOT COMPLETED|Overall Study||18
8963992|NCT02554435|10027539|FG000|STARTED|Overall Study||20
8963993|NCT02554435|10027540|FG001|STARTED|Overall Study||20
8963994|NCT02554435|10027539|FG000|COMPLETED|Overall Study||14
8963995|NCT02554435|10027540|FG001|COMPLETED|Overall Study||19
8963996|NCT02554435|10027539|FG000|NOT COMPLETED|Overall Study||6
8963997|NCT02554435|10027540|FG001|NOT COMPLETED|Overall Study||1
8963998|NCT02554474|10027549|FG000|STARTED|Overall Study||59
8963999|NCT02554474|10027550|FG001|STARTED|Overall Study||59
8964000|NCT02554474|10027549|FG000|COMPLETED|Overall Study|Indicates number of participants who completed assessment at the primary endpoint.|56
8964001|NCT02554474|10027550|FG001|COMPLETED|Overall Study|Indicates number of participants who completed assessment at the primary endpoint.|57
8964002|NCT02554474|10027549|FG000|NOT COMPLETED|Overall Study||3
8964003|NCT02554474|10027550|FG001|NOT COMPLETED|Overall Study||2
8964004|NCT02554513|10027556|FG000|STARTED|First Treatment Phase (7 Weeks)||3
8964005|NCT02554513|10027557|FG001|STARTED|First Treatment Phase (7 Weeks)||3
8964006|NCT02554513|10027556|FG000|COMPLETED|First Treatment Phase (7 Weeks)||3
8964007|NCT02554513|10027557|FG001|COMPLETED|First Treatment Phase (7 Weeks)||2
8964008|NCT02554513|10027556|FG000|NOT COMPLETED|First Treatment Phase (7 Weeks)||0
8964009|NCT02554513|10027557|FG001|NOT COMPLETED|First Treatment Phase (7 Weeks)||1
8964010|NCT02554513|10027556|FG000|STARTED|Washout (2 Weeks)||3
8964011|NCT02554513|10027557|FG001|STARTED|Washout (2 Weeks)||2
8964012|NCT02554513|10027556|FG000|COMPLETED|Washout (2 Weeks)||3
8964013|NCT02554513|10027557|FG001|COMPLETED|Washout (2 Weeks)||2
8964014|NCT02554513|10027556|FG000|NOT COMPLETED|Washout (2 Weeks)||0
8964015|NCT02554513|10027557|FG001|NOT COMPLETED|Washout (2 Weeks)||0
8964016|NCT02554513|10027556|FG000|STARTED|Second Treatment Phase (7 Weeks)||3
8964017|NCT02554513|10027557|FG001|STARTED|Second Treatment Phase (7 Weeks)||2
8964018|NCT02554513|10027556|FG000|COMPLETED|Second Treatment Phase (7 Weeks)||3
8964019|NCT02554513|10027557|FG001|COMPLETED|Second Treatment Phase (7 Weeks)||2
8964020|NCT02554513|10027556|FG000|NOT COMPLETED|Second Treatment Phase (7 Weeks)||0
8964021|NCT02554513|10027557|FG001|NOT COMPLETED|Second Treatment Phase (7 Weeks)||0
8964022|NCT02554656|10027569|FG000|STARTED|Overall Study||89
8964023|NCT02554656|10027569|FG000|COMPLETED|Overall Study||86
8964024|NCT02554656|10027569|FG000|NOT COMPLETED|Overall Study||3
8964025|NCT02554682|10027583|FG000|STARTED|Overall Study||40
8964026|NCT02554682|10027584|FG001|STARTED|Overall Study||40
8964027|NCT02554682|10027585|FG002|STARTED|Overall Study||40
8964028|NCT02554682|10027586|FG003|STARTED|Overall Study||40
8964029|NCT02554682|10027587|FG004|STARTED|Overall Study||40
8964030|NCT02554682|10027588|FG005|STARTED|Overall Study||40
8964031|NCT02554682|10027589|FG006|STARTED|Overall Study||28
8964032|NCT02554682|10027590|FG007|STARTED|Overall Study||28
8964033|NCT02554682|10027591|FG008|STARTED|Overall Study||26
8964034|NCT02554682|10027592|FG009|STARTED|Overall Study||26
8964035|NCT02554682|10027583|FG000|COMPLETED|Overall Study||25
8964036|NCT02554682|10027584|FG001|COMPLETED|Overall Study||28
8964037|NCT02554682|10027585|FG002|COMPLETED|Overall Study||36
8964038|NCT02554682|10027586|FG003|COMPLETED|Overall Study||37
8964039|NCT02554682|10027587|FG004|COMPLETED|Overall Study||38
8964040|NCT02554682|10027588|FG005|COMPLETED|Overall Study||39
8964041|NCT02554682|10027589|FG006|COMPLETED|Overall Study||22
8964042|NCT02554682|10027590|FG007|COMPLETED|Overall Study||22
8964043|NCT02554682|10027591|FG008|COMPLETED|Overall Study||24
8964044|NCT02554682|10027592|FG009|COMPLETED|Overall Study||24
8964045|NCT02554682|10027583|FG000|NOT COMPLETED|Overall Study||15
8964046|NCT02554682|10027584|FG001|NOT COMPLETED|Overall Study||12
8964047|NCT02554682|10027585|FG002|NOT COMPLETED|Overall Study||4
8964048|NCT02554682|10027586|FG003|NOT COMPLETED|Overall Study||3
8964049|NCT02554682|10027587|FG004|NOT COMPLETED|Overall Study||2
8964050|NCT02554682|10027588|FG005|NOT COMPLETED|Overall Study||1
8964051|NCT02554682|10027589|FG006|NOT COMPLETED|Overall Study||6
8964052|NCT02554682|10027590|FG007|NOT COMPLETED|Overall Study||6
8964053|NCT02554682|10027591|FG008|NOT COMPLETED|Overall Study||2
8964054|NCT02554682|10027592|FG009|NOT COMPLETED|Overall Study||2
8964055|NCT02554721|10027622|FG000|STARTED|Overall Study||20
8964056|NCT02554721|10027623|FG001|STARTED|Overall Study||19
8964057|NCT02554721|10027624|FG002|STARTED|Overall Study||19
8964058|NCT02554721|10027625|FG003|STARTED|Overall Study||17
8964059|NCT02554721|10027626|FG004|STARTED|Overall Study||2
8964060|NCT02554721|10027622|FG000|COMPLETED|Overall Study||19
8964061|NCT02554721|10027623|FG001|COMPLETED|Overall Study||19
8964062|NCT02554721|10027624|FG002|COMPLETED|Overall Study||19
8964063|NCT02554721|10027625|FG003|COMPLETED|Overall Study||17
8964064|NCT02554721|10027626|FG004|COMPLETED|Overall Study||0
8964065|NCT02554721|10027622|FG000|NOT COMPLETED|Overall Study||1
8964066|NCT02554721|10027623|FG001|NOT COMPLETED|Overall Study||0
8964067|NCT02554721|10027624|FG002|NOT COMPLETED|Overall Study||0
8964068|NCT02554721|10027625|FG003|NOT COMPLETED|Overall Study||0
8964069|NCT02554721|10027626|FG004|NOT COMPLETED|Overall Study||2
8964070|NCT02554760|10027635|FG000|STARTED|Overall Study||9
8964071|NCT02554760|10027636|FG001|STARTED|Overall Study||10
8964072|NCT02554760|10027635|FG000|COMPLETED|Overall Study||9
8964073|NCT02554760|10027636|FG001|COMPLETED|Overall Study||10
8964074|NCT02554760|10027635|FG000|NOT COMPLETED|Overall Study||0
8964075|NCT02554760|10027636|FG001|NOT COMPLETED|Overall Study||0
8964076|NCT02554786|10027650|FG000|STARTED|Overall Study||445
8964077|NCT02554786|10027651|FG001|STARTED|Overall Study||439
8964078|NCT02554786|10027652|FG002|STARTED|Overall Study||442
8964079|NCT02554786|10027653|FG003|STARTED|Overall Study||444
8964080|NCT02554786|10027654|FG004|STARTED|Overall Study||446
8964081|NCT02554786|10027650|FG000|COMPLETED|Overall Study||410
8964082|NCT02554786|10027651|FG001|COMPLETED|Overall Study||413
8964083|NCT02554786|10027652|FG002|COMPLETED|Overall Study||412
8964084|NCT02554786|10027653|FG003|COMPLETED|Overall Study||403
8964085|NCT02554786|10027654|FG004|COMPLETED|Overall Study||416
8964086|NCT02554786|10027650|FG000|NOT COMPLETED|Overall Study||35
8964087|NCT02554786|10027651|FG001|NOT COMPLETED|Overall Study||26
8964088|NCT02554786|10027652|FG002|NOT COMPLETED|Overall Study||30
8964089|NCT02554786|10027653|FG003|NOT COMPLETED|Overall Study||41
8964090|NCT02554786|10027654|FG004|NOT COMPLETED|Overall Study||30
8964091|NCT02554799|10027672|FG000|STARTED|Overall Study||9
8964092|NCT02554799|10027673|FG001|STARTED|Overall Study||9
8964093|NCT02554799|10027672|FG000|COMPLETED|Overall Study||9
8964094|NCT02554799|10027673|FG001|COMPLETED|Overall Study||9
8964095|NCT02554799|10027672|FG000|NOT COMPLETED|Overall Study||0
8964096|NCT02554799|10027673|FG001|NOT COMPLETED|Overall Study||0
8964097|NCT02554877|10027683|FG000|STARTED|Overall Study||51
8964098|NCT02554877|10027684|FG001|STARTED|Overall Study||51
8964099|NCT02554877|10027685|FG002|STARTED|Overall Study||52
8964100|NCT02554877|10027686|FG003|STARTED|Overall Study||52
8964101|NCT02554877|10027683|FG000|COMPLETED|Overall Study||39
8964102|NCT02554877|10027684|FG001|COMPLETED|Overall Study||44
8964103|NCT02554877|10027685|FG002|COMPLETED|Overall Study||46
8964104|NCT02554877|10027686|FG003|COMPLETED|Overall Study||45
8964105|NCT02554877|10027683|FG000|NOT COMPLETED|Overall Study||12
8964106|NCT02554877|10027684|FG001|NOT COMPLETED|Overall Study||7
8964107|NCT02554877|10027685|FG002|NOT COMPLETED|Overall Study||6
8964108|NCT02554877|10027686|FG003|NOT COMPLETED|Overall Study||7
8964109|NCT02554890|10027698|FG000|STARTED|Double-blind||444
8964110|NCT02554890|10027699|FG001|STARTED|Double-blind||443
8964111|NCT02554890|10027698|FG000|Treated Patients|Double-blind||436
8964112|NCT02554890|10027699|FG001|Treated Patients|Double-blind||439
8964113|NCT02554890|10027698|FG000|COMPLETED|Double-blind||348
8964114|NCT02554890|10027699|FG001|COMPLETED|Double-blind||352
8964115|NCT02554890|10027698|FG000|NOT COMPLETED|Double-blind||96
8964116|NCT02554890|10027699|FG001|NOT COMPLETED|Double-blind||91
8964117|NCT02554890|10027698|FG000|STARTED|Open-label||0
8964118|NCT02554890|10027699|FG001|STARTED|Open-label||887
8964119|NCT02554890|10027698|FG000|COMPLETED|Open-label||0
8964120|NCT02554890|10027699|FG001|COMPLETED|Open-label||835
8964121|NCT02554890|10027698|FG000|NOT COMPLETED|Open-label||0
8964122|NCT02554890|10027699|FG001|NOT COMPLETED|Open-label||52
8964123|NCT02554903|10027709|FG000|STARTED|Overall Study||28
8964124|NCT02554903|10027710|FG001|STARTED|Overall Study||29
8964125|NCT02554903|10027709|FG000|COMPLETED|Overall Study||24
8964126|NCT02554903|10027710|FG001|COMPLETED|Overall Study||24
8964127|NCT02554903|10027709|FG000|NOT COMPLETED|Overall Study||4
8964128|NCT02554903|10027710|FG001|NOT COMPLETED|Overall Study||5
8964129|NCT02554929|10027719|FG000|STARTED|Overall Study||46
8964130|NCT02554929|10027720|FG001|STARTED|Overall Study||44
8964131|NCT02554929|10027719|FG000|Per Protocol Received Intervention|Overall Study||44
8964132|NCT02554929|10027720|FG001|Per Protocol Received Intervention|Overall Study||36
8964133|NCT02554929|10027719|FG000|Per Protocol Post-Intervention|Overall Study||42
8964134|NCT02554929|10027720|FG001|Per Protocol Post-Intervention|Overall Study||36
8964135|NCT02554929|10027719|FG000|Per Protocol 6 Month Follow-up|Overall Study||40
8964136|NCT02554929|10027720|FG001|Per Protocol 6 Month Follow-up|Overall Study||32
8964137|NCT02554929|10027719|FG000|COMPLETED|Overall Study||40
8964138|NCT02554929|10027720|FG001|COMPLETED|Overall Study||32
8964139|NCT02554929|10027719|FG000|NOT COMPLETED|Overall Study||6
8964140|NCT02554929|10027720|FG001|NOT COMPLETED|Overall Study||12
8964141|NCT02554981|10027726|FG000|STARTED|Overall Study||51
8964142|NCT02554981|10027726|FG000|COMPLETED|Overall Study||46
8964143|NCT02554981|10027726|FG000|NOT COMPLETED|Overall Study||5
8964144|NCT02555098|10027730|FG000|STARTED|First Intervention||12
8964145|NCT02555098|10027731|FG001|STARTED|First Intervention||11
8964146|NCT02555098|10027730|FG000|COMPLETED|First Intervention||12
8964147|NCT02555098|10027731|FG001|COMPLETED|First Intervention||11
8964148|NCT02555098|10027730|FG000|NOT COMPLETED|First Intervention||0
8964149|NCT02555098|10027731|FG001|NOT COMPLETED|First Intervention||0
8964150|NCT02555098|10027730|FG000|STARTED|Second Intervention||12
8631681|NCT00541385|9671562|FG001|COMPLETED|Overall Study||142
8631682|NCT00541385|9671561|FG000|NOT COMPLETED|Overall Study||81
8964151|NCT02555098|10027731|FG001|STARTED|Second Intervention||11
8964152|NCT02555098|10027730|FG000|COMPLETED|Second Intervention||12
8964153|NCT02555098|10027731|FG001|COMPLETED|Second Intervention||11
8964154|NCT02555098|10027730|FG000|NOT COMPLETED|Second Intervention||0
8964155|NCT02555098|10027731|FG001|NOT COMPLETED|Second Intervention||0
8964156|NCT02555215|10027741|FG000|STARTED|Overall Study||20
8964157|NCT02555215|10027741|FG000|COMPLETED|Overall Study||17
8964158|NCT02555215|10027741|FG000|NOT COMPLETED|Overall Study||3
8964159|NCT02555228|10027747|FG000|STARTED|Overall Study|20th August 2015|27
8964160|NCT02555228|10027748|FG001|STARTED|Overall Study|14th August 2015|27
8964161|NCT02555228|10027747|FG000|COMPLETED|Overall Study|19th November 2015|27
8964162|NCT02555228|10027748|FG001|COMPLETED|Overall Study|29th October 2015|27
8964163|NCT02555228|10027747|FG000|NOT COMPLETED|Overall Study||0
8964164|NCT02555228|10027748|FG001|NOT COMPLETED|Overall Study||0
8964165|NCT02555306|10027758|FG000|STARTED|Overall Study||3
8964166|NCT02555306|10027759|FG001|STARTED|Overall Study||3
8964167|NCT02555306|10027760|FG002|STARTED|Overall Study||3
8964168|NCT02555306|10027761|FG003|STARTED|Overall Study||3
8964169|NCT02555306|10027758|FG000|COMPLETED|Overall Study||3
8964170|NCT02555306|10027759|FG001|COMPLETED|Overall Study||3
8964171|NCT02555306|10027760|FG002|COMPLETED|Overall Study||3
8964172|NCT02555306|10027761|FG003|COMPLETED|Overall Study||3
8964173|NCT02555306|10027758|FG000|NOT COMPLETED|Overall Study||0
8964174|NCT02555306|10027759|FG001|NOT COMPLETED|Overall Study||0
8964175|NCT02555306|10027760|FG002|NOT COMPLETED|Overall Study||0
8964176|NCT02555306|10027761|FG003|NOT COMPLETED|Overall Study||0
8964177|NCT02555371|10027771|FG000|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||306
8964178|NCT02555371|10027772|FG001|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||0
8964179|NCT02555371|10027773|FG002|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||0
8964180|NCT02555371|10027774|FG003|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||0
8964181|NCT02555371|10027775|FG004|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||0
8964182|NCT02555371|10027771|FG000|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||295
8964183|NCT02555371|10027772|FG001|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
8964184|NCT02555371|10027773|FG002|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
8964185|NCT02555371|10027774|FG003|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
8964186|NCT02555371|10027775|FG004|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
8964187|NCT02555371|10027771|FG000|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||11
8964188|NCT02555371|10027772|FG001|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
8964189|NCT02555371|10027773|FG002|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
8631683|NCT00541385|9671562|FG001|NOT COMPLETED|Overall Study||38
8964190|NCT02555371|10027774|FG003|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
8964191|NCT02555371|10027775|FG004|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
8964192|NCT02555371|10027771|FG000|STARTED|Part C (DB Period: Up to 52W)||0
8964193|NCT02555371|10027772|FG001|STARTED|Part C (DB Period: Up to 52W)||151
8964194|NCT02555371|10027773|FG002|STARTED|Part C (DB Period: Up to 52W)||144
8964195|NCT02555371|10027774|FG003|STARTED|Part C (DB Period: Up to 52W)||0
8964196|NCT02555371|10027775|FG004|STARTED|Part C (DB Period: Up to 52W)||0
8964197|NCT02555371|10027771|FG000|COMPLETED|Part C (DB Period: Up to 52W)||0
8964198|NCT02555371|10027772|FG001|COMPLETED|Part C (DB Period: Up to 52W)||62
8964199|NCT02555371|10027773|FG002|COMPLETED|Part C (DB Period: Up to 52W)||96
8964200|NCT02555371|10027774|FG003|COMPLETED|Part C (DB Period: Up to 52W)||0
8964201|NCT02555371|10027775|FG004|COMPLETED|Part C (DB Period: Up to 52W)||0
8964202|NCT02555371|10027771|FG000|NOT COMPLETED|Part C (DB Period: Up to 52W)||0
8964203|NCT02555371|10027772|FG001|NOT COMPLETED|Part C (DB Period: Up to 52W)||89
8964204|NCT02555371|10027773|FG002|NOT COMPLETED|Part C (DB Period: Up to 52W)||48
8964205|NCT02555371|10027774|FG003|NOT COMPLETED|Part C (DB Period: Up to 52W)||0
8964206|NCT02555371|10027775|FG004|NOT COMPLETED|Part C (DB Period: Up to 52W)||0
8964207|NCT02555371|10027771|FG000|STARTED|PartD(OL: 52W Post-randomization PartC)||0
8964208|NCT02555371|10027772|FG001|STARTED|PartD(OL: 52W Post-randomization PartC)||0
8964209|NCT02555371|10027773|FG002|STARTED|PartD(OL: 52W Post-randomization PartC)||0
8964210|NCT02555371|10027774|FG003|STARTED|PartD(OL: 52W Post-randomization PartC)||84
8964211|NCT02555371|10027775|FG004|STARTED|PartD(OL: 52W Post-randomization PartC)||45
8964212|NCT02555371|10027771|FG000|COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
8964213|NCT02555371|10027772|FG001|COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
8964214|NCT02555371|10027773|FG002|COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
8964215|NCT02555371|10027774|FG003|COMPLETED|PartD(OL: 52W Post-randomization PartC)||80
8964216|NCT02555371|10027775|FG004|COMPLETED|PartD(OL: 52W Post-randomization PartC)||42
8964217|NCT02555371|10027771|FG000|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
8964218|NCT02555371|10027772|FG001|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
8964219|NCT02555371|10027773|FG002|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
8964220|NCT02555371|10027774|FG003|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||4
8964221|NCT02555371|10027775|FG004|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||3
8964222|NCT02555449|10027784|FG000|STARTED|Overall Study||6
8964223|NCT02555449|10027784|FG000|COMPLETED|Overall Study||6
8964224|NCT02555449|10027784|FG000|NOT COMPLETED|Overall Study||0
8964225|NCT02555618|10027790|FG000|STARTED|Overall Study||200
8964226|NCT02555618|10027791|FG001|STARTED|Overall Study||200
8964227|NCT02555618|10027790|FG000|COMPLETED|Overall Study||199
8964228|NCT02555618|10027791|FG001|COMPLETED|Overall Study||200
8964229|NCT02555618|10027790|FG000|NOT COMPLETED|Overall Study||1
8964230|NCT02555618|10027791|FG001|NOT COMPLETED|Overall Study||0
8964231|NCT02555631|10027797|FG000|STARTED|Overall Study||29
8964232|NCT02555631|10027797|FG000|COMPLETED|Overall Study||25
8964233|NCT02555631|10027797|FG000|NOT COMPLETED|Overall Study||4
8964234|NCT02555683|10027804|FG000|STARTED|Overall Study||301
8964235|NCT02555683|10027805|FG001|STARTED|Overall Study||295
8964236|NCT02555683|10027806|FG002|STARTED|Overall Study||298
8964237|NCT02555683|10027804|FG000|FAS/SAF: High Eosinophil Subpopulation|Overall Study||200
8964238|NCT02555683|10027805|FG001|FAS/SAF: High Eosinophil Subpopulation|Overall Study||201
8964239|NCT02555683|10027806|FG002|FAS/SAF: High Eosinophil Subpopulation|Overall Study||201
8631684|NCT00541450|9671570|FG000|STARTED|Phase A||244
8631685|NCT00541450|9671571|FG001|STARTED|Phase A||248
8631686|NCT00541450|9671570|FG000|COMPLETED|Phase A||224
8964240|NCT02555683|10027804|FG000|FAS/SAF: Overall Population|Overall Study||299
8631687|NCT00541450|9671571|FG001|COMPLETED|Phase A||231
8631688|NCT00541450|9671570|FG000|NOT COMPLETED|Phase A||20
8631689|NCT00541450|9671571|FG001|NOT COMPLETED|Phase A||17
8631690|NCT00541450|9671570|FG000|STARTED|Phase B||224
8631691|NCT00541450|9671571|FG001|STARTED|Phase B||231
8631692|NCT00541450|9671570|FG000|COMPLETED|Phase B||187
8631693|NCT00541450|9671571|FG001|COMPLETED|Phase B||200
8631694|NCT00541450|9671570|FG000|NOT COMPLETED|Phase B||37
8631695|NCT00541450|9671571|FG001|NOT COMPLETED|Phase B||31
8725766|NCT01033227|9773100|FG001|NOT COMPLETED|Overall Study||0
8725767|NCT01033240|9773111|FG000|STARTED|Overall Study||55
8725768|NCT01033240|9773112|FG001|STARTED|Overall Study||53
8725769|NCT01033240|9773113|FG002|STARTED|Overall Study||55
8725770|NCT01033240|9773111|FG000|COMPLETED|Overall Study||6
8725771|NCT01033240|9773112|FG001|COMPLETED|Overall Study||3
8631696|NCT00541593|9671581|FG000|STARTED|Overall Study||5
8631697|NCT00541593|9671581|FG000|COMPLETED|Overall Study||5
8631698|NCT00541593|9671581|FG000|NOT COMPLETED|Overall Study||0
8631699|NCT00541658|9671588|FG000|STARTED|Overall Study||308
8631700|NCT00541658|9671589|FG001|STARTED|Overall Study||307
8725772|NCT01033240|9773113|FG002|COMPLETED|Overall Study||2
8725773|NCT01033240|9773111|FG000|NOT COMPLETED|Overall Study||49
8725774|NCT01033240|9773112|FG001|NOT COMPLETED|Overall Study||50
8725775|NCT01033240|9773113|FG002|NOT COMPLETED|Overall Study||53
8964241|NCT02555683|10027805|FG001|FAS/SAF: Overall Population|Overall Study||293
8964242|NCT02555683|10027806|FG002|FAS/SAF: Overall Population|Overall Study||298
8964243|NCT02555683|10027804|FG000|COMPLETED|Overall Study||282
8964244|NCT02555683|10027805|FG001|COMPLETED|Overall Study||278
8964245|NCT02555683|10027806|FG002|COMPLETED|Overall Study||269
8964246|NCT02555683|10027804|FG000|NOT COMPLETED|Overall Study||19
8964247|NCT02555683|10027805|FG001|NOT COMPLETED|Overall Study||17
8964248|NCT02555683|10027806|FG002|NOT COMPLETED|Overall Study||29
8964249|NCT02555722|10027816|FG000|STARTED|Lens Dispensed||60
8964250|NCT02555722|10027817|FG001|STARTED|Lens Dispensed||30
8964251|NCT02555722|10027816|FG000|COMPLETED|Lens Dispensed||60
8964252|NCT02555722|10027817|FG001|COMPLETED|Lens Dispensed||30
8964253|NCT02555722|10027816|FG000|NOT COMPLETED|Lens Dispensed||0
8964254|NCT02555722|10027817|FG001|NOT COMPLETED|Lens Dispensed||0
8964255|NCT02555722|10027816|FG000|STARTED|Week 1||60
8964256|NCT02555722|10027817|FG001|STARTED|Week 1||30
8964257|NCT02555722|10027816|FG000|COMPLETED|Week 1||60
8964258|NCT02555722|10027817|FG001|COMPLETED|Week 1||30
8964259|NCT02555722|10027816|FG000|NOT COMPLETED|Week 1||0
8964260|NCT02555722|10027817|FG001|NOT COMPLETED|Week 1||0
8964261|NCT02555722|10027816|FG000|STARTED|Week 2||60
8964262|NCT02555722|10027817|FG001|STARTED|Week 2||30
8964263|NCT02555722|10027816|FG000|COMPLETED|Week 2||59
8964264|NCT02555722|10027817|FG001|COMPLETED|Week 2||29
8964265|NCT02555722|10027816|FG000|NOT COMPLETED|Week 2||1
8964266|NCT02555722|10027817|FG001|NOT COMPLETED|Week 2||1
8964267|NCT02555722|10027816|FG000|STARTED|Month 1||59
8964268|NCT02555722|10027817|FG001|STARTED|Month 1||29
8964269|NCT02555722|10027816|FG000|COMPLETED|Month 1||58
8964270|NCT02555722|10027817|FG001|COMPLETED|Month 1||29
8964271|NCT02555722|10027816|FG000|NOT COMPLETED|Month 1||1
8964272|NCT02555722|10027817|FG001|NOT COMPLETED|Month 1||0
8964273|NCT02555722|10027816|FG000|STARTED|Month 2||58
8964274|NCT02555722|10027817|FG001|STARTED|Month 2||29
8964275|NCT02555722|10027816|FG000|COMPLETED|Month 2||54
8964276|NCT02555722|10027817|FG001|COMPLETED|Month 2||29
8631701|NCT00541658|9671590|FG002|STARTED|Overall Study||308
8964277|NCT02555722|10027816|FG000|NOT COMPLETED|Month 2||4
8964278|NCT02555722|10027817|FG001|NOT COMPLETED|Month 2||0
8964279|NCT02555722|10027816|FG000|STARTED|Month 3||54
8964280|NCT02555722|10027817|FG001|STARTED|Month 3||29
8964281|NCT02555722|10027816|FG000|COMPLETED|Month 3||54
8964282|NCT02555722|10027817|FG001|COMPLETED|Month 3||29
8964283|NCT02555722|10027816|FG000|NOT COMPLETED|Month 3||0
8964284|NCT02555722|10027817|FG001|NOT COMPLETED|Month 3||0
8964285|NCT02555878|10027848|FG000|STARTED|Overall Study||421
8964286|NCT02555878|10027849|FG001|STARTED|Overall Study||420
8964287|NCT02555878|10027848|FG000|Treated|Overall Study||404
8964288|NCT02555878|10027849|FG001|Treated|Overall Study||405
8964289|NCT02555878|10027848|FG000|COMPLETED|Overall Study||255
8964290|NCT02555878|10027849|FG001|COMPLETED|Overall Study||270
8964291|NCT02555878|10027848|FG000|NOT COMPLETED|Overall Study||166
8964292|NCT02555878|10027849|FG001|NOT COMPLETED|Overall Study||150
8964293|NCT02555930|10027855|FG000|STARTED|Overall Study||148
8964294|NCT02555930|10027855|FG000|COMPLETED|Overall Study||148
8964295|NCT02555930|10027855|FG000|NOT COMPLETED|Overall Study||0
8964296|NCT02556112|10027863|FG000|STARTED|Overall Study||40
8964297|NCT02556112|10027864|FG001|STARTED|Overall Study||40
8964298|NCT02556112|10027865|FG002|STARTED|Overall Study||42
8964299|NCT02556112|10027863|FG000|COMPLETED|Overall Study||30
8964300|NCT02556112|10027864|FG001|COMPLETED|Overall Study||23
8964301|NCT02556112|10027865|FG002|COMPLETED|Overall Study||30
8964302|NCT02556112|10027863|FG000|NOT COMPLETED|Overall Study||10
8964303|NCT02556112|10027864|FG001|NOT COMPLETED|Overall Study||17
8964304|NCT02556112|10027865|FG002|NOT COMPLETED|Overall Study||12
8964305|NCT02556138|10027874|FG000|STARTED|Overall Study||8
8964306|NCT02556138|10027874|FG000|COMPLETED|Overall Study|One patient withdrew from the study due to intolerance of the balloon after 1 month.|7
8964307|NCT02556138|10027874|FG000|NOT COMPLETED|Overall Study||1
8964308|NCT02556177|10027880|FG000|STARTED|Overall Study||325
8964309|NCT02556177|10027881|FG001|STARTED|Overall Study||152
8964310|NCT02556177|10027880|FG000|COMPLETED|Overall Study||42
8964311|NCT02556177|10027881|FG001|COMPLETED|Overall Study||91
8964312|NCT02556177|10027880|FG000|NOT COMPLETED|Overall Study||283
8964313|NCT02556177|10027881|FG001|NOT COMPLETED|Overall Study||61
8964314|NCT02556203|10027889|FG000|STARTED|Overall Study||826
8964315|NCT02556203|10027890|FG001|STARTED|Overall Study||818
8964316|NCT02556203|10027889|FG000|Received Treatment|Overall Study||801
8964317|NCT02556203|10027890|FG001|Received Treatment|Overall Study||807
8964318|NCT02556203|10027889|FG000|COMPLETED|Overall Study||799
8964319|NCT02556203|10027890|FG001|COMPLETED|Overall Study||792
8964320|NCT02556203|10027889|FG000|NOT COMPLETED|Overall Study||27
8964321|NCT02556203|10027890|FG001|NOT COMPLETED|Overall Study||26
8964322|NCT02556255|10027896|FG000|STARTED|Overall Study||50
8964323|NCT02556255|10027896|FG000|COMPLETED|Overall Study||46
8964324|NCT02556255|10027896|FG000|NOT COMPLETED|Overall Study||4
8964325|NCT02556307|10027900|FG000|STARTED|Overall Study||270
8964326|NCT02556307|10027900|FG000|Treated|Overall Study||268
8964327|NCT02556307|10027900|FG000|COMPLETED|Overall Study||217
8964328|NCT02556307|10027900|FG000|NOT COMPLETED|Overall Study||53
8964329|NCT02556333|10027904|FG000|STARTED|Overall Study||1
8964330|NCT02556333|10027904|FG000|COMPLETED|Overall Study||1
8964331|NCT02556333|10027904|FG000|NOT COMPLETED|Overall Study||0
8964332|NCT02556554|10027911|FG000|STARTED|Overall Study||8
8964333|NCT02556554|10027912|FG001|STARTED|Overall Study||14
8964334|NCT02556554|10027913|FG002|STARTED|Overall Study||19
8964335|NCT02556554|10027914|FG003|STARTED|Overall Study||12
8964336|NCT02556554|10027915|FG004|STARTED|Overall Study||14
8964337|NCT02556554|10027911|FG000|COMPLETED|Overall Study||8
8964338|NCT02556554|10027912|FG001|COMPLETED|Overall Study||13
8964339|NCT02556554|10027913|FG002|COMPLETED|Overall Study||15
8964340|NCT02556554|10027914|FG003|COMPLETED|Overall Study||12
8964341|NCT02556554|10027915|FG004|COMPLETED|Overall Study||14
8964342|NCT02556554|10027911|FG000|NOT COMPLETED|Overall Study||0
8964343|NCT02556554|10027912|FG001|NOT COMPLETED|Overall Study||1
8964344|NCT02556554|10027913|FG002|NOT COMPLETED|Overall Study||4
8964345|NCT02556554|10027914|FG003|NOT COMPLETED|Overall Study||0
8964346|NCT02556554|10027915|FG004|NOT COMPLETED|Overall Study||0
8964347|NCT02556632|10027929|FG000|STARTED|Overall Study||64
8964348|NCT02556632|10027930|FG001|STARTED|Overall Study||65
8964349|NCT02556632|10027931|FG002|STARTED|Overall Study||62
8964350|NCT02556632|10027929|FG000|COMPLETED|Overall Study||59
8964351|NCT02556632|10027930|FG001|COMPLETED|Overall Study||59
8964352|NCT02556632|10027931|FG002|COMPLETED|Overall Study||53
8964353|NCT02556632|10027929|FG000|NOT COMPLETED|Overall Study||5
8964354|NCT02556632|10027930|FG001|NOT COMPLETED|Overall Study||6
8964355|NCT02556632|10027931|FG002|NOT COMPLETED|Overall Study||9
8964356|NCT02556775|10027943|FG000|STARTED|Overall Study||7
8964357|NCT02556775|10027944|FG001|STARTED|Overall Study||2
8964358|NCT02556775|10027945|FG002|STARTED|Overall Study||5
8964359|NCT02556775|10027946|FG003|STARTED|Overall Study||2
8964360|NCT02556775|10027943|FG000|COMPLETED|Overall Study||5
8964361|NCT02556775|10027944|FG001|COMPLETED|Overall Study||2
8964362|NCT02556775|10027945|FG002|COMPLETED|Overall Study||4
8964363|NCT02556775|10027946|FG003|COMPLETED|Overall Study||2
8964364|NCT02556775|10027943|FG000|NOT COMPLETED|Overall Study||2
8964365|NCT02556775|10027944|FG001|NOT COMPLETED|Overall Study||0
8964366|NCT02556775|10027945|FG002|NOT COMPLETED|Overall Study||1
8964367|NCT02556775|10027946|FG003|NOT COMPLETED|Overall Study||0
8964368|NCT02556788|10027960|FG000|STARTED|Overall Study||602
8964369|NCT02556788|10027961|FG001|STARTED|Overall Study||610
8964370|NCT02556788|10027960|FG000|COMPLETED|Overall Study||558
8964371|NCT02556788|10027961|FG001|COMPLETED|Overall Study||573
8964372|NCT02556788|10027960|FG000|NOT COMPLETED|Overall Study||44
8964373|NCT02556788|10027961|FG001|NOT COMPLETED|Overall Study||37
8964374|NCT02556801|10027971|FG000|STARTED|Overall Study||42
8964375|NCT02556801|10027972|FG001|STARTED|Overall Study||42
8964376|NCT02556801|10027973|FG002|STARTED|Overall Study||42
8964377|NCT02556801|10027974|FG003|STARTED|Overall Study||42
8964378|NCT02556801|10027971|FG000|COMPLETED|Overall Study||40
8964379|NCT02556801|10027972|FG001|COMPLETED|Overall Study||35
8964380|NCT02556801|10027973|FG002|COMPLETED|Overall Study||38
8631702|NCT00541658|9671588|FG000|ITT Population|Overall Study||307
8631703|NCT00541658|9671589|FG001|ITT Population|Overall Study||307
8631704|NCT00541658|9671590|FG002|ITT Population|Overall Study||308
8964381|NCT02556801|10027974|FG003|COMPLETED|Overall Study||37
8964382|NCT02556801|10027971|FG000|NOT COMPLETED|Overall Study||2
8964383|NCT02556801|10027972|FG001|NOT COMPLETED|Overall Study||7
8964384|NCT02556801|10027973|FG002|NOT COMPLETED|Overall Study||4
8964385|NCT02556801|10027974|FG003|NOT COMPLETED|Overall Study||5
8964386|NCT02556918|10027986|FG000|STARTED|Overall Study||100
8964387|NCT02556918|10027987|FG001|STARTED|Overall Study||101
8964388|NCT02556918|10027986|FG000|COMPLETED|Overall Study||91
8964389|NCT02556918|10027987|FG001|COMPLETED|Overall Study||91
8964390|NCT02556918|10027986|FG000|NOT COMPLETED|Overall Study||9
8964391|NCT02556918|10027987|FG001|NOT COMPLETED|Overall Study||10
8964392|NCT02557035|10027996|FG000|STARTED|Overall Study||225
8964393|NCT02557035|10027997|FG001|STARTED|Overall Study||215
8964394|NCT02557035|10027996|FG000|COMPLETED|Overall Study||218
8964395|NCT02557035|10027997|FG001|COMPLETED|Overall Study||206
8964396|NCT02557035|10027996|FG000|NOT COMPLETED|Overall Study||7
8964397|NCT02557035|10027997|FG001|NOT COMPLETED|Overall Study||9
8964398|NCT02557100|10028006|FG000|STARTED|Single Blind Treatment Period||40
8964399|NCT02557100|10028007|FG001|STARTED|Single Blind Treatment Period||40
8964400|NCT02557100|10028008|FG002|STARTED|Single Blind Treatment Period||0
8964401|NCT02557100|10028006|FG000|COMPLETED|Single Blind Treatment Period||40
8964402|NCT02557100|10028007|FG001|COMPLETED|Single Blind Treatment Period||36
8964403|NCT02557100|10028008|FG002|COMPLETED|Single Blind Treatment Period||0
8964404|NCT02557100|10028006|FG000|NOT COMPLETED|Single Blind Treatment Period||0
8964405|NCT02557100|10028007|FG001|NOT COMPLETED|Single Blind Treatment Period||4
8964406|NCT02557100|10028008|FG002|NOT COMPLETED|Single Blind Treatment Period||0
8964407|NCT02557100|10028006|FG000|STARTED|Transition to Open Label||40
8964408|NCT02557100|10028007|FG001|STARTED|Transition to Open Label||36
8964409|NCT02557100|10028008|FG002|STARTED|Transition to Open Label||0
8631705|NCT00541658|9671588|FG000|COMPLETED|Overall Study||248
8631706|NCT00541658|9671589|FG001|COMPLETED|Overall Study||234
8631707|NCT00541658|9671590|FG002|COMPLETED|Overall Study||240
8964410|NCT02557100|10028006|FG000|COMPLETED|Transition to Open Label||0
8964411|NCT02557100|10028007|FG001|COMPLETED|Transition to Open Label||0
8964412|NCT02557100|10028008|FG002|COMPLETED|Transition to Open Label||0
8964413|NCT02557100|10028006|FG000|NOT COMPLETED|Transition to Open Label||40
8964414|NCT02557100|10028007|FG001|NOT COMPLETED|Transition to Open Label||36
8964415|NCT02557100|10028008|FG002|NOT COMPLETED|Transition to Open Label||0
8964416|NCT02557100|10028006|FG000|STARTED|Cumulative Abatacept Period||0
8964417|NCT02557100|10028007|FG001|STARTED|Cumulative Abatacept Period||0
8964418|NCT02557100|10028008|FG002|STARTED|Cumulative Abatacept Period||76
8964419|NCT02557100|10028006|FG000|COMPLETED|Cumulative Abatacept Period||0
8964420|NCT02557100|10028007|FG001|COMPLETED|Cumulative Abatacept Period||0
8964421|NCT02557100|10028008|FG002|COMPLETED|Cumulative Abatacept Period||72
8964422|NCT02557100|10028006|FG000|NOT COMPLETED|Cumulative Abatacept Period||0
8964423|NCT02557100|10028007|FG001|NOT COMPLETED|Cumulative Abatacept Period||0
8964424|NCT02557100|10028008|FG002|NOT COMPLETED|Cumulative Abatacept Period||4
8964425|NCT02557178|10028018|FG000|STARTED|Overall Study||72
8964426|NCT02557178|10028019|FG001|STARTED|Overall Study||74
8964427|NCT02557178|10028018|FG000|COMPLETED|Overall Study||56
8964428|NCT02557178|10028019|FG001|COMPLETED|Overall Study||63
8964429|NCT02557178|10028018|FG000|NOT COMPLETED|Overall Study||16
8964430|NCT02557178|10028019|FG001|NOT COMPLETED|Overall Study||11
8964431|NCT02557399|10028027|FG000|STARTED|Overall Study||172
8964432|NCT02557399|10028028|FG001|STARTED|Overall Study||177
8964433|NCT02557399|10028027|FG000|COMPLETED|Overall Study||165
8964434|NCT02557399|10028028|FG001|COMPLETED|Overall Study||169
8964435|NCT02557399|10028027|FG000|NOT COMPLETED|Overall Study||7
8964436|NCT02557399|10028028|FG001|NOT COMPLETED|Overall Study||8
8964437|NCT02557516|10028041|FG000|STARTED|Overall Study||3
8964438|NCT02557516|10028042|FG001|STARTED|Overall Study||6
8964439|NCT02557516|10028043|FG002|STARTED|Overall Study||4
8964440|NCT02557516|10028044|FG003|STARTED|Overall Study||9
8964441|NCT02557516|10028041|FG000|COMPLETED|Overall Study||2
8964442|NCT02557516|10028042|FG001|COMPLETED|Overall Study||1
8964443|NCT02557516|10028043|FG002|COMPLETED|Overall Study||0
8964444|NCT02557516|10028044|FG003|COMPLETED|Overall Study||0
8964445|NCT02557516|10028041|FG000|NOT COMPLETED|Overall Study||1
8964446|NCT02557516|10028042|FG001|NOT COMPLETED|Overall Study||5
8964447|NCT02557516|10028043|FG002|NOT COMPLETED|Overall Study||4
8964448|NCT02557516|10028044|FG003|NOT COMPLETED|Overall Study||9
8964449|NCT02557555|10028063|FG000|STARTED|Overall Study||100
8964450|NCT02557555|10028063|FG000|COMPLETED|Overall Study||100
8964451|NCT02557555|10028063|FG000|NOT COMPLETED|Overall Study||0
8964452|NCT02557646|10028068|FG000|STARTED|Overall Study||693
8964453|NCT02557646|10028068|FG000|COMPLETED|Overall Study||417
8964454|NCT02557646|10028068|FG000|NOT COMPLETED|Overall Study||276
8631708|NCT00541658|9671588|FG000|NOT COMPLETED|Overall Study||60
8631709|NCT00541658|9671589|FG001|NOT COMPLETED|Overall Study||73
8631710|NCT00541658|9671590|FG002|NOT COMPLETED|Overall Study||68
8964455|NCT02557698|10028074|FG000|STARTED|Overall Study||30
8964456|NCT02557698|10028075|FG001|STARTED|Overall Study||30
8964457|NCT02557698|10028074|FG000|COMPLETED|Overall Study||30
8964458|NCT02557698|10028075|FG001|COMPLETED|Overall Study||30
8964459|NCT02557698|10028074|FG000|NOT COMPLETED|Overall Study||0
8964460|NCT02557698|10028075|FG001|NOT COMPLETED|Overall Study||0
8964461|NCT02558231|10028083|FG000|STARTED|Overall Study||123
8964462|NCT02558231|10028084|FG001|STARTED|Overall Study||124
8964463|NCT02558231|10028083|FG000|Treated|Overall Study||123
8964464|NCT02558231|10028084|FG001|Treated|Overall Study||123
8964465|NCT02558231|10028083|FG000|COMPLETED|Overall Study||98
8964466|NCT02558231|10028084|FG001|COMPLETED|Overall Study||98
8964467|NCT02558231|10028083|FG000|NOT COMPLETED|Overall Study||25
8964468|NCT02558231|10028084|FG001|NOT COMPLETED|Overall Study||26
8964469|NCT02558296|10028092|FG000|STARTED|Completed the Study Through Week 24||1133
8964470|NCT02558296|10028093|FG001|STARTED|Completed the Study Through Week 24||567
8964471|NCT02558296|10028092|FG000|COMPLETED|Completed the Study Through Week 24||1089
8964472|NCT02558296|10028093|FG001|COMPLETED|Completed the Study Through Week 24||542
8964473|NCT02558296|10028092|FG000|NOT COMPLETED|Completed the Study Through Week 24||44
8964474|NCT02558296|10028093|FG001|NOT COMPLETED|Completed the Study Through Week 24||25
8964475|NCT02558296|10028092|FG000|STARTED|Completed the Study||1133
8964476|NCT02558296|10028093|FG001|STARTED|Completed the Study||567
8964477|NCT02558296|10028092|FG000|COMPLETED|Completed the Study||987
8964478|NCT02558296|10028093|FG001|COMPLETED|Completed the Study||482
8964479|NCT02558296|10028092|FG000|NOT COMPLETED|Completed the Study||146
8964480|NCT02558296|10028093|FG001|NOT COMPLETED|Completed the Study||85
8964481|NCT02558374|10028105|FG000|STARTED|Overall Study||351
8964482|NCT02558374|10028106|FG001|STARTED|Overall Study||357
8964483|NCT02558374|10028105|FG000|COMPLETED|Overall Study||243
8964484|NCT02558374|10028106|FG001|COMPLETED|Overall Study||314
8964485|NCT02558374|10028105|FG000|NOT COMPLETED|Overall Study||108
8964486|NCT02558374|10028106|FG001|NOT COMPLETED|Overall Study||43
8964487|NCT02558400|10028115|FG000|STARTED|Overall Study||238
8964488|NCT02558400|10028116|FG001|STARTED|Overall Study||244
8964489|NCT02558400|10028117|FG002|STARTED|Overall Study||236
8964490|NCT02558400|10028115|FG000|COMPLETED|Overall Study||159
8964491|NCT02558400|10028116|FG001|COMPLETED|Overall Study||148
8964492|NCT02558400|10028117|FG002|COMPLETED|Overall Study||203
8631711|NCT00541671|9671602|FG000|STARTED|Overall Study||13
8631712|NCT00541671|9671603|FG001|STARTED|Overall Study||12
8631713|NCT00541671|9671602|FG000|COMPLETED|Overall Study||13
8631714|NCT00541671|9671603|FG001|COMPLETED|Overall Study||12
8631715|NCT00541671|9671602|FG000|NOT COMPLETED|Overall Study||0
8631716|NCT00541671|9671603|FG001|NOT COMPLETED|Overall Study||0
8631717|NCT00541775|9671612|FG000|STARTED|Overall Study||94
8631718|NCT00541775|9671613|FG001|STARTED|Overall Study||87
8631719|NCT00541775|9671614|FG002|STARTED|Overall Study||92
8631720|NCT00541775|9671612|FG000|COMPLETED|Overall Study||85
8631721|NCT00541775|9671613|FG001|COMPLETED|Overall Study||85
8631722|NCT00541775|9671614|FG002|COMPLETED|Overall Study||84
8631723|NCT00541775|9671612|FG000|NOT COMPLETED|Overall Study||9
8631724|NCT00541775|9671613|FG001|NOT COMPLETED|Overall Study||2
8631725|NCT00541775|9671614|FG002|NOT COMPLETED|Overall Study||8
8631726|NCT00541866|9671627|FG000|STARTED|Overall Study|41 started, but only 39 treated|41
8631727|NCT00541866|9671628|FG001|STARTED|Overall Study||18
8631728|NCT00541866|9671629|FG002|STARTED|Overall Study||17
8631729|NCT00541866|9671630|FG003|STARTED|Overall Study||16
8631730|NCT00541866|9671631|FG004|STARTED|Overall Study||18
8631731|NCT00541866|9671627|FG000|COMPLETED|Overall Study||7
8631732|NCT00541866|9671628|FG001|COMPLETED|Overall Study||0
8631733|NCT00541866|9671629|FG002|COMPLETED|Overall Study||2
8631734|NCT00541866|9671630|FG003|COMPLETED|Overall Study||0
8631735|NCT00541866|9671631|FG004|COMPLETED|Overall Study||3
8631736|NCT00541866|9671627|FG000|NOT COMPLETED|Overall Study||34
8631737|NCT00541866|9671628|FG001|NOT COMPLETED|Overall Study||18
8725776|NCT01033383|9773125|FG000|STARTED|Overall Study||20
8725777|NCT01033383|9773126|FG001|STARTED|Overall Study||20
8725778|NCT01033383|9773127|FG002|STARTED|Overall Study||20
8725779|NCT01033383|9773128|FG003|STARTED|Overall Study||20
8725780|NCT01033383|9773125|FG000|COMPLETED|Overall Study||20
8725781|NCT01033383|9773126|FG001|COMPLETED|Overall Study||20
8725782|NCT01033383|9773127|FG002|COMPLETED|Overall Study||20
8725783|NCT01033383|9773128|FG003|COMPLETED|Overall Study||20
8964493|NCT02558400|10028115|FG000|NOT COMPLETED|Overall Study||79
8964494|NCT02558400|10028116|FG001|NOT COMPLETED|Overall Study||96
8964495|NCT02558400|10028117|FG002|NOT COMPLETED|Overall Study||33
8964496|NCT02558790|10028128|FG000|STARTED|Overall Study|20 subjects signed consent to participate in the study. 15 subjects began taking L-TAMS.|20
8964497|NCT02558790|10028128|FG000|Treated|Overall Study||15
8964498|NCT02558790|10028128|FG000|COMPLETED|Overall Study||13
8725784|NCT01033383|9773125|FG000|NOT COMPLETED|Overall Study||0
8725785|NCT01033383|9773126|FG001|NOT COMPLETED|Overall Study||0
8964499|NCT02558790|10028128|FG000|NOT COMPLETED|Overall Study||7
8964500|NCT02558829|10028136|FG000|STARTED|Overall Study||21
8964501|NCT02558829|10028137|FG001|STARTED|Overall Study||21
8964502|NCT02558829|10028138|FG002|STARTED|Overall Study||24
8964503|NCT02558829|10028139|FG003|STARTED|Overall Study||18
8964504|NCT02558829|10028140|FG004|STARTED|Overall Study||18
8964505|NCT02558829|10028141|FG005|STARTED|Overall Study||26
8964506|NCT02558829|10028142|FG006|STARTED|Overall Study||18
8964507|NCT02558829|10028143|FG007|STARTED|Overall Study||11
8964508|NCT02558829|10028136|FG000|COMPLETED|Overall Study||20
8964509|NCT02558829|10028137|FG001|COMPLETED|Overall Study||18
8964510|NCT02558829|10028138|FG002|COMPLETED|Overall Study||21
8964511|NCT02558829|10028139|FG003|COMPLETED|Overall Study||16
8964512|NCT02558829|10028140|FG004|COMPLETED|Overall Study||16
8964513|NCT02558829|10028141|FG005|COMPLETED|Overall Study||24
8964514|NCT02558829|10028142|FG006|COMPLETED|Overall Study||17
8964515|NCT02558829|10028143|FG007|COMPLETED|Overall Study||8
8964516|NCT02558829|10028136|FG000|NOT COMPLETED|Overall Study||1
8964517|NCT02558829|10028137|FG001|NOT COMPLETED|Overall Study||3
8964518|NCT02558829|10028138|FG002|NOT COMPLETED|Overall Study||3
8964519|NCT02558829|10028139|FG003|NOT COMPLETED|Overall Study||2
8964520|NCT02558829|10028140|FG004|NOT COMPLETED|Overall Study||2
8964521|NCT02558829|10028141|FG005|NOT COMPLETED|Overall Study||2
8964522|NCT02558829|10028142|FG006|NOT COMPLETED|Overall Study||1
8964523|NCT02558829|10028143|FG007|NOT COMPLETED|Overall Study||3
8964524|NCT02558894|10028167|FG000|STARTED|Overall Study||32
8964525|NCT02558894|10028168|FG001|STARTED|Overall Study||33
8964526|NCT02558894|10028167|FG000|Patients Who Received IP|Overall Study||32
8964527|NCT02558894|10028168|FG001|Patients Who Received IP|Overall Study||32
8964528|NCT02558894|10028167|FG000|COMPLETED|Overall Study||0
8964529|NCT02558894|10028168|FG001|COMPLETED|Overall Study||0
8964530|NCT02558894|10028167|FG000|NOT COMPLETED|Overall Study||32
8964531|NCT02558894|10028168|FG001|NOT COMPLETED|Overall Study||33
8964532|NCT02559115|10028174|FG000|STARTED|Overall Study||19
8964533|NCT02559115|10028174|FG000|COMPLETED|Overall Study||16
8964534|NCT02559115|10028174|FG000|NOT COMPLETED|Overall Study||3
8964535|NCT02559206|10028186|FG000|STARTED|Overall Study||66
8964536|NCT02559206|10028187|FG001|STARTED|Overall Study||66
8964537|NCT02559206|10028188|FG002|STARTED|Overall Study||67
8964538|NCT02559206|10028189|FG003|STARTED|Overall Study||67
8964539|NCT02559206|10028190|FG004|STARTED|Overall Study||67
8964540|NCT02559206|10028191|FG005|STARTED|Overall Study||67
8964541|NCT02559206|10028192|FG006|STARTED|Overall Study||66
8964542|NCT02559206|10028193|FG007|STARTED|Overall Study||66
8964543|NCT02559206|10028186|FG000|COMPLETED|Overall Study||58
8964544|NCT02559206|10028187|FG001|COMPLETED|Overall Study||54
8964545|NCT02559206|10028188|FG002|COMPLETED|Overall Study||58
8964546|NCT02559206|10028189|FG003|COMPLETED|Overall Study||53
8964547|NCT02559206|10028190|FG004|COMPLETED|Overall Study||55
8964548|NCT02559206|10028191|FG005|COMPLETED|Overall Study||53
8964549|NCT02559206|10028192|FG006|COMPLETED|Overall Study||60
8964550|NCT02559206|10028193|FG007|COMPLETED|Overall Study||57
8964551|NCT02559206|10028186|FG000|NOT COMPLETED|Overall Study||8
8964552|NCT02559206|10028187|FG001|NOT COMPLETED|Overall Study||12
8964553|NCT02559206|10028188|FG002|NOT COMPLETED|Overall Study||9
8964554|NCT02559206|10028189|FG003|NOT COMPLETED|Overall Study||14
8964555|NCT02559206|10028190|FG004|NOT COMPLETED|Overall Study||12
8964556|NCT02559206|10028191|FG005|NOT COMPLETED|Overall Study||14
8964557|NCT02559206|10028192|FG006|NOT COMPLETED|Overall Study||6
8964558|NCT02559206|10028193|FG007|NOT COMPLETED|Overall Study||9
8964559|NCT02559310|10028213|FG000|STARTED|Overall Study||276
8964560|NCT02559310|10028214|FG001|STARTED|Overall Study||275
8964561|NCT02559310|10028213|FG000|COMPLETED|Overall Study||249
8964562|NCT02559310|10028214|FG001|COMPLETED|Overall Study||256
8964563|NCT02559310|10028213|FG000|NOT COMPLETED|Overall Study||27
8964564|NCT02559310|10028214|FG001|NOT COMPLETED|Overall Study||19
8964565|NCT02559414|10028223|FG000|STARTED|Overall Study||11
8964566|NCT02559414|10028224|FG001|STARTED|Overall Study||22
8964567|NCT02559414|10028225|FG002|STARTED|Overall Study||22
8964568|NCT02559414|10028223|FG000|COMPLETED|Overall Study||10
8964569|NCT02559414|10028224|FG001|COMPLETED|Overall Study||20
8964570|NCT02559414|10028225|FG002|COMPLETED|Overall Study||20
8964571|NCT02559414|10028223|FG000|NOT COMPLETED|Overall Study||1
8964572|NCT02559414|10028224|FG001|NOT COMPLETED|Overall Study||2
8964573|NCT02559414|10028225|FG002|NOT COMPLETED|Overall Study||2
8964574|NCT02559505|10028250|FG000|STARTED|Overall Study||49
8964575|NCT02559505|10028251|FG001|STARTED|Overall Study||84
8964576|NCT02559505|10028250|FG000|COMPLETED|Overall Study||22
8964577|NCT02559505|10028251|FG001|COMPLETED|Overall Study||62
8964578|NCT02559505|10028250|FG000|NOT COMPLETED|Overall Study||27
8964579|NCT02559505|10028251|FG001|NOT COMPLETED|Overall Study||22
8964580|NCT02559570|10028274|FG000|STARTED|Overall Study||41
8964581|NCT02559570|10028275|FG001|STARTED|Overall Study||36
8964582|NCT02559570|10028276|FG002|STARTED|Overall Study||41
8964583|NCT02559570|10028277|FG003|STARTED|Overall Study||39
8964584|NCT02559570|10028278|FG004|STARTED|Overall Study||16
8964585|NCT02559570|10028274|FG000|COMPLETED|Overall Study||39
8964586|NCT02559570|10028275|FG001|COMPLETED|Overall Study||34
8964587|NCT02559570|10028276|FG002|COMPLETED|Overall Study||39
8964588|NCT02559570|10028277|FG003|COMPLETED|Overall Study||36
8964589|NCT02559570|10028278|FG004|COMPLETED|Overall Study||14
8964590|NCT02559570|10028274|FG000|NOT COMPLETED|Overall Study||2
8964591|NCT02559570|10028275|FG001|NOT COMPLETED|Overall Study||2
8964592|NCT02559570|10028276|FG002|NOT COMPLETED|Overall Study||2
8964593|NCT02559570|10028277|FG003|NOT COMPLETED|Overall Study||3
8964594|NCT02559570|10028278|FG004|NOT COMPLETED|Overall Study||2
8964595|NCT02559622|10028293|FG000|STARTED|Overall Study||48
8964596|NCT02559622|10028294|FG001|STARTED|Overall Study||54
8964597|NCT02559622|10028295|FG002|STARTED|Overall Study||26
8964598|NCT02559622|10028296|FG003|STARTED|Overall Study||23
8964599|NCT02559622|10028293|FG000|COMPLETED|Overall Study||47
8964600|NCT02559622|10028294|FG001|COMPLETED|Overall Study||49
8964601|NCT02559622|10028295|FG002|COMPLETED|Overall Study||24
8964602|NCT02559622|10028296|FG003|COMPLETED|Overall Study||20
8964603|NCT02559622|10028293|FG000|NOT COMPLETED|Overall Study||1
8964604|NCT02559622|10028294|FG001|NOT COMPLETED|Overall Study||5
8964605|NCT02559622|10028295|FG002|NOT COMPLETED|Overall Study||2
8964606|NCT02559622|10028296|FG003|NOT COMPLETED|Overall Study||3
8964607|NCT02559687|10028310|FG000|STARTED|Overall Study||121
8964608|NCT02559687|10028310|FG000|COMPLETED|Overall Study||0
8964609|NCT02559687|10028310|FG000|NOT COMPLETED|Overall Study||121
8964610|NCT02559713|10028314|FG000|STARTED|Overall Study||11
8964611|NCT02559713|10028314|FG000|Safety Set|Overall Study||11
8964612|NCT02559713|10028314|FG000|Pharmacokinetic Set|Overall Study||11
8964613|NCT02559713|10028314|FG000|COMPLETED|Overall Study||10
8964614|NCT02559713|10028314|FG000|NOT COMPLETED|Overall Study||1
8964615|NCT02559817|10028323|FG000|STARTED|Treatment Period||19
8964616|NCT02559817|10028324|FG001|STARTED|Treatment Period||29
8964617|NCT02559817|10028325|FG002|STARTED|Treatment Period||21
8964618|NCT02559817|10028326|FG003|STARTED|Treatment Period||24
8964619|NCT02559817|10028327|FG004|STARTED|Treatment Period||8
8964620|NCT02559817|10028323|FG000|COMPLETED|Treatment Period||18
8964621|NCT02559817|10028324|FG001|COMPLETED|Treatment Period||27
8964622|NCT02559817|10028325|FG002|COMPLETED|Treatment Period||19
8964623|NCT02559817|10028326|FG003|COMPLETED|Treatment Period||22
8964624|NCT02559817|10028327|FG004|COMPLETED|Treatment Period||8
8964625|NCT02559817|10028323|FG000|NOT COMPLETED|Treatment Period||1
8964626|NCT02559817|10028324|FG001|NOT COMPLETED|Treatment Period||2
8964627|NCT02559817|10028325|FG002|NOT COMPLETED|Treatment Period||2
8964628|NCT02559817|10028326|FG003|NOT COMPLETED|Treatment Period||2
8964629|NCT02559817|10028327|FG004|NOT COMPLETED|Treatment Period||0
8964630|NCT02559817|10028323|FG000|STARTED|Post-treatment Period||18
8964631|NCT02559817|10028324|FG001|STARTED|Post-treatment Period||27
8964632|NCT02559817|10028325|FG002|STARTED|Post-treatment Period|1 participant who did not complete the first period, entered and completed the Post-treatment Period|20
8964633|NCT02559817|10028326|FG003|STARTED|Post-treatment Period||22
8964634|NCT02559817|10028327|FG004|STARTED|Post-treatment Period||8
8964635|NCT02559817|10028323|FG000|COMPLETED|Post-treatment Period||18
8964636|NCT02559817|10028324|FG001|COMPLETED|Post-treatment Period||27
8964637|NCT02559817|10028325|FG002|COMPLETED|Post-treatment Period||20
8964638|NCT02559817|10028326|FG003|COMPLETED|Post-treatment Period||22
8964639|NCT02559817|10028327|FG004|COMPLETED|Post-treatment Period||8
8964640|NCT02559817|10028323|FG000|NOT COMPLETED|Post-treatment Period||0
8964641|NCT02559817|10028324|FG001|NOT COMPLETED|Post-treatment Period||0
8964642|NCT02559817|10028325|FG002|NOT COMPLETED|Post-treatment Period||0
8964643|NCT02559817|10028326|FG003|NOT COMPLETED|Post-treatment Period||0
8964644|NCT02559817|10028327|FG004|NOT COMPLETED|Post-treatment Period||0
8964645|NCT02559895|10028343|FG000|STARTED|Overall Study||224
8964646|NCT02559895|10028344|FG001|STARTED|Overall Study||225
8964647|NCT02559895|10028345|FG002|STARTED|Overall Study||224
8964648|NCT02559895|10028346|FG003|STARTED|Overall Study||225
8964649|NCT02559895|10028343|FG000|Participants Treated|Overall Study||222
8964650|NCT02559895|10028344|FG001|Participants Treated|Overall Study||221
8964651|NCT02559895|10028345|FG002|Participants Treated|Overall Study||223
8964652|NCT02559895|10028346|FG003|Participants Treated|Overall Study||222
8964653|NCT02559895|10028343|FG000|COMPLETED|Overall Study||169
8964654|NCT02559895|10028344|FG001|COMPLETED|Overall Study||172
8964655|NCT02559895|10028345|FG002|COMPLETED|Overall Study||170
8964656|NCT02559895|10028346|FG003|COMPLETED|Overall Study||165
8964657|NCT02559895|10028343|FG000|NOT COMPLETED|Overall Study||55
8964658|NCT02559895|10028344|FG001|NOT COMPLETED|Overall Study||53
8964659|NCT02559895|10028345|FG002|NOT COMPLETED|Overall Study||54
8964660|NCT02559895|10028346|FG003|NOT COMPLETED|Overall Study||60
8964661|NCT02560012|10028356|FG000|STARTED|Overall Study||3
8964662|NCT02560012|10028356|FG000|COMPLETED|Overall Study||1
8964663|NCT02560012|10028356|FG000|NOT COMPLETED|Overall Study||2
8964664|NCT02560025|10028360|FG000|STARTED|Overall Study||42
8964665|NCT02560025|10028360|FG000|COMPLETED|Overall Study||39
8964666|NCT02560025|10028360|FG000|NOT COMPLETED|Overall Study||3
8964667|NCT02560038|10028364|FG000|STARTED|Overall Study||3
8964668|NCT02560038|10028364|FG000|COMPLETED|Overall Study||1
8964669|NCT02560038|10028364|FG000|NOT COMPLETED|Overall Study||2
8964670|NCT02560051|10028371|FG000|STARTED|Overall Study||6
8964671|NCT02560051|10028372|FG001|STARTED|Overall Study||8
8964672|NCT02560051|10028373|FG002|STARTED|Overall Study||5
8964673|NCT02560051|10028371|FG000|COMPLETED|Overall Study||3
8964674|NCT02560051|10028372|FG001|COMPLETED|Overall Study||4
8964675|NCT02560051|10028373|FG002|COMPLETED|Overall Study||4
8964676|NCT02560051|10028371|FG000|NOT COMPLETED|Overall Study||3
8964677|NCT02560051|10028372|FG001|NOT COMPLETED|Overall Study||4
8964678|NCT02560051|10028373|FG002|NOT COMPLETED|Overall Study||1
8964679|NCT02560324|10028383|FG000|STARTED|Period 1 (2 Weeks)||35
8964680|NCT02560324|10028384|FG001|STARTED|Period 1 (2 Weeks)||34
8964681|NCT02560324|10028383|FG000|COMPLETED|Period 1 (2 Weeks)||23
8964682|NCT02560324|10028384|FG001|COMPLETED|Period 1 (2 Weeks)||25
8964683|NCT02560324|10028383|FG000|NOT COMPLETED|Period 1 (2 Weeks)||12
8964684|NCT02560324|10028384|FG001|NOT COMPLETED|Period 1 (2 Weeks)||9
8964685|NCT02560324|10028383|FG000|STARTED|Washout (2 Weeks)||23
8964686|NCT02560324|10028384|FG001|STARTED|Washout (2 Weeks)||25
8964687|NCT02560324|10028383|FG000|COMPLETED|Washout (2 Weeks)||23
8964688|NCT02560324|10028384|FG001|COMPLETED|Washout (2 Weeks)||23
8964689|NCT02560324|10028383|FG000|NOT COMPLETED|Washout (2 Weeks)||0
8964690|NCT02560324|10028384|FG001|NOT COMPLETED|Washout (2 Weeks)||2
8964691|NCT02560324|10028383|FG000|STARTED|Period 2 (2 Weeks)||23
8964692|NCT02560324|10028384|FG001|STARTED|Period 2 (2 Weeks)||23
8964693|NCT02560324|10028383|FG000|COMPLETED|Period 2 (2 Weeks)||22
8964694|NCT02560324|10028384|FG001|COMPLETED|Period 2 (2 Weeks)||21
8964695|NCT02560324|10028383|FG000|NOT COMPLETED|Period 2 (2 Weeks)||1
8964696|NCT02560324|10028384|FG001|NOT COMPLETED|Period 2 (2 Weeks)||2
8964697|NCT02560389|10028397|FG000|STARTED|Overall Study||34
8964698|NCT02560389|10028398|FG001|STARTED|Overall Study||28
8964699|NCT02560389|10028399|FG002|STARTED|Overall Study||29
8964700|NCT02560389|10028397|FG000|COMPLETED|Overall Study||33
8964701|NCT02560389|10028398|FG001|COMPLETED|Overall Study||25
8964702|NCT02560389|10028399|FG002|COMPLETED|Overall Study||27
8964703|NCT02560389|10028397|FG000|NOT COMPLETED|Overall Study||1
8964704|NCT02560389|10028398|FG001|NOT COMPLETED|Overall Study||3
8964705|NCT02560389|10028399|FG002|NOT COMPLETED|Overall Study||2
8964706|NCT02560493|10028409|FG000|STARTED|Overall Study||23
8964707|NCT02560493|10028410|FG001|STARTED|Overall Study||23
8964708|NCT02560493|10028409|FG000|COMPLETED|Overall Study||22
8964709|NCT02560493|10028410|FG001|COMPLETED|Overall Study||23
8964710|NCT02560493|10028409|FG000|NOT COMPLETED|Overall Study||1
8964711|NCT02560493|10028410|FG001|NOT COMPLETED|Overall Study||0
8964712|NCT02560558|10028418|FG000|STARTED|Overall Study||84
8964713|NCT02560558|10028419|FG001|STARTED|Overall Study||82
8964714|NCT02560558|10028418|FG000|COMPLETED|Overall Study||77
8964715|NCT02560558|10028419|FG001|COMPLETED|Overall Study||76
8964716|NCT02560558|10028418|FG000|NOT COMPLETED|Overall Study||7
8964717|NCT02560558|10028419|FG001|NOT COMPLETED|Overall Study||6
8964718|NCT02560584|10028425|FG000|STARTED|Overall Study||304
8964719|NCT02560584|10028425|FG000|COMPLETED|Overall Study||304
8964720|NCT02560584|10028425|FG000|NOT COMPLETED|Overall Study||0
8964721|NCT02560701|10028433|FG000|STARTED|Overall Study||8060
8964722|NCT02560701|10028434|FG001|STARTED|Overall Study||89242
8964723|NCT02560701|10028433|FG000|Carve Out|Overall Study||8060
8964724|NCT02560701|10028434|FG001|Carve Out|Overall Study||88729
8964725|NCT02560701|10028433|FG000|Restrict to Patients Between 12 and 64|Overall Study||7598
8964726|NCT02560701|10028434|FG001|Restrict to Patients Between 12 and 64|Overall Study||82367
8964727|NCT02560701|10028433|FG000|Bipolar Diagnosis Time Constraints|Overall Study||3533
8964728|NCT02560701|10028434|FG001|Bipolar Diagnosis Time Constraints|Overall Study||39427
8964729|NCT02560701|10028433|FG000|Matched Cohort|Overall Study||3517
8964730|NCT02560701|10028434|FG001|Matched Cohort|Overall Study||37776
8964731|NCT02560701|10028433|FG000|COMPLETED|Overall Study||3517
8964732|NCT02560701|10028434|FG001|COMPLETED|Overall Study||37776
8964733|NCT02560701|10028433|FG000|NOT COMPLETED|Overall Study||4543
8964734|NCT02560701|10028434|FG001|NOT COMPLETED|Overall Study||51466
8964735|NCT02560753|10028444|FG000|STARTED|Overall Study||9
8964736|NCT02560753|10028445|FG001|STARTED|Overall Study||9
8964737|NCT02560753|10028446|FG002|STARTED|Overall Study||10
8964738|NCT02560753|10028447|FG003|STARTED|Overall Study||8
8964739|NCT02560753|10028444|FG000|COMPLETED|Overall Study||8
8964740|NCT02560753|10028445|FG001|COMPLETED|Overall Study||9
8964741|NCT02560753|10028446|FG002|COMPLETED|Overall Study||9
8964742|NCT02560753|10028447|FG003|COMPLETED|Overall Study||8
8964743|NCT02560753|10028444|FG000|NOT COMPLETED|Overall Study||1
8964744|NCT02560753|10028445|FG001|NOT COMPLETED|Overall Study||0
8964745|NCT02560753|10028446|FG002|NOT COMPLETED|Overall Study||1
8964746|NCT02560753|10028447|FG003|NOT COMPLETED|Overall Study||0
8964747|NCT02560779|10028459|FG000|STARTED|Overall Study||14
8964748|NCT02560779|10028460|FG001|STARTED|Overall Study||13
8964749|NCT02560779|10028459|FG000|COMPLETED|Overall Study||14
8964750|NCT02560779|10028460|FG001|COMPLETED|Overall Study||13
8964751|NCT02560779|10028459|FG000|NOT COMPLETED|Overall Study||0
8964752|NCT02560779|10028460|FG001|NOT COMPLETED|Overall Study||0
8964753|NCT02560922|10028468|FG000|STARTED|Overall Study||124
8964754|NCT02560922|10028469|FG001|STARTED|Overall Study||124
8964755|NCT02560922|10028468|FG000|COMPLETED|Overall Study||98
8964756|NCT02560922|10028469|FG001|COMPLETED|Overall Study||112
8964757|NCT02560922|10028468|FG000|NOT COMPLETED|Overall Study||26
8570547|NCT00104299|9602731|FG001|NOT COMPLETED|Overall Study||10
8964758|NCT02560922|10028469|FG001|NOT COMPLETED|Overall Study||12
8964759|NCT02561000|10028478|FG000|STARTED|Overall Study||34
8964760|NCT02561000|10028479|FG001|STARTED|Overall Study||35
8964761|NCT02561000|10028480|FG002|STARTED|Overall Study||31
8964762|NCT02561000|10028478|FG000|Safety Population|Overall Study|Includes 1 additional patient who was assigned PZ-128 0.3 mg/kg but received placebo in error (evaluated as placebo for primary safety outcome and adverse events).|35
9037898|NCT03323723|10099158|FG000|COMPLETED|Screening||64
9037899|NCT03323723|10099158|FG000|NOT COMPLETED|Screening||9
9037900|NCT03323723|10099158|FG000|STARTED|Baseline Phase||64
9037901|NCT03323723|10099158|FG000|COMPLETED|Baseline Phase||60
8570548|NCT00104416|9602739|FG000|STARTED|Double-Blind Phase||77
8570549|NCT00104416|9602740|FG001|STARTED|Double-Blind Phase||76
8570550|NCT00104416|9602741|FG002|STARTED|Double-Blind Phase||0
8964763|NCT02561000|10028479|FG001|Safety Population|Overall Study|Excludes 4 patients who did not receive the study drug as allocated: 1 patient received placebo in error and was evaluated as placebo for primary safety outcome and adverse events; 2 patients withdrew full consent immediately after randomization prior to receiving any study drug; and 1 patient had an adverse event shortly after randomization prior to receiving any study drug.|31
8964764|NCT02561000|10028480|FG002|Safety Population|Overall Study||31
8964765|NCT02561000|10028478|FG000|Intent-to-Treat (ITT) Population at 30 Days|Overall Study||34
8964766|NCT02561000|10028479|FG001|Intent-to-Treat (ITT) Population at 30 Days|Overall Study|Excludes 2 patients who withdrew full consent immediately after randomization.|33
8964767|NCT02561000|10028480|FG002|Intent-to-Treat (ITT) Population at 30 Days|Overall Study||31
8964768|NCT02561000|10028478|FG000|Intent-to-Treat (ITT) Population at 90 Days|Overall Study|Excludes 1 patient who withdrew consent for follow-up 21 days after study drug dosing.|33
8964769|NCT02561000|10028479|FG001|Intent-to-Treat (ITT) Population at 90 Days|Overall Study|Excludes 4 patients: 2 patients withdrew full consent immediately after randomization; 1 patient followed only for 30 day ITT outcome (did not receive any study drug due to adverse event post randomization); and 1 patient withdrew consent for follow-up 7 days after study drug dosing.|31
8964770|NCT02561000|10028480|FG002|Intent-to-Treat (ITT) Population at 90 Days|Overall Study||31
8964771|NCT02561000|10028478|FG000|COMPLETED|Overall Study||32
8964772|NCT02561000|10028479|FG001|COMPLETED|Overall Study||31
8964773|NCT02561000|10028480|FG002|COMPLETED|Overall Study||31
8964774|NCT02561000|10028478|FG000|NOT COMPLETED|Overall Study||2
8964775|NCT02561000|10028479|FG001|NOT COMPLETED|Overall Study||4
8964776|NCT02561000|10028480|FG002|NOT COMPLETED|Overall Study||0
8964777|NCT02561078|10028490|FG000|STARTED|Overall Study||209
8964778|NCT02561078|10028491|FG001|STARTED|Overall Study||211
8964779|NCT02561078|10028490|FG000|Received at Least 1 Dose of Study Drug|Overall Study||208
8964780|NCT02561078|10028491|FG001|Received at Least 1 Dose of Study Drug|Overall Study||210
8964781|NCT02561078|10028490|FG000|COMPLETED|Overall Study||179
8964782|NCT02561078|10028491|FG001|COMPLETED|Overall Study||186
8964783|NCT02561078|10028490|FG000|NOT COMPLETED|Overall Study||30
8964784|NCT02561078|10028491|FG001|NOT COMPLETED|Overall Study||25
8964785|NCT02561130|10028499|FG000|STARTED|Overall Study||77
8964786|NCT02561130|10028500|FG001|STARTED|Overall Study||77
8964787|NCT02561130|10028499|FG000|COMPLETED|Overall Study||76
8964788|NCT02561130|10028500|FG001|COMPLETED|Overall Study||76
8964789|NCT02561130|10028499|FG000|NOT COMPLETED|Overall Study||1
8964790|NCT02561130|10028500|FG001|NOT COMPLETED|Overall Study||1
8964791|NCT02561156|10028519|FG000|STARTED|Part 1||12
8964792|NCT02561156|10028520|FG001|STARTED|Part 1||6
8964793|NCT02561156|10028521|FG002|STARTED|Part 1||6
8964794|NCT02561156|10028522|FG003|STARTED|Part 1||6
8964795|NCT02561156|10028523|FG004|STARTED|Part 1||6
8964796|NCT02561156|10028524|FG005|STARTED|Part 1||6
8964797|NCT02561156|10028525|FG006|STARTED|Part 1||6
8964798|NCT02561156|10028526|FG007|STARTED|Part 1||0
8964799|NCT02561156|10028527|FG008|STARTED|Part 1||0
8964800|NCT02561156|10028528|FG009|STARTED|Part 1||0
8964801|NCT02561156|10028529|FG010|STARTED|Part 1||0
8964802|NCT02561156|10028530|FG011|STARTED|Part 1||0
8964803|NCT02561156|10028531|FG012|STARTED|Part 1||0
8570551|NCT00104416|9602742|FG003|STARTED|Double-Blind Phase||0
8570552|NCT00104416|9602743|FG004|STARTED|Double-Blind Phase||0
8570553|NCT00104416|9602739|FG000|COMPLETED|Double-Blind Phase||69
8570554|NCT00104416|9602740|FG001|COMPLETED|Double-Blind Phase||66
8570555|NCT00104416|9602741|FG002|COMPLETED|Double-Blind Phase||0
8570556|NCT00104416|9602742|FG003|COMPLETED|Double-Blind Phase||0
8964804|NCT02561156|10028519|FG000|COMPLETED|Part 1||12
8964805|NCT02561156|10028520|FG001|COMPLETED|Part 1||6
8964806|NCT02561156|10028521|FG002|COMPLETED|Part 1||6
8964807|NCT02561156|10028522|FG003|COMPLETED|Part 1||6
8964808|NCT02561156|10028523|FG004|COMPLETED|Part 1||6
8964809|NCT02561156|10028524|FG005|COMPLETED|Part 1||6
8964810|NCT02561156|10028525|FG006|COMPLETED|Part 1||6
8964811|NCT02561156|10028526|FG007|COMPLETED|Part 1||0
8964812|NCT02561156|10028527|FG008|COMPLETED|Part 1||0
8964813|NCT02561156|10028528|FG009|COMPLETED|Part 1||0
8964814|NCT02561156|10028529|FG010|COMPLETED|Part 1||0
8964815|NCT02561156|10028530|FG011|COMPLETED|Part 1||0
8964816|NCT02561156|10028531|FG012|COMPLETED|Part 1||0
8964817|NCT02561156|10028519|FG000|NOT COMPLETED|Part 1||0
8964818|NCT02561156|10028520|FG001|NOT COMPLETED|Part 1||0
8964819|NCT02561156|10028521|FG002|NOT COMPLETED|Part 1||0
8964820|NCT02561156|10028522|FG003|NOT COMPLETED|Part 1||0
8964821|NCT02561156|10028523|FG004|NOT COMPLETED|Part 1||0
8964822|NCT02561156|10028524|FG005|NOT COMPLETED|Part 1||0
8964823|NCT02561156|10028525|FG006|NOT COMPLETED|Part 1||0
8964824|NCT02561156|10028526|FG007|NOT COMPLETED|Part 1||0
8964825|NCT02561156|10028527|FG008|NOT COMPLETED|Part 1||0
8964826|NCT02561156|10028528|FG009|NOT COMPLETED|Part 1||0
8964827|NCT02561156|10028529|FG010|NOT COMPLETED|Part 1||0
8964828|NCT02561156|10028530|FG011|NOT COMPLETED|Part 1||0
8964829|NCT02561156|10028531|FG012|NOT COMPLETED|Part 1||0
8570557|NCT00104416|9602743|FG004|COMPLETED|Double-Blind Phase||0
8570558|NCT00104416|9602739|FG000|NOT COMPLETED|Double-Blind Phase||8
8964830|NCT02561156|10028519|FG000|STARTED|Part 2||0
8964831|NCT02561156|10028520|FG001|STARTED|Part 2||0
8964832|NCT02561156|10028521|FG002|STARTED|Part 2||0
8964833|NCT02561156|10028522|FG003|STARTED|Part 2||0
8964834|NCT02561156|10028523|FG004|STARTED|Part 2||0
8964835|NCT02561156|10028524|FG005|STARTED|Part 2||0
8964836|NCT02561156|10028525|FG006|STARTED|Part 2||0
8964837|NCT02561156|10028526|FG007|STARTED|Part 2||10
8570559|NCT00104416|9602740|FG001|NOT COMPLETED|Double-Blind Phase||10
8570560|NCT00104416|9602741|FG002|NOT COMPLETED|Double-Blind Phase||0
8964838|NCT02561156|10028527|FG008|STARTED|Part 2||6
8964839|NCT02561156|10028528|FG009|STARTED|Part 2||6
8964840|NCT02561156|10028529|FG010|STARTED|Part 2||6
8964841|NCT02561156|10028530|FG011|STARTED|Part 2||6
8964842|NCT02561156|10028531|FG012|STARTED|Part 2||6
8964843|NCT02561156|10028519|FG000|COMPLETED|Part 2||0
8964844|NCT02561156|10028520|FG001|COMPLETED|Part 2||0
8964845|NCT02561156|10028521|FG002|COMPLETED|Part 2||0
8964846|NCT02561156|10028522|FG003|COMPLETED|Part 2||0
8964847|NCT02561156|10028523|FG004|COMPLETED|Part 2||0
8964848|NCT02561156|10028524|FG005|COMPLETED|Part 2||0
8964849|NCT02561156|10028525|FG006|COMPLETED|Part 2||0
8964850|NCT02561156|10028526|FG007|COMPLETED|Part 2||10
8964851|NCT02561156|10028527|FG008|COMPLETED|Part 2||6
8964852|NCT02561156|10028528|FG009|COMPLETED|Part 2||6
8964853|NCT02561156|10028529|FG010|COMPLETED|Part 2||6
8964854|NCT02561156|10028530|FG011|COMPLETED|Part 2||5
8964855|NCT02561156|10028531|FG012|COMPLETED|Part 2||6
8964856|NCT02561156|10028519|FG000|NOT COMPLETED|Part 2||0
8964857|NCT02561156|10028520|FG001|NOT COMPLETED|Part 2||0
8964858|NCT02561156|10028521|FG002|NOT COMPLETED|Part 2||0
8964859|NCT02561156|10028522|FG003|NOT COMPLETED|Part 2||0
8964860|NCT02561156|10028523|FG004|NOT COMPLETED|Part 2||0
8964861|NCT02561156|10028524|FG005|NOT COMPLETED|Part 2||0
8964862|NCT02561156|10028525|FG006|NOT COMPLETED|Part 2||0
8964863|NCT02561156|10028526|FG007|NOT COMPLETED|Part 2||0
8964864|NCT02561156|10028527|FG008|NOT COMPLETED|Part 2||0
8964865|NCT02561156|10028528|FG009|NOT COMPLETED|Part 2||0
8964866|NCT02561156|10028529|FG010|NOT COMPLETED|Part 2||0
8964867|NCT02561156|10028530|FG011|NOT COMPLETED|Part 2||1
8964868|NCT02561156|10028531|FG012|NOT COMPLETED|Part 2||0
8964869|NCT02561195|10028581|FG000|STARTED|Vaccination 1 to 3||183
8964870|NCT02561195|10028582|FG001|STARTED|Vaccination 1 to 3||184
8964871|NCT02561195|10028583|FG002|STARTED|Vaccination 1 to 3||61
8964872|NCT02561195|10028584|FG003|STARTED|Vaccination 1 to 3||183
8964873|NCT02561195|10028585|FG004|STARTED|Vaccination 1 to 3||183
8964874|NCT02561195|10028586|FG005|STARTED|Vaccination 1 to 3||61
8964875|NCT02561195|10028587|FG006|STARTED|Vaccination 1 to 3||0
8964876|NCT02561195|10028588|FG007|STARTED|Vaccination 1 to 3||0
8964877|NCT02561195|10028589|FG008|STARTED|Vaccination 1 to 3||0
8964878|NCT02561195|10028590|FG009|STARTED|Vaccination 1 to 3||0
8964879|NCT02561195|10028591|FG010|STARTED|Vaccination 1 to 3||0
8964880|NCT02561195|10028592|FG011|STARTED|Vaccination 1 to 3||0
8964881|NCT02561195|10028593|FG012|STARTED|Vaccination 1 to 3||0
8964882|NCT02561195|10028594|FG013|STARTED|Vaccination 1 to 3||0
8964883|NCT02561195|10028581|FG000|Treated|Vaccination 1 to 3||182
8964884|NCT02561195|10028582|FG001|Treated|Vaccination 1 to 3||184
8964885|NCT02561195|10028583|FG002|Treated|Vaccination 1 to 3||61
8964886|NCT02561195|10028584|FG003|Treated|Vaccination 1 to 3||183
8964887|NCT02561195|10028585|FG004|Treated|Vaccination 1 to 3||183
8964888|NCT02561195|10028586|FG005|Treated|Vaccination 1 to 3||61
8964889|NCT02561195|10028587|FG006|Treated|Vaccination 1 to 3||0
8964890|NCT02561195|10028588|FG007|Treated|Vaccination 1 to 3||0
8964891|NCT02561195|10028589|FG008|Treated|Vaccination 1 to 3||0
8964892|NCT02561195|10028590|FG009|Treated|Vaccination 1 to 3||0
8964893|NCT02561195|10028591|FG010|Treated|Vaccination 1 to 3||0
8964894|NCT02561195|10028592|FG011|Treated|Vaccination 1 to 3||0
8964895|NCT02561195|10028593|FG012|Treated|Vaccination 1 to 3||0
8964896|NCT02561195|10028594|FG013|Treated|Vaccination 1 to 3||0
8964897|NCT02561195|10028581|FG000|COMPLETED|Vaccination 1 to 3||160
8964898|NCT02561195|10028582|FG001|COMPLETED|Vaccination 1 to 3||162
8964899|NCT02561195|10028583|FG002|COMPLETED|Vaccination 1 to 3||55
8964900|NCT02561195|10028584|FG003|COMPLETED|Vaccination 1 to 3||157
8964901|NCT02561195|10028585|FG004|COMPLETED|Vaccination 1 to 3||155
8964902|NCT02561195|10028586|FG005|COMPLETED|Vaccination 1 to 3||51
8964903|NCT02561195|10028587|FG006|COMPLETED|Vaccination 1 to 3||0
8964904|NCT02561195|10028588|FG007|COMPLETED|Vaccination 1 to 3||0
8964905|NCT02561195|10028589|FG008|COMPLETED|Vaccination 1 to 3||0
8964906|NCT02561195|10028590|FG009|COMPLETED|Vaccination 1 to 3||0
8964907|NCT02561195|10028591|FG010|COMPLETED|Vaccination 1 to 3||0
8964908|NCT02561195|10028592|FG011|COMPLETED|Vaccination 1 to 3||0
8964909|NCT02561195|10028593|FG012|COMPLETED|Vaccination 1 to 3||0
8964910|NCT02561195|10028594|FG013|COMPLETED|Vaccination 1 to 3||0
8964911|NCT02561195|10028581|FG000|NOT COMPLETED|Vaccination 1 to 3||23
8964912|NCT02561195|10028582|FG001|NOT COMPLETED|Vaccination 1 to 3||22
8964913|NCT02561195|10028583|FG002|NOT COMPLETED|Vaccination 1 to 3||6
8964914|NCT02561195|10028584|FG003|NOT COMPLETED|Vaccination 1 to 3||26
8964915|NCT02561195|10028585|FG004|NOT COMPLETED|Vaccination 1 to 3||28
8964916|NCT02561195|10028586|FG005|NOT COMPLETED|Vaccination 1 to 3||10
8964917|NCT02561195|10028587|FG006|NOT COMPLETED|Vaccination 1 to 3||0
8964918|NCT02561195|10028588|FG007|NOT COMPLETED|Vaccination 1 to 3||0
8964919|NCT02561195|10028589|FG008|NOT COMPLETED|Vaccination 1 to 3||0
8964920|NCT02561195|10028590|FG009|NOT COMPLETED|Vaccination 1 to 3||0
8964921|NCT02561195|10028591|FG010|NOT COMPLETED|Vaccination 1 to 3||0
8964922|NCT02561195|10028592|FG011|NOT COMPLETED|Vaccination 1 to 3||0
8964923|NCT02561195|10028593|FG012|NOT COMPLETED|Vaccination 1 to 3||0
8964924|NCT02561195|10028594|FG013|NOT COMPLETED|Vaccination 1 to 3||0
8964925|NCT02561195|10028581|FG000|STARTED|Extension Stage (Vaccination 4)||0
8964926|NCT02561195|10028582|FG001|STARTED|Extension Stage (Vaccination 4)||0
8964927|NCT02561195|10028583|FG002|STARTED|Extension Stage (Vaccination 4)||0
8964928|NCT02561195|10028584|FG003|STARTED|Extension Stage (Vaccination 4)||0
8964929|NCT02561195|10028585|FG004|STARTED|Extension Stage (Vaccination 4)||0
8964930|NCT02561195|10028586|FG005|STARTED|Extension Stage (Vaccination 4)||0
8964931|NCT02561195|10028587|FG006|STARTED|Extension Stage (Vaccination 4)|Participants who met predefined eligibility criteria enrolled into extension stage.|16
8964932|NCT02561195|10028588|FG007|STARTED|Extension Stage (Vaccination 4)|Participants who met predefined eligibility criteria enrolled into extension stage.|18
8964933|NCT02561195|10028589|FG008|STARTED|Extension Stage (Vaccination 4)|Participants who met predefined eligibility criteria enrolled into extension stage.|24
8964934|NCT02561195|10028590|FG009|STARTED|Extension Stage (Vaccination 4)|Participants who met predefined eligibility criteria enrolled into extension stage.|22
8964935|NCT02561195|10028591|FG010|STARTED|Extension Stage (Vaccination 4)|Participants who met predefined eligibility criteria enrolled into extension stage.|51
8964936|NCT02561195|10028592|FG011|STARTED|Extension Stage (Vaccination 4)|Participants who met predefined eligibility criteria enrolled into extension stage.|52
8964937|NCT02561195|10028593|FG012|STARTED|Extension Stage (Vaccination 4)|Participants who met predefined eligibility criteria enrolled into extension stage.|58
8964938|NCT02561195|10028594|FG013|STARTED|Extension Stage (Vaccination 4)|Participants who met predefined eligibility criteria enrolled into extension stage.|59
8964939|NCT02561195|10028581|FG000|COMPLETED|Extension Stage (Vaccination 4)||0
8964940|NCT02561195|10028582|FG001|COMPLETED|Extension Stage (Vaccination 4)||0
8964941|NCT02561195|10028583|FG002|COMPLETED|Extension Stage (Vaccination 4)||0
8964942|NCT02561195|10028584|FG003|COMPLETED|Extension Stage (Vaccination 4)||0
8964943|NCT02561195|10028585|FG004|COMPLETED|Extension Stage (Vaccination 4)||0
8964944|NCT02561195|10028586|FG005|COMPLETED|Extension Stage (Vaccination 4)||0
8964945|NCT02561195|10028587|FG006|COMPLETED|Extension Stage (Vaccination 4)||14
8964946|NCT02561195|10028588|FG007|COMPLETED|Extension Stage (Vaccination 4)||17
8964947|NCT02561195|10028589|FG008|COMPLETED|Extension Stage (Vaccination 4)||21
8964948|NCT02561195|10028590|FG009|COMPLETED|Extension Stage (Vaccination 4)||20
8964949|NCT02561195|10028591|FG010|COMPLETED|Extension Stage (Vaccination 4)||43
8964950|NCT02561195|10028592|FG011|COMPLETED|Extension Stage (Vaccination 4)||45
8964951|NCT02561195|10028593|FG012|COMPLETED|Extension Stage (Vaccination 4)||51
8964952|NCT02561195|10028594|FG013|COMPLETED|Extension Stage (Vaccination 4)||54
8964953|NCT02561195|10028581|FG000|NOT COMPLETED|Extension Stage (Vaccination 4)||0
8964954|NCT02561195|10028582|FG001|NOT COMPLETED|Extension Stage (Vaccination 4)||0
8964955|NCT02561195|10028583|FG002|NOT COMPLETED|Extension Stage (Vaccination 4)||0
8964956|NCT02561195|10028584|FG003|NOT COMPLETED|Extension Stage (Vaccination 4)||0
8964957|NCT02561195|10028585|FG004|NOT COMPLETED|Extension Stage (Vaccination 4)||0
8964958|NCT02561195|10028586|FG005|NOT COMPLETED|Extension Stage (Vaccination 4)||0
8964959|NCT02561195|10028587|FG006|NOT COMPLETED|Extension Stage (Vaccination 4)||2
8964960|NCT02561195|10028588|FG007|NOT COMPLETED|Extension Stage (Vaccination 4)||1
8964961|NCT02561195|10028589|FG008|NOT COMPLETED|Extension Stage (Vaccination 4)||3
8964962|NCT02561195|10028590|FG009|NOT COMPLETED|Extension Stage (Vaccination 4)||2
8964963|NCT02561195|10028591|FG010|NOT COMPLETED|Extension Stage (Vaccination 4)||8
8964964|NCT02561195|10028592|FG011|NOT COMPLETED|Extension Stage (Vaccination 4)||7
8964965|NCT02561195|10028593|FG012|NOT COMPLETED|Extension Stage (Vaccination 4)||7
8964966|NCT02561195|10028594|FG013|NOT COMPLETED|Extension Stage (Vaccination 4)||5
8964967|NCT02561221|10028628|FG000|STARTED|Overall Study||452
8964968|NCT02561221|10028629|FG001|STARTED|Overall Study||351
8964969|NCT02561221|10028628|FG000|Month 6|Overall Study||386
8964970|NCT02561221|10028629|FG001|Month 6|Overall Study||340
8964971|NCT02561221|10028628|FG000|Month 12|Overall Study||365
8964972|NCT02561221|10028629|FG001|Month 12|Overall Study||326
8964973|NCT02561221|10028628|FG000|Month 18|Overall Study||357
8964974|NCT02561221|10028629|FG001|Month 18|Overall Study||316
8964975|NCT02561221|10028628|FG000|COMPLETED|Overall Study||362
8964976|NCT02561221|10028629|FG001|COMPLETED|Overall Study||308
8964977|NCT02561221|10028628|FG000|NOT COMPLETED|Overall Study||90
8964978|NCT02561221|10028629|FG001|NOT COMPLETED|Overall Study||43
8964979|NCT02561247|10028635|FG000|STARTED|Overall Study||23
8964980|NCT02561247|10028635|FG000|COMPLETED|Overall Study||17
8964981|NCT02561247|10028635|FG000|NOT COMPLETED|Overall Study||6
8964982|NCT02561273|10028641|FG000|STARTED|Overall Study||40
8964983|NCT02561273|10028642|FG001|STARTED|Overall Study||4
8964984|NCT02561273|10028641|FG000|COMPLETED|Overall Study||39
8964985|NCT02561273|10028642|FG001|COMPLETED|Overall Study||4
8964986|NCT02561273|10028641|FG000|NOT COMPLETED|Overall Study||1
8964987|NCT02561273|10028642|FG001|NOT COMPLETED|Overall Study||0
8964988|NCT02561338|10028655|FG000|STARTED|Overall Study||53
8964989|NCT02561338|10028656|FG001|STARTED|Overall Study||50
8964990|NCT02561338|10028657|FG002|STARTED|Overall Study||51
8631738|NCT00541866|9671629|FG002|NOT COMPLETED|Overall Study||15
8631739|NCT00541866|9671630|FG003|NOT COMPLETED|Overall Study||16
8631740|NCT00541866|9671631|FG004|NOT COMPLETED|Overall Study||15
8964991|NCT02561338|10028658|FG003|STARTED|Overall Study||51
8964992|NCT02561338|10028659|FG004|STARTED|Overall Study||53
8964993|NCT02561338|10028655|FG000|COMPLETED|Overall Study||45
8964994|NCT02561338|10028656|FG001|COMPLETED|Overall Study||44
8964995|NCT02561338|10028657|FG002|COMPLETED|Overall Study||42
8964996|NCT02561338|10028658|FG003|COMPLETED|Overall Study||46
8964997|NCT02561338|10028659|FG004|COMPLETED|Overall Study||51
8964998|NCT02561338|10028655|FG000|NOT COMPLETED|Overall Study||8
8964999|NCT02561338|10028656|FG001|NOT COMPLETED|Overall Study||6
8965000|NCT02561338|10028657|FG002|NOT COMPLETED|Overall Study||9
8965001|NCT02561338|10028658|FG003|NOT COMPLETED|Overall Study||5
8965002|NCT02561338|10028659|FG004|NOT COMPLETED|Overall Study||2
8965003|NCT02561455|10028677|FG000|STARTED|Overall Study||2
8965004|NCT02561455|10028678|FG001|STARTED|Overall Study||3
8965005|NCT02561455|10028679|FG002|STARTED|Overall Study||3
8965006|NCT02561455|10028680|FG003|STARTED|Overall Study||1
8965007|NCT02561455|10028677|FG000|COMPLETED|Overall Study||0
8965008|NCT02561455|10028678|FG001|COMPLETED|Overall Study||1
8965009|NCT02561455|10028679|FG002|COMPLETED|Overall Study||0
8965010|NCT02561455|10028680|FG003|COMPLETED|Overall Study||0
8965011|NCT02561455|10028677|FG000|NOT COMPLETED|Overall Study||2
8965012|NCT02561455|10028678|FG001|NOT COMPLETED|Overall Study||2
8965013|NCT02561455|10028679|FG002|NOT COMPLETED|Overall Study||3
8965014|NCT02561455|10028680|FG003|NOT COMPLETED|Overall Study||1
8965015|NCT02561481|10028692|FG000|STARTED|Pilot Trial||10
8965016|NCT02561481|10028693|FG001|STARTED|Pilot Trial||0
8965017|NCT02561481|10028692|FG000|COMPLETED|Pilot Trial||10
8965018|NCT02561481|10028693|FG001|COMPLETED|Pilot Trial||0
8965019|NCT02561481|10028692|FG000|NOT COMPLETED|Pilot Trial||0
8965020|NCT02561481|10028693|FG001|NOT COMPLETED|Pilot Trial||0
8965021|NCT02561481|10028692|FG000|STARTED|Main Trial - Double Blind Phase||25
8965022|NCT02561481|10028693|FG001|STARTED|Main Trial - Double Blind Phase||25
8965023|NCT02561481|10028692|FG000|COMPLETED|Main Trial - Double Blind Phase||22
8965024|NCT02561481|10028693|FG001|COMPLETED|Main Trial - Double Blind Phase||23
8965025|NCT02561481|10028692|FG000|NOT COMPLETED|Main Trial - Double Blind Phase||3
8965026|NCT02561481|10028693|FG001|NOT COMPLETED|Main Trial - Double Blind Phase||2
8965027|NCT02561481|10028692|FG000|STARTED|Main Trial - Open Label Phase||45
8965028|NCT02561481|10028693|FG001|STARTED|Main Trial - Open Label Phase||0
8965029|NCT02561481|10028692|FG000|COMPLETED|Main Trial - Open Label Phase||32
8965030|NCT02561481|10028693|FG001|COMPLETED|Main Trial - Open Label Phase||0
8965031|NCT02561481|10028692|FG000|NOT COMPLETED|Main Trial - Open Label Phase||13
8965032|NCT02561481|10028693|FG001|NOT COMPLETED|Main Trial - Open Label Phase||0
8965033|NCT02561572|10028704|FG000|STARTED|Overall Study||64
8965034|NCT02561572|10028705|FG001|STARTED|Overall Study||64
8965035|NCT02561572|10028704|FG000|COMPLETED|Overall Study||62
8965036|NCT02561572|10028705|FG001|COMPLETED|Overall Study||62
8965037|NCT02561572|10028704|FG000|NOT COMPLETED|Overall Study||2
8965038|NCT02561572|10028705|FG001|NOT COMPLETED|Overall Study||2
8965039|NCT02561585|10028713|FG000|STARTED|Overall Study||20
8965040|NCT02561585|10028714|FG001|STARTED|Overall Study||11
8965041|NCT02561585|10028713|FG000|COMPLETED|Overall Study||17
8965042|NCT02561585|10028714|FG001|COMPLETED|Overall Study||6
8965043|NCT02561585|10028713|FG000|NOT COMPLETED|Overall Study||3
8965044|NCT02561585|10028714|FG001|NOT COMPLETED|Overall Study||5
8965045|NCT02561702|10028724|FG000|STARTED|First Intervention||2
8965046|NCT02561702|10028725|FG001|STARTED|First Intervention||2
8965047|NCT02561702|10028724|FG000|COMPLETED|First Intervention||2
8965048|NCT02561702|10028725|FG001|COMPLETED|First Intervention||2
8965049|NCT02561702|10028724|FG000|NOT COMPLETED|First Intervention||0
8965050|NCT02561702|10028725|FG001|NOT COMPLETED|First Intervention||0
8965051|NCT02561702|10028724|FG000|STARTED|Washout||2
8965052|NCT02561702|10028725|FG001|STARTED|Washout||2
8965053|NCT02561702|10028724|FG000|COMPLETED|Washout||2
8965054|NCT02561702|10028725|FG001|COMPLETED|Washout||2
8965055|NCT02561702|10028724|FG000|NOT COMPLETED|Washout||0
8965056|NCT02561702|10028725|FG001|NOT COMPLETED|Washout||0
8965057|NCT02561702|10028724|FG000|STARTED|Second Intervention||2
8965058|NCT02561702|10028725|FG001|STARTED|Second Intervention||2
8965059|NCT02561702|10028724|FG000|COMPLETED|Second Intervention||2
8965060|NCT02561702|10028725|FG001|COMPLETED|Second Intervention||2
8965061|NCT02561702|10028724|FG000|NOT COMPLETED|Second Intervention||0
8965062|NCT02561702|10028725|FG001|NOT COMPLETED|Second Intervention||0
8965063|NCT02561806|10028733|FG000|STARTED|Induction Period||166
8965064|NCT02561806|10028734|FG001|STARTED|Induction Period||136
8965065|NCT02561806|10028733|FG000|Received At Least One Dose of Study Drug|Induction Period||166
8965066|NCT02561806|10028734|FG001|Received At Least One Dose of Study Drug|Induction Period||135
8965067|NCT02561806|10028733|FG000|COMPLETED|Induction Period||164
8965068|NCT02561806|10028734|FG001|COMPLETED|Induction Period||131
8965069|NCT02561806|10028733|FG000|NOT COMPLETED|Induction Period||2
8965070|NCT02561806|10028734|FG001|NOT COMPLETED|Induction Period||5
8965071|NCT02561806|10028733|FG000|STARTED|Maintenance Period||164
8965072|NCT02561806|10028734|FG001|STARTED|Maintenance Period||131
8965073|NCT02561806|10028733|FG000|COMPLETED|Maintenance Period||151
8965074|NCT02561806|10028734|FG001|COMPLETED|Maintenance Period||123
8965075|NCT02561806|10028733|FG000|NOT COMPLETED|Maintenance Period||13
8965076|NCT02561806|10028734|FG001|NOT COMPLETED|Maintenance Period||8
8965077|NCT02561806|10028733|FG000|STARTED|Post-Treatment Follow-up|Participants who discontinued previous periods had option to enter post treatment follow-up period.|157
9037902|NCT03323723|10099158|FG000|NOT COMPLETED|Baseline Phase||4
9037903|NCT03323723|10099158|FG000|STARTED|Treatment Phase||60
8965078|NCT02561806|10028734|FG001|STARTED|Post-Treatment Follow-up|Participants who discontinued previous periods had option to enter post treatment follow-up period.|60
8965079|NCT02561806|10028733|FG000|COMPLETED|Post-Treatment Follow-up||155
8965080|NCT02561806|10028734|FG001|COMPLETED|Post-Treatment Follow-up||59
8965081|NCT02561806|10028733|FG000|NOT COMPLETED|Post-Treatment Follow-up||2
8965082|NCT02561806|10028734|FG001|NOT COMPLETED|Post-Treatment Follow-up||1
8965083|NCT02561832|10028757|FG000|STARTED|Overall Study||8
8965084|NCT02561832|10028758|FG001|STARTED|Overall Study||7
8965085|NCT02561832|10028757|FG000|INFORMED CONSENT OBTAINED|Overall Study||8
8965086|NCT02561832|10028758|FG001|INFORMED CONSENT OBTAINED|Overall Study||7
8965087|NCT02561832|10028757|FG000|COMPLETED|Overall Study||1
8965088|NCT02561832|10028758|FG001|COMPLETED|Overall Study||3
8965089|NCT02561832|10028757|FG000|NOT COMPLETED|Overall Study||7
8965090|NCT02561832|10028758|FG001|NOT COMPLETED|Overall Study||4
8965091|NCT02561897|10028766|FG000|STARTED|Overall Study||2
8965092|NCT02561897|10028767|FG001|STARTED|Overall Study||3
8965093|NCT02561897|10028766|FG000|COMPLETED|Overall Study||2
8965094|NCT02561897|10028767|FG001|COMPLETED|Overall Study||3
8965095|NCT02561897|10028766|FG000|NOT COMPLETED|Overall Study||0
8965096|NCT02561897|10028767|FG001|NOT COMPLETED|Overall Study||0
9037904|NCT03323723|10099158|FG000|COMPLETED|Treatment Phase||51
9037905|NCT03323723|10099158|FG000|NOT COMPLETED|Treatment Phase||9
9037906|NCT03323801|10099163|FG000|STARTED|Overall Study||10
9037907|NCT03323801|10099163|FG000|COMPLETED|Overall Study||10
9037908|NCT03323801|10099163|FG000|NOT COMPLETED|Overall Study||0
9037909|NCT03323853|10099170|FG000|STARTED|Overall Study||213
9037910|NCT03323853|10099171|FG001|STARTED|Overall Study||238
9037911|NCT03323853|10099170|FG000|COMPLETED|Overall Study||213
9037912|NCT03323853|10099171|FG001|COMPLETED|Overall Study||238
9037913|NCT03323853|10099170|FG000|NOT COMPLETED|Overall Study||0
9037914|NCT03323853|10099171|FG001|NOT COMPLETED|Overall Study||0
9037915|NCT03324451|10099179|FG000|STARTED|Overall Study||97
9037916|NCT03324451|10099180|FG001|STARTED|Overall Study||54
9037917|NCT03324451|10099179|FG000|COMPLETED|Overall Study||65
9037918|NCT03324451|10099180|FG001|COMPLETED|Overall Study||41
9037919|NCT03324451|10099179|FG000|NOT COMPLETED|Overall Study||32
9037920|NCT03324451|10099180|FG001|NOT COMPLETED|Overall Study||13
9037921|NCT03324581|10099189|FG000|STARTED|Overall Study||77
9037922|NCT03324581|10099190|FG001|STARTED|Overall Study||80
9037923|NCT03324581|10099191|FG002|STARTED|Overall Study||82
9037924|NCT03324581|10099189|FG000|COMPLETED|Overall Study||38
9037925|NCT03324581|10099190|FG001|COMPLETED|Overall Study||44
9037926|NCT03324581|10099191|FG002|COMPLETED|Overall Study||57
9037927|NCT03324581|10099189|FG000|NOT COMPLETED|Overall Study||39
9037928|NCT03324581|10099190|FG001|NOT COMPLETED|Overall Study||36
9037929|NCT03324581|10099191|FG002|NOT COMPLETED|Overall Study||25
9037930|NCT03324607|10099199|FG000|STARTED|Overall Study||20
9037931|NCT03324607|10099199|FG000|COMPLETED|Overall Study||20
9037932|NCT03324607|10099199|FG000|NOT COMPLETED|Overall Study||0
9037933|NCT03325010|10099208|FG000|STARTED|Overall Study||64
9037934|NCT03325010|10099209|FG001|STARTED|Overall Study||63
9037935|NCT03325010|10099208|FG000|Safety Analysis Set|Overall Study||62
9037936|NCT03325010|10099209|FG001|Safety Analysis Set|Overall Study||59
9037937|NCT03325010|10099208|FG000|Full Analysis Set|Overall Study||61
9037938|NCT03325010|10099209|FG001|Full Analysis Set|Overall Study||58
9037939|NCT03325010|10099208|FG000|COMPLETED|Overall Study||55
9037940|NCT03325010|10099209|FG001|COMPLETED|Overall Study||43
9037941|NCT03325010|10099208|FG000|NOT COMPLETED|Overall Study||9
9037942|NCT03325010|10099209|FG001|NOT COMPLETED|Overall Study||20
9037943|NCT03325556|10099215|FG000|STARTED|Open-label Period||392
9037944|NCT03325556|10099216|FG001|STARTED|Open-label Period||0
9037945|NCT03325556|10099217|FG002|STARTED|Open-label Period||0
9037946|NCT03325556|10099215|FG000|COMPLETED|Open-label Period||217
9037947|NCT03325556|10099216|FG001|COMPLETED|Open-label Period||0
9037948|NCT03325556|10099217|FG002|COMPLETED|Open-label Period||0
9037949|NCT03325556|10099215|FG000|NOT COMPLETED|Open-label Period||175
9037950|NCT03325556|10099216|FG001|NOT COMPLETED|Open-label Period||0
9037951|NCT03325556|10099217|FG002|NOT COMPLETED|Open-label Period||0
9037952|NCT03325556|10099215|FG000|STARTED|Double-blind Period||0
9037953|NCT03325556|10099216|FG001|STARTED|Double-blind Period||105
9037954|NCT03325556|10099217|FG002|STARTED|Double-blind Period||112
9037955|NCT03325556|10099215|FG000|COMPLETED|Double-blind Period||0
9037956|NCT03325556|10099216|FG001|COMPLETED|Double-blind Period||44
9037957|NCT03325556|10099217|FG002|COMPLETED|Double-blind Period||35
9037958|NCT03325556|10099215|FG000|NOT COMPLETED|Double-blind Period||0
9037959|NCT03325556|10099216|FG001|NOT COMPLETED|Double-blind Period||61
9037960|NCT03325556|10099217|FG002|NOT COMPLETED|Double-blind Period||77
9037961|NCT03325673|10099226|FG000|STARTED|Overall Study||42
9037962|NCT03325673|10099227|FG001|STARTED|Overall Study||42
9037963|NCT03325673|10099226|FG000|COMPLETED|Overall Study||38
9037964|NCT03325673|10099227|FG001|COMPLETED|Overall Study||42
9037965|NCT03325673|10099226|FG000|NOT COMPLETED|Overall Study||4
9037966|NCT03325673|10099227|FG001|NOT COMPLETED|Overall Study||0
9037967|NCT03325816|10099235|FG000|STARTED|Overall Study||3
9037968|NCT03325816|10099236|FG001|STARTED|Overall Study||6
9037969|NCT03325816|10099235|FG000|COMPLETED|Overall Study||3
9037970|NCT03325816|10099236|FG001|COMPLETED|Overall Study||6
9037971|NCT03325816|10099235|FG000|NOT COMPLETED|Overall Study||0
9037972|NCT03325816|10099236|FG001|NOT COMPLETED|Overall Study||0
9037973|NCT03325881|10099246|FG000|STARTED|Overall Study||44
9037974|NCT03325881|10099247|FG001|STARTED|Overall Study||45
8631741|NCT00541931|9671661|FG000|STARTED|Overall Study||22
8631742|NCT00541931|9671662|FG001|STARTED|Overall Study||15
8631743|NCT00541931|9671661|FG000|COMPLETED|Overall Study||17
8965097|NCT02562066|10028777|FG000|STARTED|Overall Study||8
8965098|NCT02562066|10028778|FG001|STARTED|Overall Study||8
8965099|NCT02562066|10028779|FG002|STARTED|Overall Study||4
8631744|NCT00541931|9671662|FG001|COMPLETED|Overall Study||11
8631745|NCT00541931|9671661|FG000|NOT COMPLETED|Overall Study||5
8631746|NCT00541931|9671662|FG001|NOT COMPLETED|Overall Study||4
8631747|NCT00541970|9671674|FG000|STARTED|Month 7||240
8631748|NCT00541970|9671675|FG001|STARTED|Month 7||241
8631749|NCT00541970|9671676|FG002|STARTED|Month 7||240
8631750|NCT00541970|9671677|FG003|STARTED|Month 7||239
8965100|NCT02562066|10028777|FG000|COMPLETED|Overall Study||7
8965101|NCT02562066|10028778|FG001|COMPLETED|Overall Study||7
8965102|NCT02562066|10028779|FG002|COMPLETED|Overall Study||0
8965103|NCT02562066|10028777|FG000|NOT COMPLETED|Overall Study||1
8965104|NCT02562066|10028778|FG001|NOT COMPLETED|Overall Study||1
8965105|NCT02562066|10028779|FG002|NOT COMPLETED|Overall Study||4
8965106|NCT02562482|10028787|FG000|STARTED|Overall Study||201
8965107|NCT02562482|10028788|FG001|STARTED|Overall Study||199
8965108|NCT02562482|10028787|FG000|Received 1st Injection|Overall Study||197
8965109|NCT02562482|10028788|FG001|Received 1st Injection|Overall Study||199
8965110|NCT02562482|10028787|FG000|Received 2nd Injection|Overall Study||192
8965111|NCT02562482|10028788|FG001|Received 2nd Injection|Overall Study||192
8965112|NCT02562482|10028787|FG000|COMPLETED|Overall Study||180
8965113|NCT02562482|10028788|FG001|COMPLETED|Overall Study||183
8965114|NCT02562482|10028787|FG000|NOT COMPLETED|Overall Study||21
8965115|NCT02562482|10028788|FG001|NOT COMPLETED|Overall Study||16
8965116|NCT02562521|10028796|FG000|STARTED|Overall Study||18
8965117|NCT02562521|10028797|FG001|STARTED|Overall Study||7
8965118|NCT02562521|10028796|FG000|COMPLETED|Overall Study||18
8965119|NCT02562521|10028797|FG001|COMPLETED|Overall Study||7
8965120|NCT02562521|10028796|FG000|NOT COMPLETED|Overall Study||0
8965121|NCT02562521|10028797|FG001|NOT COMPLETED|Overall Study||0
8965122|NCT02562755|10028805|FG000|STARTED|Overall Study||234
8965123|NCT02562755|10028806|FG001|STARTED|Overall Study||225
8965124|NCT02562755|10028805|FG000|Safety Population|Overall Study||218
8965125|NCT02562755|10028806|FG001|Safety Population|Overall Study||217
8965126|NCT02562755|10028805|FG000|COMPLETED|Overall Study||161
8965127|NCT02562755|10028806|FG001|COMPLETED|Overall Study||153
8965128|NCT02562755|10028805|FG000|NOT COMPLETED|Overall Study||73
8965129|NCT02562755|10028806|FG001|NOT COMPLETED|Overall Study||72
8965130|NCT02562898|10028814|FG000|STARTED|Overall Study||10
8965131|NCT02562898|10028815|FG001|STARTED|Overall Study||8
8965132|NCT02562898|10028814|FG000|COMPLETED|Overall Study||10
8965133|NCT02562898|10028815|FG001|COMPLETED|Overall Study||8
8965134|NCT02562898|10028814|FG000|NOT COMPLETED|Overall Study||0
8965135|NCT02562898|10028815|FG001|NOT COMPLETED|Overall Study||0
8965136|NCT02562924|10028824|FG000|STARTED|Overall Study||13
8965137|NCT02562924|10028825|FG001|STARTED|Overall Study||12
8965138|NCT02562924|10028826|FG002|STARTED|Overall Study||12
8965139|NCT02562924|10028824|FG000|COMPLETED|Overall Study||12
8965140|NCT02562924|10028825|FG001|COMPLETED|Overall Study||1
8965141|NCT02562924|10028826|FG002|COMPLETED|Overall Study||8
8965142|NCT02562924|10028824|FG000|NOT COMPLETED|Overall Study||1
8965143|NCT02562924|10028825|FG001|NOT COMPLETED|Overall Study||11
8965144|NCT02562924|10028826|FG002|NOT COMPLETED|Overall Study||4
8965145|NCT02562989|10028840|FG000|STARTED|Overall Study||3
8965146|NCT02562989|10028841|FG001|STARTED|Overall Study||4
8965147|NCT02562989|10028842|FG002|STARTED|Overall Study||6
8965148|NCT02562989|10028840|FG000|COMPLETED|Overall Study||3
8965149|NCT02562989|10028841|FG001|COMPLETED|Overall Study||4
8965150|NCT02562989|10028842|FG002|COMPLETED|Overall Study||6
8965151|NCT02562989|10028840|FG000|NOT COMPLETED|Overall Study||0
8965152|NCT02562989|10028841|FG001|NOT COMPLETED|Overall Study||0
8965153|NCT02562989|10028842|FG002|NOT COMPLETED|Overall Study||0
8965154|NCT02563067|10028853|FG000|STARTED|Overall Study||296
8965155|NCT02563067|10028854|FG001|STARTED|Overall Study||294
8965156|NCT02563067|10028855|FG002|STARTED|Overall Study||287
8965157|NCT02563067|10028853|FG000|FAS/SAF: High Eosinophils Subpopulation|Overall Study||198
8965158|NCT02563067|10028854|FG001|FAS/SAF: High Eosinophils Subpopulation|Overall Study||196
8965159|NCT02563067|10028855|FG002|FAS/SAF: High Eosinophils Subpopulation|Overall Study||193
8965160|NCT02563067|10028853|FG000|FAS/SAF: Overall Population|Overall Study||296
8965161|NCT02563067|10028854|FG001|FAS/SAF: Overall Population|Overall Study||293
8965162|NCT02563067|10028855|FG002|FAS/SAF: Overall Population|Overall Study||287
8965163|NCT02563067|10028853|FG000|COMPLETED|Overall Study||277
8965164|NCT02563067|10028854|FG001|COMPLETED|Overall Study||268
8965165|NCT02563067|10028855|FG002|COMPLETED|Overall Study||267
8965166|NCT02563067|10028853|FG000|NOT COMPLETED|Overall Study||19
8631751|NCT00541970|9671674|FG000|COMPLETED|Month 7||231
8965167|NCT02563067|10028854|FG001|NOT COMPLETED|Overall Study||26
8965168|NCT02563067|10028855|FG002|NOT COMPLETED|Overall Study||20
8965169|NCT02563093|10028867|FG000|STARTED|Overall Study||52
8965170|NCT02563093|10028868|FG001|STARTED|Overall Study||52
8965171|NCT02563093|10028869|FG002|STARTED|Overall Study||53
8965172|NCT02563093|10028870|FG003|STARTED|Overall Study||51
8965173|NCT02563093|10028867|FG000|COMPLETED|Overall Study||52
8631752|NCT00541970|9671675|FG001|COMPLETED|Month 7||228
8965174|NCT02563093|10028868|FG001|COMPLETED|Overall Study||52
8965175|NCT02563093|10028869|FG002|COMPLETED|Overall Study||53
8965176|NCT02563093|10028870|FG003|COMPLETED|Overall Study||51
8965177|NCT02563093|10028867|FG000|NOT COMPLETED|Overall Study||0
8965178|NCT02563093|10028868|FG001|NOT COMPLETED|Overall Study||0
8965179|NCT02563093|10028869|FG002|NOT COMPLETED|Overall Study||0
8965180|NCT02563093|10028870|FG003|NOT COMPLETED|Overall Study||0
8965181|NCT02563106|10028883|FG000|STARTED|Overall Study||206
8965182|NCT02563106|10028884|FG001|STARTED|Overall Study||207
8965183|NCT02563106|10028883|FG000|COMPLETED|Overall Study||172
8965184|NCT02563106|10028884|FG001|COMPLETED|Overall Study||178
8965185|NCT02563106|10028883|FG000|NOT COMPLETED|Overall Study||34
8965186|NCT02563106|10028884|FG001|NOT COMPLETED|Overall Study||29
8965187|NCT02563496|10028895|FG000|STARTED|Overall Study|No participants were enrolled since they didn't meet inclusion/exclusion criteria.|0
8965188|NCT02563496|10028896|FG001|STARTED|Overall Study||14
8965189|NCT02563496|10028897|FG002|STARTED|Overall Study||5
8965190|NCT02563496|10028898|FG003|STARTED|Overall Study||22
8965191|NCT02563496|10028899|FG004|STARTED|Overall Study||19
8965192|NCT02563496|10028895|FG000|COMPLETED|Overall Study||0
8965193|NCT02563496|10028896|FG001|COMPLETED|Overall Study||14
8965194|NCT02563496|10028897|FG002|COMPLETED|Overall Study||5
8965195|NCT02563496|10028898|FG003|COMPLETED|Overall Study||22
8965196|NCT02563496|10028899|FG004|COMPLETED|Overall Study||19
8965197|NCT02563496|10028895|FG000|NOT COMPLETED|Overall Study||0
8965198|NCT02563496|10028896|FG001|NOT COMPLETED|Overall Study||0
8965199|NCT02563496|10028897|FG002|NOT COMPLETED|Overall Study||0
8965200|NCT02563496|10028898|FG003|NOT COMPLETED|Overall Study||0
8965201|NCT02563496|10028899|FG004|NOT COMPLETED|Overall Study||0
8965202|NCT02563548|10028913|FG000|STARTED|Dose Escalation (Up to 46 Weeks)||3
8965203|NCT02563548|10028914|FG001|STARTED|Dose Escalation (Up to 46 Weeks)||2
8965204|NCT02563548|10028915|FG002|STARTED|Dose Escalation (Up to 46 Weeks)||7
8965205|NCT02563548|10028916|FG003|STARTED|Dose Escalation (Up to 46 Weeks)||2
8965206|NCT02563548|10028917|FG004|STARTED|Dose Escalation (Up to 46 Weeks)||0
8965207|NCT02563548|10028918|FG005|STARTED|Dose Escalation (Up to 46 Weeks)||0
8965208|NCT02563548|10028913|FG000|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||3
8965209|NCT02563548|10028914|FG001|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||2
8965210|NCT02563548|10028915|FG002|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||7
8965211|NCT02563548|10028916|FG003|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||2
8965212|NCT02563548|10028917|FG004|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||0
8965213|NCT02563548|10028918|FG005|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||0
8965214|NCT02563548|10028913|FG000|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
8965215|NCT02563548|10028914|FG001|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
8965216|NCT02563548|10028915|FG002|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
8965217|NCT02563548|10028916|FG003|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
8965218|NCT02563548|10028917|FG004|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
8965219|NCT02563548|10028918|FG005|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
8965220|NCT02563548|10028913|FG000|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||3
8965221|NCT02563548|10028914|FG001|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||2
8965222|NCT02563548|10028915|FG002|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||7
8965223|NCT02563548|10028916|FG003|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||2
8965224|NCT02563548|10028917|FG004|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||0
8965225|NCT02563548|10028918|FG005|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||0
8965226|NCT02563548|10028913|FG000|STARTED|Dose Expansion (Up to 60 Weeks)||0
8965227|NCT02563548|10028914|FG001|STARTED|Dose Expansion (Up to 60 Weeks)||0
8965228|NCT02563548|10028915|FG002|STARTED|Dose Expansion (Up to 60 Weeks)||0
8965229|NCT02563548|10028916|FG003|STARTED|Dose Expansion (Up to 60 Weeks)||0
8965230|NCT02563548|10028917|FG004|STARTED|Dose Expansion (Up to 60 Weeks)||25
8965231|NCT02563548|10028918|FG005|STARTED|Dose Expansion (Up to 60 Weeks)||17
8965232|NCT02563548|10028913|FG000|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||0
8965233|NCT02563548|10028914|FG001|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||0
8965234|NCT02563548|10028915|FG002|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||0
8965235|NCT02563548|10028916|FG003|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||0
8965236|NCT02563548|10028917|FG004|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||24
8965237|NCT02563548|10028918|FG005|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||17
8965238|NCT02563548|10028913|FG000|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
8965239|NCT02563548|10028914|FG001|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
8965240|NCT02563548|10028915|FG002|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
8965241|NCT02563548|10028916|FG003|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
8965242|NCT02563548|10028917|FG004|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
8965243|NCT02563548|10028918|FG005|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
8965244|NCT02563548|10028913|FG000|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||0
8965245|NCT02563548|10028914|FG001|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||0
8965246|NCT02563548|10028915|FG002|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||0
8965247|NCT02563548|10028916|FG003|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||0
8965248|NCT02563548|10028917|FG004|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||25
8965249|NCT02563548|10028918|FG005|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||17
8965250|NCT02563561|10028941|FG000|STARTED|Overall Study||19
8965251|NCT02563561|10028942|FG001|STARTED|Overall Study||23
8965252|NCT02563561|10028943|FG002|STARTED|Overall Study||20
8965253|NCT02563561|10028941|FG000|Safety Population|Overall Study||19
8965254|NCT02563561|10028942|FG001|Safety Population|Overall Study||21
8965255|NCT02563561|10028943|FG002|Safety Population|Overall Study||17
8965256|NCT02563561|10028941|FG000|COMPLETED|Overall Study||1
8965257|NCT02563561|10028942|FG001|COMPLETED|Overall Study||2
8965258|NCT02563561|10028943|FG002|COMPLETED|Overall Study||3
8965259|NCT02563561|10028941|FG000|NOT COMPLETED|Overall Study||18
8965260|NCT02563561|10028942|FG001|NOT COMPLETED|Overall Study||21
8965261|NCT02563561|10028943|FG002|NOT COMPLETED|Overall Study||17
8965262|NCT02563808|10028953|FG000|STARTED|Overall Study||96
8965263|NCT02563808|10028954|FG001|STARTED|Overall Study|A total of 5 participants enrolled were not included in final data due to data collection error|88
8965264|NCT02563808|10028953|FG000|COMPLETED|Overall Study||96
8965265|NCT02563808|10028954|FG001|COMPLETED|Overall Study||88
8965266|NCT02563808|10028953|FG000|NOT COMPLETED|Overall Study||0
8965267|NCT02563808|10028954|FG001|NOT COMPLETED|Overall Study||0
8965268|NCT02563834|10028962|FG000|STARTED|Control (Saline) Infusion (*Day 1)||10
8965269|NCT02563834|10028963|FG001|STARTED|Control (Saline) Infusion (*Day 1)||8
8965270|NCT02563834|10028962|FG000|COMPLETED|Control (Saline) Infusion (*Day 1)||10
8965271|NCT02563834|10028963|FG001|COMPLETED|Control (Saline) Infusion (*Day 1)||8
8965272|NCT02563834|10028962|FG000|NOT COMPLETED|Control (Saline) Infusion (*Day 1)||0
8965273|NCT02563834|10028963|FG001|NOT COMPLETED|Control (Saline) Infusion (*Day 1)||0
8965274|NCT02563834|10028962|FG000|STARTED|Insulin Infusion (*Day 2)||10
8965275|NCT02563834|10028963|FG001|STARTED|Insulin Infusion (*Day 2)||8
8965276|NCT02563834|10028962|FG000|COMPLETED|Insulin Infusion (*Day 2)||10
8965277|NCT02563834|10028963|FG001|COMPLETED|Insulin Infusion (*Day 2)||8
8965278|NCT02563834|10028962|FG000|NOT COMPLETED|Insulin Infusion (*Day 2)||0
8965279|NCT02563834|10028963|FG001|NOT COMPLETED|Insulin Infusion (*Day 2)||0
8965280|NCT02563860|10028971|FG000|STARTED|Overall Study||20
8965281|NCT02563860|10028971|FG000|COMPLETED|Overall Study||19
8965282|NCT02563860|10028971|FG000|NOT COMPLETED|Overall Study||1
8965283|NCT02563899|10028979|FG000|STARTED|Overall Study||18
8965284|NCT02563899|10028980|FG001|STARTED|Overall Study||5
8965285|NCT02563899|10028981|FG002|STARTED|Overall Study||10
8965286|NCT02563899|10028982|FG003|STARTED|Overall Study||6
8965287|NCT02563899|10028979|FG000|COMPLETED|Overall Study||17
8965288|NCT02563899|10028980|FG001|COMPLETED|Overall Study||5
8965289|NCT02563899|10028981|FG002|COMPLETED|Overall Study||9
8965290|NCT02563899|10028982|FG003|COMPLETED|Overall Study||6
8965291|NCT02563899|10028979|FG000|NOT COMPLETED|Overall Study||1
8965292|NCT02563899|10028980|FG001|NOT COMPLETED|Overall Study||0
8965293|NCT02563899|10028981|FG002|NOT COMPLETED|Overall Study||1
8965294|NCT02563899|10028982|FG003|NOT COMPLETED|Overall Study||0
8965295|NCT02563990|10028995|FG000|STARTED|Overall Study||12
8965296|NCT02563990|10028996|FG001|STARTED|Overall Study||14
8965297|NCT02563990|10028995|FG000|COMPLETED|Overall Study||12
8965298|NCT02563990|10028996|FG001|COMPLETED|Overall Study||14
8965299|NCT02563990|10028995|FG000|NOT COMPLETED|Overall Study||0
8965300|NCT02563990|10028996|FG001|NOT COMPLETED|Overall Study||0
8965301|NCT02564016|10029006|FG000|STARTED|Overall Study||22
8965302|NCT02564016|10029007|FG001|STARTED|Overall Study||14
8965303|NCT02564016|10029006|FG000|COMPLETED|Overall Study||4
8965304|NCT02564016|10029007|FG001|COMPLETED|Overall Study||4
8965305|NCT02564016|10029006|FG000|NOT COMPLETED|Overall Study||18
8965306|NCT02564016|10029007|FG001|NOT COMPLETED|Overall Study||10
8965307|NCT02564029|10029013|FG000|STARTED|Overall Study||7
8965308|NCT02564029|10029013|FG000|COMPLETED|Overall Study||7
8965309|NCT02564029|10029013|FG000|NOT COMPLETED|Overall Study||0
8965310|NCT02564042|10029030|FG000|STARTED|Overall Study||38
8965311|NCT02564042|10029031|FG001|STARTED|Overall Study||38
8965312|NCT02564042|10029032|FG002|STARTED|Overall Study||38
8965313|NCT02564042|10029033|FG003|STARTED|Overall Study||38
8965314|NCT02564042|10029034|FG004|STARTED|Overall Study||37
8965315|NCT02564042|10029035|FG005|STARTED|Overall Study||38
8965316|NCT02564042|10029030|FG000|COMPLETED|Overall Study||27
8965317|NCT02564042|10029031|FG001|COMPLETED|Overall Study||30
8965318|NCT02564042|10029032|FG002|COMPLETED|Overall Study||32
8965319|NCT02564042|10029033|FG003|COMPLETED|Overall Study||35
8965320|NCT02564042|10029034|FG004|COMPLETED|Overall Study||26
8965321|NCT02564042|10029035|FG005|COMPLETED|Overall Study||24
8965322|NCT02564042|10029030|FG000|NOT COMPLETED|Overall Study||11
8965323|NCT02564042|10029031|FG001|NOT COMPLETED|Overall Study||8
8965324|NCT02564042|10029032|FG002|NOT COMPLETED|Overall Study||6
8965325|NCT02564042|10029033|FG003|NOT COMPLETED|Overall Study||3
8965326|NCT02564042|10029034|FG004|NOT COMPLETED|Overall Study||11
8965327|NCT02564042|10029035|FG005|NOT COMPLETED|Overall Study||14
8965328|NCT02564055|10029055|FG000|STARTED|Overall Study||40
8965329|NCT02564055|10029056|FG001|STARTED|Overall Study||41
8965330|NCT02564055|10029057|FG002|STARTED|Overall Study||43
8965331|NCT02564055|10029058|FG003|STARTED|Overall Study||41
8965332|NCT02564055|10029059|FG004|STARTED|Overall Study||42
8965333|NCT02564055|10029060|FG005|STARTED|Overall Study||40
8965334|NCT02564055|10029055|FG000|COMPLETED|Overall Study||34
8965335|NCT02564055|10029056|FG001|COMPLETED|Overall Study||36
8965336|NCT02564055|10029057|FG002|COMPLETED|Overall Study||31
8965337|NCT02564055|10029058|FG003|COMPLETED|Overall Study||35
8965338|NCT02564055|10029059|FG004|COMPLETED|Overall Study||27
8965339|NCT02564055|10029060|FG005|COMPLETED|Overall Study||28
8965340|NCT02564055|10029055|FG000|NOT COMPLETED|Overall Study||6
8965341|NCT02564055|10029056|FG001|NOT COMPLETED|Overall Study||5
8965342|NCT02564055|10029057|FG002|NOT COMPLETED|Overall Study||12
8965343|NCT02564055|10029058|FG003|NOT COMPLETED|Overall Study||6
8965344|NCT02564055|10029059|FG004|NOT COMPLETED|Overall Study||15
8965345|NCT02564055|10029060|FG005|NOT COMPLETED|Overall Study||12
8965346|NCT02564120|10029079|FG000|STARTED|Overall Study||1556
8965347|NCT02564120|10029079|FG000|COMPLETED|Overall Study||1110
8965348|NCT02564120|10029079|FG000|NOT COMPLETED|Overall Study||446
8965349|NCT02564198|10029096|FG000|STARTED|Overall Study||8
8965350|NCT02564198|10029097|FG001|STARTED|Overall Study||15
8965351|NCT02564198|10029098|FG002|STARTED|Overall Study||6
8965352|NCT02564198|10029096|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
8965353|NCT02564198|10029097|FG001|Received at Least 1 Dose of Study Drug|Overall Study||15
8965354|NCT02564198|10029098|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
8965355|NCT02564198|10029096|FG000|COMPLETED|Overall Study||6
8965356|NCT02564198|10029097|FG001|COMPLETED|Overall Study||10
8965357|NCT02564198|10029098|FG002|COMPLETED|Overall Study||6
8965358|NCT02564198|10029096|FG000|NOT COMPLETED|Overall Study||2
8965359|NCT02564198|10029097|FG001|NOT COMPLETED|Overall Study||5
8965360|NCT02564198|10029098|FG002|NOT COMPLETED|Overall Study||0
8965361|NCT02564211|10029108|FG000|STARTED|Overall Study||77
8965362|NCT02564211|10029108|FG000|COMPLETED|Overall Study||73
8965363|NCT02564211|10029108|FG000|NOT COMPLETED|Overall Study||4
8965364|NCT02564354|10029114|FG000|STARTED|Overall Study||10
8965365|NCT02564354|10029115|FG001|STARTED|Overall Study||8
8965366|NCT02564354|10029114|FG000|COMPLETED|Overall Study||10
8965367|NCT02564354|10029115|FG001|COMPLETED|Overall Study||8
8965368|NCT02564354|10029114|FG000|NOT COMPLETED|Overall Study||0
8965369|NCT02564354|10029115|FG001|NOT COMPLETED|Overall Study||0
8965370|NCT02564432|10029121|FG000|STARTED|Overall Study||10
8965371|NCT02564432|10029121|FG000|COMPLETED|Overall Study|1 patient suffered periprosthetic fracture at 8 months; 1 failed to osseointegrate|8
8965372|NCT02564432|10029121|FG000|NOT COMPLETED|Overall Study||2
8965373|NCT02564471|10029131|FG000|STARTED|Overall Study||25
8965374|NCT02564471|10029132|FG001|STARTED|Overall Study||26
8965375|NCT02564471|10029133|FG002|STARTED|Overall Study||27
8965376|NCT02564471|10029134|FG003|STARTED|Overall Study||25
8965377|NCT02564471|10029131|FG000|COMPLETED|Overall Study||22
8965378|NCT02564471|10029132|FG001|COMPLETED|Overall Study||23
8965379|NCT02564471|10029133|FG002|COMPLETED|Overall Study||24
8965380|NCT02564471|10029134|FG003|COMPLETED|Overall Study||25
8965381|NCT02564471|10029131|FG000|NOT COMPLETED|Overall Study||3
8965382|NCT02564471|10029132|FG001|NOT COMPLETED|Overall Study||3
8965383|NCT02564471|10029133|FG002|NOT COMPLETED|Overall Study||3
8965384|NCT02564471|10029134|FG003|NOT COMPLETED|Overall Study||0
8965385|NCT02564497|10029146|FG000|STARTED|Overall Study||74
8965386|NCT02564497|10029147|FG001|STARTED|Overall Study||72
8965387|NCT02564497|10029146|FG000|COMPLETED|Overall Study||74
8965388|NCT02564497|10029147|FG001|COMPLETED|Overall Study||72
8965389|NCT02564497|10029146|FG000|NOT COMPLETED|Overall Study||0
8965390|NCT02564497|10029147|FG001|NOT COMPLETED|Overall Study||0
8965391|NCT02564718|10029155|FG000|STARTED|Overall Study||5
8965392|NCT02564718|10029156|FG001|STARTED|Overall Study||5
8965393|NCT02564718|10029155|FG000|COMPLETED|Overall Study||5
8965394|NCT02564718|10029156|FG001|COMPLETED|Overall Study||4
8965395|NCT02564718|10029155|FG000|NOT COMPLETED|Overall Study||0
8965396|NCT02564718|10029156|FG001|NOT COMPLETED|Overall Study||1
8965397|NCT02564887|10029164|FG000|STARTED|Overall Study||16
8965398|NCT02564887|10029165|FG001|STARTED|Overall Study||10
8965399|NCT02564887|10029164|FG000|COMPLETED|Overall Study||10
8965400|NCT02564887|10029165|FG001|COMPLETED|Overall Study||10
8965401|NCT02564887|10029164|FG000|NOT COMPLETED|Overall Study||6
8965402|NCT02564887|10029165|FG001|NOT COMPLETED|Overall Study||0
8965403|NCT02564926|10029175|FG000|STARTED|Overall Study||60
8965404|NCT02564926|10029176|FG001|STARTED|Overall Study||61
8965405|NCT02564926|10029175|FG000|COMPLETED|Overall Study||52
8965406|NCT02564926|10029176|FG001|COMPLETED|Overall Study||54
8965407|NCT02564926|10029175|FG000|NOT COMPLETED|Overall Study||8
8965408|NCT02564926|10029176|FG001|NOT COMPLETED|Overall Study||7
8965409|NCT02564952|10029182|FG000|STARTED|Overall Study||18
8965410|NCT02564952|10029182|FG000|Received at Least 1 Dose of Study Drug|Overall Study||18
8965411|NCT02564952|10029182|FG000|Completed OLE Titration Period|Overall Study||16
8965412|NCT02564952|10029182|FG000|COMPLETED|Overall Study||7
8965413|NCT02564952|10029182|FG000|NOT COMPLETED|Overall Study||11
8965414|NCT02565108|10029188|FG000|STARTED|Overall Study||16
8965415|NCT02565108|10029189|FG001|STARTED|Overall Study||4
8965416|NCT02565108|10029188|FG000|Safety Set|Overall Study||16
8965417|NCT02565108|10029189|FG001|Safety Set|Overall Study||4
8965418|NCT02565108|10029188|FG000|Pharmacokinetic (PK) Set|Overall Study||10
8965419|NCT02565108|10029189|FG001|Pharmacokinetic (PK) Set|Overall Study||3
8965420|NCT02565108|10029188|FG000|COMPLETED|Overall Study||14
8965421|NCT02565108|10029189|FG001|COMPLETED|Overall Study||4
8965422|NCT02565108|10029188|FG000|NOT COMPLETED|Overall Study||2
8965423|NCT02565108|10029189|FG001|NOT COMPLETED|Overall Study||0
8965424|NCT02565147|10029197|FG000|STARTED|Overall Study||38
8965425|NCT02565147|10029198|FG001|STARTED|Overall Study||40
8965426|NCT02565147|10029197|FG000|Received Study Drug|Overall Study||38
8965427|NCT02565147|10029198|FG001|Received Study Drug|Overall Study||40
8965428|NCT02565147|10029197|FG000|Per-Protocol Population|Overall Study||28
8965429|NCT02565147|10029198|FG001|Per-Protocol Population|Overall Study||36
8965430|NCT02565147|10029197|FG000|COMPLETED|Overall Study||32
8965431|NCT02565147|10029198|FG001|COMPLETED|Overall Study||37
8965432|NCT02565147|10029197|FG000|NOT COMPLETED|Overall Study||6
8965433|NCT02565147|10029198|FG001|NOT COMPLETED|Overall Study||3
8965434|NCT02565186|10029206|FG000|STARTED|Overall Study||1046
8965435|NCT02565186|10029207|FG001|STARTED|Overall Study||1125
8965436|NCT02565186|10029206|FG000|Received at Least One Dose of Study Drug|Overall Study||991
8965437|NCT02565186|10029207|FG001|Received at Least One Dose of Study Drug|Overall Study||1039
8965438|NCT02565186|10029206|FG000|COMPLETED|Overall Study||466
8965439|NCT02565186|10029207|FG001|COMPLETED|Overall Study||504
8965440|NCT02565186|10029206|FG000|NOT COMPLETED|Overall Study||580
8965441|NCT02565186|10029207|FG001|NOT COMPLETED|Overall Study||621
8965442|NCT02565381|10029216|FG000|STARTED|Overall Study||25
8965443|NCT02565381|10029217|FG001|STARTED|Overall Study||25
8965444|NCT02565381|10029218|FG002|STARTED|Overall Study||25
8965445|NCT02565381|10029216|FG000|COMPLETED|Overall Study||24
8965446|NCT02565381|10029217|FG001|COMPLETED|Overall Study||25
8965447|NCT02565381|10029218|FG002|COMPLETED|Overall Study||24
8965448|NCT02565381|10029216|FG000|NOT COMPLETED|Overall Study||1
8965449|NCT02565381|10029217|FG001|NOT COMPLETED|Overall Study||0
8965450|NCT02565381|10029218|FG002|NOT COMPLETED|Overall Study||1
8965451|NCT02565485|10029228|FG000|STARTED|Overall Study||139
8965452|NCT02565485|10029229|FG001|STARTED|Overall Study||137
8965453|NCT02565485|10029228|FG000|COMPLETED|Overall Study||139
8965454|NCT02565485|10029229|FG001|COMPLETED|Overall Study||137
8965455|NCT02565485|10029228|FG000|NOT COMPLETED|Overall Study||0
8965456|NCT02565485|10029229|FG001|NOT COMPLETED|Overall Study||0
8965457|NCT02565511|10029239|FG000|STARTED|Overall Study||42
8965458|NCT02565511|10029240|FG001|STARTED|Overall Study||23
8965459|NCT02565511|10029241|FG002|STARTED|Overall Study||251
8965460|NCT02565511|10029242|FG003|STARTED|Overall Study||164
8965461|NCT02565511|10029239|FG000|3 Patients Were Mis-randomized|Overall Study||0
8965462|NCT02565511|10029240|FG001|3 Patients Were Mis-randomized|Overall Study||0
8965463|NCT02565511|10029241|FG002|3 Patients Were Mis-randomized|Overall Study||2
8965464|NCT02565511|10029242|FG003|3 Patients Were Mis-randomized|Overall Study||1
8965465|NCT02565511|10029239|FG000|COMPLETED|Overall Study||0
8965466|NCT02565511|10029240|FG001|COMPLETED|Overall Study||0
8965467|NCT02565511|10029241|FG002|COMPLETED|Overall Study||0
8965468|NCT02565511|10029242|FG003|COMPLETED|Overall Study||0
8965469|NCT02565511|10029239|FG000|NOT COMPLETED|Overall Study||42
8965470|NCT02565511|10029240|FG001|NOT COMPLETED|Overall Study||23
8965471|NCT02565511|10029241|FG002|NOT COMPLETED|Overall Study||251
8965472|NCT02565511|10029242|FG003|NOT COMPLETED|Overall Study||164
8965473|NCT02565576|10029254|FG000|STARTED|Overall Study||22
8965474|NCT02565576|10029255|FG001|STARTED|Overall Study||22
8965475|NCT02565576|10029254|FG000|COMPLETED|Overall Study||17
8965476|NCT02565576|10029255|FG001|COMPLETED|Overall Study||17
8965477|NCT02565576|10029254|FG000|NOT COMPLETED|Overall Study||5
8965478|NCT02565576|10029255|FG001|NOT COMPLETED|Overall Study||5
8965479|NCT02565615|10029266|FG000|STARTED|Overall Study||291
8965480|NCT02565615|10029267|FG001|STARTED|Overall Study||3080
8965481|NCT02565615|10029268|FG002|STARTED|Overall Study||21
8965482|NCT02565615|10029269|FG003|STARTED|Overall Study||101
8965483|NCT02565615|10029270|FG004|STARTED|Overall Study||1622
8965484|NCT02565615|10029266|FG000|Treated|Overall Study||291
8965485|NCT02565615|10029267|FG001|Treated|Overall Study||3080
8965486|NCT02565615|10029268|FG002|Treated|Overall Study||21
8965487|NCT02565615|10029269|FG003|Treated|Overall Study||101
8965488|NCT02565615|10029270|FG004|Treated|Overall Study||1055
8965489|NCT02565615|10029266|FG000|COMPLETED|Overall Study||288
8965490|NCT02565615|10029267|FG001|COMPLETED|Overall Study||3044
8965491|NCT02565615|10029268|FG002|COMPLETED|Overall Study||21
8965492|NCT02565615|10029269|FG003|COMPLETED|Overall Study||98
8965493|NCT02565615|10029270|FG004|COMPLETED|Overall Study||21
8965494|NCT02565615|10029266|FG000|NOT COMPLETED|Overall Study||3
8965495|NCT02565615|10029267|FG001|NOT COMPLETED|Overall Study||36
8965496|NCT02565615|10029268|FG002|NOT COMPLETED|Overall Study||0
8965497|NCT02565615|10029269|FG003|NOT COMPLETED|Overall Study||3
8965498|NCT02565615|10029270|FG004|NOT COMPLETED|Overall Study||1601
8876467|NCT01917006|9933303|FG000|STARTED|Randomized-treatment Period||5
8876468|NCT01917006|9933304|FG001|STARTED|Randomized-treatment Period||7
8876469|NCT01917006|9933305|FG002|STARTED|Randomized-treatment Period||8
8965499|NCT02565628|10029284|FG000|STARTED|Overall Study||10
8965500|NCT02565628|10029285|FG001|STARTED|Overall Study||9
8965501|NCT02565628|10029284|FG000|Received Treatment|Overall Study||10
8965502|NCT02565628|10029285|FG001|Received Treatment|Overall Study||9
8965503|NCT02565628|10029284|FG000|COMPLETED|Overall Study||10
8965504|NCT02565628|10029285|FG001|COMPLETED|Overall Study||9
8965505|NCT02565628|10029284|FG000|NOT COMPLETED|Overall Study||0
8965506|NCT02565628|10029285|FG001|NOT COMPLETED|Overall Study||0
8965507|NCT02565706|10029295|FG000|STARTED|Overall Study||178
8965508|NCT02565706|10029296|FG001|STARTED|Overall Study||172
8965509|NCT02565706|10029297|FG002|STARTED|Overall Study||193
8965510|NCT02565706|10029298|FG003|STARTED|Overall Study||201
8965511|NCT02565706|10029295|FG000|COMPLETED|Overall Study||101
8965512|NCT02565706|10029296|FG001|COMPLETED|Overall Study||90
8965513|NCT02565706|10029297|FG002|COMPLETED|Overall Study||104
8965514|NCT02565706|10029298|FG003|COMPLETED|Overall Study||116
8965515|NCT02565706|10029295|FG000|NOT COMPLETED|Overall Study||77
8965516|NCT02565706|10029296|FG001|NOT COMPLETED|Overall Study||82
8965517|NCT02565706|10029297|FG002|NOT COMPLETED|Overall Study||89
8965518|NCT02565706|10029298|FG003|NOT COMPLETED|Overall Study||85
8965519|NCT02565784|10029313|FG000|STARTED|First Treatment||100
8965520|NCT02565784|10029313|FG000|6 Months Follow-up|First Treatment||99
8965521|NCT02565784|10029313|FG000|12 Months Follow-up|First Treatment||98
8965522|NCT02565784|10029313|FG000|COMPLETED|First Treatment||98
8965523|NCT02565784|10029313|FG000|NOT COMPLETED|First Treatment||2
8965524|NCT02565784|10029313|FG000|STARTED|Second Treatment||98
8965525|NCT02565784|10029313|FG000|6 Months Follow-up|Second Treatment||97
8965526|NCT02565784|10029313|FG000|12 Months Follow-up|Second Treatment||96
8965527|NCT02565784|10029313|FG000|COMPLETED|Second Treatment||96
8965528|NCT02565784|10029313|FG000|NOT COMPLETED|Second Treatment||2
8965529|NCT02565810|10029321|FG000|STARTED|Overall Study||49
8965530|NCT02565810|10029321|FG000|COMPLETED|Overall Study||48
8965531|NCT02565810|10029321|FG000|NOT COMPLETED|Overall Study||1
8965532|NCT02565901|10029333|FG000|STARTED|Overall Study||11
8965533|NCT02565901|10029334|FG001|STARTED|Overall Study||11
8965534|NCT02565901|10029335|FG002|STARTED|Overall Study||6
8965535|NCT02565901|10029333|FG000|COMPLETED|Overall Study||11
8965536|NCT02565901|10029334|FG001|COMPLETED|Overall Study||11
8965537|NCT02565901|10029335|FG002|COMPLETED|Overall Study||6
8965538|NCT02565901|10029333|FG000|NOT COMPLETED|Overall Study||0
8965539|NCT02565901|10029334|FG001|NOT COMPLETED|Overall Study||0
8965540|NCT02565901|10029335|FG002|NOT COMPLETED|Overall Study||0
8965541|NCT02566005|10029346|FG000|STARTED|Overall Study||100
8965542|NCT02566005|10029347|FG001|STARTED|Overall Study||100
8965543|NCT02566005|10029346|FG000|COMPLETED|Overall Study||92
8965544|NCT02566005|10029347|FG001|COMPLETED|Overall Study||94
8965545|NCT02566005|10029346|FG000|NOT COMPLETED|Overall Study||8
8965546|NCT02566005|10029347|FG001|NOT COMPLETED|Overall Study||6
8965547|NCT02566031|10029355|FG000|STARTED|Overall Study||189
8965548|NCT02566031|10029356|FG001|STARTED|Overall Study||190
8965549|NCT02566031|10029355|FG000|COMPLETED|Overall Study||169
8965550|NCT02566031|10029356|FG001|COMPLETED|Overall Study||178
8965551|NCT02566031|10029355|FG000|NOT COMPLETED|Overall Study||20
8965552|NCT02566031|10029356|FG001|NOT COMPLETED|Overall Study||12
8876470|NCT01917006|9933306|FG003|STARTED|Randomized-treatment Period||8
8876471|NCT01917006|9933307|FG004|STARTED|Randomized-treatment Period||8
8876472|NCT01917006|9933308|FG005|STARTED|Randomized-treatment Period||8
8876473|NCT01917006|9933309|FG006|STARTED|Randomized-treatment Period||15
8876474|NCT01917006|9933310|FG007|STARTED|Randomized-treatment Period||0
8876475|NCT01917006|9933303|FG000|COMPLETED|Randomized-treatment Period||3
8876476|NCT01917006|9933304|FG001|COMPLETED|Randomized-treatment Period||7
8876477|NCT01917006|9933305|FG002|COMPLETED|Randomized-treatment Period||8
8876478|NCT01917006|9933306|FG003|COMPLETED|Randomized-treatment Period||7
8876479|NCT01917006|9933307|FG004|COMPLETED|Randomized-treatment Period||8
8965553|NCT02566044|10029366|FG000|STARTED|Overall Study||6
8876480|NCT01917006|9933308|FG005|COMPLETED|Randomized-treatment Period||7
8876481|NCT01917006|9933309|FG006|COMPLETED|Randomized-treatment Period||14
8876482|NCT01917006|9933310|FG007|COMPLETED|Randomized-treatment Period||0
8876483|NCT01917006|9933303|FG000|NOT COMPLETED|Randomized-treatment Period||2
8876484|NCT01917006|9933304|FG001|NOT COMPLETED|Randomized-treatment Period||0
8965554|NCT02566044|10029367|FG001|STARTED|Overall Study||6
8965555|NCT02566044|10029368|FG002|STARTED|Overall Study||4
8965556|NCT02566044|10029366|FG000|COMPLETED|Overall Study||6
8965557|NCT02566044|10029367|FG001|COMPLETED|Overall Study||6
8965558|NCT02566044|10029368|FG002|COMPLETED|Overall Study||4
8965559|NCT02566044|10029366|FG000|NOT COMPLETED|Overall Study||0
8965560|NCT02566044|10029367|FG001|NOT COMPLETED|Overall Study||0
8965561|NCT02566044|10029368|FG002|NOT COMPLETED|Overall Study||0
8965562|NCT02566083|10029383|FG000|STARTED|Overall Study||214
8965563|NCT02566083|10029384|FG001|STARTED|Overall Study||151
8965564|NCT02566083|10029383|FG000|COMPLETED|Overall Study||198
8631753|NCT00541970|9671676|FG002|COMPLETED|Month 7||229
8631754|NCT00541970|9671677|FG003|COMPLETED|Month 7||234
8631755|NCT00541970|9671674|FG000|NOT COMPLETED|Month 7||9
8876485|NCT01917006|9933305|FG002|NOT COMPLETED|Randomized-treatment Period||0
8876486|NCT01917006|9933306|FG003|NOT COMPLETED|Randomized-treatment Period||1
8876487|NCT01917006|9933307|FG004|NOT COMPLETED|Randomized-treatment Period||0
8876488|NCT01917006|9933308|FG005|NOT COMPLETED|Randomized-treatment Period||1
8570561|NCT00104416|9602742|FG003|NOT COMPLETED|Double-Blind Phase||0
8570562|NCT00104416|9602743|FG004|NOT COMPLETED|Double-Blind Phase||0
8570563|NCT00104416|9602739|FG000|STARTED|Continuation Phase||0
8570564|NCT00104416|9602740|FG001|STARTED|Continuation Phase||0
8570565|NCT00104416|9602741|FG002|STARTED|Continuation Phase||69
8570566|NCT00104416|9602742|FG003|STARTED|Continuation Phase|One participant did not complete the Double-Blind Phase but was enrolled in the Continuation Phase.|67
8570567|NCT00104416|9602743|FG004|STARTED|Continuation Phase||32
8570568|NCT00104416|9602739|FG000|COMPLETED|Continuation Phase||0
8570569|NCT00104416|9602740|FG001|COMPLETED|Continuation Phase||0
8570570|NCT00104416|9602741|FG002|COMPLETED|Continuation Phase||63
8570571|NCT00104416|9602742|FG003|COMPLETED|Continuation Phase||65
8570572|NCT00104416|9602743|FG004|COMPLETED|Continuation Phase||27
8570573|NCT00104416|9602739|FG000|NOT COMPLETED|Continuation Phase||0
8570574|NCT00104416|9602740|FG001|NOT COMPLETED|Continuation Phase||0
8570575|NCT00104416|9602741|FG002|NOT COMPLETED|Continuation Phase||6
8570576|NCT00104416|9602742|FG003|NOT COMPLETED|Continuation Phase||2
8570577|NCT00104416|9602743|FG004|NOT COMPLETED|Continuation Phase||5
8570578|NCT00104520|9602757|FG000|STARTED|Overall Study||76
8570579|NCT00104520|9602758|FG001|STARTED|Overall Study||135
8570580|NCT00104520|9602757|FG000|COMPLETED|Overall Study||26
8570581|NCT00104520|9602758|FG001|COMPLETED|Overall Study||64
8631756|NCT00541970|9671675|FG001|NOT COMPLETED|Month 7||13
8631757|NCT00541970|9671676|FG002|NOT COMPLETED|Month 7||11
8631758|NCT00541970|9671677|FG003|NOT COMPLETED|Month 7||5
8631759|NCT00541970|9671674|FG000|STARTED|Month 12||240
8876489|NCT01917006|9933309|FG006|NOT COMPLETED|Randomized-treatment Period||1
8876490|NCT01917006|9933310|FG007|NOT COMPLETED|Randomized-treatment Period||0
8876491|NCT01917006|9933303|FG000|STARTED|Open-label Period||0
8876492|NCT01917006|9933304|FG001|STARTED|Open-label Period||0
8876493|NCT01917006|9933305|FG002|STARTED|Open-label Period||0
8876494|NCT01917006|9933306|FG003|STARTED|Open-label Period||0
8876495|NCT01917006|9933307|FG004|STARTED|Open-label Period||0
8876496|NCT01917006|9933308|FG005|STARTED|Open-label Period||0
8570582|NCT00104520|9602757|FG000|NOT COMPLETED|Overall Study||50
8570583|NCT00104520|9602758|FG001|NOT COMPLETED|Overall Study||71
8570584|NCT00104572|9602767|FG000|STARTED|Overall Study|These are the analysed subjects|13
8570585|NCT00104572|9602768|FG001|STARTED|Overall Study|These are the analysed subjects|13
8577570|NCT00159419|9610332|FG001|COMPLETED|Overall Study||9
8631760|NCT00541970|9671675|FG001|STARTED|Month 12||241
8965565|NCT02566083|10029384|FG001|COMPLETED|Overall Study||141
8965566|NCT02566083|10029383|FG000|NOT COMPLETED|Overall Study||16
8965567|NCT02566083|10029384|FG001|NOT COMPLETED|Overall Study||10
8965568|NCT02566109|10029390|FG000|STARTED|Overall Study||6
8965569|NCT02566109|10029390|FG000|COMPLETED|Overall Study||5
8965570|NCT02566109|10029390|FG000|NOT COMPLETED|Overall Study||1
8965571|NCT02566135|10029396|FG000|STARTED|Overall Study||29
8965572|NCT02566135|10029397|FG001|STARTED|Overall Study||29
8965573|NCT02566135|10029396|FG000|COMPLETED|Overall Study||29
8965574|NCT02566135|10029397|FG001|COMPLETED|Overall Study||29
8965575|NCT02566135|10029396|FG000|NOT COMPLETED|Overall Study||0
8965576|NCT02566135|10029397|FG001|NOT COMPLETED|Overall Study||0
8965577|NCT02566239|10029405|FG000|STARTED|Overall Study||43
8965578|NCT02566239|10029406|FG001|STARTED|Overall Study||48
8965579|NCT02566239|10029405|FG000|COMPLETED|Overall Study||39
8965580|NCT02566239|10029406|FG001|COMPLETED|Overall Study||44
8965581|NCT02566239|10029405|FG000|NOT COMPLETED|Overall Study||4
8965582|NCT02566239|10029406|FG001|NOT COMPLETED|Overall Study||4
8965583|NCT02566265|10029414|FG000|STARTED|Overall Study||81
8965584|NCT02566265|10029415|FG001|STARTED|Overall Study||41
8965585|NCT02566265|10029414|FG000|Day 7 (+/- 2 Days) (Optional)|Overall Study||19
8965586|NCT02566265|10029415|FG001|Day 7 (+/- 2 Days) (Optional)|Overall Study||12
8965587|NCT02566265|10029414|FG000|Day of Second Vaccine|Overall Study||74
8965588|NCT02566265|10029415|FG001|Day of Second Vaccine|Overall Study||41
8965589|NCT02566265|10029414|FG000|30 Days Following 2nd Vaccine|Overall Study||72
8965590|NCT02566265|10029415|FG001|30 Days Following 2nd Vaccine|Overall Study||35
8965591|NCT02566265|10029414|FG000|End of Study Visit (Optional)|Overall Study||38
8965592|NCT02566265|10029415|FG001|End of Study Visit (Optional)|Overall Study||18
8965593|NCT02566265|10029414|FG000|COMPLETED|Overall Study||72
8965594|NCT02566265|10029415|FG001|COMPLETED|Overall Study||35
8965595|NCT02566265|10029414|FG000|NOT COMPLETED|Overall Study||9
8965596|NCT02566265|10029415|FG001|NOT COMPLETED|Overall Study||6
8965597|NCT02566317|10029423|FG000|STARTED|Overall Study||276
8965598|NCT02566317|10029424|FG001|STARTED|Overall Study||354
8965599|NCT02566317|10029423|FG000|COMPLETED|Overall Study||247
8965600|NCT02566317|10029424|FG001|COMPLETED|Overall Study||292
8965601|NCT02566317|10029423|FG000|NOT COMPLETED|Overall Study||29
8965602|NCT02566317|10029424|FG001|NOT COMPLETED|Overall Study||62
8965603|NCT02566369|10029432|FG000|STARTED|Overall Study||612
8965604|NCT02566369|10029433|FG001|STARTED|Overall Study||596
8965605|NCT02566369|10029432|FG000|COMPLETED|Overall Study||540
8965606|NCT02566369|10029433|FG001|COMPLETED|Overall Study||535
8965607|NCT02566369|10029432|FG000|NOT COMPLETED|Overall Study||72
8965608|NCT02566369|10029433|FG001|NOT COMPLETED|Overall Study||61
8965609|NCT02566525|10029441|FG000|STARTED|Overall Study|FPI - CytoSorb Patient 15 Jan 2016|23
8965610|NCT02566525|10029442|FG001|STARTED|Overall Study|FPI - Control Patient 8 Dec 2015|23
8965611|NCT02566525|10029441|FG000|COMPLETED|Overall Study|LPI - CytoSorb Patient 19 Aug 2016|20
8965612|NCT02566525|10029442|FG001|COMPLETED|Overall Study|LPI - Control 16 Aug 2016|18
8965613|NCT02566525|10029441|FG000|NOT COMPLETED|Overall Study||3
8965614|NCT02566525|10029442|FG001|NOT COMPLETED|Overall Study||5
8965615|NCT02566577|10029452|FG000|STARTED|Overall Study||9
8965616|NCT02566577|10029453|FG001|STARTED|Overall Study||6
8965617|NCT02566577|10029452|FG000|COMPLETED|Overall Study||6
8965618|NCT02566577|10029453|FG001|COMPLETED|Overall Study||4
8965619|NCT02566577|10029452|FG000|NOT COMPLETED|Overall Study||3
8965620|NCT02566577|10029453|FG001|NOT COMPLETED|Overall Study||2
8965621|NCT02566590|10029463|FG000|STARTED|Overall Study||10
8965622|NCT02566590|10029464|FG001|STARTED|Overall Study||10
8965623|NCT02566590|10029463|FG000|COMPLETED|Overall Study||10
8965624|NCT02566590|10029464|FG001|COMPLETED|Overall Study||10
8965625|NCT02566590|10029463|FG000|NOT COMPLETED|Overall Study||0
8965626|NCT02566590|10029464|FG001|NOT COMPLETED|Overall Study||0
8965627|NCT02566759|10029487|FG000|STARTED|All Parts||12
8965628|NCT02566759|10029488|FG001|STARTED|All Parts||6
8965629|NCT02566759|10029489|FG002|STARTED|All Parts||6
8965630|NCT02566759|10029490|FG003|STARTED|All Parts||6
8965631|NCT02566759|10029491|FG004|STARTED|All Parts||6
8965632|NCT02566759|10029492|FG005|STARTED|All Parts||6
8965633|NCT02566759|10029493|FG006|STARTED|All Parts||6
8965634|NCT02566759|10029494|FG007|STARTED|All Parts||8
8965635|NCT02566759|10029495|FG008|STARTED|All Parts||6
8965636|NCT02566759|10029496|FG009|STARTED|All Parts||6
8965637|NCT02566759|10029497|FG010|STARTED|All Parts||6
8965638|NCT02566759|10029498|FG011|STARTED|All Parts||6
8965639|NCT02566759|10029499|FG012|STARTED|All Parts||1
8965640|NCT02566759|10029500|FG013|STARTED|All Parts||5
8965641|NCT02566759|10029501|FG014|STARTED|All Parts||8
8965642|NCT02566759|10029502|FG015|STARTED|All Parts||8
8965643|NCT02566759|10029503|FG016|STARTED|All Parts||8
8965644|NCT02566759|10029487|FG000|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|12
8965645|NCT02566759|10029488|FG001|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|5
8965646|NCT02566759|10029489|FG002|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
8965647|NCT02566759|10029490|FG003|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
8965648|NCT02566759|10029491|FG004|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
8965649|NCT02566759|10029492|FG005|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
8965650|NCT02566759|10029493|FG006|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
8965651|NCT02566759|10029494|FG007|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|8
8965652|NCT02566759|10029495|FG008|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
8965653|NCT02566759|10029496|FG009|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
8965654|NCT02566759|10029497|FG010|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
8965655|NCT02566759|10029498|FG011|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
8965656|NCT02566759|10029499|FG012|COMPLETED|All Parts||0
8965657|NCT02566759|10029500|FG013|COMPLETED|All Parts||0
8965658|NCT02566759|10029501|FG014|COMPLETED|All Parts|Only participants of Part 4 continued in next period.|8
8965659|NCT02566759|10029502|FG015|COMPLETED|All Parts|Only participants of Part 4 continued in next period.|8
8965660|NCT02566759|10029503|FG016|COMPLETED|All Parts|Only participants of Part 4 continued in next period.|8
8965661|NCT02566759|10029487|FG000|NOT COMPLETED|All Parts||0
8965662|NCT02566759|10029488|FG001|NOT COMPLETED|All Parts||1
8965663|NCT02566759|10029489|FG002|NOT COMPLETED|All Parts||0
8965664|NCT02566759|10029490|FG003|NOT COMPLETED|All Parts||0
8965665|NCT02566759|10029491|FG004|NOT COMPLETED|All Parts||0
8965666|NCT02566759|10029492|FG005|NOT COMPLETED|All Parts||0
8965667|NCT02566759|10029493|FG006|NOT COMPLETED|All Parts||0
8965668|NCT02566759|10029494|FG007|NOT COMPLETED|All Parts||0
8965669|NCT02566759|10029495|FG008|NOT COMPLETED|All Parts||0
8965670|NCT02566759|10029496|FG009|NOT COMPLETED|All Parts||0
8965671|NCT02566759|10029497|FG010|NOT COMPLETED|All Parts||0
8965672|NCT02566759|10029498|FG011|NOT COMPLETED|All Parts||0
8965673|NCT02566759|10029499|FG012|NOT COMPLETED|All Parts||1
8965674|NCT02566759|10029500|FG013|NOT COMPLETED|All Parts||5
8965675|NCT02566759|10029501|FG014|NOT COMPLETED|All Parts||0
8965676|NCT02566759|10029502|FG015|NOT COMPLETED|All Parts||0
8965677|NCT02566759|10029503|FG016|NOT COMPLETED|All Parts||0
8965678|NCT02566759|10029487|FG000|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8965679|NCT02566759|10029488|FG001|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8965680|NCT02566759|10029489|FG002|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8965681|NCT02566759|10029490|FG003|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8965682|NCT02566759|10029491|FG004|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8965683|NCT02566759|10029492|FG005|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8965684|NCT02566759|10029493|FG006|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8965685|NCT02566759|10029494|FG007|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8965686|NCT02566759|10029495|FG008|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8965687|NCT02566759|10029496|FG009|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8965688|NCT02566759|10029497|FG010|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8965689|NCT02566759|10029498|FG011|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8965690|NCT02566759|10029499|FG012|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8965691|NCT02566759|10029500|FG013|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8965692|NCT02566759|10029501|FG014|STARTED|Washout Crossover Period (Part 4:5 Days)||8
8965693|NCT02566759|10029502|FG015|STARTED|Washout Crossover Period (Part 4:5 Days)||8
8965694|NCT02566759|10029503|FG016|STARTED|Washout Crossover Period (Part 4:5 Days)||8
8965695|NCT02566759|10029487|FG000|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8965696|NCT02566759|10029488|FG001|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8965697|NCT02566759|10029489|FG002|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8965698|NCT02566759|10029490|FG003|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8965699|NCT02566759|10029491|FG004|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8965700|NCT02566759|10029492|FG005|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8965701|NCT02566759|10029493|FG006|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8965702|NCT02566759|10029494|FG007|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8965703|NCT02566759|10029495|FG008|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8965704|NCT02566759|10029496|FG009|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8965705|NCT02566759|10029497|FG010|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8965706|NCT02566759|10029498|FG011|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8965707|NCT02566759|10029499|FG012|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8965708|NCT02566759|10029500|FG013|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8965709|NCT02566759|10029501|FG014|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
8965710|NCT02566759|10029502|FG015|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
8965711|NCT02566759|10029503|FG016|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
8965712|NCT02566759|10029487|FG000|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8965713|NCT02566759|10029488|FG001|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8965714|NCT02566759|10029489|FG002|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8965715|NCT02566759|10029490|FG003|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8965716|NCT02566759|10029491|FG004|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8965717|NCT02566759|10029492|FG005|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8965718|NCT02566759|10029493|FG006|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8965719|NCT02566759|10029494|FG007|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8965720|NCT02566759|10029495|FG008|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8965721|NCT02566759|10029496|FG009|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8965722|NCT02566759|10029497|FG010|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8570586|NCT00104572|9602769|FG002|STARTED|Overall Study|(N=11) in placebo, physician removed 2 men due to total testosterone>450 ng/DL, N=9 analysed.|9
8570587|NCT00104572|9602767|FG000|COMPLETED|Overall Study||10
8570588|NCT00104572|9602768|FG001|COMPLETED|Overall Study||10
8570589|NCT00104572|9602769|FG002|COMPLETED|Overall Study||9
8570590|NCT00104572|9602767|FG000|NOT COMPLETED|Overall Study||3
8570591|NCT00104572|9602768|FG001|NOT COMPLETED|Overall Study||3
8570592|NCT00104572|9602769|FG002|NOT COMPLETED|Overall Study||0
8570593|NCT00104637|9602777|FG000|STARTED|Period 1: ( TREATMENT: 4 Weeks)||6
8570594|NCT00104637|9602778|FG001|STARTED|Period 1: ( TREATMENT: 4 Weeks)||4
8570595|NCT00104637|9602777|FG000|COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||5
8570596|NCT00104637|9602778|FG001|COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||4
8570597|NCT00104637|9602777|FG000|NOT COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||1
8570598|NCT00104637|9602778|FG001|NOT COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||0
8570599|NCT00104637|9602777|FG000|STARTED|Period 2 (WASHOUT: 1 Week)||5
8570600|NCT00104637|9602778|FG001|STARTED|Period 2 (WASHOUT: 1 Week)||4
8570601|NCT00104637|9602777|FG000|COMPLETED|Period 2 (WASHOUT: 1 Week)||5
8570602|NCT00104637|9602778|FG001|COMPLETED|Period 2 (WASHOUT: 1 Week)||4
8570603|NCT00104637|9602777|FG000|NOT COMPLETED|Period 2 (WASHOUT: 1 Week)||0
8570604|NCT00104637|9602778|FG001|NOT COMPLETED|Period 2 (WASHOUT: 1 Week)||0
8570605|NCT00104637|9602777|FG000|STARTED|Period 3 ( TREATMENT: 4 Weeks)||5
8570606|NCT00104637|9602778|FG001|STARTED|Period 3 ( TREATMENT: 4 Weeks)||4
8570607|NCT00104637|9602777|FG000|COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||5
8570608|NCT00104637|9602778|FG001|COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||4
8570609|NCT00104637|9602777|FG000|NOT COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||0
8570610|NCT00104637|9602778|FG001|NOT COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||0
8570611|NCT00104650|9602790|FG000|STARTED|Treatment Period (25 Weeks)||37
8570612|NCT00104650|9602791|FG001|STARTED|Treatment Period (25 Weeks)||36
8570613|NCT00104650|9602792|FG002|STARTED|Treatment Period (25 Weeks)||38
8570614|NCT00104650|9602790|FG000|Received Investigational Product|Treatment Period (25 Weeks)||35
8570615|NCT00104650|9602791|FG001|Received Investigational Product|Treatment Period (25 Weeks)||35
8570616|NCT00104650|9602792|FG002|Received Investigational Product|Treatment Period (25 Weeks)||38
8570617|NCT00104650|9602790|FG000|COMPLETED|Treatment Period (25 Weeks)||25
8570618|NCT00104650|9602791|FG001|COMPLETED|Treatment Period (25 Weeks)||25
8570619|NCT00104650|9602792|FG002|COMPLETED|Treatment Period (25 Weeks)||28
8570620|NCT00104650|9602790|FG000|NOT COMPLETED|Treatment Period (25 Weeks)||12
8570621|NCT00104650|9602791|FG001|NOT COMPLETED|Treatment Period (25 Weeks)||11
8570622|NCT00104650|9602792|FG002|NOT COMPLETED|Treatment Period (25 Weeks)||10
8570623|NCT00104650|9602790|FG000|STARTED|Follow-up Period||25
8570624|NCT00104650|9602791|FG001|STARTED|Follow-up Period||25
8570625|NCT00104650|9602792|FG002|STARTED|Follow-up Period||28
8570626|NCT00104650|9602790|FG000|COMPLETED|Follow-up Period||14
8570627|NCT00104650|9602791|FG001|COMPLETED|Follow-up Period||12
8570628|NCT00104650|9602792|FG002|COMPLETED|Follow-up Period||18
8570629|NCT00104650|9602790|FG000|NOT COMPLETED|Follow-up Period||11
8570630|NCT00104650|9602791|FG001|NOT COMPLETED|Follow-up Period||13
8570631|NCT00104650|9602792|FG002|NOT COMPLETED|Follow-up Period||10
8570632|NCT00104676|9602802|FG000|STARTED|Overall Study||98
8570633|NCT00104676|9602803|FG001|STARTED|Overall Study||105
8570634|NCT00104676|9602802|FG000|COMPLETED|Overall Study||91
8570635|NCT00104676|9602803|FG001|COMPLETED|Overall Study||91
8570636|NCT00104676|9602802|FG000|NOT COMPLETED|Overall Study||7
8570637|NCT00104676|9602803|FG001|NOT COMPLETED|Overall Study||14
8570638|NCT00104858|9602809|FG000|STARTED|Overall Study||52
8965723|NCT02566759|10029498|FG011|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8965724|NCT02566759|10029499|FG012|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8965725|NCT02566759|10029500|FG013|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8965726|NCT02566759|10029501|FG014|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8965727|NCT02566759|10029502|FG015|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8965728|NCT02566759|10029503|FG016|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8965729|NCT02566759|10029487|FG000|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8965730|NCT02566759|10029488|FG001|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8965731|NCT02566759|10029489|FG002|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8965732|NCT02566759|10029490|FG003|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8965733|NCT02566759|10029491|FG004|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8965734|NCT02566759|10029492|FG005|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8965735|NCT02566759|10029493|FG006|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8965736|NCT02566759|10029494|FG007|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8965737|NCT02566759|10029495|FG008|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8965738|NCT02566759|10029496|FG009|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8965739|NCT02566759|10029497|FG010|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8965740|NCT02566759|10029498|FG011|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8965741|NCT02566759|10029499|FG012|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8965742|NCT02566759|10029500|FG013|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8965743|NCT02566759|10029501|FG014|STARTED|Crossover Treatment (Part 4: 1 Day)||8
8965744|NCT02566759|10029502|FG015|STARTED|Crossover Treatment (Part 4: 1 Day)||8
8965745|NCT02566759|10029503|FG016|STARTED|Crossover Treatment (Part 4: 1 Day)||8
8965746|NCT02566759|10029487|FG000|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8965747|NCT02566759|10029488|FG001|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8965748|NCT02566759|10029489|FG002|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8965749|NCT02566759|10029490|FG003|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8965750|NCT02566759|10029491|FG004|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8965751|NCT02566759|10029492|FG005|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8965752|NCT02566759|10029493|FG006|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8965753|NCT02566759|10029494|FG007|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8965754|NCT02566759|10029495|FG008|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8965755|NCT02566759|10029496|FG009|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8965756|NCT02566759|10029497|FG010|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8965757|NCT02566759|10029498|FG011|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8965758|NCT02566759|10029499|FG012|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8965759|NCT02566759|10029500|FG013|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8965760|NCT02566759|10029501|FG014|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8
8965761|NCT02566759|10029502|FG015|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8
8965762|NCT02566759|10029503|FG016|COMPLETED|Crossover Treatment (Part 4: 1 Day)||7
8965763|NCT02566759|10029487|FG000|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8965764|NCT02566759|10029488|FG001|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8965765|NCT02566759|10029489|FG002|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8965766|NCT02566759|10029490|FG003|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8965767|NCT02566759|10029491|FG004|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8965768|NCT02566759|10029492|FG005|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8965769|NCT02566759|10029493|FG006|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8965770|NCT02566759|10029494|FG007|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8965771|NCT02566759|10029495|FG008|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8965772|NCT02566759|10029496|FG009|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8965773|NCT02566759|10029497|FG010|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8965774|NCT02566759|10029498|FG011|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8965775|NCT02566759|10029499|FG012|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8965776|NCT02566759|10029500|FG013|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8965777|NCT02566759|10029501|FG014|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8965778|NCT02566759|10029502|FG015|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8965779|NCT02566759|10029503|FG016|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||1
8965780|NCT02566759|10029487|FG000|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8965781|NCT02566759|10029488|FG001|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8965782|NCT02566759|10029489|FG002|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8965783|NCT02566759|10029490|FG003|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8965784|NCT02566759|10029491|FG004|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8965785|NCT02566759|10029492|FG005|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8965786|NCT02566759|10029493|FG006|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8965787|NCT02566759|10029494|FG007|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8965788|NCT02566759|10029495|FG008|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8965789|NCT02566759|10029496|FG009|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8965790|NCT02566759|10029497|FG010|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8965791|NCT02566759|10029498|FG011|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8965792|NCT02566759|10029499|FG012|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8965793|NCT02566759|10029500|FG013|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8965794|NCT02566759|10029501|FG014|STARTED|Washout Crossover Period (Part 4:5 Days)||8
8965795|NCT02566759|10029502|FG015|STARTED|Washout Crossover Period (Part 4:5 Days)||8
8965796|NCT02566759|10029503|FG016|STARTED|Washout Crossover Period (Part 4:5 Days)||7
8965797|NCT02566759|10029487|FG000|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8965798|NCT02566759|10029488|FG001|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8965799|NCT02566759|10029489|FG002|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8965800|NCT02566759|10029490|FG003|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8965801|NCT02566759|10029491|FG004|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8965802|NCT02566759|10029492|FG005|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8965803|NCT02566759|10029493|FG006|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8965804|NCT02566759|10029494|FG007|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8965805|NCT02566759|10029495|FG008|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8965806|NCT02566759|10029496|FG009|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8965807|NCT02566759|10029497|FG010|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8965808|NCT02566759|10029498|FG011|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8965809|NCT02566759|10029499|FG012|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8965810|NCT02566759|10029500|FG013|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8965811|NCT02566759|10029501|FG014|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
8965812|NCT02566759|10029502|FG015|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
8965813|NCT02566759|10029503|FG016|COMPLETED|Washout Crossover Period (Part 4:5 Days)||7
8965814|NCT02566759|10029487|FG000|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8965815|NCT02566759|10029488|FG001|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8965816|NCT02566759|10029489|FG002|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8965817|NCT02566759|10029490|FG003|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8965818|NCT02566759|10029491|FG004|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8965819|NCT02566759|10029492|FG005|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8965820|NCT02566759|10029493|FG006|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8965821|NCT02566759|10029494|FG007|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
9037975|NCT03325881|10099246|FG000|Treated|Overall Study||43
8570639|NCT00104858|9602809|FG000|COMPLETED|Overall Study||52
8570640|NCT00104858|9602809|FG000|NOT COMPLETED|Overall Study||0
8570641|NCT00104871|9602815|FG000|STARTED|Overall Study||22
8570642|NCT00104871|9602815|FG000|COMPLETED|Overall Study||21
8570643|NCT00104871|9602815|FG000|NOT COMPLETED|Overall Study||1
8570644|NCT00104884|9602819|FG000|STARTED|Overall Study||4
8570645|NCT00104884|9602819|FG000|COMPLETED|Overall Study||0
8570646|NCT00104884|9602819|FG000|NOT COMPLETED|Overall Study||4
8570647|NCT00105001|9602826|FG000|STARTED|Overall Study||70
8570648|NCT00105001|9602827|FG001|STARTED|Overall Study||71
8570649|NCT00105001|9602828|FG002|STARTED|Overall Study||69
8570650|NCT00105001|9602826|FG000|COMPLETED|Overall Study||70
8570651|NCT00105001|9602827|FG001|COMPLETED|Overall Study||71
8570652|NCT00105001|9602828|FG002|COMPLETED|Overall Study||69
8570653|NCT00105001|9602826|FG000|NOT COMPLETED|Overall Study||0
8570654|NCT00105001|9602827|FG001|NOT COMPLETED|Overall Study||0
8570655|NCT00105001|9602828|FG002|NOT COMPLETED|Overall Study||0
8570656|NCT00105027|9602842|FG000|STARTED|Overall Study||88
8570657|NCT00105027|9602843|FG001|STARTED|Overall Study||92
8570658|NCT00105027|9602844|FG002|STARTED|Overall Study||91
8570659|NCT00105027|9602845|FG003|STARTED|Overall Study||137
8570660|NCT00105027|9602846|FG004|STARTED|Overall Study||136
8570661|NCT00105027|9602847|FG005|STARTED|Overall Study||138
8570662|NCT00105027|9602842|FG000|COMPLETED|Overall Study||73
8631761|NCT00541970|9671676|FG002|STARTED|Month 12||240
8631762|NCT00541970|9671677|FG003|STARTED|Month 12||239
8631763|NCT00541970|9671674|FG000|COMPLETED|Month 12||228
8570663|NCT00105027|9602843|FG001|COMPLETED|Overall Study||83
8570664|NCT00105027|9602844|FG002|COMPLETED|Overall Study||82
8570665|NCT00105027|9602845|FG003|COMPLETED|Overall Study||121
8570666|NCT00105027|9602846|FG004|COMPLETED|Overall Study||121
8570667|NCT00105027|9602847|FG005|COMPLETED|Overall Study||125
8570668|NCT00105027|9602842|FG000|NOT COMPLETED|Overall Study||15
8570669|NCT00105027|9602843|FG001|NOT COMPLETED|Overall Study||9
8570670|NCT00105027|9602844|FG002|NOT COMPLETED|Overall Study||9
8570671|NCT00105027|9602845|FG003|NOT COMPLETED|Overall Study||16
8570672|NCT00105027|9602846|FG004|NOT COMPLETED|Overall Study||15
8570673|NCT00105027|9602847|FG005|NOT COMPLETED|Overall Study||13
8570674|NCT00105066|9602863|FG000|STARTED|Overall Study||27
8570675|NCT00105066|9602864|FG001|STARTED|Overall Study||50
8631764|NCT00541970|9671675|FG001|COMPLETED|Month 12||219
8631765|NCT00541970|9671676|FG002|COMPLETED|Month 12||219
8570676|NCT00105066|9602863|FG000|COMPLETED|Overall Study||25
8570677|NCT00105066|9602864|FG001|COMPLETED|Overall Study||45
8570678|NCT00105066|9602863|FG000|NOT COMPLETED|Overall Study||2
8570679|NCT00105066|9602864|FG001|NOT COMPLETED|Overall Study||5
8570680|NCT00105079|9602872|FG000|STARTED|Overall Study||167
8570681|NCT00105079|9602873|FG001|STARTED|Overall Study||170
8570682|NCT00105079|9602872|FG000|Safety Population|Overall Study||163
8570683|NCT00105079|9602873|FG001|Safety Population|Overall Study||168
8570684|NCT00105079|9602872|FG000|COMPLETED|Overall Study||128
8570685|NCT00105079|9602873|FG001|COMPLETED|Overall Study||135
8570686|NCT00105079|9602872|FG000|NOT COMPLETED|Overall Study||39
8570687|NCT00105079|9602873|FG001|NOT COMPLETED|Overall Study||35
8570688|NCT00105157|9602883|FG000|STARTED|Double-Blind (DB)||44
8570689|NCT00105157|9602884|FG001|STARTED|Double-Blind (DB)||45
8570690|NCT00105157|9602885|FG002|STARTED|Double-Blind (DB)||45
8570691|NCT00105157|9602886|FG003|STARTED|Double-Blind (DB)||45
8631766|NCT00541970|9671677|FG003|COMPLETED|Month 12||223
8965822|NCT02566759|10029495|FG008|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8965823|NCT02566759|10029496|FG009|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8965824|NCT02566759|10029497|FG010|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8965825|NCT02566759|10029498|FG011|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8965826|NCT02566759|10029499|FG012|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8965827|NCT02566759|10029500|FG013|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8965828|NCT02566759|10029501|FG014|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8965829|NCT02566759|10029502|FG015|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8965830|NCT02566759|10029503|FG016|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8965831|NCT02566759|10029487|FG000|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8965832|NCT02566759|10029488|FG001|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8965833|NCT02566759|10029489|FG002|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8965834|NCT02566759|10029490|FG003|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8965835|NCT02566759|10029491|FG004|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8965836|NCT02566759|10029492|FG005|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8965837|NCT02566759|10029493|FG006|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8965838|NCT02566759|10029494|FG007|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8965839|NCT02566759|10029495|FG008|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8965840|NCT02566759|10029496|FG009|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8965841|NCT02566759|10029497|FG010|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8965842|NCT02566759|10029498|FG011|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8965843|NCT02566759|10029499|FG012|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8965844|NCT02566759|10029500|FG013|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8965845|NCT02566759|10029501|FG014|STARTED|Crossover Treatment (Part 4: 1 Day)||8
8965846|NCT02566759|10029502|FG015|STARTED|Crossover Treatment (Part 4: 1 Day)||8
8965847|NCT02566759|10029503|FG016|STARTED|Crossover Treatment (Part 4: 1 Day)||7
8965848|NCT02566759|10029487|FG000|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8965849|NCT02566759|10029488|FG001|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8965850|NCT02566759|10029489|FG002|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8965851|NCT02566759|10029490|FG003|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8965852|NCT02566759|10029491|FG004|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8965853|NCT02566759|10029492|FG005|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8965854|NCT02566759|10029493|FG006|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8965855|NCT02566759|10029494|FG007|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8965856|NCT02566759|10029495|FG008|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8965857|NCT02566759|10029496|FG009|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8965858|NCT02566759|10029497|FG010|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8965859|NCT02566759|10029498|FG011|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8965860|NCT02566759|10029499|FG012|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8965861|NCT02566759|10029500|FG013|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8965862|NCT02566759|10029501|FG014|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8
8965863|NCT02566759|10029502|FG015|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8
8965864|NCT02566759|10029503|FG016|COMPLETED|Crossover Treatment (Part 4: 1 Day)||7
8965865|NCT02566759|10029487|FG000|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8965866|NCT02566759|10029488|FG001|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8965867|NCT02566759|10029489|FG002|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8631767|NCT00541970|9671674|FG000|NOT COMPLETED|Month 12||12
8631768|NCT00541970|9671675|FG001|NOT COMPLETED|Month 12||22
8631769|NCT00541970|9671676|FG002|NOT COMPLETED|Month 12||21
8631770|NCT00541970|9671677|FG003|NOT COMPLETED|Month 12||16
8631771|NCT00541970|9671674|FG000|STARTED|Month 18||240
8631772|NCT00541970|9671675|FG001|STARTED|Month 18||241
8631773|NCT00541970|9671676|FG002|STARTED|Month 18||240
8876497|NCT01917006|9933309|FG006|STARTED|Open-label Period||0
8876498|NCT01917006|9933310|FG007|STARTED|Open-label Period||8
8876499|NCT01917006|9933303|FG000|COMPLETED|Open-label Period||0
8876500|NCT01917006|9933304|FG001|COMPLETED|Open-label Period||0
8876501|NCT01917006|9933305|FG002|COMPLETED|Open-label Period||0
8876502|NCT01917006|9933306|FG003|COMPLETED|Open-label Period||0
8876503|NCT01917006|9933307|FG004|COMPLETED|Open-label Period||0
8876504|NCT01917006|9933308|FG005|COMPLETED|Open-label Period||0
8876505|NCT01917006|9933309|FG006|COMPLETED|Open-label Period||0
8876506|NCT01917006|9933310|FG007|COMPLETED|Open-label Period||6
8876507|NCT01917006|9933303|FG000|NOT COMPLETED|Open-label Period||0
8965868|NCT02566759|10029490|FG003|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8965869|NCT02566759|10029491|FG004|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8965870|NCT02566759|10029492|FG005|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8965871|NCT02566759|10029493|FG006|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8965872|NCT02566759|10029494|FG007|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8965873|NCT02566759|10029495|FG008|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8965874|NCT02566759|10029496|FG009|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8965875|NCT02566759|10029497|FG010|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8965876|NCT02566759|10029498|FG011|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8965877|NCT02566759|10029499|FG012|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8965878|NCT02566759|10029500|FG013|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8631774|NCT00541970|9671677|FG003|STARTED|Month 18||239
8876508|NCT01917006|9933304|FG001|NOT COMPLETED|Open-label Period||0
8876509|NCT01917006|9933305|FG002|NOT COMPLETED|Open-label Period||0
8965879|NCT02566759|10029501|FG014|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8965880|NCT02566759|10029502|FG015|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8965881|NCT02566759|10029503|FG016|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8965882|NCT02566785|10029564|FG000|STARTED|Overall Study||15
8965883|NCT02566785|10029565|FG001|STARTED|Overall Study||18
8965884|NCT02566785|10029564|FG000|COMPLETED|Overall Study||14
8631775|NCT00541970|9671674|FG000|COMPLETED|Month 18||226
8631776|NCT00541970|9671675|FG001|COMPLETED|Month 18||217
8631777|NCT00541970|9671676|FG002|COMPLETED|Month 18||215
8631778|NCT00541970|9671677|FG003|COMPLETED|Month 18||222
8631779|NCT00541970|9671674|FG000|NOT COMPLETED|Month 18||14
8876510|NCT01917006|9933306|FG003|NOT COMPLETED|Open-label Period||0
8965885|NCT02566785|10029565|FG001|COMPLETED|Overall Study||15
8965886|NCT02566785|10029564|FG000|NOT COMPLETED|Overall Study||1
8965887|NCT02566785|10029565|FG001|NOT COMPLETED|Overall Study||3
8965888|NCT02566889|10029573|FG000|STARTED|Overall Study||45
8965889|NCT02566889|10029574|FG001|STARTED|Overall Study||8
8965890|NCT02566889|10029573|FG000|Cross-over to Dose Escalation Group|Overall Study||1
8965891|NCT02566889|10029574|FG001|Cross-over to Dose Escalation Group|Overall Study||0
8965892|NCT02566889|10029573|FG000|COMPLETED|Overall Study||32
8965893|NCT02566889|10029574|FG001|COMPLETED|Overall Study||3
8965894|NCT02566889|10029573|FG000|NOT COMPLETED|Overall Study||13
8965895|NCT02566889|10029574|FG001|NOT COMPLETED|Overall Study||5
8965896|NCT02566902|10029581|FG000|STARTED|Overall Study||60
8965897|NCT02566902|10029582|FG001|STARTED|Overall Study||58
8965898|NCT02566902|10029581|FG000|COMPLETED|Overall Study||58
8965899|NCT02566902|10029582|FG001|COMPLETED|Overall Study||57
8965900|NCT02566902|10029581|FG000|NOT COMPLETED|Overall Study||2
8965901|NCT02566902|10029582|FG001|NOT COMPLETED|Overall Study||1
8965902|NCT02566993|10029590|FG000|STARTED|Overall Study||307
8965903|NCT02566993|10029591|FG001|STARTED|Overall Study||306
8965904|NCT02566993|10029590|FG000|COMPLETED|Overall Study||0
8965905|NCT02566993|10029591|FG001|COMPLETED|Overall Study||0
8965906|NCT02566993|10029590|FG000|NOT COMPLETED|Overall Study||307
8965907|NCT02566993|10029591|FG001|NOT COMPLETED|Overall Study||306
8965908|NCT02567188|10029599|FG000|STARTED|Overall Study||144
8965909|NCT02567188|10029599|FG000|COMPLETED|Overall Study||109
8965910|NCT02567188|10029599|FG000|NOT COMPLETED|Overall Study||35
8965911|NCT02567227|10029606|FG000|STARTED|9 Weeks||192
8965912|NCT02567227|10029607|FG001|STARTED|9 Weeks||191
8965913|NCT02567227|10029606|FG000|COMPLETED|9 Weeks||158
8965914|NCT02567227|10029607|FG001|COMPLETED|9 Weeks||167
8965915|NCT02567227|10029606|FG000|NOT COMPLETED|9 Weeks||34
8965916|NCT02567227|10029607|FG001|NOT COMPLETED|9 Weeks||24
8965917|NCT02567227|10029606|FG000|STARTED|6 Month||158
8965918|NCT02567227|10029607|FG001|STARTED|6 Month||167
8965919|NCT02567227|10029606|FG000|COMPLETED|6 Month||113
8965920|NCT02567227|10029607|FG001|COMPLETED|6 Month||127
8876511|NCT01917006|9933307|FG004|NOT COMPLETED|Open-label Period||0
8876512|NCT01917006|9933308|FG005|NOT COMPLETED|Open-label Period||0
8876513|NCT01917006|9933309|FG006|NOT COMPLETED|Open-label Period||0
8965921|NCT02567227|10029606|FG000|NOT COMPLETED|6 Month||45
8965922|NCT02567227|10029607|FG001|NOT COMPLETED|6 Month||40
8965923|NCT02567227|10029606|FG000|STARTED|12 Months||113
8965924|NCT02567227|10029607|FG001|STARTED|12 Months||127
8965925|NCT02567227|10029606|FG000|COMPLETED|12 Months||82
8965926|NCT02567227|10029607|FG001|COMPLETED|12 Months||93
8965927|NCT02567227|10029606|FG000|NOT COMPLETED|12 Months||31
8965928|NCT02567227|10029607|FG001|NOT COMPLETED|12 Months||34
8965929|NCT02567266|10029616|FG000|STARTED|Overall Study||68
8965930|NCT02567266|10029617|FG001|STARTED|Overall Study||60
8965931|NCT02567266|10029618|FG002|STARTED|Overall Study||68
8965932|NCT02567266|10029616|FG000|Midpoint (8 Weeks)|Overall Study||54
8965933|NCT02567266|10029617|FG001|Midpoint (8 Weeks)|Overall Study||52
8965934|NCT02567266|10029618|FG002|Midpoint (8 Weeks)|Overall Study||55
8631780|NCT00541970|9671675|FG001|NOT COMPLETED|Month 18||24
8876514|NCT01917006|9933310|FG007|NOT COMPLETED|Open-label Period||2
8876515|NCT01917084|9933327|FG000|STARTED|Overall Study||20
8965935|NCT02567266|10029616|FG000|Post (16 Weeks)|Overall Study||49
8965936|NCT02567266|10029617|FG001|Post (16 Weeks)|Overall Study||43
8965937|NCT02567266|10029618|FG002|Post (16 Weeks)|Overall Study||53
8876516|NCT01917084|9933327|FG000|COMPLETED|Overall Study||19
8876517|NCT01917084|9933327|FG000|NOT COMPLETED|Overall Study||1
8876518|NCT01917136|9933331|FG000|STARTED|Overall Study||21
8876519|NCT01917136|9933331|FG000|COMPLETED|Overall Study||21
8965938|NCT02567266|10029616|FG000|Follow-up (28 Weeks)|Overall Study||45
8965939|NCT02567266|10029617|FG001|Follow-up (28 Weeks)|Overall Study||45
8965940|NCT02567266|10029618|FG002|Follow-up (28 Weeks)|Overall Study||52
8965941|NCT02567266|10029616|FG000|COMPLETED|Overall Study||45
8965942|NCT02567266|10029617|FG001|COMPLETED|Overall Study||45
8965943|NCT02567266|10029618|FG002|COMPLETED|Overall Study||52
8965944|NCT02567266|10029616|FG000|NOT COMPLETED|Overall Study||23
8965945|NCT02567266|10029617|FG001|NOT COMPLETED|Overall Study||15
8965946|NCT02567266|10029618|FG002|NOT COMPLETED|Overall Study||16
8965947|NCT02567552|10029628|FG000|STARTED|Overall Study||12
8631781|NCT00541970|9671676|FG002|NOT COMPLETED|Month 18||25
8965948|NCT02567552|10029629|FG001|STARTED|Overall Study||12
8631782|NCT00541970|9671677|FG003|NOT COMPLETED|Month 18||17
8965949|NCT02567552|10029628|FG000|COMPLETED|Overall Study||12
8965950|NCT02567552|10029629|FG001|COMPLETED|Overall Study|dropout by pain in the puncture site|11
8725786|NCT01033383|9773127|FG002|NOT COMPLETED|Overall Study||0
8725787|NCT01033383|9773128|FG003|NOT COMPLETED|Overall Study||0
8725788|NCT01033422|9773141|FG000|STARTED|Overall Study||34
8725789|NCT01033422|9773142|FG001|STARTED|Overall Study||32
8965951|NCT02567552|10029628|FG000|NOT COMPLETED|Overall Study||0
8965952|NCT02567552|10029629|FG001|NOT COMPLETED|Overall Study||1
8965953|NCT02567656|10029641|FG000|STARTED|Overall Study||4
8965954|NCT02567656|10029642|FG001|STARTED|Overall Study||4
8965955|NCT02567656|10029643|FG002|STARTED|Overall Study||5
8965956|NCT02567656|10029644|FG003|STARTED|Overall Study||6
8965957|NCT02567656|10029645|FG004|STARTED|Overall Study||19
8965958|NCT02567656|10029646|FG005|STARTED|Overall Study||20
8965959|NCT02567656|10029641|FG000|COMPLETED|Overall Study||3
8965960|NCT02567656|10029642|FG001|COMPLETED|Overall Study||3
8965961|NCT02567656|10029643|FG002|COMPLETED|Overall Study||3
8965962|NCT02567656|10029644|FG003|COMPLETED|Overall Study||6
8965963|NCT02567656|10029645|FG004|COMPLETED|Overall Study||19
8965964|NCT02567656|10029646|FG005|COMPLETED|Overall Study||20
8965965|NCT02567656|10029641|FG000|NOT COMPLETED|Overall Study||1
8965966|NCT02567656|10029642|FG001|NOT COMPLETED|Overall Study||1
8965967|NCT02567656|10029643|FG002|NOT COMPLETED|Overall Study||2
8965968|NCT02567656|10029644|FG003|NOT COMPLETED|Overall Study||0
8965969|NCT02567656|10029645|FG004|NOT COMPLETED|Overall Study||0
8965970|NCT02567656|10029646|FG005|NOT COMPLETED|Overall Study||0
8965971|NCT02567708|10029660|FG000|STARTED|Treatment Period 1 (Up to 4 Weeks)||24
8965972|NCT02567708|10029661|FG001|STARTED|Treatment Period 1 (Up to 4 Weeks)||26
8965973|NCT02567708|10029660|FG000|COMPLETED|Treatment Period 1 (Up to 4 Weeks)||22
8965974|NCT02567708|10029661|FG001|COMPLETED|Treatment Period 1 (Up to 4 Weeks)||23
8965975|NCT02567708|10029660|FG000|NOT COMPLETED|Treatment Period 1 (Up to 4 Weeks)||2
8965976|NCT02567708|10029661|FG001|NOT COMPLETED|Treatment Period 1 (Up to 4 Weeks)||3
8965977|NCT02567708|10029660|FG000|STARTED|Washout Period (Up to 4 Weeks)||22
8965978|NCT02567708|10029661|FG001|STARTED|Washout Period (Up to 4 Weeks)||23
8965979|NCT02567708|10029660|FG000|COMPLETED|Washout Period (Up to 4 Weeks)||22
8965980|NCT02567708|10029661|FG001|COMPLETED|Washout Period (Up to 4 Weeks)||23
8965981|NCT02567708|10029660|FG000|NOT COMPLETED|Washout Period (Up to 4 Weeks)||0
8965982|NCT02567708|10029661|FG001|NOT COMPLETED|Washout Period (Up to 4 Weeks)||0
8965983|NCT02567708|10029660|FG000|STARTED|Treatment Period 2 (Up to 4 Weeks)||22
8965984|NCT02567708|10029661|FG001|STARTED|Treatment Period 2 (Up to 4 Weeks)||23
8965985|NCT02567708|10029660|FG000|COMPLETED|Treatment Period 2 (Up to 4 Weeks)||22
8965986|NCT02567708|10029661|FG001|COMPLETED|Treatment Period 2 (Up to 4 Weeks)||20
8965987|NCT02567708|10029660|FG000|NOT COMPLETED|Treatment Period 2 (Up to 4 Weeks)||0
8965988|NCT02567708|10029661|FG001|NOT COMPLETED|Treatment Period 2 (Up to 4 Weeks)||3
8965989|NCT02567968|10029668|FG000|STARTED|First Intervention||4
8965990|NCT02567968|10029669|FG001|STARTED|First Intervention||4
8965991|NCT02567968|10029668|FG000|COMPLETED|First Intervention||4
8965992|NCT02567968|10029669|FG001|COMPLETED|First Intervention||4
8965993|NCT02567968|10029668|FG000|NOT COMPLETED|First Intervention||0
8965994|NCT02567968|10029669|FG001|NOT COMPLETED|First Intervention||0
8965995|NCT02567968|10029668|FG000|STARTED|Washout (2 Weeks)||4
8965996|NCT02567968|10029669|FG001|STARTED|Washout (2 Weeks)||4
8965997|NCT02567968|10029668|FG000|COMPLETED|Washout (2 Weeks)||4
8965998|NCT02567968|10029669|FG001|COMPLETED|Washout (2 Weeks)||4
8965999|NCT02567968|10029668|FG000|NOT COMPLETED|Washout (2 Weeks)||0
8966000|NCT02567968|10029669|FG001|NOT COMPLETED|Washout (2 Weeks)||0
8966001|NCT02567968|10029668|FG000|STARTED|Second Intervention||4
8966002|NCT02567968|10029669|FG001|STARTED|Second Intervention||4
8966003|NCT02567968|10029668|FG000|COMPLETED|Second Intervention||4
8966004|NCT02567968|10029669|FG001|COMPLETED|Second Intervention||4
8966005|NCT02567968|10029668|FG000|NOT COMPLETED|Second Intervention||0
8966006|NCT02567968|10029669|FG001|NOT COMPLETED|Second Intervention||0
8966007|NCT02568046|10029677|FG000|STARTED|Overall Study||5
8966008|NCT02568046|10029678|FG001|STARTED|Overall Study||5
8966009|NCT02568046|10029677|FG000|COMPLETED|Overall Study||0
8966010|NCT02568046|10029678|FG001|COMPLETED|Overall Study||2
8966011|NCT02568046|10029677|FG000|NOT COMPLETED|Overall Study||5
8966012|NCT02568046|10029678|FG001|NOT COMPLETED|Overall Study||3
8966013|NCT02568072|10029684|FG000|STARTED|Overall Study||120
8966014|NCT02568072|10029684|FG000|COMPLETED|Overall Study||68
8966015|NCT02568072|10029684|FG000|NOT COMPLETED|Overall Study||52
8966016|NCT02568254|10029689|FG000|STARTED|Period 1||13
8966017|NCT02568254|10029690|FG001|STARTED|Period 1||12
8966018|NCT02568254|10029691|FG002|STARTED|Period 1||13
8966019|NCT02568254|10029692|FG003|STARTED|Period 1||12
8966020|NCT02568254|10029693|FG004|STARTED|Period 1||12
8966021|NCT02568254|10029694|FG005|STARTED|Period 1||12
8966022|NCT02568254|10029689|FG000|COMPLETED|Period 1||13
8966023|NCT02568254|10029690|FG001|COMPLETED|Period 1||12
8966024|NCT02568254|10029691|FG002|COMPLETED|Period 1||13
8966025|NCT02568254|10029692|FG003|COMPLETED|Period 1||12
8966026|NCT02568254|10029693|FG004|COMPLETED|Period 1||12
8966027|NCT02568254|10029694|FG005|COMPLETED|Period 1||12
8966028|NCT02568254|10029689|FG000|NOT COMPLETED|Period 1||0
8966029|NCT02568254|10029690|FG001|NOT COMPLETED|Period 1||0
8966030|NCT02568254|10029691|FG002|NOT COMPLETED|Period 1||0
8966031|NCT02568254|10029692|FG003|NOT COMPLETED|Period 1||0
8966032|NCT02568254|10029693|FG004|NOT COMPLETED|Period 1||0
8966033|NCT02568254|10029694|FG005|NOT COMPLETED|Period 1||0
8966034|NCT02568254|10029689|FG000|STARTED|Period 2||13
8966035|NCT02568254|10029690|FG001|STARTED|Period 2||12
8966036|NCT02568254|10029691|FG002|STARTED|Period 2||13
8966037|NCT02568254|10029692|FG003|STARTED|Period 2||12
8966038|NCT02568254|10029693|FG004|STARTED|Period 2||12
8966039|NCT02568254|10029694|FG005|STARTED|Period 2||12
8966040|NCT02568254|10029689|FG000|COMPLETED|Period 2||13
8966041|NCT02568254|10029690|FG001|COMPLETED|Period 2||12
8966042|NCT02568254|10029691|FG002|COMPLETED|Period 2||12
8966043|NCT02568254|10029692|FG003|COMPLETED|Period 2||12
8966044|NCT02568254|10029693|FG004|COMPLETED|Period 2||12
8966045|NCT02568254|10029694|FG005|COMPLETED|Period 2||12
8966046|NCT02568254|10029689|FG000|NOT COMPLETED|Period 2||0
8966047|NCT02568254|10029690|FG001|NOT COMPLETED|Period 2||0
8966048|NCT02568254|10029691|FG002|NOT COMPLETED|Period 2||1
8966049|NCT02568254|10029692|FG003|NOT COMPLETED|Period 2||0
8966050|NCT02568254|10029693|FG004|NOT COMPLETED|Period 2||0
8966051|NCT02568254|10029694|FG005|NOT COMPLETED|Period 2||0
8966052|NCT02568254|10029689|FG000|STARTED|Period 3||13
8966053|NCT02568254|10029690|FG001|STARTED|Period 3||12
8966054|NCT02568254|10029691|FG002|STARTED|Period 3||12
8966055|NCT02568254|10029692|FG003|STARTED|Period 3||12
8966056|NCT02568254|10029693|FG004|STARTED|Period 3||12
8966057|NCT02568254|10029694|FG005|STARTED|Period 3||12
8966058|NCT02568254|10029689|FG000|COMPLETED|Period 3||13
8966059|NCT02568254|10029690|FG001|COMPLETED|Period 3||12
8966060|NCT02568254|10029691|FG002|COMPLETED|Period 3||12
8966061|NCT02568254|10029692|FG003|COMPLETED|Period 3||12
8966062|NCT02568254|10029693|FG004|COMPLETED|Period 3||11
8966063|NCT02568254|10029694|FG005|COMPLETED|Period 3||12
8966064|NCT02568254|10029689|FG000|NOT COMPLETED|Period 3||0
8966065|NCT02568254|10029690|FG001|NOT COMPLETED|Period 3||0
8966066|NCT02568254|10029691|FG002|NOT COMPLETED|Period 3||0
8966067|NCT02568254|10029692|FG003|NOT COMPLETED|Period 3||0
8966068|NCT02568254|10029693|FG004|NOT COMPLETED|Period 3||1
8966069|NCT02568254|10029694|FG005|NOT COMPLETED|Period 3||0
8966070|NCT02568345|10029702|FG000|STARTED|Overall Study||31
8966071|NCT02568345|10029702|FG000|Treated at 2.2 mg/kg|Overall Study|patients: 6th, 20th, 26th|3
8966072|NCT02568345|10029702|FG000|Treated at 2.4 mg/kg|Overall Study|Patients: 1st-5th; 7th; 11th-15th; 21st-25th; 27th-31st|25
8966073|NCT02568345|10029702|FG000|Treated at 2.6 mg/kg|Overall Study|Patients: 8th-10th|3
8966074|NCT02568345|10029702|FG000|COMPLETED|Overall Study||31
8966075|NCT02568345|10029702|FG000|NOT COMPLETED|Overall Study||0
8966076|NCT02568384|10029706|FG000|STARTED|Overall Study||45
8966077|NCT02568384|10029706|FG000|COMPLETED|Overall Study||43
8966078|NCT02568384|10029706|FG000|NOT COMPLETED|Overall Study||2
8966079|NCT02568397|10029710|FG000|STARTED|Period 1||60
8966080|NCT02568397|10029711|FG001|STARTED|Period 1||0
8966081|NCT02568397|10029710|FG000|Received at Least 1 Dose of Study Drug|Period 1||60
8966082|NCT02568397|10029711|FG001|Received at Least 1 Dose of Study Drug|Period 1||0
8966083|NCT02568397|10029710|FG000|COMPLETED|Period 1||60
8966084|NCT02568397|10029711|FG001|COMPLETED|Period 1||0
8966085|NCT02568397|10029710|FG000|NOT COMPLETED|Period 1||0
8966086|NCT02568397|10029711|FG001|NOT COMPLETED|Period 1||0
8966087|NCT02568397|10029710|FG000|STARTED|Period 2|A single oral dose of 150 mg dabigatran etexilate was administered on Day 1 of Period 1.|0
8966088|NCT02568397|10029711|FG001|STARTED|Period 2|Daily doses of 50 mg LY3314814 were administered daily on Days 3 to 21 of Period 2.|60
8966089|NCT02568397|10029710|FG000|COMPLETED|Period 2||0
8966090|NCT02568397|10029711|FG001|COMPLETED|Period 2||58
8966091|NCT02568397|10029710|FG000|NOT COMPLETED|Period 2||0
8966092|NCT02568397|10029711|FG001|NOT COMPLETED|Period 2||2
8966093|NCT02568475|10029728|FG000|STARTED|Overall Study||97
8966094|NCT02568475|10029729|FG001|STARTED|Overall Study||95
8966095|NCT02568475|10029728|FG000|Post-test|Overall Study||85
8966096|NCT02568475|10029729|FG001|Post-test|Overall Study||82
8966097|NCT02568475|10029728|FG000|COMPLETED|Overall Study||46
8966098|NCT02568475|10029729|FG001|COMPLETED|Overall Study||52
8966099|NCT02568475|10029728|FG000|NOT COMPLETED|Overall Study||51
8966100|NCT02568475|10029729|FG001|NOT COMPLETED|Overall Study||43
8966101|NCT02568644|10029737|FG000|STARTED|Overall Study||30
8966102|NCT02568644|10029738|FG001|STARTED|Overall Study||30
8966103|NCT02568644|10029737|FG000|COMPLETED|Overall Study||30
8966104|NCT02568644|10029738|FG001|COMPLETED|Overall Study||30
8966105|NCT02568644|10029737|FG000|NOT COMPLETED|Overall Study||0
8570692|NCT00105157|9602883|FG000|Treated|Double-Blind (DB)||43
8570693|NCT00105157|9602884|FG001|Treated|Double-Blind (DB)||45
8570694|NCT00105157|9602885|FG002|Treated|Double-Blind (DB)||45
8570695|NCT00105157|9602886|FG003|Treated|Double-Blind (DB)||45
8570696|NCT00105157|9602883|FG000|COMPLETED|Double-Blind (DB)||30
8570697|NCT00105157|9602884|FG001|COMPLETED|Double-Blind (DB)||31
8966106|NCT02568644|10029738|FG001|NOT COMPLETED|Overall Study||0
8570698|NCT00105157|9602885|FG002|COMPLETED|Double-Blind (DB)||33
8570699|NCT00105157|9602886|FG003|COMPLETED|Double-Blind (DB)||6
8570700|NCT00105157|9602883|FG000|NOT COMPLETED|Double-Blind (DB)||14
8966107|NCT02568683|10029748|FG000|STARTED|Overall Study||6
8966108|NCT02568683|10029749|FG001|STARTED|Overall Study||4
8966109|NCT02568683|10029748|FG000|COMPLETED|Overall Study||0
8966110|NCT02568683|10029749|FG001|COMPLETED|Overall Study||0
8966111|NCT02568683|10029748|FG000|NOT COMPLETED|Overall Study||6
8966112|NCT02568683|10029749|FG001|NOT COMPLETED|Overall Study||4
8966113|NCT02568852|10029757|FG000|STARTED|Overall Study||25
8966114|NCT02568852|10029758|FG001|STARTED|Overall Study||25
8966115|NCT02568852|10029757|FG000|COMPLETED|Overall Study||25
8966116|NCT02568852|10029758|FG001|COMPLETED|Overall Study||25
8966117|NCT02568852|10029757|FG000|NOT COMPLETED|Overall Study||0
8966118|NCT02568852|10029758|FG001|NOT COMPLETED|Overall Study||0
8966119|NCT02569086|10029764|FG000|STARTED|Overall Study||22
8966120|NCT02569086|10029764|FG000|COMPLETED|Overall Study||22
8966121|NCT02569086|10029764|FG000|NOT COMPLETED|Overall Study||0
8966122|NCT02569112|10029768|FG000|STARTED|Overall Study||10
8966123|NCT02569112|10029769|FG001|STARTED|Overall Study||10
8966124|NCT02569112|10029768|FG000|COMPLETED|Overall Study||10
8966125|NCT02569112|10029769|FG001|COMPLETED|Overall Study|Each subject received multipolar RF with varipulse technology to only one side of their body.|10
8966126|NCT02569112|10029768|FG000|NOT COMPLETED|Overall Study||0
8966127|NCT02569112|10029769|FG001|NOT COMPLETED|Overall Study||0
8966128|NCT02569398|10029777|FG000|STARTED|Overall Study||185
8966129|NCT02569398|10029778|FG001|STARTED|Overall Study||189
8966130|NCT02569398|10029779|FG002|STARTED|Overall Study||183
8966131|NCT02569398|10029777|FG000|COMPLETED|Overall Study||0
8966132|NCT02569398|10029778|FG001|COMPLETED|Overall Study||0
8966133|NCT02569398|10029779|FG002|COMPLETED|Overall Study||0
8966134|NCT02569398|10029777|FG000|NOT COMPLETED|Overall Study||185
8966135|NCT02569398|10029778|FG001|NOT COMPLETED|Overall Study||189
8966136|NCT02569398|10029779|FG002|NOT COMPLETED|Overall Study||183
8966137|NCT02569411|10029789|FG000|STARTED|Overall Study||65
8966138|NCT02569411|10029790|FG001|STARTED|Overall Study||64
8966139|NCT02569411|10029789|FG000|COMPLETED|Overall Study||0
8966140|NCT02569411|10029790|FG001|COMPLETED|Overall Study||0
8966141|NCT02569411|10029789|FG000|NOT COMPLETED|Overall Study||65
8966142|NCT02569411|10029790|FG001|NOT COMPLETED|Overall Study||64
8966143|NCT02569437|10029798|FG000|STARTED|Overall Study||24
8966144|NCT02569437|10029799|FG001|STARTED|Overall Study||25
8966145|NCT02569437|10029798|FG000|COMPLETED|Overall Study||12
8966146|NCT02569437|10029799|FG001|COMPLETED|Overall Study||11
8966147|NCT02569437|10029798|FG000|NOT COMPLETED|Overall Study||12
8966148|NCT02569437|10029799|FG001|NOT COMPLETED|Overall Study||14
8966149|NCT02569541|10029805|FG000|STARTED|Overall Study||30
8966150|NCT02569541|10029805|FG000|COMPLETED|Overall Study||9
8966151|NCT02569541|10029805|FG000|NOT COMPLETED|Overall Study||21
8966152|NCT02569632|10029809|FG000|STARTED|Overall Study||18
8570701|NCT00105157|9602884|FG001|NOT COMPLETED|Double-Blind (DB)||14
8570702|NCT00105157|9602885|FG002|NOT COMPLETED|Double-Blind (DB)||12
8876520|NCT01917136|9933331|FG000|NOT COMPLETED|Overall Study||0
8966153|NCT02569632|10029809|FG000|COMPLETED|Overall Study||17
8966154|NCT02569632|10029809|FG000|NOT COMPLETED|Overall Study||1
8966155|NCT02569658|10029815|FG000|STARTED|Overall Study||53
8966156|NCT02569658|10029816|FG001|STARTED|Overall Study||57
8966157|NCT02569658|10029815|FG000|COMPLETED|Overall Study||52
8966158|NCT02569658|10029816|FG001|COMPLETED|Overall Study||56
8966159|NCT02569658|10029815|FG000|NOT COMPLETED|Overall Study||1
8966160|NCT02569658|10029816|FG001|NOT COMPLETED|Overall Study||1
8966161|NCT02569710|10029832|FG000|STARTED|Overall Study||20
8966162|NCT02569710|10029833|FG001|STARTED|Overall Study||25
8966163|NCT02569710|10029834|FG002|STARTED|Overall Study||20
8966164|NCT02569710|10029835|FG003|STARTED|Overall Study||20
8966165|NCT02569710|10029836|FG004|STARTED|Overall Study||8
8966166|NCT02569710|10029837|FG005|STARTED|Overall Study||5
8966167|NCT02569710|10029838|FG006|STARTED|Overall Study||14
8966168|NCT02569710|10029839|FG007|STARTED|Overall Study||30
8966169|NCT02569710|10029840|FG008|STARTED|Overall Study||15
8966170|NCT02569710|10029841|FG009|STARTED|Overall Study||4
8966171|NCT02569710|10029832|FG000|COMPLETED|Overall Study||19
8966172|NCT02569710|10029833|FG001|COMPLETED|Overall Study||25
8966173|NCT02569710|10029834|FG002|COMPLETED|Overall Study||20
8966174|NCT02569710|10029835|FG003|COMPLETED|Overall Study||20
8876521|NCT01917188|9933338|FG000|STARTED|Overall Study||29
8876522|NCT01917188|9933339|FG001|STARTED|Overall Study||23
8876523|NCT01917188|9933340|FG002|STARTED|Overall Study||20
8876524|NCT01917188|9933338|FG000|COMPLETED|Overall Study||17
8876525|NCT01917188|9933339|FG001|COMPLETED|Overall Study||17
8876526|NCT01917188|9933340|FG002|COMPLETED|Overall Study||11
8876527|NCT01917188|9933338|FG000|NOT COMPLETED|Overall Study||12
8876528|NCT01917188|9933339|FG001|NOT COMPLETED|Overall Study||6
8876529|NCT01917188|9933340|FG002|NOT COMPLETED|Overall Study||9
8876530|NCT01917214|9933348|FG000|STARTED|Overall Study||212
8876531|NCT01917214|9933348|FG000|COMPLETED|Overall Study||212
8876532|NCT01917214|9933348|FG000|NOT COMPLETED|Overall Study||0
8876533|NCT01917344|9933353|FG000|STARTED|Overall Study||10
8876534|NCT01917344|9933353|FG000|COMPLETED|Overall Study||9
8876535|NCT01917344|9933353|FG000|NOT COMPLETED|Overall Study||1
8966175|NCT02569710|10029836|FG004|COMPLETED|Overall Study||7
8570703|NCT00105157|9602886|FG003|NOT COMPLETED|Double-Blind (DB)||39
8876536|NCT01917513|9933359|FG000|STARTED|Overall Study||502
8966176|NCT02569710|10029837|FG005|COMPLETED|Overall Study||4
8966177|NCT02569710|10029838|FG006|COMPLETED|Overall Study||12
8966178|NCT02569710|10029839|FG007|COMPLETED|Overall Study||30
8966179|NCT02569710|10029840|FG008|COMPLETED|Overall Study||14
8966180|NCT02569710|10029841|FG009|COMPLETED|Overall Study||4
8966181|NCT02569710|10029832|FG000|NOT COMPLETED|Overall Study||1
8966182|NCT02569710|10029833|FG001|NOT COMPLETED|Overall Study||0
8966183|NCT02569710|10029834|FG002|NOT COMPLETED|Overall Study||0
8966184|NCT02569710|10029835|FG003|NOT COMPLETED|Overall Study||0
8966185|NCT02569710|10029836|FG004|NOT COMPLETED|Overall Study||1
8966186|NCT02569710|10029837|FG005|NOT COMPLETED|Overall Study||1
8966187|NCT02569710|10029838|FG006|NOT COMPLETED|Overall Study||2
8966188|NCT02569710|10029839|FG007|NOT COMPLETED|Overall Study||0
8966189|NCT02569710|10029840|FG008|NOT COMPLETED|Overall Study||1
8631783|NCT00541970|9671674|FG000|STARTED|Month 24||240
8631784|NCT00541970|9671675|FG001|STARTED|Month 24||241
8631785|NCT00541970|9671676|FG002|STARTED|Month 24||240
8631786|NCT00541970|9671677|FG003|STARTED|Month 24||239
8631787|NCT00541970|9671674|FG000|COMPLETED|Month 24||211
8631788|NCT00541970|9671675|FG001|COMPLETED|Month 24||209
8966190|NCT02569710|10029841|FG009|NOT COMPLETED|Overall Study||0
8966191|NCT02569723|10029874|FG000|STARTED|Overall Study||6
8966192|NCT02569723|10029874|FG000|COMPLETED|Overall Study||6
8966193|NCT02569723|10029874|FG000|NOT COMPLETED|Overall Study||0
8966194|NCT02569801|10029880|FG000|STARTED|Overall Study||36
8966195|NCT02569801|10029881|FG001|STARTED|Overall Study||35
8966196|NCT02569801|10029880|FG000|Received Treatment|Overall Study||35
8966197|NCT02569801|10029881|FG001|Received Treatment|Overall Study||35
8966198|NCT02569801|10029880|FG000|COMPLETED|Overall Study||0
8966199|NCT02569801|10029881|FG001|COMPLETED|Overall Study||0
8966200|NCT02569801|10029880|FG000|NOT COMPLETED|Overall Study||36
8966201|NCT02569801|10029881|FG001|NOT COMPLETED|Overall Study||35
8966202|NCT02569853|10029889|FG000|STARTED|Overall Study||131
8966203|NCT02569853|10029890|FG001|STARTED|Overall Study||137
8966204|NCT02569853|10029889|FG000|COMPLETED|Overall Study||111
8966205|NCT02569853|10029890|FG001|COMPLETED|Overall Study||123
8966206|NCT02569853|10029889|FG000|NOT COMPLETED|Overall Study||20
8966207|NCT02569853|10029890|FG001|NOT COMPLETED|Overall Study||14
8966208|NCT02569892|10029898|FG000|STARTED|Overall Study||10
8966209|NCT02569892|10029899|FG001|STARTED|Overall Study||9
8966210|NCT02569892|10029898|FG000|COMPLETED|Overall Study||10
8966211|NCT02569892|10029899|FG001|COMPLETED|Overall Study||8
8966212|NCT02569892|10029898|FG000|NOT COMPLETED|Overall Study||0
8966213|NCT02569892|10029899|FG001|NOT COMPLETED|Overall Study||1
8966214|NCT02569996|10029905|FG000|STARTED|Overall Study||124
8966215|NCT02569996|10029905|FG000|COMPLETED|Overall Study||69
8631789|NCT00541970|9671676|FG002|COMPLETED|Month 24||208
8966216|NCT02569996|10029905|FG000|NOT COMPLETED|Overall Study||55
8966217|NCT02570022|10029911|FG000|STARTED|Overall Study||26
8966218|NCT02570022|10029912|FG001|STARTED|Overall Study||31
8966219|NCT02570022|10029911|FG000|COMPLETED|Overall Study||26
8966220|NCT02570022|10029912|FG001|COMPLETED|Overall Study||31
8966221|NCT02570022|10029911|FG000|NOT COMPLETED|Overall Study||0
8966222|NCT02570022|10029912|FG001|NOT COMPLETED|Overall Study||0
8966223|NCT02570074|10029920|FG000|STARTED|Period 1 (First Dosing Regimen)||9
8966224|NCT02570074|10029921|FG001|STARTED|Period 1 (First Dosing Regimen)||10
8966225|NCT02570074|10029920|FG000|COMPLETED|Period 1 (First Dosing Regimen)||9
8966226|NCT02570074|10029921|FG001|COMPLETED|Period 1 (First Dosing Regimen)||10
8966227|NCT02570074|10029920|FG000|NOT COMPLETED|Period 1 (First Dosing Regimen)||0
8966228|NCT02570074|10029921|FG001|NOT COMPLETED|Period 1 (First Dosing Regimen)||0
8966229|NCT02570074|10029920|FG000|STARTED|Period 2 (Second Dosing Regimen)||9
8966230|NCT02570074|10029921|FG001|STARTED|Period 2 (Second Dosing Regimen)||10
8966231|NCT02570074|10029920|FG000|COMPLETED|Period 2 (Second Dosing Regimen)||8
8966232|NCT02570074|10029921|FG001|COMPLETED|Period 2 (Second Dosing Regimen)||10
8966233|NCT02570074|10029920|FG000|NOT COMPLETED|Period 2 (Second Dosing Regimen)||1
8966234|NCT02570074|10029921|FG001|NOT COMPLETED|Period 2 (Second Dosing Regimen)||0
8966235|NCT02570126|10029941|FG000|STARTED|Overall Study||615
8966236|NCT02570126|10029942|FG001|STARTED|Overall Study||616
8966237|NCT02570126|10029941|FG000|COMPLETED|Overall Study||609
8966238|NCT02570126|10029942|FG001|COMPLETED|Overall Study||607
8966239|NCT02570126|10029941|FG000|NOT COMPLETED|Overall Study||6
8966240|NCT02570126|10029942|FG001|NOT COMPLETED|Overall Study||9
8966241|NCT02570139|10029950|FG000|STARTED|Overall Study|24 subjects were treated w/ Cavilon Advanced Skin Protectant. Study terminated due to low enrollment|24
8966242|NCT02570139|10029951|FG001|STARTED|Overall Study|21 subjects treated with SensiCare Protective Barrier|21
8966243|NCT02570139|10029950|FG000|COMPLETED|Overall Study||24
8966244|NCT02570139|10029951|FG001|COMPLETED|Overall Study||21
8966245|NCT02570139|10029950|FG000|NOT COMPLETED|Overall Study||0
8966246|NCT02570139|10029951|FG001|NOT COMPLETED|Overall Study||0
8966247|NCT02570152|10029957|FG000|STARTED|Overall Study||2004
8966248|NCT02570152|10029957|FG000|COMPLETED|Overall Study||1989
8966249|NCT02570152|10029957|FG000|NOT COMPLETED|Overall Study||15
9037976|NCT03325881|10099247|FG001|Treated|Overall Study||45
9037977|NCT03325881|10099246|FG000|COMPLETED|Overall Study||41
9037978|NCT03325881|10099247|FG001|COMPLETED|Overall Study||42
9037979|NCT03325881|10099246|FG000|NOT COMPLETED|Overall Study||3
9037980|NCT03325881|10099247|FG001|NOT COMPLETED|Overall Study||3
9037981|NCT03325894|10099257|FG000|STARTED|Overall Study||64
9037982|NCT03325894|10099258|FG001|STARTED|Overall Study||77
9037983|NCT03325894|10099257|FG000|COMPLETED|Overall Study||0
9037984|NCT03325894|10099258|FG001|COMPLETED|Overall Study||0
9037985|NCT03325894|10099257|FG000|NOT COMPLETED|Overall Study||64
9037986|NCT03325894|10099258|FG001|NOT COMPLETED|Overall Study||77
9037987|NCT03326323|10099267|FG000|STARTED|Overall Study||43
9037988|NCT03326323|10099267|FG000|COMPLETED|Overall Study||40
9037989|NCT03326323|10099267|FG000|NOT COMPLETED|Overall Study||3
9037990|NCT03326518|10099274|FG000|STARTED|Overall Study||19
9037991|NCT03326518|10099275|FG001|STARTED|Overall Study||12
9037992|NCT03326518|10099276|FG002|STARTED|Overall Study||14
9037993|NCT03326518|10099274|FG000|COMPLETED|Overall Study||16
9037994|NCT03326518|10099275|FG001|COMPLETED|Overall Study||12
9037995|NCT03326518|10099276|FG002|COMPLETED|Overall Study||13
9037996|NCT03326518|10099274|FG000|NOT COMPLETED|Overall Study||3
9037997|NCT03326518|10099275|FG001|NOT COMPLETED|Overall Study||0
9037998|NCT03326518|10099276|FG002|NOT COMPLETED|Overall Study||1
9037999|NCT03326843|10099284|FG000|STARTED|Overall Study||4
9038000|NCT03326843|10099284|FG000|COMPLETED|Overall Study||4
9038001|NCT03326843|10099284|FG000|NOT COMPLETED|Overall Study||0
9038002|NCT03326895|10099288|FG000|STARTED|Overall Study||168
9038003|NCT03326895|10099288|FG000|COMPLETED|Overall Study||168
9038004|NCT03326895|10099288|FG000|NOT COMPLETED|Overall Study||0
9038005|NCT03326986|10099295|FG000|STARTED|Overall Study||8
9038006|NCT03326986|10099296|FG001|STARTED|Overall Study||8
9038007|NCT03326986|10099297|FG002|STARTED|Overall Study||8
9038008|NCT03326986|10099295|FG000|COMPLETED|Overall Study||8
9038009|NCT03326986|10099296|FG001|COMPLETED|Overall Study||8
9038010|NCT03326986|10099297|FG002|COMPLETED|Overall Study||8
9038011|NCT03326986|10099295|FG000|NOT COMPLETED|Overall Study||0
9038012|NCT03326986|10099296|FG001|NOT COMPLETED|Overall Study||0
9038013|NCT03326986|10099297|FG002|NOT COMPLETED|Overall Study||0
9038014|NCT03326999|10099340|FG000|STARTED|Overall Study||30
9038015|NCT03326999|10099341|FG001|STARTED|Overall Study||30
9038016|NCT03326999|10099340|FG000|COMPLETED|Overall Study||30
9038017|NCT03326999|10099341|FG001|COMPLETED|Overall Study||30
8631790|NCT00541970|9671677|FG003|COMPLETED|Month 24||217
8631791|NCT00541970|9671674|FG000|NOT COMPLETED|Month 24||29
8631792|NCT00541970|9671675|FG001|NOT COMPLETED|Month 24||32
9038018|NCT03326999|10099340|FG000|NOT COMPLETED|Overall Study||0
9038019|NCT03326999|10099341|FG001|NOT COMPLETED|Overall Study||0
9038020|NCT03327051|10099349|FG000|STARTED|Overall Study||19
9038021|NCT03327051|10099350|FG001|STARTED|Overall Study||20
9038022|NCT03327051|10099349|FG000|Received Treatment|Overall Study||16
9038023|NCT03327051|10099350|FG001|Received Treatment|Overall Study||16
9038024|NCT03327051|10099349|FG000|Attended Visit 2 (Week 0)|Overall Study||15
9038025|NCT03327051|10099350|FG001|Attended Visit 2 (Week 0)|Overall Study||15
9038026|NCT03327051|10099349|FG000|COMPLETED|Overall Study||14
9038027|NCT03327051|10099350|FG001|COMPLETED|Overall Study||15
9038028|NCT03327051|10099349|FG000|NOT COMPLETED|Overall Study||5
9038029|NCT03327051|10099350|FG001|NOT COMPLETED|Overall Study||5
8966250|NCT02570165|10029968|FG000|STARTED|Overall Study||46
8966251|NCT02570165|10029969|FG001|STARTED|Overall Study||46
8966252|NCT02570165|10029970|FG002|STARTED|Overall Study||46
8966253|NCT02570165|10029971|FG003|STARTED|Overall Study||45
8966254|NCT02570165|10029972|FG004|STARTED|Overall Study||47
8966255|NCT02570165|10029973|FG005|STARTED|Overall Study||46
8966256|NCT02570165|10029974|FG006|STARTED|Overall Study||47
8966257|NCT02570165|10029968|FG000|COMPLETED|Overall Study||44
8966258|NCT02570165|10029969|FG001|COMPLETED|Overall Study||43
8966259|NCT02570165|10029970|FG002|COMPLETED|Overall Study||41
8966260|NCT02570165|10029971|FG003|COMPLETED|Overall Study||40
8966261|NCT02570165|10029972|FG004|COMPLETED|Overall Study||41
8966262|NCT02570165|10029973|FG005|COMPLETED|Overall Study||44
8966263|NCT02570165|10029974|FG006|COMPLETED|Overall Study||47
8966264|NCT02570165|10029968|FG000|NOT COMPLETED|Overall Study||2
8966265|NCT02570165|10029969|FG001|NOT COMPLETED|Overall Study||3
8966266|NCT02570165|10029970|FG002|NOT COMPLETED|Overall Study||5
8966267|NCT02570165|10029971|FG003|NOT COMPLETED|Overall Study||5
8966268|NCT02570165|10029972|FG004|NOT COMPLETED|Overall Study||6
8966269|NCT02570165|10029973|FG005|NOT COMPLETED|Overall Study||2
8966270|NCT02570165|10029974|FG006|NOT COMPLETED|Overall Study||0
8966271|NCT02570295|10029992|FG000|STARTED|Overall Study||375
8966272|NCT02570295|10029993|FG001|STARTED|Overall Study||347
8966273|NCT02570295|10029992|FG000|COMPLETED|Overall Study||364
8966274|NCT02570295|10029993|FG001|COMPLETED|Overall Study||289
8966275|NCT02570295|10029992|FG000|NOT COMPLETED|Overall Study||11
8966276|NCT02570295|10029993|FG001|NOT COMPLETED|Overall Study||58
8966277|NCT02570425|10030001|FG000|STARTED|Visit 1||274
8966278|NCT02570425|10030002|FG001|STARTED|Visit 1||242
8966279|NCT02570425|10030001|FG000|COMPLETED|Visit 1||274
8966280|NCT02570425|10030002|FG001|COMPLETED|Visit 1||242
8966281|NCT02570425|10030001|FG000|NOT COMPLETED|Visit 1||0
8966282|NCT02570425|10030002|FG001|NOT COMPLETED|Visit 1||0
8966283|NCT02570425|10030001|FG000|STARTED|Visit 2|In total 18 patients who completed Visit 1, did not attend Visit 2.|251
8966284|NCT02570425|10030002|FG001|STARTED|Visit 2|In total 18 patients who completed Visit 1, did not attend Visit 2.|247
8966285|NCT02570425|10030001|FG000|COMPLETED|Visit 2||251
8966286|NCT02570425|10030002|FG001|COMPLETED|Visit 2||247
8966287|NCT02570425|10030001|FG000|NOT COMPLETED|Visit 2||0
8966288|NCT02570425|10030002|FG001|NOT COMPLETED|Visit 2||0
8966289|NCT02570425|10030001|FG000|STARTED|Visit 3|In total 38 patients who completed Visit 2, did not attend Visit 3.|229
8966290|NCT02570425|10030002|FG001|STARTED|Visit 3|In total 38 patients who completed Visit 2, did not attend Visit 3.|231
8966291|NCT02570425|10030001|FG000|COMPLETED|Visit 3||229
8966292|NCT02570425|10030002|FG001|COMPLETED|Visit 3||231
8966293|NCT02570425|10030001|FG000|NOT COMPLETED|Visit 3||0
8966294|NCT02570425|10030002|FG001|NOT COMPLETED|Visit 3||0
8966295|NCT02570711|10030013|FG000|STARTED|Overall Study||1
8966296|NCT02570711|10030014|FG001|STARTED|Overall Study||2
8966297|NCT02570711|10030013|FG000|COMPLETED|Overall Study||0
8966298|NCT02570711|10030014|FG001|COMPLETED|Overall Study||0
8966299|NCT02570711|10030013|FG000|NOT COMPLETED|Overall Study||1
8966300|NCT02570711|10030014|FG001|NOT COMPLETED|Overall Study||2
8966301|NCT02570750|10030022|FG000|STARTED|Overall Study||110
8966302|NCT02570750|10030023|FG001|STARTED|Overall Study||73
8966303|NCT02570750|10030022|FG000|COMPLETED|Overall Study||96
8966304|NCT02570750|10030023|FG001|COMPLETED|Overall Study||68
8966305|NCT02570750|10030022|FG000|NOT COMPLETED|Overall Study||14
8966306|NCT02570750|10030023|FG001|NOT COMPLETED|Overall Study||5
8966307|NCT02571049|10030029|FG000|STARTED|Screening||10
8966308|NCT02571049|10030030|FG001|STARTED|Screening||14
8966309|NCT02571049|10030029|FG000|COMPLETED|Screening||8
8966310|NCT02571049|10030030|FG001|COMPLETED|Screening||12
8966311|NCT02571049|10030029|FG000|NOT COMPLETED|Screening||2
8966312|NCT02571049|10030030|FG001|NOT COMPLETED|Screening||2
8966313|NCT02571049|10030029|FG000|STARTED|Randomization||8
8966314|NCT02571049|10030030|FG001|STARTED|Randomization||12
8966315|NCT02571049|10030029|FG000|COMPLETED|Randomization||8
8966316|NCT02571049|10030030|FG001|COMPLETED|Randomization||10
8966317|NCT02571049|10030029|FG000|NOT COMPLETED|Randomization||0
8966318|NCT02571049|10030030|FG001|NOT COMPLETED|Randomization||2
8966319|NCT02571075|10030038|FG000|STARTED|Overall Study||45
8966320|NCT02571075|10030039|FG001|STARTED|Overall Study||50
8966321|NCT02571075|10030038|FG000|COMPLETED|Overall Study||25
8966322|NCT02571075|10030039|FG001|COMPLETED|Overall Study||26
8966323|NCT02571075|10030038|FG000|NOT COMPLETED|Overall Study||20
8966324|NCT02571075|10030039|FG001|NOT COMPLETED|Overall Study||24
8966325|NCT02571153|10030048|FG000|STARTED|Overall Study||45
8966326|NCT02571153|10030049|FG001|STARTED|Overall Study||45
8966327|NCT02571153|10030050|FG002|STARTED|Overall Study||45
8966328|NCT02571153|10030048|FG000|COMPLETED|Overall Study||39
8966329|NCT02571153|10030049|FG001|COMPLETED|Overall Study||37
8966330|NCT02571153|10030050|FG002|COMPLETED|Overall Study||43
8966331|NCT02571153|10030048|FG000|NOT COMPLETED|Overall Study||6
8966332|NCT02571153|10030049|FG001|NOT COMPLETED|Overall Study||8
8966333|NCT02571153|10030050|FG002|NOT COMPLETED|Overall Study||2
8966334|NCT02571218|10030060|FG000|STARTED|Overall Study||40
8966335|NCT02571218|10030061|FG001|STARTED|Overall Study||41
8966336|NCT02571218|10030060|FG000|COMPLETED|Overall Study||40
8966337|NCT02571218|10030061|FG001|COMPLETED|Overall Study||41
8966338|NCT02571218|10030060|FG000|NOT COMPLETED|Overall Study||0
8966339|NCT02571218|10030061|FG001|NOT COMPLETED|Overall Study||0
8966340|NCT02571244|10030069|FG000|STARTED|Overall Study||44
8966341|NCT02571244|10030070|FG001|STARTED|Overall Study||22
8966342|NCT02571244|10030069|FG000|COMPLETED|Overall Study||41
8966343|NCT02571244|10030070|FG001|COMPLETED|Overall Study||21
8966344|NCT02571244|10030069|FG000|NOT COMPLETED|Overall Study||3
8966345|NCT02571244|10030070|FG001|NOT COMPLETED|Overall Study||1
8966346|NCT02571439|10030081|FG000|STARTED|Overall Study||20
8966347|NCT02571439|10030082|FG001|STARTED|Overall Study||21
8966348|NCT02571439|10030081|FG000|COMPLETED|Overall Study||20
8966349|NCT02571439|10030082|FG001|COMPLETED|Overall Study||21
8966350|NCT02571439|10030081|FG000|NOT COMPLETED|Overall Study||0
8966351|NCT02571439|10030082|FG001|NOT COMPLETED|Overall Study||0
8966352|NCT02571452|10030090|FG000|STARTED|Overall Study Treatment||47
8966353|NCT02571452|10030091|FG001|STARTED|Overall Study Treatment||46
8966354|NCT02571452|10030090|FG000|COMPLETED|Overall Study Treatment||47
8966355|NCT02571452|10030091|FG001|COMPLETED|Overall Study Treatment||45
8966356|NCT02571452|10030090|FG000|NOT COMPLETED|Overall Study Treatment||0
8966357|NCT02571452|10030091|FG001|NOT COMPLETED|Overall Study Treatment||1
8966358|NCT02571452|10030090|FG000|STARTED|Overall Study 6-Month Follow-up||47
8966359|NCT02571452|10030091|FG001|STARTED|Overall Study 6-Month Follow-up|Participants in the PMRT arm were not invited to complete 6-Month Follow-up.|0
8966360|NCT02571452|10030090|FG000|COMPLETED|Overall Study 6-Month Follow-up||42
8966361|NCT02571452|10030091|FG001|COMPLETED|Overall Study 6-Month Follow-up||0
8966362|NCT02571452|10030090|FG000|NOT COMPLETED|Overall Study 6-Month Follow-up||5
8966363|NCT02571452|10030091|FG001|NOT COMPLETED|Overall Study 6-Month Follow-up||0
8966364|NCT02571634|10030097|FG000|STARTED|Overall Study|First subject wasn't enrolled until July related to receipt of medications from sponsor.|23
8966365|NCT02571634|10030097|FG000|COMPLETED|Overall Study|The final subject was enrolled on this date.|23
8966366|NCT02571634|10030097|FG000|NOT COMPLETED|Overall Study||0
8966367|NCT02571777|10030107|FG000|STARTED|Overall Study||619
8966368|NCT02571777|10030108|FG001|STARTED|Overall Study||620
8966369|NCT02571777|10030109|FG002|STARTED|Overall Study||618
8966370|NCT02571777|10030110|FG003|STARTED|Overall Study||617
8966371|NCT02571777|10030111|FG004|STARTED|Overall Study||618
8966372|NCT02571777|10030107|FG000|Full Analysis Set (FAS)|Overall Study||615
8966373|NCT02571777|10030108|FG001|Full Analysis Set (FAS)|Overall Study||616
8966374|NCT02571777|10030109|FG002|Full Analysis Set (FAS)|Overall Study||611
8966375|NCT02571777|10030110|FG003|Full Analysis Set (FAS)|Overall Study||607
8966376|NCT02571777|10030111|FG004|Full Analysis Set (FAS)|Overall Study||612
8966377|NCT02571777|10030107|FG000|Safety Set (SAF)|Overall Study||616
8966378|NCT02571777|10030108|FG001|Safety Set (SAF)|Overall Study||617
8966379|NCT02571777|10030109|FG002|Safety Set (SAF)|Overall Study||613
8966380|NCT02571777|10030110|FG003|Safety Set (SAF)|Overall Study||608
8966381|NCT02571777|10030111|FG004|Safety Set (SAF)|Overall Study||618
8966382|NCT02571777|10030107|FG000|COMPLETED|Overall Study||580
8966383|NCT02571777|10030108|FG001|COMPLETED|Overall Study||582
8966384|NCT02571777|10030109|FG002|COMPLETED|Overall Study||577
8966385|NCT02571777|10030110|FG003|COMPLETED|Overall Study||580
8966386|NCT02571777|10030111|FG004|COMPLETED|Overall Study||582
8966387|NCT02571777|10030107|FG000|NOT COMPLETED|Overall Study||39
8966388|NCT02571777|10030108|FG001|NOT COMPLETED|Overall Study||38
8966389|NCT02571777|10030109|FG002|NOT COMPLETED|Overall Study||41
8966390|NCT02571777|10030110|FG003|NOT COMPLETED|Overall Study||37
8966391|NCT02571777|10030111|FG004|NOT COMPLETED|Overall Study||36
8966392|NCT02571972|10030123|FG000|STARTED|Overall Study|2 patients signed consent but withdrew from the study prior to using dorzolamide-timolol drops.|14
8966393|NCT02571972|10030123|FG000|COMPLETED|Overall Study||10
8966394|NCT02571972|10030123|FG000|NOT COMPLETED|Overall Study||4
8966395|NCT02572076|10030127|FG000|STARTED|Overall Study||10
8966396|NCT02572076|10030127|FG000|COMPLETED|Overall Study||9
8966397|NCT02572076|10030127|FG000|NOT COMPLETED|Overall Study||1
8966398|NCT02572167|10030134|FG000|STARTED|Overall Study||6
8966399|NCT02572167|10030135|FG001|STARTED|Overall Study||56
8966400|NCT02572167|10030136|FG002|STARTED|Overall Study||31
8966401|NCT02572167|10030134|FG000|COMPLETED|Overall Study||0
8966402|NCT02572167|10030135|FG001|COMPLETED|Overall Study||0
8966403|NCT02572167|10030136|FG002|COMPLETED|Overall Study||0
8966404|NCT02572167|10030134|FG000|NOT COMPLETED|Overall Study||6
8966405|NCT02572167|10030135|FG001|NOT COMPLETED|Overall Study||56
8966406|NCT02572167|10030136|FG002|NOT COMPLETED|Overall Study||31
8966407|NCT02572388|10030148|FG000|STARTED|Overall Study||11
8966408|NCT02572388|10030149|FG001|STARTED|Overall Study||4
8966409|NCT02572388|10030150|FG002|STARTED|Overall Study||10
8966410|NCT02572388|10030151|FG003|STARTED|Overall Study||6
8966411|NCT02572388|10030148|FG000|COMPLETED|Overall Study||10
8966412|NCT02572388|10030149|FG001|COMPLETED|Overall Study||3
8966413|NCT02572388|10030150|FG002|COMPLETED|Overall Study||8
8631793|NCT00541970|9671676|FG002|NOT COMPLETED|Month 24||32
8631794|NCT00541970|9671677|FG003|NOT COMPLETED|Month 24||22
8966414|NCT02572388|10030151|FG003|COMPLETED|Overall Study||4
8966415|NCT02572388|10030148|FG000|NOT COMPLETED|Overall Study||1
8631795|NCT00541970|9671674|FG000|STARTED|Month 36||240
8966416|NCT02572388|10030149|FG001|NOT COMPLETED|Overall Study||1
8966417|NCT02572388|10030150|FG002|NOT COMPLETED|Overall Study||2
8966418|NCT02572388|10030151|FG003|NOT COMPLETED|Overall Study||2
8966419|NCT02572401|10030165|FG000|STARTED|Overall Study||97
8966420|NCT02572401|10030166|FG001|STARTED|Overall Study||98
8966421|NCT02572401|10030167|FG002|STARTED|Overall Study||98
8966422|NCT02572401|10030168|FG003|STARTED|Overall Study||98
8966423|NCT02572401|10030165|FG000|COMPLETED|Overall Study||92
8966424|NCT02572401|10030166|FG001|COMPLETED|Overall Study||90
8966425|NCT02572401|10030167|FG002|COMPLETED|Overall Study||89
8966426|NCT02572401|10030168|FG003|COMPLETED|Overall Study||88
8966427|NCT02572401|10030165|FG000|NOT COMPLETED|Overall Study||5
8966428|NCT02572401|10030166|FG001|NOT COMPLETED|Overall Study||8
8966429|NCT02572401|10030167|FG002|NOT COMPLETED|Overall Study||9
8966430|NCT02572401|10030168|FG003|NOT COMPLETED|Overall Study||10
8966431|NCT02572427|10030180|FG000|STARTED|Overall Study||37
8966432|NCT02572427|10030181|FG001|STARTED|Overall Study||45
8966433|NCT02572427|10030180|FG000|COMPLETED|Overall Study||31
8966434|NCT02572427|10030181|FG001|COMPLETED|Overall Study||36
8966435|NCT02572427|10030180|FG000|NOT COMPLETED|Overall Study||6
8966436|NCT02572427|10030181|FG001|NOT COMPLETED|Overall Study||9
8966437|NCT02572570|10030187|FG000|STARTED|Overall Study||27
8966438|NCT02572570|10030187|FG000|Filtek Bulk Fill Posterior|Overall Study||27
8966439|NCT02572570|10030187|FG000|Filtek Supreme Ultra|Overall Study||27
8966440|NCT02572570|10030187|FG000|1 Year Follow-Up|Overall Study||20
8966441|NCT02572570|10030187|FG000|2 Year Follow-Up|Overall Study||13
8966442|NCT02572570|10030187|FG000|3 Year Follow-Up|Overall Study||5
8966443|NCT02572570|10030187|FG000|5 Year Follow-Up|Overall Study||0
8966444|NCT02572570|10030187|FG000|COMPLETED|Overall Study||0
8631796|NCT00541970|9671675|FG001|STARTED|Month 36||241
8631797|NCT00541970|9671676|FG002|STARTED|Month 36||240
8631798|NCT00541970|9671677|FG003|STARTED|Month 36||239
8631799|NCT00541970|9671674|FG000|COMPLETED|Month 36||179
8966445|NCT02572570|10030187|FG000|NOT COMPLETED|Overall Study||27
8966446|NCT02572609|10030196|FG000|STARTED|Period 1: Treatment Period 1 + Washout||18
8966447|NCT02572609|10030197|FG001|STARTED|Period 1: Treatment Period 1 + Washout||18
8966448|NCT02572609|10030196|FG000|COMPLETED|Period 1: Treatment Period 1 + Washout||18
8966449|NCT02572609|10030197|FG001|COMPLETED|Period 1: Treatment Period 1 + Washout||18
8631800|NCT00541970|9671675|FG001|COMPLETED|Month 36||175
8631801|NCT00541970|9671676|FG002|COMPLETED|Month 36||174
8966450|NCT02572609|10030196|FG000|NOT COMPLETED|Period 1: Treatment Period 1 + Washout||0
8631802|NCT00541970|9671677|FG003|COMPLETED|Month 36||179
8966451|NCT02572609|10030197|FG001|NOT COMPLETED|Period 1: Treatment Period 1 + Washout||0
8966452|NCT02572609|10030196|FG000|STARTED|Period 2: Treatment Period 2||18
8966453|NCT02572609|10030197|FG001|STARTED|Period 2: Treatment Period 2||18
8966454|NCT02572609|10030196|FG000|COMPLETED|Period 2: Treatment Period 2||18
8966455|NCT02572609|10030197|FG001|COMPLETED|Period 2: Treatment Period 2||18
8966456|NCT02572609|10030196|FG000|NOT COMPLETED|Period 2: Treatment Period 2||0
8966457|NCT02572609|10030197|FG001|NOT COMPLETED|Period 2: Treatment Period 2||0
8966458|NCT02572752|10030206|FG000|STARTED|Period 1 Including Washout||23
8966459|NCT02572752|10030207|FG001|STARTED|Period 1 Including Washout||23
8966460|NCT02572752|10030208|FG002|STARTED|Period 1 Including Washout||24
8966461|NCT02572752|10030206|FG000|COMPLETED|Period 1 Including Washout||23
8966462|NCT02572752|10030207|FG001|COMPLETED|Period 1 Including Washout||23
8966463|NCT02572752|10030208|FG002|COMPLETED|Period 1 Including Washout||24
8966464|NCT02572752|10030206|FG000|NOT COMPLETED|Period 1 Including Washout||0
8966465|NCT02572752|10030207|FG001|NOT COMPLETED|Period 1 Including Washout||0
8966466|NCT02572752|10030208|FG002|NOT COMPLETED|Period 1 Including Washout||0
8966467|NCT02572752|10030206|FG000|STARTED|Period 2 Including Washout||23
8966468|NCT02572752|10030207|FG001|STARTED|Period 2 Including Washout||23
8966469|NCT02572752|10030208|FG002|STARTED|Period 2 Including Washout||24
8966470|NCT02572752|10030206|FG000|COMPLETED|Period 2 Including Washout||23
8966471|NCT02572752|10030207|FG001|COMPLETED|Period 2 Including Washout||23
8966472|NCT02572752|10030208|FG002|COMPLETED|Period 2 Including Washout||24
8966473|NCT02572752|10030206|FG000|NOT COMPLETED|Period 2 Including Washout||0
8966474|NCT02572752|10030207|FG001|NOT COMPLETED|Period 2 Including Washout||0
8966475|NCT02572752|10030208|FG002|NOT COMPLETED|Period 2 Including Washout||0
8966476|NCT02572752|10030206|FG000|STARTED|Period 3 Including Washout||23
8966477|NCT02572752|10030207|FG001|STARTED|Period 3 Including Washout||23
8631803|NCT00541970|9671674|FG000|NOT COMPLETED|Month 36||61
8631804|NCT00541970|9671675|FG001|NOT COMPLETED|Month 36||66
8631805|NCT00541970|9671676|FG002|NOT COMPLETED|Month 36||66
8631806|NCT00541970|9671677|FG003|NOT COMPLETED|Month 36||60
8631807|NCT00541970|9671674|FG000|STARTED|Month 48||240
8876537|NCT01917513|9933360|FG001|STARTED|Overall Study||498
8876538|NCT01917513|9933359|FG000|COMPLETED|Overall Study||407
8876539|NCT01917513|9933360|FG001|COMPLETED|Overall Study||396
8966478|NCT02572752|10030208|FG002|STARTED|Period 3 Including Washout||24
8966479|NCT02572752|10030206|FG000|COMPLETED|Period 3 Including Washout||23
8966480|NCT02572752|10030207|FG001|COMPLETED|Period 3 Including Washout||23
8966481|NCT02572752|10030208|FG002|COMPLETED|Period 3 Including Washout||24
8966482|NCT02572752|10030206|FG000|NOT COMPLETED|Period 3 Including Washout||0
8966483|NCT02572752|10030207|FG001|NOT COMPLETED|Period 3 Including Washout||0
8966484|NCT02572752|10030208|FG002|NOT COMPLETED|Period 3 Including Washout||0
8966485|NCT02572817|10030217|FG000|STARTED|Overall Study||91
8966486|NCT02572817|10030218|FG001|STARTED|Overall Study||47
8966487|NCT02572817|10030217|FG000|COMPLETED|Overall Study||82
8966488|NCT02572817|10030218|FG001|COMPLETED|Overall Study||41
8966489|NCT02572817|10030217|FG000|NOT COMPLETED|Overall Study||9
8966490|NCT02572817|10030218|FG001|NOT COMPLETED|Overall Study||6
8966491|NCT02573012|10030226|FG000|STARTED|Overall Study||131
8966492|NCT02573012|10030227|FG001|STARTED|Overall Study||128
8966493|NCT02573012|10030226|FG000|COMPLETED|Overall Study||116
8966494|NCT02573012|10030227|FG001|COMPLETED|Overall Study||113
8966495|NCT02573012|10030226|FG000|NOT COMPLETED|Overall Study||15
8966496|NCT02573012|10030227|FG001|NOT COMPLETED|Overall Study||15
8966497|NCT02573155|10030235|FG000|STARTED|Treatment Period 1||16
8966498|NCT02573155|10030236|FG001|STARTED|Treatment Period 1||38
8966499|NCT02573155|10030235|FG000|COMPLETED|Treatment Period 1||16
8966500|NCT02573155|10030236|FG001|COMPLETED|Treatment Period 1||38
8966501|NCT02573155|10030235|FG000|NOT COMPLETED|Treatment Period 1||0
8966502|NCT02573155|10030236|FG001|NOT COMPLETED|Treatment Period 1||0
8966503|NCT02573155|10030235|FG000|STARTED|Washout Between Treatment Period 1 and 2||16
8966504|NCT02573155|10030236|FG001|STARTED|Washout Between Treatment Period 1 and 2||38
8966505|NCT02573155|10030235|FG000|COMPLETED|Washout Between Treatment Period 1 and 2||16
8966506|NCT02573155|10030236|FG001|COMPLETED|Washout Between Treatment Period 1 and 2||33
8966507|NCT02573155|10030235|FG000|NOT COMPLETED|Washout Between Treatment Period 1 and 2||0
8631808|NCT00541970|9671675|FG001|STARTED|Month 48||241
8876540|NCT01917513|9933359|FG000|NOT COMPLETED|Overall Study||95
8876541|NCT01917513|9933360|FG001|NOT COMPLETED|Overall Study||102
8876542|NCT01917526|9933368|FG000|STARTED|Overall Study||250
8876543|NCT01917526|9933369|FG001|STARTED|Overall Study||250
8876544|NCT01917526|9933368|FG000|COMPLETED|Overall Study|One patient in oxygen mask received oxygen cannula|249
8876545|NCT01917526|9933369|FG001|COMPLETED|Overall Study|1 patient in oxygen cannula group receive oxygen mask|249
8876546|NCT01917526|9933368|FG000|NOT COMPLETED|Overall Study||1
8876547|NCT01917526|9933369|FG001|NOT COMPLETED|Overall Study||1
8876548|NCT01917656|9933377|FG000|STARTED|Overall Study||172
8876549|NCT01917656|9933378|FG001|STARTED|Overall Study||171
8876550|NCT01917656|9933377|FG000|Exposed|Overall Study|1 subject was withdrawn prior to exposure to trial products|171
8966508|NCT02573155|10030236|FG001|NOT COMPLETED|Washout Between Treatment Period 1 and 2||5
8966509|NCT02573155|10030235|FG000|STARTED|Period 2||16
8966510|NCT02573155|10030236|FG001|STARTED|Period 2||33
8631809|NCT00541970|9671676|FG002|STARTED|Month 48||240
8631810|NCT00541970|9671677|FG003|STARTED|Month 48||239
8631811|NCT00541970|9671674|FG000|COMPLETED|Month 48||169
8631812|NCT00541970|9671675|FG001|COMPLETED|Month 48||168
8966511|NCT02573155|10030235|FG000|COMPLETED|Period 2||16
8966512|NCT02573155|10030236|FG001|COMPLETED|Period 2||33
8966513|NCT02573155|10030235|FG000|NOT COMPLETED|Period 2||0
8966514|NCT02573155|10030236|FG001|NOT COMPLETED|Period 2||0
8966515|NCT02573155|10030235|FG000|STARTED|Washout Between Treatment Period 2 and 3||16
8966516|NCT02573155|10030236|FG001|STARTED|Washout Between Treatment Period 2 and 3||33
8966517|NCT02573155|10030235|FG000|COMPLETED|Washout Between Treatment Period 2 and 3||15
8966518|NCT02573155|10030236|FG001|COMPLETED|Washout Between Treatment Period 2 and 3||31
8966519|NCT02573155|10030235|FG000|NOT COMPLETED|Washout Between Treatment Period 2 and 3||1
8966520|NCT02573155|10030236|FG001|NOT COMPLETED|Washout Between Treatment Period 2 and 3||2
8966521|NCT02573155|10030235|FG000|STARTED|Period 3||15
8966522|NCT02573155|10030236|FG001|STARTED|Period 3||31
8966523|NCT02573155|10030235|FG000|COMPLETED|Period 3||15
8966524|NCT02573155|10030236|FG001|COMPLETED|Period 3||31
8966525|NCT02573155|10030235|FG000|NOT COMPLETED|Period 3||0
8966526|NCT02573155|10030236|FG001|NOT COMPLETED|Period 3||0
8966527|NCT02573155|10030235|FG000|STARTED|Washout Between Treatment Period 3 and 4|Part 1 comprised 3 treatment periods only|0
8966528|NCT02573155|10030236|FG001|STARTED|Washout Between Treatment Period 3 and 4||31
8966529|NCT02573155|10030235|FG000|COMPLETED|Washout Between Treatment Period 3 and 4|Part 1 comprised 3 treatment periods only|0
8966530|NCT02573155|10030236|FG001|COMPLETED|Washout Between Treatment Period 3 and 4||29
8966531|NCT02573155|10030235|FG000|NOT COMPLETED|Washout Between Treatment Period 3 and 4||0
8966532|NCT02573155|10030236|FG001|NOT COMPLETED|Washout Between Treatment Period 3 and 4||2
8966533|NCT02573155|10030235|FG000|STARTED|Period 4|Part 1 comprised 3 treatment periods only|0
8966534|NCT02573155|10030236|FG001|STARTED|Period 4||29
8966535|NCT02573155|10030235|FG000|COMPLETED|Period 4|Part 1 comprised 3 treatment periods only|0
8966536|NCT02573155|10030236|FG001|COMPLETED|Period 4||29
8966537|NCT02573155|10030235|FG000|NOT COMPLETED|Period 4||0
8966538|NCT02573155|10030236|FG001|NOT COMPLETED|Period 4||0
8966539|NCT02573155|10030235|FG000|STARTED|Washout Between Treatment Period 4 and 5|Part 1 comprised 3 treatment periods only|0
8966540|NCT02573155|10030236|FG001|STARTED|Washout Between Treatment Period 4 and 5||29
8966541|NCT02573155|10030235|FG000|COMPLETED|Washout Between Treatment Period 4 and 5|Part 1 comprised 3 treatment periods only|0
8966542|NCT02573155|10030236|FG001|COMPLETED|Washout Between Treatment Period 4 and 5||28
8966543|NCT02573155|10030235|FG000|NOT COMPLETED|Washout Between Treatment Period 4 and 5||0
8966544|NCT02573155|10030236|FG001|NOT COMPLETED|Washout Between Treatment Period 4 and 5||1
8966545|NCT02573155|10030235|FG000|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
8966546|NCT02573155|10030236|FG001|STARTED|Period 5||28
8966547|NCT02573155|10030235|FG000|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
8966548|NCT02573155|10030236|FG001|COMPLETED|Period 5||28
8966549|NCT02573155|10030235|FG000|NOT COMPLETED|Period 5||0
8631813|NCT00541970|9671676|FG002|COMPLETED|Month 48||167
8631814|NCT00541970|9671677|FG003|COMPLETED|Month 48||164
8631815|NCT00541970|9671674|FG000|NOT COMPLETED|Month 48||71
8631816|NCT00541970|9671675|FG001|NOT COMPLETED|Month 48||73
8631817|NCT00541970|9671676|FG002|NOT COMPLETED|Month 48||73
8631818|NCT00541970|9671677|FG003|NOT COMPLETED|Month 48||75
8966550|NCT02573155|10030236|FG001|NOT COMPLETED|Period 5||0
8966551|NCT02573181|10030264|FG000|STARTED|Overall Study||127
8966552|NCT02573181|10030265|FG001|STARTED|Overall Study||126
8966553|NCT02573181|10030264|FG000|Vaccinated|Overall Study||127
8631819|NCT00541970|9671674|FG000|STARTED|Month 60||240
8966554|NCT02573181|10030265|FG001|Vaccinated|Overall Study||126
8966555|NCT02573181|10030264|FG000|COMPLETED|Overall Study||127
8966556|NCT02573181|10030265|FG001|COMPLETED|Overall Study||126
8966557|NCT02573181|10030264|FG000|NOT COMPLETED|Overall Study||0
8966558|NCT02573181|10030265|FG001|NOT COMPLETED|Overall Study||0
8966559|NCT02573246|10030276|FG000|STARTED|Overall Study||14
8966560|NCT02573246|10030277|FG001|STARTED|Overall Study||15
8966561|NCT02573246|10030278|FG002|STARTED|Overall Study||18
8966562|NCT02573246|10030279|FG003|STARTED|Overall Study||16
8966563|NCT02573246|10030280|FG004|STARTED|Overall Study||15
8966564|NCT02573246|10030276|FG000|COMPLETED|Overall Study||11
8966565|NCT02573246|10030277|FG001|COMPLETED|Overall Study||14
8966566|NCT02573246|10030278|FG002|COMPLETED|Overall Study||15
8966567|NCT02573246|10030279|FG003|COMPLETED|Overall Study||14
8966568|NCT02573246|10030280|FG004|COMPLETED|Overall Study||11
8966569|NCT02573246|10030276|FG000|NOT COMPLETED|Overall Study||3
8966570|NCT02573246|10030277|FG001|NOT COMPLETED|Overall Study||1
8966571|NCT02573246|10030278|FG002|NOT COMPLETED|Overall Study||3
8966572|NCT02573246|10030279|FG003|NOT COMPLETED|Overall Study||2
8966573|NCT02573246|10030280|FG004|NOT COMPLETED|Overall Study||4
8966574|NCT02573311|10030299|FG000|STARTED|Disposition for Part 1|Started are subjects who entered Part 1 and answered the purchase question|1737
8966575|NCT02573311|10030300|FG001|STARTED|Disposition for Part 1|Started are subjects who entered Part 1 and answered the purchase question|364
8966576|NCT02573311|10030299|FG000|COMPLETED|Disposition for Part 1|Completed are the subjects who actually completed Part 1|1730
8966577|NCT02573311|10030300|FG001|COMPLETED|Disposition for Part 1|Completed are the subjects who actually completed Part 1|361
8966578|NCT02573311|10030299|FG000|NOT COMPLETED|Disposition for Part 1||7
8966579|NCT02573311|10030300|FG001|NOT COMPLETED|Disposition for Part 1||3
8966580|NCT02573311|10030299|FG000|STARTED|Disposition for Part 2|Started are subjects who purchased study product and are eligible to enter Part-2 of study.|964
9038030|NCT03327220|10099359|FG000|STARTED|Overall Study||62
9038031|NCT03327220|10099360|FG001|STARTED|Overall Study||62
8631820|NCT00541970|9671675|FG001|STARTED|Month 60||241
8631821|NCT00541970|9671676|FG002|STARTED|Month 60||240
8966581|NCT02573311|10030300|FG001|STARTED|Disposition for Part 2|Started are subjects who purchased study product and are eligible to enter Part-2 of study.|153
8966582|NCT02573311|10030299|FG000|COMPLETED|Disposition for Part 2|Completed are the subjects who completed use phase Part-2 (Week 24 and EOS-P2 interviews).|754
8966583|NCT02573311|10030300|FG001|COMPLETED|Disposition for Part 2|Completed are the subjects who completed use phase Part-2 (Week 24 and EOS-P2 interviews).|127
8966584|NCT02573311|10030299|FG000|NOT COMPLETED|Disposition for Part 2||210
8966585|NCT02573311|10030300|FG001|NOT COMPLETED|Disposition for Part 2||26
8966586|NCT02573350|10030308|FG000|STARTED|Overall Study||137
8966587|NCT02573350|10030309|FG001|STARTED|Overall Study||76
8966588|NCT02573350|10030308|FG000|Efficacy Analysis Population|Overall Study||132
8966589|NCT02573350|10030309|FG001|Efficacy Analysis Population|Overall Study||73
8966590|NCT02573350|10030308|FG000|Safety Population|Overall Study||137
8966591|NCT02573350|10030309|FG001|Safety Population|Overall Study||76
8966592|NCT02573350|10030308|FG000|COMPLETED|Overall Study||121
8966593|NCT02573350|10030309|FG001|COMPLETED|Overall Study||67
8966594|NCT02573350|10030308|FG000|NOT COMPLETED|Overall Study||16
8966595|NCT02573350|10030309|FG001|NOT COMPLETED|Overall Study||9
8966596|NCT02573402|10030320|FG000|STARTED|Overall Study||12
8966597|NCT02573402|10030321|FG001|STARTED|Overall Study||7
8966598|NCT02573402|10030320|FG000|COMPLETED|Overall Study||12
8631822|NCT00541970|9671677|FG003|STARTED|Month 60||239
8631823|NCT00541970|9671674|FG000|COMPLETED|Month 60||162
8631824|NCT00541970|9671675|FG001|COMPLETED|Month 60||164
8631825|NCT00541970|9671676|FG002|COMPLETED|Month 60||158
8631826|NCT00541970|9671677|FG003|COMPLETED|Month 60||167
8631827|NCT00541970|9671674|FG000|NOT COMPLETED|Month 60||78
8966599|NCT02573402|10030321|FG001|COMPLETED|Overall Study||7
8966600|NCT02573402|10030320|FG000|NOT COMPLETED|Overall Study||0
8966601|NCT02573402|10030321|FG001|NOT COMPLETED|Overall Study||0
8966602|NCT02573467|10030331|FG000|STARTED|Double-blind Treatment Epoch||53
8966603|NCT02573467|10030332|FG001|STARTED|Double-blind Treatment Epoch||52
8966604|NCT02573467|10030333|FG002|STARTED|Double-blind Treatment Epoch||51
8966605|NCT02573467|10030334|FG003|STARTED|Double-blind Treatment Epoch||55
8966606|NCT02573467|10030331|FG000|Full Analysis Set|Double-blind Treatment Epoch||53
8966607|NCT02573467|10030332|FG001|Full Analysis Set|Double-blind Treatment Epoch||52
8966608|NCT02573467|10030333|FG002|Full Analysis Set|Double-blind Treatment Epoch||51
8966609|NCT02573467|10030334|FG003|Full Analysis Set|Double-blind Treatment Epoch||55
8966610|NCT02573467|10030331|FG000|COMPLETED|Double-blind Treatment Epoch||0
8966611|NCT02573467|10030332|FG001|COMPLETED|Double-blind Treatment Epoch||0
8966612|NCT02573467|10030333|FG002|COMPLETED|Double-blind Treatment Epoch||0
8966613|NCT02573467|10030334|FG003|COMPLETED|Double-blind Treatment Epoch||0
8966614|NCT02573467|10030331|FG000|NOT COMPLETED|Double-blind Treatment Epoch||53
8966615|NCT02573467|10030332|FG001|NOT COMPLETED|Double-blind Treatment Epoch||52
8966616|NCT02573467|10030333|FG002|NOT COMPLETED|Double-blind Treatment Epoch||51
8966617|NCT02573467|10030334|FG003|NOT COMPLETED|Double-blind Treatment Epoch||55
8966618|NCT02573467|10030331|FG000|STARTED|Post-treatment Follow up Epoch||41
8966619|NCT02573467|10030332|FG001|STARTED|Post-treatment Follow up Epoch||46
8966620|NCT02573467|10030333|FG002|STARTED|Post-treatment Follow up Epoch||44
8966621|NCT02573467|10030334|FG003|STARTED|Post-treatment Follow up Epoch||47
8966622|NCT02573467|10030331|FG000|COMPLETED|Post-treatment Follow up Epoch||35
8966623|NCT02573467|10030332|FG001|COMPLETED|Post-treatment Follow up Epoch||41
8966624|NCT02573467|10030333|FG002|COMPLETED|Post-treatment Follow up Epoch||34
8966625|NCT02573467|10030334|FG003|COMPLETED|Post-treatment Follow up Epoch||44
8966626|NCT02573467|10030331|FG000|NOT COMPLETED|Post-treatment Follow up Epoch||6
8966627|NCT02573467|10030332|FG001|NOT COMPLETED|Post-treatment Follow up Epoch||5
8966628|NCT02573467|10030333|FG002|NOT COMPLETED|Post-treatment Follow up Epoch||10
8966629|NCT02573467|10030334|FG003|NOT COMPLETED|Post-treatment Follow up Epoch||3
8966630|NCT02573493|10030349|FG000|STARTED|Overall Study||40
8966631|NCT02573493|10030350|FG001|STARTED|Overall Study||40
8966632|NCT02573493|10030351|FG002|STARTED|Overall Study||15
8966633|NCT02573493|10030352|FG003|STARTED|Overall Study||1
8966634|NCT02573493|10030349|FG000|COMPLETED|Overall Study||40
8966635|NCT02573493|10030350|FG001|COMPLETED|Overall Study||40
8966636|NCT02573493|10030351|FG002|COMPLETED|Overall Study||15
8966637|NCT02573493|10030352|FG003|COMPLETED|Overall Study||0
8966638|NCT02573493|10030349|FG000|NOT COMPLETED|Overall Study||0
8966639|NCT02573493|10030350|FG001|NOT COMPLETED|Overall Study||0
8966640|NCT02573493|10030351|FG002|NOT COMPLETED|Overall Study||0
8966641|NCT02573493|10030352|FG003|NOT COMPLETED|Overall Study||1
8966642|NCT02573857|10030378|FG000|STARTED|Overall Study||8
8966643|NCT02573857|10030379|FG001|STARTED|Overall Study||8
8966644|NCT02573857|10030378|FG000|COMPLETED|Overall Study||8
8966645|NCT02573857|10030379|FG001|COMPLETED|Overall Study||8
8966646|NCT02573857|10030378|FG000|NOT COMPLETED|Overall Study||0
8966647|NCT02573857|10030379|FG001|NOT COMPLETED|Overall Study||0
8966648|NCT02573870|10030387|FG000|STARTED|Overall Study||20
8966649|NCT02573870|10030388|FG001|STARTED|Overall Study||42
8966650|NCT02573870|10030387|FG000|COMPLETED|Overall Study||20
8966651|NCT02573870|10030388|FG001|COMPLETED|Overall Study||35
8631828|NCT00541970|9671675|FG001|NOT COMPLETED|Month 60||77
8966652|NCT02573870|10030387|FG000|NOT COMPLETED|Overall Study||0
8966653|NCT02573870|10030388|FG001|NOT COMPLETED|Overall Study||7
8631829|NCT00541970|9671676|FG002|NOT COMPLETED|Month 60||82
8631830|NCT00541970|9671677|FG003|NOT COMPLETED|Month 60||72
8966654|NCT02573883|10030396|FG000|STARTED|Six Month Follow Up||25
8966655|NCT02573883|10030397|FG001|STARTED|Six Month Follow Up||27
8966656|NCT02573883|10030398|FG002|STARTED|Six Month Follow Up||0
8966657|NCT02573883|10030399|FG003|STARTED|Six Month Follow Up||0
8966658|NCT02573883|10030396|FG000|COMPLETED|Six Month Follow Up||24
8966659|NCT02573883|10030397|FG001|COMPLETED|Six Month Follow Up||27
8966660|NCT02573883|10030398|FG002|COMPLETED|Six Month Follow Up||0
8966661|NCT02573883|10030399|FG003|COMPLETED|Six Month Follow Up||0
8966662|NCT02573883|10030396|FG000|NOT COMPLETED|Six Month Follow Up||1
8966663|NCT02573883|10030397|FG001|NOT COMPLETED|Six Month Follow Up||0
8966664|NCT02573883|10030398|FG002|NOT COMPLETED|Six Month Follow Up||0
8631831|NCT00542178|9671693|FG000|STARTED|Overall Study||390
8631832|NCT00542178|9671694|FG001|STARTED|Overall Study||412
8631833|NCT00542178|9671695|FG002|STARTED|Overall Study||382
8966665|NCT02573883|10030399|FG003|NOT COMPLETED|Six Month Follow Up||0
8966666|NCT02573883|10030396|FG000|STARTED|One Year Follow Up||13
8966667|NCT02573883|10030397|FG001|STARTED|One Year Follow Up||17
8966668|NCT02573883|10030398|FG002|STARTED|One Year Follow Up||11
8966669|NCT02573883|10030399|FG003|STARTED|One Year Follow Up||10
8966670|NCT02573883|10030396|FG000|COMPLETED|One Year Follow Up||11
8966671|NCT02573883|10030397|FG001|COMPLETED|One Year Follow Up||16
8966672|NCT02573883|10030398|FG002|COMPLETED|One Year Follow Up||11
8966673|NCT02573883|10030399|FG003|COMPLETED|One Year Follow Up||10
8966674|NCT02573883|10030396|FG000|NOT COMPLETED|One Year Follow Up||2
8966675|NCT02573883|10030397|FG001|NOT COMPLETED|One Year Follow Up||1
8966676|NCT02573883|10030398|FG002|NOT COMPLETED|One Year Follow Up||0
8966677|NCT02573883|10030399|FG003|NOT COMPLETED|One Year Follow Up||0
8966678|NCT02573948|10030414|FG000|STARTED|RDS||603
8966679|NCT02573948|10030414|FG000|COMPLETED|RDS||603
8966680|NCT02573948|10030414|FG000|NOT COMPLETED|RDS||0
8631834|NCT00542178|9671696|FG003|STARTED|Overall Study||370
8631835|NCT00542178|9671697|FG004|STARTED|Overall Study||464
8631836|NCT00542178|9671698|FG005|STARTED|Overall Study||495
8631837|NCT00542178|9671699|FG006|STARTED|Overall Study||493
8966681|NCT02573948|10030414|FG000|STARTED|Longitudinal Cohort|Not on ART a/o MMT. MSM and FSW were prioritized for enrolling,|250
8966682|NCT02573948|10030414|FG000|COMPLETED|Longitudinal Cohort||194
8966683|NCT02573948|10030414|FG000|NOT COMPLETED|Longitudinal Cohort||56
8966684|NCT02574078|10030434|FG000|STARTED|Pre-Treatment Period||13
8966685|NCT02574078|10030435|FG001|STARTED|Pre-Treatment Period||6
8966686|NCT02574078|10030436|FG002|STARTED|Pre-Treatment Period||9
8966687|NCT02574078|10030437|FG003|STARTED|Pre-Treatment Period||35
8966688|NCT02574078|10030438|FG004|STARTED|Pre-Treatment Period||34
8966689|NCT02574078|10030439|FG005|STARTED|Pre-Treatment Period||35
8966690|NCT02574078|10030440|FG006|STARTED|Pre-Treatment Period||18
8966691|NCT02574078|10030441|FG007|STARTED|Pre-Treatment Period||17
8966692|NCT02574078|10030442|FG008|STARTED|Pre-Treatment Period||26
8966693|NCT02574078|10030443|FG009|STARTED|Pre-Treatment Period||26
8966694|NCT02574078|10030444|FG010|STARTED|Pre-Treatment Period||53
8966695|NCT02574078|10030445|FG011|STARTED|Pre-Treatment Period||56
8966696|NCT02574078|10030446|FG012|STARTED|Pre-Treatment Period||13
8966697|NCT02574078|10030434|FG000|COMPLETED|Pre-Treatment Period||13
8966698|NCT02574078|10030435|FG001|COMPLETED|Pre-Treatment Period||6
8966699|NCT02574078|10030436|FG002|COMPLETED|Pre-Treatment Period||9
8966700|NCT02574078|10030437|FG003|COMPLETED|Pre-Treatment Period||35
8966701|NCT02574078|10030438|FG004|COMPLETED|Pre-Treatment Period||34
8966702|NCT02574078|10030439|FG005|COMPLETED|Pre-Treatment Period||34
8966703|NCT02574078|10030440|FG006|COMPLETED|Pre-Treatment Period||14
8966704|NCT02574078|10030441|FG007|COMPLETED|Pre-Treatment Period||14
8966705|NCT02574078|10030442|FG008|COMPLETED|Pre-Treatment Period||25
8966706|NCT02574078|10030443|FG009|COMPLETED|Pre-Treatment Period||26
8966707|NCT02574078|10030444|FG010|COMPLETED|Pre-Treatment Period||49
8966708|NCT02574078|10030445|FG011|COMPLETED|Pre-Treatment Period||55
8966709|NCT02574078|10030446|FG012|COMPLETED|Pre-Treatment Period||13
8966710|NCT02574078|10030434|FG000|NOT COMPLETED|Pre-Treatment Period||0
8966711|NCT02574078|10030435|FG001|NOT COMPLETED|Pre-Treatment Period||0
8966712|NCT02574078|10030436|FG002|NOT COMPLETED|Pre-Treatment Period||0
8966713|NCT02574078|10030437|FG003|NOT COMPLETED|Pre-Treatment Period||0
8966714|NCT02574078|10030438|FG004|NOT COMPLETED|Pre-Treatment Period||0
8966715|NCT02574078|10030439|FG005|NOT COMPLETED|Pre-Treatment Period||1
8966716|NCT02574078|10030440|FG006|NOT COMPLETED|Pre-Treatment Period||4
8966717|NCT02574078|10030441|FG007|NOT COMPLETED|Pre-Treatment Period||3
8966718|NCT02574078|10030442|FG008|NOT COMPLETED|Pre-Treatment Period||1
8966719|NCT02574078|10030443|FG009|NOT COMPLETED|Pre-Treatment Period||0
8966720|NCT02574078|10030444|FG010|NOT COMPLETED|Pre-Treatment Period||4
8966721|NCT02574078|10030445|FG011|NOT COMPLETED|Pre-Treatment Period||1
8966722|NCT02574078|10030446|FG012|NOT COMPLETED|Pre-Treatment Period||0
8966723|NCT02574078|10030434|FG000|STARTED|Treatment Period||13
8966724|NCT02574078|10030435|FG001|STARTED|Treatment Period||6
8966725|NCT02574078|10030436|FG002|STARTED|Treatment Period||9
8966726|NCT02574078|10030437|FG003|STARTED|Treatment Period||35
8966727|NCT02574078|10030438|FG004|STARTED|Treatment Period||34
8966728|NCT02574078|10030439|FG005|STARTED|Treatment Period||34
8966729|NCT02574078|10030440|FG006|STARTED|Treatment Period||14
8966730|NCT02574078|10030441|FG007|STARTED|Treatment Period||14
8966731|NCT02574078|10030442|FG008|STARTED|Treatment Period||25
8966732|NCT02574078|10030443|FG009|STARTED|Treatment Period||26
8966733|NCT02574078|10030444|FG010|STARTED|Treatment Period||49
8966734|NCT02574078|10030445|FG011|STARTED|Treatment Period||55
8966735|NCT02574078|10030446|FG012|STARTED|Treatment Period||13
8966736|NCT02574078|10030434|FG000|COMPLETED|Treatment Period||3
8966737|NCT02574078|10030435|FG001|COMPLETED|Treatment Period||0
8966738|NCT02574078|10030436|FG002|COMPLETED|Treatment Period||0
8966739|NCT02574078|10030437|FG003|COMPLETED|Treatment Period||7
8966740|NCT02574078|10030438|FG004|COMPLETED|Treatment Period||3
8966741|NCT02574078|10030439|FG005|COMPLETED|Treatment Period||1
8966742|NCT02574078|10030440|FG006|COMPLETED|Treatment Period||2
8966743|NCT02574078|10030441|FG007|COMPLETED|Treatment Period||2
8966744|NCT02574078|10030442|FG008|COMPLETED|Treatment Period||1
8966745|NCT02574078|10030443|FG009|COMPLETED|Treatment Period||9
8966746|NCT02574078|10030444|FG010|COMPLETED|Treatment Period||4
8966747|NCT02574078|10030445|FG011|COMPLETED|Treatment Period||8
8966748|NCT02574078|10030446|FG012|COMPLETED|Treatment Period||0
8966749|NCT02574078|10030434|FG000|NOT COMPLETED|Treatment Period||10
8966750|NCT02574078|10030435|FG001|NOT COMPLETED|Treatment Period||6
8966751|NCT02574078|10030436|FG002|NOT COMPLETED|Treatment Period||9
8966752|NCT02574078|10030437|FG003|NOT COMPLETED|Treatment Period||28
8966753|NCT02574078|10030438|FG004|NOT COMPLETED|Treatment Period||31
8966754|NCT02574078|10030439|FG005|NOT COMPLETED|Treatment Period||33
8966755|NCT02574078|10030440|FG006|NOT COMPLETED|Treatment Period||12
8966756|NCT02574078|10030441|FG007|NOT COMPLETED|Treatment Period||12
8966757|NCT02574078|10030442|FG008|NOT COMPLETED|Treatment Period||24
8966758|NCT02574078|10030443|FG009|NOT COMPLETED|Treatment Period||17
8966759|NCT02574078|10030444|FG010|NOT COMPLETED|Treatment Period||45
8966760|NCT02574078|10030445|FG011|NOT COMPLETED|Treatment Period||47
8966761|NCT02574078|10030446|FG012|NOT COMPLETED|Treatment Period||13
8966762|NCT02574247|10030480|FG000|STARTED|Overall Study||10
8966763|NCT02574247|10030481|FG001|STARTED|Overall Study||8
8966764|NCT02574247|10030482|FG002|STARTED|Overall Study||10
8966765|NCT02574247|10030480|FG000|COMPLETED|Overall Study||5
8966766|NCT02574247|10030481|FG001|COMPLETED|Overall Study||5
8966767|NCT02574247|10030482|FG002|COMPLETED|Overall Study||5
8966768|NCT02574247|10030480|FG000|NOT COMPLETED|Overall Study||5
8966769|NCT02574247|10030481|FG001|NOT COMPLETED|Overall Study||3
8966770|NCT02574247|10030482|FG002|NOT COMPLETED|Overall Study||5
8966771|NCT02574260|10030492|FG000|STARTED|Overall Study||3
8966772|NCT02574260|10030492|FG000|COMPLETED|Overall Study||2
8966773|NCT02574260|10030492|FG000|NOT COMPLETED|Overall Study||1
8966774|NCT02574312|10030498|FG000|STARTED|Pre-Operative||44
8966775|NCT02574312|10030499|FG001|STARTED|Pre-Operative||44
8966776|NCT02574312|10030498|FG000|COMPLETED|Pre-Operative||44
8966777|NCT02574312|10030499|FG001|COMPLETED|Pre-Operative||44
8966778|NCT02574312|10030498|FG000|NOT COMPLETED|Pre-Operative||0
8966779|NCT02574312|10030499|FG001|NOT COMPLETED|Pre-Operative||0
8966780|NCT02574312|10030498|FG000|STARTED|3 Months Follow-up||44
8966781|NCT02574312|10030499|FG001|STARTED|3 Months Follow-up||44
8966782|NCT02574312|10030498|FG000|COMPLETED|3 Months Follow-up|One subject withdrew consent|43
8966783|NCT02574312|10030499|FG001|COMPLETED|3 Months Follow-up||44
8966784|NCT02574312|10030498|FG000|NOT COMPLETED|3 Months Follow-up||1
8966785|NCT02574312|10030499|FG001|NOT COMPLETED|3 Months Follow-up||0
8966786|NCT02574520|10030509|FG000|STARTED|Overall Study||48
8966787|NCT02574520|10030510|FG001|STARTED|Overall Study||46
8966788|NCT02574520|10030511|FG002|STARTED|Overall Study||153
8966789|NCT02574520|10030512|FG003|STARTED|Overall Study||152
8966790|NCT02574520|10030509|FG000|Dosed|Overall Study||46
8966791|NCT02574520|10030510|FG001|Dosed|Overall Study||46
8966792|NCT02574520|10030511|FG002|Dosed|Overall Study||148
8966793|NCT02574520|10030512|FG003|Dosed|Overall Study||148
8966794|NCT02574520|10030509|FG000|COMPLETED|Overall Study||46
8966795|NCT02574520|10030510|FG001|COMPLETED|Overall Study||46
8966796|NCT02574520|10030511|FG002|COMPLETED|Overall Study||148
8966797|NCT02574520|10030512|FG003|COMPLETED|Overall Study||144
8966798|NCT02574520|10030509|FG000|NOT COMPLETED|Overall Study||2
8966799|NCT02574520|10030510|FG001|NOT COMPLETED|Overall Study||0
8966800|NCT02574520|10030511|FG002|NOT COMPLETED|Overall Study||5
8966801|NCT02574520|10030512|FG003|NOT COMPLETED|Overall Study||8
8966802|NCT02574598|10030524|FG000|STARTED|Overall Study||40
8966803|NCT02574598|10030525|FG001|STARTED|Overall Study||38
8966804|NCT02574598|10030524|FG000|COMPLETED|Overall Study||40
8966805|NCT02574598|10030525|FG001|COMPLETED|Overall Study||38
8966806|NCT02574598|10030524|FG000|NOT COMPLETED|Overall Study||0
8966807|NCT02574598|10030525|FG001|NOT COMPLETED|Overall Study||0
8966808|NCT02574637|10030536|FG000|STARTED|Double-blind Period||5
8966809|NCT02574637|10030537|FG001|STARTED|Double-blind Period||5
8966810|NCT02574637|10030538|FG002|STARTED|Double-blind Period||9
8966811|NCT02574637|10030539|FG003|STARTED|Double-blind Period||7
8966812|NCT02574637|10030540|FG004|STARTED|Double-blind Period||3
8966813|NCT02574637|10030541|FG005|STARTED|Double-blind Period||0
8966814|NCT02574637|10030542|FG006|STARTED|Double-blind Period||0
8966815|NCT02574637|10030543|FG007|STARTED|Double-blind Period||0
8966816|NCT02574637|10030544|FG008|STARTED|Double-blind Period||0
8966817|NCT02574637|10030545|FG009|STARTED|Double-blind Period||0
8966818|NCT02574637|10030536|FG000|COMPLETED|Double-blind Period||2
8966819|NCT02574637|10030537|FG001|COMPLETED|Double-blind Period||4
8966820|NCT02574637|10030538|FG002|COMPLETED|Double-blind Period||2
8966821|NCT02574637|10030539|FG003|COMPLETED|Double-blind Period||3
8966822|NCT02574637|10030540|FG004|COMPLETED|Double-blind Period||1
8966823|NCT02574637|10030541|FG005|COMPLETED|Double-blind Period||0
8966824|NCT02574637|10030542|FG006|COMPLETED|Double-blind Period||0
8966825|NCT02574637|10030543|FG007|COMPLETED|Double-blind Period||0
8966826|NCT02574637|10030544|FG008|COMPLETED|Double-blind Period||0
8966827|NCT02574637|10030545|FG009|COMPLETED|Double-blind Period||0
8966828|NCT02574637|10030536|FG000|NOT COMPLETED|Double-blind Period||3
8966829|NCT02574637|10030537|FG001|NOT COMPLETED|Double-blind Period||1
8966830|NCT02574637|10030538|FG002|NOT COMPLETED|Double-blind Period||7
8966831|NCT02574637|10030539|FG003|NOT COMPLETED|Double-blind Period||4
8966832|NCT02574637|10030540|FG004|NOT COMPLETED|Double-blind Period||2
8966833|NCT02574637|10030541|FG005|NOT COMPLETED|Double-blind Period||0
8966834|NCT02574637|10030542|FG006|NOT COMPLETED|Double-blind Period||0
8966835|NCT02574637|10030543|FG007|NOT COMPLETED|Double-blind Period||0
8966836|NCT02574637|10030544|FG008|NOT COMPLETED|Double-blind Period||0
8966837|NCT02574637|10030545|FG009|NOT COMPLETED|Double-blind Period||0
8966838|NCT02574637|10030536|FG000|STARTED|Open-label (OL) Period||0
8966839|NCT02574637|10030537|FG001|STARTED|Open-label (OL) Period||0
8966840|NCT02574637|10030538|FG002|STARTED|Open-label (OL) Period||0
8966841|NCT02574637|10030539|FG003|STARTED|Open-label (OL) Period||0
8966842|NCT02574637|10030540|FG004|STARTED|Open-label (OL) Period||0
8966843|NCT02574637|10030541|FG005|STARTED|Open-label (OL) Period||2
8966844|NCT02574637|10030542|FG006|STARTED|Open-label (OL) Period||3
8966845|NCT02574637|10030543|FG007|STARTED|Open-label (OL) Period||2
8966846|NCT02574637|10030544|FG008|STARTED|Open-label (OL) Period||3
8966847|NCT02574637|10030545|FG009|STARTED|Open-label (OL) Period||1
8966848|NCT02574637|10030536|FG000|COMPLETED|Open-label (OL) Period||0
8966849|NCT02574637|10030537|FG001|COMPLETED|Open-label (OL) Period||0
8966850|NCT02574637|10030538|FG002|COMPLETED|Open-label (OL) Period||0
8966851|NCT02574637|10030539|FG003|COMPLETED|Open-label (OL) Period||0
8966852|NCT02574637|10030540|FG004|COMPLETED|Open-label (OL) Period||0
8966853|NCT02574637|10030541|FG005|COMPLETED|Open-label (OL) Period||0
8966854|NCT02574637|10030542|FG006|COMPLETED|Open-label (OL) Period||1
8966855|NCT02574637|10030543|FG007|COMPLETED|Open-label (OL) Period||1
8966856|NCT02574637|10030544|FG008|COMPLETED|Open-label (OL) Period||1
8966857|NCT02574637|10030545|FG009|COMPLETED|Open-label (OL) Period||0
8966858|NCT02574637|10030536|FG000|NOT COMPLETED|Open-label (OL) Period||0
8966859|NCT02574637|10030537|FG001|NOT COMPLETED|Open-label (OL) Period||0
8966860|NCT02574637|10030538|FG002|NOT COMPLETED|Open-label (OL) Period||0
8966861|NCT02574637|10030539|FG003|NOT COMPLETED|Open-label (OL) Period||0
8966862|NCT02574637|10030540|FG004|NOT COMPLETED|Open-label (OL) Period||0
8966863|NCT02574637|10030541|FG005|NOT COMPLETED|Open-label (OL) Period||2
8966864|NCT02574637|10030542|FG006|NOT COMPLETED|Open-label (OL) Period||2
8966865|NCT02574637|10030543|FG007|NOT COMPLETED|Open-label (OL) Period||1
8966866|NCT02574637|10030544|FG008|NOT COMPLETED|Open-label (OL) Period||2
8966867|NCT02574637|10030545|FG009|NOT COMPLETED|Open-label (OL) Period||1
8966868|NCT02574832|10030566|FG000|STARTED|Overall Study||2
8966869|NCT02574832|10030566|FG000|COMPLETED|Overall Study||2
8966870|NCT02574832|10030566|FG000|NOT COMPLETED|Overall Study||0
8966871|NCT02574845|10030576|FG000|STARTED|Overall Study||3
8966872|NCT02574845|10030577|FG001|STARTED|Overall Study||3
8966873|NCT02574845|10030578|FG002|STARTED|Overall Study||3
8966874|NCT02574845|10030579|FG003|STARTED|Overall Study||3
8966875|NCT02574845|10030580|FG004|STARTED|Overall Study||3
8966876|NCT02574845|10030581|FG005|STARTED|Overall Study||3
8966877|NCT02574845|10030576|FG000|Received T1|Overall Study||3
8966878|NCT02574845|10030577|FG001|Received T1|Overall Study||2
8966879|NCT02574845|10030578|FG002|Received T1|Overall Study||3
8966880|NCT02574845|10030579|FG003|Received T1|Overall Study||3
8966881|NCT02574845|10030580|FG004|Received T1|Overall Study||2
8966882|NCT02574845|10030581|FG005|Received T1|Overall Study|one subject missed treatment period 2|2
8966883|NCT02574845|10030576|FG000|Received T2|Overall Study||3
8966884|NCT02574845|10030577|FG001|Received T2|Overall Study||3
8966885|NCT02574845|10030578|FG002|Received T2|Overall Study||3
8966886|NCT02574845|10030579|FG003|Received T2|Overall Study||3
8966887|NCT02574845|10030580|FG004|Received T2|Overall Study||2
8966888|NCT02574845|10030581|FG005|Received T2|Overall Study||3
8966889|NCT02574845|10030576|FG000|Received T3|Overall Study|one subject missed treatment period 2|2
8966890|NCT02574845|10030577|FG001|Received T3|Overall Study||2
8966891|NCT02574845|10030578|FG002|Received T3|Overall Study||3
8966892|NCT02574845|10030579|FG003|Received T3|Overall Study||3
8966893|NCT02574845|10030580|FG004|Received T3|Overall Study||2
8966894|NCT02574845|10030581|FG005|Received T3|Overall Study||3
8966895|NCT02574845|10030576|FG000|Received T4|Overall Study||3
8966896|NCT02574845|10030577|FG001|Received T4|Overall Study||2
8966897|NCT02574845|10030578|FG002|Received T4|Overall Study||3
8966898|NCT02574845|10030579|FG003|Received T4|Overall Study||3
8966899|NCT02574845|10030580|FG004|Received T4|Overall Study||2
8966900|NCT02574845|10030581|FG005|Received T4|Overall Study||2
8966901|NCT02574845|10030576|FG000|Received T5|Overall Study||3
8966902|NCT02574845|10030577|FG001|Received T5|Overall Study||2
8966903|NCT02574845|10030578|FG002|Received T5|Overall Study||3
8966904|NCT02574845|10030579|FG003|Received T5|Overall Study||3
8966905|NCT02574845|10030580|FG004|Received T5|Overall Study||3
8966906|NCT02574845|10030581|FG005|Received T5|Overall Study||2
8966907|NCT02574845|10030576|FG000|Received R|Overall Study||3
8966908|NCT02574845|10030577|FG001|Received R|Overall Study||2
8966909|NCT02574845|10030578|FG002|Received R|Overall Study||3
8966910|NCT02574845|10030579|FG003|Received R|Overall Study||3
8966911|NCT02574845|10030580|FG004|Received R|Overall Study||2
8570704|NCT00105157|9602883|FG000|STARTED|Open-Label Continuation of DB||30
8966912|NCT02574845|10030581|FG005|Received R|Overall Study||3
8966913|NCT02574845|10030576|FG000|COMPLETED|Overall Study||3
8966914|NCT02574845|10030577|FG001|COMPLETED|Overall Study||2
8966915|NCT02574845|10030578|FG002|COMPLETED|Overall Study||3
8966916|NCT02574845|10030579|FG003|COMPLETED|Overall Study||3
8966917|NCT02574845|10030580|FG004|COMPLETED|Overall Study||2
8966918|NCT02574845|10030581|FG005|COMPLETED|Overall Study||2
8966919|NCT02574845|10030576|FG000|NOT COMPLETED|Overall Study||0
8966920|NCT02574845|10030577|FG001|NOT COMPLETED|Overall Study||1
8966921|NCT02574845|10030578|FG002|NOT COMPLETED|Overall Study||0
8966922|NCT02574845|10030579|FG003|NOT COMPLETED|Overall Study||0
8966923|NCT02574845|10030580|FG004|NOT COMPLETED|Overall Study||1
8966924|NCT02574845|10030581|FG005|NOT COMPLETED|Overall Study||1
8966925|NCT02574858|10030595|FG000|STARTED|Overall Study||25
8966926|NCT02574858|10030595|FG000|COMPLETED|Overall Study||25
8966927|NCT02574858|10030595|FG000|NOT COMPLETED|Overall Study||0
8966928|NCT02575079|10030601|FG000|STARTED|Overall Study||48
8966929|NCT02575079|10030602|FG001|STARTED|Overall Study||71
8966930|NCT02575079|10030601|FG000|COMPLETED|Overall Study||42
8966931|NCT02575079|10030602|FG001|COMPLETED|Overall Study||71
8966932|NCT02575079|10030601|FG000|NOT COMPLETED|Overall Study||6
8966933|NCT02575079|10030602|FG001|NOT COMPLETED|Overall Study||0
8966934|NCT02575300|10030607|FG000|STARTED|Overall Study||20
8966935|NCT02575300|10030607|FG000|COMPLETED|Overall Study||20
8966936|NCT02575300|10030607|FG000|NOT COMPLETED|Overall Study||0
8966937|NCT02575807|10030616|FG000|STARTED|Overall Study||9
8966938|NCT02575807|10030617|FG001|STARTED|Overall Study||4
8966939|NCT02575807|10030618|FG002|STARTED|Overall Study||16
8966940|NCT02575807|10030619|FG003|STARTED|Overall Study||2
8966941|NCT02575807|10030620|FG004|STARTED|Overall Study||4
8966942|NCT02575807|10030616|FG000|Treated|Overall Study||8
8966943|NCT02575807|10030617|FG001|Treated|Overall Study||4
8966944|NCT02575807|10030618|FG002|Treated|Overall Study||16
8966945|NCT02575807|10030619|FG003|Treated|Overall Study||1
8966946|NCT02575807|10030620|FG004|Treated|Overall Study||3
8966947|NCT02575807|10030616|FG000|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0
8966948|NCT02575807|10030617|FG001|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0
8966949|NCT02575807|10030618|FG002|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0
8966950|NCT02575807|10030619|FG003|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0
8966951|NCT02575807|10030620|FG004|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0
8966952|NCT02575807|10030616|FG000|NOT COMPLETED|Overall Study||9
8966953|NCT02575807|10030617|FG001|NOT COMPLETED|Overall Study||4
8966954|NCT02575807|10030618|FG002|NOT COMPLETED|Overall Study||16
8966955|NCT02575807|10030619|FG003|NOT COMPLETED|Overall Study||2
8966956|NCT02575807|10030620|FG004|NOT COMPLETED|Overall Study||4
8966957|NCT02575833|10030636|FG000|STARTED|Overall Study||44
8966958|NCT02575833|10030637|FG001|STARTED|Overall Study||45
8966959|NCT02575833|10030636|FG000|Received Study Drug|Overall Study||44
8966960|NCT02575833|10030637|FG001|Received Study Drug|Overall Study||44
8966961|NCT02575833|10030636|FG000|COMPLETED|Overall Study||43
8966962|NCT02575833|10030637|FG001|COMPLETED|Overall Study||44
8966963|NCT02575833|10030636|FG000|NOT COMPLETED|Overall Study||1
8966964|NCT02575833|10030637|FG001|NOT COMPLETED|Overall Study||1
8966965|NCT02575911|10030643|FG000|STARTED|Overall Study||30
8966966|NCT02575911|10030643|FG000|COMPLETED|Overall Study||29
8966967|NCT02575911|10030643|FG000|NOT COMPLETED|Overall Study||1
8966968|NCT02575950|10030655|FG000|STARTED|Overall Study||3
8966969|NCT02575950|10030656|FG001|STARTED|Overall Study||6
8966970|NCT02575950|10030657|FG002|STARTED|Overall Study||6
8966971|NCT02575950|10030658|FG003|STARTED|Overall Study||25
8966972|NCT02575950|10030655|FG000|COMPLETED|Overall Study||3
8966973|NCT02575950|10030656|FG001|COMPLETED|Overall Study||5
8966974|NCT02575950|10030657|FG002|COMPLETED|Overall Study||6
8966975|NCT02575950|10030658|FG003|COMPLETED|Overall Study||20
8966976|NCT02575950|10030655|FG000|NOT COMPLETED|Overall Study||0
8966977|NCT02575950|10030656|FG001|NOT COMPLETED|Overall Study||1
8966978|NCT02575950|10030657|FG002|NOT COMPLETED|Overall Study||0
8966979|NCT02575950|10030658|FG003|NOT COMPLETED|Overall Study||5
8966980|NCT02576041|10030666|FG000|STARTED|Placebo (run-in)||18
8966981|NCT02576041|10030666|FG000|COMPLETED|Placebo (run-in)||18
8966982|NCT02576041|10030666|FG000|NOT COMPLETED|Placebo (run-in)||0
8966983|NCT02576041|10030666|FG000|STARTED|Bilastine (Active Treatement)||18
8966984|NCT02576041|10030666|FG000|COMPLETED|Bilastine (Active Treatement)||18
8966985|NCT02576041|10030666|FG000|NOT COMPLETED|Bilastine (Active Treatement)||0
8966986|NCT02576054|10030670|FG000|STARTED|Overall Study||101
8966987|NCT02576054|10030670|FG000|Vaccination 1|Overall Study||100
8966988|NCT02576054|10030670|FG000|Vaccination 2|Overall Study||100
8966989|NCT02576054|10030670|FG000|Vaccination 3|Overall Study||100
8966990|NCT02576054|10030670|FG000|COMPLETED|Overall Study||100
8966991|NCT02576054|10030670|FG000|NOT COMPLETED|Overall Study||1
8966992|NCT02576067|10030678|FG000|STARTED|Overall Study||60
8966993|NCT02576067|10030679|FG001|STARTED|Overall Study||63
8966994|NCT02576067|10030678|FG000|COMPLETED|Overall Study||26
8966995|NCT02576067|10030679|FG001|COMPLETED|Overall Study||27
8966996|NCT02576067|10030678|FG000|NOT COMPLETED|Overall Study||34
8966997|NCT02576067|10030679|FG001|NOT COMPLETED|Overall Study||36
8966998|NCT02576145|10030687|FG000|STARTED|Overall Study||6
8966999|NCT02576145|10030688|FG001|STARTED|Overall Study||5
8967000|NCT02576145|10030687|FG000|COMPLETED|Overall Study||3
8967001|NCT02576145|10030688|FG001|COMPLETED|Overall Study||4
8967002|NCT02576145|10030687|FG000|NOT COMPLETED|Overall Study||3
8967003|NCT02576145|10030688|FG001|NOT COMPLETED|Overall Study||1
8967004|NCT02576249|10030696|FG000|STARTED|Overall Study||15
8967005|NCT02576249|10030697|FG001|STARTED|Overall Study||14
8967006|NCT02576249|10030696|FG000|COMPLETED|Overall Study||15
8967007|NCT02576249|10030697|FG001|COMPLETED|Overall Study||14
8967008|NCT02576249|10030696|FG000|NOT COMPLETED|Overall Study||0
8967009|NCT02576249|10030697|FG001|NOT COMPLETED|Overall Study||0
8967010|NCT02576535|10030703|FG000|STARTED|Overall Study||18
8967011|NCT02576535|10030703|FG000|COMPLETED|Overall Study||16
8967012|NCT02576535|10030703|FG000|NOT COMPLETED|Overall Study||2
8967013|NCT02576587|10030709|FG000|STARTED|Baseline|Total cases baseline visit|161
8967014|NCT02576587|10030710|FG001|STARTED|Baseline|Total controls baseline visit|156
8967015|NCT02576587|10030709|FG000|COMPLETED|Baseline|Baseline visit completed|161
8967016|NCT02576587|10030710|FG001|COMPLETED|Baseline|Baseline visit completed|155
8967017|NCT02576587|10030709|FG000|NOT COMPLETED|Baseline||0
8967018|NCT02576587|10030710|FG001|NOT COMPLETED|Baseline||1
8967019|NCT02576587|10030709|FG000|STARTED|Follow up Period (Case Only)|Completed baseline.|161
8967020|NCT02576587|10030710|FG001|STARTED|Follow up Period (Case Only)|Controls not eligible for follow-up|155
8967021|NCT02576587|10030709|FG000|Selected for Follow up|Follow up Period (Case Only)||61
8967022|NCT02576587|10030710|FG001|Selected for Follow up|Follow up Period (Case Only)||0
8967023|NCT02576587|10030709|FG000|COMPLETED|Follow up Period (Case Only)||44
8967024|NCT02576587|10030710|FG001|COMPLETED|Follow up Period (Case Only)||0
8967025|NCT02576587|10030709|FG000|NOT COMPLETED|Follow up Period (Case Only)||117
8967026|NCT02576587|10030710|FG001|NOT COMPLETED|Follow up Period (Case Only)||155
8967027|NCT02576639|10030723|FG000|STARTED|Overall Study||24
8967028|NCT02576639|10030724|FG001|STARTED|Overall Study||25
8967029|NCT02576639|10030725|FG002|STARTED|Overall Study||25
8967030|NCT02576639|10030726|FG003|STARTED|Overall Study||26
8967031|NCT02576639|10030727|FG004|STARTED|Overall Study||24
8967032|NCT02576639|10030723|FG000|Pharmacodynamic Analysis Set|Overall Study||24
8967033|NCT02576639|10030724|FG001|Pharmacodynamic Analysis Set|Overall Study||24
8967034|NCT02576639|10030725|FG002|Pharmacodynamic Analysis Set|Overall Study||25
8967035|NCT02576639|10030726|FG003|Pharmacodynamic Analysis Set|Overall Study||25
8967036|NCT02576639|10030727|FG004|Pharmacodynamic Analysis Set|Overall Study||25
8967037|NCT02576639|10030723|FG000|Pharmacokinetic Analysis Set|Overall Study||0
8967038|NCT02576639|10030724|FG001|Pharmacokinetic Analysis Set|Overall Study||25
8967039|NCT02576639|10030725|FG002|Pharmacokinetic Analysis Set|Overall Study||25
8967040|NCT02576639|10030726|FG003|Pharmacokinetic Analysis Set|Overall Study||26
8967041|NCT02576639|10030727|FG004|Pharmacokinetic Analysis Set|Overall Study||24
8967042|NCT02576639|10030723|FG000|Safety Analysis Set|Overall Study||24
8967043|NCT02576639|10030724|FG001|Safety Analysis Set|Overall Study||25
8967044|NCT02576639|10030725|FG002|Safety Analysis Set|Overall Study||25
8967045|NCT02576639|10030726|FG003|Safety Analysis Set|Overall Study||26
8967046|NCT02576639|10030727|FG004|Safety Analysis Set|Overall Study||24
8967047|NCT02576639|10030723|FG000|COMPLETED|Overall Study||22
8967048|NCT02576639|10030724|FG001|COMPLETED|Overall Study||23
8967049|NCT02576639|10030725|FG002|COMPLETED|Overall Study||23
8967050|NCT02576639|10030726|FG003|COMPLETED|Overall Study||25
8967051|NCT02576639|10030727|FG004|COMPLETED|Overall Study||20
8967052|NCT02576639|10030723|FG000|NOT COMPLETED|Overall Study||2
8967053|NCT02576639|10030724|FG001|NOT COMPLETED|Overall Study||2
8967054|NCT02576639|10030725|FG002|NOT COMPLETED|Overall Study||2
8967055|NCT02576639|10030726|FG003|NOT COMPLETED|Overall Study||1
8967056|NCT02576639|10030727|FG004|NOT COMPLETED|Overall Study||4
8967057|NCT02576652|10030743|FG000|STARTED|Overall Study||6
8967058|NCT02576652|10030743|FG000|COMPLETED|Overall Study||4
8967059|NCT02576652|10030743|FG000|NOT COMPLETED|Overall Study||2
8631838|NCT00542178|9671700|FG007|STARTED|Overall Study||466
8631839|NCT00542178|9671693|FG000|COMPLETED|Overall Study||315
8967060|NCT02576678|10030750|FG000|STARTED|Overall Study||13
8967061|NCT02576678|10030751|FG001|STARTED|Overall Study||8
8967062|NCT02576678|10030752|FG002|STARTED|Overall Study||21
8967063|NCT02576678|10030750|FG000|Pharmacokinetic (PK) Population|Overall Study||12
8967064|NCT02576678|10030751|FG001|Pharmacokinetic (PK) Population|Overall Study||8
8967065|NCT02576678|10030752|FG002|Pharmacokinetic (PK) Population|Overall Study||18
8967066|NCT02576678|10030750|FG000|COMPLETED|Overall Study||8
8967067|NCT02576678|10030751|FG001|COMPLETED|Overall Study||7
8967068|NCT02576678|10030752|FG002|COMPLETED|Overall Study||16
8967069|NCT02576678|10030750|FG000|NOT COMPLETED|Overall Study||5
8967070|NCT02576678|10030751|FG001|NOT COMPLETED|Overall Study||1
8967071|NCT02576678|10030752|FG002|NOT COMPLETED|Overall Study||5
8967072|NCT02576899|10030762|FG000|STARTED|Overall Study||16
8967073|NCT02576899|10030763|FG001|STARTED|Overall Study||20
8967074|NCT02576899|10030762|FG000|COMPLETED|Overall Study||5
8967075|NCT02576899|10030763|FG001|COMPLETED|Overall Study||7
8967076|NCT02576899|10030762|FG000|NOT COMPLETED|Overall Study||11
8967077|NCT02576899|10030763|FG001|NOT COMPLETED|Overall Study||13
8967078|NCT02576938|10030773|FG000|STARTED|Overall Study||49
8967079|NCT02576938|10030774|FG001|STARTED|Overall Study||37
8967080|NCT02576938|10030775|FG002|STARTED|Overall Study||38
8967081|NCT02576938|10030773|FG000|Received at Least One Dose of Study Drug|Overall Study||49
8967082|NCT02576938|10030774|FG001|Received at Least One Dose of Study Drug|Overall Study||37
8967083|NCT02576938|10030775|FG002|Received at Least One Dose of Study Drug|Overall Study||38
8967084|NCT02576938|10030773|FG000|COMPLETED|Overall Study||29
8967085|NCT02576938|10030774|FG001|COMPLETED|Overall Study||25
8967086|NCT02576938|10030775|FG002|COMPLETED|Overall Study||26
8967087|NCT02576938|10030773|FG000|NOT COMPLETED|Overall Study||20
8967088|NCT02576938|10030774|FG001|NOT COMPLETED|Overall Study||12
8967089|NCT02576938|10030775|FG002|NOT COMPLETED|Overall Study||12
8967090|NCT02576951|10030789|FG000|STARTED|Overall Study||15
8967091|NCT02576951|10030790|FG001|STARTED|Overall Study||3
8967092|NCT02576951|10030791|FG002|STARTED|Overall Study||80
8967093|NCT02576951|10030792|FG003|STARTED|Overall Study||80
8967094|NCT02576951|10030789|FG000|Received at Least One Dose of Study Drug|Overall Study||15
8967095|NCT02576951|10030790|FG001|Received at Least One Dose of Study Drug|Overall Study||3
8967096|NCT02576951|10030791|FG002|Received at Least One Dose of Study Drug|Overall Study||80
8967097|NCT02576951|10030792|FG003|Received at Least One Dose of Study Drug|Overall Study||80
8967098|NCT02576951|10030789|FG000|COMPLETED|Overall Study||14
8967099|NCT02576951|10030790|FG001|COMPLETED|Overall Study||3
8967100|NCT02576951|10030791|FG002|COMPLETED|Overall Study||78
8967101|NCT02576951|10030792|FG003|COMPLETED|Overall Study||75
8967102|NCT02576951|10030789|FG000|NOT COMPLETED|Overall Study||1
8967103|NCT02576951|10030790|FG001|NOT COMPLETED|Overall Study||0
8967104|NCT02576951|10030791|FG002|NOT COMPLETED|Overall Study||2
8967105|NCT02576951|10030792|FG003|NOT COMPLETED|Overall Study||5
8967106|NCT02576977|10030806|FG000|STARTED|Overall Study||126
8967107|NCT02576977|10030807|FG001|STARTED|Overall Study||125
8967108|NCT02576977|10030806|FG000|Treated|Overall Study||122
8967109|NCT02576977|10030807|FG001|Treated|Overall Study||123
8967110|NCT02576977|10030806|FG000|COMPLETED|Overall Study||0
8967111|NCT02576977|10030807|FG001|COMPLETED|Overall Study||0
8967112|NCT02576977|10030806|FG000|NOT COMPLETED|Overall Study||126
8967113|NCT02576977|10030807|FG001|NOT COMPLETED|Overall Study||125
8967114|NCT02576990|10030815|FG000|STARTED|Overall Study||56
8967115|NCT02576990|10030816|FG001|STARTED|Overall Study||24
8967116|NCT02576990|10030815|FG000|Treated|Overall Study||53
8967117|NCT02576990|10030816|FG001|Treated|Overall Study||23
8967118|NCT02576990|10030815|FG000|COMPLETED|Overall Study||0
8631840|NCT00542178|9671694|FG001|COMPLETED|Overall Study||332
8631841|NCT00542178|9671695|FG002|COMPLETED|Overall Study||308
8967119|NCT02576990|10030816|FG001|COMPLETED|Overall Study||0
8967120|NCT02576990|10030815|FG000|NOT COMPLETED|Overall Study||56
8967121|NCT02576990|10030816|FG001|NOT COMPLETED|Overall Study||24
8967122|NCT02577003|10030824|FG000|STARTED|Overall Study||73
8967123|NCT02577003|10030825|FG001|STARTED|Overall Study||70
8967124|NCT02577003|10030824|FG000|COMPLETED|Overall Study||71
8631842|NCT00542178|9671696|FG003|COMPLETED|Overall Study||308
8631843|NCT00542178|9671697|FG004|COMPLETED|Overall Study||400
8631844|NCT00542178|9671698|FG005|COMPLETED|Overall Study||406
8967125|NCT02577003|10030825|FG001|COMPLETED|Overall Study||65
8967126|NCT02577003|10030824|FG000|NOT COMPLETED|Overall Study||2
8967127|NCT02577003|10030825|FG001|NOT COMPLETED|Overall Study||5
8967128|NCT02577016|10030833|FG000|STARTED|Overall Study||70
8967129|NCT02577016|10030834|FG001|STARTED|Overall Study||71
8967130|NCT02577016|10030833|FG000|COMPLETED|Overall Study||68
8967131|NCT02577016|10030834|FG001|COMPLETED|Overall Study||69
8967132|NCT02577016|10030833|FG000|NOT COMPLETED|Overall Study||2
8967133|NCT02577016|10030834|FG001|NOT COMPLETED|Overall Study||2
8967134|NCT02577029|10030848|FG000|STARTED|Overall Study||10
8967135|NCT02577029|10030849|FG001|STARTED|Overall Study||2
8967136|NCT02577029|10030850|FG002|STARTED|Overall Study||7
8967137|NCT02577029|10030851|FG003|STARTED|Overall Study||12
8967138|NCT02577029|10030852|FG004|STARTED|Overall Study||11
8967139|NCT02577029|10030853|FG005|STARTED|Overall Study||13
8967140|NCT02577029|10030854|FG006|STARTED|Overall Study||12
8967141|NCT02577029|10030855|FG007|STARTED|Overall Study||12
8967142|NCT02577029|10030848|FG000|COMPLETED|Overall Study||0
8967143|NCT02577029|10030849|FG001|COMPLETED|Overall Study||0
8967144|NCT02577029|10030850|FG002|COMPLETED|Overall Study||0
8967145|NCT02577029|10030851|FG003|COMPLETED|Overall Study||0
8967146|NCT02577029|10030852|FG004|COMPLETED|Overall Study||0
8967147|NCT02577029|10030853|FG005|COMPLETED|Overall Study||0
8967148|NCT02577029|10030854|FG006|COMPLETED|Overall Study||0
8967149|NCT02577029|10030855|FG007|COMPLETED|Overall Study||0
8967150|NCT02577029|10030848|FG000|NOT COMPLETED|Overall Study||10
8967151|NCT02577029|10030849|FG001|NOT COMPLETED|Overall Study||2
8967152|NCT02577029|10030850|FG002|NOT COMPLETED|Overall Study||7
8967153|NCT02577029|10030851|FG003|NOT COMPLETED|Overall Study||12
8967154|NCT02577029|10030852|FG004|NOT COMPLETED|Overall Study||11
8967155|NCT02577029|10030853|FG005|NOT COMPLETED|Overall Study||13
8967156|NCT02577029|10030854|FG006|NOT COMPLETED|Overall Study||12
8967157|NCT02577029|10030855|FG007|NOT COMPLETED|Overall Study||12
8967158|NCT02577042|10030875|FG000|STARTED|Overall Study||20
8967159|NCT02577042|10030876|FG001|STARTED|Overall Study||22
8967160|NCT02577042|10030875|FG000|COMPLETED|Overall Study||15
8967161|NCT02577042|10030876|FG001|COMPLETED|Overall Study||19
8967162|NCT02577042|10030875|FG000|NOT COMPLETED|Overall Study||5
8967163|NCT02577042|10030876|FG001|NOT COMPLETED|Overall Study||3
8967164|NCT02577107|10030885|FG000|STARTED|Overall Study||6
8967165|NCT02577107|10030886|FG001|STARTED|Overall Study||6
8967166|NCT02577107|10030885|FG000|COMPLETED|Overall Study||6
8967167|NCT02577107|10030886|FG001|COMPLETED|Overall Study||5
8967168|NCT02577107|10030885|FG000|NOT COMPLETED|Overall Study||0
8967169|NCT02577107|10030886|FG001|NOT COMPLETED|Overall Study||1
8967170|NCT02577146|10030892|FG000|STARTED|Overall Study||74
8967171|NCT02577146|10030892|FG000|COMPLETED|Overall Study||46
8967172|NCT02577146|10030892|FG000|NOT COMPLETED|Overall Study||28
8967173|NCT02577315|10030898|FG000|STARTED|Treatment Period 1 (4 Days)||12
8967174|NCT02577315|10030899|FG001|STARTED|Treatment Period 1 (4 Days)||13
8967175|NCT02577315|10030898|FG000|COMPLETED|Treatment Period 1 (4 Days)||12
8967176|NCT02577315|10030899|FG001|COMPLETED|Treatment Period 1 (4 Days)||12
8967177|NCT02577315|10030898|FG000|NOT COMPLETED|Treatment Period 1 (4 Days)||0
8967178|NCT02577315|10030899|FG001|NOT COMPLETED|Treatment Period 1 (4 Days)||1
8967179|NCT02577315|10030898|FG000|STARTED|Washout Period (5 Days)||12
8967180|NCT02577315|10030899|FG001|STARTED|Washout Period (5 Days)||12
8967181|NCT02577315|10030898|FG000|COMPLETED|Washout Period (5 Days)||12
8967182|NCT02577315|10030899|FG001|COMPLETED|Washout Period (5 Days)||12
8967183|NCT02577315|10030898|FG000|NOT COMPLETED|Washout Period (5 Days)||0
8967184|NCT02577315|10030899|FG001|NOT COMPLETED|Washout Period (5 Days)||0
8967185|NCT02577315|10030898|FG000|STARTED|Treatment Period 2 (4 Days)||12
8967186|NCT02577315|10030899|FG001|STARTED|Treatment Period 2 (4 Days)||12
8967187|NCT02577315|10030898|FG000|COMPLETED|Treatment Period 2 (4 Days)||12
8967188|NCT02577315|10030899|FG001|COMPLETED|Treatment Period 2 (4 Days)||12
8967189|NCT02577315|10030898|FG000|NOT COMPLETED|Treatment Period 2 (4 Days)||0
8967190|NCT02577315|10030899|FG001|NOT COMPLETED|Treatment Period 2 (4 Days)||0
8967191|NCT02577445|10030907|FG000|STARTED|Overall Study||14
8967192|NCT02577445|10030908|FG001|STARTED|Overall Study||17
8967193|NCT02577445|10030907|FG000|COMPLETED|Overall Study|study terminated prematurely|0
8967194|NCT02577445|10030908|FG001|COMPLETED|Overall Study|study terminated prematurely|0
8967195|NCT02577445|10030907|FG000|NOT COMPLETED|Overall Study||14
8967196|NCT02577445|10030908|FG001|NOT COMPLETED|Overall Study||17
8967197|NCT02577510|10030915|FG000|STARTED|Overall Study||21
8967198|NCT02577510|10030916|FG001|STARTED|Overall Study||21
8967199|NCT02577510|10030915|FG000|COMPLETED|Overall Study||21
8967200|NCT02577510|10030916|FG001|COMPLETED|Overall Study||21
8967201|NCT02577510|10030915|FG000|NOT COMPLETED|Overall Study||0
8967202|NCT02577510|10030916|FG001|NOT COMPLETED|Overall Study||0
8967203|NCT02577601|10030925|FG000|STARTED|UPA Only (1 Month)||36
8967204|NCT02577601|10030925|FG000|COMPLETED|UPA Only (1 Month)||36
8967205|NCT02577601|10030925|FG000|NOT COMPLETED|UPA Only (1 Month)||0
8967206|NCT02577601|10030925|FG000|STARTED|Washout (1 Month)||33
8967207|NCT02577601|10030925|FG000|COMPLETED|Washout (1 Month)||33
8967208|NCT02577601|10030925|FG000|NOT COMPLETED|Washout (1 Month)||0
8967209|NCT02577601|10030925|FG000|STARTED|UPA+COC (1 Month)||33
8967210|NCT02577601|10030925|FG000|COMPLETED|UPA+COC (1 Month)||33
8967211|NCT02577601|10030925|FG000|NOT COMPLETED|UPA+COC (1 Month)||0
8967212|NCT02577640|10030936|FG000|STARTED|Dose Escalation Group 1||4
8967213|NCT02577640|10030937|FG001|STARTED|Dose Escalation Group 1||0
8967214|NCT02577640|10030938|FG002|STARTED|Dose Escalation Group 1||0
8967215|NCT02577640|10030939|FG003|STARTED|Dose Escalation Group 1||0
8967216|NCT02577640|10030936|FG000|COMPLETED|Dose Escalation Group 1||3
8967217|NCT02577640|10030937|FG001|COMPLETED|Dose Escalation Group 1||0
8967218|NCT02577640|10030938|FG002|COMPLETED|Dose Escalation Group 1||0
8967219|NCT02577640|10030939|FG003|COMPLETED|Dose Escalation Group 1||0
8725790|NCT01033422|9773143|FG002|STARTED|Overall Study||23
8725791|NCT01033422|9773141|FG000|COMPLETED|Overall Study||33
8967220|NCT02577640|10030936|FG000|NOT COMPLETED|Dose Escalation Group 1||1
8967221|NCT02577640|10030937|FG001|NOT COMPLETED|Dose Escalation Group 1||0
8967222|NCT02577640|10030938|FG002|NOT COMPLETED|Dose Escalation Group 1||0
8967223|NCT02577640|10030939|FG003|NOT COMPLETED|Dose Escalation Group 1||0
8967224|NCT02577640|10030936|FG000|STARTED|Dose Escalation Group 2||0
8967225|NCT02577640|10030937|FG001|STARTED|Dose Escalation Group 2||3
8967226|NCT02577640|10030938|FG002|STARTED|Dose Escalation Group 2||0
8967227|NCT02577640|10030939|FG003|STARTED|Dose Escalation Group 2||0
8967228|NCT02577640|10030936|FG000|COMPLETED|Dose Escalation Group 2||0
8967229|NCT02577640|10030937|FG001|COMPLETED|Dose Escalation Group 2||3
8967230|NCT02577640|10030938|FG002|COMPLETED|Dose Escalation Group 2||0
8967231|NCT02577640|10030939|FG003|COMPLETED|Dose Escalation Group 2||0
8967232|NCT02577640|10030936|FG000|NOT COMPLETED|Dose Escalation Group 2||0
8967233|NCT02577640|10030937|FG001|NOT COMPLETED|Dose Escalation Group 2||0
8967234|NCT02577640|10030938|FG002|NOT COMPLETED|Dose Escalation Group 2||0
8967235|NCT02577640|10030939|FG003|NOT COMPLETED|Dose Escalation Group 2||0
8967236|NCT02577640|10030936|FG000|STARTED|Dose Escalation Group 3||0
8967237|NCT02577640|10030937|FG001|STARTED|Dose Escalation Group 3||0
8967238|NCT02577640|10030938|FG002|STARTED|Dose Escalation Group 3||3
8967239|NCT02577640|10030939|FG003|STARTED|Dose Escalation Group 3||0
8967240|NCT02577640|10030936|FG000|COMPLETED|Dose Escalation Group 3||0
8967241|NCT02577640|10030937|FG001|COMPLETED|Dose Escalation Group 3||0
8967242|NCT02577640|10030938|FG002|COMPLETED|Dose Escalation Group 3||3
8967243|NCT02577640|10030939|FG003|COMPLETED|Dose Escalation Group 3||0
8967244|NCT02577640|10030936|FG000|NOT COMPLETED|Dose Escalation Group 3||0
8967245|NCT02577640|10030937|FG001|NOT COMPLETED|Dose Escalation Group 3||0
8967246|NCT02577640|10030938|FG002|NOT COMPLETED|Dose Escalation Group 3||0
8967247|NCT02577640|10030939|FG003|NOT COMPLETED|Dose Escalation Group 3||0
8967248|NCT02577640|10030936|FG000|STARTED|Maximally Tolerated Dose||0
8967249|NCT02577640|10030937|FG001|STARTED|Maximally Tolerated Dose||0
8967250|NCT02577640|10030938|FG002|STARTED|Maximally Tolerated Dose||0
8967251|NCT02577640|10030939|FG003|STARTED|Maximally Tolerated Dose||1
8967252|NCT02577640|10030936|FG000|COMPLETED|Maximally Tolerated Dose||0
8967253|NCT02577640|10030937|FG001|COMPLETED|Maximally Tolerated Dose||0
8967254|NCT02577640|10030938|FG002|COMPLETED|Maximally Tolerated Dose||0
8967255|NCT02577640|10030939|FG003|COMPLETED|Maximally Tolerated Dose||1
8967256|NCT02577640|10030936|FG000|NOT COMPLETED|Maximally Tolerated Dose||0
8967257|NCT02577640|10030937|FG001|NOT COMPLETED|Maximally Tolerated Dose||0
8967258|NCT02577640|10030938|FG002|NOT COMPLETED|Maximally Tolerated Dose||0
8967259|NCT02577640|10030939|FG003|NOT COMPLETED|Maximally Tolerated Dose||0
8967260|NCT02577718|10030951|FG000|STARTED|Overall Study||60
8967261|NCT02577718|10030951|FG000|COMPLETED|Overall Study||52
8967262|NCT02577718|10030951|FG000|NOT COMPLETED|Overall Study||8
8967263|NCT02577822|10030959|FG000|STARTED|Overall Study||27
8967264|NCT02577822|10030960|FG001|STARTED|Overall Study||33
8967265|NCT02577822|10030959|FG000|COMPLETED|Overall Study||21
8967266|NCT02577822|10030960|FG001|COMPLETED|Overall Study||20
8967267|NCT02577822|10030959|FG000|NOT COMPLETED|Overall Study||6
8967268|NCT02577822|10030960|FG001|NOT COMPLETED|Overall Study||13
8967269|NCT02577887|10030966|FG000|STARTED|Overall Study||2101
8967270|NCT02577887|10030966|FG000|6 Month Follow-up|Overall Study||1938
8967271|NCT02577887|10030966|FG000|COMPLETED|Overall Study||1803
8967272|NCT02577887|10030966|FG000|NOT COMPLETED|Overall Study||298
8967273|NCT02577900|10030973|FG000|STARTED|Overall Study||11
8967274|NCT02577900|10030974|FG001|STARTED|Overall Study||10
8967275|NCT02577900|10030975|FG002|STARTED|Overall Study||10
8967276|NCT02577900|10030973|FG000|COMPLETED|Overall Study||11
8967277|NCT02577900|10030974|FG001|COMPLETED|Overall Study||10
8967278|NCT02577900|10030975|FG002|COMPLETED|Overall Study||10
8967279|NCT02577900|10030973|FG000|NOT COMPLETED|Overall Study||0
8967280|NCT02577900|10030974|FG001|NOT COMPLETED|Overall Study||0
8967281|NCT02577900|10030975|FG002|NOT COMPLETED|Overall Study||0
8967282|NCT02577978|10030985|FG000|STARTED|Overall Study||32
8967283|NCT02577978|10030986|FG001|STARTED|Overall Study||29
8967284|NCT02577978|10030985|FG000|COMPLETED|Overall Study||25
8967285|NCT02577978|10030986|FG001|COMPLETED|Overall Study||25
8967286|NCT02577978|10030985|FG000|NOT COMPLETED|Overall Study||7
8967287|NCT02577978|10030986|FG001|NOT COMPLETED|Overall Study||4
8967288|NCT02577991|10030995|FG000|STARTED|Overall Study||24
8967289|NCT02577991|10030996|FG001|STARTED|Overall Study||27
8967290|NCT02577991|10030997|FG002|STARTED|Overall Study||29
8967291|NCT02577991|10030995|FG000|COMPLETED|Overall Study||21
8967292|NCT02577991|10030996|FG001|COMPLETED|Overall Study||25
8967293|NCT02577991|10030997|FG002|COMPLETED|Overall Study||29
8967294|NCT02577991|10030995|FG000|NOT COMPLETED|Overall Study||3
8967295|NCT02577991|10030996|FG001|NOT COMPLETED|Overall Study||2
8967296|NCT02577991|10030997|FG002|NOT COMPLETED|Overall Study||0
8967297|NCT02578186|10031005|FG000|STARTED|Period 1 (First of Crossover)||17
8967298|NCT02578186|10031006|FG001|STARTED|Period 1 (First of Crossover)||18
8725792|NCT01033422|9773142|FG001|COMPLETED|Overall Study||28
8967299|NCT02578186|10031005|FG000|COMPLETED|Period 1 (First of Crossover)||12
8967300|NCT02578186|10031006|FG001|COMPLETED|Period 1 (First of Crossover)||13
8967301|NCT02578186|10031005|FG000|NOT COMPLETED|Period 1 (First of Crossover)||5
8967302|NCT02578186|10031006|FG001|NOT COMPLETED|Period 1 (First of Crossover)||5
8967303|NCT02578186|10031005|FG000|STARTED|Period 2 (Second of Crossover)||12
8967304|NCT02578186|10031006|FG001|STARTED|Period 2 (Second of Crossover)||13
8967305|NCT02578186|10031005|FG000|COMPLETED|Period 2 (Second of Crossover)||12
8967306|NCT02578186|10031006|FG001|COMPLETED|Period 2 (Second of Crossover)||13
8967307|NCT02578186|10031005|FG000|NOT COMPLETED|Period 2 (Second of Crossover)||0
8967308|NCT02578186|10031006|FG001|NOT COMPLETED|Period 2 (Second of Crossover)||0
8967309|NCT02578199|10031012|FG000|STARTED|Overall Study||31
8967310|NCT02578199|10031012|FG000|COMPLETED|Overall Study||27
8967311|NCT02578199|10031012|FG000|NOT COMPLETED|Overall Study||4
8967312|NCT02578238|10031016|FG000|STARTED|Overall Study||143
8967313|NCT02578238|10031016|FG000|COMPLETED|Overall Study||143
8967314|NCT02578238|10031016|FG000|NOT COMPLETED|Overall Study||0
8967315|NCT02578316|10031020|FG000|STARTED|Study Phase||6
8967316|NCT02578316|10031020|FG000|COMPLETED|Study Phase||6
8967317|NCT02578316|10031020|FG000|NOT COMPLETED|Study Phase||0
8967318|NCT02578316|10031020|FG000|STARTED|Extension Phase||6
8967319|NCT02578316|10031020|FG000|COMPLETED|Extension Phase||0
8967320|NCT02578316|10031020|FG000|NOT COMPLETED|Extension Phase||6
8967321|NCT02578706|10031031|FG000|STARTED|Overall Study||9
8967322|NCT02578706|10031032|FG001|STARTED|Overall Study||10
8967323|NCT02578706|10031033|FG002|STARTED|Overall Study||8
8967324|NCT02578706|10031031|FG000|COMPLETED|Overall Study||8
8967325|NCT02578706|10031032|FG001|COMPLETED|Overall Study||5
8967326|NCT02578706|10031033|FG002|COMPLETED|Overall Study||8
8967327|NCT02578706|10031031|FG000|NOT COMPLETED|Overall Study||1
8967328|NCT02578706|10031032|FG001|NOT COMPLETED|Overall Study||5
8967329|NCT02578706|10031033|FG002|NOT COMPLETED|Overall Study||0
8967330|NCT02578745|10031043|FG000|STARTED|Overall Study||60
8967331|NCT02578745|10031044|FG001|STARTED|Overall Study||60
8967332|NCT02578745|10031043|FG000|COMPLETED|Overall Study||60
8967333|NCT02578745|10031044|FG001|COMPLETED|Overall Study||60
8967334|NCT02578745|10031043|FG000|NOT COMPLETED|Overall Study||0
8967335|NCT02578745|10031044|FG001|NOT COMPLETED|Overall Study||0
8967336|NCT02578862|10031053|FG000|STARTED|Overall Study||37
8967337|NCT02578862|10031054|FG001|STARTED|Overall Study||35
8967338|NCT02578862|10031053|FG000|COMPLETED|Overall Study||37
8967339|NCT02578862|10031054|FG001|COMPLETED|Overall Study||33
8967340|NCT02578862|10031053|FG000|NOT COMPLETED|Overall Study||0
8967341|NCT02578862|10031054|FG001|NOT COMPLETED|Overall Study||2
8967342|NCT02578901|10031062|FG000|STARTED|Overall Study||165
8967343|NCT02578901|10031063|FG001|STARTED|Overall Study||165
8967344|NCT02578901|10031062|FG000|COMPLETED|Overall Study||145
8967345|NCT02578901|10031063|FG001|COMPLETED|Overall Study||144
8967346|NCT02578901|10031062|FG000|NOT COMPLETED|Overall Study||20
8967347|NCT02578901|10031063|FG001|NOT COMPLETED|Overall Study||21
8967348|NCT02578940|10031069|FG000|STARTED|Overall Study||109
8967349|NCT02578940|10031069|FG000|Received 18F-fluciclovine|Overall Study||104
8967350|NCT02578940|10031069|FG000|COMPLETED|Overall Study||103
8967351|NCT02578940|10031069|FG000|NOT COMPLETED|Overall Study||6
8967352|NCT02578992|10031077|FG000|STARTED|Overall Study|November 2014|65
8967353|NCT02578992|10031078|FG001|STARTED|Overall Study|November 2014|65
8967354|NCT02578992|10031077|FG000|COMPLETED|Overall Study|October 2015|62
8967355|NCT02578992|10031078|FG001|COMPLETED|Overall Study|October 2015|62
8967356|NCT02578992|10031077|FG000|NOT COMPLETED|Overall Study||3
8967357|NCT02578992|10031078|FG001|NOT COMPLETED|Overall Study||3
8967358|NCT02579057|10031092|FG000|STARTED|Overall Study||19
8967359|NCT02579057|10031093|FG001|STARTED|Overall Study||21
8967360|NCT02579057|10031092|FG000|COMPLETED|Overall Study||19
8967361|NCT02579057|10031093|FG001|COMPLETED|Overall Study||21
8967362|NCT02579057|10031092|FG000|NOT COMPLETED|Overall Study||0
8967363|NCT02579057|10031093|FG001|NOT COMPLETED|Overall Study||0
8967364|NCT02579135|10031101|FG000|STARTED|Overall Study||107
8967365|NCT02579135|10031102|FG001|STARTED|Overall Study||115
8967366|NCT02579135|10031101|FG000|COMPLETED|Overall Study||105
8967367|NCT02579135|10031102|FG001|COMPLETED|Overall Study||106
8967368|NCT02579135|10031101|FG000|NOT COMPLETED|Overall Study||2
8967369|NCT02579135|10031102|FG001|NOT COMPLETED|Overall Study||9
8967370|NCT02579343|10031110|FG000|STARTED|Overall Study||7
8967371|NCT02579343|10031111|FG001|STARTED|Overall Study||6
8967372|NCT02579343|10031110|FG000|COMPLETED|Overall Study||7
8967373|NCT02579343|10031111|FG001|COMPLETED|Overall Study||6
8967374|NCT02579343|10031110|FG000|NOT COMPLETED|Overall Study||0
8631845|NCT00542178|9671699|FG006|COMPLETED|Overall Study||406
8631846|NCT00542178|9671700|FG007|COMPLETED|Overall Study||381
8631847|NCT00542178|9671693|FG000|NOT COMPLETED|Overall Study||75
8967375|NCT02579343|10031111|FG001|NOT COMPLETED|Overall Study||0
8967376|NCT02579382|10031121|FG000|STARTED|Main Study Phase||28
8967377|NCT02579382|10031122|FG001|STARTED|Main Study Phase||53
8631848|NCT00542178|9671694|FG001|NOT COMPLETED|Overall Study||80
8631849|NCT00542178|9671695|FG002|NOT COMPLETED|Overall Study||74
8967378|NCT02579382|10031123|FG002|STARTED|Main Study Phase||56
8967379|NCT02579382|10031124|FG003|STARTED|Main Study Phase||55
8967380|NCT02579382|10031121|FG000|COMPLETED|Main Study Phase||28
8967381|NCT02579382|10031122|FG001|COMPLETED|Main Study Phase||53
8967382|NCT02579382|10031123|FG002|COMPLETED|Main Study Phase||54
8967383|NCT02579382|10031124|FG003|COMPLETED|Main Study Phase||52
8967384|NCT02579382|10031121|FG000|NOT COMPLETED|Main Study Phase||0
8967385|NCT02579382|10031122|FG001|NOT COMPLETED|Main Study Phase||0
8967386|NCT02579382|10031123|FG002|NOT COMPLETED|Main Study Phase||2
8967387|NCT02579382|10031124|FG003|NOT COMPLETED|Main Study Phase||3
8967388|NCT02579382|10031121|FG000|STARTED|Optional Treatment Extension Phase(OTEP)|1 participant who completed the Main Study Phase did not enter the OTEP.|27
8967389|NCT02579382|10031122|FG001|STARTED|Optional Treatment Extension Phase(OTEP)|2 participants who completed the Main Study Phase did not enter the OTEP.|51
8967390|NCT02579382|10031123|FG002|STARTED|Optional Treatment Extension Phase(OTEP)||54
8967391|NCT02579382|10031124|FG003|STARTED|Optional Treatment Extension Phase(OTEP)|3 participants who completed the Main Study Phase did not enter the OTEP.|49
8967392|NCT02579382|10031121|FG000|COMPLETED|Optional Treatment Extension Phase(OTEP)||26
8967393|NCT02579382|10031122|FG001|COMPLETED|Optional Treatment Extension Phase(OTEP)||44
8967394|NCT02579382|10031123|FG002|COMPLETED|Optional Treatment Extension Phase(OTEP)||50
8967395|NCT02579382|10031124|FG003|COMPLETED|Optional Treatment Extension Phase(OTEP)||44
8967396|NCT02579382|10031121|FG000|NOT COMPLETED|Optional Treatment Extension Phase(OTEP)||1
8967397|NCT02579382|10031122|FG001|NOT COMPLETED|Optional Treatment Extension Phase(OTEP)||7
8967398|NCT02579382|10031123|FG002|NOT COMPLETED|Optional Treatment Extension Phase(OTEP)||4
8967399|NCT02579382|10031124|FG003|NOT COMPLETED|Optional Treatment Extension Phase(OTEP)||5
8967400|NCT02579421|10031146|FG000|STARTED|Overall Study||23
8967401|NCT02579421|10031147|FG001|STARTED|Overall Study||23
8967402|NCT02579421|10031148|FG002|STARTED|Overall Study||6
8967403|NCT02579421|10031149|FG003|STARTED|Overall Study||6
8631850|NCT00542178|9671696|FG003|NOT COMPLETED|Overall Study||62
8631851|NCT00542178|9671697|FG004|NOT COMPLETED|Overall Study||64
8631852|NCT00542178|9671698|FG005|NOT COMPLETED|Overall Study||89
8631853|NCT00542178|9671699|FG006|NOT COMPLETED|Overall Study||87
8631854|NCT00542178|9671700|FG007|NOT COMPLETED|Overall Study||85
8631855|NCT00542191|9671714|FG000|STARTED|Overall Study||21
8631856|NCT00542191|9671714|FG000|COMPLETED|Overall Study||18
8631857|NCT00542191|9671714|FG000|NOT COMPLETED|Overall Study||3
8631858|NCT00542269|9671721|FG000|STARTED|Overall Study||61
8876551|NCT01917656|9933378|FG001|Exposed|Overall Study|1 subject was withdrawn prior to exposure to first SU dose after randomisation|170
8876552|NCT01917656|9933377|FG000|Exposed During Ramadan (Fasting)|Overall Study||152
8876553|NCT01917656|9933378|FG001|Exposed During Ramadan (Fasting)|Overall Study||163
8876554|NCT01917656|9933377|FG000|COMPLETED|Overall Study||146
8967404|NCT02579421|10031146|FG000|COMPLETED|Overall Study||17
8967405|NCT02579421|10031147|FG001|COMPLETED|Overall Study||18
8967406|NCT02579421|10031148|FG002|COMPLETED|Overall Study||5
8967407|NCT02579421|10031149|FG003|COMPLETED|Overall Study||3
8967408|NCT02579421|10031146|FG000|NOT COMPLETED|Overall Study||6
8967409|NCT02579421|10031147|FG001|NOT COMPLETED|Overall Study||5
8967410|NCT02579421|10031148|FG002|NOT COMPLETED|Overall Study||1
8967411|NCT02579421|10031149|FG003|NOT COMPLETED|Overall Study||3
9038032|NCT03327220|10099359|FG000|Safety Population: Received Study Treatment|Overall Study||59
9038033|NCT03327220|10099360|FG001|Safety Population: Received Study Treatment|Overall Study||60
9038034|NCT03327220|10099359|FG000|COMPLETED|Overall Study||57
9038035|NCT03327220|10099360|FG001|COMPLETED|Overall Study||58
9038036|NCT03327220|10099359|FG000|NOT COMPLETED|Overall Study||5
9038037|NCT03327220|10099360|FG001|NOT COMPLETED|Overall Study||4
9038038|NCT03327402|10099366|FG000|STARTED|Overall Study||24
9038039|NCT03327402|10099366|FG000|Rich PK Sampling Group|Overall Study||12
9038040|NCT03327402|10099366|FG000|Sparse PK Sampling Group|Overall Study||12
9038041|NCT03327402|10099366|FG000|COMPLETED|Overall Study||22
9038042|NCT03327402|10099366|FG000|NOT COMPLETED|Overall Study||2
9038043|NCT03327571|10099372|FG000|STARTED|Group 1: cHL||1598
9038044|NCT03327571|10099373|FG001|STARTED|Group 1: cHL||0
9038045|NCT03327571|10099372|FG000|COMPLETED|Group 1: cHL||1598
9038046|NCT03327571|10099373|FG001|COMPLETED|Group 1: cHL||0
9038047|NCT03327571|10099372|FG000|NOT COMPLETED|Group 1: cHL||0
9038048|NCT03327571|10099373|FG001|NOT COMPLETED|Group 1: cHL||0
9038049|NCT03327571|10099372|FG000|STARTED|Group 2: RRHL||0
9038050|NCT03327571|10099373|FG001|STARTED|Group 2: RRHL|105 RRHL only participants and 321 common participants who had CHL, and subsequently RRHL between 2010-2013.|426
9038051|NCT03327571|10099372|FG000|Participants Were Counted in Both Groups|Group 2: RRHL||0
9038052|NCT03327571|10099373|FG001|Participants Were Counted in Both Groups|Group 2: RRHL|Participants who were diagnosed with CHL, and subsequently RRHL between 2010 and 2013.|321
9038053|NCT03327571|10099372|FG000|COMPLETED|Group 2: RRHL||0
9038054|NCT03327571|10099373|FG001|COMPLETED|Group 2: RRHL||426
9038055|NCT03327571|10099372|FG000|NOT COMPLETED|Group 2: RRHL||0
9038056|NCT03327571|10099373|FG001|NOT COMPLETED|Group 2: RRHL||0
8631859|NCT00542269|9671722|FG001|STARTED|Overall Study||60
8631860|NCT00542269|9671723|FG002|STARTED|Overall Study||57
8631861|NCT00542269|9671721|FG000|COMPLETED|Overall Study||48
8631862|NCT00542269|9671722|FG001|COMPLETED|Overall Study||54
8631863|NCT00542269|9671723|FG002|COMPLETED|Overall Study||51
8876555|NCT01917656|9933378|FG001|COMPLETED|Overall Study||147
8876556|NCT01917656|9933377|FG000|NOT COMPLETED|Overall Study||26
8876557|NCT01917656|9933378|FG001|NOT COMPLETED|Overall Study||24
8876558|NCT01917682|9933384|FG000|STARTED|Overall Study||754
8876559|NCT01917682|9933384|FG000|COMPLETED|Overall Study||754
8876560|NCT01917682|9933384|FG000|NOT COMPLETED|Overall Study||0
8876561|NCT01917747|9933391|FG000|STARTED|Overall Study||60
8876562|NCT01917747|9933392|FG001|STARTED|Overall Study||46
8876563|NCT01917747|9933391|FG000|COMPLETED|Overall Study||41
8631864|NCT00542269|9671721|FG000|NOT COMPLETED|Overall Study||13
8631865|NCT00542269|9671722|FG001|NOT COMPLETED|Overall Study||6
8967412|NCT02579603|10031161|FG000|STARTED|Overall Study|Started are the randomised patients|52
8967413|NCT02579603|10031162|FG001|STARTED|Overall Study|Started are the randomised patients|53
8967414|NCT02579603|10031161|FG000|Number of Patients Treated|Overall Study||51
8967415|NCT02579603|10031162|FG001|Number of Patients Treated|Overall Study||53
8967416|NCT02579603|10031161|FG000|COMPLETED|Overall Study||48
8967417|NCT02579603|10031162|FG001|COMPLETED|Overall Study||51
8967418|NCT02579603|10031161|FG000|NOT COMPLETED|Overall Study||4
8967419|NCT02579603|10031162|FG001|NOT COMPLETED|Overall Study||2
8967420|NCT02579616|10031169|FG000|STARTED|Overall Study||29
8967421|NCT02579616|10031169|FG000|Treated|Overall Study||26
8967422|NCT02579616|10031169|FG000|COMPLETED|Overall Study||26
8967423|NCT02579616|10031169|FG000|NOT COMPLETED|Overall Study||3
8967424|NCT02579629|10031176|FG000|STARTED|Overall Study||22
8967425|NCT02579629|10031177|FG001|STARTED|Overall Study||20
8967426|NCT02579629|10031178|FG002|STARTED|Overall Study||22
8967427|NCT02579629|10031176|FG000|COMPLETED|Overall Study||20
8967428|NCT02579629|10031177|FG001|COMPLETED|Overall Study||19
8967429|NCT02579629|10031178|FG002|COMPLETED|Overall Study||20
8967430|NCT02579629|10031176|FG000|NOT COMPLETED|Overall Study||2
8967431|NCT02579629|10031177|FG001|NOT COMPLETED|Overall Study||1
8967432|NCT02579629|10031178|FG002|NOT COMPLETED|Overall Study||2
8967433|NCT02579759|10031189|FG000|STARTED|Overall Study||109
8967434|NCT02579759|10031190|FG001|STARTED|Overall Study||113
8967435|NCT02579759|10031191|FG002|STARTED|Overall Study||101
8967436|NCT02579759|10031189|FG000|COMPLETED|Overall Study||85
8967437|NCT02579759|10031190|FG001|COMPLETED|Overall Study||49
8967438|NCT02579759|10031191|FG002|COMPLETED|Overall Study||80
8967439|NCT02579759|10031189|FG000|NOT COMPLETED|Overall Study||24
8967440|NCT02579759|10031190|FG001|NOT COMPLETED|Overall Study||64
8967441|NCT02579759|10031191|FG002|NOT COMPLETED|Overall Study||21
8967442|NCT02579772|10031201|FG000|STARTED|Overall Study||8
8967443|NCT02579772|10031202|FG001|STARTED|Overall Study||5
8967444|NCT02579772|10031201|FG000|COMPLETED|Overall Study||6
8967445|NCT02579772|10031202|FG001|COMPLETED|Overall Study||3
8967446|NCT02579772|10031201|FG000|NOT COMPLETED|Overall Study||2
8967447|NCT02579772|10031202|FG001|NOT COMPLETED|Overall Study||2
8967448|NCT02579811|10031208|FG000|STARTED|Overall Study||40
8967449|NCT02579811|10031208|FG000|COMPLETED|Overall Study||40
8967450|NCT02579811|10031208|FG000|NOT COMPLETED|Overall Study||0
8967451|NCT02579863|10031214|FG000|STARTED|Overall Study||156
8967452|NCT02579863|10031215|FG001|STARTED|Overall Study||154
8967453|NCT02579863|10031214|FG000|Treated|Overall Study||154
8967454|NCT02579863|10031215|FG001|Treated|Overall Study||148
8967455|NCT02579863|10031214|FG000|COMPLETED|Overall Study||0
8967456|NCT02579863|10031215|FG001|COMPLETED|Overall Study||0
8967457|NCT02579863|10031214|FG000|NOT COMPLETED|Overall Study||156
8967458|NCT02579863|10031215|FG001|NOT COMPLETED|Overall Study||154
8967459|NCT02579876|10031223|FG000|STARTED|Overall Study||15
8967460|NCT02579876|10031224|FG001|STARTED|Overall Study||5
8967461|NCT02579876|10031223|FG000|COMPLETED|Overall Study||14
8967462|NCT02579876|10031224|FG001|COMPLETED|Overall Study||5
8967463|NCT02579876|10031223|FG000|NOT COMPLETED|Overall Study||1
8967464|NCT02579876|10031224|FG001|NOT COMPLETED|Overall Study||0
8967465|NCT02579915|10031232|FG000|STARTED|Overall Study||19
8967466|NCT02579915|10031233|FG001|STARTED|Overall Study||21
8967467|NCT02579915|10031232|FG000|COMPLETED|Overall Study||9
8967468|NCT02579915|10031233|FG001|COMPLETED|Overall Study||16
8967469|NCT02579915|10031232|FG000|NOT COMPLETED|Overall Study||10
8967470|NCT02579915|10031233|FG001|NOT COMPLETED|Overall Study||5
8967471|NCT02579928|10031241|FG000|STARTED|Overall Study||6
8967472|NCT02579928|10031242|FG001|STARTED|Overall Study||11
8967473|NCT02579928|10031241|FG000|COMPLETED|Overall Study||5
8876564|NCT01917747|9933392|FG001|COMPLETED|Overall Study||35
8876565|NCT01917747|9933391|FG000|NOT COMPLETED|Overall Study||19
8876566|NCT01917747|9933392|FG001|NOT COMPLETED|Overall Study||11
8876567|NCT01917773|9933402|FG000|STARTED|Overall Study||13
8876568|NCT01917773|9933402|FG000|COMPLETED|Overall Study||13
8876569|NCT01917773|9933402|FG000|NOT COMPLETED|Overall Study||0
8876570|NCT01917812|9933411|FG000|STARTED|Overall Study||16
8876571|NCT01917812|9933412|FG001|STARTED|Overall Study||16
8876572|NCT01917812|9933413|FG002|STARTED|Overall Study||16
8876573|NCT01917812|9933411|FG000|COMPLETED|Overall Study||15
8876574|NCT01917812|9933412|FG001|COMPLETED|Overall Study||16
8967474|NCT02579928|10031242|FG001|COMPLETED|Overall Study||11
8967475|NCT02579928|10031241|FG000|NOT COMPLETED|Overall Study||1
8967476|NCT02579928|10031242|FG001|NOT COMPLETED|Overall Study||0
8967477|NCT02580188|10031250|FG000|STARTED|Overall Study||35
8967478|NCT02580188|10031251|FG001|STARTED|Overall Study||35
8967479|NCT02580188|10031250|FG000|COMPLETED|Overall Study||32
8967480|NCT02580188|10031251|FG001|COMPLETED|Overall Study||32
8967481|NCT02580188|10031250|FG000|NOT COMPLETED|Overall Study||3
8967482|NCT02580188|10031251|FG001|NOT COMPLETED|Overall Study||3
8967483|NCT02580201|10031260|FG000|STARTED|Overall Study||50
8967484|NCT02580201|10031261|FG001|STARTED|Overall Study||104
8967485|NCT02580201|10031260|FG000|COMPLETED|Overall Study||50
8967486|NCT02580201|10031261|FG001|COMPLETED|Overall Study||104
8967487|NCT02580201|10031260|FG000|NOT COMPLETED|Overall Study||0
8967488|NCT02580201|10031261|FG001|NOT COMPLETED|Overall Study||0
8876575|NCT01917812|9933413|FG002|COMPLETED|Overall Study||16
8967489|NCT02580240|10031270|FG000|STARTED|Overall Study||62
8967490|NCT02580240|10031271|FG001|STARTED|Overall Study||58
8967491|NCT02580240|10031270|FG000|COMPLETED|Overall Study||60
8967492|NCT02580240|10031271|FG001|COMPLETED|Overall Study||58
8967493|NCT02580240|10031270|FG000|NOT COMPLETED|Overall Study||2
8967494|NCT02580240|10031271|FG001|NOT COMPLETED|Overall Study||0
8967495|NCT02580318|10031277|FG000|STARTED|Overall Study||54
8967496|NCT02580318|10031277|FG000|Poor Effort|Overall Study||53
8967497|NCT02580318|10031277|FG000|Hyperventilation (Immediate)|Overall Study||54
8967498|NCT02580318|10031277|FG000|Hyperventilation (5 Minutes)|Overall Study||54
8967499|NCT02580318|10031277|FG000|Hyperventilation (10 Minutes)|Overall Study||54
8967500|NCT02580318|10031277|FG000|Drinking Water (Immediate)|Overall Study||51
8967501|NCT02580318|10031277|FG000|Drinking Water (5 Minutes)|Overall Study||54
8967502|NCT02580318|10031277|FG000|COMPLETED|Overall Study||54
8967503|NCT02580318|10031277|FG000|NOT COMPLETED|Overall Study||0
8967504|NCT02580357|10031284|FG000|STARTED|Overall Study||18
8967505|NCT02580357|10031285|FG001|STARTED|Overall Study||18
8967506|NCT02580357|10031286|FG002|STARTED|Overall Study||18
8967507|NCT02580357|10031284|FG000|COMPLETED|Overall Study||15
8967508|NCT02580357|10031285|FG001|COMPLETED|Overall Study||18
8967509|NCT02580357|10031286|FG002|COMPLETED|Overall Study||18
8967510|NCT02580357|10031284|FG000|NOT COMPLETED|Overall Study||3
8967511|NCT02580357|10031285|FG001|NOT COMPLETED|Overall Study||0
8967512|NCT02580357|10031286|FG002|NOT COMPLETED|Overall Study||0
8967513|NCT02580591|10031298|FG000|STARTED|Overall Study||242
8967514|NCT02580591|10031299|FG001|STARTED|Overall Study||242
8967515|NCT02580591|10031300|FG002|STARTED|Overall Study||248
8967516|NCT02580591|10031301|FG003|STARTED|Overall Study||245
8967517|NCT02580591|10031298|FG000|Treated|Overall Study||241
8967518|NCT02580591|10031299|FG001|Treated|Overall Study||241
8967519|NCT02580591|10031300|FG002|Treated|Overall Study||248
8967520|NCT02580591|10031301|FG003|Treated|Overall Study||245
8967521|NCT02580591|10031298|FG000|COMPLETED|Overall Study||224
8967522|NCT02580591|10031299|FG001|COMPLETED|Overall Study||232
8967523|NCT02580591|10031300|FG002|COMPLETED|Overall Study||235
8967524|NCT02580591|10031301|FG003|COMPLETED|Overall Study||233
8967525|NCT02580591|10031298|FG000|NOT COMPLETED|Overall Study||18
8967526|NCT02580591|10031299|FG001|NOT COMPLETED|Overall Study||10
8967527|NCT02580591|10031300|FG002|NOT COMPLETED|Overall Study||13
8967528|NCT02580591|10031301|FG003|NOT COMPLETED|Overall Study||12
8967529|NCT02580799|10031311|FG000|STARTED|Overall Study||30
8967530|NCT02580799|10031311|FG000|COMPLETED|Overall Study||30
8967531|NCT02580799|10031311|FG000|NOT COMPLETED|Overall Study||0
8967532|NCT02580877|10031317|FG000|STARTED|Overall Study||45
8967533|NCT02580877|10031318|FG001|STARTED|Overall Study||47
8967534|NCT02580877|10031317|FG000|COMPLETED|Overall Study||44
8967535|NCT02580877|10031318|FG001|COMPLETED|Overall Study||43
8967536|NCT02580877|10031317|FG000|NOT COMPLETED|Overall Study||1
8967537|NCT02580877|10031318|FG001|NOT COMPLETED|Overall Study||4
8967538|NCT02581111|10031327|FG000|STARTED|Overall Study||98
8967539|NCT02581111|10031328|FG001|STARTED|Overall Study||101
8967540|NCT02581111|10031327|FG000|COMPLETED|Overall Study||96
8967541|NCT02581111|10031328|FG001|COMPLETED|Overall Study||94
8967542|NCT02581111|10031327|FG000|NOT COMPLETED|Overall Study||2
8570705|NCT00105157|9602884|FG001|STARTED|Open-Label Continuation of DB||31
8570706|NCT00105157|9602885|FG002|STARTED|Open-Label Continuation of DB||33
8967543|NCT02581111|10031328|FG001|NOT COMPLETED|Overall Study||7
8967544|NCT02581163|10031334|FG000|STARTED|Overall Study||311
8967545|NCT02581163|10031334|FG000|COMPLETED|Overall Study||282
8967546|NCT02581163|10031334|FG000|NOT COMPLETED|Overall Study||29
8967547|NCT02581189|10031341|FG000|STARTED|Overall Study||534
8967548|NCT02581189|10031341|FG000|COMPLETED|Overall Study||481
8967549|NCT02581189|10031341|FG000|NOT COMPLETED|Overall Study||53
8967550|NCT02581202|10031348|FG000|STARTED|Overall Study||216
8967551|NCT02581202|10031348|FG000|COMPLETED|Overall Study||202
8967552|NCT02581202|10031348|FG000|NOT COMPLETED|Overall Study||14
8967553|NCT02581345|10031355|FG000|STARTED|Part 1: up to Week 16||286
8967554|NCT02581345|10031356|FG001|STARTED|Part 1: up to Week 16||286
8967555|NCT02581345|10031357|FG002|STARTED|Part 1: up to Week 16||0
8967556|NCT02581345|10031358|FG003|STARTED|Part 1: up to Week 16||0
8967557|NCT02581345|10031355|FG000|COMPLETED|Part 1: up to Week 16||271
8967558|NCT02581345|10031356|FG001|COMPLETED|Part 1: up to Week 16||263
8967559|NCT02581345|10031357|FG002|COMPLETED|Part 1: up to Week 16||0
8967560|NCT02581345|10031358|FG003|COMPLETED|Part 1: up to Week 16||0
8967561|NCT02581345|10031355|FG000|NOT COMPLETED|Part 1: up to Week 16||15
8967562|NCT02581345|10031356|FG001|NOT COMPLETED|Part 1: up to Week 16||23
8967563|NCT02581345|10031357|FG002|NOT COMPLETED|Part 1: up to Week 16||0
8967564|NCT02581345|10031358|FG003|NOT COMPLETED|Part 1: up to Week 16||0
8967565|NCT02581345|10031355|FG000|STARTED|Part 2: Week 17 to Week 47||271
8967566|NCT02581345|10031356|FG001|STARTED|Part 2: Week 17 to Week 47||0
8967567|NCT02581345|10031357|FG002|STARTED|Part 2: Week 17 to Week 47||132
8967568|NCT02581345|10031358|FG003|STARTED|Part 2: Week 17 to Week 47||131
8967569|NCT02581345|10031355|FG000|COMPLETED|Part 2: Week 17 to Week 47||242
8967570|NCT02581345|10031356|FG001|COMPLETED|Part 2: Week 17 to Week 47||0
8967571|NCT02581345|10031357|FG002|COMPLETED|Part 2: Week 17 to Week 47||117
8967572|NCT02581345|10031358|FG003|COMPLETED|Part 2: Week 17 to Week 47||119
8967573|NCT02581345|10031355|FG000|NOT COMPLETED|Part 2: Week 17 to Week 47||29
8967574|NCT02581345|10031356|FG001|NOT COMPLETED|Part 2: Week 17 to Week 47||0
8967575|NCT02581345|10031357|FG002|NOT COMPLETED|Part 2: Week 17 to Week 47||15
8967576|NCT02581345|10031358|FG003|NOT COMPLETED|Part 2: Week 17 to Week 47||12
8967577|NCT02581384|10031376|FG000|STARTED|Overall Study||3
8967578|NCT02581384|10031377|FG001|STARTED|Overall Study||2
8967579|NCT02581384|10031376|FG000|COMPLETED|Overall Study||3
8967580|NCT02581384|10031377|FG001|COMPLETED|Overall Study||2
8967581|NCT02581384|10031376|FG000|NOT COMPLETED|Overall Study||0
8967582|NCT02581384|10031377|FG001|NOT COMPLETED|Overall Study||0
8967583|NCT02581410|10031386|FG000|STARTED|Vaccination Phase||215
8967584|NCT02581410|10031387|FG001|STARTED|Vaccination Phase||215
8967585|NCT02581410|10031386|FG000|COMPLETED|Vaccination Phase||213
8967586|NCT02581410|10031387|FG001|COMPLETED|Vaccination Phase||212
8967587|NCT02581410|10031386|FG000|NOT COMPLETED|Vaccination Phase||2
8631866|NCT00542269|9671723|FG002|NOT COMPLETED|Overall Study||6
8631867|NCT00542308|9671733|FG000|STARTED|Overall Study||90
8967588|NCT02581410|10031387|FG001|NOT COMPLETED|Vaccination Phase||3
8967589|NCT02581410|10031386|FG000|STARTED|End of Study Phase||215
8967590|NCT02581410|10031387|FG001|STARTED|End of Study Phase||215
8967591|NCT02581410|10031386|FG000|COMPLETED|End of Study Phase||210
8967592|NCT02581410|10031387|FG001|COMPLETED|End of Study Phase||204
8967593|NCT02581410|10031386|FG000|NOT COMPLETED|End of Study Phase||5
8967594|NCT02581410|10031387|FG001|NOT COMPLETED|End of Study Phase||11
8967595|NCT02581475|10031396|FG000|STARTED|Overall Study||193
8967596|NCT02581475|10031397|FG001|STARTED|Overall Study||193
8967597|NCT02581475|10031396|FG000|COMPLETED|Overall Study||182
8967598|NCT02581475|10031397|FG001|COMPLETED|Overall Study||178
8967599|NCT02581475|10031396|FG000|NOT COMPLETED|Overall Study||11
8967600|NCT02581475|10031397|FG001|NOT COMPLETED|Overall Study||15
8967601|NCT02581488|10031405|FG000|STARTED|Overall Study||51
8967602|NCT02581488|10031406|FG001|STARTED|Overall Study||51
8967603|NCT02581488|10031405|FG000|COMPLETED|Overall Study||42
8967604|NCT02581488|10031406|FG001|COMPLETED|Overall Study||40
8967605|NCT02581488|10031405|FG000|NOT COMPLETED|Overall Study||9
8967606|NCT02581488|10031406|FG001|NOT COMPLETED|Overall Study||11
8967607|NCT02581839|10031412|FG000|STARTED|Overall Study||9
8967608|NCT02581839|10031412|FG000|COMPLETED|Overall Study||9
8967609|NCT02581839|10031412|FG000|NOT COMPLETED|Overall Study||0
8967610|NCT02581865|10031419|FG000|STARTED|Overall Study||40
8967611|NCT02581865|10031420|FG001|STARTED|Overall Study||42
8967612|NCT02581865|10031421|FG002|STARTED|Overall Study||42
8967613|NCT02581865|10031419|FG000|COMPLETED|Overall Study||36
8967614|NCT02581865|10031420|FG001|COMPLETED|Overall Study||35
8967615|NCT02581865|10031421|FG002|COMPLETED|Overall Study||26
8967616|NCT02581865|10031419|FG000|NOT COMPLETED|Overall Study||4
8967617|NCT02581865|10031420|FG001|NOT COMPLETED|Overall Study||7
8967618|NCT02581865|10031421|FG002|NOT COMPLETED|Overall Study||16
8967619|NCT02581891|10031434|FG000|STARTED|Overall Study||135
8967620|NCT02581891|10031435|FG001|STARTED|Overall Study||136
8967621|NCT02581891|10031434|FG000|Completed Treatment|Overall Study||120
8967622|NCT02581891|10031435|FG001|Completed Treatment|Overall Study||117
8967623|NCT02581891|10031434|FG000|COMPLETED|Overall Study||119
8967624|NCT02581891|10031435|FG001|COMPLETED|Overall Study||117
8967625|NCT02581891|10031434|FG000|NOT COMPLETED|Overall Study||16
8967626|NCT02581891|10031435|FG001|NOT COMPLETED|Overall Study||19
8967627|NCT02581995|10031442|FG000|STARTED|Overall Study||560
8967628|NCT02581995|10031442|FG000|Treated|Overall Study||560
8967629|NCT02581995|10031442|FG000|COMPLETED|Overall Study||529
8967630|NCT02581995|10031442|FG000|NOT COMPLETED|Overall Study||31
8967631|NCT02582151|10031448|FG000|STARTED|Overall Study||14
8967632|NCT02582151|10031449|FG001|STARTED|Overall Study||16
8967633|NCT02582151|10031448|FG000|COMPLETED|Overall Study||12
8967634|NCT02582151|10031449|FG001|COMPLETED|Overall Study||16
8967635|NCT02582151|10031448|FG000|NOT COMPLETED|Overall Study||2
8967636|NCT02582151|10031449|FG001|NOT COMPLETED|Overall Study||0
8967637|NCT02582216|10031455|FG000|STARTED|Overall Study||22
8967638|NCT02582216|10031455|FG000|COMPLETED|Overall Study||22
8967639|NCT02582216|10031455|FG000|NOT COMPLETED|Overall Study||0
8967640|NCT02582242|10031462|FG000|STARTED|Overall Study||220
8967641|NCT02582242|10031463|FG001|STARTED|Overall Study||217
8967642|NCT02582242|10031462|FG000|COMPLETED|Overall Study||200
8967643|NCT02582242|10031463|FG001|COMPLETED|Overall Study||200
8967644|NCT02582242|10031462|FG000|NOT COMPLETED|Overall Study||20
8967645|NCT02582242|10031463|FG001|NOT COMPLETED|Overall Study||17
8967646|NCT02582255|10031471|FG000|STARTED|Overall Study||50
8967647|NCT02582255|10031472|FG001|STARTED|Overall Study||50
8967648|NCT02582255|10031471|FG000|COMPLETED|Overall Study||50
8967649|NCT02582255|10031472|FG001|COMPLETED|Overall Study||47
8967650|NCT02582255|10031471|FG000|NOT COMPLETED|Overall Study||0
8967651|NCT02582255|10031472|FG001|NOT COMPLETED|Overall Study||3
8967652|NCT02582515|10031481|FG000|STARTED|Overall Study||9
8967653|NCT02582515|10031482|FG001|STARTED|Overall Study||11
8967654|NCT02582515|10031481|FG000|Received Study Intervention|Overall Study||9
8967655|NCT02582515|10031482|FG001|Received Study Intervention|Overall Study||10
8967656|NCT02582515|10031481|FG000|COMPLETED|Overall Study||9
8967657|NCT02582515|10031482|FG001|COMPLETED|Overall Study||10
8967658|NCT02582515|10031481|FG000|NOT COMPLETED|Overall Study||0
8967659|NCT02582515|10031482|FG001|NOT COMPLETED|Overall Study||1
8967660|NCT02582632|10031488|FG000|STARTED|Overall Study||166
8967661|NCT02582632|10031488|FG000|COMPLETED|Overall Study||165
8967662|NCT02582632|10031488|FG000|NOT COMPLETED|Overall Study||1
8967663|NCT02582658|10031492|FG000|STARTED|Overall Study||171
8967664|NCT02582658|10031492|FG000|COMPLETED|Overall Study||146
8967665|NCT02582658|10031492|FG000|NOT COMPLETED|Overall Study||25
8967666|NCT02582671|10031496|FG000|STARTED|Overall Study||101
8967667|NCT02582671|10031496|FG000|COMPLETED|Overall Study||99
8631868|NCT00542308|9671733|FG000|COMPLETED|Overall Study||90
8631869|NCT00542308|9671733|FG000|NOT COMPLETED|Overall Study||0
8631870|NCT00542321|9671739|FG000|STARTED|Overall Study||8
8631871|NCT00542321|9671740|FG001|STARTED|Overall Study||8
8631872|NCT00542321|9671739|FG000|COMPLETED|Overall Study||8
8631873|NCT00542321|9671740|FG001|COMPLETED|Overall Study||7
8631874|NCT00542321|9671739|FG000|NOT COMPLETED|Overall Study||0
8876576|NCT01917812|9933411|FG000|NOT COMPLETED|Overall Study||1
8876577|NCT01917812|9933412|FG001|NOT COMPLETED|Overall Study||0
8876578|NCT01917812|9933413|FG002|NOT COMPLETED|Overall Study||0
8876579|NCT01917968|9933423|FG000|STARTED|Overall Study||225
8876580|NCT01917968|9933424|FG001|STARTED|Overall Study||485
8876581|NCT01917968|9933423|FG000|COMPLETED|Overall Study||171
8876582|NCT01917968|9933424|FG001|COMPLETED|Overall Study||401
8876583|NCT01917968|9933423|FG000|NOT COMPLETED|Overall Study||54
8876584|NCT01917968|9933424|FG001|NOT COMPLETED|Overall Study||84
8876585|NCT01918072|9933437|FG000|STARTED|Controlled Trial Step One - Six Months||11
8876586|NCT01918072|9933438|FG001|STARTED|Controlled Trial Step One - Six Months||0
8876587|NCT01918072|9933439|FG002|STARTED|Controlled Trial Step One - Six Months||0
8876588|NCT01918072|9933437|FG000|Intervention|Controlled Trial Step One - Six Months||1
8876589|NCT01918072|9933438|FG001|Intervention|Controlled Trial Step One - Six Months||0
8967668|NCT02582671|10031496|FG000|NOT COMPLETED|Overall Study||2
8967669|NCT02582684|10031501|FG000|STARTED|Overall Study||122
8967670|NCT02582684|10031501|FG000|COMPLETED|Overall Study||105
8967671|NCT02582684|10031501|FG000|NOT COMPLETED|Overall Study||17
8967672|NCT02582814|10031507|FG000|STARTED|Overall Study||76
8967673|NCT02582814|10031508|FG001|STARTED|Overall Study||75
8967674|NCT02582814|10031507|FG000|COMPLETED|Overall Study||67
8967675|NCT02582814|10031508|FG001|COMPLETED|Overall Study||68
8967676|NCT02582814|10031507|FG000|NOT COMPLETED|Overall Study||9
8967677|NCT02582814|10031508|FG001|NOT COMPLETED|Overall Study||7
8631875|NCT00542321|9671740|FG001|NOT COMPLETED|Overall Study||1
8967678|NCT02582840|10031517|FG000|STARTED|Overall Study||14
8967679|NCT02582840|10031518|FG001|STARTED|Overall Study||14
8967680|NCT02582840|10031519|FG002|STARTED|Overall Study||14
8967681|NCT02582840|10031517|FG000|COMPLETED|Overall Study||14
8967682|NCT02582840|10031518|FG001|COMPLETED|Overall Study||14
8967683|NCT02582840|10031519|FG002|COMPLETED|Overall Study||14
8967684|NCT02582840|10031517|FG000|NOT COMPLETED|Overall Study||0
8967685|NCT02582840|10031518|FG001|NOT COMPLETED|Overall Study||0
8967686|NCT02582840|10031519|FG002|NOT COMPLETED|Overall Study||0
8967687|NCT02582866|10031529|FG000|STARTED|Overall Study||106
8967688|NCT02582866|10031529|FG000|COMPLETED|Overall Study||84
8967689|NCT02582866|10031529|FG000|NOT COMPLETED|Overall Study||22
8967690|NCT02582970|10031533|FG000|STARTED|Overall Study||40
8967691|NCT02582970|10031533|FG000|COMPLETED|Overall Study||40
8967692|NCT02582970|10031533|FG000|NOT COMPLETED|Overall Study||0
8967693|NCT02582983|10031537|FG000|STARTED|Overall Study||23
8967694|NCT02582983|10031537|FG000|COMPLETED|Overall Study||17
8967695|NCT02582983|10031537|FG000|NOT COMPLETED|Overall Study||6
8967696|NCT02583230|10031541|FG000|STARTED|Overall Study||11
8967697|NCT02583230|10031541|FG000|COMPLETED|Overall Study||11
8967698|NCT02583230|10031541|FG000|NOT COMPLETED|Overall Study||0
8967699|NCT02583256|10031549|FG000|STARTED|Overall Study||403
8967700|NCT02583256|10031550|FG001|STARTED|Overall Study||403
8967701|NCT02583256|10031551|FG002|STARTED|Overall Study||402
8967702|NCT02583256|10031552|FG003|STARTED|Overall Study||393
8967703|NCT02583256|10031549|FG000|Exposed|Overall Study||403
8967704|NCT02583256|10031550|FG001|Exposed|Overall Study||403
8967705|NCT02583256|10031551|FG002|Exposed|Overall Study||402
8967706|NCT02583256|10031552|FG003|Exposed|Overall Study||393
8967707|NCT02583256|10031549|FG000|COMPLETED|Overall Study||400
8967708|NCT02583256|10031550|FG001|COMPLETED|Overall Study||401
8967709|NCT02583256|10031551|FG002|COMPLETED|Overall Study||400
8967710|NCT02583256|10031552|FG003|COMPLETED|Overall Study||390
8967711|NCT02583256|10031549|FG000|NOT COMPLETED|Overall Study||3
8967712|NCT02583256|10031550|FG001|NOT COMPLETED|Overall Study||2
8967713|NCT02583256|10031551|FG002|NOT COMPLETED|Overall Study||2
8967714|NCT02583256|10031552|FG003|NOT COMPLETED|Overall Study||3
8967715|NCT02583360|10031566|FG000|STARTED|Overall Study||60
8967716|NCT02583360|10031567|FG001|STARTED|Overall Study||49
8967717|NCT02583360|10031566|FG000|COMPLETED|Overall Study||60
8967718|NCT02583360|10031567|FG001|COMPLETED|Overall Study||49
8967719|NCT02583360|10031566|FG000|NOT COMPLETED|Overall Study||0
8967720|NCT02583360|10031567|FG001|NOT COMPLETED|Overall Study||0
8967721|NCT02583399|10031573|FG000|STARTED|Overall Study||30
8967722|NCT02583399|10031573|FG000|COMPLETED|Overall Study||24
8967723|NCT02583399|10031573|FG000|NOT COMPLETED|Overall Study||6
8967724|NCT02583425|10031577|FG000|STARTED|Screening||27
8967725|NCT02583425|10031577|FG000|COMPLETED|Screening||15
8967726|NCT02583425|10031577|FG000|NOT COMPLETED|Screening||12
8967727|NCT02583425|10031577|FG000|STARTED|Baseline||15
8967728|NCT02583425|10031577|FG000|COMPLETED|Baseline||10
8967729|NCT02583425|10031577|FG000|NOT COMPLETED|Baseline||5
8967730|NCT02583425|10031577|FG000|STARTED|Treatment Period||10
8967731|NCT02583425|10031577|FG000|COMPLETED|Treatment Period||9
8967732|NCT02583425|10031577|FG000|NOT COMPLETED|Treatment Period||1
8967733|NCT02583477|10031584|FG000|STARTED|Overall Study||3
8967734|NCT02583477|10031585|FG001|STARTED|Overall Study||20
8967735|NCT02583477|10031584|FG000|Received Treatment|Overall Study||3
8967736|NCT02583477|10031585|FG001|Received Treatment|Overall Study||20
8967737|NCT02583477|10031584|FG000|Completed Treatment|Overall Study||0
8967738|NCT02583477|10031585|FG001|Completed Treatment|Overall Study||0
8967739|NCT02583477|10031584|FG000|COMPLETED|Overall Study||0
8967740|NCT02583477|10031585|FG001|COMPLETED|Overall Study||0
8967741|NCT02583477|10031584|FG000|NOT COMPLETED|Overall Study||3
8967742|NCT02583477|10031585|FG001|NOT COMPLETED|Overall Study||20
8967743|NCT02583711|10031595|FG000|STARTED|Overall Study||11
8967744|NCT02583711|10031596|FG001|STARTED|Overall Study||38
8967745|NCT02583711|10031597|FG002|STARTED|Overall Study||10
8967746|NCT02583711|10031595|FG000|COMPLETED|Overall Study||11
8967747|NCT02583711|10031596|FG001|COMPLETED|Overall Study||28
8967748|NCT02583711|10031597|FG002|COMPLETED|Overall Study||10
8967749|NCT02583711|10031595|FG000|NOT COMPLETED|Overall Study||0
8967750|NCT02583711|10031596|FG001|NOT COMPLETED|Overall Study||10
8967751|NCT02583711|10031597|FG002|NOT COMPLETED|Overall Study||0
8967752|NCT02584140|10031607|FG000|STARTED|Overall Study||136
8967753|NCT02584140|10031607|FG000|COMPLETED|Overall Study||83
8967754|NCT02584140|10031607|FG000|NOT COMPLETED|Overall Study||53
8967755|NCT02584257|10031611|FG000|STARTED|Period 1||9
8967756|NCT02584257|10031612|FG001|STARTED|Period 1||9
8967757|NCT02584257|10031613|FG002|STARTED|Period 1||9
8967758|NCT02584257|10031614|FG003|STARTED|Period 1||8
8967759|NCT02584257|10031615|FG004|STARTED|Period 1||10
8967760|NCT02584257|10031616|FG005|STARTED|Period 1||10
8967761|NCT02584257|10031617|FG006|STARTED|Period 1||18
8967762|NCT02584257|10031618|FG007|STARTED|Period 1||9
8967763|NCT02584257|10031619|FG008|STARTED|Period 1||9
8967764|NCT02584257|10031611|FG000|COMPLETED|Period 1||9
8967765|NCT02584257|10031612|FG001|COMPLETED|Period 1||9
8967766|NCT02584257|10031613|FG002|COMPLETED|Period 1||9
8967767|NCT02584257|10031614|FG003|COMPLETED|Period 1||8
8967768|NCT02584257|10031615|FG004|COMPLETED|Period 1||10
8967769|NCT02584257|10031616|FG005|COMPLETED|Period 1||10
8967770|NCT02584257|10031617|FG006|COMPLETED|Period 1||17
8967771|NCT02584257|10031618|FG007|COMPLETED|Period 1||9
8967772|NCT02584257|10031619|FG008|COMPLETED|Period 1||9
8967773|NCT02584257|10031611|FG000|NOT COMPLETED|Period 1||0
8967774|NCT02584257|10031612|FG001|NOT COMPLETED|Period 1||0
8967775|NCT02584257|10031613|FG002|NOT COMPLETED|Period 1||0
8967776|NCT02584257|10031614|FG003|NOT COMPLETED|Period 1||0
8967777|NCT02584257|10031615|FG004|NOT COMPLETED|Period 1||0
8967778|NCT02584257|10031616|FG005|NOT COMPLETED|Period 1||0
8967779|NCT02584257|10031617|FG006|NOT COMPLETED|Period 1||1
8967780|NCT02584257|10031618|FG007|NOT COMPLETED|Period 1||0
8967781|NCT02584257|10031619|FG008|NOT COMPLETED|Period 1||0
8967782|NCT02584257|10031611|FG000|STARTED|Period 2||9
8967783|NCT02584257|10031612|FG001|STARTED|Period 2||9
8967784|NCT02584257|10031613|FG002|STARTED|Period 2||9
8967785|NCT02584257|10031614|FG003|STARTED|Period 2||8
8967786|NCT02584257|10031615|FG004|STARTED|Period 2||10
8967787|NCT02584257|10031616|FG005|STARTED|Period 2||10
8967788|NCT02584257|10031617|FG006|STARTED|Period 2||17
8967789|NCT02584257|10031618|FG007|STARTED|Period 2||9
8967790|NCT02584257|10031619|FG008|STARTED|Period 2||9
8967791|NCT02584257|10031611|FG000|COMPLETED|Period 2||8
8967792|NCT02584257|10031612|FG001|COMPLETED|Period 2||8
8967793|NCT02584257|10031613|FG002|COMPLETED|Period 2||9
8967794|NCT02584257|10031614|FG003|COMPLETED|Period 2||8
8967795|NCT02584257|10031615|FG004|COMPLETED|Period 2||10
8967796|NCT02584257|10031616|FG005|COMPLETED|Period 2||10
8967797|NCT02584257|10031617|FG006|COMPLETED|Period 2||17
8967798|NCT02584257|10031618|FG007|COMPLETED|Period 2||9
8967799|NCT02584257|10031619|FG008|COMPLETED|Period 2||9
8570707|NCT00105157|9602886|FG003|STARTED|Open-Label Continuation of DB||6
8570708|NCT00105157|9602883|FG000|COMPLETED|Open-Label Continuation of DB||23
8570709|NCT00105157|9602884|FG001|COMPLETED|Open-Label Continuation of DB||21
8570710|NCT00105157|9602885|FG002|COMPLETED|Open-Label Continuation of DB||24
8570711|NCT00105157|9602886|FG003|COMPLETED|Open-Label Continuation of DB||5
8570712|NCT00105157|9602883|FG000|NOT COMPLETED|Open-Label Continuation of DB||7
8570713|NCT00105157|9602884|FG001|NOT COMPLETED|Open-Label Continuation of DB||10
8570714|NCT00105157|9602885|FG002|NOT COMPLETED|Open-Label Continuation of DB||9
8570715|NCT00105157|9602886|FG003|NOT COMPLETED|Open-Label Continuation of DB||1
8570716|NCT00105157|9602883|FG000|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|11
8570717|NCT00105157|9602884|FG001|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|13
8570718|NCT00105157|9602885|FG002|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|11
8570719|NCT00105157|9602886|FG003|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|37
8570720|NCT00105157|9602883|FG000|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||2
8570721|NCT00105157|9602884|FG001|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||7
8577571|NCT00159419|9610331|FG000|NOT COMPLETED|Overall Study||0
8967800|NCT02584257|10031611|FG000|NOT COMPLETED|Period 2||1
8967801|NCT02584257|10031612|FG001|NOT COMPLETED|Period 2||1
8967802|NCT02584257|10031613|FG002|NOT COMPLETED|Period 2||0
8967803|NCT02584257|10031614|FG003|NOT COMPLETED|Period 2||0
8967804|NCT02584257|10031615|FG004|NOT COMPLETED|Period 2||0
8967805|NCT02584257|10031616|FG005|NOT COMPLETED|Period 2||0
8967806|NCT02584257|10031617|FG006|NOT COMPLETED|Period 2||0
8967807|NCT02584257|10031618|FG007|NOT COMPLETED|Period 2||0
8967808|NCT02584257|10031619|FG008|NOT COMPLETED|Period 2||0
8967809|NCT02584257|10031611|FG000|STARTED|Period 3||8
8967810|NCT02584257|10031612|FG001|STARTED|Period 3||8
8967811|NCT02584257|10031613|FG002|STARTED|Period 3||9
8967812|NCT02584257|10031614|FG003|STARTED|Period 3||8
8967813|NCT02584257|10031615|FG004|STARTED|Period 3||10
8967814|NCT02584257|10031616|FG005|STARTED|Period 3||10
8967815|NCT02584257|10031617|FG006|STARTED|Period 3||17
8967816|NCT02584257|10031618|FG007|STARTED|Period 3||9
8967817|NCT02584257|10031619|FG008|STARTED|Period 3||9
8967818|NCT02584257|10031611|FG000|COMPLETED|Period 3||8
8967819|NCT02584257|10031612|FG001|COMPLETED|Period 3||8
8967820|NCT02584257|10031613|FG002|COMPLETED|Period 3||9
8967821|NCT02584257|10031614|FG003|COMPLETED|Period 3||8
8967822|NCT02584257|10031615|FG004|COMPLETED|Period 3||10
8967823|NCT02584257|10031616|FG005|COMPLETED|Period 3||10
8967824|NCT02584257|10031617|FG006|COMPLETED|Period 3||17
8967825|NCT02584257|10031618|FG007|COMPLETED|Period 3||9
8967826|NCT02584257|10031619|FG008|COMPLETED|Period 3||9
8967827|NCT02584257|10031611|FG000|NOT COMPLETED|Period 3||0
8967828|NCT02584257|10031612|FG001|NOT COMPLETED|Period 3||0
8967829|NCT02584257|10031613|FG002|NOT COMPLETED|Period 3||0
8967830|NCT02584257|10031614|FG003|NOT COMPLETED|Period 3||0
8967831|NCT02584257|10031615|FG004|NOT COMPLETED|Period 3||0
8967832|NCT02584257|10031616|FG005|NOT COMPLETED|Period 3||0
8967833|NCT02584257|10031617|FG006|NOT COMPLETED|Period 3||0
8967834|NCT02584257|10031618|FG007|NOT COMPLETED|Period 3||0
8967835|NCT02584257|10031619|FG008|NOT COMPLETED|Period 3||0
8876590|NCT01918072|9933439|FG002|Intervention|Controlled Trial Step One - Six Months||0
8876591|NCT01918072|9933437|FG000|Control|Controlled Trial Step One - Six Months||10
8876592|NCT01918072|9933438|FG001|Control|Controlled Trial Step One - Six Months||0
8967836|NCT02584257|10031611|FG000|STARTED|Period 4||8
8967837|NCT02584257|10031612|FG001|STARTED|Period 4||8
8967838|NCT02584257|10031613|FG002|STARTED|Period 4||9
8967839|NCT02584257|10031614|FG003|STARTED|Period 4||8
8967840|NCT02584257|10031615|FG004|STARTED|Period 4||10
8967841|NCT02584257|10031616|FG005|STARTED|Period 4||10
8967842|NCT02584257|10031617|FG006|STARTED|Period 4||17
8967843|NCT02584257|10031618|FG007|STARTED|Period 4||9
8967844|NCT02584257|10031619|FG008|STARTED|Period 4||9
8967845|NCT02584257|10031611|FG000|COMPLETED|Period 4||8
8967846|NCT02584257|10031612|FG001|COMPLETED|Period 4||8
8967847|NCT02584257|10031613|FG002|COMPLETED|Period 4||9
8967848|NCT02584257|10031614|FG003|COMPLETED|Period 4||8
8967849|NCT02584257|10031615|FG004|COMPLETED|Period 4||10
8967850|NCT02584257|10031616|FG005|COMPLETED|Period 4||10
8967851|NCT02584257|10031617|FG006|COMPLETED|Period 4||17
8967852|NCT02584257|10031618|FG007|COMPLETED|Period 4||9
8967853|NCT02584257|10031619|FG008|COMPLETED|Period 4||9
8967854|NCT02584257|10031611|FG000|NOT COMPLETED|Period 4||0
8967855|NCT02584257|10031612|FG001|NOT COMPLETED|Period 4||0
8967856|NCT02584257|10031613|FG002|NOT COMPLETED|Period 4||0
8967857|NCT02584257|10031614|FG003|NOT COMPLETED|Period 4||0
8967858|NCT02584257|10031615|FG004|NOT COMPLETED|Period 4||0
8967859|NCT02584257|10031616|FG005|NOT COMPLETED|Period 4||0
8967860|NCT02584257|10031617|FG006|NOT COMPLETED|Period 4||0
8967861|NCT02584257|10031618|FG007|NOT COMPLETED|Period 4||0
8967862|NCT02584257|10031619|FG008|NOT COMPLETED|Period 4||0
8967863|NCT02584257|10031611|FG000|STARTED|Period 5||8
8967864|NCT02584257|10031612|FG001|STARTED|Period 5||8
8967865|NCT02584257|10031613|FG002|STARTED|Period 5||9
8967866|NCT02584257|10031614|FG003|STARTED|Period 5||8
8876593|NCT01918072|9933439|FG002|Control|Controlled Trial Step One - Six Months||0
8876594|NCT01918072|9933437|FG000|COMPLETED|Controlled Trial Step One - Six Months||11
8876595|NCT01918072|9933438|FG001|COMPLETED|Controlled Trial Step One - Six Months||0
8876596|NCT01918072|9933439|FG002|COMPLETED|Controlled Trial Step One - Six Months||0
8876597|NCT01918072|9933437|FG000|NOT COMPLETED|Controlled Trial Step One - Six Months||0
8967867|NCT02584257|10031615|FG004|STARTED|Period 5||10
8967868|NCT02584257|10031616|FG005|STARTED|Period 5||10
8967869|NCT02584257|10031617|FG006|STARTED|Period 5||17
8876598|NCT01918072|9933438|FG001|NOT COMPLETED|Controlled Trial Step One - Six Months||0
8967870|NCT02584257|10031618|FG007|STARTED|Period 5||9
8967871|NCT02584257|10031619|FG008|STARTED|Period 5||9
8967872|NCT02584257|10031611|FG000|COMPLETED|Period 5||8
8967873|NCT02584257|10031612|FG001|COMPLETED|Period 5||8
8967874|NCT02584257|10031613|FG002|COMPLETED|Period 5||9
8967875|NCT02584257|10031614|FG003|COMPLETED|Period 5||8
8967876|NCT02584257|10031615|FG004|COMPLETED|Period 5||10
8967877|NCT02584257|10031616|FG005|COMPLETED|Period 5||10
8967878|NCT02584257|10031617|FG006|COMPLETED|Period 5||17
8967879|NCT02584257|10031618|FG007|COMPLETED|Period 5||9
8967880|NCT02584257|10031619|FG008|COMPLETED|Period 5||9
8967881|NCT02584257|10031611|FG000|NOT COMPLETED|Period 5||0
8967882|NCT02584257|10031612|FG001|NOT COMPLETED|Period 5||0
8967883|NCT02584257|10031613|FG002|NOT COMPLETED|Period 5||0
8967884|NCT02584257|10031614|FG003|NOT COMPLETED|Period 5||0
8967885|NCT02584257|10031615|FG004|NOT COMPLETED|Period 5||0
8967886|NCT02584257|10031616|FG005|NOT COMPLETED|Period 5||0
8967887|NCT02584257|10031617|FG006|NOT COMPLETED|Period 5||0
8967888|NCT02584257|10031618|FG007|NOT COMPLETED|Period 5||0
8967889|NCT02584257|10031619|FG008|NOT COMPLETED|Period 5||0
8967890|NCT02584452|10031633|FG000|STARTED|Overall Study||34
8967891|NCT02584452|10031634|FG001|STARTED|Overall Study||23
8967892|NCT02584452|10031633|FG000|COMPLETED|Overall Study||32
8967893|NCT02584452|10031634|FG001|COMPLETED|Overall Study||21
8967894|NCT02584452|10031633|FG000|NOT COMPLETED|Overall Study||2
8967895|NCT02584452|10031634|FG001|NOT COMPLETED|Overall Study||2
8967896|NCT02584504|10031644|FG000|STARTED|Double-blind Treatment|Randomized|54
8967897|NCT02584504|10031645|FG001|STARTED|Double-blind Treatment|Randomized|53
8967898|NCT02584504|10031646|FG002|STARTED|Double-blind Treatment|Randomized|56
8967899|NCT02584504|10031644|FG000|ITT Population|Double-blind Treatment||54
8967900|NCT02584504|10031645|FG001|ITT Population|Double-blind Treatment||53
8967901|NCT02584504|10031646|FG002|ITT Population|Double-blind Treatment||56
8967902|NCT02584504|10031644|FG000|mITT Population|Double-blind Treatment||54
8967903|NCT02584504|10031645|FG001|mITT Population|Double-blind Treatment||53
8967904|NCT02584504|10031646|FG002|mITT Population|Double-blind Treatment||56
8967905|NCT02584504|10031644|FG000|Safety Population|Double-blind Treatment||54
8967906|NCT02584504|10031645|FG001|Safety Population|Double-blind Treatment||53
8967907|NCT02584504|10031646|FG002|Safety Population|Double-blind Treatment||56
8967908|NCT02584504|10031644|FG000|COMPLETED|Double-blind Treatment||54
8967909|NCT02584504|10031645|FG001|COMPLETED|Double-blind Treatment||51
8967910|NCT02584504|10031646|FG002|COMPLETED|Double-blind Treatment||55
8967911|NCT02584504|10031644|FG000|NOT COMPLETED|Double-blind Treatment||0
8967912|NCT02584504|10031645|FG001|NOT COMPLETED|Double-blind Treatment||2
8967913|NCT02584504|10031646|FG002|NOT COMPLETED|Double-blind Treatment||1
8967914|NCT02584504|10031644|FG000|STARTED|Open-label Treatment||54
8967915|NCT02584504|10031645|FG001|STARTED|Open-label Treatment||51
8967916|NCT02584504|10031646|FG002|STARTED|Open-label Treatment||55
8967917|NCT02584504|10031644|FG000|Treated|Open-label Treatment||54
8967918|NCT02584504|10031645|FG001|Treated|Open-label Treatment||50
8967919|NCT02584504|10031646|FG002|Treated|Open-label Treatment||54
8967920|NCT02584504|10031644|FG000|COMPLETED|Open-label Treatment||52
8967921|NCT02584504|10031645|FG001|COMPLETED|Open-label Treatment||47
8967922|NCT02584504|10031646|FG002|COMPLETED|Open-label Treatment||47
8967923|NCT02584504|10031644|FG000|NOT COMPLETED|Open-label Treatment||2
8967924|NCT02584504|10031645|FG001|NOT COMPLETED|Open-label Treatment||4
8967925|NCT02584504|10031646|FG002|NOT COMPLETED|Open-label Treatment||8
8967926|NCT02584608|10031658|FG000|STARTED|Overall Study||12
8967927|NCT02584608|10031658|FG000|COMPLETED|Overall Study||12
8967928|NCT02584608|10031658|FG000|NOT COMPLETED|Overall Study||0
8967929|NCT02584660|10031664|FG000|STARTED|Overall Study||51
8967930|NCT02584660|10031665|FG001|STARTED|Overall Study||63
8967931|NCT02584660|10031664|FG000|Treated|Overall Study||49
8967932|NCT02584660|10031665|FG001|Treated|Overall Study||63
8967933|NCT02584660|10031664|FG000|COMPLETED|Overall Study||44
8967934|NCT02584660|10031665|FG001|COMPLETED|Overall Study||55
8967935|NCT02584660|10031664|FG000|NOT COMPLETED|Overall Study||7
8967936|NCT02584660|10031665|FG001|NOT COMPLETED|Overall Study||8
8967937|NCT02584673|10031673|FG000|STARTED|Overall Study||15
8967938|NCT02584673|10031674|FG001|STARTED|Overall Study||15
8967939|NCT02584673|10031673|FG000|COMPLETED|Overall Study||15
8967940|NCT02584673|10031674|FG001|COMPLETED|Overall Study||15
8967941|NCT02584673|10031673|FG000|NOT COMPLETED|Overall Study||0
8967942|NCT02584673|10031674|FG001|NOT COMPLETED|Overall Study||0
8967943|NCT02584686|10031682|FG000|STARTED|Overall Study||12
8967944|NCT02584686|10031683|FG001|STARTED|Overall Study||12
8967945|NCT02584686|10031682|FG000|COMPLETED|Overall Study||12
8967946|NCT02584686|10031683|FG001|COMPLETED|Overall Study||12
8967947|NCT02584686|10031682|FG000|NOT COMPLETED|Overall Study||0
8967948|NCT02584686|10031683|FG001|NOT COMPLETED|Overall Study||0
8967949|NCT02584725|10031693|FG000|STARTED|Overall Study||28
8967950|NCT02584725|10031694|FG001|STARTED|Overall Study||28
8967951|NCT02584725|10031695|FG002|STARTED|Overall Study||28
8967952|NCT02584725|10031693|FG000|COMPLETED|Overall Study||28
8967953|NCT02584725|10031694|FG001|COMPLETED|Overall Study||28
8967954|NCT02584725|10031695|FG002|COMPLETED|Overall Study||28
8967955|NCT02584725|10031693|FG000|NOT COMPLETED|Overall Study||0
8967956|NCT02584725|10031694|FG001|NOT COMPLETED|Overall Study||0
8967957|NCT02584725|10031695|FG002|NOT COMPLETED|Overall Study||0
8967958|NCT02584790|10031703|FG000|STARTED|Overall Study||55
8967959|NCT02584790|10031703|FG000|COMPLETED|Overall Study||40
8967960|NCT02584790|10031703|FG000|NOT COMPLETED|Overall Study||15
8967961|NCT02584855|10031707|FG000|STARTED|Open-Label Treatment Period||394
8967962|NCT02584855|10031708|FG001|STARTED|Open-Label Treatment Period|Participants completed Open-Label Treatment Period.|0
8967963|NCT02584855|10031709|FG002|STARTED|Open-Label Treatment Period|Participants were randomized to this arm during double-blind withdrawal period.|0
8967964|NCT02584855|10031710|FG003|STARTED|Open-Label Treatment Period|Participants were randomized to this arm during double-blind withdrawal period.|0
8967965|NCT02584855|10031711|FG004|STARTED|Open-Label Treatment Period||0
8967966|NCT02584855|10031712|FG005|STARTED|Open-Label Treatment Period||0
8967967|NCT02584855|10031707|FG000|Received at Least One Dose of Study Drug|Open-Label Treatment Period||394
8967968|NCT02584855|10031708|FG001|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0
8967969|NCT02584855|10031709|FG002|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0
8967970|NCT02584855|10031710|FG003|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0
8967971|NCT02584855|10031711|FG004|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0
8967972|NCT02584855|10031712|FG005|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0
8967973|NCT02584855|10031707|FG000|Met Randomization Criteria|Open-Label Treatment Period||158
8967974|NCT02584855|10031708|FG001|Met Randomization Criteria|Open-Label Treatment Period||0
8967975|NCT02584855|10031709|FG002|Met Randomization Criteria|Open-Label Treatment Period||0
8967976|NCT02584855|10031710|FG003|Met Randomization Criteria|Open-Label Treatment Period||0
8967977|NCT02584855|10031711|FG004|Met Randomization Criteria|Open-Label Treatment Period||0
8967978|NCT02584855|10031712|FG005|Met Randomization Criteria|Open-Label Treatment Period||0
8967979|NCT02584855|10031707|FG000|Non-randomized|Open-Label Treatment Period||133
8967980|NCT02584855|10031708|FG001|Non-randomized|Open-Label Treatment Period||0
8967981|NCT02584855|10031709|FG002|Non-randomized|Open-Label Treatment Period||0
8967982|NCT02584855|10031710|FG003|Non-randomized|Open-Label Treatment Period||0
8967983|NCT02584855|10031711|FG004|Non-randomized|Open-Label Treatment Period||0
8967984|NCT02584855|10031712|FG005|Non-randomized|Open-Label Treatment Period||0
8967985|NCT02584855|10031707|FG000|COMPLETED|Open-Label Treatment Period||291
8967986|NCT02584855|10031708|FG001|COMPLETED|Open-Label Treatment Period||0
8967987|NCT02584855|10031709|FG002|COMPLETED|Open-Label Treatment Period||0
8967988|NCT02584855|10031710|FG003|COMPLETED|Open-Label Treatment Period||0
8967989|NCT02584855|10031711|FG004|COMPLETED|Open-Label Treatment Period||0
8967990|NCT02584855|10031712|FG005|COMPLETED|Open-Label Treatment Period||0
8967991|NCT02584855|10031707|FG000|NOT COMPLETED|Open-Label Treatment Period||103
8967992|NCT02584855|10031708|FG001|NOT COMPLETED|Open-Label Treatment Period||0
8967993|NCT02584855|10031709|FG002|NOT COMPLETED|Open-Label Treatment Period||0
8967994|NCT02584855|10031710|FG003|NOT COMPLETED|Open-Label Treatment Period||0
8967995|NCT02584855|10031711|FG004|NOT COMPLETED|Open-Label Treatment Period||0
8967996|NCT02584855|10031712|FG005|NOT COMPLETED|Open-Label Treatment Period||0
8967997|NCT02584855|10031707|FG000|STARTED|Double-Blind Withdrawal Period||0
8967998|NCT02584855|10031708|FG001|STARTED|Double-Blind Withdrawal Period|Participants completed open label but did not meet criteria for double-blind withdrawal period.|133
8967999|NCT02584855|10031709|FG002|STARTED|Double-Blind Withdrawal Period|Participants completed open label and met criteria for double-blind withdrawal period.|79
8968000|NCT02584855|10031710|FG003|STARTED|Double-Blind Withdrawal Period|Participants completed open label and met criteria for double-blind withdrawal period.|79
8968001|NCT02584855|10031711|FG004|STARTED|Double-Blind Withdrawal Period||0
8968002|NCT02584855|10031712|FG005|STARTED|Double-Blind Withdrawal Period||0
8968003|NCT02584855|10031707|FG000|Relapsed|Double-Blind Withdrawal Period||0
8968004|NCT02584855|10031708|FG001|Relapsed|Double-Blind Withdrawal Period||0
8968005|NCT02584855|10031709|FG002|Relapsed|Double-Blind Withdrawal Period||67
8968006|NCT02584855|10031710|FG003|Relapsed|Double-Blind Withdrawal Period||30
8968007|NCT02584855|10031711|FG004|Relapsed|Double-Blind Withdrawal Period||0
8968008|NCT02584855|10031712|FG005|Relapsed|Double-Blind Withdrawal Period||0
8968009|NCT02584855|10031707|FG000|COMPLETED|Double-Blind Withdrawal Period||0
8968010|NCT02584855|10031708|FG001|COMPLETED|Double-Blind Withdrawal Period||118
8968011|NCT02584855|10031709|FG002|COMPLETED|Double-Blind Withdrawal Period||77
8968012|NCT02584855|10031710|FG003|COMPLETED|Double-Blind Withdrawal Period||78
8968013|NCT02584855|10031711|FG004|COMPLETED|Double-Blind Withdrawal Period||0
8968014|NCT02584855|10031712|FG005|COMPLETED|Double-Blind Withdrawal Period||0
8968015|NCT02584855|10031707|FG000|NOT COMPLETED|Double-Blind Withdrawal Period||0
8968016|NCT02584855|10031708|FG001|NOT COMPLETED|Double-Blind Withdrawal Period||15
8968017|NCT02584855|10031709|FG002|NOT COMPLETED|Double-Blind Withdrawal Period||2
8631876|NCT00542386|9671752|FG000|STARTED|Overall Study||104
8631877|NCT00542386|9671753|FG001|STARTED|Overall Study||102
8631878|NCT00542386|9671754|FG002|STARTED|Overall Study||99
8631879|NCT00542386|9671755|FG003|STARTED|Overall Study||103
8631880|NCT00542386|9671756|FG004|STARTED|Overall Study||102
8968018|NCT02584855|10031710|FG003|NOT COMPLETED|Double-Blind Withdrawal Period||1
8968019|NCT02584855|10031711|FG004|NOT COMPLETED|Double-Blind Withdrawal Period||0
8968020|NCT02584855|10031712|FG005|NOT COMPLETED|Double-Blind Withdrawal Period||0
8968021|NCT02584855|10031707|FG000|STARTED|Post Treatment Follow-up Period||0
8968022|NCT02584855|10031708|FG001|STARTED|Post Treatment Follow-up Period||0
8968023|NCT02584855|10031709|FG002|STARTED|Post Treatment Follow-up Period||0
8968024|NCT02584855|10031710|FG003|STARTED|Post Treatment Follow-up Period||0
8968025|NCT02584855|10031711|FG004|STARTED|Post Treatment Follow-up Period||355
8968026|NCT02584855|10031712|FG005|STARTED|Post Treatment Follow-up Period||12
8968027|NCT02584855|10031707|FG000|COMPLETED|Post Treatment Follow-up Period||0
8968028|NCT02584855|10031708|FG001|COMPLETED|Post Treatment Follow-up Period||0
8968029|NCT02584855|10031709|FG002|COMPLETED|Post Treatment Follow-up Period||0
8968030|NCT02584855|10031710|FG003|COMPLETED|Post Treatment Follow-up Period||0
8968031|NCT02584855|10031711|FG004|COMPLETED|Post Treatment Follow-up Period||347
8968032|NCT02584855|10031712|FG005|COMPLETED|Post Treatment Follow-up Period||12
8968033|NCT02584855|10031707|FG000|NOT COMPLETED|Post Treatment Follow-up Period||0
8968034|NCT02584855|10031708|FG001|NOT COMPLETED|Post Treatment Follow-up Period||0
8968035|NCT02584855|10031709|FG002|NOT COMPLETED|Post Treatment Follow-up Period||0
8968036|NCT02584855|10031710|FG003|NOT COMPLETED|Post Treatment Follow-up Period||0
8968037|NCT02584855|10031711|FG004|NOT COMPLETED|Post Treatment Follow-up Period||8
8968038|NCT02584855|10031712|FG005|NOT COMPLETED|Post Treatment Follow-up Period||0
8968039|NCT02584868|10031727|FG000|STARTED|Overall Study||44
8968040|NCT02584868|10031728|FG001|STARTED|Overall Study||44
8968041|NCT02584868|10031727|FG000|COMPLETED|Overall Study||44
8968042|NCT02584868|10031728|FG001|COMPLETED|Overall Study||44
8968043|NCT02584868|10031727|FG000|NOT COMPLETED|Overall Study||0
8968044|NCT02584868|10031728|FG001|NOT COMPLETED|Overall Study||0
8968045|NCT02584959|10031737|FG000|STARTED|Period 1||31
8631881|NCT00542386|9671757|FG005|STARTED|Overall Study||132
8631882|NCT00542386|9671752|FG000|COMPLETED|Overall Study||61
8968046|NCT02584959|10031738|FG001|STARTED|Period 1||29
8968047|NCT02584959|10031739|FG002|STARTED|Period 1||15
8968048|NCT02584959|10031737|FG000|COMPLETED|Period 1||28
8968049|NCT02584959|10031738|FG001|COMPLETED|Period 1||25
8968050|NCT02584959|10031739|FG002|COMPLETED|Period 1||15
8968051|NCT02584959|10031737|FG000|NOT COMPLETED|Period 1||3
8968052|NCT02584959|10031738|FG001|NOT COMPLETED|Period 1||4
8968053|NCT02584959|10031739|FG002|NOT COMPLETED|Period 1||0
8968054|NCT02584959|10031737|FG000|STARTED|Period 2||28
8968055|NCT02584959|10031738|FG001|STARTED|Period 2||25
8968056|NCT02584959|10031739|FG002|STARTED|Period 2||15
8968057|NCT02584959|10031737|FG000|COMPLETED|Period 2||22
8968058|NCT02584959|10031738|FG001|COMPLETED|Period 2||24
8968059|NCT02584959|10031739|FG002|COMPLETED|Period 2||13
8968060|NCT02584959|10031737|FG000|NOT COMPLETED|Period 2||6
8968061|NCT02584959|10031738|FG001|NOT COMPLETED|Period 2||1
8968062|NCT02584959|10031739|FG002|NOT COMPLETED|Period 2||2
8968063|NCT02584998|10031759|FG000|STARTED|Overall Study||260
8968064|NCT02584998|10031760|FG001|STARTED|Overall Study||261
8968065|NCT02584998|10031761|FG002|STARTED|Overall Study||261
8968066|NCT02584998|10031759|FG000|COMPLETED|Overall Study||260
8968067|NCT02584998|10031760|FG001|COMPLETED|Overall Study||261
8968068|NCT02584998|10031761|FG002|COMPLETED|Overall Study||261
8968069|NCT02584998|10031759|FG000|NOT COMPLETED|Overall Study||0
8968070|NCT02584998|10031760|FG001|NOT COMPLETED|Overall Study||0
8968071|NCT02584998|10031761|FG002|NOT COMPLETED|Overall Study||0
8968072|NCT02585245|10031769|FG000|STARTED|Overall Study||607
8968073|NCT02585245|10031769|FG000|COMPLETED|Overall Study||594
8968074|NCT02585245|10031769|FG000|NOT COMPLETED|Overall Study||13
8968075|NCT02585700|10031776|FG000|STARTED|Overall Study||30
8968076|NCT02585700|10031777|FG001|STARTED|Overall Study||30
8968077|NCT02585700|10031776|FG000|COMPLETED|Overall Study||30
8968078|NCT02585700|10031777|FG001|COMPLETED|Overall Study||30
8968079|NCT02585700|10031776|FG000|NOT COMPLETED|Overall Study||0
8968080|NCT02585700|10031777|FG001|NOT COMPLETED|Overall Study||0
8968081|NCT02585713|10031785|FG000|STARTED|Overall Study||150
8968082|NCT02585713|10031786|FG001|STARTED|Overall Study||150
8968083|NCT02585713|10031785|FG000|COMPLETED|Overall Study||145
8968084|NCT02585713|10031786|FG001|COMPLETED|Overall Study||142
8968085|NCT02585713|10031785|FG000|NOT COMPLETED|Overall Study||5
8968086|NCT02585713|10031786|FG001|NOT COMPLETED|Overall Study||8
8968087|NCT02585778|10031796|FG000|STARTED|Overall Study|Randomized|345
8968088|NCT02585778|10031797|FG001|STARTED|Overall Study|Randomized|172
8968089|NCT02585778|10031796|FG000|Treated (Safety Population)|Overall Study||344
8968090|NCT02585778|10031797|FG001|Treated (Safety Population)|Overall Study||170
8968091|NCT02585778|10031796|FG000|ITT Population|Overall Study||336
8968092|NCT02585778|10031797|FG001|ITT Population|Overall Study||167
8968093|NCT02585778|10031796|FG000|mITT Population|Overall Study||333
8968094|NCT02585778|10031797|FG001|mITT Population|Overall Study||164
8968095|NCT02585778|10031796|FG000|T1DM Participants|Overall Study||51
8968096|NCT02585778|10031797|FG001|T1DM Participants|Overall Study||25
8968097|NCT02585778|10031796|FG000|T2DM Participants|Overall Study||294
8968098|NCT02585778|10031797|FG001|T2DM Participants|Overall Study||147
8968099|NCT02585778|10031796|FG000|COMPLETED|Overall Study||312
8968100|NCT02585778|10031797|FG001|COMPLETED|Overall Study||157
8968101|NCT02585778|10031796|FG000|NOT COMPLETED|Overall Study||33
8968102|NCT02585778|10031797|FG001|NOT COMPLETED|Overall Study||15
8968103|NCT02585830|10031807|FG000|STARTED|Overall Study||25
8968104|NCT02585830|10031807|FG000|COMPLETED|Overall Study||22
8968105|NCT02585830|10031807|FG000|NOT COMPLETED|Overall Study||3
8968106|NCT02585843|10031813|FG000|STARTED|Overall Study||10
8968107|NCT02585843|10031814|FG001|STARTED|Overall Study||10
8968108|NCT02585843|10031813|FG000|COMPLETED|Overall Study||9
8968109|NCT02585843|10031814|FG001|COMPLETED|Overall Study||10
8968110|NCT02585843|10031813|FG000|NOT COMPLETED|Overall Study||1
8968111|NCT02585843|10031814|FG001|NOT COMPLETED|Overall Study||0
8968112|NCT02585895|10031822|FG000|STARTED|Primary Period||20
8968113|NCT02585895|10031823|FG001|STARTED|Primary Period||19
8968114|NCT02585895|10031822|FG000|COMPLETED|Primary Period||20
8968115|NCT02585895|10031823|FG001|COMPLETED|Primary Period||19
8968116|NCT02585895|10031822|FG000|NOT COMPLETED|Primary Period||0
8968117|NCT02585895|10031823|FG001|NOT COMPLETED|Primary Period||0
8968118|NCT02585895|10031822|FG000|STARTED|Post-primary Period||20
8968119|NCT02585895|10031823|FG001|STARTED|Post-primary Period||19
8968120|NCT02585895|10031822|FG000|COMPLETED|Post-primary Period||20
8968121|NCT02585895|10031823|FG001|COMPLETED|Post-primary Period||19
8968122|NCT02585895|10031822|FG000|NOT COMPLETED|Post-primary Period||0
8968123|NCT02585895|10031823|FG001|NOT COMPLETED|Post-primary Period||0
8968124|NCT02585934|10031834|FG000|STARTED|Overall Study||661
8968125|NCT02585934|10031835|FG001|STARTED|Overall Study||654
8968126|NCT02585934|10031834|FG000|Safety Population|Overall Study||656
8968127|NCT02585934|10031835|FG001|Safety Population|Overall Study||651
8968128|NCT02585934|10031834|FG000|Intent to Treat (ITT)|Overall Study||643
8968129|NCT02585934|10031835|FG001|Intent to Treat (ITT)|Overall Study||633
8968130|NCT02585934|10031834|FG000|Per Protocol (PP)|Overall Study||603
8968131|NCT02585934|10031835|FG001|Per Protocol (PP)|Overall Study||582
8968132|NCT02585934|10031834|FG000|COMPLETED|Overall Study||592
8968133|NCT02585934|10031835|FG001|COMPLETED|Overall Study||581
8968134|NCT02585934|10031834|FG000|NOT COMPLETED|Overall Study||69
8968135|NCT02585934|10031835|FG001|NOT COMPLETED|Overall Study||73
8968136|NCT02585960|10031849|FG000|STARTED|PK/Safety Assessment Period||57
8968137|NCT02585960|10031850|FG001|STARTED|PK/Safety Assessment Period||58
8968138|NCT02585960|10031851|FG002|STARTED|PK/Safety Assessment Period||6
8968139|NCT02585960|10031849|FG000|Completed 1st 6 Month Period|PK/Safety Assessment Period||57
8968140|NCT02585960|10031850|FG001|Completed 1st 6 Month Period|PK/Safety Assessment Period||53
8968141|NCT02585960|10031851|FG002|Completed 1st 6 Month Period|PK/Safety Assessment Period||0
8968142|NCT02585960|10031849|FG000|Completed 2nd 6 Month Period|PK/Safety Assessment Period||52
8968143|NCT02585960|10031850|FG001|Completed 2nd 6 Month Period|PK/Safety Assessment Period||48
8968144|NCT02585960|10031851|FG002|Completed 2nd 6 Month Period|PK/Safety Assessment Period||0
8968145|NCT02585960|10031849|FG000|COMPLETED|PK/Safety Assessment Period||52
8968146|NCT02585960|10031850|FG001|COMPLETED|PK/Safety Assessment Period||48
8968147|NCT02585960|10031851|FG002|COMPLETED|PK/Safety Assessment Period||0
8968148|NCT02585960|10031849|FG000|NOT COMPLETED|PK/Safety Assessment Period||5
8968149|NCT02585960|10031850|FG001|NOT COMPLETED|PK/Safety Assessment Period||10
8968150|NCT02585960|10031851|FG002|NOT COMPLETED|PK/Safety Assessment Period||6
8968151|NCT02585960|10031849|FG000|STARTED|Prophylactic Treatment Period||52
8968152|NCT02585960|10031850|FG001|STARTED|Prophylactic Treatment Period||48
8968153|NCT02585960|10031851|FG002|STARTED|Prophylactic Treatment Period||0
8968154|NCT02585960|10031849|FG000|COMPLETED|Prophylactic Treatment Period||52
8968155|NCT02585960|10031850|FG001|COMPLETED|Prophylactic Treatment Period||43
8968156|NCT02585960|10031851|FG002|COMPLETED|Prophylactic Treatment Period||0
8968157|NCT02585960|10031849|FG000|NOT COMPLETED|Prophylactic Treatment Period||0
8968158|NCT02585960|10031850|FG001|NOT COMPLETED|Prophylactic Treatment Period||5
8968159|NCT02585960|10031851|FG002|NOT COMPLETED|Prophylactic Treatment Period||0
8631883|NCT00542386|9671753|FG001|COMPLETED|Overall Study||74
8631884|NCT00542386|9671754|FG002|COMPLETED|Overall Study||66
8631885|NCT00542386|9671755|FG003|COMPLETED|Overall Study||65
8631886|NCT00542386|9671756|FG004|COMPLETED|Overall Study||62
8631887|NCT00542386|9671757|FG005|COMPLETED|Overall Study||82
8631888|NCT00542386|9671752|FG000|NOT COMPLETED|Overall Study||43
8631889|NCT00542386|9671753|FG001|NOT COMPLETED|Overall Study||28
8968160|NCT02585999|10031862|FG000|STARTED|Overall Study||28
8968161|NCT02585999|10031862|FG000|COMPLETED|Overall Study|28 participants enrolled; 2 withdrew prior to starting, leaving 26 to complete study activity.|26
8968162|NCT02585999|10031862|FG000|NOT COMPLETED|Overall Study||2
8968163|NCT02586012|10031867|FG000|STARTED|Overall Study||5
8631890|NCT00542386|9671754|FG002|NOT COMPLETED|Overall Study||33
8968164|NCT02586012|10031868|FG001|STARTED|Overall Study||5
8968165|NCT02586012|10031869|FG002|STARTED|Overall Study||5
8968166|NCT02586012|10031870|FG003|STARTED|Overall Study||5
8968167|NCT02586012|10031871|FG004|STARTED|Overall Study||5
8968168|NCT02586012|10031872|FG005|STARTED|Overall Study||5
8968169|NCT02586012|10031867|FG000|COMPLETED|Overall Study||4
8968170|NCT02586012|10031868|FG001|COMPLETED|Overall Study||2
8968171|NCT02586012|10031869|FG002|COMPLETED|Overall Study||4
8968172|NCT02586012|10031870|FG003|COMPLETED|Overall Study||3
8968173|NCT02586012|10031871|FG004|COMPLETED|Overall Study||4
8968174|NCT02586012|10031872|FG005|COMPLETED|Overall Study||2
8968175|NCT02586012|10031867|FG000|NOT COMPLETED|Overall Study||1
8968176|NCT02586012|10031868|FG001|NOT COMPLETED|Overall Study||3
8968177|NCT02586012|10031869|FG002|NOT COMPLETED|Overall Study||1
8968178|NCT02586012|10031870|FG003|NOT COMPLETED|Overall Study||2
8968179|NCT02586012|10031871|FG004|NOT COMPLETED|Overall Study||1
8968180|NCT02586012|10031872|FG005|NOT COMPLETED|Overall Study||3
8968181|NCT02586064|10031883|FG000|STARTED|Overall Study||61
8968182|NCT02586064|10031884|FG001|STARTED|Overall Study||54
8968183|NCT02586064|10031883|FG000|COMPLETED|Overall Study||43
8968184|NCT02586064|10031884|FG001|COMPLETED|Overall Study||26
8968185|NCT02586064|10031883|FG000|NOT COMPLETED|Overall Study||18
8968186|NCT02586064|10031884|FG001|NOT COMPLETED|Overall Study||28
8968187|NCT02586077|10031893|FG000|STARTED|Overall Study||36
8968188|NCT02586077|10031893|FG000|COMPLETED|Overall Study||28
8968189|NCT02586077|10031893|FG000|NOT COMPLETED|Overall Study||8
8968190|NCT02586155|10031900|FG000|STARTED|Overall Study||1215
8968191|NCT02586155|10031901|FG001|STARTED|Overall Study||1210
8968192|NCT02586155|10031900|FG000|Final Number Randomized|Overall Study||1212
8968193|NCT02586155|10031901|FG001|Final Number Randomized|Overall Study||1206
8968194|NCT02586155|10031900|FG000|COMPLETED|Overall Study||1088
8968195|NCT02586155|10031901|FG001|COMPLETED|Overall Study||1083
8968196|NCT02586155|10031900|FG000|NOT COMPLETED|Overall Study||127
8968197|NCT02586155|10031901|FG001|NOT COMPLETED|Overall Study||127
8968198|NCT02586233|10031914|FG000|STARTED|Overall Study||7
8968199|NCT02586233|10031915|FG001|STARTED|Overall Study||7
8968200|NCT02586233|10031916|FG002|STARTED|Overall Study||13
8968201|NCT02586233|10031917|FG003|STARTED|Overall Study||17
8968202|NCT02586233|10031918|FG004|STARTED|Overall Study||18
8968203|NCT02586233|10031919|FG005|STARTED|Overall Study||18
8968204|NCT02586233|10031920|FG006|STARTED|Overall Study||26
8968205|NCT02586233|10031914|FG000|COMPLETED|Overall Study||7
8968206|NCT02586233|10031915|FG001|COMPLETED|Overall Study||5
8968207|NCT02586233|10031916|FG002|COMPLETED|Overall Study||13
8968208|NCT02586233|10031917|FG003|COMPLETED|Overall Study||17
8968209|NCT02586233|10031918|FG004|COMPLETED|Overall Study||16
8968210|NCT02586233|10031919|FG005|COMPLETED|Overall Study||16
8968211|NCT02586233|10031920|FG006|COMPLETED|Overall Study||24
8968212|NCT02586233|10031914|FG000|NOT COMPLETED|Overall Study||0
8968213|NCT02586233|10031915|FG001|NOT COMPLETED|Overall Study||2
8968214|NCT02586233|10031916|FG002|NOT COMPLETED|Overall Study||0
8968215|NCT02586233|10031917|FG003|NOT COMPLETED|Overall Study||0
8968216|NCT02586233|10031918|FG004|NOT COMPLETED|Overall Study||2
8968217|NCT02586233|10031919|FG005|NOT COMPLETED|Overall Study||2
8968218|NCT02586233|10031920|FG006|NOT COMPLETED|Overall Study||2
8968219|NCT02586415|10031942|FG000|STARTED|Overall Study||92
8968220|NCT02586415|10031943|FG001|STARTED|Overall Study||90
8968221|NCT02586415|10031942|FG000|24 Hour Assessment|Overall Study||91
8968222|NCT02586415|10031943|FG001|24 Hour Assessment|Overall Study||90
8968223|NCT02586415|10031942|FG000|Day 30 Assessment|Overall Study||81
8968224|NCT02586415|10031943|FG001|Day 30 Assessment|Overall Study||70
8968225|NCT02586415|10031942|FG000|Day 90 Assessment|Overall Study||78
8968226|NCT02586415|10031943|FG001|Day 90 Assessment|Overall Study||65
8968227|NCT02586415|10031942|FG000|COMPLETED|Overall Study||78
8968228|NCT02586415|10031943|FG001|COMPLETED|Overall Study||65
8968229|NCT02586415|10031942|FG000|NOT COMPLETED|Overall Study||14
8968230|NCT02586415|10031943|FG001|NOT COMPLETED|Overall Study||25
8968231|NCT02586493|10031950|FG000|STARTED|Overall Study||278
8968232|NCT02586493|10031950|FG000|COMPLETED|Overall Study||266
8968233|NCT02586493|10031950|FG000|NOT COMPLETED|Overall Study||12
8968234|NCT02586506|10031954|FG000|STARTED|Overall Study||259
8968235|NCT02586506|10031954|FG000|COMPLETED|Overall Study||250
8968236|NCT02586506|10031954|FG000|NOT COMPLETED|Overall Study||9
8968237|NCT02586727|10031960|FG000|STARTED|Overall Study||20
8968238|NCT02586727|10031961|FG001|STARTED|Overall Study||20
8968239|NCT02586727|10031960|FG000|COMPLETED|Overall Study||19
8968240|NCT02586727|10031961|FG001|COMPLETED|Overall Study||20
8968241|NCT02586727|10031960|FG000|NOT COMPLETED|Overall Study||1
8968242|NCT02586727|10031961|FG001|NOT COMPLETED|Overall Study||0
8570722|NCT00105157|9602885|FG002|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||5
8968243|NCT02586805|10031971|FG000|STARTED|Overall Study||41
8968244|NCT02586805|10031972|FG001|STARTED|Overall Study||28
8968245|NCT02586805|10031973|FG002|STARTED|Overall Study||29
8968246|NCT02586805|10031974|FG003|STARTED|Overall Study||27
8968247|NCT02586805|10031971|FG000|COMPLETED|Overall Study||35
8968248|NCT02586805|10031972|FG001|COMPLETED|Overall Study||27
8968249|NCT02586805|10031973|FG002|COMPLETED|Overall Study||26
8968250|NCT02586805|10031974|FG003|COMPLETED|Overall Study||25
8968251|NCT02586805|10031971|FG000|NOT COMPLETED|Overall Study||6
8968252|NCT02586805|10031972|FG001|NOT COMPLETED|Overall Study||1
8968253|NCT02586805|10031973|FG002|NOT COMPLETED|Overall Study||3
8968254|NCT02586805|10031974|FG003|NOT COMPLETED|Overall Study||2
8968255|NCT02586896|10031986|FG000|STARTED|Overall Study||150
8968256|NCT02586896|10031987|FG001|STARTED|Overall Study||150
8968257|NCT02586896|10031986|FG000|3-Month Follow-up|Overall Study||126
8968258|NCT02586896|10031987|FG001|3-Month Follow-up|Overall Study||123
8968259|NCT02586896|10031986|FG000|COMPLETED|Overall Study||131
8968260|NCT02586896|10031987|FG001|COMPLETED|Overall Study||133
8968261|NCT02586896|10031986|FG000|NOT COMPLETED|Overall Study||19
8968262|NCT02586896|10031987|FG001|NOT COMPLETED|Overall Study||17
8968263|NCT02586909|10031993|FG000|STARTED|Overall Study||1099
8968264|NCT02586909|10031993|FG000|COMPLETED|Overall Study||151
8968265|NCT02586909|10031993|FG000|NOT COMPLETED|Overall Study||948
8968266|NCT02586974|10031999|FG000|STARTED|Overall Study||32
8968267|NCT02586974|10032000|FG001|STARTED|Overall Study||32
8968268|NCT02586974|10031999|FG000|COMPLETED|Overall Study||32
8968269|NCT02586974|10032000|FG001|COMPLETED|Overall Study||32
8968270|NCT02586974|10031999|FG000|NOT COMPLETED|Overall Study||0
8968271|NCT02586974|10032000|FG001|NOT COMPLETED|Overall Study||0
8968272|NCT02587065|10032008|FG000|STARTED|Overall Study||193
8968273|NCT02587065|10032008|FG000|COMPLETED|Overall Study||166
8968274|NCT02587065|10032008|FG000|NOT COMPLETED|Overall Study||27
8968275|NCT02587117|10032014|FG000|STARTED|Overall Study||13
8968276|NCT02587117|10032015|FG001|STARTED|Overall Study||15
8968277|NCT02587117|10032014|FG000|COMPLETED|Overall Study||13
8968278|NCT02587117|10032015|FG001|COMPLETED|Overall Study||15
8968279|NCT02587117|10032014|FG000|NOT COMPLETED|Overall Study||0
8968280|NCT02587117|10032015|FG001|NOT COMPLETED|Overall Study||0
8968281|NCT02587143|10032023|FG000|STARTED|Overall Study||66
8968282|NCT02587143|10032024|FG001|STARTED|Overall Study||60
8968283|NCT02587143|10032023|FG000|COMPLETED|Overall Study||65
8968284|NCT02587143|10032024|FG001|COMPLETED|Overall Study||60
8968285|NCT02587143|10032023|FG000|NOT COMPLETED|Overall Study||1
8968286|NCT02587143|10032024|FG001|NOT COMPLETED|Overall Study||0
8968287|NCT02587221|10032032|FG000|STARTED|Overall Study||3394
8968288|NCT02587221|10032033|FG001|STARTED|Overall Study||3396
8968289|NCT02587221|10032032|FG000|Treated|Overall Study||3379
8968290|NCT02587221|10032033|FG001|Treated|Overall Study||3382
8968291|NCT02587221|10032032|FG000|COMPLETED|Overall Study||3263
8968292|NCT02587221|10032033|FG001|COMPLETED|Overall Study||3273
8968293|NCT02587221|10032032|FG000|NOT COMPLETED|Overall Study||131
8968294|NCT02587221|10032033|FG001|NOT COMPLETED|Overall Study||123
8968295|NCT02587234|10032041|FG000|STARTED|Overall Study||11
8968296|NCT02587234|10032042|FG001|STARTED|Overall Study||10
8968297|NCT02587234|10032041|FG000|COMPLETED|Overall Study||10
8968298|NCT02587234|10032042|FG001|COMPLETED|Overall Study||7
8968299|NCT02587234|10032041|FG000|NOT COMPLETED|Overall Study||1
8968300|NCT02587234|10032042|FG001|NOT COMPLETED|Overall Study||3
8968301|NCT02587351|10032050|FG000|STARTED|Overall Study||268
8968302|NCT02587351|10032051|FG001|STARTED|Overall Study||264
8968303|NCT02587351|10032050|FG000|COMPLETED|Overall Study||268
8968304|NCT02587351|10032051|FG001|COMPLETED|Overall Study||264
8968305|NCT02587351|10032050|FG000|NOT COMPLETED|Overall Study||0
8968306|NCT02587351|10032051|FG001|NOT COMPLETED|Overall Study||0
8968307|NCT02587819|10032057|FG000|STARTED|Overall Study||21
8968308|NCT02587819|10032057|FG000|Exposed|Overall Study||21
8968309|NCT02587819|10032057|FG000|COMPLETED|Overall Study||19
8968310|NCT02587819|10032057|FG000|NOT COMPLETED|Overall Study||2
8968311|NCT02587962|10032067|FG000|STARTED|Overall Study||3
8968312|NCT02587962|10032068|FG001|STARTED|Overall Study||3
8968313|NCT02587962|10032069|FG002|STARTED|Overall Study||6
8968314|NCT02587962|10032070|FG003|STARTED|Overall Study||7
8968315|NCT02587962|10032071|FG004|STARTED|Overall Study||15
8968316|NCT02587962|10032067|FG000|COMPLETED|Overall Study||1
8968317|NCT02587962|10032068|FG001|COMPLETED|Overall Study||0
8968318|NCT02587962|10032069|FG002|COMPLETED|Overall Study||0
8968319|NCT02587962|10032070|FG003|COMPLETED|Overall Study||1
8968320|NCT02587962|10032071|FG004|COMPLETED|Overall Study||0
8968321|NCT02587962|10032067|FG000|NOT COMPLETED|Overall Study||2
8968322|NCT02587962|10032068|FG001|NOT COMPLETED|Overall Study||3
8968323|NCT02587962|10032069|FG002|NOT COMPLETED|Overall Study||6
8968324|NCT02587962|10032070|FG003|NOT COMPLETED|Overall Study||6
8968325|NCT02587962|10032071|FG004|NOT COMPLETED|Overall Study||15
8968326|NCT02588092|10032096|FG000|STARTED|Overall Study||4
8968327|NCT02588092|10032097|FG001|STARTED|Overall Study||3
8968328|NCT02588092|10032098|FG002|STARTED|Overall Study||3
8968329|NCT02588092|10032099|FG003|STARTED|Overall Study||3
8968330|NCT02588092|10032100|FG004|STARTED|Overall Study||3
8968331|NCT02588092|10032101|FG005|STARTED|Overall Study||3
8968332|NCT02588092|10032102|FG006|STARTED|Overall Study||3
8968333|NCT02588092|10032103|FG007|STARTED|Overall Study||4
8968334|NCT02588092|10032104|FG008|STARTED|Overall Study||6
8968335|NCT02588092|10032105|FG009|STARTED|Overall Study||3
8968336|NCT02588092|10032096|FG000|COMPLETED|Overall Study||0
8968337|NCT02588092|10032097|FG001|COMPLETED|Overall Study||0
8968338|NCT02588092|10032098|FG002|COMPLETED|Overall Study||0
8968339|NCT02588092|10032099|FG003|COMPLETED|Overall Study||0
8968340|NCT02588092|10032100|FG004|COMPLETED|Overall Study||0
8968341|NCT02588092|10032101|FG005|COMPLETED|Overall Study||0
8968342|NCT02588092|10032102|FG006|COMPLETED|Overall Study||0
8968343|NCT02588092|10032103|FG007|COMPLETED|Overall Study||0
8968344|NCT02588092|10032104|FG008|COMPLETED|Overall Study||0
8968345|NCT02588092|10032105|FG009|COMPLETED|Overall Study||0
8968346|NCT02588092|10032096|FG000|NOT COMPLETED|Overall Study||4
8968347|NCT02588092|10032097|FG001|NOT COMPLETED|Overall Study||3
8968348|NCT02588092|10032098|FG002|NOT COMPLETED|Overall Study||3
8968349|NCT02588092|10032099|FG003|NOT COMPLETED|Overall Study||3
8968350|NCT02588092|10032100|FG004|NOT COMPLETED|Overall Study||3
8968351|NCT02588092|10032101|FG005|NOT COMPLETED|Overall Study||3
8968352|NCT02588092|10032102|FG006|NOT COMPLETED|Overall Study||3
8968353|NCT02588092|10032103|FG007|NOT COMPLETED|Overall Study||4
8968354|NCT02588092|10032104|FG008|NOT COMPLETED|Overall Study||6
8968355|NCT02588092|10032105|FG009|NOT COMPLETED|Overall Study||3
9038057|NCT03328182|10099380|FG000|STARTED|Overall Study||34
9038058|NCT03328182|10099380|FG000|COMPLETED|Overall Study||30
9038059|NCT03328182|10099380|FG000|NOT COMPLETED|Overall Study||4
9038060|NCT03328208|10099386|FG000|STARTED|Overall Study||37
9038061|NCT03328208|10099387|FG001|STARTED|Overall Study||35
9038062|NCT03328208|10099386|FG000|COMPLETED|Overall Study||37
9038063|NCT03328208|10099387|FG001|COMPLETED|Overall Study||35
9038064|NCT03328208|10099386|FG000|NOT COMPLETED|Overall Study||0
9038065|NCT03328208|10099387|FG001|NOT COMPLETED|Overall Study||0
9038066|NCT03328325|10099393|FG000|STARTED|Overall Study||152
9038067|NCT03328325|10099393|FG000|COMPLETED|Overall Study||141
9038068|NCT03328325|10099393|FG000|NOT COMPLETED|Overall Study||11
9038069|NCT03328624|10099397|FG000|STARTED|Overall Study||36
9038070|NCT03328624|10099397|FG000|COMPLETED|Overall Study||36
9038071|NCT03328624|10099397|FG000|NOT COMPLETED|Overall Study||0
9038072|NCT03328832|10099403|FG000|STARTED|Overall Study||35
9038073|NCT03328832|10099404|FG001|STARTED|Overall Study||35
9038074|NCT03328832|10099403|FG000|COMPLETED|Overall Study||35
8570723|NCT00105157|9602886|FG003|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||19
8570724|NCT00105157|9602883|FG000|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||9
8570725|NCT00105157|9602884|FG001|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||6
9038075|NCT03328832|10099404|FG001|COMPLETED|Overall Study||34
9038076|NCT03328832|10099403|FG000|NOT COMPLETED|Overall Study||0
9038077|NCT03328832|10099404|FG001|NOT COMPLETED|Overall Study||1
9038078|NCT03328897|10099413|FG000|STARTED|Randomized-treatment Epoch||168
9038079|NCT03328897|10099414|FG001|STARTED|Randomized-treatment Epoch||167
9038080|NCT03328897|10099415|FG002|STARTED|Randomized-treatment Epoch||83
9038081|NCT03328897|10099413|FG000|Full Analysis Set (FAS)|Randomized-treatment Epoch||167
9038082|NCT03328897|10099414|FG001|Full Analysis Set (FAS)|Randomized-treatment Epoch||167
9038083|NCT03328897|10099415|FG002|Full Analysis Set (FAS)|Randomized-treatment Epoch||83
9038084|NCT03328897|10099413|FG000|COMPLETED|Randomized-treatment Epoch||152
9038085|NCT03328897|10099414|FG001|COMPLETED|Randomized-treatment Epoch||162
9038086|NCT03328897|10099415|FG002|COMPLETED|Randomized-treatment Epoch||81
9038087|NCT03328897|10099413|FG000|NOT COMPLETED|Randomized-treatment Epoch||16
9038088|NCT03328897|10099414|FG001|NOT COMPLETED|Randomized-treatment Epoch||5
9038089|NCT03328897|10099415|FG002|NOT COMPLETED|Randomized-treatment Epoch||2
9038090|NCT03328897|10099413|FG000|STARTED|Follow-up Epoch||161
9038091|NCT03328897|10099414|FG001|STARTED|Follow-up Epoch||163
9038092|NCT03328897|10099415|FG002|STARTED|Follow-up Epoch||81
9038093|NCT03328897|10099413|FG000|COMPLETED|Follow-up Epoch||153
9038094|NCT03328897|10099414|FG001|COMPLETED|Follow-up Epoch||160
9038095|NCT03328897|10099415|FG002|COMPLETED|Follow-up Epoch||79
9038096|NCT03328897|10099413|FG000|NOT COMPLETED|Follow-up Epoch||8
8968356|NCT04960228|10032133|FG000|STARTED|Overall Study||1098
8968357|NCT04960228|10032134|FG001|STARTED|Overall Study||999
8968358|NCT04960228|10032133|FG000|COMPLETED|Overall Study||810
8968359|NCT04960228|10032134|FG001|COMPLETED|Overall Study||813
8968360|NCT04960228|10032133|FG000|NOT COMPLETED|Overall Study||288
8968361|NCT04960228|10032134|FG001|NOT COMPLETED|Overall Study||186
8968362|NCT03922477|10032140|FG000|STARTED|Overall Study||13
8968363|NCT03922477|10032140|FG000|COMPLETED|Overall Study||0
8968364|NCT03922477|10032140|FG000|NOT COMPLETED|Overall Study||13
8968365|NCT03688074|10032146|FG000|STARTED|Overall Study||59
8968366|NCT03688074|10032147|FG001|STARTED|Overall Study||57
8968367|NCT03688074|10032146|FG000|COMPLETED|Overall Study||58
8968368|NCT03688074|10032147|FG001|COMPLETED|Overall Study||56
8968369|NCT03688074|10032146|FG000|NOT COMPLETED|Overall Study||1
8968370|NCT03688074|10032147|FG001|NOT COMPLETED|Overall Study||1
8968371|NCT03342001|10032153|FG000|STARTED|Overall Study||11
8968372|NCT03342001|10032153|FG000|COMPLETED|Overall Study||9
8968373|NCT03342001|10032153|FG000|NOT COMPLETED|Overall Study||2
8968374|NCT02871934|10032159|FG000|STARTED|Overall Study||193
8968375|NCT02871934|10032160|FG001|STARTED|Overall Study||215
8968376|NCT02871934|10032159|FG000|COMPLETED|Overall Study||193
8968377|NCT02871934|10032160|FG001|COMPLETED|Overall Study||215
8968378|NCT02871934|10032159|FG000|NOT COMPLETED|Overall Study||0
8968379|NCT02871934|10032160|FG001|NOT COMPLETED|Overall Study||0
8968380|NCT02859558|10032171|FG000|STARTED|Step 1||49
8968381|NCT02859558|10032172|FG001|STARTED|Step 1||79
8968382|NCT02859558|10032173|FG002|STARTED|Step 1||60
8968383|NCT02859558|10032174|FG003|STARTED|Step 1||4
8968384|NCT02859558|10032175|FG004|STARTED|Step 1||3
8968385|NCT02859558|10032171|FG000|Completed Week 48|Step 1||41
8968386|NCT02859558|10032172|FG001|Completed Week 48|Step 1||68
8968387|NCT02859558|10032173|FG002|Completed Week 48|Step 1||50
8968388|NCT02859558|10032174|FG003|Completed Week 48|Step 1||0
8968389|NCT02859558|10032175|FG004|Completed Week 48|Step 1||0
8968390|NCT02859558|10032171|FG000|COMPLETED|Step 1||37
8968391|NCT02859558|10032172|FG001|COMPLETED|Step 1||67
8968392|NCT02859558|10032173|FG002|COMPLETED|Step 1||49
8968393|NCT02859558|10032174|FG003|COMPLETED|Step 1||4
8968394|NCT02859558|10032175|FG004|COMPLETED|Step 1||0
8968395|NCT02859558|10032171|FG000|NOT COMPLETED|Step 1||12
8968396|NCT02859558|10032172|FG001|NOT COMPLETED|Step 1||12
8968397|NCT02859558|10032173|FG002|NOT COMPLETED|Step 1||11
8968398|NCT02859558|10032174|FG003|NOT COMPLETED|Step 1||0
8968399|NCT02859558|10032175|FG004|NOT COMPLETED|Step 1||3
8968400|NCT02859558|10032171|FG000|STARTED|Step 2||25
8968401|NCT02859558|10032172|FG001|STARTED|Step 2||39
8968402|NCT02859558|10032173|FG002|STARTED|Step 2||21
8968403|NCT02859558|10032174|FG003|STARTED|Step 2||0
8968404|NCT02859558|10032175|FG004|STARTED|Step 2||0
8968405|NCT02859558|10032171|FG000|COMPLETED|Step 2||0
8968406|NCT02859558|10032172|FG001|COMPLETED|Step 2||0
8968407|NCT02859558|10032173|FG002|COMPLETED|Step 2||0
8968408|NCT02859558|10032174|FG003|COMPLETED|Step 2||0
8968409|NCT02859558|10032175|FG004|COMPLETED|Step 2||0
8968410|NCT02859558|10032171|FG000|NOT COMPLETED|Step 2||25
8968411|NCT02859558|10032172|FG001|NOT COMPLETED|Step 2||39
8968412|NCT02859558|10032173|FG002|NOT COMPLETED|Step 2||21
8968413|NCT02859558|10032174|FG003|NOT COMPLETED|Step 2||0
8968414|NCT02859558|10032175|FG004|NOT COMPLETED|Step 2||0
8968415|NCT02818920|10032185|FG000|STARTED|Overall Study||30
8968416|NCT02818920|10032185|FG000|Completed Surgery|Overall Study||25
8968417|NCT02818920|10032185|FG000|Received Adjuvant Therapy|Overall Study||17
8968418|NCT02818920|10032185|FG000|COMPLETED|Overall Study||12
8968419|NCT02818920|10032185|FG000|NOT COMPLETED|Overall Study||18
8968420|NCT02481310|10032192|FG000|STARTED|Induction Treatment (6 Cycles)||1
8968421|NCT02481310|10032193|FG001|STARTED|Induction Treatment (6 Cycles)||36
8631891|NCT00542386|9671755|FG003|NOT COMPLETED|Overall Study||38
8631892|NCT00542386|9671756|FG004|NOT COMPLETED|Overall Study||40
8631893|NCT00542386|9671757|FG005|NOT COMPLETED|Overall Study||50
8631894|NCT00542425|9671776|FG000|STARTED|Initial 24 Weeks||46
8631895|NCT00542425|9671777|FG001|STARTED|Initial 24 Weeks||43
8968422|NCT02481310|10032194|FG002|STARTED|Induction Treatment (6 Cycles)||1
8968423|NCT02481310|10032192|FG000|Reached First Evaluable Response|Induction Treatment (6 Cycles)||1
8968424|NCT02481310|10032193|FG001|Reached First Evaluable Response|Induction Treatment (6 Cycles)||34
8968425|NCT02481310|10032194|FG002|Reached First Evaluable Response|Induction Treatment (6 Cycles)||1
8968426|NCT02481310|10032192|FG000|Complete 6 Cycles|Induction Treatment (6 Cycles)||1
8968427|NCT02481310|10032193|FG001|Complete 6 Cycles|Induction Treatment (6 Cycles)||30
8968428|NCT02481310|10032194|FG002|Complete 6 Cycles|Induction Treatment (6 Cycles)||1
8968429|NCT02481310|10032192|FG000|COMPLETED|Induction Treatment (6 Cycles)||1
8968430|NCT02481310|10032193|FG001|COMPLETED|Induction Treatment (6 Cycles)||30
8968431|NCT02481310|10032194|FG002|COMPLETED|Induction Treatment (6 Cycles)||1
8968432|NCT02481310|10032192|FG000|NOT COMPLETED|Induction Treatment (6 Cycles)||0
8968433|NCT02481310|10032193|FG001|NOT COMPLETED|Induction Treatment (6 Cycles)||6
8968434|NCT02481310|10032194|FG002|NOT COMPLETED|Induction Treatment (6 Cycles)||0
8968435|NCT02481310|10032192|FG000|STARTED|Maintenance Treatment||1
8968436|NCT02481310|10032193|FG001|STARTED|Maintenance Treatment|9 patients that competed induction did not start maintenance treatment.|21
8968437|NCT02481310|10032194|FG002|STARTED|Maintenance Treatment||1
8631896|NCT00542425|9671778|FG002|STARTED|Initial 24 Weeks||43
8968438|NCT02481310|10032192|FG000|Started Maintenance Treatment|Maintenance Treatment||1
8968439|NCT02481310|10032193|FG001|Started Maintenance Treatment|Maintenance Treatment||21
8968440|NCT02481310|10032194|FG002|Started Maintenance Treatment|Maintenance Treatment||1
8968441|NCT02481310|10032192|FG000|COMPLETED|Maintenance Treatment||1
8968442|NCT02481310|10032193|FG001|COMPLETED|Maintenance Treatment||21
8968443|NCT02481310|10032194|FG002|COMPLETED|Maintenance Treatment||1
8968444|NCT02481310|10032192|FG000|NOT COMPLETED|Maintenance Treatment||0
8968445|NCT02481310|10032193|FG001|NOT COMPLETED|Maintenance Treatment||0
8968446|NCT02481310|10032194|FG002|NOT COMPLETED|Maintenance Treatment||0
8968447|NCT02481310|10032192|FG000|STARTED|Follow up||1
8968448|NCT02481310|10032193|FG001|STARTED|Follow up|2 patients died prior to entering follow up, 1 patient withdrew consent and 1 patient currently on treatment.|32
8968449|NCT02481310|10032194|FG002|STARTED|Follow up||1
8968450|NCT02481310|10032192|FG000|COMPLETED|Follow up||1
8968451|NCT02481310|10032193|FG001|COMPLETED|Follow up||29
8968452|NCT02481310|10032194|FG002|COMPLETED|Follow up||1
8968453|NCT02481310|10032192|FG000|NOT COMPLETED|Follow up||0
8968454|NCT02481310|10032193|FG001|NOT COMPLETED|Follow up||3
8968455|NCT02481310|10032194|FG002|NOT COMPLETED|Follow up||0
8968456|NCT02343952|10032198|FG000|STARTED|Study Treatment||93
8968457|NCT02343952|10032198|FG000|COMPLETED|Study Treatment||40
8968458|NCT02343952|10032198|FG000|NOT COMPLETED|Study Treatment||53
8968459|NCT02343952|10032198|FG000|STARTED|Follow up||83
8968460|NCT02343952|10032198|FG000|COMPLETED|Follow up||38
8968461|NCT02343952|10032198|FG000|NOT COMPLETED|Follow up||45
8968462|NCT02326155|10032204|FG000|STARTED|Overall Study||407
8968463|NCT02326155|10032205|FG001|STARTED|Overall Study||63
8968464|NCT02326155|10032204|FG000|COMPLETED|Overall Study||13
8968465|NCT02326155|10032205|FG001|COMPLETED|Overall Study||1
8968466|NCT02326155|10032204|FG000|NOT COMPLETED|Overall Study||394
8968467|NCT02326155|10032205|FG001|NOT COMPLETED|Overall Study||62
8968468|NCT02304367|10032211|FG000|STARTED|Overall Study|14 participants with TIO; 1 participant with ENS; 2 participants with XLH|17
8968469|NCT02304367|10032211|FG000|Completed 48 Weeks of Study Drug|Overall Study||16
8968470|NCT02304367|10032211|FG000|Completed 144 Weeks of Study Drug|Overall Study||12
8968471|NCT02304367|10032211|FG000|COMPLETED|Overall Study||9
8968472|NCT02304367|10032211|FG000|NOT COMPLETED|Overall Study||8
8968473|NCT01810705|10032224|FG000|STARTED|Overall Study||83
8968474|NCT01810705|10032225|FG001|STARTED|Overall Study||40
8968475|NCT01810705|10032224|FG000|COMPLETED|Overall Study||10
8968476|NCT01810705|10032225|FG001|COMPLETED|Overall Study||5
8968477|NCT01810705|10032224|FG000|NOT COMPLETED|Overall Study||73
8968478|NCT01810705|10032225|FG001|NOT COMPLETED|Overall Study||35
8968479|NCT02588261|10032233|FG000|STARTED|Overall Study||267
8968480|NCT02588261|10032234|FG001|STARTED|Overall Study||263
8968481|NCT02588261|10032233|FG000|Treated|Overall Study||265
8968482|NCT02588261|10032234|FG001|Treated|Overall Study||262
8968483|NCT02588261|10032233|FG000|COMPLETED|Overall Study||0
8968484|NCT02588261|10032234|FG001|COMPLETED|Overall Study||0
8968485|NCT02588261|10032233|FG000|NOT COMPLETED|Overall Study||267
8968486|NCT02588261|10032234|FG001|NOT COMPLETED|Overall Study||263
8968487|NCT02588339|10032240|FG000|STARTED|Overall Study||42
8968488|NCT02588339|10032240|FG000|COMPLETED|Overall Study||39
8968489|NCT02588339|10032240|FG000|NOT COMPLETED|Overall Study||3
8968490|NCT02588573|10032246|FG000|STARTED|Overall Study||45
8968491|NCT02588573|10032247|FG001|STARTED|Overall Study||45
8968492|NCT02588573|10032246|FG000|Randomized Eye Etafilcon A|Overall Study||45
8968493|NCT02588573|10032247|FG001|Randomized Eye Etafilcon A|Overall Study||45
8968494|NCT02588573|10032246|FG000|Randomized Eye Somofilcon A|Overall Study||45
8968495|NCT02588573|10032247|FG001|Randomized Eye Somofilcon A|Overall Study||45
8968496|NCT02588573|10032246|FG000|COMPLETED|Overall Study||45
8968497|NCT02588573|10032247|FG001|COMPLETED|Overall Study||45
8968498|NCT02588573|10032246|FG000|NOT COMPLETED|Overall Study||0
8968499|NCT02588573|10032247|FG001|NOT COMPLETED|Overall Study||0
8968500|NCT02588586|10032265|FG000|STARTED|Overall Study||17
8968501|NCT02588586|10032265|FG000|COMPLETED|Overall Study||15
8968502|NCT02588586|10032265|FG000|NOT COMPLETED|Overall Study||2
8968503|NCT02588599|10032269|FG000|STARTED|Overall Study||54
8968504|NCT02588599|10032269|FG000|COMPLETED|Overall Study||54
8968505|NCT02588599|10032269|FG000|NOT COMPLETED|Overall Study||0
8968506|NCT02588612|10032273|FG000|STARTED|Overall Study||10
8968507|NCT02588612|10032273|FG000|Received T-cell Infusion|Overall Study||5
8968508|NCT02588612|10032273|FG000|COMPLETED|Overall Study||5
8968509|NCT02588612|10032273|FG000|NOT COMPLETED|Overall Study||5
8968510|NCT02588664|10032279|FG000|STARTED|Overall Study||3193
8968511|NCT02588664|10032280|FG001|STARTED|Overall Study||2689
8968512|NCT02588664|10032279|FG000|COMPLETED|Overall Study||1832
8968513|NCT02588664|10032280|FG001|COMPLETED|Overall Study||1644
8968514|NCT02588664|10032279|FG000|NOT COMPLETED|Overall Study||1361
8968515|NCT02588664|10032280|FG001|NOT COMPLETED|Overall Study||1045
8968516|NCT02588833|10032288|FG000|STARTED|Part 1|One subject was enrolled in both cohorts, this subject was enrolled twice.|3
8968517|NCT02588833|10032289|FG001|STARTED|Part 1|One subject was enrolled in both cohorts, this subject was enrolled twice.|20
8968518|NCT02588833|10032288|FG000|COMPLETED|Part 1||2
8968519|NCT02588833|10032289|FG001|COMPLETED|Part 1||20
8968520|NCT02588833|10032288|FG000|NOT COMPLETED|Part 1||1
8968521|NCT02588833|10032289|FG001|NOT COMPLETED|Part 1||0
8968522|NCT02588833|10032288|FG000|STARTED|Part 2A|Part 2A is not applicable since Cohort 1 subjects proceeded immediately to Part 3.|0
8968523|NCT02588833|10032289|FG001|STARTED|Part 2A||20
8968524|NCT02588833|10032288|FG000|COMPLETED|Part 2A||0
8968525|NCT02588833|10032289|FG001|COMPLETED|Part 2A||18
8968526|NCT02588833|10032288|FG000|NOT COMPLETED|Part 2A||0
8968527|NCT02588833|10032289|FG001|NOT COMPLETED|Part 2A||2
8968528|NCT02588833|10032288|FG000|STARTED|Part 2B||0
8968529|NCT02588833|10032289|FG001|STARTED|Part 2B||18
8968530|NCT02588833|10032288|FG000|COMPLETED|Part 2B||0
8968531|NCT02588833|10032289|FG001|COMPLETED|Part 2B||17
8968532|NCT02588833|10032288|FG000|NOT COMPLETED|Part 2B||0
8968533|NCT02588833|10032289|FG001|NOT COMPLETED|Part 2B||1
8968534|NCT02588833|10032288|FG000|STARTED|Part 2C||0
8968535|NCT02588833|10032289|FG001|STARTED|Part 2C|17 subjects completed Part 2B and 3 entered extension study without participating in Part 2C.|14
8968536|NCT02588833|10032288|FG000|COMPLETED|Part 2C||0
8570726|NCT00105157|9602885|FG002|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||6
8968537|NCT02588833|10032289|FG001|COMPLETED|Part 2C||12
8631897|NCT00542425|9671779|FG003|STARTED|Initial 24 Weeks||45
8631898|NCT00542425|9671780|FG004|STARTED|Initial 24 Weeks||45
8876599|NCT01918072|9933439|FG002|NOT COMPLETED|Controlled Trial Step One - Six Months||0
8876600|NCT01918072|9933437|FG000|STARTED|Controlled Trial Step Two - Six Months||11
8876601|NCT01918072|9933438|FG001|STARTED|Controlled Trial Step Two - Six Months||0
8876602|NCT01918072|9933439|FG002|STARTED|Controlled Trial Step Two - Six Months||0
8876603|NCT01918072|9933437|FG000|Intervention|Controlled Trial Step Two - Six Months||7
8876604|NCT01918072|9933438|FG001|Intervention|Controlled Trial Step Two - Six Months||0
8570727|NCT00105157|9602886|FG003|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||18
8570728|NCT00105183|9602897|FG000|STARTED|Overall Study|Randomized|82
8570729|NCT00105183|9602898|FG001|STARTED|Overall Study|Randomized|79
8876605|NCT01918072|9933439|FG002|Intervention|Controlled Trial Step Two - Six Months||0
8876606|NCT01918072|9933437|FG000|Control|Controlled Trial Step Two - Six Months||4
8876607|NCT01918072|9933438|FG001|Control|Controlled Trial Step Two - Six Months||0
8876608|NCT01918072|9933439|FG002|Control|Controlled Trial Step Two - Six Months||0
8876609|NCT01918072|9933437|FG000|COMPLETED|Controlled Trial Step Two - Six Months||11
8876610|NCT01918072|9933438|FG001|COMPLETED|Controlled Trial Step Two - Six Months||0
8876611|NCT01918072|9933439|FG002|COMPLETED|Controlled Trial Step Two - Six Months||0
8876612|NCT01918072|9933437|FG000|NOT COMPLETED|Controlled Trial Step Two - Six Months||0
8876613|NCT01918072|9933438|FG001|NOT COMPLETED|Controlled Trial Step Two - Six Months||0
8876614|NCT01918072|9933439|FG002|NOT COMPLETED|Controlled Trial Step Two - Six Months||0
8876615|NCT01918072|9933437|FG000|STARTED|Controlled Trial Step Three - Six Months||11
8876616|NCT01918072|9933438|FG001|STARTED|Controlled Trial Step Three - Six Months||0
8876617|NCT01918072|9933439|FG002|STARTED|Controlled Trial Step Three - Six Months||0
8876618|NCT01918072|9933437|FG000|Intervention|Controlled Trial Step Three - Six Months||9
8876619|NCT01918072|9933438|FG001|Intervention|Controlled Trial Step Three - Six Months||0
8876620|NCT01918072|9933439|FG002|Intervention|Controlled Trial Step Three - Six Months||0
8876621|NCT01918072|9933437|FG000|Control|Controlled Trial Step Three - Six Months||2
8876622|NCT01918072|9933438|FG001|Control|Controlled Trial Step Three - Six Months||0
8876623|NCT01918072|9933439|FG002|Control|Controlled Trial Step Three - Six Months||0
8876624|NCT01918072|9933437|FG000|COMPLETED|Controlled Trial Step Three - Six Months||11
8876625|NCT01918072|9933438|FG001|COMPLETED|Controlled Trial Step Three - Six Months||0
8876626|NCT01918072|9933439|FG002|COMPLETED|Controlled Trial Step Three - Six Months||0
8876627|NCT01918072|9933437|FG000|NOT COMPLETED|Controlled Trial Step Three - Six Months||0
8876628|NCT01918072|9933438|FG001|NOT COMPLETED|Controlled Trial Step Three - Six Months||0
8876629|NCT01918072|9933439|FG002|NOT COMPLETED|Controlled Trial Step Three - Six Months||0
8876630|NCT01918072|9933437|FG000|STARTED|Controlled Trial Step Four - Six Months||11
8876631|NCT01918072|9933438|FG001|STARTED|Controlled Trial Step Four - Six Months||0
8876632|NCT01918072|9933439|FG002|STARTED|Controlled Trial Step Four - Six Months||0
8876633|NCT01918072|9933437|FG000|Intervention|Controlled Trial Step Four - Six Months||11
8876634|NCT01918072|9933438|FG001|Intervention|Controlled Trial Step Four - Six Months||0
8876635|NCT01918072|9933439|FG002|Intervention|Controlled Trial Step Four - Six Months||0
8876636|NCT01918072|9933437|FG000|Control|Controlled Trial Step Four - Six Months||0
8876637|NCT01918072|9933438|FG001|Control|Controlled Trial Step Four - Six Months||0
8876638|NCT01918072|9933439|FG002|Control|Controlled Trial Step Four - Six Months||0
8876639|NCT01918072|9933437|FG000|COMPLETED|Controlled Trial Step Four - Six Months||11
8876640|NCT01918072|9933438|FG001|COMPLETED|Controlled Trial Step Four - Six Months||0
8876641|NCT01918072|9933439|FG002|COMPLETED|Controlled Trial Step Four - Six Months||0
8876642|NCT01918072|9933437|FG000|NOT COMPLETED|Controlled Trial Step Four - Six Months||0
8876643|NCT01918072|9933438|FG001|NOT COMPLETED|Controlled Trial Step Four - Six Months||0
8876644|NCT01918072|9933439|FG002|NOT COMPLETED|Controlled Trial Step Four - Six Months||0
8876645|NCT01918072|9933437|FG000|STARTED|Controlled Trial Step Five - Four Months||11
8876646|NCT01918072|9933438|FG001|STARTED|Controlled Trial Step Five - Four Months||0
8876647|NCT01918072|9933439|FG002|STARTED|Controlled Trial Step Five - Four Months||0
8570730|NCT00105183|9602899|FG002|STARTED|Overall Study|Randomized|62
8570731|NCT00105183|9602897|FG000|COMPLETED|Overall Study|Completed at least 12 months follow up|60
8570732|NCT00105183|9602898|FG001|COMPLETED|Overall Study|Completed at least 12 months follow up|60
8570733|NCT00105183|9602899|FG002|COMPLETED|Overall Study|Completed at least 12 months follow up|39
8570734|NCT00105183|9602897|FG000|NOT COMPLETED|Overall Study||22
8570735|NCT00105183|9602898|FG001|NOT COMPLETED|Overall Study||19
8570736|NCT00105183|9602899|FG002|NOT COMPLETED|Overall Study||23
8570737|NCT00105196|9602909|FG000|STARTED|Overall Study||177
8570738|NCT00105196|9602910|FG001|STARTED|Overall Study||172
8570739|NCT00105196|9602909|FG000|COMPLETED|Overall Study||147
8570740|NCT00105196|9602910|FG001|COMPLETED|Overall Study||149
8570741|NCT00105196|9602909|FG000|NOT COMPLETED|Overall Study||30
8570742|NCT00105196|9602910|FG001|NOT COMPLETED|Overall Study||23
8570743|NCT00105235|9602916|FG000|STARTED|Overall Study||27
8968538|NCT02588833|10032288|FG000|NOT COMPLETED|Part 2C||0
8968539|NCT02588833|10032289|FG001|NOT COMPLETED|Part 2C||2
8968540|NCT02588833|10032288|FG000|STARTED|Part 3 (Safety Follow-up)|Only subjects who did not enter extension study or Part 2C entered Part 3.|3
8968541|NCT02588833|10032289|FG001|STARTED|Part 3 (Safety Follow-up)|Only subjects who did not enter extension study or Part 2C entered Part 3.|4
8968542|NCT02588833|10032288|FG000|COMPLETED|Part 3 (Safety Follow-up)||3
8968543|NCT02588833|10032289|FG001|COMPLETED|Part 3 (Safety Follow-up)||2
8968544|NCT02588833|10032288|FG000|NOT COMPLETED|Part 3 (Safety Follow-up)||0
8968545|NCT02588833|10032289|FG001|NOT COMPLETED|Part 3 (Safety Follow-up)||2
8968546|NCT02588872|10032298|FG000|STARTED|Overall Study||59
8968547|NCT02588872|10032299|FG001|STARTED|Overall Study||52
8968548|NCT02588872|10032298|FG000|COMPLETED|Overall Study||59
8968549|NCT02588872|10032299|FG001|COMPLETED|Overall Study||52
8968550|NCT02588872|10032298|FG000|NOT COMPLETED|Overall Study||0
8968551|NCT02588872|10032299|FG001|NOT COMPLETED|Overall Study||0
8968552|NCT02588976|10032305|FG000|STARTED|Overall Study||30
8968553|NCT02588976|10032305|FG000|COMPLETED|Overall Study||30
8968554|NCT02588976|10032305|FG000|NOT COMPLETED|Overall Study||0
8968555|NCT02589067|10032312|FG000|STARTED|Overall Study||33
8968556|NCT02589067|10032313|FG001|STARTED|Overall Study||34
8968557|NCT02589067|10032312|FG000|COMPLETED|Overall Study||28
8968558|NCT02589067|10032313|FG001|COMPLETED|Overall Study||28
8968559|NCT02589067|10032312|FG000|NOT COMPLETED|Overall Study||5
8968560|NCT02589067|10032313|FG001|NOT COMPLETED|Overall Study||6
8968561|NCT02589171|10032322|FG000|STARTED|Overall Study||35
8968562|NCT02589171|10032323|FG001|STARTED|Overall Study||35
8968563|NCT02589171|10032322|FG000|Day 1 Follow up|Overall Study||35
8968564|NCT02589171|10032323|FG001|Day 1 Follow up|Overall Study||35
8968565|NCT02589171|10032322|FG000|Week 1 Follow up|Overall Study||35
8968566|NCT02589171|10032323|FG001|Week 1 Follow up|Overall Study||34
8968567|NCT02589171|10032322|FG000|Week 6 Follow up|Overall Study||28
8968568|NCT02589171|10032323|FG001|Week 6 Follow up|Overall Study||30
8968569|NCT02589171|10032322|FG000|COMPLETED|Overall Study||28
8968570|NCT02589171|10032323|FG001|COMPLETED|Overall Study||30
8968571|NCT02589171|10032322|FG000|NOT COMPLETED|Overall Study||7
8968572|NCT02589171|10032323|FG001|NOT COMPLETED|Overall Study||5
8968573|NCT02589405|10032329|FG000|STARTED|Overall Study||50
8968574|NCT02589405|10032329|FG000|COMPLETED|Overall Study||46
8968575|NCT02589405|10032329|FG000|NOT COMPLETED|Overall Study||4
8968576|NCT02589626|10032335|FG000|STARTED|Overall Study|Entered are treated patients|32
8968577|NCT02589626|10032336|FG001|STARTED|Overall Study|Entered are treated patients|33
8968578|NCT02589626|10032335|FG000|COMPLETED|Overall Study||29
8968579|NCT02589626|10032336|FG001|COMPLETED|Overall Study||31
8968580|NCT02589626|10032335|FG000|NOT COMPLETED|Overall Study||3
8968581|NCT02589626|10032336|FG001|NOT COMPLETED|Overall Study||2
8968582|NCT02589639|10032345|FG000|STARTED|Overall Study||90
8968583|NCT02589639|10032346|FG001|STARTED|Overall Study||89
8968584|NCT02589639|10032347|FG002|STARTED|Overall Study||90
8968585|NCT02589639|10032345|FG000|Treated|Overall Study||90
8968586|NCT02589639|10032346|FG001|Treated|Overall Study||86
8968587|NCT02589639|10032347|FG002|Treated|Overall Study||90
8968588|NCT02589639|10032345|FG000|COMPLETED|Overall Study||80
8968589|NCT02589639|10032346|FG001|COMPLETED|Overall Study||79
8968590|NCT02589639|10032347|FG002|COMPLETED|Overall Study||86
8968591|NCT02589639|10032345|FG000|NOT COMPLETED|Overall Study||10
8968592|NCT02589639|10032346|FG001|NOT COMPLETED|Overall Study||10
8968593|NCT02589639|10032347|FG002|NOT COMPLETED|Overall Study||4
8968594|NCT02589665|10032359|FG000|STARTED|Induction Period||63
8968595|NCT02589665|10032360|FG001|STARTED|Induction Period||63
8968596|NCT02589665|10032361|FG002|STARTED|Induction Period||62
8968597|NCT02589665|10032362|FG003|STARTED|Induction Period||61
8968598|NCT02589665|10032363|FG004|STARTED|Induction Period|Participants were assigned to this arm during maintenance period.|0
8968599|NCT02589665|10032364|FG005|STARTED|Induction Period|Participants were assigned to this arm during maintenance period.|0
8968600|NCT02589665|10032365|FG006|STARTED|Induction Period|Participants were assigned to this arm during maintenance period.|0
8968601|NCT02589665|10032366|FG007|STARTED|Induction Period||0
8968602|NCT02589665|10032367|FG008|STARTED|Induction Period||0
8968603|NCT02589665|10032368|FG009|STARTED|Induction Period||0
8968604|NCT02589665|10032359|FG000|Received at Least One Dose of Study Drug|Induction Period||63
8968605|NCT02589665|10032360|FG001|Received at Least One Dose of Study Drug|Induction Period||63
8968606|NCT02589665|10032361|FG002|Received at Least One Dose of Study Drug|Induction Period||62
8968607|NCT02589665|10032362|FG003|Received at Least One Dose of Study Drug|Induction Period||60
8968608|NCT02589665|10032363|FG004|Received at Least One Dose of Study Drug|Induction Period||0
8968609|NCT02589665|10032364|FG005|Received at Least One Dose of Study Drug|Induction Period||0
8968610|NCT02589665|10032365|FG006|Received at Least One Dose of Study Drug|Induction Period||0
8968611|NCT02589665|10032366|FG007|Received at Least One Dose of Study Drug|Induction Period||0
8968612|NCT02589665|10032367|FG008|Received at Least One Dose of Study Drug|Induction Period||0
8968613|NCT02589665|10032368|FG009|Received at Least One Dose of Study Drug|Induction Period||0
8968614|NCT02589665|10032359|FG000|COMPLETED|Induction Period||60
8968615|NCT02589665|10032360|FG001|COMPLETED|Induction Period||61
8968616|NCT02589665|10032361|FG002|COMPLETED|Induction Period||60
8968617|NCT02589665|10032362|FG003|COMPLETED|Induction Period||57
8968618|NCT02589665|10032363|FG004|COMPLETED|Induction Period||0
8968619|NCT02589665|10032364|FG005|COMPLETED|Induction Period||0
8968620|NCT02589665|10032365|FG006|COMPLETED|Induction Period||0
8968621|NCT02589665|10032366|FG007|COMPLETED|Induction Period||0
8968622|NCT02589665|10032367|FG008|COMPLETED|Induction Period||0
8968623|NCT02589665|10032368|FG009|COMPLETED|Induction Period||0
8968624|NCT02589665|10032359|FG000|NOT COMPLETED|Induction Period||3
8968625|NCT02589665|10032360|FG001|NOT COMPLETED|Induction Period||2
8968626|NCT02589665|10032361|FG002|NOT COMPLETED|Induction Period||2
8968627|NCT02589665|10032362|FG003|NOT COMPLETED|Induction Period||4
8968628|NCT02589665|10032363|FG004|NOT COMPLETED|Induction Period||0
8968629|NCT02589665|10032364|FG005|NOT COMPLETED|Induction Period||0
8968630|NCT02589665|10032365|FG006|NOT COMPLETED|Induction Period||0
8968631|NCT02589665|10032366|FG007|NOT COMPLETED|Induction Period||0
8968632|NCT02589665|10032367|FG008|NOT COMPLETED|Induction Period||0
8968633|NCT02589665|10032368|FG009|NOT COMPLETED|Induction Period||0
8968634|NCT02589665|10032359|FG000|STARTED|Maintenance Period|Participants were assigned to this arm only during induction period.|0
8968635|NCT02589665|10032360|FG001|STARTED|Maintenance Period|Participants were assigned to this arm only during induction period.|0
8968636|NCT02589665|10032361|FG002|STARTED|Maintenance Period|Participants were assigned to this arm only during induction period.|0
8968637|NCT02589665|10032362|FG003|STARTED|Maintenance Period|Participants were assigned to this arm only during induction period.|0
8968638|NCT02589665|10032363|FG004|STARTED|Maintenance Period|Only participants with a response were re-randomized in maintenance period.|13
8968639|NCT02589665|10032364|FG005|STARTED|Maintenance Period|Only participants with a response were re-randomized in maintenance period.|47
8968640|NCT02589665|10032365|FG006|STARTED|Maintenance Period|Only participants with a response were re-randomized in maintenance period.|46
8968641|NCT02589665|10032366|FG007|STARTED|Maintenance Period||0
8968642|NCT02589665|10032367|FG008|STARTED|Maintenance Period||0
8968643|NCT02589665|10032368|FG009|STARTED|Maintenance Period||0
8631899|NCT00542425|9671776|FG000|COMPLETED|Initial 24 Weeks||42
8631900|NCT00542425|9671777|FG001|COMPLETED|Initial 24 Weeks||33
8876648|NCT01918072|9933437|FG000|Intervention|Controlled Trial Step Five - Four Months||11
8876649|NCT01918072|9933438|FG001|Intervention|Controlled Trial Step Five - Four Months||0
8876650|NCT01918072|9933439|FG002|Intervention|Controlled Trial Step Five - Four Months||0
8968644|NCT02589665|10032359|FG000|COMPLETED|Maintenance Period||0
8968645|NCT02589665|10032360|FG001|COMPLETED|Maintenance Period||0
8968646|NCT02589665|10032361|FG002|COMPLETED|Maintenance Period||0
8968647|NCT02589665|10032362|FG003|COMPLETED|Maintenance Period||0
8968648|NCT02589665|10032363|FG004|COMPLETED|Maintenance Period||0
8968649|NCT02589665|10032364|FG005|COMPLETED|Maintenance Period||0
8968650|NCT02589665|10032365|FG006|COMPLETED|Maintenance Period||0
8968651|NCT02589665|10032366|FG007|COMPLETED|Maintenance Period||0
8968652|NCT02589665|10032367|FG008|COMPLETED|Maintenance Period||0
8968653|NCT02589665|10032368|FG009|COMPLETED|Maintenance Period||0
8968654|NCT02589665|10032359|FG000|NOT COMPLETED|Maintenance Period||0
8968655|NCT02589665|10032360|FG001|NOT COMPLETED|Maintenance Period||0
8968656|NCT02589665|10032361|FG002|NOT COMPLETED|Maintenance Period||0
8968657|NCT02589665|10032362|FG003|NOT COMPLETED|Maintenance Period||0
8968658|NCT02589665|10032363|FG004|NOT COMPLETED|Maintenance Period||13
8968659|NCT02589665|10032364|FG005|NOT COMPLETED|Maintenance Period||47
8968660|NCT02589665|10032365|FG006|NOT COMPLETED|Maintenance Period||46
8968661|NCT02589665|10032366|FG007|NOT COMPLETED|Maintenance Period||0
8968662|NCT02589665|10032367|FG008|NOT COMPLETED|Maintenance Period||0
8968663|NCT02589665|10032368|FG009|NOT COMPLETED|Maintenance Period||0
8968664|NCT02589665|10032359|FG000|STARTED|Induction Extension Period||0
8968665|NCT02589665|10032360|FG001|STARTED|Induction Extension Period||0
8968666|NCT02589665|10032361|FG002|STARTED|Induction Extension Period||0
8968667|NCT02589665|10032362|FG003|STARTED|Induction Extension Period||0
8968668|NCT02589665|10032363|FG004|STARTED|Induction Extension Period||0
8968669|NCT02589665|10032364|FG005|STARTED|Induction Extension Period||0
8968670|NCT02589665|10032365|FG006|STARTED|Induction Extension Period||0
8968671|NCT02589665|10032366|FG007|STARTED|Induction Extension Period||32
8631901|NCT00542425|9671778|FG002|COMPLETED|Initial 24 Weeks||36
8631902|NCT00542425|9671779|FG003|COMPLETED|Initial 24 Weeks||34
8876651|NCT01918072|9933437|FG000|Control|Controlled Trial Step Five - Four Months||0
8876652|NCT01918072|9933438|FG001|Control|Controlled Trial Step Five - Four Months||0
8876653|NCT01918072|9933439|FG002|Control|Controlled Trial Step Five - Four Months||0
8876654|NCT01918072|9933437|FG000|COMPLETED|Controlled Trial Step Five - Four Months||11
8876655|NCT01918072|9933438|FG001|COMPLETED|Controlled Trial Step Five - Four Months||0
8876656|NCT01918072|9933439|FG002|COMPLETED|Controlled Trial Step Five - Four Months||0
8876657|NCT01918072|9933437|FG000|NOT COMPLETED|Controlled Trial Step Five - Four Months||0
8876658|NCT01918072|9933438|FG001|NOT COMPLETED|Controlled Trial Step Five - Four Months||0
8876659|NCT01918072|9933439|FG002|NOT COMPLETED|Controlled Trial Step Five - Four Months||0
8876660|NCT01918072|9933437|FG000|STARTED|E-consult Assessment Period||0
8876661|NCT01918072|9933438|FG001|STARTED|E-consult Assessment Period||42
8876662|NCT01918072|9933439|FG002|STARTED|E-consult Assessment Period||0
8876663|NCT01918072|9933437|FG000|COMPLETED|E-consult Assessment Period||0
8876664|NCT01918072|9933438|FG001|COMPLETED|E-consult Assessment Period||42
8876665|NCT01918072|9933439|FG002|COMPLETED|E-consult Assessment Period||0
8968672|NCT02589665|10032367|FG008|STARTED|Induction Extension Period||96
8876666|NCT01918072|9933437|FG000|NOT COMPLETED|E-consult Assessment Period||0
8876667|NCT01918072|9933438|FG001|NOT COMPLETED|E-consult Assessment Period||0
8876668|NCT01918072|9933439|FG002|NOT COMPLETED|E-consult Assessment Period||0
8876669|NCT01918072|9933437|FG000|STARTED|Quality Assessment Period||0
8876670|NCT01918072|9933438|FG001|STARTED|Quality Assessment Period||0
8968673|NCT02589665|10032368|FG009|STARTED|Induction Extension Period||0
8968674|NCT02589665|10032359|FG000|COMPLETED|Induction Extension Period||0
8968675|NCT02589665|10032360|FG001|COMPLETED|Induction Extension Period||0
8570744|NCT00105235|9602916|FG000|COMPLETED|Overall Study||20
8570745|NCT00105235|9602916|FG000|NOT COMPLETED|Overall Study||7
8570746|NCT00105443|9602926|FG000|STARTED|Double-Blind Treatment||242
8570747|NCT00105443|9602927|FG001|STARTED|Double-Blind Treatment||57
8570748|NCT00105443|9602928|FG002|STARTED|Double-Blind Treatment||256
8570749|NCT00105443|9602929|FG003|STARTED|Double-Blind Treatment||47
8570750|NCT00105443|9602926|FG000|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG1 and RG3 (RG = Reporting Group for Safety Data)|240
8570751|NCT00105443|9602927|FG001|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG1 and RG3|57
8570752|NCT00105443|9602928|FG002|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG2 and RG4|255
8570753|NCT00105443|9602929|FG003|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG2 and RG4 as well as RG5|47
8570754|NCT00105443|9602926|FG000|COMPLETED|Double-Blind Treatment|228 participants directly switched to the Follow-up (FU) phase only|228
8570755|NCT00105443|9602927|FG001|COMPLETED|Double-Blind Treatment|47 participants continued with Sorafenib Open Label (OL); 10 first to FU prior to also switch to OL|57
8570756|NCT00105443|9602928|FG002|COMPLETED|Double-Blind Treatment|245 participants directly switched to the Follow-up (FU) phase|245
8570757|NCT00105443|9602929|FG003|COMPLETED|Double-Blind Treatment|36 participants switched to Sorafenib Open Label (OL); 11 first to FU prior to also switch to OL|47
8570758|NCT00105443|9602926|FG000|NOT COMPLETED|Double-Blind Treatment||14
8570759|NCT00105443|9602927|FG001|NOT COMPLETED|Double-Blind Treatment||0
8570760|NCT00105443|9602928|FG002|NOT COMPLETED|Double-Blind Treatment||11
8570761|NCT00105443|9602929|FG003|NOT COMPLETED|Double-Blind Treatment||0
8570762|NCT00105443|9602926|FG000|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 228 participants directly switched to Follow-up (FU)|228
8570763|NCT00105443|9602927|FG001|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 47 participants directly switched to Open Label (OL) Sorafenib treatment|57
8570764|NCT00105443|9602928|FG002|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 245 participants directly switched to Follow-up (FU)|245
8570765|NCT00105443|9602929|FG003|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 36 participants directly switched to Open Label (OL) Sorafenib treatment|47
8570766|NCT00105443|9602926|FG000|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar|"In parallel to Open Label treatment only phase"|228
8570767|NCT00105443|9602927|FG001|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar||0
8570768|NCT00105443|9602928|FG002|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar|"In parallel to Open Label treatment only phase"|245
8570769|NCT00105443|9602929|FG003|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar||0
8570770|NCT00105443|9602926|FG000|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar||0
8570771|NCT00105443|9602927|FG001|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar|"In parallel to Follow-up only phase; participants received Sorafenib 400 mg bid"|47
8570772|NCT00105443|9602928|FG002|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar||0
8570773|NCT00105443|9602929|FG003|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar|"In parallel to Follow-up only phase; participants received Sorafenib 400 mg bid"|36
8570774|NCT00105443|9602926|FG000|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||0
8570775|NCT00105443|9602927|FG001|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||10
8570776|NCT00105443|9602928|FG002|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||0
8570777|NCT00105443|9602929|FG003|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||11
8570778|NCT00105443|9602926|FG000|COMPLETED|Follow-up and/or Open Label Nexavar||0
8570779|NCT00105443|9602927|FG001|COMPLETED|Follow-up and/or Open Label Nexavar|57 participants in total (47 + 10) received Open Label Sorafenib treatment (Subjects at Risk)|0
8570780|NCT00105443|9602928|FG002|COMPLETED|Follow-up and/or Open Label Nexavar||0
8570781|NCT00105443|9602929|FG003|COMPLETED|Follow-up and/or Open Label Nexavar|47 participants in total (36 + 11) received Open Label Sorafenib treatment (Subjects at Risk)|0
8570782|NCT00105443|9602926|FG000|NOT COMPLETED|Follow-up and/or Open Label Nexavar||228
8570783|NCT00105443|9602927|FG001|NOT COMPLETED|Follow-up and/or Open Label Nexavar||57
8570784|NCT00105443|9602928|FG002|NOT COMPLETED|Follow-up and/or Open Label Nexavar||245
8570785|NCT00105443|9602929|FG003|NOT COMPLETED|Follow-up and/or Open Label Nexavar||47
8570786|NCT00105469|9602940|FG000|STARTED|Overall Study||365
8570787|NCT00105469|9602941|FG001|STARTED|Overall Study||378
8570788|NCT00105469|9602940|FG000|COMPLETED|Overall Study||343
8570789|NCT00105469|9602941|FG001|COMPLETED|Overall Study||367
8570790|NCT00105469|9602940|FG000|NOT COMPLETED|Overall Study||22
8968676|NCT02589665|10032361|FG002|COMPLETED|Induction Extension Period||0
8968677|NCT02589665|10032362|FG003|COMPLETED|Induction Extension Period||0
8968678|NCT02589665|10032363|FG004|COMPLETED|Induction Extension Period||0
8968679|NCT02589665|10032364|FG005|COMPLETED|Induction Extension Period||0
8968680|NCT02589665|10032365|FG006|COMPLETED|Induction Extension Period||0
8968681|NCT02589665|10032366|FG007|COMPLETED|Induction Extension Period||30
8968682|NCT02589665|10032367|FG008|COMPLETED|Induction Extension Period||84
8968683|NCT02589665|10032368|FG009|COMPLETED|Induction Extension Period||0
8968684|NCT02589665|10032359|FG000|NOT COMPLETED|Induction Extension Period||0
8968685|NCT02589665|10032360|FG001|NOT COMPLETED|Induction Extension Period||0
8968686|NCT02589665|10032361|FG002|NOT COMPLETED|Induction Extension Period||0
8968687|NCT02589665|10032362|FG003|NOT COMPLETED|Induction Extension Period||0
8968688|NCT02589665|10032363|FG004|NOT COMPLETED|Induction Extension Period||0
8968689|NCT02589665|10032364|FG005|NOT COMPLETED|Induction Extension Period||0
8968690|NCT02589665|10032365|FG006|NOT COMPLETED|Induction Extension Period||0
8968691|NCT02589665|10032366|FG007|NOT COMPLETED|Induction Extension Period||2
8968692|NCT02589665|10032367|FG008|NOT COMPLETED|Induction Extension Period||12
8968693|NCT02589665|10032368|FG009|NOT COMPLETED|Induction Extension Period||0
8968694|NCT02589665|10032359|FG000|STARTED|Maintenance Extension Period||0
8968695|NCT02589665|10032360|FG001|STARTED|Maintenance Extension Period||0
8968696|NCT02589665|10032361|FG002|STARTED|Maintenance Extension Period||0
8968697|NCT02589665|10032362|FG003|STARTED|Maintenance Extension Period||0
8968698|NCT02589665|10032363|FG004|STARTED|Maintenance Extension Period||0
8968699|NCT02589665|10032364|FG005|STARTED|Maintenance Extension Period||0
8968700|NCT02589665|10032365|FG006|STARTED|Maintenance Extension Period||0
8968701|NCT02589665|10032366|FG007|STARTED|Maintenance Extension Period||0
8968702|NCT02589665|10032367|FG008|STARTED|Maintenance Extension Period||0
8968703|NCT02589665|10032368|FG009|STARTED|Maintenance Extension Period||68
8968704|NCT02589665|10032359|FG000|COMPLETED|Maintenance Extension Period||0
8968705|NCT02589665|10032360|FG001|COMPLETED|Maintenance Extension Period||0
8968706|NCT02589665|10032361|FG002|COMPLETED|Maintenance Extension Period||0
8968707|NCT02589665|10032362|FG003|COMPLETED|Maintenance Extension Period||0
8968708|NCT02589665|10032363|FG004|COMPLETED|Maintenance Extension Period||0
8968709|NCT02589665|10032364|FG005|COMPLETED|Maintenance Extension Period||0
8968710|NCT02589665|10032365|FG006|COMPLETED|Maintenance Extension Period||0
8968711|NCT02589665|10032366|FG007|COMPLETED|Maintenance Extension Period||0
8968712|NCT02589665|10032367|FG008|COMPLETED|Maintenance Extension Period||0
8968713|NCT02589665|10032368|FG009|COMPLETED|Maintenance Extension Period||0
8968714|NCT02589665|10032359|FG000|NOT COMPLETED|Maintenance Extension Period||0
8968715|NCT02589665|10032360|FG001|NOT COMPLETED|Maintenance Extension Period||0
8968716|NCT02589665|10032361|FG002|NOT COMPLETED|Maintenance Extension Period||0
8968717|NCT02589665|10032362|FG003|NOT COMPLETED|Maintenance Extension Period||0
8968718|NCT02589665|10032363|FG004|NOT COMPLETED|Maintenance Extension Period||0
8968719|NCT02589665|10032364|FG005|NOT COMPLETED|Maintenance Extension Period||0
8968720|NCT02589665|10032365|FG006|NOT COMPLETED|Maintenance Extension Period||0
8968721|NCT02589665|10032366|FG007|NOT COMPLETED|Maintenance Extension Period||0
8968722|NCT02589665|10032367|FG008|NOT COMPLETED|Maintenance Extension Period||0
8968723|NCT02589665|10032368|FG009|NOT COMPLETED|Maintenance Extension Period||68
8968724|NCT02589808|10032392|FG000|STARTED|Overall Study||76
8968725|NCT02589808|10032392|FG000|COMPLETED|Overall Study||76
8968726|NCT02589808|10032392|FG000|NOT COMPLETED|Overall Study||0
8968727|NCT02589847|10032398|FG000|STARTED|Overall Study||162
8968728|NCT02589847|10032399|FG001|STARTED|Overall Study||110
8968729|NCT02589847|10032398|FG000|Safety Population|Overall Study||149
8968730|NCT02589847|10032399|FG001|Safety Population|Overall Study||0
8968731|NCT02589847|10032398|FG000|Full Analysis Set (FAS)|Overall Study||149
8968732|NCT02589847|10032399|FG001|Full Analysis Set (FAS)|Overall Study||104
8968733|NCT02589847|10032398|FG000|Evaluable|Overall Study||142
8968734|NCT02589847|10032399|FG001|Evaluable|Overall Study||75
8968735|NCT02589847|10032398|FG000|COMPLETED|Overall Study||107
8968736|NCT02589847|10032399|FG001|COMPLETED|Overall Study||39
8968737|NCT02589847|10032398|FG000|NOT COMPLETED|Overall Study||55
8968738|NCT02589847|10032399|FG001|NOT COMPLETED|Overall Study||71
8968739|NCT02589977|10032409|FG000|STARTED|Overall Study||23
8968740|NCT02589977|10032410|FG001|STARTED|Overall Study||20
8968741|NCT02589977|10032411|FG002|STARTED|Overall Study||12
8968742|NCT02589977|10032409|FG000|COMPLETED|Overall Study||17
8968743|NCT02589977|10032410|FG001|COMPLETED|Overall Study||15
8968744|NCT02589977|10032411|FG002|COMPLETED|Overall Study||8
8968745|NCT02589977|10032409|FG000|NOT COMPLETED|Overall Study||6
8968746|NCT02589977|10032410|FG001|NOT COMPLETED|Overall Study||5
8968747|NCT02589977|10032411|FG002|NOT COMPLETED|Overall Study||4
8968748|NCT02590003|10032421|FG000|STARTED|Overall Study||1
8968749|NCT02590003|10032422|FG001|STARTED|Overall Study||2
8968750|NCT02590003|10032421|FG000|COMPLETED|Overall Study||0
8968751|NCT02590003|10032422|FG001|COMPLETED|Overall Study||0
8968752|NCT02590003|10032421|FG000|NOT COMPLETED|Overall Study||1
8968753|NCT02590003|10032422|FG001|NOT COMPLETED|Overall Study||2
8968754|NCT02590354|10032428|FG000|STARTED|Phase 1||114
8968755|NCT02590354|10032428|FG000|COMPLETED|Phase 1||16
8968756|NCT02590354|10032428|FG000|NOT COMPLETED|Phase 1||98
8968757|NCT02590354|10032428|FG000|STARTED|Phase 2 - Treatment Interruption||16
8968758|NCT02590354|10032428|FG000|COMPLETED|Phase 2 - Treatment Interruption||14
8968759|NCT02590354|10032428|FG000|NOT COMPLETED|Phase 2 - Treatment Interruption||2
8968760|NCT02590406|10032435|FG000|STARTED|Overall Study||25
8968761|NCT02590406|10032436|FG001|STARTED|Overall Study||25
8968762|NCT02590406|10032435|FG000|COMPLETED|Overall Study||24
8968763|NCT02590406|10032436|FG001|COMPLETED|Overall Study||24
8968764|NCT02590406|10032435|FG000|NOT COMPLETED|Overall Study||1
8968765|NCT02590406|10032436|FG001|NOT COMPLETED|Overall Study||1
8968766|NCT02590432|10032444|FG000|STARTED|Open-label Treatment Period||508
8968767|NCT02590432|10032445|FG001|STARTED|Open-label Treatment Period||318
8968768|NCT02590432|10032446|FG002|STARTED|Open-label Treatment Period||0
8968769|NCT02590432|10032447|FG003|STARTED|Open-label Treatment Period||0
8968770|NCT02590432|10032448|FG004|STARTED|Open-label Treatment Period||0
8968771|NCT02590432|10032449|FG005|STARTED|Open-label Treatment Period||0
8968772|NCT02590432|10032450|FG006|STARTED|Open-label Treatment Period||0
8968773|NCT02590432|10032451|FG007|STARTED|Open-label Treatment Period||0
8968774|NCT02590432|10032452|FG008|STARTED|Open-label Treatment Period||0
8968775|NCT02590432|10032444|FG000|COMPLETED|Open-label Treatment Period|Participants were not randomized to Double-blind Treatment Period.|276
8968776|NCT02590432|10032445|FG001|COMPLETED|Open-label Treatment Period|Participants were not randomized to Double-blind Treatment Period.|166
8968777|NCT02590432|10032446|FG002|COMPLETED|Open-label Treatment Period||0
8968778|NCT02590432|10032447|FG003|COMPLETED|Open-label Treatment Period||0
8968779|NCT02590432|10032448|FG004|COMPLETED|Open-label Treatment Period||0
8968780|NCT02590432|10032449|FG005|COMPLETED|Open-label Treatment Period||0
8968781|NCT02590432|10032450|FG006|COMPLETED|Open-label Treatment Period||0
8968782|NCT02590432|10032451|FG007|COMPLETED|Open-label Treatment Period||0
8968783|NCT02590432|10032452|FG008|COMPLETED|Open-label Treatment Period||0
8968784|NCT02590432|10032444|FG000|NOT COMPLETED|Open-label Treatment Period||232
8968785|NCT02590432|10032445|FG001|NOT COMPLETED|Open-label Treatment Period||152
8968786|NCT02590432|10032446|FG002|NOT COMPLETED|Open-label Treatment Period||0
8968787|NCT02590432|10032447|FG003|NOT COMPLETED|Open-label Treatment Period||0
8968788|NCT02590432|10032448|FG004|NOT COMPLETED|Open-label Treatment Period||0
8968789|NCT02590432|10032449|FG005|NOT COMPLETED|Open-label Treatment Period||0
8968790|NCT02590432|10032450|FG006|NOT COMPLETED|Open-label Treatment Period||0
8968791|NCT02590432|10032451|FG007|NOT COMPLETED|Open-label Treatment Period||0
8968792|NCT02590432|10032452|FG008|NOT COMPLETED|Open-label Treatment Period||0
8968793|NCT02590432|10032444|FG000|STARTED|Double-blind Treatment Period||0
8968794|NCT02590432|10032445|FG001|STARTED|Double-blind Treatment Period||0
8968795|NCT02590432|10032446|FG002|STARTED|Double-blind Treatment Period||18
8968796|NCT02590432|10032447|FG003|STARTED|Double-blind Treatment Period||18
8968797|NCT02590432|10032448|FG004|STARTED|Double-blind Treatment Period||16
8968798|NCT02590432|10032449|FG005|STARTED|Double-blind Treatment Period||32
8631903|NCT00542425|9671780|FG004|COMPLETED|Initial 24 Weeks||39
8631904|NCT00542425|9671776|FG000|NOT COMPLETED|Initial 24 Weeks||4
8631905|NCT00542425|9671777|FG001|NOT COMPLETED|Initial 24 Weeks||10
8631906|NCT00542425|9671778|FG002|NOT COMPLETED|Initial 24 Weeks||7
8968799|NCT02590432|10032450|FG006|STARTED|Double-blind Treatment Period||30
8968800|NCT02590432|10032451|FG007|STARTED|Double-blind Treatment Period||0
8968801|NCT02590432|10032452|FG008|STARTED|Double-blind Treatment Period||0
8968802|NCT02590432|10032444|FG000|COMPLETED|Double-blind Treatment Period||0
8968803|NCT02590432|10032445|FG001|COMPLETED|Double-blind Treatment Period||0
8968804|NCT02590432|10032446|FG002|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|1
8968805|NCT02590432|10032447|FG003|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|3
8968806|NCT02590432|10032448|FG004|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|7
8968807|NCT02590432|10032449|FG005|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|6
8968808|NCT02590432|10032450|FG006|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|9
8968809|NCT02590432|10032451|FG007|COMPLETED|Double-blind Treatment Period||0
8968810|NCT02590432|10032452|FG008|COMPLETED|Double-blind Treatment Period||0
8968811|NCT02590432|10032444|FG000|NOT COMPLETED|Double-blind Treatment Period||0
8968812|NCT02590432|10032445|FG001|NOT COMPLETED|Double-blind Treatment Period||0
8968813|NCT02590432|10032446|FG002|NOT COMPLETED|Double-blind Treatment Period||17
8968814|NCT02590432|10032447|FG003|NOT COMPLETED|Double-blind Treatment Period||15
8968815|NCT02590432|10032448|FG004|NOT COMPLETED|Double-blind Treatment Period||9
8968816|NCT02590432|10032449|FG005|NOT COMPLETED|Double-blind Treatment Period||26
8968817|NCT02590432|10032450|FG006|NOT COMPLETED|Double-blind Treatment Period||21
8968818|NCT02590432|10032451|FG007|NOT COMPLETED|Double-blind Treatment Period||0
8968819|NCT02590432|10032452|FG008|NOT COMPLETED|Double-blind Treatment Period||0
8968820|NCT02590432|10032444|FG000|STARTED|Dose-reduced Open Label Treatment Period||0
8968821|NCT02590432|10032445|FG001|STARTED|Dose-reduced Open Label Treatment Period||0
8968822|NCT02590432|10032446|FG002|STARTED|Dose-reduced Open Label Treatment Period||0
8968823|NCT02590432|10032447|FG003|STARTED|Dose-reduced Open Label Treatment Period||0
8968824|NCT02590432|10032448|FG004|STARTED|Dose-reduced Open Label Treatment Period||0
8968825|NCT02590432|10032449|FG005|STARTED|Dose-reduced Open Label Treatment Period||0
8968826|NCT02590432|10032450|FG006|STARTED|Dose-reduced Open Label Treatment Period||0
8968827|NCT02590432|10032451|FG007|STARTED|Dose-reduced Open Label Treatment Period||31
8968828|NCT02590432|10032452|FG008|STARTED|Dose-reduced Open Label Treatment Period||26
8968829|NCT02590432|10032444|FG000|COMPLETED|Dose-reduced Open Label Treatment Period||0
8968830|NCT02590432|10032445|FG001|COMPLETED|Dose-reduced Open Label Treatment Period||0
8968831|NCT02590432|10032446|FG002|COMPLETED|Dose-reduced Open Label Treatment Period||0
8968832|NCT02590432|10032447|FG003|COMPLETED|Dose-reduced Open Label Treatment Period||0
8968833|NCT02590432|10032448|FG004|COMPLETED|Dose-reduced Open Label Treatment Period||0
8968834|NCT02590432|10032449|FG005|COMPLETED|Dose-reduced Open Label Treatment Period||0
8570791|NCT00105469|9602941|FG001|NOT COMPLETED|Overall Study||11
8570792|NCT00105482|9602949|FG000|STARTED|Overall Study||87
8570793|NCT00105482|9602950|FG001|STARTED|Overall Study||85
8570794|NCT00105482|9602949|FG000|COMPLETED|Overall Study||28
8570795|NCT00105482|9602950|FG001|COMPLETED|Overall Study||30
8570796|NCT00105482|9602949|FG000|NOT COMPLETED|Overall Study||59
8570797|NCT00105482|9602950|FG001|NOT COMPLETED|Overall Study||55
8570798|NCT00105508|9602958|FG000|STARTED|Overall Study||253
8570799|NCT00105508|9602959|FG001|STARTED|Overall Study||253
8570800|NCT00105508|9602958|FG000|COMPLETED|Overall Study||213
8570801|NCT00105508|9602959|FG001|COMPLETED|Overall Study||217
8570802|NCT00105508|9602958|FG000|NOT COMPLETED|Overall Study||40
8570803|NCT00105508|9602959|FG001|NOT COMPLETED|Overall Study||36
8570804|NCT00105521|9602969|FG000|STARTED|Overall Study||98
8570805|NCT00105521|9602970|FG001|STARTED|Overall Study||101
8570806|NCT00105521|9602971|FG002|STARTED|Overall Study||97
8570807|NCT00105521|9602972|FG003|STARTED|Overall Study||102
8570808|NCT00105521|9602969|FG000|COMPLETED|Overall Study||83
8570809|NCT00105521|9602970|FG001|COMPLETED|Overall Study||90
8570810|NCT00105521|9602971|FG002|COMPLETED|Overall Study||80
8570811|NCT00105521|9602972|FG003|COMPLETED|Overall Study||85
8570812|NCT00105521|9602969|FG000|NOT COMPLETED|Overall Study||15
8570813|NCT00105521|9602970|FG001|NOT COMPLETED|Overall Study||11
8570814|NCT00105521|9602971|FG002|NOT COMPLETED|Overall Study||17
8570815|NCT00105521|9602972|FG003|NOT COMPLETED|Overall Study||17
8570816|NCT00105534|9602984|FG000|STARTED|Overall Study||335
8570817|NCT00105534|9602985|FG001|STARTED|Overall Study||350
8570818|NCT00105534|9602984|FG000|COMPLETED|Overall Study||313
8570819|NCT00105534|9602985|FG001|COMPLETED|Overall Study||317
8570820|NCT00105534|9602984|FG000|NOT COMPLETED|Overall Study||22
8570821|NCT00105534|9602985|FG001|NOT COMPLETED|Overall Study||33
8570822|NCT00105586|9602993|FG000|STARTED|Overall Study||92
8570823|NCT00105586|9602994|FG001|STARTED|Overall Study||85
8570824|NCT00105586|9602993|FG000|COMPLETED|Overall Study||75
8570825|NCT00105586|9602994|FG001|COMPLETED|Overall Study||69
8570826|NCT00105586|9602993|FG000|NOT COMPLETED|Overall Study||17
8570827|NCT00105586|9602994|FG001|NOT COMPLETED|Overall Study||16
8570828|NCT00105989|9603002|FG000|STARTED|Acute - Open Label: Week 0-10||514
8570829|NCT00105989|9603003|FG001|STARTED|Acute - Open Label: Week 0-10||0
8570830|NCT00105989|9603002|FG000|COMPLETED|Acute - Open Label: Week 0-10||413
8570831|NCT00105989|9603003|FG001|COMPLETED|Acute - Open Label: Week 0-10||0
8570832|NCT00105989|9603002|FG000|NOT COMPLETED|Acute - Open Label: Week 0-10||101
8570833|NCT00105989|9603003|FG001|NOT COMPLETED|Acute - Open Label: Week 0-10||0
8968835|NCT02590432|10032450|FG006|COMPLETED|Dose-reduced Open Label Treatment Period||0
8968836|NCT02590432|10032451|FG007|COMPLETED|Dose-reduced Open Label Treatment Period||13
8968837|NCT02590432|10032452|FG008|COMPLETED|Dose-reduced Open Label Treatment Period||8
8968838|NCT02590432|10032444|FG000|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
8968839|NCT02590432|10032445|FG001|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
8968840|NCT02590432|10032446|FG002|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
8968841|NCT02590432|10032447|FG003|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
8631907|NCT00542425|9671779|FG003|NOT COMPLETED|Initial 24 Weeks||11
8876671|NCT01918072|9933439|FG002|STARTED|Quality Assessment Period||202
8876672|NCT01918072|9933437|FG000|COMPLETED|Quality Assessment Period||0
8876673|NCT01918072|9933438|FG001|COMPLETED|Quality Assessment Period||0
8876674|NCT01918072|9933439|FG002|COMPLETED|Quality Assessment Period||202
8968842|NCT02590432|10032448|FG004|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
8968843|NCT02590432|10032449|FG005|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
8968844|NCT02590432|10032450|FG006|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
8968845|NCT02590432|10032451|FG007|NOT COMPLETED|Dose-reduced Open Label Treatment Period||18
8968846|NCT02590432|10032452|FG008|NOT COMPLETED|Dose-reduced Open Label Treatment Period||18
8968847|NCT02590562|10032464|FG000|STARTED|Overall Study||808
8968848|NCT02590562|10032464|FG000|COMPLETED|Overall Study||802
8968849|NCT02590562|10032464|FG000|NOT COMPLETED|Overall Study||6
8968850|NCT02590588|10032474|FG000|STARTED|Overall Study||1
8968851|NCT02590588|10032474|FG000|COMPLETED|Overall Study||0
8968852|NCT02590588|10032474|FG000|NOT COMPLETED|Overall Study||1
8968853|NCT02590939|10032480|FG000|STARTED|Overall Study||52
8968854|NCT02590939|10032481|FG001|STARTED|Overall Study||54
8968855|NCT02590939|10032480|FG000|COMPLETED|Overall Study||47
8968856|NCT02590939|10032481|FG001|COMPLETED|Overall Study||52
8968857|NCT02590939|10032480|FG000|NOT COMPLETED|Overall Study||5
8968858|NCT02590939|10032481|FG001|NOT COMPLETED|Overall Study||2
8968859|NCT02591056|10032487|FG000|STARTED|Overall Study||27
8968860|NCT02591056|10032487|FG000|COMPLETED|Overall Study||27
8968861|NCT02591056|10032487|FG000|NOT COMPLETED|Overall Study||0
8968862|NCT02591238|10032495|FG000|STARTED|Overall Study||16
8968863|NCT02591238|10032496|FG001|STARTED|Overall Study||17
8968864|NCT02591238|10032497|FG002|STARTED|Overall Study||17
8968865|NCT02591238|10032498|FG003|STARTED|Overall Study||18
8968866|NCT02591238|10032495|FG000|COMPLETED|Overall Study||15
8968867|NCT02591238|10032496|FG001|COMPLETED|Overall Study||16
8968868|NCT02591238|10032497|FG002|COMPLETED|Overall Study||17
8968869|NCT02591238|10032498|FG003|COMPLETED|Overall Study||15
8968870|NCT02591238|10032495|FG000|NOT COMPLETED|Overall Study||1
8968871|NCT02591238|10032496|FG001|NOT COMPLETED|Overall Study||1
8968872|NCT02591238|10032497|FG002|NOT COMPLETED|Overall Study||0
8968873|NCT02591238|10032498|FG003|NOT COMPLETED|Overall Study||3
8968874|NCT02591290|10032508|FG000|STARTED|Overall Study||60
8968875|NCT02591290|10032508|FG000|Vaccinated Dose 1|Overall Study||60
8968876|NCT02591290|10032508|FG000|Vaccinated Dose 2|Overall Study||58
8968877|NCT02591290|10032508|FG000|COMPLETED|Overall Study||58
8968878|NCT02591290|10032508|FG000|NOT COMPLETED|Overall Study||2
8968879|NCT02591511|10032514|FG000|STARTED|Overall Study||30
8968880|NCT02591511|10032515|FG001|STARTED|Overall Study||33
8968881|NCT02591511|10032514|FG000|COMPLETED|Overall Study||30
8968882|NCT02591511|10032515|FG001|COMPLETED|Overall Study||33
8968883|NCT02591511|10032514|FG000|NOT COMPLETED|Overall Study||0
8968884|NCT02591511|10032515|FG001|NOT COMPLETED|Overall Study||0
8968885|NCT02591537|10032523|FG000|STARTED|Overall Study||8
8968886|NCT02591537|10032524|FG001|STARTED|Overall Study||8
8968887|NCT02591537|10032523|FG000|COMPLETED|Overall Study||8
8968888|NCT02591537|10032524|FG001|COMPLETED|Overall Study||8
8968889|NCT02591537|10032523|FG000|NOT COMPLETED|Overall Study||0
8968890|NCT02591537|10032524|FG001|NOT COMPLETED|Overall Study||0
8968891|NCT02592018|10032531|FG000|STARTED|Overall Study||15
8968892|NCT02592018|10032531|FG000|COMPLETED|Overall Study||13
8968893|NCT02592018|10032531|FG000|NOT COMPLETED|Overall Study||2
8968894|NCT02592421|10032537|FG000|STARTED|Study 1||20
8968895|NCT02592421|10032538|FG001|STARTED|Study 1||10
8968896|NCT02592421|10032537|FG000|COMPLETED|Study 1||20
8968897|NCT02592421|10032538|FG001|COMPLETED|Study 1||10
8968898|NCT02592421|10032537|FG000|NOT COMPLETED|Study 1||0
8968899|NCT02592421|10032538|FG001|NOT COMPLETED|Study 1||0
8968900|NCT02592421|10032537|FG000|STARTED|Study 2: Glucose Clamp Conditions||20
8968901|NCT02592421|10032538|FG001|STARTED|Study 2: Glucose Clamp Conditions||10
8968902|NCT02592421|10032537|FG000|COMPLETED|Study 2: Glucose Clamp Conditions||20
8968903|NCT02592421|10032538|FG001|COMPLETED|Study 2: Glucose Clamp Conditions||10
8631908|NCT00542425|9671780|FG004|NOT COMPLETED|Initial 24 Weeks||6
8691277|NCT00853905|9736500|FG001|COMPLETED|Overall Study||36
8876675|NCT01918072|9933437|FG000|NOT COMPLETED|Quality Assessment Period||0
8876676|NCT01918072|9933438|FG001|NOT COMPLETED|Quality Assessment Period||0
8876677|NCT01918072|9933439|FG002|NOT COMPLETED|Quality Assessment Period||0
8876678|NCT01918085|9933451|FG000|STARTED|Test Period 1: Strata Strip||10
8876679|NCT01918085|9933452|FG001|STARTED|Test Period 1: Strata Strip||12
8876680|NCT01918085|9933451|FG000|COMPLETED|Test Period 1: Strata Strip||10
8876681|NCT01918085|9933452|FG001|COMPLETED|Test Period 1: Strata Strip||11
8968904|NCT02592421|10032537|FG000|NOT COMPLETED|Study 2: Glucose Clamp Conditions||0
8968905|NCT02592421|10032538|FG001|NOT COMPLETED|Study 2: Glucose Clamp Conditions||0
8691278|NCT00853905|9736499|FG000|NOT COMPLETED|Overall Study||2
8968906|NCT02592421|10032537|FG000|STARTED|Study 3: Pancreatic Clamp Conditions||20
8968907|NCT02592421|10032538|FG001|STARTED|Study 3: Pancreatic Clamp Conditions||10
8968908|NCT02592421|10032537|FG000|COMPLETED|Study 3: Pancreatic Clamp Conditions||20
8968909|NCT02592421|10032538|FG001|COMPLETED|Study 3: Pancreatic Clamp Conditions||10
8968910|NCT02592421|10032537|FG000|NOT COMPLETED|Study 3: Pancreatic Clamp Conditions||0
8968911|NCT02592421|10032538|FG001|NOT COMPLETED|Study 3: Pancreatic Clamp Conditions||0
9038097|NCT03328897|10099414|FG001|NOT COMPLETED|Follow-up Epoch||3
9038098|NCT03328897|10099415|FG002|NOT COMPLETED|Follow-up Epoch||2
9038099|NCT03328949|10099423|FG000|STARTED|Overall Study||120
9038100|NCT03328949|10099423|FG000|COMPLETED|Overall Study||120
9038101|NCT03328949|10099423|FG000|NOT COMPLETED|Overall Study||0
9038102|NCT03329196|10099430|FG000|STARTED|Overall Study||151
9038103|NCT03329196|10099431|FG001|STARTED|Overall Study||153
9038104|NCT03329196|10099430|FG000|COMPLETED|Overall Study||111
9038105|NCT03329196|10099431|FG001|COMPLETED|Overall Study||123
9038106|NCT03329196|10099430|FG000|NOT COMPLETED|Overall Study||40
9038107|NCT03329196|10099431|FG001|NOT COMPLETED|Overall Study||30
9038108|NCT03329209|10099437|FG000|STARTED|Overall Study||16
9038109|NCT03329209|10099437|FG000|COMPLETED|Overall Study||16
9038110|NCT03329209|10099437|FG000|NOT COMPLETED|Overall Study||0
9038111|NCT03329352|10099441|FG000|STARTED|F&P Toffee Full Face Mask Validation||44
9038112|NCT03329352|10099441|FG000|COMPLETED|F&P Toffee Full Face Mask Validation||42
9038113|NCT03329352|10099441|FG000|NOT COMPLETED|F&P Toffee Full Face Mask Validation||2
9038114|NCT03329352|10099441|FG000|STARTED|Extension||29
9038115|NCT03329352|10099441|FG000|COMPLETED|Extension||22
9038116|NCT03329352|10099441|FG000|NOT COMPLETED|Extension||7
9038117|NCT03329573|10099451|FG000|STARTED|Treatment Period 1 (Up to 5 Days)||23
9038118|NCT03329573|10099452|FG001|STARTED|Treatment Period 1 (Up to 5 Days)||24
9038119|NCT03329573|10099453|FG002|STARTED|Treatment Period 1 (Up to 5 Days)||19
9038120|NCT03329573|10099454|FG003|STARTED|Treatment Period 1 (Up to 5 Days)||19
9038121|NCT03329573|10099451|FG000|COMPLETED|Treatment Period 1 (Up to 5 Days)||22
9038122|NCT03329573|10099452|FG001|COMPLETED|Treatment Period 1 (Up to 5 Days)||21
9038123|NCT03329573|10099453|FG002|COMPLETED|Treatment Period 1 (Up to 5 Days)||19
9038124|NCT03329573|10099454|FG003|COMPLETED|Treatment Period 1 (Up to 5 Days)||19
9038125|NCT03329573|10099451|FG000|NOT COMPLETED|Treatment Period 1 (Up to 5 Days)||1
9038126|NCT03329573|10099452|FG001|NOT COMPLETED|Treatment Period 1 (Up to 5 Days)||3
9038127|NCT03329573|10099453|FG002|NOT COMPLETED|Treatment Period 1 (Up to 5 Days)||0
9038128|NCT03329573|10099454|FG003|NOT COMPLETED|Treatment Period 1 (Up to 5 Days)||0
9038129|NCT03329573|10099451|FG000|STARTED|Washout Period (Day 6 to Day 11)||22
9038130|NCT03329573|10099452|FG001|STARTED|Washout Period (Day 6 to Day 11)||21
9038131|NCT03329573|10099453|FG002|STARTED|Washout Period (Day 6 to Day 11)||19
9038132|NCT03329573|10099454|FG003|STARTED|Washout Period (Day 6 to Day 11)||19
9038133|NCT03329573|10099451|FG000|COMPLETED|Washout Period (Day 6 to Day 11)||22
9038134|NCT03329573|10099452|FG001|COMPLETED|Washout Period (Day 6 to Day 11)||21
9038135|NCT03329573|10099453|FG002|COMPLETED|Washout Period (Day 6 to Day 11)||19
9038136|NCT03329573|10099454|FG003|COMPLETED|Washout Period (Day 6 to Day 11)||19
9038137|NCT03329573|10099451|FG000|NOT COMPLETED|Washout Period (Day 6 to Day 11)||0
9038138|NCT03329573|10099452|FG001|NOT COMPLETED|Washout Period (Day 6 to Day 11)||0
9038139|NCT03329573|10099453|FG002|NOT COMPLETED|Washout Period (Day 6 to Day 11)||0
9038140|NCT03329573|10099454|FG003|NOT COMPLETED|Washout Period (Day 6 to Day 11)||0
9038141|NCT03329573|10099451|FG000|STARTED|Treatment Period 2 (Day 12 to Day 26)||22
9038142|NCT03329573|10099452|FG001|STARTED|Treatment Period 2 (Day 12 to Day 26)||21
9038143|NCT03329573|10099453|FG002|STARTED|Treatment Period 2 (Day 12 to Day 26)||19
9038144|NCT03329573|10099454|FG003|STARTED|Treatment Period 2 (Day 12 to Day 26)||19
9038145|NCT03329573|10099451|FG000|COMPLETED|Treatment Period 2 (Day 12 to Day 26)||21
9038146|NCT03329573|10099452|FG001|COMPLETED|Treatment Period 2 (Day 12 to Day 26)||20
9038147|NCT03329573|10099453|FG002|COMPLETED|Treatment Period 2 (Day 12 to Day 26)||19
9038148|NCT03329573|10099454|FG003|COMPLETED|Treatment Period 2 (Day 12 to Day 26)||19
9038149|NCT03329573|10099451|FG000|NOT COMPLETED|Treatment Period 2 (Day 12 to Day 26)||1
9038150|NCT03329573|10099452|FG001|NOT COMPLETED|Treatment Period 2 (Day 12 to Day 26)||1
9038151|NCT03329573|10099453|FG002|NOT COMPLETED|Treatment Period 2 (Day 12 to Day 26)||0
9038152|NCT03329573|10099454|FG003|NOT COMPLETED|Treatment Period 2 (Day 12 to Day 26)||0
9038153|NCT03329846|10099466|FG000|STARTED|Overall Study||10
9038154|NCT03329846|10099467|FG001|STARTED|Overall Study||10
9038155|NCT03329846|10099466|FG000|COMPLETED|Overall Study||2
9038156|NCT03329846|10099467|FG001|COMPLETED|Overall Study||1
9038157|NCT03329846|10099466|FG000|NOT COMPLETED|Overall Study||8
9038158|NCT03329846|10099467|FG001|NOT COMPLETED|Overall Study||9
9038159|NCT03329885|10099479|FG000|STARTED|Overall Study||9
9038160|NCT03329885|10099480|FG001|STARTED|Overall Study||6
9038161|NCT03329885|10099481|FG002|STARTED|Overall Study||6
9038162|NCT03329885|10099482|FG003|STARTED|Overall Study||6
9038163|NCT03329885|10099483|FG004|STARTED|Overall Study||6
9038164|NCT03329885|10099484|FG005|STARTED|Overall Study||3
9038165|NCT03329885|10099485|FG006|STARTED|Overall Study||1
9038166|NCT03329885|10099486|FG007|STARTED|Overall Study||1
9038167|NCT03329885|10099487|FG008|STARTED|Overall Study|Due to early termination of study, Part C was cancelled and no patients were dosed|0
9038168|NCT03329885|10099479|FG000|COMPLETED|Overall Study||9
9038169|NCT03329885|10099480|FG001|COMPLETED|Overall Study||6
9038170|NCT03329885|10099481|FG002|COMPLETED|Overall Study||6
9038171|NCT03329885|10099482|FG003|COMPLETED|Overall Study||6
9038172|NCT03329885|10099483|FG004|COMPLETED|Overall Study||6
9038173|NCT03329885|10099484|FG005|COMPLETED|Overall Study||3
8968912|NCT02592434|10032544|FG000|STARTED|Open-Label Phase (18 Weeks)||225
8968913|NCT02592434|10032545|FG001|STARTED|Open-Label Phase (18 Weeks)||0
8968914|NCT02592434|10032546|FG002|STARTED|Open-Label Phase (18 Weeks)||0
8968915|NCT02592434|10032544|FG000|Treated|Open-Label Phase (18 Weeks)||225
8968916|NCT02592434|10032545|FG001|Treated|Open-Label Phase (18 Weeks)||0
8968917|NCT02592434|10032546|FG002|Treated|Open-Label Phase (18 Weeks)||0
8968918|NCT02592434|10032544|FG000|COMPLETED|Open-Label Phase (18 Weeks)||185
8968919|NCT02592434|10032545|FG001|COMPLETED|Open-Label Phase (18 Weeks)||0
8968920|NCT02592434|10032546|FG002|COMPLETED|Open-Label Phase (18 Weeks)||0
8968921|NCT02592434|10032544|FG000|NOT COMPLETED|Open-Label Phase (18 Weeks)||40
8968922|NCT02592434|10032545|FG001|NOT COMPLETED|Open-Label Phase (18 Weeks)||0
8968923|NCT02592434|10032546|FG002|NOT COMPLETED|Open-Label Phase (18 Weeks)||0
8968924|NCT02592434|10032544|FG000|STARTED|Double Blind Phase (26 Weeks)||0
8968925|NCT02592434|10032545|FG001|STARTED|Double Blind Phase (26 Weeks)|Only those participants who completed OL phase, achieved at least a JIA ACR 30 response in OL phase.|88
8968926|NCT02592434|10032546|FG002|STARTED|Double Blind Phase (26 Weeks)|Only those participants who completed OL phase,achieved at least a JIA ACR 30 response in OL phase.|85
8968927|NCT02592434|10032544|FG000|Treated|Double Blind Phase (26 Weeks)||0
8968928|NCT02592434|10032545|FG001|Treated|Double Blind Phase (26 Weeks)||88
8968929|NCT02592434|10032546|FG002|Treated|Double Blind Phase (26 Weeks)||85
8968930|NCT02592434|10032544|FG000|COMPLETED|Double Blind Phase (26 Weeks)||0
8968931|NCT02592434|10032545|FG001|COMPLETED|Double Blind Phase (26 Weeks)||61
8968932|NCT02592434|10032546|FG002|COMPLETED|Double Blind Phase (26 Weeks)||38
8968933|NCT02592434|10032544|FG000|NOT COMPLETED|Double Blind Phase (26 Weeks)||0
8968934|NCT02592434|10032545|FG001|NOT COMPLETED|Double Blind Phase (26 Weeks)||27
8968935|NCT02592434|10032546|FG002|NOT COMPLETED|Double Blind Phase (26 Weeks)||47
8968936|NCT02592447|10032556|FG000|STARTED|Overall Study||29
8968937|NCT02592447|10032557|FG001|STARTED|Overall Study||15
8968938|NCT02592447|10032556|FG000|COMPLETED|Overall Study||27
8968939|NCT02592447|10032557|FG001|COMPLETED|Overall Study||14
8968940|NCT02592447|10032556|FG000|NOT COMPLETED|Overall Study||2
8968941|NCT02592447|10032557|FG001|NOT COMPLETED|Overall Study||1
8968942|NCT02592486|10032565|FG000|STARTED|Overall Study||81
8968943|NCT02592486|10032566|FG001|STARTED|Overall Study||81
8968944|NCT02592486|10032565|FG000|COMPLETED|Overall Study||81
8968945|NCT02592486|10032566|FG001|COMPLETED|Overall Study||76
8968946|NCT02592486|10032565|FG000|NOT COMPLETED|Overall Study||0
8968947|NCT02592486|10032566|FG001|NOT COMPLETED|Overall Study||5
8968948|NCT02592629|10032575|FG000|STARTED|Overall Study||5
8968949|NCT02592629|10032576|FG001|STARTED|Overall Study||9
8968950|NCT02592629|10032577|FG002|STARTED|Overall Study||5
8968951|NCT02592629|10032575|FG000|COMPLETED|Overall Study||5
8968952|NCT02592629|10032576|FG001|COMPLETED|Overall Study||9
8968953|NCT02592629|10032577|FG002|COMPLETED|Overall Study||5
8968954|NCT02592629|10032575|FG000|NOT COMPLETED|Overall Study||0
8968955|NCT02592629|10032576|FG001|NOT COMPLETED|Overall Study||0
8968956|NCT02592629|10032577|FG002|NOT COMPLETED|Overall Study||0
8968957|NCT02592655|10032587|FG000|STARTED|First Tourniquet, Left Thigh.||19
8968958|NCT02592655|10032587|FG000|ATS (Pneumatic)|First Tourniquet, Left Thigh.||5
8968959|NCT02592655|10032587|FG000|Windlass Tourniquet|First Tourniquet, Left Thigh.||7
8968960|NCT02592655|10032587|FG000|Tourniquet Tape 10 cm Width|First Tourniquet, Left Thigh.||5
8968961|NCT02592655|10032587|FG000|Tourniquet Tape 5 cm Width|First Tourniquet, Left Thigh.||2
8968962|NCT02592655|10032587|FG000|COMPLETED|First Tourniquet, Left Thigh.||19
8968963|NCT02592655|10032587|FG000|NOT COMPLETED|First Tourniquet, Left Thigh.||0
8968964|NCT02592655|10032587|FG000|STARTED|Second Tourniquet Right Thigh.||19
8968965|NCT02592655|10032587|FG000|ATS (Pneumatic)|Second Tourniquet Right Thigh.||5
8968966|NCT02592655|10032587|FG000|Windlass Tourniquet|Second Tourniquet Right Thigh.||8
8968967|NCT02592655|10032587|FG000|Tourniquet Tape 10 cm Width|Second Tourniquet Right Thigh.||5
8968968|NCT02592655|10032587|FG000|Tourniquet Tape 5 cm Width|Second Tourniquet Right Thigh.||1
8968969|NCT02592655|10032587|FG000|COMPLETED|Second Tourniquet Right Thigh.||19
8968970|NCT02592655|10032587|FG000|NOT COMPLETED|Second Tourniquet Right Thigh.||0
8968971|NCT02592655|10032587|FG000|STARTED|Third Tourniquet, Left Thigh.||19
8968972|NCT02592655|10032587|FG000|ATS (Pneumatic)|Third Tourniquet, Left Thigh.||8
8968973|NCT02592655|10032587|FG000|Windlass Tourniquet|Third Tourniquet, Left Thigh.||4
8968974|NCT02592655|10032587|FG000|Tourniquet Tape 10 cm Width|Third Tourniquet, Left Thigh.||6
8968975|NCT02592655|10032587|FG000|Tourniquet Tape 5 cm Width|Third Tourniquet, Left Thigh.||1
8968976|NCT02592655|10032587|FG000|COMPLETED|Third Tourniquet, Left Thigh.||19
8968977|NCT02592655|10032587|FG000|NOT COMPLETED|Third Tourniquet, Left Thigh.||0
8968978|NCT02592655|10032587|FG000|STARTED|Fourth Tourniquet Right Thigh.|Only the first 4 participants received all four interventions.|4
8968979|NCT02592655|10032587|FG000|ATS (Pneumatic)|Fourth Tourniquet Right Thigh.||1
8631909|NCT00542425|9671776|FG000|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|11
8631910|NCT00542425|9671777|FG001|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|13
8968980|NCT02592655|10032587|FG000|Windlass Tourniquet|Fourth Tourniquet Right Thigh.||0
8968981|NCT02592655|10032587|FG000|Tourniquet Tape 10 cm Width|Fourth Tourniquet Right Thigh.||3
8968982|NCT02592655|10032587|FG000|Tourniquet Tape 5 cm Width|Fourth Tourniquet Right Thigh.||0
8968983|NCT02592655|10032587|FG000|COMPLETED|Fourth Tourniquet Right Thigh.||4
8968984|NCT02592655|10032587|FG000|NOT COMPLETED|Fourth Tourniquet Right Thigh.||0
8876682|NCT01918085|9933451|FG000|NOT COMPLETED|Test Period 1: Strata Strip||0
8968985|NCT02592798|10032604|FG000|STARTED|Double-Blind Period 1 (DB1)||17
8968986|NCT02592798|10032605|FG001|STARTED|Double-Blind Period 1 (DB1)||19
8968987|NCT02592798|10032604|FG000|COMPLETED|Double-Blind Period 1 (DB1)||14
8968988|NCT02592798|10032605|FG001|COMPLETED|Double-Blind Period 1 (DB1)||13
8968989|NCT02592798|10032604|FG000|NOT COMPLETED|Double-Blind Period 1 (DB1)||3
8968990|NCT02592798|10032605|FG001|NOT COMPLETED|Double-Blind Period 1 (DB1)||6
8968991|NCT02592798|10032604|FG000|STARTED|Transition From DB1 to DB2||14
8968992|NCT02592798|10032605|FG001|STARTED|Transition From DB1 to DB2||13
8968993|NCT02592798|10032604|FG000|COMPLETED|Transition From DB1 to DB2||11
8968994|NCT02592798|10032605|FG001|COMPLETED|Transition From DB1 to DB2||11
8968995|NCT02592798|10032604|FG000|NOT COMPLETED|Transition From DB1 to DB2||3
8968996|NCT02592798|10032605|FG001|NOT COMPLETED|Transition From DB1 to DB2||2
8968997|NCT02592798|10032604|FG000|STARTED|Double-Blind Period 2 (DB2)||11
8968998|NCT02592798|10032605|FG001|STARTED|Double-Blind Period 2 (DB2)||11
8968999|NCT02592798|10032604|FG000|COMPLETED|Double-Blind Period 2 (DB2)||6
8969000|NCT02592798|10032605|FG001|COMPLETED|Double-Blind Period 2 (DB2)||9
8969001|NCT02592798|10032604|FG000|NOT COMPLETED|Double-Blind Period 2 (DB2)||5
8969002|NCT02592798|10032605|FG001|NOT COMPLETED|Double-Blind Period 2 (DB2)||2
8969003|NCT02592798|10032604|FG000|STARTED|Transition From DB2 to OLE||6
8969004|NCT02592798|10032605|FG001|STARTED|Transition From DB2 to OLE||9
8969005|NCT02592798|10032604|FG000|COMPLETED|Transition From DB2 to OLE||5
8969006|NCT02592798|10032605|FG001|COMPLETED|Transition From DB2 to OLE||9
8969007|NCT02592798|10032604|FG000|NOT COMPLETED|Transition From DB2 to OLE||1
8969008|NCT02592798|10032605|FG001|NOT COMPLETED|Transition From DB2 to OLE||0
8969009|NCT02592798|10032604|FG000|STARTED|Open Label Period (OLE)||10
8969010|NCT02592798|10032605|FG001|STARTED|Open Label Period (OLE)||13
8969011|NCT02592798|10032604|FG000|COMPLETED|Open Label Period (OLE)||6
8969012|NCT02592798|10032605|FG001|COMPLETED|Open Label Period (OLE)||4
8969013|NCT02592798|10032604|FG000|NOT COMPLETED|Open Label Period (OLE)||4
8969014|NCT02592798|10032605|FG001|NOT COMPLETED|Open Label Period (OLE)||9
8969015|NCT02592876|10032620|FG000|STARTED|Overall Study||41
8969016|NCT02592876|10032621|FG001|STARTED|Overall Study||40
8969017|NCT02592876|10032620|FG000|Received Study Drug|Overall Study||40
8969018|NCT02592876|10032621|FG001|Received Study Drug|Overall Study||40
8969019|NCT02592876|10032620|FG000|Completed Treatment|Overall Study||34
8969020|NCT02592876|10032621|FG001|Completed Treatment|Overall Study||32
8969021|NCT02592876|10032620|FG000|COMPLETED|Overall Study||0
8969022|NCT02592876|10032621|FG001|COMPLETED|Overall Study||0
8969023|NCT02592876|10032620|FG000|NOT COMPLETED|Overall Study||41
8969024|NCT02592876|10032621|FG001|NOT COMPLETED|Overall Study||40
8969025|NCT02593006|10032630|FG000|STARTED|Overall Study||257
8969026|NCT02593006|10032631|FG001|STARTED|Overall Study||100
8969027|NCT02593006|10032632|FG002|STARTED|Overall Study||43
8969028|NCT02593006|10032630|FG000|COMPLETED|Overall Study||250
8969029|NCT02593006|10032631|FG001|COMPLETED|Overall Study||93
8969030|NCT02593006|10032632|FG002|COMPLETED|Overall Study||38
8969031|NCT02593006|10032630|FG000|NOT COMPLETED|Overall Study||7
8969032|NCT02593006|10032631|FG001|NOT COMPLETED|Overall Study||7
8969033|NCT02593006|10032632|FG002|NOT COMPLETED|Overall Study||5
8969034|NCT02593032|10032643|FG000|STARTED|Overall Study||17
8969035|NCT02593032|10032644|FG001|STARTED|Overall Study||33
8969036|NCT02593032|10032643|FG000|COMPLETED|Overall Study||17
8969037|NCT02593032|10032644|FG001|COMPLETED|Overall Study||33
8969038|NCT02593032|10032643|FG000|NOT COMPLETED|Overall Study||0
8969039|NCT02593032|10032644|FG001|NOT COMPLETED|Overall Study||0
8969040|NCT02593097|10032652|FG000|STARTED|First Intervention (12 Weeks)||14
8876683|NCT01918085|9933452|FG001|NOT COMPLETED|Test Period 1: Strata Strip||1
8876684|NCT01918085|9933451|FG000|STARTED|Test Period 1: Hydrocolloid Strip||10
8876685|NCT01918085|9933452|FG001|STARTED|Test Period 1: Hydrocolloid Strip||11
8876686|NCT01918085|9933451|FG000|COMPLETED|Test Period 1: Hydrocolloid Strip||10
8876687|NCT01918085|9933452|FG001|COMPLETED|Test Period 1: Hydrocolloid Strip||11
8876688|NCT01918085|9933451|FG000|NOT COMPLETED|Test Period 1: Hydrocolloid Strip||0
8876689|NCT01918085|9933452|FG001|NOT COMPLETED|Test Period 1: Hydrocolloid Strip||0
8876690|NCT01918085|9933451|FG000|STARTED|Test Period 2: Strata Strip||10
8969041|NCT02593097|10032653|FG001|STARTED|First Intervention (12 Weeks)||20
8969042|NCT02593097|10032652|FG000|Received Intervention|First Intervention (12 Weeks)||14
8969043|NCT02593097|10032653|FG001|Received Intervention|First Intervention (12 Weeks)||20
8969044|NCT02593097|10032652|FG000|COMPLETED|First Intervention (12 Weeks)||12
8969045|NCT02593097|10032653|FG001|COMPLETED|First Intervention (12 Weeks)||16
8969046|NCT02593097|10032652|FG000|NOT COMPLETED|First Intervention (12 Weeks)||2
8969047|NCT02593097|10032653|FG001|NOT COMPLETED|First Intervention (12 Weeks)||4
8969048|NCT02593097|10032652|FG000|STARTED|Washout (4 Weeks)||12
8876691|NCT01918085|9933452|FG001|STARTED|Test Period 2: Strata Strip||11
8876692|NCT01918085|9933451|FG000|COMPLETED|Test Period 2: Strata Strip||10
8876693|NCT01918085|9933452|FG001|COMPLETED|Test Period 2: Strata Strip||11
8876694|NCT01918085|9933451|FG000|NOT COMPLETED|Test Period 2: Strata Strip||0
8876695|NCT01918085|9933452|FG001|NOT COMPLETED|Test Period 2: Strata Strip||0
8876696|NCT01918085|9933451|FG000|STARTED|Test Period 2: Hydrocolloid Strip||10
8876697|NCT01918085|9933452|FG001|STARTED|Test Period 2: Hydrocolloid Strip||11
8969049|NCT02593097|10032653|FG001|STARTED|Washout (4 Weeks)||16
8969050|NCT02593097|10032652|FG000|COMPLETED|Washout (4 Weeks)||12
8969051|NCT02593097|10032653|FG001|COMPLETED|Washout (4 Weeks)||16
8969052|NCT02593097|10032652|FG000|NOT COMPLETED|Washout (4 Weeks)||0
8969053|NCT02593097|10032653|FG001|NOT COMPLETED|Washout (4 Weeks)||0
8969054|NCT02593097|10032652|FG000|STARTED|Second Intervention (12 Weeks)||12
8969055|NCT02593097|10032653|FG001|STARTED|Second Intervention (12 Weeks)||16
8969056|NCT02593097|10032652|FG000|COMPLETED|Second Intervention (12 Weeks)||9
8969057|NCT02593097|10032653|FG001|COMPLETED|Second Intervention (12 Weeks)||15
8969058|NCT02593097|10032652|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||3
8969059|NCT02593097|10032653|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||1
8969060|NCT02593149|10032661|FG000|STARTED|Run-In||340
8969061|NCT02593149|10032662|FG001|STARTED|Run-In||361
8969062|NCT02593149|10032661|FG000|COMPLETED|Run-In||304
8969063|NCT02593149|10032662|FG001|COMPLETED|Run-In||323
8969064|NCT02593149|10032661|FG000|NOT COMPLETED|Run-In||36
8969065|NCT02593149|10032662|FG001|NOT COMPLETED|Run-In||38
8969066|NCT02593149|10032661|FG000|STARTED|Intervention||942
8969067|NCT02593149|10032662|FG001|STARTED|Intervention||960
8969068|NCT02593149|10032661|FG000|COMPLETED|Intervention||826
8969069|NCT02593149|10032662|FG001|COMPLETED|Intervention||845
8969070|NCT02593149|10032661|FG000|NOT COMPLETED|Intervention||116
8969071|NCT02593149|10032662|FG001|NOT COMPLETED|Intervention||115
8969072|NCT02593305|10032671|FG000|STARTED|Baseline 1||7
8969073|NCT02593305|10032672|FG001|STARTED|Baseline 1||6
8969074|NCT02593305|10032673|FG002|STARTED|Baseline 1||10
8969075|NCT02593305|10032671|FG000|COMPLETED|Baseline 1||7
8969076|NCT02593305|10032672|FG001|COMPLETED|Baseline 1||6
8969077|NCT02593305|10032673|FG002|COMPLETED|Baseline 1||10
8969078|NCT02593305|10032671|FG000|NOT COMPLETED|Baseline 1||0
8969079|NCT02593305|10032672|FG001|NOT COMPLETED|Baseline 1||0
8969080|NCT02593305|10032673|FG002|NOT COMPLETED|Baseline 1||0
8969081|NCT02593305|10032671|FG000|STARTED|Post 1||7
8969082|NCT02593305|10032672|FG001|STARTED|Post 1||6
8969083|NCT02593305|10032673|FG002|STARTED|Post 1||10
8969084|NCT02593305|10032671|FG000|COMPLETED|Post 1||7
8969085|NCT02593305|10032672|FG001|COMPLETED|Post 1||6
8969086|NCT02593305|10032673|FG002|COMPLETED|Post 1||0
8969087|NCT02593305|10032671|FG000|NOT COMPLETED|Post 1||0
8969088|NCT02593305|10032672|FG001|NOT COMPLETED|Post 1||0
8969089|NCT02593305|10032673|FG002|NOT COMPLETED|Post 1||10
8969090|NCT02593305|10032671|FG000|STARTED|Baseline 2||7
8969091|NCT02593305|10032672|FG001|STARTED|Baseline 2||6
8969092|NCT02593305|10032673|FG002|STARTED|Baseline 2||0
8969093|NCT02593305|10032671|FG000|COMPLETED|Baseline 2||7
8969094|NCT02593305|10032672|FG001|COMPLETED|Baseline 2||6
8969095|NCT02593305|10032673|FG002|COMPLETED|Baseline 2||0
8969096|NCT02593305|10032671|FG000|NOT COMPLETED|Baseline 2||0
8969097|NCT02593305|10032672|FG001|NOT COMPLETED|Baseline 2||0
8969098|NCT02593305|10032673|FG002|NOT COMPLETED|Baseline 2||0
8969099|NCT02593305|10032671|FG000|STARTED|Post 2||7
8969100|NCT02593305|10032672|FG001|STARTED|Post 2||6
8969101|NCT02593305|10032673|FG002|STARTED|Post 2||0
8969102|NCT02593305|10032671|FG000|COMPLETED|Post 2||7
8969103|NCT02593305|10032672|FG001|COMPLETED|Post 2||6
8969104|NCT02593305|10032673|FG002|COMPLETED|Post 2||0
8969105|NCT02593305|10032671|FG000|NOT COMPLETED|Post 2||0
8969106|NCT02593305|10032672|FG001|NOT COMPLETED|Post 2||0
8969107|NCT02593305|10032673|FG002|NOT COMPLETED|Post 2||0
8969108|NCT02593318|10032684|FG000|STARTED|Overall Study||16
8969109|NCT02593318|10032685|FG001|STARTED|Overall Study||16
8969110|NCT02593318|10032684|FG000|COMPLETED|Overall Study||15
8969111|NCT02593318|10032685|FG001|COMPLETED|Overall Study||15
8969112|NCT02593318|10032684|FG000|NOT COMPLETED|Overall Study||1
8969113|NCT02593318|10032685|FG001|NOT COMPLETED|Overall Study||1
8969114|NCT02593396|10032699|FG000|STARTED|Overall Study||40
8969115|NCT02593396|10032700|FG001|STARTED|Overall Study||40
8969116|NCT02593396|10032699|FG000|At Least Done One Efficacy Assessment|Overall Study||36
8969117|NCT02593396|10032700|FG001|At Least Done One Efficacy Assessment|Overall Study||36
8969118|NCT02593396|10032699|FG000|COMPLETED|Overall Study||25
8969119|NCT02593396|10032700|FG001|COMPLETED|Overall Study||26
8969120|NCT02593396|10032699|FG000|NOT COMPLETED|Overall Study||15
8969121|NCT02593396|10032700|FG001|NOT COMPLETED|Overall Study||14
8969122|NCT02593539|10032706|FG000|STARTED|Overall Study||5
8969123|NCT02593539|10032706|FG000|COMPLETED|Overall Study||4
8969124|NCT02593539|10032706|FG000|NOT COMPLETED|Overall Study||1
8969125|NCT02593630|10032713|FG000|STARTED|Overall Study||54
8969126|NCT02593630|10032713|FG000|COMPLETED|Overall Study||53
8969127|NCT02593630|10032713|FG000|NOT COMPLETED|Overall Study||1
8969128|NCT02593773|10032718|FG000|STARTED|Overall Study||86
8969129|NCT02593773|10032718|FG000|COMPLETED|Overall Study||51
8969130|NCT02593773|10032718|FG000|NOT COMPLETED|Overall Study||35
8969131|NCT02593825|10032724|FG000|STARTED|Intervention||67
8969132|NCT02593825|10032725|FG001|STARTED|Intervention||67
8969133|NCT02593825|10032724|FG000|COMPLETED|Intervention||57
8969134|NCT02593825|10032725|FG001|COMPLETED|Intervention||55
8969135|NCT02593825|10032724|FG000|NOT COMPLETED|Intervention||10
8969136|NCT02593825|10032725|FG001|NOT COMPLETED|Intervention||12
8969137|NCT02593825|10032724|FG000|STARTED|Follow-up||57
8969138|NCT02593825|10032725|FG001|STARTED|Follow-up||55
8969139|NCT02593825|10032724|FG000|COMPLETED|Follow-up||57
8969140|NCT02593825|10032725|FG001|COMPLETED|Follow-up||55
8969141|NCT02593825|10032724|FG000|NOT COMPLETED|Follow-up||0
8969142|NCT02593825|10032725|FG001|NOT COMPLETED|Follow-up||0
8969143|NCT02593864|10032733|FG000|STARTED|Overall Study||25
8969144|NCT02593864|10032733|FG000|COMPLETED|Overall Study||19
8969145|NCT02593864|10032733|FG000|NOT COMPLETED|Overall Study||6
9038174|NCT03329885|10099485|FG006|COMPLETED|Overall Study||0
9038175|NCT03329885|10099486|FG007|COMPLETED|Overall Study||0
8969146|NCT04142242|10032743|FG000|STARTED|Overall Study||139
8969147|NCT04142242|10032744|FG001|STARTED|Overall Study||176
8969148|NCT04142242|10032745|FG002|STARTED|Overall Study||31
8969149|NCT04142242|10032746|FG003|STARTED|Overall Study||39
8969150|NCT04142242|10032747|FG004|STARTED|Overall Study||26
8969151|NCT04142242|10032748|FG005|STARTED|Overall Study||60
8969152|NCT04142242|10032743|FG000|Vaccinated|Overall Study||138
8969153|NCT04142242|10032744|FG001|Vaccinated|Overall Study||175
8969154|NCT04142242|10032745|FG002|Vaccinated|Overall Study||0
8969155|NCT04142242|10032746|FG003|Vaccinated|Overall Study||0
8969156|NCT04142242|10032747|FG004|Vaccinated|Overall Study||0
8969157|NCT04142242|10032748|FG005|Vaccinated|Overall Study||0
8969158|NCT04142242|10032743|FG000|Full Analysis Set (FAS)|Overall Study||138
8969159|NCT04142242|10032744|FG001|Full Analysis Set (FAS)|Overall Study||175
8969160|NCT04142242|10032745|FG002|Full Analysis Set (FAS)|Overall Study||31
8969161|NCT04142242|10032746|FG003|Full Analysis Set (FAS)|Overall Study||39
8969162|NCT04142242|10032747|FG004|Full Analysis Set (FAS)|Overall Study||26
8969163|NCT04142242|10032748|FG005|Full Analysis Set (FAS)|Overall Study||59
8969164|NCT04142242|10032743|FG000|Safety Analysis Set (SAfAS)|Overall Study|1 MenACYW Conjugate vaccine-primed participant was erroneously assigned by Investigator to Group 1 but per planned analysis was counted in Group 2 for safety analysis.|151
8969165|NCT04142242|10032744|FG001|Safety Analysis Set (SAfAS)|Overall Study|14 Menomune-primed participants were erroneously assigned by Investigator to Group 2 but per planned analysis they were counted in Group 1 for safety analysis.|162
8969166|NCT04142242|10032745|FG002|Safety Analysis Set (SAfAS)|Overall Study||0
8969167|NCT04142242|10032746|FG003|Safety Analysis Set (SAfAS)|Overall Study||0
8969168|NCT04142242|10032747|FG004|Safety Analysis Set (SAfAS)|Overall Study||0
8969169|NCT04142242|10032748|FG005|Safety Analysis Set (SAfAS)|Overall Study||0
8969170|NCT04142242|10032743|FG000|COMPLETED|Overall Study||138
8969171|NCT04142242|10032744|FG001|COMPLETED|Overall Study||175
8969172|NCT04142242|10032745|FG002|COMPLETED|Overall Study||0
8969173|NCT04142242|10032746|FG003|COMPLETED|Overall Study||0
8969174|NCT04142242|10032747|FG004|COMPLETED|Overall Study||26
8969175|NCT04142242|10032748|FG005|COMPLETED|Overall Study||59
8969176|NCT04142242|10032743|FG000|NOT COMPLETED|Overall Study||1
8969177|NCT04142242|10032744|FG001|NOT COMPLETED|Overall Study||1
8969178|NCT04142242|10032745|FG002|NOT COMPLETED|Overall Study||31
8969179|NCT04142242|10032746|FG003|NOT COMPLETED|Overall Study||39
8969180|NCT04142242|10032747|FG004|NOT COMPLETED|Overall Study||0
8969181|NCT04142242|10032748|FG005|NOT COMPLETED|Overall Study||1
8969182|NCT04087122|10032761|FG000|STARTED|Overall Study||20
8969183|NCT04087122|10032761|FG000|COMPLETED|Overall Study||20
8969184|NCT04087122|10032761|FG000|NOT COMPLETED|Overall Study||0
8969185|NCT03990389|10032769|FG000|STARTED|Overall Study||15
8969186|NCT03990389|10032770|FG001|STARTED|Overall Study||16
8969187|NCT03990389|10032769|FG000|COMPLETED|Overall Study||12
8969188|NCT03990389|10032770|FG001|COMPLETED|Overall Study||16
8969189|NCT03990389|10032769|FG000|NOT COMPLETED|Overall Study||3
8969190|NCT03990389|10032770|FG001|NOT COMPLETED|Overall Study||0
8969191|NCT03939312|10032776|FG000|STARTED|OL Treatment Period (40 Weeks)||685
8969192|NCT03939312|10032776|FG000|COMPLETED|OL Treatment Period (40 Weeks)||511
8969193|NCT03939312|10032776|FG000|NOT COMPLETED|OL Treatment Period (40 Weeks)||174
8969194|NCT03939312|10032776|FG000|STARTED|Safety Follow-up 4 Weeks (Up to Week 44)|Out of 685 participants, 640 participants who received treatment including 511 participants who completed the treatment entered safety follow-up period.|640
8969195|NCT03939312|10032776|FG000|COMPLETED|Safety Follow-up 4 Weeks (Up to Week 44)||624
8969196|NCT03939312|10032776|FG000|NOT COMPLETED|Safety Follow-up 4 Weeks (Up to Week 44)||16
8969197|NCT03934541|10032786|FG000|STARTED|Overall Study||5
8969198|NCT03934541|10032787|FG001|STARTED|Overall Study||15
8969199|NCT03934541|10032788|FG002|STARTED|Overall Study||1
8969200|NCT03934541|10032789|FG003|STARTED|Overall Study||3
8969201|NCT03934541|10032786|FG000|COMPLETED|Overall Study||5
8969202|NCT03934541|10032787|FG001|COMPLETED|Overall Study||14
8969203|NCT03934541|10032788|FG002|COMPLETED|Overall Study||1
8969204|NCT03934541|10032789|FG003|COMPLETED|Overall Study||3
8969205|NCT03934541|10032786|FG000|NOT COMPLETED|Overall Study||0
8969206|NCT03934541|10032787|FG001|NOT COMPLETED|Overall Study||1
8969207|NCT03934541|10032788|FG002|NOT COMPLETED|Overall Study||0
8969208|NCT03934541|10032789|FG003|NOT COMPLETED|Overall Study||0
8969209|NCT03903640|10032799|FG000|STARTED|Overall Study||2
8969210|NCT03903640|10032799|FG000|COMPLETED|Overall Study||2
8969211|NCT03903640|10032799|FG000|NOT COMPLETED|Overall Study||0
8969212|NCT03895034|10032803|FG000|STARTED|Overall Study||66
8969213|NCT03895034|10032803|FG000|COMPLETED|Overall Study||64
8969214|NCT03895034|10032803|FG000|NOT COMPLETED|Overall Study||2
8969215|NCT03870477|10032807|FG000|STARTED|Overall Study||1
8969216|NCT03870477|10032807|FG000|COMPLETED|Overall Study||0
8969217|NCT03870477|10032807|FG000|NOT COMPLETED|Overall Study||1
8969218|NCT03351244|10032814|FG000|STARTED|Overall Study||89
8969219|NCT03351244|10032815|FG001|STARTED|Overall Study||88
8969220|NCT03351244|10032816|FG002|STARTED|Overall Study||87
8969221|NCT03351244|10032814|FG000|COMPLETED|Overall Study||62
8969222|NCT03351244|10032815|FG001|COMPLETED|Overall Study||48
8969223|NCT03351244|10032816|FG002|COMPLETED|Overall Study||53
8969224|NCT03351244|10032814|FG000|NOT COMPLETED|Overall Study||27
8969225|NCT03351244|10032815|FG001|NOT COMPLETED|Overall Study||40
8969226|NCT03351244|10032816|FG002|NOT COMPLETED|Overall Study||34
8969227|NCT03292926|10032828|FG000|STARTED|Overall Study||39
8969228|NCT03292926|10032829|FG001|STARTED|Overall Study||39
8969229|NCT03292926|10032828|FG000|COMPLETED|Overall Study||39
8969230|NCT03292926|10032829|FG001|COMPLETED|Overall Study||39
8969231|NCT03292926|10032828|FG000|NOT COMPLETED|Overall Study||0
8570834|NCT00105989|9603002|FG000|STARTED|Continuation - Open Label:Week 10-34||413
8570835|NCT00105989|9603003|FG001|STARTED|Continuation - Open Label:Week 10-34||0
8570836|NCT00105989|9603002|FG000|COMPLETED|Continuation - Open Label:Week 10-34||288
8570837|NCT00105989|9603003|FG001|COMPLETED|Continuation - Open Label:Week 10-34||0
8570838|NCT00105989|9603002|FG000|NOT COMPLETED|Continuation - Open Label:Week 10-34||125
8570839|NCT00105989|9603003|FG001|NOT COMPLETED|Continuation - Open Label:Week 10-34||0
8969232|NCT03292926|10032829|FG001|NOT COMPLETED|Overall Study||0
8969233|NCT03084666|10032837|FG000|STARTED|Overall Study||20
8969234|NCT03084666|10032838|FG001|STARTED|Overall Study||20
8969235|NCT03084666|10032837|FG000|COMPLETED|Overall Study||20
8969236|NCT03084666|10032838|FG001|COMPLETED|Overall Study||20
8969237|NCT03084666|10032837|FG000|NOT COMPLETED|Overall Study||0
8969238|NCT03084666|10032838|FG001|NOT COMPLETED|Overall Study||0
9038176|NCT03329885|10099487|FG008|COMPLETED|Overall Study||0
9038177|NCT03329885|10099479|FG000|NOT COMPLETED|Overall Study||0
9038178|NCT03329885|10099480|FG001|NOT COMPLETED|Overall Study||0
9038179|NCT03329885|10099481|FG002|NOT COMPLETED|Overall Study||0
9038180|NCT03329885|10099482|FG003|NOT COMPLETED|Overall Study||0
9038181|NCT03329885|10099483|FG004|NOT COMPLETED|Overall Study||0
9038182|NCT03329885|10099484|FG005|NOT COMPLETED|Overall Study||0
9038183|NCT03329885|10099485|FG006|NOT COMPLETED|Overall Study||1
9038184|NCT03329885|10099486|FG007|NOT COMPLETED|Overall Study||1
9038185|NCT03329885|10099487|FG008|NOT COMPLETED|Overall Study||0
9038186|NCT03329911|10099509|FG000|STARTED|Overall Study||326
9038187|NCT03329911|10099510|FG001|STARTED|Overall Study||325
9038188|NCT03329911|10099509|FG000|COMPLETED|Overall Study||209
9038189|NCT03329911|10099510|FG001|COMPLETED|Overall Study||222
9038190|NCT03329911|10099509|FG000|NOT COMPLETED|Overall Study||117
9038191|NCT03329911|10099510|FG001|NOT COMPLETED|Overall Study||103
9038192|NCT03329937|10099516|FG000|STARTED|Overall Study||21
9038193|NCT03329937|10099516|FG000|COMPLETED|Overall Study||21
9038194|NCT03329937|10099516|FG000|NOT COMPLETED|Overall Study||0
8725793|NCT01033422|9773143|FG002|COMPLETED|Overall Study||22
8876698|NCT01918085|9933451|FG000|COMPLETED|Test Period 2: Hydrocolloid Strip||10
8876699|NCT01918085|9933452|FG001|COMPLETED|Test Period 2: Hydrocolloid Strip||11
9038195|NCT03329989|10099520|FG000|STARTED|Overall Study||158
9038196|NCT03329989|10099520|FG000|COMPLETED|Overall Study||135
9038197|NCT03329989|10099520|FG000|NOT COMPLETED|Overall Study||23
9038198|NCT03330002|10099524|FG000|STARTED|Overall Study|Subjects that received the MANTA VCD|500
9038199|NCT03330002|10099524|FG000|COMPLETED|Overall Study|Subjects that received the MANTA VCD and completed 30 day follow-up visit|478
9038200|NCT03330002|10099524|FG000|NOT COMPLETED|Overall Study||22
9038201|NCT03330041|10099528|FG000|STARTED|Overall Study||50
9038202|NCT03330041|10099528|FG000|COMPLETED|Overall Study||48
9038203|NCT03330041|10099528|FG000|NOT COMPLETED|Overall Study||2
9038204|NCT03330119|10099536|FG000|STARTED|Overall Study||641
9038205|NCT03330119|10099537|FG001|STARTED|Overall Study||853
9038206|NCT03330119|10099536|FG000|COMPLETED|Overall Study||475
8876700|NCT01918085|9933451|FG000|NOT COMPLETED|Test Period 2: Hydrocolloid Strip||0
8876701|NCT01918085|9933452|FG001|NOT COMPLETED|Test Period 2: Hydrocolloid Strip||0
8876702|NCT01918189|9933460|FG000|STARTED|Overall Study||59
8725794|NCT01033422|9773141|FG000|NOT COMPLETED|Overall Study||1
8725795|NCT01033422|9773142|FG001|NOT COMPLETED|Overall Study||4
8725796|NCT01033422|9773143|FG002|NOT COMPLETED|Overall Study||1
8725797|NCT01033448|9773151|FG000|STARTED|Overall Study||59
8725798|NCT01033448|9773151|FG000|COMPLETED|Overall Study||47
8725799|NCT01033448|9773151|FG000|NOT COMPLETED|Overall Study||12
8725800|NCT01033487|9773157|FG000|STARTED|First Intervention Period||2
8969239|NCT02982954|10032848|FG000|STARTED|Treatment Period||106
8969240|NCT02982954|10032849|FG001|STARTED|Treatment Period||52
8969241|NCT02982954|10032850|FG002|STARTED|Treatment Period||28
8969242|NCT02982954|10032851|FG003|STARTED|Treatment Period||25
8969243|NCT02982954|10032848|FG000|COMPLETED|Treatment Period||0
8969244|NCT02982954|10032849|FG001|COMPLETED|Treatment Period||0
8969245|NCT02982954|10032850|FG002|COMPLETED|Treatment Period||0
8969246|NCT02982954|10032851|FG003|COMPLETED|Treatment Period||0
8969247|NCT02982954|10032848|FG000|NOT COMPLETED|Treatment Period||106
8969248|NCT02982954|10032849|FG001|NOT COMPLETED|Treatment Period||52
8969249|NCT02982954|10032850|FG002|NOT COMPLETED|Treatment Period||28
8969250|NCT02982954|10032851|FG003|NOT COMPLETED|Treatment Period||25
8969251|NCT02982954|10032848|FG000|STARTED|Continuing in Study||106
8969252|NCT02982954|10032849|FG001|STARTED|Continuing in Study||52
8969253|NCT02982954|10032850|FG002|STARTED|Continuing in Study||28
8969254|NCT02982954|10032851|FG003|STARTED|Continuing in Study||25
8969255|NCT02982954|10032848|FG000|COMPLETED|Continuing in Study||52
8969256|NCT02982954|10032849|FG001|COMPLETED|Continuing in Study||19
8969257|NCT02982954|10032850|FG002|COMPLETED|Continuing in Study||17
8969258|NCT02982954|10032851|FG003|COMPLETED|Continuing in Study||7
8969259|NCT02982954|10032848|FG000|NOT COMPLETED|Continuing in Study||54
8969260|NCT02982954|10032849|FG001|NOT COMPLETED|Continuing in Study||33
8969261|NCT02982954|10032850|FG002|NOT COMPLETED|Continuing in Study||11
8969262|NCT02982954|10032851|FG003|NOT COMPLETED|Continuing in Study||18
8969263|NCT02964078|10032861|FG000|STARTED|Overall Study||27
8969264|NCT02964078|10032861|FG000|COMPLETED|Overall Study||27
8969265|NCT02964078|10032861|FG000|NOT COMPLETED|Overall Study||0
8969266|NCT02903914|10032873|FG000|STARTED|Overall Study||8
8969267|NCT02903914|10032874|FG001|STARTED|Overall Study||7
8969268|NCT02903914|10032875|FG002|STARTED|Overall Study||85
8969269|NCT02903914|10032876|FG003|STARTED|Overall Study||7
8876703|NCT01918189|9933460|FG000|Completed Baseline Assessment|Overall Study||58
8876704|NCT01918189|9933460|FG000|Completed Follow-up Assessment|Overall Study||41
8876705|NCT01918189|9933460|FG000|COMPLETED|Overall Study||41
8876706|NCT01918189|9933460|FG000|NOT COMPLETED|Overall Study||18
8876707|NCT01918306|9933467|FG000|STARTED|Overall Study||6
8876708|NCT01918306|9933468|FG001|STARTED|Overall Study|No patients enrolled|0
8876709|NCT01918306|9933469|FG002|STARTED|Overall Study|1 participant Crossed-over to ARM 2|2
8876710|NCT01918306|9933470|FG003|STARTED|Overall Study||3
8876711|NCT01918306|9933467|FG000|COMPLETED|Overall Study||0
8876712|NCT01918306|9933468|FG001|COMPLETED|Overall Study||0
8876713|NCT01918306|9933469|FG002|COMPLETED|Overall Study||0
8876714|NCT01918306|9933470|FG003|COMPLETED|Overall Study||0
8876715|NCT01918306|9933467|FG000|NOT COMPLETED|Overall Study||6
8876716|NCT01918306|9933468|FG001|NOT COMPLETED|Overall Study||0
8876717|NCT01918306|9933469|FG002|NOT COMPLETED|Overall Study||2
8876718|NCT01918306|9933470|FG003|NOT COMPLETED|Overall Study||3
8876719|NCT01918332|9933494|FG000|STARTED|Overall Study||43
8876720|NCT01918332|9933495|FG001|STARTED|Overall Study||41
8876721|NCT01918332|9933496|FG002|STARTED|Overall Study||39
8876722|NCT01918332|9933497|FG003|STARTED|Overall Study||45
8876723|NCT01918332|9933494|FG000|COMPLETED|Overall Study||35
8876724|NCT01918332|9933495|FG001|COMPLETED|Overall Study||36
8876725|NCT01918332|9933496|FG002|COMPLETED|Overall Study||30
8876726|NCT01918332|9933497|FG003|COMPLETED|Overall Study||38
8876727|NCT01918332|9933494|FG000|NOT COMPLETED|Overall Study||8
8876728|NCT01918332|9933495|FG001|NOT COMPLETED|Overall Study||5
8876729|NCT01918332|9933496|FG002|NOT COMPLETED|Overall Study||9
8969270|NCT02903914|10032877|FG004|STARTED|Overall Study||10
8969271|NCT02903914|10032878|FG005|STARTED|Overall Study||14
8969272|NCT02903914|10032879|FG006|STARTED|Overall Study||123
8969273|NCT02903914|10032880|FG007|STARTED|Overall Study||6
8969274|NCT02903914|10032873|FG000|COMPLETED|Overall Study||0
8969275|NCT02903914|10032874|FG001|COMPLETED|Overall Study||0
8876730|NCT01918332|9933497|FG003|NOT COMPLETED|Overall Study||7
8876731|NCT01918371|9933509|FG000|STARTED|Overall Study||166
8876732|NCT01918371|9933510|FG001|STARTED|Overall Study||157
8876733|NCT01918371|9933509|FG000|Participants With Complete Data|Overall Study||165
8969276|NCT02903914|10032875|FG002|COMPLETED|Overall Study||0
8969277|NCT02903914|10032876|FG003|COMPLETED|Overall Study||0
8969278|NCT02903914|10032877|FG004|COMPLETED|Overall Study||0
8969279|NCT02903914|10032878|FG005|COMPLETED|Overall Study||0
8969280|NCT02903914|10032879|FG006|COMPLETED|Overall Study||6
8969281|NCT02903914|10032880|FG007|COMPLETED|Overall Study||1
8969282|NCT02903914|10032873|FG000|NOT COMPLETED|Overall Study||8
8969283|NCT02903914|10032874|FG001|NOT COMPLETED|Overall Study||7
8969284|NCT02903914|10032875|FG002|NOT COMPLETED|Overall Study||85
8969285|NCT02903914|10032876|FG003|NOT COMPLETED|Overall Study||7
8969286|NCT02903914|10032877|FG004|NOT COMPLETED|Overall Study||10
8969287|NCT02903914|10032878|FG005|NOT COMPLETED|Overall Study||14
8969288|NCT02903914|10032879|FG006|NOT COMPLETED|Overall Study||117
8969289|NCT02903914|10032880|FG007|NOT COMPLETED|Overall Study||5
8969290|NCT02727699|10032902|FG000|STARTED|Overall Study||91
8969291|NCT02727699|10032903|FG001|STARTED|Overall Study||94
8969292|NCT02727699|10032902|FG000|COMPLETED|Overall Study||82
8969293|NCT02727699|10032903|FG001|COMPLETED|Overall Study||89
8969294|NCT02727699|10032902|FG000|NOT COMPLETED|Overall Study||9
8969295|NCT02727699|10032903|FG001|NOT COMPLETED|Overall Study||5
8969296|NCT02640950|10032909|FG000|STARTED|Overall Study||31
8969297|NCT02640950|10032909|FG000|COMPLETED|Overall Study||29
8969298|NCT02640950|10032909|FG000|NOT COMPLETED|Overall Study||2
8969299|NCT02429375|10032916|FG000|STARTED|Overall Study||3
8969300|NCT02429375|10032917|FG001|STARTED|Overall Study||3
8969301|NCT02429375|10032918|FG002|STARTED|Overall Study||1
8969302|NCT02429375|10032916|FG000|COMPLETED|Overall Study||3
8969303|NCT02429375|10032917|FG001|COMPLETED|Overall Study||3
8969304|NCT02429375|10032918|FG002|COMPLETED|Overall Study||1
8969305|NCT02429375|10032916|FG000|NOT COMPLETED|Overall Study||0
8969306|NCT02429375|10032917|FG001|NOT COMPLETED|Overall Study||0
8969307|NCT02429375|10032918|FG002|NOT COMPLETED|Overall Study||0
8969308|NCT02230254|10032927|FG000|STARTED|Overall Study||101
8969309|NCT02230254|10032927|FG000|COMPLETED|Overall Study||98
8969310|NCT02230254|10032927|FG000|NOT COMPLETED|Overall Study||3
8969311|NCT01909453|10032936|FG000|STARTED|Overall Study||192
8969312|NCT01909453|10032937|FG001|STARTED|Overall Study||194
8969313|NCT01909453|10032938|FG002|STARTED|Overall Study||191
8969314|NCT01909453|10032939|FG003|STARTED|Overall Study||258
8969315|NCT01909453|10032940|FG004|STARTED|Overall Study||86
8969316|NCT01909453|10032936|FG000|COMPLETED|Overall Study||0
8969317|NCT01909453|10032937|FG001|COMPLETED|Overall Study||0
8969318|NCT01909453|10032938|FG002|COMPLETED|Overall Study||0
8969319|NCT01909453|10032939|FG003|COMPLETED|Overall Study||0
8969320|NCT01909453|10032940|FG004|COMPLETED|Overall Study||0
8969321|NCT01909453|10032936|FG000|NOT COMPLETED|Overall Study||192
8969322|NCT01909453|10032937|FG001|NOT COMPLETED|Overall Study||194
8969323|NCT01909453|10032938|FG002|NOT COMPLETED|Overall Study||191
8969324|NCT01909453|10032939|FG003|NOT COMPLETED|Overall Study||258
8969325|NCT01909453|10032940|FG004|NOT COMPLETED|Overall Study||86
8969326|NCT01891396|10032961|FG000|STARTED|Overall Study||149
8969327|NCT01891396|10032962|FG001|STARTED|Overall Study||150
8969328|NCT01891396|10032963|FG002|STARTED|Overall Study||69
8969329|NCT01891396|10032961|FG000|Received Study Injection|Overall Study||149
8969330|NCT01891396|10032962|FG001|Received Study Injection|Overall Study||150
8969331|NCT01891396|10032963|FG002|Received Study Injection|Overall Study||69
8969332|NCT01891396|10032961|FG000|COMPLETED|Overall Study||145
8969333|NCT01891396|10032962|FG001|COMPLETED|Overall Study||145
8969334|NCT01891396|10032963|FG002|COMPLETED|Overall Study||66
8969335|NCT01891396|10032961|FG000|NOT COMPLETED|Overall Study||4
8969336|NCT01891396|10032962|FG001|NOT COMPLETED|Overall Study||5
8969337|NCT01891396|10032963|FG002|NOT COMPLETED|Overall Study||3
8969338|NCT01589523|10032975|FG000|STARTED|Overall Study||5
8969339|NCT01589523|10032975|FG000|COMPLETED|Overall Study||4
8969340|NCT01589523|10032975|FG000|NOT COMPLETED|Overall Study||1
8969341|NCT01525901|10032985|FG000|STARTED|Period 1: 12 Weeks||5
8969342|NCT01525901|10032986|FG001|STARTED|Period 1: 12 Weeks||4
8969343|NCT01525901|10032987|FG002|STARTED|Period 1: 12 Weeks||5
8969344|NCT01525901|10032988|FG003|STARTED|Period 1: 12 Weeks||5
8969345|NCT01525901|10032985|FG000|COMPLETED|Period 1: 12 Weeks||5
8969346|NCT01525901|10032986|FG001|COMPLETED|Period 1: 12 Weeks||4
8969347|NCT01525901|10032987|FG002|COMPLETED|Period 1: 12 Weeks||5
8969348|NCT01525901|10032988|FG003|COMPLETED|Period 1: 12 Weeks||5
8969349|NCT01525901|10032985|FG000|NOT COMPLETED|Period 1: 12 Weeks||0
8969350|NCT01525901|10032986|FG001|NOT COMPLETED|Period 1: 12 Weeks||0
8969351|NCT01525901|10032987|FG002|NOT COMPLETED|Period 1: 12 Weeks||0
8969352|NCT01525901|10032988|FG003|NOT COMPLETED|Period 1: 12 Weeks||0
8969353|NCT01525901|10032985|FG000|STARTED|Washout 4 Weeks||5
8969354|NCT01525901|10032986|FG001|STARTED|Washout 4 Weeks||4
8969355|NCT01525901|10032987|FG002|STARTED|Washout 4 Weeks||5
8969356|NCT01525901|10032988|FG003|STARTED|Washout 4 Weeks||5
8969357|NCT01525901|10032985|FG000|COMPLETED|Washout 4 Weeks||5
8969358|NCT01525901|10032986|FG001|COMPLETED|Washout 4 Weeks||4
8969359|NCT01525901|10032987|FG002|COMPLETED|Washout 4 Weeks||5
8969360|NCT01525901|10032988|FG003|COMPLETED|Washout 4 Weeks||5
8969361|NCT01525901|10032985|FG000|NOT COMPLETED|Washout 4 Weeks||0
8969362|NCT01525901|10032986|FG001|NOT COMPLETED|Washout 4 Weeks||0
8969363|NCT01525901|10032987|FG002|NOT COMPLETED|Washout 4 Weeks||0
8969364|NCT01525901|10032988|FG003|NOT COMPLETED|Washout 4 Weeks||0
8969365|NCT01525901|10032985|FG000|STARTED|Period 2: 12 Weeks||5
8969366|NCT01525901|10032986|FG001|STARTED|Period 2: 12 Weeks||4
8969367|NCT01525901|10032987|FG002|STARTED|Period 2: 12 Weeks||5
8969368|NCT01525901|10032988|FG003|STARTED|Period 2: 12 Weeks||5
8969369|NCT01525901|10032985|FG000|COMPLETED|Period 2: 12 Weeks||5
8969370|NCT01525901|10032986|FG001|COMPLETED|Period 2: 12 Weeks||3
8969371|NCT01525901|10032987|FG002|COMPLETED|Period 2: 12 Weeks||5
8969372|NCT01525901|10032988|FG003|COMPLETED|Period 2: 12 Weeks||5
8969373|NCT01525901|10032985|FG000|NOT COMPLETED|Period 2: 12 Weeks||0
8969374|NCT01525901|10032986|FG001|NOT COMPLETED|Period 2: 12 Weeks||1
8969375|NCT01525901|10032987|FG002|NOT COMPLETED|Period 2: 12 Weeks||0
8969376|NCT01525901|10032988|FG003|NOT COMPLETED|Period 2: 12 Weeks||0
8969377|NCT01354431|10033001|FG000|STARTED|Pre-Treatment Period||60
8969378|NCT01354431|10033002|FG001|STARTED|Pre-Treatment Period||54
8969379|NCT01354431|10033003|FG002|STARTED|Pre-Treatment Period||54
8969380|NCT01354431|10033001|FG000|COMPLETED|Pre-Treatment Period||59
8969381|NCT01354431|10033002|FG001|COMPLETED|Pre-Treatment Period||54
8969382|NCT01354431|10033003|FG002|COMPLETED|Pre-Treatment Period||54
8969383|NCT01354431|10033001|FG000|NOT COMPLETED|Pre-Treatment Period||1
8969384|NCT01354431|10033002|FG001|NOT COMPLETED|Pre-Treatment Period||0
8969385|NCT01354431|10033003|FG002|NOT COMPLETED|Pre-Treatment Period||0
8969386|NCT01354431|10033001|FG000|STARTED|Treatment Period||59
8969387|NCT01354431|10033002|FG001|STARTED|Treatment Period||54
8969388|NCT01354431|10033003|FG002|STARTED|Treatment Period||54
8969389|NCT01354431|10033001|FG000|COMPLETED|Treatment Period||0
8969390|NCT01354431|10033002|FG001|COMPLETED|Treatment Period||0
8969391|NCT01354431|10033003|FG002|COMPLETED|Treatment Period||0
8631911|NCT00542425|9671778|FG002|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|10
8631912|NCT00542425|9671779|FG003|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|7
8691279|NCT00853905|9736500|FG001|NOT COMPLETED|Overall Study||4
8969392|NCT01354431|10033001|FG000|NOT COMPLETED|Treatment Period||59
8969393|NCT01354431|10033002|FG001|NOT COMPLETED|Treatment Period||54
8969394|NCT01354431|10033003|FG002|NOT COMPLETED|Treatment Period||54
8969395|NCT01003691|10033015|FG000|STARTED|Overall Study||6
8969396|NCT01003691|10033016|FG001|STARTED|Overall Study||6
8969397|NCT01003691|10033017|FG002|STARTED|Overall Study||6
8969398|NCT01003691|10033018|FG003|STARTED|Overall Study||6
8969399|NCT01003691|10033015|FG000|COMPLETED|Overall Study||6
8969400|NCT01003691|10033016|FG001|COMPLETED|Overall Study||6
8969401|NCT01003691|10033017|FG002|COMPLETED|Overall Study||6
8969402|NCT01003691|10033018|FG003|COMPLETED|Overall Study||5
8969403|NCT01003691|10033015|FG000|NOT COMPLETED|Overall Study||0
8969404|NCT01003691|10033016|FG001|NOT COMPLETED|Overall Study||0
8969405|NCT01003691|10033017|FG002|NOT COMPLETED|Overall Study||0
8969406|NCT01003691|10033018|FG003|NOT COMPLETED|Overall Study||1
8969407|NCT02593903|10033031|FG000|STARTED|Overall Study||35
8969408|NCT02593903|10033032|FG001|STARTED|Overall Study||32
8969409|NCT02593903|10033031|FG000|COMPLETED|Overall Study||35
8969410|NCT02593903|10033032|FG001|COMPLETED|Overall Study||31
8969411|NCT02593903|10033031|FG000|NOT COMPLETED|Overall Study||0
8969412|NCT02593903|10033032|FG001|NOT COMPLETED|Overall Study||1
8969413|NCT02594098|10033040|FG000|STARTED|Overall Study||27
8969414|NCT02594098|10033041|FG001|STARTED|Overall Study||14
8969415|NCT02594098|10033040|FG000|COMPLETED|Overall Study||1
8969416|NCT02594098|10033041|FG001|COMPLETED|Overall Study||1
8969417|NCT02594098|10033040|FG000|NOT COMPLETED|Overall Study||26
8969418|NCT02594098|10033041|FG001|NOT COMPLETED|Overall Study||13
8969419|NCT02594111|10033051|FG000|STARTED|Overall Study||366
8969420|NCT02594111|10033052|FG001|STARTED|Overall Study||348
8969421|NCT02594111|10033051|FG000|COMPLETED|Overall Study||366
8969422|NCT02594111|10033052|FG001|COMPLETED|Overall Study||348
8969423|NCT02594111|10033051|FG000|NOT COMPLETED|Overall Study||0
8969424|NCT02594111|10033052|FG001|NOT COMPLETED|Overall Study||0
8969425|NCT02594163|10033060|FG000|STARTED|Treatment Period||12
8969426|NCT02594163|10033061|FG001|STARTED|Treatment Period||13
8969427|NCT02594163|10033060|FG000|COMPLETED|Treatment Period||5
8969428|NCT02594163|10033061|FG001|COMPLETED|Treatment Period||1
8969429|NCT02594163|10033060|FG000|NOT COMPLETED|Treatment Period||7
8969430|NCT02594163|10033061|FG001|NOT COMPLETED|Treatment Period||12
8969431|NCT02594163|10033060|FG000|STARTED|Follow-up Period|All participants were to be followed after treatment|12
8969432|NCT02594163|10033061|FG001|STARTED|Follow-up Period|All participants were to be followed after treatment|13
8969433|NCT02594163|10033060|FG000|COMPLETED|Follow-up Period||1
8969434|NCT02594163|10033061|FG001|COMPLETED|Follow-up Period||1
8969435|NCT02594163|10033060|FG000|NOT COMPLETED|Follow-up Period||11
8969436|NCT02594163|10033061|FG001|NOT COMPLETED|Follow-up Period||12
8969437|NCT02594644|10033069|FG000|STARTED|Overall Study||16
8969438|NCT02594644|10033070|FG001|STARTED|Overall Study||16
8969439|NCT02594644|10033069|FG000|COMPLETED|Overall Study||16
8969440|NCT02594644|10033070|FG001|COMPLETED|Overall Study||15
8969441|NCT02594644|10033069|FG000|NOT COMPLETED|Overall Study||0
8969442|NCT02594644|10033070|FG001|NOT COMPLETED|Overall Study||1
8969443|NCT02594826|10033088|FG000|STARTED|Overall Study||347
8969444|NCT02594826|10033089|FG001|STARTED|Overall Study||358
8969445|NCT02594826|10033088|FG000|COMPLETED|Overall Study||290
8969446|NCT02594826|10033089|FG001|COMPLETED|Overall Study||298
8969447|NCT02594826|10033088|FG000|NOT COMPLETED|Overall Study||57
8969448|NCT02594826|10033089|FG001|NOT COMPLETED|Overall Study||60
8969449|NCT02595008|10033097|FG000|STARTED|Overall Study||20
8969450|NCT02595008|10033098|FG001|STARTED|Overall Study||4
8969451|NCT02595008|10033097|FG000|COMPLETED|Overall Study||19
8969452|NCT02595008|10033098|FG001|COMPLETED|Overall Study||4
8969453|NCT02595008|10033097|FG000|NOT COMPLETED|Overall Study||1
8969454|NCT02595008|10033098|FG001|NOT COMPLETED|Overall Study||0
8969455|NCT02595073|10033106|FG000|STARTED|Overall Study||61
8969456|NCT02595073|10033107|FG001|STARTED|Overall Study||63
8969457|NCT02595073|10033106|FG000|COMPLETED|Overall Study||59
8969458|NCT02595073|10033107|FG001|COMPLETED|Overall Study||62
8969459|NCT02595073|10033106|FG000|NOT COMPLETED|Overall Study||2
8969460|NCT02595073|10033107|FG001|NOT COMPLETED|Overall Study||1
8969461|NCT02595398|10033115|FG000|STARTED|Overall Study||96
8969462|NCT02595398|10033116|FG001|STARTED|Overall Study||64
8969463|NCT02595398|10033115|FG000|Intention-to-Treat (ITT) Population|Overall Study||96
8969464|NCT02595398|10033116|FG001|Intention-to-Treat (ITT) Population|Overall Study||64
8969465|NCT02595398|10033115|FG000|Safety Population|Overall Study||96
8969466|NCT02595398|10033116|FG001|Safety Population|Overall Study||64
8969467|NCT02595398|10033115|FG000|COMPLETED|Overall Study||92
8969468|NCT02595398|10033116|FG001|COMPLETED|Overall Study||63
8969469|NCT02595398|10033115|FG000|NOT COMPLETED|Overall Study||4
8969470|NCT02595398|10033116|FG001|NOT COMPLETED|Overall Study||1
8969471|NCT02595437|10033122|FG000|STARTED|Triferic Via IV||22
8969472|NCT02595437|10033122|FG000|COMPLETED|Triferic Via IV||21
8969473|NCT02595437|10033122|FG000|NOT COMPLETED|Triferic Via IV||1
8969474|NCT02595437|10033122|FG000|STARTED|Triferic Via Hemodialysate||21
8969475|NCT02595437|10033122|FG000|COMPLETED|Triferic Via Hemodialysate||21
8969476|NCT02595437|10033122|FG000|NOT COMPLETED|Triferic Via Hemodialysate||0
8969477|NCT02595450|10033134|FG000|STARTED|Overall Study||299
8969478|NCT02595450|10033134|FG000|Treated|Overall Study||291
8969479|NCT02595450|10033134|FG000|COMPLETED|Overall Study||218
8969480|NCT02595450|10033134|FG000|NOT COMPLETED|Overall Study||81
8969481|NCT02595502|10033138|FG000|STARTED|Period 1||143
8969482|NCT02595502|10033139|FG001|STARTED|Period 1||142
8969483|NCT02595502|10033138|FG000|COMPLETED|Period 1||142
8969484|NCT02595502|10033139|FG001|COMPLETED|Period 1||140
8969485|NCT02595502|10033138|FG000|NOT COMPLETED|Period 1||1
8969486|NCT02595502|10033139|FG001|NOT COMPLETED|Period 1||2
8969487|NCT02595502|10033138|FG000|STARTED|Period 2||142
8969488|NCT02595502|10033139|FG001|STARTED|Period 2||140
8969489|NCT02595502|10033138|FG000|COMPLETED|Period 2||141
8969490|NCT02595502|10033139|FG001|COMPLETED|Period 2||138
8969491|NCT02595502|10033138|FG000|NOT COMPLETED|Period 2||1
8969492|NCT02595502|10033139|FG001|NOT COMPLETED|Period 2||2
8969493|NCT02595502|10033138|FG000|STARTED|Period 3||141
8969494|NCT02595502|10033139|FG001|STARTED|Period 3||138
8969495|NCT02595502|10033138|FG000|COMPLETED|Period 3||140
8969496|NCT02595502|10033139|FG001|COMPLETED|Period 3||136
8691280|NCT00853957|9736511|FG000|STARTED|Overall Study||220
8969497|NCT02595502|10033138|FG000|NOT COMPLETED|Period 3||1
8969498|NCT02595502|10033139|FG001|NOT COMPLETED|Period 3||2
8969499|NCT02595528|10033149|FG000|STARTED|Overall Study||41
8969500|NCT02595528|10033150|FG001|STARTED|Overall Study||40
8969501|NCT02595528|10033151|FG002|STARTED|Overall Study||42
8969502|NCT02595528|10033152|FG003|STARTED|Overall Study||40
8969503|NCT02595528|10033149|FG000|COMPLETED|Overall Study||39
8969504|NCT02595528|10033150|FG001|COMPLETED|Overall Study||37
8969505|NCT02595528|10033151|FG002|COMPLETED|Overall Study||41
8969506|NCT02595528|10033152|FG003|COMPLETED|Overall Study||36
8969507|NCT02595528|10033149|FG000|NOT COMPLETED|Overall Study||2
8969508|NCT02595528|10033150|FG001|NOT COMPLETED|Overall Study||3
8969509|NCT02595528|10033151|FG002|NOT COMPLETED|Overall Study||1
8969510|NCT02595528|10033152|FG003|NOT COMPLETED|Overall Study||4
8969511|NCT02595567|10033162|FG000|STARTED|Overall Study||25
8969512|NCT02595567|10033162|FG000|COMPLETED|Overall Study||25
8969513|NCT02595567|10033162|FG000|NOT COMPLETED|Overall Study||0
8969514|NCT02595684|10033168|FG000|STARTED|Overall Study||9
8969515|NCT02595684|10033169|FG001|STARTED|Overall Study||9
8969516|NCT02595684|10033168|FG000|COMPLETED|Overall Study||9
8969517|NCT02595684|10033169|FG001|COMPLETED|Overall Study||9
8969518|NCT02595684|10033168|FG000|NOT COMPLETED|Overall Study||0
8969519|NCT02595684|10033169|FG001|NOT COMPLETED|Overall Study||0
8969520|NCT02595723|10033178|FG000|STARTED|First Intervention (4 Days)||8
8969521|NCT02595723|10033179|FG001|STARTED|First Intervention (4 Days)||6
8969522|NCT02595723|10033180|FG002|STARTED|First Intervention (4 Days)||7
8969523|NCT02595723|10033178|FG000|COMPLETED|First Intervention (4 Days)||8
8969524|NCT02595723|10033179|FG001|COMPLETED|First Intervention (4 Days)||6
8969525|NCT02595723|10033180|FG002|COMPLETED|First Intervention (4 Days)||7
8969526|NCT02595723|10033178|FG000|NOT COMPLETED|First Intervention (4 Days)||0
8969527|NCT02595723|10033179|FG001|NOT COMPLETED|First Intervention (4 Days)||0
8969528|NCT02595723|10033180|FG002|NOT COMPLETED|First Intervention (4 Days)||0
8969529|NCT02595723|10033178|FG000|STARTED|First Washout (21 Days)||8
8969530|NCT02595723|10033179|FG001|STARTED|First Washout (21 Days)||6
8969531|NCT02595723|10033180|FG002|STARTED|First Washout (21 Days)||7
8969532|NCT02595723|10033178|FG000|COMPLETED|First Washout (21 Days)||6
8969533|NCT02595723|10033179|FG001|COMPLETED|First Washout (21 Days)||6
8969534|NCT02595723|10033180|FG002|COMPLETED|First Washout (21 Days)||7
8969535|NCT02595723|10033178|FG000|NOT COMPLETED|First Washout (21 Days)||2
8969536|NCT02595723|10033179|FG001|NOT COMPLETED|First Washout (21 Days)||0
8969537|NCT02595723|10033180|FG002|NOT COMPLETED|First Washout (21 Days)||0
8969538|NCT02595723|10033178|FG000|STARTED|Second Intervention (4 Days)||6
8969539|NCT02595723|10033179|FG001|STARTED|Second Intervention (4 Days)||6
8969540|NCT02595723|10033180|FG002|STARTED|Second Intervention (4 Days)||7
8969541|NCT02595723|10033178|FG000|COMPLETED|Second Intervention (4 Days)||6
8969542|NCT02595723|10033179|FG001|COMPLETED|Second Intervention (4 Days)||6
8969543|NCT02595723|10033180|FG002|COMPLETED|Second Intervention (4 Days)||7
8969544|NCT02595723|10033178|FG000|NOT COMPLETED|Second Intervention (4 Days)||0
8969545|NCT02595723|10033179|FG001|NOT COMPLETED|Second Intervention (4 Days)||0
8969546|NCT02595723|10033180|FG002|NOT COMPLETED|Second Intervention (4 Days)||0
8969547|NCT02595723|10033178|FG000|STARTED|Second Washout (21 Days)||6
8969548|NCT02595723|10033179|FG001|STARTED|Second Washout (21 Days)||6
8969549|NCT02595723|10033180|FG002|STARTED|Second Washout (21 Days)||7
8969550|NCT02595723|10033178|FG000|COMPLETED|Second Washout (21 Days)||6
8969551|NCT02595723|10033179|FG001|COMPLETED|Second Washout (21 Days)||5
8969552|NCT02595723|10033180|FG002|COMPLETED|Second Washout (21 Days)||7
8969553|NCT02595723|10033178|FG000|NOT COMPLETED|Second Washout (21 Days)||0
8969554|NCT02595723|10033179|FG001|NOT COMPLETED|Second Washout (21 Days)||1
8969555|NCT02595723|10033180|FG002|NOT COMPLETED|Second Washout (21 Days)||0
8969556|NCT02595723|10033178|FG000|STARTED|Third Intervention (4 Days)||6
8969557|NCT02595723|10033179|FG001|STARTED|Third Intervention (4 Days)||5
8969558|NCT02595723|10033180|FG002|STARTED|Third Intervention (4 Days)||7
8969559|NCT02595723|10033178|FG000|COMPLETED|Third Intervention (4 Days)||6
8969560|NCT02595723|10033179|FG001|COMPLETED|Third Intervention (4 Days)||5
8969561|NCT02595723|10033180|FG002|COMPLETED|Third Intervention (4 Days)||7
8969562|NCT02595723|10033178|FG000|NOT COMPLETED|Third Intervention (4 Days)||0
8969563|NCT02595723|10033179|FG001|NOT COMPLETED|Third Intervention (4 Days)||0
8969564|NCT02595723|10033180|FG002|NOT COMPLETED|Third Intervention (4 Days)||0
8969565|NCT02595749|10033190|FG000|STARTED|Overall Study||45
8969566|NCT02595749|10033191|FG001|STARTED|Overall Study||38
8969567|NCT02595749|10033190|FG000|COMPLETED|Overall Study||33
8969568|NCT02595749|10033191|FG001|COMPLETED|Overall Study||31
8969569|NCT02595749|10033190|FG000|NOT COMPLETED|Overall Study||12
8969570|NCT02595749|10033191|FG001|NOT COMPLETED|Overall Study||7
8969571|NCT02595970|10033197|FG000|STARTED|Overall Study||120
8969572|NCT02595970|10033197|FG000|COMPLETED|Overall Study|Out of 100 patients who completed treatment period 2, 20 patients completed the extension period.|100
8969573|NCT02595970|10033197|FG000|NOT COMPLETED|Overall Study||20
9038207|NCT03330119|10099537|FG001|COMPLETED|Overall Study||571
9038208|NCT03330119|10099536|FG000|NOT COMPLETED|Overall Study||166
9038209|NCT03330119|10099537|FG001|NOT COMPLETED|Overall Study||282
9038210|NCT03330236|10099545|FG000|STARTED|Overall Study||779
9038211|NCT03330236|10099546|FG001|STARTED|Overall Study||781
9038212|NCT03330236|10099545|FG000|Received Surgery|Overall Study||779
9038213|NCT03330236|10099546|FG001|Received Surgery|Overall Study||781
9038214|NCT03330236|10099545|FG000|Modified ITT|Overall Study||773
9038215|NCT03330236|10099546|FG001|Modified ITT|Overall Study||774
9038216|NCT03330236|10099545|FG000|COMPLETED|Overall Study||679
9038217|NCT03330236|10099546|FG001|COMPLETED|Overall Study||697
9038218|NCT03330236|10099545|FG000|NOT COMPLETED|Overall Study||100
9038219|NCT03330236|10099546|FG001|NOT COMPLETED|Overall Study||84
9038220|NCT03330262|10099554|FG000|STARTED|First Six Weeks||7
9038221|NCT03330262|10099555|FG001|STARTED|First Six Weeks||6
9038222|NCT03330262|10099554|FG000|COMPLETED|First Six Weeks||7
9038223|NCT03330262|10099555|FG001|COMPLETED|First Six Weeks||6
9038224|NCT03330262|10099554|FG000|NOT COMPLETED|First Six Weeks||0
8577572|NCT00159419|9610332|FG001|NOT COMPLETED|Overall Study||0
9038225|NCT03330262|10099555|FG001|NOT COMPLETED|First Six Weeks||0
9038226|NCT03330262|10099554|FG000|STARTED|Second Six Weeks||7
9038227|NCT03330262|10099555|FG001|STARTED|Second Six Weeks||6
9038228|NCT03330262|10099554|FG000|COMPLETED|Second Six Weeks||5
9038229|NCT03330262|10099555|FG001|COMPLETED|Second Six Weeks||5
9038230|NCT03330262|10099554|FG000|NOT COMPLETED|Second Six Weeks||2
8969574|NCT02595983|10033201|FG000|STARTED|Overall Study||12
8969575|NCT02595983|10033201|FG000|COMPLETED|Overall Study||8
8969576|NCT02595983|10033201|FG000|NOT COMPLETED|Overall Study||4
8969577|NCT02596009|10033206|FG000|STARTED|Overall Study||14
8969578|NCT02596009|10033207|FG001|STARTED|Overall Study||16
8969579|NCT02596009|10033208|FG002|STARTED|Overall Study||16
8969580|NCT02596009|10033209|FG003|STARTED|Overall Study||16
8570840|NCT00105989|9603002|FG000|STARTED|Maintenance - Double-Blind:Week 34-86||146
8570841|NCT00105989|9603003|FG001|STARTED|Maintenance - Double-Blind:Week 34-86||142
8570842|NCT00105989|9603002|FG000|COMPLETED|Maintenance - Double-Blind:Week 34-86||96
8570843|NCT00105989|9603003|FG001|COMPLETED|Maintenance - Double-Blind:Week 34-86||73
8570844|NCT00105989|9603002|FG000|NOT COMPLETED|Maintenance - Double-Blind:Week 34-86||50
8570845|NCT00105989|9603003|FG001|NOT COMPLETED|Maintenance - Double-Blind:Week 34-86||69
8570846|NCT00106002|9603019|FG000|STARTED|Overall Study||37
8570847|NCT00106002|9603019|FG000|COMPLETED|Overall Study|Completed means that the patient was evaluable for response.|35
8570848|NCT00106002|9603019|FG000|NOT COMPLETED|Overall Study||2
8570849|NCT00106028|9603025|FG000|STARTED|Overall Study|ITT Population: Patients Randomized and Received at least 1 Dose of Study Drug|49
8570850|NCT00106028|9603026|FG001|STARTED|Overall Study|ITT Population: Patients Randomized and Received at least 1 Dose of Study Drug|94
8570851|NCT00106028|9603025|FG000|Month 12 Completed/Started Open Label|Overall Study||49
8570852|NCT00106028|9603026|FG001|Month 12 Completed/Started Open Label|Overall Study||87
8570853|NCT00106028|9603025|FG000|COMPLETED|Overall Study|Completed Month 36|43
8570854|NCT00106028|9603026|FG001|COMPLETED|Overall Study|Completed Month 36|82
8570855|NCT00106028|9603025|FG000|NOT COMPLETED|Overall Study||6
8570856|NCT00106028|9603026|FG001|NOT COMPLETED|Overall Study||12
8570857|NCT00106080|9603036|FG000|STARTED|Overall Study||194
8570858|NCT00106080|9603037|FG001|STARTED|Overall Study||182
8570859|NCT00106080|9603036|FG000|COMPLETED|Overall Study||151
8570860|NCT00106080|9603037|FG001|COMPLETED|Overall Study||155
8570861|NCT00106080|9603036|FG000|NOT COMPLETED|Overall Study||43
8570862|NCT00106080|9603037|FG001|NOT COMPLETED|Overall Study||27
8969581|NCT02596009|10033210|FG004|STARTED|Overall Study||18
8969582|NCT02596009|10033211|FG005|STARTED|Overall Study||17
8969583|NCT02596009|10033206|FG000|COMPLETED|Overall Study||14
8969584|NCT02596009|10033207|FG001|COMPLETED|Overall Study||15
8969585|NCT02596009|10033208|FG002|COMPLETED|Overall Study||16
8969586|NCT02596009|10033209|FG003|COMPLETED|Overall Study||16
8969587|NCT02596009|10033210|FG004|COMPLETED|Overall Study||18
8969588|NCT02596009|10033211|FG005|COMPLETED|Overall Study||17
8969589|NCT02596009|10033206|FG000|NOT COMPLETED|Overall Study||0
8969590|NCT02596009|10033207|FG001|NOT COMPLETED|Overall Study||1
8969591|NCT02596009|10033208|FG002|NOT COMPLETED|Overall Study||0
8969592|NCT02596009|10033209|FG003|NOT COMPLETED|Overall Study||0
8969593|NCT02596009|10033210|FG004|NOT COMPLETED|Overall Study||0
8969594|NCT02596009|10033211|FG005|NOT COMPLETED|Overall Study||0
8969595|NCT02596022|10033219|FG000|STARTED|Overall Study||10
8969596|NCT02596022|10033220|FG001|STARTED|Overall Study||8
8969597|NCT02596022|10033219|FG000|COMPLETED|Overall Study||10
8969598|NCT02596022|10033220|FG001|COMPLETED|Overall Study||8
8969599|NCT02596022|10033219|FG000|NOT COMPLETED|Overall Study||0
8969600|NCT02596022|10033220|FG001|NOT COMPLETED|Overall Study||0
8969601|NCT02596230|10033231|FG000|STARTED|Objective 1, One Visit During 14 Days||3714
8969602|NCT02596230|10033232|FG001|STARTED|Objective 1, One Visit During 14 Days||1006
8969603|NCT02596230|10033233|FG002|STARTED|Objective 1, One Visit During 14 Days||0
8969604|NCT02596230|10033234|FG003|STARTED|Objective 1, One Visit During 14 Days||1375
8969605|NCT02596230|10033235|FG004|STARTED|Objective 1, One Visit During 14 Days||0
8969606|NCT02596230|10033231|FG000|COMPLETED|Objective 1, One Visit During 14 Days||3714
8969607|NCT02596230|10033232|FG001|COMPLETED|Objective 1, One Visit During 14 Days||1006
8969608|NCT02596230|10033233|FG002|COMPLETED|Objective 1, One Visit During 14 Days||0
8969609|NCT02596230|10033234|FG003|COMPLETED|Objective 1, One Visit During 14 Days||1375
8969610|NCT02596230|10033235|FG004|COMPLETED|Objective 1, One Visit During 14 Days||0
8969611|NCT02596230|10033231|FG000|NOT COMPLETED|Objective 1, One Visit During 14 Days||0
8969612|NCT02596230|10033232|FG001|NOT COMPLETED|Objective 1, One Visit During 14 Days||0
8969613|NCT02596230|10033233|FG002|NOT COMPLETED|Objective 1, One Visit During 14 Days||0
8969614|NCT02596230|10033234|FG003|NOT COMPLETED|Objective 1, One Visit During 14 Days||0
8969615|NCT02596230|10033235|FG004|NOT COMPLETED|Objective 1, One Visit During 14 Days||0
8969616|NCT02596230|10033231|FG000|STARTED|Screening Period for Objective 2||3714
8969617|NCT02596230|10033232|FG001|STARTED|Screening Period for Objective 2||1006
8969618|NCT02596230|10033233|FG002|STARTED|Screening Period for Objective 2|Participants entering the study after the completion of objective 1.|910
8969619|NCT02596230|10033234|FG003|STARTED|Screening Period for Objective 2||1375
8969620|NCT02596230|10033235|FG004|STARTED|Screening Period for Objective 2|Participants entering the study after the completion of objective 1.|792
8969621|NCT02596230|10033231|FG000|COMPLETED|Screening Period for Objective 2||0
8969622|NCT02596230|10033232|FG001|COMPLETED|Screening Period for Objective 2||778
8969623|NCT02596230|10033233|FG002|COMPLETED|Screening Period for Objective 2||910
8969624|NCT02596230|10033234|FG003|COMPLETED|Screening Period for Objective 2||529
8969625|NCT02596230|10033235|FG004|COMPLETED|Screening Period for Objective 2||792
8969626|NCT02596230|10033231|FG000|NOT COMPLETED|Screening Period for Objective 2||3714
8969627|NCT02596230|10033232|FG001|NOT COMPLETED|Screening Period for Objective 2||228
8969628|NCT02596230|10033233|FG002|NOT COMPLETED|Screening Period for Objective 2||0
8969629|NCT02596230|10033234|FG003|NOT COMPLETED|Screening Period for Objective 2||846
8969630|NCT02596230|10033235|FG004|NOT COMPLETED|Screening Period for Objective 2||0
8969631|NCT02596230|10033231|FG000|STARTED|Objective 2, One Year||0
8969632|NCT02596230|10033232|FG001|STARTED|Objective 2, One Year||778
8969633|NCT02596230|10033233|FG002|STARTED|Objective 2, One Year||910
8969634|NCT02596230|10033234|FG003|STARTED|Objective 2, One Year||529
8969635|NCT02596230|10033235|FG004|STARTED|Objective 2, One Year||792
8969636|NCT02596230|10033231|FG000|COMPLETED|Objective 2, One Year||0
8969637|NCT02596230|10033232|FG001|COMPLETED|Objective 2, One Year||710
8969638|NCT02596230|10033233|FG002|COMPLETED|Objective 2, One Year||812
8969639|NCT02596230|10033234|FG003|COMPLETED|Objective 2, One Year||471
8969640|NCT02596230|10033235|FG004|COMPLETED|Objective 2, One Year||714
8969641|NCT02596230|10033231|FG000|NOT COMPLETED|Objective 2, One Year||0
8969642|NCT02596230|10033232|FG001|NOT COMPLETED|Objective 2, One Year||68
8969643|NCT02596230|10033233|FG002|NOT COMPLETED|Objective 2, One Year||98
8969644|NCT02596230|10033234|FG003|NOT COMPLETED|Objective 2, One Year||58
8969645|NCT02596230|10033235|FG004|NOT COMPLETED|Objective 2, One Year||78
8969646|NCT02596321|10033247|FG000|STARTED|Overall Study||56
8969647|NCT02596321|10033248|FG001|STARTED|Overall Study||56
8969648|NCT02596321|10033247|FG000|COMPLETED|Overall Study||53
8969649|NCT02596321|10033248|FG001|COMPLETED|Overall Study||56
8969650|NCT02596321|10033247|FG000|NOT COMPLETED|Overall Study||3
8969651|NCT02596321|10033248|FG001|NOT COMPLETED|Overall Study||0
8570863|NCT00106106|9603045|FG000|STARTED|Overall Study||26
8570864|NCT00106106|9603046|FG001|STARTED|Overall Study||23
8570865|NCT00106106|9603045|FG000|Completed Both MRS Scans|Overall Study||18
8570866|NCT00106106|9603046|FG001|Completed Both MRS Scans|Overall Study||15
8969652|NCT02596451|10033257|FG000|STARTED|Overall Study||385
8969653|NCT02596451|10033258|FG001|STARTED|Overall Study||392
8969654|NCT02596451|10033259|FG002|STARTED|Overall Study||387
8969655|NCT02596451|10033257|FG000|COMPLETED|Overall Study||381
8969656|NCT02596451|10033258|FG001|COMPLETED|Overall Study||374
8969657|NCT02596451|10033259|FG002|COMPLETED|Overall Study||373
8969658|NCT02596451|10033257|FG000|NOT COMPLETED|Overall Study||4
8969659|NCT02596451|10033258|FG001|NOT COMPLETED|Overall Study||18
8969660|NCT02596451|10033259|FG002|NOT COMPLETED|Overall Study||14
8969661|NCT02596620|10033268|FG000|STARTED|Overall Study|Started from 1st October 2013|82
8969662|NCT02596620|10033269|FG001|STARTED|Overall Study|Started from 1st October 2013|82
8969663|NCT02596620|10033268|FG000|COMPLETED|Overall Study|Completed on 30th September 2015|81
8969664|NCT02596620|10033269|FG001|COMPLETED|Overall Study|Completed on 30th September 2015|81
8969665|NCT02596620|10033268|FG000|NOT COMPLETED|Overall Study||1
8969666|NCT02596620|10033269|FG001|NOT COMPLETED|Overall Study||1
8969667|NCT02596711|10033278|FG000|STARTED|Overall Study||9
8969668|NCT02596711|10033279|FG001|STARTED|Overall Study||8
8969669|NCT02596711|10033280|FG002|STARTED|Overall Study||8
8969670|NCT02596711|10033278|FG000|Visit 2|Overall Study||9
8969671|NCT02596711|10033279|FG001|Visit 2|Overall Study||7
8969672|NCT02596711|10033280|FG002|Visit 2|Overall Study||6
8969673|NCT02596711|10033278|FG000|Visit 3|Overall Study||7
8969674|NCT02596711|10033279|FG001|Visit 3|Overall Study||8
8969675|NCT02596711|10033280|FG002|Visit 3|Overall Study||6
8969676|NCT02596711|10033278|FG000|3 Month Follow-up|Overall Study||8
8969677|NCT02596711|10033279|FG001|3 Month Follow-up|Overall Study||6
8969678|NCT02596711|10033280|FG002|3 Month Follow-up|Overall Study||6
8969679|NCT02596711|10033278|FG000|6 Month Follow-up|Overall Study||8
8969680|NCT02596711|10033279|FG001|6 Month Follow-up|Overall Study||6
8969681|NCT02596711|10033280|FG002|6 Month Follow-up|Overall Study||5
8969682|NCT02596711|10033278|FG000|COMPLETED|Overall Study||8
8969683|NCT02596711|10033279|FG001|COMPLETED|Overall Study||6
8969684|NCT02596711|10033280|FG002|COMPLETED|Overall Study||5
8969685|NCT02596711|10033278|FG000|NOT COMPLETED|Overall Study||1
8969686|NCT02596711|10033279|FG001|NOT COMPLETED|Overall Study||2
8969687|NCT02596711|10033280|FG002|NOT COMPLETED|Overall Study||3
8969688|NCT02596750|10033290|FG000|STARTED|Baseline||21
8969689|NCT02596750|10033291|FG001|STARTED|Baseline||21
8969690|NCT02596750|10033290|FG000|COMPLETED|Baseline||21
8969691|NCT02596750|10033291|FG001|COMPLETED|Baseline||21
8969692|NCT02596750|10033290|FG000|NOT COMPLETED|Baseline||0
8969693|NCT02596750|10033291|FG001|NOT COMPLETED|Baseline||0
8969694|NCT02596750|10033290|FG000|STARTED|2 Minutes||21
8969695|NCT02596750|10033291|FG001|STARTED|2 Minutes||21
8969696|NCT02596750|10033290|FG000|COMPLETED|2 Minutes||21
8969697|NCT02596750|10033291|FG001|COMPLETED|2 Minutes||21
8969698|NCT02596750|10033290|FG000|NOT COMPLETED|2 Minutes||0
8969699|NCT02596750|10033291|FG001|NOT COMPLETED|2 Minutes||0
8969700|NCT02596750|10033290|FG000|STARTED|5 Minutes||21
8969701|NCT02596750|10033291|FG001|STARTED|5 Minutes||21
8969702|NCT02596750|10033290|FG000|COMPLETED|5 Minutes||21
8969703|NCT02596750|10033291|FG001|COMPLETED|5 Minutes||21
8969704|NCT02596750|10033290|FG000|NOT COMPLETED|5 Minutes||0
8969705|NCT02596750|10033291|FG001|NOT COMPLETED|5 Minutes||0
8969706|NCT02596750|10033290|FG000|STARTED|10 Minutes||21
8969707|NCT02596750|10033291|FG001|STARTED|10 Minutes||21
8969708|NCT02596750|10033290|FG000|COMPLETED|10 Minutes||21
8969709|NCT02596750|10033291|FG001|COMPLETED|10 Minutes||21
8631913|NCT00542425|9671780|FG004|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|14
8631914|NCT00542425|9671776|FG000|COMPLETED|Extended 24 Weeks of Treatment||10
8631915|NCT00542425|9671777|FG001|COMPLETED|Extended 24 Weeks of Treatment||11
8631916|NCT00542425|9671778|FG002|COMPLETED|Extended 24 Weeks of Treatment||8
8631917|NCT00542425|9671779|FG003|COMPLETED|Extended 24 Weeks of Treatment||6
8969710|NCT02596750|10033290|FG000|NOT COMPLETED|10 Minutes||0
8969711|NCT02596750|10033291|FG001|NOT COMPLETED|10 Minutes||0
8969712|NCT02596750|10033290|FG000|STARTED|30 Minutes||21
8969713|NCT02596750|10033291|FG001|STARTED|30 Minutes||21
8969714|NCT02596750|10033290|FG000|COMPLETED|30 Minutes||21
8969715|NCT02596750|10033291|FG001|COMPLETED|30 Minutes||21
8969716|NCT02596750|10033290|FG000|NOT COMPLETED|30 Minutes||0
8969717|NCT02596750|10033291|FG001|NOT COMPLETED|30 Minutes||0
8969718|NCT02596854|10033298|FG000|STARTED|Overall Study||117
8969719|NCT02596854|10033298|FG000|COMPLETED|Overall Study||109
8969720|NCT02596854|10033298|FG000|NOT COMPLETED|Overall Study||8
8969721|NCT02596867|10033302|FG000|STARTED|Overall Study||2
8969722|NCT02596867|10033302|FG000|2 Patients Prospectively Recruited|Overall Study||2
8969723|NCT02596867|10033302|FG000|COMPLETED|Overall Study||2
8969724|NCT02596867|10033302|FG000|NOT COMPLETED|Overall Study||0
8969725|NCT02596893|10033311|FG000|STARTED|Overall Double-Blind Period Weeks 0-52||174
8969726|NCT02596893|10033312|FG001|STARTED|Overall Double-Blind Period Weeks 0-52||176
8969727|NCT02596893|10033313|FG002|STARTED|Overall Double-Blind Period Weeks 0-52||176
8969728|NCT02596893|10033314|FG003|STARTED|Overall Double-Blind Period Weeks 0-52||175
8969729|NCT02596893|10033311|FG000|COMPLETED|Overall Double-Blind Period Weeks 0-52||10
8969730|NCT02596893|10033312|FG001|COMPLETED|Overall Double-Blind Period Weeks 0-52||8
8969731|NCT02596893|10033313|FG002|COMPLETED|Overall Double-Blind Period Weeks 0-52||14
8969732|NCT02596893|10033314|FG003|COMPLETED|Overall Double-Blind Period Weeks 0-52||9
8969733|NCT02596893|10033311|FG000|NOT COMPLETED|Overall Double-Blind Period Weeks 0-52||164
8969734|NCT02596893|10033312|FG001|NOT COMPLETED|Overall Double-Blind Period Weeks 0-52||168
8969735|NCT02596893|10033313|FG002|NOT COMPLETED|Overall Double-Blind Period Weeks 0-52||162
8969736|NCT02596893|10033314|FG003|NOT COMPLETED|Overall Double-Blind Period Weeks 0-52||166
8969737|NCT02596893|10033311|FG000|STARTED|Follow-Up Period Weeks 0 to 52||57
8969738|NCT02596893|10033312|FG001|STARTED|Follow-Up Period Weeks 0 to 52||51
8969739|NCT02596893|10033313|FG002|STARTED|Follow-Up Period Weeks 0 to 52||56
8969740|NCT02596893|10033314|FG003|STARTED|Follow-Up Period Weeks 0 to 52||47
8969741|NCT02596893|10033311|FG000|COMPLETED|Follow-Up Period Weeks 0 to 52||57
8969742|NCT02596893|10033312|FG001|COMPLETED|Follow-Up Period Weeks 0 to 52||51
8969743|NCT02596893|10033313|FG002|COMPLETED|Follow-Up Period Weeks 0 to 52||56
8969744|NCT02596893|10033314|FG003|COMPLETED|Follow-Up Period Weeks 0 to 52||47
8969745|NCT02596893|10033311|FG000|NOT COMPLETED|Follow-Up Period Weeks 0 to 52||0
8969746|NCT02596893|10033312|FG001|NOT COMPLETED|Follow-Up Period Weeks 0 to 52||0
8969747|NCT02596893|10033313|FG002|NOT COMPLETED|Follow-Up Period Weeks 0 to 52||0
8969748|NCT02596893|10033314|FG003|NOT COMPLETED|Follow-Up Period Weeks 0 to 52||0
8969749|NCT02596906|10033326|FG000|STARTED|Overall Study||12
8969750|NCT02596906|10033327|FG001|STARTED|Overall Study||10
8969751|NCT02596906|10033326|FG000|COMPLETED|Overall Study||8
8969752|NCT02596906|10033327|FG001|COMPLETED|Overall Study||7
8969753|NCT02596906|10033326|FG000|NOT COMPLETED|Overall Study||4
8969754|NCT02596906|10033327|FG001|NOT COMPLETED|Overall Study||3
8969755|NCT02596945|10033333|FG000|STARTED|Overall Study||223
8969756|NCT02596945|10033333|FG000|Treated|Overall Study||220
8969757|NCT02596945|10033333|FG000|COMPLETED|Overall Study||167
8969758|NCT02596945|10033333|FG000|NOT COMPLETED|Overall Study||56
8969759|NCT02596958|10033337|FG000|STARTED|Overall Study||996
8969760|NCT02596958|10033337|FG000|COMPLETED|Overall Study||0
8969761|NCT02596958|10033337|FG000|NOT COMPLETED|Overall Study||996
8969762|NCT02596971|10033344|FG000|STARTED|Overall Study||42
8969763|NCT02596971|10033345|FG001|STARTED|Overall Study||7
8969764|NCT02596971|10033346|FG002|STARTED|Overall Study||42
8969765|NCT02596971|10033344|FG000|COMPLETED|Overall Study||32
8969766|NCT02596971|10033345|FG001|COMPLETED|Overall Study||5
8969767|NCT02596971|10033346|FG002|COMPLETED|Overall Study||33
8969768|NCT02596971|10033344|FG000|NOT COMPLETED|Overall Study||10
8969769|NCT02596971|10033345|FG001|NOT COMPLETED|Overall Study||2
8969770|NCT02596971|10033346|FG002|NOT COMPLETED|Overall Study||9
8969771|NCT02597049|10033360|FG000|STARTED|Overall Study||142
8969772|NCT02597049|10033361|FG001|STARTED|Overall Study||142
8969773|NCT02597049|10033362|FG002|STARTED|Overall Study||140
8969774|NCT02597049|10033360|FG000|Received at Least One Dose of Study Drug|Overall Study||142
8969775|NCT02597049|10033361|FG001|Received at Least One Dose of Study Drug|Overall Study||141
8969776|NCT02597049|10033362|FG002|Received at Least One Dose of Study Drug|Overall Study||140
8969777|NCT02597049|10033360|FG000|COMPLETED|Overall Study||135
8969778|NCT02597049|10033361|FG001|COMPLETED|Overall Study||137
8969779|NCT02597049|10033362|FG002|COMPLETED|Overall Study||137
8969780|NCT02597049|10033360|FG000|NOT COMPLETED|Overall Study||7
8969781|NCT02597049|10033361|FG001|NOT COMPLETED|Overall Study||5
8969782|NCT02597049|10033362|FG002|NOT COMPLETED|Overall Study||3
8969783|NCT02597101|10033372|FG000|STARTED|Overall Study||4
8969784|NCT02597101|10033373|FG001|STARTED|Overall Study||5
8969785|NCT02597101|10033372|FG000|COMPLETED|Overall Study||4
8969786|NCT02597101|10033373|FG001|COMPLETED|Overall Study||5
8969787|NCT02597101|10033372|FG000|NOT COMPLETED|Overall Study||0
8969788|NCT02597101|10033373|FG001|NOT COMPLETED|Overall Study||0
8969789|NCT02597127|10033387|FG000|STARTED|Overall Study||60
8969790|NCT02597127|10033388|FG001|STARTED|Overall Study||62
8969791|NCT02597127|10033389|FG002|STARTED|Overall Study||66
8570867|NCT00106106|9603045|FG000|COMPLETED|Overall Study|Although 22 subjects completed all other assessments for the study, only 18 completed both MRS scans|22
8570868|NCT00106106|9603046|FG001|COMPLETED|Overall Study|Although 19 subjects completed all other assessments for the study, only 15 completed both MRS scans|19
8570869|NCT00106106|9603045|FG000|NOT COMPLETED|Overall Study||4
8570870|NCT00106106|9603046|FG001|NOT COMPLETED|Overall Study||4
8570871|NCT00106119|9603052|FG000|STARTED|First Intervention||7
8570872|NCT00106119|9603053|FG001|STARTED|First Intervention||7
8570873|NCT00106119|9603052|FG000|COMPLETED|First Intervention||7
8969792|NCT02597127|10033390|FG003|STARTED|Overall Study||65
8969793|NCT02597127|10033391|FG004|STARTED|Overall Study||62
8969794|NCT02597127|10033392|FG005|STARTED|Overall Study||63
8969795|NCT02597127|10033393|FG006|STARTED|Overall Study||61
8969796|NCT02597127|10033394|FG007|STARTED|Overall Study||62
8969797|NCT02597127|10033387|FG000|Treated|Overall Study||60
8969798|NCT02597127|10033388|FG001|Treated|Overall Study||61
8969799|NCT02597127|10033389|FG002|Treated|Overall Study||65
8969800|NCT02597127|10033390|FG003|Treated|Overall Study||65
8969801|NCT02597127|10033391|FG004|Treated|Overall Study||61
8969802|NCT02597127|10033392|FG005|Treated|Overall Study||62
8969803|NCT02597127|10033393|FG006|Treated|Overall Study||61
8969804|NCT02597127|10033394|FG007|Treated|Overall Study||62
8969805|NCT02597127|10033387|FG000|COMPLETED|Overall Study||59
8969806|NCT02597127|10033388|FG001|COMPLETED|Overall Study||59
8969807|NCT02597127|10033389|FG002|COMPLETED|Overall Study||58
8969808|NCT02597127|10033390|FG003|COMPLETED|Overall Study||60
8969809|NCT02597127|10033391|FG004|COMPLETED|Overall Study||57
8969810|NCT02597127|10033392|FG005|COMPLETED|Overall Study||59
8969811|NCT02597127|10033393|FG006|COMPLETED|Overall Study||57
8969812|NCT02597127|10033394|FG007|COMPLETED|Overall Study||60
8969813|NCT02597127|10033387|FG000|NOT COMPLETED|Overall Study||1
8969814|NCT02597127|10033388|FG001|NOT COMPLETED|Overall Study||3
8969815|NCT02597127|10033389|FG002|NOT COMPLETED|Overall Study||8
8969816|NCT02597127|10033390|FG003|NOT COMPLETED|Overall Study||5
8969817|NCT02597127|10033391|FG004|NOT COMPLETED|Overall Study||5
8969818|NCT02597127|10033392|FG005|NOT COMPLETED|Overall Study||4
8969819|NCT02597127|10033393|FG006|NOT COMPLETED|Overall Study||4
8969820|NCT02597127|10033394|FG007|NOT COMPLETED|Overall Study||2
8969821|NCT02597452|10033433|FG000|STARTED|Overall Study||516
8969822|NCT02597452|10033433|FG000|COMPLETED|Overall Study||486
8969823|NCT02597452|10033433|FG000|NOT COMPLETED|Overall Study||30
8969824|NCT02597478|10033439|FG000|STARTED|Overall Study||16
8969825|NCT02597478|10033440|FG001|STARTED|Overall Study||18
8969826|NCT02597478|10033439|FG000|COMPLETED|Overall Study||13
8969827|NCT02597478|10033440|FG001|COMPLETED|Overall Study||17
8969828|NCT02597478|10033439|FG000|NOT COMPLETED|Overall Study||3
8969829|NCT02597478|10033440|FG001|NOT COMPLETED|Overall Study||1
8969830|NCT02597543|10033448|FG000|STARTED|Overall Study||6
8969831|NCT02597543|10033449|FG001|STARTED|Overall Study||8
8969832|NCT02597543|10033448|FG000|COMPLETED|Overall Study||6
8969833|NCT02597543|10033449|FG001|COMPLETED|Overall Study||8
8969834|NCT02597543|10033448|FG000|NOT COMPLETED|Overall Study||0
8969835|NCT02597543|10033449|FG001|NOT COMPLETED|Overall Study||0
8969836|NCT02597582|10033457|FG000|STARTED|Overall Study||21
8631918|NCT00542425|9671780|FG004|COMPLETED|Extended 24 Weeks of Treatment||13
8631919|NCT00542425|9671776|FG000|NOT COMPLETED|Extended 24 Weeks of Treatment||1
8631920|NCT00542425|9671777|FG001|NOT COMPLETED|Extended 24 Weeks of Treatment||2
8631921|NCT00542425|9671778|FG002|NOT COMPLETED|Extended 24 Weeks of Treatment||2
8631922|NCT00542425|9671779|FG003|NOT COMPLETED|Extended 24 Weeks of Treatment||1
8631923|NCT00542425|9671780|FG004|NOT COMPLETED|Extended 24 Weeks of Treatment||1
8631924|NCT00542490|9671792|FG000|STARTED|Overall Study||23
8631925|NCT00542490|9671792|FG000|COMPLETED|Overall Study||21
8969837|NCT02597582|10033458|FG001|STARTED|Overall Study||20
8969838|NCT02597582|10033457|FG000|COMPLETED|Overall Study||21
8969839|NCT02597582|10033458|FG001|COMPLETED|Overall Study||20
8969840|NCT02597582|10033457|FG000|NOT COMPLETED|Overall Study||0
8969841|NCT02597582|10033458|FG001|NOT COMPLETED|Overall Study||0
8969842|NCT02597673|10033470|FG000|STARTED|Overall Study||34
8969843|NCT02597673|10033471|FG001|STARTED|Overall Study||33
8969844|NCT02597673|10033472|FG002|STARTED|Overall Study||33
8969845|NCT02597673|10033473|FG003|STARTED|Overall Study||30
8969846|NCT02597673|10033470|FG000|COMPLETED|Overall Study||31
8969847|NCT02597673|10033471|FG001|COMPLETED|Overall Study||27
8969848|NCT02597673|10033472|FG002|COMPLETED|Overall Study||28
8969849|NCT02597673|10033473|FG003|COMPLETED|Overall Study||25
8969850|NCT02597673|10033470|FG000|NOT COMPLETED|Overall Study||3
8969851|NCT02597673|10033471|FG001|NOT COMPLETED|Overall Study||6
8969852|NCT02597673|10033472|FG002|NOT COMPLETED|Overall Study||5
8969853|NCT02597673|10033473|FG003|NOT COMPLETED|Overall Study||5
8969854|NCT02597712|10033486|FG000|STARTED|Overall Study||13
8969855|NCT02597712|10033487|FG001|STARTED|Overall Study||11
8969856|NCT02597712|10033486|FG000|COMPLETED|Overall Study||10
8969857|NCT02597712|10033487|FG001|COMPLETED|Overall Study||10
8969858|NCT02597712|10033486|FG000|NOT COMPLETED|Overall Study||3
8969859|NCT02597712|10033487|FG001|NOT COMPLETED|Overall Study||1
8969860|NCT02597855|10033495|FG000|STARTED|Overall Study||18
8969861|NCT02597855|10033496|FG001|STARTED|Overall Study||14
8969862|NCT02597855|10033495|FG000|COMPLETED|Overall Study||16
8969863|NCT02597855|10033496|FG001|COMPLETED|Overall Study||13
8969864|NCT02597855|10033495|FG000|NOT COMPLETED|Overall Study||2
8969865|NCT02597855|10033496|FG001|NOT COMPLETED|Overall Study||1
8969866|NCT02597907|10033504|FG000|STARTED|Overall Study||44
8969867|NCT02597907|10033505|FG001|STARTED|Overall Study||44
8969868|NCT02597907|10033504|FG000|COMPLETED|Overall Study||44
8969869|NCT02597907|10033505|FG001|COMPLETED|Overall Study||44
8969870|NCT02597907|10033504|FG000|NOT COMPLETED|Overall Study||0
8969871|NCT02597907|10033505|FG001|NOT COMPLETED|Overall Study||0
8969872|NCT02597920|10033514|FG000|STARTED|Overall Study|Information about study termination is not available for 1 subject.|585
8969873|NCT02597920|10033515|FG001|STARTED|Overall Study||1159
8969874|NCT02597920|10033516|FG002|STARTED|Overall Study||78
8969875|NCT02597920|10033514|FG000|COMPLETED|Overall Study||544
8969876|NCT02597920|10033515|FG001|COMPLETED|Overall Study||1075
8969877|NCT02597920|10033516|FG002|COMPLETED|Overall Study||72
8969878|NCT02597920|10033514|FG000|NOT COMPLETED|Overall Study||41
8969879|NCT02597920|10033515|FG001|NOT COMPLETED|Overall Study||84
8969880|NCT02597920|10033516|FG002|NOT COMPLETED|Overall Study||6
8969881|NCT02597933|10033528|FG000|STARTED|Overall Study|Started are randomised|290
8969882|NCT02597933|10033529|FG001|STARTED|Overall Study|Started are randomised|290
8969883|NCT02597933|10033528|FG000|Treated Patients|Overall Study||288
8969884|NCT02597933|10033529|FG001|Treated Patients|Overall Study||288
8969885|NCT02597933|10033528|FG000|COMPLETED|Overall Study||252
8969886|NCT02597933|10033529|FG001|COMPLETED|Overall Study||239
8969887|NCT02597933|10033528|FG000|NOT COMPLETED|Overall Study||38
8969888|NCT02597933|10033529|FG001|NOT COMPLETED|Overall Study||51
8969889|NCT02597946|10033535|FG000|STARTED|Overall Study||18
8969890|NCT02597946|10033535|FG000|COMPLETED|Overall Study||0
8969891|NCT02597946|10033535|FG000|NOT COMPLETED|Overall Study||18
8969892|NCT02598076|10033541|FG000|STARTED|Overall Study||31
8969893|NCT02598076|10033542|FG001|STARTED|Overall Study||29
8969894|NCT02598076|10033541|FG000|COMPLETED|Overall Study||29
8969895|NCT02598076|10033542|FG001|COMPLETED|Overall Study||26
8969896|NCT02598076|10033541|FG000|NOT COMPLETED|Overall Study||2
8969897|NCT02598076|10033542|FG001|NOT COMPLETED|Overall Study||3
8969898|NCT02598089|10033550|FG000|STARTED|Overall Study||30
8969899|NCT02598089|10033551|FG001|STARTED|Overall Study||30
8969900|NCT02598089|10033550|FG000|COMPLETED|Overall Study||30
8969901|NCT02598089|10033551|FG001|COMPLETED|Overall Study||30
8969902|NCT02598089|10033550|FG000|NOT COMPLETED|Overall Study||0
8969903|NCT02598089|10033551|FG001|NOT COMPLETED|Overall Study||0
8969904|NCT02598128|10033564|FG000|STARTED|Period A: Days -7 to -1||34
8969905|NCT02598128|10033565|FG001|STARTED|Period A: Days -7 to -1||0
8969906|NCT02598128|10033566|FG002|STARTED|Period A: Days -7 to -1||0
8969907|NCT02598128|10033567|FG003|STARTED|Period A: Days -7 to -1||0
8969908|NCT02598128|10033564|FG000|COMPLETED|Period A: Days -7 to -1||33
8969909|NCT02598128|10033565|FG001|COMPLETED|Period A: Days -7 to -1||0
8969910|NCT02598128|10033566|FG002|COMPLETED|Period A: Days -7 to -1||0
8969911|NCT02598128|10033567|FG003|COMPLETED|Period A: Days -7 to -1||0
8969912|NCT02598128|10033564|FG000|NOT COMPLETED|Period A: Days -7 to -1||1
8969913|NCT02598128|10033565|FG001|NOT COMPLETED|Period A: Days -7 to -1||0
8969914|NCT02598128|10033566|FG002|NOT COMPLETED|Period A: Days -7 to -1||0
8969915|NCT02598128|10033567|FG003|NOT COMPLETED|Period A: Days -7 to -1||0
8969916|NCT02598128|10033564|FG000|STARTED|Period B: Days 1 to 11||0
8969917|NCT02598128|10033565|FG001|STARTED|Period B: Days 1 to 11||17
8969918|NCT02598128|10033566|FG002|STARTED|Period B: Days 1 to 11||16
8969919|NCT02598128|10033567|FG003|STARTED|Period B: Days 1 to 11||0
8969920|NCT02598128|10033564|FG000|COMPLETED|Period B: Days 1 to 11||0
8969921|NCT02598128|10033565|FG001|COMPLETED|Period B: Days 1 to 11||17
8969922|NCT02598128|10033566|FG002|COMPLETED|Period B: Days 1 to 11||16
8969923|NCT02598128|10033567|FG003|COMPLETED|Period B: Days 1 to 11||0
8969924|NCT02598128|10033564|FG000|NOT COMPLETED|Period B: Days 1 to 11||0
8969925|NCT02598128|10033565|FG001|NOT COMPLETED|Period B: Days 1 to 11||0
8969926|NCT02598128|10033566|FG002|NOT COMPLETED|Period B: Days 1 to 11||0
8969927|NCT02598128|10033567|FG003|NOT COMPLETED|Period B: Days 1 to 11||0
8969928|NCT02598128|10033564|FG000|STARTED|Period C: Days 12 to 20||0
8969929|NCT02598128|10033565|FG001|STARTED|Period C: Days 12 to 20||0
8969930|NCT02598128|10033566|FG002|STARTED|Period C: Days 12 to 20||0
8969931|NCT02598128|10033567|FG003|STARTED|Period C: Days 12 to 20||33
8969932|NCT02598128|10033564|FG000|COMPLETED|Period C: Days 12 to 20||0
8969933|NCT02598128|10033565|FG001|COMPLETED|Period C: Days 12 to 20||0
8969934|NCT02598128|10033566|FG002|COMPLETED|Period C: Days 12 to 20||0
8969935|NCT02598128|10033567|FG003|COMPLETED|Period C: Days 12 to 20||33
8969936|NCT02598128|10033564|FG000|NOT COMPLETED|Period C: Days 12 to 20||0
8969937|NCT02598128|10033565|FG001|NOT COMPLETED|Period C: Days 12 to 20||0
8969938|NCT02598128|10033566|FG002|NOT COMPLETED|Period C: Days 12 to 20||0
8969939|NCT02598128|10033567|FG003|NOT COMPLETED|Period C: Days 12 to 20||0
8969940|NCT02598193|10033579|FG000|STARTED|Overall Study||89
8969941|NCT02598193|10033579|FG000|COMPLETED|Overall Study||73
8969942|NCT02598193|10033579|FG000|NOT COMPLETED|Overall Study||16
8969943|NCT02598297|10033585|FG000|STARTED|Overall Study|One subject in the ruxolitinib arm was not treated with the study drug|25
8969944|NCT02598297|10033586|FG001|STARTED|Overall Study||24
8969945|NCT02598297|10033585|FG000|Not Treted Wit Study Drug|Overall Study||1
8969946|NCT02598297|10033586|FG001|Not Treted Wit Study Drug|Overall Study||0
8969947|NCT02598297|10033585|FG000|Subjects Followed for Survival|Overall Study||1
8969948|NCT02598297|10033586|FG001|Subjects Followed for Survival|Overall Study||0
8969949|NCT02598297|10033585|FG000|COMPLETED|Overall Study||0
8969950|NCT02598297|10033586|FG001|COMPLETED|Overall Study||0
8969951|NCT02598297|10033585|FG000|NOT COMPLETED|Overall Study||25
8969952|NCT02598297|10033586|FG001|NOT COMPLETED|Overall Study||24
8969953|NCT02598934|10033594|FG000|STARTED|Overall Study||154
8969954|NCT02598934|10033595|FG001|STARTED|Overall Study||154
8969955|NCT02598934|10033594|FG000|COMPLETED|Overall Study||135
8969956|NCT02598934|10033595|FG001|COMPLETED|Overall Study||132
8969957|NCT02598934|10033594|FG000|NOT COMPLETED|Overall Study||19
8969958|NCT02598934|10033595|FG001|NOT COMPLETED|Overall Study||22
8969959|NCT02599129|10033603|FG000|STARTED|Overall Study||7
8969960|NCT02599129|10033604|FG001|STARTED|Overall Study||4
8969961|NCT02599129|10033603|FG000|COMPLETED|Overall Study||2
8969962|NCT02599129|10033604|FG001|COMPLETED|Overall Study||1
8969963|NCT02599129|10033603|FG000|NOT COMPLETED|Overall Study||5
8969964|NCT02599129|10033604|FG001|NOT COMPLETED|Overall Study||3
8969965|NCT02599194|10033610|FG000|STARTED|Overall Study||7
8969966|NCT02599194|10033610|FG000|COMPLETED|Overall Study||7
8969967|NCT02599194|10033610|FG000|NOT COMPLETED|Overall Study||0
8969968|NCT02599402|10033616|FG000|STARTED|Overall Study||533
8969969|NCT02599402|10033616|FG000|COMPLETED|Overall Study||0
8969970|NCT02599402|10033616|FG000|NOT COMPLETED|Overall Study||533
8969971|NCT02599441|10033646|FG000|STARTED|Overall Study||9
8969972|NCT02599441|10033646|FG000|COMPLETED|Overall Study||9
8969973|NCT02599441|10033646|FG000|NOT COMPLETED|Overall Study||0
8969974|NCT02599649|10033654|FG000|STARTED|Overall Study||2
8969975|NCT02599649|10033655|FG001|STARTED|Overall Study||0
8969976|NCT02599649|10033656|FG002|STARTED|Overall Study||8
8969977|NCT02599649|10033657|FG003|STARTED|Overall Study||0
8969978|NCT02599649|10033654|FG000|COMPLETED|Overall Study||2
8969979|NCT02599649|10033655|FG001|COMPLETED|Overall Study||0
8969980|NCT02599649|10033656|FG002|COMPLETED|Overall Study||8
8969981|NCT02599649|10033657|FG003|COMPLETED|Overall Study||0
8969982|NCT02599649|10033654|FG000|NOT COMPLETED|Overall Study||0
8969983|NCT02599649|10033655|FG001|NOT COMPLETED|Overall Study||0
8969984|NCT02599649|10033656|FG002|NOT COMPLETED|Overall Study||0
8969985|NCT02599649|10033657|FG003|NOT COMPLETED|Overall Study||0
8969986|NCT02599688|10033667|FG000|STARTED|Overall Study||18
8969987|NCT02599688|10033667|FG000|COMPLETED|Overall Study||14
8969988|NCT02599688|10033667|FG000|NOT COMPLETED|Overall Study||4
8969989|NCT02599766|10033671|FG000|STARTED|Overall Study||22
8969990|NCT02599766|10033671|FG000|COMPLETED|Overall Study||19
8969991|NCT02599766|10033671|FG000|NOT COMPLETED|Overall Study||3
8969992|NCT02599961|10033679|FG000|STARTED|Overall Study||15
8969993|NCT02599961|10033679|FG000|COMPLETED|Overall Study||0
8969994|NCT02599961|10033679|FG000|NOT COMPLETED|Overall Study||15
8969995|NCT02600325|10033683|FG000|STARTED|Overall Study||80
8969996|NCT02600325|10033683|FG000|COMPLETED|Overall Study||80
8969997|NCT02600325|10033683|FG000|NOT COMPLETED|Overall Study||0
8969998|NCT02600351|10033691|FG000|STARTED|Overall Study||17
8969999|NCT02600351|10033692|FG001|STARTED|Overall Study||17
8970000|NCT02600351|10033693|FG002|STARTED|Overall Study||26
8970001|NCT02600351|10033694|FG003|STARTED|Overall Study||27
8970002|NCT02600351|10033691|FG000|COMPLETED|Overall Study||12
8970003|NCT02600351|10033692|FG001|COMPLETED|Overall Study||17
8970004|NCT02600351|10033693|FG002|COMPLETED|Overall Study||20
8970005|NCT02600351|10033694|FG003|COMPLETED|Overall Study||22
8970006|NCT02600351|10033691|FG000|NOT COMPLETED|Overall Study||5
8970007|NCT02600351|10033692|FG001|NOT COMPLETED|Overall Study||0
8970008|NCT02600351|10033693|FG002|NOT COMPLETED|Overall Study||6
8970009|NCT02600351|10033694|FG003|NOT COMPLETED|Overall Study||5
8970010|NCT02600403|10033709|FG000|STARTED|Overall Study||44
8970011|NCT02600403|10033710|FG001|STARTED|Overall Study||6
8970012|NCT02600403|10033711|FG002|STARTED|Overall Study||11
8970013|NCT02600403|10033709|FG000|COMPLETED|Overall Study||44
8970014|NCT02600403|10033710|FG001|COMPLETED|Overall Study||6
8970015|NCT02600403|10033711|FG002|COMPLETED|Overall Study||11
8970016|NCT02600403|10033709|FG000|NOT COMPLETED|Overall Study||0
8970017|NCT02600403|10033710|FG001|NOT COMPLETED|Overall Study||0
8970018|NCT02600403|10033711|FG002|NOT COMPLETED|Overall Study||0
8970019|NCT02600559|10033722|FG000|STARTED|Overall Study||501
8970020|NCT02600559|10033722|FG000|COMPLETED|Overall Study||478
8970021|NCT02600559|10033722|FG000|NOT COMPLETED|Overall Study||23
8970022|NCT02600611|10033728|FG000|STARTED|Overall Study||300
8970023|NCT02600611|10033729|FG001|STARTED|Overall Study||300
8970024|NCT02600611|10033728|FG000|COMPLETED|Overall Study||298
8970025|NCT02600611|10033729|FG001|COMPLETED|Overall Study||300
8970026|NCT02600611|10033728|FG000|NOT COMPLETED|Overall Study||2
8970027|NCT02600611|10033729|FG001|NOT COMPLETED|Overall Study||0
8970028|NCT02600637|10033737|FG000|STARTED|Overall Study||19
8970029|NCT02600637|10033738|FG001|STARTED|Overall Study||18
8970030|NCT02600637|10033737|FG000|COMPLETED|Overall Study||14
8970031|NCT02600637|10033738|FG001|COMPLETED|Overall Study||13
8970032|NCT02600637|10033737|FG000|NOT COMPLETED|Overall Study||5
8970033|NCT02600637|10033738|FG001|NOT COMPLETED|Overall Study||5
8970034|NCT02600715|10033746|FG000|STARTED|Overall Study||13
8970035|NCT02600715|10033747|FG001|STARTED|Overall Study||13
8970036|NCT02600715|10033746|FG000|Allocated to Randomization|Overall Study||13
8970037|NCT02600715|10033747|FG001|Allocated to Randomization|Overall Study||13
8970038|NCT02600715|10033746|FG000|Received Treatment and Suppository|Overall Study||13
8970039|NCT02600715|10033747|FG001|Received Treatment and Suppository|Overall Study||13
8970040|NCT02600715|10033746|FG000|Completed 2-week Follow-up Appointment|Overall Study||13
8970041|NCT02600715|10033747|FG001|Completed 2-week Follow-up Appointment|Overall Study||12
8970042|NCT02600715|10033746|FG000|COMPLETED|Overall Study||13
8970043|NCT02600715|10033747|FG001|COMPLETED|Overall Study||13
8970044|NCT02600715|10033746|FG000|NOT COMPLETED|Overall Study||0
8970045|NCT02600715|10033747|FG001|NOT COMPLETED|Overall Study||0
8970046|NCT02600767|10033756|FG000|STARTED|Overall Study||79
8970047|NCT02600767|10033756|FG000|COMPLETED|Overall Study||74
8970048|NCT02600767|10033756|FG000|NOT COMPLETED|Overall Study||5
8970049|NCT02600819|10033760|FG000|STARTED|GEN Phase||55
8970050|NCT02600819|10033761|FG001|STARTED|GEN Phase||0
8970051|NCT02600819|10033760|FG000|COMPLETED|GEN Phase||39
8970052|NCT02600819|10033761|FG001|COMPLETED|GEN Phase||0
8970053|NCT02600819|10033760|FG000|NOT COMPLETED|GEN Phase||16
8970054|NCT02600819|10033761|FG001|NOT COMPLETED|GEN Phase||0
8970055|NCT02600819|10033760|FG000|STARTED|BVY OL Extension Phase|Only US participants were eligible to roll over into the Extension Phase per the study protocol.|0
8970056|NCT02600819|10033761|FG001|STARTED|BVY OL Extension Phase|Only US participants were eligible to roll over into the Extension Phase per the study protocol.|10
8970057|NCT02600819|10033760|FG000|COMPLETED|BVY OL Extension Phase||0
8970058|NCT02600819|10033761|FG001|COMPLETED|BVY OL Extension Phase||10
8970059|NCT02600819|10033760|FG000|NOT COMPLETED|BVY OL Extension Phase||0
8970060|NCT02600819|10033761|FG001|NOT COMPLETED|BVY OL Extension Phase||0
8970061|NCT02600845|10033767|FG000|STARTED|Overall Study||122
8970062|NCT02600845|10033767|FG000|COMPLETED|Overall Study||104
8970063|NCT02600845|10033767|FG000|NOT COMPLETED|Overall Study||18
8970064|NCT02600871|10033773|FG000|STARTED|Overall Study||52
8631926|NCT00542490|9671792|FG000|NOT COMPLETED|Overall Study||2
8631927|NCT00542620|9671798|FG000|STARTED|Overall Study||13
8970065|NCT02600871|10033774|FG001|STARTED|Overall Study||49
8970066|NCT02600871|10033773|FG000|COMPLETED|Overall Study|51 subjects completed the 7-10 day follow up 39 subjects completed the 30-day follow up|39
8970067|NCT02600871|10033774|FG001|COMPLETED|Overall Study|45 subjects completed the 7-10 day follow up 39 subjects completed the 30-day follow up|39
8970068|NCT02600871|10033773|FG000|NOT COMPLETED|Overall Study||13
8970069|NCT02600871|10033774|FG001|NOT COMPLETED|Overall Study||10
8970070|NCT02601001|10033784|FG000|STARTED|Dosing Period 1||10
8970071|NCT02601001|10033785|FG001|STARTED|Dosing Period 1||20
8970072|NCT02601001|10033786|FG002|STARTED|Dosing Period 1||20
8970073|NCT02601001|10033787|FG003|STARTED|Dosing Period 1||0
8970074|NCT02601001|10033788|FG004|STARTED|Dosing Period 1||0
8970075|NCT02601001|10033789|FG005|STARTED|Dosing Period 1||0
8970076|NCT02601001|10033790|FG006|STARTED|Dosing Period 1||0
8970077|NCT02601001|10033784|FG000|COMPLETED|Dosing Period 1||10
8970078|NCT02601001|10033785|FG001|COMPLETED|Dosing Period 1||20
8970079|NCT02601001|10033786|FG002|COMPLETED|Dosing Period 1||20
8970080|NCT02601001|10033787|FG003|COMPLETED|Dosing Period 1||0
8970081|NCT02601001|10033788|FG004|COMPLETED|Dosing Period 1||0
8970082|NCT02601001|10033789|FG005|COMPLETED|Dosing Period 1||0
8970083|NCT02601001|10033790|FG006|COMPLETED|Dosing Period 1||0
8970084|NCT02601001|10033784|FG000|NOT COMPLETED|Dosing Period 1||0
8970085|NCT02601001|10033785|FG001|NOT COMPLETED|Dosing Period 1||0
8970086|NCT02601001|10033786|FG002|NOT COMPLETED|Dosing Period 1||0
8970087|NCT02601001|10033787|FG003|NOT COMPLETED|Dosing Period 1||0
8970088|NCT02601001|10033788|FG004|NOT COMPLETED|Dosing Period 1||0
8970089|NCT02601001|10033789|FG005|NOT COMPLETED|Dosing Period 1||0
8970090|NCT02601001|10033790|FG006|NOT COMPLETED|Dosing Period 1||0
8970091|NCT02601001|10033784|FG000|STARTED|Dosing Period 2||10
8970092|NCT02601001|10033785|FG001|STARTED|Dosing Period 2||0
8970093|NCT02601001|10033786|FG002|STARTED|Dosing Period 2||0
8970094|NCT02601001|10033787|FG003|STARTED|Dosing Period 2||7
8970095|NCT02601001|10033788|FG004|STARTED|Dosing Period 2||13
8970096|NCT02601001|10033789|FG005|STARTED|Dosing Period 2||7
8970097|NCT02601001|10033790|FG006|STARTED|Dosing Period 2||13
8970098|NCT02601001|10033784|FG000|COMPLETED|Dosing Period 2||10
8970099|NCT02601001|10033785|FG001|COMPLETED|Dosing Period 2||0
8970100|NCT02601001|10033786|FG002|COMPLETED|Dosing Period 2||0
8970101|NCT02601001|10033787|FG003|COMPLETED|Dosing Period 2||7
8970102|NCT02601001|10033788|FG004|COMPLETED|Dosing Period 2||13
8970103|NCT02601001|10033789|FG005|COMPLETED|Dosing Period 2||7
8970104|NCT02601001|10033790|FG006|COMPLETED|Dosing Period 2||12
8970105|NCT02601001|10033784|FG000|NOT COMPLETED|Dosing Period 2||0
8970106|NCT02601001|10033785|FG001|NOT COMPLETED|Dosing Period 2||0
8970107|NCT02601001|10033786|FG002|NOT COMPLETED|Dosing Period 2||0
8970108|NCT02601001|10033787|FG003|NOT COMPLETED|Dosing Period 2||0
8970109|NCT02601001|10033788|FG004|NOT COMPLETED|Dosing Period 2||0
8970110|NCT02601001|10033789|FG005|NOT COMPLETED|Dosing Period 2||0
8970111|NCT02601001|10033790|FG006|NOT COMPLETED|Dosing Period 2||1
8970112|NCT02601027|10033813|FG000|STARTED|Registration to Surgery||64
8970113|NCT02601027|10033814|FG001|STARTED|Registration to Surgery||56
8970114|NCT02601027|10033813|FG000|COMPLETED|Registration to Surgery||44
8970115|NCT02601027|10033814|FG001|COMPLETED|Registration to Surgery||46
8970116|NCT02601027|10033813|FG000|NOT COMPLETED|Registration to Surgery||20
8970117|NCT02601027|10033814|FG001|NOT COMPLETED|Registration to Surgery||10
8970118|NCT02601027|10033813|FG000|STARTED|Surgery to Assessments||44
8970119|NCT02601027|10033814|FG001|STARTED|Surgery to Assessments||46
8970120|NCT02601027|10033813|FG000|COMPLETED|Surgery to Assessments||44
8970121|NCT02601027|10033814|FG001|COMPLETED|Surgery to Assessments||46
8970122|NCT02601027|10033813|FG000|NOT COMPLETED|Surgery to Assessments||0
8970123|NCT02601027|10033814|FG001|NOT COMPLETED|Surgery to Assessments||0
8970124|NCT02601105|10033820|FG000|STARTED|Placebo Cream; Centella Asiatica Bsln.||15
8970125|NCT02601105|10033820|FG000|COMPLETED|Placebo Cream; Centella Asiatica Bsln.||15
8970126|NCT02601105|10033820|FG000|NOT COMPLETED|Placebo Cream; Centella Asiatica Bsln.||0
8970127|NCT02601105|10033820|FG000|STARTED|Placebo Cream; Centella Asiatica Week 6||15
8970128|NCT02601105|10033820|FG000|COMPLETED|Placebo Cream; Centella Asiatica Week 6||15
8970129|NCT02601105|10033820|FG000|NOT COMPLETED|Placebo Cream; Centella Asiatica Week 6||0
8970130|NCT02601105|10033820|FG000|STARTED|Placebo Cream; Centella Asiatica Week 12||15
8970131|NCT02601105|10033820|FG000|COMPLETED|Placebo Cream; Centella Asiatica Week 12||13
8970132|NCT02601105|10033820|FG000|NOT COMPLETED|Placebo Cream; Centella Asiatica Week 12||2
8970133|NCT02601170|10033828|FG000|STARTED|Overall Study||11
8970134|NCT02601170|10033829|FG001|STARTED|Overall Study||11
8970135|NCT02601170|10033828|FG000|COMPLETED|Overall Study||11
8970136|NCT02601170|10033829|FG001|COMPLETED|Overall Study||11
8970137|NCT02601170|10033828|FG000|NOT COMPLETED|Overall Study||0
8970138|NCT02601170|10033829|FG001|NOT COMPLETED|Overall Study||0
8970139|NCT02601300|10033835|FG000|STARTED|Induction Phase||41
8970140|NCT02601300|10033835|FG000|COMPLETED|Induction Phase||38
8970141|NCT02601300|10033835|FG000|NOT COMPLETED|Induction Phase||3
8970142|NCT02601300|10033835|FG000|STARTED|Extension Phase|3 completed induction phase; did not enter extension due to withdrawal and lack of efficacy|35
8970143|NCT02601300|10033835|FG000|Treated With IP|Extension Phase||34
8970144|NCT02601300|10033835|FG000|COMPLETED|Extension Phase||18
8970145|NCT02601300|10033835|FG000|NOT COMPLETED|Extension Phase||17
8970146|NCT02601469|10033843|FG000|STARTED|Overall Study||25
8970147|NCT02601469|10033844|FG001|STARTED|Overall Study||1
8970148|NCT02601469|10033843|FG000|COMPLETED|Overall Study||24
8970149|NCT02601469|10033844|FG001|COMPLETED|Overall Study||1
8970150|NCT02601469|10033843|FG000|NOT COMPLETED|Overall Study||1
8970151|NCT02601469|10033844|FG001|NOT COMPLETED|Overall Study||0
8876734|NCT01918371|9933510|FG001|Participants With Complete Data|Overall Study||156
8876735|NCT01918371|9933509|FG000|COMPLETED|Overall Study||165
8876736|NCT01918371|9933510|FG001|COMPLETED|Overall Study||156
8970152|NCT02601560|10033858|FG000|STARTED|Overall Study||8
8970153|NCT02601560|10033859|FG001|STARTED|Overall Study||6
8970154|NCT02601560|10033860|FG002|STARTED|Overall Study||6
8970155|NCT02601560|10033861|FG003|STARTED|Overall Study||6
8970156|NCT02601560|10033862|FG004|STARTED|Overall Study||6
8876737|NCT01918371|9933509|FG000|NOT COMPLETED|Overall Study||1
8876738|NCT01918371|9933510|FG001|NOT COMPLETED|Overall Study||1
8876739|NCT01918761|9933516|FG000|STARTED|Overall Study||5
8876740|NCT01918761|9933516|FG000|COMPLETED|Overall Study||5
8876741|NCT01918761|9933516|FG000|NOT COMPLETED|Overall Study||0
8876742|NCT01918774|9933520|FG000|STARTED|Overall Study||57
8876743|NCT01918774|9933520|FG000|COMPLETED|Overall Study||52
8876744|NCT01918774|9933520|FG000|NOT COMPLETED|Overall Study||5
8970157|NCT02601560|10033863|FG005|STARTED|Overall Study||4
8970158|NCT02601560|10033864|FG006|STARTED|Overall Study||6
8970159|NCT02601560|10033865|FG007|STARTED|Overall Study||6
8970160|NCT02601560|10033858|FG000|COMPLETED|Overall Study||8
8970161|NCT02601560|10033859|FG001|COMPLETED|Overall Study||6
8970162|NCT02601560|10033860|FG002|COMPLETED|Overall Study||6
8970163|NCT02601560|10033861|FG003|COMPLETED|Overall Study||6
8970164|NCT02601560|10033862|FG004|COMPLETED|Overall Study||6
8970165|NCT02601560|10033863|FG005|COMPLETED|Overall Study||4
8876745|NCT01918800|9933526|FG000|STARTED|Overall Study||109
8876746|NCT01918800|9933527|FG001|STARTED|Overall Study||109
8970166|NCT02601560|10033864|FG006|COMPLETED|Overall Study||5
8970167|NCT02601560|10033865|FG007|COMPLETED|Overall Study||6
8970168|NCT02601560|10033858|FG000|NOT COMPLETED|Overall Study||0
8970169|NCT02601560|10033859|FG001|NOT COMPLETED|Overall Study||0
8970170|NCT02601560|10033860|FG002|NOT COMPLETED|Overall Study||0
8970171|NCT02601560|10033861|FG003|NOT COMPLETED|Overall Study||0
8970172|NCT02601560|10033862|FG004|NOT COMPLETED|Overall Study||0
8970173|NCT02601560|10033863|FG005|NOT COMPLETED|Overall Study||0
8970174|NCT02601560|10033864|FG006|NOT COMPLETED|Overall Study||1
8970175|NCT02601560|10033865|FG007|NOT COMPLETED|Overall Study||0
8970176|NCT02601573|10033895|FG000|STARTED|Overall Study|Number randomized and treated.|23
8970177|NCT02601573|10033896|FG001|STARTED|Overall Study|Number randomized and treated.|24
8970178|NCT02601573|10033897|FG002|STARTED|Overall Study|Number randomized and treated.|17
8970179|NCT02601573|10033898|FG003|STARTED|Overall Study|Number randomized and treated.|18
8970180|NCT02601573|10033899|FG004|STARTED|Overall Study|Number randomized and treated.|18
8970181|NCT02601573|10033895|FG000|COMPLETED|Overall Study||23
8970182|NCT02601573|10033896|FG001|COMPLETED|Overall Study||20
8970183|NCT02601573|10033897|FG002|COMPLETED|Overall Study||16
8970184|NCT02601573|10033898|FG003|COMPLETED|Overall Study||17
8970185|NCT02601573|10033899|FG004|COMPLETED|Overall Study||16
8970186|NCT02601573|10033895|FG000|NOT COMPLETED|Overall Study||0
8970187|NCT02601573|10033896|FG001|NOT COMPLETED|Overall Study||4
8970188|NCT02601573|10033897|FG002|NOT COMPLETED|Overall Study||1
8970189|NCT02601573|10033898|FG003|NOT COMPLETED|Overall Study||1
8970190|NCT02601573|10033899|FG004|NOT COMPLETED|Overall Study||2
8970191|NCT02601625|10033915|FG000|STARTED|Overall Study||6
8970192|NCT02601625|10033916|FG001|STARTED|Overall Study||6
8970193|NCT02601625|10033917|FG002|STARTED|Overall Study||6
8970194|NCT02601625|10033918|FG003|STARTED|Overall Study||12
8970195|NCT02601625|10033915|FG000|COMPLETED|Overall Study||6
8970196|NCT02601625|10033916|FG001|COMPLETED|Overall Study||6
8970197|NCT02601625|10033917|FG002|COMPLETED|Overall Study||5
8970198|NCT02601625|10033918|FG003|COMPLETED|Overall Study||11
8970199|NCT02601625|10033915|FG000|NOT COMPLETED|Overall Study||0
8970200|NCT02601625|10033916|FG001|NOT COMPLETED|Overall Study||0
8970201|NCT02601625|10033917|FG002|NOT COMPLETED|Overall Study||1
8970202|NCT02601625|10033918|FG003|NOT COMPLETED|Overall Study||1
8970203|NCT02601820|10033942|FG000|STARTED|Pre-Treatment (T1)|1601 patients were enrolled and completed Baseline PROs (T1).|1601
8970204|NCT02601820|10033942|FG000|COMPLETED|Pre-Treatment (T1)||1601
8970205|NCT02601820|10033942|FG000|NOT COMPLETED|Pre-Treatment (T1)||0
8970206|NCT02601820|10033942|FG000|STARTED|Early On-Treatment (T2)|Of 1601, 17 were excluded at T2 due to death, withdrawal, other reason. 1584 remained in the study.|1584
8970207|NCT02601820|10033942|FG000|COMPLETED|Early On-Treatment (T2)|Of 1584, 51 were excluded for a missing T2 record. 1533 provided data at T2. Some outcomes missing.|1533
8970208|NCT02601820|10033942|FG000|NOT COMPLETED|Early On-Treatment (T2)||51
8631928|NCT00542620|9671799|FG001|STARTED|Overall Study||12
8631929|NCT00542620|9671798|FG000|Exposed to Drug|Overall Study|One subject randomly assigned to receive mixed injections, but received a separate injection mode|12
8631930|NCT00542620|9671799|FG001|Exposed to Drug|Overall Study|One subject randomly assigned to receive mixed injections, but received a separate injection mode|13
8631931|NCT00542620|9671798|FG000|COMPLETED|Overall Study||13
8631932|NCT00542620|9671799|FG001|COMPLETED|Overall Study||12
8970209|NCT02601820|10033942|FG000|STARTED|Late On-Treatment (T3)|Of 1601, 28 were excluded at T3 due to death, withdrawal, other reason. 1573 remained in the study.|1573
8970210|NCT02601820|10033942|FG000|COMPLETED|Late On-Treatment (T3)|Of 1573, 49 were excluded for a missing T3 record. 1524 provided data at T3. Some outcomes missing.|1524
8970211|NCT02601820|10033942|FG000|NOT COMPLETED|Late On-Treatment (T3)||49
8970212|NCT02601820|10033942|FG000|STARTED|12 Weeks Post-Treatment (T4)|Of 1601, 37 were excluded at T4 due to death, withdrawal, other reason. 1564 remained in the study.|1564
8970213|NCT02601820|10033942|FG000|COMPLETED|12 Weeks Post-Treatment (T4)|Of 1564, 3 were excluded for a missing T4 record. 1561 provided data at T4. Some outcomes missing.|1561
8970214|NCT02601820|10033942|FG000|NOT COMPLETED|12 Weeks Post-Treatment (T4)||3
8970215|NCT02601820|10033942|FG000|STARTED|1-Yr Post-Treatment (T5)|Of 1601, 73 were excluded at T5 due to death, withdrawal, other reason. 1528 remained in the study.|1528
8970216|NCT02601820|10033942|FG000|COMPLETED|1-Yr Post-Treatment (T5)|Of 1528, 88 were excluded for a missing T5 record. 1440 provided data at T5. Some outcomes missing.|1440
8970217|NCT02601820|10033942|FG000|NOT COMPLETED|1-Yr Post-Treatment (T5)||88
8970218|NCT02601833|10033961|FG000|STARTED|Overall Study||56
8970219|NCT02601833|10033962|FG001|STARTED|Overall Study||42
8970220|NCT02601833|10033961|FG000|COMPLETED|Overall Study||40
8970221|NCT02601833|10033962|FG001|COMPLETED|Overall Study||29
8970222|NCT02601833|10033961|FG000|NOT COMPLETED|Overall Study||16
8970223|NCT02601833|10033962|FG001|NOT COMPLETED|Overall Study||13
8970224|NCT02601976|10033971|FG000|STARTED|Overall Study||64
8970225|NCT02601976|10033971|FG000|COMPLETED|Overall Study||64
8970226|NCT02601976|10033971|FG000|NOT COMPLETED|Overall Study||0
8970227|NCT02602080|10033978|FG000|STARTED|Overall Study||21
8970228|NCT02602080|10033979|FG001|STARTED|Overall Study||16
8970229|NCT02602080|10033980|FG002|STARTED|Overall Study||18
8970230|NCT02602080|10033978|FG000|COMPLETED|Overall Study||15
8970231|NCT02602080|10033979|FG001|COMPLETED|Overall Study||15
8970232|NCT02602080|10033980|FG002|COMPLETED|Overall Study||15
8970233|NCT02602080|10033978|FG000|NOT COMPLETED|Overall Study||6
8970234|NCT02602080|10033979|FG001|NOT COMPLETED|Overall Study||1
8970235|NCT02602080|10033980|FG002|NOT COMPLETED|Overall Study||3
8970236|NCT02602223|10033988|FG000|STARTED|Overall Study||9
8970237|NCT02602223|10033988|FG000|COMPLETED|Overall Study||9
8970238|NCT02602223|10033988|FG000|NOT COMPLETED|Overall Study||0
8970239|NCT02602496|10033997|FG000|STARTED|Overall Study||15
8970240|NCT02602496|10033998|FG001|STARTED|Overall Study||20
8970241|NCT02602496|10033999|FG002|STARTED|Overall Study||17
8970242|NCT02602496|10033997|FG000|COMPLETED|Overall Study||14
8970243|NCT02602496|10033998|FG001|COMPLETED|Overall Study||18
8970244|NCT02602496|10033999|FG002|COMPLETED|Overall Study||17
8970245|NCT02602496|10033997|FG000|NOT COMPLETED|Overall Study||1
8970246|NCT02602496|10033998|FG001|NOT COMPLETED|Overall Study||2
8970247|NCT02602496|10033999|FG002|NOT COMPLETED|Overall Study||0
8970248|NCT02603107|10034009|FG000|STARTED|Randomized Phase||290
8570874|NCT00106119|9603053|FG001|COMPLETED|First Intervention||7
8570875|NCT00106119|9603052|FG000|NOT COMPLETED|First Intervention||0
8570876|NCT00106119|9603053|FG001|NOT COMPLETED|First Intervention||0
8570877|NCT00106119|9603052|FG000|STARTED|Washout Period of 30 Days||7
8570878|NCT00106119|9603053|FG001|STARTED|Washout Period of 30 Days||7
8570879|NCT00106119|9603052|FG000|COMPLETED|Washout Period of 30 Days||7
8570880|NCT00106119|9603053|FG001|COMPLETED|Washout Period of 30 Days||7
8570881|NCT00106119|9603052|FG000|NOT COMPLETED|Washout Period of 30 Days||0
8570882|NCT00106119|9603053|FG001|NOT COMPLETED|Washout Period of 30 Days||0
8570883|NCT00106119|9603052|FG000|STARTED|Second Intervention||7
8570884|NCT00106119|9603053|FG001|STARTED|Second Intervention||7
8570885|NCT00106119|9603052|FG000|COMPLETED|Second Intervention||7
8570886|NCT00106119|9603053|FG001|COMPLETED|Second Intervention||7
8570887|NCT00106119|9603052|FG000|NOT COMPLETED|Second Intervention||0
8570888|NCT00106119|9603053|FG001|NOT COMPLETED|Second Intervention||0
8570889|NCT00106184|9603061|FG000|STARTED|Overall Study||96
8570890|NCT00106184|9603062|FG001|STARTED|Overall Study||104
8577573|NCT00159432|9610338|FG000|STARTED|Overall Study||63
8970249|NCT02603107|10034010|FG001|STARTED|Randomized Phase||287
8970250|NCT02603107|10034009|FG000|COMPLETED|Randomized Phase||275
8970251|NCT02603107|10034010|FG001|COMPLETED|Randomized Phase||266
8970252|NCT02603107|10034009|FG000|NOT COMPLETED|Randomized Phase||15
8970253|NCT02603107|10034010|FG001|NOT COMPLETED|Randomized Phase||21
8970254|NCT02603107|10034009|FG000|STARTED|Optional Extension Phase|3 participants who completed the Randomized Phase did not continue in the Optional Extension Phase.|272
8970255|NCT02603107|10034010|FG001|STARTED|Optional Extension Phase|21 participants who completed the Randomized Phase did not continue in the Optional Extension Phase.|245
8970256|NCT02603107|10034009|FG000|COMPLETED|Optional Extension Phase||263
8970257|NCT02603107|10034010|FG001|COMPLETED|Optional Extension Phase||232
8970258|NCT02603107|10034009|FG000|NOT COMPLETED|Optional Extension Phase||9
8970259|NCT02603107|10034010|FG001|NOT COMPLETED|Optional Extension Phase||13
8970260|NCT02603120|10034020|FG000|STARTED|Double-Blind Treatment Phase||284
8970261|NCT02603120|10034021|FG001|STARTED|Double-Blind Treatment Phase||283
8970262|NCT02603120|10034020|FG000|COMPLETED|Double-Blind Treatment Phase||265
8970263|NCT02603120|10034021|FG001|COMPLETED|Double-Blind Treatment Phase||267
8970264|NCT02603120|10034020|FG000|NOT COMPLETED|Double-Blind Treatment Phase||19
8970265|NCT02603120|10034021|FG001|NOT COMPLETED|Double-Blind Treatment Phase||16
8970266|NCT02603120|10034020|FG000|STARTED|OL Extension B/F/TAF Treatment Phase||259
8970267|NCT02603120|10034021|FG001|STARTED|OL Extension B/F/TAF Treatment Phase||265
8970268|NCT02603120|10034020|FG000|COMPLETED|OL Extension B/F/TAF Treatment Phase||254
8970269|NCT02603120|10034021|FG001|COMPLETED|OL Extension B/F/TAF Treatment Phase||254
8970270|NCT02603120|10034020|FG000|NOT COMPLETED|OL Extension B/F/TAF Treatment Phase||5
8970271|NCT02603120|10034021|FG001|NOT COMPLETED|OL Extension B/F/TAF Treatment Phase||11
8970272|NCT02603172|10034037|FG000|STARTED|Part A (Approximately 16 Weeks)||7
8970273|NCT02603172|10034038|FG001|STARTED|Part A (Approximately 16 Weeks)||1
8970274|NCT02603172|10034039|FG002|STARTED|Part A (Approximately 16 Weeks)||8
8970275|NCT02603172|10034040|FG003|STARTED|Part A (Approximately 16 Weeks)||1
8970276|NCT02603172|10034041|FG004|STARTED|Part A (Approximately 16 Weeks)||0
8970277|NCT02603172|10034042|FG005|STARTED|Part A (Approximately 16 Weeks)||0
8970278|NCT02603172|10034043|FG006|STARTED|Part A (Approximately 16 Weeks)||0
8970279|NCT02603172|10034044|FG007|STARTED|Part A (Approximately 16 Weeks)||0
8970280|NCT02603172|10034037|FG000|COMPLETED|Part A (Approximately 16 Weeks)||7
8970281|NCT02603172|10034038|FG001|COMPLETED|Part A (Approximately 16 Weeks)||1
8970282|NCT02603172|10034039|FG002|COMPLETED|Part A (Approximately 16 Weeks)||7
8970283|NCT02603172|10034040|FG003|COMPLETED|Part A (Approximately 16 Weeks)||1
8970284|NCT02603172|10034041|FG004|COMPLETED|Part A (Approximately 16 Weeks)||0
8970285|NCT02603172|10034042|FG005|COMPLETED|Part A (Approximately 16 Weeks)||0
8970286|NCT02603172|10034043|FG006|COMPLETED|Part A (Approximately 16 Weeks)||0
8970287|NCT02603172|10034044|FG007|COMPLETED|Part A (Approximately 16 Weeks)||0
8970288|NCT02603172|10034037|FG000|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
8970289|NCT02603172|10034038|FG001|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
8970290|NCT02603172|10034039|FG002|NOT COMPLETED|Part A (Approximately 16 Weeks)||1
8970291|NCT02603172|10034040|FG003|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
8970292|NCT02603172|10034041|FG004|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
8970293|NCT02603172|10034042|FG005|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
8970294|NCT02603172|10034043|FG006|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
8970295|NCT02603172|10034044|FG007|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
8970296|NCT02603172|10034037|FG000|STARTED|Part B (Approximately 7 Weeks)||0
8970297|NCT02603172|10034038|FG001|STARTED|Part B (Approximately 7 Weeks)||1
8970298|NCT02603172|10034039|FG002|STARTED|Part B (Approximately 7 Weeks)||0
8970299|NCT02603172|10034040|FG003|STARTED|Part B (Approximately 7 Weeks)||1
8970300|NCT02603172|10034041|FG004|STARTED|Part B (Approximately 7 Weeks)||6
8970301|NCT02603172|10034042|FG005|STARTED|Part B (Approximately 7 Weeks)||0
8970302|NCT02603172|10034043|FG006|STARTED|Part B (Approximately 7 Weeks)||0
8970303|NCT02603172|10034044|FG007|STARTED|Part B (Approximately 7 Weeks)||0
8970304|NCT02603172|10034037|FG000|COMPLETED|Part B (Approximately 7 Weeks)||0
8970305|NCT02603172|10034038|FG001|COMPLETED|Part B (Approximately 7 Weeks)||1
8970306|NCT02603172|10034039|FG002|COMPLETED|Part B (Approximately 7 Weeks)||0
8970307|NCT02603172|10034040|FG003|COMPLETED|Part B (Approximately 7 Weeks)||1
8970308|NCT02603172|10034041|FG004|COMPLETED|Part B (Approximately 7 Weeks)||6
8970309|NCT02603172|10034042|FG005|COMPLETED|Part B (Approximately 7 Weeks)||0
8970310|NCT02603172|10034043|FG006|COMPLETED|Part B (Approximately 7 Weeks)||0
8970311|NCT02603172|10034044|FG007|COMPLETED|Part B (Approximately 7 Weeks)||0
8970312|NCT02603172|10034037|FG000|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
8970313|NCT02603172|10034038|FG001|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
8970314|NCT02603172|10034039|FG002|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
8970315|NCT02603172|10034040|FG003|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
8970316|NCT02603172|10034041|FG004|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
8631933|NCT00542620|9671798|FG000|NOT COMPLETED|Overall Study||0
8631934|NCT00542620|9671799|FG001|NOT COMPLETED|Overall Study||0
8631935|NCT00542750|9671805|FG000|STARTED|Overall Study||24
8970317|NCT02603172|10034042|FG005|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
8970318|NCT02603172|10034043|FG006|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
8631936|NCT00542750|9671805|FG000|COMPLETED|Overall Study||24
8970319|NCT02603172|10034044|FG007|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
8970320|NCT02603172|10034037|FG000|STARTED|Part C (Approximately 13 Weeks)||0
8631937|NCT00542750|9671805|FG000|NOT COMPLETED|Overall Study||0
8970321|NCT02603172|10034038|FG001|STARTED|Part C (Approximately 13 Weeks)||0
8970322|NCT02603172|10034039|FG002|STARTED|Part C (Approximately 13 Weeks)||0
8970323|NCT02603172|10034040|FG003|STARTED|Part C (Approximately 13 Weeks)||0
8970324|NCT02603172|10034041|FG004|STARTED|Part C (Approximately 13 Weeks)||0
8970325|NCT02603172|10034042|FG005|STARTED|Part C (Approximately 13 Weeks)||0
8970326|NCT02603172|10034043|FG006|STARTED|Part C (Approximately 13 Weeks)||0
8970327|NCT02603172|10034044|FG007|STARTED|Part C (Approximately 13 Weeks)||0
8970328|NCT02603172|10034037|FG000|COMPLETED|Part C (Approximately 13 Weeks)||0
8970329|NCT02603172|10034038|FG001|COMPLETED|Part C (Approximately 13 Weeks)||0
8970330|NCT02603172|10034039|FG002|COMPLETED|Part C (Approximately 13 Weeks)||0
8970331|NCT02603172|10034040|FG003|COMPLETED|Part C (Approximately 13 Weeks)||0
8970332|NCT02603172|10034041|FG004|COMPLETED|Part C (Approximately 13 Weeks)||0
8970333|NCT02603172|10034042|FG005|COMPLETED|Part C (Approximately 13 Weeks)||0
8876747|NCT01918800|9933526|FG000|COMPLETED|Overall Study||100
8876748|NCT01918800|9933527|FG001|COMPLETED|Overall Study||104
8876749|NCT01918800|9933526|FG000|NOT COMPLETED|Overall Study||9
8876750|NCT01918800|9933527|FG001|NOT COMPLETED|Overall Study||5
8876751|NCT01919112|9933536|FG000|STARTED|Primary Analysis-day 5 of Intervention||14
8876752|NCT01919112|9933537|FG001|STARTED|Primary Analysis-day 5 of Intervention||13
8876753|NCT01919112|9933538|FG002|STARTED|Primary Analysis-day 5 of Intervention||15
8876754|NCT01919112|9933536|FG000|COMPLETED|Primary Analysis-day 5 of Intervention||14
8876755|NCT01919112|9933537|FG001|COMPLETED|Primary Analysis-day 5 of Intervention||13
8876756|NCT01919112|9933538|FG002|COMPLETED|Primary Analysis-day 5 of Intervention||15
8876757|NCT01919112|9933536|FG000|NOT COMPLETED|Primary Analysis-day 5 of Intervention||0
8970334|NCT02603172|10034043|FG006|COMPLETED|Part C (Approximately 13 Weeks)||0
8970335|NCT02603172|10034044|FG007|COMPLETED|Part C (Approximately 13 Weeks)||0
8970336|NCT02603172|10034037|FG000|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
8970337|NCT02603172|10034038|FG001|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
8970338|NCT02603172|10034039|FG002|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
8970339|NCT02603172|10034040|FG003|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
8970340|NCT02603172|10034041|FG004|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
8970341|NCT02603172|10034042|FG005|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
8970342|NCT02603172|10034043|FG006|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
8970343|NCT02603172|10034044|FG007|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
8970344|NCT02603211|10034060|FG000|STARTED|Overall Study||20
8970345|NCT02603211|10034060|FG000|COMPLETED|Overall Study||20
8970346|NCT02603211|10034060|FG000|NOT COMPLETED|Overall Study||0
8970347|NCT02603393|10034067|FG000|STARTED|Overall Study||527
8970348|NCT02603393|10034068|FG001|STARTED|Overall Study||526
8970349|NCT02603393|10034067|FG000|COMPLETED|Overall Study||456
8970350|NCT02603393|10034068|FG001|COMPLETED|Overall Study||472
8970351|NCT02603393|10034067|FG000|NOT COMPLETED|Overall Study||71
8970352|NCT02603393|10034068|FG001|NOT COMPLETED|Overall Study||54
8970353|NCT02603419|10034080|FG000|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||6
8970354|NCT02603419|10034081|FG001|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||7
8970355|NCT02603419|10034082|FG002|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||6
8970356|NCT02603419|10034083|FG003|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||6
8970357|NCT02603419|10034084|FG004|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||6
8970358|NCT02603419|10034085|FG005|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||0
8970359|NCT02603419|10034080|FG000|Treated|Lead-in Phase:Maximum Exposure:123Weeks||6
8970360|NCT02603419|10034081|FG001|Treated|Lead-in Phase:Maximum Exposure:123Weeks||6
8970361|NCT02603419|10034082|FG002|Treated|Lead-in Phase:Maximum Exposure:123Weeks||6
8970362|NCT02603419|10034083|FG003|Treated|Lead-in Phase:Maximum Exposure:123Weeks||6
8970363|NCT02603419|10034084|FG004|Treated|Lead-in Phase:Maximum Exposure:123Weeks||6
8970364|NCT02603419|10034085|FG005|Treated|Lead-in Phase:Maximum Exposure:123Weeks||0
8970365|NCT02603419|10034080|FG000|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
8970366|NCT02603419|10034081|FG001|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
8970367|NCT02603419|10034082|FG002|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
8970368|NCT02603419|10034083|FG003|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
8970369|NCT02603419|10034084|FG004|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
8970370|NCT02603419|10034085|FG005|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
8970371|NCT02603419|10034080|FG000|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||6
8970372|NCT02603419|10034081|FG001|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||7
8970373|NCT02603419|10034082|FG002|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||6
8970374|NCT02603419|10034083|FG003|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||6
8970375|NCT02603419|10034084|FG004|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||6
8970376|NCT02603419|10034085|FG005|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
8970377|NCT02603419|10034080|FG000|STARTED|Expansion Phase:Maximum Exposure:48Weeks||0
8970378|NCT02603419|10034081|FG001|STARTED|Expansion Phase:Maximum Exposure:48Weeks||0
8970379|NCT02603419|10034082|FG002|STARTED|Expansion Phase:Maximum Exposure:48Weeks||0
8970380|NCT02603419|10034083|FG003|STARTED|Expansion Phase:Maximum Exposure:48Weeks||0
8970381|NCT02603419|10034084|FG004|STARTED|Expansion Phase:Maximum Exposure:48Weeks||0
8970382|NCT02603419|10034085|FG005|STARTED|Expansion Phase:Maximum Exposure:48Weeks|Participants started expansion phase while other few participants were completing lead-in phase.|3
8970383|NCT02603419|10034080|FG000|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
8970384|NCT02603419|10034081|FG001|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
8970385|NCT02603419|10034082|FG002|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
8970386|NCT02603419|10034083|FG003|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
8970387|NCT02603419|10034084|FG004|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
8970388|NCT02603419|10034085|FG005|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
8970389|NCT02603419|10034080|FG000|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
8970390|NCT02603419|10034081|FG001|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
8970391|NCT02603419|10034082|FG002|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
8970392|NCT02603419|10034083|FG003|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
8970393|NCT02603419|10034084|FG004|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
8970394|NCT02603419|10034085|FG005|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||3
8970395|NCT02603666|10034100|FG000|STARTED|Overall Study||130
8970396|NCT02603666|10034100|FG000|COMPLETED|Overall Study||130
8970397|NCT02603666|10034100|FG000|NOT COMPLETED|Overall Study||0
8970398|NCT02603809|10034110|FG000|STARTED|Overall Study||82
8970399|NCT02603809|10034111|FG001|STARTED|Overall Study||82
8970400|NCT02603809|10034112|FG002|STARTED|Overall Study||82
8970401|NCT02603809|10034113|FG003|STARTED|Overall Study||82
8970402|NCT02603809|10034114|FG004|STARTED|Overall Study||81
8970403|NCT02603809|10034115|FG005|STARTED|Overall Study||81
8970404|NCT02603809|10034110|FG000|Per-protocol Set|Overall Study||67
8970405|NCT02603809|10034111|FG001|Per-protocol Set|Overall Study||68
8970406|NCT02603809|10034112|FG002|Per-protocol Set|Overall Study||71
8970407|NCT02603809|10034113|FG003|Per-protocol Set|Overall Study||67
8970408|NCT02603809|10034114|FG004|Per-protocol Set|Overall Study||68
8970409|NCT02603809|10034115|FG005|Per-protocol Set|Overall Study||69
9038231|NCT03330262|10099555|FG001|NOT COMPLETED|Second Six Weeks||1
8970410|NCT02603809|10034110|FG000|Modified Per-Protocol Set|Overall Study|One participant had out of analysis window blood pressure measurements.|66
8970411|NCT02603809|10034111|FG001|Modified Per-Protocol Set|Overall Study||68
8970412|NCT02603809|10034112|FG002|Modified Per-Protocol Set|Overall Study||71
8970413|NCT02603809|10034113|FG003|Modified Per-Protocol Set|Overall Study||67
8970414|NCT02603809|10034114|FG004|Modified Per-Protocol Set|Overall Study||68
8970415|NCT02603809|10034115|FG005|Modified Per-Protocol Set|Overall Study||69
8970416|NCT02603809|10034110|FG000|Completed Study|Overall Study||75
8970417|NCT02603809|10034111|FG001|Completed Study|Overall Study||79
8970418|NCT02603809|10034112|FG002|Completed Study|Overall Study||79
8970419|NCT02603809|10034113|FG003|Completed Study|Overall Study||76
8970420|NCT02603809|10034114|FG004|Completed Study|Overall Study||78
8970421|NCT02603809|10034115|FG005|Completed Study|Overall Study||75
8970422|NCT02603809|10034110|FG000|COMPLETED|Overall Study||70
8970423|NCT02603809|10034111|FG001|COMPLETED|Overall Study||74
8970424|NCT02603809|10034112|FG002|COMPLETED|Overall Study||75
8970425|NCT02603809|10034113|FG003|COMPLETED|Overall Study||70
8970426|NCT02603809|10034114|FG004|COMPLETED|Overall Study||70
8970427|NCT02603809|10034115|FG005|COMPLETED|Overall Study||71
8970428|NCT02603809|10034110|FG000|NOT COMPLETED|Overall Study||12
8970429|NCT02603809|10034111|FG001|NOT COMPLETED|Overall Study||8
8970430|NCT02603809|10034112|FG002|NOT COMPLETED|Overall Study||7
8970431|NCT02603809|10034113|FG003|NOT COMPLETED|Overall Study||12
8970432|NCT02603809|10034114|FG004|NOT COMPLETED|Overall Study||11
8970433|NCT02603809|10034115|FG005|NOT COMPLETED|Overall Study||10
8970434|NCT02603926|10034131|FG000|STARTED|Overall Study||6
8970435|NCT02603926|10034131|FG000|COMPLETED|Overall Study||6
8970436|NCT02603926|10034131|FG000|NOT COMPLETED|Overall Study||0
8970437|NCT02603952|10034140|FG000|STARTED|Overall Study||32
8970438|NCT02603952|10034141|FG001|STARTED|Overall Study||31
8970439|NCT02603952|10034142|FG002|STARTED|Overall Study||31
8970440|NCT02603952|10034143|FG003|STARTED|Overall Study||32
8970441|NCT02603952|10034140|FG000|Treated|Overall Study||32
8970442|NCT02603952|10034141|FG001|Treated|Overall Study||31
8970443|NCT02603952|10034142|FG002|Treated|Overall Study||31
8970444|NCT02603952|10034143|FG003|Treated|Overall Study||31
8970445|NCT02603952|10034140|FG000|COMPLETED|Overall Study||31
8970446|NCT02603952|10034141|FG001|COMPLETED|Overall Study||31
8970447|NCT02603952|10034142|FG002|COMPLETED|Overall Study||31
8970448|NCT02603952|10034143|FG003|COMPLETED|Overall Study||31
8970449|NCT02603952|10034140|FG000|NOT COMPLETED|Overall Study||1
8970450|NCT02603952|10034141|FG001|NOT COMPLETED|Overall Study||0
8970451|NCT02603952|10034142|FG002|NOT COMPLETED|Overall Study||0
8970452|NCT02603952|10034143|FG003|NOT COMPLETED|Overall Study||1
8970453|NCT02604017|10034158|FG000|STARTED|Overall Study||352
8970454|NCT02604017|10034159|FG001|STARTED|Overall Study||351
8970455|NCT02604017|10034158|FG000|COMPLETED|Overall Study||346
8970456|NCT02604017|10034159|FG001|COMPLETED|Overall Study||343
8970457|NCT02604017|10034158|FG000|NOT COMPLETED|Overall Study||6
8970458|NCT02604017|10034159|FG001|NOT COMPLETED|Overall Study||8
8970459|NCT02604160|10034167|FG000|STARTED|Overall Study||2
8970460|NCT02604160|10034168|FG001|STARTED|Overall Study||5
8970461|NCT02604160|10034167|FG000|Received at Least One Dose of Study Drug|Overall Study||2
8970462|NCT02604160|10034168|FG001|Received at Least One Dose of Study Drug|Overall Study||5
8970463|NCT02604160|10034167|FG000|COMPLETED|Overall Study||2
8970464|NCT02604160|10034168|FG001|COMPLETED|Overall Study||3
8970465|NCT02604160|10034167|FG000|NOT COMPLETED|Overall Study||0
8970466|NCT02604160|10034168|FG001|NOT COMPLETED|Overall Study||2
8970467|NCT02604173|10034179|FG000|STARTED|Overall Study||33
8970468|NCT02604173|10034180|FG001|STARTED|Overall Study||35
8970469|NCT02604173|10034181|FG002|STARTED|Overall Study||35
8970470|NCT02604173|10034179|FG000|COMPLETED|Overall Study||33
8970471|NCT02604173|10034180|FG001|COMPLETED|Overall Study||35
8970472|NCT02604173|10034181|FG002|COMPLETED|Overall Study||35
8970473|NCT02604173|10034179|FG000|NOT COMPLETED|Overall Study||0
8631938|NCT00542789|9671811|FG000|STARTED|Overall Study|Randomised|175
8631939|NCT00542789|9671812|FG001|STARTED|Overall Study|Randomised|168
8631940|NCT00542789|9671811|FG000|COMPLETED|Overall Study||134
8631941|NCT00542789|9671812|FG001|COMPLETED|Overall Study||90
8631942|NCT00542789|9671811|FG000|NOT COMPLETED|Overall Study||41
8631943|NCT00542789|9671812|FG001|NOT COMPLETED|Overall Study||78
8631944|NCT00542815|9671821|FG000|STARTED|Overall Study||432
8631945|NCT00542815|9671822|FG001|STARTED|Overall Study||76
8631946|NCT00542815|9671823|FG002|STARTED|Overall Study||124
8631947|NCT00542815|9671821|FG000|COMPLETED|Overall Study||326
8631948|NCT00542815|9671822|FG001|COMPLETED|Overall Study||44
8631949|NCT00542815|9671823|FG002|COMPLETED|Overall Study||92
8631950|NCT00542815|9671821|FG000|NOT COMPLETED|Overall Study||106
8631951|NCT00542815|9671822|FG001|NOT COMPLETED|Overall Study||32
8970474|NCT02604173|10034180|FG001|NOT COMPLETED|Overall Study||0
8970475|NCT02604173|10034181|FG002|NOT COMPLETED|Overall Study||0
8970476|NCT02604199|10034193|FG000|STARTED|Overall Study||9
8970477|NCT02604199|10034194|FG001|STARTED|Overall Study||11
8970478|NCT02604199|10034195|FG002|STARTED|Overall Study||17
8970479|NCT02604199|10034196|FG003|STARTED|Overall Study||21
8970480|NCT02604199|10034193|FG000|COMPLETED|Overall Study||9
8970481|NCT02604199|10034194|FG001|COMPLETED|Overall Study||8
8970482|NCT02604199|10034195|FG002|COMPLETED|Overall Study||17
8970483|NCT02604199|10034196|FG003|COMPLETED|Overall Study||18
8970484|NCT02604199|10034193|FG000|NOT COMPLETED|Overall Study||0
8970485|NCT02604199|10034194|FG001|NOT COMPLETED|Overall Study||3
8970486|NCT02604199|10034195|FG002|NOT COMPLETED|Overall Study||0
8970487|NCT02604199|10034196|FG003|NOT COMPLETED|Overall Study||3
8970488|NCT02604212|10034213|FG000|STARTED|Overall Study||6
8970489|NCT02604212|10034214|FG001|STARTED|Overall Study||5
8970490|NCT02604212|10034215|FG002|STARTED|Overall Study||10
8970491|NCT02604212|10034216|FG003|STARTED|Overall Study||11
8970492|NCT02604212|10034213|FG000|COMPLETED|Overall Study||4
8970493|NCT02604212|10034214|FG001|COMPLETED|Overall Study||4
8970494|NCT02604212|10034215|FG002|COMPLETED|Overall Study||6
8970495|NCT02604212|10034216|FG003|COMPLETED|Overall Study||8
8970496|NCT02604212|10034213|FG000|NOT COMPLETED|Overall Study||2
8970497|NCT02604212|10034214|FG001|NOT COMPLETED|Overall Study||1
8970498|NCT02604212|10034215|FG002|NOT COMPLETED|Overall Study||4
8970499|NCT02604212|10034216|FG003|NOT COMPLETED|Overall Study||3
8970500|NCT02604264|10034233|FG000|STARTED|Run-In||618
8970501|NCT02604264|10034234|FG001|STARTED|Run-In|The 1-mo run-in period data was used to determine pre-study demographics and PBC rate.|611
8970502|NCT02604264|10034233|FG000|COMPLETED|Run-In||618
8970503|NCT02604264|10034234|FG001|COMPLETED|Run-In||611
8970504|NCT02604264|10034233|FG000|NOT COMPLETED|Run-In||0
8970505|NCT02604264|10034234|FG001|NOT COMPLETED|Run-In||0
8970506|NCT02604264|10034233|FG000|STARTED|Intervention||1445
8970507|NCT02604264|10034234|FG001|STARTED|Intervention||1467
8970508|NCT02604264|10034233|FG000|COMPLETED|Intervention||1245
8970509|NCT02604264|10034234|FG001|COMPLETED|Intervention||1225
8970510|NCT02604264|10034233|FG000|NOT COMPLETED|Intervention||200
8970511|NCT02604264|10034234|FG001|NOT COMPLETED|Intervention||242
8970512|NCT02604342|10034242|FG000|STARTED|Overall Study||79
8970513|NCT02604342|10034243|FG001|STARTED|Overall Study||40
8970514|NCT02604342|10034242|FG000|COMPLETED|Overall Study||36
8970515|NCT02604342|10034243|FG001|COMPLETED|Overall Study||17
8970516|NCT02604342|10034242|FG000|NOT COMPLETED|Overall Study||43
8970517|NCT02604342|10034243|FG001|NOT COMPLETED|Overall Study||23
8631952|NCT00542815|9671823|FG002|NOT COMPLETED|Overall Study||32
8631953|NCT00542828|9671831|FG000|STARTED|Overall Study|Number of participants enrolled in the study; of the 16 enrolled, 14 received study treatment.|16
8631954|NCT00542828|9671831|FG000|COMPLETED|Overall Study|Number of participants who completed the 12-month study period.|3
8970518|NCT02604407|10034252|FG000|STARTED|Overall Study||91
8970519|NCT02604407|10034253|FG001|STARTED|Overall Study||92
8970520|NCT02604407|10034254|FG002|STARTED|Overall Study||92
8970521|NCT02604407|10034252|FG000|TREATED|Overall Study||89
8970522|NCT02604407|10034253|FG001|TREATED|Overall Study||92
8970523|NCT02604407|10034254|FG002|TREATED|Overall Study||90
8970524|NCT02604407|10034252|FG000|COMPLETED|Overall Study||80
8970525|NCT02604407|10034253|FG001|COMPLETED|Overall Study||80
8970526|NCT02604407|10034254|FG002|COMPLETED|Overall Study||76
8970527|NCT02604407|10034252|FG000|NOT COMPLETED|Overall Study||11
8970528|NCT02604407|10034253|FG001|NOT COMPLETED|Overall Study||12
8970529|NCT02604407|10034254|FG002|NOT COMPLETED|Overall Study||16
8970530|NCT02604550|10034264|FG000|STARTED|Overall Study||56
8970531|NCT02604550|10034265|FG001|STARTED|Overall Study||59
8970532|NCT02604550|10034264|FG000|COMPLETED|Overall Study||31
8970533|NCT02604550|10034265|FG001|COMPLETED|Overall Study||33
8970534|NCT02604550|10034264|FG000|NOT COMPLETED|Overall Study||25
8970535|NCT02604550|10034265|FG001|NOT COMPLETED|Overall Study||26
8970536|NCT02604589|10034274|FG000|STARTED|Overall Study||3
8970537|NCT02604589|10034275|FG001|STARTED|Overall Study||5
8970538|NCT02604589|10034276|FG002|STARTED|Overall Study||2
8970539|NCT02604589|10034274|FG000|COMPLETED|Overall Study||3
8970540|NCT02604589|10034275|FG001|COMPLETED|Overall Study||5
8970541|NCT02604589|10034276|FG002|COMPLETED|Overall Study||1
8970542|NCT02604589|10034274|FG000|NOT COMPLETED|Overall Study||0
8970543|NCT02604589|10034275|FG001|NOT COMPLETED|Overall Study||0
8970544|NCT02604589|10034276|FG002|NOT COMPLETED|Overall Study||1
8970545|NCT02604810|10034284|FG000|STARTED|IGIV-C 10%, 4-5 Weeks||52
8970546|NCT02604810|10034284|FG000|COMPLETED|IGIV-C 10%, 4-5 Weeks||49
8970547|NCT02604810|10034284|FG000|NOT COMPLETED|IGIV-C 10%, 4-5 Weeks||3
8970548|NCT02604810|10034284|FG000|STARTED|IGSC 20%, 24 Weeks||49
8970549|NCT02604810|10034284|FG000|COMPLETED|IGSC 20%, 24 Weeks||42
8970550|NCT02604810|10034284|FG000|NOT COMPLETED|IGSC 20%, 24 Weeks||7
8970551|NCT02605122|10034292|FG000|STARTED|Overall Study||73
8970552|NCT02605122|10034293|FG001|STARTED|Overall Study||24
8970553|NCT02605122|10034292|FG000|Received Study Drug|Overall Study||70
8970554|NCT02605122|10034293|FG001|Received Study Drug|Overall Study||24
8970555|NCT02605122|10034292|FG000|COMPLETED|Overall Study||68
8970556|NCT02605122|10034293|FG001|COMPLETED|Overall Study||22
8970557|NCT02605122|10034292|FG000|NOT COMPLETED|Overall Study||5
8970558|NCT02605122|10034293|FG001|NOT COMPLETED|Overall Study||2
8970559|NCT02605174|10034303|FG000|STARTED|Overall Study||501
8970560|NCT02605174|10034304|FG001|STARTED|Overall Study||249
8970561|NCT02605174|10034305|FG002|STARTED|Overall Study||502
8970562|NCT02605174|10034306|FG003|STARTED|Overall Study||252
8970563|NCT02605174|10034307|FG004|STARTED|Overall Study||501
8970564|NCT02605174|10034308|FG005|STARTED|Overall Study||249
8970565|NCT02605174|10034309|FG006|STARTED|Overall Study||751
8970566|NCT02605174|10034303|FG000|Received at Least 1 Dose of Study Drug|Overall Study||429
8970567|NCT02605174|10034304|FG001|Received at Least 1 Dose of Study Drug|Overall Study||225
8970568|NCT02605174|10034305|FG002|Received at Least 1 Dose of Study Drug|Overall Study||423
8970569|NCT02605174|10034306|FG003|Received at Least 1 Dose of Study Drug|Overall Study||212
8970570|NCT02605174|10034307|FG004|Received at Least 1 Dose of Study Drug|Overall Study||434
8970571|NCT02605174|10034308|FG005|Received at Least 1 Dose of Study Drug|Overall Study||215
8970572|NCT02605174|10034309|FG006|Received at Least 1 Dose of Study Drug|Overall Study||645
8970573|NCT02605174|10034303|FG000|Received Optional 2nd Dose|Overall Study||206
8970574|NCT02605174|10034304|FG001|Received Optional 2nd Dose|Overall Study||96
8970575|NCT02605174|10034305|FG002|Received Optional 2nd Dose|Overall Study||177
8970576|NCT02605174|10034306|FG003|Received Optional 2nd Dose|Overall Study||83
8970577|NCT02605174|10034307|FG004|Received Optional 2nd Dose|Overall Study||144
8970578|NCT02605174|10034308|FG005|Received Optional 2nd Dose|Overall Study||74
8970579|NCT02605174|10034309|FG006|Received Optional 2nd Dose|Overall Study||361
8970580|NCT02605174|10034303|FG000|COMPLETED|Overall Study||437
8970581|NCT02605174|10034304|FG001|COMPLETED|Overall Study||226
8970582|NCT02605174|10034305|FG002|COMPLETED|Overall Study||426
8970583|NCT02605174|10034306|FG003|COMPLETED|Overall Study||216
8970584|NCT02605174|10034307|FG004|COMPLETED|Overall Study||448
8970585|NCT02605174|10034308|FG005|COMPLETED|Overall Study||217
8970586|NCT02605174|10034309|FG006|COMPLETED|Overall Study||662
8970587|NCT02605174|10034303|FG000|NOT COMPLETED|Overall Study||64
8970588|NCT02605174|10034304|FG001|NOT COMPLETED|Overall Study||23
8970589|NCT02605174|10034305|FG002|NOT COMPLETED|Overall Study||76
8970590|NCT02605174|10034306|FG003|NOT COMPLETED|Overall Study||36
8970591|NCT02605174|10034307|FG004|NOT COMPLETED|Overall Study||53
8970592|NCT02605174|10034308|FG005|NOT COMPLETED|Overall Study||32
8970593|NCT02605174|10034309|FG006|NOT COMPLETED|Overall Study||89
8970594|NCT02605187|10034339|FG000|STARTED|Overall Study||40
8970595|NCT02605187|10034340|FG001|STARTED|Overall Study||21
8970596|NCT02605187|10034341|FG002|STARTED|Overall Study||83
8970597|NCT02605187|10034342|FG003|STARTED|Overall Study||16
8970598|NCT02605187|10034339|FG000|COMPLETED|Overall Study||32
8970599|NCT02605187|10034340|FG001|COMPLETED|Overall Study||19
8970600|NCT02605187|10034341|FG002|COMPLETED|Overall Study||72
8970601|NCT02605187|10034342|FG003|COMPLETED|Overall Study||15
8970602|NCT02605187|10034339|FG000|NOT COMPLETED|Overall Study||8
8970603|NCT02605187|10034340|FG001|NOT COMPLETED|Overall Study||2
8970604|NCT02605187|10034341|FG002|NOT COMPLETED|Overall Study||11
8970605|NCT02605187|10034342|FG003|NOT COMPLETED|Overall Study||1
8970606|NCT02605304|10034354|FG000|STARTED|Overall Study||4
8970607|NCT02605304|10034355|FG001|STARTED|Overall Study||3
8970608|NCT02605304|10034354|FG000|COMPLETED|Overall Study||4
8970609|NCT02605304|10034355|FG001|COMPLETED|Overall Study||3
8970610|NCT02605304|10034354|FG000|NOT COMPLETED|Overall Study||0
8970611|NCT02605304|10034355|FG001|NOT COMPLETED|Overall Study||0
8970612|NCT02605395|10034361|FG000|STARTED|Period 1, Day 1||35
8970613|NCT02605395|10034362|FG001|STARTED|Period 1, Day 1||35
8970614|NCT02605395|10034361|FG000|COMPLETED|Period 1, Day 1||35
8970615|NCT02605395|10034362|FG001|COMPLETED|Period 1, Day 1||35
8970616|NCT02605395|10034361|FG000|NOT COMPLETED|Period 1, Day 1||0
8970617|NCT02605395|10034362|FG001|NOT COMPLETED|Period 1, Day 1||0
8570891|NCT00106184|9603061|FG000|Treated|Overall Study|96 subjects were randomized.|93
8570892|NCT00106184|9603062|FG001|Treated|Overall Study|104 subjects were randomized.|102
8970618|NCT02605395|10034361|FG000|STARTED|Washout Period, Day 2 to Day 7||35
8970619|NCT02605395|10034362|FG001|STARTED|Washout Period, Day 2 to Day 7||35
8970620|NCT02605395|10034361|FG000|COMPLETED|Washout Period, Day 2 to Day 7||35
8970621|NCT02605395|10034362|FG001|COMPLETED|Washout Period, Day 2 to Day 7||35
8970622|NCT02605395|10034361|FG000|NOT COMPLETED|Washout Period, Day 2 to Day 7||0
8970623|NCT02605395|10034362|FG001|NOT COMPLETED|Washout Period, Day 2 to Day 7||0
8970624|NCT02605395|10034361|FG000|STARTED|Period 2, Day 8||35
8970625|NCT02605395|10034362|FG001|STARTED|Period 2, Day 8||35
8970626|NCT02605395|10034361|FG000|COMPLETED|Period 2, Day 8||35
8970627|NCT02605395|10034362|FG001|COMPLETED|Period 2, Day 8||35
8970628|NCT02605395|10034361|FG000|NOT COMPLETED|Period 2, Day 8||0
8970629|NCT02605395|10034362|FG001|NOT COMPLETED|Period 2, Day 8||0
8970630|NCT02605447|10034368|FG000|STARTED|Overall Study||1487
8970631|NCT02605447|10034368|FG000|COMPLETED|Overall Study||1385
8970632|NCT02605447|10034368|FG000|NOT COMPLETED|Overall Study||102
8970633|NCT02605642|10034375|FG000|STARTED|Overall Study||227
8970634|NCT02605642|10034376|FG001|STARTED|Overall Study||107
8970635|NCT02605642|10034375|FG000|Safety Set|Overall Study||221
8970636|NCT02605642|10034376|FG001|Safety Set|Overall Study||107
8970637|NCT02605642|10034375|FG000|COMPLETED|Overall Study||131
8970638|NCT02605642|10034376|FG001|COMPLETED|Overall Study||86
8970639|NCT02605642|10034375|FG000|NOT COMPLETED|Overall Study||96
8970640|NCT02605642|10034376|FG001|NOT COMPLETED|Overall Study||21
8970641|NCT02605837|10034384|FG000|STARTED|Overall Study||105
8970642|NCT02605837|10034385|FG001|STARTED|Overall Study||213
8970643|NCT02605837|10034384|FG000|COMPLETED|Overall Study||94
8970644|NCT02605837|10034385|FG001|COMPLETED|Overall Study||202
8970645|NCT02605837|10034384|FG000|NOT COMPLETED|Overall Study||11
8970646|NCT02605837|10034385|FG001|NOT COMPLETED|Overall Study||11
8970647|NCT02605863|10034394|FG000|STARTED|Overall Study||1
8970648|NCT02605863|10034395|FG001|STARTED|Overall Study||0
8970649|NCT02605863|10034394|FG000|COMPLETED|Overall Study||1
8970650|NCT02605863|10034395|FG001|COMPLETED|Overall Study||0
8970651|NCT02605863|10034394|FG000|NOT COMPLETED|Overall Study||0
8970652|NCT02605863|10034395|FG001|NOT COMPLETED|Overall Study||0
9038232|NCT03330275|10099564|FG000|STARTED|Visit 1 - Period 1||6
9038233|NCT03330275|10099565|FG001|STARTED|Visit 1 - Period 1||6
9038234|NCT03330275|10099566|FG002|STARTED|Visit 1 - Period 1||6
9038235|NCT03330275|10099567|FG003|STARTED|Visit 1 - Period 1||6
9038236|NCT03330275|10099568|FG004|STARTED|Visit 1 - Period 1||0
9038237|NCT03330275|10099569|FG005|STARTED|Visit 1 - Period 1||0
9038238|NCT03330275|10099570|FG006|STARTED|Visit 1 - Period 1||0
9038239|NCT03330275|10099571|FG007|STARTED|Visit 1 - Period 1||0
9038240|NCT03330275|10099572|FG008|STARTED|Visit 1 - Period 1||0
9038241|NCT03330275|10099573|FG009|STARTED|Visit 1 - Period 1||0
9038242|NCT03330275|10099564|FG000|COMPLETED|Visit 1 - Period 1||6
9038243|NCT03330275|10099565|FG001|COMPLETED|Visit 1 - Period 1||6
9038244|NCT03330275|10099566|FG002|COMPLETED|Visit 1 - Period 1||6
9038245|NCT03330275|10099567|FG003|COMPLETED|Visit 1 - Period 1||6
9038246|NCT03330275|10099568|FG004|COMPLETED|Visit 1 - Period 1||0
9038247|NCT03330275|10099569|FG005|COMPLETED|Visit 1 - Period 1||0
9038248|NCT03330275|10099570|FG006|COMPLETED|Visit 1 - Period 1||0
9038249|NCT03330275|10099571|FG007|COMPLETED|Visit 1 - Period 1||0
9038250|NCT03330275|10099572|FG008|COMPLETED|Visit 1 - Period 1||0
9038251|NCT03330275|10099573|FG009|COMPLETED|Visit 1 - Period 1||0
9038252|NCT03330275|10099564|FG000|NOT COMPLETED|Visit 1 - Period 1||0
9038253|NCT03330275|10099565|FG001|NOT COMPLETED|Visit 1 - Period 1||0
9038254|NCT03330275|10099566|FG002|NOT COMPLETED|Visit 1 - Period 1||0
9038255|NCT03330275|10099567|FG003|NOT COMPLETED|Visit 1 - Period 1||0
9038256|NCT03330275|10099568|FG004|NOT COMPLETED|Visit 1 - Period 1||0
9038257|NCT03330275|10099569|FG005|NOT COMPLETED|Visit 1 - Period 1||0
9038258|NCT03330275|10099570|FG006|NOT COMPLETED|Visit 1 - Period 1||0
9038259|NCT03330275|10099571|FG007|NOT COMPLETED|Visit 1 - Period 1||0
9038260|NCT03330275|10099572|FG008|NOT COMPLETED|Visit 1 - Period 1||0
9038261|NCT03330275|10099573|FG009|NOT COMPLETED|Visit 1 - Period 1||0
9038262|NCT03330275|10099564|FG000|STARTED|Visit 1 - Period 2||6
9038263|NCT03330275|10099565|FG001|STARTED|Visit 1 - Period 2||6
9038264|NCT03330275|10099566|FG002|STARTED|Visit 1 - Period 2||6
9038265|NCT03330275|10099567|FG003|STARTED|Visit 1 - Period 2||6
9038266|NCT03330275|10099568|FG004|STARTED|Visit 1 - Period 2||0
9038267|NCT03330275|10099569|FG005|STARTED|Visit 1 - Period 2||0
9038268|NCT03330275|10099570|FG006|STARTED|Visit 1 - Period 2||0
9038269|NCT03330275|10099571|FG007|STARTED|Visit 1 - Period 2||0
9038270|NCT03330275|10099572|FG008|STARTED|Visit 1 - Period 2||0
9038271|NCT03330275|10099573|FG009|STARTED|Visit 1 - Period 2||0
9038272|NCT03330275|10099564|FG000|COMPLETED|Visit 1 - Period 2||6
9038273|NCT03330275|10099565|FG001|COMPLETED|Visit 1 - Period 2||6
9038274|NCT03330275|10099566|FG002|COMPLETED|Visit 1 - Period 2||6
9038275|NCT03330275|10099567|FG003|COMPLETED|Visit 1 - Period 2||6
9038276|NCT03330275|10099568|FG004|COMPLETED|Visit 1 - Period 2||0
9038277|NCT03330275|10099569|FG005|COMPLETED|Visit 1 - Period 2||0
9038278|NCT03330275|10099570|FG006|COMPLETED|Visit 1 - Period 2||0
9038279|NCT03330275|10099571|FG007|COMPLETED|Visit 1 - Period 2||0
9038280|NCT03330275|10099572|FG008|COMPLETED|Visit 1 - Period 2||0
9038281|NCT03330275|10099573|FG009|COMPLETED|Visit 1 - Period 2||0
9038282|NCT03330275|10099564|FG000|NOT COMPLETED|Visit 1 - Period 2||0
9038283|NCT03330275|10099565|FG001|NOT COMPLETED|Visit 1 - Period 2||0
9038284|NCT03330275|10099566|FG002|NOT COMPLETED|Visit 1 - Period 2||0
9038285|NCT03330275|10099567|FG003|NOT COMPLETED|Visit 1 - Period 2||0
9038286|NCT03330275|10099568|FG004|NOT COMPLETED|Visit 1 - Period 2||0
8970653|NCT02605876|10034404|FG000|STARTED|Overall Study||25
8970654|NCT02605876|10034405|FG001|STARTED|Overall Study||25
8970655|NCT02605876|10034406|FG002|STARTED|Overall Study||25
8970656|NCT02605876|10034404|FG000|COMPLETED|Overall Study||25
8970657|NCT02605876|10034405|FG001|COMPLETED|Overall Study||25
8970658|NCT02605876|10034406|FG002|COMPLETED|Overall Study||25
8970659|NCT02605876|10034404|FG000|NOT COMPLETED|Overall Study||0
8970660|NCT02605876|10034405|FG001|NOT COMPLETED|Overall Study||0
8970661|NCT02605876|10034406|FG002|NOT COMPLETED|Overall Study||0
8970662|NCT02605928|10034414|FG000|STARTED|Overall Study||79
8970663|NCT02605928|10034414|FG000|Pivotal Phase, Statistical Phase|Overall Study||51
8970664|NCT02605928|10034414|FG000|COMPLETED|Overall Study||46
8970665|NCT02605928|10034414|FG000|NOT COMPLETED|Overall Study||33
8970666|NCT02605954|10034420|FG000|STARTED|Overall Study||183
8970667|NCT02605954|10034421|FG001|STARTED|Overall Study||92
8970668|NCT02605954|10034420|FG000|COMPLETED|Overall Study||171
8970669|NCT02605954|10034421|FG001|COMPLETED|Overall Study||88
8970670|NCT02605954|10034420|FG000|NOT COMPLETED|Overall Study||12
8970671|NCT02605954|10034421|FG001|NOT COMPLETED|Overall Study||4
8970672|NCT02606253|10034433|FG000|STARTED|Overall Study||20
8970673|NCT02606253|10034434|FG001|STARTED|Overall Study||20
8970674|NCT02606253|10034435|FG002|STARTED|Overall Study||20
8970675|NCT02606253|10034433|FG000|COMPLETED|Overall Study||15
8970676|NCT02606253|10034434|FG001|COMPLETED|Overall Study||18
8970677|NCT02606253|10034435|FG002|COMPLETED|Overall Study||20
8970678|NCT02606253|10034433|FG000|NOT COMPLETED|Overall Study||5
8970679|NCT02606253|10034434|FG001|NOT COMPLETED|Overall Study||2
8970680|NCT02606253|10034435|FG002|NOT COMPLETED|Overall Study||0
8970681|NCT02606500|10034445|FG000|STARTED|Overall Study||35
8970682|NCT02606500|10034446|FG001|STARTED|Overall Study||35
8970683|NCT02606500|10034445|FG000|COMPLETED|Overall Study||35
8970684|NCT02606500|10034446|FG001|COMPLETED|Overall Study||35
8970685|NCT02606500|10034445|FG000|NOT COMPLETED|Overall Study||0
8970686|NCT02606500|10034446|FG001|NOT COMPLETED|Overall Study||0
8970687|NCT02606604|10034454|FG000|STARTED|Overall Study||8
8970688|NCT02606604|10034455|FG001|STARTED|Overall Study||7
8970689|NCT02606604|10034454|FG000|COMPLETED|Overall Study||7
8970690|NCT02606604|10034455|FG001|COMPLETED|Overall Study||7
8970691|NCT02606604|10034454|FG000|NOT COMPLETED|Overall Study||1
8970692|NCT02606604|10034455|FG001|NOT COMPLETED|Overall Study||0
8970693|NCT02606643|10034465|FG000|STARTED|Overall Study||68
8970694|NCT02606643|10034466|FG001|STARTED|Overall Study||76
8970695|NCT02606643|10034465|FG000|COMPLETED|Overall Study||67
8970696|NCT02606643|10034466|FG001|COMPLETED|Overall Study||73
8970697|NCT02606643|10034465|FG000|NOT COMPLETED|Overall Study||1
8970698|NCT02606643|10034466|FG001|NOT COMPLETED|Overall Study||3
8970699|NCT02606708|10034476|FG000|STARTED|Overall Study||314
8970700|NCT02606708|10034476|FG000|COMPLETED|Overall Study||314
8876758|NCT01919112|9933537|FG001|NOT COMPLETED|Primary Analysis-day 5 of Intervention||0
8876759|NCT01919112|9933538|FG002|NOT COMPLETED|Primary Analysis-day 5 of Intervention||0
8876760|NCT01919112|9933536|FG000|STARTED|Secondary Analysis-day 30||14
8970701|NCT02606708|10034476|FG000|NOT COMPLETED|Overall Study||0
8970702|NCT02606734|10034480|FG000|STARTED|Overall Study||44
8970703|NCT02606734|10034480|FG000|COMPLETED|Overall Study||44
8970704|NCT02606734|10034480|FG000|NOT COMPLETED|Overall Study||0
8970705|NCT02606838|10034484|FG000|STARTED|Overall Study||119
8970706|NCT02606838|10034484|FG000|COMPLETED|Overall Study||119
8970707|NCT02606838|10034484|FG000|NOT COMPLETED|Overall Study||0
8970708|NCT02606877|10034494|FG000|STARTED|Overall Study||20
8970709|NCT02606877|10034495|FG001|STARTED|Overall Study||17
8970710|NCT02606877|10034494|FG000|COMPLETED|Overall Study||16
8970711|NCT02606877|10034495|FG001|COMPLETED|Overall Study||16
8970712|NCT02606877|10034494|FG000|NOT COMPLETED|Overall Study||4
8970713|NCT02606877|10034495|FG001|NOT COMPLETED|Overall Study||1
8970714|NCT02606903|10034505|FG000|STARTED|Overall Study||35
8970715|NCT02606903|10034506|FG001|STARTED|Overall Study||36
8970716|NCT02606903|10034505|FG000|COMPLETED|Overall Study||35
8970717|NCT02606903|10034506|FG001|COMPLETED|Overall Study||36
8970718|NCT02606903|10034505|FG000|NOT COMPLETED|Overall Study||0
8970719|NCT02606903|10034506|FG001|NOT COMPLETED|Overall Study||0
8970720|NCT02607124|10034512|FG000|STARTED|Overall Study|11 participants were enrolled however 1 participant withdrew before starting study treatment.|10
8970721|NCT02607124|10034512|FG000|COMPLETED|Overall Study||10
8970722|NCT02607124|10034512|FG000|NOT COMPLETED|Overall Study||0
8970723|NCT02607228|10034524|FG000|STARTED|Overall Study||5
8970724|NCT02607228|10034525|FG001|STARTED|Overall Study||4
8970725|NCT02607228|10034526|FG002|STARTED|Overall Study||3
8970726|NCT02607228|10034527|FG003|STARTED|Overall Study||6
8970727|NCT02607228|10034528|FG004|STARTED|Overall Study||5
8970728|NCT02607228|10034529|FG005|STARTED|Overall Study||6
8970729|NCT02607228|10034530|FG006|STARTED|Overall Study||2
8970730|NCT02607228|10034524|FG000|COMPLETED|Overall Study||0
8970731|NCT02607228|10034525|FG001|COMPLETED|Overall Study||0
8970732|NCT02607228|10034526|FG002|COMPLETED|Overall Study||0
8970733|NCT02607228|10034527|FG003|COMPLETED|Overall Study||0
8970734|NCT02607228|10034528|FG004|COMPLETED|Overall Study||0
8970735|NCT02607228|10034529|FG005|COMPLETED|Overall Study||0
8970736|NCT02607228|10034530|FG006|COMPLETED|Overall Study||0
8970737|NCT02607228|10034524|FG000|NOT COMPLETED|Overall Study||5
8970738|NCT02607228|10034525|FG001|NOT COMPLETED|Overall Study||4
8970739|NCT02607228|10034526|FG002|NOT COMPLETED|Overall Study||3
8970740|NCT02607228|10034527|FG003|NOT COMPLETED|Overall Study||6
8970741|NCT02607228|10034528|FG004|NOT COMPLETED|Overall Study||5
8970742|NCT02607228|10034529|FG005|NOT COMPLETED|Overall Study||6
8970743|NCT02607228|10034530|FG006|NOT COMPLETED|Overall Study||2
8970744|NCT02607254|10034550|FG000|STARTED|Overall Study||3
8970745|NCT02607254|10034551|FG001|STARTED|Overall Study||3
8970746|NCT02607254|10034552|FG002|STARTED|Overall Study||5
8970747|NCT02607254|10034550|FG000|COMPLETED|Overall Study||3
8970748|NCT02607254|10034551|FG001|COMPLETED|Overall Study||3
8970749|NCT02607254|10034552|FG002|COMPLETED|Overall Study||5
8970750|NCT02607254|10034550|FG000|NOT COMPLETED|Overall Study||0
8970751|NCT02607254|10034551|FG001|NOT COMPLETED|Overall Study||0
8970752|NCT02607254|10034552|FG002|NOT COMPLETED|Overall Study||0
8970753|NCT02607280|10034568|FG000|STARTED|Overall Study||30
8970754|NCT02607280|10034569|FG001|STARTED|Overall Study||5
8970755|NCT02607280|10034568|FG000|Received Study Drug|Overall Study||30
8970756|NCT02607280|10034569|FG001|Received Study Drug|Overall Study||5
8970757|NCT02607280|10034568|FG000|COMPLETED|Overall Study||26
8970758|NCT02607280|10034569|FG001|COMPLETED|Overall Study||4
8970759|NCT02607280|10034568|FG000|NOT COMPLETED|Overall Study||4
8970760|NCT02607280|10034569|FG001|NOT COMPLETED|Overall Study||1
8970761|NCT02607306|10034578|FG000|STARTED|Overall Study||275
8970762|NCT02607306|10034579|FG001|STARTED|Overall Study||271
8970763|NCT02607306|10034580|FG002|STARTED|Overall Study||273
8970764|NCT02607306|10034578|FG000|COMPLETED|Overall Study||254
8970765|NCT02607306|10034579|FG001|COMPLETED|Overall Study||248
8970766|NCT02607306|10034580|FG002|COMPLETED|Overall Study||263
8970767|NCT02607306|10034578|FG000|NOT COMPLETED|Overall Study||21
8970768|NCT02607306|10034579|FG001|NOT COMPLETED|Overall Study||23
8970769|NCT02607306|10034580|FG002|NOT COMPLETED|Overall Study||10
8876761|NCT01919112|9933537|FG001|STARTED|Secondary Analysis-day 30||13
8876762|NCT01919112|9933538|FG002|STARTED|Secondary Analysis-day 30||15
8876763|NCT01919112|9933536|FG000|COMPLETED|Secondary Analysis-day 30||12
8876764|NCT01919112|9933537|FG001|COMPLETED|Secondary Analysis-day 30||12
8876765|NCT01919112|9933538|FG002|COMPLETED|Secondary Analysis-day 30||14
8876766|NCT01919112|9933536|FG000|NOT COMPLETED|Secondary Analysis-day 30||2
8876767|NCT01919112|9933537|FG001|NOT COMPLETED|Secondary Analysis-day 30||1
8876768|NCT01919112|9933538|FG002|NOT COMPLETED|Secondary Analysis-day 30||1
8876769|NCT01919164|9933551|FG000|STARTED|Overall Study||108
8970770|NCT02607618|10034591|FG000|STARTED|Overall Study||306
8970771|NCT02607618|10034592|FG001|STARTED|Overall Study||307
8970772|NCT02607618|10034591|FG000|COMPLETED|Overall Study||295
8970773|NCT02607618|10034592|FG001|COMPLETED|Overall Study||305
8970774|NCT02607618|10034591|FG000|NOT COMPLETED|Overall Study||11
8970775|NCT02607618|10034592|FG001|NOT COMPLETED|Overall Study||2
8970776|NCT02607735|10034600|FG000|STARTED|Primary Study||264
8876770|NCT01919164|9933552|FG001|STARTED|Overall Study||110
8970777|NCT02607735|10034601|FG001|STARTED|Primary Study||152
8970778|NCT02607735|10034602|FG002|STARTED|Primary Study||0
8970779|NCT02607735|10034600|FG000|COMPLETED|Primary Study||257
8970780|NCT02607735|10034601|FG001|COMPLETED|Primary Study||152
8970781|NCT02607735|10034602|FG002|COMPLETED|Primary Study||0
8970782|NCT02607735|10034600|FG000|NOT COMPLETED|Primary Study||7
8970783|NCT02607735|10034601|FG001|NOT COMPLETED|Primary Study||0
8970784|NCT02607735|10034602|FG002|NOT COMPLETED|Primary Study||0
8970785|NCT02607735|10034600|FG000|STARTED|Deferred Treatment Substudy||0
8970786|NCT02607735|10034601|FG001|STARTED|Deferred Treatment Substudy||0
8970787|NCT02607735|10034602|FG002|STARTED|Deferred Treatment Substudy||147
8970788|NCT02607735|10034600|FG000|COMPLETED|Deferred Treatment Substudy||0
8970789|NCT02607735|10034601|FG001|COMPLETED|Deferred Treatment Substudy||0
8970790|NCT02607735|10034602|FG002|COMPLETED|Deferred Treatment Substudy||142
8970791|NCT02607735|10034600|FG000|NOT COMPLETED|Deferred Treatment Substudy||0
8970792|NCT02607735|10034601|FG001|NOT COMPLETED|Deferred Treatment Substudy||0
8970793|NCT02607735|10034602|FG002|NOT COMPLETED|Deferred Treatment Substudy||5
8970794|NCT02607800|10034612|FG000|STARTED|Overall Study||502
8970795|NCT02607800|10034613|FG001|STARTED|Overall Study||441
8970796|NCT02607800|10034612|FG000|COMPLETED|Overall Study||492
8970797|NCT02607800|10034613|FG001|COMPLETED|Overall Study||430
8970798|NCT02607800|10034612|FG000|NOT COMPLETED|Overall Study||10
8970799|NCT02607800|10034613|FG001|NOT COMPLETED|Overall Study||11
8970800|NCT02607865|10034624|FG000|STARTED|Overall Study||466
8970801|NCT02607865|10034625|FG001|STARTED|Overall Study||466
8970802|NCT02607865|10034626|FG002|STARTED|Overall Study||465
8970803|NCT02607865|10034627|FG003|STARTED|Overall Study||467
8970804|NCT02607865|10034624|FG000|Full Analysis Set (FAS)|Overall Study||466
8970805|NCT02607865|10034625|FG001|Full Analysis Set (FAS)|Overall Study||465
8970806|NCT02607865|10034626|FG002|Full Analysis Set (FAS)|Overall Study||465
8970807|NCT02607865|10034627|FG003|Full Analysis Set (FAS)|Overall Study||467
8970808|NCT02607865|10034624|FG000|Safety Analysis Set (SAS)|Overall Study||466
8970809|NCT02607865|10034625|FG001|Safety Analysis Set (SAS)|Overall Study||464
8970810|NCT02607865|10034626|FG002|Safety Analysis Set (SAS)|Overall Study||465
8970811|NCT02607865|10034627|FG003|Safety Analysis Set (SAS)|Overall Study||466
8970812|NCT02607865|10034624|FG000|COMPLETED|Overall Study||433
8970813|NCT02607865|10034625|FG001|COMPLETED|Overall Study||436
8970814|NCT02607865|10034626|FG002|COMPLETED|Overall Study||438
8970815|NCT02607865|10034627|FG003|COMPLETED|Overall Study||451
8970816|NCT02607865|10034624|FG000|NOT COMPLETED|Overall Study||33
8970817|NCT02607865|10034625|FG001|NOT COMPLETED|Overall Study||30
8970818|NCT02607865|10034626|FG002|NOT COMPLETED|Overall Study||27
8970819|NCT02607865|10034627|FG003|NOT COMPLETED|Overall Study||16
8970820|NCT02608099|10034639|FG000|STARTED|Overall Study||148
8970821|NCT02608099|10034640|FG001|STARTED|Overall Study||152
8970822|NCT02608099|10034639|FG000|Safety|Overall Study||149
8970823|NCT02608099|10034640|FG001|Safety|Overall Study||151
8970824|NCT02608099|10034639|FG000|COMPLETED|Overall Study||145
8970825|NCT02608099|10034640|FG001|COMPLETED|Overall Study||150
8970826|NCT02608099|10034639|FG000|NOT COMPLETED|Overall Study||3
8970827|NCT02608099|10034640|FG001|NOT COMPLETED|Overall Study||2
8970828|NCT02608177|10034648|FG000|STARTED|Overall Study||2
8970829|NCT02608177|10034649|FG001|STARTED|Overall Study||1
8970830|NCT02608177|10034648|FG000|COMPLETED|Overall Study||2
8970831|NCT02608177|10034649|FG001|COMPLETED|Overall Study||1
8970832|NCT02608177|10034648|FG000|NOT COMPLETED|Overall Study||0
8970833|NCT02608177|10034649|FG001|NOT COMPLETED|Overall Study||0
8970834|NCT02608229|10034659|FG000|STARTED|Overall Study||10
8970835|NCT02608229|10034660|FG001|STARTED|Overall Study||8
8970836|NCT02608229|10034659|FG000|600 mg BVD-523|Overall Study||10
8970837|NCT02608229|10034660|FG001|600 mg BVD-523|Overall Study||2
8970838|NCT02608229|10034659|FG000|450 mg BVD-523|Overall Study||0
8970839|NCT02608229|10034660|FG001|450 mg BVD-523|Overall Study||6
8970840|NCT02608229|10034659|FG000|COMPLETED|Overall Study||10
8970841|NCT02608229|10034660|FG001|COMPLETED|Overall Study||8
8970842|NCT02608229|10034659|FG000|NOT COMPLETED|Overall Study||0
8970843|NCT02608229|10034660|FG001|NOT COMPLETED|Overall Study||0
8970844|NCT02608450|10034670|FG000|STARTED|Overall Study||353
8970845|NCT02608450|10034671|FG001|STARTED|Overall Study||355
8970846|NCT02608450|10034670|FG000|COMPLETED|Overall Study||287
8970847|NCT02608450|10034671|FG001|COMPLETED|Overall Study||290
8970848|NCT02608450|10034670|FG000|NOT COMPLETED|Overall Study||66
8970849|NCT02608450|10034671|FG001|NOT COMPLETED|Overall Study||65
8970850|NCT02608463|10034680|FG000|STARTED|Overall Study||10
8970851|NCT02608463|10034681|FG001|STARTED|Overall Study||5
8970852|NCT02608463|10034682|FG002|STARTED|Overall Study||0
8970853|NCT02608463|10034683|FG003|STARTED|Overall Study|No study participants were enrolled in Part B.|0
8970854|NCT02608463|10034680|FG000|COMPLETED|Overall Study||10
8970855|NCT02608463|10034681|FG001|COMPLETED|Overall Study||5
8970856|NCT02608463|10034682|FG002|COMPLETED|Overall Study||0
8970857|NCT02608463|10034683|FG003|COMPLETED|Overall Study||0
8970858|NCT02608463|10034680|FG000|NOT COMPLETED|Overall Study||0
8970859|NCT02608463|10034681|FG001|NOT COMPLETED|Overall Study||0
8970860|NCT02608463|10034682|FG002|NOT COMPLETED|Overall Study||0
8970861|NCT02608463|10034683|FG003|NOT COMPLETED|Overall Study||0
8970862|NCT02608476|10034693|FG000|STARTED|Overall Study||369
8970863|NCT02608476|10034694|FG001|STARTED|Overall Study||363
8970864|NCT02608476|10034693|FG000|COMPLETED|Overall Study||302
8970865|NCT02608476|10034694|FG001|COMPLETED|Overall Study||282
8970866|NCT02608476|10034693|FG000|NOT COMPLETED|Overall Study||67
8970867|NCT02608476|10034694|FG001|NOT COMPLETED|Overall Study||81
8970868|NCT02608489|10034702|FG000|STARTED|Overall Study||43
8970869|NCT02608489|10034703|FG001|STARTED|Overall Study||43
8970870|NCT02608489|10034702|FG000|COMPLETED|Overall Study||30
8970871|NCT02608489|10034703|FG001|COMPLETED|Overall Study||33
8970872|NCT02608489|10034702|FG000|NOT COMPLETED|Overall Study||13
8970873|NCT02608489|10034703|FG001|NOT COMPLETED|Overall Study||10
8970874|NCT02608879|10034712|FG000|STARTED|Overall Study||10
8970875|NCT02608879|10034713|FG001|STARTED|Overall Study||6
8970876|NCT02608879|10034714|FG002|STARTED|Overall Study||3
8970877|NCT02608879|10034712|FG000|COMPLETED|Overall Study||9
8970878|NCT02608879|10034713|FG001|COMPLETED|Overall Study||6
8970879|NCT02608879|10034714|FG002|COMPLETED|Overall Study||0
8970880|NCT02608879|10034712|FG000|NOT COMPLETED|Overall Study||1
8970881|NCT02608879|10034713|FG001|NOT COMPLETED|Overall Study||0
8970882|NCT02608879|10034714|FG002|NOT COMPLETED|Overall Study||3
8970883|NCT02608892|10034724|FG000|STARTED|Overall Study||51
8970884|NCT02608892|10034725|FG001|STARTED|Overall Study||49
8970885|NCT02608892|10034724|FG000|COMPLETED|Overall Study||50
8970886|NCT02608892|10034725|FG001|COMPLETED|Overall Study||49
8970887|NCT02608892|10034724|FG000|NOT COMPLETED|Overall Study||1
8970888|NCT02608892|10034725|FG001|NOT COMPLETED|Overall Study||0
8970889|NCT02609100|10034734|FG000|STARTED|Overall Study||2
8970890|NCT02609100|10034735|FG001|STARTED|Overall Study||2
8970891|NCT02609100|10034734|FG000|COMPLETED|Overall Study||2
8970892|NCT02609100|10034735|FG001|COMPLETED|Overall Study||2
8970893|NCT02609100|10034734|FG000|NOT COMPLETED|Overall Study||0
8970894|NCT02609100|10034735|FG001|NOT COMPLETED|Overall Study||0
8970895|NCT02609113|10034745|FG000|STARTED|Overall Study||11
8970896|NCT02609113|10034746|FG001|STARTED|Overall Study||11
8970897|NCT02609113|10034745|FG000|COMPLETED|Overall Study||9
8970898|NCT02609113|10034746|FG001|COMPLETED|Overall Study||9
8970899|NCT02609113|10034745|FG000|NOT COMPLETED|Overall Study||2
8970900|NCT02609113|10034746|FG001|NOT COMPLETED|Overall Study||2
8970901|NCT02609178|10034752|FG000|STARTED|First Crown||0
8970902|NCT02609178|10034753|FG001|STARTED|First Crown||1
8970903|NCT02609178|10034754|FG002|STARTED|First Crown||6
8970904|NCT02609178|10034755|FG003|STARTED|First Crown||3
8970905|NCT02609178|10034756|FG004|STARTED|First Crown||0
8970906|NCT02609178|10034757|FG005|STARTED|First Crown||2
8970907|NCT02609178|10034752|FG000|COMPLETED|First Crown||0
8970908|NCT02609178|10034753|FG001|COMPLETED|First Crown||1
8970909|NCT02609178|10034754|FG002|COMPLETED|First Crown||5
8970910|NCT02609178|10034755|FG003|COMPLETED|First Crown||2
8970911|NCT02609178|10034756|FG004|COMPLETED|First Crown||0
8970912|NCT02609178|10034757|FG005|COMPLETED|First Crown||2
8970913|NCT02609178|10034752|FG000|NOT COMPLETED|First Crown||0
8970914|NCT02609178|10034753|FG001|NOT COMPLETED|First Crown||0
8970915|NCT02609178|10034754|FG002|NOT COMPLETED|First Crown||1
8970916|NCT02609178|10034755|FG003|NOT COMPLETED|First Crown||1
8970917|NCT02609178|10034756|FG004|NOT COMPLETED|First Crown||0
8970918|NCT02609178|10034757|FG005|NOT COMPLETED|First Crown||0
8970919|NCT02609178|10034752|FG000|STARTED|5-minute Washout Time||0
8970920|NCT02609178|10034753|FG001|STARTED|5-minute Washout Time||1
8970921|NCT02609178|10034754|FG002|STARTED|5-minute Washout Time||5
8970922|NCT02609178|10034755|FG003|STARTED|5-minute Washout Time||2
8970923|NCT02609178|10034756|FG004|STARTED|5-minute Washout Time||0
8970924|NCT02609178|10034757|FG005|STARTED|5-minute Washout Time||2
8970925|NCT02609178|10034752|FG000|COMPLETED|5-minute Washout Time||0
8970926|NCT02609178|10034753|FG001|COMPLETED|5-minute Washout Time||1
8970927|NCT02609178|10034754|FG002|COMPLETED|5-minute Washout Time||5
8970928|NCT02609178|10034755|FG003|COMPLETED|5-minute Washout Time||2
8970929|NCT02609178|10034756|FG004|COMPLETED|5-minute Washout Time||0
8970930|NCT02609178|10034757|FG005|COMPLETED|5-minute Washout Time||2
8970931|NCT02609178|10034752|FG000|NOT COMPLETED|5-minute Washout Time||0
8570893|NCT00106184|9603061|FG000|COMPLETED|Overall Study||93
8570894|NCT00106184|9603062|FG001|COMPLETED|Overall Study||102
8970932|NCT02609178|10034753|FG001|NOT COMPLETED|5-minute Washout Time||0
8970933|NCT02609178|10034754|FG002|NOT COMPLETED|5-minute Washout Time||0
8970934|NCT02609178|10034755|FG003|NOT COMPLETED|5-minute Washout Time||0
8970935|NCT02609178|10034756|FG004|NOT COMPLETED|5-minute Washout Time||0
8970936|NCT02609178|10034757|FG005|NOT COMPLETED|5-minute Washout Time||0
8970937|NCT02609178|10034752|FG000|STARTED|Second Crown||0
8970938|NCT02609178|10034753|FG001|STARTED|Second Crown||1
8970939|NCT02609178|10034754|FG002|STARTED|Second Crown||5
8970940|NCT02609178|10034755|FG003|STARTED|Second Crown||2
8970941|NCT02609178|10034756|FG004|STARTED|Second Crown||0
8970942|NCT02609178|10034757|FG005|STARTED|Second Crown||2
8970943|NCT02609178|10034752|FG000|COMPLETED|Second Crown||0
8570895|NCT00106184|9603061|FG000|NOT COMPLETED|Overall Study||3
8970944|NCT02609178|10034753|FG001|COMPLETED|Second Crown||1
8970945|NCT02609178|10034754|FG002|COMPLETED|Second Crown||5
8970946|NCT02609178|10034755|FG003|COMPLETED|Second Crown||2
8970947|NCT02609178|10034756|FG004|COMPLETED|Second Crown||0
8970948|NCT02609178|10034757|FG005|COMPLETED|Second Crown||2
8970949|NCT02609178|10034752|FG000|NOT COMPLETED|Second Crown||0
8970950|NCT02609178|10034753|FG001|NOT COMPLETED|Second Crown||0
8970951|NCT02609178|10034754|FG002|NOT COMPLETED|Second Crown||0
8970952|NCT02609178|10034755|FG003|NOT COMPLETED|Second Crown||0
8970953|NCT02609178|10034756|FG004|NOT COMPLETED|Second Crown||0
8970954|NCT02609178|10034757|FG005|NOT COMPLETED|Second Crown||0
8970955|NCT02609178|10034752|FG000|STARTED|5-minute Washout Time||0
8970956|NCT02609178|10034753|FG001|STARTED|5-minute Washout Time||1
8970957|NCT02609178|10034754|FG002|STARTED|5-minute Washout Time||5
8970958|NCT02609178|10034755|FG003|STARTED|5-minute Washout Time||2
8970959|NCT02609178|10034756|FG004|STARTED|5-minute Washout Time||0
8970960|NCT02609178|10034757|FG005|STARTED|5-minute Washout Time||2
8970961|NCT02609178|10034752|FG000|COMPLETED|5-minute Washout Time||0
8970962|NCT02609178|10034753|FG001|COMPLETED|5-minute Washout Time||1
8970963|NCT02609178|10034754|FG002|COMPLETED|5-minute Washout Time||5
8970964|NCT02609178|10034755|FG003|COMPLETED|5-minute Washout Time||2
8970965|NCT02609178|10034756|FG004|COMPLETED|5-minute Washout Time||0
8970966|NCT02609178|10034757|FG005|COMPLETED|5-minute Washout Time||2
8970967|NCT02609178|10034752|FG000|NOT COMPLETED|5-minute Washout Time||0
8970968|NCT02609178|10034753|FG001|NOT COMPLETED|5-minute Washout Time||0
8970969|NCT02609178|10034754|FG002|NOT COMPLETED|5-minute Washout Time||0
8970970|NCT02609178|10034755|FG003|NOT COMPLETED|5-minute Washout Time||0
8970971|NCT02609178|10034756|FG004|NOT COMPLETED|5-minute Washout Time||0
8970972|NCT02609178|10034757|FG005|NOT COMPLETED|5-minute Washout Time||0
8970973|NCT02609178|10034752|FG000|STARTED|Third Crown||0
8970974|NCT02609178|10034753|FG001|STARTED|Third Crown||1
8970975|NCT02609178|10034754|FG002|STARTED|Third Crown||5
8970976|NCT02609178|10034755|FG003|STARTED|Third Crown||2
8970977|NCT02609178|10034756|FG004|STARTED|Third Crown||0
8970978|NCT02609178|10034757|FG005|STARTED|Third Crown||2
8970979|NCT02609178|10034752|FG000|COMPLETED|Third Crown||0
8970980|NCT02609178|10034753|FG001|COMPLETED|Third Crown||1
8970981|NCT02609178|10034754|FG002|COMPLETED|Third Crown||5
8970982|NCT02609178|10034755|FG003|COMPLETED|Third Crown||2
8970983|NCT02609178|10034756|FG004|COMPLETED|Third Crown||0
8970984|NCT02609178|10034757|FG005|COMPLETED|Third Crown||2
8970985|NCT02609178|10034752|FG000|NOT COMPLETED|Third Crown||0
8970986|NCT02609178|10034753|FG001|NOT COMPLETED|Third Crown||0
8970987|NCT02609178|10034754|FG002|NOT COMPLETED|Third Crown||0
8970988|NCT02609178|10034755|FG003|NOT COMPLETED|Third Crown||0
8970989|NCT02609178|10034756|FG004|NOT COMPLETED|Third Crown||0
8970990|NCT02609178|10034757|FG005|NOT COMPLETED|Third Crown||0
8970991|NCT02609204|10034763|FG000|STARTED|Overall Study||51
8970992|NCT02609204|10034763|FG000|COMPLETED|Overall Study||51
8970993|NCT02609204|10034763|FG000|NOT COMPLETED|Overall Study||0
8970994|NCT02609308|10034770|FG000|STARTED|Overall Study||10
8970995|NCT02609308|10034771|FG001|STARTED|Overall Study||11
8970996|NCT02609308|10034770|FG000|COMPLETED|Overall Study||10
8970997|NCT02609308|10034771|FG001|COMPLETED|Overall Study||11
8970998|NCT02609308|10034770|FG000|NOT COMPLETED|Overall Study||0
8970999|NCT02609308|10034771|FG001|NOT COMPLETED|Overall Study||0
8971000|NCT02609399|10034779|FG000|STARTED|Influenza Season 2015-2016||27
8971001|NCT02609399|10034780|FG001|STARTED|Influenza Season 2015-2016||31
8971002|NCT02609399|10034779|FG000|COMPLETED|Influenza Season 2015-2016||24
8971003|NCT02609399|10034780|FG001|COMPLETED|Influenza Season 2015-2016||29
8971004|NCT02609399|10034779|FG000|NOT COMPLETED|Influenza Season 2015-2016||3
8971005|NCT02609399|10034780|FG001|NOT COMPLETED|Influenza Season 2015-2016||2
8971006|NCT02609399|10034779|FG000|STARTED|Influenza Season 2016-2017||58
8971007|NCT02609399|10034780|FG001|STARTED|Influenza Season 2016-2017||64
8971008|NCT02609399|10034779|FG000|COMPLETED|Influenza Season 2016-2017||49
8971009|NCT02609399|10034780|FG001|COMPLETED|Influenza Season 2016-2017||59
8971010|NCT02609399|10034779|FG000|NOT COMPLETED|Influenza Season 2016-2017||9
8971011|NCT02609399|10034780|FG001|NOT COMPLETED|Influenza Season 2016-2017||5
8971012|NCT02609607|10034790|FG000|STARTED|Overall Study||6
8570896|NCT00106184|9603062|FG001|NOT COMPLETED|Overall Study||2
8577574|NCT00159432|9610338|FG000|COMPLETED|Overall Study||53
8577575|NCT00159432|9610338|FG000|NOT COMPLETED|Overall Study||10
8577576|NCT00159822|9610342|FG000|STARTED|Voriconazole Treatment Period||48
8971013|NCT02609607|10034791|FG001|STARTED|Overall Study||5
8971014|NCT02609607|10034790|FG000|COMPLETED|Overall Study||6
8971015|NCT02609607|10034791|FG001|COMPLETED|Overall Study||4
8971016|NCT02609607|10034790|FG000|NOT COMPLETED|Overall Study||0
8971017|NCT02609607|10034791|FG001|NOT COMPLETED|Overall Study||1
8971018|NCT02609633|10034799|FG000|STARTED|Overall Study||42
8971019|NCT02609633|10034800|FG001|STARTED|Overall Study||56
8971020|NCT02609633|10034799|FG000|Full Analysis Set (FAS)|Overall Study||32
8971021|NCT02609633|10034800|FG001|Full Analysis Set (FAS)|Overall Study||46
8971022|NCT02609633|10034799|FG000|COMPLETED|Overall Study||37
8971023|NCT02609633|10034800|FG001|COMPLETED|Overall Study||54
8971024|NCT02609633|10034799|FG000|NOT COMPLETED|Overall Study||5
8971025|NCT02609633|10034800|FG001|NOT COMPLETED|Overall Study||2
8971026|NCT02609659|10034807|FG000|STARTED|Overall Study||105
8971027|NCT02609659|10034807|FG000|COMPLETED|Overall Study||97
8971028|NCT02609659|10034807|FG000|NOT COMPLETED|Overall Study||8
8971029|NCT02609672|10034813|FG000|STARTED|Overall Study||12
8971030|NCT02609672|10034814|FG001|STARTED|Overall Study||12
8971031|NCT02609672|10034813|FG000|COMPLETED|Overall Study||9
8971032|NCT02609672|10034814|FG001|COMPLETED|Overall Study||11
8971033|NCT02609672|10034813|FG000|NOT COMPLETED|Overall Study||3
8971034|NCT02609672|10034814|FG001|NOT COMPLETED|Overall Study||1
8971035|NCT02609841|10034822|FG000|STARTED|Overall Study||240
8971036|NCT02609841|10034822|FG000|COMPLETED|Overall Study||212
8971037|NCT02609841|10034822|FG000|NOT COMPLETED|Overall Study||28
8971038|NCT02609984|10034830|FG000|STARTED|Overall Study||45
8971039|NCT02609984|10034831|FG001|STARTED|Overall Study||44
8971040|NCT02609984|10034830|FG000|Treated|Overall Study||45
8971041|NCT02609984|10034831|FG001|Treated|Overall Study||43
8971042|NCT02609984|10034830|FG000|COMPLETED|Overall Study||1
8971043|NCT02609984|10034831|FG001|COMPLETED|Overall Study||5
8971044|NCT02609984|10034830|FG000|NOT COMPLETED|Overall Study||44
8971045|NCT02609984|10034831|FG001|NOT COMPLETED|Overall Study||39
8971046|NCT02610140|10034839|FG000|STARTED|Randomization and Treatment Period||166
8971047|NCT02610140|10034840|FG001|STARTED|Randomization and Treatment Period||82
8971048|NCT02610140|10034839|FG000|Participants Received Treatment|Randomization and Treatment Period|Safety analysis set|163
8971049|NCT02610140|10034840|FG001|Participants Received Treatment|Randomization and Treatment Period|Safety analysis set|72
8971050|NCT02610140|10034839|FG000|COMPLETED|Randomization and Treatment Period||0
8971051|NCT02610140|10034840|FG001|COMPLETED|Randomization and Treatment Period||0
8971052|NCT02610140|10034839|FG000|NOT COMPLETED|Randomization and Treatment Period||166
8971053|NCT02610140|10034840|FG001|NOT COMPLETED|Randomization and Treatment Period||82
8971054|NCT02610140|10034839|FG000|STARTED|Safety Follow-up||102
8971055|NCT02610140|10034840|FG001|STARTED|Safety Follow-up||45
8971056|NCT02610140|10034839|FG000|COMPLETED|Safety Follow-up||57
8971057|NCT02610140|10034840|FG001|COMPLETED|Safety Follow-up||21
8971058|NCT02610140|10034839|FG000|NOT COMPLETED|Safety Follow-up||45
8971059|NCT02610140|10034840|FG001|NOT COMPLETED|Safety Follow-up||24
8971060|NCT02610140|10034839|FG000|STARTED|Active Follow-up||48
8971061|NCT02610140|10034840|FG001|STARTED|Active Follow-up||26
8971062|NCT02610140|10034839|FG000|COMPLETED|Active Follow-up||0
8971063|NCT02610140|10034840|FG001|COMPLETED|Active Follow-up||0
8971064|NCT02610140|10034839|FG000|NOT COMPLETED|Active Follow-up||48
8971065|NCT02610140|10034840|FG001|NOT COMPLETED|Active Follow-up||26
8971066|NCT02610140|10034839|FG000|STARTED|Long-term Follow-up||123
8971067|NCT02610140|10034840|FG001|STARTED|Long-term Follow-up||66
8971068|NCT02610140|10034839|FG000|COMPLETED|Long-term Follow-up||0
8971069|NCT02610140|10034840|FG001|COMPLETED|Long-term Follow-up||0
8725801|NCT01033487|9773158|FG001|STARTED|First Intervention Period||3
8725802|NCT01033487|9773159|FG002|STARTED|First Intervention Period||2
8725803|NCT01033487|9773160|FG003|STARTED|First Intervention Period||2
8725804|NCT01033487|9773161|FG004|STARTED|First Intervention Period||2
8971070|NCT02610140|10034839|FG000|NOT COMPLETED|Long-term Follow-up||123
8971071|NCT02610140|10034840|FG001|NOT COMPLETED|Long-term Follow-up||66
8971072|NCT02610192|10034846|FG000|STARTED|Overall Study|52 subjects had signed consent form, but 50 subjects have been treated. 2 subjects became SF.|50
8971073|NCT02610192|10034846|FG000|COMPLETED|Overall Study||41
8971074|NCT02610192|10034846|FG000|NOT COMPLETED|Overall Study||9
8971075|NCT02610231|10034850|FG000|STARTED|Overall Study||239
8971076|NCT02610231|10034850|FG000|COMPLETED|Overall Study||179
8971077|NCT02610231|10034850|FG000|NOT COMPLETED|Overall Study||60
8971078|NCT02610634|10034859|FG000|STARTED|Overall Study||60
8971079|NCT02610634|10034860|FG001|STARTED|Overall Study||40
8971080|NCT02610634|10034859|FG000|COMPLETED|Overall Study||60
8971081|NCT02610634|10034860|FG001|COMPLETED|Overall Study||40
8971082|NCT02610634|10034859|FG000|NOT COMPLETED|Overall Study||0
8971083|NCT02610634|10034860|FG001|NOT COMPLETED|Overall Study||0
8971084|NCT02610725|10034866|FG000|STARTED|Overall Study||281
8971085|NCT02610725|10034866|FG000|COMPLETED|Overall Study||75
8971086|NCT02610725|10034866|FG000|NOT COMPLETED|Overall Study||206
8971087|NCT02610777|10034872|FG000|STARTED|Overall Study||62
8971088|NCT02610777|10034873|FG001|STARTED|Overall Study||58
8971089|NCT02610777|10034872|FG000|COMPLETED|Overall Study||41
8971090|NCT02610777|10034873|FG001|COMPLETED|Overall Study||36
8971091|NCT02610777|10034872|FG000|NOT COMPLETED|Overall Study||21
8971092|NCT02610777|10034873|FG001|NOT COMPLETED|Overall Study||22
8971093|NCT02610816|10034881|FG000|STARTED|Phase 1||38
8971094|NCT02610816|10034882|FG001|STARTED|Phase 1||25
8971095|NCT02610816|10034883|FG002|STARTED|Phase 1||0
8725805|NCT01033487|9773162|FG005|STARTED|First Intervention Period||2
8971096|NCT02610816|10034884|FG003|STARTED|Phase 1||0
8971097|NCT02610816|10034881|FG000|COMPLETED|Phase 1||34
8971098|NCT02610816|10034882|FG001|COMPLETED|Phase 1||17
8971099|NCT02610816|10034883|FG002|COMPLETED|Phase 1||0
8971100|NCT02610816|10034884|FG003|COMPLETED|Phase 1||0
8971101|NCT02610816|10034881|FG000|NOT COMPLETED|Phase 1||4
8971102|NCT02610816|10034882|FG001|NOT COMPLETED|Phase 1||8
8971103|NCT02610816|10034883|FG002|NOT COMPLETED|Phase 1||0
8971104|NCT02610816|10034884|FG003|NOT COMPLETED|Phase 1||0
8971105|NCT02610816|10034881|FG000|STARTED|Phase 2||0
8971106|NCT02610816|10034882|FG001|STARTED|Phase 2||0
8971107|NCT02610816|10034883|FG002|STARTED|Phase 2||19
8971108|NCT02610816|10034884|FG003|STARTED|Phase 2||10
8971109|NCT02610816|10034881|FG000|COMPLETED|Phase 2||0
8971110|NCT02610816|10034882|FG001|COMPLETED|Phase 2||0
8971111|NCT02610816|10034883|FG002|COMPLETED|Phase 2||8
8971112|NCT02610816|10034884|FG003|COMPLETED|Phase 2||4
8971113|NCT02610816|10034881|FG000|NOT COMPLETED|Phase 2||0
8971114|NCT02610816|10034882|FG001|NOT COMPLETED|Phase 2||0
8971115|NCT02610816|10034883|FG002|NOT COMPLETED|Phase 2||11
8971116|NCT02610816|10034884|FG003|NOT COMPLETED|Phase 2||6
8971117|NCT02610842|10034894|FG000|STARTED|Overall Study||27
8971118|NCT02610842|10034894|FG000|COMPLETED|Overall Study||22
8971119|NCT02610842|10034894|FG000|NOT COMPLETED|Overall Study||5
8971120|NCT02610868|10034900|FG000|STARTED|MYOBLOC: Treatment Session 1||187
8971121|NCT02610868|10034900|FG000|COMPLETED|MYOBLOC: Treatment Session 1||180
8971122|NCT02610868|10034900|FG000|NOT COMPLETED|MYOBLOC: Treatment Session 1||7
8971123|NCT02610868|10034900|FG000|STARTED|MYOBLOC: Treatment Session 2||177
8971124|NCT02610868|10034900|FG000|COMPLETED|MYOBLOC: Treatment Session 2||165
8971125|NCT02610868|10034900|FG000|NOT COMPLETED|MYOBLOC: Treatment Session 2||12
8971126|NCT02610868|10034900|FG000|STARTED|MYOBLOC: Treatment Session 3||50
8971127|NCT02610868|10034900|FG000|COMPLETED|MYOBLOC: Treatment Session 3||43
8971128|NCT02610868|10034900|FG000|NOT COMPLETED|MYOBLOC: Treatment Session 3||7
8971129|NCT02610868|10034900|FG000|STARTED|MYOBLOC: Treatment Session 4||24
8971130|NCT02610868|10034900|FG000|COMPLETED|MYOBLOC: Treatment Session 4||22
8971131|NCT02610868|10034900|FG000|NOT COMPLETED|MYOBLOC: Treatment Session 4||2
8971132|NCT02610972|10034922|FG000|STARTED|Overall Study||100
8971133|NCT02610972|10034923|FG001|STARTED|Overall Study||50
8971134|NCT02610972|10034922|FG000|COMPLETED|Overall Study||100
8971135|NCT02610972|10034923|FG001|COMPLETED|Overall Study||50
8971136|NCT02610972|10034922|FG000|NOT COMPLETED|Overall Study||0
8971137|NCT02610972|10034923|FG001|NOT COMPLETED|Overall Study||0
8971138|NCT02611154|10034929|FG000|STARTED|Overall Study||5
8971139|NCT02611154|10034929|FG000|COMPLETED|Overall Study||5
8971140|NCT02611154|10034929|FG000|NOT COMPLETED|Overall Study||0
8971141|NCT02611362|10034950|FG000|STARTED|Overall Study||41
8971142|NCT02611362|10034951|FG001|STARTED|Overall Study||41
8971143|NCT02611362|10034950|FG000|Immediate Posttest (3 Months)|Overall Study||33
8971144|NCT02611362|10034951|FG001|Immediate Posttest (3 Months)|Overall Study||34
8971145|NCT02611362|10034950|FG000|6-month Follow-up|Overall Study||32
8971146|NCT02611362|10034951|FG001|6-month Follow-up|Overall Study||35
8971147|NCT02611362|10034950|FG000|COMPLETED|Overall Study||32
8971148|NCT02611362|10034951|FG001|COMPLETED|Overall Study||35
8971149|NCT02611362|10034950|FG000|NOT COMPLETED|Overall Study||9
8971150|NCT02611362|10034951|FG001|NOT COMPLETED|Overall Study||6
8971151|NCT02611479|10034958|FG000|STARTED|Baseline Enrollment||184
8971152|NCT02611479|10034958|FG000|COMPLETED|Baseline Enrollment||171
8971153|NCT02611479|10034958|FG000|NOT COMPLETED|Baseline Enrollment||13
8971154|NCT02611479|10034958|FG000|STARTED|Post-Surgery Follow-up at 30-90 Days||171
8971155|NCT02611479|10034958|FG000|COMPLETED|Post-Surgery Follow-up at 30-90 Days||169
8971156|NCT02611479|10034958|FG000|NOT COMPLETED|Post-Surgery Follow-up at 30-90 Days||2
8971157|NCT02611479|10034958|FG000|STARTED|Post-Surgery Follow-up at 1-Year||169
8570897|NCT00106249|9603072|FG000|STARTED|Overall Study||14
8570898|NCT00106249|9603073|FG001|STARTED|Overall Study||13
8570899|NCT00106249|9603072|FG000|COMPLETED|Overall Study||11
8570900|NCT00106249|9603073|FG001|COMPLETED|Overall Study||11
8570901|NCT00106249|9603072|FG000|NOT COMPLETED|Overall Study||3
8570902|NCT00106249|9603073|FG001|NOT COMPLETED|Overall Study||2
8570903|NCT00106353|9603081|FG000|STARTED|Part 1||4
8570904|NCT00106353|9603082|FG001|STARTED|Part 1||5
8570905|NCT00106353|9603083|FG002|STARTED|Part 1||3
8570906|NCT00106353|9603084|FG003|STARTED|Part 1||7
8570907|NCT00106353|9603085|FG004|STARTED|Part 1||0
8570908|NCT00106353|9603086|FG005|STARTED|Part 1||0
8570909|NCT00106353|9603087|FG006|STARTED|Part 1||0
8570910|NCT00106353|9603081|FG000|COMPLETED|Part 1||0
8570911|NCT00106353|9603082|FG001|COMPLETED|Part 1||0
8570912|NCT00106353|9603083|FG002|COMPLETED|Part 1||0
8570913|NCT00106353|9603084|FG003|COMPLETED|Part 1||0
8570914|NCT00106353|9603085|FG004|COMPLETED|Part 1||0
8570915|NCT00106353|9603086|FG005|COMPLETED|Part 1||0
8570916|NCT00106353|9603087|FG006|COMPLETED|Part 1||0
8570917|NCT00106353|9603081|FG000|NOT COMPLETED|Part 1||4
8570918|NCT00106353|9603082|FG001|NOT COMPLETED|Part 1||5
8570919|NCT00106353|9603083|FG002|NOT COMPLETED|Part 1||3
8570920|NCT00106353|9603084|FG003|NOT COMPLETED|Part 1||7
8570921|NCT00106353|9603085|FG004|NOT COMPLETED|Part 1||0
8570922|NCT00106353|9603086|FG005|NOT COMPLETED|Part 1||0
8570923|NCT00106353|9603087|FG006|NOT COMPLETED|Part 1||0
8570924|NCT00106353|9603081|FG000|STARTED|Part 2||0
8570925|NCT00106353|9603082|FG001|STARTED|Part 2||0
8570926|NCT00106353|9603083|FG002|STARTED|Part 2||0
8570927|NCT00106353|9603084|FG003|STARTED|Part 2||0
8570928|NCT00106353|9603085|FG004|STARTED|Part 2||17
8570929|NCT00106353|9603086|FG005|STARTED|Part 2||19
8570930|NCT00106353|9603087|FG006|STARTED|Part 2||16
8570931|NCT00106353|9603081|FG000|COMPLETED|Part 2||0
8570932|NCT00106353|9603082|FG001|COMPLETED|Part 2||0
8570933|NCT00106353|9603083|FG002|COMPLETED|Part 2||0
8570934|NCT00106353|9603084|FG003|COMPLETED|Part 2||0
8570935|NCT00106353|9603085|FG004|COMPLETED|Part 2||1
8570936|NCT00106353|9603086|FG005|COMPLETED|Part 2||1
8971158|NCT02611479|10034958|FG000|COMPLETED|Post-Surgery Follow-up at 1-Year||151
8971159|NCT02611479|10034958|FG000|NOT COMPLETED|Post-Surgery Follow-up at 1-Year||18
8570937|NCT00106353|9603087|FG006|COMPLETED|Part 2||0
8570938|NCT00106353|9603081|FG000|NOT COMPLETED|Part 2||0
8570939|NCT00106353|9603082|FG001|NOT COMPLETED|Part 2||0
8570940|NCT00106353|9603083|FG002|NOT COMPLETED|Part 2||0
8570941|NCT00106353|9603084|FG003|NOT COMPLETED|Part 2||0
8570942|NCT00106353|9603085|FG004|NOT COMPLETED|Part 2||16
8570943|NCT00106353|9603086|FG005|NOT COMPLETED|Part 2||18
8570944|NCT00106353|9603087|FG006|NOT COMPLETED|Part 2||16
8570945|NCT00106392|9603110|FG000|STARTED|Overall Study||62
8570946|NCT00106392|9603111|FG001|STARTED|Overall Study||69
8570947|NCT00106392|9603110|FG000|Baseline Participants|Overall Study|3 patients withdrew: 2 prior to surgery and study drug; 1 took study drug but did not have surgery|59
8876771|NCT01919164|9933553|FG002|STARTED|Overall Study||111
8876772|NCT01919164|9933554|FG003|STARTED|Overall Study||110
8876773|NCT01919164|9933555|FG004|STARTED|Overall Study||110
8876774|NCT01919164|9933551|FG000|Safety Analysis Set|Overall Study||107
8876775|NCT01919164|9933552|FG001|Safety Analysis Set|Overall Study|1 participant assigned to Placebo arm who inadvertently received 30 mcg was included in this arm.|109
8876776|NCT01919164|9933553|FG002|Safety Analysis Set|Overall Study||111
8876777|NCT01919164|9933554|FG003|Safety Analysis Set|Overall Study|1 participant in Sprifermin2 Cycles arm who inadvertently received 100 mcg was included in this arm.|111
8876778|NCT01919164|9933555|FG004|Safety Analysis Set|Overall Study||109
8876779|NCT01919164|9933551|FG000|COMPLETED|Overall Study||65
8876780|NCT01919164|9933552|FG001|COMPLETED|Overall Study||80
8876781|NCT01919164|9933553|FG002|COMPLETED|Overall Study||74
8876782|NCT01919164|9933554|FG003|COMPLETED|Overall Study||82
8876783|NCT01919164|9933555|FG004|COMPLETED|Overall Study||77
8876784|NCT01919164|9933551|FG000|NOT COMPLETED|Overall Study||43
8876785|NCT01919164|9933552|FG001|NOT COMPLETED|Overall Study||30
8876786|NCT01919164|9933553|FG002|NOT COMPLETED|Overall Study||37
8876787|NCT01919164|9933554|FG003|NOT COMPLETED|Overall Study||28
8876788|NCT01919164|9933555|FG004|NOT COMPLETED|Overall Study||33
8876789|NCT01919190|9933569|FG000|STARTED|Overall Study|Met eligibility criteria|33
8876790|NCT01919190|9933570|FG001|STARTED|Overall Study|Met eligibility criteria|34
8876791|NCT01919190|9933569|FG000|COMPLETED|Overall Study||30
8876792|NCT01919190|9933570|FG001|COMPLETED|Overall Study||34
8876793|NCT01919190|9933569|FG000|NOT COMPLETED|Overall Study||3
8876794|NCT01919190|9933570|FG001|NOT COMPLETED|Overall Study||0
8631955|NCT00542828|9671831|FG000|NOT COMPLETED|Overall Study||13
8631956|NCT00542880|9671837|FG000|STARTED|Period 1|This was a cross-over study|217
8631957|NCT00542880|9671838|FG001|STARTED|Period 1||225
8631958|NCT00542880|9671837|FG000|COMPLETED|Period 1||211
8631959|NCT00542880|9671838|FG001|COMPLETED|Period 1||213
8631960|NCT00542880|9671837|FG000|NOT COMPLETED|Period 1||6
8631961|NCT00542880|9671838|FG001|NOT COMPLETED|Period 1||12
8631962|NCT00542880|9671837|FG000|STARTED|Period 2||211
8631963|NCT00542880|9671838|FG001|STARTED|Period 2||213
8631964|NCT00542880|9671837|FG000|COMPLETED|Period 2||204
8631965|NCT00542880|9671838|FG001|COMPLETED|Period 2||203
8631966|NCT00542880|9671837|FG000|NOT COMPLETED|Period 2||7
8631967|NCT00542880|9671838|FG001|NOT COMPLETED|Period 2||10
8876795|NCT01919216|9933580|FG000|STARTED|Overall Study||28
8876796|NCT01919216|9933581|FG001|STARTED|Overall Study||21
8876797|NCT01919216|9933582|FG002|STARTED|Overall Study||5
8876798|NCT01919216|9933580|FG000|COMPLETED|Overall Study||26
8876799|NCT01919216|9933581|FG001|COMPLETED|Overall Study||20
8876800|NCT01919216|9933582|FG002|COMPLETED|Overall Study||4
8876801|NCT01919216|9933580|FG000|NOT COMPLETED|Overall Study||2
8876802|NCT01919216|9933581|FG001|NOT COMPLETED|Overall Study||1
8876803|NCT01919216|9933582|FG002|NOT COMPLETED|Overall Study||1
8876804|NCT01919229|9933593|FG000|STARTED|Overall Study||4
8876805|NCT01919229|9933594|FG001|STARTED|Overall Study||6
8876806|NCT01919229|9933595|FG002|STARTED|Overall Study||4
8876807|NCT01919229|9933593|FG000|COMPLETED|Overall Study||4
8876808|NCT01919229|9933594|FG001|COMPLETED|Overall Study||6
8876809|NCT01919229|9933595|FG002|COMPLETED|Overall Study||3
8876810|NCT01919229|9933593|FG000|NOT COMPLETED|Overall Study||0
8876811|NCT01919229|9933594|FG001|NOT COMPLETED|Overall Study||0
8876812|NCT01919229|9933595|FG002|NOT COMPLETED|Overall Study||1
8876813|NCT01919307|9933603|FG000|STARTED|Overall Study||29
8876814|NCT01919307|9933603|FG000|COMPLETED|Overall Study||20
8876815|NCT01919307|9933603|FG000|NOT COMPLETED|Overall Study||9
8876816|NCT01919398|9933610|FG000|STARTED|Overall Study||3
8971160|NCT02611479|10034958|FG000|STARTED|Data Cleaning||151
8971161|NCT02611479|10034958|FG000|COMPLETED|Data Cleaning||149
8971162|NCT02611479|10034958|FG000|NOT COMPLETED|Data Cleaning||2
8971163|NCT02611752|10034964|FG000|STARTED|Overall Study||22
8971164|NCT02611752|10034965|FG001|STARTED|Overall Study||25
8971165|NCT02611752|10034964|FG000|Day 1-3 Hydromorphone Challenge Injs|Overall Study||22
8971166|NCT02611752|10034965|FG001|Day 1-3 Hydromorphone Challenge Injs|Overall Study||25
8971167|NCT02611752|10034964|FG000|Day 4-6 Hydromorphone Challenge Injs|Overall Study||22
8971168|NCT02611752|10034965|FG001|Day 4-6 Hydromorphone Challenge Injs|Overall Study||24
8971169|NCT02611752|10034964|FG000|Day 8-10 Hydromorphone Challenge Injs|Overall Study||22
8971170|NCT02611752|10034965|FG001|Day 8-10 Hydromorphone Challenge Injs|Overall Study||24
8971171|NCT02611752|10034964|FG000|Day11-13 Hydromorphone Challenge Injs|Overall Study||22
8971172|NCT02611752|10034965|FG001|Day11-13 Hydromorphone Challenge Injs|Overall Study||24
8971173|NCT02611752|10034964|FG000|COMPLETED|Overall Study||22
8631968|NCT00542880|9671837|FG000|STARTED|Period 3||204
8631969|NCT00542880|9671838|FG001|STARTED|Period 3||203
8631970|NCT00542880|9671837|FG000|COMPLETED|Period 3||204
8876817|NCT01919398|9933611|FG001|STARTED|Overall Study||3
8876818|NCT01919398|9933612|FG002|STARTED|Overall Study||13
8876819|NCT01919398|9933610|FG000|Received at Least One Dose of Study Drug|Overall Study||3
8876820|NCT01919398|9933611|FG001|Received at Least One Dose of Study Drug|Overall Study||3
8876821|NCT01919398|9933612|FG002|Received at Least One Dose of Study Drug|Overall Study||13
8876822|NCT01919398|9933610|FG000|COMPLETED|Overall Study||3
8876823|NCT01919398|9933611|FG001|COMPLETED|Overall Study||3
8876824|NCT01919398|9933612|FG002|COMPLETED|Overall Study||9
8971174|NCT02611752|10034965|FG001|COMPLETED|Overall Study||24
8971175|NCT02611752|10034964|FG000|NOT COMPLETED|Overall Study||0
8971176|NCT02611752|10034965|FG001|NOT COMPLETED|Overall Study||1
8971177|NCT02611765|10034986|FG000|STARTED|Overall Study||29
8971178|NCT02611765|10034987|FG001|STARTED|Overall Study||35
8971179|NCT02611765|10034986|FG000|COMPLETED|Overall Study||27
8971180|NCT02611765|10034987|FG001|COMPLETED|Overall Study||29
8971181|NCT02611765|10034986|FG000|NOT COMPLETED|Overall Study||2
8971182|NCT02611765|10034987|FG001|NOT COMPLETED|Overall Study||6
8971183|NCT02611778|10034995|FG000|STARTED|Overall Study||238
8971184|NCT02611778|10034996|FG001|STARTED|Overall Study||239
8971185|NCT02611778|10034995|FG000|COMPLETED|Overall Study||226
8971186|NCT02611778|10034996|FG001|COMPLETED|Overall Study||226
8971187|NCT02611778|10034995|FG000|NOT COMPLETED|Overall Study||12
8971188|NCT02611778|10034996|FG001|NOT COMPLETED|Overall Study||13
8971189|NCT02611882|10035006|FG000|STARTED|Overall Study||75
8971190|NCT02611882|10035007|FG001|STARTED|Overall Study||150
8971191|NCT02611882|10035008|FG002|STARTED|Overall Study||0
8971192|NCT02611882|10035006|FG000|Completed Surgery Per Protocol|Overall Study||42
8971193|NCT02611882|10035007|FG001|Completed Surgery Per Protocol|Overall Study||0
8971194|NCT02611882|10035008|FG002|Completed Surgery Per Protocol|Overall Study||0
8971195|NCT02611882|10035006|FG000|COMPLETED|Overall Study||42
8971196|NCT02611882|10035007|FG001|COMPLETED|Overall Study||150
8971197|NCT02611882|10035008|FG002|COMPLETED|Overall Study||0
8971198|NCT02611882|10035006|FG000|NOT COMPLETED|Overall Study||33
8971199|NCT02611882|10035007|FG001|NOT COMPLETED|Overall Study||0
8971200|NCT02611882|10035008|FG002|NOT COMPLETED|Overall Study||0
8971201|NCT02612064|10035017|FG000|STARTED|Overall Study||115
8971202|NCT02612064|10035018|FG001|STARTED|Overall Study||115
8971203|NCT02612064|10035017|FG000|COMPLETED|Overall Study||114
8971204|NCT02612064|10035018|FG001|COMPLETED|Overall Study||112
8971205|NCT02612064|10035017|FG000|NOT COMPLETED|Overall Study||1
8971206|NCT02612064|10035018|FG001|NOT COMPLETED|Overall Study||3
8971207|NCT02612077|10035024|FG000|STARTED|Overall Study||765
8971208|NCT02612077|10035024|FG000|Did Not Receive Study Product|Overall Study||5
8971209|NCT02612077|10035024|FG000|Safety Analysis Set|Overall Study||760
8971210|NCT02612077|10035024|FG000|Efficacy Analysis Set|Overall Study||737
8971211|NCT02612077|10035024|FG000|COMPLETED|Overall Study||299
8971212|NCT02612077|10035024|FG000|NOT COMPLETED|Overall Study||466
8971213|NCT02612155|10035033|FG000|STARTED|Overall Study||17
8971214|NCT02612155|10035034|FG001|STARTED|Overall Study||18
8971215|NCT02612155|10035033|FG000|COMPLETED|Overall Study||14
8971216|NCT02612155|10035034|FG001|COMPLETED|Overall Study||15
8971217|NCT02612155|10035033|FG000|NOT COMPLETED|Overall Study||3
8971218|NCT02612155|10035034|FG001|NOT COMPLETED|Overall Study||3
8971219|NCT02612428|10035042|FG000|STARTED|VTL-308||78
8971220|NCT02612428|10035043|FG001|STARTED|VTL-308||73
8971221|NCT02612428|10035042|FG000|COMPLETED|VTL-308||64
8971222|NCT02612428|10035043|FG001|COMPLETED|VTL-308||56
8971223|NCT02612428|10035042|FG000|NOT COMPLETED|VTL-308||14
8971224|NCT02612428|10035043|FG001|NOT COMPLETED|VTL-308||17
8971225|NCT02612428|10035042|FG000|STARTED|VTL-308E||64
8971226|NCT02612428|10035043|FG001|STARTED|VTL-308E||56
8971227|NCT02612428|10035042|FG000|COMPLETED|VTL-308E||53
8971228|NCT02612428|10035043|FG001|COMPLETED|VTL-308E||49
8971229|NCT02612428|10035042|FG000|NOT COMPLETED|VTL-308E||11
8971230|NCT02612428|10035043|FG001|NOT COMPLETED|VTL-308E||7
8971231|NCT02612610|10035053|FG000|STARTED|Overall Study||63
8971232|NCT02612610|10035054|FG001|STARTED|Overall Study||64
8570948|NCT00106392|9603111|FG001|Baseline Participants|Overall Study|4 patients withdrew: all prior to surgery and study drug|65
8570949|NCT00106392|9603110|FG000|Full Analysis Set (FAS)|Overall Study||53
8570950|NCT00106392|9603111|FG001|Full Analysis Set (FAS)|Overall Study||61
8570951|NCT00106392|9603110|FG000|COMPLETED|Overall Study||36
8570952|NCT00106392|9603111|FG001|COMPLETED|Overall Study||42
8570953|NCT00106392|9603110|FG000|NOT COMPLETED|Overall Study||26
8570954|NCT00106392|9603111|FG001|NOT COMPLETED|Overall Study||27
8570955|NCT00106431|9603117|FG000|STARTED|Overall Study||102
8570956|NCT00106431|9603117|FG000|COMPLETED|Overall Study|37 represents the number of patients who reached at least 6 months treatment|37
8570957|NCT00106431|9603117|FG000|NOT COMPLETED|Overall Study||65
8570958|NCT00106535|9603124|FG000|STARTED|2-year Placebo Controlled Period||394
8570959|NCT00106535|9603125|FG001|STARTED|2-year Placebo Controlled Period||401
8570960|NCT00106535|9603126|FG002|STARTED|2-year Placebo Controlled Period||401
8570961|NCT00106535|9603127|FG003|STARTED|2-year Placebo Controlled Period||0
8577810|NCT00162266|9610687|FG002|STARTED|Double-Blind Period||119
8971233|NCT02612610|10035055|FG002|STARTED|Overall Study||63
8971234|NCT02612610|10035056|FG003|STARTED|Overall Study||63
8971235|NCT02612610|10035053|FG000|Treated|Overall Study||63
8971236|NCT02612610|10035054|FG001|Treated|Overall Study||63
8971237|NCT02612610|10035055|FG002|Treated|Overall Study||63
8971238|NCT02612610|10035056|FG003|Treated|Overall Study||63
8971239|NCT02612610|10035053|FG000|COMPLETED|Overall Study||58
8971240|NCT02612610|10035054|FG001|COMPLETED|Overall Study||56
8971241|NCT02612610|10035055|FG002|COMPLETED|Overall Study||58
8971242|NCT02612610|10035056|FG003|COMPLETED|Overall Study||50
8971243|NCT02612610|10035053|FG000|NOT COMPLETED|Overall Study||5
8971244|NCT02612610|10035054|FG001|NOT COMPLETED|Overall Study||8
8971245|NCT02612610|10035055|FG002|NOT COMPLETED|Overall Study||5
8971246|NCT02612610|10035056|FG003|NOT COMPLETED|Overall Study||13
8971247|NCT02612623|10035070|FG000|STARTED|Overall Study||8
8971248|NCT02612623|10035071|FG001|STARTED|Overall Study||6
8971249|NCT02612623|10035072|FG002|STARTED|Overall Study||6
8971250|NCT02612623|10035073|FG003|STARTED|Overall Study||4
8971251|NCT02612623|10035070|FG000|Treated|Overall Study||8
8971252|NCT02612623|10035071|FG001|Treated|Overall Study||5
8971253|NCT02612623|10035072|FG002|Treated|Overall Study||6
8971254|NCT02612623|10035073|FG003|Treated|Overall Study||4
8971255|NCT02612623|10035070|FG000|COMPLETED|Overall Study||7
8971256|NCT02612623|10035071|FG001|COMPLETED|Overall Study||5
8971257|NCT02612623|10035072|FG002|COMPLETED|Overall Study||5
8971258|NCT02612623|10035073|FG003|COMPLETED|Overall Study||4
8971259|NCT02612623|10035070|FG000|NOT COMPLETED|Overall Study||1
8971260|NCT02612623|10035071|FG001|NOT COMPLETED|Overall Study||1
8971261|NCT02612623|10035072|FG002|NOT COMPLETED|Overall Study||1
8971262|NCT02612623|10035073|FG003|NOT COMPLETED|Overall Study||0
8971263|NCT02612688|10035085|FG000|STARTED|Overall Study||33035
8971264|NCT02612688|10035086|FG001|STARTED|Overall Study||70013
8971265|NCT02612688|10035085|FG000|COMPLETED|Overall Study||33035
8971266|NCT02612688|10035086|FG001|COMPLETED|Overall Study||70013
8971267|NCT02612688|10035085|FG000|NOT COMPLETED|Overall Study||0
8971268|NCT02612688|10035086|FG001|NOT COMPLETED|Overall Study||0
8971269|NCT02612727|10035096|FG000|STARTED|Overall Study||87
8971270|NCT02612727|10035097|FG001|STARTED|Overall Study||87
8971271|NCT02612727|10035096|FG000|COMPLETED|Overall Study||82
8971272|NCT02612727|10035097|FG001|COMPLETED|Overall Study||83
8971273|NCT02612727|10035096|FG000|NOT COMPLETED|Overall Study||5
8971274|NCT02612727|10035097|FG001|NOT COMPLETED|Overall Study||4
8971275|NCT02612779|10035105|FG000|STARTED|Overall Study||68
8971276|NCT02612779|10035106|FG001|STARTED|Overall Study||6
8971277|NCT02612779|10035105|FG000|COMPLETED|Overall Study||0
8971278|NCT02612779|10035106|FG001|COMPLETED|Overall Study||0
8971279|NCT02612779|10035105|FG000|NOT COMPLETED|Overall Study||68
8971280|NCT02612779|10035106|FG001|NOT COMPLETED|Overall Study||6
8971281|NCT02612857|10035116|FG000|STARTED|Overall Study||11
8971282|NCT02612857|10035117|FG001|STARTED|Overall Study||9
8971283|NCT02612857|10035118|FG002|STARTED|Overall Study||10
8971284|NCT02612857|10035116|FG000|COMPLETED|Overall Study||8
8971285|NCT02612857|10035117|FG001|COMPLETED|Overall Study||5
8971286|NCT02612857|10035118|FG002|COMPLETED|Overall Study||6
8971287|NCT02612857|10035116|FG000|NOT COMPLETED|Overall Study||3
8971288|NCT02612857|10035117|FG001|NOT COMPLETED|Overall Study||4
8971289|NCT02612857|10035118|FG002|NOT COMPLETED|Overall Study||4
8971290|NCT02612909|10035131|FG000|STARTED|Phase 2||100
8971291|NCT02612909|10035132|FG001|STARTED|Phase 2||100
8971292|NCT02612909|10035133|FG002|STARTED|Phase 2||100
8971293|NCT02612909|10035134|FG003|STARTED|Phase 2||0
8971294|NCT02612909|10035135|FG004|STARTED|Phase 2||0
8971295|NCT02612909|10035131|FG000|Received Injection 1|Phase 2||100
8971296|NCT02612909|10035132|FG001|Received Injection 1|Phase 2||100
8971297|NCT02612909|10035133|FG002|Received Injection 1|Phase 2||100
8971298|NCT02612909|10035134|FG003|Received Injection 1|Phase 2||0
8971299|NCT02612909|10035135|FG004|Received Injection 1|Phase 2||0
8971300|NCT02612909|10035131|FG000|Received Injection 2|Phase 2||98
8971301|NCT02612909|10035132|FG001|Received Injection 2|Phase 2||95
8971302|NCT02612909|10035133|FG002|Received Injection 2|Phase 2||99
8971303|NCT02612909|10035134|FG003|Received Injection 2|Phase 2||0
8971304|NCT02612909|10035135|FG004|Received Injection 2|Phase 2||0
8971305|NCT02612909|10035131|FG000|Completed Day 29 Clinic Visit|Phase 2||98
8971306|NCT02612909|10035132|FG001|Completed Day 29 Clinic Visit|Phase 2||95
8971307|NCT02612909|10035133|FG002|Completed Day 29 Clinic Visit|Phase 2||99
8971308|NCT02612909|10035134|FG003|Completed Day 29 Clinic Visit|Phase 2||0
8971309|NCT02612909|10035135|FG004|Completed Day 29 Clinic Visit|Phase 2||0
8971310|NCT02612909|10035131|FG000|Completed Day 43 Clinic Visit|Phase 2||97
8971311|NCT02612909|10035132|FG001|Completed Day 43 Clinic Visit|Phase 2||94
8971312|NCT02612909|10035133|FG002|Completed Day 43 Clinic Visit|Phase 2||99
8971313|NCT02612909|10035134|FG003|Completed Day 43 Clinic Visit|Phase 2||0
8971314|NCT02612909|10035135|FG004|Completed Day 43 Clinic Visit|Phase 2||0
8971315|NCT02612909|10035131|FG000|COMPLETED|Phase 2||98
8971316|NCT02612909|10035132|FG001|COMPLETED|Phase 2||95
8971317|NCT02612909|10035133|FG002|COMPLETED|Phase 2||99
8971318|NCT02612909|10035134|FG003|COMPLETED|Phase 2||0
8971319|NCT02612909|10035135|FG004|COMPLETED|Phase 2||0
8971320|NCT02612909|10035131|FG000|NOT COMPLETED|Phase 2||2
8971321|NCT02612909|10035132|FG001|NOT COMPLETED|Phase 2||5
8971322|NCT02612909|10035133|FG002|NOT COMPLETED|Phase 2||1
8971323|NCT02612909|10035134|FG003|NOT COMPLETED|Phase 2||0
8971324|NCT02612909|10035135|FG004|NOT COMPLETED|Phase 2||0
8971325|NCT02612909|10035131|FG000|STARTED|Phase 3||0
8971326|NCT02612909|10035132|FG001|STARTED|Phase 3||0
8971327|NCT02612909|10035133|FG002|STARTED|Phase 3||0
8971328|NCT02612909|10035134|FG003|STARTED|Phase 3||105
8971329|NCT02612909|10035135|FG004|STARTED|Phase 3||525
8971330|NCT02612909|10035131|FG000|Received Injection 1|Phase 3||0
8971331|NCT02612909|10035132|FG001|Received Injection 1|Phase 3||0
8971332|NCT02612909|10035133|FG002|Received Injection 1|Phase 3||0
8971333|NCT02612909|10035134|FG003|Received Injection 1|Phase 3||105
8971334|NCT02612909|10035135|FG004|Received Injection 1|Phase 3||525
8971335|NCT02612909|10035131|FG000|Received Injection 2|Phase 3||0
8971336|NCT02612909|10035132|FG001|Received Injection 2|Phase 3||0
8971337|NCT02612909|10035133|FG002|Received Injection 2|Phase 3||0
8971338|NCT02612909|10035134|FG003|Received Injection 2|Phase 3||103
8971339|NCT02612909|10035135|FG004|Received Injection 2|Phase 3||520
8971340|NCT02612909|10035131|FG000|Completed Day 29 Clinic Visit|Phase 3||0
8971341|NCT02612909|10035132|FG001|Completed Day 29 Clinic Visit|Phase 3||0
8971342|NCT02612909|10035133|FG002|Completed Day 29 Clinic Visit|Phase 3||0
8971343|NCT02612909|10035134|FG003|Completed Day 29 Clinic Visit|Phase 3||104
8971344|NCT02612909|10035135|FG004|Completed Day 29 Clinic Visit|Phase 3||525
8971345|NCT02612909|10035131|FG000|Completed Day 43 Clinic Visit|Phase 3||0
8971346|NCT02612909|10035132|FG001|Completed Day 43 Clinic Visit|Phase 3||0
8971347|NCT02612909|10035133|FG002|Completed Day 43 Clinic Visit|Phase 3||0
8971348|NCT02612909|10035134|FG003|Completed Day 43 Clinic Visit|Phase 3||104
8971349|NCT02612909|10035135|FG004|Completed Day 43 Clinic Visit|Phase 3||524
8971350|NCT02612909|10035131|FG000|COMPLETED|Phase 3||0
8971351|NCT02612909|10035132|FG001|COMPLETED|Phase 3||0
8971352|NCT02612909|10035133|FG002|COMPLETED|Phase 3||0
8971353|NCT02612909|10035134|FG003|COMPLETED|Phase 3||104
8971354|NCT02612909|10035135|FG004|COMPLETED|Phase 3||525
8971355|NCT02612909|10035131|FG000|NOT COMPLETED|Phase 3||0
8971356|NCT02612909|10035132|FG001|NOT COMPLETED|Phase 3||0
8971357|NCT02612909|10035133|FG002|NOT COMPLETED|Phase 3||0
8971358|NCT02612909|10035134|FG003|NOT COMPLETED|Phase 3||1
8971359|NCT02612909|10035135|FG004|NOT COMPLETED|Phase 3||0
8971360|NCT02613117|10035151|FG000|STARTED|Overall Study||57
8971361|NCT02613117|10035152|FG001|STARTED|Overall Study||47
8971362|NCT02613117|10035151|FG000|COMPLETED|Overall Study||57
8971363|NCT02613117|10035152|FG001|COMPLETED|Overall Study||47
8971364|NCT02613117|10035151|FG000|NOT COMPLETED|Overall Study||0
8971365|NCT02613117|10035152|FG001|NOT COMPLETED|Overall Study||0
8971366|NCT02613169|10035160|FG000|STARTED|Overall Study||150
8971367|NCT02613169|10035161|FG001|STARTED|Overall Study||150
8971368|NCT02613169|10035160|FG000|COMPLETED|Overall Study||132
8971369|NCT02613169|10035161|FG001|COMPLETED|Overall Study||133
8971370|NCT02613169|10035160|FG000|NOT COMPLETED|Overall Study||18
8971371|NCT02613169|10035161|FG001|NOT COMPLETED|Overall Study||17
8971372|NCT02613182|10035167|FG000|STARTED|Overall Study||34
8971373|NCT02613182|10035167|FG000|Number of Patients Dosed|Overall Study||34
8971374|NCT02613182|10035167|FG000|COMPLETED|Overall Study||0
8971375|NCT02613182|10035167|FG000|NOT COMPLETED|Overall Study||34
8971376|NCT02613208|10035171|FG000|STARTED|Overall Study||111
8971377|NCT02613208|10035171|FG000|COMPLETED|Overall Study||64
8971378|NCT02613208|10035171|FG000|NOT COMPLETED|Overall Study||47
8971379|NCT02613221|10035175|FG000|STARTED|Overall Study||56
8971380|NCT02613221|10035175|FG000|Safety Population: Received Study Drug|Overall Study||55
8971381|NCT02613221|10035175|FG000|COMPLETED|Overall Study||1
8971382|NCT02613221|10035175|FG000|NOT COMPLETED|Overall Study||55
8971383|NCT02613338|10035179|FG000|STARTED|Overall Study||30
8971384|NCT02613338|10035179|FG000|COMPLETED|Overall Study||30
8971385|NCT02613338|10035179|FG000|NOT COMPLETED|Overall Study||0
8631971|NCT00542880|9671838|FG001|COMPLETED|Period 3||201
8631972|NCT00542880|9671837|FG000|NOT COMPLETED|Period 3||0
8631973|NCT00542880|9671838|FG001|NOT COMPLETED|Period 3||2
8631974|NCT00542919|9671848|FG000|STARTED|Overall Study||23
8631975|NCT00542919|9671849|FG001|STARTED|Overall Study||19
8631976|NCT00542919|9671850|FG002|STARTED|Overall Study||15
8631977|NCT00542919|9671848|FG000|Received At Least One Dose of Study Drug|Overall Study||23
8631978|NCT00542919|9671849|FG001|Received At Least One Dose of Study Drug|Overall Study||19
8631979|NCT00542919|9671850|FG002|Received At Least One Dose of Study Drug|Overall Study||15
8631980|NCT00542919|9671848|FG000|Progressive Disease|Overall Study||15
8631981|NCT00542919|9671849|FG001|Progressive Disease|Overall Study||11
8631982|NCT00542919|9671850|FG002|Progressive Disease|Overall Study||7
8631983|NCT00542919|9671848|FG000|Death|Overall Study||1
8631984|NCT00542919|9671849|FG001|Death|Overall Study||1
8631985|NCT00542919|9671850|FG002|Death|Overall Study||2
8631986|NCT00542919|9671848|FG000|COMPLETED|Overall Study||16
8631987|NCT00542919|9671849|FG001|COMPLETED|Overall Study||12
8971386|NCT02613364|10035186|FG000|STARTED|Overall Study||251
8971387|NCT02613364|10035187|FG001|STARTED|Overall Study||238
8971388|NCT02613364|10035188|FG002|STARTED|Overall Study||251
8971389|NCT02613364|10035186|FG000|COMPLETED|Overall Study||185
8971390|NCT02613364|10035187|FG001|COMPLETED|Overall Study||148
8971391|NCT02613364|10035188|FG002|COMPLETED|Overall Study||175
8971392|NCT02613364|10035186|FG000|NOT COMPLETED|Overall Study||66
8971393|NCT02613364|10035187|FG001|NOT COMPLETED|Overall Study||90
8971394|NCT02613364|10035188|FG002|NOT COMPLETED|Overall Study||76
8971395|NCT02613403|10035200|FG000|STARTED|Overall Study||36
8971396|NCT02613403|10035201|FG001|STARTED|Overall Study||36
8971397|NCT02613403|10035202|FG002|STARTED|Overall Study||9
8971398|NCT02613403|10035203|FG003|STARTED|Overall Study||13
8971399|NCT02613403|10035204|FG004|STARTED|Overall Study|Study terminated prior to participant recruitment for study Part B.|0
8971400|NCT02613403|10035200|FG000|Treated|Overall Study||35
8971401|NCT02613403|10035201|FG001|Treated|Overall Study||36
8971402|NCT02613403|10035202|FG002|Treated|Overall Study||9
8971403|NCT02613403|10035203|FG003|Treated|Overall Study||13
8971404|NCT02613403|10035204|FG004|Treated|Overall Study|Study terminated prior to participant recruitment for study Part B.|0
8971405|NCT02613403|10035200|FG000|COMPLETED|Overall Study||34
8971406|NCT02613403|10035201|FG001|COMPLETED|Overall Study||35
8971407|NCT02613403|10035202|FG002|COMPLETED|Overall Study||9
8971408|NCT02613403|10035203|FG003|COMPLETED|Overall Study||13
8971409|NCT02613403|10035204|FG004|COMPLETED|Overall Study|Study terminated prior to participant recruitment for study Part B.|0
8971410|NCT02613403|10035200|FG000|NOT COMPLETED|Overall Study||2
8971411|NCT02613403|10035201|FG001|NOT COMPLETED|Overall Study||1
8971412|NCT02613403|10035202|FG002|NOT COMPLETED|Overall Study||0
8971413|NCT02613403|10035203|FG003|NOT COMPLETED|Overall Study||0
8971414|NCT02613403|10035204|FG004|NOT COMPLETED|Overall Study||0
8971415|NCT02613481|10035214|FG000|STARTED|Overall Study||50
8971416|NCT02613481|10035214|FG000|COMPLETED|Overall Study||41
8971417|NCT02613481|10035214|FG000|NOT COMPLETED|Overall Study||9
8971418|NCT02613572|10035221|FG000|STARTED|Phase I: Tolerability, 600, 800, 1200 mg||15
8971419|NCT02613572|10035222|FG001|STARTED|Phase I: Tolerability, 600, 800, 1200 mg||0
8971420|NCT02613572|10035223|FG002|STARTED|Phase I: Tolerability, 600, 800, 1200 mg||0
8971421|NCT02613572|10035221|FG000|600 mg|Phase I: Tolerability, 600, 800, 1200 mg||15
8971422|NCT02613572|10035222|FG001|600 mg|Phase I: Tolerability, 600, 800, 1200 mg||0
8971423|NCT02613572|10035223|FG002|600 mg|Phase I: Tolerability, 600, 800, 1200 mg||0
8971424|NCT02613572|10035221|FG000|800 mg|Phase I: Tolerability, 600, 800, 1200 mg||15
8971425|NCT02613572|10035222|FG001|800 mg|Phase I: Tolerability, 600, 800, 1200 mg||0
8971426|NCT02613572|10035223|FG002|800 mg|Phase I: Tolerability, 600, 800, 1200 mg||0
8971427|NCT02613572|10035221|FG000|1200 mg|Phase I: Tolerability, 600, 800, 1200 mg||14
8971428|NCT02613572|10035222|FG001|1200 mg|Phase I: Tolerability, 600, 800, 1200 mg||0
8971429|NCT02613572|10035223|FG002|1200 mg|Phase I: Tolerability, 600, 800, 1200 mg||0
8971430|NCT02613572|10035221|FG000|COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||14
8971431|NCT02613572|10035222|FG001|COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||0
8971432|NCT02613572|10035223|FG002|COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||0
8971433|NCT02613572|10035221|FG000|NOT COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||1
8971434|NCT02613572|10035222|FG001|NOT COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||0
8971435|NCT02613572|10035223|FG002|NOT COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||0
8971436|NCT02613572|10035221|FG000|STARTED|Phase II: Double-Blind Rand Plac Control||0
8971437|NCT02613572|10035222|FG001|STARTED|Phase II: Double-Blind Rand Plac Control||27
8971438|NCT02613572|10035223|FG002|STARTED|Phase II: Double-Blind Rand Plac Control||26
8971439|NCT02613572|10035221|FG000|COMPLETED|Phase II: Double-Blind Rand Plac Control||0
8971440|NCT02613572|10035222|FG001|COMPLETED|Phase II: Double-Blind Rand Plac Control||26
8971441|NCT02613572|10035223|FG002|COMPLETED|Phase II: Double-Blind Rand Plac Control||26
8971442|NCT02613572|10035221|FG000|NOT COMPLETED|Phase II: Double-Blind Rand Plac Control||0
8971443|NCT02613572|10035222|FG001|NOT COMPLETED|Phase II: Double-Blind Rand Plac Control||1
8971444|NCT02613572|10035223|FG002|NOT COMPLETED|Phase II: Double-Blind Rand Plac Control||0
8971445|NCT02613871|10035235|FG000|STARTED|Overall Study||111
8971446|NCT02613871|10035235|FG000|COMPLETED|Overall Study||108
8971447|NCT02613871|10035235|FG000|NOT COMPLETED|Overall Study||3
8971448|NCT02613884|10035239|FG000|STARTED|Overall Study||26
8971449|NCT02613884|10035239|FG000|Safety Endpoint 1|Overall Study||26
8971450|NCT02613884|10035239|FG000|Feasibility Questionnaire|Overall Study||26
8971451|NCT02613884|10035239|FG000|Safety Endpoint 2|Overall Study||26
8971452|NCT02613884|10035239|FG000|Efficacy Endpoint 1|Overall Study||25
8971453|NCT02613884|10035239|FG000|Efficacy Timepoint 2|Overall Study||25
8971454|NCT02613884|10035239|FG000|Efficacy Timepoint 3|Overall Study||24
8971455|NCT02613884|10035239|FG000|COMPLETED|Overall Study||24
8971456|NCT02613884|10035239|FG000|NOT COMPLETED|Overall Study||2
8971457|NCT02613897|10035247|FG000|STARTED|Overall Study||22
8971458|NCT02613897|10035248|FG001|STARTED|Overall Study||22
8971459|NCT02613897|10035249|FG002|STARTED|Overall Study||12
8971460|NCT02613897|10035247|FG000|COMPLETED|Overall Study||22
8971461|NCT02613897|10035248|FG001|COMPLETED|Overall Study||22
8971462|NCT02613897|10035249|FG002|COMPLETED|Overall Study||12
8971463|NCT02613897|10035247|FG000|NOT COMPLETED|Overall Study||0
8971464|NCT02613897|10035248|FG001|NOT COMPLETED|Overall Study||0
8971465|NCT02613897|10035249|FG002|NOT COMPLETED|Overall Study||0
8971466|NCT02613910|10035258|FG000|STARTED|Overall Study||1
8971467|NCT02613910|10035258|FG000|COMPLETED|Overall Study||0
8971468|NCT02613910|10035258|FG000|NOT COMPLETED|Overall Study||1
8971469|NCT02614079|10035262|FG000|STARTED|Overall Study||6
8971470|NCT02614079|10035262|FG000|COMPLETED|Overall Study|1 participant withdrew from the study prior to completion of DSSEP testing|5
8971471|NCT02614079|10035262|FG000|NOT COMPLETED|Overall Study||1
8971472|NCT02614131|10035273|FG000|STARTED|Overall Study||11
8971473|NCT02614131|10035274|FG001|STARTED|Overall Study||8
8971474|NCT02614131|10035275|FG002|STARTED|Overall Study||8
8971475|NCT02614131|10035276|FG003|STARTED|Overall Study||8
8971476|NCT02614131|10035277|FG004|STARTED|Overall Study||8
8971477|NCT02614131|10035278|FG005|STARTED|Overall Study||2
8971478|NCT02614131|10035279|FG006|STARTED|Overall Study||5
8971479|NCT02614131|10035273|FG000|Received at Least One Dose of Drug|Overall Study||11
8971480|NCT02614131|10035274|FG001|Received at Least One Dose of Drug|Overall Study||8
8971481|NCT02614131|10035275|FG002|Received at Least One Dose of Drug|Overall Study||8
8971482|NCT02614131|10035276|FG003|Received at Least One Dose of Drug|Overall Study||8
8971483|NCT02614131|10035277|FG004|Received at Least One Dose of Drug|Overall Study||8
8971484|NCT02614131|10035278|FG005|Received at Least One Dose of Drug|Overall Study||2
8971485|NCT02614131|10035279|FG006|Received at Least One Dose of Drug|Overall Study||5
8971486|NCT02614131|10035273|FG000|COMPLETED|Overall Study||10
8971487|NCT02614131|10035274|FG001|COMPLETED|Overall Study||8
8971488|NCT02614131|10035275|FG002|COMPLETED|Overall Study||8
8971489|NCT02614131|10035276|FG003|COMPLETED|Overall Study||8
8971490|NCT02614131|10035277|FG004|COMPLETED|Overall Study||8
8971491|NCT02614131|10035278|FG005|COMPLETED|Overall Study||2
8971492|NCT02614131|10035279|FG006|COMPLETED|Overall Study||4
8971493|NCT02614131|10035273|FG000|NOT COMPLETED|Overall Study||1
8971494|NCT02614131|10035274|FG001|NOT COMPLETED|Overall Study||0
8971495|NCT02614131|10035275|FG002|NOT COMPLETED|Overall Study||0
8971496|NCT02614131|10035276|FG003|NOT COMPLETED|Overall Study||0
8971497|NCT02614131|10035277|FG004|NOT COMPLETED|Overall Study||0
8971498|NCT02614131|10035278|FG005|NOT COMPLETED|Overall Study||0
8971499|NCT02614131|10035279|FG006|NOT COMPLETED|Overall Study||1
8971500|NCT02614183|10035304|FG000|STARTED|Double Blind Treatment Phase||434
8971501|NCT02614183|10035305|FG001|STARTED|Double Blind Treatment Phase||214
8971502|NCT02614183|10035306|FG002|STARTED|Double Blind Treatment Phase||214
8971503|NCT02614183|10035304|FG000|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||433
8971504|NCT02614183|10035305|FG001|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||213
8971505|NCT02614183|10035306|FG002|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||212
8971506|NCT02614183|10035304|FG000|Safety Population|Double Blind Treatment Phase||432
8971507|NCT02614183|10035305|FG001|Safety Population|Double Blind Treatment Phase|One pt randomized to placebo received galcanezumab 120mg due to dosing error moved to this group.|206
8971508|NCT02614183|10035306|FG002|Safety Population|Double Blind Treatment Phase|Eight pts discontinued after loading dose of 240mg galcanezumab in 120mg group moved to this group.|220
8971509|NCT02614183|10035304|FG000|COMPLETED|Double Blind Treatment Phase||351
8971510|NCT02614183|10035305|FG001|COMPLETED|Double Blind Treatment Phase||177
8971511|NCT02614183|10035306|FG002|COMPLETED|Double Blind Treatment Phase||175
8971512|NCT02614183|10035304|FG000|NOT COMPLETED|Double Blind Treatment Phase||83
8971513|NCT02614183|10035305|FG001|NOT COMPLETED|Double Blind Treatment Phase||37
8971514|NCT02614183|10035306|FG002|NOT COMPLETED|Double Blind Treatment Phase||39
8971515|NCT02614183|10035304|FG000|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post-treatment phase.|372
8971516|NCT02614183|10035305|FG001|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post-treatment phase.|185
8971517|NCT02614183|10035306|FG002|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post-treatment phase.|183
8971518|NCT02614183|10035304|FG000|Safety Population|Post Treatment Follow-up Phase||372
8971519|NCT02614183|10035305|FG001|Safety Population|Post Treatment Follow-up Phase||183
8971520|NCT02614183|10035306|FG002|Safety Population|Post Treatment Follow-up Phase|Two participants who received only 240mg loading dose prior to discontinuation moved to this group.|185
8971521|NCT02614183|10035304|FG000|COMPLETED|Post Treatment Follow-up Phase||354
8971522|NCT02614183|10035305|FG001|COMPLETED|Post Treatment Follow-up Phase||179
8971523|NCT02614183|10035306|FG002|COMPLETED|Post Treatment Follow-up Phase||171
8971524|NCT02614183|10035304|FG000|NOT COMPLETED|Post Treatment Follow-up Phase||18
8971525|NCT02614183|10035305|FG001|NOT COMPLETED|Post Treatment Follow-up Phase||6
8971526|NCT02614183|10035306|FG002|NOT COMPLETED|Post Treatment Follow-up Phase||12
8971527|NCT02614196|10035326|FG000|STARTED|Double Blind Treatment Phase||463
8971528|NCT02614196|10035327|FG001|STARTED|Double Blind Treatment Phase||233
8971529|NCT02614196|10035328|FG002|STARTED|Double Blind Treatment Phase||226
8971530|NCT02614196|10035329|FG003|STARTED|Double Blind Treatment Phase||30
8971531|NCT02614196|10035330|FG004|STARTED|Double Blind Treatment Phase||15
8971532|NCT02614196|10035331|FG005|STARTED|Double Blind Treatment Phase||19
8971533|NCT02614196|10035326|FG000|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||461
8971534|NCT02614196|10035327|FG001|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||231
8971535|NCT02614196|10035328|FG002|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||223
8971536|NCT02614196|10035329|FG003|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||30
8971537|NCT02614196|10035330|FG004|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||14
8971538|NCT02614196|10035331|FG005|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||19
8971539|NCT02614196|10035326|FG000|COMPLETED|Double Blind Treatment Phase||387
8971540|NCT02614196|10035327|FG001|COMPLETED|Double Blind Treatment Phase||203
8971541|NCT02614196|10035328|FG002|COMPLETED|Double Blind Treatment Phase||195
8971542|NCT02614196|10035329|FG003|COMPLETED|Double Blind Treatment Phase||26
8971543|NCT02614196|10035330|FG004|COMPLETED|Double Blind Treatment Phase||14
8971544|NCT02614196|10035331|FG005|COMPLETED|Double Blind Treatment Phase||19
8971545|NCT02614196|10035326|FG000|NOT COMPLETED|Double Blind Treatment Phase||76
8971546|NCT02614196|10035327|FG001|NOT COMPLETED|Double Blind Treatment Phase||30
8971547|NCT02614196|10035328|FG002|NOT COMPLETED|Double Blind Treatment Phase||31
8971548|NCT02614196|10035329|FG003|NOT COMPLETED|Double Blind Treatment Phase||4
8971549|NCT02614196|10035330|FG004|NOT COMPLETED|Double Blind Treatment Phase||1
8971550|NCT02614196|10035331|FG005|NOT COMPLETED|Double Blind Treatment Phase||0
8971551|NCT02614196|10035326|FG000|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|410
8971552|NCT02614196|10035327|FG001|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|213
8971553|NCT02614196|10035328|FG002|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|207
8971554|NCT02614196|10035329|FG003|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|25
9038287|NCT03330275|10099569|FG005|NOT COMPLETED|Visit 1 - Period 2||0
8971555|NCT02614196|10035330|FG004|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|15
8971556|NCT02614196|10035331|FG005|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|19
8971557|NCT02614196|10035326|FG000|COMPLETED|Post Treatment Follow-up Phase||390
8971558|NCT02614196|10035327|FG001|COMPLETED|Post Treatment Follow-up Phase||208
8971559|NCT02614196|10035328|FG002|COMPLETED|Post Treatment Follow-up Phase||199
8971560|NCT02614196|10035329|FG003|COMPLETED|Post Treatment Follow-up Phase||24
8971561|NCT02614196|10035330|FG004|COMPLETED|Post Treatment Follow-up Phase||13
8971562|NCT02614196|10035331|FG005|COMPLETED|Post Treatment Follow-up Phase||19
8971563|NCT02614196|10035326|FG000|NOT COMPLETED|Post Treatment Follow-up Phase||20
8971564|NCT02614196|10035327|FG001|NOT COMPLETED|Post Treatment Follow-up Phase||5
8971565|NCT02614196|10035328|FG002|NOT COMPLETED|Post Treatment Follow-up Phase||8
8971566|NCT02614196|10035329|FG003|NOT COMPLETED|Post Treatment Follow-up Phase||1
8971567|NCT02614196|10035330|FG004|NOT COMPLETED|Post Treatment Follow-up Phase||2
8971568|NCT02614196|10035331|FG005|NOT COMPLETED|Post Treatment Follow-up Phase||0
8971569|NCT02614222|10035361|FG000|STARTED|Overall Study||13
8971570|NCT02614222|10035362|FG001|STARTED|Overall Study||14
8971571|NCT02614222|10035361|FG000|COMPLETED|Overall Study||13
8971572|NCT02614222|10035362|FG001|COMPLETED|Overall Study||14
8971573|NCT02614222|10035361|FG000|NOT COMPLETED|Overall Study||0
8971574|NCT02614222|10035362|FG001|NOT COMPLETED|Overall Study||0
8971575|NCT02614274|10035368|FG000|STARTED|Overall Study||9
8971576|NCT02614274|10035368|FG000|COMPLETED|Overall Study||5
8971577|NCT02614274|10035368|FG000|NOT COMPLETED|Overall Study||4
8971578|NCT02614287|10035374|FG000|STARTED|Open Label (OL) Treatment Phase||135
8971579|NCT02614287|10035375|FG001|STARTED|Open Label (OL) Treatment Phase||135
8971580|NCT02614287|10035374|FG000|Received at Least One Dose of Study Drug|Open Label (OL) Treatment Phase||135
8971581|NCT02614287|10035375|FG001|Received at Least One Dose of Study Drug|Open Label (OL) Treatment Phase||135
8971582|NCT02614287|10035374|FG000|COMPLETED|Open Label (OL) Treatment Phase||97
8971583|NCT02614287|10035375|FG001|COMPLETED|Open Label (OL) Treatment Phase||113
8971584|NCT02614287|10035374|FG000|NOT COMPLETED|Open Label (OL) Treatment Phase||38
8971585|NCT02614287|10035375|FG001|NOT COMPLETED|Open Label (OL) Treatment Phase||22
8971586|NCT02614287|10035374|FG000|STARTED|Post Treatment Follow-up Phase|Follow-up period was optional, few participants who completed OL period didn't enter follow-up.|112
8971587|NCT02614287|10035375|FG001|STARTED|Post Treatment Follow-up Phase|Follow-up period was optional, few participants who completed OL period didn't enter follow-up.|124
8971588|NCT02614287|10035374|FG000|COMPLETED|Post Treatment Follow-up Phase||103
8971589|NCT02614287|10035375|FG001|COMPLETED|Post Treatment Follow-up Phase||119
8971590|NCT02614287|10035374|FG000|NOT COMPLETED|Post Treatment Follow-up Phase||9
8971591|NCT02614287|10035375|FG001|NOT COMPLETED|Post Treatment Follow-up Phase||5
8971592|NCT02614469|10035388|FG000|STARTED|Period 1||9
8971593|NCT02614469|10035389|FG001|STARTED|Period 1||9
8971594|NCT02614469|10035388|FG000|COMPLETED|Period 1||9
8971595|NCT02614469|10035389|FG001|COMPLETED|Period 1||9
8971596|NCT02614469|10035388|FG000|NOT COMPLETED|Period 1||0
8971597|NCT02614469|10035389|FG001|NOT COMPLETED|Period 1||0
8971598|NCT02614469|10035388|FG000|STARTED|Period 2||9
8971599|NCT02614469|10035389|FG001|STARTED|Period 2||9
8971600|NCT02614469|10035388|FG000|COMPLETED|Period 2||9
8971601|NCT02614469|10035389|FG001|COMPLETED|Period 2||9
8971602|NCT02614469|10035388|FG000|NOT COMPLETED|Period 2||0
8971603|NCT02614469|10035389|FG001|NOT COMPLETED|Period 2||0
8971604|NCT02614560|10035397|FG000|STARTED|Overall Study||6
8971605|NCT02614560|10035398|FG001|STARTED|Overall Study||8
8971606|NCT02614560|10035397|FG000|COMPLETED|Overall Study||0
8971607|NCT02614560|10035398|FG001|COMPLETED|Overall Study||6
8971608|NCT02614560|10035397|FG000|NOT COMPLETED|Overall Study||6
8971609|NCT02614560|10035398|FG001|NOT COMPLETED|Overall Study||2
8971610|NCT02614703|10035406|FG000|STARTED|Overall Study||31
8971611|NCT02614703|10035407|FG001|STARTED|Overall Study||29
8971612|NCT02614703|10035406|FG000|COMPLETED|Overall Study||24
8971613|NCT02614703|10035407|FG001|COMPLETED|Overall Study||28
8971614|NCT02614703|10035406|FG000|NOT COMPLETED|Overall Study||7
8971615|NCT02614703|10035407|FG001|NOT COMPLETED|Overall Study||1
8971616|NCT02614729|10035415|FG000|STARTED|Overall Study||18
8971617|NCT02614729|10035416|FG001|STARTED|Overall Study||17
8971618|NCT02614729|10035415|FG000|COMPLETED|Overall Study||17
8971619|NCT02614729|10035416|FG001|COMPLETED|Overall Study||17
8971620|NCT02614729|10035415|FG000|NOT COMPLETED|Overall Study||1
8631988|NCT00542919|9671850|FG002|COMPLETED|Overall Study||9
8631989|NCT00542919|9671848|FG000|NOT COMPLETED|Overall Study||7
8631990|NCT00542919|9671849|FG001|NOT COMPLETED|Overall Study||7
8971621|NCT02614729|10035416|FG001|NOT COMPLETED|Overall Study||0
8971622|NCT02614794|10035426|FG000|STARTED|Overall Study||410
8971623|NCT02614794|10035427|FG001|STARTED|Overall Study||202
8971624|NCT02614794|10035426|FG000|COMPLETED|Overall Study||0
8971625|NCT02614794|10035427|FG001|COMPLETED|Overall Study||0
8971626|NCT02614794|10035426|FG000|NOT COMPLETED|Overall Study||410
8971627|NCT02614794|10035427|FG001|NOT COMPLETED|Overall Study||202
8971628|NCT02614924|10035435|FG000|STARTED|Overall Study||20
8971629|NCT02614924|10035436|FG001|STARTED|Overall Study||20
8971630|NCT02614924|10035435|FG000|COMPLETED|Overall Study||20
8971631|NCT02614924|10035436|FG001|COMPLETED|Overall Study||20
8971632|NCT02614924|10035435|FG000|NOT COMPLETED|Overall Study||0
8971633|NCT02614924|10035436|FG001|NOT COMPLETED|Overall Study||0
8631991|NCT00542919|9671850|FG002|NOT COMPLETED|Overall Study||6
8971634|NCT02615145|10035446|FG000|STARTED|Overall Study||145
8971635|NCT02615145|10035447|FG001|STARTED|Overall Study||278
8971636|NCT02615145|10035448|FG002|STARTED|Overall Study||48
8971637|NCT02615145|10035449|FG003|STARTED|Overall Study||1
8971638|NCT02615145|10035446|FG000|2 DAA + Ribavirin (RBV)|Overall Study||0
8971639|NCT02615145|10035447|FG001|2 DAA + Ribavirin (RBV)|Overall Study||0
8971640|NCT02615145|10035448|FG002|2 DAA + Ribavirin (RBV)|Overall Study||45
8971641|NCT02615145|10035449|FG003|2 DAA + Ribavirin (RBV)|Overall Study||0
8971642|NCT02615145|10035446|FG000|3DAA|Overall Study||5
8971643|NCT02615145|10035447|FG001|3DAA|Overall Study||261
8971644|NCT02615145|10035448|FG002|3DAA|Overall Study||0
8971645|NCT02615145|10035449|FG003|3DAA|Overall Study||0
8971646|NCT02615145|10035446|FG000|3DAA + RBV|Overall Study||140
8971647|NCT02615145|10035447|FG001|3DAA + RBV|Overall Study||17
8971648|NCT02615145|10035448|FG002|3DAA + RBV|Overall Study||2
8971649|NCT02615145|10035449|FG003|3DAA + RBV|Overall Study||0
8971650|NCT02615145|10035446|FG000|COMPLETED|Overall Study||118
8971651|NCT02615145|10035447|FG001|COMPLETED|Overall Study||263
8971652|NCT02615145|10035448|FG002|COMPLETED|Overall Study||40
8971653|NCT02615145|10035449|FG003|COMPLETED|Overall Study||0
8971654|NCT02615145|10035446|FG000|NOT COMPLETED|Overall Study||27
8971655|NCT02615145|10035447|FG001|NOT COMPLETED|Overall Study||15
8971656|NCT02615145|10035448|FG002|NOT COMPLETED|Overall Study||8
8971657|NCT02615145|10035449|FG003|NOT COMPLETED|Overall Study||1
8971658|NCT02615158|10035478|FG000|STARTED|Overall Study||94
8971659|NCT02615158|10035479|FG001|STARTED|Overall Study||92
8971660|NCT02615158|10035480|FG002|STARTED|Overall Study||91
8971661|NCT02615158|10035478|FG000|COMPLETED|Overall Study||73
8971662|NCT02615158|10035479|FG001|COMPLETED|Overall Study||76
8971663|NCT02615158|10035480|FG002|COMPLETED|Overall Study||75
8971664|NCT02615158|10035478|FG000|NOT COMPLETED|Overall Study||21
8971665|NCT02615158|10035479|FG001|NOT COMPLETED|Overall Study||16
8971666|NCT02615158|10035480|FG002|NOT COMPLETED|Overall Study||16
8971667|NCT02615171|10035490|FG000|STARTED|Overall Study||32
8971668|NCT02615171|10035491|FG001|STARTED|Overall Study||32
8971669|NCT02615171|10035490|FG000|COMPLETED|Overall Study||30
8971670|NCT02615171|10035491|FG001|COMPLETED|Overall Study||31
8971671|NCT02615171|10035490|FG000|NOT COMPLETED|Overall Study||2
8971672|NCT02615171|10035491|FG001|NOT COMPLETED|Overall Study||1
9038288|NCT03330275|10099570|FG006|NOT COMPLETED|Visit 1 - Period 2||0
9038289|NCT03330275|10099571|FG007|NOT COMPLETED|Visit 1 - Period 2||0
9038290|NCT03330275|10099572|FG008|NOT COMPLETED|Visit 1 - Period 2||0
9038291|NCT03330275|10099573|FG009|NOT COMPLETED|Visit 1 - Period 2||0
9038292|NCT03330275|10099564|FG000|STARTED|Visits 2, 3 and 4 - Period 1||0
9038293|NCT03330275|10099565|FG001|STARTED|Visits 2, 3 and 4 - Period 1||0
9038294|NCT03330275|10099566|FG002|STARTED|Visits 2, 3 and 4 - Period 1||0
9038295|NCT03330275|10099567|FG003|STARTED|Visits 2, 3 and 4 - Period 1||0
9038296|NCT03330275|10099568|FG004|STARTED|Visits 2, 3 and 4 - Period 1||4
9038297|NCT03330275|10099569|FG005|STARTED|Visits 2, 3 and 4 - Period 1||4
9038298|NCT03330275|10099570|FG006|STARTED|Visits 2, 3 and 4 - Period 1||4
9038299|NCT03330275|10099571|FG007|STARTED|Visits 2, 3 and 4 - Period 1||4
9038300|NCT03330275|10099572|FG008|STARTED|Visits 2, 3 and 4 - Period 1||4
9038301|NCT03330275|10099573|FG009|STARTED|Visits 2, 3 and 4 - Period 1||4
9038302|NCT03330275|10099564|FG000|COMPLETED|Visits 2, 3 and 4 - Period 1||0
9038303|NCT03330275|10099565|FG001|COMPLETED|Visits 2, 3 and 4 - Period 1||0
9038304|NCT03330275|10099566|FG002|COMPLETED|Visits 2, 3 and 4 - Period 1||0
9038305|NCT03330275|10099567|FG003|COMPLETED|Visits 2, 3 and 4 - Period 1||0
9038306|NCT03330275|10099568|FG004|COMPLETED|Visits 2, 3 and 4 - Period 1||4
8631992|NCT00542971|9671873|FG000|STARTED|Overall Study||75
8631993|NCT00542971|9671873|FG000|COMPLETED|Overall Study||75
9038307|NCT03330275|10099569|FG005|COMPLETED|Visits 2, 3 and 4 - Period 1||4
9038308|NCT03330275|10099570|FG006|COMPLETED|Visits 2, 3 and 4 - Period 1||4
9038309|NCT03330275|10099571|FG007|COMPLETED|Visits 2, 3 and 4 - Period 1||4
9038310|NCT03330275|10099572|FG008|COMPLETED|Visits 2, 3 and 4 - Period 1||4
9038311|NCT03330275|10099573|FG009|COMPLETED|Visits 2, 3 and 4 - Period 1||4
9038312|NCT03330275|10099564|FG000|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
9038313|NCT03330275|10099565|FG001|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
9038314|NCT03330275|10099566|FG002|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
9038315|NCT03330275|10099567|FG003|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
9038316|NCT03330275|10099568|FG004|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
9038317|NCT03330275|10099569|FG005|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
9038318|NCT03330275|10099570|FG006|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
9038319|NCT03330275|10099571|FG007|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
9038320|NCT03330275|10099572|FG008|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
9038321|NCT03330275|10099573|FG009|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
9038322|NCT03330275|10099564|FG000|STARTED|Visits 2, 3 and 4 - Period 2||0
9038323|NCT03330275|10099565|FG001|STARTED|Visits 2, 3 and 4 - Period 2||0
9038324|NCT03330275|10099566|FG002|STARTED|Visits 2, 3 and 4 - Period 2||0
9038325|NCT03330275|10099567|FG003|STARTED|Visits 2, 3 and 4 - Period 2||0
9038326|NCT03330275|10099568|FG004|STARTED|Visits 2, 3 and 4 - Period 2||4
9038327|NCT03330275|10099569|FG005|STARTED|Visits 2, 3 and 4 - Period 2||4
9038328|NCT03330275|10099570|FG006|STARTED|Visits 2, 3 and 4 - Period 2||4
9038329|NCT03330275|10099571|FG007|STARTED|Visits 2, 3 and 4 - Period 2||4
9038330|NCT03330275|10099572|FG008|STARTED|Visits 2, 3 and 4 - Period 2||4
9038331|NCT03330275|10099573|FG009|STARTED|Visits 2, 3 and 4 - Period 2||4
8971673|NCT02615249|10035497|FG000|STARTED|Overall Study||122
8971674|NCT02615249|10035497|FG000|COMPLETED|Overall Study||121
8971675|NCT02615249|10035497|FG000|NOT COMPLETED|Overall Study||1
8971676|NCT02615470|10035504|FG000|STARTED|Overall Study||58
8971677|NCT02615470|10035505|FG001|STARTED|Overall Study||62
8971678|NCT02615470|10035504|FG000|Completed the Baseline Surveys|Overall Study||46
8971679|NCT02615470|10035505|FG001|Completed the Baseline Surveys|Overall Study||47
8971680|NCT02615470|10035504|FG000|COMPLETED|Overall Study||37
8971681|NCT02615470|10035505|FG001|COMPLETED|Overall Study||30
8971682|NCT02615470|10035504|FG000|NOT COMPLETED|Overall Study||21
8971683|NCT02615470|10035505|FG001|NOT COMPLETED|Overall Study||32
8971684|NCT02615509|10035511|FG000|STARTED|Overall Study||347
8971685|NCT02615509|10035511|FG000|COMPLETED|Overall Study||201
8971686|NCT02615509|10035511|FG000|NOT COMPLETED|Overall Study||146
8971687|NCT02615535|10035517|FG000|STARTED|Overall Study||14
8971688|NCT02615535|10035518|FG001|STARTED|Overall Study||11
8971689|NCT02615535|10035517|FG000|COMPLETED|Overall Study||10
8971690|NCT02615535|10035518|FG001|COMPLETED|Overall Study||10
8971691|NCT02615535|10035517|FG000|NOT COMPLETED|Overall Study||4
8971692|NCT02615535|10035518|FG001|NOT COMPLETED|Overall Study||1
8971693|NCT02615717|10035526|FG000|STARTED|Overall Study||3
8971694|NCT02615717|10035527|FG001|STARTED|Overall Study||3
8971695|NCT02615717|10035526|FG000|COMPLETED|Overall Study||3
8971696|NCT02615717|10035527|FG001|COMPLETED|Overall Study||3
8971697|NCT02615717|10035526|FG000|NOT COMPLETED|Overall Study||0
8971698|NCT02615717|10035527|FG001|NOT COMPLETED|Overall Study||0
8971699|NCT02615743|10035535|FG000|STARTED|Overall Study||21
8971700|NCT02615743|10035536|FG001|STARTED|Overall Study||20
8971701|NCT02615743|10035535|FG000|COMPLETED|Overall Study||15
8971702|NCT02615743|10035536|FG001|COMPLETED|Overall Study||17
8971703|NCT02615743|10035535|FG000|NOT COMPLETED|Overall Study||6
8971704|NCT02615743|10035536|FG001|NOT COMPLETED|Overall Study||3
8971705|NCT02616029|10035544|FG000|STARTED|Overall Study||38
8971706|NCT02616029|10035545|FG001|STARTED|Overall Study||28
8971707|NCT02616029|10035544|FG000|COMPLETED|Overall Study||34
8971708|NCT02616029|10035545|FG001|COMPLETED|Overall Study||26
8971709|NCT02616029|10035544|FG000|NOT COMPLETED|Overall Study||4
8971710|NCT02616029|10035545|FG001|NOT COMPLETED|Overall Study||2
8971711|NCT02616250|10035553|FG000|STARTED|Overall Study||95
8971712|NCT02616250|10035554|FG001|STARTED|Overall Study||95
8971713|NCT02616250|10035553|FG000|COMPLETED|Overall Study||85
8971714|NCT02616250|10035554|FG001|COMPLETED|Overall Study||86
8971715|NCT02616250|10035553|FG000|NOT COMPLETED|Overall Study||10
8971716|NCT02616250|10035554|FG001|NOT COMPLETED|Overall Study||9
8570962|NCT00106535|9603124|FG000|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||393
8570963|NCT00106535|9603125|FG001|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||399
8570964|NCT00106535|9603126|FG002|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||398
8570965|NCT00106535|9603127|FG003|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||0
8570966|NCT00106535|9603124|FG000|Safety: Actual Treatment Received|2-year Placebo Controlled Period||392
8570967|NCT00106535|9603125|FG001|Safety: Actual Treatment Received|2-year Placebo Controlled Period||399
8570968|NCT00106535|9603126|FG002|Safety: Actual Treatment Received|2-year Placebo Controlled Period||399
8570969|NCT00106535|9603127|FG003|Safety: Actual Treatment Received|2-year Placebo Controlled Period||0
8570970|NCT00106535|9603124|FG000|Completed Week 24|2-year Placebo Controlled Period||356
8570971|NCT00106535|9603125|FG001|Completed Week 24|2-year Placebo Controlled Period||373
8570972|NCT00106535|9603126|FG002|Completed Week 24|2-year Placebo Controlled Period||366
8570973|NCT00106535|9603127|FG003|Completed Week 24|2-year Placebo Controlled Period||0
8570974|NCT00106535|9603124|FG000|Completed Week 52|2-year Placebo Controlled Period||326
8570975|NCT00106535|9603125|FG001|Completed Week 52|2-year Placebo Controlled Period||342
8570976|NCT00106535|9603126|FG002|Completed Week 52|2-year Placebo Controlled Period||338
8631994|NCT00542971|9671873|FG000|NOT COMPLETED|Overall Study||0
8631995|NCT00542997|9671877|FG000|STARTED|Wash in / Wash Out Period||51
8631996|NCT00542997|9671877|FG000|COMPLETED|Wash in / Wash Out Period||46
8631997|NCT00542997|9671877|FG000|NOT COMPLETED|Wash in / Wash Out Period||5
8631998|NCT00542997|9671877|FG000|STARTED|Efficacy Period||46
8631999|NCT00542997|9671877|FG000|COMPLETED|Efficacy Period||43
8632000|NCT00542997|9671877|FG000|NOT COMPLETED|Efficacy Period||3
8632001|NCT00543062|9671884|FG000|STARTED|Overall Study||12
8570977|NCT00106535|9603127|FG003|Completed Week 52|2-year Placebo Controlled Period||0
8570978|NCT00106535|9603124|FG000|COMPLETED|2-year Placebo Controlled Period|Completed Week 104 (Year 2). 284 participants randomized to the Placebo arm entered the LTE period.|287
8570979|NCT00106535|9603125|FG001|COMPLETED|2-year Placebo Controlled Period|Completed Week 104. 304 participants randomized to the TCZ 4 mg/kg arm entered the LTE period.|309
8570980|NCT00106535|9603126|FG002|COMPLETED|2-year Placebo Controlled Period|Completed Week 104. 306 participants randomized to the TCZ 8 mg/kg arm entered the LTE period.|310
8632002|NCT00543062|9671885|FG001|STARTED|Overall Study||12
8632003|NCT00543062|9671886|FG002|STARTED|Overall Study||12
8632004|NCT00543062|9671887|FG003|STARTED|Overall Study||12
8971717|NCT02616380|10035560|FG000|STARTED|Overall Study||100
8971718|NCT02616380|10035560|FG000|COMPLETED|Overall Study||97
8971719|NCT02616380|10035560|FG000|NOT COMPLETED|Overall Study||3
8971720|NCT02616523|10035567|FG000|STARTED|Overall Study|June 2014|20
8971721|NCT02616523|10035568|FG001|STARTED|Overall Study|June 2014|20
8971722|NCT02616523|10035569|FG002|STARTED|Overall Study|June 2014|20
8971723|NCT02616523|10035567|FG000|COMPLETED|Overall Study|April 2015|19
8971724|NCT02616523|10035568|FG001|COMPLETED|Overall Study|April 2015|20
8971725|NCT02616523|10035569|FG002|COMPLETED|Overall Study|April 2015|20
8971726|NCT02616523|10035567|FG000|NOT COMPLETED|Overall Study||1
8971727|NCT02616523|10035568|FG001|NOT COMPLETED|Overall Study||0
8971728|NCT02616523|10035569|FG002|NOT COMPLETED|Overall Study||0
8971729|NCT02616601|10035583|FG000|STARTED|Overall Study||140
8971730|NCT02616601|10035584|FG001|STARTED|Overall Study||140
8971731|NCT02616601|10035585|FG002|STARTED|Overall Study||142
8971732|NCT02616601|10035583|FG000|Safety Population|Overall Study||140
8971733|NCT02616601|10035584|FG001|Safety Population|Overall Study||140
8971734|NCT02616601|10035585|FG002|Safety Population|Overall Study||142
8971735|NCT02616601|10035583|FG000|mITT Population|Overall Study||137
8971736|NCT02616601|10035584|FG001|mITT Population|Overall Study||136
8971737|NCT02616601|10035585|FG002|mITT Population|Overall Study||138
8971738|NCT02616601|10035583|FG000|PP Population|Overall Study||112
8971739|NCT02616601|10035584|FG001|PP Population|Overall Study||121
8971740|NCT02616601|10035585|FG002|PP Population|Overall Study||123
8971741|NCT02616601|10035583|FG000|COMPLETED|Overall Study||131
8971742|NCT02616601|10035584|FG001|COMPLETED|Overall Study||136
8971743|NCT02616601|10035585|FG002|COMPLETED|Overall Study||135
8971744|NCT02616601|10035583|FG000|NOT COMPLETED|Overall Study||9
8971745|NCT02616601|10035584|FG001|NOT COMPLETED|Overall Study||4
8971746|NCT02616601|10035585|FG002|NOT COMPLETED|Overall Study||7
8971747|NCT02616614|10035596|FG000|STARTED|Overall Study||347
8570981|NCT00106535|9603127|FG003|COMPLETED|2-year Placebo Controlled Period||0
8570982|NCT00106535|9603124|FG000|NOT COMPLETED|2-year Placebo Controlled Period||107
8570983|NCT00106535|9603125|FG001|NOT COMPLETED|2-year Placebo Controlled Period||92
8570984|NCT00106535|9603126|FG002|NOT COMPLETED|2-year Placebo Controlled Period||91
8570985|NCT00106535|9603127|FG003|NOT COMPLETED|2-year Placebo Controlled Period||0
8570986|NCT00106535|9603124|FG000|STARTED|Long-term Extension Period (Year 3 to 5)||0
8570987|NCT00106535|9603125|FG001|STARTED|Long-term Extension Period (Year 3 to 5)||0
8570988|NCT00106535|9603126|FG002|STARTED|Long-term Extension Period (Year 3 to 5)||0
8570989|NCT00106535|9603127|FG003|STARTED|Long-term Extension Period (Year 3 to 5)|Entered the Long-term Extension.|894
8570990|NCT00106535|9603124|FG000|COMPLETED|Long-term Extension Period (Year 3 to 5)||0
8570991|NCT00106535|9603125|FG001|COMPLETED|Long-term Extension Period (Year 3 to 5)||0
8570992|NCT00106535|9603126|FG002|COMPLETED|Long-term Extension Period (Year 3 to 5)||0
8570993|NCT00106535|9603127|FG003|COMPLETED|Long-term Extension Period (Year 3 to 5)|Completed the study.|704
8570994|NCT00106535|9603124|FG000|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||0
8570995|NCT00106535|9603125|FG001|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||0
8570996|NCT00106535|9603126|FG002|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||0
8570997|NCT00106535|9603127|FG003|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||190
8570998|NCT00106639|9603142|FG000|STARTED|Overall Study||20
8570999|NCT00106639|9603143|FG001|STARTED|Overall Study||20
8571000|NCT00106639|9603144|FG002|STARTED|Overall Study||21
8571001|NCT00106639|9603142|FG000|COMPLETED|Overall Study||17
8571002|NCT00106639|9603143|FG001|COMPLETED|Overall Study||13
8571003|NCT00106639|9603144|FG002|COMPLETED|Overall Study||19
8571004|NCT00106639|9603142|FG000|NOT COMPLETED|Overall Study||3
8571005|NCT00106639|9603143|FG001|NOT COMPLETED|Overall Study||7
8571006|NCT00106639|9603144|FG002|NOT COMPLETED|Overall Study||2
8571007|NCT00106704|9603155|FG000|STARTED|Overall Study||222
8571008|NCT00106704|9603156|FG001|STARTED|Overall Study||219
8571009|NCT00106704|9603155|FG000|COMPLETED|Overall Study||91
8571010|NCT00106704|9603156|FG001|COMPLETED|Overall Study||68
8571011|NCT00106704|9603155|FG000|NOT COMPLETED|Overall Study||131
8571012|NCT00106704|9603156|FG001|NOT COMPLETED|Overall Study||151
8571013|NCT00106938|9603164|FG000|STARTED|Overall Study||1089
8571014|NCT00106938|9603165|FG001|STARTED|Overall Study||364
8971748|NCT02616614|10035597|FG001|STARTED|Overall Study||345
8971749|NCT02616614|10035598|FG002|STARTED|Overall Study||170
8971750|NCT02616614|10035596|FG000|Safety Population|Overall Study||329
8571015|NCT00106938|9603164|FG000|COMPLETED|Overall Study||913
8571016|NCT00106938|9603165|FG001|COMPLETED|Overall Study||293
8971751|NCT02616614|10035597|FG001|Safety Population|Overall Study||328
8971752|NCT02616614|10035598|FG002|Safety Population|Overall Study||161
8971753|NCT02616614|10035596|FG000|mITT Population|Overall Study||325
8971754|NCT02616614|10035597|FG001|mITT Population|Overall Study||325
8971755|NCT02616614|10035598|FG002|mITT Population|Overall Study||160
8971756|NCT02616614|10035596|FG000|PP Population|Overall Study||253
8971757|NCT02616614|10035597|FG001|PP Population|Overall Study||255
8971758|NCT02616614|10035598|FG002|PP Population|Overall Study||122
8971759|NCT02616614|10035596|FG000|COMPLETED|Overall Study||282
8971760|NCT02616614|10035597|FG001|COMPLETED|Overall Study||285
8971761|NCT02616614|10035598|FG002|COMPLETED|Overall Study||141
8971762|NCT02616614|10035596|FG000|NOT COMPLETED|Overall Study||65
8971763|NCT02616614|10035597|FG001|NOT COMPLETED|Overall Study||60
8971764|NCT02616614|10035598|FG002|NOT COMPLETED|Overall Study||29
8971765|NCT02616783|10035609|FG000|STARTED|Overall Study||111
8971766|NCT02616783|10035610|FG001|STARTED|Overall Study||56
8971767|NCT02616783|10035609|FG000|COMPLETED|Overall Study||105
8971768|NCT02616783|10035610|FG001|COMPLETED|Overall Study||54
8971769|NCT02616783|10035609|FG000|NOT COMPLETED|Overall Study||6
8971770|NCT02616783|10035610|FG001|NOT COMPLETED|Overall Study||2
8971771|NCT02616900|10035616|FG000|STARTED|Overall Study||74
8971772|NCT02616900|10035616|FG000|Completed 3mo Trial|Overall Study||57
8971773|NCT02616900|10035616|FG000|COMPLETED|Overall Study|Six participants not included in study results because of incomplete data.|51
8971774|NCT02616900|10035616|FG000|NOT COMPLETED|Overall Study||23
8971775|NCT02617628|10035622|FG000|STARTED|Overall Study||74
8971776|NCT02617628|10035623|FG001|STARTED|Overall Study||72
8971777|NCT02617628|10035622|FG000|COMPLETED|Overall Study||12
8971778|NCT02617628|10035623|FG001|COMPLETED|Overall Study||11
8971779|NCT02617628|10035622|FG000|NOT COMPLETED|Overall Study||62
8971780|NCT02617628|10035623|FG001|NOT COMPLETED|Overall Study||61
8971781|NCT02617667|10035635|FG000|STARTED|Overall Study||51
8971782|NCT02617667|10035636|FG001|STARTED|Overall Study||51
8971783|NCT02617667|10035637|FG002|STARTED|Overall Study||52
8971784|NCT02617667|10035638|FG003|STARTED|Overall Study||53
8971785|NCT02617667|10035635|FG000|COMPLETED|Overall Study||50
8971786|NCT02617667|10035636|FG001|COMPLETED|Overall Study||50
8971787|NCT02617667|10035637|FG002|COMPLETED|Overall Study||48
8971788|NCT02617667|10035638|FG003|COMPLETED|Overall Study||52
8971789|NCT02617667|10035635|FG000|NOT COMPLETED|Overall Study||1
8971790|NCT02617667|10035636|FG001|NOT COMPLETED|Overall Study||1
8971791|NCT02617667|10035637|FG002|NOT COMPLETED|Overall Study||4
8971792|NCT02617667|10035638|FG003|NOT COMPLETED|Overall Study||1
8971793|NCT02617784|10035649|FG000|STARTED|Overall Study|None were prematurely withdrawn; 1 switched to CAPD mid-study and was excluded from second analysis.|12
8971794|NCT02617784|10035650|FG001|STARTED|Overall Study||12
8971795|NCT02617784|10035649|FG000|First Dose Assessment Period|Overall Study||12
8971796|NCT02617784|10035650|FG001|First Dose Assessment Period|Overall Study||12
8971797|NCT02617784|10035649|FG000|Second Dose Assessment Period|Overall Study||11
8971798|NCT02617784|10035650|FG001|Second Dose Assessment Period|Overall Study||12
8971799|NCT02617784|10035649|FG000|COMPLETED|Overall Study||12
8971800|NCT02617784|10035650|FG001|COMPLETED|Overall Study||12
8971801|NCT02617784|10035649|FG000|NOT COMPLETED|Overall Study||0
8971802|NCT02617784|10035650|FG001|NOT COMPLETED|Overall Study||0
8971803|NCT02617888|10035659|FG000|STARTED|Overall Study||50
8971804|NCT02617888|10035660|FG001|STARTED|Overall Study||51
8971805|NCT02617888|10035661|FG002|STARTED|Overall Study||127
8971806|NCT02617888|10035659|FG000|COMPLETED|Overall Study|Incomplete due to inadequate double-strand DNA break sample.|49
8971807|NCT02617888|10035660|FG001|COMPLETED|Overall Study|Incomplete due to inadequate double-strand DNA break samples.|44
8971808|NCT02617888|10035661|FG002|COMPLETED|Overall Study||127
8971809|NCT02617888|10035659|FG000|NOT COMPLETED|Overall Study||1
8971810|NCT02617888|10035660|FG001|NOT COMPLETED|Overall Study||7
8971811|NCT02617888|10035661|FG002|NOT COMPLETED|Overall Study||0
8971812|NCT02617901|10035668|FG000|STARTED|Overall Study||20
8971813|NCT02617901|10035668|FG000|COMPLETED|Overall Study||20
8971814|NCT02617901|10035668|FG000|NOT COMPLETED|Overall Study||0
8971815|NCT02618031|10035674|FG000|STARTED|Overall Study||46
8971816|NCT02618031|10035675|FG001|STARTED|Overall Study||11
8971817|NCT02618031|10035674|FG000|COMPLETED|Overall Study||45
8971818|NCT02618031|10035675|FG001|COMPLETED|Overall Study||11
8971819|NCT02618031|10035674|FG000|NOT COMPLETED|Overall Study||1
8971820|NCT02618031|10035675|FG001|NOT COMPLETED|Overall Study||0
8971821|NCT02618187|10035689|FG000|STARTED|Overall Study||15
8971822|NCT02618187|10035690|FG001|STARTED|Overall Study||11
8971823|NCT02618187|10035691|FG002|STARTED|Overall Study||15
8971824|NCT02618187|10035692|FG003|STARTED|Overall Study||17
8971825|NCT02618187|10035689|FG000|Completed|Overall Study||13
8971826|NCT02618187|10035690|FG001|Completed|Overall Study||10
8971827|NCT02618187|10035691|FG002|Completed|Overall Study||13
8971828|NCT02618187|10035692|FG003|Completed|Overall Study||13
8971829|NCT02618187|10035689|FG000|COMPLETED|Overall Study||13
8971830|NCT02618187|10035690|FG001|COMPLETED|Overall Study||9
8971831|NCT02618187|10035691|FG002|COMPLETED|Overall Study||11
8971832|NCT02618187|10035692|FG003|COMPLETED|Overall Study||12
8971833|NCT02618187|10035689|FG000|NOT COMPLETED|Overall Study||2
8971834|NCT02618187|10035690|FG001|NOT COMPLETED|Overall Study||2
8971835|NCT02618187|10035691|FG002|NOT COMPLETED|Overall Study||4
8971836|NCT02618187|10035692|FG003|NOT COMPLETED|Overall Study||5
8971837|NCT02618343|10035704|FG000|STARTED|Overall Study||28
8971838|NCT02618343|10035705|FG001|STARTED|Overall Study||23
8971839|NCT02618343|10035704|FG000|COMPLETED|Overall Study||28
8971840|NCT02618343|10035705|FG001|COMPLETED|Overall Study||23
8971841|NCT02618343|10035704|FG000|NOT COMPLETED|Overall Study||0
8971842|NCT02618343|10035705|FG001|NOT COMPLETED|Overall Study||0
8971843|NCT02618382|10035711|FG000|STARTED|Overall Study|Enrolled and consented for study treatment|32
8971844|NCT02618382|10035711|FG000|COMPLETED|Overall Study|Completed Study treatment|29
8971845|NCT02618382|10035711|FG000|NOT COMPLETED|Overall Study||3
8876825|NCT01919398|9933610|FG000|NOT COMPLETED|Overall Study||0
8876826|NCT01919398|9933611|FG001|NOT COMPLETED|Overall Study||0
8876827|NCT01919398|9933612|FG002|NOT COMPLETED|Overall Study||4
8876828|NCT01919411|9933622|FG000|STARTED|Overall Study||43
8876829|NCT01919411|9933623|FG001|STARTED|Overall Study||46
8876830|NCT01919411|9933622|FG000|COMPLETED|Overall Study||38
8971846|NCT02618512|10035715|FG000|STARTED|Overall Study||3
8971847|NCT02618512|10035715|FG000|COMPLETED|Overall Study||3
8971848|NCT02618512|10035715|FG000|NOT COMPLETED|Overall Study||0
8971849|NCT02618616|10035721|FG000|STARTED|Overall Study||87
8971850|NCT02618616|10035722|FG001|STARTED|Overall Study||42
8971851|NCT02618616|10035721|FG000|COMPLETED|Overall Study||66
8971852|NCT02618616|10035722|FG001|COMPLETED|Overall Study||35
8971853|NCT02618616|10035721|FG000|NOT COMPLETED|Overall Study||21
8971854|NCT02618616|10035722|FG001|NOT COMPLETED|Overall Study||7
8971855|NCT02618642|10035733|FG000|STARTED|Before 10 PILER Irradiation Treatments||15
8971856|NCT02618642|10035734|FG001|STARTED|Before 10 PILER Irradiation Treatments||15
8971857|NCT02618642|10035735|FG002|STARTED|Before 10 PILER Irradiation Treatments||15
8632005|NCT00543062|9671884|FG000|COMPLETED|Overall Study||10
8632006|NCT00543062|9671885|FG001|COMPLETED|Overall Study||11
8632007|NCT00543062|9671886|FG002|COMPLETED|Overall Study||9
8632008|NCT00543062|9671887|FG003|COMPLETED|Overall Study||11
8632009|NCT00543062|9671884|FG000|NOT COMPLETED|Overall Study||2
8632010|NCT00543062|9671885|FG001|NOT COMPLETED|Overall Study||1
8632011|NCT00543062|9671886|FG002|NOT COMPLETED|Overall Study||3
8632012|NCT00543062|9671887|FG003|NOT COMPLETED|Overall Study||1
8876831|NCT01919411|9933623|FG001|COMPLETED|Overall Study||41
8876832|NCT01919411|9933622|FG000|NOT COMPLETED|Overall Study||5
8876833|NCT01919411|9933623|FG001|NOT COMPLETED|Overall Study||5
8876834|NCT01919450|9933633|FG000|STARTED|Overall Study||20
8876835|NCT01919450|9933634|FG001|STARTED|Overall Study||20
8876836|NCT01919450|9933635|FG002|STARTED|Overall Study||20
8876837|NCT01919450|9933636|FG003|STARTED|Overall Study||20
8876838|NCT01919450|9933633|FG000|COMPLETED|Overall Study||20
8971858|NCT02618642|10035736|FG003|STARTED|Before 10 PILER Irradiation Treatments||15
8971859|NCT02618642|10035733|FG000|COMPLETED|Before 10 PILER Irradiation Treatments||15
8571017|NCT00106938|9603164|FG000|NOT COMPLETED|Overall Study||176
8571018|NCT00106938|9603165|FG001|NOT COMPLETED|Overall Study||71
8571019|NCT00106964|9603174|FG000|STARTED|Overall Study||118
8571020|NCT00106964|9603175|FG001|STARTED|Overall Study||126
8571021|NCT00106964|9603176|FG002|STARTED|Overall Study||127
8571022|NCT00106964|9603174|FG000|COMPLETED|Overall Study|The number of those those who completed the vaccine series was 105.|105
8571023|NCT00106964|9603175|FG001|COMPLETED|Overall Study|The number of those who completed the vaccine series was 111.|111
8571024|NCT00106964|9603176|FG002|COMPLETED|Overall Study|The number of those who completed the vaccine series was 120.|120
8571025|NCT00106964|9603174|FG000|NOT COMPLETED|Overall Study||13
8571026|NCT00106964|9603175|FG001|NOT COMPLETED|Overall Study||15
8571027|NCT00106964|9603176|FG002|NOT COMPLETED|Overall Study||7
8571028|NCT00107042|9603195|FG000|STARTED|Overall Study||60
8571029|NCT00107042|9603196|FG001|STARTED|Overall Study||63
8571030|NCT00107042|9603195|FG000|COMPLETED|Overall Study||38
8571031|NCT00107042|9603196|FG001|COMPLETED|Overall Study||47
8632013|NCT00543101|9671907|FG000|STARTED|Overall Study||12
8632014|NCT00543101|9671908|FG001|STARTED|Overall Study||12
8632015|NCT00543101|9671907|FG000|COMPLETED|Overall Study||12
8632016|NCT00543101|9671908|FG001|COMPLETED|Overall Study||12
8876839|NCT01919450|9933634|FG001|COMPLETED|Overall Study||20
8876840|NCT01919450|9933635|FG002|COMPLETED|Overall Study||20
8876841|NCT01919450|9933636|FG003|COMPLETED|Overall Study||19
8876842|NCT01919450|9933633|FG000|NOT COMPLETED|Overall Study||0
8876843|NCT01919450|9933634|FG001|NOT COMPLETED|Overall Study||0
8876844|NCT01919450|9933635|FG002|NOT COMPLETED|Overall Study||0
8876845|NCT01919450|9933636|FG003|NOT COMPLETED|Overall Study||1
8876846|NCT01919489|9933648|FG000|STARTED|Overall Study||136
8971860|NCT02618642|10035734|FG001|COMPLETED|Before 10 PILER Irradiation Treatments||15
8971861|NCT02618642|10035735|FG002|COMPLETED|Before 10 PILER Irradiation Treatments||15
8971862|NCT02618642|10035736|FG003|COMPLETED|Before 10 PILER Irradiation Treatments||15
8971863|NCT02618642|10035733|FG000|NOT COMPLETED|Before 10 PILER Irradiation Treatments||0
8971864|NCT02618642|10035734|FG001|NOT COMPLETED|Before 10 PILER Irradiation Treatments||0
8971865|NCT02618642|10035735|FG002|NOT COMPLETED|Before 10 PILER Irradiation Treatments||0
8971866|NCT02618642|10035736|FG003|NOT COMPLETED|Before 10 PILER Irradiation Treatments||0
8971867|NCT02618642|10035733|FG000|STARTED|After 10 PILER Irradiation Treatments||15
8971868|NCT02618642|10035734|FG001|STARTED|After 10 PILER Irradiation Treatments||15
8971869|NCT02618642|10035735|FG002|STARTED|After 10 PILER Irradiation Treatments||15
8971870|NCT02618642|10035736|FG003|STARTED|After 10 PILER Irradiation Treatments||15
8971871|NCT02618642|10035733|FG000|COMPLETED|After 10 PILER Irradiation Treatments||15
8971872|NCT02618642|10035734|FG001|COMPLETED|After 10 PILER Irradiation Treatments||15
8971873|NCT02618642|10035735|FG002|COMPLETED|After 10 PILER Irradiation Treatments||15
8971874|NCT02618642|10035736|FG003|COMPLETED|After 10 PILER Irradiation Treatments||15
8971875|NCT02618642|10035733|FG000|NOT COMPLETED|After 10 PILER Irradiation Treatments||0
8971876|NCT02618642|10035734|FG001|NOT COMPLETED|After 10 PILER Irradiation Treatments||0
8971877|NCT02618642|10035735|FG002|NOT COMPLETED|After 10 PILER Irradiation Treatments||0
8971878|NCT02618642|10035736|FG003|NOT COMPLETED|After 10 PILER Irradiation Treatments||0
8971879|NCT02618759|10035755|FG000|STARTED|Overall Study||60
8971880|NCT02618759|10035756|FG001|STARTED|Overall Study||59
8971881|NCT02618759|10035755|FG000|COMPLETED|Overall Study||58
8971882|NCT02618759|10035756|FG001|COMPLETED|Overall Study||54
8971883|NCT02618759|10035755|FG000|NOT COMPLETED|Overall Study||2
8971884|NCT02618759|10035756|FG001|NOT COMPLETED|Overall Study||5
8971885|NCT02618772|10035764|FG000|STARTED|Overall Study||39
8971886|NCT02618772|10035765|FG001|STARTED|Overall Study||40
8971887|NCT02618772|10035764|FG000|Withdrawal by Subject|Overall Study|The participant's family withdrew from the study after administration of the trial intervention.|1
8971888|NCT02618772|10035765|FG001|Withdrawal by Subject|Overall Study||0
8971889|NCT02618772|10035764|FG000|COMPLETED|Overall Study||38
8971890|NCT02618772|10035765|FG001|COMPLETED|Overall Study||40
8971891|NCT02618772|10035764|FG000|NOT COMPLETED|Overall Study||1
8971892|NCT02618772|10035765|FG001|NOT COMPLETED|Overall Study||0
8971893|NCT02618915|10035773|FG000|STARTED|Overall Study||3
8971894|NCT02618915|10035774|FG001|STARTED|Overall Study||3
8971895|NCT02618915|10035773|FG000|COMPLETED|Overall Study||3
8971896|NCT02618915|10035774|FG001|COMPLETED|Overall Study||3
8632017|NCT00543101|9671907|FG000|NOT COMPLETED|Overall Study||0
8632018|NCT00543101|9671908|FG001|NOT COMPLETED|Overall Study||0
8632019|NCT00543127|9671917|FG000|STARTED|Overall Study||433
8632020|NCT00543127|9671918|FG001|STARTED|Overall Study||437
8632021|NCT00543127|9671917|FG000|COMPLETED|Overall Study||303
8632022|NCT00543127|9671918|FG001|COMPLETED|Overall Study||350
8876847|NCT01919489|9933649|FG001|STARTED|Overall Study||137
8876848|NCT01919489|9933648|FG000|COMPLETED|Overall Study||80
8876849|NCT01919489|9933649|FG001|COMPLETED|Overall Study||93
8876850|NCT01919489|9933648|FG000|NOT COMPLETED|Overall Study||56
8876851|NCT01919489|9933649|FG001|NOT COMPLETED|Overall Study||44
8876852|NCT01919606|9933657|FG000|STARTED|Overall Study||1
8876853|NCT01919606|9933658|FG001|STARTED|Overall Study||0
8876854|NCT01919606|9933657|FG000|COMPLETED|Overall Study||1
8876855|NCT01919606|9933658|FG001|COMPLETED|Overall Study||0
8876856|NCT01919606|9933657|FG000|NOT COMPLETED|Overall Study||0
8876857|NCT01919606|9933658|FG001|NOT COMPLETED|Overall Study||0
8876858|NCT01919697|9933666|FG000|STARTED|Overall Study||224
8876859|NCT01919697|9933667|FG001|STARTED|Overall Study||2146
8876860|NCT01919697|9933666|FG000|COMPLETED|Overall Study||171
8876861|NCT01919697|9933667|FG001|COMPLETED|Overall Study||1761
8876862|NCT01919697|9933666|FG000|NOT COMPLETED|Overall Study||53
8876863|NCT01919697|9933667|FG001|NOT COMPLETED|Overall Study||385
8971897|NCT02618915|10035773|FG000|NOT COMPLETED|Overall Study||0
8971898|NCT02618915|10035774|FG001|NOT COMPLETED|Overall Study||0
8971899|NCT02618928|10035782|FG000|STARTED|Overall Study||735
8971900|NCT02618928|10035782|FG000|Received Treatment|Overall Study||728
8971901|NCT02618928|10035782|FG000|COMPLETED|Overall Study||677
8971902|NCT02618928|10035782|FG000|NOT COMPLETED|Overall Study||58
8971903|NCT02618967|10035797|FG000|STARTED|Overall Study||6
8971904|NCT02618967|10035798|FG001|STARTED|Overall Study||6
8971905|NCT02618967|10035799|FG002|STARTED|Overall Study||6
8971906|NCT02618967|10035800|FG003|STARTED|Overall Study||6
8971907|NCT02618967|10035801|FG004|STARTED|Overall Study||6
8971908|NCT02618967|10035802|FG005|STARTED|Overall Study||6
8971909|NCT02618967|10035803|FG006|STARTED|Overall Study||6
8971910|NCT02618967|10035804|FG007|STARTED|Overall Study||14
8971911|NCT02618967|10035797|FG000|Received Treatment|Overall Study||6
8971912|NCT02618967|10035798|FG001|Received Treatment|Overall Study||6
8971913|NCT02618967|10035799|FG002|Received Treatment|Overall Study||6
8971914|NCT02618967|10035800|FG003|Received Treatment|Overall Study||6
8971915|NCT02618967|10035801|FG004|Received Treatment|Overall Study||6
8971916|NCT02618967|10035802|FG005|Received Treatment|Overall Study||6
8971917|NCT02618967|10035803|FG006|Received Treatment|Overall Study||6
8971918|NCT02618967|10035804|FG007|Received Treatment|Overall Study||14
8971919|NCT02618967|10035797|FG000|COMPLETED|Overall Study||5
8971920|NCT02618967|10035798|FG001|COMPLETED|Overall Study||6
8971921|NCT02618967|10035799|FG002|COMPLETED|Overall Study||5
8971922|NCT02618967|10035800|FG003|COMPLETED|Overall Study||6
8971923|NCT02618967|10035801|FG004|COMPLETED|Overall Study||4
8971924|NCT02618967|10035802|FG005|COMPLETED|Overall Study||6
8971925|NCT02618967|10035803|FG006|COMPLETED|Overall Study||6
8971926|NCT02618967|10035804|FG007|COMPLETED|Overall Study||14
8971927|NCT02618967|10035797|FG000|NOT COMPLETED|Overall Study||1
8971928|NCT02618967|10035798|FG001|NOT COMPLETED|Overall Study||0
8971929|NCT02618967|10035799|FG002|NOT COMPLETED|Overall Study||1
8971930|NCT02618967|10035800|FG003|NOT COMPLETED|Overall Study||0
8971931|NCT02618967|10035801|FG004|NOT COMPLETED|Overall Study||2
8971932|NCT02618967|10035802|FG005|NOT COMPLETED|Overall Study||0
8971933|NCT02618967|10035803|FG006|NOT COMPLETED|Overall Study||0
8632023|NCT00543127|9671917|FG000|NOT COMPLETED|Overall Study||130
8632024|NCT00543127|9671918|FG001|NOT COMPLETED|Overall Study||87
8632025|NCT00543140|9671924|FG000|STARTED|Overall Study||303
8632026|NCT00543140|9671924|FG000|COMPLETED|Overall Study||231
8632027|NCT00543140|9671924|FG000|NOT COMPLETED|Overall Study||72
8876864|NCT01919723|9933676|FG000|STARTED|Overall Study||35
8876865|NCT01919723|9933677|FG001|STARTED|Overall Study||35
8876866|NCT01919723|9933676|FG000|COMPLETED|Overall Study||33
8876867|NCT01919723|9933677|FG001|COMPLETED|Overall Study||33
8876868|NCT01919723|9933676|FG000|NOT COMPLETED|Overall Study||2
8876869|NCT01919723|9933677|FG001|NOT COMPLETED|Overall Study||2
8876870|NCT01919801|9933685|FG000|STARTED|Overall Study||61
8876871|NCT01919801|9933686|FG001|STARTED|Overall Study||60
8876872|NCT01919801|9933685|FG000|COMPLETED|Overall Study||60
8876873|NCT01919801|9933686|FG001|COMPLETED|Overall Study||57
8876874|NCT01919801|9933685|FG000|NOT COMPLETED|Overall Study||1
8876875|NCT01919801|9933686|FG001|NOT COMPLETED|Overall Study||3
8876876|NCT01919814|9933692|FG000|STARTED|Overall Study||30
8876877|NCT01919814|9933693|FG001|STARTED|Overall Study||30
8876878|NCT01919814|9933692|FG000|COMPLETED|Overall Study||27
8876879|NCT01919814|9933693|FG001|COMPLETED|Overall Study||30
8876880|NCT01919814|9933692|FG000|NOT COMPLETED|Overall Study||3
8876881|NCT01919814|9933693|FG001|NOT COMPLETED|Overall Study||0
8876882|NCT01919970|9933701|FG000|STARTED|Overall Study||14
8876883|NCT01919970|9933702|FG001|STARTED|Overall Study||18
8876884|NCT01919970|9933701|FG000|COMPLETED|Overall Study||11
8876885|NCT01919970|9933702|FG001|COMPLETED|Overall Study||18
8876886|NCT01919970|9933701|FG000|NOT COMPLETED|Overall Study||3
8876887|NCT01919970|9933702|FG001|NOT COMPLETED|Overall Study||0
8876888|NCT01919996|9933708|FG000|STARTED|Overall Study||8
8876889|NCT01919996|9933708|FG000|COMPLETED|Overall Study||8
8876890|NCT01919996|9933708|FG000|NOT COMPLETED|Overall Study||0
8876891|NCT01920061|9933732|FG000|STARTED|Overall Study||4
8876892|NCT01920061|9933733|FG001|STARTED|Overall Study||5
8876893|NCT01920061|9933734|FG002|STARTED|Overall Study||3
8971934|NCT02618967|10035804|FG007|NOT COMPLETED|Overall Study||0
8971935|NCT02619175|10035824|FG000|STARTED|Overall Study||18
8971936|NCT02619175|10035825|FG001|STARTED|Overall Study||16
8971937|NCT02619175|10035824|FG000|COMPLETED|Overall Study||16
8971938|NCT02619175|10035825|FG001|COMPLETED|Overall Study||16
8971939|NCT02619175|10035824|FG000|NOT COMPLETED|Overall Study||2
8971940|NCT02619175|10035825|FG001|NOT COMPLETED|Overall Study||0
8971941|NCT02619396|10035839|FG000|STARTED|Overall Study||20
8971942|NCT02619396|10035840|FG001|STARTED|Overall Study||20
8971943|NCT02619396|10035841|FG002|STARTED|Overall Study||20
8971944|NCT02619396|10035842|FG003|STARTED|Overall Study||20
8971945|NCT02619396|10035839|FG000|COMPLETED|Overall Study||20
8971946|NCT02619396|10035840|FG001|COMPLETED|Overall Study||20
8971947|NCT02619396|10035841|FG002|COMPLETED|Overall Study||20
8971948|NCT02619396|10035842|FG003|COMPLETED|Overall Study||20
8971949|NCT02619396|10035839|FG000|NOT COMPLETED|Overall Study||0
8971950|NCT02619396|10035840|FG001|NOT COMPLETED|Overall Study||0
8971951|NCT02619396|10035841|FG002|NOT COMPLETED|Overall Study||0
8971952|NCT02619396|10035842|FG003|NOT COMPLETED|Overall Study||0
8971953|NCT02619409|10035858|FG000|STARTED|Overall Study||6
8971954|NCT02619409|10035859|FG001|STARTED|Overall Study||6
8971955|NCT02619409|10035860|FG002|STARTED|Overall Study||6
8971956|NCT02619409|10035861|FG003|STARTED|Overall Study||6
8971957|NCT02619409|10035862|FG004|STARTED|Overall Study||6
8971958|NCT02619409|10035858|FG000|COMPLETED|Overall Study||6
8971959|NCT02619409|10035859|FG001|COMPLETED|Overall Study||6
8971960|NCT02619409|10035860|FG002|COMPLETED|Overall Study||6
8971961|NCT02619409|10035861|FG003|COMPLETED|Overall Study||6
8971962|NCT02619409|10035862|FG004|COMPLETED|Overall Study||6
8971963|NCT02619409|10035858|FG000|NOT COMPLETED|Overall Study||0
8971964|NCT02619409|10035859|FG001|NOT COMPLETED|Overall Study||0
8971965|NCT02619409|10035860|FG002|NOT COMPLETED|Overall Study||0
8971966|NCT02619409|10035861|FG003|NOT COMPLETED|Overall Study||0
8971967|NCT02619409|10035862|FG004|NOT COMPLETED|Overall Study||0
8971968|NCT02619591|10035876|FG000|STARTED|Overall Study||139
8971969|NCT02619591|10035877|FG001|STARTED|Overall Study||121
8971970|NCT02619591|10035876|FG000|COMPLETED|Overall Study||0
8971971|NCT02619591|10035877|FG001|COMPLETED|Overall Study||0
8971972|NCT02619591|10035876|FG000|NOT COMPLETED|Overall Study||139
8971973|NCT02619591|10035877|FG001|NOT COMPLETED|Overall Study||121
8971974|NCT02619617|10035883|FG000|STARTED|Period 1 Placebo - 1st AttacK||28
8971975|NCT02619617|10035884|FG001|STARTED|Period 1 Placebo - 1st AttacK||0
8971976|NCT02619617|10035883|FG000|Participants Included in PD Analysis|Period 1 Placebo - 1st AttacK||20
8971977|NCT02619617|10035884|FG001|Participants Included in PD Analysis|Period 1 Placebo - 1st AttacK||0
8971978|NCT02619617|10035883|FG000|Participants in Safety Set for Period 1|Period 1 Placebo - 1st AttacK||28
8971979|NCT02619617|10035884|FG001|Participants in Safety Set for Period 1|Period 1 Placebo - 1st AttacK||0
8971980|NCT02619617|10035883|FG000|COMPLETED|Period 1 Placebo - 1st AttacK||28
8971981|NCT02619617|10035884|FG001|COMPLETED|Period 1 Placebo - 1st AttacK||0
8971982|NCT02619617|10035883|FG000|NOT COMPLETED|Period 1 Placebo - 1st AttacK||0
8971983|NCT02619617|10035884|FG001|NOT COMPLETED|Period 1 Placebo - 1st AttacK||0
8971984|NCT02619617|10035883|FG000|STARTED|Period 2 SOM230 - 2nd Attack||0
8971985|NCT02619617|10035884|FG001|STARTED|Period 2 SOM230 - 2nd Attack||28
8971986|NCT02619617|10035883|FG000|Participants in Safety Set for Period 2|Period 2 SOM230 - 2nd Attack||0
8971987|NCT02619617|10035884|FG001|Participants in Safety Set for Period 2|Period 2 SOM230 - 2nd Attack||28
8971988|NCT02619617|10035883|FG000|COMPLETED|Period 2 SOM230 - 2nd Attack||0
8971989|NCT02619617|10035884|FG001|COMPLETED|Period 2 SOM230 - 2nd Attack||24
8971990|NCT02619617|10035883|FG000|NOT COMPLETED|Period 2 SOM230 - 2nd Attack||0
8971991|NCT02619617|10035884|FG001|NOT COMPLETED|Period 2 SOM230 - 2nd Attack||4
8971992|NCT02619799|10035894|FG000|STARTED|Overall Study||25
8971993|NCT02619799|10035895|FG001|STARTED|Overall Study||25
8971994|NCT02619799|10035894|FG000|COMPLETED|Overall Study||25
8971995|NCT02619799|10035895|FG001|COMPLETED|Overall Study||25
8971996|NCT02619799|10035894|FG000|NOT COMPLETED|Overall Study||0
8971997|NCT02619799|10035895|FG001|NOT COMPLETED|Overall Study||0
8971998|NCT02620020|10035905|FG000|STARTED|Overall Study||141
8971999|NCT02620020|10035906|FG001|STARTED|Overall Study||141
8972000|NCT02620020|10035907|FG002|STARTED|Overall Study||140
8972001|NCT02620020|10035908|FG003|STARTED|Overall Study||141
8972002|NCT02620020|10035905|FG000|Modified Intent to Treat Set (mITT)|Overall Study||140
8972003|NCT02620020|10035906|FG001|Modified Intent to Treat Set (mITT)|Overall Study||139
8972004|NCT02620020|10035907|FG002|Modified Intent to Treat Set (mITT)|Overall Study||139
8972005|NCT02620020|10035908|FG003|Modified Intent to Treat Set (mITT)|Overall Study||140
8972006|NCT02620020|10035905|FG000|COMPLETED|Overall Study||97
8972007|NCT02620020|10035906|FG001|COMPLETED|Overall Study||106
8972008|NCT02620020|10035907|FG002|COMPLETED|Overall Study||115
8972009|NCT02620020|10035908|FG003|COMPLETED|Overall Study||115
8972010|NCT02620020|10035905|FG000|NOT COMPLETED|Overall Study||44
8972011|NCT02620020|10035906|FG001|NOT COMPLETED|Overall Study||35
8972012|NCT02620020|10035907|FG002|NOT COMPLETED|Overall Study||25
8972013|NCT02620020|10035908|FG003|NOT COMPLETED|Overall Study||26
8972014|NCT02620384|10035920|FG000|STARTED|Overall Study||70
8972015|NCT02620384|10035921|FG001|STARTED|Overall Study||73
8972016|NCT02620384|10035920|FG000|COMPLETED|Overall Study|Per protocol design patients must receive both doses of investigational product to be in analysis.|66
8972017|NCT02620384|10035921|FG001|COMPLETED|Overall Study|Per protocol design patients must receive both doses of investigational product to be in analysis.|66
8972018|NCT02620384|10035920|FG000|NOT COMPLETED|Overall Study||4
8972019|NCT02620384|10035921|FG001|NOT COMPLETED|Overall Study||7
8972020|NCT02620683|10035927|FG000|STARTED|First Intervention (Visit 1)||12
8972021|NCT02620683|10035928|FG001|STARTED|First Intervention (Visit 1)||11
8972022|NCT02620683|10035927|FG000|COMPLETED|First Intervention (Visit 1)||12
8972023|NCT02620683|10035928|FG001|COMPLETED|First Intervention (Visit 1)||11
8972024|NCT02620683|10035927|FG000|NOT COMPLETED|First Intervention (Visit 1)||0
8972025|NCT02620683|10035928|FG001|NOT COMPLETED|First Intervention (Visit 1)||0
8972026|NCT02620683|10035927|FG000|STARTED|Washout (2 Weeks)||12
8972027|NCT02620683|10035928|FG001|STARTED|Washout (2 Weeks)||11
8972028|NCT02620683|10035927|FG000|COMPLETED|Washout (2 Weeks)||12
8972029|NCT02620683|10035928|FG001|COMPLETED|Washout (2 Weeks)||11
8972030|NCT02620683|10035927|FG000|NOT COMPLETED|Washout (2 Weeks)||0
8972031|NCT02620683|10035928|FG001|NOT COMPLETED|Washout (2 Weeks)||0
8972032|NCT02620683|10035927|FG000|STARTED|Second Intervention (Visit 2)||12
8972033|NCT02620683|10035928|FG001|STARTED|Second Intervention (Visit 2)||11
8972034|NCT02620683|10035927|FG000|COMPLETED|Second Intervention (Visit 2)||12
8972035|NCT02620683|10035928|FG001|COMPLETED|Second Intervention (Visit 2)||11
8972036|NCT02620683|10035927|FG000|NOT COMPLETED|Second Intervention (Visit 2)||0
8972037|NCT02620683|10035928|FG001|NOT COMPLETED|Second Intervention (Visit 2)||0
8972038|NCT02620774|10035935|FG000|STARTED|Overall Study||10
8972039|NCT02620774|10035936|FG001|STARTED|Overall Study||6
8972040|NCT02620774|10035935|FG000|COMPLETED|Overall Study||10
8972041|NCT02620774|10035936|FG001|COMPLETED|Overall Study||6
8972042|NCT02620774|10035935|FG000|NOT COMPLETED|Overall Study||0
8972043|NCT02620774|10035936|FG001|NOT COMPLETED|Overall Study||0
8972044|NCT02620787|10035944|FG000|STARTED|Overall Study||12
8972045|NCT02620787|10035945|FG001|STARTED|Overall Study||6
8972046|NCT02620787|10035944|FG000|COMPLETED|Overall Study||10
8972047|NCT02620787|10035945|FG001|COMPLETED|Overall Study||6
8972048|NCT02620787|10035944|FG000|NOT COMPLETED|Overall Study||2
8972049|NCT02620787|10035945|FG001|NOT COMPLETED|Overall Study||0
8972050|NCT02620878|10035951|FG000|STARTED|Overall Study||16
8972051|NCT02620878|10035952|FG001|STARTED|Overall Study||16
8972052|NCT02620878|10035951|FG000|COMPLETED|Overall Study||16
8972053|NCT02620878|10035952|FG001|COMPLETED|Overall Study||16
8972054|NCT02620878|10035951|FG000|NOT COMPLETED|Overall Study||0
8972055|NCT02620878|10035952|FG001|NOT COMPLETED|Overall Study||0
8972056|NCT02620904|10035960|FG000|STARTED|Overall Study||4
8972057|NCT02620904|10035961|FG001|STARTED|Overall Study||5
8972058|NCT02620904|10035960|FG000|COMPLETED|Overall Study||4
8972059|NCT02620904|10035961|FG001|COMPLETED|Overall Study||5
8972060|NCT02620904|10035960|FG000|NOT COMPLETED|Overall Study||0
8972061|NCT02620904|10035961|FG001|NOT COMPLETED|Overall Study||0
8972062|NCT02620917|10035967|FG000|STARTED|Overall Study||6623
8972063|NCT02620917|10035967|FG000|COMPLETED|Overall Study||6623
8972064|NCT02620917|10035967|FG000|NOT COMPLETED|Overall Study||0
8972065|NCT02621034|10035976|FG000|STARTED|Overall Study||53
8972066|NCT02621034|10035977|FG001|STARTED|Overall Study||52
8972067|NCT02621034|10035978|FG002|STARTED|Overall Study||55
8972068|NCT02621034|10035976|FG000|COMPLETED|Overall Study||50
8972069|NCT02621034|10035977|FG001|COMPLETED|Overall Study||50
8972070|NCT02621034|10035978|FG002|COMPLETED|Overall Study||50
8972071|NCT02621034|10035976|FG000|NOT COMPLETED|Overall Study||3
8972072|NCT02621034|10035977|FG001|NOT COMPLETED|Overall Study||2
8972073|NCT02621034|10035978|FG002|NOT COMPLETED|Overall Study||5
8972074|NCT02621047|10035991|FG000|STARTED|Overall Study||8
8972075|NCT02621047|10035992|FG001|STARTED|Overall Study||8
8972076|NCT02621047|10035993|FG002|STARTED|Overall Study||12
8972077|NCT02621047|10035991|FG000|COMPLETED|Overall Study||8
8972078|NCT02621047|10035992|FG001|COMPLETED|Overall Study||8
8972079|NCT02621047|10035993|FG002|COMPLETED|Overall Study||11
8972080|NCT02621047|10035991|FG000|NOT COMPLETED|Overall Study||0
8972081|NCT02621047|10035992|FG001|NOT COMPLETED|Overall Study||0
8972082|NCT02621047|10035993|FG002|NOT COMPLETED|Overall Study||1
8972083|NCT02621060|10036004|FG000|STARTED|Overall Study||15
8972084|NCT02621060|10036005|FG001|STARTED|Overall Study||15
8972085|NCT02621060|10036004|FG000|COMPLETED|Overall Study||12
8972086|NCT02621060|10036005|FG001|COMPLETED|Overall Study||14
8972087|NCT02621060|10036004|FG000|NOT COMPLETED|Overall Study||3
8972088|NCT02621060|10036005|FG001|NOT COMPLETED|Overall Study||1
8972089|NCT02621073|10036013|FG000|STARTED|Overall Study||4
8972090|NCT02621073|10036014|FG001|STARTED|Overall Study||3
8972091|NCT02621073|10036013|FG000|COMPLETED|Overall Study||1
8972092|NCT02621073|10036014|FG001|COMPLETED|Overall Study||0
8972093|NCT02621073|10036013|FG000|NOT COMPLETED|Overall Study||3
8972094|NCT02621073|10036014|FG001|NOT COMPLETED|Overall Study||3
8725806|NCT01033487|9773163|FG006|STARTED|First Intervention Period||2
8972095|NCT02621463|10036020|FG000|STARTED|Overall Study||29
8972096|NCT02621463|10036020|FG000|COMPLETED|Overall Study||29
8972097|NCT02621463|10036020|FG000|NOT COMPLETED|Overall Study||0
8972098|NCT02621619|10036026|FG000|STARTED|Overall Study||80
8972099|NCT02621619|10036027|FG001|STARTED|Overall Study||79
8972100|NCT02621619|10036026|FG000|COMPLETED|Overall Study||80
8972101|NCT02621619|10036027|FG001|COMPLETED|Overall Study||79
8972102|NCT02621619|10036026|FG000|NOT COMPLETED|Overall Study||0
8972103|NCT02621619|10036027|FG001|NOT COMPLETED|Overall Study||0
8972104|NCT02621892|10036035|FG000|STARTED|Treatment Period||307
8972105|NCT02621892|10036036|FG001|STARTED|Treatment Period||299
8972106|NCT02621892|10036035|FG000|COMPLETED|Treatment Period||261
8972107|NCT02621892|10036036|FG001|COMPLETED|Treatment Period||272
8972108|NCT02621892|10036035|FG000|NOT COMPLETED|Treatment Period||46
8972109|NCT02621892|10036036|FG001|NOT COMPLETED|Treatment Period||27
8972110|NCT02621892|10036035|FG000|STARTED|Randomized Withdrawal Period||261
8972111|NCT02621892|10036036|FG001|STARTED|Randomized Withdrawal Period||272
8972112|NCT02621892|10036035|FG000|COMPLETED|Randomized Withdrawal Period||250
8972113|NCT02621892|10036036|FG001|COMPLETED|Randomized Withdrawal Period||260
8972114|NCT02621892|10036035|FG000|NOT COMPLETED|Randomized Withdrawal Period||11
8972115|NCT02621892|10036036|FG001|NOT COMPLETED|Randomized Withdrawal Period||12
8972116|NCT02621931|10036045|FG000|STARTED|Overall Study||375
8972117|NCT02621931|10036046|FG001|STARTED|Overall Study||376
8972118|NCT02621931|10036047|FG002|STARTED|Overall Study||379
8972119|NCT02621931|10036045|FG000|Safety and ITT Populations|Overall Study||375
8972120|NCT02621931|10036046|FG001|Safety and ITT Populations|Overall Study||376
8972121|NCT02621931|10036047|FG002|Safety and ITT Populations|Overall Study||379
8972122|NCT02621931|10036045|FG000|Full Analysis Set|Overall Study||371
8972123|NCT02621931|10036046|FG001|Full Analysis Set|Overall Study||375
8972124|NCT02621931|10036047|FG002|Full Analysis Set|Overall Study||375
8972125|NCT02621931|10036045|FG000|COMPLETED|Overall Study||342
8972126|NCT02621931|10036046|FG001|COMPLETED|Overall Study||349
8972127|NCT02621931|10036047|FG002|COMPLETED|Overall Study||343
8972128|NCT02621931|10036045|FG000|NOT COMPLETED|Overall Study||33
8972129|NCT02621931|10036046|FG001|NOT COMPLETED|Overall Study||27
8972130|NCT02621931|10036047|FG002|NOT COMPLETED|Overall Study||36
8972131|NCT02621983|10036059|FG000|STARTED|Overall Study||21
8972132|NCT02621983|10036060|FG001|STARTED|Overall Study||17
8972133|NCT02621983|10036059|FG000|COMPLETED|Overall Study||9
8972134|NCT02621983|10036060|FG001|COMPLETED|Overall Study||6
8972135|NCT02621983|10036059|FG000|NOT COMPLETED|Overall Study||12
8972136|NCT02621983|10036060|FG001|NOT COMPLETED|Overall Study||11
8972137|NCT02622074|10036072|FG000|STARTED|Overall Study||10
8972138|NCT02622074|10036073|FG001|STARTED|Overall Study||10
8972139|NCT02622074|10036074|FG002|STARTED|Overall Study||10
8972140|NCT02622074|10036075|FG003|STARTED|Overall Study||10
8972141|NCT02622074|10036076|FG004|STARTED|Overall Study||10
8972142|NCT02622074|10036077|FG005|STARTED|Overall Study||10
8972143|NCT02622074|10036072|FG000|COMPLETED|Overall Study||6
8972144|NCT02622074|10036073|FG001|COMPLETED|Overall Study||9
8972145|NCT02622074|10036074|FG002|COMPLETED|Overall Study||10
8972146|NCT02622074|10036075|FG003|COMPLETED|Overall Study||9
8972147|NCT02622074|10036076|FG004|COMPLETED|Overall Study||9
8972148|NCT02622074|10036077|FG005|COMPLETED|Overall Study||10
8972149|NCT02622074|10036072|FG000|NOT COMPLETED|Overall Study||4
8972150|NCT02622074|10036073|FG001|NOT COMPLETED|Overall Study||1
8972151|NCT02622074|10036074|FG002|NOT COMPLETED|Overall Study||0
8972152|NCT02622074|10036075|FG003|NOT COMPLETED|Overall Study||1
8972153|NCT02622074|10036076|FG004|NOT COMPLETED|Overall Study||1
8972154|NCT02622074|10036077|FG005|NOT COMPLETED|Overall Study||0
8972155|NCT02622113|10036093|FG000|STARTED|Overall Study||67
8972156|NCT02622113|10036094|FG001|STARTED|Overall Study||76
8972157|NCT02622113|10036093|FG000|COMPLETED|Overall Study||62
8972158|NCT02622113|10036094|FG001|COMPLETED|Overall Study||66
8972159|NCT02622113|10036093|FG000|NOT COMPLETED|Overall Study||5
8972160|NCT02622113|10036094|FG001|NOT COMPLETED|Overall Study||10
8972161|NCT02622178|10036103|FG000|STARTED|Overall Study||42
8972162|NCT02622178|10036104|FG001|STARTED|Overall Study||45
8972163|NCT02622178|10036105|FG002|STARTED|Overall Study||49
8972164|NCT02622178|10036103|FG000|COMPLETED|Overall Study||42
8972165|NCT02622178|10036104|FG001|COMPLETED|Overall Study||45
8972166|NCT02622178|10036105|FG002|COMPLETED|Overall Study||49
8972167|NCT02622178|10036103|FG000|NOT COMPLETED|Overall Study||0
8972168|NCT02622178|10036104|FG001|NOT COMPLETED|Overall Study||0
8972169|NCT02622178|10036105|FG002|NOT COMPLETED|Overall Study||0
8972170|NCT02622191|10036116|FG000|STARTED|Overall Study||19
8972171|NCT02622191|10036117|FG001|STARTED|Overall Study||14
8972172|NCT02622191|10036116|FG000|COMPLETED|Overall Study||19
8972173|NCT02622191|10036117|FG001|COMPLETED|Overall Study||14
8972174|NCT02622191|10036116|FG000|NOT COMPLETED|Overall Study||0
8972175|NCT02622191|10036117|FG001|NOT COMPLETED|Overall Study||0
8972176|NCT02622321|10036128|FG000|STARTED|Overall Study||35
8972177|NCT02622321|10036129|FG001|STARTED|Overall Study||18
8972178|NCT02622321|10036130|FG002|STARTED|Overall Study||49
8972179|NCT02622321|10036131|FG003|STARTED|Overall Study||11
8972180|NCT02622321|10036128|FG000|Received at Least One Dose of Treatment|Overall Study|1 participant withdrew prior to study Day 1.|34
8972181|NCT02622321|10036129|FG001|Received at Least One Dose of Treatment|Overall Study||18
8972182|NCT02622321|10036130|FG002|Received at Least One Dose of Treatment|Overall Study||49
8972183|NCT02622321|10036131|FG003|Received at Least One Dose of Treatment|Overall Study||11
8972184|NCT02622321|10036128|FG000|Completed 24 Weeks in the Study|Overall Study||31
8972185|NCT02622321|10036129|FG001|Completed 24 Weeks in the Study|Overall Study|After 24 weeks, all 18 participants in Arm B switched to receive emicizumab prophylaxis.|18
8972186|NCT02622321|10036130|FG002|Completed 24 Weeks in the Study|Overall Study||49
8972187|NCT02622321|10036131|FG003|Completed 24 Weeks in the Study|Overall Study||11
8972188|NCT02622321|10036128|FG000|Dose Up-Titrated to 3 mg/kg QW|Overall Study||2
8972189|NCT02622321|10036129|FG001|Dose Up-Titrated to 3 mg/kg QW|Overall Study||0
8972190|NCT02622321|10036130|FG002|Dose Up-Titrated to 3 mg/kg QW|Overall Study||3
8972191|NCT02622321|10036131|FG003|Dose Up-Titrated to 3 mg/kg QW|Overall Study||2
8972192|NCT02622321|10036128|FG000|COMPLETED|Overall Study||32
8972193|NCT02622321|10036129|FG001|COMPLETED|Overall Study||18
8972194|NCT02622321|10036130|FG002|COMPLETED|Overall Study||48
8972195|NCT02622321|10036131|FG003|COMPLETED|Overall Study||11
8972196|NCT02622321|10036128|FG000|NOT COMPLETED|Overall Study||3
8972197|NCT02622321|10036129|FG001|NOT COMPLETED|Overall Study||0
8972198|NCT02622321|10036130|FG002|NOT COMPLETED|Overall Study||1
8972199|NCT02622321|10036131|FG003|NOT COMPLETED|Overall Study||0
8972200|NCT02622568|10036157|FG000|STARTED|Overall Study||14
8972201|NCT02622568|10036158|FG001|STARTED|Overall Study||14
8972202|NCT02622568|10036157|FG000|COMPLETED|Overall Study||9
8972203|NCT02622568|10036158|FG001|COMPLETED|Overall Study||9
8972204|NCT02622568|10036157|FG000|NOT COMPLETED|Overall Study||5
8972205|NCT02622568|10036158|FG001|NOT COMPLETED|Overall Study||5
8972206|NCT02622724|10036166|FG000|STARTED|Overall Study||144
8972207|NCT02622724|10036167|FG001|STARTED|Overall Study||152
8972208|NCT02622724|10036166|FG000|Subjects Randomised|Overall Study||146
8972209|NCT02622724|10036167|FG001|Subjects Randomised|Overall Study||155
8972210|NCT02622724|10036166|FG000|Short-Term Follow-Up (Day 28)|Overall Study||105
8972211|NCT02622724|10036167|FG001|Short-Term Follow-Up (Day 28)|Overall Study||115
8972212|NCT02622724|10036166|FG000|Long-Term Follow-Up (Day 90)|Overall Study||96
8972213|NCT02622724|10036167|FG001|Long-Term Follow-Up (Day 90)|Overall Study||101
8972214|NCT02622724|10036166|FG000|Long-Term Follow-Up (Day 180)|Overall Study||73
8972215|NCT02622724|10036167|FG001|Long-Term Follow-Up (Day 180)|Overall Study||74
8972216|NCT02622724|10036166|FG000|COMPLETED|Overall Study||51
8972217|NCT02622724|10036167|FG001|COMPLETED|Overall Study||49
8972218|NCT02622724|10036166|FG000|NOT COMPLETED|Overall Study||93
8972219|NCT02622724|10036167|FG001|NOT COMPLETED|Overall Study||103
8972220|NCT02623218|10036184|FG000|STARTED|Overall Study||5
8972221|NCT02623218|10036185|FG001|STARTED|Overall Study||4
8972222|NCT02623218|10036186|FG002|STARTED|Overall Study||4
8972223|NCT02623218|10036187|FG003|STARTED|Overall Study||4
8972224|NCT02623218|10036188|FG004|STARTED|Overall Study||4
8972225|NCT02623218|10036184|FG000|COMPLETED|Overall Study||5
8972226|NCT02623218|10036185|FG001|COMPLETED|Overall Study||3
8972227|NCT02623218|10036186|FG002|COMPLETED|Overall Study||4
8972228|NCT02623218|10036187|FG003|COMPLETED|Overall Study||4
8972229|NCT02623218|10036188|FG004|COMPLETED|Overall Study||4
8972230|NCT02623218|10036184|FG000|NOT COMPLETED|Overall Study||0
8972231|NCT02623218|10036185|FG001|NOT COMPLETED|Overall Study||1
8972232|NCT02623218|10036186|FG002|NOT COMPLETED|Overall Study||0
8972233|NCT02623218|10036187|FG003|NOT COMPLETED|Overall Study||0
8972234|NCT02623218|10036188|FG004|NOT COMPLETED|Overall Study||0
8972235|NCT02623322|10036203|FG000|STARTED|Overall Study||43
8972236|NCT02623322|10036204|FG001|STARTED|Overall Study||41
8972237|NCT02623322|10036205|FG002|STARTED|Overall Study||40
8972238|NCT02623322|10036203|FG000|COMPLETED|Overall Study||41
8972239|NCT02623322|10036204|FG001|COMPLETED|Overall Study||40
8972240|NCT02623322|10036205|FG002|COMPLETED|Overall Study||40
8972241|NCT02623322|10036203|FG000|NOT COMPLETED|Overall Study||2
8972242|NCT02623322|10036204|FG001|NOT COMPLETED|Overall Study||1
8972243|NCT02623322|10036205|FG002|NOT COMPLETED|Overall Study||0
8972244|NCT02623335|10036217|FG000|STARTED|Overall Study||223
8972245|NCT02623335|10036218|FG001|STARTED|Overall Study||223
8972246|NCT02623335|10036217|FG000|T0 Audio Recording (Day of Consultation)|Overall Study||223
8972247|NCT02623335|10036218|FG001|T0 Audio Recording (Day of Consultation)|Overall Study||222
8972248|NCT02623335|10036217|FG000|T1 Survey (24-48 Hours)|Overall Study||216
8972249|NCT02623335|10036218|FG001|T1 Survey (24-48 Hours)|Overall Study||214
8972250|NCT02623335|10036217|FG000|T2 Survey (6-8 Weeks)|Overall Study||199
8972251|NCT02623335|10036218|FG001|T2 Survey (6-8 Weeks)|Overall Study||192
8972252|NCT02623335|10036217|FG000|T3 Survey (12-14 Weeks)|Overall Study||196
8972253|NCT02623335|10036218|FG001|T3 Survey (12-14 Weeks)|Overall Study||187
8972254|NCT02623335|10036217|FG000|COMPLETED|Overall Study||196
8972255|NCT02623335|10036218|FG001|COMPLETED|Overall Study||187
8972256|NCT02623335|10036217|FG000|NOT COMPLETED|Overall Study||27
8972257|NCT02623335|10036218|FG001|NOT COMPLETED|Overall Study||36
8972258|NCT02623348|10036226|FG000|STARTED|Overall Study||30
8972259|NCT02623348|10036227|FG001|STARTED|Overall Study||30
8972260|NCT02623348|10036226|FG000|3-month Assessment|Overall Study||27
8972261|NCT02623348|10036227|FG001|3-month Assessment|Overall Study||26
8972262|NCT02623348|10036226|FG000|COMPLETED|Overall Study||27
8972263|NCT02623348|10036227|FG001|COMPLETED|Overall Study||28
8972264|NCT02623348|10036226|FG000|NOT COMPLETED|Overall Study||3
8972265|NCT02623348|10036227|FG001|NOT COMPLETED|Overall Study||2
8972266|NCT02623361|10036235|FG000|STARTED|Overall Study||40
8972267|NCT02623361|10036236|FG001|STARTED|Overall Study||40
8972268|NCT02623361|10036235|FG000|COMPLETED|Overall Study||40
8972269|NCT02623361|10036236|FG001|COMPLETED|Overall Study||38
8972270|NCT02623361|10036235|FG000|NOT COMPLETED|Overall Study||0
8972271|NCT02623361|10036236|FG001|NOT COMPLETED|Overall Study||2
8972272|NCT02623803|10036244|FG000|STARTED|Overall Study||25
8972273|NCT02623803|10036245|FG001|STARTED|Overall Study||23
8972274|NCT02623803|10036244|FG000|COMPLETED|Overall Study||25
8972275|NCT02623803|10036245|FG001|COMPLETED|Overall Study||23
8972276|NCT02623803|10036244|FG000|NOT COMPLETED|Overall Study||0
8972277|NCT02623803|10036245|FG001|NOT COMPLETED|Overall Study||0
8972278|NCT02623829|10036253|FG000|STARTED|Overall Study||21
8972279|NCT02623829|10036254|FG001|STARTED|Overall Study||21
8972280|NCT02623829|10036253|FG000|COMPLETED|Overall Study||20
8972281|NCT02623829|10036254|FG001|COMPLETED|Overall Study||20
8972282|NCT02623829|10036253|FG000|NOT COMPLETED|Overall Study||1
8972283|NCT02623829|10036254|FG001|NOT COMPLETED|Overall Study||1
8972284|NCT02623855|10036262|FG000|STARTED|Overall Study||56
8972285|NCT02623855|10036263|FG001|STARTED|Overall Study||100
8972286|NCT02623855|10036262|FG000|COMPLETED|Overall Study||46
8972287|NCT02623855|10036263|FG001|COMPLETED|Overall Study||84
8972288|NCT02623855|10036262|FG000|NOT COMPLETED|Overall Study||10
8972289|NCT02623855|10036263|FG001|NOT COMPLETED|Overall Study||16
8972290|NCT02624050|10036271|FG000|STARTED|Overall Study||26
8972291|NCT02624050|10036272|FG001|STARTED|Overall Study||25
8972292|NCT02624050|10036271|FG000|COMPLETED|Overall Study||20
8972293|NCT02624050|10036272|FG001|COMPLETED|Overall Study||25
8972294|NCT02624050|10036271|FG000|NOT COMPLETED|Overall Study||6
8972295|NCT02624050|10036272|FG001|NOT COMPLETED|Overall Study||0
8972296|NCT02624180|10036280|FG000|STARTED|Overall Study||43
8972297|NCT02624180|10036281|FG001|STARTED|Overall Study||38
8972298|NCT02624180|10036280|FG000|COMPLETED|Overall Study||37
8972299|NCT02624180|10036281|FG001|COMPLETED|Overall Study||34
8972300|NCT02624180|10036280|FG000|NOT COMPLETED|Overall Study||6
8972301|NCT02624180|10036281|FG001|NOT COMPLETED|Overall Study||4
8972302|NCT02624284|10036290|FG000|STARTED|Overall Study||49
8972303|NCT02624284|10036291|FG001|STARTED|Overall Study||53
8972304|NCT02624284|10036292|FG002|STARTED|Overall Study||47
8972305|NCT02624284|10036290|FG000|COMPLETED|Overall Study||35
8972306|NCT02624284|10036291|FG001|COMPLETED|Overall Study||35
8972307|NCT02624284|10036292|FG002|COMPLETED|Overall Study||36
8632028|NCT00543296|9671928|FG000|STARTED|Overall Study||21
8632029|NCT00543296|9671928|FG000|COMPLETED|Overall Study||14
8632030|NCT00543296|9671928|FG000|NOT COMPLETED|Overall Study||7
8632031|NCT00543309|9671935|FG000|STARTED|Overall Study||35
8876894|NCT01920061|9933735|FG003|STARTED|Overall Study||4
8876895|NCT01920061|9933736|FG004|STARTED|Overall Study||5
8876896|NCT01920061|9933737|FG005|STARTED|Overall Study||4
8972308|NCT02624284|10036290|FG000|NOT COMPLETED|Overall Study||14
8972309|NCT02624284|10036291|FG001|NOT COMPLETED|Overall Study||18
8972310|NCT02624284|10036292|FG002|NOT COMPLETED|Overall Study||11
8972311|NCT02624375|10036300|FG000|STARTED|Overall Study||10
8972312|NCT02624375|10036300|FG000|COMPLETED|Overall Study||10
8972313|NCT02624375|10036300|FG000|NOT COMPLETED|Overall Study||0
8972314|NCT02624492|10036307|FG000|STARTED|Overall Study||5
8972315|NCT02624492|10036308|FG001|STARTED|Overall Study||8
8972316|NCT02624492|10036309|FG002|STARTED|Overall Study||8
8972317|NCT02624492|10036307|FG000|COMPLETED|Overall Study||3
8972318|NCT02624492|10036308|FG001|COMPLETED|Overall Study||4
8972319|NCT02624492|10036309|FG002|COMPLETED|Overall Study||3
8972320|NCT02624492|10036307|FG000|NOT COMPLETED|Overall Study||2
8972321|NCT02624492|10036308|FG001|NOT COMPLETED|Overall Study||4
8972322|NCT02624492|10036309|FG002|NOT COMPLETED|Overall Study||5
8972323|NCT02624687|10036319|FG000|STARTED|Overall Study||13
8972324|NCT02624687|10036320|FG001|STARTED|Overall Study||14
8972325|NCT02624687|10036319|FG000|COMPLETED|Overall Study||12
8972326|NCT02624687|10036320|FG001|COMPLETED|Overall Study||12
8972327|NCT02624687|10036319|FG000|NOT COMPLETED|Overall Study||1
8972328|NCT02624687|10036320|FG001|NOT COMPLETED|Overall Study||2
8972329|NCT02624700|10036328|FG000|STARTED|Overall Study||9
8972330|NCT02624700|10036329|FG001|STARTED|Overall Study||4
8972331|NCT02624700|10036328|FG000|COMPLETED|Overall Study||9
8972332|NCT02624700|10036329|FG001|COMPLETED|Overall Study||4
8972333|NCT02624700|10036328|FG000|NOT COMPLETED|Overall Study||0
8972334|NCT02624700|10036329|FG001|NOT COMPLETED|Overall Study||0
8972335|NCT02624713|10036339|FG000|STARTED|Overall Study||78
8972336|NCT02624713|10036340|FG001|STARTED|Overall Study||81
8972337|NCT02624713|10036339|FG000|COMPLETED|Overall Study||64
8972338|NCT02624713|10036340|FG001|COMPLETED|Overall Study||81
8972339|NCT02624713|10036339|FG000|NOT COMPLETED|Overall Study||14
8972340|NCT02624713|10036340|FG001|NOT COMPLETED|Overall Study||0
8972341|NCT02624791|10036347|FG000|STARTED|Overall Study||2
8972342|NCT02624791|10036348|FG001|STARTED|Overall Study||1
8972343|NCT02624791|10036349|FG002|STARTED|Overall Study||2
8972344|NCT02624791|10036350|FG003|STARTED|Overall Study||2
8972345|NCT02624791|10036351|FG004|STARTED|Overall Study||2
8972346|NCT02624791|10036352|FG005|STARTED|Overall Study||2
8972347|NCT02624791|10036347|FG000|COMPLETED|Overall Study||0
8972348|NCT02624791|10036348|FG001|COMPLETED|Overall Study||1
8972349|NCT02624791|10036349|FG002|COMPLETED|Overall Study||2
8972350|NCT02624791|10036350|FG003|COMPLETED|Overall Study||2
8972351|NCT02624791|10036351|FG004|COMPLETED|Overall Study||2
8972352|NCT02624791|10036352|FG005|COMPLETED|Overall Study||2
8972353|NCT02624791|10036347|FG000|NOT COMPLETED|Overall Study||2
8972354|NCT02624791|10036348|FG001|NOT COMPLETED|Overall Study||0
8972355|NCT02624791|10036349|FG002|NOT COMPLETED|Overall Study||0
8972356|NCT02624791|10036350|FG003|NOT COMPLETED|Overall Study||0
8972357|NCT02624791|10036351|FG004|NOT COMPLETED|Overall Study||0
8972358|NCT02624791|10036352|FG005|NOT COMPLETED|Overall Study||0
8972359|NCT02624843|10036359|FG000|STARTED|Overall Study||107
8972360|NCT02624843|10036360|FG001|STARTED|Overall Study||108
8972361|NCT02624843|10036361|FG002|STARTED|Overall Study||24
8972362|NCT02624843|10036359|FG000|COMPLETED|Overall Study||70
8972363|NCT02624843|10036360|FG001|COMPLETED|Overall Study||72
8972364|NCT02624843|10036361|FG002|COMPLETED|Overall Study||16
8972365|NCT02624843|10036359|FG000|NOT COMPLETED|Overall Study||37
8972366|NCT02624843|10036360|FG001|NOT COMPLETED|Overall Study||36
8972367|NCT02624843|10036361|FG002|NOT COMPLETED|Overall Study||8
8876897|NCT01920061|9933738|FG006|STARTED|Overall Study||3
8876898|NCT01920061|9933739|FG007|STARTED|Overall Study||3
8876899|NCT01920061|9933740|FG008|STARTED|Overall Study||3
8876900|NCT01920061|9933741|FG009|STARTED|Overall Study||3
8876901|NCT01920061|9933742|FG010|STARTED|Overall Study||10
8876902|NCT01920061|9933743|FG011|STARTED|Overall Study||5
8876903|NCT01920061|9933744|FG012|STARTED|Overall Study||3
8876904|NCT01920061|9933745|FG013|STARTED|Overall Study||16
8876905|NCT01920061|9933746|FG014|STARTED|Overall Study||4
8876906|NCT01920061|9933747|FG015|STARTED|Overall Study||7
8876907|NCT01920061|9933748|FG016|STARTED|Overall Study||3
8972368|NCT02624986|10036377|FG000|STARTED|Overall Study||2
8972369|NCT02624986|10036378|FG001|STARTED|Overall Study||3
8972370|NCT02624986|10036379|FG002|STARTED|Overall Study||2
8972371|NCT02624986|10036380|FG003|STARTED|Overall Study||3
8876908|NCT01920061|9933749|FG017|STARTED|Overall Study||3
8876909|NCT01920061|9933750|FG018|STARTED|Overall Study||10
8972372|NCT02624986|10036381|FG004|STARTED|Overall Study||4
8972373|NCT02624986|10036382|FG005|STARTED|Overall Study||2
8972374|NCT02624986|10036383|FG006|STARTED|Overall Study||4
8632032|NCT00543309|9671936|FG001|STARTED|Overall Study||36
8632033|NCT00543309|9671937|FG002|STARTED|Overall Study||35
8876910|NCT01920061|9933751|FG019|STARTED|Overall Study||12
8972375|NCT02624986|10036384|FG007|STARTED|Overall Study||5
8972376|NCT02624986|10036377|FG000|Received Any Study Treatment|Overall Study||1
8972377|NCT02624986|10036378|FG001|Received Any Study Treatment|Overall Study||3
9038332|NCT03330275|10099564|FG000|COMPLETED|Visits 2, 3 and 4 - Period 2||0
8972378|NCT02624986|10036379|FG002|Received Any Study Treatment|Overall Study||2
8972379|NCT02624986|10036380|FG003|Received Any Study Treatment|Overall Study||3
8972380|NCT02624986|10036381|FG004|Received Any Study Treatment|Overall Study||4
8972381|NCT02624986|10036382|FG005|Received Any Study Treatment|Overall Study||2
8972382|NCT02624986|10036383|FG006|Received Any Study Treatment|Overall Study||4
8972383|NCT02624986|10036384|FG007|Received Any Study Treatment|Overall Study||5
8972384|NCT02624986|10036377|FG000|COMPLETED|Overall Study||0
8972385|NCT02624986|10036378|FG001|COMPLETED|Overall Study||0
8972386|NCT02624986|10036379|FG002|COMPLETED|Overall Study||0
8972387|NCT02624986|10036380|FG003|COMPLETED|Overall Study||0
8972388|NCT02624986|10036381|FG004|COMPLETED|Overall Study||0
8972389|NCT02624986|10036382|FG005|COMPLETED|Overall Study||0
8972390|NCT02624986|10036383|FG006|COMPLETED|Overall Study||0
8972391|NCT02624986|10036384|FG007|COMPLETED|Overall Study||0
8972392|NCT02624986|10036377|FG000|NOT COMPLETED|Overall Study||2
8972393|NCT02624986|10036378|FG001|NOT COMPLETED|Overall Study||3
8972394|NCT02624986|10036379|FG002|NOT COMPLETED|Overall Study||2
8972395|NCT02624986|10036380|FG003|NOT COMPLETED|Overall Study||3
8972396|NCT02624986|10036381|FG004|NOT COMPLETED|Overall Study||4
8972397|NCT02624986|10036382|FG005|NOT COMPLETED|Overall Study||2
8972398|NCT02624986|10036383|FG006|NOT COMPLETED|Overall Study||4
8972399|NCT02624986|10036384|FG007|NOT COMPLETED|Overall Study||5
8972400|NCT02625181|10036409|FG000|STARTED|Overall Study||1518
8972401|NCT02625181|10036410|FG001|STARTED|Overall Study||12809
8972402|NCT02625181|10036411|FG002|STARTED|Overall Study||12707
8972403|NCT02625181|10036409|FG000|COMPLETED|Overall Study||1518
8972404|NCT02625181|10036410|FG001|COMPLETED|Overall Study||12809
8972405|NCT02625181|10036411|FG002|COMPLETED|Overall Study||12707
8972406|NCT02625181|10036409|FG000|NOT COMPLETED|Overall Study||0
8972407|NCT02625181|10036410|FG001|NOT COMPLETED|Overall Study||0
8972408|NCT02625181|10036411|FG002|NOT COMPLETED|Overall Study||0
8972409|NCT02625207|10036421|FG000|STARTED|Part 1 (6 Days)||11
8972410|NCT02625207|10036422|FG001|STARTED|Part 1 (6 Days)||12
8972411|NCT02625207|10036423|FG002|STARTED|Part 1 (6 Days)||12
8972412|NCT02625207|10036424|FG003|STARTED|Part 1 (6 Days)||12
8972413|NCT02625207|10036421|FG000|COMPLETED|Part 1 (6 Days)||11
8972414|NCT02625207|10036422|FG001|COMPLETED|Part 1 (6 Days)||12
8972415|NCT02625207|10036423|FG002|COMPLETED|Part 1 (6 Days)||12
8972416|NCT02625207|10036424|FG003|COMPLETED|Part 1 (6 Days)||12
8972417|NCT02625207|10036421|FG000|NOT COMPLETED|Part 1 (6 Days)||0
8972418|NCT02625207|10036422|FG001|NOT COMPLETED|Part 1 (6 Days)||0
8972419|NCT02625207|10036423|FG002|NOT COMPLETED|Part 1 (6 Days)||0
8972420|NCT02625207|10036424|FG003|NOT COMPLETED|Part 1 (6 Days)||0
8972421|NCT02625207|10036421|FG000|STARTED|Part 2 (11 Days)||11
8972422|NCT02625207|10036422|FG001|STARTED|Part 2 (11 Days)|Part 2 was conducted only in Cohorts 1 and 3, as pre-specified in protocol.|0
8972423|NCT02625207|10036423|FG002|STARTED|Part 2 (11 Days)||12
8972424|NCT02625207|10036424|FG003|STARTED|Part 2 (11 Days)|Part 2 was conducted only in Cohorts 1 and 3, as pre-specified in protocol.|0
8972425|NCT02625207|10036421|FG000|COMPLETED|Part 2 (11 Days)||11
8972426|NCT02625207|10036422|FG001|COMPLETED|Part 2 (11 Days)||0
8972427|NCT02625207|10036423|FG002|COMPLETED|Part 2 (11 Days)||12
8972428|NCT02625207|10036424|FG003|COMPLETED|Part 2 (11 Days)||0
8972429|NCT02625207|10036421|FG000|NOT COMPLETED|Part 2 (11 Days)||0
8972430|NCT02625207|10036422|FG001|NOT COMPLETED|Part 2 (11 Days)||0
8972431|NCT02625207|10036423|FG002|NOT COMPLETED|Part 2 (11 Days)||0
8972432|NCT02625207|10036424|FG003|NOT COMPLETED|Part 2 (11 Days)||0
8972433|NCT02625220|10036440|FG000|STARTED|Overall Study||170
8972434|NCT02625220|10036440|FG000|COMPLETED|Overall Study||163
8972435|NCT02625220|10036440|FG000|NOT COMPLETED|Overall Study||7
8972436|NCT02625233|10036446|FG000|STARTED|Overall Study||49
8972437|NCT02625233|10036447|FG001|STARTED|Overall Study||56
8972438|NCT02625233|10036446|FG000|COMPLETED|Overall Study||47
8972439|NCT02625233|10036447|FG001|COMPLETED|Overall Study||56
8972440|NCT02625233|10036446|FG000|NOT COMPLETED|Overall Study||2
8972441|NCT02625233|10036447|FG001|NOT COMPLETED|Overall Study||0
8972442|NCT02625259|10036458|FG000|STARTED|First Intervention (Day 1)||11
8972443|NCT02625259|10036459|FG001|STARTED|First Intervention (Day 1)||9
8972444|NCT02625259|10036460|FG002|STARTED|First Intervention (Day 1)||8
8972445|NCT02625259|10036461|FG003|STARTED|First Intervention (Day 1)||10
8972446|NCT02625259|10036462|FG004|STARTED|First Intervention (Day 1)||16
8972447|NCT02625259|10036458|FG000|COMPLETED|First Intervention (Day 1)||9
8972448|NCT02625259|10036459|FG001|COMPLETED|First Intervention (Day 1)||8
8972449|NCT02625259|10036460|FG002|COMPLETED|First Intervention (Day 1)||7
8972450|NCT02625259|10036461|FG003|COMPLETED|First Intervention (Day 1)||9
8972451|NCT02625259|10036462|FG004|COMPLETED|First Intervention (Day 1)||16
8972452|NCT02625259|10036458|FG000|NOT COMPLETED|First Intervention (Day 1)||2
8972453|NCT02625259|10036459|FG001|NOT COMPLETED|First Intervention (Day 1)||1
8972454|NCT02625259|10036460|FG002|NOT COMPLETED|First Intervention (Day 1)||1
8972455|NCT02625259|10036461|FG003|NOT COMPLETED|First Intervention (Day 1)||1
8972456|NCT02625259|10036462|FG004|NOT COMPLETED|First Intervention (Day 1)||0
8972457|NCT02625259|10036458|FG000|STARTED|Washout (Day 2 to Day 14)||9
8972458|NCT02625259|10036459|FG001|STARTED|Washout (Day 2 to Day 14)||8
8972459|NCT02625259|10036460|FG002|STARTED|Washout (Day 2 to Day 14)||7
8972460|NCT02625259|10036461|FG003|STARTED|Washout (Day 2 to Day 14)||9
8972461|NCT02625259|10036462|FG004|STARTED|Washout (Day 2 to Day 14)||0
8972462|NCT02625259|10036458|FG000|COMPLETED|Washout (Day 2 to Day 14)||9
8972463|NCT02625259|10036459|FG001|COMPLETED|Washout (Day 2 to Day 14)||8
8972464|NCT02625259|10036460|FG002|COMPLETED|Washout (Day 2 to Day 14)||7
8632034|NCT00543309|9671935|FG000|COMPLETED|Overall Study||35
8632035|NCT00543309|9671936|FG001|COMPLETED|Overall Study||35
8632036|NCT00543309|9671937|FG002|COMPLETED|Overall Study||35
8632037|NCT00543309|9671935|FG000|NOT COMPLETED|Overall Study||0
8632038|NCT00543309|9671936|FG001|NOT COMPLETED|Overall Study||1
8632039|NCT00543309|9671937|FG002|NOT COMPLETED|Overall Study||0
8632040|NCT00543387|9671955|FG000|STARTED|Panel 1 + Panel 2||3
8632041|NCT00543387|9671956|FG001|STARTED|Panel 1 + Panel 2||3
8632042|NCT00543387|9671957|FG002|STARTED|Panel 1 + Panel 2||3
8632043|NCT00543387|9671958|FG003|STARTED|Panel 1 + Panel 2||3
8632044|NCT00543387|9671959|FG004|STARTED|Panel 1 + Panel 2||3
8632045|NCT00543387|9671960|FG005|STARTED|Panel 1 + Panel 2||3
8972465|NCT02625259|10036461|FG003|COMPLETED|Washout (Day 2 to Day 14)||9
8972466|NCT02625259|10036462|FG004|COMPLETED|Washout (Day 2 to Day 14)||0
8972467|NCT02625259|10036458|FG000|NOT COMPLETED|Washout (Day 2 to Day 14)||0
8972468|NCT02625259|10036459|FG001|NOT COMPLETED|Washout (Day 2 to Day 14)||0
8972469|NCT02625259|10036460|FG002|NOT COMPLETED|Washout (Day 2 to Day 14)||0
8972470|NCT02625259|10036461|FG003|NOT COMPLETED|Washout (Day 2 to Day 14)||0
8972471|NCT02625259|10036462|FG004|NOT COMPLETED|Washout (Day 2 to Day 14)||0
8972472|NCT02625259|10036458|FG000|STARTED|Second Intervention (Day 15)||9
8972473|NCT02625259|10036459|FG001|STARTED|Second Intervention (Day 15)||8
8972474|NCT02625259|10036460|FG002|STARTED|Second Intervention (Day 15)||7
8972475|NCT02625259|10036461|FG003|STARTED|Second Intervention (Day 15)||9
8972476|NCT02625259|10036462|FG004|STARTED|Second Intervention (Day 15)||0
8972477|NCT02625259|10036458|FG000|COMPLETED|Second Intervention (Day 15)||9
8972478|NCT02625259|10036459|FG001|COMPLETED|Second Intervention (Day 15)||8
8972479|NCT02625259|10036460|FG002|COMPLETED|Second Intervention (Day 15)||7
8972480|NCT02625259|10036461|FG003|COMPLETED|Second Intervention (Day 15)||9
8972481|NCT02625259|10036462|FG004|COMPLETED|Second Intervention (Day 15)||0
8972482|NCT02625259|10036458|FG000|NOT COMPLETED|Second Intervention (Day 15)||0
8972483|NCT02625259|10036459|FG001|NOT COMPLETED|Second Intervention (Day 15)||0
8972484|NCT02625259|10036460|FG002|NOT COMPLETED|Second Intervention (Day 15)||0
8972485|NCT02625259|10036461|FG003|NOT COMPLETED|Second Intervention (Day 15)||0
8972486|NCT02625259|10036462|FG004|NOT COMPLETED|Second Intervention (Day 15)||0
8972487|NCT02625298|10036479|FG000|STARTED|Overall Study||11
8972488|NCT02625298|10036480|FG001|STARTED|Overall Study||13
8972489|NCT02625298|10036479|FG000|COMPLETED|Overall Study||10
8972490|NCT02625298|10036480|FG001|COMPLETED|Overall Study||13
8972491|NCT02625298|10036479|FG000|NOT COMPLETED|Overall Study||1
8972492|NCT02625298|10036480|FG001|NOT COMPLETED|Overall Study||0
8972493|NCT02625402|10036490|FG000|STARTED|Overall Study||42
8972494|NCT02625402|10036491|FG001|STARTED|Overall Study||37
8972495|NCT02625402|10036490|FG000|COMPLETED|Overall Study||33
8972496|NCT02625402|10036491|FG001|COMPLETED|Overall Study||25
8972497|NCT02625402|10036490|FG000|NOT COMPLETED|Overall Study||9
8972498|NCT02625402|10036491|FG001|NOT COMPLETED|Overall Study||12
8972499|NCT02625428|10036499|FG000|STARTED|Overall Study||20
8972500|NCT02625428|10036500|FG001|STARTED|Overall Study||20
8972501|NCT02625428|10036499|FG000|COMPLETED|Overall Study||20
8972502|NCT02625428|10036500|FG001|COMPLETED|Overall Study||20
8972503|NCT02625428|10036499|FG000|NOT COMPLETED|Overall Study||0
8972504|NCT02625428|10036500|FG001|NOT COMPLETED|Overall Study||0
8972505|NCT02625545|10036506|FG000|STARTED|Overall Study||45
8972506|NCT02625545|10036506|FG000|3 Month|Overall Study||45
8972507|NCT02625545|10036506|FG000|6 Month|Overall Study||45
8972508|NCT02625545|10036506|FG000|12 Month|Overall Study||45
8972509|NCT02625545|10036506|FG000|COMPLETED|Overall Study||45
8972510|NCT02625545|10036506|FG000|NOT COMPLETED|Overall Study||0
8972511|NCT02625571|10036510|FG000|STARTED|Overall Study||13
8972512|NCT02625571|10036510|FG000|COMPLETED|Overall Study||10
8972513|NCT02625571|10036510|FG000|NOT COMPLETED|Overall Study||3
8972514|NCT02625610|10036516|FG000|STARTED|Overall Study||250
8972515|NCT02625610|10036517|FG001|STARTED|Overall Study||249
8972516|NCT02625610|10036516|FG000|Safety-Maintenance Analysis Set|Overall Study||238
8972517|NCT02625610|10036517|FG001|Safety-Maintenance Analysis Set|Overall Study||243
8972518|NCT02625610|10036516|FG000|COMPLETED|Overall Study||216
8632046|NCT00543387|9671961|FG006|STARTED|Panel 1 + Panel 2||6
8632047|NCT00543387|9671962|FG007|STARTED|Panel 1 + Panel 2||6
8632048|NCT00543387|9671963|FG008|STARTED|Panel 1 + Panel 2||5
8725807|NCT01033487|9773164|FG007|STARTED|First Intervention Period||3
8725808|NCT01033487|9773165|FG008|STARTED|First Intervention Period||2
8972519|NCT02625610|10036517|FG001|COMPLETED|Overall Study||195
8972520|NCT02625610|10036516|FG000|NOT COMPLETED|Overall Study||34
8972521|NCT02625610|10036517|FG001|NOT COMPLETED|Overall Study||54
8972522|NCT02625623|10036525|FG000|STARTED|Overall Study||186
8972523|NCT02625623|10036526|FG001|STARTED|Overall Study||185
8632049|NCT00543387|9671964|FG009|STARTED|Panel 1 + Panel 2||0
8632050|NCT00543387|9671965|FG010|STARTED|Panel 1 + Panel 2||0
8632051|NCT00543387|9671955|FG000|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
8725809|NCT01033487|9773166|FG009|STARTED|First Intervention Period||2
8972524|NCT02625623|10036525|FG000|Treated|Overall Study||177
8972525|NCT02625623|10036526|FG001|Treated|Overall Study||184
8972526|NCT02625623|10036525|FG000|COMPLETED|Overall Study||177
8972527|NCT02625623|10036526|FG001|COMPLETED|Overall Study||184
8972528|NCT02625623|10036525|FG000|NOT COMPLETED|Overall Study||9
8972529|NCT02625623|10036526|FG001|NOT COMPLETED|Overall Study||1
8972530|NCT02625844|10036534|FG000|STARTED|Overall Study||110
8972531|NCT02625844|10036534|FG000|COMPLETED|Overall Study||110
8972532|NCT02625844|10036534|FG000|NOT COMPLETED|Overall Study||0
8972533|NCT02625909|10036540|FG000|STARTED|Overall Study||93
8972534|NCT02625909|10036541|FG001|STARTED|Overall Study||95
8972535|NCT02625909|10036540|FG000|COMPLETED|Overall Study||76
8972536|NCT02625909|10036541|FG001|COMPLETED|Overall Study||86
8972537|NCT02625909|10036540|FG000|NOT COMPLETED|Overall Study||17
8972538|NCT02625909|10036541|FG001|NOT COMPLETED|Overall Study||9
8972539|NCT02625922|10036549|FG000|STARTED|Overall Study||14
8972540|NCT02625922|10036550|FG001|STARTED|Overall Study||12
8972541|NCT02625922|10036549|FG000|Completed Treatment Period 1|Overall Study||12
8972542|NCT02625922|10036550|FG001|Completed Treatment Period 1|Overall Study||10
8972543|NCT02625922|10036549|FG000|Completed Treatment Period 2|Overall Study||11
8972544|NCT02625922|10036550|FG001|Completed Treatment Period 2|Overall Study||8
8972545|NCT02625922|10036549|FG000|COMPLETED|Overall Study||12
8972546|NCT02625922|10036550|FG001|COMPLETED|Overall Study||10
8972547|NCT02625922|10036549|FG000|NOT COMPLETED|Overall Study||2
8972548|NCT02625922|10036550|FG001|NOT COMPLETED|Overall Study||2
8972549|NCT02625974|10036561|FG000|STARTED|Overall Study||219
8972550|NCT02625974|10036562|FG001|STARTED|Overall Study||111
8972551|NCT02625974|10036561|FG000|Received Treatment|Overall Study||219
8972552|NCT02625974|10036562|FG001|Received Treatment|Overall Study||111
8972553|NCT02625974|10036561|FG000|COMPLETED|Overall Study||203
8972554|NCT02625974|10036562|FG001|COMPLETED|Overall Study||105
8972555|NCT02625974|10036561|FG000|NOT COMPLETED|Overall Study||16
8725810|NCT01033487|9773157|FG000|COMPLETED|First Intervention Period||2
8876911|NCT01920061|9933732|FG000|Received Treatment|Overall Study||4
8876912|NCT01920061|9933733|FG001|Received Treatment|Overall Study||5
8972556|NCT02625974|10036562|FG001|NOT COMPLETED|Overall Study||6
8972557|NCT02626000|10036604|FG000|STARTED|Overall Study||36
8972558|NCT02626000|10036604|FG000|COMPLETED|Overall Study||6
8972559|NCT02626000|10036604|FG000|NOT COMPLETED|Overall Study||30
8972560|NCT02626026|10036615|FG000|STARTED|Overall Study||8
8972561|NCT02626026|10036616|FG001|STARTED|Overall Study||2
8972562|NCT02626026|10036617|FG002|STARTED|Overall Study||8
8972563|NCT02626026|10036618|FG003|STARTED|Overall Study||2
8972564|NCT02626026|10036619|FG004|STARTED|Overall Study||17
8972565|NCT02626026|10036620|FG005|STARTED|Overall Study||5
8972566|NCT02626026|10036615|FG000|COMPLETED|Overall Study||8
8972567|NCT02626026|10036616|FG001|COMPLETED|Overall Study||2
8972568|NCT02626026|10036617|FG002|COMPLETED|Overall Study||8
8571032|NCT00107042|9603195|FG000|NOT COMPLETED|Overall Study||22
8876913|NCT01920061|9933734|FG002|Received Treatment|Overall Study||3
8876914|NCT01920061|9933735|FG003|Received Treatment|Overall Study||3
8876915|NCT01920061|9933736|FG004|Received Treatment|Overall Study||5
8876916|NCT01920061|9933737|FG005|Received Treatment|Overall Study||4
8876917|NCT01920061|9933738|FG006|Received Treatment|Overall Study||3
8876918|NCT01920061|9933739|FG007|Received Treatment|Overall Study||3
8876919|NCT01920061|9933740|FG008|Received Treatment|Overall Study||3
8876920|NCT01920061|9933741|FG009|Received Treatment|Overall Study||3
8876921|NCT01920061|9933742|FG010|Received Treatment|Overall Study||10
8876922|NCT01920061|9933743|FG011|Received Treatment|Overall Study||5
8876923|NCT01920061|9933744|FG012|Received Treatment|Overall Study||2
8876924|NCT01920061|9933745|FG013|Received Treatment|Overall Study||15
8876925|NCT01920061|9933746|FG014|Received Treatment|Overall Study||4
8876926|NCT01920061|9933747|FG015|Received Treatment|Overall Study||7
8876927|NCT01920061|9933748|FG016|Received Treatment|Overall Study||3
8876928|NCT01920061|9933749|FG017|Received Treatment|Overall Study||3
8876929|NCT01920061|9933750|FG018|Received Treatment|Overall Study||10
8876930|NCT01920061|9933751|FG019|Received Treatment|Overall Study||12
8876931|NCT01920061|9933732|FG000|COMPLETED|Overall Study||2
8876932|NCT01920061|9933733|FG001|COMPLETED|Overall Study||1
8876933|NCT01920061|9933734|FG002|COMPLETED|Overall Study||1
8876934|NCT01920061|9933735|FG003|COMPLETED|Overall Study||2
8876935|NCT01920061|9933736|FG004|COMPLETED|Overall Study||3
8876936|NCT01920061|9933737|FG005|COMPLETED|Overall Study||2
8876937|NCT01920061|9933738|FG006|COMPLETED|Overall Study||2
8876938|NCT01920061|9933739|FG007|COMPLETED|Overall Study||2
8876939|NCT01920061|9933740|FG008|COMPLETED|Overall Study||2
8876940|NCT01920061|9933741|FG009|COMPLETED|Overall Study||1
8876941|NCT01920061|9933742|FG010|COMPLETED|Overall Study||5
8876942|NCT01920061|9933743|FG011|COMPLETED|Overall Study||2
8876943|NCT01920061|9933744|FG012|COMPLETED|Overall Study||1
8876944|NCT01920061|9933745|FG013|COMPLETED|Overall Study||10
8876945|NCT01920061|9933746|FG014|COMPLETED|Overall Study||3
8972569|NCT02626026|10036618|FG003|COMPLETED|Overall Study||2
8972570|NCT02626026|10036619|FG004|COMPLETED|Overall Study||16
8972571|NCT02626026|10036620|FG005|COMPLETED|Overall Study||5
8972572|NCT02626026|10036615|FG000|NOT COMPLETED|Overall Study||0
8972573|NCT02626026|10036616|FG001|NOT COMPLETED|Overall Study||0
8972574|NCT02626026|10036617|FG002|NOT COMPLETED|Overall Study||0
8972575|NCT02626026|10036618|FG003|NOT COMPLETED|Overall Study||0
8972576|NCT02626026|10036619|FG004|NOT COMPLETED|Overall Study||1
8571033|NCT00107042|9603196|FG001|NOT COMPLETED|Overall Study||16
8577811|NCT00162266|9610688|FG003|STARTED|Double-Blind Period||0
8972577|NCT02626026|10036620|FG005|NOT COMPLETED|Overall Study||0
8972578|NCT02626156|10036640|FG000|STARTED|Baseline (Visit 1 to Visit 2)||29
8972579|NCT02626156|10036641|FG001|STARTED|Baseline (Visit 1 to Visit 2)||29
8972580|NCT02626156|10036642|FG002|STARTED|Baseline (Visit 1 to Visit 2)||42
8972581|NCT02626156|10036643|FG003|STARTED|Baseline (Visit 1 to Visit 2)||40
8972582|NCT02626156|10036640|FG000|COMPLETED|Baseline (Visit 1 to Visit 2)||23
8972583|NCT02626156|10036641|FG001|COMPLETED|Baseline (Visit 1 to Visit 2)||22
8972584|NCT02626156|10036642|FG002|COMPLETED|Baseline (Visit 1 to Visit 2)||37
8972585|NCT02626156|10036643|FG003|COMPLETED|Baseline (Visit 1 to Visit 2)||35
8972586|NCT02626156|10036640|FG000|NOT COMPLETED|Baseline (Visit 1 to Visit 2)||6
8972587|NCT02626156|10036641|FG001|NOT COMPLETED|Baseline (Visit 1 to Visit 2)||7
8972588|NCT02626156|10036642|FG002|NOT COMPLETED|Baseline (Visit 1 to Visit 2)||5
8972589|NCT02626156|10036643|FG003|NOT COMPLETED|Baseline (Visit 1 to Visit 2)||5
8972590|NCT02626156|10036640|FG000|STARTED|Study Visit 3||23
8972591|NCT02626156|10036641|FG001|STARTED|Study Visit 3||22
8972592|NCT02626156|10036642|FG002|STARTED|Study Visit 3||37
8972593|NCT02626156|10036643|FG003|STARTED|Study Visit 3||35
8972594|NCT02626156|10036640|FG000|COMPLETED|Study Visit 3||15
8972595|NCT02626156|10036641|FG001|COMPLETED|Study Visit 3||17
8972596|NCT02626156|10036642|FG002|COMPLETED|Study Visit 3||33
8972597|NCT02626156|10036643|FG003|COMPLETED|Study Visit 3||33
8972598|NCT02626156|10036640|FG000|NOT COMPLETED|Study Visit 3||8
8972599|NCT02626156|10036641|FG001|NOT COMPLETED|Study Visit 3||5
8972600|NCT02626156|10036642|FG002|NOT COMPLETED|Study Visit 3||4
8972601|NCT02626156|10036643|FG003|NOT COMPLETED|Study Visit 3||2
8972602|NCT02626156|10036640|FG000|STARTED|Study Visit 4||15
8972603|NCT02626156|10036641|FG001|STARTED|Study Visit 4||17
8972604|NCT02626156|10036642|FG002|STARTED|Study Visit 4||33
8972605|NCT02626156|10036643|FG003|STARTED|Study Visit 4||33
8972606|NCT02626156|10036640|FG000|COMPLETED|Study Visit 4||12
8972607|NCT02626156|10036641|FG001|COMPLETED|Study Visit 4||15
8972608|NCT02626156|10036642|FG002|COMPLETED|Study Visit 4||24
8972609|NCT02626156|10036643|FG003|COMPLETED|Study Visit 4||28
8972610|NCT02626156|10036640|FG000|NOT COMPLETED|Study Visit 4||3
8972611|NCT02626156|10036641|FG001|NOT COMPLETED|Study Visit 4||2
8972612|NCT02626156|10036642|FG002|NOT COMPLETED|Study Visit 4||9
8972613|NCT02626156|10036643|FG003|NOT COMPLETED|Study Visit 4||5
8972614|NCT02626182|10036661|FG000|STARTED|Overall Study||11
8972615|NCT02626182|10036662|FG001|STARTED|Overall Study||3
8972616|NCT02626182|10036661|FG000|COMPLETED|Overall Study||9
8972617|NCT02626182|10036662|FG001|COMPLETED|Overall Study||3
8972618|NCT02626182|10036661|FG000|NOT COMPLETED|Overall Study||2
8972619|NCT02626182|10036662|FG001|NOT COMPLETED|Overall Study||0
9038333|NCT03330275|10099565|FG001|COMPLETED|Visits 2, 3 and 4 - Period 2||0
9038334|NCT03330275|10099566|FG002|COMPLETED|Visits 2, 3 and 4 - Period 2||0
9038335|NCT03330275|10099567|FG003|COMPLETED|Visits 2, 3 and 4 - Period 2||0
9038336|NCT03330275|10099568|FG004|COMPLETED|Visits 2, 3 and 4 - Period 2||4
9038337|NCT03330275|10099569|FG005|COMPLETED|Visits 2, 3 and 4 - Period 2||4
9038338|NCT03330275|10099570|FG006|COMPLETED|Visits 2, 3 and 4 - Period 2||4
9038339|NCT03330275|10099571|FG007|COMPLETED|Visits 2, 3 and 4 - Period 2||4
9038340|NCT03330275|10099572|FG008|COMPLETED|Visits 2, 3 and 4 - Period 2||4
9038341|NCT03330275|10099573|FG009|COMPLETED|Visits 2, 3 and 4 - Period 2||4
9038342|NCT03330275|10099564|FG000|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
9038343|NCT03330275|10099565|FG001|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
9038344|NCT03330275|10099566|FG002|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
9038345|NCT03330275|10099567|FG003|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
9038346|NCT03330275|10099568|FG004|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
9038347|NCT03330275|10099569|FG005|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
9038348|NCT03330275|10099570|FG006|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
9038349|NCT03330275|10099571|FG007|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
9038350|NCT03330275|10099572|FG008|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
9038351|NCT03330275|10099573|FG009|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
9038352|NCT03330275|10099564|FG000|STARTED|Visits 2, 3 and 4 - Period 3||0
9038353|NCT03330275|10099565|FG001|STARTED|Visits 2, 3 and 4 - Period 3||0
9038354|NCT03330275|10099566|FG002|STARTED|Visits 2, 3 and 4 - Period 3||0
9038355|NCT03330275|10099567|FG003|STARTED|Visits 2, 3 and 4 - Period 3||0
9038356|NCT03330275|10099568|FG004|STARTED|Visits 2, 3 and 4 - Period 3||4
9038357|NCT03330275|10099569|FG005|STARTED|Visits 2, 3 and 4 - Period 3||4
9038358|NCT03330275|10099570|FG006|STARTED|Visits 2, 3 and 4 - Period 3||4
9038359|NCT03330275|10099571|FG007|STARTED|Visits 2, 3 and 4 - Period 3||4
9038360|NCT03330275|10099572|FG008|STARTED|Visits 2, 3 and 4 - Period 3||4
9038361|NCT03330275|10099573|FG009|STARTED|Visits 2, 3 and 4 - Period 3||4
9038362|NCT03330275|10099564|FG000|COMPLETED|Visits 2, 3 and 4 - Period 3||0
9038363|NCT03330275|10099565|FG001|COMPLETED|Visits 2, 3 and 4 - Period 3||0
9038364|NCT03330275|10099566|FG002|COMPLETED|Visits 2, 3 and 4 - Period 3||0
9038365|NCT03330275|10099567|FG003|COMPLETED|Visits 2, 3 and 4 - Period 3||0
9038366|NCT03330275|10099568|FG004|COMPLETED|Visits 2, 3 and 4 - Period 3||4
9038367|NCT03330275|10099569|FG005|COMPLETED|Visits 2, 3 and 4 - Period 3||4
9038368|NCT03330275|10099570|FG006|COMPLETED|Visits 2, 3 and 4 - Period 3||4
9038369|NCT03330275|10099571|FG007|COMPLETED|Visits 2, 3 and 4 - Period 3||4
9038370|NCT03330275|10099572|FG008|COMPLETED|Visits 2, 3 and 4 - Period 3||4
8972620|NCT02626611|10036671|FG000|STARTED|Overall Study||20
8972621|NCT02626611|10036672|FG001|STARTED|Overall Study||21
8972622|NCT02626611|10036673|FG002|STARTED|Overall Study||19
8972623|NCT02626611|10036671|FG000|COMPLETED|Overall Study||16
8972624|NCT02626611|10036672|FG001|COMPLETED|Overall Study||20
8972625|NCT02626611|10036673|FG002|COMPLETED|Overall Study||16
8972626|NCT02626611|10036671|FG000|NOT COMPLETED|Overall Study||4
8972627|NCT02626611|10036672|FG001|NOT COMPLETED|Overall Study||1
8972628|NCT02626611|10036673|FG002|NOT COMPLETED|Overall Study||3
8972629|NCT02626780|10036688|FG000|STARTED|Overall Study||7
8972630|NCT02626780|10036688|FG000|Withdrew From Study|Overall Study||3
8972631|NCT02626780|10036688|FG000|COMPLETED|Overall Study||4
8972632|NCT02626780|10036688|FG000|NOT COMPLETED|Overall Study||3
8972633|NCT02626819|10036694|FG000|STARTED|Overall Study||22
8972634|NCT02626819|10036695|FG001|STARTED|Overall Study||23
8972635|NCT02626819|10036694|FG000|COMPLETED|Overall Study||18
8972636|NCT02626819|10036695|FG001|COMPLETED|Overall Study||20
8972637|NCT02626819|10036694|FG000|NOT COMPLETED|Overall Study||4
8972638|NCT02626819|10036695|FG001|NOT COMPLETED|Overall Study||3
8972639|NCT02626910|10036705|FG000|STARTED|Overall Study||23
8972640|NCT02626910|10036706|FG001|STARTED|Overall Study||10
8972641|NCT02626910|10036707|FG002|STARTED|Overall Study||6
8972642|NCT02626910|10036708|FG003|STARTED|Overall Study||10
8972643|NCT02626910|10036705|FG000|COMPLETED|Overall Study||23
8972644|NCT02626910|10036706|FG001|COMPLETED|Overall Study||10
8972645|NCT02626910|10036707|FG002|COMPLETED|Overall Study||6
8972646|NCT02626910|10036708|FG003|COMPLETED|Overall Study||10
8972647|NCT02626910|10036705|FG000|NOT COMPLETED|Overall Study||0
8972648|NCT02626910|10036706|FG001|NOT COMPLETED|Overall Study||0
8972649|NCT02626910|10036707|FG002|NOT COMPLETED|Overall Study||0
8972650|NCT02626910|10036708|FG003|NOT COMPLETED|Overall Study||0
8972651|NCT02627001|10036720|FG000|STARTED|Overall Study||13
8972652|NCT02627001|10036721|FG001|STARTED|Overall Study||14
8972653|NCT02627001|10036720|FG000|COMPLETED|Overall Study||13
8972654|NCT02627001|10036721|FG001|COMPLETED|Overall Study||14
8972655|NCT02627001|10036720|FG000|NOT COMPLETED|Overall Study||0
8972656|NCT02627001|10036721|FG001|NOT COMPLETED|Overall Study||0
8972657|NCT02627118|10036727|FG000|STARTED|Overall Study||10
8972658|NCT02627118|10036727|FG000|COMPLETED|Overall Study||10
8972659|NCT02627118|10036727|FG000|NOT COMPLETED|Overall Study||0
8972660|NCT02627144|10036732|FG000|STARTED|Overall Study||365
8972661|NCT02627144|10036732|FG000|Treated|Overall Study||359
8972662|NCT02627144|10036732|FG000|COMPLETED|Overall Study||0
8972663|NCT02627144|10036732|FG000|NOT COMPLETED|Overall Study||365
8632052|NCT00543387|9671956|FG001|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||1
8876946|NCT01920061|9933747|FG015|COMPLETED|Overall Study||4
8876947|NCT01920061|9933748|FG016|COMPLETED|Overall Study||1
8972664|NCT02627495|10036736|FG000|STARTED|Overall Study||9
8972665|NCT02627495|10036736|FG000|COMPLETED|Overall Study||5
8972666|NCT02627495|10036736|FG000|NOT COMPLETED|Overall Study||4
8972667|NCT02627677|10036743|FG000|STARTED|Overall Study||11
8972668|NCT02627677|10036744|FG001|STARTED|Overall Study||21
8632053|NCT00543387|9671957|FG002|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
8876948|NCT01920061|9933749|FG017|COMPLETED|Overall Study||1
8876949|NCT01920061|9933750|FG018|COMPLETED|Overall Study||4
8876950|NCT01920061|9933751|FG019|COMPLETED|Overall Study||8
8876951|NCT01920061|9933732|FG000|NOT COMPLETED|Overall Study||2
8876952|NCT01920061|9933733|FG001|NOT COMPLETED|Overall Study||4
8876953|NCT01920061|9933734|FG002|NOT COMPLETED|Overall Study||2
8876954|NCT01920061|9933735|FG003|NOT COMPLETED|Overall Study||2
8876955|NCT01920061|9933736|FG004|NOT COMPLETED|Overall Study||2
8876956|NCT01920061|9933737|FG005|NOT COMPLETED|Overall Study||2
8876957|NCT01920061|9933738|FG006|NOT COMPLETED|Overall Study||1
8876958|NCT01920061|9933739|FG007|NOT COMPLETED|Overall Study||1
8876959|NCT01920061|9933740|FG008|NOT COMPLETED|Overall Study||1
8876960|NCT01920061|9933741|FG009|NOT COMPLETED|Overall Study||2
8876961|NCT01920061|9933742|FG010|NOT COMPLETED|Overall Study||5
8876962|NCT01920061|9933743|FG011|NOT COMPLETED|Overall Study||3
8876963|NCT01920061|9933744|FG012|NOT COMPLETED|Overall Study||2
8876964|NCT01920061|9933745|FG013|NOT COMPLETED|Overall Study||6
8876965|NCT01920061|9933746|FG014|NOT COMPLETED|Overall Study||1
8876966|NCT01920061|9933747|FG015|NOT COMPLETED|Overall Study||3
8876967|NCT01920061|9933748|FG016|NOT COMPLETED|Overall Study||2
8972669|NCT02627677|10036745|FG002|STARTED|Overall Study||12
8972670|NCT02627677|10036743|FG000|COMPLETED|Overall Study||0
8972671|NCT02627677|10036744|FG001|COMPLETED|Overall Study||0
8972672|NCT02627677|10036745|FG002|COMPLETED|Overall Study||0
8972673|NCT02627677|10036743|FG000|NOT COMPLETED|Overall Study||11
8972674|NCT02627677|10036744|FG001|NOT COMPLETED|Overall Study||21
8972675|NCT02627677|10036745|FG002|NOT COMPLETED|Overall Study||12
8972676|NCT02627794|10036754|FG000|STARTED|Overall Study||3
8972677|NCT02627794|10036754|FG000|COMPLETED|Overall Study||3
8972678|NCT02627794|10036754|FG000|NOT COMPLETED|Overall Study||0
8972679|NCT02627924|10036761|FG000|STARTED|Overall Study||91
8972680|NCT02627924|10036761|FG000|COMPLETED|Overall Study||79
8972681|NCT02627924|10036761|FG000|NOT COMPLETED|Overall Study||12
8972682|NCT02628028|10036776|FG000|STARTED|Dosing Period||9
8972683|NCT02628028|10036777|FG001|STARTED|Dosing Period||9
8972684|NCT02628028|10036778|FG002|STARTED|Dosing Period||10
8972685|NCT02628028|10036779|FG003|STARTED|Dosing Period||8
8972686|NCT02628028|10036780|FG004|STARTED|Dosing Period||62
8972687|NCT02628028|10036781|FG005|STARTED|Dosing Period||63
8972688|NCT02628028|10036782|FG006|STARTED|Dosing Period||62
8972689|NCT02628028|10036783|FG007|STARTED|Dosing Period||63
8972690|NCT02628028|10036776|FG000|Received at Least 1dose of Study Drug|Dosing Period||9
8972691|NCT02628028|10036777|FG001|Received at Least 1dose of Study Drug|Dosing Period||9
8972692|NCT02628028|10036778|FG002|Received at Least 1dose of Study Drug|Dosing Period||10
8972693|NCT02628028|10036779|FG003|Received at Least 1dose of Study Drug|Dosing Period||8
8972694|NCT02628028|10036780|FG004|Received at Least 1dose of Study Drug|Dosing Period||62
8632054|NCT00543387|9671958|FG003|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
8632055|NCT00543387|9671959|FG004|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||2
8632056|NCT00543387|9671960|FG005|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||1
8632057|NCT00543387|9671961|FG006|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
8632058|NCT00543387|9671962|FG007|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
8876968|NCT01920061|9933749|FG017|NOT COMPLETED|Overall Study||2
8876969|NCT01920061|9933750|FG018|NOT COMPLETED|Overall Study||6
8876970|NCT01920061|9933751|FG019|NOT COMPLETED|Overall Study||4
8876971|NCT01920152|9933816|FG000|STARTED|Overall Study||19
8972695|NCT02628028|10036781|FG005|Received at Least 1dose of Study Drug|Dosing Period||63
8972696|NCT02628028|10036782|FG006|Received at Least 1dose of Study Drug|Dosing Period||62
8972697|NCT02628028|10036783|FG007|Received at Least 1dose of Study Drug|Dosing Period||63
8972698|NCT02628028|10036776|FG000|COMPLETED|Dosing Period||9
8972699|NCT02628028|10036777|FG001|COMPLETED|Dosing Period||9
8972700|NCT02628028|10036778|FG002|COMPLETED|Dosing Period||9
8972701|NCT02628028|10036779|FG003|COMPLETED|Dosing Period||8
8972702|NCT02628028|10036780|FG004|COMPLETED|Dosing Period||46
8972703|NCT02628028|10036781|FG005|COMPLETED|Dosing Period||49
8972704|NCT02628028|10036782|FG006|COMPLETED|Dosing Period||46
8972705|NCT02628028|10036783|FG007|COMPLETED|Dosing Period||48
8972706|NCT02628028|10036776|FG000|NOT COMPLETED|Dosing Period||0
8972707|NCT02628028|10036777|FG001|NOT COMPLETED|Dosing Period||0
8972708|NCT02628028|10036778|FG002|NOT COMPLETED|Dosing Period||1
8972709|NCT02628028|10036779|FG003|NOT COMPLETED|Dosing Period||0
8972710|NCT02628028|10036780|FG004|NOT COMPLETED|Dosing Period||16
8972711|NCT02628028|10036781|FG005|NOT COMPLETED|Dosing Period||14
8972712|NCT02628028|10036782|FG006|NOT COMPLETED|Dosing Period||16
8972713|NCT02628028|10036783|FG007|NOT COMPLETED|Dosing Period||15
8876972|NCT01920152|9933817|FG001|STARTED|Overall Study||15
8876973|NCT01920152|9933816|FG000|COMPLETED|Overall Study||18
8876974|NCT01920152|9933817|FG001|COMPLETED|Overall Study||13
8876975|NCT01920152|9933816|FG000|NOT COMPLETED|Overall Study||1
8876976|NCT01920152|9933817|FG001|NOT COMPLETED|Overall Study||2
8876977|NCT01920178|9933825|FG000|STARTED|Overall Study||5
8876978|NCT01920178|9933826|FG001|STARTED|Overall Study||2
8876979|NCT01920178|9933825|FG000|COMPLETED|Overall Study||3
8876980|NCT01920178|9933826|FG001|COMPLETED|Overall Study||1
8972714|NCT02628028|10036776|FG000|STARTED|Long-term Extension (LTE) Period|LTE period included participants who completed Part B of the study.|0
8972715|NCT02628028|10036777|FG001|STARTED|Long-term Extension (LTE) Period|LTE period included participants who completed Part B of the study.|0
8972716|NCT02628028|10036778|FG002|STARTED|Long-term Extension (LTE) Period|LTE period included participants who completed Part B of the study.|0
8972717|NCT02628028|10036779|FG003|STARTED|Long-term Extension (LTE) Period|LTE period included participants who completed Part B of the study.|0
8972718|NCT02628028|10036780|FG004|STARTED|Long-term Extension (LTE) Period|Part B LTE was optional;42 participants completed part B placebo period,re-randomized to LTE period.|0
8972719|NCT02628028|10036781|FG005|STARTED|Long-term Extension (LTE) Period|Part B LTE was optional;14 participants completed part B placebo period,re-randomized to LTE period.|61
8972720|NCT02628028|10036782|FG006|STARTED|Long-term Extension (LTE) Period|Part B LTE was optional;14 participants completed part B placebo period,re-randomized to LTE period.|58
8972721|NCT02628028|10036783|FG007|STARTED|Long-term Extension (LTE) Period|Part B LTE was optional;14 participants completed part B placebo period,re-randomized to LTE period.|61
8972722|NCT02628028|10036776|FG000|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0
8972723|NCT02628028|10036777|FG001|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0
8972724|NCT02628028|10036778|FG002|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0
8972725|NCT02628028|10036779|FG003|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0
8972726|NCT02628028|10036780|FG004|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0
8972727|NCT02628028|10036781|FG005|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||14
8972728|NCT02628028|10036782|FG006|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||14
8972729|NCT02628028|10036783|FG007|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||14
8972730|NCT02628028|10036776|FG000|COMPLETED|Long-term Extension (LTE) Period||0
8972731|NCT02628028|10036777|FG001|COMPLETED|Long-term Extension (LTE) Period||0
8972732|NCT02628028|10036778|FG002|COMPLETED|Long-term Extension (LTE) Period||0
8972733|NCT02628028|10036779|FG003|COMPLETED|Long-term Extension (LTE) Period||0
8972734|NCT02628028|10036780|FG004|COMPLETED|Long-term Extension (LTE) Period||0
8972735|NCT02628028|10036781|FG005|COMPLETED|Long-term Extension (LTE) Period||1
8972736|NCT02628028|10036782|FG006|COMPLETED|Long-term Extension (LTE) Period||0
8972737|NCT02628028|10036783|FG007|COMPLETED|Long-term Extension (LTE) Period||0
8972738|NCT02628028|10036776|FG000|NOT COMPLETED|Long-term Extension (LTE) Period||0
8972739|NCT02628028|10036777|FG001|NOT COMPLETED|Long-term Extension (LTE) Period||0
8972740|NCT02628028|10036778|FG002|NOT COMPLETED|Long-term Extension (LTE) Period||0
8972741|NCT02628028|10036779|FG003|NOT COMPLETED|Long-term Extension (LTE) Period||0
8972742|NCT02628028|10036780|FG004|NOT COMPLETED|Long-term Extension (LTE) Period||0
8972743|NCT02628028|10036781|FG005|NOT COMPLETED|Long-term Extension (LTE) Period||60
8972744|NCT02628028|10036782|FG006|NOT COMPLETED|Long-term Extension (LTE) Period||58
8972745|NCT02628028|10036783|FG007|NOT COMPLETED|Long-term Extension (LTE) Period||61
8972746|NCT02628093|10036807|FG000|STARTED|Overall Study||31
8972747|NCT02628093|10036808|FG001|STARTED|Overall Study||29
8972748|NCT02628093|10036807|FG000|COMPLETED|Overall Study||31
8972749|NCT02628093|10036808|FG001|COMPLETED|Overall Study||29
8972750|NCT02628093|10036807|FG000|NOT COMPLETED|Overall Study||0
8972751|NCT02628093|10036808|FG001|NOT COMPLETED|Overall Study||0
8972752|NCT02628106|10036814|FG000|STARTED|Overall Study||21
8972753|NCT02628106|10036814|FG000|COMPLETED|Overall Study||21
8972754|NCT02628106|10036814|FG000|NOT COMPLETED|Overall Study||0
8972755|NCT02628223|10036820|FG000|STARTED|Overall Study||38
8972756|NCT02628223|10036821|FG001|STARTED|Overall Study||38
8972757|NCT02628223|10036820|FG000|COMPLETED|Overall Study||38
8972758|NCT02628223|10036821|FG001|COMPLETED|Overall Study||36
8972759|NCT02628223|10036820|FG000|NOT COMPLETED|Overall Study||0
8972760|NCT02628223|10036821|FG001|NOT COMPLETED|Overall Study||2
8972761|NCT02628236|10036827|FG000|STARTED|Overall Study||14
8972762|NCT02628236|10036827|FG000|COMPLETED|Overall Study||14
8972763|NCT02628236|10036827|FG000|NOT COMPLETED|Overall Study||0
8972764|NCT02628418|10036833|FG000|STARTED|Overall Study||15
8972765|NCT02628418|10036834|FG001|STARTED|Overall Study||15
8972766|NCT02628418|10036833|FG000|COMPLETED|Overall Study||14
8632059|NCT00543387|9671963|FG008|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
8632060|NCT00543387|9671964|FG009|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
8632061|NCT00543387|9671965|FG010|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
8632062|NCT00543387|9671955|FG000|COMPLETED|Panel 1 + Panel 2||0
8632063|NCT00543387|9671956|FG001|COMPLETED|Panel 1 + Panel 2||0
8632064|NCT00543387|9671957|FG002|COMPLETED|Panel 1 + Panel 2||0
8972767|NCT02628418|10036834|FG001|COMPLETED|Overall Study||13
8972768|NCT02628418|10036833|FG000|NOT COMPLETED|Overall Study||1
8972769|NCT02628418|10036834|FG001|NOT COMPLETED|Overall Study||2
8972770|NCT02628600|10036848|FG000|STARTED|Overall Study||73
8972771|NCT02628600|10036849|FG001|STARTED|Overall Study||90
8972772|NCT02628600|10036848|FG000|Participant Discontinued the Study|Overall Study||24
8972773|NCT02628600|10036849|FG001|Participant Discontinued the Study|Overall Study||32
8972774|NCT02628600|10036848|FG000|COMPLETED|Overall Study||49
8972775|NCT02628600|10036849|FG001|COMPLETED|Overall Study||58
8972776|NCT02628600|10036848|FG000|NOT COMPLETED|Overall Study||24
8632065|NCT00543387|9671958|FG003|COMPLETED|Panel 1 + Panel 2||0
8632066|NCT00543387|9671959|FG004|COMPLETED|Panel 1 + Panel 2||0
8632067|NCT00543387|9671960|FG005|COMPLETED|Panel 1 + Panel 2||0
8632068|NCT00543387|9671961|FG006|COMPLETED|Panel 1 + Panel 2||0
8632069|NCT00543387|9671962|FG007|COMPLETED|Panel 1 + Panel 2||0
8632070|NCT00543387|9671963|FG008|COMPLETED|Panel 1 + Panel 2||0
8632071|NCT00543387|9671964|FG009|COMPLETED|Panel 1 + Panel 2||0
8972777|NCT02628600|10036849|FG001|NOT COMPLETED|Overall Study||32
8972778|NCT02628743|10036855|FG000|STARTED|Overall Study||131
8972779|NCT02628743|10036855|FG000|COMPLETED|Overall Study||0
8972780|NCT02628743|10036855|FG000|NOT COMPLETED|Overall Study||131
8972781|NCT02628769|10036859|FG000|STARTED|First Intervention||3
8972782|NCT02628769|10036860|FG001|STARTED|First Intervention||3
8972783|NCT02628769|10036859|FG000|COMPLETED|First Intervention||2
8972784|NCT02628769|10036860|FG001|COMPLETED|First Intervention||2
8972785|NCT02628769|10036859|FG000|NOT COMPLETED|First Intervention||1
8972786|NCT02628769|10036860|FG001|NOT COMPLETED|First Intervention||1
8972787|NCT02628769|10036859|FG000|STARTED|Wash Out (28 Days)||2
8972788|NCT02628769|10036860|FG001|STARTED|Wash Out (28 Days)||2
8972789|NCT02628769|10036859|FG000|COMPLETED|Wash Out (28 Days)||2
8972790|NCT02628769|10036860|FG001|COMPLETED|Wash Out (28 Days)||2
8972791|NCT02628769|10036859|FG000|NOT COMPLETED|Wash Out (28 Days)||0
8972792|NCT02628769|10036860|FG001|NOT COMPLETED|Wash Out (28 Days)||0
8972793|NCT02628769|10036859|FG000|STARTED|Second Intervention||2
8972794|NCT02628769|10036860|FG001|STARTED|Second Intervention||2
8972795|NCT02628769|10036859|FG000|COMPLETED|Second Intervention||0
8972796|NCT02628769|10036860|FG001|COMPLETED|Second Intervention||1
8972797|NCT02628769|10036859|FG000|NOT COMPLETED|Second Intervention||2
8972798|NCT02628769|10036860|FG001|NOT COMPLETED|Second Intervention||1
8972799|NCT02628873|10036868|FG000|STARTED|First Test (1 Hour)||14
8972800|NCT02628873|10036869|FG001|STARTED|First Test (1 Hour)||7
8972801|NCT02628873|10036868|FG000|COMPLETED|First Test (1 Hour)||14
8972802|NCT02628873|10036869|FG001|COMPLETED|First Test (1 Hour)||7
8972803|NCT02628873|10036868|FG000|NOT COMPLETED|First Test (1 Hour)||0
8972804|NCT02628873|10036869|FG001|NOT COMPLETED|First Test (1 Hour)||0
8972805|NCT02628873|10036868|FG000|STARTED|Break (1 Hour)||14
8972806|NCT02628873|10036869|FG001|STARTED|Break (1 Hour)||7
8972807|NCT02628873|10036868|FG000|COMPLETED|Break (1 Hour)||14
8972808|NCT02628873|10036869|FG001|COMPLETED|Break (1 Hour)||6
8972809|NCT02628873|10036868|FG000|NOT COMPLETED|Break (1 Hour)||0
8972810|NCT02628873|10036869|FG001|NOT COMPLETED|Break (1 Hour)||1
8972811|NCT02628873|10036868|FG000|STARTED|Second Test (1 Hour)||14
8972812|NCT02628873|10036869|FG001|STARTED|Second Test (1 Hour)||6
8972813|NCT02628873|10036868|FG000|COMPLETED|Second Test (1 Hour)||13
8972814|NCT02628873|10036869|FG001|COMPLETED|Second Test (1 Hour)||6
8972815|NCT02628873|10036868|FG000|NOT COMPLETED|Second Test (1 Hour)||1
8972816|NCT02628873|10036869|FG001|NOT COMPLETED|Second Test (1 Hour)||0
8972817|NCT02628938|10036878|FG000|STARTED|Overall Study||15
8972818|NCT02628938|10036879|FG001|STARTED|Overall Study||15
8972819|NCT02628938|10036880|FG002|STARTED|Overall Study||15
8972820|NCT02628938|10036878|FG000|COMPLETED|Overall Study||10
8972821|NCT02628938|10036879|FG001|COMPLETED|Overall Study||13
8972822|NCT02628938|10036880|FG002|COMPLETED|Overall Study||11
8972823|NCT02628938|10036878|FG000|NOT COMPLETED|Overall Study||5
8972824|NCT02628938|10036879|FG001|NOT COMPLETED|Overall Study||2
8972825|NCT02628938|10036880|FG002|NOT COMPLETED|Overall Study||4
8972826|NCT02628964|10036890|FG000|STARTED|Overall Study||50
8972827|NCT02628964|10036891|FG001|STARTED|Overall Study||50
8972828|NCT02628964|10036890|FG000|COMPLETED|Overall Study||50
8972829|NCT02628964|10036891|FG001|COMPLETED|Overall Study||49
8972830|NCT02628964|10036890|FG000|NOT COMPLETED|Overall Study||0
8972831|NCT02628964|10036891|FG001|NOT COMPLETED|Overall Study||1
8972832|NCT02629094|10036897|FG000|STARTED|Overall Study||5
8972833|NCT02629094|10036897|FG000|COMPLETED|Overall Study||5
8972834|NCT02629094|10036897|FG000|NOT COMPLETED|Overall Study||0
8972835|NCT02629133|10036903|FG000|STARTED|Overall Study||25
8972836|NCT02629133|10036904|FG001|STARTED|Overall Study||25
8972837|NCT02629133|10036903|FG000|COMPLETED|Overall Study||21
8571034|NCT00107120|9603246|FG000|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug|155
8571035|NCT00107120|9603247|FG001|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug|157
8571036|NCT00107120|9603246|FG000|COMPLETED|Overall Study||126
8571037|NCT00107120|9603247|FG001|COMPLETED|Overall Study||133
8571038|NCT00107120|9603246|FG000|NOT COMPLETED|Overall Study||29
8571039|NCT00107120|9603247|FG001|NOT COMPLETED|Overall Study||24
8571040|NCT00107172|9603255|FG000|STARTED|Overall Study||114
8571041|NCT00107172|9603256|FG001|STARTED|Overall Study||108
8571042|NCT00107172|9603255|FG000|COMPLETED|Overall Study||109
8571043|NCT00107172|9603256|FG001|COMPLETED|Overall Study||103
8571044|NCT00107172|9603255|FG000|NOT COMPLETED|Overall Study||5
8571045|NCT00107172|9603256|FG001|NOT COMPLETED|Overall Study||5
8571046|NCT00107198|9603262|FG000|STARTED|Overall Study||188
8571047|NCT00107198|9603262|FG000|COMPLETED|Overall Study||136
8571048|NCT00107198|9603262|FG000|NOT COMPLETED|Overall Study||52
8571049|NCT00107276|9603266|FG000|STARTED|Overall Study||112
8571050|NCT00107276|9603266|FG000|Eligible|Overall Study||96
8571051|NCT00107276|9603266|FG000|COMPLETED|Overall Study||40
8571052|NCT00107276|9603266|FG000|NOT COMPLETED|Overall Study||72
8571053|NCT00107380|9603271|FG000|STARTED|Overall Study||86
8571054|NCT00107380|9603271|FG000|Eligible|Overall Study||84
8571055|NCT00107380|9603271|FG000|COMPLETED|Overall Study||56
8972838|NCT02629133|10036904|FG001|COMPLETED|Overall Study||23
8972839|NCT02629133|10036903|FG000|NOT COMPLETED|Overall Study||4
8972840|NCT02629133|10036904|FG001|NOT COMPLETED|Overall Study||2
8972841|NCT02629354|10036912|FG000|STARTED|Period 1||18
8972842|NCT02629354|10036913|FG001|STARTED|Period 1||18
8972843|NCT02629354|10036912|FG000|COMPLETED|Period 1||18
8972844|NCT02629354|10036913|FG001|COMPLETED|Period 1||18
8972845|NCT02629354|10036912|FG000|NOT COMPLETED|Period 1||0
8972846|NCT02629354|10036913|FG001|NOT COMPLETED|Period 1||0
8972847|NCT02629354|10036912|FG000|STARTED|Washout Period||18
8972848|NCT02629354|10036913|FG001|STARTED|Washout Period||18
8972849|NCT02629354|10036912|FG000|COMPLETED|Washout Period||18
8972850|NCT02629354|10036913|FG001|COMPLETED|Washout Period||18
8972851|NCT02629354|10036912|FG000|NOT COMPLETED|Washout Period||0
8972852|NCT02629354|10036913|FG001|NOT COMPLETED|Washout Period||0
8972853|NCT02629354|10036912|FG000|STARTED|Period 2||18
8972854|NCT02629354|10036913|FG001|STARTED|Period 2||18
8972855|NCT02629354|10036912|FG000|COMPLETED|Period 2||18
8972856|NCT02629354|10036913|FG001|COMPLETED|Period 2||18
8972857|NCT02629354|10036912|FG000|NOT COMPLETED|Period 2||0
8972858|NCT02629354|10036913|FG001|NOT COMPLETED|Period 2||0
8972859|NCT02629354|10036912|FG000|STARTED|Follow-up||18
8972860|NCT02629354|10036913|FG001|STARTED|Follow-up||18
8972861|NCT02629354|10036912|FG000|COMPLETED|Follow-up||18
8972862|NCT02629354|10036913|FG001|COMPLETED|Follow-up||18
8972863|NCT02629354|10036912|FG000|NOT COMPLETED|Follow-up||0
8972864|NCT02629354|10036913|FG001|NOT COMPLETED|Follow-up||0
8972865|NCT02629822|10036919|FG000|STARTED|Base Study||10
8972866|NCT02629822|10036919|FG000|COMPLETED|Base Study||7
8972867|NCT02629822|10036919|FG000|NOT COMPLETED|Base Study||3
8972868|NCT02629822|10036919|FG000|STARTED|Extension Study|Enrollment in Extension Study was voluntary.|6
8972869|NCT02629822|10036919|FG000|COMPLETED|Extension Study||4
8972870|NCT02629822|10036919|FG000|NOT COMPLETED|Extension Study||2
8972871|NCT02629861|10036927|FG000|STARTED|Overall Study||294
8972872|NCT02629861|10036928|FG001|STARTED|Overall Study||291
8972873|NCT02629861|10036929|FG002|STARTED|Overall Study||290
8972874|NCT02629861|10036927|FG000|Intent to Treat (ITT)|Overall Study||294
8972875|NCT02629861|10036928|FG001|Intent to Treat (ITT)|Overall Study||291
8972876|NCT02629861|10036929|FG002|Intent to Treat (ITT)|Overall Study||290
8972877|NCT02629861|10036927|FG000|Safety Population|Overall Study||294
8972878|NCT02629861|10036928|FG001|Safety Population|Overall Study||291
8972879|NCT02629861|10036929|FG002|Safety Population|Overall Study||289
8972880|NCT02629861|10036927|FG000|Full Analysis Set|Overall Study||290
8972881|NCT02629861|10036928|FG001|Full Analysis Set|Overall Study||288
8972882|NCT02629861|10036929|FG002|Full Analysis Set|Overall Study||287
8972883|NCT02629861|10036927|FG000|COMPLETED|Overall Study||265
8972884|NCT02629861|10036928|FG001|COMPLETED|Overall Study||264
8972885|NCT02629861|10036929|FG002|COMPLETED|Overall Study||262
8972886|NCT02629861|10036927|FG000|NOT COMPLETED|Overall Study||29
8972887|NCT02629861|10036928|FG001|NOT COMPLETED|Overall Study||27
8972888|NCT02629861|10036929|FG002|NOT COMPLETED|Overall Study||28
8972889|NCT02629965|10036937|FG000|STARTED|Period 1||92
8972890|NCT02629965|10036938|FG001|STARTED|Period 1||92
8972891|NCT02629965|10036937|FG000|COMPLETED|Period 1||88
8972892|NCT02629965|10036938|FG001|COMPLETED|Period 1||90
8972893|NCT02629965|10036937|FG000|NOT COMPLETED|Period 1||4
8972894|NCT02629965|10036938|FG001|NOT COMPLETED|Period 1||2
8972895|NCT02629965|10036937|FG000|STARTED|Period 2||88
8972896|NCT02629965|10036938|FG001|STARTED|Period 2||90
8972897|NCT02629965|10036937|FG000|COMPLETED|Period 2||87
8972898|NCT02629965|10036938|FG001|COMPLETED|Period 2||90
8972899|NCT02629965|10036937|FG000|NOT COMPLETED|Period 2||1
8972900|NCT02629965|10036938|FG001|NOT COMPLETED|Period 2||0
8972901|NCT02629991|10036946|FG000|STARTED|Overall Study||11
8972902|NCT02629991|10036947|FG001|STARTED|Overall Study||12
8972903|NCT02629991|10036946|FG000|COMPLETED|Overall Study||10
8972904|NCT02629991|10036947|FG001|COMPLETED|Overall Study||11
8972905|NCT02629991|10036946|FG000|NOT COMPLETED|Overall Study||1
8972906|NCT02629991|10036947|FG001|NOT COMPLETED|Overall Study||1
8972907|NCT02630017|10036958|FG000|STARTED|Overall Study||13
8972908|NCT02630017|10036959|FG001|STARTED|Overall Study||12
8972909|NCT02630017|10036960|FG002|STARTED|Overall Study||13
8972910|NCT02630017|10036961|FG003|STARTED|Overall Study||13
8972911|NCT02630017|10036958|FG000|COMPLETED|Overall Study||12
8972912|NCT02630017|10036959|FG001|COMPLETED|Overall Study||11
8972913|NCT02630017|10036960|FG002|COMPLETED|Overall Study||11
8972914|NCT02630017|10036961|FG003|COMPLETED|Overall Study||12
8972915|NCT02630017|10036958|FG000|NOT COMPLETED|Overall Study||1
8972916|NCT02630017|10036959|FG001|NOT COMPLETED|Overall Study||1
8972917|NCT02630017|10036960|FG002|NOT COMPLETED|Overall Study||2
8972918|NCT02630017|10036961|FG003|NOT COMPLETED|Overall Study||1
8972919|NCT02630030|10036971|FG000|STARTED|Overall Study||3
8972920|NCT02630030|10036971|FG000|COMPLETED|Overall Study||3
8972921|NCT02630030|10036971|FG000|NOT COMPLETED|Overall Study||0
8972922|NCT02630186|10036975|FG000|STARTED|Overall Study||3
8972923|NCT02630186|10036975|FG000|COMPLETED|Overall Study||2
8972924|NCT02630186|10036975|FG000|NOT COMPLETED|Overall Study||1
8972925|NCT02630251|10036983|FG000|STARTED|Overall Study||2
8972926|NCT02630251|10036984|FG001|STARTED|Overall Study||1
8972927|NCT02630251|10036985|FG002|STARTED|Overall Study||1
8972928|NCT02630251|10036986|FG003|STARTED|Overall Study||1
8972929|NCT02630251|10036983|FG000|COMPLETED|Overall Study||2
8972930|NCT02630251|10036984|FG001|COMPLETED|Overall Study||1
8972931|NCT02630251|10036985|FG002|COMPLETED|Overall Study||0
8972932|NCT02630251|10036986|FG003|COMPLETED|Overall Study||1
8972933|NCT02630251|10036983|FG000|NOT COMPLETED|Overall Study||0
8972934|NCT02630251|10036984|FG001|NOT COMPLETED|Overall Study||0
8972935|NCT02630251|10036985|FG002|NOT COMPLETED|Overall Study||1
8972936|NCT02630251|10036986|FG003|NOT COMPLETED|Overall Study||0
8972937|NCT02630316|10036998|FG000|STARTED|Overall Study||163
8972938|NCT02630316|10036999|FG001|STARTED|Overall Study||163
8972939|NCT02630316|10036998|FG000|COMPLETED|Overall Study||128
8972940|NCT02630316|10036999|FG001|COMPLETED|Overall Study||130
8972941|NCT02630316|10036998|FG000|NOT COMPLETED|Overall Study||35
8972942|NCT02630316|10036999|FG001|NOT COMPLETED|Overall Study||33
8972943|NCT02630563|10037005|FG000|STARTED|Overall Study||9
8972944|NCT02630563|10037005|FG000|COMPLETED|Overall Study||8
8972945|NCT02630563|10037005|FG000|NOT COMPLETED|Overall Study||1
8972946|NCT02630693|10037012|FG000|STARTED|Overall Study||90
8972947|NCT02630693|10037013|FG001|STARTED|Overall Study||90
8972948|NCT02630693|10037012|FG000|COMPLETED|Overall Study||90
8972949|NCT02630693|10037013|FG001|COMPLETED|Overall Study||89
8972950|NCT02630693|10037012|FG000|NOT COMPLETED|Overall Study||0
8972951|NCT02630693|10037013|FG001|NOT COMPLETED|Overall Study||1
8972952|NCT02630706|10037022|FG000|STARTED|Overall Study||170
8972953|NCT02630706|10037023|FG001|STARTED|Overall Study||169
8972954|NCT02630706|10037024|FG002|STARTED|Overall Study||167
8972955|NCT02630706|10037022|FG000|Treated|Overall Study||170
8972956|NCT02630706|10037023|FG001|Treated|Overall Study||169
8972957|NCT02630706|10037024|FG002|Treated|Overall Study||167
8972958|NCT02630706|10037022|FG000|COMPLETED|Overall Study||163
8972959|NCT02630706|10037023|FG001|COMPLETED|Overall Study||160
8972960|NCT02630706|10037024|FG002|COMPLETED|Overall Study||157
8972961|NCT02630706|10037022|FG000|NOT COMPLETED|Overall Study||7
8972962|NCT02630706|10037023|FG001|NOT COMPLETED|Overall Study||9
8972963|NCT02630706|10037024|FG002|NOT COMPLETED|Overall Study||10
8972964|NCT02630719|10037034|FG000|STARTED|Overall Study||4
8972965|NCT02630719|10037035|FG001|STARTED|Overall Study||6
8972966|NCT02630719|10037034|FG000|COMPLETED|Overall Study||4
8972967|NCT02630719|10037035|FG001|COMPLETED|Overall Study||6
8972968|NCT02630719|10037034|FG000|NOT COMPLETED|Overall Study||0
8972969|NCT02630719|10037035|FG001|NOT COMPLETED|Overall Study||0
8972970|NCT02630953|10037043|FG000|STARTED|6 Month Assessment||97
8972971|NCT02630953|10037044|FG001|STARTED|6 Month Assessment||102
8972972|NCT02630953|10037043|FG000|COMPLETED|6 Month Assessment||83
8972973|NCT02630953|10037044|FG001|COMPLETED|6 Month Assessment||70
8972974|NCT02630953|10037043|FG000|NOT COMPLETED|6 Month Assessment||14
8972975|NCT02630953|10037044|FG001|NOT COMPLETED|6 Month Assessment||32
8972976|NCT02630953|10037043|FG000|STARTED|12 Month Assessment||97
8972977|NCT02630953|10037044|FG001|STARTED|12 Month Assessment||102
8972978|NCT02630953|10037043|FG000|COMPLETED|12 Month Assessment||73
8972979|NCT02630953|10037044|FG001|COMPLETED|12 Month Assessment||64
8972980|NCT02630953|10037043|FG000|NOT COMPLETED|12 Month Assessment||24
8972981|NCT02630953|10037044|FG001|NOT COMPLETED|12 Month Assessment||38
8972982|NCT02630966|10037052|FG000|STARTED|Overall Study||16
8972983|NCT02630966|10037053|FG001|STARTED|Overall Study||18
8972984|NCT02630966|10037052|FG000|COMPLETED|Overall Study||14
8972985|NCT02630966|10037053|FG001|COMPLETED|Overall Study||10
8972986|NCT02630966|10037052|FG000|NOT COMPLETED|Overall Study||2
8972987|NCT02630966|10037053|FG001|NOT COMPLETED|Overall Study||8
8972988|NCT02630992|10037059|FG000|STARTED|Overall Study||112
8972989|NCT02630992|10037059|FG000|COMPLETED|Overall Study||99
8972990|NCT02630992|10037059|FG000|NOT COMPLETED|Overall Study||13
8972991|NCT02631057|10037065|FG000|STARTED|Overall Study||899
8972992|NCT02631057|10037066|FG001|STARTED|Overall Study||3414
8972993|NCT02631057|10037065|FG000|COMPLETED|Overall Study||899
8972994|NCT02631057|10037066|FG001|COMPLETED|Overall Study||3414
8972995|NCT02631057|10037065|FG000|NOT COMPLETED|Overall Study||0
8972996|NCT02631057|10037066|FG001|NOT COMPLETED|Overall Study||0
8972997|NCT02631525|10037074|FG000|STARTED|Overall Study||20
8972998|NCT02631525|10037075|FG001|STARTED|Overall Study||20
8972999|NCT02631525|10037074|FG000|COMPLETED|Overall Study||20
8973000|NCT02631525|10037075|FG001|COMPLETED|Overall Study||20
8973001|NCT02631525|10037074|FG000|NOT COMPLETED|Overall Study||0
8632072|NCT00543387|9671965|FG010|COMPLETED|Panel 1 + Panel 2||0
8632073|NCT00543387|9671955|FG000|NOT COMPLETED|Panel 1 + Panel 2||3
8632074|NCT00543387|9671956|FG001|NOT COMPLETED|Panel 1 + Panel 2||3
8632075|NCT00543387|9671957|FG002|NOT COMPLETED|Panel 1 + Panel 2||3
8632076|NCT00543387|9671958|FG003|NOT COMPLETED|Panel 1 + Panel 2||3
8632077|NCT00543387|9671959|FG004|NOT COMPLETED|Panel 1 + Panel 2||3
8632078|NCT00543387|9671960|FG005|NOT COMPLETED|Panel 1 + Panel 2||3
8632079|NCT00543387|9671961|FG006|NOT COMPLETED|Panel 1 + Panel 2||6
8632080|NCT00543387|9671962|FG007|NOT COMPLETED|Panel 1 + Panel 2||6
8632081|NCT00543387|9671963|FG008|NOT COMPLETED|Panel 1 + Panel 2||5
8632082|NCT00543387|9671964|FG009|NOT COMPLETED|Panel 1 + Panel 2||0
8632083|NCT00543387|9671965|FG010|NOT COMPLETED|Panel 1 + Panel 2||0
8632084|NCT00543387|9671955|FG000|STARTED|Crossover Participants||0
8632085|NCT00543387|9671956|FG001|STARTED|Crossover Participants||0
8632086|NCT00543387|9671957|FG002|STARTED|Crossover Participants||0
8632087|NCT00543387|9671958|FG003|STARTED|Crossover Participants||0
8632088|NCT00543387|9671959|FG004|STARTED|Crossover Participants||0
8632089|NCT00543387|9671960|FG005|STARTED|Crossover Participants||0
8876981|NCT01920178|9933825|FG000|NOT COMPLETED|Overall Study||2
8876982|NCT01920178|9933826|FG001|NOT COMPLETED|Overall Study||1
8876983|NCT01920282|9933835|FG000|STARTED|Overall Study||15
8876984|NCT01920282|9933836|FG001|STARTED|Overall Study||15
8876985|NCT01920282|9933837|FG002|STARTED|Overall Study||15
8876986|NCT01920282|9933835|FG000|COMPLETED|Overall Study||15
8876987|NCT01920282|9933836|FG001|COMPLETED|Overall Study||15
8876988|NCT01920282|9933837|FG002|COMPLETED|Overall Study||15
8876989|NCT01920282|9933835|FG000|NOT COMPLETED|Overall Study||0
8876990|NCT01920282|9933836|FG001|NOT COMPLETED|Overall Study||0
8876991|NCT01920282|9933837|FG002|NOT COMPLETED|Overall Study||0
8876992|NCT01920477|9933847|FG000|STARTED|Overall Study||17
8876993|NCT01920477|9933848|FG001|STARTED|Overall Study||18
8876994|NCT01920477|9933847|FG000|Requiried Individualized Follow-up|Overall Study||1
8876995|NCT01920477|9933848|FG001|Requiried Individualized Follow-up|Overall Study||0
8876996|NCT01920477|9933847|FG000|COMPLETED|Overall Study||2
8876997|NCT01920477|9933848|FG001|COMPLETED|Overall Study||1
8876998|NCT01920477|9933847|FG000|NOT COMPLETED|Overall Study||15
8876999|NCT01920477|9933848|FG001|NOT COMPLETED|Overall Study||17
8877000|NCT01920555|9933859|FG000|STARTED|Overall Study||18
8877001|NCT01920555|9933860|FG001|STARTED|Overall Study||20
8877002|NCT01920555|9933861|FG002|STARTED|Overall Study||22
8877003|NCT01920555|9933862|FG003|STARTED|Overall Study||20
8877004|NCT01920555|9933863|FG004|STARTED|Overall Study||19
8877005|NCT01920555|9933859|FG000|COMPLETED|Overall Study||14
8877006|NCT01920555|9933860|FG001|COMPLETED|Overall Study||16
8877007|NCT01920555|9933861|FG002|COMPLETED|Overall Study||21
8877008|NCT01920555|9933862|FG003|COMPLETED|Overall Study||17
8877009|NCT01920555|9933863|FG004|COMPLETED|Overall Study||18
8877010|NCT01920555|9933859|FG000|NOT COMPLETED|Overall Study||4
8877011|NCT01920555|9933860|FG001|NOT COMPLETED|Overall Study||4
8877012|NCT01920555|9933861|FG002|NOT COMPLETED|Overall Study||1
8877013|NCT01920555|9933862|FG003|NOT COMPLETED|Overall Study||3
8877014|NCT01920555|9933863|FG004|NOT COMPLETED|Overall Study||1
8877015|NCT01920568|9933877|FG000|STARTED|Overall Study||326
8877016|NCT01920568|9933878|FG001|STARTED|Overall Study||159
8877017|NCT01920568|9933877|FG000|COMPLETED|Overall Study||175
8877018|NCT01920568|9933878|FG001|COMPLETED|Overall Study||75
8877019|NCT01920568|9933877|FG000|NOT COMPLETED|Overall Study||151
8877020|NCT01920568|9933878|FG001|NOT COMPLETED|Overall Study||84
8877021|NCT01920594|9933887|FG000|STARTED|Overall Study||27
8877022|NCT01920594|9933888|FG001|STARTED|Overall Study||28
8877023|NCT01920594|9933887|FG000|COMPLETED|Overall Study||20
8877024|NCT01920594|9933888|FG001|COMPLETED|Overall Study||25
8877025|NCT01920594|9933887|FG000|NOT COMPLETED|Overall Study||7
8877026|NCT01920594|9933888|FG001|NOT COMPLETED|Overall Study||3
8877027|NCT01920711|9933896|FG000|STARTED|Overall Study||2419
8877028|NCT01920711|9933897|FG001|STARTED|Overall Study||2403
8877029|NCT01920711|9933896|FG000|COMPLETED|Overall Study||2055
8877030|NCT01920711|9933897|FG001|COMPLETED|Overall Study||2030
8877031|NCT01920711|9933896|FG000|NOT COMPLETED|Overall Study||364
8877032|NCT01920711|9933897|FG001|NOT COMPLETED|Overall Study||373
8877033|NCT01920802|9933907|FG000|STARTED|Overall Study||11
8877034|NCT01920802|9933908|FG001|STARTED|Overall Study||9
8877035|NCT01920802|9933909|FG002|STARTED|Overall Study||11
8877036|NCT01920802|9933907|FG000|COMPLETED|Overall Study||7
8725811|NCT01033487|9773158|FG001|COMPLETED|First Intervention Period||3
8725812|NCT01033487|9773159|FG002|COMPLETED|First Intervention Period||2
8632090|NCT00543387|9671961|FG006|STARTED|Crossover Participants||0
8632091|NCT00543387|9671962|FG007|STARTED|Crossover Participants||0
8632092|NCT00543387|9671963|FG008|STARTED|Crossover Participants||0
8632093|NCT00543387|9671964|FG009|STARTED|Crossover Participants|Participant originally treated in MK-5108 400 mg BID (Panel 1) in Period 1|1
8632094|NCT00543387|9671965|FG010|STARTED|Crossover Participants|3 participants originally treated with 1500 (2) and 1800 mg (1) MK-5108 in Panel 1 Period 1|3
8632095|NCT00543387|9671955|FG000|COMPLETED|Crossover Participants||0
8725813|NCT01033487|9773160|FG003|COMPLETED|First Intervention Period||2
8725814|NCT01033487|9773161|FG004|COMPLETED|First Intervention Period||2
8725815|NCT01033487|9773162|FG005|COMPLETED|First Intervention Period||2
8973002|NCT02631525|10037075|FG001|NOT COMPLETED|Overall Study||0
8973003|NCT02631538|10037085|FG000|STARTED|Treatment Period (Up to Week 52)||13
8973004|NCT02631538|10037086|FG001|STARTED|Treatment Period (Up to Week 52)||24
8973005|NCT02631538|10037087|FG002|STARTED|Treatment Period (Up to Week 52)||24
8973006|NCT02631538|10037088|FG003|STARTED|Treatment Period (Up to Week 52)||25
8973007|NCT02631538|10037085|FG000|COMPLETED|Treatment Period (Up to Week 52)||9
8973008|NCT02631538|10037086|FG001|COMPLETED|Treatment Period (Up to Week 52)||17
8973009|NCT02631538|10037087|FG002|COMPLETED|Treatment Period (Up to Week 52)||19
8973010|NCT02631538|10037088|FG003|COMPLETED|Treatment Period (Up to Week 52)||17
8973011|NCT02631538|10037085|FG000|NOT COMPLETED|Treatment Period (Up to Week 52)||4
8973012|NCT02631538|10037086|FG001|NOT COMPLETED|Treatment Period (Up to Week 52)||7
8973013|NCT02631538|10037087|FG002|NOT COMPLETED|Treatment Period (Up to Week 52)||5
8973014|NCT02631538|10037088|FG003|NOT COMPLETED|Treatment Period (Up to Week 52)||8
8973015|NCT02631538|10037085|FG000|STARTED|General Follow-up (GFU) (Up to Week 68)||9
8973016|NCT02631538|10037086|FG001|STARTED|General Follow-up (GFU) (Up to Week 68)||17
8973017|NCT02631538|10037087|FG002|STARTED|General Follow-up (GFU) (Up to Week 68)||19
8973018|NCT02631538|10037088|FG003|STARTED|General Follow-up (GFU) (Up to Week 68)||17
8973019|NCT02631538|10037085|FG000|COMPLETED|General Follow-up (GFU) (Up to Week 68)||8
8973020|NCT02631538|10037086|FG001|COMPLETED|General Follow-up (GFU) (Up to Week 68)||17
8973021|NCT02631538|10037087|FG002|COMPLETED|General Follow-up (GFU) (Up to Week 68)||19
8973022|NCT02631538|10037088|FG003|COMPLETED|General Follow-up (GFU) (Up to Week 68)||16
8973023|NCT02631538|10037085|FG000|NOT COMPLETED|General Follow-up (GFU) (Up to Week 68)||1
8973024|NCT02631538|10037086|FG001|NOT COMPLETED|General Follow-up (GFU) (Up to Week 68)||0
8973025|NCT02631538|10037087|FG002|NOT COMPLETED|General Follow-up (GFU) (Up to Week 68)||0
8973026|NCT02631538|10037088|FG003|NOT COMPLETED|General Follow-up (GFU) (Up to Week 68)||1
8973027|NCT02631551|10037102|FG000|STARTED|Overall Study||302
8973028|NCT02631551|10037103|FG001|STARTED|Overall Study||297
8973029|NCT02631551|10037104|FG002|STARTED|Overall Study||294
8973030|NCT02631551|10037105|FG003|STARTED|Overall Study||287
8973031|NCT02631551|10037102|FG000|COMPLETED|Overall Study||289
8973032|NCT02631551|10037103|FG001|COMPLETED|Overall Study||278
8973033|NCT02631551|10037104|FG002|COMPLETED|Overall Study||283
8973034|NCT02631551|10037105|FG003|COMPLETED|Overall Study||276
8973035|NCT02631551|10037102|FG000|NOT COMPLETED|Overall Study||13
8973036|NCT02631551|10037103|FG001|NOT COMPLETED|Overall Study||19
8973037|NCT02631551|10037104|FG002|NOT COMPLETED|Overall Study||11
8973038|NCT02631551|10037105|FG003|NOT COMPLETED|Overall Study||11
8973039|NCT02631590|10037115|FG000|STARTED|Overall Study||24
8973040|NCT02631590|10037115|FG000|COMPLETED|Overall Study||24
8973041|NCT02631590|10037115|FG000|NOT COMPLETED|Overall Study||0
8973042|NCT02631746|10037119|FG000|STARTED|Overall Study||3
8973043|NCT02631746|10037119|FG000|COMPLETED|Overall Study||0
8973044|NCT02631746|10037119|FG000|NOT COMPLETED|Overall Study||3
8973045|NCT02631772|10037125|FG000|STARTED|Overall Study||16
8973046|NCT02631772|10037126|FG001|STARTED|Overall Study||16
8973047|NCT02631772|10037125|FG000|COMPLETED|Overall Study||16
8973048|NCT02631772|10037126|FG001|COMPLETED|Overall Study||16
8973049|NCT02631772|10037125|FG000|NOT COMPLETED|Overall Study||0
8973050|NCT02631772|10037126|FG001|NOT COMPLETED|Overall Study||0
8973051|NCT02631850|10037136|FG000|STARTED|Treatment Period|One participant was withdrawn during treatment because medical records review revealed that the motor deficit was due to an old orthopedic injury and not stroke. This participant had experienced a Transient Ischemic Attack, but no stroke that resulted in lasting neurological motor deficit. 40 participants were thus analyzed for this group in the intent-to-treat analysis even though 41 began treatment.|41
8973052|NCT02631850|10037137|FG001|STARTED|Treatment Period||44
8973053|NCT02631850|10037138|FG002|STARTED|Treatment Period||45
8973054|NCT02631850|10037139|FG003|STARTED|Treatment Period||38
8973055|NCT02631850|10037136|FG000|COMPLETED|Treatment Period||38
8973056|NCT02631850|10037137|FG001|COMPLETED|Treatment Period||38
8973057|NCT02631850|10037138|FG002|COMPLETED|Treatment Period||41
8973058|NCT02631850|10037139|FG003|COMPLETED|Treatment Period||33
8973059|NCT02631850|10037136|FG000|NOT COMPLETED|Treatment Period||3
8632096|NCT00543387|9671956|FG001|COMPLETED|Crossover Participants||0
8632097|NCT00543387|9671957|FG002|COMPLETED|Crossover Participants||0
8632098|NCT00543387|9671958|FG003|COMPLETED|Crossover Participants||0
8632099|NCT00543387|9671959|FG004|COMPLETED|Crossover Participants||0
8973060|NCT02631850|10037137|FG001|NOT COMPLETED|Treatment Period||6
8973061|NCT02631850|10037138|FG002|NOT COMPLETED|Treatment Period||4
8973062|NCT02631850|10037139|FG003|NOT COMPLETED|Treatment Period||5
8973063|NCT02631850|10037136|FG000|STARTED|6 Month Follow up||38
8973064|NCT02631850|10037137|FG001|STARTED|6 Month Follow up||38
8973065|NCT02631850|10037138|FG002|STARTED|6 Month Follow up||41
8973066|NCT02631850|10037139|FG003|STARTED|6 Month Follow up||33
8973067|NCT02631850|10037136|FG000|COMPLETED|6 Month Follow up||31
8973068|NCT02631850|10037137|FG001|COMPLETED|6 Month Follow up||25
8973069|NCT02631850|10037138|FG002|COMPLETED|6 Month Follow up||35
8973070|NCT02631850|10037139|FG003|COMPLETED|6 Month Follow up||22
8973071|NCT02631850|10037136|FG000|NOT COMPLETED|6 Month Follow up||7
8973072|NCT02631850|10037137|FG001|NOT COMPLETED|6 Month Follow up||13
8973073|NCT02631850|10037138|FG002|NOT COMPLETED|6 Month Follow up||6
8973074|NCT02631850|10037139|FG003|NOT COMPLETED|6 Month Follow up||11
8973075|NCT02631876|10037152|FG000|STARTED|Overall Study||248
8973076|NCT02631876|10037153|FG001|STARTED|Overall Study||118
8973077|NCT02631876|10037152|FG000|Safety Population|Overall Study||243
8973078|NCT02631876|10037153|FG001|Safety Population|Overall Study||109
8973079|NCT02631876|10037152|FG000|COMPLETED|Overall Study||129
8973080|NCT02631876|10037153|FG001|COMPLETED|Overall Study||55
8973081|NCT02631876|10037152|FG000|NOT COMPLETED|Overall Study||119
8973082|NCT02631876|10037153|FG001|NOT COMPLETED|Overall Study||63
8973083|NCT02631954|10037162|FG000|STARTED|Overall Study||12
8973084|NCT02631954|10037163|FG001|STARTED|Overall Study||12
8973085|NCT02631954|10037162|FG000|COMPLETED|Overall Study||12
8973086|NCT02631954|10037163|FG001|COMPLETED|Overall Study||12
8973087|NCT02631954|10037162|FG000|NOT COMPLETED|Overall Study||0
8973088|NCT02631954|10037163|FG001|NOT COMPLETED|Overall Study||0
8973089|NCT02632110|10037174|FG000|STARTED|Overall Study||25
8973090|NCT02632110|10037175|FG001|STARTED|Overall Study||25
8973091|NCT02632110|10037176|FG002|STARTED|Overall Study||27
8973092|NCT02632110|10037177|FG003|STARTED|Overall Study||27
8973093|NCT02632110|10037178|FG004|STARTED|Overall Study||29
8973094|NCT02632110|10037179|FG005|STARTED|Overall Study||29
8973095|NCT02632110|10037180|FG006|STARTED|Overall Study||26
8973096|NCT02632110|10037181|FG007|STARTED|Overall Study||26
8973097|NCT02632110|10037182|FG008|STARTED|Overall Study||30
8973098|NCT02632110|10037183|FG009|STARTED|Overall Study||30
8973099|NCT02632110|10037174|FG000|COMPLETED|Overall Study||24
8973100|NCT02632110|10037175|FG001|COMPLETED|Overall Study||24
8973101|NCT02632110|10037176|FG002|COMPLETED|Overall Study||27
8973102|NCT02632110|10037177|FG003|COMPLETED|Overall Study||27
8973103|NCT02632110|10037178|FG004|COMPLETED|Overall Study||28
8973104|NCT02632110|10037179|FG005|COMPLETED|Overall Study||28
8973105|NCT02632110|10037180|FG006|COMPLETED|Overall Study||23
8973106|NCT02632110|10037181|FG007|COMPLETED|Overall Study||23
8973107|NCT02632110|10037182|FG008|COMPLETED|Overall Study||29
8973108|NCT02632110|10037183|FG009|COMPLETED|Overall Study||29
8973109|NCT02632110|10037174|FG000|NOT COMPLETED|Overall Study||1
8973110|NCT02632110|10037175|FG001|NOT COMPLETED|Overall Study||1
8973111|NCT02632110|10037176|FG002|NOT COMPLETED|Overall Study||0
8973112|NCT02632110|10037177|FG003|NOT COMPLETED|Overall Study||0
8973113|NCT02632110|10037178|FG004|NOT COMPLETED|Overall Study||1
8725816|NCT01033487|9773163|FG006|COMPLETED|First Intervention Period||2
8725817|NCT01033487|9773164|FG007|COMPLETED|First Intervention Period||3
8973114|NCT02632110|10037179|FG005|NOT COMPLETED|Overall Study||1
8973115|NCT02632110|10037180|FG006|NOT COMPLETED|Overall Study||3
8973116|NCT02632110|10037181|FG007|NOT COMPLETED|Overall Study||3
8973117|NCT02632110|10037182|FG008|NOT COMPLETED|Overall Study||1
8973118|NCT02632110|10037183|FG009|NOT COMPLETED|Overall Study||1
8973119|NCT02632526|10037206|FG000|STARTED|Overall Study||36
8973120|NCT02632526|10037207|FG001|STARTED|Overall Study||12
8973121|NCT02632526|10037208|FG002|STARTED|Overall Study||24
8973122|NCT02632526|10037209|FG003|STARTED|Overall Study||12
8973123|NCT02632526|10037210|FG004|STARTED|Overall Study||4
8973124|NCT02632526|10037211|FG005|STARTED|Overall Study||8
8973125|NCT02632526|10037206|FG000|COMPLETED|Overall Study||36
8973126|NCT02632526|10037207|FG001|COMPLETED|Overall Study||12
8973127|NCT02632526|10037208|FG002|COMPLETED|Overall Study||24
8973128|NCT02632526|10037209|FG003|COMPLETED|Overall Study||12
8973129|NCT02632526|10037210|FG004|COMPLETED|Overall Study||4
8973130|NCT02632526|10037211|FG005|COMPLETED|Overall Study||8
8973131|NCT02632526|10037206|FG000|NOT COMPLETED|Overall Study||0
8973132|NCT02632526|10037207|FG001|NOT COMPLETED|Overall Study||0
8973133|NCT02632526|10037208|FG002|NOT COMPLETED|Overall Study||0
8973134|NCT02632526|10037209|FG003|NOT COMPLETED|Overall Study||0
8973135|NCT02632526|10037210|FG004|NOT COMPLETED|Overall Study||0
8973136|NCT02632526|10037211|FG005|NOT COMPLETED|Overall Study||0
8973137|NCT02632552|10037258|FG000|STARTED|Overall Study||80
8973138|NCT02632552|10037259|FG001|STARTED|Overall Study||60
8973139|NCT02632552|10037258|FG000|COMPLETED|Overall Study||57
8973140|NCT02632552|10037259|FG001|COMPLETED|Overall Study||50
8973141|NCT02632552|10037258|FG000|NOT COMPLETED|Overall Study||23
8973142|NCT02632552|10037259|FG001|NOT COMPLETED|Overall Study||10
8973143|NCT02632747|10037268|FG000|STARTED|Treatment Period 1||16
8973144|NCT02632747|10037269|FG001|STARTED|Treatment Period 1||15
8973145|NCT02632747|10037268|FG000|COMPLETED|Treatment Period 1||16
8973146|NCT02632747|10037269|FG001|COMPLETED|Treatment Period 1||15
8973147|NCT02632747|10037268|FG000|NOT COMPLETED|Treatment Period 1||0
8973148|NCT02632747|10037269|FG001|NOT COMPLETED|Treatment Period 1||0
8973149|NCT02632747|10037268|FG000|STARTED|Wash-out Period||16
8973150|NCT02632747|10037269|FG001|STARTED|Wash-out Period||15
8973151|NCT02632747|10037268|FG000|COMPLETED|Wash-out Period||15
8973152|NCT02632747|10037269|FG001|COMPLETED|Wash-out Period||15
8973153|NCT02632747|10037268|FG000|NOT COMPLETED|Wash-out Period||1
8973154|NCT02632747|10037269|FG001|NOT COMPLETED|Wash-out Period||0
8973155|NCT02632747|10037268|FG000|STARTED|Treatment Period 2||15
8973156|NCT02632747|10037269|FG001|STARTED|Treatment Period 2||15
8973157|NCT02632747|10037268|FG000|COMPLETED|Treatment Period 2||15
8973158|NCT02632747|10037269|FG001|COMPLETED|Treatment Period 2||15
8973159|NCT02632747|10037268|FG000|NOT COMPLETED|Treatment Period 2||0
8973160|NCT02632747|10037269|FG001|NOT COMPLETED|Treatment Period 2||0
8973161|NCT02632786|10037277|FG000|STARTED|Overall Study||66
8973162|NCT02632786|10037278|FG001|STARTED|Overall Study||63
8973163|NCT02632786|10037277|FG000|Informed Consent Obtained|Overall Study||66
8973164|NCT02632786|10037278|FG001|Informed Consent Obtained|Overall Study||63
8973165|NCT02632786|10037277|FG000|Randomized and Dosed|Overall Study||66
8973166|NCT02632786|10037278|FG001|Randomized and Dosed|Overall Study||63
8973167|NCT02632786|10037277|FG000|COMPLETED|Overall Study||55
8973168|NCT02632786|10037278|FG001|COMPLETED|Overall Study||56
8973169|NCT02632786|10037277|FG000|NOT COMPLETED|Overall Study||11
8973170|NCT02632786|10037278|FG001|NOT COMPLETED|Overall Study||7
8973171|NCT02632812|10037287|FG000|STARTED|Overall Study||12
8973172|NCT02632812|10037288|FG001|STARTED|Overall Study||12
8973173|NCT02632812|10037287|FG000|COMPLETED|Overall Study||12
8973174|NCT02632812|10037288|FG001|COMPLETED|Overall Study||12
8973175|NCT02632812|10037287|FG000|NOT COMPLETED|Overall Study||0
8973176|NCT02632812|10037288|FG001|NOT COMPLETED|Overall Study||0
8973177|NCT02632838|10037296|FG000|STARTED|Overall Study||15
8973178|NCT02632838|10037297|FG001|STARTED|Overall Study||15
8973179|NCT02632838|10037296|FG000|COMPLETED|Overall Study||12
8973180|NCT02632838|10037297|FG001|COMPLETED|Overall Study||13
8973181|NCT02632838|10037296|FG000|NOT COMPLETED|Overall Study||3
8973182|NCT02632838|10037297|FG001|NOT COMPLETED|Overall Study||2
8973183|NCT02633020|10037309|FG000|STARTED|Overall Study||19
8973184|NCT02633020|10037310|FG001|STARTED|Overall Study||9
8973185|NCT02633020|10037309|FG000|COMPLETED|Overall Study||18
8973186|NCT02633020|10037310|FG001|COMPLETED|Overall Study||9
8973187|NCT02633020|10037309|FG000|NOT COMPLETED|Overall Study||1
8973188|NCT02633020|10037310|FG001|NOT COMPLETED|Overall Study||0
8973189|NCT02633046|10037316|FG000|STARTED|Overall Study||63
8973190|NCT02633046|10037316|FG000|Safety Population|Overall Study||63
8973191|NCT02633046|10037316|FG000|COMPLETED|Overall Study||36
8973192|NCT02633046|10037316|FG000|NOT COMPLETED|Overall Study||27
8973193|NCT02633215|10037322|FG000|STARTED|Overall Study||18
8973194|NCT02633215|10037323|FG001|STARTED|Overall Study||18
8973195|NCT02633215|10037322|FG000|COMPLETED|Overall Study||16
8973196|NCT02633215|10037323|FG001|COMPLETED|Overall Study||15
8973197|NCT02633215|10037322|FG000|NOT COMPLETED|Overall Study||2
8973198|NCT02633215|10037323|FG001|NOT COMPLETED|Overall Study||3
8973199|NCT02633306|10037329|FG000|STARTED|Overall Study||9
8973200|NCT02633306|10037329|FG000|COMPLETED|Overall Study||6
8973201|NCT02633306|10037329|FG000|NOT COMPLETED|Overall Study||3
8973202|NCT02633358|10037336|FG000|STARTED|Overall Study||87
8973203|NCT02633358|10037337|FG001|STARTED|Overall Study||54
8973204|NCT02633358|10037336|FG000|COMPLETED|Overall Study||87
8973205|NCT02633358|10037337|FG001|COMPLETED|Overall Study||54
8973206|NCT02633358|10037336|FG000|NOT COMPLETED|Overall Study||0
8973207|NCT02633358|10037337|FG001|NOT COMPLETED|Overall Study||0
8973208|NCT02633371|10037344|FG000|STARTED|Overall Study||10
8973209|NCT02633371|10037344|FG000|COMPLETED|Overall Study||7
8973210|NCT02633371|10037344|FG000|NOT COMPLETED|Overall Study||3
8973211|NCT02633488|10037350|FG000|STARTED|Overall Study||6
8973212|NCT02633488|10037351|FG001|STARTED|Overall Study||5
8973213|NCT02633488|10037350|FG000|COMPLETED|Overall Study||6
8973214|NCT02633488|10037351|FG001|COMPLETED|Overall Study||5
8973215|NCT02633488|10037350|FG000|NOT COMPLETED|Overall Study||0
8973216|NCT02633488|10037351|FG001|NOT COMPLETED|Overall Study||0
8973217|NCT02633501|10037363|FG000|STARTED|Overall Study||14
8973218|NCT02633501|10037364|FG001|STARTED|Overall Study||14
8973219|NCT02633501|10037365|FG002|STARTED|Overall Study||62
8973220|NCT02633501|10037366|FG003|STARTED|Overall Study||63
8973221|NCT02633501|10037367|FG004|STARTED|Overall Study||64
8973222|NCT02633501|10037368|FG005|STARTED|Overall Study||63
8973223|NCT02633501|10037363|FG000|COMPLETED|Overall Study||12
8973224|NCT02633501|10037364|FG001|COMPLETED|Overall Study||11
8973225|NCT02633501|10037365|FG002|COMPLETED|Overall Study||55
8973226|NCT02633501|10037366|FG003|COMPLETED|Overall Study||59
8973227|NCT02633501|10037367|FG004|COMPLETED|Overall Study||53
8973228|NCT02633501|10037368|FG005|COMPLETED|Overall Study||48
8973229|NCT02633501|10037363|FG000|NOT COMPLETED|Overall Study||2
8973230|NCT02633501|10037364|FG001|NOT COMPLETED|Overall Study||3
8973231|NCT02633501|10037365|FG002|NOT COMPLETED|Overall Study||7
8973232|NCT02633501|10037366|FG003|NOT COMPLETED|Overall Study||4
8973233|NCT02633501|10037367|FG004|NOT COMPLETED|Overall Study||11
8973234|NCT02633501|10037368|FG005|NOT COMPLETED|Overall Study||15
8973235|NCT02633527|10037392|FG000|STARTED|Overall Study||24
8973236|NCT02633527|10037393|FG001|STARTED|Overall Study||48
8973237|NCT02633527|10037394|FG002|STARTED|Overall Study||50
8973238|NCT02633527|10037395|FG003|STARTED|Overall Study||49
8973239|NCT02633527|10037396|FG004|STARTED|Overall Study||51
8973240|NCT02633527|10037392|FG000|COMPLETED|Overall Study||21
8973241|NCT02633527|10037393|FG001|COMPLETED|Overall Study||37
8973242|NCT02633527|10037394|FG002|COMPLETED|Overall Study||33
8973243|NCT02633527|10037395|FG003|COMPLETED|Overall Study||35
8973244|NCT02633527|10037396|FG004|COMPLETED|Overall Study||34
8973245|NCT02633527|10037392|FG000|NOT COMPLETED|Overall Study||3
8973246|NCT02633527|10037393|FG001|NOT COMPLETED|Overall Study||11
8973247|NCT02633527|10037394|FG002|NOT COMPLETED|Overall Study||17
8973248|NCT02633527|10037395|FG003|NOT COMPLETED|Overall Study||14
8973249|NCT02633527|10037396|FG004|NOT COMPLETED|Overall Study||17
8973250|NCT02633735|10037410|FG000|STARTED|Pre-implementation Phase||788
8973251|NCT02633735|10037411|FG001|STARTED|Pre-implementation Phase||1011
8973252|NCT02633735|10037410|FG000|COMPLETED|Pre-implementation Phase||788
8973253|NCT02633735|10037411|FG001|COMPLETED|Pre-implementation Phase||1011
8973254|NCT02633735|10037410|FG000|NOT COMPLETED|Pre-implementation Phase||0
8973255|NCT02633735|10037411|FG001|NOT COMPLETED|Pre-implementation Phase||0
8973256|NCT02633735|10037410|FG000|STARTED|Implementation Phase||1991
8973257|NCT02633735|10037411|FG001|STARTED|Implementation Phase||2150
8973258|NCT02633735|10037410|FG000|COMPLETED|Implementation Phase||1991
8973259|NCT02633735|10037411|FG001|COMPLETED|Implementation Phase||2150
8973260|NCT02633735|10037410|FG000|NOT COMPLETED|Implementation Phase||0
8973261|NCT02633735|10037411|FG001|NOT COMPLETED|Implementation Phase||0
8973262|NCT02633787|10037417|FG000|STARTED|Overall Study||110
8973263|NCT02633787|10037417|FG000|COMPLETED|Overall Study||109
8973264|NCT02633787|10037417|FG000|NOT COMPLETED|Overall Study||1
8973265|NCT02633800|10037423|FG000|STARTED|Overall Study||44
8973266|NCT02633800|10037424|FG001|STARTED|Overall Study||43
8973267|NCT02633800|10037423|FG000|COMPLETED|Overall Study||0
8973268|NCT02633800|10037424|FG001|COMPLETED|Overall Study||0
8973269|NCT02633800|10037423|FG000|NOT COMPLETED|Overall Study||44
8973270|NCT02633800|10037424|FG001|NOT COMPLETED|Overall Study||43
8973271|NCT02633956|10037434|FG000|STARTED|Overall Study||20
8973272|NCT02633956|10037435|FG001|STARTED|Overall Study||21
8973273|NCT02633956|10037436|FG002|STARTED|Overall Study||22
8973274|NCT02633956|10037437|FG003|STARTED|Overall Study||21
8973275|NCT02633956|10037434|FG000|COMPLETED|Overall Study||19
8973276|NCT02633956|10037435|FG001|COMPLETED|Overall Study||19
8973277|NCT02633956|10037436|FG002|COMPLETED|Overall Study||20
8973278|NCT02633956|10037437|FG003|COMPLETED|Overall Study||21
8973279|NCT02633956|10037434|FG000|NOT COMPLETED|Overall Study||1
8973280|NCT02633956|10037435|FG001|NOT COMPLETED|Overall Study||2
8973281|NCT02633956|10037436|FG002|NOT COMPLETED|Overall Study||2
8973282|NCT02633956|10037437|FG003|NOT COMPLETED|Overall Study||0
8973283|NCT02634073|10037451|FG000|STARTED|Overall Study||4
8973284|NCT02634073|10037452|FG001|STARTED|Overall Study||4
8973285|NCT02634073|10037453|FG002|STARTED|Overall Study||4
8973286|NCT02634073|10037454|FG003|STARTED|Overall Study||4
8973287|NCT02634073|10037451|FG000|COMPLETED|Overall Study||4
8973288|NCT02634073|10037452|FG001|COMPLETED|Overall Study||4
8973289|NCT02634073|10037453|FG002|COMPLETED|Overall Study||4
8973290|NCT02634073|10037454|FG003|COMPLETED|Overall Study||4
8973291|NCT02634073|10037451|FG000|NOT COMPLETED|Overall Study||0
8973292|NCT02634073|10037452|FG001|NOT COMPLETED|Overall Study||0
8973293|NCT02634073|10037453|FG002|NOT COMPLETED|Overall Study||0
8973294|NCT02634073|10037454|FG003|NOT COMPLETED|Overall Study||0
8632100|NCT00543387|9671960|FG005|COMPLETED|Crossover Participants||0
8632101|NCT00543387|9671961|FG006|COMPLETED|Crossover Participants||0
8973295|NCT02634151|10037466|FG000|STARTED|Overall Study||53
8973296|NCT02634151|10037467|FG001|STARTED|Overall Study||52
8973297|NCT02634151|10037466|FG000|Full Analysis Set|Overall Study||53
8973298|NCT02634151|10037467|FG001|Full Analysis Set|Overall Study||52
8973299|NCT02634151|10037466|FG000|Safety Set|Overall Study||54
8973300|NCT02634151|10037467|FG001|Safety Set|Overall Study||51
8973301|NCT02634151|10037466|FG000|COMPLETED|Overall Study||52
8973302|NCT02634151|10037467|FG001|COMPLETED|Overall Study||50
8973303|NCT02634151|10037466|FG000|NOT COMPLETED|Overall Study||1
8973304|NCT02634151|10037467|FG001|NOT COMPLETED|Overall Study||2
8973305|NCT02634177|10037475|FG000|STARTED|Overall Study||151
8973306|NCT02634177|10037476|FG001|STARTED|Overall Study||153
8973307|NCT02634177|10037475|FG000|COMPLETED|Overall Study||140
8973308|NCT02634177|10037476|FG001|COMPLETED|Overall Study||141
8973309|NCT02634177|10037475|FG000|NOT COMPLETED|Overall Study||11
8973310|NCT02634177|10037476|FG001|NOT COMPLETED|Overall Study||12
8973311|NCT02634320|10037482|FG000|STARTED|Overall Study||51
8973312|NCT02634320|10037482|FG000|COMPLETED|Overall Study||35
8973313|NCT02634320|10037482|FG000|NOT COMPLETED|Overall Study||16
8973314|NCT02634333|10037488|FG000|STARTED|Overall Study|Number of Eyes|200
8973315|NCT02634333|10037489|FG001|STARTED|Overall Study|Number of Eyes|199
8973316|NCT02634333|10037488|FG000|COMPLETED|Overall Study|Number of Eyes|160
8632102|NCT00543387|9671962|FG007|COMPLETED|Crossover Participants||0
8632103|NCT00543387|9671963|FG008|COMPLETED|Crossover Participants||0
8632104|NCT00543387|9671964|FG009|COMPLETED|Crossover Participants||0
8632105|NCT00543387|9671965|FG010|COMPLETED|Crossover Participants||0
8632106|NCT00543387|9671955|FG000|NOT COMPLETED|Crossover Participants||0
8632107|NCT00543387|9671956|FG001|NOT COMPLETED|Crossover Participants||0
8973317|NCT02634333|10037489|FG001|COMPLETED|Overall Study|Number of Eyes|167
8973318|NCT02634333|10037488|FG000|NOT COMPLETED|Overall Study||40
8973319|NCT02634333|10037489|FG001|NOT COMPLETED|Overall Study||32
8973320|NCT02634346|10037499|FG000|STARTED|Overall Study||134
8973321|NCT02634346|10037500|FG001|STARTED|Overall Study||133
8973322|NCT02634346|10037501|FG002|STARTED|Overall Study||134
8973323|NCT02634346|10037499|FG000|COMPLETED|Overall Study||122
8973324|NCT02634346|10037500|FG001|COMPLETED|Overall Study||119
8632108|NCT00543387|9671957|FG002|NOT COMPLETED|Crossover Participants||0
8632109|NCT00543387|9671958|FG003|NOT COMPLETED|Crossover Participants||0
8632110|NCT00543387|9671959|FG004|NOT COMPLETED|Crossover Participants||0
8632111|NCT00543387|9671960|FG005|NOT COMPLETED|Crossover Participants||0
8632112|NCT00543387|9671961|FG006|NOT COMPLETED|Crossover Participants||0
8973325|NCT02634346|10037501|FG002|COMPLETED|Overall Study||111
8973326|NCT02634346|10037499|FG000|NOT COMPLETED|Overall Study||12
8973327|NCT02634346|10037500|FG001|NOT COMPLETED|Overall Study||14
8973328|NCT02634346|10037501|FG002|NOT COMPLETED|Overall Study||23
8973329|NCT02634580|10037513|FG000|STARTED|Double-blind Treatment Period||10
8973330|NCT02634580|10037514|FG001|STARTED|Double-blind Treatment Period||11
8973331|NCT02634580|10037515|FG002|STARTED|Double-blind Treatment Period||19
8973332|NCT02634580|10037516|FG003|STARTED|Double-blind Treatment Period||21
8973333|NCT02634580|10037513|FG000|COMPLETED|Double-blind Treatment Period||9
8973334|NCT02634580|10037514|FG001|COMPLETED|Double-blind Treatment Period||11
8973335|NCT02634580|10037515|FG002|COMPLETED|Double-blind Treatment Period||18
8973336|NCT02634580|10037516|FG003|COMPLETED|Double-blind Treatment Period||20
8973337|NCT02634580|10037513|FG000|NOT COMPLETED|Double-blind Treatment Period||1
8973338|NCT02634580|10037514|FG001|NOT COMPLETED|Double-blind Treatment Period||0
8973339|NCT02634580|10037515|FG002|NOT COMPLETED|Double-blind Treatment Period||1
8973340|NCT02634580|10037516|FG003|NOT COMPLETED|Double-blind Treatment Period||1
8973341|NCT02634580|10037513|FG000|STARTED|Open-label Extension Period||9
8973342|NCT02634580|10037514|FG001|STARTED|Open-label Extension Period||11
8973343|NCT02634580|10037515|FG002|STARTED|Open-label Extension Period||18
8973344|NCT02634580|10037516|FG003|STARTED|Open-label Extension Period|Includes 1 participant who did not complete the double-blind period but had study visits during OLE|21
8973345|NCT02634580|10037513|FG000|Received Open-label Treatment|Open-label Extension Period||9
8973346|NCT02634580|10037514|FG001|Received Open-label Treatment|Open-label Extension Period||11
8973347|NCT02634580|10037515|FG002|Received Open-label Treatment|Open-label Extension Period||18
8973348|NCT02634580|10037516|FG003|Received Open-label Treatment|Open-label Extension Period||20
8973349|NCT02634580|10037513|FG000|COMPLETED|Open-label Extension Period||9
8973350|NCT02634580|10037514|FG001|COMPLETED|Open-label Extension Period||10
8973351|NCT02634580|10037515|FG002|COMPLETED|Open-label Extension Period||18
8973352|NCT02634580|10037516|FG003|COMPLETED|Open-label Extension Period||20
8973353|NCT02634580|10037513|FG000|NOT COMPLETED|Open-label Extension Period||0
8973354|NCT02634580|10037514|FG001|NOT COMPLETED|Open-label Extension Period||1
8973355|NCT02634580|10037515|FG002|NOT COMPLETED|Open-label Extension Period||0
8973356|NCT02634580|10037516|FG003|NOT COMPLETED|Open-label Extension Period||1
8973357|NCT02634684|10037529|FG000|STARTED|Overall Study||19
8973358|NCT02634684|10037530|FG001|STARTED|Overall Study||19
8973359|NCT02634684|10037531|FG002|STARTED|Overall Study||21
8973360|NCT02634684|10037532|FG003|STARTED|Overall Study||23
8973361|NCT02634684|10037529|FG000|COMPLETED|Overall Study||19
8973362|NCT02634684|10037530|FG001|COMPLETED|Overall Study||19
8973363|NCT02634684|10037531|FG002|COMPLETED|Overall Study||21
8973364|NCT02634684|10037532|FG003|COMPLETED|Overall Study||23
8973365|NCT02634684|10037529|FG000|NOT COMPLETED|Overall Study||0
8973366|NCT02634684|10037530|FG001|NOT COMPLETED|Overall Study||0
8973367|NCT02634684|10037531|FG002|NOT COMPLETED|Overall Study||0
8973368|NCT02634684|10037532|FG003|NOT COMPLETED|Overall Study||0
8973369|NCT02634788|10037546|FG000|STARTED|Overall Study||79
8973370|NCT02634788|10037547|FG001|STARTED|Overall Study||81
8632113|NCT00543387|9671962|FG007|NOT COMPLETED|Crossover Participants||0
8877037|NCT01920802|9933908|FG001|COMPLETED|Overall Study||7
8877038|NCT01920802|9933909|FG002|COMPLETED|Overall Study||10
8877039|NCT01920802|9933907|FG000|NOT COMPLETED|Overall Study||4
8877040|NCT01920802|9933908|FG001|NOT COMPLETED|Overall Study||2
8877041|NCT01920802|9933909|FG002|NOT COMPLETED|Overall Study||1
8877042|NCT01920854|9933924|FG000|STARTED|Overall Study||12
8877043|NCT01920854|9933925|FG001|STARTED|Overall Study||6
8877044|NCT01920854|9933926|FG002|STARTED|Overall Study||6
8877045|NCT01920854|9933927|FG003|STARTED|Overall Study||6
8877046|NCT01920854|9933928|FG004|STARTED|Overall Study||6
8877047|NCT01920854|9933929|FG005|STARTED|Overall Study||6
8877048|NCT01920854|9933930|FG006|STARTED|Overall Study||6
8877049|NCT01920854|9933924|FG000|COMPLETED|Overall Study||11
8877050|NCT01920854|9933925|FG001|COMPLETED|Overall Study||6
8877051|NCT01920854|9933926|FG002|COMPLETED|Overall Study||6
8877052|NCT01920854|9933927|FG003|COMPLETED|Overall Study||6
8877053|NCT01920854|9933928|FG004|COMPLETED|Overall Study||5
8877054|NCT01920854|9933929|FG005|COMPLETED|Overall Study||6
8877055|NCT01920854|9933930|FG006|COMPLETED|Overall Study||5
8973371|NCT02634788|10037548|FG002|STARTED|Overall Study||80
8973372|NCT02634788|10037549|FG003|STARTED|Overall Study||82
8973373|NCT02634788|10037546|FG000|COMPLETED|Overall Study||75
8973374|NCT02634788|10037547|FG001|COMPLETED|Overall Study||71
8973375|NCT02634788|10037548|FG002|COMPLETED|Overall Study||75
8973376|NCT02634788|10037549|FG003|COMPLETED|Overall Study||77
8973377|NCT02634788|10037546|FG000|NOT COMPLETED|Overall Study||4
8973378|NCT02634788|10037547|FG001|NOT COMPLETED|Overall Study||10
8973379|NCT02634788|10037548|FG002|NOT COMPLETED|Overall Study||5
8973380|NCT02634788|10037549|FG003|NOT COMPLETED|Overall Study||5
8973381|NCT02634801|10037562|FG000|STARTED|Treatment Period (Weeks 0 to 24)||54
8973382|NCT02634801|10037563|FG001|STARTED|Treatment Period (Weeks 0 to 24)||54
8973383|NCT02634801|10037564|FG002|STARTED|Treatment Period (Weeks 0 to 24)||54
8973384|NCT02634801|10037562|FG000|Received at Least 1 Dose of Study Drug|Treatment Period (Weeks 0 to 24)||54
8973385|NCT02634801|10037563|FG001|Received at Least 1 Dose of Study Drug|Treatment Period (Weeks 0 to 24)||52
8973386|NCT02634801|10037564|FG002|Received at Least 1 Dose of Study Drug|Treatment Period (Weeks 0 to 24)||52
8973387|NCT02634801|10037562|FG000|COMPLETED|Treatment Period (Weeks 0 to 24)||50
8973388|NCT02634801|10037563|FG001|COMPLETED|Treatment Period (Weeks 0 to 24)||23
8973389|NCT02634801|10037564|FG002|COMPLETED|Treatment Period (Weeks 0 to 24)||49
8973390|NCT02634801|10037562|FG000|NOT COMPLETED|Treatment Period (Weeks 0 to 24)||4
8973391|NCT02634801|10037563|FG001|NOT COMPLETED|Treatment Period (Weeks 0 to 24)||31
8973392|NCT02634801|10037564|FG002|NOT COMPLETED|Treatment Period (Weeks 0 to 24)||5
8973393|NCT02634801|10037562|FG000|STARTED|Extension Period (Weeks 24 to 36)|Participants had the option to enter the Extension Period or proceed directly to the Followup Period|48
8973394|NCT02634801|10037563|FG001|STARTED|Extension Period (Weeks 24 to 36)|Participants had the option to enter the Extension Period or proceed directly to the Followup Period|19
8973395|NCT02634801|10037564|FG002|STARTED|Extension Period (Weeks 24 to 36)|Participants had the option to enter the Extension Period or proceed directly to the Followup Period|31
8973396|NCT02634801|10037562|FG000|COMPLETED|Extension Period (Weeks 24 to 36)||45
8973397|NCT02634801|10037563|FG001|COMPLETED|Extension Period (Weeks 24 to 36)||18
8973398|NCT02634801|10037564|FG002|COMPLETED|Extension Period (Weeks 24 to 36)||29
8973399|NCT02634801|10037562|FG000|NOT COMPLETED|Extension Period (Weeks 24 to 36)||3
8973400|NCT02634801|10037563|FG001|NOT COMPLETED|Extension Period (Weeks 24 to 36)||1
8973401|NCT02634801|10037564|FG002|NOT COMPLETED|Extension Period (Weeks 24 to 36)||2
8973402|NCT02634801|10037562|FG000|STARTED|Follow-up Period|Participants who discontinued previous periods had option to enter post treatment follow-up period.|41
8973403|NCT02634801|10037563|FG001|STARTED|Follow-up Period|Participants who discontinued previous periods had option to enter post treatment follow-up period.|26
8973404|NCT02634801|10037564|FG002|STARTED|Follow-up Period|Participants who discontinued previous periods had option to enter post treatment follow-up period.|46
8973405|NCT02634801|10037562|FG000|COMPLETED|Follow-up Period||36
8973406|NCT02634801|10037563|FG001|COMPLETED|Follow-up Period||18
8973407|NCT02634801|10037564|FG002|COMPLETED|Follow-up Period||38
8973408|NCT02634801|10037562|FG000|NOT COMPLETED|Follow-up Period||5
8973409|NCT02634801|10037563|FG001|NOT COMPLETED|Follow-up Period||8
8973410|NCT02634801|10037564|FG002|NOT COMPLETED|Follow-up Period||8
8973411|NCT02634814|10037579|FG000|STARTED|Overall Study||32
8973412|NCT02634814|10037580|FG001|STARTED|Overall Study||29
8973413|NCT02634814|10037581|FG002|STARTED|Overall Study||29
8973414|NCT02634814|10037579|FG000|COMPLETED|Overall Study||30
8973415|NCT02634814|10037580|FG001|COMPLETED|Overall Study||23
8973416|NCT02634814|10037581|FG002|COMPLETED|Overall Study||29
8973417|NCT02634814|10037579|FG000|NOT COMPLETED|Overall Study||2
8973418|NCT02634814|10037580|FG001|NOT COMPLETED|Overall Study||6
8973419|NCT02634814|10037581|FG002|NOT COMPLETED|Overall Study||0
8973420|NCT02634983|10037589|FG000|STARTED|Period One (First Treatment, 8-10 Days)||16
8973421|NCT02634983|10037590|FG001|STARTED|Period One (First Treatment, 8-10 Days)||15
8973422|NCT02634983|10037589|FG000|COMPLETED|Period One (First Treatment, 8-10 Days)||16
8973423|NCT02634983|10037590|FG001|COMPLETED|Period One (First Treatment, 8-10 Days)||15
8973424|NCT02634983|10037589|FG000|NOT COMPLETED|Period One (First Treatment, 8-10 Days)||0
8973425|NCT02634983|10037590|FG001|NOT COMPLETED|Period One (First Treatment, 8-10 Days)||0
8973426|NCT02634983|10037589|FG000|STARTED|Washout (Approximately 7-14 Days)||16
8973427|NCT02634983|10037590|FG001|STARTED|Washout (Approximately 7-14 Days)||15
8973428|NCT02634983|10037589|FG000|COMPLETED|Washout (Approximately 7-14 Days)||16
8973429|NCT02634983|10037590|FG001|COMPLETED|Washout (Approximately 7-14 Days)||15
8973430|NCT02634983|10037589|FG000|NOT COMPLETED|Washout (Approximately 7-14 Days)||0
8973431|NCT02634983|10037590|FG001|NOT COMPLETED|Washout (Approximately 7-14 Days)||0
8973432|NCT02634983|10037589|FG000|STARTED|Period 2 (Second Treatment, 8-10 Days)||16
8973433|NCT02634983|10037590|FG001|STARTED|Period 2 (Second Treatment, 8-10 Days)||15
8973434|NCT02634983|10037589|FG000|COMPLETED|Period 2 (Second Treatment, 8-10 Days)||14
8973435|NCT02634983|10037590|FG001|COMPLETED|Period 2 (Second Treatment, 8-10 Days)||15
8973436|NCT02634983|10037589|FG000|NOT COMPLETED|Period 2 (Second Treatment, 8-10 Days)||2
8973437|NCT02634983|10037590|FG001|NOT COMPLETED|Period 2 (Second Treatment, 8-10 Days)||0
8973438|NCT02635035|10037598|FG000|STARTED|Overall Study||17
8973439|NCT02635035|10037599|FG001|STARTED|Overall Study||21
8973440|NCT02635035|10037598|FG000|COMPLETED|Overall Study||17
8973441|NCT02635035|10037599|FG001|COMPLETED|Overall Study||21
8973442|NCT02635035|10037598|FG000|NOT COMPLETED|Overall Study||0
8973443|NCT02635035|10037599|FG001|NOT COMPLETED|Overall Study||0
8973444|NCT02635204|10037607|FG000|STARTED|Overall Study||178
8973445|NCT02635204|10037608|FG001|STARTED|Overall Study||89
8973446|NCT02635204|10037607|FG000|COMPLETED|Overall Study||176
8973447|NCT02635204|10037608|FG001|COMPLETED|Overall Study||88
8973448|NCT02635204|10037607|FG000|NOT COMPLETED|Overall Study||2
8973449|NCT02635204|10037608|FG001|NOT COMPLETED|Overall Study||1
8973450|NCT02635347|10037616|FG000|STARTED|Overall Study||51
8973451|NCT02635347|10037617|FG001|STARTED|Overall Study||70
8973452|NCT02635347|10037616|FG000|Screening|Overall Study||51
8973453|NCT02635347|10037617|FG001|Screening|Overall Study||70
8973454|NCT02635347|10037616|FG000|Enrollment|Overall Study||31
8973455|NCT02635347|10037617|FG001|Enrollment|Overall Study||63
8973456|NCT02635347|10037616|FG000|Protocol Completion|Overall Study||22
8973457|NCT02635347|10037617|FG001|Protocol Completion|Overall Study||63
8973458|NCT02635347|10037616|FG000|Follow up|Overall Study||31
8973459|NCT02635347|10037617|FG001|Follow up|Overall Study||63
8973460|NCT02635347|10037616|FG000|Analyses|Overall Study||30
8973461|NCT02635347|10037617|FG001|Analyses|Overall Study||63
8973462|NCT02635347|10037616|FG000|COMPLETED|Overall Study||31
8973463|NCT02635347|10037617|FG001|COMPLETED|Overall Study||63
8973464|NCT02635347|10037616|FG000|NOT COMPLETED|Overall Study||20
8973465|NCT02635347|10037617|FG001|NOT COMPLETED|Overall Study||7
8973466|NCT02635386|10037629|FG000|STARTED|Overall Study||23
8973467|NCT02635386|10037630|FG001|STARTED|Overall Study||23
8973468|NCT02635386|10037631|FG002|STARTED|Overall Study||22
8973469|NCT02635386|10037632|FG003|STARTED|Overall Study||26
8973470|NCT02635386|10037633|FG004|STARTED|Overall Study||25
8973471|NCT02635386|10037629|FG000|COMPLETED|Overall Study||20
8973472|NCT02635386|10037630|FG001|COMPLETED|Overall Study||17
8973473|NCT02635386|10037631|FG002|COMPLETED|Overall Study||20
8973474|NCT02635386|10037632|FG003|COMPLETED|Overall Study||19
8973475|NCT02635386|10037633|FG004|COMPLETED|Overall Study||16
8973476|NCT02635386|10037629|FG000|NOT COMPLETED|Overall Study||3
8973477|NCT02635386|10037630|FG001|NOT COMPLETED|Overall Study||6
8973478|NCT02635386|10037631|FG002|NOT COMPLETED|Overall Study||2
8973479|NCT02635386|10037632|FG003|NOT COMPLETED|Overall Study||7
8973480|NCT02635386|10037633|FG004|NOT COMPLETED|Overall Study||9
8973481|NCT02635425|10037652|FG000|STARTED|Overall Study||15
8973482|NCT02635425|10037653|FG001|STARTED|Overall Study||15
8973483|NCT02635425|10037652|FG000|COMPLETED|Overall Study||15
8973484|NCT02635425|10037653|FG001|COMPLETED|Overall Study||15
8973485|NCT02635425|10037652|FG000|NOT COMPLETED|Overall Study||0
8973486|NCT02635425|10037653|FG001|NOT COMPLETED|Overall Study||0
8973487|NCT02635542|10037661|FG000|STARTED|Overall Study||50
8973488|NCT02635542|10037662|FG001|STARTED|Overall Study||50
8973489|NCT02635542|10037661|FG000|COMPLETED|Overall Study||50
8973490|NCT02635542|10037662|FG001|COMPLETED|Overall Study||50
8973491|NCT02635542|10037661|FG000|NOT COMPLETED|Overall Study||0
8973492|NCT02635542|10037662|FG001|NOT COMPLETED|Overall Study||0
8973493|NCT02635646|10037670|FG000|STARTED|Overall Study||57
8973494|NCT02635646|10037671|FG001|STARTED|Overall Study||65
8973495|NCT02635646|10037670|FG000|COMPLETED|Overall Study||32
8973496|NCT02635646|10037671|FG001|COMPLETED|Overall Study||39
8973497|NCT02635646|10037670|FG000|NOT COMPLETED|Overall Study||25
8973498|NCT02635646|10037671|FG001|NOT COMPLETED|Overall Study||26
8973499|NCT02635724|10037686|FG000|STARTED|Overall Study||41
8973500|NCT02635724|10037687|FG001|STARTED|Overall Study||26
8973501|NCT02635724|10037688|FG002|STARTED|Overall Study||7
8973502|NCT02635724|10037686|FG000|ITT Population|Overall Study||41
8973503|NCT02635724|10037687|FG001|ITT Population|Overall Study||26
8973504|NCT02635724|10037688|FG002|ITT Population|Overall Study||7
8973505|NCT02635724|10037686|FG000|Safety Population|Overall Study||41
8973506|NCT02635724|10037687|FG001|Safety Population|Overall Study||25
8973507|NCT02635724|10037688|FG002|Safety Population|Overall Study||7
8973508|NCT02635724|10037686|FG000|ITTI Population|Overall Study||28
8973509|NCT02635724|10037687|FG001|ITTI Population|Overall Study||19
8973510|NCT02635724|10037688|FG002|ITTI Population|Overall Study||5
8973511|NCT02635724|10037686|FG000|E-R Population|Overall Study||28
8973512|NCT02635724|10037687|FG001|E-R Population|Overall Study||19
8973513|NCT02635724|10037688|FG002|E-R Population|Overall Study||5
8973514|NCT02635724|10037686|FG000|COMPLETED|Overall Study||41
8973515|NCT02635724|10037687|FG001|COMPLETED|Overall Study||25
8973516|NCT02635724|10037688|FG002|COMPLETED|Overall Study||7
8973517|NCT02635724|10037686|FG000|NOT COMPLETED|Overall Study||0
8973518|NCT02635724|10037687|FG001|NOT COMPLETED|Overall Study||1
8973519|NCT02635724|10037688|FG002|NOT COMPLETED|Overall Study||0
8973520|NCT02635737|10037696|FG000|STARTED|Overall Study||29
8973521|NCT02635737|10037696|FG000|COMPLETED|Overall Study||28
8973522|NCT02635737|10037696|FG000|NOT COMPLETED|Overall Study||1
8973523|NCT02635828|10037700|FG000|STARTED|Overall Study||54
8973524|NCT02635828|10037700|FG000|COMPLETED|Overall Study||40
8973525|NCT02635828|10037700|FG000|NOT COMPLETED|Overall Study||14
8973526|NCT02635880|10037704|FG000|STARTED|Overall Study||32
8973527|NCT02635880|10037704|FG000|COMPLETED|Overall Study||32
8973528|NCT02635880|10037704|FG000|NOT COMPLETED|Overall Study||0
8973529|NCT02635984|10037710|FG000|STARTED|Overall Study||53
8973530|NCT02635984|10037711|FG001|STARTED|Overall Study||55
8973531|NCT02635984|10037710|FG000|COMPLETED|Overall Study||50
8973532|NCT02635984|10037711|FG001|COMPLETED|Overall Study||51
8973533|NCT02635984|10037710|FG000|NOT COMPLETED|Overall Study||3
8973534|NCT02635984|10037711|FG001|NOT COMPLETED|Overall Study||4
8973535|NCT02636049|10037717|FG000|STARTED|Overall Study||12
8973536|NCT02636049|10037717|FG000|Triferic 6 mg IV Over 3 Hours|Overall Study||12
8973537|NCT02636049|10037717|FG000|Triferic 35 Micrograms/kg IV Push|Overall Study||12
8973538|NCT02636049|10037717|FG000|COMPLETED|Overall Study||12
8973539|NCT02636049|10037717|FG000|NOT COMPLETED|Overall Study||0
8973540|NCT02636361|10037723|FG000|STARTED|Period 1||5
8973541|NCT02636361|10037724|FG001|STARTED|Period 1||6
8973542|NCT02636361|10037725|FG002|STARTED|Period 1||5
8973543|NCT02636361|10037726|FG003|STARTED|Period 1||5
8973544|NCT02636361|10037727|FG004|STARTED|Period 1||5
8973545|NCT02636361|10037723|FG000|Received at Least One Dose of Study Drug|Period 1||5
8973546|NCT02636361|10037724|FG001|Received at Least One Dose of Study Drug|Period 1||5
8973547|NCT02636361|10037725|FG002|Received at Least One Dose of Study Drug|Period 1||5
8973548|NCT02636361|10037726|FG003|Received at Least One Dose of Study Drug|Period 1||5
8973549|NCT02636361|10037727|FG004|Received at Least One Dose of Study Drug|Period 1||4
8973550|NCT02636361|10037723|FG000|COMPLETED|Period 1||5
8973551|NCT02636361|10037724|FG001|COMPLETED|Period 1||5
8973552|NCT02636361|10037725|FG002|COMPLETED|Period 1||5
8973553|NCT02636361|10037726|FG003|COMPLETED|Period 1||5
8973554|NCT02636361|10037727|FG004|COMPLETED|Period 1||4
8973555|NCT02636361|10037723|FG000|NOT COMPLETED|Period 1||0
8973556|NCT02636361|10037724|FG001|NOT COMPLETED|Period 1||1
8973557|NCT02636361|10037725|FG002|NOT COMPLETED|Period 1||0
8973558|NCT02636361|10037726|FG003|NOT COMPLETED|Period 1||0
8973559|NCT02636361|10037727|FG004|NOT COMPLETED|Period 1||1
8973560|NCT02636361|10037723|FG000|STARTED|Period 2||5
8973561|NCT02636361|10037724|FG001|STARTED|Period 2||5
8973562|NCT02636361|10037725|FG002|STARTED|Period 2||5
8973563|NCT02636361|10037726|FG003|STARTED|Period 2||5
8973564|NCT02636361|10037727|FG004|STARTED|Period 2||4
8973565|NCT02636361|10037723|FG000|COMPLETED|Period 2||5
8973566|NCT02636361|10037724|FG001|COMPLETED|Period 2||5
8973567|NCT02636361|10037725|FG002|COMPLETED|Period 2||5
8973568|NCT02636361|10037726|FG003|COMPLETED|Period 2||5
8973569|NCT02636361|10037727|FG004|COMPLETED|Period 2||4
8973570|NCT02636361|10037723|FG000|NOT COMPLETED|Period 2||0
8973571|NCT02636361|10037724|FG001|NOT COMPLETED|Period 2||0
8973572|NCT02636361|10037725|FG002|NOT COMPLETED|Period 2||0
8973573|NCT02636361|10037726|FG003|NOT COMPLETED|Period 2||0
8973574|NCT02636361|10037727|FG004|NOT COMPLETED|Period 2||0
8973575|NCT02636361|10037723|FG000|STARTED|Period 3||5
8973576|NCT02636361|10037724|FG001|STARTED|Period 3||5
8973577|NCT02636361|10037725|FG002|STARTED|Period 3||5
8973578|NCT02636361|10037726|FG003|STARTED|Period 3||5
8973579|NCT02636361|10037727|FG004|STARTED|Period 3||4
8973580|NCT02636361|10037723|FG000|COMPLETED|Period 3||5
8973581|NCT02636361|10037724|FG001|COMPLETED|Period 3||5
8973582|NCT02636361|10037725|FG002|COMPLETED|Period 3||5
8973583|NCT02636361|10037726|FG003|COMPLETED|Period 3||5
8973584|NCT02636361|10037727|FG004|COMPLETED|Period 3||4
8973585|NCT02636361|10037723|FG000|NOT COMPLETED|Period 3||0
8973586|NCT02636361|10037724|FG001|NOT COMPLETED|Period 3||0
8973587|NCT02636361|10037725|FG002|NOT COMPLETED|Period 3||0
8973588|NCT02636361|10037726|FG003|NOT COMPLETED|Period 3||0
8973589|NCT02636361|10037727|FG004|NOT COMPLETED|Period 3||0
8973590|NCT02636361|10037723|FG000|STARTED|Period 4||5
8973591|NCT02636361|10037724|FG001|STARTED|Period 4||5
8973592|NCT02636361|10037725|FG002|STARTED|Period 4||5
8973593|NCT02636361|10037726|FG003|STARTED|Period 4||5
8973594|NCT02636361|10037727|FG004|STARTED|Period 4||4
8973595|NCT02636361|10037723|FG000|COMPLETED|Period 4||5
8973596|NCT02636361|10037724|FG001|COMPLETED|Period 4||5
8973597|NCT02636361|10037725|FG002|COMPLETED|Period 4||5
8973598|NCT02636361|10037726|FG003|COMPLETED|Period 4||4
8973599|NCT02636361|10037727|FG004|COMPLETED|Period 4||4
8973600|NCT02636361|10037723|FG000|NOT COMPLETED|Period 4||0
8973601|NCT02636361|10037724|FG001|NOT COMPLETED|Period 4||0
8973602|NCT02636361|10037725|FG002|NOT COMPLETED|Period 4||0
8973603|NCT02636361|10037726|FG003|NOT COMPLETED|Period 4||1
8973604|NCT02636361|10037727|FG004|NOT COMPLETED|Period 4||0
8973605|NCT02636361|10037723|FG000|STARTED|Period 5||5
8973606|NCT02636361|10037724|FG001|STARTED|Period 5||5
8973607|NCT02636361|10037725|FG002|STARTED|Period 5||5
8973608|NCT02636361|10037726|FG003|STARTED|Period 5||4
8973609|NCT02636361|10037727|FG004|STARTED|Period 5||4
8973610|NCT02636361|10037723|FG000|COMPLETED|Period 5||5
8973611|NCT02636361|10037724|FG001|COMPLETED|Period 5||5
8973612|NCT02636361|10037725|FG002|COMPLETED|Period 5||5
8973613|NCT02636361|10037726|FG003|COMPLETED|Period 5||4
8973614|NCT02636361|10037727|FG004|COMPLETED|Period 5||4
8973615|NCT02636361|10037723|FG000|NOT COMPLETED|Period 5||0
8973616|NCT02636361|10037724|FG001|NOT COMPLETED|Period 5||0
8973617|NCT02636361|10037725|FG002|NOT COMPLETED|Period 5||0
8973618|NCT02636361|10037726|FG003|NOT COMPLETED|Period 5||0
8973619|NCT02636361|10037727|FG004|NOT COMPLETED|Period 5||0
8973620|NCT02636595|10037741|FG000|STARTED|Overall Study||121
8973621|NCT02636595|10037741|FG000|COMPLETED|Overall Study||119
8973622|NCT02636595|10037741|FG000|NOT COMPLETED|Overall Study||2
8973623|NCT02636608|10037745|FG000|STARTED|Overall Study||244
8973624|NCT02636608|10037745|FG000|Received Treatment|Overall Study||243
8973625|NCT02636608|10037745|FG000|COMPLETED|Overall Study||233
8973626|NCT02636608|10037745|FG000|NOT COMPLETED|Overall Study||11
9038371|NCT03330275|10099573|FG009|COMPLETED|Visits 2, 3 and 4 - Period 3||4
9038372|NCT03330275|10099564|FG000|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
9038373|NCT03330275|10099565|FG001|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
9038374|NCT03330275|10099566|FG002|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
9038375|NCT03330275|10099567|FG003|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
9038376|NCT03330275|10099568|FG004|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
9038377|NCT03330275|10099569|FG005|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
9038378|NCT03330275|10099570|FG006|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
9038379|NCT03330275|10099571|FG007|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
9038380|NCT03330275|10099572|FG008|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
9038381|NCT03330275|10099573|FG009|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
9038382|NCT03330288|10099583|FG000|STARTED|Overall Study|Enrolled|824
9038383|NCT03330288|10099584|FG001|STARTED|Overall Study|Enrolled|278
9038384|NCT03330288|10099583|FG000|COMPLETED|Overall Study||794
9038385|NCT03330288|10099584|FG001|COMPLETED|Overall Study||270
9038386|NCT03330288|10099583|FG000|NOT COMPLETED|Overall Study||30
9038387|NCT03330288|10099584|FG001|NOT COMPLETED|Overall Study||8
9038388|NCT03330457|10099594|FG000|STARTED|Overall Study||6
9038389|NCT03330457|10099595|FG001|STARTED|Overall Study||3
9038390|NCT03330457|10099596|FG002|STARTED|Overall Study||6
9038391|NCT03330457|10099597|FG003|STARTED|Overall Study||3
9038392|NCT03330457|10099594|FG000|COMPLETED|Overall Study||6
9038393|NCT03330457|10099595|FG001|COMPLETED|Overall Study||3
9038394|NCT03330457|10099596|FG002|COMPLETED|Overall Study||6
9038395|NCT03330457|10099597|FG003|COMPLETED|Overall Study||3
9038396|NCT03330457|10099594|FG000|NOT COMPLETED|Overall Study||0
9038397|NCT03330457|10099595|FG001|NOT COMPLETED|Overall Study||0
9038398|NCT03330457|10099596|FG002|NOT COMPLETED|Overall Study||0
9038399|NCT03330457|10099597|FG003|NOT COMPLETED|Overall Study||0
9038400|NCT03330834|10099607|FG000|STARTED|Overall Study||1
9038401|NCT03330834|10099607|FG000|COMPLETED|Overall Study||1
9038402|NCT03330834|10099607|FG000|NOT COMPLETED|Overall Study||0
9038403|NCT03331042|10099615|FG000|STARTED|Overall Study||22
9038404|NCT03331042|10099616|FG001|STARTED|Overall Study||21
9038405|NCT03331042|10099617|FG002|STARTED|Overall Study||21
9038406|NCT03331042|10099618|FG003|STARTED|Overall Study||21
9038407|NCT03331042|10099615|FG000|COMPLETED|Overall Study||21
9038408|NCT03331042|10099616|FG001|COMPLETED|Overall Study||21
9038409|NCT03331042|10099617|FG002|COMPLETED|Overall Study||20
9038410|NCT03331042|10099618|FG003|COMPLETED|Overall Study||20
9038411|NCT03331042|10099615|FG000|NOT COMPLETED|Overall Study||1
9038412|NCT03331042|10099616|FG001|NOT COMPLETED|Overall Study||0
9038413|NCT03331042|10099617|FG002|NOT COMPLETED|Overall Study||1
9038414|NCT03331042|10099618|FG003|NOT COMPLETED|Overall Study||1
9038415|NCT03331185|10099636|FG000|STARTED|Overall Study||14
9038416|NCT03331185|10099637|FG001|STARTED|Overall Study||12
9038417|NCT03331185|10099636|FG000|COMPLETED|Overall Study||14
9038418|NCT03331185|10099637|FG001|COMPLETED|Overall Study||12
9038419|NCT03331185|10099636|FG000|NOT COMPLETED|Overall Study||0
9038420|NCT03331185|10099637|FG001|NOT COMPLETED|Overall Study||0
9038421|NCT03331315|10099645|FG000|STARTED|Overall Study||88
8632114|NCT00543387|9671963|FG008|NOT COMPLETED|Crossover Participants||0
8632115|NCT00543387|9671964|FG009|NOT COMPLETED|Crossover Participants||1
8632116|NCT00543387|9671965|FG010|NOT COMPLETED|Crossover Participants||3
8632117|NCT00543400|9671993|FG000|STARTED|Overall Study||151
8632118|NCT00543400|9671994|FG001|STARTED|Overall Study||44
9038422|NCT03331315|10099646|FG001|STARTED|Overall Study||82
9038423|NCT03331315|10099645|FG000|COMPLETED|Overall Study||70
9038424|NCT03331315|10099646|FG001|COMPLETED|Overall Study||68
9038425|NCT03331315|10099645|FG000|NOT COMPLETED|Overall Study||18
9038426|NCT03331315|10099646|FG001|NOT COMPLETED|Overall Study||14
9038427|NCT03331666|10099656|FG000|STARTED|Overall Study||2
9038428|NCT03331666|10099657|FG001|STARTED|Overall Study||2
9038429|NCT03331666|10099656|FG000|COMPLETED|Overall Study||0
9038430|NCT03331666|10099657|FG001|COMPLETED|Overall Study||0
9038431|NCT03331666|10099656|FG000|NOT COMPLETED|Overall Study||2
9038432|NCT03331666|10099657|FG001|NOT COMPLETED|Overall Study||2
9038433|NCT03331835|10099665|FG000|STARTED|Overall Study||105
9038434|NCT03331835|10099666|FG001|STARTED|Overall Study||105
9038435|NCT03331835|10099665|FG000|COMPLETED|Overall Study||91
9038436|NCT03331835|10099666|FG001|COMPLETED|Overall Study||58
9038437|NCT03331835|10099665|FG000|NOT COMPLETED|Overall Study||14
9038438|NCT03331835|10099666|FG001|NOT COMPLETED|Overall Study||47
8973627|NCT02636699|10037754|FG000|STARTED|Overall Study||238
8973628|NCT02636699|10037755|FG001|STARTED|Overall Study||118
8973629|NCT02636699|10037754|FG000|COMPLETED|Overall Study||213
8973630|NCT02636699|10037755|FG001|COMPLETED|Overall Study||107
8973631|NCT02636699|10037754|FG000|NOT COMPLETED|Overall Study||25
8973632|NCT02636699|10037755|FG001|NOT COMPLETED|Overall Study||11
8973633|NCT02636712|10037761|FG000|STARTED|Overall Study||10
8973634|NCT02636712|10037761|FG000|COMPLETED|Overall Study||10
8973635|NCT02636712|10037761|FG000|NOT COMPLETED|Overall Study||0
8973636|NCT02636725|10037766|FG000|STARTED|Baseline||33
8973637|NCT02636725|10037766|FG000|COMPLETED|Baseline||30
8973638|NCT02636725|10037766|FG000|NOT COMPLETED|Baseline||3
8973639|NCT02636725|10037766|FG000|STARTED|Post-Baseline Imaging Assessment||30
8973640|NCT02636725|10037766|FG000|COMPLETED|Post-Baseline Imaging Assessment||30
8973641|NCT02636725|10037766|FG000|NOT COMPLETED|Post-Baseline Imaging Assessment||0
8973642|NCT02636868|10037773|FG000|STARTED|Overall Study||73
8973643|NCT02636868|10037774|FG001|STARTED|Overall Study||76
8973644|NCT02636868|10037775|FG002|STARTED|Overall Study||72
8973645|NCT02636868|10037773|FG000|COMPLETED|Overall Study||73
8973646|NCT02636868|10037774|FG001|COMPLETED|Overall Study||75
8973647|NCT02636868|10037775|FG002|COMPLETED|Overall Study||70
8973648|NCT02636868|10037773|FG000|NOT COMPLETED|Overall Study||0
8973649|NCT02636868|10037774|FG001|NOT COMPLETED|Overall Study||1
8973650|NCT02636868|10037775|FG002|NOT COMPLETED|Overall Study||2
8973651|NCT02636907|10037783|FG000|STARTED|Autoinjector Assessment Period|Assigned to treatment.|77
8973652|NCT02636907|10037783|FG000|COMPLETED|Autoinjector Assessment Period|Completed autoinjector assessment period (Day 50).|73
8973653|NCT02636907|10037783|FG000|NOT COMPLETED|Autoinjector Assessment Period||4
8973654|NCT02636907|10037783|FG000|STARTED|Extension Phase||72
8973655|NCT02636907|10037783|FG000|COMPLETED|Extension Phase||62
8632119|NCT00543400|9671995|FG002|STARTED|Overall Study||152
8632120|NCT00543400|9671996|FG003|STARTED|Overall Study||156
8632121|NCT00543400|9671993|FG000|COMPLETED|Overall Study||146
8632122|NCT00543400|9671994|FG001|COMPLETED|Overall Study||43
8632123|NCT00543400|9671995|FG002|COMPLETED|Overall Study||148
8973656|NCT02636907|10037783|FG000|NOT COMPLETED|Extension Phase||10
8973657|NCT02637037|10037789|FG000|STARTED|Overall Study||40
8973658|NCT02637037|10037790|FG001|STARTED|Overall Study||40
8973659|NCT02637037|10037789|FG000|COMPLETED|Overall Study||36
8973660|NCT02637037|10037790|FG001|COMPLETED|Overall Study||39
8973661|NCT02637037|10037789|FG000|NOT COMPLETED|Overall Study||4
8973662|NCT02637037|10037790|FG001|NOT COMPLETED|Overall Study||1
8973663|NCT02637063|10037811|FG000|STARTED|Overall Study||67
8973664|NCT02637063|10037812|FG001|STARTED|Overall Study||68
8973665|NCT02637063|10037813|FG002|STARTED|Overall Study||68
8973666|NCT02637063|10037811|FG000|COMPLETED|Overall Study||62
8973667|NCT02637063|10037812|FG001|COMPLETED|Overall Study||64
8973668|NCT02637063|10037813|FG002|COMPLETED|Overall Study||62
8973669|NCT02637063|10037811|FG000|NOT COMPLETED|Overall Study||5
8973670|NCT02637063|10037812|FG001|NOT COMPLETED|Overall Study||4
8973671|NCT02637063|10037813|FG002|NOT COMPLETED|Overall Study||6
8973672|NCT02637076|10037823|FG000|STARTED|Overall Study||2
8973673|NCT02637076|10037824|FG001|STARTED|Overall Study||15
8973674|NCT02637076|10037823|FG000|COMPLETED|Overall Study||1
8973675|NCT02637076|10037824|FG001|COMPLETED|Overall Study||10
8632124|NCT00543400|9671996|FG003|COMPLETED|Overall Study||151
8632125|NCT00543400|9671993|FG000|NOT COMPLETED|Overall Study||5
8973676|NCT02637076|10037823|FG000|NOT COMPLETED|Overall Study||1
8632126|NCT00543400|9671994|FG001|NOT COMPLETED|Overall Study||1
8632127|NCT00543400|9671995|FG002|NOT COMPLETED|Overall Study||4
8632128|NCT00543400|9671996|FG003|NOT COMPLETED|Overall Study||5
8632129|NCT00543439|9672009|FG000|STARTED|Period 1||10
8632130|NCT00543439|9672010|FG001|STARTED|Period 1||29
8973677|NCT02637076|10037824|FG001|NOT COMPLETED|Overall Study||5
8973678|NCT02637141|10037833|FG000|STARTED|Overall Study||22
8973679|NCT02637141|10037834|FG001|STARTED|Overall Study||22
8973680|NCT02637141|10037835|FG002|STARTED|Overall Study||20
8973681|NCT02637141|10037833|FG000|Received Study Drug|Overall Study||22
8973682|NCT02637141|10037834|FG001|Received Study Drug|Overall Study||21
8973683|NCT02637141|10037835|FG002|Received Study Drug|Overall Study||19
8973684|NCT02637141|10037833|FG000|COMPLETED|Overall Study||20
8973685|NCT02637141|10037834|FG001|COMPLETED|Overall Study||20
8973686|NCT02637141|10037835|FG002|COMPLETED|Overall Study||19
8973687|NCT02637141|10037833|FG000|NOT COMPLETED|Overall Study||2
8973688|NCT02637141|10037834|FG001|NOT COMPLETED|Overall Study||2
8973689|NCT02637141|10037835|FG002|NOT COMPLETED|Overall Study||1
8973690|NCT02637232|10037843|FG000|STARTED|Overall Study||301
8973691|NCT02637232|10037843|FG000|COMPLETED|Overall Study||246
8973692|NCT02637232|10037843|FG000|NOT COMPLETED|Overall Study||55
8973693|NCT02637323|10037849|FG000|STARTED|Overall Study||63
8973694|NCT02637323|10037850|FG001|STARTED|Overall Study||18
8973695|NCT02637323|10037849|FG000|COMPLETED|Overall Study||61
8973696|NCT02637323|10037850|FG001|COMPLETED|Overall Study||17
8973697|NCT02637323|10037849|FG000|NOT COMPLETED|Overall Study||2
8973698|NCT02637323|10037850|FG001|NOT COMPLETED|Overall Study||1
8973699|NCT02637427|10037859|FG000|STARTED|Overall Study||27
8973700|NCT02637427|10037860|FG001|STARTED|Overall Study||30
8973701|NCT02637427|10037859|FG000|COMPLETED|Overall Study||27
8973702|NCT02637427|10037860|FG001|COMPLETED|Overall Study||30
8973703|NCT02637427|10037859|FG000|NOT COMPLETED|Overall Study||0
8973704|NCT02637427|10037860|FG001|NOT COMPLETED|Overall Study||0
8973705|NCT02637557|10037870|FG000|STARTED|Overall Study||71
8877056|NCT01920854|9933924|FG000|NOT COMPLETED|Overall Study||1
8877057|NCT01920854|9933925|FG001|NOT COMPLETED|Overall Study||0
8877058|NCT01920854|9933926|FG002|NOT COMPLETED|Overall Study||0
8877059|NCT01920854|9933927|FG003|NOT COMPLETED|Overall Study||0
8877060|NCT01920854|9933928|FG004|NOT COMPLETED|Overall Study||1
8877061|NCT01920854|9933929|FG005|NOT COMPLETED|Overall Study||0
8877062|NCT01920854|9933930|FG006|NOT COMPLETED|Overall Study||1
8877063|NCT01920893|9933967|FG000|STARTED|Overall Study||30
8877064|NCT01920893|9933968|FG001|STARTED|Overall Study||30
8973706|NCT02637557|10037871|FG001|STARTED|Overall Study||71
8973707|NCT02637557|10037872|FG002|STARTED|Overall Study||71
8973708|NCT02637557|10037873|FG003|STARTED|Overall Study||69
8973709|NCT02637557|10037870|FG000|COMPLETED|Overall Study||63
8973710|NCT02637557|10037871|FG001|COMPLETED|Overall Study||66
8973711|NCT02637557|10037872|FG002|COMPLETED|Overall Study||62
8973712|NCT02637557|10037873|FG003|COMPLETED|Overall Study||62
8973713|NCT02637557|10037870|FG000|NOT COMPLETED|Overall Study||8
8973714|NCT02637557|10037871|FG001|NOT COMPLETED|Overall Study||5
8973715|NCT02637557|10037872|FG002|NOT COMPLETED|Overall Study||9
8973716|NCT02637557|10037873|FG003|NOT COMPLETED|Overall Study||7
8973717|NCT02637804|10037885|FG000|STARTED|First Intervention (1 Week)||27
8973718|NCT02637804|10037886|FG001|STARTED|First Intervention (1 Week)||28
8973719|NCT02637804|10037887|FG002|STARTED|First Intervention (1 Week)||25
8973720|NCT02637804|10037888|FG003|STARTED|First Intervention (1 Week)||26
8877065|NCT01920893|9933967|FG000|Treated (Safety Population)|Overall Study||30
8973721|NCT02637804|10037885|FG000|COMPLETED|First Intervention (1 Week)||27
8973722|NCT02637804|10037886|FG001|COMPLETED|First Intervention (1 Week)||28
8973723|NCT02637804|10037887|FG002|COMPLETED|First Intervention (1 Week)||25
8973724|NCT02637804|10037888|FG003|COMPLETED|First Intervention (1 Week)||26
8973725|NCT02637804|10037885|FG000|NOT COMPLETED|First Intervention (1 Week)||0
8973726|NCT02637804|10037886|FG001|NOT COMPLETED|First Intervention (1 Week)||0
8973727|NCT02637804|10037887|FG002|NOT COMPLETED|First Intervention (1 Week)||0
8973728|NCT02637804|10037888|FG003|NOT COMPLETED|First Intervention (1 Week)||0
8973729|NCT02637804|10037885|FG000|STARTED|Second Intervention (1 Week)||27
8973730|NCT02637804|10037886|FG001|STARTED|Second Intervention (1 Week)||28
8973731|NCT02637804|10037887|FG002|STARTED|Second Intervention (1 Week)||25
8973732|NCT02637804|10037888|FG003|STARTED|Second Intervention (1 Week)||26
8973733|NCT02637804|10037885|FG000|COMPLETED|Second Intervention (1 Week)||27
8973734|NCT02637804|10037886|FG001|COMPLETED|Second Intervention (1 Week)||28
8973735|NCT02637804|10037887|FG002|COMPLETED|Second Intervention (1 Week)||25
8973736|NCT02637804|10037888|FG003|COMPLETED|Second Intervention (1 Week)||26
8973737|NCT02637804|10037885|FG000|NOT COMPLETED|Second Intervention (1 Week)||0
8973738|NCT02637804|10037886|FG001|NOT COMPLETED|Second Intervention (1 Week)||0
8973739|NCT02637804|10037887|FG002|NOT COMPLETED|Second Intervention (1 Week)||0
8973740|NCT02637804|10037888|FG003|NOT COMPLETED|Second Intervention (1 Week)||0
8973741|NCT02637856|10037905|FG000|STARTED|Main Study (Baseline to Week 100)||608
8973742|NCT02637856|10037906|FG001|STARTED|Main Study (Baseline to Week 100)||0
8973743|NCT02637856|10037905|FG000|COMPLETED|Main Study (Baseline to Week 100)||389
8973744|NCT02637856|10037906|FG001|COMPLETED|Main Study (Baseline to Week 100)||0
8973745|NCT02637856|10037905|FG000|NOT COMPLETED|Main Study (Baseline to Week 100)||219
8973746|NCT02637856|10037906|FG001|NOT COMPLETED|Main Study (Baseline to Week 100)||0
8973747|NCT02637856|10037905|FG000|STARTED|Sub-Study (Week 72 to Week 100)||0
8973748|NCT02637856|10037906|FG001|STARTED|Sub-Study (Week 72 to Week 100)||129
8973749|NCT02637856|10037905|FG000|COMPLETED|Sub-Study (Week 72 to Week 100)||0
8973750|NCT02637856|10037906|FG001|COMPLETED|Sub-Study (Week 72 to Week 100)||125
8973751|NCT02637856|10037905|FG000|NOT COMPLETED|Sub-Study (Week 72 to Week 100)||0
8973752|NCT02637856|10037906|FG001|NOT COMPLETED|Sub-Study (Week 72 to Week 100)||4
8973753|NCT02637895|10037914|FG000|STARTED|Overall Study||21
8973754|NCT02637895|10037915|FG001|STARTED|Overall Study||20
8973755|NCT02637895|10037914|FG000|COMPLETED|Overall Study||15
8973756|NCT02637895|10037915|FG001|COMPLETED|Overall Study||17
8973757|NCT02637895|10037914|FG000|NOT COMPLETED|Overall Study||6
8973758|NCT02637895|10037915|FG001|NOT COMPLETED|Overall Study||3
8973759|NCT02637999|10037925|FG000|STARTED|Overall Study||8
8973760|NCT02637999|10037926|FG001|STARTED|Overall Study||8
8973761|NCT02637999|10037927|FG002|STARTED|Overall Study||8
8973762|NCT02637999|10037925|FG000|COMPLETED|Overall Study||7
8973763|NCT02637999|10037926|FG001|COMPLETED|Overall Study||6
8973764|NCT02637999|10037927|FG002|COMPLETED|Overall Study||6
8973765|NCT02637999|10037925|FG000|NOT COMPLETED|Overall Study||1
8973766|NCT02637999|10037926|FG001|NOT COMPLETED|Overall Study||2
8973767|NCT02637999|10037927|FG002|NOT COMPLETED|Overall Study||2
8973768|NCT02638012|10037935|FG000|STARTED|Overall Study||8
8973769|NCT02638012|10037935|FG000|COMPLETED|Overall Study||7
8973770|NCT02638012|10037935|FG000|NOT COMPLETED|Overall Study||1
8973771|NCT02638051|10037941|FG000|STARTED|Overall Study||130
8973772|NCT02638051|10037942|FG001|STARTED|Overall Study||130
8973773|NCT02638051|10037941|FG000|COMPLETED|Overall Study||130
8973774|NCT02638051|10037942|FG001|COMPLETED|Overall Study||130
8973775|NCT02638051|10037941|FG000|NOT COMPLETED|Overall Study||0
8973776|NCT02638051|10037942|FG001|NOT COMPLETED|Overall Study||0
8973777|NCT02638103|10037952|FG000|STARTED|Overall Study||419
8973778|NCT02638103|10037953|FG001|STARTED|Overall Study||526
8973779|NCT02638103|10037954|FG002|STARTED|Overall Study||420
8973780|NCT02638103|10037955|FG003|STARTED|Overall Study||525
8973781|NCT02638103|10037952|FG000|Safety Analysis Set|Overall Study||418
8973782|NCT02638103|10037953|FG001|Safety Analysis Set|Overall Study||526
8973783|NCT02638103|10037954|FG002|Safety Analysis Set|Overall Study||419
8973784|NCT02638103|10037955|FG003|Safety Analysis Set|Overall Study||525
8973785|NCT02638103|10037952|FG000|Full Analysis Set (FAS)|Overall Study||416
8973786|NCT02638103|10037953|FG001|Full Analysis Set (FAS)|Overall Study||520
8973787|NCT02638103|10037954|FG002|Full Analysis Set (FAS)|Overall Study||419
8973788|NCT02638103|10037955|FG003|Full Analysis Set (FAS)|Overall Study||523
8973789|NCT02638103|10037952|FG000|COMPLETED|Overall Study||313
8973790|NCT02638103|10037953|FG001|COMPLETED|Overall Study||408
8973791|NCT02638103|10037954|FG002|COMPLETED|Overall Study||335
8973792|NCT02638103|10037955|FG003|COMPLETED|Overall Study||383
8973793|NCT02638103|10037952|FG000|NOT COMPLETED|Overall Study||106
8973794|NCT02638103|10037953|FG001|NOT COMPLETED|Overall Study||118
8973795|NCT02638103|10037954|FG002|NOT COMPLETED|Overall Study||85
8973796|NCT02638103|10037955|FG003|NOT COMPLETED|Overall Study||142
8973797|NCT02638168|10037973|FG000|STARTED|Overall Study||3
8973798|NCT02638168|10037974|FG001|STARTED|Overall Study||0
8973799|NCT02638168|10037973|FG000|COMPLETED|Overall Study||3
8973800|NCT02638168|10037974|FG001|COMPLETED|Overall Study||0
8973801|NCT02638168|10037973|FG000|NOT COMPLETED|Overall Study||0
8571056|NCT00107380|9603271|FG000|NOT COMPLETED|Overall Study||30
8973802|NCT02638168|10037974|FG001|NOT COMPLETED|Overall Study||0
8973803|NCT02638207|10037981|FG000|STARTED|Overall Study||35
8973804|NCT02638207|10037982|FG001|STARTED|Overall Study||69
8973805|NCT02638207|10037983|FG002|STARTED|Overall Study||38
8973806|NCT02638207|10037981|FG000|COMPLETED|Overall Study||28
8973807|NCT02638207|10037982|FG001|COMPLETED|Overall Study||61
8973808|NCT02638207|10037983|FG002|COMPLETED|Overall Study||34
8973809|NCT02638207|10037981|FG000|NOT COMPLETED|Overall Study||7
8973810|NCT02638207|10037982|FG001|NOT COMPLETED|Overall Study||8
8973811|NCT02638207|10037983|FG002|NOT COMPLETED|Overall Study||4
8973812|NCT02638259|10037995|FG000|STARTED|Treatment Period 1||186
8973813|NCT02638259|10037996|FG001|STARTED|Treatment Period 1||190
8973814|NCT02638259|10037995|FG000|COMPLETED|Treatment Period 1||181
8973815|NCT02638259|10037996|FG001|COMPLETED|Treatment Period 1||172
8973816|NCT02638259|10037995|FG000|NOT COMPLETED|Treatment Period 1||5
8973817|NCT02638259|10037996|FG001|NOT COMPLETED|Treatment Period 1||18
8973818|NCT02638259|10037995|FG000|STARTED|Treatment Period 2|6 patients did not proceed to TP2 (3 not eligible, 2 consent withdrawal, 1 IP delay)|175
8973819|NCT02638259|10037996|FG001|STARTED|Treatment Period 2|6 patients did not proceed to TP2 (4 not eligible, 1 consent withdrawal, 1 adverse event).|166
8973820|NCT02638259|10037995|FG000|COMPLETED|Treatment Period 2||169
8973821|NCT02638259|10037996|FG001|COMPLETED|Treatment Period 2||155
8973822|NCT02638259|10037995|FG000|NOT COMPLETED|Treatment Period 2||6
8973823|NCT02638259|10037996|FG001|NOT COMPLETED|Treatment Period 2||11
8973824|NCT02638337|10038008|FG000|STARTED|Overall Study||316
8973825|NCT02638337|10038009|FG001|STARTED|Overall Study||315
8973826|NCT02638337|10038008|FG000|Received Treatment|Overall Study||313
8973827|NCT02638337|10038009|FG001|Received Treatment|Overall Study||315
8973828|NCT02638337|10038008|FG000|COMPLETED|Overall Study||283
8973829|NCT02638337|10038009|FG001|COMPLETED|Overall Study||279
8973830|NCT02638337|10038008|FG000|NOT COMPLETED|Overall Study||33
8973831|NCT02638337|10038009|FG001|NOT COMPLETED|Overall Study||36
8973832|NCT02638493|10038018|FG000|STARTED|Overall Study|Two men were not able to provide semen samples, and thus were replaced|10
8973833|NCT02638493|10038019|FG001|STARTED|Overall Study||8
8973834|NCT02638493|10038020|FG002|STARTED|Overall Study||8
8973835|NCT02638493|10038018|FG000|COMPLETED|Overall Study||8
8973836|NCT02638493|10038019|FG001|COMPLETED|Overall Study||8
8973837|NCT02638493|10038020|FG002|COMPLETED|Overall Study||8
8973838|NCT02638493|10038018|FG000|NOT COMPLETED|Overall Study||2
8973839|NCT02638493|10038019|FG001|NOT COMPLETED|Overall Study||0
8973840|NCT02638493|10038020|FG002|NOT COMPLETED|Overall Study||0
8973841|NCT02638597|10038030|FG000|STARTED|Overall Study||8
8973842|NCT02638597|10038031|FG001|STARTED|Overall Study||8
8973843|NCT02638597|10038030|FG000|COMPLETED|Overall Study||4
8973844|NCT02638597|10038031|FG001|COMPLETED|Overall Study||3
8973845|NCT02638597|10038030|FG000|NOT COMPLETED|Overall Study||4
8973846|NCT02638597|10038031|FG001|NOT COMPLETED|Overall Study||5
8973847|NCT02638623|10038041|FG000|STARTED|Overall Study||27
8973848|NCT02638623|10038042|FG001|STARTED|Overall Study||25
8973849|NCT02638623|10038041|FG000|COMPLETED|Overall Study||20
8973850|NCT02638623|10038042|FG001|COMPLETED|Overall Study||19
8973851|NCT02638623|10038041|FG000|NOT COMPLETED|Overall Study||7
8973852|NCT02638623|10038042|FG001|NOT COMPLETED|Overall Study||6
8973853|NCT02638948|10038052|FG000|STARTED|Overall Study||75
8973854|NCT02638948|10038053|FG001|STARTED|Overall Study||73
8973855|NCT02638948|10038054|FG002|STARTED|Overall Study||73
8973856|NCT02638948|10038055|FG003|STARTED|Overall Study||26
8632131|NCT00543439|9672011|FG002|STARTED|Period 1||27
8632132|NCT00543439|9672009|FG000|Treated|Period 1||9
8632133|NCT00543439|9672010|FG001|Treated|Period 1||29
8632134|NCT00543439|9672011|FG002|Treated|Period 1||27
8632135|NCT00543439|9672009|FG000|COMPLETED|Period 1||9
8632136|NCT00543439|9672010|FG001|COMPLETED|Period 1||26
8632137|NCT00543439|9672011|FG002|COMPLETED|Period 1||25
8973857|NCT02638948|10038052|FG000|COMPLETED|Overall Study||66
8973858|NCT02638948|10038053|FG001|COMPLETED|Overall Study||62
8973859|NCT02638948|10038054|FG002|COMPLETED|Overall Study||66
8973860|NCT02638948|10038055|FG003|COMPLETED|Overall Study||18
8973861|NCT02638948|10038052|FG000|NOT COMPLETED|Overall Study||9
8973862|NCT02638948|10038053|FG001|NOT COMPLETED|Overall Study||11
8973863|NCT02638948|10038054|FG002|NOT COMPLETED|Overall Study||7
8973864|NCT02638948|10038055|FG003|NOT COMPLETED|Overall Study||8
8973865|NCT02638974|10038070|FG000|STARTED|Overall Study||26
8973866|NCT02638974|10038071|FG001|STARTED|Overall Study||25
8973867|NCT02638974|10038070|FG000|COMPLETED|Overall Study||23
8973868|NCT02638974|10038071|FG001|COMPLETED|Overall Study||22
8973869|NCT02638974|10038070|FG000|NOT COMPLETED|Overall Study||3
8973870|NCT02638974|10038071|FG001|NOT COMPLETED|Overall Study||3
8973871|NCT02639052|10038077|FG000|STARTED|Overall Study||35
8973872|NCT02639052|10038077|FG000|Visit 1 (Baseline)|Overall Study||35
8973873|NCT02639052|10038077|FG000|Visit 2 (1-week Follow-up)|Overall Study||35
8973874|NCT02639052|10038077|FG000|Visit 3 (1-month Follow-up)|Overall Study||35
8973875|NCT02639052|10038077|FG000|Visit 4 (3-month Follow-up)|Overall Study||34
8973876|NCT02639052|10038077|FG000|COMPLETED|Overall Study||34
8973877|NCT02639052|10038077|FG000|NOT COMPLETED|Overall Study||1
8973878|NCT02639182|10038085|FG000|STARTED|Overall Study||67
8973879|NCT02639182|10038086|FG001|STARTED|Overall Study||66
8632138|NCT00543439|9672009|FG000|NOT COMPLETED|Period 1||1
8632139|NCT00543439|9672010|FG001|NOT COMPLETED|Period 1||3
8973880|NCT02639182|10038085|FG000|Treated|Overall Study||66
8973881|NCT02639182|10038086|FG001|Treated|Overall Study||65
8973882|NCT02639182|10038085|FG000|COMPLETED|Overall Study||0
8973883|NCT02639182|10038086|FG001|COMPLETED|Overall Study||0
8973884|NCT02639182|10038085|FG000|NOT COMPLETED|Overall Study||67
8973885|NCT02639182|10038086|FG001|NOT COMPLETED|Overall Study||66
8973886|NCT02639247|10038094|FG000|STARTED|Overall Study||182
8973887|NCT02639247|10038095|FG001|STARTED|Overall Study||151
8973888|NCT02639247|10038094|FG000|COMPLETED|Overall Study||177
8973889|NCT02639247|10038095|FG001|COMPLETED|Overall Study||149
8973890|NCT02639247|10038094|FG000|NOT COMPLETED|Overall Study||5
8973891|NCT02639247|10038095|FG001|NOT COMPLETED|Overall Study||2
8632140|NCT00543439|9672011|FG002|NOT COMPLETED|Period 1||2
8632141|NCT00543439|9672009|FG000|STARTED|Period 2||9
8877066|NCT01920893|9933968|FG001|Treated (Safety Population)|Overall Study||30
8877067|NCT01920893|9933967|FG000|COMPLETED|Overall Study||23
8877068|NCT01920893|9933968|FG001|COMPLETED|Overall Study||28
8877069|NCT01920893|9933967|FG000|NOT COMPLETED|Overall Study||7
8877070|NCT01920893|9933968|FG001|NOT COMPLETED|Overall Study||2
8877071|NCT01920958|9933975|FG000|STARTED|Overall Study||233
8877072|NCT01920958|9933975|FG000|COMPLETED|Overall Study|Intent-to-Treat (ITT) Population|228
8877073|NCT01920958|9933975|FG000|NOT COMPLETED|Overall Study||5
8877074|NCT01921101|9933981|FG000|STARTED|Overall Study||40
8877075|NCT01921101|9933982|FG001|STARTED|Overall Study||38
8877076|NCT01921101|9933981|FG000|COMPLETED|Overall Study||24
8877077|NCT01921101|9933982|FG001|COMPLETED|Overall Study||32
8877078|NCT01921101|9933981|FG000|NOT COMPLETED|Overall Study||16
8877079|NCT01921101|9933982|FG001|NOT COMPLETED|Overall Study||6
8877080|NCT01921179|9933990|FG000|STARTED|5 Week Randomized GOALS vs EDU Training||24
8877081|NCT01921179|9933991|FG001|STARTED|5 Week Randomized GOALS vs EDU Training||22
8877082|NCT01921179|9933990|FG000|COMPLETED|5 Week Randomized GOALS vs EDU Training||21
8877083|NCT01921179|9933991|FG001|COMPLETED|5 Week Randomized GOALS vs EDU Training||19
8877084|NCT01921179|9933990|FG000|NOT COMPLETED|5 Week Randomized GOALS vs EDU Training||3
8877085|NCT01921179|9933991|FG001|NOT COMPLETED|5 Week Randomized GOALS vs EDU Training||3
8877086|NCT01921179|9933990|FG000|STARTED|Long Term Follow-up After GOALS Training||34
8877087|NCT01921179|9933991|FG001|STARTED|Long Term Follow-up After GOALS Training|13 out of 19 participants who completed EDU, also completed GOALS training|0
8877088|NCT01921179|9933990|FG000|COMPLETED|Long Term Follow-up After GOALS Training||32
8877089|NCT01921179|9933991|FG001|COMPLETED|Long Term Follow-up After GOALS Training||0
8877090|NCT01921179|9933990|FG000|NOT COMPLETED|Long Term Follow-up After GOALS Training||2
8877091|NCT01921179|9933991|FG001|NOT COMPLETED|Long Term Follow-up After GOALS Training||0
8877092|NCT01921205|9934000|FG000|STARTED|Overall Study||172
8877093|NCT01921205|9934001|FG001|STARTED|Overall Study||171
8877094|NCT01921205|9934000|FG000|COMPLETED|Overall Study||151
8877095|NCT01921205|9934001|FG001|COMPLETED|Overall Study||151
8877096|NCT01921205|9934000|FG000|NOT COMPLETED|Overall Study||21
8877097|NCT01921205|9934001|FG001|NOT COMPLETED|Overall Study||20
8877098|NCT01921257|9934007|FG000|STARTED|Overall Study||16
8877099|NCT01921257|9934007|FG000|Placebo run-in|Overall Study||16
8877100|NCT01921257|9934007|FG000|Active Treatment|Overall Study||13
8877101|NCT01921257|9934007|FG000|COMPLETED|Overall Study||13
8877102|NCT01921257|9934007|FG000|NOT COMPLETED|Overall Study||3
8877103|NCT01921270|9934012|FG000|STARTED|Overall Study||18
8877104|NCT01921270|9934012|FG000|COMPLETED|Overall Study||17
8877105|NCT01921270|9934012|FG000|NOT COMPLETED|Overall Study||1
8877106|NCT01921296|9934016|FG000|STARTED|Overall Study||2
8877107|NCT01921296|9934016|FG000|COMPLETED|Overall Study||2
8877108|NCT01921296|9934016|FG000|NOT COMPLETED|Overall Study||0
8877109|NCT01921322|9934022|FG000|STARTED|Overall Study||57
8877110|NCT01921322|9934023|FG001|STARTED|Overall Study||61
8877111|NCT01921322|9934022|FG000|COMPLETED|Overall Study||42
8877112|NCT01921322|9934023|FG001|COMPLETED|Overall Study||44
8877113|NCT01921322|9934022|FG000|NOT COMPLETED|Overall Study||15
8877114|NCT01921322|9934023|FG001|NOT COMPLETED|Overall Study||17
8877115|NCT01921348|9934031|FG000|STARTED|Overall Study||9
8877116|NCT01921348|9934032|FG001|STARTED|Overall Study||9
8877117|NCT01921348|9934031|FG000|COMPLETED|Overall Study||8
8877118|NCT01921348|9934032|FG001|COMPLETED|Overall Study||7
8877119|NCT01921348|9934031|FG000|NOT COMPLETED|Overall Study||1
8877120|NCT01921348|9934032|FG001|NOT COMPLETED|Overall Study||2
8877121|NCT01921387|9934038|FG000|STARTED|Overall Study||20
8877122|NCT01921387|9934038|FG000|COMPLETED|Overall Study||19
8877123|NCT01921387|9934038|FG000|NOT COMPLETED|Overall Study||1
8877124|NCT01921452|9934042|FG000|STARTED|Overall Study||283
8877125|NCT01921452|9934042|FG000|COMPLETED|Overall Study||283
8877126|NCT01921452|9934042|FG000|NOT COMPLETED|Overall Study||0
8877127|NCT01921517|9934049|FG000|STARTED|Overall Study||42
8877128|NCT01921517|9934050|FG001|STARTED|Overall Study||38
8877129|NCT01921517|9934049|FG000|COMPLETED|Overall Study||27
8877130|NCT01921517|9934050|FG001|COMPLETED|Overall Study||29
8877131|NCT01921517|9934049|FG000|NOT COMPLETED|Overall Study||15
8877132|NCT01921517|9934050|FG001|NOT COMPLETED|Overall Study||9
8877133|NCT01921634|9934056|FG000|STARTED|Overall Study||300
8877134|NCT01921634|9934056|FG000|COMPLETED|Overall Study||300
8877135|NCT01921634|9934056|FG000|NOT COMPLETED|Overall Study||0
8877136|NCT01921751|9934064|FG000|STARTED|Overall Study||4
8877137|NCT01921751|9934065|FG001|STARTED|Overall Study||4
8877138|NCT01921751|9934066|FG002|STARTED|Overall Study||5
8877139|NCT01921751|9934064|FG000|COMPLETED|Overall Study|All randomized patients are reported here.|4
8877140|NCT01921751|9934065|FG001|COMPLETED|Overall Study|All randomized patients are reported here.|4
8877141|NCT01921751|9934066|FG002|COMPLETED|Overall Study|All randomized patients are reported here.|5
8877142|NCT01921751|9934064|FG000|NOT COMPLETED|Overall Study||0
8877143|NCT01921751|9934065|FG001|NOT COMPLETED|Overall Study||0
8877144|NCT01921751|9934066|FG002|NOT COMPLETED|Overall Study||0
8877145|NCT01921829|9934077|FG000|STARTED|Overall Study||10
8877146|NCT01921829|9934078|FG001|STARTED|Overall Study||9
8877147|NCT01921829|9934077|FG000|COMPLETED|Overall Study||10
8877148|NCT01921829|9934078|FG001|COMPLETED|Overall Study||8
8877149|NCT01921829|9934077|FG000|NOT COMPLETED|Overall Study||0
8973892|NCT02639286|10038103|FG000|STARTED|Overall Study||3
8973893|NCT02639286|10038104|FG001|STARTED|Overall Study||2
8973894|NCT02639286|10038103|FG000|COMPLETED|Overall Study||3
8973895|NCT02639286|10038104|FG001|COMPLETED|Overall Study||2
8973896|NCT02639286|10038103|FG000|NOT COMPLETED|Overall Study||0
8973897|NCT02639286|10038104|FG001|NOT COMPLETED|Overall Study||0
8973898|NCT02639338|10038112|FG000|STARTED|Overall Study||110
8973899|NCT02639338|10038113|FG001|STARTED|Overall Study||110
8973900|NCT02639338|10038112|FG000|COMPLETED|Overall Study||106
8973901|NCT02639338|10038113|FG001|COMPLETED|Overall Study||105
8973902|NCT02639338|10038112|FG000|NOT COMPLETED|Overall Study||4
8973903|NCT02639338|10038113|FG001|NOT COMPLETED|Overall Study||5
8973904|NCT02639351|10038124|FG000|STARTED|Overall Study||16
8973905|NCT02639351|10038125|FG001|STARTED|Overall Study||16
8973906|NCT02639351|10038126|FG002|STARTED|Overall Study||16
8973907|NCT02639351|10038127|FG003|STARTED|Overall Study||16
8973908|NCT02639351|10038128|FG004|STARTED|Overall Study||16
8632142|NCT00543439|9672010|FG001|STARTED|Period 2||26
8632143|NCT00543439|9672011|FG002|STARTED|Period 2||25
8632144|NCT00543439|9672009|FG000|COMPLETED|Period 2||8
8632145|NCT00543439|9672010|FG001|COMPLETED|Period 2||25
8632146|NCT00543439|9672011|FG002|COMPLETED|Period 2||23
8632147|NCT00543439|9672009|FG000|NOT COMPLETED|Period 2||1
8973909|NCT02639351|10038124|FG000|COMPLETED|Overall Study||16
8973910|NCT02639351|10038125|FG001|COMPLETED|Overall Study||16
8973911|NCT02639351|10038126|FG002|COMPLETED|Overall Study||16
8973912|NCT02639351|10038127|FG003|COMPLETED|Overall Study||16
8973913|NCT02639351|10038128|FG004|COMPLETED|Overall Study||16
8973914|NCT02639351|10038124|FG000|NOT COMPLETED|Overall Study||0
8973915|NCT02639351|10038125|FG001|NOT COMPLETED|Overall Study||0
8973916|NCT02639351|10038126|FG002|NOT COMPLETED|Overall Study||0
8973917|NCT02639351|10038127|FG003|NOT COMPLETED|Overall Study||0
8973918|NCT02639351|10038128|FG004|NOT COMPLETED|Overall Study||0
8973919|NCT02639429|10038144|FG000|STARTED|Overall Study||113
8571057|NCT00107536|9603276|FG000|STARTED|Overall Study||26
8571058|NCT00107536|9603276|FG000|COMPLETED|Overall Study||26
8571059|NCT00107536|9603276|FG000|NOT COMPLETED|Overall Study||0
8571060|NCT00107575|9603282|FG000|STARTED|Overall Study||119
8571061|NCT00107575|9603283|FG001|STARTED|Overall Study||117
8571062|NCT00107575|9603282|FG000|COMPLETED|Overall Study||108
8571063|NCT00107575|9603283|FG001|COMPLETED|Overall Study||107
8571064|NCT00107575|9603282|FG000|NOT COMPLETED|Overall Study||11
8571065|NCT00107575|9603283|FG001|NOT COMPLETED|Overall Study||10
8571066|NCT00107653|9603291|FG000|STARTED|Overall Study||269
8571067|NCT00107653|9603292|FG001|STARTED|Overall Study||300
8973920|NCT02639429|10038145|FG001|STARTED|Overall Study||123
8973921|NCT02639429|10038144|FG000|COMPLETED|Overall Study||113
8973922|NCT02639429|10038145|FG001|COMPLETED|Overall Study||123
8973923|NCT02639429|10038144|FG000|NOT COMPLETED|Overall Study||0
8973924|NCT02639429|10038145|FG001|NOT COMPLETED|Overall Study||0
8973925|NCT02639494|10038151|FG000|STARTED|Overall Study||20
8973926|NCT02639494|10038151|FG000|COMPLETED|Overall Study||20
8973927|NCT02639494|10038151|FG000|NOT COMPLETED|Overall Study||0
8973928|NCT02639637|10038158|FG000|STARTED|Overall Study||7
8973929|NCT02639637|10038159|FG001|STARTED|Overall Study||6
8973930|NCT02639637|10038160|FG002|STARTED|Overall Study||2
8973931|NCT02639637|10038161|FG003|STARTED|Overall Study||3
8973932|NCT02639637|10038158|FG000|COMPLETED|Overall Study||7
8973933|NCT02639637|10038159|FG001|COMPLETED|Overall Study||6
8973934|NCT02639637|10038160|FG002|COMPLETED|Overall Study||2
8571068|NCT00107653|9603291|FG000|COMPLETED|Overall Study||190
8571069|NCT00107653|9603292|FG001|COMPLETED|Overall Study||224
8571070|NCT00107653|9603291|FG000|NOT COMPLETED|Overall Study||79
8571071|NCT00107653|9603292|FG001|NOT COMPLETED|Overall Study||76
8571072|NCT00107744|9603301|FG000|STARTED|Intervention 1 (8 Weeks)||117
8571073|NCT00107744|9603302|FG001|STARTED|Intervention 1 (8 Weeks)||117
8571074|NCT00107744|9603303|FG002|STARTED|Intervention 1 (8 Weeks)||118
8571075|NCT00107744|9603301|FG000|COMPLETED|Intervention 1 (8 Weeks)||101
8973935|NCT02639637|10038161|FG003|COMPLETED|Overall Study||3
8973936|NCT02639637|10038158|FG000|NOT COMPLETED|Overall Study||0
8973937|NCT02639637|10038159|FG001|NOT COMPLETED|Overall Study||0
8973938|NCT02639637|10038160|FG002|NOT COMPLETED|Overall Study||0
8973939|NCT02639637|10038161|FG003|NOT COMPLETED|Overall Study||0
8973940|NCT02639884|10038177|FG000|STARTED|Overall Study||51
8973941|NCT02639884|10038177|FG000|COMPLETED|Overall Study||47
8973942|NCT02639884|10038177|FG000|NOT COMPLETED|Overall Study||4
8973943|NCT02640053|10038184|FG000|STARTED|Overall Study||21
8973944|NCT02640053|10038185|FG001|STARTED|Overall Study||21
8973945|NCT02640053|10038184|FG000|COMPLETED|Overall Study||17
8973946|NCT02640053|10038185|FG001|COMPLETED|Overall Study||17
8973947|NCT02640053|10038184|FG000|NOT COMPLETED|Overall Study||4
8973948|NCT02640053|10038185|FG001|NOT COMPLETED|Overall Study||4
8973949|NCT02640157|10038194|FG000|STARTED|Overall Study|Intent-to-treat population: all participants who received at least 1 dose of study drug|233
8973950|NCT02640157|10038195|FG001|STARTED|Overall Study||116
8973951|NCT02640157|10038196|FG002|STARTED|Overall Study|Intent-to-treat population: all participants who received at least 1 dose of study drug|157
8973952|NCT02640157|10038194|FG000|Received Study Drug|Overall Study||233
8973953|NCT02640157|10038195|FG001|Received Study Drug|Overall Study|One participant in Arm B was randomized in error and never dispensed study drug.|115
8973954|NCT02640157|10038196|FG002|Received Study Drug|Overall Study||157
8973955|NCT02640157|10038194|FG000|Completed Study Drug|Overall Study||225
8973956|NCT02640157|10038195|FG001|Completed Study Drug|Overall Study||112
8973957|NCT02640157|10038196|FG002|Completed Study Drug|Overall Study||154
8973958|NCT02640157|10038194|FG000|Discontinued Study Drug|Overall Study||8
8973959|NCT02640157|10038195|FG001|Discontinued Study Drug|Overall Study||3
8973960|NCT02640157|10038196|FG002|Discontinued Study Drug|Overall Study||3
8973961|NCT02640157|10038194|FG000|COMPLETED|Overall Study||220
8973962|NCT02640157|10038195|FG001|COMPLETED|Overall Study||111
8973963|NCT02640157|10038196|FG002|COMPLETED|Overall Study||147
8973964|NCT02640157|10038194|FG000|NOT COMPLETED|Overall Study||13
8973965|NCT02640157|10038195|FG001|NOT COMPLETED|Overall Study||5
8973966|NCT02640157|10038196|FG002|NOT COMPLETED|Overall Study||10
8973967|NCT02640235|10038207|FG000|STARTED|Overall Study||131
8973968|NCT02640235|10038208|FG001|STARTED|Overall Study||129
8973969|NCT02640235|10038207|FG000|COMPLETED|Overall Study||117
8973970|NCT02640235|10038208|FG001|COMPLETED|Overall Study||115
8973971|NCT02640235|10038207|FG000|NOT COMPLETED|Overall Study||14
8973972|NCT02640235|10038208|FG001|NOT COMPLETED|Overall Study||14
8973973|NCT02640404|10038216|FG000|STARTED|Overall Study||112
8973974|NCT02640404|10038217|FG001|STARTED|Overall Study||112
8973975|NCT02640404|10038216|FG000|COMPLETED|Overall Study||110
8973976|NCT02640404|10038217|FG001|COMPLETED|Overall Study||112
8973977|NCT02640404|10038216|FG000|NOT COMPLETED|Overall Study||2
8973978|NCT02640404|10038217|FG001|NOT COMPLETED|Overall Study||0
8973979|NCT02640482|10038225|FG000|STARTED|Overall Study||202
8973980|NCT02640482|10038226|FG001|STARTED|Overall Study||100
8973981|NCT02640482|10038225|FG000|COMPLETED|Overall Study||199
8973982|NCT02640482|10038226|FG001|COMPLETED|Overall Study||100
8973983|NCT02640482|10038225|FG000|NOT COMPLETED|Overall Study||3
8973984|NCT02640482|10038226|FG001|NOT COMPLETED|Overall Study||0
8571076|NCT00107744|9603302|FG001|COMPLETED|Intervention 1 (8 Weeks)||104
8571077|NCT00107744|9603303|FG002|COMPLETED|Intervention 1 (8 Weeks)||101
8571078|NCT00107744|9603301|FG000|NOT COMPLETED|Intervention 1 (8 Weeks)||16
8973985|NCT02640547|10038232|FG000|STARTED|Overall Study||394
8973986|NCT02640547|10038232|FG000|COMPLETED|Overall Study||383
8973987|NCT02640547|10038232|FG000|NOT COMPLETED|Overall Study||11
8973988|NCT02640612|10038247|FG000|STARTED|Overall Study||225
8973989|NCT02640612|10038248|FG001|STARTED|Overall Study||103
8973990|NCT02640612|10038249|FG002|STARTED|Overall Study||102
8973991|NCT02640612|10038247|FG000|COMPLETED|Overall Study||203
8973992|NCT02640612|10038248|FG001|COMPLETED|Overall Study||89
8973993|NCT02640612|10038249|FG002|COMPLETED|Overall Study||96
8973994|NCT02640612|10038247|FG000|NOT COMPLETED|Overall Study||22
8973995|NCT02640612|10038248|FG001|NOT COMPLETED|Overall Study||14
8973996|NCT02640612|10038249|FG002|NOT COMPLETED|Overall Study||6
8973997|NCT02640716|10038259|FG000|STARTED|Overall Study||30
8973998|NCT02640716|10038260|FG001|STARTED|Overall Study||30
8973999|NCT02640716|10038259|FG000|Training Completion|Overall Study||27
8974000|NCT02640716|10038260|FG001|Training Completion|Overall Study||27
8974001|NCT02640716|10038259|FG000|COMPLETED|Overall Study||23
8974002|NCT02640716|10038260|FG001|COMPLETED|Overall Study||21
8974003|NCT02640716|10038259|FG000|NOT COMPLETED|Overall Study||7
8571079|NCT00107744|9603302|FG001|NOT COMPLETED|Intervention 1 (8 Weeks)||13
8571080|NCT00107744|9603303|FG002|NOT COMPLETED|Intervention 1 (8 Weeks)||17
8974004|NCT02640716|10038260|FG001|NOT COMPLETED|Overall Study||9
8974005|NCT02640755|10038268|FG000|STARTED|Single Dose Period (Day 1 - 8)||3
8974006|NCT02640755|10038269|FG001|STARTED|Single Dose Period (Day 1 - 8)||1
8974007|NCT02640755|10038268|FG000|COMPLETED|Single Dose Period (Day 1 - 8)||3
8974008|NCT02640755|10038269|FG001|COMPLETED|Single Dose Period (Day 1 - 8)||1
8974009|NCT02640755|10038268|FG000|NOT COMPLETED|Single Dose Period (Day 1 - 8)||0
8974010|NCT02640755|10038269|FG001|NOT COMPLETED|Single Dose Period (Day 1 - 8)||0
8974011|NCT02640755|10038268|FG000|STARTED|Multiple Dose Period (Day 8 - EoS)||3
8974012|NCT02640755|10038269|FG001|STARTED|Multiple Dose Period (Day 8 - EoS)||1
8974013|NCT02640755|10038268|FG000|COMPLETED|Multiple Dose Period (Day 8 - EoS)||1
8974014|NCT02640755|10038269|FG001|COMPLETED|Multiple Dose Period (Day 8 - EoS)||0
8974015|NCT02640755|10038268|FG000|NOT COMPLETED|Multiple Dose Period (Day 8 - EoS)||2
8974016|NCT02640755|10038269|FG001|NOT COMPLETED|Multiple Dose Period (Day 8 - EoS)||1
8974017|NCT02640807|10038279|FG000|STARTED|Overall Study||9
8974018|NCT02640807|10038280|FG001|STARTED|Overall Study||8
8632148|NCT00543439|9672010|FG001|NOT COMPLETED|Period 2||1
8632149|NCT00543439|9672011|FG002|NOT COMPLETED|Period 2||2
8632150|NCT00543543|9672032|FG000|STARTED|Base Study||315
8632151|NCT00543543|9672033|FG001|STARTED|Base Study||7106
8632152|NCT00543543|9672034|FG002|STARTED|Base Study||310
8632153|NCT00543543|9672035|FG003|STARTED|Base Study||7109
8632154|NCT00543543|9672032|FG000|Completed 3 Vaccinations|Base Study||300
8632155|NCT00543543|9672033|FG001|Completed 3 Vaccinations|Base Study||6928
8632156|NCT00543543|9672034|FG002|Completed 3 Vaccinations|Base Study||297
8632157|NCT00543543|9672035|FG003|Completed 3 Vaccinations|Base Study||6934
8632158|NCT00543543|9672032|FG000|COMPLETED|Base Study|Follow-up was up to 7 months|295
8632159|NCT00543543|9672033|FG001|COMPLETED|Base Study|Follow-up was up to 54 months|5854
8632160|NCT00543543|9672034|FG002|COMPLETED|Base Study|Follow-up was up to 7 months|296
8632161|NCT00543543|9672035|FG003|COMPLETED|Base Study|Follow-up was up to 54 months|5887
8632162|NCT00543543|9672032|FG000|NOT COMPLETED|Base Study||20
8632163|NCT00543543|9672033|FG001|NOT COMPLETED|Base Study||1252
8632164|NCT00543543|9672034|FG002|NOT COMPLETED|Base Study||14
8632165|NCT00543543|9672035|FG003|NOT COMPLETED|Base Study||1222
8632166|NCT00543543|9672032|FG000|STARTED|Extension Study|This group did not participate in the Extension Study|0
8632167|NCT00543543|9672033|FG001|STARTED|Extension Study|Cohort 1|150
8632168|NCT00543543|9672034|FG002|STARTED|Extension Study|This group did not participate in the Extension Study|0
8632169|NCT00543543|9672035|FG003|STARTED|Extension Study|Cohort 2|3050
8632170|NCT00543543|9672032|FG000|COMPLETED|Extension Study||0
8632171|NCT00543543|9672033|FG001|COMPLETED|Extension Study||150
8974019|NCT02640807|10038281|FG002|STARTED|Overall Study||10
8974020|NCT02640807|10038279|FG000|COMPLETED|Overall Study||9
8974021|NCT02640807|10038280|FG001|COMPLETED|Overall Study||8
8974022|NCT02640807|10038281|FG002|COMPLETED|Overall Study||10
8974023|NCT02640807|10038279|FG000|NOT COMPLETED|Overall Study||0
8974024|NCT02640807|10038280|FG001|NOT COMPLETED|Overall Study||0
8974025|NCT02640807|10038281|FG002|NOT COMPLETED|Overall Study||0
8974026|NCT02641067|10038291|FG000|STARTED|Overall Study||8
8974027|NCT02641067|10038292|FG001|STARTED|Overall Study||8
8974028|NCT02641067|10038291|FG000|COMPLETED|Overall Study||8
8974029|NCT02641067|10038292|FG001|COMPLETED|Overall Study||8
8974030|NCT02641067|10038291|FG000|NOT COMPLETED|Overall Study||0
8974031|NCT02641067|10038292|FG001|NOT COMPLETED|Overall Study||0
8974032|NCT02641080|10038300|FG000|STARTED|Overall Study||40
8974033|NCT02641080|10038301|FG001|STARTED|Overall Study||40
8974034|NCT02641080|10038300|FG000|COMPLETED|Overall Study||38
8974035|NCT02641080|10038301|FG001|COMPLETED|Overall Study||33
8974036|NCT02641080|10038300|FG000|NOT COMPLETED|Overall Study||2
8974037|NCT02641080|10038301|FG001|NOT COMPLETED|Overall Study||7
8974038|NCT02641249|10038307|FG000|STARTED|Overall Study||19
8974039|NCT02641249|10038307|FG000|COMPLETED|Overall Study||15
8974040|NCT02641249|10038307|FG000|NOT COMPLETED|Overall Study||4
8974041|NCT02641353|10038312|FG000|STARTED|Overall Study||5
8974042|NCT02641353|10038313|FG001|STARTED|Overall Study||5
8974043|NCT02641353|10038314|FG002|STARTED|Overall Study||6
8974044|NCT02641353|10038315|FG003|STARTED|Overall Study||6
8974045|NCT02641353|10038316|FG004|STARTED|Overall Study||6
8974046|NCT02641353|10038317|FG005|STARTED|Overall Study||6
8632172|NCT00543543|9672034|FG002|COMPLETED|Extension Study||0
8725818|NCT01033487|9773165|FG008|COMPLETED|First Intervention Period||2
8974047|NCT02641353|10038312|FG000|COMPLETED|Overall Study||5
8974048|NCT02641353|10038313|FG001|COMPLETED|Overall Study||5
8974049|NCT02641353|10038314|FG002|COMPLETED|Overall Study||6
8974050|NCT02641353|10038315|FG003|COMPLETED|Overall Study||6
8974051|NCT02641353|10038316|FG004|COMPLETED|Overall Study||6
8974052|NCT02641353|10038317|FG005|COMPLETED|Overall Study||6
8974053|NCT02641353|10038312|FG000|NOT COMPLETED|Overall Study||0
8974054|NCT02641353|10038313|FG001|NOT COMPLETED|Overall Study||0
8974055|NCT02641353|10038314|FG002|NOT COMPLETED|Overall Study||0
8974056|NCT02641353|10038315|FG003|NOT COMPLETED|Overall Study||0
8974057|NCT02641353|10038316|FG004|NOT COMPLETED|Overall Study||0
8632173|NCT00543543|9672035|FG003|COMPLETED|Extension Study||2824
8632174|NCT00543543|9672032|FG000|NOT COMPLETED|Extension Study||0
8632175|NCT00543543|9672033|FG001|NOT COMPLETED|Extension Study||0
8974058|NCT02641353|10038317|FG005|NOT COMPLETED|Overall Study||0
8632176|NCT00543543|9672034|FG002|NOT COMPLETED|Extension Study||0
8974059|NCT02641379|10038339|FG000|STARTED|Overall Study||142
8974060|NCT02641379|10038340|FG001|STARTED|Overall Study||152
8974061|NCT02641379|10038341|FG002|STARTED|Overall Study||78
8974062|NCT02641379|10038342|FG003|STARTED|Overall Study||156
8974063|NCT02641379|10038343|FG004|STARTED|Overall Study||17
8974064|NCT02641379|10038344|FG005|STARTED|Overall Study||36
8974065|NCT02641379|10038345|FG006|STARTED|Overall Study||25
8974066|NCT02641379|10038346|FG007|STARTED|Overall Study||20
8974067|NCT02641379|10038347|FG008|STARTED|Overall Study||42
8974068|NCT02641379|10038348|FG009|STARTED|Overall Study||45
8974069|NCT02641379|10038349|FG010|STARTED|Overall Study||8
8974070|NCT02641379|10038339|FG000|COMPLETED|Overall Study||107
8974071|NCT02641379|10038340|FG001|COMPLETED|Overall Study||101
8974072|NCT02641379|10038341|FG002|COMPLETED|Overall Study||7
8974073|NCT02641379|10038342|FG003|COMPLETED|Overall Study||139
8974074|NCT02641379|10038343|FG004|COMPLETED|Overall Study||0
8974075|NCT02641379|10038344|FG005|COMPLETED|Overall Study||20
8974076|NCT02641379|10038345|FG006|COMPLETED|Overall Study||12
8974077|NCT02641379|10038346|FG007|COMPLETED|Overall Study||1
8974078|NCT02641379|10038347|FG008|COMPLETED|Overall Study||36
8974079|NCT02641379|10038348|FG009|COMPLETED|Overall Study||36
8974080|NCT02641379|10038349|FG010|COMPLETED|Overall Study||0
8974081|NCT02641379|10038339|FG000|NOT COMPLETED|Overall Study||35
8974082|NCT02641379|10038340|FG001|NOT COMPLETED|Overall Study||51
8974083|NCT02641379|10038341|FG002|NOT COMPLETED|Overall Study||71
8974084|NCT02641379|10038342|FG003|NOT COMPLETED|Overall Study||17
8974085|NCT02641379|10038343|FG004|NOT COMPLETED|Overall Study||17
8974086|NCT02641379|10038344|FG005|NOT COMPLETED|Overall Study||16
8974087|NCT02641379|10038345|FG006|NOT COMPLETED|Overall Study||13
8974088|NCT02641379|10038346|FG007|NOT COMPLETED|Overall Study||19
8974089|NCT02641379|10038347|FG008|NOT COMPLETED|Overall Study||6
8974090|NCT02641379|10038348|FG009|NOT COMPLETED|Overall Study||9
8974091|NCT02641379|10038349|FG010|NOT COMPLETED|Overall Study||8
8974092|NCT02641392|10038381|FG000|STARTED|Overall Study||4
8974093|NCT02641392|10038382|FG001|STARTED|Overall Study||13
8974094|NCT02641392|10038383|FG002|STARTED|Overall Study||293
8974095|NCT02641392|10038381|FG000|COMPLETED|Overall Study||0
8974096|NCT02641392|10038382|FG001|COMPLETED|Overall Study||0
8974097|NCT02641392|10038383|FG002|COMPLETED|Overall Study||0
8974098|NCT02641392|10038381|FG000|NOT COMPLETED|Overall Study||4
8974099|NCT02641392|10038382|FG001|NOT COMPLETED|Overall Study||13
8974100|NCT02641392|10038383|FG002|NOT COMPLETED|Overall Study||293
8974101|NCT02641522|10038391|FG000|STARTED|Overall Study||10
8974102|NCT02641522|10038391|FG000|COMPLETED|Overall Study||10
8974103|NCT02641522|10038391|FG000|NOT COMPLETED|Overall Study||0
8974104|NCT02641561|10038399|FG000|STARTED|Overall Study||48
8974105|NCT02641561|10038400|FG001|STARTED|Overall Study||48
8974106|NCT02641561|10038401|FG002|STARTED|Overall Study||48
8974107|NCT02641561|10038402|FG003|STARTED|Overall Study||48
8974108|NCT02641561|10038399|FG000|COMPLETED|Overall Study||48
8974109|NCT02641561|10038400|FG001|COMPLETED|Overall Study||48
8974110|NCT02641561|10038401|FG002|COMPLETED|Overall Study||48
8974111|NCT02641561|10038402|FG003|COMPLETED|Overall Study||48
8974112|NCT02641561|10038399|FG000|NOT COMPLETED|Overall Study||0
8974113|NCT02641561|10038400|FG001|NOT COMPLETED|Overall Study||0
8974114|NCT02641561|10038401|FG002|NOT COMPLETED|Overall Study||0
8974115|NCT02641561|10038402|FG003|NOT COMPLETED|Overall Study||0
8974116|NCT02641587|10038415|FG000|STARTED|Confinement Period||80
8974117|NCT02641587|10038416|FG001|STARTED|Confinement Period||40
8974118|NCT02641587|10038415|FG000|COMPLETED|Confinement Period||77
8974119|NCT02641587|10038416|FG001|COMPLETED|Confinement Period||39
8974120|NCT02641587|10038415|FG000|NOT COMPLETED|Confinement Period||3
8974121|NCT02641587|10038416|FG001|NOT COMPLETED|Confinement Period||1
8974122|NCT02641587|10038415|FG000|STARTED|Ambulatory Period||77
8974123|NCT02641587|10038416|FG001|STARTED|Ambulatory Period||39
8974124|NCT02641587|10038415|FG000|COMPLETED|Ambulatory Period||76
8974125|NCT02641587|10038416|FG001|COMPLETED|Ambulatory Period||39
8974126|NCT02641587|10038415|FG000|NOT COMPLETED|Ambulatory Period||1
8974127|NCT02641587|10038416|FG001|NOT COMPLETED|Ambulatory Period||0
8974128|NCT02641691|10038429|FG000|STARTED|Overall Study||20
8974129|NCT02641691|10038429|FG000|COMPLETED|Overall Study||20
8974130|NCT02641691|10038429|FG000|NOT COMPLETED|Overall Study||0
8974131|NCT02641730|10038442|FG000|STARTED|Placebo Controlled Period (Week 0 - 16)||53
8974132|NCT02641730|10038443|FG001|STARTED|Placebo Controlled Period (Week 0 - 16)||0
8974133|NCT02641730|10038444|FG002|STARTED|Placebo Controlled Period (Week 0 - 16)||0
8974134|NCT02641730|10038445|FG003|STARTED|Placebo Controlled Period (Week 0 - 16)||54
8974135|NCT02641730|10038446|FG004|STARTED|Placebo Controlled Period (Week 0 - 16)||52
8974136|NCT02641730|10038442|FG000|COMPLETED|Placebo Controlled Period (Week 0 - 16)||51
8974137|NCT02641730|10038443|FG001|COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
8974138|NCT02641730|10038444|FG002|COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
8974139|NCT02641730|10038445|FG003|COMPLETED|Placebo Controlled Period (Week 0 - 16)||53
8974140|NCT02641730|10038446|FG004|COMPLETED|Placebo Controlled Period (Week 0 - 16)||50
8974141|NCT02641730|10038442|FG000|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||2
8974142|NCT02641730|10038443|FG001|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
8974143|NCT02641730|10038444|FG002|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
8974144|NCT02641730|10038445|FG003|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||1
8974145|NCT02641730|10038446|FG004|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||2
8974146|NCT02641730|10038442|FG000|STARTED|After Controlled Period (Week 16 - 52)||0
8974147|NCT02641730|10038443|FG001|STARTED|After Controlled Period (Week 16 - 52)||25
8974148|NCT02641730|10038444|FG002|STARTED|After Controlled Period (Week 16 - 52)||26
8974149|NCT02641730|10038445|FG003|STARTED|After Controlled Period (Week 16 - 52)||53
8974150|NCT02641730|10038446|FG004|STARTED|After Controlled Period (Week 16 - 52)||50
8974151|NCT02641730|10038442|FG000|COMPLETED|After Controlled Period (Week 16 - 52)||0
8974152|NCT02641730|10038443|FG001|COMPLETED|After Controlled Period (Week 16 - 52)||21
8974153|NCT02641730|10038444|FG002|COMPLETED|After Controlled Period (Week 16 - 52)||24
8974154|NCT02641730|10038445|FG003|COMPLETED|After Controlled Period (Week 16 - 52)||45
8974155|NCT02641730|10038446|FG004|COMPLETED|After Controlled Period (Week 16 - 52)||44
8974156|NCT02641730|10038442|FG000|NOT COMPLETED|After Controlled Period (Week 16 - 52)||0
8974157|NCT02641730|10038443|FG001|NOT COMPLETED|After Controlled Period (Week 16 - 52)||4
8974158|NCT02641730|10038444|FG002|NOT COMPLETED|After Controlled Period (Week 16 - 52)||2
8974159|NCT02641730|10038445|FG003|NOT COMPLETED|After Controlled Period (Week 16 - 52)||8
8974160|NCT02641730|10038446|FG004|NOT COMPLETED|After Controlled Period (Week 16 - 52)||6
8974161|NCT02641730|10038442|FG000|STARTED|Observational Period (Week 60 - Week 84)||0
8974162|NCT02641730|10038443|FG001|STARTED|Observational Period (Week 60 - Week 84)||21
8974163|NCT02641730|10038444|FG002|STARTED|Observational Period (Week 60 - Week 84)||24
8974164|NCT02641730|10038445|FG003|STARTED|Observational Period (Week 60 - Week 84)||45
8974165|NCT02641730|10038446|FG004|STARTED|Observational Period (Week 60 - Week 84)||44
8974166|NCT02641730|10038442|FG000|COMPLETED|Observational Period (Week 60 - Week 84)||0
8974167|NCT02641730|10038443|FG001|COMPLETED|Observational Period (Week 60 - Week 84)||21
8974168|NCT02641730|10038444|FG002|COMPLETED|Observational Period (Week 60 - Week 84)||24
8974169|NCT02641730|10038445|FG003|COMPLETED|Observational Period (Week 60 - Week 84)||45
8974170|NCT02641730|10038446|FG004|COMPLETED|Observational Period (Week 60 - Week 84)||43
8974171|NCT02641730|10038442|FG000|NOT COMPLETED|Observational Period (Week 60 - Week 84)||0
8974172|NCT02641730|10038443|FG001|NOT COMPLETED|Observational Period (Week 60 - Week 84)||0
8974173|NCT02641730|10038444|FG002|NOT COMPLETED|Observational Period (Week 60 - Week 84)||0
8974174|NCT02641730|10038445|FG003|NOT COMPLETED|Observational Period (Week 60 - Week 84)||0
8974175|NCT02641730|10038446|FG004|NOT COMPLETED|Observational Period (Week 60 - Week 84)||1
8974176|NCT02641834|10038462|FG000|STARTED|Overall Study||60
8974177|NCT02641834|10038463|FG001|STARTED|Overall Study||58
8974178|NCT02641834|10038462|FG000|COMPLETED|Overall Study||50
8974179|NCT02641834|10038463|FG001|COMPLETED|Overall Study||50
8974180|NCT02641834|10038462|FG000|NOT COMPLETED|Overall Study||10
8974181|NCT02641834|10038463|FG001|NOT COMPLETED|Overall Study||8
8974182|NCT02641912|10038472|FG000|STARTED|Overall Study||53
8974183|NCT02641912|10038473|FG001|STARTED|Overall Study||47
8974184|NCT02641912|10038472|FG000|COMPLETED|Overall Study||53
8974185|NCT02641912|10038473|FG001|COMPLETED|Overall Study||47
8974186|NCT02641912|10038472|FG000|NOT COMPLETED|Overall Study||0
8974187|NCT02641912|10038473|FG001|NOT COMPLETED|Overall Study||0
8974188|NCT02642159|10038485|FG000|STARTED|Overall Study|Randomized|276
8974189|NCT02642159|10038486|FG001|STARTED|Overall Study|Randomized|137
8974190|NCT02642159|10038485|FG000|Treated (Safety Population)|Overall Study||275
8974191|NCT02642159|10038486|FG001|Treated (Safety Population)|Overall Study||137
8974192|NCT02642159|10038485|FG000|ITT Population|Overall Study||273
8974193|NCT02642159|10038486|FG001|ITT Population|Overall Study||136
8974194|NCT02642159|10038485|FG000|ITT: Intent to Prescribe Fenofibrate|Overall Study|Fenofibrate was only 'intended to prescribe' in the Alirocumab arm but not actually administered.|47
8974195|NCT02642159|10038486|FG001|ITT: Intent to Prescribe Fenofibrate|Overall Study||24
8974196|NCT02642159|10038485|FG000|COMPLETED|Overall Study||245
8974197|NCT02642159|10038486|FG001|COMPLETED|Overall Study||129
8974198|NCT02642159|10038485|FG000|NOT COMPLETED|Overall Study||31
8974199|NCT02642159|10038486|FG001|NOT COMPLETED|Overall Study||8
8974200|NCT02642237|10038495|FG000|STARTED|Overall Study||15
8974201|NCT02642237|10038496|FG001|STARTED|Overall Study||15
8974202|NCT02642237|10038495|FG000|COMPLETED|Overall Study||15
8974203|NCT02642237|10038496|FG001|COMPLETED|Overall Study||15
8974204|NCT02642237|10038495|FG000|NOT COMPLETED|Overall Study||0
8974205|NCT02642237|10038496|FG001|NOT COMPLETED|Overall Study||0
8974206|NCT02642393|10038504|FG000|STARTED|Overall Study||149
8974207|NCT02642393|10038505|FG001|STARTED|Overall Study||149
8974208|NCT02642393|10038504|FG000|COMPLETED|Overall Study|"Participants who completed the study:~On-drug: 31; In-person off-drug:13; By telephone off-drug: 6"|50
8974209|NCT02642393|10038505|FG001|COMPLETED|Overall Study|"Participants who completed the study:~On-drug: 40; In-person off-drug: 16; By telephone off-drug: 1"|57
8974210|NCT02642393|10038504|FG000|NOT COMPLETED|Overall Study||99
8974211|NCT02642393|10038505|FG001|NOT COMPLETED|Overall Study||92
8974212|NCT02642432|10038511|FG000|STARTED|Overall Study||146
8974213|NCT02642432|10038511|FG000|COMPLETED|Overall Study||138
8974214|NCT02642432|10038511|FG000|NOT COMPLETED|Overall Study||8
8974215|NCT02642536|10038517|FG000|STARTED|Overall Study||21
8974216|NCT02642536|10038518|FG001|STARTED|Overall Study||23
8974217|NCT02642536|10038517|FG000|COMPLETED|Overall Study||19
8974218|NCT02642536|10038518|FG001|COMPLETED|Overall Study||18
8974219|NCT02642536|10038517|FG000|NOT COMPLETED|Overall Study||2
8974220|NCT02642536|10038518|FG001|NOT COMPLETED|Overall Study||5
8974221|NCT02642575|10038524|FG000|STARTED|Overall Study||67
8974222|NCT02642575|10038524|FG000|COMPLETED|Overall Study||67
8974223|NCT02642575|10038524|FG000|NOT COMPLETED|Overall Study||0
8974224|NCT02642614|10038532|FG000|STARTED|Overall Study||30
8974225|NCT02642614|10038533|FG001|STARTED|Overall Study||30
8974226|NCT02642614|10038534|FG002|STARTED|Overall Study||30
8974227|NCT02642614|10038535|FG003|STARTED|Overall Study||30
8974228|NCT02642614|10038532|FG000|COMPLETED|Overall Study||27
8974229|NCT02642614|10038533|FG001|COMPLETED|Overall Study||28
8974230|NCT02642614|10038534|FG002|COMPLETED|Overall Study||28
8974231|NCT02642614|10038535|FG003|COMPLETED|Overall Study||28
8974232|NCT02642614|10038532|FG000|NOT COMPLETED|Overall Study||3
8974233|NCT02642614|10038533|FG001|NOT COMPLETED|Overall Study||2
8974234|NCT02642614|10038534|FG002|NOT COMPLETED|Overall Study||2
8974235|NCT02642614|10038535|FG003|NOT COMPLETED|Overall Study||2
8974236|NCT02642627|10038548|FG000|STARTED|Overall Study||42
8974237|NCT02642627|10038548|FG000|COMPLETED|Overall Study||39
8974238|NCT02642627|10038548|FG000|NOT COMPLETED|Overall Study||3
8974239|NCT02642653|10038555|FG000|STARTED|Overall Study||14
8974240|NCT02642653|10038556|FG001|STARTED|Overall Study||16
8974241|NCT02642653|10038555|FG000|COMPLETED|Overall Study||12
8974242|NCT02642653|10038556|FG001|COMPLETED|Overall Study||16
8974243|NCT02642653|10038555|FG000|NOT COMPLETED|Overall Study||2
8974244|NCT02642653|10038556|FG001|NOT COMPLETED|Overall Study||0
8974245|NCT02642679|10038562|FG000|STARTED|Overall Study||19
8974246|NCT02642679|10038562|FG000|COMPLETED|Overall Study||16
8974247|NCT02642679|10038562|FG000|NOT COMPLETED|Overall Study||3
8877150|NCT01921829|9934078|FG001|NOT COMPLETED|Overall Study||1
8877151|NCT01921894|9934087|FG000|STARTED|Overall Study||8
8877152|NCT01921894|9934088|FG001|STARTED|Overall Study||8
8974248|NCT02642835|10038566|FG000|STARTED|Overall Study||48
8974249|NCT02642835|10038566|FG000|COMPLETED|Overall Study||48
8974250|NCT02642835|10038566|FG000|NOT COMPLETED|Overall Study||0
8974251|NCT02642952|10038572|FG000|STARTED|Overall Study||21
8974252|NCT02642952|10038573|FG001|STARTED|Overall Study||30
8974253|NCT02642952|10038572|FG000|COMPLETED|Overall Study||19
8974254|NCT02642952|10038573|FG001|COMPLETED|Overall Study||25
8974255|NCT02642952|10038572|FG000|NOT COMPLETED|Overall Study||2
8877153|NCT01921894|9934089|FG002|STARTED|Overall Study||8
8877154|NCT01921894|9934087|FG000|COMPLETED|Overall Study||8
8877155|NCT01921894|9934088|FG001|COMPLETED|Overall Study||8
8974256|NCT02642952|10038573|FG001|NOT COMPLETED|Overall Study||5
8974257|NCT02642991|10038579|FG000|STARTED|First Intervention||22
8974258|NCT02642991|10038580|FG001|STARTED|First Intervention||22
8974259|NCT02642991|10038579|FG000|COMPLETED|First Intervention||22
8974260|NCT02642991|10038580|FG001|COMPLETED|First Intervention||22
8974261|NCT02642991|10038579|FG000|NOT COMPLETED|First Intervention||0
8974262|NCT02642991|10038580|FG001|NOT COMPLETED|First Intervention||0
8974263|NCT02642991|10038579|FG000|STARTED|Second Intervention||22
8974264|NCT02642991|10038580|FG001|STARTED|Second Intervention||22
8974265|NCT02642991|10038579|FG000|COMPLETED|Second Intervention||22
8974266|NCT02642991|10038580|FG001|COMPLETED|Second Intervention||22
8974267|NCT02642991|10038579|FG000|NOT COMPLETED|Second Intervention||0
8974268|NCT02642991|10038580|FG001|NOT COMPLETED|Second Intervention||0
8974269|NCT02643004|10038589|FG000|STARTED|First Intervention (One Week)||35
8974270|NCT02643004|10038590|FG001|STARTED|First Intervention (One Week)||35
8974271|NCT02643004|10038589|FG000|COMPLETED|First Intervention (One Week)||35
8974272|NCT02643004|10038590|FG001|COMPLETED|First Intervention (One Week)||35
8974273|NCT02643004|10038589|FG000|NOT COMPLETED|First Intervention (One Week)||0
8974274|NCT02643004|10038590|FG001|NOT COMPLETED|First Intervention (One Week)||0
8974275|NCT02643004|10038589|FG000|STARTED|Second Intervention (One Week)||35
8974276|NCT02643004|10038590|FG001|STARTED|Second Intervention (One Week)||35
8974277|NCT02643004|10038589|FG000|COMPLETED|Second Intervention (One Week)||35
8974278|NCT02643004|10038590|FG001|COMPLETED|Second Intervention (One Week)||35
8974279|NCT02643004|10038589|FG000|NOT COMPLETED|Second Intervention (One Week)||0
8974280|NCT02643004|10038590|FG001|NOT COMPLETED|Second Intervention (One Week)||0
8974281|NCT02643082|10038596|FG000|STARTED|Period 1||10
8974282|NCT02643082|10038597|FG001|STARTED|Period 1||10
8974283|NCT02643082|10038596|FG000|COMPLETED|Period 1||9
8974284|NCT02643082|10038597|FG001|COMPLETED|Period 1||10
8974285|NCT02643082|10038596|FG000|NOT COMPLETED|Period 1||1
8974286|NCT02643082|10038597|FG001|NOT COMPLETED|Period 1||0
8974287|NCT02643082|10038596|FG000|STARTED|Washout||9
8877156|NCT01921894|9934089|FG002|COMPLETED|Overall Study||8
8877157|NCT01921894|9934087|FG000|NOT COMPLETED|Overall Study||0
8877158|NCT01921894|9934088|FG001|NOT COMPLETED|Overall Study||0
8877159|NCT01921894|9934089|FG002|NOT COMPLETED|Overall Study||0
8877160|NCT01922011|9934111|FG000|STARTED|Overall Study|Randomized participants|75
8877161|NCT01922011|9934112|FG001|STARTED|Overall Study|Randomized participants|74
8877162|NCT01922011|9934111|FG000|Treated|Overall Study|Treated Participants|73
8974288|NCT02643082|10038597|FG001|STARTED|Washout||10
8974289|NCT02643082|10038596|FG000|COMPLETED|Washout||9
8877163|NCT01922011|9934112|FG001|Treated|Overall Study|Treated Participants|73
8974290|NCT02643082|10038597|FG001|COMPLETED|Washout||10
8974291|NCT02643082|10038596|FG000|NOT COMPLETED|Washout||0
8974292|NCT02643082|10038597|FG001|NOT COMPLETED|Washout||0
8974293|NCT02643082|10038596|FG000|STARTED|Period 2||9
8632177|NCT00543543|9672035|FG003|NOT COMPLETED|Extension Study||226
8632178|NCT00543569|9672054|FG000|STARTED|Overall Study||82
8632179|NCT00543569|9672055|FG001|STARTED|Overall Study||80
8632180|NCT00543569|9672056|FG002|STARTED|Overall Study||80
8974294|NCT02643082|10038597|FG001|STARTED|Period 2||10
8974295|NCT02643082|10038596|FG000|COMPLETED|Period 2||9
8974296|NCT02643082|10038597|FG001|COMPLETED|Period 2||10
8974297|NCT02643082|10038596|FG000|NOT COMPLETED|Period 2||0
8974298|NCT02643082|10038597|FG001|NOT COMPLETED|Period 2||0
8974299|NCT02643095|10038604|FG000|STARTED|Overall Study||22
8974300|NCT02643095|10038604|FG000|COMPLETED|Overall Study||21
8974301|NCT02643095|10038604|FG000|NOT COMPLETED|Overall Study||1
8974302|NCT02643199|10038608|FG000|STARTED|Overall Study||90
8974303|NCT02643199|10038608|FG000|COMPLETED|Overall Study||90
8974304|NCT02643199|10038608|FG000|NOT COMPLETED|Overall Study||0
8974305|NCT02643225|10038614|FG000|STARTED|Overall Study||40
8974306|NCT02643225|10038615|FG001|STARTED|Overall Study||40
8974307|NCT02643225|10038614|FG000|COMPLETED|Overall Study||40
8974308|NCT02643225|10038615|FG001|COMPLETED|Overall Study||40
8974309|NCT02643225|10038614|FG000|NOT COMPLETED|Overall Study||0
8974310|NCT02643225|10038615|FG001|NOT COMPLETED|Overall Study||0
8974311|NCT02643251|10038624|FG000|STARTED|Overall Study||69
8974312|NCT02643251|10038625|FG001|STARTED|Overall Study||69
8974313|NCT02643251|10038624|FG000|COMPLETED|Overall Study||58
8974314|NCT02643251|10038625|FG001|COMPLETED|Overall Study||67
8974315|NCT02643251|10038624|FG000|NOT COMPLETED|Overall Study||11
8974316|NCT02643251|10038625|FG001|NOT COMPLETED|Overall Study||2
8974317|NCT02643355|10038633|FG000|STARTED|Overall Study||34
8974318|NCT02643355|10038634|FG001|STARTED|Overall Study||35
8974319|NCT02643355|10038633|FG000|COMPLETED|Overall Study||33
8974320|NCT02643355|10038634|FG001|COMPLETED|Overall Study||30
8974321|NCT02643355|10038633|FG000|NOT COMPLETED|Overall Study||1
8974322|NCT02643355|10038634|FG001|NOT COMPLETED|Overall Study||5
8974323|NCT02643394|10038642|FG000|STARTED|Overall Study||55
8974324|NCT02643394|10038643|FG001|STARTED|Overall Study||55
8974325|NCT02643394|10038642|FG000|COMPLETED|Overall Study||51
8974326|NCT02643394|10038643|FG001|COMPLETED|Overall Study||50
8974327|NCT02643394|10038642|FG000|NOT COMPLETED|Overall Study||4
8974328|NCT02643394|10038643|FG001|NOT COMPLETED|Overall Study||5
8974329|NCT02643459|10038651|FG000|STARTED|Overall Study||7901
8974330|NCT02643459|10038652|FG001|STARTED|Overall Study||8900
8974331|NCT02643459|10038651|FG000|COMPLETED|Overall Study||7901
8974332|NCT02643459|10038652|FG001|COMPLETED|Overall Study||8900
8974333|NCT02643459|10038651|FG000|NOT COMPLETED|Overall Study||0
8974334|NCT02643459|10038652|FG001|NOT COMPLETED|Overall Study||0
8974335|NCT02643472|10038661|FG000|STARTED|Overall Study||150
8974336|NCT02643472|10038662|FG001|STARTED|Overall Study||150
8974337|NCT02643472|10038661|FG000|COMPLETED|Overall Study||123
8974338|NCT02643472|10038662|FG001|COMPLETED|Overall Study|One participant completed CESD-10 but not other measures at 12 months; n=115 for other measures.|116
8974339|NCT02643472|10038661|FG000|NOT COMPLETED|Overall Study||27
8974340|NCT02643472|10038662|FG001|NOT COMPLETED|Overall Study||34
8974341|NCT02643615|10038672|FG000|STARTED|Overall Study||9
8974342|NCT02643615|10038673|FG001|STARTED|Overall Study||11
8974343|NCT02643615|10038672|FG000|COMPLETED|Overall Study||9
8974344|NCT02643615|10038673|FG001|COMPLETED|Overall Study||11
8974345|NCT02643615|10038672|FG000|NOT COMPLETED|Overall Study||0
8974346|NCT02643615|10038673|FG001|NOT COMPLETED|Overall Study||0
8974347|NCT02643628|10038682|FG000|STARTED|Overall Study||21
8974348|NCT02643628|10038683|FG001|STARTED|Overall Study||23
8974349|NCT02643628|10038682|FG000|COMPLETED|Overall Study||20
8974350|NCT02643628|10038683|FG001|COMPLETED|Overall Study||17
8974351|NCT02643628|10038682|FG000|NOT COMPLETED|Overall Study||1
8974352|NCT02643628|10038683|FG001|NOT COMPLETED|Overall Study||6
8974353|NCT02643693|10038691|FG000|STARTED|Overall Study||4
8974354|NCT02643693|10038692|FG001|STARTED|Overall Study||4
8974355|NCT02643693|10038693|FG002|STARTED|Overall Study||4
8974356|NCT02643693|10038694|FG003|STARTED|Overall Study||4
8974357|NCT02643693|10038695|FG004|STARTED|Overall Study||4
8974358|NCT02643693|10038696|FG005|STARTED|Overall Study||4
8974359|NCT02643693|10038691|FG000|COMPLETED|Overall Study||2
8974360|NCT02643693|10038692|FG001|COMPLETED|Overall Study||2
8974361|NCT02643693|10038693|FG002|COMPLETED|Overall Study||3
8974362|NCT02643693|10038694|FG003|COMPLETED|Overall Study||4
8974363|NCT02643693|10038695|FG004|COMPLETED|Overall Study||4
8974364|NCT02643693|10038696|FG005|COMPLETED|Overall Study||3
8632181|NCT00543569|9672057|FG003|STARTED|Overall Study||81
8974365|NCT02643693|10038691|FG000|NOT COMPLETED|Overall Study||2
8974366|NCT02643693|10038692|FG001|NOT COMPLETED|Overall Study||2
8974367|NCT02643693|10038693|FG002|NOT COMPLETED|Overall Study||1
8974368|NCT02643693|10038694|FG003|NOT COMPLETED|Overall Study||0
8974369|NCT02643693|10038695|FG004|NOT COMPLETED|Overall Study||0
8974370|NCT02643693|10038696|FG005|NOT COMPLETED|Overall Study||1
8974371|NCT02643849|10038704|FG000|STARTED|Overall Study||107
8974372|NCT02643849|10038704|FG000|COMPLETED|Overall Study||82
8974373|NCT02643849|10038704|FG000|NOT COMPLETED|Overall Study||25
8974374|NCT02643862|10038710|FG000|STARTED|Overall Study||36
8974375|NCT02643862|10038711|FG001|STARTED|Overall Study||12
8974376|NCT02643862|10038710|FG000|COMPLETED|Overall Study||36
8632182|NCT00543569|9672054|FG000|Received Treatment|Overall Study||79
8974377|NCT02643862|10038711|FG001|COMPLETED|Overall Study||12
8974378|NCT02643862|10038710|FG000|NOT COMPLETED|Overall Study||0
8632183|NCT00543569|9672055|FG001|Received Treatment|Overall Study||77
8974379|NCT02643862|10038711|FG001|NOT COMPLETED|Overall Study||0
8974380|NCT02643875|10038717|FG000|STARTED|Overall Study||36
8974381|NCT02643875|10038717|FG000|Received 0.75|Overall Study||36
8974382|NCT02643875|10038717|FG000|Received 1.75 D|Overall Study||36
8974383|NCT02643875|10038717|FG000|COMPLETED|Overall Study||28
8974384|NCT02643875|10038717|FG000|NOT COMPLETED|Overall Study||8
8974385|NCT02643979|10038724|FG000|STARTED|Overall Study||11
8974386|NCT02643979|10038725|FG001|STARTED|Overall Study||11
8974387|NCT02643979|10038724|FG000|COMPLETED|Overall Study||11
8974388|NCT02643979|10038725|FG001|COMPLETED|Overall Study||11
8974389|NCT02643979|10038724|FG000|NOT COMPLETED|Overall Study||0
8974390|NCT02643979|10038725|FG001|NOT COMPLETED|Overall Study||0
8974391|NCT02644096|10038733|FG000|STARTED|Overall Study||93
8974392|NCT02644096|10038734|FG001|STARTED|Overall Study||82
8974393|NCT02644096|10038733|FG000|2 Week Interview|Overall Study|Not done in control group|0
8974394|NCT02644096|10038734|FG001|2 Week Interview|Overall Study||68
8974395|NCT02644096|10038733|FG000|10 Week Interview|Overall Study|Not done in control group|0
8974396|NCT02644096|10038734|FG001|10 Week Interview|Overall Study||59
8974397|NCT02644096|10038733|FG000|12 Week SF-36 Questionnaire|Overall Study||68
8974398|NCT02644096|10038734|FG001|12 Week SF-36 Questionnaire|Overall Study||59
8974399|NCT02644096|10038733|FG000|9 Month SF-36 Questionnaire|Overall Study||65
8974400|NCT02644096|10038734|FG001|9 Month SF-36 Questionnaire|Overall Study||57
8974401|NCT02644096|10038733|FG000|COMPLETED|Overall Study||65
8974402|NCT02644096|10038734|FG001|COMPLETED|Overall Study||57
8974403|NCT02644096|10038733|FG000|NOT COMPLETED|Overall Study||28
8974404|NCT02644096|10038734|FG001|NOT COMPLETED|Overall Study||25
8974405|NCT02644109|10038742|FG000|STARTED|Overall Study||24
8974406|NCT02644109|10038743|FG001|STARTED|Overall Study||28
8974407|NCT02644109|10038742|FG000|COMPLETED|Overall Study||24
8974408|NCT02644109|10038743|FG001|COMPLETED|Overall Study||24
8974409|NCT02644109|10038742|FG000|NOT COMPLETED|Overall Study||0
8974410|NCT02644109|10038743|FG001|NOT COMPLETED|Overall Study||4
8974411|NCT02644122|10038749|FG000|STARTED|Overall Study||1
8974412|NCT02644122|10038749|FG000|COMPLETED|Overall Study||0
8974413|NCT02644122|10038749|FG000|NOT COMPLETED|Overall Study||1
8974414|NCT02644278|10038758|FG000|STARTED|Overall Study||3
8974415|NCT02644278|10038759|FG001|STARTED|Overall Study||3
8974416|NCT02644278|10038760|FG002|STARTED|Overall Study||6
8974417|NCT02644278|10038761|FG003|STARTED|Overall Study||3
8974418|NCT02644278|10038758|FG000|COMPLETED|Overall Study||3
8974419|NCT02644278|10038759|FG001|COMPLETED|Overall Study||3
8974420|NCT02644278|10038760|FG002|COMPLETED|Overall Study||6
8974421|NCT02644278|10038761|FG003|COMPLETED|Overall Study||3
8974422|NCT02644278|10038758|FG000|NOT COMPLETED|Overall Study||0
8974423|NCT02644278|10038759|FG001|NOT COMPLETED|Overall Study||0
8974424|NCT02644278|10038760|FG002|NOT COMPLETED|Overall Study||0
8974425|NCT02644278|10038761|FG003|NOT COMPLETED|Overall Study||0
8974426|NCT02644343|10038771|FG000|STARTED|Overall Study||40
8974427|NCT02644343|10038771|FG000|COMPLETED|Overall Study||39
8974428|NCT02644343|10038771|FG000|NOT COMPLETED|Overall Study||1
8974429|NCT02644356|10038775|FG000|STARTED|Overall Study||51
8974430|NCT02644356|10038775|FG000|COMPLETED|Overall Study|49 of the 51 consented subjects completed pre-post knowledge testing (96%)|49
8974431|NCT02644356|10038775|FG000|NOT COMPLETED|Overall Study||2
8974432|NCT02644668|10038782|FG000|STARTED|Overall Study||26
8974433|NCT02644668|10038783|FG001|STARTED|Overall Study||24
8974434|NCT02644668|10038784|FG002|STARTED|Overall Study||20
8974435|NCT02644668|10038782|FG000|COMPLETED|Overall Study||24
8974436|NCT02644668|10038783|FG001|COMPLETED|Overall Study||24
8974437|NCT02644668|10038784|FG002|COMPLETED|Overall Study||17
8974438|NCT02644668|10038782|FG000|NOT COMPLETED|Overall Study||2
8974439|NCT02644668|10038783|FG001|NOT COMPLETED|Overall Study||0
8974440|NCT02644668|10038784|FG002|NOT COMPLETED|Overall Study||3
8974441|NCT02645019|10038799|FG000|STARTED|Overall Study||13
8974442|NCT02645019|10038800|FG001|STARTED|Overall Study||15
8974443|NCT02645019|10038801|FG002|STARTED|Overall Study||15
8974444|NCT02645019|10038802|FG003|STARTED|Overall Study||33
8974445|NCT02645019|10038803|FG004|STARTED|Overall Study||24
8974446|NCT02645019|10038799|FG000|COMPLETED|Overall Study||13
8974447|NCT02645019|10038800|FG001|COMPLETED|Overall Study||15
8974448|NCT02645019|10038801|FG002|COMPLETED|Overall Study||15
8974449|NCT02645019|10038802|FG003|COMPLETED|Overall Study||33
8974450|NCT02645019|10038803|FG004|COMPLETED|Overall Study||24
8974451|NCT02645019|10038799|FG000|NOT COMPLETED|Overall Study||0
8974452|NCT02645019|10038800|FG001|NOT COMPLETED|Overall Study||0
8974453|NCT02645019|10038801|FG002|NOT COMPLETED|Overall Study||0
8974454|NCT02645019|10038802|FG003|NOT COMPLETED|Overall Study||0
8974455|NCT02645019|10038803|FG004|NOT COMPLETED|Overall Study||0
9038439|NCT03331965|10099674|FG000|STARTED|Overall Study||55
9038440|NCT03331965|10099675|FG001|STARTED|Overall Study||55
9038441|NCT03331965|10099674|FG000|COMPLETED|Overall Study||45
9038442|NCT03331965|10099675|FG001|COMPLETED|Overall Study||51
9038443|NCT03331965|10099674|FG000|NOT COMPLETED|Overall Study||10
9038444|NCT03331965|10099675|FG001|NOT COMPLETED|Overall Study||4
9038445|NCT03332160|10099683|FG000|STARTED|Overall Study||25
9038446|NCT03332160|10099684|FG001|STARTED|Overall Study||24
9038447|NCT03332160|10099683|FG000|COMPLETED|Overall Study||24
9038448|NCT03332160|10099684|FG001|COMPLETED|Overall Study||19
9038449|NCT03332160|10099683|FG000|NOT COMPLETED|Overall Study||1
9038450|NCT03332160|10099684|FG001|NOT COMPLETED|Overall Study||5
9038451|NCT03332212|10099695|FG000|STARTED|Overall Study||19
9038452|NCT03332212|10099696|FG001|STARTED|Overall Study||18
9038453|NCT03332212|10099697|FG002|STARTED|Overall Study||17
8974456|NCT02645123|10038818|FG000|STARTED|Overall Study||25
8974457|NCT02645123|10038819|FG001|STARTED|Overall Study||25
8974458|NCT02645123|10038820|FG002|STARTED|Overall Study||25
8974459|NCT02645123|10038818|FG000|COMPLETED|Overall Study||25
8974460|NCT02645123|10038819|FG001|COMPLETED|Overall Study||25
8974461|NCT02645123|10038820|FG002|COMPLETED|Overall Study||25
8974462|NCT02645123|10038818|FG000|NOT COMPLETED|Overall Study||0
8974463|NCT02645123|10038819|FG001|NOT COMPLETED|Overall Study||0
8974464|NCT02645123|10038820|FG002|NOT COMPLETED|Overall Study||0
8974465|NCT02645253|10038832|FG000|STARTED|Overall Study||7
8974466|NCT02645253|10038833|FG001|STARTED|Overall Study||7
8974467|NCT02645253|10038834|FG002|STARTED|Overall Study||7
8974468|NCT02645253|10038835|FG003|STARTED|Overall Study||6
8974469|NCT02645253|10038832|FG000|COMPLETED|Overall Study||7
8974470|NCT02645253|10038833|FG001|COMPLETED|Overall Study||7
8974471|NCT02645253|10038834|FG002|COMPLETED|Overall Study||7
8974472|NCT02645253|10038835|FG003|COMPLETED|Overall Study||6
8974473|NCT02645253|10038832|FG000|NOT COMPLETED|Overall Study||0
8974474|NCT02645253|10038833|FG001|NOT COMPLETED|Overall Study||0
8974475|NCT02645253|10038834|FG002|NOT COMPLETED|Overall Study||0
8974476|NCT02645253|10038835|FG003|NOT COMPLETED|Overall Study||0
8974477|NCT02645409|10038852|FG000|STARTED|Overall Study||14
8974478|NCT02645409|10038853|FG001|STARTED|Overall Study|It was decided to not continue with the Radical Nephrectomy arm of the study.|0
8974479|NCT02645409|10038852|FG000|COMPLETED|Overall Study||10
8974480|NCT02645409|10038853|FG001|COMPLETED|Overall Study||0
8974481|NCT02645409|10038852|FG000|NOT COMPLETED|Overall Study||4
8974482|NCT02645409|10038853|FG001|NOT COMPLETED|Overall Study||0
8974483|NCT02645617|10038858|FG000|STARTED|Overall Study||12
8974484|NCT02645617|10038858|FG000|COMPLETED|Overall Study||12
8974485|NCT02645617|10038858|FG000|NOT COMPLETED|Overall Study||0
8974486|NCT02645760|10038864|FG000|STARTED|Overall Study||19
8974487|NCT02645760|10038865|FG001|STARTED|Overall Study||19
8974488|NCT02645760|10038864|FG000|COMPLETED|Overall Study||19
8974489|NCT02645760|10038865|FG001|COMPLETED|Overall Study||19
8974490|NCT02645760|10038864|FG000|NOT COMPLETED|Overall Study||0
8974491|NCT02645760|10038865|FG001|NOT COMPLETED|Overall Study||0
8974492|NCT02646124|10038874|FG000|STARTED|Overall Study||57
8974493|NCT02646124|10038875|FG001|STARTED|Overall Study||57
8974494|NCT02646124|10038874|FG000|COMPLETED|Overall Study||57
8974495|NCT02646124|10038875|FG001|COMPLETED|Overall Study||55
8974496|NCT02646124|10038874|FG000|NOT COMPLETED|Overall Study||0
8974497|NCT02646124|10038875|FG001|NOT COMPLETED|Overall Study||2
8974498|NCT02646332|10038883|FG000|STARTED|Overall Study||124
8974499|NCT02646332|10038884|FG001|STARTED|Overall Study||124
8974500|NCT02646332|10038883|FG000|COMPLETED|Overall Study||124
8974501|NCT02646332|10038884|FG001|COMPLETED|Overall Study||121
8974502|NCT02646332|10038883|FG000|NOT COMPLETED|Overall Study||0
8974503|NCT02646332|10038884|FG001|NOT COMPLETED|Overall Study||3
8974504|NCT02646371|10038892|FG000|STARTED|Overall Study||34
8974505|NCT02646371|10038893|FG001|STARTED|Overall Study||33
8974506|NCT02646371|10038892|FG000|COMPLETED|Overall Study||34
8974507|NCT02646371|10038893|FG001|COMPLETED|Overall Study||33
8974508|NCT02646371|10038892|FG000|NOT COMPLETED|Overall Study||0
8974509|NCT02646371|10038893|FG001|NOT COMPLETED|Overall Study||0
8974510|NCT02646423|10038901|FG000|STARTED|Overall Study||742
8974511|NCT02646423|10038902|FG001|STARTED|Overall Study||743
8974512|NCT02646423|10038901|FG000|COMPLETED|Overall Study||735
8974513|NCT02646423|10038902|FG001|COMPLETED|Overall Study||735
8974514|NCT02646423|10038901|FG000|NOT COMPLETED|Overall Study||7
8974515|NCT02646423|10038902|FG001|NOT COMPLETED|Overall Study||8
8974516|NCT02646449|10038910|FG000|STARTED|Overall Study||4
8974517|NCT02646449|10038911|FG001|STARTED|Overall Study||3
8974518|NCT02646449|10038910|FG000|COMPLETED|Overall Study||4
8974519|NCT02646449|10038911|FG001|COMPLETED|Overall Study||3
8974520|NCT02646449|10038910|FG000|NOT COMPLETED|Overall Study||0
8974521|NCT02646449|10038911|FG001|NOT COMPLETED|Overall Study||0
8974522|NCT02646566|10038920|FG000|STARTED|Overall Study||237
8632184|NCT00543569|9672056|FG002|Received Treatment|Overall Study||75
8632185|NCT00543569|9672057|FG003|Received Treatment|Overall Study||78
8632186|NCT00543569|9672054|FG000|COMPLETED|Overall Study||70
8632187|NCT00543569|9672055|FG001|COMPLETED|Overall Study||72
8632188|NCT00543569|9672056|FG002|COMPLETED|Overall Study||60
8974523|NCT02646566|10038921|FG001|STARTED|Overall Study||230
8974524|NCT02646566|10038922|FG002|STARTED|Overall Study||235
8974525|NCT02646566|10038920|FG000|COMPLETED|Overall Study||231
8974526|NCT02646566|10038921|FG001|COMPLETED|Overall Study||226
8974527|NCT02646566|10038922|FG002|COMPLETED|Overall Study||230
8974528|NCT02646566|10038920|FG000|NOT COMPLETED|Overall Study||6
8974529|NCT02646566|10038921|FG001|NOT COMPLETED|Overall Study||4
8974530|NCT02646566|10038922|FG002|NOT COMPLETED|Overall Study||5
8974531|NCT02646618|10038932|FG000|STARTED|Overall Study||167
8974532|NCT02646618|10038933|FG001|STARTED|Overall Study||162
8632189|NCT00543569|9672057|FG003|COMPLETED|Overall Study||72
8974533|NCT02646618|10038932|FG000|6 Month Follow-up|Overall Study||152
8974534|NCT02646618|10038933|FG001|6 Month Follow-up|Overall Study||150
8974535|NCT02646618|10038932|FG000|COMPLETED|Overall Study||157
8974536|NCT02646618|10038933|FG001|COMPLETED|Overall Study||148
8974537|NCT02646618|10038932|FG000|NOT COMPLETED|Overall Study||10
8974538|NCT02646618|10038933|FG001|NOT COMPLETED|Overall Study||14
8974539|NCT02646761|10038943|FG000|STARTED|Overall Study||18
8974540|NCT02646761|10038944|FG001|STARTED|Overall Study||20
8974541|NCT02646761|10038943|FG000|Subject Withdrew Before Baseline|Overall Study||5
8974542|NCT02646761|10038944|FG001|Subject Withdrew Before Baseline|Overall Study||8
8974543|NCT02646761|10038943|FG000|Baseline Assessment|Overall Study||13
8974544|NCT02646761|10038944|FG001|Baseline Assessment|Overall Study||12
8974545|NCT02646761|10038943|FG000|5-week Assessment|Overall Study||12
8974546|NCT02646761|10038944|FG001|5-week Assessment|Overall Study||10
8974547|NCT02646761|10038943|FG000|COMPLETED|Overall Study||10
8974548|NCT02646761|10038944|FG001|COMPLETED|Overall Study||10
8974549|NCT02646761|10038943|FG000|NOT COMPLETED|Overall Study||8
8974550|NCT02646761|10038944|FG001|NOT COMPLETED|Overall Study||10
8974551|NCT02646826|10038954|FG000|STARTED|Overall Study||21
8974552|NCT02646826|10038955|FG001|STARTED|Overall Study||22
8974553|NCT02646826|10038956|FG002|STARTED|Overall Study||21
8974554|NCT02646826|10038957|FG003|STARTED|Overall Study||22
8974555|NCT02646826|10038954|FG000|COMPLETED|Overall Study||19
8974556|NCT02646826|10038955|FG001|COMPLETED|Overall Study||22
8974557|NCT02646826|10038956|FG002|COMPLETED|Overall Study||20
8974558|NCT02646826|10038957|FG003|COMPLETED|Overall Study||21
8974559|NCT02646826|10038954|FG000|NOT COMPLETED|Overall Study||2
8974560|NCT02646826|10038955|FG001|NOT COMPLETED|Overall Study||0
8974561|NCT02646826|10038956|FG002|NOT COMPLETED|Overall Study||1
8974562|NCT02646826|10038957|FG003|NOT COMPLETED|Overall Study||1
8974563|NCT02646891|10038977|FG000|STARTED|Overall Study||6
8974564|NCT02646891|10038978|FG001|STARTED|Overall Study||12
8974565|NCT02646891|10038979|FG002|STARTED|Overall Study||12
8974566|NCT02646891|10038980|FG003|STARTED|Overall Study||6
8974567|NCT02646891|10038981|FG004|STARTED|Overall Study||12
8974568|NCT02646891|10038982|FG005|STARTED|Overall Study||12
8974569|NCT02646891|10038983|FG006|STARTED|Overall Study||139
8974570|NCT02646891|10038984|FG007|STARTED|Overall Study||140
8974571|NCT02646891|10038985|FG008|STARTED|Overall Study||140
8974572|NCT02646891|10038986|FG009|STARTED|Overall Study||139
8974573|NCT02646891|10038977|FG000|Received at Least 1 Dose|Overall Study||6
8974574|NCT02646891|10038978|FG001|Received at Least 1 Dose|Overall Study||12
8974575|NCT02646891|10038979|FG002|Received at Least 1 Dose|Overall Study||12
8974576|NCT02646891|10038980|FG003|Received at Least 1 Dose|Overall Study||6
8974577|NCT02646891|10038981|FG004|Received at Least 1 Dose|Overall Study||12
8974578|NCT02646891|10038982|FG005|Received at Least 1 Dose|Overall Study||12
8974579|NCT02646891|10038983|FG006|Received at Least 1 Dose|Overall Study||139
8974580|NCT02646891|10038984|FG007|Received at Least 1 Dose|Overall Study|One participant was randomized but determined to be ineligible pre-vaccination.|139
8974581|NCT02646891|10038985|FG008|Received at Least 1 Dose|Overall Study||140
8974582|NCT02646891|10038986|FG009|Received at Least 1 Dose|Overall Study||139
8974583|NCT02646891|10038977|FG000|COMPLETED|Overall Study||4
8974584|NCT02646891|10038978|FG001|COMPLETED|Overall Study||11
8974585|NCT02646891|10038979|FG002|COMPLETED|Overall Study||11
8974586|NCT02646891|10038980|FG003|COMPLETED|Overall Study||6
8974587|NCT02646891|10038981|FG004|COMPLETED|Overall Study||12
8974588|NCT02646891|10038982|FG005|COMPLETED|Overall Study||12
8974589|NCT02646891|10038983|FG006|COMPLETED|Overall Study||130
8974590|NCT02646891|10038984|FG007|COMPLETED|Overall Study||127
8974591|NCT02646891|10038985|FG008|COMPLETED|Overall Study||130
8974592|NCT02646891|10038986|FG009|COMPLETED|Overall Study||134
8974593|NCT02646891|10038977|FG000|NOT COMPLETED|Overall Study||2
8974594|NCT02646891|10038978|FG001|NOT COMPLETED|Overall Study||1
8974595|NCT02646891|10038979|FG002|NOT COMPLETED|Overall Study||1
8974596|NCT02646891|10038980|FG003|NOT COMPLETED|Overall Study||0
8974597|NCT02646891|10038981|FG004|NOT COMPLETED|Overall Study||0
8974598|NCT02646891|10038982|FG005|NOT COMPLETED|Overall Study||0
8974599|NCT02646891|10038983|FG006|NOT COMPLETED|Overall Study||9
8974600|NCT02646891|10038984|FG007|NOT COMPLETED|Overall Study||13
8974601|NCT02646891|10038985|FG008|NOT COMPLETED|Overall Study||10
8974602|NCT02646891|10038986|FG009|NOT COMPLETED|Overall Study||5
8974603|NCT02646917|10039022|FG000|STARTED|Overall Study||21
8974604|NCT02646917|10039023|FG001|STARTED|Overall Study||20
8974605|NCT02646917|10039022|FG000|COMPLETED|Overall Study||21
8974606|NCT02646917|10039023|FG001|COMPLETED|Overall Study||20
8974607|NCT02646917|10039022|FG000|NOT COMPLETED|Overall Study||0
8974608|NCT02646917|10039023|FG001|NOT COMPLETED|Overall Study||0
8974609|NCT02647203|10039036|FG000|STARTED|12 Month Follow-up||173
8974610|NCT02647203|10039037|FG001|STARTED|12 Month Follow-up||172
8974611|NCT02647203|10039036|FG000|COMPLETED|12 Month Follow-up||148
8974612|NCT02647203|10039037|FG001|COMPLETED|12 Month Follow-up||149
8974613|NCT02647203|10039036|FG000|NOT COMPLETED|12 Month Follow-up||25
8974614|NCT02647203|10039037|FG001|NOT COMPLETED|12 Month Follow-up||23
8974615|NCT02647203|10039036|FG000|STARTED|24 Month Follow-up||148
8974616|NCT02647203|10039037|FG001|STARTED|24 Month Follow-up||149
8974617|NCT02647203|10039036|FG000|COMPLETED|24 Month Follow-up||142
8974618|NCT02647203|10039037|FG001|COMPLETED|24 Month Follow-up||138
8974619|NCT02647203|10039036|FG000|NOT COMPLETED|24 Month Follow-up||6
8974620|NCT02647203|10039037|FG001|NOT COMPLETED|24 Month Follow-up||11
8974621|NCT02647281|10039052|FG000|STARTED|Single-Ascending Dose(Part 1-62 Days)||8
8974622|NCT02647281|10039053|FG001|STARTED|Single-Ascending Dose(Part 1-62 Days)||6
8974623|NCT02647281|10039054|FG002|STARTED|Single-Ascending Dose(Part 1-62 Days)||6
8974624|NCT02647281|10039055|FG003|STARTED|Single-Ascending Dose(Part 1-62 Days)||6
8974625|NCT02647281|10039056|FG004|STARTED|Single-Ascending Dose(Part 1-62 Days)||6
8974626|NCT02647281|10039057|FG005|STARTED|Single-Ascending Dose(Part 1-62 Days)||0
8974627|NCT02647281|10039058|FG006|STARTED|Single-Ascending Dose(Part 1-62 Days)||0
8974628|NCT02647281|10039059|FG007|STARTED|Single-Ascending Dose(Part 1-62 Days)||0
8974629|NCT02647281|10039060|FG008|STARTED|Single-Ascending Dose(Part 1-62 Days)||0
8974630|NCT02647281|10039052|FG000|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||8
8974631|NCT02647281|10039053|FG001|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||6
8974632|NCT02647281|10039054|FG002|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||6
8974633|NCT02647281|10039055|FG003|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||6
8974634|NCT02647281|10039056|FG004|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||6
8974635|NCT02647281|10039057|FG005|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
8632190|NCT00543569|9672054|FG000|NOT COMPLETED|Overall Study||12
8877164|NCT01922011|9934111|FG000|Treatment Actually Received|Overall Study|One participant intended for treatment with Vancomycin or Nafcillin was treated with Daptomycin|74
8974636|NCT02647281|10039058|FG006|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
8974637|NCT02647281|10039059|FG007|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
8974638|NCT02647281|10039060|FG008|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
8974639|NCT02647281|10039052|FG000|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
8974640|NCT02647281|10039053|FG001|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
8974641|NCT02647281|10039054|FG002|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
8974642|NCT02647281|10039055|FG003|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
8974643|NCT02647281|10039056|FG004|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
8974644|NCT02647281|10039057|FG005|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
8974645|NCT02647281|10039058|FG006|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
8974646|NCT02647281|10039059|FG007|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
8974647|NCT02647281|10039060|FG008|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
8974648|NCT02647281|10039052|FG000|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
8974649|NCT02647281|10039053|FG001|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
8974650|NCT02647281|10039054|FG002|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
8974651|NCT02647281|10039055|FG003|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
8974652|NCT02647281|10039056|FG004|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
8974653|NCT02647281|10039057|FG005|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||6
8974654|NCT02647281|10039058|FG006|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||6
8974655|NCT02647281|10039059|FG007|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||6
8974656|NCT02647281|10039060|FG008|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||6
8974657|NCT02647281|10039052|FG000|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
8974658|NCT02647281|10039053|FG001|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
8974659|NCT02647281|10039054|FG002|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
8974660|NCT02647281|10039055|FG003|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
8974661|NCT02647281|10039056|FG004|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
8877165|NCT01922011|9934112|FG001|Treatment Actually Received|Overall Study|One participant intended for treatment with Vancomycin or Nafcillin was treated with Daptomycin|72
8877166|NCT01922011|9934111|FG000|COMPLETED|Overall Study||69
8877167|NCT01922011|9934112|FG001|COMPLETED|Overall Study||69
8877168|NCT01922011|9934111|FG000|NOT COMPLETED|Overall Study||6
8877169|NCT01922011|9934112|FG001|NOT COMPLETED|Overall Study||5
8877170|NCT01922024|9934126|FG000|STARTED|Overall Study||1653
8877171|NCT01922024|9934127|FG001|STARTED|Overall Study||471
8974662|NCT02647281|10039057|FG005|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||6
8974663|NCT02647281|10039058|FG006|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||6
8974664|NCT02647281|10039059|FG007|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||6
8974665|NCT02647281|10039060|FG008|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||5
8974666|NCT02647281|10039052|FG000|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
8974667|NCT02647281|10039053|FG001|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
8974668|NCT02647281|10039054|FG002|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
8974669|NCT02647281|10039055|FG003|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
8974670|NCT02647281|10039056|FG004|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
8974671|NCT02647281|10039057|FG005|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
8974672|NCT02647281|10039058|FG006|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
8974673|NCT02647281|10039059|FG007|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
8974674|NCT02647281|10039060|FG008|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||1
8974675|NCT02647320|10039094|FG000|STARTED|Overall Study||46
8974676|NCT02647320|10039095|FG001|STARTED|Overall Study||46
8974677|NCT02647320|10039096|FG002|STARTED|Overall Study||69
8974678|NCT02647320|10039097|FG003|STARTED|Overall Study||68
8974679|NCT02647320|10039098|FG004|STARTED|Overall Study||69
8974680|NCT02647320|10039094|FG000|Inadvertently Randomized|Overall Study||0
8974681|NCT02647320|10039095|FG001|Inadvertently Randomized|Overall Study||0
8974682|NCT02647320|10039096|FG002|Inadvertently Randomized|Overall Study||0
8974683|NCT02647320|10039097|FG003|Inadvertently Randomized|Overall Study||1
8974684|NCT02647320|10039098|FG004|Inadvertently Randomized|Overall Study||0
8974685|NCT02647320|10039094|FG000|Safety Set|Overall Study||43
8974686|NCT02647320|10039095|FG001|Safety Set|Overall Study||44
8974687|NCT02647320|10039096|FG002|Safety Set|Overall Study||68
8974688|NCT02647320|10039097|FG003|Safety Set|Overall Study||68
8974689|NCT02647320|10039098|FG004|Safety Set|Overall Study||69
8974690|NCT02647320|10039094|FG000|Modified Intent-to-Treat Set (mITT)|Overall Study||40
8974691|NCT02647320|10039095|FG001|Modified Intent-to-Treat Set (mITT)|Overall Study||38
8974692|NCT02647320|10039096|FG002|Modified Intent-to-Treat Set (mITT)|Overall Study||61
8974693|NCT02647320|10039097|FG003|Modified Intent-to-Treat Set (mITT)|Overall Study||62
8974694|NCT02647320|10039098|FG004|Modified Intent-to-Treat Set (mITT)|Overall Study||62
8974695|NCT02647320|10039094|FG000|COMPLETED|Overall Study||34
8974696|NCT02647320|10039095|FG001|COMPLETED|Overall Study||35
8974697|NCT02647320|10039096|FG002|COMPLETED|Overall Study||54
8974698|NCT02647320|10039097|FG003|COMPLETED|Overall Study||58
8974699|NCT02647320|10039098|FG004|COMPLETED|Overall Study||52
8974700|NCT02647320|10039094|FG000|NOT COMPLETED|Overall Study||12
8974701|NCT02647320|10039095|FG001|NOT COMPLETED|Overall Study||11
8974702|NCT02647320|10039096|FG002|NOT COMPLETED|Overall Study||15
8974703|NCT02647320|10039097|FG003|NOT COMPLETED|Overall Study||10
8974704|NCT02647320|10039098|FG004|NOT COMPLETED|Overall Study||17
8974705|NCT02647346|10039112|FG000|STARTED|Overall Study||132
8974706|NCT02647346|10039112|FG000|COMPLETED|Overall Study||129
8974707|NCT02647346|10039112|FG000|NOT COMPLETED|Overall Study||3
8974708|NCT02647645|10039118|FG000|STARTED|Overall Study||11
8974709|NCT02647645|10039119|FG001|STARTED|Overall Study||10
8974710|NCT02647645|10039118|FG000|COMPLETED|Overall Study||9
8571081|NCT00107744|9603301|FG000|STARTED|Intervention 2 (8 Weeks)||101
8571082|NCT00107744|9603302|FG001|STARTED|Intervention 2 (8 Weeks)||104
8571083|NCT00107744|9603303|FG002|STARTED|Intervention 2 (8 Weeks)||101
8571084|NCT00107744|9603301|FG000|COMPLETED|Intervention 2 (8 Weeks)||93
8571085|NCT00107744|9603302|FG001|COMPLETED|Intervention 2 (8 Weeks)||92
8571086|NCT00107744|9603303|FG002|COMPLETED|Intervention 2 (8 Weeks)||88
8974711|NCT02647645|10039119|FG001|COMPLETED|Overall Study||9
8974712|NCT02647645|10039118|FG000|NOT COMPLETED|Overall Study||2
8974713|NCT02647645|10039119|FG001|NOT COMPLETED|Overall Study||1
8974714|NCT02647658|10039127|FG000|STARTED|Overall Study||1207
8974715|NCT02647658|10039128|FG001|STARTED|Overall Study||1093
8974716|NCT02647658|10039127|FG000|6 Month Assessment|Overall Study||658
8974717|NCT02647658|10039128|FG001|6 Month Assessment|Overall Study||635
8974718|NCT02647658|10039127|FG000|COMPLETED|Overall Study||1192
8974719|NCT02647658|10039128|FG001|COMPLETED|Overall Study||1069
8974720|NCT02647658|10039127|FG000|NOT COMPLETED|Overall Study||15
8974721|NCT02647658|10039128|FG001|NOT COMPLETED|Overall Study||24
8974722|NCT02647788|10039136|FG000|STARTED|Overall Study||70
8974723|NCT02647788|10039137|FG001|STARTED|Overall Study||70
8974724|NCT02647788|10039136|FG000|COMPLETED|Overall Study||54
8974725|NCT02647788|10039137|FG001|COMPLETED|Overall Study||57
8974726|NCT02647788|10039136|FG000|NOT COMPLETED|Overall Study||16
8974727|NCT02647788|10039137|FG001|NOT COMPLETED|Overall Study||13
8974728|NCT02647866|10039148|FG000|STARTED|Overall Study||9
8974729|NCT02647866|10039149|FG001|STARTED|Overall Study||10
8974730|NCT02647866|10039150|FG002|STARTED|Overall Study||9
8974731|NCT02647866|10039151|FG003|STARTED|Overall Study||21
8974732|NCT02647866|10039152|FG004|STARTED|Overall Study||17
8974733|NCT02647866|10039148|FG000|Completed Induction Therapy|Overall Study|Subjects received KHK4083 1.0 mg/kg for 12 weeks|8
8974734|NCT02647866|10039149|FG001|Completed Induction Therapy|Overall Study|Subjects received KHK4083 3.0 mg/kg for 12 weeks|9
8974735|NCT02647866|10039150|FG002|Completed Induction Therapy|Overall Study|Subjects received KHK4083 10.0 mg/kg for 12 weeks|8
8974736|NCT02647866|10039151|FG003|Completed Induction Therapy|Overall Study|Subjects received the maximum tolerated dose of KHK4083 10.0 mg/kg for 12 weeks|19
8974737|NCT02647866|10039152|FG004|Completed Induction Therapy|Overall Study|Subjects received Placebo for 12 weeks|17
8974738|NCT02647866|10039148|FG000|Completed Induction Therapy Follow-Up|Overall Study||5
8974739|NCT02647866|10039149|FG001|Completed Induction Therapy Follow-Up|Overall Study||1
8974740|NCT02647866|10039150|FG002|Completed Induction Therapy Follow-Up|Overall Study||2
8974741|NCT02647866|10039151|FG003|Completed Induction Therapy Follow-Up|Overall Study||0
8632191|NCT00543569|9672055|FG001|NOT COMPLETED|Overall Study||8
8632192|NCT00543569|9672056|FG002|NOT COMPLETED|Overall Study||20
8632193|NCT00543569|9672057|FG003|NOT COMPLETED|Overall Study||9
8974742|NCT02647866|10039152|FG004|Completed Induction Therapy Follow-Up|Overall Study||2
8974743|NCT02647866|10039148|FG000|Completed Long-Term Extension Therapy|Overall Study|10 add'l treatments of KHK4083 (same dose as Induction Therapy) as maintenance therapy.|3
8974744|NCT02647866|10039149|FG001|Completed Long-Term Extension Therapy|Overall Study||0
8974745|NCT02647866|10039150|FG002|Completed Long-Term Extension Therapy|Overall Study||0
8974746|NCT02647866|10039151|FG003|Completed Long-Term Extension Therapy|Overall Study||0
8974747|NCT02647866|10039152|FG004|Completed Long-Term Extension Therapy|Overall Study||0
8974748|NCT02647866|10039148|FG000|Completed LTE Follow-up|Overall Study||2
8974749|NCT02647866|10039149|FG001|Completed LTE Follow-up|Overall Study||0
8974750|NCT02647866|10039150|FG002|Completed LTE Follow-up|Overall Study||0
8974751|NCT02647866|10039151|FG003|Completed LTE Follow-up|Overall Study||0
8974752|NCT02647866|10039152|FG004|Completed LTE Follow-up|Overall Study||0
8974753|NCT02647866|10039148|FG000|Completed Open-Label Extension Therapy|Overall Study||0
8974754|NCT02647866|10039149|FG001|Completed Open-Label Extension Therapy|Overall Study|10 add'l treatments of Open-Label KHK4083 (same dose as Induction Therapy) as maintenance therapy.|7
8974755|NCT02647866|10039150|FG002|Completed Open-Label Extension Therapy|Overall Study|10 add'l treatments of Open-Label KHK4083 (same dose as Induction Therapy) as maintenance therapy|4
8974756|NCT02647866|10039151|FG003|Completed Open-Label Extension Therapy|Overall Study|10 add'l treatments of Open-Label KHK4083 (same dose as Induction Therapy) as maintenance therapy|17
8974757|NCT02647866|10039152|FG004|Completed Open-Label Extension Therapy|Overall Study|10 add'l treatments of Open-Label KHK4083 (same dose as Induction Therapy) as maintenance therapy|13
8974758|NCT02647866|10039148|FG000|Completed OLE Follow-up|Overall Study||0
8974759|NCT02647866|10039149|FG001|Completed OLE Follow-up|Overall Study||6
8974760|NCT02647866|10039150|FG002|Completed OLE Follow-up|Overall Study||4
8974761|NCT02647866|10039151|FG003|Completed OLE Follow-up|Overall Study||14
8974762|NCT02647866|10039152|FG004|Completed OLE Follow-up|Overall Study||10
8632194|NCT00543725|9672069|FG000|STARTED|Overall Study||340
8632195|NCT00543725|9672070|FG001|STARTED|Overall Study||338
8632196|NCT00543725|9672069|FG000|COMPLETED|Overall Study||272
8632197|NCT00543725|9672070|FG001|COMPLETED|Overall Study||264
8632198|NCT00543725|9672069|FG000|NOT COMPLETED|Overall Study||68
8632199|NCT00543725|9672070|FG001|NOT COMPLETED|Overall Study||74
8632200|NCT00543764|9672078|FG000|STARTED|Overall Study||100
8632201|NCT00543764|9672079|FG001|STARTED|Overall Study||50
8632202|NCT00543764|9672078|FG000|COMPLETED|Overall Study||100
8632203|NCT00543764|9672079|FG001|COMPLETED|Overall Study||50
8974763|NCT02647866|10039148|FG000|Moved From LTE to OLE Therapy|Overall Study||0
8974764|NCT02647866|10039149|FG001|Moved From LTE to OLE Therapy|Overall Study||5
8974765|NCT02647866|10039150|FG002|Moved From LTE to OLE Therapy|Overall Study||0
8974766|NCT02647866|10039151|FG003|Moved From LTE to OLE Therapy|Overall Study||0
8974767|NCT02647866|10039152|FG004|Moved From LTE to OLE Therapy|Overall Study||2
8974768|NCT02647866|10039148|FG000|Discontinued the Treatment|Overall Study||4
8974769|NCT02647866|10039149|FG001|Discontinued the Treatment|Overall Study||5
8974770|NCT02647866|10039150|FG002|Discontinued the Treatment|Overall Study||5
8974771|NCT02647866|10039151|FG003|Discontinued the Treatment|Overall Study||5
8974772|NCT02647866|10039152|FG004|Discontinued the Treatment|Overall Study||8
8632204|NCT00543764|9672078|FG000|NOT COMPLETED|Overall Study||0
8632205|NCT00543764|9672079|FG001|NOT COMPLETED|Overall Study||0
8632206|NCT00543777|9672085|FG000|STARTED|Overall Study||44
8974773|NCT02647866|10039148|FG000|Discontinued the Study|Overall Study||5
8974774|NCT02647866|10039149|FG001|Discontinued the Study|Overall Study||4
8974775|NCT02647866|10039150|FG002|Discontinued the Study|Overall Study||5
8974776|NCT02647866|10039151|FG003|Discontinued the Study|Overall Study||6
8974777|NCT02647866|10039152|FG004|Discontinued the Study|Overall Study||8
8974778|NCT02647866|10039148|FG000|COMPLETED|Overall Study||4
8974779|NCT02647866|10039149|FG001|COMPLETED|Overall Study||6
8974780|NCT02647866|10039150|FG002|COMPLETED|Overall Study||4
8974781|NCT02647866|10039151|FG003|COMPLETED|Overall Study||15
8974782|NCT02647866|10039152|FG004|COMPLETED|Overall Study||9
8974783|NCT02647866|10039148|FG000|NOT COMPLETED|Overall Study||5
8974784|NCT02647866|10039149|FG001|NOT COMPLETED|Overall Study||4
8974785|NCT02647866|10039150|FG002|NOT COMPLETED|Overall Study||5
8974786|NCT02647866|10039151|FG003|NOT COMPLETED|Overall Study||6
8974787|NCT02647866|10039152|FG004|NOT COMPLETED|Overall Study||8
8974788|NCT02647905|10039172|FG000|STARTED|Overall Study||90
8974789|NCT02647905|10039172|FG000|COMPLETED|Overall Study||87
8974790|NCT02647905|10039172|FG000|NOT COMPLETED|Overall Study||3
8974791|NCT02647944|10039178|FG000|STARTED|Overall Study||19
8974792|NCT02647944|10039179|FG001|STARTED|Overall Study||21
8974793|NCT02647944|10039178|FG000|COMPLETED|Overall Study||17
8974794|NCT02647944|10039179|FG001|COMPLETED|Overall Study||18
8974795|NCT02647944|10039178|FG000|NOT COMPLETED|Overall Study||2
8974796|NCT02647944|10039179|FG001|NOT COMPLETED|Overall Study||3
8974797|NCT02648022|10039187|FG000|STARTED|Overall Study||40
8974798|NCT02648022|10039188|FG001|STARTED|Overall Study||39
8974799|NCT02648022|10039187|FG000|COMPLETED|Overall Study||40
8974800|NCT02648022|10039188|FG001|COMPLETED|Overall Study||39
8974801|NCT02648022|10039187|FG000|NOT COMPLETED|Overall Study||0
8974802|NCT02648022|10039188|FG001|NOT COMPLETED|Overall Study||0
8974803|NCT02648178|10039194|FG000|STARTED|Overall Study||19
8974804|NCT02648178|10039194|FG000|COMPLETED|Overall Study||10
8974805|NCT02648178|10039194|FG000|NOT COMPLETED|Overall Study||9
8974806|NCT02648204|10039202|FG000|STARTED|Overall Study||301
8974807|NCT02648204|10039203|FG001|STARTED|Overall Study||300
8974808|NCT02648204|10039204|FG002|STARTED|Overall Study||300
8974809|NCT02648204|10039205|FG003|STARTED|Overall Study||300
8974810|NCT02648204|10039202|FG000|Exposed|Overall Study||301
8974811|NCT02648204|10039203|FG001|Exposed|Overall Study||300
8974812|NCT02648204|10039204|FG002|Exposed|Overall Study||299
8974813|NCT02648204|10039205|FG003|Exposed|Overall Study||299
8974814|NCT02648204|10039202|FG000|COMPLETED|Overall Study||279
8974815|NCT02648204|10039203|FG001|COMPLETED|Overall Study||279
8974816|NCT02648204|10039204|FG002|COMPLETED|Overall Study||287
8974817|NCT02648204|10039205|FG003|COMPLETED|Overall Study||284
8974818|NCT02648204|10039202|FG000|NOT COMPLETED|Overall Study||22
8974819|NCT02648204|10039203|FG001|NOT COMPLETED|Overall Study||21
8974820|NCT02648204|10039204|FG002|NOT COMPLETED|Overall Study||13
8974821|NCT02648204|10039205|FG003|NOT COMPLETED|Overall Study||16
8974822|NCT02648217|10039217|FG000|STARTED|Overall Study||131
8974823|NCT02648217|10039218|FG001|STARTED|Overall Study||132
8974824|NCT02648217|10039217|FG000|Exposed|Overall Study||130
8632207|NCT00543777|9672085|FG000|COMPLETED|Overall Study||44
8632208|NCT00543777|9672085|FG000|NOT COMPLETED|Overall Study||0
8632209|NCT00543803|9672089|FG000|STARTED|Overall Study||334
8632210|NCT00543803|9672089|FG000|COMPLETED|Overall Study||192
8632211|NCT00543803|9672089|FG000|NOT COMPLETED|Overall Study||142
8632212|NCT00543855|9672099|FG000|STARTED|Overall Study||35
8632213|NCT00543855|9672100|FG001|STARTED|Overall Study||33
8632214|NCT00543855|9672101|FG002|STARTED|Overall Study||37
8632215|NCT00543855|9672102|FG003|STARTED|Overall Study||34
8725819|NCT01033487|9773166|FG009|COMPLETED|First Intervention Period||2
8725820|NCT01033487|9773157|FG000|NOT COMPLETED|First Intervention Period||0
8725821|NCT01033487|9773158|FG001|NOT COMPLETED|First Intervention Period||0
8725822|NCT01033487|9773159|FG002|NOT COMPLETED|First Intervention Period||0
8974825|NCT02648217|10039218|FG001|Exposed|Overall Study||132
8974826|NCT02648217|10039217|FG000|COMPLETED|Overall Study||121
8974827|NCT02648217|10039218|FG001|COMPLETED|Overall Study||127
8974828|NCT02648217|10039217|FG000|NOT COMPLETED|Overall Study||10
8974829|NCT02648217|10039218|FG001|NOT COMPLETED|Overall Study||5
8974830|NCT02648230|10039224|FG000|STARTED|Overall Study||74
8974831|NCT02648230|10039224|FG000|COMPLETED|Overall Study||74
8974832|NCT02648230|10039224|FG000|NOT COMPLETED|Overall Study||0
8974833|NCT02648438|10039231|FG000|STARTED|Overall Study||12
8974834|NCT02648438|10039232|FG001|STARTED|Overall Study||12
8632216|NCT00543855|9672099|FG000|COMPLETED|Overall Study||31
8632217|NCT00543855|9672100|FG001|COMPLETED|Overall Study||31
8974835|NCT02648438|10039233|FG002|STARTED|Overall Study||6
8974836|NCT02648438|10039231|FG000|COMPLETED|Overall Study||9
8974837|NCT02648438|10039232|FG001|COMPLETED|Overall Study||9
8974838|NCT02648438|10039233|FG002|COMPLETED|Overall Study||6
8974839|NCT02648438|10039231|FG000|NOT COMPLETED|Overall Study||3
8974840|NCT02648438|10039232|FG001|NOT COMPLETED|Overall Study||3
8974841|NCT02648438|10039233|FG002|NOT COMPLETED|Overall Study||0
8974842|NCT02648646|10039249|FG000|STARTED|Overall Study||10
8974843|NCT02648646|10039249|FG000|COMPLETED|Overall Study||8
8974844|NCT02648646|10039249|FG000|NOT COMPLETED|Overall Study||2
8974845|NCT02648880|10039253|FG000|STARTED|Overall Study|Recruitment was significantly limited, only 3 participants were eligible, all enrolled. All three were assigned to the exercise arm, per protocol. No participants were recruited into the control arm and it was eliminated.|3
8974846|NCT02648880|10039253|FG000|COMPLETED|Overall Study||3
8974847|NCT02648880|10039253|FG000|NOT COMPLETED|Overall Study||0
8974848|NCT02648919|10039257|FG000|STARTED|Overall Study||6
8974849|NCT02648919|10039257|FG000|COMPLETED|Overall Study||6
8974850|NCT02648919|10039257|FG000|NOT COMPLETED|Overall Study||0
8974851|NCT02648932|10039264|FG000|STARTED|Overall Study||5
8974852|NCT02648932|10039265|FG001|STARTED|Overall Study||4
8974853|NCT02648932|10039264|FG000|COMPLETED|Overall Study||2
8974854|NCT02648932|10039265|FG001|COMPLETED|Overall Study||3
8974855|NCT02648932|10039264|FG000|NOT COMPLETED|Overall Study||3
8974856|NCT02648932|10039265|FG001|NOT COMPLETED|Overall Study||1
8974857|NCT02648971|10039273|FG000|STARTED|Overall Study||18
8571087|NCT00107744|9603301|FG000|NOT COMPLETED|Intervention 2 (8 Weeks)||8
8974858|NCT02648971|10039274|FG001|STARTED|Overall Study||18
8974859|NCT02648971|10039273|FG000|COMPLETED|Overall Study||18
8974860|NCT02648971|10039274|FG001|COMPLETED|Overall Study||18
8974861|NCT02648971|10039273|FG000|NOT COMPLETED|Overall Study||0
8974862|NCT02648971|10039274|FG001|NOT COMPLETED|Overall Study||0
8974863|NCT02649192|10039286|FG000|STARTED|Overall Study||5
8877172|NCT01922024|9934126|FG000|COMPLETED|Overall Study||1653
8877173|NCT01922024|9934127|FG001|COMPLETED|Overall Study||471
8877174|NCT01922024|9934126|FG000|NOT COMPLETED|Overall Study||0
8877175|NCT01922024|9934127|FG001|NOT COMPLETED|Overall Study||0
8877176|NCT01922037|9934135|FG000|STARTED|Overall Study||69
8877177|NCT01922037|9934136|FG001|STARTED|Overall Study||737
8877178|NCT01922037|9934135|FG000|Treated|Overall Study||69
8877179|NCT01922037|9934136|FG001|Treated|Overall Study||732
8877180|NCT01922037|9934135|FG000|COMPLETED|Overall Study||59
8877181|NCT01922037|9934136|FG001|COMPLETED|Overall Study||563
8877182|NCT01922037|9934135|FG000|NOT COMPLETED|Overall Study||10
8877183|NCT01922037|9934136|FG001|NOT COMPLETED|Overall Study||174
8974864|NCT02649192|10039287|FG001|STARTED|Overall Study||4
8974865|NCT02649192|10039288|FG002|STARTED|Overall Study||22
8974866|NCT02649192|10039289|FG003|STARTED|Overall Study||22
8974867|NCT02649192|10039290|FG004|STARTED|Overall Study||12
8974868|NCT02649192|10039291|FG005|STARTED|Overall Study||14
8974869|NCT02649192|10039286|FG000|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||2
8974870|NCT02649192|10039287|FG001|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||2
8974871|NCT02649192|10039288|FG002|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||11
8974872|NCT02649192|10039289|FG003|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||12
8974873|NCT02649192|10039290|FG004|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||7
8974874|NCT02649192|10039291|FG005|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||8
8974875|NCT02649192|10039286|FG000|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||3
8974876|NCT02649192|10039287|FG001|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||2
8974877|NCT02649192|10039288|FG002|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||11
8974878|NCT02649192|10039289|FG003|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||10
8974879|NCT02649192|10039290|FG004|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||5
8974880|NCT02649192|10039291|FG005|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||6
8974881|NCT02649192|10039286|FG000|COMPLETED|Overall Study||5
8974882|NCT02649192|10039287|FG001|COMPLETED|Overall Study||4
8974883|NCT02649192|10039288|FG002|COMPLETED|Overall Study||21
8974884|NCT02649192|10039289|FG003|COMPLETED|Overall Study||20
8974885|NCT02649192|10039290|FG004|COMPLETED|Overall Study||11
8974886|NCT02649192|10039291|FG005|COMPLETED|Overall Study||14
8974887|NCT02649192|10039286|FG000|NOT COMPLETED|Overall Study||0
8974888|NCT02649192|10039287|FG001|NOT COMPLETED|Overall Study||0
8974889|NCT02649192|10039288|FG002|NOT COMPLETED|Overall Study||1
8974890|NCT02649192|10039289|FG003|NOT COMPLETED|Overall Study||2
8974891|NCT02649192|10039290|FG004|NOT COMPLETED|Overall Study||1
8974892|NCT02649192|10039291|FG005|NOT COMPLETED|Overall Study||0
8974893|NCT02649218|10039318|FG000|STARTED|Overall Study||226
8974894|NCT02649218|10039318|FG000|COMPLETED|Overall Study||201
8974895|NCT02649218|10039318|FG000|NOT COMPLETED|Overall Study||25
8974896|NCT02649231|10039327|FG000|STARTED|Overall Study||24
8974897|NCT02649231|10039328|FG001|STARTED|Overall Study||24
8974898|NCT02649231|10039329|FG002|STARTED|Overall Study||23
8974899|NCT02649231|10039330|FG003|STARTED|Overall Study||25
8974900|NCT02649231|10039327|FG000|COMPLETED|Overall Study||20
8974901|NCT02649231|10039328|FG001|COMPLETED|Overall Study||21
8974902|NCT02649231|10039329|FG002|COMPLETED|Overall Study||21
8974903|NCT02649231|10039330|FG003|COMPLETED|Overall Study||23
8974904|NCT02649231|10039327|FG000|NOT COMPLETED|Overall Study||4
8974905|NCT02649231|10039328|FG001|NOT COMPLETED|Overall Study||3
8974906|NCT02649231|10039329|FG002|NOT COMPLETED|Overall Study||2
8974907|NCT02649231|10039330|FG003|NOT COMPLETED|Overall Study||2
8974908|NCT02649322|10039342|FG000|STARTED|Overall Study||58
8974909|NCT02649322|10039343|FG001|STARTED|Overall Study||57
8974910|NCT02649322|10039342|FG000|COMPLETED|Overall Study||58
8974911|NCT02649322|10039343|FG001|COMPLETED|Overall Study||57
8974912|NCT02649322|10039342|FG000|NOT COMPLETED|Overall Study||0
8974913|NCT02649322|10039343|FG001|NOT COMPLETED|Overall Study||0
8974914|NCT02649439|10039351|FG000|STARTED|Overall Study||40
8974915|NCT02649439|10039352|FG001|STARTED|Overall Study||40
8974916|NCT02649439|10039351|FG000|COMPLETED|Overall Study||13
8974917|NCT02649439|10039352|FG001|COMPLETED|Overall Study||12
8974918|NCT02649439|10039351|FG000|NOT COMPLETED|Overall Study||27
8974919|NCT02649439|10039352|FG001|NOT COMPLETED|Overall Study||28
8974920|NCT02649556|10039369|FG000|STARTED|Overall Study||230
8974921|NCT02649556|10039370|FG001|STARTED|Overall Study||424
8974922|NCT02649556|10039371|FG002|STARTED|Overall Study||152
8974923|NCT02649556|10039372|FG003|STARTED|Overall Study||51
8974924|NCT02649556|10039369|FG000|COMPLETED|Overall Study||167
8974925|NCT02649556|10039370|FG001|COMPLETED|Overall Study||312
8974926|NCT02649556|10039371|FG002|COMPLETED|Overall Study||102
8974927|NCT02649556|10039372|FG003|COMPLETED|Overall Study||28
8974928|NCT02649556|10039369|FG000|NOT COMPLETED|Overall Study||63
8974929|NCT02649556|10039370|FG001|NOT COMPLETED|Overall Study||112
8974930|NCT02649556|10039371|FG002|NOT COMPLETED|Overall Study||50
8974931|NCT02649556|10039372|FG003|NOT COMPLETED|Overall Study||23
8974932|NCT02649608|10039382|FG000|STARTED|Overall Study||2
8974933|NCT02649608|10039383|FG001|STARTED|Overall Study||1
8974934|NCT02649608|10039384|FG002|STARTED|Overall Study||3
8974935|NCT02649608|10039385|FG003|STARTED|Overall Study||3
8974936|NCT02649608|10039386|FG004|STARTED|Overall Study||3
8974937|NCT02649608|10039387|FG005|STARTED|Overall Study||2
8974938|NCT02649608|10039388|FG006|STARTED|Overall Study||1
8974939|NCT02649608|10039382|FG000|COMPLETED|Overall Study||2
8974940|NCT02649608|10039383|FG001|COMPLETED|Overall Study||1
8974941|NCT02649608|10039384|FG002|COMPLETED|Overall Study||3
8974942|NCT02649608|10039385|FG003|COMPLETED|Overall Study||3
8632218|NCT00543855|9672101|FG002|COMPLETED|Overall Study||31
8632219|NCT00543855|9672102|FG003|COMPLETED|Overall Study||30
8974943|NCT02649608|10039386|FG004|COMPLETED|Overall Study||3
8974944|NCT02649608|10039387|FG005|COMPLETED|Overall Study||2
8974945|NCT02649608|10039388|FG006|COMPLETED|Overall Study||1
8974946|NCT02649608|10039382|FG000|NOT COMPLETED|Overall Study||0
8974947|NCT02649608|10039383|FG001|NOT COMPLETED|Overall Study||0
8974948|NCT02649608|10039384|FG002|NOT COMPLETED|Overall Study||0
8974949|NCT02649608|10039385|FG003|NOT COMPLETED|Overall Study||0
8974950|NCT02649608|10039386|FG004|NOT COMPLETED|Overall Study||0
8974951|NCT02649608|10039387|FG005|NOT COMPLETED|Overall Study||0
8974952|NCT02649608|10039388|FG006|NOT COMPLETED|Overall Study||0
8974953|NCT02649634|10039419|FG000|STARTED|Overall Study||69
8974954|NCT02649634|10039420|FG001|STARTED|Overall Study||66
8974955|NCT02649634|10039419|FG000|COMPLETED|Overall Study||66
8974956|NCT02649634|10039420|FG001|COMPLETED|Overall Study||60
8974957|NCT02649634|10039419|FG000|NOT COMPLETED|Overall Study||3
8974958|NCT02649634|10039420|FG001|NOT COMPLETED|Overall Study||6
8974959|NCT02649842|10039426|FG000|STARTED|Overall Study||101
8974960|NCT02649842|10039426|FG000|COMPLETED|Overall Study||101
8974961|NCT02649842|10039426|FG000|NOT COMPLETED|Overall Study||0
8974962|NCT02649894|10039434|FG000|STARTED|Overall Study||81
8974963|NCT02649894|10039435|FG001|STARTED|Overall Study||38
8974964|NCT02649894|10039434|FG000|Device Inserted|Overall Study||77
8974965|NCT02649894|10039435|FG001|Device Inserted|Overall Study||37
8974966|NCT02649894|10039434|FG000|Completed Day 30|Overall Study||56
8974967|NCT02649894|10039435|FG001|Completed Day 30|Overall Study||35
8974968|NCT02649894|10039434|FG000|COMPLETED|Overall Study||37
8974969|NCT02649894|10039435|FG001|COMPLETED|Overall Study||27
8974970|NCT02649894|10039434|FG000|NOT COMPLETED|Overall Study||44
8974971|NCT02649894|10039435|FG001|NOT COMPLETED|Overall Study||11
8974972|NCT02650128|10039441|FG000|STARTED|Overall Study||60
8974973|NCT02650128|10039441|FG000|30 Day Primary and Safety Endpoint|Overall Study||60
8974974|NCT02650128|10039441|FG000|COMPLETED|Overall Study||58
8974975|NCT02650128|10039441|FG000|NOT COMPLETED|Overall Study||2
8974976|NCT02650193|10039449|FG000|STARTED|Overall Study||6
8974977|NCT02650193|10039450|FG001|STARTED|Overall Study||6
8974978|NCT02650193|10039451|FG002|STARTED|Overall Study||13
8974979|NCT02650193|10039449|FG000|COMPLETED|Overall Study||6
8974980|NCT02650193|10039450|FG001|COMPLETED|Overall Study||6
8974981|NCT02650193|10039451|FG002|COMPLETED|Overall Study||13
8974982|NCT02650193|10039449|FG000|NOT COMPLETED|Overall Study||0
8974983|NCT02650193|10039450|FG001|NOT COMPLETED|Overall Study||0
8974984|NCT02650193|10039451|FG002|NOT COMPLETED|Overall Study||0
8974985|NCT02650219|10039462|FG000|STARTED|Overall Study||40
8974986|NCT02650219|10039463|FG001|STARTED|Overall Study||20
8974987|NCT02650219|10039462|FG000|COMPLETED|Overall Study||40
8974988|NCT02650219|10039463|FG001|COMPLETED|Overall Study||20
8974989|NCT02650219|10039462|FG000|NOT COMPLETED|Overall Study||0
8974990|NCT02650219|10039463|FG001|NOT COMPLETED|Overall Study||0
8974991|NCT02650440|10039471|FG000|STARTED|Overall Study||10
8974992|NCT02650440|10039472|FG001|STARTED|Overall Study||10
8974993|NCT02650440|10039471|FG000|COMPLETED|Overall Study||10
8974994|NCT02650440|10039472|FG001|COMPLETED|Overall Study||8
8974995|NCT02650440|10039471|FG000|NOT COMPLETED|Overall Study||0
8974996|NCT02650440|10039472|FG001|NOT COMPLETED|Overall Study||2
8974997|NCT02650466|10039478|FG000|STARTED|Overall Study||24
8974998|NCT02650466|10039478|FG000|COMPLETED|Overall Study||17
8974999|NCT02650466|10039478|FG000|NOT COMPLETED|Overall Study||7
8975000|NCT02650856|10039486|FG000|STARTED|Overall Study||19
8975001|NCT02650856|10039487|FG001|STARTED|Overall Study||21
8975002|NCT02650856|10039486|FG000|Baseline|Overall Study||19
8975003|NCT02650856|10039487|FG001|Baseline|Overall Study||21
8975004|NCT02650856|10039486|FG000|24 Hours|Overall Study||19
8975005|NCT02650856|10039487|FG001|24 Hours|Overall Study||21
8975006|NCT02650856|10039486|FG000|48 Hours|Overall Study||19
8975007|NCT02650856|10039487|FG001|48 Hours|Overall Study||21
8975008|NCT02650856|10039486|FG000|72 Hours|Overall Study||19
8975009|NCT02650856|10039487|FG001|72 Hours|Overall Study||21
8975010|NCT02650856|10039486|FG000|COMPLETED|Overall Study||19
8975011|NCT02650856|10039487|FG001|COMPLETED|Overall Study||21
8975012|NCT02650856|10039486|FG000|NOT COMPLETED|Overall Study||0
8975013|NCT02650856|10039487|FG001|NOT COMPLETED|Overall Study||0
8975014|NCT02650895|10039499|FG000|STARTED|Overall Study||10
8975015|NCT02650895|10039500|FG001|STARTED|Overall Study||6
8975016|NCT02650895|10039501|FG002|STARTED|Overall Study||6
8975017|NCT02650895|10039502|FG003|STARTED|Overall Study||6
8975018|NCT02650895|10039503|FG004|STARTED|Overall Study||6
8975019|NCT02650895|10039504|FG005|STARTED|Overall Study||6
8975020|NCT02650895|10039499|FG000|COMPLETED|Overall Study||10
8975021|NCT02650895|10039500|FG001|COMPLETED|Overall Study||5
8975022|NCT02650895|10039501|FG002|COMPLETED|Overall Study||6
8975023|NCT02650895|10039502|FG003|COMPLETED|Overall Study||6
8975024|NCT02650895|10039503|FG004|COMPLETED|Overall Study||6
8975025|NCT02650895|10039504|FG005|COMPLETED|Overall Study||6
8975026|NCT02650895|10039499|FG000|NOT COMPLETED|Overall Study||0
8975027|NCT02650895|10039500|FG001|NOT COMPLETED|Overall Study||1
8975028|NCT02650895|10039501|FG002|NOT COMPLETED|Overall Study||0
8975029|NCT02650895|10039502|FG003|NOT COMPLETED|Overall Study||0
8975030|NCT02650895|10039503|FG004|NOT COMPLETED|Overall Study||0
8975031|NCT02650895|10039504|FG005|NOT COMPLETED|Overall Study||0
8975032|NCT02650921|10039523|FG000|STARTED|Overall Study||92
8975033|NCT02650921|10039523|FG000|COMPLETED|Overall Study||84
8975034|NCT02650921|10039523|FG000|NOT COMPLETED|Overall Study||8
8975035|NCT02650999|10039529|FG000|STARTED|Overall Study||12
8975036|NCT02650999|10039529|FG000|COMPLETED|Overall Study||12
8975037|NCT02650999|10039529|FG000|NOT COMPLETED|Overall Study||0
8975038|NCT02651103|10039533|FG000|STARTED|Overall Study||30
8975039|NCT02651103|10039533|FG000|COMPLETED|Overall Study||30
8975040|NCT02651103|10039533|FG000|NOT COMPLETED|Overall Study||0
8975041|NCT02651116|10039539|FG000|STARTED|Overall Study||68
8975042|NCT02651116|10039540|FG001|STARTED|Overall Study||63
8975043|NCT02651116|10039539|FG000|Treated|Overall Study||68
8975044|NCT02651116|10039540|FG001|Treated|Overall Study||63
8975045|NCT02651116|10039539|FG000|COMPLETED|Overall Study||67
8975046|NCT02651116|10039540|FG001|COMPLETED|Overall Study||62
8975047|NCT02651116|10039539|FG000|NOT COMPLETED|Overall Study||1
8975048|NCT02651116|10039540|FG001|NOT COMPLETED|Overall Study||1
8975049|NCT02651155|10039548|FG000|STARTED|Overall Study||99
8975050|NCT02651155|10039549|FG001|STARTED|Overall Study||105
8975051|NCT02651155|10039548|FG000|COMPLETED|Overall Study||93
8975052|NCT02651155|10039549|FG001|COMPLETED|Overall Study||103
8975053|NCT02651155|10039548|FG000|NOT COMPLETED|Overall Study||6
8975054|NCT02651155|10039549|FG001|NOT COMPLETED|Overall Study||2
8571088|NCT00107744|9603302|FG001|NOT COMPLETED|Intervention 2 (8 Weeks)||12
8975055|NCT02651194|10039555|FG000|STARTED|Overall Study||104
8975056|NCT02651194|10039555|FG000|COMPLETED|Overall Study||99
8975057|NCT02651194|10039555|FG000|NOT COMPLETED|Overall Study||5
8975058|NCT02651220|10039562|FG000|STARTED|Overall Study||337
8975059|NCT02651220|10039563|FG001|STARTED|Overall Study||335
8975060|NCT02651220|10039564|FG002|STARTED|Overall Study||329
8975061|NCT02651220|10039562|FG000|COMPLETED|Overall Study||314
8975062|NCT02651220|10039563|FG001|COMPLETED|Overall Study||308
8975063|NCT02651220|10039564|FG002|COMPLETED|Overall Study||300
8975064|NCT02651220|10039562|FG000|NOT COMPLETED|Overall Study||23
8975065|NCT02651220|10039563|FG001|NOT COMPLETED|Overall Study||27
8975066|NCT02651220|10039564|FG002|NOT COMPLETED|Overall Study||29
8975067|NCT02651259|10039574|FG000|STARTED|Overall Study||25
8975068|NCT02651259|10039575|FG001|STARTED|Overall Study||25
8975069|NCT02651259|10039574|FG000|COMPLETED|Overall Study||25
8975070|NCT02651259|10039575|FG001|COMPLETED|Overall Study||25
8975071|NCT02651259|10039574|FG000|NOT COMPLETED|Overall Study||0
8975072|NCT02651259|10039575|FG001|NOT COMPLETED|Overall Study||0
8975073|NCT02651272|10039589|FG000|STARTED|Overall Study||4
8975074|NCT02651272|10039589|FG000|COMPLETED|Overall Study||1
8975075|NCT02651272|10039589|FG000|NOT COMPLETED|Overall Study||3
8975076|NCT02651337|10039593|FG000|STARTED|Overall Study||5
8975077|NCT02651337|10039593|FG000|COMPLETED|Overall Study||4
8975078|NCT02651337|10039593|FG000|NOT COMPLETED|Overall Study||1
8975079|NCT02651415|10039597|FG000|STARTED|Overall Study|12 patients were enrolled.|12
8975080|NCT02651415|10039597|FG000|COMPLETED|Overall Study|10 patients were evaluable.|10
8975081|NCT02651415|10039597|FG000|NOT COMPLETED|Overall Study||2
8975082|NCT02651428|10039603|FG000|STARTED|Overall Study||403
8975083|NCT02651428|10039604|FG001|STARTED|Overall Study||403
8975084|NCT02651428|10039603|FG000|COMPLETED|Overall Study||359
8975085|NCT02651428|10039604|FG001|COMPLETED|Overall Study||359
8975086|NCT02651428|10039603|FG000|NOT COMPLETED|Overall Study||44
8975087|NCT02651428|10039604|FG001|NOT COMPLETED|Overall Study||44
8975088|NCT02651467|10039613|FG000|STARTED|Overall Study||74
8975089|NCT02651467|10039614|FG001|STARTED|Overall Study||74
8975090|NCT02651467|10039615|FG002|STARTED|Overall Study||73
8975091|NCT02651467|10039613|FG000|COMPLETED|Overall Study||73
8975092|NCT02651467|10039614|FG001|COMPLETED|Overall Study||74
8975093|NCT02651467|10039615|FG002|COMPLETED|Overall Study||69
8975094|NCT02651467|10039613|FG000|NOT COMPLETED|Overall Study||1
8975095|NCT02651467|10039614|FG001|NOT COMPLETED|Overall Study||0
8975096|NCT02651467|10039615|FG002|NOT COMPLETED|Overall Study||4
8975097|NCT02651545|10039626|FG000|STARTED|Overall Study||30
8975098|NCT02651545|10039627|FG001|STARTED|Overall Study||30
8975099|NCT02651545|10039626|FG000|COMPLETED|Overall Study||7
8975100|NCT02651545|10039627|FG001|COMPLETED|Overall Study||17
8975101|NCT02651545|10039626|FG000|NOT COMPLETED|Overall Study||23
8975102|NCT02651545|10039627|FG001|NOT COMPLETED|Overall Study||13
8975103|NCT02651584|10039635|FG000|STARTED|Overall Study||215
8975104|NCT02651584|10039636|FG001|STARTED|Overall Study||213
8975105|NCT02651584|10039635|FG000|COMPLETED|Overall Study||126
8975106|NCT02651584|10039636|FG001|COMPLETED|Overall Study||121
8975107|NCT02651584|10039635|FG000|NOT COMPLETED|Overall Study||89
8975108|NCT02651584|10039636|FG001|NOT COMPLETED|Overall Study||92
8975109|NCT02651688|10039648|FG000|STARTED|Overall Study||18
8975110|NCT02651688|10039649|FG001|STARTED|Overall Study||17
8975111|NCT02651688|10039650|FG002|STARTED|Overall Study||15
8975112|NCT02651688|10039648|FG000|COMPLETED|Overall Study||16
8975113|NCT02651688|10039649|FG001|COMPLETED|Overall Study||12
8975114|NCT02651688|10039650|FG002|COMPLETED|Overall Study||12
8975115|NCT02651688|10039648|FG000|NOT COMPLETED|Overall Study||2
8975116|NCT02651688|10039649|FG001|NOT COMPLETED|Overall Study||5
8975117|NCT02651688|10039650|FG002|NOT COMPLETED|Overall Study||3
8975118|NCT02651922|10039658|FG000|STARTED|Overall Study||156
8975119|NCT02651922|10039658|FG000|COMPLETED|Overall Study||154
8975120|NCT02651922|10039658|FG000|NOT COMPLETED|Overall Study||2
8975121|NCT02651987|10039664|FG000|STARTED|Overall Study||48
8632220|NCT00543855|9672099|FG000|NOT COMPLETED|Overall Study||4
8632221|NCT00543855|9672100|FG001|NOT COMPLETED|Overall Study||2
8632222|NCT00543855|9672101|FG002|NOT COMPLETED|Overall Study||6
8632223|NCT00543855|9672102|FG003|NOT COMPLETED|Overall Study||4
8975122|NCT02651987|10039665|FG001|STARTED|Overall Study||51
8975123|NCT02651987|10039664|FG000|COMPLETED|Overall Study||43
8975124|NCT02651987|10039665|FG001|COMPLETED|Overall Study||46
8975125|NCT02651987|10039664|FG000|NOT COMPLETED|Overall Study||5
8975126|NCT02651987|10039665|FG001|NOT COMPLETED|Overall Study||5
8975127|NCT02652156|10039677|FG000|STARTED|Overall Study||4
8975128|NCT02652156|10039678|FG001|STARTED|Overall Study||6
8975129|NCT02652156|10039679|FG002|STARTED|Overall Study||4
8975130|NCT02652156|10039677|FG000|COMPLETED|Overall Study||3
8975131|NCT02652156|10039678|FG001|COMPLETED|Overall Study||6
8975132|NCT02652156|10039679|FG002|COMPLETED|Overall Study||4
8975133|NCT02652156|10039677|FG000|NOT COMPLETED|Overall Study||1
8975134|NCT02652156|10039678|FG001|NOT COMPLETED|Overall Study||0
8975135|NCT02652156|10039679|FG002|NOT COMPLETED|Overall Study||0
8975136|NCT02652208|10039689|FG000|STARTED|Overall Study||17
8975137|NCT02652208|10039690|FG001|STARTED|Overall Study||17
8975138|NCT02652208|10039689|FG000|COMPLETED|Overall Study||13
8975139|NCT02652208|10039690|FG001|COMPLETED|Overall Study||15
8975140|NCT02652208|10039689|FG000|NOT COMPLETED|Overall Study||4
8975141|NCT02652208|10039690|FG001|NOT COMPLETED|Overall Study||2
8975142|NCT02652221|10039696|FG000|STARTED|Overall Study||55
8975143|NCT02652221|10039696|FG000|COMPLETED|Overall Study||55
8975144|NCT02652221|10039696|FG000|NOT COMPLETED|Overall Study||0
8975145|NCT02652260|10039703|FG000|STARTED|Overall Study||43
8975146|NCT02652260|10039704|FG001|STARTED|Overall Study||43
8975147|NCT02652260|10039703|FG000|COMPLETED|Overall Study||43
8975148|NCT02652260|10039704|FG001|COMPLETED|Overall Study||41
8975149|NCT02652260|10039703|FG000|NOT COMPLETED|Overall Study||0
8975150|NCT02652260|10039704|FG001|NOT COMPLETED|Overall Study||2
8975151|NCT02652390|10039716|FG000|STARTED|Overall Study||37
8975152|NCT02652390|10039717|FG001|STARTED|Overall Study||37
8975153|NCT02652390|10039718|FG002|STARTED|Overall Study||37
8975154|NCT02652390|10039716|FG000|COMPLETED|Overall Study||37
8975155|NCT02652390|10039717|FG001|COMPLETED|Overall Study||37
8975156|NCT02652390|10039718|FG002|COMPLETED|Overall Study||37
8975157|NCT02652390|10039716|FG000|NOT COMPLETED|Overall Study||0
8975158|NCT02652390|10039717|FG001|NOT COMPLETED|Overall Study||0
8975159|NCT02652390|10039718|FG002|NOT COMPLETED|Overall Study||0
8975160|NCT02652416|10039732|FG000|STARTED|Overall Study||18
8975161|NCT02652416|10039733|FG001|STARTED|Overall Study||18
8975162|NCT02652416|10039734|FG002|STARTED|Overall Study||18
8975163|NCT02652416|10039735|FG003|STARTED|Overall Study||18
8975164|NCT02652416|10039732|FG000|Subjects Who Participated in MD Part|Overall Study||6
8975165|NCT02652416|10039733|FG001|Subjects Who Participated in MD Part|Overall Study||0
8975166|NCT02652416|10039734|FG002|Subjects Who Participated in MD Part|Overall Study||0
8975167|NCT02652416|10039735|FG003|Subjects Who Participated in MD Part|Overall Study||18
8975168|NCT02652416|10039732|FG000|COMPLETED|Overall Study||18
8975169|NCT02652416|10039733|FG001|COMPLETED|Overall Study||18
8975170|NCT02652416|10039734|FG002|COMPLETED|Overall Study||18
8975171|NCT02652416|10039735|FG003|COMPLETED|Overall Study||18
8975172|NCT02652416|10039732|FG000|NOT COMPLETED|Overall Study||0
8975173|NCT02652416|10039733|FG001|NOT COMPLETED|Overall Study||0
8975174|NCT02652416|10039734|FG002|NOT COMPLETED|Overall Study||0
8975175|NCT02652416|10039735|FG003|NOT COMPLETED|Overall Study||0
8975176|NCT02652442|10039749|FG000|STARTED|Centrifugation - Distance||6
8975177|NCT02652442|10039749|FG000|COMPLETED|Centrifugation - Distance||5
8975178|NCT02652442|10039749|FG000|NOT COMPLETED|Centrifugation - Distance||1
8975179|NCT02652442|10039749|FG000|STARTED|Centrifugation - Duration||5
8975180|NCT02652442|10039749|FG000|COMPLETED|Centrifugation - Duration||5
8975181|NCT02652442|10039749|FG000|NOT COMPLETED|Centrifugation - Duration||0
8975182|NCT02652442|10039749|FG000|STARTED|Centrifugation - Schedule||5
8975183|NCT02652442|10039749|FG000|COMPLETED|Centrifugation - Schedule||5
8975184|NCT02652442|10039749|FG000|NOT COMPLETED|Centrifugation - Schedule||0
8975185|NCT02652481|10039761|FG000|STARTED|Phase 1||239
8975186|NCT02652481|10039761|FG000|COMPLETED|Phase 1||141
8975187|NCT02652481|10039761|FG000|NOT COMPLETED|Phase 1||98
8975188|NCT02652481|10039761|FG000|STARTED|Phase 2||261
8975189|NCT02652481|10039761|FG000|COMPLETED|Phase 2||243
8975190|NCT02652481|10039761|FG000|NOT COMPLETED|Phase 2||18
8975191|NCT02652624|10039767|FG000|STARTED|Randomized Phase||234
8975192|NCT02652624|10039768|FG001|STARTED|Randomized Phase||236
8975193|NCT02652624|10039767|FG000|COMPLETED|Randomized Phase||231
8975194|NCT02652624|10039768|FG001|COMPLETED|Randomized Phase||231
8975195|NCT02652624|10039767|FG000|NOT COMPLETED|Randomized Phase||3
8975196|NCT02652624|10039768|FG001|NOT COMPLETED|Randomized Phase||5
8975197|NCT02652624|10039767|FG000|STARTED|Extension Phase||231
8975198|NCT02652624|10039768|FG001|STARTED|Extension Phase|3 participants completed the Randomized Phase, but did not enter the Extension Phase.|228
8975199|NCT02652624|10039767|FG000|COMPLETED|Extension Phase||227
8975200|NCT02652624|10039768|FG001|COMPLETED|Extension Phase||224
8975201|NCT02652624|10039767|FG000|NOT COMPLETED|Extension Phase||4
8975202|NCT02652624|10039768|FG001|NOT COMPLETED|Extension Phase||4
8975203|NCT02652767|10039776|FG000|STARTED|Overall Study||39
8975204|NCT02652767|10039776|FG000|Completed Week 48|Overall Study||38
8975205|NCT02652767|10039776|FG000|COMPLETED|Overall Study||35
8975206|NCT02652767|10039776|FG000|NOT COMPLETED|Overall Study||4
8975207|NCT02652780|10039782|FG000|STARTED|Overall Study||37
8975208|NCT02652780|10039782|FG000|COMPLETED|Overall Study||37
8975209|NCT02652780|10039782|FG000|NOT COMPLETED|Overall Study||0
8975210|NCT02653144|10039792|FG000|STARTED|Overall Study||30
8975211|NCT02653144|10039793|FG001|STARTED|Overall Study||28
8975212|NCT02653144|10039794|FG002|STARTED|Overall Study||31
8975213|NCT02653144|10039792|FG000|COMPLETED|Overall Study||30
8975214|NCT02653144|10039793|FG001|COMPLETED|Overall Study||28
8975215|NCT02653144|10039794|FG002|COMPLETED|Overall Study||31
8975216|NCT02653144|10039792|FG000|NOT COMPLETED|Overall Study||0
8975217|NCT02653144|10039793|FG001|NOT COMPLETED|Overall Study||0
8975218|NCT02653144|10039794|FG002|NOT COMPLETED|Overall Study||0
8975219|NCT02653170|10039805|FG000|STARTED|Overall Study||87
8975220|NCT02653170|10039806|FG001|STARTED|Overall Study||88
8975221|NCT02653170|10039807|FG002|STARTED|Overall Study||90
8975222|NCT02653170|10039805|FG000|COMPLETED|Overall Study||70
8975223|NCT02653170|10039806|FG001|COMPLETED|Overall Study||72
8975224|NCT02653170|10039807|FG002|COMPLETED|Overall Study||72
8975225|NCT02653170|10039805|FG000|NOT COMPLETED|Overall Study||17
8975226|NCT02653170|10039806|FG001|NOT COMPLETED|Overall Study||16
8975227|NCT02653170|10039807|FG002|NOT COMPLETED|Overall Study||18
8975228|NCT02653183|10039817|FG000|STARTED|Overall Study||53
8975229|NCT02653183|10039818|FG001|STARTED|Overall Study||50
8975230|NCT02653183|10039817|FG000|COMPLETED|Overall Study||49
8975231|NCT02653183|10039818|FG001|COMPLETED|Overall Study||46
8975232|NCT02653183|10039817|FG000|NOT COMPLETED|Overall Study||4
8975233|NCT02653183|10039818|FG001|NOT COMPLETED|Overall Study||4
8975234|NCT02653300|10039824|FG000|STARTED|Overall Study||10
8975235|NCT02653300|10039824|FG000|COMPLETED|Overall Study||8
8975236|NCT02653300|10039824|FG000|NOT COMPLETED|Overall Study||2
8975237|NCT02653326|10039830|FG000|STARTED|Overall Study||32
8975238|NCT02653326|10039831|FG001|STARTED|Overall Study||34
8975239|NCT02653326|10039830|FG000|COMPLETED|Overall Study||22
8975240|NCT02653326|10039831|FG001|COMPLETED|Overall Study||27
8975241|NCT02653326|10039830|FG000|NOT COMPLETED|Overall Study||10
8975242|NCT02653326|10039831|FG001|NOT COMPLETED|Overall Study||7
8975243|NCT02653391|10039840|FG000|STARTED|Overall Study||18
8975244|NCT02653391|10039841|FG001|STARTED|Overall Study||3
8975245|NCT02653391|10039842|FG002|STARTED|Overall Study||1
8975246|NCT02653391|10039840|FG000|COMPLETED|Overall Study||16
8975247|NCT02653391|10039841|FG001|COMPLETED|Overall Study||1
8975248|NCT02653391|10039842|FG002|COMPLETED|Overall Study||1
8975249|NCT02653391|10039840|FG000|NOT COMPLETED|Overall Study||2
8975250|NCT02653391|10039841|FG001|NOT COMPLETED|Overall Study||2
8975251|NCT02653391|10039842|FG002|NOT COMPLETED|Overall Study||0
8975252|NCT02653417|10039890|FG000|STARTED|Overall Study||38
8975253|NCT02653417|10039891|FG001|STARTED|Overall Study||34
8975254|NCT02653417|10039892|FG002|STARTED|Overall Study||29
8975255|NCT02653417|10039893|FG003|STARTED|Overall Study||38
8975256|NCT02653417|10039890|FG000|COMPLETED|Overall Study||37
8975257|NCT02653417|10039891|FG001|COMPLETED|Overall Study||32
8975258|NCT02653417|10039892|FG002|COMPLETED|Overall Study||26
8975259|NCT02653417|10039893|FG003|COMPLETED|Overall Study||33
8975260|NCT02653417|10039890|FG000|NOT COMPLETED|Overall Study||1
8975261|NCT02653417|10039891|FG001|NOT COMPLETED|Overall Study||2
8632224|NCT00543985|9672112|FG000|STARTED|Overall Study||36
8632225|NCT00543985|9672112|FG000|COMPLETED|Overall Study||32
8632226|NCT00543985|9672112|FG000|NOT COMPLETED|Overall Study||4
8632227|NCT00544076|9672122|FG000|STARTED|Overall Study||34
8632228|NCT00544076|9672123|FG001|STARTED|Overall Study||35
8632229|NCT00544076|9672124|FG002|STARTED|Overall Study||31
8632230|NCT00544076|9672122|FG000|COMPLETED|Overall Study||17
8632231|NCT00544076|9672123|FG001|COMPLETED|Overall Study||19
8632232|NCT00544076|9672124|FG002|COMPLETED|Overall Study||20
8975262|NCT02653417|10039892|FG002|NOT COMPLETED|Overall Study||3
8975263|NCT02653417|10039893|FG003|NOT COMPLETED|Overall Study||5
8975264|NCT02653456|10039907|FG000|STARTED|Overall Study||64
8975265|NCT02653456|10039907|FG000|COMPLETED|Overall Study||59
8975266|NCT02653456|10039907|FG000|NOT COMPLETED|Overall Study||5
8975267|NCT02653560|10039912|FG000|STARTED|KMgCit Phase||30
8975268|NCT02653560|10039913|FG001|STARTED|KMgCit Phase||0
8975269|NCT02653560|10039914|FG002|STARTED|KMgCit Phase||0
8975270|NCT02653560|10039915|FG003|STARTED|KMgCit Phase||0
8975271|NCT02653560|10039912|FG000|COMPLETED|KMgCit Phase||30
8975272|NCT02653560|10039913|FG001|COMPLETED|KMgCit Phase||0
8975273|NCT02653560|10039914|FG002|COMPLETED|KMgCit Phase||0
8975274|NCT02653560|10039915|FG003|COMPLETED|KMgCit Phase||0
8975275|NCT02653560|10039912|FG000|NOT COMPLETED|KMgCit Phase||0
8975276|NCT02653560|10039913|FG001|NOT COMPLETED|KMgCit Phase||0
8975277|NCT02653560|10039914|FG002|NOT COMPLETED|KMgCit Phase||0
8975278|NCT02653560|10039915|FG003|NOT COMPLETED|KMgCit Phase||0
8975279|NCT02653560|10039912|FG000|STARTED|K Citrate Phase||0
8975280|NCT02653560|10039913|FG001|STARTED|K Citrate Phase||30
8975281|NCT02653560|10039914|FG002|STARTED|K Citrate Phase||0
8975282|NCT02653560|10039915|FG003|STARTED|K Citrate Phase||0
8975283|NCT02653560|10039912|FG000|COMPLETED|K Citrate Phase||0
8975284|NCT02653560|10039913|FG001|COMPLETED|K Citrate Phase||30
8975285|NCT02653560|10039914|FG002|COMPLETED|K Citrate Phase||0
8975286|NCT02653560|10039915|FG003|COMPLETED|K Citrate Phase||0
8975287|NCT02653560|10039912|FG000|NOT COMPLETED|K Citrate Phase||0
8975288|NCT02653560|10039913|FG001|NOT COMPLETED|K Citrate Phase||0
8975289|NCT02653560|10039914|FG002|NOT COMPLETED|K Citrate Phase||0
8975290|NCT02653560|10039915|FG003|NOT COMPLETED|K Citrate Phase||0
8975291|NCT02653560|10039912|FG000|STARTED|KCl Phase||0
8975292|NCT02653560|10039913|FG001|STARTED|KCl Phase||0
8975293|NCT02653560|10039914|FG002|STARTED|KCl Phase||30
8975294|NCT02653560|10039915|FG003|STARTED|KCl Phase||0
8975295|NCT02653560|10039912|FG000|COMPLETED|KCl Phase||0
8975296|NCT02653560|10039913|FG001|COMPLETED|KCl Phase||0
8975297|NCT02653560|10039914|FG002|COMPLETED|KCl Phase||30
8975298|NCT02653560|10039915|FG003|COMPLETED|KCl Phase||0
8975299|NCT02653560|10039912|FG000|NOT COMPLETED|KCl Phase||0
8975300|NCT02653560|10039913|FG001|NOT COMPLETED|KCl Phase||0
8975301|NCT02653560|10039914|FG002|NOT COMPLETED|KCl Phase||0
8975302|NCT02653560|10039915|FG003|NOT COMPLETED|KCl Phase||0
8975303|NCT02653560|10039912|FG000|STARTED|Placebo Phase||0
8975304|NCT02653560|10039913|FG001|STARTED|Placebo Phase||0
8975305|NCT02653560|10039914|FG002|STARTED|Placebo Phase||0
8975306|NCT02653560|10039915|FG003|STARTED|Placebo Phase||30
8975307|NCT02653560|10039912|FG000|COMPLETED|Placebo Phase||0
8975308|NCT02653560|10039913|FG001|COMPLETED|Placebo Phase||0
8975309|NCT02653560|10039914|FG002|COMPLETED|Placebo Phase||0
8975310|NCT02653560|10039915|FG003|COMPLETED|Placebo Phase||30
8975311|NCT02653560|10039912|FG000|NOT COMPLETED|Placebo Phase||0
8975312|NCT02653560|10039913|FG001|NOT COMPLETED|Placebo Phase||0
8975313|NCT02653560|10039914|FG002|NOT COMPLETED|Placebo Phase||0
8975314|NCT02653560|10039915|FG003|NOT COMPLETED|Placebo Phase||0
8975315|NCT02653625|10039925|FG000|STARTED|Overall Study||24
8975316|NCT02653625|10039925|FG000|COMPLETED|Overall Study||20
8975317|NCT02653625|10039925|FG000|NOT COMPLETED|Overall Study||4
8632233|NCT00544076|9672122|FG000|NOT COMPLETED|Overall Study||17
8632234|NCT00544076|9672123|FG001|NOT COMPLETED|Overall Study||16
8632235|NCT00544076|9672124|FG002|NOT COMPLETED|Overall Study||11
8975318|NCT02653664|10039932|FG000|STARTED|Post-Treatment||110
8975319|NCT02653664|10039933|FG001|STARTED|Post-Treatment||110
8975320|NCT02653664|10039934|FG002|STARTED|Post-Treatment||108
8975321|NCT02653664|10039932|FG000|Primary and Secondary Data|Post-Treatment||93
8975322|NCT02653664|10039933|FG001|Primary and Secondary Data|Post-Treatment||104
8975323|NCT02653664|10039934|FG002|Primary and Secondary Data|Post-Treatment||91
8975324|NCT02653664|10039932|FG000|Primary Outcome Data Only|Post-Treatment||3
8975325|NCT02653664|10039933|FG001|Primary Outcome Data Only|Post-Treatment||0
8975326|NCT02653664|10039934|FG002|Primary Outcome Data Only|Post-Treatment||3
8975327|NCT02653664|10039932|FG000|COMPLETED|Post-Treatment||96
8975328|NCT02653664|10039933|FG001|COMPLETED|Post-Treatment||104
8975329|NCT02653664|10039934|FG002|COMPLETED|Post-Treatment||94
8975330|NCT02653664|10039932|FG000|NOT COMPLETED|Post-Treatment||14
8975331|NCT02653664|10039933|FG001|NOT COMPLETED|Post-Treatment||6
8975332|NCT02653664|10039934|FG002|NOT COMPLETED|Post-Treatment||14
8975333|NCT02653664|10039932|FG000|STARTED|3 Month Follow-Up||110
8975334|NCT02653664|10039933|FG001|STARTED|3 Month Follow-Up||110
8975335|NCT02653664|10039934|FG002|STARTED|3 Month Follow-Up||108
8975336|NCT02653664|10039932|FG000|Primary and Secondary Data|3 Month Follow-Up||83
8975337|NCT02653664|10039933|FG001|Primary and Secondary Data|3 Month Follow-Up||95
8975338|NCT02653664|10039934|FG002|Primary and Secondary Data|3 Month Follow-Up||82
8975339|NCT02653664|10039932|FG000|Primary Outcome Data Only|3 Month Follow-Up||6
8975340|NCT02653664|10039933|FG001|Primary Outcome Data Only|3 Month Follow-Up||0
8975341|NCT02653664|10039934|FG002|Primary Outcome Data Only|3 Month Follow-Up||1
8975342|NCT02653664|10039932|FG000|COMPLETED|3 Month Follow-Up||89
8975343|NCT02653664|10039933|FG001|COMPLETED|3 Month Follow-Up||95
8975344|NCT02653664|10039934|FG002|COMPLETED|3 Month Follow-Up||83
8975345|NCT02653664|10039932|FG000|NOT COMPLETED|3 Month Follow-Up||21
8975346|NCT02653664|10039933|FG001|NOT COMPLETED|3 Month Follow-Up||15
8975347|NCT02653664|10039934|FG002|NOT COMPLETED|3 Month Follow-Up||25
8975348|NCT02653664|10039932|FG000|STARTED|6 Month Follow-Up||110
8975349|NCT02653664|10039933|FG001|STARTED|6 Month Follow-Up||110
8975350|NCT02653664|10039934|FG002|STARTED|6 Month Follow-Up||108
8975351|NCT02653664|10039932|FG000|Primary and Secondary Outcome Data|6 Month Follow-Up||85
8975352|NCT02653664|10039933|FG001|Primary and Secondary Outcome Data|6 Month Follow-Up||87
8975353|NCT02653664|10039934|FG002|Primary and Secondary Outcome Data|6 Month Follow-Up||83
8975354|NCT02653664|10039932|FG000|Primary Outcome Data Only|6 Month Follow-Up||2
8975355|NCT02653664|10039933|FG001|Primary Outcome Data Only|6 Month Follow-Up||2
8975356|NCT02653664|10039934|FG002|Primary Outcome Data Only|6 Month Follow-Up||2
8975357|NCT02653664|10039932|FG000|COMPLETED|6 Month Follow-Up||87
8975358|NCT02653664|10039933|FG001|COMPLETED|6 Month Follow-Up||89
8975359|NCT02653664|10039934|FG002|COMPLETED|6 Month Follow-Up||85
8975360|NCT02653664|10039932|FG000|NOT COMPLETED|6 Month Follow-Up||23
8975361|NCT02653664|10039933|FG001|NOT COMPLETED|6 Month Follow-Up||21
8975362|NCT02653664|10039934|FG002|NOT COMPLETED|6 Month Follow-Up||23
8975363|NCT02653768|10039947|FG000|STARTED|3-Month Follow-Up||230
8975364|NCT02653768|10039948|FG001|STARTED|3-Month Follow-Up||115
8975365|NCT02653768|10039947|FG000|COMPLETED|3-Month Follow-Up||164
8975366|NCT02653768|10039948|FG001|COMPLETED|3-Month Follow-Up||100
8975367|NCT02653768|10039947|FG000|NOT COMPLETED|3-Month Follow-Up||66
8975368|NCT02653768|10039948|FG001|NOT COMPLETED|3-Month Follow-Up||15
8975369|NCT02653768|10039947|FG000|STARTED|6-Month Follow-Up|21 participants withdrew/excluded by 3-months, others missed that assessment but remained in study|209
8975370|NCT02653768|10039948|FG001|STARTED|6-Month Follow-Up|2 participants withdrew/excluded by 3-months, others missed that assessment but remained in study|113
8975371|NCT02653768|10039947|FG000|COMPLETED|6-Month Follow-Up||164
8975372|NCT02653768|10039948|FG001|COMPLETED|6-Month Follow-Up||100
8975373|NCT02653768|10039947|FG000|NOT COMPLETED|6-Month Follow-Up||45
8975374|NCT02653768|10039948|FG001|NOT COMPLETED|6-Month Follow-Up||13
8975375|NCT02653768|10039947|FG000|STARTED|9-Month Follow-Up (Primary)|34 withdrew/excluded before 9 months; others missed prior assessments but remained in study|196
8975376|NCT02653768|10039948|FG001|STARTED|9-Month Follow-Up (Primary)|4 withdrew/excluded before 9 months; others missed prior assessments but remained in study|111
8975377|NCT02653768|10039947|FG000|COMPLETED|9-Month Follow-Up (Primary)|13 withdrew/refused before 9 months; others missed prior assessments but remained in study|163
8975378|NCT02653768|10039948|FG001|COMPLETED|9-Month Follow-Up (Primary)||95
8975379|NCT02653768|10039947|FG000|NOT COMPLETED|9-Month Follow-Up (Primary)||33
8975380|NCT02653768|10039948|FG001|NOT COMPLETED|9-Month Follow-Up (Primary)||16
8975381|NCT02653872|10039954|FG000|STARTED|Overall Study||15
8975382|NCT02653872|10039954|FG000|Treatment Period 1:|Overall Study|Participants received single AZD7986 (25 mg).|15
8975383|NCT02653872|10039954|FG000|Treatment Period 2:|Overall Study|Participants received Verapamil (240 mg; extended release formulation) + AZD7986 (25 mg).|15
8975384|NCT02653872|10039954|FG000|Treatment Period 3:|Overall Study|Participants received: itraconazole 200 mg + AZD7986.|15
8975385|NCT02653872|10039954|FG000|COMPLETED|Overall Study||15
8975386|NCT02653872|10039954|FG000|NOT COMPLETED|Overall Study||0
8975387|NCT02654002|10039977|FG000|STARTED|Overall Study||12
8975388|NCT02654002|10039978|FG001|STARTED|Overall Study||12
8975389|NCT02654002|10039979|FG002|STARTED|Overall Study||12
8975390|NCT02654002|10039980|FG003|STARTED|Overall Study||12
8975391|NCT02654002|10039981|FG004|STARTED|Overall Study||12
8975392|NCT02654002|10039982|FG005|STARTED|Overall Study||12
8975393|NCT02654002|10039983|FG006|STARTED|Overall Study||12
8975394|NCT02654002|10039984|FG007|STARTED|Overall Study||12
8975395|NCT02654002|10039985|FG008|STARTED|Overall Study||24
8975396|NCT02654002|10039977|FG000|COMPLETED|Overall Study||12
8975397|NCT02654002|10039978|FG001|COMPLETED|Overall Study||12
8975398|NCT02654002|10039979|FG002|COMPLETED|Overall Study||12
8975399|NCT02654002|10039980|FG003|COMPLETED|Overall Study||12
8975400|NCT02654002|10039981|FG004|COMPLETED|Overall Study||12
8975401|NCT02654002|10039982|FG005|COMPLETED|Overall Study||11
8975402|NCT02654002|10039983|FG006|COMPLETED|Overall Study||11
8975403|NCT02654002|10039984|FG007|COMPLETED|Overall Study||11
8975404|NCT02654002|10039985|FG008|COMPLETED|Overall Study||24
8975405|NCT02654002|10039977|FG000|NOT COMPLETED|Overall Study||0
8975406|NCT02654002|10039978|FG001|NOT COMPLETED|Overall Study||0
8975407|NCT02654002|10039979|FG002|NOT COMPLETED|Overall Study||0
8975408|NCT02654002|10039980|FG003|NOT COMPLETED|Overall Study||0
8975409|NCT02654002|10039981|FG004|NOT COMPLETED|Overall Study||0
8975410|NCT02654002|10039982|FG005|NOT COMPLETED|Overall Study||1
8975411|NCT02654002|10039983|FG006|NOT COMPLETED|Overall Study||1
8975412|NCT02654002|10039984|FG007|NOT COMPLETED|Overall Study||1
8975413|NCT02654002|10039985|FG008|NOT COMPLETED|Overall Study||0
8975414|NCT02654054|10040023|FG000|STARTED|Treatment Period||102
8975415|NCT02654054|10040024|FG001|STARTED|Treatment Period||104
8975416|NCT02654054|10040025|FG002|STARTED|Treatment Period||207
8975417|NCT02654054|10040023|FG000|Randomized and Treated|Treatment Period||102
8975418|NCT02654054|10040024|FG001|Randomized and Treated|Treatment Period||104
8975419|NCT02654054|10040025|FG002|Randomized and Treated|Treatment Period||206
8975420|NCT02654054|10040023|FG000|COMPLETED|Treatment Period||83
8975421|NCT02654054|10040024|FG001|COMPLETED|Treatment Period||81
8975422|NCT02654054|10040025|FG002|COMPLETED|Treatment Period||164
8975423|NCT02654054|10040023|FG000|NOT COMPLETED|Treatment Period||19
8571089|NCT00107744|9603303|FG002|NOT COMPLETED|Intervention 2 (8 Weeks)||13
8571090|NCT00107744|9603301|FG000|STARTED|Intervention 3 (8 Weeks)||93
8571091|NCT00107744|9603302|FG001|STARTED|Intervention 3 (8 Weeks)||92
8571092|NCT00107744|9603303|FG002|STARTED|Intervention 3 (8 Weeks)||88
8571093|NCT00107744|9603301|FG000|COMPLETED|Intervention 3 (8 Weeks)||93
8571094|NCT00107744|9603302|FG001|COMPLETED|Intervention 3 (8 Weeks)||92
8571095|NCT00107744|9603303|FG002|COMPLETED|Intervention 3 (8 Weeks)||88
8571096|NCT00107744|9603301|FG000|NOT COMPLETED|Intervention 3 (8 Weeks)||0
8571097|NCT00107744|9603302|FG001|NOT COMPLETED|Intervention 3 (8 Weeks)||0
8571098|NCT00107744|9603303|FG002|NOT COMPLETED|Intervention 3 (8 Weeks)||0
8571099|NCT00107783|9603313|FG000|STARTED|Overall Study||20
8571100|NCT00107783|9603314|FG001|STARTED|Overall Study||20
8571101|NCT00107783|9603313|FG000|COMPLETED|Overall Study||17
8571102|NCT00107783|9603314|FG001|COMPLETED|Overall Study||16
8877184|NCT01922050|9934158|FG000|STARTED|Part 1 Open-label, Dose-escalation Phase||3
8877185|NCT01922050|9934159|FG001|STARTED|Part 1 Open-label, Dose-escalation Phase||3
8877186|NCT01922050|9934160|FG002|STARTED|Part 1 Open-label, Dose-escalation Phase||6
8877187|NCT01922050|9934161|FG003|STARTED|Part 1 Open-label, Dose-escalation Phase||6
8877188|NCT01922050|9934162|FG004|STARTED|Part 1 Open-label, Dose-escalation Phase||17
8877189|NCT01922050|9934163|FG005|STARTED|Part 1 Open-label, Dose-escalation Phase||18
8877190|NCT01922050|9934164|FG006|STARTED|Part 1 Open-label, Dose-escalation Phase||3
8877191|NCT01922050|9934165|FG007|STARTED|Part 1 Open-label, Dose-escalation Phase||3
8877192|NCT01922050|9934166|FG008|STARTED|Part 1 Open-label, Dose-escalation Phase||6
8877193|NCT01922050|9934167|FG009|STARTED|Part 1 Open-label, Dose-escalation Phase||12
8877194|NCT01922050|9934168|FG010|STARTED|Part 1 Open-label, Dose-escalation Phase||0
8877195|NCT01922050|9934169|FG011|STARTED|Part 1 Open-label, Dose-escalation Phase||0
8877196|NCT01922050|9934170|FG012|STARTED|Part 1 Open-label, Dose-escalation Phase||0
8877197|NCT01922050|9934171|FG013|STARTED|Part 1 Open-label, Dose-escalation Phase||0
8877198|NCT01922050|9934158|FG000|COMPLETED|Part 1 Open-label, Dose-escalation Phase||3
8877199|NCT01922050|9934159|FG001|COMPLETED|Part 1 Open-label, Dose-escalation Phase||3
8877200|NCT01922050|9934160|FG002|COMPLETED|Part 1 Open-label, Dose-escalation Phase||6
8877201|NCT01922050|9934161|FG003|COMPLETED|Part 1 Open-label, Dose-escalation Phase||6
8877202|NCT01922050|9934162|FG004|COMPLETED|Part 1 Open-label, Dose-escalation Phase||17
8877203|NCT01922050|9934163|FG005|COMPLETED|Part 1 Open-label, Dose-escalation Phase||18
8877204|NCT01922050|9934164|FG006|COMPLETED|Part 1 Open-label, Dose-escalation Phase||3
8877205|NCT01922050|9934165|FG007|COMPLETED|Part 1 Open-label, Dose-escalation Phase||3
8877206|NCT01922050|9934166|FG008|COMPLETED|Part 1 Open-label, Dose-escalation Phase||6
8877207|NCT01922050|9934167|FG009|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
8877208|NCT01922050|9934168|FG010|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8877209|NCT01922050|9934169|FG011|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8877210|NCT01922050|9934170|FG012|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8877211|NCT01922050|9934171|FG013|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8877212|NCT01922050|9934158|FG000|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8877213|NCT01922050|9934159|FG001|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8877214|NCT01922050|9934160|FG002|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8877215|NCT01922050|9934161|FG003|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8877216|NCT01922050|9934162|FG004|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8877217|NCT01922050|9934163|FG005|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8877218|NCT01922050|9934164|FG006|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8877219|NCT01922050|9934165|FG007|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8877220|NCT01922050|9934166|FG008|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8877221|NCT01922050|9934167|FG009|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8877222|NCT01922050|9934168|FG010|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8877223|NCT01922050|9934169|FG011|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8877224|NCT01922050|9934170|FG012|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8877225|NCT01922050|9934171|FG013|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8877226|NCT01922050|9934158|FG000|STARTED|Part 2 Double-blind Phase||0
8877227|NCT01922050|9934159|FG001|STARTED|Part 2 Double-blind Phase||0
8877228|NCT01922050|9934160|FG002|STARTED|Part 2 Double-blind Phase||0
8877229|NCT01922050|9934161|FG003|STARTED|Part 2 Double-blind Phase||0
8877230|NCT01922050|9934162|FG004|STARTED|Part 2 Double-blind Phase||0
8877231|NCT01922050|9934163|FG005|STARTED|Part 2 Double-blind Phase||0
8975424|NCT02654054|10040024|FG001|NOT COMPLETED|Treatment Period||23
8975425|NCT02654054|10040025|FG002|NOT COMPLETED|Treatment Period||43
8975426|NCT02654054|10040023|FG000|STARTED|Post-Treatment Follow-Up Period||25
8975427|NCT02654054|10040024|FG001|STARTED|Post-Treatment Follow-Up Period||32
8975428|NCT02654054|10040025|FG002|STARTED|Post-Treatment Follow-Up Period||59
8975429|NCT02654054|10040023|FG000|COMPLETED|Post-Treatment Follow-Up Period||17
8975430|NCT02654054|10040024|FG001|COMPLETED|Post-Treatment Follow-Up Period||24
8975431|NCT02654054|10040025|FG002|COMPLETED|Post-Treatment Follow-Up Period||29
8975432|NCT02654054|10040023|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||8
8975433|NCT02654054|10040024|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||8
8975434|NCT02654054|10040025|FG002|NOT COMPLETED|Post-Treatment Follow-Up Period||30
8975435|NCT02654145|10040034|FG000|STARTED|Overall Study||145
8975436|NCT02654145|10040034|FG000|COMPLETED|Overall Study||138
8975437|NCT02654145|10040034|FG000|NOT COMPLETED|Overall Study||7
8975438|NCT02654483|10040040|FG000|STARTED|Double-blind||7
8975439|NCT02654483|10040041|FG001|STARTED|Double-blind||7
8975440|NCT02654483|10040040|FG000|COMPLETED|Double-blind||7
8975441|NCT02654483|10040041|FG001|COMPLETED|Double-blind||7
8975442|NCT02654483|10040040|FG000|NOT COMPLETED|Double-blind||0
8975443|NCT02654483|10040041|FG001|NOT COMPLETED|Double-blind||0
8975444|NCT02654483|10040040|FG000|STARTED|Open-label|2 participants did not proceed to open-label arm|5
8975445|NCT02654483|10040041|FG001|STARTED|Open-label|4 participants did not continue to open-label arm|3
8975446|NCT02654483|10040040|FG000|COMPLETED|Open-label||5
8975447|NCT02654483|10040041|FG001|COMPLETED|Open-label||3
8975448|NCT02654483|10040040|FG000|NOT COMPLETED|Open-label||0
8975449|NCT02654483|10040041|FG001|NOT COMPLETED|Open-label||0
9038454|NCT03332212|10099698|FG003|STARTED|Overall Study||18
9038455|NCT03332212|10099695|FG000|Treated|Overall Study||19
9038456|NCT03332212|10099696|FG001|Treated|Overall Study||17
9038457|NCT03332212|10099697|FG002|Treated|Overall Study||17
9038458|NCT03332212|10099698|FG003|Treated|Overall Study||18
9038459|NCT03332212|10099695|FG000|COMPLETED|Overall Study||18
9038460|NCT03332212|10099696|FG001|COMPLETED|Overall Study||16
9038461|NCT03332212|10099697|FG002|COMPLETED|Overall Study||17
9038462|NCT03332212|10099698|FG003|COMPLETED|Overall Study||17
9038463|NCT03332212|10099695|FG000|NOT COMPLETED|Overall Study||1
9038464|NCT03332212|10099696|FG001|NOT COMPLETED|Overall Study||2
9038465|NCT03332212|10099697|FG002|NOT COMPLETED|Overall Study||0
9038466|NCT03332212|10099698|FG003|NOT COMPLETED|Overall Study||1
9038467|NCT03332459|10099709|FG000|STARTED|Overall Study||3
9038468|NCT03332459|10099710|FG001|STARTED|Overall Study||1
9038469|NCT03332459|10099711|FG002|STARTED|Overall Study||3
9038470|NCT03332459|10099709|FG000|COMPLETED|Overall Study||3
9038471|NCT03332459|10099710|FG001|COMPLETED|Overall Study||1
9038472|NCT03332459|10099711|FG002|COMPLETED|Overall Study||3
9038473|NCT03332459|10099709|FG000|NOT COMPLETED|Overall Study||0
9038474|NCT03332459|10099710|FG001|NOT COMPLETED|Overall Study||0
9038475|NCT03332459|10099711|FG002|NOT COMPLETED|Overall Study||0
9038476|NCT03332628|10099719|FG000|STARTED|Overall Study||113
9038477|NCT03332628|10099719|FG000|COMPLETED|Overall Study||111
9038478|NCT03332628|10099719|FG000|NOT COMPLETED|Overall Study||2
9038479|NCT03332771|10099728|FG000|STARTED|Overall Study||159
9038480|NCT03332771|10099729|FG001|STARTED|Overall Study||317
9038481|NCT03332771|10099730|FG002|STARTED|Overall Study||160
9038482|NCT03332771|10099731|FG003|STARTED|Overall Study||318
9038483|NCT03332771|10099728|FG000|COMPLETED|Overall Study||125
9038484|NCT03332771|10099729|FG001|COMPLETED|Overall Study||266
9038485|NCT03332771|10099730|FG002|COMPLETED|Overall Study||128
9038486|NCT03332771|10099731|FG003|COMPLETED|Overall Study||270
9038487|NCT03332771|10099728|FG000|NOT COMPLETED|Overall Study||34
9038488|NCT03332771|10099729|FG001|NOT COMPLETED|Overall Study||51
9038489|NCT03332771|10099730|FG002|NOT COMPLETED|Overall Study||32
9038490|NCT03332771|10099731|FG003|NOT COMPLETED|Overall Study||48
9038491|NCT03332784|10099761|FG000|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
9038492|NCT03332784|10099762|FG001|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
9038493|NCT03332784|10099763|FG002|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
9038494|NCT03332784|10099764|FG003|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
9038495|NCT03332784|10099765|FG004|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
9038496|NCT03332784|10099766|FG005|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
9038497|NCT03332784|10099767|FG006|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
9038498|NCT03332784|10099768|FG007|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
9038499|NCT03332784|10099769|FG008|STARTED|Parts 1 and 2 - Period 1 (1 Day)||4
9038500|NCT03332784|10099770|FG009|STARTED|Parts 1 and 2 - Period 1 (1 Day)||6
9038501|NCT03332784|10099771|FG010|STARTED|Parts 1 and 2 - Period 1 (1 Day)||6
9038502|NCT03332784|10099772|FG011|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
9038503|NCT03332784|10099773|FG012|STARTED|Parts 1 and 2 - Period 1 (1 Day)||6
9038504|NCT03332784|10099774|FG013|STARTED|Parts 1 and 2 - Period 1 (1 Day)||4
9038505|NCT03332784|10099775|FG014|STARTED|Parts 1 and 2 - Period 1 (1 Day)|A washout period of 7 days was required before the dosing on Day 1 for prior medications.|2
9038506|NCT03332784|10099776|FG015|STARTED|Parts 1 and 2 - Period 1 (1 Day)|A washout period of 7 days was required before the dosing on Day 1 for prior medications.|2
9038507|NCT03332784|10099777|FG016|STARTED|Parts 1 and 2 - Period 1 (1 Day)|A washout period of 7 days was required before the dosing on Day 1 for prior medications.|2
9038508|NCT03332784|10099778|FG017|STARTED|Parts 1 and 2 - Period 1 (1 Day)|A washout period of 7 days was required before the dosing on Day 1 for prior medications.|2
8975450|NCT02654652|10040055|FG000|STARTED|Overall Study||19
8975451|NCT02654652|10040056|FG001|STARTED|Overall Study||21
8975452|NCT02654652|10040055|FG000|COMPLETED|Overall Study||18
8975453|NCT02654652|10040056|FG001|COMPLETED|Overall Study||18
8975454|NCT02654652|10040055|FG000|NOT COMPLETED|Overall Study||1
8975455|NCT02654652|10040056|FG001|NOT COMPLETED|Overall Study||3
8975456|NCT02654691|10040062|FG000|STARTED|Overall Study||63
8975457|NCT02654691|10040062|FG000|COMPLETED|Overall Study||63
8975458|NCT02654691|10040062|FG000|NOT COMPLETED|Overall Study||0
8975459|NCT02654717|10040068|FG000|STARTED|Overall Study||56
8975460|NCT02654717|10040069|FG001|STARTED|Overall Study||55
8975461|NCT02654717|10040068|FG000|COMPLETED|Overall Study||50
8975462|NCT02654717|10040069|FG001|COMPLETED|Overall Study||50
8975463|NCT02654717|10040068|FG000|NOT COMPLETED|Overall Study||6
8975464|NCT02654717|10040069|FG001|NOT COMPLETED|Overall Study||5
8975465|NCT02654769|10040078|FG000|STARTED|Overall Study||149
8975466|NCT02654769|10040079|FG001|STARTED|Overall Study||149
8975467|NCT02654769|10040080|FG002|STARTED|Overall Study||143
8975468|NCT02654769|10040078|FG000|COMPLETED|Overall Study||145
8975469|NCT02654769|10040079|FG001|COMPLETED|Overall Study||148
8975470|NCT02654769|10040080|FG002|COMPLETED|Overall Study||142
8975471|NCT02654769|10040078|FG000|NOT COMPLETED|Overall Study||4
8975472|NCT02654769|10040079|FG001|NOT COMPLETED|Overall Study||1
8975473|NCT02654769|10040080|FG002|NOT COMPLETED|Overall Study||1
8975474|NCT02654808|10040092|FG000|STARTED|Overall Study||33
8975475|NCT02654808|10040093|FG001|STARTED|Overall Study||33
8975476|NCT02654808|10040094|FG002|STARTED|Overall Study||33
8975477|NCT02654808|10040095|FG003|STARTED|Overall Study||33
8975478|NCT02654808|10040092|FG000|COMPLETED|Overall Study||33
8975479|NCT02654808|10040093|FG001|COMPLETED|Overall Study||33
8975480|NCT02654808|10040094|FG002|COMPLETED|Overall Study||33
8975481|NCT02654808|10040095|FG003|COMPLETED|Overall Study||33
8975482|NCT02654808|10040092|FG000|NOT COMPLETED|Overall Study||0
8975483|NCT02654808|10040093|FG001|NOT COMPLETED|Overall Study||0
8975484|NCT02654808|10040094|FG002|NOT COMPLETED|Overall Study||0
8975485|NCT02654808|10040095|FG003|NOT COMPLETED|Overall Study||0
8975486|NCT02654860|10040113|FG000|STARTED|First Part||3
8975487|NCT02654860|10040114|FG001|STARTED|First Part||3
8975488|NCT02654860|10040115|FG002|STARTED|First Part||3
8975489|NCT02654860|10040116|FG003|STARTED|First Part||0
8975490|NCT02654860|10040113|FG000|COMPLETED|First Part||3
8975491|NCT02654860|10040114|FG001|COMPLETED|First Part||3
8975492|NCT02654860|10040115|FG002|COMPLETED|First Part||3
8975493|NCT02654860|10040116|FG003|COMPLETED|First Part||0
8975494|NCT02654860|10040113|FG000|NOT COMPLETED|First Part||0
8975495|NCT02654860|10040114|FG001|NOT COMPLETED|First Part||0
8975496|NCT02654860|10040115|FG002|NOT COMPLETED|First Part||0
8975497|NCT02654860|10040116|FG003|NOT COMPLETED|First Part||0
8975498|NCT02654860|10040113|FG000|STARTED|Second Part||15
8975499|NCT02654860|10040114|FG001|STARTED|Second Part||15
8975500|NCT02654860|10040115|FG002|STARTED|Second Part||15
8975501|NCT02654860|10040116|FG003|STARTED|Second Part||15
8975502|NCT02654860|10040113|FG000|COMPLETED|Second Part||15
8975503|NCT02654860|10040114|FG001|COMPLETED|Second Part||15
8975504|NCT02654860|10040115|FG002|COMPLETED|Second Part||15
8975505|NCT02654860|10040116|FG003|COMPLETED|Second Part||15
8975506|NCT02654860|10040113|FG000|NOT COMPLETED|Second Part||0
8975507|NCT02654860|10040114|FG001|NOT COMPLETED|Second Part||0
8632236|NCT00544167|9672133|FG000|STARTED|Overall Study||45
8632237|NCT00544167|9672133|FG000|COMPLETED|Overall Study||16
8632238|NCT00544167|9672133|FG000|NOT COMPLETED|Overall Study||29
8632239|NCT00544440|9672137|FG000|STARTED|Overall Study||57
8632240|NCT00544440|9672137|FG000|COMPLETED|Overall Study||0
8632241|NCT00544440|9672137|FG000|NOT COMPLETED|Overall Study||57
8975508|NCT02654860|10040115|FG002|NOT COMPLETED|Second Part||0
8975509|NCT02654860|10040116|FG003|NOT COMPLETED|Second Part||0
8975510|NCT02654977|10040126|FG000|STARTED|Overall Study||11
8975511|NCT02654977|10040126|FG000|COMPLETED|Overall Study||4
8975512|NCT02654977|10040126|FG000|NOT COMPLETED|Overall Study||7
8975513|NCT02655224|10040132|FG000|STARTED|Overall Study||33
8975514|NCT02655224|10040133|FG001|STARTED|Overall Study||32
8975515|NCT02655224|10040132|FG000|COMPLETED|Overall Study||32
8632242|NCT00544544|9672141|FG000|STARTED|Overall Study||14
8975516|NCT02655224|10040133|FG001|COMPLETED|Overall Study||31
8975517|NCT02655224|10040132|FG000|NOT COMPLETED|Overall Study||1
8632243|NCT00544544|9672141|FG000|COMPLETED|Overall Study||11
8975518|NCT02655224|10040133|FG001|NOT COMPLETED|Overall Study||1
8975519|NCT02655237|10040141|FG000|STARTED|Overall Study||139
8975520|NCT02655237|10040142|FG001|STARTED|Overall Study||142
8975521|NCT02655237|10040141|FG000|COMPLETED|Overall Study||122
8975522|NCT02655237|10040142|FG001|COMPLETED|Overall Study||131
8975523|NCT02655237|10040141|FG000|NOT COMPLETED|Overall Study||17
8975524|NCT02655237|10040142|FG001|NOT COMPLETED|Overall Study||11
8975525|NCT02655354|10040150|FG000|STARTED|Overall Study||265
8975526|NCT02655354|10040151|FG001|STARTED|Overall Study||370
8975527|NCT02655354|10040150|FG000|COMPLETED|Overall Study||188
8975528|NCT02655354|10040151|FG001|COMPLETED|Overall Study||289
8975529|NCT02655354|10040150|FG000|NOT COMPLETED|Overall Study||77
8975530|NCT02655354|10040151|FG001|NOT COMPLETED|Overall Study||81
8975531|NCT02655419|10040159|FG000|STARTED|Overall Study||17
8975532|NCT02655419|10040160|FG001|STARTED|Overall Study||23
8975533|NCT02655419|10040159|FG000|Treated|Overall Study||16
8975534|NCT02655419|10040160|FG001|Treated|Overall Study||18
8975535|NCT02655419|10040159|FG000|COMPLETED|Overall Study||12
8975536|NCT02655419|10040160|FG001|COMPLETED|Overall Study||16
8975537|NCT02655419|10040159|FG000|NOT COMPLETED|Overall Study||5
8975538|NCT02655419|10040160|FG001|NOT COMPLETED|Overall Study||7
8975539|NCT02655510|10040173|FG000|STARTED|Overall Study||6
8975540|NCT02655510|10040174|FG001|STARTED|Overall Study||6
8975541|NCT02655510|10040175|FG002|STARTED|Overall Study||6
8975542|NCT02655510|10040173|FG000|COMPLETED|Overall Study||6
8975543|NCT02655510|10040174|FG001|COMPLETED|Overall Study||6
8975544|NCT02655510|10040175|FG002|COMPLETED|Overall Study||6
8975545|NCT02655510|10040173|FG000|NOT COMPLETED|Overall Study||0
8975546|NCT02655510|10040174|FG001|NOT COMPLETED|Overall Study||0
8975547|NCT02655510|10040175|FG002|NOT COMPLETED|Overall Study||0
8975548|NCT02655653|10040185|FG000|STARTED|Overall Study||56
8975549|NCT02655653|10040186|FG001|STARTED|Overall Study||58
8975550|NCT02655653|10040185|FG000|COMPLETED|Overall Study||56
8975551|NCT02655653|10040186|FG001|COMPLETED|Overall Study||58
8975552|NCT02655653|10040185|FG000|NOT COMPLETED|Overall Study||0
8975553|NCT02655653|10040186|FG001|NOT COMPLETED|Overall Study||0
8975554|NCT02655666|10040198|FG000|STARTED|Overall Study||16
8975555|NCT02655666|10040198|FG000|COMPLETED|Overall Study||4
8975556|NCT02655666|10040198|FG000|NOT COMPLETED|Overall Study||12
8975557|NCT02655679|10040207|FG000|STARTED|Overall Study||21
8975558|NCT02655679|10040208|FG001|STARTED|Overall Study||19
8975559|NCT02655679|10040209|FG002|STARTED|Overall Study||20
8975560|NCT02655679|10040210|FG003|STARTED|Overall Study||24
8975561|NCT02655679|10040211|FG004|STARTED|Overall Study||20
8975562|NCT02655679|10040207|FG000|Received Study Drug (Safety Population)|Overall Study||20
8975563|NCT02655679|10040208|FG001|Received Study Drug (Safety Population)|Overall Study||19
8975564|NCT02655679|10040209|FG002|Received Study Drug (Safety Population)|Overall Study||20
8975565|NCT02655679|10040210|FG003|Received Study Drug (Safety Population)|Overall Study||24
8975566|NCT02655679|10040211|FG004|Received Study Drug (Safety Population)|Overall Study||20
8975567|NCT02655679|10040207|FG000|COMPLETED|Overall Study||18
8975568|NCT02655679|10040208|FG001|COMPLETED|Overall Study||16
8975569|NCT02655679|10040209|FG002|COMPLETED|Overall Study||19
8975570|NCT02655679|10040210|FG003|COMPLETED|Overall Study||20
8975571|NCT02655679|10040211|FG004|COMPLETED|Overall Study||19
8975572|NCT02655679|10040207|FG000|NOT COMPLETED|Overall Study||3
8975573|NCT02655679|10040208|FG001|NOT COMPLETED|Overall Study||3
8975574|NCT02655679|10040209|FG002|NOT COMPLETED|Overall Study||1
8975575|NCT02655679|10040210|FG003|NOT COMPLETED|Overall Study||4
8975576|NCT02655679|10040211|FG004|NOT COMPLETED|Overall Study||1
8975577|NCT02655887|10040224|FG000|STARTED|Overall Study|Intent to Treat (ITT) population.|170
8975578|NCT02655887|10040224|FG000|COMPLETED|Overall Study|Completed 12-month follow-up.|156
8975579|NCT02655887|10040224|FG000|NOT COMPLETED|Overall Study||14
8975580|NCT02656069|10040230|FG000|STARTED|First Intervention||44
8975581|NCT02656069|10040231|FG001|STARTED|First Intervention||36
8975582|NCT02656069|10040230|FG000|COMPLETED|First Intervention||44
8975583|NCT02656069|10040231|FG001|COMPLETED|First Intervention||36
8975584|NCT02656069|10040230|FG000|NOT COMPLETED|First Intervention||0
8975585|NCT02656069|10040231|FG001|NOT COMPLETED|First Intervention||0
8975586|NCT02656069|10040230|FG000|STARTED|Second Intervention||44
8975587|NCT02656069|10040231|FG001|STARTED|Second Intervention||36
8975588|NCT02656069|10040230|FG000|COMPLETED|Second Intervention||43
8975589|NCT02656069|10040231|FG001|COMPLETED|Second Intervention||35
8975590|NCT02656069|10040230|FG000|NOT COMPLETED|Second Intervention||1
8975591|NCT02656069|10040231|FG001|NOT COMPLETED|Second Intervention||1
8975592|NCT02656160|10040237|FG000|STARTED|First Study Night||7
8975593|NCT02656160|10040238|FG001|STARTED|First Study Night||6
8975594|NCT02656160|10040237|FG000|COMPLETED|First Study Night||7
8975595|NCT02656160|10040238|FG001|COMPLETED|First Study Night||6
8975596|NCT02656160|10040237|FG000|NOT COMPLETED|First Study Night||0
8975597|NCT02656160|10040238|FG001|NOT COMPLETED|First Study Night||0
8975598|NCT02656160|10040237|FG000|STARTED|Second Study Night|3 subjects did not return for the second study night|4
8975599|NCT02656160|10040238|FG001|STARTED|Second Study Night||6
8975600|NCT02656160|10040237|FG000|COMPLETED|Second Study Night||4
8975601|NCT02656160|10040238|FG001|COMPLETED|Second Study Night||6
8975602|NCT02656160|10040237|FG000|NOT COMPLETED|Second Study Night||0
8975603|NCT02656160|10040238|FG001|NOT COMPLETED|Second Study Night||0
8975604|NCT02656173|10040246|FG000|STARTED|Overall Study||285
8975605|NCT02656173|10040247|FG001|STARTED|Overall Study||283
8975606|NCT02656173|10040246|FG000|Received Treatment|Overall Study||284
8975607|NCT02656173|10040247|FG001|Received Treatment|Overall Study||282
8975608|NCT02656173|10040246|FG000|COMPLETED|Overall Study||272
8975609|NCT02656173|10040247|FG001|COMPLETED|Overall Study||272
8975610|NCT02656173|10040246|FG000|NOT COMPLETED|Overall Study||13
8975611|NCT02656173|10040247|FG001|NOT COMPLETED|Overall Study||11
8975612|NCT02656329|10040257|FG000|STARTED|Overall Study||164
8975613|NCT02656329|10040258|FG001|STARTED|Overall Study||157
8975614|NCT02656329|10040257|FG000|COMPLETED|Overall Study||0
8975615|NCT02656329|10040258|FG001|COMPLETED|Overall Study||0
8975616|NCT02656329|10040257|FG000|NOT COMPLETED|Overall Study||164
8975617|NCT02656329|10040258|FG001|NOT COMPLETED|Overall Study||157
8975618|NCT02656420|10040269|FG000|STARTED|Overall Study||55
8975619|NCT02656420|10040270|FG001|STARTED|Overall Study||25
8975620|NCT02656420|10040271|FG002|STARTED|Overall Study||35
8975621|NCT02656420|10040272|FG003|STARTED|Overall Study||55
8975622|NCT02656420|10040269|FG000|COMPLETED|Overall Study||55
8975623|NCT02656420|10040270|FG001|COMPLETED|Overall Study||24
8975624|NCT02656420|10040271|FG002|COMPLETED|Overall Study||35
8975625|NCT02656420|10040272|FG003|COMPLETED|Overall Study||55
8975626|NCT02656420|10040269|FG000|NOT COMPLETED|Overall Study||0
8975627|NCT02656420|10040270|FG001|NOT COMPLETED|Overall Study||1
8975628|NCT02656420|10040271|FG002|NOT COMPLETED|Overall Study||0
8975629|NCT02656420|10040272|FG003|NOT COMPLETED|Overall Study||0
8975630|NCT02656485|10040288|FG000|STARTED|Overall Study||9
8975631|NCT02656485|10040289|FG001|STARTED|Overall Study||9
8975632|NCT02656485|10040290|FG002|STARTED|Overall Study||9
8975633|NCT02656485|10040291|FG003|STARTED|Overall Study||9
8975634|NCT02656485|10040288|FG000|COMPLETED|Overall Study||7
8975635|NCT02656485|10040289|FG001|COMPLETED|Overall Study||6
8975636|NCT02656485|10040290|FG002|COMPLETED|Overall Study||7
8975637|NCT02656485|10040291|FG003|COMPLETED|Overall Study||7
8975638|NCT02656485|10040288|FG000|NOT COMPLETED|Overall Study||2
8975639|NCT02656485|10040289|FG001|NOT COMPLETED|Overall Study||3
8975640|NCT02656485|10040290|FG002|NOT COMPLETED|Overall Study||2
8975641|NCT02656485|10040291|FG003|NOT COMPLETED|Overall Study||2
8975642|NCT02656680|10040305|FG000|STARTED|Overall Study||40
8975643|NCT02656680|10040306|FG001|STARTED|Overall Study||40
8975644|NCT02656680|10040305|FG000|COMPLETED|Overall Study||40
8975645|NCT02656680|10040306|FG001|COMPLETED|Overall Study||39
8975646|NCT02656680|10040305|FG000|NOT COMPLETED|Overall Study||0
8975647|NCT02656680|10040306|FG001|NOT COMPLETED|Overall Study||1
8975648|NCT02656693|10040317|FG000|STARTED|Overall Study||326
8975649|NCT02656693|10040318|FG001|STARTED|Overall Study||216
8975650|NCT02656693|10040319|FG002|STARTED|Overall Study||298
8975651|NCT02656693|10040317|FG000|COMPLETED|Overall Study||325
8975652|NCT02656693|10040318|FG001|COMPLETED|Overall Study||214
8975653|NCT02656693|10040319|FG002|COMPLETED|Overall Study||295
8975654|NCT02656693|10040317|FG000|NOT COMPLETED|Overall Study||1
8975655|NCT02656693|10040318|FG001|NOT COMPLETED|Overall Study||2
8975656|NCT02656693|10040319|FG002|NOT COMPLETED|Overall Study||3
8975657|NCT02656745|10040327|FG000|STARTED|Overall Study||416
8975658|NCT02656745|10040327|FG000|COMPLETED|Overall Study||416
8975659|NCT02656745|10040327|FG000|NOT COMPLETED|Overall Study||0
8975660|NCT02656836|10040334|FG000|STARTED|Overall Study||9
8975661|NCT02656836|10040334|FG000|COMPLETED|Overall Study||6
8975662|NCT02656836|10040334|FG000|NOT COMPLETED|Overall Study||3
8975663|NCT02656875|10040338|FG000|STARTED|Overall Study||768
8975664|NCT02656875|10040338|FG000|COMPLETED|Overall Study||698
8975665|NCT02656875|10040338|FG000|NOT COMPLETED|Overall Study||70
8975666|NCT02657031|10040344|FG000|STARTED|Overall Study||29
8975667|NCT02657031|10040345|FG001|STARTED|Overall Study||25
8975668|NCT02657031|10040344|FG000|COMPLETED|Overall Study||28
8975669|NCT02657031|10040345|FG001|COMPLETED|Overall Study||23
8975670|NCT02657031|10040344|FG000|NOT COMPLETED|Overall Study||1
8975671|NCT02657031|10040345|FG001|NOT COMPLETED|Overall Study||2
8975672|NCT02657226|10040351|FG000|STARTED|Overall Study||15724
8975673|NCT02657226|10040351|FG000|COMPLETED|Overall Study||15724
8975674|NCT02657226|10040351|FG000|NOT COMPLETED|Overall Study||0
8975675|NCT02657252|10040360|FG000|STARTED|Overall Study||57
8975676|NCT02657252|10040361|FG001|STARTED|Overall Study||58
8975677|NCT02657252|10040360|FG000|COMPLETED|Overall Study||47
8975678|NCT02657252|10040361|FG001|COMPLETED|Overall Study||51
8975679|NCT02657252|10040360|FG000|NOT COMPLETED|Overall Study||10
8975680|NCT02657252|10040361|FG001|NOT COMPLETED|Overall Study||7
8975681|NCT02657369|10040367|FG000|STARTED|Overall Study||34
8975682|NCT02657369|10040367|FG000|COMPLETED|Overall Study||0
8975683|NCT02657369|10040367|FG000|NOT COMPLETED|Overall Study||34
8975684|NCT02657408|10040373|FG000|STARTED|Overall Study||28
8975685|NCT02657408|10040374|FG001|STARTED|Overall Study||29
8975686|NCT02657408|10040373|FG000|COMPLETED|Overall Study||25
8975687|NCT02657408|10040374|FG001|COMPLETED|Overall Study||22
8975688|NCT02657408|10040373|FG000|NOT COMPLETED|Overall Study||3
8975689|NCT02657408|10040374|FG001|NOT COMPLETED|Overall Study||7
8975690|NCT02657538|10040380|FG000|STARTED|Overall Study||35
8975691|NCT02657538|10040380|FG000|Received Near Infrared Transillumination|Overall Study||35
8975692|NCT02657538|10040380|FG000|Received Visual Caries Detection + Bite|Overall Study||35
8975693|NCT02657538|10040380|FG000|COMPLETED|Overall Study||31
8975694|NCT02657538|10040380|FG000|NOT COMPLETED|Overall Study||4
8975695|NCT02657564|10040387|FG000|STARTED|Overall Study||1237
8975696|NCT02657564|10040387|FG000|COMPLETED|Overall Study||1163
8975697|NCT02657564|10040387|FG000|NOT COMPLETED|Overall Study||74
8975698|NCT02657629|10040394|FG000|STARTED|Overall Study||14
8975699|NCT02657629|10040395|FG001|STARTED|Overall Study||14
8975700|NCT02657629|10040394|FG000|COMPLETED|Overall Study||12
8975701|NCT02657629|10040395|FG001|COMPLETED|Overall Study||14
8975702|NCT02657629|10040394|FG000|NOT COMPLETED|Overall Study||2
8975703|NCT02657629|10040395|FG001|NOT COMPLETED|Overall Study||0
8975704|NCT02657889|10040405|FG000|STARTED|Overall Study||7
8975705|NCT02657889|10040406|FG001|STARTED|Overall Study||7
8975706|NCT02657889|10040407|FG002|STARTED|Overall Study||53
8975707|NCT02657889|10040408|FG003|STARTED|Overall Study||55
8975708|NCT02657889|10040405|FG000|COMPLETED|Overall Study||0
8975709|NCT02657889|10040406|FG001|COMPLETED|Overall Study||0
8975710|NCT02657889|10040407|FG002|COMPLETED|Overall Study||0
8975711|NCT02657889|10040408|FG003|COMPLETED|Overall Study||0
8975712|NCT02657889|10040405|FG000|NOT COMPLETED|Overall Study||7
8975713|NCT02657889|10040406|FG001|NOT COMPLETED|Overall Study||7
8975714|NCT02657889|10040407|FG002|NOT COMPLETED|Overall Study||53
8975715|NCT02657889|10040408|FG003|NOT COMPLETED|Overall Study||55
8975716|NCT02657915|10040422|FG000|STARTED|Overall Study||24
8975717|NCT02657915|10040423|FG001|STARTED|Overall Study||28
8975718|NCT02657915|10040422|FG000|Intent-to Treat (ITT) Population|Overall Study||24
8975719|NCT02657915|10040423|FG001|Intent-to Treat (ITT) Population|Overall Study||28
8975720|NCT02657915|10040422|FG000|Per-protocol Population|Overall Study||23
8975721|NCT02657915|10040423|FG001|Per-protocol Population|Overall Study||24
8975722|NCT02657915|10040422|FG000|COMPLETED|Overall Study||24
8975723|NCT02657915|10040423|FG001|COMPLETED|Overall Study||28
8975724|NCT02657915|10040422|FG000|NOT COMPLETED|Overall Study||0
8975725|NCT02657915|10040423|FG001|NOT COMPLETED|Overall Study||0
8975726|NCT02657928|10040431|FG000|STARTED|Overall Study||20
8975727|NCT02657928|10040432|FG001|STARTED|Overall Study||20
8975728|NCT02657928|10040431|FG000|COMPLETED|Overall Study||20
8975729|NCT02657928|10040432|FG001|COMPLETED|Overall Study||20
8975730|NCT02657928|10040431|FG000|NOT COMPLETED|Overall Study||0
8975731|NCT02657928|10040432|FG001|NOT COMPLETED|Overall Study||0
8975732|NCT02658019|10040439|FG000|STARTED|Overall Study||29
8975733|NCT02658019|10040439|FG000|COMPLETED|Overall Study||28
8975734|NCT02658019|10040439|FG000|NOT COMPLETED|Overall Study||1
8975735|NCT02658084|10040445|FG000|STARTED|Overall Study||2
8975736|NCT02658084|10040446|FG001|STARTED|Overall Study||0
8975737|NCT02658084|10040445|FG000|COMPLETED|Overall Study||0
8975738|NCT02658084|10040446|FG001|COMPLETED|Overall Study||0
8975739|NCT02658084|10040445|FG000|NOT COMPLETED|Overall Study||2
8975740|NCT02658084|10040446|FG001|NOT COMPLETED|Overall Study||0
8975741|NCT02658149|10040453|FG000|STARTED|Overall Study||50
8975742|NCT02658149|10040454|FG001|STARTED|Overall Study||50
8975743|NCT02658149|10040453|FG000|COMPLETED|Overall Study||49
8975744|NCT02658149|10040454|FG001|COMPLETED|Overall Study||50
8975745|NCT02658149|10040453|FG000|NOT COMPLETED|Overall Study||1
8975746|NCT02658149|10040454|FG001|NOT COMPLETED|Overall Study||0
8975747|NCT02658175|10040463|FG000|STARTED|Treatment Period: Weeks 1 to 52||51
8975748|NCT02658175|10040464|FG001|STARTED|Treatment Period: Weeks 1 to 52||14
8975749|NCT02658175|10040465|FG002|STARTED|Treatment Period: Weeks 1 to 52||3
8975750|NCT02658175|10040463|FG000|COMPLETED|Treatment Period: Weeks 1 to 52||36
8975751|NCT02658175|10040464|FG001|COMPLETED|Treatment Period: Weeks 1 to 52||7
8975752|NCT02658175|10040465|FG002|COMPLETED|Treatment Period: Weeks 1 to 52||3
8632244|NCT00544544|9672141|FG000|NOT COMPLETED|Overall Study||3
8632245|NCT00544557|9672145|FG000|STARTED|Overall Study||1685
8632246|NCT00544557|9672145|FG000|COMPLETED|Overall Study||1251
8877232|NCT01922050|9934164|FG006|STARTED|Part 2 Double-blind Phase||0
8877233|NCT01922050|9934165|FG007|STARTED|Part 2 Double-blind Phase||0
8877234|NCT01922050|9934166|FG008|STARTED|Part 2 Double-blind Phase||0
8877235|NCT01922050|9934167|FG009|STARTED|Part 2 Double-blind Phase||0
8877236|NCT01922050|9934168|FG010|STARTED|Part 2 Double-blind Phase||62
8877237|NCT01922050|9934169|FG011|STARTED|Part 2 Double-blind Phase||60
8877238|NCT01922050|9934170|FG012|STARTED|Part 2 Double-blind Phase||62
8877239|NCT01922050|9934171|FG013|STARTED|Part 2 Double-blind Phase||59
8877240|NCT01922050|9934158|FG000|COMPLETED|Part 2 Double-blind Phase||0
8632247|NCT00544557|9672145|FG000|NOT COMPLETED|Overall Study||434
8975753|NCT02658175|10040463|FG000|NOT COMPLETED|Treatment Period: Weeks 1 to 52||15
8975754|NCT02658175|10040464|FG001|NOT COMPLETED|Treatment Period: Weeks 1 to 52||7
8975755|NCT02658175|10040465|FG002|NOT COMPLETED|Treatment Period: Weeks 1 to 52||0
8975756|NCT02658175|10040463|FG000|STARTED|1st Extended Treatment: Weeks 53 to 104||36
8975757|NCT02658175|10040464|FG001|STARTED|1st Extended Treatment: Weeks 53 to 104||7
8975758|NCT02658175|10040465|FG002|STARTED|1st Extended Treatment: Weeks 53 to 104||3
8975759|NCT02658175|10040463|FG000|COMPLETED|1st Extended Treatment: Weeks 53 to 104||15
8975760|NCT02658175|10040464|FG001|COMPLETED|1st Extended Treatment: Weeks 53 to 104||5
8975761|NCT02658175|10040465|FG002|COMPLETED|1st Extended Treatment: Weeks 53 to 104||1
8975762|NCT02658175|10040463|FG000|NOT COMPLETED|1st Extended Treatment: Weeks 53 to 104||21
8975763|NCT02658175|10040464|FG001|NOT COMPLETED|1st Extended Treatment: Weeks 53 to 104||2
8975764|NCT02658175|10040465|FG002|NOT COMPLETED|1st Extended Treatment: Weeks 53 to 104||2
8975765|NCT02658175|10040463|FG000|STARTED|2nd Extended Treatment: Weeks 105 to156||1
8975766|NCT02658175|10040464|FG001|STARTED|2nd Extended Treatment: Weeks 105 to156||0
8975767|NCT02658175|10040465|FG002|STARTED|2nd Extended Treatment: Weeks 105 to156||1
8975768|NCT02658175|10040463|FG000|COMPLETED|2nd Extended Treatment: Weeks 105 to156||0
8975769|NCT02658175|10040464|FG001|COMPLETED|2nd Extended Treatment: Weeks 105 to156||0
8975770|NCT02658175|10040465|FG002|COMPLETED|2nd Extended Treatment: Weeks 105 to156||0
8975771|NCT02658175|10040463|FG000|NOT COMPLETED|2nd Extended Treatment: Weeks 105 to156||1
8975772|NCT02658175|10040464|FG001|NOT COMPLETED|2nd Extended Treatment: Weeks 105 to156||0
8975773|NCT02658175|10040465|FG002|NOT COMPLETED|2nd Extended Treatment: Weeks 105 to156||1
8975774|NCT02658240|10040475|FG000|STARTED|Overall Study||30
8975775|NCT02658240|10040476|FG001|STARTED|Overall Study||30
8975776|NCT02658240|10040475|FG000|COMPLETED|Overall Study||30
8975777|NCT02658240|10040476|FG001|COMPLETED|Overall Study||30
8975778|NCT02658240|10040475|FG000|NOT COMPLETED|Overall Study||0
8975779|NCT02658240|10040476|FG001|NOT COMPLETED|Overall Study||0
8975780|NCT02658448|10040482|FG000|STARTED|Overall Study||19
8975781|NCT02658448|10040482|FG000|COMPLETED|Overall Study|One patient was lost to follow-up after enrollment and prior to visit 1|18
8975782|NCT02658448|10040482|FG000|NOT COMPLETED|Overall Study||1
8975783|NCT02658461|10040489|FG000|STARTED|Overall Study|The enrollment reflects episodes of care and not number of actual participants.|12
8975784|NCT02658461|10040490|FG001|STARTED|Overall Study|The enrollment reflects episodes of care and not number of actual participants.|12
8975785|NCT02658461|10040491|FG002|STARTED|Overall Study|The enrollment reflects episodes of care and not number of actual participants.|12
8975786|NCT02658461|10040489|FG000|COMPLETED|Overall Study||12
8975787|NCT02658461|10040490|FG001|COMPLETED|Overall Study||12
8975788|NCT02658461|10040491|FG002|COMPLETED|Overall Study||12
8975789|NCT02658461|10040489|FG000|NOT COMPLETED|Overall Study||0
8975790|NCT02658461|10040490|FG001|NOT COMPLETED|Overall Study||0
8975791|NCT02658461|10040491|FG002|NOT COMPLETED|Overall Study||0
8975792|NCT02658487|10040501|FG000|STARTED|Overall Study||42
8975793|NCT02658487|10040501|FG000|COMPLETED|Overall Study||26
8975794|NCT02658487|10040501|FG000|NOT COMPLETED|Overall Study||16
8975795|NCT02658630|10040506|FG000|STARTED|Overall Study||46
8975796|NCT02658630|10040506|FG000|COMPLETED|Overall Study||42
8975797|NCT02658630|10040506|FG000|NOT COMPLETED|Overall Study||4
8975798|NCT02658734|10040510|FG000|STARTED|Overall Study||70
8975799|NCT02658734|10040510|FG000|COMPLETED|Overall Study||13
8975800|NCT02658734|10040510|FG000|NOT COMPLETED|Overall Study||57
8975801|NCT02658851|10040514|FG000|STARTED|Overall Study||100
8975802|NCT02658851|10040514|FG000|COMPLETED|Overall Study||100
8975803|NCT02658851|10040514|FG000|NOT COMPLETED|Overall Study||0
8975804|NCT02658994|10040521|FG000|STARTED|Enrollment||287
8975805|NCT02658994|10040522|FG001|STARTED|Enrollment||283
8975806|NCT02658994|10040523|FG002|STARTED|Enrollment||584
8975807|NCT02658994|10040521|FG000|COMPLETED|Enrollment||287
8975808|NCT02658994|10040522|FG001|COMPLETED|Enrollment||283
8975809|NCT02658994|10040523|FG002|COMPLETED|Enrollment||584
8975810|NCT02658994|10040521|FG000|NOT COMPLETED|Enrollment||0
8975811|NCT02658994|10040522|FG001|NOT COMPLETED|Enrollment||0
8975812|NCT02658994|10040523|FG002|NOT COMPLETED|Enrollment||0
8975813|NCT02658994|10040521|FG000|STARTED|3 Month Follow up||287
8975814|NCT02658994|10040522|FG001|STARTED|3 Month Follow up||283
8975815|NCT02658994|10040523|FG002|STARTED|3 Month Follow up||584
8975816|NCT02658994|10040521|FG000|COMPLETED|3 Month Follow up||221
8975817|NCT02658994|10040522|FG001|COMPLETED|3 Month Follow up||223
8975818|NCT02658994|10040523|FG002|COMPLETED|3 Month Follow up||451
8975819|NCT02658994|10040521|FG000|NOT COMPLETED|3 Month Follow up||66
8975820|NCT02658994|10040522|FG001|NOT COMPLETED|3 Month Follow up||60
8975821|NCT02658994|10040523|FG002|NOT COMPLETED|3 Month Follow up||133
8975822|NCT02658994|10040521|FG000|STARTED|6 Month Follow up|Participants who did not complete 3 month follow up were still eligible for 6 month follow up|287
8975823|NCT02658994|10040522|FG001|STARTED|6 Month Follow up|Participants who did not complete 3 month follow up were still eligible for 6 month follow up|283
8975824|NCT02658994|10040523|FG002|STARTED|6 Month Follow up|Participants who did not complete 3 month follow up were still eligible for 6 month follow up|584
8975825|NCT02658994|10040521|FG000|COMPLETED|6 Month Follow up||228
8975826|NCT02658994|10040522|FG001|COMPLETED|6 Month Follow up||230
8975827|NCT02658994|10040523|FG002|COMPLETED|6 Month Follow up||471
8975828|NCT02658994|10040521|FG000|NOT COMPLETED|6 Month Follow up||59
8975829|NCT02658994|10040522|FG001|NOT COMPLETED|6 Month Follow up||53
8975830|NCT02658994|10040523|FG002|NOT COMPLETED|6 Month Follow up||113
8975831|NCT02658994|10040521|FG000|STARTED|12 Month Follow up|Participants who did not complete 6 month follow up were still eligible for 12 month follow up|287
8975832|NCT02658994|10040522|FG001|STARTED|12 Month Follow up|Participants who did not complete 6 month follow up were still eligible for 12 month follow up|283
8975833|NCT02658994|10040523|FG002|STARTED|12 Month Follow up|Participants who did not complete 6 month follow up were still eligible for 12 month follow up|584
8975834|NCT02658994|10040521|FG000|COMPLETED|12 Month Follow up||228
8975835|NCT02658994|10040522|FG001|COMPLETED|12 Month Follow up||223
8975836|NCT02658994|10040523|FG002|COMPLETED|12 Month Follow up||489
8975837|NCT02658994|10040521|FG000|NOT COMPLETED|12 Month Follow up||59
8975838|NCT02658994|10040522|FG001|NOT COMPLETED|12 Month Follow up||60
8975839|NCT02658994|10040523|FG002|NOT COMPLETED|12 Month Follow up||95
8975840|NCT02658994|10040521|FG000|STARTED|24 Month Follow up|Participants who did not complete 12 month follow up were still eligible for 24 month follow up|287
8975841|NCT02658994|10040522|FG001|STARTED|24 Month Follow up|Participants who did not complete 12 month follow up were still eligible for 24 month follow up|283
8975842|NCT02658994|10040523|FG002|STARTED|24 Month Follow up|Participants who did not complete 12 month follow up were still eligible for 24 month follow up|584
8975843|NCT02658994|10040521|FG000|COMPLETED|24 Month Follow up||220
8975844|NCT02658994|10040522|FG001|COMPLETED|24 Month Follow up||210
8975845|NCT02658994|10040523|FG002|COMPLETED|24 Month Follow up||473
8975846|NCT02658994|10040521|FG000|NOT COMPLETED|24 Month Follow up||67
8975847|NCT02658994|10040522|FG001|NOT COMPLETED|24 Month Follow up||73
8975848|NCT02658994|10040523|FG002|NOT COMPLETED|24 Month Follow up||111
8975849|NCT02658994|10040521|FG000|STARTED|36 Month Follow up|Participants who did not complete 24 month follow up were still eligible for 36 month follow up|287
8975850|NCT02658994|10040522|FG001|STARTED|36 Month Follow up|Participants who did not complete 24 month follow up were still eligible for 36 month follow up|283
8975851|NCT02658994|10040523|FG002|STARTED|36 Month Follow up|Participants who did not complete 24 month follow up were still eligible for 36 month follow up|584
8975852|NCT02658994|10040521|FG000|COMPLETED|36 Month Follow up||216
8975853|NCT02658994|10040522|FG001|COMPLETED|36 Month Follow up||206
8975854|NCT02658994|10040523|FG002|COMPLETED|36 Month Follow up||467
8975855|NCT02658994|10040521|FG000|NOT COMPLETED|36 Month Follow up||71
8975856|NCT02658994|10040522|FG001|NOT COMPLETED|36 Month Follow up||77
8975857|NCT02658994|10040523|FG002|NOT COMPLETED|36 Month Follow up||117
8975858|NCT02659098|10040532|FG000|STARTED|Overall Study||21
8975859|NCT02659098|10040532|FG000|COMPLETED|Overall Study||14
8975860|NCT02659098|10040532|FG000|NOT COMPLETED|Overall Study||7
8975861|NCT02659150|10040536|FG000|STARTED|Subject Enrollment||16
8975862|NCT02659150|10040536|FG000|COMPLETED|Subject Enrollment||11
8975863|NCT02659150|10040536|FG000|NOT COMPLETED|Subject Enrollment||5
8975864|NCT02659150|10040536|FG000|STARTED|Baseline Imaging||11
8975865|NCT02659150|10040536|FG000|COMPLETED|Baseline Imaging||9
8975866|NCT02659150|10040536|FG000|NOT COMPLETED|Baseline Imaging||2
8975867|NCT02659150|10040536|FG000|STARTED|Study Drug Dosing||9
8975868|NCT02659150|10040536|FG000|COMPLETED|Study Drug Dosing||8
8975869|NCT02659150|10040536|FG000|NOT COMPLETED|Study Drug Dosing||1
8975870|NCT02659150|10040536|FG000|STARTED|Follow-up Imaging||8
8975871|NCT02659150|10040536|FG000|COMPLETED|Follow-up Imaging||8
8975872|NCT02659150|10040536|FG000|NOT COMPLETED|Follow-up Imaging||0
8975873|NCT02659501|10040543|FG000|STARTED|Overall Study||12
8975874|NCT02659501|10040544|FG001|STARTED|Overall Study||12
8975875|NCT02659501|10040543|FG000|COMPLETED|Overall Study||12
8975876|NCT02659501|10040544|FG001|COMPLETED|Overall Study||12
8975877|NCT02659501|10040543|FG000|NOT COMPLETED|Overall Study||0
8975878|NCT02659501|10040544|FG001|NOT COMPLETED|Overall Study||0
8975879|NCT02659540|10040552|FG000|STARTED|Overall Study||10
8975880|NCT02659540|10040553|FG001|STARTED|Overall Study||10
8975881|NCT02659540|10040552|FG000|COMPLETED|Overall Study||4
8975882|NCT02659540|10040553|FG001|COMPLETED|Overall Study||2
8975883|NCT02659540|10040552|FG000|NOT COMPLETED|Overall Study||6
8975884|NCT02659540|10040553|FG001|NOT COMPLETED|Overall Study||8
8975885|NCT02659631|10040569|FG000|STARTED|Overall Study||1
8975886|NCT02659631|10040570|FG001|STARTED|Overall Study||2
8975887|NCT02659631|10040571|FG002|STARTED|Overall Study||3
8975888|NCT02659631|10040572|FG003|STARTED|Overall Study||2
8975889|NCT02659631|10040573|FG004|STARTED|Overall Study||5
8975890|NCT02659631|10040574|FG005|STARTED|Overall Study||5
8975891|NCT02659631|10040575|FG006|STARTED|Overall Study||4
8975892|NCT02659631|10040576|FG007|STARTED|Overall Study||3
8975893|NCT02659631|10040577|FG008|STARTED|Overall Study||2
8975894|NCT02659631|10040578|FG009|STARTED|Overall Study||1
8975895|NCT02659631|10040569|FG000|COMPLETED|Overall Study||0
8975896|NCT02659631|10040570|FG001|COMPLETED|Overall Study||0
8975897|NCT02659631|10040571|FG002|COMPLETED|Overall Study||0
8975898|NCT02659631|10040572|FG003|COMPLETED|Overall Study||0
8975899|NCT02659631|10040573|FG004|COMPLETED|Overall Study||0
8975900|NCT02659631|10040574|FG005|COMPLETED|Overall Study||2
8975901|NCT02659631|10040575|FG006|COMPLETED|Overall Study||3
8975902|NCT02659631|10040576|FG007|COMPLETED|Overall Study||0
8975903|NCT02659631|10040577|FG008|COMPLETED|Overall Study||0
8975904|NCT02659631|10040578|FG009|COMPLETED|Overall Study||1
8975905|NCT02659631|10040569|FG000|NOT COMPLETED|Overall Study||1
8632248|NCT00544648|9672151|FG000|STARTED|Overall Study||11
8632249|NCT00544648|9672152|FG001|STARTED|Overall Study||2
8632250|NCT00544648|9672151|FG000|COMPLETED|Overall Study||8
8632251|NCT00544648|9672152|FG001|COMPLETED|Overall Study||1
8632252|NCT00544648|9672151|FG000|NOT COMPLETED|Overall Study||3
8632253|NCT00544648|9672152|FG001|NOT COMPLETED|Overall Study||1
8632254|NCT00544674|9672160|FG000|STARTED|Overall Study|1 subject registered and expired prior to dosing|5
8632255|NCT00544674|9672160|FG000|COMPLETED|Overall Study||4
8632256|NCT00544674|9672160|FG000|NOT COMPLETED|Overall Study||1
8632257|NCT00544713|9672166|FG000|STARTED|Overall Study||114
8632258|NCT00544713|9672167|FG001|STARTED|Overall Study||114
8632259|NCT00544713|9672166|FG000|COMPLETED|Overall Study||111
8632260|NCT00544713|9672167|FG001|COMPLETED|Overall Study||109
8725823|NCT01033487|9773160|FG003|NOT COMPLETED|First Intervention Period||0
8975906|NCT02659631|10040570|FG001|NOT COMPLETED|Overall Study||2
8975907|NCT02659631|10040571|FG002|NOT COMPLETED|Overall Study||3
8632261|NCT00544713|9672166|FG000|NOT COMPLETED|Overall Study||3
8975908|NCT02659631|10040572|FG003|NOT COMPLETED|Overall Study||2
8975909|NCT02659631|10040573|FG004|NOT COMPLETED|Overall Study||5
8975910|NCT02659631|10040574|FG005|NOT COMPLETED|Overall Study||3
8975911|NCT02659631|10040575|FG006|NOT COMPLETED|Overall Study||1
8975912|NCT02659631|10040576|FG007|NOT COMPLETED|Overall Study||3
8975913|NCT02659631|10040577|FG008|NOT COMPLETED|Overall Study||2
8975914|NCT02659631|10040578|FG009|NOT COMPLETED|Overall Study||0
8975915|NCT02659709|10040602|FG000|STARTED|Overall Study||50
8975916|NCT02659709|10040602|FG000|COMPLETED|Overall Study||50
8975917|NCT02659709|10040602|FG000|NOT COMPLETED|Overall Study||0
8975918|NCT02659787|10040606|FG000|STARTED|First Intervention (1 Day)||19
8975919|NCT02659787|10040607|FG001|STARTED|First Intervention (1 Day)||19
8975920|NCT02659787|10040606|FG000|COMPLETED|First Intervention (1 Day)||19
8975921|NCT02659787|10040607|FG001|COMPLETED|First Intervention (1 Day)||19
8975922|NCT02659787|10040606|FG000|NOT COMPLETED|First Intervention (1 Day)||0
8975923|NCT02659787|10040607|FG001|NOT COMPLETED|First Intervention (1 Day)||0
8975924|NCT02659787|10040606|FG000|STARTED|Washout (3 Days)||19
8975925|NCT02659787|10040607|FG001|STARTED|Washout (3 Days)||19
8975926|NCT02659787|10040606|FG000|COMPLETED|Washout (3 Days)||19
8975927|NCT02659787|10040607|FG001|COMPLETED|Washout (3 Days)||19
8975928|NCT02659787|10040606|FG000|NOT COMPLETED|Washout (3 Days)||0
8975929|NCT02659787|10040607|FG001|NOT COMPLETED|Washout (3 Days)||0
8975930|NCT02659787|10040606|FG000|STARTED|Second Intervention (1 Day)||19
8975931|NCT02659787|10040607|FG001|STARTED|Second Intervention (1 Day)||19
8975932|NCT02659787|10040606|FG000|COMPLETED|Second Intervention (1 Day)||19
8975933|NCT02659787|10040607|FG001|COMPLETED|Second Intervention (1 Day)||19
8975934|NCT02659787|10040606|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
8975935|NCT02659787|10040607|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
8975936|NCT02659943|10040620|FG000|STARTED|Overall Study||3
8975937|NCT02659943|10040621|FG001|STARTED|Overall Study||2
8975938|NCT02659943|10040622|FG002|STARTED|Overall Study||1
8975939|NCT02659943|10040623|FG003|STARTED|Overall Study||4
8975940|NCT02659943|10040624|FG004|STARTED|Overall Study||2
8975941|NCT02659943|10040625|FG005|STARTED|Overall Study||9
8975942|NCT02659943|10040626|FG006|STARTED|Overall Study||6
8975943|NCT02659943|10040620|FG000|COMPLETED|Overall Study||2
8975944|NCT02659943|10040621|FG001|COMPLETED|Overall Study||0
8975945|NCT02659943|10040622|FG002|COMPLETED|Overall Study||0
8975946|NCT02659943|10040623|FG003|COMPLETED|Overall Study||1
8975947|NCT02659943|10040624|FG004|COMPLETED|Overall Study||0
8975948|NCT02659943|10040625|FG005|COMPLETED|Overall Study||4
8975949|NCT02659943|10040626|FG006|COMPLETED|Overall Study||0
8975950|NCT02659943|10040620|FG000|NOT COMPLETED|Overall Study||1
8975951|NCT02659943|10040621|FG001|NOT COMPLETED|Overall Study||2
8975952|NCT02659943|10040622|FG002|NOT COMPLETED|Overall Study||1
8975953|NCT02659943|10040623|FG003|NOT COMPLETED|Overall Study||3
8975954|NCT02659943|10040624|FG004|NOT COMPLETED|Overall Study||2
8975955|NCT02659943|10040625|FG005|NOT COMPLETED|Overall Study||5
8975956|NCT02659943|10040626|FG006|NOT COMPLETED|Overall Study||6
8632262|NCT00544713|9672167|FG001|NOT COMPLETED|Overall Study||5
8632263|NCT00544778|9672173|FG000|STARTED|Overall Study||7
8632264|NCT00544778|9672173|FG000|COMPLETED|Overall Study||7
8877241|NCT01922050|9934159|FG001|COMPLETED|Part 2 Double-blind Phase||0
8877242|NCT01922050|9934160|FG002|COMPLETED|Part 2 Double-blind Phase||0
8877243|NCT01922050|9934161|FG003|COMPLETED|Part 2 Double-blind Phase||0
8877244|NCT01922050|9934162|FG004|COMPLETED|Part 2 Double-blind Phase||0
8877245|NCT01922050|9934163|FG005|COMPLETED|Part 2 Double-blind Phase||0
8877246|NCT01922050|9934164|FG006|COMPLETED|Part 2 Double-blind Phase||0
8877247|NCT01922050|9934165|FG007|COMPLETED|Part 2 Double-blind Phase||0
8877248|NCT01922050|9934166|FG008|COMPLETED|Part 2 Double-blind Phase||0
8975957|NCT02660112|10040647|FG000|STARTED|Overall Study||10
8975958|NCT02660112|10040647|FG000|COMPLETED|Overall Study||10
8975959|NCT02660112|10040647|FG000|NOT COMPLETED|Overall Study||0
8975960|NCT02660138|10040654|FG000|STARTED|Overall Study||76
8632265|NCT00544778|9672173|FG000|NOT COMPLETED|Overall Study||0
8632266|NCT00544817|9672177|FG000|STARTED|Combined Modality||47
8632267|NCT00544817|9672177|FG000|COMPLETED|Combined Modality||40
8975961|NCT02660138|10040655|FG001|STARTED|Overall Study||76
8975962|NCT02660138|10040656|FG002|STARTED|Overall Study||75
8975963|NCT02660138|10040654|FG000|Subjects Treated in DBPC Cycle|Overall Study||76
8975964|NCT02660138|10040655|FG001|Subjects Treated in DBPC Cycle|Overall Study||75
8632268|NCT00544817|9672177|FG000|NOT COMPLETED|Combined Modality||7
8632269|NCT00544817|9672177|FG000|STARTED|No Treatment Interval||40
8632270|NCT00544817|9672177|FG000|COMPLETED|No Treatment Interval||28
8975965|NCT02660138|10040656|FG002|Subjects Treated in DBPC Cycle|Overall Study||75
8975966|NCT02660138|10040654|FG000|Subjects Entered in the Dysport Cycles|Overall Study||49
8975967|NCT02660138|10040655|FG001|Subjects Entered in the Dysport Cycles|Overall Study||75
8975968|NCT02660138|10040656|FG002|Subjects Entered in the Dysport Cycles|Overall Study||75
8975969|NCT02660138|10040654|FG000|COMPLETED|Overall Study||6
8975970|NCT02660138|10040655|FG001|COMPLETED|Overall Study||2
8975971|NCT02660138|10040656|FG002|COMPLETED|Overall Study||3
8975972|NCT02660138|10040654|FG000|NOT COMPLETED|Overall Study||70
8975973|NCT02660138|10040655|FG001|NOT COMPLETED|Overall Study||74
8975974|NCT02660138|10040656|FG002|NOT COMPLETED|Overall Study||72
8975975|NCT02660229|10040669|FG000|STARTED|Overall Study|Randomization|34
8975976|NCT02660229|10040670|FG001|STARTED|Overall Study|Randomization|32
8975977|NCT02660229|10040669|FG000|Safety Analysis Set|Overall Study||34
8975978|NCT02660229|10040670|FG001|Safety Analysis Set|Overall Study||32
8975979|NCT02660229|10040669|FG000|FAS Set|Overall Study|Oxycodone group: 1 patient was missed any efficacy assessment.|33
8975980|NCT02660229|10040670|FG001|FAS Set|Overall Study||32
8975981|NCT02660229|10040669|FG000|Per Protocol Set|Overall Study|Adverse events N=1, Prohibited medication N=4|28
8975982|NCT02660229|10040670|FG001|Per Protocol Set|Overall Study|Withdrawal of ICF N=1, IC/EC deviation N=1, Prohibited medication N=1|29
8975983|NCT02660229|10040669|FG000|COMPLETED|Overall Study||32
8975984|NCT02660229|10040670|FG001|COMPLETED|Overall Study||31
8975985|NCT02660229|10040669|FG000|NOT COMPLETED|Overall Study||2
8975986|NCT02660229|10040670|FG001|NOT COMPLETED|Overall Study||1
8975987|NCT02660242|10040676|FG000|STARTED|Control||16
8975988|NCT02660242|10040676|FG000|COMPLETED|Control||16
8975989|NCT02660242|10040676|FG000|NOT COMPLETED|Control||0
8975990|NCT02660242|10040676|FG000|STARTED|Basal Insulin Reduction||16
8975991|NCT02660242|10040676|FG000|COMPLETED|Basal Insulin Reduction||16
8975992|NCT02660242|10040676|FG000|NOT COMPLETED|Basal Insulin Reduction||0
8975993|NCT02660242|10040676|FG000|STARTED|Glucose Tabs|16 participants were randomized but only 15 completed all 4 periods.|16
8975994|NCT02660242|10040676|FG000|COMPLETED|Glucose Tabs||15
8975995|NCT02660242|10040676|FG000|NOT COMPLETED|Glucose Tabs||1
8975996|NCT02660242|10040676|FG000|STARTED|Glucagon Injection|16 participants were randomized but only 15 completed all 4 periods.|16
8975997|NCT02660242|10040676|FG000|COMPLETED|Glucagon Injection||15
8975998|NCT02660242|10040676|FG000|NOT COMPLETED|Glucagon Injection||1
8975999|NCT02660359|10040692|FG000|STARTED|Overall Study||86
8976000|NCT02660359|10040693|FG001|STARTED|Overall Study||86
8976001|NCT02660359|10040694|FG002|STARTED|Overall Study||85
8976002|NCT02660359|10040692|FG000|Subjects Entered in the Dysport Cycles|Overall Study||56
8976003|NCT02660359|10040693|FG001|Subjects Entered in the Dysport Cycles|Overall Study||86
8976004|NCT02660359|10040694|FG002|Subjects Entered in the Dysport Cycles|Overall Study||85
8976005|NCT02660359|10040692|FG000|COMPLETED|Overall Study||0
8976006|NCT02660359|10040693|FG001|COMPLETED|Overall Study||0
8976007|NCT02660359|10040694|FG002|COMPLETED|Overall Study||1
8976008|NCT02660359|10040692|FG000|NOT COMPLETED|Overall Study||86
8976009|NCT02660359|10040693|FG001|NOT COMPLETED|Overall Study||86
8976010|NCT02660359|10040694|FG002|NOT COMPLETED|Overall Study||84
8976011|NCT02660489|10040704|FG000|STARTED|Overall Study||22
8976012|NCT02660489|10040705|FG001|STARTED|Overall Study||22
8976013|NCT02660489|10040704|FG000|COMPLETED|Overall Study|Completed with confirmed rhinovirus infection|16
8976014|NCT02660489|10040705|FG001|COMPLETED|Overall Study|Completed with confirmed rhinovirus infection|14
8976015|NCT02660489|10040704|FG000|NOT COMPLETED|Overall Study||6
8976016|NCT02660489|10040705|FG001|NOT COMPLETED|Overall Study||8
8976017|NCT02660580|10040713|FG000|STARTED|Core Treatment Period (Week 1 to 16)||222
8976018|NCT02660580|10040714|FG001|STARTED|Core Treatment Period (Week 1 to 16)||221
8976019|NCT02660580|10040715|FG002|STARTED|Core Treatment Period (Week 1 to 16)||0
8976020|NCT02660580|10040716|FG003|STARTED|Core Treatment Period (Week 1 to 16)||0
8976021|NCT02660580|10040717|FG004|STARTED|Core Treatment Period (Week 1 to 16)||0
8976022|NCT02660580|10040713|FG000|Treated|Core Treatment Period (Week 1 to 16)||221
8976023|NCT02660580|10040714|FG001|Treated|Core Treatment Period (Week 1 to 16)||220
8976024|NCT02660580|10040715|FG002|Treated|Core Treatment Period (Week 1 to 16)||0
8976025|NCT02660580|10040716|FG003|Treated|Core Treatment Period (Week 1 to 16)||0
8976026|NCT02660580|10040717|FG004|Treated|Core Treatment Period (Week 1 to 16)||0
8976027|NCT02660580|10040713|FG000|COMPLETED|Core Treatment Period (Week 1 to 16)||213
8976028|NCT02660580|10040714|FG001|COMPLETED|Core Treatment Period (Week 1 to 16)||202
8976029|NCT02660580|10040715|FG002|COMPLETED|Core Treatment Period (Week 1 to 16)||0
8976030|NCT02660580|10040716|FG003|COMPLETED|Core Treatment Period (Week 1 to 16)||0
8976031|NCT02660580|10040717|FG004|COMPLETED|Core Treatment Period (Week 1 to 16)||0
8976032|NCT02660580|10040713|FG000|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||9
8976033|NCT02660580|10040714|FG001|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||19
8976034|NCT02660580|10040715|FG002|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||0
8976035|NCT02660580|10040716|FG003|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||0
8976036|NCT02660580|10040717|FG004|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||0
8976037|NCT02660580|10040713|FG000|STARTED|Extended Treatment Period(Week 16 to 52)||0
8632271|NCT00544817|9672177|FG000|NOT COMPLETED|No Treatment Interval||12
8632272|NCT00544817|9672177|FG000|STARTED|Follow-up Systemic Therapy||28
8632273|NCT00544817|9672177|FG000|COMPLETED|Follow-up Systemic Therapy||9
8632274|NCT00544817|9672177|FG000|NOT COMPLETED|Follow-up Systemic Therapy||19
8632275|NCT00544869|9672184|FG000|STARTED|Overall Study||36
8976038|NCT02660580|10040714|FG001|STARTED|Extended Treatment Period(Week 16 to 52)||0
8976039|NCT02660580|10040715|FG002|STARTED|Extended Treatment Period(Week 16 to 52)||213
8976040|NCT02660580|10040716|FG003|STARTED|Extended Treatment Period(Week 16 to 52)||101
8976041|NCT02660580|10040717|FG004|STARTED|Extended Treatment Period(Week 16 to 52)||101
8976042|NCT02660580|10040713|FG000|COMPLETED|Extended Treatment Period(Week 16 to 52)||0
8976043|NCT02660580|10040714|FG001|COMPLETED|Extended Treatment Period(Week 16 to 52)||0
8976044|NCT02660580|10040715|FG002|COMPLETED|Extended Treatment Period(Week 16 to 52)||195
8976045|NCT02660580|10040716|FG003|COMPLETED|Extended Treatment Period(Week 16 to 52)||90
8976046|NCT02660580|10040717|FG004|COMPLETED|Extended Treatment Period(Week 16 to 52)||90
8976047|NCT02660580|10040713|FG000|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||0
8976048|NCT02660580|10040714|FG001|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||0
8976049|NCT02660580|10040715|FG002|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||18
8976050|NCT02660580|10040716|FG003|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||11
8976051|NCT02660580|10040717|FG004|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||11
8976052|NCT02660788|10040738|FG000|STARTED|Overall Study||2749
8976053|NCT02660788|10040739|FG001|STARTED|Overall Study||2749
8976054|NCT02660788|10040738|FG000|COMPLETED|Overall Study||2749
8976055|NCT02660788|10040739|FG001|COMPLETED|Overall Study||2749
8976056|NCT02660788|10040738|FG000|NOT COMPLETED|Overall Study||0
8976057|NCT02660788|10040739|FG001|NOT COMPLETED|Overall Study||0
8976058|NCT02660801|10040745|FG000|STARTED|Overall Study||11
8976059|NCT02660801|10040746|FG001|STARTED|Overall Study||15
8976060|NCT02660801|10040745|FG000|COMPLETED|Overall Study||11
8976061|NCT02660801|10040746|FG001|COMPLETED|Overall Study||15
8976062|NCT02660801|10040745|FG000|NOT COMPLETED|Overall Study||0
8976063|NCT02660801|10040746|FG001|NOT COMPLETED|Overall Study||0
8976064|NCT02660853|10040752|FG000|STARTED|Overall Study||25
8976065|NCT02660853|10040752|FG000|COMPLETED|Overall Study||25
8976066|NCT02660853|10040752|FG000|NOT COMPLETED|Overall Study||0
8976067|NCT02660918|10040758|FG000|STARTED|Overall Study||42
8976068|NCT02660918|10040759|FG001|STARTED|Overall Study||42
8976069|NCT02660918|10040758|FG000|COMPLETED|Overall Study|Age ineligible|41
8976070|NCT02660918|10040759|FG001|COMPLETED|Overall Study|Age ineligible|41
8976071|NCT02660918|10040758|FG000|NOT COMPLETED|Overall Study||1
8976072|NCT02660918|10040759|FG001|NOT COMPLETED|Overall Study||1
8976073|NCT02660944|10040768|FG000|STARTED|Overall Study||42
8976074|NCT02660944|10040769|FG001|STARTED|Overall Study||22
8976075|NCT02660944|10040768|FG000|COMPLETED|Overall Study||25
8976076|NCT02660944|10040769|FG001|COMPLETED|Overall Study||12
8976077|NCT02660944|10040768|FG000|NOT COMPLETED|Overall Study||17
8976078|NCT02660944|10040769|FG001|NOT COMPLETED|Overall Study||10
8976079|NCT02660983|10040777|FG000|STARTED|Double-blind (DB) Phase (24 Weeks)||154
8976080|NCT02660983|10040778|FG001|STARTED|Double-blind (DB) Phase (24 Weeks)||148
8976081|NCT02660983|10040777|FG000|Treated/Safety Set|Double-blind (DB) Phase (24 Weeks)||153
8976082|NCT02660983|10040778|FG001|Treated/Safety Set|Double-blind (DB) Phase (24 Weeks)||147
8976083|NCT02660983|10040777|FG000|COMPLETED|Double-blind (DB) Phase (24 Weeks)||130
8976084|NCT02660983|10040778|FG001|COMPLETED|Double-blind (DB) Phase (24 Weeks)||122
8976085|NCT02660983|10040777|FG000|NOT COMPLETED|Double-blind (DB) Phase (24 Weeks)||24
8976086|NCT02660983|10040778|FG001|NOT COMPLETED|Double-blind (DB) Phase (24 Weeks)||26
8976087|NCT02660983|10040777|FG000|STARTED|Open Label Extension Phase (24 Weeks)|Eligible participants who consented to continue from DB phase to OLE phase.|86
8976088|NCT02660983|10040778|FG001|STARTED|Open Label Extension Phase (24 Weeks)|Eligible participants who consented to continue from DB phase to OLE phase.|75
8976089|NCT02660983|10040777|FG000|Safety Set|Open Label Extension Phase (24 Weeks)||86
8976090|NCT02660983|10040778|FG001|Safety Set|Open Label Extension Phase (24 Weeks)||75
8976091|NCT02660983|10040777|FG000|COMPLETED|Open Label Extension Phase (24 Weeks)||83
8976092|NCT02660983|10040778|FG001|COMPLETED|Open Label Extension Phase (24 Weeks)||66
8976093|NCT02660983|10040777|FG000|NOT COMPLETED|Open Label Extension Phase (24 Weeks)||3
8976094|NCT02660983|10040778|FG001|NOT COMPLETED|Open Label Extension Phase (24 Weeks)||9
8976095|NCT02661061|10040787|FG000|STARTED|Overall Study||5
8976096|NCT02661061|10040788|FG001|STARTED|Overall Study||4
8976097|NCT02661061|10040787|FG000|COMPLETED|Overall Study||3
8976098|NCT02661061|10040788|FG001|COMPLETED|Overall Study||2
8976099|NCT02661061|10040787|FG000|NOT COMPLETED|Overall Study||2
8976100|NCT02661061|10040788|FG001|NOT COMPLETED|Overall Study||2
8976101|NCT02661126|10040796|FG000|STARTED|Overall Study||8
8976102|NCT02661126|10040797|FG001|STARTED|Overall Study||8
8976103|NCT02661126|10040796|FG000|COMPLETED|Overall Study||8
8976104|NCT02661126|10040797|FG001|COMPLETED|Overall Study||8
8976105|NCT02661126|10040796|FG000|NOT COMPLETED|Overall Study||0
8976106|NCT02661126|10040797|FG001|NOT COMPLETED|Overall Study||0
8976107|NCT02661178|10040818|FG000|STARTED|Part 1||1
8976108|NCT02661178|10040819|FG001|STARTED|Part 1||5
8976109|NCT02661178|10040820|FG002|STARTED|Part 1||6
8976110|NCT02661178|10040821|FG003|STARTED|Part 1||6
8632276|NCT00544869|9672185|FG001|STARTED|Overall Study||14
8976111|NCT02661178|10040822|FG004|STARTED|Part 1||5
8976112|NCT02661178|10040823|FG005|STARTED|Part 1||6
8976113|NCT02661178|10040824|FG006|STARTED|Part 1||6
8976114|NCT02661178|10040825|FG007|STARTED|Part 1||6
8976115|NCT02661178|10040826|FG008|STARTED|Part 1||6
8976116|NCT02661178|10040827|FG009|STARTED|Part 1||12
8976117|NCT02661178|10040828|FG010|STARTED|Part 1||4
8976118|NCT02661178|10040829|FG011|STARTED|Part 1||0
8976119|NCT02661178|10040830|FG012|STARTED|Part 1||0
8976120|NCT02661178|10040831|FG013|STARTED|Part 1||0
8976121|NCT02661178|10040832|FG014|STARTED|Part 1||0
8976122|NCT02661178|10040818|FG000|COMPLETED|Part 1||0
8976123|NCT02661178|10040819|FG001|COMPLETED|Part 1||5
8976124|NCT02661178|10040820|FG002|COMPLETED|Part 1||6
8976125|NCT02661178|10040821|FG003|COMPLETED|Part 1||6
8976126|NCT02661178|10040822|FG004|COMPLETED|Part 1||5
8976127|NCT02661178|10040823|FG005|COMPLETED|Part 1||6
8976128|NCT02661178|10040824|FG006|COMPLETED|Part 1||6
8976129|NCT02661178|10040825|FG007|COMPLETED|Part 1||6
8976130|NCT02661178|10040826|FG008|COMPLETED|Part 1||6
8976131|NCT02661178|10040827|FG009|COMPLETED|Part 1||12
8976132|NCT02661178|10040828|FG010|COMPLETED|Part 1||4
8976133|NCT02661178|10040829|FG011|COMPLETED|Part 1||0
8976134|NCT02661178|10040830|FG012|COMPLETED|Part 1||0
8976135|NCT02661178|10040831|FG013|COMPLETED|Part 1||0
8976136|NCT02661178|10040832|FG014|COMPLETED|Part 1||0
8976137|NCT02661178|10040818|FG000|NOT COMPLETED|Part 1||1
8976138|NCT02661178|10040819|FG001|NOT COMPLETED|Part 1||0
8976139|NCT02661178|10040820|FG002|NOT COMPLETED|Part 1||0
8976140|NCT02661178|10040821|FG003|NOT COMPLETED|Part 1||0
8976141|NCT02661178|10040822|FG004|NOT COMPLETED|Part 1||0
8976142|NCT02661178|10040823|FG005|NOT COMPLETED|Part 1||0
8976143|NCT02661178|10040824|FG006|NOT COMPLETED|Part 1||0
8976144|NCT02661178|10040825|FG007|NOT COMPLETED|Part 1||0
8976145|NCT02661178|10040826|FG008|NOT COMPLETED|Part 1||0
8976146|NCT02661178|10040827|FG009|NOT COMPLETED|Part 1||0
8976147|NCT02661178|10040828|FG010|NOT COMPLETED|Part 1||0
8976148|NCT02661178|10040829|FG011|NOT COMPLETED|Part 1||0
8976149|NCT02661178|10040830|FG012|NOT COMPLETED|Part 1||0
8976150|NCT02661178|10040831|FG013|NOT COMPLETED|Part 1||0
8976151|NCT02661178|10040832|FG014|NOT COMPLETED|Part 1||0
8976152|NCT02661178|10040818|FG000|STARTED|Part 2||0
8976153|NCT02661178|10040819|FG001|STARTED|Part 2||0
8976154|NCT02661178|10040820|FG002|STARTED|Part 2||0
8976155|NCT02661178|10040821|FG003|STARTED|Part 2||0
8976156|NCT02661178|10040822|FG004|STARTED|Part 2||0
8976157|NCT02661178|10040823|FG005|STARTED|Part 2||0
8976158|NCT02661178|10040824|FG006|STARTED|Part 2||0
8976159|NCT02661178|10040825|FG007|STARTED|Part 2||0
8976160|NCT02661178|10040826|FG008|STARTED|Part 2||0
8976161|NCT02661178|10040827|FG009|STARTED|Part 2||0
8976162|NCT02661178|10040828|FG010|STARTED|Part 2||0
8976163|NCT02661178|10040829|FG011|STARTED|Part 2||6
8976164|NCT02661178|10040830|FG012|STARTED|Part 2||6
8976165|NCT02661178|10040831|FG013|STARTED|Part 2||2
8877249|NCT01922050|9934167|FG009|COMPLETED|Part 2 Double-blind Phase||0
8877250|NCT01922050|9934168|FG010|COMPLETED|Part 2 Double-blind Phase||61
8877251|NCT01922050|9934169|FG011|COMPLETED|Part 2 Double-blind Phase||58
8877252|NCT01922050|9934170|FG012|COMPLETED|Part 2 Double-blind Phase||62
8877253|NCT01922050|9934171|FG013|COMPLETED|Part 2 Double-blind Phase||56
8877254|NCT01922050|9934158|FG000|NOT COMPLETED|Part 2 Double-blind Phase||0
8877255|NCT01922050|9934159|FG001|NOT COMPLETED|Part 2 Double-blind Phase||0
8877256|NCT01922050|9934160|FG002|NOT COMPLETED|Part 2 Double-blind Phase||0
8877257|NCT01922050|9934161|FG003|NOT COMPLETED|Part 2 Double-blind Phase||0
8877258|NCT01922050|9934162|FG004|NOT COMPLETED|Part 2 Double-blind Phase||0
8877259|NCT01922050|9934163|FG005|NOT COMPLETED|Part 2 Double-blind Phase||0
8877260|NCT01922050|9934164|FG006|NOT COMPLETED|Part 2 Double-blind Phase||0
8877261|NCT01922050|9934165|FG007|NOT COMPLETED|Part 2 Double-blind Phase||0
8976166|NCT02661178|10040832|FG014|STARTED|Part 2||2
8976167|NCT02661178|10040818|FG000|COMPLETED|Part 2||0
8976168|NCT02661178|10040819|FG001|COMPLETED|Part 2||0
8976169|NCT02661178|10040820|FG002|COMPLETED|Part 2||0
8976170|NCT02661178|10040821|FG003|COMPLETED|Part 2||0
8976171|NCT02661178|10040822|FG004|COMPLETED|Part 2||0
8976172|NCT02661178|10040823|FG005|COMPLETED|Part 2||0
8976173|NCT02661178|10040824|FG006|COMPLETED|Part 2||0
8976174|NCT02661178|10040825|FG007|COMPLETED|Part 2||0
8976175|NCT02661178|10040826|FG008|COMPLETED|Part 2||0
8976176|NCT02661178|10040827|FG009|COMPLETED|Part 2||0
8976177|NCT02661178|10040828|FG010|COMPLETED|Part 2||0
8976178|NCT02661178|10040829|FG011|COMPLETED|Part 2||6
8976179|NCT02661178|10040830|FG012|COMPLETED|Part 2||6
8976180|NCT02661178|10040831|FG013|COMPLETED|Part 2||2
8976181|NCT02661178|10040832|FG014|COMPLETED|Part 2||2
8976182|NCT02661178|10040818|FG000|NOT COMPLETED|Part 2||0
8976183|NCT02661178|10040819|FG001|NOT COMPLETED|Part 2||0
8976184|NCT02661178|10040820|FG002|NOT COMPLETED|Part 2||0
8976185|NCT02661178|10040821|FG003|NOT COMPLETED|Part 2||0
8976186|NCT02661178|10040822|FG004|NOT COMPLETED|Part 2||0
8976187|NCT02661178|10040823|FG005|NOT COMPLETED|Part 2||0
8976188|NCT02661178|10040824|FG006|NOT COMPLETED|Part 2||0
8976189|NCT02661178|10040825|FG007|NOT COMPLETED|Part 2||0
8976190|NCT02661178|10040826|FG008|NOT COMPLETED|Part 2||0
8632277|NCT00544869|9672186|FG002|STARTED|Overall Study||2
8632278|NCT00544869|9672184|FG000|COMPLETED|Overall Study||24
8632279|NCT00544869|9672185|FG001|COMPLETED|Overall Study||12
8632280|NCT00544869|9672186|FG002|COMPLETED|Overall Study||2
8632281|NCT00544869|9672184|FG000|NOT COMPLETED|Overall Study||12
8632282|NCT00544869|9672185|FG001|NOT COMPLETED|Overall Study||2
8632283|NCT00544869|9672186|FG002|NOT COMPLETED|Overall Study||0
8632284|NCT00544882|9672196|FG000|STARTED|Cycle 1: Run-in Cycle||61
8976191|NCT02661178|10040827|FG009|NOT COMPLETED|Part 2||0
8976192|NCT02661178|10040828|FG010|NOT COMPLETED|Part 2||0
8976193|NCT02661178|10040829|FG011|NOT COMPLETED|Part 2||0
8976194|NCT02661178|10040830|FG012|NOT COMPLETED|Part 2||0
8976195|NCT02661178|10040831|FG013|NOT COMPLETED|Part 2||0
8976196|NCT02661178|10040832|FG014|NOT COMPLETED|Part 2||0
8976197|NCT02661217|10040884|FG000|STARTED|Overall Study||500
8976198|NCT02661217|10040885|FG001|STARTED|Overall Study||502
8976199|NCT02661217|10040884|FG000|Started 10 Weeks Treatment Epoch|Overall Study||497
8976200|NCT02661217|10040885|FG001|Started 10 Weeks Treatment Epoch|Overall Study||501
8976201|NCT02661217|10040884|FG000|Completed 10 Weeks Treatment Epoch|Overall Study||460
8976202|NCT02661217|10040885|FG001|Completed 10 Weeks Treatment Epoch|Overall Study||455
8976203|NCT02661217|10040884|FG000|COMPLETED|Overall Study||425
8976204|NCT02661217|10040885|FG001|COMPLETED|Overall Study||419
8976205|NCT02661217|10040884|FG000|NOT COMPLETED|Overall Study||75
8976206|NCT02661217|10040885|FG001|NOT COMPLETED|Overall Study||83
8976207|NCT02661256|10040892|FG000|STARTED|Overall Study|Each participant went through arms in same order: on nCPAP then off nCPAP. 1 participant at a time.|7
8976208|NCT02661256|10040892|FG000|COMPLETED|Overall Study||7
8976209|NCT02661256|10040892|FG000|NOT COMPLETED|Overall Study||0
8976210|NCT02661490|10040903|FG000|STARTED|Overall Study||76
8976211|NCT02661490|10040904|FG001|STARTED|Overall Study||74
8976212|NCT02661490|10040905|FG002|STARTED|Overall Study||72
8976213|NCT02661490|10040906|FG003|STARTED|Overall Study||72
8976214|NCT02661490|10040907|FG004|STARTED|Overall Study||26
8976215|NCT02661490|10040903|FG000|COMPLETED|Overall Study||73
8976216|NCT02661490|10040904|FG001|COMPLETED|Overall Study||72
8976217|NCT02661490|10040905|FG002|COMPLETED|Overall Study||70
8976218|NCT02661490|10040906|FG003|COMPLETED|Overall Study||71
8976219|NCT02661490|10040907|FG004|COMPLETED|Overall Study||23
8976220|NCT02661490|10040903|FG000|NOT COMPLETED|Overall Study||3
8976221|NCT02661490|10040904|FG001|NOT COMPLETED|Overall Study||2
8976222|NCT02661490|10040905|FG002|NOT COMPLETED|Overall Study||2
8976223|NCT02661490|10040906|FG003|NOT COMPLETED|Overall Study||1
8976224|NCT02661490|10040907|FG004|NOT COMPLETED|Overall Study||3
8976225|NCT02661594|10040923|FG000|STARTED|Overall Study||10
8976226|NCT02661594|10040924|FG001|STARTED|Overall Study||11
8976227|NCT02661594|10040925|FG002|STARTED|Overall Study||10
8976228|NCT02661594|10040926|FG003|STARTED|Overall Study||9
8976229|NCT02661594|10040923|FG000|COMPLETED|Overall Study||9
8976230|NCT02661594|10040924|FG001|COMPLETED|Overall Study||11
8976231|NCT02661594|10040925|FG002|COMPLETED|Overall Study||9
8976232|NCT02661594|10040926|FG003|COMPLETED|Overall Study||9
8976233|NCT02661594|10040923|FG000|NOT COMPLETED|Overall Study||1
8976234|NCT02661594|10040924|FG001|NOT COMPLETED|Overall Study||0
8976235|NCT02661594|10040925|FG002|NOT COMPLETED|Overall Study||1
8976236|NCT02661594|10040926|FG003|NOT COMPLETED|Overall Study||0
8976237|NCT02661737|10040936|FG000|STARTED|Overall Study||503
8976238|NCT02661737|10040936|FG000|COMPLETED|Overall Study||469
8976239|NCT02661737|10040936|FG000|NOT COMPLETED|Overall Study||34
8976240|NCT02661815|10040944|FG000|STARTED|Overall Study||6
8976241|NCT02661815|10040945|FG001|STARTED|Overall Study||0
8976242|NCT02661815|10040946|FG002|STARTED|Overall Study||0
8976243|NCT02661815|10040947|FG003|STARTED|Overall Study||0
8976244|NCT02661815|10040944|FG000|COMPLETED|Overall Study||5
8976245|NCT02661815|10040945|FG001|COMPLETED|Overall Study||0
8976246|NCT02661815|10040946|FG002|COMPLETED|Overall Study||0
8976247|NCT02661815|10040947|FG003|COMPLETED|Overall Study||0
8976248|NCT02661815|10040944|FG000|NOT COMPLETED|Overall Study||1
8976249|NCT02661815|10040945|FG001|NOT COMPLETED|Overall Study||0
8632285|NCT00544882|9672197|FG001|STARTED|Cycle 1: Run-in Cycle||0
8632286|NCT00544882|9672198|FG002|STARTED|Cycle 1: Run-in Cycle||0
8976250|NCT02661815|10040946|FG002|NOT COMPLETED|Overall Study||0
8976251|NCT02661815|10040947|FG003|NOT COMPLETED|Overall Study||0
8976252|NCT02661828|10040963|FG000|STARTED|Overall Study||1
8976253|NCT02661828|10040964|FG001|STARTED|Overall Study||0
8976254|NCT02661828|10040963|FG000|COMPLETED|Overall Study||1
8976255|NCT02661828|10040964|FG001|COMPLETED|Overall Study||0
8976256|NCT02661828|10040963|FG000|NOT COMPLETED|Overall Study||0
8976257|NCT02661828|10040964|FG001|NOT COMPLETED|Overall Study||0
8976258|NCT02662023|10040971|FG000|STARTED|Overall Study||12
8976259|NCT02662023|10040972|FG001|STARTED|Overall Study||12
8976260|NCT02662023|10040971|FG000|COMPLETED|Overall Study||12
8976261|NCT02662023|10040972|FG001|COMPLETED|Overall Study||12
8976262|NCT02662023|10040971|FG000|NOT COMPLETED|Overall Study||0
8976263|NCT02662023|10040972|FG001|NOT COMPLETED|Overall Study||0
8976264|NCT02662036|10040980|FG000|STARTED|Overall Study||35
8976265|NCT02662036|10040981|FG001|STARTED|Overall Study||35
8976266|NCT02662036|10040980|FG000|COMPLETED|Overall Study||22
8976267|NCT02662036|10040981|FG001|COMPLETED|Overall Study||22
8976268|NCT02662036|10040980|FG000|NOT COMPLETED|Overall Study||13
8976269|NCT02662036|10040981|FG001|NOT COMPLETED|Overall Study||13
8976270|NCT02662244|10040987|FG000|STARTED|Overall Study||33
8976271|NCT02662244|10040987|FG000|COMPLETED|Overall Study||31
8976272|NCT02662244|10040987|FG000|NOT COMPLETED|Overall Study||2
8976273|NCT02662387|10040995|FG000|STARTED|Overall Study||27
8976274|NCT02662387|10040996|FG001|STARTED|Overall Study||28
8976275|NCT02662387|10040995|FG000|COMPLETED|Overall Study||27
8976276|NCT02662387|10040996|FG001|COMPLETED|Overall Study||28
8976277|NCT02662387|10040995|FG000|NOT COMPLETED|Overall Study||0
8976278|NCT02662387|10040996|FG001|NOT COMPLETED|Overall Study||0
8976279|NCT02662556|10041004|FG000|STARTED|Overall Study||140
8976280|NCT02662556|10041004|FG000|COMPLETED|Overall Study||132
8976281|NCT02662556|10041004|FG000|NOT COMPLETED|Overall Study||8
8976282|NCT02662569|10041013|FG000|STARTED|Overall Study||166
8976283|NCT02662569|10041014|FG001|STARTED|Overall Study||161
8976284|NCT02662569|10041015|FG002|STARTED|Overall Study||327
8976285|NCT02662569|10041016|FG003|STARTED|Overall Study||332
8976286|NCT02662569|10041013|FG000|Received Study Drug|Overall Study||164
8976287|NCT02662569|10041014|FG001|Received Study Drug|Overall Study||160
8976288|NCT02662569|10041015|FG002|Received Study Drug|Overall Study||325
8976289|NCT02662569|10041016|FG003|Received Study Drug|Overall Study||332
8976290|NCT02662569|10041013|FG000|COMPLETED|Overall Study||159
8976291|NCT02662569|10041014|FG001|COMPLETED|Overall Study||160
8976292|NCT02662569|10041015|FG002|COMPLETED|Overall Study||321
8976293|NCT02662569|10041016|FG003|COMPLETED|Overall Study||328
8976294|NCT02662569|10041013|FG000|NOT COMPLETED|Overall Study||7
8976295|NCT02662569|10041014|FG001|NOT COMPLETED|Overall Study||1
8976296|NCT02662569|10041015|FG002|NOT COMPLETED|Overall Study||6
8976297|NCT02662569|10041016|FG003|NOT COMPLETED|Overall Study||4
8976298|NCT02662582|10041028|FG000|STARTED|Treatment Period 1 (14 Days)||23
8976299|NCT02662582|10041029|FG001|STARTED|Treatment Period 1 (14 Days)||23
8976300|NCT02662582|10041028|FG000|COMPLETED|Treatment Period 1 (14 Days)||18
8976301|NCT02662582|10041029|FG001|COMPLETED|Treatment Period 1 (14 Days)||19
8976302|NCT02662582|10041028|FG000|NOT COMPLETED|Treatment Period 1 (14 Days)||5
8976303|NCT02662582|10041029|FG001|NOT COMPLETED|Treatment Period 1 (14 Days)||4
8976304|NCT02662582|10041028|FG000|STARTED|Washout Period (14 Days)||18
8976305|NCT02662582|10041029|FG001|STARTED|Washout Period (14 Days)||19
8976306|NCT02662582|10041028|FG000|COMPLETED|Washout Period (14 Days)||18
8976307|NCT02662582|10041029|FG001|COMPLETED|Washout Period (14 Days)||19
8976308|NCT02662582|10041028|FG000|NOT COMPLETED|Washout Period (14 Days)||0
8976309|NCT02662582|10041029|FG001|NOT COMPLETED|Washout Period (14 Days)||0
8976310|NCT02662582|10041028|FG000|STARTED|Treatment Period 2 (14 Days)||18
8976311|NCT02662582|10041029|FG001|STARTED|Treatment Period 2 (14 Days)||19
8976312|NCT02662582|10041028|FG000|COMPLETED|Treatment Period 2 (14 Days)||18
8976313|NCT02662582|10041029|FG001|COMPLETED|Treatment Period 2 (14 Days)||19
8976314|NCT02662582|10041028|FG000|NOT COMPLETED|Treatment Period 2 (14 Days)||0
8976315|NCT02662582|10041029|FG001|NOT COMPLETED|Treatment Period 2 (14 Days)||0
8976316|NCT02662608|10041036|FG000|STARTED|Overall Study||1
8976317|NCT02662608|10041036|FG000|COMPLETED|Overall Study||1
8976318|NCT02662608|10041036|FG000|NOT COMPLETED|Overall Study||0
8976319|NCT02662764|10041040|FG000|STARTED|Overall Study||320
8976320|NCT02662764|10041040|FG000|COMPLETED|Overall Study|First 24-hours of study treatment|290
8976321|NCT02662764|10041040|FG000|NOT COMPLETED|Overall Study||30
8976322|NCT02663128|10041051|FG000|STARTED|Period 1||3
8976323|NCT02663128|10041052|FG001|STARTED|Period 1||3
8976324|NCT02663128|10041053|FG002|STARTED|Period 1||3
8976325|NCT02663128|10041054|FG003|STARTED|Period 1||3
8976326|NCT02663128|10041055|FG004|STARTED|Period 1||3
8976327|NCT02663128|10041056|FG005|STARTED|Period 1||3
8976328|NCT02663128|10041051|FG000|Received at Least One Dose of Study Drug|Period 1||3
8976329|NCT02663128|10041052|FG001|Received at Least One Dose of Study Drug|Period 1||3
8976330|NCT02663128|10041053|FG002|Received at Least One Dose of Study Drug|Period 1||3
8976331|NCT02663128|10041054|FG003|Received at Least One Dose of Study Drug|Period 1||3
8976332|NCT02663128|10041055|FG004|Received at Least One Dose of Study Drug|Period 1||3
8976333|NCT02663128|10041056|FG005|Received at Least One Dose of Study Drug|Period 1||3
8976334|NCT02663128|10041051|FG000|COMPLETED|Period 1||3
8976335|NCT02663128|10041052|FG001|COMPLETED|Period 1||3
8976336|NCT02663128|10041053|FG002|COMPLETED|Period 1||3
8976337|NCT02663128|10041054|FG003|COMPLETED|Period 1||3
8976338|NCT02663128|10041055|FG004|COMPLETED|Period 1||3
8976339|NCT02663128|10041056|FG005|COMPLETED|Period 1||3
8976340|NCT02663128|10041051|FG000|NOT COMPLETED|Period 1||0
8976341|NCT02663128|10041052|FG001|NOT COMPLETED|Period 1||0
8632287|NCT00544882|9672196|FG000|COMPLETED|Cycle 1: Run-in Cycle||58
8632288|NCT00544882|9672197|FG001|COMPLETED|Cycle 1: Run-in Cycle||0
8632289|NCT00544882|9672198|FG002|COMPLETED|Cycle 1: Run-in Cycle||0
8632290|NCT00544882|9672196|FG000|NOT COMPLETED|Cycle 1: Run-in Cycle||3
8632291|NCT00544882|9672197|FG001|NOT COMPLETED|Cycle 1: Run-in Cycle||0
8632292|NCT00544882|9672198|FG002|NOT COMPLETED|Cycle 1: Run-in Cycle||0
8632293|NCT00544882|9672196|FG000|STARTED|Cycle 2: Randomized Treatment Cycle||0
8632294|NCT00544882|9672197|FG001|STARTED|Cycle 2: Randomized Treatment Cycle||29
8976342|NCT02663128|10041053|FG002|NOT COMPLETED|Period 1||0
8976343|NCT02663128|10041054|FG003|NOT COMPLETED|Period 1||0
8976344|NCT02663128|10041055|FG004|NOT COMPLETED|Period 1||0
8976345|NCT02663128|10041056|FG005|NOT COMPLETED|Period 1||0
8976346|NCT02663128|10041051|FG000|STARTED|Period 2||3
8976347|NCT02663128|10041052|FG001|STARTED|Period 2||3
8976348|NCT02663128|10041053|FG002|STARTED|Period 2||3
8976349|NCT02663128|10041054|FG003|STARTED|Period 2||3
8976350|NCT02663128|10041055|FG004|STARTED|Period 2||3
8976351|NCT02663128|10041056|FG005|STARTED|Period 2||3
8976352|NCT02663128|10041051|FG000|COMPLETED|Period 2||3
8976353|NCT02663128|10041052|FG001|COMPLETED|Period 2||3
8976354|NCT02663128|10041053|FG002|COMPLETED|Period 2||3
8976355|NCT02663128|10041054|FG003|COMPLETED|Period 2||3
8976356|NCT02663128|10041055|FG004|COMPLETED|Period 2||2
8976357|NCT02663128|10041056|FG005|COMPLETED|Period 2||3
8976358|NCT02663128|10041051|FG000|NOT COMPLETED|Period 2||0
8976359|NCT02663128|10041052|FG001|NOT COMPLETED|Period 2||0
8976360|NCT02663128|10041053|FG002|NOT COMPLETED|Period 2||0
8976361|NCT02663128|10041054|FG003|NOT COMPLETED|Period 2||0
8976362|NCT02663128|10041055|FG004|NOT COMPLETED|Period 2||1
8976363|NCT02663128|10041056|FG005|NOT COMPLETED|Period 2||0
8976364|NCT02663128|10041051|FG000|STARTED|Period 3||3
8976365|NCT02663128|10041052|FG001|STARTED|Period 3||3
8976366|NCT02663128|10041053|FG002|STARTED|Period 3||3
8976367|NCT02663128|10041054|FG003|STARTED|Period 3||3
8976368|NCT02663128|10041055|FG004|STARTED|Period 3||2
8976369|NCT02663128|10041056|FG005|STARTED|Period 3||3
8976370|NCT02663128|10041051|FG000|COMPLETED|Period 3||3
8976371|NCT02663128|10041052|FG001|COMPLETED|Period 3||3
8976372|NCT02663128|10041053|FG002|COMPLETED|Period 3||3
8976373|NCT02663128|10041054|FG003|COMPLETED|Period 3||3
8976374|NCT02663128|10041055|FG004|COMPLETED|Period 3||2
8976375|NCT02663128|10041056|FG005|COMPLETED|Period 3||3
8976376|NCT02663128|10041051|FG000|NOT COMPLETED|Period 3||0
8976377|NCT02663128|10041052|FG001|NOT COMPLETED|Period 3||0
8976378|NCT02663128|10041053|FG002|NOT COMPLETED|Period 3||0
8976379|NCT02663128|10041054|FG003|NOT COMPLETED|Period 3||0
8976380|NCT02663128|10041055|FG004|NOT COMPLETED|Period 3||0
8976381|NCT02663128|10041056|FG005|NOT COMPLETED|Period 3||0
8976382|NCT02663232|10041065|FG000|STARTED|Overall Study||264
8976383|NCT02663232|10041065|FG000|COMPLETED|Overall Study||264
8976384|NCT02663232|10041065|FG000|NOT COMPLETED|Overall Study||0
8976385|NCT02663453|10041071|FG000|STARTED|Overall Study||22
8976386|NCT02663453|10041072|FG001|STARTED|Overall Study||22
8976387|NCT02663453|10041071|FG000|COMPLETED|Overall Study||17
8976388|NCT02663453|10041072|FG001|COMPLETED|Overall Study||18
8976389|NCT02663453|10041071|FG000|NOT COMPLETED|Overall Study||5
8976390|NCT02663453|10041072|FG001|NOT COMPLETED|Overall Study||4
8976391|NCT02663674|10041080|FG000|STARTED|Overall Study||33
8976392|NCT02663674|10041081|FG001|STARTED|Overall Study||39
8976393|NCT02663674|10041080|FG000|COMPLETED|Overall Study||26
8976394|NCT02663674|10041081|FG001|COMPLETED|Overall Study||29
8976395|NCT02663674|10041080|FG000|NOT COMPLETED|Overall Study||7
8976396|NCT02663674|10041081|FG001|NOT COMPLETED|Overall Study||10
8976397|NCT02663687|10041092|FG000|STARTED|Overall Study||12
8976398|NCT02663687|10041093|FG001|STARTED|Overall Study||9
8976399|NCT02663687|10041094|FG002|STARTED|Overall Study||9
8976400|NCT02663687|10041095|FG003|STARTED|Overall Study||9
8976401|NCT02663687|10041096|FG004|STARTED|Overall Study||9
8976402|NCT02663687|10041092|FG000|Treatment Period 1 (IV)|Overall Study||12
8976403|NCT02663687|10041093|FG001|Treatment Period 1 (IV)|Overall Study||9
8976404|NCT02663687|10041094|FG002|Treatment Period 1 (IV)|Overall Study||9
8632295|NCT00544882|9672198|FG002|STARTED|Cycle 2: Randomized Treatment Cycle||29
8632296|NCT00544882|9672196|FG000|Treated|Cycle 2: Randomized Treatment Cycle||0
8691281|NCT00853957|9736512|FG001|STARTED|Overall Study||223
8976405|NCT02663687|10041095|FG003|Treatment Period 1 (IV)|Overall Study||9
8976406|NCT02663687|10041096|FG004|Treatment Period 1 (IV)|Overall Study||9
8976407|NCT02663687|10041092|FG000|Treatment Period 2 (SC)|Overall Study||10
8976408|NCT02663687|10041093|FG001|Treatment Period 2 (SC)|Overall Study||9
8976409|NCT02663687|10041094|FG002|Treatment Period 2 (SC)|Overall Study||8
8976410|NCT02663687|10041095|FG003|Treatment Period 2 (SC)|Overall Study||9
8976411|NCT02663687|10041096|FG004|Treatment Period 2 (SC)|Overall Study||9
8976412|NCT02663687|10041092|FG000|COMPLETED|Overall Study||10
8976413|NCT02663687|10041093|FG001|COMPLETED|Overall Study||9
8976414|NCT02663687|10041094|FG002|COMPLETED|Overall Study||8
8976415|NCT02663687|10041095|FG003|COMPLETED|Overall Study||9
8976416|NCT02663687|10041096|FG004|COMPLETED|Overall Study||9
8976417|NCT02663687|10041092|FG000|NOT COMPLETED|Overall Study||2
8976418|NCT02663687|10041093|FG001|NOT COMPLETED|Overall Study||0
8976419|NCT02663687|10041094|FG002|NOT COMPLETED|Overall Study||1
8976420|NCT02663687|10041095|FG003|NOT COMPLETED|Overall Study||0
8976421|NCT02663687|10041096|FG004|NOT COMPLETED|Overall Study||0
8976422|NCT02663817|10041121|FG000|STARTED|Overall Study||52
8976423|NCT02663817|10041121|FG000|COMPLETED|Overall Study||50
8976424|NCT02663817|10041121|FG000|NOT COMPLETED|Overall Study||2
8976425|NCT02663882|10041129|FG000|STARTED|Overall Study||39
8976426|NCT02663882|10041130|FG001|STARTED|Overall Study||36
8976427|NCT02663882|10041129|FG000|COMPLETED|Overall Study||35
8976428|NCT02663882|10041130|FG001|COMPLETED|Overall Study||34
8976429|NCT02663882|10041129|FG000|NOT COMPLETED|Overall Study||4
8976430|NCT02663882|10041130|FG001|NOT COMPLETED|Overall Study||2
8976431|NCT02663895|10041136|FG000|STARTED|Overall Study||12
8976432|NCT02663895|10041136|FG000|COMPLETED|Overall Study||5
8976433|NCT02663895|10041136|FG000|NOT COMPLETED|Overall Study||7
8976434|NCT02664220|10041143|FG000|STARTED|Overall Study||50
8976435|NCT02664220|10041144|FG001|STARTED|Overall Study||50
8976436|NCT02664220|10041143|FG000|COMPLETED|Overall Study||50
8976437|NCT02664220|10041144|FG001|COMPLETED|Overall Study||50
8976438|NCT02664220|10041143|FG000|NOT COMPLETED|Overall Study||0
8976439|NCT02664220|10041144|FG001|NOT COMPLETED|Overall Study||0
8976440|NCT02664272|10041150|FG000|STARTED|Overall Study||40
8976441|NCT02664272|10041150|FG000|COMPLETED|Overall Study||38
8976442|NCT02664272|10041150|FG000|NOT COMPLETED|Overall Study||2
9038509|NCT03332784|10099779|FG018|STARTED|Parts 1 and 2 - Period 1 (1 Day)|A washout period of 7 days was required before the dosing on Day 1 for prior medications.|3
9038510|NCT03332784|10099780|FG019|STARTED|Parts 1 and 2 - Period 1 (1 Day)|A washout period of 7 days was required before the dosing on Day 1 for prior medications.|3
9038511|NCT03332784|10099761|FG000|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
9038512|NCT03332784|10099762|FG001|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||1
9038513|NCT03332784|10099763|FG002|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
9038514|NCT03332784|10099764|FG003|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
8571103|NCT00107783|9603313|FG000|NOT COMPLETED|Overall Study||3
8571104|NCT00107783|9603314|FG001|NOT COMPLETED|Overall Study||4
8571105|NCT00107900|9603326|FG000|STARTED|Overall Study||85
8571106|NCT00107900|9603327|FG001|STARTED|Overall Study||75
8571107|NCT00107900|9603328|FG002|STARTED|Overall Study||129
8571108|NCT00107900|9603329|FG003|STARTED|Overall Study||99
8571109|NCT00107900|9603330|FG004|STARTED|Overall Study||115
8571110|NCT00107900|9603331|FG005|STARTED|Overall Study||103
8571111|NCT00107900|9603326|FG000|COMPLETED|Overall Study||75
8571112|NCT00107900|9603327|FG001|COMPLETED|Overall Study||72
8571113|NCT00107900|9603328|FG002|COMPLETED|Overall Study||104
8571114|NCT00107900|9603329|FG003|COMPLETED|Overall Study||87
8571115|NCT00107900|9603330|FG004|COMPLETED|Overall Study||94
8571116|NCT00107900|9603331|FG005|COMPLETED|Overall Study||94
8571117|NCT00107900|9603326|FG000|NOT COMPLETED|Overall Study||10
8976443|NCT02664311|10041156|FG000|STARTED|Overall Study||6
8976444|NCT02664311|10041157|FG001|STARTED|Overall Study||3
8976445|NCT02664311|10041156|FG000|COMPLETED|Overall Study||6
8976446|NCT02664311|10041157|FG001|COMPLETED|Overall Study||3
8976447|NCT02664311|10041156|FG000|NOT COMPLETED|Overall Study||0
8976448|NCT02664311|10041157|FG001|NOT COMPLETED|Overall Study||0
8976449|NCT02664363|10041163|FG000|STARTED|Overall Study||3
8976450|NCT02664363|10041163|FG000|COMPLETED|Overall Study||3
8976451|NCT02664363|10041163|FG000|NOT COMPLETED|Overall Study||0
8976452|NCT02664415|10041169|FG000|STARTED|Overall Study||14
8976453|NCT02664415|10041170|FG001|STARTED|Overall Study||5
8976454|NCT02664415|10041169|FG000|COMPLETED|Overall Study||13
8976455|NCT02664415|10041170|FG001|COMPLETED|Overall Study||5
8976456|NCT02664415|10041169|FG000|NOT COMPLETED|Overall Study||1
8976457|NCT02664415|10041170|FG001|NOT COMPLETED|Overall Study||0
8976458|NCT02664532|10041178|FG000|STARTED|Overall Study||75
8976459|NCT02664532|10041179|FG001|STARTED|Overall Study||75
8976460|NCT02664532|10041178|FG000|COMPLETED|Overall Study||75
8976461|NCT02664532|10041179|FG001|COMPLETED|Overall Study||75
8976462|NCT02664532|10041178|FG000|NOT COMPLETED|Overall Study||0
8976463|NCT02664532|10041179|FG001|NOT COMPLETED|Overall Study||0
8976464|NCT02664610|10041187|FG000|STARTED|Overall Study||46
8976465|NCT02664610|10041188|FG001|STARTED|Overall Study||48
8976466|NCT02664610|10041187|FG000|COMPLETED|Overall Study||32
8976467|NCT02664610|10041188|FG001|COMPLETED|Overall Study||41
8976468|NCT02664610|10041187|FG000|NOT COMPLETED|Overall Study||14
8976469|NCT02664610|10041188|FG001|NOT COMPLETED|Overall Study||7
8976470|NCT02664909|10041196|FG000|STARTED|Overall Study||17
8976471|NCT02664909|10041197|FG001|STARTED|Overall Study||19
8976472|NCT02664909|10041196|FG000|COMPLETED|Overall Study||15
8976473|NCT02664909|10041197|FG001|COMPLETED|Overall Study||16
8976474|NCT02664909|10041196|FG000|NOT COMPLETED|Overall Study||2
8976475|NCT02664909|10041197|FG001|NOT COMPLETED|Overall Study||3
8976476|NCT02664922|10041207|FG000|STARTED|Overall Study||11
8976477|NCT02664922|10041208|FG001|STARTED|Overall Study||12
8976478|NCT02664922|10041209|FG002|STARTED|Overall Study||7
8976479|NCT02664922|10041210|FG003|STARTED|Overall Study||5
8976480|NCT02664922|10041207|FG000|COMPLETED|Overall Study||10
8976481|NCT02664922|10041208|FG001|COMPLETED|Overall Study||12
8976482|NCT02664922|10041209|FG002|COMPLETED|Overall Study||7
8976483|NCT02664922|10041210|FG003|COMPLETED|Overall Study||5
8976484|NCT02664922|10041207|FG000|NOT COMPLETED|Overall Study||1
8976485|NCT02664922|10041208|FG001|NOT COMPLETED|Overall Study||0
8976486|NCT02664922|10041209|FG002|NOT COMPLETED|Overall Study||0
8976487|NCT02664922|10041210|FG003|NOT COMPLETED|Overall Study||0
8976488|NCT02664961|10041220|FG000|STARTED|Overall Study||3
8976489|NCT02664961|10041220|FG000|COMPLETED|Overall Study||3
8976490|NCT02664961|10041220|FG000|NOT COMPLETED|Overall Study||0
8976491|NCT02664987|10041224|FG000|STARTED|Overall Study||462
8976492|NCT02664987|10041224|FG000|COMPLETED|Overall Study||462
8976493|NCT02664987|10041224|FG000|NOT COMPLETED|Overall Study||0
8976494|NCT02665052|10041232|FG000|STARTED|Overall Study||11
8976495|NCT02665052|10041233|FG001|STARTED|Overall Study||9
8976496|NCT02665052|10041234|FG002|STARTED|Overall Study||9
8976497|NCT02665052|10041235|FG003|STARTED|Overall Study||19
8976498|NCT02665052|10041232|FG000|COMPLETED|Overall Study||8
8976499|NCT02665052|10041233|FG001|COMPLETED|Overall Study||7
8976500|NCT02665052|10041234|FG002|COMPLETED|Overall Study||9
8976501|NCT02665052|10041235|FG003|COMPLETED|Overall Study||14
8976502|NCT02665052|10041232|FG000|NOT COMPLETED|Overall Study||3
8976503|NCT02665052|10041233|FG001|NOT COMPLETED|Overall Study||2
8976504|NCT02665052|10041234|FG002|NOT COMPLETED|Overall Study||0
8976505|NCT02665052|10041235|FG003|NOT COMPLETED|Overall Study||5
8976506|NCT02665260|10041250|FG000|STARTED|Overall Study||24
8976507|NCT02665260|10041251|FG001|STARTED|Overall Study||23
8976508|NCT02665260|10041252|FG002|STARTED|Overall Study||25
8976509|NCT02665260|10041253|FG003|STARTED|Overall Study||22
8976510|NCT02665260|10041250|FG000|COMPLETED|Overall Study||22
8976511|NCT02665260|10041251|FG001|COMPLETED|Overall Study||22
8976512|NCT02665260|10041252|FG002|COMPLETED|Overall Study||21
8976513|NCT02665260|10041253|FG003|COMPLETED|Overall Study||21
8976514|NCT02665260|10041250|FG000|NOT COMPLETED|Overall Study||2
8976515|NCT02665260|10041251|FG001|NOT COMPLETED|Overall Study||1
8976516|NCT02665260|10041252|FG002|NOT COMPLETED|Overall Study||4
8976517|NCT02665260|10041253|FG003|NOT COMPLETED|Overall Study||1
8976518|NCT02665273|10041269|FG000|STARTED|Overall Study||13
8976519|NCT02665273|10041270|FG001|STARTED|Overall Study||15
8976520|NCT02665273|10041269|FG000|COMPLETED|Overall Study||13
8976521|NCT02665273|10041270|FG001|COMPLETED|Overall Study||15
8976522|NCT02665273|10041269|FG000|NOT COMPLETED|Overall Study||0
8976523|NCT02665273|10041270|FG001|NOT COMPLETED|Overall Study||0
8976524|NCT02665286|10041279|FG000|STARTED|Overall Study||79
8976525|NCT02665286|10041280|FG001|STARTED|Overall Study||80
8976526|NCT02665286|10041281|FG002|STARTED|Overall Study||81
8976527|NCT02665286|10041279|FG000|COMPLETED|Overall Study||76
8976528|NCT02665286|10041280|FG001|COMPLETED|Overall Study||78
8976529|NCT02665286|10041281|FG002|COMPLETED|Overall Study||80
8976530|NCT02665286|10041279|FG000|NOT COMPLETED|Overall Study||3
8976531|NCT02665286|10041280|FG001|NOT COMPLETED|Overall Study||2
8976532|NCT02665286|10041281|FG002|NOT COMPLETED|Overall Study||1
8976533|NCT02665364|10041291|FG000|STARTED|Overall Study||91
8976534|NCT02665364|10041292|FG001|STARTED|Overall Study||93
8976535|NCT02665364|10041291|FG000|COMPLETED|Overall Study||85
8976536|NCT02665364|10041292|FG001|COMPLETED|Overall Study||84
8976537|NCT02665364|10041291|FG000|NOT COMPLETED|Overall Study||6
8976538|NCT02665364|10041292|FG001|NOT COMPLETED|Overall Study||9
8976539|NCT02665455|10041298|FG000|STARTED|Overall Study||83
8976540|NCT02665455|10041298|FG000|COMPLETED|Overall Study||74
8976541|NCT02665455|10041298|FG000|NOT COMPLETED|Overall Study||9
8976542|NCT02665468|10041304|FG000|STARTED|Overall Study||595
8976543|NCT02665468|10041305|FG001|STARTED|Overall Study||601
8976544|NCT02665468|10041304|FG000|COMPLETED|Overall Study||595
8976545|NCT02665468|10041305|FG001|COMPLETED|Overall Study||601
8976546|NCT02665468|10041304|FG000|NOT COMPLETED|Overall Study||0
8976547|NCT02665468|10041305|FG001|NOT COMPLETED|Overall Study||0
8976548|NCT02665689|10041313|FG000|STARTED|Overall Study||2
8976549|NCT02665689|10041314|FG001|STARTED|Overall Study||2
8976550|NCT02665689|10041313|FG000|COMPLETED|Overall Study||0
8976551|NCT02665689|10041314|FG001|COMPLETED|Overall Study||0
8976552|NCT02665689|10041313|FG000|NOT COMPLETED|Overall Study||2
8976553|NCT02665689|10041314|FG001|NOT COMPLETED|Overall Study||2
8976554|NCT02665728|10041320|FG000|STARTED|Overall Study||33
8976555|NCT02665728|10041320|FG000|COMPLETED|Overall Study||33
8976556|NCT02665728|10041320|FG000|NOT COMPLETED|Overall Study||0
8976557|NCT02665741|10041327|FG000|STARTED|Overall Study||42
8976558|NCT02665741|10041328|FG001|STARTED|Overall Study||42
8976559|NCT02665741|10041329|FG002|STARTED|Overall Study||42
8976560|NCT02665741|10041327|FG000|COMPLETED|Overall Study||42
8976561|NCT02665741|10041328|FG001|COMPLETED|Overall Study||42
8976562|NCT02665741|10041329|FG002|COMPLETED|Overall Study||42
8976563|NCT02665741|10041327|FG000|NOT COMPLETED|Overall Study||0
8976564|NCT02665741|10041328|FG001|NOT COMPLETED|Overall Study||0
8976565|NCT02665741|10041329|FG002|NOT COMPLETED|Overall Study||0
8976566|NCT02665975|10041339|FG000|STARTED|Overall Study||46
8976567|NCT02665975|10041340|FG001|STARTED|Overall Study||46
8976568|NCT02665975|10041339|FG000|COMPLETED|Overall Study||37
8976569|NCT02665975|10041340|FG001|COMPLETED|Overall Study||37
8976570|NCT02665975|10041339|FG000|NOT COMPLETED|Overall Study||9
8976571|NCT02665975|10041340|FG001|NOT COMPLETED|Overall Study||9
8976572|NCT02666222|10041346|FG000|STARTED|Overall Study||51
8976573|NCT02666222|10041346|FG000|COMPLETED|Overall Study||49
8976574|NCT02666222|10041346|FG000|NOT COMPLETED|Overall Study||2
8976575|NCT02666352|10041353|FG000|STARTED|Overall Study||8
8976576|NCT02666352|10041354|FG001|STARTED|Overall Study||8
8976577|NCT02666352|10041355|FG002|STARTED|Overall Study||8
8976578|NCT02666352|10041353|FG000|COMPLETED|Overall Study||8
8976579|NCT02666352|10041354|FG001|COMPLETED|Overall Study||8
8976580|NCT02666352|10041355|FG002|COMPLETED|Overall Study||8
8976581|NCT02666352|10041353|FG000|NOT COMPLETED|Overall Study||0
8976582|NCT02666352|10041354|FG001|NOT COMPLETED|Overall Study||0
8976583|NCT02666352|10041355|FG002|NOT COMPLETED|Overall Study||0
8976584|NCT02666508|10041365|FG000|STARTED|Overall Study||31
8976585|NCT02666508|10041366|FG001|STARTED|Overall Study||30
8976586|NCT02666508|10041365|FG000|COMPLETED|Overall Study||31
8976587|NCT02666508|10041366|FG001|COMPLETED|Overall Study||30
8976588|NCT02666508|10041365|FG000|NOT COMPLETED|Overall Study||0
8976589|NCT02666508|10041366|FG001|NOT COMPLETED|Overall Study||0
8976590|NCT02666560|10041376|FG000|STARTED|Condition 1 (1 Day)||8
8976591|NCT02666560|10041377|FG001|STARTED|Condition 1 (1 Day)||11
8976592|NCT02666560|10041376|FG000|COMPLETED|Condition 1 (1 Day)||8
8976593|NCT02666560|10041377|FG001|COMPLETED|Condition 1 (1 Day)||11
8976594|NCT02666560|10041376|FG000|NOT COMPLETED|Condition 1 (1 Day)||0
8976595|NCT02666560|10041377|FG001|NOT COMPLETED|Condition 1 (1 Day)||0
8976596|NCT02666560|10041376|FG000|STARTED|Condition 2 (1 Day)||8
8976597|NCT02666560|10041377|FG001|STARTED|Condition 2 (1 Day)||11
8976598|NCT02666560|10041376|FG000|COMPLETED|Condition 2 (1 Day)||8
8976599|NCT02666560|10041377|FG001|COMPLETED|Condition 2 (1 Day)||11
8976600|NCT02666560|10041376|FG000|NOT COMPLETED|Condition 2 (1 Day)||0
8976601|NCT02666560|10041377|FG001|NOT COMPLETED|Condition 2 (1 Day)||0
8632297|NCT00544882|9672197|FG001|Treated|Cycle 2: Randomized Treatment Cycle|One participant withdrew prior to treatment|28
8691282|NCT00853957|9736511|FG000|COMPLETED|Overall Study||206
8976602|NCT02666664|10041386|FG000|STARTED|Overall Study||742
8976603|NCT02666664|10041387|FG001|STARTED|Overall Study||1488
8976604|NCT02666664|10041386|FG000|COMPLETED|Overall Study||706
8976605|NCT02666664|10041387|FG001|COMPLETED|Overall Study||1404
8976606|NCT02666664|10041386|FG000|NOT COMPLETED|Overall Study||36
8976607|NCT02666664|10041387|FG001|NOT COMPLETED|Overall Study||84
8976608|NCT02666742|10041395|FG000|STARTED|Overall Study||123
8976609|NCT02666742|10041396|FG001|STARTED|Overall Study||123
8976610|NCT02666742|10041395|FG000|COMPLETED|Overall Study||123
8976611|NCT02666742|10041396|FG001|COMPLETED|Overall Study||123
8976612|NCT02666742|10041395|FG000|NOT COMPLETED|Overall Study||0
8976613|NCT02666742|10041396|FG001|NOT COMPLETED|Overall Study||0
8976614|NCT02666846|10041407|FG000|STARTED|Overall Study||20
8976615|NCT02666846|10041408|FG001|STARTED|Overall Study||20
8976616|NCT02666846|10041409|FG002|STARTED|Overall Study||20
8976617|NCT02666846|10041407|FG000|COMPLETED|Overall Study||20
8976618|NCT02666846|10041408|FG001|COMPLETED|Overall Study||20
8976619|NCT02666846|10041409|FG002|COMPLETED|Overall Study||20
8976620|NCT02666846|10041407|FG000|NOT COMPLETED|Overall Study||0
8976621|NCT02666846|10041408|FG001|NOT COMPLETED|Overall Study||0
8976622|NCT02666846|10041409|FG002|NOT COMPLETED|Overall Study||0
8976623|NCT02666950|10041439|FG000|STARTED|Overall Study||3
8976624|NCT02666950|10041439|FG000|COMPLETED|Overall Study||3
8976625|NCT02666950|10041439|FG000|NOT COMPLETED|Overall Study||0
8976626|NCT02667236|10041445|FG000|STARTED|Overall Study||223
8976627|NCT02667236|10041446|FG001|STARTED|Overall Study||227
8976628|NCT02667236|10041445|FG000|COMPLETED|Overall Study||220
8976629|NCT02667236|10041446|FG001|COMPLETED|Overall Study||226
8976630|NCT02667236|10041445|FG000|NOT COMPLETED|Overall Study||3
8976631|NCT02667236|10041446|FG001|NOT COMPLETED|Overall Study||1
8976632|NCT02667275|10041454|FG000|STARTED|Overall Study||244
8976633|NCT02667275|10041455|FG001|STARTED|Overall Study||243
8976634|NCT02667275|10041454|FG000|COMPLETED|Overall Study||233
8976635|NCT02667275|10041455|FG001|COMPLETED|Overall Study||228
8976636|NCT02667275|10041454|FG000|NOT COMPLETED|Overall Study||11
8976637|NCT02667275|10041455|FG001|NOT COMPLETED|Overall Study||15
8976638|NCT02667288|10041461|FG000|STARTED|Overall Study||147
8976639|NCT02667288|10041461|FG000|COMPLETED|Overall Study||134
8976640|NCT02667288|10041461|FG000|NOT COMPLETED|Overall Study||13
8976641|NCT02667301|10041465|FG000|STARTED|Overall Study||16
8976642|NCT02667301|10041465|FG000|COMPLETED|Overall Study||14
8976643|NCT02667301|10041465|FG000|NOT COMPLETED|Overall Study||2
8976644|NCT02667392|10041471|FG000|STARTED|Overall Study||11
8976645|NCT02667392|10041471|FG000|COMPLETED|Overall Study||11
8976646|NCT02667392|10041471|FG000|NOT COMPLETED|Overall Study||0
8976647|NCT02667457|10041477|FG000|STARTED|Overall Study||27
8976648|NCT02667457|10041478|FG001|STARTED|Overall Study||12
8976649|NCT02667457|10041477|FG000|Dosed Participants|Overall Study||26
8976650|NCT02667457|10041478|FG001|Dosed Participants|Overall Study||10
8976651|NCT02667457|10041477|FG000|Full Analysis Set Population (FAS)|Overall Study||25
8976652|NCT02667457|10041478|FG001|Full Analysis Set Population (FAS)|Overall Study||10
8976653|NCT02667457|10041477|FG000|COMPLETED|Overall Study||26
8976654|NCT02667457|10041478|FG001|COMPLETED|Overall Study||10
8976655|NCT02667457|10041477|FG000|NOT COMPLETED|Overall Study||1
8976656|NCT02667457|10041478|FG001|NOT COMPLETED|Overall Study||2
8976657|NCT02667626|10041487|FG000|STARTED|Overall Study||86
8976658|NCT02667626|10041488|FG001|STARTED|Overall Study||96
8976659|NCT02667626|10041487|FG000|COMPLETED|Overall Study||86
8976660|NCT02667626|10041488|FG001|COMPLETED|Overall Study||95
8976661|NCT02667626|10041487|FG000|NOT COMPLETED|Overall Study||0
8976662|NCT02667626|10041488|FG001|NOT COMPLETED|Overall Study||1
8976663|NCT02667704|10041497|FG000|STARTED|Treatment Period 1||13
8976664|NCT02667704|10041497|FG000|COMPLETED|Treatment Period 1||13
8976665|NCT02667704|10041497|FG000|NOT COMPLETED|Treatment Period 1||0
8976666|NCT02667704|10041497|FG000|STARTED|Treatment Period 2||13
8976667|NCT02667704|10041497|FG000|COMPLETED|Treatment Period 2||13
8976668|NCT02667704|10041497|FG000|NOT COMPLETED|Treatment Period 2||0
8976669|NCT02667821|10041504|FG000|STARTED|Overall Study||20
8976670|NCT02667821|10041504|FG000|COMPLETED|Overall Study||20
8976671|NCT02667821|10041504|FG000|NOT COMPLETED|Overall Study||0
8976672|NCT02667912|10041511|FG000|STARTED|Overall Study||28
8976673|NCT02667912|10041512|FG001|STARTED|Overall Study||27
8976674|NCT02667912|10041511|FG000|Six Months|Overall Study||27
8976675|NCT02667912|10041512|FG001|Six Months|Overall Study||24
8976676|NCT02667912|10041511|FG000|COMPLETED|Overall Study||23
8976677|NCT02667912|10041512|FG001|COMPLETED|Overall Study||24
8976678|NCT02667912|10041511|FG000|NOT COMPLETED|Overall Study||5
8976679|NCT02667912|10041512|FG001|NOT COMPLETED|Overall Study||3
8976680|NCT02667951|10041520|FG000|STARTED|Overall Study||66
8976681|NCT02667951|10041521|FG001|STARTED|Overall Study||63
8976682|NCT02667951|10041520|FG000|COMPLETED|Overall Study||45
8976683|NCT02667951|10041521|FG001|COMPLETED|Overall Study||40
8976684|NCT02667951|10041520|FG000|NOT COMPLETED|Overall Study||21
8976685|NCT02667951|10041521|FG001|NOT COMPLETED|Overall Study||23
8976686|NCT02668003|10041529|FG000|STARTED|Overall Study||501
8976687|NCT02668003|10041530|FG001|STARTED|Overall Study||501
8976688|NCT02668003|10041529|FG000|COMPLETED|Overall Study||500
8571118|NCT00107900|9603327|FG001|NOT COMPLETED|Overall Study||3
8571119|NCT00107900|9603328|FG002|NOT COMPLETED|Overall Study||25
8571120|NCT00107900|9603329|FG003|NOT COMPLETED|Overall Study||12
8571121|NCT00107900|9603330|FG004|NOT COMPLETED|Overall Study||21
8571122|NCT00107900|9603331|FG005|NOT COMPLETED|Overall Study||9
8571123|NCT00107952|9603347|FG000|STARTED|Overall Study||381
8571124|NCT00107952|9603348|FG001|STARTED|Overall Study||380
8571125|NCT00107952|9603347|FG000|COMPLETED|Overall Study||286
8571126|NCT00107952|9603348|FG001|COMPLETED|Overall Study||299
8571127|NCT00107952|9603347|FG000|NOT COMPLETED|Overall Study||95
8571128|NCT00107952|9603348|FG001|NOT COMPLETED|Overall Study||81
8571129|NCT00107978|9603356|FG000|STARTED|Overall Study||458
8571130|NCT00107978|9603357|FG001|STARTED|Overall Study||481
8571131|NCT00107978|9603356|FG000|COMPLETED|Overall Study||425
8976689|NCT02668003|10041530|FG001|COMPLETED|Overall Study||496
8571132|NCT00107978|9603357|FG001|COMPLETED|Overall Study||431
8976690|NCT02668003|10041529|FG000|NOT COMPLETED|Overall Study||1
8976691|NCT02668003|10041530|FG001|NOT COMPLETED|Overall Study||5
8976692|NCT02668185|10041536|FG000|STARTED|Baseline Period (2 Weeks)||20
8976693|NCT02668185|10041537|FG001|STARTED|Baseline Period (2 Weeks)||17
8976694|NCT02668185|10041536|FG000|COMPLETED|Baseline Period (2 Weeks)||20
8976695|NCT02668185|10041537|FG001|COMPLETED|Baseline Period (2 Weeks)||17
8976696|NCT02668185|10041536|FG000|NOT COMPLETED|Baseline Period (2 Weeks)||0
8976697|NCT02668185|10041537|FG001|NOT COMPLETED|Baseline Period (2 Weeks)||0
8976698|NCT02668185|10041536|FG000|STARTED|First Intervention (4 Weeks)||20
8976699|NCT02668185|10041537|FG001|STARTED|First Intervention (4 Weeks)||17
8976700|NCT02668185|10041536|FG000|COMPLETED|First Intervention (4 Weeks)||18
8976701|NCT02668185|10041537|FG001|COMPLETED|First Intervention (4 Weeks)||17
8976702|NCT02668185|10041536|FG000|NOT COMPLETED|First Intervention (4 Weeks)||2
8976703|NCT02668185|10041537|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0
8976704|NCT02668185|10041536|FG000|STARTED|Washout Period (2 Weeks)||18
8976705|NCT02668185|10041537|FG001|STARTED|Washout Period (2 Weeks)||17
8976706|NCT02668185|10041536|FG000|COMPLETED|Washout Period (2 Weeks)||17
8976707|NCT02668185|10041537|FG001|COMPLETED|Washout Period (2 Weeks)||15
8976708|NCT02668185|10041536|FG000|NOT COMPLETED|Washout Period (2 Weeks)||1
8976709|NCT02668185|10041537|FG001|NOT COMPLETED|Washout Period (2 Weeks)||2
8976710|NCT02668185|10041536|FG000|STARTED|Second Intervention (4 Weeks)||17
8976711|NCT02668185|10041537|FG001|STARTED|Second Intervention (4 Weeks)||15
8976712|NCT02668185|10041536|FG000|COMPLETED|Second Intervention (4 Weeks)||16
8976713|NCT02668185|10041537|FG001|COMPLETED|Second Intervention (4 Weeks)||12
8976714|NCT02668185|10041536|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||1
8976715|NCT02668185|10041537|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||3
8976716|NCT02668185|10041536|FG000|STARTED|Moitoring Period (2 Weeks)||16
8976717|NCT02668185|10041537|FG001|STARTED|Moitoring Period (2 Weeks)||12
8976718|NCT02668185|10041536|FG000|COMPLETED|Moitoring Period (2 Weeks)||16
8976719|NCT02668185|10041537|FG001|COMPLETED|Moitoring Period (2 Weeks)||12
8976720|NCT02668185|10041536|FG000|NOT COMPLETED|Moitoring Period (2 Weeks)||0
8976721|NCT02668185|10041537|FG001|NOT COMPLETED|Moitoring Period (2 Weeks)||0
8976722|NCT02668198|10041543|FG000|STARTED|Overall Study||230
8976723|NCT02668198|10041543|FG000|COMPLETED|Overall Study||230
8976724|NCT02668198|10041543|FG000|NOT COMPLETED|Overall Study||0
8976725|NCT02668302|10041550|FG000|STARTED|Overall Study||20
8976726|NCT02668302|10041551|FG001|STARTED|Overall Study||20
8976727|NCT02668302|10041550|FG000|COMPLETED|Overall Study||19
8976728|NCT02668302|10041551|FG001|COMPLETED|Overall Study||20
8976729|NCT02668302|10041550|FG000|NOT COMPLETED|Overall Study||1
8976730|NCT02668302|10041551|FG001|NOT COMPLETED|Overall Study||0
8976731|NCT02668393|10041559|FG000|STARTED|Overall Study||7
8976732|NCT02668393|10041560|FG001|STARTED|Overall Study||7
8976733|NCT02668393|10041559|FG000|COMPLETED|Overall Study||0
8976734|NCT02668393|10041560|FG001|COMPLETED|Overall Study||1
8976735|NCT02668393|10041559|FG000|NOT COMPLETED|Overall Study||7
8976736|NCT02668393|10041560|FG001|NOT COMPLETED|Overall Study||6
8976737|NCT02668432|10041569|FG000|STARTED|Overall Study||5
8976738|NCT02668432|10041570|FG001|STARTED|Overall Study||4
8976739|NCT02668432|10041569|FG000|COMPLETED|Overall Study||5
8976740|NCT02668432|10041570|FG001|COMPLETED|Overall Study||4
8976741|NCT02668432|10041569|FG000|NOT COMPLETED|Overall Study||0
8976742|NCT02668432|10041570|FG001|NOT COMPLETED|Overall Study||0
8976743|NCT02668640|10041576|FG000|STARTED|Overall Study||55
8976744|NCT02668640|10041576|FG000|COMPLETED|Overall Study||41
8976745|NCT02668640|10041576|FG000|NOT COMPLETED|Overall Study||14
8976746|NCT02668692|10041582|FG000|STARTED|Overall Study||101
8976747|NCT02668692|10041583|FG001|STARTED|Overall Study||105
8976748|NCT02668692|10041582|FG000|COMPLETED|Overall Study||100
8976749|NCT02668692|10041583|FG001|COMPLETED|Overall Study||105
8976750|NCT02668692|10041582|FG000|NOT COMPLETED|Overall Study||1
8976751|NCT02668692|10041583|FG001|NOT COMPLETED|Overall Study||0
8976752|NCT02668952|10041591|FG000|STARTED|Overall Study||16
8976753|NCT02668952|10041592|FG001|STARTED|Overall Study||14
8976754|NCT02668952|10041591|FG000|COMPLETED|Overall Study||16
8976755|NCT02668952|10041592|FG001|COMPLETED|Overall Study||14
8976756|NCT02668952|10041591|FG000|NOT COMPLETED|Overall Study||0
8976757|NCT02668952|10041592|FG001|NOT COMPLETED|Overall Study||0
8976758|NCT02669017|10041607|FG000|STARTED|Overall Study||4
8976759|NCT02669017|10041608|FG001|STARTED|Overall Study||4
8976760|NCT02669017|10041609|FG002|STARTED|Overall Study||4
8976761|NCT02669017|10041610|FG003|STARTED|Overall Study||5
8976762|NCT02669017|10041611|FG004|STARTED|Overall Study||16
8632298|NCT00544882|9672198|FG002|Treated|Cycle 2: Randomized Treatment Cycle|One participant was dropped from the study due to noncompliance prior to treatment.|28
8632299|NCT00544882|9672196|FG000|COMPLETED|Cycle 2: Randomized Treatment Cycle||0
8632300|NCT00544882|9672197|FG001|COMPLETED|Cycle 2: Randomized Treatment Cycle||28
8632301|NCT00544882|9672198|FG002|COMPLETED|Cycle 2: Randomized Treatment Cycle||28
8976763|NCT02669017|10041612|FG005|STARTED|Overall Study||26
8976764|NCT02669017|10041613|FG006|STARTED|Overall Study||19
8976765|NCT02669017|10041614|FG007|STARTED|Overall Study||69
8976766|NCT02669017|10041615|FG008|STARTED|Overall Study||36
8976767|NCT02669017|10041607|FG000|COMPLETED|Overall Study||3
8976768|NCT02669017|10041608|FG001|COMPLETED|Overall Study||2
8976769|NCT02669017|10041609|FG002|COMPLETED|Overall Study||2
8976770|NCT02669017|10041610|FG003|COMPLETED|Overall Study||1
8976771|NCT02669017|10041611|FG004|COMPLETED|Overall Study||4
8976772|NCT02669017|10041612|FG005|COMPLETED|Overall Study||7
8976773|NCT02669017|10041613|FG006|COMPLETED|Overall Study||8
8976774|NCT02669017|10041614|FG007|COMPLETED|Overall Study||7
8976775|NCT02669017|10041615|FG008|COMPLETED|Overall Study||11
8976776|NCT02669017|10041607|FG000|NOT COMPLETED|Overall Study||1
8976777|NCT02669017|10041608|FG001|NOT COMPLETED|Overall Study||2
8976778|NCT02669017|10041609|FG002|NOT COMPLETED|Overall Study||2
8976779|NCT02669017|10041610|FG003|NOT COMPLETED|Overall Study||4
8976780|NCT02669017|10041611|FG004|NOT COMPLETED|Overall Study||12
8976781|NCT02669017|10041612|FG005|NOT COMPLETED|Overall Study||19
8976782|NCT02669017|10041613|FG006|NOT COMPLETED|Overall Study||11
8976783|NCT02669017|10041614|FG007|NOT COMPLETED|Overall Study||62
8976784|NCT02669017|10041615|FG008|NOT COMPLETED|Overall Study||25
8976785|NCT02669043|10041643|FG000|STARTED|Overall Study||8
8976786|NCT02669043|10041643|FG000|COMPLETED|Overall Study||4
8976787|NCT02669043|10041643|FG000|NOT COMPLETED|Overall Study||4
8976788|NCT02669082|10041647|FG000|STARTED|Overall Study||26
8976789|NCT02669082|10041647|FG000|COMPLETED|Overall Study||25
8976790|NCT02669082|10041647|FG000|NOT COMPLETED|Overall Study||1
8976791|NCT02669095|10041653|FG000|STARTED|Overall Study||75
8976792|NCT02669095|10041654|FG001|STARTED|Overall Study||75
8976793|NCT02669095|10041653|FG000|COMPLETED|Overall Study||74
8976794|NCT02669095|10041654|FG001|COMPLETED|Overall Study||72
8976795|NCT02669095|10041653|FG000|NOT COMPLETED|Overall Study||1
8976796|NCT02669095|10041654|FG001|NOT COMPLETED|Overall Study||3
8571133|NCT00107978|9603356|FG000|NOT COMPLETED|Overall Study||33
8571134|NCT00107978|9603357|FG001|NOT COMPLETED|Overall Study||50
8976797|NCT02669121|10041662|FG000|STARTED|Overall Study||2377
8976798|NCT02669121|10041663|FG001|STARTED|Overall Study||2371
8976799|NCT02669121|10041662|FG000|Treated (Safety Analysis Set)|Overall Study||2357
8976800|NCT02669121|10041663|FG001|Treated (Safety Analysis Set)|Overall Study||2355
8976801|NCT02669121|10041662|FG000|COMPLETED|Overall Study||2087
8976802|NCT02669121|10041663|FG001|COMPLETED|Overall Study||2089
8976803|NCT02669121|10041662|FG000|NOT COMPLETED|Overall Study||290
8976804|NCT02669121|10041663|FG001|NOT COMPLETED|Overall Study||282
8976805|NCT02669264|10041676|FG000|STARTED|Overall Study||5
8976806|NCT02669264|10041677|FG001|STARTED|Overall Study||7
8976807|NCT02669264|10041678|FG002|STARTED|Overall Study||3
8976808|NCT02669264|10041679|FG003|STARTED|Overall Study||4
8976809|NCT02669264|10041680|FG004|STARTED|Overall Study||5
8976810|NCT02669264|10041681|FG005|STARTED|Overall Study||6
8976811|NCT02669264|10041682|FG006|STARTED|Overall Study||5
8976812|NCT02669264|10041676|FG000|COMPLETED|Overall Study||0
8976813|NCT02669264|10041677|FG001|COMPLETED|Overall Study||1
8976814|NCT02669264|10041678|FG002|COMPLETED|Overall Study||0
8976815|NCT02669264|10041679|FG003|COMPLETED|Overall Study||1
8976816|NCT02669264|10041680|FG004|COMPLETED|Overall Study||0
8976817|NCT02669264|10041681|FG005|COMPLETED|Overall Study||0
8976818|NCT02669264|10041682|FG006|COMPLETED|Overall Study||0
8976819|NCT02669264|10041676|FG000|NOT COMPLETED|Overall Study||5
8976820|NCT02669264|10041677|FG001|NOT COMPLETED|Overall Study||6
8976821|NCT02669264|10041678|FG002|NOT COMPLETED|Overall Study||3
8976822|NCT02669264|10041679|FG003|NOT COMPLETED|Overall Study||3
8976823|NCT02669264|10041680|FG004|NOT COMPLETED|Overall Study||5
8976824|NCT02669264|10041681|FG005|NOT COMPLETED|Overall Study||6
8976825|NCT02669264|10041682|FG006|NOT COMPLETED|Overall Study||5
8976826|NCT02669329|10041700|FG000|STARTED|Overall Study||30
8976827|NCT02669329|10041700|FG000|COMPLETED|Overall Study||30
8976828|NCT02669329|10041700|FG000|NOT COMPLETED|Overall Study||0
8976829|NCT02669407|10041704|FG000|STARTED|Overall Study||14
8976830|NCT02669407|10041704|FG000|COMPLETED|Overall Study||11
8976831|NCT02669407|10041704|FG000|NOT COMPLETED|Overall Study||3
8976832|NCT02669433|10041711|FG000|STARTED|Overall Study||91
8976833|NCT02669433|10041712|FG001|STARTED|Overall Study||89
8976834|NCT02669433|10041713|FG002|STARTED|Overall Study||89
8976835|NCT02669433|10041711|FG000|Safety Population|Overall Study||91
8976836|NCT02669433|10041712|FG001|Safety Population|Overall Study||89
8976837|NCT02669433|10041713|FG002|Safety Population|Overall Study||88
8976838|NCT02669433|10041711|FG000|Intent to Treat (ITT) Population|Overall Study||89
8976839|NCT02669433|10041712|FG001|Intent to Treat (ITT) Population|Overall Study||89
8976840|NCT02669433|10041713|FG002|Intent to Treat (ITT) Population|Overall Study||87
8976841|NCT02669433|10041711|FG000|Per-Protocol Population|Overall Study||78
8976842|NCT02669433|10041712|FG001|Per-Protocol Population|Overall Study||79
8976843|NCT02669433|10041713|FG002|Per-Protocol Population|Overall Study||82
8976844|NCT02669433|10041711|FG000|Completers Population|Overall Study||73
8976845|NCT02669433|10041712|FG001|Completers Population|Overall Study||72
8976846|NCT02669433|10041713|FG002|Completers Population|Overall Study||69
8976847|NCT02669433|10041711|FG000|UPDRS Primary Population|Overall Study||87
8976848|NCT02669433|10041712|FG001|UPDRS Primary Population|Overall Study||87
8976849|NCT02669433|10041713|FG002|UPDRS Primary Population|Overall Study||84
8976850|NCT02669433|10041711|FG000|COMPLETED|Overall Study||76
8976851|NCT02669433|10041712|FG001|COMPLETED|Overall Study||75
8976852|NCT02669433|10041713|FG002|COMPLETED|Overall Study||74
8976853|NCT02669433|10041711|FG000|NOT COMPLETED|Overall Study||15
8976854|NCT02669433|10041712|FG001|NOT COMPLETED|Overall Study||14
8976855|NCT02669433|10041713|FG002|NOT COMPLETED|Overall Study||15
8976856|NCT02669615|10041721|FG000|STARTED|Overall Study||24
8976857|NCT02669615|10041721|FG000|COMPLETED|Overall Study||24
8976858|NCT02669615|10041721|FG000|NOT COMPLETED|Overall Study||0
8976859|NCT02669667|10041732|FG000|STARTED|Overall Study||12
8976860|NCT02669667|10041733|FG001|STARTED|Overall Study||4
8976861|NCT02669667|10041734|FG002|STARTED|Overall Study||4
8976862|NCT02669667|10041735|FG003|STARTED|Overall Study||6
8976863|NCT02669667|10041736|FG004|STARTED|Overall Study||6
8976864|NCT02669667|10041737|FG005|STARTED|Overall Study||6
8976865|NCT02669667|10041738|FG006|STARTED|Overall Study||6
8976866|NCT02669667|10041732|FG000|COMPLETED|Overall Study||12
8976867|NCT02669667|10041733|FG001|COMPLETED|Overall Study||4
8976868|NCT02669667|10041734|FG002|COMPLETED|Overall Study||4
8976869|NCT02669667|10041735|FG003|COMPLETED|Overall Study||6
8976870|NCT02669667|10041736|FG004|COMPLETED|Overall Study||6
8976871|NCT02669667|10041737|FG005|COMPLETED|Overall Study||5
8976872|NCT02669667|10041738|FG006|COMPLETED|Overall Study||6
8976873|NCT02669667|10041732|FG000|NOT COMPLETED|Overall Study||0
8976874|NCT02669667|10041733|FG001|NOT COMPLETED|Overall Study||0
8976875|NCT02669667|10041734|FG002|NOT COMPLETED|Overall Study||0
8976876|NCT02669667|10041735|FG003|NOT COMPLETED|Overall Study||0
8976877|NCT02669667|10041736|FG004|NOT COMPLETED|Overall Study||0
8976878|NCT02669667|10041737|FG005|NOT COMPLETED|Overall Study||1
8976879|NCT02669667|10041738|FG006|NOT COMPLETED|Overall Study||0
8976880|NCT02669758|10041760|FG000|STARTED|Overall Study||277
8976881|NCT02669758|10041760|FG000|COMPLETED|Overall Study||183
8976882|NCT02669758|10041760|FG000|NOT COMPLETED|Overall Study||94
8976883|NCT02669784|10041766|FG000|STARTED|Overall Study||18
8976884|NCT02669784|10041767|FG001|STARTED|Overall Study||16
8976885|NCT02669784|10041766|FG000|COMPLETED|Overall Study||18
8976886|NCT02669784|10041767|FG001|COMPLETED|Overall Study||16
8976887|NCT02669784|10041766|FG000|NOT COMPLETED|Overall Study||0
8976888|NCT02669784|10041767|FG001|NOT COMPLETED|Overall Study||0
8976889|NCT02669849|10041776|FG000|STARTED|Overall Study||29
8976890|NCT02669849|10041777|FG001|STARTED|Overall Study||6
8976891|NCT02669849|10041778|FG002|STARTED|Overall Study||32
8976892|NCT02669849|10041776|FG000|COMPLETED|Overall Study||11
8976893|NCT02669849|10041777|FG001|COMPLETED|Overall Study||4
8976894|NCT02669849|10041778|FG002|COMPLETED|Overall Study||8
8976895|NCT02669849|10041776|FG000|NOT COMPLETED|Overall Study||18
8976896|NCT02669849|10041777|FG001|NOT COMPLETED|Overall Study||2
8976897|NCT02669849|10041778|FG002|NOT COMPLETED|Overall Study||24
8976898|NCT02669862|10041789|FG000|STARTED|Overall Study||33
8976899|NCT02669862|10041790|FG001|STARTED|Overall Study||34
8976900|NCT02669862|10041791|FG002|STARTED|Overall Study||31
8976901|NCT02669862|10041789|FG000|COMPLETED|Overall Study||31
8976902|NCT02669862|10041790|FG001|COMPLETED|Overall Study||29
8976903|NCT02669862|10041791|FG002|COMPLETED|Overall Study||26
8976904|NCT02669862|10041789|FG000|NOT COMPLETED|Overall Study||2
8976905|NCT02669862|10041790|FG001|NOT COMPLETED|Overall Study||5
8976906|NCT02669862|10041791|FG002|NOT COMPLETED|Overall Study||5
8976907|NCT02669914|10041805|FG000|STARTED|Overall Study||4
8976908|NCT02669914|10041806|FG001|STARTED|Overall Study||0
8976909|NCT02669914|10041807|FG002|STARTED|Overall Study||0
8976910|NCT02669914|10041805|FG000|COMPLETED|Overall Study||4
8976911|NCT02669914|10041806|FG001|COMPLETED|Overall Study||0
8976912|NCT02669914|10041807|FG002|COMPLETED|Overall Study||0
8976913|NCT02669914|10041805|FG000|NOT COMPLETED|Overall Study||0
8976914|NCT02669914|10041806|FG001|NOT COMPLETED|Overall Study||0
8976915|NCT02669914|10041807|FG002|NOT COMPLETED|Overall Study||0
8976916|NCT02669940|10041817|FG000|STARTED|Overall Study||63
8976917|NCT02669940|10041818|FG001|STARTED|Overall Study||95
8976918|NCT02669940|10041817|FG000|COMPLETED|Overall Study||62
8976919|NCT02669940|10041818|FG001|COMPLETED|Overall Study||92
8976920|NCT02669940|10041817|FG000|NOT COMPLETED|Overall Study||1
8976921|NCT02669940|10041818|FG001|NOT COMPLETED|Overall Study||3
8976922|NCT02670083|10041833|FG000|STARTED|Overall Study||409
8976923|NCT02670083|10041834|FG001|STARTED|Overall Study||404
8976924|NCT02670083|10041833|FG000|COMPLETED|Overall Study||88
8976925|NCT02670083|10041834|FG001|COMPLETED|Overall Study||85
8976926|NCT02670083|10041833|FG000|NOT COMPLETED|Overall Study||321
8976927|NCT02670083|10041834|FG001|NOT COMPLETED|Overall Study||319
8976928|NCT02670122|10041841|FG000|STARTED|Overall Study||131
8976929|NCT02670122|10041841|FG000|COMPLETED|Overall Study|18 patients recieved liver transplantation|127
8976930|NCT02670122|10041841|FG000|NOT COMPLETED|Overall Study||4
8976931|NCT02670330|10041854|FG000|STARTED|Overall Study||75
8976932|NCT02670330|10041855|FG001|STARTED|Overall Study||77
8976933|NCT02670330|10041854|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||75
8571135|NCT00107991|9603363|FG000|STARTED|Eligibility Assessment||38
8571136|NCT00107991|9603363|FG000|COMPLETED|Eligibility Assessment||15
8632302|NCT00544882|9672196|FG000|NOT COMPLETED|Cycle 2: Randomized Treatment Cycle||0
8632303|NCT00544882|9672197|FG001|NOT COMPLETED|Cycle 2: Randomized Treatment Cycle||1
8632304|NCT00544882|9672198|FG002|NOT COMPLETED|Cycle 2: Randomized Treatment Cycle||1
8632305|NCT00544882|9672196|FG000|STARTED|Cycle 3: Follow-up||0
8571137|NCT00107991|9603363|FG000|NOT COMPLETED|Eligibility Assessment||23
8571138|NCT00107991|9603363|FG000|STARTED|12 Week Treatment Period||15
8571139|NCT00107991|9603363|FG000|COMPLETED|12 Week Treatment Period||10
8571140|NCT00107991|9603363|FG000|NOT COMPLETED|12 Week Treatment Period||5
8571141|NCT00107991|9603363|FG000|STARTED|18-Week Post Treatment Assessment||10
8571142|NCT00107991|9603363|FG000|COMPLETED|18-Week Post Treatment Assessment||8
8571143|NCT00107991|9603363|FG000|NOT COMPLETED|18-Week Post Treatment Assessment||2
8571144|NCT00108069|9603369|FG000|STARTED|Overall Study||30
8571145|NCT00108069|9603370|FG001|STARTED|Overall Study||13
8571146|NCT00108069|9603369|FG000|COMPLETED|Overall Study||0
8571147|NCT00108069|9603370|FG001|COMPLETED|Overall Study||0
8632306|NCT00544882|9672197|FG001|STARTED|Cycle 3: Follow-up||28
8632307|NCT00544882|9672198|FG002|STARTED|Cycle 3: Follow-up||28
8632308|NCT00544882|9672196|FG000|COMPLETED|Cycle 3: Follow-up||0
8976934|NCT02670330|10041855|FG001|Received At Least 1 Dose Of Study Drug|Overall Study||77
8976935|NCT02670330|10041854|FG000|COMPLETED|Overall Study||0
8976936|NCT02670330|10041855|FG001|COMPLETED|Overall Study||0
8976937|NCT02670330|10041854|FG000|NOT COMPLETED|Overall Study||75
8976938|NCT02670330|10041855|FG001|NOT COMPLETED|Overall Study||77
8976939|NCT02670343|10041861|FG000|STARTED|Overall Study||8
8976940|NCT02670343|10041861|FG000|COMPLETED|Overall Study||8
8976941|NCT02670343|10041861|FG000|NOT COMPLETED|Overall Study||0
8976942|NCT02670382|10041865|FG000|STARTED|Placebo lead-in Phase||12
8976943|NCT02670382|10041866|FG001|STARTED|Placebo lead-in Phase||12
8976944|NCT02670382|10041865|FG000|COMPLETED|Placebo lead-in Phase|Two enrolled subjects randomized to receive EPA as the first intervention decided to stop participation during the placebo lead-in phase. Therefore, only 10 subjects continued to the EPA and then DHA supplementation phases. No data were collected from these two subjects.|10
8725824|NCT01033487|9773161|FG004|NOT COMPLETED|First Intervention Period||0
8976945|NCT02670382|10041866|FG001|COMPLETED|Placebo lead-in Phase|One enrolled subjects randomized to receive EDHA as the first intervention decided to stop participation during the placebo lead-in phase. Therefore, only 11 subjects continued to the DHA and then EPA supplementation phases. No data were collected from this subject.|11
8976946|NCT02670382|10041865|FG000|NOT COMPLETED|Placebo lead-in Phase||2
8976947|NCT02670382|10041866|FG001|NOT COMPLETED|Placebo lead-in Phase||1
8976948|NCT02670382|10041865|FG000|STARTED|First Active Intervention|Only 10 of the 12 enrolled subjects randomized to receive EPA as the first supplementation completed the lead-in placebo phase and then entered the EPA supplementation phase.|10
8976949|NCT02670382|10041866|FG001|STARTED|First Active Intervention|Only 11 of the 12 enrolled subjects randomized to receive DHA as the first supplementation completed the lead-in placebo phase and then entered the EDHA supplementation phase.|11
8976950|NCT02670382|10041865|FG000|COMPLETED|First Active Intervention||10
8976951|NCT02670382|10041866|FG001|COMPLETED|First Active Intervention||11
8976952|NCT02670382|10041865|FG000|NOT COMPLETED|First Active Intervention||0
8976953|NCT02670382|10041866|FG001|NOT COMPLETED|First Active Intervention||0
8976954|NCT02670382|10041865|FG000|STARTED|Second Active Intervention||10
8976955|NCT02670382|10041866|FG001|STARTED|Second Active Intervention||11
8976956|NCT02670382|10041865|FG000|COMPLETED|Second Active Intervention||10
8976957|NCT02670382|10041866|FG001|COMPLETED|Second Active Intervention||11
8976958|NCT02670382|10041865|FG000|NOT COMPLETED|Second Active Intervention||0
8976959|NCT02670382|10041866|FG001|NOT COMPLETED|Second Active Intervention||0
8976960|NCT02670473|10041874|FG000|STARTED|Overall Study||35
8976961|NCT02670473|10041874|FG000|COMPLETED|Overall Study||34
8976962|NCT02670473|10041874|FG000|NOT COMPLETED|Overall Study||1
8976963|NCT02670538|10041890|FG000|STARTED|Overall Study||167
8976964|NCT02670538|10041891|FG001|STARTED|Overall Study||168
8976965|NCT02670538|10041892|FG002|STARTED|Overall Study||158
8976966|NCT02670538|10041890|FG000|Safety Population : Received Study Drug|Overall Study||165
8976967|NCT02670538|10041891|FG001|Safety Population : Received Study Drug|Overall Study||167
8976968|NCT02670538|10041892|FG002|Safety Population : Received Study Drug|Overall Study||158
8976969|NCT02670538|10041890|FG000|Intent-to-Treat Population|Overall Study||163
8976970|NCT02670538|10041891|FG001|Intent-to-Treat Population|Overall Study||162
8976971|NCT02670538|10041892|FG002|Intent-to-Treat Population|Overall Study||153
8976972|NCT02670538|10041890|FG000|COMPLETED|Overall Study||135
8976973|NCT02670538|10041891|FG001|COMPLETED|Overall Study||136
8976974|NCT02670538|10041892|FG002|COMPLETED|Overall Study||128
8976975|NCT02670538|10041890|FG000|NOT COMPLETED|Overall Study||32
8976976|NCT02670538|10041891|FG001|NOT COMPLETED|Overall Study||32
8976977|NCT02670538|10041892|FG002|NOT COMPLETED|Overall Study||30
8976978|NCT02670551|10041903|FG000|STARTED|Overall Study||163
8976979|NCT02670551|10041904|FG001|STARTED|Overall Study||160
8976980|NCT02670551|10041905|FG002|STARTED|Overall Study||165
8976981|NCT02670551|10041903|FG000|Received Treatment (Safety Population)|Overall Study||158
8976982|NCT02670551|10041904|FG001|Received Treatment (Safety Population)|Overall Study||157
8976983|NCT02670551|10041905|FG002|Received Treatment (Safety Population)|Overall Study||165
8976984|NCT02670551|10041903|FG000|COMPLETED|Overall Study||135
8976985|NCT02670551|10041904|FG001|COMPLETED|Overall Study||134
8976986|NCT02670551|10041905|FG002|COMPLETED|Overall Study||134
8976987|NCT02670551|10041903|FG000|NOT COMPLETED|Overall Study||28
8976988|NCT02670551|10041904|FG001|NOT COMPLETED|Overall Study||26
8976989|NCT02670551|10041905|FG002|NOT COMPLETED|Overall Study||31
8976990|NCT02670629|10041915|FG000|STARTED|Overall Study||29
8976991|NCT02670629|10041916|FG001|STARTED|Overall Study||29
8976992|NCT02670629|10041915|FG000|COMPLETED|Overall Study||29
8976993|NCT02670629|10041916|FG001|COMPLETED|Overall Study||29
8976994|NCT02670629|10041915|FG000|NOT COMPLETED|Overall Study||0
8976995|NCT02670629|10041916|FG001|NOT COMPLETED|Overall Study||0
8976996|NCT02670811|10041924|FG000|STARTED|Overall Study||18
8976997|NCT02670811|10041925|FG001|STARTED|Overall Study||18
8976998|NCT02670811|10041924|FG000|COMPLETED|Overall Study||17
8976999|NCT02670811|10041925|FG001|COMPLETED|Overall Study||18
8977000|NCT02670811|10041924|FG000|NOT COMPLETED|Overall Study||1
8977001|NCT02670811|10041925|FG001|NOT COMPLETED|Overall Study||0
8977002|NCT02670915|10041934|FG000|STARTED|Overall Study||260
8977003|NCT02670915|10041935|FG001|STARTED|Overall Study||259
8977004|NCT02670915|10041936|FG002|STARTED|Overall Study||258
8977005|NCT02670915|10041934|FG000|COMPLETED|Overall Study||256
8977006|NCT02670915|10041935|FG001|COMPLETED|Overall Study||251
8977007|NCT02670915|10041936|FG002|COMPLETED|Overall Study||253
8977008|NCT02670915|10041934|FG000|NOT COMPLETED|Overall Study||4
8977009|NCT02670915|10041935|FG001|NOT COMPLETED|Overall Study||8
8977010|NCT02670915|10041936|FG002|NOT COMPLETED|Overall Study||5
8977011|NCT02670928|10041946|FG000|STARTED|Overall Study||100
8977012|NCT02670928|10041947|FG001|STARTED|Overall Study||30
8977013|NCT02670928|10041946|FG000|COMPLETED|Overall Study||90
8977014|NCT02670928|10041947|FG001|COMPLETED|Overall Study||29
8977015|NCT02670928|10041946|FG000|NOT COMPLETED|Overall Study||10
8977016|NCT02670928|10041947|FG001|NOT COMPLETED|Overall Study||1
8977017|NCT02671032|10041953|FG000|STARTED|Overall Study||12
8977018|NCT02671032|10041953|FG000|COMPLETED|Overall Study||12
8977019|NCT02671032|10041953|FG000|NOT COMPLETED|Overall Study||0
8977020|NCT02671266|10041959|FG000|STARTED|Overall Study||20
8977021|NCT02671266|10041960|FG001|STARTED|Overall Study||21
8977022|NCT02671266|10041959|FG000|BDD Participants|Overall Study||9
8977023|NCT02671266|10041960|FG001|BDD Participants|Overall Study||9
8977024|NCT02671266|10041959|FG000|OCD Participants|Overall Study||2
8977025|NCT02671266|10041960|FG001|OCD Participants|Overall Study||3
8977026|NCT02671266|10041959|FG000|Healthy Participants|Overall Study||8
8977027|NCT02671266|10041960|FG001|Healthy Participants|Overall Study||8
8977028|NCT02671266|10041959|FG000|COMPLETED|Overall Study||19
8977029|NCT02671266|10041960|FG001|COMPLETED|Overall Study||20
8977030|NCT02671266|10041959|FG000|NOT COMPLETED|Overall Study||1
8977031|NCT02671266|10041960|FG001|NOT COMPLETED|Overall Study||1
8977032|NCT02671422|10041966|FG000|STARTED|Overall Study||260
8977033|NCT02671422|10041966|FG000|Not Treated With Vargatef®|Overall Study||3
8977034|NCT02671422|10041966|FG000|COMPLETED|Overall Study||0
8977035|NCT02671422|10041966|FG000|NOT COMPLETED|Overall Study||260
8977036|NCT02671500|10041970|FG000|STARTED|Overall Study||375
8977037|NCT02671500|10041970|FG000|COMPLETED|Overall Study||361
8977038|NCT02671500|10041970|FG000|NOT COMPLETED|Overall Study||14
8977039|NCT02671760|10041978|FG000|STARTED|Overall Study||13
8977040|NCT02671760|10041979|FG001|STARTED|Overall Study||13
8977041|NCT02671760|10041980|FG002|STARTED|Overall Study||13
8977042|NCT02671760|10041978|FG000|COMPLETED|Overall Study||13
8977043|NCT02671760|10041979|FG001|COMPLETED|Overall Study|1 Subject could not be contacted for f/u phone call. Data included in safety and efficacy analyses.|12
8977044|NCT02671760|10041980|FG002|COMPLETED|Overall Study||13
8977045|NCT02671760|10041978|FG000|NOT COMPLETED|Overall Study||0
8977046|NCT02671760|10041979|FG001|NOT COMPLETED|Overall Study||1
8632309|NCT00544882|9672197|FG001|COMPLETED|Cycle 3: Follow-up|Completed 21 days of Cycle 3|26
8632310|NCT00544882|9672198|FG002|COMPLETED|Cycle 3: Follow-up|Completed 21 days of Cycle 3|28
8977047|NCT02671760|10041980|FG002|NOT COMPLETED|Overall Study||0
8977048|NCT02672111|10041990|FG000|STARTED|Overall Study||190
8977049|NCT02672111|10041991|FG001|STARTED|Overall Study||37
8977050|NCT02672111|10041990|FG000|Completed Treatment|Overall Study||138
8977051|NCT02672111|10041991|FG001|Completed Treatment|Overall Study||29
8977052|NCT02672111|10041990|FG000|COMPLETED|Overall Study||132
8977053|NCT02672111|10041991|FG001|COMPLETED|Overall Study||25
8977054|NCT02672111|10041990|FG000|NOT COMPLETED|Overall Study||58
8977055|NCT02672111|10041991|FG001|NOT COMPLETED|Overall Study||12
8977056|NCT02672176|10042000|FG000|STARTED|Overall Study||161
8977057|NCT02672176|10042001|FG001|STARTED|Overall Study||158
8977058|NCT02672176|10042000|FG000|COMPLETED|Overall Study||155
8977059|NCT02672176|10042001|FG001|COMPLETED|Overall Study||132
8977060|NCT02672176|10042000|FG000|NOT COMPLETED|Overall Study||6
8977061|NCT02672176|10042001|FG001|NOT COMPLETED|Overall Study||26
8977062|NCT02672423|10042013|FG000|STARTED|Period 1||7
8977063|NCT02672423|10042014|FG001|STARTED|Period 1||7
8977064|NCT02672423|10042015|FG002|STARTED|Period 1||14
8977065|NCT02672423|10042016|FG003|STARTED|Period 1||15
8977066|NCT02672423|10042017|FG004|STARTED|Period 1||15
8977067|NCT02672423|10042018|FG005|STARTED|Period 1||15
8977068|NCT02672423|10042019|FG006|STARTED|Period 1||15
8977069|NCT02672423|10042020|FG007|STARTED|Period 1||15
8977070|NCT02672423|10042021|FG008|STARTED|Period 1||12
8977071|NCT02672423|10042022|FG009|STARTED|Period 1||12
8977072|NCT02672423|10042013|FG000|Received at Least One Dose of Study Drug|Period 1||7
8977073|NCT02672423|10042014|FG001|Received at Least One Dose of Study Drug|Period 1||7
8977074|NCT02672423|10042015|FG002|Received at Least One Dose of Study Drug|Period 1||14
8977075|NCT02672423|10042016|FG003|Received at Least One Dose of Study Drug|Period 1||15
8977076|NCT02672423|10042017|FG004|Received at Least One Dose of Study Drug|Period 1||15
8977077|NCT02672423|10042018|FG005|Received at Least One Dose of Study Drug|Period 1||15
8977078|NCT02672423|10042019|FG006|Received at Least One Dose of Study Drug|Period 1||15
8977079|NCT02672423|10042020|FG007|Received at Least One Dose of Study Drug|Period 1||15
8977080|NCT02672423|10042021|FG008|Received at Least One Dose of Study Drug|Period 1||12
8977081|NCT02672423|10042022|FG009|Received at Least One Dose of Study Drug|Period 1||12
8977082|NCT02672423|10042013|FG000|COMPLETED|Period 1||7
8977083|NCT02672423|10042014|FG001|COMPLETED|Period 1||7
8977084|NCT02672423|10042015|FG002|COMPLETED|Period 1||14
8977085|NCT02672423|10042016|FG003|COMPLETED|Period 1||15
8977086|NCT02672423|10042017|FG004|COMPLETED|Period 1||14
8977087|NCT02672423|10042018|FG005|COMPLETED|Period 1||15
8977088|NCT02672423|10042019|FG006|COMPLETED|Period 1||15
8977089|NCT02672423|10042020|FG007|COMPLETED|Period 1||15
8977090|NCT02672423|10042021|FG008|COMPLETED|Period 1||12
8977091|NCT02672423|10042022|FG009|COMPLETED|Period 1||12
8977092|NCT02672423|10042013|FG000|NOT COMPLETED|Period 1||0
8977093|NCT02672423|10042014|FG001|NOT COMPLETED|Period 1||0
8977094|NCT02672423|10042015|FG002|NOT COMPLETED|Period 1||0
8977095|NCT02672423|10042016|FG003|NOT COMPLETED|Period 1||0
8977096|NCT02672423|10042017|FG004|NOT COMPLETED|Period 1||1
8977097|NCT02672423|10042018|FG005|NOT COMPLETED|Period 1||0
8977098|NCT02672423|10042019|FG006|NOT COMPLETED|Period 1||0
8977099|NCT02672423|10042020|FG007|NOT COMPLETED|Period 1||0
8977100|NCT02672423|10042021|FG008|NOT COMPLETED|Period 1||0
8977101|NCT02672423|10042022|FG009|NOT COMPLETED|Period 1||0
8632311|NCT00544882|9672196|FG000|NOT COMPLETED|Cycle 3: Follow-up||0
8977102|NCT02672423|10042013|FG000|STARTED|Washout 1||7
8977103|NCT02672423|10042014|FG001|STARTED|Washout 1||7
8977104|NCT02672423|10042015|FG002|STARTED|Washout 1||14
8977105|NCT02672423|10042016|FG003|STARTED|Washout 1||15
8977106|NCT02672423|10042017|FG004|STARTED|Washout 1||14
8977107|NCT02672423|10042018|FG005|STARTED|Washout 1||15
8977108|NCT02672423|10042019|FG006|STARTED|Washout 1||15
8977109|NCT02672423|10042020|FG007|STARTED|Washout 1||15
8977110|NCT02672423|10042021|FG008|STARTED|Washout 1||12
8977111|NCT02672423|10042022|FG009|STARTED|Washout 1||12
8977112|NCT02672423|10042013|FG000|COMPLETED|Washout 1||7
8977113|NCT02672423|10042014|FG001|COMPLETED|Washout 1||7
8977114|NCT02672423|10042015|FG002|COMPLETED|Washout 1||14
8977115|NCT02672423|10042016|FG003|COMPLETED|Washout 1||15
8977116|NCT02672423|10042017|FG004|COMPLETED|Washout 1||14
8977117|NCT02672423|10042018|FG005|COMPLETED|Washout 1||15
8977118|NCT02672423|10042019|FG006|COMPLETED|Washout 1||15
8977119|NCT02672423|10042020|FG007|COMPLETED|Washout 1||15
8977120|NCT02672423|10042021|FG008|COMPLETED|Washout 1||12
8977121|NCT02672423|10042022|FG009|COMPLETED|Washout 1||12
8632312|NCT00544882|9672197|FG001|NOT COMPLETED|Cycle 3: Follow-up||2
8632313|NCT00544882|9672198|FG002|NOT COMPLETED|Cycle 3: Follow-up||0
8632314|NCT00544908|9672204|FG000|STARTED|Overall Study||7
8632315|NCT00544908|9672204|FG000|COMPLETED|Overall Study||7
8632316|NCT00544908|9672204|FG000|NOT COMPLETED|Overall Study||0
8632317|NCT00545025|9672210|FG000|STARTED|Overall Study||160
8632318|NCT00545025|9672211|FG001|STARTED|Overall Study||83
8632319|NCT00545025|9672210|FG000|COMPLETED|Overall Study||160
8632320|NCT00545025|9672211|FG001|COMPLETED|Overall Study||83
8632321|NCT00545025|9672210|FG000|NOT COMPLETED|Overall Study||0
8632322|NCT00545025|9672211|FG001|NOT COMPLETED|Overall Study||0
8632323|NCT00545051|9672219|FG000|STARTED|Overall Study||68
8632324|NCT00545051|9672220|FG001|STARTED|Overall Study||72
8632325|NCT00545051|9672219|FG000|COMPLETED|Overall Study||59
8632326|NCT00545051|9672220|FG001|COMPLETED|Overall Study||65
8632327|NCT00545051|9672219|FG000|NOT COMPLETED|Overall Study||9
8632328|NCT00545051|9672220|FG001|NOT COMPLETED|Overall Study||7
8632329|NCT00545064|9672226|FG000|STARTED|Overall Study||178
8632330|NCT00545064|9672226|FG000|Visit 1 (Baseline)|Overall Study||178
8632331|NCT00545064|9672226|FG000|Visit 2 (Week 4)|Overall Study||169
8977122|NCT02672423|10042013|FG000|NOT COMPLETED|Washout 1||0
8977123|NCT02672423|10042014|FG001|NOT COMPLETED|Washout 1||0
8977124|NCT02672423|10042015|FG002|NOT COMPLETED|Washout 1||0
8977125|NCT02672423|10042016|FG003|NOT COMPLETED|Washout 1||0
8977126|NCT02672423|10042017|FG004|NOT COMPLETED|Washout 1||0
8977127|NCT02672423|10042018|FG005|NOT COMPLETED|Washout 1||0
8977128|NCT02672423|10042019|FG006|NOT COMPLETED|Washout 1||0
8977129|NCT02672423|10042020|FG007|NOT COMPLETED|Washout 1||0
8977130|NCT02672423|10042021|FG008|NOT COMPLETED|Washout 1||0
8977131|NCT02672423|10042022|FG009|NOT COMPLETED|Washout 1||0
8977132|NCT02672423|10042013|FG000|STARTED|Period 2||7
8977133|NCT02672423|10042014|FG001|STARTED|Period 2||7
8977134|NCT02672423|10042015|FG002|STARTED|Period 2||14
8977135|NCT02672423|10042016|FG003|STARTED|Period 2||15
8977136|NCT02672423|10042017|FG004|STARTED|Period 2||14
8977137|NCT02672423|10042018|FG005|STARTED|Period 2||15
8977138|NCT02672423|10042019|FG006|STARTED|Period 2||15
8977139|NCT02672423|10042020|FG007|STARTED|Period 2||15
8977140|NCT02672423|10042021|FG008|STARTED|Period 2||12
8977141|NCT02672423|10042022|FG009|STARTED|Period 2||12
8977142|NCT02672423|10042013|FG000|COMPLETED|Period 2||7
8977143|NCT02672423|10042014|FG001|COMPLETED|Period 2||7
8977144|NCT02672423|10042015|FG002|COMPLETED|Period 2||13
8977145|NCT02672423|10042016|FG003|COMPLETED|Period 2||15
8977146|NCT02672423|10042017|FG004|COMPLETED|Period 2||14
8977147|NCT02672423|10042018|FG005|COMPLETED|Period 2||15
8977148|NCT02672423|10042019|FG006|COMPLETED|Period 2||15
8977149|NCT02672423|10042020|FG007|COMPLETED|Period 2||15
8977150|NCT02672423|10042021|FG008|COMPLETED|Period 2||12
8977151|NCT02672423|10042022|FG009|COMPLETED|Period 2||12
8977152|NCT02672423|10042013|FG000|NOT COMPLETED|Period 2||0
8977153|NCT02672423|10042014|FG001|NOT COMPLETED|Period 2||0
8977154|NCT02672423|10042015|FG002|NOT COMPLETED|Period 2||1
8977155|NCT02672423|10042016|FG003|NOT COMPLETED|Period 2||0
8977156|NCT02672423|10042017|FG004|NOT COMPLETED|Period 2||0
8977157|NCT02672423|10042018|FG005|NOT COMPLETED|Period 2||0
8977158|NCT02672423|10042019|FG006|NOT COMPLETED|Period 2||0
8977159|NCT02672423|10042020|FG007|NOT COMPLETED|Period 2||0
8977160|NCT02672423|10042021|FG008|NOT COMPLETED|Period 2||0
8977161|NCT02672423|10042022|FG009|NOT COMPLETED|Period 2||0
8977162|NCT02672423|10042013|FG000|STARTED|Washout 2||7
8977163|NCT02672423|10042014|FG001|STARTED|Washout 2||7
8977164|NCT02672423|10042015|FG002|STARTED|Washout 2||13
8977165|NCT02672423|10042016|FG003|STARTED|Washout 2||15
8977166|NCT02672423|10042017|FG004|STARTED|Washout 2||14
8977167|NCT02672423|10042018|FG005|STARTED|Washout 2||15
8977168|NCT02672423|10042019|FG006|STARTED|Washout 2||15
8977169|NCT02672423|10042020|FG007|STARTED|Washout 2||15
8977170|NCT02672423|10042021|FG008|STARTED|Washout 2||12
8977171|NCT02672423|10042022|FG009|STARTED|Washout 2||12
8977172|NCT02672423|10042013|FG000|COMPLETED|Washout 2||7
8977173|NCT02672423|10042014|FG001|COMPLETED|Washout 2||7
8977174|NCT02672423|10042015|FG002|COMPLETED|Washout 2||13
8977175|NCT02672423|10042016|FG003|COMPLETED|Washout 2||15
8977176|NCT02672423|10042017|FG004|COMPLETED|Washout 2||14
8977177|NCT02672423|10042018|FG005|COMPLETED|Washout 2||15
8977178|NCT02672423|10042019|FG006|COMPLETED|Washout 2||15
8977179|NCT02672423|10042020|FG007|COMPLETED|Washout 2||15
8977180|NCT02672423|10042021|FG008|COMPLETED|Washout 2||12
8977181|NCT02672423|10042022|FG009|COMPLETED|Washout 2||12
8977182|NCT02672423|10042013|FG000|NOT COMPLETED|Washout 2||0
8977183|NCT02672423|10042014|FG001|NOT COMPLETED|Washout 2||0
8977184|NCT02672423|10042015|FG002|NOT COMPLETED|Washout 2||0
8977185|NCT02672423|10042016|FG003|NOT COMPLETED|Washout 2||0
8977186|NCT02672423|10042017|FG004|NOT COMPLETED|Washout 2||0
8977187|NCT02672423|10042018|FG005|NOT COMPLETED|Washout 2||0
8977188|NCT02672423|10042019|FG006|NOT COMPLETED|Washout 2||0
8977189|NCT02672423|10042020|FG007|NOT COMPLETED|Washout 2||0
8977190|NCT02672423|10042021|FG008|NOT COMPLETED|Washout 2||0
8977191|NCT02672423|10042022|FG009|NOT COMPLETED|Washout 2||0
8977192|NCT02672423|10042013|FG000|STARTED|Period 3|Part A was a 2-period study design.|0
8977193|NCT02672423|10042014|FG001|STARTED|Period 3|Part A was a 2-period study design.|0
8977194|NCT02672423|10042015|FG002|STARTED|Period 3||13
8977195|NCT02672423|10042016|FG003|STARTED|Period 3||15
8977196|NCT02672423|10042017|FG004|STARTED|Period 3||14
8977197|NCT02672423|10042018|FG005|STARTED|Period 3||15
8977198|NCT02672423|10042019|FG006|STARTED|Period 3||15
8977199|NCT02672423|10042020|FG007|STARTED|Period 3||15
8977200|NCT02672423|10042021|FG008|STARTED|Period 3|Part C was a 2-period study design.|0
8977201|NCT02672423|10042022|FG009|STARTED|Period 3|Part C was a 2-period study design.|0
8977202|NCT02672423|10042013|FG000|COMPLETED|Period 3||0
8977203|NCT02672423|10042014|FG001|COMPLETED|Period 3||0
8977204|NCT02672423|10042015|FG002|COMPLETED|Period 3||13
8977205|NCT02672423|10042016|FG003|COMPLETED|Period 3||15
8977206|NCT02672423|10042017|FG004|COMPLETED|Period 3||14
8977207|NCT02672423|10042018|FG005|COMPLETED|Period 3||14
8977208|NCT02672423|10042019|FG006|COMPLETED|Period 3||15
8977209|NCT02672423|10042020|FG007|COMPLETED|Period 3||14
8977210|NCT02672423|10042021|FG008|COMPLETED|Period 3||0
8977211|NCT02672423|10042022|FG009|COMPLETED|Period 3||0
8977212|NCT02672423|10042013|FG000|NOT COMPLETED|Period 3||0
8977213|NCT02672423|10042014|FG001|NOT COMPLETED|Period 3||0
8977214|NCT02672423|10042015|FG002|NOT COMPLETED|Period 3||0
8977215|NCT02672423|10042016|FG003|NOT COMPLETED|Period 3||0
8977216|NCT02672423|10042017|FG004|NOT COMPLETED|Period 3||0
8977217|NCT02672423|10042018|FG005|NOT COMPLETED|Period 3||1
8977218|NCT02672423|10042019|FG006|NOT COMPLETED|Period 3||0
8977219|NCT02672423|10042020|FG007|NOT COMPLETED|Period 3||1
8977220|NCT02672423|10042021|FG008|NOT COMPLETED|Period 3||0
8977221|NCT02672423|10042022|FG009|NOT COMPLETED|Period 3||0
8977222|NCT02672514|10042045|FG000|STARTED|Overall Study||53
8977223|NCT02672514|10042046|FG001|STARTED|Overall Study||51
8977224|NCT02672514|10042045|FG000|COMPLETED|Overall Study||53
8977225|NCT02672514|10042046|FG001|COMPLETED|Overall Study||51
8977226|NCT02672514|10042045|FG000|NOT COMPLETED|Overall Study||0
8977227|NCT02672514|10042046|FG001|NOT COMPLETED|Overall Study||0
8977228|NCT02672553|10042054|FG000|STARTED|Overall Study||51
8977229|NCT02672553|10042055|FG001|STARTED|Overall Study||49
8977230|NCT02672553|10042054|FG000|Intent To Treated (ITT) Randomized Arm|Overall Study|Two (2) subjects randomized to Edwards INTUITY were intraoperative screen failures|49
8977231|NCT02672553|10042055|FG001|Intent To Treated (ITT) Randomized Arm|Overall Study|One (1) subject randomized to Control arm/group withdrew prior to study procedure|48
8977232|NCT02672553|10042054|FG000|As Treated (AT) Randomized Arm/Group|Overall Study||46
8977233|NCT02672553|10042055|FG001|As Treated (AT) Randomized Arm/Group|Overall Study||51
8977234|NCT02672553|10042054|FG000|As Intended (AI) Randomized Arm/Group|Overall Study||46
8977235|NCT02672553|10042055|FG001|As Intended (AI) Randomized Arm/Group|Overall Study||48
8977236|NCT02672553|10042054|FG000|COMPLETED|Overall Study||39
8977237|NCT02672553|10042055|FG001|COMPLETED|Overall Study||41
8977238|NCT02672553|10042054|FG000|NOT COMPLETED|Overall Study||12
8977239|NCT02672553|10042055|FG001|NOT COMPLETED|Overall Study||8
8977240|NCT02672852|10042064|FG000|STARTED|Part A1||100
8977241|NCT02672852|10042065|FG001|STARTED|Part A1||407
8977242|NCT02672852|10042066|FG002|STARTED|Part A1||0
8977243|NCT02672852|10042067|FG003|STARTED|Part A1||0
8977244|NCT02672852|10042068|FG004|STARTED|Part A1||0
8977245|NCT02672852|10042069|FG005|STARTED|Part A1||0
8977246|NCT02672852|10042070|FG006|STARTED|Part A1||0
8977247|NCT02672852|10042064|FG000|COMPLETED|Part A1||97
8977248|NCT02672852|10042065|FG001|COMPLETED|Part A1||403
8977249|NCT02672852|10042066|FG002|COMPLETED|Part A1||0
8977250|NCT02672852|10042067|FG003|COMPLETED|Part A1||0
8977251|NCT02672852|10042068|FG004|COMPLETED|Part A1||0
8977252|NCT02672852|10042069|FG005|COMPLETED|Part A1||0
8977253|NCT02672852|10042070|FG006|COMPLETED|Part A1||0
8977254|NCT02672852|10042064|FG000|NOT COMPLETED|Part A1||3
8977255|NCT02672852|10042065|FG001|NOT COMPLETED|Part A1||4
8977256|NCT02672852|10042066|FG002|NOT COMPLETED|Part A1||0
8977257|NCT02672852|10042067|FG003|NOT COMPLETED|Part A1||0
8977258|NCT02672852|10042068|FG004|NOT COMPLETED|Part A1||0
8977259|NCT02672852|10042069|FG005|NOT COMPLETED|Part A1||0
8977260|NCT02672852|10042070|FG006|NOT COMPLETED|Part A1||0
8977261|NCT02672852|10042064|FG000|STARTED|Part A2|Participants that completed Part A1 continued on to Part A2.|0
8977262|NCT02672852|10042065|FG001|STARTED|Part A2|Participants that completed Part A1 continued on to Part A2.|0
8977263|NCT02672852|10042066|FG002|STARTED|Part A2|Participants that completed Part A1 continued on to Part A2.|93
8977264|NCT02672852|10042067|FG003|STARTED|Part A2|Participants that completed Part A1 continued on to Part A2.|403
8977265|NCT02672852|10042068|FG004|STARTED|Part A2||0
8977266|NCT02672852|10042069|FG005|STARTED|Part A2||0
8977267|NCT02672852|10042070|FG006|STARTED|Part A2||0
8977268|NCT02672852|10042064|FG000|COMPLETED|Part A2||0
8977269|NCT02672852|10042065|FG001|COMPLETED|Part A2||0
8977270|NCT02672852|10042066|FG002|COMPLETED|Part A2||83
8977271|NCT02672852|10042067|FG003|COMPLETED|Part A2||399
8977272|NCT02672852|10042068|FG004|COMPLETED|Part A2||0
8977273|NCT02672852|10042069|FG005|COMPLETED|Part A2||0
8977274|NCT02672852|10042070|FG006|COMPLETED|Part A2||0
8977275|NCT02672852|10042064|FG000|NOT COMPLETED|Part A2||0
8977276|NCT02672852|10042065|FG001|NOT COMPLETED|Part A2||0
8977277|NCT02672852|10042066|FG002|NOT COMPLETED|Part A2||10
8977278|NCT02672852|10042067|FG003|NOT COMPLETED|Part A2||4
8977279|NCT02672852|10042068|FG004|NOT COMPLETED|Part A2||0
8977280|NCT02672852|10042069|FG005|NOT COMPLETED|Part A2||0
8977281|NCT02672852|10042070|FG006|NOT COMPLETED|Part A2||0
8977282|NCT02672852|10042064|FG000|STARTED|Part B||0
8977283|NCT02672852|10042065|FG001|STARTED|Part B||0
8977284|NCT02672852|10042066|FG002|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|0
8977285|NCT02672852|10042067|FG003|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|0
8977286|NCT02672852|10042068|FG004|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|225
8977287|NCT02672852|10042069|FG005|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|111
8977288|NCT02672852|10042070|FG006|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|63
8977289|NCT02672852|10042064|FG000|COMPLETED|Part B||0
8977290|NCT02672852|10042065|FG001|COMPLETED|Part B||0
8977291|NCT02672852|10042066|FG002|COMPLETED|Part B||0
8977292|NCT02672852|10042067|FG003|COMPLETED|Part B||0
8977293|NCT02672852|10042068|FG004|COMPLETED|Part B||209
8977294|NCT02672852|10042069|FG005|COMPLETED|Part B||100
8977295|NCT02672852|10042070|FG006|COMPLETED|Part B||51
8977296|NCT02672852|10042064|FG000|NOT COMPLETED|Part B||0
8977297|NCT02672852|10042065|FG001|NOT COMPLETED|Part B||0
8977298|NCT02672852|10042066|FG002|NOT COMPLETED|Part B||0
8977299|NCT02672852|10042067|FG003|NOT COMPLETED|Part B||0
8977300|NCT02672852|10042068|FG004|NOT COMPLETED|Part B||16
8977301|NCT02672852|10042069|FG005|NOT COMPLETED|Part B||11
8977302|NCT02672852|10042070|FG006|NOT COMPLETED|Part B||12
8977303|NCT02673138|10042081|FG000|STARTED|Overall Study||10
8977304|NCT02673138|10042081|FG000|Started Day 1|Overall Study||10
8977305|NCT02673138|10042081|FG000|Ended Day 1|Overall Study||10
8977306|NCT02673138|10042081|FG000|Started Day 2|Overall Study||10
8977307|NCT02673138|10042081|FG000|Ended Day 2|Overall Study||10
8977308|NCT02673138|10042081|FG000|COMPLETED|Overall Study||10
8977309|NCT02673138|10042081|FG000|NOT COMPLETED|Overall Study||0
8977310|NCT02673372|10042089|FG000|STARTED|Overall Study||30
8977311|NCT02673372|10042090|FG001|STARTED|Overall Study||30
8977312|NCT02673372|10042089|FG000|COMPLETED|Overall Study||30
8977313|NCT02673372|10042090|FG001|COMPLETED|Overall Study||30
8977314|NCT02673372|10042089|FG000|NOT COMPLETED|Overall Study||0
8977315|NCT02673372|10042090|FG001|NOT COMPLETED|Overall Study||0
8977316|NCT02673489|10042098|FG000|STARTED|Treatment Period||54
8977317|NCT02673489|10042099|FG001|STARTED|Treatment Period||24
8977318|NCT02673489|10042098|FG000|COMPLETED|Treatment Period||49
8977319|NCT02673489|10042099|FG001|COMPLETED|Treatment Period||21
8977320|NCT02673489|10042098|FG000|NOT COMPLETED|Treatment Period||5
8977321|NCT02673489|10042099|FG001|NOT COMPLETED|Treatment Period||3
8977322|NCT02673489|10042098|FG000|STARTED|Follow Up Period||50
8977323|NCT02673489|10042099|FG001|STARTED|Follow Up Period||23
8977324|NCT02673489|10042098|FG000|COMPLETED|Follow Up Period||50
8977325|NCT02673489|10042099|FG001|COMPLETED|Follow Up Period||21
8977326|NCT02673489|10042098|FG000|NOT COMPLETED|Follow Up Period||0
8977327|NCT02673489|10042099|FG001|NOT COMPLETED|Follow Up Period||2
8977328|NCT02673515|10042108|FG000|STARTED|Overall Study||30
8977329|NCT02673515|10042109|FG001|STARTED|Overall Study||30
8977330|NCT02673515|10042108|FG000|COMPLETED|Overall Study||28
8977331|NCT02673515|10042109|FG001|COMPLETED|Overall Study||29
8977332|NCT02673515|10042108|FG000|NOT COMPLETED|Overall Study||2
8977333|NCT02673515|10042109|FG001|NOT COMPLETED|Overall Study||1
8977334|NCT02673541|10042117|FG000|STARTED|Overall Study||3
8977335|NCT02673541|10042118|FG001|STARTED|Overall Study||2
8977336|NCT02673541|10042117|FG000|COMPLETED|Overall Study||3
8977337|NCT02673541|10042118|FG001|COMPLETED|Overall Study||2
8977338|NCT02673541|10042117|FG000|NOT COMPLETED|Overall Study||0
8977339|NCT02673541|10042118|FG001|NOT COMPLETED|Overall Study||0
8977340|NCT02673619|10042128|FG000|STARTED|Overall Study||20
8977341|NCT02673619|10042129|FG001|STARTED|Overall Study||5
8977342|NCT02673619|10042130|FG002|STARTED|Overall Study||26
8977343|NCT02673619|10042131|FG003|STARTED|Overall Study||7
8977344|NCT02673619|10042128|FG000|COMPLETED|Overall Study||18
8977345|NCT02673619|10042129|FG001|COMPLETED|Overall Study||4
8977346|NCT02673619|10042130|FG002|COMPLETED|Overall Study||23
8977347|NCT02673619|10042131|FG003|COMPLETED|Overall Study||7
8977348|NCT02673619|10042128|FG000|NOT COMPLETED|Overall Study||2
8977349|NCT02673619|10042129|FG001|NOT COMPLETED|Overall Study||1
8571148|NCT00108069|9603369|FG000|NOT COMPLETED|Overall Study||30
8571149|NCT00108069|9603370|FG001|NOT COMPLETED|Overall Study||13
8571150|NCT00108082|9603385|FG000|STARTED|Overall Study||91
8571151|NCT00108082|9603386|FG001|STARTED|Overall Study||100
8571152|NCT00108082|9603387|FG002|STARTED|Overall Study||96
8977350|NCT02673619|10042130|FG002|NOT COMPLETED|Overall Study||3
8571153|NCT00108082|9603385|FG000|COMPLETED|Overall Study|Per protocol Amendment 4, participants who had completed Month 12 prior to amendment were withdrawn.|53
8977351|NCT02673619|10042131|FG003|NOT COMPLETED|Overall Study||0
8977352|NCT02673918|10042144|FG000|STARTED|Overall Study||35
8977353|NCT02673918|10042145|FG001|STARTED|Overall Study||24
8977354|NCT02673918|10042144|FG000|COMPLETED|Overall Study||29
8977355|NCT02673918|10042145|FG001|COMPLETED|Overall Study||20
8577923|NCT00165958|9610870|FG000|STARTED|Overall Study||19
8977356|NCT02673918|10042144|FG000|NOT COMPLETED|Overall Study||6
8977357|NCT02673918|10042145|FG001|NOT COMPLETED|Overall Study||4
8977358|NCT02673944|10042153|FG000|STARTED|Overall Study||10
8977359|NCT02673944|10042153|FG000|COMPLETED|Overall Study||10
8977360|NCT02673944|10042153|FG000|NOT COMPLETED|Overall Study||0
8977361|NCT02674334|10042160|FG000|STARTED|Overall Study||47
8977362|NCT02674334|10042161|FG001|STARTED|Overall Study||43
8977363|NCT02674334|10042160|FG000|COMPLETED|Overall Study||40
8977364|NCT02674334|10042161|FG001|COMPLETED|Overall Study||40
8977365|NCT02674334|10042160|FG000|NOT COMPLETED|Overall Study||7
8977366|NCT02674334|10042161|FG001|NOT COMPLETED|Overall Study||3
8977367|NCT02674386|10042170|FG000|STARTED|Overall Study||20
8977368|NCT02674386|10042171|FG001|STARTED|Overall Study||117
8977369|NCT02674386|10042172|FG002|STARTED|Overall Study||17
8977370|NCT02674386|10042170|FG000|Safety Analysis Set|Overall Study||20
8977371|NCT02674386|10042171|FG001|Safety Analysis Set|Overall Study||113
8977372|NCT02674386|10042172|FG002|Safety Analysis Set|Overall Study||17
8977373|NCT02674386|10042170|FG000|COMPLETED|Overall Study||20
8977374|NCT02674386|10042171|FG001|COMPLETED|Overall Study||107
8977375|NCT02674386|10042172|FG002|COMPLETED|Overall Study||16
8977376|NCT02674386|10042170|FG000|NOT COMPLETED|Overall Study||0
8977377|NCT02674386|10042171|FG001|NOT COMPLETED|Overall Study||10
8977378|NCT02674386|10042172|FG002|NOT COMPLETED|Overall Study||1
8977379|NCT02674399|10042187|FG000|STARTED|Overall Study||19
8977380|NCT02674399|10042188|FG001|STARTED|Overall Study||9
8977381|NCT02674399|10042187|FG000|COMPLETED|Overall Study||17
8977382|NCT02674399|10042188|FG001|COMPLETED|Overall Study||9
8977383|NCT02674399|10042187|FG000|NOT COMPLETED|Overall Study||2
8977384|NCT02674399|10042188|FG001|NOT COMPLETED|Overall Study||0
8977385|NCT02674412|10042194|FG000|STARTED|Overall Study||5
8632332|NCT00545064|9672226|FG000|Visit 3 (Week 8)|Overall Study|8 patients didn't complete the 8-week period. 6 were retrieved and considered as Visit 3 (Week 8)|176
8632333|NCT00545064|9672226|FG000|COMPLETED|Overall Study||170
8632334|NCT00545064|9672226|FG000|NOT COMPLETED|Overall Study||8
8977386|NCT02674412|10042195|FG001|STARTED|Overall Study||5
8977387|NCT02674412|10042194|FG000|COMPLETED|Overall Study||5
8977388|NCT02674412|10042195|FG001|COMPLETED|Overall Study||5
8977389|NCT02674412|10042194|FG000|NOT COMPLETED|Overall Study||0
8977390|NCT02674412|10042195|FG001|NOT COMPLETED|Overall Study||0
9038515|NCT03332784|10099765|FG004|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
9038516|NCT03332784|10099766|FG005|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
9038517|NCT03332784|10099767|FG006|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
9038518|NCT03332784|10099768|FG007|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
9038519|NCT03332784|10099769|FG008|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||4
9038520|NCT03332784|10099770|FG009|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||6
9038521|NCT03332784|10099771|FG010|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||6
9038522|NCT03332784|10099772|FG011|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
9038523|NCT03332784|10099773|FG012|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||6
9038524|NCT03332784|10099774|FG013|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||4
9038525|NCT03332784|10099775|FG014|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||1
9038526|NCT03332784|10099776|FG015|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
9038527|NCT03332784|10099777|FG016|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
9038528|NCT03332784|10099778|FG017|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
9038529|NCT03332784|10099779|FG018|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||3
9038530|NCT03332784|10099780|FG019|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||3
9038531|NCT03332784|10099761|FG000|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
9038532|NCT03332784|10099762|FG001|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||1
9038533|NCT03332784|10099763|FG002|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
9038534|NCT03332784|10099764|FG003|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
9038535|NCT03332784|10099765|FG004|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
9038536|NCT03332784|10099766|FG005|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
9038537|NCT03332784|10099767|FG006|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
9038538|NCT03332784|10099768|FG007|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
9038539|NCT03332784|10099769|FG008|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
9038540|NCT03332784|10099770|FG009|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
9038541|NCT03332784|10099771|FG010|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
9038542|NCT03332784|10099772|FG011|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
9038543|NCT03332784|10099773|FG012|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
9038544|NCT03332784|10099774|FG013|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
9038545|NCT03332784|10099775|FG014|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||1
9038546|NCT03332784|10099776|FG015|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
9038547|NCT03332784|10099777|FG016|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
9038548|NCT03332784|10099778|FG017|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
9038549|NCT03332784|10099779|FG018|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
8632335|NCT00545077|9672234|FG000|STARTED|Overall Study||189
8632336|NCT00545077|9672235|FG001|STARTED|Overall Study||191
8632337|NCT00545077|9672234|FG000|COMPLETED|Overall Study||41
9038550|NCT03332784|10099780|FG019|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
8977391|NCT02674477|10042204|FG000|STARTED|Overall Study||48
8977392|NCT02674477|10042205|FG001|STARTED|Overall Study||47
8977393|NCT02674477|10042204|FG000|COMPLETED|Overall Study||40
8977394|NCT02674477|10042205|FG001|COMPLETED|Overall Study||45
8977395|NCT02674477|10042204|FG000|NOT COMPLETED|Overall Study||8
8977396|NCT02674477|10042205|FG001|NOT COMPLETED|Overall Study||2
8977397|NCT02674568|10042211|FG000|STARTED|Overall Study|Enrolled and dosed.|339
8977398|NCT02674568|10042211|FG000|Delta-like Protein 3 (DLL3) High|Overall Study||238
8977399|NCT02674568|10042211|FG000|DLL3 Positive|Overall Study||287
8977400|NCT02674568|10042211|FG000|COMPLETED|Overall Study||0
8977401|NCT02674568|10042211|FG000|NOT COMPLETED|Overall Study||339
8977402|NCT02674633|10042222|FG000|STARTED|Overall Study||180
8977403|NCT02674633|10042223|FG001|STARTED|Overall Study||168
8977404|NCT02674633|10042222|FG000|COMPLETED|Overall Study||175
8977405|NCT02674633|10042223|FG001|COMPLETED|Overall Study||164
8977406|NCT02674633|10042222|FG000|NOT COMPLETED|Overall Study||5
8977407|NCT02674633|10042223|FG001|NOT COMPLETED|Overall Study||4
8977408|NCT02674659|10042231|FG000|STARTED|Overall Study||43
8977409|NCT02674659|10042232|FG001|STARTED|Overall Study||44
8977410|NCT02674659|10042231|FG000|COMPLETED|Overall Study||39
8977411|NCT02674659|10042232|FG001|COMPLETED|Overall Study||40
8977412|NCT02674659|10042231|FG000|NOT COMPLETED|Overall Study||4
8977413|NCT02674659|10042232|FG001|NOT COMPLETED|Overall Study||4
8977414|NCT02674685|10042238|FG000|STARTED|Overall Study||237
8977415|NCT02674685|10042238|FG000|COMPLETED|Overall Study||233
8977416|NCT02674685|10042238|FG000|NOT COMPLETED|Overall Study||4
8977417|NCT02674854|10042245|FG000|STARTED|Overall Study||245
8977418|NCT02674854|10042246|FG001|STARTED|Overall Study||255
8977419|NCT02674854|10042247|FG002|STARTED|Overall Study||250
8977420|NCT02674854|10042245|FG000|COMPLETED|Overall Study||221
8977421|NCT02674854|10042246|FG001|COMPLETED|Overall Study||228
8977422|NCT02674854|10042247|FG002|COMPLETED|Overall Study||236
8977423|NCT02674854|10042245|FG000|NOT COMPLETED|Overall Study||24
8977424|NCT02674854|10042246|FG001|NOT COMPLETED|Overall Study||27
8977425|NCT02674854|10042247|FG002|NOT COMPLETED|Overall Study||14
8977426|NCT02675075|10042257|FG000|STARTED|Overall Study||15
8977427|NCT02675075|10042258|FG001|STARTED|Overall Study||19
8977428|NCT02675075|10042257|FG000|COMPLETED|Overall Study||12
8977429|NCT02675075|10042258|FG001|COMPLETED|Overall Study||19
8977430|NCT02675075|10042257|FG000|NOT COMPLETED|Overall Study||3
8977431|NCT02675075|10042258|FG001|NOT COMPLETED|Overall Study||0
8977432|NCT02675517|10042266|FG000|STARTED|Overall Study||1737
8977433|NCT02675517|10042266|FG000|COMPLETED|Overall Study||1578
8977434|NCT02675517|10042266|FG000|NOT COMPLETED|Overall Study||159
8977435|NCT02675543|10042272|FG000|STARTED|Overall Study||15
8977436|NCT02675543|10042273|FG001|STARTED|Overall Study||20
8977437|NCT02675543|10042272|FG000|COMPLETED|Overall Study||15
8977438|NCT02675543|10042273|FG001|COMPLETED|Overall Study||20
8977439|NCT02675543|10042272|FG000|NOT COMPLETED|Overall Study||0
8977440|NCT02675543|10042273|FG001|NOT COMPLETED|Overall Study||0
8977441|NCT02675634|10042279|FG000|STARTED|Test Period 1||10
8977442|NCT02675634|10042280|FG001|STARTED|Test Period 1||8
8977443|NCT02675634|10042281|FG002|STARTED|Test Period 1||9
8977444|NCT02675634|10042282|FG003|STARTED|Test Period 1||9
8977445|NCT02675634|10042283|FG004|STARTED|Test Period 1||10
8977446|NCT02675634|10042284|FG005|STARTED|Test Period 1||9
8977447|NCT02675634|10042279|FG000|COMPLETED|Test Period 1||10
8977448|NCT02675634|10042280|FG001|COMPLETED|Test Period 1||7
8977449|NCT02675634|10042281|FG002|COMPLETED|Test Period 1||8
8977450|NCT02675634|10042282|FG003|COMPLETED|Test Period 1||8
8977451|NCT02675634|10042283|FG004|COMPLETED|Test Period 1||10
8977452|NCT02675634|10042284|FG005|COMPLETED|Test Period 1||9
8977453|NCT02675634|10042279|FG000|NOT COMPLETED|Test Period 1||0
8977454|NCT02675634|10042280|FG001|NOT COMPLETED|Test Period 1||1
8977455|NCT02675634|10042281|FG002|NOT COMPLETED|Test Period 1||1
8977456|NCT02675634|10042282|FG003|NOT COMPLETED|Test Period 1||1
8977457|NCT02675634|10042283|FG004|NOT COMPLETED|Test Period 1||0
8977458|NCT02675634|10042284|FG005|NOT COMPLETED|Test Period 1||0
8977459|NCT02675634|10042279|FG000|STARTED|Test Period 2||10
8977460|NCT02675634|10042280|FG001|STARTED|Test Period 2||7
8977461|NCT02675634|10042281|FG002|STARTED|Test Period 2||8
8977462|NCT02675634|10042282|FG003|STARTED|Test Period 2||8
8977463|NCT02675634|10042283|FG004|STARTED|Test Period 2||10
8977464|NCT02675634|10042284|FG005|STARTED|Test Period 2||9
8977465|NCT02675634|10042279|FG000|COMPLETED|Test Period 2||9
8977466|NCT02675634|10042280|FG001|COMPLETED|Test Period 2||7
8977467|NCT02675634|10042281|FG002|COMPLETED|Test Period 2||8
8977468|NCT02675634|10042282|FG003|COMPLETED|Test Period 2||8
8977469|NCT02675634|10042283|FG004|COMPLETED|Test Period 2||10
8977470|NCT02675634|10042284|FG005|COMPLETED|Test Period 2||8
8977471|NCT02675634|10042279|FG000|NOT COMPLETED|Test Period 2||1
8977472|NCT02675634|10042280|FG001|NOT COMPLETED|Test Period 2||0
8977473|NCT02675634|10042281|FG002|NOT COMPLETED|Test Period 2||0
8977474|NCT02675634|10042282|FG003|NOT COMPLETED|Test Period 2||0
8977475|NCT02675634|10042283|FG004|NOT COMPLETED|Test Period 2||0
8977476|NCT02675634|10042284|FG005|NOT COMPLETED|Test Period 2||1
8977477|NCT02675634|10042279|FG000|STARTED|Test Period 3||9
8977478|NCT02675634|10042280|FG001|STARTED|Test Period 3||7
8977479|NCT02675634|10042281|FG002|STARTED|Test Period 3||8
8977480|NCT02675634|10042282|FG003|STARTED|Test Period 3||8
8977481|NCT02675634|10042283|FG004|STARTED|Test Period 3||10
8977482|NCT02675634|10042284|FG005|STARTED|Test Period 3||8
8977483|NCT02675634|10042279|FG000|COMPLETED|Test Period 3||9
8977484|NCT02675634|10042280|FG001|COMPLETED|Test Period 3||7
8977485|NCT02675634|10042281|FG002|COMPLETED|Test Period 3||8
8977486|NCT02675634|10042282|FG003|COMPLETED|Test Period 3||8
8977487|NCT02675634|10042283|FG004|COMPLETED|Test Period 3||10
8977488|NCT02675634|10042284|FG005|COMPLETED|Test Period 3||8
8977489|NCT02675634|10042279|FG000|NOT COMPLETED|Test Period 3||0
8977490|NCT02675634|10042280|FG001|NOT COMPLETED|Test Period 3||0
8977491|NCT02675634|10042281|FG002|NOT COMPLETED|Test Period 3||0
8977492|NCT02675634|10042282|FG003|NOT COMPLETED|Test Period 3||0
8977493|NCT02675634|10042283|FG004|NOT COMPLETED|Test Period 3||0
8977494|NCT02675634|10042284|FG005|NOT COMPLETED|Test Period 3||0
8977495|NCT02675764|10042294|FG000|STARTED|Overall Study||6
8977496|NCT02675764|10042295|FG001|STARTED|Overall Study||6
8977497|NCT02675764|10042294|FG000|COMPLETED|Overall Study||6
8977498|NCT02675764|10042295|FG001|COMPLETED|Overall Study||6
8977499|NCT02675764|10042294|FG000|NOT COMPLETED|Overall Study||0
8977500|NCT02675764|10042295|FG001|NOT COMPLETED|Overall Study||0
8977501|NCT02675907|10042303|FG000|STARTED|Treatment Phase (48 Hours Post-Dose 1)||100
8977502|NCT02675907|10042304|FG001|STARTED|Treatment Phase (48 Hours Post-Dose 1)||101
8977503|NCT02675907|10042303|FG000|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||95
8977504|NCT02675907|10042304|FG001|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||96
8977505|NCT02675907|10042303|FG000|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||5
8977506|NCT02675907|10042304|FG001|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||5
8977507|NCT02675907|10042303|FG000|STARTED|Study Overall||100
8977508|NCT02675907|10042304|FG001|STARTED|Study Overall||101
8877262|NCT01922050|9934166|FG008|NOT COMPLETED|Part 2 Double-blind Phase||0
8877263|NCT01922050|9934167|FG009|NOT COMPLETED|Part 2 Double-blind Phase||0
8877264|NCT01922050|9934168|FG010|NOT COMPLETED|Part 2 Double-blind Phase||1
8977509|NCT02675907|10042303|FG000|COMPLETED|Study Overall||97
8977510|NCT02675907|10042304|FG001|COMPLETED|Study Overall||97
8977511|NCT02675907|10042303|FG000|NOT COMPLETED|Study Overall||3
8977512|NCT02675907|10042304|FG001|NOT COMPLETED|Study Overall||4
8977513|NCT02675998|10042314|FG000|STARTED|8-Week Treatment Period||74
8977514|NCT02675998|10042315|FG001|STARTED|8-Week Treatment Period||73
8977515|NCT02675998|10042316|FG002|STARTED|8-Week Treatment Period||72
8977516|NCT02675998|10042317|FG003|STARTED|8-Week Treatment Period||0
8977517|NCT02675998|10042314|FG000|COMPLETED|8-Week Treatment Period||57
8977518|NCT02675998|10042315|FG001|COMPLETED|8-Week Treatment Period||54
8977519|NCT02675998|10042316|FG002|COMPLETED|8-Week Treatment Period||53
8977520|NCT02675998|10042317|FG003|COMPLETED|8-Week Treatment Period||0
8977521|NCT02675998|10042314|FG000|NOT COMPLETED|8-Week Treatment Period||17
8977522|NCT02675998|10042315|FG001|NOT COMPLETED|8-Week Treatment Period||19
8977523|NCT02675998|10042316|FG002|NOT COMPLETED|8-Week Treatment Period||19
8977524|NCT02675998|10042317|FG003|NOT COMPLETED|8-Week Treatment Period||0
8977525|NCT02675998|10042314|FG000|STARTED|4-Week Randomized Withdrawal Period||25
8977526|NCT02675998|10042315|FG001|STARTED|4-Week Randomized Withdrawal Period||23
8977527|NCT02675998|10042316|FG002|STARTED|4-Week Randomized Withdrawal Period||34
8977528|NCT02675998|10042317|FG003|STARTED|4-Week Randomized Withdrawal Period||82
8977529|NCT02675998|10042314|FG000|COMPLETED|4-Week Randomized Withdrawal Period||24
8977530|NCT02675998|10042315|FG001|COMPLETED|4-Week Randomized Withdrawal Period||22
8977531|NCT02675998|10042316|FG002|COMPLETED|4-Week Randomized Withdrawal Period||32
8977532|NCT02675998|10042317|FG003|COMPLETED|4-Week Randomized Withdrawal Period||74
8977533|NCT02675998|10042314|FG000|NOT COMPLETED|4-Week Randomized Withdrawal Period||1
8977534|NCT02675998|10042315|FG001|NOT COMPLETED|4-Week Randomized Withdrawal Period||1
8977535|NCT02675998|10042316|FG002|NOT COMPLETED|4-Week Randomized Withdrawal Period||2
8977536|NCT02675998|10042317|FG003|NOT COMPLETED|4-Week Randomized Withdrawal Period||8
8977537|NCT02676375|10042330|FG000|STARTED|Overall Study||14
8977538|NCT02676375|10042331|FG001|STARTED|Overall Study||14
8977539|NCT02676375|10042332|FG002|STARTED|Overall Study||14
8977540|NCT02676375|10042330|FG000|COMPLETED|Overall Study||13
8977541|NCT02676375|10042331|FG001|COMPLETED|Overall Study||10
8977542|NCT02676375|10042332|FG002|COMPLETED|Overall Study||11
8977543|NCT02676375|10042330|FG000|NOT COMPLETED|Overall Study||1
8977544|NCT02676375|10042331|FG001|NOT COMPLETED|Overall Study||4
8977545|NCT02676375|10042332|FG002|NOT COMPLETED|Overall Study||3
8977546|NCT02676466|10042348|FG000|STARTED|Overall Study||109
8977547|NCT02676466|10042349|FG001|STARTED|Overall Study||71
8977548|NCT02676466|10042350|FG002|STARTED|Overall Study||26
8877265|NCT01922050|9934169|FG011|NOT COMPLETED|Part 2 Double-blind Phase||2
8877266|NCT01922050|9934170|FG012|NOT COMPLETED|Part 2 Double-blind Phase||0
8877267|NCT01922050|9934171|FG013|NOT COMPLETED|Part 2 Double-blind Phase||3
8877268|NCT01922089|9934203|FG000|STARTED|Overall Study||247
8877269|NCT01922089|9934204|FG001|STARTED|Overall Study||251
8877270|NCT01922089|9934203|FG000|Safety Set|Overall Study||246
8877271|NCT01922089|9934204|FG001|Safety Set|Overall Study||251
8877272|NCT01922089|9934203|FG000|COMPLETED|Overall Study||208
8877273|NCT01922089|9934204|FG001|COMPLETED|Overall Study||221
8877274|NCT01922089|9934203|FG000|NOT COMPLETED|Overall Study||39
8877275|NCT01922089|9934204|FG001|NOT COMPLETED|Overall Study||30
8977549|NCT02676466|10042351|FG003|STARTED|Overall Study||17
8977550|NCT02676466|10042352|FG004|STARTED|Overall Study||26
8977551|NCT02676466|10042353|FG005|STARTED|Overall Study||13
8977552|NCT02676466|10042354|FG006|STARTED|Overall Study||13
8977553|NCT02676466|10042355|FG007|STARTED|Overall Study||14
8977554|NCT02676466|10042348|FG000|COMPLETED|Overall Study||105
8977555|NCT02676466|10042349|FG001|COMPLETED|Overall Study||66
8977556|NCT02676466|10042350|FG002|COMPLETED|Overall Study||24
8977557|NCT02676466|10042351|FG003|COMPLETED|Overall Study||17
8977558|NCT02676466|10042352|FG004|COMPLETED|Overall Study||23
8977559|NCT02676466|10042353|FG005|COMPLETED|Overall Study||12
8977560|NCT02676466|10042354|FG006|COMPLETED|Overall Study||12
8977561|NCT02676466|10042355|FG007|COMPLETED|Overall Study||13
8977562|NCT02676466|10042348|FG000|NOT COMPLETED|Overall Study||4
8977563|NCT02676466|10042349|FG001|NOT COMPLETED|Overall Study||5
8977564|NCT02676466|10042350|FG002|NOT COMPLETED|Overall Study||2
8977565|NCT02676466|10042351|FG003|NOT COMPLETED|Overall Study||0
8977566|NCT02676466|10042352|FG004|NOT COMPLETED|Overall Study||3
8977567|NCT02676466|10042353|FG005|NOT COMPLETED|Overall Study||1
8977568|NCT02676466|10042354|FG006|NOT COMPLETED|Overall Study||1
8977569|NCT02676466|10042355|FG007|NOT COMPLETED|Overall Study||1
8977570|NCT02676778|10042380|FG000|STARTED|Overall Study||17
8977571|NCT02676778|10042381|FG001|STARTED|Overall Study||19
8977572|NCT02676778|10042382|FG002|STARTED|Overall Study||1
8977573|NCT02676778|10042380|FG000|COMPLETED|Overall Study||0
8977574|NCT02676778|10042381|FG001|COMPLETED|Overall Study||7
8977575|NCT02676778|10042382|FG002|COMPLETED|Overall Study||0
8977576|NCT02676778|10042380|FG000|NOT COMPLETED|Overall Study||17
8977577|NCT02676778|10042381|FG001|NOT COMPLETED|Overall Study||12
8977578|NCT02676778|10042382|FG002|NOT COMPLETED|Overall Study||1
8977579|NCT02676843|10042391|FG000|STARTED|Overall Study||7
8977580|NCT02676843|10042391|FG000|COMPLETED|Overall Study||7
8977581|NCT02676843|10042391|FG000|NOT COMPLETED|Overall Study||0
8977582|NCT02676882|10042398|FG000|STARTED|Overall Study||13
8977583|NCT02676882|10042399|FG001|STARTED|Overall Study||7
8977584|NCT02676882|10042398|FG000|Evaluable|Overall Study||11
8977585|NCT02676882|10042399|FG001|Evaluable|Overall Study||6
8977586|NCT02676882|10042398|FG000|COMPLETED|Overall Study||10
8977587|NCT02676882|10042399|FG001|COMPLETED|Overall Study||5
8977588|NCT02676882|10042398|FG000|NOT COMPLETED|Overall Study||3
8977589|NCT02676882|10042399|FG001|NOT COMPLETED|Overall Study||2
8977590|NCT02676895|10042408|FG000|STARTED|Overall Study||22
8977591|NCT02676895|10042409|FG001|STARTED|Overall Study||26
8977592|NCT02676895|10042410|FG002|STARTED|Overall Study||24
8977593|NCT02676895|10042408|FG000|COMPLETED|Overall Study||20
8977594|NCT02676895|10042409|FG001|COMPLETED|Overall Study||23
8977595|NCT02676895|10042410|FG002|COMPLETED|Overall Study||21
8977596|NCT02676895|10042408|FG000|NOT COMPLETED|Overall Study||2
8977597|NCT02676895|10042409|FG001|NOT COMPLETED|Overall Study||3
8977598|NCT02676895|10042410|FG002|NOT COMPLETED|Overall Study||3
8977599|NCT02677116|10042428|FG000|STARTED|Overall Study||10
8977600|NCT02677116|10042429|FG001|STARTED|Overall Study||11
8977601|NCT02677116|10042430|FG002|STARTED|Overall Study||9
8977602|NCT02677116|10042431|FG003|STARTED|Overall Study||10
8977603|NCT02677116|10042432|FG004|STARTED|Overall Study||1
8977604|NCT02677116|10042433|FG005|STARTED|Overall Study||13
8977605|NCT02677116|10042434|FG006|STARTED|Overall Study||6
8977606|NCT02677116|10042435|FG007|STARTED|Overall Study||4
8977607|NCT02677116|10042436|FG008|STARTED|Overall Study||4
8977608|NCT02677116|10042428|FG000|Cycle 1 Olaratumab Alone|Overall Study||10
8977609|NCT02677116|10042429|FG001|Cycle 1 Olaratumab Alone|Overall Study||11
8977610|NCT02677116|10042430|FG002|Cycle 1 Olaratumab Alone|Overall Study||9
8977611|NCT02677116|10042431|FG003|Cycle 1 Olaratumab Alone|Overall Study||10
8977612|NCT02677116|10042432|FG004|Cycle 1 Olaratumab Alone|Overall Study||1
8977613|NCT02677116|10042433|FG005|Cycle 1 Olaratumab Alone|Overall Study||13
8977614|NCT02677116|10042434|FG006|Cycle 1 Olaratumab Alone|Overall Study||6
8977615|NCT02677116|10042435|FG007|Cycle 1 Olaratumab Alone|Overall Study||4
8977616|NCT02677116|10042436|FG008|Cycle 1 Olaratumab Alone|Overall Study||4
8977617|NCT02677116|10042428|FG000|Progressive Disease|Overall Study||7
8977618|NCT02677116|10042429|FG001|Progressive Disease|Overall Study||7
8977619|NCT02677116|10042430|FG002|Progressive Disease|Overall Study||6
8977620|NCT02677116|10042431|FG003|Progressive Disease|Overall Study||7
8977621|NCT02677116|10042432|FG004|Progressive Disease|Overall Study||0
8977622|NCT02677116|10042433|FG005|Progressive Disease|Overall Study||9
8977623|NCT02677116|10042434|FG006|Progressive Disease|Overall Study||2
8977624|NCT02677116|10042435|FG007|Progressive Disease|Overall Study||2
8977625|NCT02677116|10042436|FG008|Progressive Disease|Overall Study||2
8977626|NCT02677116|10042428|FG000|COMPLETED|Overall Study||7
8977627|NCT02677116|10042429|FG001|COMPLETED|Overall Study||7
8977628|NCT02677116|10042430|FG002|COMPLETED|Overall Study||6
8977629|NCT02677116|10042431|FG003|COMPLETED|Overall Study||7
8977630|NCT02677116|10042432|FG004|COMPLETED|Overall Study||0
8977631|NCT02677116|10042433|FG005|COMPLETED|Overall Study||9
8977632|NCT02677116|10042434|FG006|COMPLETED|Overall Study||2
8977633|NCT02677116|10042435|FG007|COMPLETED|Overall Study||2
8977634|NCT02677116|10042436|FG008|COMPLETED|Overall Study||2
8977635|NCT02677116|10042428|FG000|NOT COMPLETED|Overall Study||3
8977636|NCT02677116|10042429|FG001|NOT COMPLETED|Overall Study||4
8977637|NCT02677116|10042430|FG002|NOT COMPLETED|Overall Study||3
8977638|NCT02677116|10042431|FG003|NOT COMPLETED|Overall Study||3
8977639|NCT02677116|10042432|FG004|NOT COMPLETED|Overall Study||1
8977640|NCT02677116|10042433|FG005|NOT COMPLETED|Overall Study||4
8977641|NCT02677116|10042434|FG006|NOT COMPLETED|Overall Study||4
8977642|NCT02677116|10042435|FG007|NOT COMPLETED|Overall Study||2
8977643|NCT02677116|10042436|FG008|NOT COMPLETED|Overall Study||2
8977644|NCT02677220|10042479|FG000|STARTED|Overall Study||1
8977645|NCT02677220|10042479|FG000|COMPLETED|Overall Study||0
8977646|NCT02677220|10042479|FG000|NOT COMPLETED|Overall Study||1
8977647|NCT02677428|10042486|FG000|STARTED|Overall Study||63
8977648|NCT02677428|10042487|FG001|STARTED|Overall Study||55
8977649|NCT02677428|10042486|FG000|COMPLETED|Overall Study||63
8977650|NCT02677428|10042487|FG001|COMPLETED|Overall Study||55
8977651|NCT02677428|10042486|FG000|NOT COMPLETED|Overall Study||0
8977652|NCT02677428|10042487|FG001|NOT COMPLETED|Overall Study||0
8977653|NCT02677493|10042496|FG000|STARTED|Overall Study||1197
8977654|NCT02677493|10042497|FG001|STARTED|Overall Study||298
8977655|NCT02677493|10042498|FG002|STARTED|Overall Study||299
8977656|NCT02677493|10042496|FG000|COMPLETED|Overall Study||1186
8977657|NCT02677493|10042497|FG001|COMPLETED|Overall Study||296
8977658|NCT02677493|10042498|FG002|COMPLETED|Overall Study||296
8977659|NCT02677493|10042496|FG000|NOT COMPLETED|Overall Study||11
8977660|NCT02677493|10042497|FG001|NOT COMPLETED|Overall Study||2
8977661|NCT02677493|10042498|FG002|NOT COMPLETED|Overall Study||3
8977662|NCT02677623|10042513|FG000|STARTED|Overall Study||33
8977663|NCT02677623|10042514|FG001|STARTED|Overall Study||32
8977664|NCT02677623|10042515|FG002|STARTED|Overall Study||32
8977665|NCT02677623|10042516|FG003|STARTED|Overall Study||33
8977666|NCT02677623|10042513|FG000|COMPLETED|Overall Study||33
8977667|NCT02677623|10042514|FG001|COMPLETED|Overall Study||32
8977668|NCT02677623|10042515|FG002|COMPLETED|Overall Study||32
8977669|NCT02677623|10042516|FG003|COMPLETED|Overall Study||33
8977670|NCT02677623|10042513|FG000|NOT COMPLETED|Overall Study||0
8977671|NCT02677623|10042514|FG001|NOT COMPLETED|Overall Study||0
8977672|NCT02677623|10042515|FG002|NOT COMPLETED|Overall Study||0
8977673|NCT02677623|10042516|FG003|NOT COMPLETED|Overall Study||0
8977674|NCT02677701|10042528|FG000|STARTED|Overall Study||62
8977675|NCT02677701|10042529|FG001|STARTED|Overall Study||57
8977676|NCT02677701|10042528|FG000|Treated|Overall Study||61
8977677|NCT02677701|10042529|FG001|Treated|Overall Study||54
8977678|NCT02677701|10042528|FG000|COMPLETED|Overall Study||56
8977679|NCT02677701|10042529|FG001|COMPLETED|Overall Study||52
8977680|NCT02677701|10042528|FG000|NOT COMPLETED|Overall Study||6
8977681|NCT02677701|10042529|FG001|NOT COMPLETED|Overall Study||5
8977682|NCT02677714|10042537|FG000|STARTED|Overall Study||12
8977683|NCT02677714|10042538|FG001|STARTED|Overall Study||2
8977684|NCT02677714|10042537|FG000|COMPLETED|Overall Study||10
8977685|NCT02677714|10042538|FG001|COMPLETED|Overall Study||2
8977686|NCT02677714|10042537|FG000|NOT COMPLETED|Overall Study||2
8977687|NCT02677714|10042538|FG001|NOT COMPLETED|Overall Study||0
8977688|NCT02677740|10042546|FG000|STARTED|Overall Study||7
8977689|NCT02677740|10042547|FG001|STARTED|Overall Study||1
8977690|NCT02677740|10042546|FG000|COMPLETED|Overall Study||7
8977691|NCT02677740|10042547|FG001|COMPLETED|Overall Study||1
8977692|NCT02677740|10042546|FG000|NOT COMPLETED|Overall Study||0
8977693|NCT02677740|10042547|FG001|NOT COMPLETED|Overall Study||0
8977694|NCT02677753|10042555|FG000|STARTED|Overall Study||37
8977695|NCT02677753|10042556|FG001|STARTED|Overall Study||38
8977696|NCT02677753|10042555|FG000|COMPLETED|Overall Study||36
8977697|NCT02677753|10042556|FG001|COMPLETED|Overall Study||38
8977698|NCT02677753|10042555|FG000|NOT COMPLETED|Overall Study||1
8977699|NCT02677753|10042556|FG001|NOT COMPLETED|Overall Study||0
8977700|NCT02677766|10042564|FG000|STARTED|Overall Study||20
8977701|NCT02677766|10042565|FG001|STARTED|Overall Study||20
8977702|NCT02677766|10042564|FG000|COMPLETED|Overall Study||15
8977703|NCT02677766|10042565|FG001|COMPLETED|Overall Study||17
8977704|NCT02677766|10042564|FG000|NOT COMPLETED|Overall Study||5
8977705|NCT02677766|10042565|FG001|NOT COMPLETED|Overall Study||3
8977706|NCT02677779|10042573|FG000|STARTED|Overall Study||10
8977707|NCT02677779|10042574|FG001|STARTED|Overall Study||10
8977708|NCT02677779|10042573|FG000|COMPLETED|Overall Study||10
8977709|NCT02677779|10042574|FG001|COMPLETED|Overall Study||10
8977710|NCT02677779|10042573|FG000|NOT COMPLETED|Overall Study||0
8977711|NCT02677779|10042574|FG001|NOT COMPLETED|Overall Study||0
8977712|NCT02677844|10042582|FG000|STARTED|Period 1||5
8977713|NCT02677844|10042583|FG001|STARTED|Period 1||5
8977714|NCT02677844|10042584|FG002|STARTED|Period 1||5
8977715|NCT02677844|10042585|FG003|STARTED|Period 1||5
8977716|NCT02677844|10042586|FG004|STARTED|Period 1||0
8977717|NCT02677844|10042587|FG005|STARTED|Period 1||0
8977718|NCT02677844|10042588|FG006|STARTED|Period 1||0
8977719|NCT02677844|10042582|FG000|COMPLETED|Period 1||5
8977720|NCT02677844|10042583|FG001|COMPLETED|Period 1||5
8977721|NCT02677844|10042584|FG002|COMPLETED|Period 1||5
8977722|NCT02677844|10042585|FG003|COMPLETED|Period 1||5
8977723|NCT02677844|10042586|FG004|COMPLETED|Period 1||0
8977724|NCT02677844|10042587|FG005|COMPLETED|Period 1||0
8977725|NCT02677844|10042588|FG006|COMPLETED|Period 1||0
8977726|NCT02677844|10042582|FG000|NOT COMPLETED|Period 1||0
8977727|NCT02677844|10042583|FG001|NOT COMPLETED|Period 1||0
8977728|NCT02677844|10042584|FG002|NOT COMPLETED|Period 1||0
8977729|NCT02677844|10042585|FG003|NOT COMPLETED|Period 1||0
8977730|NCT02677844|10042586|FG004|NOT COMPLETED|Period 1||0
8977731|NCT02677844|10042587|FG005|NOT COMPLETED|Period 1||0
8977732|NCT02677844|10042588|FG006|NOT COMPLETED|Period 1||0
8977733|NCT02677844|10042582|FG000|STARTED|Period 2||5
8977734|NCT02677844|10042583|FG001|STARTED|Period 2||5
8977735|NCT02677844|10042584|FG002|STARTED|Period 2||5
8977736|NCT02677844|10042585|FG003|STARTED|Period 2||5
8977737|NCT02677844|10042586|FG004|STARTED|Period 2||0
8977738|NCT02677844|10042587|FG005|STARTED|Period 2||0
8977739|NCT02677844|10042588|FG006|STARTED|Period 2||0
8977740|NCT02677844|10042582|FG000|COMPLETED|Period 2||5
8977741|NCT02677844|10042583|FG001|COMPLETED|Period 2||5
8977742|NCT02677844|10042584|FG002|COMPLETED|Period 2||5
8977743|NCT02677844|10042585|FG003|COMPLETED|Period 2||5
8977744|NCT02677844|10042586|FG004|COMPLETED|Period 2||0
8977745|NCT02677844|10042587|FG005|COMPLETED|Period 2||0
8977746|NCT02677844|10042588|FG006|COMPLETED|Period 2||0
8977747|NCT02677844|10042582|FG000|NOT COMPLETED|Period 2||0
8977748|NCT02677844|10042583|FG001|NOT COMPLETED|Period 2||0
8977749|NCT02677844|10042584|FG002|NOT COMPLETED|Period 2||0
8977750|NCT02677844|10042585|FG003|NOT COMPLETED|Period 2||0
8977751|NCT02677844|10042586|FG004|NOT COMPLETED|Period 2||0
8977752|NCT02677844|10042587|FG005|NOT COMPLETED|Period 2||0
8977753|NCT02677844|10042588|FG006|NOT COMPLETED|Period 2||0
8977754|NCT02677844|10042582|FG000|STARTED|Period 3||5
8977755|NCT02677844|10042583|FG001|STARTED|Period 3||5
8977756|NCT02677844|10042584|FG002|STARTED|Period 3||5
8977757|NCT02677844|10042585|FG003|STARTED|Period 3||5
8977758|NCT02677844|10042586|FG004|STARTED|Period 3||0
8977759|NCT02677844|10042587|FG005|STARTED|Period 3||0
8977760|NCT02677844|10042588|FG006|STARTED|Period 3||0
8977761|NCT02677844|10042582|FG000|COMPLETED|Period 3||5
8977762|NCT02677844|10042583|FG001|COMPLETED|Period 3||5
8977763|NCT02677844|10042584|FG002|COMPLETED|Period 3||5
8977764|NCT02677844|10042585|FG003|COMPLETED|Period 3||4
8977765|NCT02677844|10042586|FG004|COMPLETED|Period 3||0
8977766|NCT02677844|10042587|FG005|COMPLETED|Period 3||0
8977767|NCT02677844|10042588|FG006|COMPLETED|Period 3||0
8977768|NCT02677844|10042582|FG000|NOT COMPLETED|Period 3||0
8977769|NCT02677844|10042583|FG001|NOT COMPLETED|Period 3||0
8977770|NCT02677844|10042584|FG002|NOT COMPLETED|Period 3||0
8977771|NCT02677844|10042585|FG003|NOT COMPLETED|Period 3||1
8977772|NCT02677844|10042586|FG004|NOT COMPLETED|Period 3||0
8977773|NCT02677844|10042587|FG005|NOT COMPLETED|Period 3||0
8977774|NCT02677844|10042588|FG006|NOT COMPLETED|Period 3||0
8977775|NCT02677844|10042582|FG000|STARTED|Period 4||5
8977776|NCT02677844|10042583|FG001|STARTED|Period 4||5
8977777|NCT02677844|10042584|FG002|STARTED|Period 4||5
8977778|NCT02677844|10042585|FG003|STARTED|Period 4||4
8977779|NCT02677844|10042586|FG004|STARTED|Period 4||0
8977780|NCT02677844|10042587|FG005|STARTED|Period 4||0
8977781|NCT02677844|10042588|FG006|STARTED|Period 4||0
8977782|NCT02677844|10042582|FG000|COMPLETED|Period 4||5
8977783|NCT02677844|10042583|FG001|COMPLETED|Period 4||5
8977784|NCT02677844|10042584|FG002|COMPLETED|Period 4||5
8632338|NCT00545077|9672235|FG001|COMPLETED|Overall Study||36
8977785|NCT02677844|10042585|FG003|COMPLETED|Period 4||4
8977786|NCT02677844|10042586|FG004|COMPLETED|Period 4||0
8977787|NCT02677844|10042587|FG005|COMPLETED|Period 4||0
8977788|NCT02677844|10042588|FG006|COMPLETED|Period 4||0
8977789|NCT02677844|10042582|FG000|NOT COMPLETED|Period 4||0
8977790|NCT02677844|10042583|FG001|NOT COMPLETED|Period 4||0
8977791|NCT02677844|10042584|FG002|NOT COMPLETED|Period 4||0
8977792|NCT02677844|10042585|FG003|NOT COMPLETED|Period 4||0
8977793|NCT02677844|10042586|FG004|NOT COMPLETED|Period 4||0
8977794|NCT02677844|10042587|FG005|NOT COMPLETED|Period 4||0
8977795|NCT02677844|10042588|FG006|NOT COMPLETED|Period 4||0
8977796|NCT02677844|10042582|FG000|STARTED|Period 4 (DDI)||0
8977797|NCT02677844|10042583|FG001|STARTED|Period 4 (DDI)||0
8977798|NCT02677844|10042584|FG002|STARTED|Period 4 (DDI)||0
8977799|NCT02677844|10042585|FG003|STARTED|Period 4 (DDI)||0
8977800|NCT02677844|10042586|FG004|STARTED|Period 4 (DDI)||7
8977801|NCT02677844|10042587|FG005|STARTED|Period 4 (DDI)||4
8977802|NCT02677844|10042588|FG006|STARTED|Period 4 (DDI)||4
8977803|NCT02677844|10042582|FG000|COMPLETED|Period 4 (DDI)||0
8977804|NCT02677844|10042583|FG001|COMPLETED|Period 4 (DDI)||0
8977805|NCT02677844|10042584|FG002|COMPLETED|Period 4 (DDI)||0
8977806|NCT02677844|10042585|FG003|COMPLETED|Period 4 (DDI)||0
8977807|NCT02677844|10042586|FG004|COMPLETED|Period 4 (DDI)||7
8977808|NCT02677844|10042587|FG005|COMPLETED|Period 4 (DDI)||4
8977809|NCT02677844|10042588|FG006|COMPLETED|Period 4 (DDI)||4
8977810|NCT02677844|10042582|FG000|NOT COMPLETED|Period 4 (DDI)||0
8977811|NCT02677844|10042583|FG001|NOT COMPLETED|Period 4 (DDI)||0
8977812|NCT02677844|10042584|FG002|NOT COMPLETED|Period 4 (DDI)||0
8977813|NCT02677844|10042585|FG003|NOT COMPLETED|Period 4 (DDI)||0
8977814|NCT02677844|10042586|FG004|NOT COMPLETED|Period 4 (DDI)||0
8977815|NCT02677844|10042587|FG005|NOT COMPLETED|Period 4 (DDI)||0
8977816|NCT02677844|10042588|FG006|NOT COMPLETED|Period 4 (DDI)||0
8977817|NCT02677844|10042582|FG000|STARTED|Period 5||0
8977818|NCT02677844|10042583|FG001|STARTED|Period 5||0
8977819|NCT02677844|10042584|FG002|STARTED|Period 5||0
8977820|NCT02677844|10042585|FG003|STARTED|Period 5||0
8977821|NCT02677844|10042586|FG004|STARTED|Period 5||7
8977822|NCT02677844|10042587|FG005|STARTED|Period 5||4
8977823|NCT02677844|10042588|FG006|STARTED|Period 5||4
8977824|NCT02677844|10042582|FG000|COMPLETED|Period 5||0
8977825|NCT02677844|10042583|FG001|COMPLETED|Period 5||0
8977826|NCT02677844|10042584|FG002|COMPLETED|Period 5||0
8977827|NCT02677844|10042585|FG003|COMPLETED|Period 5||0
8977828|NCT02677844|10042586|FG004|COMPLETED|Period 5||7
8977829|NCT02677844|10042587|FG005|COMPLETED|Period 5||4
8977830|NCT02677844|10042588|FG006|COMPLETED|Period 5||4
8977831|NCT02677844|10042582|FG000|NOT COMPLETED|Period 5||0
8977832|NCT02677844|10042583|FG001|NOT COMPLETED|Period 5||0
8977833|NCT02677844|10042584|FG002|NOT COMPLETED|Period 5||0
8977834|NCT02677844|10042585|FG003|NOT COMPLETED|Period 5||0
8977835|NCT02677844|10042586|FG004|NOT COMPLETED|Period 5||0
8977836|NCT02677844|10042587|FG005|NOT COMPLETED|Period 5||0
8977837|NCT02677844|10042588|FG006|NOT COMPLETED|Period 5||0
8977838|NCT02677844|10042582|FG000|STARTED|Period 6||0
8977839|NCT02677844|10042583|FG001|STARTED|Period 6||0
8977840|NCT02677844|10042584|FG002|STARTED|Period 6||0
8977841|NCT02677844|10042585|FG003|STARTED|Period 6||0
8977842|NCT02677844|10042586|FG004|STARTED|Period 6||7
8977843|NCT02677844|10042587|FG005|STARTED|Period 6||4
8977844|NCT02677844|10042588|FG006|STARTED|Period 6||4
8977845|NCT02677844|10042582|FG000|COMPLETED|Period 6||0
8977846|NCT02677844|10042583|FG001|COMPLETED|Period 6||0
8977847|NCT02677844|10042584|FG002|COMPLETED|Period 6||0
8977848|NCT02677844|10042585|FG003|COMPLETED|Period 6||0
8977849|NCT02677844|10042586|FG004|COMPLETED|Period 6||7
8977850|NCT02677844|10042587|FG005|COMPLETED|Period 6||4
8977851|NCT02677844|10042588|FG006|COMPLETED|Period 6||4
8977852|NCT02677844|10042582|FG000|NOT COMPLETED|Period 6||0
8977853|NCT02677844|10042583|FG001|NOT COMPLETED|Period 6||0
8977854|NCT02677844|10042584|FG002|NOT COMPLETED|Period 6||0
8977855|NCT02677844|10042585|FG003|NOT COMPLETED|Period 6||0
8977856|NCT02677844|10042586|FG004|NOT COMPLETED|Period 6||0
8977857|NCT02677844|10042587|FG005|NOT COMPLETED|Period 6||0
8977858|NCT02677844|10042588|FG006|NOT COMPLETED|Period 6||0
8977859|NCT02677844|10042582|FG000|STARTED|Period 7||0
8977860|NCT02677844|10042583|FG001|STARTED|Period 7||0
8977861|NCT02677844|10042584|FG002|STARTED|Period 7||0
8977862|NCT02677844|10042585|FG003|STARTED|Period 7||0
8977863|NCT02677844|10042586|FG004|STARTED|Period 7||7
8977864|NCT02677844|10042587|FG005|STARTED|Period 7||4
8977865|NCT02677844|10042588|FG006|STARTED|Period 7||4
8977866|NCT02677844|10042582|FG000|COMPLETED|Period 7||0
8977867|NCT02677844|10042583|FG001|COMPLETED|Period 7||0
8977868|NCT02677844|10042584|FG002|COMPLETED|Period 7||0
8977869|NCT02677844|10042585|FG003|COMPLETED|Period 7||0
8977870|NCT02677844|10042586|FG004|COMPLETED|Period 7||7
8977871|NCT02677844|10042587|FG005|COMPLETED|Period 7||4
8977872|NCT02677844|10042588|FG006|COMPLETED|Period 7||4
8977873|NCT02677844|10042582|FG000|NOT COMPLETED|Period 7||0
8977874|NCT02677844|10042583|FG001|NOT COMPLETED|Period 7||0
8977875|NCT02677844|10042584|FG002|NOT COMPLETED|Period 7||0
8977876|NCT02677844|10042585|FG003|NOT COMPLETED|Period 7||0
8977877|NCT02677844|10042586|FG004|NOT COMPLETED|Period 7||0
8977878|NCT02677844|10042587|FG005|NOT COMPLETED|Period 7||0
8977879|NCT02677844|10042588|FG006|NOT COMPLETED|Period 7||0
8977880|NCT02678000|10042612|FG000|STARTED|PART 1||7
8977881|NCT02678000|10042613|FG001|STARTED|PART 1||4
8977882|NCT02678000|10042614|FG002|STARTED|PART 1||0
8977883|NCT02678000|10042615|FG003|STARTED|PART 1||0
8977884|NCT02678000|10042616|FG004|STARTED|PART 1||0
8977885|NCT02678000|10042612|FG000|COMPLETED|PART 1||7
8977886|NCT02678000|10042613|FG001|COMPLETED|PART 1||4
8977887|NCT02678000|10042614|FG002|COMPLETED|PART 1||0
8977888|NCT02678000|10042615|FG003|COMPLETED|PART 1||0
8977889|NCT02678000|10042616|FG004|COMPLETED|PART 1||0
8977890|NCT02678000|10042612|FG000|NOT COMPLETED|PART 1||0
8977891|NCT02678000|10042613|FG001|NOT COMPLETED|PART 1||0
8977892|NCT02678000|10042614|FG002|NOT COMPLETED|PART 1||0
8977893|NCT02678000|10042615|FG003|NOT COMPLETED|PART 1||0
8977894|NCT02678000|10042616|FG004|NOT COMPLETED|PART 1||0
8977895|NCT02678000|10042612|FG000|STARTED|PART 2||0
8977896|NCT02678000|10042613|FG001|STARTED|PART 2||0
8977897|NCT02678000|10042614|FG002|STARTED|PART 2||28
8977898|NCT02678000|10042615|FG003|STARTED|PART 2||27
8977899|NCT02678000|10042616|FG004|STARTED|PART 2||18
8977900|NCT02678000|10042612|FG000|COMPLETED|PART 2||0
8977901|NCT02678000|10042613|FG001|COMPLETED|PART 2||0
8977902|NCT02678000|10042614|FG002|COMPLETED|PART 2||25
8977903|NCT02678000|10042615|FG003|COMPLETED|PART 2||26
8977904|NCT02678000|10042616|FG004|COMPLETED|PART 2||18
8977905|NCT02678000|10042612|FG000|NOT COMPLETED|PART 2||0
8977906|NCT02678000|10042613|FG001|NOT COMPLETED|PART 2||0
8977907|NCT02678000|10042614|FG002|NOT COMPLETED|PART 2||3
8977908|NCT02678000|10042615|FG003|NOT COMPLETED|PART 2||1
8977909|NCT02678000|10042616|FG004|NOT COMPLETED|PART 2||0
8977910|NCT02678039|10042643|FG000|STARTED|Overall Study||53
8977911|NCT02678039|10042644|FG001|STARTED|Overall Study||47
8977912|NCT02678039|10042643|FG000|COMPLETED|Overall Study||53
8977913|NCT02678039|10042644|FG001|COMPLETED|Overall Study||47
8977914|NCT02678039|10042643|FG000|NOT COMPLETED|Overall Study||0
8977915|NCT02678039|10042644|FG001|NOT COMPLETED|Overall Study||0
8977916|NCT02678247|10042652|FG000|STARTED|First Intervention (7 Weeks)||15
8977917|NCT02678247|10042653|FG001|STARTED|First Intervention (7 Weeks)||15
8977918|NCT02678247|10042652|FG000|COMPLETED|First Intervention (7 Weeks)||13
8977919|NCT02678247|10042653|FG001|COMPLETED|First Intervention (7 Weeks)||11
8977920|NCT02678247|10042652|FG000|NOT COMPLETED|First Intervention (7 Weeks)||2
8977921|NCT02678247|10042653|FG001|NOT COMPLETED|First Intervention (7 Weeks)||4
8977922|NCT02678247|10042652|FG000|STARTED|Second Intervention (7 Weeks)|One subject crossed over despite not completing all data collection time points for the preceding socket.|14
8977923|NCT02678247|10042653|FG001|STARTED|Second Intervention (7 Weeks)||11
8977924|NCT02678247|10042652|FG000|COMPLETED|Second Intervention (7 Weeks)||10
8977925|NCT02678247|10042653|FG001|COMPLETED|Second Intervention (7 Weeks)||9
8977926|NCT02678247|10042652|FG000|NOT COMPLETED|Second Intervention (7 Weeks)||4
8977927|NCT02678247|10042653|FG001|NOT COMPLETED|Second Intervention (7 Weeks)||2
8977928|NCT02678286|10042666|FG000|STARTED|Treatment Phase (48 Hours Post-Dose 1)||110
8977929|NCT02678286|10042667|FG001|STARTED|Treatment Phase (48 Hours Post-Dose 1)||109
8977930|NCT02678286|10042666|FG000|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||108
8977931|NCT02678286|10042667|FG001|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||107
8977932|NCT02678286|10042666|FG000|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||2
8977933|NCT02678286|10042667|FG001|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||2
8977934|NCT02678286|10042666|FG000|STARTED|Study Overall (28 Day Follow-Up)||110
8977935|NCT02678286|10042667|FG001|STARTED|Study Overall (28 Day Follow-Up)||109
8977936|NCT02678286|10042666|FG000|COMPLETED|Study Overall (28 Day Follow-Up)||104
8977937|NCT02678286|10042667|FG001|COMPLETED|Study Overall (28 Day Follow-Up)||105
8977938|NCT02678286|10042666|FG000|NOT COMPLETED|Study Overall (28 Day Follow-Up)||6
8977939|NCT02678286|10042667|FG001|NOT COMPLETED|Study Overall (28 Day Follow-Up)||4
8977940|NCT02678390|10042675|FG000|STARTED|Control (5 Days)||10
8977941|NCT02678390|10042676|FG001|STARTED|Control (5 Days)||10
8977942|NCT02678390|10042675|FG000|COMPLETED|Control (5 Days)||10
8977943|NCT02678390|10042676|FG001|COMPLETED|Control (5 Days)||10
8977944|NCT02678390|10042675|FG000|NOT COMPLETED|Control (5 Days)||0
8977945|NCT02678390|10042676|FG001|NOT COMPLETED|Control (5 Days)||0
8977946|NCT02678390|10042675|FG000|STARTED|MCT (5 Days)||10
8977947|NCT02678390|10042676|FG001|STARTED|MCT (5 Days)||10
8977948|NCT02678390|10042675|FG000|COMPLETED|MCT (5 Days)||10
8977949|NCT02678390|10042676|FG001|COMPLETED|MCT (5 Days)||10
8977950|NCT02678390|10042675|FG000|NOT COMPLETED|MCT (5 Days)||0
8977951|NCT02678390|10042676|FG001|NOT COMPLETED|MCT (5 Days)||0
8977952|NCT02678390|10042675|FG000|STARTED|AE (1 Day)||10
8977953|NCT02678390|10042676|FG001|STARTED|AE (1 Day)||10
8977954|NCT02678390|10042675|FG000|COMPLETED|AE (1 Day)||10
8977955|NCT02678390|10042676|FG001|COMPLETED|AE (1 Day)||9
8977956|NCT02678390|10042675|FG000|NOT COMPLETED|AE (1 Day)||0
8977957|NCT02678390|10042676|FG001|NOT COMPLETED|AE (1 Day)||1
8977958|NCT02678390|10042675|FG000|STARTED|MCT + AE (5 Days)||10
8977959|NCT02678390|10042676|FG001|STARTED|MCT + AE (5 Days)||9
8977960|NCT02678390|10042675|FG000|COMPLETED|MCT + AE (5 Days)||10
8977961|NCT02678390|10042676|FG001|COMPLETED|MCT + AE (5 Days)||9
8977962|NCT02678390|10042675|FG000|NOT COMPLETED|MCT + AE (5 Days)||0
8977963|NCT02678390|10042676|FG001|NOT COMPLETED|MCT + AE (5 Days)||0
8977964|NCT02678416|10042684|FG000|STARTED|Part 1||12
8977965|NCT02678416|10042684|FG000|Safety Population|Part 1||12
8977966|NCT02678416|10042684|FG000|Modified Intent to Treat (mITT)|Part 1||12
8977967|NCT02678416|10042684|FG000|Per Protocol Population|Part 1||8
8977968|NCT02678416|10042684|FG000|COMPLETED|Part 1||11
8977969|NCT02678416|10042684|FG000|NOT COMPLETED|Part 1||1
8977970|NCT02678416|10042684|FG000|STARTED|Part 2|Part 2 enrolled all new participants|67
8977971|NCT02678416|10042684|FG000|Treated (Safety Population)|Part 2||66
8977972|NCT02678416|10042684|FG000|Modified Intent to Treat Population|Part 2||66
8977973|NCT02678416|10042684|FG000|Pharmacokinetic Population|Part 2||65
8977974|NCT02678416|10042684|FG000|Per Protocol Population|Part 2||64
8977975|NCT02678416|10042684|FG000|COMPLETED|Part 2||64
8977976|NCT02678416|10042684|FG000|NOT COMPLETED|Part 2||3
8977977|NCT02678442|10042704|FG000|STARTED|First Intervention||25
8977978|NCT02678442|10042705|FG001|STARTED|First Intervention||25
8977979|NCT02678442|10042704|FG000|COMPLETED|First Intervention||25
8977980|NCT02678442|10042705|FG001|COMPLETED|First Intervention||25
8977981|NCT02678442|10042704|FG000|NOT COMPLETED|First Intervention||0
8977982|NCT02678442|10042705|FG001|NOT COMPLETED|First Intervention||0
8977983|NCT02678442|10042704|FG000|STARTED|Second Intervention||25
8977984|NCT02678442|10042705|FG001|STARTED|Second Intervention||25
8977985|NCT02678442|10042704|FG000|COMPLETED|Second Intervention||23
8977986|NCT02678442|10042705|FG001|COMPLETED|Second Intervention||23
8977987|NCT02678442|10042704|FG000|NOT COMPLETED|Second Intervention||2
8977988|NCT02678442|10042705|FG001|NOT COMPLETED|Second Intervention||2
8977989|NCT02678676|10042713|FG000|STARTED|Overall Study||1820
8877276|NCT01922102|9934213|FG000|STARTED|Overall Study||182
8877277|NCT01922102|9934214|FG001|STARTED|Overall Study||184
8877278|NCT01922102|9934215|FG002|STARTED|Overall Study||91
8877279|NCT01922102|9934213|FG000|COMPLETED|Overall Study||173
8877280|NCT01922102|9934214|FG001|COMPLETED|Overall Study||175
8877281|NCT01922102|9934215|FG002|COMPLETED|Overall Study||83
8877282|NCT01922102|9934213|FG000|NOT COMPLETED|Overall Study||9
8877283|NCT01922102|9934214|FG001|NOT COMPLETED|Overall Study||9
8877284|NCT01922102|9934215|FG002|NOT COMPLETED|Overall Study||8
8877285|NCT01922115|9934229|FG000|STARTED|Overall Study||28
8877286|NCT01922115|9934230|FG001|STARTED|Overall Study||31
8877287|NCT01922115|9934229|FG000|COMPLETED|Overall Study||21
8877288|NCT01922115|9934230|FG001|COMPLETED|Overall Study||24
8977990|NCT02678676|10042714|FG001|STARTED|Overall Study||1779
8977991|NCT02678676|10042713|FG000|COMPLETED|Overall Study||932
8977992|NCT02678676|10042714|FG001|COMPLETED|Overall Study||907
8977993|NCT02678676|10042713|FG000|NOT COMPLETED|Overall Study||888
8977994|NCT02678676|10042714|FG001|NOT COMPLETED|Overall Study||872
8977995|NCT02678923|10042722|FG000|STARTED|Overall Study||59
8977996|NCT02678923|10042723|FG001|STARTED|Overall Study||67
8977997|NCT02678923|10042722|FG000|Received at Least 1 Dose of Study Drug|Overall Study||58
8977998|NCT02678923|10042723|FG001|Received at Least 1 Dose of Study Drug|Overall Study||64
8977999|NCT02678923|10042722|FG000|mITT Population|Overall Study||52
8978000|NCT02678923|10042723|FG001|mITT Population|Overall Study||61
8978001|NCT02678923|10042722|FG000|COMPLETED|Overall Study||53
8978002|NCT02678923|10042723|FG001|COMPLETED|Overall Study||62
8978003|NCT02678923|10042722|FG000|NOT COMPLETED|Overall Study||6
8978004|NCT02678923|10042723|FG001|NOT COMPLETED|Overall Study||5
8978005|NCT02679079|10042732|FG000|STARTED|Overall Study||33
8978006|NCT02679079|10042733|FG001|STARTED|Overall Study||32
8978007|NCT02679079|10042734|FG002|STARTED|Overall Study||33
8978008|NCT02679079|10042732|FG000|ITT Analysis Set|Overall Study||31
8978009|NCT02679079|10042733|FG001|ITT Analysis Set|Overall Study||32
8978010|NCT02679079|10042734|FG002|ITT Analysis Set|Overall Study||32
8978011|NCT02679079|10042732|FG000|COMPLETED|Overall Study||29
8978012|NCT02679079|10042733|FG001|COMPLETED|Overall Study||30
8978013|NCT02679079|10042734|FG002|COMPLETED|Overall Study||31
8978014|NCT02679079|10042732|FG000|NOT COMPLETED|Overall Study||4
8978015|NCT02679079|10042733|FG001|NOT COMPLETED|Overall Study||2
8978016|NCT02679079|10042734|FG002|NOT COMPLETED|Overall Study||2
8978017|NCT02679222|10042742|FG000|STARTED|Overall Study||10
8978018|NCT02679222|10042742|FG000|COMPLETED|Overall Study||9
8978019|NCT02679222|10042742|FG000|NOT COMPLETED|Overall Study||1
8978020|NCT02679235|10042754|FG000|STARTED|Overall Study||15
8978021|NCT02679235|10042754|FG000|COMPLETED|Overall Study||11
8978022|NCT02679235|10042754|FG000|NOT COMPLETED|Overall Study||4
8978023|NCT02679274|10042760|FG000|STARTED|Overall Study||2
8978024|NCT02679274|10042761|FG001|STARTED|Overall Study||1
8978025|NCT02679274|10042760|FG000|COMPLETED|Overall Study||1
8978026|NCT02679274|10042761|FG001|COMPLETED|Overall Study||1
8978027|NCT02679274|10042760|FG000|NOT COMPLETED|Overall Study||1
8978028|NCT02679274|10042761|FG001|NOT COMPLETED|Overall Study||0
8978029|NCT02679287|10042769|FG000|STARTED|Period 1: Randomization-Study Session 1||47
8978030|NCT02679287|10042770|FG001|STARTED|Period 1: Randomization-Study Session 1||46
8978031|NCT02679287|10042769|FG000|COMPLETED|Period 1: Randomization-Study Session 1||43
8978032|NCT02679287|10042770|FG001|COMPLETED|Period 1: Randomization-Study Session 1||40
8978033|NCT02679287|10042769|FG000|NOT COMPLETED|Period 1: Randomization-Study Session 1||4
8978034|NCT02679287|10042770|FG001|NOT COMPLETED|Period 1: Randomization-Study Session 1||6
8978035|NCT02679287|10042769|FG000|STARTED|Period 2||43
8978036|NCT02679287|10042770|FG001|STARTED|Period 2||40
8978037|NCT02679287|10042769|FG000|COMPLETED|Period 2||40
8978038|NCT02679287|10042770|FG001|COMPLETED|Period 2||40
8978039|NCT02679287|10042769|FG000|NOT COMPLETED|Period 2||3
8978040|NCT02679287|10042770|FG001|NOT COMPLETED|Period 2||0
8978041|NCT02679287|10042769|FG000|STARTED|Period 3||40
8978042|NCT02679287|10042770|FG001|STARTED|Period 3||40
8978043|NCT02679287|10042769|FG000|COMPLETED|Period 3||40
8978044|NCT02679287|10042770|FG001|COMPLETED|Period 3||39
8978045|NCT02679287|10042769|FG000|NOT COMPLETED|Period 3||0
8978046|NCT02679287|10042770|FG001|NOT COMPLETED|Period 3||1
8978047|NCT02679287|10042769|FG000|STARTED|Phase 4||40
8978048|NCT02679287|10042770|FG001|STARTED|Phase 4||39
8978049|NCT02679287|10042769|FG000|COMPLETED|Phase 4||40
8978050|NCT02679287|10042770|FG001|COMPLETED|Phase 4||39
8978051|NCT02679287|10042769|FG000|NOT COMPLETED|Phase 4||0
8978052|NCT02679287|10042770|FG001|NOT COMPLETED|Phase 4||0
8978053|NCT02679469|10042782|FG000|STARTED|Overall Study||7
8978054|NCT02679469|10042782|FG000|COMPLETED|Overall Study||7
8978055|NCT02679469|10042782|FG000|NOT COMPLETED|Overall Study||0
8978056|NCT02679573|10042788|FG000|STARTED|Overall Study||431
8978057|NCT02679573|10042789|FG001|STARTED|Overall Study||428
8978058|NCT02679573|10042788|FG000|COMPLETED|Overall Study||394
8978059|NCT02679573|10042789|FG001|COMPLETED|Overall Study||389
8978060|NCT02679573|10042788|FG000|NOT COMPLETED|Overall Study||37
8978061|NCT02679573|10042789|FG001|NOT COMPLETED|Overall Study||39
8978062|NCT02679690|10042795|FG000|STARTED|Overall Study||10
8978063|NCT02679690|10042795|FG000|COMPLETED|Overall Study||9
8978064|NCT02679690|10042795|FG000|NOT COMPLETED|Overall Study||1
8978065|NCT02679729|10042810|FG000|STARTED|Overall Study||6
8978066|NCT02679729|10042811|FG001|STARTED|Overall Study||7
8978067|NCT02679729|10042812|FG002|STARTED|Overall Study||6
8978068|NCT02679729|10042813|FG003|STARTED|Overall Study||6
8978069|NCT02679729|10042814|FG004|STARTED|Overall Study||6
8978070|NCT02679729|10042815|FG005|STARTED|Overall Study||6
8978071|NCT02679729|10042816|FG006|STARTED|Overall Study||6
8978072|NCT02679729|10042817|FG007|STARTED|Overall Study||14
8978073|NCT02679729|10042818|FG008|STARTED|Overall Study||6
8978074|NCT02679729|10042810|FG000|COMPLETED|Overall Study||6
8978075|NCT02679729|10042811|FG001|COMPLETED|Overall Study||5
8978076|NCT02679729|10042812|FG002|COMPLETED|Overall Study||6
8978077|NCT02679729|10042813|FG003|COMPLETED|Overall Study||6
8978078|NCT02679729|10042814|FG004|COMPLETED|Overall Study||5
8978079|NCT02679729|10042815|FG005|COMPLETED|Overall Study||6
8571154|NCT00108082|9603386|FG001|COMPLETED|Overall Study|Per protocol Amendment 4, participants who had completed Month 12 prior to amendment were withdrawn.|68
8571155|NCT00108082|9603387|FG002|COMPLETED|Overall Study|Per protocol Amendment 4, participants who had completed Month 12 prior to amendment were withdrawn.|53
8571156|NCT00108082|9603385|FG000|NOT COMPLETED|Overall Study||38
8571157|NCT00108082|9603386|FG001|NOT COMPLETED|Overall Study||32
8571158|NCT00108082|9603387|FG002|NOT COMPLETED|Overall Study||43
8571159|NCT00108160|9603397|FG000|STARTED|Overall Study||83
8571160|NCT00108160|9603398|FG001|STARTED|Overall Study||63
8571161|NCT00108160|9603397|FG000|Completed Visit 0 (Baseline)|Overall Study|4 patients who signed consent and were randomized did not complete the initial visit to start drug|79
8571162|NCT00108160|9603398|FG001|Completed Visit 0 (Baseline)|Overall Study|3 patients who signed a consent and were randomized did not complete the initial visit to start drug|60
8571163|NCT00108160|9603397|FG000|Completed Visit 1 (2 Wks)|Overall Study||72
8571164|NCT00108160|9603398|FG001|Completed Visit 1 (2 Wks)|Overall Study||54
8571165|NCT00108160|9603397|FG000|Completed Visit 2 (3 mo)|Overall Study||54
8571166|NCT00108160|9603398|FG001|Completed Visit 2 (3 mo)|Overall Study||46
8571167|NCT00108160|9603397|FG000|Completed Visit 3 (6 mo)|Overall Study||44
8571168|NCT00108160|9603398|FG001|Completed Visit 3 (6 mo)|Overall Study||38
8571169|NCT00108160|9603397|FG000|Completed Visit 4 (9 mo)|Overall Study||38
8571170|NCT00108160|9603398|FG001|Completed Visit 4 (9 mo)|Overall Study||37
8571171|NCT00108160|9603397|FG000|Completed Visit 5 (12 mo)|Overall Study||37
8571172|NCT00108160|9603398|FG001|Completed Visit 5 (12 mo)|Overall Study||37
8571173|NCT00108160|9603397|FG000|Completed Visit 6 (15 mo)|Overall Study||36
8571174|NCT00108160|9603398|FG001|Completed Visit 6 (15 mo)|Overall Study||33
8571175|NCT00108160|9603397|FG000|Completed Visit 7 (18 mo)|Overall Study||34
8571176|NCT00108160|9603398|FG001|Completed Visit 7 (18 mo)|Overall Study||31
8571177|NCT00108160|9603397|FG000|COMPLETED|Overall Study|Patients who completed 18 months of mupirocin or developed new (recurrent) S. aureus infection.|44
8571178|NCT00108160|9603398|FG001|COMPLETED|Overall Study|Participants who completed 18 months of placebo or developed new (recurrent) S. aureus infection.|42
8571179|NCT00108160|9603397|FG000|NOT COMPLETED|Overall Study||39
8571180|NCT00108160|9603398|FG001|NOT COMPLETED|Overall Study||21
8571181|NCT00108277|9603409|FG000|STARTED|Overall Study||29
8571182|NCT00108277|9603410|FG001|STARTED|Overall Study||28
8571183|NCT00108277|9603411|FG002|STARTED|Overall Study||35
8571184|NCT00108277|9603409|FG000|COMPLETED|Overall Study||19
8571185|NCT00108277|9603410|FG001|COMPLETED|Overall Study||16
8571186|NCT00108277|9603411|FG002|COMPLETED|Overall Study||19
8571187|NCT00108277|9603409|FG000|NOT COMPLETED|Overall Study||10
8571188|NCT00108277|9603410|FG001|NOT COMPLETED|Overall Study||12
8571189|NCT00108277|9603411|FG002|NOT COMPLETED|Overall Study||16
8571190|NCT00108303|9603422|FG000|STARTED|Overall Study||179
8571191|NCT00108303|9603423|FG001|STARTED|Overall Study||179
8571192|NCT00108303|9603424|FG002|STARTED|Overall Study||180
8571193|NCT00108303|9603422|FG000|COMPLETED|Overall Study||179
8571194|NCT00108303|9603423|FG001|COMPLETED|Overall Study||179
8571195|NCT00108303|9603424|FG002|COMPLETED|Overall Study||180
8571196|NCT00108303|9603422|FG000|NOT COMPLETED|Overall Study||0
8978080|NCT02679729|10042816|FG006|COMPLETED|Overall Study||5
8571197|NCT00108303|9603423|FG001|NOT COMPLETED|Overall Study||0
8571198|NCT00108303|9603424|FG002|NOT COMPLETED|Overall Study||0
8571199|NCT00108355|9603438|FG000|STARTED|Overall Study|Two patients met inclusion criteria not randomized, one had peritonitis , other loculated ascites.|15
8577924|NCT00165958|9610871|FG001|STARTED|Overall Study||21
8978081|NCT02679729|10042817|FG007|COMPLETED|Overall Study||14
8978082|NCT02679729|10042818|FG008|COMPLETED|Overall Study||6
8978083|NCT02679729|10042810|FG000|NOT COMPLETED|Overall Study||0
8978084|NCT02679729|10042811|FG001|NOT COMPLETED|Overall Study||2
8978085|NCT02679729|10042812|FG002|NOT COMPLETED|Overall Study||0
8978086|NCT02679729|10042813|FG003|NOT COMPLETED|Overall Study||0
8978087|NCT02679729|10042814|FG004|NOT COMPLETED|Overall Study||1
8978088|NCT02679729|10042815|FG005|NOT COMPLETED|Overall Study||0
8978089|NCT02679729|10042816|FG006|NOT COMPLETED|Overall Study||1
8978090|NCT02679729|10042817|FG007|NOT COMPLETED|Overall Study||0
8978091|NCT02679729|10042818|FG008|NOT COMPLETED|Overall Study||0
8978092|NCT02679755|10042852|FG000|STARTED|Overall Study||100
8978093|NCT02679755|10042853|FG001|STARTED|Overall Study||152
8978094|NCT02679755|10042852|FG000|COMPLETED|Overall Study||66
8978095|NCT02679755|10042853|FG001|COMPLETED|Overall Study||47
8978096|NCT02679755|10042852|FG000|NOT COMPLETED|Overall Study||34
8978097|NCT02679755|10042853|FG001|NOT COMPLETED|Overall Study||105
8978098|NCT02679807|10042864|FG000|STARTED|Overall Study||165
8978099|NCT02679807|10042865|FG001|STARTED|Overall Study||169
8978100|NCT02679807|10042864|FG000|COMPLETED|Overall Study||143
8978101|NCT02679807|10042865|FG001|COMPLETED|Overall Study||153
8978102|NCT02679807|10042864|FG000|NOT COMPLETED|Overall Study||22
8978103|NCT02679807|10042865|FG001|NOT COMPLETED|Overall Study||16
8978104|NCT02679911|10042871|FG000|STARTED|Overall Study|Intra-individual study|20
8978105|NCT02679911|10042871|FG000|COMPLETED|Overall Study||20
8978106|NCT02679911|10042871|FG000|NOT COMPLETED|Overall Study||0
8978107|NCT02679976|10042876|FG000|STARTED|Overall Study||30
8978108|NCT02679976|10042876|FG000|Hyperopes|Overall Study||16
8978109|NCT02679976|10042876|FG000|Myopes|Overall Study||14
8978110|NCT02679976|10042876|FG000|COMPLETED|Overall Study||30
8978111|NCT02679976|10042876|FG000|NOT COMPLETED|Overall Study||0
8978112|NCT02680002|10042887|FG000|STARTED|Overall Study||71
8978113|NCT02680002|10042888|FG001|STARTED|Overall Study||70
8978114|NCT02680002|10042889|FG002|STARTED|Overall Study||70
8978115|NCT02680002|10042890|FG003|STARTED|Overall Study||71
8978116|NCT02680002|10042891|FG004|STARTED|Overall Study||70
8978117|NCT02680002|10042892|FG005|STARTED|Overall Study||70
8978118|NCT02680002|10042887|FG000|Day 0 (Dose 1)|Overall Study||70
8978119|NCT02680002|10042888|FG001|Day 0 (Dose 1)|Overall Study||70
8978120|NCT02680002|10042889|FG002|Day 0 (Dose 1)|Overall Study||70
8978121|NCT02680002|10042890|FG003|Day 0 (Dose 1)|Overall Study||71
8978122|NCT02680002|10042891|FG004|Day 0 (Dose 1)|Overall Study||70
8978123|NCT02680002|10042892|FG005|Day 0 (Dose 1)|Overall Study||68
8978124|NCT02680002|10042887|FG000|Day 21 (Dose 2)|Overall Study||63
8978125|NCT02680002|10042888|FG001|Day 21 (Dose 2)|Overall Study||68
8978126|NCT02680002|10042889|FG002|Day 21 (Dose 2)|Overall Study||65
8978127|NCT02680002|10042890|FG003|Day 21 (Dose 2)|Overall Study||69
8978128|NCT02680002|10042891|FG004|Day 21 (Dose 2)|Overall Study||65
8978129|NCT02680002|10042892|FG005|Day 21 (Dose 2)|Overall Study||63
8978130|NCT02680002|10042887|FG000|Day 201|Overall Study||58
8978131|NCT02680002|10042888|FG001|Day 201|Overall Study||66
8978132|NCT02680002|10042889|FG002|Day 201|Overall Study||60
8978133|NCT02680002|10042890|FG003|Day 201|Overall Study||67
8978134|NCT02680002|10042891|FG004|Day 201|Overall Study||59
8978135|NCT02680002|10042892|FG005|Day 201|Overall Study||61
8978136|NCT02680002|10042887|FG000|COMPLETED|Overall Study||58
8978137|NCT02680002|10042888|FG001|COMPLETED|Overall Study||66
8978138|NCT02680002|10042889|FG002|COMPLETED|Overall Study||60
8978139|NCT02680002|10042890|FG003|COMPLETED|Overall Study||67
8978140|NCT02680002|10042891|FG004|COMPLETED|Overall Study||59
8978141|NCT02680002|10042892|FG005|COMPLETED|Overall Study||61
8978142|NCT02680002|10042887|FG000|NOT COMPLETED|Overall Study||13
8978143|NCT02680002|10042888|FG001|NOT COMPLETED|Overall Study||4
8978144|NCT02680002|10042889|FG002|NOT COMPLETED|Overall Study||10
8978145|NCT02680002|10042890|FG003|NOT COMPLETED|Overall Study||4
8978146|NCT02680002|10042891|FG004|NOT COMPLETED|Overall Study||11
8978147|NCT02680002|10042892|FG005|NOT COMPLETED|Overall Study||9
8978148|NCT02680041|10042909|FG000|STARTED|Overall Study||221
8978149|NCT02680041|10042909|FG000|Received 18F-fluciclovine|Overall Study||213
8978150|NCT02680041|10042909|FG000|COMPLETED|Overall Study||211
8978151|NCT02680041|10042909|FG000|NOT COMPLETED|Overall Study||10
8978152|NCT02680054|10042914|FG000|STARTED|Overall Study||38
8978153|NCT02680054|10042914|FG000|COMPLETED|Overall Study||27
8978154|NCT02680054|10042914|FG000|NOT COMPLETED|Overall Study||11
8978155|NCT02680145|10042923|FG000|STARTED|Overall Study||58
8978156|NCT02680145|10042923|FG000|COMPLETED|Overall Study||47
8978157|NCT02680145|10042923|FG000|NOT COMPLETED|Overall Study||11
8978158|NCT02680158|10042927|FG000|STARTED|Overall Study||8
8978159|NCT02680158|10042928|FG001|STARTED|Overall Study||8
8978160|NCT02680158|10042929|FG002|STARTED|Overall Study||8
8978161|NCT02680158|10042930|FG003|STARTED|Overall Study||8
8978162|NCT02680158|10042931|FG004|STARTED|Overall Study||8
8978163|NCT02680158|10042932|FG005|STARTED|Overall Study||8
8978164|NCT02680158|10042927|FG000|COMPLETED|Overall Study||8
8725825|NCT01033487|9773162|FG005|NOT COMPLETED|First Intervention Period||0
8725826|NCT01033487|9773163|FG006|NOT COMPLETED|First Intervention Period||0
8978165|NCT02680158|10042928|FG001|COMPLETED|Overall Study||8
8725827|NCT01033487|9773164|FG007|NOT COMPLETED|First Intervention Period||0
8978166|NCT02680158|10042929|FG002|COMPLETED|Overall Study||8
8978167|NCT02680158|10042930|FG003|COMPLETED|Overall Study||8
8978168|NCT02680158|10042931|FG004|COMPLETED|Overall Study||8
8978169|NCT02680158|10042932|FG005|COMPLETED|Overall Study||8
8978170|NCT02680158|10042927|FG000|NOT COMPLETED|Overall Study||0
8978171|NCT02680158|10042928|FG001|NOT COMPLETED|Overall Study||0
8978172|NCT02680158|10042929|FG002|NOT COMPLETED|Overall Study||0
8978173|NCT02680158|10042930|FG003|NOT COMPLETED|Overall Study||0
8978174|NCT02680158|10042931|FG004|NOT COMPLETED|Overall Study||0
8978175|NCT02680158|10042932|FG005|NOT COMPLETED|Overall Study||0
8978176|NCT02680301|10042942|FG000|STARTED|Overall Study||22
8978177|NCT02680301|10042943|FG001|STARTED|Overall Study||18
8978178|NCT02680301|10042942|FG000|COMPLETED|Overall Study||22
8978179|NCT02680301|10042943|FG001|COMPLETED|Overall Study||17
8978180|NCT02680301|10042942|FG000|NOT COMPLETED|Overall Study||0
8978181|NCT02680301|10042943|FG001|NOT COMPLETED|Overall Study||1
8978182|NCT02680314|10042952|FG000|STARTED|Overall Study||120
8978183|NCT02680314|10042953|FG001|STARTED|Overall Study||123
8978184|NCT02680314|10042952|FG000|COMPLETED|Overall Study||120
8978185|NCT02680314|10042953|FG001|COMPLETED|Overall Study||123
8978186|NCT02680314|10042952|FG000|NOT COMPLETED|Overall Study||0
8978187|NCT02680314|10042953|FG001|NOT COMPLETED|Overall Study||0
8978188|NCT02680457|10042959|FG000|STARTED|Initial Intervention||6
8978189|NCT02680457|10042960|FG001|STARTED|Initial Intervention||6
8978190|NCT02680457|10042959|FG000|COMPLETED|Initial Intervention||6
8978191|NCT02680457|10042960|FG001|COMPLETED|Initial Intervention||6
8978192|NCT02680457|10042959|FG000|NOT COMPLETED|Initial Intervention||0
8978193|NCT02680457|10042960|FG001|NOT COMPLETED|Initial Intervention||0
8978194|NCT02680457|10042959|FG000|STARTED|Washout Period||6
8978195|NCT02680457|10042960|FG001|STARTED|Washout Period||6
8978196|NCT02680457|10042959|FG000|COMPLETED|Washout Period||6
8978197|NCT02680457|10042960|FG001|COMPLETED|Washout Period||6
8978198|NCT02680457|10042959|FG000|NOT COMPLETED|Washout Period||0
8978199|NCT02680457|10042960|FG001|NOT COMPLETED|Washout Period||0
8978200|NCT02680457|10042959|FG000|STARTED|Cross-over Intervention||6
8978201|NCT02680457|10042960|FG001|STARTED|Cross-over Intervention||6
8978202|NCT02680457|10042959|FG000|COMPLETED|Cross-over Intervention||6
8978203|NCT02680457|10042960|FG001|COMPLETED|Cross-over Intervention||6
8978204|NCT02680457|10042959|FG000|NOT COMPLETED|Cross-over Intervention||0
8978205|NCT02680457|10042960|FG001|NOT COMPLETED|Cross-over Intervention||0
8978206|NCT02680639|10042966|FG000|STARTED|Screening Period||10
8978207|NCT02680639|10042967|FG001|STARTED|Screening Period||0
8978208|NCT02680639|10042968|FG002|STARTED|Screening Period||0
8978209|NCT02680639|10042966|FG000|COMPLETED|Screening Period||3
8978210|NCT02680639|10042967|FG001|COMPLETED|Screening Period||0
8978211|NCT02680639|10042968|FG002|COMPLETED|Screening Period||0
8978212|NCT02680639|10042966|FG000|NOT COMPLETED|Screening Period||7
8978213|NCT02680639|10042967|FG001|NOT COMPLETED|Screening Period||0
8978214|NCT02680639|10042968|FG002|NOT COMPLETED|Screening Period||0
8978215|NCT02680639|10042966|FG000|STARTED|High Frequency Oscillation (HFO) Therapy||0
8978216|NCT02680639|10042967|FG001|STARTED|High Frequency Oscillation (HFO) Therapy||2
8978217|NCT02680639|10042968|FG002|STARTED|High Frequency Oscillation (HFO) Therapy||1
8978218|NCT02680639|10042966|FG000|COMPLETED|High Frequency Oscillation (HFO) Therapy||0
8978219|NCT02680639|10042967|FG001|COMPLETED|High Frequency Oscillation (HFO) Therapy||2
8978220|NCT02680639|10042968|FG002|COMPLETED|High Frequency Oscillation (HFO) Therapy||1
8978221|NCT02680639|10042966|FG000|NOT COMPLETED|High Frequency Oscillation (HFO) Therapy||0
8978222|NCT02680639|10042967|FG001|NOT COMPLETED|High Frequency Oscillation (HFO) Therapy||0
8978223|NCT02680639|10042968|FG002|NOT COMPLETED|High Frequency Oscillation (HFO) Therapy||0
8978224|NCT02680665|10042978|FG000|STARTED|Overall Study||120
8978225|NCT02680665|10042978|FG000|COMPLETED|Overall Study||115
8978226|NCT02680665|10042978|FG000|NOT COMPLETED|Overall Study||5
8978227|NCT02680756|10042984|FG000|STARTED|Overall Study||125
8978228|NCT02680756|10042985|FG001|STARTED|Overall Study||125
8978229|NCT02680756|10042984|FG000|Received Treatment|Overall Study||127
8978230|NCT02680756|10042985|FG001|Received Treatment|Overall Study||120
8978231|NCT02680756|10042984|FG000|COMPLETED|Overall Study||93
8978232|NCT02680756|10042985|FG001|COMPLETED|Overall Study||106
8978233|NCT02680756|10042984|FG000|NOT COMPLETED|Overall Study||32
8978234|NCT02680756|10042985|FG001|NOT COMPLETED|Overall Study||19
8978235|NCT02680834|10042993|FG000|STARTED|Overall Study||26
8978236|NCT02680834|10042994|FG001|STARTED|Overall Study||30
8978237|NCT02680834|10042993|FG000|COMPLETED|Overall Study||15
8978238|NCT02680834|10042994|FG001|COMPLETED|Overall Study||27
8978239|NCT02680834|10042993|FG000|NOT COMPLETED|Overall Study||11
8978240|NCT02680834|10042994|FG001|NOT COMPLETED|Overall Study||3
8978241|NCT02680847|10043003|FG000|STARTED|Overall Study||16
8978242|NCT02680847|10043004|FG001|STARTED|Overall Study||9
8978243|NCT02680847|10043005|FG002|STARTED|Overall Study||7
8978244|NCT02680847|10043003|FG000|COMPLETED|Overall Study||11
8978245|NCT02680847|10043004|FG001|COMPLETED|Overall Study||6
8978246|NCT02680847|10043005|FG002|COMPLETED|Overall Study||4
8978247|NCT02680847|10043003|FG000|NOT COMPLETED|Overall Study||5
8978248|NCT02680847|10043004|FG001|NOT COMPLETED|Overall Study||3
8978249|NCT02680847|10043005|FG002|NOT COMPLETED|Overall Study||3
8978250|NCT02681094|10043016|FG000|STARTED|1 -Modified Enrolled Participants Set||293
8978251|NCT02681094|10043017|FG001|STARTED|1 -Modified Enrolled Participants Set|A participant was randomized but did not receive treatment|294
8978252|NCT02681094|10043018|FG002|STARTED|1 -Modified Enrolled Participants Set|A participant was randomized but did not receive treatment|296
8978253|NCT02681094|10043016|FG000|Participants Completed Treatment Period|1 -Modified Enrolled Participants Set||273
8978254|NCT02681094|10043017|FG001|Participants Completed Treatment Period|1 -Modified Enrolled Participants Set||276
8978255|NCT02681094|10043018|FG002|Participants Completed Treatment Period|1 -Modified Enrolled Participants Set||283
8978256|NCT02681094|10043016|FG000|COMPLETED|1 -Modified Enrolled Participants Set||256
8978257|NCT02681094|10043017|FG001|COMPLETED|1 -Modified Enrolled Participants Set||255
8978258|NCT02681094|10043018|FG002|COMPLETED|1 -Modified Enrolled Participants Set||243
8978259|NCT02681094|10043016|FG000|NOT COMPLETED|1 -Modified Enrolled Participants Set||37
8978260|NCT02681094|10043017|FG001|NOT COMPLETED|1 -Modified Enrolled Participants Set||39
8978261|NCT02681094|10043018|FG002|NOT COMPLETED|1 -Modified Enrolled Participants Set||53
8978262|NCT02681094|10043016|FG000|STARTED|2 - Enrolled Participants Set|Population was used for the sensitivity analysis to assess the robustness of the treatment effect.|301
8978263|NCT02681094|10043017|FG001|STARTED|2 - Enrolled Participants Set|Population was used for the sensitivity analysis to assess the robustness of the treatment effect.|302
8978264|NCT02681094|10043018|FG002|STARTED|2 - Enrolled Participants Set|Population was used for the sensitivity analysis to assess the robustness of the treatment effect.|302
8978265|NCT02681094|10043016|FG000|Participants Completed Treatment Period|2 - Enrolled Participants Set||281
9038551|NCT03332784|10099761|FG000|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
9038552|NCT03332784|10099762|FG001|STARTED|Parts 1 and 2- Period 2 (1 Day)||1
9038553|NCT03332784|10099763|FG002|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
9038554|NCT03332784|10099764|FG003|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
9038555|NCT03332784|10099765|FG004|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
9038556|NCT03332784|10099766|FG005|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
9038557|NCT03332784|10099767|FG006|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
9038558|NCT03332784|10099768|FG007|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
9038559|NCT03332784|10099769|FG008|STARTED|Parts 1 and 2- Period 2 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
9038560|NCT03332784|10099770|FG009|STARTED|Parts 1 and 2- Period 2 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
9038561|NCT03332784|10099771|FG010|STARTED|Parts 1 and 2- Period 2 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
9038562|NCT03332784|10099772|FG011|STARTED|Parts 1 and 2- Period 2 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
8978266|NCT02681094|10043017|FG001|Participants Completed Treatment Period|2 - Enrolled Participants Set|A participant was randomized but did not receive treatment due to screen failure.|284
8978267|NCT02681094|10043018|FG002|Participants Completed Treatment Period|2 - Enrolled Participants Set|A participant was randomized but did not receive treatment due to screen failure.|289
8978268|NCT02681094|10043016|FG000|COMPLETED|2 - Enrolled Participants Set||261
8978269|NCT02681094|10043017|FG001|COMPLETED|2 - Enrolled Participants Set||261
8978270|NCT02681094|10043018|FG002|COMPLETED|2 - Enrolled Participants Set||248
8978271|NCT02681094|10043016|FG000|NOT COMPLETED|2 - Enrolled Participants Set||40
8978272|NCT02681094|10043017|FG001|NOT COMPLETED|2 - Enrolled Participants Set||41
8978273|NCT02681094|10043018|FG002|NOT COMPLETED|2 - Enrolled Participants Set||54
8978274|NCT02681172|10043027|FG000|STARTED|Overall Study||218
8978275|NCT02681172|10043027|FG000|Safety Analysis Set|Overall Study||205
8978276|NCT02681172|10043027|FG000|Full Analysis Set|Overall Study||205
8978277|NCT02681172|10043027|FG000|Per Protocol Set|Overall Study||205
8978278|NCT02681172|10043027|FG000|COMPLETED|Overall Study||205
8978279|NCT02681172|10043027|FG000|NOT COMPLETED|Overall Study||13
8978280|NCT02681458|10043033|FG000|STARTED|Overall Study||718
8978281|NCT02681458|10043034|FG001|STARTED|Overall Study||718
8978282|NCT02681458|10043033|FG000|COMPLETED|Overall Study||73
8978283|NCT02681458|10043034|FG001|COMPLETED|Overall Study||62
8978284|NCT02681458|10043033|FG000|NOT COMPLETED|Overall Study||645
8978285|NCT02681458|10043034|FG001|NOT COMPLETED|Overall Study||656
8978286|NCT02681510|10043040|FG000|STARTED|Overall Study||36
8978287|NCT02681510|10043040|FG000|COMPLETED|Overall Study||26
8978288|NCT02681510|10043040|FG000|NOT COMPLETED|Overall Study||10
8978289|NCT02681523|10043044|FG000|STARTED|Overall Study||8
8978290|NCT02681523|10043044|FG000|COMPLETED|Overall Study||6
8978291|NCT02681523|10043044|FG000|NOT COMPLETED|Overall Study||2
8978292|NCT02681614|10043048|FG000|STARTED|Overall Study||5
8978293|NCT02681614|10043048|FG000|COMPLETED|Overall Study||5
8978294|NCT02681614|10043048|FG000|NOT COMPLETED|Overall Study||0
8978295|NCT02681757|10043055|FG000|STARTED|Overall Study||47
8978296|NCT02681757|10043056|FG001|STARTED|Overall Study||49
8978297|NCT02681757|10043055|FG000|COMPLETED|Overall Study||47
8978298|NCT02681757|10043056|FG001|COMPLETED|Overall Study||49
8978299|NCT02681757|10043055|FG000|NOT COMPLETED|Overall Study||0
8978300|NCT02681757|10043056|FG001|NOT COMPLETED|Overall Study||0
8978301|NCT02681809|10043065|FG000|STARTED|Overall Study||20
8978302|NCT02681809|10043066|FG001|STARTED|Overall Study||19
8978303|NCT02681809|10043067|FG002|STARTED|Overall Study||9
8978304|NCT02681809|10043065|FG000|COMPLETED|Overall Study||15
8978305|NCT02681809|10043066|FG001|COMPLETED|Overall Study||15
8978306|NCT02681809|10043067|FG002|COMPLETED|Overall Study||8
8978307|NCT02681809|10043065|FG000|NOT COMPLETED|Overall Study||5
8978308|NCT02681809|10043066|FG001|NOT COMPLETED|Overall Study||4
8978309|NCT02681809|10043067|FG002|NOT COMPLETED|Overall Study||1
8978310|NCT02682030|10043077|FG000|STARTED|Overall Study||1
8978311|NCT02682030|10043078|FG001|STARTED|Overall Study||4
8978312|NCT02682030|10043077|FG000|COMPLETED|Overall Study||0
8978313|NCT02682030|10043078|FG001|COMPLETED|Overall Study||2
8978314|NCT02682030|10043077|FG000|NOT COMPLETED|Overall Study||1
8978315|NCT02682030|10043078|FG001|NOT COMPLETED|Overall Study||2
8978316|NCT02682056|10043085|FG000|STARTED|Overall Study||15
8978317|NCT02682056|10043085|FG000|COMPLETED|Overall Study||15
8978318|NCT02682056|10043085|FG000|NOT COMPLETED|Overall Study||0
8978319|NCT02682069|10043093|FG000|STARTED|Overall Study||30
8978320|NCT02682069|10043093|FG000|COMPLETED|Overall Study||30
8978321|NCT02682069|10043093|FG000|NOT COMPLETED|Overall Study||0
8978322|NCT02682264|10043099|FG000|STARTED|Overall Study||317
8978323|NCT02682264|10043100|FG001|STARTED|Overall Study||290
8978324|NCT02682264|10043099|FG000|COMPLETED|Overall Study||179
8877289|NCT01922115|9934229|FG000|NOT COMPLETED|Overall Study||7
8877290|NCT01922115|9934230|FG001|NOT COMPLETED|Overall Study||7
8877291|NCT01922219|9934236|FG000|STARTED|Overall Study||37
8877292|NCT01922219|9934236|FG000|COMPLETED|Overall Study||28
8877293|NCT01922219|9934236|FG000|NOT COMPLETED|Overall Study||9
8877294|NCT01922258|9934242|FG000|STARTED|Overall Study||133
8978325|NCT02682264|10043100|FG001|COMPLETED|Overall Study||168
8978326|NCT02682264|10043099|FG000|NOT COMPLETED|Overall Study||138
8877295|NCT01922258|9934243|FG001|STARTED|Overall Study||137
8877296|NCT01922258|9934242|FG000|COMPLETED|Overall Study||117
8877297|NCT01922258|9934243|FG001|COMPLETED|Overall Study||121
8571200|NCT00108355|9603439|FG001|STARTED|Overall Study|Two patients met inclusion criteria not randomized, one had peritonitis, other loculated ascites.|14
8571201|NCT00108355|9603438|FG000|COMPLETED|Overall Study||13
8571202|NCT00108355|9603439|FG001|COMPLETED|Overall Study||12
8571203|NCT00108355|9603438|FG000|NOT COMPLETED|Overall Study||2
8571204|NCT00108355|9603439|FG001|NOT COMPLETED|Overall Study||2
8877298|NCT01922258|9934242|FG000|NOT COMPLETED|Overall Study||16
8978327|NCT02682264|10043100|FG001|NOT COMPLETED|Overall Study||122
8978328|NCT02682381|10043109|FG000|STARTED|Overall Study||24
8978329|NCT02682381|10043110|FG001|STARTED|Overall Study||26
8978330|NCT02682381|10043111|FG002|STARTED|Overall Study||9
8978331|NCT02682381|10043109|FG000|COMPLETED|Overall Study||24
8978332|NCT02682381|10043110|FG001|COMPLETED|Overall Study||26
8978333|NCT02682381|10043111|FG002|COMPLETED|Overall Study||9
8978334|NCT02682381|10043109|FG000|NOT COMPLETED|Overall Study||0
8978335|NCT02682381|10043110|FG001|NOT COMPLETED|Overall Study||0
8978336|NCT02682381|10043111|FG002|NOT COMPLETED|Overall Study||0
8978337|NCT02682420|10043119|FG000|STARTED|Overall Study||100
8978338|NCT02682420|10043119|FG000|COMPLETED|Overall Study|Note: 63 participants completed the 6-month visit. The study was discontinued prematurely due to company acquisition and therefore, many participants did not complete their 12-month visit.|63
8978339|NCT02682420|10043119|FG000|NOT COMPLETED|Overall Study||37
8978340|NCT02682498|10043132|FG000|STARTED|Overall Study||18
8978341|NCT02682498|10043133|FG001|STARTED|Overall Study||20
8978342|NCT02682498|10043132|FG000|COMPLETED|Overall Study||18
8978343|NCT02682498|10043133|FG001|COMPLETED|Overall Study||20
8978344|NCT02682498|10043132|FG000|NOT COMPLETED|Overall Study||0
8978345|NCT02682498|10043133|FG001|NOT COMPLETED|Overall Study||0
8978346|NCT02682563|10043142|FG000|STARTED|Overall Study||24
8978347|NCT02682563|10043143|FG001|STARTED|Overall Study||20
8978348|NCT02682563|10043142|FG000|COMPLETED|Overall Study||24
8978349|NCT02682563|10043143|FG001|COMPLETED|Overall Study||20
8978350|NCT02682563|10043142|FG000|NOT COMPLETED|Overall Study||0
8978351|NCT02682563|10043143|FG001|NOT COMPLETED|Overall Study||0
8978352|NCT02682602|10043151|FG000|STARTED|Pre-operative Diseased & Normal Hips||11
8978353|NCT02682602|10043152|FG001|STARTED|Pre-operative Diseased & Normal Hips||10
8978354|NCT02682602|10043151|FG000|COMPLETED|Pre-operative Diseased & Normal Hips||10
8978355|NCT02682602|10043152|FG001|COMPLETED|Pre-operative Diseased & Normal Hips||10
8978356|NCT02682602|10043151|FG000|NOT COMPLETED|Pre-operative Diseased & Normal Hips||1
8978357|NCT02682602|10043152|FG001|NOT COMPLETED|Pre-operative Diseased & Normal Hips||0
8978358|NCT02682602|10043151|FG000|STARTED|Post-operative Fluoroscopy for Implanted||10
8978359|NCT02682602|10043152|FG001|STARTED|Post-operative Fluoroscopy for Implanted||0
8978360|NCT02682602|10043151|FG000|COMPLETED|Post-operative Fluoroscopy for Implanted||7
8978361|NCT02682602|10043152|FG001|COMPLETED|Post-operative Fluoroscopy for Implanted|Nonimplanted subjects were not analyzed again for the second period, because this would be redundant|0
8978362|NCT02682602|10043151|FG000|NOT COMPLETED|Post-operative Fluoroscopy for Implanted||3
8978363|NCT02682602|10043152|FG001|NOT COMPLETED|Post-operative Fluoroscopy for Implanted||0
8978364|NCT02682784|10043166|FG000|STARTED|Overall Study||40
8978365|NCT02682784|10043167|FG001|STARTED|Overall Study||37
8978366|NCT02682784|10043168|FG002|STARTED|Overall Study||29
8978367|NCT02682784|10043169|FG003|STARTED|Overall Study||32
8978368|NCT02682784|10043166|FG000|COMPLETED|Overall Study||39
8978369|NCT02682784|10043167|FG001|COMPLETED|Overall Study||35
8978370|NCT02682784|10043168|FG002|COMPLETED|Overall Study||27
8632339|NCT00545077|9672234|FG000|NOT COMPLETED|Overall Study||148
8632340|NCT00545077|9672235|FG001|NOT COMPLETED|Overall Study||155
8632341|NCT00545103|9672245|FG000|STARTED|Overall Study||148
8632342|NCT00545103|9672246|FG001|STARTED|Overall Study||148
8632343|NCT00545103|9672247|FG002|STARTED|Overall Study||150
8632344|NCT00545103|9672248|FG003|STARTED|Overall Study||146
8632345|NCT00545103|9672245|FG000|COMPLETED|Overall Study||73
8632346|NCT00545103|9672246|FG001|COMPLETED|Overall Study||70
8632347|NCT00545103|9672247|FG002|COMPLETED|Overall Study||74
8632348|NCT00545103|9672248|FG003|COMPLETED|Overall Study||76
8632349|NCT00545103|9672245|FG000|NOT COMPLETED|Overall Study||75
8877299|NCT01922258|9934243|FG001|NOT COMPLETED|Overall Study||16
8877300|NCT01922271|9934251|FG000|STARTED|PERIOD 1||76
8877301|NCT01922271|9934252|FG001|STARTED|PERIOD 1||76
8877302|NCT01922271|9934251|FG000|COMPLETED|PERIOD 1||76
8877303|NCT01922271|9934252|FG001|COMPLETED|PERIOD 1||76
8877304|NCT01922271|9934251|FG000|NOT COMPLETED|PERIOD 1||0
8877305|NCT01922271|9934252|FG001|NOT COMPLETED|PERIOD 1||0
8877306|NCT01922271|9934251|FG000|STARTED|WASHOUT Period||76
8877307|NCT01922271|9934252|FG001|STARTED|WASHOUT Period||76
8877308|NCT01922271|9934251|FG000|COMPLETED|WASHOUT Period||75
8877309|NCT01922271|9934252|FG001|COMPLETED|WASHOUT Period||76
8877310|NCT01922271|9934251|FG000|NOT COMPLETED|WASHOUT Period||1
8877311|NCT01922271|9934252|FG001|NOT COMPLETED|WASHOUT Period||0
8877312|NCT01922271|9934251|FG000|STARTED|PERIOD 2||75
8877313|NCT01922271|9934252|FG001|STARTED|PERIOD 2||76
8877314|NCT01922271|9934251|FG000|COMPLETED|PERIOD 2||75
8877315|NCT01922271|9934252|FG001|COMPLETED|PERIOD 2||76
8877316|NCT01922271|9934251|FG000|NOT COMPLETED|PERIOD 2||0
8877317|NCT01922271|9934252|FG001|NOT COMPLETED|PERIOD 2||0
8877318|NCT01922336|9934261|FG000|STARTED|Overall Study||53
8877319|NCT01922336|9934262|FG001|STARTED|Overall Study||53
8877320|NCT01922336|9934263|FG002|STARTED|Overall Study||53
8877321|NCT01922336|9934261|FG000|COMPLETED|Overall Study||53
8978371|NCT02682784|10043169|FG003|COMPLETED|Overall Study||29
8978372|NCT02682784|10043166|FG000|NOT COMPLETED|Overall Study||1
8978373|NCT02682784|10043167|FG001|NOT COMPLETED|Overall Study||2
8877322|NCT01922336|9934262|FG001|COMPLETED|Overall Study||53
8632350|NCT00545103|9672246|FG001|NOT COMPLETED|Overall Study||78
8877323|NCT01922336|9934263|FG002|COMPLETED|Overall Study||53
8877324|NCT01922336|9934261|FG000|NOT COMPLETED|Overall Study||0
8877325|NCT01922336|9934262|FG001|NOT COMPLETED|Overall Study||0
8877326|NCT01922336|9934263|FG002|NOT COMPLETED|Overall Study||0
8877327|NCT01922349|9934275|FG000|STARTED|Single Rising Dose (SRD) Period||25
8877328|NCT01922349|9934276|FG001|STARTED|Single Rising Dose (SRD) Period||27
8978374|NCT02682784|10043168|FG002|NOT COMPLETED|Overall Study||2
8877329|NCT01922349|9934277|FG002|STARTED|Single Rising Dose (SRD) Period||18
8877330|NCT01922349|9934278|FG003|STARTED|Single Rising Dose (SRD) Period||27
8877331|NCT01922349|9934275|FG000|COMPLETED|Single Rising Dose (SRD) Period||25
8877332|NCT01922349|9934276|FG001|COMPLETED|Single Rising Dose (SRD) Period||27
8877333|NCT01922349|9934277|FG002|COMPLETED|Single Rising Dose (SRD) Period||18
8632351|NCT00545103|9672247|FG002|NOT COMPLETED|Overall Study||76
8978375|NCT02682784|10043169|FG003|NOT COMPLETED|Overall Study||3
8978376|NCT02682823|10043184|FG000|STARTED|Overall Study||17
8978377|NCT02682823|10043185|FG001|STARTED|Overall Study||19
8978378|NCT02682823|10043186|FG002|STARTED|Overall Study||19
8978379|NCT02682823|10043187|FG003|STARTED|Overall Study||17
8978380|NCT02682823|10043188|FG004|STARTED|Overall Study||19
8978381|NCT02682823|10043184|FG000|Safety Population|Overall Study|All CGs who administered at least one dose of study drug.|17
8978382|NCT02682823|10043185|FG001|Safety Population|Overall Study|All HCPs who administered at least one dose of study drug.|19
8978383|NCT02682823|10043186|FG002|Safety Population|Overall Study|All participants who received at least one dose of study drug.|18
8978384|NCT02682823|10043187|FG003|Safety Population|Overall Study|All participants who received at least one dose of study drug.|17
8978385|NCT02682823|10043188|FG004|Safety Population|Overall Study|All participants who received at least one dose of study drug.|19
8978386|NCT02682823|10043184|FG000|COMPLETED|Overall Study||17
8978387|NCT02682823|10043185|FG001|COMPLETED|Overall Study||18
8978388|NCT02682823|10043186|FG002|COMPLETED|Overall Study||18
8978389|NCT02682823|10043187|FG003|COMPLETED|Overall Study||16
8978390|NCT02682823|10043188|FG004|COMPLETED|Overall Study||18
8978391|NCT02682823|10043184|FG000|NOT COMPLETED|Overall Study||0
8978392|NCT02682823|10043185|FG001|NOT COMPLETED|Overall Study||1
8978393|NCT02682823|10043186|FG002|NOT COMPLETED|Overall Study||1
8978394|NCT02682823|10043187|FG003|NOT COMPLETED|Overall Study||1
8978395|NCT02682823|10043188|FG004|NOT COMPLETED|Overall Study||1
8978396|NCT02683083|10043200|FG000|STARTED|Overall Study||9
8978397|NCT02683083|10043200|FG000|COMPLETED|Overall Study||9
8978398|NCT02683083|10043200|FG000|NOT COMPLETED|Overall Study||0
8978399|NCT02683109|10043206|FG000|STARTED|Overall Study||110
8978400|NCT02683109|10043207|FG001|STARTED|Overall Study||111
8978401|NCT02683109|10043206|FG000|COMPLETED|Overall Study||109
8978402|NCT02683109|10043207|FG001|COMPLETED|Overall Study||111
8978403|NCT02683109|10043206|FG000|NOT COMPLETED|Overall Study||1
8978404|NCT02683109|10043207|FG001|NOT COMPLETED|Overall Study||0
8978405|NCT02683161|10043214|FG000|STARTED|Overall Study||5
8978406|NCT02683161|10043214|FG000|COMPLETED|Overall Study||5
8978407|NCT02683161|10043214|FG000|NOT COMPLETED|Overall Study||0
8978408|NCT02683174|10043218|FG000|STARTED|Overall Study||86
8978409|NCT02683174|10043218|FG000|COMPLETED|Overall Study||86
8978410|NCT02683174|10043218|FG000|NOT COMPLETED|Overall Study||0
8978411|NCT02683187|10043223|FG000|STARTED|Overall Study||40
8978412|NCT02683187|10043223|FG000|COMPLETED|Overall Study||32
8978413|NCT02683187|10043223|FG000|NOT COMPLETED|Overall Study||8
8978414|NCT02683421|10043235|FG000|STARTED|Overall Study||5
8978415|NCT02683421|10043236|FG001|STARTED|Overall Study||4
8978416|NCT02683421|10043237|FG002|STARTED|Overall Study||4
8632352|NCT00545103|9672248|FG003|NOT COMPLETED|Overall Study||70
8632353|NCT00545155|9672258|FG000|STARTED|Overall Study||187
8632354|NCT00545155|9672258|FG000|COMPLETED|Overall Study||187
8632355|NCT00545155|9672258|FG000|NOT COMPLETED|Overall Study||0
8632356|NCT00545168|9672265|FG000|STARTED|Overall Study||203
8632357|NCT00545168|9672266|FG001|STARTED|Overall Study||63
8632358|NCT00545168|9672267|FG002|STARTED|Overall Study||214
8632359|NCT00545168|9672265|FG000|COMPLETED|Overall Study||187
8632360|NCT00545168|9672266|FG001|COMPLETED|Overall Study||58
8978417|NCT02683421|10043238|FG003|STARTED|Overall Study||5
8978418|NCT02683421|10043235|FG000|COMPLETED|Overall Study||5
8978419|NCT02683421|10043236|FG001|COMPLETED|Overall Study||4
8978420|NCT02683421|10043237|FG002|COMPLETED|Overall Study||4
8978421|NCT02683421|10043238|FG003|COMPLETED|Overall Study||5
8978422|NCT02683421|10043235|FG000|NOT COMPLETED|Overall Study||0
8978423|NCT02683421|10043236|FG001|NOT COMPLETED|Overall Study||0
8978424|NCT02683421|10043237|FG002|NOT COMPLETED|Overall Study||0
8978425|NCT02683421|10043238|FG003|NOT COMPLETED|Overall Study||0
8978426|NCT02683525|10043248|FG000|STARTED|Overall Study||37
8978427|NCT02683525|10043248|FG000|COMPLETED|Overall Study||29
8978428|NCT02683525|10043248|FG000|NOT COMPLETED|Overall Study||8
8978429|NCT02683577|10043255|FG000|STARTED|Overall Study||8
8978430|NCT02683577|10043256|FG001|STARTED|Overall Study||8
8978431|NCT02683577|10043257|FG002|STARTED|Overall Study||8
8978432|NCT02683577|10043255|FG000|COMPLETED|Overall Study||8
8978433|NCT02683577|10043256|FG001|COMPLETED|Overall Study||8
8978434|NCT02683577|10043257|FG002|COMPLETED|Overall Study||8
8978435|NCT02683577|10043255|FG000|NOT COMPLETED|Overall Study||0
8978436|NCT02683577|10043256|FG001|NOT COMPLETED|Overall Study||0
8978437|NCT02683577|10043257|FG002|NOT COMPLETED|Overall Study||0
8978438|NCT02683668|10043267|FG000|STARTED|Period 1||44
8632361|NCT00545168|9672267|FG002|COMPLETED|Overall Study||193
8978439|NCT02683668|10043268|FG001|STARTED|Period 1||0
8632362|NCT00545168|9672265|FG000|NOT COMPLETED|Overall Study||16
8632363|NCT00545168|9672266|FG001|NOT COMPLETED|Overall Study||5
8978440|NCT02683668|10043269|FG002|STARTED|Period 1||0
8978441|NCT02683668|10043267|FG000|COMPLETED|Period 1||44
8978442|NCT02683668|10043268|FG001|COMPLETED|Period 1||0
8978443|NCT02683668|10043269|FG002|COMPLETED|Period 1||0
8978444|NCT02683668|10043267|FG000|NOT COMPLETED|Period 1||0
8978445|NCT02683668|10043268|FG001|NOT COMPLETED|Period 1||0
8978446|NCT02683668|10043269|FG002|NOT COMPLETED|Period 1||0
8978447|NCT02683668|10043267|FG000|STARTED|Period 2||0
8978448|NCT02683668|10043268|FG001|STARTED|Period 2||44
8978449|NCT02683668|10043269|FG002|STARTED|Period 2||0
8978450|NCT02683668|10043267|FG000|COMPLETED|Period 2||0
8978451|NCT02683668|10043268|FG001|COMPLETED|Period 2||43
8978452|NCT02683668|10043269|FG002|COMPLETED|Period 2||0
8978453|NCT02683668|10043267|FG000|NOT COMPLETED|Period 2||0
8978454|NCT02683668|10043268|FG001|NOT COMPLETED|Period 2||1
8978455|NCT02683668|10043269|FG002|NOT COMPLETED|Period 2||0
8978456|NCT02683668|10043267|FG000|STARTED|Period 3||0
8978457|NCT02683668|10043268|FG001|STARTED|Period 3||0
8978458|NCT02683668|10043269|FG002|STARTED|Period 3||43
8978459|NCT02683668|10043267|FG000|COMPLETED|Period 3||0
8978460|NCT02683668|10043268|FG001|COMPLETED|Period 3||0
8978461|NCT02683668|10043269|FG002|COMPLETED|Period 3||43
8978462|NCT02683668|10043267|FG000|NOT COMPLETED|Period 3||0
8978463|NCT02683668|10043268|FG001|NOT COMPLETED|Period 3||0
8978464|NCT02683668|10043269|FG002|NOT COMPLETED|Period 3||0
8978465|NCT02683707|10043277|FG000|STARTED|Overall Study||105
8978466|NCT02683707|10043278|FG001|STARTED|Overall Study||107
8978467|NCT02683707|10043277|FG000|COMPLETED|Overall Study||105
8978468|NCT02683707|10043278|FG001|COMPLETED|Overall Study||107
8978469|NCT02683707|10043277|FG000|NOT COMPLETED|Overall Study||0
8978470|NCT02683707|10043278|FG001|NOT COMPLETED|Overall Study||0
8978471|NCT02683746|10043286|FG000|STARTED|Overall Study||154
8978472|NCT02683746|10043287|FG001|STARTED|Overall Study||154
8978473|NCT02683746|10043286|FG000|COMPLETED|Overall Study||138
8978474|NCT02683746|10043287|FG001|COMPLETED|Overall Study||140
8978475|NCT02683746|10043286|FG000|NOT COMPLETED|Overall Study||16
8978476|NCT02683746|10043287|FG001|NOT COMPLETED|Overall Study||14
8978477|NCT02683772|10043293|FG000|STARTED|Overall Study||15
8978478|NCT02683772|10043294|FG001|STARTED|Overall Study||23
8978479|NCT02683772|10043293|FG000|COMPLETED|Overall Study||15
8978480|NCT02683772|10043294|FG001|COMPLETED|Overall Study||23
8978481|NCT02683772|10043293|FG000|NOT COMPLETED|Overall Study||0
8978482|NCT02683772|10043294|FG001|NOT COMPLETED|Overall Study||0
8978483|NCT02683785|10043306|FG000|STARTED|Overall Study||22
8978484|NCT02683785|10043307|FG001|STARTED|Overall Study||22
8978485|NCT02683785|10043306|FG000|COMPLETED|Overall Study||21
8978486|NCT02683785|10043307|FG001|COMPLETED|Overall Study||18
8978487|NCT02683785|10043306|FG000|NOT COMPLETED|Overall Study||1
8978488|NCT02683785|10043307|FG001|NOT COMPLETED|Overall Study||4
8978489|NCT02683876|10043317|FG000|STARTED|Overall Study||17
8978490|NCT02683876|10043318|FG001|STARTED|Overall Study||22
8978491|NCT02683876|10043317|FG000|COMPLETED|Overall Study||15
8978492|NCT02683876|10043318|FG001|COMPLETED|Overall Study||22
8978493|NCT02683876|10043317|FG000|NOT COMPLETED|Overall Study||2
8978494|NCT02683876|10043318|FG001|NOT COMPLETED|Overall Study||0
8978495|NCT02683928|10043328|FG000|STARTED|Overall Study||48
8978496|NCT02683928|10043329|FG001|STARTED|Overall Study||16
8978497|NCT02683928|10043328|FG000|COMPLETED|Overall Study||26
8978498|NCT02683928|10043329|FG001|COMPLETED|Overall Study||8
8978499|NCT02683928|10043328|FG000|NOT COMPLETED|Overall Study||22
8978500|NCT02683928|10043329|FG001|NOT COMPLETED|Overall Study||8
9038563|NCT03332784|10099773|FG012|STARTED|Parts 1 and 2- Period 2 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
9038564|NCT03332784|10099774|FG013|STARTED|Parts 1 and 2- Period 2 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
9038565|NCT03332784|10099775|FG014|STARTED|Parts 1 and 2- Period 2 (1 Day)||1
9038566|NCT03332784|10099776|FG015|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
9038567|NCT03332784|10099777|FG016|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
9038568|NCT03332784|10099778|FG017|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
9038569|NCT03332784|10099779|FG018|STARTED|Parts 1 and 2- Period 2 (1 Day)||3
9038570|NCT03332784|10099780|FG019|STARTED|Parts 1 and 2- Period 2 (1 Day)||3
9038571|NCT03332784|10099761|FG000|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
9038572|NCT03332784|10099762|FG001|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||1
9038573|NCT03332784|10099763|FG002|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
9038574|NCT03332784|10099764|FG003|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
9038575|NCT03332784|10099765|FG004|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
8632364|NCT00545168|9672267|FG002|NOT COMPLETED|Overall Study||21
8632365|NCT00545181|9672278|FG000|STARTED|Overall Study||29
8632366|NCT00545181|9672279|FG001|STARTED|Overall Study||25
8632367|NCT00545181|9672278|FG000|COMPLETED|Overall Study||29
9038576|NCT03332784|10099766|FG005|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
9038577|NCT03332784|10099767|FG006|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
8632368|NCT00545181|9672279|FG001|COMPLETED|Overall Study||25
9038578|NCT03332784|10099768|FG007|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
9038579|NCT03332784|10099769|FG008|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
9038580|NCT03332784|10099770|FG009|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
9038581|NCT03332784|10099771|FG010|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
9038582|NCT03332784|10099772|FG011|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
9038583|NCT03332784|10099773|FG012|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
9038584|NCT03332784|10099774|FG013|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
9038585|NCT03332784|10099775|FG014|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||1
9038586|NCT03332784|10099776|FG015|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
9038587|NCT03332784|10099777|FG016|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
9038588|NCT03332784|10099778|FG017|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
9038589|NCT03332784|10099779|FG018|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||3
8632369|NCT00545181|9672278|FG000|NOT COMPLETED|Overall Study||0
9038590|NCT03332784|10099780|FG019|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||3
9038591|NCT03332784|10099761|FG000|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
9038592|NCT03332784|10099762|FG001|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
8978501|NCT02683941|10043337|FG000|STARTED|Double-blind Phase||51
8978502|NCT02683941|10043338|FG001|STARTED|Double-blind Phase||26
8978503|NCT02683941|10043337|FG000|COMPLETED|Double-blind Phase||41
8978504|NCT02683941|10043338|FG001|COMPLETED|Double-blind Phase||21
8978505|NCT02683941|10043337|FG000|NOT COMPLETED|Double-blind Phase||10
8978506|NCT02683941|10043338|FG001|NOT COMPLETED|Double-blind Phase||5
8978507|NCT02683941|10043337|FG000|STARTED|Open-label Treatment Phase||21
8978508|NCT02683941|10043338|FG001|STARTED|Open-label Treatment Phase||19
8978509|NCT02683941|10043337|FG000|COMPLETED|Open-label Treatment Phase||1
8978510|NCT02683941|10043338|FG001|COMPLETED|Open-label Treatment Phase||6
8978511|NCT02683941|10043337|FG000|NOT COMPLETED|Open-label Treatment Phase||20
8978512|NCT02683941|10043338|FG001|NOT COMPLETED|Open-label Treatment Phase||13
8978513|NCT02683941|10043337|FG000|STARTED|Open-label Follow-up Phase||18
8978514|NCT02683941|10043338|FG001|STARTED|Open-label Follow-up Phase||8
8978515|NCT02683941|10043337|FG000|COMPLETED|Open-label Follow-up Phase||0
8978516|NCT02683941|10043338|FG001|COMPLETED|Open-label Follow-up Phase||0
8978517|NCT02683941|10043337|FG000|NOT COMPLETED|Open-label Follow-up Phase||18
8978518|NCT02683941|10043338|FG001|NOT COMPLETED|Open-label Follow-up Phase||8
8978519|NCT02683954|10043350|FG000|STARTED|Overall Study||30
8978520|NCT02683954|10043351|FG001|STARTED|Overall Study||30
8978521|NCT02683954|10043350|FG000|COMPLETED|Overall Study||30
8978522|NCT02683954|10043351|FG001|COMPLETED|Overall Study||30
8978523|NCT02683954|10043350|FG000|NOT COMPLETED|Overall Study||0
8978524|NCT02683954|10043351|FG001|NOT COMPLETED|Overall Study||0
8978525|NCT02684097|10043359|FG000|STARTED|Overall Study||15
8978526|NCT02684097|10043360|FG001|STARTED|Overall Study||7
8978527|NCT02684097|10043359|FG000|COMPLETED|Overall Study||2
8978528|NCT02684097|10043360|FG001|COMPLETED|Overall Study||1
8978529|NCT02684097|10043359|FG000|NOT COMPLETED|Overall Study||13
8978530|NCT02684097|10043360|FG001|NOT COMPLETED|Overall Study||6
8978531|NCT02684136|10043366|FG000|STARTED|First Intervention (9 Nights)||5
8978532|NCT02684136|10043367|FG001|STARTED|First Intervention (9 Nights)||5
8978533|NCT02684136|10043366|FG000|COMPLETED|First Intervention (9 Nights)||5
8978534|NCT02684136|10043367|FG001|COMPLETED|First Intervention (9 Nights)||5
8978535|NCT02684136|10043366|FG000|NOT COMPLETED|First Intervention (9 Nights)||0
8978536|NCT02684136|10043367|FG001|NOT COMPLETED|First Intervention (9 Nights)||0
8978537|NCT02684136|10043366|FG000|STARTED|Washout (7 Days)||5
8978538|NCT02684136|10043367|FG001|STARTED|Washout (7 Days)||5
8978539|NCT02684136|10043366|FG000|COMPLETED|Washout (7 Days)||5
8978540|NCT02684136|10043367|FG001|COMPLETED|Washout (7 Days)||5
8978541|NCT02684136|10043366|FG000|NOT COMPLETED|Washout (7 Days)||0
8978542|NCT02684136|10043367|FG001|NOT COMPLETED|Washout (7 Days)||0
8978543|NCT02684136|10043366|FG000|STARTED|Second Intervention (9 Nights)||5
8978544|NCT02684136|10043367|FG001|STARTED|Second Intervention (9 Nights)||5
8978545|NCT02684136|10043366|FG000|COMPLETED|Second Intervention (9 Nights)||5
8978546|NCT02684136|10043367|FG001|COMPLETED|Second Intervention (9 Nights)||5
8978547|NCT02684136|10043366|FG000|NOT COMPLETED|Second Intervention (9 Nights)||0
8978548|NCT02684136|10043367|FG001|NOT COMPLETED|Second Intervention (9 Nights)||0
8978549|NCT02684188|10043375|FG000|STARTED|Overall Study||77
8978550|NCT02684188|10043376|FG001|STARTED|Overall Study||50
8978551|NCT02684188|10043375|FG000|COMPLETED|Overall Study||75
8978552|NCT02684188|10043376|FG001|COMPLETED|Overall Study||47
8978553|NCT02684188|10043375|FG000|NOT COMPLETED|Overall Study||2
8978554|NCT02684188|10043376|FG001|NOT COMPLETED|Overall Study||3
8978555|NCT02684279|10043385|FG000|STARTED|Overall Study||528
8978556|NCT02684279|10043385|FG000|COMPLETED|Overall Study||249
8978557|NCT02684279|10043385|FG000|NOT COMPLETED|Overall Study||279
8978558|NCT02684344|10043391|FG000|STARTED|Overall Study||1
8978559|NCT02684344|10043392|FG001|STARTED|Overall Study||4
8978560|NCT02684344|10043391|FG000|COMPLETED|Overall Study||1
8978561|NCT02684344|10043392|FG001|COMPLETED|Overall Study||3
8978562|NCT02684344|10043391|FG000|NOT COMPLETED|Overall Study||0
8978563|NCT02684344|10043392|FG001|NOT COMPLETED|Overall Study||1
8978564|NCT02684357|10043401|FG000|STARTED|Part A||98
8978565|NCT02684357|10043402|FG001|STARTED|Part A||99
8978566|NCT02684357|10043403|FG002|STARTED|Part A||294
8978567|NCT02684357|10043404|FG003|STARTED|Part A||0
8978568|NCT02684357|10043405|FG004|STARTED|Part A||0
8978569|NCT02684357|10043406|FG005|STARTED|Part A||0
8978570|NCT02684357|10043401|FG000|COMPLETED|Part A||94
8978571|NCT02684357|10043402|FG001|COMPLETED|Part A||96
8978572|NCT02684357|10043403|FG002|COMPLETED|Part A||292
8978573|NCT02684357|10043404|FG003|COMPLETED|Part A||0
8978574|NCT02684357|10043405|FG004|COMPLETED|Part A||0
8978575|NCT02684357|10043406|FG005|COMPLETED|Part A||0
8978576|NCT02684357|10043401|FG000|NOT COMPLETED|Part A||4
8978577|NCT02684357|10043402|FG001|NOT COMPLETED|Part A||3
8978578|NCT02684357|10043403|FG002|NOT COMPLETED|Part A||2
8978579|NCT02684357|10043404|FG003|NOT COMPLETED|Part A||0
8978580|NCT02684357|10043405|FG004|NOT COMPLETED|Part A||0
8571205|NCT00108485|9603447|FG000|STARTED|Overall Study||5
8571206|NCT00108485|9603448|FG001|STARTED|Overall Study||4
8571207|NCT00108485|9603447|FG000|COMPLETED|Overall Study||2
8571208|NCT00108485|9603448|FG001|COMPLETED|Overall Study||2
8571209|NCT00108485|9603447|FG000|NOT COMPLETED|Overall Study||3
8571210|NCT00108485|9603448|FG001|NOT COMPLETED|Overall Study||2
8571211|NCT00108524|9603456|FG000|STARTED|Overall Study||81
8571212|NCT00108524|9603457|FG001|STARTED|Overall Study||79
8571213|NCT00108524|9603456|FG000|COMPLETED|Overall Study||52
8571214|NCT00108524|9603457|FG001|COMPLETED|Overall Study||61
8571215|NCT00108524|9603456|FG000|NOT COMPLETED|Overall Study||29
8978581|NCT02684357|10043406|FG005|NOT COMPLETED|Part A||0
8978582|NCT02684357|10043401|FG000|STARTED|Part B||0
8978583|NCT02684357|10043402|FG001|STARTED|Part B||0
8571216|NCT00108524|9603457|FG001|NOT COMPLETED|Overall Study||18
8571217|NCT00108550|9603465|FG000|STARTED|Overall Study||55
8978584|NCT02684357|10043403|FG002|STARTED|Part B||0
8978585|NCT02684357|10043404|FG003|STARTED|Part B|Participants who received placebo in Part A received risankizumab in Part B|94
8978586|NCT02684357|10043405|FG004|STARTED|Part B|2 participants who received ustekinumab in Part A did not receive a dose of study drug in Part B.|94
8978587|NCT02684357|10043406|FG005|STARTED|Part B|1 participant who received risankizumab in Part A did not receive a dose of study drug in Part B|291
8978588|NCT02684357|10043401|FG000|COMPLETED|Part B||0
8978589|NCT02684357|10043402|FG001|COMPLETED|Part B||0
8978590|NCT02684357|10043403|FG002|COMPLETED|Part B||0
8978591|NCT02684357|10043404|FG003|COMPLETED|Part B||91
8725828|NCT01033487|9773165|FG008|NOT COMPLETED|First Intervention Period||0
8725829|NCT01033487|9773166|FG009|NOT COMPLETED|First Intervention Period||0
8725830|NCT01033487|9773157|FG000|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
8725831|NCT01033487|9773158|FG001|STARTED|Between Period 1 and 2 (At Least 7 Days)||3
8725832|NCT01033487|9773159|FG002|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
8978592|NCT02684357|10043405|FG004|COMPLETED|Part B||90
8978593|NCT02684357|10043406|FG005|COMPLETED|Part B||278
8978594|NCT02684357|10043401|FG000|NOT COMPLETED|Part B||0
8978595|NCT02684357|10043402|FG001|NOT COMPLETED|Part B||0
8978596|NCT02684357|10043403|FG002|NOT COMPLETED|Part B||0
8978597|NCT02684357|10043404|FG003|NOT COMPLETED|Part B||3
8978598|NCT02684357|10043405|FG004|NOT COMPLETED|Part B||4
8978599|NCT02684357|10043406|FG005|NOT COMPLETED|Part B||13
8978600|NCT02684370|10043422|FG000|STARTED|Part A||102
8978601|NCT02684370|10043423|FG001|STARTED|Part A||100
8978602|NCT02684370|10043424|FG002|STARTED|Part A||304
8978603|NCT02684370|10043425|FG003|STARTED|Part A||0
8978604|NCT02684370|10043426|FG004|STARTED|Part A||0
8978605|NCT02684370|10043427|FG005|STARTED|Part A||0
8978606|NCT02684370|10043422|FG000|COMPLETED|Part A||98
8978607|NCT02684370|10043423|FG001|COMPLETED|Part A||99
8978608|NCT02684370|10043424|FG002|COMPLETED|Part A||299
8978609|NCT02684370|10043425|FG003|COMPLETED|Part A||0
8978610|NCT02684370|10043426|FG004|COMPLETED|Part A||0
8978611|NCT02684370|10043427|FG005|COMPLETED|Part A||0
8978612|NCT02684370|10043422|FG000|NOT COMPLETED|Part A||4
8978613|NCT02684370|10043423|FG001|NOT COMPLETED|Part A||1
8877334|NCT01922349|9934278|FG003|COMPLETED|Single Rising Dose (SRD) Period||27
8877335|NCT01922349|9934275|FG000|NOT COMPLETED|Single Rising Dose (SRD) Period||0
8877336|NCT01922349|9934276|FG001|NOT COMPLETED|Single Rising Dose (SRD) Period||0
8877337|NCT01922349|9934277|FG002|NOT COMPLETED|Single Rising Dose (SRD) Period||0
8877338|NCT01922349|9934278|FG003|NOT COMPLETED|Single Rising Dose (SRD) Period||0
8877339|NCT01922349|9934275|FG000|STARTED|Multiple Rising Dose (MRD) Period|One subject discontinued the trial after the SRD period due to non-compliance with the protocol.|24
8877340|NCT01922349|9934276|FG001|STARTED|Multiple Rising Dose (MRD) Period||27
8877341|NCT01922349|9934277|FG002|STARTED|Multiple Rising Dose (MRD) Period||18
8877342|NCT01922349|9934278|FG003|STARTED|Multiple Rising Dose (MRD) Period||27
8877343|NCT01922349|9934275|FG000|COMPLETED|Multiple Rising Dose (MRD) Period||24
8877344|NCT01922349|9934276|FG001|COMPLETED|Multiple Rising Dose (MRD) Period||27
8877345|NCT01922349|9934277|FG002|COMPLETED|Multiple Rising Dose (MRD) Period||18
8877346|NCT01922349|9934278|FG003|COMPLETED|Multiple Rising Dose (MRD) Period||26
8877347|NCT01922349|9934275|FG000|NOT COMPLETED|Multiple Rising Dose (MRD) Period||0
8877348|NCT01922349|9934276|FG001|NOT COMPLETED|Multiple Rising Dose (MRD) Period||0
8877349|NCT01922349|9934277|FG002|NOT COMPLETED|Multiple Rising Dose (MRD) Period||0
8877350|NCT01922349|9934278|FG003|NOT COMPLETED|Multiple Rising Dose (MRD) Period||1
8877351|NCT01922739|9934314|FG000|STARTED|Titration/Adjustment Period||182
8877352|NCT01922739|9934314|FG000|Safety Analysis Set|Titration/Adjustment Period||182
8877353|NCT01922739|9934314|FG000|COMPLETED|Titration/Adjustment Period||170
8877354|NCT01922739|9934314|FG000|NOT COMPLETED|Titration/Adjustment Period||12
8877355|NCT01922739|9934314|FG000|STARTED|Open-label Treatment Period||170
8877356|NCT01922739|9934314|FG000|Treatment SAS and FAS|Open-label Treatment Period|SAS = safety analysis set FAS = full analysis set|170
8877357|NCT01922739|9934314|FG000|COMPLETED|Open-label Treatment Period||136
8877358|NCT01922739|9934314|FG000|NOT COMPLETED|Open-label Treatment Period||34
8877359|NCT01922934|9934332|FG000|STARTED|Eligible Patients||428
8877360|NCT01922934|9934333|FG001|STARTED|Eligible Patients||4302
8877361|NCT01922934|9934332|FG000|COMPLETED|Eligible Patients|375 patients determined eligible after original random selection from DHHA data warehouse.|375
8978614|NCT02684370|10043424|FG002|NOT COMPLETED|Part A||5
8978615|NCT02684370|10043425|FG003|NOT COMPLETED|Part A||0
8978616|NCT02684370|10043426|FG004|NOT COMPLETED|Part A||0
8978617|NCT02684370|10043427|FG005|NOT COMPLETED|Part A||0
8978618|NCT02684370|10043422|FG000|STARTED|Part B||0
8978619|NCT02684370|10043423|FG001|STARTED|Part B||0
8978620|NCT02684370|10043424|FG002|STARTED|Part B||0
8978621|NCT02684370|10043425|FG003|STARTED|Part B|1 participant who received placebo in Part A did not receive a dose of study drug in Part B|97
8978622|NCT02684370|10043426|FG004|STARTED|Part B|Participants who received ustekinumab in Part A received ustekinumab in Part B|99
8978623|NCT02684370|10043427|FG005|STARTED|Part B|2 participants who received risankizumab in Part A did not receive a dose of study drug in Part B|297
8978624|NCT02684370|10043422|FG000|COMPLETED|Part B||0
8978625|NCT02684370|10043423|FG001|COMPLETED|Part B||0
8978626|NCT02684370|10043424|FG002|COMPLETED|Part B||0
8978627|NCT02684370|10043425|FG003|COMPLETED|Part B||95
8978628|NCT02684370|10043426|FG004|COMPLETED|Part B||94
8978629|NCT02684370|10043427|FG005|COMPLETED|Part B||289
8978630|NCT02684370|10043422|FG000|NOT COMPLETED|Part B||0
8978631|NCT02684370|10043423|FG001|NOT COMPLETED|Part B||0
8978632|NCT02684370|10043424|FG002|NOT COMPLETED|Part B||0
8978633|NCT02684370|10043425|FG003|NOT COMPLETED|Part B||2
8978634|NCT02684370|10043426|FG004|NOT COMPLETED|Part B||5
8978635|NCT02684370|10043427|FG005|NOT COMPLETED|Part B||8
8978636|NCT02684396|10043447|FG000|STARTED|Overall Study||6
8978637|NCT02684396|10043448|FG001|STARTED|Overall Study||6
8978638|NCT02684396|10043449|FG002|STARTED|Overall Study||6
8978639|NCT02684396|10043450|FG003|STARTED|Overall Study||6
8978640|NCT02684396|10043451|FG004|STARTED|Overall Study||5
8978641|NCT02684396|10043452|FG005|STARTED|Overall Study||10
8978642|NCT02684396|10043447|FG000|COMPLETED|Overall Study||6
8978643|NCT02684396|10043448|FG001|COMPLETED|Overall Study||6
8978644|NCT02684396|10043449|FG002|COMPLETED|Overall Study||6
8978645|NCT02684396|10043450|FG003|COMPLETED|Overall Study||6
8978646|NCT02684396|10043451|FG004|COMPLETED|Overall Study||5
8978647|NCT02684396|10043452|FG005|COMPLETED|Overall Study||10
8978648|NCT02684396|10043447|FG000|NOT COMPLETED|Overall Study||0
8978649|NCT02684396|10043448|FG001|NOT COMPLETED|Overall Study||0
8978650|NCT02684396|10043449|FG002|NOT COMPLETED|Overall Study||0
8978651|NCT02684396|10043450|FG003|NOT COMPLETED|Overall Study||0
8978652|NCT02684396|10043451|FG004|NOT COMPLETED|Overall Study||0
8978653|NCT02684396|10043452|FG005|NOT COMPLETED|Overall Study||0
8978654|NCT02684435|10043466|FG000|STARTED|Overall Study||63
8978655|NCT02684435|10043466|FG000|COMPLETED|Overall Study||63
8978656|NCT02684435|10043466|FG000|NOT COMPLETED|Overall Study||0
8978657|NCT02684591|10043472|FG000|STARTED|Overall Study||25
8978658|NCT02684591|10043473|FG001|STARTED|Overall Study||25
8978659|NCT02684591|10043472|FG000|COMPLETED|Overall Study||24
8978660|NCT02684591|10043473|FG001|COMPLETED|Overall Study||22
8978661|NCT02684591|10043472|FG000|NOT COMPLETED|Overall Study||1
8978662|NCT02684591|10043473|FG001|NOT COMPLETED|Overall Study||3
8978663|NCT02684604|10043481|FG000|STARTED|Overall Study||44
8978664|NCT02684604|10043482|FG001|STARTED|Overall Study||44
8978665|NCT02684604|10043481|FG000|COMPLETED|Overall Study||44
8978666|NCT02684604|10043482|FG001|COMPLETED|Overall Study||44
8978667|NCT02684604|10043481|FG000|NOT COMPLETED|Overall Study||0
8978668|NCT02684604|10043482|FG001|NOT COMPLETED|Overall Study||0
8978669|NCT02684617|10043491|FG000|STARTED|Overall Study||18
8978670|NCT02684617|10043492|FG001|STARTED|Overall Study||17
8978671|NCT02684617|10043493|FG002|STARTED|Overall Study||40
8978672|NCT02684617|10043491|FG000|Treated|Overall Study||17
8978673|NCT02684617|10043492|FG001|Treated|Overall Study||17
8978674|NCT02684617|10043493|FG002|Treated|Overall Study||38
8978675|NCT02684617|10043491|FG000|COMPLETED|Overall Study||0
8978676|NCT02684617|10043492|FG001|COMPLETED|Overall Study||0
8978677|NCT02684617|10043493|FG002|COMPLETED|Overall Study||0
8978678|NCT02684617|10043491|FG000|NOT COMPLETED|Overall Study||18
8978679|NCT02684617|10043492|FG001|NOT COMPLETED|Overall Study||17
8978680|NCT02684617|10043493|FG002|NOT COMPLETED|Overall Study||40
8978681|NCT02684630|10043503|FG000|STARTED|Overall Study||65
8978682|NCT02684630|10043504|FG001|STARTED|Overall Study||63
8978683|NCT02684630|10043503|FG000|COMPLETED|Overall Study||60
8978684|NCT02684630|10043504|FG001|COMPLETED|Overall Study||60
8978685|NCT02684630|10043503|FG000|NOT COMPLETED|Overall Study||5
8978686|NCT02684630|10043504|FG001|NOT COMPLETED|Overall Study||3
8978687|NCT02684942|10043512|FG000|STARTED|Overall Study||7
8978688|NCT02684942|10043513|FG001|STARTED|Overall Study||7
8978689|NCT02684942|10043514|FG002|STARTED|Overall Study||7
8978690|NCT02684942|10043515|FG003|STARTED|Overall Study||7
8978691|NCT02684942|10043516|FG004|STARTED|Overall Study||6
8978692|NCT02684942|10043517|FG005|STARTED|Overall Study||6
8978693|NCT02684942|10043512|FG000|COMPLETED|Overall Study||7
8978694|NCT02684942|10043513|FG001|COMPLETED|Overall Study||7
8978695|NCT02684942|10043514|FG002|COMPLETED|Overall Study||7
8978696|NCT02684942|10043515|FG003|COMPLETED|Overall Study||7
8978697|NCT02684942|10043516|FG004|COMPLETED|Overall Study||6
8978698|NCT02684942|10043517|FG005|COMPLETED|Overall Study||6
8632370|NCT00545181|9672279|FG001|NOT COMPLETED|Overall Study||0
8632371|NCT00545233|9672287|FG000|STARTED|Overall Study||79
8632372|NCT00545233|9672288|FG001|STARTED|Overall Study||76
8632373|NCT00545233|9672287|FG000|Safety Set|Overall Study||77
8632374|NCT00545233|9672288|FG001|Safety Set|Overall Study||75
8632375|NCT00545233|9672287|FG000|Intent-to-Treat (ITT)|Overall Study||77
8978699|NCT02684942|10043512|FG000|NOT COMPLETED|Overall Study||0
8978700|NCT02684942|10043513|FG001|NOT COMPLETED|Overall Study||0
8978701|NCT02684942|10043514|FG002|NOT COMPLETED|Overall Study||0
8978702|NCT02684942|10043515|FG003|NOT COMPLETED|Overall Study||0
8978703|NCT02684942|10043516|FG004|NOT COMPLETED|Overall Study||0
8978704|NCT02684942|10043517|FG005|NOT COMPLETED|Overall Study||0
8978705|NCT02684981|10043531|FG000|STARTED|Overall Study||4100
8978706|NCT02684981|10043532|FG001|STARTED|Overall Study||3179
8978707|NCT02684981|10043533|FG002|STARTED|Overall Study||2186
8978708|NCT02684981|10043531|FG000|COMPLETED|Overall Study||3860
8978709|NCT02684981|10043532|FG001|COMPLETED|Overall Study||2969
8978710|NCT02684981|10043533|FG002|COMPLETED|Overall Study||2059
8978711|NCT02684981|10043531|FG000|NOT COMPLETED|Overall Study||240
8978712|NCT02684981|10043532|FG001|NOT COMPLETED|Overall Study||210
8978713|NCT02684981|10043533|FG002|NOT COMPLETED|Overall Study||127
8978714|NCT02685007|10043547|FG000|STARTED|Overall Study||131
8978715|NCT02685007|10043547|FG000|COMPLETED|Overall Study||131
8978716|NCT02685007|10043547|FG000|NOT COMPLETED|Overall Study||0
8978717|NCT02685033|10043553|FG000|STARTED|Overall Study||70
8978718|NCT02685033|10043554|FG001|STARTED|Overall Study||10
8978719|NCT02685033|10043553|FG000|COMPLETED|Overall Study||67
8978720|NCT02685033|10043554|FG001|COMPLETED|Overall Study||8
8978721|NCT02685033|10043553|FG000|NOT COMPLETED|Overall Study||3
8978722|NCT02685033|10043554|FG001|NOT COMPLETED|Overall Study||2
8978723|NCT02685072|10043562|FG000|STARTED|Treatment Period||33
8978724|NCT02685072|10043563|FG001|STARTED|Treatment Period||31
8978725|NCT02685072|10043562|FG000|Completed Week 2 Visit|Treatment Period||23
8978726|NCT02685072|10043563|FG001|Completed Week 2 Visit|Treatment Period||26
8978727|NCT02685072|10043562|FG000|Completed Week 3 Visit|Treatment Period||20
8978728|NCT02685072|10043563|FG001|Completed Week 3 Visit|Treatment Period||23
8632376|NCT00545233|9672288|FG001|Intent-to-Treat (ITT)|Overall Study||73
8632377|NCT00545233|9672287|FG000|COMPLETED|Overall Study||33
8632378|NCT00545233|9672288|FG001|COMPLETED|Overall Study||41
8978729|NCT02685072|10043562|FG000|Completed Week 4 Visit|Treatment Period||19
8632379|NCT00545233|9672287|FG000|NOT COMPLETED|Overall Study||46
8632380|NCT00545233|9672288|FG001|NOT COMPLETED|Overall Study||35
8632381|NCT00545272|9672301|FG000|STARTED|Overall Study||61
8632382|NCT00545272|9672302|FG001|STARTED|Overall Study||68
8632383|NCT00545272|9672303|FG002|STARTED|Overall Study||65
8632384|NCT00545272|9672304|FG003|STARTED|Overall Study||72
8632385|NCT00545272|9672305|FG004|STARTED|Overall Study||64
8978730|NCT02685072|10043563|FG001|Completed Week 4 Visit|Treatment Period||23
8978731|NCT02685072|10043562|FG000|Completed Week 5 Visit|Treatment Period||19
8978732|NCT02685072|10043563|FG001|Completed Week 5 Visit|Treatment Period||22
8978733|NCT02685072|10043562|FG000|Completed Week 6 Visit|Treatment Period||18
8978734|NCT02685072|10043563|FG001|Completed Week 6 Visit|Treatment Period||19
8632386|NCT00545272|9672306|FG005|STARTED|Overall Study||62
8978735|NCT02685072|10043562|FG000|Completed Week 7 Visit|Treatment Period||17
8978736|NCT02685072|10043563|FG001|Completed Week 7 Visit|Treatment Period||18
8978737|NCT02685072|10043562|FG000|Completed Week 8 Visit|Treatment Period||20
8632387|NCT00545272|9672301|FG000|COMPLETED|Overall Study||61
8632388|NCT00545272|9672302|FG001|COMPLETED|Overall Study||67
8978738|NCT02685072|10043563|FG001|Completed Week 8 Visit|Treatment Period|Week 8 data were collected at the 1-month follow-up for 1 participant|22
8978739|NCT02685072|10043562|FG000|COMPLETED|Treatment Period||20
8978740|NCT02685072|10043563|FG001|COMPLETED|Treatment Period||22
8978741|NCT02685072|10043562|FG000|NOT COMPLETED|Treatment Period||13
8978742|NCT02685072|10043563|FG001|NOT COMPLETED|Treatment Period||9
8978743|NCT02685072|10043562|FG000|STARTED|1-Month Follow-Up||20
8978744|NCT02685072|10043563|FG001|STARTED|1-Month Follow-Up||22
8978745|NCT02685072|10043562|FG000|COMPLETED|1-Month Follow-Up||19
8978746|NCT02685072|10043563|FG001|COMPLETED|1-Month Follow-Up||22
8978747|NCT02685072|10043562|FG000|NOT COMPLETED|1-Month Follow-Up||1
8571218|NCT00108550|9603466|FG001|STARTED|Overall Study||53
8571219|NCT00108550|9603465|FG000|COMPLETED|Overall Study||39
8571220|NCT00108550|9603466|FG001|COMPLETED|Overall Study||37
8571221|NCT00108550|9603465|FG000|NOT COMPLETED|Overall Study||16
8571222|NCT00108550|9603466|FG001|NOT COMPLETED|Overall Study||16
8571223|NCT00108628|9603474|FG000|STARTED|Overall Study||61
8571224|NCT00108628|9603475|FG001|STARTED|Overall Study||63
8571225|NCT00108628|9603474|FG000|Received One or More Sessions|Overall Study||53
8571226|NCT00108628|9603475|FG001|Received One or More Sessions|Overall Study||58
8571227|NCT00108628|9603474|FG000|Completed Treatment|Overall Study||42
8571228|NCT00108628|9603475|FG001|Completed Treatment|Overall Study||57
8571229|NCT00108628|9603474|FG000|COMPLETED|Overall Study||41
8571230|NCT00108628|9603475|FG001|COMPLETED|Overall Study||53
8571231|NCT00108628|9603474|FG000|NOT COMPLETED|Overall Study||20
8571232|NCT00108628|9603475|FG001|NOT COMPLETED|Overall Study||10
8571233|NCT00108732|9603481|FG000|STARTED|Step 1 (Vaccinia/Fowlpox/GM-CSF)||50
8571234|NCT00108732|9603481|FG000|Eligible and Treated|Step 1 (Vaccinia/Fowlpox/GM-CSF)||40
8571235|NCT00108732|9603481|FG000|COMPLETED|Step 1 (Vaccinia/Fowlpox/GM-CSF)||36
8571236|NCT00108732|9603481|FG000|NOT COMPLETED|Step 1 (Vaccinia/Fowlpox/GM-CSF)||14
8571237|NCT00108732|9603481|FG000|STARTED|Step 2 (Androgen Ablation and Vaccine)||31
8571238|NCT00108732|9603481|FG000|COMPLETED|Step 2 (Androgen Ablation and Vaccine)||26
8571239|NCT00108732|9603481|FG000|NOT COMPLETED|Step 2 (Androgen Ablation and Vaccine)||5
8571240|NCT00108745|9603488|FG000|STARTED|Overall Study||387
8571241|NCT00108745|9603489|FG001|STARTED|Overall Study||384
8571242|NCT00108745|9603490|FG002|STARTED|Overall Study||386
8571243|NCT00108745|9603488|FG000|COMPLETED|Overall Study||353
8571244|NCT00108745|9603489|FG001|COMPLETED|Overall Study||349
8571245|NCT00108745|9603490|FG002|COMPLETED|Overall Study||349
8571246|NCT00108745|9603488|FG000|NOT COMPLETED|Overall Study||34
8571247|NCT00108745|9603489|FG001|NOT COMPLETED|Overall Study||35
8571248|NCT00108745|9603490|FG002|NOT COMPLETED|Overall Study||37
8571249|NCT00108862|9603500|FG000|STARTED|Overall Study||405
8571250|NCT00108862|9603501|FG001|STARTED|Overall Study|Three participants who were deemed clinically ineligible and taken off study were omitted.|401
8571251|NCT00108862|9603500|FG000|COMPLETED|Overall Study||337
8571252|NCT00108862|9603501|FG001|COMPLETED|Overall Study||339
8571253|NCT00108862|9603500|FG000|NOT COMPLETED|Overall Study||68
8571254|NCT00108862|9603501|FG001|NOT COMPLETED|Overall Study||62
8571255|NCT00108953|9603509|FG000|STARTED|Treatment Period|ITT population|47
8571256|NCT00108953|9603510|FG001|STARTED|Treatment Period|ITT population|49
8571257|NCT00108953|9603509|FG000|COMPLETED|Treatment Period|No patient under study medication anymore|47
8571258|NCT00108953|9603510|FG001|COMPLETED|Treatment Period|No patient under study medication anymore|49
8571259|NCT00108953|9603509|FG000|NOT COMPLETED|Treatment Period||0
8571260|NCT00108953|9603510|FG001|NOT COMPLETED|Treatment Period||0
8571261|NCT00108953|9603509|FG000|STARTED|Follow-up|40 out of 47 patients were followed after end of double blind treatment|40
8571262|NCT00108953|9603510|FG001|STARTED|Follow-up|45 out of 49 patients were followed after end of double blind treatment|45
8571263|NCT00108953|9603509|FG000|COMPLETED|Follow-up||11
8571264|NCT00108953|9603510|FG001|COMPLETED|Follow-up||12
8571265|NCT00108953|9603509|FG000|NOT COMPLETED|Follow-up||29
8571266|NCT00108953|9603510|FG001|NOT COMPLETED|Follow-up||33
8571267|NCT00109005|9603520|FG000|STARTED|Overall Study||8
8571268|NCT00109005|9603521|FG001|STARTED|Overall Study||9
8571269|NCT00109005|9603520|FG000|COMPLETED|Overall Study||8
8571270|NCT00109005|9603521|FG001|COMPLETED|Overall Study||9
8571271|NCT00109005|9603520|FG000|NOT COMPLETED|Overall Study||0
8978748|NCT02685072|10043563|FG001|NOT COMPLETED|1-Month Follow-Up||0
8978749|NCT02685072|10043562|FG000|STARTED|3-Month Follow-Up||19
8978750|NCT02685072|10043563|FG001|STARTED|3-Month Follow-Up||22
8978751|NCT02685072|10043562|FG000|COMPLETED|3-Month Follow-Up||19
8978752|NCT02685072|10043563|FG001|COMPLETED|3-Month Follow-Up||22
8978753|NCT02685072|10043562|FG000|NOT COMPLETED|3-Month Follow-Up||0
8978754|NCT02685072|10043563|FG001|NOT COMPLETED|3-Month Follow-Up||0
8978755|NCT02685267|10043572|FG000|STARTED|Overall Study||5
8978756|NCT02685267|10043573|FG001|STARTED|Overall Study||4
8978757|NCT02685267|10043572|FG000|COMPLETED|Overall Study||5
8978758|NCT02685267|10043573|FG001|COMPLETED|Overall Study||4
8978759|NCT02685267|10043572|FG000|NOT COMPLETED|Overall Study||0
8978760|NCT02685267|10043573|FG001|NOT COMPLETED|Overall Study||0
8978761|NCT02685293|10043579|FG000|STARTED|Treatment Period 1||1
8978762|NCT02685293|10043580|FG001|STARTED|Treatment Period 1||3
8978763|NCT02685293|10043579|FG000|COMPLETED|Treatment Period 1||1
8978764|NCT02685293|10043580|FG001|COMPLETED|Treatment Period 1||3
8978765|NCT02685293|10043579|FG000|NOT COMPLETED|Treatment Period 1||0
8978766|NCT02685293|10043580|FG001|NOT COMPLETED|Treatment Period 1||0
8978767|NCT02685293|10043579|FG000|STARTED|Washout Period||1
8978768|NCT02685293|10043580|FG001|STARTED|Washout Period||3
8978769|NCT02685293|10043579|FG000|COMPLETED|Washout Period||1
8978770|NCT02685293|10043580|FG001|COMPLETED|Washout Period||3
8978771|NCT02685293|10043579|FG000|NOT COMPLETED|Washout Period||0
8978772|NCT02685293|10043580|FG001|NOT COMPLETED|Washout Period||0
8978773|NCT02685293|10043579|FG000|STARTED|Treatment Period 2||1
8978774|NCT02685293|10043580|FG001|STARTED|Treatment Period 2||3
8978775|NCT02685293|10043579|FG000|COMPLETED|Treatment Period 2||1
8978776|NCT02685293|10043580|FG001|COMPLETED|Treatment Period 2||3
8978777|NCT02685293|10043579|FG000|NOT COMPLETED|Treatment Period 2||0
8978778|NCT02685293|10043580|FG001|NOT COMPLETED|Treatment Period 2||0
8978779|NCT02685436|10043586|FG000|STARTED|Overall Study|the overall studied group|52
8978780|NCT02685436|10043586|FG000|COMPLETED|Overall Study|GERD positive patients by either combined MII-pH or esophageal biopsy|38
8978781|NCT02685436|10043586|FG000|NOT COMPLETED|Overall Study||14
8978782|NCT02685488|10043592|FG000|STARTED|Overall Study||12
8978783|NCT02685488|10043593|FG001|STARTED|Overall Study||14
8978784|NCT02685488|10043592|FG000|COMPLETED|Overall Study||12
8978785|NCT02685488|10043593|FG001|COMPLETED|Overall Study||13
8978786|NCT02685488|10043592|FG000|NOT COMPLETED|Overall Study||0
8978787|NCT02685488|10043593|FG001|NOT COMPLETED|Overall Study||1
8978788|NCT02685566|10043599|FG000|STARTED|First Reading Session||50
8978789|NCT02685566|10043600|FG001|STARTED|First Reading Session||50
8978790|NCT02685566|10043599|FG000|COMPLETED|First Reading Session||50
8978791|NCT02685566|10043600|FG001|COMPLETED|First Reading Session||50
8978792|NCT02685566|10043599|FG000|NOT COMPLETED|First Reading Session||0
8978793|NCT02685566|10043600|FG001|NOT COMPLETED|First Reading Session||0
8978794|NCT02685566|10043599|FG000|STARTED|4 Week Memory Washout Period||50
8978795|NCT02685566|10043600|FG001|STARTED|4 Week Memory Washout Period||50
8978796|NCT02685566|10043599|FG000|COMPLETED|4 Week Memory Washout Period||50
8978797|NCT02685566|10043600|FG001|COMPLETED|4 Week Memory Washout Period||50
8978798|NCT02685566|10043599|FG000|NOT COMPLETED|4 Week Memory Washout Period||0
8978799|NCT02685566|10043600|FG001|NOT COMPLETED|4 Week Memory Washout Period||0
8978800|NCT02685566|10043599|FG000|STARTED|Second Reading Session||50
8978801|NCT02685566|10043600|FG001|STARTED|Second Reading Session||50
8978802|NCT02685566|10043599|FG000|COMPLETED|Second Reading Session||50
8978803|NCT02685566|10043600|FG001|COMPLETED|Second Reading Session||50
8978804|NCT02685566|10043599|FG000|NOT COMPLETED|Second Reading Session||0
8978805|NCT02685566|10043600|FG001|NOT COMPLETED|Second Reading Session||0
8978806|NCT02685826|10043611|FG000|STARTED|Overall Study||25
8978807|NCT02685826|10043612|FG001|STARTED|Overall Study||10
8978808|NCT02685826|10043613|FG002|STARTED|Overall Study||21
8978809|NCT02685826|10043611|FG000|COMPLETED|Overall Study||0
8978810|NCT02685826|10043612|FG001|COMPLETED|Overall Study||0
8978811|NCT02685826|10043613|FG002|COMPLETED|Overall Study||0
8978812|NCT02685826|10043611|FG000|NOT COMPLETED|Overall Study||25
8978813|NCT02685826|10043612|FG001|NOT COMPLETED|Overall Study||10
8632389|NCT00545272|9672303|FG002|COMPLETED|Overall Study||64
8632390|NCT00545272|9672304|FG003|COMPLETED|Overall Study||71
8632391|NCT00545272|9672305|FG004|COMPLETED|Overall Study||62
8632392|NCT00545272|9672306|FG005|COMPLETED|Overall Study||59
8632393|NCT00545272|9672301|FG000|NOT COMPLETED|Overall Study||0
8632394|NCT00545272|9672302|FG001|NOT COMPLETED|Overall Study||1
8632395|NCT00545272|9672303|FG002|NOT COMPLETED|Overall Study||1
8632396|NCT00545272|9672304|FG003|NOT COMPLETED|Overall Study||1
8632397|NCT00545272|9672305|FG004|NOT COMPLETED|Overall Study||2
8632398|NCT00545272|9672306|FG005|NOT COMPLETED|Overall Study||3
8632399|NCT00545298|9672323|FG000|STARTED|Overall Study||2
8632400|NCT00545298|9672324|FG001|STARTED|Overall Study||1
8978814|NCT02685826|10043613|FG002|NOT COMPLETED|Overall Study||21
8978815|NCT02685956|10043623|FG000|STARTED|Overall Study||317
8978816|NCT02685956|10043624|FG001|STARTED|Overall Study||1978
8978817|NCT02685956|10043623|FG000|COMPLETED|Overall Study||317
8978818|NCT02685956|10043624|FG001|COMPLETED|Overall Study||1978
8978819|NCT02685956|10043623|FG000|NOT COMPLETED|Overall Study||0
8978820|NCT02685956|10043624|FG001|NOT COMPLETED|Overall Study||0
8632401|NCT00545298|9672325|FG002|STARTED|Overall Study||1
8978821|NCT02685995|10043634|FG000|STARTED|Overall Study||50
8978822|NCT02685995|10043635|FG001|STARTED|Overall Study||50
8978823|NCT02685995|10043634|FG000|COMPLETED|Overall Study||49
8978824|NCT02685995|10043635|FG001|COMPLETED|Overall Study||49
8978825|NCT02685995|10043634|FG000|NOT COMPLETED|Overall Study||1
8978826|NCT02685995|10043635|FG001|NOT COMPLETED|Overall Study||1
8978827|NCT02686034|10043643|FG000|STARTED|Run-In Period 1||142
8978828|NCT02686034|10043644|FG001|STARTED|Run-In Period 1||143
8978829|NCT02686034|10043643|FG000|COMPLETED|Run-In Period 1||122
8978830|NCT02686034|10043644|FG001|COMPLETED|Run-In Period 1||126
8978831|NCT02686034|10043643|FG000|NOT COMPLETED|Run-In Period 1||20
8978832|NCT02686034|10043644|FG001|NOT COMPLETED|Run-In Period 1||17
8978833|NCT02686034|10043643|FG000|STARTED|Randomized Controlled Period 2||122
8978834|NCT02686034|10043644|FG001|STARTED|Randomized Controlled Period 2||126
8978835|NCT02686034|10043643|FG000|COMPLETED|Randomized Controlled Period 2||117
8978836|NCT02686034|10043644|FG001|COMPLETED|Randomized Controlled Period 2||122
8978837|NCT02686034|10043643|FG000|NOT COMPLETED|Randomized Controlled Period 2||5
8632402|NCT00545298|9672323|FG000|COMPLETED|Overall Study||0
8632403|NCT00545298|9672324|FG001|COMPLETED|Overall Study||1
8978838|NCT02686034|10043644|FG001|NOT COMPLETED|Randomized Controlled Period 2||4
8978839|NCT02686034|10043643|FG000|STARTED|Open Label Period 3||117
8978840|NCT02686034|10043644|FG001|STARTED|Open Label Period 3||122
8978841|NCT02686034|10043643|FG000|COMPLETED|Open Label Period 3||117
8978842|NCT02686034|10043644|FG001|COMPLETED|Open Label Period 3||121
8978843|NCT02686034|10043643|FG000|NOT COMPLETED|Open Label Period 3||0
8978844|NCT02686034|10043644|FG001|NOT COMPLETED|Open Label Period 3||1
8978845|NCT02686138|10043652|FG000|STARTED|Overall Study||293
8978846|NCT02686138|10043653|FG001|STARTED|Overall Study||300
8978847|NCT02686138|10043652|FG000|COMPLETED|Overall Study||219
8978848|NCT02686138|10043653|FG001|COMPLETED|Overall Study||235
8978849|NCT02686138|10043652|FG000|NOT COMPLETED|Overall Study||74
8978850|NCT02686138|10043653|FG001|NOT COMPLETED|Overall Study||65
8978851|NCT02686164|10043659|FG000|STARTED|Overall Study||30
8978852|NCT02686164|10043659|FG000|COMPLETED|Overall Study||27
8978853|NCT02686164|10043659|FG000|NOT COMPLETED|Overall Study||3
8978854|NCT02686437|10043668|FG000|STARTED|Overall Study||16
8978855|NCT02686437|10043669|FG001|STARTED|Overall Study||20
8978856|NCT02686437|10043668|FG000|COMPLETED|Overall Study||13
8978857|NCT02686437|10043669|FG001|COMPLETED|Overall Study||12
8978858|NCT02686437|10043668|FG000|NOT COMPLETED|Overall Study||3
8978859|NCT02686437|10043669|FG001|NOT COMPLETED|Overall Study||8
8978860|NCT02687035|10043675|FG000|STARTED|Overall Study||1822
8978861|NCT02687035|10043675|FG000|COMPLETED|Overall Study||1638
8978862|NCT02687035|10043675|FG000|NOT COMPLETED|Overall Study||184
8978863|NCT02687126|10043679|FG000|STARTED|Data Collection||106
8978864|NCT02687126|10043679|FG000|COMPLETED|Data Collection||106
8978865|NCT02687126|10043679|FG000|NOT COMPLETED|Data Collection||0
8978866|NCT02687126|10043679|FG000|STARTED|Data Analysis||106
8978867|NCT02687126|10043679|FG000|COMPLETED|Data Analysis||106
8978868|NCT02687126|10043679|FG000|NOT COMPLETED|Data Analysis||0
8978869|NCT02687139|10043686|FG000|STARTED|Overall Study||34
8978870|NCT02687139|10043686|FG000|COMPLETED|Overall Study||34
8978871|NCT02687139|10043686|FG000|NOT COMPLETED|Overall Study||0
8978872|NCT02687191|10043696|FG000|STARTED|Overall Study||3
8978873|NCT02687191|10043697|FG001|STARTED|Overall Study||3
8978874|NCT02687191|10043698|FG002|STARTED|Overall Study||3
8978875|NCT02687191|10043699|FG003|STARTED|Overall Study||6
8978876|NCT02687191|10043700|FG004|STARTED|Overall Study||3
8978877|NCT02687191|10043701|FG005|STARTED|Overall Study||3
8978878|NCT02687191|10043696|FG000|COMPLETED|Overall Study||3
8978879|NCT02687191|10043697|FG001|COMPLETED|Overall Study||2
8978880|NCT02687191|10043698|FG002|COMPLETED|Overall Study||2
8978881|NCT02687191|10043699|FG003|COMPLETED|Overall Study||5
8978882|NCT02687191|10043700|FG004|COMPLETED|Overall Study||2
8978883|NCT02687191|10043701|FG005|COMPLETED|Overall Study||2
8978884|NCT02687191|10043696|FG000|NOT COMPLETED|Overall Study||0
8978885|NCT02687191|10043697|FG001|NOT COMPLETED|Overall Study||1
8978886|NCT02687191|10043698|FG002|NOT COMPLETED|Overall Study||1
8978887|NCT02687191|10043699|FG003|NOT COMPLETED|Overall Study||1
8978888|NCT02687191|10043700|FG004|NOT COMPLETED|Overall Study||1
8978889|NCT02687191|10043701|FG005|NOT COMPLETED|Overall Study||1
8978890|NCT02687217|10043717|FG000|STARTED|Overall Study||30
8978891|NCT02687217|10043718|FG001|STARTED|Overall Study||30
8978892|NCT02687217|10043717|FG000|COMPLETED|Overall Study||30
8978893|NCT02687217|10043718|FG001|COMPLETED|Overall Study||30
8978894|NCT02687217|10043717|FG000|NOT COMPLETED|Overall Study||0
8978895|NCT02687217|10043718|FG001|NOT COMPLETED|Overall Study||0
8978896|NCT02687412|10043726|FG000|STARTED|Overall Study||50
8978897|NCT02687412|10043727|FG001|STARTED|Overall Study||57
8978898|NCT02687412|10043726|FG000|COMPLETED|Overall Study||50
8978899|NCT02687412|10043727|FG001|COMPLETED|Overall Study||57
8978900|NCT02687412|10043726|FG000|NOT COMPLETED|Overall Study||0
8978901|NCT02687412|10043727|FG001|NOT COMPLETED|Overall Study||0
8978902|NCT02687451|10043739|FG000|STARTED|Overall Study||6
8978903|NCT02687451|10043740|FG001|STARTED|Overall Study||5
8978904|NCT02687451|10043741|FG002|STARTED|Overall Study||5
8978905|NCT02687451|10043742|FG003|STARTED|Overall Study||5
8978906|NCT02687451|10043743|FG004|STARTED|Overall Study||4
8978907|NCT02687451|10043744|FG005|STARTED|Overall Study||3
8978908|NCT02687451|10043739|FG000|COMPLETED|Overall Study||5
8978909|NCT02687451|10043740|FG001|COMPLETED|Overall Study||5
8978910|NCT02687451|10043741|FG002|COMPLETED|Overall Study||5
8978911|NCT02687451|10043742|FG003|COMPLETED|Overall Study||5
8978912|NCT02687451|10043743|FG004|COMPLETED|Overall Study||4
8978913|NCT02687451|10043744|FG005|COMPLETED|Overall Study||2
8978914|NCT02687451|10043739|FG000|NOT COMPLETED|Overall Study||1
8978915|NCT02687451|10043740|FG001|NOT COMPLETED|Overall Study||0
8978916|NCT02687451|10043741|FG002|NOT COMPLETED|Overall Study||0
8978917|NCT02687451|10043742|FG003|NOT COMPLETED|Overall Study||0
8978918|NCT02687451|10043743|FG004|NOT COMPLETED|Overall Study||0
8978919|NCT02687451|10043744|FG005|NOT COMPLETED|Overall Study||1
8978920|NCT02687529|10043762|FG000|STARTED|Overall Study||34
8978921|NCT02687529|10043763|FG001|STARTED|Overall Study||32
8978922|NCT02687529|10043762|FG000|COMPLETED|Overall Study||34
8978923|NCT02687529|10043763|FG001|COMPLETED|Overall Study||32
8978924|NCT02687529|10043762|FG000|NOT COMPLETED|Overall Study||0
8978925|NCT02687529|10043763|FG001|NOT COMPLETED|Overall Study||0
8978926|NCT02687542|10043774|FG000|STARTED|Overall Study||23
8978927|NCT02687542|10043775|FG001|STARTED|Overall Study||13
8978928|NCT02687542|10043776|FG002|STARTED|Overall Study||15
8978929|NCT02687542|10043777|FG003|STARTED|Overall Study||13
8978930|NCT02687542|10043778|FG004|STARTED|Overall Study||44
8978931|NCT02687542|10043774|FG000|COMPLETED|Overall Study||15
8978932|NCT02687542|10043775|FG001|COMPLETED|Overall Study||1
8978933|NCT02687542|10043776|FG002|COMPLETED|Overall Study||1
8978934|NCT02687542|10043777|FG003|COMPLETED|Overall Study||3
8978935|NCT02687542|10043778|FG004|COMPLETED|Overall Study||24
8978936|NCT02687542|10043774|FG000|NOT COMPLETED|Overall Study||8
8978937|NCT02687542|10043775|FG001|NOT COMPLETED|Overall Study||12
8978938|NCT02687542|10043776|FG002|NOT COMPLETED|Overall Study||14
8978939|NCT02687542|10043777|FG003|NOT COMPLETED|Overall Study||10
8978940|NCT02687542|10043778|FG004|NOT COMPLETED|Overall Study||20
8978941|NCT02687711|10043790|FG000|STARTED|Overall Study||544
8978942|NCT02687711|10043790|FG000|COMPLETED|Overall Study||332
8978943|NCT02687711|10043790|FG000|NOT COMPLETED|Overall Study||212
8978944|NCT02687815|10043796|FG000|STARTED|Overall Study||96
8978945|NCT02687815|10043797|FG001|STARTED|Overall Study||96
8978946|NCT02687815|10043796|FG000|COMPLETED|Overall Study||92
8978947|NCT02687815|10043797|FG001|COMPLETED|Overall Study||88
8978948|NCT02687815|10043796|FG000|NOT COMPLETED|Overall Study||4
8978949|NCT02687815|10043797|FG001|NOT COMPLETED|Overall Study||8
8978950|NCT02687919|10043805|FG000|STARTED|Overall Study||16
8978951|NCT02687919|10043806|FG001|STARTED|Overall Study||15
8978952|NCT02687919|10043805|FG000|COMPLETED|Overall Study||8
8978953|NCT02687919|10043806|FG001|COMPLETED|Overall Study||9
8978954|NCT02687919|10043805|FG000|NOT COMPLETED|Overall Study||8
8978955|NCT02687919|10043806|FG001|NOT COMPLETED|Overall Study||6
8978956|NCT02688153|10043814|FG000|STARTED|Overall Study||62
8978957|NCT02688153|10043815|FG001|STARTED|Overall Study||58
8978958|NCT02688153|10043814|FG000|Final Randomized Arm/Group|Overall Study||59
8978959|NCT02688153|10043815|FG001|Final Randomized Arm/Group|Overall Study||61
8978960|NCT02688153|10043814|FG000|COMPLETED|Overall Study||47
8978961|NCT02688153|10043815|FG001|COMPLETED|Overall Study||51
8978962|NCT02688153|10043814|FG000|NOT COMPLETED|Overall Study||15
8978963|NCT02688153|10043815|FG001|NOT COMPLETED|Overall Study||7
8978964|NCT02688192|10043824|FG000|STARTED|Overall Study||25
8978965|NCT02688192|10043825|FG001|STARTED|Overall Study||24
8978966|NCT02688192|10043824|FG000|COMPLETED|Overall Study||13
8978967|NCT02688192|10043825|FG001|COMPLETED|Overall Study||19
8978968|NCT02688192|10043824|FG000|NOT COMPLETED|Overall Study||12
8978969|NCT02688192|10043825|FG001|NOT COMPLETED|Overall Study||5
8978970|NCT02688218|10043834|FG000|STARTED|First Exercise Intervention (2 Hours)||24
8978971|NCT02688218|10043835|FG001|STARTED|First Exercise Intervention (2 Hours)||6
8978972|NCT02688218|10043834|FG000|COMPLETED|First Exercise Intervention (2 Hours)||24
8978973|NCT02688218|10043835|FG001|COMPLETED|First Exercise Intervention (2 Hours)||6
8978974|NCT02688218|10043834|FG000|NOT COMPLETED|First Exercise Intervention (2 Hours)||0
8978975|NCT02688218|10043835|FG001|NOT COMPLETED|First Exercise Intervention (2 Hours)||0
8978976|NCT02688218|10043834|FG000|STARTED|Washout (30 Minutes)||24
8978977|NCT02688218|10043835|FG001|STARTED|Washout (30 Minutes)||6
8978978|NCT02688218|10043834|FG000|COMPLETED|Washout (30 Minutes)||24
8978979|NCT02688218|10043835|FG001|COMPLETED|Washout (30 Minutes)||6
8978980|NCT02688218|10043834|FG000|NOT COMPLETED|Washout (30 Minutes)||0
8978981|NCT02688218|10043835|FG001|NOT COMPLETED|Washout (30 Minutes)||0
8978982|NCT02688218|10043834|FG000|STARTED|Second Exercise Intervention (2 Hours)||24
8978983|NCT02688218|10043835|FG001|STARTED|Second Exercise Intervention (2 Hours)||6
8978984|NCT02688218|10043834|FG000|COMPLETED|Second Exercise Intervention (2 Hours)||24
8978985|NCT02688218|10043835|FG001|COMPLETED|Second Exercise Intervention (2 Hours)||6
8978986|NCT02688218|10043834|FG000|NOT COMPLETED|Second Exercise Intervention (2 Hours)||0
8978987|NCT02688218|10043835|FG001|NOT COMPLETED|Second Exercise Intervention (2 Hours)||0
8978988|NCT02688387|10043845|FG000|STARTED|Part 1, Period 1 (up to 6 Days)||3
8978989|NCT02688387|10043846|FG001|STARTED|Part 1, Period 1 (up to 6 Days)||3
8978990|NCT02688387|10043847|FG002|STARTED|Part 1, Period 1 (up to 6 Days)||4
8978991|NCT02688387|10043848|FG003|STARTED|Part 1, Period 1 (up to 6 Days)||3
8978992|NCT02688387|10043849|FG004|STARTED|Part 1, Period 1 (up to 6 Days)||3
8978993|NCT02688387|10043850|FG005|STARTED|Part 1, Period 1 (up to 6 Days)||2
8978994|NCT02688387|10043851|FG006|STARTED|Part 1, Period 1 (up to 6 Days)||2
8978995|NCT02688387|10043852|FG007|STARTED|Part 1, Period 1 (up to 6 Days)||2
8978996|NCT02688387|10043853|FG008|STARTED|Part 1, Period 1 (up to 6 Days)||2
8978997|NCT02688387|10043854|FG009|STARTED|Part 1, Period 1 (up to 6 Days)||2
8978998|NCT02688387|10043855|FG010|STARTED|Part 1, Period 1 (up to 6 Days)||0
8978999|NCT02688387|10043856|FG011|STARTED|Part 1, Period 1 (up to 6 Days)||0
8979000|NCT02688387|10043857|FG012|STARTED|Part 1, Period 1 (up to 6 Days)||0
8979001|NCT02688387|10043858|FG013|STARTED|Part 1, Period 1 (up to 6 Days)||0
8979002|NCT02688387|10043859|FG014|STARTED|Part 1, Period 1 (up to 6 Days)||0
8979003|NCT02688387|10043860|FG015|STARTED|Part 1, Period 1 (up to 6 Days)||0
8979004|NCT02688387|10043861|FG016|STARTED|Part 1, Period 1 (up to 6 Days)||0
8979005|NCT02688387|10043862|FG017|STARTED|Part 1, Period 1 (up to 6 Days)||0
8979006|NCT02688387|10043863|FG018|STARTED|Part 1, Period 1 (up to 6 Days)||0
8979007|NCT02688387|10043864|FG019|STARTED|Part 1, Period 1 (up to 6 Days)||0
8979008|NCT02688387|10043865|FG020|STARTED|Part 1, Period 1 (up to 6 Days)||0
8979009|NCT02688387|10043866|FG021|STARTED|Part 1, Period 1 (up to 6 Days)||0
8979010|NCT02688387|10043845|FG000|COMPLETED|Part 1, Period 1 (up to 6 Days)||3
8979011|NCT02688387|10043846|FG001|COMPLETED|Part 1, Period 1 (up to 6 Days)||3
8979012|NCT02688387|10043847|FG002|COMPLETED|Part 1, Period 1 (up to 6 Days)||3
8979013|NCT02688387|10043848|FG003|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
8979014|NCT02688387|10043849|FG004|COMPLETED|Part 1, Period 1 (up to 6 Days)||3
8979015|NCT02688387|10043850|FG005|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
8979016|NCT02688387|10043851|FG006|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
8979017|NCT02688387|10043852|FG007|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
8979018|NCT02688387|10043853|FG008|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
8979019|NCT02688387|10043854|FG009|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
8979020|NCT02688387|10043855|FG010|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8979021|NCT02688387|10043856|FG011|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8979022|NCT02688387|10043857|FG012|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8979023|NCT02688387|10043858|FG013|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8632404|NCT00545298|9672325|FG002|COMPLETED|Overall Study||0
8632405|NCT00545298|9672323|FG000|NOT COMPLETED|Overall Study||2
8632406|NCT00545298|9672324|FG001|NOT COMPLETED|Overall Study||0
8632407|NCT00545298|9672325|FG002|NOT COMPLETED|Overall Study||1
8979024|NCT02688387|10043859|FG014|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8979025|NCT02688387|10043860|FG015|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8979026|NCT02688387|10043861|FG016|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8979027|NCT02688387|10043862|FG017|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8979028|NCT02688387|10043863|FG018|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8979029|NCT02688387|10043864|FG019|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8979030|NCT02688387|10043865|FG020|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8979031|NCT02688387|10043866|FG021|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8979032|NCT02688387|10043845|FG000|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8979033|NCT02688387|10043846|FG001|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8979034|NCT02688387|10043847|FG002|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||1
8979035|NCT02688387|10043848|FG003|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||1
8979036|NCT02688387|10043849|FG004|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8979037|NCT02688387|10043850|FG005|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8979038|NCT02688387|10043851|FG006|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8979039|NCT02688387|10043852|FG007|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8979040|NCT02688387|10043853|FG008|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8979041|NCT02688387|10043854|FG009|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8979042|NCT02688387|10043855|FG010|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8979043|NCT02688387|10043856|FG011|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8979044|NCT02688387|10043857|FG012|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8979045|NCT02688387|10043858|FG013|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8979046|NCT02688387|10043859|FG014|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8979047|NCT02688387|10043860|FG015|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8979048|NCT02688387|10043861|FG016|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8979049|NCT02688387|10043862|FG017|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8979050|NCT02688387|10043863|FG018|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8979051|NCT02688387|10043864|FG019|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8979052|NCT02688387|10043865|FG020|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8979053|NCT02688387|10043866|FG021|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8979054|NCT02688387|10043845|FG000|STARTED|Part 1, Washout Period 1 (7 Days)||3
8979055|NCT02688387|10043846|FG001|STARTED|Part 1, Washout Period 1 (7 Days)||3
8979056|NCT02688387|10043847|FG002|STARTED|Part 1, Washout Period 1 (7 Days)||3
8979057|NCT02688387|10043848|FG003|STARTED|Part 1, Washout Period 1 (7 Days)||2
8979058|NCT02688387|10043849|FG004|STARTED|Part 1, Washout Period 1 (7 Days)||3
8979059|NCT02688387|10043850|FG005|STARTED|Part 1, Washout Period 1 (7 Days)||2
8979060|NCT02688387|10043851|FG006|STARTED|Part 1, Washout Period 1 (7 Days)||2
8979061|NCT02688387|10043852|FG007|STARTED|Part 1, Washout Period 1 (7 Days)||2
8979062|NCT02688387|10043853|FG008|STARTED|Part 1, Washout Period 1 (7 Days)||2
8979063|NCT02688387|10043854|FG009|STARTED|Part 1, Washout Period 1 (7 Days)||2
8979064|NCT02688387|10043855|FG010|STARTED|Part 1, Washout Period 1 (7 Days)||0
8979065|NCT02688387|10043856|FG011|STARTED|Part 1, Washout Period 1 (7 Days)||0
8979066|NCT02688387|10043857|FG012|STARTED|Part 1, Washout Period 1 (7 Days)||0
8979067|NCT02688387|10043858|FG013|STARTED|Part 1, Washout Period 1 (7 Days)||0
8979068|NCT02688387|10043859|FG014|STARTED|Part 1, Washout Period 1 (7 Days)||0
8979069|NCT02688387|10043860|FG015|STARTED|Part 1, Washout Period 1 (7 Days)||0
8979070|NCT02688387|10043861|FG016|STARTED|Part 1, Washout Period 1 (7 Days)||0
8979071|NCT02688387|10043862|FG017|STARTED|Part 1, Washout Period 1 (7 Days)||0
8979072|NCT02688387|10043863|FG018|STARTED|Part 1, Washout Period 1 (7 Days)||0
8979073|NCT02688387|10043864|FG019|STARTED|Part 1, Washout Period 1 (7 Days)||0
8979074|NCT02688387|10043865|FG020|STARTED|Part 1, Washout Period 1 (7 Days)||0
8979075|NCT02688387|10043866|FG021|STARTED|Part 1, Washout Period 1 (7 Days)||0
8979076|NCT02688387|10043845|FG000|COMPLETED|Part 1, Washout Period 1 (7 Days)||3
8979077|NCT02688387|10043846|FG001|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
8979078|NCT02688387|10043847|FG002|COMPLETED|Part 1, Washout Period 1 (7 Days)||3
8979079|NCT02688387|10043848|FG003|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
8979080|NCT02688387|10043849|FG004|COMPLETED|Part 1, Washout Period 1 (7 Days)||3
8979081|NCT02688387|10043850|FG005|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
8979082|NCT02688387|10043851|FG006|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
8979083|NCT02688387|10043852|FG007|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
8979084|NCT02688387|10043853|FG008|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
8979085|NCT02688387|10043854|FG009|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
8979086|NCT02688387|10043855|FG010|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8979087|NCT02688387|10043856|FG011|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8979088|NCT02688387|10043857|FG012|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8979089|NCT02688387|10043858|FG013|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8979090|NCT02688387|10043859|FG014|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8979091|NCT02688387|10043860|FG015|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8979092|NCT02688387|10043861|FG016|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8979093|NCT02688387|10043862|FG017|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8979094|NCT02688387|10043863|FG018|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8979095|NCT02688387|10043864|FG019|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8979096|NCT02688387|10043865|FG020|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8979097|NCT02688387|10043866|FG021|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8979098|NCT02688387|10043845|FG000|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8979099|NCT02688387|10043846|FG001|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||1
8979100|NCT02688387|10043847|FG002|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8979101|NCT02688387|10043848|FG003|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8979102|NCT02688387|10043849|FG004|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8979103|NCT02688387|10043850|FG005|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8979104|NCT02688387|10043851|FG006|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8979105|NCT02688387|10043852|FG007|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8979106|NCT02688387|10043853|FG008|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8979107|NCT02688387|10043854|FG009|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8979108|NCT02688387|10043855|FG010|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8979109|NCT02688387|10043856|FG011|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8979110|NCT02688387|10043857|FG012|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8979111|NCT02688387|10043858|FG013|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8979112|NCT02688387|10043859|FG014|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8979113|NCT02688387|10043860|FG015|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8979114|NCT02688387|10043861|FG016|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8632408|NCT00545363|9672338|FG000|STARTED|Overall Study||358
8632409|NCT00545363|9672339|FG001|STARTED|Overall Study||358
8632410|NCT00545363|9672338|FG000|Treated|Overall Study||354
8632411|NCT00545363|9672339|FG001|Treated|Overall Study||357
8877362|NCT01922934|9934333|FG001|COMPLETED|Eligible Patients|81 patients did not meet inclusion criteria as they were 80 years or older. 7 patients had died.|4214
8877363|NCT01922934|9934332|FG000|NOT COMPLETED|Eligible Patients||53
8877364|NCT01922934|9934333|FG001|NOT COMPLETED|Eligible Patients||88
8877365|NCT01922934|9934332|FG000|STARTED|Visit 0 - Patient Contacted & Consented||375
8877366|NCT01922934|9934333|FG001|STARTED|Visit 0 - Patient Contacted & Consented|Control group patients were not contacted or offered intervention|4214
8877367|NCT01922934|9934332|FG000|COMPLETED|Visit 0 - Patient Contacted & Consented|reflects number of patients that were contacted and agreed to attend Visit 0|140
8877368|NCT01922934|9934333|FG001|COMPLETED|Visit 0 - Patient Contacted & Consented||4214
8877369|NCT01922934|9934332|FG000|NOT COMPLETED|Visit 0 - Patient Contacted & Consented||235
8877370|NCT01922934|9934333|FG001|NOT COMPLETED|Visit 0 - Patient Contacted & Consented||0
8877371|NCT01922934|9934332|FG000|STARTED|Visit 1- Weight Measured|21 patients did not return for Visit 1 to receive tool or have weight measured.|140
8877372|NCT01922934|9934333|FG001|STARTED|Visit 1- Weight Measured||4214
8877373|NCT01922934|9934332|FG000|COMPLETED|Visit 1- Weight Measured|Patients first received tool and were weighed at Visit 1|119
8877374|NCT01922934|9934333|FG001|COMPLETED|Visit 1- Weight Measured|1284 patients did not have any weights recorded in EMR during study timeframe|2930
8877375|NCT01922934|9934332|FG000|NOT COMPLETED|Visit 1- Weight Measured||21
8877376|NCT01922934|9934333|FG001|NOT COMPLETED|Visit 1- Weight Measured||1284
8877377|NCT01922934|9934332|FG000|STARTED|Visit 12 / Final Visits||119
8877378|NCT01922934|9934333|FG001|STARTED|Visit 12 / Final Visits||2930
8877379|NCT01922934|9934332|FG000|COMPLETED|Visit 12 / Final Visits|6 patients did not return for final visit and weight measure|113
8877380|NCT01922934|9934333|FG001|COMPLETED|Visit 12 / Final Visits|290 patients did not have a second weight recorded at one year (+/- 6months) of first weight|2640
8877381|NCT01922934|9934332|FG000|NOT COMPLETED|Visit 12 / Final Visits||6
8877382|NCT01922934|9934333|FG001|NOT COMPLETED|Visit 12 / Final Visits||290
8877383|NCT01922986|9934343|FG000|STARTED|Overall Study||2
8877384|NCT01922986|9934344|FG001|STARTED|Overall Study||2
8877385|NCT01922986|9934343|FG000|COMPLETED|Overall Study||2
8877386|NCT01922986|9934344|FG001|COMPLETED|Overall Study||2
8877387|NCT01922986|9934343|FG000|NOT COMPLETED|Overall Study||0
8877388|NCT01922986|9934344|FG001|NOT COMPLETED|Overall Study||0
8877389|NCT01923129|9934352|FG000|STARTED|Overall Study||71
8632412|NCT00545363|9672338|FG000|COMPLETED|Overall Study||339
8632413|NCT00545363|9672339|FG001|COMPLETED|Overall Study||343
8632414|NCT00545363|9672338|FG000|NOT COMPLETED|Overall Study||19
8632415|NCT00545363|9672339|FG001|NOT COMPLETED|Overall Study||15
8632416|NCT00545402|9672347|FG000|STARTED|Overall Study||90
8632417|NCT00545402|9672348|FG001|STARTED|Overall Study||90
8979115|NCT02688387|10043862|FG017|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8979116|NCT02688387|10043863|FG018|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8979117|NCT02688387|10043864|FG019|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8979118|NCT02688387|10043865|FG020|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8979119|NCT02688387|10043866|FG021|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8979120|NCT02688387|10043845|FG000|STARTED|Part 1, Period 2 (up to 6 Days)||3
8979121|NCT02688387|10043846|FG001|STARTED|Part 1, Period 2 (up to 6 Days)||2
8979122|NCT02688387|10043847|FG002|STARTED|Part 1, Period 2 (up to 6 Days)||3
8979123|NCT02688387|10043848|FG003|STARTED|Part 1, Period 2 (up to 6 Days)||2
8979124|NCT02688387|10043849|FG004|STARTED|Part 1, Period 2 (up to 6 Days)||3
8979125|NCT02688387|10043850|FG005|STARTED|Part 1, Period 2 (up to 6 Days)||2
8979126|NCT02688387|10043851|FG006|STARTED|Part 1, Period 2 (up to 6 Days)||2
8979127|NCT02688387|10043852|FG007|STARTED|Part 1, Period 2 (up to 6 Days)||2
8979128|NCT02688387|10043853|FG008|STARTED|Part 1, Period 2 (up to 6 Days)||2
8979129|NCT02688387|10043854|FG009|STARTED|Part 1, Period 2 (up to 6 Days)||2
8979130|NCT02688387|10043855|FG010|STARTED|Part 1, Period 2 (up to 6 Days)||0
8979131|NCT02688387|10043856|FG011|STARTED|Part 1, Period 2 (up to 6 Days)||0
8979132|NCT02688387|10043857|FG012|STARTED|Part 1, Period 2 (up to 6 Days)||0
8979133|NCT02688387|10043858|FG013|STARTED|Part 1, Period 2 (up to 6 Days)||0
8979134|NCT02688387|10043859|FG014|STARTED|Part 1, Period 2 (up to 6 Days)||0
8979135|NCT02688387|10043860|FG015|STARTED|Part 1, Period 2 (up to 6 Days)||0
8979136|NCT02688387|10043861|FG016|STARTED|Part 1, Period 2 (up to 6 Days)||0
8979137|NCT02688387|10043862|FG017|STARTED|Part 1, Period 2 (up to 6 Days)||0
8979138|NCT02688387|10043863|FG018|STARTED|Part 1, Period 2 (up to 6 Days)||0
8979139|NCT02688387|10043864|FG019|STARTED|Part 1, Period 2 (up to 6 Days)||0
8979140|NCT02688387|10043865|FG020|STARTED|Part 1, Period 2 (up to 6 Days)||0
8979141|NCT02688387|10043866|FG021|STARTED|Part 1, Period 2 (up to 6 Days)||0
8979142|NCT02688387|10043845|FG000|COMPLETED|Part 1, Period 2 (up to 6 Days)||3
8979143|NCT02688387|10043846|FG001|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
8979144|NCT02688387|10043847|FG002|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
8979145|NCT02688387|10043848|FG003|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
8979146|NCT02688387|10043849|FG004|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
8979147|NCT02688387|10043850|FG005|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
8979148|NCT02688387|10043851|FG006|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
8979149|NCT02688387|10043852|FG007|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
8979150|NCT02688387|10043853|FG008|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
8979151|NCT02688387|10043854|FG009|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
8979152|NCT02688387|10043855|FG010|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8979153|NCT02688387|10043856|FG011|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8979154|NCT02688387|10043857|FG012|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8979155|NCT02688387|10043858|FG013|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8979156|NCT02688387|10043859|FG014|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8979157|NCT02688387|10043860|FG015|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8979158|NCT02688387|10043861|FG016|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8979159|NCT02688387|10043862|FG017|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8979160|NCT02688387|10043863|FG018|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8979161|NCT02688387|10043864|FG019|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8979162|NCT02688387|10043865|FG020|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8979163|NCT02688387|10043866|FG021|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8979164|NCT02688387|10043845|FG000|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8979165|NCT02688387|10043846|FG001|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8979166|NCT02688387|10043847|FG002|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||1
8979167|NCT02688387|10043848|FG003|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8979168|NCT02688387|10043849|FG004|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||1
8979169|NCT02688387|10043850|FG005|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8979170|NCT02688387|10043851|FG006|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8979171|NCT02688387|10043852|FG007|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8979172|NCT02688387|10043853|FG008|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8979173|NCT02688387|10043854|FG009|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8979174|NCT02688387|10043855|FG010|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8979175|NCT02688387|10043856|FG011|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8979176|NCT02688387|10043857|FG012|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8979177|NCT02688387|10043858|FG013|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8979178|NCT02688387|10043859|FG014|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8979179|NCT02688387|10043860|FG015|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8979180|NCT02688387|10043861|FG016|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8979181|NCT02688387|10043862|FG017|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8979182|NCT02688387|10043863|FG018|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8979183|NCT02688387|10043864|FG019|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8979184|NCT02688387|10043865|FG020|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8979185|NCT02688387|10043866|FG021|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8979186|NCT02688387|10043845|FG000|STARTED|Part 1, Washout Period 2 (7 Days)||3
8979187|NCT02688387|10043846|FG001|STARTED|Part 1, Washout Period 2 (7 Days)||2
8979188|NCT02688387|10043847|FG002|STARTED|Part 1, Washout Period 2 (7 Days)||2
8632418|NCT00545402|9672347|FG000|COMPLETED|Overall Study||56
8979189|NCT02688387|10043848|FG003|STARTED|Part 1, Washout Period 2 (7 Days)||2
8979190|NCT02688387|10043849|FG004|STARTED|Part 1, Washout Period 2 (7 Days)||2
8979191|NCT02688387|10043850|FG005|STARTED|Part 1, Washout Period 2 (7 Days)||2
8979192|NCT02688387|10043851|FG006|STARTED|Part 1, Washout Period 2 (7 Days)||2
8979193|NCT02688387|10043852|FG007|STARTED|Part 1, Washout Period 2 (7 Days)||2
8979194|NCT02688387|10043853|FG008|STARTED|Part 1, Washout Period 2 (7 Days)||2
8979195|NCT02688387|10043854|FG009|STARTED|Part 1, Washout Period 2 (7 Days)||2
8979196|NCT02688387|10043855|FG010|STARTED|Part 1, Washout Period 2 (7 Days)||0
8979197|NCT02688387|10043856|FG011|STARTED|Part 1, Washout Period 2 (7 Days)||0
8979198|NCT02688387|10043857|FG012|STARTED|Part 1, Washout Period 2 (7 Days)||0
8979199|NCT02688387|10043858|FG013|STARTED|Part 1, Washout Period 2 (7 Days)||0
8979200|NCT02688387|10043859|FG014|STARTED|Part 1, Washout Period 2 (7 Days)||0
8979201|NCT02688387|10043860|FG015|STARTED|Part 1, Washout Period 2 (7 Days)||0
8979202|NCT02688387|10043861|FG016|STARTED|Part 1, Washout Period 2 (7 Days)||0
8979203|NCT02688387|10043862|FG017|STARTED|Part 1, Washout Period 2 (7 Days)||0
8979204|NCT02688387|10043863|FG018|STARTED|Part 1, Washout Period 2 (7 Days)||0
8979205|NCT02688387|10043864|FG019|STARTED|Part 1, Washout Period 2 (7 Days)||0
8979206|NCT02688387|10043865|FG020|STARTED|Part 1, Washout Period 2 (7 Days)||0
8979207|NCT02688387|10043866|FG021|STARTED|Part 1, Washout Period 2 (7 Days)||0
8979208|NCT02688387|10043845|FG000|COMPLETED|Part 1, Washout Period 2 (7 Days)||3
8979209|NCT02688387|10043846|FG001|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
8979210|NCT02688387|10043847|FG002|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
8979211|NCT02688387|10043848|FG003|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
8979212|NCT02688387|10043849|FG004|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
8979213|NCT02688387|10043850|FG005|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
8979214|NCT02688387|10043851|FG006|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
8979215|NCT02688387|10043852|FG007|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
8979216|NCT02688387|10043853|FG008|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
8979217|NCT02688387|10043854|FG009|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
8979218|NCT02688387|10043855|FG010|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8979219|NCT02688387|10043856|FG011|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8979220|NCT02688387|10043857|FG012|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8979221|NCT02688387|10043858|FG013|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8979222|NCT02688387|10043859|FG014|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8979223|NCT02688387|10043860|FG015|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8979224|NCT02688387|10043861|FG016|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8979225|NCT02688387|10043862|FG017|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8979226|NCT02688387|10043863|FG018|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8979227|NCT02688387|10043864|FG019|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8979228|NCT02688387|10043865|FG020|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8979229|NCT02688387|10043866|FG021|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8979230|NCT02688387|10043845|FG000|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8979231|NCT02688387|10043846|FG001|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8979232|NCT02688387|10043847|FG002|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8979233|NCT02688387|10043848|FG003|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8979234|NCT02688387|10043849|FG004|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8979235|NCT02688387|10043850|FG005|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8979236|NCT02688387|10043851|FG006|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8979237|NCT02688387|10043852|FG007|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8979238|NCT02688387|10043853|FG008|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8979239|NCT02688387|10043854|FG009|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8979240|NCT02688387|10043855|FG010|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8979241|NCT02688387|10043856|FG011|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8979242|NCT02688387|10043857|FG012|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8979243|NCT02688387|10043858|FG013|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8979244|NCT02688387|10043859|FG014|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8979245|NCT02688387|10043860|FG015|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8979246|NCT02688387|10043861|FG016|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8979247|NCT02688387|10043862|FG017|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8979248|NCT02688387|10043863|FG018|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8979249|NCT02688387|10043864|FG019|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8979250|NCT02688387|10043865|FG020|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8979251|NCT02688387|10043866|FG021|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8979252|NCT02688387|10043845|FG000|STARTED|Part 1, Period 3 (up to 6 Days)||3
8979253|NCT02688387|10043846|FG001|STARTED|Part 1, Period 3 (up to 6 Days)||2
8979254|NCT02688387|10043847|FG002|STARTED|Part 1, Period 3 (up to 6 Days)||2
8979255|NCT02688387|10043848|FG003|STARTED|Part 1, Period 3 (up to 6 Days)||2
8979256|NCT02688387|10043849|FG004|STARTED|Part 1, Period 3 (up to 6 Days)||2
8979257|NCT02688387|10043850|FG005|STARTED|Part 1, Period 3 (up to 6 Days)||2
8979258|NCT02688387|10043851|FG006|STARTED|Part 1, Period 3 (up to 6 Days)||2
8979259|NCT02688387|10043852|FG007|STARTED|Part 1, Period 3 (up to 6 Days)||2
8979260|NCT02688387|10043853|FG008|STARTED|Part 1, Period 3 (up to 6 Days)||2
8979261|NCT02688387|10043854|FG009|STARTED|Part 1, Period 3 (up to 6 Days)||2
8979262|NCT02688387|10043855|FG010|STARTED|Part 1, Period 3 (up to 6 Days)||0
8979263|NCT02688387|10043856|FG011|STARTED|Part 1, Period 3 (up to 6 Days)||0
8979264|NCT02688387|10043857|FG012|STARTED|Part 1, Period 3 (up to 6 Days)||0
8979265|NCT02688387|10043858|FG013|STARTED|Part 1, Period 3 (up to 6 Days)||0
8979266|NCT02688387|10043859|FG014|STARTED|Part 1, Period 3 (up to 6 Days)||0
8979267|NCT02688387|10043860|FG015|STARTED|Part 1, Period 3 (up to 6 Days)||0
8979268|NCT02688387|10043861|FG016|STARTED|Part 1, Period 3 (up to 6 Days)||0
8979269|NCT02688387|10043862|FG017|STARTED|Part 1, Period 3 (up to 6 Days)||0
8979270|NCT02688387|10043863|FG018|STARTED|Part 1, Period 3 (up to 6 Days)||0
8979271|NCT02688387|10043864|FG019|STARTED|Part 1, Period 3 (up to 6 Days)||0
8979272|NCT02688387|10043865|FG020|STARTED|Part 1, Period 3 (up to 6 Days)||0
8979273|NCT02688387|10043866|FG021|STARTED|Part 1, Period 3 (up to 6 Days)||0
8979274|NCT02688387|10043845|FG000|COMPLETED|Part 1, Period 3 (up to 6 Days)||3
8979275|NCT02688387|10043846|FG001|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
8979276|NCT02688387|10043847|FG002|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
8979277|NCT02688387|10043848|FG003|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
8979278|NCT02688387|10043849|FG004|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
8979279|NCT02688387|10043850|FG005|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
8979280|NCT02688387|10043851|FG006|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
8979281|NCT02688387|10043852|FG007|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
8979282|NCT02688387|10043853|FG008|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
8979283|NCT02688387|10043854|FG009|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
8979284|NCT02688387|10043855|FG010|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8979285|NCT02688387|10043856|FG011|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8979286|NCT02688387|10043857|FG012|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8979287|NCT02688387|10043858|FG013|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8979288|NCT02688387|10043859|FG014|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8979289|NCT02688387|10043860|FG015|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8979290|NCT02688387|10043861|FG016|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8979291|NCT02688387|10043862|FG017|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8979292|NCT02688387|10043863|FG018|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8979293|NCT02688387|10043864|FG019|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8979294|NCT02688387|10043865|FG020|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8979295|NCT02688387|10043866|FG021|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8979296|NCT02688387|10043845|FG000|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8979297|NCT02688387|10043846|FG001|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8979298|NCT02688387|10043847|FG002|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8979299|NCT02688387|10043848|FG003|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8979300|NCT02688387|10043849|FG004|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8979301|NCT02688387|10043850|FG005|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8979302|NCT02688387|10043851|FG006|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8979303|NCT02688387|10043852|FG007|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8979304|NCT02688387|10043853|FG008|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8979305|NCT02688387|10043854|FG009|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8979306|NCT02688387|10043855|FG010|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8979307|NCT02688387|10043856|FG011|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8979308|NCT02688387|10043857|FG012|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8979309|NCT02688387|10043858|FG013|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8979310|NCT02688387|10043859|FG014|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8979311|NCT02688387|10043860|FG015|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8979312|NCT02688387|10043861|FG016|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8979313|NCT02688387|10043862|FG017|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8979314|NCT02688387|10043863|FG018|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8979315|NCT02688387|10043864|FG019|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8979316|NCT02688387|10043865|FG020|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8979317|NCT02688387|10043866|FG021|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8979318|NCT02688387|10043845|FG000|STARTED|Part 1, Washout Period 3 (7 Days)||3
8979319|NCT02688387|10043846|FG001|STARTED|Part 1, Washout Period 3 (7 Days)||2
8979320|NCT02688387|10043847|FG002|STARTED|Part 1, Washout Period 3 (7 Days)||2
8979321|NCT02688387|10043848|FG003|STARTED|Part 1, Washout Period 3 (7 Days)||2
8979322|NCT02688387|10043849|FG004|STARTED|Part 1, Washout Period 3 (7 Days)||2
8979323|NCT02688387|10043850|FG005|STARTED|Part 1, Washout Period 3 (7 Days)||2
8979324|NCT02688387|10043851|FG006|STARTED|Part 1, Washout Period 3 (7 Days)||2
8979325|NCT02688387|10043852|FG007|STARTED|Part 1, Washout Period 3 (7 Days)||2
8979326|NCT02688387|10043853|FG008|STARTED|Part 1, Washout Period 3 (7 Days)||2
8979327|NCT02688387|10043854|FG009|STARTED|Part 1, Washout Period 3 (7 Days)||2
8979328|NCT02688387|10043855|FG010|STARTED|Part 1, Washout Period 3 (7 Days)||0
8979329|NCT02688387|10043856|FG011|STARTED|Part 1, Washout Period 3 (7 Days)||0
8979330|NCT02688387|10043857|FG012|STARTED|Part 1, Washout Period 3 (7 Days)||0
8979331|NCT02688387|10043858|FG013|STARTED|Part 1, Washout Period 3 (7 Days)||0
8979332|NCT02688387|10043859|FG014|STARTED|Part 1, Washout Period 3 (7 Days)||0
8979333|NCT02688387|10043860|FG015|STARTED|Part 1, Washout Period 3 (7 Days)||0
8979334|NCT02688387|10043861|FG016|STARTED|Part 1, Washout Period 3 (7 Days)||0
8979335|NCT02688387|10043862|FG017|STARTED|Part 1, Washout Period 3 (7 Days)||0
8979336|NCT02688387|10043863|FG018|STARTED|Part 1, Washout Period 3 (7 Days)||0
8979337|NCT02688387|10043864|FG019|STARTED|Part 1, Washout Period 3 (7 Days)||0
8979338|NCT02688387|10043865|FG020|STARTED|Part 1, Washout Period 3 (7 Days)||0
8979339|NCT02688387|10043866|FG021|STARTED|Part 1, Washout Period 3 (7 Days)||0
8979340|NCT02688387|10043845|FG000|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
8979341|NCT02688387|10043846|FG001|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
8979342|NCT02688387|10043847|FG002|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
8979343|NCT02688387|10043848|FG003|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
8979344|NCT02688387|10043849|FG004|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
8979345|NCT02688387|10043850|FG005|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
8979346|NCT02688387|10043851|FG006|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
8979347|NCT02688387|10043852|FG007|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
8979348|NCT02688387|10043853|FG008|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
8979349|NCT02688387|10043854|FG009|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
8979350|NCT02688387|10043855|FG010|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8979351|NCT02688387|10043856|FG011|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8979352|NCT02688387|10043857|FG012|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8979353|NCT02688387|10043858|FG013|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8979354|NCT02688387|10043859|FG014|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8979355|NCT02688387|10043860|FG015|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8979356|NCT02688387|10043861|FG016|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8979357|NCT02688387|10043862|FG017|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8979358|NCT02688387|10043863|FG018|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8979359|NCT02688387|10043864|FG019|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8979360|NCT02688387|10043865|FG020|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8632419|NCT00545402|9672348|FG001|COMPLETED|Overall Study||61
8632420|NCT00545402|9672347|FG000|NOT COMPLETED|Overall Study||34
8979361|NCT02688387|10043866|FG021|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8979362|NCT02688387|10043845|FG000|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||1
8979363|NCT02688387|10043846|FG001|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8979364|NCT02688387|10043847|FG002|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8979365|NCT02688387|10043848|FG003|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8979366|NCT02688387|10043849|FG004|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8632421|NCT00545402|9672348|FG001|NOT COMPLETED|Overall Study||29
8632422|NCT00545441|9672356|FG000|STARTED|Overall Study||44
8632423|NCT00545441|9672357|FG001|STARTED|Overall Study||42
8632424|NCT00545441|9672356|FG000|COMPLETED|Overall Study||26
8632425|NCT00545441|9672357|FG001|COMPLETED|Overall Study||26
8877390|NCT01923129|9934353|FG001|STARTED|Overall Study||71
8571272|NCT00109005|9603521|FG001|NOT COMPLETED|Overall Study||0
8571273|NCT00109031|9603532|FG000|STARTED|Overall Study||11
8571274|NCT00109031|9603533|FG001|STARTED|Overall Study||10
8571275|NCT00109031|9603534|FG002|STARTED|Overall Study||14
8571276|NCT00109031|9603535|FG003|STARTED|Overall Study||12
8571277|NCT00109031|9603532|FG000|COMPLETED|Overall Study||11
8571278|NCT00109031|9603533|FG001|COMPLETED|Overall Study||8
8571279|NCT00109031|9603534|FG002|COMPLETED|Overall Study||12
8571280|NCT00109031|9603535|FG003|COMPLETED|Overall Study||12
8571281|NCT00109031|9603532|FG000|NOT COMPLETED|Overall Study||0
8571282|NCT00109031|9603533|FG001|NOT COMPLETED|Overall Study||2
8571283|NCT00109031|9603534|FG002|NOT COMPLETED|Overall Study||2
8571284|NCT00109031|9603535|FG003|NOT COMPLETED|Overall Study||0
8571285|NCT00109343|9603548|FG000|STARTED|Overall Study||510
8571286|NCT00109343|9603549|FG001|STARTED|Overall Study||258
8571287|NCT00109343|9603550|FG002|STARTED|Overall Study||259
8571288|NCT00109343|9603548|FG000|Vaccinated at Visit 1|Overall Study||510
8571289|NCT00109343|9603549|FG001|Vaccinated at Visit 1|Overall Study||258
8571290|NCT00109343|9603550|FG002|Vaccinated at Visit 1|Overall Study||259
8571291|NCT00109343|9603548|FG000|Vaccinated at Visit 2|Overall Study|Per-protocol, subjects in Group 1 were not vaccinated at Visit 2|0
8571292|NCT00109343|9603549|FG001|Vaccinated at Visit 2|Overall Study||246
8571293|NCT00109343|9603550|FG002|Vaccinated at Visit 2|Overall Study||246
8571294|NCT00109343|9603548|FG000|Vaccinated at Visit 4|Overall Study||466
8571295|NCT00109343|9603549|FG001|Vaccinated at Visit 4|Overall Study||235
8571296|NCT00109343|9603550|FG002|Vaccinated at Visit 4|Overall Study||240
8571297|NCT00109343|9603548|FG000|COMPLETED|Overall Study||446
8571298|NCT00109343|9603549|FG001|COMPLETED|Overall Study||221
8571299|NCT00109343|9603550|FG002|COMPLETED|Overall Study||229
8571300|NCT00109343|9603548|FG000|NOT COMPLETED|Overall Study||64
8571301|NCT00109343|9603549|FG001|NOT COMPLETED|Overall Study||37
8571302|NCT00109343|9603550|FG002|NOT COMPLETED|Overall Study||30
8877391|NCT01923129|9934352|FG000|COMPLETED|Overall Study||71
8877392|NCT01923129|9934353|FG001|COMPLETED|Overall Study||71
8877393|NCT01923129|9934352|FG000|NOT COMPLETED|Overall Study||0
8877394|NCT01923129|9934353|FG001|NOT COMPLETED|Overall Study||0
8877395|NCT01923181|9934368|FG000|STARTED|Overall Study||70
8877396|NCT01923181|9934369|FG001|STARTED|Overall Study||70
8877397|NCT01923181|9934370|FG002|STARTED|Overall Study||69
8877398|NCT01923181|9934371|FG003|STARTED|Overall Study||70
8877399|NCT01923181|9934372|FG004|STARTED|Overall Study||71
8979367|NCT02688387|10043850|FG005|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8571303|NCT00109473|9603560|FG000|STARTED|Baseline (0 Through 12 Weeks)|11 subjects allocated to Group A; one withdrew consent, only 10 receieved intervention.|10
8571304|NCT00109473|9603561|FG001|STARTED|Baseline (0 Through 12 Weeks)||10
8571305|NCT00109473|9603560|FG000|Analyzed|Baseline (0 Through 12 Weeks)||10
8632426|NCT00545441|9672356|FG000|NOT COMPLETED|Overall Study||18
8632427|NCT00545441|9672357|FG001|NOT COMPLETED|Overall Study||16
8632428|NCT00545532|9672365|FG000|STARTED|Overall Study||105
8979368|NCT02688387|10043851|FG006|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8979369|NCT02688387|10043852|FG007|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8979370|NCT02688387|10043853|FG008|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8979371|NCT02688387|10043854|FG009|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8979372|NCT02688387|10043855|FG010|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8979373|NCT02688387|10043856|FG011|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8979374|NCT02688387|10043857|FG012|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8979375|NCT02688387|10043858|FG013|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8979376|NCT02688387|10043859|FG014|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8979377|NCT02688387|10043860|FG015|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8979378|NCT02688387|10043861|FG016|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8979379|NCT02688387|10043862|FG017|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8979380|NCT02688387|10043863|FG018|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8979381|NCT02688387|10043864|FG019|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8979382|NCT02688387|10043865|FG020|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8979383|NCT02688387|10043866|FG021|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8979384|NCT02688387|10043845|FG000|STARTED|Part 1, Period 4 (up to 6 Days)||2
8979385|NCT02688387|10043846|FG001|STARTED|Part 1, Period 4 (up to 6 Days)||2
8979386|NCT02688387|10043847|FG002|STARTED|Part 1, Period 4 (up to 6 Days)||2
8979387|NCT02688387|10043848|FG003|STARTED|Part 1, Period 4 (up to 6 Days)||2
8979388|NCT02688387|10043849|FG004|STARTED|Part 1, Period 4 (up to 6 Days)||2
8979389|NCT02688387|10043850|FG005|STARTED|Part 1, Period 4 (up to 6 Days)||2
8979390|NCT02688387|10043851|FG006|STARTED|Part 1, Period 4 (up to 6 Days)||2
8979391|NCT02688387|10043852|FG007|STARTED|Part 1, Period 4 (up to 6 Days)||2
8979392|NCT02688387|10043853|FG008|STARTED|Part 1, Period 4 (up to 6 Days)||2
8979393|NCT02688387|10043854|FG009|STARTED|Part 1, Period 4 (up to 6 Days)||2
8979394|NCT02688387|10043855|FG010|STARTED|Part 1, Period 4 (up to 6 Days)||0
8979395|NCT02688387|10043856|FG011|STARTED|Part 1, Period 4 (up to 6 Days)||0
8979396|NCT02688387|10043857|FG012|STARTED|Part 1, Period 4 (up to 6 Days)||0
8979397|NCT02688387|10043858|FG013|STARTED|Part 1, Period 4 (up to 6 Days)||0
8979398|NCT02688387|10043859|FG014|STARTED|Part 1, Period 4 (up to 6 Days)||0
8979399|NCT02688387|10043860|FG015|STARTED|Part 1, Period 4 (up to 6 Days)||0
8979400|NCT02688387|10043861|FG016|STARTED|Part 1, Period 4 (up to 6 Days)||0
8979401|NCT02688387|10043862|FG017|STARTED|Part 1, Period 4 (up to 6 Days)||0
8979402|NCT02688387|10043863|FG018|STARTED|Part 1, Period 4 (up to 6 Days)||0
8979403|NCT02688387|10043864|FG019|STARTED|Part 1, Period 4 (up to 6 Days)||0
8979404|NCT02688387|10043865|FG020|STARTED|Part 1, Period 4 (up to 6 Days)||0
8979405|NCT02688387|10043866|FG021|STARTED|Part 1, Period 4 (up to 6 Days)||0
8979406|NCT02688387|10043845|FG000|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
8979407|NCT02688387|10043846|FG001|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
8979408|NCT02688387|10043847|FG002|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
8979409|NCT02688387|10043848|FG003|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
8979410|NCT02688387|10043849|FG004|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
8979411|NCT02688387|10043850|FG005|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
8979412|NCT02688387|10043851|FG006|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
8979413|NCT02688387|10043852|FG007|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
8979414|NCT02688387|10043853|FG008|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
8979415|NCT02688387|10043854|FG009|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
8979416|NCT02688387|10043855|FG010|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8979417|NCT02688387|10043856|FG011|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8979418|NCT02688387|10043857|FG012|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8979419|NCT02688387|10043858|FG013|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8979420|NCT02688387|10043859|FG014|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8979421|NCT02688387|10043860|FG015|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8979422|NCT02688387|10043861|FG016|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8979423|NCT02688387|10043862|FG017|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8979424|NCT02688387|10043863|FG018|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8979425|NCT02688387|10043864|FG019|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8979426|NCT02688387|10043865|FG020|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8979427|NCT02688387|10043866|FG021|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8979428|NCT02688387|10043845|FG000|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8979429|NCT02688387|10043846|FG001|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8979430|NCT02688387|10043847|FG002|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8979431|NCT02688387|10043848|FG003|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8979432|NCT02688387|10043849|FG004|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8979433|NCT02688387|10043850|FG005|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8979434|NCT02688387|10043851|FG006|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8979435|NCT02688387|10043852|FG007|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8979436|NCT02688387|10043853|FG008|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8979437|NCT02688387|10043854|FG009|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8979438|NCT02688387|10043855|FG010|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8979439|NCT02688387|10043856|FG011|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8979440|NCT02688387|10043857|FG012|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8979441|NCT02688387|10043858|FG013|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8979442|NCT02688387|10043859|FG014|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8979443|NCT02688387|10043860|FG015|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8979444|NCT02688387|10043861|FG016|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8979445|NCT02688387|10043862|FG017|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8632429|NCT00545532|9672366|FG001|STARTED|Overall Study||110
8877400|NCT01923181|9934373|FG005|STARTED|Overall Study||70
8877401|NCT01923181|9934374|FG006|STARTED|Overall Study||70
8877402|NCT01923181|9934375|FG007|STARTED|Overall Study||69
8877403|NCT01923181|9934376|FG008|STARTED|Overall Study||71
8877404|NCT01923181|9934368|FG000|Full Analysis Set (FAS)|Overall Study||70
8877405|NCT01923181|9934369|FG001|Full Analysis Set (FAS)|Overall Study||70
8877406|NCT01923181|9934370|FG002|Full Analysis Set (FAS)|Overall Study||69
8877407|NCT01923181|9934371|FG003|Full Analysis Set (FAS)|Overall Study||70
8979446|NCT02688387|10043863|FG018|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8877408|NCT01923181|9934372|FG004|Full Analysis Set (FAS)|Overall Study||71
8979447|NCT02688387|10043864|FG019|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8979448|NCT02688387|10043865|FG020|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8979449|NCT02688387|10043866|FG021|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8979450|NCT02688387|10043845|FG000|STARTED|Part 1, Washout Period 4 (7 Days)||2
8979451|NCT02688387|10043846|FG001|STARTED|Part 1, Washout Period 4 (7 Days)||2
8979452|NCT02688387|10043847|FG002|STARTED|Part 1, Washout Period 4 (7 Days)||2
8979453|NCT02688387|10043848|FG003|STARTED|Part 1, Washout Period 4 (7 Days)||2
8979454|NCT02688387|10043849|FG004|STARTED|Part 1, Washout Period 4 (7 Days)||2
8632430|NCT00545532|9672365|FG000|COMPLETED|Overall Study||99
8632431|NCT00545532|9672366|FG001|COMPLETED|Overall Study||100
8877409|NCT01923181|9934373|FG005|Full Analysis Set (FAS)|Overall Study||70
8979455|NCT02688387|10043850|FG005|STARTED|Part 1, Washout Period 4 (7 Days)||2
8979456|NCT02688387|10043851|FG006|STARTED|Part 1, Washout Period 4 (7 Days)||2
8979457|NCT02688387|10043852|FG007|STARTED|Part 1, Washout Period 4 (7 Days)||2
8979458|NCT02688387|10043853|FG008|STARTED|Part 1, Washout Period 4 (7 Days)||2
8979459|NCT02688387|10043854|FG009|STARTED|Part 1, Washout Period 4 (7 Days)||2
8979460|NCT02688387|10043855|FG010|STARTED|Part 1, Washout Period 4 (7 Days)||0
8979461|NCT02688387|10043856|FG011|STARTED|Part 1, Washout Period 4 (7 Days)||0
8979462|NCT02688387|10043857|FG012|STARTED|Part 1, Washout Period 4 (7 Days)||0
8979463|NCT02688387|10043858|FG013|STARTED|Part 1, Washout Period 4 (7 Days)||0
8979464|NCT02688387|10043859|FG014|STARTED|Part 1, Washout Period 4 (7 Days)||0
8979465|NCT02688387|10043860|FG015|STARTED|Part 1, Washout Period 4 (7 Days)||0
8979466|NCT02688387|10043861|FG016|STARTED|Part 1, Washout Period 4 (7 Days)||0
8979467|NCT02688387|10043862|FG017|STARTED|Part 1, Washout Period 4 (7 Days)||0
8979468|NCT02688387|10043863|FG018|STARTED|Part 1, Washout Period 4 (7 Days)||0
8979469|NCT02688387|10043864|FG019|STARTED|Part 1, Washout Period 4 (7 Days)||0
8979470|NCT02688387|10043865|FG020|STARTED|Part 1, Washout Period 4 (7 Days)||0
8979471|NCT02688387|10043866|FG021|STARTED|Part 1, Washout Period 4 (7 Days)||0
8979472|NCT02688387|10043845|FG000|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
8979473|NCT02688387|10043846|FG001|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
8979474|NCT02688387|10043847|FG002|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
8979475|NCT02688387|10043848|FG003|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
8979476|NCT02688387|10043849|FG004|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
8979477|NCT02688387|10043850|FG005|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
8979478|NCT02688387|10043851|FG006|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
8979479|NCT02688387|10043852|FG007|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
8979480|NCT02688387|10043853|FG008|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
8979481|NCT02688387|10043854|FG009|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
8979482|NCT02688387|10043855|FG010|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8979483|NCT02688387|10043856|FG011|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8979484|NCT02688387|10043857|FG012|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8979485|NCT02688387|10043858|FG013|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8979486|NCT02688387|10043859|FG014|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8979487|NCT02688387|10043860|FG015|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8979488|NCT02688387|10043861|FG016|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8979489|NCT02688387|10043862|FG017|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8979490|NCT02688387|10043863|FG018|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8979491|NCT02688387|10043864|FG019|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8979492|NCT02688387|10043865|FG020|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8979493|NCT02688387|10043866|FG021|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8979494|NCT02688387|10043845|FG000|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8571306|NCT00109473|9603561|FG001|Analyzed|Baseline (0 Through 12 Weeks)||10
8571307|NCT00109473|9603560|FG000|COMPLETED|Baseline (0 Through 12 Weeks)||10
8571308|NCT00109473|9603561|FG001|COMPLETED|Baseline (0 Through 12 Weeks)|One subject discontinued intervention because of active disease requiring imfliximab|9
8571309|NCT00109473|9603560|FG000|NOT COMPLETED|Baseline (0 Through 12 Weeks)||0
8571310|NCT00109473|9603561|FG001|NOT COMPLETED|Baseline (0 Through 12 Weeks)||1
8571311|NCT00109473|9603560|FG000|STARTED|Week 12 to Week 24||10
8571312|NCT00109473|9603561|FG001|STARTED|Week 12 to Week 24||9
8571313|NCT00109473|9603560|FG000|Analyzed|Week 12 to Week 24||9
8571314|NCT00109473|9603561|FG001|Analyzed|Week 12 to Week 24||9
8577925|NCT00165958|9610870|FG000|COMPLETED|Overall Study||18
8877410|NCT01923181|9934374|FG006|Full Analysis Set (FAS)|Overall Study||70
8877411|NCT01923181|9934375|FG007|Full Analysis Set (FAS)|Overall Study||69
8877412|NCT01923181|9934376|FG008|Full Analysis Set (FAS)|Overall Study||71
8877413|NCT01923181|9934368|FG000|Safety Analysis Set (SAS)|Overall Study||70
8877414|NCT01923181|9934369|FG001|Safety Analysis Set (SAS)|Overall Study||70
8877415|NCT01923181|9934370|FG002|Safety Analysis Set (SAS)|Overall Study||69
8877416|NCT01923181|9934371|FG003|Safety Analysis Set (SAS)|Overall Study||70
8877417|NCT01923181|9934372|FG004|Safety Analysis Set (SAS)|Overall Study||71
8632432|NCT00545532|9672365|FG000|NOT COMPLETED|Overall Study||6
8632433|NCT00545532|9672366|FG001|NOT COMPLETED|Overall Study||10
8632434|NCT00545571|9672374|FG000|STARTED|Overall Study||120
8877418|NCT01923181|9934373|FG005|Safety Analysis Set (SAS)|Overall Study||70
8571315|NCT00109473|9603560|FG000|COMPLETED|Week 12 to Week 24|One subject withdrew consent|9
8571316|NCT00109473|9603561|FG001|COMPLETED|Week 12 to Week 24|one subject discontinued intervention due to active disease requiring surgery|9
8571317|NCT00109473|9603560|FG000|NOT COMPLETED|Week 12 to Week 24||1
8571318|NCT00109473|9603561|FG001|NOT COMPLETED|Week 12 to Week 24||0
8571319|NCT00109473|9603560|FG000|STARTED|52 Week Extension Phase||9
8979495|NCT02688387|10043846|FG001|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8979496|NCT02688387|10043847|FG002|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8979497|NCT02688387|10043848|FG003|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8979498|NCT02688387|10043849|FG004|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8979499|NCT02688387|10043850|FG005|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8979500|NCT02688387|10043851|FG006|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8979501|NCT02688387|10043852|FG007|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8979502|NCT02688387|10043853|FG008|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8979503|NCT02688387|10043854|FG009|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8979504|NCT02688387|10043855|FG010|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8979505|NCT02688387|10043856|FG011|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8979506|NCT02688387|10043857|FG012|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8979507|NCT02688387|10043858|FG013|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8979508|NCT02688387|10043859|FG014|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8979509|NCT02688387|10043860|FG015|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8979510|NCT02688387|10043861|FG016|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8979511|NCT02688387|10043862|FG017|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8979512|NCT02688387|10043863|FG018|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8979513|NCT02688387|10043864|FG019|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8979514|NCT02688387|10043865|FG020|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8979515|NCT02688387|10043866|FG021|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8979516|NCT02688387|10043845|FG000|STARTED|Part 1, Period 5 (up to 6 Days)||2
8979517|NCT02688387|10043846|FG001|STARTED|Part 1, Period 5 (up to 6 Days)||2
8979518|NCT02688387|10043847|FG002|STARTED|Part 1, Period 5 (up to 6 Days)||2
8571320|NCT00109473|9603561|FG001|STARTED|52 Week Extension Phase||8
8571321|NCT00109473|9603560|FG000|Analyzed|52 Week Extension Phase||9
8571322|NCT00109473|9603561|FG001|Analyzed|52 Week Extension Phase||8
8571323|NCT00109473|9603560|FG000|COMPLETED|52 Week Extension Phase|Extension phase ends when subjects discontinue intervention due to active disease or reaches week 64|5
8571324|NCT00109473|9603561|FG001|COMPLETED|52 Week Extension Phase|Extension phase ends when subjects discontinue intervention due to active disease or reaches week 64|3
8578533|NCT00174967|9611605|FG001|NOT COMPLETED|Overall Study||3
8578534|NCT00174967|9611606|FG002|NOT COMPLETED|Overall Study||2
8578535|NCT00174967|9611607|FG003|NOT COMPLETED|Overall Study||2
8979519|NCT02688387|10043848|FG003|STARTED|Part 1, Period 5 (up to 6 Days)||2
8979520|NCT02688387|10043849|FG004|STARTED|Part 1, Period 5 (up to 6 Days)||2
8979521|NCT02688387|10043850|FG005|STARTED|Part 1, Period 5 (up to 6 Days)||2
8979522|NCT02688387|10043851|FG006|STARTED|Part 1, Period 5 (up to 6 Days)||2
8979523|NCT02688387|10043852|FG007|STARTED|Part 1, Period 5 (up to 6 Days)||2
8979524|NCT02688387|10043853|FG008|STARTED|Part 1, Period 5 (up to 6 Days)||2
8979525|NCT02688387|10043854|FG009|STARTED|Part 1, Period 5 (up to 6 Days)||2
8979526|NCT02688387|10043855|FG010|STARTED|Part 1, Period 5 (up to 6 Days)||0
8979527|NCT02688387|10043856|FG011|STARTED|Part 1, Period 5 (up to 6 Days)||0
8979528|NCT02688387|10043857|FG012|STARTED|Part 1, Period 5 (up to 6 Days)||0
8979529|NCT02688387|10043858|FG013|STARTED|Part 1, Period 5 (up to 6 Days)||0
8979530|NCT02688387|10043859|FG014|STARTED|Part 1, Period 5 (up to 6 Days)||0
8979531|NCT02688387|10043860|FG015|STARTED|Part 1, Period 5 (up to 6 Days)||0
8979532|NCT02688387|10043861|FG016|STARTED|Part 1, Period 5 (up to 6 Days)||0
8979533|NCT02688387|10043862|FG017|STARTED|Part 1, Period 5 (up to 6 Days)||0
8979534|NCT02688387|10043863|FG018|STARTED|Part 1, Period 5 (up to 6 Days)||0
8979535|NCT02688387|10043864|FG019|STARTED|Part 1, Period 5 (up to 6 Days)||0
8979536|NCT02688387|10043865|FG020|STARTED|Part 1, Period 5 (up to 6 Days)||0
8979537|NCT02688387|10043866|FG021|STARTED|Part 1, Period 5 (up to 6 Days)||0
8979538|NCT02688387|10043845|FG000|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
8979539|NCT02688387|10043846|FG001|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
8979540|NCT02688387|10043847|FG002|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
8979541|NCT02688387|10043848|FG003|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
8979542|NCT02688387|10043849|FG004|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
8979543|NCT02688387|10043850|FG005|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
8979544|NCT02688387|10043851|FG006|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
8979545|NCT02688387|10043852|FG007|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
8979546|NCT02688387|10043853|FG008|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
8979547|NCT02688387|10043854|FG009|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
8979548|NCT02688387|10043855|FG010|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8979549|NCT02688387|10043856|FG011|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8979550|NCT02688387|10043857|FG012|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8979551|NCT02688387|10043858|FG013|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8979552|NCT02688387|10043859|FG014|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8979553|NCT02688387|10043860|FG015|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8979554|NCT02688387|10043861|FG016|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8979555|NCT02688387|10043862|FG017|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8979556|NCT02688387|10043863|FG018|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8979557|NCT02688387|10043864|FG019|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8979558|NCT02688387|10043865|FG020|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8979559|NCT02688387|10043866|FG021|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8979560|NCT02688387|10043845|FG000|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8979561|NCT02688387|10043846|FG001|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8979562|NCT02688387|10043847|FG002|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8979563|NCT02688387|10043848|FG003|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8979564|NCT02688387|10043849|FG004|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8979565|NCT02688387|10043850|FG005|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8979566|NCT02688387|10043851|FG006|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8979567|NCT02688387|10043852|FG007|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8979568|NCT02688387|10043853|FG008|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8979569|NCT02688387|10043854|FG009|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8979570|NCT02688387|10043855|FG010|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8979571|NCT02688387|10043856|FG011|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8979572|NCT02688387|10043857|FG012|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8979573|NCT02688387|10043858|FG013|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8979574|NCT02688387|10043859|FG014|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8979575|NCT02688387|10043860|FG015|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8979576|NCT02688387|10043861|FG016|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8979577|NCT02688387|10043862|FG017|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8979578|NCT02688387|10043863|FG018|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8979579|NCT02688387|10043864|FG019|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8979580|NCT02688387|10043865|FG020|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8979581|NCT02688387|10043866|FG021|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8979582|NCT02688387|10043845|FG000|STARTED|Part 2, Period 1 (up to 6 Days)||0
8979583|NCT02688387|10043846|FG001|STARTED|Part 2, Period 1 (up to 6 Days)||0
8979584|NCT02688387|10043847|FG002|STARTED|Part 2, Period 1 (up to 6 Days)||0
8979585|NCT02688387|10043848|FG003|STARTED|Part 2, Period 1 (up to 6 Days)||0
8979586|NCT02688387|10043849|FG004|STARTED|Part 2, Period 1 (up to 6 Days)||0
8979587|NCT02688387|10043850|FG005|STARTED|Part 2, Period 1 (up to 6 Days)||0
8979588|NCT02688387|10043851|FG006|STARTED|Part 2, Period 1 (up to 6 Days)||0
8979589|NCT02688387|10043852|FG007|STARTED|Part 2, Period 1 (up to 6 Days)||0
8979590|NCT02688387|10043853|FG008|STARTED|Part 2, Period 1 (up to 6 Days)||0
8979591|NCT02688387|10043854|FG009|STARTED|Part 2, Period 1 (up to 6 Days)||0
8979592|NCT02688387|10043855|FG010|STARTED|Part 2, Period 1 (up to 6 Days)||6
8979593|NCT02688387|10043856|FG011|STARTED|Part 2, Period 1 (up to 6 Days)||5
8979594|NCT02688387|10043857|FG012|STARTED|Part 2, Period 1 (up to 6 Days)||5
8979595|NCT02688387|10043858|FG013|STARTED|Part 2, Period 1 (up to 6 Days)||5
8979596|NCT02688387|10043859|FG014|STARTED|Part 2, Period 1 (up to 6 Days)||0
8979597|NCT02688387|10043860|FG015|STARTED|Part 2, Period 1 (up to 6 Days)||0
8979598|NCT02688387|10043861|FG016|STARTED|Part 2, Period 1 (up to 6 Days)||0
8979599|NCT02688387|10043862|FG017|STARTED|Part 2, Period 1 (up to 6 Days)||0
8979600|NCT02688387|10043863|FG018|STARTED|Part 2, Period 1 (up to 6 Days)||0
8979601|NCT02688387|10043864|FG019|STARTED|Part 2, Period 1 (up to 6 Days)||0
8979602|NCT02688387|10043865|FG020|STARTED|Part 2, Period 1 (up to 6 Days)||0
8979603|NCT02688387|10043866|FG021|STARTED|Part 2, Period 1 (up to 6 Days)||0
8979604|NCT02688387|10043845|FG000|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8979605|NCT02688387|10043846|FG001|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8979606|NCT02688387|10043847|FG002|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8979607|NCT02688387|10043848|FG003|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8979608|NCT02688387|10043849|FG004|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8979609|NCT02688387|10043850|FG005|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8979610|NCT02688387|10043851|FG006|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8979611|NCT02688387|10043852|FG007|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8979612|NCT02688387|10043853|FG008|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8979613|NCT02688387|10043854|FG009|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8979614|NCT02688387|10043855|FG010|COMPLETED|Part 2, Period 1 (up to 6 Days)||5
8979615|NCT02688387|10043856|FG011|COMPLETED|Part 2, Period 1 (up to 6 Days)||5
8979616|NCT02688387|10043857|FG012|COMPLETED|Part 2, Period 1 (up to 6 Days)||5
8979617|NCT02688387|10043858|FG013|COMPLETED|Part 2, Period 1 (up to 6 Days)||5
8979618|NCT02688387|10043859|FG014|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8979619|NCT02688387|10043860|FG015|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8979620|NCT02688387|10043861|FG016|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8979621|NCT02688387|10043862|FG017|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8979622|NCT02688387|10043863|FG018|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8979623|NCT02688387|10043864|FG019|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8979624|NCT02688387|10043865|FG020|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8979625|NCT02688387|10043866|FG021|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8979626|NCT02688387|10043845|FG000|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8979627|NCT02688387|10043846|FG001|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8979628|NCT02688387|10043847|FG002|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8979629|NCT02688387|10043848|FG003|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8979630|NCT02688387|10043849|FG004|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8979631|NCT02688387|10043850|FG005|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8979632|NCT02688387|10043851|FG006|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8979633|NCT02688387|10043852|FG007|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8979634|NCT02688387|10043853|FG008|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8979635|NCT02688387|10043854|FG009|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8979636|NCT02688387|10043855|FG010|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||1
8979637|NCT02688387|10043856|FG011|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8979638|NCT02688387|10043857|FG012|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8979639|NCT02688387|10043858|FG013|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8979640|NCT02688387|10043859|FG014|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8979641|NCT02688387|10043860|FG015|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8979642|NCT02688387|10043861|FG016|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8979643|NCT02688387|10043862|FG017|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8979644|NCT02688387|10043863|FG018|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8979645|NCT02688387|10043864|FG019|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8979646|NCT02688387|10043865|FG020|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8979647|NCT02688387|10043866|FG021|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8979648|NCT02688387|10043845|FG000|STARTED|Part 2, Washout Period 1 (10 Days)||0
8979649|NCT02688387|10043846|FG001|STARTED|Part 2, Washout Period 1 (10 Days)||0
8979650|NCT02688387|10043847|FG002|STARTED|Part 2, Washout Period 1 (10 Days)||0
8979651|NCT02688387|10043848|FG003|STARTED|Part 2, Washout Period 1 (10 Days)||0
8979652|NCT02688387|10043849|FG004|STARTED|Part 2, Washout Period 1 (10 Days)||0
8979653|NCT02688387|10043850|FG005|STARTED|Part 2, Washout Period 1 (10 Days)||0
8979654|NCT02688387|10043851|FG006|STARTED|Part 2, Washout Period 1 (10 Days)||0
8979655|NCT02688387|10043852|FG007|STARTED|Part 2, Washout Period 1 (10 Days)||0
8979656|NCT02688387|10043853|FG008|STARTED|Part 2, Washout Period 1 (10 Days)||0
8979657|NCT02688387|10043854|FG009|STARTED|Part 2, Washout Period 1 (10 Days)||0
8979658|NCT02688387|10043855|FG010|STARTED|Part 2, Washout Period 1 (10 Days)||5
8979659|NCT02688387|10043856|FG011|STARTED|Part 2, Washout Period 1 (10 Days)||5
8979660|NCT02688387|10043857|FG012|STARTED|Part 2, Washout Period 1 (10 Days)||5
8979661|NCT02688387|10043858|FG013|STARTED|Part 2, Washout Period 1 (10 Days)||5
8979662|NCT02688387|10043859|FG014|STARTED|Part 2, Washout Period 1 (10 Days)||0
8979663|NCT02688387|10043860|FG015|STARTED|Part 2, Washout Period 1 (10 Days)||0
8578536|NCT00175006|9611617|FG000|STARTED|Overall Study||13
8578537|NCT00175006|9611617|FG000|COMPLETED|Overall Study||13
8578538|NCT00175006|9611617|FG000|NOT COMPLETED|Overall Study||0
8632435|NCT00545571|9672374|FG000|COMPLETED|Overall Study||53
8632436|NCT00545571|9672374|FG000|NOT COMPLETED|Overall Study||67
8979664|NCT02688387|10043861|FG016|STARTED|Part 2, Washout Period 1 (10 Days)||0
8979665|NCT02688387|10043862|FG017|STARTED|Part 2, Washout Period 1 (10 Days)||0
8979666|NCT02688387|10043863|FG018|STARTED|Part 2, Washout Period 1 (10 Days)||0
8979667|NCT02688387|10043864|FG019|STARTED|Part 2, Washout Period 1 (10 Days)||0
8632437|NCT00545584|9672381|FG000|STARTED|Overall Study||412
8632438|NCT00545584|9672382|FG001|STARTED|Overall Study||414
8632439|NCT00545584|9672383|FG002|STARTED|Overall Study|306 subjects were randomized but only 305 were treated.|306
8979668|NCT02688387|10043865|FG020|STARTED|Part 2, Washout Period 1 (10 Days)||0
8979669|NCT02688387|10043866|FG021|STARTED|Part 2, Washout Period 1 (10 Days)||0
8979670|NCT02688387|10043845|FG000|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8979671|NCT02688387|10043846|FG001|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8979672|NCT02688387|10043847|FG002|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8979673|NCT02688387|10043848|FG003|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8979674|NCT02688387|10043849|FG004|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8979675|NCT02688387|10043850|FG005|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8979676|NCT02688387|10043851|FG006|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8979677|NCT02688387|10043852|FG007|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8979678|NCT02688387|10043853|FG008|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8979679|NCT02688387|10043854|FG009|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8979680|NCT02688387|10043855|FG010|COMPLETED|Part 2, Washout Period 1 (10 Days)||5
8979681|NCT02688387|10043856|FG011|COMPLETED|Part 2, Washout Period 1 (10 Days)||5
8979682|NCT02688387|10043857|FG012|COMPLETED|Part 2, Washout Period 1 (10 Days)||5
8979683|NCT02688387|10043858|FG013|COMPLETED|Part 2, Washout Period 1 (10 Days)||5
8979684|NCT02688387|10043859|FG014|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8979685|NCT02688387|10043860|FG015|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8979686|NCT02688387|10043861|FG016|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8979687|NCT02688387|10043862|FG017|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8979688|NCT02688387|10043863|FG018|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8979689|NCT02688387|10043864|FG019|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8979690|NCT02688387|10043865|FG020|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8979691|NCT02688387|10043866|FG021|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8979692|NCT02688387|10043845|FG000|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8979693|NCT02688387|10043846|FG001|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8979694|NCT02688387|10043847|FG002|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8979695|NCT02688387|10043848|FG003|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8979696|NCT02688387|10043849|FG004|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8979697|NCT02688387|10043850|FG005|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8979698|NCT02688387|10043851|FG006|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8979699|NCT02688387|10043852|FG007|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8979700|NCT02688387|10043853|FG008|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8979701|NCT02688387|10043854|FG009|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8979702|NCT02688387|10043855|FG010|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8979703|NCT02688387|10043856|FG011|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8979704|NCT02688387|10043857|FG012|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8979705|NCT02688387|10043858|FG013|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8571325|NCT00109473|9603560|FG000|NOT COMPLETED|52 Week Extension Phase||4
8571326|NCT00109473|9603561|FG001|NOT COMPLETED|52 Week Extension Phase||5
8571327|NCT00109577|9603572|FG000|STARTED|Overall Study||20
8571328|NCT00109577|9603573|FG001|STARTED|Overall Study||20
8571329|NCT00109577|9603572|FG000|COMPLETED|Overall Study||17
8571330|NCT00109577|9603573|FG001|COMPLETED|Overall Study||17
8571331|NCT00109577|9603572|FG000|NOT COMPLETED|Overall Study||3
8571332|NCT00109577|9603573|FG001|NOT COMPLETED|Overall Study||3
8571333|NCT00109590|9603582|FG000|STARTED|Overall Study||57
8571334|NCT00109590|9603583|FG001|STARTED|Overall Study||58
8571335|NCT00109590|9603584|FG002|STARTED|Overall Study||60
8571336|NCT00109590|9603582|FG000|RECEIVED TREATMENT|Overall Study||56
8571337|NCT00109590|9603583|FG001|RECEIVED TREATMENT|Overall Study||56
8571338|NCT00109590|9603584|FG002|RECEIVED TREATMENT|Overall Study||57
8571339|NCT00109590|9603582|FG000|COMPLETED|Overall Study||55
8571340|NCT00109590|9603583|FG001|COMPLETED|Overall Study||56
8571341|NCT00109590|9603584|FG002|COMPLETED|Overall Study||56
8571342|NCT00109590|9603582|FG000|NOT COMPLETED|Overall Study||2
8571343|NCT00109590|9603583|FG001|NOT COMPLETED|Overall Study||2
8571344|NCT00109590|9603584|FG002|NOT COMPLETED|Overall Study||4
8571345|NCT00109707|9603609|FG000|STARTED|Overall Study||321
8571346|NCT00109707|9603610|FG001|STARTED|Overall Study||137
8571347|NCT00109707|9603611|FG002|STARTED|Overall Study||49
8571348|NCT00109707|9603609|FG000|Entered Extension Study|Overall Study||106
8571349|NCT00109707|9603610|FG001|Entered Extension Study|Overall Study||15
8571350|NCT00109707|9603611|FG002|Entered Extension Study|Overall Study||15
8571351|NCT00109707|9603609|FG000|COMPLETED|Overall Study||67
8571352|NCT00109707|9603610|FG001|COMPLETED|Overall Study||8
8571353|NCT00109707|9603611|FG002|COMPLETED|Overall Study||8
8571354|NCT00109707|9603609|FG000|NOT COMPLETED|Overall Study||254
8571355|NCT00109707|9603610|FG001|NOT COMPLETED|Overall Study||129
8571356|NCT00109707|9603611|FG002|NOT COMPLETED|Overall Study||41
8571357|NCT00109733|9603625|FG000|STARTED|Overall Study||15
8571358|NCT00109733|9603626|FG001|STARTED|Overall Study||16
8571359|NCT00109733|9603625|FG000|COMPLETED|Overall Study||13
8979706|NCT02688387|10043859|FG014|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8979707|NCT02688387|10043860|FG015|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8979708|NCT02688387|10043861|FG016|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8979709|NCT02688387|10043862|FG017|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8979710|NCT02688387|10043863|FG018|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8979711|NCT02688387|10043864|FG019|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8571360|NCT00109733|9603626|FG001|COMPLETED|Overall Study||12
8571361|NCT00109733|9603625|FG000|NOT COMPLETED|Overall Study||2
8571362|NCT00109733|9603626|FG001|NOT COMPLETED|Overall Study||4
8571363|NCT00109772|9603634|FG000|STARTED|Double-blind Treatment||90
8571364|NCT00109772|9603635|FG001|STARTED|Double-blind Treatment||94
8571365|NCT00109772|9603634|FG000|Safety and ITT Population|Double-blind Treatment|Safety: at least one dose of study drug ITT: treated and at least one post dose diary measurement|87
8571366|NCT00109772|9603635|FG001|Safety and ITT Population|Double-blind Treatment|Safety: at least one dose of study drug ITT: treated and at least one post dose diary measurement|93
8571367|NCT00109772|9603634|FG000|COMPLETED|Double-blind Treatment||68
8571368|NCT00109772|9603635|FG001|COMPLETED|Double-blind Treatment||79
8571369|NCT00109772|9603634|FG000|NOT COMPLETED|Double-blind Treatment||22
8571370|NCT00109772|9603635|FG001|NOT COMPLETED|Double-blind Treatment||15
8571371|NCT00109772|9603634|FG000|STARTED|Open-label Extension|Four double-blind participants did not continue into the open-label extension|64
8571372|NCT00109772|9603635|FG001|STARTED|Open-label Extension|One double-blind participant did not continue into the open-label extension|78
8632440|NCT00545584|9672381|FG000|COMPLETED|Overall Study||333
8632441|NCT00545584|9672382|FG001|COMPLETED|Overall Study||334
8632442|NCT00545584|9672383|FG002|COMPLETED|Overall Study||250
8632443|NCT00545584|9672381|FG000|NOT COMPLETED|Overall Study||79
8632444|NCT00545584|9672382|FG001|NOT COMPLETED|Overall Study||80
8632445|NCT00545584|9672383|FG002|NOT COMPLETED|Overall Study||56
8632446|NCT00545623|9672395|FG000|STARTED|Overall Study||32
8632447|NCT00545623|9672396|FG001|STARTED|Overall Study||31
8632448|NCT00545623|9672397|FG002|STARTED|Overall Study||33
8632449|NCT00545623|9672398|FG003|STARTED|Overall Study||34
8632450|NCT00545623|9672395|FG000|COMPLETED|Overall Study||25
8632451|NCT00545623|9672396|FG001|COMPLETED|Overall Study||21
8632452|NCT00545623|9672397|FG002|COMPLETED|Overall Study||20
8632453|NCT00545623|9672398|FG003|COMPLETED|Overall Study||23
8632454|NCT00545623|9672395|FG000|NOT COMPLETED|Overall Study||7
8632455|NCT00545623|9672396|FG001|NOT COMPLETED|Overall Study||10
8632456|NCT00545623|9672397|FG002|NOT COMPLETED|Overall Study||13
8632457|NCT00545623|9672398|FG003|NOT COMPLETED|Overall Study||11
8632458|NCT00545662|9672410|FG000|STARTED|Overall Study||606
8632459|NCT00545662|9672411|FG001|STARTED|Overall Study||607
8632460|NCT00545662|9672410|FG000|COMPLETED|Overall Study||521
8632461|NCT00545662|9672411|FG001|COMPLETED|Overall Study||528
8632462|NCT00545662|9672410|FG000|NOT COMPLETED|Overall Study||85
8632463|NCT00545662|9672411|FG001|NOT COMPLETED|Overall Study||79
8632464|NCT00545688|9672421|FG000|STARTED|Neo-Adjuvant Treatment Period||107
8632465|NCT00545688|9672422|FG001|STARTED|Neo-Adjuvant Treatment Period||107
8632466|NCT00545688|9672423|FG002|STARTED|Neo-Adjuvant Treatment Period||108
8632467|NCT00545688|9672424|FG003|STARTED|Neo-Adjuvant Treatment Period||94
8632468|NCT00545688|9672421|FG000|COMPLETED|Neo-Adjuvant Treatment Period||103
8632469|NCT00545688|9672422|FG001|COMPLETED|Neo-Adjuvant Treatment Period||102
8632470|NCT00545688|9672423|FG002|COMPLETED|Neo-Adjuvant Treatment Period||94
8632471|NCT00545688|9672424|FG003|COMPLETED|Neo-Adjuvant Treatment Period||88
8632472|NCT00545688|9672421|FG000|NOT COMPLETED|Neo-Adjuvant Treatment Period||4
8632473|NCT00545688|9672422|FG001|NOT COMPLETED|Neo-Adjuvant Treatment Period||5
8725833|NCT01033487|9773160|FG003|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
8725834|NCT01033487|9773161|FG004|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
8725835|NCT01033487|9773162|FG005|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
8725836|NCT01033487|9773163|FG006|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
8979712|NCT02688387|10043865|FG020|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8632474|NCT00545688|9672423|FG002|NOT COMPLETED|Neo-Adjuvant Treatment Period||14
8632475|NCT00545688|9672424|FG003|NOT COMPLETED|Neo-Adjuvant Treatment Period||6
8632476|NCT00545688|9672421|FG000|STARTED|Adjuvant Treatment Period||103
8632477|NCT00545688|9672422|FG001|STARTED|Adjuvant Treatment Period||102
8632478|NCT00545688|9672423|FG002|STARTED|Adjuvant Treatment Period||94
8632479|NCT00545688|9672424|FG003|STARTED|Adjuvant Treatment Period||88
8632480|NCT00545688|9672421|FG000|COMPLETED|Adjuvant Treatment Period||98
8632481|NCT00545688|9672422|FG001|COMPLETED|Adjuvant Treatment Period||94
8632482|NCT00545688|9672423|FG002|COMPLETED|Adjuvant Treatment Period||90
8632483|NCT00545688|9672424|FG003|COMPLETED|Adjuvant Treatment Period||74
8632484|NCT00545688|9672421|FG000|NOT COMPLETED|Adjuvant Treatment Period||5
8632485|NCT00545688|9672422|FG001|NOT COMPLETED|Adjuvant Treatment Period||8
8632486|NCT00545688|9672423|FG002|NOT COMPLETED|Adjuvant Treatment Period||4
8979713|NCT02688387|10043866|FG021|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8979714|NCT02688387|10043845|FG000|STARTED|Part 2, Period 2 (up to 6 Days)||0
8979715|NCT02688387|10043846|FG001|STARTED|Part 2, Period 2 (up to 6 Days)||0
8979716|NCT02688387|10043847|FG002|STARTED|Part 2, Period 2 (up to 6 Days)||0
8979717|NCT02688387|10043848|FG003|STARTED|Part 2, Period 2 (up to 6 Days)||0
8979718|NCT02688387|10043849|FG004|STARTED|Part 2, Period 2 (up to 6 Days)||0
8979719|NCT02688387|10043850|FG005|STARTED|Part 2, Period 2 (up to 6 Days)||0
8979720|NCT02688387|10043851|FG006|STARTED|Part 2, Period 2 (up to 6 Days)||0
8979721|NCT02688387|10043852|FG007|STARTED|Part 2, Period 2 (up to 6 Days)||0
8979722|NCT02688387|10043853|FG008|STARTED|Part 2, Period 2 (up to 6 Days)||0
8979723|NCT02688387|10043854|FG009|STARTED|Part 2, Period 2 (up to 6 Days)||0
8979724|NCT02688387|10043855|FG010|STARTED|Part 2, Period 2 (up to 6 Days)||5
8979725|NCT02688387|10043856|FG011|STARTED|Part 2, Period 2 (up to 6 Days)||5
8979726|NCT02688387|10043857|FG012|STARTED|Part 2, Period 2 (up to 6 Days)||5
8979727|NCT02688387|10043858|FG013|STARTED|Part 2, Period 2 (up to 6 Days)||5
8979728|NCT02688387|10043859|FG014|STARTED|Part 2, Period 2 (up to 6 Days)||0
8979729|NCT02688387|10043860|FG015|STARTED|Part 2, Period 2 (up to 6 Days)||0
8979730|NCT02688387|10043861|FG016|STARTED|Part 2, Period 2 (up to 6 Days)||0
8979731|NCT02688387|10043862|FG017|STARTED|Part 2, Period 2 (up to 6 Days)||0
8979732|NCT02688387|10043863|FG018|STARTED|Part 2, Period 2 (up to 6 Days)||0
8979733|NCT02688387|10043864|FG019|STARTED|Part 2, Period 2 (up to 6 Days)||0
8979734|NCT02688387|10043865|FG020|STARTED|Part 2, Period 2 (up to 6 Days)||0
8979735|NCT02688387|10043866|FG021|STARTED|Part 2, Period 2 (up to 6 Days)||0
8979736|NCT02688387|10043845|FG000|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8979737|NCT02688387|10043846|FG001|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8979738|NCT02688387|10043847|FG002|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8979739|NCT02688387|10043848|FG003|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8979740|NCT02688387|10043849|FG004|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8979741|NCT02688387|10043850|FG005|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8979742|NCT02688387|10043851|FG006|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8979743|NCT02688387|10043852|FG007|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8979744|NCT02688387|10043853|FG008|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8979745|NCT02688387|10043854|FG009|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8979746|NCT02688387|10043855|FG010|COMPLETED|Part 2, Period 2 (up to 6 Days)||5
8979747|NCT02688387|10043856|FG011|COMPLETED|Part 2, Period 2 (up to 6 Days)||5
8979748|NCT02688387|10043857|FG012|COMPLETED|Part 2, Period 2 (up to 6 Days)||5
8979749|NCT02688387|10043858|FG013|COMPLETED|Part 2, Period 2 (up to 6 Days)||5
8979750|NCT02688387|10043859|FG014|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8979751|NCT02688387|10043860|FG015|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8979752|NCT02688387|10043861|FG016|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8979753|NCT02688387|10043862|FG017|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8979754|NCT02688387|10043863|FG018|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8979755|NCT02688387|10043864|FG019|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8979756|NCT02688387|10043865|FG020|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8979757|NCT02688387|10043866|FG021|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8979758|NCT02688387|10043845|FG000|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8979759|NCT02688387|10043846|FG001|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8979760|NCT02688387|10043847|FG002|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8979761|NCT02688387|10043848|FG003|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8979762|NCT02688387|10043849|FG004|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8979763|NCT02688387|10043850|FG005|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8979764|NCT02688387|10043851|FG006|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8979765|NCT02688387|10043852|FG007|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8979766|NCT02688387|10043853|FG008|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8979767|NCT02688387|10043854|FG009|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8979768|NCT02688387|10043855|FG010|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8979769|NCT02688387|10043856|FG011|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8979770|NCT02688387|10043857|FG012|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8979771|NCT02688387|10043858|FG013|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8979772|NCT02688387|10043859|FG014|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8979773|NCT02688387|10043860|FG015|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8979774|NCT02688387|10043861|FG016|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8979775|NCT02688387|10043862|FG017|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8979776|NCT02688387|10043863|FG018|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8979777|NCT02688387|10043864|FG019|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8979778|NCT02688387|10043865|FG020|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8979779|NCT02688387|10043866|FG021|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8979780|NCT02688387|10043845|FG000|STARTED|Part 2, Washout Period 2 (10 Days)||0
8979781|NCT02688387|10043846|FG001|STARTED|Part 2, Washout Period 2 (10 Days)||0
8979782|NCT02688387|10043847|FG002|STARTED|Part 2, Washout Period 2 (10 Days)||0
8979783|NCT02688387|10043848|FG003|STARTED|Part 2, Washout Period 2 (10 Days)||0
8979784|NCT02688387|10043849|FG004|STARTED|Part 2, Washout Period 2 (10 Days)||0
8979785|NCT02688387|10043850|FG005|STARTED|Part 2, Washout Period 2 (10 Days)||0
8979786|NCT02688387|10043851|FG006|STARTED|Part 2, Washout Period 2 (10 Days)||0
8979787|NCT02688387|10043852|FG007|STARTED|Part 2, Washout Period 2 (10 Days)||0
8979788|NCT02688387|10043853|FG008|STARTED|Part 2, Washout Period 2 (10 Days)||0
8979789|NCT02688387|10043854|FG009|STARTED|Part 2, Washout Period 2 (10 Days)||0
8632487|NCT00545688|9672424|FG003|NOT COMPLETED|Adjuvant Treatment Period||14
8979790|NCT02688387|10043855|FG010|STARTED|Part 2, Washout Period 2 (10 Days)||5
8979791|NCT02688387|10043856|FG011|STARTED|Part 2, Washout Period 2 (10 Days)||5
8979792|NCT02688387|10043857|FG012|STARTED|Part 2, Washout Period 2 (10 Days)||5
8979793|NCT02688387|10043858|FG013|STARTED|Part 2, Washout Period 2 (10 Days)||5
8979794|NCT02688387|10043859|FG014|STARTED|Part 2, Washout Period 2 (10 Days)||0
8979795|NCT02688387|10043860|FG015|STARTED|Part 2, Washout Period 2 (10 Days)||0
8979796|NCT02688387|10043861|FG016|STARTED|Part 2, Washout Period 2 (10 Days)||0
8979797|NCT02688387|10043862|FG017|STARTED|Part 2, Washout Period 2 (10 Days)||0
8979798|NCT02688387|10043863|FG018|STARTED|Part 2, Washout Period 2 (10 Days)||0
8979799|NCT02688387|10043864|FG019|STARTED|Part 2, Washout Period 2 (10 Days)||0
8979800|NCT02688387|10043865|FG020|STARTED|Part 2, Washout Period 2 (10 Days)||0
8979801|NCT02688387|10043866|FG021|STARTED|Part 2, Washout Period 2 (10 Days)||0
8979802|NCT02688387|10043845|FG000|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8979803|NCT02688387|10043846|FG001|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8979804|NCT02688387|10043847|FG002|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8979805|NCT02688387|10043848|FG003|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8979806|NCT02688387|10043849|FG004|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8979807|NCT02688387|10043850|FG005|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8979808|NCT02688387|10043851|FG006|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8979809|NCT02688387|10043852|FG007|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8979810|NCT02688387|10043853|FG008|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8979811|NCT02688387|10043854|FG009|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8979812|NCT02688387|10043855|FG010|COMPLETED|Part 2, Washout Period 2 (10 Days)||5
8979813|NCT02688387|10043856|FG011|COMPLETED|Part 2, Washout Period 2 (10 Days)||5
8979814|NCT02688387|10043857|FG012|COMPLETED|Part 2, Washout Period 2 (10 Days)||5
8979815|NCT02688387|10043858|FG013|COMPLETED|Part 2, Washout Period 2 (10 Days)||5
8979816|NCT02688387|10043859|FG014|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8632488|NCT00545688|9672421|FG000|STARTED|Follow-Up Period||98
8632489|NCT00545688|9672422|FG001|STARTED|Follow-Up Period||102
8632490|NCT00545688|9672423|FG002|STARTED|Follow-Up Period||98
8979817|NCT02688387|10043860|FG015|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8979818|NCT02688387|10043861|FG016|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8979819|NCT02688387|10043862|FG017|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8979820|NCT02688387|10043863|FG018|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8979821|NCT02688387|10043864|FG019|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8979822|NCT02688387|10043865|FG020|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8979823|NCT02688387|10043866|FG021|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8979824|NCT02688387|10043845|FG000|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8979825|NCT02688387|10043846|FG001|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8979826|NCT02688387|10043847|FG002|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8979827|NCT02688387|10043848|FG003|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8979828|NCT02688387|10043849|FG004|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8979829|NCT02688387|10043850|FG005|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8979830|NCT02688387|10043851|FG006|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8979831|NCT02688387|10043852|FG007|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8979832|NCT02688387|10043853|FG008|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8979833|NCT02688387|10043854|FG009|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8979834|NCT02688387|10043855|FG010|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8979835|NCT02688387|10043856|FG011|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8979836|NCT02688387|10043857|FG012|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8979837|NCT02688387|10043858|FG013|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8979838|NCT02688387|10043859|FG014|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8979839|NCT02688387|10043860|FG015|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8979840|NCT02688387|10043861|FG016|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8979841|NCT02688387|10043862|FG017|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8979842|NCT02688387|10043863|FG018|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8979843|NCT02688387|10043864|FG019|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8979844|NCT02688387|10043865|FG020|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8979845|NCT02688387|10043866|FG021|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8979846|NCT02688387|10043845|FG000|STARTED|Part 2, Period 3 (up to 6 Days)||0
8979847|NCT02688387|10043846|FG001|STARTED|Part 2, Period 3 (up to 6 Days)||0
8979848|NCT02688387|10043847|FG002|STARTED|Part 2, Period 3 (up to 6 Days)||0
8979849|NCT02688387|10043848|FG003|STARTED|Part 2, Period 3 (up to 6 Days)||0
8979850|NCT02688387|10043849|FG004|STARTED|Part 2, Period 3 (up to 6 Days)||0
8979851|NCT02688387|10043850|FG005|STARTED|Part 2, Period 3 (up to 6 Days)||0
8979852|NCT02688387|10043851|FG006|STARTED|Part 2, Period 3 (up to 6 Days)||0
8979853|NCT02688387|10043852|FG007|STARTED|Part 2, Period 3 (up to 6 Days)||0
8979854|NCT02688387|10043853|FG008|STARTED|Part 2, Period 3 (up to 6 Days)||0
8979855|NCT02688387|10043854|FG009|STARTED|Part 2, Period 3 (up to 6 Days)||0
8979856|NCT02688387|10043855|FG010|STARTED|Part 2, Period 3 (up to 6 Days)||5
8979857|NCT02688387|10043856|FG011|STARTED|Part 2, Period 3 (up to 6 Days)||5
8979858|NCT02688387|10043857|FG012|STARTED|Part 2, Period 3 (up to 6 Days)||5
8979859|NCT02688387|10043858|FG013|STARTED|Part 2, Period 3 (up to 6 Days)||5
8979860|NCT02688387|10043859|FG014|STARTED|Part 2, Period 3 (up to 6 Days)||0
8979861|NCT02688387|10043860|FG015|STARTED|Part 2, Period 3 (up to 6 Days)||0
8632491|NCT00545688|9672424|FG003|STARTED|Follow-Up Period||87
8632492|NCT00545688|9672421|FG000|COMPLETED|Follow-Up Period||77
8979862|NCT02688387|10043861|FG016|STARTED|Part 2, Period 3 (up to 6 Days)||0
8979863|NCT02688387|10043862|FG017|STARTED|Part 2, Period 3 (up to 6 Days)||0
8979864|NCT02688387|10043863|FG018|STARTED|Part 2, Period 3 (up to 6 Days)||0
8979865|NCT02688387|10043864|FG019|STARTED|Part 2, Period 3 (up to 6 Days)||0
8979866|NCT02688387|10043865|FG020|STARTED|Part 2, Period 3 (up to 6 Days)||0
8979867|NCT02688387|10043866|FG021|STARTED|Part 2, Period 3 (up to 6 Days)||0
8979868|NCT02688387|10043845|FG000|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8979869|NCT02688387|10043846|FG001|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8979870|NCT02688387|10043847|FG002|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8979871|NCT02688387|10043848|FG003|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8979872|NCT02688387|10043849|FG004|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8979873|NCT02688387|10043850|FG005|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8979874|NCT02688387|10043851|FG006|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8979875|NCT02688387|10043852|FG007|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8979876|NCT02688387|10043853|FG008|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8979877|NCT02688387|10043854|FG009|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8979878|NCT02688387|10043855|FG010|COMPLETED|Part 2, Period 3 (up to 6 Days)||5
8979879|NCT02688387|10043856|FG011|COMPLETED|Part 2, Period 3 (up to 6 Days)||5
8979880|NCT02688387|10043857|FG012|COMPLETED|Part 2, Period 3 (up to 6 Days)||5
8979881|NCT02688387|10043858|FG013|COMPLETED|Part 2, Period 3 (up to 6 Days)||5
8979882|NCT02688387|10043859|FG014|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8979883|NCT02688387|10043860|FG015|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8979884|NCT02688387|10043861|FG016|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8979885|NCT02688387|10043862|FG017|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8979886|NCT02688387|10043863|FG018|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8979887|NCT02688387|10043864|FG019|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8979888|NCT02688387|10043865|FG020|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8979889|NCT02688387|10043866|FG021|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8979890|NCT02688387|10043845|FG000|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8979891|NCT02688387|10043846|FG001|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8979892|NCT02688387|10043847|FG002|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8979893|NCT02688387|10043848|FG003|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8979894|NCT02688387|10043849|FG004|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8979895|NCT02688387|10043850|FG005|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8979896|NCT02688387|10043851|FG006|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8979897|NCT02688387|10043852|FG007|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8979898|NCT02688387|10043853|FG008|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8979899|NCT02688387|10043854|FG009|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8979900|NCT02688387|10043855|FG010|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8979901|NCT02688387|10043856|FG011|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8571373|NCT00109772|9603634|FG000|COMPLETED|Open-label Extension|Participants who were active in extension period when the sponsor terminated the study.|19
8725837|NCT01033487|9773164|FG007|STARTED|Between Period 1 and 2 (At Least 7 Days)||3
8725838|NCT01033487|9773165|FG008|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
8877419|NCT01923181|9934374|FG006|Safety Analysis Set (SAS)|Overall Study||70
8877420|NCT01923181|9934375|FG007|Safety Analysis Set (SAS)|Overall Study||69
8877421|NCT01923181|9934376|FG008|Safety Analysis Set (SAS)|Overall Study||71
8877422|NCT01923181|9934368|FG000|COMPLETED|Overall Study||67
8877423|NCT01923181|9934369|FG001|COMPLETED|Overall Study||64
8877424|NCT01923181|9934370|FG002|COMPLETED|Overall Study||67
8877425|NCT01923181|9934371|FG003|COMPLETED|Overall Study||65
8877426|NCT01923181|9934372|FG004|COMPLETED|Overall Study||63
8877427|NCT01923181|9934373|FG005|COMPLETED|Overall Study||66
8877428|NCT01923181|9934374|FG006|COMPLETED|Overall Study||62
8877429|NCT01923181|9934375|FG007|COMPLETED|Overall Study||61
8877430|NCT01923181|9934376|FG008|COMPLETED|Overall Study||68
8877431|NCT01923181|9934368|FG000|NOT COMPLETED|Overall Study||3
8877432|NCT01923181|9934369|FG001|NOT COMPLETED|Overall Study||6
8877433|NCT01923181|9934370|FG002|NOT COMPLETED|Overall Study||2
8877434|NCT01923181|9934371|FG003|NOT COMPLETED|Overall Study||5
8877435|NCT01923181|9934372|FG004|NOT COMPLETED|Overall Study||8
8877436|NCT01923181|9934373|FG005|NOT COMPLETED|Overall Study||4
8877437|NCT01923181|9934374|FG006|NOT COMPLETED|Overall Study||8
8877438|NCT01923181|9934375|FG007|NOT COMPLETED|Overall Study||8
8877439|NCT01923181|9934376|FG008|NOT COMPLETED|Overall Study||3
8877440|NCT01923285|9934401|FG000|STARTED|Overall Study||76
8877441|NCT01923285|9934402|FG001|STARTED|Overall Study||76
8979902|NCT02688387|10043857|FG012|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8632493|NCT00545688|9672422|FG001|COMPLETED|Follow-Up Period||83
8632494|NCT00545688|9672423|FG002|COMPLETED|Follow-Up Period||78
8632495|NCT00545688|9672424|FG003|COMPLETED|Follow-Up Period||60
8632496|NCT00545688|9672421|FG000|NOT COMPLETED|Follow-Up Period||21
8632497|NCT00545688|9672422|FG001|NOT COMPLETED|Follow-Up Period||19
8632498|NCT00545688|9672423|FG002|NOT COMPLETED|Follow-Up Period||20
8632499|NCT00545688|9672424|FG003|NOT COMPLETED|Follow-Up Period||27
8632500|NCT00545714|9672437|FG000|STARTED|Induction Phase (6 Months)||86
8877442|NCT01923285|9934401|FG000|Modified Intent-to-treat|Overall Study||73
8877443|NCT01923285|9934402|FG001|Modified Intent-to-treat|Overall Study||73
8877444|NCT01923285|9934401|FG000|COMPLETED|Overall Study||69
8877445|NCT01923285|9934402|FG001|COMPLETED|Overall Study||70
8877446|NCT01923285|9934401|FG000|NOT COMPLETED|Overall Study||7
8877447|NCT01923285|9934402|FG001|NOT COMPLETED|Overall Study||6
8877448|NCT01923311|9934410|FG000|STARTED|Overall Study||17
8877449|NCT01923311|9934411|FG001|STARTED|Overall Study||14
8877450|NCT01923311|9934410|FG000|COMPLETED|Overall Study||0
8877451|NCT01923311|9934411|FG001|COMPLETED|Overall Study||13
8877452|NCT01923311|9934410|FG000|NOT COMPLETED|Overall Study||17
8877453|NCT01923311|9934411|FG001|NOT COMPLETED|Overall Study||1
8877454|NCT01923363|9934418|FG000|STARTED|Overall Study||29
8877455|NCT01923363|9934418|FG000|COMPLETED|Overall Study||28
8877456|NCT01923363|9934418|FG000|NOT COMPLETED|Overall Study||1
8877457|NCT01923389|9934424|FG000|STARTED|Overall Study||2
8877458|NCT01923389|9934425|FG001|STARTED|Overall Study||2
8877459|NCT01923389|9934424|FG000|COMPLETED|Overall Study||1
8877460|NCT01923389|9934425|FG001|COMPLETED|Overall Study||2
8877461|NCT01923389|9934424|FG000|NOT COMPLETED|Overall Study||1
8877462|NCT01923389|9934425|FG001|NOT COMPLETED|Overall Study||0
8877463|NCT01923428|9934436|FG000|STARTED|Overall Study||88
8877464|NCT01923428|9934437|FG001|STARTED|Overall Study||89
8877465|NCT01923428|9934438|FG002|STARTED|Overall Study||89
8877466|NCT01923428|9934439|FG003|STARTED|Overall Study||90
8877467|NCT01923428|9934436|FG000|COMPLETED|Overall Study||69
8877468|NCT01923428|9934437|FG001|COMPLETED|Overall Study||77
8877469|NCT01923428|9934438|FG002|COMPLETED|Overall Study||78
8877470|NCT01923428|9934439|FG003|COMPLETED|Overall Study||80
8877471|NCT01923428|9934436|FG000|NOT COMPLETED|Overall Study||19
8877472|NCT01923428|9934437|FG001|NOT COMPLETED|Overall Study||12
8877473|NCT01923428|9934438|FG002|NOT COMPLETED|Overall Study||11
8877474|NCT01923428|9934439|FG003|NOT COMPLETED|Overall Study||10
8877475|NCT01923467|9934449|FG000|STARTED|Overall Study|Offered stop smoking program|767
8877476|NCT01923467|9934449|FG000|Baseline Completed, Enrolled|Overall Study||288
8877477|NCT01923467|9934449|FG000|COMPLETED|Overall Study|Completed 3-month follow up survey|226
8877478|NCT01923467|9934449|FG000|NOT COMPLETED|Overall Study||541
8877479|NCT01923740|9934455|FG000|STARTED|Overall Study||227
8877480|NCT01923740|9934456|FG001|STARTED|Overall Study||232
8877481|NCT01923740|9934455|FG000|COMPLETED|Overall Study||221
8877482|NCT01923740|9934456|FG001|COMPLETED|Overall Study||223
8877483|NCT01923740|9934455|FG000|NOT COMPLETED|Overall Study||6
8877484|NCT01923740|9934456|FG001|NOT COMPLETED|Overall Study||9
8877485|NCT01923805|9934464|FG000|STARTED|Overall Study|early termination|3
8877486|NCT01923805|9934465|FG001|STARTED|Overall Study|early termination|5
8877487|NCT01923805|9934464|FG000|COMPLETED|Overall Study||0
8877488|NCT01923805|9934465|FG001|COMPLETED|Overall Study||0
8877489|NCT01923805|9934464|FG000|NOT COMPLETED|Overall Study||3
8877490|NCT01923805|9934465|FG001|NOT COMPLETED|Overall Study||5
8877491|NCT01923896|9934473|FG000|STARTED|Overall Study||8
8877492|NCT01923896|9934474|FG001|STARTED|Overall Study||8
8877493|NCT01923896|9934473|FG000|COMPLETED|Overall Study||7
8877494|NCT01923896|9934474|FG001|COMPLETED|Overall Study||8
8877495|NCT01923896|9934473|FG000|NOT COMPLETED|Overall Study||1
8877496|NCT01923896|9934474|FG001|NOT COMPLETED|Overall Study||0
8877497|NCT01923961|9934483|FG000|STARTED|First Intervention||3
8877498|NCT01923961|9934484|FG001|STARTED|First Intervention||3
8877499|NCT01923961|9934485|FG002|STARTED|First Intervention||2
8877500|NCT01923961|9934483|FG000|COMPLETED|First Intervention||3
8877501|NCT01923961|9934484|FG001|COMPLETED|First Intervention||3
8877502|NCT01923961|9934485|FG002|COMPLETED|First Intervention||2
8877503|NCT01923961|9934483|FG000|NOT COMPLETED|First Intervention||0
8877504|NCT01923961|9934484|FG001|NOT COMPLETED|First Intervention||0
8632501|NCT00545714|9672437|FG000|Safety Population|Induction Phase (6 Months)||86
8691283|NCT00853957|9736512|FG001|COMPLETED|Overall Study||204
8877505|NCT01923961|9934485|FG002|NOT COMPLETED|First Intervention||0
8877506|NCT01923961|9934483|FG000|STARTED|Washout (1 Week)||3
8877507|NCT01923961|9934484|FG001|STARTED|Washout (1 Week)||3
8877508|NCT01923961|9934485|FG002|STARTED|Washout (1 Week)||2
8877509|NCT01923961|9934483|FG000|COMPLETED|Washout (1 Week)||3
8979903|NCT02688387|10043858|FG013|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8877510|NCT01923961|9934484|FG001|COMPLETED|Washout (1 Week)||3
8877511|NCT01923961|9934485|FG002|COMPLETED|Washout (1 Week)||2
8877512|NCT01923961|9934483|FG000|NOT COMPLETED|Washout (1 Week)||0
8877513|NCT01923961|9934484|FG001|NOT COMPLETED|Washout (1 Week)||0
8877514|NCT01923961|9934485|FG002|NOT COMPLETED|Washout (1 Week)||0
8877515|NCT01923961|9934483|FG000|STARTED|Second Intervention||3
8877516|NCT01923961|9934484|FG001|STARTED|Second Intervention||3
8877517|NCT01923961|9934485|FG002|STARTED|Second Intervention||2
8979904|NCT02688387|10043859|FG014|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8979905|NCT02688387|10043860|FG015|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8979906|NCT02688387|10043861|FG016|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8979907|NCT02688387|10043862|FG017|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8979908|NCT02688387|10043863|FG018|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8979909|NCT02688387|10043864|FG019|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8979910|NCT02688387|10043865|FG020|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8979911|NCT02688387|10043866|FG021|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8979912|NCT02688387|10043845|FG000|STARTED|Part 2, Washout Period 3 (10 Days)||0
8979913|NCT02688387|10043846|FG001|STARTED|Part 2, Washout Period 3 (10 Days)||0
8979914|NCT02688387|10043847|FG002|STARTED|Part 2, Washout Period 3 (10 Days)||0
8979915|NCT02688387|10043848|FG003|STARTED|Part 2, Washout Period 3 (10 Days)||0
8979916|NCT02688387|10043849|FG004|STARTED|Part 2, Washout Period 3 (10 Days)||0
8979917|NCT02688387|10043850|FG005|STARTED|Part 2, Washout Period 3 (10 Days)||0
8979918|NCT02688387|10043851|FG006|STARTED|Part 2, Washout Period 3 (10 Days)||0
8979919|NCT02688387|10043852|FG007|STARTED|Part 2, Washout Period 3 (10 Days)||0
8979920|NCT02688387|10043853|FG008|STARTED|Part 2, Washout Period 3 (10 Days)||0
8979921|NCT02688387|10043854|FG009|STARTED|Part 2, Washout Period 3 (10 Days)||0
8979922|NCT02688387|10043855|FG010|STARTED|Part 2, Washout Period 3 (10 Days)||5
8979923|NCT02688387|10043856|FG011|STARTED|Part 2, Washout Period 3 (10 Days)||5
8979924|NCT02688387|10043857|FG012|STARTED|Part 2, Washout Period 3 (10 Days)||5
8979925|NCT02688387|10043858|FG013|STARTED|Part 2, Washout Period 3 (10 Days)||5
8979926|NCT02688387|10043859|FG014|STARTED|Part 2, Washout Period 3 (10 Days)||0
8979927|NCT02688387|10043860|FG015|STARTED|Part 2, Washout Period 3 (10 Days)||0
8979928|NCT02688387|10043861|FG016|STARTED|Part 2, Washout Period 3 (10 Days)||0
8979929|NCT02688387|10043862|FG017|STARTED|Part 2, Washout Period 3 (10 Days)||0
8979930|NCT02688387|10043863|FG018|STARTED|Part 2, Washout Period 3 (10 Days)||0
8979931|NCT02688387|10043864|FG019|STARTED|Part 2, Washout Period 3 (10 Days)||0
8979932|NCT02688387|10043865|FG020|STARTED|Part 2, Washout Period 3 (10 Days)||0
8979933|NCT02688387|10043866|FG021|STARTED|Part 2, Washout Period 3 (10 Days)||0
8979934|NCT02688387|10043845|FG000|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8979935|NCT02688387|10043846|FG001|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8979936|NCT02688387|10043847|FG002|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8979937|NCT02688387|10043848|FG003|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8979938|NCT02688387|10043849|FG004|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8979939|NCT02688387|10043850|FG005|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8979940|NCT02688387|10043851|FG006|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8979941|NCT02688387|10043852|FG007|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8979942|NCT02688387|10043853|FG008|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8979943|NCT02688387|10043854|FG009|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8979944|NCT02688387|10043855|FG010|COMPLETED|Part 2, Washout Period 3 (10 Days)||5
8979945|NCT02688387|10043856|FG011|COMPLETED|Part 2, Washout Period 3 (10 Days)||5
8979946|NCT02688387|10043857|FG012|COMPLETED|Part 2, Washout Period 3 (10 Days)||5
8979947|NCT02688387|10043858|FG013|COMPLETED|Part 2, Washout Period 3 (10 Days)||5
8979948|NCT02688387|10043859|FG014|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8979949|NCT02688387|10043860|FG015|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8979950|NCT02688387|10043861|FG016|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8979951|NCT02688387|10043862|FG017|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8979952|NCT02688387|10043863|FG018|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8979953|NCT02688387|10043864|FG019|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8979954|NCT02688387|10043865|FG020|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8979955|NCT02688387|10043866|FG021|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8979956|NCT02688387|10043845|FG000|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8979957|NCT02688387|10043846|FG001|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8979958|NCT02688387|10043847|FG002|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8979959|NCT02688387|10043848|FG003|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8979960|NCT02688387|10043849|FG004|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8979961|NCT02688387|10043850|FG005|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8979962|NCT02688387|10043851|FG006|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8979963|NCT02688387|10043852|FG007|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8979964|NCT02688387|10043853|FG008|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8979965|NCT02688387|10043854|FG009|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8979966|NCT02688387|10043855|FG010|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8979967|NCT02688387|10043856|FG011|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8979968|NCT02688387|10043857|FG012|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8979969|NCT02688387|10043858|FG013|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8979970|NCT02688387|10043859|FG014|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8979971|NCT02688387|10043860|FG015|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8979972|NCT02688387|10043861|FG016|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8979973|NCT02688387|10043862|FG017|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8979974|NCT02688387|10043863|FG018|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8979975|NCT02688387|10043864|FG019|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8979976|NCT02688387|10043865|FG020|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8979977|NCT02688387|10043866|FG021|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8979978|NCT02688387|10043845|FG000|STARTED|Part 2, Period 4 (up to 6 Days)||0
8979979|NCT02688387|10043846|FG001|STARTED|Part 2, Period 4 (up to 6 Days)||0
8979980|NCT02688387|10043847|FG002|STARTED|Part 2, Period 4 (up to 6 Days)||0
8979981|NCT02688387|10043848|FG003|STARTED|Part 2, Period 4 (up to 6 Days)||0
8632502|NCT00545714|9672437|FG000|Intent-to-Treat (ITT) Population|Induction Phase (6 Months)||84
8632503|NCT00545714|9672437|FG000|COMPLETED|Induction Phase (6 Months)||74
8632504|NCT00545714|9672437|FG000|NOT COMPLETED|Induction Phase (6 Months)||12
8632505|NCT00545714|9672437|FG000|STARTED|Maintenance Phase (36 Months)||74
8632506|NCT00545714|9672437|FG000|COMPLETED|Maintenance Phase (36 Months)||42
8632507|NCT00545714|9672437|FG000|NOT COMPLETED|Maintenance Phase (36 Months)||32
8632508|NCT00545740|9672445|FG000|STARTED|Overall Study||145
8632509|NCT00545740|9672446|FG001|STARTED|Overall Study||145
8979982|NCT02688387|10043849|FG004|STARTED|Part 2, Period 4 (up to 6 Days)||0
8979983|NCT02688387|10043850|FG005|STARTED|Part 2, Period 4 (up to 6 Days)||0
8979984|NCT02688387|10043851|FG006|STARTED|Part 2, Period 4 (up to 6 Days)||0
8979985|NCT02688387|10043852|FG007|STARTED|Part 2, Period 4 (up to 6 Days)||0
8979986|NCT02688387|10043853|FG008|STARTED|Part 2, Period 4 (up to 6 Days)||0
8979987|NCT02688387|10043854|FG009|STARTED|Part 2, Period 4 (up to 6 Days)||0
8979988|NCT02688387|10043855|FG010|STARTED|Part 2, Period 4 (up to 6 Days)||5
8979989|NCT02688387|10043856|FG011|STARTED|Part 2, Period 4 (up to 6 Days)||5
8979990|NCT02688387|10043857|FG012|STARTED|Part 2, Period 4 (up to 6 Days)||5
8979991|NCT02688387|10043858|FG013|STARTED|Part 2, Period 4 (up to 6 Days)||5
8979992|NCT02688387|10043859|FG014|STARTED|Part 2, Period 4 (up to 6 Days)||0
8979993|NCT02688387|10043860|FG015|STARTED|Part 2, Period 4 (up to 6 Days)||0
8979994|NCT02688387|10043861|FG016|STARTED|Part 2, Period 4 (up to 6 Days)||0
8979995|NCT02688387|10043862|FG017|STARTED|Part 2, Period 4 (up to 6 Days)||0
8979996|NCT02688387|10043863|FG018|STARTED|Part 2, Period 4 (up to 6 Days)||0
8979997|NCT02688387|10043864|FG019|STARTED|Part 2, Period 4 (up to 6 Days)||0
8979998|NCT02688387|10043865|FG020|STARTED|Part 2, Period 4 (up to 6 Days)||0
8979999|NCT02688387|10043866|FG021|STARTED|Part 2, Period 4 (up to 6 Days)||0
8980000|NCT02688387|10043845|FG000|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8980001|NCT02688387|10043846|FG001|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8980002|NCT02688387|10043847|FG002|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8980003|NCT02688387|10043848|FG003|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8980004|NCT02688387|10043849|FG004|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8980005|NCT02688387|10043850|FG005|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8980006|NCT02688387|10043851|FG006|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8980007|NCT02688387|10043852|FG007|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8980008|NCT02688387|10043853|FG008|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8980009|NCT02688387|10043854|FG009|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8980010|NCT02688387|10043855|FG010|COMPLETED|Part 2, Period 4 (up to 6 Days)||5
8980011|NCT02688387|10043856|FG011|COMPLETED|Part 2, Period 4 (up to 6 Days)||5
8980012|NCT02688387|10043857|FG012|COMPLETED|Part 2, Period 4 (up to 6 Days)||5
8980013|NCT02688387|10043858|FG013|COMPLETED|Part 2, Period 4 (up to 6 Days)||5
8980014|NCT02688387|10043859|FG014|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8980015|NCT02688387|10043860|FG015|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8980016|NCT02688387|10043861|FG016|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8980017|NCT02688387|10043862|FG017|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8980018|NCT02688387|10043863|FG018|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8980019|NCT02688387|10043864|FG019|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8980020|NCT02688387|10043865|FG020|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8980021|NCT02688387|10043866|FG021|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8980022|NCT02688387|10043845|FG000|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8980023|NCT02688387|10043846|FG001|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8980024|NCT02688387|10043847|FG002|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8980025|NCT02688387|10043848|FG003|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8980026|NCT02688387|10043849|FG004|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8980027|NCT02688387|10043850|FG005|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8980028|NCT02688387|10043851|FG006|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8980029|NCT02688387|10043852|FG007|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8980030|NCT02688387|10043853|FG008|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8980031|NCT02688387|10043854|FG009|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8980032|NCT02688387|10043855|FG010|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8980033|NCT02688387|10043856|FG011|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8980034|NCT02688387|10043857|FG012|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8980035|NCT02688387|10043858|FG013|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8980036|NCT02688387|10043859|FG014|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8980037|NCT02688387|10043860|FG015|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8980038|NCT02688387|10043861|FG016|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8980039|NCT02688387|10043862|FG017|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8980040|NCT02688387|10043863|FG018|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8980041|NCT02688387|10043864|FG019|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8980042|NCT02688387|10043865|FG020|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8980043|NCT02688387|10043866|FG021|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8980044|NCT02688387|10043845|FG000|STARTED|Part 3A, Period 1 (up to 6 Days)||0
8980045|NCT02688387|10043846|FG001|STARTED|Part 3A, Period 1 (up to 6 Days)||0
8980046|NCT02688387|10043847|FG002|STARTED|Part 3A, Period 1 (up to 6 Days)||0
8980047|NCT02688387|10043848|FG003|STARTED|Part 3A, Period 1 (up to 6 Days)||0
8632510|NCT00545740|9672447|FG002|STARTED|Overall Study||151
8980048|NCT02688387|10043849|FG004|STARTED|Part 3A, Period 1 (up to 6 Days)||0
8980049|NCT02688387|10043850|FG005|STARTED|Part 3A, Period 1 (up to 6 Days)||0
8980050|NCT02688387|10043851|FG006|STARTED|Part 3A, Period 1 (up to 6 Days)||0
8980051|NCT02688387|10043852|FG007|STARTED|Part 3A, Period 1 (up to 6 Days)||0
8980052|NCT02688387|10043853|FG008|STARTED|Part 3A, Period 1 (up to 6 Days)||0
8980053|NCT02688387|10043854|FG009|STARTED|Part 3A, Period 1 (up to 6 Days)||0
8980054|NCT02688387|10043855|FG010|STARTED|Part 3A, Period 1 (up to 6 Days)||0
8980055|NCT02688387|10043856|FG011|STARTED|Part 3A, Period 1 (up to 6 Days)||0
8980056|NCT02688387|10043857|FG012|STARTED|Part 3A, Period 1 (up to 6 Days)||0
8980057|NCT02688387|10043858|FG013|STARTED|Part 3A, Period 1 (up to 6 Days)||0
8980058|NCT02688387|10043859|FG014|STARTED|Part 3A, Period 1 (up to 6 Days)||9
8980059|NCT02688387|10043860|FG015|STARTED|Part 3A, Period 1 (up to 6 Days)||8
8980060|NCT02688387|10043861|FG016|STARTED|Part 3A, Period 1 (up to 6 Days)||8
8980061|NCT02688387|10043862|FG017|STARTED|Part 3A, Period 1 (up to 6 Days)||8
8980062|NCT02688387|10043863|FG018|STARTED|Part 3A, Period 1 (up to 6 Days)||0
8980063|NCT02688387|10043864|FG019|STARTED|Part 3A, Period 1 (up to 6 Days)||0
8980064|NCT02688387|10043865|FG020|STARTED|Part 3A, Period 1 (up to 6 Days)||0
8980065|NCT02688387|10043866|FG021|STARTED|Part 3A, Period 1 (up to 6 Days)||0
8980066|NCT02688387|10043845|FG000|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8980067|NCT02688387|10043846|FG001|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8980068|NCT02688387|10043847|FG002|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8877518|NCT01923961|9934483|FG000|COMPLETED|Second Intervention||3
8877519|NCT01923961|9934484|FG001|COMPLETED|Second Intervention||3
8877520|NCT01923961|9934485|FG002|COMPLETED|Second Intervention||2
8877521|NCT01923961|9934483|FG000|NOT COMPLETED|Second Intervention||0
8877522|NCT01923961|9934484|FG001|NOT COMPLETED|Second Intervention||0
8980069|NCT02688387|10043848|FG003|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8980070|NCT02688387|10043849|FG004|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8980071|NCT02688387|10043850|FG005|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8980072|NCT02688387|10043851|FG006|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8980073|NCT02688387|10043852|FG007|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8980074|NCT02688387|10043853|FG008|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8980075|NCT02688387|10043854|FG009|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8980076|NCT02688387|10043855|FG010|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8980077|NCT02688387|10043856|FG011|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8980078|NCT02688387|10043857|FG012|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8980079|NCT02688387|10043858|FG013|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8980080|NCT02688387|10043859|FG014|COMPLETED|Part 3A, Period 1 (up to 6 Days)||8
8980081|NCT02688387|10043860|FG015|COMPLETED|Part 3A, Period 1 (up to 6 Days)||8
8980082|NCT02688387|10043861|FG016|COMPLETED|Part 3A, Period 1 (up to 6 Days)||8
8980083|NCT02688387|10043862|FG017|COMPLETED|Part 3A, Period 1 (up to 6 Days)||8
8980084|NCT02688387|10043863|FG018|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8980085|NCT02688387|10043864|FG019|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8980086|NCT02688387|10043865|FG020|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8980087|NCT02688387|10043866|FG021|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8980088|NCT02688387|10043845|FG000|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8980089|NCT02688387|10043846|FG001|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8980090|NCT02688387|10043847|FG002|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8980091|NCT02688387|10043848|FG003|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8980092|NCT02688387|10043849|FG004|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8877523|NCT01923961|9934485|FG002|NOT COMPLETED|Second Intervention||0
8877524|NCT01923961|9934483|FG000|STARTED|Washout (1 Week)||3
8877525|NCT01923961|9934484|FG001|STARTED|Washout (1 Week)||3
8877526|NCT01923961|9934485|FG002|STARTED|Washout (1 Week)||2
8877527|NCT01923961|9934483|FG000|COMPLETED|Washout (1 Week)||3
8877528|NCT01923961|9934484|FG001|COMPLETED|Washout (1 Week)||3
8877529|NCT01923961|9934485|FG002|COMPLETED|Washout (1 Week)||2
8877530|NCT01923961|9934483|FG000|NOT COMPLETED|Washout (1 Week)||0
8877531|NCT01923961|9934484|FG001|NOT COMPLETED|Washout (1 Week)||0
8877532|NCT01923961|9934485|FG002|NOT COMPLETED|Washout (1 Week)||0
8877533|NCT01923961|9934483|FG000|STARTED|Third Intervention||3
8877534|NCT01923961|9934484|FG001|STARTED|Third Intervention||3
8877535|NCT01923961|9934485|FG002|STARTED|Third Intervention||2
8877536|NCT01923961|9934483|FG000|COMPLETED|Third Intervention||3
8980093|NCT02688387|10043850|FG005|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8980094|NCT02688387|10043851|FG006|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8980095|NCT02688387|10043852|FG007|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8980096|NCT02688387|10043853|FG008|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8980097|NCT02688387|10043854|FG009|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8980098|NCT02688387|10043855|FG010|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8980099|NCT02688387|10043856|FG011|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8980100|NCT02688387|10043857|FG012|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8980101|NCT02688387|10043858|FG013|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8980102|NCT02688387|10043859|FG014|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||1
8980103|NCT02688387|10043860|FG015|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8877537|NCT01923961|9934484|FG001|COMPLETED|Third Intervention||3
8877538|NCT01923961|9934485|FG002|COMPLETED|Third Intervention||2
8877539|NCT01923961|9934483|FG000|NOT COMPLETED|Third Intervention||0
8877540|NCT01923961|9934484|FG001|NOT COMPLETED|Third Intervention||0
8980104|NCT02688387|10043861|FG016|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8980105|NCT02688387|10043862|FG017|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8980106|NCT02688387|10043863|FG018|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8980107|NCT02688387|10043864|FG019|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8980108|NCT02688387|10043865|FG020|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8980109|NCT02688387|10043866|FG021|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8980110|NCT02688387|10043845|FG000|STARTED|Part 3A, Washout Period 1 (10 Days)||0
8980111|NCT02688387|10043846|FG001|STARTED|Part 3A, Washout Period 1 (10 Days)||0
8980112|NCT02688387|10043847|FG002|STARTED|Part 3A, Washout Period 1 (10 Days)||0
8980113|NCT02688387|10043848|FG003|STARTED|Part 3A, Washout Period 1 (10 Days)||0
8980114|NCT02688387|10043849|FG004|STARTED|Part 3A, Washout Period 1 (10 Days)||0
8980115|NCT02688387|10043850|FG005|STARTED|Part 3A, Washout Period 1 (10 Days)||0
8980116|NCT02688387|10043851|FG006|STARTED|Part 3A, Washout Period 1 (10 Days)||0
8980117|NCT02688387|10043852|FG007|STARTED|Part 3A, Washout Period 1 (10 Days)||0
8980118|NCT02688387|10043853|FG008|STARTED|Part 3A, Washout Period 1 (10 Days)||0
8980119|NCT02688387|10043854|FG009|STARTED|Part 3A, Washout Period 1 (10 Days)||0
8980120|NCT02688387|10043855|FG010|STARTED|Part 3A, Washout Period 1 (10 Days)||0
8980121|NCT02688387|10043856|FG011|STARTED|Part 3A, Washout Period 1 (10 Days)||0
8980122|NCT02688387|10043857|FG012|STARTED|Part 3A, Washout Period 1 (10 Days)||0
8980123|NCT02688387|10043858|FG013|STARTED|Part 3A, Washout Period 1 (10 Days)||0
8980124|NCT02688387|10043859|FG014|STARTED|Part 3A, Washout Period 1 (10 Days)||8
8980125|NCT02688387|10043860|FG015|STARTED|Part 3A, Washout Period 1 (10 Days)||8
8980126|NCT02688387|10043861|FG016|STARTED|Part 3A, Washout Period 1 (10 Days)||8
8980127|NCT02688387|10043862|FG017|STARTED|Part 3A, Washout Period 1 (10 Days)||8
8980128|NCT02688387|10043863|FG018|STARTED|Part 3A, Washout Period 1 (10 Days)||0
8980129|NCT02688387|10043864|FG019|STARTED|Part 3A, Washout Period 1 (10 Days)||0
8980130|NCT02688387|10043865|FG020|STARTED|Part 3A, Washout Period 1 (10 Days)||0
8980131|NCT02688387|10043866|FG021|STARTED|Part 3A, Washout Period 1 (10 Days)||0
8980132|NCT02688387|10043845|FG000|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8980133|NCT02688387|10043846|FG001|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8980134|NCT02688387|10043847|FG002|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8980135|NCT02688387|10043848|FG003|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8980136|NCT02688387|10043849|FG004|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8980137|NCT02688387|10043850|FG005|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8980138|NCT02688387|10043851|FG006|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8980139|NCT02688387|10043852|FG007|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8980140|NCT02688387|10043853|FG008|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8980141|NCT02688387|10043854|FG009|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8980142|NCT02688387|10043855|FG010|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8980143|NCT02688387|10043856|FG011|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8980144|NCT02688387|10043857|FG012|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8980145|NCT02688387|10043858|FG013|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8980146|NCT02688387|10043859|FG014|COMPLETED|Part 3A, Washout Period 1 (10 Days)||8
8980147|NCT02688387|10043860|FG015|COMPLETED|Part 3A, Washout Period 1 (10 Days)||8
8980148|NCT02688387|10043861|FG016|COMPLETED|Part 3A, Washout Period 1 (10 Days)||8
8980149|NCT02688387|10043862|FG017|COMPLETED|Part 3A, Washout Period 1 (10 Days)||8
8980150|NCT02688387|10043863|FG018|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8980151|NCT02688387|10043864|FG019|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8980152|NCT02688387|10043865|FG020|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8980153|NCT02688387|10043866|FG021|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8980154|NCT02688387|10043845|FG000|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8980155|NCT02688387|10043846|FG001|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8980156|NCT02688387|10043847|FG002|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8980157|NCT02688387|10043848|FG003|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8980158|NCT02688387|10043849|FG004|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8980159|NCT02688387|10043850|FG005|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8980160|NCT02688387|10043851|FG006|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8980161|NCT02688387|10043852|FG007|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8980162|NCT02688387|10043853|FG008|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8980163|NCT02688387|10043854|FG009|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8980164|NCT02688387|10043855|FG010|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8980165|NCT02688387|10043856|FG011|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8980166|NCT02688387|10043857|FG012|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8980167|NCT02688387|10043858|FG013|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8980168|NCT02688387|10043859|FG014|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8980169|NCT02688387|10043860|FG015|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8980170|NCT02688387|10043861|FG016|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8980171|NCT02688387|10043862|FG017|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8980172|NCT02688387|10043863|FG018|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8980173|NCT02688387|10043864|FG019|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8980174|NCT02688387|10043865|FG020|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8980175|NCT02688387|10043866|FG021|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8980176|NCT02688387|10043845|FG000|STARTED|Part 3A, Period 2 (up to 6 Days)||0
8980177|NCT02688387|10043846|FG001|STARTED|Part 3A, Period 2 (up to 6 Days)||0
8980178|NCT02688387|10043847|FG002|STARTED|Part 3A, Period 2 (up to 6 Days)||0
8980179|NCT02688387|10043848|FG003|STARTED|Part 3A, Period 2 (up to 6 Days)||0
8980180|NCT02688387|10043849|FG004|STARTED|Part 3A, Period 2 (up to 6 Days)||0
8980181|NCT02688387|10043850|FG005|STARTED|Part 3A, Period 2 (up to 6 Days)||0
8980182|NCT02688387|10043851|FG006|STARTED|Part 3A, Period 2 (up to 6 Days)||0
8980183|NCT02688387|10043852|FG007|STARTED|Part 3A, Period 2 (up to 6 Days)||0
8980184|NCT02688387|10043853|FG008|STARTED|Part 3A, Period 2 (up to 6 Days)||0
8980185|NCT02688387|10043854|FG009|STARTED|Part 3A, Period 2 (up to 6 Days)||0
8980186|NCT02688387|10043855|FG010|STARTED|Part 3A, Period 2 (up to 6 Days)||0
8980187|NCT02688387|10043856|FG011|STARTED|Part 3A, Period 2 (up to 6 Days)||0
8980188|NCT02688387|10043857|FG012|STARTED|Part 3A, Period 2 (up to 6 Days)||0
8980189|NCT02688387|10043858|FG013|STARTED|Part 3A, Period 2 (up to 6 Days)||0
8980190|NCT02688387|10043859|FG014|STARTED|Part 3A, Period 2 (up to 6 Days)||8
8980191|NCT02688387|10043860|FG015|STARTED|Part 3A, Period 2 (up to 6 Days)||8
8980192|NCT02688387|10043861|FG016|STARTED|Part 3A, Period 2 (up to 6 Days)||8
8980193|NCT02688387|10043862|FG017|STARTED|Part 3A, Period 2 (up to 6 Days)||8
8980194|NCT02688387|10043863|FG018|STARTED|Part 3A, Period 2 (up to 6 Days)||0
8980195|NCT02688387|10043864|FG019|STARTED|Part 3A, Period 2 (up to 6 Days)||0
8980196|NCT02688387|10043865|FG020|STARTED|Part 3A, Period 2 (up to 6 Days)||0
8980197|NCT02688387|10043866|FG021|STARTED|Part 3A, Period 2 (up to 6 Days)||0
8980198|NCT02688387|10043845|FG000|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8980199|NCT02688387|10043846|FG001|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8980200|NCT02688387|10043847|FG002|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8980201|NCT02688387|10043848|FG003|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8980202|NCT02688387|10043849|FG004|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8980203|NCT02688387|10043850|FG005|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8980204|NCT02688387|10043851|FG006|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8980205|NCT02688387|10043852|FG007|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8980206|NCT02688387|10043853|FG008|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8980207|NCT02688387|10043854|FG009|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8980208|NCT02688387|10043855|FG010|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8980209|NCT02688387|10043856|FG011|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8980210|NCT02688387|10043857|FG012|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8980211|NCT02688387|10043858|FG013|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8980212|NCT02688387|10043859|FG014|COMPLETED|Part 3A, Period 2 (up to 6 Days)||8
8980213|NCT02688387|10043860|FG015|COMPLETED|Part 3A, Period 2 (up to 6 Days)||8
8980214|NCT02688387|10043861|FG016|COMPLETED|Part 3A, Period 2 (up to 6 Days)||8
8980215|NCT02688387|10043862|FG017|COMPLETED|Part 3A, Period 2 (up to 6 Days)||8
8980216|NCT02688387|10043863|FG018|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8980217|NCT02688387|10043864|FG019|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8980218|NCT02688387|10043865|FG020|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8980219|NCT02688387|10043866|FG021|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8980220|NCT02688387|10043845|FG000|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8980221|NCT02688387|10043846|FG001|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8980222|NCT02688387|10043847|FG002|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8980223|NCT02688387|10043848|FG003|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8980224|NCT02688387|10043849|FG004|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8980225|NCT02688387|10043850|FG005|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8980226|NCT02688387|10043851|FG006|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8980227|NCT02688387|10043852|FG007|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8980228|NCT02688387|10043853|FG008|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8980229|NCT02688387|10043854|FG009|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8980230|NCT02688387|10043855|FG010|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8980231|NCT02688387|10043856|FG011|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8980232|NCT02688387|10043857|FG012|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8980233|NCT02688387|10043858|FG013|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8980234|NCT02688387|10043859|FG014|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8980235|NCT02688387|10043860|FG015|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8980236|NCT02688387|10043861|FG016|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8980237|NCT02688387|10043862|FG017|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8980238|NCT02688387|10043863|FG018|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8980239|NCT02688387|10043864|FG019|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8980240|NCT02688387|10043865|FG020|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8980241|NCT02688387|10043866|FG021|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8980242|NCT02688387|10043845|FG000|STARTED|Part 3A, Washout Period 2 (10 Days)||0
8980243|NCT02688387|10043846|FG001|STARTED|Part 3A, Washout Period 2 (10 Days)||0
8980244|NCT02688387|10043847|FG002|STARTED|Part 3A, Washout Period 2 (10 Days)||0
8980245|NCT02688387|10043848|FG003|STARTED|Part 3A, Washout Period 2 (10 Days)||0
8980246|NCT02688387|10043849|FG004|STARTED|Part 3A, Washout Period 2 (10 Days)||0
8980247|NCT02688387|10043850|FG005|STARTED|Part 3A, Washout Period 2 (10 Days)||0
8980248|NCT02688387|10043851|FG006|STARTED|Part 3A, Washout Period 2 (10 Days)||0
8980249|NCT02688387|10043852|FG007|STARTED|Part 3A, Washout Period 2 (10 Days)||0
8980250|NCT02688387|10043853|FG008|STARTED|Part 3A, Washout Period 2 (10 Days)||0
8980251|NCT02688387|10043854|FG009|STARTED|Part 3A, Washout Period 2 (10 Days)||0
8980252|NCT02688387|10043855|FG010|STARTED|Part 3A, Washout Period 2 (10 Days)||0
8980253|NCT02688387|10043856|FG011|STARTED|Part 3A, Washout Period 2 (10 Days)||0
8980254|NCT02688387|10043857|FG012|STARTED|Part 3A, Washout Period 2 (10 Days)||0
8980255|NCT02688387|10043858|FG013|STARTED|Part 3A, Washout Period 2 (10 Days)||0
8980256|NCT02688387|10043859|FG014|STARTED|Part 3A, Washout Period 2 (10 Days)||8
8980257|NCT02688387|10043860|FG015|STARTED|Part 3A, Washout Period 2 (10 Days)||8
8980258|NCT02688387|10043861|FG016|STARTED|Part 3A, Washout Period 2 (10 Days)||8
8980259|NCT02688387|10043862|FG017|STARTED|Part 3A, Washout Period 2 (10 Days)||8
8980260|NCT02688387|10043863|FG018|STARTED|Part 3A, Washout Period 2 (10 Days)||0
8980261|NCT02688387|10043864|FG019|STARTED|Part 3A, Washout Period 2 (10 Days)||0
8980262|NCT02688387|10043865|FG020|STARTED|Part 3A, Washout Period 2 (10 Days)||0
8980263|NCT02688387|10043866|FG021|STARTED|Part 3A, Washout Period 2 (10 Days)||0
8980264|NCT02688387|10043845|FG000|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8980265|NCT02688387|10043846|FG001|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8980266|NCT02688387|10043847|FG002|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8980267|NCT02688387|10043848|FG003|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8980268|NCT02688387|10043849|FG004|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8980269|NCT02688387|10043850|FG005|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8980270|NCT02688387|10043851|FG006|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8980271|NCT02688387|10043852|FG007|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8980272|NCT02688387|10043853|FG008|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8980273|NCT02688387|10043854|FG009|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8980274|NCT02688387|10043855|FG010|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8980275|NCT02688387|10043856|FG011|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8980276|NCT02688387|10043857|FG012|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8980277|NCT02688387|10043858|FG013|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8980278|NCT02688387|10043859|FG014|COMPLETED|Part 3A, Washout Period 2 (10 Days)||8
8980279|NCT02688387|10043860|FG015|COMPLETED|Part 3A, Washout Period 2 (10 Days)||8
8980280|NCT02688387|10043861|FG016|COMPLETED|Part 3A, Washout Period 2 (10 Days)||8
8980281|NCT02688387|10043862|FG017|COMPLETED|Part 3A, Washout Period 2 (10 Days)||8
8980282|NCT02688387|10043863|FG018|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8980283|NCT02688387|10043864|FG019|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8980284|NCT02688387|10043865|FG020|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8980285|NCT02688387|10043866|FG021|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8980286|NCT02688387|10043845|FG000|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8980287|NCT02688387|10043846|FG001|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8980288|NCT02688387|10043847|FG002|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8980289|NCT02688387|10043848|FG003|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8980290|NCT02688387|10043849|FG004|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8980291|NCT02688387|10043850|FG005|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8980292|NCT02688387|10043851|FG006|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8980293|NCT02688387|10043852|FG007|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8980294|NCT02688387|10043853|FG008|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8980295|NCT02688387|10043854|FG009|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8980296|NCT02688387|10043855|FG010|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8980297|NCT02688387|10043856|FG011|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8980298|NCT02688387|10043857|FG012|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8980299|NCT02688387|10043858|FG013|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8980300|NCT02688387|10043859|FG014|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8980301|NCT02688387|10043860|FG015|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8980302|NCT02688387|10043861|FG016|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8980303|NCT02688387|10043862|FG017|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8980304|NCT02688387|10043863|FG018|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8980305|NCT02688387|10043864|FG019|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8980306|NCT02688387|10043865|FG020|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8980307|NCT02688387|10043866|FG021|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8980308|NCT02688387|10043845|FG000|STARTED|Part 3A, Period 3 (up to 6 Days)||0
8980309|NCT02688387|10043846|FG001|STARTED|Part 3A, Period 3 (up to 6 Days)||0
8980310|NCT02688387|10043847|FG002|STARTED|Part 3A, Period 3 (up to 6 Days)||0
8980311|NCT02688387|10043848|FG003|STARTED|Part 3A, Period 3 (up to 6 Days)||0
8980312|NCT02688387|10043849|FG004|STARTED|Part 3A, Period 3 (up to 6 Days)||0
8980313|NCT02688387|10043850|FG005|STARTED|Part 3A, Period 3 (up to 6 Days)||0
8980314|NCT02688387|10043851|FG006|STARTED|Part 3A, Period 3 (up to 6 Days)||0
8980315|NCT02688387|10043852|FG007|STARTED|Part 3A, Period 3 (up to 6 Days)||0
8980316|NCT02688387|10043853|FG008|STARTED|Part 3A, Period 3 (up to 6 Days)||0
8980317|NCT02688387|10043854|FG009|STARTED|Part 3A, Period 3 (up to 6 Days)||0
8980318|NCT02688387|10043855|FG010|STARTED|Part 3A, Period 3 (up to 6 Days)||0
8980319|NCT02688387|10043856|FG011|STARTED|Part 3A, Period 3 (up to 6 Days)||0
8980320|NCT02688387|10043857|FG012|STARTED|Part 3A, Period 3 (up to 6 Days)||0
8980321|NCT02688387|10043858|FG013|STARTED|Part 3A, Period 3 (up to 6 Days)||0
8980322|NCT02688387|10043859|FG014|STARTED|Part 3A, Period 3 (up to 6 Days)||8
8980323|NCT02688387|10043860|FG015|STARTED|Part 3A, Period 3 (up to 6 Days)||8
8980324|NCT02688387|10043861|FG016|STARTED|Part 3A, Period 3 (up to 6 Days)||8
8980325|NCT02688387|10043862|FG017|STARTED|Part 3A, Period 3 (up to 6 Days)||8
8980326|NCT02688387|10043863|FG018|STARTED|Part 3A, Period 3 (up to 6 Days)||0
8980327|NCT02688387|10043864|FG019|STARTED|Part 3A, Period 3 (up to 6 Days)||0
8980328|NCT02688387|10043865|FG020|STARTED|Part 3A, Period 3 (up to 6 Days)||0
8980329|NCT02688387|10043866|FG021|STARTED|Part 3A, Period 3 (up to 6 Days)||0
8980330|NCT02688387|10043845|FG000|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8980331|NCT02688387|10043846|FG001|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8980332|NCT02688387|10043847|FG002|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8980333|NCT02688387|10043848|FG003|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8980334|NCT02688387|10043849|FG004|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8980335|NCT02688387|10043850|FG005|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8980336|NCT02688387|10043851|FG006|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8980337|NCT02688387|10043852|FG007|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8980338|NCT02688387|10043853|FG008|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8980339|NCT02688387|10043854|FG009|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8980340|NCT02688387|10043855|FG010|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8980341|NCT02688387|10043856|FG011|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8980342|NCT02688387|10043857|FG012|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8980343|NCT02688387|10043858|FG013|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8980344|NCT02688387|10043859|FG014|COMPLETED|Part 3A, Period 3 (up to 6 Days)||8
8980345|NCT02688387|10043860|FG015|COMPLETED|Part 3A, Period 3 (up to 6 Days)||8
8980346|NCT02688387|10043861|FG016|COMPLETED|Part 3A, Period 3 (up to 6 Days)||8
8980347|NCT02688387|10043862|FG017|COMPLETED|Part 3A, Period 3 (up to 6 Days)||8
8980348|NCT02688387|10043863|FG018|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8980349|NCT02688387|10043864|FG019|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8980350|NCT02688387|10043865|FG020|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8980351|NCT02688387|10043866|FG021|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8980352|NCT02688387|10043845|FG000|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8980353|NCT02688387|10043846|FG001|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8980354|NCT02688387|10043847|FG002|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8980355|NCT02688387|10043848|FG003|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8980356|NCT02688387|10043849|FG004|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8980357|NCT02688387|10043850|FG005|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8980358|NCT02688387|10043851|FG006|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8980359|NCT02688387|10043852|FG007|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8980360|NCT02688387|10043853|FG008|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8980361|NCT02688387|10043854|FG009|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8980362|NCT02688387|10043855|FG010|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8980363|NCT02688387|10043856|FG011|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8980364|NCT02688387|10043857|FG012|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8980365|NCT02688387|10043858|FG013|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8980366|NCT02688387|10043859|FG014|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8980367|NCT02688387|10043860|FG015|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8980368|NCT02688387|10043861|FG016|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8980369|NCT02688387|10043862|FG017|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8980370|NCT02688387|10043863|FG018|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8980371|NCT02688387|10043864|FG019|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8980372|NCT02688387|10043865|FG020|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8980373|NCT02688387|10043866|FG021|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8980374|NCT02688387|10043845|FG000|STARTED|Part 3A, Washout Period 3 (10 Days)||0
8980375|NCT02688387|10043846|FG001|STARTED|Part 3A, Washout Period 3 (10 Days)||0
8980376|NCT02688387|10043847|FG002|STARTED|Part 3A, Washout Period 3 (10 Days)||0
8980377|NCT02688387|10043848|FG003|STARTED|Part 3A, Washout Period 3 (10 Days)||0
8980378|NCT02688387|10043849|FG004|STARTED|Part 3A, Washout Period 3 (10 Days)||0
8980379|NCT02688387|10043850|FG005|STARTED|Part 3A, Washout Period 3 (10 Days)||0
8980380|NCT02688387|10043851|FG006|STARTED|Part 3A, Washout Period 3 (10 Days)||0
8980381|NCT02688387|10043852|FG007|STARTED|Part 3A, Washout Period 3 (10 Days)||0
8980382|NCT02688387|10043853|FG008|STARTED|Part 3A, Washout Period 3 (10 Days)||0
8980383|NCT02688387|10043854|FG009|STARTED|Part 3A, Washout Period 3 (10 Days)||0
8980384|NCT02688387|10043855|FG010|STARTED|Part 3A, Washout Period 3 (10 Days)||0
8980385|NCT02688387|10043856|FG011|STARTED|Part 3A, Washout Period 3 (10 Days)||0
8980386|NCT02688387|10043857|FG012|STARTED|Part 3A, Washout Period 3 (10 Days)||0
8980387|NCT02688387|10043858|FG013|STARTED|Part 3A, Washout Period 3 (10 Days)||0
8980388|NCT02688387|10043859|FG014|STARTED|Part 3A, Washout Period 3 (10 Days)||8
8980389|NCT02688387|10043860|FG015|STARTED|Part 3A, Washout Period 3 (10 Days)||8
8980390|NCT02688387|10043861|FG016|STARTED|Part 3A, Washout Period 3 (10 Days)||8
8980391|NCT02688387|10043862|FG017|STARTED|Part 3A, Washout Period 3 (10 Days)||8
8980392|NCT02688387|10043863|FG018|STARTED|Part 3A, Washout Period 3 (10 Days)||0
8980393|NCT02688387|10043864|FG019|STARTED|Part 3A, Washout Period 3 (10 Days)||0
8980394|NCT02688387|10043865|FG020|STARTED|Part 3A, Washout Period 3 (10 Days)||0
8980395|NCT02688387|10043866|FG021|STARTED|Part 3A, Washout Period 3 (10 Days)||0
8980396|NCT02688387|10043845|FG000|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8980397|NCT02688387|10043846|FG001|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8980398|NCT02688387|10043847|FG002|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8980399|NCT02688387|10043848|FG003|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8980400|NCT02688387|10043849|FG004|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8980401|NCT02688387|10043850|FG005|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8980402|NCT02688387|10043851|FG006|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8980403|NCT02688387|10043852|FG007|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8980404|NCT02688387|10043853|FG008|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8980405|NCT02688387|10043854|FG009|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8980406|NCT02688387|10043855|FG010|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8980407|NCT02688387|10043856|FG011|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8980408|NCT02688387|10043857|FG012|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8980409|NCT02688387|10043858|FG013|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8980410|NCT02688387|10043859|FG014|COMPLETED|Part 3A, Washout Period 3 (10 Days)||8
8980411|NCT02688387|10043860|FG015|COMPLETED|Part 3A, Washout Period 3 (10 Days)||8
8980412|NCT02688387|10043861|FG016|COMPLETED|Part 3A, Washout Period 3 (10 Days)||8
8980413|NCT02688387|10043862|FG017|COMPLETED|Part 3A, Washout Period 3 (10 Days)||8
8980414|NCT02688387|10043863|FG018|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8980415|NCT02688387|10043864|FG019|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8980416|NCT02688387|10043865|FG020|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8980417|NCT02688387|10043866|FG021|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8980418|NCT02688387|10043845|FG000|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8980419|NCT02688387|10043846|FG001|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8980420|NCT02688387|10043847|FG002|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8980421|NCT02688387|10043848|FG003|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8980422|NCT02688387|10043849|FG004|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8980423|NCT02688387|10043850|FG005|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8980424|NCT02688387|10043851|FG006|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8980425|NCT02688387|10043852|FG007|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8980426|NCT02688387|10043853|FG008|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8980427|NCT02688387|10043854|FG009|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8980428|NCT02688387|10043855|FG010|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8980429|NCT02688387|10043856|FG011|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8980430|NCT02688387|10043857|FG012|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8980431|NCT02688387|10043858|FG013|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8980432|NCT02688387|10043859|FG014|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8980433|NCT02688387|10043860|FG015|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8980434|NCT02688387|10043861|FG016|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8980435|NCT02688387|10043862|FG017|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8980436|NCT02688387|10043863|FG018|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8980437|NCT02688387|10043864|FG019|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8980438|NCT02688387|10043865|FG020|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8980439|NCT02688387|10043866|FG021|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8980440|NCT02688387|10043845|FG000|STARTED|Part 3A, Period 4 (up to 6 Days)||0
8980441|NCT02688387|10043846|FG001|STARTED|Part 3A, Period 4 (up to 6 Days)||0
8980442|NCT02688387|10043847|FG002|STARTED|Part 3A, Period 4 (up to 6 Days)||0
8980443|NCT02688387|10043848|FG003|STARTED|Part 3A, Period 4 (up to 6 Days)||0
8980444|NCT02688387|10043849|FG004|STARTED|Part 3A, Period 4 (up to 6 Days)||0
8980445|NCT02688387|10043850|FG005|STARTED|Part 3A, Period 4 (up to 6 Days)||0
8980446|NCT02688387|10043851|FG006|STARTED|Part 3A, Period 4 (up to 6 Days)||0
8980447|NCT02688387|10043852|FG007|STARTED|Part 3A, Period 4 (up to 6 Days)||0
8980448|NCT02688387|10043853|FG008|STARTED|Part 3A, Period 4 (up to 6 Days)||0
8980449|NCT02688387|10043854|FG009|STARTED|Part 3A, Period 4 (up to 6 Days)||0
8980450|NCT02688387|10043855|FG010|STARTED|Part 3A, Period 4 (up to 6 Days)||0
8980451|NCT02688387|10043856|FG011|STARTED|Part 3A, Period 4 (up to 6 Days)||0
8980452|NCT02688387|10043857|FG012|STARTED|Part 3A, Period 4 (up to 6 Days)||0
8980453|NCT02688387|10043858|FG013|STARTED|Part 3A, Period 4 (up to 6 Days)||0
8980454|NCT02688387|10043859|FG014|STARTED|Part 3A, Period 4 (up to 6 Days)||8
8980455|NCT02688387|10043860|FG015|STARTED|Part 3A, Period 4 (up to 6 Days)||8
8980456|NCT02688387|10043861|FG016|STARTED|Part 3A, Period 4 (up to 6 Days)||8
8980457|NCT02688387|10043862|FG017|STARTED|Part 3A, Period 4 (up to 6 Days)||8
8980458|NCT02688387|10043863|FG018|STARTED|Part 3A, Period 4 (up to 6 Days)||0
8980459|NCT02688387|10043864|FG019|STARTED|Part 3A, Period 4 (up to 6 Days)||0
8980460|NCT02688387|10043865|FG020|STARTED|Part 3A, Period 4 (up to 6 Days)||0
8980461|NCT02688387|10043866|FG021|STARTED|Part 3A, Period 4 (up to 6 Days)||0
8980462|NCT02688387|10043845|FG000|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8980463|NCT02688387|10043846|FG001|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8980464|NCT02688387|10043847|FG002|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8980465|NCT02688387|10043848|FG003|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8980466|NCT02688387|10043849|FG004|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8980467|NCT02688387|10043850|FG005|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8980468|NCT02688387|10043851|FG006|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8980469|NCT02688387|10043852|FG007|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8980470|NCT02688387|10043853|FG008|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8980471|NCT02688387|10043854|FG009|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8980472|NCT02688387|10043855|FG010|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8980473|NCT02688387|10043856|FG011|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8980474|NCT02688387|10043857|FG012|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8980475|NCT02688387|10043858|FG013|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8980476|NCT02688387|10043859|FG014|COMPLETED|Part 3A, Period 4 (up to 6 Days)||8
8980477|NCT02688387|10043860|FG015|COMPLETED|Part 3A, Period 4 (up to 6 Days)||8
8980478|NCT02688387|10043861|FG016|COMPLETED|Part 3A, Period 4 (up to 6 Days)||8
8980479|NCT02688387|10043862|FG017|COMPLETED|Part 3A, Period 4 (up to 6 Days)||8
8980480|NCT02688387|10043863|FG018|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8980481|NCT02688387|10043864|FG019|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8980482|NCT02688387|10043865|FG020|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8980483|NCT02688387|10043866|FG021|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8980484|NCT02688387|10043845|FG000|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8980485|NCT02688387|10043846|FG001|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8980486|NCT02688387|10043847|FG002|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8980487|NCT02688387|10043848|FG003|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8980488|NCT02688387|10043849|FG004|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8980489|NCT02688387|10043850|FG005|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8980490|NCT02688387|10043851|FG006|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8980491|NCT02688387|10043852|FG007|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8980492|NCT02688387|10043853|FG008|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8980493|NCT02688387|10043854|FG009|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8980494|NCT02688387|10043855|FG010|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8980495|NCT02688387|10043856|FG011|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8980496|NCT02688387|10043857|FG012|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8980497|NCT02688387|10043858|FG013|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8980498|NCT02688387|10043859|FG014|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8980499|NCT02688387|10043860|FG015|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8980500|NCT02688387|10043861|FG016|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8980501|NCT02688387|10043862|FG017|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8980502|NCT02688387|10043863|FG018|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8980503|NCT02688387|10043864|FG019|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8980504|NCT02688387|10043865|FG020|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8980505|NCT02688387|10043866|FG021|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8980506|NCT02688387|10043845|FG000|STARTED|Part 3B, Period 1 (up to 6 Days)||0
8980507|NCT02688387|10043846|FG001|STARTED|Part 3B, Period 1 (up to 6 Days)||0
8980508|NCT02688387|10043847|FG002|STARTED|Part 3B, Period 1 (up to 6 Days)||0
8980509|NCT02688387|10043848|FG003|STARTED|Part 3B, Period 1 (up to 6 Days)||0
8980510|NCT02688387|10043849|FG004|STARTED|Part 3B, Period 1 (up to 6 Days)||0
8980511|NCT02688387|10043850|FG005|STARTED|Part 3B, Period 1 (up to 6 Days)||0
8980512|NCT02688387|10043851|FG006|STARTED|Part 3B, Period 1 (up to 6 Days)||0
8980513|NCT02688387|10043852|FG007|STARTED|Part 3B, Period 1 (up to 6 Days)||0
8980514|NCT02688387|10043853|FG008|STARTED|Part 3B, Period 1 (up to 6 Days)||0
8980515|NCT02688387|10043854|FG009|STARTED|Part 3B, Period 1 (up to 6 Days)||0
8980516|NCT02688387|10043855|FG010|STARTED|Part 3B, Period 1 (up to 6 Days)||0
8980517|NCT02688387|10043856|FG011|STARTED|Part 3B, Period 1 (up to 6 Days)||0
8980518|NCT02688387|10043857|FG012|STARTED|Part 3B, Period 1 (up to 6 Days)||0
8980519|NCT02688387|10043858|FG013|STARTED|Part 3B, Period 1 (up to 6 Days)||0
8980520|NCT02688387|10043859|FG014|STARTED|Part 3B, Period 1 (up to 6 Days)||0
8980521|NCT02688387|10043860|FG015|STARTED|Part 3B, Period 1 (up to 6 Days)||0
8980522|NCT02688387|10043861|FG016|STARTED|Part 3B, Period 1 (up to 6 Days)||0
8980523|NCT02688387|10043862|FG017|STARTED|Part 3B, Period 1 (up to 6 Days)||0
8980524|NCT02688387|10043863|FG018|STARTED|Part 3B, Period 1 (up to 6 Days)||8
8980525|NCT02688387|10043864|FG019|STARTED|Part 3B, Period 1 (up to 6 Days)||8
8980526|NCT02688387|10043865|FG020|STARTED|Part 3B, Period 1 (up to 6 Days)||8
8980527|NCT02688387|10043866|FG021|STARTED|Part 3B, Period 1 (up to 6 Days)||8
8980528|NCT02688387|10043845|FG000|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8980529|NCT02688387|10043846|FG001|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8980530|NCT02688387|10043847|FG002|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8980531|NCT02688387|10043848|FG003|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8980532|NCT02688387|10043849|FG004|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8980533|NCT02688387|10043850|FG005|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8980534|NCT02688387|10043851|FG006|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8980535|NCT02688387|10043852|FG007|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8980536|NCT02688387|10043853|FG008|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8980537|NCT02688387|10043854|FG009|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8980538|NCT02688387|10043855|FG010|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8980539|NCT02688387|10043856|FG011|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8980540|NCT02688387|10043857|FG012|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8980541|NCT02688387|10043858|FG013|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8980542|NCT02688387|10043859|FG014|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8980543|NCT02688387|10043860|FG015|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8980544|NCT02688387|10043861|FG016|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8980545|NCT02688387|10043862|FG017|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8980546|NCT02688387|10043863|FG018|COMPLETED|Part 3B, Period 1 (up to 6 Days)||8
8980547|NCT02688387|10043864|FG019|COMPLETED|Part 3B, Period 1 (up to 6 Days)||8
8980548|NCT02688387|10043865|FG020|COMPLETED|Part 3B, Period 1 (up to 6 Days)||8
8980549|NCT02688387|10043866|FG021|COMPLETED|Part 3B, Period 1 (up to 6 Days)||8
8980550|NCT02688387|10043845|FG000|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8980551|NCT02688387|10043846|FG001|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8980552|NCT02688387|10043847|FG002|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8980553|NCT02688387|10043848|FG003|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8980554|NCT02688387|10043849|FG004|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8980555|NCT02688387|10043850|FG005|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8980556|NCT02688387|10043851|FG006|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8980557|NCT02688387|10043852|FG007|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8980558|NCT02688387|10043853|FG008|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8980559|NCT02688387|10043854|FG009|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8980560|NCT02688387|10043855|FG010|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8980561|NCT02688387|10043856|FG011|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8980562|NCT02688387|10043857|FG012|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8980563|NCT02688387|10043858|FG013|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8980564|NCT02688387|10043859|FG014|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8980565|NCT02688387|10043860|FG015|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8980566|NCT02688387|10043861|FG016|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8980567|NCT02688387|10043862|FG017|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8980568|NCT02688387|10043863|FG018|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8980569|NCT02688387|10043864|FG019|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8980570|NCT02688387|10043865|FG020|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8980571|NCT02688387|10043866|FG021|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8980572|NCT02688387|10043845|FG000|STARTED|Part 3B, Washout Period 1 (10 Days)||0
8980573|NCT02688387|10043846|FG001|STARTED|Part 3B, Washout Period 1 (10 Days)||0
8980574|NCT02688387|10043847|FG002|STARTED|Part 3B, Washout Period 1 (10 Days)||0
8980575|NCT02688387|10043848|FG003|STARTED|Part 3B, Washout Period 1 (10 Days)||0
8980576|NCT02688387|10043849|FG004|STARTED|Part 3B, Washout Period 1 (10 Days)||0
8980577|NCT02688387|10043850|FG005|STARTED|Part 3B, Washout Period 1 (10 Days)||0
8980578|NCT02688387|10043851|FG006|STARTED|Part 3B, Washout Period 1 (10 Days)||0
8980579|NCT02688387|10043852|FG007|STARTED|Part 3B, Washout Period 1 (10 Days)||0
8980580|NCT02688387|10043853|FG008|STARTED|Part 3B, Washout Period 1 (10 Days)||0
8980581|NCT02688387|10043854|FG009|STARTED|Part 3B, Washout Period 1 (10 Days)||0
8980582|NCT02688387|10043855|FG010|STARTED|Part 3B, Washout Period 1 (10 Days)||0
8980583|NCT02688387|10043856|FG011|STARTED|Part 3B, Washout Period 1 (10 Days)||0
8980584|NCT02688387|10043857|FG012|STARTED|Part 3B, Washout Period 1 (10 Days)||0
8980585|NCT02688387|10043858|FG013|STARTED|Part 3B, Washout Period 1 (10 Days)||0
8980586|NCT02688387|10043859|FG014|STARTED|Part 3B, Washout Period 1 (10 Days)||0
8980587|NCT02688387|10043860|FG015|STARTED|Part 3B, Washout Period 1 (10 Days)||0
8980588|NCT02688387|10043861|FG016|STARTED|Part 3B, Washout Period 1 (10 Days)||0
8980589|NCT02688387|10043862|FG017|STARTED|Part 3B, Washout Period 1 (10 Days)||0
8980590|NCT02688387|10043863|FG018|STARTED|Part 3B, Washout Period 1 (10 Days)||8
8980591|NCT02688387|10043864|FG019|STARTED|Part 3B, Washout Period 1 (10 Days)||8
8980592|NCT02688387|10043865|FG020|STARTED|Part 3B, Washout Period 1 (10 Days)||8
8980593|NCT02688387|10043866|FG021|STARTED|Part 3B, Washout Period 1 (10 Days)||8
8980594|NCT02688387|10043845|FG000|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8980595|NCT02688387|10043846|FG001|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8980596|NCT02688387|10043847|FG002|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8980597|NCT02688387|10043848|FG003|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8980598|NCT02688387|10043849|FG004|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8980599|NCT02688387|10043850|FG005|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8980600|NCT02688387|10043851|FG006|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8980601|NCT02688387|10043852|FG007|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8980602|NCT02688387|10043853|FG008|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8980603|NCT02688387|10043854|FG009|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8980604|NCT02688387|10043855|FG010|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8980605|NCT02688387|10043856|FG011|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8980606|NCT02688387|10043857|FG012|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8980607|NCT02688387|10043858|FG013|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8980608|NCT02688387|10043859|FG014|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8980609|NCT02688387|10043860|FG015|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8980610|NCT02688387|10043861|FG016|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8980611|NCT02688387|10043862|FG017|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8980612|NCT02688387|10043863|FG018|COMPLETED|Part 3B, Washout Period 1 (10 Days)||8
8980613|NCT02688387|10043864|FG019|COMPLETED|Part 3B, Washout Period 1 (10 Days)||8
8980614|NCT02688387|10043865|FG020|COMPLETED|Part 3B, Washout Period 1 (10 Days)||8
8980615|NCT02688387|10043866|FG021|COMPLETED|Part 3B, Washout Period 1 (10 Days)||8
8980616|NCT02688387|10043845|FG000|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8980617|NCT02688387|10043846|FG001|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8980618|NCT02688387|10043847|FG002|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8980619|NCT02688387|10043848|FG003|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8980620|NCT02688387|10043849|FG004|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8980621|NCT02688387|10043850|FG005|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8980622|NCT02688387|10043851|FG006|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8980623|NCT02688387|10043852|FG007|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8980624|NCT02688387|10043853|FG008|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8980625|NCT02688387|10043854|FG009|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8980626|NCT02688387|10043855|FG010|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8980627|NCT02688387|10043856|FG011|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8980628|NCT02688387|10043857|FG012|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8980629|NCT02688387|10043858|FG013|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8980630|NCT02688387|10043859|FG014|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8980631|NCT02688387|10043860|FG015|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8980632|NCT02688387|10043861|FG016|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8980633|NCT02688387|10043862|FG017|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8980634|NCT02688387|10043863|FG018|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8980635|NCT02688387|10043864|FG019|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8980636|NCT02688387|10043865|FG020|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8980637|NCT02688387|10043866|FG021|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8980638|NCT02688387|10043845|FG000|STARTED|Part 3B, Period 2 (up to 6 Days)||0
8980639|NCT02688387|10043846|FG001|STARTED|Part 3B, Period 2 (up to 6 Days)||0
8980640|NCT02688387|10043847|FG002|STARTED|Part 3B, Period 2 (up to 6 Days)||0
8980641|NCT02688387|10043848|FG003|STARTED|Part 3B, Period 2 (up to 6 Days)||0
8980642|NCT02688387|10043849|FG004|STARTED|Part 3B, Period 2 (up to 6 Days)||0
8980643|NCT02688387|10043850|FG005|STARTED|Part 3B, Period 2 (up to 6 Days)||0
8980644|NCT02688387|10043851|FG006|STARTED|Part 3B, Period 2 (up to 6 Days)||0
8980645|NCT02688387|10043852|FG007|STARTED|Part 3B, Period 2 (up to 6 Days)||0
8980646|NCT02688387|10043853|FG008|STARTED|Part 3B, Period 2 (up to 6 Days)||0
8980647|NCT02688387|10043854|FG009|STARTED|Part 3B, Period 2 (up to 6 Days)||0
8980648|NCT02688387|10043855|FG010|STARTED|Part 3B, Period 2 (up to 6 Days)||0
8980649|NCT02688387|10043856|FG011|STARTED|Part 3B, Period 2 (up to 6 Days)||0
8980650|NCT02688387|10043857|FG012|STARTED|Part 3B, Period 2 (up to 6 Days)||0
8980651|NCT02688387|10043858|FG013|STARTED|Part 3B, Period 2 (up to 6 Days)||0
8980652|NCT02688387|10043859|FG014|STARTED|Part 3B, Period 2 (up to 6 Days)||0
8980653|NCT02688387|10043860|FG015|STARTED|Part 3B, Period 2 (up to 6 Days)||0
8980654|NCT02688387|10043861|FG016|STARTED|Part 3B, Period 2 (up to 6 Days)||0
8980655|NCT02688387|10043862|FG017|STARTED|Part 3B, Period 2 (up to 6 Days)||0
8980656|NCT02688387|10043863|FG018|STARTED|Part 3B, Period 2 (up to 6 Days)||8
8980657|NCT02688387|10043864|FG019|STARTED|Part 3B, Period 2 (up to 6 Days)||8
8980658|NCT02688387|10043865|FG020|STARTED|Part 3B, Period 2 (up to 6 Days)||8
8980659|NCT02688387|10043866|FG021|STARTED|Part 3B, Period 2 (up to 6 Days)||8
8980660|NCT02688387|10043845|FG000|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8980661|NCT02688387|10043846|FG001|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8980662|NCT02688387|10043847|FG002|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8980663|NCT02688387|10043848|FG003|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8980664|NCT02688387|10043849|FG004|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8980665|NCT02688387|10043850|FG005|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8980666|NCT02688387|10043851|FG006|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8980667|NCT02688387|10043852|FG007|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8980668|NCT02688387|10043853|FG008|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8980669|NCT02688387|10043854|FG009|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8980670|NCT02688387|10043855|FG010|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8980671|NCT02688387|10043856|FG011|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8980672|NCT02688387|10043857|FG012|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8980673|NCT02688387|10043858|FG013|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8980674|NCT02688387|10043859|FG014|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8980675|NCT02688387|10043860|FG015|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8980676|NCT02688387|10043861|FG016|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8980677|NCT02688387|10043862|FG017|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8980678|NCT02688387|10043863|FG018|COMPLETED|Part 3B, Period 2 (up to 6 Days)||8
8980679|NCT02688387|10043864|FG019|COMPLETED|Part 3B, Period 2 (up to 6 Days)||8
8980680|NCT02688387|10043865|FG020|COMPLETED|Part 3B, Period 2 (up to 6 Days)||8
8980681|NCT02688387|10043866|FG021|COMPLETED|Part 3B, Period 2 (up to 6 Days)||8
8980682|NCT02688387|10043845|FG000|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8980683|NCT02688387|10043846|FG001|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8980684|NCT02688387|10043847|FG002|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8980685|NCT02688387|10043848|FG003|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8980686|NCT02688387|10043849|FG004|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8980687|NCT02688387|10043850|FG005|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8980688|NCT02688387|10043851|FG006|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8980689|NCT02688387|10043852|FG007|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8980690|NCT02688387|10043853|FG008|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8980691|NCT02688387|10043854|FG009|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8980692|NCT02688387|10043855|FG010|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8980693|NCT02688387|10043856|FG011|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8980694|NCT02688387|10043857|FG012|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8980695|NCT02688387|10043858|FG013|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8980696|NCT02688387|10043859|FG014|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8980697|NCT02688387|10043860|FG015|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8980698|NCT02688387|10043861|FG016|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8980699|NCT02688387|10043862|FG017|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8980700|NCT02688387|10043863|FG018|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8980701|NCT02688387|10043864|FG019|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8980702|NCT02688387|10043865|FG020|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8577812|NCT00162266|9610685|FG000|Completed Day 1 to Day 181|Double-Blind Period||98
8980703|NCT02688387|10043866|FG021|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8980704|NCT02688387|10043845|FG000|STARTED|Part 3B, Washout Period 2 (10 Days)||0
8980705|NCT02688387|10043846|FG001|STARTED|Part 3B, Washout Period 2 (10 Days)||0
8980706|NCT02688387|10043847|FG002|STARTED|Part 3B, Washout Period 2 (10 Days)||0
8980707|NCT02688387|10043848|FG003|STARTED|Part 3B, Washout Period 2 (10 Days)||0
8980708|NCT02688387|10043849|FG004|STARTED|Part 3B, Washout Period 2 (10 Days)||0
8980709|NCT02688387|10043850|FG005|STARTED|Part 3B, Washout Period 2 (10 Days)||0
8980710|NCT02688387|10043851|FG006|STARTED|Part 3B, Washout Period 2 (10 Days)||0
8980711|NCT02688387|10043852|FG007|STARTED|Part 3B, Washout Period 2 (10 Days)||0
8980712|NCT02688387|10043853|FG008|STARTED|Part 3B, Washout Period 2 (10 Days)||0
8980713|NCT02688387|10043854|FG009|STARTED|Part 3B, Washout Period 2 (10 Days)||0
8980714|NCT02688387|10043855|FG010|STARTED|Part 3B, Washout Period 2 (10 Days)||0
8980715|NCT02688387|10043856|FG011|STARTED|Part 3B, Washout Period 2 (10 Days)||0
8980716|NCT02688387|10043857|FG012|STARTED|Part 3B, Washout Period 2 (10 Days)||0
8980717|NCT02688387|10043858|FG013|STARTED|Part 3B, Washout Period 2 (10 Days)||0
8980718|NCT02688387|10043859|FG014|STARTED|Part 3B, Washout Period 2 (10 Days)||0
8980719|NCT02688387|10043860|FG015|STARTED|Part 3B, Washout Period 2 (10 Days)||0
8980720|NCT02688387|10043861|FG016|STARTED|Part 3B, Washout Period 2 (10 Days)||0
8980721|NCT02688387|10043862|FG017|STARTED|Part 3B, Washout Period 2 (10 Days)||0
8980722|NCT02688387|10043863|FG018|STARTED|Part 3B, Washout Period 2 (10 Days)||8
8980723|NCT02688387|10043864|FG019|STARTED|Part 3B, Washout Period 2 (10 Days)||8
8980724|NCT02688387|10043865|FG020|STARTED|Part 3B, Washout Period 2 (10 Days)||8
8980725|NCT02688387|10043866|FG021|STARTED|Part 3B, Washout Period 2 (10 Days)||8
8980726|NCT02688387|10043845|FG000|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8980727|NCT02688387|10043846|FG001|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8980728|NCT02688387|10043847|FG002|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8980729|NCT02688387|10043848|FG003|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8980730|NCT02688387|10043849|FG004|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8980731|NCT02688387|10043850|FG005|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8980732|NCT02688387|10043851|FG006|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8980733|NCT02688387|10043852|FG007|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8980734|NCT02688387|10043853|FG008|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8980735|NCT02688387|10043854|FG009|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8980736|NCT02688387|10043855|FG010|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8980737|NCT02688387|10043856|FG011|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8980738|NCT02688387|10043857|FG012|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8980739|NCT02688387|10043858|FG013|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8980740|NCT02688387|10043859|FG014|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8980741|NCT02688387|10043860|FG015|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8980742|NCT02688387|10043861|FG016|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8980743|NCT02688387|10043862|FG017|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8980744|NCT02688387|10043863|FG018|COMPLETED|Part 3B, Washout Period 2 (10 Days)||8
8980745|NCT02688387|10043864|FG019|COMPLETED|Part 3B, Washout Period 2 (10 Days)||8
8980746|NCT02688387|10043865|FG020|COMPLETED|Part 3B, Washout Period 2 (10 Days)||8
8980747|NCT02688387|10043866|FG021|COMPLETED|Part 3B, Washout Period 2 (10 Days)||8
8980748|NCT02688387|10043845|FG000|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8980749|NCT02688387|10043846|FG001|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8980750|NCT02688387|10043847|FG002|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8980751|NCT02688387|10043848|FG003|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8980752|NCT02688387|10043849|FG004|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8632511|NCT00545740|9672448|FG003|STARTED|Overall Study||149
8632512|NCT00545740|9672445|FG000|COMPLETED|Overall Study||70
8632513|NCT00545740|9672446|FG001|COMPLETED|Overall Study||62
8632514|NCT00545740|9672447|FG002|COMPLETED|Overall Study||55
8632515|NCT00545740|9672448|FG003|COMPLETED|Overall Study||78
8632516|NCT00545740|9672445|FG000|NOT COMPLETED|Overall Study||75
8980753|NCT02688387|10043850|FG005|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8980754|NCT02688387|10043851|FG006|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8980755|NCT02688387|10043852|FG007|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8980756|NCT02688387|10043853|FG008|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8980757|NCT02688387|10043854|FG009|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8980758|NCT02688387|10043855|FG010|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8980759|NCT02688387|10043856|FG011|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8980760|NCT02688387|10043857|FG012|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8980761|NCT02688387|10043858|FG013|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8980762|NCT02688387|10043859|FG014|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8980763|NCT02688387|10043860|FG015|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8980764|NCT02688387|10043861|FG016|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8980765|NCT02688387|10043862|FG017|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8980766|NCT02688387|10043863|FG018|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8980767|NCT02688387|10043864|FG019|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8980768|NCT02688387|10043865|FG020|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8980769|NCT02688387|10043866|FG021|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8980770|NCT02688387|10043845|FG000|STARTED|Part 3B, Period 3 (up to 6 Days)||0
8980771|NCT02688387|10043846|FG001|STARTED|Part 3B, Period 3 (up to 6 Days)||0
8980772|NCT02688387|10043847|FG002|STARTED|Part 3B, Period 3 (up to 6 Days)||0
8980773|NCT02688387|10043848|FG003|STARTED|Part 3B, Period 3 (up to 6 Days)||0
8980774|NCT02688387|10043849|FG004|STARTED|Part 3B, Period 3 (up to 6 Days)||0
8980775|NCT02688387|10043850|FG005|STARTED|Part 3B, Period 3 (up to 6 Days)||0
8980776|NCT02688387|10043851|FG006|STARTED|Part 3B, Period 3 (up to 6 Days)||0
8980777|NCT02688387|10043852|FG007|STARTED|Part 3B, Period 3 (up to 6 Days)||0
8980778|NCT02688387|10043853|FG008|STARTED|Part 3B, Period 3 (up to 6 Days)||0
8980779|NCT02688387|10043854|FG009|STARTED|Part 3B, Period 3 (up to 6 Days)||0
8980780|NCT02688387|10043855|FG010|STARTED|Part 3B, Period 3 (up to 6 Days)||0
8980781|NCT02688387|10043856|FG011|STARTED|Part 3B, Period 3 (up to 6 Days)||0
8980782|NCT02688387|10043857|FG012|STARTED|Part 3B, Period 3 (up to 6 Days)||0
8980783|NCT02688387|10043858|FG013|STARTED|Part 3B, Period 3 (up to 6 Days)||0
8980784|NCT02688387|10043859|FG014|STARTED|Part 3B, Period 3 (up to 6 Days)||0
8980785|NCT02688387|10043860|FG015|STARTED|Part 3B, Period 3 (up to 6 Days)||0
8980786|NCT02688387|10043861|FG016|STARTED|Part 3B, Period 3 (up to 6 Days)||0
8980787|NCT02688387|10043862|FG017|STARTED|Part 3B, Period 3 (up to 6 Days)||0
8980788|NCT02688387|10043863|FG018|STARTED|Part 3B, Period 3 (up to 6 Days)||8
8980789|NCT02688387|10043864|FG019|STARTED|Part 3B, Period 3 (up to 6 Days)||8
8980790|NCT02688387|10043865|FG020|STARTED|Part 3B, Period 3 (up to 6 Days)||8
8980791|NCT02688387|10043866|FG021|STARTED|Part 3B, Period 3 (up to 6 Days)||8
8980792|NCT02688387|10043845|FG000|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8632517|NCT00545740|9672446|FG001|NOT COMPLETED|Overall Study||83
8632518|NCT00545740|9672447|FG002|NOT COMPLETED|Overall Study||96
8980793|NCT02688387|10043846|FG001|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8980794|NCT02688387|10043847|FG002|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8980795|NCT02688387|10043848|FG003|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8980796|NCT02688387|10043849|FG004|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8980797|NCT02688387|10043850|FG005|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8980798|NCT02688387|10043851|FG006|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8980799|NCT02688387|10043852|FG007|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8980800|NCT02688387|10043853|FG008|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8980801|NCT02688387|10043854|FG009|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8980802|NCT02688387|10043855|FG010|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8980803|NCT02688387|10043856|FG011|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8980804|NCT02688387|10043857|FG012|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8980805|NCT02688387|10043858|FG013|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8980806|NCT02688387|10043859|FG014|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8980807|NCT02688387|10043860|FG015|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8980808|NCT02688387|10043861|FG016|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8980809|NCT02688387|10043862|FG017|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8980810|NCT02688387|10043863|FG018|COMPLETED|Part 3B, Period 3 (up to 6 Days)||8
8980811|NCT02688387|10043864|FG019|COMPLETED|Part 3B, Period 3 (up to 6 Days)||8
8980812|NCT02688387|10043865|FG020|COMPLETED|Part 3B, Period 3 (up to 6 Days)||7
8980813|NCT02688387|10043866|FG021|COMPLETED|Part 3B, Period 3 (up to 6 Days)||8
8980814|NCT02688387|10043845|FG000|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8980815|NCT02688387|10043846|FG001|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8980816|NCT02688387|10043847|FG002|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8980817|NCT02688387|10043848|FG003|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8980818|NCT02688387|10043849|FG004|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8980819|NCT02688387|10043850|FG005|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8980820|NCT02688387|10043851|FG006|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8980821|NCT02688387|10043852|FG007|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8980822|NCT02688387|10043853|FG008|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8980823|NCT02688387|10043854|FG009|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8980824|NCT02688387|10043855|FG010|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8980825|NCT02688387|10043856|FG011|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8980826|NCT02688387|10043857|FG012|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8980827|NCT02688387|10043858|FG013|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8980828|NCT02688387|10043859|FG014|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8980829|NCT02688387|10043860|FG015|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8980830|NCT02688387|10043861|FG016|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8980831|NCT02688387|10043862|FG017|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8980832|NCT02688387|10043863|FG018|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8980833|NCT02688387|10043864|FG019|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8980834|NCT02688387|10043865|FG020|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||1
8980835|NCT02688387|10043866|FG021|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8980836|NCT02688387|10043845|FG000|STARTED|Part 3B, Washout Period 3 (10 Days)||0
8980837|NCT02688387|10043846|FG001|STARTED|Part 3B, Washout Period 3 (10 Days)||0
8980838|NCT02688387|10043847|FG002|STARTED|Part 3B, Washout Period 3 (10 Days)||0
8980839|NCT02688387|10043848|FG003|STARTED|Part 3B, Washout Period 3 (10 Days)||0
8980840|NCT02688387|10043849|FG004|STARTED|Part 3B, Washout Period 3 (10 Days)||0
8980841|NCT02688387|10043850|FG005|STARTED|Part 3B, Washout Period 3 (10 Days)||0
8632519|NCT00545740|9672448|FG003|NOT COMPLETED|Overall Study||71
8632520|NCT00545753|9672461|FG000|STARTED|Overall Study||243
8632521|NCT00545753|9672462|FG001|STARTED|Overall Study||59
8632522|NCT00545753|9672463|FG002|STARTED|Overall Study||256
8632523|NCT00545753|9672461|FG000|COMPLETED|Overall Study||227
8632524|NCT00545753|9672462|FG001|COMPLETED|Overall Study||54
8632525|NCT00545753|9672463|FG002|COMPLETED|Overall Study||230
8632526|NCT00545753|9672461|FG000|NOT COMPLETED|Overall Study||16
8632527|NCT00545753|9672462|FG001|NOT COMPLETED|Overall Study||5
8632528|NCT00545753|9672463|FG002|NOT COMPLETED|Overall Study||26
8632529|NCT00545779|9672472|FG000|STARTED|Overall Study||677
8632530|NCT00545779|9672472|FG000|COMPLETED|Overall Study||633
8725839|NCT01033487|9773166|FG009|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
8725840|NCT01033487|9773157|FG000|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
8725841|NCT01033487|9773158|FG001|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||3
8725842|NCT01033487|9773159|FG002|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
8877541|NCT01923961|9934485|FG002|NOT COMPLETED|Third Intervention||0
8877542|NCT01924169|9934493|FG000|STARTED|Overall Study||3
8877543|NCT01924169|9934493|FG000|COMPLETED|Overall Study||3
8877544|NCT01924169|9934493|FG000|NOT COMPLETED|Overall Study||0
8877545|NCT01924182|9934499|FG000|STARTED|Overall Study||3
8877546|NCT01924182|9934500|FG001|STARTED|Overall Study||0
8877547|NCT01924182|9934499|FG000|COMPLETED|Overall Study||2
8632531|NCT00545779|9672472|FG000|NOT COMPLETED|Overall Study||44
8632532|NCT00545792|9672476|FG000|STARTED|Overall Study||21
8632533|NCT00545792|9672476|FG000|COMPLETED|Overall Study||20
8877548|NCT01924182|9934500|FG001|COMPLETED|Overall Study||0
8877549|NCT01924182|9934499|FG000|NOT COMPLETED|Overall Study||1
8877550|NCT01924182|9934500|FG001|NOT COMPLETED|Overall Study||0
8877551|NCT01924299|9934508|FG000|STARTED|Period 1||18
8877552|NCT01924299|9934509|FG001|STARTED|Period 1||18
8980842|NCT02688387|10043851|FG006|STARTED|Part 3B, Washout Period 3 (10 Days)||0
8980843|NCT02688387|10043852|FG007|STARTED|Part 3B, Washout Period 3 (10 Days)||0
8980844|NCT02688387|10043853|FG008|STARTED|Part 3B, Washout Period 3 (10 Days)||0
8980845|NCT02688387|10043854|FG009|STARTED|Part 3B, Washout Period 3 (10 Days)||0
8980846|NCT02688387|10043855|FG010|STARTED|Part 3B, Washout Period 3 (10 Days)||0
8980847|NCT02688387|10043856|FG011|STARTED|Part 3B, Washout Period 3 (10 Days)||0
8980848|NCT02688387|10043857|FG012|STARTED|Part 3B, Washout Period 3 (10 Days)||0
8980849|NCT02688387|10043858|FG013|STARTED|Part 3B, Washout Period 3 (10 Days)||0
8980850|NCT02688387|10043859|FG014|STARTED|Part 3B, Washout Period 3 (10 Days)||0
8980851|NCT02688387|10043860|FG015|STARTED|Part 3B, Washout Period 3 (10 Days)||0
8980852|NCT02688387|10043861|FG016|STARTED|Part 3B, Washout Period 3 (10 Days)||0
8980853|NCT02688387|10043862|FG017|STARTED|Part 3B, Washout Period 3 (10 Days)||0
8980854|NCT02688387|10043863|FG018|STARTED|Part 3B, Washout Period 3 (10 Days)||8
8980855|NCT02688387|10043864|FG019|STARTED|Part 3B, Washout Period 3 (10 Days)||8
8980856|NCT02688387|10043865|FG020|STARTED|Part 3B, Washout Period 3 (10 Days)||7
8980857|NCT02688387|10043866|FG021|STARTED|Part 3B, Washout Period 3 (10 Days)||8
8980858|NCT02688387|10043845|FG000|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8980859|NCT02688387|10043846|FG001|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8980860|NCT02688387|10043847|FG002|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8980861|NCT02688387|10043848|FG003|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8980862|NCT02688387|10043849|FG004|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8980863|NCT02688387|10043850|FG005|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8980864|NCT02688387|10043851|FG006|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8980865|NCT02688387|10043852|FG007|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8980866|NCT02688387|10043853|FG008|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8980867|NCT02688387|10043854|FG009|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8980868|NCT02688387|10043855|FG010|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8980869|NCT02688387|10043856|FG011|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8980870|NCT02688387|10043857|FG012|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8980871|NCT02688387|10043858|FG013|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8980872|NCT02688387|10043859|FG014|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8980873|NCT02688387|10043860|FG015|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8980874|NCT02688387|10043861|FG016|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8980875|NCT02688387|10043862|FG017|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8980876|NCT02688387|10043863|FG018|COMPLETED|Part 3B, Washout Period 3 (10 Days)||7
8980877|NCT02688387|10043864|FG019|COMPLETED|Part 3B, Washout Period 3 (10 Days)||7
8980878|NCT02688387|10043865|FG020|COMPLETED|Part 3B, Washout Period 3 (10 Days)||6
8980879|NCT02688387|10043866|FG021|COMPLETED|Part 3B, Washout Period 3 (10 Days)||8
8980880|NCT02688387|10043845|FG000|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8980881|NCT02688387|10043846|FG001|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8980882|NCT02688387|10043847|FG002|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8980883|NCT02688387|10043848|FG003|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8980884|NCT02688387|10043849|FG004|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8980885|NCT02688387|10043850|FG005|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8980886|NCT02688387|10043851|FG006|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8980887|NCT02688387|10043852|FG007|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8980888|NCT02688387|10043853|FG008|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8980889|NCT02688387|10043854|FG009|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8980890|NCT02688387|10043855|FG010|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8980891|NCT02688387|10043856|FG011|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8980892|NCT02688387|10043857|FG012|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8980893|NCT02688387|10043858|FG013|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8980894|NCT02688387|10043859|FG014|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8980895|NCT02688387|10043860|FG015|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8980896|NCT02688387|10043861|FG016|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8980897|NCT02688387|10043862|FG017|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8980898|NCT02688387|10043863|FG018|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||1
8980899|NCT02688387|10043864|FG019|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||1
8980900|NCT02688387|10043865|FG020|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||1
8980901|NCT02688387|10043866|FG021|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8980902|NCT02688387|10043845|FG000|STARTED|Part 3B, Period 4 (up to 6 Days)||0
8980903|NCT02688387|10043846|FG001|STARTED|Part 3B, Period 4 (up to 6 Days)||0
8980904|NCT02688387|10043847|FG002|STARTED|Part 3B, Period 4 (up to 6 Days)||0
8980905|NCT02688387|10043848|FG003|STARTED|Part 3B, Period 4 (up to 6 Days)||0
8980906|NCT02688387|10043849|FG004|STARTED|Part 3B, Period 4 (up to 6 Days)||0
8980907|NCT02688387|10043850|FG005|STARTED|Part 3B, Period 4 (up to 6 Days)||0
8980908|NCT02688387|10043851|FG006|STARTED|Part 3B, Period 4 (up to 6 Days)||0
8980909|NCT02688387|10043852|FG007|STARTED|Part 3B, Period 4 (up to 6 Days)||0
8980910|NCT02688387|10043853|FG008|STARTED|Part 3B, Period 4 (up to 6 Days)||0
8980911|NCT02688387|10043854|FG009|STARTED|Part 3B, Period 4 (up to 6 Days)||0
8980912|NCT02688387|10043855|FG010|STARTED|Part 3B, Period 4 (up to 6 Days)||0
8980913|NCT02688387|10043856|FG011|STARTED|Part 3B, Period 4 (up to 6 Days)||0
8980914|NCT02688387|10043857|FG012|STARTED|Part 3B, Period 4 (up to 6 Days)||0
8980915|NCT02688387|10043858|FG013|STARTED|Part 3B, Period 4 (up to 6 Days)||0
8980916|NCT02688387|10043859|FG014|STARTED|Part 3B, Period 4 (up to 6 Days)||0
8980917|NCT02688387|10043860|FG015|STARTED|Part 3B, Period 4 (up to 6 Days)||0
8980918|NCT02688387|10043861|FG016|STARTED|Part 3B, Period 4 (up to 6 Days)||0
8980919|NCT02688387|10043862|FG017|STARTED|Part 3B, Period 4 (up to 6 Days)||0
8980920|NCT02688387|10043863|FG018|STARTED|Part 3B, Period 4 (up to 6 Days)||7
8980921|NCT02688387|10043864|FG019|STARTED|Part 3B, Period 4 (up to 6 Days)||7
8980922|NCT02688387|10043865|FG020|STARTED|Part 3B, Period 4 (up to 6 Days)||6
8980923|NCT02688387|10043866|FG021|STARTED|Part 3B, Period 4 (up to 6 Days)||8
8980924|NCT02688387|10043845|FG000|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8980925|NCT02688387|10043846|FG001|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8980926|NCT02688387|10043847|FG002|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8980927|NCT02688387|10043848|FG003|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8980928|NCT02688387|10043849|FG004|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8980929|NCT02688387|10043850|FG005|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8980930|NCT02688387|10043851|FG006|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8980931|NCT02688387|10043852|FG007|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8980932|NCT02688387|10043853|FG008|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8980933|NCT02688387|10043854|FG009|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8980934|NCT02688387|10043855|FG010|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8980935|NCT02688387|10043856|FG011|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8980936|NCT02688387|10043857|FG012|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8980937|NCT02688387|10043858|FG013|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8980938|NCT02688387|10043859|FG014|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8980939|NCT02688387|10043860|FG015|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8980940|NCT02688387|10043861|FG016|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8980941|NCT02688387|10043862|FG017|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8980942|NCT02688387|10043863|FG018|COMPLETED|Part 3B, Period 4 (up to 6 Days)||7
8980943|NCT02688387|10043864|FG019|COMPLETED|Part 3B, Period 4 (up to 6 Days)||7
8980944|NCT02688387|10043865|FG020|COMPLETED|Part 3B, Period 4 (up to 6 Days)||6
8980945|NCT02688387|10043866|FG021|COMPLETED|Part 3B, Period 4 (up to 6 Days)||8
8980946|NCT02688387|10043845|FG000|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8980947|NCT02688387|10043846|FG001|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8980948|NCT02688387|10043847|FG002|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8980949|NCT02688387|10043848|FG003|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8980950|NCT02688387|10043849|FG004|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8980951|NCT02688387|10043850|FG005|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8980952|NCT02688387|10043851|FG006|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8980953|NCT02688387|10043852|FG007|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8980954|NCT02688387|10043853|FG008|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8980955|NCT02688387|10043854|FG009|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8980956|NCT02688387|10043855|FG010|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8980957|NCT02688387|10043856|FG011|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8980958|NCT02688387|10043857|FG012|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8980959|NCT02688387|10043858|FG013|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8980960|NCT02688387|10043859|FG014|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8980961|NCT02688387|10043860|FG015|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8980962|NCT02688387|10043861|FG016|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8980963|NCT02688387|10043862|FG017|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8980964|NCT02688387|10043863|FG018|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8980965|NCT02688387|10043864|FG019|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8980966|NCT02688387|10043865|FG020|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8980967|NCT02688387|10043866|FG021|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8980968|NCT02688556|10043914|FG000|STARTED|Overall Study||372
8980969|NCT02688556|10043915|FG001|STARTED|Overall Study||373
8980970|NCT02688556|10043914|FG000|COMPLETED|Overall Study||347
8980971|NCT02688556|10043915|FG001|COMPLETED|Overall Study||361
8980972|NCT02688556|10043914|FG000|NOT COMPLETED|Overall Study||25
8980973|NCT02688556|10043915|FG001|NOT COMPLETED|Overall Study||12
8980974|NCT02688621|10043923|FG000|STARTED|Overall Study||212
8980975|NCT02688621|10043924|FG001|STARTED|Overall Study||206
8980976|NCT02688621|10043923|FG000|COMPLETED|Overall Study||172
8980977|NCT02688621|10043924|FG001|COMPLETED|Overall Study||188
8980978|NCT02688621|10043923|FG000|NOT COMPLETED|Overall Study||40
8980979|NCT02688621|10043924|FG001|NOT COMPLETED|Overall Study||18
8980980|NCT02688764|10043935|FG000|STARTED|Overall Study||66
8980981|NCT02688764|10043936|FG001|STARTED|Overall Study||19
8980982|NCT02688764|10043935|FG000|Treated in Stage 1|Overall Study||66
8980983|NCT02688764|10043936|FG001|Treated in Stage 1|Overall Study||19
8980984|NCT02688764|10043935|FG000|Treated in Stage 2|Overall Study||43
8980985|NCT02688764|10043936|FG001|Treated in Stage 2|Overall Study||8
8980986|NCT02688764|10043935|FG000|COMPLETED|Overall Study||26
8980987|NCT02688764|10043936|FG001|COMPLETED|Overall Study||2
8980988|NCT02688764|10043935|FG000|NOT COMPLETED|Overall Study||40
8980989|NCT02688764|10043936|FG001|NOT COMPLETED|Overall Study||17
8980990|NCT02688829|10043945|FG000|STARTED|Overall Study||21
8980991|NCT02688829|10043945|FG000|COMPLETED|Overall Study||19
8980992|NCT02688829|10043945|FG000|NOT COMPLETED|Overall Study||2
8980993|NCT02688842|10043949|FG000|STARTED|Overall Study||38
8980994|NCT02688842|10043949|FG000|COMPLETED|Overall Study||38
8980995|NCT02688842|10043949|FG000|NOT COMPLETED|Overall Study||0
8980996|NCT02688868|10043953|FG000|STARTED|Overall Study||38
8980997|NCT02688868|10043953|FG000|COMPLETED|Overall Study||34
8980998|NCT02688868|10043953|FG000|NOT COMPLETED|Overall Study||4
8980999|NCT02689063|10043961|FG000|STARTED|Overall Study||75
8981000|NCT02689063|10043962|FG001|STARTED|Overall Study||75
8981001|NCT02689063|10043963|FG002|STARTED|Overall Study||76
8981002|NCT02689063|10043964|FG003|STARTED|Overall Study||50
8981003|NCT02689063|10043961|FG000|COMPLETED|Overall Study||75
8981004|NCT02689063|10043962|FG001|COMPLETED|Overall Study||73
8981005|NCT02689063|10043963|FG002|COMPLETED|Overall Study||73
8981006|NCT02689063|10043964|FG003|COMPLETED|Overall Study||50
8981007|NCT02689063|10043961|FG000|NOT COMPLETED|Overall Study||0
8981008|NCT02689063|10043962|FG001|NOT COMPLETED|Overall Study||2
8981009|NCT02689063|10043963|FG002|NOT COMPLETED|Overall Study||3
8981010|NCT02689063|10043964|FG003|NOT COMPLETED|Overall Study||0
8981011|NCT02689076|10043977|FG000|STARTED|Overall Study||268
8981012|NCT02689076|10043978|FG001|STARTED|Overall Study||337
8981013|NCT02689076|10043979|FG002|STARTED|Overall Study||191
8981014|NCT02689076|10043977|FG000|COMPLETED|Overall Study||87
8981015|NCT02689076|10043978|FG001|COMPLETED|Overall Study||115
8981016|NCT02689076|10043979|FG002|COMPLETED|Overall Study||191
8981017|NCT02689076|10043977|FG000|NOT COMPLETED|Overall Study||181
8981018|NCT02689076|10043978|FG001|NOT COMPLETED|Overall Study||222
8981019|NCT02689076|10043979|FG002|NOT COMPLETED|Overall Study||0
8981020|NCT02689154|10043987|FG000|STARTED|Overall Study||18
8981021|NCT02689154|10043987|FG000|COMPLETED|Overall Study||18
8981022|NCT02689154|10043987|FG000|NOT COMPLETED|Overall Study||0
8981023|NCT02689206|10043996|FG000|STARTED|Overall Study||20
8981024|NCT02689206|10043997|FG001|STARTED|Overall Study||20
8981025|NCT02689206|10043998|FG002|STARTED|Overall Study||20
8981026|NCT02689206|10043999|FG003|STARTED|Overall Study||21
8981027|NCT02689206|10044000|FG004|STARTED|Overall Study||22
8981028|NCT02689206|10043996|FG000|COMPLETED|Overall Study||17
8981029|NCT02689206|10043997|FG001|COMPLETED|Overall Study||19
8981030|NCT02689206|10043998|FG002|COMPLETED|Overall Study||16
8981031|NCT02689206|10043999|FG003|COMPLETED|Overall Study||17
8981032|NCT02689206|10044000|FG004|COMPLETED|Overall Study||14
8981033|NCT02689206|10043996|FG000|NOT COMPLETED|Overall Study||3
8981034|NCT02689206|10043997|FG001|NOT COMPLETED|Overall Study||1
8981035|NCT02689206|10043998|FG002|NOT COMPLETED|Overall Study||4
8981036|NCT02689206|10043999|FG003|NOT COMPLETED|Overall Study||4
8981037|NCT02689206|10044000|FG004|NOT COMPLETED|Overall Study||8
8981038|NCT02689219|10044018|FG000|STARTED|Overall Study||11
8981039|NCT02689219|10044019|FG001|STARTED|Overall Study||7
8981040|NCT02689219|10044018|FG000|COMPLETED|Overall Study||0
8981041|NCT02689219|10044019|FG001|COMPLETED|Overall Study||0
8981042|NCT02689219|10044018|FG000|NOT COMPLETED|Overall Study||11
8981043|NCT02689219|10044019|FG001|NOT COMPLETED|Overall Study||7
8981044|NCT02689492|10044025|FG000|STARTED|Overall Study||401
8981045|NCT02689492|10044025|FG000|COMPLETED|Overall Study||315
8981046|NCT02689492|10044025|FG000|NOT COMPLETED|Overall Study||86
8981047|NCT02689804|10044034|FG000|STARTED|Overall Study||18
8981048|NCT02689804|10044035|FG001|STARTED|Overall Study||16
8981049|NCT02689804|10044034|FG000|COMPLETED|Overall Study||16
8981050|NCT02689804|10044035|FG001|COMPLETED|Overall Study||16
8981051|NCT02689804|10044034|FG000|NOT COMPLETED|Overall Study||2
8981052|NCT02689804|10044035|FG001|NOT COMPLETED|Overall Study||0
8981053|NCT02689973|10044048|FG000|STARTED|Overall Study||311
8981054|NCT02689973|10044049|FG001|STARTED|Overall Study||270
8981055|NCT02689973|10044050|FG002|STARTED|Overall Study||351
8981056|NCT02689973|10044051|FG003|STARTED|Overall Study||285
8981057|NCT02689973|10044048|FG000|COMPLETED|Overall Study||257
8981058|NCT02689973|10044049|FG001|COMPLETED|Overall Study||221
8981059|NCT02689973|10044050|FG002|COMPLETED|Overall Study||279
8981060|NCT02689973|10044051|FG003|COMPLETED|Overall Study||232
8981061|NCT02689973|10044048|FG000|NOT COMPLETED|Overall Study||54
8981062|NCT02689973|10044049|FG001|NOT COMPLETED|Overall Study||49
8981063|NCT02689973|10044050|FG002|NOT COMPLETED|Overall Study||72
8981064|NCT02689973|10044051|FG003|NOT COMPLETED|Overall Study||53
8981065|NCT02690168|10044062|FG000|STARTED|Overall Study||6
8981066|NCT02690168|10044062|FG000|COMPLETED|Overall Study||6
8981067|NCT02690168|10044062|FG000|NOT COMPLETED|Overall Study||0
8981068|NCT02690181|10044073|FG000|STARTED|Overall Study||14
8981069|NCT02690181|10044074|FG001|STARTED|Overall Study||14
8981070|NCT02690181|10044075|FG002|STARTED|Overall Study||15
8981071|NCT02690181|10044076|FG003|STARTED|Overall Study||10
8981072|NCT02690181|10044077|FG004|STARTED|Overall Study||6
8981073|NCT02690181|10044078|FG005|STARTED|Overall Study||21
8981074|NCT02690181|10044073|FG000|COMPLETED|Overall Study||14
8981075|NCT02690181|10044074|FG001|COMPLETED|Overall Study||14
8981076|NCT02690181|10044075|FG002|COMPLETED|Overall Study||15
8981077|NCT02690181|10044076|FG003|COMPLETED|Overall Study||10
8981078|NCT02690181|10044077|FG004|COMPLETED|Overall Study||6
8981079|NCT02690181|10044078|FG005|COMPLETED|Overall Study||21
8981080|NCT02690181|10044073|FG000|NOT COMPLETED|Overall Study||0
8981081|NCT02690181|10044074|FG001|NOT COMPLETED|Overall Study||0
8981082|NCT02690181|10044075|FG002|NOT COMPLETED|Overall Study||0
8981083|NCT02690181|10044076|FG003|NOT COMPLETED|Overall Study||0
8981084|NCT02690181|10044077|FG004|NOT COMPLETED|Overall Study||0
8981085|NCT02690181|10044078|FG005|NOT COMPLETED|Overall Study||0
8981086|NCT02690194|10044095|FG000|STARTED|Overall Study||17
8981087|NCT02690194|10044096|FG001|STARTED|Overall Study||18
8981088|NCT02690194|10044097|FG002|STARTED|Overall Study||19
8981089|NCT02690194|10044095|FG000|COMPLETED|Overall Study||16
8981090|NCT02690194|10044096|FG001|COMPLETED|Overall Study||14
8981091|NCT02690194|10044097|FG002|COMPLETED|Overall Study||19
8981092|NCT02690194|10044095|FG000|NOT COMPLETED|Overall Study||1
8981093|NCT02690194|10044096|FG001|NOT COMPLETED|Overall Study||4
8981094|NCT02690194|10044097|FG002|NOT COMPLETED|Overall Study||0
8981095|NCT02690207|10044105|FG000|STARTED|Overall Study||8687
8981096|NCT02690207|10044105|FG000|COMPLETED|Overall Study||8434
8981097|NCT02690207|10044105|FG000|NOT COMPLETED|Overall Study||253
8981098|NCT02690558|10044109|FG000|STARTED|Overall Study||39
8981099|NCT02690558|10044109|FG000|COMPLETED|Overall Study||39
8981100|NCT02690558|10044109|FG000|NOT COMPLETED|Overall Study||0
8981101|NCT02690649|10044115|FG000|STARTED|Overall Study||80
8981102|NCT02690649|10044116|FG001|STARTED|Overall Study||80
8981103|NCT02690649|10044115|FG000|COMPLETED|Overall Study||79
8981104|NCT02690649|10044116|FG001|COMPLETED|Overall Study||76
8981105|NCT02690649|10044115|FG000|NOT COMPLETED|Overall Study||1
8981106|NCT02690649|10044116|FG001|NOT COMPLETED|Overall Study||4
8981107|NCT02690701|10044126|FG000|STARTED|Treatment Period 1||46
8981108|NCT02690701|10044127|FG001|STARTED|Treatment Period 1||45
8981109|NCT02690701|10044126|FG000|COMPLETED|Treatment Period 1||44
8981110|NCT02690701|10044127|FG001|COMPLETED|Treatment Period 1||42
8981111|NCT02690701|10044126|FG000|NOT COMPLETED|Treatment Period 1||2
8981112|NCT02690701|10044127|FG001|NOT COMPLETED|Treatment Period 1||3
8981113|NCT02690701|10044126|FG000|STARTED|Treatment Period 2|Completed Treatment Period 1 and continued to Treatment Period 2|44
8981114|NCT02690701|10044127|FG001|STARTED|Treatment Period 2||42
8981115|NCT02690701|10044126|FG000|COMPLETED|Treatment Period 2|Completed Treatment Period 2|41
8981116|NCT02690701|10044127|FG001|COMPLETED|Treatment Period 2||37
8981117|NCT02690701|10044126|FG000|NOT COMPLETED|Treatment Period 2||3
8981118|NCT02690701|10044127|FG001|NOT COMPLETED|Treatment Period 2||5
8981119|NCT02690714|10044134|FG000|STARTED|Segment 1: Single-dose Day -4 to Day 0||9
8981120|NCT02690714|10044134|FG000|COMPLETED|Segment 1: Single-dose Day -4 to Day 0|Six participants skipped Segment 1 as they had PK data from Phase 1 study 2002C005G.|9
8981121|NCT02690714|10044134|FG000|NOT COMPLETED|Segment 1: Single-dose Day -4 to Day 0||0
8981122|NCT02690714|10044134|FG000|STARTED|Segment 2: Multi-dose Day 0 to Week 12||15
8981123|NCT02690714|10044134|FG000|COMPLETED|Segment 2: Multi-dose Day 0 to Week 12||15
8981124|NCT02690714|10044134|FG000|NOT COMPLETED|Segment 2: Multi-dose Day 0 to Week 12||0
8981125|NCT02690714|10044134|FG000|STARTED|Segment 3: Extended Treatment Wks 12-48||15
8981126|NCT02690714|10044134|FG000|COMPLETED|Segment 3: Extended Treatment Wks 12-48||15
8981127|NCT02690714|10044134|FG000|NOT COMPLETED|Segment 3: Extended Treatment Wks 12-48||0
8981128|NCT02690714|10044134|FG000|STARTED|Post-Wk 48: Safety Week 48 to EoS Visit|3 subjects from Norway did not go past 48 weeks|12
8981129|NCT02690714|10044134|FG000|COMPLETED|Post-Wk 48: Safety Week 48 to EoS Visit||10
8981130|NCT02690714|10044134|FG000|NOT COMPLETED|Post-Wk 48: Safety Week 48 to EoS Visit||2
8981131|NCT02690727|10044142|FG000|STARTED|Overall Study||9
8981132|NCT02690727|10044143|FG001|STARTED|Overall Study||9
8981133|NCT02690727|10044142|FG000|COMPLETED|Overall Study||7
8981134|NCT02690727|10044143|FG001|COMPLETED|Overall Study||7
8981135|NCT02690727|10044142|FG000|NOT COMPLETED|Overall Study||2
8981136|NCT02690727|10044143|FG001|NOT COMPLETED|Overall Study||2
8981137|NCT02690935|10044153|FG000|STARTED|Overall Study|Count of participants|51
8981138|NCT02690935|10044154|FG001|STARTED|Overall Study|Count of participants|51
8981139|NCT02690935|10044153|FG000|COMPLETED|Overall Study|Count of participants|51
8981140|NCT02690935|10044154|FG001|COMPLETED|Overall Study|Count of participants|51
8981141|NCT02690935|10044153|FG000|NOT COMPLETED|Overall Study||0
8981142|NCT02690935|10044154|FG001|NOT COMPLETED|Overall Study||0
8981143|NCT02690948|10044162|FG000|STARTED|Overall Study||9
8981144|NCT02690948|10044163|FG001|STARTED|Overall Study||7
8981145|NCT02690948|10044162|FG000|COMPLETED|Overall Study||9
8981146|NCT02690948|10044163|FG001|COMPLETED|Overall Study||7
8981147|NCT02690948|10044162|FG000|NOT COMPLETED|Overall Study||0
8981148|NCT02690948|10044163|FG001|NOT COMPLETED|Overall Study||0
8981149|NCT02690974|10044169|FG000|STARTED|Overall Study||302
8981150|NCT02690974|10044169|FG000|COMPLETED|Overall Study||262
8981151|NCT02690974|10044169|FG000|NOT COMPLETED|Overall Study||40
8981152|NCT02691143|10044175|FG000|STARTED|Overall Study||27
8981153|NCT02691143|10044176|FG001|STARTED|Overall Study||23
8981154|NCT02691143|10044175|FG000|COMPLETED|Overall Study||27
8981155|NCT02691143|10044176|FG001|COMPLETED|Overall Study||23
8981156|NCT02691143|10044175|FG000|NOT COMPLETED|Overall Study||0
8981157|NCT02691143|10044176|FG001|NOT COMPLETED|Overall Study||0
8981158|NCT02691247|10044185|FG000|STARTED|Overall Study||40
8981159|NCT02691247|10044186|FG001|STARTED|Overall Study||24
8981160|NCT02691247|10044187|FG002|STARTED|Overall Study||46
8981161|NCT02691247|10044185|FG000|COMPLETED|Overall Study||37
8981162|NCT02691247|10044186|FG001|COMPLETED|Overall Study||22
8981163|NCT02691247|10044187|FG002|COMPLETED|Overall Study||43
8981164|NCT02691247|10044185|FG000|NOT COMPLETED|Overall Study||3
8981165|NCT02691247|10044186|FG001|NOT COMPLETED|Overall Study||2
8981166|NCT02691247|10044187|FG002|NOT COMPLETED|Overall Study||3
8981167|NCT02691260|10044199|FG000|STARTED|Overall Study||26
8981168|NCT02691260|10044200|FG001|STARTED|Overall Study||26
8981169|NCT02691260|10044201|FG002|STARTED|Overall Study||27
8981170|NCT02691260|10044202|FG003|STARTED|Overall Study||26
8981171|NCT02691260|10044199|FG000|COMPLETED|Overall Study||24
8981172|NCT02691260|10044200|FG001|COMPLETED|Overall Study||24
8981173|NCT02691260|10044201|FG002|COMPLETED|Overall Study||25
8981174|NCT02691260|10044202|FG003|COMPLETED|Overall Study||23
8981175|NCT02691260|10044199|FG000|NOT COMPLETED|Overall Study||2
8981176|NCT02691260|10044200|FG001|NOT COMPLETED|Overall Study||2
8981177|NCT02691260|10044201|FG002|NOT COMPLETED|Overall Study||2
8981178|NCT02691260|10044202|FG003|NOT COMPLETED|Overall Study||3
8981179|NCT02691416|10044214|FG000|STARTED|Overall Study||30
8981180|NCT02691416|10044215|FG001|STARTED|Overall Study||30
8981181|NCT02691416|10044214|FG000|COMPLETED|Overall Study||30
8981182|NCT02691416|10044215|FG001|COMPLETED|Overall Study||30
8981183|NCT02691416|10044214|FG000|NOT COMPLETED|Overall Study||0
8981184|NCT02691416|10044215|FG001|NOT COMPLETED|Overall Study||0
8571374|NCT00109772|9603635|FG001|COMPLETED|Open-label Extension|Participants who were active in extension period when the sponsor terminated the study.|29
8571375|NCT00109772|9603634|FG000|NOT COMPLETED|Open-label Extension||45
8571376|NCT00109772|9603635|FG001|NOT COMPLETED|Open-label Extension||49
8571377|NCT00109837|9603641|FG000|STARTED|Overall Study||79
8571378|NCT00109837|9603641|FG000|Eligible|Overall Study||78
8571379|NCT00109837|9603641|FG000|Eligible and Ph-|Overall Study||61
8571380|NCT00109837|9603641|FG000|Eligible and Ph- and Treated|Overall Study||60
8571381|NCT00109837|9603641|FG000|COMPLETED|Overall Study||56
8571382|NCT00109837|9603641|FG000|NOT COMPLETED|Overall Study||23
8571383|NCT00109850|9603649|FG000|STARTED|Overall Study||22
8571384|NCT00109850|9603649|FG000|Eligible|Overall Study||21
8571385|NCT00109850|9603649|FG000|Eligible and Began Protocol Therapy|Overall Study||21
8981185|NCT02691455|10044227|FG000|STARTED|Overall Study||23
8981186|NCT02691455|10044228|FG001|STARTED|Overall Study||22
8981187|NCT02691455|10044227|FG000|Randomized|Overall Study||23
8981188|NCT02691455|10044228|FG001|Randomized|Overall Study||22
8981189|NCT02691455|10044227|FG000|Received Assigned Intervention|Overall Study||22
8981190|NCT02691455|10044228|FG001|Received Assigned Intervention|Overall Study||20
8981191|NCT02691455|10044227|FG000|Week 1 Follow up|Overall Study||22
8981192|NCT02691455|10044228|FG001|Week 1 Follow up|Overall Study||19
8981193|NCT02691455|10044227|FG000|Month 1 Follow up|Overall Study||22
8981194|NCT02691455|10044228|FG001|Month 1 Follow up|Overall Study||18
8981195|NCT02691455|10044227|FG000|Month 3 Follow up|Overall Study||21
8981196|NCT02691455|10044228|FG001|Month 3 Follow up|Overall Study||18
8981197|NCT02691455|10044227|FG000|Month 6 Follow up|Overall Study||19
8981198|NCT02691455|10044228|FG001|Month 6 Follow up|Overall Study||19
8981199|NCT02691455|10044227|FG000|Month 12 Follow up|Overall Study||16
8981200|NCT02691455|10044228|FG001|Month 12 Follow up|Overall Study||16
8981201|NCT02691455|10044227|FG000|Year 2 Follow up|Overall Study||6
8981202|NCT02691455|10044228|FG001|Year 2 Follow up|Overall Study||9
8571386|NCT00109850|9603649|FG000|COMPLETED|Overall Study||18
8981203|NCT02691455|10044227|FG000|Year 3 Follow up|Overall Study||7
8981204|NCT02691455|10044228|FG001|Year 3 Follow up|Overall Study||5
8981205|NCT02691455|10044227|FG000|COMPLETED|Overall Study||7
8981206|NCT02691455|10044228|FG001|COMPLETED|Overall Study||5
8981207|NCT02691455|10044227|FG000|NOT COMPLETED|Overall Study||16
8981208|NCT02691455|10044228|FG001|NOT COMPLETED|Overall Study||17
8981209|NCT02691468|10044236|FG000|STARTED|Overall Study||54
8981210|NCT02691468|10044237|FG001|STARTED|Overall Study||54
8981211|NCT02691468|10044236|FG000|COMPLETED|Overall Study||48
8981212|NCT02691468|10044237|FG001|COMPLETED|Overall Study||52
8981213|NCT02691468|10044236|FG000|NOT COMPLETED|Overall Study||6
8981214|NCT02691468|10044237|FG001|NOT COMPLETED|Overall Study||2
8981215|NCT02691494|10044246|FG000|STARTED|Treatment Period||94
8981216|NCT02691494|10044247|FG001|STARTED|Treatment Period||95
8981217|NCT02691494|10044248|FG002|STARTED|Treatment Period||189
8981218|NCT02691494|10044246|FG000|COMPLETED|Treatment Period|completed treatment period|72
8981219|NCT02691494|10044247|FG001|COMPLETED|Treatment Period|completed treatment period|69
8981220|NCT02691494|10044248|FG002|COMPLETED|Treatment Period|completed treatment period|148
8981221|NCT02691494|10044246|FG000|NOT COMPLETED|Treatment Period||22
8981222|NCT02691494|10044247|FG001|NOT COMPLETED|Treatment Period||26
8981223|NCT02691494|10044248|FG002|NOT COMPLETED|Treatment Period||41
8981224|NCT02691494|10044246|FG000|STARTED|Post-Treatment Follow-Up Period||14
8981225|NCT02691494|10044247|FG001|STARTED|Post-Treatment Follow-Up Period||25
8981226|NCT02691494|10044248|FG002|STARTED|Post-Treatment Follow-Up Period||59
8981227|NCT02691494|10044246|FG000|COMPLETED|Post-Treatment Follow-Up Period||9
8981228|NCT02691494|10044247|FG001|COMPLETED|Post-Treatment Follow-Up Period||18
8981229|NCT02691494|10044248|FG002|COMPLETED|Post-Treatment Follow-Up Period||42
8981230|NCT02691494|10044246|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||5
8981231|NCT02691494|10044247|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||7
8981232|NCT02691494|10044248|FG002|NOT COMPLETED|Post-Treatment Follow-Up Period||17
8981233|NCT02691507|10044258|FG000|STARTED|Overall Study||40
8981234|NCT02691507|10044259|FG001|STARTED|Overall Study||13
8981235|NCT02691507|10044258|FG000|COMPLETED|Overall Study||40
8981236|NCT02691507|10044259|FG001|COMPLETED|Overall Study||12
8981237|NCT02691507|10044258|FG000|NOT COMPLETED|Overall Study||0
8981238|NCT02691507|10044259|FG001|NOT COMPLETED|Overall Study||1
8981239|NCT02691572|10044267|FG000|STARTED|Overall Study||40
8981240|NCT02691572|10044268|FG001|STARTED|Overall Study||40
8981241|NCT02691572|10044267|FG000|COMPLETED|Overall Study||39
8981242|NCT02691572|10044268|FG001|COMPLETED|Overall Study||39
8981243|NCT02691572|10044267|FG000|NOT COMPLETED|Overall Study||1
8981244|NCT02691572|10044268|FG001|NOT COMPLETED|Overall Study||1
8981245|NCT02691702|10044285|FG000|STARTED|Overall Study||10
8981246|NCT02691702|10044286|FG001|STARTED|Overall Study||11
8981247|NCT02691702|10044287|FG002|STARTED|Overall Study||8
8981248|NCT02691702|10044288|FG003|STARTED|Overall Study||8
8981249|NCT02691702|10044289|FG004|STARTED|Overall Study||8
8981250|NCT02691702|10044290|FG005|STARTED|Overall Study||8
8981251|NCT02691702|10044291|FG006|STARTED|Overall Study||8
8981252|NCT02691702|10044292|FG007|STARTED|Overall Study||12
8981253|NCT02691702|10044293|FG008|STARTED|Overall Study||8
8981254|NCT02691702|10044294|FG009|STARTED|Overall Study||8
8981255|NCT02691702|10044295|FG010|STARTED|Overall Study||8
8981256|NCT02691702|10044285|FG000|COMPLETED|Overall Study||8
8981257|NCT02691702|10044286|FG001|COMPLETED|Overall Study||10
8981258|NCT02691702|10044287|FG002|COMPLETED|Overall Study||7
8981259|NCT02691702|10044288|FG003|COMPLETED|Overall Study||8
8981260|NCT02691702|10044289|FG004|COMPLETED|Overall Study||8
8981261|NCT02691702|10044290|FG005|COMPLETED|Overall Study||5
8981262|NCT02691702|10044291|FG006|COMPLETED|Overall Study||5
8981263|NCT02691702|10044292|FG007|COMPLETED|Overall Study||12
8981264|NCT02691702|10044293|FG008|COMPLETED|Overall Study||6
8981265|NCT02691702|10044294|FG009|COMPLETED|Overall Study||6
8981266|NCT02691702|10044295|FG010|COMPLETED|Overall Study||6
8981267|NCT02691702|10044285|FG000|NOT COMPLETED|Overall Study||2
8981268|NCT02691702|10044286|FG001|NOT COMPLETED|Overall Study||1
8981269|NCT02691702|10044287|FG002|NOT COMPLETED|Overall Study||1
8981270|NCT02691702|10044288|FG003|NOT COMPLETED|Overall Study||0
8981271|NCT02691702|10044289|FG004|NOT COMPLETED|Overall Study||0
8981272|NCT02691702|10044290|FG005|NOT COMPLETED|Overall Study||3
8981273|NCT02691702|10044291|FG006|NOT COMPLETED|Overall Study||3
8981274|NCT02691702|10044292|FG007|NOT COMPLETED|Overall Study||0
8981275|NCT02691702|10044293|FG008|NOT COMPLETED|Overall Study||2
8981276|NCT02691702|10044294|FG009|NOT COMPLETED|Overall Study||2
8981277|NCT02691702|10044295|FG010|NOT COMPLETED|Overall Study||2
8981278|NCT02691741|10044329|FG000|STARTED|Overall Study||94
8981279|NCT02691741|10044330|FG001|STARTED|Overall Study||94
8981280|NCT02691741|10044329|FG000|All-Implanted Analysis Set|Overall Study||93
8981281|NCT02691741|10044330|FG001|All-Implanted Analysis Set|Overall Study||89
8981282|NCT02691741|10044329|FG000|Best-Case Analysis Set|Overall Study||86
8981283|NCT02691741|10044330|FG001|Best-Case Analysis Set|Overall Study||85
8981284|NCT02691741|10044329|FG000|Safety Analysis Set|Overall Study||93
8981285|NCT02691741|10044330|FG001|Safety Analysis Set|Overall Study||89
8981286|NCT02691741|10044329|FG000|COMPLETED|Overall Study||93
8981287|NCT02691741|10044330|FG001|COMPLETED|Overall Study||87
8981288|NCT02691741|10044329|FG000|NOT COMPLETED|Overall Study||1
8981289|NCT02691741|10044330|FG001|NOT COMPLETED|Overall Study||7
8981290|NCT02691936|10044343|FG000|STARTED|Overall Study||35
8981291|NCT02691936|10044344|FG001|STARTED|Overall Study||34
8981292|NCT02691936|10044343|FG000|COMPLETED|Overall Study||33
8981293|NCT02691936|10044344|FG001|COMPLETED|Overall Study||29
8981294|NCT02691936|10044343|FG000|NOT COMPLETED|Overall Study||2
8981295|NCT02691936|10044344|FG001|NOT COMPLETED|Overall Study||5
8981296|NCT02691962|10044350|FG000|STARTED|Overall Study||75
8981297|NCT02691962|10044350|FG000|COMPLETED|Overall Study||59
8981298|NCT02691962|10044350|FG000|NOT COMPLETED|Overall Study||16
8981299|NCT02692040|10044372|FG000|STARTED|Overall Study||10
8981300|NCT02692040|10044373|FG001|STARTED|Overall Study||4
8981301|NCT02692040|10044374|FG002|STARTED|Overall Study||5
8981302|NCT02692040|10044375|FG003|STARTED|Overall Study||5
8981303|NCT02692040|10044376|FG004|STARTED|Overall Study||4
8981304|NCT02692040|10044377|FG005|STARTED|Overall Study||5
8981305|NCT02692040|10044378|FG006|STARTED|Overall Study||5
8981306|NCT02692040|10044379|FG007|STARTED|Overall Study||5
8981307|NCT02692040|10044380|FG008|STARTED|Overall Study||5
8981308|NCT02692040|10044381|FG009|STARTED|Overall Study||4
8981309|NCT02692040|10044382|FG010|STARTED|Overall Study||5
8981310|NCT02692040|10044383|FG011|STARTED|Overall Study||5
8981311|NCT02692040|10044384|FG012|STARTED|Overall Study||6
8981312|NCT02692040|10044385|FG013|STARTED|Overall Study||6
8981313|NCT02692040|10044386|FG014|STARTED|Overall Study||6
8981314|NCT02692040|10044387|FG015|STARTED|Overall Study||6
8981315|NCT02692040|10044388|FG016|STARTED|Overall Study||4
8981316|NCT02692040|10044372|FG000|COMPLETED|Overall Study||10
8981317|NCT02692040|10044373|FG001|COMPLETED|Overall Study||4
8981318|NCT02692040|10044374|FG002|COMPLETED|Overall Study||5
8981319|NCT02692040|10044375|FG003|COMPLETED|Overall Study||5
8981320|NCT02692040|10044376|FG004|COMPLETED|Overall Study||4
8981321|NCT02692040|10044377|FG005|COMPLETED|Overall Study||5
8981322|NCT02692040|10044378|FG006|COMPLETED|Overall Study||5
8981323|NCT02692040|10044379|FG007|COMPLETED|Overall Study||5
8981324|NCT02692040|10044380|FG008|COMPLETED|Overall Study||5
8981325|NCT02692040|10044381|FG009|COMPLETED|Overall Study||4
8981326|NCT02692040|10044382|FG010|COMPLETED|Overall Study||5
8981327|NCT02692040|10044383|FG011|COMPLETED|Overall Study||5
8981328|NCT02692040|10044384|FG012|COMPLETED|Overall Study||5
8981329|NCT02692040|10044385|FG013|COMPLETED|Overall Study||3
8981330|NCT02692040|10044386|FG014|COMPLETED|Overall Study||5
8981331|NCT02692040|10044387|FG015|COMPLETED|Overall Study||5
8981332|NCT02692040|10044388|FG016|COMPLETED|Overall Study||4
8981333|NCT02692040|10044372|FG000|NOT COMPLETED|Overall Study||0
8981334|NCT02692040|10044373|FG001|NOT COMPLETED|Overall Study||0
8981335|NCT02692040|10044374|FG002|NOT COMPLETED|Overall Study||0
8981336|NCT02692040|10044375|FG003|NOT COMPLETED|Overall Study||0
8981337|NCT02692040|10044376|FG004|NOT COMPLETED|Overall Study||0
8981338|NCT02692040|10044377|FG005|NOT COMPLETED|Overall Study||0
8981339|NCT02692040|10044378|FG006|NOT COMPLETED|Overall Study||0
8981340|NCT02692040|10044379|FG007|NOT COMPLETED|Overall Study||0
8981341|NCT02692040|10044380|FG008|NOT COMPLETED|Overall Study||0
8981342|NCT02692040|10044381|FG009|NOT COMPLETED|Overall Study||0
8981343|NCT02692040|10044382|FG010|NOT COMPLETED|Overall Study||0
8981344|NCT02692040|10044383|FG011|NOT COMPLETED|Overall Study||0
8981345|NCT02692040|10044384|FG012|NOT COMPLETED|Overall Study||1
8981346|NCT02692040|10044385|FG013|NOT COMPLETED|Overall Study||3
8981347|NCT02692040|10044386|FG014|NOT COMPLETED|Overall Study||1
8981348|NCT02692040|10044387|FG015|NOT COMPLETED|Overall Study||1
8981349|NCT02692040|10044388|FG016|NOT COMPLETED|Overall Study||0
8981350|NCT02692209|10044465|FG000|STARTED|Overall Study||298
8981351|NCT02692209|10044465|FG000|COMPLETED|Overall Study||298
8981352|NCT02692209|10044465|FG000|NOT COMPLETED|Overall Study||0
8981353|NCT02692235|10044473|FG000|STARTED|Overall Study||14
8981354|NCT02692235|10044474|FG001|STARTED|Overall Study||14
8981355|NCT02692235|10044473|FG000|COMPLETED|Overall Study||11
8981356|NCT02692235|10044474|FG001|COMPLETED|Overall Study||11
8981357|NCT02692235|10044473|FG000|NOT COMPLETED|Overall Study||3
8981358|NCT02692235|10044474|FG001|NOT COMPLETED|Overall Study||3
8981359|NCT02692391|10044482|FG000|STARTED|Overall Study||24
8981360|NCT02692391|10044483|FG001|STARTED|Overall Study||18
8981361|NCT02692391|10044482|FG000|COMPLETED|Overall Study||24
8981362|NCT02692391|10044483|FG001|COMPLETED|Overall Study||18
8981363|NCT02692391|10044482|FG000|NOT COMPLETED|Overall Study||0
8981364|NCT02692391|10044483|FG001|NOT COMPLETED|Overall Study||0
8981365|NCT02692417|10044491|FG000|STARTED|Overall Study||9
8981366|NCT02692417|10044492|FG001|STARTED|Overall Study||7
8981367|NCT02692417|10044491|FG000|COMPLETED|Overall Study||3
8981368|NCT02692417|10044492|FG001|COMPLETED|Overall Study||6
8981369|NCT02692417|10044491|FG000|NOT COMPLETED|Overall Study||6
8981370|NCT02692417|10044492|FG001|NOT COMPLETED|Overall Study||1
8981371|NCT02692482|10044500|FG000|STARTED|Overall Study||177
8981372|NCT02692482|10044501|FG001|STARTED|Overall Study||182
8981373|NCT02692482|10044500|FG000|COMPLETED|Overall Study||174
8981374|NCT02692482|10044501|FG001|COMPLETED|Overall Study||178
8981375|NCT02692482|10044500|FG000|NOT COMPLETED|Overall Study||3
8981376|NCT02692482|10044501|FG001|NOT COMPLETED|Overall Study||4
8981377|NCT02692495|10044510|FG000|STARTED|Overall Study||12
8981378|NCT02692495|10044511|FG001|STARTED|Overall Study||4
8981379|NCT02692495|10044510|FG000|COMPLETED|Overall Study||12
8981380|NCT02692495|10044511|FG001|COMPLETED|Overall Study||4
8981381|NCT02692495|10044510|FG000|NOT COMPLETED|Overall Study||0
8981382|NCT02692495|10044511|FG001|NOT COMPLETED|Overall Study||0
8981383|NCT02692560|10044523|FG000|STARTED|Overall Study||29
8981384|NCT02692560|10044524|FG001|STARTED|Overall Study||31
8981385|NCT02692560|10044523|FG000|COMPLETED|Overall Study||29
8981386|NCT02692560|10044524|FG001|COMPLETED|Overall Study||25
8981387|NCT02692560|10044523|FG000|NOT COMPLETED|Overall Study||0
8981388|NCT02692560|10044524|FG001|NOT COMPLETED|Overall Study||6
8981389|NCT02692586|10044530|FG000|STARTED|Overall Study||106
8981390|NCT02692586|10044530|FG000|COMPLETED|Overall Study||103
8981391|NCT02692586|10044530|FG000|NOT COMPLETED|Overall Study||3
8981392|NCT02692703|10044534|FG000|STARTED|Overall Study||100
8981393|NCT02692703|10044534|FG000|COMPLETED|Overall Study||98
8981394|NCT02692703|10044534|FG000|NOT COMPLETED|Overall Study||2
8981395|NCT02692716|10044540|FG000|STARTED|Overall Study||1591
8981396|NCT02692716|10044541|FG001|STARTED|Overall Study||1592
8981397|NCT02692716|10044540|FG000|Full Analysis Set (FAS)|Overall Study||1591
8981398|NCT02692716|10044541|FG001|Full Analysis Set (FAS)|Overall Study||1592
8981399|NCT02692716|10044540|FG000|Exposed|Overall Study||1591
8981400|NCT02692716|10044541|FG001|Exposed|Overall Study||1591
8981401|NCT02692716|10044540|FG000|COMPLETED|Overall Study||1586
8981402|NCT02692716|10044541|FG001|COMPLETED|Overall Study||1586
8981403|NCT02692716|10044540|FG000|NOT COMPLETED|Overall Study||5
8981404|NCT02692716|10044541|FG001|NOT COMPLETED|Overall Study||6
8981405|NCT02692755|10044547|FG000|STARTED|Overall Study||35
8981406|NCT02692755|10044547|FG000|COMPLETED|Overall Study||35
8981407|NCT02692755|10044547|FG000|NOT COMPLETED|Overall Study||0
8981408|NCT02692859|10044554|FG000|STARTED|Overall Study||996
8981409|NCT02692859|10044555|FG001|STARTED|Overall Study||996
8981410|NCT02692859|10044554|FG000|COMPLETED|Overall Study||912
8981411|NCT02692859|10044555|FG001|COMPLETED|Overall Study||901
8981412|NCT02692859|10044554|FG000|NOT COMPLETED|Overall Study||84
8981413|NCT02692859|10044555|FG001|NOT COMPLETED|Overall Study||95
9038593|NCT03332784|10099763|FG002|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
9038594|NCT03332784|10099764|FG003|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
9038595|NCT03332784|10099765|FG004|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
9038596|NCT03332784|10099766|FG005|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
9038597|NCT03332784|10099767|FG006|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
9038598|NCT03332784|10099768|FG007|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
9038599|NCT03332784|10099769|FG008|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
9038600|NCT03332784|10099770|FG009|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
9038601|NCT03332784|10099771|FG010|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
9038602|NCT03332784|10099772|FG011|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
9038603|NCT03332784|10099773|FG012|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
9038604|NCT03332784|10099774|FG013|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
9038605|NCT03332784|10099775|FG014|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
9038606|NCT03332784|10099776|FG015|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
9038607|NCT03332784|10099777|FG016|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
8981414|NCT02693106|10044561|FG000|STARTED|Overall Study||13
8981415|NCT02693106|10044561|FG000|COMPLETED|Overall Study||10
8981416|NCT02693106|10044561|FG000|NOT COMPLETED|Overall Study||3
8981417|NCT02693119|10044573|FG000|STARTED|Double-Blind Period||8
8981418|NCT02693119|10044574|FG001|STARTED|Double-Blind Period||4
8981419|NCT02693119|10044573|FG000|COMPLETED|Double-Blind Period||8
8981420|NCT02693119|10044574|FG001|COMPLETED|Double-Blind Period||4
8981421|NCT02693119|10044573|FG000|NOT COMPLETED|Double-Blind Period||0
8981422|NCT02693119|10044574|FG001|NOT COMPLETED|Double-Blind Period||0
8981423|NCT02693119|10044573|FG000|STARTED|Open-Label Period||8
8981424|NCT02693119|10044574|FG001|STARTED|Open-Label Period||4
8981425|NCT02693119|10044573|FG000|COMPLETED|Open-Label Period||8
8981426|NCT02693119|10044574|FG001|COMPLETED|Open-Label Period||3
8981427|NCT02693119|10044573|FG000|NOT COMPLETED|Open-Label Period||0
8981428|NCT02693119|10044574|FG001|NOT COMPLETED|Open-Label Period||1
8981429|NCT02693132|10044613|FG000|STARTED|Overall Study||17
8981430|NCT02693132|10044614|FG001|STARTED|Overall Study||17
8981431|NCT02693132|10044615|FG002|STARTED|Overall Study||18
8981432|NCT02693132|10044613|FG000|COMPLETED|Overall Study||16
8981433|NCT02693132|10044614|FG001|COMPLETED|Overall Study||16
8981434|NCT02693132|10044615|FG002|COMPLETED|Overall Study||17
8981435|NCT02693132|10044613|FG000|NOT COMPLETED|Overall Study||1
8981436|NCT02693132|10044614|FG001|NOT COMPLETED|Overall Study||1
8981437|NCT02693132|10044615|FG002|NOT COMPLETED|Overall Study||1
8981438|NCT02693262|10044623|FG000|STARTED|Overall Study||4
8981439|NCT02693262|10044624|FG001|STARTED|Overall Study||5
8981440|NCT02693262|10044623|FG000|COMPLETED|Overall Study||4
8981441|NCT02693262|10044624|FG001|COMPLETED|Overall Study||5
8981442|NCT02693262|10044623|FG000|NOT COMPLETED|Overall Study||0
8981443|NCT02693262|10044624|FG001|NOT COMPLETED|Overall Study||0
8632534|NCT00545792|9672476|FG000|NOT COMPLETED|Overall Study||1
8632535|NCT00545818|9672482|FG000|STARTED|Overall Study||49
8632536|NCT00545818|9672483|FG001|STARTED|Overall Study||46
8632537|NCT00545818|9672482|FG000|COMPLETED|Overall Study||46
8632538|NCT00545818|9672483|FG001|COMPLETED|Overall Study||39
8632539|NCT00545818|9672482|FG000|NOT COMPLETED|Overall Study||3
8632540|NCT00545818|9672483|FG001|NOT COMPLETED|Overall Study||7
8632541|NCT00545948|9672492|FG000|STARTED|Overall Study|Registered patients assigned to receive vinorelbine + cisplatin protocol therapy.|9
8632542|NCT00545948|9672493|FG001|STARTED|Overall Study|Registered patients assigned to receive pemetrexed + cisplatin protocol therapy.|15
8632543|NCT00545948|9672494|FG002|STARTED|Overall Study|Registered patients who were not assigned to receive protocol therapy.|7
8981444|NCT02693418|10044635|FG000|STARTED|Overall Study||22
8981445|NCT02693418|10044636|FG001|STARTED|Overall Study||21
8981446|NCT02693418|10044637|FG002|STARTED|Overall Study||21
8981447|NCT02693418|10044638|FG003|STARTED|Overall Study||20
8981448|NCT02693418|10044639|FG004|STARTED|Overall Study||21
8981449|NCT02693418|10044635|FG000|COMPLETED|Overall Study||21
8981450|NCT02693418|10044636|FG001|COMPLETED|Overall Study||19
8981451|NCT02693418|10044637|FG002|COMPLETED|Overall Study||19
8981452|NCT02693418|10044638|FG003|COMPLETED|Overall Study||20
8981453|NCT02693418|10044639|FG004|COMPLETED|Overall Study||21
8981454|NCT02693418|10044635|FG000|NOT COMPLETED|Overall Study||1
8981455|NCT02693418|10044636|FG001|NOT COMPLETED|Overall Study||2
8981456|NCT02693418|10044637|FG002|NOT COMPLETED|Overall Study||2
8981457|NCT02693418|10044638|FG003|NOT COMPLETED|Overall Study||0
8981458|NCT02693418|10044639|FG004|NOT COMPLETED|Overall Study||0
8981459|NCT02693704|10044655|FG000|STARTED|Overall Study||10
8981460|NCT02693704|10044656|FG001|STARTED|Overall Study||10
8981461|NCT02693704|10044657|FG002|STARTED|Overall Study||10
8981462|NCT02693704|10044658|FG003|STARTED|Overall Study||10
8981463|NCT02693704|10044655|FG000|COMPLETED|Overall Study||10
8981464|NCT02693704|10044656|FG001|COMPLETED|Overall Study||10
8981465|NCT02693704|10044657|FG002|COMPLETED|Overall Study||10
8981466|NCT02693704|10044658|FG003|COMPLETED|Overall Study||10
8981467|NCT02693704|10044655|FG000|NOT COMPLETED|Overall Study||0
8981468|NCT02693704|10044656|FG001|NOT COMPLETED|Overall Study||0
8981469|NCT02693704|10044657|FG002|NOT COMPLETED|Overall Study||0
8981470|NCT02693704|10044658|FG003|NOT COMPLETED|Overall Study||0
8981471|NCT02693834|10044668|FG000|STARTED|Baseline Measurement|10 were randomized to PLS AFO first week group (2 dropped out at baseline)|12
8981472|NCT02693834|10044669|FG001|STARTED|Baseline Measurement|11 participants were assigned to DA AFO first group|11
8981473|NCT02693834|10044668|FG000|COMPLETED|Baseline Measurement|10 particiapnts completed wearing PLS AFO during the first week and 10 during the second week|10
8981474|NCT02693834|10044669|FG001|COMPLETED|Baseline Measurement|10 particiapnts completed wearing DA AFO during the first week and 10 the second week (1 was lost)|11
8981475|NCT02693834|10044668|FG000|NOT COMPLETED|Baseline Measurement||2
8981476|NCT02693834|10044669|FG001|NOT COMPLETED|Baseline Measurement||0
8981477|NCT02693834|10044668|FG000|STARTED|Week 1 Practice|During the first week of practice, 10 participants were assigned to PLS AFO group|10
8981478|NCT02693834|10044669|FG001|STARTED|Week 1 Practice|During the first week of practice, 11 participants were assigned to DAAFO group|11
8981479|NCT02693834|10044668|FG000|COMPLETED|Week 1 Practice||10
8981480|NCT02693834|10044669|FG001|COMPLETED|Week 1 Practice||11
8981481|NCT02693834|10044668|FG000|NOT COMPLETED|Week 1 Practice||0
8981482|NCT02693834|10044669|FG001|NOT COMPLETED|Week 1 Practice||0
8981483|NCT02693834|10044668|FG000|STARTED|Week 2 Practice||10
8981484|NCT02693834|10044669|FG001|STARTED|Week 2 Practice||11
8981485|NCT02693834|10044668|FG000|COMPLETED|Week 2 Practice||10
8981486|NCT02693834|10044669|FG001|COMPLETED|Week 2 Practice||10
8981487|NCT02693834|10044668|FG000|NOT COMPLETED|Week 2 Practice||0
8981488|NCT02693834|10044669|FG001|NOT COMPLETED|Week 2 Practice||1
8981489|NCT02694029|10044677|FG000|STARTED|Overall Study||5
8981490|NCT02694029|10044678|FG001|STARTED|Overall Study||5
8981491|NCT02694029|10044677|FG000|First Intervention|Overall Study||5
8981492|NCT02694029|10044678|FG001|First Intervention|Overall Study||5
8981493|NCT02694029|10044677|FG000|Second Intervention|Overall Study||5
8981494|NCT02694029|10044678|FG001|Second Intervention|Overall Study||5
8981495|NCT02694029|10044677|FG000|COMPLETED|Overall Study||5
8981496|NCT02694029|10044678|FG001|COMPLETED|Overall Study||5
8981497|NCT02694029|10044677|FG000|NOT COMPLETED|Overall Study||0
8981498|NCT02694029|10044678|FG001|NOT COMPLETED|Overall Study||0
8981499|NCT02694198|10044688|FG000|STARTED|Overall Study||135
8981500|NCT02694198|10044688|FG000|COMPLETED|Overall Study||135
8981501|NCT02694198|10044688|FG000|NOT COMPLETED|Overall Study||0
8981502|NCT02694315|10044692|FG000|STARTED|Overall Study||200
8981503|NCT02694315|10044692|FG000|COMPLETED|Overall Study||200
8981504|NCT02694315|10044692|FG000|NOT COMPLETED|Overall Study||0
8981505|NCT02694328|10044698|FG000|STARTED|Overall Study||276
8981506|NCT02694328|10044699|FG001|STARTED|Overall Study||274
8981507|NCT02694328|10044698|FG000|COMPLETED|Overall Study||176
8981508|NCT02694328|10044699|FG001|COMPLETED|Overall Study||176
8981509|NCT02694328|10044698|FG000|NOT COMPLETED|Overall Study||100
8981510|NCT02694328|10044699|FG001|NOT COMPLETED|Overall Study||98
8981511|NCT02694445|10044705|FG000|STARTED|Overall Study||3098
8981512|NCT02694445|10044705|FG000|COMPLETED|Overall Study||3046
8981513|NCT02694445|10044705|FG000|NOT COMPLETED|Overall Study||52
8981514|NCT02694523|10044711|FG000|STARTED|Part A||304
8981515|NCT02694523|10044712|FG001|STARTED|Part A||301
8981516|NCT02694523|10044713|FG002|STARTED|Part A||0
8981517|NCT02694523|10044714|FG003|STARTED|Part A||0
8981518|NCT02694523|10044715|FG004|STARTED|Part A||0
8981519|NCT02694523|10044716|FG005|STARTED|Part A||0
8981520|NCT02694523|10044717|FG006|STARTED|Part A||0
8981521|NCT02694523|10044711|FG000|COMPLETED|Part A||291
8981522|NCT02694523|10044712|FG001|COMPLETED|Part A||294
8981523|NCT02694523|10044713|FG002|COMPLETED|Part A||0
8981524|NCT02694523|10044714|FG003|COMPLETED|Part A||0
8981525|NCT02694523|10044715|FG004|COMPLETED|Part A||0
8981526|NCT02694523|10044716|FG005|COMPLETED|Part A||0
8981527|NCT02694523|10044717|FG006|COMPLETED|Part A||0
8981528|NCT02694523|10044711|FG000|NOT COMPLETED|Part A||13
8981529|NCT02694523|10044712|FG001|NOT COMPLETED|Part A||7
8981530|NCT02694523|10044713|FG002|NOT COMPLETED|Part A||0
8981531|NCT02694523|10044714|FG003|NOT COMPLETED|Part A||0
8981532|NCT02694523|10044715|FG004|NOT COMPLETED|Part A||0
8981533|NCT02694523|10044716|FG005|NOT COMPLETED|Part A||0
8981534|NCT02694523|10044717|FG006|NOT COMPLETED|Part A||0
8981535|NCT02694523|10044711|FG000|STARTED|Part B||0
8981536|NCT02694523|10044712|FG001|STARTED|Part B||0
8981537|NCT02694523|10044713|FG002|STARTED|Part B|Participants who received risankizumab in Part A continued to received risankizumab in Part B|294
8981538|NCT02694523|10044714|FG003|STARTED|Part B|Adalimumab responders in Part A continued to received adalimumab in Part B|144
8632544|NCT00545948|9672492|FG000|Assigned Treatment|Overall Study||9
8632545|NCT00545948|9672493|FG001|Assigned Treatment|Overall Study||15
8981539|NCT02694523|10044715|FG004|STARTED|Part B|Adalimumab nonresponders in Part A switched to risankizumab in Part B|38
8981540|NCT02694523|10044716|FG005|STARTED|Part B|Adalimumab inadequate responders in Part A, rerandomized to adalimumab in Part B|56
8981541|NCT02694523|10044717|FG006|STARTED|Part B|Adalimumab inadequate responders in Part A, rerandomized to risankizumab in Part B|53
8981542|NCT02694523|10044711|FG000|COMPLETED|Part B||0
8981543|NCT02694523|10044712|FG001|COMPLETED|Part B||0
8981544|NCT02694523|10044713|FG002|COMPLETED|Part B||274
8981545|NCT02694523|10044714|FG003|COMPLETED|Part B||140
8981546|NCT02694523|10044715|FG004|COMPLETED|Part B||34
8981547|NCT02694523|10044716|FG005|COMPLETED|Part B||51
8981548|NCT02694523|10044717|FG006|COMPLETED|Part B||51
8981549|NCT02694523|10044711|FG000|NOT COMPLETED|Part B||0
8981550|NCT02694523|10044712|FG001|NOT COMPLETED|Part B||0
8981551|NCT02694523|10044713|FG002|NOT COMPLETED|Part B||20
8981552|NCT02694523|10044714|FG003|NOT COMPLETED|Part B||4
8981553|NCT02694523|10044715|FG004|NOT COMPLETED|Part B||4
8981554|NCT02694523|10044716|FG005|NOT COMPLETED|Part B||5
8981555|NCT02694523|10044717|FG006|NOT COMPLETED|Part B||2
8981556|NCT02694536|10044729|FG000|STARTED|Overall Study||80
8981557|NCT02694536|10044729|FG000|COMPLETED|Overall Study||0
8981558|NCT02694536|10044729|FG000|NOT COMPLETED|Overall Study||80
8981559|NCT02694549|10044733|FG000|STARTED|Overall Study||12
8981560|NCT02694549|10044733|FG000|COMPLETED|Overall Study||10
8981561|NCT02694549|10044733|FG000|NOT COMPLETED|Overall Study||2
8981562|NCT02694562|10044737|FG000|STARTED|Overall Study||20
8981563|NCT02694562|10044737|FG000|COMPLETED|Overall Study||2
8981564|NCT02694562|10044737|FG000|NOT COMPLETED|Overall Study||18
8981565|NCT02694601|10044741|FG000|STARTED|Overall Study||10
8981566|NCT02694601|10044741|FG000|COMPLETED|Overall Study||10
8981567|NCT02694601|10044741|FG000|NOT COMPLETED|Overall Study||0
8981568|NCT02694718|10044745|FG000|STARTED|Overall Study||60
8981569|NCT02694718|10044745|FG000|COMPLETED|Overall Study||58
8571387|NCT00109850|9603649|FG000|NOT COMPLETED|Overall Study||4
8571388|NCT00109876|9603653|FG000|STARTED|Overall Study||51
8571389|NCT00109876|9603653|FG000|COMPLETED|Overall Study||51
8571390|NCT00109876|9603653|FG000|NOT COMPLETED|Overall Study||0
8571391|NCT00109928|9603657|FG000|STARTED|Overall Study||34
8571392|NCT00109928|9603657|FG000|Eligible|Overall Study||33
8571393|NCT00109928|9603657|FG000|Eligible and Began Protocol Therapy|Overall Study||33
8632546|NCT00545948|9672494|FG002|Assigned Treatment|Overall Study||0
8806545|NCT01478256|9858776|FG000|STARTED|Overall Study||15
8571394|NCT00109928|9603657|FG000|COMPLETED|Overall Study||21
8571395|NCT00109928|9603657|FG000|NOT COMPLETED|Overall Study||13
8571396|NCT00109967|9603664|FG000|STARTED|Overall Study||50
8571397|NCT00109967|9603665|FG001|STARTED|Overall Study||21
8571398|NCT00109967|9603664|FG000|COMPLETED|Overall Study||30
8571399|NCT00109967|9603665|FG001|COMPLETED|Overall Study||15
8571400|NCT00109967|9603664|FG000|NOT COMPLETED|Overall Study||20
8571401|NCT00109967|9603665|FG001|NOT COMPLETED|Overall Study||6
8571402|NCT00110019|9603673|FG000|STARTED|Overall Study||410
8571403|NCT00110019|9603674|FG001|STARTED|Overall Study||413
8571404|NCT00110019|9603673|FG000|Eligible|Overall Study||395
8571405|NCT00110019|9603674|FG001|Eligible|Overall Study||398
8571406|NCT00110019|9603673|FG000|Treated|Overall Study||393
8571407|NCT00110019|9603674|FG001|Treated|Overall Study||397
8571408|NCT00110019|9603673|FG000|COMPLETED|Overall Study||4
8571409|NCT00110019|9603674|FG001|COMPLETED|Overall Study||0
8571410|NCT00110019|9603673|FG000|NOT COMPLETED|Overall Study||406
8571411|NCT00110019|9603674|FG001|NOT COMPLETED|Overall Study||413
8571412|NCT00110084|9603680|FG000|STARTED|Overall Study||50
8571413|NCT00110084|9603680|FG000|COMPLETED|Overall Study||22
8571414|NCT00110084|9603680|FG000|NOT COMPLETED|Overall Study||28
8571415|NCT00110136|9603684|FG000|STARTED|Overall Study||9
8571416|NCT00110136|9603684|FG000|COMPLETED|Overall Study||9
8571417|NCT00110136|9603684|FG000|NOT COMPLETED|Overall Study||0
8571418|NCT00110149|9603689|FG000|STARTED|Overall Study|total number that signed consent to be screened.|12
8571419|NCT00110149|9603689|FG000|Received Treatment|Overall Study|total number of patient that passed screening and received treatment.|9
8571420|NCT00110149|9603689|FG000|COMPLETED|Overall Study||9
8571421|NCT00110149|9603689|FG000|NOT COMPLETED|Overall Study||3
8571422|NCT00110214|9603696|FG000|STARTED|Overall Study||526
8571423|NCT00110214|9603697|FG001|STARTED|Overall Study||524
8571424|NCT00110214|9603696|FG000|COMPLETED|Overall Study||17
8571425|NCT00110214|9603697|FG001|COMPLETED|Overall Study||21
8981570|NCT02694718|10044745|FG000|NOT COMPLETED|Overall Study||2
8981571|NCT02694744|10044751|FG000|STARTED|Overall Study||57
8571426|NCT00110214|9603696|FG000|NOT COMPLETED|Overall Study||509
8571427|NCT00110214|9603697|FG001|NOT COMPLETED|Overall Study||503
8571428|NCT00110266|9603703|FG000|STARTED|Overall Study||173
8571429|NCT00110266|9603703|FG000|COMPLETED|Overall Study||95
8691284|NCT00853957|9736511|FG000|NOT COMPLETED|Overall Study||14
8981572|NCT02694744|10044752|FG001|STARTED|Overall Study||57
8981573|NCT02694744|10044751|FG000|Safety Population|Overall Study||57
8981574|NCT02694744|10044752|FG001|Safety Population|Overall Study||56
8981575|NCT02694744|10044751|FG000|ITT|Overall Study||57
8981576|NCT02694744|10044752|FG001|ITT|Overall Study||55
8981577|NCT02694744|10044751|FG000|COMPLETED|Overall Study||51
8981578|NCT02694744|10044752|FG001|COMPLETED|Overall Study||52
8981579|NCT02694744|10044751|FG000|NOT COMPLETED|Overall Study||6
8981580|NCT02694744|10044752|FG001|NOT COMPLETED|Overall Study||5
8981581|NCT02694835|10044762|FG000|STARTED|Overall Study||41
8981582|NCT02694835|10044763|FG001|STARTED|Overall Study||39
8981583|NCT02694835|10044762|FG000|COMPLETED|Overall Study||41
8981584|NCT02694835|10044763|FG001|COMPLETED|Overall Study||39
8981585|NCT02694835|10044762|FG000|NOT COMPLETED|Overall Study||0
8981586|NCT02694835|10044763|FG001|NOT COMPLETED|Overall Study||0
8981587|NCT02694978|10044771|FG000|STARTED|Overall Study||1006
8981588|NCT02694978|10044772|FG001|STARTED|Overall Study||1008
8981589|NCT02694978|10044771|FG000|Received at Least 1 Dose of Study Drug|Overall Study||997
8981590|NCT02694978|10044772|FG001|Received at Least 1 Dose of Study Drug|Overall Study||1000
8981591|NCT02694978|10044771|FG000|COMPLETED|Overall Study||935
8981592|NCT02694978|10044772|FG001|COMPLETED|Overall Study||948
8981593|NCT02694978|10044771|FG000|NOT COMPLETED|Overall Study||71
8981594|NCT02694978|10044772|FG001|NOT COMPLETED|Overall Study||60
8981595|NCT02695290|10044778|FG000|STARTED|Overall Study||1
8981596|NCT02695290|10044778|FG000|COMPLETED|Overall Study||1
8981597|NCT02695290|10044778|FG000|NOT COMPLETED|Overall Study||0
8981598|NCT02695329|10044784|FG000|STARTED|Overall Study||50
8571430|NCT00110266|9603703|FG000|NOT COMPLETED|Overall Study||78
8981599|NCT02695329|10044785|FG001|STARTED|Overall Study||50
8981600|NCT02695329|10044784|FG000|COMPLETED|Overall Study||45
8981601|NCT02695329|10044785|FG001|COMPLETED|Overall Study||45
8981602|NCT02695329|10044784|FG000|NOT COMPLETED|Overall Study||5
8981603|NCT02695329|10044785|FG001|NOT COMPLETED|Overall Study||5
8981604|NCT02695420|10044795|FG000|STARTED|Overall Study||21
8981605|NCT02695420|10044796|FG001|STARTED|Overall Study||21
8981606|NCT02695420|10044797|FG002|STARTED|Overall Study||19
8981607|NCT02695420|10044798|FG003|STARTED|Overall Study||20
8981608|NCT02695420|10044795|FG000|COMPLETED|Overall Study||21
8981609|NCT02695420|10044796|FG001|COMPLETED|Overall Study||20
8981610|NCT02695420|10044797|FG002|COMPLETED|Overall Study||19
8981611|NCT02695420|10044798|FG003|COMPLETED|Overall Study||20
8981612|NCT02695420|10044795|FG000|NOT COMPLETED|Overall Study||0
8981613|NCT02695420|10044796|FG001|NOT COMPLETED|Overall Study||1
8981614|NCT02695420|10044797|FG002|NOT COMPLETED|Overall Study||0
8981615|NCT02695420|10044798|FG003|NOT COMPLETED|Overall Study||0
8981616|NCT02695446|10044811|FG000|STARTED|Overall Study||12
8981617|NCT02695446|10044811|FG000|COMPLETED|Overall Study||12
8981618|NCT02695446|10044811|FG000|NOT COMPLETED|Overall Study||0
8981619|NCT02695524|10044817|FG000|STARTED|Overall Study||30
8981620|NCT02695524|10044818|FG001|STARTED|Overall Study||30
8981621|NCT02695524|10044817|FG000|COMPLETED|Overall Study||27
8981622|NCT02695524|10044818|FG001|COMPLETED|Overall Study||27
8981623|NCT02695524|10044817|FG000|NOT COMPLETED|Overall Study||3
8981624|NCT02695524|10044818|FG001|NOT COMPLETED|Overall Study||3
8981625|NCT02695537|10044824|FG000|STARTED|Overall Study||89
8981626|NCT02695537|10044824|FG000|COMPLETED|Overall Study||51
8981627|NCT02695537|10044824|FG000|NOT COMPLETED|Overall Study||38
8981628|NCT02695628|10044828|FG000|STARTED|Overall Study||5
8981629|NCT02695628|10044828|FG000|COMPLETED|Overall Study||4
8981630|NCT02695628|10044828|FG000|NOT COMPLETED|Overall Study||1
8981631|NCT02695719|10044834|FG000|STARTED|Overall Study||74
8981632|NCT02695719|10044835|FG001|STARTED|Overall Study||82
8981633|NCT02695719|10044834|FG000|COMPLETED|Overall Study||71
8981634|NCT02695719|10044835|FG001|COMPLETED|Overall Study||72
8981635|NCT02695719|10044834|FG000|NOT COMPLETED|Overall Study||3
8981636|NCT02695719|10044835|FG001|NOT COMPLETED|Overall Study||10
8981637|NCT02696070|10044843|FG000|STARTED|Overall Study||8
8981638|NCT02696070|10044844|FG001|STARTED|Overall Study||14
8981639|NCT02696070|10044843|FG000|COMPLETED|Overall Study||7
8981640|NCT02696070|10044844|FG001|COMPLETED|Overall Study||12
8981641|NCT02696070|10044843|FG000|NOT COMPLETED|Overall Study||1
8981642|NCT02696070|10044844|FG001|NOT COMPLETED|Overall Study||2
8981643|NCT02696083|10044850|FG000|STARTED|Overall Study||19
8981644|NCT02696083|10044850|FG000|COMPLETED|Overall Study||13
8981645|NCT02696083|10044850|FG000|NOT COMPLETED|Overall Study||6
8981646|NCT02696200|10044861|FG000|STARTED|Overall Study||32
8981647|NCT02696200|10044862|FG001|STARTED|Overall Study||30
8981648|NCT02696200|10044861|FG000|COMPLETED|Overall Study||32
8981649|NCT02696200|10044862|FG001|COMPLETED|Overall Study||30
8981650|NCT02696200|10044861|FG000|NOT COMPLETED|Overall Study||0
8981651|NCT02696200|10044862|FG001|NOT COMPLETED|Overall Study||0
8981652|NCT02696291|10044870|FG000|STARTED|Overall Study||5
8981653|NCT02696291|10044871|FG001|STARTED|Overall Study||2
8981654|NCT02696291|10044870|FG000|COMPLETED|Overall Study||5
8981655|NCT02696291|10044871|FG001|COMPLETED|Overall Study||2
8981656|NCT02696291|10044870|FG000|NOT COMPLETED|Overall Study||0
8981657|NCT02696291|10044871|FG001|NOT COMPLETED|Overall Study||0
8981658|NCT02696317|10044877|FG000|STARTED|Habitual, 10 Days of Wear||42
8981659|NCT02696317|10044878|FG001|STARTED|Habitual, 10 Days of Wear||40
8981660|NCT02696317|10044877|FG000|COMPLETED|Habitual, 10 Days of Wear||40
8981661|NCT02696317|10044878|FG001|COMPLETED|Habitual, 10 Days of Wear||36
8981662|NCT02696317|10044877|FG000|NOT COMPLETED|Habitual, 10 Days of Wear||2
8981663|NCT02696317|10044878|FG001|NOT COMPLETED|Habitual, 10 Days of Wear||4
8981664|NCT02696317|10044877|FG000|STARTED|Period 1, 10 Days of Wear||40
8981665|NCT02696317|10044878|FG001|STARTED|Period 1, 10 Days of Wear||36
8981666|NCT02696317|10044877|FG000|COMPLETED|Period 1, 10 Days of Wear||40
8981667|NCT02696317|10044878|FG001|COMPLETED|Period 1, 10 Days of Wear||36
8981668|NCT02696317|10044877|FG000|NOT COMPLETED|Period 1, 10 Days of Wear||0
8981669|NCT02696317|10044878|FG001|NOT COMPLETED|Period 1, 10 Days of Wear||0
8981670|NCT02696317|10044877|FG000|STARTED|Period 2, 10 Days of Wear||40
8981671|NCT02696317|10044878|FG001|STARTED|Period 2, 10 Days of Wear||36
8981672|NCT02696317|10044877|FG000|COMPLETED|Period 2, 10 Days of Wear||39
8981673|NCT02696317|10044878|FG001|COMPLETED|Period 2, 10 Days of Wear||36
8981674|NCT02696317|10044877|FG000|NOT COMPLETED|Period 2, 10 Days of Wear||1
8981675|NCT02696317|10044878|FG001|NOT COMPLETED|Period 2, 10 Days of Wear||0
8981676|NCT02696434|10044888|FG000|STARTED|Overall Study||50
8981677|NCT02696434|10044889|FG001|STARTED|Overall Study||51
8981678|NCT02696434|10044888|FG000|COMPLETED|Overall Study||28
8981679|NCT02696434|10044889|FG001|COMPLETED|Overall Study||33
8981680|NCT02696434|10044888|FG000|NOT COMPLETED|Overall Study||22
8981681|NCT02696434|10044889|FG001|NOT COMPLETED|Overall Study||18
8981682|NCT02696785|10044899|FG000|STARTED|Blinded Treatment Period||87
8981683|NCT02696785|10044900|FG001|STARTED|Blinded Treatment Period||90
8981684|NCT02696785|10044901|FG002|STARTED|Blinded Treatment Period||83
8981685|NCT02696785|10044902|FG003|STARTED|Blinded Treatment Period||81
8981686|NCT02696785|10044899|FG000|Received at Least One Dose of Study Drug|Blinded Treatment Period||86
8981687|NCT02696785|10044900|FG001|Received at Least One Dose of Study Drug|Blinded Treatment Period||90
8981688|NCT02696785|10044901|FG002|Received at Least One Dose of Study Drug|Blinded Treatment Period||83
8981689|NCT02696785|10044902|FG003|Received at Least One Dose of Study Drug|Blinded Treatment Period||81
8632547|NCT00545948|9672492|FG000|COMPLETED|Overall Study|Patients who received vinorelbine + cisplatin protocol therapy.|8
8632548|NCT00545948|9672493|FG001|COMPLETED|Overall Study|Patients who received pemetrexed + cisplatin protocol therapy.|14
8632549|NCT00545948|9672494|FG002|COMPLETED|Overall Study||0
8632550|NCT00545948|9672492|FG000|NOT COMPLETED|Overall Study||1
8632551|NCT00545948|9672493|FG001|NOT COMPLETED|Overall Study||1
8632552|NCT00545948|9672494|FG002|NOT COMPLETED|Overall Study||7
8632553|NCT00545974|9672505|FG000|STARTED|Overall Study|subjects randomized to memantine cohort|39
8632554|NCT00545974|9672506|FG001|STARTED|Overall Study|subjects randomized to placebo cohort|42
8632555|NCT00545974|9672505|FG000|COMPLETED|Overall Study|subjects completed 26 weeks treatment in memantine cohort|37
8632556|NCT00545974|9672506|FG001|COMPLETED|Overall Study|subjects completed 26 weeks treatment in placebo cohort|39
8632557|NCT00545974|9672505|FG000|NOT COMPLETED|Overall Study||2
8632558|NCT00545974|9672506|FG001|NOT COMPLETED|Overall Study||3
8981690|NCT02696785|10044899|FG000|COMPLETED|Blinded Treatment Period||86
8981691|NCT02696785|10044900|FG001|COMPLETED|Blinded Treatment Period||88
8981692|NCT02696785|10044901|FG002|COMPLETED|Blinded Treatment Period||79
8981693|NCT02696785|10044902|FG003|COMPLETED|Blinded Treatment Period||78
8981694|NCT02696785|10044899|FG000|NOT COMPLETED|Blinded Treatment Period||1
8981695|NCT02696785|10044900|FG001|NOT COMPLETED|Blinded Treatment Period||2
8981696|NCT02696785|10044901|FG002|NOT COMPLETED|Blinded Treatment Period||4
8981697|NCT02696785|10044902|FG003|NOT COMPLETED|Blinded Treatment Period||3
8981698|NCT02696785|10044899|FG000|STARTED|Washout Period|Washout period occurred only for Adalimumab group.|0
8981699|NCT02696785|10044900|FG001|STARTED|Washout Period||88
8981700|NCT02696785|10044901|FG002|STARTED|Washout Period|Washout period occurred only for Adalimumab group.|0
8981701|NCT02696785|10044902|FG003|STARTED|Washout Period|Washout period occurred only for Adalimumab group.|0
8981702|NCT02696785|10044899|FG000|COMPLETED|Washout Period||0
8981703|NCT02696785|10044900|FG001|COMPLETED|Washout Period||86
8981704|NCT02696785|10044901|FG002|COMPLETED|Washout Period||0
8981705|NCT02696785|10044902|FG003|COMPLETED|Washout Period||0
8981706|NCT02696785|10044899|FG000|NOT COMPLETED|Washout Period||0
8981707|NCT02696785|10044900|FG001|NOT COMPLETED|Washout Period||2
8981708|NCT02696785|10044901|FG002|NOT COMPLETED|Washout Period||0
8981709|NCT02696785|10044902|FG003|NOT COMPLETED|Washout Period||0
8981710|NCT02696785|10044899|FG000|STARTED|Extended Treatment Period||86
8981711|NCT02696785|10044900|FG001|STARTED|Extended Treatment Period||86
8981712|NCT02696785|10044901|FG002|STARTED|Extended Treatment Period||79
8981713|NCT02696785|10044902|FG003|STARTED|Extended Treatment Period||78
8981714|NCT02696785|10044899|FG000|COMPLETED|Extended Treatment Period||83
8981715|NCT02696785|10044900|FG001|COMPLETED|Extended Treatment Period||80
8981716|NCT02696785|10044901|FG002|COMPLETED|Extended Treatment Period||74
8981717|NCT02696785|10044902|FG003|COMPLETED|Extended Treatment Period||72
8981718|NCT02696785|10044899|FG000|NOT COMPLETED|Extended Treatment Period||3
8981719|NCT02696785|10044900|FG001|NOT COMPLETED|Extended Treatment Period||6
8981720|NCT02696785|10044901|FG002|NOT COMPLETED|Extended Treatment Period||5
8981721|NCT02696785|10044902|FG003|NOT COMPLETED|Extended Treatment Period||6
8981722|NCT02696785|10044899|FG000|STARTED|Follow-up Period|Participants who completed study were eligible to enroll RHBY & who didn't enroll entered Follow-Up.|1
8981723|NCT02696785|10044900|FG001|STARTED|Follow-up Period|Participants who completed study were eligible to enroll RHBY & who didn't enroll entered Follow-Up.|0
8981724|NCT02696785|10044901|FG002|STARTED|Follow-up Period|Participants who completed study were eligible to enroll RHBY & who didn't enroll entered Follow-Up.|24
8981725|NCT02696785|10044902|FG003|STARTED|Follow-up Period|Participants who completed study were eligible to enroll RHBY & who didn't enroll entered Follow-Up.|16
8981726|NCT02696785|10044899|FG000|COMPLETED|Follow-up Period||0
8981727|NCT02696785|10044900|FG001|COMPLETED|Follow-up Period||0
8981728|NCT02696785|10044901|FG002|COMPLETED|Follow-up Period||11
8981729|NCT02696785|10044902|FG003|COMPLETED|Follow-up Period||8
8981730|NCT02696785|10044899|FG000|NOT COMPLETED|Follow-up Period||1
8981731|NCT02696785|10044900|FG001|NOT COMPLETED|Follow-up Period||0
8981732|NCT02696785|10044901|FG002|NOT COMPLETED|Follow-up Period||13
8981733|NCT02696785|10044902|FG003|NOT COMPLETED|Follow-up Period||8
8981734|NCT02696798|10044933|FG000|STARTED|Blinded Treatment Dosing Period||104
8981735|NCT02696798|10044934|FG001|STARTED|Blinded Treatment Dosing Period||114
8981736|NCT02696798|10044935|FG002|STARTED|Blinded Treatment Dosing Period||98
8981737|NCT02696798|10044933|FG000|COMPLETED|Blinded Treatment Dosing Period||93
8981738|NCT02696798|10044934|FG001|COMPLETED|Blinded Treatment Dosing Period||99
8981739|NCT02696798|10044935|FG002|COMPLETED|Blinded Treatment Dosing Period||90
8981740|NCT02696798|10044933|FG000|NOT COMPLETED|Blinded Treatment Dosing Period||11
8981741|NCT02696798|10044934|FG001|NOT COMPLETED|Blinded Treatment Dosing Period||15
8981742|NCT02696798|10044935|FG002|NOT COMPLETED|Blinded Treatment Dosing Period||8
8981743|NCT02696798|10044933|FG000|STARTED|Extended Treatment Period||93
8981744|NCT02696798|10044934|FG001|STARTED|Extended Treatment Period|1 participant completed blinded treatment period and entered post-treatment followup period directly|98
8981745|NCT02696798|10044935|FG002|STARTED|Extended Treatment Period||90
8981746|NCT02696798|10044933|FG000|COMPLETED|Extended Treatment Period||81
8981747|NCT02696798|10044934|FG001|COMPLETED|Extended Treatment Period||89
8981748|NCT02696798|10044935|FG002|COMPLETED|Extended Treatment Period||80
8981749|NCT02696798|10044933|FG000|NOT COMPLETED|Extended Treatment Period||12
8981750|NCT02696798|10044934|FG001|NOT COMPLETED|Extended Treatment Period||9
8981751|NCT02696798|10044935|FG002|NOT COMPLETED|Extended Treatment Period||10
8632559|NCT00546000|9672512|FG000|STARTED|Overall Study||56
8806546|NCT01478256|9858777|FG001|STARTED|Overall Study||15
8981752|NCT02696798|10044933|FG000|STARTED|Post-treatment Follow-up Period|Participants who terminate RHBW early or who didn't enroll into RHBY entered Follow-Up Period.|5
8981753|NCT02696798|10044934|FG001|STARTED|Post-treatment Follow-up Period|Participants who terminate RHBW early or who didn't enroll into RHBY entered Follow-Up Period.|34
8981754|NCT02696798|10044935|FG002|STARTED|Post-treatment Follow-up Period|Participants who terminate RHBW early or who didn't enroll into RHBY entered Follow-Up Period.|22
8981755|NCT02696798|10044933|FG000|COMPLETED|Post-treatment Follow-up Period||0
8981756|NCT02696798|10044934|FG001|COMPLETED|Post-treatment Follow-up Period||8
8981757|NCT02696798|10044935|FG002|COMPLETED|Post-treatment Follow-up Period||3
8981758|NCT02696798|10044933|FG000|NOT COMPLETED|Post-treatment Follow-up Period||5
8981759|NCT02696798|10044934|FG001|NOT COMPLETED|Post-treatment Follow-up Period||26
8981760|NCT02696798|10044935|FG002|NOT COMPLETED|Post-treatment Follow-up Period||19
8981761|NCT02696850|10044959|FG000|STARTED|Overall Study||40
8981762|NCT02696850|10044960|FG001|STARTED|Overall Study||40
8981763|NCT02696850|10044959|FG000|COMPLETED|Overall Study||29
8981764|NCT02696850|10044960|FG001|COMPLETED|Overall Study||32
8981765|NCT02696850|10044959|FG000|NOT COMPLETED|Overall Study||11
8981766|NCT02696850|10044960|FG001|NOT COMPLETED|Overall Study||8
8981767|NCT02696902|10044969|FG000|STARTED|Overall Study||85
8981768|NCT02696902|10044970|FG001|STARTED|Overall Study||16
8981769|NCT02696902|10044971|FG002|STARTED|Overall Study||87
8981770|NCT02696902|10044969|FG000|Treated|Overall Study||83
8981771|NCT02696902|10044970|FG001|Treated|Overall Study||16
8981772|NCT02696902|10044971|FG002|Treated|Overall Study||85
8981773|NCT02696902|10044969|FG000|Intent-to-treat (ITT) Population|Overall Study||85
8981774|NCT02696902|10044970|FG001|Intent-to-treat (ITT) Population|Overall Study||16
8981775|NCT02696902|10044971|FG002|Intent-to-treat (ITT) Population|Overall Study||87
8981776|NCT02696902|10044969|FG000|As-treated Population|Overall Study||83
8981777|NCT02696902|10044970|FG001|As-treated Population|Overall Study||16
8981778|NCT02696902|10044971|FG002|As-treated Population|Overall Study||85
8981779|NCT02696902|10044969|FG000|Modified Intent-to-treat (mITT) Population|Overall Study||83
8981780|NCT02696902|10044970|FG001|Modified Intent-to-treat (mITT) Population|Overall Study||16
8981781|NCT02696902|10044971|FG002|Modified Intent-to-treat (mITT) Population|Overall Study||85
8981782|NCT02696902|10044969|FG000|COMPLETED|Overall Study||63
8981783|NCT02696902|10044970|FG001|COMPLETED|Overall Study||12
8981784|NCT02696902|10044971|FG002|COMPLETED|Overall Study||59
8981785|NCT02696902|10044969|FG000|NOT COMPLETED|Overall Study||22
8981786|NCT02696902|10044970|FG001|NOT COMPLETED|Overall Study||4
8981787|NCT02696902|10044971|FG002|NOT COMPLETED|Overall Study||28
8981788|NCT02696967|10044985|FG000|STARTED|Overall Study||4
8981789|NCT02696967|10044986|FG001|STARTED|Overall Study||6
8981790|NCT02696967|10044987|FG002|STARTED|Overall Study||6
8981791|NCT02696967|10044988|FG003|STARTED|Overall Study||10
8981792|NCT02696967|10044985|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||4
8981793|NCT02696967|10044986|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||6
8981794|NCT02696967|10044987|FG002|Pharmacokinetic (PK) Analysis Set|Overall Study||4
8981795|NCT02696967|10044988|FG003|Pharmacokinetic (PK) Analysis Set|Overall Study||0
8981796|NCT02696967|10044985|FG000|COMPLETED|Overall Study||4
8981797|NCT02696967|10044986|FG001|COMPLETED|Overall Study||6
8981798|NCT02696967|10044987|FG002|COMPLETED|Overall Study||6
8981799|NCT02696967|10044988|FG003|COMPLETED|Overall Study||10
8981800|NCT02696967|10044985|FG000|NOT COMPLETED|Overall Study||0
8981801|NCT02696967|10044986|FG001|NOT COMPLETED|Overall Study||0
8981802|NCT02696967|10044987|FG002|NOT COMPLETED|Overall Study||0
8981803|NCT02696967|10044988|FG003|NOT COMPLETED|Overall Study||0
8981804|NCT02697071|10045000|FG000|STARTED|Overall Study||18
8981805|NCT02697071|10045001|FG001|STARTED|Overall Study||16
8981806|NCT02697071|10045000|FG000|COMPLETED|Overall Study||18
8981807|NCT02697071|10045001|FG001|COMPLETED|Overall Study||16
8981808|NCT02697071|10045000|FG000|NOT COMPLETED|Overall Study||0
8981809|NCT02697071|10045001|FG001|NOT COMPLETED|Overall Study||0
8981810|NCT02697188|10045007|FG000|STARTED|TE Period 1 - 400 mg QD||12
8981811|NCT02697188|10045007|FG000|COMPLETED|TE Period 1 - 400 mg QD||12
8981812|NCT02697188|10045007|FG000|NOT COMPLETED|TE Period 1 - 400 mg QD||0
8981813|NCT02697188|10045007|FG000|STARTED|TU Period 2 - 200 mg QD||12
8981814|NCT02697188|10045007|FG000|COMPLETED|TU Period 2 - 200 mg QD||12
8981815|NCT02697188|10045007|FG000|NOT COMPLETED|TU Period 2 - 200 mg QD||0
8981816|NCT02697188|10045007|FG000|STARTED|TU Period 3 - 200 mg BID||12
8981817|NCT02697188|10045007|FG000|COMPLETED|TU Period 3 - 200 mg BID||12
8981818|NCT02697188|10045007|FG000|NOT COMPLETED|TU Period 3 - 200 mg BID||0
8981819|NCT02697188|10045007|FG000|STARTED|TU Period 4 - 400 BID||12
8981820|NCT02697188|10045007|FG000|COMPLETED|TU Period 4 - 400 BID||12
8981821|NCT02697188|10045007|FG000|NOT COMPLETED|TU Period 4 - 400 BID||0
8981822|NCT02697188|10045007|FG000|STARTED|TE Period 5 - 800 mg BID||12
8981823|NCT02697188|10045007|FG000|COMPLETED|TE Period 5 - 800 mg BID||12
8981824|NCT02697188|10045007|FG000|NOT COMPLETED|TE Period 5 - 800 mg BID||0
8981825|NCT02697214|10045019|FG000|STARTED|Overall Study||26
8981826|NCT02697214|10045020|FG001|STARTED|Overall Study||25
8981827|NCT02697214|10045021|FG002|STARTED|Overall Study||25
8571431|NCT00110305|9603712|FG000|STARTED|Overall Study||279
8981828|NCT02697214|10045022|FG003|STARTED|Overall Study||24
8981829|NCT02697214|10045023|FG004|STARTED|Overall Study||50
8981830|NCT02697214|10045024|FG005|STARTED|Overall Study||50
8571432|NCT00110305|9603713|FG001|STARTED|Overall Study||89
8571433|NCT00110305|9603712|FG000|COMPLETED|Overall Study||165
8571434|NCT00110305|9603713|FG001|COMPLETED|Overall Study||57
8981831|NCT02697214|10045019|FG000|Heart Rate at 2mph|Overall Study||26
8981832|NCT02697214|10045020|FG001|Heart Rate at 2mph|Overall Study||25
8981833|NCT02697214|10045021|FG002|Heart Rate at 2mph|Overall Study||25
8981834|NCT02697214|10045022|FG003|Heart Rate at 2mph|Overall Study||24
8981835|NCT02697214|10045023|FG004|Heart Rate at 2mph|Overall Study||50
8981836|NCT02697214|10045024|FG005|Heart Rate at 2mph|Overall Study||50
8981837|NCT02697214|10045019|FG000|Heart Rate at 3mph|Overall Study||26
8981838|NCT02697214|10045020|FG001|Heart Rate at 3mph|Overall Study||25
8981839|NCT02697214|10045021|FG002|Heart Rate at 3mph|Overall Study||25
8981840|NCT02697214|10045022|FG003|Heart Rate at 3mph|Overall Study||24
8981841|NCT02697214|10045023|FG004|Heart Rate at 3mph|Overall Study||50
8981842|NCT02697214|10045024|FG005|Heart Rate at 3mph|Overall Study||50
8981843|NCT02697214|10045019|FG000|Heart Rate at 4mph|Overall Study||26
8981844|NCT02697214|10045020|FG001|Heart Rate at 4mph|Overall Study||25
8981845|NCT02697214|10045021|FG002|Heart Rate at 4mph|Overall Study||25
8981846|NCT02697214|10045022|FG003|Heart Rate at 4mph|Overall Study||24
8981847|NCT02697214|10045023|FG004|Heart Rate at 4mph|Overall Study||50
8981848|NCT02697214|10045024|FG005|Heart Rate at 4mph|Overall Study||50
8981849|NCT02697214|10045019|FG000|Heart Rate at 6mph|Overall Study||26
8981850|NCT02697214|10045020|FG001|Heart Rate at 6mph|Overall Study||25
8981851|NCT02697214|10045021|FG002|Heart Rate at 6mph|Overall Study||25
8981852|NCT02697214|10045022|FG003|Heart Rate at 6mph|Overall Study||24
8981853|NCT02697214|10045023|FG004|Heart Rate at 6mph|Overall Study||50
8981854|NCT02697214|10045024|FG005|Heart Rate at 6mph|Overall Study||50
8981855|NCT02697214|10045019|FG000|COMPLETED|Overall Study||26
8981856|NCT02697214|10045020|FG001|COMPLETED|Overall Study||25
8981857|NCT02697214|10045021|FG002|COMPLETED|Overall Study||25
8981858|NCT02697214|10045022|FG003|COMPLETED|Overall Study||24
8981859|NCT02697214|10045023|FG004|COMPLETED|Overall Study||50
8981860|NCT02697214|10045024|FG005|COMPLETED|Overall Study||50
8981861|NCT02697214|10045019|FG000|NOT COMPLETED|Overall Study||0
8981862|NCT02697214|10045020|FG001|NOT COMPLETED|Overall Study||0
8981863|NCT02697214|10045021|FG002|NOT COMPLETED|Overall Study||0
8981864|NCT02697214|10045022|FG003|NOT COMPLETED|Overall Study||0
8981865|NCT02697214|10045023|FG004|NOT COMPLETED|Overall Study||0
8981866|NCT02697214|10045024|FG005|NOT COMPLETED|Overall Study||0
8981867|NCT02697240|10045034|FG000|STARTED|Overall Study||4
8981868|NCT02697240|10045034|FG000|COMPLETED|Overall Study||4
8981869|NCT02697240|10045034|FG000|NOT COMPLETED|Overall Study||0
8981870|NCT02697292|10045040|FG000|STARTED|Overall Study||9
8981871|NCT02697292|10045041|FG001|STARTED|Overall Study||8
8981872|NCT02697292|10045040|FG000|COMPLETED|Overall Study||9
8981873|NCT02697292|10045041|FG001|COMPLETED|Overall Study||8
8981874|NCT02697292|10045040|FG000|NOT COMPLETED|Overall Study||0
8981875|NCT02697292|10045041|FG001|NOT COMPLETED|Overall Study||0
8981876|NCT02697435|10045050|FG000|STARTED|Overall Study||25
8981877|NCT02697435|10045051|FG001|STARTED|Overall Study||30
8981878|NCT02697435|10045050|FG000|COMPLETED|Overall Study||24
8981879|NCT02697435|10045051|FG001|COMPLETED|Overall Study||26
8981880|NCT02697435|10045050|FG000|NOT COMPLETED|Overall Study||1
8981881|NCT02697435|10045051|FG001|NOT COMPLETED|Overall Study||4
8981882|NCT02697591|10045068|FG000|STARTED|Overall Study||4
8981883|NCT02697591|10045069|FG001|STARTED|Overall Study||4
8981884|NCT02697591|10045070|FG002|STARTED|Overall Study||4
8981885|NCT02697591|10045071|FG003|STARTED|Overall Study||3
8981886|NCT02697591|10045072|FG004|STARTED|Overall Study||15
8981887|NCT02697591|10045073|FG005|STARTED|Overall Study||18
8981888|NCT02697591|10045074|FG006|STARTED|Overall Study||16
8981889|NCT02697591|10045075|FG007|STARTED|Overall Study||4
8981890|NCT02697591|10045076|FG008|STARTED|Overall Study||10
8981891|NCT02697591|10045077|FG009|STARTED|Overall Study||22
8981892|NCT02697591|10045068|FG000|COMPLETED|Overall Study||0
8981893|NCT02697591|10045069|FG001|COMPLETED|Overall Study||0
8981894|NCT02697591|10045070|FG002|COMPLETED|Overall Study||1
8981895|NCT02697591|10045071|FG003|COMPLETED|Overall Study||0
8981896|NCT02697591|10045072|FG004|COMPLETED|Overall Study||2
8981897|NCT02697591|10045073|FG005|COMPLETED|Overall Study||2
8981898|NCT02697591|10045074|FG006|COMPLETED|Overall Study||0
8981899|NCT02697591|10045075|FG007|COMPLETED|Overall Study||1
8981900|NCT02697591|10045076|FG008|COMPLETED|Overall Study||1
8981901|NCT02697591|10045077|FG009|COMPLETED|Overall Study||2
8981902|NCT02697591|10045068|FG000|NOT COMPLETED|Overall Study||4
8981903|NCT02697591|10045069|FG001|NOT COMPLETED|Overall Study||4
8981904|NCT02697591|10045070|FG002|NOT COMPLETED|Overall Study||3
8981905|NCT02697591|10045071|FG003|NOT COMPLETED|Overall Study||3
8981906|NCT02697591|10045072|FG004|NOT COMPLETED|Overall Study||13
8981907|NCT02697591|10045073|FG005|NOT COMPLETED|Overall Study||16
8981908|NCT02697591|10045074|FG006|NOT COMPLETED|Overall Study||16
8981909|NCT02697591|10045075|FG007|NOT COMPLETED|Overall Study||3
8981910|NCT02697591|10045076|FG008|NOT COMPLETED|Overall Study||9
8981911|NCT02697591|10045077|FG009|NOT COMPLETED|Overall Study||20
8981912|NCT02697617|10045100|FG000|STARTED|Overall Study||9
8981913|NCT02697617|10045101|FG001|STARTED|Overall Study||9
8981914|NCT02697617|10045100|FG000|COMPLETED|Overall Study|15 completed both arms|8
8981915|NCT02697617|10045101|FG001|COMPLETED|Overall Study||7
8981916|NCT02697617|10045100|FG000|NOT COMPLETED|Overall Study||1
8981917|NCT02697617|10045101|FG001|NOT COMPLETED|Overall Study||2
8981918|NCT02697734|10045113|FG000|STARTED|Core Phase - up to Week 48||48
8981919|NCT02697734|10045114|FG001|STARTED|Core Phase - up to Week 48||25
8981920|NCT02697734|10045113|FG000|COMPLETED|Core Phase - up to Week 48||42
8981921|NCT02697734|10045114|FG001|COMPLETED|Core Phase - up to Week 48||23
8981922|NCT02697734|10045113|FG000|NOT COMPLETED|Core Phase - up to Week 48||6
8981923|NCT02697734|10045114|FG001|NOT COMPLETED|Core Phase - up to Week 48||2
8981924|NCT02697734|10045113|FG000|STARTED|Optional Extension Phase||38
8981925|NCT02697734|10045114|FG001|STARTED|Optional Extension Phase||22
8981926|NCT02697734|10045113|FG000|COMPLETED|Optional Extension Phase||33
8981927|NCT02697734|10045114|FG001|COMPLETED|Optional Extension Phase||20
8981928|NCT02697734|10045113|FG000|NOT COMPLETED|Optional Extension Phase||5
8981929|NCT02697734|10045114|FG001|NOT COMPLETED|Optional Extension Phase||2
8981930|NCT02697773|10045131|FG000|STARTED|Overall Study||233
8981931|NCT02697773|10045132|FG001|STARTED|Overall Study||232
8981932|NCT02697773|10045133|FG002|STARTED|Overall Study||233
8981933|NCT02697773|10045131|FG000|Treated|Overall Study||232
8981934|NCT02697773|10045132|FG001|Treated|Overall Study||231
8981935|NCT02697773|10045133|FG002|Treated|Overall Study||233
8981936|NCT02697773|10045131|FG000|COMPLETED|Overall Study||195
8981937|NCT02697773|10045132|FG001|COMPLETED|Overall Study||194
8981938|NCT02697773|10045133|FG002|COMPLETED|Overall Study||193
8981939|NCT02697773|10045131|FG000|NOT COMPLETED|Overall Study||38
8981940|NCT02697773|10045132|FG001|NOT COMPLETED|Overall Study||38
8981941|NCT02697773|10045133|FG002|NOT COMPLETED|Overall Study||40
8981942|NCT02697890|10045143|FG000|STARTED|Overall Study||14
8981943|NCT02697890|10045144|FG001|STARTED|Overall Study||14
8981944|NCT02697890|10045143|FG000|COMPLETED|Overall Study||14
8981945|NCT02697890|10045144|FG001|COMPLETED|Overall Study||14
8981946|NCT02697890|10045143|FG000|NOT COMPLETED|Overall Study||0
8981947|NCT02697890|10045144|FG001|NOT COMPLETED|Overall Study||0
8981948|NCT02697916|10045152|FG000|STARTED|Overall Study||7540
8981949|NCT02697916|10045153|FG001|STARTED|Overall Study||7536
8981950|NCT02697916|10045152|FG000|COMPLETED|Overall Study||6962
8981951|NCT02697916|10045153|FG001|COMPLETED|Overall Study||6828
8981952|NCT02697916|10045152|FG000|NOT COMPLETED|Overall Study||578
8981953|NCT02697916|10045153|FG001|NOT COMPLETED|Overall Study||708
8981954|NCT02698033|10045159|FG000|STARTED|Overall Study||7
8981955|NCT02698033|10045159|FG000|COMPLETED|Overall Study||6
8981956|NCT02698033|10045159|FG000|NOT COMPLETED|Overall Study||1
8981957|NCT02698176|10045166|FG000|STARTED|Overall Study||9
8981958|NCT02698176|10045167|FG001|STARTED|Overall Study||3
8981959|NCT02698176|10045168|FG002|STARTED|Overall Study||1
8981960|NCT02698176|10045169|FG003|STARTED|Overall Study|No participants were enrolled in Part B.|0
8981961|NCT02698176|10045166|FG000|COMPLETED|Overall Study||0
8981962|NCT02698176|10045167|FG001|COMPLETED|Overall Study||0
8981963|NCT02698176|10045168|FG002|COMPLETED|Overall Study||0
8981964|NCT02698176|10045169|FG003|COMPLETED|Overall Study||0
8981965|NCT02698176|10045166|FG000|NOT COMPLETED|Overall Study||9
8981966|NCT02698176|10045167|FG001|NOT COMPLETED|Overall Study||3
8981967|NCT02698176|10045168|FG002|NOT COMPLETED|Overall Study||1
8981968|NCT02698176|10045169|FG003|NOT COMPLETED|Overall Study||0
8981969|NCT02698189|10045182|FG000|STARTED|Overall Study||3
8981970|NCT02698189|10045183|FG001|STARTED|Overall Study||6
8981971|NCT02698189|10045182|FG000|COMPLETED|Overall Study||0
8981972|NCT02698189|10045183|FG001|COMPLETED|Overall Study||0
8981973|NCT02698189|10045182|FG000|NOT COMPLETED|Overall Study||3
8981974|NCT02698189|10045183|FG001|NOT COMPLETED|Overall Study||6
8981975|NCT02698215|10045193|FG000|STARTED|Overall Study||83
8981976|NCT02698215|10045194|FG001|STARTED|Overall Study||82
8981977|NCT02698215|10045193|FG000|COMPLETED|Overall Study||55
8981978|NCT02698215|10045194|FG001|COMPLETED|Overall Study||64
8981979|NCT02698215|10045193|FG000|NOT COMPLETED|Overall Study||28
8981980|NCT02698215|10045194|FG001|NOT COMPLETED|Overall Study||18
8981981|NCT02698241|10045200|FG000|STARTED|Overall Study|Number of subjects enrolled the study|79
8981982|NCT02698241|10045200|FG000|Baseline & Programming|Overall Study|Number of subjects that passed screening and completed baseline and programming visit|66
8981983|NCT02698241|10045200|FG000|COMPLETED|Overall Study|Number of subjects completed the study (no early exit or death)|45
8981984|NCT02698241|10045200|FG000|NOT COMPLETED|Overall Study||34
8981985|NCT02698371|10045204|FG000|STARTED|All Participants Flow||38
8981986|NCT02698371|10045204|FG000|COMPLETED|All Participants Flow||35
8981987|NCT02698371|10045204|FG000|NOT COMPLETED|All Participants Flow||3
8981988|NCT02698371|10045204|FG000|STARTED|FBDC-SE (G1; Control) Arm/Group Flow|Each participant received one NCCLs restoration with FBDC-SE (G1control Arm/Group).|35
8981989|NCT02698371|10045204|FG000|COMPLETED|FBDC-SE (G1; Control) Arm/Group Flow||32
8981990|NCT02698371|10045204|FG000|NOT COMPLETED|FBDC-SE (G1; Control) Arm/Group Flow||3
8981991|NCT02698371|10045204|FG000|STARTED|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Each participant received one NCCLs restoration with FBDC-SE-EE (G2 control Arm/group)|35
8981992|NCT02698371|10045204|FG000|COMPLETED|FBDC-SE-EE (G2; Control ) Arm/Group Flow||32
8981993|NCT02698371|10045204|FG000|NOT COMPLETED|FBDC-SE-EE (G2; Control ) Arm/Group Flow||3
8981994|NCT02698371|10045204|FG000|STARTED|FBU-ER (G3) Arm/Group Flow|Each participant received one NCCLs restoration with FBU-ER (G3 Arm/group)|35
8981995|NCT02698371|10045204|FG000|COMPLETED|FBU-ER (G3) Arm/Group Flow||32
8981996|NCT02698371|10045204|FG000|NOT COMPLETED|FBU-ER (G3) Arm/Group Flow||3
8981997|NCT02698371|10045204|FG000|STARTED|FBU-SE (G4) Arm/Group Flow|Each participant received one NCCLs restoration with FBU-SE (G4 Arm/group)|35
8981998|NCT02698371|10045204|FG000|COMPLETED|FBU-SE (G4) Arm/Group Flow||32
8981999|NCT02698371|10045204|FG000|NOT COMPLETED|FBU-SE (G4) Arm/Group Flow||3
8982000|NCT02698371|10045204|FG000|STARTED|ADU-ER (G5) Arm/Group Flow|Each participant received one NCCLs restoration with ADU-ER (G5 Arm/group)|35
8982001|NCT02698371|10045204|FG000|COMPLETED|ADU-ER (G5) Arm/Group Flow||32
8982002|NCT02698371|10045204|FG000|NOT COMPLETED|ADU-ER (G5) Arm/Group Flow||3
8982003|NCT02698371|10045204|FG000|STARTED|ADU-SE (G6) Arm/Group Flow|Each participant received one NCCLs restoration with ADU-SE (G6 Arm/group)|35
8982004|NCT02698371|10045204|FG000|COMPLETED|ADU-SE (G6) Arm/Group Flow||33
8982005|NCT02698371|10045204|FG000|NOT COMPLETED|ADU-SE (G6) Arm/Group Flow||2
8982006|NCT02698410|10045220|FG000|STARTED|Overall Study||40
8982007|NCT02698410|10045220|FG000|COMPLETED|Overall Study||36
8982008|NCT02698410|10045220|FG000|NOT COMPLETED|Overall Study||4
8982009|NCT02698423|10045226|FG000|STARTED|Overall Study||336
8982010|NCT02698423|10045227|FG001|STARTED|Overall Study||331
8982011|NCT02698423|10045226|FG000|COMPLETED|Overall Study||317
8982012|NCT02698423|10045227|FG001|COMPLETED|Overall Study||307
8982013|NCT02698423|10045226|FG000|NOT COMPLETED|Overall Study||19
8982014|NCT02698423|10045227|FG001|NOT COMPLETED|Overall Study||24
8982015|NCT02698436|10045237|FG000|STARTED|Overall Study||59
8982016|NCT02698436|10045238|FG001|STARTED|Overall Study||58
8982017|NCT02698436|10045237|FG000|COMPLETED|Overall Study||52
8982018|NCT02698436|10045238|FG001|COMPLETED|Overall Study||51
8982019|NCT02698436|10045237|FG000|NOT COMPLETED|Overall Study||7
8982020|NCT02698436|10045238|FG001|NOT COMPLETED|Overall Study||7
8982021|NCT02698475|10045244|FG000|STARTED|Main Study Period||44
8982022|NCT02698475|10045244|FG000|COMPLETED|Main Study Period||41
8982023|NCT02698475|10045244|FG000|NOT COMPLETED|Main Study Period||3
8982024|NCT02698475|10045244|FG000|STARTED|Long-Term Extension Period|13 participants did not enter the long-term extension period.|28
8982025|NCT02698475|10045244|FG000|COMPLETED|Long-Term Extension Period||0
8982026|NCT02698475|10045244|FG000|NOT COMPLETED|Long-Term Extension Period||28
8982027|NCT02698566|10045251|FG000|STARTED|Overall Study||35
8982028|NCT02698566|10045252|FG001|STARTED|Overall Study||3
8982029|NCT02698566|10045251|FG000|COMPLETED|Overall Study||35
8982030|NCT02698566|10045252|FG001|COMPLETED|Overall Study||3
8982031|NCT02698566|10045251|FG000|NOT COMPLETED|Overall Study||0
8982032|NCT02698566|10045252|FG001|NOT COMPLETED|Overall Study||0
8982033|NCT02698735|10045256|FG000|STARTED|Overall Study||5
8982034|NCT02698735|10045256|FG000|COMPLETED|Overall Study|There are only 18 out of 20 samples because one patient declined intradermal injection intervention.|5
8982035|NCT02698735|10045256|FG000|NOT COMPLETED|Overall Study||0
8982036|NCT02698787|10045268|FG000|STARTED|First Intervention (3 Months)||6
8982037|NCT02698787|10045269|FG001|STARTED|First Intervention (3 Months)||5
8982038|NCT02698787|10045268|FG000|COMPLETED|First Intervention (3 Months)||6
8982039|NCT02698787|10045269|FG001|COMPLETED|First Intervention (3 Months)||5
8982040|NCT02698787|10045268|FG000|NOT COMPLETED|First Intervention (3 Months)||0
8982041|NCT02698787|10045269|FG001|NOT COMPLETED|First Intervention (3 Months)||0
8982042|NCT02698787|10045268|FG000|STARTED|Second Intervention (3 Months)||6
8982043|NCT02698787|10045269|FG001|STARTED|Second Intervention (3 Months)||5
8982044|NCT02698787|10045268|FG000|COMPLETED|Second Intervention (3 Months)||6
8982045|NCT02698787|10045269|FG001|COMPLETED|Second Intervention (3 Months)||4
8982046|NCT02698787|10045268|FG000|NOT COMPLETED|Second Intervention (3 Months)||0
8982047|NCT02698787|10045269|FG001|NOT COMPLETED|Second Intervention (3 Months)||1
8982048|NCT02698800|10045276|FG000|STARTED|Overall Study||7
8982049|NCT02698800|10045277|FG001|STARTED|Overall Study||8
8982050|NCT02698800|10045276|FG000|COMPLETED|Overall Study||6
8982051|NCT02698800|10045277|FG001|COMPLETED|Overall Study||8
8982052|NCT02698800|10045276|FG000|NOT COMPLETED|Overall Study||1
8982053|NCT02698800|10045277|FG001|NOT COMPLETED|Overall Study||0
8982054|NCT02699099|10045286|FG000|STARTED|Overall Study||231
8982055|NCT02699099|10045287|FG001|STARTED|Overall Study||236
8982056|NCT02699099|10045288|FG002|STARTED|Overall Study||232
8982057|NCT02699099|10045286|FG000|COMPLETED|Overall Study||223
8982058|NCT02699099|10045287|FG001|COMPLETED|Overall Study||233
8982059|NCT02699099|10045288|FG002|COMPLETED|Overall Study||226
8982060|NCT02699099|10045286|FG000|NOT COMPLETED|Overall Study||8
8982061|NCT02699099|10045287|FG001|NOT COMPLETED|Overall Study||3
8982062|NCT02699099|10045288|FG002|NOT COMPLETED|Overall Study||6
8982063|NCT02699125|10045298|FG000|STARTED|Placebo||21
8982064|NCT02699125|10045299|FG001|STARTED|Placebo||20
8982065|NCT02699125|10045298|FG000|COMPLETED|Placebo||18
8982066|NCT02699125|10045299|FG001|COMPLETED|Placebo||16
8982067|NCT02699125|10045298|FG000|NOT COMPLETED|Placebo||3
8982068|NCT02699125|10045299|FG001|NOT COMPLETED|Placebo||4
8982069|NCT02699125|10045298|FG000|STARTED|First Intervention (6 Weeks).||18
8982070|NCT02699125|10045299|FG001|STARTED|First Intervention (6 Weeks).||16
8982071|NCT02699125|10045298|FG000|COMPLETED|First Intervention (6 Weeks).||18
8982072|NCT02699125|10045299|FG001|COMPLETED|First Intervention (6 Weeks).||16
8982073|NCT02699125|10045298|FG000|NOT COMPLETED|First Intervention (6 Weeks).||0
8982074|NCT02699125|10045299|FG001|NOT COMPLETED|First Intervention (6 Weeks).||0
8982075|NCT02699125|10045298|FG000|STARTED|Second Intervention (6 Weeks).||18
8982076|NCT02699125|10045299|FG001|STARTED|Second Intervention (6 Weeks).||16
8982077|NCT02699125|10045298|FG000|COMPLETED|Second Intervention (6 Weeks).||11
8982078|NCT02699125|10045299|FG001|COMPLETED|Second Intervention (6 Weeks).||14
8982079|NCT02699125|10045298|FG000|NOT COMPLETED|Second Intervention (6 Weeks).||7
8982080|NCT02699125|10045299|FG001|NOT COMPLETED|Second Intervention (6 Weeks).||2
8982081|NCT02699450|10045312|FG000|STARTED|Overall Study||90
8982082|NCT02699450|10045313|FG001|STARTED|Overall Study||55
8982083|NCT02699450|10045314|FG002|STARTED|Overall Study||82
8982084|NCT02699450|10045312|FG000|Received at Least One Dose of Study Drug|Overall Study||89
8982085|NCT02699450|10045313|FG001|Received at Least One Dose of Study Drug|Overall Study||55
8982086|NCT02699450|10045314|FG002|Received at Least One Dose of Study Drug|Overall Study||80
8982087|NCT02699450|10045312|FG000|Completed up to Week 24|Overall Study||81
8982088|NCT02699450|10045313|FG001|Completed up to Week 24|Overall Study||53
8982089|NCT02699450|10045314|FG002|Completed up to Week 24|Overall Study||73
8982090|NCT02699450|10045312|FG000|COMPLETED|Overall Study||75
8982091|NCT02699450|10045313|FG001|COMPLETED|Overall Study||50
8982092|NCT02699450|10045314|FG002|COMPLETED|Overall Study||67
8982093|NCT02699450|10045312|FG000|NOT COMPLETED|Overall Study||15
8982094|NCT02699450|10045313|FG001|NOT COMPLETED|Overall Study||5
8982095|NCT02699450|10045314|FG002|NOT COMPLETED|Overall Study||15
8982096|NCT02699463|10045325|FG000|STARTED|Overall Study||115
8982097|NCT02699463|10045326|FG001|STARTED|Overall Study||118
8982098|NCT02699463|10045325|FG000|COMPLETED|Overall Study||100
8982099|NCT02699463|10045326|FG001|COMPLETED|Overall Study||109
8982100|NCT02699463|10045325|FG000|NOT COMPLETED|Overall Study||15
8982101|NCT02699463|10045326|FG001|NOT COMPLETED|Overall Study||9
8982102|NCT02699593|10045332|FG000|STARTED|Period 1||72
8982103|NCT02699593|10045333|FG001|STARTED|Period 1||69
8982104|NCT02699593|10045332|FG000|COMPLETED|Period 1||67
8982105|NCT02699593|10045333|FG001|COMPLETED|Period 1||62
8982106|NCT02699593|10045332|FG000|NOT COMPLETED|Period 1||5
8982107|NCT02699593|10045333|FG001|NOT COMPLETED|Period 1||7
8982108|NCT02699593|10045332|FG000|STARTED|Period 2||67
8982109|NCT02699593|10045333|FG001|STARTED|Period 2||62
8982110|NCT02699593|10045332|FG000|COMPLETED|Period 2||65
8982111|NCT02699593|10045333|FG001|COMPLETED|Period 2||60
8982112|NCT02699593|10045332|FG000|NOT COMPLETED|Period 2||2
8982113|NCT02699593|10045333|FG001|NOT COMPLETED|Period 2||2
8982114|NCT02699632|10045339|FG000|STARTED|Overall Study||360
8982115|NCT02699632|10045339|FG000|COMPLETED|Overall Study||358
8982116|NCT02699632|10045339|FG000|NOT COMPLETED|Overall Study||2
8982117|NCT02699684|10045346|FG000|STARTED|Period 1, First 30 Days of Wear||37
8982118|NCT02699684|10045347|FG001|STARTED|Period 1, First 30 Days of Wear||38
8982119|NCT02699684|10045346|FG000|COMPLETED|Period 1, First 30 Days of Wear||37
8982120|NCT02699684|10045347|FG001|COMPLETED|Period 1, First 30 Days of Wear||38
8982121|NCT02699684|10045346|FG000|NOT COMPLETED|Period 1, First 30 Days of Wear||0
8982122|NCT02699684|10045347|FG001|NOT COMPLETED|Period 1, First 30 Days of Wear||0
8982123|NCT02699684|10045346|FG000|STARTED|Period 2, Second 30 Days of Wear||37
8571435|NCT00110305|9603712|FG000|NOT COMPLETED|Overall Study||114
8571436|NCT00110305|9603713|FG001|NOT COMPLETED|Overall Study||32
8571437|NCT00110357|9603732|FG000|STARTED|Overall Study||27
8571438|NCT00110357|9603733|FG001|STARTED|Overall Study||19
8571439|NCT00110357|9603732|FG000|COMPLETED|Overall Study|Number Still on Study|0
8982124|NCT02699684|10045347|FG001|STARTED|Period 2, Second 30 Days of Wear||38
8982125|NCT02699684|10045346|FG000|COMPLETED|Period 2, Second 30 Days of Wear||36
8982126|NCT02699684|10045347|FG001|COMPLETED|Period 2, Second 30 Days of Wear||38
8982127|NCT02699684|10045346|FG000|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
8982128|NCT02699684|10045347|FG001|NOT COMPLETED|Period 2, Second 30 Days of Wear||0
8982129|NCT02699749|10045368|FG000|STARTED|Overall Study||3
8982130|NCT02699749|10045369|FG001|STARTED|Overall Study||3
8982131|NCT02699749|10045370|FG002|STARTED|Overall Study||16
8982132|NCT02699749|10045371|FG003|STARTED|Overall Study||3
8982133|NCT02699749|10045372|FG004|STARTED|Overall Study||3
8982134|NCT02699749|10045373|FG005|STARTED|Overall Study||9
8982135|NCT02699749|10045374|FG006|STARTED|Overall Study||6
8982136|NCT02699749|10045375|FG007|STARTED|Overall Study||6
8982137|NCT02699749|10045376|FG008|STARTED|Overall Study||6
8982138|NCT02699749|10045377|FG009|STARTED|Overall Study||6
8725843|NCT01033487|9773160|FG003|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
8571440|NCT00110357|9603733|FG001|COMPLETED|Overall Study|Number Still on Study|0
8982139|NCT02699749|10045378|FG010|STARTED|Overall Study||6
8982140|NCT02699749|10045379|FG011|STARTED|Overall Study||4
8982141|NCT02699749|10045380|FG012|STARTED|Overall Study||3
8982142|NCT02699749|10045381|FG013|STARTED|Overall Study||6
8982143|NCT02699749|10045368|FG000|COMPLETED|Overall Study||0
8982144|NCT02699749|10045369|FG001|COMPLETED|Overall Study||0
8982145|NCT02699749|10045370|FG002|COMPLETED|Overall Study||0
8982146|NCT02699749|10045371|FG003|COMPLETED|Overall Study||0
8982147|NCT02699749|10045372|FG004|COMPLETED|Overall Study||0
8982148|NCT02699749|10045373|FG005|COMPLETED|Overall Study||0
8982149|NCT02699749|10045374|FG006|COMPLETED|Overall Study||0
8982150|NCT02699749|10045375|FG007|COMPLETED|Overall Study||0
8982151|NCT02699749|10045376|FG008|COMPLETED|Overall Study||0
8982152|NCT02699749|10045377|FG009|COMPLETED|Overall Study||0
8982153|NCT02699749|10045378|FG010|COMPLETED|Overall Study||0
8982154|NCT02699749|10045379|FG011|COMPLETED|Overall Study||0
8982155|NCT02699749|10045380|FG012|COMPLETED|Overall Study||0
8982156|NCT02699749|10045381|FG013|COMPLETED|Overall Study||0
8982157|NCT02699749|10045368|FG000|NOT COMPLETED|Overall Study||3
8982158|NCT02699749|10045369|FG001|NOT COMPLETED|Overall Study||3
8982159|NCT02699749|10045370|FG002|NOT COMPLETED|Overall Study||16
8982160|NCT02699749|10045371|FG003|NOT COMPLETED|Overall Study||3
8982161|NCT02699749|10045372|FG004|NOT COMPLETED|Overall Study||3
8982162|NCT02699749|10045373|FG005|NOT COMPLETED|Overall Study||9
8982163|NCT02699749|10045374|FG006|NOT COMPLETED|Overall Study||6
8982164|NCT02699749|10045375|FG007|NOT COMPLETED|Overall Study||6
8982165|NCT02699749|10045376|FG008|NOT COMPLETED|Overall Study||6
8982166|NCT02699749|10045377|FG009|NOT COMPLETED|Overall Study||6
8982167|NCT02699749|10045378|FG010|NOT COMPLETED|Overall Study||6
8982168|NCT02699749|10045379|FG011|NOT COMPLETED|Overall Study||4
8982169|NCT02699749|10045380|FG012|NOT COMPLETED|Overall Study||3
8982170|NCT02699749|10045381|FG013|NOT COMPLETED|Overall Study||6
8982171|NCT02699866|10045411|FG000|STARTED|Overall Study|First study centre initiation.|46
8982172|NCT02699866|10045411|FG000|Included|Overall Study||41
8982173|NCT02699866|10045411|FG000|COMPLETED|Overall Study|Last study centre close-out.|38
8982174|NCT02699866|10045411|FG000|NOT COMPLETED|Overall Study||8
8982175|NCT02699892|10045415|FG000|STARTED|Overall Study||130
8982176|NCT02699892|10045415|FG000|COMPLETED|Overall Study||94
8982177|NCT02699892|10045415|FG000|NOT COMPLETED|Overall Study||36
8982178|NCT02699970|10045419|FG000|STARTED|Overall Study||399
8982179|NCT02699970|10045419|FG000|Intra-system|Overall Study||399
8982180|NCT02699970|10045419|FG000|Inter-system|Overall Study||399
8982181|NCT02699970|10045419|FG000|COMPLETED|Overall Study||399
8982182|NCT02699970|10045419|FG000|NOT COMPLETED|Overall Study||0
8982183|NCT02699983|10045426|FG000|STARTED|Overall Study||18
8982184|NCT02699983|10045427|FG001|STARTED|Overall Study||17
8982185|NCT02699983|10045426|FG000|COMPLETED|Overall Study||17
8982186|NCT02699983|10045427|FG001|COMPLETED|Overall Study||17
8982187|NCT02699983|10045426|FG000|NOT COMPLETED|Overall Study||1
8982188|NCT02699983|10045427|FG001|NOT COMPLETED|Overall Study||0
8982189|NCT02699996|10045439|FG000|STARTED|Overall Study||20
8982190|NCT02699996|10045440|FG001|STARTED|Overall Study||11
8982191|NCT02699996|10045439|FG000|COMPLETED|Overall Study||15
8982192|NCT02699996|10045440|FG001|COMPLETED|Overall Study||9
8982193|NCT02699996|10045439|FG000|NOT COMPLETED|Overall Study||5
8982194|NCT02699996|10045440|FG001|NOT COMPLETED|Overall Study||2
8982195|NCT02700165|10045447|FG000|STARTED|Overall Study||14
8982196|NCT02700165|10045447|FG000|COMPLETED|Overall Study||14
8982197|NCT02700165|10045447|FG000|NOT COMPLETED|Overall Study||0
8982198|NCT02700334|10045454|FG000|STARTED|Overall Study||12
8982199|NCT02700334|10045455|FG001|STARTED|Overall Study||12
8982200|NCT02700334|10045454|FG000|COMPLETED|Overall Study||12
8982201|NCT02700334|10045455|FG001|COMPLETED|Overall Study||12
8982202|NCT02700334|10045454|FG000|NOT COMPLETED|Overall Study||0
8982203|NCT02700334|10045455|FG001|NOT COMPLETED|Overall Study||0
8982204|NCT02700412|10045461|FG000|STARTED|Overall Study||80
8982205|NCT02700412|10045461|FG000|COMPLETED|Overall Study||47
8982206|NCT02700412|10045461|FG000|NOT COMPLETED|Overall Study||33
8982207|NCT02700425|10045467|FG000|STARTED|Overall Study||21
8982208|NCT02700425|10045468|FG001|STARTED|Overall Study||20
8982209|NCT02700425|10045467|FG000|COMPLETED|Overall Study||21
8982210|NCT02700425|10045468|FG001|COMPLETED|Overall Study|1 patient withdrew after randomization|19
8982211|NCT02700425|10045467|FG000|NOT COMPLETED|Overall Study||0
8982212|NCT02700425|10045468|FG001|NOT COMPLETED|Overall Study||1
8982213|NCT02700815|10045478|FG000|STARTED|Overall Study||75
8982214|NCT02700815|10045479|FG001|STARTED|Overall Study||223
8982215|NCT02700815|10045480|FG002|STARTED|Overall Study||223
8982216|NCT02700815|10045481|FG003|STARTED|Overall Study||225
8571441|NCT00110357|9603732|FG000|NOT COMPLETED|Overall Study||27
8982217|NCT02700815|10045478|FG000|COMPLETED|Overall Study||74
8982218|NCT02700815|10045479|FG001|COMPLETED|Overall Study||216
8982219|NCT02700815|10045480|FG002|COMPLETED|Overall Study||219
8982220|NCT02700815|10045481|FG003|COMPLETED|Overall Study||218
8982221|NCT02700815|10045478|FG000|NOT COMPLETED|Overall Study||1
8982222|NCT02700815|10045479|FG001|NOT COMPLETED|Overall Study||7
8982223|NCT02700815|10045480|FG002|NOT COMPLETED|Overall Study||4
8982224|NCT02700815|10045481|FG003|NOT COMPLETED|Overall Study||7
8982225|NCT02700919|10045494|FG000|STARTED|Overall Study||94
8982226|NCT02700919|10045495|FG001|STARTED|Overall Study||97
8982227|NCT02700919|10045496|FG002|STARTED|Overall Study||91
8982228|NCT02700919|10045494|FG000|COMPLETED|Overall Study||82
8982229|NCT02700919|10045495|FG001|COMPLETED|Overall Study||85
8982230|NCT02700919|10045496|FG002|COMPLETED|Overall Study||87
8982231|NCT02700919|10045494|FG000|NOT COMPLETED|Overall Study||12
8982232|NCT02700919|10045495|FG001|NOT COMPLETED|Overall Study||12
8982233|NCT02700919|10045496|FG002|NOT COMPLETED|Overall Study||4
8982234|NCT02700984|10045506|FG000|STARTED|Overall Study||215
8982235|NCT02700984|10045507|FG001|STARTED|Overall Study||67
8982236|NCT02700984|10045506|FG000|COMPLETED|Overall Study||200
8982237|NCT02700984|10045507|FG001|COMPLETED|Overall Study||53
8982238|NCT02700984|10045506|FG000|NOT COMPLETED|Overall Study||15
8982239|NCT02700984|10045507|FG001|NOT COMPLETED|Overall Study||14
8982240|NCT02700997|10045523|FG000|STARTED|Overall Study||17
8982241|NCT02700997|10045523|FG000|COMPLETED|Overall Study||15
8982242|NCT02700997|10045523|FG000|NOT COMPLETED|Overall Study||2
8982243|NCT02701049|10045530|FG000|STARTED|Overall Study|Patients who completed a follow-up survey|209
8982244|NCT02701049|10045531|FG001|STARTED|Overall Study|Patients who completed a follow-up survey|342
8982245|NCT02701049|10045532|FG002|STARTED|Overall Study|Patients who completed a follow-up survey|198
8982246|NCT02701049|10045530|FG000|COMPLETED|Overall Study|Total patients included in analysis|209
8982247|NCT02701049|10045531|FG001|COMPLETED|Overall Study|Total patients included in analysis|342
8982248|NCT02701049|10045532|FG002|COMPLETED|Overall Study|Total patients included in analysis|198
8982249|NCT02701049|10045530|FG000|NOT COMPLETED|Overall Study||0
8982250|NCT02701049|10045531|FG001|NOT COMPLETED|Overall Study||0
8982251|NCT02701049|10045532|FG002|NOT COMPLETED|Overall Study||0
8982252|NCT02701062|10045546|FG000|STARTED|Baseline||376
8982253|NCT02701062|10045547|FG001|STARTED|Baseline||186
8982254|NCT02701062|10045546|FG000|COMPLETED|Baseline||376
8982255|NCT02701062|10045547|FG001|COMPLETED|Baseline||186
8982256|NCT02701062|10045546|FG000|NOT COMPLETED|Baseline||0
8982257|NCT02701062|10045547|FG001|NOT COMPLETED|Baseline||0
8982258|NCT02701062|10045546|FG000|STARTED|Index Procedure||376
8982259|NCT02701062|10045547|FG001|STARTED|Index Procedure||186
8982260|NCT02701062|10045546|FG000|COMPLETED|Index Procedure||376
8982261|NCT02701062|10045547|FG001|COMPLETED|Index Procedure||186
8982262|NCT02701062|10045546|FG000|NOT COMPLETED|Index Procedure||0
8982263|NCT02701062|10045547|FG001|NOT COMPLETED|Index Procedure||0
8982264|NCT02701062|10045546|FG000|STARTED|Discharge||376
8982265|NCT02701062|10045547|FG001|STARTED|Discharge||186
8982266|NCT02701062|10045546|FG000|COMPLETED|Discharge||376
8982267|NCT02701062|10045547|FG001|COMPLETED|Discharge||186
8982268|NCT02701062|10045546|FG000|NOT COMPLETED|Discharge||0
8982269|NCT02701062|10045547|FG001|NOT COMPLETED|Discharge||0
8982270|NCT02701062|10045546|FG000|STARTED|30 Day Follow-up||376
8982271|NCT02701062|10045547|FG001|STARTED|30 Day Follow-up||186
8982272|NCT02701062|10045546|FG000|COMPLETED|30 Day Follow-up||366
8982273|NCT02701062|10045547|FG001|COMPLETED|30 Day Follow-up||183
8982274|NCT02701062|10045546|FG000|NOT COMPLETED|30 Day Follow-up||10
8982275|NCT02701062|10045547|FG001|NOT COMPLETED|30 Day Follow-up||3
8982276|NCT02701062|10045546|FG000|STARTED|90 Day Follow-up||366
8982277|NCT02701062|10045547|FG001|STARTED|90 Day Follow-up||183
8982278|NCT02701062|10045546|FG000|COMPLETED|90 Day Follow-up||308
8982279|NCT02701062|10045547|FG001|COMPLETED|90 Day Follow-up||72
8982280|NCT02701062|10045546|FG000|NOT COMPLETED|90 Day Follow-up||58
8982281|NCT02701062|10045547|FG001|NOT COMPLETED|90 Day Follow-up||111
8982282|NCT02701062|10045546|FG000|STARTED|365 Day Follow-up||308
8982283|NCT02701062|10045547|FG001|STARTED|365 Day Follow-up||72
8982284|NCT02701062|10045546|FG000|COMPLETED|365 Day Follow-up||294
8982285|NCT02701062|10045547|FG001|COMPLETED|365 Day Follow-up||69
8982286|NCT02701062|10045546|FG000|NOT COMPLETED|365 Day Follow-up||14
8982287|NCT02701062|10045547|FG001|NOT COMPLETED|365 Day Follow-up||3
8982288|NCT02701101|10045561|FG000|STARTED|Overall Study||189
8982289|NCT02701101|10045561|FG000|COMPLETED|Overall Study||189
8982290|NCT02701101|10045561|FG000|NOT COMPLETED|Overall Study||0
8982291|NCT02701257|10045571|FG000|STARTED|Overall Study||6
8982292|NCT02701257|10045572|FG001|STARTED|Overall Study||6
8982293|NCT02701257|10045573|FG002|STARTED|Overall Study||0
8982294|NCT02701257|10045574|FG003|STARTED|Overall Study||4
8982295|NCT02701257|10045575|FG004|STARTED|Overall Study||4
8982296|NCT02701257|10045571|FG000|COMPLETED|Overall Study||6
8982297|NCT02701257|10045572|FG001|COMPLETED|Overall Study||3
8982298|NCT02701257|10045573|FG002|COMPLETED|Overall Study||0
8982299|NCT02701257|10045574|FG003|COMPLETED|Overall Study||3
8982300|NCT02701257|10045575|FG004|COMPLETED|Overall Study||1
8982301|NCT02701257|10045571|FG000|NOT COMPLETED|Overall Study||0
8982302|NCT02701257|10045572|FG001|NOT COMPLETED|Overall Study||3
8982303|NCT02701257|10045573|FG002|NOT COMPLETED|Overall Study||0
8982304|NCT02701257|10045574|FG003|NOT COMPLETED|Overall Study||1
8982305|NCT02701257|10045575|FG004|NOT COMPLETED|Overall Study||3
8982306|NCT02701270|10045591|FG000|STARTED|First Intervention at Visit 1||2
8982307|NCT02701270|10045592|FG001|STARTED|First Intervention at Visit 1||3
8982308|NCT02701270|10045593|FG002|STARTED|First Intervention at Visit 1||3
8982309|NCT02701270|10045594|FG003|STARTED|First Intervention at Visit 1||3
8982310|NCT02701270|10045591|FG000|COMPLETED|First Intervention at Visit 1||2
8982311|NCT02701270|10045592|FG001|COMPLETED|First Intervention at Visit 1||3
8982312|NCT02701270|10045593|FG002|COMPLETED|First Intervention at Visit 1||3
8982313|NCT02701270|10045594|FG003|COMPLETED|First Intervention at Visit 1||3
8982314|NCT02701270|10045591|FG000|NOT COMPLETED|First Intervention at Visit 1||0
8982315|NCT02701270|10045592|FG001|NOT COMPLETED|First Intervention at Visit 1||0
8982316|NCT02701270|10045593|FG002|NOT COMPLETED|First Intervention at Visit 1||0
8982317|NCT02701270|10045594|FG003|NOT COMPLETED|First Intervention at Visit 1||0
8982318|NCT02701270|10045591|FG000|STARTED|Second Intervention at Visit 2||2
8982319|NCT02701270|10045592|FG001|STARTED|Second Intervention at Visit 2||3
8632560|NCT00546000|9672512|FG000|COMPLETED|Overall Study||52
8632561|NCT00546000|9672512|FG000|NOT COMPLETED|Overall Study||4
8632562|NCT00546078|9672518|FG000|STARTED|Overall Study||65
8632563|NCT00546078|9672519|FG001|STARTED|Overall Study||50
8632564|NCT00546078|9672518|FG000|Month 18|Overall Study||61
8632565|NCT00546078|9672519|FG001|Month 18|Overall Study||45
8632566|NCT00546078|9672518|FG000|COMPLETED|Overall Study||61
8632567|NCT00546078|9672519|FG001|COMPLETED|Overall Study||43
8632568|NCT00546078|9672518|FG000|NOT COMPLETED|Overall Study||4
8632569|NCT00546078|9672519|FG001|NOT COMPLETED|Overall Study||7
8632570|NCT00546104|9672525|FG000|STARTED|Overall Study||31
8632571|NCT00546104|9672525|FG000|COMPLETED|Overall Study||31
8632572|NCT00546104|9672525|FG000|NOT COMPLETED|Overall Study||0
8632573|NCT00546117|9672531|FG000|STARTED|Overall Study||9
8632574|NCT00546117|9672532|FG001|STARTED|Overall Study||7
8632575|NCT00546117|9672531|FG000|COMPLETED|Overall Study||5
8632576|NCT00546117|9672532|FG001|COMPLETED|Overall Study||7
8632577|NCT00546117|9672531|FG000|NOT COMPLETED|Overall Study||4
8632578|NCT00546117|9672532|FG001|NOT COMPLETED|Overall Study||0
8632579|NCT00546156|9672542|FG000|STARTED|Overall Study||84
8632580|NCT00546156|9672543|FG001|STARTED|Overall Study||20
8982320|NCT02701270|10045593|FG002|STARTED|Second Intervention at Visit 2||3
8982321|NCT02701270|10045594|FG003|STARTED|Second Intervention at Visit 2||3
8982322|NCT02701270|10045591|FG000|COMPLETED|Second Intervention at Visit 2||2
8982323|NCT02701270|10045592|FG001|COMPLETED|Second Intervention at Visit 2||3
8982324|NCT02701270|10045593|FG002|COMPLETED|Second Intervention at Visit 2||3
8982325|NCT02701270|10045594|FG003|COMPLETED|Second Intervention at Visit 2||3
8982326|NCT02701270|10045591|FG000|NOT COMPLETED|Second Intervention at Visit 2||0
8982327|NCT02701270|10045592|FG001|NOT COMPLETED|Second Intervention at Visit 2||0
8982328|NCT02701270|10045593|FG002|NOT COMPLETED|Second Intervention at Visit 2||0
8982329|NCT02701270|10045594|FG003|NOT COMPLETED|Second Intervention at Visit 2||0
8982330|NCT02701270|10045591|FG000|STARTED|Third Intervention at Visit 3||2
8982331|NCT02701270|10045592|FG001|STARTED|Third Intervention at Visit 3||3
8982332|NCT02701270|10045593|FG002|STARTED|Third Intervention at Visit 3||3
8982333|NCT02701270|10045594|FG003|STARTED|Third Intervention at Visit 3||3
8982334|NCT02701270|10045591|FG000|COMPLETED|Third Intervention at Visit 3||2
8982335|NCT02701270|10045592|FG001|COMPLETED|Third Intervention at Visit 3||3
8982336|NCT02701270|10045593|FG002|COMPLETED|Third Intervention at Visit 3||3
8982337|NCT02701270|10045594|FG003|COMPLETED|Third Intervention at Visit 3||3
8632581|NCT00546156|9672542|FG000|COMPLETED|Overall Study||70
8632582|NCT00546156|9672543|FG001|COMPLETED|Overall Study||19
8632583|NCT00546156|9672542|FG000|NOT COMPLETED|Overall Study||14
8632584|NCT00546156|9672543|FG001|NOT COMPLETED|Overall Study||1
8632585|NCT00546260|9672550|FG000|STARTED|Overall Study||36
8632586|NCT00546260|9672551|FG001|STARTED|Overall Study||34
8632587|NCT00546260|9672550|FG000|COMPLETED|Overall Study||28
8632588|NCT00546260|9672551|FG001|COMPLETED|Overall Study||32
8982338|NCT02701270|10045591|FG000|NOT COMPLETED|Third Intervention at Visit 3||0
8982339|NCT02701270|10045592|FG001|NOT COMPLETED|Third Intervention at Visit 3||0
8982340|NCT02701270|10045593|FG002|NOT COMPLETED|Third Intervention at Visit 3||0
8982341|NCT02701270|10045594|FG003|NOT COMPLETED|Third Intervention at Visit 3||0
8982342|NCT02701270|10045591|FG000|STARTED|Fourth Intervention at Visit 4||2
8982343|NCT02701270|10045592|FG001|STARTED|Fourth Intervention at Visit 4||3
8982344|NCT02701270|10045593|FG002|STARTED|Fourth Intervention at Visit 4||3
8982345|NCT02701270|10045594|FG003|STARTED|Fourth Intervention at Visit 4||3
8982346|NCT02701270|10045591|FG000|COMPLETED|Fourth Intervention at Visit 4||2
8982347|NCT02701270|10045592|FG001|COMPLETED|Fourth Intervention at Visit 4||3
8982348|NCT02701270|10045593|FG002|COMPLETED|Fourth Intervention at Visit 4||3
8982349|NCT02701270|10045594|FG003|COMPLETED|Fourth Intervention at Visit 4||3
8982350|NCT02701270|10045591|FG000|NOT COMPLETED|Fourth Intervention at Visit 4||0
8982351|NCT02701270|10045592|FG001|NOT COMPLETED|Fourth Intervention at Visit 4||0
8982352|NCT02701270|10045593|FG002|NOT COMPLETED|Fourth Intervention at Visit 4||0
8982353|NCT02701270|10045594|FG003|NOT COMPLETED|Fourth Intervention at Visit 4||0
8982354|NCT02701296|10045607|FG000|STARTED|Overall Study||42
8982355|NCT02701296|10045608|FG001|STARTED|Overall Study||38
8982356|NCT02701296|10045607|FG000|COMPLETED|Overall Study||42
8982357|NCT02701296|10045608|FG001|COMPLETED|Overall Study|Data was incomplete for two participants their data was not included in the overall data analysis.|36
8982358|NCT02701296|10045607|FG000|NOT COMPLETED|Overall Study||0
8982359|NCT02701296|10045608|FG001|NOT COMPLETED|Overall Study||2
8982360|NCT02701361|10045617|FG000|STARTED|Overall Study||31
8982361|NCT02701361|10045618|FG001|STARTED|Overall Study||31
8982362|NCT02701361|10045619|FG002|STARTED|Overall Study||18
8982363|NCT02701361|10045617|FG000|COMPLETED|Overall Study||22
8982364|NCT02701361|10045618|FG001|COMPLETED|Overall Study||28
8982365|NCT02701361|10045619|FG002|COMPLETED|Overall Study||16
8982366|NCT02701361|10045617|FG000|NOT COMPLETED|Overall Study||9
8982367|NCT02701361|10045618|FG001|NOT COMPLETED|Overall Study||3
8982368|NCT02701361|10045619|FG002|NOT COMPLETED|Overall Study||2
8982369|NCT02701387|10045629|FG000|STARTED|Overall Study||7
8982370|NCT02701387|10045629|FG000|COMPLETED|Overall Study||7
8982371|NCT02701387|10045629|FG000|NOT COMPLETED|Overall Study||0
8982372|NCT02701400|10045636|FG000|STARTED|Overall Study||9
8571442|NCT00110357|9603733|FG001|NOT COMPLETED|Overall Study||19
8571443|NCT00110396|9603766|FG000|STARTED|Overall Study||260
8571444|NCT00110396|9603766|FG000|COMPLETED|Overall Study|260 participants included in the Safety Population.207 completed treatment. 224 completed the trial|224
8571445|NCT00110396|9603766|FG000|NOT COMPLETED|Overall Study||36
8982373|NCT02701400|10045637|FG001|STARTED|Overall Study||9
8982374|NCT02701400|10045636|FG000|COMPLETED|Overall Study||9
8982375|NCT02701400|10045637|FG001|COMPLETED|Overall Study||9
8982376|NCT02701400|10045636|FG000|NOT COMPLETED|Overall Study||0
8982377|NCT02701400|10045637|FG001|NOT COMPLETED|Overall Study||0
8982378|NCT02701413|10045646|FG000|STARTED|Overall Study||33
8982379|NCT02701413|10045647|FG001|STARTED|Overall Study||33
8982380|NCT02701413|10045646|FG000|COMPLETED|Overall Study||26
8982381|NCT02701413|10045647|FG001|COMPLETED|Overall Study||22
8982382|NCT02701413|10045646|FG000|NOT COMPLETED|Overall Study||7
8982383|NCT02701413|10045647|FG001|NOT COMPLETED|Overall Study||11
8982384|NCT02701582|10045655|FG000|STARTED|Overall Study||35
8982385|NCT02701582|10045656|FG001|STARTED|Overall Study||33
8982386|NCT02701582|10045655|FG000|COMPLETED|Overall Study||33
8982387|NCT02701582|10045656|FG001|COMPLETED|Overall Study||33
8982388|NCT02701582|10045655|FG000|NOT COMPLETED|Overall Study||2
8982389|NCT02701582|10045656|FG001|NOT COMPLETED|Overall Study||0
8982390|NCT02701634|10045666|FG000|STARTED|Overall Study||33
8982391|NCT02701634|10045667|FG001|STARTED|Overall Study||33
8982392|NCT02701634|10045666|FG000|COMPLETED|Overall Study||1
8982393|NCT02701634|10045667|FG001|COMPLETED|Overall Study||2
8982394|NCT02701634|10045666|FG000|NOT COMPLETED|Overall Study||32
8982395|NCT02701634|10045667|FG001|NOT COMPLETED|Overall Study||31
8982396|NCT02701647|10045677|FG000|STARTED|Overall Study||17
8982397|NCT02701647|10045678|FG001|STARTED|Overall Study||17
8982398|NCT02701647|10045679|FG002|STARTED|Overall Study||17
8982399|NCT02701647|10045677|FG000|COMPLETED|Overall Study||17
8982400|NCT02701647|10045678|FG001|COMPLETED|Overall Study||17
8982401|NCT02701647|10045679|FG002|COMPLETED|Overall Study|One participant from sham-TT withdraw due a back injury unrelated to study.|16
8982402|NCT02701647|10045677|FG000|NOT COMPLETED|Overall Study||0
8982403|NCT02701647|10045678|FG001|NOT COMPLETED|Overall Study||0
8982404|NCT02701647|10045679|FG002|NOT COMPLETED|Overall Study||1
9038608|NCT03332784|10099778|FG017|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
9038609|NCT03332784|10099779|FG018|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
9038610|NCT03332784|10099780|FG019|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
9038611|NCT03332784|10099761|FG000|STARTED|Part 1- Period 3 (1 Day)||2
9038612|NCT03332784|10099762|FG001|STARTED|Part 1- Period 3 (1 Day)||1
9038613|NCT03332784|10099763|FG002|STARTED|Part 1- Period 3 (1 Day)||2
9038614|NCT03332784|10099764|FG003|STARTED|Part 1- Period 3 (1 Day)||2
9038615|NCT03332784|10099765|FG004|STARTED|Part 1- Period 3 (1 Day)||2
9038616|NCT03332784|10099766|FG005|STARTED|Part 1- Period 3 (1 Day)||2
9038617|NCT03332784|10099767|FG006|STARTED|Part 1- Period 3 (1 Day)||2
9038618|NCT03332784|10099768|FG007|STARTED|Part 1- Period 3 (1 Day)||2
9038619|NCT03332784|10099769|FG008|STARTED|Part 1- Period 3 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
9038620|NCT03332784|10099770|FG009|STARTED|Part 1- Period 3 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
9038621|NCT03332784|10099771|FG010|STARTED|Part 1- Period 3 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
9038622|NCT03332784|10099772|FG011|STARTED|Part 1- Period 3 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
9038623|NCT03332784|10099773|FG012|STARTED|Part 1- Period 3 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
9038624|NCT03332784|10099774|FG013|STARTED|Part 1- Period 3 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
9038625|NCT03332784|10099775|FG014|STARTED|Part 1- Period 3 (1 Day)|Part 2 participants did not continue in subsequent periods after Period 2.|0
9038626|NCT03332784|10099776|FG015|STARTED|Part 1- Period 3 (1 Day)|Part 2 participants did not continue in subsequent periods after Period 2.|0
9038627|NCT03332784|10099777|FG016|STARTED|Part 1- Period 3 (1 Day)|Part 2 participants did not continue in subsequent periods after Period 2.|0
9038628|NCT03332784|10099778|FG017|STARTED|Part 1- Period 3 (1 Day)|Part 2 participants did not continue in subsequent periods after Period 2.|0
9038629|NCT03332784|10099779|FG018|STARTED|Part 1- Period 3 (1 Day)|Part 2 participants did not continue in subsequent periods after Period 2.|0
9038630|NCT03332784|10099780|FG019|STARTED|Part 1- Period 3 (1 Day)|Part 2 participants did not continue in subsequent periods after Period 2.|0
9038631|NCT03332784|10099761|FG000|COMPLETED|Part 1- Period 3 (1 Day)||2
9038632|NCT03332784|10099762|FG001|COMPLETED|Part 1- Period 3 (1 Day)||1
9038633|NCT03332784|10099763|FG002|COMPLETED|Part 1- Period 3 (1 Day)||2
9038634|NCT03332784|10099764|FG003|COMPLETED|Part 1- Period 3 (1 Day)||2
9038635|NCT03332784|10099765|FG004|COMPLETED|Part 1- Period 3 (1 Day)||2
9038636|NCT03332784|10099766|FG005|COMPLETED|Part 1- Period 3 (1 Day)||2
9038637|NCT03332784|10099767|FG006|COMPLETED|Part 1- Period 3 (1 Day)||2
9038638|NCT03332784|10099768|FG007|COMPLETED|Part 1- Period 3 (1 Day)||2
9038639|NCT03332784|10099769|FG008|COMPLETED|Part 1- Period 3 (1 Day)||0
9038640|NCT03332784|10099770|FG009|COMPLETED|Part 1- Period 3 (1 Day)||0
9038641|NCT03332784|10099771|FG010|COMPLETED|Part 1- Period 3 (1 Day)||0
9038642|NCT03332784|10099772|FG011|COMPLETED|Part 1- Period 3 (1 Day)||0
9038643|NCT03332784|10099773|FG012|COMPLETED|Part 1- Period 3 (1 Day)||0
9038644|NCT03332784|10099774|FG013|COMPLETED|Part 1- Period 3 (1 Day)||0
9038645|NCT03332784|10099775|FG014|COMPLETED|Part 1- Period 3 (1 Day)||0
9038646|NCT03332784|10099776|FG015|COMPLETED|Part 1- Period 3 (1 Day)||0
9038647|NCT03332784|10099777|FG016|COMPLETED|Part 1- Period 3 (1 Day)||0
9038648|NCT03332784|10099778|FG017|COMPLETED|Part 1- Period 3 (1 Day)||0
9038649|NCT03332784|10099779|FG018|COMPLETED|Part 1- Period 3 (1 Day)||0
9038650|NCT03332784|10099780|FG019|COMPLETED|Part 1- Period 3 (1 Day)||0
9038651|NCT03332784|10099761|FG000|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
9038652|NCT03332784|10099762|FG001|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
9038653|NCT03332784|10099763|FG002|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
8982405|NCT02701764|10045695|FG000|STARTED|Overall Study||21
8982406|NCT02701764|10045696|FG001|STARTED|Overall Study||22
8982407|NCT02701764|10045695|FG000|COMPLETED|Overall Study||21
8982408|NCT02701764|10045696|FG001|COMPLETED|Overall Study||21
8982409|NCT02701764|10045695|FG000|NOT COMPLETED|Overall Study||0
8982410|NCT02701764|10045696|FG001|NOT COMPLETED|Overall Study||1
8982411|NCT02701868|10045705|FG000|STARTED|Overall Study||21
8982412|NCT02701868|10045706|FG001|STARTED|Overall Study||75
8982413|NCT02701868|10045707|FG002|STARTED|Overall Study||75
8982414|NCT02701868|10045705|FG000|COMPLETED|Overall Study||21
8982415|NCT02701868|10045706|FG001|COMPLETED|Overall Study||75
8982416|NCT02701868|10045707|FG002|COMPLETED|Overall Study||75
8982417|NCT02701868|10045705|FG000|NOT COMPLETED|Overall Study||0
8982418|NCT02701868|10045706|FG001|NOT COMPLETED|Overall Study||0
8982419|NCT02701868|10045707|FG002|NOT COMPLETED|Overall Study||0
8982420|NCT02701985|10045718|FG000|STARTED|Overall Study||37
8982421|NCT02701985|10045719|FG001|STARTED|Overall Study||38
8982422|NCT02701985|10045718|FG000|COMPLETED|Overall Study||34
8982423|NCT02701985|10045719|FG001|COMPLETED|Overall Study||32
8982424|NCT02701985|10045718|FG000|NOT COMPLETED|Overall Study||3
8982425|NCT02701985|10045719|FG001|NOT COMPLETED|Overall Study||6
8982426|NCT02702011|10045730|FG000|STARTED|Overall Study|Started are the treated patients.|11
8982427|NCT02702011|10045731|FG001|STARTED|Overall Study|Started are the treated patients.|13
8982428|NCT02702011|10045732|FG002|STARTED|Overall Study|Started are the treated patients.|12
8982429|NCT02702011|10045733|FG003|STARTED|Overall Study|Started are the treated patients.|12
8982430|NCT02702011|10045730|FG000|COMPLETED|Overall Study||11
8982431|NCT02702011|10045731|FG001|COMPLETED|Overall Study||12
8982432|NCT02702011|10045732|FG002|COMPLETED|Overall Study||12
8982433|NCT02702011|10045733|FG003|COMPLETED|Overall Study||12
8982434|NCT02702011|10045730|FG000|NOT COMPLETED|Overall Study||0
8982435|NCT02702011|10045731|FG001|NOT COMPLETED|Overall Study||1
8982436|NCT02702011|10045732|FG002|NOT COMPLETED|Overall Study||0
8982437|NCT02702011|10045733|FG003|NOT COMPLETED|Overall Study||0
8982438|NCT02702193|10045745|FG000|STARTED|Baseline Assessment/Randomization||86
8982439|NCT02702193|10045746|FG001|STARTED|Baseline Assessment/Randomization||87
8982440|NCT02702193|10045745|FG000|COMPLETED|Baseline Assessment/Randomization||85
8982441|NCT02702193|10045746|FG001|COMPLETED|Baseline Assessment/Randomization||87
8982442|NCT02702193|10045745|FG000|NOT COMPLETED|Baseline Assessment/Randomization||1
8982443|NCT02702193|10045746|FG001|NOT COMPLETED|Baseline Assessment/Randomization||0
8982444|NCT02702193|10045745|FG000|STARTED|4 Month Follow up||86
8982445|NCT02702193|10045746|FG001|STARTED|4 Month Follow up||87
8982446|NCT02702193|10045745|FG000|COMPLETED|4 Month Follow up||68
8982447|NCT02702193|10045746|FG001|COMPLETED|4 Month Follow up||69
8982448|NCT02702193|10045745|FG000|NOT COMPLETED|4 Month Follow up||18
8982449|NCT02702193|10045746|FG001|NOT COMPLETED|4 Month Follow up||18
8982450|NCT02702193|10045745|FG000|STARTED|8 Month Follow up||86
8982451|NCT02702193|10045746|FG001|STARTED|8 Month Follow up||87
8982452|NCT02702193|10045745|FG000|COMPLETED|8 Month Follow up||71
8982453|NCT02702193|10045746|FG001|COMPLETED|8 Month Follow up||69
8982454|NCT02702193|10045745|FG000|NOT COMPLETED|8 Month Follow up||15
8982455|NCT02702193|10045746|FG001|NOT COMPLETED|8 Month Follow up||18
8982456|NCT02702193|10045745|FG000|STARTED|12 Month Follow up||86
8982457|NCT02702193|10045746|FG001|STARTED|12 Month Follow up||87
8982458|NCT02702193|10045745|FG000|COMPLETED|12 Month Follow up||69
8982459|NCT02702193|10045746|FG001|COMPLETED|12 Month Follow up||69
8982460|NCT02702193|10045745|FG000|NOT COMPLETED|12 Month Follow up||17
8982461|NCT02702193|10045746|FG001|NOT COMPLETED|12 Month Follow up||18
8982462|NCT02702388|10045754|FG000|STARTED|Overall Study||75
8982463|NCT02702388|10045755|FG001|STARTED|Overall Study||77
8982464|NCT02702388|10045754|FG000|COMPLETED|Overall Study||35
8982465|NCT02702388|10045755|FG001|COMPLETED|Overall Study||26
8982466|NCT02702388|10045754|FG000|NOT COMPLETED|Overall Study||40
8982467|NCT02702388|10045755|FG001|NOT COMPLETED|Overall Study||51
8982468|NCT02702401|10045772|FG000|STARTED|Overall Study||278
8982469|NCT02702401|10045773|FG001|STARTED|Overall Study||135
8982470|NCT02702401|10045772|FG000|Treated|Overall Study||278
8982471|NCT02702401|10045773|FG001|Treated|Overall Study||135
8982472|NCT02702401|10045772|FG000|COMPLETED|Overall Study||0
8982473|NCT02702401|10045773|FG001|COMPLETED|Overall Study||0
8982474|NCT02702401|10045772|FG000|NOT COMPLETED|Overall Study||278
8982475|NCT02702401|10045773|FG001|NOT COMPLETED|Overall Study||135
8982476|NCT02702518|10045781|FG000|STARTED|Overall Study||29
8982477|NCT02702518|10045782|FG001|STARTED|Overall Study||29
8982478|NCT02702518|10045781|FG000|COMPLETED|Overall Study||26
8982479|NCT02702518|10045782|FG001|COMPLETED|Overall Study||25
8982480|NCT02702518|10045781|FG000|NOT COMPLETED|Overall Study||3
8982481|NCT02702518|10045782|FG001|NOT COMPLETED|Overall Study||4
8982482|NCT02702609|10045790|FG000|STARTED|Overall Study||24
8982483|NCT02702609|10045791|FG001|STARTED|Overall Study||21
8982484|NCT02702609|10045790|FG000|Implant Placement|Overall Study||23
8982485|NCT02702609|10045791|FG001|Implant Placement|Overall Study||21
8982486|NCT02702609|10045790|FG000|Crown Delivery|Overall Study||16
8982487|NCT02702609|10045791|FG001|Crown Delivery|Overall Study||18
8982488|NCT02702609|10045790|FG000|COMPLETED|Overall Study||15
8982489|NCT02702609|10045791|FG001|COMPLETED|Overall Study||17
8982490|NCT02702609|10045790|FG000|NOT COMPLETED|Overall Study||9
8982491|NCT02702609|10045791|FG001|NOT COMPLETED|Overall Study||4
8982492|NCT02702921|10045799|FG000|STARTED|Overall Study||98
8982493|NCT02702921|10045800|FG001|STARTED|Overall Study||103
8982494|NCT02702921|10045799|FG000|COMPLETED|Overall Study||84
8982495|NCT02702921|10045800|FG001|COMPLETED|Overall Study||95
8982496|NCT02702921|10045799|FG000|NOT COMPLETED|Overall Study||14
8982497|NCT02702921|10045800|FG001|NOT COMPLETED|Overall Study||8
8982498|NCT02702999|10045808|FG000|STARTED|Overall Study||102
8982499|NCT02702999|10045809|FG001|STARTED|Overall Study||104
8982500|NCT02702999|10045808|FG000|COMPLETED|Overall Study||102
8982501|NCT02702999|10045809|FG001|COMPLETED|Overall Study||104
8982502|NCT02702999|10045808|FG000|NOT COMPLETED|Overall Study||0
8982503|NCT02702999|10045809|FG001|NOT COMPLETED|Overall Study||0
8982504|NCT02703259|10045817|FG000|STARTED|24 Hours Postoperative Assessment||70
8982505|NCT02703259|10045818|FG001|STARTED|24 Hours Postoperative Assessment||67
8982506|NCT02703259|10045817|FG000|COMPLETED|24 Hours Postoperative Assessment||68
8982507|NCT02703259|10045818|FG001|COMPLETED|24 Hours Postoperative Assessment||61
8982508|NCT02703259|10045817|FG000|NOT COMPLETED|24 Hours Postoperative Assessment||2
8982509|NCT02703259|10045818|FG001|NOT COMPLETED|24 Hours Postoperative Assessment||6
8982510|NCT02703259|10045817|FG000|STARTED|2 Weeks Postoperative Assessment||68
8982511|NCT02703259|10045818|FG001|STARTED|2 Weeks Postoperative Assessment||61
8982512|NCT02703259|10045817|FG000|COMPLETED|2 Weeks Postoperative Assessment||58
8982513|NCT02703259|10045818|FG001|COMPLETED|2 Weeks Postoperative Assessment||51
8982514|NCT02703259|10045817|FG000|NOT COMPLETED|2 Weeks Postoperative Assessment||10
8982515|NCT02703259|10045818|FG001|NOT COMPLETED|2 Weeks Postoperative Assessment||10
8982516|NCT02703311|10045824|FG000|STARTED|Overall Study||11
8982517|NCT02703311|10045824|FG000|Implanted|Overall Study||11
8632589|NCT00546260|9672550|FG000|NOT COMPLETED|Overall Study||8
8571446|NCT00110461|9603773|FG000|STARTED|30-Week, Double-blind Treatment Phase||98
8571447|NCT00110461|9603774|FG001|STARTED|30-Week, Double-blind Treatment Phase||99
8571448|NCT00110461|9603775|FG002|STARTED|30-Week, Double-blind Treatment Phase||99
8571449|NCT00110461|9603773|FG000|COMPLETED|30-Week, Double-blind Treatment Phase||34
8571450|NCT00110461|9603774|FG001|COMPLETED|30-Week, Double-blind Treatment Phase||22
8571451|NCT00110461|9603775|FG002|COMPLETED|30-Week, Double-blind Treatment Phase||12
8571452|NCT00110461|9603773|FG000|NOT COMPLETED|30-Week, Double-blind Treatment Phase||64
8571453|NCT00110461|9603774|FG001|NOT COMPLETED|30-Week, Double-blind Treatment Phase||77
8571454|NCT00110461|9603775|FG002|NOT COMPLETED|30-Week, Double-blind Treatment Phase||87
8571455|NCT00110461|9603773|FG000|STARTED|Acute Phase||98
8571456|NCT00110461|9603774|FG001|STARTED|Acute Phase||99
8571457|NCT00110461|9603775|FG002|STARTED|Acute Phase||99
8571458|NCT00110461|9603773|FG000|COMPLETED|Acute Phase||84
8571459|NCT00110461|9603774|FG001|COMPLETED|Acute Phase||77
8571460|NCT00110461|9603775|FG002|COMPLETED|Acute Phase||76
8571461|NCT00110461|9603773|FG000|NOT COMPLETED|Acute Phase||14
8571462|NCT00110461|9603774|FG001|NOT COMPLETED|Acute Phase||22
8571463|NCT00110461|9603775|FG002|NOT COMPLETED|Acute Phase||23
8571464|NCT00110513|9603783|FG000|STARTED|Overall Study||18
8571465|NCT00110513|9603783|FG000|COMPLETED|Overall Study||18
8571466|NCT00110513|9603783|FG000|NOT COMPLETED|Overall Study||0
8571467|NCT00110617|9603789|FG000|STARTED|Overall Study||135
8806547|NCT01478256|9858776|FG000|COMPLETED|Overall Study||15
8982518|NCT02703311|10045824|FG000|30 Day Follow-Up Completed|Overall Study||9
8632590|NCT00546260|9672551|FG001|NOT COMPLETED|Overall Study||2
8571468|NCT00110617|9603790|FG001|STARTED|Overall Study|Full Analysis Set 1 does not include 9 participants who were excluded due to GCP violations.|68
8571469|NCT00110617|9603789|FG000|Safety Set 1; Received Study Drug|Overall Study||135
8571470|NCT00110617|9603790|FG001|Safety Set 1; Received Study Drug|Overall Study||56
8571471|NCT00110617|9603789|FG000|Full Analysis 2; Received ICL670|Overall Study||135
8571472|NCT00110617|9603790|FG001|Full Analysis 2; Received ICL670|Overall Study||53
8571473|NCT00110617|9603789|FG000|On Going at Week 24|Overall Study||126
8632591|NCT00546351|9672557|FG000|STARTED|Overall Study||621
8982519|NCT02703311|10045824|FG000|COMPLETED|Overall Study||3
8982520|NCT02703311|10045824|FG000|NOT COMPLETED|Overall Study||8
8982521|NCT02703324|10045828|FG000|STARTED|Period One||5
8982522|NCT02703324|10045829|FG001|STARTED|Period One||5
8982523|NCT02703324|10045830|FG002|STARTED|Period One||5
8982524|NCT02703324|10045831|FG003|STARTED|Period One||5
8982525|NCT02703324|10045832|FG004|STARTED|Period One||5
8982526|NCT02703324|10045833|FG005|STARTED|Period One||5
8982527|NCT02703324|10045828|FG000|Received Study Drug|Period One||5
8982528|NCT02703324|10045829|FG001|Received Study Drug|Period One||5
8982529|NCT02703324|10045830|FG002|Received Study Drug|Period One||5
8982530|NCT02703324|10045831|FG003|Received Study Drug|Period One||5
8982531|NCT02703324|10045832|FG004|Received Study Drug|Period One||5
8982532|NCT02703324|10045833|FG005|Received Study Drug|Period One||5
8982533|NCT02703324|10045828|FG000|COMPLETED|Period One||5
8982534|NCT02703324|10045829|FG001|COMPLETED|Period One||5
8982535|NCT02703324|10045830|FG002|COMPLETED|Period One||5
8982536|NCT02703324|10045831|FG003|COMPLETED|Period One||5
8982537|NCT02703324|10045832|FG004|COMPLETED|Period One||5
8982538|NCT02703324|10045833|FG005|COMPLETED|Period One||5
8982539|NCT02703324|10045828|FG000|NOT COMPLETED|Period One||0
8982540|NCT02703324|10045829|FG001|NOT COMPLETED|Period One||0
8982541|NCT02703324|10045830|FG002|NOT COMPLETED|Period One||0
8982542|NCT02703324|10045831|FG003|NOT COMPLETED|Period One||0
8982543|NCT02703324|10045832|FG004|NOT COMPLETED|Period One||0
8982544|NCT02703324|10045833|FG005|NOT COMPLETED|Period One||0
8982545|NCT02703324|10045828|FG000|STARTED|Period Two||5
8982546|NCT02703324|10045829|FG001|STARTED|Period Two||5
8982547|NCT02703324|10045830|FG002|STARTED|Period Two||5
8982548|NCT02703324|10045831|FG003|STARTED|Period Two||5
8982549|NCT02703324|10045832|FG004|STARTED|Period Two||5
8982550|NCT02703324|10045833|FG005|STARTED|Period Two||5
8982551|NCT02703324|10045828|FG000|Received Study Drug|Period Two||5
8982552|NCT02703324|10045829|FG001|Received Study Drug|Period Two||5
8632592|NCT00546351|9672557|FG000|COMPLETED|Overall Study||385
8632593|NCT00546351|9672557|FG000|NOT COMPLETED|Overall Study||236
8982553|NCT02703324|10045830|FG002|Received Study Drug|Period Two||5
8982554|NCT02703324|10045831|FG003|Received Study Drug|Period Two||5
8982555|NCT02703324|10045832|FG004|Received Study Drug|Period Two||5
8982556|NCT02703324|10045833|FG005|Received Study Drug|Period Two||5
8982557|NCT02703324|10045828|FG000|COMPLETED|Period Two||5
8982558|NCT02703324|10045829|FG001|COMPLETED|Period Two||5
8982559|NCT02703324|10045830|FG002|COMPLETED|Period Two||4
8982560|NCT02703324|10045831|FG003|COMPLETED|Period Two||5
8982561|NCT02703324|10045832|FG004|COMPLETED|Period Two||5
8982562|NCT02703324|10045833|FG005|COMPLETED|Period Two||5
8982563|NCT02703324|10045828|FG000|NOT COMPLETED|Period Two||0
8982564|NCT02703324|10045829|FG001|NOT COMPLETED|Period Two||0
8982565|NCT02703324|10045830|FG002|NOT COMPLETED|Period Two||1
8982566|NCT02703324|10045831|FG003|NOT COMPLETED|Period Two||0
8982567|NCT02703324|10045832|FG004|NOT COMPLETED|Period Two||0
8982568|NCT02703324|10045833|FG005|NOT COMPLETED|Period Two||0
8982569|NCT02703324|10045828|FG000|STARTED|Period Three||5
8982570|NCT02703324|10045829|FG001|STARTED|Period Three||5
8982571|NCT02703324|10045830|FG002|STARTED|Period Three||4
8982572|NCT02703324|10045831|FG003|STARTED|Period Three||5
8982573|NCT02703324|10045832|FG004|STARTED|Period Three||5
8982574|NCT02703324|10045833|FG005|STARTED|Period Three||5
8982575|NCT02703324|10045828|FG000|Received Study Drug|Period Three||5
8982576|NCT02703324|10045829|FG001|Received Study Drug|Period Three||5
8982577|NCT02703324|10045830|FG002|Received Study Drug|Period Three||4
8982578|NCT02703324|10045831|FG003|Received Study Drug|Period Three||5
8982579|NCT02703324|10045832|FG004|Received Study Drug|Period Three||5
8982580|NCT02703324|10045833|FG005|Received Study Drug|Period Three||5
8982581|NCT02703324|10045828|FG000|COMPLETED|Period Three||5
8982582|NCT02703324|10045829|FG001|COMPLETED|Period Three|One participant discontinued after Period 3. Did not enter Period 4.|5
8982583|NCT02703324|10045830|FG002|COMPLETED|Period Three||4
8982584|NCT02703324|10045831|FG003|COMPLETED|Period Three||5
8982585|NCT02703324|10045832|FG004|COMPLETED|Period Three||5
8982586|NCT02703324|10045833|FG005|COMPLETED|Period Three||5
8982587|NCT02703324|10045828|FG000|NOT COMPLETED|Period Three||0
8982588|NCT02703324|10045829|FG001|NOT COMPLETED|Period Three||0
8982589|NCT02703324|10045830|FG002|NOT COMPLETED|Period Three||0
8982590|NCT02703324|10045831|FG003|NOT COMPLETED|Period Three||0
8982591|NCT02703324|10045832|FG004|NOT COMPLETED|Period Three||0
8982592|NCT02703324|10045833|FG005|NOT COMPLETED|Period Three||0
8982593|NCT02703324|10045828|FG000|STARTED|Period Four||5
8982594|NCT02703324|10045829|FG001|STARTED|Period Four|One participant discontinued after Period 3. Did not enter Period 4.|4
8982595|NCT02703324|10045830|FG002|STARTED|Period Four||4
8632594|NCT00546364|9672564|FG000|STARTED|Overall Study||20
8632595|NCT00546364|9672565|FG001|STARTED|Overall Study||22
8982596|NCT02703324|10045831|FG003|STARTED|Period Four||5
8982597|NCT02703324|10045832|FG004|STARTED|Period Four||5
8982598|NCT02703324|10045833|FG005|STARTED|Period Four||5
8982599|NCT02703324|10045828|FG000|Received Study Drug|Period Four||5
8982600|NCT02703324|10045829|FG001|Received Study Drug|Period Four||4
8982601|NCT02703324|10045830|FG002|Received Study Drug|Period Four||4
8982602|NCT02703324|10045831|FG003|Received Study Drug|Period Four||5
8982603|NCT02703324|10045832|FG004|Received Study Drug|Period Four||5
8982604|NCT02703324|10045833|FG005|Received Study Drug|Period Four||5
8982605|NCT02703324|10045828|FG000|COMPLETED|Period Four||5
8982606|NCT02703324|10045829|FG001|COMPLETED|Period Four||4
8982607|NCT02703324|10045830|FG002|COMPLETED|Period Four||4
8982608|NCT02703324|10045831|FG003|COMPLETED|Period Four||5
8982609|NCT02703324|10045832|FG004|COMPLETED|Period Four||5
8982610|NCT02703324|10045833|FG005|COMPLETED|Period Four||5
8982611|NCT02703324|10045828|FG000|NOT COMPLETED|Period Four||0
8982612|NCT02703324|10045829|FG001|NOT COMPLETED|Period Four||0
8982613|NCT02703324|10045830|FG002|NOT COMPLETED|Period Four||0
8982614|NCT02703324|10045831|FG003|NOT COMPLETED|Period Four||0
8982615|NCT02703324|10045832|FG004|NOT COMPLETED|Period Four||0
8982616|NCT02703324|10045833|FG005|NOT COMPLETED|Period Four||0
8982617|NCT02703337|10045842|FG000|STARTED|Period One (Part A)||5
8982618|NCT02703337|10045843|FG001|STARTED|Period One (Part A)||5
8982619|NCT02703337|10045844|FG002|STARTED|Period One (Part A)||5
8982620|NCT02703337|10045845|FG003|STARTED|Period One (Part A)||5
8982621|NCT02703337|10045846|FG004|STARTED|Period One (Part A)||5
8982622|NCT02703337|10045847|FG005|STARTED|Period One (Part A)||5
8982623|NCT02703337|10045848|FG006|STARTED|Period One (Part A)||0
8982624|NCT02703337|10045849|FG007|STARTED|Period One (Part A)||0
8982625|NCT02703337|10045842|FG000|Received Study Drug|Period One (Part A)||5
8982626|NCT02703337|10045843|FG001|Received Study Drug|Period One (Part A)||5
8982627|NCT02703337|10045844|FG002|Received Study Drug|Period One (Part A)||5
8982628|NCT02703337|10045845|FG003|Received Study Drug|Period One (Part A)||5
8982629|NCT02703337|10045846|FG004|Received Study Drug|Period One (Part A)||5
8982630|NCT02703337|10045847|FG005|Received Study Drug|Period One (Part A)||5
8982631|NCT02703337|10045848|FG006|Received Study Drug|Period One (Part A)||0
8982632|NCT02703337|10045849|FG007|Received Study Drug|Period One (Part A)||0
8982633|NCT02703337|10045842|FG000|COMPLETED|Period One (Part A)||5
8982634|NCT02703337|10045843|FG001|COMPLETED|Period One (Part A)||5
8982635|NCT02703337|10045844|FG002|COMPLETED|Period One (Part A)||5
8982636|NCT02703337|10045845|FG003|COMPLETED|Period One (Part A)||5
8982637|NCT02703337|10045846|FG004|COMPLETED|Period One (Part A)||4
8982638|NCT02703337|10045847|FG005|COMPLETED|Period One (Part A)||5
8982639|NCT02703337|10045848|FG006|COMPLETED|Period One (Part A)||0
8982640|NCT02703337|10045849|FG007|COMPLETED|Period One (Part A)||0
8982641|NCT02703337|10045842|FG000|NOT COMPLETED|Period One (Part A)||0
8982642|NCT02703337|10045843|FG001|NOT COMPLETED|Period One (Part A)||0
8982643|NCT02703337|10045844|FG002|NOT COMPLETED|Period One (Part A)||0
8982644|NCT02703337|10045845|FG003|NOT COMPLETED|Period One (Part A)||0
8982645|NCT02703337|10045846|FG004|NOT COMPLETED|Period One (Part A)||1
8982646|NCT02703337|10045847|FG005|NOT COMPLETED|Period One (Part A)||0
8982647|NCT02703337|10045848|FG006|NOT COMPLETED|Period One (Part A)||0
8982648|NCT02703337|10045849|FG007|NOT COMPLETED|Period One (Part A)||0
8982649|NCT02703337|10045842|FG000|STARTED|Period Two (Part A)||5
8982650|NCT02703337|10045843|FG001|STARTED|Period Two (Part A)||5
8982651|NCT02703337|10045844|FG002|STARTED|Period Two (Part A)||5
8982652|NCT02703337|10045845|FG003|STARTED|Period Two (Part A)||5
8982653|NCT02703337|10045846|FG004|STARTED|Period Two (Part A)||4
8982654|NCT02703337|10045847|FG005|STARTED|Period Two (Part A)||5
8982655|NCT02703337|10045848|FG006|STARTED|Period Two (Part A)||0
8982656|NCT02703337|10045849|FG007|STARTED|Period Two (Part A)||0
8982657|NCT02703337|10045842|FG000|Received Study Drug|Period Two (Part A)||5
8982658|NCT02703337|10045843|FG001|Received Study Drug|Period Two (Part A)||5
8982659|NCT02703337|10045844|FG002|Received Study Drug|Period Two (Part A)||5
8982660|NCT02703337|10045845|FG003|Received Study Drug|Period Two (Part A)||5
8982661|NCT02703337|10045846|FG004|Received Study Drug|Period Two (Part A)||4
8982662|NCT02703337|10045847|FG005|Received Study Drug|Period Two (Part A)||5
8982663|NCT02703337|10045848|FG006|Received Study Drug|Period Two (Part A)||0
8982664|NCT02703337|10045849|FG007|Received Study Drug|Period Two (Part A)||0
8982665|NCT02703337|10045842|FG000|COMPLETED|Period Two (Part A)||5
8982666|NCT02703337|10045843|FG001|COMPLETED|Period Two (Part A)||5
8982667|NCT02703337|10045844|FG002|COMPLETED|Period Two (Part A)||5
8982668|NCT02703337|10045845|FG003|COMPLETED|Period Two (Part A)||5
8982669|NCT02703337|10045846|FG004|COMPLETED|Period Two (Part A)||4
8982670|NCT02703337|10045847|FG005|COMPLETED|Period Two (Part A)||5
8982671|NCT02703337|10045848|FG006|COMPLETED|Period Two (Part A)||0
8982672|NCT02703337|10045849|FG007|COMPLETED|Period Two (Part A)||0
8982673|NCT02703337|10045842|FG000|NOT COMPLETED|Period Two (Part A)||0
8982674|NCT02703337|10045843|FG001|NOT COMPLETED|Period Two (Part A)||0
8982675|NCT02703337|10045844|FG002|NOT COMPLETED|Period Two (Part A)||0
8982676|NCT02703337|10045845|FG003|NOT COMPLETED|Period Two (Part A)||0
8982677|NCT02703337|10045846|FG004|NOT COMPLETED|Period Two (Part A)||0
8982678|NCT02703337|10045847|FG005|NOT COMPLETED|Period Two (Part A)||0
8982679|NCT02703337|10045848|FG006|NOT COMPLETED|Period Two (Part A)||0
8982680|NCT02703337|10045849|FG007|NOT COMPLETED|Period Two (Part A)||0
8982681|NCT02703337|10045842|FG000|STARTED|Period Three (Part A)||5
8982682|NCT02703337|10045843|FG001|STARTED|Period Three (Part A)||5
8982683|NCT02703337|10045844|FG002|STARTED|Period Three (Part A)||5
8982684|NCT02703337|10045845|FG003|STARTED|Period Three (Part A)||5
8982685|NCT02703337|10045846|FG004|STARTED|Period Three (Part A)||4
8982686|NCT02703337|10045847|FG005|STARTED|Period Three (Part A)||5
8982687|NCT02703337|10045848|FG006|STARTED|Period Three (Part A)||0
8982688|NCT02703337|10045849|FG007|STARTED|Period Three (Part A)||0
8982689|NCT02703337|10045842|FG000|Received Study Drug|Period Three (Part A)||5
8982690|NCT02703337|10045843|FG001|Received Study Drug|Period Three (Part A)||5
8982691|NCT02703337|10045844|FG002|Received Study Drug|Period Three (Part A)||5
8982692|NCT02703337|10045845|FG003|Received Study Drug|Period Three (Part A)||5
8982693|NCT02703337|10045846|FG004|Received Study Drug|Period Three (Part A)||4
8982694|NCT02703337|10045847|FG005|Received Study Drug|Period Three (Part A)||5
8982695|NCT02703337|10045848|FG006|Received Study Drug|Period Three (Part A)||0
8982696|NCT02703337|10045849|FG007|Received Study Drug|Period Three (Part A)||0
8982697|NCT02703337|10045842|FG000|COMPLETED|Period Three (Part A)||5
8982698|NCT02703337|10045843|FG001|COMPLETED|Period Three (Part A)||5
8982699|NCT02703337|10045844|FG002|COMPLETED|Period Three (Part A)||5
8982700|NCT02703337|10045845|FG003|COMPLETED|Period Three (Part A)||5
8982701|NCT02703337|10045846|FG004|COMPLETED|Period Three (Part A)||4
8982702|NCT02703337|10045847|FG005|COMPLETED|Period Three (Part A)||5
8982703|NCT02703337|10045848|FG006|COMPLETED|Period Three (Part A)||0
8982704|NCT02703337|10045849|FG007|COMPLETED|Period Three (Part A)||0
8982705|NCT02703337|10045842|FG000|NOT COMPLETED|Period Three (Part A)||0
8982706|NCT02703337|10045843|FG001|NOT COMPLETED|Period Three (Part A)||0
8982707|NCT02703337|10045844|FG002|NOT COMPLETED|Period Three (Part A)||0
8982708|NCT02703337|10045845|FG003|NOT COMPLETED|Period Three (Part A)||0
8982709|NCT02703337|10045846|FG004|NOT COMPLETED|Period Three (Part A)||0
8982710|NCT02703337|10045847|FG005|NOT COMPLETED|Period Three (Part A)||0
8982711|NCT02703337|10045848|FG006|NOT COMPLETED|Period Three (Part A)||0
8982712|NCT02703337|10045849|FG007|NOT COMPLETED|Period Three (Part A)||0
8982713|NCT02703337|10045842|FG000|STARTED|Period Four (Part A)||5
8982714|NCT02703337|10045843|FG001|STARTED|Period Four (Part A)||5
8982715|NCT02703337|10045844|FG002|STARTED|Period Four (Part A)||5
8982716|NCT02703337|10045845|FG003|STARTED|Period Four (Part A)||5
8982717|NCT02703337|10045846|FG004|STARTED|Period Four (Part A)||4
8982718|NCT02703337|10045847|FG005|STARTED|Period Four (Part A)||5
8982719|NCT02703337|10045848|FG006|STARTED|Period Four (Part A)||0
8982720|NCT02703337|10045849|FG007|STARTED|Period Four (Part A)||0
8982721|NCT02703337|10045842|FG000|Received Study Drug|Period Four (Part A)||5
8982722|NCT02703337|10045843|FG001|Received Study Drug|Period Four (Part A)||5
8982723|NCT02703337|10045844|FG002|Received Study Drug|Period Four (Part A)||5
8982724|NCT02703337|10045845|FG003|Received Study Drug|Period Four (Part A)||5
8982725|NCT02703337|10045846|FG004|Received Study Drug|Period Four (Part A)||4
8982726|NCT02703337|10045847|FG005|Received Study Drug|Period Four (Part A)||5
8982727|NCT02703337|10045848|FG006|Received Study Drug|Period Four (Part A)||0
8982728|NCT02703337|10045849|FG007|Received Study Drug|Period Four (Part A)||0
8982729|NCT02703337|10045842|FG000|COMPLETED|Period Four (Part A)||5
8982730|NCT02703337|10045843|FG001|COMPLETED|Period Four (Part A)||5
8982731|NCT02703337|10045844|FG002|COMPLETED|Period Four (Part A)||5
8982732|NCT02703337|10045845|FG003|COMPLETED|Period Four (Part A)||5
8982733|NCT02703337|10045846|FG004|COMPLETED|Period Four (Part A)||4
8982734|NCT02703337|10045847|FG005|COMPLETED|Period Four (Part A)||5
8982735|NCT02703337|10045848|FG006|COMPLETED|Period Four (Part A)||0
8982736|NCT02703337|10045849|FG007|COMPLETED|Period Four (Part A)||0
8982737|NCT02703337|10045842|FG000|NOT COMPLETED|Period Four (Part A)||0
8982738|NCT02703337|10045843|FG001|NOT COMPLETED|Period Four (Part A)||0
8982739|NCT02703337|10045844|FG002|NOT COMPLETED|Period Four (Part A)||0
8982740|NCT02703337|10045845|FG003|NOT COMPLETED|Period Four (Part A)||0
8982741|NCT02703337|10045846|FG004|NOT COMPLETED|Period Four (Part A)||0
8982742|NCT02703337|10045847|FG005|NOT COMPLETED|Period Four (Part A)||0
8877553|NCT01924299|9934508|FG000|Received Baricitinib|Period 1||18
8877554|NCT01924299|9934509|FG001|Received Baricitinib|Period 1||18
8877555|NCT01924299|9934508|FG000|COMPLETED|Period 1||18
8982743|NCT02703337|10045848|FG006|NOT COMPLETED|Period Four (Part A)||0
8982744|NCT02703337|10045849|FG007|NOT COMPLETED|Period Four (Part A)||0
8982745|NCT02703337|10045842|FG000|STARTED|Period Five (Part A)||5
8982746|NCT02703337|10045843|FG001|STARTED|Period Five (Part A)||5
8982747|NCT02703337|10045844|FG002|STARTED|Period Five (Part A)||5
8982748|NCT02703337|10045845|FG003|STARTED|Period Five (Part A)||5
8982749|NCT02703337|10045846|FG004|STARTED|Period Five (Part A)||4
8982750|NCT02703337|10045847|FG005|STARTED|Period Five (Part A)||5
8982751|NCT02703337|10045848|FG006|STARTED|Period Five (Part A)||0
8982752|NCT02703337|10045849|FG007|STARTED|Period Five (Part A)||0
8982753|NCT02703337|10045842|FG000|Received Study Drug|Period Five (Part A)||5
8982754|NCT02703337|10045843|FG001|Received Study Drug|Period Five (Part A)||5
8982755|NCT02703337|10045844|FG002|Received Study Drug|Period Five (Part A)||5
8982756|NCT02703337|10045845|FG003|Received Study Drug|Period Five (Part A)||5
8982757|NCT02703337|10045846|FG004|Received Study Drug|Period Five (Part A)||4
8982758|NCT02703337|10045847|FG005|Received Study Drug|Period Five (Part A)||5
8982759|NCT02703337|10045848|FG006|Received Study Drug|Period Five (Part A)||0
8982760|NCT02703337|10045849|FG007|Received Study Drug|Period Five (Part A)||0
8877556|NCT01924299|9934509|FG001|COMPLETED|Period 1||18
8877557|NCT01924299|9934508|FG000|NOT COMPLETED|Period 1||0
8877558|NCT01924299|9934509|FG001|NOT COMPLETED|Period 1||0
8877559|NCT01924299|9934508|FG000|STARTED|Period 2||18
8877560|NCT01924299|9934509|FG001|STARTED|Period 2||18
8877561|NCT01924299|9934508|FG000|Received at Least 1 Dose of Study Drug|Period 2||18
8877562|NCT01924299|9934509|FG001|Received at Least 1 Dose of Study Drug|Period 2||18
8982761|NCT02703337|10045842|FG000|COMPLETED|Period Five (Part A)||5
8982762|NCT02703337|10045843|FG001|COMPLETED|Period Five (Part A)||5
8877563|NCT01924299|9934508|FG000|Received Baricitinib|Period 2||17
8877564|NCT01924299|9934509|FG001|Received Baricitinib|Period 2||17
8877565|NCT01924299|9934508|FG000|COMPLETED|Period 2||17
8982763|NCT02703337|10045844|FG002|COMPLETED|Period Five (Part A)||5
8982764|NCT02703337|10045845|FG003|COMPLETED|Period Five (Part A)||5
8982765|NCT02703337|10045846|FG004|COMPLETED|Period Five (Part A)||4
8982766|NCT02703337|10045847|FG005|COMPLETED|Period Five (Part A)||5
8877566|NCT01924299|9934509|FG001|COMPLETED|Period 2||17
8877567|NCT01924299|9934508|FG000|NOT COMPLETED|Period 2||1
8982767|NCT02703337|10045848|FG006|COMPLETED|Period Five (Part A)||0
8982768|NCT02703337|10045849|FG007|COMPLETED|Period Five (Part A)||0
8982769|NCT02703337|10045842|FG000|NOT COMPLETED|Period Five (Part A)||0
8982770|NCT02703337|10045843|FG001|NOT COMPLETED|Period Five (Part A)||0
8982771|NCT02703337|10045844|FG002|NOT COMPLETED|Period Five (Part A)||0
8982772|NCT02703337|10045845|FG003|NOT COMPLETED|Period Five (Part A)||0
8982773|NCT02703337|10045846|FG004|NOT COMPLETED|Period Five (Part A)||0
8982774|NCT02703337|10045847|FG005|NOT COMPLETED|Period Five (Part A)||0
8982775|NCT02703337|10045848|FG006|NOT COMPLETED|Period Five (Part A)||0
8982776|NCT02703337|10045849|FG007|NOT COMPLETED|Period Five (Part A)||0
8982777|NCT02703337|10045842|FG000|STARTED|Period Six (Part A)||5
8982778|NCT02703337|10045843|FG001|STARTED|Period Six (Part A)||5
8982779|NCT02703337|10045844|FG002|STARTED|Period Six (Part A)||5
8982780|NCT02703337|10045845|FG003|STARTED|Period Six (Part A)||5
8982781|NCT02703337|10045846|FG004|STARTED|Period Six (Part A)||4
8982782|NCT02703337|10045847|FG005|STARTED|Period Six (Part A)||5
8982783|NCT02703337|10045848|FG006|STARTED|Period Six (Part A)||0
8982784|NCT02703337|10045849|FG007|STARTED|Period Six (Part A)||0
8632596|NCT00546364|9672566|FG002|STARTED|Overall Study||20
8632597|NCT00546364|9672564|FG000|Never Treated|Overall Study||0
8632598|NCT00546364|9672565|FG001|Never Treated|Overall Study||0
8632599|NCT00546364|9672566|FG002|Never Treated|Overall Study||0
8632600|NCT00546364|9672564|FG000|COMPLETED|Overall Study|Still on treatment|3
8982785|NCT02703337|10045842|FG000|Received Study Drug|Period Six (Part A)||5
8982786|NCT02703337|10045843|FG001|Received Study Drug|Period Six (Part A)||5
8982787|NCT02703337|10045844|FG002|Received Study Drug|Period Six (Part A)||5
8982788|NCT02703337|10045845|FG003|Received Study Drug|Period Six (Part A)||5
8982789|NCT02703337|10045846|FG004|Received Study Drug|Period Six (Part A)||4
8982790|NCT02703337|10045847|FG005|Received Study Drug|Period Six (Part A)||5
8982791|NCT02703337|10045848|FG006|Received Study Drug|Period Six (Part A)||0
8982792|NCT02703337|10045849|FG007|Received Study Drug|Period Six (Part A)||0
8982793|NCT02703337|10045842|FG000|COMPLETED|Period Six (Part A)||5
8982794|NCT02703337|10045843|FG001|COMPLETED|Period Six (Part A)||5
8982795|NCT02703337|10045844|FG002|COMPLETED|Period Six (Part A)||5
8982796|NCT02703337|10045845|FG003|COMPLETED|Period Six (Part A)||5
8982797|NCT02703337|10045846|FG004|COMPLETED|Period Six (Part A)||4
8982798|NCT02703337|10045847|FG005|COMPLETED|Period Six (Part A)||5
8982799|NCT02703337|10045848|FG006|COMPLETED|Period Six (Part A)||0
8982800|NCT02703337|10045849|FG007|COMPLETED|Period Six (Part A)||0
8982801|NCT02703337|10045842|FG000|NOT COMPLETED|Period Six (Part A)||0
8982802|NCT02703337|10045843|FG001|NOT COMPLETED|Period Six (Part A)||0
8982803|NCT02703337|10045844|FG002|NOT COMPLETED|Period Six (Part A)||0
8982804|NCT02703337|10045845|FG003|NOT COMPLETED|Period Six (Part A)||0
8982805|NCT02703337|10045846|FG004|NOT COMPLETED|Period Six (Part A)||0
8982806|NCT02703337|10045847|FG005|NOT COMPLETED|Period Six (Part A)||0
8982807|NCT02703337|10045848|FG006|NOT COMPLETED|Period Six (Part A)||0
8982808|NCT02703337|10045849|FG007|NOT COMPLETED|Period Six (Part A)||0
8982809|NCT02703337|10045842|FG000|STARTED|Part B||0
8982810|NCT02703337|10045843|FG001|STARTED|Part B||0
8982811|NCT02703337|10045844|FG002|STARTED|Part B||0
8982812|NCT02703337|10045845|FG003|STARTED|Part B||0
8982813|NCT02703337|10045846|FG004|STARTED|Part B||0
8982814|NCT02703337|10045847|FG005|STARTED|Part B||0
8982815|NCT02703337|10045848|FG006|STARTED|Part B||15
8982816|NCT02703337|10045849|FG007|STARTED|Part B||14
8982817|NCT02703337|10045842|FG000|Received Study Drug|Part B||0
8982818|NCT02703337|10045843|FG001|Received Study Drug|Part B||0
8982819|NCT02703337|10045844|FG002|Received Study Drug|Part B||0
8982820|NCT02703337|10045845|FG003|Received Study Drug|Part B||0
8982821|NCT02703337|10045846|FG004|Received Study Drug|Part B||0
8982822|NCT02703337|10045847|FG005|Received Study Drug|Part B||0
8982823|NCT02703337|10045848|FG006|Received Study Drug|Part B||15
8982824|NCT02703337|10045849|FG007|Received Study Drug|Part B||14
8982825|NCT02703337|10045842|FG000|COMPLETED|Part B||0
8982826|NCT02703337|10045843|FG001|COMPLETED|Part B||0
8982827|NCT02703337|10045844|FG002|COMPLETED|Part B||0
8982828|NCT02703337|10045845|FG003|COMPLETED|Part B||0
8982829|NCT02703337|10045846|FG004|COMPLETED|Part B||0
8982830|NCT02703337|10045847|FG005|COMPLETED|Part B||0
8982831|NCT02703337|10045848|FG006|COMPLETED|Part B||15
8982832|NCT02703337|10045849|FG007|COMPLETED|Part B||14
8982833|NCT02703337|10045842|FG000|NOT COMPLETED|Part B||0
8982834|NCT02703337|10045843|FG001|NOT COMPLETED|Part B||0
8982835|NCT02703337|10045844|FG002|NOT COMPLETED|Part B||0
8982836|NCT02703337|10045845|FG003|NOT COMPLETED|Part B||0
8982837|NCT02703337|10045846|FG004|NOT COMPLETED|Part B||0
8982838|NCT02703337|10045847|FG005|NOT COMPLETED|Part B||0
8982839|NCT02703337|10045848|FG006|NOT COMPLETED|Part B||0
8982840|NCT02703337|10045849|FG007|NOT COMPLETED|Part B||0
8982841|NCT02703350|10045867|FG000|STARTED|Period One (Part A)||5
8982842|NCT02703350|10045868|FG001|STARTED|Period One (Part A)||5
8982843|NCT02703350|10045869|FG002|STARTED|Period One (Part A)||5
8982844|NCT02703350|10045870|FG003|STARTED|Period One (Part A)||5
8982845|NCT02703350|10045871|FG004|STARTED|Period One (Part A)||5
8982846|NCT02703350|10045872|FG005|STARTED|Period One (Part A)||5
8982847|NCT02703350|10045873|FG006|STARTED|Period One (Part A)||0
8982848|NCT02703350|10045874|FG007|STARTED|Period One (Part A)||0
8632601|NCT00546364|9672565|FG001|COMPLETED|Overall Study|Still on treatment|4
8982849|NCT02703350|10045867|FG000|Received Study Drug|Period One (Part A)||5
8982850|NCT02703350|10045868|FG001|Received Study Drug|Period One (Part A)||5
8982851|NCT02703350|10045869|FG002|Received Study Drug|Period One (Part A)||5
8982852|NCT02703350|10045870|FG003|Received Study Drug|Period One (Part A)||5
8982853|NCT02703350|10045871|FG004|Received Study Drug|Period One (Part A)||5
8982854|NCT02703350|10045872|FG005|Received Study Drug|Period One (Part A)||5
8982855|NCT02703350|10045873|FG006|Received Study Drug|Period One (Part A)||0
8982856|NCT02703350|10045874|FG007|Received Study Drug|Period One (Part A)||0
8982857|NCT02703350|10045867|FG000|COMPLETED|Period One (Part A)||5
8982858|NCT02703350|10045868|FG001|COMPLETED|Period One (Part A)||5
8982859|NCT02703350|10045869|FG002|COMPLETED|Period One (Part A)||5
8982860|NCT02703350|10045870|FG003|COMPLETED|Period One (Part A)||5
8982861|NCT02703350|10045871|FG004|COMPLETED|Period One (Part A)||5
8982862|NCT02703350|10045872|FG005|COMPLETED|Period One (Part A)||5
8982863|NCT02703350|10045873|FG006|COMPLETED|Period One (Part A)||0
8982864|NCT02703350|10045874|FG007|COMPLETED|Period One (Part A)||0
8982865|NCT02703350|10045867|FG000|NOT COMPLETED|Period One (Part A)||0
8982866|NCT02703350|10045868|FG001|NOT COMPLETED|Period One (Part A)||0
8982867|NCT02703350|10045869|FG002|NOT COMPLETED|Period One (Part A)||0
8982868|NCT02703350|10045870|FG003|NOT COMPLETED|Period One (Part A)||0
8982869|NCT02703350|10045871|FG004|NOT COMPLETED|Period One (Part A)||0
8982870|NCT02703350|10045872|FG005|NOT COMPLETED|Period One (Part A)||0
8982871|NCT02703350|10045873|FG006|NOT COMPLETED|Period One (Part A)||0
8982872|NCT02703350|10045874|FG007|NOT COMPLETED|Period One (Part A)||0
8982873|NCT02703350|10045867|FG000|STARTED|Period Two (Part A)||5
8982874|NCT02703350|10045868|FG001|STARTED|Period Two (Part A)||5
8982875|NCT02703350|10045869|FG002|STARTED|Period Two (Part A)||5
8982876|NCT02703350|10045870|FG003|STARTED|Period Two (Part A)||5
8982877|NCT02703350|10045871|FG004|STARTED|Period Two (Part A)||5
8982878|NCT02703350|10045872|FG005|STARTED|Period Two (Part A)||5
8982879|NCT02703350|10045873|FG006|STARTED|Period Two (Part A)||0
8982880|NCT02703350|10045874|FG007|STARTED|Period Two (Part A)||0
8982881|NCT02703350|10045867|FG000|Received Study Drug|Period Two (Part A)||5
8982882|NCT02703350|10045868|FG001|Received Study Drug|Period Two (Part A)||5
8982883|NCT02703350|10045869|FG002|Received Study Drug|Period Two (Part A)||5
8982884|NCT02703350|10045870|FG003|Received Study Drug|Period Two (Part A)||5
8982885|NCT02703350|10045871|FG004|Received Study Drug|Period Two (Part A)||5
8982886|NCT02703350|10045872|FG005|Received Study Drug|Period Two (Part A)||5
8632602|NCT00546364|9672566|FG002|COMPLETED|Overall Study|Still on treatment|3
8632603|NCT00546364|9672564|FG000|NOT COMPLETED|Overall Study||17
8632604|NCT00546364|9672565|FG001|NOT COMPLETED|Overall Study||18
8632605|NCT00546364|9672566|FG002|NOT COMPLETED|Overall Study||17
8632606|NCT00546377|9672574|FG000|STARTED|Overall Study||50
8632607|NCT00546377|9672574|FG000|COMPLETED|Overall Study||43
8982887|NCT02703350|10045873|FG006|Received Study Drug|Period Two (Part A)||0
8982888|NCT02703350|10045874|FG007|Received Study Drug|Period Two (Part A)||0
8982889|NCT02703350|10045867|FG000|COMPLETED|Period Two (Part A)||5
8982890|NCT02703350|10045868|FG001|COMPLETED|Period Two (Part A)||5
8982891|NCT02703350|10045869|FG002|COMPLETED|Period Two (Part A)||5
8982892|NCT02703350|10045870|FG003|COMPLETED|Period Two (Part A)||5
8982893|NCT02703350|10045871|FG004|COMPLETED|Period Two (Part A)||5
8632608|NCT00546377|9672574|FG000|NOT COMPLETED|Overall Study||7
8632609|NCT00546390|9672580|FG000|STARTED|Overall Study||27
8632610|NCT00546390|9672581|FG001|STARTED|Overall Study||28
8632611|NCT00546390|9672580|FG000|COMPLETED|Overall Study||27
8632612|NCT00546390|9672581|FG001|COMPLETED|Overall Study||28
8632613|NCT00546390|9672580|FG000|NOT COMPLETED|Overall Study||0
8632614|NCT00546390|9672581|FG001|NOT COMPLETED|Overall Study||0
8691285|NCT00853957|9736512|FG001|NOT COMPLETED|Overall Study||19
8691286|NCT00853970|9736520|FG000|STARTED|Overall Study||152
8691287|NCT00853970|9736521|FG001|STARTED|Overall Study||147
8691288|NCT00853970|9736520|FG000|COMPLETED|Overall Study||146
8691289|NCT00853970|9736521|FG001|COMPLETED|Overall Study||144
8691290|NCT00853970|9736520|FG000|NOT COMPLETED|Overall Study||6
8982894|NCT02703350|10045872|FG005|COMPLETED|Period Two (Part A)||5
8982895|NCT02703350|10045873|FG006|COMPLETED|Period Two (Part A)||0
8982896|NCT02703350|10045874|FG007|COMPLETED|Period Two (Part A)||0
8982897|NCT02703350|10045867|FG000|NOT COMPLETED|Period Two (Part A)||0
8982898|NCT02703350|10045868|FG001|NOT COMPLETED|Period Two (Part A)||0
8982899|NCT02703350|10045869|FG002|NOT COMPLETED|Period Two (Part A)||0
8982900|NCT02703350|10045870|FG003|NOT COMPLETED|Period Two (Part A)||0
8982901|NCT02703350|10045871|FG004|NOT COMPLETED|Period Two (Part A)||0
8982902|NCT02703350|10045872|FG005|NOT COMPLETED|Period Two (Part A)||0
8982903|NCT02703350|10045873|FG006|NOT COMPLETED|Period Two (Part A)||0
8982904|NCT02703350|10045874|FG007|NOT COMPLETED|Period Two (Part A)||0
8982905|NCT02703350|10045867|FG000|STARTED|Period Three (Part A)||5
8982906|NCT02703350|10045868|FG001|STARTED|Period Three (Part A)||5
8982907|NCT02703350|10045869|FG002|STARTED|Period Three (Part A)||5
8982908|NCT02703350|10045870|FG003|STARTED|Period Three (Part A)||5
8982909|NCT02703350|10045871|FG004|STARTED|Period Three (Part A)||5
8982910|NCT02703350|10045872|FG005|STARTED|Period Three (Part A)||5
8982911|NCT02703350|10045873|FG006|STARTED|Period Three (Part A)||0
8982912|NCT02703350|10045874|FG007|STARTED|Period Three (Part A)||0
8982913|NCT02703350|10045867|FG000|Received Study Drug|Period Three (Part A)||5
8691291|NCT00853970|9736521|FG001|NOT COMPLETED|Overall Study||3
8691292|NCT00853996|9736527|FG000|STARTED|Overall Study||25
8691293|NCT00853996|9736527|FG000|COMPLETED|Overall Study||25
8691294|NCT00853996|9736527|FG000|NOT COMPLETED|Overall Study||0
8691295|NCT00854061|9736531|FG000|STARTED|Overall Study||172
8982914|NCT02703350|10045868|FG001|Received Study Drug|Period Three (Part A)||5
8982915|NCT02703350|10045869|FG002|Received Study Drug|Period Three (Part A)||5
8982916|NCT02703350|10045870|FG003|Received Study Drug|Period Three (Part A)||5
8982917|NCT02703350|10045871|FG004|Received Study Drug|Period Three (Part A)||5
8982918|NCT02703350|10045872|FG005|Received Study Drug|Period Three (Part A)||5
8982919|NCT02703350|10045873|FG006|Received Study Drug|Period Three (Part A)||0
8982920|NCT02703350|10045874|FG007|Received Study Drug|Period Three (Part A)||0
8982921|NCT02703350|10045867|FG000|COMPLETED|Period Three (Part A)||5
8982922|NCT02703350|10045868|FG001|COMPLETED|Period Three (Part A)||5
8982923|NCT02703350|10045869|FG002|COMPLETED|Period Three (Part A)||5
8982924|NCT02703350|10045870|FG003|COMPLETED|Period Three (Part A)||5
8982925|NCT02703350|10045871|FG004|COMPLETED|Period Three (Part A)||5
8982926|NCT02703350|10045872|FG005|COMPLETED|Period Three (Part A)||5
8982927|NCT02703350|10045873|FG006|COMPLETED|Period Three (Part A)||0
8982928|NCT02703350|10045874|FG007|COMPLETED|Period Three (Part A)||0
8982929|NCT02703350|10045867|FG000|NOT COMPLETED|Period Three (Part A)||0
8982930|NCT02703350|10045868|FG001|NOT COMPLETED|Period Three (Part A)||0
8982931|NCT02703350|10045869|FG002|NOT COMPLETED|Period Three (Part A)||0
8982932|NCT02703350|10045870|FG003|NOT COMPLETED|Period Three (Part A)||0
8982933|NCT02703350|10045871|FG004|NOT COMPLETED|Period Three (Part A)||0
8982934|NCT02703350|10045872|FG005|NOT COMPLETED|Period Three (Part A)||0
8982935|NCT02703350|10045873|FG006|NOT COMPLETED|Period Three (Part A)||0
8982936|NCT02703350|10045874|FG007|NOT COMPLETED|Period Three (Part A)||0
8982937|NCT02703350|10045867|FG000|STARTED|Period Four (Part A)||5
8982938|NCT02703350|10045868|FG001|STARTED|Period Four (Part A)||5
8982939|NCT02703350|10045869|FG002|STARTED|Period Four (Part A)||5
8982940|NCT02703350|10045870|FG003|STARTED|Period Four (Part A)||5
8982941|NCT02703350|10045871|FG004|STARTED|Period Four (Part A)||5
8982942|NCT02703350|10045872|FG005|STARTED|Period Four (Part A)||5
8982943|NCT02703350|10045873|FG006|STARTED|Period Four (Part A)||0
8982944|NCT02703350|10045874|FG007|STARTED|Period Four (Part A)||0
8982945|NCT02703350|10045867|FG000|Received Study Drug|Period Four (Part A)||5
8982946|NCT02703350|10045868|FG001|Received Study Drug|Period Four (Part A)||5
8982947|NCT02703350|10045869|FG002|Received Study Drug|Period Four (Part A)||5
8982948|NCT02703350|10045870|FG003|Received Study Drug|Period Four (Part A)||5
8982949|NCT02703350|10045871|FG004|Received Study Drug|Period Four (Part A)||5
8982950|NCT02703350|10045872|FG005|Received Study Drug|Period Four (Part A)||5
8982951|NCT02703350|10045873|FG006|Received Study Drug|Period Four (Part A)||0
8982952|NCT02703350|10045874|FG007|Received Study Drug|Period Four (Part A)||0
8982953|NCT02703350|10045867|FG000|COMPLETED|Period Four (Part A)||5
8982954|NCT02703350|10045868|FG001|COMPLETED|Period Four (Part A)||5
8982955|NCT02703350|10045869|FG002|COMPLETED|Period Four (Part A)||5
8982956|NCT02703350|10045870|FG003|COMPLETED|Period Four (Part A)||5
8982957|NCT02703350|10045871|FG004|COMPLETED|Period Four (Part A)||5
8982958|NCT02703350|10045872|FG005|COMPLETED|Period Four (Part A)||5
8982959|NCT02703350|10045873|FG006|COMPLETED|Period Four (Part A)||0
8982960|NCT02703350|10045874|FG007|COMPLETED|Period Four (Part A)||0
8982961|NCT02703350|10045867|FG000|NOT COMPLETED|Period Four (Part A)||0
8982962|NCT02703350|10045868|FG001|NOT COMPLETED|Period Four (Part A)||0
8982963|NCT02703350|10045869|FG002|NOT COMPLETED|Period Four (Part A)||0
8982964|NCT02703350|10045870|FG003|NOT COMPLETED|Period Four (Part A)||0
8982965|NCT02703350|10045871|FG004|NOT COMPLETED|Period Four (Part A)||0
8982966|NCT02703350|10045872|FG005|NOT COMPLETED|Period Four (Part A)||0
8982967|NCT02703350|10045873|FG006|NOT COMPLETED|Period Four (Part A)||0
8982968|NCT02703350|10045874|FG007|NOT COMPLETED|Period Four (Part A)||0
8982969|NCT02703350|10045867|FG000|STARTED|Period Five (Part A)||5
8982970|NCT02703350|10045868|FG001|STARTED|Period Five (Part A)||5
8982971|NCT02703350|10045869|FG002|STARTED|Period Five (Part A)||5
8982972|NCT02703350|10045870|FG003|STARTED|Period Five (Part A)||5
8982973|NCT02703350|10045871|FG004|STARTED|Period Five (Part A)||5
8982974|NCT02703350|10045872|FG005|STARTED|Period Five (Part A)||5
8982975|NCT02703350|10045873|FG006|STARTED|Period Five (Part A)||0
8982976|NCT02703350|10045874|FG007|STARTED|Period Five (Part A)||0
8982977|NCT02703350|10045867|FG000|Received Study Drug|Period Five (Part A)||5
8982978|NCT02703350|10045868|FG001|Received Study Drug|Period Five (Part A)||5
8982979|NCT02703350|10045869|FG002|Received Study Drug|Period Five (Part A)||5
8982980|NCT02703350|10045870|FG003|Received Study Drug|Period Five (Part A)||5
8982981|NCT02703350|10045871|FG004|Received Study Drug|Period Five (Part A)||5
8982982|NCT02703350|10045872|FG005|Received Study Drug|Period Five (Part A)||5
8982983|NCT02703350|10045873|FG006|Received Study Drug|Period Five (Part A)||0
8982984|NCT02703350|10045874|FG007|Received Study Drug|Period Five (Part A)||0
8982985|NCT02703350|10045867|FG000|COMPLETED|Period Five (Part A)||5
8982986|NCT02703350|10045868|FG001|COMPLETED|Period Five (Part A)||5
8982987|NCT02703350|10045869|FG002|COMPLETED|Period Five (Part A)||5
8982988|NCT02703350|10045870|FG003|COMPLETED|Period Five (Part A)||5
8982989|NCT02703350|10045871|FG004|COMPLETED|Period Five (Part A)||5
8982990|NCT02703350|10045872|FG005|COMPLETED|Period Five (Part A)||5
8982991|NCT02703350|10045873|FG006|COMPLETED|Period Five (Part A)||0
8982992|NCT02703350|10045874|FG007|COMPLETED|Period Five (Part A)||0
8982993|NCT02703350|10045867|FG000|NOT COMPLETED|Period Five (Part A)||0
8982994|NCT02703350|10045868|FG001|NOT COMPLETED|Period Five (Part A)||0
8982995|NCT02703350|10045869|FG002|NOT COMPLETED|Period Five (Part A)||0
8982996|NCT02703350|10045870|FG003|NOT COMPLETED|Period Five (Part A)||0
8982997|NCT02703350|10045871|FG004|NOT COMPLETED|Period Five (Part A)||0
8982998|NCT02703350|10045872|FG005|NOT COMPLETED|Period Five (Part A)||0
8982999|NCT02703350|10045873|FG006|NOT COMPLETED|Period Five (Part A)||0
8983000|NCT02703350|10045874|FG007|NOT COMPLETED|Period Five (Part A)||0
8983001|NCT02703350|10045867|FG000|STARTED|Period Six (Part A)||5
8983002|NCT02703350|10045868|FG001|STARTED|Period Six (Part A)||5
8983003|NCT02703350|10045869|FG002|STARTED|Period Six (Part A)||5
8983004|NCT02703350|10045870|FG003|STARTED|Period Six (Part A)||5
8983005|NCT02703350|10045871|FG004|STARTED|Period Six (Part A)||5
8983006|NCT02703350|10045872|FG005|STARTED|Period Six (Part A)||5
8983007|NCT02703350|10045873|FG006|STARTED|Period Six (Part A)||0
8983008|NCT02703350|10045874|FG007|STARTED|Period Six (Part A)||0
8983009|NCT02703350|10045867|FG000|Received Study Drug|Period Six (Part A)||5
8983010|NCT02703350|10045868|FG001|Received Study Drug|Period Six (Part A)||5
8632615|NCT00546429|9672588|FG000|STARTED|Overall Study|2 subjects did not have a preoperative Merle D'Aubigne score.|62
8632616|NCT00546429|9672588|FG000|COMPLETED|Overall Study||32
8632617|NCT00546429|9672588|FG000|NOT COMPLETED|Overall Study||30
8632618|NCT00546481|9672594|FG000|STARTED|Correction Phase (CERA or Epoetin Beta)||39
8632619|NCT00546481|9672595|FG001|STARTED|Correction Phase (CERA or Epoetin Beta)||41
8632620|NCT00546481|9672596|FG002|STARTED|Correction Phase (CERA or Epoetin Beta)||0
8983011|NCT02703350|10045869|FG002|Received Study Drug|Period Six (Part A)||5
8571474|NCT00110617|9603790|FG001|On Going at Week 24|Overall Study||53
8571475|NCT00110617|9603789|FG000|COMPLETED|Overall Study||96
8571476|NCT00110617|9603790|FG001|COMPLETED|Overall Study||39
8571477|NCT00110617|9603789|FG000|NOT COMPLETED|Overall Study||39
8571478|NCT00110617|9603790|FG001|NOT COMPLETED|Overall Study||29
8571479|NCT00110812|9603801|FG000|STARTED|Main Study||91
8571480|NCT00110812|9603802|FG001|STARTED|Main Study||89
8571481|NCT00110812|9603803|FG002|STARTED|Main Study||87
8571482|NCT00110812|9603801|FG000|COMPLETED|Main Study||83
8571483|NCT00110812|9603802|FG001|COMPLETED|Main Study||78
8571484|NCT00110812|9603803|FG002|COMPLETED|Main Study||74
8571485|NCT00110812|9603801|FG000|NOT COMPLETED|Main Study||8
8571486|NCT00110812|9603802|FG001|NOT COMPLETED|Main Study||11
8571487|NCT00110812|9603803|FG002|NOT COMPLETED|Main Study||13
8571488|NCT00110812|9603801|FG000|STARTED|Extended Follow-up||80
8571489|NCT00110812|9603802|FG001|STARTED|Extended Follow-up||69
8571490|NCT00110812|9603803|FG002|STARTED|Extended Follow-up||73
8571491|NCT00110812|9603801|FG000|COMPLETED|Extended Follow-up||78
8571492|NCT00110812|9603802|FG001|COMPLETED|Extended Follow-up||65
8571493|NCT00110812|9603803|FG002|COMPLETED|Extended Follow-up||69
8571494|NCT00110812|9603801|FG000|NOT COMPLETED|Extended Follow-up||2
8571495|NCT00110812|9603802|FG001|NOT COMPLETED|Extended Follow-up||4
8571496|NCT00110812|9603803|FG002|NOT COMPLETED|Extended Follow-up||4
8571497|NCT00110890|9603818|FG000|STARTED|Overall Study||368
8571498|NCT00110890|9603819|FG001|STARTED|Overall Study||184
8571499|NCT00110890|9603818|FG000|End of Dose Optimization Phase|Overall Study|Weeks 1 to 16|316
8571500|NCT00110890|9603819|FG001|End of Dose Optimization Phase|Overall Study|Weeks 1 to 16|170
8571501|NCT00110890|9603818|FG000|End of Efficacy Assessment Phase|Overall Study|Weeks 17 to 23|280
8571502|NCT00110890|9603819|FG001|End of Efficacy Assessment Phase|Overall Study|Weeks 17 to 23|150
8571503|NCT00110890|9603818|FG000|COMPLETED|Overall Study|Follow-up Phase|7
8571504|NCT00110890|9603819|FG001|COMPLETED|Overall Study|Follow-up Phase|5
8571505|NCT00110890|9603818|FG000|NOT COMPLETED|Overall Study||361
8571506|NCT00110890|9603819|FG001|NOT COMPLETED|Overall Study||179
8571507|NCT00110994|9603827|FG000|STARTED|Double-blind (DB) Treatment|ITT population|51
8571508|NCT00110994|9603828|FG001|STARTED|Double-blind (DB) Treatment|ITT population|50
8571509|NCT00110994|9603827|FG000|Received Treatment|Double-blind (DB) Treatment|Safety population|51
8571510|NCT00110994|9603828|FG001|Received Treatment|Double-blind (DB) Treatment|Safety population|50
8571511|NCT00110994|9603827|FG000|COMPLETED|Double-blind (DB) Treatment||9
8571512|NCT00110994|9603828|FG001|COMPLETED|Double-blind (DB) Treatment||3
8571513|NCT00110994|9603827|FG000|NOT COMPLETED|Double-blind (DB) Treatment||42
8571514|NCT00110994|9603828|FG001|NOT COMPLETED|Double-blind (DB) Treatment||47
8571515|NCT00110994|9603827|FG000|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|1
8571516|NCT00110994|9603828|FG001|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|2
8571517|NCT00110994|9603827|FG000|COMPLETED|Active Follow-up||0
8571518|NCT00110994|9603828|FG001|COMPLETED|Active Follow-up||0
8571519|NCT00110994|9603827|FG000|NOT COMPLETED|Active Follow-up||1
8571520|NCT00110994|9603828|FG001|NOT COMPLETED|Active Follow-up||2
8571521|NCT00110994|9603827|FG000|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|41
8571522|NCT00110994|9603828|FG001|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|47
8571523|NCT00110994|9603827|FG000|COMPLETED|Long Term Follow-up||22
8571524|NCT00110994|9603828|FG001|COMPLETED|Long Term Follow-up||30
8571525|NCT00110994|9603827|FG000|NOT COMPLETED|Long Term Follow-up||19
8571526|NCT00110994|9603828|FG001|NOT COMPLETED|Long Term Follow-up||17
8571527|NCT00111007|9603836|FG000|STARTED|Double-blind (DB) Treatment|ITT population|135
8983012|NCT02703350|10045870|FG003|Received Study Drug|Period Six (Part A)||5
8571528|NCT00111007|9603837|FG001|STARTED|Double-blind (DB) Treatment|ITT population|135
8571529|NCT00111007|9603836|FG000|Received Treatment|Double-blind (DB) Treatment|Safety population|134
8983013|NCT02703350|10045871|FG004|Received Study Drug|Period Six (Part A)||5
8983014|NCT02703350|10045872|FG005|Received Study Drug|Period Six (Part A)||5
8983015|NCT02703350|10045873|FG006|Received Study Drug|Period Six (Part A)||0
8983016|NCT02703350|10045874|FG007|Received Study Drug|Period Six (Part A)||0
8983017|NCT02703350|10045867|FG000|COMPLETED|Period Six (Part A)||5
8983018|NCT02703350|10045868|FG001|COMPLETED|Period Six (Part A)||5
8983019|NCT02703350|10045869|FG002|COMPLETED|Period Six (Part A)||5
8983020|NCT02703350|10045870|FG003|COMPLETED|Period Six (Part A)||5
8983021|NCT02703350|10045871|FG004|COMPLETED|Period Six (Part A)||5
8983022|NCT02703350|10045872|FG005|COMPLETED|Period Six (Part A)||5
8983023|NCT02703350|10045873|FG006|COMPLETED|Period Six (Part A)||0
8983024|NCT02703350|10045874|FG007|COMPLETED|Period Six (Part A)||0
8983025|NCT02703350|10045867|FG000|NOT COMPLETED|Period Six (Part A)||0
8983026|NCT02703350|10045868|FG001|NOT COMPLETED|Period Six (Part A)||0
8983027|NCT02703350|10045869|FG002|NOT COMPLETED|Period Six (Part A)||0
8983028|NCT02703350|10045870|FG003|NOT COMPLETED|Period Six (Part A)||0
8983029|NCT02703350|10045871|FG004|NOT COMPLETED|Period Six (Part A)||0
8983030|NCT02703350|10045872|FG005|NOT COMPLETED|Period Six (Part A)||0
8983031|NCT02703350|10045873|FG006|NOT COMPLETED|Period Six (Part A)||0
8983032|NCT02703350|10045874|FG007|NOT COMPLETED|Period Six (Part A)||0
8983033|NCT02703350|10045867|FG000|STARTED|Part B||0
8983034|NCT02703350|10045868|FG001|STARTED|Part B||0
8983035|NCT02703350|10045869|FG002|STARTED|Part B||0
8983036|NCT02703350|10045870|FG003|STARTED|Part B||0
8983037|NCT02703350|10045871|FG004|STARTED|Part B||0
8983038|NCT02703350|10045872|FG005|STARTED|Part B||0
8983039|NCT02703350|10045873|FG006|STARTED|Part B||15
8983040|NCT02703350|10045874|FG007|STARTED|Part B||15
8983041|NCT02703350|10045867|FG000|Received Study Drug|Part B||0
8983042|NCT02703350|10045868|FG001|Received Study Drug|Part B||0
8983043|NCT02703350|10045869|FG002|Received Study Drug|Part B||0
8983044|NCT02703350|10045870|FG003|Received Study Drug|Part B||0
8983045|NCT02703350|10045871|FG004|Received Study Drug|Part B||0
8983046|NCT02703350|10045872|FG005|Received Study Drug|Part B||0
8983047|NCT02703350|10045873|FG006|Received Study Drug|Part B||15
8983048|NCT02703350|10045874|FG007|Received Study Drug|Part B||15
8983049|NCT02703350|10045867|FG000|COMPLETED|Part B||0
8983050|NCT02703350|10045868|FG001|COMPLETED|Part B||0
8983051|NCT02703350|10045869|FG002|COMPLETED|Part B||0
8983052|NCT02703350|10045870|FG003|COMPLETED|Part B||0
8983053|NCT02703350|10045871|FG004|COMPLETED|Part B||0
8983054|NCT02703350|10045872|FG005|COMPLETED|Part B||0
8983055|NCT02703350|10045873|FG006|COMPLETED|Part B||15
8983056|NCT02703350|10045874|FG007|COMPLETED|Part B||15
8983057|NCT02703350|10045867|FG000|NOT COMPLETED|Part B||0
8983058|NCT02703350|10045868|FG001|NOT COMPLETED|Part B||0
8983059|NCT02703350|10045869|FG002|NOT COMPLETED|Part B||0
8983060|NCT02703350|10045870|FG003|NOT COMPLETED|Part B||0
8983061|NCT02703350|10045871|FG004|NOT COMPLETED|Part B||0
8983062|NCT02703350|10045872|FG005|NOT COMPLETED|Part B||0
8983063|NCT02703350|10045873|FG006|NOT COMPLETED|Part B||0
8983064|NCT02703350|10045874|FG007|NOT COMPLETED|Part B||0
8983065|NCT02703454|10045894|FG000|STARTED|Overall Study||24
8983066|NCT02703454|10045895|FG001|STARTED|Overall Study||27
8983067|NCT02703454|10045894|FG000|Treated|Overall Study||23
8983068|NCT02703454|10045895|FG001|Treated|Overall Study||24
8983069|NCT02703454|10045894|FG000|COMPLETED|Overall Study||13
8983070|NCT02703454|10045895|FG001|COMPLETED|Overall Study||11
8983071|NCT02703454|10045894|FG000|NOT COMPLETED|Overall Study||11
8983072|NCT02703454|10045895|FG001|NOT COMPLETED|Overall Study||16
8983073|NCT02703467|10045904|FG000|STARTED|Overall Study||20
8983074|NCT02703467|10045905|FG001|STARTED|Overall Study||5
8983075|NCT02703467|10045906|FG002|STARTED|Overall Study||45
8983076|NCT02703467|10045904|FG000|COMPLETED|Overall Study||20
8983077|NCT02703467|10045905|FG001|COMPLETED|Overall Study||5
8983078|NCT02703467|10045906|FG002|COMPLETED|Overall Study||45
8983079|NCT02703467|10045904|FG000|NOT COMPLETED|Overall Study||0
8983080|NCT02703467|10045905|FG001|NOT COMPLETED|Overall Study||0
8983081|NCT02703467|10045906|FG002|NOT COMPLETED|Overall Study||0
8983082|NCT02703532|10045922|FG000|STARTED|Overall Study||21
8983083|NCT02703532|10045923|FG001|STARTED|Overall Study||11
8983084|NCT02703532|10045924|FG002|STARTED|Overall Study||21
8983085|NCT02703532|10045925|FG003|STARTED|Overall Study||11
8983086|NCT02703532|10045922|FG000|COMPLETED|Overall Study||19
8983087|NCT02703532|10045923|FG001|COMPLETED|Overall Study||10
8983088|NCT02703532|10045924|FG002|COMPLETED|Overall Study||19
8983089|NCT02703532|10045925|FG003|COMPLETED|Overall Study||10
8983090|NCT02703532|10045922|FG000|NOT COMPLETED|Overall Study||2
8983091|NCT02703532|10045923|FG001|NOT COMPLETED|Overall Study||1
8983092|NCT02703532|10045924|FG002|NOT COMPLETED|Overall Study||2
8983093|NCT02703532|10045925|FG003|NOT COMPLETED|Overall Study||1
8983094|NCT02703636|10045935|FG000|STARTED|Overall Study||118
8983095|NCT02703636|10045935|FG000|COMPLETED|Overall Study||102
8983096|NCT02703636|10045935|FG000|NOT COMPLETED|Overall Study||16
8983097|NCT02703779|10045941|FG000|STARTED|Overall Study||51
8983098|NCT02703779|10045942|FG001|STARTED|Overall Study||50
8983099|NCT02703779|10045941|FG000|COMPLETED|Overall Study||51
8983100|NCT02703779|10045942|FG001|COMPLETED|Overall Study||50
8983101|NCT02703779|10045941|FG000|NOT COMPLETED|Overall Study||0
8983102|NCT02703779|10045942|FG001|NOT COMPLETED|Overall Study||0
8983103|NCT02703909|10045952|FG000|STARTED|Overall Study||36
8983104|NCT02703909|10045953|FG001|STARTED|Overall Study||37
8983105|NCT02703909|10045954|FG002|STARTED|Overall Study||36
8983106|NCT02703909|10045955|FG003|STARTED|Overall Study||35
8983107|NCT02703909|10045952|FG000|COMPLETED|Overall Study||36
8983108|NCT02703909|10045953|FG001|COMPLETED|Overall Study||37
8983109|NCT02703909|10045954|FG002|COMPLETED|Overall Study||36
8983110|NCT02703909|10045955|FG003|COMPLETED|Overall Study||35
8983111|NCT02703909|10045952|FG000|NOT COMPLETED|Overall Study||0
8983112|NCT02703909|10045953|FG001|NOT COMPLETED|Overall Study||0
8983113|NCT02703909|10045954|FG002|NOT COMPLETED|Overall Study||0
8983114|NCT02703909|10045955|FG003|NOT COMPLETED|Overall Study||0
8983115|NCT02703948|10045967|FG000|STARTED|Overall Study||60
8983116|NCT02703948|10045967|FG000|COMPLETED|Overall Study||57
8983117|NCT02703948|10045967|FG000|NOT COMPLETED|Overall Study||3
8983118|NCT02703987|10045973|FG000|STARTED|Visit 3 Intervention (1 Day)||14
8983119|NCT02703987|10045974|FG001|STARTED|Visit 3 Intervention (1 Day)||14
8983120|NCT02703987|10045973|FG000|COMPLETED|Visit 3 Intervention (1 Day)||13
8983121|NCT02703987|10045974|FG001|COMPLETED|Visit 3 Intervention (1 Day)||11
8983122|NCT02703987|10045973|FG000|NOT COMPLETED|Visit 3 Intervention (1 Day)||1
8983123|NCT02703987|10045974|FG001|NOT COMPLETED|Visit 3 Intervention (1 Day)||3
8983124|NCT02703987|10045973|FG000|STARTED|Washout (Minimum 5 Days)||13
8983125|NCT02703987|10045974|FG001|STARTED|Washout (Minimum 5 Days)||11
8983126|NCT02703987|10045973|FG000|COMPLETED|Washout (Minimum 5 Days)||13
8983127|NCT02703987|10045974|FG001|COMPLETED|Washout (Minimum 5 Days)||11
8983128|NCT02703987|10045973|FG000|NOT COMPLETED|Washout (Minimum 5 Days)||0
8983129|NCT02703987|10045974|FG001|NOT COMPLETED|Washout (Minimum 5 Days)||0
8983130|NCT02703987|10045973|FG000|STARTED|Visit 4 Intervention (1 Day)||13
8983131|NCT02703987|10045974|FG001|STARTED|Visit 4 Intervention (1 Day)||11
8983132|NCT02703987|10045973|FG000|COMPLETED|Visit 4 Intervention (1 Day)||12
8983133|NCT02703987|10045974|FG001|COMPLETED|Visit 4 Intervention (1 Day)||10
8983134|NCT02703987|10045973|FG000|NOT COMPLETED|Visit 4 Intervention (1 Day)||1
8632621|NCT00546481|9672594|FG000|COMPLETED|Correction Phase (CERA or Epoetin Beta)||33
8632622|NCT00546481|9672595|FG001|COMPLETED|Correction Phase (CERA or Epoetin Beta)||36
8877568|NCT01924299|9934509|FG001|NOT COMPLETED|Period 2||1
8983135|NCT02703987|10045974|FG001|NOT COMPLETED|Visit 4 Intervention (1 Day)||1
8983136|NCT02704091|10045982|FG000|STARTED|Overall Study||430
8983137|NCT02704091|10045983|FG001|STARTED|Overall Study||423
8983138|NCT02704091|10045982|FG000|COMPLETED|Overall Study||402
8983139|NCT02704091|10045983|FG001|COMPLETED|Overall Study||400
8983140|NCT02704091|10045982|FG000|NOT COMPLETED|Overall Study||28
8983141|NCT02704091|10045983|FG001|NOT COMPLETED|Overall Study||23
8983142|NCT02704104|10045989|FG000|STARTED|Overall Study||46
8983143|NCT02704104|10045989|FG000|COMPLETED|Overall Study||46
8983144|NCT02704104|10045989|FG000|NOT COMPLETED|Overall Study||0
8983145|NCT02704143|10045997|FG000|STARTED|Overall Study||63
8983146|NCT02704143|10045997|FG000|COMPLETED|Overall Study||53
8983147|NCT02704143|10045997|FG000|NOT COMPLETED|Overall Study||10
8983148|NCT02704689|10046001|FG000|STARTED|Overall Study||9
8983149|NCT02704689|10046001|FG000|COMPLETED|Overall Study||6
8983150|NCT02704689|10046001|FG000|NOT COMPLETED|Overall Study||3
8983151|NCT02704702|10046011|FG000|STARTED|Overall Study||6
8983152|NCT02704702|10046012|FG001|STARTED|Overall Study||6
8983153|NCT02704702|10046013|FG002|STARTED|Overall Study||6
8877569|NCT01924364|9934521|FG000|STARTED|Overall Study||7
8877570|NCT01924364|9934521|FG000|COMPLETED|Overall Study||4
8877571|NCT01924364|9934521|FG000|NOT COMPLETED|Overall Study||3
8877572|NCT01924390|9934538|FG000|STARTED|Overall Study||22
8877573|NCT01924390|9934539|FG001|STARTED|Overall Study||22
8877574|NCT01924390|9934538|FG000|COMPLETED|Overall Study||21
8877575|NCT01924390|9934539|FG001|COMPLETED|Overall Study||21
8983154|NCT02704702|10046014|FG003|STARTED|Overall Study||6
8983155|NCT02704702|10046015|FG004|STARTED|Overall Study||6
8983156|NCT02704702|10046016|FG005|STARTED|Overall Study||6
8983157|NCT02704702|10046011|FG000|COMPLETED|Overall Study||5
8632623|NCT00546481|9672596|FG002|COMPLETED|Correction Phase (CERA or Epoetin Beta)||0
8877576|NCT01924390|9934538|FG000|NOT COMPLETED|Overall Study||1
8983158|NCT02704702|10046012|FG001|COMPLETED|Overall Study||6
8983159|NCT02704702|10046013|FG002|COMPLETED|Overall Study||6
8983160|NCT02704702|10046014|FG003|COMPLETED|Overall Study||5
8983161|NCT02704702|10046015|FG004|COMPLETED|Overall Study||4
8877577|NCT01924390|9934539|FG001|NOT COMPLETED|Overall Study||1
8983162|NCT02704702|10046016|FG005|COMPLETED|Overall Study||4
8983163|NCT02704702|10046011|FG000|NOT COMPLETED|Overall Study||1
8983164|NCT02704702|10046012|FG001|NOT COMPLETED|Overall Study||0
8983165|NCT02704702|10046013|FG002|NOT COMPLETED|Overall Study||0
8983166|NCT02704702|10046014|FG003|NOT COMPLETED|Overall Study||1
8983167|NCT02704702|10046015|FG004|NOT COMPLETED|Overall Study||2
8983168|NCT02704702|10046016|FG005|NOT COMPLETED|Overall Study||2
8983169|NCT02705105|10046042|FG000|STARTED|Treatment||4
8983170|NCT02705105|10046043|FG001|STARTED|Treatment||110
8983171|NCT02705105|10046042|FG000|Subjects Who Were Replaced|Treatment||1
8983172|NCT02705105|10046043|FG001|Subjects Who Were Replaced|Treatment||0
8983173|NCT02705105|10046042|FG000|D/C From Treatment Phase|Treatment||4
8983174|NCT02705105|10046043|FG001|D/C From Treatment Phase|Treatment||107
8983175|NCT02705105|10046042|FG000|D/C From Follow-Up|Treatment||4
8983176|NCT02705105|10046043|FG001|D/C From Follow-Up|Treatment||110
8983177|NCT02705105|10046042|FG000|COMPLETED|Treatment||0
8983178|NCT02705105|10046043|FG001|COMPLETED|Treatment||1
8983179|NCT02705105|10046042|FG000|NOT COMPLETED|Treatment||4
8983180|NCT02705105|10046043|FG001|NOT COMPLETED|Treatment||109
8983181|NCT02705105|10046042|FG000|STARTED|Follow-Up||4
8983182|NCT02705105|10046043|FG001|STARTED|Follow-Up||110
8983183|NCT02705105|10046042|FG000|COMPLETED|Follow-Up||0
8983184|NCT02705105|10046043|FG001|COMPLETED|Follow-Up||0
8983185|NCT02705105|10046042|FG000|NOT COMPLETED|Follow-Up||4
8983186|NCT02705105|10046043|FG001|NOT COMPLETED|Follow-Up||110
8983187|NCT02705352|10046063|FG000|STARTED|Overall Study||1
8983188|NCT02705352|10046064|FG001|STARTED|Overall Study||0
8983189|NCT02705352|10046063|FG000|COMPLETED|Overall Study||1
8983190|NCT02705352|10046064|FG001|COMPLETED|Overall Study||0
8983191|NCT02705352|10046063|FG000|NOT COMPLETED|Overall Study||0
8983192|NCT02705352|10046064|FG001|NOT COMPLETED|Overall Study||0
8983193|NCT02705365|10046072|FG000|STARTED|Overall Study||400
8983194|NCT02705365|10046073|FG001|STARTED|Overall Study||800
8983195|NCT02705365|10046072|FG000|COMPLETED|Overall Study||400
8983196|NCT02705365|10046073|FG001|COMPLETED|Overall Study||800
8983197|NCT02705365|10046072|FG000|NOT COMPLETED|Overall Study||0
8983198|NCT02705365|10046073|FG001|NOT COMPLETED|Overall Study||0
8983199|NCT02705586|10046079|FG000|STARTED|Overall Study||13
8983200|NCT02705586|10046079|FG000|COMPLETED|Overall Study||5
8983201|NCT02705586|10046079|FG000|NOT COMPLETED|Overall Study||8
8983202|NCT02705625|10046086|FG000|STARTED|Overall Study||82
8983203|NCT02705625|10046087|FG001|STARTED|Overall Study||82
8983204|NCT02705625|10046088|FG002|STARTED|Overall Study||80
8983205|NCT02705625|10046086|FG000|COMPLETED|Overall Study||74
8983206|NCT02705625|10046087|FG001|COMPLETED|Overall Study||72
8983207|NCT02705625|10046088|FG002|COMPLETED|Overall Study||69
8983208|NCT02705625|10046086|FG000|NOT COMPLETED|Overall Study||8
8983209|NCT02705625|10046087|FG001|NOT COMPLETED|Overall Study||10
8983210|NCT02705625|10046088|FG002|NOT COMPLETED|Overall Study||11
8983211|NCT02705716|10046098|FG000|STARTED|Overall Study||72
8983212|NCT02705716|10046099|FG001|STARTED|Overall Study||70
8983213|NCT02705716|10046098|FG000|COMPLETED|Overall Study||68
8983214|NCT02705716|10046099|FG001|COMPLETED|Overall Study||68
8983215|NCT02705716|10046098|FG000|NOT COMPLETED|Overall Study||4
8983216|NCT02705716|10046099|FG001|NOT COMPLETED|Overall Study||2
8983217|NCT02705807|10046105|FG000|STARTED|Overall Study||10
8983218|NCT02705807|10046105|FG000|COMPLETED|Overall Study||10
8983219|NCT02705807|10046105|FG000|NOT COMPLETED|Overall Study||0
8983220|NCT02706041|10046111|FG000|STARTED|Overall Study||18
8983221|NCT02706041|10046112|FG001|STARTED|Overall Study||21
8983222|NCT02706041|10046111|FG000|Received Allocated Intervention|Overall Study||18
8983223|NCT02706041|10046112|FG001|Received Allocated Intervention|Overall Study||18
8983224|NCT02706041|10046111|FG000|COMPLETED|Overall Study||18
8983225|NCT02706041|10046112|FG001|COMPLETED|Overall Study||18
8983226|NCT02706041|10046111|FG000|NOT COMPLETED|Overall Study||0
8983227|NCT02706041|10046112|FG001|NOT COMPLETED|Overall Study||3
8983228|NCT02706249|10046120|FG000|STARTED|Overall Study||25
8983229|NCT02706249|10046121|FG001|STARTED|Overall Study||25
8983230|NCT02706249|10046120|FG000|COMPLETED|Overall Study||23
8983231|NCT02706249|10046121|FG001|COMPLETED|Overall Study||24
8983232|NCT02706249|10046120|FG000|NOT COMPLETED|Overall Study||2
8983233|NCT02706249|10046121|FG001|NOT COMPLETED|Overall Study||1
8983234|NCT02706327|10046132|FG000|STARTED|Overall Study||22
8983235|NCT02706327|10046133|FG001|STARTED|Overall Study||22
8983236|NCT02706327|10046134|FG002|STARTED|Overall Study||23
8983237|NCT02706327|10046132|FG000|COMPLETED|Overall Study||21
8983238|NCT02706327|10046133|FG001|COMPLETED|Overall Study||21
8983239|NCT02706327|10046134|FG002|COMPLETED|Overall Study||21
8983240|NCT02706327|10046132|FG000|NOT COMPLETED|Overall Study||1
8983241|NCT02706327|10046133|FG001|NOT COMPLETED|Overall Study||1
8983242|NCT02706327|10046134|FG002|NOT COMPLETED|Overall Study||2
8983243|NCT02706483|10046142|FG000|STARTED|Overall Study||2272
8983244|NCT02706483|10046142|FG000|COMPLETED|Overall Study||1842
8983245|NCT02706483|10046142|FG000|NOT COMPLETED|Overall Study||430
8983246|NCT02706717|10046148|FG000|STARTED|Overall Study||47
8983247|NCT02706717|10046149|FG001|STARTED|Overall Study|3 placebo participants never initiated study treatment.|46
8983248|NCT02706717|10046148|FG000|COMPLETED|Overall Study||46
8983249|NCT02706717|10046149|FG001|COMPLETED|Overall Study||35
8983250|NCT02706717|10046148|FG000|NOT COMPLETED|Overall Study||1
8983251|NCT02706717|10046149|FG001|NOT COMPLETED|Overall Study||11
8983252|NCT02706834|10046166|FG000|STARTED|Overall Study||3
8983253|NCT02706834|10046167|FG001|STARTED|Overall Study||3
8983254|NCT02706834|10046168|FG002|STARTED|Overall Study||3
8983255|NCT02706834|10046169|FG003|STARTED|Overall Study||3
8983256|NCT02706834|10046170|FG004|STARTED|Overall Study||3
8983257|NCT02706834|10046171|FG005|STARTED|Overall Study||3
8983258|NCT02706834|10046172|FG006|STARTED|Overall Study||3
8983259|NCT02706834|10046173|FG007|STARTED|Overall Study||3
8983260|NCT02706834|10046174|FG008|STARTED|Overall Study||4
8983261|NCT02706834|10046175|FG009|STARTED|Overall Study||4
8983262|NCT02706834|10046176|FG010|STARTED|Overall Study||4
8983263|NCT02706834|10046166|FG000|COMPLETED|Overall Study|Completed = completed study drug|1
8983264|NCT02706834|10046167|FG001|COMPLETED|Overall Study||2
8983265|NCT02706834|10046168|FG002|COMPLETED|Overall Study||2
8983266|NCT02706834|10046169|FG003|COMPLETED|Overall Study||3
8983267|NCT02706834|10046170|FG004|COMPLETED|Overall Study||2
8983268|NCT02706834|10046171|FG005|COMPLETED|Overall Study||3
8983269|NCT02706834|10046172|FG006|COMPLETED|Overall Study||3
8983270|NCT02706834|10046173|FG007|COMPLETED|Overall Study||3
8983271|NCT02706834|10046174|FG008|COMPLETED|Overall Study||4
8983272|NCT02706834|10046175|FG009|COMPLETED|Overall Study||3
8983273|NCT02706834|10046176|FG010|COMPLETED|Overall Study||3
8983274|NCT02706834|10046166|FG000|NOT COMPLETED|Overall Study||2
8983275|NCT02706834|10046167|FG001|NOT COMPLETED|Overall Study||1
8983276|NCT02706834|10046168|FG002|NOT COMPLETED|Overall Study||1
8983277|NCT02706834|10046169|FG003|NOT COMPLETED|Overall Study||0
8983278|NCT02706834|10046170|FG004|NOT COMPLETED|Overall Study||1
8983279|NCT02706834|10046171|FG005|NOT COMPLETED|Overall Study||0
8983280|NCT02706834|10046172|FG006|NOT COMPLETED|Overall Study||0
8983281|NCT02706834|10046173|FG007|NOT COMPLETED|Overall Study||0
8983282|NCT02706834|10046174|FG008|NOT COMPLETED|Overall Study||0
8983283|NCT02706834|10046175|FG009|NOT COMPLETED|Overall Study||1
8983284|NCT02706834|10046176|FG010|NOT COMPLETED|Overall Study||1
8983285|NCT02706873|10046225|FG000|STARTED|Overall Study||315
8983286|NCT02706873|10046226|FG001|STARTED|Overall Study||55
8983287|NCT02706873|10046227|FG002|STARTED|Overall Study||317
8983288|NCT02706873|10046228|FG003|STARTED|Overall Study||315
8983289|NCT02706873|10046225|FG000|Received Study Drug|Overall Study||314
8983290|NCT02706873|10046226|FG001|Received Study Drug|Overall Study||55
8983291|NCT02706873|10046227|FG002|Received Study Drug|Overall Study||317
8983292|NCT02706873|10046228|FG003|Received Study Drug|Overall Study||314
8983293|NCT02706873|10046225|FG000|Global Analysis Population|Overall Study|Includes 28 participants in the Japan sub-study|314
8983294|NCT02706873|10046226|FG001|Global Analysis Population|Overall Study||0
8983295|NCT02706873|10046227|FG002|Global Analysis Population|Overall Study|Includes 27 participants in the Japan sub-study|317
8983296|NCT02706873|10046228|FG003|Global Analysis Population|Overall Study|Includes 28 participants in the Japan sub-study|314
8983297|NCT02706873|10046225|FG000|Japan Sub-study|Overall Study||28
8983298|NCT02706873|10046226|FG001|Japan Sub-study|Overall Study||55
8983299|NCT02706873|10046227|FG002|Japan Sub-study|Overall Study||27
8983300|NCT02706873|10046228|FG003|Japan Sub-study|Overall Study||28
8983301|NCT02706873|10046225|FG000|COMPLETED|Overall Study||268
8983302|NCT02706873|10046226|FG001|COMPLETED|Overall Study||51
8983303|NCT02706873|10046227|FG002|COMPLETED|Overall Study||290
8983304|NCT02706873|10046228|FG003|COMPLETED|Overall Study||282
8983305|NCT02706873|10046225|FG000|NOT COMPLETED|Overall Study||47
8983306|NCT02706873|10046226|FG001|NOT COMPLETED|Overall Study||4
8983307|NCT02706873|10046227|FG002|NOT COMPLETED|Overall Study||27
8983308|NCT02706873|10046228|FG003|NOT COMPLETED|Overall Study||33
8983309|NCT02706886|10046249|FG000|STARTED|Part A: SAD Period||8
8983310|NCT02706886|10046250|FG001|STARTED|Part A: SAD Period||6
8983311|NCT02706886|10046251|FG002|STARTED|Part A: SAD Period||6
8983312|NCT02706886|10046252|FG003|STARTED|Part A: SAD Period||6
8983313|NCT02706886|10046253|FG004|STARTED|Part A: SAD Period||6
8983314|NCT02706886|10046254|FG005|STARTED|Part A: SAD Period||0
8983315|NCT02706886|10046255|FG006|STARTED|Part A: SAD Period||0
8983316|NCT02706886|10046256|FG007|STARTED|Part A: SAD Period||0
8983317|NCT02706886|10046257|FG008|STARTED|Part A: SAD Period||0
8983318|NCT02706886|10046249|FG000|COMPLETED|Part A: SAD Period||8
8983319|NCT02706886|10046250|FG001|COMPLETED|Part A: SAD Period||6
8983320|NCT02706886|10046251|FG002|COMPLETED|Part A: SAD Period||6
8983321|NCT02706886|10046252|FG003|COMPLETED|Part A: SAD Period||4
8983322|NCT02706886|10046253|FG004|COMPLETED|Part A: SAD Period||6
8983323|NCT02706886|10046254|FG005|COMPLETED|Part A: SAD Period||0
8983324|NCT02706886|10046255|FG006|COMPLETED|Part A: SAD Period||0
8983325|NCT02706886|10046256|FG007|COMPLETED|Part A: SAD Period||0
8983326|NCT02706886|10046257|FG008|COMPLETED|Part A: SAD Period||0
8983327|NCT02706886|10046249|FG000|NOT COMPLETED|Part A: SAD Period||0
8983328|NCT02706886|10046250|FG001|NOT COMPLETED|Part A: SAD Period||0
8983329|NCT02706886|10046251|FG002|NOT COMPLETED|Part A: SAD Period||0
8983330|NCT02706886|10046252|FG003|NOT COMPLETED|Part A: SAD Period||2
8983331|NCT02706886|10046253|FG004|NOT COMPLETED|Part A: SAD Period||0
8983332|NCT02706886|10046254|FG005|NOT COMPLETED|Part A: SAD Period||0
8983333|NCT02706886|10046255|FG006|NOT COMPLETED|Part A: SAD Period||0
8983334|NCT02706886|10046256|FG007|NOT COMPLETED|Part A: SAD Period||0
8983335|NCT02706886|10046257|FG008|NOT COMPLETED|Part A: SAD Period||0
8983336|NCT02706886|10046249|FG000|STARTED|Part B: MAD Study Days 1-85||0
8983337|NCT02706886|10046250|FG001|STARTED|Part B: MAD Study Days 1-85||0
8983338|NCT02706886|10046251|FG002|STARTED|Part B: MAD Study Days 1-85||0
8983339|NCT02706886|10046252|FG003|STARTED|Part B: MAD Study Days 1-85||0
8983340|NCT02706886|10046253|FG004|STARTED|Part B: MAD Study Days 1-85||0
8983341|NCT02706886|10046254|FG005|STARTED|Part B: MAD Study Days 1-85||3
8983342|NCT02706886|10046255|FG006|STARTED|Part B: MAD Study Days 1-85||7
8983343|NCT02706886|10046256|FG007|STARTED|Part B: MAD Study Days 1-85||7
8983344|NCT02706886|10046257|FG008|STARTED|Part B: MAD Study Days 1-85||3
8983345|NCT02706886|10046249|FG000|COMPLETED|Part B: MAD Study Days 1-85||0
8983346|NCT02706886|10046250|FG001|COMPLETED|Part B: MAD Study Days 1-85||0
8983347|NCT02706886|10046251|FG002|COMPLETED|Part B: MAD Study Days 1-85||0
8983348|NCT02706886|10046252|FG003|COMPLETED|Part B: MAD Study Days 1-85||0
8983349|NCT02706886|10046253|FG004|COMPLETED|Part B: MAD Study Days 1-85||0
8983350|NCT02706886|10046254|FG005|COMPLETED|Part B: MAD Study Days 1-85||3
8983351|NCT02706886|10046255|FG006|COMPLETED|Part B: MAD Study Days 1-85||7
8983352|NCT02706886|10046256|FG007|COMPLETED|Part B: MAD Study Days 1-85||7
8983353|NCT02706886|10046257|FG008|COMPLETED|Part B: MAD Study Days 1-85||3
8983354|NCT02706886|10046249|FG000|NOT COMPLETED|Part B: MAD Study Days 1-85||0
8983355|NCT02706886|10046250|FG001|NOT COMPLETED|Part B: MAD Study Days 1-85||0
8983356|NCT02706886|10046251|FG002|NOT COMPLETED|Part B: MAD Study Days 1-85||0
8983357|NCT02706886|10046252|FG003|NOT COMPLETED|Part B: MAD Study Days 1-85||0
8983358|NCT02706886|10046253|FG004|NOT COMPLETED|Part B: MAD Study Days 1-85||0
8983359|NCT02706886|10046254|FG005|NOT COMPLETED|Part B: MAD Study Days 1-85||0
8983360|NCT02706886|10046255|FG006|NOT COMPLETED|Part B: MAD Study Days 1-85||0
8983361|NCT02706886|10046256|FG007|NOT COMPLETED|Part B: MAD Study Days 1-85||0
8983362|NCT02706886|10046257|FG008|NOT COMPLETED|Part B: MAD Study Days 1-85||0
8983363|NCT02706886|10046249|FG000|STARTED|Part B: MAD Study Day 85-End of Study||0
8983364|NCT02706886|10046250|FG001|STARTED|Part B: MAD Study Day 85-End of Study||0
8983365|NCT02706886|10046251|FG002|STARTED|Part B: MAD Study Day 85-End of Study||0
8983366|NCT02706886|10046252|FG003|STARTED|Part B: MAD Study Day 85-End of Study||0
8983367|NCT02706886|10046253|FG004|STARTED|Part B: MAD Study Day 85-End of Study||0
8983368|NCT02706886|10046254|FG005|STARTED|Part B: MAD Study Day 85-End of Study||0
8983369|NCT02706886|10046255|FG006|STARTED|Part B: MAD Study Day 85-End of Study|One participant from the Part B: MAD: Placebo arm crossed over to this lumasiran arm.|8
8983370|NCT02706886|10046256|FG007|STARTED|Part B: MAD Study Day 85-End of Study|One participant from the Part B: MAD: Placebo arm crossed over to this lumasiran arm.|8
8983371|NCT02706886|10046257|FG008|STARTED|Part B: MAD Study Day 85-End of Study|One participant from the Part B: MAD: Placebo arm crossed over to this lumasiran arm.|4
8983372|NCT02706886|10046249|FG000|COMPLETED|Part B: MAD Study Day 85-End of Study||0
8983373|NCT02706886|10046250|FG001|COMPLETED|Part B: MAD Study Day 85-End of Study||0
8983374|NCT02706886|10046251|FG002|COMPLETED|Part B: MAD Study Day 85-End of Study||0
8983375|NCT02706886|10046252|FG003|COMPLETED|Part B: MAD Study Day 85-End of Study||0
8983376|NCT02706886|10046253|FG004|COMPLETED|Part B: MAD Study Day 85-End of Study||0
8983377|NCT02706886|10046254|FG005|COMPLETED|Part B: MAD Study Day 85-End of Study||0
8983378|NCT02706886|10046255|FG006|COMPLETED|Part B: MAD Study Day 85-End of Study||8
8983379|NCT02706886|10046256|FG007|COMPLETED|Part B: MAD Study Day 85-End of Study||8
8983380|NCT02706886|10046257|FG008|COMPLETED|Part B: MAD Study Day 85-End of Study||4
8983381|NCT02706886|10046249|FG000|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
8983382|NCT02706886|10046250|FG001|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
8983383|NCT02706886|10046251|FG002|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
8983384|NCT02706886|10046252|FG003|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
8983385|NCT02706886|10046253|FG004|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
8983386|NCT02706886|10046254|FG005|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
8983387|NCT02706886|10046255|FG006|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
8983388|NCT02706886|10046256|FG007|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
8983389|NCT02706886|10046257|FG008|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
8983390|NCT02706899|10046302|FG000|STARTED|Overall Study||13
8983391|NCT02706899|10046303|FG001|STARTED|Overall Study||6
8983392|NCT02706899|10046302|FG000|COMPLETED|Overall Study||0
8983393|NCT02706899|10046303|FG001|COMPLETED|Overall Study||0
8983394|NCT02706899|10046302|FG000|NOT COMPLETED|Overall Study||13
8983395|NCT02706899|10046303|FG001|NOT COMPLETED|Overall Study||6
8983396|NCT02706925|10046318|FG000|STARTED|Overall Study||16
8983397|NCT02706925|10046319|FG001|STARTED|Overall Study||6
8983398|NCT02706925|10046320|FG002|STARTED|Overall Study||6
8983399|NCT02706925|10046321|FG003|STARTED|Overall Study||6
8983400|NCT02706925|10046322|FG004|STARTED|Overall Study||6
8983401|NCT02706925|10046323|FG005|STARTED|Overall Study||5
8983402|NCT02706925|10046324|FG006|STARTED|Overall Study||6
8983403|NCT02706925|10046325|FG007|STARTED|Overall Study||6
8983404|NCT02706925|10046326|FG008|STARTED|Overall Study||6
8983405|NCT02706925|10046318|FG000|COMPLETED|Overall Study||16
8983406|NCT02706925|10046319|FG001|COMPLETED|Overall Study||6
8983407|NCT02706925|10046320|FG002|COMPLETED|Overall Study||6
8983408|NCT02706925|10046321|FG003|COMPLETED|Overall Study||6
8983409|NCT02706925|10046322|FG004|COMPLETED|Overall Study||6
8983410|NCT02706925|10046323|FG005|COMPLETED|Overall Study||5
8983411|NCT02706925|10046324|FG006|COMPLETED|Overall Study||6
8983412|NCT02706925|10046325|FG007|COMPLETED|Overall Study||6
8983413|NCT02706925|10046326|FG008|COMPLETED|Overall Study||6
8983414|NCT02706925|10046318|FG000|NOT COMPLETED|Overall Study||0
8983415|NCT02706925|10046319|FG001|NOT COMPLETED|Overall Study||0
8983416|NCT02706925|10046320|FG002|NOT COMPLETED|Overall Study||0
8983417|NCT02706925|10046321|FG003|NOT COMPLETED|Overall Study||0
8983418|NCT02706925|10046322|FG004|NOT COMPLETED|Overall Study||0
8983419|NCT02706925|10046323|FG005|NOT COMPLETED|Overall Study||0
8983420|NCT02706925|10046324|FG006|NOT COMPLETED|Overall Study||0
8983421|NCT02706925|10046325|FG007|NOT COMPLETED|Overall Study||0
8983422|NCT02706925|10046326|FG008|NOT COMPLETED|Overall Study||0
8983423|NCT02706938|10046356|FG000|STARTED|First Period, 6 Weeks||32
8983424|NCT02706938|10046357|FG001|STARTED|First Period, 6 Weeks||33
8983425|NCT02706938|10046356|FG000|COMPLETED|First Period, 6 Weeks||21
8983426|NCT02706938|10046357|FG001|COMPLETED|First Period, 6 Weeks||31
8983427|NCT02706938|10046356|FG000|NOT COMPLETED|First Period, 6 Weeks||11
8983428|NCT02706938|10046357|FG001|NOT COMPLETED|First Period, 6 Weeks||2
8983429|NCT02706938|10046356|FG000|STARTED|Second Period, 6 Weeks||21
8983430|NCT02706938|10046357|FG001|STARTED|Second Period, 6 Weeks||31
8983431|NCT02706938|10046356|FG000|COMPLETED|Second Period, 6 Weeks|Only data from 20 patients were finally analyzed because of missing data.|21
8983432|NCT02706938|10046357|FG001|COMPLETED|Second Period, 6 Weeks|Only data from 19 patients were finally analyzed because of missing data.|21
8983433|NCT02706938|10046356|FG000|NOT COMPLETED|Second Period, 6 Weeks||0
8983434|NCT02706938|10046357|FG001|NOT COMPLETED|Second Period, 6 Weeks||10
8983435|NCT02706951|10046367|FG000|STARTED|Overall Study||216
8983436|NCT02706951|10046368|FG001|STARTED|Overall Study||217
8983437|NCT02706951|10046369|FG002|STARTED|Overall Study||215
8983438|NCT02706951|10046367|FG000|COMPLETED|Overall Study||202
8983439|NCT02706951|10046368|FG001|COMPLETED|Overall Study||201
8983440|NCT02706951|10046369|FG002|COMPLETED|Overall Study||205
8983441|NCT02706951|10046367|FG000|NOT COMPLETED|Overall Study||14
8983442|NCT02706951|10046368|FG001|NOT COMPLETED|Overall Study||16
8983443|NCT02706951|10046369|FG002|NOT COMPLETED|Overall Study||10
8983444|NCT02707146|10046379|FG000|STARTED|Overall Study||359
8983445|NCT02707146|10046380|FG001|STARTED|Overall Study||391
8983446|NCT02707146|10046379|FG000|COMPLETED|Overall Study||359
8983447|NCT02707146|10046380|FG001|COMPLETED|Overall Study||388
8983448|NCT02707146|10046379|FG000|NOT COMPLETED|Overall Study||0
8983449|NCT02707146|10046380|FG001|NOT COMPLETED|Overall Study||3
8983450|NCT02707172|10046386|FG000|STARTED|1st Set of Experiment||28
8983451|NCT02707172|10046386|FG000|COMPLETED|1st Set of Experiment||28
8983452|NCT02707172|10046386|FG000|NOT COMPLETED|1st Set of Experiment||0
8983453|NCT02707172|10046386|FG000|STARTED|Wash Out||28
8983454|NCT02707172|10046386|FG000|COMPLETED|Wash Out||28
8983455|NCT02707172|10046386|FG000|NOT COMPLETED|Wash Out||0
8983456|NCT02707172|10046386|FG000|STARTED|2nd Set of Experiment||28
8983457|NCT02707172|10046386|FG000|COMPLETED|2nd Set of Experiment||28
8983458|NCT02707172|10046386|FG000|NOT COMPLETED|2nd Set of Experiment||0
8983459|NCT02707432|10046393|FG000|STARTED|Overall Study||72
8983460|NCT02707432|10046394|FG001|STARTED|Overall Study||71
8983461|NCT02707432|10046393|FG000|COMPLETED|Overall Study||57
8983462|NCT02707432|10046394|FG001|COMPLETED|Overall Study||51
8983463|NCT02707432|10046393|FG000|NOT COMPLETED|Overall Study||15
8983464|NCT02707432|10046394|FG001|NOT COMPLETED|Overall Study||20
8983465|NCT02707523|10046403|FG000|STARTED|Overall Study||16
8983466|NCT02707523|10046404|FG001|STARTED|Overall Study||16
8983467|NCT02707523|10046405|FG002|STARTED|Overall Study||16
8983468|NCT02707523|10046403|FG000|COMPLETED|Overall Study||16
8983469|NCT02707523|10046404|FG001|COMPLETED|Overall Study||16
8983470|NCT02707523|10046405|FG002|COMPLETED|Overall Study||16
8983471|NCT02707523|10046403|FG000|NOT COMPLETED|Overall Study||0
8983472|NCT02707523|10046404|FG001|NOT COMPLETED|Overall Study||0
8983473|NCT02707523|10046405|FG002|NOT COMPLETED|Overall Study||0
8983474|NCT02707601|10046415|FG000|STARTED|Overall Study||76
8983475|NCT02707601|10046416|FG001|STARTED|Overall Study||74
8983476|NCT02707601|10046415|FG000|COMPLETED|Overall Study||72
8983477|NCT02707601|10046416|FG001|COMPLETED|Overall Study||70
8983478|NCT02707601|10046415|FG000|NOT COMPLETED|Overall Study||4
8983479|NCT02707601|10046416|FG001|NOT COMPLETED|Overall Study||4
8983480|NCT02707640|10046428|FG000|STARTED|Overall Study||61
8983481|NCT02707640|10046429|FG001|STARTED|Overall Study||62
8983482|NCT02707640|10046428|FG000|COMPLETED|Overall Study||52
8983483|NCT02707640|10046429|FG001|COMPLETED|Overall Study||55
8983484|NCT02707640|10046428|FG000|NOT COMPLETED|Overall Study||9
8983485|NCT02707640|10046429|FG001|NOT COMPLETED|Overall Study||7
8983486|NCT02707757|10046437|FG000|STARTED|Overall Study||88
8983487|NCT02707757|10046438|FG001|STARTED|Overall Study||96
8983488|NCT02707757|10046437|FG000|COMPLETED|Overall Study||76
8983489|NCT02707757|10046438|FG001|COMPLETED|Overall Study||84
8983490|NCT02707757|10046437|FG000|NOT COMPLETED|Overall Study||12
8983491|NCT02707757|10046438|FG001|NOT COMPLETED|Overall Study||12
8983492|NCT02707770|10046446|FG000|STARTED|Overall Study||10
8983493|NCT02707770|10046447|FG001|STARTED|Overall Study||10
8983494|NCT02707770|10046446|FG000|COMPLETED|Overall Study|One patient withdrew from the study following consent, initial assessment and randomisation|9
8983495|NCT02707770|10046447|FG001|COMPLETED|Overall Study||10
8983496|NCT02707770|10046446|FG000|NOT COMPLETED|Overall Study||1
8983497|NCT02707770|10046447|FG001|NOT COMPLETED|Overall Study||0
8983498|NCT02707861|10046457|FG000|STARTED|Overall Study||41
8983499|NCT02707861|10046458|FG001|STARTED|Overall Study||38
8983500|NCT02707861|10046457|FG000|COMPLETED|Overall Study||0
8983501|NCT02707861|10046458|FG001|COMPLETED|Overall Study||0
8983502|NCT02707861|10046457|FG000|NOT COMPLETED|Overall Study||41
8983503|NCT02707861|10046458|FG001|NOT COMPLETED|Overall Study||38
8983504|NCT02707952|10046468|FG000|STARTED|Overall Study||129
8983505|NCT02707952|10046469|FG001|STARTED|Overall Study||53
8983506|NCT02707952|10046470|FG002|STARTED|Overall Study||103
8983507|NCT02707952|10046471|FG003|STARTED|Overall Study||10
8983508|NCT02707952|10046468|FG000|Participants Who Received Study Drug|Overall Study||129
8983509|NCT02707952|10046469|FG001|Participants Who Received Study Drug|Overall Study||52
8983510|NCT02707952|10046470|FG002|Participants Who Received Study Drug|Overall Study||103
8983511|NCT02707952|10046471|FG003|Participants Who Received Study Drug|Overall Study||10
8983512|NCT02707952|10046468|FG000|COMPLETED|Overall Study||127
8983513|NCT02707952|10046469|FG001|COMPLETED|Overall Study||52
8983514|NCT02707952|10046470|FG002|COMPLETED|Overall Study||101
8983515|NCT02707952|10046471|FG003|COMPLETED|Overall Study||10
8983516|NCT02707952|10046468|FG000|NOT COMPLETED|Overall Study||2
8983517|NCT02707952|10046469|FG001|NOT COMPLETED|Overall Study||1
8983518|NCT02707952|10046470|FG002|NOT COMPLETED|Overall Study||2
8983519|NCT02707952|10046471|FG003|NOT COMPLETED|Overall Study||0
8983520|NCT02707965|10046492|FG000|STARTED|Overall Study||3
8983521|NCT02707965|10046493|FG001|STARTED|Overall Study||2
8983522|NCT02707965|10046494|FG002|STARTED|Overall Study||4
8983523|NCT02707965|10046495|FG003|STARTED|Overall Study||0
8983524|NCT02707965|10046496|FG004|STARTED|Overall Study||2
8983525|NCT02707965|10046497|FG005|STARTED|Overall Study||1
8983526|NCT02707965|10046498|FG006|STARTED|Overall Study||0
8983527|NCT02707965|10046499|FG007|STARTED|Overall Study||3
8983528|NCT02707965|10046500|FG008|STARTED|Overall Study||1
8983529|NCT02707965|10046501|FG009|STARTED|Overall Study||0
8983530|NCT02707965|10046502|FG010|STARTED|Overall Study||1
8983531|NCT02707965|10046503|FG011|STARTED|Overall Study||0
8983532|NCT02707965|10046504|FG012|STARTED|Overall Study||0
8983533|NCT02707965|10046505|FG013|STARTED|Overall Study||2
8983534|NCT02707965|10046506|FG014|STARTED|Overall Study||2
8983535|NCT02707965|10046507|FG015|STARTED|Overall Study||0
8983536|NCT02707965|10046492|FG000|COMPLETED|Overall Study||2
8983537|NCT02707965|10046493|FG001|COMPLETED|Overall Study||1
8983538|NCT02707965|10046494|FG002|COMPLETED|Overall Study||3
8983539|NCT02707965|10046495|FG003|COMPLETED|Overall Study||0
8983540|NCT02707965|10046496|FG004|COMPLETED|Overall Study||2
8983541|NCT02707965|10046497|FG005|COMPLETED|Overall Study||1
8983542|NCT02707965|10046498|FG006|COMPLETED|Overall Study||0
8983543|NCT02707965|10046499|FG007|COMPLETED|Overall Study||0
8983544|NCT02707965|10046500|FG008|COMPLETED|Overall Study||1
8983545|NCT02707965|10046501|FG009|COMPLETED|Overall Study||0
8983546|NCT02707965|10046502|FG010|COMPLETED|Overall Study||1
8983547|NCT02707965|10046503|FG011|COMPLETED|Overall Study||0
8983548|NCT02707965|10046504|FG012|COMPLETED|Overall Study||0
8983549|NCT02707965|10046505|FG013|COMPLETED|Overall Study||2
8983550|NCT02707965|10046506|FG014|COMPLETED|Overall Study||0
8983551|NCT02707965|10046507|FG015|COMPLETED|Overall Study||0
8983552|NCT02707965|10046492|FG000|NOT COMPLETED|Overall Study||1
8983553|NCT02707965|10046493|FG001|NOT COMPLETED|Overall Study||1
8983554|NCT02707965|10046494|FG002|NOT COMPLETED|Overall Study||1
8983555|NCT02707965|10046495|FG003|NOT COMPLETED|Overall Study||0
8983556|NCT02707965|10046496|FG004|NOT COMPLETED|Overall Study||0
8983557|NCT02707965|10046497|FG005|NOT COMPLETED|Overall Study||0
8983558|NCT02707965|10046498|FG006|NOT COMPLETED|Overall Study||0
8983559|NCT02707965|10046499|FG007|NOT COMPLETED|Overall Study||3
8983560|NCT02707965|10046500|FG008|NOT COMPLETED|Overall Study||0
8983561|NCT02707965|10046501|FG009|NOT COMPLETED|Overall Study||0
8983562|NCT02707965|10046502|FG010|NOT COMPLETED|Overall Study||0
8983563|NCT02707965|10046503|FG011|NOT COMPLETED|Overall Study||0
8983564|NCT02707965|10046504|FG012|NOT COMPLETED|Overall Study||0
8983565|NCT02707965|10046505|FG013|NOT COMPLETED|Overall Study||0
8983566|NCT02707965|10046506|FG014|NOT COMPLETED|Overall Study||2
8983567|NCT02707965|10046507|FG015|NOT COMPLETED|Overall Study||0
8983568|NCT02707991|10046542|FG000|STARTED|Overall Study||33
8983569|NCT02707991|10046543|FG001|STARTED|Overall Study||35
8983570|NCT02707991|10046542|FG000|Day 60 Data Collectio|Overall Study||32
8983571|NCT02707991|10046543|FG001|Day 60 Data Collectio|Overall Study||34
8983572|NCT02707991|10046542|FG000|Month 6 Data Collection|Overall Study||32
8983573|NCT02707991|10046543|FG001|Month 6 Data Collection|Overall Study||34
8983574|NCT02707991|10046542|FG000|COMPLETED|Overall Study||32
8983575|NCT02707991|10046543|FG001|COMPLETED|Overall Study||34
8983576|NCT02707991|10046542|FG000|NOT COMPLETED|Overall Study||1
8983577|NCT02707991|10046543|FG001|NOT COMPLETED|Overall Study||1
8983578|NCT02708095|10046552|FG000|STARTED|Overall Study||105
8983579|NCT02708095|10046553|FG001|STARTED|Overall Study||105
8983580|NCT02708095|10046554|FG002|STARTED|Overall Study||104
8983581|NCT02708095|10046552|FG000|Received at Least 1 Dose of Study Drug|Overall Study||105
8983582|NCT02708095|10046553|FG001|Received at Least 1 Dose of Study Drug|Overall Study||105
8983583|NCT02708095|10046554|FG002|Received at Least 1 Dose of Study Drug|Overall Study||104
8983584|NCT02708095|10046552|FG000|COMPLETED|Overall Study||83
8983585|NCT02708095|10046553|FG001|COMPLETED|Overall Study||86
8983586|NCT02708095|10046554|FG002|COMPLETED|Overall Study||86
8983587|NCT02708095|10046552|FG000|NOT COMPLETED|Overall Study||22
8983588|NCT02708095|10046553|FG001|NOT COMPLETED|Overall Study||19
8983589|NCT02708095|10046554|FG002|NOT COMPLETED|Overall Study||18
8983590|NCT02708121|10046566|FG000|STARTED|Overall Study||35
8983591|NCT02708121|10046567|FG001|STARTED|Overall Study||31
8983592|NCT02708121|10046566|FG000|Provided Acceptability Data|Overall Study||20
8983593|NCT02708121|10046567|FG001|Provided Acceptability Data|Overall Study|This condition did not participate in acceptability survey|0
8983594|NCT02708121|10046566|FG000|Treatment Program Use Data Available|Overall Study||34
8983595|NCT02708121|10046567|FG001|Treatment Program Use Data Available|Overall Study||24
8983596|NCT02708121|10046566|FG000|6 Month In-Person Follow Up Data|Overall Study||22
8983597|NCT02708121|10046567|FG001|6 Month In-Person Follow Up Data|Overall Study||19
8983598|NCT02708121|10046566|FG000|6 Month Weight Data Via EHR|Overall Study||14
8983599|NCT02708121|10046567|FG001|6 Month Weight Data Via EHR|Overall Study||13
8983600|NCT02708121|10046566|FG000|COMPLETED|Overall Study||34
8983601|NCT02708121|10046567|FG001|COMPLETED|Overall Study||26
8983602|NCT02708121|10046566|FG000|NOT COMPLETED|Overall Study||1
8983603|NCT02708121|10046567|FG001|NOT COMPLETED|Overall Study||5
8983604|NCT02708186|10046575|FG000|STARTED|Overall Study||16
8983605|NCT02708186|10046576|FG001|STARTED|Overall Study||18
8983606|NCT02708186|10046575|FG000|COMPLETED|Overall Study||14
8983607|NCT02708186|10046576|FG001|COMPLETED|Overall Study||16
8983608|NCT02708186|10046575|FG000|NOT COMPLETED|Overall Study||2
8983609|NCT02708186|10046576|FG001|NOT COMPLETED|Overall Study||2
8571530|NCT00111007|9603837|FG001|Received Treatment|Double-blind (DB) Treatment|Safety population|134
8571531|NCT00111007|9603836|FG000|COMPLETED|Double-blind (DB) Treatment||27
8571532|NCT00111007|9603837|FG001|COMPLETED|Double-blind (DB) Treatment||24
8571533|NCT00111007|9603836|FG000|NOT COMPLETED|Double-blind (DB) Treatment||108
8571534|NCT00111007|9603837|FG001|NOT COMPLETED|Double-blind (DB) Treatment||111
8983610|NCT02708212|10046584|FG000|STARTED|Overall Study||60
8983611|NCT02708212|10046585|FG001|STARTED|Overall Study||60
8983612|NCT02708212|10046584|FG000|COMPLETED|Overall Study||60
8983613|NCT02708212|10046585|FG001|COMPLETED|Overall Study||60
8983614|NCT02708212|10046584|FG000|NOT COMPLETED|Overall Study||0
8983615|NCT02708212|10046585|FG001|NOT COMPLETED|Overall Study||0
8983616|NCT02708238|10046598|FG000|STARTED|Overall Study||60
8983617|NCT02708238|10046599|FG001|STARTED|Overall Study||60
8983618|NCT02708238|10046600|FG002|STARTED|Overall Study||60
8571535|NCT00111007|9603836|FG000|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|6
8571536|NCT00111007|9603837|FG001|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|4
8983619|NCT02708238|10046598|FG000|COMPLETED|Overall Study||60
8983620|NCT02708238|10046599|FG001|COMPLETED|Overall Study||59
8983621|NCT02708238|10046600|FG002|COMPLETED|Overall Study||57
8983622|NCT02708238|10046598|FG000|NOT COMPLETED|Overall Study||0
8983623|NCT02708238|10046599|FG001|NOT COMPLETED|Overall Study||1
8983624|NCT02708238|10046600|FG002|NOT COMPLETED|Overall Study||3
8983625|NCT02708277|10046610|FG000|STARTED|Overall Study||50
8983626|NCT02708277|10046611|FG001|STARTED|Overall Study||43
8983627|NCT02708277|10046610|FG000|COMPLETED|Overall Study||43
8983628|NCT02708277|10046611|FG001|COMPLETED|Overall Study||39
8983629|NCT02708277|10046610|FG000|NOT COMPLETED|Overall Study||7
8983630|NCT02708277|10046611|FG001|NOT COMPLETED|Overall Study||4
8983631|NCT02708290|10046619|FG000|STARTED|Overall Study||1009
8983632|NCT02708290|10046620|FG001|STARTED|Overall Study||1009
8983633|NCT02708290|10046619|FG000|COMPLETED|Overall Study||1009
8983634|NCT02708290|10046620|FG001|COMPLETED|Overall Study||1009
8983635|NCT02708290|10046619|FG000|NOT COMPLETED|Overall Study||0
8983636|NCT02708290|10046620|FG001|NOT COMPLETED|Overall Study||0
8983637|NCT02708355|10046629|FG000|STARTED|Overall Study||21
8983638|NCT02708355|10046630|FG001|STARTED|Overall Study||22
8983639|NCT02708355|10046631|FG002|STARTED|Overall Study||12
8983640|NCT02708355|10046629|FG000|COMPLETED|Overall Study||20
8983641|NCT02708355|10046630|FG001|COMPLETED|Overall Study||22
8983642|NCT02708355|10046631|FG002|COMPLETED|Overall Study||12
8983643|NCT02708355|10046629|FG000|NOT COMPLETED|Overall Study||1
8983644|NCT02708355|10046630|FG001|NOT COMPLETED|Overall Study||0
8983645|NCT02708355|10046631|FG002|NOT COMPLETED|Overall Study||0
8983646|NCT02708433|10046639|FG000|STARTED|First Intervention (Visit 1)||12
8983647|NCT02708433|10046640|FG001|STARTED|First Intervention (Visit 1)||11
8983648|NCT02708433|10046639|FG000|COMPLETED|First Intervention (Visit 1)||12
8983649|NCT02708433|10046640|FG001|COMPLETED|First Intervention (Visit 1)||11
8983650|NCT02708433|10046639|FG000|NOT COMPLETED|First Intervention (Visit 1)||0
8983651|NCT02708433|10046640|FG001|NOT COMPLETED|First Intervention (Visit 1)||0
8983652|NCT02708433|10046639|FG000|STARTED|Washout (at Least 1 Week)||12
8983653|NCT02708433|10046640|FG001|STARTED|Washout (at Least 1 Week)||11
8983654|NCT02708433|10046639|FG000|COMPLETED|Washout (at Least 1 Week)||12
8983655|NCT02708433|10046640|FG001|COMPLETED|Washout (at Least 1 Week)||11
8983656|NCT02708433|10046639|FG000|NOT COMPLETED|Washout (at Least 1 Week)||0
8983657|NCT02708433|10046640|FG001|NOT COMPLETED|Washout (at Least 1 Week)||0
8983658|NCT02708433|10046639|FG000|STARTED|Second Intervention (Visit 2)||12
8983659|NCT02708433|10046640|FG001|STARTED|Second Intervention (Visit 2)||11
8983660|NCT02708433|10046639|FG000|COMPLETED|Second Intervention (Visit 2)||12
8983661|NCT02708433|10046640|FG001|COMPLETED|Second Intervention (Visit 2)||11
8983662|NCT02708433|10046639|FG000|NOT COMPLETED|Second Intervention (Visit 2)||0
8983663|NCT02708433|10046640|FG001|NOT COMPLETED|Second Intervention (Visit 2)||0
8983664|NCT02708485|10046648|FG000|STARTED|Overall Study||3
8983665|NCT02708485|10046649|FG001|STARTED|Overall Study||12
8983666|NCT02708485|10046648|FG000|COMPLETED|Overall Study||0
8983667|NCT02708485|10046649|FG001|COMPLETED|Overall Study||10
8983668|NCT02708485|10046648|FG000|NOT COMPLETED|Overall Study||3
8983669|NCT02708485|10046649|FG001|NOT COMPLETED|Overall Study||2
8983670|NCT02708498|10046663|FG000|STARTED|Overall Study||42
8983671|NCT02708498|10046664|FG001|STARTED|Overall Study||40
8983672|NCT02708498|10046665|FG002|STARTED|Overall Study||152
8983673|NCT02708498|10046666|FG003|STARTED|Overall Study||156
8983674|NCT02708498|10046667|FG004|STARTED|Overall Study||363
8983675|NCT02708498|10046668|FG005|STARTED|Overall Study||330
8983676|NCT02708498|10046669|FG006|STARTED|Overall Study||20
8983677|NCT02708498|10046670|FG007|STARTED|Overall Study||48
8983678|NCT02708498|10046663|FG000|COMPLETED|Overall Study||22
8983679|NCT02708498|10046664|FG001|COMPLETED|Overall Study||21
8983680|NCT02708498|10046665|FG002|COMPLETED|Overall Study||90
8983681|NCT02708498|10046666|FG003|COMPLETED|Overall Study||105
8983682|NCT02708498|10046667|FG004|COMPLETED|Overall Study||167
8983683|NCT02708498|10046668|FG005|COMPLETED|Overall Study||198
8983684|NCT02708498|10046669|FG006|COMPLETED|Overall Study||20
8983685|NCT02708498|10046670|FG007|COMPLETED|Overall Study||48
8983686|NCT02708498|10046663|FG000|NOT COMPLETED|Overall Study||20
8983687|NCT02708498|10046664|FG001|NOT COMPLETED|Overall Study||19
8983688|NCT02708498|10046665|FG002|NOT COMPLETED|Overall Study||62
8983689|NCT02708498|10046666|FG003|NOT COMPLETED|Overall Study||51
8983690|NCT02708498|10046667|FG004|NOT COMPLETED|Overall Study||196
8983691|NCT02708498|10046668|FG005|NOT COMPLETED|Overall Study||132
8983692|NCT02708498|10046669|FG006|NOT COMPLETED|Overall Study||0
8983693|NCT02708498|10046670|FG007|NOT COMPLETED|Overall Study||0
8983694|NCT02708524|10046690|FG000|STARTED|Overall Study||139
8983695|NCT02708524|10046691|FG001|STARTED|Overall Study||136
8983696|NCT02708524|10046692|FG002|STARTED|Overall Study||137
8983697|NCT02708524|10046693|FG003|STARTED|Overall Study||136
8983698|NCT02708524|10046690|FG000|COMPLETED|Overall Study||135
8983699|NCT02708524|10046691|FG001|COMPLETED|Overall Study||130
8983700|NCT02708524|10046692|FG002|COMPLETED|Overall Study||134
8983701|NCT02708524|10046693|FG003|COMPLETED|Overall Study||136
8983702|NCT02708524|10046690|FG000|NOT COMPLETED|Overall Study||4
8983703|NCT02708524|10046691|FG001|NOT COMPLETED|Overall Study||6
8983704|NCT02708524|10046692|FG002|NOT COMPLETED|Overall Study||3
8983705|NCT02708524|10046693|FG003|NOT COMPLETED|Overall Study||0
8983706|NCT02708641|10046703|FG000|STARTED|Overall Study||12
8983707|NCT02708641|10046703|FG000|COMPLETED|Overall Study||12
8983708|NCT02708641|10046703|FG000|NOT COMPLETED|Overall Study||0
8983709|NCT02708745|10046711|FG000|STARTED|Overall Study||91
8983710|NCT02708745|10046712|FG001|STARTED|Overall Study||69
8983711|NCT02708745|10046713|FG002|STARTED|Overall Study||204
8983712|NCT02708745|10046714|FG003|STARTED|Overall Study||198
8983713|NCT02708745|10046711|FG000|COMPLETED|Overall Study||91
8983714|NCT02708745|10046712|FG001|COMPLETED|Overall Study||65
8571537|NCT00111007|9603836|FG000|COMPLETED|Active Follow-up||0
8571538|NCT00111007|9603837|FG001|COMPLETED|Active Follow-up||2
8571539|NCT00111007|9603836|FG000|NOT COMPLETED|Active Follow-up||6
8571540|NCT00111007|9603837|FG001|NOT COMPLETED|Active Follow-up||2
8571541|NCT00111007|9603836|FG000|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|101
8571542|NCT00111007|9603837|FG001|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|107
8571543|NCT00111007|9603836|FG000|COMPLETED|Long Term Follow-up||54
8571544|NCT00111007|9603837|FG001|COMPLETED|Long Term Follow-up||62
8571545|NCT00111007|9603836|FG000|NOT COMPLETED|Long Term Follow-up||47
8571546|NCT00111007|9603837|FG001|NOT COMPLETED|Long Term Follow-up||45
8571547|NCT00111228|9603846|FG000|STARTED|Overall Study||54
8571548|NCT00111228|9603847|FG001|STARTED|Overall Study||54
8571549|NCT00111228|9603848|FG002|STARTED|Overall Study||54
8571550|NCT00111228|9603846|FG000|COMPLETED|Overall Study||49
8632624|NCT00546481|9672594|FG000|NOT COMPLETED|Correction Phase (CERA or Epoetin Beta)||6
8632625|NCT00546481|9672595|FG001|NOT COMPLETED|Correction Phase (CERA or Epoetin Beta)||5
8632626|NCT00546481|9672596|FG002|NOT COMPLETED|Correction Phase (CERA or Epoetin Beta)||0
8632627|NCT00546481|9672594|FG000|STARTED|Maintenance Phase (CERA)||0
8632628|NCT00546481|9672595|FG001|STARTED|Maintenance Phase (CERA)||0
8632629|NCT00546481|9672596|FG002|STARTED|Maintenance Phase (CERA)||54
8632630|NCT00546481|9672594|FG000|COMPLETED|Maintenance Phase (CERA)||0
8632631|NCT00546481|9672595|FG001|COMPLETED|Maintenance Phase (CERA)||0
8632632|NCT00546481|9672596|FG002|COMPLETED|Maintenance Phase (CERA)||50
8632633|NCT00546481|9672594|FG000|NOT COMPLETED|Maintenance Phase (CERA)||0
8632634|NCT00546481|9672595|FG001|NOT COMPLETED|Maintenance Phase (CERA)||0
8632635|NCT00546481|9672596|FG002|NOT COMPLETED|Maintenance Phase (CERA)||4
8632636|NCT00546572|9672606|FG000|STARTED|Vax 1 / Year 0||464
8632637|NCT00546572|9672607|FG001|STARTED|Vax 1 / Year 0||474
8632638|NCT00546572|9672606|FG000|Received Vax 1|Vax 1 / Year 0||463
8632639|NCT00546572|9672607|FG001|Received Vax 1|Vax 1 / Year 0||473
8632640|NCT00546572|9672606|FG000|COMPLETED|Vax 1 / Year 0||391
8632641|NCT00546572|9672607|FG001|COMPLETED|Vax 1 / Year 0||404
8632642|NCT00546572|9672606|FG000|NOT COMPLETED|Vax 1 / Year 0||73
8632643|NCT00546572|9672607|FG001|NOT COMPLETED|Vax 1 / Year 0||70
8632644|NCT00546572|9672606|FG000|STARTED|Vax 2 / Year 1||391
8632645|NCT00546572|9672607|FG001|STARTED|Vax 2 / Year 1||404
8632646|NCT00546572|9672606|FG000|Received Vax 2|Vax 2 / Year 1||391
8632647|NCT00546572|9672607|FG001|Received Vax 2|Vax 2 / Year 1||404
8632648|NCT00546572|9672606|FG000|COMPLETED|Vax 2 / Year 1||387
8632649|NCT00546572|9672607|FG001|COMPLETED|Vax 2 / Year 1||402
8632650|NCT00546572|9672606|FG000|NOT COMPLETED|Vax 2 / Year 1||4
8632651|NCT00546572|9672607|FG001|NOT COMPLETED|Vax 2 / Year 1||2
8632652|NCT00546637|9672626|FG000|STARTED|Overall Study||474
8632653|NCT00546637|9672627|FG001|STARTED|Overall Study||473
8632654|NCT00546637|9672626|FG000|Received Treatment|Overall Study||471
8632655|NCT00546637|9672627|FG001|Received Treatment|Overall Study||472
8632656|NCT00546637|9672626|FG000|COMPLETED|Overall Study||401
8632657|NCT00546637|9672627|FG001|COMPLETED|Overall Study||424
8632658|NCT00546637|9672626|FG000|NOT COMPLETED|Overall Study||73
8632659|NCT00546637|9672627|FG001|NOT COMPLETED|Overall Study||49
8632660|NCT00546715|9672637|FG000|STARTED|Overall Study||6
8632661|NCT00546715|9672638|FG001|STARTED|Overall Study||5
8632662|NCT00546715|9672639|FG002|STARTED|Overall Study||5
8632663|NCT00546715|9672640|FG003|STARTED|Overall Study||2
8632664|NCT00546715|9672637|FG000|COMPLETED|Overall Study||6
8632665|NCT00546715|9672638|FG001|COMPLETED|Overall Study||4
8632666|NCT00546715|9672639|FG002|COMPLETED|Overall Study||5
8632667|NCT00546715|9672640|FG003|COMPLETED|Overall Study||2
8632668|NCT00546715|9672637|FG000|NOT COMPLETED|Overall Study||0
8632669|NCT00546715|9672638|FG001|NOT COMPLETED|Overall Study||1
8632670|NCT00546715|9672639|FG002|NOT COMPLETED|Overall Study||0
8983715|NCT02708745|10046713|FG002|COMPLETED|Overall Study||121
8632671|NCT00546715|9672640|FG003|NOT COMPLETED|Overall Study||0
8632672|NCT00546728|9672652|FG000|STARTED|Overall Study||25
8632673|NCT00546728|9672653|FG001|STARTED|Overall Study||25
8632674|NCT00546728|9672652|FG000|COMPLETED|Overall Study||25
8632675|NCT00546728|9672653|FG001|COMPLETED|Overall Study||25
8632676|NCT00546728|9672652|FG000|NOT COMPLETED|Overall Study||0
8632677|NCT00546728|9672653|FG001|NOT COMPLETED|Overall Study||0
8632678|NCT00546819|9672661|FG000|STARTED|Overall Study||207
8632679|NCT00546819|9672662|FG001|STARTED|Overall Study||102
8632680|NCT00546819|9672661|FG000|VACCINATED|Overall Study||206
8632681|NCT00546819|9672662|FG001|VACCINATED|Overall Study||100
8632682|NCT00546819|9672661|FG000|COMPLETED|Overall Study||199
8632683|NCT00546819|9672662|FG001|COMPLETED|Overall Study||96
8877578|NCT01924429|9934547|FG000|STARTED|Period 1 - First Intervention (4 Weeks)||17
8877579|NCT01924429|9934548|FG001|STARTED|Period 1 - First Intervention (4 Weeks)||13
8877580|NCT01924429|9934547|FG000|COMPLETED|Period 1 - First Intervention (4 Weeks)||17
8877581|NCT01924429|9934548|FG001|COMPLETED|Period 1 - First Intervention (4 Weeks)||13
8877582|NCT01924429|9934547|FG000|NOT COMPLETED|Period 1 - First Intervention (4 Weeks)||0
8877583|NCT01924429|9934548|FG001|NOT COMPLETED|Period 1 - First Intervention (4 Weeks)||0
8877584|NCT01924429|9934547|FG000|STARTED|Washout Period (2 Weeks)||17
8877585|NCT01924429|9934548|FG001|STARTED|Washout Period (2 Weeks)||13
8877586|NCT01924429|9934547|FG000|COMPLETED|Washout Period (2 Weeks)||14
8877587|NCT01924429|9934548|FG001|COMPLETED|Washout Period (2 Weeks)||11
8877588|NCT01924429|9934547|FG000|NOT COMPLETED|Washout Period (2 Weeks)||3
8877589|NCT01924429|9934548|FG001|NOT COMPLETED|Washout Period (2 Weeks)||2
8877590|NCT01924429|9934547|FG000|STARTED|Period 2 - Second Intervention (4 Weeks)||14
8877591|NCT01924429|9934548|FG001|STARTED|Period 2 - Second Intervention (4 Weeks)||11
8877592|NCT01924429|9934547|FG000|COMPLETED|Period 2 - Second Intervention (4 Weeks)||14
8877593|NCT01924429|9934548|FG001|COMPLETED|Period 2 - Second Intervention (4 Weeks)||11
8877594|NCT01924429|9934547|FG000|NOT COMPLETED|Period 2 - Second Intervention (4 Weeks)||0
8877595|NCT01924429|9934548|FG001|NOT COMPLETED|Period 2 - Second Intervention (4 Weeks)||0
8877596|NCT01924442|9934558|FG000|STARTED|Overall Study||1099
8877597|NCT01924442|9934559|FG001|STARTED|Overall Study||1104
8877598|NCT01924442|9934558|FG000|COMPLETED|Overall Study||1059
8877599|NCT01924442|9934559|FG001|COMPLETED|Overall Study||967
8877600|NCT01924442|9934558|FG000|NOT COMPLETED|Overall Study||40
8877601|NCT01924442|9934559|FG001|NOT COMPLETED|Overall Study||137
8877602|NCT01924559|9934565|FG000|STARTED|Overall Study|All 37 participants were scored under the same six scenarios, resulting in 222 observations.|37
8877603|NCT01924559|9934565|FG000|COMPLETED|Overall Study|The order in which subjects started scenarios (in biohazard gear vs street clothing) was randomized|37
8877604|NCT01924559|9934565|FG000|NOT COMPLETED|Overall Study||0
8877605|NCT01924689|9934585|FG000|STARTED|Overall Study||3
8877606|NCT01924689|9934586|FG001|STARTED|Overall Study||3
8877607|NCT01924689|9934587|FG002|STARTED|Overall Study||4
8877608|NCT01924689|9934588|FG003|STARTED|Overall Study||6
8877609|NCT01924689|9934589|FG004|STARTED|Overall Study||6
8877610|NCT01924689|9934590|FG005|STARTED|Overall Study||2
8877611|NCT01924689|9934585|FG000|COMPLETED|Overall Study||0
8877612|NCT01924689|9934586|FG001|COMPLETED|Overall Study||0
8877613|NCT01924689|9934587|FG002|COMPLETED|Overall Study||0
8877614|NCT01924689|9934588|FG003|COMPLETED|Overall Study||0
8877615|NCT01924689|9934589|FG004|COMPLETED|Overall Study||0
8877616|NCT01924689|9934590|FG005|COMPLETED|Overall Study||0
8877617|NCT01924689|9934585|FG000|NOT COMPLETED|Overall Study||3
8877618|NCT01924689|9934586|FG001|NOT COMPLETED|Overall Study||3
8877619|NCT01924689|9934587|FG002|NOT COMPLETED|Overall Study||4
8877620|NCT01924689|9934588|FG003|NOT COMPLETED|Overall Study||6
8877621|NCT01924689|9934589|FG004|NOT COMPLETED|Overall Study||6
8877622|NCT01924689|9934590|FG005|NOT COMPLETED|Overall Study||2
8877623|NCT01924754|9934611|FG000|STARTED|Overall Study||50
8877624|NCT01924754|9934612|FG001|STARTED|Overall Study||50
8877625|NCT01924754|9934613|FG002|STARTED|Overall Study||50
8877626|NCT01924754|9934611|FG000|COMPLETED|Overall Study||49
8877627|NCT01924754|9934612|FG001|COMPLETED|Overall Study||47
8877628|NCT01924754|9934613|FG002|COMPLETED|Overall Study||47
8877629|NCT01924754|9934611|FG000|NOT COMPLETED|Overall Study||1
8877630|NCT01924754|9934612|FG001|NOT COMPLETED|Overall Study||3
8877631|NCT01924754|9934613|FG002|NOT COMPLETED|Overall Study||3
8877632|NCT01924767|9934629|FG000|STARTED|Overall Study||12
8877633|NCT01924767|9934630|FG001|STARTED|Overall Study||9
8877634|NCT01924767|9934631|FG002|STARTED|Overall Study||9
8877635|NCT01924767|9934632|FG003|STARTED|Overall Study||9
8877636|NCT01924767|9934633|FG004|STARTED|Overall Study||9
8877637|NCT01924767|9934629|FG000|COMPLETED|Overall Study||11
8877638|NCT01924767|9934630|FG001|COMPLETED|Overall Study||9
8877639|NCT01924767|9934631|FG002|COMPLETED|Overall Study||8
8877640|NCT01924767|9934632|FG003|COMPLETED|Overall Study||9
8877641|NCT01924767|9934633|FG004|COMPLETED|Overall Study||9
8877642|NCT01924767|9934629|FG000|NOT COMPLETED|Overall Study||1
8877643|NCT01924767|9934630|FG001|NOT COMPLETED|Overall Study||0
8877644|NCT01924767|9934631|FG002|NOT COMPLETED|Overall Study||1
8877645|NCT01924767|9934632|FG003|NOT COMPLETED|Overall Study||0
8877646|NCT01924767|9934633|FG004|NOT COMPLETED|Overall Study||0
8877647|NCT01924806|9934652|FG000|STARTED|Overall Study||5
8877648|NCT01924806|9934653|FG001|STARTED|Overall Study||4
8877649|NCT01924806|9934652|FG000|COMPLETED|Overall Study||3
8877650|NCT01924806|9934653|FG001|COMPLETED|Overall Study||3
8877651|NCT01924806|9934652|FG000|NOT COMPLETED|Overall Study||2
8877652|NCT01924806|9934653|FG001|NOT COMPLETED|Overall Study||1
8877653|NCT01924845|9934659|FG000|STARTED|Overall Study||24
8632684|NCT00546819|9672661|FG000|NOT COMPLETED|Overall Study||8
8632685|NCT00546819|9672662|FG001|NOT COMPLETED|Overall Study||6
8877654|NCT01924845|9934659|FG000|COMPLETED|Overall Study||18
8983716|NCT02708745|10046714|FG003|COMPLETED|Overall Study||116
8983717|NCT02708745|10046711|FG000|NOT COMPLETED|Overall Study||0
8983718|NCT02708745|10046712|FG001|NOT COMPLETED|Overall Study||4
8983719|NCT02708745|10046713|FG002|NOT COMPLETED|Overall Study||83
8983720|NCT02708745|10046714|FG003|NOT COMPLETED|Overall Study||82
8983721|NCT02708862|10046726|FG000|STARTED|Overall Study||26
8983722|NCT02708862|10046726|FG000|COMPLETED|Overall Study||26
8983723|NCT02708862|10046726|FG000|NOT COMPLETED|Overall Study||0
8983724|NCT02708966|10046735|FG000|STARTED|Overall Study||15
8983725|NCT02708966|10046736|FG001|STARTED|Overall Study||15
8983726|NCT02708966|10046735|FG000|COMPLETED|Overall Study||13
8983727|NCT02708966|10046736|FG001|COMPLETED|Overall Study||13
8983728|NCT02708966|10046735|FG000|NOT COMPLETED|Overall Study||2
8983729|NCT02708966|10046736|FG001|NOT COMPLETED|Overall Study||2
8983730|NCT02709005|10046744|FG000|STARTED|Overall Study||73
8983731|NCT02709005|10046745|FG001|STARTED|Overall Study||36
8983732|NCT02709005|10046744|FG000|COMPLETED|Overall Study||69
8983733|NCT02709005|10046745|FG001|COMPLETED|Overall Study||35
8983734|NCT02709005|10046744|FG000|NOT COMPLETED|Overall Study||4
8983735|NCT02709005|10046745|FG001|NOT COMPLETED|Overall Study||1
8983736|NCT02709018|10046753|FG000|STARTED|Overall Study||75
8983737|NCT02709018|10046754|FG001|STARTED|Overall Study||74
8983738|NCT02709018|10046753|FG000|COMPLETED|Overall Study||59
8983739|NCT02709018|10046754|FG001|COMPLETED|Overall Study||58
8983740|NCT02709018|10046753|FG000|NOT COMPLETED|Overall Study||16
8983741|NCT02709018|10046754|FG001|NOT COMPLETED|Overall Study||16
8983742|NCT02709096|10046764|FG000|STARTED|Overall Study||22
8983743|NCT02709096|10046765|FG001|STARTED|Overall Study||11
8983744|NCT02709096|10046764|FG000|COMPLETED|Overall Study||21
8983745|NCT02709096|10046765|FG001|COMPLETED|Overall Study||10
8983746|NCT02709096|10046764|FG000|NOT COMPLETED|Overall Study||1
8983747|NCT02709096|10046765|FG001|NOT COMPLETED|Overall Study||1
8983748|NCT02709109|10046775|FG000|STARTED|Treatment Period 1 (28 Days)||49
8983749|NCT02709109|10046776|FG001|STARTED|Treatment Period 1 (28 Days)||47
8983750|NCT02709109|10046777|FG002|STARTED|Treatment Period 1 (28 Days)||22
8983751|NCT02709109|10046778|FG003|STARTED|Treatment Period 1 (28 Days)||24
8983752|NCT02709109|10046775|FG000|COMPLETED|Treatment Period 1 (28 Days)||45
8983753|NCT02709109|10046776|FG001|COMPLETED|Treatment Period 1 (28 Days)||42
8983754|NCT02709109|10046777|FG002|COMPLETED|Treatment Period 1 (28 Days)||21
8983755|NCT02709109|10046778|FG003|COMPLETED|Treatment Period 1 (28 Days)||24
8983756|NCT02709109|10046775|FG000|NOT COMPLETED|Treatment Period 1 (28 Days)||4
8983757|NCT02709109|10046776|FG001|NOT COMPLETED|Treatment Period 1 (28 Days)||5
8983758|NCT02709109|10046777|FG002|NOT COMPLETED|Treatment Period 1 (28 Days)||1
8983759|NCT02709109|10046778|FG003|NOT COMPLETED|Treatment Period 1 (28 Days)||0
8983760|NCT02709109|10046775|FG000|STARTED|Washout Period (28 Days)||45
8983761|NCT02709109|10046776|FG001|STARTED|Washout Period (28 Days)||42
8983762|NCT02709109|10046777|FG002|STARTED|Washout Period (28 Days)||21
8983763|NCT02709109|10046778|FG003|STARTED|Washout Period (28 Days)||24
8983764|NCT02709109|10046775|FG000|COMPLETED|Washout Period (28 Days)||43
8983765|NCT02709109|10046776|FG001|COMPLETED|Washout Period (28 Days)||40
8983766|NCT02709109|10046777|FG002|COMPLETED|Washout Period (28 Days)||18
8983767|NCT02709109|10046778|FG003|COMPLETED|Washout Period (28 Days)||24
8983768|NCT02709109|10046775|FG000|NOT COMPLETED|Washout Period (28 Days)||2
8983769|NCT02709109|10046776|FG001|NOT COMPLETED|Washout Period (28 Days)||2
8983770|NCT02709109|10046777|FG002|NOT COMPLETED|Washout Period (28 Days)||3
8983771|NCT02709109|10046778|FG003|NOT COMPLETED|Washout Period (28 Days)||0
8983772|NCT02709109|10046775|FG000|STARTED|Treatment Period 2 (28 Days)||43
8983773|NCT02709109|10046776|FG001|STARTED|Treatment Period 2 (28 Days)||40
8983774|NCT02709109|10046777|FG002|STARTED|Treatment Period 2 (28 Days)||18
8983775|NCT02709109|10046778|FG003|STARTED|Treatment Period 2 (28 Days)||24
8983776|NCT02709109|10046775|FG000|COMPLETED|Treatment Period 2 (28 Days)||41
8983777|NCT02709109|10046776|FG001|COMPLETED|Treatment Period 2 (28 Days)||36
8983778|NCT02709109|10046777|FG002|COMPLETED|Treatment Period 2 (28 Days)||15
8983779|NCT02709109|10046778|FG003|COMPLETED|Treatment Period 2 (28 Days)||24
8983780|NCT02709109|10046775|FG000|NOT COMPLETED|Treatment Period 2 (28 Days)||2
8983781|NCT02709109|10046776|FG001|NOT COMPLETED|Treatment Period 2 (28 Days)||4
8983782|NCT02709109|10046777|FG002|NOT COMPLETED|Treatment Period 2 (28 Days)||3
8983783|NCT02709109|10046778|FG003|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8983784|NCT02709330|10046789|FG000|STARTED|Overall Study||50
8983785|NCT02709330|10046790|FG001|STARTED|Overall Study||10
8983786|NCT02709330|10046789|FG000|COMPLETED|Overall Study||37
8983787|NCT02709330|10046790|FG001|COMPLETED|Overall Study||10
8983788|NCT02709330|10046789|FG000|NOT COMPLETED|Overall Study||13
8983789|NCT02709330|10046790|FG001|NOT COMPLETED|Overall Study||0
8983790|NCT02709369|10046796|FG000|STARTED|Overall Study||300
8983791|NCT02709369|10046796|FG000|COMPLETED|Overall Study||273
8983792|NCT02709369|10046796|FG000|NOT COMPLETED|Overall Study||27
8983793|NCT02709486|10046803|FG000|STARTED|Overall Study||282
8983794|NCT02709486|10046804|FG001|STARTED|Overall Study||283
8983795|NCT02709486|10046805|FG002|STARTED|Overall Study||284
8983796|NCT02709486|10046803|FG000|COMPLETED|Overall Study||238
8983797|NCT02709486|10046804|FG001|COMPLETED|Overall Study||249
8983798|NCT02709486|10046805|FG002|COMPLETED|Overall Study||239
8983799|NCT02709486|10046803|FG000|NOT COMPLETED|Overall Study||44
8983800|NCT02709486|10046804|FG001|NOT COMPLETED|Overall Study||34
8983801|NCT02709486|10046805|FG002|NOT COMPLETED|Overall Study||45
8983802|NCT02709538|10046816|FG000|STARTED|Overall Study||400
8983803|NCT02709538|10046817|FG001|STARTED|Overall Study||100
8983804|NCT02709538|10046818|FG002|STARTED|Overall Study||101
8983805|NCT02709538|10046816|FG000|COMPLETED|Overall Study||287
8983806|NCT02709538|10046817|FG001|COMPLETED|Overall Study||72
8983807|NCT02709538|10046818|FG002|COMPLETED|Overall Study||81
8983808|NCT02709538|10046816|FG000|NOT COMPLETED|Overall Study||113
8983809|NCT02709538|10046817|FG001|NOT COMPLETED|Overall Study||28
8983810|NCT02709538|10046818|FG002|NOT COMPLETED|Overall Study||20
8983811|NCT02709577|10046828|FG000|STARTED|Overall Study||12
8983812|NCT02709577|10046829|FG001|STARTED|Overall Study||13
8983813|NCT02709577|10046830|FG002|STARTED|Overall Study||6
8983814|NCT02709577|10046831|FG003|STARTED|Overall Study||5
8983815|NCT02709577|10046828|FG000|COMPLETED|Overall Study||10
8983816|NCT02709577|10046829|FG001|COMPLETED|Overall Study||8
8983817|NCT02709577|10046830|FG002|COMPLETED|Overall Study||4
8983818|NCT02709577|10046831|FG003|COMPLETED|Overall Study||5
8983819|NCT02709577|10046828|FG000|NOT COMPLETED|Overall Study||2
8983820|NCT02709577|10046829|FG001|NOT COMPLETED|Overall Study||5
8983821|NCT02709577|10046830|FG002|NOT COMPLETED|Overall Study||2
8983822|NCT02709577|10046831|FG003|NOT COMPLETED|Overall Study||0
8983823|NCT02709694|10046842|FG000|STARTED|Overall Study||33
8983824|NCT02709694|10046842|FG000|Any Back Pain|Overall Study||19
8983825|NCT02709694|10046842|FG000|No Back Pain|Overall Study||14
8983826|NCT02709694|10046842|FG000|MRI Showing Presence of Sacroiliitis|Overall Study||4
8983827|NCT02709694|10046842|FG000|MRI Not Showing Sacroiliitis|Overall Study||29
8983828|NCT02709694|10046842|FG000|Classified as Having Inflammatory Back Pain by the ASAS Criteria|Overall Study||6
8983829|NCT02709694|10046842|FG000|Not Classified as Having Inflammatory Back Pain by the ASAS Criteria|Overall Study||25
8983830|NCT02709694|10046842|FG000|Having Bone Marrow Edema Seen in MRI|Overall Study||33
8983831|NCT02709694|10046842|FG000|Having Erosion (a Structural Lesion) Seen in MRI|Overall Study||33
8983832|NCT02709694|10046842|FG000|Having Fat Metaplasia Seen in MRI|Overall Study||33
8983833|NCT02709694|10046842|FG000|Having Backfill (Type of Structural Lesion) Seen in MRI|Overall Study||33
8983834|NCT02709694|10046842|FG000|Having Ankylosis Seen in MRI|Overall Study||33
8983835|NCT02709694|10046842|FG000|COMPLETED|Overall Study||33
8983836|NCT02709694|10046842|FG000|NOT COMPLETED|Overall Study||0
8983837|NCT02709746|10046861|FG000|STARTED|Phase A (Single-blind Treatment Period)||784
8983838|NCT02709746|10046862|FG001|STARTED|Phase A (Single-blind Treatment Period)||0
8983839|NCT02709746|10046863|FG002|STARTED|Phase A (Single-blind Treatment Period)||0
8983840|NCT02709746|10046864|FG003|STARTED|Phase A (Single-blind Treatment Period)||0
8983841|NCT02709746|10046865|FG004|STARTED|Phase A (Single-blind Treatment Period)||0
8983842|NCT02709746|10046861|FG000|COMPLETED|Phase A (Single-blind Treatment Period)||616
8983843|NCT02709746|10046862|FG001|COMPLETED|Phase A (Single-blind Treatment Period)||0
8983844|NCT02709746|10046863|FG002|COMPLETED|Phase A (Single-blind Treatment Period)||0
8983845|NCT02709746|10046864|FG003|COMPLETED|Phase A (Single-blind Treatment Period)||0
8983846|NCT02709746|10046865|FG004|COMPLETED|Phase A (Single-blind Treatment Period)||0
8983847|NCT02709746|10046861|FG000|NOT COMPLETED|Phase A (Single-blind Treatment Period)||168
8983848|NCT02709746|10046862|FG001|NOT COMPLETED|Phase A (Single-blind Treatment Period)||0
8983849|NCT02709746|10046863|FG002|NOT COMPLETED|Phase A (Single-blind Treatment Period)||0
8983850|NCT02709746|10046864|FG003|NOT COMPLETED|Phase A (Single-blind Treatment Period)||0
8983851|NCT02709746|10046865|FG004|NOT COMPLETED|Phase A (Single-blind Treatment Period)||0
8983852|NCT02709746|10046861|FG000|STARTED|Phase B (Double-blind Treatment Period)||0
8983853|NCT02709746|10046862|FG001|STARTED|Phase B (Double-blind Treatment Period)||147
8983854|NCT02709746|10046863|FG002|STARTED|Phase B (Double-blind Treatment Period)||162
8983855|NCT02709746|10046864|FG003|STARTED|Phase B (Double-blind Treatment Period)||153
8983856|NCT02709746|10046865|FG004|STARTED|Phase B (Double-blind Treatment Period)||154
8983857|NCT02709746|10046861|FG000|COMPLETED|Phase B (Double-blind Treatment Period)||0
8983858|NCT02709746|10046862|FG001|COMPLETED|Phase B (Double-blind Treatment Period)||126
8983859|NCT02709746|10046863|FG002|COMPLETED|Phase B (Double-blind Treatment Period)||140
8983860|NCT02709746|10046864|FG003|COMPLETED|Phase B (Double-blind Treatment Period)||138
8983861|NCT02709746|10046865|FG004|COMPLETED|Phase B (Double-blind Treatment Period)||138
8983862|NCT02709746|10046861|FG000|NOT COMPLETED|Phase B (Double-blind Treatment Period)||0
8983863|NCT02709746|10046862|FG001|NOT COMPLETED|Phase B (Double-blind Treatment Period)||21
8983864|NCT02709746|10046863|FG002|NOT COMPLETED|Phase B (Double-blind Treatment Period)||22
8983865|NCT02709746|10046864|FG003|NOT COMPLETED|Phase B (Double-blind Treatment Period)||15
8983866|NCT02709746|10046865|FG004|NOT COMPLETED|Phase B (Double-blind Treatment Period)||16
8632686|NCT00546871|9672668|FG000|STARTED|Part 1 - IV Infusions of IGIV, PK||14
8632687|NCT00546871|9672669|FG001|STARTED|Part 1 - IV Infusions of IGIV, PK||35
8632688|NCT00546871|9672668|FG000|COMPLETED|Part 1 - IV Infusions of IGIV, PK||13
8632689|NCT00546871|9672669|FG001|COMPLETED|Part 1 - IV Infusions of IGIV, PK||35
8632690|NCT00546871|9672668|FG000|NOT COMPLETED|Part 1 - IV Infusions of IGIV, PK||1
8983867|NCT02709785|10046880|FG000|STARTED|Overall Study||24
8983868|NCT02709785|10046881|FG001|STARTED|Overall Study||28
8983869|NCT02709785|10046882|FG002|STARTED|Overall Study||28
8983870|NCT02709785|10046880|FG000|3 Weeks|Overall Study||23
8983871|NCT02709785|10046881|FG001|3 Weeks|Overall Study||27
8983872|NCT02709785|10046882|FG002|3 Weeks|Overall Study||27
8983873|NCT02709785|10046880|FG000|6 Weeks|Overall Study||23
8983874|NCT02709785|10046881|FG001|6 Weeks|Overall Study||26
8983875|NCT02709785|10046882|FG002|6 Weeks|Overall Study||27
8983876|NCT02709785|10046880|FG000|COMPLETED|Overall Study||23
8983877|NCT02709785|10046881|FG001|COMPLETED|Overall Study||26
8983878|NCT02709785|10046882|FG002|COMPLETED|Overall Study||27
8983879|NCT02709785|10046880|FG000|NOT COMPLETED|Overall Study||1
8983880|NCT02709785|10046881|FG001|NOT COMPLETED|Overall Study||2
8983881|NCT02709785|10046882|FG002|NOT COMPLETED|Overall Study||1
9038654|NCT03332784|10099764|FG003|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
9038655|NCT03332784|10099765|FG004|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
9038656|NCT03332784|10099766|FG005|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
9038657|NCT03332784|10099767|FG006|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
9038658|NCT03332784|10099768|FG007|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
9038659|NCT03332784|10099769|FG008|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
9038660|NCT03332784|10099770|FG009|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
9038661|NCT03332784|10099771|FG010|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
9038662|NCT03332784|10099772|FG011|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
9038663|NCT03332784|10099773|FG012|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
9038664|NCT03332784|10099774|FG013|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
9038665|NCT03332784|10099775|FG014|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
9038666|NCT03332784|10099776|FG015|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
9038667|NCT03332784|10099777|FG016|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
9038668|NCT03332784|10099778|FG017|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
9038669|NCT03332784|10099779|FG018|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
9038670|NCT03332784|10099780|FG019|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
9038671|NCT03332979|10099834|FG000|STARTED|Overall Study||150
9038672|NCT03332979|10099834|FG000|COMPLETED|Overall Study||150
9038673|NCT03332979|10099834|FG000|NOT COMPLETED|Overall Study||0
9038674|NCT03333109|10099841|FG000|STARTED|Double-blind Treatment Period (DBTP)||338
9038675|NCT03333109|10099842|FG001|STARTED|Double-blind Treatment Period (DBTP)||224
9038676|NCT03333109|10099843|FG002|STARTED|Double-blind Treatment Period (DBTP)||338
9038677|NCT03333109|10099841|FG000|Full Analysis Set|Double-blind Treatment Period (DBTP)||329
9038678|NCT03333109|10099842|FG001|Full Analysis Set|Double-blind Treatment Period (DBTP)||219
9038679|NCT03333109|10099843|FG002|Full Analysis Set|Double-blind Treatment Period (DBTP)||330
9038680|NCT03333109|10099841|FG000|Safety Analysis Set|Double-blind Treatment Period (DBTP)||335
9038681|NCT03333109|10099842|FG001|Safety Analysis Set|Double-blind Treatment Period (DBTP)||224
9038682|NCT03333109|10099843|FG002|Safety Analysis Set|Double-blind Treatment Period (DBTP)||335
9038683|NCT03333109|10099841|FG000|COMPLETED|Double-blind Treatment Period (DBTP)||321
9038684|NCT03333109|10099842|FG001|COMPLETED|Double-blind Treatment Period (DBTP)||218
9038685|NCT03333109|10099843|FG002|COMPLETED|Double-blind Treatment Period (DBTP)||326
9038686|NCT03333109|10099841|FG000|NOT COMPLETED|Double-blind Treatment Period (DBTP)||17
9038687|NCT03333109|10099842|FG001|NOT COMPLETED|Double-blind Treatment Period (DBTP)||6
9038688|NCT03333109|10099843|FG002|NOT COMPLETED|Double-blind Treatment Period (DBTP)||12
9038689|NCT03333109|10099841|FG000|STARTED|Safety Follow-up Period|Subjects discontinued from DBTP and still entered the safety follow-up.|324
9038690|NCT03333109|10099842|FG001|STARTED|Safety Follow-up Period||218
9038691|NCT03333109|10099843|FG002|STARTED|Safety Follow-up Period|Subjects discontinued from DBTP and still entered the safety follow-up.|328
9038692|NCT03333109|10099841|FG000|COMPLETED|Safety Follow-up Period||311
9038693|NCT03333109|10099842|FG001|COMPLETED|Safety Follow-up Period||214
9038694|NCT03333109|10099843|FG002|COMPLETED|Safety Follow-up Period||315
9038695|NCT03333109|10099841|FG000|NOT COMPLETED|Safety Follow-up Period||13
9038696|NCT03333109|10099842|FG001|NOT COMPLETED|Safety Follow-up Period||4
9038697|NCT03333109|10099843|FG002|NOT COMPLETED|Safety Follow-up Period||13
9038698|NCT03333317|10099854|FG000|STARTED|Overall Study||3
9038699|NCT03333317|10099855|FG001|STARTED|Overall Study||1
9038700|NCT03333317|10099856|FG002|STARTED|Overall Study||3
9038701|NCT03333317|10099854|FG000|COMPLETED|Overall Study||3
9038702|NCT03333317|10099855|FG001|COMPLETED|Overall Study||1
9038703|NCT03333317|10099856|FG002|COMPLETED|Overall Study||3
9038704|NCT03333317|10099854|FG000|NOT COMPLETED|Overall Study||0
9038705|NCT03333317|10099855|FG001|NOT COMPLETED|Overall Study||0
9038706|NCT03333317|10099856|FG002|NOT COMPLETED|Overall Study||0
9038707|NCT03333577|10099866|FG000|STARTED|Overall Study||32
9038708|NCT03333577|10099866|FG000|COMPLETED|Overall Study||25
9038709|NCT03333577|10099866|FG000|NOT COMPLETED|Overall Study||7
9038710|NCT03333876|10099872|FG000|STARTED|Screening Period||58
9038711|NCT03333876|10099872|FG000|COMPLETED|Screening Period||54
9038712|NCT03333876|10099872|FG000|NOT COMPLETED|Screening Period||4
9038713|NCT03333876|10099872|FG000|STARTED|Nasal Dilator||54
9038714|NCT03333876|10099872|FG000|COMPLETED|Nasal Dilator||48
9038715|NCT03333876|10099872|FG000|NOT COMPLETED|Nasal Dilator||6
9038716|NCT03333876|10099872|FG000|STARTED|Mandibular Advancement||54
9038717|NCT03333876|10099872|FG000|COMPLETED|Mandibular Advancement||50
9038718|NCT03333876|10099872|FG000|NOT COMPLETED|Mandibular Advancement||4
9038719|NCT03333876|10099872|FG000|STARTED|Positional Therapy||54
9038720|NCT03333876|10099872|FG000|COMPLETED|Positional Therapy||54
9038721|NCT03333876|10099872|FG000|NOT COMPLETED|Positional Therapy||0
9038722|NCT03333941|10099885|FG000|STARTED|Overall Study||76
9038723|NCT03333941|10099885|FG000|COMPLETED|Overall Study||63
9038724|NCT03333941|10099885|FG000|NOT COMPLETED|Overall Study||13
9038725|NCT03334175|10099891|FG000|STARTED|Overall Study||8
9038726|NCT03334175|10099892|FG001|STARTED|Overall Study||10
9038727|NCT03334175|10099891|FG000|COMPLETED|Overall Study||8
9038728|NCT03334175|10099892|FG001|COMPLETED|Overall Study||9
9038729|NCT03334175|10099891|FG000|NOT COMPLETED|Overall Study||0
9038730|NCT03334175|10099892|FG001|NOT COMPLETED|Overall Study||1
9038731|NCT03334188|10099900|FG000|STARTED|Overall Study||153
9038732|NCT03334188|10099901|FG001|STARTED|Overall Study||153
8983882|NCT02709889|10046898|FG000|STARTED|Overall Study||43
8983883|NCT02709889|10046899|FG001|STARTED|Overall Study||57
8983884|NCT02709889|10046900|FG002|STARTED|Overall Study||12
8983885|NCT02709889|10046901|FG003|STARTED|Overall Study||88
8983886|NCT02709889|10046898|FG000|Large Cell Neuroendocrine Carcinoma(NEC)|Overall Study||3
8983887|NCT02709889|10046899|FG001|Large Cell Neuroendocrine Carcinoma(NEC)|Overall Study||4
8983888|NCT02709889|10046900|FG002|Large Cell Neuroendocrine Carcinoma(NEC)|Overall Study||2
8983889|NCT02709889|10046901|FG003|Large Cell Neuroendocrine Carcinoma(NEC)|Overall Study||4
8983890|NCT02709889|10046898|FG000|Neuroendocrine Prostate Cancer|Overall Study||4
8983891|NCT02709889|10046899|FG001|Neuroendocrine Prostate Cancer|Overall Study||7
8983892|NCT02709889|10046900|FG002|Neuroendocrine Prostate Cancer|Overall Study||3
8983893|NCT02709889|10046901|FG003|Neuroendocrine Prostate Cancer|Overall Study||7
8983894|NCT02709889|10046898|FG000|Gastroenteropancreatic NEC|Overall Study||6
8983895|NCT02709889|10046899|FG001|Gastroenteropancreatic NEC|Overall Study||5
8983896|NCT02709889|10046900|FG002|Gastroenteropancreatic NEC|Overall Study||2
8983897|NCT02709889|10046901|FG003|Gastroenteropancreatic NEC|Overall Study||23
8983898|NCT02709889|10046898|FG000|Other NEC|Overall Study||11
8983899|NCT02709889|10046899|FG001|Other NEC|Overall Study||12
8983900|NCT02709889|10046900|FG002|Other NEC|Overall Study||1
8983901|NCT02709889|10046901|FG003|Other NEC|Overall Study||7
8983902|NCT02709889|10046898|FG000|Malignant Melanoma|Overall Study||3
8983903|NCT02709889|10046899|FG001|Malignant Melanoma|Overall Study||6
8983904|NCT02709889|10046900|FG002|Malignant Melanoma|Overall Study||0
8983905|NCT02709889|10046901|FG003|Malignant Melanoma|Overall Study||11
8983906|NCT02709889|10046898|FG000|Medullary Thyroid Cancer|Overall Study||3
8983907|NCT02709889|10046899|FG001|Medullary Thyroid Cancer|Overall Study||3
8983908|NCT02709889|10046900|FG002|Medullary Thyroid Cancer|Overall Study||0
8983909|NCT02709889|10046901|FG003|Medullary Thyroid Cancer|Overall Study||7
8983910|NCT02709889|10046898|FG000|Glioblastoma|Overall Study||4
8983911|NCT02709889|10046899|FG001|Glioblastoma|Overall Study||4
8983912|NCT02709889|10046900|FG002|Glioblastoma|Overall Study||1
8877655|NCT01924845|9934659|FG000|NOT COMPLETED|Overall Study||6
8877656|NCT01924871|9934665|FG000|STARTED|Overall Study||31
8877657|NCT01924871|9934666|FG001|STARTED|Overall Study||31
8877658|NCT01924871|9934665|FG000|COMPLETED|Overall Study||25
8877659|NCT01924871|9934666|FG001|COMPLETED|Overall Study||29
8877660|NCT01924871|9934665|FG000|NOT COMPLETED|Overall Study||6
8877661|NCT01924871|9934666|FG001|NOT COMPLETED|Overall Study||2
8877662|NCT01924949|9934672|FG000|STARTED|Overall Study||5
8877663|NCT01924949|9934672|FG000|COMPLETED|Overall Study||5
8877664|NCT01924949|9934672|FG000|NOT COMPLETED|Overall Study||0
8877665|NCT01924975|9934678|FG000|STARTED|Overall Study||51
8877666|NCT01924975|9934679|FG001|STARTED|Overall Study||51
8877667|NCT01924975|9934678|FG000|COMPLETED|Overall Study||51
8877668|NCT01924975|9934679|FG001|COMPLETED|Overall Study||51
8877669|NCT01924975|9934678|FG000|NOT COMPLETED|Overall Study||0
8877670|NCT01924975|9934679|FG001|NOT COMPLETED|Overall Study||0
8877671|NCT01924988|9934685|FG000|STARTED|Overall Study||15
8877672|NCT01924988|9934685|FG000|COMPLETED|Overall Study||15
8877673|NCT01924988|9934685|FG000|NOT COMPLETED|Overall Study||0
8877674|NCT01925014|9934694|FG000|STARTED|Overall Study||1535
8877675|NCT01925014|9934695|FG001|STARTED|Overall Study||1539
8877676|NCT01925014|9934694|FG000|COMPLETED|Overall Study||1526
8877677|NCT01925014|9934695|FG001|COMPLETED|Overall Study||1520
8877678|NCT01925014|9934694|FG000|NOT COMPLETED|Overall Study||9
8877679|NCT01925014|9934695|FG001|NOT COMPLETED|Overall Study||19
8877680|NCT01925144|9934701|FG000|STARTED|Period 1 (Day 1 Through Predose Day 3)||30
8877681|NCT01925144|9934701|FG000|Received Baricitinib|Period 1 (Day 1 Through Predose Day 3)||30
8983913|NCT02709889|10046901|FG003|Glioblastoma|Overall Study||14
8571551|NCT00111228|9603847|FG001|COMPLETED|Overall Study||53
8571552|NCT00111228|9603848|FG002|COMPLETED|Overall Study||54
8571553|NCT00111228|9603846|FG000|NOT COMPLETED|Overall Study||5
8571554|NCT00111228|9603847|FG001|NOT COMPLETED|Overall Study||1
8571555|NCT00111228|9603848|FG002|NOT COMPLETED|Overall Study||0
8571556|NCT00111241|9603858|FG000|STARTED|Overall Study||45
8571557|NCT00111241|9603859|FG001|STARTED|Overall Study||70
8571558|NCT00111241|9603858|FG000|COMPLETED|Overall Study||30
8571559|NCT00111241|9603859|FG001|COMPLETED|Overall Study||62
8571560|NCT00111241|9603858|FG000|NOT COMPLETED|Overall Study||15
8571561|NCT00111241|9603859|FG001|NOT COMPLETED|Overall Study||8
8571562|NCT00111475|9603877|FG000|STARTED|Overall Study||4
8877682|NCT01925144|9934701|FG000|COMPLETED|Period 1 (Day 1 Through Predose Day 3)||30
8877683|NCT01925144|9934701|FG000|NOT COMPLETED|Period 1 (Day 1 Through Predose Day 3)||0
8877684|NCT01925144|9934701|FG000|STARTED|Period 2 (At Dosing Day 3 Through Day12)||30
8571563|NCT00111475|9603878|FG001|STARTED|Overall Study||4
8877685|NCT01925144|9934701|FG000|Received Baricitinib|Period 2 (At Dosing Day 3 Through Day12)||30
8877686|NCT01925144|9934701|FG000|Received 8 Doses of Omeprazole|Period 2 (At Dosing Day 3 Through Day12)||30
8877687|NCT01925144|9934701|FG000|COMPLETED|Period 2 (At Dosing Day 3 Through Day12)||30
8877688|NCT01925144|9934701|FG000|NOT COMPLETED|Period 2 (At Dosing Day 3 Through Day12)||0
8877689|NCT01925170|9934708|FG000|STARTED|Overall Study||1638
8877690|NCT01925170|9934708|FG000|COMPLETED|Overall Study||1585
8877691|NCT01925170|9934708|FG000|NOT COMPLETED|Overall Study||53
8877692|NCT01925183|9934716|FG000|STARTED|Overall Study||3
8877693|NCT01925183|9934717|FG001|STARTED|Overall Study||3
8877694|NCT01925183|9934716|FG000|COMPLETED|Overall Study||2
8983914|NCT02709889|10046898|FG000|Other Solid Tumors|Overall Study||9
8983915|NCT02709889|10046899|FG001|Other Solid Tumors|Overall Study||16
8983916|NCT02709889|10046900|FG002|Other Solid Tumors|Overall Study||3
8983917|NCT02709889|10046901|FG003|Other Solid Tumors|Overall Study||15
8983918|NCT02709889|10046898|FG000|COMPLETED|Overall Study||0
8983919|NCT02709889|10046899|FG001|COMPLETED|Overall Study||0
8983920|NCT02709889|10046900|FG002|COMPLETED|Overall Study||0
8983921|NCT02709889|10046901|FG003|COMPLETED|Overall Study||0
8983922|NCT02709889|10046898|FG000|NOT COMPLETED|Overall Study||43
8983923|NCT02709889|10046899|FG001|NOT COMPLETED|Overall Study||57
8983924|NCT02709889|10046900|FG002|NOT COMPLETED|Overall Study||12
8983925|NCT02709889|10046901|FG003|NOT COMPLETED|Overall Study||88
8983926|NCT02710045|10046949|FG000|STARTED|Overall Study||106
8983927|NCT02710045|10046950|FG001|STARTED|Overall Study||115
8983928|NCT02710045|10046951|FG002|STARTED|Overall Study||81
8983929|NCT02710045|10046949|FG000|COMPLETED|Overall Study||95
8983930|NCT02710045|10046950|FG001|COMPLETED|Overall Study||98
8983931|NCT02710045|10046951|FG002|COMPLETED|Overall Study||68
8983932|NCT02710045|10046949|FG000|NOT COMPLETED|Overall Study||11
8983933|NCT02710045|10046950|FG001|NOT COMPLETED|Overall Study||17
8983934|NCT02710045|10046951|FG002|NOT COMPLETED|Overall Study||13
8983935|NCT02710071|10046961|FG000|STARTED|Placebo (2 Weeks).||21
8983936|NCT02710071|10046962|FG001|STARTED|Placebo (2 Weeks).||20
8983937|NCT02710071|10046961|FG000|COMPLETED|Placebo (2 Weeks).||21
8983938|NCT02710071|10046962|FG001|COMPLETED|Placebo (2 Weeks).||20
8983939|NCT02710071|10046961|FG000|NOT COMPLETED|Placebo (2 Weeks).||0
8983940|NCT02710071|10046962|FG001|NOT COMPLETED|Placebo (2 Weeks).||0
8983941|NCT02710071|10046961|FG000|STARTED|First Intervention (6 Weeks).||21
8983942|NCT02710071|10046962|FG001|STARTED|First Intervention (6 Weeks).||20
8983943|NCT02710071|10046961|FG000|COMPLETED|First Intervention (6 Weeks).||18
8983944|NCT02710071|10046962|FG001|COMPLETED|First Intervention (6 Weeks).||16
8983945|NCT02710071|10046961|FG000|NOT COMPLETED|First Intervention (6 Weeks).||3
8983946|NCT02710071|10046962|FG001|NOT COMPLETED|First Intervention (6 Weeks).||4
8983947|NCT02710071|10046961|FG000|STARTED|Second Intervention (6 Weeks).||18
8983948|NCT02710071|10046962|FG001|STARTED|Second Intervention (6 Weeks).||16
8983949|NCT02710071|10046961|FG000|COMPLETED|Second Intervention (6 Weeks).||17
8983950|NCT02710071|10046962|FG001|COMPLETED|Second Intervention (6 Weeks).||14
8983951|NCT02710071|10046961|FG000|NOT COMPLETED|Second Intervention (6 Weeks).||1
8983952|NCT02710071|10046962|FG001|NOT COMPLETED|Second Intervention (6 Weeks).||2
8983953|NCT02710136|10046971|FG000|STARTED|Study Enrollment||10
8983954|NCT02710136|10046972|FG001|STARTED|Study Enrollment||25
8983955|NCT02710136|10046971|FG000|COMPLETED|Study Enrollment||10
8983956|NCT02710136|10046972|FG001|COMPLETED|Study Enrollment||25
8983957|NCT02710136|10046971|FG000|NOT COMPLETED|Study Enrollment||0
8983958|NCT02710136|10046972|FG001|NOT COMPLETED|Study Enrollment||0
8983959|NCT02710136|10046971|FG000|STARTED|Phase 1a[Refer to Arm/Group Description]||10
8983960|NCT02710136|10046972|FG001|STARTED|Phase 1a[Refer to Arm/Group Description]||0
8983961|NCT02710136|10046971|FG000|COMPLETED|Phase 1a[Refer to Arm/Group Description]||9
8983962|NCT02710136|10046972|FG001|COMPLETED|Phase 1a[Refer to Arm/Group Description]||0
8983963|NCT02710136|10046971|FG000|NOT COMPLETED|Phase 1a[Refer to Arm/Group Description]||1
8983964|NCT02710136|10046972|FG001|NOT COMPLETED|Phase 1a[Refer to Arm/Group Description]||0
8983965|NCT02710136|10046971|FG000|STARTED|Phase 1b[Refer to Arm/Group Description]||4
8983966|NCT02710136|10046972|FG001|STARTED|Phase 1b[Refer to Arm/Group Description]||0
8983967|NCT02710136|10046971|FG000|COMPLETED|Phase 1b[Refer to Arm/Group Description]||4
8983968|NCT02710136|10046972|FG001|COMPLETED|Phase 1b[Refer to Arm/Group Description]||0
8983969|NCT02710136|10046971|FG000|NOT COMPLETED|Phase 1b[Refer to Arm/Group Description]||0
8983970|NCT02710136|10046972|FG001|NOT COMPLETED|Phase 1b[Refer to Arm/Group Description]||0
8983971|NCT02710136|10046971|FG000|STARTED|Phase 2 [Refer to Arm/Group Description]||0
8983972|NCT02710136|10046972|FG001|STARTED|Phase 2 [Refer to Arm/Group Description]||25
8983973|NCT02710136|10046971|FG000|COMPLETED|Phase 2 [Refer to Arm/Group Description]||0
8983974|NCT02710136|10046972|FG001|COMPLETED|Phase 2 [Refer to Arm/Group Description]||25
8983975|NCT02710136|10046971|FG000|NOT COMPLETED|Phase 2 [Refer to Arm/Group Description]||0
8983976|NCT02710136|10046972|FG001|NOT COMPLETED|Phase 2 [Refer to Arm/Group Description]||0
8983977|NCT02710214|10046981|FG000|STARTED|Overall Study||12
8983978|NCT02710214|10046982|FG001|STARTED|Overall Study||12
8983979|NCT02710214|10046981|FG000|COMPLETED|Overall Study||11
8983980|NCT02710214|10046982|FG001|COMPLETED|Overall Study||10
8983981|NCT02710214|10046981|FG000|NOT COMPLETED|Overall Study||1
8983982|NCT02710214|10046982|FG001|NOT COMPLETED|Overall Study||2
8983983|NCT02710240|10046988|FG000|STARTED|Overall Study||336
8983984|NCT02710240|10046988|FG000|COMPLETED|Overall Study||336
8983985|NCT02710240|10046988|FG000|NOT COMPLETED|Overall Study||0
8983986|NCT02710292|10046992|FG000|STARTED|Period 1, First 10 Days of Wear||47
8983987|NCT02710292|10046993|FG001|STARTED|Period 1, First 10 Days of Wear||52
8983988|NCT02710292|10046992|FG000|COMPLETED|Period 1, First 10 Days of Wear||46
8983989|NCT02710292|10046993|FG001|COMPLETED|Period 1, First 10 Days of Wear||49
8983990|NCT02710292|10046992|FG000|NOT COMPLETED|Period 1, First 10 Days of Wear||1
8983991|NCT02710292|10046993|FG001|NOT COMPLETED|Period 1, First 10 Days of Wear||3
8983992|NCT02710292|10046992|FG000|STARTED|Period 2, Second 10 Days of Wear||46
8983993|NCT02710292|10046993|FG001|STARTED|Period 2, Second 10 Days of Wear||49
8983994|NCT02710292|10046992|FG000|COMPLETED|Period 2, Second 10 Days of Wear||46
8983995|NCT02710292|10046993|FG001|COMPLETED|Period 2, Second 10 Days of Wear||49
8983996|NCT02710292|10046992|FG000|NOT COMPLETED|Period 2, Second 10 Days of Wear||0
8983997|NCT02710292|10046993|FG001|NOT COMPLETED|Period 2, Second 10 Days of Wear||0
8983998|NCT02710422|10047002|FG000|STARTED|Overall Study||12
8983999|NCT02710422|10047003|FG001|STARTED|Overall Study||12
8984000|NCT02710422|10047002|FG000|3 Month Visit|Overall Study||9
8984001|NCT02710422|10047003|FG001|3 Month Visit|Overall Study||11
8984002|NCT02710422|10047002|FG000|6 Month Visit|Overall Study||7
8984003|NCT02710422|10047003|FG001|6 Month Visit|Overall Study||8
8984004|NCT02710422|10047002|FG000|9 Month Visit|Overall Study||5
8984005|NCT02710422|10047003|FG001|9 Month Visit|Overall Study||5
8984006|NCT02710422|10047002|FG000|12 Month Visit|Overall Study||3
8984007|NCT02710422|10047003|FG001|12 Month Visit|Overall Study||3
8984008|NCT02710422|10047002|FG000|COMPLETED|Overall Study||3
8984009|NCT02710422|10047003|FG001|COMPLETED|Overall Study||3
8984010|NCT02710422|10047002|FG000|NOT COMPLETED|Overall Study||9
8984011|NCT02710422|10047003|FG001|NOT COMPLETED|Overall Study||9
8984012|NCT02710526|10047014|FG000|STARTED|Treatment Phase||28
8984013|NCT02710526|10047015|FG001|STARTED|Treatment Phase||20
8984014|NCT02710526|10047016|FG002|STARTED|Treatment Phase||18
8984015|NCT02710526|10047014|FG000|COMPLETED|Treatment Phase||22
8984016|NCT02710526|10047015|FG001|COMPLETED|Treatment Phase||16
8984017|NCT02710526|10047016|FG002|COMPLETED|Treatment Phase||12
8984018|NCT02710526|10047014|FG000|NOT COMPLETED|Treatment Phase||6
8984019|NCT02710526|10047015|FG001|NOT COMPLETED|Treatment Phase||4
8984020|NCT02710526|10047016|FG002|NOT COMPLETED|Treatment Phase||6
8984021|NCT02710526|10047014|FG000|STARTED|Safety Extension||15
8984022|NCT02710526|10047015|FG001|STARTED|Safety Extension||12
8984023|NCT02710526|10047016|FG002|STARTED|Safety Extension||0
8984024|NCT02710526|10047014|FG000|COMPLETED|Safety Extension||14
8984025|NCT02710526|10047015|FG001|COMPLETED|Safety Extension||12
8984026|NCT02710526|10047016|FG002|COMPLETED|Safety Extension||0
8984027|NCT02710526|10047014|FG000|NOT COMPLETED|Safety Extension||1
8984028|NCT02710526|10047015|FG001|NOT COMPLETED|Safety Extension||0
8984029|NCT02710526|10047016|FG002|NOT COMPLETED|Safety Extension||0
8984030|NCT02710591|10047038|FG000|STARTED|Overall Study||5
8984031|NCT02710591|10047039|FG001|STARTED|Overall Study||5
8984032|NCT02710591|10047040|FG002|STARTED|Overall Study||5
8984033|NCT02710591|10047041|FG003|STARTED|Overall Study||5
8984034|NCT02710591|10047038|FG000|COMPLETED|Overall Study||5
8984035|NCT02710591|10047039|FG001|COMPLETED|Overall Study||5
8984036|NCT02710591|10047040|FG002|COMPLETED|Overall Study||5
8984037|NCT02710591|10047041|FG003|COMPLETED|Overall Study||5
8984038|NCT02710591|10047038|FG000|NOT COMPLETED|Overall Study||0
8984039|NCT02710591|10047039|FG001|NOT COMPLETED|Overall Study||0
8984040|NCT02710591|10047040|FG002|NOT COMPLETED|Overall Study||0
8984041|NCT02710591|10047041|FG003|NOT COMPLETED|Overall Study||0
8984042|NCT02710630|10047056|FG000|STARTED|Period 1||7
8984043|NCT02710630|10047057|FG001|STARTED|Period 1||7
8984044|NCT02710630|10047058|FG002|STARTED|Period 1||7
8984045|NCT02710630|10047059|FG003|STARTED|Period 1||7
8984046|NCT02710630|10047060|FG004|STARTED|Period 1||7
8984047|NCT02710630|10047056|FG000|COMPLETED|Period 1||7
8984048|NCT02710630|10047057|FG001|COMPLETED|Period 1||7
8984049|NCT02710630|10047058|FG002|COMPLETED|Period 1||7
8984050|NCT02710630|10047059|FG003|COMPLETED|Period 1||7
8984051|NCT02710630|10047060|FG004|COMPLETED|Period 1||7
8984052|NCT02710630|10047056|FG000|NOT COMPLETED|Period 1||0
8984053|NCT02710630|10047057|FG001|NOT COMPLETED|Period 1||0
8984054|NCT02710630|10047058|FG002|NOT COMPLETED|Period 1||0
8984055|NCT02710630|10047059|FG003|NOT COMPLETED|Period 1||0
8984056|NCT02710630|10047060|FG004|NOT COMPLETED|Period 1||0
8571564|NCT00111475|9603879|FG002|STARTED|Overall Study||4
8571565|NCT00111475|9603880|FG003|STARTED|Overall Study||4
8571566|NCT00111475|9603881|FG004|STARTED|Overall Study||4
8571567|NCT00111475|9603882|FG005|STARTED|Overall Study||4
8984057|NCT02710630|10047056|FG000|STARTED|Period 2||7
8984058|NCT02710630|10047057|FG001|STARTED|Period 2||7
8984059|NCT02710630|10047058|FG002|STARTED|Period 2||7
8984060|NCT02710630|10047059|FG003|STARTED|Period 2||7
8984061|NCT02710630|10047060|FG004|STARTED|Period 2||7
8984062|NCT02710630|10047056|FG000|Not Treated|Period 2||1
8984063|NCT02710630|10047057|FG001|Not Treated|Period 2||0
8984064|NCT02710630|10047058|FG002|Not Treated|Period 2||0
8984065|NCT02710630|10047059|FG003|Not Treated|Period 2||0
8984066|NCT02710630|10047060|FG004|Not Treated|Period 2||0
8984067|NCT02710630|10047056|FG000|COMPLETED|Period 2||7
8984068|NCT02710630|10047057|FG001|COMPLETED|Period 2||7
8984069|NCT02710630|10047058|FG002|COMPLETED|Period 2||7
8984070|NCT02710630|10047059|FG003|COMPLETED|Period 2||7
8984071|NCT02710630|10047060|FG004|COMPLETED|Period 2||7
8984072|NCT02710630|10047056|FG000|NOT COMPLETED|Period 2||0
8984073|NCT02710630|10047057|FG001|NOT COMPLETED|Period 2||0
8984074|NCT02710630|10047058|FG002|NOT COMPLETED|Period 2||0
8984075|NCT02710630|10047059|FG003|NOT COMPLETED|Period 2||0
8984076|NCT02710630|10047060|FG004|NOT COMPLETED|Period 2||0
8984077|NCT02710630|10047056|FG000|STARTED|Period 3||7
8984078|NCT02710630|10047057|FG001|STARTED|Period 3||7
8984079|NCT02710630|10047058|FG002|STARTED|Period 3||7
8984080|NCT02710630|10047059|FG003|STARTED|Period 3||7
8984081|NCT02710630|10047060|FG004|STARTED|Period 3||7
8984082|NCT02710630|10047056|FG000|COMPLETED|Period 3||7
8984083|NCT02710630|10047057|FG001|COMPLETED|Period 3||7
8984084|NCT02710630|10047058|FG002|COMPLETED|Period 3||7
8984085|NCT02710630|10047059|FG003|COMPLETED|Period 3||7
8984086|NCT02710630|10047060|FG004|COMPLETED|Period 3||7
8984087|NCT02710630|10047056|FG000|NOT COMPLETED|Period 3||0
8984088|NCT02710630|10047057|FG001|NOT COMPLETED|Period 3||0
8984089|NCT02710630|10047058|FG002|NOT COMPLETED|Period 3||0
8984090|NCT02710630|10047059|FG003|NOT COMPLETED|Period 3||0
8984091|NCT02710630|10047060|FG004|NOT COMPLETED|Period 3||0
8984092|NCT02710630|10047056|FG000|STARTED|Period 4||7
8984093|NCT02710630|10047057|FG001|STARTED|Period 4||7
8984094|NCT02710630|10047058|FG002|STARTED|Period 4||7
8984095|NCT02710630|10047059|FG003|STARTED|Period 4||7
8984096|NCT02710630|10047060|FG004|STARTED|Period 4||7
8984097|NCT02710630|10047056|FG000|COMPLETED|Period 4||7
8984098|NCT02710630|10047057|FG001|COMPLETED|Period 4||7
8984099|NCT02710630|10047058|FG002|COMPLETED|Period 4||7
8984100|NCT02710630|10047059|FG003|COMPLETED|Period 4||7
8984101|NCT02710630|10047060|FG004|COMPLETED|Period 4||7
8984102|NCT02710630|10047056|FG000|NOT COMPLETED|Period 4||0
8984103|NCT02710630|10047057|FG001|NOT COMPLETED|Period 4||0
8984104|NCT02710630|10047058|FG002|NOT COMPLETED|Period 4||0
8984105|NCT02710630|10047059|FG003|NOT COMPLETED|Period 4||0
8984106|NCT02710630|10047060|FG004|NOT COMPLETED|Period 4||0
8984107|NCT02710630|10047056|FG000|STARTED|Period 5||7
8984108|NCT02710630|10047057|FG001|STARTED|Period 5||7
8984109|NCT02710630|10047058|FG002|STARTED|Period 5||7
8984110|NCT02710630|10047059|FG003|STARTED|Period 5||7
8984111|NCT02710630|10047060|FG004|STARTED|Period 5||7
8984112|NCT02710630|10047056|FG000|COMPLETED|Period 5||7
8984113|NCT02710630|10047057|FG001|COMPLETED|Period 5||7
8984114|NCT02710630|10047058|FG002|COMPLETED|Period 5||7
8984115|NCT02710630|10047059|FG003|COMPLETED|Period 5||7
8984116|NCT02710630|10047060|FG004|COMPLETED|Period 5||7
8984117|NCT02710630|10047056|FG000|NOT COMPLETED|Period 5||0
8984118|NCT02710630|10047057|FG001|NOT COMPLETED|Period 5||0
8984119|NCT02710630|10047058|FG002|NOT COMPLETED|Period 5||0
8984120|NCT02710630|10047059|FG003|NOT COMPLETED|Period 5||0
8984121|NCT02710630|10047060|FG004|NOT COMPLETED|Period 5||0
8984122|NCT02710630|10047056|FG000|STARTED|Period 6||7
8984123|NCT02710630|10047057|FG001|STARTED|Period 6||7
8984124|NCT02710630|10047058|FG002|STARTED|Period 6||7
8984125|NCT02710630|10047059|FG003|STARTED|Period 6||7
8984126|NCT02710630|10047060|FG004|STARTED|Period 6||7
8984127|NCT02710630|10047056|FG000|COMPLETED|Period 6||7
8984128|NCT02710630|10047057|FG001|COMPLETED|Period 6||7
8984129|NCT02710630|10047058|FG002|COMPLETED|Period 6||7
8984130|NCT02710630|10047059|FG003|COMPLETED|Period 6||7
8984131|NCT02710630|10047060|FG004|COMPLETED|Period 6||7
8984132|NCT02710630|10047056|FG000|NOT COMPLETED|Period 6||0
8984133|NCT02710630|10047057|FG001|NOT COMPLETED|Period 6||0
8984134|NCT02710630|10047058|FG002|NOT COMPLETED|Period 6||0
8984135|NCT02710630|10047059|FG003|NOT COMPLETED|Period 6||0
8984136|NCT02710630|10047060|FG004|NOT COMPLETED|Period 6||0
8984137|NCT02710669|10047077|FG000|STARTED|Overall Study||85
8984138|NCT02710669|10047078|FG001|STARTED|Overall Study||86
8984139|NCT02710669|10047079|FG002|STARTED|Overall Study||21
8984140|NCT02710669|10047077|FG000|COMPLETED|Overall Study||71
8984141|NCT02710669|10047078|FG001|COMPLETED|Overall Study||75
8984142|NCT02710669|10047079|FG002|COMPLETED|Overall Study||19
8984143|NCT02710669|10047077|FG000|NOT COMPLETED|Overall Study||14
8984144|NCT02710669|10047078|FG001|NOT COMPLETED|Overall Study||11
8984145|NCT02710669|10047079|FG002|NOT COMPLETED|Overall Study||2
9038733|NCT03334188|10099900|FG000|COMPLETED|Overall Study||145
9038734|NCT03334188|10099901|FG001|COMPLETED|Overall Study||145
9038735|NCT03334188|10099900|FG000|NOT COMPLETED|Overall Study||8
9038736|NCT03334188|10099901|FG001|NOT COMPLETED|Overall Study||8
9038737|NCT03334214|10099910|FG000|STARTED|Overall Study||15
9038738|NCT03334214|10099911|FG001|STARTED|Overall Study||29
9038739|NCT03334214|10099910|FG000|COMPLETED|Overall Study||14
9038740|NCT03334214|10099911|FG001|COMPLETED|Overall Study||27
9038741|NCT03334214|10099910|FG000|NOT COMPLETED|Overall Study||1
9038742|NCT03334214|10099911|FG001|NOT COMPLETED|Overall Study||2
9038743|NCT03334396|10099926|FG000|STARTED|Overall Study||249
9038744|NCT03334396|10099927|FG001|STARTED|Overall Study||127
9038745|NCT03334396|10099928|FG002|STARTED|Overall Study||123
9038746|NCT03334396|10099929|FG003|STARTED|Overall Study||125
9038747|NCT03334396|10099930|FG004|STARTED|Overall Study||15
9038748|NCT03334396|10099931|FG005|STARTED|Overall Study||5
9038749|NCT03334396|10099932|FG006|STARTED|Overall Study||8
9038750|NCT03334396|10099933|FG007|STARTED|Overall Study||8
9038751|NCT03334396|10099926|FG000|Received at Least One Dose of Study Drug|Overall Study||249
9038752|NCT03334396|10099927|FG001|Received at Least One Dose of Study Drug|Overall Study||127
9038753|NCT03334396|10099928|FG002|Received at Least One Dose of Study Drug|Overall Study||123
9038754|NCT03334396|10099929|FG003|Received at Least One Dose of Study Drug|Overall Study||125
9038755|NCT03334396|10099930|FG004|Received at Least One Dose of Study Drug|Overall Study||15
8984146|NCT02710890|10047089|FG000|STARTED|Overall Study||48
8984147|NCT02710890|10047090|FG001|STARTED|Overall Study||55
8984148|NCT02710890|10047089|FG000|COMPLETED|Overall Study||48
8984149|NCT02710890|10047090|FG001|COMPLETED|Overall Study||55
8984150|NCT02710890|10047089|FG000|NOT COMPLETED|Overall Study||0
8984151|NCT02710890|10047090|FG001|NOT COMPLETED|Overall Study||0
8984152|NCT02710981|10047096|FG000|STARTED|6th Ovulation Induction Cycle (5 Days)||42
8984153|NCT02710981|10047097|FG001|STARTED|6th Ovulation Induction Cycle (5 Days)||0
8984154|NCT02710981|10047096|FG000|COMPLETED|6th Ovulation Induction Cycle (5 Days)||41
8984155|NCT02710981|10047097|FG001|COMPLETED|6th Ovulation Induction Cycle (5 Days)||0
8984156|NCT02710981|10047096|FG000|NOT COMPLETED|6th Ovulation Induction Cycle (5 Days)||1
8984157|NCT02710981|10047097|FG001|NOT COMPLETED|6th Ovulation Induction Cycle (5 Days)||0
8984158|NCT02710981|10047096|FG000|STARTED|7th Ovulation Induction Cycle (5 Days)||0
8984159|NCT02710981|10047097|FG001|STARTED|7th Ovulation Induction Cycle (5 Days)||41
8984160|NCT02710981|10047096|FG000|COMPLETED|7th Ovulation Induction Cycle (5 Days)||0
8984161|NCT02710981|10047097|FG001|COMPLETED|7th Ovulation Induction Cycle (5 Days)||36
8984162|NCT02710981|10047096|FG000|NOT COMPLETED|7th Ovulation Induction Cycle (5 Days)||0
8984163|NCT02710981|10047097|FG001|NOT COMPLETED|7th Ovulation Induction Cycle (5 Days)||5
8984164|NCT02711306|10047107|FG000|STARTED|Overall Study||18
8984165|NCT02711306|10047108|FG001|STARTED|Overall Study||18
8984166|NCT02711306|10047107|FG000|COMPLETED|Overall Study||16
8984167|NCT02711306|10047108|FG001|COMPLETED|Overall Study||16
8984168|NCT02711306|10047107|FG000|NOT COMPLETED|Overall Study||2
8984169|NCT02711306|10047108|FG001|NOT COMPLETED|Overall Study||2
8984170|NCT02711345|10047124|FG000|STARTED|Overall Study||2
8984171|NCT02711345|10047125|FG001|STARTED|Overall Study||3
8984172|NCT02711345|10047126|FG002|STARTED|Overall Study||6
8984173|NCT02711345|10047127|FG003|STARTED|Overall Study||4
8984174|NCT02711345|10047128|FG004|STARTED|Overall Study||8
8984175|NCT02711345|10047129|FG005|STARTED|Overall Study||6
8984176|NCT02711345|10047130|FG006|STARTED|Overall Study||12
8984177|NCT02711345|10047131|FG007|STARTED|Overall Study||6
8984178|NCT02711345|10047132|FG008|STARTED|Overall Study||6
8984179|NCT02711345|10047133|FG009|STARTED|Overall Study||12
8984180|NCT02711345|10047124|FG000|COMPLETED|Overall Study||0
8984181|NCT02711345|10047125|FG001|COMPLETED|Overall Study||0
8984182|NCT02711345|10047126|FG002|COMPLETED|Overall Study||0
8984183|NCT02711345|10047127|FG003|COMPLETED|Overall Study||0
8984184|NCT02711345|10047128|FG004|COMPLETED|Overall Study||0
8984185|NCT02711345|10047129|FG005|COMPLETED|Overall Study||0
8984186|NCT02711345|10047130|FG006|COMPLETED|Overall Study||0
8984187|NCT02711345|10047131|FG007|COMPLETED|Overall Study||0
8984188|NCT02711345|10047132|FG008|COMPLETED|Overall Study||0
8984189|NCT02711345|10047133|FG009|COMPLETED|Overall Study||0
8984190|NCT02711345|10047124|FG000|NOT COMPLETED|Overall Study||2
8984191|NCT02711345|10047125|FG001|NOT COMPLETED|Overall Study||3
8984192|NCT02711345|10047126|FG002|NOT COMPLETED|Overall Study||6
8984193|NCT02711345|10047127|FG003|NOT COMPLETED|Overall Study||4
8984194|NCT02711345|10047128|FG004|NOT COMPLETED|Overall Study||8
8984195|NCT02711345|10047129|FG005|NOT COMPLETED|Overall Study||6
8984196|NCT02711345|10047130|FG006|NOT COMPLETED|Overall Study||12
8984197|NCT02711345|10047131|FG007|NOT COMPLETED|Overall Study||6
8984198|NCT02711345|10047132|FG008|NOT COMPLETED|Overall Study||6
8984199|NCT02711345|10047133|FG009|NOT COMPLETED|Overall Study||12
8984200|NCT02711553|10047164|FG000|STARTED|Overall Study||106
8984201|NCT02711553|10047165|FG001|STARTED|Overall Study||52
8984202|NCT02711553|10047166|FG002|STARTED|Overall Study||102
8984203|NCT02711553|10047167|FG003|STARTED|Overall Study||49
8984204|NCT02711553|10047164|FG000|Received at Least 1 Dose of Study Drug|Overall Study||104
8984205|NCT02711553|10047165|FG001|Received at Least 1 Dose of Study Drug|Overall Study||52
8984206|NCT02711553|10047166|FG002|Received at Least 1 Dose of Study Drug|Overall Study||102
8984207|NCT02711553|10047167|FG003|Received at Least 1 Dose of Study Drug|Overall Study||48
8984208|NCT02711553|10047164|FG000|COMPLETED|Overall Study||100
8984209|NCT02711553|10047165|FG001|COMPLETED|Overall Study||47
8984210|NCT02711553|10047166|FG002|COMPLETED|Overall Study||92
8984211|NCT02711553|10047167|FG003|COMPLETED|Overall Study||45
8984212|NCT02711553|10047164|FG000|NOT COMPLETED|Overall Study||6
8984213|NCT02711553|10047165|FG001|NOT COMPLETED|Overall Study||5
8984214|NCT02711553|10047166|FG002|NOT COMPLETED|Overall Study||10
8984215|NCT02711553|10047167|FG003|NOT COMPLETED|Overall Study||4
8571568|NCT00111475|9603883|FG006|STARTED|Overall Study||4
8984216|NCT02711800|10047179|FG000|STARTED|Overall Study||9
8984217|NCT02711800|10047179|FG000|COMPLETED|Overall Study||7
8984218|NCT02711800|10047179|FG000|NOT COMPLETED|Overall Study||2
8984219|NCT02711839|10047185|FG000|STARTED|Overall Study||20
8984220|NCT02711839|10047186|FG001|STARTED|Overall Study||34
8984221|NCT02711839|10047185|FG000|COMPLETED|Overall Study||16
8984222|NCT02711839|10047186|FG001|COMPLETED|Overall Study||24
8984223|NCT02711839|10047185|FG000|NOT COMPLETED|Overall Study||4
8984224|NCT02711839|10047186|FG001|NOT COMPLETED|Overall Study||10
8984225|NCT02711956|10047207|FG000|STARTED|Overall Study||2
8984226|NCT02711956|10047208|FG001|STARTED|Overall Study||2
8984227|NCT02711956|10047209|FG002|STARTED|Overall Study||3
8984228|NCT02711956|10047210|FG003|STARTED|Overall Study||5
8984229|NCT02711956|10047211|FG004|STARTED|Overall Study||4
8984230|NCT02711956|10047212|FG005|STARTED|Overall Study||3
8984231|NCT02711956|10047213|FG006|STARTED|Overall Study||4
8984232|NCT02711956|10047214|FG007|STARTED|Overall Study||4
8984233|NCT02711956|10047215|FG008|STARTED|Overall Study||4
8984234|NCT02711956|10047216|FG009|STARTED|Overall Study||3
8984235|NCT02711956|10047217|FG010|STARTED|Overall Study||1
8984236|NCT02711956|10047218|FG011|STARTED|Overall Study||9
8984237|NCT02711956|10047219|FG012|STARTED|Overall Study||17
8984238|NCT02711956|10047220|FG013|STARTED|Overall Study||6
8984239|NCT02711956|10047221|FG014|STARTED|Overall Study||8
8984240|NCT02711956|10047207|FG000|COMPLETED|Overall Study||0
8984241|NCT02711956|10047208|FG001|COMPLETED|Overall Study||0
8984242|NCT02711956|10047209|FG002|COMPLETED|Overall Study||1
8984243|NCT02711956|10047210|FG003|COMPLETED|Overall Study||2
8984244|NCT02711956|10047211|FG004|COMPLETED|Overall Study||0
8984245|NCT02711956|10047212|FG005|COMPLETED|Overall Study||1
8984246|NCT02711956|10047213|FG006|COMPLETED|Overall Study||0
8984247|NCT02711956|10047214|FG007|COMPLETED|Overall Study||2
8984248|NCT02711956|10047215|FG008|COMPLETED|Overall Study||0
8984249|NCT02711956|10047216|FG009|COMPLETED|Overall Study||0
8984250|NCT02711956|10047217|FG010|COMPLETED|Overall Study||0
8984251|NCT02711956|10047218|FG011|COMPLETED|Overall Study||0
8984252|NCT02711956|10047219|FG012|COMPLETED|Overall Study||1
8984253|NCT02711956|10047220|FG013|COMPLETED|Overall Study||1
8984254|NCT02711956|10047221|FG014|COMPLETED|Overall Study||0
8984255|NCT02711956|10047207|FG000|NOT COMPLETED|Overall Study||2
8984256|NCT02711956|10047208|FG001|NOT COMPLETED|Overall Study||2
8984257|NCT02711956|10047209|FG002|NOT COMPLETED|Overall Study||2
8984258|NCT02711956|10047210|FG003|NOT COMPLETED|Overall Study||3
8984259|NCT02711956|10047211|FG004|NOT COMPLETED|Overall Study||4
8984260|NCT02711956|10047212|FG005|NOT COMPLETED|Overall Study||2
8984261|NCT02711956|10047213|FG006|NOT COMPLETED|Overall Study||4
8984262|NCT02711956|10047214|FG007|NOT COMPLETED|Overall Study||2
8984263|NCT02711956|10047215|FG008|NOT COMPLETED|Overall Study||4
8984264|NCT02711956|10047216|FG009|NOT COMPLETED|Overall Study||3
8984265|NCT02711956|10047217|FG010|NOT COMPLETED|Overall Study||1
8984266|NCT02711956|10047218|FG011|NOT COMPLETED|Overall Study||9
8984267|NCT02711956|10047219|FG012|NOT COMPLETED|Overall Study||16
8984268|NCT02711956|10047220|FG013|NOT COMPLETED|Overall Study||5
8984269|NCT02711956|10047221|FG014|NOT COMPLETED|Overall Study||8
8984270|NCT02711995|10047262|FG000|STARTED|First Intervention (30 Days)||8
8984271|NCT02711995|10047262|FG000|COMPLETED|First Intervention (30 Days)||8
8984272|NCT02711995|10047262|FG000|NOT COMPLETED|First Intervention (30 Days)||0
8984273|NCT02711995|10047262|FG000|STARTED|Washout (90 Days)||8
8984274|NCT02711995|10047262|FG000|COMPLETED|Washout (90 Days)||7
8984275|NCT02711995|10047262|FG000|NOT COMPLETED|Washout (90 Days)||1
8984276|NCT02711995|10047262|FG000|STARTED|Second Intervention (30 Days)||7
8984277|NCT02711995|10047262|FG000|COMPLETED|Second Intervention (30 Days)||7
8984278|NCT02711995|10047262|FG000|NOT COMPLETED|Second Intervention (30 Days)||0
8984279|NCT02712008|10047271|FG000|STARTED|Baseline (Day 1) up to Week 12||50
8984280|NCT02712008|10047272|FG001|STARTED|Baseline (Day 1) up to Week 12||100
8984281|NCT02712008|10047273|FG002|STARTED|Baseline (Day 1) up to Week 12||152
8984282|NCT02712008|10047274|FG003|STARTED|Baseline (Day 1) up to Week 12||0
8984283|NCT02712008|10047275|FG004|STARTED|Baseline (Day 1) up to Week 12||0
8984284|NCT02712008|10047276|FG005|STARTED|Baseline (Day 1) up to Week 12||0
8984285|NCT02712008|10047277|FG006|STARTED|Baseline (Day 1) up to Week 12||0
8984286|NCT02712008|10047278|FG007|STARTED|Baseline (Day 1) up to Week 12||0
8984287|NCT02712008|10047271|FG000|COMPLETED|Baseline (Day 1) up to Week 12||46
8984288|NCT02712008|10047272|FG001|COMPLETED|Baseline (Day 1) up to Week 12||97
8984289|NCT02712008|10047273|FG002|COMPLETED|Baseline (Day 1) up to Week 12||148
8984290|NCT02712008|10047274|FG003|COMPLETED|Baseline (Day 1) up to Week 12||0
8984291|NCT02712008|10047275|FG004|COMPLETED|Baseline (Day 1) up to Week 12||0
8984292|NCT02712008|10047276|FG005|COMPLETED|Baseline (Day 1) up to Week 12||0
8984293|NCT02712008|10047277|FG006|COMPLETED|Baseline (Day 1) up to Week 12||0
8984294|NCT02712008|10047278|FG007|COMPLETED|Baseline (Day 1) up to Week 12||0
8984295|NCT02712008|10047271|FG000|NOT COMPLETED|Baseline (Day 1) up to Week 12||4
8984296|NCT02712008|10047272|FG001|NOT COMPLETED|Baseline (Day 1) up to Week 12||3
8984297|NCT02712008|10047273|FG002|NOT COMPLETED|Baseline (Day 1) up to Week 12||4
8984298|NCT02712008|10047274|FG003|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
8984299|NCT02712008|10047275|FG004|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
8984300|NCT02712008|10047276|FG005|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
8984301|NCT02712008|10047277|FG006|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
8984302|NCT02712008|10047278|FG007|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
8984303|NCT02712008|10047271|FG000|STARTED|From Week 12 up to Week 36|Out of 46 participants that completed Week 12, 45 re-randomized for treatment from Week 12 to 36|45
8984304|NCT02712008|10047272|FG001|STARTED|From Week 12 up to Week 36|Out of 97 participants that completed Week 12, 96 re-randomized to REGN910-3 (6:2mg) Q8 and Q12|0
8984305|NCT02712008|10047273|FG002|STARTED|From Week 12 up to Week 36|Out of 148 that completed Week 12,143 re-randomized to Aflibercept 2mg Q8, Q12, REGN910-3 (6:2mg) Q8|0
8984306|NCT02712008|10047274|FG003|STARTED|From Week 12 up to Week 36|Out of 96 that were re-randomized, 44 re-randomized from REGN910-3(6:2 mg)Q4 to REGN910-3(6:2 mg)Q8|44
8984307|NCT02712008|10047275|FG004|STARTED|From Week 12 up to Week 36|Out of 96 that were re-randomized, 52 re-randomized from REGN910-3(6:2 mg)Q4 to REGN910-3(6:2 mg)Q12|52
8984308|NCT02712008|10047276|FG005|STARTED|From Week 12 up to Week 36|Out of 143 that were re-randomized, 46 re-randomized from Aflibercept 2mg Q4 to Aflibercept 2mg Q8|46
8984309|NCT02712008|10047277|FG006|STARTED|From Week 12 up to Week 36|Out of 143 that were re-randomized, 48 re-randomized from Aflibercept 2mg Q4 to Aflibercept 2mg Q12|48
8984310|NCT02712008|10047278|FG007|STARTED|From Week 12 up to Week 36|Out of 143 that were re-randomized, 49 re-randomized from Aflibercept 2mg Q4 to REGN910-3 (6:2mg) Q8|49
8984311|NCT02712008|10047271|FG000|COMPLETED|From Week 12 up to Week 36||44
8984312|NCT02712008|10047272|FG001|COMPLETED|From Week 12 up to Week 36||0
8984313|NCT02712008|10047273|FG002|COMPLETED|From Week 12 up to Week 36||0
8984314|NCT02712008|10047274|FG003|COMPLETED|From Week 12 up to Week 36||42
8984315|NCT02712008|10047275|FG004|COMPLETED|From Week 12 up to Week 36||50
8984316|NCT02712008|10047276|FG005|COMPLETED|From Week 12 up to Week 36||46
8984317|NCT02712008|10047277|FG006|COMPLETED|From Week 12 up to Week 36||43
8984318|NCT02712008|10047278|FG007|COMPLETED|From Week 12 up to Week 36||45
8984319|NCT02712008|10047271|FG000|NOT COMPLETED|From Week 12 up to Week 36||1
8984320|NCT02712008|10047272|FG001|NOT COMPLETED|From Week 12 up to Week 36||0
8984321|NCT02712008|10047273|FG002|NOT COMPLETED|From Week 12 up to Week 36||0
8984322|NCT02712008|10047274|FG003|NOT COMPLETED|From Week 12 up to Week 36||2
8984323|NCT02712008|10047275|FG004|NOT COMPLETED|From Week 12 up to Week 36||2
8984324|NCT02712008|10047276|FG005|NOT COMPLETED|From Week 12 up to Week 36||0
8984325|NCT02712008|10047277|FG006|NOT COMPLETED|From Week 12 up to Week 36||5
8984326|NCT02712008|10047278|FG007|NOT COMPLETED|From Week 12 up to Week 36||4
8984327|NCT02712047|10047292|FG000|STARTED|Treatment Period 1 (35 Days)||14
8984328|NCT02712047|10047293|FG001|STARTED|Treatment Period 1 (35 Days)||13
8984329|NCT02712047|10047292|FG000|COMPLETED|Treatment Period 1 (35 Days)||14
8984330|NCT02712047|10047293|FG001|COMPLETED|Treatment Period 1 (35 Days)||13
8984331|NCT02712047|10047292|FG000|NOT COMPLETED|Treatment Period 1 (35 Days)||0
8984332|NCT02712047|10047293|FG001|NOT COMPLETED|Treatment Period 1 (35 Days)||0
8984333|NCT02712047|10047292|FG000|STARTED|Washout Period (21 Days)||14
8984334|NCT02712047|10047293|FG001|STARTED|Washout Period (21 Days)||13
8984335|NCT02712047|10047292|FG000|COMPLETED|Washout Period (21 Days)||14
8984336|NCT02712047|10047293|FG001|COMPLETED|Washout Period (21 Days)||13
8984337|NCT02712047|10047292|FG000|NOT COMPLETED|Washout Period (21 Days)||0
8984338|NCT02712047|10047293|FG001|NOT COMPLETED|Washout Period (21 Days)||0
8984339|NCT02712047|10047292|FG000|STARTED|Treatment Period 2 (35 Days)||14
8984340|NCT02712047|10047293|FG001|STARTED|Treatment Period 2 (35 Days)||13
8984341|NCT02712047|10047292|FG000|COMPLETED|Treatment Period 2 (35 Days)||14
8984342|NCT02712047|10047293|FG001|COMPLETED|Treatment Period 2 (35 Days)||13
8984343|NCT02712047|10047292|FG000|NOT COMPLETED|Treatment Period 2 (35 Days)||0
8984344|NCT02712047|10047293|FG001|NOT COMPLETED|Treatment Period 2 (35 Days)||0
8984345|NCT02712099|10047301|FG000|STARTED|Overall Study||30
8984346|NCT02712099|10047302|FG001|STARTED|Overall Study||20
8984347|NCT02712099|10047301|FG000|COMPLETED|Overall Study||30
8984348|NCT02712099|10047302|FG001|COMPLETED|Overall Study||20
8984349|NCT02712099|10047301|FG000|NOT COMPLETED|Overall Study||0
8984350|NCT02712099|10047302|FG001|NOT COMPLETED|Overall Study||0
8984351|NCT02712320|10047308|FG000|STARTED|Overall Study||30
8984352|NCT02712320|10047308|FG000|COMPLETED|Overall Study||25
8984353|NCT02712320|10047308|FG000|NOT COMPLETED|Overall Study||5
8984354|NCT02712333|10047314|FG000|STARTED|First Period||34
8984355|NCT02712333|10047315|FG001|STARTED|First Period||26
8984356|NCT02712333|10047314|FG000|COMPLETED|First Period||31
8984357|NCT02712333|10047315|FG001|COMPLETED|First Period||24
8984358|NCT02712333|10047314|FG000|NOT COMPLETED|First Period||3
8984359|NCT02712333|10047315|FG001|NOT COMPLETED|First Period||2
8984360|NCT02712333|10047314|FG000|STARTED|Second Period||31
8984361|NCT02712333|10047315|FG001|STARTED|Second Period||24
8984362|NCT02712333|10047314|FG000|COMPLETED|Second Period||31
8984363|NCT02712333|10047315|FG001|COMPLETED|Second Period||24
8984364|NCT02712333|10047314|FG000|NOT COMPLETED|Second Period||0
8984365|NCT02712333|10047315|FG001|NOT COMPLETED|Second Period||0
8984366|NCT02712359|10047330|FG000|STARTED|Epoch 001: Persistence at Year 8||300
8984367|NCT02712359|10047331|FG001|STARTED|Epoch 001: Persistence at Year 8||300
8984368|NCT02712359|10047332|FG002|STARTED|Epoch 001: Persistence at Year 8||0
8984369|NCT02712359|10047333|FG003|STARTED|Epoch 001: Persistence at Year 8||0
8984370|NCT02712359|10047330|FG000|COMPLETED|Epoch 001: Persistence at Year 8||300
8984371|NCT02712359|10047331|FG001|COMPLETED|Epoch 001: Persistence at Year 8||300
8984372|NCT02712359|10047332|FG002|COMPLETED|Epoch 001: Persistence at Year 8||0
8984373|NCT02712359|10047333|FG003|COMPLETED|Epoch 001: Persistence at Year 8||0
8984374|NCT02712359|10047330|FG000|NOT COMPLETED|Epoch 001: Persistence at Year 8||0
8984375|NCT02712359|10047331|FG001|NOT COMPLETED|Epoch 001: Persistence at Year 8||0
8984376|NCT02712359|10047332|FG002|NOT COMPLETED|Epoch 001: Persistence at Year 8||0
8984377|NCT02712359|10047333|FG003|NOT COMPLETED|Epoch 001: Persistence at Year 8||0
8984378|NCT02712359|10047330|FG000|STARTED|Epoch 002: Persistence at Year 10||0
8984379|NCT02712359|10047331|FG001|STARTED|Epoch 002: Persistence at Year 10||0
8984380|NCT02712359|10047332|FG002|STARTED|Epoch 002: Persistence at Year 10||299
8984381|NCT02712359|10047333|FG003|STARTED|Epoch 002: Persistence at Year 10||300
8984382|NCT02712359|10047330|FG000|COMPLETED|Epoch 002: Persistence at Year 10||0
8984383|NCT02712359|10047331|FG001|COMPLETED|Epoch 002: Persistence at Year 10||0
8984384|NCT02712359|10047332|FG002|COMPLETED|Epoch 002: Persistence at Year 10||299
8984385|NCT02712359|10047333|FG003|COMPLETED|Epoch 002: Persistence at Year 10||300
8984386|NCT02712359|10047330|FG000|NOT COMPLETED|Epoch 002: Persistence at Year 10||0
8984387|NCT02712359|10047331|FG001|NOT COMPLETED|Epoch 002: Persistence at Year 10||0
8984388|NCT02712359|10047332|FG002|NOT COMPLETED|Epoch 002: Persistence at Year 10||0
8984389|NCT02712359|10047333|FG003|NOT COMPLETED|Epoch 002: Persistence at Year 10||0
8984390|NCT02712398|10047343|FG000|STARTED|Overall Study||120
8984391|NCT02712398|10047343|FG000|COMPLETED|Overall Study||83
8984392|NCT02712398|10047343|FG000|NOT COMPLETED|Overall Study||37
8984393|NCT02712424|10047349|FG000|STARTED|Overall Study||315
8984394|NCT02712424|10047350|FG001|STARTED|Overall Study||310
8984395|NCT02712424|10047349|FG000|COMPLETED|Overall Study||281
8984396|NCT02712424|10047350|FG001|COMPLETED|Overall Study||278
8984397|NCT02712424|10047349|FG000|NOT COMPLETED|Overall Study||34
8984398|NCT02712424|10047350|FG001|NOT COMPLETED|Overall Study||32
8984399|NCT02712554|10047358|FG000|STARTED|Part A: Dose Selection Phase||12
8984400|NCT02712554|10047359|FG001|STARTED|Part A: Dose Selection Phase||0
8984401|NCT02712554|10047358|FG000|COMPLETED|Part A: Dose Selection Phase||12
8984402|NCT02712554|10047359|FG001|COMPLETED|Part A: Dose Selection Phase|Subjects who participated in Dose Selection Phase were not eligible to participate in Part B.|0
8984403|NCT02712554|10047358|FG000|NOT COMPLETED|Part A: Dose Selection Phase||0
8984404|NCT02712554|10047359|FG001|NOT COMPLETED|Part A: Dose Selection Phase||0
8984405|NCT02712554|10047358|FG000|STARTED|Part B: Qualification Phase||0
8984406|NCT02712554|10047359|FG001|STARTED|Part B: Qualification Phase||61
8984407|NCT02712554|10047358|FG000|COMPLETED|Part B: Qualification Phase||0
8984408|NCT02712554|10047359|FG001|COMPLETED|Part B: Qualification Phase||40
8984409|NCT02712554|10047358|FG000|NOT COMPLETED|Part B: Qualification Phase||0
8984410|NCT02712554|10047359|FG001|NOT COMPLETED|Part B: Qualification Phase||21
8984411|NCT02712554|10047358|FG000|STARTED|Part B: Treatment Phase||0
8984412|NCT02712554|10047359|FG001|STARTED|Part B: Treatment Phase||40
8984413|NCT02712554|10047358|FG000|COMPLETED|Part B: Treatment Phase||0
8984414|NCT02712554|10047359|FG001|COMPLETED|Part B: Treatment Phase||37
8984415|NCT02712554|10047358|FG000|NOT COMPLETED|Part B: Treatment Phase||0
8984416|NCT02712554|10047359|FG001|NOT COMPLETED|Part B: Treatment Phase||3
8984417|NCT02712788|10047384|FG000|STARTED|Overall Study||2
8984418|NCT02712788|10047385|FG001|STARTED|Overall Study||2
8984419|NCT02712788|10047384|FG000|COMPLETED|Overall Study||0
8984420|NCT02712788|10047385|FG001|COMPLETED|Overall Study||2
8984421|NCT02712788|10047384|FG000|NOT COMPLETED|Overall Study||2
8984422|NCT02712788|10047385|FG001|NOT COMPLETED|Overall Study||0
8984423|NCT02712983|10047400|FG000|STARTED|Treatment Phase||14
8984424|NCT02712983|10047401|FG001|STARTED|Treatment Phase||13
8984425|NCT02712983|10047402|FG002|STARTED|Treatment Phase||7
8984426|NCT02712983|10047403|FG003|STARTED|Treatment Phase||15
8984427|NCT02712983|10047404|FG004|STARTED|Treatment Phase||14
8984428|NCT02712983|10047405|FG005|STARTED|Treatment Phase||7
8984429|NCT02712983|10047406|FG006|STARTED|Treatment Phase||15
8984430|NCT02712983|10047407|FG007|STARTED|Treatment Phase||15
8984431|NCT02712983|10047408|FG008|STARTED|Treatment Phase||7
8984432|NCT02712983|10047400|FG000|Pharmacokinetic Analysis Set|Treatment Phase||14
8984433|NCT02712983|10047401|FG001|Pharmacokinetic Analysis Set|Treatment Phase||13
8984434|NCT02712983|10047402|FG002|Pharmacokinetic Analysis Set|Treatment Phase||0
8984435|NCT02712983|10047403|FG003|Pharmacokinetic Analysis Set|Treatment Phase||15
8984436|NCT02712983|10047404|FG004|Pharmacokinetic Analysis Set|Treatment Phase||14
8984437|NCT02712983|10047405|FG005|Pharmacokinetic Analysis Set|Treatment Phase||0
8984438|NCT02712983|10047406|FG006|Pharmacokinetic Analysis Set|Treatment Phase||15
8984439|NCT02712983|10047407|FG007|Pharmacokinetic Analysis Set|Treatment Phase||14
8984440|NCT02712983|10047408|FG008|Pharmacokinetic Analysis Set|Treatment Phase||0
8984441|NCT02712983|10047400|FG000|COMPLETED|Treatment Phase||9
8984442|NCT02712983|10047401|FG001|COMPLETED|Treatment Phase||12
8984443|NCT02712983|10047402|FG002|COMPLETED|Treatment Phase||6
8984444|NCT02712983|10047403|FG003|COMPLETED|Treatment Phase||7
8984445|NCT02712983|10047404|FG004|COMPLETED|Treatment Phase||10
8984446|NCT02712983|10047405|FG005|COMPLETED|Treatment Phase||7
8984447|NCT02712983|10047406|FG006|COMPLETED|Treatment Phase||6
8984448|NCT02712983|10047407|FG007|COMPLETED|Treatment Phase||6
8984449|NCT02712983|10047408|FG008|COMPLETED|Treatment Phase||5
8984450|NCT02712983|10047400|FG000|NOT COMPLETED|Treatment Phase||5
8984451|NCT02712983|10047401|FG001|NOT COMPLETED|Treatment Phase||1
8984452|NCT02712983|10047402|FG002|NOT COMPLETED|Treatment Phase||1
8984453|NCT02712983|10047403|FG003|NOT COMPLETED|Treatment Phase||8
8984454|NCT02712983|10047404|FG004|NOT COMPLETED|Treatment Phase||4
8984455|NCT02712983|10047405|FG005|NOT COMPLETED|Treatment Phase||0
8984456|NCT02712983|10047406|FG006|NOT COMPLETED|Treatment Phase||9
8984457|NCT02712983|10047407|FG007|NOT COMPLETED|Treatment Phase||9
8984458|NCT02712983|10047408|FG008|NOT COMPLETED|Treatment Phase||2
8984459|NCT02712983|10047400|FG000|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|0
8984460|NCT02712983|10047401|FG001|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|1
8984461|NCT02712983|10047402|FG002|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|0
8984462|NCT02712983|10047403|FG003|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|1
8984463|NCT02712983|10047404|FG004|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|2
8984464|NCT02712983|10047405|FG005|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|1
8984465|NCT02712983|10047406|FG006|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|2
8984466|NCT02712983|10047407|FG007|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|3
8984467|NCT02712983|10047408|FG008|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|0
8984468|NCT02712983|10047400|FG000|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
8984469|NCT02712983|10047401|FG001|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
8984470|NCT02712983|10047402|FG002|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
8984471|NCT02712983|10047403|FG003|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
8984472|NCT02712983|10047404|FG004|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
8984473|NCT02712983|10047405|FG005|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
8984474|NCT02712983|10047406|FG006|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
8984475|NCT02712983|10047407|FG007|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
8984476|NCT02712983|10047408|FG008|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
8984477|NCT02712983|10047400|FG000|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
8984478|NCT02712983|10047401|FG001|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||1
8984479|NCT02712983|10047402|FG002|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
8984480|NCT02712983|10047403|FG003|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||1
8984481|NCT02712983|10047404|FG004|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||2
8984482|NCT02712983|10047405|FG005|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||1
8984483|NCT02712983|10047406|FG006|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||2
8984484|NCT02712983|10047407|FG007|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||3
8984485|NCT02712983|10047408|FG008|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
8984486|NCT02712996|10047430|FG000|STARTED|First Intervention (Study Days 1-42)||8
8984487|NCT02712996|10047431|FG001|STARTED|First Intervention (Study Days 1-42)||9
8984488|NCT02712996|10047430|FG000|COMPLETED|First Intervention (Study Days 1-42)||8
8984489|NCT02712996|10047431|FG001|COMPLETED|First Intervention (Study Days 1-42)||9
8984490|NCT02712996|10047430|FG000|NOT COMPLETED|First Intervention (Study Days 1-42)||0
8984491|NCT02712996|10047431|FG001|NOT COMPLETED|First Intervention (Study Days 1-42)||0
8984492|NCT02712996|10047430|FG000|STARTED|Second Intervention (Study Days 43-84)||8
8984493|NCT02712996|10047431|FG001|STARTED|Second Intervention (Study Days 43-84)||9
8984494|NCT02712996|10047430|FG000|COMPLETED|Second Intervention (Study Days 43-84)||8
8984495|NCT02712996|10047431|FG001|COMPLETED|Second Intervention (Study Days 43-84)||8
8984496|NCT02712996|10047430|FG000|NOT COMPLETED|Second Intervention (Study Days 43-84)||0
8984497|NCT02712996|10047431|FG001|NOT COMPLETED|Second Intervention (Study Days 43-84)||1
8984498|NCT02713178|10047442|FG000|STARTED|Overall Study||76
8984499|NCT02713178|10047443|FG001|STARTED|Overall Study||77
8984500|NCT02713178|10047444|FG002|STARTED|Overall Study||79
8984501|NCT02713178|10047442|FG000|COMPLETED|Overall Study||75
8984502|NCT02713178|10047443|FG001|COMPLETED|Overall Study||73
8984503|NCT02713178|10047444|FG002|COMPLETED|Overall Study||74
8984504|NCT02713178|10047442|FG000|NOT COMPLETED|Overall Study||1
8984505|NCT02713178|10047443|FG001|NOT COMPLETED|Overall Study||4
8984506|NCT02713178|10047444|FG002|NOT COMPLETED|Overall Study||5
8984507|NCT02713204|10047455|FG000|STARTED|Baseline (Day 1) up to Week 12||60
8984508|NCT02713204|10047456|FG001|STARTED|Baseline (Day 1) up to Week 12||122
8984509|NCT02713204|10047457|FG002|STARTED|Baseline (Day 1) up to Week 12||183
8984510|NCT02713204|10047458|FG003|STARTED|Baseline (Day 1) up to Week 12||0
8984511|NCT02713204|10047459|FG004|STARTED|Baseline (Day 1) up to Week 12||0
8984512|NCT02713204|10047460|FG005|STARTED|Baseline (Day 1) up to Week 12||0
8984513|NCT02713204|10047461|FG006|STARTED|Baseline (Day 1) up to Week 12||0
8984514|NCT02713204|10047462|FG007|STARTED|Baseline (Day 1) up to Week 12||0
8984515|NCT02713204|10047455|FG000|COMPLETED|Baseline (Day 1) up to Week 12||59
8984516|NCT02713204|10047456|FG001|COMPLETED|Baseline (Day 1) up to Week 12||121
8984517|NCT02713204|10047457|FG002|COMPLETED|Baseline (Day 1) up to Week 12||181
8984518|NCT02713204|10047458|FG003|COMPLETED|Baseline (Day 1) up to Week 12||0
8984519|NCT02713204|10047459|FG004|COMPLETED|Baseline (Day 1) up to Week 12||0
8984520|NCT02713204|10047460|FG005|COMPLETED|Baseline (Day 1) up to Week 12||0
8984521|NCT02713204|10047461|FG006|COMPLETED|Baseline (Day 1) up to Week 12||0
8984522|NCT02713204|10047462|FG007|COMPLETED|Baseline (Day 1) up to Week 12||0
8984523|NCT02713204|10047455|FG000|NOT COMPLETED|Baseline (Day 1) up to Week 12||1
8984524|NCT02713204|10047456|FG001|NOT COMPLETED|Baseline (Day 1) up to Week 12||1
8984525|NCT02713204|10047457|FG002|NOT COMPLETED|Baseline (Day 1) up to Week 12||2
8984526|NCT02713204|10047458|FG003|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
8984527|NCT02713204|10047459|FG004|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
8984528|NCT02713204|10047460|FG005|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
8984529|NCT02713204|10047461|FG006|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
8984530|NCT02713204|10047462|FG007|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
8984531|NCT02713204|10047455|FG000|STARTED|From Week 12 up to Week 36||58
8984532|NCT02713204|10047456|FG001|STARTED|From Week 12 up to Week 36||0
8984533|NCT02713204|10047457|FG002|STARTED|From Week 12 up to Week 36||0
8984534|NCT02713204|10047458|FG003|STARTED|From Week 12 up to Week 36||57
8984535|NCT02713204|10047459|FG004|STARTED|From Week 12 up to Week 36||62
8984536|NCT02713204|10047460|FG005|STARTED|From Week 12 up to Week 36||60
8984537|NCT02713204|10047461|FG006|STARTED|From Week 12 up to Week 36||62
8984538|NCT02713204|10047462|FG007|STARTED|From Week 12 up to Week 36||58
8984539|NCT02713204|10047455|FG000|COMPLETED|From Week 12 up to Week 36||57
8984540|NCT02713204|10047456|FG001|COMPLETED|From Week 12 up to Week 36||0
8984541|NCT02713204|10047457|FG002|COMPLETED|From Week 12 up to Week 36||0
8984542|NCT02713204|10047458|FG003|COMPLETED|From Week 12 up to Week 36||53
8984543|NCT02713204|10047459|FG004|COMPLETED|From Week 12 up to Week 36||60
8984544|NCT02713204|10047460|FG005|COMPLETED|From Week 12 up to Week 36||59
8984545|NCT02713204|10047461|FG006|COMPLETED|From Week 12 up to Week 36||60
8984546|NCT02713204|10047462|FG007|COMPLETED|From Week 12 up to Week 36||54
8984547|NCT02713204|10047455|FG000|NOT COMPLETED|From Week 12 up to Week 36||1
8984548|NCT02713204|10047456|FG001|NOT COMPLETED|From Week 12 up to Week 36||0
8984549|NCT02713204|10047457|FG002|NOT COMPLETED|From Week 12 up to Week 36||0
8984550|NCT02713204|10047458|FG003|NOT COMPLETED|From Week 12 up to Week 36||4
8984551|NCT02713204|10047459|FG004|NOT COMPLETED|From Week 12 up to Week 36||2
8984552|NCT02713204|10047460|FG005|NOT COMPLETED|From Week 12 up to Week 36||1
8984553|NCT02713204|10047461|FG006|NOT COMPLETED|From Week 12 up to Week 36||2
8984554|NCT02713204|10047462|FG007|NOT COMPLETED|From Week 12 up to Week 36||4
8984555|NCT02713230|10047482|FG000|STARTED|Overall Study||69
8984556|NCT02713230|10047483|FG001|STARTED|Overall Study||15
8632691|NCT00546871|9672669|FG001|NOT COMPLETED|Part 1 - IV Infusions of IGIV, PK||0
8632692|NCT00546871|9672668|FG000|STARTED|Part 2 - Subcutaneous (SC) IGIV, PK||13
8632693|NCT00546871|9672669|FG001|STARTED|Part 2 - Subcutaneous (SC) IGIV, PK||35
8632694|NCT00546871|9672668|FG000|COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||12
8632695|NCT00546871|9672669|FG001|COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||32
8632696|NCT00546871|9672668|FG000|NOT COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||1
8632697|NCT00546871|9672669|FG001|NOT COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||3
8984557|NCT02713230|10047484|FG002|STARTED|Overall Study||71
8984558|NCT02713230|10047482|FG000|COMPLETED|Overall Study||68
8984559|NCT02713230|10047483|FG001|COMPLETED|Overall Study||15
8984560|NCT02713230|10047484|FG002|COMPLETED|Overall Study||71
8984561|NCT02713230|10047482|FG000|NOT COMPLETED|Overall Study||1
8984562|NCT02713230|10047483|FG001|NOT COMPLETED|Overall Study||0
8984563|NCT02713230|10047484|FG002|NOT COMPLETED|Overall Study||0
8984564|NCT02713243|10047493|FG000|STARTED|Overall Study||10
8984565|NCT02713243|10047494|FG001|STARTED|Overall Study||10
8984566|NCT02713243|10047493|FG000|PD Analysis Set|Overall Study||9
8984567|NCT02713243|10047494|FG001|PD Analysis Set|Overall Study||10
8984568|NCT02713243|10047493|FG000|PK Analysis Set|Overall Study||8
8984569|NCT02713243|10047494|FG001|PK Analysis Set|Overall Study||9
8984570|NCT02713243|10047493|FG000|COMPLETED|Overall Study||9
8984571|NCT02713243|10047494|FG001|COMPLETED|Overall Study||8
8984572|NCT02713243|10047493|FG000|NOT COMPLETED|Overall Study||1
8984573|NCT02713243|10047494|FG001|NOT COMPLETED|Overall Study||2
8984574|NCT02713256|10047500|FG000|STARTED|Overall Study||15
8984575|NCT02713256|10047500|FG000|COMPLETED|Overall Study||15
8984576|NCT02713256|10047500|FG000|NOT COMPLETED|Overall Study||0
8984577|NCT02713425|10047504|FG000|STARTED|Overall Study||20
8984578|NCT02713425|10047504|FG000|COMPLETED|Overall Study||20
8984579|NCT02713425|10047504|FG000|NOT COMPLETED|Overall Study||0
8984580|NCT02713490|10047510|FG000|STARTED|Overall Study||71
8984581|NCT02713490|10047511|FG001|STARTED|Overall Study||69
8632698|NCT00546871|9672668|FG000|STARTED|Part 3a- SC IGIV Adjusted Dose, PK Based||12
8984582|NCT02713490|10047510|FG000|COMPLETED|Overall Study||68
8984583|NCT02713490|10047511|FG001|COMPLETED|Overall Study||67
8984584|NCT02713490|10047510|FG000|NOT COMPLETED|Overall Study||3
8984585|NCT02713490|10047511|FG001|NOT COMPLETED|Overall Study||2
8984586|NCT02713529|10047524|FG000|STARTED|Overall Study||8
8984587|NCT02713529|10047525|FG001|STARTED|Overall Study||7
8984588|NCT02713529|10047526|FG002|STARTED|Overall Study||42
8984589|NCT02713529|10047527|FG003|STARTED|Overall Study||31
8984590|NCT02713529|10047528|FG004|STARTED|Overall Study||4
8984591|NCT02713529|10047529|FG005|STARTED|Overall Study||19
8984592|NCT02713529|10047530|FG006|STARTED|Overall Study||6
8632699|NCT00546871|9672669|FG001|STARTED|Part 3a- SC IGIV Adjusted Dose, PK Based||32
8571569|NCT00111475|9603884|FG007|STARTED|Overall Study||8
8571570|NCT00111475|9603885|FG008|STARTED|Overall Study||8
8571571|NCT00111475|9603886|FG009|STARTED|Overall Study||1
8571572|NCT00111475|9603877|FG000|COMPLETED|Overall Study||4
8571573|NCT00111475|9603878|FG001|COMPLETED|Overall Study||4
8571574|NCT00111475|9603879|FG002|COMPLETED|Overall Study||4
8571575|NCT00111475|9603880|FG003|COMPLETED|Overall Study||4
8571576|NCT00111475|9603881|FG004|COMPLETED|Overall Study||4
8571577|NCT00111475|9603882|FG005|COMPLETED|Overall Study||3
8571578|NCT00111475|9603883|FG006|COMPLETED|Overall Study||4
8571579|NCT00111475|9603884|FG007|COMPLETED|Overall Study||8
8571580|NCT00111475|9603885|FG008|COMPLETED|Overall Study||8
8571581|NCT00111475|9603886|FG009|COMPLETED|Overall Study||1
8571582|NCT00111475|9603877|FG000|NOT COMPLETED|Overall Study||0
8571583|NCT00111475|9603878|FG001|NOT COMPLETED|Overall Study||0
8571584|NCT00111475|9603879|FG002|NOT COMPLETED|Overall Study||0
8571585|NCT00111475|9603880|FG003|NOT COMPLETED|Overall Study||0
8571586|NCT00111475|9603881|FG004|NOT COMPLETED|Overall Study||0
8571587|NCT00111475|9603882|FG005|NOT COMPLETED|Overall Study||1
8571588|NCT00111475|9603883|FG006|NOT COMPLETED|Overall Study||0
8571589|NCT00111475|9603884|FG007|NOT COMPLETED|Overall Study||0
8571590|NCT00111475|9603885|FG008|NOT COMPLETED|Overall Study||0
8571591|NCT00111475|9603886|FG009|NOT COMPLETED|Overall Study||0
8571592|NCT00111657|9603913|FG000|STARTED|Overall Study|37 consented. 30 initiated treatment. 29 completed at least 1 dose.|37
8571593|NCT00111657|9603913|FG000|COMPLETED|Overall Study|Completed all intended doses.|21
8571594|NCT00111657|9603913|FG000|NOT COMPLETED|Overall Study||16
8571595|NCT00111761|9603921|FG000|STARTED|Part 1|This treatment group was not initiated until Part 2|0
8725844|NCT01033487|9773161|FG004|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
8725845|NCT01033487|9773162|FG005|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
8725846|NCT01033487|9773163|FG006|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
8725847|NCT01033487|9773164|FG007|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||3
8725848|NCT01033487|9773165|FG008|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
8725849|NCT01033487|9773166|FG009|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
8725850|NCT01033487|9773157|FG000|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
8725851|NCT01033487|9773158|FG001|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
8725852|NCT01033487|9773159|FG002|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
8877695|NCT01925183|9934717|FG001|COMPLETED|Overall Study||3
8877696|NCT01925183|9934716|FG000|NOT COMPLETED|Overall Study||1
8877697|NCT01925183|9934717|FG001|NOT COMPLETED|Overall Study||0
8984593|NCT02713529|10047524|FG000|COMPLETED|Overall Study||1
8984594|NCT02713529|10047525|FG001|COMPLETED|Overall Study||3
8984595|NCT02713529|10047526|FG002|COMPLETED|Overall Study||11
8571596|NCT00111761|9603922|FG001|STARTED|Part 1||19
8571597|NCT00111761|9603921|FG000|COMPLETED|Part 1||0
8571598|NCT00111761|9603922|FG001|COMPLETED|Part 1|Completed through safety followup|14
8571599|NCT00111761|9603921|FG000|NOT COMPLETED|Part 1||0
8571600|NCT00111761|9603922|FG001|NOT COMPLETED|Part 1||5
8877698|NCT01925209|9934727|FG000|STARTED|Treatment Epoch||63
8877699|NCT01925209|9934728|FG001|STARTED|Treatment Epoch||63
8877700|NCT01925209|9934729|FG002|STARTED|Treatment Epoch||63
8984596|NCT02713529|10047527|FG003|COMPLETED|Overall Study||2
8877701|NCT01925209|9934730|FG003|STARTED|Treatment Epoch||62
8877702|NCT01925209|9934727|FG000|Full Analysis Set|Treatment Epoch||63
8877703|NCT01925209|9934728|FG001|Full Analysis Set|Treatment Epoch||63
8877704|NCT01925209|9934729|FG002|Full Analysis Set|Treatment Epoch||63
8877705|NCT01925209|9934730|FG003|Full Analysis Set|Treatment Epoch||62
8877706|NCT01925209|9934727|FG000|COMPLETED|Treatment Epoch||54
8877707|NCT01925209|9934728|FG001|COMPLETED|Treatment Epoch||55
8877708|NCT01925209|9934729|FG002|COMPLETED|Treatment Epoch||56
8877709|NCT01925209|9934730|FG003|COMPLETED|Treatment Epoch||57
8877710|NCT01925209|9934727|FG000|NOT COMPLETED|Treatment Epoch||9
8877711|NCT01925209|9934728|FG001|NOT COMPLETED|Treatment Epoch||8
8877712|NCT01925209|9934729|FG002|NOT COMPLETED|Treatment Epoch||7
8877713|NCT01925209|9934730|FG003|NOT COMPLETED|Treatment Epoch||5
8877714|NCT01925209|9934727|FG000|STARTED|Maintenance Treatment Epoch||49
8877715|NCT01925209|9934728|FG001|STARTED|Maintenance Treatment Epoch||46
8984597|NCT02713529|10047528|FG004|COMPLETED|Overall Study||1
8571601|NCT00111761|9603921|FG000|STARTED|Part 2||24
8571602|NCT00111761|9603922|FG001|STARTED|Part 2|This treatment group was used in Part 1 only|0
8984598|NCT02713529|10047529|FG005|COMPLETED|Overall Study||5
8984599|NCT02713529|10047530|FG006|COMPLETED|Overall Study||2
8984600|NCT02713529|10047524|FG000|NOT COMPLETED|Overall Study||7
8984601|NCT02713529|10047525|FG001|NOT COMPLETED|Overall Study||4
8984602|NCT02713529|10047526|FG002|NOT COMPLETED|Overall Study||31
8984603|NCT02713529|10047527|FG003|NOT COMPLETED|Overall Study||29
8984604|NCT02713529|10047528|FG004|NOT COMPLETED|Overall Study||3
8984605|NCT02713529|10047529|FG005|NOT COMPLETED|Overall Study||14
8984606|NCT02713529|10047530|FG006|NOT COMPLETED|Overall Study||4
8984607|NCT02713542|10047552|FG000|STARTED|Overall Study||60
8984608|NCT02713542|10047553|FG001|STARTED|Overall Study||30
8984609|NCT02713542|10047552|FG000|COMPLETED|Overall Study||42
8984610|NCT02713542|10047553|FG001|COMPLETED|Overall Study||24
8984611|NCT02713542|10047552|FG000|NOT COMPLETED|Overall Study||18
8984612|NCT02713542|10047553|FG001|NOT COMPLETED|Overall Study||6
8984613|NCT02713594|10047561|FG000|STARTED|Overall Study||952
8984614|NCT02713594|10047562|FG001|STARTED|Overall Study||948
8984615|NCT02713594|10047561|FG000|COMPLETED|Overall Study||562
8984616|NCT02713594|10047562|FG001|COMPLETED|Overall Study||552
8984617|NCT02713594|10047561|FG000|NOT COMPLETED|Overall Study||390
8984618|NCT02713594|10047562|FG001|NOT COMPLETED|Overall Study||396
8984619|NCT02713659|10047572|FG000|STARTED|Baseline||60
8984620|NCT02713659|10047573|FG001|STARTED|Baseline||60
8984621|NCT02713659|10047572|FG000|COMPLETED|Baseline||60
8984622|NCT02713659|10047573|FG001|COMPLETED|Baseline||60
8984623|NCT02713659|10047572|FG000|NOT COMPLETED|Baseline||0
8984624|NCT02713659|10047573|FG001|NOT COMPLETED|Baseline||0
8984625|NCT02713659|10047572|FG000|STARTED|6 Month Study Visit||60
8984626|NCT02713659|10047573|FG001|STARTED|6 Month Study Visit||60
8984627|NCT02713659|10047572|FG000|COMPLETED|6 Month Study Visit||53
8984628|NCT02713659|10047573|FG001|COMPLETED|6 Month Study Visit||47
8984629|NCT02713659|10047572|FG000|NOT COMPLETED|6 Month Study Visit||7
8984630|NCT02713659|10047573|FG001|NOT COMPLETED|6 Month Study Visit||13
8984631|NCT02713659|10047572|FG000|STARTED|12 Month Study Visit||57
8984632|NCT02713659|10047573|FG001|STARTED|12 Month Study Visit||55
8984633|NCT02713659|10047572|FG000|COMPLETED|12 Month Study Visit||54
8984634|NCT02713659|10047573|FG001|COMPLETED|12 Month Study Visit||52
8984635|NCT02713659|10047572|FG000|NOT COMPLETED|12 Month Study Visit||3
8984636|NCT02713659|10047573|FG001|NOT COMPLETED|12 Month Study Visit||3
8984637|NCT02713659|10047572|FG000|STARTED|18 Month Study Visit||58
8984638|NCT02713659|10047573|FG001|STARTED|18 Month Study Visit||53
8984639|NCT02713659|10047572|FG000|COMPLETED|18 Month Study Visit||50
8984640|NCT02713659|10047573|FG001|COMPLETED|18 Month Study Visit||50
8984641|NCT02713659|10047572|FG000|NOT COMPLETED|18 Month Study Visit||8
8984642|NCT02713659|10047573|FG001|NOT COMPLETED|18 Month Study Visit||3
8984643|NCT02713659|10047572|FG000|STARTED|24 Month Study Visit||57
8984644|NCT02713659|10047573|FG001|STARTED|24 Month Study Visit||52
8984645|NCT02713659|10047572|FG000|COMPLETED|24 Month Study Visit||49
8984646|NCT02713659|10047573|FG001|COMPLETED|24 Month Study Visit||44
8984647|NCT02713659|10047572|FG000|NOT COMPLETED|24 Month Study Visit||8
8984648|NCT02713659|10047573|FG001|NOT COMPLETED|24 Month Study Visit||8
8984649|NCT02713698|10047582|FG000|STARTED|Overall Study||20
8984650|NCT02713698|10047583|FG001|STARTED|Overall Study||20
8984651|NCT02713698|10047584|FG002|STARTED|Overall Study||20
8984652|NCT02713698|10047582|FG000|COMPLETED|Overall Study||20
8984653|NCT02713698|10047583|FG001|COMPLETED|Overall Study||20
8984654|NCT02713698|10047584|FG002|COMPLETED|Overall Study||20
8984655|NCT02713698|10047582|FG000|NOT COMPLETED|Overall Study||0
8984656|NCT02713698|10047583|FG001|NOT COMPLETED|Overall Study||0
8984657|NCT02713698|10047584|FG002|NOT COMPLETED|Overall Study||0
8984658|NCT02713711|10047592|FG000|STARTED|Overall Study||9
8984659|NCT02713711|10047593|FG001|STARTED|Overall Study||6
8984660|NCT02713711|10047594|FG002|STARTED|Overall Study||6
8984661|NCT02713711|10047595|FG003|STARTED|Overall Study||10
8984662|NCT02713711|10047592|FG000|COMPLETED|Overall Study||9
8984663|NCT02713711|10047593|FG001|COMPLETED|Overall Study||6
8984664|NCT02713711|10047594|FG002|COMPLETED|Overall Study||6
8984665|NCT02713711|10047595|FG003|COMPLETED|Overall Study||10
8984666|NCT02713711|10047592|FG000|NOT COMPLETED|Overall Study||0
8984667|NCT02713711|10047593|FG001|NOT COMPLETED|Overall Study||0
8984668|NCT02713711|10047594|FG002|NOT COMPLETED|Overall Study||0
8984669|NCT02713711|10047595|FG003|NOT COMPLETED|Overall Study||0
8984670|NCT02713789|10047611|FG000|STARTED|Overall Study||8
8984671|NCT02713789|10047612|FG001|STARTED|Overall Study||10
8984672|NCT02713789|10047613|FG002|STARTED|Overall Study||8
8984673|NCT02713789|10047611|FG000|COMPLETED|Overall Study||8
8984674|NCT02713789|10047612|FG001|COMPLETED|Overall Study||9
8984675|NCT02713789|10047613|FG002|COMPLETED|Overall Study||7
8984676|NCT02713789|10047611|FG000|NOT COMPLETED|Overall Study||0
8984677|NCT02713789|10047612|FG001|NOT COMPLETED|Overall Study||1
8984678|NCT02713789|10047613|FG002|NOT COMPLETED|Overall Study||1
8984679|NCT02713828|10047623|FG000|STARTED|Overall Study||13
8984680|NCT02713828|10047624|FG001|STARTED|Overall Study||0
8984681|NCT02713828|10047623|FG000|COMPLETED|Overall Study||8
8984682|NCT02713828|10047624|FG001|COMPLETED|Overall Study||0
8984683|NCT02713828|10047623|FG000|NOT COMPLETED|Overall Study||5
8984684|NCT02713828|10047624|FG001|NOT COMPLETED|Overall Study||0
8984685|NCT02714153|10047629|FG000|STARTED|Overall Study||23
8984686|NCT02714153|10047629|FG000|COMPLETED|Overall Study||22
8984687|NCT02714153|10047629|FG000|NOT COMPLETED|Overall Study||1
8984688|NCT02714283|10047635|FG000|STARTED|Overall Study||83589
8984689|NCT02714283|10047636|FG001|STARTED|Overall Study||6500
8984690|NCT02714283|10047635|FG000|COMPLETED|Overall Study||83589
8984691|NCT02714283|10047636|FG001|COMPLETED|Overall Study||6500
8571603|NCT00111761|9603921|FG000|COMPLETED|Part 2||16
8571604|NCT00111761|9603922|FG001|COMPLETED|Part 2||0
8571605|NCT00111761|9603921|FG000|NOT COMPLETED|Part 2||8
8571606|NCT00111761|9603922|FG001|NOT COMPLETED|Part 2||0
8571607|NCT00111800|9603934|FG000|STARTED|Period 1: Main Phase (12 Weeks)||64
8571608|NCT00111800|9603935|FG001|STARTED|Period 1: Main Phase (12 Weeks)||61
8571609|NCT00111800|9603936|FG002|STARTED|Period 1: Main Phase (12 Weeks)||63
8571610|NCT00111800|9603937|FG003|STARTED|Period 1: Main Phase (12 Weeks)||66
8571611|NCT00111800|9603938|FG004|STARTED|Period 1: Main Phase (12 Weeks)||60
8571612|NCT00111800|9603939|FG005|STARTED|Period 1: Main Phase (12 Weeks)||61
8571613|NCT00111800|9603934|FG000|COMPLETED|Period 1: Main Phase (12 Weeks)||49
8571614|NCT00111800|9603935|FG001|COMPLETED|Period 1: Main Phase (12 Weeks)||47
8571615|NCT00111800|9603936|FG002|COMPLETED|Period 1: Main Phase (12 Weeks)||54
8571616|NCT00111800|9603937|FG003|COMPLETED|Period 1: Main Phase (12 Weeks)||60
8632700|NCT00546871|9672668|FG000|COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||12
8632701|NCT00546871|9672669|FG001|COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||32
8632702|NCT00546871|9672668|FG000|NOT COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||0
8632703|NCT00546871|9672669|FG001|NOT COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||0
8632704|NCT00546871|9672668|FG000|STARTED|Part 3b - SC IGIV 12 Weeks||12
8632705|NCT00546871|9672669|FG001|STARTED|Part 3b - SC IGIV 12 Weeks||32
8632706|NCT00546871|9672668|FG000|COMPLETED|Part 3b - SC IGIV 12 Weeks||12
8632707|NCT00546871|9672669|FG001|COMPLETED|Part 3b - SC IGIV 12 Weeks||32
8632708|NCT00546871|9672668|FG000|NOT COMPLETED|Part 3b - SC IGIV 12 Weeks||0
8632709|NCT00546871|9672669|FG001|NOT COMPLETED|Part 3b - SC IGIV 12 Weeks||0
8632710|NCT00546871|9672668|FG000|STARTED|Study Extension Period|2 withdrawn after Part 3b|10
8632711|NCT00546871|9672669|FG001|STARTED|Study Extension Period|6 withdrawn after Part 3b|26
8632712|NCT00546871|9672668|FG000|COMPLETED|Study Extension Period||9
8632713|NCT00546871|9672669|FG001|COMPLETED|Study Extension Period||25
8632714|NCT00546871|9672668|FG000|NOT COMPLETED|Study Extension Period||1
8632715|NCT00546871|9672669|FG001|NOT COMPLETED|Study Extension Period||1
8632716|NCT00546884|9672700|FG000|STARTED|Overall Study||145
8632717|NCT00546884|9672701|FG001|STARTED|Overall Study||117
8632718|NCT00546884|9672700|FG000|COMPLETED|Overall Study||145
8632719|NCT00546884|9672701|FG001|COMPLETED|Overall Study||117
8632720|NCT00546884|9672700|FG000|NOT COMPLETED|Overall Study||0
8632721|NCT00546884|9672701|FG001|NOT COMPLETED|Overall Study||0
8632722|NCT00546897|9672709|FG000|STARTED|Overall Study||15
8632723|NCT00546897|9672710|FG001|STARTED|Overall Study||33
8632724|NCT00546897|9672709|FG000|COMPLETED|Overall Study||15
8632725|NCT00546897|9672710|FG001|COMPLETED|Overall Study||33
8632726|NCT00546897|9672709|FG000|NOT COMPLETED|Overall Study||0
8632727|NCT00546897|9672710|FG001|NOT COMPLETED|Overall Study||0
8632728|NCT00546910|9672718|FG000|STARTED|Overall Study||63
8632729|NCT00546910|9672719|FG001|STARTED|Overall Study||62
8632730|NCT00546910|9672718|FG000|COMPLETED|Overall Study||54
8632731|NCT00546910|9672719|FG001|COMPLETED|Overall Study||51
8632732|NCT00546910|9672718|FG000|NOT COMPLETED|Overall Study||9
8632733|NCT00546910|9672719|FG001|NOT COMPLETED|Overall Study||11
8632734|NCT00547105|9672725|FG000|STARTED|Overall Study||24
8632735|NCT00547105|9672725|FG000|COMPLETED|Overall Study||24
8632736|NCT00547105|9672725|FG000|NOT COMPLETED|Overall Study||0
8632737|NCT00547118|9672731|FG000|STARTED|Overall Study||8
8632738|NCT00547118|9672732|FG001|STARTED|Overall Study||9
8632739|NCT00547118|9672731|FG000|COMPLETED|Overall Study||0
8632740|NCT00547118|9672732|FG001|COMPLETED|Overall Study||0
8632741|NCT00547118|9672731|FG000|NOT COMPLETED|Overall Study||8
8632742|NCT00547118|9672732|FG001|NOT COMPLETED|Overall Study||9
8632743|NCT00547157|9672742|FG000|STARTED|Overall Study||90
8632744|NCT00547157|9672743|FG001|STARTED|Overall Study||62
8632745|NCT00547157|9672742|FG000|COMPLETED|Overall Study||41
8984692|NCT02714283|10047635|FG000|NOT COMPLETED|Overall Study||0
8571617|NCT00111800|9603938|FG004|COMPLETED|Period 1: Main Phase (12 Weeks)||55
8571618|NCT00111800|9603939|FG005|COMPLETED|Period 1: Main Phase (12 Weeks)||56
8632746|NCT00547157|9672743|FG001|COMPLETED|Overall Study||39
8632747|NCT00547157|9672742|FG000|NOT COMPLETED|Overall Study||49
8632748|NCT00547157|9672743|FG001|NOT COMPLETED|Overall Study||23
8984693|NCT02714283|10047636|FG001|NOT COMPLETED|Overall Study||0
8984694|NCT02714400|10047646|FG000|STARTED|First Intervention (1 Day)||12
8984695|NCT02714400|10047647|FG001|STARTED|First Intervention (1 Day)||8
8984696|NCT02714400|10047646|FG000|COMPLETED|First Intervention (1 Day)||12
8984697|NCT02714400|10047647|FG001|COMPLETED|First Intervention (1 Day)||8
8984698|NCT02714400|10047646|FG000|NOT COMPLETED|First Intervention (1 Day)||0
8984699|NCT02714400|10047647|FG001|NOT COMPLETED|First Intervention (1 Day)||0
8984700|NCT02714400|10047646|FG000|STARTED|Washout (>4 Days)||12
8984701|NCT02714400|10047647|FG001|STARTED|Washout (>4 Days)||8
8984702|NCT02714400|10047646|FG000|COMPLETED|Washout (>4 Days)||12
8984703|NCT02714400|10047647|FG001|COMPLETED|Washout (>4 Days)||8
8984704|NCT02714400|10047646|FG000|NOT COMPLETED|Washout (>4 Days)||0
8984705|NCT02714400|10047647|FG001|NOT COMPLETED|Washout (>4 Days)||0
8984706|NCT02714400|10047646|FG000|STARTED|Second Intervention (1 Day)||12
8984707|NCT02714400|10047647|FG001|STARTED|Second Intervention (1 Day)||8
8984708|NCT02714400|10047646|FG000|COMPLETED|Second Intervention (1 Day)||12
8984709|NCT02714400|10047647|FG001|COMPLETED|Second Intervention (1 Day)||8
8984710|NCT02714400|10047646|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
8984711|NCT02714400|10047647|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
8984712|NCT02714426|10047655|FG000|STARTED|Overall Study||21
8984713|NCT02714426|10047656|FG001|STARTED|Overall Study||21
8984714|NCT02714426|10047655|FG000|COMPLETED|Overall Study||19
8984715|NCT02714426|10047656|FG001|COMPLETED|Overall Study||19
8984716|NCT02714426|10047655|FG000|NOT COMPLETED|Overall Study||2
8984717|NCT02714426|10047656|FG001|NOT COMPLETED|Overall Study||2
8984718|NCT02714504|10047664|FG000|STARTED|Overall Study||61
8984719|NCT02714504|10047665|FG001|STARTED|Overall Study||178
8984720|NCT02714504|10047664|FG000|COMPLETED|Overall Study||61
8984721|NCT02714504|10047665|FG001|COMPLETED|Overall Study||178
8984722|NCT02714504|10047664|FG000|NOT COMPLETED|Overall Study||0
8984723|NCT02714504|10047665|FG001|NOT COMPLETED|Overall Study||0
8984724|NCT02714569|10047682|FG000|STARTED|Part A First Intervention||3
8984725|NCT02714569|10047683|FG001|STARTED|Part A First Intervention||3
8984726|NCT02714569|10047684|FG002|STARTED|Part A First Intervention||3
8984727|NCT02714569|10047685|FG003|STARTED|Part A First Intervention||3
8984728|NCT02714569|10047686|FG004|STARTED|Part A First Intervention||3
8984729|NCT02714569|10047687|FG005|STARTED|Part A First Intervention||3
8984730|NCT02714569|10047688|FG006|STARTED|Part A First Intervention||0
8984731|NCT02714569|10047689|FG007|STARTED|Part A First Intervention||0
8984732|NCT02714569|10047690|FG008|STARTED|Part A First Intervention||0
8984733|NCT02714569|10047691|FG009|STARTED|Part A First Intervention||0
8984734|NCT02714569|10047692|FG010|STARTED|Part A First Intervention||0
8984735|NCT02714569|10047682|FG000|Received at Least One Dose of Study Drug|Part A First Intervention||3
8984736|NCT02714569|10047683|FG001|Received at Least One Dose of Study Drug|Part A First Intervention||3
8984737|NCT02714569|10047684|FG002|Received at Least One Dose of Study Drug|Part A First Intervention||3
8984738|NCT02714569|10047685|FG003|Received at Least One Dose of Study Drug|Part A First Intervention||3
8984739|NCT02714569|10047686|FG004|Received at Least One Dose of Study Drug|Part A First Intervention||3
8984740|NCT02714569|10047687|FG005|Received at Least One Dose of Study Drug|Part A First Intervention||3
8984741|NCT02714569|10047688|FG006|Received at Least One Dose of Study Drug|Part A First Intervention||0
8984742|NCT02714569|10047689|FG007|Received at Least One Dose of Study Drug|Part A First Intervention||0
8984743|NCT02714569|10047690|FG008|Received at Least One Dose of Study Drug|Part A First Intervention||0
8984744|NCT02714569|10047691|FG009|Received at Least One Dose of Study Drug|Part A First Intervention||0
8984745|NCT02714569|10047692|FG010|Received at Least One Dose of Study Drug|Part A First Intervention||0
8984746|NCT02714569|10047682|FG000|COMPLETED|Part A First Intervention||3
8984747|NCT02714569|10047683|FG001|COMPLETED|Part A First Intervention||3
8984748|NCT02714569|10047684|FG002|COMPLETED|Part A First Intervention||3
8984749|NCT02714569|10047685|FG003|COMPLETED|Part A First Intervention||3
8984750|NCT02714569|10047686|FG004|COMPLETED|Part A First Intervention||3
8984751|NCT02714569|10047687|FG005|COMPLETED|Part A First Intervention||3
8984752|NCT02714569|10047688|FG006|COMPLETED|Part A First Intervention||0
8984753|NCT02714569|10047689|FG007|COMPLETED|Part A First Intervention||0
8984754|NCT02714569|10047690|FG008|COMPLETED|Part A First Intervention||0
8984755|NCT02714569|10047691|FG009|COMPLETED|Part A First Intervention||0
8984756|NCT02714569|10047692|FG010|COMPLETED|Part A First Intervention||0
8984757|NCT02714569|10047682|FG000|NOT COMPLETED|Part A First Intervention||0
8984758|NCT02714569|10047683|FG001|NOT COMPLETED|Part A First Intervention||0
8984759|NCT02714569|10047684|FG002|NOT COMPLETED|Part A First Intervention||0
8984760|NCT02714569|10047685|FG003|NOT COMPLETED|Part A First Intervention||0
8984761|NCT02714569|10047686|FG004|NOT COMPLETED|Part A First Intervention||0
8984762|NCT02714569|10047687|FG005|NOT COMPLETED|Part A First Intervention||0
8984763|NCT02714569|10047688|FG006|NOT COMPLETED|Part A First Intervention||0
8984764|NCT02714569|10047689|FG007|NOT COMPLETED|Part A First Intervention||0
8984765|NCT02714569|10047690|FG008|NOT COMPLETED|Part A First Intervention||0
8984766|NCT02714569|10047691|FG009|NOT COMPLETED|Part A First Intervention||0
8984767|NCT02714569|10047692|FG010|NOT COMPLETED|Part A First Intervention||0
8984768|NCT02714569|10047682|FG000|STARTED|Part A Second Intervention||3
8984769|NCT02714569|10047683|FG001|STARTED|Part A Second Intervention||3
8984770|NCT02714569|10047684|FG002|STARTED|Part A Second Intervention||3
8984771|NCT02714569|10047685|FG003|STARTED|Part A Second Intervention||3
8984772|NCT02714569|10047686|FG004|STARTED|Part A Second Intervention||3
8984773|NCT02714569|10047687|FG005|STARTED|Part A Second Intervention||3
8984774|NCT02714569|10047688|FG006|STARTED|Part A Second Intervention||0
8984775|NCT02714569|10047689|FG007|STARTED|Part A Second Intervention||0
8984776|NCT02714569|10047690|FG008|STARTED|Part A Second Intervention||0
8984777|NCT02714569|10047691|FG009|STARTED|Part A Second Intervention||0
8984778|NCT02714569|10047692|FG010|STARTED|Part A Second Intervention||0
8984779|NCT02714569|10047682|FG000|Received at Least One Dose of Study Drug|Part A Second Intervention||3
8984780|NCT02714569|10047683|FG001|Received at Least One Dose of Study Drug|Part A Second Intervention||2
8984781|NCT02714569|10047684|FG002|Received at Least One Dose of Study Drug|Part A Second Intervention||3
8984782|NCT02714569|10047685|FG003|Received at Least One Dose of Study Drug|Part A Second Intervention||3
8984783|NCT02714569|10047686|FG004|Received at Least One Dose of Study Drug|Part A Second Intervention||3
8984784|NCT02714569|10047687|FG005|Received at Least One Dose of Study Drug|Part A Second Intervention||3
8984785|NCT02714569|10047688|FG006|Received at Least One Dose of Study Drug|Part A Second Intervention||0
8984786|NCT02714569|10047689|FG007|Received at Least One Dose of Study Drug|Part A Second Intervention||0
8984787|NCT02714569|10047690|FG008|Received at Least One Dose of Study Drug|Part A Second Intervention||0
8984788|NCT02714569|10047691|FG009|Received at Least One Dose of Study Drug|Part A Second Intervention||0
8984789|NCT02714569|10047692|FG010|Received at Least One Dose of Study Drug|Part A Second Intervention||0
8984790|NCT02714569|10047682|FG000|COMPLETED|Part A Second Intervention||3
8984791|NCT02714569|10047683|FG001|COMPLETED|Part A Second Intervention||2
8984792|NCT02714569|10047684|FG002|COMPLETED|Part A Second Intervention||3
8984793|NCT02714569|10047685|FG003|COMPLETED|Part A Second Intervention||3
8984794|NCT02714569|10047686|FG004|COMPLETED|Part A Second Intervention||3
8984795|NCT02714569|10047687|FG005|COMPLETED|Part A Second Intervention||3
8984796|NCT02714569|10047688|FG006|COMPLETED|Part A Second Intervention||0
8984797|NCT02714569|10047689|FG007|COMPLETED|Part A Second Intervention||0
8984798|NCT02714569|10047690|FG008|COMPLETED|Part A Second Intervention||0
8984799|NCT02714569|10047691|FG009|COMPLETED|Part A Second Intervention||0
8984800|NCT02714569|10047692|FG010|COMPLETED|Part A Second Intervention||0
8984801|NCT02714569|10047682|FG000|NOT COMPLETED|Part A Second Intervention||0
8984802|NCT02714569|10047683|FG001|NOT COMPLETED|Part A Second Intervention||1
8984803|NCT02714569|10047684|FG002|NOT COMPLETED|Part A Second Intervention||0
8984804|NCT02714569|10047685|FG003|NOT COMPLETED|Part A Second Intervention||0
8984805|NCT02714569|10047686|FG004|NOT COMPLETED|Part A Second Intervention||0
8984806|NCT02714569|10047687|FG005|NOT COMPLETED|Part A Second Intervention||0
8984807|NCT02714569|10047688|FG006|NOT COMPLETED|Part A Second Intervention||0
8984808|NCT02714569|10047689|FG007|NOT COMPLETED|Part A Second Intervention||0
8984809|NCT02714569|10047690|FG008|NOT COMPLETED|Part A Second Intervention||0
8984810|NCT02714569|10047691|FG009|NOT COMPLETED|Part A Second Intervention||0
8984811|NCT02714569|10047692|FG010|NOT COMPLETED|Part A Second Intervention||0
8984812|NCT02714569|10047682|FG000|STARTED|Part A Third Intervention||3
8984813|NCT02714569|10047683|FG001|STARTED|Part A Third Intervention||2
8984814|NCT02714569|10047684|FG002|STARTED|Part A Third Intervention||3
8984815|NCT02714569|10047685|FG003|STARTED|Part A Third Intervention||3
8984816|NCT02714569|10047686|FG004|STARTED|Part A Third Intervention||3
8984817|NCT02714569|10047687|FG005|STARTED|Part A Third Intervention||3
8984818|NCT02714569|10047688|FG006|STARTED|Part A Third Intervention||0
8984819|NCT02714569|10047689|FG007|STARTED|Part A Third Intervention||0
8984820|NCT02714569|10047690|FG008|STARTED|Part A Third Intervention||0
8984821|NCT02714569|10047691|FG009|STARTED|Part A Third Intervention||0
8984822|NCT02714569|10047692|FG010|STARTED|Part A Third Intervention||0
8984823|NCT02714569|10047682|FG000|Received at Least One Dose of Study Drug|Part A Third Intervention||3
8984824|NCT02714569|10047683|FG001|Received at Least One Dose of Study Drug|Part A Third Intervention||2
8984825|NCT02714569|10047684|FG002|Received at Least One Dose of Study Drug|Part A Third Intervention||2
8984826|NCT02714569|10047685|FG003|Received at Least One Dose of Study Drug|Part A Third Intervention||2
8984827|NCT02714569|10047686|FG004|Received at Least One Dose of Study Drug|Part A Third Intervention||3
8984828|NCT02714569|10047687|FG005|Received at Least One Dose of Study Drug|Part A Third Intervention||3
8984829|NCT02714569|10047688|FG006|Received at Least One Dose of Study Drug|Part A Third Intervention||0
8984830|NCT02714569|10047689|FG007|Received at Least One Dose of Study Drug|Part A Third Intervention||0
8984831|NCT02714569|10047690|FG008|Received at Least One Dose of Study Drug|Part A Third Intervention||0
8984832|NCT02714569|10047691|FG009|Received at Least One Dose of Study Drug|Part A Third Intervention||0
8984833|NCT02714569|10047692|FG010|Received at Least One Dose of Study Drug|Part A Third Intervention||0
8984834|NCT02714569|10047682|FG000|COMPLETED|Part A Third Intervention||3
8984835|NCT02714569|10047683|FG001|COMPLETED|Part A Third Intervention||2
8984836|NCT02714569|10047684|FG002|COMPLETED|Part A Third Intervention||2
8984837|NCT02714569|10047685|FG003|COMPLETED|Part A Third Intervention||2
8984838|NCT02714569|10047686|FG004|COMPLETED|Part A Third Intervention||3
8984839|NCT02714569|10047687|FG005|COMPLETED|Part A Third Intervention||3
8984840|NCT02714569|10047688|FG006|COMPLETED|Part A Third Intervention||0
8984841|NCT02714569|10047689|FG007|COMPLETED|Part A Third Intervention||0
8984842|NCT02714569|10047690|FG008|COMPLETED|Part A Third Intervention||0
8984843|NCT02714569|10047691|FG009|COMPLETED|Part A Third Intervention||0
8984844|NCT02714569|10047692|FG010|COMPLETED|Part A Third Intervention||0
8984845|NCT02714569|10047682|FG000|NOT COMPLETED|Part A Third Intervention||0
8984846|NCT02714569|10047683|FG001|NOT COMPLETED|Part A Third Intervention||0
8984847|NCT02714569|10047684|FG002|NOT COMPLETED|Part A Third Intervention||1
8984848|NCT02714569|10047685|FG003|NOT COMPLETED|Part A Third Intervention||1
8984849|NCT02714569|10047686|FG004|NOT COMPLETED|Part A Third Intervention||0
8984850|NCT02714569|10047687|FG005|NOT COMPLETED|Part A Third Intervention||0
8984851|NCT02714569|10047688|FG006|NOT COMPLETED|Part A Third Intervention||0
8984852|NCT02714569|10047689|FG007|NOT COMPLETED|Part A Third Intervention||0
8984853|NCT02714569|10047690|FG008|NOT COMPLETED|Part A Third Intervention||0
8984854|NCT02714569|10047691|FG009|NOT COMPLETED|Part A Third Intervention||0
8984855|NCT02714569|10047692|FG010|NOT COMPLETED|Part A Third Intervention||0
8984856|NCT02714569|10047682|FG000|STARTED|Part A Fourth Intervention|An additional participant replaced a discontinued participant.|4
8984857|NCT02714569|10047683|FG001|STARTED|Part A Fourth Intervention||2
8984858|NCT02714569|10047684|FG002|STARTED|Part A Fourth Intervention|An additional participant replaced a discontinued participant.|3
8725853|NCT01033487|9773160|FG003|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
8725854|NCT01033487|9773161|FG004|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
8725855|NCT01033487|9773162|FG005|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
8725856|NCT01033487|9773163|FG006|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
8984859|NCT02714569|10047685|FG003|STARTED|Part A Fourth Intervention||2
8984860|NCT02714569|10047686|FG004|STARTED|Part A Fourth Intervention||3
8984861|NCT02714569|10047687|FG005|STARTED|Part A Fourth Intervention||3
8984862|NCT02714569|10047688|FG006|STARTED|Part A Fourth Intervention||0
8984863|NCT02714569|10047689|FG007|STARTED|Part A Fourth Intervention||0
8984864|NCT02714569|10047690|FG008|STARTED|Part A Fourth Intervention||0
8984865|NCT02714569|10047691|FG009|STARTED|Part A Fourth Intervention||0
8984866|NCT02714569|10047692|FG010|STARTED|Part A Fourth Intervention||0
8984867|NCT02714569|10047682|FG000|Received at Least One Dose of Study Drug|Part A Fourth Intervention||3
8984868|NCT02714569|10047683|FG001|Received at Least One Dose of Study Drug|Part A Fourth Intervention||2
8984869|NCT02714569|10047684|FG002|Received at Least One Dose of Study Drug|Part A Fourth Intervention||3
8984870|NCT02714569|10047685|FG003|Received at Least One Dose of Study Drug|Part A Fourth Intervention||2
8984871|NCT02714569|10047686|FG004|Received at Least One Dose of Study Drug|Part A Fourth Intervention||3
8984872|NCT02714569|10047687|FG005|Received at Least One Dose of Study Drug|Part A Fourth Intervention||2
8984873|NCT02714569|10047688|FG006|Received at Least One Dose of Study Drug|Part A Fourth Intervention||0
8984874|NCT02714569|10047689|FG007|Received at Least One Dose of Study Drug|Part A Fourth Intervention||0
8984875|NCT02714569|10047690|FG008|Received at Least One Dose of Study Drug|Part A Fourth Intervention||0
8984876|NCT02714569|10047691|FG009|Received at Least One Dose of Study Drug|Part A Fourth Intervention||0
8984877|NCT02714569|10047692|FG010|Received at Least One Dose of Study Drug|Part A Fourth Intervention||0
8984878|NCT02714569|10047682|FG000|COMPLETED|Part A Fourth Intervention||3
8984879|NCT02714569|10047683|FG001|COMPLETED|Part A Fourth Intervention||2
8984880|NCT02714569|10047684|FG002|COMPLETED|Part A Fourth Intervention||3
8984881|NCT02714569|10047685|FG003|COMPLETED|Part A Fourth Intervention||2
8984882|NCT02714569|10047686|FG004|COMPLETED|Part A Fourth Intervention||3
8984883|NCT02714569|10047687|FG005|COMPLETED|Part A Fourth Intervention||2
8984884|NCT02714569|10047688|FG006|COMPLETED|Part A Fourth Intervention||0
8984885|NCT02714569|10047689|FG007|COMPLETED|Part A Fourth Intervention||0
8984886|NCT02714569|10047690|FG008|COMPLETED|Part A Fourth Intervention||0
8984887|NCT02714569|10047691|FG009|COMPLETED|Part A Fourth Intervention||0
8984888|NCT02714569|10047692|FG010|COMPLETED|Part A Fourth Intervention||0
8984889|NCT02714569|10047682|FG000|NOT COMPLETED|Part A Fourth Intervention||1
8984890|NCT02714569|10047683|FG001|NOT COMPLETED|Part A Fourth Intervention||0
8984891|NCT02714569|10047684|FG002|NOT COMPLETED|Part A Fourth Intervention||0
8984892|NCT02714569|10047685|FG003|NOT COMPLETED|Part A Fourth Intervention||0
8984893|NCT02714569|10047686|FG004|NOT COMPLETED|Part A Fourth Intervention||0
8984894|NCT02714569|10047687|FG005|NOT COMPLETED|Part A Fourth Intervention||1
8984895|NCT02714569|10047688|FG006|NOT COMPLETED|Part A Fourth Intervention||0
8984896|NCT02714569|10047689|FG007|NOT COMPLETED|Part A Fourth Intervention||0
8984897|NCT02714569|10047690|FG008|NOT COMPLETED|Part A Fourth Intervention||0
8984898|NCT02714569|10047691|FG009|NOT COMPLETED|Part A Fourth Intervention||0
8984899|NCT02714569|10047692|FG010|NOT COMPLETED|Part A Fourth Intervention||0
8984900|NCT02714569|10047682|FG000|STARTED|Part B (Overall)|Part A participants completed period 4 and were not in part B.|0
8984901|NCT02714569|10047683|FG001|STARTED|Part B (Overall)|Part A participants completed period 4 and were not in part B.|0
8984902|NCT02714569|10047684|FG002|STARTED|Part B (Overall)|Part A participants completed period 4 and were not in part B.|0
8984903|NCT02714569|10047685|FG003|STARTED|Part B (Overall)|Part A participants completed period 4 and were not in part B.|0
8984904|NCT02714569|10047686|FG004|STARTED|Part B (Overall)|Part A participants completed period 4 and were not in part B.|0
8984905|NCT02714569|10047687|FG005|STARTED|Part B (Overall)|Part A participants completed period 4 and were not in part B.|0
8984906|NCT02714569|10047688|FG006|STARTED|Part B (Overall)|Part B participants randomized to receive 5 mg of LY3202328 + atorvastatin/simvastatin.|8
8984907|NCT02714569|10047689|FG007|STARTED|Part B (Overall)|Part B participants randomized to receive 20 mg of LY3202328 + atorvastatin/simvastatin.|8
8984908|NCT02714569|10047690|FG008|STARTED|Part B (Overall)|Part B participants randomized to receive 100 mg of LY3202328 + atorvastatin/simvastatin.|8
8984909|NCT02714569|10047691|FG009|STARTED|Part B (Overall)|Part B participants randomized to receive 300 mg of LY3202328 + atorvastatin/simvastatin.|8
8984910|NCT02714569|10047692|FG010|STARTED|Part B (Overall)|Part B participants randomized to receive placebo instead of LY3202328 + atorvastatin/simvastatin.|8
8984911|NCT02714569|10047682|FG000|COMPLETED|Part B (Overall)||0
8984912|NCT02714569|10047683|FG001|COMPLETED|Part B (Overall)||0
8984913|NCT02714569|10047684|FG002|COMPLETED|Part B (Overall)||0
8984914|NCT02714569|10047685|FG003|COMPLETED|Part B (Overall)||0
8984915|NCT02714569|10047686|FG004|COMPLETED|Part B (Overall)||0
8984916|NCT02714569|10047687|FG005|COMPLETED|Part B (Overall)||0
8984917|NCT02714569|10047688|FG006|COMPLETED|Part B (Overall)||7
8571619|NCT00111800|9603934|FG000|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||15
8571620|NCT00111800|9603935|FG001|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||14
8571621|NCT00111800|9603936|FG002|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||9
8571622|NCT00111800|9603937|FG003|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||6
8571623|NCT00111800|9603938|FG004|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||5
8984918|NCT02714569|10047689|FG007|COMPLETED|Part B (Overall)||7
8984919|NCT02714569|10047690|FG008|COMPLETED|Part B (Overall)||8
8984920|NCT02714569|10047691|FG009|COMPLETED|Part B (Overall)||6
8984921|NCT02714569|10047692|FG010|COMPLETED|Part B (Overall)||8
8984922|NCT02714569|10047682|FG000|NOT COMPLETED|Part B (Overall)||0
8984923|NCT02714569|10047683|FG001|NOT COMPLETED|Part B (Overall)||0
8984924|NCT02714569|10047684|FG002|NOT COMPLETED|Part B (Overall)||0
8984925|NCT02714569|10047685|FG003|NOT COMPLETED|Part B (Overall)||0
8984926|NCT02714569|10047686|FG004|NOT COMPLETED|Part B (Overall)||0
8984927|NCT02714569|10047687|FG005|NOT COMPLETED|Part B (Overall)||0
8984928|NCT02714569|10047688|FG006|NOT COMPLETED|Part B (Overall)||1
8984929|NCT02714569|10047689|FG007|NOT COMPLETED|Part B (Overall)||1
8984930|NCT02714569|10047690|FG008|NOT COMPLETED|Part B (Overall)||0
8984931|NCT02714569|10047691|FG009|NOT COMPLETED|Part B (Overall)||2
8984932|NCT02714569|10047692|FG010|NOT COMPLETED|Part B (Overall)||0
8984933|NCT02714595|10047754|FG000|STARTED|Overall Study||101
8984934|NCT02714595|10047755|FG001|STARTED|Overall Study||51
8984935|NCT02714595|10047754|FG000|Received Treatment|Overall Study||101
8984936|NCT02714595|10047755|FG001|Received Treatment|Overall Study||49
8984937|NCT02714595|10047754|FG000|Carbapenem-resistant Microbiological Intent-to-treat|Overall Study||80
8984938|NCT02714595|10047755|FG001|Carbapenem-resistant Microbiological Intent-to-treat|Overall Study||38
8984939|NCT02714595|10047754|FG000|COMPLETED|Overall Study||69
8984940|NCT02714595|10047755|FG001|COMPLETED|Overall Study||38
8984941|NCT02714595|10047754|FG000|NOT COMPLETED|Overall Study||32
8984942|NCT02714595|10047755|FG001|NOT COMPLETED|Overall Study||13
8984943|NCT02714868|10047781|FG000|STARTED|Overall Study||47
8984944|NCT02714868|10047782|FG001|STARTED|Overall Study||35
8984945|NCT02714868|10047781|FG000|COMPLETED|Overall Study||42
8984946|NCT02714868|10047782|FG001|COMPLETED|Overall Study||35
8984947|NCT02714868|10047781|FG000|NOT COMPLETED|Overall Study||5
8984948|NCT02714868|10047782|FG001|NOT COMPLETED|Overall Study||0
8984949|NCT02715076|10047795|FG000|STARTED|Overall Study||48
8984950|NCT02715076|10047796|FG001|STARTED|Overall Study||50
8984951|NCT02715076|10047797|FG002|STARTED|Overall Study||49
8984952|NCT02715076|10047798|FG003|STARTED|Overall Study||50
8984953|NCT02715076|10047799|FG004|STARTED|Overall Study||47
8984954|NCT02715076|10047800|FG005|STARTED|Overall Study||48
8984955|NCT02715076|10047795|FG000|COMPLETED|Overall Study||48
8984956|NCT02715076|10047796|FG001|COMPLETED|Overall Study||50
8984957|NCT02715076|10047797|FG002|COMPLETED|Overall Study||49
8984958|NCT02715076|10047798|FG003|COMPLETED|Overall Study||50
8984959|NCT02715076|10047799|FG004|COMPLETED|Overall Study||47
8984960|NCT02715076|10047800|FG005|COMPLETED|Overall Study||48
8984961|NCT02715076|10047795|FG000|NOT COMPLETED|Overall Study||0
8984962|NCT02715076|10047796|FG001|NOT COMPLETED|Overall Study||0
8984963|NCT02715076|10047797|FG002|NOT COMPLETED|Overall Study||0
8984964|NCT02715076|10047798|FG003|NOT COMPLETED|Overall Study||0
8984965|NCT02715076|10047799|FG004|NOT COMPLETED|Overall Study||0
8984966|NCT02715076|10047800|FG005|NOT COMPLETED|Overall Study||0
8984967|NCT02715258|10047816|FG000|STARTED|Overall Study||140
8984968|NCT02715258|10047817|FG001|STARTED|Overall Study||70
8984969|NCT02715258|10047816|FG000|Intent to Treat/Safety Analysis|Overall Study||138
8984970|NCT02715258|10047817|FG001|Intent to Treat/Safety Analysis|Overall Study||69
8984971|NCT02715258|10047816|FG000|COMPLETED|Overall Study||124
8984972|NCT02715258|10047817|FG001|COMPLETED|Overall Study||64
8984973|NCT02715258|10047816|FG000|NOT COMPLETED|Overall Study||16
8984974|NCT02715258|10047817|FG001|NOT COMPLETED|Overall Study||6
8984975|NCT02715700|10047823|FG000|STARTED|Overall Study||14
8984976|NCT02715700|10047823|FG000|COMPLETED|Overall Study||14
8984977|NCT02715700|10047823|FG000|NOT COMPLETED|Overall Study||0
8984978|NCT02715726|10047833|FG000|STARTED|Overall Study|Randomized|208
8984979|NCT02715726|10047834|FG001|STARTED|Overall Study|Randomized|407
8984980|NCT02715726|10047833|FG000|Treated|Overall Study||207
8984981|NCT02715726|10047834|FG001|Treated|Overall Study||405
8984982|NCT02715726|10047833|FG000|Safety Population|Overall Study||206
8984983|NCT02715726|10047834|FG001|Safety Population|Overall Study||406
8984984|NCT02715726|10047833|FG000|COMPLETED|Overall Study||190
8984985|NCT02715726|10047834|FG001|COMPLETED|Overall Study||380
8984986|NCT02715726|10047833|FG000|NOT COMPLETED|Overall Study||18
8984987|NCT02715726|10047834|FG001|NOT COMPLETED|Overall Study||27
8984988|NCT02715804|10047842|FG000|STARTED|Overall Study||327
8984989|NCT02715804|10047843|FG001|STARTED|Overall Study||165
8984990|NCT02715804|10047842|FG000|Received at Least 1 Dose of Study Drug|Overall Study||323
8984991|NCT02715804|10047843|FG001|Received at Least 1 Dose of Study Drug|Overall Study||158
8984992|NCT02715804|10047842|FG000|Safety Population|Overall Study|3 participants randomized to AG but received PAG|325
8984993|NCT02715804|10047843|FG001|Safety Population|Overall Study|1 participant randomized to PAG but received AG|156
8984994|NCT02715804|10047842|FG000|COMPLETED|Overall Study||98
8984995|NCT02715804|10047843|FG001|COMPLETED|Overall Study||52
8984996|NCT02715804|10047842|FG000|NOT COMPLETED|Overall Study||229
8984997|NCT02715804|10047843|FG001|NOT COMPLETED|Overall Study||113
8984998|NCT02716194|10047852|FG000|STARTED|Period 1 - ADVATE||11
8984999|NCT02716194|10047853|FG001|STARTED|Period 1 - ADVATE||16
8985000|NCT02716194|10047854|FG002|STARTED|Period 1 - ADVATE||13
8985001|NCT02716194|10047852|FG000|COMPLETED|Period 1 - ADVATE||10
8985002|NCT02716194|10047853|FG001|COMPLETED|Period 1 - ADVATE||15
8985003|NCT02716194|10047854|FG002|COMPLETED|Period 1 - ADVATE||13
8985004|NCT02716194|10047852|FG000|NOT COMPLETED|Period 1 - ADVATE||1
8985005|NCT02716194|10047853|FG001|NOT COMPLETED|Period 1 - ADVATE||1
8985006|NCT02716194|10047854|FG002|NOT COMPLETED|Period 1 - ADVATE||0
8985007|NCT02716194|10047852|FG000|STARTED|Period 2 - BAX 826||10
8985008|NCT02716194|10047853|FG001|STARTED|Period 2 - BAX 826||15
8985009|NCT02716194|10047854|FG002|STARTED|Period 2 - BAX 826||13
8985010|NCT02716194|10047852|FG000|COMPLETED|Period 2 - BAX 826||10
8985011|NCT02716194|10047853|FG001|COMPLETED|Period 2 - BAX 826||15
8985012|NCT02716194|10047854|FG002|COMPLETED|Period 2 - BAX 826||13
8985013|NCT02716194|10047852|FG000|NOT COMPLETED|Period 2 - BAX 826||0
8985014|NCT02716194|10047853|FG001|NOT COMPLETED|Period 2 - BAX 826||0
8985015|NCT02716194|10047854|FG002|NOT COMPLETED|Period 2 - BAX 826||0
8985016|NCT02716298|10047875|FG000|STARTED|First Intervention (1 Month)||25
8985017|NCT02716298|10047876|FG001|STARTED|First Intervention (1 Month)||24
8985018|NCT02716298|10047875|FG000|COMPLETED|First Intervention (1 Month)||24
8985019|NCT02716298|10047876|FG001|COMPLETED|First Intervention (1 Month)||23
8985020|NCT02716298|10047875|FG000|NOT COMPLETED|First Intervention (1 Month)||1
8985021|NCT02716298|10047876|FG001|NOT COMPLETED|First Intervention (1 Month)||1
8985022|NCT02716298|10047875|FG000|STARTED|Second Intervention (1 Month)||24
8985023|NCT02716298|10047876|FG001|STARTED|Second Intervention (1 Month)||23
8985024|NCT02716298|10047875|FG000|COMPLETED|Second Intervention (1 Month)||24
8985025|NCT02716298|10047876|FG001|COMPLETED|Second Intervention (1 Month)||23
8985026|NCT02716298|10047875|FG000|NOT COMPLETED|Second Intervention (1 Month)||0
8985027|NCT02716298|10047876|FG001|NOT COMPLETED|Second Intervention (1 Month)||0
8985028|NCT02716324|10047889|FG000|STARTED|Overall Study||149
8985029|NCT02716324|10047890|FG001|STARTED|Overall Study||154
8985030|NCT02716324|10047889|FG000|COMPLETED|Overall Study||130
8985031|NCT02716324|10047890|FG001|COMPLETED|Overall Study||143
8985032|NCT02716324|10047889|FG000|NOT COMPLETED|Overall Study||19
8985033|NCT02716324|10047890|FG001|NOT COMPLETED|Overall Study||11
8985034|NCT02716506|10047896|FG000|STARTED|Overall Study||3515
8985035|NCT02716506|10047896|FG000|6 Months|Overall Study|Patients that completed the questionnaires six months after the operation.|2528
8985036|NCT02716506|10047896|FG000|2 Years|Overall Study|Patients that completed the questionnaires two years after the operation.|2351
8985037|NCT02716506|10047896|FG000|COMPLETED|Overall Study||2351
8985038|NCT02716506|10047896|FG000|NOT COMPLETED|Overall Study||1164
8985039|NCT02716584|10047902|FG000|STARTED|Overall Study||35
8985040|NCT02716584|10047903|FG001|STARTED|Overall Study||18
8985041|NCT02716584|10047902|FG000|COMPLETED|Overall Study||27
8985042|NCT02716584|10047903|FG001|COMPLETED|Overall Study||13
8985043|NCT02716584|10047902|FG000|NOT COMPLETED|Overall Study||8
8985044|NCT02716584|10047903|FG001|NOT COMPLETED|Overall Study||5
8985045|NCT02716714|10047911|FG000|STARTED|Overall Study||67
8985046|NCT02716714|10047912|FG001|STARTED|Overall Study||10
8985047|NCT02716714|10047911|FG000|COMPLETED|Overall Study||55
8985048|NCT02716714|10047912|FG001|COMPLETED|Overall Study||8
8985049|NCT02716714|10047911|FG000|NOT COMPLETED|Overall Study||12
8985050|NCT02716714|10047912|FG001|NOT COMPLETED|Overall Study||2
8985051|NCT02716727|10047924|FG000|STARTED|Overall Study||7
8985052|NCT02716727|10047925|FG001|STARTED|Overall Study||9
8985053|NCT02716727|10047924|FG000|COMPLETED|Overall Study||7
8985054|NCT02716727|10047925|FG001|COMPLETED|Overall Study||9
8985055|NCT02716727|10047924|FG000|NOT COMPLETED|Overall Study||0
8985056|NCT02716727|10047925|FG001|NOT COMPLETED|Overall Study||0
8985057|NCT02716779|10047934|FG000|STARTED|Monotherapy||14
8985058|NCT02716779|10047935|FG001|STARTED|Monotherapy||26
8985059|NCT02716779|10047936|FG002|STARTED|Monotherapy||27
8985060|NCT02716779|10047934|FG000|COMPLETED|Monotherapy||14
8985061|NCT02716779|10047935|FG001|COMPLETED|Monotherapy||25
8985062|NCT02716779|10047936|FG002|COMPLETED|Monotherapy||26
8985063|NCT02716779|10047934|FG000|NOT COMPLETED|Monotherapy||0
8985064|NCT02716779|10047935|FG001|NOT COMPLETED|Monotherapy||1
8985065|NCT02716779|10047936|FG002|NOT COMPLETED|Monotherapy||1
8985066|NCT02716779|10047934|FG000|STARTED|Combination Therapy||14
8985067|NCT02716779|10047935|FG001|STARTED|Combination Therapy||25
8985068|NCT02716779|10047936|FG002|STARTED|Combination Therapy||26
8985069|NCT02716779|10047934|FG000|COMPLETED|Combination Therapy||14
8985070|NCT02716779|10047935|FG001|COMPLETED|Combination Therapy||23
8985071|NCT02716779|10047936|FG002|COMPLETED|Combination Therapy||25
8985072|NCT02716779|10047934|FG000|NOT COMPLETED|Combination Therapy||0
8985073|NCT02716779|10047935|FG001|NOT COMPLETED|Combination Therapy||2
8985074|NCT02716779|10047936|FG002|NOT COMPLETED|Combination Therapy||1
8985075|NCT02716805|10047950|FG000|STARTED|Overall Study||6
8985076|NCT02716805|10047951|FG001|STARTED|Overall Study||0
8985077|NCT02716805|10047952|FG002|STARTED|Overall Study||0
8985078|NCT02716805|10047953|FG003|STARTED|Overall Study||0
8985079|NCT02716805|10047950|FG000|COMPLETED|Overall Study||4
8985080|NCT02716805|10047951|FG001|COMPLETED|Overall Study||0
8985081|NCT02716805|10047952|FG002|COMPLETED|Overall Study||0
8985082|NCT02716805|10047953|FG003|COMPLETED|Overall Study||0
8985083|NCT02716805|10047950|FG000|NOT COMPLETED|Overall Study||2
8985084|NCT02716805|10047951|FG001|NOT COMPLETED|Overall Study||0
8985085|NCT02716805|10047952|FG002|NOT COMPLETED|Overall Study||0
8985086|NCT02716805|10047953|FG003|NOT COMPLETED|Overall Study||0
8985087|NCT02716818|10047959|FG000|STARTED|Overall Study||61
8985088|NCT02716818|10047960|FG001|STARTED|Overall Study||61
8985089|NCT02716818|10047959|FG000|COMPLETED|Overall Study||58
8985090|NCT02716818|10047960|FG001|COMPLETED|Overall Study||59
8985091|NCT02716818|10047959|FG000|NOT COMPLETED|Overall Study||3
8985092|NCT02716818|10047960|FG001|NOT COMPLETED|Overall Study||2
8985093|NCT02716896|10047990|FG000|STARTED|Overall Study||1
8985094|NCT02716896|10047991|FG001|STARTED|Overall Study||1
8985095|NCT02716896|10047990|FG000|COMPLETED|Overall Study||1
8985096|NCT02716896|10047991|FG001|COMPLETED|Overall Study||0
8985097|NCT02716896|10047990|FG000|NOT COMPLETED|Overall Study||0
8985098|NCT02716896|10047991|FG001|NOT COMPLETED|Overall Study||1
8985099|NCT02716987|10048003|FG000|STARTED|Overall Study||4
8877716|NCT01925209|9934729|FG002|STARTED|Maintenance Treatment Epoch||52
8877717|NCT01925209|9934730|FG003|STARTED|Maintenance Treatment Epoch||50
8877718|NCT01925209|9934727|FG000|COMPLETED|Maintenance Treatment Epoch||49
8877719|NCT01925209|9934728|FG001|COMPLETED|Maintenance Treatment Epoch||45
8877720|NCT01925209|9934729|FG002|COMPLETED|Maintenance Treatment Epoch||50
8877721|NCT01925209|9934730|FG003|COMPLETED|Maintenance Treatment Epoch||48
8985100|NCT02716987|10048004|FG001|STARTED|Overall Study||2
8985101|NCT02716987|10048005|FG002|STARTED|Overall Study||5
8985102|NCT02716987|10048006|FG003|STARTED|Overall Study||2
8985103|NCT02716987|10048007|FG004|STARTED|Overall Study||6
8985104|NCT02716987|10048008|FG005|STARTED|Overall Study||1
8985105|NCT02716987|10048003|FG000|COMPLETED|Overall Study||4
8985106|NCT02716987|10048004|FG001|COMPLETED|Overall Study||2
8985107|NCT02716987|10048005|FG002|COMPLETED|Overall Study||4
8985108|NCT02716987|10048006|FG003|COMPLETED|Overall Study||2
8985109|NCT02716987|10048007|FG004|COMPLETED|Overall Study||5
8985110|NCT02716987|10048008|FG005|COMPLETED|Overall Study||0
8985111|NCT02716987|10048003|FG000|NOT COMPLETED|Overall Study||0
8985112|NCT02716987|10048004|FG001|NOT COMPLETED|Overall Study||0
8985113|NCT02716987|10048005|FG002|NOT COMPLETED|Overall Study||1
8985114|NCT02716987|10048006|FG003|NOT COMPLETED|Overall Study||0
8985115|NCT02716987|10048007|FG004|NOT COMPLETED|Overall Study||1
8985116|NCT02716987|10048008|FG005|NOT COMPLETED|Overall Study||1
8985117|NCT02717195|10048037|FG000|STARTED|Prospective Confirmation (PC) Period||711
8985118|NCT02717195|10048038|FG001|STARTED|Prospective Confirmation (PC) Period||387
8985119|NCT02717195|10048039|FG002|STARTED|Prospective Confirmation (PC) Period||0
8985120|NCT02717195|10048040|FG003|STARTED|Prospective Confirmation (PC) Period||0
8985121|NCT02717195|10048041|FG004|STARTED|Prospective Confirmation (PC) Period||0
8985122|NCT02717195|10048037|FG000|COMPLETED|Prospective Confirmation (PC) Period||421
8985123|NCT02717195|10048038|FG001|COMPLETED|Prospective Confirmation (PC) Period||276
8985124|NCT02717195|10048039|FG002|COMPLETED|Prospective Confirmation (PC) Period||0
8985125|NCT02717195|10048040|FG003|COMPLETED|Prospective Confirmation (PC) Period||0
8985126|NCT02717195|10048041|FG004|COMPLETED|Prospective Confirmation (PC) Period||0
8985127|NCT02717195|10048037|FG000|NOT COMPLETED|Prospective Confirmation (PC) Period||290
8985128|NCT02717195|10048038|FG001|NOT COMPLETED|Prospective Confirmation (PC) Period||111
8985129|NCT02717195|10048039|FG002|NOT COMPLETED|Prospective Confirmation (PC) Period||0
8985130|NCT02717195|10048040|FG003|NOT COMPLETED|Prospective Confirmation (PC) Period||0
8985131|NCT02717195|10048041|FG004|NOT COMPLETED|Prospective Confirmation (PC) Period||0
8985132|NCT02717195|10048037|FG000|STARTED|Double-blind Treatment (DBT) Period||0
8985133|NCT02717195|10048038|FG001|STARTED|Double-blind Treatment (DBT) Period||0
8985134|NCT02717195|10048039|FG002|STARTED|Double-blind Treatment (DBT) Period||235
8985135|NCT02717195|10048040|FG003|STARTED|Double-blind Treatment (DBT) Period||232
8985136|NCT02717195|10048041|FG004|STARTED|Double-blind Treatment (DBT) Period||230
8985137|NCT02717195|10048037|FG000|COMPLETED|Double-blind Treatment (DBT) Period||0
8985138|NCT02717195|10048038|FG001|COMPLETED|Double-blind Treatment (DBT) Period||0
8985139|NCT02717195|10048039|FG002|COMPLETED|Double-blind Treatment (DBT) Period||198
8985140|NCT02717195|10048040|FG003|COMPLETED|Double-blind Treatment (DBT) Period||188
8985141|NCT02717195|10048041|FG004|COMPLETED|Double-blind Treatment (DBT) Period||200
8985142|NCT02717195|10048037|FG000|NOT COMPLETED|Double-blind Treatment (DBT) Period||0
8985143|NCT02717195|10048038|FG001|NOT COMPLETED|Double-blind Treatment (DBT) Period||0
8985144|NCT02717195|10048039|FG002|NOT COMPLETED|Double-blind Treatment (DBT) Period||37
8985145|NCT02717195|10048040|FG003|NOT COMPLETED|Double-blind Treatment (DBT) Period||44
8985146|NCT02717195|10048041|FG004|NOT COMPLETED|Double-blind Treatment (DBT) Period||30
8985147|NCT02717273|10048056|FG000|STARTED|Overall Study||52
8985148|NCT02717273|10048057|FG001|STARTED|Overall Study||50
8877722|NCT01925209|9934727|FG000|NOT COMPLETED|Maintenance Treatment Epoch||0
8877723|NCT01925209|9934728|FG001|NOT COMPLETED|Maintenance Treatment Epoch||1
8877724|NCT01925209|9934729|FG002|NOT COMPLETED|Maintenance Treatment Epoch||2
8877725|NCT01925209|9934730|FG003|NOT COMPLETED|Maintenance Treatment Epoch||2
8877726|NCT01925209|9934727|FG000|STARTED|Follow-up||57
8877727|NCT01925209|9934728|FG001|STARTED|Follow-up||61
8985149|NCT02717273|10048056|FG000|COMPLETED|Overall Study||49
8985150|NCT02717273|10048057|FG001|COMPLETED|Overall Study||48
8985151|NCT02717273|10048056|FG000|NOT COMPLETED|Overall Study||3
8985152|NCT02717273|10048057|FG001|NOT COMPLETED|Overall Study||2
8985153|NCT02717494|10048066|FG000|STARTED|First Intervention (Step 1)||115
8985154|NCT02717494|10048067|FG001|STARTED|First Intervention (Step 1)||115
8985155|NCT02717494|10048068|FG002|STARTED|First Intervention (Step 1)||116
8985156|NCT02717494|10048066|FG000|Were Randomized to Step 2A (PPV-23)|First Intervention (Step 1)||0
8985157|NCT02717494|10048067|FG001|Were Randomized to Step 2A (PPV-23)|First Intervention (Step 1)||0
8985158|NCT02717494|10048068|FG002|Were Randomized to Step 2A (PPV-23)|First Intervention (Step 1)||53
8985159|NCT02717494|10048066|FG000|Were Randomized to Step 2B (PCV-10)|First Intervention (Step 1)||0
8877728|NCT01925209|9934729|FG002|STARTED|Follow-up||56
8877729|NCT01925209|9934730|FG003|STARTED|Follow-up||58
8877730|NCT01925209|9934727|FG000|COMPLETED|Follow-up||56
8877731|NCT01925209|9934728|FG001|COMPLETED|Follow-up||55
8877732|NCT01925209|9934729|FG002|COMPLETED|Follow-up||55
8985160|NCT02717494|10048067|FG001|Were Randomized to Step 2B (PCV-10)|First Intervention (Step 1)||0
8985161|NCT02717494|10048068|FG002|Were Randomized to Step 2B (PCV-10)|First Intervention (Step 1)||53
8985162|NCT02717494|10048066|FG000|Were Enrolled in Step 3 (PCV-10)|First Intervention (Step 1)||0
8985163|NCT02717494|10048067|FG001|Were Enrolled in Step 3 (PCV-10)|First Intervention (Step 1)||0
8985164|NCT02717494|10048068|FG002|Were Enrolled in Step 3 (PCV-10)|First Intervention (Step 1)||4
8985165|NCT02717494|10048066|FG000|COMPLETED|First Intervention (Step 1)||109
8985166|NCT02717494|10048067|FG001|COMPLETED|First Intervention (Step 1)||108
8985167|NCT02717494|10048068|FG002|COMPLETED|First Intervention (Step 1)||111
8985168|NCT02717494|10048066|FG000|NOT COMPLETED|First Intervention (Step 1)||6
8985169|NCT02717494|10048067|FG001|NOT COMPLETED|First Intervention (Step 1)||7
8985170|NCT02717494|10048068|FG002|NOT COMPLETED|First Intervention (Step 1)||5
8985171|NCT02717494|10048066|FG000|STARTED|Second Intervention (Step 2 or Step 3)|Only Step 1 placebo recipients were enrolled in Step 2.|0
8985172|NCT02717494|10048067|FG001|STARTED|Second Intervention (Step 2 or Step 3)|Only Step 1 placebo recipients were enrolled in Step 2.|0
8985173|NCT02717494|10048068|FG002|STARTED|Second Intervention (Step 2 or Step 3)|One participant who completed Step 1 did not enroll in Step 2.|110
8985174|NCT02717494|10048066|FG000|Completed Step 2A|Second Intervention (Step 2 or Step 3)||0
8985175|NCT02717494|10048067|FG001|Completed Step 2A|Second Intervention (Step 2 or Step 3)||0
8985176|NCT02717494|10048068|FG002|Completed Step 2A|Second Intervention (Step 2 or Step 3)||52
8985177|NCT02717494|10048066|FG000|Completed Step 2B|Second Intervention (Step 2 or Step 3)||0
8985178|NCT02717494|10048067|FG001|Completed Step 2B|Second Intervention (Step 2 or Step 3)||0
8985179|NCT02717494|10048068|FG002|Completed Step 2B|Second Intervention (Step 2 or Step 3)||50
8985180|NCT02717494|10048066|FG000|Completed Step 3|Second Intervention (Step 2 or Step 3)||0
8985181|NCT02717494|10048067|FG001|Completed Step 3|Second Intervention (Step 2 or Step 3)||0
8985182|NCT02717494|10048068|FG002|Completed Step 3|Second Intervention (Step 2 or Step 3)||4
8985183|NCT02717494|10048066|FG000|COMPLETED|Second Intervention (Step 2 or Step 3)||0
8985184|NCT02717494|10048067|FG001|COMPLETED|Second Intervention (Step 2 or Step 3)||0
8985185|NCT02717494|10048068|FG002|COMPLETED|Second Intervention (Step 2 or Step 3)||106
8985186|NCT02717494|10048066|FG000|NOT COMPLETED|Second Intervention (Step 2 or Step 3)||0
8985187|NCT02717494|10048067|FG001|NOT COMPLETED|Second Intervention (Step 2 or Step 3)||0
8985188|NCT02717494|10048068|FG002|NOT COMPLETED|Second Intervention (Step 2 or Step 3)||4
8985189|NCT02717546|10048094|FG000|STARTED|Overall Study||32
8985190|NCT02717546|10048094|FG000|COMPLETED|Overall Study||20
8632749|NCT00547248|9672753|FG000|STARTED|Overall Study||280
8632750|NCT00547248|9672754|FG001|STARTED|Overall Study||93
8632751|NCT00547248|9672755|FG002|STARTED|Overall Study||285
8632752|NCT00547248|9672756|FG003|STARTED|Overall Study||98
8632753|NCT00547248|9672753|FG000|COMPLETED|Overall Study||280
8632754|NCT00547248|9672754|FG001|COMPLETED|Overall Study||93
8632755|NCT00547248|9672755|FG002|COMPLETED|Overall Study||275
8985191|NCT02717546|10048094|FG000|NOT COMPLETED|Overall Study||12
8985192|NCT02717754|10048104|FG000|STARTED|Overall Study||10
8985193|NCT02717754|10048105|FG001|STARTED|Overall Study||19
8985194|NCT02717754|10048106|FG002|STARTED|Overall Study||20
8985195|NCT02717754|10048107|FG003|STARTED|Overall Study||10
8985196|NCT02717754|10048108|FG004|STARTED|Overall Study||20
8985197|NCT02717754|10048109|FG005|STARTED|Overall Study||20
8985198|NCT02717754|10048104|FG000|COMPLETED|Overall Study||10
8985199|NCT02717754|10048105|FG001|COMPLETED|Overall Study||19
8985200|NCT02717754|10048106|FG002|COMPLETED|Overall Study||20
8985201|NCT02717754|10048107|FG003|COMPLETED|Overall Study||0
8985202|NCT02717754|10048108|FG004|COMPLETED|Overall Study||0
8985203|NCT02717754|10048109|FG005|COMPLETED|Overall Study||0
8985204|NCT02717754|10048104|FG000|NOT COMPLETED|Overall Study||0
8985205|NCT02717754|10048105|FG001|NOT COMPLETED|Overall Study||0
8985206|NCT02717754|10048106|FG002|NOT COMPLETED|Overall Study||0
8985207|NCT02717754|10048107|FG003|NOT COMPLETED|Overall Study||10
8985208|NCT02717754|10048108|FG004|NOT COMPLETED|Overall Study||20
8985209|NCT02717754|10048109|FG005|NOT COMPLETED|Overall Study||20
8985210|NCT02718040|10048119|FG000|STARTED|Overall Study||30
8985211|NCT02718040|10048119|FG000|COMPLETED|Overall Study||30
8985212|NCT02718040|10048119|FG000|NOT COMPLETED|Overall Study||0
8985213|NCT02718118|10048125|FG000|STARTED|Overall Study||30
8985214|NCT02718118|10048126|FG001|STARTED|Overall Study||30
8985215|NCT02718118|10048125|FG000|COMPLETED|Overall Study||28
8985216|NCT02718118|10048126|FG001|COMPLETED|Overall Study||29
8985217|NCT02718118|10048125|FG000|NOT COMPLETED|Overall Study||2
8985218|NCT02718118|10048126|FG001|NOT COMPLETED|Overall Study||1
8985219|NCT02718131|10048134|FG000|STARTED|Overall Study||5
8985220|NCT02718131|10048135|FG001|STARTED|Overall Study||0
8985221|NCT02718131|10048134|FG000|Completed 12 Months|Overall Study||2
8985222|NCT02718131|10048135|FG001|Completed 12 Months|Overall Study||0
8985223|NCT02718131|10048134|FG000|COMPLETED|Overall Study||2
8985224|NCT02718131|10048135|FG001|COMPLETED|Overall Study||0
8985225|NCT02718131|10048134|FG000|NOT COMPLETED|Overall Study||3
8985226|NCT02718131|10048135|FG001|NOT COMPLETED|Overall Study||0
8985227|NCT02718157|10048143|FG000|STARTED|Overall Study||771
8985228|NCT02718157|10048143|FG000|COMPLETED|Overall Study||609
8985229|NCT02718157|10048143|FG000|NOT COMPLETED|Overall Study||162
8985230|NCT02718248|10048147|FG000|STARTED|Overall Study||7
8632756|NCT00547248|9672756|FG003|COMPLETED|Overall Study||96
8632757|NCT00547248|9672753|FG000|NOT COMPLETED|Overall Study||0
8632758|NCT00547248|9672754|FG001|NOT COMPLETED|Overall Study||0
8632759|NCT00547248|9672755|FG002|NOT COMPLETED|Overall Study||10
8985231|NCT02718248|10048147|FG000|COMPLETED|Overall Study||7
8985232|NCT02718248|10048147|FG000|NOT COMPLETED|Overall Study||0
8985233|NCT02718326|10048154|FG000|STARTED|Overall Study||133
8985234|NCT02718326|10048155|FG001|STARTED|Overall Study||135
8985235|NCT02718326|10048156|FG002|STARTED|Overall Study||134
8985236|NCT02718326|10048154|FG000|Completed Week 52|Overall Study||109
8985237|NCT02718326|10048155|FG001|Completed Week 52|Overall Study||122
8985238|NCT02718326|10048156|FG002|Completed Week 52|Overall Study||124
8985239|NCT02718326|10048154|FG000|COMPLETED|Overall Study||97
8985240|NCT02718326|10048155|FG001|COMPLETED|Overall Study||111
8985241|NCT02718326|10048156|FG002|COMPLETED|Overall Study||112
8985242|NCT02718326|10048154|FG000|NOT COMPLETED|Overall Study||36
8985243|NCT02718326|10048155|FG001|NOT COMPLETED|Overall Study||24
8985244|NCT02718326|10048156|FG002|NOT COMPLETED|Overall Study||22
8985245|NCT02718417|10048169|FG000|STARTED|Chemotherapy Phase (CP)||332
8985246|NCT02718417|10048170|FG001|STARTED|Chemotherapy Phase (CP)||331
8985247|NCT02718417|10048171|FG002|STARTED|Chemotherapy Phase (CP)||335
8985248|NCT02718417|10048169|FG000|Safety Population|Chemotherapy Phase (CP)||328
8985249|NCT02718417|10048170|FG001|Safety Population|Chemotherapy Phase (CP)||329
8985250|NCT02718417|10048171|FG002|Safety Population|Chemotherapy Phase (CP)||334
8985251|NCT02718417|10048169|FG000|COMPLETED|Chemotherapy Phase (CP)||280
8985252|NCT02718417|10048170|FG001|COMPLETED|Chemotherapy Phase (CP)||294
8985253|NCT02718417|10048171|FG002|COMPLETED|Chemotherapy Phase (CP)||289
8985254|NCT02718417|10048169|FG000|NOT COMPLETED|Chemotherapy Phase (CP)||52
8985255|NCT02718417|10048170|FG001|NOT COMPLETED|Chemotherapy Phase (CP)||37
8985256|NCT02718417|10048171|FG002|NOT COMPLETED|Chemotherapy Phase (CP)||46
8985257|NCT02718417|10048169|FG000|STARTED|Maintenance Phase (MP)|Included participants without evidence of disease progression at the end of Chemotherapy phase.|267
8985258|NCT02718417|10048170|FG001|STARTED|Maintenance Phase (MP)|Included participants without evidence of disease progression at the end of Chemotherapy phase.|288
8985259|NCT02718417|10048171|FG002|STARTED|Maintenance Phase (MP)|After completing CP, participants moved to observation phase. MP was not applicable for this arm.|0
8985260|NCT02718417|10048169|FG000|COMPLETED|Maintenance Phase (MP)||1
8985261|NCT02718417|10048170|FG001|COMPLETED|Maintenance Phase (MP)||1
8985262|NCT02718417|10048171|FG002|COMPLETED|Maintenance Phase (MP)||0
8985263|NCT02718417|10048169|FG000|NOT COMPLETED|Maintenance Phase (MP)||266
8985264|NCT02718417|10048170|FG001|NOT COMPLETED|Maintenance Phase (MP)||287
8985265|NCT02718417|10048171|FG002|NOT COMPLETED|Maintenance Phase (MP)||0
8985266|NCT02718417|10048169|FG000|STARTED|Observation Phase (OP)|After completing MP, participants moved to follow-up phase. OP was not applicable.|0
8985267|NCT02718417|10048170|FG001|STARTED|Observation Phase (OP)|After completing MP, participants moved to follow-up phase. OP was not applicable.|0
8985268|NCT02718417|10048171|FG002|STARTED|Observation Phase (OP)|Included participants without evidence of disease progression at the end of Chemotherapy phase.|284
8985269|NCT02718417|10048169|FG000|COMPLETED|Observation Phase (OP)||0
8985270|NCT02718417|10048170|FG001|COMPLETED|Observation Phase (OP)||0
8985271|NCT02718417|10048171|FG002|COMPLETED|Observation Phase (OP)||2
8985272|NCT02718417|10048169|FG000|NOT COMPLETED|Observation Phase (OP)||0
8985273|NCT02718417|10048170|FG001|NOT COMPLETED|Observation Phase (OP)||0
8985274|NCT02718417|10048171|FG002|NOT COMPLETED|Observation Phase (OP)||282
8985275|NCT02718417|10048169|FG000|STARTED|Follow-up Phase|Participants not completing MP could also start this phase.|238
8985276|NCT02718417|10048170|FG001|STARTED|Follow-up Phase|Participants not completing MP could also start this phase.|263
8985277|NCT02718417|10048171|FG002|STARTED|Follow-up Phase|Participants not completing OP could also start this phase.|39
8985278|NCT02718417|10048169|FG000|COMPLETED|Follow-up Phase||103
8985279|NCT02718417|10048170|FG001|COMPLETED|Follow-up Phase||91
8985280|NCT02718417|10048171|FG002|COMPLETED|Follow-up Phase||20
8985281|NCT02718417|10048169|FG000|NOT COMPLETED|Follow-up Phase||135
8985282|NCT02718417|10048170|FG001|NOT COMPLETED|Follow-up Phase||172
8985283|NCT02718417|10048171|FG002|NOT COMPLETED|Follow-up Phase||19
8985284|NCT02718417|10048169|FG000|STARTED|Long-term Follow-up Phase|Participants not completing follow-up phase could also start this phase.|139
8985285|NCT02718417|10048170|FG001|STARTED|Long-term Follow-up Phase|Participants not completing follow-up phase could also start this phase.|112
8985286|NCT02718417|10048171|FG002|STARTED|Long-term Follow-up Phase|Participants not completing follow-up could also start this phase.|135
8985287|NCT02718417|10048169|FG000|COMPLETED|Long-term Follow-up Phase||0
8985288|NCT02718417|10048170|FG001|COMPLETED|Long-term Follow-up Phase||0
8985289|NCT02718417|10048171|FG002|COMPLETED|Long-term Follow-up Phase||0
8985290|NCT02718417|10048169|FG000|NOT COMPLETED|Long-term Follow-up Phase||139
8985291|NCT02718417|10048170|FG001|NOT COMPLETED|Long-term Follow-up Phase||112
8985292|NCT02718417|10048171|FG002|NOT COMPLETED|Long-term Follow-up Phase||135
8985293|NCT02718625|10048188|FG000|STARTED|Overall Study||1
8985294|NCT02718625|10048189|FG001|STARTED|Overall Study||2
8985295|NCT02718625|10048188|FG000|COMPLETED|Overall Study||1
8985296|NCT02718625|10048189|FG001|COMPLETED|Overall Study||0
8985297|NCT02718625|10048188|FG000|NOT COMPLETED|Overall Study||0
8985298|NCT02718625|10048189|FG001|NOT COMPLETED|Overall Study||2
8985299|NCT02718898|10048197|FG000|STARTED|Blinded Treatment Period||74
8985300|NCT02718898|10048198|FG001|STARTED|Blinded Treatment Period||75
8985301|NCT02718898|10048199|FG002|STARTED|Blinded Treatment Period||0
8985302|NCT02718898|10048200|FG003|STARTED|Blinded Treatment Period||0
8985303|NCT02718898|10048201|FG004|STARTED|Blinded Treatment Period||0
8985304|NCT02718898|10048202|FG005|STARTED|Blinded Treatment Period||0
8985305|NCT02718898|10048203|FG006|STARTED|Blinded Treatment Period||0
8985306|NCT02718898|10048197|FG000|COMPLETED|Blinded Treatment Period||65
8985307|NCT02718898|10048198|FG001|COMPLETED|Blinded Treatment Period||74
8985308|NCT02718898|10048199|FG002|COMPLETED|Blinded Treatment Period||0
8985309|NCT02718898|10048200|FG003|COMPLETED|Blinded Treatment Period||0
8985310|NCT02718898|10048201|FG004|COMPLETED|Blinded Treatment Period||0
8985311|NCT02718898|10048202|FG005|COMPLETED|Blinded Treatment Period||0
8985312|NCT02718898|10048203|FG006|COMPLETED|Blinded Treatment Period||0
8985313|NCT02718898|10048197|FG000|NOT COMPLETED|Blinded Treatment Period||9
8985314|NCT02718898|10048198|FG001|NOT COMPLETED|Blinded Treatment Period||1
8985315|NCT02718898|10048199|FG002|NOT COMPLETED|Blinded Treatment Period||0
8985316|NCT02718898|10048200|FG003|NOT COMPLETED|Blinded Treatment Period||0
8985317|NCT02718898|10048201|FG004|NOT COMPLETED|Blinded Treatment Period||0
8985318|NCT02718898|10048202|FG005|NOT COMPLETED|Blinded Treatment Period||0
8985319|NCT02718898|10048203|FG006|NOT COMPLETED|Blinded Treatment Period||0
8985320|NCT02718898|10048197|FG000|STARTED|Open Label Treatment Period (OLTP)||0
8985321|NCT02718898|10048198|FG001|STARTED|Open Label Treatment Period (OLTP)||0
8985322|NCT02718898|10048199|FG002|STARTED|Open Label Treatment Period (OLTP)||65
8985323|NCT02718898|10048200|FG003|STARTED|Open Label Treatment Period (OLTP)||74
8985324|NCT02718898|10048201|FG004|STARTED|Open Label Treatment Period (OLTP)||0
8985325|NCT02718898|10048202|FG005|STARTED|Open Label Treatment Period (OLTP)||0
8985326|NCT02718898|10048203|FG006|STARTED|Open Label Treatment Period (OLTP)||0
8985327|NCT02718898|10048197|FG000|COMPLETED|Open Label Treatment Period (OLTP)||0
8985328|NCT02718898|10048198|FG001|COMPLETED|Open Label Treatment Period (OLTP)||0
8985329|NCT02718898|10048199|FG002|COMPLETED|Open Label Treatment Period (OLTP)||62
8985330|NCT02718898|10048200|FG003|COMPLETED|Open Label Treatment Period (OLTP)||64
8985331|NCT02718898|10048201|FG004|COMPLETED|Open Label Treatment Period (OLTP)||0
8985332|NCT02718898|10048202|FG005|COMPLETED|Open Label Treatment Period (OLTP)||0
8985333|NCT02718898|10048203|FG006|COMPLETED|Open Label Treatment Period (OLTP)||0
8985334|NCT02718898|10048197|FG000|NOT COMPLETED|Open Label Treatment Period (OLTP)||0
8985335|NCT02718898|10048198|FG001|NOT COMPLETED|Open Label Treatment Period (OLTP)||0
8985336|NCT02718898|10048199|FG002|NOT COMPLETED|Open Label Treatment Period (OLTP)||3
8985337|NCT02718898|10048200|FG003|NOT COMPLETED|Open Label Treatment Period (OLTP)||10
8985338|NCT02718898|10048201|FG004|NOT COMPLETED|Open Label Treatment Period (OLTP)||0
8985339|NCT02718898|10048202|FG005|NOT COMPLETED|Open Label Treatment Period (OLTP)||0
8985340|NCT02718898|10048203|FG006|NOT COMPLETED|Open Label Treatment Period (OLTP)||0
8985341|NCT02718898|10048197|FG000|STARTED|Post Treatment Follow-up Period||0
8985342|NCT02718898|10048198|FG001|STARTED|Post Treatment Follow-up Period||0
8985343|NCT02718898|10048199|FG002|STARTED|Post Treatment Follow-up Period||0
8985344|NCT02718898|10048200|FG003|STARTED|Post Treatment Follow-up Period||0
8985345|NCT02718898|10048201|FG004|STARTED|Post Treatment Follow-up Period|One participant who discontinued from placebo blinded treatment had entered post-treatment follow-up|1
8985346|NCT02718898|10048202|FG005|STARTED|Post Treatment Follow-up Period||78
8985347|NCT02718898|10048203|FG006|STARTED|Post Treatment Follow-up Period||49
8985348|NCT02718898|10048197|FG000|COMPLETED|Post Treatment Follow-up Period||0
8985349|NCT02718898|10048198|FG001|COMPLETED|Post Treatment Follow-up Period||0
8985350|NCT02718898|10048199|FG002|COMPLETED|Post Treatment Follow-up Period||0
8985351|NCT02718898|10048200|FG003|COMPLETED|Post Treatment Follow-up Period||0
8985352|NCT02718898|10048201|FG004|COMPLETED|Post Treatment Follow-up Period||0
8985353|NCT02718898|10048202|FG005|COMPLETED|Post Treatment Follow-up Period||67
8985354|NCT02718898|10048203|FG006|COMPLETED|Post Treatment Follow-up Period||44
8985355|NCT02718898|10048197|FG000|NOT COMPLETED|Post Treatment Follow-up Period||0
8985356|NCT02718898|10048198|FG001|NOT COMPLETED|Post Treatment Follow-up Period||0
8985357|NCT02718898|10048199|FG002|NOT COMPLETED|Post Treatment Follow-up Period||0
8985358|NCT02718898|10048200|FG003|NOT COMPLETED|Post Treatment Follow-up Period||0
8985359|NCT02718898|10048201|FG004|NOT COMPLETED|Post Treatment Follow-up Period||1
8985360|NCT02718898|10048202|FG005|NOT COMPLETED|Post Treatment Follow-up Period||11
8985361|NCT02718898|10048203|FG006|NOT COMPLETED|Post Treatment Follow-up Period||5
8985362|NCT02718963|10048218|FG000|STARTED|Overall Study||10
8985363|NCT02718963|10048219|FG001|STARTED|Overall Study||10
8985364|NCT02718963|10048218|FG000|COMPLETED|Overall Study||9
8985365|NCT02718963|10048219|FG001|COMPLETED|Overall Study||9
8985366|NCT02718963|10048218|FG000|NOT COMPLETED|Overall Study||1
8985367|NCT02718963|10048219|FG001|NOT COMPLETED|Overall Study||1
8985368|NCT02719028|10048229|FG000|STARTED|Overall Study||30
8985369|NCT02719028|10048230|FG001|STARTED|Overall Study||30
8985370|NCT02719028|10048231|FG002|STARTED|Overall Study||30
8985371|NCT02719028|10048232|FG003|STARTED|Overall Study||30
8985372|NCT02719028|10048229|FG000|COMPLETED|Overall Study||28
8985373|NCT02719028|10048230|FG001|COMPLETED|Overall Study||28
8985374|NCT02719028|10048231|FG002|COMPLETED|Overall Study||24
8985375|NCT02719028|10048232|FG003|COMPLETED|Overall Study||20
8985376|NCT02719028|10048229|FG000|NOT COMPLETED|Overall Study||2
8571624|NCT00111800|9603939|FG005|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||5
8985377|NCT02719028|10048230|FG001|NOT COMPLETED|Overall Study||2
8985378|NCT02719028|10048231|FG002|NOT COMPLETED|Overall Study||6
8985379|NCT02719028|10048232|FG003|NOT COMPLETED|Overall Study||10
8985380|NCT02719158|10048245|FG000|STARTED|Overall Study||38
8985381|NCT02719158|10048246|FG001|STARTED|Overall Study||38
8985382|NCT02719158|10048247|FG002|STARTED|Overall Study||19
8985383|NCT02719158|10048245|FG000|COMPLETED|Overall Study||38
8985384|NCT02719158|10048246|FG001|COMPLETED|Overall Study||38
8985385|NCT02719158|10048247|FG002|COMPLETED|Overall Study||18
8985386|NCT02719158|10048245|FG000|NOT COMPLETED|Overall Study||0
8985387|NCT02719158|10048246|FG001|NOT COMPLETED|Overall Study||0
8985388|NCT02719158|10048247|FG002|NOT COMPLETED|Overall Study||1
8985389|NCT02719171|10048260|FG000|STARTED|Overall Study||42
8632760|NCT00547248|9672756|FG003|NOT COMPLETED|Overall Study||2
8877733|NCT01925209|9934730|FG003|COMPLETED|Follow-up||54
8985390|NCT02719171|10048261|FG001|STARTED|Overall Study||42
8985391|NCT02719171|10048262|FG002|STARTED|Overall Study||42
8985392|NCT02719171|10048263|FG003|STARTED|Overall Study||39
8985393|NCT02719171|10048264|FG004|STARTED|Overall Study||20
8985394|NCT02719171|10048260|FG000|COMPLETED|Overall Study||41
8985395|NCT02719171|10048261|FG001|COMPLETED|Overall Study||38
8985396|NCT02719171|10048262|FG002|COMPLETED|Overall Study||39
8571625|NCT00111800|9603934|FG000|STARTED|Period 2: Extension Phase (12 Weeks)||48
8571626|NCT00111800|9603935|FG001|STARTED|Period 2: Extension Phase (12 Weeks)||47
8571627|NCT00111800|9603936|FG002|STARTED|Period 2: Extension Phase (12 Weeks)||54
8571628|NCT00111800|9603937|FG003|STARTED|Period 2: Extension Phase (12 Weeks)||59
8571629|NCT00111800|9603938|FG004|STARTED|Period 2: Extension Phase (12 Weeks)||55
8571630|NCT00111800|9603939|FG005|STARTED|Period 2: Extension Phase (12 Weeks)||55
8571631|NCT00111800|9603934|FG000|COMPLETED|Period 2: Extension Phase (12 Weeks)||46
8571632|NCT00111800|9603935|FG001|COMPLETED|Period 2: Extension Phase (12 Weeks)||40
8571633|NCT00111800|9603936|FG002|COMPLETED|Period 2: Extension Phase (12 Weeks)||47
8571634|NCT00111800|9603937|FG003|COMPLETED|Period 2: Extension Phase (12 Weeks)||54
8571635|NCT00111800|9603938|FG004|COMPLETED|Period 2: Extension Phase (12 Weeks)||51
8571636|NCT00111800|9603939|FG005|COMPLETED|Period 2: Extension Phase (12 Weeks)||53
8577904|NCT00165776|9610832|FG003|NOT COMPLETED|Overall Study||2
8632761|NCT00547365|9672769|FG000|STARTED|Overall Study||10
8632762|NCT00547365|9672769|FG000|COMPLETED|Overall Study||2
8632763|NCT00547365|9672769|FG000|NOT COMPLETED|Overall Study||8
8632764|NCT00547378|9672777|FG000|STARTED|Randomized Cohort||70
8632765|NCT00547378|9672778|FG001|STARTED|Randomized Cohort||77
8632766|NCT00547378|9672779|FG002|STARTED|Randomized Cohort||0
8632767|NCT00547378|9672777|FG000|Month 3|Randomized Cohort|This includes IST subjects reached Month 3 visit, regardless of implant or not.|62
8632768|NCT00547378|9672778|FG001|Month 3|Randomized Cohort|This included SMT subjects who reached SMT Month 3 visit.|72
8632769|NCT00547378|9672779|FG002|Month 3|Randomized Cohort||0
8632770|NCT00547378|9672777|FG000|Month 6|Randomized Cohort|This includes IST subjects reached Month 6 visit, regardless of implant or not.|59
8632771|NCT00547378|9672778|FG001|Month 6|Randomized Cohort|This included SMT subjects who reached SMT Month 6 visit.|71
8632772|NCT00547378|9672779|FG002|Month 6|Randomized Cohort||0
8632773|NCT00547378|9672777|FG000|COMPLETED|Randomized Cohort||59
8632774|NCT00547378|9672778|FG001|COMPLETED|Randomized Cohort||71
8632775|NCT00547378|9672779|FG002|COMPLETED|Randomized Cohort||0
8632776|NCT00547378|9672777|FG000|NOT COMPLETED|Randomized Cohort||11
8632777|NCT00547378|9672778|FG001|NOT COMPLETED|Randomized Cohort||6
8632778|NCT00547378|9672779|FG002|NOT COMPLETED|Randomized Cohort||0
8632779|NCT00547378|9672777|FG000|STARTED|All Implanted Cohort|This included subjects who received full system implant after randomized to IST.|51
8877734|NCT01925209|9934727|FG000|NOT COMPLETED|Follow-up||1
8877735|NCT01925209|9934728|FG001|NOT COMPLETED|Follow-up||6
8877736|NCT01925209|9934729|FG002|NOT COMPLETED|Follow-up||1
8877737|NCT01925209|9934730|FG003|NOT COMPLETED|Follow-up||4
8877738|NCT01925274|9934743|FG000|STARTED|Overall Study||7
8877739|NCT01925274|9934744|FG001|STARTED|Overall Study||6
8877740|NCT01925274|9934745|FG002|STARTED|Overall Study||6
8877741|NCT01925274|9934743|FG000|COMPLETED|Overall Study||0
8877742|NCT01925274|9934744|FG001|COMPLETED|Overall Study||0
8877743|NCT01925274|9934745|FG002|COMPLETED|Overall Study||0
8877744|NCT01925274|9934743|FG000|NOT COMPLETED|Overall Study||7
8877745|NCT01925274|9934744|FG001|NOT COMPLETED|Overall Study||6
8877746|NCT01925274|9934745|FG002|NOT COMPLETED|Overall Study||6
8877747|NCT01925339|9934757|FG000|STARTED|Overall Study||20
8877748|NCT01925339|9934758|FG001|STARTED|Overall Study||20
8877749|NCT01925339|9934757|FG000|COMPLETED|Overall Study||18
8877750|NCT01925339|9934758|FG001|COMPLETED|Overall Study||20
8877751|NCT01925339|9934757|FG000|NOT COMPLETED|Overall Study||2
8877752|NCT01925339|9934758|FG001|NOT COMPLETED|Overall Study||0
8877753|NCT01925404|9934768|FG000|STARTED|Overall Study|"The primary outcome of this study is at the level of a park.~The park is the unit of analysis. We did not recruit participants, but had measure of park use by counting observed users"|
8877754|NCT01925404|9934769|FG001|STARTED|Overall Study|The park is the unit of analysis. We did not recruit participants, but had measure of park use by counting observed users|
8985397|NCT02719171|10048263|FG003|COMPLETED|Overall Study||37
8985398|NCT02719171|10048264|FG004|COMPLETED|Overall Study||18
8985399|NCT02719171|10048260|FG000|NOT COMPLETED|Overall Study||1
8985400|NCT02719171|10048261|FG001|NOT COMPLETED|Overall Study||4
8985401|NCT02719171|10048262|FG002|NOT COMPLETED|Overall Study||3
8985402|NCT02719171|10048263|FG003|NOT COMPLETED|Overall Study||2
8985403|NCT02719171|10048264|FG004|NOT COMPLETED|Overall Study||2
8985404|NCT02719353|10048279|FG000|STARTED|First Intervention||7
8985405|NCT02719353|10048280|FG001|STARTED|First Intervention||7
8985406|NCT02719353|10048279|FG000|COMPLETED|First Intervention||7
8985407|NCT02719353|10048280|FG001|COMPLETED|First Intervention||6
8985408|NCT02719353|10048279|FG000|NOT COMPLETED|First Intervention||0
8985409|NCT02719353|10048280|FG001|NOT COMPLETED|First Intervention||1
8985410|NCT02719353|10048279|FG000|STARTED|Second Intervention||7
8985411|NCT02719353|10048280|FG001|STARTED|Second Intervention||6
8985412|NCT02719353|10048279|FG000|COMPLETED|Second Intervention||7
8985413|NCT02719353|10048280|FG001|COMPLETED|Second Intervention||6
8985414|NCT02719353|10048279|FG000|NOT COMPLETED|Second Intervention||0
8985415|NCT02719353|10048280|FG001|NOT COMPLETED|Second Intervention||0
8985416|NCT02719366|10048287|FG000|STARTED|First Intervention||6
8985417|NCT02719366|10048288|FG001|STARTED|First Intervention||6
8985418|NCT02719366|10048287|FG000|COMPLETED|First Intervention||6
8985419|NCT02719366|10048288|FG001|COMPLETED|First Intervention||6
8985420|NCT02719366|10048287|FG000|NOT COMPLETED|First Intervention||0
8985421|NCT02719366|10048288|FG001|NOT COMPLETED|First Intervention||0
8985422|NCT02719366|10048287|FG000|STARTED|Second Intervention||6
8985423|NCT02719366|10048288|FG001|STARTED|Second Intervention||6
8985424|NCT02719366|10048287|FG000|COMPLETED|Second Intervention||6
8985425|NCT02719366|10048288|FG001|COMPLETED|Second Intervention||6
8985426|NCT02719366|10048287|FG000|NOT COMPLETED|Second Intervention||0
8985427|NCT02719366|10048288|FG001|NOT COMPLETED|Second Intervention||0
8985428|NCT02719535|10048295|FG000|STARTED|Overall Study||59
8985429|NCT02719535|10048295|FG000|COMPLETED|Overall Study||37
8985430|NCT02719535|10048295|FG000|NOT COMPLETED|Overall Study||22
8985431|NCT02719639|10048299|FG000|STARTED|Overall Study||7443
8985432|NCT02719639|10048299|FG000|COMPLETED|Overall Study||7443
8985433|NCT02719639|10048299|FG000|NOT COMPLETED|Overall Study||0
8985434|NCT02719743|10048308|FG000|STARTED|Overall Study||38
8985435|NCT02719743|10048309|FG001|STARTED|Overall Study||37
8985436|NCT02719743|10048310|FG002|STARTED|Overall Study||38
8985437|NCT02719743|10048311|FG003|STARTED|Overall Study||37
8985438|NCT02719743|10048312|FG004|STARTED|Overall Study||35
8985439|NCT02719743|10048308|FG000|COMPLETED|Overall Study||37
8985440|NCT02719743|10048309|FG001|COMPLETED|Overall Study||34
8985441|NCT02719743|10048310|FG002|COMPLETED|Overall Study||38
8985442|NCT02719743|10048311|FG003|COMPLETED|Overall Study||36
8985443|NCT02719743|10048312|FG004|COMPLETED|Overall Study||33
8985444|NCT02719743|10048308|FG000|NOT COMPLETED|Overall Study||1
8985445|NCT02719743|10048309|FG001|NOT COMPLETED|Overall Study||3
8985446|NCT02719743|10048310|FG002|NOT COMPLETED|Overall Study||0
8985447|NCT02719743|10048311|FG003|NOT COMPLETED|Overall Study||1
8985448|NCT02719743|10048312|FG004|NOT COMPLETED|Overall Study||2
8985449|NCT02719938|10048326|FG000|STARTED|Overall Study||30
8985450|NCT02719938|10048327|FG001|STARTED|Overall Study||32
8985451|NCT02719938|10048326|FG000|COMPLETED|Overall Study||26
8985452|NCT02719938|10048327|FG001|COMPLETED|Overall Study||31
8985453|NCT02719938|10048326|FG000|NOT COMPLETED|Overall Study||4
8985454|NCT02719938|10048327|FG001|NOT COMPLETED|Overall Study||1
8985455|NCT02720042|10048333|FG000|STARTED|Overall Study||84
8985456|NCT02720042|10048333|FG000|COMPLETED|Overall Study||69
8985457|NCT02720042|10048333|FG000|NOT COMPLETED|Overall Study||15
8985458|NCT02720081|10048339|FG000|STARTED|Overall Study||72
8985459|NCT02720081|10048340|FG001|STARTED|Overall Study||70
8985460|NCT02720081|10048339|FG000|Treated|Overall Study||70
8985461|NCT02720081|10048340|FG001|Treated|Overall Study||69
8985462|NCT02720081|10048339|FG000|COMPLETED|Overall Study||68
8985463|NCT02720081|10048340|FG001|COMPLETED|Overall Study||66
8985464|NCT02720081|10048339|FG000|NOT COMPLETED|Overall Study||4
8985465|NCT02720081|10048340|FG001|NOT COMPLETED|Overall Study||4
8985466|NCT02720107|10048346|FG000|STARTED|Overall Study||130
8985467|NCT02720107|10048346|FG000|COMPLETED|Overall Study||130
8985468|NCT02720107|10048346|FG000|NOT COMPLETED|Overall Study||0
8693637|NCT00867659|9739178|FG000|NOT COMPLETED|Overall Study||0
8985469|NCT02720198|10048352|FG000|STARTED|Overall Study||29
8985470|NCT02720198|10048353|FG001|STARTED|Overall Study||31
8985471|NCT02720198|10048352|FG000|COMPLETED|Overall Study||29
8985472|NCT02720198|10048353|FG001|COMPLETED|Overall Study||30
8985473|NCT02720198|10048352|FG000|NOT COMPLETED|Overall Study||0
8985474|NCT02720198|10048353|FG001|NOT COMPLETED|Overall Study||1
8985475|NCT02720224|10048359|FG000|STARTED|Overall Study||6
8985476|NCT02720224|10048359|FG000|COMPLETED|Overall Study||6
8985477|NCT02720224|10048359|FG000|NOT COMPLETED|Overall Study||0
8985478|NCT02720484|10048363|FG000|STARTED|Treatment on Study||10
8985479|NCT02720484|10048363|FG000|Reached 1st Response/2 Cycles|Treatment on Study||7
8985480|NCT02720484|10048363|FG000|Treated Cycle 3|Treatment on Study||4
8985481|NCT02720484|10048363|FG000|COMPLETED|Treatment on Study||4
8985482|NCT02720484|10048363|FG000|NOT COMPLETED|Treatment on Study||6
8985483|NCT02720484|10048363|FG000|STARTED|Follow Up for 2 Years|All patients that receive at least one treatment on study go into follow up.|7
8985484|NCT02720484|10048363|FG000|COMPLETED|Follow Up for 2 Years||1
8985485|NCT02720484|10048363|FG000|NOT COMPLETED|Follow Up for 2 Years||6
8985486|NCT02720523|10048371|FG000|STARTED|Period 1: Placebo-controlled Period||49
8985487|NCT02720523|10048372|FG001|STARTED|Period 1: Placebo-controlled Period||49
8985488|NCT02720523|10048373|FG002|STARTED|Period 1: Placebo-controlled Period||49
8985489|NCT02720523|10048374|FG003|STARTED|Period 1: Placebo-controlled Period||50
8985490|NCT02720523|10048375|FG004|STARTED|Period 1: Placebo-controlled Period||0
8985491|NCT02720523|10048376|FG005|STARTED|Period 1: Placebo-controlled Period||0
8985492|NCT02720523|10048377|FG006|STARTED|Period 1: Placebo-controlled Period||0
8985493|NCT02720523|10048371|FG000|COMPLETED|Period 1: Placebo-controlled Period||47
8985494|NCT02720523|10048372|FG001|COMPLETED|Period 1: Placebo-controlled Period||49
8985495|NCT02720523|10048373|FG002|COMPLETED|Period 1: Placebo-controlled Period||47
8985496|NCT02720523|10048374|FG003|COMPLETED|Period 1: Placebo-controlled Period||44
8985497|NCT02720523|10048375|FG004|COMPLETED|Period 1: Placebo-controlled Period||0
8985498|NCT02720523|10048376|FG005|COMPLETED|Period 1: Placebo-controlled Period||0
8985499|NCT02720523|10048377|FG006|COMPLETED|Period 1: Placebo-controlled Period||0
8985500|NCT02720523|10048371|FG000|NOT COMPLETED|Period 1: Placebo-controlled Period||2
8985501|NCT02720523|10048372|FG001|NOT COMPLETED|Period 1: Placebo-controlled Period||0
8985502|NCT02720523|10048373|FG002|NOT COMPLETED|Period 1: Placebo-controlled Period||2
8985503|NCT02720523|10048374|FG003|NOT COMPLETED|Period 1: Placebo-controlled Period||6
8985504|NCT02720523|10048375|FG004|NOT COMPLETED|Period 1: Placebo-controlled Period||0
8985505|NCT02720523|10048376|FG005|NOT COMPLETED|Period 1: Placebo-controlled Period||0
8985506|NCT02720523|10048377|FG006|NOT COMPLETED|Period 1: Placebo-controlled Period||0
8985507|NCT02720523|10048371|FG000|STARTED|Period 2: Long-term Extension Period||0
8985508|NCT02720523|10048372|FG001|STARTED|Period 2: Long-term Extension Period||0
8985509|NCT02720523|10048373|FG002|STARTED|Period 2: Long-term Extension Period||0
8985510|NCT02720523|10048374|FG003|STARTED|Period 2: Long-term Extension Period||0
8985511|NCT02720523|10048375|FG004|STARTED|Period 2: Long-term Extension Period|Includes participants originally randomized to placebo and upadacitinib 7.5 mg|65
8985512|NCT02720523|10048376|FG005|STARTED|Period 2: Long-term Extension Period|Includes participants originally randomized to placebo and upadacitinib 15 mg|62
8985513|NCT02720523|10048377|FG006|STARTED|Period 2: Long-term Extension Period|Includes participants originally randomized to placebo and upadacitinib 30 mg|60
8985514|NCT02720523|10048371|FG000|COMPLETED|Period 2: Long-term Extension Period||0
8985515|NCT02720523|10048372|FG001|COMPLETED|Period 2: Long-term Extension Period||0
8985516|NCT02720523|10048373|FG002|COMPLETED|Period 2: Long-term Extension Period||0
8985517|NCT02720523|10048374|FG003|COMPLETED|Period 2: Long-term Extension Period||0
8985518|NCT02720523|10048375|FG004|COMPLETED|Period 2: Long-term Extension Period||0
8985519|NCT02720523|10048376|FG005|COMPLETED|Period 2: Long-term Extension Period||0
8985520|NCT02720523|10048377|FG006|COMPLETED|Period 2: Long-term Extension Period||0
8985521|NCT02720523|10048371|FG000|NOT COMPLETED|Period 2: Long-term Extension Period||0
8985522|NCT02720523|10048372|FG001|NOT COMPLETED|Period 2: Long-term Extension Period||0
8985523|NCT02720523|10048373|FG002|NOT COMPLETED|Period 2: Long-term Extension Period||0
8985524|NCT02720523|10048374|FG003|NOT COMPLETED|Period 2: Long-term Extension Period||0
8985525|NCT02720523|10048375|FG004|NOT COMPLETED|Period 2: Long-term Extension Period||65
8985526|NCT02720523|10048376|FG005|NOT COMPLETED|Period 2: Long-term Extension Period||62
8985527|NCT02720523|10048377|FG006|NOT COMPLETED|Period 2: Long-term Extension Period||60
8985528|NCT02720536|10048390|FG000|STARTED|Overall Study||53
8985529|NCT02720536|10048390|FG000|COMPLETED|Overall Study||34
8985530|NCT02720536|10048390|FG000|NOT COMPLETED|Overall Study||19
8985531|NCT02720627|10048400|FG000|STARTED|Overall Study||27
8985532|NCT02720627|10048400|FG000|COMPLETED|Overall Study||27
8985533|NCT02720627|10048400|FG000|NOT COMPLETED|Overall Study||0
8985534|NCT02720757|10048404|FG000|STARTED|Overall Study||132
8985535|NCT02720757|10048404|FG000|COMPLETED|Overall Study||114
8985536|NCT02720757|10048404|FG000|NOT COMPLETED|Overall Study||18
8985537|NCT02721017|10048410|FG000|STARTED|Hospital Stay|Intraoperative Application of Cryoanalgesia started on Date of Surgery (DOS).|10
8985538|NCT02721017|10048411|FG001|STARTED|Hospital Stay|Thoracic Epidural placed on Date of Surgery (DOS).|10
8985539|NCT02721017|10048410|FG000|COMPLETED|Hospital Stay|Completed during the course of surgery.|10
8985540|NCT02721017|10048411|FG001|COMPLETED|Hospital Stay|Removal occurs prior to Hospital Discharge.|10
8985541|NCT02721017|10048410|FG000|NOT COMPLETED|Hospital Stay||0
8985542|NCT02721017|10048411|FG001|NOT COMPLETED|Hospital Stay||0
8985543|NCT02721017|10048410|FG000|STARTED|Participant Follow Up|Assessment of recovery at 2 weeks, 1 month, 3 month and 12 month intervals.|10
8985544|NCT02721017|10048411|FG001|STARTED|Participant Follow Up|Assessment of recovery at 2 weeks, 1 month, 3 month and 12 month intervals.|10
8985545|NCT02721017|10048410|FG000|COMPLETED|Participant Follow Up|12 months after Date of Surgery.|10
8985546|NCT02721017|10048411|FG001|COMPLETED|Participant Follow Up|12 months after Date of Surgery.|10
8985547|NCT02721017|10048410|FG000|NOT COMPLETED|Participant Follow Up||0
8985548|NCT02721017|10048411|FG001|NOT COMPLETED|Participant Follow Up||0
8985549|NCT02721147|10048422|FG000|STARTED|Overall Study||40
8985550|NCT02721147|10048423|FG001|STARTED|Overall Study||18
8632780|NCT00547378|9672778|FG001|STARTED|All Implanted Cohort|This included SMT subjects who received full system implant after completing randomization period.|40
8632781|NCT00547378|9672779|FG002|STARTED|All Implanted Cohort|This included subjects who received full system implant from non-randomized subjects.|181
8632782|NCT00547378|9672777|FG000|Month 3|All Implanted Cohort||51
8632783|NCT00547378|9672778|FG001|Month 3|All Implanted Cohort||39
8632784|NCT00547378|9672779|FG002|Month 3|All Implanted Cohort||178
8985551|NCT02721147|10048424|FG002|STARTED|Overall Study||31
8985552|NCT02721147|10048422|FG000|COMPLETED|Overall Study||38
8985553|NCT02721147|10048423|FG001|COMPLETED|Overall Study||18
8985554|NCT02721147|10048424|FG002|COMPLETED|Overall Study||31
8985555|NCT02721147|10048422|FG000|NOT COMPLETED|Overall Study||2
8985556|NCT02721147|10048423|FG001|NOT COMPLETED|Overall Study||0
8985557|NCT02721147|10048424|FG002|NOT COMPLETED|Overall Study||0
8985558|NCT02721251|10048435|FG000|STARTED|Overall Study||14
8985559|NCT02721251|10048436|FG001|STARTED|Overall Study||16
8985560|NCT02721251|10048437|FG002|STARTED|Overall Study||17
8985561|NCT02721251|10048435|FG000|COMPLETED|Overall Study||4
8985562|NCT02721251|10048436|FG001|COMPLETED|Overall Study||7
8985563|NCT02721251|10048437|FG002|COMPLETED|Overall Study||6
8985564|NCT02721251|10048435|FG000|NOT COMPLETED|Overall Study||10
8632785|NCT00547378|9672777|FG000|Month 6|All Implanted Cohort||50
8877755|NCT01925404|9934770|FG002|STARTED|Overall Study|The park is the unit of analysis. We did not recruit participants, but had measure of park use by counting observed users|
8985565|NCT02721251|10048436|FG001|NOT COMPLETED|Overall Study||9
8985566|NCT02721251|10048437|FG002|NOT COMPLETED|Overall Study||11
8985567|NCT02721355|10048448|FG000|STARTED|Overall Study||42
8985568|NCT02721355|10048449|FG001|STARTED|Overall Study||42
8985569|NCT02721355|10048448|FG000|COMPLETED|Overall Study||36
8985570|NCT02721355|10048449|FG001|COMPLETED|Overall Study||41
8985571|NCT02721355|10048448|FG000|NOT COMPLETED|Overall Study||6
8985572|NCT02721355|10048449|FG001|NOT COMPLETED|Overall Study||1
8985573|NCT02721641|10048455|FG000|STARTED|Overall Study||69
8985574|NCT02721641|10048455|FG000|COMPLETED|Overall Study|In this continued access study, all participants were considered to have completed per protocol.|69
8985575|NCT02721641|10048455|FG000|NOT COMPLETED|Overall Study||0
9038756|NCT03334396|10099931|FG005|Received at Least One Dose of Study Drug|Overall Study||5
9038757|NCT03334396|10099932|FG006|Received at Least One Dose of Study Drug|Overall Study||8
9038758|NCT03334396|10099933|FG007|Received at Least One Dose of Study Drug|Overall Study||8
9038759|NCT03334396|10099926|FG000|COMPLETED|Overall Study||226
9038760|NCT03334396|10099927|FG001|COMPLETED|Overall Study||116
9038761|NCT03334396|10099928|FG002|COMPLETED|Overall Study||113
9038762|NCT03334396|10099929|FG003|COMPLETED|Overall Study||120
9038763|NCT03334396|10099930|FG004|COMPLETED|Overall Study||12
9038764|NCT03334396|10099931|FG005|COMPLETED|Overall Study||4
9038765|NCT03334396|10099932|FG006|COMPLETED|Overall Study||5
9038766|NCT03334396|10099933|FG007|COMPLETED|Overall Study||7
9038767|NCT03334396|10099926|FG000|NOT COMPLETED|Overall Study||23
9038768|NCT03334396|10099927|FG001|NOT COMPLETED|Overall Study||11
9038769|NCT03334396|10099928|FG002|NOT COMPLETED|Overall Study||10
9038770|NCT03334396|10099929|FG003|NOT COMPLETED|Overall Study||5
9038771|NCT03334396|10099930|FG004|NOT COMPLETED|Overall Study||3
9038772|NCT03334396|10099931|FG005|NOT COMPLETED|Overall Study||1
8632786|NCT00547378|9672778|FG001|Month 6|All Implanted Cohort||36
8632787|NCT00547378|9672779|FG002|Month 6|All Implanted Cohort||178
8632788|NCT00547378|9672777|FG000|Month 12|All Implanted Cohort||48
8632789|NCT00547378|9672778|FG001|Month 12|All Implanted Cohort||32
8632790|NCT00547378|9672779|FG002|Month 12|All Implanted Cohort||175
8877756|NCT01925404|9934771|FG003|STARTED|Overall Study|The park is the unit of analysis. We did not recruit participants, but had measure of park use by counting observed users|
8877757|NCT01925404|9934768|FG000|COMPLETED|Overall Study|We did not recruit participants or follow the same park users over time. The follow up numbers of users are greater than at baseline, and this generates an error message.|
9038773|NCT03334396|10099932|FG006|NOT COMPLETED|Overall Study||3
8985576|NCT02721875|10048461|FG000|STARTED|Overall Study||1
8985577|NCT02721875|10048462|FG001|STARTED|Overall Study||0
8985578|NCT02721875|10048461|FG000|COMPLETED|Overall Study||0
8985579|NCT02721875|10048462|FG001|COMPLETED|Overall Study||0
8985580|NCT02721875|10048461|FG000|NOT COMPLETED|Overall Study||1
8985581|NCT02721875|10048462|FG001|NOT COMPLETED|Overall Study||0
8985582|NCT02721966|10048471|FG000|STARTED|Overall Study||167
8985583|NCT02721966|10048472|FG001|STARTED|Overall Study||165
8985584|NCT02721966|10048473|FG002|STARTED|Overall Study||81
8985585|NCT02721966|10048474|FG003|STARTED|Overall Study||80
8985586|NCT02721966|10048475|FG004|STARTED|Overall Study||5
8985587|NCT02721966|10048471|FG000|Completed Period 1 & Went to Period 2|Overall Study||162
8985588|NCT02721966|10048472|FG001|Completed Period 1 & Went to Period 2|Overall Study||153
8985589|NCT02721966|10048473|FG002|Completed Period 1 & Went to Period 2|Overall Study||81
8985590|NCT02721966|10048474|FG003|Completed Period 1 & Went to Period 2|Overall Study||80
8985591|NCT02721966|10048475|FG004|Completed Period 1 & Went to Period 2|Overall Study||0
8985592|NCT02721966|10048471|FG000|COMPLETED|Overall Study||138
8985593|NCT02721966|10048472|FG001|COMPLETED|Overall Study||142
8985594|NCT02721966|10048473|FG002|COMPLETED|Overall Study||72
8985595|NCT02721966|10048474|FG003|COMPLETED|Overall Study||73
8985596|NCT02721966|10048475|FG004|COMPLETED|Overall Study||0
8985597|NCT02721966|10048471|FG000|NOT COMPLETED|Overall Study||29
8985598|NCT02721966|10048472|FG001|NOT COMPLETED|Overall Study||23
8985599|NCT02721966|10048473|FG002|NOT COMPLETED|Overall Study||9
8985600|NCT02721966|10048474|FG003|NOT COMPLETED|Overall Study||7
8985601|NCT02721966|10048475|FG004|NOT COMPLETED|Overall Study||5
8985602|NCT02722044|10048483|FG000|STARTED|Overall Study||33
8985603|NCT02722044|10048483|FG000|COMPLETED|Overall Study||28
8985604|NCT02722044|10048483|FG000|NOT COMPLETED|Overall Study||5
8985605|NCT02722148|10048488|FG000|STARTED|Overall Study||24
8985606|NCT02722148|10048488|FG000|COMPLETED|Overall Study||19
8985607|NCT02722148|10048488|FG000|NOT COMPLETED|Overall Study||5
8985608|NCT02722239|10048494|FG000|STARTED|Overall Study||20
8985609|NCT02722239|10048495|FG001|STARTED|Overall Study||20
8985610|NCT02722239|10048494|FG000|First Intervention (1 Day)|Overall Study||20
8985611|NCT02722239|10048495|FG001|First Intervention (1 Day)|Overall Study||20
8985612|NCT02722239|10048494|FG000|Washout (7 Days)|Overall Study||20
8985613|NCT02722239|10048495|FG001|Washout (7 Days)|Overall Study||20
8985614|NCT02722239|10048494|FG000|Second Intervention (1 Day)|Overall Study||20
8985615|NCT02722239|10048495|FG001|Second Intervention (1 Day)|Overall Study||20
8632791|NCT00547378|9672777|FG000|Month 24|All Implanted Cohort||42
8632792|NCT00547378|9672778|FG001|Month 24|All Implanted Cohort||30
8632793|NCT00547378|9672779|FG002|Month 24|All Implanted Cohort||161
8985616|NCT02722239|10048494|FG000|COMPLETED|Overall Study||20
8985617|NCT02722239|10048495|FG001|COMPLETED|Overall Study||20
8985618|NCT02722239|10048494|FG000|NOT COMPLETED|Overall Study||0
8985619|NCT02722239|10048495|FG001|NOT COMPLETED|Overall Study||0
8985620|NCT02722278|10048504|FG000|STARTED|Overall Study||166
8985621|NCT02722278|10048505|FG001|STARTED|Overall Study||56
8985622|NCT02722278|10048504|FG000|COMPLETED|Overall Study||154
8985623|NCT02722278|10048505|FG001|COMPLETED|Overall Study||49
8985624|NCT02722278|10048504|FG000|NOT COMPLETED|Overall Study||12
8985625|NCT02722278|10048505|FG001|NOT COMPLETED|Overall Study||7
8985626|NCT02722304|10048518|FG000|STARTED|Overall Study||1
8985627|NCT02722304|10048519|FG001|STARTED|Overall Study||0
8985628|NCT02722304|10048520|FG002|STARTED|Overall Study||2
8985629|NCT02722304|10048521|FG003|STARTED|Overall Study||2
8985630|NCT02722304|10048522|FG004|STARTED|Overall Study||2
8985631|NCT02722304|10048518|FG000|Treated|Overall Study||1
8985632|NCT02722304|10048519|FG001|Treated|Overall Study||0
8985633|NCT02722304|10048520|FG002|Treated|Overall Study||1
8985634|NCT02722304|10048521|FG003|Treated|Overall Study||1
8985635|NCT02722304|10048522|FG004|Treated|Overall Study||2
8985636|NCT02722304|10048518|FG000|COMPLETED|Overall Study||0
8985637|NCT02722304|10048519|FG001|COMPLETED|Overall Study||0
8985638|NCT02722304|10048520|FG002|COMPLETED|Overall Study||0
8985639|NCT02722304|10048521|FG003|COMPLETED|Overall Study||0
8632794|NCT00547378|9672777|FG000|Month 36|All Implanted Cohort||42
8877758|NCT01925404|9934769|FG001|COMPLETED|Overall Study|We did not recruit participants or follow the same park users over time. The follow up numbers of users are greater than at baseline, and this generates an error message.|
8877759|NCT01925404|9934770|FG002|COMPLETED|Overall Study|We did not recruit participants or follow the same park users over time. The follow up numbers of users are greater than at baseline, and this generates an error message.|
8877760|NCT01925404|9934771|FG003|COMPLETED|Overall Study|We did not recruit participants or follow the same park users over time. The follow up numbers of users are greater than at baseline, and this generates an error message.|
8877761|NCT01925404|9934768|FG000|NOT COMPLETED|Overall Study||
8877762|NCT01925404|9934769|FG001|NOT COMPLETED|Overall Study||
8877763|NCT01925404|9934770|FG002|NOT COMPLETED|Overall Study||
8985640|NCT02722304|10048522|FG004|COMPLETED|Overall Study||0
8985641|NCT02722304|10048518|FG000|NOT COMPLETED|Overall Study||1
8985642|NCT02722304|10048519|FG001|NOT COMPLETED|Overall Study||0
8985643|NCT02722304|10048520|FG002|NOT COMPLETED|Overall Study||2
8985644|NCT02722304|10048521|FG003|NOT COMPLETED|Overall Study||2
8985645|NCT02722304|10048522|FG004|NOT COMPLETED|Overall Study||2
8985646|NCT02722330|10048536|FG000|STARTED|Overall Study||23
8985647|NCT02722330|10048536|FG000|COMPLETED|Overall Study||23
8985648|NCT02722330|10048536|FG000|NOT COMPLETED|Overall Study||0
8985649|NCT02722408|10048540|FG000|STARTED|Overall Study||8
8985650|NCT02722408|10048540|FG000|COMPLETED|Overall Study||8
8985651|NCT02722408|10048540|FG000|NOT COMPLETED|Overall Study||0
8985652|NCT02722499|10048549|FG000|STARTED|Overall Study||20
8985653|NCT02722499|10048550|FG001|STARTED|Overall Study||20
8985654|NCT02722499|10048551|FG002|STARTED|Overall Study||20
8985655|NCT02722499|10048549|FG000|COMPLETED|Overall Study||18
8985656|NCT02722499|10048550|FG001|COMPLETED|Overall Study||20
8985657|NCT02722499|10048551|FG002|COMPLETED|Overall Study||19
8985658|NCT02722499|10048549|FG000|NOT COMPLETED|Overall Study||2
8985659|NCT02722499|10048550|FG001|NOT COMPLETED|Overall Study||0
8985660|NCT02722499|10048551|FG002|NOT COMPLETED|Overall Study||1
8985661|NCT02722564|10048559|FG000|STARTED|Overall Study||55
8985662|NCT02722564|10048559|FG000|COMPLETED|Overall Study||55
8985663|NCT02722564|10048559|FG000|NOT COMPLETED|Overall Study||0
8985664|NCT02722577|10048563|FG000|STARTED|Overall Study||20
8985665|NCT02722577|10048563|FG000|COMPLETED|Overall Study||20
8985666|NCT02722577|10048563|FG000|NOT COMPLETED|Overall Study||0
8985667|NCT02722837|10048567|FG000|STARTED|Overall Study||119
8985668|NCT02722837|10048567|FG000|COMPLETED|Overall Study||119
8985669|NCT02722837|10048567|FG000|NOT COMPLETED|Overall Study||0
8985670|NCT02722863|10048571|FG000|STARTED|Overall Study||908
8985671|NCT02722863|10048571|FG000|COMPLETED|Overall Study||908
8985672|NCT02722863|10048571|FG000|NOT COMPLETED|Overall Study||0
8985673|NCT02722928|10048578|FG000|STARTED|Overall Study||49
8985674|NCT02722928|10048579|FG001|STARTED|Overall Study||51
8985675|NCT02722928|10048578|FG000|COMPLETED|Overall Study||39
8985676|NCT02722928|10048579|FG001|COMPLETED|Overall Study||31
8985677|NCT02722928|10048578|FG000|NOT COMPLETED|Overall Study||10
8985678|NCT02722928|10048579|FG001|NOT COMPLETED|Overall Study||20
8985679|NCT02722967|10048592|FG000|STARTED|Overall Study||22
8985680|NCT02722967|10048593|FG001|STARTED|Overall Study||12
8985681|NCT02722967|10048594|FG002|STARTED|Overall Study||15
8985682|NCT02722967|10048592|FG000|COMPLETED|Overall Study||17
8985683|NCT02722967|10048593|FG001|COMPLETED|Overall Study||10
8985684|NCT02722967|10048594|FG002|COMPLETED|Overall Study||11
8985685|NCT02722967|10048592|FG000|NOT COMPLETED|Overall Study||5
8985686|NCT02722967|10048593|FG001|NOT COMPLETED|Overall Study||2
8985687|NCT02722967|10048594|FG002|NOT COMPLETED|Overall Study||4
8985688|NCT02723006|10048605|FG000|STARTED|Overall Study||1
8985689|NCT02723006|10048606|FG001|STARTED|Overall Study||9
8985690|NCT02723006|10048607|FG002|STARTED|Overall Study||12
8985691|NCT02723006|10048605|FG000|COMPLETED|Overall Study||0
8985692|NCT02723006|10048606|FG001|COMPLETED|Overall Study||2
8985693|NCT02723006|10048607|FG002|COMPLETED|Overall Study||5
8985694|NCT02723006|10048605|FG000|NOT COMPLETED|Overall Study||1
8985695|NCT02723006|10048606|FG001|NOT COMPLETED|Overall Study||7
8985696|NCT02723006|10048607|FG002|NOT COMPLETED|Overall Study||7
8985697|NCT02723084|10048617|FG000|STARTED|Overall Study||90
8985698|NCT02723084|10048618|FG001|STARTED|Overall Study||46
8985699|NCT02723084|10048617|FG000|COMPLETED|Overall Study||86
8985700|NCT02723084|10048618|FG001|COMPLETED|Overall Study||45
8985701|NCT02723084|10048617|FG000|NOT COMPLETED|Overall Study||4
8985702|NCT02723084|10048618|FG001|NOT COMPLETED|Overall Study||1
8985703|NCT02723175|10048626|FG000|STARTED|Overall Study||8
8985704|NCT02723175|10048627|FG001|STARTED|Overall Study||7
8985705|NCT02723175|10048626|FG000|COMPLETED|Overall Study||4
8985706|NCT02723175|10048627|FG001|COMPLETED|Overall Study||4
8985707|NCT02723175|10048626|FG000|NOT COMPLETED|Overall Study||4
8985708|NCT02723175|10048627|FG001|NOT COMPLETED|Overall Study||3
8985709|NCT02723188|10048636|FG000|STARTED|Overall Study||15
8985710|NCT02723188|10048637|FG001|STARTED|Overall Study||15
8985711|NCT02723188|10048638|FG002|STARTED|Overall Study||15
8985712|NCT02723188|10048636|FG000|COMPLETED|Overall Study||14
8985713|NCT02723188|10048637|FG001|COMPLETED|Overall Study||15
8985714|NCT02723188|10048638|FG002|COMPLETED|Overall Study||15
8985715|NCT02723188|10048636|FG000|NOT COMPLETED|Overall Study||1
8985716|NCT02723188|10048637|FG001|NOT COMPLETED|Overall Study||0
8985717|NCT02723188|10048638|FG002|NOT COMPLETED|Overall Study||0
8985718|NCT02723201|10048649|FG000|STARTED|First Intervention Period||11
8985719|NCT02723201|10048650|FG001|STARTED|First Intervention Period||7
8985720|NCT02723201|10048651|FG002|STARTED|First Intervention Period||7
8985721|NCT02723201|10048649|FG000|COMPLETED|First Intervention Period||11
8985722|NCT02723201|10048650|FG001|COMPLETED|First Intervention Period||7
8985723|NCT02723201|10048651|FG002|COMPLETED|First Intervention Period||7
8985724|NCT02723201|10048649|FG000|NOT COMPLETED|First Intervention Period||0
8985725|NCT02723201|10048650|FG001|NOT COMPLETED|First Intervention Period||0
8985726|NCT02723201|10048651|FG002|NOT COMPLETED|First Intervention Period||0
8985727|NCT02723201|10048649|FG000|STARTED|Washout Period 1||11
8985728|NCT02723201|10048650|FG001|STARTED|Washout Period 1||7
8985729|NCT02723201|10048651|FG002|STARTED|Washout Period 1||7
8985730|NCT02723201|10048649|FG000|COMPLETED|Washout Period 1||11
8985731|NCT02723201|10048650|FG001|COMPLETED|Washout Period 1||7
8985732|NCT02723201|10048651|FG002|COMPLETED|Washout Period 1||7
8985733|NCT02723201|10048649|FG000|NOT COMPLETED|Washout Period 1||0
8985734|NCT02723201|10048650|FG001|NOT COMPLETED|Washout Period 1||0
8985735|NCT02723201|10048651|FG002|NOT COMPLETED|Washout Period 1||0
8985736|NCT02723201|10048649|FG000|STARTED|Second Intervention Period||11
8985737|NCT02723201|10048650|FG001|STARTED|Second Intervention Period||7
8985738|NCT02723201|10048651|FG002|STARTED|Second Intervention Period||7
8985739|NCT02723201|10048649|FG000|COMPLETED|Second Intervention Period||9
8985740|NCT02723201|10048650|FG001|COMPLETED|Second Intervention Period||7
8985741|NCT02723201|10048651|FG002|COMPLETED|Second Intervention Period||7
8985742|NCT02723201|10048649|FG000|NOT COMPLETED|Second Intervention Period||2
8985743|NCT02723201|10048650|FG001|NOT COMPLETED|Second Intervention Period||0
8985744|NCT02723201|10048651|FG002|NOT COMPLETED|Second Intervention Period||0
8985745|NCT02723201|10048649|FG000|STARTED|Washout Period 2||9
8985746|NCT02723201|10048650|FG001|STARTED|Washout Period 2||0
8985747|NCT02723201|10048651|FG002|STARTED|Washout Period 2||0
8985748|NCT02723201|10048649|FG000|COMPLETED|Washout Period 2||9
8985749|NCT02723201|10048650|FG001|COMPLETED|Washout Period 2||0
8985750|NCT02723201|10048651|FG002|COMPLETED|Washout Period 2||0
8985751|NCT02723201|10048649|FG000|NOT COMPLETED|Washout Period 2||0
8985752|NCT02723201|10048650|FG001|NOT COMPLETED|Washout Period 2||0
8985753|NCT02723201|10048651|FG002|NOT COMPLETED|Washout Period 2||0
8985754|NCT02723201|10048649|FG000|STARTED|Third Intervention Period||9
8985755|NCT02723201|10048650|FG001|STARTED|Third Intervention Period||0
8985756|NCT02723201|10048651|FG002|STARTED|Third Intervention Period||0
8985757|NCT02723201|10048649|FG000|COMPLETED|Third Intervention Period||9
8985758|NCT02723201|10048650|FG001|COMPLETED|Third Intervention Period||0
8985759|NCT02723201|10048651|FG002|COMPLETED|Third Intervention Period||0
8985760|NCT02723201|10048649|FG000|NOT COMPLETED|Third Intervention Period||0
8985761|NCT02723201|10048650|FG001|NOT COMPLETED|Third Intervention Period||0
8985762|NCT02723201|10048651|FG002|NOT COMPLETED|Third Intervention Period||0
8985763|NCT02723201|10048649|FG000|STARTED|Washout Period 3||9
8985764|NCT02723201|10048650|FG001|STARTED|Washout Period 3||0
8985765|NCT02723201|10048651|FG002|STARTED|Washout Period 3||0
8985766|NCT02723201|10048649|FG000|COMPLETED|Washout Period 3||9
8985767|NCT02723201|10048650|FG001|COMPLETED|Washout Period 3||0
8985768|NCT02723201|10048651|FG002|COMPLETED|Washout Period 3||0
8985769|NCT02723201|10048649|FG000|NOT COMPLETED|Washout Period 3||0
8985770|NCT02723201|10048650|FG001|NOT COMPLETED|Washout Period 3||0
8985771|NCT02723201|10048651|FG002|NOT COMPLETED|Washout Period 3||0
8985772|NCT02723201|10048649|FG000|STARTED|Fourth Intervention Period||9
8985773|NCT02723201|10048650|FG001|STARTED|Fourth Intervention Period||0
8985774|NCT02723201|10048651|FG002|STARTED|Fourth Intervention Period||0
8985775|NCT02723201|10048649|FG000|COMPLETED|Fourth Intervention Period||9
8985776|NCT02723201|10048650|FG001|COMPLETED|Fourth Intervention Period||0
8985777|NCT02723201|10048651|FG002|COMPLETED|Fourth Intervention Period||0
8985778|NCT02723201|10048649|FG000|NOT COMPLETED|Fourth Intervention Period||0
8985779|NCT02723201|10048650|FG001|NOT COMPLETED|Fourth Intervention Period||0
8985780|NCT02723201|10048651|FG002|NOT COMPLETED|Fourth Intervention Period||0
8985781|NCT02723344|10048667|FG000|STARTED|Overall Study||15
8985782|NCT02723344|10048668|FG001|STARTED|Overall Study||16
8985783|NCT02723344|10048667|FG000|COMPLETED|Overall Study||15
8985784|NCT02723344|10048668|FG001|COMPLETED|Overall Study||12
8985785|NCT02723344|10048667|FG000|NOT COMPLETED|Overall Study||0
8985786|NCT02723344|10048668|FG001|NOT COMPLETED|Overall Study||4
8985787|NCT02723591|10048676|FG000|STARTED|Overall Study||300
8985788|NCT02723591|10048677|FG001|STARTED|Overall Study||299
8985789|NCT02723591|10048676|FG000|COMPLETED|Overall Study||204
8985790|NCT02723591|10048677|FG001|COMPLETED|Overall Study||198
8985791|NCT02723591|10048676|FG000|NOT COMPLETED|Overall Study||96
8985792|NCT02723591|10048677|FG001|NOT COMPLETED|Overall Study||101
8985793|NCT02723630|10048689|FG000|STARTED|Intervention Period 1||10
8985794|NCT02723630|10048690|FG001|STARTED|Intervention Period 1||10
8985795|NCT02723630|10048691|FG002|STARTED|Intervention Period 1||10
8985796|NCT02723630|10048692|FG003|STARTED|Intervention Period 1||10
8985797|NCT02723630|10048693|FG004|STARTED|Intervention Period 1||10
8985798|NCT02723630|10048694|FG005|STARTED|Intervention Period 1||10
8985799|NCT02723630|10048689|FG000|COMPLETED|Intervention Period 1||9
8985800|NCT02723630|10048690|FG001|COMPLETED|Intervention Period 1||10
8985801|NCT02723630|10048691|FG002|COMPLETED|Intervention Period 1||10
8985802|NCT02723630|10048692|FG003|COMPLETED|Intervention Period 1||10
8985803|NCT02723630|10048693|FG004|COMPLETED|Intervention Period 1||10
8985804|NCT02723630|10048694|FG005|COMPLETED|Intervention Period 1||10
8985805|NCT02723630|10048689|FG000|NOT COMPLETED|Intervention Period 1||1
8985806|NCT02723630|10048690|FG001|NOT COMPLETED|Intervention Period 1||0
8985807|NCT02723630|10048691|FG002|NOT COMPLETED|Intervention Period 1||0
8985808|NCT02723630|10048692|FG003|NOT COMPLETED|Intervention Period 1||0
8985809|NCT02723630|10048693|FG004|NOT COMPLETED|Intervention Period 1||0
8985810|NCT02723630|10048694|FG005|NOT COMPLETED|Intervention Period 1||0
8985811|NCT02723630|10048689|FG000|STARTED|Intervention Period 2||9
8985812|NCT02723630|10048690|FG001|STARTED|Intervention Period 2||10
8985813|NCT02723630|10048691|FG002|STARTED|Intervention Period 2||10
8985814|NCT02723630|10048692|FG003|STARTED|Intervention Period 2||10
8985815|NCT02723630|10048693|FG004|STARTED|Intervention Period 2||10
8985816|NCT02723630|10048694|FG005|STARTED|Intervention Period 2||10
8985817|NCT02723630|10048689|FG000|COMPLETED|Intervention Period 2||9
8985818|NCT02723630|10048690|FG001|COMPLETED|Intervention Period 2||10
8985819|NCT02723630|10048691|FG002|COMPLETED|Intervention Period 2||10
8985820|NCT02723630|10048692|FG003|COMPLETED|Intervention Period 2||10
8985821|NCT02723630|10048693|FG004|COMPLETED|Intervention Period 2||10
8985822|NCT02723630|10048694|FG005|COMPLETED|Intervention Period 2||10
8985823|NCT02723630|10048689|FG000|NOT COMPLETED|Intervention Period 2||0
8985824|NCT02723630|10048690|FG001|NOT COMPLETED|Intervention Period 2||0
8985825|NCT02723630|10048691|FG002|NOT COMPLETED|Intervention Period 2||0
8985826|NCT02723630|10048692|FG003|NOT COMPLETED|Intervention Period 2||0
8985827|NCT02723630|10048693|FG004|NOT COMPLETED|Intervention Period 2||0
8985828|NCT02723630|10048694|FG005|NOT COMPLETED|Intervention Period 2||0
8985829|NCT02723630|10048689|FG000|STARTED|Intervention Period 3||9
8985830|NCT02723630|10048690|FG001|STARTED|Intervention Period 3||10
8985831|NCT02723630|10048691|FG002|STARTED|Intervention Period 3||10
8985832|NCT02723630|10048692|FG003|STARTED|Intervention Period 3||10
8985833|NCT02723630|10048693|FG004|STARTED|Intervention Period 3||10
8985834|NCT02723630|10048694|FG005|STARTED|Intervention Period 3||10
8985835|NCT02723630|10048689|FG000|COMPLETED|Intervention Period 3||9
8985836|NCT02723630|10048690|FG001|COMPLETED|Intervention Period 3||9
8985837|NCT02723630|10048691|FG002|COMPLETED|Intervention Period 3||10
8985838|NCT02723630|10048692|FG003|COMPLETED|Intervention Period 3||10
8985839|NCT02723630|10048693|FG004|COMPLETED|Intervention Period 3||10
8985840|NCT02723630|10048694|FG005|COMPLETED|Intervention Period 3||10
8985841|NCT02723630|10048689|FG000|NOT COMPLETED|Intervention Period 3||0
8985842|NCT02723630|10048690|FG001|NOT COMPLETED|Intervention Period 3||1
8985843|NCT02723630|10048691|FG002|NOT COMPLETED|Intervention Period 3||0
8985844|NCT02723630|10048692|FG003|NOT COMPLETED|Intervention Period 3||0
8985845|NCT02723630|10048693|FG004|NOT COMPLETED|Intervention Period 3||0
8985846|NCT02723630|10048694|FG005|NOT COMPLETED|Intervention Period 3||0
8985847|NCT02723786|10048707|FG000|STARTED|Overall Study||7
8985848|NCT02723786|10048707|FG000|COMPLETED|Overall Study||6
8985849|NCT02723786|10048707|FG000|NOT COMPLETED|Overall Study||1
8985850|NCT02723916|10048713|FG000|STARTED|Overall Study||144
8985851|NCT02723916|10048714|FG001|STARTED|Overall Study||143
8985852|NCT02723916|10048713|FG000|COMPLETED|Overall Study||135
8985853|NCT02723916|10048714|FG001|COMPLETED|Overall Study||137
8985854|NCT02723916|10048713|FG000|NOT COMPLETED|Overall Study||9
8985855|NCT02723916|10048714|FG001|NOT COMPLETED|Overall Study||6
8985856|NCT02723929|10048722|FG000|STARTED|Overall Study||30
8985857|NCT02723929|10048723|FG001|STARTED|Overall Study||34
8985858|NCT02723929|10048722|FG000|COMPLETED|Overall Study||24
8985859|NCT02723929|10048723|FG001|COMPLETED|Overall Study||24
8985860|NCT02723929|10048722|FG000|NOT COMPLETED|Overall Study||6
8985861|NCT02723929|10048723|FG001|NOT COMPLETED|Overall Study||10
8985862|NCT02724020|10048734|FG000|STARTED|Overall Study||32
8985863|NCT02724020|10048735|FG001|STARTED|Overall Study||32
8985864|NCT02724020|10048736|FG002|STARTED|Overall Study||32
8985865|NCT02724020|10048734|FG000|Treated (Safety Analysis Set)|Overall Study||32
8985866|NCT02724020|10048735|FG001|Treated (Safety Analysis Set)|Overall Study||32
8985867|NCT02724020|10048736|FG002|Treated (Safety Analysis Set)|Overall Study||31
8985868|NCT02724020|10048734|FG000|COMPLETED|Overall Study||0
8985869|NCT02724020|10048735|FG001|COMPLETED|Overall Study||0
8985870|NCT02724020|10048736|FG002|COMPLETED|Overall Study||0
8985871|NCT02724020|10048734|FG000|NOT COMPLETED|Overall Study||32
8985872|NCT02724020|10048735|FG001|NOT COMPLETED|Overall Study||32
8985873|NCT02724020|10048736|FG002|NOT COMPLETED|Overall Study||32
8725857|NCT01033487|9773164|FG007|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
8725858|NCT01033487|9773165|FG008|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
8725859|NCT01033487|9773166|FG009|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
8877764|NCT01925404|9934771|FG003|NOT COMPLETED|Overall Study||
8877765|NCT01925417|9934781|FG000|STARTED|Overall Study||34
8877766|NCT01925417|9934781|FG000|COMPLETED|Overall Study||31
8877767|NCT01925417|9934781|FG000|NOT COMPLETED|Overall Study||3
8877768|NCT01925469|9934788|FG000|STARTED|Overall Study||15
8877769|NCT01925469|9934789|FG001|STARTED|Overall Study||15
8877770|NCT01925469|9934788|FG000|COMPLETED|Overall Study||14
8877771|NCT01925469|9934789|FG001|COMPLETED|Overall Study||15
8877772|NCT01925469|9934788|FG000|NOT COMPLETED|Overall Study||1
8877773|NCT01925469|9934789|FG001|NOT COMPLETED|Overall Study||0
8877774|NCT01925612|9934800|FG000|STARTED|Overall Study||29
8877775|NCT01925612|9934801|FG001|STARTED|Overall Study||22
8877776|NCT01925612|9934802|FG002|STARTED|Overall Study||11
8877777|NCT01925612|9934803|FG003|STARTED|Overall Study||11
8877778|NCT01925612|9934804|FG004|STARTED|Overall Study||12
8877779|NCT01925612|9934800|FG000|COMPLETED|Overall Study||25
8985874|NCT02724033|10048747|FG000|STARTED|Overall Study||11
8985875|NCT02724033|10048748|FG001|STARTED|Overall Study||14
8985876|NCT02724033|10048749|FG002|STARTED|Overall Study||12
8985877|NCT02724033|10048747|FG000|COMPLETED|Overall Study||11
8725860|NCT01033487|9773157|FG000|STARTED|Second Intervention Period||2
8877780|NCT01925612|9934801|FG001|COMPLETED|Overall Study||18
8985878|NCT02724033|10048748|FG001|COMPLETED|Overall Study||14
8985879|NCT02724033|10048749|FG002|COMPLETED|Overall Study||12
8985880|NCT02724033|10048747|FG000|NOT COMPLETED|Overall Study||0
8985881|NCT02724033|10048748|FG001|NOT COMPLETED|Overall Study||0
8985882|NCT02724033|10048749|FG002|NOT COMPLETED|Overall Study||0
8985883|NCT02724111|10048759|FG000|STARTED|Overall Study||45
8985884|NCT02724111|10048760|FG001|STARTED|Overall Study||45
8985885|NCT02724111|10048759|FG000|COMPLETED|Overall Study||43
8985886|NCT02724111|10048760|FG001|COMPLETED|Overall Study||40
8985887|NCT02724111|10048759|FG000|NOT COMPLETED|Overall Study||2
8985888|NCT02724111|10048760|FG001|NOT COMPLETED|Overall Study||5
8632795|NCT00547378|9672778|FG001|Month 36|All Implanted Cohort||29
8632796|NCT00547378|9672779|FG002|Month 36|All Implanted Cohort||146
8632797|NCT00547378|9672777|FG000|Month 48|All Implanted Cohort||38
8632798|NCT00547378|9672778|FG001|Month 48|All Implanted Cohort||27
8632799|NCT00547378|9672779|FG002|Month 48|All Implanted Cohort||136
8632800|NCT00547378|9672777|FG000|Month 60|All Implanted Cohort||36
8632801|NCT00547378|9672778|FG001|Month 60|All Implanted Cohort||23
8632802|NCT00547378|9672779|FG002|Month 60|All Implanted Cohort||114
8632803|NCT00547378|9672777|FG000|COMPLETED|All Implanted Cohort||36
8632804|NCT00547378|9672778|FG001|COMPLETED|All Implanted Cohort||22
8632805|NCT00547378|9672779|FG002|COMPLETED|All Implanted Cohort||111
8632806|NCT00547378|9672777|FG000|NOT COMPLETED|All Implanted Cohort||15
8985889|NCT02724423|10048766|FG000|STARTED|Overall Study||57
8985890|NCT02724423|10048766|FG000|COMPLETED|Overall Study||54
8985891|NCT02724423|10048766|FG000|NOT COMPLETED|Overall Study||3
8985892|NCT02724449|10048771|FG000|STARTED|Overall Study||16
8985893|NCT02724449|10048771|FG000|COMPLETED|Overall Study||16
8985894|NCT02724449|10048771|FG000|NOT COMPLETED|Overall Study||0
8985895|NCT02724462|10048777|FG000|STARTED|3 Month Follow-up Survey||1254
8985896|NCT02724462|10048778|FG001|STARTED|3 Month Follow-up Survey||1249
8985897|NCT02724462|10048777|FG000|COMPLETED|3 Month Follow-up Survey||1043
8985898|NCT02724462|10048778|FG001|COMPLETED|3 Month Follow-up Survey||1050
8985899|NCT02724462|10048777|FG000|NOT COMPLETED|3 Month Follow-up Survey||211
8985900|NCT02724462|10048778|FG001|NOT COMPLETED|3 Month Follow-up Survey||199
8985901|NCT02724462|10048777|FG000|STARTED|6 Month Follow-up Survey||1254
8985902|NCT02724462|10048778|FG001|STARTED|6 Month Follow-up Survey||1249
8985903|NCT02724462|10048777|FG000|COMPLETED|6 Month Follow-up Survey||1058
8985904|NCT02724462|10048778|FG001|COMPLETED|6 Month Follow-up Survey||1078
8985905|NCT02724462|10048777|FG000|NOT COMPLETED|6 Month Follow-up Survey||196
8985906|NCT02724462|10048778|FG001|NOT COMPLETED|6 Month Follow-up Survey||171
8571637|NCT00111800|9603934|FG000|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||2
8571638|NCT00111800|9603935|FG001|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||7
8571639|NCT00111800|9603936|FG002|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||7
8571640|NCT00111800|9603937|FG003|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||5
8571641|NCT00111800|9603938|FG004|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||4
8571642|NCT00111800|9603939|FG005|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||2
8571643|NCT00111813|9603962|FG000|STARTED|Overall Study||3
8571644|NCT00111813|9603963|FG001|STARTED|Overall Study||3
8571645|NCT00111813|9603964|FG002|STARTED|Overall Study||10
8571646|NCT00111813|9603965|FG003|STARTED|Overall Study||6
8571647|NCT00111813|9603966|FG004|STARTED|Overall Study||6
8571648|NCT00111813|9603967|FG005|STARTED|Overall Study||6
8571649|NCT00111813|9603962|FG000|COMPLETED|Overall Study||0
8571650|NCT00111813|9603963|FG001|COMPLETED|Overall Study||0
8571651|NCT00111813|9603964|FG002|COMPLETED|Overall Study||0
8571652|NCT00111813|9603965|FG003|COMPLETED|Overall Study||1
8571653|NCT00111813|9603966|FG004|COMPLETED|Overall Study||0
8571654|NCT00111813|9603967|FG005|COMPLETED|Overall Study||0
8571655|NCT00111813|9603962|FG000|NOT COMPLETED|Overall Study||3
8571656|NCT00111813|9603963|FG001|NOT COMPLETED|Overall Study||3
8571657|NCT00111813|9603964|FG002|NOT COMPLETED|Overall Study||10
8632807|NCT00547378|9672778|FG001|NOT COMPLETED|All Implanted Cohort||18
8632808|NCT00547378|9672779|FG002|NOT COMPLETED|All Implanted Cohort||70
8985907|NCT02724462|10048777|FG000|STARTED|12 Month Follow-up Survey||1254
8632809|NCT00547521|9672789|FG000|STARTED|Short Term Study (4 Months)|Number of participants treated.|51
8985908|NCT02724462|10048778|FG001|STARTED|12 Month Follow-up Survey||1249
8985909|NCT02724462|10048777|FG000|COMPLETED|12 Month Follow-up Survey||1040
8985910|NCT02724462|10048778|FG001|COMPLETED|12 Month Follow-up Survey||1067
8985911|NCT02724462|10048777|FG000|NOT COMPLETED|12 Month Follow-up Survey||214
8985912|NCT02724462|10048778|FG001|NOT COMPLETED|12 Month Follow-up Survey||182
8985913|NCT02724592|10048786|FG000|STARTED|Overall Study||35
8985914|NCT02724592|10048787|FG001|STARTED|Overall Study||35
8985915|NCT02724592|10048786|FG000|COMPLETED|Overall Study||31
8985916|NCT02724592|10048787|FG001|COMPLETED|Overall Study||34
8985917|NCT02724592|10048786|FG000|NOT COMPLETED|Overall Study||4
8985918|NCT02724592|10048787|FG001|NOT COMPLETED|Overall Study||1
8985919|NCT02724644|10048795|FG000|STARTED|Overall Study||189
8985920|NCT02724644|10048796|FG001|STARTED|Overall Study||186
8985921|NCT02724644|10048795|FG000|COMPLETED|Overall Study||168
8985922|NCT02724644|10048796|FG001|COMPLETED|Overall Study||182
8985923|NCT02724644|10048795|FG000|NOT COMPLETED|Overall Study||21
8985924|NCT02724644|10048796|FG001|NOT COMPLETED|Overall Study||4
8985925|NCT02724787|10048802|FG000|STARTED|Overall Study||24
8985926|NCT02724787|10048802|FG000|COMPLETED|Overall Study|22 completed treatment. 20 participants returned for post-treatment assessment.|22
8985927|NCT02724787|10048802|FG000|NOT COMPLETED|Overall Study||2
8985928|NCT02724800|10048808|FG000|STARTED|Overall Study||32
8985929|NCT02724800|10048809|FG001|STARTED|Overall Study||31
8985930|NCT02724800|10048808|FG000|COMPLETED|Overall Study||15
8985931|NCT02724800|10048809|FG001|COMPLETED|Overall Study||22
8985932|NCT02724800|10048808|FG000|NOT COMPLETED|Overall Study||17
8985933|NCT02724800|10048809|FG001|NOT COMPLETED|Overall Study||9
8985934|NCT02724839|10048818|FG000|STARTED|Overall Study||13
8985935|NCT02724839|10048819|FG001|STARTED|Overall Study||12
8985936|NCT02724839|10048820|FG002|STARTED|Overall Study||11
8985937|NCT02724839|10048818|FG000|COMPLETED|Overall Study||12
8985938|NCT02724839|10048819|FG001|COMPLETED|Overall Study||8
8985939|NCT02724839|10048820|FG002|COMPLETED|Overall Study||6
8985940|NCT02724839|10048818|FG000|NOT COMPLETED|Overall Study||1
8985941|NCT02724839|10048819|FG001|NOT COMPLETED|Overall Study||4
8985942|NCT02724839|10048820|FG002|NOT COMPLETED|Overall Study||5
8985943|NCT02724956|10048837|FG000|STARTED|Overall Study||27
8985944|NCT02724956|10048838|FG001|STARTED|Overall Study||26
8985945|NCT02724956|10048837|FG000|COMPLETED|Overall Study||26
8985946|NCT02724956|10048838|FG001|COMPLETED|Overall Study||24
8985947|NCT02724956|10048837|FG000|NOT COMPLETED|Overall Study||1
8985948|NCT02724956|10048838|FG001|NOT COMPLETED|Overall Study||2
8985949|NCT02725008|10048846|FG000|STARTED|Overall Study||46
8985950|NCT02725008|10048847|FG001|STARTED|Overall Study||51
8985951|NCT02725008|10048846|FG000|COMPLETED|Overall Study||37
8985952|NCT02725008|10048847|FG001|COMPLETED|Overall Study||39
8985953|NCT02725008|10048846|FG000|NOT COMPLETED|Overall Study||9
8985954|NCT02725008|10048847|FG001|NOT COMPLETED|Overall Study||12
8985955|NCT02725268|10048857|FG000|STARTED|Overall Study||90
8985956|NCT02725268|10048858|FG001|STARTED|Overall Study||90
8985957|NCT02725268|10048859|FG002|STARTED|Overall Study||41
8985958|NCT02725268|10048860|FG003|STARTED|Overall Study||20
8985959|NCT02725268|10048857|FG000|Started|Overall Study||90
8985960|NCT02725268|10048858|FG001|Started|Overall Study||90
8985961|NCT02725268|10048859|FG002|Started|Overall Study||41
8985962|NCT02725268|10048860|FG003|Started|Overall Study||20
8985963|NCT02725268|10048857|FG000|Completed|Overall Study||18
8985964|NCT02725268|10048858|FG001|Completed|Overall Study||20
8985965|NCT02725268|10048859|FG002|Completed|Overall Study||3
8985966|NCT02725268|10048860|FG003|Completed|Overall Study||2
8985967|NCT02725268|10048857|FG000|COMPLETED|Overall Study||18
8985968|NCT02725268|10048858|FG001|COMPLETED|Overall Study||20
8985969|NCT02725268|10048859|FG002|COMPLETED|Overall Study||3
8985970|NCT02725268|10048860|FG003|COMPLETED|Overall Study||2
8985971|NCT02725268|10048857|FG000|NOT COMPLETED|Overall Study||72
8985972|NCT02725268|10048858|FG001|NOT COMPLETED|Overall Study||70
8985973|NCT02725268|10048859|FG002|NOT COMPLETED|Overall Study||38
8985974|NCT02725268|10048860|FG003|NOT COMPLETED|Overall Study||18
8985975|NCT02725411|10048873|FG000|STARTED|Treatment Period (56 Weeks)||92
8985976|NCT02725411|10048874|FG001|STARTED|Treatment Period (56 Weeks)||93
8985977|NCT02725411|10048875|FG002|STARTED|Treatment Period (56 Weeks)||92
8985978|NCT02725411|10048873|FG000|Treated|Treatment Period (56 Weeks)||92
8985979|NCT02725411|10048874|FG001|Treated|Treatment Period (56 Weeks)||93
8985980|NCT02725411|10048875|FG002|Treated|Treatment Period (56 Weeks)||92
8985981|NCT02725411|10048873|FG000|COMPLETED|Treatment Period (56 Weeks)||62
8985982|NCT02725411|10048874|FG001|COMPLETED|Treatment Period (56 Weeks)||43
8985983|NCT02725411|10048875|FG002|COMPLETED|Treatment Period (56 Weeks)||43
8985984|NCT02725411|10048873|FG000|NOT COMPLETED|Treatment Period (56 Weeks)||30
8985985|NCT02725411|10048874|FG001|NOT COMPLETED|Treatment Period (56 Weeks)||50
8985986|NCT02725411|10048875|FG002|NOT COMPLETED|Treatment Period (56 Weeks)||49
9038774|NCT03334396|10099933|FG007|NOT COMPLETED|Overall Study||1
9038775|NCT03334422|10099954|FG000|STARTED|Overall Study||244
9038776|NCT03334422|10099955|FG001|STARTED|Overall Study||125
9038777|NCT03334422|10099956|FG002|STARTED|Overall Study||123
9038778|NCT03334422|10099957|FG003|STARTED|Overall Study||123
9038779|NCT03334422|10099954|FG000|Received at Least One Dose of Study Drug|Overall Study||244
9038780|NCT03334422|10099955|FG001|Received at Least One Dose of Study Drug|Overall Study||124
9038781|NCT03334422|10099956|FG002|Received at Least One Dose of Study Drug|Overall Study||123
8632810|NCT00547521|9672790|FG001|STARTED|Short Term Study (4 Months)|Number of participants treated.|49
8632811|NCT00547521|9672789|FG000|COMPLETED|Short Term Study (4 Months)||50
8632812|NCT00547521|9672790|FG001|COMPLETED|Short Term Study (4 Months)||45
8632813|NCT00547521|9672789|FG000|NOT COMPLETED|Short Term Study (4 Months)||1
8632814|NCT00547521|9672790|FG001|NOT COMPLETED|Short Term Study (4 Months)||4
8877781|NCT01925612|9934802|FG002|COMPLETED|Overall Study||10
8877782|NCT01925612|9934803|FG003|COMPLETED|Overall Study||10
8877783|NCT01925612|9934804|FG004|COMPLETED|Overall Study||10
8877784|NCT01925612|9934800|FG000|NOT COMPLETED|Overall Study||4
8877785|NCT01925612|9934801|FG001|NOT COMPLETED|Overall Study||4
8877786|NCT01925612|9934802|FG002|NOT COMPLETED|Overall Study||1
8877787|NCT01925612|9934803|FG003|NOT COMPLETED|Overall Study||1
8877788|NCT01925612|9934804|FG004|NOT COMPLETED|Overall Study||2
8877789|NCT01925677|9934816|FG000|STARTED|Overall Study||3
8877790|NCT01925677|9934816|FG000|COMPLETED|Overall Study||3
8877791|NCT01925677|9934816|FG000|NOT COMPLETED|Overall Study||0
8877792|NCT01925703|9934820|FG000|STARTED|Overall Study||13
8877793|NCT01925703|9934820|FG000|Dosing Regimen Completed|Overall Study||12
8877794|NCT01925703|9934820|FG000|Full Iron Repletion Achieved|Overall Study||11
8877795|NCT01925703|9934820|FG000|Follow-up Completed|Overall Study||9
8877796|NCT01925703|9934820|FG000|COMPLETED|Overall Study||9
8877797|NCT01925703|9934820|FG000|NOT COMPLETED|Overall Study||4
8877798|NCT01925768|9934826|FG000|STARTED|Placebo-controlled Phase (Week 0 - 24)||109
8877799|NCT01925768|9934827|FG001|STARTED|Placebo-controlled Phase (Week 0 - 24)||110
8877800|NCT01925768|9934826|FG000|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||109
8877801|NCT01925768|9934827|FG001|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||109
8877802|NCT01925768|9934826|FG000|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||101
8877803|NCT01925768|9934827|FG001|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||91
8877804|NCT01925768|9934826|FG000|Escaped Early (EE)|Placebo-controlled Phase (Week 0 - 24)||35
8877805|NCT01925768|9934827|FG001|Escaped Early (EE)|Placebo-controlled Phase (Week 0 - 24)||13
8877806|NCT01925768|9934826|FG000|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|3 participants who completed Week 24 did not enter the active treatment phase|98
8877807|NCT01925768|9934827|FG001|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|2 participants who completed Week 24 did not enter the active treatment phase|87
8877808|NCT01925768|9934826|FG000|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||11
8877809|NCT01925768|9934827|FG001|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||23
8877810|NCT01925768|9934826|FG000|STARTED|ActiveTreatment/Extension (Weeks 24-104)||95
8877811|NCT01925768|9934827|FG001|STARTED|ActiveTreatment/Extension (Weeks 24-104)||85
8877812|NCT01925768|9934826|FG000|COMPLETED|ActiveTreatment/Extension (Weeks 24-104)||75
8877813|NCT01925768|9934827|FG001|COMPLETED|ActiveTreatment/Extension (Weeks 24-104)|Completed Apremilast treatment at Week 104|67
8877814|NCT01925768|9934826|FG000|NOT COMPLETED|ActiveTreatment/Extension (Weeks 24-104)||20
8877815|NCT01925768|9934827|FG001|NOT COMPLETED|ActiveTreatment/Extension (Weeks 24-104)||18
8877816|NCT01925781|9934839|FG000|STARTED|Overall Study||5
8877817|NCT01925781|9934840|FG001|STARTED|Overall Study||5
8877818|NCT01925781|9934839|FG000|COMPLETED|Overall Study||3
8877819|NCT01925781|9934840|FG001|COMPLETED|Overall Study||1
8877820|NCT01925781|9934839|FG000|NOT COMPLETED|Overall Study||2
8877821|NCT01925781|9934840|FG001|NOT COMPLETED|Overall Study||4
8877822|NCT01925950|9934848|FG000|STARTED|Part 1||1
8877823|NCT01925950|9934849|FG001|STARTED|Part 1||1
8877824|NCT01925950|9934848|FG000|COMPLETED|Part 1||1
8877825|NCT01925950|9934849|FG001|COMPLETED|Part 1||1
8877826|NCT01925950|9934848|FG000|NOT COMPLETED|Part 1||0
8877827|NCT01925950|9934849|FG001|NOT COMPLETED|Part 1||0
8877828|NCT01925950|9934848|FG000|STARTED|Part 2||1
8877829|NCT01925950|9934849|FG001|STARTED|Part 2|The 1 orBec subject completed Part 1 but did not meet the criteria of a CR to continue to Part 2|0
8877830|NCT01925950|9934848|FG000|COMPLETED|Part 2||0
8877831|NCT01925950|9934849|FG001|COMPLETED|Part 2||0
8877832|NCT01925950|9934848|FG000|NOT COMPLETED|Part 2||1
8877833|NCT01925950|9934849|FG001|NOT COMPLETED|Part 2||0
8877834|NCT01925989|9934857|FG000|STARTED|Period 1||7
8877835|NCT01925989|9934858|FG001|STARTED|Period 1||8
8877836|NCT01925989|9934859|FG002|STARTED|Period 1||12
8877837|NCT01925989|9934857|FG000|Received at Least 1 Dose of Study Drug|Period 1||7
8877838|NCT01925989|9934858|FG001|Received at Least 1 Dose of Study Drug|Period 1||8
8877839|NCT01925989|9934859|FG002|Received at Least 1 Dose of Study Drug|Period 1||0
8877840|NCT01925989|9934857|FG000|COMPLETED|Period 1||6
8877841|NCT01925989|9934858|FG001|COMPLETED|Period 1||6
8877842|NCT01925989|9934859|FG002|COMPLETED|Period 1||12
8877843|NCT01925989|9934857|FG000|NOT COMPLETED|Period 1||1
8877844|NCT01925989|9934858|FG001|NOT COMPLETED|Period 1||2
8877845|NCT01925989|9934859|FG002|NOT COMPLETED|Period 1||0
8877846|NCT01925989|9934857|FG000|STARTED|Period 2||6
8877847|NCT01925989|9934858|FG001|STARTED|Period 2||6
8877848|NCT01925989|9934859|FG002|STARTED|Period 2||12
8877849|NCT01925989|9934857|FG000|COMPLETED|Period 2||6
8877850|NCT01925989|9934858|FG001|COMPLETED|Period 2||6
8877851|NCT01925989|9934859|FG002|COMPLETED|Period 2||12
8877852|NCT01925989|9934857|FG000|NOT COMPLETED|Period 2||0
8877853|NCT01925989|9934858|FG001|NOT COMPLETED|Period 2||0
8877854|NCT01925989|9934859|FG002|NOT COMPLETED|Period 2||0
8877855|NCT01926015|9934873|FG000|STARTED|Overall Study|Participants who passed all entry criteria and who were randomized into the study|96
8985987|NCT02725411|10048873|FG000|STARTED|Follow-up Period (24 Weeks)|All participants on either completion or discontinuation of treatment, entered follow up period.|92
8985988|NCT02725411|10048874|FG001|STARTED|Follow-up Period (24 Weeks)|All participants on either completion or discontinuation of treatment, entered follow up period.|93
8985989|NCT02725411|10048875|FG002|STARTED|Follow-up Period (24 Weeks)|All participants on either completion or discontinuation of treatment, entered follow up period.|92
8985990|NCT02725411|10048873|FG000|COMPLETED|Follow-up Period (24 Weeks)||88
8985991|NCT02725411|10048874|FG001|COMPLETED|Follow-up Period (24 Weeks)||82
8985992|NCT02725411|10048875|FG002|COMPLETED|Follow-up Period (24 Weeks)||87
8985993|NCT02725411|10048873|FG000|NOT COMPLETED|Follow-up Period (24 Weeks)||4
8985994|NCT02725411|10048874|FG001|NOT COMPLETED|Follow-up Period (24 Weeks)||11
8985995|NCT02725411|10048875|FG002|NOT COMPLETED|Follow-up Period (24 Weeks)||5
8985996|NCT02725476|10048885|FG000|STARTED|Overall Study||15
8985997|NCT02725476|10048886|FG001|STARTED|Overall Study||5
8985998|NCT02725476|10048885|FG000|COMPLETED|Overall Study||12
8985999|NCT02725476|10048886|FG001|COMPLETED|Overall Study||4
8986000|NCT02725476|10048885|FG000|NOT COMPLETED|Overall Study||3
8986001|NCT02725476|10048886|FG001|NOT COMPLETED|Overall Study||1
8986002|NCT02725515|10048894|FG000|STARTED|Overall Study||53
8986003|NCT02725515|10048895|FG001|STARTED|Overall Study||52
8986004|NCT02725515|10048894|FG000|COMPLETED|Overall Study||28
8986005|NCT02725515|10048895|FG001|COMPLETED|Overall Study||17
8986006|NCT02725515|10048894|FG000|NOT COMPLETED|Overall Study||25
8986007|NCT02725515|10048895|FG001|NOT COMPLETED|Overall Study||35
8986008|NCT02725645|10048901|FG000|STARTED|Overall Study||14
8986009|NCT02725645|10048901|FG000|COMPLETED|Overall Study||14
8986010|NCT02725645|10048901|FG000|NOT COMPLETED|Overall Study||0
8986011|NCT02725710|10048907|FG000|STARTED|Overall Study||48
8986012|NCT02725710|10048908|FG001|STARTED|Overall Study||47
8986013|NCT02725710|10048907|FG000|COMPLETED|Overall Study||47
8986014|NCT02725710|10048908|FG001|COMPLETED|Overall Study||47
8986015|NCT02725710|10048907|FG000|NOT COMPLETED|Overall Study||1
8986016|NCT02725710|10048908|FG001|NOT COMPLETED|Overall Study||0
8986017|NCT02725788|10048916|FG000|STARTED|Overall Study||123
8986018|NCT02725788|10048917|FG001|STARTED|Overall Study||124
8986019|NCT02725788|10048916|FG000|COMPLETED|Overall Study||122
8986020|NCT02725788|10048917|FG001|COMPLETED|Overall Study||122
8986021|NCT02725788|10048916|FG000|NOT COMPLETED|Overall Study||1
8986022|NCT02725788|10048917|FG001|NOT COMPLETED|Overall Study||2
8986023|NCT02725801|10048925|FG000|STARTED|Overall Study||8
8986024|NCT02725801|10048926|FG001|STARTED|Overall Study||12
8986025|NCT02725801|10048925|FG000|COMPLETED|Overall Study||8
8986026|NCT02725801|10048926|FG001|COMPLETED|Overall Study||12
8986027|NCT02725801|10048925|FG000|NOT COMPLETED|Overall Study||0
8986028|NCT02725801|10048926|FG001|NOT COMPLETED|Overall Study||0
8986029|NCT02725866|10048932|FG000|STARTED|Overall Study||216
8986030|NCT02725866|10048932|FG000|COMPLETED|Overall Study||202
8986031|NCT02725866|10048932|FG000|NOT COMPLETED|Overall Study||14
8986032|NCT02726022|10048936|FG000|STARTED|Overall Study||114
8986033|NCT02726022|10048936|FG000|COMPLETED|Overall Study||78
8986034|NCT02726022|10048936|FG000|NOT COMPLETED|Overall Study||36
8986035|NCT02726074|10048940|FG000|STARTED|Overall Study||106
8986036|NCT02726074|10048940|FG000|Treated|Overall Study||102
8986037|NCT02726074|10048940|FG000|COMPLETED|Overall Study||80
8986038|NCT02726074|10048940|FG000|NOT COMPLETED|Overall Study||26
8986039|NCT02726113|10048946|FG000|STARTED|Total Enrollment||28
8986040|NCT02726113|10048947|FG001|STARTED|Total Enrollment||22
8986041|NCT02726113|10048946|FG000|COMPLETED|Total Enrollment||24
8986042|NCT02726113|10048947|FG001|COMPLETED|Total Enrollment||19
8986043|NCT02726113|10048946|FG000|NOT COMPLETED|Total Enrollment||4
8986044|NCT02726113|10048947|FG001|NOT COMPLETED|Total Enrollment||3
8986045|NCT02726113|10048946|FG000|STARTED|Genomic Analysis||19
8986046|NCT02726113|10048947|FG001|STARTED|Genomic Analysis||14
8986047|NCT02726113|10048946|FG000|COMPLETED|Genomic Analysis||15
8986048|NCT02726113|10048947|FG001|COMPLETED|Genomic Analysis||12
8986049|NCT02726113|10048946|FG000|NOT COMPLETED|Genomic Analysis||4
8986050|NCT02726113|10048947|FG001|NOT COMPLETED|Genomic Analysis||2
8986051|NCT02726178|10048956|FG000|STARTED|Overall Study||28
8986052|NCT02726178|10048957|FG001|STARTED|Overall Study||28
8986053|NCT02726178|10048956|FG000|COMPLETED|Overall Study||28
8986054|NCT02726178|10048957|FG001|COMPLETED|Overall Study||28
8986055|NCT02726178|10048956|FG000|NOT COMPLETED|Overall Study||0
8986056|NCT02726178|10048957|FG001|NOT COMPLETED|Overall Study||0
8986057|NCT02726451|10048967|FG000|STARTED|Overall Study||10
8986058|NCT02726451|10048968|FG001|STARTED|Overall Study||10
8986059|NCT02726451|10048967|FG000|COMPLETED|Overall Study||10
8986060|NCT02726451|10048968|FG001|COMPLETED|Overall Study||10
8986061|NCT02726451|10048967|FG000|NOT COMPLETED|Overall Study||0
8986062|NCT02726451|10048968|FG001|NOT COMPLETED|Overall Study||0
8986063|NCT02726542|10048976|FG000|STARTED|Overall Study||13
8986064|NCT02726542|10048977|FG001|STARTED|Overall Study||11
8986065|NCT02726542|10048976|FG000|COMPLETED|Overall Study||10
8877856|NCT01926015|9934874|FG001|STARTED|Overall Study|Participants who passed all entry criteria and who were randomized into the study|96
8877857|NCT01926015|9934873|FG000|Received >=1 Vaccination|Overall Study||94
8877858|NCT01926015|9934874|FG001|Received >=1 Vaccination|Overall Study||96
8877859|NCT01926015|9934873|FG000|COMPLETED|Overall Study||94
8877860|NCT01926015|9934874|FG001|COMPLETED|Overall Study||95
8877861|NCT01926015|9934873|FG000|NOT COMPLETED|Overall Study||2
8877862|NCT01926015|9934874|FG001|NOT COMPLETED|Overall Study||1
8877863|NCT01926028|9934883|FG000|STARTED|Overall Study||85
8877864|NCT01926028|9934884|FG001|STARTED|Overall Study||89
8632815|NCT00547521|9672789|FG000|STARTED|Long Term Extension (LTE) Study|ST Study had 2 arms, LTE Study pooled all participants who had abatacept injection.|0
8632816|NCT00547521|9672790|FG001|STARTED|Long Term Extension (LTE) Study|ST Study had 2 arms, LTE Study pooled all participants who had abatacept injection.|90
8632817|NCT00547521|9672789|FG000|COMPLETED|Long Term Extension (LTE) Study||0
8571658|NCT00111813|9603965|FG003|NOT COMPLETED|Overall Study||5
8571659|NCT00111813|9603966|FG004|NOT COMPLETED|Overall Study||6
8571660|NCT00111813|9603967|FG005|NOT COMPLETED|Overall Study||6
8571661|NCT00111839|9603985|FG000|STARTED|Overall Study||50
8632818|NCT00547521|9672790|FG001|COMPLETED|Long Term Extension (LTE) Study||59
8877865|NCT01926028|9934885|FG002|STARTED|Overall Study||14
8877866|NCT01926028|9934883|FG000|COMPLETED|Overall Study||64
8877867|NCT01926028|9934884|FG001|COMPLETED|Overall Study||67
8877868|NCT01926028|9934885|FG002|COMPLETED|Overall Study||12
8877869|NCT01926028|9934883|FG000|NOT COMPLETED|Overall Study||21
8877870|NCT01926028|9934884|FG001|NOT COMPLETED|Overall Study||22
8877871|NCT01926028|9934885|FG002|NOT COMPLETED|Overall Study||2
8877872|NCT01926119|9934894|FG000|STARTED|Overall Study||4
8877873|NCT01926119|9934894|FG000|COMPLETED|Overall Study||3
8877874|NCT01926119|9934894|FG000|NOT COMPLETED|Overall Study||1
8571662|NCT00111839|9603986|FG001|STARTED|Overall Study||51
8571663|NCT00111839|9603987|FG002|STARTED|Overall Study||49
8571664|NCT00111839|9603985|FG000|Treated|Overall Study||50
8571665|NCT00111839|9603986|FG001|Treated|Overall Study||51
8571666|NCT00111839|9603987|FG002|Treated|Overall Study||47
8571667|NCT00111839|9603985|FG000|COMPLETED|Overall Study||2
8571668|NCT00111839|9603986|FG001|COMPLETED|Overall Study||5
8571669|NCT00111839|9603987|FG002|COMPLETED|Overall Study||0
8571670|NCT00111839|9603985|FG000|NOT COMPLETED|Overall Study||48
8986066|NCT02726542|10048977|FG001|COMPLETED|Overall Study||10
8986067|NCT02726542|10048976|FG000|NOT COMPLETED|Overall Study||3
8986068|NCT02726542|10048977|FG001|NOT COMPLETED|Overall Study||1
8986069|NCT02726620|10048985|FG000|STARTED|Historic Cohort - Three Years||17463
8986070|NCT02726620|10048986|FG001|STARTED|Historic Cohort - Three Years||0
8986071|NCT02726620|10048985|FG000|MAP < 65 mmHg: Primary Analysis|Historic Cohort - Three Years||15624
8571671|NCT00111839|9603986|FG001|NOT COMPLETED|Overall Study||46
8986072|NCT02726620|10048986|FG001|MAP < 65 mmHg: Primary Analysis|Historic Cohort - Three Years||0
8986073|NCT02726620|10048985|FG000|COMPLETED|Historic Cohort - Three Years||17463
8986074|NCT02726620|10048986|FG001|COMPLETED|Historic Cohort - Three Years||0
8986075|NCT02726620|10048985|FG000|NOT COMPLETED|Historic Cohort - Three Years||0
8986076|NCT02726620|10048986|FG001|NOT COMPLETED|Historic Cohort - Three Years||0
8986077|NCT02726620|10048985|FG000|STARTED|Month 1: Attending Randomization||0
8986078|NCT02726620|10048986|FG001|STARTED|Month 1: Attending Randomization||485
8986079|NCT02726620|10048985|FG000|MAP < 65 mmHg: Primary Analysis|Month 1: Attending Randomization||0
8986080|NCT02726620|10048986|FG001|MAP < 65 mmHg: Primary Analysis|Month 1: Attending Randomization||432
8986081|NCT02726620|10048985|FG000|Correct IOH Notifications|Month 1: Attending Randomization||0
8986082|NCT02726620|10048986|FG001|Correct IOH Notifications|Month 1: Attending Randomization||313
8986083|NCT02726620|10048985|FG000|COMPLETED|Month 1: Attending Randomization||0
8986084|NCT02726620|10048986|FG001|COMPLETED|Month 1: Attending Randomization||485
8986085|NCT02726620|10048985|FG000|NOT COMPLETED|Month 1: Attending Randomization||0
8986086|NCT02726620|10048986|FG001|NOT COMPLETED|Month 1: Attending Randomization||0
8986087|NCT02726620|10048985|FG000|STARTED|Months 2-3: In-room Providers Randomized||0
8986088|NCT02726620|10048986|FG001|STARTED|Months 2-3: In-room Providers Randomized||1253
8986089|NCT02726620|10048985|FG000|MAP < 65 mmHg: Primary Analysis|Months 2-3: In-room Providers Randomized||0
8986090|NCT02726620|10048986|FG001|MAP < 65 mmHg: Primary Analysis|Months 2-3: In-room Providers Randomized||1103
8986091|NCT02726620|10048985|FG000|Correct IOH Notifications|Months 2-3: In-room Providers Randomized||0
8986092|NCT02726620|10048986|FG001|Correct IOH Notifications|Months 2-3: In-room Providers Randomized||825
8986093|NCT02726620|10048985|FG000|COMPLETED|Months 2-3: In-room Providers Randomized||0
8986094|NCT02726620|10048986|FG001|COMPLETED|Months 2-3: In-room Providers Randomized||1253
8986095|NCT02726620|10048985|FG000|NOT COMPLETED|Months 2-3: In-room Providers Randomized||0
8986096|NCT02726620|10048986|FG001|NOT COMPLETED|Months 2-3: In-room Providers Randomized||0
8986097|NCT02726620|10048985|FG000|STARTED|Through End of Study: All Interventions||0
8986098|NCT02726620|10048986|FG001|STARTED|Through End of Study: All Interventions||3234
8986099|NCT02726620|10048985|FG000|MAP < 65 mmHg: Primary Analysis|Through End of Study: All Interventions||0
8986100|NCT02726620|10048986|FG001|MAP < 65 mmHg: Primary Analysis|Through End of Study: All Interventions||2793
8986101|NCT02726620|10048985|FG000|Correct IOH Notifications|Through End of Study: All Interventions||0
8986102|NCT02726620|10048986|FG001|Correct IOH Notifications|Through End of Study: All Interventions||2072
8986103|NCT02726620|10048985|FG000|COMPLETED|Through End of Study: All Interventions||0
8986104|NCT02726620|10048986|FG001|COMPLETED|Through End of Study: All Interventions||3234
8986105|NCT02726620|10048985|FG000|NOT COMPLETED|Through End of Study: All Interventions||0
8986106|NCT02726620|10048986|FG001|NOT COMPLETED|Through End of Study: All Interventions||0
8986107|NCT02726789|10048992|FG000|STARTED|Overall Study||5
8986108|NCT02726789|10048992|FG000|COMPLETED|Overall Study||5
8986109|NCT02726789|10048992|FG000|NOT COMPLETED|Overall Study||0
8986110|NCT02726945|10049000|FG000|STARTED|Overall Study||13
8986111|NCT02726945|10049001|FG001|STARTED|Overall Study||13
8986112|NCT02726945|10049002|FG002|STARTED|Overall Study||13
8986113|NCT02726945|10049000|FG000|COMPLETED|Overall Study||13
8986114|NCT02726945|10049001|FG001|COMPLETED|Overall Study||12
8986115|NCT02726945|10049002|FG002|COMPLETED|Overall Study||12
8986116|NCT02726945|10049000|FG000|NOT COMPLETED|Overall Study||0
8986117|NCT02726945|10049001|FG001|NOT COMPLETED|Overall Study||1
8986118|NCT02726945|10049002|FG002|NOT COMPLETED|Overall Study||1
8986119|NCT02726971|10049012|FG000|STARTED|Overall Study||70
8632819|NCT00547521|9672789|FG000|NOT COMPLETED|Long Term Extension (LTE) Study||0
8632820|NCT00547521|9672790|FG001|NOT COMPLETED|Long Term Extension (LTE) Study||31
8877875|NCT01926444|9934902|FG000|STARTED|Overall Study||56
8877876|NCT01926444|9934903|FG001|STARTED|Overall Study||52
8877877|NCT01926444|9934904|FG002|STARTED|Overall Study||57
8877878|NCT01926444|9934905|FG003|STARTED|Overall Study||103
8571672|NCT00111839|9603987|FG002|NOT COMPLETED|Overall Study||49
8571673|NCT00111917|9603997|FG000|STARTED|Overall Study||9
8571674|NCT00111917|9603998|FG001|STARTED|Overall Study||4
8571675|NCT00111917|9603997|FG000|COMPLETED|Overall Study||8
8571676|NCT00111917|9603998|FG001|COMPLETED|Overall Study||3
8571677|NCT00111917|9603997|FG000|NOT COMPLETED|Overall Study||1
8571678|NCT00111917|9603998|FG001|NOT COMPLETED|Overall Study||1
8571679|NCT00112047|9604010|FG000|STARTED|Randomized Phase|Intention to treat (ITT) population N=255 (2 participants had received prior antiretroviral therapy)|257
8571680|NCT00112047|9604011|FG001|STARTED|Randomized Phase|ITT analysis population|254
8571681|NCT00112047|9604010|FG000|COMPLETED|Randomized Phase||187
8571682|NCT00112047|9604011|FG001|COMPLETED|Randomized Phase||166
8571683|NCT00112047|9604010|FG000|NOT COMPLETED|Randomized Phase||70
8571684|NCT00112047|9604011|FG001|NOT COMPLETED|Randomized Phase||88
8571685|NCT00112047|9604010|FG000|STARTED|Atripla Phase|Number of participants who completed randomized phase and opted to roll over to Atripla at Week 144|160
8877879|NCT01926444|9934902|FG000|COMPLETED|Overall Study||56
8877880|NCT01926444|9934903|FG001|COMPLETED|Overall Study||52
8877881|NCT01926444|9934904|FG002|COMPLETED|Overall Study||53
8877882|NCT01926444|9934905|FG003|COMPLETED|Overall Study||101
8877883|NCT01926444|9934902|FG000|NOT COMPLETED|Overall Study||0
8877884|NCT01926444|9934903|FG001|NOT COMPLETED|Overall Study||0
8877885|NCT01926444|9934904|FG002|NOT COMPLETED|Overall Study||4
8877886|NCT01926444|9934905|FG003|NOT COMPLETED|Overall Study||2
8877887|NCT01926496|9934917|FG000|STARTED|Overall Study||240
8632821|NCT00547534|9672803|FG000|STARTED|Overall Study|31 patients enrolled; one patient was determined to be ineligible, and did not receive any therapy.|30
8632822|NCT00547534|9672803|FG000|COMPLETED|Overall Study|25 patients received at least 4 cycles. 29 patients were evaluable for response.|19
8632823|NCT00547534|9672803|FG000|NOT COMPLETED|Overall Study||11
8632824|NCT00547586|9672813|FG000|STARTED|Overall Study||33
8632825|NCT00547586|9672814|FG001|STARTED|Overall Study||7
8632826|NCT00547586|9672815|FG002|STARTED|Overall Study||14
8632827|NCT00547586|9672816|FG003|STARTED|Overall Study||33
8632828|NCT00547586|9672817|FG004|STARTED|Overall Study||35
8632829|NCT00547586|9672813|FG000|COMPLETED|Overall Study||28
8632830|NCT00547586|9672814|FG001|COMPLETED|Overall Study||6
8632831|NCT00547586|9672815|FG002|COMPLETED|Overall Study||13
8632832|NCT00547586|9672816|FG003|COMPLETED|Overall Study||27
8632833|NCT00547586|9672817|FG004|COMPLETED|Overall Study||32
8632834|NCT00547586|9672813|FG000|NOT COMPLETED|Overall Study||5
8986120|NCT02726971|10049013|FG001|STARTED|Overall Study||71
8986121|NCT02726971|10049012|FG000|COMPLETED|Overall Study||59
8986122|NCT02726971|10049013|FG001|COMPLETED|Overall Study||62
8986123|NCT02726971|10049012|FG000|NOT COMPLETED|Overall Study||11
8986124|NCT02726971|10049013|FG001|NOT COMPLETED|Overall Study||9
8986125|NCT02727192|10049021|FG000|STARTED|Overall Study||54
8986126|NCT02727192|10049022|FG001|STARTED|Overall Study||54
8986127|NCT02727192|10049023|FG002|STARTED|Overall Study||1
8986128|NCT02727192|10049021|FG000|COMPLETED|Overall Study||53
8986129|NCT02727192|10049022|FG001|COMPLETED|Overall Study||54
8986130|NCT02727192|10049023|FG002|COMPLETED|Overall Study||1
8986131|NCT02727192|10049021|FG000|NOT COMPLETED|Overall Study||1
8986132|NCT02727192|10049022|FG001|NOT COMPLETED|Overall Study||0
8986133|NCT02727192|10049023|FG002|NOT COMPLETED|Overall Study||0
8986134|NCT02727322|10049032|FG000|STARTED|Overall Study||77
8986135|NCT02727322|10049033|FG001|STARTED|Overall Study||77
8986136|NCT02727322|10049032|FG000|COMPLETED|Overall Study||75
8986137|NCT02727322|10049033|FG001|COMPLETED|Overall Study||76
8986138|NCT02727322|10049032|FG000|NOT COMPLETED|Overall Study||2
8986139|NCT02727322|10049033|FG001|NOT COMPLETED|Overall Study||1
8986140|NCT02727660|10049046|FG000|STARTED|Overall Study||619
8986141|NCT02727660|10049047|FG001|STARTED|Overall Study||617
8986142|NCT02727660|10049048|FG002|STARTED|Overall Study||607
8986143|NCT02727660|10049046|FG000|COMPLETED|Overall Study||503
8986144|NCT02727660|10049047|FG001|COMPLETED|Overall Study||501
8986145|NCT02727660|10049048|FG002|COMPLETED|Overall Study||442
8986146|NCT02727660|10049046|FG000|NOT COMPLETED|Overall Study||116
8986147|NCT02727660|10049047|FG001|NOT COMPLETED|Overall Study||116
8986148|NCT02727660|10049048|FG002|NOT COMPLETED|Overall Study||165
8986149|NCT02727751|10049056|FG000|STARTED|Overall Study||312
8986150|NCT02727751|10049056|FG000|COMPLETED|Overall Study||262
8986151|NCT02727751|10049056|FG000|NOT COMPLETED|Overall Study||50
8986152|NCT02727777|10049063|FG000|STARTED|Overall Study||4
8986153|NCT02727777|10049064|FG001|STARTED|Overall Study||0
8986154|NCT02727777|10049065|FG002|STARTED|Overall Study||0
8986155|NCT02727777|10049063|FG000|COMPLETED|Overall Study||0
8986156|NCT02727777|10049064|FG001|COMPLETED|Overall Study||0
8986157|NCT02727777|10049065|FG002|COMPLETED|Overall Study||0
8986158|NCT02727777|10049063|FG000|NOT COMPLETED|Overall Study||4
8986159|NCT02727777|10049064|FG001|NOT COMPLETED|Overall Study||0
8986160|NCT02727777|10049065|FG002|NOT COMPLETED|Overall Study||0
8986161|NCT02727816|10049073|FG000|STARTED|Overall Study||35
8986162|NCT02727816|10049073|FG000|COMPLETED|Overall Study||35
8986163|NCT02727816|10049073|FG000|NOT COMPLETED|Overall Study||0
8986164|NCT02727842|10049093|FG000|STARTED|Overall Study||30
8986165|NCT02727842|10049093|FG000|COMPLETED|Overall Study||30
8986166|NCT02727842|10049093|FG000|NOT COMPLETED|Overall Study||0
8986167|NCT02727894|10049099|FG000|STARTED|Overall Study|March 2013|73
8986168|NCT02727894|10049100|FG001|STARTED|Overall Study|March 2013|192
8986169|NCT02727894|10049099|FG000|COMPLETED|Overall Study|September 2015|73
8986170|NCT02727894|10049100|FG001|COMPLETED|Overall Study|September 2015|192
8986171|NCT02727894|10049099|FG000|NOT COMPLETED|Overall Study||0
8986172|NCT02727894|10049100|FG001|NOT COMPLETED|Overall Study||0
8986173|NCT02728089|10049109|FG000|STARTED|Overall Study||115
8986174|NCT02728089|10049109|FG000|Treated|Overall Study||114
8986175|NCT02728089|10049109|FG000|COMPLETED|Overall Study||112
8986176|NCT02728089|10049109|FG000|NOT COMPLETED|Overall Study||3
8986177|NCT02728102|10049116|FG000|STARTED|Overall Study||68
8986178|NCT02728102|10049117|FG001|STARTED|Overall Study||37
8986179|NCT02728102|10049118|FG002|STARTED|Overall Study||35
8986180|NCT02728102|10049116|FG000|COMPLETED|Overall Study||67
8986181|NCT02728102|10049117|FG001|COMPLETED|Overall Study||35
8986182|NCT02728102|10049118|FG002|COMPLETED|Overall Study||33
8632835|NCT00547586|9672814|FG001|NOT COMPLETED|Overall Study||1
8632836|NCT00547586|9672815|FG002|NOT COMPLETED|Overall Study||1
8632837|NCT00547586|9672816|FG003|NOT COMPLETED|Overall Study||6
8986183|NCT02728102|10049116|FG000|NOT COMPLETED|Overall Study||1
8986184|NCT02728102|10049117|FG001|NOT COMPLETED|Overall Study||2
8986185|NCT02728102|10049118|FG002|NOT COMPLETED|Overall Study||2
8986186|NCT02728206|10049125|FG000|STARTED|Overall Study||9
8986187|NCT02728206|10049125|FG000|COMPLETED|Overall Study||8
8986188|NCT02728206|10049125|FG000|NOT COMPLETED|Overall Study||1
8986189|NCT02728830|10049129|FG000|STARTED|Overall Study||39
8986190|NCT02728830|10049129|FG000|COMPLETED|Overall Study||15
8986191|NCT02728830|10049129|FG000|NOT COMPLETED|Overall Study||24
8986192|NCT02728895|10049135|FG000|STARTED|Overall Study||3
8986193|NCT02728895|10049136|FG001|STARTED|Overall Study||21
8986194|NCT02728895|10049135|FG000|COMPLETED|Overall Study||2
8986195|NCT02728895|10049136|FG001|COMPLETED|Overall Study||16
8986196|NCT02728895|10049135|FG000|NOT COMPLETED|Overall Study||1
8986197|NCT02728895|10049136|FG001|NOT COMPLETED|Overall Study||5
8986198|NCT02729025|10049144|FG000|STARTED|Overall Study||64
8986199|NCT02729025|10049145|FG001|STARTED|Overall Study||65
8986200|NCT02729025|10049144|FG000|COMPLETED|Overall Study||64
8986201|NCT02729025|10049145|FG001|COMPLETED|Overall Study||64
8986202|NCT02729025|10049144|FG000|NOT COMPLETED|Overall Study||0
8986203|NCT02729025|10049145|FG001|NOT COMPLETED|Overall Study||1
8986204|NCT02729038|10049155|FG000|STARTED|Part 1 (Up to 44 Days)||8
8986205|NCT02729038|10049156|FG001|STARTED|Part 1 (Up to 44 Days)||8
8986206|NCT02729038|10049157|FG002|STARTED|Part 1 (Up to 44 Days)||8
8986207|NCT02729038|10049158|FG003|STARTED|Part 1 (Up to 44 Days)||0
8986208|NCT02729038|10049155|FG000|COMPLETED|Part 1 (Up to 44 Days)||8
8986209|NCT02729038|10049156|FG001|COMPLETED|Part 1 (Up to 44 Days)||8
8986210|NCT02729038|10049157|FG002|COMPLETED|Part 1 (Up to 44 Days)||8
8986211|NCT02729038|10049158|FG003|COMPLETED|Part 1 (Up to 44 Days)||0
8986212|NCT02729038|10049155|FG000|NOT COMPLETED|Part 1 (Up to 44 Days)||0
8986213|NCT02729038|10049156|FG001|NOT COMPLETED|Part 1 (Up to 44 Days)||0
8986214|NCT02729038|10049157|FG002|NOT COMPLETED|Part 1 (Up to 44 Days)||0
8986215|NCT02729038|10049158|FG003|NOT COMPLETED|Part 1 (Up to 44 Days)||0
8986216|NCT02729038|10049155|FG000|STARTED|Part 2 (Up to 50 Days)||0
8986217|NCT02729038|10049156|FG001|STARTED|Part 2 (Up to 50 Days)||0
8986218|NCT02729038|10049157|FG002|STARTED|Part 2 (Up to 50 Days)||0
8986219|NCT02729038|10049158|FG003|STARTED|Part 2 (Up to 50 Days)||8
8986220|NCT02729038|10049155|FG000|COMPLETED|Part 2 (Up to 50 Days)||0
8986221|NCT02729038|10049156|FG001|COMPLETED|Part 2 (Up to 50 Days)||0
8571686|NCT00112047|9604011|FG001|STARTED|Atripla Phase|Number of participants who completed randomized phase and opted to roll over to Atripla at Week 144|126
8571687|NCT00112047|9604010|FG000|COMPLETED|Atripla Phase||142
8571688|NCT00112047|9604011|FG001|COMPLETED|Atripla Phase||106
8571689|NCT00112047|9604010|FG000|NOT COMPLETED|Atripla Phase||18
8571690|NCT00112047|9604011|FG001|NOT COMPLETED|Atripla Phase||20
8571691|NCT00112112|9604024|FG000|STARTED|Overall Study||10
8571692|NCT00112112|9604025|FG001|STARTED|Overall Study||10
8571693|NCT00112112|9604024|FG000|COMPLETED|Overall Study||10
8571694|NCT00112112|9604025|FG001|COMPLETED|Overall Study||10
8571695|NCT00112112|9604024|FG000|NOT COMPLETED|Overall Study||0
8571696|NCT00112112|9604025|FG001|NOT COMPLETED|Overall Study||0
8571697|NCT00112125|9604033|FG000|STARTED|Overall Study||213
8571698|NCT00112125|9604034|FG001|STARTED|Overall Study||215
8986222|NCT02729038|10049157|FG002|COMPLETED|Part 2 (Up to 50 Days)||0
8986223|NCT02729038|10049158|FG003|COMPLETED|Part 2 (Up to 50 Days)||8
8986224|NCT02729038|10049155|FG000|NOT COMPLETED|Part 2 (Up to 50 Days)||0
8986225|NCT02729038|10049156|FG001|NOT COMPLETED|Part 2 (Up to 50 Days)||0
8986226|NCT02729038|10049157|FG002|NOT COMPLETED|Part 2 (Up to 50 Days)||0
8986227|NCT02729038|10049158|FG003|NOT COMPLETED|Part 2 (Up to 50 Days)||0
8986228|NCT02729051|10049177|FG000|STARTED|Overall Study||527
8986229|NCT02729051|10049178|FG001|STARTED|Overall Study||528
8571699|NCT00112125|9604033|FG000|COMPLETED|Overall Study||189
8986230|NCT02729051|10049177|FG000|COMPLETED|Overall Study||497
8986231|NCT02729051|10049178|FG001|COMPLETED|Overall Study||496
8986232|NCT02729051|10049177|FG000|NOT COMPLETED|Overall Study||30
8986233|NCT02729051|10049178|FG001|NOT COMPLETED|Overall Study||32
8986234|NCT02729194|10049184|FG000|STARTED|Overall Study||16
8986235|NCT02729194|10049184|FG000|COMPLETED|Overall Study||13
8986236|NCT02729194|10049184|FG000|NOT COMPLETED|Overall Study||3
8986237|NCT02729545|10049190|FG000|STARTED|Overall Study||30
8986238|NCT02729545|10049191|FG001|STARTED|Overall Study||30
8986239|NCT02729545|10049190|FG000|COMPLETED|Overall Study||27
8986240|NCT02729545|10049191|FG001|COMPLETED|Overall Study||25
8986241|NCT02729545|10049190|FG000|NOT COMPLETED|Overall Study||3
8986242|NCT02729545|10049191|FG001|NOT COMPLETED|Overall Study||5
8986243|NCT02729740|10049197|FG000|STARTED|Overall Study||995
8986244|NCT02729740|10049197|FG000|COMPLETED|Overall Study||864
8986245|NCT02729740|10049197|FG000|NOT COMPLETED|Overall Study||131
8986246|NCT02729831|10049205|FG000|STARTED|Baseline (Post Decision Aid, Pre-visit)||320
8986247|NCT02729831|10049206|FG001|STARTED|Baseline (Post Decision Aid, Pre-visit)||315
8986248|NCT02729831|10049207|FG002|STARTED|Baseline (Post Decision Aid, Pre-visit)||293
8986249|NCT02729831|10049208|FG003|STARTED|Baseline (Post Decision Aid, Pre-visit)||292
8986250|NCT02729831|10049205|FG000|COMPLETED|Baseline (Post Decision Aid, Pre-visit)||282
8986251|NCT02729831|10049206|FG001|COMPLETED|Baseline (Post Decision Aid, Pre-visit)||292
8986252|NCT02729831|10049207|FG002|COMPLETED|Baseline (Post Decision Aid, Pre-visit)||275
8986253|NCT02729831|10049208|FG003|COMPLETED|Baseline (Post Decision Aid, Pre-visit)||275
8986254|NCT02729831|10049205|FG000|NOT COMPLETED|Baseline (Post Decision Aid, Pre-visit)||38
8986255|NCT02729831|10049206|FG001|NOT COMPLETED|Baseline (Post Decision Aid, Pre-visit)||23
8986256|NCT02729831|10049207|FG002|NOT COMPLETED|Baseline (Post Decision Aid, Pre-visit)||18
8986257|NCT02729831|10049208|FG003|NOT COMPLETED|Baseline (Post Decision Aid, Pre-visit)||17
8986258|NCT02729831|10049205|FG000|STARTED|1 Week Post-visit||282
8986259|NCT02729831|10049206|FG001|STARTED|1 Week Post-visit||292
8986260|NCT02729831|10049207|FG002|STARTED|1 Week Post-visit||275
8986261|NCT02729831|10049208|FG003|STARTED|1 Week Post-visit||275
8986262|NCT02729831|10049205|FG000|COMPLETED|1 Week Post-visit||239
8986263|NCT02729831|10049206|FG001|COMPLETED|1 Week Post-visit||252
8986264|NCT02729831|10049207|FG002|COMPLETED|1 Week Post-visit||237
8986265|NCT02729831|10049208|FG003|COMPLETED|1 Week Post-visit||239
8986266|NCT02729831|10049205|FG000|NOT COMPLETED|1 Week Post-visit||43
8986267|NCT02729831|10049206|FG001|NOT COMPLETED|1 Week Post-visit||40
8986268|NCT02729831|10049207|FG002|NOT COMPLETED|1 Week Post-visit||38
8986269|NCT02729831|10049208|FG003|NOT COMPLETED|1 Week Post-visit||36
8986270|NCT02729831|10049205|FG000|STARTED|6 Month Follow-up||282
8986271|NCT02729831|10049206|FG001|STARTED|6 Month Follow-up||292
8986272|NCT02729831|10049207|FG002|STARTED|6 Month Follow-up||275
8986273|NCT02729831|10049208|FG003|STARTED|6 Month Follow-up||275
8986274|NCT02729831|10049205|FG000|COMPLETED|6 Month Follow-up||227
8986275|NCT02729831|10049206|FG001|COMPLETED|6 Month Follow-up||238
8986276|NCT02729831|10049207|FG002|COMPLETED|6 Month Follow-up||227
8986277|NCT02729831|10049208|FG003|COMPLETED|6 Month Follow-up||232
8986278|NCT02729831|10049205|FG000|NOT COMPLETED|6 Month Follow-up||55
8986279|NCT02729831|10049206|FG001|NOT COMPLETED|6 Month Follow-up||54
8986280|NCT02729831|10049207|FG002|NOT COMPLETED|6 Month Follow-up||48
8986281|NCT02729831|10049208|FG003|NOT COMPLETED|6 Month Follow-up||43
8986282|NCT02729896|10049221|FG000|STARTED|Overall Study||3
8986283|NCT02729896|10049222|FG001|STARTED|Overall Study||10
8986284|NCT02729896|10049223|FG002|STARTED|Overall Study||23
8986285|NCT02729896|10049221|FG000|COMPLETED|Overall Study||1
8986286|NCT02729896|10049222|FG001|COMPLETED|Overall Study||1
8986287|NCT02729896|10049223|FG002|COMPLETED|Overall Study||1
8986288|NCT02729896|10049221|FG000|NOT COMPLETED|Overall Study||2
8986289|NCT02729896|10049222|FG001|NOT COMPLETED|Overall Study||9
8986290|NCT02729896|10049223|FG002|NOT COMPLETED|Overall Study||22
8986291|NCT02729909|10049234|FG000|STARTED|Overall Study||105
8986292|NCT02729909|10049235|FG001|STARTED|Overall Study||106
8986293|NCT02729909|10049234|FG000|COMPLETED|Overall Study||104
8986294|NCT02729909|10049235|FG001|COMPLETED|Overall Study||101
8986295|NCT02729909|10049234|FG000|NOT COMPLETED|Overall Study||1
8986296|NCT02729909|10049235|FG001|NOT COMPLETED|Overall Study||5
8986297|NCT02730169|10049245|FG000|STARTED|Overall Study||67
8986298|NCT02730169|10049246|FG001|STARTED|Overall Study||66
8986299|NCT02730169|10049247|FG002|STARTED|Overall Study||67
8986300|NCT02730169|10049248|FG003|STARTED|Overall Study||71
8986301|NCT02730169|10049245|FG000|COMPLETED|Overall Study||53
8986302|NCT02730169|10049246|FG001|COMPLETED|Overall Study||45
8986303|NCT02730169|10049247|FG002|COMPLETED|Overall Study||50
8986304|NCT02730169|10049248|FG003|COMPLETED|Overall Study||55
8986305|NCT02730169|10049245|FG000|NOT COMPLETED|Overall Study||14
8986306|NCT02730169|10049246|FG001|NOT COMPLETED|Overall Study||21
8986307|NCT02730169|10049247|FG002|NOT COMPLETED|Overall Study||17
8986308|NCT02730169|10049248|FG003|NOT COMPLETED|Overall Study||16
8986309|NCT02730195|10049258|FG000|STARTED|Overall Study||9
8986310|NCT02730195|10049258|FG000|COMPLETED|Overall Study||8
8986311|NCT02730195|10049258|FG000|NOT COMPLETED|Overall Study||1
8986312|NCT02730208|10049264|FG000|STARTED|Overall Study||20
8986313|NCT02730208|10049265|FG001|STARTED|Overall Study||21
8986314|NCT02730208|10049264|FG000|COMPLETED|Overall Study||20
8986315|NCT02730208|10049265|FG001|COMPLETED|Overall Study||20
8986316|NCT02730208|10049264|FG000|NOT COMPLETED|Overall Study||0
8986317|NCT02730208|10049265|FG001|NOT COMPLETED|Overall Study||1
8986318|NCT02730234|10049271|FG000|STARTED|Overall Study||60
8986319|NCT02730234|10049271|FG000|COMPLETED|Overall Study|8 Deaths|52
8986320|NCT02730234|10049271|FG000|NOT COMPLETED|Overall Study||8
8986321|NCT02730247|10049275|FG000|STARTED|Overall Study||7
8986322|NCT02730247|10049275|FG000|COMPLETED|Overall Study||7
8986323|NCT02730247|10049275|FG000|NOT COMPLETED|Overall Study||0
8986324|NCT02730260|10049281|FG000|STARTED|Overall Study||258
8986325|NCT02730260|10049282|FG001|STARTED|Overall Study||260
8986326|NCT02730260|10049281|FG000|COMPLETED|Overall Study||176
8986327|NCT02730260|10049282|FG001|COMPLETED|Overall Study||185
8986328|NCT02730260|10049281|FG000|NOT COMPLETED|Overall Study||82
8986329|NCT02730260|10049282|FG001|NOT COMPLETED|Overall Study||75
8986330|NCT02730351|10049288|FG000|STARTED|Treatment Period 1 (2 Weeks)||37
8986331|NCT02730351|10049289|FG001|STARTED|Treatment Period 1 (2 Weeks)||37
8986332|NCT02730351|10049288|FG000|COMPLETED|Treatment Period 1 (2 Weeks)||36
8986333|NCT02730351|10049289|FG001|COMPLETED|Treatment Period 1 (2 Weeks)||37
8986334|NCT02730351|10049288|FG000|NOT COMPLETED|Treatment Period 1 (2 Weeks)||1
8986335|NCT02730351|10049289|FG001|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
8986336|NCT02730351|10049288|FG000|STARTED|Wash-out Period (2 Weeks)||36
8986337|NCT02730351|10049289|FG001|STARTED|Wash-out Period (2 Weeks)||37
8986338|NCT02730351|10049288|FG000|COMPLETED|Wash-out Period (2 Weeks)||35
8986339|NCT02730351|10049289|FG001|COMPLETED|Wash-out Period (2 Weeks)||36
8986340|NCT02730351|10049288|FG000|NOT COMPLETED|Wash-out Period (2 Weeks)||1
8986341|NCT02730351|10049289|FG001|NOT COMPLETED|Wash-out Period (2 Weeks)||1
8986342|NCT02730351|10049288|FG000|STARTED|Treatment Period 2 (2 Weeks)||35
8986343|NCT02730351|10049289|FG001|STARTED|Treatment Period 2 (2 Weeks)||36
8986344|NCT02730351|10049288|FG000|COMPLETED|Treatment Period 2 (2 Weeks)||33
8986345|NCT02730351|10049289|FG001|COMPLETED|Treatment Period 2 (2 Weeks)||36
8986346|NCT02730351|10049288|FG000|NOT COMPLETED|Treatment Period 2 (2 Weeks)||2
8986347|NCT02730351|10049289|FG001|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
8986348|NCT02730377|10049297|FG000|STARTED|Overall Study||996
8986349|NCT02730377|10049298|FG001|STARTED|Overall Study||995
8986350|NCT02730377|10049297|FG000|Treated|Overall Study||980
8986351|NCT02730377|10049298|FG001|Treated|Overall Study||984
8986352|NCT02730377|10049297|FG000|Full Analysis Set (FAS)|Overall Study||996
8986353|NCT02730377|10049298|FG001|Full Analysis Set (FAS)|Overall Study||995
8986354|NCT02730377|10049297|FG000|Safety Analysis Set (SAS)|Overall Study||980
8986355|NCT02730377|10049298|FG001|Safety Analysis Set (SAS)|Overall Study||984
8986356|NCT02730377|10049297|FG000|COMPLETED|Overall Study||446
8986357|NCT02730377|10049298|FG001|COMPLETED|Overall Study||362
8986358|NCT02730377|10049297|FG000|NOT COMPLETED|Overall Study||550
8986359|NCT02730377|10049298|FG001|NOT COMPLETED|Overall Study||633
8986360|NCT02730403|10049304|FG000|STARTED|Overall Study||211
8986361|NCT02730403|10049304|FG000|COMPLETED|Overall Study||157
8986362|NCT02730403|10049304|FG000|NOT COMPLETED|Overall Study||54
8986363|NCT02730455|10049312|FG000|STARTED|Overall Study||94
8986364|NCT02730455|10049313|FG001|STARTED|Overall Study||91
8986365|NCT02730455|10049314|FG002|STARTED|Overall Study||92
8986366|NCT02730455|10049312|FG000|Safety Population|Overall Study||91
8986367|NCT02730455|10049313|FG001|Safety Population|Overall Study||90
8986368|NCT02730455|10049314|FG002|Safety Population|Overall Study||89
8986369|NCT02730455|10049312|FG000|Participants Dosed|Overall Study||91
8986370|NCT02730455|10049313|FG001|Participants Dosed|Overall Study||88
8986371|NCT02730455|10049314|FG002|Participants Dosed|Overall Study||91
8986372|NCT02730455|10049312|FG000|Who Received Total Volume of Study Drug|Overall Study||90
8986373|NCT02730455|10049313|FG001|Who Received Total Volume of Study Drug|Overall Study||88
8986374|NCT02730455|10049314|FG002|Who Received Total Volume of Study Drug|Overall Study||89
8986375|NCT02730455|10049312|FG000|COMPLETED|Overall Study||81
8986376|NCT02730455|10049313|FG001|COMPLETED|Overall Study||77
8986377|NCT02730455|10049314|FG002|COMPLETED|Overall Study||81
8986378|NCT02730455|10049312|FG000|NOT COMPLETED|Overall Study||13
8986379|NCT02730455|10049313|FG001|NOT COMPLETED|Overall Study||14
8986380|NCT02730455|10049314|FG002|NOT COMPLETED|Overall Study||11
8986381|NCT02730598|10049324|FG000|STARTED|Overall Study||14
8986382|NCT02730598|10049325|FG001|STARTED|Overall Study||14
8986383|NCT02730598|10049324|FG000|COMPLETED|Overall Study||10
8986384|NCT02730598|10049325|FG001|COMPLETED|Overall Study||10
8986385|NCT02730598|10049324|FG000|NOT COMPLETED|Overall Study||4
8986386|NCT02730598|10049325|FG001|NOT COMPLETED|Overall Study||4
8986387|NCT02730663|10049331|FG000|STARTED|Overall Study||36
8986388|NCT02730663|10049331|FG000|COMPLETED|Overall Study||35
8986389|NCT02730663|10049331|FG000|NOT COMPLETED|Overall Study||1
8986390|NCT02730728|10049338|FG000|STARTED|Overall Study||53
8986391|NCT02730728|10049339|FG001|STARTED|Overall Study||53
8986392|NCT02730728|10049340|FG002|STARTED|Overall Study||53
8986393|NCT02730728|10049338|FG000|COMPLETED|Overall Study||53
8986394|NCT02730728|10049339|FG001|COMPLETED|Overall Study||51
8986395|NCT02730728|10049340|FG002|COMPLETED|Overall Study||52
8986396|NCT02730728|10049338|FG000|NOT COMPLETED|Overall Study||0
8986397|NCT02730728|10049339|FG001|NOT COMPLETED|Overall Study||2
8986398|NCT02730728|10049340|FG002|NOT COMPLETED|Overall Study||1
8986399|NCT02730819|10049348|FG000|STARTED|Overall Study||19
8986400|NCT02730819|10049348|FG000|Follow-up Week 2|Overall Study||15
8986401|NCT02730819|10049348|FG000|Follow-up Week 4|Overall Study||16
8986402|NCT02730819|10049348|FG000|Follow-up Week 8|Overall Study||14
8986403|NCT02730819|10049348|FG000|Follow-up Week 12|Overall Study||11
8986404|NCT02730819|10049348|FG000|Follow-up Week 16|Overall Study||11
8986405|NCT02730819|10049348|FG000|Follow-up Week 20|Overall Study||10
8986406|NCT02730819|10049348|FG000|COMPLETED|Overall Study||10
8986407|NCT02730819|10049348|FG000|NOT COMPLETED|Overall Study||9
8986408|NCT02730871|10049354|FG000|STARTED|Overall Study||67
8986409|NCT02730871|10049355|FG001|STARTED|Overall Study||67
8986410|NCT02730871|10049354|FG000|Full Analysis Set (FAS)|Overall Study||67
8986411|NCT02730871|10049355|FG001|Full Analysis Set (FAS)|Overall Study||67
8986412|NCT02730871|10049354|FG000|Safety Analysis Set|Overall Study||67
8986413|NCT02730871|10049355|FG001|Safety Analysis Set|Overall Study||67
8986414|NCT02730871|10049354|FG000|COMPLETED|Overall Study||61
8986415|NCT02730871|10049355|FG001|COMPLETED|Overall Study||67
8986416|NCT02730871|10049354|FG000|NOT COMPLETED|Overall Study||6
8986417|NCT02730871|10049355|FG001|NOT COMPLETED|Overall Study||0
8986418|NCT02730884|10049361|FG000|STARTED|Overall Study||3
8986419|NCT02730884|10049361|FG000|COMPLETED|Overall Study||3
8986420|NCT02730884|10049361|FG000|NOT COMPLETED|Overall Study||0
8986421|NCT02730962|10049367|FG000|STARTED|Overall Study||7
8986422|NCT02730962|10049368|FG001|STARTED|Overall Study||5
8632838|NCT00547586|9672817|FG004|NOT COMPLETED|Overall Study||3
8632839|NCT00547638|9672831|FG000|STARTED|Overall Study||143
8986423|NCT02730962|10049367|FG000|COMPLETED|Overall Study||7
8986424|NCT02730962|10049368|FG001|COMPLETED|Overall Study||5
8986425|NCT02730962|10049367|FG000|NOT COMPLETED|Overall Study||0
8986426|NCT02730962|10049368|FG001|NOT COMPLETED|Overall Study||0
8986427|NCT02730988|10049376|FG000|STARTED|Overall Study||47
8986428|NCT02730988|10049377|FG001|STARTED|Overall Study||49
8986429|NCT02730988|10049376|FG000|COMPLETED|Overall Study||43
8986430|NCT02730988|10049377|FG001|COMPLETED|Overall Study||39
8986431|NCT02730988|10049376|FG000|NOT COMPLETED|Overall Study||4
8986432|NCT02730988|10049377|FG001|NOT COMPLETED|Overall Study||10
8986433|NCT02731131|10049385|FG000|STARTED|Overall Study||6
8986434|NCT02731131|10049386|FG001|STARTED|Overall Study||6
8986435|NCT02731131|10049385|FG000|COMPLETED|Overall Study||6
8986436|NCT02731131|10049386|FG001|COMPLETED|Overall Study||4
8986437|NCT02731131|10049385|FG000|NOT COMPLETED|Overall Study||0
8986438|NCT02731131|10049386|FG001|NOT COMPLETED|Overall Study||2
9038782|NCT03334422|10099957|FG003|Received at Least One Dose of Study Drug|Overall Study||123
9038783|NCT03334422|10099954|FG000|COMPLETED|Overall Study||225
9038784|NCT03334422|10099955|FG001|COMPLETED|Overall Study||115
9038785|NCT03334422|10099956|FG002|COMPLETED|Overall Study||113
9038786|NCT03334422|10099957|FG003|COMPLETED|Overall Study||117
9038787|NCT03334422|10099954|FG000|NOT COMPLETED|Overall Study||19
9038788|NCT03334422|10099955|FG001|NOT COMPLETED|Overall Study||10
9038789|NCT03334422|10099956|FG002|NOT COMPLETED|Overall Study||10
9038790|NCT03334422|10099957|FG003|NOT COMPLETED|Overall Study||6
9038791|NCT03334448|10099972|FG000|STARTED|Period 1||12
9038792|NCT03334448|10099973|FG001|STARTED|Period 1||12
9038793|NCT03334448|10099974|FG002|STARTED|Period 1||13
9038794|NCT03334448|10099975|FG003|STARTED|Period 1||12
9038795|NCT03334448|10099972|FG000|Received at Least 1 Dose of Study Drug|Period 1||12
9038796|NCT03334448|10099973|FG001|Received at Least 1 Dose of Study Drug|Period 1||12
9038797|NCT03334448|10099974|FG002|Received at Least 1 Dose of Study Drug|Period 1||13
9038798|NCT03334448|10099975|FG003|Received at Least 1 Dose of Study Drug|Period 1||12
9038799|NCT03334448|10099972|FG000|COMPLETED|Period 1||12
9038800|NCT03334448|10099973|FG001|COMPLETED|Period 1||12
9038801|NCT03334448|10099974|FG002|COMPLETED|Period 1||13
9038802|NCT03334448|10099975|FG003|COMPLETED|Period 1||12
9038803|NCT03334448|10099972|FG000|NOT COMPLETED|Period 1||0
9038804|NCT03334448|10099973|FG001|NOT COMPLETED|Period 1||0
9038805|NCT03334448|10099974|FG002|NOT COMPLETED|Period 1||0
9038806|NCT03334448|10099975|FG003|NOT COMPLETED|Period 1||0
9038807|NCT03334448|10099972|FG000|STARTED|Washout||12
9038808|NCT03334448|10099973|FG001|STARTED|Washout||12
9038809|NCT03334448|10099974|FG002|STARTED|Washout||13
9038810|NCT03334448|10099975|FG003|STARTED|Washout||12
9038811|NCT03334448|10099972|FG000|COMPLETED|Washout||12
9038812|NCT03334448|10099973|FG001|COMPLETED|Washout||12
9038813|NCT03334448|10099974|FG002|COMPLETED|Washout||13
9038814|NCT03334448|10099975|FG003|COMPLETED|Washout||12
9038815|NCT03334448|10099972|FG000|NOT COMPLETED|Washout||0
9038816|NCT03334448|10099973|FG001|NOT COMPLETED|Washout||0
9038817|NCT03334448|10099974|FG002|NOT COMPLETED|Washout||0
9038818|NCT03334448|10099975|FG003|NOT COMPLETED|Washout||0
9038819|NCT03334448|10099972|FG000|STARTED|Period 2||12
9038820|NCT03334448|10099973|FG001|STARTED|Period 2||12
9038821|NCT03334448|10099974|FG002|STARTED|Period 2||13
9038822|NCT03334448|10099975|FG003|STARTED|Period 2||12
9038823|NCT03334448|10099972|FG000|Received at Least 1 Dose of Study Drug|Period 2||12
9038824|NCT03334448|10099973|FG001|Received at Least 1 Dose of Study Drug|Period 2||12
9038825|NCT03334448|10099974|FG002|Received at Least 1 Dose of Study Drug|Period 2||13
9038826|NCT03334448|10099975|FG003|Received at Least 1 Dose of Study Drug|Period 2||12
9038827|NCT03334448|10099972|FG000|COMPLETED|Period 2||12
9038828|NCT03334448|10099973|FG001|COMPLETED|Period 2||12
9038829|NCT03334448|10099974|FG002|COMPLETED|Period 2||13
9038830|NCT03334448|10099975|FG003|COMPLETED|Period 2||12
9038831|NCT03334448|10099972|FG000|NOT COMPLETED|Period 2||0
9038832|NCT03334448|10099973|FG001|NOT COMPLETED|Period 2||0
8632840|NCT00547638|9672832|FG001|STARTED|Overall Study||73
9038833|NCT03334448|10099974|FG002|NOT COMPLETED|Period 2||0
8632841|NCT00547638|9672831|FG000|COMPLETED|Overall Study||119
9038834|NCT03334448|10099975|FG003|NOT COMPLETED|Period 2||0
9038835|NCT03334448|10099972|FG000|STARTED|Washout||12
9038836|NCT03334448|10099973|FG001|STARTED|Washout||12
9038837|NCT03334448|10099974|FG002|STARTED|Washout||13
9038838|NCT03334448|10099975|FG003|STARTED|Washout||12
9038839|NCT03334448|10099972|FG000|COMPLETED|Washout||12
8632842|NCT00547638|9672832|FG001|COMPLETED|Overall Study||59
8632843|NCT00547638|9672831|FG000|NOT COMPLETED|Overall Study||24
8632844|NCT00547638|9672832|FG001|NOT COMPLETED|Overall Study||14
8632845|NCT00547703|9672840|FG000|STARTED|Overall Study||4
8632846|NCT00547703|9672841|FG001|STARTED|Overall Study||1
8632847|NCT00547703|9672840|FG000|COMPLETED|Overall Study||3
8632848|NCT00547703|9672841|FG001|COMPLETED|Overall Study||1
8632849|NCT00547703|9672840|FG000|NOT COMPLETED|Overall Study||1
8632850|NCT00547703|9672841|FG001|NOT COMPLETED|Overall Study||0
8632851|NCT00547729|9672847|FG000|STARTED|Overall Study||71
8632852|NCT00547729|9672847|FG000|COMPLETED|Overall Study||71
8632853|NCT00547729|9672847|FG000|NOT COMPLETED|Overall Study||0
8986439|NCT02731157|10049392|FG000|STARTED|First Standard RCE||4
8986440|NCT02731157|10049392|FG000|COMPLETED|First Standard RCE||4
8986441|NCT02731157|10049392|FG000|NOT COMPLETED|First Standard RCE||0
8986442|NCT02731157|10049392|FG000|STARTED|First Rejuvenated RCE||4
8986443|NCT02731157|10049392|FG000|COMPLETED|First Rejuvenated RCE||3
8986444|NCT02731157|10049392|FG000|NOT COMPLETED|First Rejuvenated RCE||1
8986445|NCT02731157|10049392|FG000|STARTED|Second Rejuvenated RCE||3
8986446|NCT02731157|10049392|FG000|COMPLETED|Second Rejuvenated RCE||3
8986447|NCT02731157|10049392|FG000|NOT COMPLETED|Second Rejuvenated RCE||0
8986448|NCT02731157|10049392|FG000|STARTED|Third Rejuvenated RCE||3
8725861|NCT01033487|9773158|FG001|STARTED|Second Intervention Period||3
8725862|NCT01033487|9773159|FG002|STARTED|Second Intervention Period||2
8725863|NCT01033487|9773160|FG003|STARTED|Second Intervention Period||2
8725864|NCT01033487|9773161|FG004|STARTED|Second Intervention Period||2
8725865|NCT01033487|9773162|FG005|STARTED|Second Intervention Period||2
8986449|NCT02731157|10049392|FG000|COMPLETED|Third Rejuvenated RCE||3
8986450|NCT02731157|10049392|FG000|NOT COMPLETED|Third Rejuvenated RCE||0
8986451|NCT02731157|10049392|FG000|STARTED|Second Standard RCE||3
8986452|NCT02731157|10049392|FG000|COMPLETED|Second Standard RCE||3
8986453|NCT02731157|10049392|FG000|NOT COMPLETED|Second Standard RCE||0
8986454|NCT02731157|10049392|FG000|STARTED|Third Standard RCE||3
8986455|NCT02731157|10049392|FG000|COMPLETED|Third Standard RCE||3
8986456|NCT02731157|10049392|FG000|NOT COMPLETED|Third Standard RCE||0
8986457|NCT02731300|10049400|FG000|STARTED|Overall Study||15
8986458|NCT02731300|10049401|FG001|STARTED|Overall Study||7
8986459|NCT02731300|10049400|FG000|COMPLETED|Overall Study||15
8986460|NCT02731300|10049401|FG001|COMPLETED|Overall Study||7
8986461|NCT02731300|10049400|FG000|NOT COMPLETED|Overall Study||0
8986462|NCT02731300|10049401|FG001|NOT COMPLETED|Overall Study||0
8986463|NCT02731313|10049407|FG000|STARTED|Overall Study||367
8986464|NCT02731313|10049407|FG000|COMPLETED|Overall Study||367
8986465|NCT02731313|10049407|FG000|NOT COMPLETED|Overall Study||0
8986466|NCT02731469|10049422|FG000|STARTED|Overall Study||3
8986467|NCT02731469|10049423|FG001|STARTED|Overall Study||3
8986468|NCT02731469|10049424|FG002|STARTED|Overall Study||3
8986469|NCT02731469|10049425|FG003|STARTED|Overall Study||3
8986470|NCT02731469|10049426|FG004|STARTED|Overall Study||3
8986471|NCT02731469|10049427|FG005|STARTED|Overall Study||3
8986472|NCT02731469|10049428|FG006|STARTED|Overall Study||3
8986473|NCT02731469|10049429|FG007|STARTED|Overall Study||6
8986474|NCT02731469|10049430|FG008|STARTED|Overall Study||6
8986475|NCT02731469|10049431|FG009|STARTED|Overall Study||6
8986476|NCT02731469|10049432|FG010|STARTED|Overall Study||6
8986477|NCT02731469|10049422|FG000|COMPLETED|Overall Study||3
8632854|NCT00547898|9672855|FG000|STARTED|Overall Study||138
8632855|NCT00547898|9672856|FG001|STARTED|Overall Study||136
8986478|NCT02731469|10049423|FG001|COMPLETED|Overall Study||3
8986479|NCT02731469|10049424|FG002|COMPLETED|Overall Study||3
8986480|NCT02731469|10049425|FG003|COMPLETED|Overall Study||3
8986481|NCT02731469|10049426|FG004|COMPLETED|Overall Study||3
8986482|NCT02731469|10049427|FG005|COMPLETED|Overall Study||3
8986483|NCT02731469|10049428|FG006|COMPLETED|Overall Study||3
8986484|NCT02731469|10049429|FG007|COMPLETED|Overall Study||6
8986485|NCT02731469|10049430|FG008|COMPLETED|Overall Study||6
8725866|NCT01033487|9773163|FG006|STARTED|Second Intervention Period||2
8877888|NCT01926496|9934918|FG001|STARTED|Overall Study||245
8877889|NCT01926496|9934917|FG000|COMPLETED|Overall Study||203
8877890|NCT01926496|9934918|FG001|COMPLETED|Overall Study||197
8877891|NCT01926496|9934917|FG000|NOT COMPLETED|Overall Study||37
8877892|NCT01926496|9934918|FG001|NOT COMPLETED|Overall Study||48
8877893|NCT01926509|9934932|FG000|STARTED|Overall Study||6
8877894|NCT01926509|9934933|FG001|STARTED|Overall Study||6
8877895|NCT01926509|9934934|FG002|STARTED|Overall Study||5
8877896|NCT01926509|9934935|FG003|STARTED|Overall Study||6
8877897|NCT01926509|9934932|FG000|COMPLETED|Overall Study||5
8877898|NCT01926509|9934933|FG001|COMPLETED|Overall Study||6
8877899|NCT01926509|9934934|FG002|COMPLETED|Overall Study||5
8877900|NCT01926509|9934935|FG003|COMPLETED|Overall Study||6
8877901|NCT01926509|9934932|FG000|NOT COMPLETED|Overall Study||1
8877902|NCT01926509|9934933|FG001|NOT COMPLETED|Overall Study||0
8877903|NCT01926509|9934934|FG002|NOT COMPLETED|Overall Study||0
8877904|NCT01926509|9934935|FG003|NOT COMPLETED|Overall Study||0
8877905|NCT01926626|9934945|FG000|STARTED|Overall Study||38
8877906|NCT01926626|9934945|FG000|Received Moclobemide|Overall Study||37
8877907|NCT01926626|9934945|FG000|COMPLETED|Overall Study||16
8877908|NCT01926626|9934945|FG000|NOT COMPLETED|Overall Study||22
8877909|NCT01926782|9934955|FG000|STARTED|Overall Study||157
8877910|NCT01926782|9934956|FG001|STARTED|Overall Study||78
8877911|NCT01926782|9934957|FG002|STARTED|Overall Study||312
8877912|NCT01926782|9934958|FG003|STARTED|Overall Study||73
8877913|NCT01926782|9934959|FG004|STARTED|Overall Study||37
8877914|NCT01926782|9934960|FG005|STARTED|Overall Study||146
8877915|NCT01926782|9934955|FG000|Treated|Overall Study||157
8877916|NCT01926782|9934956|FG001|Treated|Overall Study||78
8877917|NCT01926782|9934957|FG002|Treated|Overall Study||312
8877918|NCT01926782|9934958|FG003|Treated|Overall Study||72
8877919|NCT01926782|9934959|FG004|Treated|Overall Study||37
8877920|NCT01926782|9934960|FG005|Treated|Overall Study||146
8877921|NCT01926782|9934955|FG000|Completed 24 Weeks Treatment Period|Overall Study||137
8877922|NCT01926782|9934956|FG001|Completed 24 Weeks Treatment Period|Overall Study||68
8877923|NCT01926782|9934957|FG002|Completed 24 Weeks Treatment Period|Overall Study||285
8877924|NCT01926782|9934958|FG003|Completed 24 Weeks Treatment Period|Overall Study||58
8877925|NCT01926782|9934959|FG004|Completed 24 Weeks Treatment Period|Overall Study||31
8877926|NCT01926782|9934960|FG005|Completed 24 Weeks Treatment Period|Overall Study||120
8877927|NCT01926782|9934955|FG000|COMPLETED|Overall Study||129
8877928|NCT01926782|9934956|FG001|COMPLETED|Overall Study||65
8877929|NCT01926782|9934957|FG002|COMPLETED|Overall Study||272
8877930|NCT01926782|9934958|FG003|COMPLETED|Overall Study||53
8877931|NCT01926782|9934959|FG004|COMPLETED|Overall Study||29
8877932|NCT01926782|9934960|FG005|COMPLETED|Overall Study||105
8877933|NCT01926782|9934955|FG000|NOT COMPLETED|Overall Study||28
8877934|NCT01926782|9934956|FG001|NOT COMPLETED|Overall Study||13
8877935|NCT01926782|9934957|FG002|NOT COMPLETED|Overall Study||40
8877936|NCT01926782|9934958|FG003|NOT COMPLETED|Overall Study||20
8877937|NCT01926782|9934959|FG004|NOT COMPLETED|Overall Study||8
8877938|NCT01926782|9934960|FG005|NOT COMPLETED|Overall Study||41
8877939|NCT01926886|9934975|FG000|STARTED|Overall Study||102
8877940|NCT01926886|9934976|FG001|STARTED|Overall Study|HCPs were not enrolled in the study. No baseline data were collected for these participants.|21
8877941|NCT01926886|9934975|FG000|Received at Least 1 Dose of Study Drug|Overall Study||101
8877942|NCT01926886|9934976|FG001|Received at Least 1 Dose of Study Drug|Overall Study|Partcipants were HCPs included for polling purposes. HCPs were not enrolled in the study.|0
8877943|NCT01926886|9934975|FG000|COMPLETED|Overall Study||70
8877944|NCT01926886|9934976|FG001|COMPLETED|Overall Study|Partcipants were HCPs included for polling purposes. HCPs were not enrolled in the study.|21
8877945|NCT01926886|9934975|FG000|NOT COMPLETED|Overall Study||32
8877946|NCT01926886|9934976|FG001|NOT COMPLETED|Overall Study||0
8877947|NCT01926977|9934984|FG000|STARTED|Overall Study||47
8877948|NCT01926977|9934985|FG001|STARTED|Overall Study||53
8877949|NCT01926977|9934984|FG000|COMPLETED|Overall Study||47
8877950|NCT01926977|9934985|FG001|COMPLETED|Overall Study||53
8877951|NCT01926977|9934984|FG000|NOT COMPLETED|Overall Study||0
8877952|NCT01926977|9934985|FG001|NOT COMPLETED|Overall Study||0
8877953|NCT01927055|9934994|FG000|STARTED|Open-label||61
8877954|NCT01927055|9934995|FG001|STARTED|Open-label||0
8877955|NCT01927055|9934996|FG002|STARTED|Open-label||0
8877956|NCT01927055|9934994|FG000|COMPLETED|Open-label||45
8877957|NCT01927055|9934995|FG001|COMPLETED|Open-label||0
8877958|NCT01927055|9934996|FG002|COMPLETED|Open-label||0
8877959|NCT01927055|9934994|FG000|NOT COMPLETED|Open-label||16
8877960|NCT01927055|9934995|FG001|NOT COMPLETED|Open-label||0
8877961|NCT01927055|9934996|FG002|NOT COMPLETED|Open-label||0
8877962|NCT01927055|9934994|FG000|STARTED|Double-Blind||0
8877963|NCT01927055|9934995|FG001|STARTED|Double-Blind||22
8877964|NCT01927055|9934996|FG002|STARTED|Double-Blind||23
8877965|NCT01927055|9934994|FG000|COMPLETED|Double-Blind||0
8877966|NCT01927055|9934995|FG001|COMPLETED|Double-Blind||11
8877967|NCT01927055|9934996|FG002|COMPLETED|Double-Blind||10
8877968|NCT01927055|9934994|FG000|NOT COMPLETED|Double-Blind||0
8877969|NCT01927055|9934995|FG001|NOT COMPLETED|Double-Blind||11
8877970|NCT01927055|9934996|FG002|NOT COMPLETED|Double-Blind||13
8877971|NCT01927120|9935003|FG000|STARTED|Overall Study||20
8877972|NCT01927120|9935003|FG000|COMPLETED|Overall Study||10
8877973|NCT01927120|9935003|FG000|NOT COMPLETED|Overall Study||10
8986486|NCT02731469|10049431|FG009|COMPLETED|Overall Study||6
8986487|NCT02731469|10049432|FG010|COMPLETED|Overall Study||6
8986488|NCT02731469|10049422|FG000|NOT COMPLETED|Overall Study||0
8986489|NCT02731469|10049423|FG001|NOT COMPLETED|Overall Study||0
8986490|NCT02731469|10049424|FG002|NOT COMPLETED|Overall Study||0
8986491|NCT02731469|10049425|FG003|NOT COMPLETED|Overall Study||0
8986492|NCT02731469|10049426|FG004|NOT COMPLETED|Overall Study||0
8986493|NCT02731469|10049427|FG005|NOT COMPLETED|Overall Study||0
8986494|NCT02731469|10049428|FG006|NOT COMPLETED|Overall Study||0
8986495|NCT02731469|10049429|FG007|NOT COMPLETED|Overall Study||0
8986496|NCT02731469|10049430|FG008|NOT COMPLETED|Overall Study||0
8986497|NCT02731469|10049431|FG009|NOT COMPLETED|Overall Study||0
8986498|NCT02731469|10049432|FG010|NOT COMPLETED|Overall Study||0
8986499|NCT02731638|10049458|FG000|STARTED|Overall Study||35
8986500|NCT02731638|10049459|FG001|STARTED|Overall Study||35
8986501|NCT02731638|10049458|FG000|COMPLETED|Overall Study||29
8986502|NCT02731638|10049459|FG001|COMPLETED|Overall Study||26
8986503|NCT02731638|10049458|FG000|NOT COMPLETED|Overall Study||6
8986504|NCT02731638|10049459|FG001|NOT COMPLETED|Overall Study||9
8986505|NCT02731690|10049465|FG000|STARTED|Overall Study||42
8986506|NCT02731690|10049465|FG000|COMPLETED|Overall Study||12
8986507|NCT02731690|10049465|FG000|NOT COMPLETED|Overall Study||30
8986508|NCT02731729|10049471|FG000|STARTED|Overall Study||10
8986509|NCT02731729|10049472|FG001|STARTED|Overall Study||10
8986510|NCT02731729|10049471|FG000|COMPLETED|Overall Study||1
8986511|NCT02731729|10049472|FG001|COMPLETED|Overall Study||2
8986512|NCT02731729|10049471|FG000|NOT COMPLETED|Overall Study||9
8986513|NCT02731729|10049472|FG001|NOT COMPLETED|Overall Study||8
8986514|NCT02731742|10049482|FG000|STARTED|Overall Study||3
8986515|NCT02731742|10049483|FG001|STARTED|Overall Study||3
8986516|NCT02731742|10049484|FG002|STARTED|Overall Study||6
8986517|NCT02731742|10049485|FG003|STARTED|Overall Study||2
8986518|NCT02731742|10049482|FG000|COMPLETED|Overall Study||0
8986519|NCT02731742|10049483|FG001|COMPLETED|Overall Study||0
8986520|NCT02731742|10049484|FG002|COMPLETED|Overall Study||0
8986521|NCT02731742|10049485|FG003|COMPLETED|Overall Study||0
8986522|NCT02731742|10049482|FG000|NOT COMPLETED|Overall Study||3
8986523|NCT02731742|10049483|FG001|NOT COMPLETED|Overall Study||3
8986524|NCT02731742|10049484|FG002|NOT COMPLETED|Overall Study||6
8986525|NCT02731742|10049485|FG003|NOT COMPLETED|Overall Study||2
8986526|NCT02731755|10049495|FG000|STARTED|First Intervention||8
8986527|NCT02731755|10049496|FG001|STARTED|First Intervention||10
8986528|NCT02731755|10049495|FG000|COMPLETED|First Intervention||8
8986529|NCT02731755|10049496|FG001|COMPLETED|First Intervention||8
8986530|NCT02731755|10049495|FG000|NOT COMPLETED|First Intervention||0
8986531|NCT02731755|10049496|FG001|NOT COMPLETED|First Intervention||2
8986532|NCT02731755|10049495|FG000|STARTED|Second Intervention||8
8986533|NCT02731755|10049496|FG001|STARTED|Second Intervention||8
8986534|NCT02731755|10049495|FG000|COMPLETED|Second Intervention||8
8986535|NCT02731755|10049496|FG001|COMPLETED|Second Intervention||8
8986536|NCT02731755|10049495|FG000|NOT COMPLETED|Second Intervention||0
8986537|NCT02731755|10049496|FG001|NOT COMPLETED|Second Intervention||0
8986538|NCT02731820|10049504|FG000|STARTED|Overall Study||20
8986539|NCT02731820|10049505|FG001|STARTED|Overall Study||20
8986540|NCT02731820|10049504|FG000|COMPLETED|Overall Study||17
8986541|NCT02731820|10049505|FG001|COMPLETED|Overall Study||18
8986542|NCT02731820|10049504|FG000|NOT COMPLETED|Overall Study||3
8986543|NCT02731820|10049505|FG001|NOT COMPLETED|Overall Study||2
8986544|NCT02731833|10049513|FG000|STARTED|Overall Study||111
8986545|NCT02731833|10049514|FG001|STARTED|Overall Study||111
8986546|NCT02731833|10049513|FG000|COMPLETED|Overall Study||111
8986547|NCT02731833|10049514|FG001|COMPLETED|Overall Study||111
8986548|NCT02731833|10049513|FG000|NOT COMPLETED|Overall Study||0
8986549|NCT02731833|10049514|FG001|NOT COMPLETED|Overall Study||0
8986550|NCT02732015|10049522|FG000|STARTED|Overall Study||9
8986551|NCT02732015|10049523|FG001|STARTED|Overall Study||27
8986552|NCT02732015|10049522|FG000|COMPLETED|Overall Study||9
8632856|NCT00547898|9672857|FG002|STARTED|Overall Study||54
8632857|NCT00547898|9672858|FG003|STARTED|Overall Study||46
8632858|NCT00547898|9672855|FG000|COMPLETED|Overall Study||129
8632859|NCT00547898|9672856|FG001|COMPLETED|Overall Study||126
8632860|NCT00547898|9672857|FG002|COMPLETED|Overall Study||54
8986553|NCT02732015|10049523|FG001|COMPLETED|Overall Study||26
8632861|NCT00547898|9672858|FG003|COMPLETED|Overall Study||40
8986554|NCT02732015|10049522|FG000|NOT COMPLETED|Overall Study||0
8986555|NCT02732015|10049523|FG001|NOT COMPLETED|Overall Study||1
8986556|NCT02732119|10049534|FG000|STARTED|Phase I||8
8986557|NCT02732119|10049535|FG001|STARTED|Phase I||10
8986558|NCT02732119|10049536|FG002|STARTED|Phase I||7
8986559|NCT02732119|10049537|FG003|STARTED|Phase I||0
8986560|NCT02732119|10049538|FG004|STARTED|Phase I||0
8986561|NCT02732119|10049534|FG000|COMPLETED|Phase I||0
8986562|NCT02732119|10049535|FG001|COMPLETED|Phase I||0
8986563|NCT02732119|10049536|FG002|COMPLETED|Phase I||0
8986564|NCT02732119|10049537|FG003|COMPLETED|Phase I||0
8986565|NCT02732119|10049538|FG004|COMPLETED|Phase I||0
8986566|NCT02732119|10049534|FG000|NOT COMPLETED|Phase I||8
8986567|NCT02732119|10049535|FG001|NOT COMPLETED|Phase I||10
8986568|NCT02732119|10049536|FG002|NOT COMPLETED|Phase I||7
8986569|NCT02732119|10049537|FG003|NOT COMPLETED|Phase I||0
8986570|NCT02732119|10049538|FG004|NOT COMPLETED|Phase I||0
8986571|NCT02732119|10049534|FG000|STARTED|Phase II||0
8986572|NCT02732119|10049535|FG001|STARTED|Phase II||0
8986573|NCT02732119|10049536|FG002|STARTED|Phase II||0
8986574|NCT02732119|10049537|FG003|STARTED|Phase II||46
8986575|NCT02732119|10049538|FG004|STARTED|Phase II||33
8986576|NCT02732119|10049534|FG000|Protocol Analysis Set|Phase II||0
8986577|NCT02732119|10049535|FG001|Protocol Analysis Set|Phase II||0
8986578|NCT02732119|10049536|FG002|Protocol Analysis Set|Phase II||0
8986579|NCT02732119|10049537|FG003|Protocol Analysis Set|Phase II||46
8986580|NCT02732119|10049538|FG004|Protocol Analysis Set|Phase II||32
8986581|NCT02732119|10049534|FG000|COMPLETED|Phase II||0
8986582|NCT02732119|10049535|FG001|COMPLETED|Phase II||0
8986583|NCT02732119|10049536|FG002|COMPLETED|Phase II||0
8986584|NCT02732119|10049537|FG003|COMPLETED|Phase II||0
8986585|NCT02732119|10049538|FG004|COMPLETED|Phase II||0
8986586|NCT02732119|10049534|FG000|NOT COMPLETED|Phase II||0
8986587|NCT02732119|10049535|FG001|NOT COMPLETED|Phase II||0
8986588|NCT02732119|10049536|FG002|NOT COMPLETED|Phase II||0
8986589|NCT02732119|10049537|FG003|NOT COMPLETED|Phase II||46
8986590|NCT02732119|10049538|FG004|NOT COMPLETED|Phase II||33
8986591|NCT02732145|10049554|FG000|STARTED|Overall Study||82
8986592|NCT02732145|10049555|FG001|STARTED|Overall Study||82
8986593|NCT02732145|10049556|FG002|STARTED|Overall Study||82
8986594|NCT02732145|10049557|FG003|STARTED|Overall Study||82
8986595|NCT02732145|10049554|FG000|COMPLETED|Overall Study||82
8986596|NCT02732145|10049555|FG001|COMPLETED|Overall Study||82
8986597|NCT02732145|10049556|FG002|COMPLETED|Overall Study||82
8986598|NCT02732145|10049557|FG003|COMPLETED|Overall Study||82
8986599|NCT02732145|10049554|FG000|NOT COMPLETED|Overall Study||0
8986600|NCT02732145|10049555|FG001|NOT COMPLETED|Overall Study||0
8986601|NCT02732145|10049556|FG002|NOT COMPLETED|Overall Study||0
8986602|NCT02732145|10049557|FG003|NOT COMPLETED|Overall Study||0
8986603|NCT02732210|10049589|FG000|STARTED|Overall Study||303
8986604|NCT02732210|10049590|FG001|STARTED|Overall Study||632
8986605|NCT02732210|10049589|FG000|COMPLETED|Overall Study||218
8986606|NCT02732210|10049590|FG001|COMPLETED|Overall Study||338
8986607|NCT02732210|10049589|FG000|NOT COMPLETED|Overall Study||85
8986608|NCT02732210|10049590|FG001|NOT COMPLETED|Overall Study||294
8877974|NCT01927341|9935012|FG000|STARTED|Phase 1b||10
8877975|NCT01927341|9935013|FG001|STARTED|Phase 1b||0
8877976|NCT01927341|9935014|FG002|STARTED|Phase 1b||0
8877977|NCT01927341|9935015|FG003|STARTED|Phase 1b||0
8877978|NCT01927341|9935016|FG004|STARTED|Phase 1b||0
8877979|NCT01927341|9935012|FG000|COMPLETED|Phase 1b||0
8877980|NCT01927341|9935013|FG001|COMPLETED|Phase 1b||0
8877981|NCT01927341|9935014|FG002|COMPLETED|Phase 1b||0
8877982|NCT01927341|9935015|FG003|COMPLETED|Phase 1b||0
8877983|NCT01927341|9935016|FG004|COMPLETED|Phase 1b||0
8877984|NCT01927341|9935012|FG000|NOT COMPLETED|Phase 1b||10
8877985|NCT01927341|9935013|FG001|NOT COMPLETED|Phase 1b||0
8877986|NCT01927341|9935014|FG002|NOT COMPLETED|Phase 1b||0
8877987|NCT01927341|9935015|FG003|NOT COMPLETED|Phase 1b||0
8986609|NCT02732366|10049598|FG000|STARTED|Overall Study||23
8986610|NCT02732366|10049599|FG001|STARTED|Overall Study||23
8986611|NCT02732366|10049598|FG000|Withdrawal by Participant|Overall Study||5
8986612|NCT02732366|10049599|FG001|Withdrawal by Participant|Overall Study||2
8986613|NCT02732366|10049598|FG000|COMPLETED|Overall Study||18
8986614|NCT02732366|10049599|FG001|COMPLETED|Overall Study||21
8986615|NCT02732366|10049598|FG000|NOT COMPLETED|Overall Study||5
8986616|NCT02732366|10049599|FG001|NOT COMPLETED|Overall Study||2
8986617|NCT02732561|10049610|FG000|STARTED|Overall Study||5
8986618|NCT02732561|10049611|FG001|STARTED|Overall Study||5
8986619|NCT02732561|10049610|FG000|COMPLETED|Overall Study||3
8986620|NCT02732561|10049611|FG001|COMPLETED|Overall Study||4
8986621|NCT02732561|10049610|FG000|NOT COMPLETED|Overall Study||2
8877988|NCT01927341|9935016|FG004|NOT COMPLETED|Phase 1b||0
8986622|NCT02732561|10049611|FG001|NOT COMPLETED|Overall Study||1
8986623|NCT02732587|10049617|FG000|STARTED|Overall Study||5
8986624|NCT02732587|10049617|FG000|COMPLETED|Overall Study||5
8986625|NCT02732587|10049617|FG000|NOT COMPLETED|Overall Study||0
8986626|NCT02732600|10049623|FG000|STARTED|Overall Study||3525
8986627|NCT02732600|10049624|FG001|STARTED|Overall Study||2091
8877989|NCT01927341|9935012|FG000|STARTED|Phase 2||0
8877990|NCT01927341|9935013|FG001|STARTED|Phase 2|Participants of phase 2 enrolled after enrollment of participants of phase 1b.|15
8877991|NCT01927341|9935014|FG002|STARTED|Phase 2|Participants of phase 2 enrolled after enrollment of participants of phase 1b.|5
8986628|NCT02732600|10049623|FG000|Sub-set of Sites Newly Delivering PS Services|Overall Study||899
8986629|NCT02732600|10049624|FG001|Sub-set of Sites Newly Delivering PS Services|Overall Study||1484
8986630|NCT02732600|10049623|FG000|Veteran Baseline Veteran (Sub-set of 23 Sites)|Overall Study||118
8986631|NCT02732600|10049624|FG001|Veteran Baseline Veteran (Sub-set of 23 Sites)|Overall Study||145
8986632|NCT02732600|10049623|FG000|Veteran 6-months (Sub-set 23 Sites)|Overall Study||70
8986633|NCT02732600|10049624|FG001|Veteran 6-months (Sub-set 23 Sites)|Overall Study||84
8986634|NCT02732600|10049623|FG000|Veteran 1-year (Sub-set 23 Sites)|Overall Study||54
8986635|NCT02732600|10049624|FG001|Veteran 1-year (Sub-set 23 Sites)|Overall Study||71
8986636|NCT02732600|10049623|FG000|Peer Specialist Responses at 6-months (All 25 Sites)|Overall Study||12
8986637|NCT02732600|10049624|FG001|Peer Specialist Responses at 6-months (All 25 Sites)|Overall Study||14
8986638|NCT02732600|10049623|FG000|Peer Specialist Responses at 1-year (All 25 Sites)|Overall Study||5
8986639|NCT02732600|10049624|FG001|Peer Specialist Responses at 1-year (All 25 Sites)|Overall Study||12
8986640|NCT02732600|10049623|FG000|Supervisor Responses 6-months (All 25 Sites)|Overall Study||10
8986641|NCT02732600|10049624|FG001|Supervisor Responses 6-months (All 25 Sites)|Overall Study||21
8986642|NCT02732600|10049623|FG000|Supervisor 1-year (All 25 Sites)|Overall Study||6
8986643|NCT02732600|10049624|FG001|Supervisor 1-year (All 25 Sites)|Overall Study||10
8986644|NCT02732600|10049623|FG000|COMPLETED|Overall Study||100
8986645|NCT02732600|10049624|FG001|COMPLETED|Overall Study||113
8986646|NCT02732600|10049623|FG000|NOT COMPLETED|Overall Study||3425
8986647|NCT02732600|10049624|FG001|NOT COMPLETED|Overall Study||1978
8986648|NCT02732639|10049631|FG000|STARTED|Overall Study||31
8986649|NCT02732639|10049631|FG000|COMPLETED|Overall Study||30
8986650|NCT02732639|10049631|FG000|NOT COMPLETED|Overall Study||1
8986651|NCT02732847|10049637|FG000|STARTED|Overall Study||75
8986652|NCT02732847|10049638|FG001|STARTED|Overall Study||74
8986653|NCT02732847|10049637|FG000|COMPLETED|Overall Study||33
8986654|NCT02732847|10049638|FG001|COMPLETED|Overall Study||32
8986655|NCT02732847|10049637|FG000|NOT COMPLETED|Overall Study||42
8986656|NCT02732847|10049638|FG001|NOT COMPLETED|Overall Study||42
8986657|NCT02732899|10049646|FG000|STARTED|Overall Study||10
8986658|NCT02732899|10049647|FG001|STARTED|Overall Study||10
8986659|NCT02732899|10049646|FG000|COMPLETED|Overall Study||10
8986660|NCT02732899|10049647|FG001|COMPLETED|Overall Study||10
8986661|NCT02732899|10049646|FG000|NOT COMPLETED|Overall Study||0
8986662|NCT02732899|10049647|FG001|NOT COMPLETED|Overall Study||0
8986663|NCT02732912|10049655|FG000|STARTED|Overall Study||97
8986664|NCT02732912|10049656|FG001|STARTED|Overall Study||109
8986665|NCT02732912|10049655|FG000|COMPLETED|Overall Study||87
8986666|NCT02732912|10049656|FG001|COMPLETED|Overall Study||91
8986667|NCT02732912|10049655|FG000|NOT COMPLETED|Overall Study||10
8986668|NCT02732912|10049656|FG001|NOT COMPLETED|Overall Study||18
8986669|NCT02732938|10049664|FG000|STARTED|Overall Study||4
8986670|NCT02732938|10049665|FG001|STARTED|Overall Study||18
8986671|NCT02732938|10049666|FG002|STARTED|Overall Study||0
8986672|NCT02732938|10049664|FG000|Received Treatment|Overall Study||4
8986673|NCT02732938|10049665|FG001|Received Treatment|Overall Study||17
8986674|NCT02732938|10049666|FG002|Received Treatment|Overall Study||0
8986675|NCT02732938|10049664|FG000|COMPLETED|Overall Study||0
8986676|NCT02732938|10049665|FG001|COMPLETED|Overall Study||0
8986677|NCT02732938|10049666|FG002|COMPLETED|Overall Study||0
8986678|NCT02732938|10049664|FG000|NOT COMPLETED|Overall Study||4
8986679|NCT02732938|10049665|FG001|NOT COMPLETED|Overall Study||18
8986680|NCT02732938|10049666|FG002|NOT COMPLETED|Overall Study||0
8986681|NCT02732951|10049676|FG000|STARTED|Overall Study||53
8986682|NCT02732951|10049677|FG001|STARTED|Overall Study||52
8986683|NCT02732951|10049676|FG000|COMPLETED|Overall Study||48
8986684|NCT02732951|10049677|FG001|COMPLETED|Overall Study||46
8986685|NCT02732951|10049676|FG000|NOT COMPLETED|Overall Study||5
8986686|NCT02732951|10049677|FG001|NOT COMPLETED|Overall Study||6
8986687|NCT02733367|10049683|FG000|STARTED|Overall Study||18
8986688|NCT02733367|10049683|FG000|COMPLETED|Overall Study||12
8986689|NCT02733367|10049683|FG000|NOT COMPLETED|Overall Study||6
8986690|NCT02733588|10049688|FG000|STARTED|Overall Study||7
8986691|NCT02733588|10049688|FG000|COMPLETED|Overall Study||7
8986692|NCT02733588|10049688|FG000|NOT COMPLETED|Overall Study||0
8986693|NCT02733627|10049696|FG000|STARTED|Overall Study||9
8986694|NCT02733627|10049697|FG001|STARTED|Overall Study||9
8986695|NCT02733627|10049698|FG002|STARTED|Overall Study||9
8986696|NCT02733627|10049699|FG003|STARTED|Overall Study||9
8986697|NCT02733627|10049696|FG000|COMPLETED|Overall Study||9
8986698|NCT02733627|10049697|FG001|COMPLETED|Overall Study||8
8986699|NCT02733627|10049698|FG002|COMPLETED|Overall Study||7
8986700|NCT02733627|10049699|FG003|COMPLETED|Overall Study||9
8986701|NCT02733627|10049696|FG000|NOT COMPLETED|Overall Study||0
8986702|NCT02733627|10049697|FG001|NOT COMPLETED|Overall Study||1
8986703|NCT02733627|10049698|FG002|NOT COMPLETED|Overall Study||2
8986704|NCT02733627|10049699|FG003|NOT COMPLETED|Overall Study||0
8986705|NCT02733653|10049709|FG000|STARTED|Overall Study||50
8986706|NCT02733653|10049709|FG000|COMPLETED|Overall Study||49
8986707|NCT02733653|10049709|FG000|NOT COMPLETED|Overall Study||1
8986708|NCT02733757|10049717|FG000|STARTED|Overall Study||20
8986709|NCT02733757|10049718|FG001|STARTED|Overall Study||20
8986710|NCT02733757|10049719|FG002|STARTED|Overall Study||20
8986711|NCT02733757|10049720|FG003|STARTED|Overall Study||20
8986712|NCT02733757|10049717|FG000|COMPLETED|Overall Study||20
8986713|NCT02733757|10049718|FG001|COMPLETED|Overall Study||20
8986714|NCT02733757|10049719|FG002|COMPLETED|Overall Study||20
8986715|NCT02733757|10049720|FG003|COMPLETED|Overall Study||20
8986716|NCT02733757|10049717|FG000|NOT COMPLETED|Overall Study||0
8986717|NCT02733757|10049718|FG001|NOT COMPLETED|Overall Study||0
8986718|NCT02733757|10049719|FG002|NOT COMPLETED|Overall Study||0
8986719|NCT02733757|10049720|FG003|NOT COMPLETED|Overall Study||0
8986720|NCT02733991|10049732|FG000|STARTED|Overall Study||76
8986721|NCT02733991|10049733|FG001|STARTED|Overall Study||77
8986722|NCT02733991|10049732|FG000|COMPLETED|Overall Study||75
8986723|NCT02733991|10049733|FG001|COMPLETED|Overall Study||72
8986724|NCT02733991|10049732|FG000|NOT COMPLETED|Overall Study||1
8986725|NCT02733991|10049733|FG001|NOT COMPLETED|Overall Study||5
8986726|NCT02734056|10049741|FG000|STARTED|Overall Study||50
8986727|NCT02734056|10049742|FG001|STARTED|Overall Study||50
8986728|NCT02734056|10049741|FG000|COMPLETED|Overall Study||50
8986729|NCT02734056|10049742|FG001|COMPLETED|Overall Study||49
8986730|NCT02734056|10049741|FG000|NOT COMPLETED|Overall Study||0
8986731|NCT02734056|10049742|FG001|NOT COMPLETED|Overall Study||1
8986732|NCT02734147|10049750|FG000|STARTED|Overall Study||12
8986733|NCT02734147|10049751|FG001|STARTED|Overall Study||12
8986734|NCT02734147|10049750|FG000|COMPLETED|Overall Study||9
8986735|NCT02734147|10049751|FG001|COMPLETED|Overall Study||11
8986736|NCT02734147|10049750|FG000|NOT COMPLETED|Overall Study||3
8986737|NCT02734147|10049751|FG001|NOT COMPLETED|Overall Study||1
8986738|NCT02734212|10049759|FG000|STARTED|Overall Study||29
8986739|NCT02734212|10049760|FG001|STARTED|Overall Study||28
8986740|NCT02734212|10049759|FG000|COMPLETED|Overall Study||24
8986741|NCT02734212|10049760|FG001|COMPLETED|Overall Study||18
8986742|NCT02734212|10049759|FG000|NOT COMPLETED|Overall Study||5
8986743|NCT02734212|10049760|FG001|NOT COMPLETED|Overall Study||10
8986744|NCT02734238|10049769|FG000|STARTED|Overall Study||26
8986745|NCT02734238|10049770|FG001|STARTED|Overall Study||24
8986746|NCT02734238|10049769|FG000|COMPLETED|Overall Study||26
8986747|NCT02734238|10049770|FG001|COMPLETED|Overall Study||24
8986748|NCT02734238|10049769|FG000|NOT COMPLETED|Overall Study||0
8986749|NCT02734238|10049770|FG001|NOT COMPLETED|Overall Study||0
8986750|NCT02734355|10049778|FG000|STARTED|Overall Study||34
8986751|NCT02734355|10049779|FG001|STARTED|Overall Study||30
8986752|NCT02734355|10049778|FG000|COMPLETED|Overall Study||34
8986753|NCT02734355|10049779|FG001|COMPLETED|Overall Study||30
8986754|NCT02734355|10049778|FG000|NOT COMPLETED|Overall Study||0
8986755|NCT02734355|10049779|FG001|NOT COMPLETED|Overall Study||0
8632862|NCT00547898|9672855|FG000|NOT COMPLETED|Overall Study||9
8632863|NCT00547898|9672856|FG001|NOT COMPLETED|Overall Study||10
8632864|NCT00547898|9672857|FG002|NOT COMPLETED|Overall Study||0
8632865|NCT00547898|9672858|FG003|NOT COMPLETED|Overall Study||6
8632866|NCT00547911|9672874|FG000|STARTED|Overall Study||2
8632867|NCT00547911|9672875|FG001|STARTED|Overall Study||2
8632868|NCT00547911|9672876|FG002|STARTED|Overall Study||2
8632869|NCT00547911|9672877|FG003|STARTED|Overall Study||2
8632870|NCT00547911|9672878|FG004|STARTED|Overall Study||3
8632871|NCT00547911|9672879|FG005|STARTED|Overall Study||3
8632872|NCT00547911|9672874|FG000|COMPLETED|Overall Study||2
8632873|NCT00547911|9672875|FG001|COMPLETED|Overall Study||2
8986756|NCT02734498|10049788|FG000|STARTED|Overall Study||2
8632874|NCT00547911|9672876|FG002|COMPLETED|Overall Study||2
8632875|NCT00547911|9672877|FG003|COMPLETED|Overall Study||1
8632876|NCT00547911|9672878|FG004|COMPLETED|Overall Study||3
8632877|NCT00547911|9672879|FG005|COMPLETED|Overall Study||3
8632878|NCT00547911|9672874|FG000|NOT COMPLETED|Overall Study||0
8632879|NCT00547911|9672875|FG001|NOT COMPLETED|Overall Study||0
8632880|NCT00547911|9672876|FG002|NOT COMPLETED|Overall Study||0
8632881|NCT00547911|9672877|FG003|NOT COMPLETED|Overall Study||1
8632882|NCT00547911|9672878|FG004|NOT COMPLETED|Overall Study||0
8632883|NCT00547911|9672879|FG005|NOT COMPLETED|Overall Study||0
8632884|NCT00548041|9672892|FG000|STARTED|Overall Study||100
8632885|NCT00548041|9672892|FG000|COMPLETED|Overall Study||100
8632886|NCT00548041|9672892|FG000|NOT COMPLETED|Overall Study||0
8632887|NCT00548132|9672898|FG000|STARTED|Overall Study||534
8632888|NCT00548132|9672899|FG001|STARTED|Overall Study||554
8632889|NCT00548132|9672898|FG000|Consented to Study|Overall Study||534
8632890|NCT00548132|9672899|FG001|Consented to Study|Overall Study||554
8632891|NCT00548132|9672898|FG000|COMPLETED|Overall Study||534
8632892|NCT00548132|9672899|FG001|COMPLETED|Overall Study||554
8632893|NCT00548132|9672898|FG000|NOT COMPLETED|Overall Study||0
8632894|NCT00548132|9672899|FG001|NOT COMPLETED|Overall Study||0
8632895|NCT00548145|9672909|FG000|STARTED|Overall Study||18
8632896|NCT00548145|9672910|FG001|STARTED|Overall Study||20
8632897|NCT00548145|9672909|FG000|COMPLETED|Overall Study||17
8632898|NCT00548145|9672910|FG001|COMPLETED|Overall Study||16
8632899|NCT00548145|9672909|FG000|NOT COMPLETED|Overall Study||1
8986757|NCT02734498|10049789|FG001|STARTED|Overall Study||0
8986758|NCT02734498|10049790|FG002|STARTED|Overall Study||0
8986759|NCT02734498|10049788|FG000|COMPLETED|Overall Study||2
8986760|NCT02734498|10049789|FG001|COMPLETED|Overall Study||0
8986761|NCT02734498|10049790|FG002|COMPLETED|Overall Study||0
8986762|NCT02734498|10049788|FG000|NOT COMPLETED|Overall Study||0
8986763|NCT02734498|10049789|FG001|NOT COMPLETED|Overall Study||0
8986764|NCT02734498|10049790|FG002|NOT COMPLETED|Overall Study||0
8986765|NCT02734576|10049798|FG000|STARTED|Overall Study||10
8986766|NCT02734576|10049798|FG000|COMPLETED|Overall Study||10
8986767|NCT02734576|10049798|FG000|NOT COMPLETED|Overall Study||0
8986768|NCT02734693|10049805|FG000|STARTED|Overall Study||56
8986769|NCT02734693|10049806|FG001|STARTED|Overall Study||56
8986770|NCT02734693|10049807|FG002|STARTED|Overall Study||20
8986771|NCT02734693|10049805|FG000|COMPLETED|Overall Study||50
8986772|NCT02734693|10049806|FG001|COMPLETED|Overall Study||53
8986773|NCT02734693|10049807|FG002|COMPLETED|Overall Study||17
8986774|NCT02734693|10049805|FG000|NOT COMPLETED|Overall Study||6
8986775|NCT02734693|10049806|FG001|NOT COMPLETED|Overall Study||3
8986776|NCT02734693|10049807|FG002|NOT COMPLETED|Overall Study||3
8986777|NCT02734810|10049817|FG000|STARTED|Overall Study||15
8632900|NCT00548145|9672910|FG001|NOT COMPLETED|Overall Study||4
8632901|NCT00548171|9672918|FG000|STARTED|Overall Study||164
8632902|NCT00548171|9672919|FG001|STARTED|Overall Study||39
8632903|NCT00548171|9672918|FG000|COMPLETED|Overall Study||164
8632904|NCT00548171|9672919|FG001|COMPLETED|Overall Study||39
8877992|NCT01927341|9935015|FG003|STARTED|Phase 2|Participants of phase 2 enrolled after enrollment of participants of phase 1b.|15
8877993|NCT01927341|9935016|FG004|STARTED|Phase 2|Participants of phase 2 enrolled after enrollment of participants of phase 1b.|8
8877994|NCT01927341|9935012|FG000|COMPLETED|Phase 2||0
8877995|NCT01927341|9935013|FG001|COMPLETED|Phase 2||0
8877996|NCT01927341|9935014|FG002|COMPLETED|Phase 2||0
8877997|NCT01927341|9935015|FG003|COMPLETED|Phase 2||0
8877998|NCT01927341|9935016|FG004|COMPLETED|Phase 2||0
8877999|NCT01927341|9935012|FG000|NOT COMPLETED|Phase 2||0
8878000|NCT01927341|9935013|FG001|NOT COMPLETED|Phase 2||15
8878001|NCT01927341|9935014|FG002|NOT COMPLETED|Phase 2||5
8632905|NCT00548171|9672918|FG000|NOT COMPLETED|Overall Study||0
8632906|NCT00548171|9672919|FG001|NOT COMPLETED|Overall Study||0
8632907|NCT00548184|9672925|FG000|STARTED|Overall Study||65
8632908|NCT00548184|9672925|FG000|COMPLETED|Overall Study|65 patients were on treatment. 5 did not complete due to adverse events or other reasons.|60
8632909|NCT00548184|9672925|FG000|NOT COMPLETED|Overall Study||5
8632910|NCT00548197|9672931|FG000|STARTED|Overall Study||18
8986778|NCT02734810|10049818|FG001|STARTED|Overall Study||0
8986779|NCT02734810|10049817|FG000|COMPLETED|Overall Study||13
8986780|NCT02734810|10049818|FG001|COMPLETED|Overall Study||0
8986781|NCT02734810|10049817|FG000|NOT COMPLETED|Overall Study||2
8986782|NCT02734810|10049818|FG001|NOT COMPLETED|Overall Study||0
8986783|NCT02734849|10049827|FG000|STARTED|Overall Study|One patient was randomized but never received study treatment and excluded from all analysis sets.|16
8986784|NCT02734849|10049828|FG001|STARTED|Overall Study||14
8878002|NCT01927341|9935015|FG003|NOT COMPLETED|Phase 2||15
8878003|NCT01927341|9935016|FG004|NOT COMPLETED|Phase 2||8
8878004|NCT01927367|9935034|FG000|STARTED|Overall Study||597
8878005|NCT01927367|9935035|FG001|STARTED|Overall Study||548
8878006|NCT01927367|9935034|FG000|COMPLETED|Overall Study||590
8878007|NCT01927367|9935035|FG001|COMPLETED|Overall Study||543
8878008|NCT01927367|9935034|FG000|NOT COMPLETED|Overall Study||7
8878009|NCT01927367|9935035|FG001|NOT COMPLETED|Overall Study||5
8632911|NCT00548197|9672932|FG001|STARTED|Overall Study||22
8632912|NCT00548197|9672931|FG000|COMPLETED|Overall Study||18
8632913|NCT00548197|9672932|FG001|COMPLETED|Overall Study||22
8632914|NCT00548197|9672931|FG000|NOT COMPLETED|Overall Study||0
8632915|NCT00548197|9672932|FG001|NOT COMPLETED|Overall Study||0
8632916|NCT00548249|9672945|FG000|STARTED|Overall Study||26
8632917|NCT00548249|9672946|FG001|STARTED|Overall Study||26
8632918|NCT00548249|9672947|FG002|STARTED|Overall Study||29
8632919|NCT00548249|9672948|FG003|STARTED|Overall Study||22
8632920|NCT00548249|9672949|FG004|STARTED|Overall Study||28
8632921|NCT00548249|9672945|FG000|COMPLETED|Overall Study||10
8632922|NCT00548249|9672946|FG001|COMPLETED|Overall Study||13
8632923|NCT00548249|9672947|FG002|COMPLETED|Overall Study||9
8878010|NCT01927497|9935043|FG000|STARTED|Overall Study||50
8878011|NCT01927497|9935044|FG001|STARTED|Overall Study||54
8986785|NCT02734849|10049829|FG002|STARTED|Overall Study||10
8986786|NCT02734849|10049827|FG000|COMPLETED|Overall Study||12
8986787|NCT02734849|10049828|FG001|COMPLETED|Overall Study||14
8986788|NCT02734849|10049829|FG002|COMPLETED|Overall Study||9
8986789|NCT02734849|10049827|FG000|NOT COMPLETED|Overall Study||4
8986790|NCT02734849|10049828|FG001|NOT COMPLETED|Overall Study||0
8986791|NCT02734849|10049829|FG002|NOT COMPLETED|Overall Study||1
8986792|NCT02734862|10049840|FG000|STARTED|Part A||35
8986793|NCT02734862|10049841|FG001|STARTED|Part A||36
8986794|NCT02734862|10049842|FG002|STARTED|Part A||36
8986795|NCT02734862|10049840|FG000|COMPLETED|Part A||23
8986796|NCT02734862|10049841|FG001|COMPLETED|Part A||28
8986797|NCT02734862|10049842|FG002|COMPLETED|Part A||22
8986798|NCT02734862|10049840|FG000|NOT COMPLETED|Part A||12
8986799|NCT02734862|10049841|FG001|NOT COMPLETED|Part A||8
8986800|NCT02734862|10049842|FG002|NOT COMPLETED|Part A||14
8986801|NCT02734862|10049840|FG000|STARTED|Part B||46
8986802|NCT02734862|10049841|FG001|STARTED|Part B||21
8986803|NCT02734862|10049842|FG002|STARTED|Part B||33
8986804|NCT02734862|10049840|FG000|COMPLETED|Part B||33
8986805|NCT02734862|10049841|FG001|COMPLETED|Part B||14
8986806|NCT02734862|10049842|FG002|COMPLETED|Part B||28
8986807|NCT02734862|10049840|FG000|NOT COMPLETED|Part B||13
8986808|NCT02734862|10049841|FG001|NOT COMPLETED|Part B||7
8986809|NCT02734862|10049842|FG002|NOT COMPLETED|Part B||5
8986810|NCT02734953|10049851|FG000|STARTED|Overall Study||10
8986811|NCT02734953|10049851|FG000|COMPLETED|Overall Study||10
8986812|NCT02734953|10049851|FG000|NOT COMPLETED|Overall Study||0
8986813|NCT02734979|10049855|FG000|STARTED|Overall Study||1
8986814|NCT02734979|10049855|FG000|COMPLETED|Overall Study||1
8986815|NCT02734979|10049855|FG000|NOT COMPLETED|Overall Study||0
8986816|NCT02735096|10049867|FG000|STARTED|Overall Study||4
8986817|NCT02735096|10049867|FG000|COMPLETED|Overall Study||3
8986818|NCT02735096|10049867|FG000|NOT COMPLETED|Overall Study||1
8986819|NCT02735174|10049871|FG000|STARTED|Overall Study||21
8986820|NCT02735174|10049871|FG000|COMPLETED|Overall Study||21
8986821|NCT02735174|10049871|FG000|NOT COMPLETED|Overall Study||0
8986822|NCT02735187|10049877|FG000|STARTED|Overall Study||25
8986823|NCT02735187|10049878|FG001|STARTED|Overall Study||26
8986824|NCT02735187|10049877|FG000|COMPLETED|Overall Study||21
8986825|NCT02735187|10049878|FG001|COMPLETED|Overall Study||25
8986826|NCT02735187|10049877|FG000|NOT COMPLETED|Overall Study||4
8986827|NCT02735187|10049878|FG001|NOT COMPLETED|Overall Study||1
8878012|NCT01927497|9935043|FG000|COMPLETED|Overall Study||48
8878013|NCT01927497|9935044|FG001|COMPLETED|Overall Study||53
8878014|NCT01927497|9935043|FG000|NOT COMPLETED|Overall Study||2
8878015|NCT01927497|9935044|FG001|NOT COMPLETED|Overall Study||1
8986828|NCT02735200|10049892|FG000|STARTED|Overall Study||200
8986829|NCT02735200|10049893|FG001|STARTED|Overall Study||350
8986830|NCT02735200|10049892|FG000|COMPLETED|Overall Study||192
8986831|NCT02735200|10049893|FG001|COMPLETED|Overall Study||345
8986832|NCT02735200|10049892|FG000|NOT COMPLETED|Overall Study||8
8986833|NCT02735200|10049893|FG001|NOT COMPLETED|Overall Study||5
8632924|NCT00548249|9672948|FG003|COMPLETED|Overall Study||9
8632925|NCT00548249|9672949|FG004|COMPLETED|Overall Study||7
8986834|NCT02735382|10049903|FG000|STARTED|Overall Study||7481
8986835|NCT02735382|10049904|FG001|STARTED|Overall Study||7155
8632926|NCT00548249|9672945|FG000|NOT COMPLETED|Overall Study||16
8632927|NCT00548249|9672946|FG001|NOT COMPLETED|Overall Study||13
8632928|NCT00548249|9672947|FG002|NOT COMPLETED|Overall Study||20
8878016|NCT01927562|9935050|FG000|STARTED|Overall Study||57
8878017|NCT01927562|9935050|FG000|COMPLETED|Overall Study|5 at M24, 2 at M30,12 at M36 due to two protocol changes moving followups from M24 to M30 to M36|19
8878018|NCT01927562|9935050|FG000|NOT COMPLETED|Overall Study||38
8986836|NCT02735382|10049905|FG002|STARTED|Overall Study||184
8986837|NCT02735382|10049906|FG003|STARTED|Overall Study||110
8986838|NCT02735382|10049903|FG000|COMPLETED|Overall Study||7481
8986839|NCT02735382|10049904|FG001|COMPLETED|Overall Study||7155
8986840|NCT02735382|10049905|FG002|COMPLETED|Overall Study||184
8986841|NCT02735382|10049906|FG003|COMPLETED|Overall Study||110
8986842|NCT02735382|10049903|FG000|NOT COMPLETED|Overall Study||0
8986843|NCT02735382|10049904|FG001|NOT COMPLETED|Overall Study||0
8986844|NCT02735382|10049905|FG002|NOT COMPLETED|Overall Study||0
8986845|NCT02735382|10049906|FG003|NOT COMPLETED|Overall Study||0
8986846|NCT02735421|10049916|FG000|STARTED|Overall Study||67
8986847|NCT02735421|10049916|FG000|COMPLETED|Overall Study||54
8986848|NCT02735421|10049916|FG000|NOT COMPLETED|Overall Study||13
8986849|NCT02735551|10049926|FG000|STARTED|Overall Study||3
8986850|NCT02735551|10049927|FG001|STARTED|Overall Study||0
8986851|NCT02735551|10049928|FG002|STARTED|Overall Study||0
8986852|NCT02735551|10049926|FG000|COMPLETED|Overall Study||3
8986853|NCT02735551|10049927|FG001|COMPLETED|Overall Study||0
8986854|NCT02735551|10049928|FG002|COMPLETED|Overall Study||0
8986855|NCT02735551|10049926|FG000|NOT COMPLETED|Overall Study||0
8632929|NCT00548249|9672948|FG003|NOT COMPLETED|Overall Study||13
8632930|NCT00548249|9672949|FG004|NOT COMPLETED|Overall Study||21
8986856|NCT02735551|10049927|FG001|NOT COMPLETED|Overall Study||0
8571700|NCT00112125|9604034|FG001|COMPLETED|Overall Study||193
8571701|NCT00112125|9604033|FG000|NOT COMPLETED|Overall Study||24
8571702|NCT00112125|9604034|FG001|NOT COMPLETED|Overall Study||22
8571703|NCT00112151|9604046|FG000|STARTED|Overall Study||28
8571704|NCT00112151|9604047|FG001|STARTED|Overall Study||28
8571705|NCT00112151|9604048|FG002|STARTED|Overall Study||28
8571706|NCT00112151|9604049|FG003|STARTED|Overall Study||27
8571707|NCT00112151|9604050|FG004|STARTED|Overall Study||28
8571708|NCT00112151|9604051|FG005|STARTED|Overall Study||28
8571709|NCT00112151|9604046|FG000|COMPLETED|Overall Study||24
8571710|NCT00112151|9604047|FG001|COMPLETED|Overall Study||23
8571711|NCT00112151|9604048|FG002|COMPLETED|Overall Study||25
8571712|NCT00112151|9604049|FG003|COMPLETED|Overall Study||24
8571713|NCT00112151|9604050|FG004|COMPLETED|Overall Study||22
8571714|NCT00112151|9604051|FG005|COMPLETED|Overall Study||25
8571715|NCT00112151|9604046|FG000|NOT COMPLETED|Overall Study||4
8571716|NCT00112151|9604047|FG001|NOT COMPLETED|Overall Study||5
8571717|NCT00112151|9604048|FG002|NOT COMPLETED|Overall Study||3
8571718|NCT00112151|9604049|FG003|NOT COMPLETED|Overall Study||3
8986857|NCT02735551|10049928|FG002|NOT COMPLETED|Overall Study||0
8986858|NCT02735577|10049936|FG000|STARTED|Disulfiram Treatment||7
8986859|NCT02735577|10049936|FG000|COMPLETED|Disulfiram Treatment||6
8986860|NCT02735577|10049936|FG000|NOT COMPLETED|Disulfiram Treatment||1
8986861|NCT02735577|10049936|FG000|STARTED|Optional 28 Days of Disulfiram Treatment||6
8571719|NCT00112151|9604050|FG004|NOT COMPLETED|Overall Study||6
8571720|NCT00112151|9604051|FG005|NOT COMPLETED|Overall Study||3
8632931|NCT00548262|9672961|FG000|STARTED|Overall Study|1 participant (N) had death recorded twice; reported as 1 death in reason for discontinuation (D/C)|54
8571721|NCT00112242|9604067|FG000|STARTED|Overall Study||10
8986862|NCT02735577|10049936|FG000|COMPLETED|Optional 28 Days of Disulfiram Treatment||4
8986863|NCT02735577|10049936|FG000|NOT COMPLETED|Optional 28 Days of Disulfiram Treatment||2
8986864|NCT02735642|10049942|FG000|STARTED|Overall Study||1046
8986865|NCT02735642|10049943|FG001|STARTED|Overall Study||152
8986866|NCT02735642|10049942|FG000|COMPLETED|Overall Study||1046
8986867|NCT02735642|10049943|FG001|COMPLETED|Overall Study||152
8986868|NCT02735642|10049942|FG000|NOT COMPLETED|Overall Study||0
8986869|NCT02735642|10049943|FG001|NOT COMPLETED|Overall Study||0
8986870|NCT02735915|10049953|FG000|STARTED|Overall Study||70
8986871|NCT02735915|10049953|FG000|Vaccinated|Overall Study||62
8986872|NCT02735915|10049953|FG000|COMPLETED|Overall Study||59
8986873|NCT02735915|10049953|FG000|NOT COMPLETED|Overall Study||11
8986874|NCT02735980|10049962|FG000|STARTED|Overall Study||58
8986875|NCT02735980|10049963|FG001|STARTED|Overall Study||60
8986876|NCT02735980|10049964|FG002|STARTED|Overall Study||15
8986877|NCT02735980|10049962|FG000|Received at Least 1 Dose of Study Drug|Overall Study||56
8986878|NCT02735980|10049963|FG001|Received at Least 1 Dose of Study Drug|Overall Study||60
8986879|NCT02735980|10049964|FG002|Received at Least 1 Dose of Study Drug|Overall Study||15
8986880|NCT02735980|10049962|FG000|COMPLETED|Overall Study||48
8986881|NCT02735980|10049963|FG001|COMPLETED|Overall Study||49
8986882|NCT02735980|10049964|FG002|COMPLETED|Overall Study||14
8986883|NCT02735980|10049962|FG000|NOT COMPLETED|Overall Study||10
8986884|NCT02735980|10049963|FG001|NOT COMPLETED|Overall Study||11
8986885|NCT02735980|10049964|FG002|NOT COMPLETED|Overall Study||1
8986886|NCT02736175|10049979|FG000|STARTED|Overall Study||216
8986887|NCT02736175|10049980|FG001|STARTED|Overall Study||222
8986888|NCT02736175|10049979|FG000|COMPLETED|Overall Study||214
8986889|NCT02736175|10049980|FG001|COMPLETED|Overall Study||221
8986890|NCT02736175|10049979|FG000|NOT COMPLETED|Overall Study||2
8986891|NCT02736175|10049980|FG001|NOT COMPLETED|Overall Study||1
8986892|NCT02736188|10049986|FG000|STARTED|Overall Study||142
8986893|NCT02736188|10049986|FG000|COMPLETED|Overall Study||0
8986894|NCT02736188|10049986|FG000|NOT COMPLETED|Overall Study||142
8986895|NCT02736409|10049996|FG000|STARTED|Overall Study||23
8986896|NCT02736409|10049997|FG001|STARTED|Overall Study||25
8986897|NCT02736409|10049998|FG002|STARTED|Overall Study||106
8986898|NCT02736409|10049999|FG003|STARTED|Overall Study||65
8986899|NCT02736409|10049996|FG000|COMPLETED|Overall Study||19
8986900|NCT02736409|10049997|FG001|COMPLETED|Overall Study||22
8986901|NCT02736409|10049998|FG002|COMPLETED|Overall Study||80
8986902|NCT02736409|10049999|FG003|COMPLETED|Overall Study||53
8986903|NCT02736409|10049996|FG000|NOT COMPLETED|Overall Study||4
8986904|NCT02736409|10049997|FG001|NOT COMPLETED|Overall Study||3
8986905|NCT02736409|10049998|FG002|NOT COMPLETED|Overall Study||26
8986906|NCT02736409|10049999|FG003|NOT COMPLETED|Overall Study||12
8986907|NCT02736474|10050012|FG000|STARTED|Overall Study||11
8986908|NCT02736474|10050013|FG001|STARTED|Overall Study||11
8986909|NCT02736474|10050012|FG000|COMPLETED|Overall Study||11
8878019|NCT01927575|9935054|FG000|STARTED|Overall Study||1
8878020|NCT01927575|9935054|FG000|COMPLETED|Overall Study||1
8878021|NCT01927575|9935054|FG000|NOT COMPLETED|Overall Study||0
8878022|NCT01927627|9935062|FG000|STARTED|Overall Study||42
8878023|NCT01927627|9935062|FG000|COMPLETED|Overall Study||37
8878024|NCT01927627|9935062|FG000|NOT COMPLETED|Overall Study||5
8878025|NCT01927718|9935066|FG000|STARTED|Overall Study||10
8878026|NCT01927718|9935066|FG000|COMPLETED|Overall Study||10
8878027|NCT01927718|9935066|FG000|NOT COMPLETED|Overall Study||0
8878028|NCT01927757|9935070|FG000|STARTED|Overall Study||90
8878029|NCT01927757|9935070|FG000|Received Etanercept|Overall Study||88
8878030|NCT01927757|9935070|FG000|COMPLETED|Overall Study||67
8878031|NCT01927757|9935070|FG000|NOT COMPLETED|Overall Study||23
8878032|NCT01927861|9935080|FG000|STARTED|Pivotal Phase (104 Weeks)||25
8878033|NCT01927861|9935081|FG001|STARTED|Pivotal Phase (104 Weeks)||26
8878034|NCT01927861|9935080|FG000|COMPLETED|Pivotal Phase (104 Weeks)||25
8986910|NCT02736474|10050013|FG001|COMPLETED|Overall Study||10
8986911|NCT02736474|10050012|FG000|NOT COMPLETED|Overall Study||0
8986912|NCT02736474|10050013|FG001|NOT COMPLETED|Overall Study||1
8986913|NCT02736578|10050021|FG000|STARTED|Overall Study||6
8986914|NCT02736578|10050022|FG001|STARTED|Overall Study||2
8986915|NCT02736578|10050021|FG000|COMPLETED|Overall Study||5
8986916|NCT02736578|10050022|FG001|COMPLETED|Overall Study||2
8986917|NCT02736578|10050021|FG000|NOT COMPLETED|Overall Study||1
8986918|NCT02736578|10050022|FG001|NOT COMPLETED|Overall Study||0
8986919|NCT02736721|10050032|FG000|STARTED|Overall Study||41
8986920|NCT02736721|10050032|FG000|COMPLETED|Overall Study||25
8986921|NCT02736721|10050032|FG000|NOT COMPLETED|Overall Study||16
8986922|NCT02736825|10050038|FG000|STARTED|Overall Study||127
8986923|NCT02736825|10050039|FG001|STARTED|Overall Study||135
8986924|NCT02736825|10050038|FG000|COMPLETED|Overall Study||117
8986925|NCT02736825|10050039|FG001|COMPLETED|Overall Study||123
8986926|NCT02736825|10050038|FG000|NOT COMPLETED|Overall Study||10
8986927|NCT02736825|10050039|FG001|NOT COMPLETED|Overall Study||12
8986928|NCT02736890|10050048|FG000|STARTED|First 12 Weeks||5
8986929|NCT02736890|10050049|FG001|STARTED|First 12 Weeks||3
8986930|NCT02736890|10050048|FG000|COMPLETED|First 12 Weeks||5
8986931|NCT02736890|10050049|FG001|COMPLETED|First 12 Weeks||3
8878035|NCT01927861|9935081|FG001|COMPLETED|Pivotal Phase (104 Weeks)||26
8878036|NCT01927861|9935080|FG000|NOT COMPLETED|Pivotal Phase (104 Weeks)||0
8986932|NCT02736890|10050048|FG000|NOT COMPLETED|First 12 Weeks||0
8986933|NCT02736890|10050049|FG001|NOT COMPLETED|First 12 Weeks||0
8986934|NCT02736890|10050048|FG000|STARTED|Crossover Next 12 Weeks||5
8878037|NCT01927861|9935081|FG001|NOT COMPLETED|Pivotal Phase (104 Weeks)||0
8986935|NCT02736890|10050049|FG001|STARTED|Crossover Next 12 Weeks||3
8986936|NCT02736890|10050048|FG000|COMPLETED|Crossover Next 12 Weeks||3
8986937|NCT02736890|10050049|FG001|COMPLETED|Crossover Next 12 Weeks||1
8986938|NCT02736890|10050048|FG000|NOT COMPLETED|Crossover Next 12 Weeks||2
8986939|NCT02736890|10050049|FG001|NOT COMPLETED|Crossover Next 12 Weeks||2
8986940|NCT02736955|10050058|FG000|STARTED|Overall Study||36
8986941|NCT02736955|10050059|FG001|STARTED|Overall Study||117
8986942|NCT02736955|10050060|FG002|STARTED|Overall Study||8
8986943|NCT02736955|10050058|FG000|COMPLETED|Overall Study||29
8986944|NCT02736955|10050059|FG001|COMPLETED|Overall Study||103
8986945|NCT02736955|10050060|FG002|COMPLETED|Overall Study||6
8986946|NCT02736955|10050058|FG000|NOT COMPLETED|Overall Study||7
8986947|NCT02736955|10050059|FG001|NOT COMPLETED|Overall Study||14
8986948|NCT02736955|10050060|FG002|NOT COMPLETED|Overall Study||2
8986949|NCT02737072|10050072|FG000|STARTED|Overall Study||3
8986950|NCT02737072|10050073|FG001|STARTED|Overall Study||3
8986951|NCT02737072|10050074|FG002|STARTED|Overall Study||3
8986952|NCT02737072|10050072|FG000|Received at Least One Dose of Drug|Overall Study||3
8986953|NCT02737072|10050073|FG001|Received at Least One Dose of Drug|Overall Study||3
8986954|NCT02737072|10050074|FG002|Received at Least One Dose of Drug|Overall Study||3
8986955|NCT02737072|10050072|FG000|COMPLETED|Overall Study||3
8986956|NCT02737072|10050073|FG001|COMPLETED|Overall Study||3
8986957|NCT02737072|10050074|FG002|COMPLETED|Overall Study||3
8986958|NCT02737072|10050072|FG000|NOT COMPLETED|Overall Study||0
8986959|NCT02737072|10050073|FG001|NOT COMPLETED|Overall Study||0
8986960|NCT02737072|10050074|FG002|NOT COMPLETED|Overall Study||0
8986961|NCT02737163|10050086|FG000|STARTED|Overall Study|114 encounter assessments were completed on 95 participants over 15 months|95
8986962|NCT02737163|10050086|FG000|COMPLETED|Overall Study||95
8986963|NCT02737163|10050086|FG000|NOT COMPLETED|Overall Study||0
8986964|NCT02737332|10050092|FG000|STARTED|Overall Study||29
8986965|NCT02737332|10050093|FG001|STARTED|Overall Study||24
8986966|NCT02737332|10050092|FG000|COMPLETED|Overall Study||28
8986967|NCT02737332|10050093|FG001|COMPLETED|Overall Study||23
8986968|NCT02737332|10050092|FG000|NOT COMPLETED|Overall Study||1
8986969|NCT02737332|10050093|FG001|NOT COMPLETED|Overall Study||1
8986970|NCT02737358|10050103|FG000|STARTED|Overall Study||55
8986971|NCT02737358|10050104|FG001|STARTED|Overall Study||59
8986972|NCT02737358|10050103|FG000|COMPLETED|Overall Study||46
8986973|NCT02737358|10050104|FG001|COMPLETED|Overall Study||44
8986974|NCT02737358|10050103|FG000|NOT COMPLETED|Overall Study||9
8986975|NCT02737358|10050104|FG001|NOT COMPLETED|Overall Study||15
8986976|NCT02737397|10050110|FG000|STARTED|Overall Study||13
8986977|NCT02737397|10050110|FG000|JMI-001|Overall Study||13
8986978|NCT02737397|10050110|FG000|SJP-304|Overall Study||12
8986979|NCT02737397|10050110|FG000|SJP-223|Overall Study||13
8986980|NCT02737397|10050110|FG000|Placebo|Overall Study||13
8986981|NCT02737397|10050110|FG000|COMPLETED|Overall Study||13
8986982|NCT02737397|10050110|FG000|NOT COMPLETED|Overall Study||0
8986983|NCT02737501|10050122|FG000|STARTED|Randomized Phase||137
8986984|NCT02737501|10050123|FG001|STARTED|Randomized Phase||138
8986985|NCT02737501|10050124|FG002|STARTED|Randomized Phase||0
8986986|NCT02737501|10050122|FG000|Safety Analysis Set|Randomized Phase||136
8986987|NCT02737501|10050123|FG001|Safety Analysis Set|Randomized Phase||137
8986988|NCT02737501|10050124|FG002|Safety Analysis Set|Randomized Phase||0
8986989|NCT02737501|10050122|FG000|COMPLETED|Randomized Phase||20
8986990|NCT02737501|10050123|FG001|COMPLETED|Randomized Phase||84
8986991|NCT02737501|10050124|FG002|COMPLETED|Randomized Phase||0
8986992|NCT02737501|10050122|FG000|NOT COMPLETED|Randomized Phase||117
8986993|NCT02737501|10050123|FG001|NOT COMPLETED|Randomized Phase||54
8986994|NCT02737501|10050124|FG002|NOT COMPLETED|Randomized Phase||0
8986995|NCT02737501|10050122|FG000|STARTED|Crossover Phase||0
8986996|NCT02737501|10050123|FG001|STARTED|Crossover Phase||0
8986997|NCT02737501|10050124|FG002|STARTED|Crossover Phase||65
8986998|NCT02737501|10050122|FG000|COMPLETED|Crossover Phase||0
8986999|NCT02737501|10050123|FG001|COMPLETED|Crossover Phase||0
8987000|NCT02737501|10050124|FG002|COMPLETED|Crossover Phase||10
8987001|NCT02737501|10050122|FG000|NOT COMPLETED|Crossover Phase||0
8987002|NCT02737501|10050123|FG001|NOT COMPLETED|Crossover Phase||0
8987003|NCT02737501|10050124|FG002|NOT COMPLETED|Crossover Phase||55
8987004|NCT02737592|10050132|FG000|STARTED|Overall Study||34
8987005|NCT02737592|10050132|FG000|COMPLETED|Overall Study||33
8987006|NCT02737592|10050132|FG000|NOT COMPLETED|Overall Study||1
8987007|NCT02737618|10050136|FG000|STARTED|Overall Study||43
8987008|NCT02737618|10050136|FG000|COMPLETED|Overall Study||34
8987009|NCT02737618|10050136|FG000|NOT COMPLETED|Overall Study||9
8987010|NCT02737631|10050140|FG000|STARTED|Overall Study||222
8987011|NCT02737631|10050140|FG000|COMPLETED|Overall Study||222
8987012|NCT02737631|10050140|FG000|NOT COMPLETED|Overall Study||0
8987013|NCT02737722|10050148|FG000|STARTED|Overall Study||8
8987014|NCT02737722|10050149|FG001|STARTED|Overall Study||8
8987015|NCT02737722|10050150|FG002|STARTED|Overall Study||8
8987016|NCT02737722|10050151|FG003|STARTED|Overall Study||6
8987017|NCT02737722|10050148|FG000|COMPLETED|Overall Study||8
8987018|NCT02737722|10050149|FG001|COMPLETED|Overall Study||8
8987019|NCT02737722|10050150|FG002|COMPLETED|Overall Study||7
8987020|NCT02737722|10050151|FG003|COMPLETED|Overall Study||6
8987021|NCT02737722|10050148|FG000|NOT COMPLETED|Overall Study||0
8987022|NCT02737722|10050149|FG001|NOT COMPLETED|Overall Study||0
8987023|NCT02737722|10050150|FG002|NOT COMPLETED|Overall Study||1
8987024|NCT02737722|10050151|FG003|NOT COMPLETED|Overall Study||0
8987025|NCT02737826|10050161|FG000|STARTED|Phase I - Buprenorphine Initiation||27
8987026|NCT02737826|10050162|FG001|STARTED|Phase I - Buprenorphine Initiation||0
8987027|NCT02737826|10050163|FG002|STARTED|Phase I - Buprenorphine Initiation||0
8987028|NCT02737826|10050161|FG000|COMPLETED|Phase I - Buprenorphine Initiation||27
8987029|NCT02737826|10050162|FG001|COMPLETED|Phase I - Buprenorphine Initiation||0
8987030|NCT02737826|10050163|FG002|COMPLETED|Phase I - Buprenorphine Initiation||0
8987031|NCT02737826|10050161|FG000|NOT COMPLETED|Phase I - Buprenorphine Initiation||0
8987032|NCT02737826|10050162|FG001|NOT COMPLETED|Phase I - Buprenorphine Initiation||0
8987033|NCT02737826|10050163|FG002|NOT COMPLETED|Phase I - Buprenorphine Initiation||0
8987034|NCT02737826|10050161|FG000|STARTED|Phase II - Randomization + Taper||0
8987035|NCT02737826|10050162|FG001|STARTED|Phase II - Randomization + Taper||13
8987036|NCT02737826|10050163|FG002|STARTED|Phase II - Randomization + Taper||14
8987037|NCT02737826|10050161|FG000|COMPLETED|Phase II - Randomization + Taper||0
8987038|NCT02737826|10050162|FG001|COMPLETED|Phase II - Randomization + Taper||1
8987039|NCT02737826|10050163|FG002|COMPLETED|Phase II - Randomization + Taper||0
8987040|NCT02737826|10050161|FG000|NOT COMPLETED|Phase II - Randomization + Taper||0
8987041|NCT02737826|10050162|FG001|NOT COMPLETED|Phase II - Randomization + Taper||12
8987042|NCT02737826|10050163|FG002|NOT COMPLETED|Phase II - Randomization + Taper||14
8987043|NCT02737852|10050172|FG000|STARTED|Overall Study||32
8987044|NCT02737852|10050172|FG000|COMPLETED|Overall Study||30
8987045|NCT02737852|10050172|FG000|NOT COMPLETED|Overall Study||2
8987046|NCT02737891|10050178|FG000|STARTED|Overall Study||30
8987047|NCT02737891|10050179|FG001|STARTED|Overall Study||30
8987048|NCT02737891|10050178|FG000|COMPLETED|Overall Study||30
8987049|NCT02737891|10050179|FG001|COMPLETED|Overall Study||28
8987050|NCT02737891|10050178|FG000|NOT COMPLETED|Overall Study||0
8987051|NCT02737891|10050179|FG001|NOT COMPLETED|Overall Study||2
8987052|NCT02737917|10050187|FG000|STARTED|Overall Study||103
8987053|NCT02737917|10050188|FG001|STARTED|Overall Study||103
8987054|NCT02737917|10050187|FG000|COMPLETED|Overall Study||100
8987055|NCT02737917|10050188|FG001|COMPLETED|Overall Study||100
8987056|NCT02737917|10050187|FG000|NOT COMPLETED|Overall Study||3
8878038|NCT01927861|9935080|FG000|STARTED|Extension Phase (104 Weeks)||25
8878039|NCT01927861|9935081|FG001|STARTED|Extension Phase (104 Weeks)||26
8878040|NCT01927861|9935080|FG000|COMPLETED|Extension Phase (104 Weeks)||25
8878041|NCT01927861|9935081|FG001|COMPLETED|Extension Phase (104 Weeks)||23
8878042|NCT01927861|9935080|FG000|NOT COMPLETED|Extension Phase (104 Weeks)||0
8878043|NCT01927861|9935081|FG001|NOT COMPLETED|Extension Phase (104 Weeks)||3
8878044|NCT01927861|9935080|FG000|STARTED|Extended Treatment Phase (26 Weeks)|15 participants agreed to continue the treatment for 26 weeks in the extended treatment phase.|15
8878045|NCT01927861|9935081|FG001|STARTED|Extended Treatment Phase (26 Weeks)|14 participants agreed to continue the treatment for 26 weeks in the extended treatment phase.|14
8878046|NCT01927861|9935080|FG000|COMPLETED|Extended Treatment Phase (26 Weeks)||15
8987057|NCT02737917|10050188|FG001|NOT COMPLETED|Overall Study||3
8987058|NCT02737930|10050196|FG000|STARTED|Overall Study||5
8987059|NCT02737930|10050197|FG001|STARTED|Overall Study||7
8987060|NCT02737930|10050196|FG000|COMPLETED|Overall Study||5
8987061|NCT02737930|10050197|FG001|COMPLETED|Overall Study||6
8987062|NCT02737930|10050196|FG000|NOT COMPLETED|Overall Study||0
8987063|NCT02737930|10050197|FG001|NOT COMPLETED|Overall Study||1
8987064|NCT02738008|10050206|FG000|STARTED|Overall Study||1
8987065|NCT02738008|10050207|FG001|STARTED|Overall Study||6
8987066|NCT02738008|10050208|FG002|STARTED|Overall Study||5
8987067|NCT02738008|10050206|FG000|COMPLETED|Overall Study||0
8987068|NCT02738008|10050207|FG001|COMPLETED|Overall Study||0
8987069|NCT02738008|10050208|FG002|COMPLETED|Overall Study||0
8987070|NCT02738008|10050206|FG000|NOT COMPLETED|Overall Study||1
8987071|NCT02738008|10050207|FG001|NOT COMPLETED|Overall Study||6
8987072|NCT02738008|10050208|FG002|NOT COMPLETED|Overall Study||5
8987073|NCT02738086|10050218|FG000|STARTED|Overall Study||16
8987074|NCT02738086|10050219|FG001|STARTED|Overall Study||15
8987075|NCT02738086|10050218|FG000|COMPLETED|Overall Study||14
8987076|NCT02738086|10050219|FG001|COMPLETED|Overall Study||13
8987077|NCT02738086|10050218|FG000|NOT COMPLETED|Overall Study||2
8987078|NCT02738086|10050219|FG001|NOT COMPLETED|Overall Study||2
8987079|NCT02738138|10050230|FG000|STARTED|Overall Study||137
8987080|NCT02738138|10050231|FG001|STARTED|Overall Study||16
8987081|NCT02738138|10050230|FG000|COMPLETED|Overall Study||134
8987082|NCT02738138|10050231|FG001|COMPLETED|Overall Study||15
8987083|NCT02738138|10050230|FG000|NOT COMPLETED|Overall Study||3
8987084|NCT02738138|10050231|FG001|NOT COMPLETED|Overall Study||1
8987085|NCT02738151|10050238|FG000|STARTED|Overall Study||466
8878047|NCT01927861|9935081|FG001|COMPLETED|Extended Treatment Phase (26 Weeks)||14
8878048|NCT01927861|9935080|FG000|NOT COMPLETED|Extended Treatment Phase (26 Weeks)||0
8878049|NCT01927861|9935081|FG001|NOT COMPLETED|Extended Treatment Phase (26 Weeks)||0
8878050|NCT01927887|9935087|FG000|STARTED|Overall Study||12
8987086|NCT02738151|10050239|FG001|STARTED|Overall Study||463
8987087|NCT02738151|10050238|FG000|Treated|Overall Study||462
8987088|NCT02738151|10050239|FG001|Treated|Overall Study||462
8987089|NCT02738151|10050238|FG000|COMPLETED|Overall Study||443
8987090|NCT02738151|10050239|FG001|COMPLETED|Overall Study||432
8987091|NCT02738151|10050238|FG000|NOT COMPLETED|Overall Study||23
8987092|NCT02738151|10050239|FG001|NOT COMPLETED|Overall Study||31
8987093|NCT02738203|10050247|FG000|STARTED|Overall Study||110
8987094|NCT02738203|10050248|FG001|STARTED|Overall Study||110
8987095|NCT02738203|10050247|FG000|COMPLETED|Overall Study||108
8987096|NCT02738203|10050248|FG001|COMPLETED|Overall Study||107
8987097|NCT02738203|10050247|FG000|NOT COMPLETED|Overall Study||2
8987098|NCT02738203|10050248|FG001|NOT COMPLETED|Overall Study||3
8987099|NCT02738333|10050257|FG000|STARTED|Overall Study||106
8987100|NCT02738333|10050258|FG001|STARTED|Overall Study||108
8987101|NCT02738333|10050259|FG002|STARTED|Overall Study||25
8987102|NCT02738333|10050257|FG000|COMPLETED|Overall Study||104
8987103|NCT02738333|10050258|FG001|COMPLETED|Overall Study||108
8987104|NCT02738333|10050259|FG002|COMPLETED|Overall Study||25
8987105|NCT02738333|10050257|FG000|NOT COMPLETED|Overall Study||2
8987106|NCT02738333|10050258|FG001|NOT COMPLETED|Overall Study||0
8987107|NCT02738333|10050259|FG002|NOT COMPLETED|Overall Study||0
8987108|NCT02738450|10050271|FG000|STARTED|Overall Study||6
8987109|NCT02738450|10050272|FG001|STARTED|Overall Study||6
8987110|NCT02738450|10050273|FG002|STARTED|Overall Study||4
8987111|NCT02738450|10050271|FG000|COMPLETED|Overall Study||6
8987112|NCT02738450|10050272|FG001|COMPLETED|Overall Study||4
8987113|NCT02738450|10050273|FG002|COMPLETED|Overall Study||4
8987114|NCT02738450|10050271|FG000|NOT COMPLETED|Overall Study||0
8987115|NCT02738450|10050272|FG001|NOT COMPLETED|Overall Study||2
8987116|NCT02738450|10050273|FG002|NOT COMPLETED|Overall Study||0
8987117|NCT02738580|10050284|FG000|STARTED|Overall Study|56 patients were assigned to this arms.|56
8987118|NCT02738580|10050285|FG001|STARTED|Overall Study||56
8987119|NCT02738580|10050284|FG000|COMPLETED|Overall Study|"3 cycles cancelled due to por response to stimullation.~1 cycle cancelled due to SAE."|52
8987120|NCT02738580|10050285|FG001|COMPLETED|Overall Study|"2 cycles cancelled due to por response to stimullation~1 patient withdrawal~1 excluded"|52
8987121|NCT02738580|10050284|FG000|NOT COMPLETED|Overall Study||4
8987122|NCT02738580|10050285|FG001|NOT COMPLETED|Overall Study||4
8987123|NCT02738775|10050297|FG000|STARTED|Overall Study||8
8987124|NCT02738775|10050298|FG001|STARTED|Overall Study||8
8987125|NCT02738775|10050299|FG002|STARTED|Overall Study||8
8987126|NCT02738775|10050300|FG003|STARTED|Overall Study||9
8987127|NCT02738775|10050301|FG004|STARTED|Overall Study||8
8987128|NCT02738775|10050302|FG005|STARTED|Overall Study||8
8987129|NCT02738775|10050297|FG000|Initially Treated With Placebo|Overall Study||0
8987130|NCT02738775|10050298|FG001|Initially Treated With Placebo|Overall Study||0
8987131|NCT02738775|10050299|FG002|Initially Treated With Placebo|Overall Study||0
8987132|NCT02738775|10050300|FG003|Initially Treated With Placebo|Overall Study||1
8987133|NCT02738775|10050301|FG004|Initially Treated With Placebo|Overall Study||0
8987134|NCT02738775|10050302|FG005|Initially Treated With Placebo|Overall Study||0
8987135|NCT02738775|10050297|FG000|COMPLETED|Overall Study||8
8987136|NCT02738775|10050298|FG001|COMPLETED|Overall Study||6
8987137|NCT02738775|10050299|FG002|COMPLETED|Overall Study||8
8987138|NCT02738775|10050300|FG003|COMPLETED|Overall Study||8
8987139|NCT02738775|10050301|FG004|COMPLETED|Overall Study||8
8987140|NCT02738775|10050302|FG005|COMPLETED|Overall Study||7
8987141|NCT02738775|10050297|FG000|NOT COMPLETED|Overall Study||0
8987142|NCT02738775|10050298|FG001|NOT COMPLETED|Overall Study||2
8987143|NCT02738775|10050299|FG002|NOT COMPLETED|Overall Study||0
8987144|NCT02738775|10050300|FG003|NOT COMPLETED|Overall Study||1
8987145|NCT02738775|10050301|FG004|NOT COMPLETED|Overall Study||0
8987146|NCT02738775|10050302|FG005|NOT COMPLETED|Overall Study||1
8987147|NCT02738801|10050322|FG000|STARTED|Overall Study||6
8987148|NCT02738801|10050323|FG001|STARTED|Overall Study||17
8632932|NCT00548262|9672961|FG000|COMPLETED|Overall Study|1 N had D/C recorded as died and as lack of efficacy; reported as lack of efficacy in reason for D/C|22
8632933|NCT00548262|9672961|FG000|NOT COMPLETED|Overall Study||32
8632934|NCT00548340|9672968|FG000|STARTED|Overall Study||109
8632935|NCT00548340|9672969|FG001|STARTED|Overall Study||109
8632936|NCT00548340|9672970|FG002|STARTED|Overall Study||104
8632937|NCT00548340|9672968|FG000|COMPLETED|Overall Study||101
8987149|NCT02738801|10050322|FG000|COMPLETED|Overall Study||5
8987150|NCT02738801|10050323|FG001|COMPLETED|Overall Study||15
8987151|NCT02738801|10050322|FG000|NOT COMPLETED|Overall Study||1
8987152|NCT02738801|10050323|FG001|NOT COMPLETED|Overall Study||2
8987153|NCT02738840|10050330|FG000|STARTED|Overall Study||56
8987154|NCT02738840|10050330|FG000|COMPLETED|Overall Study||48
8987155|NCT02738840|10050330|FG000|NOT COMPLETED|Overall Study||8
8987156|NCT02738879|10050336|FG000|STARTED|Overall Study||374
8987157|NCT02738879|10050337|FG001|STARTED|Overall Study||372
8987158|NCT02738879|10050336|FG000|Treated|Overall Study||373
8987159|NCT02738879|10050337|FG001|Treated|Overall Study||370
8987160|NCT02738879|10050336|FG000|COMPLETED|Overall Study||361
8987161|NCT02738879|10050337|FG001|COMPLETED|Overall Study||347
8987162|NCT02738879|10050336|FG000|NOT COMPLETED|Overall Study||13
8987163|NCT02738879|10050337|FG001|NOT COMPLETED|Overall Study||25
8987164|NCT02739100|10050343|FG000|STARTED|Overall Study||13
8987165|NCT02739100|10050343|FG000|Triferic 2 Micromolar Via Hemodialysate|Overall Study||13
8987166|NCT02739100|10050343|FG000|Triferic 6.6 mg IV Predialyzer|Overall Study||13
8987167|NCT02739100|10050343|FG000|Triferic 6.6. mg IV Post-dialyzer|Overall Study||13
8987168|NCT02739100|10050343|FG000|COMPLETED|Overall Study||13
8987169|NCT02739100|10050343|FG000|NOT COMPLETED|Overall Study||0
8987170|NCT02739269|10050353|FG000|STARTED|Overall Study||100
8987171|NCT02739269|10050354|FG001|STARTED|Overall Study||100
8987172|NCT02739269|10050353|FG000|COMPLETED|Overall Study||93
8987173|NCT02739269|10050354|FG001|COMPLETED|Overall Study||96
8987174|NCT02739269|10050353|FG000|NOT COMPLETED|Overall Study||7
8632938|NCT00548340|9672969|FG001|COMPLETED|Overall Study||98
8632939|NCT00548340|9672970|FG002|COMPLETED|Overall Study||95
8987175|NCT02739269|10050354|FG001|NOT COMPLETED|Overall Study||4
8987176|NCT02739321|10050362|FG000|STARTED|Overall Study||23
8987177|NCT02739321|10050363|FG001|STARTED|Overall Study||22
8987178|NCT02739321|10050362|FG000|COMPLETED|Overall Study||20
8987179|NCT02739321|10050363|FG001|COMPLETED|Overall Study||18
8987180|NCT02739321|10050362|FG000|NOT COMPLETED|Overall Study||3
8987181|NCT02739321|10050363|FG001|NOT COMPLETED|Overall Study||4
8987182|NCT02739360|10050378|FG000|STARTED|Overall Study||3
8987183|NCT02739360|10050378|FG000|COMPLETED|Overall Study||0
8987184|NCT02739360|10050378|FG000|NOT COMPLETED|Overall Study||3
8987185|NCT02739594|10050384|FG000|STARTED|Overall Study||46
8987186|NCT02739594|10050385|FG001|STARTED|Overall Study||43
8987187|NCT02739594|10050384|FG000|Completed at Week 44|Overall Study||11
8987188|NCT02739594|10050385|FG001|Completed at Week 44|Overall Study||5
8987189|NCT02739594|10050384|FG000|Completed at Week 96|Overall Study||10
8987190|NCT02739594|10050385|FG001|Completed at Week 96|Overall Study||10
8987191|NCT02739594|10050384|FG000|COMPLETED|Overall Study|Includes all participants who reached the protocol-defined end of study (either Week 44 or 96).|21
8987192|NCT02739594|10050385|FG001|COMPLETED|Overall Study|Includes all participants who reached the protocol-defined end of study (either Week 44 or 96).|15
8987193|NCT02739594|10050384|FG000|NOT COMPLETED|Overall Study||25
8987194|NCT02739594|10050385|FG001|NOT COMPLETED|Overall Study||28
8987195|NCT02739698|10050394|FG000|STARTED|Overall Study||22
8987196|NCT02739698|10050395|FG001|STARTED|Overall Study||21
8987197|NCT02739698|10050394|FG000|COMPLETED|Overall Study||16
8987198|NCT02739698|10050395|FG001|COMPLETED|Overall Study||16
8987199|NCT02739698|10050394|FG000|NOT COMPLETED|Overall Study||6
8987200|NCT02739698|10050395|FG001|NOT COMPLETED|Overall Study||5
8987201|NCT02739789|10050403|FG000|STARTED|First fMRI Scan||9
8987202|NCT02739789|10050404|FG001|STARTED|First fMRI Scan||10
8987203|NCT02739789|10050403|FG000|COMPLETED|First fMRI Scan||9
8987204|NCT02739789|10050404|FG001|COMPLETED|First fMRI Scan||10
8987205|NCT02739789|10050403|FG000|NOT COMPLETED|First fMRI Scan||0
8987206|NCT02739789|10050404|FG001|NOT COMPLETED|First fMRI Scan||0
8987207|NCT02739789|10050403|FG000|STARTED|~1 Week Waiting Period||9
8987208|NCT02739789|10050404|FG001|STARTED|~1 Week Waiting Period||10
8987209|NCT02739789|10050403|FG000|COMPLETED|~1 Week Waiting Period||9
8987210|NCT02739789|10050404|FG001|COMPLETED|~1 Week Waiting Period||7
8987211|NCT02739789|10050403|FG000|NOT COMPLETED|~1 Week Waiting Period||0
8987212|NCT02739789|10050404|FG001|NOT COMPLETED|~1 Week Waiting Period||3
8987213|NCT02739789|10050403|FG000|STARTED|Second fMRI Scan||9
8987214|NCT02739789|10050404|FG001|STARTED|Second fMRI Scan||7
8987215|NCT02739789|10050403|FG000|COMPLETED|Second fMRI Scan||9
8987216|NCT02739789|10050404|FG001|COMPLETED|Second fMRI Scan||7
8987217|NCT02739789|10050403|FG000|NOT COMPLETED|Second fMRI Scan||0
8987218|NCT02739789|10050404|FG001|NOT COMPLETED|Second fMRI Scan||0
8987219|NCT02739828|10050410|FG000|STARTED|Overall Study||24
8987220|NCT02739828|10050410|FG000|COMPLETED|Overall Study||19
8987221|NCT02739828|10050410|FG000|NOT COMPLETED|Overall Study||5
8987222|NCT02739984|10050416|FG000|STARTED|Overall Study||143
8987223|NCT02739984|10050417|FG001|STARTED|Overall Study||281
8987224|NCT02739984|10050416|FG000|Received Study Drug|Overall Study||141
8987225|NCT02739984|10050417|FG001|Received Study Drug|Overall Study||280
8987226|NCT02739984|10050416|FG000|COMPLETED|Overall Study||138
8987227|NCT02739984|10050417|FG001|COMPLETED|Overall Study||279
8987228|NCT02739984|10050416|FG000|NOT COMPLETED|Overall Study||5
8987229|NCT02739984|10050417|FG001|NOT COMPLETED|Overall Study||2
9038840|NCT03334448|10099973|FG001|COMPLETED|Washout||11
9038841|NCT03334448|10099974|FG002|COMPLETED|Washout||13
9038842|NCT03334448|10099975|FG003|COMPLETED|Washout||12
9038843|NCT03334448|10099972|FG000|NOT COMPLETED|Washout||0
9038844|NCT03334448|10099973|FG001|NOT COMPLETED|Washout||1
9038845|NCT03334448|10099974|FG002|NOT COMPLETED|Washout||0
9038846|NCT03334448|10099975|FG003|NOT COMPLETED|Washout||0
9038847|NCT03334448|10099972|FG000|STARTED|Period 3||12
9038848|NCT03334448|10099973|FG001|STARTED|Period 3||11
9038849|NCT03334448|10099974|FG002|STARTED|Period 3||13
9038850|NCT03334448|10099975|FG003|STARTED|Period 3||12
9038851|NCT03334448|10099972|FG000|Received at Least 1 Dose of Study Drug|Period 3||12
9038852|NCT03334448|10099973|FG001|Received at Least 1 Dose of Study Drug|Period 3||11
9038853|NCT03334448|10099974|FG002|Received at Least 1 Dose of Study Drug|Period 3||13
9038854|NCT03334448|10099975|FG003|Received at Least 1 Dose of Study Drug|Period 3||12
9038855|NCT03334448|10099972|FG000|COMPLETED|Period 3||12
9038856|NCT03334448|10099973|FG001|COMPLETED|Period 3||11
9038857|NCT03334448|10099974|FG002|COMPLETED|Period 3||13
9038858|NCT03334448|10099975|FG003|COMPLETED|Period 3||12
9038859|NCT03334448|10099972|FG000|NOT COMPLETED|Period 3||0
9038860|NCT03334448|10099973|FG001|NOT COMPLETED|Period 3||0
9038861|NCT03334448|10099974|FG002|NOT COMPLETED|Period 3||0
9038862|NCT03334448|10099975|FG003|NOT COMPLETED|Period 3||0
9038863|NCT03334448|10099972|FG000|STARTED|Washout||12
9038864|NCT03334448|10099973|FG001|STARTED|Washout||11
9038865|NCT03334448|10099974|FG002|STARTED|Washout||13
9038866|NCT03334448|10099975|FG003|STARTED|Washout||12
9038867|NCT03334448|10099972|FG000|COMPLETED|Washout||12
9038868|NCT03334448|10099973|FG001|COMPLETED|Washout||11
9038869|NCT03334448|10099974|FG002|COMPLETED|Washout||13
9038870|NCT03334448|10099975|FG003|COMPLETED|Washout||11
9038871|NCT03334448|10099972|FG000|NOT COMPLETED|Washout||0
9038872|NCT03334448|10099973|FG001|NOT COMPLETED|Washout||0
9038873|NCT03334448|10099974|FG002|NOT COMPLETED|Washout||0
9038874|NCT03334448|10099975|FG003|NOT COMPLETED|Washout||1
9038875|NCT03334448|10099972|FG000|STARTED|Period 4||12
9038876|NCT03334448|10099973|FG001|STARTED|Period 4||11
9038877|NCT03334448|10099974|FG002|STARTED|Period 4||13
9038878|NCT03334448|10099975|FG003|STARTED|Period 4||11
9038879|NCT03334448|10099972|FG000|Received at Least 1 Dose of Study Drug|Period 4||12
8987230|NCT02739997|10050423|FG000|STARTED|Overall Study||100
8987231|NCT02739997|10050423|FG000|COMPLETED|Overall Study||98
8987232|NCT02739997|10050423|FG000|NOT COMPLETED|Overall Study||2
8987233|NCT02740049|10050427|FG000|STARTED|Overall Study||9
8987234|NCT02740049|10050427|FG000|COMPLETED|Overall Study||8
8987235|NCT02740049|10050427|FG000|NOT COMPLETED|Overall Study||1
8987236|NCT02740114|10050433|FG000|STARTED|Overall Study||54
8987237|NCT02740114|10050434|FG001|STARTED|Overall Study||48
8987238|NCT02740114|10050433|FG000|COMPLETED|Overall Study||54
8987239|NCT02740114|10050434|FG001|COMPLETED|Overall Study||48
8987240|NCT02740114|10050433|FG000|NOT COMPLETED|Overall Study||0
8987241|NCT02740114|10050434|FG001|NOT COMPLETED|Overall Study||0
8987242|NCT02740153|10050442|FG000|STARTED|Overall Study||101
8987243|NCT02740153|10050443|FG001|STARTED|Overall Study||86
8987244|NCT02740153|10050442|FG000|COMPLETED|Overall Study||101
8987245|NCT02740153|10050443|FG001|COMPLETED|Overall Study||86
8987246|NCT02740153|10050442|FG000|NOT COMPLETED|Overall Study||0
8987247|NCT02740153|10050443|FG001|NOT COMPLETED|Overall Study||0
8987248|NCT02740413|10050451|FG000|STARTED|Overall Study||86
8987249|NCT02740413|10050451|FG000|COMPLETED|Overall Study||86
8987250|NCT02740413|10050451|FG000|NOT COMPLETED|Overall Study||0
8987251|NCT02740478|10050459|FG000|STARTED|Overall Study|Volunteers recruited until quantity 20 completed the study|21
8987252|NCT02740478|10050459|FG000|COMPLETED|Overall Study|One volunteer was very high BMI and uncomfortable lying still during the recordings: test stopped.|20
8987253|NCT02740478|10050459|FG000|NOT COMPLETED|Overall Study||1
8987254|NCT02740504|10050463|FG000|STARTED|Overall Study||20
8987255|NCT02740504|10050463|FG000|COMPLETED|Overall Study||20
8987256|NCT02740504|10050463|FG000|NOT COMPLETED|Overall Study||0
8987257|NCT02740517|10050470|FG000|STARTED|Overall Study||19
8987258|NCT02740517|10050471|FG001|STARTED|Overall Study||11
8987259|NCT02740517|10050472|FG002|STARTED|Overall Study||18
8987260|NCT02740517|10050470|FG000|COMPLETED|Overall Study||19
8987261|NCT02740517|10050471|FG001|COMPLETED|Overall Study||11
8987262|NCT02740517|10050472|FG002|COMPLETED|Overall Study||18
8987263|NCT02740517|10050470|FG000|NOT COMPLETED|Overall Study||0
8987264|NCT02740517|10050471|FG001|NOT COMPLETED|Overall Study||0
8987265|NCT02740517|10050472|FG002|NOT COMPLETED|Overall Study||0
8987266|NCT02740543|10050482|FG000|STARTED|Overall Study||9
8878051|NCT01927887|9935087|FG000|COMPLETED|Overall Study||12
8878052|NCT01927887|9935087|FG000|NOT COMPLETED|Overall Study||0
8878053|NCT01928030|9935092|FG000|STARTED|Overall Study||3
8878054|NCT01928030|9935093|FG001|STARTED|Overall Study||0
8878055|NCT01928030|9935094|FG002|STARTED|Overall Study||0
8878056|NCT01928030|9935092|FG000|COMPLETED|Overall Study||3
8878057|NCT01928030|9935093|FG001|COMPLETED|Overall Study||0
8878058|NCT01928030|9935094|FG002|COMPLETED|Overall Study||0
8987267|NCT02740543|10050483|FG001|STARTED|Overall Study||9
8987268|NCT02740543|10050482|FG000|COMPLETED|Overall Study||9
8987269|NCT02740543|10050483|FG001|COMPLETED|Overall Study||9
8987270|NCT02740543|10050482|FG000|NOT COMPLETED|Overall Study||0
8987271|NCT02740543|10050483|FG001|NOT COMPLETED|Overall Study||0
8987272|NCT02740582|10050491|FG000|STARTED|First Intervention||29
8987273|NCT02740582|10050492|FG001|STARTED|First Intervention||33
8987274|NCT02740582|10050491|FG000|COMPLETED|First Intervention||24
8987275|NCT02740582|10050492|FG001|COMPLETED|First Intervention||31
8987276|NCT02740582|10050491|FG000|NOT COMPLETED|First Intervention||5
8987277|NCT02740582|10050492|FG001|NOT COMPLETED|First Intervention||2
8987278|NCT02740582|10050491|FG000|STARTED|Washout||24
8987279|NCT02740582|10050492|FG001|STARTED|Washout||31
8987280|NCT02740582|10050491|FG000|COMPLETED|Washout||24
8987281|NCT02740582|10050492|FG001|COMPLETED|Washout||31
8987282|NCT02740582|10050491|FG000|NOT COMPLETED|Washout||0
8987283|NCT02740582|10050492|FG001|NOT COMPLETED|Washout||0
8987284|NCT02740582|10050491|FG000|STARTED|Second Intervention||24
8987285|NCT02740582|10050492|FG001|STARTED|Second Intervention||31
8987286|NCT02740582|10050491|FG000|COMPLETED|Second Intervention||23
8987287|NCT02740582|10050492|FG001|COMPLETED|Second Intervention||28
8987288|NCT02740582|10050491|FG000|NOT COMPLETED|Second Intervention||1
8987289|NCT02740582|10050492|FG001|NOT COMPLETED|Second Intervention||3
8878059|NCT01928030|9935092|FG000|NOT COMPLETED|Overall Study||0
8878060|NCT01928030|9935093|FG001|NOT COMPLETED|Overall Study||0
8878061|NCT01928030|9935094|FG002|NOT COMPLETED|Overall Study||0
8878062|NCT01928186|9935101|FG000|STARTED|Overall Study||28
8987290|NCT02740660|10050500|FG000|STARTED|Overall Study||6
8987291|NCT02740660|10050501|FG001|STARTED|Overall Study||6
8987292|NCT02740660|10050500|FG000|COMPLETED|Overall Study||6
8987293|NCT02740660|10050501|FG001|COMPLETED|Overall Study||6
8987294|NCT02740660|10050500|FG000|NOT COMPLETED|Overall Study||0
8987295|NCT02740660|10050501|FG001|NOT COMPLETED|Overall Study||0
8987296|NCT02740920|10050507|FG000|STARTED|Overall Study||9
8987297|NCT02740920|10050507|FG000|COMPLETED|Overall Study||9
8987298|NCT02740920|10050507|FG000|NOT COMPLETED|Overall Study||0
8987299|NCT02741076|10050515|FG000|STARTED|Overall Study||13
8987300|NCT02741076|10050516|FG001|STARTED|Overall Study||12
8987301|NCT02741076|10050517|FG002|STARTED|Overall Study||3
8987302|NCT02741076|10050518|FG003|STARTED|Overall Study||4
8987303|NCT02741076|10050515|FG000|COMPLETED|Overall Study||10
8987304|NCT02741076|10050516|FG001|COMPLETED|Overall Study||7
8987305|NCT02741076|10050517|FG002|COMPLETED|Overall Study||1
8987306|NCT02741076|10050518|FG003|COMPLETED|Overall Study||2
8987307|NCT02741076|10050515|FG000|NOT COMPLETED|Overall Study||3
8987308|NCT02741076|10050516|FG001|NOT COMPLETED|Overall Study||5
8987309|NCT02741076|10050517|FG002|NOT COMPLETED|Overall Study||2
8987310|NCT02741076|10050518|FG003|NOT COMPLETED|Overall Study||2
8987311|NCT02741284|10050531|FG000|STARTED|Overall Study||57
8987312|NCT02741284|10050532|FG001|STARTED|Overall Study||57
8987313|NCT02741284|10050531|FG000|COMPLETED|Overall Study||51
8987314|NCT02741284|10050532|FG001|COMPLETED|Overall Study||48
8987315|NCT02741284|10050531|FG000|NOT COMPLETED|Overall Study||6
8987316|NCT02741284|10050532|FG001|NOT COMPLETED|Overall Study||9
8987317|NCT02741297|10050540|FG000|STARTED|Overall Study||73
8987318|NCT02741297|10050540|FG000|COMPLETED|Overall Study||59
8987319|NCT02741297|10050540|FG000|NOT COMPLETED|Overall Study||14
8987320|NCT02741310|10050546|FG000|STARTED|Overall Study||12
8987321|NCT02741310|10050547|FG001|STARTED|Overall Study||22
8987322|NCT02741310|10050546|FG000|COMPLETED|Overall Study||10
8987323|NCT02741310|10050547|FG001|COMPLETED|Overall Study||20
8987324|NCT02741310|10050546|FG000|NOT COMPLETED|Overall Study||2
8987325|NCT02741310|10050547|FG001|NOT COMPLETED|Overall Study||2
8987326|NCT02741518|10050563|FG000|STARTED|Overall Study||11
8987327|NCT02741518|10050564|FG001|STARTED|Overall Study||11
8987328|NCT02741518|10050563|FG000|COMPLETED|Overall Study||10
8987329|NCT02741518|10050564|FG001|COMPLETED|Overall Study||10
8987330|NCT02741518|10050563|FG000|NOT COMPLETED|Overall Study||1
8987331|NCT02741518|10050564|FG001|NOT COMPLETED|Overall Study||1
8987332|NCT02741596|10050572|FG000|STARTED|Overall Study||109
8987333|NCT02741596|10050573|FG001|STARTED|Overall Study||103
8987334|NCT02741596|10050572|FG000|COMPLETED|Overall Study||31
8632940|NCT00548340|9672968|FG000|NOT COMPLETED|Overall Study||8
8632941|NCT00548340|9672969|FG001|NOT COMPLETED|Overall Study||11
8632942|NCT00548340|9672970|FG002|NOT COMPLETED|Overall Study||9
8987335|NCT02741596|10050573|FG001|COMPLETED|Overall Study||25
8987336|NCT02741596|10050572|FG000|NOT COMPLETED|Overall Study||78
8987337|NCT02741596|10050573|FG001|NOT COMPLETED|Overall Study||78
8987338|NCT02741635|10050579|FG000|STARTED|Overall Study||15
8987339|NCT02741635|10050579|FG000|COMPLETED|Overall Study||14
8987340|NCT02741635|10050579|FG000|NOT COMPLETED|Overall Study||1
8987341|NCT02741687|10050586|FG000|STARTED|Overall Study||36
8987342|NCT02741687|10050587|FG001|STARTED|Overall Study||44
8987343|NCT02741687|10050586|FG000|COMPLETED|Overall Study||36
8987344|NCT02741687|10050587|FG001|COMPLETED|Overall Study||44
8987345|NCT02741687|10050586|FG000|NOT COMPLETED|Overall Study||0
8987346|NCT02741687|10050587|FG001|NOT COMPLETED|Overall Study||0
8987347|NCT02741713|10050595|FG000|STARTED|Overall Study||20
8987348|NCT02741713|10050596|FG001|STARTED|Overall Study||20
8987349|NCT02741713|10050595|FG000|COMPLETED|Overall Study||18
8987350|NCT02741713|10050596|FG001|COMPLETED|Overall Study||19
8987351|NCT02741713|10050595|FG000|NOT COMPLETED|Overall Study||2
8987352|NCT02741713|10050596|FG001|NOT COMPLETED|Overall Study||1
8987353|NCT02742077|10050603|FG000|STARTED|Overall Study||20
8987354|NCT02742077|10050603|FG000|COMPLETED|Overall Study||20
8987355|NCT02742077|10050603|FG000|NOT COMPLETED|Overall Study||0
8987356|NCT02742103|10050609|FG000|STARTED|Overall Study||55
8987357|NCT02742103|10050610|FG001|STARTED|Overall Study||28
8987358|NCT02742103|10050609|FG000|COMPLETED|Overall Study||46
8987359|NCT02742103|10050610|FG001|COMPLETED|Overall Study||23
8987360|NCT02742103|10050609|FG000|NOT COMPLETED|Overall Study||9
8987361|NCT02742103|10050610|FG001|NOT COMPLETED|Overall Study||5
8987362|NCT02742129|10050618|FG000|STARTED|Phase 1||53
8987363|NCT02742129|10050619|FG001|STARTED|Phase 1||52
8987364|NCT02742129|10050618|FG000|COMPLETED|Phase 1||51
8987365|NCT02742129|10050619|FG001|COMPLETED|Phase 1||50
8987366|NCT02742129|10050618|FG000|NOT COMPLETED|Phase 1||2
8987367|NCT02742129|10050619|FG001|NOT COMPLETED|Phase 1||2
8987368|NCT02742129|10050618|FG000|STARTED|Phase 2||51
8987369|NCT02742129|10050619|FG001|STARTED|Phase 2||50
8987370|NCT02742129|10050618|FG000|COMPLETED|Phase 2||50
8987371|NCT02742129|10050619|FG001|COMPLETED|Phase 2||48
8987372|NCT02742129|10050618|FG000|NOT COMPLETED|Phase 2||1
8987373|NCT02742129|10050619|FG001|NOT COMPLETED|Phase 2||2
8987374|NCT02742441|10050630|FG000|STARTED|Overall Study||205
8987375|NCT02742441|10050631|FG001|STARTED|Overall Study||204
8987376|NCT02742441|10050630|FG000|COMPLETED|Overall Study||199
8987377|NCT02742441|10050631|FG001|COMPLETED|Overall Study||196
8987378|NCT02742441|10050630|FG000|NOT COMPLETED|Overall Study||6
8987379|NCT02742441|10050631|FG001|NOT COMPLETED|Overall Study||8
8987380|NCT02742519|10050639|FG000|STARTED|Part 1 Treatment Period 1 (8 Weeks)||8
8987381|NCT02742519|10050640|FG001|STARTED|Part 1 Treatment Period 1 (8 Weeks)||6
8987382|NCT02742519|10050641|FG002|STARTED|Part 1 Treatment Period 1 (8 Weeks)||0
8987383|NCT02742519|10050639|FG000|COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||8
8987384|NCT02742519|10050640|FG001|COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||6
8987385|NCT02742519|10050641|FG002|COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||0
8987386|NCT02742519|10050639|FG000|NOT COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||0
8632943|NCT00548405|9672981|FG000|STARTED|Overall Study|Randomized.|231
8987387|NCT02742519|10050640|FG001|NOT COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||0
8987388|NCT02742519|10050641|FG002|NOT COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||0
8987389|NCT02742519|10050639|FG000|STARTED|Part 1 Treatment Period 2 (8 Weeks)||8
8987390|NCT02742519|10050640|FG001|STARTED|Part 1 Treatment Period 2 (8 Weeks)||6
8987391|NCT02742519|10050641|FG002|STARTED|Part 1 Treatment Period 2 (8 Weeks)||0
8987392|NCT02742519|10050639|FG000|COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||7
8987393|NCT02742519|10050640|FG001|COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||5
8987394|NCT02742519|10050641|FG002|COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||0
8987395|NCT02742519|10050639|FG000|NOT COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||1
8987396|NCT02742519|10050640|FG001|NOT COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||1
8987397|NCT02742519|10050641|FG002|NOT COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||0
8987398|NCT02742519|10050639|FG000|STARTED|Part 2 Open Label Period (32 Weeks)||0
8987399|NCT02742519|10050640|FG001|STARTED|Part 2 Open Label Period (32 Weeks)||0
8987400|NCT02742519|10050641|FG002|STARTED|Part 2 Open Label Period (32 Weeks)|Of 12 participants who completed DB period, only 10 entered OL period & 2 opted for commercial drug.|10
8987401|NCT02742519|10050639|FG000|COMPLETED|Part 2 Open Label Period (32 Weeks)||0
8987402|NCT02742519|10050640|FG001|COMPLETED|Part 2 Open Label Period (32 Weeks)||0
8987403|NCT02742519|10050641|FG002|COMPLETED|Part 2 Open Label Period (32 Weeks)||0
8987404|NCT02742519|10050639|FG000|NOT COMPLETED|Part 2 Open Label Period (32 Weeks)||0
8987405|NCT02742519|10050640|FG001|NOT COMPLETED|Part 2 Open Label Period (32 Weeks)||0
8987406|NCT02742519|10050641|FG002|NOT COMPLETED|Part 2 Open Label Period (32 Weeks)||10
8987407|NCT02742532|10050651|FG000|STARTED|Overall Study||31
8987408|NCT02742532|10050652|FG001|STARTED|Overall Study||32
8987409|NCT02742532|10050651|FG000|COMPLETED|Overall Study||28
8987410|NCT02742532|10050652|FG001|COMPLETED|Overall Study||31
8987411|NCT02742532|10050651|FG000|NOT COMPLETED|Overall Study||3
8987412|NCT02742532|10050652|FG001|NOT COMPLETED|Overall Study||1
8987413|NCT02742649|10050661|FG000|STARTED|Pre-Randomization Washout Period||55
8987414|NCT02742649|10050662|FG001|STARTED|Pre-Randomization Washout Period||0
8987415|NCT02742649|10050663|FG002|STARTED|Pre-Randomization Washout Period||0
8987416|NCT02742649|10050664|FG003|STARTED|Pre-Randomization Washout Period||0
8987417|NCT02742649|10050665|FG004|STARTED|Pre-Randomization Washout Period||0
8987418|NCT02742649|10050661|FG000|COMPLETED|Pre-Randomization Washout Period||50
8987419|NCT02742649|10050662|FG001|COMPLETED|Pre-Randomization Washout Period||0
8987420|NCT02742649|10050663|FG002|COMPLETED|Pre-Randomization Washout Period||0
8987421|NCT02742649|10050664|FG003|COMPLETED|Pre-Randomization Washout Period||0
8987422|NCT02742649|10050665|FG004|COMPLETED|Pre-Randomization Washout Period||0
8987423|NCT02742649|10050661|FG000|NOT COMPLETED|Pre-Randomization Washout Period||5
8987424|NCT02742649|10050662|FG001|NOT COMPLETED|Pre-Randomization Washout Period||0
8987425|NCT02742649|10050663|FG002|NOT COMPLETED|Pre-Randomization Washout Period||0
8987426|NCT02742649|10050664|FG003|NOT COMPLETED|Pre-Randomization Washout Period||0
8987427|NCT02742649|10050665|FG004|NOT COMPLETED|Pre-Randomization Washout Period||0
8987428|NCT02742649|10050661|FG000|STARTED|Double-Blind Treatment Period||0
8987429|NCT02742649|10050662|FG001|STARTED|Double-Blind Treatment Period||17
8987430|NCT02742649|10050663|FG002|STARTED|Double-Blind Treatment Period||17
8987431|NCT02742649|10050664|FG003|STARTED|Double-Blind Treatment Period||16
8987432|NCT02742649|10050665|FG004|STARTED|Double-Blind Treatment Period||0
8987433|NCT02742649|10050661|FG000|COMPLETED|Double-Blind Treatment Period||0
8987434|NCT02742649|10050662|FG001|COMPLETED|Double-Blind Treatment Period||16
8987435|NCT02742649|10050663|FG002|COMPLETED|Double-Blind Treatment Period||17
8987436|NCT02742649|10050664|FG003|COMPLETED|Double-Blind Treatment Period||16
8987437|NCT02742649|10050665|FG004|COMPLETED|Double-Blind Treatment Period||0
8987438|NCT02742649|10050661|FG000|NOT COMPLETED|Double-Blind Treatment Period||0
8987439|NCT02742649|10050662|FG001|NOT COMPLETED|Double-Blind Treatment Period||1
8987440|NCT02742649|10050663|FG002|NOT COMPLETED|Double-Blind Treatment Period||0
8987441|NCT02742649|10050664|FG003|NOT COMPLETED|Double-Blind Treatment Period||0
8987442|NCT02742649|10050665|FG004|NOT COMPLETED|Double-Blind Treatment Period||0
8987443|NCT02742649|10050661|FG000|STARTED|Open-Label Period||0
8987444|NCT02742649|10050662|FG001|STARTED|Open-Label Period||0
8987445|NCT02742649|10050663|FG002|STARTED|Open-Label Period||0
8987446|NCT02742649|10050664|FG003|STARTED|Open-Label Period||0
8987447|NCT02742649|10050665|FG004|STARTED|Open-Label Period||49
8987448|NCT02742649|10050661|FG000|COMPLETED|Open-Label Period||0
8987449|NCT02742649|10050662|FG001|COMPLETED|Open-Label Period||0
8987450|NCT02742649|10050663|FG002|COMPLETED|Open-Label Period||0
8987451|NCT02742649|10050664|FG003|COMPLETED|Open-Label Period||0
8987452|NCT02742649|10050665|FG004|COMPLETED|Open-Label Period||48
8987453|NCT02742649|10050661|FG000|NOT COMPLETED|Open-Label Period||0
8987454|NCT02742649|10050662|FG001|NOT COMPLETED|Open-Label Period||0
8987455|NCT02742649|10050663|FG002|NOT COMPLETED|Open-Label Period||0
8987456|NCT02742649|10050664|FG003|NOT COMPLETED|Open-Label Period||0
8987457|NCT02742649|10050665|FG004|NOT COMPLETED|Open-Label Period||1
8987458|NCT02742766|10050695|FG000|STARTED|Part 1 (Up to 8 Days)||20
8987459|NCT02742766|10050696|FG001|STARTED|Part 1 (Up to 8 Days)||6
8987460|NCT02742766|10050697|FG002|STARTED|Part 1 (Up to 8 Days)||6
8987461|NCT02742766|10050698|FG003|STARTED|Part 1 (Up to 8 Days)||6
8987462|NCT02742766|10050699|FG004|STARTED|Part 1 (Up to 8 Days)||6
8987463|NCT02742766|10050700|FG005|STARTED|Part 1 (Up to 8 Days)||6
8987464|NCT02742766|10050701|FG006|STARTED|Part 1 (Up to 8 Days)||6
8987465|NCT02742766|10050702|FG007|STARTED|Part 1 (Up to 8 Days)||6
8987466|NCT02742766|10050703|FG008|STARTED|Part 1 (Up to 8 Days)||6
8987467|NCT02742766|10050704|FG009|STARTED|Part 1 (Up to 8 Days)||0
8987468|NCT02742766|10050705|FG010|STARTED|Part 1 (Up to 8 Days)||6
8987469|NCT02742766|10050706|FG011|STARTED|Part 1 (Up to 8 Days)||6
8987470|NCT02742766|10050707|FG012|STARTED|Part 1 (Up to 8 Days)||0
8987471|NCT02742766|10050708|FG013|STARTED|Part 1 (Up to 8 Days)||0
8987472|NCT02742766|10050709|FG014|STARTED|Part 1 (Up to 8 Days)||0
8987473|NCT02742766|10050710|FG015|STARTED|Part 1 (Up to 8 Days)||0
8987474|NCT02742766|10050711|FG016|STARTED|Part 1 (Up to 8 Days)||0
8987475|NCT02742766|10050712|FG017|STARTED|Part 1 (Up to 8 Days)||0
8987476|NCT02742766|10050713|FG018|STARTED|Part 1 (Up to 8 Days)||0
8987477|NCT02742766|10050695|FG000|COMPLETED|Part 1 (Up to 8 Days)||20
8987478|NCT02742766|10050696|FG001|COMPLETED|Part 1 (Up to 8 Days)||6
8987479|NCT02742766|10050697|FG002|COMPLETED|Part 1 (Up to 8 Days)||6
8987480|NCT02742766|10050698|FG003|COMPLETED|Part 1 (Up to 8 Days)||6
8987481|NCT02742766|10050699|FG004|COMPLETED|Part 1 (Up to 8 Days)||6
8987482|NCT02742766|10050700|FG005|COMPLETED|Part 1 (Up to 8 Days)||6
8987483|NCT02742766|10050701|FG006|COMPLETED|Part 1 (Up to 8 Days)||6
8987484|NCT02742766|10050702|FG007|COMPLETED|Part 1 (Up to 8 Days)||6
8987485|NCT02742766|10050703|FG008|COMPLETED|Part 1 (Up to 8 Days)||6
8987486|NCT02742766|10050704|FG009|COMPLETED|Part 1 (Up to 8 Days)||0
8987487|NCT02742766|10050705|FG010|COMPLETED|Part 1 (Up to 8 Days)||6
8987488|NCT02742766|10050706|FG011|COMPLETED|Part 1 (Up to 8 Days)||6
8987489|NCT02742766|10050707|FG012|COMPLETED|Part 1 (Up to 8 Days)||0
8987490|NCT02742766|10050708|FG013|COMPLETED|Part 1 (Up to 8 Days)||0
8987491|NCT02742766|10050709|FG014|COMPLETED|Part 1 (Up to 8 Days)||0
8987492|NCT02742766|10050710|FG015|COMPLETED|Part 1 (Up to 8 Days)||0
8987493|NCT02742766|10050711|FG016|COMPLETED|Part 1 (Up to 8 Days)||0
8987494|NCT02742766|10050712|FG017|COMPLETED|Part 1 (Up to 8 Days)||0
8987495|NCT02742766|10050713|FG018|COMPLETED|Part 1 (Up to 8 Days)||0
8987496|NCT02742766|10050695|FG000|NOT COMPLETED|Part 1 (Up to 8 Days)||0
8987497|NCT02742766|10050696|FG001|NOT COMPLETED|Part 1 (Up to 8 Days)||0
8987498|NCT02742766|10050697|FG002|NOT COMPLETED|Part 1 (Up to 8 Days)||0
8987499|NCT02742766|10050698|FG003|NOT COMPLETED|Part 1 (Up to 8 Days)||0
8987500|NCT02742766|10050699|FG004|NOT COMPLETED|Part 1 (Up to 8 Days)||0
8987501|NCT02742766|10050700|FG005|NOT COMPLETED|Part 1 (Up to 8 Days)||0
8987502|NCT02742766|10050701|FG006|NOT COMPLETED|Part 1 (Up to 8 Days)||0
8987503|NCT02742766|10050702|FG007|NOT COMPLETED|Part 1 (Up to 8 Days)||0
8987504|NCT02742766|10050703|FG008|NOT COMPLETED|Part 1 (Up to 8 Days)||0
8987505|NCT02742766|10050704|FG009|NOT COMPLETED|Part 1 (Up to 8 Days)||0
8987506|NCT02742766|10050705|FG010|NOT COMPLETED|Part 1 (Up to 8 Days)||0
8987507|NCT02742766|10050706|FG011|NOT COMPLETED|Part 1 (Up to 8 Days)||0
8987508|NCT02742766|10050707|FG012|NOT COMPLETED|Part 1 (Up to 8 Days)||0
8987509|NCT02742766|10050708|FG013|NOT COMPLETED|Part 1 (Up to 8 Days)||0
8987510|NCT02742766|10050709|FG014|NOT COMPLETED|Part 1 (Up to 8 Days)||0
8987511|NCT02742766|10050710|FG015|NOT COMPLETED|Part 1 (Up to 8 Days)||0
8987512|NCT02742766|10050711|FG016|NOT COMPLETED|Part 1 (Up to 8 Days)||0
8987513|NCT02742766|10050712|FG017|NOT COMPLETED|Part 1 (Up to 8 Days)||0
8987514|NCT02742766|10050713|FG018|NOT COMPLETED|Part 1 (Up to 8 Days)||0
8987515|NCT02742766|10050695|FG000|STARTED|Part 2 (Up to 22 Days)||0
8987516|NCT02742766|10050696|FG001|STARTED|Part 2 (Up to 22 Days)||0
8987517|NCT02742766|10050697|FG002|STARTED|Part 2 (Up to 22 Days)||0
8987518|NCT02742766|10050698|FG003|STARTED|Part 2 (Up to 22 Days)||0
8987519|NCT02742766|10050699|FG004|STARTED|Part 2 (Up to 22 Days)||0
8987520|NCT02742766|10050700|FG005|STARTED|Part 2 (Up to 22 Days)||0
8987521|NCT02742766|10050701|FG006|STARTED|Part 2 (Up to 22 Days)||0
8632944|NCT00548405|9672982|FG001|STARTED|Overall Study|Randomized.|436
8878063|NCT01928186|9935101|FG000|COMPLETED|Overall Study||28
8878064|NCT01928186|9935101|FG000|NOT COMPLETED|Overall Study||0
8987522|NCT02742766|10050702|FG007|STARTED|Part 2 (Up to 22 Days)||0
8987523|NCT02742766|10050703|FG008|STARTED|Part 2 (Up to 22 Days)||0
8987524|NCT02742766|10050704|FG009|STARTED|Part 2 (Up to 22 Days)||0
8987525|NCT02742766|10050705|FG010|STARTED|Part 2 (Up to 22 Days)||0
8987526|NCT02742766|10050706|FG011|STARTED|Part 2 (Up to 22 Days)||0
8987527|NCT02742766|10050707|FG012|STARTED|Part 2 (Up to 22 Days)||6
8987528|NCT02742766|10050708|FG013|STARTED|Part 2 (Up to 22 Days)||6
8987529|NCT02742766|10050709|FG014|STARTED|Part 2 (Up to 22 Days)||6
8987530|NCT02742766|10050710|FG015|STARTED|Part 2 (Up to 22 Days)||6
8987531|NCT02742766|10050711|FG016|STARTED|Part 2 (Up to 22 Days)||0
8987532|NCT02742766|10050712|FG017|STARTED|Part 2 (Up to 22 Days)||0
8987533|NCT02742766|10050713|FG018|STARTED|Part 2 (Up to 22 Days)||0
8987534|NCT02742766|10050695|FG000|COMPLETED|Part 2 (Up to 22 Days)||0
8632945|NCT00548405|9672983|FG002|STARTED|Overall Study|Randomized.|173
8878065|NCT01928199|9935107|FG000|STARTED|Overall Study||32
8878066|NCT01928199|9935108|FG001|STARTED|Overall Study||29
8878067|NCT01928199|9935107|FG000|COMPLETED|Overall Study||32
8878068|NCT01928199|9935108|FG001|COMPLETED|Overall Study||29
8878069|NCT01928199|9935107|FG000|NOT COMPLETED|Overall Study||0
8878070|NCT01928199|9935108|FG001|NOT COMPLETED|Overall Study||0
8878071|NCT01928225|9935116|FG000|STARTED|Overall Study||90
8987535|NCT02742766|10050696|FG001|COMPLETED|Part 2 (Up to 22 Days)||0
8987536|NCT02742766|10050697|FG002|COMPLETED|Part 2 (Up to 22 Days)||0
8987537|NCT02742766|10050698|FG003|COMPLETED|Part 2 (Up to 22 Days)||0
8987538|NCT02742766|10050699|FG004|COMPLETED|Part 2 (Up to 22 Days)||0
8987539|NCT02742766|10050700|FG005|COMPLETED|Part 2 (Up to 22 Days)||0
8987540|NCT02742766|10050701|FG006|COMPLETED|Part 2 (Up to 22 Days)||0
8987541|NCT02742766|10050702|FG007|COMPLETED|Part 2 (Up to 22 Days)||0
8987542|NCT02742766|10050703|FG008|COMPLETED|Part 2 (Up to 22 Days)||0
8878072|NCT01928225|9935117|FG001|STARTED|Overall Study||90
8987543|NCT02742766|10050704|FG009|COMPLETED|Part 2 (Up to 22 Days)||0
8987544|NCT02742766|10050705|FG010|COMPLETED|Part 2 (Up to 22 Days)||0
8987545|NCT02742766|10050706|FG011|COMPLETED|Part 2 (Up to 22 Days)||0
8987546|NCT02742766|10050707|FG012|COMPLETED|Part 2 (Up to 22 Days)||4
8987547|NCT02742766|10050708|FG013|COMPLETED|Part 2 (Up to 22 Days)||0
8987548|NCT02742766|10050709|FG014|COMPLETED|Part 2 (Up to 22 Days)||6
8987549|NCT02742766|10050710|FG015|COMPLETED|Part 2 (Up to 22 Days)|Day 4 study medication interrupted due to an AE and eventually withdrew from study on Day 5.|5
8987550|NCT02742766|10050711|FG016|COMPLETED|Part 2 (Up to 22 Days)||0
8987551|NCT02742766|10050712|FG017|COMPLETED|Part 2 (Up to 22 Days)||0
8987552|NCT02742766|10050713|FG018|COMPLETED|Part 2 (Up to 22 Days)||0
8987553|NCT02742766|10050695|FG000|NOT COMPLETED|Part 2 (Up to 22 Days)||0
8987554|NCT02742766|10050696|FG001|NOT COMPLETED|Part 2 (Up to 22 Days)||0
8987555|NCT02742766|10050697|FG002|NOT COMPLETED|Part 2 (Up to 22 Days)||0
8987556|NCT02742766|10050698|FG003|NOT COMPLETED|Part 2 (Up to 22 Days)||0
8987557|NCT02742766|10050699|FG004|NOT COMPLETED|Part 2 (Up to 22 Days)||0
8987558|NCT02742766|10050700|FG005|NOT COMPLETED|Part 2 (Up to 22 Days)||0
8987559|NCT02742766|10050701|FG006|NOT COMPLETED|Part 2 (Up to 22 Days)||0
8987560|NCT02742766|10050702|FG007|NOT COMPLETED|Part 2 (Up to 22 Days)||0
8987561|NCT02742766|10050703|FG008|NOT COMPLETED|Part 2 (Up to 22 Days)||0
8987562|NCT02742766|10050704|FG009|NOT COMPLETED|Part 2 (Up to 22 Days)||0
8987563|NCT02742766|10050705|FG010|NOT COMPLETED|Part 2 (Up to 22 Days)||0
8987564|NCT02742766|10050706|FG011|NOT COMPLETED|Part 2 (Up to 22 Days)||0
8987565|NCT02742766|10050707|FG012|NOT COMPLETED|Part 2 (Up to 22 Days)||2
8987566|NCT02742766|10050708|FG013|NOT COMPLETED|Part 2 (Up to 22 Days)||6
8987567|NCT02742766|10050709|FG014|NOT COMPLETED|Part 2 (Up to 22 Days)||0
8987568|NCT02742766|10050710|FG015|NOT COMPLETED|Part 2 (Up to 22 Days)||1
8987569|NCT02742766|10050711|FG016|NOT COMPLETED|Part 2 (Up to 22 Days)||0
8987570|NCT02742766|10050712|FG017|NOT COMPLETED|Part 2 (Up to 22 Days)||0
8987571|NCT02742766|10050713|FG018|NOT COMPLETED|Part 2 (Up to 22 Days)||0
8987572|NCT02742766|10050695|FG000|STARTED|Part 3 (Up to 36 Days)||0
8987573|NCT02742766|10050696|FG001|STARTED|Part 3 (Up to 36 Days)||0
8571722|NCT00112242|9604068|FG001|STARTED|Overall Study||5
8571723|NCT00112242|9604069|FG002|STARTED|Overall Study||5
8571724|NCT00112242|9604070|FG003|STARTED|Overall Study||10
8571725|NCT00112242|9604071|FG004|STARTED|Overall Study|One patient received only 1 vaccine however this minimum dose allowed the safety evaluation|9
8571726|NCT00112242|9604067|FG000|Cycle 1 Completed|Overall Study||10
8571727|NCT00112242|9604068|FG001|Cycle 1 Completed|Overall Study||5
8571728|NCT00112242|9604069|FG002|Cycle 1 Completed|Overall Study||5
8571729|NCT00112242|9604070|FG003|Cycle 1 Completed|Overall Study||9
8571730|NCT00112242|9604071|FG004|Cycle 1 Completed|Overall Study||7
8571731|NCT00112242|9604067|FG000|Cycle 2 Completed|Overall Study||8
8571732|NCT00112242|9604068|FG001|Cycle 2 Completed|Overall Study||3
8571733|NCT00112242|9604069|FG002|Cycle 2 Completed|Overall Study||4
8571734|NCT00112242|9604070|FG003|Cycle 2 Completed|Overall Study||8
8571735|NCT00112242|9604071|FG004|Cycle 2 Completed|Overall Study||4
8571736|NCT00112242|9604067|FG000|Cycle 3 Completed|Overall Study||5
8571737|NCT00112242|9604068|FG001|Cycle 3 Completed|Overall Study||3
8571738|NCT00112242|9604069|FG002|Cycle 3 Completed|Overall Study||4
8571739|NCT00112242|9604070|FG003|Cycle 3 Completed|Overall Study||4
8571740|NCT00112242|9604071|FG004|Cycle 3 Completed|Overall Study||2
8987574|NCT02742766|10050697|FG002|STARTED|Part 3 (Up to 36 Days)||0
8987575|NCT02742766|10050698|FG003|STARTED|Part 3 (Up to 36 Days)||0
8987576|NCT02742766|10050699|FG004|STARTED|Part 3 (Up to 36 Days)||0
8987577|NCT02742766|10050700|FG005|STARTED|Part 3 (Up to 36 Days)||0
8987578|NCT02742766|10050701|FG006|STARTED|Part 3 (Up to 36 Days)||0
8987579|NCT02742766|10050702|FG007|STARTED|Part 3 (Up to 36 Days)||0
8987580|NCT02742766|10050703|FG008|STARTED|Part 3 (Up to 36 Days)||0
8987581|NCT02742766|10050704|FG009|STARTED|Part 3 (Up to 36 Days)||0
8987582|NCT02742766|10050705|FG010|STARTED|Part 3 (Up to 36 Days)||0
8987583|NCT02742766|10050706|FG011|STARTED|Part 3 (Up to 36 Days)||0
8987584|NCT02742766|10050707|FG012|STARTED|Part 3 (Up to 36 Days)||0
8987585|NCT02742766|10050708|FG013|STARTED|Part 3 (Up to 36 Days)||0
8987586|NCT02742766|10050709|FG014|STARTED|Part 3 (Up to 36 Days)||0
8987587|NCT02742766|10050710|FG015|STARTED|Part 3 (Up to 36 Days)||0
8571741|NCT00112242|9604067|FG000|COMPLETED|Overall Study||5
8571742|NCT00112242|9604068|FG001|COMPLETED|Overall Study||3
8571743|NCT00112242|9604069|FG002|COMPLETED|Overall Study||4
8987588|NCT02742766|10050711|FG016|STARTED|Part 3 (Up to 36 Days)||0
8987589|NCT02742766|10050712|FG017|STARTED|Part 3 (Up to 36 Days)||0
8987590|NCT02742766|10050713|FG018|STARTED|Part 3 (Up to 36 Days)||0
8987591|NCT02742766|10050695|FG000|COMPLETED|Part 3 (Up to 36 Days)||0
8987592|NCT02742766|10050696|FG001|COMPLETED|Part 3 (Up to 36 Days)||0
8987593|NCT02742766|10050697|FG002|COMPLETED|Part 3 (Up to 36 Days)||0
8987594|NCT02742766|10050698|FG003|COMPLETED|Part 3 (Up to 36 Days)||0
8987595|NCT02742766|10050699|FG004|COMPLETED|Part 3 (Up to 36 Days)||0
8987596|NCT02742766|10050700|FG005|COMPLETED|Part 3 (Up to 36 Days)||0
8987597|NCT02742766|10050701|FG006|COMPLETED|Part 3 (Up to 36 Days)||0
8987598|NCT02742766|10050702|FG007|COMPLETED|Part 3 (Up to 36 Days)||0
8987599|NCT02742766|10050703|FG008|COMPLETED|Part 3 (Up to 36 Days)||0
8987600|NCT02742766|10050704|FG009|COMPLETED|Part 3 (Up to 36 Days)||0
8987601|NCT02742766|10050705|FG010|COMPLETED|Part 3 (Up to 36 Days)||0
8987602|NCT02742766|10050706|FG011|COMPLETED|Part 3 (Up to 36 Days)||0
8987603|NCT02742766|10050707|FG012|COMPLETED|Part 3 (Up to 36 Days)||0
8987604|NCT02742766|10050708|FG013|COMPLETED|Part 3 (Up to 36 Days)||0
8987605|NCT02742766|10050709|FG014|COMPLETED|Part 3 (Up to 36 Days)||0
8987606|NCT02742766|10050710|FG015|COMPLETED|Part 3 (Up to 36 Days)||0
8987607|NCT02742766|10050711|FG016|COMPLETED|Part 3 (Up to 36 Days)||0
8987608|NCT02742766|10050712|FG017|COMPLETED|Part 3 (Up to 36 Days)||0
8987609|NCT02742766|10050713|FG018|COMPLETED|Part 3 (Up to 36 Days)||0
8987610|NCT02742766|10050695|FG000|NOT COMPLETED|Part 3 (Up to 36 Days)||0
8987611|NCT02742766|10050696|FG001|NOT COMPLETED|Part 3 (Up to 36 Days)||0
8987612|NCT02742766|10050697|FG002|NOT COMPLETED|Part 3 (Up to 36 Days)||0
8987613|NCT02742766|10050698|FG003|NOT COMPLETED|Part 3 (Up to 36 Days)||0
8987614|NCT02742766|10050699|FG004|NOT COMPLETED|Part 3 (Up to 36 Days)||0
8987615|NCT02742766|10050700|FG005|NOT COMPLETED|Part 3 (Up to 36 Days)||0
8987616|NCT02742766|10050701|FG006|NOT COMPLETED|Part 3 (Up to 36 Days)||0
8987617|NCT02742766|10050702|FG007|NOT COMPLETED|Part 3 (Up to 36 Days)||0
8987618|NCT02742766|10050703|FG008|NOT COMPLETED|Part 3 (Up to 36 Days)||0
8987619|NCT02742766|10050704|FG009|NOT COMPLETED|Part 3 (Up to 36 Days)||0
8987620|NCT02742766|10050705|FG010|NOT COMPLETED|Part 3 (Up to 36 Days)||0
8987621|NCT02742766|10050706|FG011|NOT COMPLETED|Part 3 (Up to 36 Days)||0
8987622|NCT02742766|10050707|FG012|NOT COMPLETED|Part 3 (Up to 36 Days)||0
8987623|NCT02742766|10050708|FG013|NOT COMPLETED|Part 3 (Up to 36 Days)||0
8987624|NCT02742766|10050709|FG014|NOT COMPLETED|Part 3 (Up to 36 Days)||0
8987625|NCT02742766|10050710|FG015|NOT COMPLETED|Part 3 (Up to 36 Days)||0
8987626|NCT02742766|10050711|FG016|NOT COMPLETED|Part 3 (Up to 36 Days)||0
8987627|NCT02742766|10050712|FG017|NOT COMPLETED|Part 3 (Up to 36 Days)||0
8987628|NCT02742766|10050713|FG018|NOT COMPLETED|Part 3 (Up to 36 Days)||0
8987629|NCT02742818|10050775|FG000|STARTED|Overall Study||25
8987630|NCT02742818|10050776|FG001|STARTED|Overall Study||25
8987631|NCT02742818|10050775|FG000|COMPLETED|Overall Study||25
8987632|NCT02742818|10050776|FG001|COMPLETED|Overall Study||23
8987633|NCT02742818|10050775|FG000|NOT COMPLETED|Overall Study||0
8987634|NCT02742818|10050776|FG001|NOT COMPLETED|Overall Study||2
8987635|NCT02742987|10050786|FG000|STARTED|Overall Study||21
8987636|NCT02742987|10050787|FG001|STARTED|Overall Study||21
8987637|NCT02742987|10050786|FG000|COMPLETED|Overall Study||21
8878073|NCT01928225|9935116|FG000|COMPLETED|Overall Study||87
8878074|NCT01928225|9935117|FG001|COMPLETED|Overall Study||87
8878075|NCT01928225|9935116|FG000|NOT COMPLETED|Overall Study||3
8878076|NCT01928225|9935117|FG001|NOT COMPLETED|Overall Study||3
8878077|NCT01928290|9935126|FG000|STARTED|Overall Study||41
8878078|NCT01928290|9935127|FG001|STARTED|Overall Study||26
8878079|NCT01928290|9935126|FG000|COMPLETED|Overall Study||41
8878080|NCT01928290|9935127|FG001|COMPLETED|Overall Study||26
8878081|NCT01928290|9935126|FG000|NOT COMPLETED|Overall Study||0
8878082|NCT01928290|9935127|FG001|NOT COMPLETED|Overall Study||0
8878083|NCT01928329|9935135|FG000|STARTED|Overall Study||40
8878084|NCT01928329|9935136|FG001|STARTED|Overall Study||39
8878085|NCT01928329|9935135|FG000|COMPLETED|Overall Study||28
8878086|NCT01928329|9935136|FG001|COMPLETED|Overall Study||25
8878087|NCT01928329|9935135|FG000|NOT COMPLETED|Overall Study||12
8878088|NCT01928329|9935136|FG001|NOT COMPLETED|Overall Study||14
8878089|NCT01928381|9935142|FG000|STARTED|Screening for Pain Training||143
8878090|NCT01928381|9935143|FG001|STARTED|Screening for Pain Training||0
8878091|NCT01928381|9935144|FG002|STARTED|Screening for Pain Training||0
8878092|NCT01928381|9935145|FG003|STARTED|Screening for Pain Training||0
8878093|NCT01928381|9935146|FG004|STARTED|Screening for Pain Training||0
8878094|NCT01928381|9935147|FG005|STARTED|Screening for Pain Training||0
8878095|NCT01928381|9935148|FG006|STARTED|Screening for Pain Training||0
8878096|NCT01928381|9935142|FG000|COMPLETED|Screening for Pain Training||83
8878097|NCT01928381|9935143|FG001|COMPLETED|Screening for Pain Training||0
8878098|NCT01928381|9935144|FG002|COMPLETED|Screening for Pain Training||0
8878099|NCT01928381|9935145|FG003|COMPLETED|Screening for Pain Training||0
8878100|NCT01928381|9935146|FG004|COMPLETED|Screening for Pain Training||0
8878101|NCT01928381|9935147|FG005|COMPLETED|Screening for Pain Training||0
8878102|NCT01928381|9935148|FG006|COMPLETED|Screening for Pain Training||0
8878103|NCT01928381|9935142|FG000|NOT COMPLETED|Screening for Pain Training||60
8987638|NCT02742987|10050787|FG001|COMPLETED|Overall Study||21
8987639|NCT02742987|10050786|FG000|NOT COMPLETED|Overall Study||0
8878104|NCT01928381|9935143|FG001|NOT COMPLETED|Screening for Pain Training||0
8878105|NCT01928381|9935144|FG002|NOT COMPLETED|Screening for Pain Training||0
8878106|NCT01928381|9935145|FG003|NOT COMPLETED|Screening for Pain Training||0
8987640|NCT02742987|10050787|FG001|NOT COMPLETED|Overall Study||0
8987641|NCT02743078|10050793|FG000|STARTED|Overall Study||3
8987642|NCT02743078|10050793|FG000|Eligible Populaton|Overall Study||3
8987643|NCT02743078|10050793|FG000|Eligible With Six-month Follow-up Data|Overall Study||3
8987644|NCT02743078|10050793|FG000|COMPLETED|Overall Study||3
8987645|NCT02743078|10050793|FG000|NOT COMPLETED|Overall Study||0
8987646|NCT02743117|10050799|FG000|STARTED|Overall Study||60
8987647|NCT02743117|10050800|FG001|STARTED|Overall Study||241
8987648|NCT02743117|10050799|FG000|Treated|Overall Study||59
8987649|NCT02743117|10050800|FG001|Treated|Overall Study||241
8987650|NCT02743117|10050799|FG000|COMPLETED|Overall Study||59
8987651|NCT02743117|10050800|FG001|COMPLETED|Overall Study||240
8987652|NCT02743117|10050799|FG000|NOT COMPLETED|Overall Study||1
8987653|NCT02743117|10050800|FG001|NOT COMPLETED|Overall Study||1
8987654|NCT02743221|10050808|FG000|STARTED|Overall Study||77
8987655|NCT02743221|10050809|FG001|STARTED|Overall Study||77
8987656|NCT02743221|10050808|FG000|COMPLETED|Overall Study||21
8987657|NCT02743221|10050809|FG001|COMPLETED|Overall Study||17
8987658|NCT02743221|10050808|FG000|NOT COMPLETED|Overall Study||56
8987659|NCT02743221|10050809|FG001|NOT COMPLETED|Overall Study||60
8987660|NCT02743312|10050817|FG000|STARTED|Overall Study||3
8987661|NCT02743312|10050818|FG001|STARTED|Overall Study||2
8987662|NCT02743312|10050817|FG000|COMPLETED|Overall Study||3
8987663|NCT02743312|10050818|FG001|COMPLETED|Overall Study||2
8987664|NCT02743312|10050817|FG000|NOT COMPLETED|Overall Study||0
8571744|NCT00112242|9604070|FG003|COMPLETED|Overall Study||4
8571745|NCT00112242|9604071|FG004|COMPLETED|Overall Study||2
8571746|NCT00112242|9604067|FG000|NOT COMPLETED|Overall Study||5
8571747|NCT00112242|9604068|FG001|NOT COMPLETED|Overall Study||2
8571748|NCT00112242|9604069|FG002|NOT COMPLETED|Overall Study||1
8571749|NCT00112242|9604070|FG003|NOT COMPLETED|Overall Study||6
8571750|NCT00112242|9604071|FG004|NOT COMPLETED|Overall Study||7
8571751|NCT00112294|9604093|FG000|STARTED|Overall Study|338 randomized and 325 treated.|325
8571752|NCT00112294|9604094|FG001|STARTED|Overall Study|338 randomized and 320 treated.|320
8571753|NCT00112294|9604093|FG000|Never Treated|Overall Study|Number by randomized group = 11, but 2 participants received C/T/C instead of T/C.|13
8571754|NCT00112294|9604094|FG001|Never Treated|Overall Study|Number by randomized group = 20, but 2 participants received C/T/C instead of T/C.|18
8878107|NCT01928381|9935146|FG004|NOT COMPLETED|Screening for Pain Training||0
8987665|NCT02743312|10050818|FG001|NOT COMPLETED|Overall Study||0
8987666|NCT02743377|10050835|FG000|STARTED|Overall Study||9
8987667|NCT02743377|10050836|FG001|STARTED|Overall Study||6
8987668|NCT02743377|10050835|FG000|Brain PET With 11C Rolipram|Overall Study||8
8987669|NCT02743377|10050836|FG001|Brain PET With 11C Rolipram|Overall Study||3
8987670|NCT02743377|10050835|FG000|Whole Body PET Baseline With 11C Rolipra|Overall Study||5
8987671|NCT02743377|10050836|FG001|Whole Body PET Baseline With 11C Rolipra|Overall Study||4
8987672|NCT02743377|10050835|FG000|Whole Body PET Baseline & Blocked|Overall Study||0
8987673|NCT02743377|10050836|FG001|Whole Body PET Baseline & Blocked|Overall Study||2
8987674|NCT02743377|10050835|FG000|COMPLETED|Overall Study||7
8987675|NCT02743377|10050836|FG001|COMPLETED|Overall Study||6
8987676|NCT02743377|10050835|FG000|NOT COMPLETED|Overall Study||2
8987677|NCT02743377|10050836|FG001|NOT COMPLETED|Overall Study||0
8987678|NCT02743442|10050843|FG000|STARTED|Overall Study||8
8987679|NCT02743442|10050843|FG000|COMPLETED|Overall Study||8
8987680|NCT02743442|10050843|FG000|NOT COMPLETED|Overall Study||0
8987681|NCT02743520|10050847|FG000|STARTED|Overall Study||86
8987682|NCT02743520|10050847|FG000|COMPLETED|Overall Study||85
8987683|NCT02743520|10050847|FG000|NOT COMPLETED|Overall Study||1
8987684|NCT02743702|10050853|FG000|STARTED|Overall Study||11
8987685|NCT02743702|10050854|FG001|STARTED|Overall Study||10
8987686|NCT02743702|10050853|FG000|COMPLETED|Overall Study||11
8987687|NCT02743702|10050854|FG001|COMPLETED|Overall Study||10
8878108|NCT01928381|9935147|FG005|NOT COMPLETED|Screening for Pain Training||0
8878109|NCT01928381|9935148|FG006|NOT COMPLETED|Screening for Pain Training||0
8878110|NCT01928381|9935142|FG000|STARTED|Part 1 - Pain Training||83
8878111|NCT01928381|9935143|FG001|STARTED|Part 1 - Pain Training||0
8878112|NCT01928381|9935144|FG002|STARTED|Part 1 - Pain Training||0
8878113|NCT01928381|9935145|FG003|STARTED|Part 1 - Pain Training||0
8878114|NCT01928381|9935146|FG004|STARTED|Part 1 - Pain Training||0
8878115|NCT01928381|9935147|FG005|STARTED|Part 1 - Pain Training||0
8878116|NCT01928381|9935148|FG006|STARTED|Part 1 - Pain Training||0
8878117|NCT01928381|9935142|FG000|COMPLETED|Part 1 - Pain Training||48
8878118|NCT01928381|9935143|FG001|COMPLETED|Part 1 - Pain Training||0
8878119|NCT01928381|9935144|FG002|COMPLETED|Part 1 - Pain Training||0
8878120|NCT01928381|9935145|FG003|COMPLETED|Part 1 - Pain Training||0
8878121|NCT01928381|9935146|FG004|COMPLETED|Part 1 - Pain Training||0
8878122|NCT01928381|9935147|FG005|COMPLETED|Part 1 - Pain Training||0
8878123|NCT01928381|9935148|FG006|COMPLETED|Part 1 - Pain Training||0
8987688|NCT02743702|10050853|FG000|NOT COMPLETED|Overall Study||0
8987689|NCT02743702|10050854|FG001|NOT COMPLETED|Overall Study||0
8987690|NCT02743780|10050865|FG000|STARTED|Part 1 (3 Days)||6
8987691|NCT02743780|10050866|FG001|STARTED|Part 1 (3 Days)||6
8987692|NCT02743780|10050867|FG002|STARTED|Part 1 (3 Days)||6
8987693|NCT02743780|10050868|FG003|STARTED|Part 1 (3 Days)||6
8987694|NCT02743780|10050869|FG004|STARTED|Part 1 (3 Days)||8
8987695|NCT02743780|10050865|FG000|COMPLETED|Part 1 (3 Days)||6
8987696|NCT02743780|10050866|FG001|COMPLETED|Part 1 (3 Days)||6
8987697|NCT02743780|10050867|FG002|COMPLETED|Part 1 (3 Days)||6
8987698|NCT02743780|10050868|FG003|COMPLETED|Part 1 (3 Days)||6
8987699|NCT02743780|10050869|FG004|COMPLETED|Part 1 (3 Days)||8
8632946|NCT00548405|9672981|FG000|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug as per initial randomization.|202
8632947|NCT00548405|9672982|FG001|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug as per initial randomization.|426
8987700|NCT02743780|10050865|FG000|NOT COMPLETED|Part 1 (3 Days)||0
8987701|NCT02743780|10050866|FG001|NOT COMPLETED|Part 1 (3 Days)||0
8987702|NCT02743780|10050867|FG002|NOT COMPLETED|Part 1 (3 Days)||0
8987703|NCT02743780|10050868|FG003|NOT COMPLETED|Part 1 (3 Days)||0
8987704|NCT02743780|10050869|FG004|NOT COMPLETED|Part 1 (3 Days)||0
8987705|NCT02743780|10050865|FG000|STARTED|Part 2 (8 Days)||0
8987706|NCT02743780|10050866|FG001|STARTED|Part 2 (8 Days)||6
8987707|NCT02743780|10050867|FG002|STARTED|Part 2 (8 Days)||6
8987708|NCT02743780|10050868|FG003|STARTED|Part 2 (8 Days)||0
8987709|NCT02743780|10050869|FG004|STARTED|Part 2 (8 Days)||4
8987710|NCT02743780|10050865|FG000|COMPLETED|Part 2 (8 Days)||0
8987711|NCT02743780|10050866|FG001|COMPLETED|Part 2 (8 Days)||6
8987712|NCT02743780|10050867|FG002|COMPLETED|Part 2 (8 Days)||6
8987713|NCT02743780|10050868|FG003|COMPLETED|Part 2 (8 Days)||0
8987714|NCT02743780|10050869|FG004|COMPLETED|Part 2 (8 Days)||4
8987715|NCT02743780|10050865|FG000|NOT COMPLETED|Part 2 (8 Days)||0
8987716|NCT02743780|10050866|FG001|NOT COMPLETED|Part 2 (8 Days)||0
8987717|NCT02743780|10050867|FG002|NOT COMPLETED|Part 2 (8 Days)||0
8987718|NCT02743780|10050868|FG003|NOT COMPLETED|Part 2 (8 Days)||0
8987719|NCT02743780|10050869|FG004|NOT COMPLETED|Part 2 (8 Days)||0
8987720|NCT02743780|10050865|FG000|STARTED|Part 3 (7 Days)||0
8987721|NCT02743780|10050866|FG001|STARTED|Part 3 (7 Days)||0
8987722|NCT02743780|10050867|FG002|STARTED|Part 3 (7 Days)||25
8987723|NCT02743780|10050868|FG003|STARTED|Part 3 (7 Days)||0
8987724|NCT02743780|10050869|FG004|STARTED|Part 3 (7 Days)||25
8987725|NCT02743780|10050865|FG000|COMPLETED|Part 3 (7 Days)||0
8987726|NCT02743780|10050866|FG001|COMPLETED|Part 3 (7 Days)||0
8987727|NCT02743780|10050867|FG002|COMPLETED|Part 3 (7 Days)||24
8987728|NCT02743780|10050868|FG003|COMPLETED|Part 3 (7 Days)||0
8987729|NCT02743780|10050869|FG004|COMPLETED|Part 3 (7 Days)||25
8987730|NCT02743780|10050865|FG000|NOT COMPLETED|Part 3 (7 Days)||0
8987731|NCT02743780|10050866|FG001|NOT COMPLETED|Part 3 (7 Days)||0
8987732|NCT02743780|10050867|FG002|NOT COMPLETED|Part 3 (7 Days)||1
8987733|NCT02743780|10050868|FG003|NOT COMPLETED|Part 3 (7 Days)||0
8987734|NCT02743780|10050869|FG004|NOT COMPLETED|Part 3 (7 Days)||0
8987735|NCT02743793|10050891|FG000|STARTED|Overall Study||5
8987736|NCT02743793|10050892|FG001|STARTED|Overall Study||36
8987737|NCT02743793|10050891|FG000|COMPLETED|Overall Study||0
8987738|NCT02743793|10050892|FG001|COMPLETED|Overall Study||0
8987739|NCT02743793|10050891|FG000|NOT COMPLETED|Overall Study||5
8987740|NCT02743793|10050892|FG001|NOT COMPLETED|Overall Study||36
8987741|NCT02743936|10050899|FG000|STARTED|Overall Study||32
8987742|NCT02743936|10050900|FG001|STARTED|Overall Study||32
8987743|NCT02743936|10050899|FG000|COMPLETED|Overall Study||32
8987744|NCT02743936|10050900|FG001|COMPLETED|Overall Study||32
8987745|NCT02743936|10050899|FG000|NOT COMPLETED|Overall Study||0
8987746|NCT02743936|10050900|FG001|NOT COMPLETED|Overall Study||0
8987747|NCT02743949|10050909|FG000|STARTED|Overall Study||86
8987748|NCT02743949|10050910|FG001|STARTED|Overall Study||85
8987749|NCT02743949|10050911|FG002|STARTED|Overall Study||85
8987750|NCT02743949|10050909|FG000|COMPLETED|Overall Study||82
8987751|NCT02743949|10050910|FG001|COMPLETED|Overall Study||84
8987752|NCT02743949|10050911|FG002|COMPLETED|Overall Study||82
8987753|NCT02743949|10050909|FG000|NOT COMPLETED|Overall Study||4
8987754|NCT02743949|10050910|FG001|NOT COMPLETED|Overall Study||1
8987755|NCT02743949|10050911|FG002|NOT COMPLETED|Overall Study||3
8987756|NCT02743962|10050921|FG000|STARTED|Overall Study||5
8987757|NCT02743962|10050922|FG001|STARTED|Overall Study||5
8987758|NCT02743962|10050921|FG000|COMPLETED|Overall Study||4
8987759|NCT02743962|10050922|FG001|COMPLETED|Overall Study||5
8987760|NCT02743962|10050921|FG000|NOT COMPLETED|Overall Study||1
8987761|NCT02743962|10050922|FG001|NOT COMPLETED|Overall Study||0
8987762|NCT02744066|10050933|FG000|STARTED|Overall Study||25
8987763|NCT02744066|10050934|FG001|STARTED|Overall Study||30
8987764|NCT02744066|10050933|FG000|COMPLETED|Overall Study||25
8987765|NCT02744066|10050934|FG001|COMPLETED|Overall Study||25
8987766|NCT02744066|10050933|FG000|NOT COMPLETED|Overall Study||0
8987767|NCT02744066|10050934|FG001|NOT COMPLETED|Overall Study||5
8987768|NCT02744391|10050942|FG000|STARTED|Overall Study||47
8987769|NCT02744391|10050942|FG000|COMPLETED|Overall Study||33
8987770|NCT02744391|10050942|FG000|NOT COMPLETED|Overall Study||14
8987771|NCT02744534|10050946|FG000|STARTED|Overall Study||21
8987772|NCT02744534|10050946|FG000|COMPLETED|Overall Study||21
8987773|NCT02744534|10050946|FG000|NOT COMPLETED|Overall Study||0
8987774|NCT02744755|10050954|FG000|STARTED|Study Period 1||177
8987775|NCT02744755|10050955|FG001|STARTED|Study Period 1||176
8987776|NCT02744755|10050954|FG000|COMPLETED|Study Period 1||163
8987777|NCT02744755|10050955|FG001|COMPLETED|Study Period 1||168
8987778|NCT02744755|10050954|FG000|NOT COMPLETED|Study Period 1||14
8987779|NCT02744755|10050955|FG001|NOT COMPLETED|Study Period 1||8
8987780|NCT02744755|10050954|FG000|STARTED|Study Period 2||159
8987781|NCT02744755|10050955|FG001|STARTED|Study Period 2||166
8987782|NCT02744755|10050954|FG000|COMPLETED|Study Period 2||145
8987783|NCT02744755|10050955|FG001|COMPLETED|Study Period 2||158
8987784|NCT02744755|10050954|FG000|NOT COMPLETED|Study Period 2||14
8987785|NCT02744755|10050955|FG001|NOT COMPLETED|Study Period 2||8
8987786|NCT02744846|10050965|FG000|STARTED|5 Year Outcome Assessment||681739
9038880|NCT03334448|10099973|FG001|Received at Least 1 Dose of Study Drug|Period 4||11
8987787|NCT02744846|10050965|FG000|Excluded Ineligible Patients|5 Year Outcome Assessment|Includes lost to follow-up and patients that had not reached age 4 years by end of study period|319189
8987788|NCT02744846|10050965|FG000|COMPLETED|5 Year Outcome Assessment|Number of patients that meet eligibility criteria|362550
8987789|NCT02744846|10050965|FG000|NOT COMPLETED|5 Year Outcome Assessment||319189
8987790|NCT02744846|10050965|FG000|STARTED|10 Year Outcome Assessment||362550
8987791|NCT02744846|10050965|FG000|Exclude Ineligible Patients|10 Year Outcome Assessment|Loss to follow-up, patients not yet 9 years, or systems that only had data from 2009 to 2016 or less|305820
8987792|NCT02744846|10050965|FG000|COMPLETED|10 Year Outcome Assessment||56730
8987793|NCT02744846|10050965|FG000|NOT COMPLETED|10 Year Outcome Assessment||305820
8987794|NCT02744898|10050973|FG000|STARTED|Overall Study||23
8987795|NCT02744898|10050973|FG000|COMPLETED|Overall Study||19
8987796|NCT02744898|10050973|FG000|NOT COMPLETED|Overall Study||4
8987797|NCT02745080|10050979|FG000|STARTED|Overall Study||426
8987798|NCT02745080|10050980|FG001|STARTED|Overall Study||427
8987799|NCT02745080|10050979|FG000|COMPLETED|Overall Study||371
8987800|NCT02745080|10050980|FG001|COMPLETED|Overall Study||338
8987801|NCT02745080|10050979|FG000|NOT COMPLETED|Overall Study||55
8987802|NCT02745080|10050980|FG001|NOT COMPLETED|Overall Study||89
8987803|NCT02745119|10050991|FG000|STARTED|Overall Study||145
8987804|NCT02745119|10050992|FG001|STARTED|Overall Study||274
8987805|NCT02745119|10050993|FG002|STARTED|Overall Study||146
8987806|NCT02745119|10050994|FG003|STARTED|Overall Study||277
8987807|NCT02745119|10050991|FG000|COMPLETED|Overall Study||0
8987808|NCT02745119|10050992|FG001|COMPLETED|Overall Study||0
8987809|NCT02745119|10050993|FG002|COMPLETED|Overall Study||0
8987810|NCT02745119|10050994|FG003|COMPLETED|Overall Study||0
8987811|NCT02745119|10050991|FG000|NOT COMPLETED|Overall Study||145
8987812|NCT02745119|10050992|FG001|NOT COMPLETED|Overall Study||274
8987813|NCT02745119|10050993|FG002|NOT COMPLETED|Overall Study||146
8987814|NCT02745119|10050994|FG003|NOT COMPLETED|Overall Study||277
8987815|NCT02745145|10051009|FG000|STARTED|Overall Study||10
8987816|NCT02745145|10051010|FG001|STARTED|Overall Study||5
8987817|NCT02745145|10051011|FG002|STARTED|Overall Study||9
8987818|NCT02745145|10051009|FG000|COMPLETED|Overall Study||0
8987819|NCT02745145|10051010|FG001|COMPLETED|Overall Study||0
8987820|NCT02745145|10051011|FG002|COMPLETED|Overall Study||0
8987821|NCT02745145|10051009|FG000|NOT COMPLETED|Overall Study||10
8987822|NCT02745145|10051010|FG001|NOT COMPLETED|Overall Study||5
8987823|NCT02745145|10051011|FG002|NOT COMPLETED|Overall Study||9
8987824|NCT02745353|10051021|FG000|STARTED|First Intervention (2 Weeks)||4
8987825|NCT02745353|10051022|FG001|STARTED|First Intervention (2 Weeks)||3
8987826|NCT02745353|10051021|FG000|COMPLETED|First Intervention (2 Weeks)||1
8987827|NCT02745353|10051022|FG001|COMPLETED|First Intervention (2 Weeks)||1
8987828|NCT02745353|10051021|FG000|NOT COMPLETED|First Intervention (2 Weeks)||3
8987829|NCT02745353|10051022|FG001|NOT COMPLETED|First Intervention (2 Weeks)||2
8987830|NCT02745353|10051021|FG000|STARTED|Washout (3 Days)||1
8987831|NCT02745353|10051022|FG001|STARTED|Washout (3 Days)||1
8987832|NCT02745353|10051021|FG000|COMPLETED|Washout (3 Days)||1
8987833|NCT02745353|10051022|FG001|COMPLETED|Washout (3 Days)||1
8987834|NCT02745353|10051021|FG000|NOT COMPLETED|Washout (3 Days)||0
8987835|NCT02745353|10051022|FG001|NOT COMPLETED|Washout (3 Days)||0
8987836|NCT02745353|10051021|FG000|STARTED|Second Intervention (2 Weeks)||1
8987837|NCT02745353|10051022|FG001|STARTED|Second Intervention (2 Weeks)||1
8987838|NCT02745353|10051021|FG000|COMPLETED|Second Intervention (2 Weeks)||1
8987839|NCT02745353|10051022|FG001|COMPLETED|Second Intervention (2 Weeks)||0
8987840|NCT02745353|10051021|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0
8987841|NCT02745353|10051022|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||1
8987842|NCT02745392|10051032|FG000|STARTED|Overall Study||91
8987843|NCT02745392|10051033|FG001|STARTED|Overall Study||90
8987844|NCT02745392|10051034|FG002|STARTED|Overall Study||92
8987845|NCT02745392|10051035|FG003|STARTED|Overall Study||92
8987846|NCT02745392|10051032|FG000|COMPLETED|Overall Study||91
8987847|NCT02745392|10051033|FG001|COMPLETED|Overall Study||89
8987848|NCT02745392|10051034|FG002|COMPLETED|Overall Study||92
8987849|NCT02745392|10051035|FG003|COMPLETED|Overall Study||92
8987850|NCT02745392|10051032|FG000|NOT COMPLETED|Overall Study||0
8987851|NCT02745392|10051033|FG001|NOT COMPLETED|Overall Study||1
8987852|NCT02745392|10051034|FG002|NOT COMPLETED|Overall Study||0
8987853|NCT02745392|10051035|FG003|NOT COMPLETED|Overall Study||0
8987854|NCT02745626|10051048|FG000|STARTED|Overall Study||24
8987855|NCT02745626|10051049|FG001|STARTED|Overall Study||22
8987856|NCT02745626|10051050|FG002|STARTED|Overall Study||22
8987857|NCT02745626|10051048|FG000|COMPLETED|Overall Study||21
8571755|NCT00112294|9604093|FG000|COMPLETED|Overall Study|Off all study therapies.|320
8571756|NCT00112294|9604094|FG001|COMPLETED|Overall Study|Off all study therapies.|320
8571757|NCT00112294|9604093|FG000|NOT COMPLETED|Overall Study||5
8571758|NCT00112294|9604094|FG001|NOT COMPLETED|Overall Study||0
8571759|NCT00112359|9604102|FG000|STARTED|Overall Study||84
8571760|NCT00112359|9604103|FG001|STARTED|Overall Study||80
8571761|NCT00112359|9604102|FG000|COMPLETED|Overall Study||57
8571762|NCT00112359|9604103|FG001|COMPLETED|Overall Study||67
8571763|NCT00112359|9604102|FG000|NOT COMPLETED|Overall Study||27
8987858|NCT02745626|10051049|FG001|COMPLETED|Overall Study||16
8987859|NCT02745626|10051050|FG002|COMPLETED|Overall Study||19
8987860|NCT02745626|10051048|FG000|NOT COMPLETED|Overall Study||3
8987861|NCT02745626|10051049|FG001|NOT COMPLETED|Overall Study||6
8987862|NCT02745626|10051050|FG002|NOT COMPLETED|Overall Study||3
8987863|NCT02746107|10051058|FG000|STARTED|Overall Study||968
8987864|NCT02746107|10051058|FG000|2 Diagrams DA|Overall Study||482
8987865|NCT02746107|10051058|FG000|1 Diagram DA|Overall Study||486
8987866|NCT02746107|10051058|FG000|1year Risk Estimate|Overall Study||483
8987867|NCT02746107|10051058|FG000|5year Risk Estimate|Overall Study||485
8987868|NCT02746107|10051058|FG000|Target=Patient|Overall Study||486
8987869|NCT02746107|10051058|FG000|Target=Physician|Overall Study||482
8987870|NCT02746107|10051058|FG000|CHA2DS2-VASC Score = 1|Overall Study||195
8987871|NCT02746107|10051058|FG000|CHA2DS2-VASC Score = 2|Overall Study||189
8987872|NCT02746107|10051058|FG000|CHA2DS2-VASC Score = 3|Overall Study||195
8987873|NCT02746107|10051058|FG000|CHA2DS2-VASC Score = 4|Overall Study||197
8987874|NCT02746107|10051058|FG000|CHA2DS2-VASC Score = 5|Overall Study||192
8987875|NCT02746107|10051058|FG000|COMPLETED|Overall Study||968
8987876|NCT02746107|10051058|FG000|NOT COMPLETED|Overall Study||0
8987877|NCT02746406|10051073|FG000|STARTED|Overall Study||5
8987878|NCT02746406|10051073|FG000|COMPLETED|Overall Study||5
8987879|NCT02746406|10051073|FG000|NOT COMPLETED|Overall Study||0
8987880|NCT02746575|10051077|FG000|STARTED|Overall Study||70
8987881|NCT02746575|10051077|FG000|COMPLETED|Overall Study||20
8987882|NCT02746575|10051077|FG000|NOT COMPLETED|Overall Study||50
8987883|NCT02746627|10051084|FG000|STARTED|Overall Study||60
8987884|NCT02746627|10051085|FG001|STARTED|Overall Study||30
8987885|NCT02746627|10051086|FG002|STARTED|Overall Study||30
8987886|NCT02746627|10051084|FG000|COMPLETED|Overall Study||59
8987887|NCT02746627|10051085|FG001|COMPLETED|Overall Study||29
8987888|NCT02746627|10051086|FG002|COMPLETED|Overall Study||29
8987889|NCT02746627|10051084|FG000|NOT COMPLETED|Overall Study||1
8987890|NCT02746627|10051085|FG001|NOT COMPLETED|Overall Study||1
8987891|NCT02746627|10051086|FG002|NOT COMPLETED|Overall Study||1
8987892|NCT02746679|10051096|FG000|STARTED|Overall Study||80
8987893|NCT02746679|10051097|FG001|STARTED|Overall Study||81
8987894|NCT02746679|10051096|FG000|COMPLETED|Overall Study||76
8987895|NCT02746679|10051097|FG001|COMPLETED|Overall Study||75
8987896|NCT02746679|10051096|FG000|NOT COMPLETED|Overall Study||4
8987897|NCT02746679|10051097|FG001|NOT COMPLETED|Overall Study||6
8987898|NCT02746705|10051105|FG000|STARTED|Overall Study||17
8987899|NCT02746705|10051106|FG001|STARTED|Overall Study||14
8987900|NCT02746705|10051105|FG000|COMPLETED|Overall Study||15
8987901|NCT02746705|10051106|FG001|COMPLETED|Overall Study||12
8987902|NCT02746705|10051105|FG000|NOT COMPLETED|Overall Study||2
8987903|NCT02746705|10051106|FG001|NOT COMPLETED|Overall Study||2
8987904|NCT02746874|10051114|FG000|STARTED|Overall Study||35
8987905|NCT02746874|10051115|FG001|STARTED|Overall Study||35
8987906|NCT02746874|10051114|FG000|COMPLETED|Overall Study||35
8987907|NCT02746874|10051115|FG001|COMPLETED|Overall Study||32
8987908|NCT02746874|10051114|FG000|NOT COMPLETED|Overall Study||0
8987909|NCT02746874|10051115|FG001|NOT COMPLETED|Overall Study||3
8987910|NCT02746991|10051123|FG000|STARTED|Overall Study||52
8987911|NCT02746991|10051124|FG001|STARTED|Overall Study||101
8987912|NCT02746991|10051123|FG000|COMPLETED|Overall Study||24
8987913|NCT02746991|10051124|FG001|COMPLETED|Overall Study||67
8571764|NCT00112359|9604103|FG001|NOT COMPLETED|Overall Study||13
8571765|NCT00112385|9604111|FG000|STARTED|Overall Study||11
8987914|NCT02746991|10051123|FG000|NOT COMPLETED|Overall Study||28
8987915|NCT02746991|10051124|FG001|NOT COMPLETED|Overall Study||34
8987916|NCT02747004|10051135|FG000|STARTED|Overall Study||78
8987917|NCT02747004|10051136|FG001|STARTED|Overall Study||79
8987918|NCT02747004|10051137|FG002|STARTED|Overall Study||77
8987919|NCT02747004|10051135|FG000|Received at Least One Dose of Study Drug|Overall Study||78
8987920|NCT02747004|10051136|FG001|Received at Least One Dose of Study Drug|Overall Study||79
8571766|NCT00112385|9604112|FG001|STARTED|Overall Study||5
8987921|NCT02747004|10051137|FG002|Received at Least One Dose of Study Drug|Overall Study||77
8987922|NCT02747004|10051135|FG000|COMPLETED|Overall Study||21
8987923|NCT02747004|10051136|FG001|COMPLETED|Overall Study||30
8987924|NCT02747004|10051137|FG002|COMPLETED|Overall Study||30
8987925|NCT02747004|10051135|FG000|NOT COMPLETED|Overall Study||57
8987926|NCT02747004|10051136|FG001|NOT COMPLETED|Overall Study||49
8987927|NCT02747004|10051137|FG002|NOT COMPLETED|Overall Study||47
8987928|NCT02747043|10051147|FG000|STARTED|Overall Study||128
8987929|NCT02747043|10051148|FG001|STARTED|Overall Study||128
8987930|NCT02747043|10051147|FG000|Treated|Overall Study||128
8987931|NCT02747043|10051148|FG001|Treated|Overall Study||126
8987932|NCT02747043|10051147|FG000|COMPLETED|Overall Study||118
8987933|NCT02747043|10051148|FG001|COMPLETED|Overall Study||123
8987934|NCT02747043|10051147|FG000|NOT COMPLETED|Overall Study||10
8987935|NCT02747043|10051148|FG001|NOT COMPLETED|Overall Study||5
8987936|NCT02747108|10051156|FG000|STARTED|Overall Study||253
8987937|NCT02747108|10051157|FG001|STARTED|Overall Study||62
8987938|NCT02747108|10051156|FG000|COMPLETED|Overall Study||248
8987939|NCT02747108|10051157|FG001|COMPLETED|Overall Study||60
8987940|NCT02747108|10051156|FG000|NOT COMPLETED|Overall Study||5
8987941|NCT02747108|10051157|FG001|NOT COMPLETED|Overall Study||2
8987942|NCT02747186|10051170|FG000|STARTED|First Intervention||12
8987943|NCT02747186|10051171|FG001|STARTED|First Intervention||12
8987944|NCT02747186|10051170|FG000|COMPLETED|First Intervention||12
8987945|NCT02747186|10051171|FG001|COMPLETED|First Intervention||12
8987946|NCT02747186|10051170|FG000|NOT COMPLETED|First Intervention||0
8987947|NCT02747186|10051171|FG001|NOT COMPLETED|First Intervention||0
8987948|NCT02747186|10051170|FG000|STARTED|Washout (1 Week)||12
8987949|NCT02747186|10051171|FG001|STARTED|Washout (1 Week)||12
8987950|NCT02747186|10051170|FG000|COMPLETED|Washout (1 Week)||12
8632948|NCT00548405|9672983|FG002|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug as per initial randomization.|170
8987951|NCT02747186|10051171|FG001|COMPLETED|Washout (1 Week)||12
8987952|NCT02747186|10051170|FG000|NOT COMPLETED|Washout (1 Week)||0
8987953|NCT02747186|10051171|FG001|NOT COMPLETED|Washout (1 Week)||0
8987954|NCT02747186|10051170|FG000|STARTED|Second Intervention||12
8987955|NCT02747186|10051171|FG001|STARTED|Second Intervention||12
8987956|NCT02747186|10051170|FG000|COMPLETED|Second Intervention||12
8987957|NCT02747186|10051171|FG001|COMPLETED|Second Intervention||12
8987958|NCT02747186|10051170|FG000|NOT COMPLETED|Second Intervention||0
8987959|NCT02747186|10051171|FG001|NOT COMPLETED|Second Intervention||0
8878124|NCT01928381|9935142|FG000|NOT COMPLETED|Part 1 - Pain Training||35
8878125|NCT01928381|9935143|FG001|NOT COMPLETED|Part 1 - Pain Training||0
8878126|NCT01928381|9935144|FG002|NOT COMPLETED|Part 1 - Pain Training||0
8878127|NCT01928381|9935145|FG003|NOT COMPLETED|Part 1 - Pain Training||0
8878128|NCT01928381|9935146|FG004|NOT COMPLETED|Part 1 - Pain Training||0
8878129|NCT01928381|9935147|FG005|NOT COMPLETED|Part 1 - Pain Training||0
8878130|NCT01928381|9935148|FG006|NOT COMPLETED|Part 1 - Pain Training||0
8878131|NCT01928381|9935142|FG000|STARTED|Placebo run-in & Part 2 Eligibility||48
8987960|NCT02747238|10051179|FG000|STARTED|Overall Study||12
8987961|NCT02747238|10051180|FG001|STARTED|Overall Study||20
8987962|NCT02747238|10051179|FG000|COMPLETED|Overall Study||9
8987963|NCT02747238|10051180|FG001|COMPLETED|Overall Study||14
8987964|NCT02747238|10051179|FG000|NOT COMPLETED|Overall Study||3
8987965|NCT02747238|10051180|FG001|NOT COMPLETED|Overall Study||6
8987966|NCT02747420|10051188|FG000|STARTED|Overall Study||18
8987967|NCT02747420|10051189|FG001|STARTED|Overall Study||22
8987968|NCT02747420|10051188|FG000|COMPLETED|Overall Study||11
8987969|NCT02747420|10051189|FG001|COMPLETED|Overall Study||18
8987970|NCT02747420|10051188|FG000|NOT COMPLETED|Overall Study||7
8987971|NCT02747420|10051189|FG001|NOT COMPLETED|Overall Study||4
8632949|NCT00548405|9672981|FG000|COMPLETED|Overall Study||175
8632950|NCT00548405|9672982|FG001|COMPLETED|Overall Study||416
8632951|NCT00548405|9672983|FG002|COMPLETED|Overall Study||164
8632952|NCT00548405|9672981|FG000|NOT COMPLETED|Overall Study||56
8632953|NCT00548405|9672982|FG001|NOT COMPLETED|Overall Study||20
8632954|NCT00548405|9672983|FG002|NOT COMPLETED|Overall Study||9
8632955|NCT00548418|9672992|FG000|STARTED|Overall Study||27
8878132|NCT01928381|9935143|FG001|STARTED|Placebo run-in & Part 2 Eligibility||0
8878133|NCT01928381|9935144|FG002|STARTED|Placebo run-in & Part 2 Eligibility||0
8987978|NCT02747615|10051209|FG000|STARTED|Overall Study||30
8987979|NCT02747615|10051210|FG001|STARTED|Overall Study||30
8987980|NCT02747615|10051209|FG000|COMPLETED|Overall Study||30
8987981|NCT02747615|10051210|FG001|COMPLETED|Overall Study||30
8987982|NCT02747615|10051209|FG000|NOT COMPLETED|Overall Study||0
8987983|NCT02747615|10051210|FG001|NOT COMPLETED|Overall Study||0
8987984|NCT02747628|10051219|FG000|STARTED|Overall Study||20
8632956|NCT00548418|9672992|FG000|COMPLETED|Overall Study||27
8878134|NCT01928381|9935145|FG003|STARTED|Placebo run-in & Part 2 Eligibility||0
8878135|NCT01928381|9935146|FG004|STARTED|Placebo run-in & Part 2 Eligibility||0
8878136|NCT01928381|9935147|FG005|STARTED|Placebo run-in & Part 2 Eligibility||0
8878137|NCT01928381|9935148|FG006|STARTED|Placebo run-in & Part 2 Eligibility||0
8878138|NCT01928381|9935142|FG000|COMPLETED|Placebo run-in & Part 2 Eligibility||34
8878139|NCT01928381|9935143|FG001|COMPLETED|Placebo run-in & Part 2 Eligibility||0
8878140|NCT01928381|9935144|FG002|COMPLETED|Placebo run-in & Part 2 Eligibility||0
8878141|NCT01928381|9935145|FG003|COMPLETED|Placebo run-in & Part 2 Eligibility||0
8878142|NCT01928381|9935146|FG004|COMPLETED|Placebo run-in & Part 2 Eligibility||0
8878143|NCT01928381|9935147|FG005|COMPLETED|Placebo run-in & Part 2 Eligibility||0
8878144|NCT01928381|9935148|FG006|COMPLETED|Placebo run-in & Part 2 Eligibility||0
8878145|NCT01928381|9935142|FG000|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||14
8878146|NCT01928381|9935143|FG001|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
8878147|NCT01928381|9935144|FG002|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
8987985|NCT02747628|10051220|FG001|STARTED|Overall Study||20
8987986|NCT02747628|10051221|FG002|STARTED|Overall Study||20
8987987|NCT02747628|10051219|FG000|COMPLETED|Overall Study||20
8987988|NCT02747628|10051220|FG001|COMPLETED|Overall Study||20
8987989|NCT02747628|10051221|FG002|COMPLETED|Overall Study||20
8987990|NCT02747628|10051219|FG000|NOT COMPLETED|Overall Study||0
8987991|NCT02747628|10051220|FG001|NOT COMPLETED|Overall Study||0
8987992|NCT02747628|10051221|FG002|NOT COMPLETED|Overall Study||0
8987993|NCT02747875|10051231|FG000|STARTED|Overall Study||12
8987994|NCT02747875|10051232|FG001|STARTED|Overall Study||14
8987995|NCT02747875|10051231|FG000|COMPLETED|Overall Study||11
8987996|NCT02747875|10051232|FG001|COMPLETED|Overall Study||13
8987997|NCT02747875|10051231|FG000|NOT COMPLETED|Overall Study||1
8987998|NCT02747875|10051232|FG001|NOT COMPLETED|Overall Study||1
8987999|NCT02747927|10051240|FG000|STARTED|Overall Study||6698
8988000|NCT02747927|10051241|FG001|STARTED|Overall Study||13401
8988001|NCT02747927|10051240|FG000|Treated: Safety Set|Overall Study||6687
8988002|NCT02747927|10051241|FG001|Treated: Safety Set|Overall Study||13380
8988003|NCT02747927|10051240|FG000|COMPLETED|Overall Study||6477
8988004|NCT02747927|10051241|FG001|COMPLETED|Overall Study||12943
8988005|NCT02747927|10051240|FG000|NOT COMPLETED|Overall Study||221
8988006|NCT02747927|10051241|FG001|NOT COMPLETED|Overall Study||458
8988007|NCT02748070|10051249|FG000|STARTED|Overall Study||41
8988008|NCT02748070|10051250|FG001|STARTED|Overall Study||40
8988009|NCT02748070|10051249|FG000|Randomized and Treated|Overall Study||40
8988010|NCT02748070|10051250|FG001|Randomized and Treated|Overall Study||40
8988011|NCT02748070|10051249|FG000|COMPLETED|Overall Study||33
8988012|NCT02748070|10051250|FG001|COMPLETED|Overall Study||39
8988013|NCT02748070|10051249|FG000|NOT COMPLETED|Overall Study||8
8988014|NCT02748070|10051250|FG001|NOT COMPLETED|Overall Study||1
8988015|NCT02748096|10051258|FG000|STARTED|Overall Study||23
8988016|NCT02748096|10051259|FG001|STARTED|Overall Study||22
8988017|NCT02748096|10051258|FG000|COMPLETED|Overall Study||23
8988018|NCT02748096|10051259|FG001|COMPLETED|Overall Study||22
8632957|NCT00548418|9672992|FG000|NOT COMPLETED|Overall Study||0
8632958|NCT00548431|9672996|FG000|STARTED|Overall Study||38
8632959|NCT00548431|9672996|FG000|COMPLETED|Overall Study||38
8988019|NCT02748096|10051258|FG000|NOT COMPLETED|Overall Study||0
8988020|NCT02748096|10051259|FG001|NOT COMPLETED|Overall Study||0
8988021|NCT02748213|10051267|FG000|STARTED|Overall Study||113
8988022|NCT02748213|10051268|FG001|STARTED|Overall Study||112
8988023|NCT02748213|10051267|FG000|Treated|Overall Study||112
8988024|NCT02748213|10051268|FG001|Treated|Overall Study||110
8988025|NCT02748213|10051267|FG000|COMPLETED|Overall Study|"*The reason Refused Treatment also includes those who did not cooperate or withdrew consent."|0
8988026|NCT02748213|10051268|FG001|COMPLETED|Overall Study||0
8988027|NCT02748213|10051267|FG000|NOT COMPLETED|Overall Study||113
8988028|NCT02748213|10051268|FG001|NOT COMPLETED|Overall Study||112
8988029|NCT02748317|10051274|FG000|STARTED|Overall Study||96
8988030|NCT02748317|10051274|FG000|COMPLETED|Overall Study||73
8988031|NCT02748317|10051274|FG000|NOT COMPLETED|Overall Study||23
8988032|NCT02748356|10051278|FG000|STARTED|Overall Study||7
8632960|NCT00548431|9672996|FG000|NOT COMPLETED|Overall Study||0
8632961|NCT00548470|9673000|FG000|STARTED|Overall Study||14
8632962|NCT00548470|9673000|FG000|COMPLETED|Overall Study||12
8632963|NCT00548470|9673000|FG000|NOT COMPLETED|Overall Study||2
8988033|NCT02748356|10051278|FG000|COMPLETED|Overall Study||6
8632964|NCT00548548|9673006|FG000|STARTED|Overall Study||387
8632965|NCT00548548|9673007|FG001|STARTED|Overall Study||387
8632966|NCT00548548|9673006|FG000|Treated|Overall Study||383
8632967|NCT00548548|9673007|FG001|Treated|Overall Study||384
8632968|NCT00548548|9673006|FG000|Safety Population|Overall Study|Four patients randomized to placebo received single doses of bevacizumab in error.|386
8632969|NCT00548548|9673007|FG001|Safety Population|Overall Study||381
8632970|NCT00548548|9673006|FG000|COMPLETED|Overall Study|Completed treatment discontinuation form was not completed; patient was counted alive on treatment.|25
8632971|NCT00548548|9673007|FG001|COMPLETED|Overall Study||21
8632972|NCT00548548|9673006|FG000|NOT COMPLETED|Overall Study||362
8632973|NCT00548548|9673007|FG001|NOT COMPLETED|Overall Study||366
8632974|NCT00548652|9673016|FG000|STARTED|Overall Study||18
8632975|NCT00548652|9673017|FG001|STARTED|Overall Study||38
8988034|NCT02748356|10051278|FG000|NOT COMPLETED|Overall Study||1
8988035|NCT02748512|10051284|FG000|STARTED|Overall Study||14
8988036|NCT02748512|10051285|FG001|STARTED|Overall Study||12
8988037|NCT02748512|10051284|FG000|COMPLETED|Overall Study||13
8988038|NCT02748512|10051285|FG001|COMPLETED|Overall Study||11
8988039|NCT02748512|10051284|FG000|NOT COMPLETED|Overall Study||1
8988040|NCT02748512|10051285|FG001|NOT COMPLETED|Overall Study||1
8988041|NCT02748525|10051291|FG000|STARTED|Overall Study||50
8632976|NCT00548652|9673018|FG002|STARTED|Overall Study||45
8988042|NCT02748525|10051291|FG000|Completed Study Intervention|Overall Study||50
8988043|NCT02748525|10051291|FG000|COMPLETED|Overall Study|Completed 6 months follow up|39
8988044|NCT02748525|10051291|FG000|NOT COMPLETED|Overall Study||11
8988045|NCT02748694|10051310|FG000|STARTED|Overall Study||10
8988046|NCT02748694|10051311|FG001|STARTED|Overall Study||6
8988047|NCT02748694|10051312|FG002|STARTED|Overall Study||6
8988048|NCT02748694|10051313|FG003|STARTED|Overall Study||6
8988049|NCT02748694|10051314|FG004|STARTED|Overall Study||6
8632977|NCT00548652|9673016|FG000|COMPLETED|Overall Study||16
8632978|NCT00548652|9673017|FG001|COMPLETED|Overall Study||29
8988050|NCT02748694|10051315|FG005|STARTED|Overall Study||6
8988051|NCT02748694|10051316|FG006|STARTED|Overall Study||8
8988052|NCT02748694|10051317|FG007|STARTED|Overall Study||6
8988053|NCT02748694|10051318|FG008|STARTED|Overall Study||6
8988054|NCT02748694|10051319|FG009|STARTED|Overall Study||6
8988055|NCT02748694|10051320|FG010|STARTED|Overall Study||6
8988056|NCT02748694|10051321|FG011|STARTED|Overall Study||9
8988057|NCT02748694|10051322|FG012|STARTED|Overall Study||9
8988058|NCT02748694|10051323|FG013|STARTED|Overall Study||8
8988059|NCT02748694|10051324|FG014|STARTED|Overall Study||16
8988060|NCT02748694|10051310|FG000|COMPLETED|Overall Study||10
8988061|NCT02748694|10051311|FG001|COMPLETED|Overall Study||6
8988062|NCT02748694|10051312|FG002|COMPLETED|Overall Study||6
8988063|NCT02748694|10051313|FG003|COMPLETED|Overall Study||6
8988064|NCT02748694|10051314|FG004|COMPLETED|Overall Study||6
8988065|NCT02748694|10051315|FG005|COMPLETED|Overall Study||6
8988066|NCT02748694|10051316|FG006|COMPLETED|Overall Study||8
8988067|NCT02748694|10051317|FG007|COMPLETED|Overall Study||6
8988068|NCT02748694|10051318|FG008|COMPLETED|Overall Study||6
8988069|NCT02748694|10051319|FG009|COMPLETED|Overall Study||6
8988070|NCT02748694|10051320|FG010|COMPLETED|Overall Study||6
8988071|NCT02748694|10051321|FG011|COMPLETED|Overall Study||9
8988072|NCT02748694|10051322|FG012|COMPLETED|Overall Study||9
8988073|NCT02748694|10051323|FG013|COMPLETED|Overall Study||8
8988074|NCT02748694|10051324|FG014|COMPLETED|Overall Study||14
8988075|NCT02748694|10051310|FG000|NOT COMPLETED|Overall Study||0
8988076|NCT02748694|10051311|FG001|NOT COMPLETED|Overall Study||0
8988077|NCT02748694|10051312|FG002|NOT COMPLETED|Overall Study||0
8988078|NCT02748694|10051313|FG003|NOT COMPLETED|Overall Study||0
8988079|NCT02748694|10051314|FG004|NOT COMPLETED|Overall Study||0
8988080|NCT02748694|10051315|FG005|NOT COMPLETED|Overall Study||0
8988081|NCT02748694|10051316|FG006|NOT COMPLETED|Overall Study||0
8988082|NCT02748694|10051317|FG007|NOT COMPLETED|Overall Study||0
8988083|NCT02748694|10051318|FG008|NOT COMPLETED|Overall Study||0
8988084|NCT02748694|10051319|FG009|NOT COMPLETED|Overall Study||0
8988085|NCT02748694|10051320|FG010|NOT COMPLETED|Overall Study||0
8988086|NCT02748694|10051321|FG011|NOT COMPLETED|Overall Study||0
8988087|NCT02748694|10051322|FG012|NOT COMPLETED|Overall Study||0
8988088|NCT02748694|10051323|FG013|NOT COMPLETED|Overall Study||0
8988089|NCT02748694|10051324|FG014|NOT COMPLETED|Overall Study||2
8988090|NCT02748785|10051384|FG000|STARTED|Visit 1- Visit 2||69
8988091|NCT02748785|10051385|FG001|STARTED|Visit 1- Visit 2||68
8988092|NCT02748785|10051386|FG002|STARTED|Visit 1- Visit 2||71
8988093|NCT02748785|10051387|FG003|STARTED|Visit 1- Visit 2||69
8988094|NCT02748785|10051384|FG000|COMPLETED|Visit 1- Visit 2||59
8988095|NCT02748785|10051385|FG001|COMPLETED|Visit 1- Visit 2||49
8988096|NCT02748785|10051386|FG002|COMPLETED|Visit 1- Visit 2||57
8988097|NCT02748785|10051387|FG003|COMPLETED|Visit 1- Visit 2||63
8988098|NCT02748785|10051384|FG000|NOT COMPLETED|Visit 1- Visit 2||10
8988099|NCT02748785|10051385|FG001|NOT COMPLETED|Visit 1- Visit 2||19
8988100|NCT02748785|10051386|FG002|NOT COMPLETED|Visit 1- Visit 2||14
8988101|NCT02748785|10051387|FG003|NOT COMPLETED|Visit 1- Visit 2||6
8988102|NCT02748785|10051384|FG000|STARTED|Visit 2-Visit 3||59
8988103|NCT02748785|10051385|FG001|STARTED|Visit 2-Visit 3||49
8988104|NCT02748785|10051386|FG002|STARTED|Visit 2-Visit 3||57
8988105|NCT02748785|10051387|FG003|STARTED|Visit 2-Visit 3||63
8988106|NCT02748785|10051384|FG000|COMPLETED|Visit 2-Visit 3||54
8988107|NCT02748785|10051385|FG001|COMPLETED|Visit 2-Visit 3||44
8988108|NCT02748785|10051386|FG002|COMPLETED|Visit 2-Visit 3||49
8988109|NCT02748785|10051387|FG003|COMPLETED|Visit 2-Visit 3||52
8988110|NCT02748785|10051384|FG000|NOT COMPLETED|Visit 2-Visit 3||5
8988111|NCT02748785|10051385|FG001|NOT COMPLETED|Visit 2-Visit 3||5
8988112|NCT02748785|10051386|FG002|NOT COMPLETED|Visit 2-Visit 3||8
8988113|NCT02748785|10051387|FG003|NOT COMPLETED|Visit 2-Visit 3||11
8988114|NCT02748785|10051384|FG000|STARTED|Visit 3- Visit 4||54
8988115|NCT02748785|10051385|FG001|STARTED|Visit 3- Visit 4||44
8988116|NCT02748785|10051386|FG002|STARTED|Visit 3- Visit 4||49
8988117|NCT02748785|10051387|FG003|STARTED|Visit 3- Visit 4||52
8988118|NCT02748785|10051384|FG000|COMPLETED|Visit 3- Visit 4||53
8988119|NCT02748785|10051385|FG001|COMPLETED|Visit 3- Visit 4||43
8988120|NCT02748785|10051386|FG002|COMPLETED|Visit 3- Visit 4||47
8988121|NCT02748785|10051387|FG003|COMPLETED|Visit 3- Visit 4||50
8988122|NCT02748785|10051384|FG000|NOT COMPLETED|Visit 3- Visit 4||1
8988123|NCT02748785|10051385|FG001|NOT COMPLETED|Visit 3- Visit 4||1
8988124|NCT02748785|10051386|FG002|NOT COMPLETED|Visit 3- Visit 4||2
8988125|NCT02748785|10051387|FG003|NOT COMPLETED|Visit 3- Visit 4||2
8988126|NCT02748863|10051400|FG000|STARTED|Treatment Period 1||72
8988127|NCT02748863|10051401|FG001|STARTED|Treatment Period 1||71
8988128|NCT02748863|10051402|FG002|STARTED|Treatment Period 1||71
8988129|NCT02748863|10051403|FG003|STARTED|Treatment Period 1|Not applicable for this period|0
8988130|NCT02748863|10051404|FG004|STARTED|Treatment Period 1|Not applicable for this period|0
8988131|NCT02748863|10051400|FG000|COMPLETED|Treatment Period 1||72
8988132|NCT02748863|10051401|FG001|COMPLETED|Treatment Period 1||69
8988133|NCT02748863|10051402|FG002|COMPLETED|Treatment Period 1||69
8988134|NCT02748863|10051403|FG003|COMPLETED|Treatment Period 1||0
8988135|NCT02748863|10051404|FG004|COMPLETED|Treatment Period 1||0
8988136|NCT02748863|10051400|FG000|NOT COMPLETED|Treatment Period 1||0
8988137|NCT02748863|10051401|FG001|NOT COMPLETED|Treatment Period 1||2
8988138|NCT02748863|10051402|FG002|NOT COMPLETED|Treatment Period 1||2
8988139|NCT02748863|10051403|FG003|NOT COMPLETED|Treatment Period 1||0
8988140|NCT02748863|10051404|FG004|NOT COMPLETED|Treatment Period 1||0
8988141|NCT02748863|10051400|FG000|STARTED|Treatment Period 2||72
8988142|NCT02748863|10051401|FG001|STARTED|Treatment Period 2||69
8988143|NCT02748863|10051402|FG002|STARTED|Treatment Period 2||0
8988144|NCT02748863|10051403|FG003|STARTED|Treatment Period 2||34
8988145|NCT02748863|10051404|FG004|STARTED|Treatment Period 2||34
8988146|NCT02748863|10051400|FG000|COMPLETED|Treatment Period 2||67
8988147|NCT02748863|10051401|FG001|COMPLETED|Treatment Period 2||66
8988148|NCT02748863|10051402|FG002|COMPLETED|Treatment Period 2||0
8988149|NCT02748863|10051403|FG003|COMPLETED|Treatment Period 2||32
8988150|NCT02748863|10051404|FG004|COMPLETED|Treatment Period 2||33
8988151|NCT02748863|10051400|FG000|NOT COMPLETED|Treatment Period 2||5
8988152|NCT02748863|10051401|FG001|NOT COMPLETED|Treatment Period 2||3
8988153|NCT02748863|10051402|FG002|NOT COMPLETED|Treatment Period 2||0
8988154|NCT02748863|10051403|FG003|NOT COMPLETED|Treatment Period 2||2
8988155|NCT02748863|10051404|FG004|NOT COMPLETED|Treatment Period 2||1
8988156|NCT02748889|10051421|FG000|STARTED|Overall Study||0
8988157|NCT02748889|10051422|FG001|STARTED|Overall Study||1
8988158|NCT02748889|10051421|FG000|COMPLETED|Overall Study||0
8988159|NCT02748889|10051422|FG001|COMPLETED|Overall Study||1
8988160|NCT02748889|10051421|FG000|NOT COMPLETED|Overall Study||0
8988161|NCT02748889|10051422|FG001|NOT COMPLETED|Overall Study||0
8988162|NCT02748928|10051426|FG000|STARTED|Overall Study||62
8988163|NCT02748928|10051426|FG000|COMPLETED|Overall Study||62
8988164|NCT02748928|10051426|FG000|NOT COMPLETED|Overall Study||0
8988165|NCT02749201|10051431|FG000|STARTED|Overall Study||10
8988166|NCT02749201|10051431|FG000|COMPLETED|Overall Study||10
8988167|NCT02749201|10051431|FG000|NOT COMPLETED|Overall Study||0
8988168|NCT02749370|10051435|FG000|STARTED|Overall Study||80
8988169|NCT02749370|10051435|FG000|COMPLETED|Overall Study||66
8988170|NCT02749370|10051435|FG000|NOT COMPLETED|Overall Study||14
8988171|NCT02749721|10051439|FG000|STARTED|Screening||31
8988172|NCT02749721|10051439|FG000|COMPLETED|Screening||25
8988173|NCT02749721|10051439|FG000|NOT COMPLETED|Screening||6
8988174|NCT02749721|10051439|FG000|STARTED|8-week Open-Label Treatment Phase||25
8988175|NCT02749721|10051439|FG000|COMPLETED|8-week Open-Label Treatment Phase||22
8988176|NCT02749721|10051439|FG000|NOT COMPLETED|8-week Open-Label Treatment Phase||3
8988177|NCT02749799|10051445|FG000|STARTED|Overall Study||45
8988178|NCT02749799|10051445|FG000|COMPLETED|Overall Study||37
8988179|NCT02749799|10051445|FG000|NOT COMPLETED|Overall Study||8
8988180|NCT02749903|10051449|FG000|STARTED|Overall Study||46
8988181|NCT02749903|10051449|FG000|COMPLETED|Overall Study||46
8988182|NCT02749903|10051449|FG000|NOT COMPLETED|Overall Study||0
8988183|NCT02750267|10051455|FG000|STARTED|Overall Study||6
8988184|NCT02750267|10051456|FG001|STARTED|Overall Study||6
8988185|NCT02750267|10051455|FG000|COMPLETED|Overall Study||6
8988186|NCT02750267|10051456|FG001|COMPLETED|Overall Study||6
8988187|NCT02750267|10051455|FG000|NOT COMPLETED|Overall Study||0
8988188|NCT02750267|10051456|FG001|NOT COMPLETED|Overall Study||0
8988189|NCT02750306|10051466|FG000|STARTED|Overall Study||142
8988190|NCT02750306|10051467|FG001|STARTED|Overall Study||143
8988191|NCT02750306|10051466|FG000|COMPLETED|Overall Study||136
8988192|NCT02750306|10051467|FG001|COMPLETED|Overall Study||141
8988193|NCT02750306|10051466|FG000|NOT COMPLETED|Overall Study||6
8988194|NCT02750306|10051467|FG001|NOT COMPLETED|Overall Study||2
8988195|NCT02750332|10051473|FG000|STARTED|Treatment Period 1||10
8988196|NCT02750332|10051474|FG001|STARTED|Treatment Period 1||10
8988197|NCT02750332|10051473|FG000|COMPLETED|Treatment Period 1||10
8988198|NCT02750332|10051474|FG001|COMPLETED|Treatment Period 1||9
8988199|NCT02750332|10051473|FG000|NOT COMPLETED|Treatment Period 1||0
8988200|NCT02750332|10051474|FG001|NOT COMPLETED|Treatment Period 1||1
8988201|NCT02750332|10051473|FG000|STARTED|Treatment Period 2||10
8988202|NCT02750332|10051474|FG001|STARTED|Treatment Period 2||9
8988203|NCT02750332|10051473|FG000|COMPLETED|Treatment Period 2||10
8725867|NCT01033487|9773164|FG007|STARTED|Second Intervention Period||3
8725868|NCT01033487|9773165|FG008|STARTED|Second Intervention Period||2
8725869|NCT01033487|9773166|FG009|STARTED|Second Intervention Period||2
8725870|NCT01033487|9773157|FG000|COMPLETED|Second Intervention Period||2
8725871|NCT01033487|9773158|FG001|COMPLETED|Second Intervention Period||3
8725872|NCT01033487|9773159|FG002|COMPLETED|Second Intervention Period||2
8725873|NCT01033487|9773160|FG003|COMPLETED|Second Intervention Period||2
8988204|NCT02750332|10051474|FG001|COMPLETED|Treatment Period 2||9
8988205|NCT02750332|10051473|FG000|NOT COMPLETED|Treatment Period 2||0
8725874|NCT01033487|9773161|FG004|COMPLETED|Second Intervention Period||2
8725875|NCT01033487|9773162|FG005|COMPLETED|Second Intervention Period||2
8725876|NCT01033487|9773163|FG006|COMPLETED|Second Intervention Period||2
8725877|NCT01033487|9773164|FG007|COMPLETED|Second Intervention Period||3
8988206|NCT02750332|10051474|FG001|NOT COMPLETED|Treatment Period 2||0
8988207|NCT02750345|10051480|FG000|STARTED|Intervention 1||4
8988208|NCT02750345|10051481|FG001|STARTED|Intervention 1||4
8988209|NCT02750345|10051482|FG002|STARTED|Intervention 1||4
8988210|NCT02750345|10051483|FG003|STARTED|Intervention 1||4
8988211|NCT02750345|10051484|FG004|STARTED|Intervention 1||4
8988212|NCT02750345|10051485|FG005|STARTED|Intervention 1||4
8988213|NCT02750345|10051480|FG000|COMPLETED|Intervention 1||4
8988214|NCT02750345|10051481|FG001|COMPLETED|Intervention 1||4
8988215|NCT02750345|10051482|FG002|COMPLETED|Intervention 1||4
8988216|NCT02750345|10051483|FG003|COMPLETED|Intervention 1||4
8988217|NCT02750345|10051484|FG004|COMPLETED|Intervention 1||3
8988218|NCT02750345|10051485|FG005|COMPLETED|Intervention 1||4
8988219|NCT02750345|10051480|FG000|NOT COMPLETED|Intervention 1||0
8988220|NCT02750345|10051481|FG001|NOT COMPLETED|Intervention 1||0
8988221|NCT02750345|10051482|FG002|NOT COMPLETED|Intervention 1||0
8988222|NCT02750345|10051483|FG003|NOT COMPLETED|Intervention 1||0
8988223|NCT02750345|10051484|FG004|NOT COMPLETED|Intervention 1||1
8988224|NCT02750345|10051485|FG005|NOT COMPLETED|Intervention 1||0
8988225|NCT02750345|10051480|FG000|STARTED|Intervention 2||4
8988226|NCT02750345|10051481|FG001|STARTED|Intervention 2||4
8988227|NCT02750345|10051482|FG002|STARTED|Intervention 2||4
8988228|NCT02750345|10051483|FG003|STARTED|Intervention 2||4
8988229|NCT02750345|10051484|FG004|STARTED|Intervention 2||3
8988230|NCT02750345|10051485|FG005|STARTED|Intervention 2||4
8988231|NCT02750345|10051480|FG000|COMPLETED|Intervention 2||4
8988232|NCT02750345|10051481|FG001|COMPLETED|Intervention 2||4
8988233|NCT02750345|10051482|FG002|COMPLETED|Intervention 2||4
8988234|NCT02750345|10051483|FG003|COMPLETED|Intervention 2||4
8988235|NCT02750345|10051484|FG004|COMPLETED|Intervention 2||3
8988236|NCT02750345|10051485|FG005|COMPLETED|Intervention 2||4
8988237|NCT02750345|10051480|FG000|NOT COMPLETED|Intervention 2||0
8988238|NCT02750345|10051481|FG001|NOT COMPLETED|Intervention 2||0
8988239|NCT02750345|10051482|FG002|NOT COMPLETED|Intervention 2||0
8988240|NCT02750345|10051483|FG003|NOT COMPLETED|Intervention 2||0
8988241|NCT02750345|10051484|FG004|NOT COMPLETED|Intervention 2||0
8988242|NCT02750345|10051485|FG005|NOT COMPLETED|Intervention 2||0
8988243|NCT02750345|10051480|FG000|STARTED|Intervention 3||4
8988244|NCT02750345|10051481|FG001|STARTED|Intervention 3||4
8988245|NCT02750345|10051482|FG002|STARTED|Intervention 3||4
8988246|NCT02750345|10051483|FG003|STARTED|Intervention 3||4
8988247|NCT02750345|10051484|FG004|STARTED|Intervention 3||3
8988248|NCT02750345|10051485|FG005|STARTED|Intervention 3||4
8988249|NCT02750345|10051480|FG000|COMPLETED|Intervention 3||4
8988250|NCT02750345|10051481|FG001|COMPLETED|Intervention 3||4
8988251|NCT02750345|10051482|FG002|COMPLETED|Intervention 3||4
8988252|NCT02750345|10051483|FG003|COMPLETED|Intervention 3||4
8988253|NCT02750345|10051484|FG004|COMPLETED|Intervention 3||3
8988254|NCT02750345|10051485|FG005|COMPLETED|Intervention 3||4
8988255|NCT02750345|10051480|FG000|NOT COMPLETED|Intervention 3||0
8988256|NCT02750345|10051481|FG001|NOT COMPLETED|Intervention 3||0
8988257|NCT02750345|10051482|FG002|NOT COMPLETED|Intervention 3||0
8988258|NCT02750345|10051483|FG003|NOT COMPLETED|Intervention 3||0
8988259|NCT02750345|10051484|FG004|NOT COMPLETED|Intervention 3||0
8988260|NCT02750345|10051485|FG005|NOT COMPLETED|Intervention 3||0
8988261|NCT02750410|10051497|FG000|STARTED|Double-Blind Treatment Period||39
8988262|NCT02750410|10051498|FG001|STARTED|Double-Blind Treatment Period||120
8988263|NCT02750410|10051497|FG000|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||39
8988264|NCT02750410|10051498|FG001|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||120
8988265|NCT02750410|10051497|FG000|COMPLETED|Double-Blind Treatment Period||37
8988266|NCT02750410|10051498|FG001|COMPLETED|Double-Blind Treatment Period||117
8988267|NCT02750410|10051497|FG000|NOT COMPLETED|Double-Blind Treatment Period||2
8988268|NCT02750410|10051498|FG001|NOT COMPLETED|Double-Blind Treatment Period||3
8988269|NCT02750410|10051497|FG000|STARTED|Open-Label Extension Period||37
8988270|NCT02750410|10051498|FG001|STARTED|Open-Label Extension Period||117
8988271|NCT02750410|10051497|FG000|COMPLETED|Open-Label Extension Period||31
8988272|NCT02750410|10051498|FG001|COMPLETED|Open-Label Extension Period||111
8878148|NCT01928381|9935145|FG003|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
8878149|NCT01928381|9935146|FG004|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
8878150|NCT01928381|9935147|FG005|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
8878151|NCT01928381|9935148|FG006|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
8878152|NCT01928381|9935142|FG000|STARTED|Part 2 - First Intervention||0
8878153|NCT01928381|9935143|FG001|STARTED|Part 2 - First Intervention||6
8878154|NCT01928381|9935144|FG002|STARTED|Part 2 - First Intervention||6
8878155|NCT01928381|9935145|FG003|STARTED|Part 2 - First Intervention||6
8878156|NCT01928381|9935146|FG004|STARTED|Part 2 - First Intervention||4
8878157|NCT01928381|9935147|FG005|STARTED|Part 2 - First Intervention||6
8878158|NCT01928381|9935148|FG006|STARTED|Part 2 - First Intervention||6
8878159|NCT01928381|9935142|FG000|COMPLETED|Part 2 - First Intervention||0
8878160|NCT01928381|9935143|FG001|COMPLETED|Part 2 - First Intervention||6
8878161|NCT01928381|9935144|FG002|COMPLETED|Part 2 - First Intervention||4
8878162|NCT01928381|9935145|FG003|COMPLETED|Part 2 - First Intervention||5
8988273|NCT02750410|10051497|FG000|NOT COMPLETED|Open-Label Extension Period||6
8988274|NCT02750410|10051498|FG001|NOT COMPLETED|Open-Label Extension Period||6
8988275|NCT02750501|10051508|FG000|STARTED|Overall Study||44
8988276|NCT02750501|10051508|FG000|Enrolled|Overall Study||44
8988277|NCT02750501|10051508|FG000|Treated|Overall Study||39
8988278|NCT02750501|10051508|FG000|COMPLETED|Overall Study||36
8988279|NCT02750501|10051508|FG000|NOT COMPLETED|Overall Study||8
8988280|NCT02750514|10051521|FG000|STARTED|Track 1||40
8988281|NCT02750514|10051522|FG001|STARTED|Track 1||4
8988282|NCT02750514|10051523|FG002|STARTED|Track 1||0
8988283|NCT02750514|10051524|FG003|STARTED|Track 1||3
8988284|NCT02750514|10051525|FG004|STARTED|Track 1||0
8988285|NCT02750514|10051521|FG000|COMPLETED|Track 1|3 participants were re-randomized to track 3 (2 part.) or track 5 (1 part.)|13
8988286|NCT02750514|10051522|FG001|COMPLETED|Track 1||2
8988287|NCT02750514|10051523|FG002|COMPLETED|Track 1||0
8988288|NCT02750514|10051524|FG003|COMPLETED|Track 1||1
8988289|NCT02750514|10051525|FG004|COMPLETED|Track 1||0
8988290|NCT02750514|10051521|FG000|NOT COMPLETED|Track 1||27
8988291|NCT02750514|10051522|FG001|NOT COMPLETED|Track 1||2
8988292|NCT02750514|10051523|FG002|NOT COMPLETED|Track 1||0
8988293|NCT02750514|10051524|FG003|NOT COMPLETED|Track 1||2
8988294|NCT02750514|10051525|FG004|NOT COMPLETED|Track 1||0
8988295|NCT02750514|10051521|FG000|STARTED|Track 2||9
8988296|NCT02750514|10051522|FG001|STARTED|Track 2||8
8988297|NCT02750514|10051523|FG002|STARTED|Track 2||2
8988298|NCT02750514|10051524|FG003|STARTED|Track 2||12
8988299|NCT02750514|10051525|FG004|STARTED|Track 2||0
8988300|NCT02750514|10051521|FG000|COMPLETED|Track 2|2 participants were re-randomized to track 3 (1 part.) or track 5 (1 part.)|3
8988301|NCT02750514|10051522|FG001|COMPLETED|Track 2||0
8988302|NCT02750514|10051523|FG002|COMPLETED|Track 2||0
8988303|NCT02750514|10051524|FG003|COMPLETED|Track 2|1 participant was re-randomized to track 5|5
8988304|NCT02750514|10051525|FG004|COMPLETED|Track 2||0
8988305|NCT02750514|10051521|FG000|NOT COMPLETED|Track 2||6
8988306|NCT02750514|10051522|FG001|NOT COMPLETED|Track 2||8
8988307|NCT02750514|10051523|FG002|NOT COMPLETED|Track 2||2
8632979|NCT00548652|9673018|FG002|COMPLETED|Overall Study||34
8632980|NCT00548652|9673016|FG000|NOT COMPLETED|Overall Study||2
8632981|NCT00548652|9673017|FG001|NOT COMPLETED|Overall Study||9
8632982|NCT00548652|9673018|FG002|NOT COMPLETED|Overall Study||11
8878163|NCT01928381|9935146|FG004|COMPLETED|Part 2 - First Intervention||4
8878164|NCT01928381|9935147|FG005|COMPLETED|Part 2 - First Intervention||5
8988308|NCT02750514|10051524|FG003|NOT COMPLETED|Track 2||7
8988309|NCT02750514|10051525|FG004|NOT COMPLETED|Track 2||0
8878165|NCT01928381|9935148|FG006|COMPLETED|Part 2 - First Intervention||5
8878166|NCT01928381|9935142|FG000|NOT COMPLETED|Part 2 - First Intervention||0
8878167|NCT01928381|9935143|FG001|NOT COMPLETED|Part 2 - First Intervention||0
8878168|NCT01928381|9935144|FG002|NOT COMPLETED|Part 2 - First Intervention||2
8878169|NCT01928381|9935145|FG003|NOT COMPLETED|Part 2 - First Intervention||1
8878170|NCT01928381|9935146|FG004|NOT COMPLETED|Part 2 - First Intervention||0
8878171|NCT01928381|9935147|FG005|NOT COMPLETED|Part 2 - First Intervention||1
8878172|NCT01928381|9935148|FG006|NOT COMPLETED|Part 2 - First Intervention||1
8878173|NCT01928381|9935142|FG000|STARTED|Washout First Intervention||0
8878174|NCT01928381|9935143|FG001|STARTED|Washout First Intervention||6
8878175|NCT01928381|9935144|FG002|STARTED|Washout First Intervention||4
8878176|NCT01928381|9935145|FG003|STARTED|Washout First Intervention||5
8878177|NCT01928381|9935146|FG004|STARTED|Washout First Intervention||4
8878178|NCT01928381|9935147|FG005|STARTED|Washout First Intervention||5
8878179|NCT01928381|9935148|FG006|STARTED|Washout First Intervention||5
8878180|NCT01928381|9935142|FG000|COMPLETED|Washout First Intervention||0
8878181|NCT01928381|9935143|FG001|COMPLETED|Washout First Intervention||6
8878182|NCT01928381|9935144|FG002|COMPLETED|Washout First Intervention||4
8878183|NCT01928381|9935145|FG003|COMPLETED|Washout First Intervention||5
8878184|NCT01928381|9935146|FG004|COMPLETED|Washout First Intervention||3
8878185|NCT01928381|9935147|FG005|COMPLETED|Washout First Intervention||5
8878186|NCT01928381|9935148|FG006|COMPLETED|Washout First Intervention||5
8878187|NCT01928381|9935142|FG000|NOT COMPLETED|Washout First Intervention||0
8878188|NCT01928381|9935143|FG001|NOT COMPLETED|Washout First Intervention||0
8878189|NCT01928381|9935144|FG002|NOT COMPLETED|Washout First Intervention||0
8878190|NCT01928381|9935145|FG003|NOT COMPLETED|Washout First Intervention||0
8878191|NCT01928381|9935146|FG004|NOT COMPLETED|Washout First Intervention||1
8878192|NCT01928381|9935147|FG005|NOT COMPLETED|Washout First Intervention||0
8878193|NCT01928381|9935148|FG006|NOT COMPLETED|Washout First Intervention||0
8878194|NCT01928381|9935142|FG000|STARTED|Part 2 - Second Intervention||0
8878195|NCT01928381|9935143|FG001|STARTED|Part 2 - Second Intervention||6
8878196|NCT01928381|9935144|FG002|STARTED|Part 2 - Second Intervention||4
8878197|NCT01928381|9935145|FG003|STARTED|Part 2 - Second Intervention||5
8878198|NCT01928381|9935146|FG004|STARTED|Part 2 - Second Intervention||3
8878199|NCT01928381|9935147|FG005|STARTED|Part 2 - Second Intervention||5
8878200|NCT01928381|9935148|FG006|STARTED|Part 2 - Second Intervention||5
8878201|NCT01928381|9935142|FG000|COMPLETED|Part 2 - Second Intervention||0
8878202|NCT01928381|9935143|FG001|COMPLETED|Part 2 - Second Intervention||5
8878203|NCT01928381|9935144|FG002|COMPLETED|Part 2 - Second Intervention||4
8878204|NCT01928381|9935145|FG003|COMPLETED|Part 2 - Second Intervention||4
8878205|NCT01928381|9935146|FG004|COMPLETED|Part 2 - Second Intervention||3
8878206|NCT01928381|9935147|FG005|COMPLETED|Part 2 - Second Intervention||5
8878207|NCT01928381|9935148|FG006|COMPLETED|Part 2 - Second Intervention||5
8878208|NCT01928381|9935142|FG000|NOT COMPLETED|Part 2 - Second Intervention||0
8988310|NCT02750514|10051521|FG000|STARTED|Track 3||0
8988311|NCT02750514|10051522|FG001|STARTED|Track 3|2 participants had prior treatment in track 1 (1 part.) or track 2 (1 part.)|41
8988312|NCT02750514|10051523|FG002|STARTED|Track 3|1 participant had prior treatment in track 3|16
8988313|NCT02750514|10051524|FG003|STARTED|Track 3|5 participants had prior treatment in track 1 (1 part.) or track 3 (4 part.)|18
8988314|NCT02750514|10051525|FG004|STARTED|Track 3||0
8988315|NCT02750514|10051521|FG000|COMPLETED|Track 3||0
8988316|NCT02750514|10051522|FG001|COMPLETED|Track 3|6 participants were re-randomized to track 3 (5 part.) or to track 5 (1 part.)|5
8988317|NCT02750514|10051523|FG002|COMPLETED|Track 3||1
8988318|NCT02750514|10051524|FG003|COMPLETED|Track 3|1 participant was re-randomized to track 5|2
8988319|NCT02750514|10051525|FG004|COMPLETED|Track 3||0
8988320|NCT02750514|10051521|FG000|NOT COMPLETED|Track 3||0
8988321|NCT02750514|10051522|FG001|NOT COMPLETED|Track 3||36
8988322|NCT02750514|10051523|FG002|NOT COMPLETED|Track 3||15
8988323|NCT02750514|10051524|FG003|NOT COMPLETED|Track 3||16
8988324|NCT02750514|10051525|FG004|NOT COMPLETED|Track 3||0
8988325|NCT02750514|10051521|FG000|STARTED|Track 4||0
8988326|NCT02750514|10051522|FG001|STARTED|Track 4||53
8988327|NCT02750514|10051523|FG002|STARTED|Track 4||0
8988328|NCT02750514|10051524|FG003|STARTED|Track 4||60
8988329|NCT02750514|10051525|FG004|STARTED|Track 4||0
8988330|NCT02750514|10051521|FG000|COMPLETED|Track 4||0
8988331|NCT02750514|10051522|FG001|COMPLETED|Track 4|1 participant was re-randomized to track 5|2
8988332|NCT02750514|10051523|FG002|COMPLETED|Track 4||0
8988333|NCT02750514|10051524|FG003|COMPLETED|Track 4||18
8988334|NCT02750514|10051525|FG004|COMPLETED|Track 4||0
8988335|NCT02750514|10051521|FG000|NOT COMPLETED|Track 4||0
8988336|NCT02750514|10051522|FG001|NOT COMPLETED|Track 4||51
8988337|NCT02750514|10051523|FG002|NOT COMPLETED|Track 4||0
8988338|NCT02750514|10051524|FG003|NOT COMPLETED|Track 4||42
8988339|NCT02750514|10051525|FG004|NOT COMPLETED|Track 4||0
8571767|NCT00112385|9604111|FG000|COMPLETED|Overall Study||10
8571768|NCT00112385|9604112|FG001|COMPLETED|Overall Study||4
8571769|NCT00112385|9604111|FG000|NOT COMPLETED|Overall Study||1
8571770|NCT00112385|9604112|FG001|NOT COMPLETED|Overall Study||1
8571771|NCT00112437|9604123|FG000|STARTED|Year 1 (12-Month Base Study)||83
8571772|NCT00112437|9604124|FG001|STARTED|Year 1 (12-Month Base Study)||82
8571773|NCT00112437|9604125|FG002|STARTED|Year 1 (12-Month Base Study)||77
8571774|NCT00112437|9604126|FG003|STARTED|Year 1 (12-Month Base Study)||79
8571775|NCT00112437|9604127|FG004|STARTED|Year 1 (12-Month Base Study)||78
8571776|NCT00112437|9604128|FG005|STARTED|Year 1 (12-Month Base Study)||0
8571777|NCT00112437|9604129|FG006|STARTED|Year 1 (12-Month Base Study)||0
8571778|NCT00112437|9604130|FG007|STARTED|Year 1 (12-Month Base Study)||0
8571779|NCT00112437|9604131|FG008|STARTED|Year 1 (12-Month Base Study)||0
8571780|NCT00112437|9604132|FG009|STARTED|Year 1 (12-Month Base Study)||0
8571781|NCT00112437|9604133|FG010|STARTED|Year 1 (12-Month Base Study)||0
8571782|NCT00112437|9604134|FG011|STARTED|Year 1 (12-Month Base Study)||0
8571783|NCT00112437|9604135|FG012|STARTED|Year 1 (12-Month Base Study)||0
8571784|NCT00112437|9604136|FG013|STARTED|Year 1 (12-Month Base Study)||0
8571785|NCT00112437|9604137|FG014|STARTED|Year 1 (12-Month Base Study)||0
8632983|NCT00548691|9673028|FG000|STARTED|Overall Study||258
8632984|NCT00548691|9673029|FG001|STARTED|Overall Study||259
8988340|NCT02750514|10051521|FG000|STARTED|Track 5||0
8988341|NCT02750514|10051522|FG001|STARTED|Track 5||0
8988342|NCT02750514|10051523|FG002|STARTED|Track 5||0
8988343|NCT02750514|10051524|FG003|STARTED|Track 5||0
8988344|NCT02750514|10051525|FG004|STARTED|Track 5|6 participants had prior treatment in track 1 (1 part.), 2 (2 part.), 3 (2 part.) or 4 (1 part.)|43
8988345|NCT02750514|10051521|FG000|COMPLETED|Track 5||0
8988346|NCT02750514|10051522|FG001|COMPLETED|Track 5||0
8988347|NCT02750514|10051523|FG002|COMPLETED|Track 5||0
8988348|NCT02750514|10051524|FG003|COMPLETED|Track 5||0
8988349|NCT02750514|10051525|FG004|COMPLETED|Track 5||0
8988350|NCT02750514|10051521|FG000|NOT COMPLETED|Track 5||0
8988351|NCT02750514|10051522|FG001|NOT COMPLETED|Track 5||0
8988352|NCT02750514|10051523|FG002|NOT COMPLETED|Track 5||0
8988353|NCT02750514|10051524|FG003|NOT COMPLETED|Track 5||0
8988354|NCT02750514|10051525|FG004|NOT COMPLETED|Track 5||43
8988355|NCT02750592|10051545|FG000|STARTED|Overall Study||30
8988356|NCT02750592|10051545|FG000|COMPLETED|Overall Study||25
8988357|NCT02750592|10051545|FG000|NOT COMPLETED|Overall Study||5
9038881|NCT03334448|10099974|FG002|Received at Least 1 Dose of Study Drug|Period 4||13
9038882|NCT03334448|10099975|FG003|Received at Least 1 Dose of Study Drug|Period 4||11
9038883|NCT03334448|10099972|FG000|COMPLETED|Period 4||12
9038884|NCT03334448|10099973|FG001|COMPLETED|Period 4||11
9038885|NCT03334448|10099974|FG002|COMPLETED|Period 4||13
9038886|NCT03334448|10099975|FG003|COMPLETED|Period 4||11
9038887|NCT03334448|10099972|FG000|NOT COMPLETED|Period 4||0
9038888|NCT03334448|10099973|FG001|NOT COMPLETED|Period 4||0
9038889|NCT03334448|10099974|FG002|NOT COMPLETED|Period 4||0
9038890|NCT03334448|10099975|FG003|NOT COMPLETED|Period 4||0
9038891|NCT03334630|10099983|FG000|STARTED|Overall Study||239
9038892|NCT03334630|10099984|FG001|STARTED|Overall Study||243
9038893|NCT03334630|10099983|FG000|COMPLETED|Overall Study||225
9038894|NCT03334630|10099984|FG001|COMPLETED|Overall Study||230
9038895|NCT03334630|10099983|FG000|NOT COMPLETED|Overall Study||14
9038896|NCT03334630|10099984|FG001|NOT COMPLETED|Overall Study||13
9038897|NCT03334695|10099992|FG000|STARTED|Overall Study||31
9038898|NCT03334695|10099993|FG001|STARTED|Overall Study||32
9038899|NCT03334695|10099992|FG000|COMPLETED|Overall Study||27
9038900|NCT03334695|10099993|FG001|COMPLETED|Overall Study||26
9038901|NCT03334695|10099992|FG000|NOT COMPLETED|Overall Study||4
9038902|NCT03334695|10099993|FG001|NOT COMPLETED|Overall Study||6
9038903|NCT03334721|10100003|FG000|STARTED|Overall Study||12
9038904|NCT03334721|10100004|FG001|STARTED|Overall Study||11
9038905|NCT03334721|10100003|FG000|COMPLETED|Overall Study||10
9038906|NCT03334721|10100004|FG001|COMPLETED|Overall Study||11
9038907|NCT03334721|10100003|FG000|NOT COMPLETED|Overall Study||2
9038908|NCT03334721|10100004|FG001|NOT COMPLETED|Overall Study||0
9038909|NCT03334734|10100014|FG000|STARTED|Overall Study||4
9038910|NCT03334734|10100015|FG001|STARTED|Overall Study||4
9038911|NCT03334734|10100016|FG002|STARTED|Overall Study||7
9038912|NCT03334734|10100017|FG003|STARTED|Overall Study||1
9038913|NCT03334734|10100014|FG000|COMPLETED|Overall Study||4
9038914|NCT03334734|10100015|FG001|COMPLETED|Overall Study||4
9038915|NCT03334734|10100016|FG002|COMPLETED|Overall Study||5
9038916|NCT03334734|10100017|FG003|COMPLETED|Overall Study||1
9038917|NCT03334734|10100014|FG000|NOT COMPLETED|Overall Study||0
9038918|NCT03334734|10100015|FG001|NOT COMPLETED|Overall Study||0
9038919|NCT03334734|10100016|FG002|NOT COMPLETED|Overall Study||2
9038920|NCT03334734|10100017|FG003|NOT COMPLETED|Overall Study||0
9038921|NCT03334747|10100036|FG000|STARTED|Treatment Phase||10
9038922|NCT03334747|10100037|FG001|STARTED|Treatment Phase||10
9038923|NCT03334747|10100038|FG002|STARTED|Treatment Phase||12
9038924|NCT03334747|10100039|FG003|STARTED|Treatment Phase||20
9038925|NCT03334747|10100040|FG004|STARTED|Treatment Phase||22
9038926|NCT03334747|10100041|FG005|STARTED|Treatment Phase||20
9038927|NCT03334747|10100042|FG006|STARTED|Treatment Phase||21
9038928|NCT03334747|10100043|FG007|STARTED|Treatment Phase||22
9038929|NCT03334747|10100044|FG008|STARTED|Treatment Phase||51
9038930|NCT03334747|10100036|FG000|COMPLETED|Treatment Phase||9
9038931|NCT03334747|10100037|FG001|COMPLETED|Treatment Phase||10
9038932|NCT03334747|10100038|FG002|COMPLETED|Treatment Phase||12
9038933|NCT03334747|10100039|FG003|COMPLETED|Treatment Phase||20
9038934|NCT03334747|10100040|FG004|COMPLETED|Treatment Phase||21
9038935|NCT03334747|10100041|FG005|COMPLETED|Treatment Phase||19
9038936|NCT03334747|10100042|FG006|COMPLETED|Treatment Phase||21
9038937|NCT03334747|10100043|FG007|COMPLETED|Treatment Phase||22
9038938|NCT03334747|10100044|FG008|COMPLETED|Treatment Phase||51
9038939|NCT03334747|10100036|FG000|NOT COMPLETED|Treatment Phase||1
9038940|NCT03334747|10100037|FG001|NOT COMPLETED|Treatment Phase||0
9038941|NCT03334747|10100038|FG002|NOT COMPLETED|Treatment Phase||0
9038942|NCT03334747|10100039|FG003|NOT COMPLETED|Treatment Phase||0
9038943|NCT03334747|10100040|FG004|NOT COMPLETED|Treatment Phase||1
9038944|NCT03334747|10100041|FG005|NOT COMPLETED|Treatment Phase||1
9038945|NCT03334747|10100042|FG006|NOT COMPLETED|Treatment Phase||0
9038946|NCT03334747|10100043|FG007|NOT COMPLETED|Treatment Phase||0
9038947|NCT03334747|10100044|FG008|NOT COMPLETED|Treatment Phase||0
9038948|NCT03334747|10100036|FG000|STARTED|Follow-Up Phase||9
9038949|NCT03334747|10100037|FG001|STARTED|Follow-Up Phase||10
9038950|NCT03334747|10100038|FG002|STARTED|Follow-Up Phase||12
9038951|NCT03334747|10100039|FG003|STARTED|Follow-Up Phase||20
9038952|NCT03334747|10100040|FG004|STARTED|Follow-Up Phase||21
9038953|NCT03334747|10100041|FG005|STARTED|Follow-Up Phase||19
9038954|NCT03334747|10100042|FG006|STARTED|Follow-Up Phase||21
9038955|NCT03334747|10100043|FG007|STARTED|Follow-Up Phase||22
9038956|NCT03334747|10100044|FG008|STARTED|Follow-Up Phase||51
9038957|NCT03334747|10100036|FG000|COMPLETED|Follow-Up Phase||9
9038958|NCT03334747|10100037|FG001|COMPLETED|Follow-Up Phase||10
9038959|NCT03334747|10100038|FG002|COMPLETED|Follow-Up Phase||12
9038960|NCT03334747|10100039|FG003|COMPLETED|Follow-Up Phase||20
9038961|NCT03334747|10100040|FG004|COMPLETED|Follow-Up Phase||21
9038962|NCT03334747|10100041|FG005|COMPLETED|Follow-Up Phase||19
9038963|NCT03334747|10100042|FG006|COMPLETED|Follow-Up Phase||20
8988358|NCT02750618|10051549|FG000|STARTED|Overall Study||13
8988359|NCT02750618|10051549|FG000|Completed Week 40|Overall Study||13
8988360|NCT02750618|10051549|FG000|Completed Week 64|Overall Study||13
8988361|NCT02750618|10051549|FG000|COMPLETED|Overall Study||12
8988362|NCT02750618|10051549|FG000|NOT COMPLETED|Overall Study||1
8988363|NCT02750709|10051553|FG000|STARTED|Treatment Period 1||4
8988364|NCT02750709|10051554|FG001|STARTED|Treatment Period 1||4
8988365|NCT02750709|10051555|FG002|STARTED|Treatment Period 1||4
8988366|NCT02750709|10051556|FG003|STARTED|Treatment Period 1||4
8988367|NCT02750709|10051557|FG004|STARTED|Treatment Period 1||4
8988368|NCT02750709|10051558|FG005|STARTED|Treatment Period 1||4
8988369|NCT02750709|10051553|FG000|COMPLETED|Treatment Period 1||4
8988370|NCT02750709|10051554|FG001|COMPLETED|Treatment Period 1||4
8988371|NCT02750709|10051555|FG002|COMPLETED|Treatment Period 1||4
8988372|NCT02750709|10051556|FG003|COMPLETED|Treatment Period 1||4
8988373|NCT02750709|10051557|FG004|COMPLETED|Treatment Period 1||4
8988374|NCT02750709|10051558|FG005|COMPLETED|Treatment Period 1||3
8988375|NCT02750709|10051553|FG000|NOT COMPLETED|Treatment Period 1||0
8988376|NCT02750709|10051554|FG001|NOT COMPLETED|Treatment Period 1||0
8988377|NCT02750709|10051555|FG002|NOT COMPLETED|Treatment Period 1||0
8988378|NCT02750709|10051556|FG003|NOT COMPLETED|Treatment Period 1||0
8988379|NCT02750709|10051557|FG004|NOT COMPLETED|Treatment Period 1||0
8988380|NCT02750709|10051558|FG005|NOT COMPLETED|Treatment Period 1||1
8988381|NCT02750709|10051553|FG000|STARTED|Treatment Period 2||4
8988382|NCT02750709|10051554|FG001|STARTED|Treatment Period 2||4
8988383|NCT02750709|10051555|FG002|STARTED|Treatment Period 2||4
8988384|NCT02750709|10051556|FG003|STARTED|Treatment Period 2||4
8988385|NCT02750709|10051557|FG004|STARTED|Treatment Period 2||4
8988386|NCT02750709|10051558|FG005|STARTED|Treatment Period 2||3
8988387|NCT02750709|10051553|FG000|COMPLETED|Treatment Period 2||4
8988388|NCT02750709|10051554|FG001|COMPLETED|Treatment Period 2||4
8988389|NCT02750709|10051555|FG002|COMPLETED|Treatment Period 2||4
8988390|NCT02750709|10051556|FG003|COMPLETED|Treatment Period 2||4
8988391|NCT02750709|10051557|FG004|COMPLETED|Treatment Period 2||4
8988392|NCT02750709|10051558|FG005|COMPLETED|Treatment Period 2||3
8988393|NCT02750709|10051553|FG000|NOT COMPLETED|Treatment Period 2||0
8988394|NCT02750709|10051554|FG001|NOT COMPLETED|Treatment Period 2||0
8988395|NCT02750709|10051555|FG002|NOT COMPLETED|Treatment Period 2||0
8988396|NCT02750709|10051556|FG003|NOT COMPLETED|Treatment Period 2||0
8988397|NCT02750709|10051557|FG004|NOT COMPLETED|Treatment Period 2||0
8988398|NCT02750709|10051558|FG005|NOT COMPLETED|Treatment Period 2||0
8988399|NCT02750709|10051553|FG000|STARTED|Treatment Period 3||4
8988400|NCT02750709|10051554|FG001|STARTED|Treatment Period 3||4
8988401|NCT02750709|10051555|FG002|STARTED|Treatment Period 3||4
8988402|NCT02750709|10051556|FG003|STARTED|Treatment Period 3||4
8988403|NCT02750709|10051557|FG004|STARTED|Treatment Period 3||4
8988404|NCT02750709|10051558|FG005|STARTED|Treatment Period 3||3
8988405|NCT02750709|10051553|FG000|COMPLETED|Treatment Period 3||4
8988406|NCT02750709|10051554|FG001|COMPLETED|Treatment Period 3||4
8988407|NCT02750709|10051555|FG002|COMPLETED|Treatment Period 3||4
8988408|NCT02750709|10051556|FG003|COMPLETED|Treatment Period 3||4
8988409|NCT02750709|10051557|FG004|COMPLETED|Treatment Period 3||4
8988410|NCT02750709|10051558|FG005|COMPLETED|Treatment Period 3||3
8988411|NCT02750709|10051553|FG000|NOT COMPLETED|Treatment Period 3||0
8988412|NCT02750709|10051554|FG001|NOT COMPLETED|Treatment Period 3||0
8988413|NCT02750709|10051555|FG002|NOT COMPLETED|Treatment Period 3||0
8988414|NCT02750709|10051556|FG003|NOT COMPLETED|Treatment Period 3||0
8988415|NCT02750709|10051557|FG004|NOT COMPLETED|Treatment Period 3||0
8988416|NCT02750709|10051558|FG005|NOT COMPLETED|Treatment Period 3||0
8988417|NCT02750761|10051572|FG000|STARTED|Overall Study||5
8725878|NCT01033487|9773165|FG008|COMPLETED|Second Intervention Period||2
8725879|NCT01033487|9773166|FG009|COMPLETED|Second Intervention Period||2
8725880|NCT01033487|9773157|FG000|NOT COMPLETED|Second Intervention Period||0
8725881|NCT01033487|9773158|FG001|NOT COMPLETED|Second Intervention Period||0
8725882|NCT01033487|9773159|FG002|NOT COMPLETED|Second Intervention Period||0
8988418|NCT02750761|10051573|FG001|STARTED|Overall Study||5
8988419|NCT02750761|10051574|FG002|STARTED|Overall Study||5
8988420|NCT02750761|10051575|FG003|STARTED|Overall Study||5
8988421|NCT02750761|10051576|FG004|STARTED|Overall Study||6
8988422|NCT02750761|10051577|FG005|STARTED|Overall Study||6
8988423|NCT02750761|10051572|FG000|COMPLETED|Overall Study||5
8988424|NCT02750761|10051573|FG001|COMPLETED|Overall Study||5
8988425|NCT02750761|10051574|FG002|COMPLETED|Overall Study||4
8988426|NCT02750761|10051575|FG003|COMPLETED|Overall Study||5
8988427|NCT02750761|10051576|FG004|COMPLETED|Overall Study||6
8988428|NCT02750761|10051577|FG005|COMPLETED|Overall Study||6
8988429|NCT02750761|10051572|FG000|NOT COMPLETED|Overall Study||0
8988430|NCT02750761|10051573|FG001|NOT COMPLETED|Overall Study||0
8988431|NCT02750761|10051574|FG002|NOT COMPLETED|Overall Study||1
8988432|NCT02750761|10051575|FG003|NOT COMPLETED|Overall Study||0
8725883|NCT01033487|9773160|FG003|NOT COMPLETED|Second Intervention Period||0
8988433|NCT02750761|10051576|FG004|NOT COMPLETED|Overall Study||0
8988434|NCT02750761|10051577|FG005|NOT COMPLETED|Overall Study||0
8988435|NCT02750800|10051601|FG000|STARTED|Overall Study||412
8988436|NCT02750800|10051601|FG000|COMPLETED|Overall Study||314
8988437|NCT02750800|10051601|FG000|NOT COMPLETED|Overall Study||98
8988438|NCT02750813|10051619|FG000|STARTED|Period 1, First 14 Days of Wear||125
8988439|NCT02750813|10051620|FG001|STARTED|Period 1, First 14 Days of Wear||121
8988440|NCT02750813|10051619|FG000|COMPLETED|Period 1, First 14 Days of Wear||124
8988441|NCT02750813|10051620|FG001|COMPLETED|Period 1, First 14 Days of Wear||120
8988442|NCT02750813|10051619|FG000|NOT COMPLETED|Period 1, First 14 Days of Wear||1
8988443|NCT02750813|10051620|FG001|NOT COMPLETED|Period 1, First 14 Days of Wear||1
8988444|NCT02750813|10051619|FG000|STARTED|Period 2, Second 14 Days of Wear||124
8988445|NCT02750813|10051620|FG001|STARTED|Period 2, Second 14 Days of Wear||120
8988446|NCT02750813|10051619|FG000|COMPLETED|Period 2, Second 14 Days of Wear||124
8988447|NCT02750813|10051620|FG001|COMPLETED|Period 2, Second 14 Days of Wear||120
8988448|NCT02750813|10051619|FG000|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
8988449|NCT02750813|10051620|FG001|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
8988450|NCT02750930|10051627|FG000|STARTED|Overall Study||8
8988451|NCT02750930|10051627|FG000|COMPLETED|Overall Study||0
8988452|NCT02750930|10051627|FG000|NOT COMPLETED|Overall Study||8
8988453|NCT02750943|10051633|FG000|STARTED|Overall Study||125
8988454|NCT02750943|10051634|FG001|STARTED|Overall Study||128
8988455|NCT02750943|10051633|FG000|COMPLETED|Overall Study||119
8988456|NCT02750943|10051634|FG001|COMPLETED|Overall Study||119
8988457|NCT02750943|10051633|FG000|NOT COMPLETED|Overall Study||6
8988458|NCT02750943|10051634|FG001|NOT COMPLETED|Overall Study||9
8988459|NCT02751320|10051640|FG000|STARTED|Overall Study||45
8988460|NCT02751320|10051640|FG000|Received Test Product 1|Overall Study||29
8988461|NCT02751320|10051640|FG000|Received Test Prodcut 2|Overall Study||28
8988462|NCT02751320|10051640|FG000|Received Test Prodcut 3|Overall Study||28
8988463|NCT02751320|10051640|FG000|Received Reference Product 1|Overall Study||29
8988464|NCT02751320|10051640|FG000|Received Reference Product 2|Overall Study||28
8988465|NCT02751320|10051640|FG000|Received Reference Product 3|Overall Study||28
8988466|NCT02751320|10051640|FG000|COMPLETED|Overall Study||42
8988467|NCT02751320|10051640|FG000|NOT COMPLETED|Overall Study||3
8988468|NCT02751359|10051665|FG000|STARTED|Overall Study||18
8988469|NCT02751359|10051665|FG000|COMPLETED|Overall Study||17
8988470|NCT02751359|10051665|FG000|NOT COMPLETED|Overall Study||1
8988471|NCT02751385|10051675|FG000|STARTED|Period 1||2
8988472|NCT02751385|10051676|FG001|STARTED|Period 1||0
8988473|NCT02751385|10051675|FG000|COMPLETED|Period 1||2
8988474|NCT02751385|10051676|FG001|COMPLETED|Period 1||0
8988475|NCT02751385|10051675|FG000|NOT COMPLETED|Period 1||0
8988476|NCT02751385|10051676|FG001|NOT COMPLETED|Period 1||0
8988477|NCT02751385|10051675|FG000|STARTED|Period 2||0
8988478|NCT02751385|10051676|FG001|STARTED|Period 2||2
8988479|NCT02751385|10051675|FG000|COMPLETED|Period 2||0
8988480|NCT02751385|10051676|FG001|COMPLETED|Period 2||2
8988481|NCT02751385|10051675|FG000|NOT COMPLETED|Period 2||0
8988482|NCT02751385|10051676|FG001|NOT COMPLETED|Period 2||0
8988483|NCT02751424|10051693|FG000|STARTED|Part 1||6
8988484|NCT02751424|10051694|FG001|STARTED|Part 1||6
8988485|NCT02751424|10051695|FG002|STARTED|Part 1||6
8988486|NCT02751424|10051696|FG003|STARTED|Part 1||6
8988487|NCT02751424|10051697|FG004|STARTED|Part 1||6
8988488|NCT02751424|10051698|FG005|STARTED|Part 1||6
8988489|NCT02751424|10051699|FG006|STARTED|Part 1||12
8988490|NCT02751424|10051700|FG007|STARTED|Part 1||0
8988491|NCT02751424|10051701|FG008|STARTED|Part 1||0
8988492|NCT02751424|10051693|FG000|COMPLETED|Part 1||6
8988493|NCT02751424|10051694|FG001|COMPLETED|Part 1||6
8988494|NCT02751424|10051695|FG002|COMPLETED|Part 1||6
8988495|NCT02751424|10051696|FG003|COMPLETED|Part 1||6
8988496|NCT02751424|10051697|FG004|COMPLETED|Part 1||6
8988497|NCT02751424|10051698|FG005|COMPLETED|Part 1||6
8988498|NCT02751424|10051699|FG006|COMPLETED|Part 1||12
8988499|NCT02751424|10051700|FG007|COMPLETED|Part 1||0
8988500|NCT02751424|10051701|FG008|COMPLETED|Part 1||0
8988501|NCT02751424|10051693|FG000|NOT COMPLETED|Part 1||0
8988502|NCT02751424|10051694|FG001|NOT COMPLETED|Part 1||0
8988503|NCT02751424|10051695|FG002|NOT COMPLETED|Part 1||0
8988504|NCT02751424|10051696|FG003|NOT COMPLETED|Part 1||0
8988505|NCT02751424|10051697|FG004|NOT COMPLETED|Part 1||0
8988506|NCT02751424|10051698|FG005|NOT COMPLETED|Part 1||0
8988507|NCT02751424|10051699|FG006|NOT COMPLETED|Part 1||0
8988508|NCT02751424|10051700|FG007|NOT COMPLETED|Part 1||0
8988509|NCT02751424|10051701|FG008|NOT COMPLETED|Part 1||0
8988510|NCT02751424|10051693|FG000|STARTED|Part 2||0
8988511|NCT02751424|10051694|FG001|STARTED|Part 2||0
8988512|NCT02751424|10051695|FG002|STARTED|Part 2||0
8988513|NCT02751424|10051696|FG003|STARTED|Part 2||0
8988514|NCT02751424|10051697|FG004|STARTED|Part 2||0
8988515|NCT02751424|10051698|FG005|STARTED|Part 2||0
8988516|NCT02751424|10051699|FG006|STARTED|Part 2||0
8988517|NCT02751424|10051700|FG007|STARTED|Part 2||11
8988518|NCT02751424|10051701|FG008|STARTED|Part 2||3
8988519|NCT02751424|10051693|FG000|COMPLETED|Part 2||0
8988520|NCT02751424|10051694|FG001|COMPLETED|Part 2||0
8988521|NCT02751424|10051695|FG002|COMPLETED|Part 2||0
8988522|NCT02751424|10051696|FG003|COMPLETED|Part 2||0
8988523|NCT02751424|10051697|FG004|COMPLETED|Part 2||0
8988524|NCT02751424|10051698|FG005|COMPLETED|Part 2||0
8988525|NCT02751424|10051699|FG006|COMPLETED|Part 2||0
8988526|NCT02751424|10051700|FG007|COMPLETED|Part 2||6
8988527|NCT02751424|10051701|FG008|COMPLETED|Part 2||3
8988528|NCT02751424|10051693|FG000|NOT COMPLETED|Part 2||0
8988529|NCT02751424|10051694|FG001|NOT COMPLETED|Part 2||0
8988530|NCT02751424|10051695|FG002|NOT COMPLETED|Part 2||0
8988531|NCT02751424|10051696|FG003|NOT COMPLETED|Part 2||0
8988532|NCT02751424|10051697|FG004|NOT COMPLETED|Part 2||0
8988533|NCT02751424|10051698|FG005|NOT COMPLETED|Part 2||0
8988534|NCT02751424|10051699|FG006|NOT COMPLETED|Part 2||0
8988535|NCT02751424|10051700|FG007|NOT COMPLETED|Part 2||5
8988536|NCT02751424|10051701|FG008|NOT COMPLETED|Part 2||0
8988537|NCT02751450|10051726|FG000|STARTED|Overall Study||117
8988538|NCT02751450|10051727|FG001|STARTED|Overall Study||116
8988539|NCT02751450|10051726|FG000|COMPLETED|Overall Study||116
8988540|NCT02751450|10051727|FG001|COMPLETED|Overall Study||116
8988541|NCT02751450|10051726|FG000|NOT COMPLETED|Overall Study||1
8988542|NCT02751450|10051727|FG001|NOT COMPLETED|Overall Study||0
8988543|NCT02751580|10051735|FG000|STARTED|Overall Study||37
8988544|NCT02751580|10051735|FG000|COMPLETED|Overall Study||31
8988545|NCT02751580|10051735|FG000|NOT COMPLETED|Overall Study||6
8988546|NCT02751827|10051742|FG000|STARTED|Overall Study||41
8988547|NCT02751827|10051743|FG001|STARTED|Overall Study||171
8988548|NCT02751827|10051744|FG002|STARTED|Overall Study||100
8988549|NCT02751827|10051742|FG000|COMPLETED|Overall Study||41
8988550|NCT02751827|10051743|FG001|COMPLETED|Overall Study||171
8988551|NCT02751827|10051744|FG002|COMPLETED|Overall Study||99
8988552|NCT02751827|10051742|FG000|NOT COMPLETED|Overall Study||0
8988553|NCT02751827|10051743|FG001|NOT COMPLETED|Overall Study||0
8988554|NCT02751827|10051744|FG002|NOT COMPLETED|Overall Study||1
8988555|NCT02751879|10051754|FG000|STARTED|Overall Study||157
8988556|NCT02751879|10051755|FG001|STARTED|Overall Study||71
8988557|NCT02751879|10051754|FG000|On Treatment at Study Completion|Overall Study||81
8988558|NCT02751879|10051755|FG001|On Treatment at Study Completion|Overall Study||41
8988559|NCT02751879|10051754|FG000|COMPLETED|Overall Study||157
8988560|NCT02751879|10051755|FG001|COMPLETED|Overall Study||71
8988561|NCT02751879|10051754|FG000|NOT COMPLETED|Overall Study||0
8988562|NCT02751879|10051755|FG001|NOT COMPLETED|Overall Study||0
8988563|NCT02751931|10051766|FG000|STARTED|Overall Study||56
8988564|NCT02751931|10051767|FG001|STARTED|Overall Study||35
8988565|NCT02751931|10051766|FG000|Treated|Overall Study||55
8878209|NCT01928381|9935143|FG001|NOT COMPLETED|Part 2 - Second Intervention||1
8878210|NCT01928381|9935144|FG002|NOT COMPLETED|Part 2 - Second Intervention||0
8878211|NCT01928381|9935145|FG003|NOT COMPLETED|Part 2 - Second Intervention||1
8878212|NCT01928381|9935146|FG004|NOT COMPLETED|Part 2 - Second Intervention||0
8878213|NCT01928381|9935147|FG005|NOT COMPLETED|Part 2 - Second Intervention||0
8878214|NCT01928381|9935148|FG006|NOT COMPLETED|Part 2 - Second Intervention||0
8878215|NCT01928381|9935142|FG000|STARTED|Washout Second Intervention||0
8878216|NCT01928381|9935143|FG001|STARTED|Washout Second Intervention||5
8878217|NCT01928381|9935144|FG002|STARTED|Washout Second Intervention||4
8878218|NCT01928381|9935145|FG003|STARTED|Washout Second Intervention||4
8878219|NCT01928381|9935146|FG004|STARTED|Washout Second Intervention||3
8878220|NCT01928381|9935147|FG005|STARTED|Washout Second Intervention||5
8878221|NCT01928381|9935148|FG006|STARTED|Washout Second Intervention||5
8878222|NCT01928381|9935142|FG000|COMPLETED|Washout Second Intervention||0
8878223|NCT01928381|9935143|FG001|COMPLETED|Washout Second Intervention||5
8878224|NCT01928381|9935144|FG002|COMPLETED|Washout Second Intervention||4
8878225|NCT01928381|9935145|FG003|COMPLETED|Washout Second Intervention||4
8878226|NCT01928381|9935146|FG004|COMPLETED|Washout Second Intervention||3
8878227|NCT01928381|9935147|FG005|COMPLETED|Washout Second Intervention||5
8878228|NCT01928381|9935148|FG006|COMPLETED|Washout Second Intervention||5
8878229|NCT01928381|9935142|FG000|NOT COMPLETED|Washout Second Intervention||0
8988566|NCT02751931|10051767|FG001|Treated|Overall Study||31
8988567|NCT02751931|10051766|FG000|COMPLETED|Overall Study||43
8988568|NCT02751931|10051767|FG001|COMPLETED|Overall Study||27
8988569|NCT02751931|10051766|FG000|NOT COMPLETED|Overall Study||13
8988570|NCT02751931|10051767|FG001|NOT COMPLETED|Overall Study||8
8988571|NCT02751983|10051781|FG000|STARTED|Baseline and Randomization||35
8988572|NCT02751983|10051782|FG001|STARTED|Baseline and Randomization||35
8988573|NCT02751983|10051781|FG000|COMPLETED|Baseline and Randomization||35
8988574|NCT02751983|10051782|FG001|COMPLETED|Baseline and Randomization||35
8988575|NCT02751983|10051781|FG000|NOT COMPLETED|Baseline and Randomization||0
8988576|NCT02751983|10051782|FG001|NOT COMPLETED|Baseline and Randomization||0
8988577|NCT02751983|10051781|FG000|STARTED|Treatment||35
8988578|NCT02751983|10051782|FG001|STARTED|Treatment||35
8988579|NCT02751983|10051781|FG000|COMPLETED|Treatment||31
8988580|NCT02751983|10051782|FG001|COMPLETED|Treatment||35
8988581|NCT02751983|10051781|FG000|NOT COMPLETED|Treatment||4
8988582|NCT02751983|10051782|FG001|NOT COMPLETED|Treatment||0
8988583|NCT02751983|10051781|FG000|STARTED|Post-Treatment Assessment||35
8988584|NCT02751983|10051782|FG001|STARTED|Post-Treatment Assessment||0
8988585|NCT02751983|10051781|FG000|COMPLETED|Post-Treatment Assessment||30
8988586|NCT02751983|10051782|FG001|COMPLETED|Post-Treatment Assessment||0
8988587|NCT02751983|10051781|FG000|NOT COMPLETED|Post-Treatment Assessment||5
8988588|NCT02751983|10051782|FG001|NOT COMPLETED|Post-Treatment Assessment||0
8988589|NCT02751983|10051781|FG000|STARTED|One-Month Follow-Up Assessments||35
8988590|NCT02751983|10051782|FG001|STARTED|One-Month Follow-Up Assessments||35
8988591|NCT02751983|10051781|FG000|COMPLETED|One-Month Follow-Up Assessments||21
8988592|NCT02751983|10051782|FG001|COMPLETED|One-Month Follow-Up Assessments||23
8988593|NCT02751983|10051781|FG000|NOT COMPLETED|One-Month Follow-Up Assessments||14
8988594|NCT02751983|10051782|FG001|NOT COMPLETED|One-Month Follow-Up Assessments||12
8988595|NCT02751983|10051781|FG000|STARTED|Three-Month Follow-Up Assessments||35
8988596|NCT02751983|10051782|FG001|STARTED|Three-Month Follow-Up Assessments||35
8988597|NCT02751983|10051781|FG000|COMPLETED|Three-Month Follow-Up Assessments||23
8988598|NCT02751983|10051782|FG001|COMPLETED|Three-Month Follow-Up Assessments||19
8988599|NCT02751983|10051781|FG000|NOT COMPLETED|Three-Month Follow-Up Assessments||12
8988600|NCT02751983|10051782|FG001|NOT COMPLETED|Three-Month Follow-Up Assessments||16
8988601|NCT02752048|10051791|FG000|STARTED|Overall Study||11
8988602|NCT02752048|10051792|FG001|STARTED|Overall Study||12
8988603|NCT02752048|10051793|FG002|STARTED|Overall Study||13
8988604|NCT02752048|10051791|FG000|COMPLETED|Overall Study||11
8988605|NCT02752048|10051792|FG001|COMPLETED|Overall Study||12
8988606|NCT02752048|10051793|FG002|COMPLETED|Overall Study||10
8988607|NCT02752048|10051791|FG000|NOT COMPLETED|Overall Study||0
8988608|NCT02752048|10051792|FG001|NOT COMPLETED|Overall Study||0
8988609|NCT02752048|10051793|FG002|NOT COMPLETED|Overall Study||3
8988610|NCT02752074|10051803|FG000|STARTED|Overall Study||354
8988611|NCT02752074|10051804|FG001|STARTED|Overall Study||352
8988612|NCT02752074|10051803|FG000|Treated|Overall Study||353
8988613|NCT02752074|10051804|FG001|Treated|Overall Study||352
8988614|NCT02752074|10051803|FG000|COMPLETED|Overall Study||198
8988615|NCT02752074|10051804|FG001|COMPLETED|Overall Study||209
8988616|NCT02752074|10051803|FG000|NOT COMPLETED|Overall Study||156
8988617|NCT02752074|10051804|FG001|NOT COMPLETED|Overall Study||143
8988618|NCT02752087|10051810|FG000|STARTED|Study Period 1||12
8988619|NCT02752087|10051811|FG001|STARTED|Study Period 1||12
8988620|NCT02752087|10051810|FG000|Received Study Drug|Study Period 1||12
8988621|NCT02752087|10051811|FG001|Received Study Drug|Study Period 1||12
8988622|NCT02752087|10051810|FG000|COMPLETED|Study Period 1||12
8988623|NCT02752087|10051811|FG001|COMPLETED|Study Period 1||12
8878230|NCT01928381|9935143|FG001|NOT COMPLETED|Washout Second Intervention||0
8878231|NCT01928381|9935144|FG002|NOT COMPLETED|Washout Second Intervention||0
8878232|NCT01928381|9935145|FG003|NOT COMPLETED|Washout Second Intervention||0
8878233|NCT01928381|9935146|FG004|NOT COMPLETED|Washout Second Intervention||0
8878234|NCT01928381|9935147|FG005|NOT COMPLETED|Washout Second Intervention||0
8878235|NCT01928381|9935148|FG006|NOT COMPLETED|Washout Second Intervention||0
8878236|NCT01928381|9935142|FG000|STARTED|Part 2 - Third Intervention||0
8878237|NCT01928381|9935143|FG001|STARTED|Part 2 - Third Intervention||5
8878238|NCT01928381|9935144|FG002|STARTED|Part 2 - Third Intervention||4
8878239|NCT01928381|9935145|FG003|STARTED|Part 2 - Third Intervention||4
8878240|NCT01928381|9935146|FG004|STARTED|Part 2 - Third Intervention||3
8878241|NCT01928381|9935147|FG005|STARTED|Part 2 - Third Intervention||5
8878242|NCT01928381|9935148|FG006|STARTED|Part 2 - Third Intervention||5
8878243|NCT01928381|9935142|FG000|COMPLETED|Part 2 - Third Intervention||0
8878244|NCT01928381|9935143|FG001|COMPLETED|Part 2 - Third Intervention||5
8988624|NCT02752087|10051810|FG000|NOT COMPLETED|Study Period 1||0
8988625|NCT02752087|10051811|FG001|NOT COMPLETED|Study Period 1||0
8988626|NCT02752087|10051810|FG000|STARTED|Washout||12
8988627|NCT02752087|10051811|FG001|STARTED|Washout||12
8988628|NCT02752087|10051810|FG000|COMPLETED|Washout||11
8988629|NCT02752087|10051811|FG001|COMPLETED|Washout||12
8988630|NCT02752087|10051810|FG000|NOT COMPLETED|Washout||1
8988631|NCT02752087|10051811|FG001|NOT COMPLETED|Washout||0
8988632|NCT02752087|10051810|FG000|STARTED|Study Period 2||11
8988633|NCT02752087|10051811|FG001|STARTED|Study Period 2||12
8988634|NCT02752087|10051810|FG000|Received Study Drug|Study Period 2||11
8878245|NCT01928381|9935144|FG002|COMPLETED|Part 2 - Third Intervention||4
8878246|NCT01928381|9935145|FG003|COMPLETED|Part 2 - Third Intervention||4
8878247|NCT01928381|9935146|FG004|COMPLETED|Part 2 - Third Intervention||3
8878248|NCT01928381|9935147|FG005|COMPLETED|Part 2 - Third Intervention||5
8878249|NCT01928381|9935148|FG006|COMPLETED|Part 2 - Third Intervention||5
8988635|NCT02752087|10051811|FG001|Received Study Drug|Study Period 2||12
8988636|NCT02752087|10051810|FG000|COMPLETED|Study Period 2||11
8988637|NCT02752087|10051811|FG001|COMPLETED|Study Period 2||12
8988638|NCT02752087|10051810|FG000|NOT COMPLETED|Study Period 2||0
8988639|NCT02752087|10051811|FG001|NOT COMPLETED|Study Period 2||0
8988640|NCT02752087|10051810|FG000|STARTED|Washout||11
8988641|NCT02752087|10051811|FG001|STARTED|Washout||12
8988642|NCT02752087|10051810|FG000|COMPLETED|Washout||11
8988643|NCT02752087|10051811|FG001|COMPLETED|Washout||12
8988644|NCT02752087|10051810|FG000|NOT COMPLETED|Washout||0
8988645|NCT02752087|10051811|FG001|NOT COMPLETED|Washout||0
8988646|NCT02752087|10051810|FG000|STARTED|Study Period 3||11
8988647|NCT02752087|10051811|FG001|STARTED|Study Period 3||12
8988648|NCT02752087|10051810|FG000|Received Study Drug|Study Period 3||11
8988649|NCT02752087|10051811|FG001|Received Study Drug|Study Period 3||12
8988650|NCT02752087|10051810|FG000|COMPLETED|Study Period 3||11
8988651|NCT02752087|10051811|FG001|COMPLETED|Study Period 3||12
8988652|NCT02752087|10051810|FG000|NOT COMPLETED|Study Period 3||0
8988653|NCT02752087|10051811|FG001|NOT COMPLETED|Study Period 3||0
8988654|NCT02752087|10051810|FG000|STARTED|Washout||11
8632985|NCT00548691|9673028|FG000|COMPLETED|Overall Study||251
8632986|NCT00548691|9673029|FG001|COMPLETED|Overall Study||250
8632987|NCT00548691|9673028|FG000|NOT COMPLETED|Overall Study||7
8632988|NCT00548691|9673029|FG001|NOT COMPLETED|Overall Study||9
8632989|NCT00548717|9673037|FG000|STARTED|Overall Study||13
8632990|NCT00548717|9673038|FG001|STARTED|Overall Study||2
8878250|NCT01928381|9935142|FG000|NOT COMPLETED|Part 2 - Third Intervention||0
8878251|NCT01928381|9935143|FG001|NOT COMPLETED|Part 2 - Third Intervention||0
8878252|NCT01928381|9935144|FG002|NOT COMPLETED|Part 2 - Third Intervention||0
8878253|NCT01928381|9935145|FG003|NOT COMPLETED|Part 2 - Third Intervention||0
8878254|NCT01928381|9935146|FG004|NOT COMPLETED|Part 2 - Third Intervention||0
8878255|NCT01928381|9935147|FG005|NOT COMPLETED|Part 2 - Third Intervention||0
8878256|NCT01928381|9935148|FG006|NOT COMPLETED|Part 2 - Third Intervention||0
8878257|NCT01928381|9935142|FG000|STARTED|Part 2 - Post Third Intervention||0
8878258|NCT01928381|9935143|FG001|STARTED|Part 2 - Post Third Intervention||5
8878259|NCT01928381|9935144|FG002|STARTED|Part 2 - Post Third Intervention||4
8878260|NCT01928381|9935145|FG003|STARTED|Part 2 - Post Third Intervention||4
8878261|NCT01928381|9935146|FG004|STARTED|Part 2 - Post Third Intervention||3
8878262|NCT01928381|9935147|FG005|STARTED|Part 2 - Post Third Intervention||5
8878263|NCT01928381|9935148|FG006|STARTED|Part 2 - Post Third Intervention||5
8878264|NCT01928381|9935142|FG000|COMPLETED|Part 2 - Post Third Intervention||0
8878265|NCT01928381|9935143|FG001|COMPLETED|Part 2 - Post Third Intervention||5
8878266|NCT01928381|9935144|FG002|COMPLETED|Part 2 - Post Third Intervention||3
8878267|NCT01928381|9935145|FG003|COMPLETED|Part 2 - Post Third Intervention||4
8878268|NCT01928381|9935146|FG004|COMPLETED|Part 2 - Post Third Intervention||3
8878269|NCT01928381|9935147|FG005|COMPLETED|Part 2 - Post Third Intervention||5
8878270|NCT01928381|9935148|FG006|COMPLETED|Part 2 - Post Third Intervention||5
8878271|NCT01928381|9935142|FG000|NOT COMPLETED|Part 2 - Post Third Intervention||0
8878272|NCT01928381|9935143|FG001|NOT COMPLETED|Part 2 - Post Third Intervention||0
8878273|NCT01928381|9935144|FG002|NOT COMPLETED|Part 2 - Post Third Intervention||1
8878274|NCT01928381|9935145|FG003|NOT COMPLETED|Part 2 - Post Third Intervention||0
8878275|NCT01928381|9935146|FG004|NOT COMPLETED|Part 2 - Post Third Intervention||0
8878276|NCT01928381|9935147|FG005|NOT COMPLETED|Part 2 - Post Third Intervention||0
8878277|NCT01928381|9935148|FG006|NOT COMPLETED|Part 2 - Post Third Intervention||0
8878278|NCT01928433|9935161|FG000|STARTED|Overall Study||76
8878279|NCT01928433|9935162|FG001|STARTED|Overall Study||75
8878280|NCT01928433|9935163|FG002|STARTED|Overall Study||74
8878281|NCT01928433|9935161|FG000|COMPLETED|Overall Study||56
8878282|NCT01928433|9935162|FG001|COMPLETED|Overall Study||54
8878283|NCT01928433|9935163|FG002|COMPLETED|Overall Study||46
8878284|NCT01928433|9935161|FG000|NOT COMPLETED|Overall Study||20
8878285|NCT01928433|9935162|FG001|NOT COMPLETED|Overall Study||21
8878286|NCT01928433|9935163|FG002|NOT COMPLETED|Overall Study||28
8878287|NCT01928446|9935176|FG000|STARTED|Overall Study||255
8878288|NCT01928446|9935177|FG001|STARTED|Overall Study||264
8878289|NCT01928446|9935176|FG000|COMPLETED|Overall Study|39 subjects stopped study drug but continued with followup|144
8878290|NCT01928446|9935177|FG001|COMPLETED|Overall Study|23 subjects stopped study drug but continued with followup|125
8878291|NCT01928446|9935176|FG000|NOT COMPLETED|Overall Study||111
8878292|NCT01928446|9935177|FG001|NOT COMPLETED|Overall Study||139
8878293|NCT01928472|9935189|FG000|STARTED|Overall Study||98
8878294|NCT01928472|9935190|FG001|STARTED|Overall Study||104
8878295|NCT01928472|9935191|FG002|STARTED|Overall Study||98
8878296|NCT01928472|9935192|FG003|STARTED|Overall Study||102
8878297|NCT01928472|9935189|FG000|COMPLETED|Overall Study||90
8878298|NCT01928472|9935190|FG001|COMPLETED|Overall Study||96
8878299|NCT01928472|9935191|FG002|COMPLETED|Overall Study||91
8878300|NCT01928472|9935192|FG003|COMPLETED|Overall Study||100
8878301|NCT01928472|9935189|FG000|NOT COMPLETED|Overall Study||8
8878302|NCT01928472|9935190|FG001|NOT COMPLETED|Overall Study||8
8878303|NCT01928472|9935191|FG002|NOT COMPLETED|Overall Study||7
8988655|NCT02752087|10051811|FG001|STARTED|Washout||12
8632991|NCT00548717|9673037|FG000|COMPLETED|Overall Study||4
8988656|NCT02752087|10051810|FG000|COMPLETED|Washout||11
8988657|NCT02752087|10051811|FG001|COMPLETED|Washout||12
8632992|NCT00548717|9673038|FG001|COMPLETED|Overall Study||0
8632993|NCT00548717|9673037|FG000|NOT COMPLETED|Overall Study||9
8632994|NCT00548717|9673038|FG001|NOT COMPLETED|Overall Study||2
8988658|NCT02752087|10051810|FG000|NOT COMPLETED|Washout||0
8988659|NCT02752087|10051811|FG001|NOT COMPLETED|Washout||0
8988660|NCT02752087|10051810|FG000|STARTED|Study Period 4||11
8988661|NCT02752087|10051811|FG001|STARTED|Study Period 4||12
8988662|NCT02752087|10051810|FG000|Received Study Drug|Study Period 4||11
8988663|NCT02752087|10051811|FG001|Received Study Drug|Study Period 4||12
8988664|NCT02752087|10051810|FG000|COMPLETED|Study Period 4||11
8988665|NCT02752087|10051811|FG001|COMPLETED|Study Period 4||12
8988666|NCT02752087|10051810|FG000|NOT COMPLETED|Study Period 4||0
8988667|NCT02752087|10051811|FG001|NOT COMPLETED|Study Period 4||0
8988668|NCT02752087|10051810|FG000|STARTED|Follow-up||11
8988669|NCT02752087|10051811|FG001|STARTED|Follow-up||12
8988670|NCT02752087|10051810|FG000|COMPLETED|Follow-up||11
8988671|NCT02752087|10051811|FG001|COMPLETED|Follow-up||12
8988672|NCT02752087|10051810|FG000|NOT COMPLETED|Follow-up||0
8988673|NCT02752087|10051811|FG001|NOT COMPLETED|Follow-up||0
8988674|NCT02752256|10051819|FG000|STARTED|Overall Study||35
8988675|NCT02752256|10051820|FG001|STARTED|Overall Study||41
8988676|NCT02752256|10051819|FG000|COMPLETED|Overall Study||35
8988677|NCT02752256|10051820|FG001|COMPLETED|Overall Study||41
8988678|NCT02752256|10051819|FG000|NOT COMPLETED|Overall Study||0
8988679|NCT02752256|10051820|FG001|NOT COMPLETED|Overall Study||0
8988680|NCT02752490|10051828|FG000|STARTED|Overall Study||409
8988681|NCT02752490|10051829|FG001|STARTED|Overall Study||435
8988682|NCT02752490|10051828|FG000|COMPLETED|Overall Study||409
8988683|NCT02752490|10051829|FG001|COMPLETED|Overall Study||435
8988684|NCT02752490|10051828|FG000|NOT COMPLETED|Overall Study||0
8988685|NCT02752490|10051829|FG001|NOT COMPLETED|Overall Study||0
8988686|NCT02752633|10051835|FG000|STARTED|Overall Study||9
8988687|NCT02752633|10051835|FG000|COMPLETED|Overall Study||8
8988688|NCT02752633|10051835|FG000|NOT COMPLETED|Overall Study||1
8988689|NCT02752776|10051842|FG000|STARTED|Overall Study||663
8988690|NCT02752776|10051843|FG001|STARTED|Overall Study||673
8632995|NCT00548808|9673049|FG000|STARTED|Overall Study||214
8632996|NCT00548808|9673050|FG001|STARTED|Overall Study||212
8632997|NCT00548808|9673049|FG000|Full Analysis Set|Overall Study||211
8632998|NCT00548808|9673050|FG001|Full Analysis Set|Overall Study||212
8632999|NCT00548808|9673049|FG000|Per-Protocol Set|Overall Study||177
8633000|NCT00548808|9673050|FG001|Per-Protocol Set|Overall Study||184
8633001|NCT00548808|9673049|FG000|COMPLETED|Overall Study||172
8633002|NCT00548808|9673050|FG001|COMPLETED|Overall Study||186
8633003|NCT00548808|9673049|FG000|NOT COMPLETED|Overall Study||42
8633004|NCT00548808|9673050|FG001|NOT COMPLETED|Overall Study||26
8633005|NCT00548847|9673056|FG000|STARTED|Overall Study||15
8633006|NCT00548847|9673056|FG000|COMPLETED|Overall Study||8
8633007|NCT00548847|9673056|FG000|NOT COMPLETED|Overall Study||7
8633008|NCT00548860|9673062|FG000|STARTED|Overall Study||996
8633009|NCT00548860|9673063|FG001|STARTED|Overall Study||1022
8633010|NCT00548860|9673062|FG000|COMPLETED|Overall Study||860
8633011|NCT00548860|9673063|FG001|COMPLETED|Overall Study||847
8633012|NCT00548860|9673062|FG000|NOT COMPLETED|Overall Study||136
8633013|NCT00548860|9673063|FG001|NOT COMPLETED|Overall Study||175
8633014|NCT00549042|9673071|FG000|STARTED|Conversion and Titration Phase||459
8633015|NCT00549042|9673072|FG001|STARTED|Conversion and Titration Phase|Per the study design, no patients received placebo during this phase.|0
8633016|NCT00549042|9673071|FG000|COMPLETED|Conversion and Titration Phase||268
8633017|NCT00549042|9673072|FG001|COMPLETED|Conversion and Titration Phase|Per the study design, no patients received placebo during this phase.|0
8878304|NCT01928472|9935192|FG003|NOT COMPLETED|Overall Study||2
8878305|NCT01928485|9935205|FG000|STARTED|Overall Study||4
8878306|NCT01928485|9935206|FG001|STARTED|Overall Study||2
8878307|NCT01928485|9935205|FG000|COMPLETED|Overall Study||4
8878308|NCT01928485|9935206|FG001|COMPLETED|Overall Study||1
8878309|NCT01928485|9935205|FG000|NOT COMPLETED|Overall Study||0
8878310|NCT01928485|9935206|FG001|NOT COMPLETED|Overall Study||1
8878311|NCT01928524|9935219|FG000|STARTED|Overall Study||3
8878312|NCT01928524|9935220|FG001|STARTED|Overall Study||3
8878313|NCT01928524|9935221|FG002|STARTED|Overall Study||6
8878314|NCT01928524|9935222|FG003|STARTED|Overall Study||6
8878315|NCT01928524|9935223|FG004|STARTED|Overall Study||3
8878316|NCT01928524|9935224|FG005|STARTED|Overall Study||8
8878317|NCT01928524|9935225|FG006|STARTED|Overall Study||5
8878318|NCT01928524|9935219|FG000|COMPLETED|Overall Study||3
8878319|NCT01928524|9935220|FG001|COMPLETED|Overall Study||3
8878320|NCT01928524|9935221|FG002|COMPLETED|Overall Study||6
8878321|NCT01928524|9935222|FG003|COMPLETED|Overall Study||6
8878322|NCT01928524|9935223|FG004|COMPLETED|Overall Study||3
8878323|NCT01928524|9935224|FG005|COMPLETED|Overall Study||8
8633018|NCT00549042|9673071|FG000|NOT COMPLETED|Conversion and Titration Phase||191
8878324|NCT01928524|9935225|FG006|COMPLETED|Overall Study||5
8878325|NCT01928524|9935219|FG000|NOT COMPLETED|Overall Study||0
8878326|NCT01928524|9935220|FG001|NOT COMPLETED|Overall Study||0
8988691|NCT02752776|10051844|FG002|STARTED|Overall Study||324
8988692|NCT02752776|10051842|FG000|COMPLETED|Overall Study||611
8988693|NCT02752776|10051843|FG001|COMPLETED|Overall Study||597
8988694|NCT02752776|10051844|FG002|COMPLETED|Overall Study||276
8988695|NCT02752776|10051842|FG000|NOT COMPLETED|Overall Study||52
8988696|NCT02752776|10051843|FG001|NOT COMPLETED|Overall Study||76
8988697|NCT02752776|10051844|FG002|NOT COMPLETED|Overall Study||48
8988698|NCT02752802|10051856|FG000|STARTED|Overall Study||48
8988699|NCT02752802|10051857|FG001|STARTED|Overall Study||48
8988700|NCT02752802|10051856|FG000|COMPLETED|Overall Study||47
8988701|NCT02752802|10051857|FG001|COMPLETED|Overall Study||48
8633019|NCT00549042|9673072|FG001|NOT COMPLETED|Conversion and Titration Phase||0
8633020|NCT00549042|9673071|FG000|STARTED|Double-blind Phase||134
8633021|NCT00549042|9673072|FG001|STARTED|Double-blind Phase||134
8633022|NCT00549042|9673071|FG000|COMPLETED|Double-blind Phase||66
8633023|NCT00549042|9673072|FG001|COMPLETED|Double-blind Phase||44
8633024|NCT00549042|9673071|FG000|NOT COMPLETED|Double-blind Phase||68
8633025|NCT00549042|9673072|FG001|NOT COMPLETED|Double-blind Phase||90
8633026|NCT00549055|9673079|FG000|STARTED|Overall Study||38
8633027|NCT00549055|9673079|FG000|COMPLETED|Overall Study||3
8633028|NCT00549055|9673079|FG000|NOT COMPLETED|Overall Study||35
8633029|NCT00549172|9673085|FG000|STARTED|Overall Study||70
8633030|NCT00549172|9673086|FG001|STARTED|Overall Study||76
8633031|NCT00549172|9673085|FG000|COMPLETED|Overall Study||70
8633032|NCT00549172|9673086|FG001|COMPLETED|Overall Study||76
8633033|NCT00549172|9673085|FG000|NOT COMPLETED|Overall Study||0
8633034|NCT00549172|9673086|FG001|NOT COMPLETED|Overall Study||0
8633035|NCT00549198|9673094|FG000|STARTED|Overall Study|Three participants were randomized but were not exposed to study drug (ABC/3TC).|195
8633036|NCT00549198|9673095|FG001|STARTED|Overall Study|Four participants were randomized but were not exposed to study drug (TDF/FTC).|197
8633037|NCT00549198|9673094|FG000|COMPLETED|Overall Study||115
8633038|NCT00549198|9673095|FG001|COMPLETED|Overall Study||134
8633039|NCT00549198|9673094|FG000|NOT COMPLETED|Overall Study||80
8633040|NCT00549198|9673095|FG001|NOT COMPLETED|Overall Study||63
8633041|NCT00549302|9673103|FG000|STARTED|Double-Blind||63
8633042|NCT00549302|9673104|FG001|STARTED|Double-Blind||294
8633043|NCT00549302|9673105|FG002|STARTED|Double-Blind||0
8633044|NCT00549302|9673103|FG000|Received at Least One Dose of Study Drug|Double-Blind||63
8633045|NCT00549302|9673104|FG001|Received at Least One Dose of Study Drug|Double-Blind||294
8633046|NCT00549302|9673105|FG002|Received at Least One Dose of Study Drug|Double-Blind||0
8633047|NCT00549302|9673103|FG000|COMPLETED|Double-Blind|Participants who completed the Double-Blind Period were eligible to enter the Open-Label Period.|52
8878327|NCT01928524|9935221|FG002|NOT COMPLETED|Overall Study||0
8878328|NCT01928524|9935222|FG003|NOT COMPLETED|Overall Study||0
8878329|NCT01928524|9935223|FG004|NOT COMPLETED|Overall Study||0
8878330|NCT01928524|9935224|FG005|NOT COMPLETED|Overall Study||0
8878331|NCT01928524|9935225|FG006|NOT COMPLETED|Overall Study||0
8878332|NCT01928680|9935241|FG000|STARTED|Overall Study||33
8878333|NCT01928680|9935241|FG000|COMPLETED|Overall Study||33
8878334|NCT01928680|9935241|FG000|NOT COMPLETED|Overall Study||0
8878335|NCT01928693|9935248|FG000|STARTED|Overall Study||0
8878336|NCT01928693|9935249|FG001|STARTED|Overall Study||1
8878337|NCT01928693|9935250|FG002|STARTED|Overall Study||1
8878338|NCT01928693|9935248|FG000|COMPLETED|Overall Study||0
8878339|NCT01928693|9935249|FG001|COMPLETED|Overall Study||1
8878340|NCT01928693|9935250|FG002|COMPLETED|Overall Study||1
8878341|NCT01928693|9935248|FG000|NOT COMPLETED|Overall Study||0
8878342|NCT01928693|9935249|FG001|NOT COMPLETED|Overall Study||0
8878343|NCT01928693|9935250|FG002|NOT COMPLETED|Overall Study||0
8878344|NCT01928719|9935260|FG000|STARTED|Overall Study||122
8878345|NCT01928719|9935261|FG001|STARTED|Overall Study||123
8878346|NCT01928719|9935260|FG000|COMPLETED|Overall Study||70
8878347|NCT01928719|9935261|FG001|COMPLETED|Overall Study||104
8878348|NCT01928719|9935260|FG000|NOT COMPLETED|Overall Study||52
8878349|NCT01928719|9935261|FG001|NOT COMPLETED|Overall Study||19
8878350|NCT01928758|9935271|FG000|STARTED|Overall Study||94
8878351|NCT01928758|9935272|FG001|STARTED|Overall Study||94
8878352|NCT01928758|9935271|FG000|COMPLETED|Overall Study||69
8878353|NCT01928758|9935272|FG001|COMPLETED|Overall Study||74
8878354|NCT01928758|9935271|FG000|NOT COMPLETED|Overall Study||25
8878355|NCT01928758|9935272|FG001|NOT COMPLETED|Overall Study||20
8878356|NCT01928771|9935282|FG000|STARTED|Overall Study||400
8878357|NCT01928771|9935283|FG001|STARTED|Overall Study||398
8878358|NCT01928771|9935284|FG002|STARTED|Overall Study||407
8878359|NCT01928771|9935282|FG000|Received Treatment|Overall Study||399
8878360|NCT01928771|9935283|FG001|Received Treatment|Overall Study||398
8878361|NCT01928771|9935284|FG002|Received Treatment|Overall Study||407
8878362|NCT01928771|9935282|FG000|COMPLETED|Overall Study||354
8878363|NCT01928771|9935283|FG001|COMPLETED|Overall Study||358
8878364|NCT01928771|9935284|FG002|COMPLETED|Overall Study||367
8878365|NCT01928771|9935282|FG000|NOT COMPLETED|Overall Study||46
8878366|NCT01928771|9935283|FG001|NOT COMPLETED|Overall Study||40
8878367|NCT01928771|9935284|FG002|NOT COMPLETED|Overall Study||40
8878368|NCT01928797|9935294|FG000|STARTED|Overall Study||30
8878369|NCT01928797|9935295|FG001|STARTED|Overall Study||30
8878370|NCT01928797|9935294|FG000|COMPLETED|Overall Study||30
8878371|NCT01928797|9935295|FG001|COMPLETED|Overall Study||30
8633048|NCT00549302|9673104|FG001|COMPLETED|Double-Blind|Participants who completed the Double-Blind Period were eligible to enter the Open-Label Period.|241
8878372|NCT01928797|9935294|FG000|NOT COMPLETED|Overall Study||0
8878373|NCT01928797|9935295|FG001|NOT COMPLETED|Overall Study||0
8878374|NCT01928849|9935305|FG000|STARTED|Overall Study||66
8878375|NCT01928849|9935306|FG001|STARTED|Overall Study||62
8878376|NCT01928849|9935305|FG000|COMPLETED|Overall Study||52
8878377|NCT01928849|9935306|FG001|COMPLETED|Overall Study||55
8878378|NCT01928849|9935305|FG000|NOT COMPLETED|Overall Study||14
8878379|NCT01928849|9935306|FG001|NOT COMPLETED|Overall Study||7
8878380|NCT01928862|9935317|FG000|STARTED|Overall Study||16
8878381|NCT01928862|9935318|FG001|STARTED|Overall Study||16
8878382|NCT01928862|9935319|FG002|STARTED|Overall Study||16
8878383|NCT01928862|9935320|FG003|STARTED|Overall Study||16
8633049|NCT00549302|9673105|FG002|COMPLETED|Double-Blind||0
8633050|NCT00549302|9673103|FG000|NOT COMPLETED|Double-Blind||11
8633051|NCT00549302|9673104|FG001|NOT COMPLETED|Double-Blind||53
8633052|NCT00549302|9673105|FG002|NOT COMPLETED|Double-Blind||0
8633053|NCT00549302|9673103|FG000|STARTED|Open-Label||0
8633054|NCT00549302|9673104|FG001|STARTED|Open-Label||0
8633055|NCT00549302|9673105|FG002|STARTED|Open-Label|7 participants who completed the Double-Blind Period did not enter the Open-Label Period.|286
8633056|NCT00549302|9673103|FG000|COMPLETED|Open-Label||0
8633057|NCT00549302|9673104|FG001|COMPLETED|Open-Label||0
8633058|NCT00549302|9673105|FG002|COMPLETED|Open-Label|Another death occurred during the 30-day follow-up period after study drug discontinuation|217
8633059|NCT00549302|9673103|FG000|NOT COMPLETED|Open-Label||0
8633060|NCT00549302|9673104|FG001|NOT COMPLETED|Open-Label||0
8633061|NCT00549302|9673105|FG002|NOT COMPLETED|Open-Label||69
8633062|NCT00549393|9673115|FG000|STARTED|Period 1 (6 Months)|intention to treat (ITT)|1319
8633063|NCT00549393|9673116|FG001|STARTED|Period 1 (6 Months)|ITT|1199
8633064|NCT00549393|9673115|FG000|Per Protocol|Period 1 (6 Months)||880
8633065|NCT00549393|9673116|FG001|Per Protocol|Period 1 (6 Months)||1199
8633066|NCT00549393|9673115|FG000|COMPLETED|Period 1 (6 Months)||1319
8633067|NCT00549393|9673116|FG001|COMPLETED|Period 1 (6 Months)||1199
8633068|NCT00549393|9673115|FG000|NOT COMPLETED|Period 1 (6 Months)||0
8633069|NCT00549393|9673116|FG001|NOT COMPLETED|Period 1 (6 Months)||0
8633070|NCT00549393|9673115|FG000|STARTED|Period 2 Washout (2 Weeks)||0
8633071|NCT00549393|9673116|FG001|STARTED|Period 2 Washout (2 Weeks)||0
8633072|NCT00549393|9673115|FG000|COMPLETED|Period 2 Washout (2 Weeks)||0
8633073|NCT00549393|9673116|FG001|COMPLETED|Period 2 Washout (2 Weeks)||0
8633074|NCT00549393|9673115|FG000|NOT COMPLETED|Period 2 Washout (2 Weeks)||0
8633075|NCT00549393|9673116|FG001|NOT COMPLETED|Period 2 Washout (2 Weeks)||0
8633076|NCT00549393|9673115|FG000|STARTED|Period 3 (6 Months)|number not equal to period 1 due to unit cross over design|1103
8633077|NCT00549393|9673116|FG001|STARTED|Period 3 (6 Months)|number not equal to period 1 due to unit cross over design|1326
8878384|NCT01928862|9935321|FG004|STARTED|Overall Study||14
8878385|NCT01928862|9935317|FG000|COMPLETED|Overall Study||15
8878386|NCT01928862|9935318|FG001|COMPLETED|Overall Study||16
8878387|NCT01928862|9935319|FG002|COMPLETED|Overall Study||16
8878388|NCT01928862|9935320|FG003|COMPLETED|Overall Study||16
8878389|NCT01928862|9935321|FG004|COMPLETED|Overall Study||13
8878390|NCT01928862|9935317|FG000|NOT COMPLETED|Overall Study||1
8878391|NCT01928862|9935318|FG001|NOT COMPLETED|Overall Study||0
8878392|NCT01928862|9935319|FG002|NOT COMPLETED|Overall Study||0
8878393|NCT01928862|9935320|FG003|NOT COMPLETED|Overall Study||0
8878394|NCT01928862|9935321|FG004|NOT COMPLETED|Overall Study||1
8878395|NCT01928927|9935336|FG000|STARTED|Overall Study||29
8878396|NCT01928927|9935337|FG001|STARTED|Overall Study||15
8878397|NCT01928927|9935336|FG000|COMPLETED|Overall Study||27
8878398|NCT01928927|9935337|FG001|COMPLETED|Overall Study||14
8878399|NCT01928927|9935336|FG000|NOT COMPLETED|Overall Study||2
8878400|NCT01928927|9935337|FG001|NOT COMPLETED|Overall Study||1
8878401|NCT01928940|9935349|FG000|STARTED|Overall Study||6
8878402|NCT01928940|9935350|FG001|STARTED|Overall Study||6
8878403|NCT01928940|9935349|FG000|COMPLETED|Overall Study||6
8878404|NCT01928940|9935350|FG001|COMPLETED|Overall Study||5
8878405|NCT01928940|9935349|FG000|NOT COMPLETED|Overall Study||0
8878406|NCT01928940|9935350|FG001|NOT COMPLETED|Overall Study||1
8878407|NCT01929018|9935359|FG000|STARTED|Overall Study||19
8878408|NCT01929018|9935360|FG001|STARTED|Overall Study||19
8878409|NCT01929018|9935359|FG000|COMPLETED|Overall Study||18
8878410|NCT01929018|9935360|FG001|COMPLETED|Overall Study||18
8878411|NCT01929018|9935359|FG000|NOT COMPLETED|Overall Study||1
8878412|NCT01929018|9935360|FG001|NOT COMPLETED|Overall Study||1
8878413|NCT01929031|9935370|FG000|STARTED|Overall Study||213
8878414|NCT01929031|9935371|FG001|STARTED|Overall Study||209
8878415|NCT01929031|9935372|FG002|STARTED|Overall Study||35
8878416|NCT01929031|9935373|FG003|STARTED|Overall Study||35
8878417|NCT01929031|9935374|FG004|STARTED|Overall Study||34
8633078|NCT00549393|9673115|FG000|Per Protocol|Period 3 (6 Months)||667
8633079|NCT00549393|9673116|FG001|Per Protocol|Period 3 (6 Months)||1326
8633080|NCT00549393|9673115|FG000|COMPLETED|Period 3 (6 Months)||1103
8633081|NCT00549393|9673116|FG001|COMPLETED|Period 3 (6 Months)||1326
8633082|NCT00549393|9673115|FG000|NOT COMPLETED|Period 3 (6 Months)||0
8633083|NCT00549393|9673116|FG001|NOT COMPLETED|Period 3 (6 Months)||0
8633084|NCT00549445|9673126|FG000|STARTED|Overall Study||23
8633085|NCT00549445|9673127|FG001|STARTED|Overall Study||30
8633086|NCT00549445|9673126|FG000|COMPLETED|Overall Study||8
8633087|NCT00549445|9673127|FG001|COMPLETED|Overall Study||13
8633088|NCT00549445|9673126|FG000|NOT COMPLETED|Overall Study||15
8633089|NCT00549445|9673127|FG001|NOT COMPLETED|Overall Study||17
8633090|NCT00549549|9673137|FG000|STARTED|Overall Study||101
8725884|NCT01033487|9773161|FG004|NOT COMPLETED|Second Intervention Period||0
8878418|NCT01929031|9935375|FG005|STARTED|Overall Study||36
8878419|NCT01929031|9935370|FG000|COMPLETED|Overall Study||209
8878420|NCT01929031|9935371|FG001|COMPLETED|Overall Study||207
8878421|NCT01929031|9935372|FG002|COMPLETED|Overall Study||34
8878422|NCT01929031|9935373|FG003|COMPLETED|Overall Study||35
8878423|NCT01929031|9935374|FG004|COMPLETED|Overall Study||33
8878424|NCT01929031|9935375|FG005|COMPLETED|Overall Study||35
8878425|NCT01929031|9935370|FG000|NOT COMPLETED|Overall Study||4
8878426|NCT01929031|9935371|FG001|NOT COMPLETED|Overall Study||2
8878427|NCT01929031|9935372|FG002|NOT COMPLETED|Overall Study||1
8878428|NCT01929031|9935373|FG003|NOT COMPLETED|Overall Study||0
8633091|NCT00549549|9673138|FG001|STARTED|Overall Study||99
8633092|NCT00549549|9673139|FG002|STARTED|Overall Study||99
8633093|NCT00549549|9673140|FG003|STARTED|Overall Study||103
8633094|NCT00549549|9673137|FG000|Treated|Overall Study||101
8633095|NCT00549549|9673138|FG001|Treated|Overall Study||99
8633096|NCT00549549|9673139|FG002|Treated|Overall Study||98
8633097|NCT00549549|9673140|FG003|Treated|Overall Study||102
8633098|NCT00549549|9673137|FG000|COMPLETED|Overall Study||77
8633099|NCT00549549|9673138|FG001|COMPLETED|Overall Study||77
8988702|NCT02752802|10051856|FG000|NOT COMPLETED|Overall Study||1
8988703|NCT02752802|10051857|FG001|NOT COMPLETED|Overall Study||0
8988704|NCT02752880|10051867|FG000|STARTED|Overall Study||23
8988705|NCT02752880|10051868|FG001|STARTED|Overall Study||23
8988706|NCT02752880|10051867|FG000|COMPLETED|Overall Study||21
8988707|NCT02752880|10051868|FG001|COMPLETED|Overall Study||20
8988708|NCT02752880|10051867|FG000|NOT COMPLETED|Overall Study||2
8988709|NCT02752880|10051868|FG001|NOT COMPLETED|Overall Study||3
8988710|NCT02752958|10051875|FG000|STARTED|Overall Study||75
8988711|NCT02752958|10051875|FG000|COMPLETED|Overall Study||66
8633100|NCT00549549|9673139|FG002|COMPLETED|Overall Study||82
8633101|NCT00549549|9673140|FG003|COMPLETED|Overall Study||78
8633102|NCT00549549|9673137|FG000|NOT COMPLETED|Overall Study||24
8633103|NCT00549549|9673138|FG001|NOT COMPLETED|Overall Study||22
8633104|NCT00549549|9673139|FG002|NOT COMPLETED|Overall Study||17
8633105|NCT00549549|9673140|FG003|NOT COMPLETED|Overall Study||25
8633106|NCT00549562|9673150|FG000|STARTED|Overall Study||25
8633107|NCT00549562|9673150|FG000|COMPLETED|Overall Study||23
8633108|NCT00549562|9673150|FG000|NOT COMPLETED|Overall Study||2
8633109|NCT00549601|9673157|FG000|STARTED|Randomized||43
8633110|NCT00549601|9673158|FG001|STARTED|Randomized||48
8633111|NCT00549601|9673159|FG002|STARTED|Randomized||51
8633112|NCT00549601|9673157|FG000|COMPLETED|Randomized||43
8633113|NCT00549601|9673158|FG001|COMPLETED|Randomized||47
8633114|NCT00549601|9673159|FG002|COMPLETED|Randomized||49
8633115|NCT00549601|9673157|FG000|NOT COMPLETED|Randomized||0
8633116|NCT00549601|9673158|FG001|NOT COMPLETED|Randomized||1
8633117|NCT00549601|9673159|FG002|NOT COMPLETED|Randomized||2
8633118|NCT00549601|9673157|FG000|STARTED|Received Study Drug|Subjects who started this period (safety population) received at least 1 dose of study drug.|43
8633119|NCT00549601|9673158|FG001|STARTED|Received Study Drug|Subjects who started this period (safety population) received at least 1 dose of study drug.|47
8633120|NCT00549601|9673159|FG002|STARTED|Received Study Drug|Subjects who started this period (safety population) received at least 1 dose of study drug.|49
8633121|NCT00549601|9673157|FG000|COMPLETED|Received Study Drug||36
8633122|NCT00549601|9673158|FG001|COMPLETED|Received Study Drug||36
8633123|NCT00549601|9673159|FG002|COMPLETED|Received Study Drug||45
8633124|NCT00549601|9673157|FG000|NOT COMPLETED|Received Study Drug||7
8633125|NCT00549601|9673158|FG001|NOT COMPLETED|Received Study Drug||11
8633126|NCT00549601|9673159|FG002|NOT COMPLETED|Received Study Drug||4
8633127|NCT00549640|9673171|FG000|STARTED|Overall Study||40
8633128|NCT00549640|9673172|FG001|STARTED|Overall Study||40
8633129|NCT00549640|9673171|FG000|COMPLETED|Overall Study|For the primary endpoint, subjects who discontinued participation were assumed to be smoking.|22
8633130|NCT00549640|9673172|FG001|COMPLETED|Overall Study||24
8633131|NCT00549640|9673171|FG000|NOT COMPLETED|Overall Study||18
8633132|NCT00549640|9673172|FG001|NOT COMPLETED|Overall Study||16
8633133|NCT00549718|9673182|FG000|STARTED|Overall Study||125
8633134|NCT00549718|9673183|FG001|STARTED|Overall Study||123
8633135|NCT00549718|9673184|FG002|STARTED|Overall Study||124
8633136|NCT00549718|9673185|FG003|STARTED|Overall Study||128
8633137|NCT00549718|9673182|FG000|COMPLETED|Overall Study||84
8633138|NCT00549718|9673183|FG001|COMPLETED|Overall Study||86
8633139|NCT00549718|9673184|FG002|COMPLETED|Overall Study||85
8633140|NCT00549718|9673185|FG003|COMPLETED|Overall Study||73
8633141|NCT00549718|9673182|FG000|NOT COMPLETED|Overall Study||41
8633142|NCT00549718|9673183|FG001|NOT COMPLETED|Overall Study||37
8633143|NCT00549718|9673184|FG002|NOT COMPLETED|Overall Study||39
8633144|NCT00549718|9673185|FG003|NOT COMPLETED|Overall Study||55
8633145|NCT00549757|9673197|FG000|STARTED|Active Treatment Phase: Max. 50 Months|"Started indicates randomized patients."|4296
8633146|NCT00549757|9673198|FG001|STARTED|Active Treatment Phase: Max. 50 Months||4310
8633147|NCT00549757|9673197|FG000|Full Analysis Set|Active Treatment Phase: Max. 50 Months||4274
8633148|NCT00549757|9673198|FG001|Full Analysis Set|Active Treatment Phase: Max. 50 Months||4287
8633149|NCT00549757|9673197|FG000|Safety Set|Active Treatment Phase: Max. 50 Months||4272
8633150|NCT00549757|9673198|FG001|Safety Set|Active Treatment Phase: Max. 50 Months||4285
8633151|NCT00549757|9673197|FG000|COMPLETED|Active Treatment Phase: Max. 50 Months||0
8633152|NCT00549757|9673198|FG001|COMPLETED|Active Treatment Phase: Max. 50 Months||0
8633153|NCT00549757|9673197|FG000|NOT COMPLETED|Active Treatment Phase: Max. 50 Months||4296
8988712|NCT02752958|10051875|FG000|NOT COMPLETED|Overall Study||9
8988713|NCT02753075|10051884|FG000|STARTED|Overall Study||79
8988714|NCT02753075|10051885|FG001|STARTED|Overall Study||80
8988715|NCT02753075|10051886|FG002|STARTED|Overall Study||81
8633154|NCT00549757|9673198|FG001|NOT COMPLETED|Active Treatment Phase: Max. 50 Months||4310
8633155|NCT00549757|9673197|FG000|STARTED|Extension Period (in Average 9 Months)|"As explained in pre-assignment detail, follow up was made after drug discontinuation"|3773
8633156|NCT00549757|9673198|FG001|STARTED|Extension Period (in Average 9 Months)|"As explained in pre-assignment detail, follow up was made after drug discontinuation"|3817
8633157|NCT00549757|9673197|FG000|COMPLETED|Extension Period (in Average 9 Months)||3148
8988716|NCT02753075|10051884|FG000|COMPLETED|Overall Study||71
8988717|NCT02753075|10051885|FG001|COMPLETED|Overall Study||77
8988718|NCT02753075|10051886|FG002|COMPLETED|Overall Study||78
8988719|NCT02753075|10051884|FG000|NOT COMPLETED|Overall Study||8
8988720|NCT02753075|10051885|FG001|NOT COMPLETED|Overall Study||3
8988721|NCT02753075|10051886|FG002|NOT COMPLETED|Overall Study||3
8988722|NCT02753400|10051897|FG000|STARTED|Overall Study||12
8988723|NCT02753400|10051898|FG001|STARTED|Overall Study||12
8988724|NCT02753400|10051897|FG000|COMPLETED|Overall Study||7
8988725|NCT02753400|10051898|FG001|COMPLETED|Overall Study||11
8988726|NCT02753400|10051897|FG000|NOT COMPLETED|Overall Study||5
8988727|NCT02753400|10051898|FG001|NOT COMPLETED|Overall Study||1
8988728|NCT02753413|10051906|FG000|STARTED|Overall Study||49
8988729|NCT02753413|10051907|FG001|STARTED|Overall Study||51
8988730|NCT02753413|10051906|FG000|COMPLETED|Overall Study||49
8988731|NCT02753413|10051907|FG001|COMPLETED|Overall Study||51
8988732|NCT02753413|10051906|FG000|NOT COMPLETED|Overall Study||0
8988733|NCT02753413|10051907|FG001|NOT COMPLETED|Overall Study||0
8988734|NCT02753595|10051915|FG000|STARTED|Overall Study||5
8988735|NCT02753595|10051916|FG001|STARTED|Overall Study||9
8633158|NCT00549757|9673198|FG001|COMPLETED|Extension Period (in Average 9 Months)||3182
8633159|NCT00549757|9673197|FG000|NOT COMPLETED|Extension Period (in Average 9 Months)||625
8633160|NCT00549757|9673198|FG001|NOT COMPLETED|Extension Period (in Average 9 Months)||635
8633161|NCT00549770|9673218|FG000|STARTED|Overall Study||156
8633162|NCT00549770|9673219|FG001|STARTED|Overall Study||169
8633163|NCT00549770|9673220|FG002|STARTED|Overall Study||172
8633164|NCT00549770|9673221|FG003|STARTED|Overall Study||163
8633165|NCT00549770|9673222|FG004|STARTED|Overall Study||166
8633166|NCT00549770|9673223|FG005|STARTED|Overall Study||164
8633167|NCT00549770|9673224|FG006|STARTED|Overall Study||165
8633168|NCT00549770|9673225|FG007|STARTED|Overall Study||173
8633169|NCT00549770|9673218|FG000|Intent-to-treat Population|Overall Study||154
8633170|NCT00549770|9673219|FG001|Intent-to-treat Population|Overall Study||168
8633171|NCT00549770|9673220|FG002|Intent-to-treat Population|Overall Study||170
8633172|NCT00549770|9673221|FG003|Intent-to-treat Population|Overall Study||163
8633173|NCT00549770|9673222|FG004|Intent-to-treat Population|Overall Study||163
8633174|NCT00549770|9673223|FG005|Intent-to-treat Population|Overall Study||163
8633175|NCT00549770|9673224|FG006|Intent-to-treat Population|Overall Study||164
8633176|NCT00549770|9673225|FG007|Intent-to-treat Population|Overall Study||172
8633177|NCT00549770|9673218|FG000|Ambulatory Blood Pressure Monitoring|Overall Study||48
8633178|NCT00549770|9673219|FG001|Ambulatory Blood Pressure Monitoring|Overall Study||61
8633179|NCT00549770|9673220|FG002|Ambulatory Blood Pressure Monitoring|Overall Study||53
8633180|NCT00549770|9673221|FG003|Ambulatory Blood Pressure Monitoring|Overall Study||55
8633181|NCT00549770|9673222|FG004|Ambulatory Blood Pressure Monitoring|Overall Study||49
8633182|NCT00549770|9673223|FG005|Ambulatory Blood Pressure Monitoring|Overall Study||54
8633183|NCT00549770|9673224|FG006|Ambulatory Blood Pressure Monitoring|Overall Study||50
8633184|NCT00549770|9673225|FG007|Ambulatory Blood Pressure Monitoring|Overall Study||57
8633185|NCT00549770|9673218|FG000|COMPLETED|Overall Study||149
8633186|NCT00549770|9673219|FG001|COMPLETED|Overall Study||158
8633187|NCT00549770|9673220|FG002|COMPLETED|Overall Study||162
8633188|NCT00549770|9673221|FG003|COMPLETED|Overall Study||147
8633189|NCT00549770|9673222|FG004|COMPLETED|Overall Study||149
8633190|NCT00549770|9673223|FG005|COMPLETED|Overall Study||151
8633191|NCT00549770|9673224|FG006|COMPLETED|Overall Study||151
8633192|NCT00549770|9673225|FG007|COMPLETED|Overall Study||148
8633193|NCT00549770|9673218|FG000|NOT COMPLETED|Overall Study||7
8633194|NCT00549770|9673219|FG001|NOT COMPLETED|Overall Study||11
8633195|NCT00549770|9673220|FG002|NOT COMPLETED|Overall Study||10
8633196|NCT00549770|9673221|FG003|NOT COMPLETED|Overall Study||16
8633197|NCT00549770|9673222|FG004|NOT COMPLETED|Overall Study||17
8633198|NCT00549770|9673223|FG005|NOT COMPLETED|Overall Study||13
8633199|NCT00549770|9673224|FG006|NOT COMPLETED|Overall Study||14
8633200|NCT00549770|9673225|FG007|NOT COMPLETED|Overall Study||25
8633201|NCT00549783|9673245|FG000|STARTED|Overall Study||139
8633202|NCT00549783|9673246|FG001|STARTED|Overall Study||135
8633203|NCT00549783|9673245|FG000|COMPLETED|Overall Study||131
8633204|NCT00549783|9673246|FG001|COMPLETED|Overall Study||122
8633205|NCT00549783|9673245|FG000|NOT COMPLETED|Overall Study||8
8633206|NCT00549783|9673246|FG001|NOT COMPLETED|Overall Study||13
8633207|NCT00549822|9673252|FG000|STARTED|Overall Study||3
8633208|NCT00549822|9673252|FG000|COMPLETED|Overall Study||3
8633209|NCT00549822|9673252|FG000|NOT COMPLETED|Overall Study||0
8633210|NCT00549900|9673256|FG000|STARTED|Overall Study||30
8633211|NCT00549900|9673256|FG000|COMPLETED|Overall Study||29
8633212|NCT00549900|9673256|FG000|NOT COMPLETED|Overall Study||1
8633213|NCT00549939|9673263|FG000|STARTED|12-week Double Blind Treatment Period|29 (Alfuzosin 0.1 mg/kg/day matching placebo) + 28 (Alfuzosin 0.2 mg/kg/day matching placebo)|57
8633214|NCT00549939|9673264|FG001|STARTED|12-week Double Blind Treatment Period||57
8633215|NCT00549939|9673265|FG002|STARTED|12-week Double Blind Treatment Period||58
8633216|NCT00549939|9673263|FG000|COMPLETED|12-week Double Blind Treatment Period||56
8633217|NCT00549939|9673264|FG001|COMPLETED|12-week Double Blind Treatment Period||55
8633218|NCT00549939|9673265|FG002|COMPLETED|12-week Double Blind Treatment Period||56
8988736|NCT02753595|10051915|FG000|COMPLETED|Overall Study||3
8988737|NCT02753595|10051916|FG001|COMPLETED|Overall Study||7
8988738|NCT02753595|10051915|FG000|NOT COMPLETED|Overall Study||2
8988739|NCT02753595|10051916|FG001|NOT COMPLETED|Overall Study||2
8988740|NCT02753699|10051924|FG000|STARTED|Overall Study||164
8988741|NCT02753699|10051925|FG001|STARTED|Overall Study||397
8988742|NCT02753699|10051926|FG002|STARTED|Overall Study||162
8988743|NCT02753699|10051924|FG000|COMPLETED|Overall Study||150
8988744|NCT02753699|10051925|FG001|COMPLETED|Overall Study||354
8988745|NCT02753699|10051926|FG002|COMPLETED|Overall Study||139
8988746|NCT02753699|10051924|FG000|NOT COMPLETED|Overall Study||14
8988747|NCT02753699|10051925|FG001|NOT COMPLETED|Overall Study||43
8988748|NCT02753699|10051926|FG002|NOT COMPLETED|Overall Study||23
8988749|NCT02753816|10051939|FG000|STARTED|Overall Study||7
8988750|NCT02753816|10051940|FG001|STARTED|Overall Study||11
8988751|NCT02753816|10051941|FG002|STARTED|Overall Study||7
8988752|NCT02753816|10051939|FG000|Tranexamic Acid|Overall Study||7
8988753|NCT02753816|10051940|FG001|Tranexamic Acid|Overall Study||0
8988754|NCT02753816|10051941|FG002|Tranexamic Acid|Overall Study||7
8988755|NCT02753816|10051939|FG000|Placebo|Overall Study||0
8988756|NCT02753816|10051940|FG001|Placebo|Overall Study||11
8988757|NCT02753816|10051941|FG002|Placebo|Overall Study||7
8988758|NCT02753816|10051939|FG000|COMPLETED|Overall Study||7
8988759|NCT02753816|10051940|FG001|COMPLETED|Overall Study||10
8988760|NCT02753816|10051941|FG002|COMPLETED|Overall Study||7
8988761|NCT02753816|10051939|FG000|NOT COMPLETED|Overall Study||0
8988762|NCT02753816|10051940|FG001|NOT COMPLETED|Overall Study||1
8988763|NCT02753816|10051941|FG002|NOT COMPLETED|Overall Study||0
8988764|NCT02753842|10051953|FG000|STARTED|First Follow-Up (Set of Condoms)||85
8988765|NCT02753842|10051954|FG001|STARTED|First Follow-Up (Set of Condoms)||84
8988766|NCT02753842|10051955|FG002|STARTED|First Follow-Up (Set of Condoms)||85
8988767|NCT02753842|10051956|FG003|STARTED|First Follow-Up (Set of Condoms)||83
8988768|NCT02753842|10051957|FG004|STARTED|First Follow-Up (Set of Condoms)||83
8988769|NCT02753842|10051958|FG005|STARTED|First Follow-Up (Set of Condoms)||84
8988770|NCT02753842|10051953|FG000|COMPLETED|First Follow-Up (Set of Condoms)||75
8988771|NCT02753842|10051954|FG001|COMPLETED|First Follow-Up (Set of Condoms)||76
8988772|NCT02753842|10051955|FG002|COMPLETED|First Follow-Up (Set of Condoms)||76
8988773|NCT02753842|10051956|FG003|COMPLETED|First Follow-Up (Set of Condoms)||81
8988774|NCT02753842|10051957|FG004|COMPLETED|First Follow-Up (Set of Condoms)||76
8988775|NCT02753842|10051958|FG005|COMPLETED|First Follow-Up (Set of Condoms)||79
8988776|NCT02753842|10051953|FG000|NOT COMPLETED|First Follow-Up (Set of Condoms)||10
8988777|NCT02753842|10051954|FG001|NOT COMPLETED|First Follow-Up (Set of Condoms)||8
8633219|NCT00549939|9673263|FG000|NOT COMPLETED|12-week Double Blind Treatment Period||1
8633220|NCT00549939|9673264|FG001|NOT COMPLETED|12-week Double Blind Treatment Period||2
8633221|NCT00549939|9673265|FG002|NOT COMPLETED|12-week Double Blind Treatment Period||2
8633222|NCT00549939|9673263|FG000|STARTED|40-week Open Label Treatment Period|54 patients continued and switched to Alfuzosin: 26 to 0.1 mg/kg/day and 28 to 0.2 mg/kg/day.|0
8633223|NCT00549939|9673264|FG001|STARTED|40-week Open Label Treatment Period|54 patients continued Alfuzosin 0.1 mg/kg/day and 26 patients started Alfuzosin 0.1 mg/kg/day.|80
8633224|NCT00549939|9673265|FG002|STARTED|40-week Open Label Treatment Period|55 patients continued Alfuzosin 0.2 mg/kg/day and 28 patients started Alfuzosin 0.2 mg/kg/day.|83
8633225|NCT00549939|9673263|FG000|COMPLETED|40-week Open Label Treatment Period||0
8633226|NCT00549939|9673264|FG001|COMPLETED|40-week Open Label Treatment Period||75
8633227|NCT00549939|9673265|FG002|COMPLETED|40-week Open Label Treatment Period||78
8633228|NCT00549939|9673263|FG000|NOT COMPLETED|40-week Open Label Treatment Period||0
8633229|NCT00549939|9673264|FG001|NOT COMPLETED|40-week Open Label Treatment Period||5
8633230|NCT00549939|9673265|FG002|NOT COMPLETED|40-week Open Label Treatment Period||5
8633231|NCT00550043|9673280|FG000|STARTED|Overall Study||9
8633232|NCT00550043|9673281|FG001|STARTED|Overall Study||12
8633233|NCT00550043|9673282|FG002|STARTED|Overall Study||9
8633234|NCT00550043|9673283|FG003|STARTED|Overall Study||10
8633235|NCT00550043|9673284|FG004|STARTED|Overall Study||10
8633236|NCT00550043|9673280|FG000|COMPLETED|Overall Study||9
8633237|NCT00550043|9673281|FG001|COMPLETED|Overall Study||9
8633238|NCT00550043|9673282|FG002|COMPLETED|Overall Study||8
8633239|NCT00550043|9673283|FG003|COMPLETED|Overall Study||8
8633240|NCT00550043|9673284|FG004|COMPLETED|Overall Study||9
8725885|NCT01033487|9773162|FG005|NOT COMPLETED|Second Intervention Period||0
8725886|NCT01033487|9773163|FG006|NOT COMPLETED|Second Intervention Period||0
8725887|NCT01033487|9773164|FG007|NOT COMPLETED|Second Intervention Period||0
8725888|NCT01033487|9773165|FG008|NOT COMPLETED|Second Intervention Period||0
8725889|NCT01033487|9773166|FG009|NOT COMPLETED|Second Intervention Period||0
8725890|NCT01033487|9773157|FG000|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
8725891|NCT01033487|9773158|FG001|STARTED|Between Period 2 and 3 (At Least 7 Days)||3
8725892|NCT01033487|9773159|FG002|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
8725893|NCT01033487|9773160|FG003|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
8988778|NCT02753842|10051955|FG002|NOT COMPLETED|First Follow-Up (Set of Condoms)||9
8633241|NCT00550043|9673280|FG000|NOT COMPLETED|Overall Study||0
8633242|NCT00550043|9673281|FG001|NOT COMPLETED|Overall Study||3
8633243|NCT00550043|9673282|FG002|NOT COMPLETED|Overall Study||1
8633244|NCT00550043|9673283|FG003|NOT COMPLETED|Overall Study||2
8633245|NCT00550043|9673284|FG004|NOT COMPLETED|Overall Study||1
8988779|NCT02753842|10051956|FG003|NOT COMPLETED|First Follow-Up (Set of Condoms)||2
8988780|NCT02753842|10051957|FG004|NOT COMPLETED|First Follow-Up (Set of Condoms)||7
8988781|NCT02753842|10051958|FG005|NOT COMPLETED|First Follow-Up (Set of Condoms)||5
8988782|NCT02753842|10051953|FG000|STARTED|Second Follow-Up (Set of Condoms)||75
8988783|NCT02753842|10051954|FG001|STARTED|Second Follow-Up (Set of Condoms)||76
8988784|NCT02753842|10051955|FG002|STARTED|Second Follow-Up (Set of Condoms)||76
8988785|NCT02753842|10051956|FG003|STARTED|Second Follow-Up (Set of Condoms)||81
8988786|NCT02753842|10051957|FG004|STARTED|Second Follow-Up (Set of Condoms)||76
8988787|NCT02753842|10051958|FG005|STARTED|Second Follow-Up (Set of Condoms)||79
8988788|NCT02753842|10051953|FG000|COMPLETED|Second Follow-Up (Set of Condoms)||71
8988789|NCT02753842|10051954|FG001|COMPLETED|Second Follow-Up (Set of Condoms)||71
8988790|NCT02753842|10051955|FG002|COMPLETED|Second Follow-Up (Set of Condoms)||71
8988791|NCT02753842|10051956|FG003|COMPLETED|Second Follow-Up (Set of Condoms)||76
8988792|NCT02753842|10051957|FG004|COMPLETED|Second Follow-Up (Set of Condoms)||75
8988793|NCT02753842|10051958|FG005|COMPLETED|Second Follow-Up (Set of Condoms)||72
8988794|NCT02753842|10051953|FG000|NOT COMPLETED|Second Follow-Up (Set of Condoms)||4
8988795|NCT02753842|10051954|FG001|NOT COMPLETED|Second Follow-Up (Set of Condoms)||5
8988796|NCT02753842|10051955|FG002|NOT COMPLETED|Second Follow-Up (Set of Condoms)||5
8988797|NCT02753842|10051956|FG003|NOT COMPLETED|Second Follow-Up (Set of Condoms)||5
8988798|NCT02753842|10051957|FG004|NOT COMPLETED|Second Follow-Up (Set of Condoms)||1
8988799|NCT02753842|10051958|FG005|NOT COMPLETED|Second Follow-Up (Set of Condoms)||7
8988800|NCT02753842|10051953|FG000|STARTED|Third Follow-Up (Set of Condoms)||71
8988801|NCT02753842|10051954|FG001|STARTED|Third Follow-Up (Set of Condoms)||71
8988802|NCT02753842|10051955|FG002|STARTED|Third Follow-Up (Set of Condoms)||71
8988803|NCT02753842|10051956|FG003|STARTED|Third Follow-Up (Set of Condoms)||76
8988804|NCT02753842|10051957|FG004|STARTED|Third Follow-Up (Set of Condoms)||75
8988805|NCT02753842|10051958|FG005|STARTED|Third Follow-Up (Set of Condoms)||72
8988806|NCT02753842|10051953|FG000|COMPLETED|Third Follow-Up (Set of Condoms)||65
8988807|NCT02753842|10051954|FG001|COMPLETED|Third Follow-Up (Set of Condoms)||66
8988808|NCT02753842|10051955|FG002|COMPLETED|Third Follow-Up (Set of Condoms)||68
8988809|NCT02753842|10051956|FG003|COMPLETED|Third Follow-Up (Set of Condoms)||70
8988810|NCT02753842|10051957|FG004|COMPLETED|Third Follow-Up (Set of Condoms)||71
8988811|NCT02753842|10051958|FG005|COMPLETED|Third Follow-Up (Set of Condoms)||69
8988812|NCT02753842|10051953|FG000|NOT COMPLETED|Third Follow-Up (Set of Condoms)||6
8988813|NCT02753842|10051954|FG001|NOT COMPLETED|Third Follow-Up (Set of Condoms)||5
8633246|NCT00550147|9673296|FG000|STARTED|OROS Methylphenidate Monotherapy||30
8633247|NCT00550147|9673296|FG000|COMPLETED|OROS Methylphenidate Monotherapy||24
8633248|NCT00550147|9673296|FG000|NOT COMPLETED|OROS Methylphenidate Monotherapy||6
8633249|NCT00550147|9673296|FG000|STARTED|Quetiapine Addition Treatment Period||24
8633250|NCT00550147|9673296|FG000|COMPLETED|Quetiapine Addition Treatment Period||18
8633251|NCT00550147|9673296|FG000|NOT COMPLETED|Quetiapine Addition Treatment Period||6
8633252|NCT00550173|9673312|FG000|STARTED|Overall Study||81
8633253|NCT00550173|9673313|FG001|STARTED|Overall Study||82
8633254|NCT00550173|9673314|FG002|STARTED|Overall Study||84
8633255|NCT00550173|9673312|FG000|Qualified Participants|Overall Study|Participants with tumors of nonsquamous histology|78
8633256|NCT00550173|9673313|FG001|Qualified Participants|Overall Study|Participants with tumors of nonsquamous histology|82
8633257|NCT00550173|9673314|FG002|Qualified Participants|Overall Study|Participants with tumors of nonsquamous histology|80
8633258|NCT00550173|9673312|FG000|Not Discontinued at 18 Months|Overall Study||9
8633259|NCT00550173|9673313|FG001|Not Discontinued at 18 Months|Overall Study||19
8633260|NCT00550173|9673314|FG002|Not Discontinued at 18 Months|Overall Study||11
8633261|NCT00550173|9673312|FG000|COMPLETED|Overall Study||9
8633262|NCT00550173|9673313|FG001|COMPLETED|Overall Study||19
8633263|NCT00550173|9673314|FG002|COMPLETED|Overall Study||11
8633264|NCT00550173|9673312|FG000|NOT COMPLETED|Overall Study||72
8633265|NCT00550173|9673313|FG001|NOT COMPLETED|Overall Study||63
8633266|NCT00550173|9673314|FG002|NOT COMPLETED|Overall Study||73
8633267|NCT00550238|9673323|FG000|STARTED|Overall Study||459
8633268|NCT00550238|9673323|FG000|COMPLETED|Overall Study||0
8633269|NCT00550238|9673323|FG000|NOT COMPLETED|Overall Study||459
8633270|NCT00550277|9673327|FG000|STARTED|Overall Study||20
8633271|NCT00550277|9673327|FG000|COMPLETED|Overall Study||11
8633272|NCT00550277|9673327|FG000|NOT COMPLETED|Overall Study||9
8633273|NCT00550290|9673333|FG000|STARTED|Overall Study||10
8633274|NCT00550290|9673334|FG001|STARTED|Overall Study||8
8633275|NCT00550290|9673333|FG000|COMPLETED|Overall Study||10
8633276|NCT00550290|9673334|FG001|COMPLETED|Overall Study||8
8633277|NCT00550290|9673333|FG000|NOT COMPLETED|Overall Study||0
8633278|NCT00550290|9673334|FG001|NOT COMPLETED|Overall Study||0
8633279|NCT00550368|9673342|FG000|STARTED|Overall Study||26
8633280|NCT00550368|9673343|FG001|STARTED|Overall Study||19
8633281|NCT00550368|9673342|FG000|COMPLETED|Overall Study||26
8633282|NCT00550368|9673343|FG001|COMPLETED|Overall Study||19
8633283|NCT00550368|9673342|FG000|NOT COMPLETED|Overall Study||0
8633284|NCT00550368|9673343|FG001|NOT COMPLETED|Overall Study||0
8633285|NCT00550394|9673351|FG000|STARTED|Overall Study||21
8633286|NCT00550394|9673352|FG001|STARTED|Overall Study||18
8633287|NCT00550394|9673351|FG000|COMPLETED|Overall Study||9
8633288|NCT00550394|9673352|FG001|COMPLETED|Overall Study||5
8633289|NCT00550394|9673351|FG000|NOT COMPLETED|Overall Study||12
8633290|NCT00550394|9673352|FG001|NOT COMPLETED|Overall Study||13
8633291|NCT00550407|9673362|FG000|STARTED|8-16 Week Preliminary (Open-Label) Phase||215
8633292|NCT00550407|9673363|FG001|STARTED|8-16 Week Preliminary (Open-Label) Phase||0
8988814|NCT02753842|10051955|FG002|NOT COMPLETED|Third Follow-Up (Set of Condoms)||3
8988815|NCT02753842|10051956|FG003|NOT COMPLETED|Third Follow-Up (Set of Condoms)||6
8988816|NCT02753842|10051957|FG004|NOT COMPLETED|Third Follow-Up (Set of Condoms)||4
8988817|NCT02753842|10051958|FG005|NOT COMPLETED|Third Follow-Up (Set of Condoms)||3
8988818|NCT02753881|10051975|FG000|STARTED|Overall Study||10
8988819|NCT02753881|10051976|FG001|STARTED|Overall Study||10
8988820|NCT02753881|10051977|FG002|STARTED|Overall Study||10
8988821|NCT02753881|10051975|FG000|COMPLETED|Overall Study||10
8988822|NCT02753881|10051976|FG001|COMPLETED|Overall Study||10
8988823|NCT02753881|10051977|FG002|COMPLETED|Overall Study||10
8988824|NCT02753881|10051975|FG000|NOT COMPLETED|Overall Study||0
8988825|NCT02753881|10051976|FG001|NOT COMPLETED|Overall Study||0
8633293|NCT00550407|9673364|FG002|STARTED|8-16 Week Preliminary (Open-Label) Phase||0
8633294|NCT00550407|9673362|FG000|COMPLETED|8-16 Week Preliminary (Open-Label) Phase||103
8633295|NCT00550407|9673363|FG001|COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
8633296|NCT00550407|9673364|FG002|COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
8633297|NCT00550407|9673362|FG000|NOT COMPLETED|8-16 Week Preliminary (Open-Label) Phase||112
8633298|NCT00550407|9673363|FG001|NOT COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
8633299|NCT00550407|9673364|FG002|NOT COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
8633300|NCT00550407|9673362|FG000|STARTED|26-Week Randomized Phase||0
8633301|NCT00550407|9673363|FG001|STARTED|26-Week Randomized Phase||58
8633302|NCT00550407|9673364|FG002|STARTED|26-Week Randomized Phase||45
8633303|NCT00550407|9673362|FG000|COMPLETED|26-Week Randomized Phase||0
8633304|NCT00550407|9673363|FG001|COMPLETED|26-Week Randomized Phase||15
8633305|NCT00550407|9673364|FG002|COMPLETED|26-Week Randomized Phase||21
8633306|NCT00550407|9673362|FG000|NOT COMPLETED|26-Week Randomized Phase||0
8633307|NCT00550407|9673363|FG001|NOT COMPLETED|26-Week Randomized Phase||43
8633308|NCT00550407|9673364|FG002|NOT COMPLETED|26-Week Randomized Phase||24
8633309|NCT00550420|9673372|FG000|STARTED|Overall Study||331
8633310|NCT00550420|9673372|FG000|COMPLETED|Overall Study||26
8633311|NCT00550420|9673372|FG000|NOT COMPLETED|Overall Study||305
8633312|NCT00550446|9673385|FG000|STARTED|Up To Week 12||54
8633313|NCT00550446|9673386|FG001|STARTED|Up To Week 12||52
8633314|NCT00550446|9673387|FG002|STARTED|Up To Week 12||50
8633315|NCT00550446|9673388|FG003|STARTED|Up To Week 12||61
8633316|NCT00550446|9673389|FG004|STARTED|Up To Week 12||57
8633317|NCT00550446|9673390|FG005|STARTED|Up To Week 12||53
8633318|NCT00550446|9673391|FG006|STARTED|Up To Week 12||59
8633319|NCT00550446|9673392|FG007|STARTED|Up To Week 12||0
8633320|NCT00550446|9673393|FG008|STARTED|Up To Week 12||0
8878429|NCT01929031|9935374|FG004|NOT COMPLETED|Overall Study||1
8878430|NCT01929031|9935375|FG005|NOT COMPLETED|Overall Study||1
8878431|NCT01929044|9935387|FG000|STARTED|Overall Study||153
8878432|NCT01929044|9935388|FG001|STARTED|Overall Study||146
8878433|NCT01929044|9935387|FG000|COMPLETED|Overall Study||142
8878434|NCT01929044|9935388|FG001|COMPLETED|Overall Study||129
8878435|NCT01929044|9935387|FG000|NOT COMPLETED|Overall Study||11
8878436|NCT01929044|9935388|FG001|NOT COMPLETED|Overall Study||17
8878437|NCT01929057|9935396|FG000|STARTED|Overall Study||31
8878438|NCT01929057|9935397|FG001|STARTED|Overall Study||3
8878439|NCT01929057|9935396|FG000|COMPLETED|Overall Study||31
8878440|NCT01929057|9935397|FG001|COMPLETED|Overall Study||3
8878441|NCT01929057|9935396|FG000|NOT COMPLETED|Overall Study||0
8878442|NCT01929057|9935397|FG001|NOT COMPLETED|Overall Study||0
8633321|NCT00550446|9673394|FG009|STARTED|Up To Week 12||0
8633322|NCT00550446|9673395|FG010|STARTED|Up To Week 12||0
8633323|NCT00550446|9673385|FG000|Treated|Up To Week 12||54
8878443|NCT01929083|9935405|FG000|STARTED|Intervention 1|Number of patients randomized to receive progesterone first|10
8878444|NCT01929083|9935406|FG001|STARTED|Intervention 1||9
8878445|NCT01929083|9935405|FG000|Returned for 1st Ibutilide Administratio|Intervention 1||7
8878446|NCT01929083|9935406|FG001|Returned for 1st Ibutilide Administratio|Intervention 1||9
8878447|NCT01929083|9935405|FG000|COMPLETED|Intervention 1||7
8878448|NCT01929083|9935406|FG001|COMPLETED|Intervention 1||9
8878449|NCT01929083|9935405|FG000|NOT COMPLETED|Intervention 1||3
8878450|NCT01929083|9935406|FG001|NOT COMPLETED|Intervention 1||0
8878451|NCT01929083|9935405|FG000|STARTED|Intervention 2||7
8878452|NCT01929083|9935406|FG001|STARTED|Intervention 2||9
8878453|NCT01929083|9935405|FG000|Returned for 2nd Ibutilide Administratio|Intervention 2||7
8878454|NCT01929083|9935406|FG001|Returned for 2nd Ibutilide Administratio|Intervention 2||8
8878455|NCT01929083|9935405|FG000|COMPLETED|Intervention 2||7
8878456|NCT01929083|9935406|FG001|COMPLETED|Intervention 2||8
8878457|NCT01929083|9935405|FG000|NOT COMPLETED|Intervention 2||0
8878458|NCT01929083|9935406|FG001|NOT COMPLETED|Intervention 2||1
8878459|NCT01929109|9935417|FG000|STARTED|Period 1 (All Groups)||14
8878460|NCT01929109|9935418|FG001|STARTED|Period 1 (All Groups)||8
8878461|NCT01929109|9935419|FG002|STARTED|Period 1 (All Groups)||9
8878462|NCT01929109|9935420|FG003|STARTED|Period 1 (All Groups)||8
8878463|NCT01929109|9935421|FG004|STARTED|Period 1 (All Groups)||8
8878464|NCT01929109|9935417|FG000|COMPLETED|Period 1 (All Groups)||14
8878465|NCT01929109|9935418|FG001|COMPLETED|Period 1 (All Groups)||8
8878466|NCT01929109|9935419|FG002|COMPLETED|Period 1 (All Groups)||8
8878467|NCT01929109|9935420|FG003|COMPLETED|Period 1 (All Groups)||8
8988826|NCT02753881|10051977|FG002|NOT COMPLETED|Overall Study||0
8988827|NCT02753920|10051987|FG000|STARTED|Overall Study||87
8988828|NCT02753920|10051988|FG001|STARTED|Overall Study||86
8988829|NCT02753920|10051987|FG000|COMPLETED|Overall Study||87
8988830|NCT02753920|10051988|FG001|COMPLETED|Overall Study||86
8988831|NCT02753920|10051987|FG000|NOT COMPLETED|Overall Study||0
8988832|NCT02753920|10051988|FG001|NOT COMPLETED|Overall Study||0
8988833|NCT02753946|10052000|FG000|STARTED|Overall Study||233
8988834|NCT02753946|10052001|FG001|STARTED|Overall Study||231
8988835|NCT02753946|10052000|FG000|COMPLETED|Overall Study||219
8988836|NCT02753946|10052001|FG001|COMPLETED|Overall Study||222
8988837|NCT02753946|10052000|FG000|NOT COMPLETED|Overall Study||14
8878468|NCT01929109|9935421|FG004|COMPLETED|Period 1 (All Groups)||8
8878469|NCT01929109|9935417|FG000|NOT COMPLETED|Period 1 (All Groups)||0
8878470|NCT01929109|9935418|FG001|NOT COMPLETED|Period 1 (All Groups)||0
8878471|NCT01929109|9935419|FG002|NOT COMPLETED|Period 1 (All Groups)||1
8878472|NCT01929109|9935420|FG003|NOT COMPLETED|Period 1 (All Groups)||0
8878473|NCT01929109|9935421|FG004|NOT COMPLETED|Period 1 (All Groups)||0
8878474|NCT01929109|9935417|FG000|STARTED|Period 2 (End Stage Renal Disease Only)||0
8878475|NCT01929109|9935418|FG001|STARTED|Period 2 (End Stage Renal Disease Only)||0
8878476|NCT01929109|9935419|FG002|STARTED|Period 2 (End Stage Renal Disease Only)||0
8878477|NCT01929109|9935420|FG003|STARTED|Period 2 (End Stage Renal Disease Only)||0
8878478|NCT01929109|9935421|FG004|STARTED|Period 2 (End Stage Renal Disease Only)||8
8878479|NCT01929109|9935417|FG000|COMPLETED|Period 2 (End Stage Renal Disease Only)||0
8878480|NCT01929109|9935418|FG001|COMPLETED|Period 2 (End Stage Renal Disease Only)||0
8878481|NCT01929109|9935419|FG002|COMPLETED|Period 2 (End Stage Renal Disease Only)||0
8878482|NCT01929109|9935420|FG003|COMPLETED|Period 2 (End Stage Renal Disease Only)||0
8878483|NCT01929109|9935421|FG004|COMPLETED|Period 2 (End Stage Renal Disease Only)||8
8878484|NCT01929109|9935417|FG000|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
8878485|NCT01929109|9935418|FG001|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
8878486|NCT01929109|9935419|FG002|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
8878487|NCT01929109|9935420|FG003|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
8878488|NCT01929109|9935421|FG004|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
8878489|NCT01929135|9935438|FG000|STARTED|Overall Study||19
8878490|NCT01929135|9935439|FG001|STARTED|Overall Study||19
8878491|NCT01929135|9935438|FG000|COMPLETED|Overall Study||18
8878492|NCT01929135|9935439|FG001|COMPLETED|Overall Study||18
8878493|NCT01929135|9935438|FG000|NOT COMPLETED|Overall Study||1
8878494|NCT01929135|9935439|FG001|NOT COMPLETED|Overall Study||1
8878495|NCT01929226|9935449|FG000|STARTED|Overall Study||210
8878496|NCT01929226|9935450|FG001|STARTED|Overall Study||70
8878497|NCT01929226|9935449|FG000|COMPLETED|Overall Study||205
8988838|NCT02753946|10052001|FG001|NOT COMPLETED|Overall Study||9
8988839|NCT02754310|10052009|FG000|STARTED|Overall Study||42
8988840|NCT02754310|10052010|FG001|STARTED|Overall Study||43
8988841|NCT02754310|10052009|FG000|COMPLETED|Overall Study||42
8988842|NCT02754310|10052010|FG001|COMPLETED|Overall Study||43
8988843|NCT02754310|10052009|FG000|NOT COMPLETED|Overall Study||0
8988844|NCT02754310|10052010|FG001|NOT COMPLETED|Overall Study||0
8988845|NCT02754427|10052018|FG000|STARTED|Overall Study||21
8988846|NCT02754427|10052019|FG001|STARTED|Overall Study||20
8988847|NCT02754427|10052018|FG000|COMPLETED|Overall Study||21
8988848|NCT02754427|10052019|FG001|COMPLETED|Overall Study||19
8988849|NCT02754427|10052018|FG000|NOT COMPLETED|Overall Study||0
8988850|NCT02754427|10052019|FG001|NOT COMPLETED|Overall Study||1
8571786|NCT00112437|9604138|FG015|STARTED|Year 1 (12-Month Base Study)||0
8571787|NCT00112437|9604139|FG016|STARTED|Year 1 (12-Month Base Study)||0
8571788|NCT00112437|9604140|FG017|STARTED|Year 1 (12-Month Base Study)||0
8571789|NCT00112437|9604141|FG018|STARTED|Year 1 (12-Month Base Study)||0
8571790|NCT00112437|9604142|FG019|STARTED|Year 1 (12-Month Base Study)||0
8988851|NCT02754440|10052029|FG000|STARTED|Overall Study||99
8571791|NCT00112437|9604143|FG020|STARTED|Year 1 (12-Month Base Study)||0
8988852|NCT02754440|10052030|FG001|STARTED|Overall Study||101
8988853|NCT02754440|10052031|FG002|STARTED|Overall Study||100
8988854|NCT02754440|10052032|FG003|STARTED|Overall Study||35
8988855|NCT02754440|10052029|FG000|COMPLETED|Overall Study||93
8988856|NCT02754440|10052030|FG001|COMPLETED|Overall Study||93
8988857|NCT02754440|10052031|FG002|COMPLETED|Overall Study||93
8988858|NCT02754440|10052032|FG003|COMPLETED|Overall Study||0
8988859|NCT02754440|10052029|FG000|NOT COMPLETED|Overall Study||6
8988860|NCT02754440|10052030|FG001|NOT COMPLETED|Overall Study||8
8988861|NCT02754440|10052031|FG002|NOT COMPLETED|Overall Study||7
8988862|NCT02754440|10052032|FG003|NOT COMPLETED|Overall Study||35
8988863|NCT02754492|10052045|FG000|STARTED|Overall Study||97
8988864|NCT02754492|10052046|FG001|STARTED|Overall Study||95
8988865|NCT02754492|10052047|FG002|STARTED|Overall Study||95
8988866|NCT02754492|10052048|FG003|STARTED|Overall Study||23
8988867|NCT02754492|10052045|FG000|COMPLETED|Overall Study||93
8988868|NCT02754492|10052046|FG001|COMPLETED|Overall Study||93
8988869|NCT02754492|10052047|FG002|COMPLETED|Overall Study||93
8988870|NCT02754492|10052048|FG003|COMPLETED|Overall Study||0
8988871|NCT02754492|10052045|FG000|NOT COMPLETED|Overall Study||4
8988872|NCT02754492|10052046|FG001|NOT COMPLETED|Overall Study||2
8988873|NCT02754492|10052047|FG002|NOT COMPLETED|Overall Study||2
8988874|NCT02754492|10052048|FG003|NOT COMPLETED|Overall Study||23
8988875|NCT02754518|10052057|FG000|STARTED|Overall Study||40
8988876|NCT02754518|10052057|FG000|COMPLETED|Overall Study||40
8988877|NCT02754518|10052057|FG000|NOT COMPLETED|Overall Study||0
8988878|NCT02754570|10052061|FG000|STARTED|Overall Study||27
8988879|NCT02754570|10052061|FG000|Visits 1 and 2 (PGA Only)|Overall Study||27
8988880|NCT02754570|10052061|FG000|Visit 3 (PGA + Pilocarpine)|Overall Study||27
8988881|NCT02754570|10052061|FG000|COMPLETED|Overall Study||27
8988882|NCT02754570|10052061|FG000|NOT COMPLETED|Overall Study||0
8878498|NCT01929226|9935450|FG001|COMPLETED|Overall Study||69
8878499|NCT01929226|9935449|FG000|NOT COMPLETED|Overall Study||5
8878500|NCT01929226|9935450|FG001|NOT COMPLETED|Overall Study||1
8878501|NCT01929291|9935457|FG000|STARTED|Overall Study||672
8878502|NCT01929291|9935457|FG000|COMPLETED|Overall Study||672
8878503|NCT01929291|9935457|FG000|NOT COMPLETED|Overall Study||0
8878504|NCT01929317|9935463|FG000|STARTED|Dose Increase Effect Verification Phase||61
8878505|NCT01929317|9935464|FG001|STARTED|Dose Increase Effect Verification Phase||20
8878506|NCT01929317|9935463|FG000|COMPLETED|Dose Increase Effect Verification Phase||52
8878507|NCT01929317|9935464|FG001|COMPLETED|Dose Increase Effect Verification Phase||19
8878508|NCT01929317|9935463|FG000|NOT COMPLETED|Dose Increase Effect Verification Phase||9
8878509|NCT01929317|9935464|FG001|NOT COMPLETED|Dose Increase Effect Verification Phase||1
8878510|NCT01929317|9935463|FG000|STARTED|Long-term Phase||44
8878511|NCT01929317|9935464|FG001|STARTED|Long-term Phase||18
8878512|NCT01929317|9935463|FG000|COMPLETED|Long-term Phase||25
8878513|NCT01929317|9935464|FG001|COMPLETED|Long-term Phase||14
8878514|NCT01929317|9935463|FG000|NOT COMPLETED|Long-term Phase||19
8878515|NCT01929317|9935464|FG001|NOT COMPLETED|Long-term Phase||4
8878516|NCT01929343|9935479|FG000|STARTED|Overall Study||12
8878517|NCT01929343|9935480|FG001|STARTED|Overall Study||9
8878518|NCT01929343|9935481|FG002|STARTED|Overall Study||12
8878519|NCT01929343|9935479|FG000|COMPLETED|Overall Study||11
8878520|NCT01929343|9935480|FG001|COMPLETED|Overall Study||7
8878521|NCT01929343|9935481|FG002|COMPLETED|Overall Study||12
8878522|NCT01929343|9935479|FG000|NOT COMPLETED|Overall Study||1
8878523|NCT01929343|9935480|FG001|NOT COMPLETED|Overall Study||2
8878524|NCT01929343|9935481|FG002|NOT COMPLETED|Overall Study||0
8878525|NCT01929395|9935492|FG000|STARTED|Overall Study||19
8878526|NCT01929395|9935493|FG001|STARTED|Overall Study||70
8878527|NCT01929395|9935494|FG002|STARTED|Overall Study||70
8878528|NCT01929395|9935492|FG000|COMPLETED|Overall Study||18
8878529|NCT01929395|9935493|FG001|COMPLETED|Overall Study||69
8878530|NCT01929395|9935494|FG002|COMPLETED|Overall Study||69
8878531|NCT01929395|9935492|FG000|NOT COMPLETED|Overall Study||1
8878532|NCT01929395|9935493|FG001|NOT COMPLETED|Overall Study||1
8878533|NCT01929395|9935494|FG002|NOT COMPLETED|Overall Study||1
8878534|NCT01929408|9935502|FG000|STARTED|Overall Study||703
8878535|NCT01929408|9935502|FG000|COMPLETED|Overall Study||695
8878536|NCT01929408|9935502|FG000|NOT COMPLETED|Overall Study||8
8878537|NCT01929460|9935508|FG000|STARTED|Overall Study||13
8878538|NCT01929460|9935509|FG001|STARTED|Overall Study||13
8878539|NCT01929460|9935508|FG000|COMPLETED|Overall Study||13
8878540|NCT01929460|9935509|FG001|COMPLETED|Overall Study||13
8878541|NCT01929460|9935508|FG000|NOT COMPLETED|Overall Study||0
8878542|NCT01929460|9935509|FG001|NOT COMPLETED|Overall Study||0
8878543|NCT01929473|9935515|FG000|STARTED|Overall Study|0 day|3830
8878544|NCT01929473|9935515|FG000|365 Day|Overall Study||3589
8878545|NCT01929473|9935515|FG000|COMPLETED|Overall Study||3243
8988883|NCT02754661|10052069|FG000|STARTED|Overall Study||160
8988884|NCT02754661|10052070|FG001|STARTED|Overall Study||160
8988885|NCT02754661|10052069|FG000|COMPLETED|Overall Study||145
8988886|NCT02754661|10052070|FG001|COMPLETED|Overall Study||141
8988887|NCT02754661|10052069|FG000|NOT COMPLETED|Overall Study||15
8988888|NCT02754661|10052070|FG001|NOT COMPLETED|Overall Study||19
8988889|NCT02754674|10052080|FG000|STARTED|Overall Study||34
8988890|NCT02754674|10052081|FG001|STARTED|Overall Study||33
8988891|NCT02754674|10052080|FG000|COMPLETED|Overall Study||28
8878546|NCT01929473|9935515|FG000|NOT COMPLETED|Overall Study||587
8878547|NCT01929642|9935519|FG000|STARTED|Overall Study||3
8878548|NCT01929642|9935519|FG000|COMPLETED|Overall Study||1
8878549|NCT01929642|9935519|FG000|NOT COMPLETED|Overall Study||2
8988892|NCT02754674|10052081|FG001|COMPLETED|Overall Study||26
8988893|NCT02754674|10052080|FG000|NOT COMPLETED|Overall Study||6
8988894|NCT02754674|10052081|FG001|NOT COMPLETED|Overall Study||7
8988895|NCT02755090|10052089|FG000|STARTED|Overall Study||19
8988896|NCT02755090|10052090|FG001|STARTED|Overall Study||20
8988897|NCT02755090|10052089|FG000|COMPLETED|Overall Study||18
8988898|NCT02755090|10052090|FG001|COMPLETED|Overall Study||20
8988899|NCT02755090|10052089|FG000|NOT COMPLETED|Overall Study||1
8988900|NCT02755090|10052090|FG001|NOT COMPLETED|Overall Study||0
8988901|NCT02755116|10052098|FG000|STARTED|Overall Study||74
8988902|NCT02755116|10052099|FG001|STARTED|Overall Study||70
8988903|NCT02755116|10052098|FG000|COMPLETED|Overall Study||71
8988904|NCT02755116|10052099|FG001|COMPLETED|Overall Study||69
8988905|NCT02755116|10052098|FG000|NOT COMPLETED|Overall Study||3
8988906|NCT02755116|10052099|FG001|NOT COMPLETED|Overall Study||1
8988907|NCT02755129|10052105|FG000|STARTED|Overall Study||15
8988908|NCT02755129|10052105|FG000|COMPLETED|Overall Study||15
8988909|NCT02755129|10052105|FG000|NOT COMPLETED|Overall Study||0
8988910|NCT02755285|10052112|FG000|STARTED|Overall Study||20
8988911|NCT02755285|10052112|FG000|COMPLETED|Overall Study||20
8988912|NCT02755285|10052112|FG000|NOT COMPLETED|Overall Study||0
8988913|NCT02755649|10052119|FG000|STARTED|Overall Study||108
8988914|NCT02755649|10052120|FG001|STARTED|Overall Study||107
8988915|NCT02755649|10052121|FG002|STARTED|Overall Study||110
8988916|NCT02755649|10052119|FG000|Completed Treatment (Week 16)|Overall Study||107
8988917|NCT02755649|10052120|FG001|Completed Treatment (Week 16)|Overall Study||106
8988918|NCT02755649|10052121|FG002|Completed Treatment (Week 16)|Overall Study||109
8988919|NCT02755649|10052119|FG000|Completed Study (Week 28)|Overall Study||7
8988920|NCT02755649|10052120|FG001|Completed Study (Week 28)|Overall Study||8
8988921|NCT02755649|10052121|FG002|Completed Study (Week 28)|Overall Study||8
8988922|NCT02755649|10052119|FG000|COMPLETED|Overall Study||7
8988923|NCT02755649|10052120|FG001|COMPLETED|Overall Study||8
8988924|NCT02755649|10052121|FG002|COMPLETED|Overall Study||8
8988925|NCT02755649|10052119|FG000|NOT COMPLETED|Overall Study||101
8878550|NCT01929681|9935527|FG000|STARTED|Overall Study||28
8878551|NCT01929681|9935528|FG001|STARTED|Overall Study||25
8878552|NCT01929681|9935527|FG000|COMPLETED|Overall Study||26
8878553|NCT01929681|9935528|FG001|COMPLETED|Overall Study||24
8878554|NCT01929681|9935527|FG000|NOT COMPLETED|Overall Study||2
8878555|NCT01929681|9935528|FG001|NOT COMPLETED|Overall Study||1
8878556|NCT01929707|9935534|FG000|STARTED|Intervention Period 1||6
8878557|NCT01929707|9935535|FG001|STARTED|Intervention Period 1||8
8878558|NCT01929707|9935536|FG002|STARTED|Intervention Period 1||12
8878559|NCT01929707|9935537|FG003|STARTED|Intervention Period 1||10
8878560|NCT01929707|9935538|FG004|STARTED|Intervention Period 1||0
8878561|NCT01929707|9935539|FG005|STARTED|Intervention Period 1||0
8878562|NCT01929707|9935540|FG006|STARTED|Intervention Period 1||0
8878563|NCT01929707|9935541|FG007|STARTED|Intervention Period 1||0
8878564|NCT01929707|9935534|FG000|Received at Least 1 Dose of Study Drug|Intervention Period 1||6
8878565|NCT01929707|9935535|FG001|Received at Least 1 Dose of Study Drug|Intervention Period 1||8
8878566|NCT01929707|9935536|FG002|Received at Least 1 Dose of Study Drug|Intervention Period 1||12
8878567|NCT01929707|9935537|FG003|Received at Least 1 Dose of Study Drug|Intervention Period 1||10
8878568|NCT01929707|9935538|FG004|Received at Least 1 Dose of Study Drug|Intervention Period 1||0
8878569|NCT01929707|9935539|FG005|Received at Least 1 Dose of Study Drug|Intervention Period 1||0
8878570|NCT01929707|9935540|FG006|Received at Least 1 Dose of Study Drug|Intervention Period 1||0
8878571|NCT01929707|9935541|FG007|Received at Least 1 Dose of Study Drug|Intervention Period 1||0
8878572|NCT01929707|9935534|FG000|COMPLETED|Intervention Period 1||6
8878573|NCT01929707|9935535|FG001|COMPLETED|Intervention Period 1||8
8878574|NCT01929707|9935536|FG002|COMPLETED|Intervention Period 1||12
8878575|NCT01929707|9935537|FG003|COMPLETED|Intervention Period 1|Two discontinued participants were replaced in Period 2|7
8878576|NCT01929707|9935538|FG004|COMPLETED|Intervention Period 1||0
8878577|NCT01929707|9935539|FG005|COMPLETED|Intervention Period 1||0
8878578|NCT01929707|9935540|FG006|COMPLETED|Intervention Period 1||0
8878579|NCT01929707|9935541|FG007|COMPLETED|Intervention Period 1||0
8878580|NCT01929707|9935534|FG000|NOT COMPLETED|Intervention Period 1||0
8878581|NCT01929707|9935535|FG001|NOT COMPLETED|Intervention Period 1||0
8878582|NCT01929707|9935536|FG002|NOT COMPLETED|Intervention Period 1||0
8878583|NCT01929707|9935537|FG003|NOT COMPLETED|Intervention Period 1||3
8878584|NCT01929707|9935538|FG004|NOT COMPLETED|Intervention Period 1||0
8878585|NCT01929707|9935539|FG005|NOT COMPLETED|Intervention Period 1||0
8878586|NCT01929707|9935540|FG006|NOT COMPLETED|Intervention Period 1||0
8878587|NCT01929707|9935541|FG007|NOT COMPLETED|Intervention Period 1||0
8878588|NCT01929707|9935534|FG000|STARTED|Washout Period ≥7 Days||6
8878589|NCT01929707|9935535|FG001|STARTED|Washout Period ≥7 Days||8
8878590|NCT01929707|9935536|FG002|STARTED|Washout Period ≥7 Days||12
8878591|NCT01929707|9935537|FG003|STARTED|Washout Period ≥7 Days||7
8878592|NCT01929707|9935538|FG004|STARTED|Washout Period ≥7 Days||0
8988926|NCT02755649|10052120|FG001|NOT COMPLETED|Overall Study||99
8988927|NCT02755649|10052121|FG002|NOT COMPLETED|Overall Study||102
8988928|NCT02755805|10052131|FG000|STARTED|Overall Study||15
8988929|NCT02755805|10052132|FG001|STARTED|Overall Study||15
8988930|NCT02755805|10052131|FG000|COMPLETED|Overall Study||13
8988931|NCT02755805|10052132|FG001|COMPLETED|Overall Study||11
8988932|NCT02755805|10052131|FG000|NOT COMPLETED|Overall Study||2
8988933|NCT02755805|10052132|FG001|NOT COMPLETED|Overall Study||4
8988934|NCT02755818|10052142|FG000|STARTED|Overall Study||30
8988935|NCT02755818|10052143|FG001|STARTED|Overall Study||2
8988936|NCT02755818|10052144|FG002|STARTED|Overall Study||2
8988937|NCT02755818|10052145|FG003|STARTED|Overall Study||17
8988938|NCT02755818|10052142|FG000|COMPLETED|Overall Study||30
8988939|NCT02755818|10052143|FG001|COMPLETED|Overall Study||2
8988940|NCT02755818|10052144|FG002|COMPLETED|Overall Study||1
8988941|NCT02755818|10052145|FG003|COMPLETED|Overall Study||14
8988942|NCT02755818|10052142|FG000|NOT COMPLETED|Overall Study||0
8988943|NCT02755818|10052143|FG001|NOT COMPLETED|Overall Study||0
8988944|NCT02755818|10052144|FG002|NOT COMPLETED|Overall Study||1
8988945|NCT02755818|10052145|FG003|NOT COMPLETED|Overall Study||3
8988946|NCT02755831|10052159|FG000|STARTED|Overall Study||100
8988947|NCT02755831|10052160|FG001|STARTED|Overall Study||93
8988948|NCT02755831|10052159|FG000|COMPLETED|Overall Study||97
8988949|NCT02755831|10052160|FG001|COMPLETED|Overall Study||90
8878593|NCT01929707|9935539|FG005|STARTED|Washout Period ≥7 Days||0
8878594|NCT01929707|9935540|FG006|STARTED|Washout Period ≥7 Days||0
8878595|NCT01929707|9935541|FG007|STARTED|Washout Period ≥7 Days||0
8878596|NCT01929707|9935534|FG000|COMPLETED|Washout Period ≥7 Days||6
8878597|NCT01929707|9935535|FG001|COMPLETED|Washout Period ≥7 Days||8
8878598|NCT01929707|9935536|FG002|COMPLETED|Washout Period ≥7 Days||12
8878599|NCT01929707|9935537|FG003|COMPLETED|Washout Period ≥7 Days||7
8878600|NCT01929707|9935538|FG004|COMPLETED|Washout Period ≥7 Days||0
8878601|NCT01929707|9935539|FG005|COMPLETED|Washout Period ≥7 Days||0
8878602|NCT01929707|9935540|FG006|COMPLETED|Washout Period ≥7 Days||0
8878603|NCT01929707|9935541|FG007|COMPLETED|Washout Period ≥7 Days||0
8878604|NCT01929707|9935534|FG000|NOT COMPLETED|Washout Period ≥7 Days||0
8878605|NCT01929707|9935535|FG001|NOT COMPLETED|Washout Period ≥7 Days||0
8878606|NCT01929707|9935536|FG002|NOT COMPLETED|Washout Period ≥7 Days||0
8878607|NCT01929707|9935537|FG003|NOT COMPLETED|Washout Period ≥7 Days||0
8878608|NCT01929707|9935538|FG004|NOT COMPLETED|Washout Period ≥7 Days||0
8878609|NCT01929707|9935539|FG005|NOT COMPLETED|Washout Period ≥7 Days||0
8878610|NCT01929707|9935540|FG006|NOT COMPLETED|Washout Period ≥7 Days||0
8878611|NCT01929707|9935541|FG007|NOT COMPLETED|Washout Period ≥7 Days||0
8878612|NCT01929707|9935534|FG000|STARTED|Intervention Period 2|Incomplete-crossover design|0
8878613|NCT01929707|9935535|FG001|STARTED|Intervention Period 2|Incomplete-crossover design|0
8878614|NCT01929707|9935536|FG002|STARTED|Intervention Period 2|Incomplete-crossover design|0
8878615|NCT01929707|9935537|FG003|STARTED|Intervention Period 2|Incomplete-crossover design|5
8878616|NCT01929707|9935538|FG004|STARTED|Intervention Period 2|Incomplete-crossover design|6
8878617|NCT01929707|9935539|FG005|STARTED|Intervention Period 2|Incomplete-crossover design|8
8878618|NCT01929707|9935540|FG006|STARTED|Intervention Period 2|Incomplete-crossover design|12
8878619|NCT01929707|9935541|FG007|STARTED|Intervention Period 2|Incomplete-crossover design|4
8878620|NCT01929707|9935534|FG000|COMPLETED|Intervention Period 2||0
8878621|NCT01929707|9935535|FG001|COMPLETED|Intervention Period 2||0
8878622|NCT01929707|9935536|FG002|COMPLETED|Intervention Period 2||0
8878623|NCT01929707|9935537|FG003|COMPLETED|Intervention Period 2||5
8878624|NCT01929707|9935538|FG004|COMPLETED|Intervention Period 2||6
8878625|NCT01929707|9935539|FG005|COMPLETED|Intervention Period 2||6
8878626|NCT01929707|9935540|FG006|COMPLETED|Intervention Period 2||12
8878627|NCT01929707|9935541|FG007|COMPLETED|Intervention Period 2||4
8878628|NCT01929707|9935534|FG000|NOT COMPLETED|Intervention Period 2||0
8878629|NCT01929707|9935535|FG001|NOT COMPLETED|Intervention Period 2||0
8878630|NCT01929707|9935536|FG002|NOT COMPLETED|Intervention Period 2||0
8878631|NCT01929707|9935537|FG003|NOT COMPLETED|Intervention Period 2||0
8878632|NCT01929707|9935538|FG004|NOT COMPLETED|Intervention Period 2||0
8878633|NCT01929707|9935539|FG005|NOT COMPLETED|Intervention Period 2||2
8878634|NCT01929707|9935540|FG006|NOT COMPLETED|Intervention Period 2||0
8878635|NCT01929707|9935541|FG007|NOT COMPLETED|Intervention Period 2||0
8878636|NCT01929759|9935562|FG000|STARTED|Overall Study||10
8878637|NCT01929759|9935562|FG000|COMPLETED|Overall Study||10
8878638|NCT01929759|9935562|FG000|NOT COMPLETED|Overall Study||0
8878639|NCT01929863|9935566|FG000|STARTED|Period 1:Intervention Period 1 (7 Days)||7
8878640|NCT01929863|9935567|FG001|STARTED|Period 1:Intervention Period 1 (7 Days)||8
8878641|NCT01929863|9935566|FG000|COMPLETED|Period 1:Intervention Period 1 (7 Days)||6
8878642|NCT01929863|9935567|FG001|COMPLETED|Period 1:Intervention Period 1 (7 Days)||7
8878643|NCT01929863|9935566|FG000|NOT COMPLETED|Period 1:Intervention Period 1 (7 Days)||1
8878644|NCT01929863|9935567|FG001|NOT COMPLETED|Period 1:Intervention Period 1 (7 Days)||1
8878645|NCT01929863|9935566|FG000|STARTED|Period 2:Washout Period (13-15 Days)||6
8878646|NCT01929863|9935567|FG001|STARTED|Period 2:Washout Period (13-15 Days)||7
8878647|NCT01929863|9935566|FG000|COMPLETED|Period 2:Washout Period (13-15 Days)||6
8878648|NCT01929863|9935567|FG001|COMPLETED|Period 2:Washout Period (13-15 Days)||7
8878649|NCT01929863|9935566|FG000|NOT COMPLETED|Period 2:Washout Period (13-15 Days)||0
8988950|NCT02755831|10052159|FG000|NOT COMPLETED|Overall Study||3
8988951|NCT02755831|10052160|FG001|NOT COMPLETED|Overall Study||3
8988952|NCT02755935|10052166|FG000|STARTED|Overall Study||24
8988953|NCT02755935|10052166|FG000|COMPLETED|Overall Study||22
8988954|NCT02755935|10052166|FG000|NOT COMPLETED|Overall Study||2
8988955|NCT02756013|10052170|FG000|STARTED|Overall Study||3
8988956|NCT02756013|10052170|FG000|COMPLETED|Overall Study||1
8988957|NCT02756013|10052170|FG000|NOT COMPLETED|Overall Study||2
8988958|NCT02756078|10052174|FG000|STARTED|Period 1||85
8988959|NCT02756078|10052175|FG001|STARTED|Period 1||86
8988960|NCT02756078|10052174|FG000|COMPLETED|Period 1||76
8988961|NCT02756078|10052175|FG001|COMPLETED|Period 1||64
8988962|NCT02756078|10052174|FG000|NOT COMPLETED|Period 1||9
8988963|NCT02756078|10052175|FG001|NOT COMPLETED|Period 1||22
8988964|NCT02756078|10052174|FG000|STARTED|Period 2||76
8988965|NCT02756078|10052175|FG001|STARTED|Period 2||64
8988966|NCT02756078|10052174|FG000|COMPLETED|Period 2||70
8988967|NCT02756078|10052175|FG001|COMPLETED|Period 2||57
8633324|NCT00550446|9673386|FG001|Treated|Up To Week 12||51
8633325|NCT00550446|9673387|FG002|Treated|Up To Week 12||49
8633326|NCT00550446|9673388|FG003|Treated|Up To Week 12||61
8633327|NCT00550446|9673389|FG004|Treated|Up To Week 12||57
8633328|NCT00550446|9673390|FG005|Treated|Up To Week 12||53
8633329|NCT00550446|9673391|FG006|Treated|Up To Week 12||59
8633330|NCT00550446|9673392|FG007|Treated|Up To Week 12||0
8633331|NCT00550446|9673393|FG008|Treated|Up To Week 12||0
8878650|NCT01929863|9935567|FG001|NOT COMPLETED|Period 2:Washout Period (13-15 Days)||0
8878651|NCT01929863|9935566|FG000|STARTED|Period 3:Intervention Period 2 (7 Days)||6
8878652|NCT01929863|9935567|FG001|STARTED|Period 3:Intervention Period 2 (7 Days)||7
8988968|NCT02756078|10052174|FG000|NOT COMPLETED|Period 2||6
8988969|NCT02756078|10052175|FG001|NOT COMPLETED|Period 2||7
8633332|NCT00550446|9673394|FG009|Treated|Up To Week 12||0
8633333|NCT00550446|9673395|FG010|Treated|Up To Week 12||0
8633334|NCT00550446|9673385|FG000|COMPLETED|Up To Week 12||44
8633335|NCT00550446|9673386|FG001|COMPLETED|Up To Week 12||47
8878653|NCT01929863|9935566|FG000|COMPLETED|Period 3:Intervention Period 2 (7 Days)||6
8988970|NCT02756182|10052181|FG000|STARTED|Overall Study||25
8988971|NCT02756182|10052181|FG000|COMPLETED|Overall Study||21
8988972|NCT02756182|10052181|FG000|NOT COMPLETED|Overall Study||4
8988973|NCT02756338|10052187|FG000|STARTED|Overall Study||77
8988974|NCT02756338|10052187|FG000|COMPLETED|Overall Study||72
8988975|NCT02756338|10052187|FG000|NOT COMPLETED|Overall Study||5
8988976|NCT02756351|10052193|FG000|STARTED|Overall Study||24
8988977|NCT02756351|10052194|FG001|STARTED|Overall Study||24
8988978|NCT02756351|10052193|FG000|COMPLETED|Overall Study||24
8988979|NCT02756351|10052194|FG001|COMPLETED|Overall Study||24
8988980|NCT02756351|10052193|FG000|NOT COMPLETED|Overall Study||0
8988981|NCT02756351|10052194|FG001|NOT COMPLETED|Overall Study||0
8988982|NCT02756364|10052203|FG000|STARTED|Overall Study||46
8988983|NCT02756364|10052204|FG001|STARTED|Overall Study||47
8988984|NCT02756364|10052205|FG002|STARTED|Overall Study||48
8988985|NCT02756364|10052203|FG000|Treated Participants|Overall Study||46
8988986|NCT02756364|10052204|FG001|Treated Participants|Overall Study||47
8988987|NCT02756364|10052205|FG002|Treated Participants|Overall Study||47
8988988|NCT02756364|10052203|FG000|COMPLETED|Overall Study||0
8988989|NCT02756364|10052204|FG001|COMPLETED|Overall Study||0
8988990|NCT02756364|10052205|FG002|COMPLETED|Overall Study||0
8988991|NCT02756364|10052203|FG000|NOT COMPLETED|Overall Study||46
8988992|NCT02756364|10052204|FG001|NOT COMPLETED|Overall Study||47
8988993|NCT02756364|10052205|FG002|NOT COMPLETED|Overall Study||48
8988994|NCT02756572|10052213|FG000|STARTED|Overall Study||30
8988995|NCT02756572|10052213|FG000|COMPLETED|Overall Study||30
8988996|NCT02756572|10052213|FG000|NOT COMPLETED|Overall Study||0
8988997|NCT02756624|10052224|FG000|STARTED|Overall Study||343
8988998|NCT02756624|10052225|FG001|STARTED|Overall Study||173
8988999|NCT02756624|10052224|FG000|COMPLETED|Overall Study||327
8989000|NCT02756624|10052225|FG001|COMPLETED|Overall Study||166
8989001|NCT02756624|10052224|FG000|NOT COMPLETED|Overall Study||16
8989002|NCT02756624|10052225|FG001|NOT COMPLETED|Overall Study||7
8989003|NCT02756637|10052233|FG000|STARTED|Overall Study||317
8878654|NCT01929863|9935567|FG001|COMPLETED|Period 3:Intervention Period 2 (7 Days)||6
8878655|NCT01929863|9935566|FG000|NOT COMPLETED|Period 3:Intervention Period 2 (7 Days)||0
8878656|NCT01929863|9935567|FG001|NOT COMPLETED|Period 3:Intervention Period 2 (7 Days)||1
8878657|NCT01929863|9935566|FG000|STARTED|Period 4:Follow-up-Metformin (7-10 Days)||6
8878658|NCT01929863|9935567|FG001|STARTED|Period 4:Follow-up-Metformin (7-10 Days)||6
8878659|NCT01929863|9935566|FG000|COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||0
8989004|NCT02756637|10052234|FG001|STARTED|Overall Study||317
8989005|NCT02756637|10052233|FG000|Eligible for SWOG 8710|Overall Study||307
8633336|NCT00550446|9673387|FG002|COMPLETED|Up To Week 12||46
8633337|NCT00550446|9673388|FG003|COMPLETED|Up To Week 12||58
8989006|NCT02756637|10052234|FG001|Eligible for SWOG 8710|Overall Study||307
8989007|NCT02756637|10052233|FG000|Had NLR Value|Overall Study||263
8989008|NCT02756637|10052234|FG001|Had NLR Value|Overall Study||263
8989009|NCT02756637|10052233|FG000|Completed Curative Treatment|Overall Study||230
8989010|NCT02756637|10052234|FG001|Completed Curative Treatment|Overall Study||0
8989011|NCT02756637|10052233|FG000|COMPLETED|Overall Study||230
8989012|NCT02756637|10052234|FG001|COMPLETED|Overall Study||263
8989013|NCT02756637|10052233|FG000|NOT COMPLETED|Overall Study||87
8989014|NCT02756637|10052234|FG001|NOT COMPLETED|Overall Study||54
8989015|NCT02756650|10052240|FG000|STARTED|Overall Study||8
8989016|NCT02756650|10052240|FG000|COMPLETED|Overall Study||6
8989017|NCT02756650|10052240|FG000|NOT COMPLETED|Overall Study||2
8989018|NCT02756689|10052246|FG000|STARTED|Overall Study||64
8989019|NCT02756689|10052247|FG001|STARTED|Overall Study||65
8989020|NCT02756689|10052246|FG000|COMPLETED|Overall Study||64
8989021|NCT02756689|10052247|FG001|COMPLETED|Overall Study||65
8989022|NCT02756689|10052246|FG000|NOT COMPLETED|Overall Study||0
8989023|NCT02756689|10052247|FG001|NOT COMPLETED|Overall Study||0
8989024|NCT02756819|10052287|FG000|STARTED|Overall Study||1945
8989025|NCT02756819|10052287|FG000|Per-protocol Set (PPS)|Overall Study|Participants who were enrolled, received Edarbi® therapy and did not have major protocol deviations.|1724
8989026|NCT02756819|10052287|FG000|Safety Analysis Set (SAS)|Overall Study|Participants who received at least one dose of Edarbi® therapy and had any follow-up data.|1934
8989027|NCT02756819|10052287|FG000|COMPLETED|Overall Study||1893
8989028|NCT02756819|10052287|FG000|NOT COMPLETED|Overall Study||52
8989029|NCT02756832|10052291|FG000|STARTED|Overall Study||1409
8989030|NCT02756832|10052291|FG000|Received Therapy|Overall Study||1393
8989031|NCT02756832|10052291|FG000|Included in Efficacy and Safety Analysis|Overall Study||1399
8989032|NCT02756832|10052291|FG000|COMPLETED|Overall Study||1356
8989033|NCT02756832|10052291|FG000|NOT COMPLETED|Overall Study||53
8989034|NCT02756910|10052295|FG000|STARTED|Overall Study||80
8989035|NCT02756910|10052295|FG000|COMPLETED|Overall Study||80
8989036|NCT02756910|10052295|FG000|NOT COMPLETED|Overall Study||0
8633338|NCT00550446|9673389|FG004|COMPLETED|Up To Week 12||54
8633339|NCT00550446|9673390|FG005|COMPLETED|Up To Week 12||45
8878660|NCT01929863|9935567|FG001|COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||0
8878661|NCT01929863|9935566|FG000|NOT COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||6
8878662|NCT01929863|9935567|FG001|NOT COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||6
8878663|NCT01929876|9935578|FG000|STARTED|Period 1||16
8878664|NCT01929876|9935578|FG000|COMPLETED|Period 1||16
8878665|NCT01929876|9935578|FG000|NOT COMPLETED|Period 1||0
8878666|NCT01929876|9935578|FG000|STARTED|Period 2||16
8878667|NCT01929876|9935578|FG000|COMPLETED|Period 2||15
8878668|NCT01929876|9935578|FG000|NOT COMPLETED|Period 2||1
8878669|NCT01929889|9935582|FG000|STARTED|Overall Study|Target enrollment goal was 20 completed subjects.|8
8878670|NCT01929889|9935582|FG000|COMPLETED|Overall Study|3 subjects completed the study.|3
8878671|NCT01929889|9935582|FG000|NOT COMPLETED|Overall Study||5
8878672|NCT01929980|9935586|FG000|STARTED|Overall Study||4
8878673|NCT01929980|9935586|FG000|COMPLETED|Overall Study||3
8878674|NCT01929980|9935586|FG000|NOT COMPLETED|Overall Study||1
8878675|NCT01929993|9935592|FG000|STARTED|Overall Study||82
8878676|NCT01929993|9935593|FG001|STARTED|Overall Study||82
8878677|NCT01929993|9935592|FG000|COMPLETED|Overall Study||52
8878678|NCT01929993|9935593|FG001|COMPLETED|Overall Study||54
8878679|NCT01929993|9935592|FG000|NOT COMPLETED|Overall Study||30
8878680|NCT01929993|9935593|FG001|NOT COMPLETED|Overall Study||28
8878681|NCT01930045|9935599|FG000|STARTED|Part 1 - Period 1||3
8878682|NCT01930045|9935600|FG001|STARTED|Part 1 - Period 1||3
8878683|NCT01930045|9935601|FG002|STARTED|Part 1 - Period 1||3
8989037|NCT02756949|10052301|FG000|STARTED|Overall Study||181
8989038|NCT02756949|10052302|FG001|STARTED|Overall Study||172
8989039|NCT02756949|10052301|FG000|COMPLETED|Overall Study||181
8989040|NCT02756949|10052302|FG001|COMPLETED|Overall Study||164
8989041|NCT02756949|10052301|FG000|NOT COMPLETED|Overall Study||0
8989042|NCT02756949|10052302|FG001|NOT COMPLETED|Overall Study||8
8989043|NCT02757092|10052310|FG000|STARTED|Overall Study|Random assignment was to encode subjects from opaque envelopes and sealed, on the day of discharge|18
8989044|NCT02757092|10052311|FG001|STARTED|Overall Study|Random assignment was to encode subjects from opaque envelopes and sealed, on the day of discharge|18
8989045|NCT02757092|10052310|FG000|COMPLETED|Overall Study|All subjects completed the study|18
8989046|NCT02757092|10052311|FG001|COMPLETED|Overall Study|All subjects completed the study|18
8989047|NCT02757092|10052310|FG000|NOT COMPLETED|Overall Study||0
8989048|NCT02757092|10052311|FG001|NOT COMPLETED|Overall Study||0
8989049|NCT02757105|10052377|FG000|STARTED|Overall Study||75
8989050|NCT02757105|10052378|FG001|STARTED|Overall Study||52
8989051|NCT02757105|10052377|FG000|Treated|Overall Study||75
8989052|NCT02757105|10052378|FG001|Treated|Overall Study||51
8989053|NCT02757105|10052377|FG000|COMPLETED|Overall Study||63
8989054|NCT02757105|10052378|FG001|COMPLETED|Overall Study||41
8989055|NCT02757105|10052377|FG000|NOT COMPLETED|Overall Study||12
8989056|NCT02757105|10052378|FG001|NOT COMPLETED|Overall Study||11
8989057|NCT02757326|10052388|FG000|STARTED|Overall Study||3
8633340|NCT00550446|9673391|FG006|COMPLETED|Up To Week 12||46
8633341|NCT00550446|9673392|FG007|COMPLETED|Up To Week 12||0
8633342|NCT00550446|9673393|FG008|COMPLETED|Up To Week 12||0
8633343|NCT00550446|9673394|FG009|COMPLETED|Up To Week 12||0
8633344|NCT00550446|9673395|FG010|COMPLETED|Up To Week 12||0
8633345|NCT00550446|9673385|FG000|NOT COMPLETED|Up To Week 12||10
8633346|NCT00550446|9673386|FG001|NOT COMPLETED|Up To Week 12||5
8633347|NCT00550446|9673387|FG002|NOT COMPLETED|Up To Week 12||4
8633348|NCT00550446|9673388|FG003|NOT COMPLETED|Up To Week 12||3
8878684|NCT01930045|9935602|FG003|STARTED|Part 1 - Period 1||3
8878685|NCT01930045|9935603|FG004|STARTED|Part 1 - Period 1||3
8878686|NCT01930045|9935604|FG005|STARTED|Part 1 - Period 1||3
8989058|NCT02757326|10052389|FG001|STARTED|Overall Study||4
8989059|NCT02757326|10052390|FG002|STARTED|Overall Study||6
8989060|NCT02757326|10052388|FG000|COMPLETED|Overall Study||3
8989061|NCT02757326|10052389|FG001|COMPLETED|Overall Study||4
8989062|NCT02757326|10052390|FG002|COMPLETED|Overall Study||6
8989063|NCT02757326|10052388|FG000|NOT COMPLETED|Overall Study||0
8989064|NCT02757326|10052389|FG001|NOT COMPLETED|Overall Study||0
8989065|NCT02757326|10052390|FG002|NOT COMPLETED|Overall Study||0
8633349|NCT00550446|9673389|FG004|NOT COMPLETED|Up To Week 12||3
8633350|NCT00550446|9673390|FG005|NOT COMPLETED|Up To Week 12||8
8989066|NCT02757352|10052405|FG000|STARTED|Double-Blind Period (Week 0 - Week 16)||105
8989067|NCT02757352|10052406|FG001|STARTED|Double-Blind Period (Week 0 - Week 16)||96
8989068|NCT02757352|10052407|FG002|STARTED|Double-Blind Period (Week 0 - Week 16)||102
8989069|NCT02757352|10052408|FG003|STARTED|Double-Blind Period (Week 0 - Week 16)||0
8989070|NCT02757352|10052409|FG004|STARTED|Double-Blind Period (Week 0 - Week 16)||0
8878687|NCT01930045|9935599|FG000|COMPLETED|Part 1 - Period 1||3
8878688|NCT01930045|9935600|FG001|COMPLETED|Part 1 - Period 1||3
8878689|NCT01930045|9935601|FG002|COMPLETED|Part 1 - Period 1||3
8878690|NCT01930045|9935602|FG003|COMPLETED|Part 1 - Period 1||3
8878691|NCT01930045|9935603|FG004|COMPLETED|Part 1 - Period 1||3
8878692|NCT01930045|9935604|FG005|COMPLETED|Part 1 - Period 1||3
8878693|NCT01930045|9935599|FG000|NOT COMPLETED|Part 1 - Period 1||0
8878694|NCT01930045|9935600|FG001|NOT COMPLETED|Part 1 - Period 1||0
8878695|NCT01930045|9935601|FG002|NOT COMPLETED|Part 1 - Period 1||0
8878696|NCT01930045|9935602|FG003|NOT COMPLETED|Part 1 - Period 1||0
8878697|NCT01930045|9935603|FG004|NOT COMPLETED|Part 1 - Period 1||0
8878698|NCT01930045|9935604|FG005|NOT COMPLETED|Part 1 - Period 1||0
8878699|NCT01930045|9935599|FG000|STARTED|Part 1 - Period 2||3
8878700|NCT01930045|9935600|FG001|STARTED|Part 1 - Period 2||3
8878701|NCT01930045|9935601|FG002|STARTED|Part 1 - Period 2||3
8878702|NCT01930045|9935602|FG003|STARTED|Part 1 - Period 2||3
8878703|NCT01930045|9935603|FG004|STARTED|Part 1 - Period 2||3
8878704|NCT01930045|9935604|FG005|STARTED|Part 1 - Period 2||3
8878705|NCT01930045|9935599|FG000|COMPLETED|Part 1 - Period 2||3
8878706|NCT01930045|9935600|FG001|COMPLETED|Part 1 - Period 2||3
8878707|NCT01930045|9935601|FG002|COMPLETED|Part 1 - Period 2||3
8878708|NCT01930045|9935602|FG003|COMPLETED|Part 1 - Period 2||3
8878709|NCT01930045|9935603|FG004|COMPLETED|Part 1 - Period 2||3
8878710|NCT01930045|9935604|FG005|COMPLETED|Part 1 - Period 2||3
8878711|NCT01930045|9935599|FG000|NOT COMPLETED|Part 1 - Period 2||0
8878712|NCT01930045|9935600|FG001|NOT COMPLETED|Part 1 - Period 2||0
8878713|NCT01930045|9935601|FG002|NOT COMPLETED|Part 1 - Period 2||0
8878714|NCT01930045|9935602|FG003|NOT COMPLETED|Part 1 - Period 2||0
8878715|NCT01930045|9935603|FG004|NOT COMPLETED|Part 1 - Period 2||0
8878716|NCT01930045|9935604|FG005|NOT COMPLETED|Part 1 - Period 2||0
8878717|NCT01930045|9935599|FG000|STARTED|Part 1 - Period 3||3
8878718|NCT01930045|9935600|FG001|STARTED|Part 1 - Period 3||3
8878719|NCT01930045|9935601|FG002|STARTED|Part 1 - Period 3|One participant missed treatment during Period 3 only.|2
8878720|NCT01930045|9935602|FG003|STARTED|Part 1 - Period 3||3
8878721|NCT01930045|9935603|FG004|STARTED|Part 1 - Period 3||3
8878722|NCT01930045|9935604|FG005|STARTED|Part 1 - Period 3||3
8878723|NCT01930045|9935599|FG000|COMPLETED|Part 1 - Period 3||3
8878724|NCT01930045|9935600|FG001|COMPLETED|Part 1 - Period 3||3
8878725|NCT01930045|9935601|FG002|COMPLETED|Part 1 - Period 3||2
8878726|NCT01930045|9935602|FG003|COMPLETED|Part 1 - Period 3||3
8878727|NCT01930045|9935603|FG004|COMPLETED|Part 1 - Period 3||3
8878728|NCT01930045|9935604|FG005|COMPLETED|Part 1 - Period 3||3
8878729|NCT01930045|9935599|FG000|NOT COMPLETED|Part 1 - Period 3||0
8878730|NCT01930045|9935600|FG001|NOT COMPLETED|Part 1 - Period 3||0
8878731|NCT01930045|9935601|FG002|NOT COMPLETED|Part 1 - Period 3||0
8878732|NCT01930045|9935602|FG003|NOT COMPLETED|Part 1 - Period 3||0
8878733|NCT01930045|9935603|FG004|NOT COMPLETED|Part 1 - Period 3||0
8878734|NCT01930045|9935604|FG005|NOT COMPLETED|Part 1 - Period 3||0
8878735|NCT01930045|9935599|FG000|STARTED|Pause (up to 37 Days)||3
8878736|NCT01930045|9935600|FG001|STARTED|Pause (up to 37 Days)||3
8878737|NCT01930045|9935601|FG002|STARTED|Pause (up to 37 Days)|The participant who missed treatment in Period 3, resumed the study|3
8878738|NCT01930045|9935602|FG003|STARTED|Pause (up to 37 Days)||3
8989071|NCT02757352|10052410|FG005|STARTED|Double-Blind Period (Week 0 - Week 16)||0
8989072|NCT02757352|10052411|FG006|STARTED|Double-Blind Period (Week 0 - Week 16)||0
8989073|NCT02757352|10052412|FG007|STARTED|Double-Blind Period (Week 0 - Week 16)||0
8989074|NCT02757352|10052413|FG008|STARTED|Double-Blind Period (Week 0 - Week 16)||0
8989075|NCT02757352|10052414|FG009|STARTED|Double-Blind Period (Week 0 - Week 16)||0
8989076|NCT02757352|10052405|FG000|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||104
8989077|NCT02757352|10052406|FG001|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||96
8989078|NCT02757352|10052407|FG002|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||102
8989079|NCT02757352|10052408|FG003|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
8989080|NCT02757352|10052409|FG004|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
8989081|NCT02757352|10052410|FG005|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
8989082|NCT02757352|10052411|FG006|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
8989083|NCT02757352|10052412|FG007|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
8989084|NCT02757352|10052413|FG008|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
8989085|NCT02757352|10052414|FG009|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
8989086|NCT02757352|10052405|FG000|COMPLETED|Double-Blind Period (Week 0 - Week 16)||97
8989087|NCT02757352|10052406|FG001|COMPLETED|Double-Blind Period (Week 0 - Week 16)||95
8989088|NCT02757352|10052407|FG002|COMPLETED|Double-Blind Period (Week 0 - Week 16)||98
8989089|NCT02757352|10052408|FG003|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
8989090|NCT02757352|10052409|FG004|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
9038964|NCT03334747|10100043|FG007|COMPLETED|Follow-Up Phase||22
8878739|NCT01930045|9935603|FG004|STARTED|Pause (up to 37 Days)||3
8878740|NCT01930045|9935604|FG005|STARTED|Pause (up to 37 Days)||3
8989091|NCT02757352|10052410|FG005|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
8989092|NCT02757352|10052411|FG006|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
8989093|NCT02757352|10052412|FG007|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
8989094|NCT02757352|10052413|FG008|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
8633351|NCT00550446|9673391|FG006|NOT COMPLETED|Up To Week 12||13
8878741|NCT01930045|9935599|FG000|COMPLETED|Pause (up to 37 Days)||3
8878742|NCT01930045|9935600|FG001|COMPLETED|Pause (up to 37 Days)||3
8878743|NCT01930045|9935601|FG002|COMPLETED|Pause (up to 37 Days)||3
8878744|NCT01930045|9935602|FG003|COMPLETED|Pause (up to 37 Days)||3
8878745|NCT01930045|9935603|FG004|COMPLETED|Pause (up to 37 Days)||3
8878746|NCT01930045|9935604|FG005|COMPLETED|Pause (up to 37 Days)||1
8878747|NCT01930045|9935599|FG000|NOT COMPLETED|Pause (up to 37 Days)||0
8878748|NCT01930045|9935600|FG001|NOT COMPLETED|Pause (up to 37 Days)||0
8878749|NCT01930045|9935601|FG002|NOT COMPLETED|Pause (up to 37 Days)||0
8878750|NCT01930045|9935602|FG003|NOT COMPLETED|Pause (up to 37 Days)||0
8878751|NCT01930045|9935603|FG004|NOT COMPLETED|Pause (up to 37 Days)||0
8878752|NCT01930045|9935604|FG005|NOT COMPLETED|Pause (up to 37 Days)||2
8878753|NCT01930045|9935599|FG000|STARTED|Part 2 - Period 4||3
8878754|NCT01930045|9935600|FG001|STARTED|Part 2 - Period 4||3
8878755|NCT01930045|9935601|FG002|STARTED|Part 2 - Period 4||3
8878756|NCT01930045|9935602|FG003|STARTED|Part 2 - Period 4||3
8878757|NCT01930045|9935603|FG004|STARTED|Part 2 - Period 4||3
8878758|NCT01930045|9935604|FG005|STARTED|Part 2 - Period 4||1
8878759|NCT01930045|9935599|FG000|COMPLETED|Part 2 - Period 4||3
8878760|NCT01930045|9935600|FG001|COMPLETED|Part 2 - Period 4||3
8878761|NCT01930045|9935601|FG002|COMPLETED|Part 2 - Period 4||3
8878762|NCT01930045|9935602|FG003|COMPLETED|Part 2 - Period 4||3
8878763|NCT01930045|9935603|FG004|COMPLETED|Part 2 - Period 4||3
8878764|NCT01930045|9935604|FG005|COMPLETED|Part 2 - Period 4||1
8878765|NCT01930045|9935599|FG000|NOT COMPLETED|Part 2 - Period 4||0
8878766|NCT01930045|9935600|FG001|NOT COMPLETED|Part 2 - Period 4||0
8878767|NCT01930045|9935601|FG002|NOT COMPLETED|Part 2 - Period 4||0
8878768|NCT01930045|9935602|FG003|NOT COMPLETED|Part 2 - Period 4||0
8878769|NCT01930045|9935603|FG004|NOT COMPLETED|Part 2 - Period 4||0
8878770|NCT01930045|9935604|FG005|NOT COMPLETED|Part 2 - Period 4||0
8878771|NCT01930045|9935599|FG000|STARTED|Part 2 - Period 5||3
8878772|NCT01930045|9935600|FG001|STARTED|Part 2 - Period 5||3
8878773|NCT01930045|9935601|FG002|STARTED|Part 2 - Period 5||3
8878774|NCT01930045|9935602|FG003|STARTED|Part 2 - Period 5||3
8878775|NCT01930045|9935603|FG004|STARTED|Part 2 - Period 5||3
8878776|NCT01930045|9935604|FG005|STARTED|Part 2 - Period 5||1
8878777|NCT01930045|9935599|FG000|COMPLETED|Part 2 - Period 5||3
8878778|NCT01930045|9935600|FG001|COMPLETED|Part 2 - Period 5||3
8878779|NCT01930045|9935601|FG002|COMPLETED|Part 2 - Period 5||3
8878780|NCT01930045|9935602|FG003|COMPLETED|Part 2 - Period 5||3
8878781|NCT01930045|9935603|FG004|COMPLETED|Part 2 - Period 5||3
8878782|NCT01930045|9935604|FG005|COMPLETED|Part 2 - Period 5||1
8878783|NCT01930045|9935599|FG000|NOT COMPLETED|Part 2 - Period 5||0
8878784|NCT01930045|9935600|FG001|NOT COMPLETED|Part 2 - Period 5||0
8878785|NCT01930045|9935601|FG002|NOT COMPLETED|Part 2 - Period 5||0
8878786|NCT01930045|9935602|FG003|NOT COMPLETED|Part 2 - Period 5||0
8878787|NCT01930045|9935603|FG004|NOT COMPLETED|Part 2 - Period 5||0
8878788|NCT01930045|9935604|FG005|NOT COMPLETED|Part 2 - Period 5||0
8878789|NCT01930058|9935619|FG000|STARTED|Overall Study||3
8878790|NCT01930058|9935620|FG001|STARTED|Overall Study||3
8878791|NCT01930058|9935621|FG002|STARTED|Overall Study||3
8878792|NCT01930058|9935619|FG000|COMPLETED|Overall Study||3
8878793|NCT01930058|9935620|FG001|COMPLETED|Overall Study||3
8878794|NCT01930058|9935621|FG002|COMPLETED|Overall Study||3
8878795|NCT01930058|9935619|FG000|NOT COMPLETED|Overall Study||0
8878796|NCT01930058|9935620|FG001|NOT COMPLETED|Overall Study||0
8878797|NCT01930058|9935621|FG002|NOT COMPLETED|Overall Study||0
8878798|NCT01930162|9935628|FG000|STARTED|Overall Study||9
8878799|NCT01930162|9935628|FG000|COMPLETED|Overall Study||4
8878800|NCT01930162|9935628|FG000|NOT COMPLETED|Overall Study||5
8989095|NCT02757352|10052414|FG009|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
8989096|NCT02757352|10052405|FG000|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||8
8989097|NCT02757352|10052406|FG001|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||1
8989098|NCT02757352|10052407|FG002|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||4
8989099|NCT02757352|10052408|FG003|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
8989100|NCT02757352|10052409|FG004|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
8989101|NCT02757352|10052410|FG005|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
8989102|NCT02757352|10052411|FG006|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
8989103|NCT02757352|10052412|FG007|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
8989104|NCT02757352|10052413|FG008|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
8989105|NCT02757352|10052414|FG009|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
8989106|NCT02757352|10052405|FG000|STARTED|Double-Blind Period (Week 16 - Week 52)||97
8989107|NCT02757352|10052406|FG001|STARTED|Double-Blind Period (Week 16 - Week 52)||95
8989108|NCT02757352|10052407|FG002|STARTED|Double-Blind Period (Week 16 - Week 52)||98
8989109|NCT02757352|10052408|FG003|STARTED|Double-Blind Period (Week 16 - Week 52)||0
8989110|NCT02757352|10052409|FG004|STARTED|Double-Blind Period (Week 16 - Week 52)||0
8989111|NCT02757352|10052410|FG005|STARTED|Double-Blind Period (Week 16 - Week 52)||0
8633352|NCT00550446|9673392|FG007|NOT COMPLETED|Up To Week 12||0
8989112|NCT02757352|10052411|FG006|STARTED|Double-Blind Period (Week 16 - Week 52)||0
8989113|NCT02757352|10052412|FG007|STARTED|Double-Blind Period (Week 16 - Week 52)||0
8989114|NCT02757352|10052413|FG008|STARTED|Double-Blind Period (Week 16 - Week 52)||0
8989115|NCT02757352|10052414|FG009|STARTED|Double-Blind Period (Week 16 - Week 52)||0
8989116|NCT02757352|10052405|FG000|COMPLETED|Double-Blind Period (Week 16 - Week 52)||34
8878801|NCT01930175|9935636|FG000|STARTED|Core Study||7
8878802|NCT01930175|9935637|FG001|STARTED|Core Study||2
8878803|NCT01930175|9935638|FG002|STARTED|Core Study||4
8878804|NCT01930175|9935636|FG000|Safety Analysis Set|Core Study||7
8878805|NCT01930175|9935637|FG001|Safety Analysis Set|Core Study||2
8878806|NCT01930175|9935638|FG002|Safety Analysis Set|Core Study||4
8878807|NCT01930175|9935636|FG000|Pharmacokinetics (PK) Analysis Set|Core Study||7
8878808|NCT01930175|9935637|FG001|Pharmacokinetics (PK) Analysis Set|Core Study||2
8878809|NCT01930175|9935638|FG002|Pharmacokinetics (PK) Analysis Set|Core Study|Placebo patients were excluded from the PK analyses|0
8878810|NCT01930175|9935636|FG000|COMPLETED|Core Study||7
8878811|NCT01930175|9935637|FG001|COMPLETED|Core Study||1
8878812|NCT01930175|9935638|FG002|COMPLETED|Core Study||3
8878813|NCT01930175|9935636|FG000|NOT COMPLETED|Core Study||0
8878814|NCT01930175|9935637|FG001|NOT COMPLETED|Core Study||1
8878815|NCT01930175|9935638|FG002|NOT COMPLETED|Core Study||1
8878816|NCT01930175|9935636|FG000|STARTED|Open Label VAY736 10 mg/kg at Week 24|Only patients originally randomized to Placebo were allowed to enter this Period.|0
8878817|NCT01930175|9935637|FG001|STARTED|Open Label VAY736 10 mg/kg at Week 24|Only patients originally randomized to Placebo were allowed to enter this Period.|0
8878818|NCT01930175|9935638|FG002|STARTED|Open Label VAY736 10 mg/kg at Week 24|Only patients originally randomized to Placebo were allowed to enter this Period.|3
8878819|NCT01930175|9935636|FG000|COMPLETED|Open Label VAY736 10 mg/kg at Week 24||0
8878820|NCT01930175|9935637|FG001|COMPLETED|Open Label VAY736 10 mg/kg at Week 24||0
8878821|NCT01930175|9935638|FG002|COMPLETED|Open Label VAY736 10 mg/kg at Week 24||3
8878822|NCT01930175|9935636|FG000|NOT COMPLETED|Open Label VAY736 10 mg/kg at Week 24||0
8878823|NCT01930175|9935637|FG001|NOT COMPLETED|Open Label VAY736 10 mg/kg at Week 24||0
8878824|NCT01930175|9935638|FG002|NOT COMPLETED|Open Label VAY736 10 mg/kg at Week 24||0
8878825|NCT01930188|9935650|FG000|STARTED|Overall Study||409
8878826|NCT01930188|9935651|FG001|STARTED|Overall Study||409
8878827|NCT01930188|9935652|FG002|STARTED|Overall Study||407
8878828|NCT01930188|9935650|FG000|Premature Discontinuation of Treatment|Overall Study|Subjects prematurely discontinued treatment were allowed to continue participation in the trial.|53
8878829|NCT01930188|9935651|FG001|Premature Discontinuation of Treatment|Overall Study|Subjects prematurely discontinued treatment were allowed to continue participation in the trial.|61
8878830|NCT01930188|9935652|FG002|Premature Discontinuation of Treatment|Overall Study|Subjects prematurely discontinued treatment were allowed to continue participation in the trial.|32
8878831|NCT01930188|9935650|FG000|COMPLETED|Overall Study||387
8878832|NCT01930188|9935651|FG001|COMPLETED|Overall Study||388
8878833|NCT01930188|9935652|FG002|COMPLETED|Overall Study||388
8878834|NCT01930188|9935650|FG000|NOT COMPLETED|Overall Study||22
8878835|NCT01930188|9935651|FG001|NOT COMPLETED|Overall Study||21
8878836|NCT01930188|9935652|FG002|NOT COMPLETED|Overall Study||19
8878837|NCT01930214|9935664|FG000|STARTED|Overall Study||100
8878838|NCT01930214|9935665|FG001|STARTED|Overall Study||117
8878839|NCT01930214|9935666|FG002|STARTED|Overall Study||133
8878840|NCT01930214|9935664|FG000|COMPLETED|Overall Study||80
8878841|NCT01930214|9935665|FG001|COMPLETED|Overall Study||96
8878842|NCT01930214|9935666|FG002|COMPLETED|Overall Study||108
8878843|NCT01930214|9935664|FG000|NOT COMPLETED|Overall Study||20
8878844|NCT01930214|9935665|FG001|NOT COMPLETED|Overall Study||21
8878845|NCT01930214|9935666|FG002|NOT COMPLETED|Overall Study||25
8878846|NCT01930435|9935674|FG000|STARTED|Overall Study||20
8878847|NCT01930435|9935674|FG000|COMPLETED|Overall Study||20
8878848|NCT01930435|9935674|FG000|NOT COMPLETED|Overall Study||0
8878849|NCT01930487|9935679|FG000|STARTED|First Intervention (30 Days)||21
8878850|NCT01930487|9935680|FG001|STARTED|First Intervention (30 Days)||25
8878851|NCT01930487|9935679|FG000|COMPLETED|First Intervention (30 Days)||19
8878852|NCT01930487|9935680|FG001|COMPLETED|First Intervention (30 Days)||23
8878853|NCT01930487|9935679|FG000|NOT COMPLETED|First Intervention (30 Days)||2
8878854|NCT01930487|9935680|FG001|NOT COMPLETED|First Intervention (30 Days)||2
8878855|NCT01930487|9935679|FG000|STARTED|Washout Period (3 Weeks)||19
8878856|NCT01930487|9935680|FG001|STARTED|Washout Period (3 Weeks)||23
8878857|NCT01930487|9935679|FG000|COMPLETED|Washout Period (3 Weeks)||19
8878858|NCT01930487|9935680|FG001|COMPLETED|Washout Period (3 Weeks)||23
8878859|NCT01930487|9935679|FG000|NOT COMPLETED|Washout Period (3 Weeks)||0
8878860|NCT01930487|9935680|FG001|NOT COMPLETED|Washout Period (3 Weeks)||0
8878861|NCT01930487|9935679|FG000|STARTED|Second Intervention (30 Days)||19
8878862|NCT01930487|9935680|FG001|STARTED|Second Intervention (30 Days)||23
8878863|NCT01930487|9935679|FG000|COMPLETED|Second Intervention (30 Days)||19
8878864|NCT01930487|9935680|FG001|COMPLETED|Second Intervention (30 Days)||23
8878865|NCT01930487|9935679|FG000|NOT COMPLETED|Second Intervention (30 Days)||0
8878866|NCT01930487|9935680|FG001|NOT COMPLETED|Second Intervention (30 Days)||0
8878867|NCT01930643|9935688|FG000|STARTED|Overall Study||7
8878868|NCT01930643|9935689|FG001|STARTED|Overall Study||6
8878869|NCT01930643|9935688|FG000|COMPLETED|Overall Study||7
8878870|NCT01930643|9935689|FG001|COMPLETED|Overall Study||6
8878871|NCT01930643|9935688|FG000|NOT COMPLETED|Overall Study||0
8878872|NCT01930643|9935689|FG001|NOT COMPLETED|Overall Study||0
8878873|NCT01930747|9935698|FG000|STARTED|Overall Study||16
8878874|NCT01930747|9935699|FG001|STARTED|Overall Study||14
8989117|NCT02757352|10052406|FG001|COMPLETED|Double-Blind Period (Week 16 - Week 52)||52
8989118|NCT02757352|10052407|FG002|COMPLETED|Double-Blind Period (Week 16 - Week 52)||52
8989119|NCT02757352|10052408|FG003|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
8989120|NCT02757352|10052409|FG004|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
8989121|NCT02757352|10052410|FG005|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
8878875|NCT01930747|9935700|FG002|STARTED|Overall Study||12
8878876|NCT01930747|9935698|FG000|COMPLETED|Overall Study||16
8878877|NCT01930747|9935699|FG001|COMPLETED|Overall Study||14
8878878|NCT01930747|9935700|FG002|COMPLETED|Overall Study||12
8878879|NCT01930747|9935698|FG000|NOT COMPLETED|Overall Study||0
8878880|NCT01930747|9935699|FG001|NOT COMPLETED|Overall Study||0
8878881|NCT01930747|9935700|FG002|NOT COMPLETED|Overall Study||0
8878882|NCT01930799|9935708|FG000|STARTED|Overall Study||120
8878883|NCT01930799|9935708|FG000|COMPLETED|Overall Study||112
8878884|NCT01930799|9935708|FG000|NOT COMPLETED|Overall Study||8
8878885|NCT01930890|9935716|FG000|STARTED|Overall Study||14
8878886|NCT01930890|9935717|FG001|STARTED|Overall Study||33
8878887|NCT01930890|9935718|FG002|STARTED|Overall Study||13
8878888|NCT01930890|9935719|FG003|STARTED|Overall Study||27
8878889|NCT01930890|9935716|FG000|COMPLETED|Overall Study||0
8878890|NCT01930890|9935717|FG001|COMPLETED|Overall Study||0
8878891|NCT01930890|9935718|FG002|COMPLETED|Overall Study||0
8878892|NCT01930890|9935719|FG003|COMPLETED|Overall Study||0
8878893|NCT01930890|9935716|FG000|NOT COMPLETED|Overall Study||14
8878894|NCT01930890|9935717|FG001|NOT COMPLETED|Overall Study||33
8878895|NCT01930890|9935718|FG002|NOT COMPLETED|Overall Study||13
8878896|NCT01930890|9935719|FG003|NOT COMPLETED|Overall Study||27
8878897|NCT01931059|9935731|FG000|STARTED|Day 1||6
8878898|NCT01931059|9935732|FG001|STARTED|Day 1||5
8878899|NCT01931059|9935731|FG000|COMPLETED|Day 1||6
8878900|NCT01931059|9935732|FG001|COMPLETED|Day 1||4
8878901|NCT01931059|9935731|FG000|NOT COMPLETED|Day 1||0
8878902|NCT01931059|9935732|FG001|NOT COMPLETED|Day 1||1
8878903|NCT01931059|9935731|FG000|STARTED|Day2||6
8878904|NCT01931059|9935732|FG001|STARTED|Day2||4
8878905|NCT01931059|9935731|FG000|COMPLETED|Day2||6
8878906|NCT01931059|9935732|FG001|COMPLETED|Day2||4
8878907|NCT01931059|9935731|FG000|NOT COMPLETED|Day2||0
8878908|NCT01931059|9935732|FG001|NOT COMPLETED|Day2||0
8878909|NCT01931059|9935731|FG000|STARTED|Day3||6
8878910|NCT01931059|9935732|FG001|STARTED|Day3||4
8878911|NCT01931059|9935731|FG000|COMPLETED|Day3||5
8878912|NCT01931059|9935732|FG001|COMPLETED|Day3||4
8878913|NCT01931059|9935731|FG000|NOT COMPLETED|Day3||1
8878914|NCT01931059|9935732|FG001|NOT COMPLETED|Day3||0
8878915|NCT01931150|9935746|FG000|STARTED|Overall Study||5
8878916|NCT01931150|9935747|FG001|STARTED|Overall Study||6
8878917|NCT01931150|9935746|FG000|COMPLETED|Overall Study||4
8878918|NCT01931150|9935747|FG001|COMPLETED|Overall Study||4
8878919|NCT01931150|9935746|FG000|NOT COMPLETED|Overall Study||1
8878920|NCT01931150|9935747|FG001|NOT COMPLETED|Overall Study||2
8878921|NCT01931163|9935753|FG000|STARTED|Overall Study||22
8878922|NCT01931163|9935753|FG000|COMPLETED|Overall Study||22
8878923|NCT01931163|9935753|FG000|NOT COMPLETED|Overall Study||0
8878924|NCT01931202|9935760|FG000|STARTED|Overall Study||8
8878925|NCT01931202|9935761|FG001|STARTED|Overall Study||51
8878926|NCT01931202|9935762|FG002|STARTED|Overall Study||49
8878927|NCT01931202|9935760|FG000|COMPLETED|Overall Study||8
8878928|NCT01931202|9935761|FG001|COMPLETED|Overall Study||46
8878929|NCT01931202|9935762|FG002|COMPLETED|Overall Study||45
8878930|NCT01931202|9935760|FG000|NOT COMPLETED|Overall Study||0
8878931|NCT01931202|9935761|FG001|NOT COMPLETED|Overall Study||5
8878932|NCT01931202|9935762|FG002|NOT COMPLETED|Overall Study||4
8878933|NCT01931397|9935773|FG000|STARTED|Overall Study||30
8878934|NCT01931397|9935773|FG000|COMPLETED|Overall Study||19
8878935|NCT01931397|9935773|FG000|NOT COMPLETED|Overall Study||11
8878936|NCT01931462|9935781|FG000|STARTED|Overall Study||2
8878937|NCT01931462|9935781|FG000|COMPLETED|Overall Study||1
8878938|NCT01931462|9935781|FG000|NOT COMPLETED|Overall Study||1
8878939|NCT01931475|9935787|FG000|STARTED|Period 1: Double-Blind Treatment Phase||205
8878940|NCT01931475|9935788|FG001|STARTED|Period 1: Double-Blind Treatment Phase||202
8878941|NCT01931475|9935787|FG000|Received at Least 1 Dose of Study Drug|Period 1: Double-Blind Treatment Phase||199
8878942|NCT01931475|9935788|FG001|Received at Least 1 Dose of Study Drug|Period 1: Double-Blind Treatment Phase||198
8878943|NCT01931475|9935787|FG000|COMPLETED|Period 1: Double-Blind Treatment Phase||166
8878944|NCT01931475|9935788|FG001|COMPLETED|Period 1: Double-Blind Treatment Phase||176
8878945|NCT01931475|9935787|FG000|NOT COMPLETED|Period 1: Double-Blind Treatment Phase||39
8878946|NCT01931475|9935788|FG001|NOT COMPLETED|Period 1: Double-Blind Treatment Phase||26
8878947|NCT01931475|9935787|FG000|STARTED|Period 2: Extension Treatment Phase||166
8878948|NCT01931475|9935788|FG001|STARTED|Period 2: Extension Treatment Phase||176
8878949|NCT01931475|9935787|FG000|Received at Least 1 Dose of Study Drug|Period 2: Extension Treatment Phase||166
8878950|NCT01931475|9935788|FG001|Received at Least 1 Dose of Study Drug|Period 2: Extension Treatment Phase||175
8878951|NCT01931475|9935787|FG000|COMPLETED|Period 2: Extension Treatment Phase||162
8878952|NCT01931475|9935788|FG001|COMPLETED|Period 2: Extension Treatment Phase||157
8878953|NCT01931475|9935787|FG000|NOT COMPLETED|Period 2: Extension Treatment Phase||4
8878954|NCT01931475|9935788|FG001|NOT COMPLETED|Period 2: Extension Treatment Phase||19
8878955|NCT01931527|9935801|FG000|STARTED|Overall Study||16
8878956|NCT01931527|9935802|FG001|STARTED|Overall Study||15
8878957|NCT01931527|9935801|FG000|COMPLETED|Overall Study||16
8989122|NCT02757352|10052411|FG006|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
8989123|NCT02757352|10052412|FG007|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
8989124|NCT02757352|10052413|FG008|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
8989125|NCT02757352|10052414|FG009|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
8989126|NCT02757352|10052405|FG000|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||63
8989127|NCT02757352|10052406|FG001|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||43
8989128|NCT02757352|10052407|FG002|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||46
8989129|NCT02757352|10052408|FG003|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
8989130|NCT02757352|10052409|FG004|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
8989131|NCT02757352|10052410|FG005|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
8989132|NCT02757352|10052411|FG006|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
8989133|NCT02757352|10052412|FG007|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
8989134|NCT02757352|10052413|FG008|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
8989135|NCT02757352|10052414|FG009|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
8989136|NCT02757352|10052405|FG000|STARTED|IR-Open Label Period (Week 16 - Week 52)|Participants continued with original assigned treatment without switching to open label ixeQ2W.|0
8989137|NCT02757352|10052406|FG001|STARTED|IR-Open Label Period (Week 16 - Week 52)|Participants continued with original assigned treatment without switching to open label ixeQ2W.|0
8989138|NCT02757352|10052407|FG002|STARTED|IR-Open Label Period (Week 16 - Week 52)|Participants continued with original assigned treatment without switching to open label ixeQ2W.|0
8989139|NCT02757352|10052408|FG003|STARTED|IR-Open Label Period (Week 16 - Week 52)|IR based on the investigator's opinion switched to ixekizumab open label 80 mg Q2W.|62
8989140|NCT02757352|10052409|FG004|STARTED|IR-Open Label Period (Week 16 - Week 52)|IR based on the investigator's opinion switched to ixekizumab open label 80 mg Q2W.|40
8989141|NCT02757352|10052410|FG005|STARTED|IR-Open Label Period (Week 16 - Week 52)|IR based on the investigator's opinion switched to ixekizumab open label 80 mg Q2W.|42
8989142|NCT02757352|10052411|FG006|STARTED|IR-Open Label Period (Week 16 - Week 52)||0
8989143|NCT02757352|10052412|FG007|STARTED|IR-Open Label Period (Week 16 - Week 52)||0
8989144|NCT02757352|10052413|FG008|STARTED|IR-Open Label Period (Week 16 - Week 52)||0
8989145|NCT02757352|10052414|FG009|STARTED|IR-Open Label Period (Week 16 - Week 52)||0
8989146|NCT02757352|10052405|FG000|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
8989147|NCT02757352|10052406|FG001|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
8989148|NCT02757352|10052407|FG002|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
8989149|NCT02757352|10052408|FG003|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||2
8989150|NCT02757352|10052409|FG004|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
8989151|NCT02757352|10052410|FG005|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||3
8989152|NCT02757352|10052411|FG006|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
8989153|NCT02757352|10052412|FG007|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
8989154|NCT02757352|10052413|FG008|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
8989155|NCT02757352|10052414|FG009|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
8989156|NCT02757352|10052405|FG000|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
8989157|NCT02757352|10052406|FG001|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
8989158|NCT02757352|10052407|FG002|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
8989159|NCT02757352|10052408|FG003|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||55
8989160|NCT02757352|10052409|FG004|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||37
8989161|NCT02757352|10052410|FG005|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||35
8989162|NCT02757352|10052411|FG006|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
8989163|NCT02757352|10052412|FG007|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
8989164|NCT02757352|10052413|FG008|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
8989165|NCT02757352|10052414|FG009|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
8989166|NCT02757352|10052405|FG000|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
8989167|NCT02757352|10052406|FG001|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
8989168|NCT02757352|10052407|FG002|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
8878958|NCT01931527|9935802|FG001|COMPLETED|Overall Study||15
8878959|NCT01931527|9935801|FG000|NOT COMPLETED|Overall Study||0
8878960|NCT01931527|9935802|FG001|NOT COMPLETED|Overall Study||0
8878961|NCT01931566|9935815|FG000|STARTED|Overall Study||433
8878962|NCT01931566|9935816|FG001|STARTED|Overall Study||1516
8878963|NCT01931566|9935817|FG002|STARTED|Overall Study||1545
8878964|NCT01931566|9935815|FG000|Treated|Overall Study||427
8878965|NCT01931566|9935816|FG001|Treated|Overall Study||1507
8878966|NCT01931566|9935817|FG002|Treated|Overall Study||1531
8878967|NCT01931566|9935815|FG000|COMPLETED|Overall Study||4
8878968|NCT01931566|9935816|FG001|COMPLETED|Overall Study||40
8878969|NCT01931566|9935817|FG002|COMPLETED|Overall Study||39
8878970|NCT01931566|9935815|FG000|NOT COMPLETED|Overall Study||429
8878971|NCT01931566|9935816|FG001|NOT COMPLETED|Overall Study||1476
8878972|NCT01931566|9935817|FG002|NOT COMPLETED|Overall Study||1506
8878973|NCT01931670|9935829|FG000|STARTED|Treatment Period||360
8878974|NCT01931670|9935830|FG001|STARTED|Treatment Period||226
8878975|NCT01931670|9935831|FG002|STARTED|Treatment Period||229
8878976|NCT01931670|9935829|FG000|COMPLETED|Treatment Period||270
8878977|NCT01931670|9935830|FG001|COMPLETED|Treatment Period||178
8571792|NCT00112437|9604144|FG021|STARTED|Year 1 (12-Month Base Study)||0
8878978|NCT01931670|9935831|FG002|COMPLETED|Treatment Period||184
8989169|NCT02757352|10052408|FG003|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||7
8989170|NCT02757352|10052409|FG004|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||3
8989171|NCT02757352|10052410|FG005|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||7
8989172|NCT02757352|10052411|FG006|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
8989173|NCT02757352|10052412|FG007|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
8989174|NCT02757352|10052413|FG008|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
8989175|NCT02757352|10052414|FG009|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
8989176|NCT02757352|10052405|FG000|STARTED|Follow-Up Period||0
8989177|NCT02757352|10052406|FG001|STARTED|Follow-Up Period||0
8989178|NCT02757352|10052407|FG002|STARTED|Follow-Up Period||0
8989179|NCT02757352|10052408|FG003|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|0
8989180|NCT02757352|10052409|FG004|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|0
8989181|NCT02757352|10052410|FG005|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|0
8989182|NCT02757352|10052411|FG006|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|3
8989183|NCT02757352|10052412|FG007|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|5
8989184|NCT02757352|10052413|FG008|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|28
8989185|NCT02757352|10052414|FG009|STARTED|Follow-Up Period||5
8989186|NCT02757352|10052405|FG000|COMPLETED|Follow-Up Period||0
8989187|NCT02757352|10052406|FG001|COMPLETED|Follow-Up Period||0
8989188|NCT02757352|10052407|FG002|COMPLETED|Follow-Up Period||0
8989189|NCT02757352|10052408|FG003|COMPLETED|Follow-Up Period||0
8989190|NCT02757352|10052409|FG004|COMPLETED|Follow-Up Period||0
8989191|NCT02757352|10052410|FG005|COMPLETED|Follow-Up Period||0
8989192|NCT02757352|10052411|FG006|COMPLETED|Follow-Up Period||2
8989193|NCT02757352|10052412|FG007|COMPLETED|Follow-Up Period||4
8989194|NCT02757352|10052413|FG008|COMPLETED|Follow-Up Period||18
8989195|NCT02757352|10052414|FG009|COMPLETED|Follow-Up Period||2
8989196|NCT02757352|10052405|FG000|NOT COMPLETED|Follow-Up Period||0
8989197|NCT02757352|10052406|FG001|NOT COMPLETED|Follow-Up Period||0
8989198|NCT02757352|10052407|FG002|NOT COMPLETED|Follow-Up Period||0
8989199|NCT02757352|10052408|FG003|NOT COMPLETED|Follow-Up Period||0
8989200|NCT02757352|10052409|FG004|NOT COMPLETED|Follow-Up Period||0
8989201|NCT02757352|10052410|FG005|NOT COMPLETED|Follow-Up Period||0
8989202|NCT02757352|10052411|FG006|NOT COMPLETED|Follow-Up Period||1
8989203|NCT02757352|10052412|FG007|NOT COMPLETED|Follow-Up Period||1
8989204|NCT02757352|10052413|FG008|NOT COMPLETED|Follow-Up Period||10
8989205|NCT02757352|10052414|FG009|NOT COMPLETED|Follow-Up Period||3
8989206|NCT02757430|10052445|FG000|STARTED|Overall Study||515
8989207|NCT02757430|10052445|FG000|Baseline Visits|Overall Study||503
8989208|NCT02757430|10052445|FG000|EP Mapping/Ablation Procedure|Overall Study||503
8989209|NCT02757430|10052445|FG000|COMPLETED|Overall Study|Subjects with pre-discharge visit were considered completed.|503
8989210|NCT02757430|10052445|FG000|NOT COMPLETED|Overall Study||12
8989211|NCT02757625|10052462|FG000|STARTED|Overall Study||14
8989212|NCT02757625|10052463|FG001|STARTED|Overall Study||18
8989213|NCT02757625|10052464|FG002|STARTED|Overall Study||19
8989214|NCT02757625|10052465|FG003|STARTED|Overall Study||12
8989215|NCT02757625|10052462|FG000|COMPLETED|Overall Study||14
8989216|NCT02757625|10052463|FG001|COMPLETED|Overall Study||18
8989217|NCT02757625|10052464|FG002|COMPLETED|Overall Study||17
8989218|NCT02757625|10052465|FG003|COMPLETED|Overall Study||12
8989219|NCT02757625|10052462|FG000|NOT COMPLETED|Overall Study||0
8989220|NCT02757625|10052463|FG001|NOT COMPLETED|Overall Study||0
8989221|NCT02757625|10052464|FG002|NOT COMPLETED|Overall Study||2
8989222|NCT02757625|10052465|FG003|NOT COMPLETED|Overall Study||0
8989223|NCT02757768|10052479|FG000|STARTED|Overall Study||356
8989224|NCT02757768|10052480|FG001|STARTED|Overall Study||359
8989225|NCT02757768|10052479|FG000|Treated|Overall Study||352
8989226|NCT02757768|10052480|FG001|Treated|Overall Study||354
8989227|NCT02757768|10052479|FG000|COMPLETED|Overall Study||323
8989228|NCT02757768|10052480|FG001|COMPLETED|Overall Study||331
8989229|NCT02757768|10052479|FG000|NOT COMPLETED|Overall Study||33
8989230|NCT02757768|10052480|FG001|NOT COMPLETED|Overall Study||28
8989231|NCT02757950|10052490|FG000|STARTED|Overall Study||1203
8989232|NCT02757950|10052491|FG001|STARTED|Overall Study||1259
8989233|NCT02757950|10052490|FG000|COMPLETED|Overall Study||1199
8989234|NCT02757950|10052491|FG001|COMPLETED|Overall Study||1248
8989235|NCT02757950|10052490|FG000|NOT COMPLETED|Overall Study||4
8989236|NCT02757950|10052491|FG001|NOT COMPLETED|Overall Study||11
8989237|NCT02757963|10052498|FG000|STARTED|Overall Study||1658
8989238|NCT02757963|10052498|FG000|COMPLETED|Overall Study||561
8989239|NCT02757963|10052498|FG000|NOT COMPLETED|Overall Study||1097
8989240|NCT02758119|10052515|FG000|STARTED|Overall Study||41
8989241|NCT02758119|10052516|FG001|STARTED|Overall Study||41
8989242|NCT02758119|10052515|FG000|COMPLETED|Overall Study||39
8989243|NCT02758119|10052516|FG001|COMPLETED|Overall Study||40
8989244|NCT02758119|10052515|FG000|NOT COMPLETED|Overall Study||2
8989245|NCT02758119|10052516|FG001|NOT COMPLETED|Overall Study||1
8989246|NCT02758171|10052526|FG000|STARTED|Treatment Period 1||28
8989247|NCT02758171|10052527|FG001|STARTED|Treatment Period 1||28
8989248|NCT02758171|10052526|FG000|COMPLETED|Treatment Period 1||28
8989249|NCT02758171|10052527|FG001|COMPLETED|Treatment Period 1||28
8989250|NCT02758171|10052526|FG000|NOT COMPLETED|Treatment Period 1||0
8989251|NCT02758171|10052527|FG001|NOT COMPLETED|Treatment Period 1||0
8989252|NCT02758171|10052526|FG000|STARTED|Wash-out||28
8989253|NCT02758171|10052527|FG001|STARTED|Wash-out||28
8989254|NCT02758171|10052526|FG000|COMPLETED|Wash-out||26
8989255|NCT02758171|10052527|FG001|COMPLETED|Wash-out||28
8989256|NCT02758171|10052526|FG000|NOT COMPLETED|Wash-out||2
8989257|NCT02758171|10052527|FG001|NOT COMPLETED|Wash-out||0
8989258|NCT02758171|10052526|FG000|STARTED|Treatment Period 2||26
8989259|NCT02758171|10052527|FG001|STARTED|Treatment Period 2||28
8989260|NCT02758171|10052526|FG000|COMPLETED|Treatment Period 2||26
8989261|NCT02758171|10052527|FG001|COMPLETED|Treatment Period 2||28
8989262|NCT02758171|10052526|FG000|NOT COMPLETED|Treatment Period 2||0
8989263|NCT02758171|10052527|FG001|NOT COMPLETED|Treatment Period 2||0
8989264|NCT02758210|10052533|FG000|STARTED|Overall Study||20
8989265|NCT02758210|10052533|FG000|COMPLETED|Overall Study||20
8989266|NCT02758210|10052533|FG000|NOT COMPLETED|Overall Study||0
8989267|NCT02758301|10052539|FG000|STARTED|Overall Study||104
8989268|NCT02758301|10052540|FG001|STARTED|Overall Study||8
8989269|NCT02758301|10052539|FG000|COMPLETED|Overall Study||70
8989270|NCT02758301|10052540|FG001|COMPLETED|Overall Study||0
8989271|NCT02758301|10052539|FG000|NOT COMPLETED|Overall Study||34
8989272|NCT02758301|10052540|FG001|NOT COMPLETED|Overall Study||8
8989273|NCT02758613|10052550|FG000|STARTED|Treatment||8
8989274|NCT02758613|10052551|FG001|STARTED|Treatment||8
8989275|NCT02758613|10052552|FG002|STARTED|Treatment||9
8989276|NCT02758613|10052553|FG003|STARTED|Treatment||8
8989277|NCT02758613|10052550|FG000|Received at Least One Dose of Study Drug|Treatment||8
8989278|NCT02758613|10052551|FG001|Received at Least One Dose of Study Drug|Treatment||8
8989279|NCT02758613|10052552|FG002|Received at Least One Dose of Study Drug|Treatment||9
8989280|NCT02758613|10052553|FG003|Received at Least One Dose of Study Drug|Treatment||8
8989281|NCT02758613|10052550|FG000|COMPLETED|Treatment||6
8989282|NCT02758613|10052551|FG001|COMPLETED|Treatment||8
8989283|NCT02758613|10052552|FG002|COMPLETED|Treatment||8
8989284|NCT02758613|10052553|FG003|COMPLETED|Treatment||8
8989285|NCT02758613|10052550|FG000|NOT COMPLETED|Treatment||2
8989286|NCT02758613|10052551|FG001|NOT COMPLETED|Treatment||0
8989287|NCT02758613|10052552|FG002|NOT COMPLETED|Treatment||1
8989288|NCT02758613|10052553|FG003|NOT COMPLETED|Treatment||0
8989289|NCT02758613|10052550|FG000|STARTED|Follow-up||6
8989290|NCT02758613|10052551|FG001|STARTED|Follow-up||8
8989291|NCT02758613|10052552|FG002|STARTED|Follow-up||8
8989292|NCT02758613|10052553|FG003|STARTED|Follow-up||8
8989293|NCT02758613|10052550|FG000|COMPLETED|Follow-up||6
8989294|NCT02758613|10052551|FG001|COMPLETED|Follow-up||8
8989295|NCT02758613|10052552|FG002|COMPLETED|Follow-up||8
8989296|NCT02758613|10052553|FG003|COMPLETED|Follow-up||8
8989297|NCT02758613|10052550|FG000|NOT COMPLETED|Follow-up||0
8989298|NCT02758613|10052551|FG001|NOT COMPLETED|Follow-up||0
8989299|NCT02758613|10052552|FG002|NOT COMPLETED|Follow-up||0
8989300|NCT02758613|10052553|FG003|NOT COMPLETED|Follow-up||0
8989301|NCT02758899|10052568|FG000|STARTED|Overall Study||11
8989302|NCT02758899|10052569|FG001|STARTED|Overall Study||10
8989303|NCT02758899|10052568|FG000|COMPLETED|Overall Study||9
8989304|NCT02758899|10052569|FG001|COMPLETED|Overall Study||9
8989305|NCT02758899|10052568|FG000|NOT COMPLETED|Overall Study||2
8989306|NCT02758899|10052569|FG001|NOT COMPLETED|Overall Study||1
8989307|NCT02759016|10052577|FG000|STARTED|Overall Study||4
8989308|NCT02759016|10052578|FG001|STARTED|Overall Study||3
8989309|NCT02759016|10052577|FG000|Treated With BI 836826 and Ibrutinib|Overall Study||3
8989310|NCT02759016|10052578|FG001|Treated With BI 836826 and Ibrutinib|Overall Study||3
8989311|NCT02759016|10052577|FG000|COMPLETED|Overall Study||0
8989312|NCT02759016|10052578|FG001|COMPLETED|Overall Study||0
8989313|NCT02759016|10052577|FG000|NOT COMPLETED|Overall Study||4
8989314|NCT02759016|10052578|FG001|NOT COMPLETED|Overall Study||3
8989315|NCT02759055|10052587|FG000|STARTED|Overall Study||12702
8989316|NCT02759055|10052588|FG001|STARTED|Overall Study||8962
8989317|NCT02759055|10052587|FG000|COMPLETED|Overall Study||10775
8989318|NCT02759055|10052588|FG001|COMPLETED|Overall Study||7454
8989319|NCT02759055|10052587|FG000|NOT COMPLETED|Overall Study||1927
8989320|NCT02759055|10052588|FG001|NOT COMPLETED|Overall Study||1508
8989321|NCT02759120|10052596|FG000|STARTED|Overall Study||254
8989322|NCT02759120|10052597|FG001|STARTED|Overall Study||259
8989323|NCT02759120|10052596|FG000|COMPLETED|Overall Study||169
8989324|NCT02759120|10052597|FG001|COMPLETED|Overall Study||180
8989325|NCT02759120|10052596|FG000|NOT COMPLETED|Overall Study||85
8989326|NCT02759120|10052597|FG001|NOT COMPLETED|Overall Study||79
8989327|NCT02759146|10052609|FG000|STARTED|Week 1-4||57
8989328|NCT02759146|10052610|FG001|STARTED|Week 1-4||36
8989329|NCT02759146|10052611|FG002|STARTED|Week 1-4||33
8989330|NCT02759146|10052612|FG003|STARTED|Week 1-4|One control participant could continue without the other after baseline.|44
8989331|NCT02759146|10052613|FG004|STARTED|Week 1-4||49
8989332|NCT02759146|10052614|FG005|STARTED|Week 1-4||30
8989333|NCT02759146|10052615|FG006|STARTED|Week 1-4||27
8989334|NCT02759146|10052609|FG000|COMPLETED|Week 1-4||56
8989335|NCT02759146|10052610|FG001|COMPLETED|Week 1-4||34
8989336|NCT02759146|10052611|FG002|COMPLETED|Week 1-4||32
8989337|NCT02759146|10052612|FG003|COMPLETED|Week 1-4||44
8989338|NCT02759146|10052613|FG004|COMPLETED|Week 1-4||49
8989339|NCT02759146|10052614|FG005|COMPLETED|Week 1-4||29
8989340|NCT02759146|10052615|FG006|COMPLETED|Week 1-4||26
8989341|NCT02759146|10052609|FG000|NOT COMPLETED|Week 1-4||1
8989342|NCT02759146|10052610|FG001|NOT COMPLETED|Week 1-4||2
8989343|NCT02759146|10052611|FG002|NOT COMPLETED|Week 1-4||1
8989344|NCT02759146|10052612|FG003|NOT COMPLETED|Week 1-4||0
8989345|NCT02759146|10052613|FG004|NOT COMPLETED|Week 1-4||0
8989346|NCT02759146|10052614|FG005|NOT COMPLETED|Week 1-4||1
8989347|NCT02759146|10052615|FG006|NOT COMPLETED|Week 1-4||1
8989348|NCT02759146|10052609|FG000|STARTED|Week 5-8||56
8989349|NCT02759146|10052610|FG001|STARTED|Week 5-8||34
8989350|NCT02759146|10052611|FG002|STARTED|Week 5-8||32
8989351|NCT02759146|10052612|FG003|STARTED|Week 5-8||44
8989352|NCT02759146|10052613|FG004|STARTED|Week 5-8||49
8989353|NCT02759146|10052614|FG005|STARTED|Week 5-8||29
8989354|NCT02759146|10052615|FG006|STARTED|Week 5-8||26
8989355|NCT02759146|10052609|FG000|COMPLETED|Week 5-8||46
8989356|NCT02759146|10052610|FG001|COMPLETED|Week 5-8||29
8989357|NCT02759146|10052611|FG002|COMPLETED|Week 5-8||22
8989358|NCT02759146|10052612|FG003|COMPLETED|Week 5-8||37
8989359|NCT02759146|10052613|FG004|COMPLETED|Week 5-8||44
8989360|NCT02759146|10052614|FG005|COMPLETED|Week 5-8||23
8989361|NCT02759146|10052615|FG006|COMPLETED|Week 5-8||20
8989362|NCT02759146|10052609|FG000|NOT COMPLETED|Week 5-8||10
8989363|NCT02759146|10052610|FG001|NOT COMPLETED|Week 5-8||5
8989364|NCT02759146|10052611|FG002|NOT COMPLETED|Week 5-8||10
8989365|NCT02759146|10052612|FG003|NOT COMPLETED|Week 5-8||7
8989366|NCT02759146|10052613|FG004|NOT COMPLETED|Week 5-8||5
8989367|NCT02759146|10052614|FG005|NOT COMPLETED|Week 5-8||6
8989368|NCT02759146|10052615|FG006|NOT COMPLETED|Week 5-8||6
8989369|NCT02759315|10052636|FG000|STARTED|Overall Study||69
8989370|NCT02759315|10052637|FG001|STARTED|Overall Study||29
8989371|NCT02759315|10052638|FG002|STARTED|Overall Study||39
8989372|NCT02759315|10052639|FG003|STARTED|Overall Study||20
8989373|NCT02759315|10052640|FG004|STARTED|Overall Study||3
8989374|NCT02759315|10052636|FG000|COMPLETED|Overall Study||65
8989375|NCT02759315|10052637|FG001|COMPLETED|Overall Study||28
8989376|NCT02759315|10052638|FG002|COMPLETED|Overall Study||29
8989377|NCT02759315|10052639|FG003|COMPLETED|Overall Study||19
8989378|NCT02759315|10052640|FG004|COMPLETED|Overall Study||2
8989379|NCT02759315|10052636|FG000|NOT COMPLETED|Overall Study||4
8989380|NCT02759315|10052637|FG001|NOT COMPLETED|Overall Study||1
8989381|NCT02759315|10052638|FG002|NOT COMPLETED|Overall Study||10
8989382|NCT02759315|10052639|FG003|NOT COMPLETED|Overall Study||1
8989383|NCT02759315|10052640|FG004|NOT COMPLETED|Overall Study||1
8989384|NCT02759354|10052658|FG000|STARTED|Overall Study||192
8989385|NCT02759354|10052659|FG001|STARTED|Overall Study||190
8989386|NCT02759354|10052660|FG002|STARTED|Overall Study||181
8989387|NCT02759354|10052661|FG003|STARTED|Overall Study||191
8989388|NCT02759354|10052658|FG000|COMPLETED|Overall Study||192
8989389|NCT02759354|10052659|FG001|COMPLETED|Overall Study||190
8989390|NCT02759354|10052660|FG002|COMPLETED|Overall Study||181
8989391|NCT02759354|10052661|FG003|COMPLETED|Overall Study||191
8989392|NCT02759354|10052658|FG000|NOT COMPLETED|Overall Study||0
8989393|NCT02759354|10052659|FG001|NOT COMPLETED|Overall Study||0
8989394|NCT02759354|10052660|FG002|NOT COMPLETED|Overall Study||0
8989395|NCT02759354|10052661|FG003|NOT COMPLETED|Overall Study||0
8989396|NCT02759471|10052673|FG000|STARTED|Overall Study||54
8989397|NCT02759471|10052673|FG000|COMPLETED|Overall Study||52
8989398|NCT02759471|10052673|FG000|NOT COMPLETED|Overall Study||2
8989399|NCT02759562|10052681|FG000|STARTED|Double-Blind Treatment Period (8 Weeks)||3
8989400|NCT02759562|10052682|FG001|STARTED|Double-Blind Treatment Period (8 Weeks)||3
8989401|NCT02759562|10052681|FG000|COMPLETED|Double-Blind Treatment Period (8 Weeks)||3
8989402|NCT02759562|10052682|FG001|COMPLETED|Double-Blind Treatment Period (8 Weeks)||3
8989403|NCT02759562|10052681|FG000|NOT COMPLETED|Double-Blind Treatment Period (8 Weeks)||0
8989404|NCT02759562|10052682|FG001|NOT COMPLETED|Double-Blind Treatment Period (8 Weeks)||0
8989405|NCT02759562|10052681|FG000|STARTED|Open-Label Treatment Period||2
8989406|NCT02759562|10052682|FG001|STARTED|Open-Label Treatment Period||2
8989407|NCT02759562|10052681|FG000|COMPLETED|Open-Label Treatment Period||0
8989408|NCT02759562|10052682|FG001|COMPLETED|Open-Label Treatment Period||0
8989409|NCT02759562|10052681|FG000|NOT COMPLETED|Open-Label Treatment Period||2
8989410|NCT02759562|10052682|FG001|NOT COMPLETED|Open-Label Treatment Period||2
8989411|NCT02759575|10052689|FG000|STARTED|Overall Study||9
8989412|NCT02759575|10052689|FG000|COMPLETED|Overall Study||9
8989413|NCT02759575|10052689|FG000|NOT COMPLETED|Overall Study||0
8989414|NCT02759692|10052693|FG000|STARTED|Period 1||141
8989415|NCT02759692|10052694|FG001|STARTED|Period 1||142
8989416|NCT02759692|10052693|FG000|COMPLETED|Period 1||138
8989417|NCT02759692|10052694|FG001|COMPLETED|Period 1||140
8989418|NCT02759692|10052693|FG000|NOT COMPLETED|Period 1||3
8989419|NCT02759692|10052694|FG001|NOT COMPLETED|Period 1||2
8989420|NCT02759692|10052693|FG000|STARTED|Period 2||138
8989421|NCT02759692|10052694|FG001|STARTED|Period 2||140
8989422|NCT02759692|10052693|FG000|COMPLETED|Period 2||137
8989423|NCT02759692|10052694|FG001|COMPLETED|Period 2||139
8989424|NCT02759692|10052693|FG000|NOT COMPLETED|Period 2||1
8989425|NCT02759692|10052694|FG001|NOT COMPLETED|Period 2||1
8989426|NCT02759692|10052693|FG000|STARTED|Period 3||137
8989427|NCT02759692|10052694|FG001|STARTED|Period 3||139
8989428|NCT02759692|10052693|FG000|COMPLETED|Period 3||137
8989429|NCT02759692|10052694|FG001|COMPLETED|Period 3||139
8989430|NCT02759692|10052693|FG000|NOT COMPLETED|Period 3||0
8989431|NCT02759692|10052694|FG001|NOT COMPLETED|Period 3||0
8989432|NCT02759939|10052704|FG000|STARTED|Overall Study||1256
8989433|NCT02759939|10052705|FG001|STARTED|Overall Study||1143
8989434|NCT02759939|10052706|FG002|STARTED|Overall Study||1393
8989435|NCT02759939|10052707|FG003|STARTED|Overall Study||1246
8989436|NCT02759939|10052704|FG000|Analyzed at T1|Overall Study||1245
8989437|NCT02759939|10052705|FG001|Analyzed at T1|Overall Study||1141
8989438|NCT02759939|10052706|FG002|Analyzed at T1|Overall Study||1388
8989439|NCT02759939|10052707|FG003|Analyzed at T1|Overall Study||1244
8989440|NCT02759939|10052704|FG000|Eligible for T2 and T3|Overall Study||935
8989441|NCT02759939|10052705|FG001|Eligible for T2 and T3|Overall Study||962
8989442|NCT02759939|10052706|FG002|Eligible for T2 and T3|Overall Study||1022
8989443|NCT02759939|10052707|FG003|Eligible for T2 and T3|Overall Study||853
8989444|NCT02759939|10052704|FG000|Analyzed at T2 and/or T3|Overall Study||303
8989445|NCT02759939|10052705|FG001|Analyzed at T2 and/or T3|Overall Study||278
8989446|NCT02759939|10052706|FG002|Analyzed at T2 and/or T3|Overall Study||373
8989447|NCT02759939|10052707|FG003|Analyzed at T2 and/or T3|Overall Study||304
8989448|NCT02759939|10052704|FG000|Consented to T2 and T3|Overall Study||579
8989449|NCT02759939|10052705|FG001|Consented to T2 and T3|Overall Study||626
8989450|NCT02759939|10052706|FG002|Consented to T2 and T3|Overall Study||702
8989451|NCT02759939|10052707|FG003|Consented to T2 and T3|Overall Study||564
8989452|NCT02759939|10052704|FG000|COMPLETED|Overall Study||200
8989453|NCT02759939|10052705|FG001|COMPLETED|Overall Study||171
8989454|NCT02759939|10052706|FG002|COMPLETED|Overall Study||239
8989455|NCT02759939|10052707|FG003|COMPLETED|Overall Study||203
8989456|NCT02759939|10052704|FG000|NOT COMPLETED|Overall Study||1056
8989457|NCT02759939|10052705|FG001|NOT COMPLETED|Overall Study||972
8989458|NCT02759939|10052706|FG002|NOT COMPLETED|Overall Study||1154
8989459|NCT02759939|10052707|FG003|NOT COMPLETED|Overall Study||1043
8989460|NCT02760056|10052719|FG000|STARTED|Overall Study||10
8989461|NCT02760056|10052720|FG001|STARTED|Overall Study||5
8989462|NCT02760056|10052719|FG000|COMPLETED|Overall Study||10
8989463|NCT02760056|10052720|FG001|COMPLETED|Overall Study||5
8989464|NCT02760056|10052719|FG000|NOT COMPLETED|Overall Study||0
8989465|NCT02760056|10052720|FG001|NOT COMPLETED|Overall Study||0
8989466|NCT02760069|10052730|FG000|STARTED|Overall Study||40
8633353|NCT00550446|9673393|FG008|NOT COMPLETED|Up To Week 12||0
8633354|NCT00550446|9673394|FG009|NOT COMPLETED|Up To Week 12||0
8633355|NCT00550446|9673395|FG010|NOT COMPLETED|Up To Week 12||0
8989467|NCT02760069|10052731|FG001|STARTED|Overall Study||41
8989468|NCT02760069|10052732|FG002|STARTED|Overall Study||41
8989469|NCT02760069|10052730|FG000|COMPLETED|Overall Study||40
8989470|NCT02760069|10052731|FG001|COMPLETED|Overall Study||40
8989471|NCT02760069|10052732|FG002|COMPLETED|Overall Study||40
8989472|NCT02760069|10052730|FG000|NOT COMPLETED|Overall Study||0
8989473|NCT02760069|10052731|FG001|NOT COMPLETED|Overall Study||1
8989474|NCT02760069|10052732|FG002|NOT COMPLETED|Overall Study||1
8989475|NCT02760264|10052744|FG000|STARTED|0.25 mg/kg/Day||12
8989476|NCT02760264|10052745|FG001|STARTED|0.25 mg/kg/Day||0
8989477|NCT02760264|10052746|FG002|STARTED|0.25 mg/kg/Day||0
8989478|NCT02760264|10052747|FG003|STARTED|0.25 mg/kg/Day||0
8989479|NCT02760264|10052744|FG000|COMPLETED|0.25 mg/kg/Day||12
8989480|NCT02760264|10052745|FG001|COMPLETED|0.25 mg/kg/Day||0
8989481|NCT02760264|10052746|FG002|COMPLETED|0.25 mg/kg/Day||0
8989482|NCT02760264|10052747|FG003|COMPLETED|0.25 mg/kg/Day||0
8989483|NCT02760264|10052744|FG000|NOT COMPLETED|0.25 mg/kg/Day||0
8989484|NCT02760264|10052745|FG001|NOT COMPLETED|0.25 mg/kg/Day||0
8989485|NCT02760264|10052746|FG002|NOT COMPLETED|0.25 mg/kg/Day||0
8989486|NCT02760264|10052747|FG003|NOT COMPLETED|0.25 mg/kg/Day||0
8989487|NCT02760264|10052744|FG000|STARTED|0.75 mg/kg/Day||0
8989488|NCT02760264|10052745|FG001|STARTED|0.75 mg/kg/Day||12
8989489|NCT02760264|10052746|FG002|STARTED|0.75 mg/kg/Day||0
8989490|NCT02760264|10052747|FG003|STARTED|0.75 mg/kg/Day||0
8989491|NCT02760264|10052744|FG000|COMPLETED|0.75 mg/kg/Day||0
8989492|NCT02760264|10052745|FG001|COMPLETED|0.75 mg/kg/Day||12
8989493|NCT02760264|10052746|FG002|COMPLETED|0.75 mg/kg/Day||0
8989494|NCT02760264|10052747|FG003|COMPLETED|0.75 mg/kg/Day||0
8989495|NCT02760264|10052744|FG000|NOT COMPLETED|0.75 mg/kg/Day||0
8989496|NCT02760264|10052745|FG001|NOT COMPLETED|0.75 mg/kg/Day||0
8989497|NCT02760264|10052746|FG002|NOT COMPLETED|0.75 mg/kg/Day||0
8989498|NCT02760264|10052747|FG003|NOT COMPLETED|0.75 mg/kg/Day||0
8633356|NCT00550446|9673385|FG000|STARTED|Post Week 12||27
8989499|NCT02760264|10052744|FG000|STARTED|2.0 mg/kg/Day||0
8989500|NCT02760264|10052745|FG001|STARTED|2.0 mg/kg/Day||0
8989501|NCT02760264|10052746|FG002|STARTED|2.0 mg/kg/Day||12
8989502|NCT02760264|10052747|FG003|STARTED|2.0 mg/kg/Day||0
8989503|NCT02760264|10052744|FG000|COMPLETED|2.0 mg/kg/Day||0
8989504|NCT02760264|10052745|FG001|COMPLETED|2.0 mg/kg/Day||0
8989505|NCT02760264|10052746|FG002|COMPLETED|2.0 mg/kg/Day||12
8989506|NCT02760264|10052747|FG003|COMPLETED|2.0 mg/kg/Day||0
8989507|NCT02760264|10052744|FG000|NOT COMPLETED|2.0 mg/kg/Day||0
8989508|NCT02760264|10052745|FG001|NOT COMPLETED|2.0 mg/kg/Day||0
8989509|NCT02760264|10052746|FG002|NOT COMPLETED|2.0 mg/kg/Day||0
8989510|NCT02760264|10052747|FG003|NOT COMPLETED|2.0 mg/kg/Day||0
8989511|NCT02760264|10052744|FG000|STARTED|6.0 mg/kg/Day||0
8989512|NCT02760264|10052745|FG001|STARTED|6.0 mg/kg/Day||0
8989513|NCT02760264|10052746|FG002|STARTED|6.0 mg/kg/Day||0
8989514|NCT02760264|10052747|FG003|STARTED|6.0 mg/kg/Day||12
8989515|NCT02760264|10052744|FG000|COMPLETED|6.0 mg/kg/Day||0
8989516|NCT02760264|10052745|FG001|COMPLETED|6.0 mg/kg/Day||0
8989517|NCT02760264|10052746|FG002|COMPLETED|6.0 mg/kg/Day||0
8989518|NCT02760264|10052747|FG003|COMPLETED|6.0 mg/kg/Day||12
8989519|NCT02760264|10052744|FG000|NOT COMPLETED|6.0 mg/kg/Day||0
8989520|NCT02760264|10052745|FG001|NOT COMPLETED|6.0 mg/kg/Day||0
8989521|NCT02760264|10052746|FG002|NOT COMPLETED|6.0 mg/kg/Day||0
8989522|NCT02760264|10052747|FG003|NOT COMPLETED|6.0 mg/kg/Day||0
8989523|NCT02760277|10052762|FG000|STARTED|Vamorolone 0.25 mg/kg/Day||12
8989524|NCT02760277|10052763|FG001|STARTED|Vamorolone 0.25 mg/kg/Day||0
8989525|NCT02760277|10052764|FG002|STARTED|Vamorolone 0.25 mg/kg/Day||0
8989526|NCT02760277|10052765|FG003|STARTED|Vamorolone 0.25 mg/kg/Day||0
8989527|NCT02760277|10052762|FG000|COMPLETED|Vamorolone 0.25 mg/kg/Day||12
8989528|NCT02760277|10052763|FG001|COMPLETED|Vamorolone 0.25 mg/kg/Day||0
8989529|NCT02760277|10052764|FG002|COMPLETED|Vamorolone 0.25 mg/kg/Day||0
8989530|NCT02760277|10052765|FG003|COMPLETED|Vamorolone 0.25 mg/kg/Day||0
8989531|NCT02760277|10052762|FG000|NOT COMPLETED|Vamorolone 0.25 mg/kg/Day||0
8989532|NCT02760277|10052763|FG001|NOT COMPLETED|Vamorolone 0.25 mg/kg/Day||0
8989533|NCT02760277|10052764|FG002|NOT COMPLETED|Vamorolone 0.25 mg/kg/Day||0
8989534|NCT02760277|10052765|FG003|NOT COMPLETED|Vamorolone 0.25 mg/kg/Day||0
8989535|NCT02760277|10052762|FG000|STARTED|0.75 mg/kg/Day||0
8989536|NCT02760277|10052763|FG001|STARTED|0.75 mg/kg/Day||12
8989537|NCT02760277|10052764|FG002|STARTED|0.75 mg/kg/Day||0
8989538|NCT02760277|10052765|FG003|STARTED|0.75 mg/kg/Day||0
8989539|NCT02760277|10052762|FG000|COMPLETED|0.75 mg/kg/Day||0
8989540|NCT02760277|10052763|FG001|COMPLETED|0.75 mg/kg/Day||12
8989541|NCT02760277|10052764|FG002|COMPLETED|0.75 mg/kg/Day||0
8989542|NCT02760277|10052765|FG003|COMPLETED|0.75 mg/kg/Day||0
8989543|NCT02760277|10052762|FG000|NOT COMPLETED|0.75 mg/kg/Day||0
8989544|NCT02760277|10052763|FG001|NOT COMPLETED|0.75 mg/kg/Day||0
8989545|NCT02760277|10052764|FG002|NOT COMPLETED|0.75 mg/kg/Day||0
8989546|NCT02760277|10052765|FG003|NOT COMPLETED|0.75 mg/kg/Day||0
8989547|NCT02760277|10052762|FG000|STARTED|2.0 mg/kg/Day||0
8989548|NCT02760277|10052763|FG001|STARTED|2.0 mg/kg/Day||0
8989549|NCT02760277|10052764|FG002|STARTED|2.0 mg/kg/Day||12
8989550|NCT02760277|10052765|FG003|STARTED|2.0 mg/kg/Day||0
8989551|NCT02760277|10052762|FG000|COMPLETED|2.0 mg/kg/Day||0
8989552|NCT02760277|10052763|FG001|COMPLETED|2.0 mg/kg/Day||0
8989553|NCT02760277|10052764|FG002|COMPLETED|2.0 mg/kg/Day||12
8989554|NCT02760277|10052765|FG003|COMPLETED|2.0 mg/kg/Day||0
8989555|NCT02760277|10052762|FG000|NOT COMPLETED|2.0 mg/kg/Day||0
8989556|NCT02760277|10052763|FG001|NOT COMPLETED|2.0 mg/kg/Day||0
8989557|NCT02760277|10052764|FG002|NOT COMPLETED|2.0 mg/kg/Day||0
8989558|NCT02760277|10052765|FG003|NOT COMPLETED|2.0 mg/kg/Day||0
8989559|NCT02760277|10052762|FG000|STARTED|6.0 mg/kg/Day||0
8989560|NCT02760277|10052763|FG001|STARTED|6.0 mg/kg/Day||0
8989561|NCT02760277|10052764|FG002|STARTED|6.0 mg/kg/Day||0
8989562|NCT02760277|10052765|FG003|STARTED|6.0 mg/kg/Day||12
8989563|NCT02760277|10052762|FG000|COMPLETED|6.0 mg/kg/Day||0
8989564|NCT02760277|10052763|FG001|COMPLETED|6.0 mg/kg/Day||0
8989565|NCT02760277|10052764|FG002|COMPLETED|6.0 mg/kg/Day||0
8989566|NCT02760277|10052765|FG003|COMPLETED|6.0 mg/kg/Day||12
8989567|NCT02760277|10052762|FG000|NOT COMPLETED|6.0 mg/kg/Day||0
8989568|NCT02760277|10052763|FG001|NOT COMPLETED|6.0 mg/kg/Day||0
8989569|NCT02760277|10052764|FG002|NOT COMPLETED|6.0 mg/kg/Day||0
8989570|NCT02760277|10052765|FG003|NOT COMPLETED|6.0 mg/kg/Day||0
8989571|NCT02760368|10052778|FG000|STARTED|Overall Study||143
8633357|NCT00550446|9673386|FG001|STARTED|Post Week 12||30
8633358|NCT00550446|9673387|FG002|STARTED|Post Week 12||46
8633359|NCT00550446|9673388|FG003|STARTED|Post Week 12||58
8633360|NCT00550446|9673389|FG004|STARTED|Post Week 12||54
8633361|NCT00550446|9673390|FG005|STARTED|Post Week 12||1
8633362|NCT00550446|9673391|FG006|STARTED|Post Week 12||21
8989572|NCT02760368|10052779|FG001|STARTED|Overall Study||142
8989573|NCT02760368|10052780|FG002|STARTED|Overall Study||143
8989574|NCT02760368|10052778|FG000|COMPLETED|Overall Study||130
8989575|NCT02760368|10052779|FG001|COMPLETED|Overall Study||134
8989576|NCT02760368|10052780|FG002|COMPLETED|Overall Study||132
8989577|NCT02760368|10052778|FG000|NOT COMPLETED|Overall Study||13
8989578|NCT02760368|10052779|FG001|NOT COMPLETED|Overall Study||8
8989579|NCT02760368|10052780|FG002|NOT COMPLETED|Overall Study||11
9038965|NCT03334747|10100044|FG008|COMPLETED|Follow-Up Phase||50
9038966|NCT03334747|10100036|FG000|NOT COMPLETED|Follow-Up Phase||0
9038967|NCT03334747|10100037|FG001|NOT COMPLETED|Follow-Up Phase||0
9038968|NCT03334747|10100038|FG002|NOT COMPLETED|Follow-Up Phase||0
9038969|NCT03334747|10100039|FG003|NOT COMPLETED|Follow-Up Phase||0
9038970|NCT03334747|10100040|FG004|NOT COMPLETED|Follow-Up Phase||0
9038971|NCT03334747|10100041|FG005|NOT COMPLETED|Follow-Up Phase||0
9038972|NCT03334747|10100042|FG006|NOT COMPLETED|Follow-Up Phase||1
9038973|NCT03334747|10100043|FG007|NOT COMPLETED|Follow-Up Phase||0
9038974|NCT03334747|10100044|FG008|NOT COMPLETED|Follow-Up Phase||1
9038975|NCT03334812|10100066|FG000|STARTED|Overall Study||9
9038976|NCT03334812|10100067|FG001|STARTED|Overall Study||5
9038977|NCT03334812|10100068|FG002|STARTED|Overall Study||0
9038978|NCT03334812|10100069|FG003|STARTED|Overall Study||0
9038979|NCT03334812|10100066|FG000|COMPLETED|Overall Study||9
9038980|NCT03334812|10100067|FG001|COMPLETED|Overall Study||5
9038981|NCT03334812|10100068|FG002|COMPLETED|Overall Study||0
9038982|NCT03334812|10100069|FG003|COMPLETED|Overall Study||0
9038983|NCT03334812|10100066|FG000|NOT COMPLETED|Overall Study||0
9038984|NCT03334812|10100067|FG001|NOT COMPLETED|Overall Study||0
9038985|NCT03334812|10100068|FG002|NOT COMPLETED|Overall Study||0
9038986|NCT03334812|10100069|FG003|NOT COMPLETED|Overall Study||0
9038987|NCT03334825|10100077|FG000|STARTED|Overall Study||119
9038988|NCT03334825|10100078|FG001|STARTED|Overall Study||117
9038989|NCT03334825|10100077|FG000|COMPLETED|Overall Study||112
8633363|NCT00550446|9673392|FG007|STARTED|Post Week 12||17
9038990|NCT03334825|10100078|FG001|COMPLETED|Overall Study||113
8633364|NCT00550446|9673393|FG008|STARTED|Post Week 12||17
8633365|NCT00550446|9673394|FG009|STARTED|Post Week 12||44
9038991|NCT03334825|10100077|FG000|NOT COMPLETED|Overall Study||7
9038992|NCT03334825|10100078|FG001|NOT COMPLETED|Overall Study||4
9038993|NCT03334903|10100086|FG000|STARTED|Overall Study||39
9038994|NCT03334903|10100087|FG001|STARTED|Overall Study||38
9038995|NCT03334903|10100086|FG000|COMPLETED|Overall Study||35
9038996|NCT03334903|10100087|FG001|COMPLETED|Overall Study||33
8989580|NCT02760407|10052792|FG000|STARTED|Overall Study||479
8989581|NCT02760407|10052793|FG001|STARTED|Overall Study||464
8989582|NCT02760407|10052794|FG002|STARTED|Overall Study||462
8989583|NCT02760407|10052795|FG003|STARTED|Overall Study||243
8989584|NCT02760407|10052792|FG000|COMPLETED|Overall Study||443
8989585|NCT02760407|10052793|FG001|COMPLETED|Overall Study||421
8989586|NCT02760407|10052794|FG002|COMPLETED|Overall Study||412
8989587|NCT02760407|10052795|FG003|COMPLETED|Overall Study||207
8989588|NCT02760407|10052792|FG000|NOT COMPLETED|Overall Study||36
8989589|NCT02760407|10052793|FG001|NOT COMPLETED|Overall Study||43
8989590|NCT02760407|10052794|FG002|NOT COMPLETED|Overall Study||50
8989591|NCT02760407|10052795|FG003|NOT COMPLETED|Overall Study||36
8989592|NCT02760433|10052811|FG000|STARTED|Overall Study||161
8989593|NCT02760433|10052812|FG001|STARTED|Overall Study||138
8989594|NCT02760433|10052813|FG002|STARTED|Overall Study||26
8989595|NCT02760433|10052814|FG003|STARTED|Overall Study||32
8989596|NCT02760433|10052815|FG004|STARTED|Overall Study||11
8989597|NCT02760433|10052811|FG000|COMPLETED|Overall Study||134
8989598|NCT02760433|10052812|FG001|COMPLETED|Overall Study||128
8989599|NCT02760433|10052813|FG002|COMPLETED|Overall Study||25
8989600|NCT02760433|10052814|FG003|COMPLETED|Overall Study||30
8989601|NCT02760433|10052815|FG004|COMPLETED|Overall Study||1
8989602|NCT02760433|10052811|FG000|NOT COMPLETED|Overall Study||27
8989603|NCT02760433|10052812|FG001|NOT COMPLETED|Overall Study||10
8989604|NCT02760433|10052813|FG002|NOT COMPLETED|Overall Study||1
8989605|NCT02760433|10052814|FG003|NOT COMPLETED|Overall Study||2
8989606|NCT02760433|10052815|FG004|NOT COMPLETED|Overall Study||10
8989607|NCT02760654|10052834|FG000|STARTED|Overall Study||30
8989608|NCT02760654|10052835|FG001|STARTED|Overall Study||30
8989609|NCT02760654|10052834|FG000|COMPLETED|Overall Study||23
8989610|NCT02760654|10052835|FG001|COMPLETED|Overall Study||24
8989611|NCT02760654|10052834|FG000|NOT COMPLETED|Overall Study||7
8989612|NCT02760654|10052835|FG001|NOT COMPLETED|Overall Study||6
8989613|NCT02760810|10052841|FG000|STARTED|Overall Study||30
8989614|NCT02760810|10052841|FG000|COMPLETED|Overall Study||29
8989615|NCT02760810|10052841|FG000|NOT COMPLETED|Overall Study||1
8989616|NCT02760862|10052847|FG000|STARTED|Overall Study||25
8989617|NCT02760862|10052848|FG001|STARTED|Overall Study||25
8989618|NCT02760862|10052847|FG000|COMPLETED|Overall Study||25
8989619|NCT02760862|10052848|FG001|COMPLETED|Overall Study||25
8989620|NCT02760862|10052847|FG000|NOT COMPLETED|Overall Study||0
8989621|NCT02760862|10052848|FG001|NOT COMPLETED|Overall Study||0
8989622|NCT02760927|10052854|FG000|STARTED|Overall Study||4
8989623|NCT02760927|10052854|FG000|COMPLETED|Overall Study||3
8989624|NCT02760927|10052854|FG000|NOT COMPLETED|Overall Study||1
8989625|NCT02761252|10052861|FG000|STARTED|Overall Study||143
8989626|NCT02761252|10052862|FG001|STARTED|Overall Study||140
8989627|NCT02761252|10052863|FG002|STARTED|Overall Study||137
8989628|NCT02761252|10052861|FG000|COMPLETED|Overall Study||133
8989629|NCT02761252|10052862|FG001|COMPLETED|Overall Study||132
8989630|NCT02761252|10052863|FG002|COMPLETED|Overall Study||123
8989631|NCT02761252|10052861|FG000|NOT COMPLETED|Overall Study||10
8989632|NCT02761252|10052862|FG001|NOT COMPLETED|Overall Study||8
8989633|NCT02761252|10052863|FG002|NOT COMPLETED|Overall Study||14
8989634|NCT02761330|10052873|FG000|STARTED|Treatment Week 1||2
8989635|NCT02761330|10052874|FG001|STARTED|Treatment Week 1||3
8989636|NCT02761330|10052875|FG002|STARTED|Treatment Week 1||2
8989637|NCT02761330|10052876|FG003|STARTED|Treatment Week 1||3
8989638|NCT02761330|10052877|FG004|STARTED|Treatment Week 1||1
8989639|NCT02761330|10052878|FG005|STARTED|Treatment Week 1||3
8989640|NCT02761330|10052873|FG000|COMPLETED|Treatment Week 1||2
8989641|NCT02761330|10052874|FG001|COMPLETED|Treatment Week 1||3
8989642|NCT02761330|10052875|FG002|COMPLETED|Treatment Week 1||2
8989643|NCT02761330|10052876|FG003|COMPLETED|Treatment Week 1||2
8989644|NCT02761330|10052877|FG004|COMPLETED|Treatment Week 1||1
8989645|NCT02761330|10052878|FG005|COMPLETED|Treatment Week 1||2
8989646|NCT02761330|10052873|FG000|NOT COMPLETED|Treatment Week 1||0
8989647|NCT02761330|10052874|FG001|NOT COMPLETED|Treatment Week 1||0
8633366|NCT00550446|9673395|FG010|STARTED|Post Week 12||25
8633367|NCT00550446|9673385|FG000|COMPLETED|Post Week 12||24
8633368|NCT00550446|9673386|FG001|COMPLETED|Post Week 12||28
8989648|NCT02761330|10052875|FG002|NOT COMPLETED|Treatment Week 1||0
8989649|NCT02761330|10052876|FG003|NOT COMPLETED|Treatment Week 1||1
8989650|NCT02761330|10052877|FG004|NOT COMPLETED|Treatment Week 1||0
8989651|NCT02761330|10052878|FG005|NOT COMPLETED|Treatment Week 1||1
8989652|NCT02761330|10052873|FG000|STARTED|Treatment Week 2||2
8989653|NCT02761330|10052874|FG001|STARTED|Treatment Week 2||3
8989654|NCT02761330|10052875|FG002|STARTED|Treatment Week 2||2
8989655|NCT02761330|10052876|FG003|STARTED|Treatment Week 2|1 pt. in this group completed Week 1, but did not begin Week 2 due to withdraw.|1
8989656|NCT02761330|10052877|FG004|STARTED|Treatment Week 2||1
8989657|NCT02761330|10052878|FG005|STARTED|Treatment Week 2|1 pt. in this group completed Week 1, but did not begin Week 2 due to cancellation of treatment.|1
8989658|NCT02761330|10052873|FG000|COMPLETED|Treatment Week 2||2
8989659|NCT02761330|10052874|FG001|COMPLETED|Treatment Week 2||3
8989660|NCT02761330|10052875|FG002|COMPLETED|Treatment Week 2||2
8633369|NCT00550446|9673387|FG002|COMPLETED|Post Week 12||43
8633370|NCT00550446|9673388|FG003|COMPLETED|Post Week 12||55
8633371|NCT00550446|9673389|FG004|COMPLETED|Post Week 12||52
8989661|NCT02761330|10052876|FG003|COMPLETED|Treatment Week 2||1
8989662|NCT02761330|10052877|FG004|COMPLETED|Treatment Week 2||1
8989663|NCT02761330|10052878|FG005|COMPLETED|Treatment Week 2||1
8989664|NCT02761330|10052873|FG000|NOT COMPLETED|Treatment Week 2||0
8989665|NCT02761330|10052874|FG001|NOT COMPLETED|Treatment Week 2||0
8989666|NCT02761330|10052875|FG002|NOT COMPLETED|Treatment Week 2||0
8989667|NCT02761330|10052876|FG003|NOT COMPLETED|Treatment Week 2||0
8989668|NCT02761330|10052877|FG004|NOT COMPLETED|Treatment Week 2||0
8989669|NCT02761330|10052878|FG005|NOT COMPLETED|Treatment Week 2||0
8989670|NCT02761629|10052894|FG000|STARTED|Overall Study||90
8989671|NCT02761629|10052895|FG001|STARTED|Overall Study||90
8571793|NCT00112437|9604145|FG022|STARTED|Year 1 (12-Month Base Study)||0
8571794|NCT00112437|9604146|FG023|STARTED|Year 1 (12-Month Base Study)||0
8571795|NCT00112437|9604147|FG024|STARTED|Year 1 (12-Month Base Study)||0
8571796|NCT00112437|9604148|FG025|STARTED|Year 1 (12-Month Base Study)||0
8571797|NCT00112437|9604123|FG000|COMPLETED|Year 1 (12-Month Base Study)|1 patient completed base study after December 19, 2006 and is not included in completed total.|68
8571798|NCT00112437|9604124|FG001|COMPLETED|Year 1 (12-Month Base Study)|1 patient completed base study after December 19, 2006 and is not included in completed total.|64
8571799|NCT00112437|9604125|FG002|COMPLETED|Year 1 (12-Month Base Study)||65
8571800|NCT00112437|9604126|FG003|COMPLETED|Year 1 (12-Month Base Study)||71
8571801|NCT00112437|9604127|FG004|COMPLETED|Year 1 (12-Month Base Study)|1 patient completed base study after December 19, 2006 and is not included in the completed total.|66
8571802|NCT00112437|9604128|FG005|COMPLETED|Year 1 (12-Month Base Study)||0
8571803|NCT00112437|9604129|FG006|COMPLETED|Year 1 (12-Month Base Study)||0
8571804|NCT00112437|9604130|FG007|COMPLETED|Year 1 (12-Month Base Study)||0
8571805|NCT00112437|9604131|FG008|COMPLETED|Year 1 (12-Month Base Study)||0
8571806|NCT00112437|9604132|FG009|COMPLETED|Year 1 (12-Month Base Study)||0
8571807|NCT00112437|9604133|FG010|COMPLETED|Year 1 (12-Month Base Study)||0
8571808|NCT00112437|9604134|FG011|COMPLETED|Year 1 (12-Month Base Study)||0
8571809|NCT00112437|9604135|FG012|COMPLETED|Year 1 (12-Month Base Study)||0
8571810|NCT00112437|9604136|FG013|COMPLETED|Year 1 (12-Month Base Study)||0
8571811|NCT00112437|9604137|FG014|COMPLETED|Year 1 (12-Month Base Study)||0
8571812|NCT00112437|9604138|FG015|COMPLETED|Year 1 (12-Month Base Study)||0
8989672|NCT02761629|10052894|FG000|Treated|Overall Study||82
8989673|NCT02761629|10052895|FG001|Treated|Overall Study||86
8989674|NCT02761629|10052894|FG000|COMPLETED|Overall Study||63
8989675|NCT02761629|10052895|FG001|COMPLETED|Overall Study||58
8989676|NCT02761629|10052894|FG000|NOT COMPLETED|Overall Study||27
8989677|NCT02761629|10052895|FG001|NOT COMPLETED|Overall Study||32
8989678|NCT02761642|10052901|FG000|STARTED|Overall Study||200
8989679|NCT02761642|10052901|FG000|Treated|Overall Study||197
8989680|NCT02761642|10052901|FG000|COMPLETED|Overall Study||130
8989681|NCT02761642|10052901|FG000|NOT COMPLETED|Overall Study||70
8989682|NCT02761733|10052909|FG000|STARTED|Overall Study||60
8989683|NCT02761733|10052910|FG001|STARTED|Overall Study||60
8989684|NCT02761733|10052911|FG002|STARTED|Overall Study||60
8989685|NCT02761733|10052912|FG003|STARTED|Overall Study||60
8989686|NCT02761733|10052909|FG000|9/30/2014|Overall Study||53
8989687|NCT02761733|10052910|FG001|9/30/2014|Overall Study||56
8989688|NCT02761733|10052911|FG002|9/30/2014|Overall Study||48
8989689|NCT02761733|10052912|FG003|9/30/2014|Overall Study||55
8989690|NCT02761733|10052909|FG000|3/31/2015|Overall Study||48
8989691|NCT02761733|10052910|FG001|3/31/2015|Overall Study||47
8989692|NCT02761733|10052911|FG002|3/31/2015|Overall Study||43
8989693|NCT02761733|10052912|FG003|3/31/2015|Overall Study||50
8989694|NCT02761733|10052909|FG000|9/30/2015|Overall Study||40
8989695|NCT02761733|10052910|FG001|9/30/2015|Overall Study||44
8989696|NCT02761733|10052911|FG002|9/30/2015|Overall Study||33
8989697|NCT02761733|10052912|FG003|9/30/2015|Overall Study||50
8989698|NCT02761733|10052909|FG000|COMPLETED|Overall Study||30
8989699|NCT02761733|10052910|FG001|COMPLETED|Overall Study||39
8989700|NCT02761733|10052911|FG002|COMPLETED|Overall Study||33
8989701|NCT02761733|10052912|FG003|COMPLETED|Overall Study||45
8989702|NCT02761733|10052909|FG000|NOT COMPLETED|Overall Study||30
8989703|NCT02761733|10052910|FG001|NOT COMPLETED|Overall Study||21
8989704|NCT02761733|10052911|FG002|NOT COMPLETED|Overall Study||27
8989705|NCT02761733|10052912|FG003|NOT COMPLETED|Overall Study||15
8989706|NCT02761915|10052928|FG000|STARTED|Overall Study||4
8989707|NCT02761915|10052929|FG001|STARTED|Overall Study||1
8989708|NCT02761915|10052930|FG002|STARTED|Overall Study||1
8989709|NCT02761915|10052931|FG003|STARTED|Overall Study||3
8989710|NCT02761915|10052932|FG004|STARTED|Overall Study||3
8989711|NCT02761915|10052933|FG005|STARTED|Overall Study||5
8989712|NCT02761915|10052928|FG000|Underwent Leukapheresis|Overall Study||4
8989713|NCT02761915|10052929|FG001|Underwent Leukapheresis|Overall Study||1
8989714|NCT02761915|10052930|FG002|Underwent Leukapheresis|Overall Study||1
8989715|NCT02761915|10052931|FG003|Underwent Leukapheresis|Overall Study||3
8989716|NCT02761915|10052932|FG004|Underwent Leukapheresis|Overall Study||3
8989717|NCT02761915|10052933|FG005|Underwent Leukapheresis|Overall Study||5
8989718|NCT02761915|10052928|FG000|Received Investigational Medicinal Product|Overall Study||4
8989719|NCT02761915|10052929|FG001|Received Investigational Medicinal Product|Overall Study||1
8989720|NCT02761915|10052930|FG002|Received Investigational Medicinal Product|Overall Study||1
8989721|NCT02761915|10052931|FG003|Received Investigational Medicinal Product|Overall Study||3
8989722|NCT02761915|10052932|FG004|Received Investigational Medicinal Product|Overall Study||3
8989723|NCT02761915|10052933|FG005|Received Investigational Medicinal Product|Overall Study||0
8989724|NCT02761915|10052928|FG000|COMPLETED|Overall Study||0
8989725|NCT02761915|10052929|FG001|COMPLETED|Overall Study||0
8989726|NCT02761915|10052930|FG002|COMPLETED|Overall Study||0
8989727|NCT02761915|10052931|FG003|COMPLETED|Overall Study||0
8989728|NCT02761915|10052932|FG004|COMPLETED|Overall Study||0
8989729|NCT02761915|10052933|FG005|COMPLETED|Overall Study||0
8989730|NCT02761915|10052928|FG000|NOT COMPLETED|Overall Study||4
8989731|NCT02761915|10052929|FG001|NOT COMPLETED|Overall Study||1
8989732|NCT02761915|10052930|FG002|NOT COMPLETED|Overall Study||1
8989733|NCT02761915|10052931|FG003|NOT COMPLETED|Overall Study||3
8989734|NCT02761915|10052932|FG004|NOT COMPLETED|Overall Study||3
8989735|NCT02761915|10052933|FG005|NOT COMPLETED|Overall Study||5
8989736|NCT02761967|10052953|FG000|STARTED|Overall Study||70
8989737|NCT02761967|10052954|FG001|STARTED|Overall Study||70
8989738|NCT02761967|10052953|FG000|COMPLETED|Overall Study||65
8989739|NCT02761967|10052954|FG001|COMPLETED|Overall Study||64
8989740|NCT02761967|10052953|FG000|NOT COMPLETED|Overall Study||5
8989741|NCT02761967|10052954|FG001|NOT COMPLETED|Overall Study||6
8989742|NCT02761980|10052967|FG000|STARTED|Overall Study||29
8989743|NCT02761980|10052968|FG001|STARTED|Overall Study||87
8989744|NCT02761980|10052969|FG002|STARTED|Overall Study||87
8989745|NCT02761980|10052970|FG003|STARTED|Overall Study||87
8989746|NCT02761980|10052967|FG000|COMPLETED|Overall Study||25
8989747|NCT02761980|10052968|FG001|COMPLETED|Overall Study||80
8989748|NCT02761980|10052969|FG002|COMPLETED|Overall Study||81
8989749|NCT02761980|10052970|FG003|COMPLETED|Overall Study||81
8989750|NCT02761980|10052967|FG000|NOT COMPLETED|Overall Study||4
8989751|NCT02761980|10052968|FG001|NOT COMPLETED|Overall Study||7
8989752|NCT02761980|10052969|FG002|NOT COMPLETED|Overall Study||6
8989753|NCT02761980|10052970|FG003|NOT COMPLETED|Overall Study||6
8989754|NCT02761993|10052983|FG000|STARTED|Overall Study||52
8989755|NCT02761993|10052984|FG001|STARTED|Overall Study||49
8989756|NCT02761993|10052985|FG002|STARTED|Overall Study||50
8989757|NCT02761993|10052983|FG000|COMPLETED|Overall Study||50
8989758|NCT02761993|10052984|FG001|COMPLETED|Overall Study||43
8989759|NCT02761993|10052985|FG002|COMPLETED|Overall Study||46
8989760|NCT02761993|10052983|FG000|NOT COMPLETED|Overall Study||2
8989761|NCT02761993|10052984|FG001|NOT COMPLETED|Overall Study||6
8989762|NCT02761993|10052985|FG002|NOT COMPLETED|Overall Study||4
8633372|NCT00550446|9673390|FG005|COMPLETED|Post Week 12||0
8633373|NCT00550446|9673391|FG006|COMPLETED|Post Week 12||19
8633374|NCT00550446|9673392|FG007|COMPLETED|Post Week 12||16
8633375|NCT00550446|9673393|FG008|COMPLETED|Post Week 12||15
8633376|NCT00550446|9673394|FG009|COMPLETED|Post Week 12||37
8633377|NCT00550446|9673395|FG010|COMPLETED|Post Week 12||24
8633378|NCT00550446|9673385|FG000|NOT COMPLETED|Post Week 12||3
8633379|NCT00550446|9673386|FG001|NOT COMPLETED|Post Week 12||2
8633380|NCT00550446|9673387|FG002|NOT COMPLETED|Post Week 12||3
8633381|NCT00550446|9673388|FG003|NOT COMPLETED|Post Week 12||3
8633382|NCT00550446|9673389|FG004|NOT COMPLETED|Post Week 12||2
8633383|NCT00550446|9673390|FG005|NOT COMPLETED|Post Week 12||1
8989763|NCT02762071|10052995|FG000|STARTED|Overall Study||54
8989764|NCT02762071|10052996|FG001|STARTED|Overall Study||54
8989765|NCT02762071|10052995|FG000|COMPLETED|Overall Study||54
8989766|NCT02762071|10052996|FG001|COMPLETED|Overall Study||54
8989767|NCT02762071|10052995|FG000|NOT COMPLETED|Overall Study||0
8989768|NCT02762071|10052996|FG001|NOT COMPLETED|Overall Study||0
8633384|NCT00550446|9673391|FG006|NOT COMPLETED|Post Week 12||2
8633385|NCT00550446|9673392|FG007|NOT COMPLETED|Post Week 12||1
8633386|NCT00550446|9673393|FG008|NOT COMPLETED|Post Week 12||2
8633387|NCT00550446|9673394|FG009|NOT COMPLETED|Post Week 12||7
8633388|NCT00550446|9673395|FG010|NOT COMPLETED|Post Week 12||1
8633389|NCT00550459|9673435|FG000|STARTED|Overall Study||28
8633390|NCT00550459|9673436|FG001|STARTED|Overall Study||29
8633391|NCT00550459|9673435|FG000|COMPLETED|Overall Study||27
8633392|NCT00550459|9673436|FG001|COMPLETED|Overall Study||26
8989769|NCT02762084|10053006|FG000|STARTED|Overall Study||6
8989770|NCT02762084|10053007|FG001|STARTED|Overall Study||6
8989771|NCT02762084|10053008|FG002|STARTED|Overall Study||5
8989772|NCT02762084|10053006|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
8989773|NCT02762084|10053007|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
8989774|NCT02762084|10053008|FG002|Received at Least 1 Dose of Study Drug|Overall Study||5
8989775|NCT02762084|10053006|FG000|By Tumor Per Protocol Population (PP)|Overall Study||6
8989776|NCT02762084|10053007|FG001|By Tumor Per Protocol Population (PP)|Overall Study||6
8989777|NCT02762084|10053008|FG002|By Tumor Per Protocol Population (PP)|Overall Study||4
8989778|NCT02762084|10053006|FG000|COMPLETED|Overall Study||5
8989779|NCT02762084|10053007|FG001|COMPLETED|Overall Study||6
8989780|NCT02762084|10053008|FG002|COMPLETED|Overall Study||4
8633393|NCT00550459|9673435|FG000|NOT COMPLETED|Overall Study||1
8989781|NCT02762084|10053006|FG000|NOT COMPLETED|Overall Study||1
8989782|NCT02762084|10053007|FG001|NOT COMPLETED|Overall Study||0
8989783|NCT02762084|10053008|FG002|NOT COMPLETED|Overall Study||1
8989784|NCT02762331|10053020|FG000|STARTED|Overall Study||4
8989785|NCT02762331|10053021|FG001|STARTED|Overall Study||2
8989786|NCT02762331|10053020|FG000|COMPLETED|Overall Study||4
8989787|NCT02762331|10053021|FG001|COMPLETED|Overall Study||2
8989788|NCT02762331|10053020|FG000|NOT COMPLETED|Overall Study||0
8989789|NCT02762331|10053021|FG001|NOT COMPLETED|Overall Study||0
8989790|NCT02762370|10053029|FG000|STARTED|Overall Study||18
8989791|NCT02762370|10053030|FG001|STARTED|Overall Study||15
8989792|NCT02762370|10053029|FG000|COMPLETED|Overall Study||17
8989793|NCT02762370|10053030|FG001|COMPLETED|Overall Study||15
8989794|NCT02762370|10053029|FG000|NOT COMPLETED|Overall Study||1
8989795|NCT02762370|10053030|FG001|NOT COMPLETED|Overall Study||0
8989796|NCT02762500|10053040|FG000|STARTED|Overall Study||62
8989797|NCT02762500|10053041|FG001|STARTED|Overall Study||62
8989798|NCT02762500|10053040|FG000|COMPLETED|Overall Study||60
8989799|NCT02762500|10053041|FG001|COMPLETED|Overall Study||59
8989800|NCT02762500|10053040|FG000|NOT COMPLETED|Overall Study||2
8989801|NCT02762500|10053041|FG001|NOT COMPLETED|Overall Study||3
8989802|NCT02762513|10053047|FG000|STARTED|Overall Study||28
8989803|NCT02762513|10053047|FG000|COMPLETED|Overall Study||28
8989804|NCT02762513|10053047|FG000|NOT COMPLETED|Overall Study||0
8989805|NCT02762565|10053051|FG000|STARTED|Overall Study||89
8989806|NCT02762565|10053051|FG000|COMPLETED|Overall Study||78
8989807|NCT02762565|10053051|FG000|NOT COMPLETED|Overall Study||11
8989808|NCT02762578|10053057|FG000|STARTED|Overall Study||361
8989809|NCT02762578|10053058|FG001|STARTED|Overall Study||182
8633394|NCT00550459|9673436|FG001|NOT COMPLETED|Overall Study||3
8633395|NCT00550537|9673442|FG000|STARTED|Overall Study||116
8633396|NCT00550537|9673442|FG000|COMPLETED|Overall Study||12
8633397|NCT00550537|9673442|FG000|NOT COMPLETED|Overall Study||104
8633398|NCT00550550|9673453|FG000|STARTED|Overall Study||176
8989810|NCT02762578|10053057|FG000|Exposed|Overall Study||360
8989811|NCT02762578|10053058|FG001|Exposed|Overall Study||181
8989812|NCT02762578|10053057|FG000|COMPLETED|Overall Study||346
8989813|NCT02762578|10053058|FG001|COMPLETED|Overall Study||172
8989814|NCT02762578|10053057|FG000|NOT COMPLETED|Overall Study||15
8989815|NCT02762578|10053058|FG001|NOT COMPLETED|Overall Study||10
8989816|NCT02762799|10053068|FG000|STARTED|Overall Study||18
8989817|NCT02762799|10053069|FG001|STARTED|Overall Study||18
8989818|NCT02762799|10053070|FG002|STARTED|Overall Study||12
8989819|NCT02762799|10053071|FG003|STARTED|Overall Study||12
8989820|NCT02762799|10053068|FG000|COMPLETED|Overall Study||18
8989821|NCT02762799|10053069|FG001|COMPLETED|Overall Study||18
8989822|NCT02762799|10053070|FG002|COMPLETED|Overall Study||11
8989823|NCT02762799|10053071|FG003|COMPLETED|Overall Study||12
8989824|NCT02762799|10053068|FG000|NOT COMPLETED|Overall Study||0
8989825|NCT02762799|10053069|FG001|NOT COMPLETED|Overall Study||0
8989826|NCT02762799|10053070|FG002|NOT COMPLETED|Overall Study||1
8989827|NCT02762799|10053071|FG003|NOT COMPLETED|Overall Study||0
8989828|NCT02762877|10053085|FG000|STARTED|Overall Study||121
8989829|NCT02762877|10053086|FG001|STARTED|Overall Study||19
8989830|NCT02762877|10053085|FG000|COMPLETED|Overall Study||121
8989831|NCT02762877|10053086|FG001|COMPLETED|Overall Study||19
8989832|NCT02762877|10053085|FG000|NOT COMPLETED|Overall Study||0
8989833|NCT02762877|10053086|FG001|NOT COMPLETED|Overall Study||0
8989834|NCT02762994|10053097|FG000|STARTED|Overall Study||31
8989835|NCT02762994|10053098|FG001|STARTED|Overall Study||31
8989836|NCT02762994|10053099|FG002|STARTED|Overall Study||30
8989837|NCT02762994|10053100|FG003|STARTED|Overall Study||28
8989838|NCT02762994|10053097|FG000|COMPLETED|Overall Study||30
8989839|NCT02762994|10053098|FG001|COMPLETED|Overall Study||30
8989840|NCT02762994|10053099|FG002|COMPLETED|Overall Study||28
8989841|NCT02762994|10053100|FG003|COMPLETED|Overall Study||26
8989842|NCT02762994|10053097|FG000|NOT COMPLETED|Overall Study||1
8989843|NCT02762994|10053098|FG001|NOT COMPLETED|Overall Study||1
8989844|NCT02762994|10053099|FG002|NOT COMPLETED|Overall Study||2
8989845|NCT02762994|10053100|FG003|NOT COMPLETED|Overall Study||2
8989846|NCT02763046|10053117|FG000|STARTED|Overall Study||71
8989847|NCT02763046|10053118|FG001|STARTED|Overall Study||70
8989848|NCT02763046|10053119|FG002|STARTED|Overall Study||70
8989849|NCT02763046|10053117|FG000|COMPLETED|Overall Study||62
8989850|NCT02763046|10053118|FG001|COMPLETED|Overall Study||65
8989851|NCT02763046|10053119|FG002|COMPLETED|Overall Study||62
8989852|NCT02763046|10053117|FG000|NOT COMPLETED|Overall Study||9
8989853|NCT02763046|10053118|FG001|NOT COMPLETED|Overall Study||5
8989854|NCT02763046|10053119|FG002|NOT COMPLETED|Overall Study||8
8989855|NCT02763124|10053133|FG000|STARTED|Overall Study||18
8989856|NCT02763124|10053133|FG000|COMPLETED|Overall Study||18
8989857|NCT02763124|10053133|FG000|NOT COMPLETED|Overall Study||0
8989858|NCT02763215|10053137|FG000|STARTED|Overall Study||64
8989859|NCT02763215|10053137|FG000|COMPLETED|Overall Study||57
8989860|NCT02763215|10053137|FG000|NOT COMPLETED|Overall Study||7
8989861|NCT02763254|10053141|FG000|STARTED|Overall Study||1
8989862|NCT02763254|10053141|FG000|COMPLETED|Overall Study||0
8989863|NCT02763254|10053141|FG000|NOT COMPLETED|Overall Study||1
8989864|NCT02763566|10053149|FG000|STARTED|Overall Study||207
8989865|NCT02763566|10053150|FG001|STARTED|Overall Study||99
8989866|NCT02763566|10053151|FG002|STARTED|Overall Study||104
8989867|NCT02763566|10053152|FG003|STARTED|Overall Study||53
8989868|NCT02763566|10053149|FG000|COMPLETED|Overall Study||89
8989869|NCT02763566|10053150|FG001|COMPLETED|Overall Study||60
8989870|NCT02763566|10053151|FG002|COMPLETED|Overall Study||50
8989871|NCT02763566|10053152|FG003|COMPLETED|Overall Study||39
8989872|NCT02763566|10053149|FG000|NOT COMPLETED|Overall Study||118
8989873|NCT02763566|10053150|FG001|NOT COMPLETED|Overall Study||39
8989874|NCT02763566|10053151|FG002|NOT COMPLETED|Overall Study||54
8989875|NCT02763566|10053152|FG003|NOT COMPLETED|Overall Study||14
8989876|NCT02763644|10053168|FG000|STARTED|Overall Study||3
8989877|NCT02763644|10053169|FG001|STARTED|Overall Study||4
8989878|NCT02763644|10053168|FG000|COMPLETED|Overall Study||0
8989879|NCT02763644|10053169|FG001|COMPLETED|Overall Study||2
8989880|NCT02763644|10053168|FG000|NOT COMPLETED|Overall Study||3
8989881|NCT02763644|10053169|FG001|NOT COMPLETED|Overall Study||2
8989882|NCT02763826|10053184|FG000|STARTED|Part 1 Dose Escalation, 1 mA||3
8989883|NCT02763826|10053185|FG001|STARTED|Part 1 Dose Escalation, 1 mA||0
8989884|NCT02763826|10053186|FG002|STARTED|Part 1 Dose Escalation, 1 mA||0
8989885|NCT02763826|10053187|FG003|STARTED|Part 1 Dose Escalation, 1 mA||0
8989886|NCT02763826|10053188|FG004|STARTED|Part 1 Dose Escalation, 1 mA||0
8989887|NCT02763826|10053189|FG005|STARTED|Part 1 Dose Escalation, 1 mA||0
8989888|NCT02763826|10053190|FG006|STARTED|Part 1 Dose Escalation, 1 mA||0
8989889|NCT02763826|10053191|FG007|STARTED|Part 1 Dose Escalation, 1 mA||0
8989890|NCT02763826|10053184|FG000|COMPLETED|Part 1 Dose Escalation, 1 mA||3
8989891|NCT02763826|10053185|FG001|COMPLETED|Part 1 Dose Escalation, 1 mA||0
8989892|NCT02763826|10053186|FG002|COMPLETED|Part 1 Dose Escalation, 1 mA||0
8989893|NCT02763826|10053187|FG003|COMPLETED|Part 1 Dose Escalation, 1 mA||0
8989894|NCT02763826|10053188|FG004|COMPLETED|Part 1 Dose Escalation, 1 mA||0
8989895|NCT02763826|10053189|FG005|COMPLETED|Part 1 Dose Escalation, 1 mA||0
8989896|NCT02763826|10053190|FG006|COMPLETED|Part 1 Dose Escalation, 1 mA||0
8989897|NCT02763826|10053191|FG007|COMPLETED|Part 1 Dose Escalation, 1 mA||0
8989898|NCT02763826|10053184|FG000|NOT COMPLETED|Part 1 Dose Escalation, 1 mA||0
8989899|NCT02763826|10053185|FG001|NOT COMPLETED|Part 1 Dose Escalation, 1 mA||0
8989900|NCT02763826|10053186|FG002|NOT COMPLETED|Part 1 Dose Escalation, 1 mA||0
8989901|NCT02763826|10053187|FG003|NOT COMPLETED|Part 1 Dose Escalation, 1 mA||0
8989902|NCT02763826|10053188|FG004|NOT COMPLETED|Part 1 Dose Escalation, 1 mA||0
8989903|NCT02763826|10053189|FG005|NOT COMPLETED|Part 1 Dose Escalation, 1 mA||0
8989904|NCT02763826|10053190|FG006|NOT COMPLETED|Part 1 Dose Escalation, 1 mA||0
8989905|NCT02763826|10053191|FG007|NOT COMPLETED|Part 1 Dose Escalation, 1 mA||0
8989906|NCT02763826|10053184|FG000|STARTED|Part 1 Dose Escalation, 2 mA||0
8989907|NCT02763826|10053185|FG001|STARTED|Part 1 Dose Escalation, 2 mA||3
8989908|NCT02763826|10053186|FG002|STARTED|Part 1 Dose Escalation, 2 mA||0
8989909|NCT02763826|10053187|FG003|STARTED|Part 1 Dose Escalation, 2 mA||0
8989910|NCT02763826|10053188|FG004|STARTED|Part 1 Dose Escalation, 2 mA||0
8989911|NCT02763826|10053189|FG005|STARTED|Part 1 Dose Escalation, 2 mA||0
8989912|NCT02763826|10053190|FG006|STARTED|Part 1 Dose Escalation, 2 mA||0
8989913|NCT02763826|10053191|FG007|STARTED|Part 1 Dose Escalation, 2 mA||0
8989914|NCT02763826|10053184|FG000|COMPLETED|Part 1 Dose Escalation, 2 mA||0
8989915|NCT02763826|10053185|FG001|COMPLETED|Part 1 Dose Escalation, 2 mA||3
8989916|NCT02763826|10053186|FG002|COMPLETED|Part 1 Dose Escalation, 2 mA||0
8989917|NCT02763826|10053187|FG003|COMPLETED|Part 1 Dose Escalation, 2 mA||0
8989918|NCT02763826|10053188|FG004|COMPLETED|Part 1 Dose Escalation, 2 mA||0
8989919|NCT02763826|10053189|FG005|COMPLETED|Part 1 Dose Escalation, 2 mA||0
8989920|NCT02763826|10053190|FG006|COMPLETED|Part 1 Dose Escalation, 2 mA||0
8989921|NCT02763826|10053191|FG007|COMPLETED|Part 1 Dose Escalation, 2 mA||0
8989922|NCT02763826|10053184|FG000|NOT COMPLETED|Part 1 Dose Escalation, 2 mA||0
8989923|NCT02763826|10053185|FG001|NOT COMPLETED|Part 1 Dose Escalation, 2 mA||0
8989924|NCT02763826|10053186|FG002|NOT COMPLETED|Part 1 Dose Escalation, 2 mA||0
8989925|NCT02763826|10053187|FG003|NOT COMPLETED|Part 1 Dose Escalation, 2 mA||0
8989926|NCT02763826|10053188|FG004|NOT COMPLETED|Part 1 Dose Escalation, 2 mA||0
8989927|NCT02763826|10053189|FG005|NOT COMPLETED|Part 1 Dose Escalation, 2 mA||0
8989928|NCT02763826|10053190|FG006|NOT COMPLETED|Part 1 Dose Escalation, 2 mA||0
8989929|NCT02763826|10053191|FG007|NOT COMPLETED|Part 1 Dose Escalation, 2 mA||0
8989930|NCT02763826|10053184|FG000|STARTED|Part 1 Dose Escalation, 2.5 mA||0
8989931|NCT02763826|10053185|FG001|STARTED|Part 1 Dose Escalation, 2.5 mA||0
8989932|NCT02763826|10053186|FG002|STARTED|Part 1 Dose Escalation, 2.5 mA||3
8989933|NCT02763826|10053187|FG003|STARTED|Part 1 Dose Escalation, 2.5 mA||0
8989934|NCT02763826|10053188|FG004|STARTED|Part 1 Dose Escalation, 2.5 mA||0
8989935|NCT02763826|10053189|FG005|STARTED|Part 1 Dose Escalation, 2.5 mA||0
8989936|NCT02763826|10053190|FG006|STARTED|Part 1 Dose Escalation, 2.5 mA||0
8989937|NCT02763826|10053191|FG007|STARTED|Part 1 Dose Escalation, 2.5 mA||0
8989938|NCT02763826|10053184|FG000|COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
8989939|NCT02763826|10053185|FG001|COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
8989940|NCT02763826|10053186|FG002|COMPLETED|Part 1 Dose Escalation, 2.5 mA||3
8989941|NCT02763826|10053187|FG003|COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
8989942|NCT02763826|10053188|FG004|COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
8989943|NCT02763826|10053189|FG005|COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
8989944|NCT02763826|10053190|FG006|COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
8989945|NCT02763826|10053191|FG007|COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
8989946|NCT02763826|10053184|FG000|NOT COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
8989947|NCT02763826|10053185|FG001|NOT COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
8989948|NCT02763826|10053186|FG002|NOT COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
8989949|NCT02763826|10053187|FG003|NOT COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
8989950|NCT02763826|10053188|FG004|NOT COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
8989951|NCT02763826|10053189|FG005|NOT COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
8989952|NCT02763826|10053190|FG006|NOT COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
8989953|NCT02763826|10053191|FG007|NOT COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
8989954|NCT02763826|10053184|FG000|STARTED|Part 1 Dose Escalation, 3 mA||0
8989955|NCT02763826|10053185|FG001|STARTED|Part 1 Dose Escalation, 3 mA||0
8989956|NCT02763826|10053186|FG002|STARTED|Part 1 Dose Escalation, 3 mA||0
8989957|NCT02763826|10053187|FG003|STARTED|Part 1 Dose Escalation, 3 mA||3
8989958|NCT02763826|10053188|FG004|STARTED|Part 1 Dose Escalation, 3 mA||0
8989959|NCT02763826|10053189|FG005|STARTED|Part 1 Dose Escalation, 3 mA||0
8989960|NCT02763826|10053190|FG006|STARTED|Part 1 Dose Escalation, 3 mA||0
8989961|NCT02763826|10053191|FG007|STARTED|Part 1 Dose Escalation, 3 mA||0
8989962|NCT02763826|10053184|FG000|COMPLETED|Part 1 Dose Escalation, 3 mA||0
8989963|NCT02763826|10053185|FG001|COMPLETED|Part 1 Dose Escalation, 3 mA||0
8989964|NCT02763826|10053186|FG002|COMPLETED|Part 1 Dose Escalation, 3 mA||0
8989965|NCT02763826|10053187|FG003|COMPLETED|Part 1 Dose Escalation, 3 mA||3
8989966|NCT02763826|10053188|FG004|COMPLETED|Part 1 Dose Escalation, 3 mA||0
8989967|NCT02763826|10053189|FG005|COMPLETED|Part 1 Dose Escalation, 3 mA||0
8989968|NCT02763826|10053190|FG006|COMPLETED|Part 1 Dose Escalation, 3 mA||0
8989969|NCT02763826|10053191|FG007|COMPLETED|Part 1 Dose Escalation, 3 mA||0
8989970|NCT02763826|10053184|FG000|NOT COMPLETED|Part 1 Dose Escalation, 3 mA||0
8989971|NCT02763826|10053185|FG001|NOT COMPLETED|Part 1 Dose Escalation, 3 mA||0
8989972|NCT02763826|10053186|FG002|NOT COMPLETED|Part 1 Dose Escalation, 3 mA||0
8989973|NCT02763826|10053187|FG003|NOT COMPLETED|Part 1 Dose Escalation, 3 mA||0
8989974|NCT02763826|10053188|FG004|NOT COMPLETED|Part 1 Dose Escalation, 3 mA||0
8989975|NCT02763826|10053189|FG005|NOT COMPLETED|Part 1 Dose Escalation, 3 mA||0
8989976|NCT02763826|10053190|FG006|NOT COMPLETED|Part 1 Dose Escalation, 3 mA||0
8989977|NCT02763826|10053191|FG007|NOT COMPLETED|Part 1 Dose Escalation, 3 mA||0
8989978|NCT02763826|10053184|FG000|STARTED|Part 1 Dose Escalation, 3.5 mA||0
8989979|NCT02763826|10053185|FG001|STARTED|Part 1 Dose Escalation, 3.5 mA||0
8989980|NCT02763826|10053186|FG002|STARTED|Part 1 Dose Escalation, 3.5 mA||0
8989981|NCT02763826|10053187|FG003|STARTED|Part 1 Dose Escalation, 3.5 mA||0
8989982|NCT02763826|10053188|FG004|STARTED|Part 1 Dose Escalation, 3.5 mA||3
8989983|NCT02763826|10053189|FG005|STARTED|Part 1 Dose Escalation, 3.5 mA||0
8989984|NCT02763826|10053190|FG006|STARTED|Part 1 Dose Escalation, 3.5 mA||0
8989985|NCT02763826|10053191|FG007|STARTED|Part 1 Dose Escalation, 3.5 mA||0
8989986|NCT02763826|10053184|FG000|COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
8989987|NCT02763826|10053185|FG001|COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
8989988|NCT02763826|10053186|FG002|COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
8989989|NCT02763826|10053187|FG003|COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
8989990|NCT02763826|10053188|FG004|COMPLETED|Part 1 Dose Escalation, 3.5 mA||3
8989991|NCT02763826|10053189|FG005|COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
8989992|NCT02763826|10053190|FG006|COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
8989993|NCT02763826|10053191|FG007|COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
8989994|NCT02763826|10053184|FG000|NOT COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
8989995|NCT02763826|10053185|FG001|NOT COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
8989996|NCT02763826|10053186|FG002|NOT COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
8989997|NCT02763826|10053187|FG003|NOT COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
8989998|NCT02763826|10053188|FG004|NOT COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
8989999|NCT02763826|10053189|FG005|NOT COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
8990000|NCT02763826|10053190|FG006|NOT COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
8990001|NCT02763826|10053191|FG007|NOT COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
8990002|NCT02763826|10053184|FG000|STARTED|Part 1 Dose Escalation, 4 mA||0
8990003|NCT02763826|10053185|FG001|STARTED|Part 1 Dose Escalation, 4 mA||0
8990004|NCT02763826|10053186|FG002|STARTED|Part 1 Dose Escalation, 4 mA||0
8990005|NCT02763826|10053187|FG003|STARTED|Part 1 Dose Escalation, 4 mA||0
8990006|NCT02763826|10053188|FG004|STARTED|Part 1 Dose Escalation, 4 mA||0
8990007|NCT02763826|10053189|FG005|STARTED|Part 1 Dose Escalation, 4 mA||3
8990008|NCT02763826|10053190|FG006|STARTED|Part 1 Dose Escalation, 4 mA||0
8990009|NCT02763826|10053191|FG007|STARTED|Part 1 Dose Escalation, 4 mA||0
8990010|NCT02763826|10053184|FG000|COMPLETED|Part 1 Dose Escalation, 4 mA||0
8990011|NCT02763826|10053185|FG001|COMPLETED|Part 1 Dose Escalation, 4 mA||0
8990012|NCT02763826|10053186|FG002|COMPLETED|Part 1 Dose Escalation, 4 mA||0
8990013|NCT02763826|10053187|FG003|COMPLETED|Part 1 Dose Escalation, 4 mA||0
8990014|NCT02763826|10053188|FG004|COMPLETED|Part 1 Dose Escalation, 4 mA||0
8990015|NCT02763826|10053189|FG005|COMPLETED|Part 1 Dose Escalation, 4 mA||3
8990016|NCT02763826|10053190|FG006|COMPLETED|Part 1 Dose Escalation, 4 mA||0
8990017|NCT02763826|10053191|FG007|COMPLETED|Part 1 Dose Escalation, 4 mA||0
8990018|NCT02763826|10053184|FG000|NOT COMPLETED|Part 1 Dose Escalation, 4 mA||0
8990019|NCT02763826|10053185|FG001|NOT COMPLETED|Part 1 Dose Escalation, 4 mA||0
8990020|NCT02763826|10053186|FG002|NOT COMPLETED|Part 1 Dose Escalation, 4 mA||0
8990021|NCT02763826|10053187|FG003|NOT COMPLETED|Part 1 Dose Escalation, 4 mA||0
8990022|NCT02763826|10053188|FG004|NOT COMPLETED|Part 1 Dose Escalation, 4 mA||0
8990023|NCT02763826|10053189|FG005|NOT COMPLETED|Part 1 Dose Escalation, 4 mA||0
8990024|NCT02763826|10053190|FG006|NOT COMPLETED|Part 1 Dose Escalation, 4 mA||0
8990025|NCT02763826|10053191|FG007|NOT COMPLETED|Part 1 Dose Escalation, 4 mA||0
8990026|NCT02763826|10053184|FG000|STARTED|Part 2 Montage Effect, 1st Intervention||0
8990027|NCT02763826|10053185|FG001|STARTED|Part 2 Montage Effect, 1st Intervention||0
8990028|NCT02763826|10053186|FG002|STARTED|Part 2 Montage Effect, 1st Intervention||0
8990029|NCT02763826|10053187|FG003|STARTED|Part 2 Montage Effect, 1st Intervention||0
8990030|NCT02763826|10053188|FG004|STARTED|Part 2 Montage Effect, 1st Intervention||0
8990031|NCT02763826|10053189|FG005|STARTED|Part 2 Montage Effect, 1st Intervention||6
8990032|NCT02763826|10053190|FG006|STARTED|Part 2 Montage Effect, 1st Intervention||6
8990033|NCT02763826|10053191|FG007|STARTED|Part 2 Montage Effect, 1st Intervention||7
8990034|NCT02763826|10053184|FG000|COMPLETED|Part 2 Montage Effect, 1st Intervention||0
8990035|NCT02763826|10053185|FG001|COMPLETED|Part 2 Montage Effect, 1st Intervention||0
8990036|NCT02763826|10053186|FG002|COMPLETED|Part 2 Montage Effect, 1st Intervention||0
8990037|NCT02763826|10053187|FG003|COMPLETED|Part 2 Montage Effect, 1st Intervention||0
8990038|NCT02763826|10053188|FG004|COMPLETED|Part 2 Montage Effect, 1st Intervention||0
8990039|NCT02763826|10053189|FG005|COMPLETED|Part 2 Montage Effect, 1st Intervention||6
8990040|NCT02763826|10053190|FG006|COMPLETED|Part 2 Montage Effect, 1st Intervention||6
8990041|NCT02763826|10053191|FG007|COMPLETED|Part 2 Montage Effect, 1st Intervention||7
8990042|NCT02763826|10053184|FG000|NOT COMPLETED|Part 2 Montage Effect, 1st Intervention||0
8990043|NCT02763826|10053185|FG001|NOT COMPLETED|Part 2 Montage Effect, 1st Intervention||0
8990044|NCT02763826|10053186|FG002|NOT COMPLETED|Part 2 Montage Effect, 1st Intervention||0
8990045|NCT02763826|10053187|FG003|NOT COMPLETED|Part 2 Montage Effect, 1st Intervention||0
8990046|NCT02763826|10053188|FG004|NOT COMPLETED|Part 2 Montage Effect, 1st Intervention||0
8990047|NCT02763826|10053189|FG005|NOT COMPLETED|Part 2 Montage Effect, 1st Intervention||0
8990048|NCT02763826|10053190|FG006|NOT COMPLETED|Part 2 Montage Effect, 1st Intervention||0
8990049|NCT02763826|10053191|FG007|NOT COMPLETED|Part 2 Montage Effect, 1st Intervention||0
8990050|NCT02763826|10053184|FG000|STARTED|Part 2 Montage Effect, 2nd Intervention||0
8990051|NCT02763826|10053185|FG001|STARTED|Part 2 Montage Effect, 2nd Intervention||0
8990052|NCT02763826|10053186|FG002|STARTED|Part 2 Montage Effect, 2nd Intervention||0
8990053|NCT02763826|10053187|FG003|STARTED|Part 2 Montage Effect, 2nd Intervention||0
8990054|NCT02763826|10053188|FG004|STARTED|Part 2 Montage Effect, 2nd Intervention||0
8990055|NCT02763826|10053189|FG005|STARTED|Part 2 Montage Effect, 2nd Intervention||6
8990056|NCT02763826|10053190|FG006|STARTED|Part 2 Montage Effect, 2nd Intervention||6
8990057|NCT02763826|10053191|FG007|STARTED|Part 2 Montage Effect, 2nd Intervention||6
8990058|NCT02763826|10053184|FG000|COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
8990059|NCT02763826|10053185|FG001|COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
8990060|NCT02763826|10053186|FG002|COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
8990061|NCT02763826|10053187|FG003|COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
8990062|NCT02763826|10053188|FG004|COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
8990063|NCT02763826|10053189|FG005|COMPLETED|Part 2 Montage Effect, 2nd Intervention||6
8990064|NCT02763826|10053190|FG006|COMPLETED|Part 2 Montage Effect, 2nd Intervention||6
8990065|NCT02763826|10053191|FG007|COMPLETED|Part 2 Montage Effect, 2nd Intervention||6
8990066|NCT02763826|10053184|FG000|NOT COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
8990067|NCT02763826|10053185|FG001|NOT COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
8990068|NCT02763826|10053186|FG002|NOT COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
8990069|NCT02763826|10053187|FG003|NOT COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
8990070|NCT02763826|10053188|FG004|NOT COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
8990071|NCT02763826|10053189|FG005|NOT COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
8990072|NCT02763826|10053190|FG006|NOT COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
8990073|NCT02763826|10053191|FG007|NOT COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
8990074|NCT02763826|10053184|FG000|STARTED|Part 2 Montage Effect, 3rd Intervention||0
8990075|NCT02763826|10053185|FG001|STARTED|Part 2 Montage Effect, 3rd Intervention||0
8990076|NCT02763826|10053186|FG002|STARTED|Part 2 Montage Effect, 3rd Intervention||0
8990077|NCT02763826|10053187|FG003|STARTED|Part 2 Montage Effect, 3rd Intervention||0
8990078|NCT02763826|10053188|FG004|STARTED|Part 2 Montage Effect, 3rd Intervention||0
8990079|NCT02763826|10053189|FG005|STARTED|Part 2 Montage Effect, 3rd Intervention||6
8990080|NCT02763826|10053190|FG006|STARTED|Part 2 Montage Effect, 3rd Intervention||6
8990081|NCT02763826|10053191|FG007|STARTED|Part 2 Montage Effect, 3rd Intervention||6
8990082|NCT02763826|10053184|FG000|COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
8990083|NCT02763826|10053185|FG001|COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
8990084|NCT02763826|10053186|FG002|COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
8990085|NCT02763826|10053187|FG003|COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
8990086|NCT02763826|10053188|FG004|COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
8990087|NCT02763826|10053189|FG005|COMPLETED|Part 2 Montage Effect, 3rd Intervention||6
8990088|NCT02763826|10053190|FG006|COMPLETED|Part 2 Montage Effect, 3rd Intervention||6
8990089|NCT02763826|10053191|FG007|COMPLETED|Part 2 Montage Effect, 3rd Intervention||6
8990090|NCT02763826|10053184|FG000|NOT COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
8990091|NCT02763826|10053185|FG001|NOT COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
8990092|NCT02763826|10053186|FG002|NOT COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
8990093|NCT02763826|10053187|FG003|NOT COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
8990094|NCT02763826|10053188|FG004|NOT COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
8633399|NCT00550550|9673454|FG001|STARTED|Overall Study||169
8633400|NCT00550550|9673453|FG000|Number Treated|Overall Study||175
8633401|NCT00550550|9673454|FG001|Number Treated|Overall Study||169
8633402|NCT00550550|9673453|FG000|COMPLETED|Overall Study||142
8633403|NCT00550550|9673454|FG001|COMPLETED|Overall Study||140
8633404|NCT00550550|9673453|FG000|NOT COMPLETED|Overall Study||34
8633405|NCT00550550|9673454|FG001|NOT COMPLETED|Overall Study||29
8633406|NCT00550589|9673460|FG000|STARTED|Overall Study||33
8633407|NCT00550589|9673460|FG000|COMPLETED|Overall Study||33
8633408|NCT00550589|9673460|FG000|NOT COMPLETED|Overall Study||0
8633409|NCT00550615|9673468|FG000|STARTED|Overall Study||3
8633410|NCT00550615|9673469|FG001|STARTED|Overall Study||3
8633411|NCT00550615|9673470|FG002|STARTED|Overall Study||10
8633412|NCT00550615|9673471|FG003|STARTED|Overall Study||22
8633413|NCT00550615|9673468|FG000|COMPLETED|Overall Study||3
8633414|NCT00550615|9673469|FG001|COMPLETED|Overall Study||3
8633415|NCT00550615|9673470|FG002|COMPLETED|Overall Study||6
8633416|NCT00550615|9673471|FG003|COMPLETED|Overall Study||12
8633417|NCT00550615|9673468|FG000|NOT COMPLETED|Overall Study||0
8633418|NCT00550615|9673469|FG001|NOT COMPLETED|Overall Study||0
8633419|NCT00550615|9673470|FG002|NOT COMPLETED|Overall Study||4
8633420|NCT00550615|9673471|FG003|NOT COMPLETED|Overall Study||10
8633421|NCT00550654|9673477|FG000|STARTED|Overall Study||1
8633422|NCT00550654|9673477|FG000|COMPLETED|Overall Study||1
8990095|NCT02763826|10053189|FG005|NOT COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
8990096|NCT02763826|10053190|FG006|NOT COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
8990097|NCT02763826|10053191|FG007|NOT COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
8990098|NCT02763865|10053211|FG000|STARTED|Overall Study||5
8990099|NCT02763865|10053212|FG001|STARTED|Overall Study||5
8990100|NCT02763865|10053211|FG000|COMPLETED|Overall Study||5
8990101|NCT02763865|10053212|FG001|COMPLETED|Overall Study||5
8990102|NCT02763865|10053211|FG000|NOT COMPLETED|Overall Study||0
8990103|NCT02763865|10053212|FG001|NOT COMPLETED|Overall Study||0
8633423|NCT00550654|9673477|FG000|NOT COMPLETED|Overall Study||0
8633424|NCT00550680|9673481|FG000|STARTED|Overall Study||208
8633425|NCT00550680|9673481|FG000|COMPLETED|Overall Study||152
8633426|NCT00550680|9673481|FG000|NOT COMPLETED|Overall Study||56
8990104|NCT02764151|10053224|FG000|STARTED|Overall Study||2
8990105|NCT02764151|10053225|FG001|STARTED|Overall Study||4
8990106|NCT02764151|10053226|FG002|STARTED|Overall Study||3
8990107|NCT02764151|10053227|FG003|STARTED|Overall Study||8
8990108|NCT02764151|10053224|FG000|COMPLETED|Overall Study||2
8990109|NCT02764151|10053225|FG001|COMPLETED|Overall Study||4
8990110|NCT02764151|10053226|FG002|COMPLETED|Overall Study||3
8990111|NCT02764151|10053227|FG003|COMPLETED|Overall Study||5
8633427|NCT00550732|9673485|FG000|STARTED|Overall Study||40
8633428|NCT00550732|9673485|FG000|COMPLETED|Overall Study||29
8633429|NCT00550732|9673485|FG000|NOT COMPLETED|Overall Study||11
8633430|NCT00550745|9673492|FG000|STARTED|Overall Study||6000
8633431|NCT00550745|9673493|FG001|STARTED|Overall Study||5999
8990112|NCT02764151|10053224|FG000|NOT COMPLETED|Overall Study||0
8990113|NCT02764151|10053225|FG001|NOT COMPLETED|Overall Study||0
8990114|NCT02764151|10053226|FG002|NOT COMPLETED|Overall Study||0
8990115|NCT02764151|10053227|FG003|NOT COMPLETED|Overall Study||3
8990116|NCT02764164|10053237|FG000|STARTED|Overall Study||1
8990117|NCT02764164|10053237|FG000|COMPLETED|Overall Study|Duration flexible up to 12mo, ended early (funding), 2 week time point achieved|1
8990118|NCT02764164|10053237|FG000|NOT COMPLETED|Overall Study||0
8990119|NCT02764190|10053243|FG000|STARTED|Overall Study||167
8990120|NCT02764190|10053244|FG001|STARTED|Overall Study||135
8990121|NCT02764190|10053243|FG000|1 Day Follow-up|Overall Study||161
8990122|NCT02764190|10053244|FG001|1 Day Follow-up|Overall Study||131
8990123|NCT02764190|10053243|FG000|3 Month Follow-up|Overall Study||156
8990124|NCT02764190|10053244|FG001|3 Month Follow-up|Overall Study||128
8990125|NCT02764190|10053243|FG000|6 Month Follow-up|Overall Study||155
8990126|NCT02764190|10053244|FG001|6 Month Follow-up|Overall Study||128
8990127|NCT02764190|10053243|FG000|12 Month Follow-up|Overall Study||150
8990128|NCT02764190|10053244|FG001|12 Month Follow-up|Overall Study||122
8990129|NCT02764190|10053243|FG000|COMPLETED|Overall Study||150
8990130|NCT02764190|10053244|FG001|COMPLETED|Overall Study||122
8990131|NCT02764190|10053243|FG000|NOT COMPLETED|Overall Study||17
8990132|NCT02764190|10053244|FG001|NOT COMPLETED|Overall Study||13
8878979|NCT01931670|9935829|FG000|NOT COMPLETED|Treatment Period||90
8878980|NCT01931670|9935830|FG001|NOT COMPLETED|Treatment Period||48
8878981|NCT01931670|9935831|FG002|NOT COMPLETED|Treatment Period||45
8878982|NCT01931670|9935829|FG000|STARTED|Post-Treatment Follow-Up (PTFU) Period||61
8990133|NCT02764229|10053250|FG000|STARTED|Overall Study||112
8990134|NCT02764229|10053250|FG000|COMPLETED|Overall Study||10
8990135|NCT02764229|10053250|FG000|NOT COMPLETED|Overall Study||102
8990136|NCT02764320|10053256|FG000|STARTED|Overall Study||361
8990137|NCT02764320|10053257|FG001|STARTED|Overall Study||359
8990138|NCT02764320|10053256|FG000|COMPLETED|Overall Study||310
8990139|NCT02764320|10053257|FG001|COMPLETED|Overall Study||310
8990140|NCT02764320|10053256|FG000|NOT COMPLETED|Overall Study||51
8990141|NCT02764320|10053257|FG001|NOT COMPLETED|Overall Study||49
8990142|NCT02764333|10053263|FG000|STARTED|Overall Study||29
8990143|NCT02764333|10053263|FG000|COMPLETED|Overall Study||28
8990144|NCT02764333|10053263|FG000|NOT COMPLETED|Overall Study||1
8990145|NCT02764385|10053269|FG000|STARTED|Overall Study||9145
8990146|NCT02764385|10053270|FG001|STARTED|Overall Study||6641
8990147|NCT02764385|10053269|FG000|COMPLETED|Overall Study||9145
8990148|NCT02764385|10053270|FG001|COMPLETED|Overall Study||6641
8990149|NCT02764385|10053269|FG000|NOT COMPLETED|Overall Study||0
8990150|NCT02764385|10053270|FG001|NOT COMPLETED|Overall Study||0
8990151|NCT02764697|10053276|FG000|STARTED|Overall Study||5
8990152|NCT02764697|10053276|FG000|COMPLETED|Overall Study||2
8990153|NCT02764697|10053276|FG000|NOT COMPLETED|Overall Study||3
8990154|NCT02764762|10053280|FG000|STARTED|Overall Study||55
8990155|NCT02764762|10053280|FG000|COMPLETED|Overall Study||46
8990156|NCT02764762|10053280|FG000|NOT COMPLETED|Overall Study||9
8990157|NCT02764775|10053284|FG000|STARTED|Overall Study|All 14 participants were assigned to the Headpod utilization group.|14
8990158|NCT02764775|10053284|FG000|COMPLETED|Overall Study||8
8990159|NCT02764775|10053284|FG000|NOT COMPLETED|Overall Study||6
8990160|NCT02764970|10053290|FG000|STARTED|Overall Study||65
8990161|NCT02764970|10053291|FG001|STARTED|Overall Study||47
8990162|NCT02764970|10053290|FG000|COMPLETED|Overall Study||65
8990163|NCT02764970|10053291|FG001|COMPLETED|Overall Study||47
8990164|NCT02764970|10053290|FG000|NOT COMPLETED|Overall Study||0
8990165|NCT02764970|10053291|FG001|NOT COMPLETED|Overall Study||0
8990166|NCT02765035|10053299|FG000|STARTED|First Intervention (90 Days)||5
8990167|NCT02765035|10053300|FG001|STARTED|First Intervention (90 Days)||8
8990168|NCT02765035|10053299|FG000|COMPLETED|First Intervention (90 Days)||4
8990169|NCT02765035|10053300|FG001|COMPLETED|First Intervention (90 Days)||7
8990170|NCT02765035|10053299|FG000|NOT COMPLETED|First Intervention (90 Days)||1
8990171|NCT02765035|10053300|FG001|NOT COMPLETED|First Intervention (90 Days)||1
8990172|NCT02765035|10053299|FG000|STARTED|Second Intervention (30 Days)||4
8990173|NCT02765035|10053300|FG001|STARTED|Second Intervention (30 Days)||7
8990174|NCT02765035|10053299|FG000|COMPLETED|Second Intervention (30 Days)||2
8878983|NCT01931670|9935830|FG001|STARTED|Post-Treatment Follow-Up (PTFU) Period||40
8878984|NCT01931670|9935831|FG002|STARTED|Post-Treatment Follow-Up (PTFU) Period||54
8878985|NCT01931670|9935829|FG000|Completed PTFU Month 6|Post-Treatment Follow-Up (PTFU) Period||42
8878986|NCT01931670|9935830|FG001|Completed PTFU Month 6|Post-Treatment Follow-Up (PTFU) Period||24
8990175|NCT02765035|10053300|FG001|COMPLETED|Second Intervention (30 Days)||5
8990176|NCT02765035|10053299|FG000|NOT COMPLETED|Second Intervention (30 Days)||2
8990177|NCT02765035|10053300|FG001|NOT COMPLETED|Second Intervention (30 Days)||2
8990178|NCT02765100|10053309|FG000|STARTED|Overall Study||9
8990179|NCT02765100|10053310|FG001|STARTED|Overall Study||12
8990180|NCT02765100|10053309|FG000|COMPLETED|Overall Study||8
8990181|NCT02765100|10053310|FG001|COMPLETED|Overall Study||10
8990182|NCT02765100|10053309|FG000|NOT COMPLETED|Overall Study||1
8990183|NCT02765100|10053310|FG001|NOT COMPLETED|Overall Study||2
8990184|NCT02765165|10053323|FG000|STARTED|Treatment Period||3
8990185|NCT02765165|10053324|FG001|STARTED|Treatment Period||4
8990186|NCT02765165|10053325|FG002|STARTED|Treatment Period||3
8990187|NCT02765165|10053326|FG003|STARTED|Treatment Period||3
8990188|NCT02765165|10053327|FG004|STARTED|Treatment Period||6
8990189|NCT02765165|10053328|FG005|STARTED|Treatment Period||3
8990190|NCT02765165|10053329|FG006|STARTED|Treatment Period||4
8725894|NCT01033487|9773161|FG004|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
8725895|NCT01033487|9773162|FG005|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
8725896|NCT01033487|9773163|FG006|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
8725897|NCT01033487|9773164|FG007|STARTED|Between Period 2 and 3 (At Least 7 Days)||3
8725898|NCT01033487|9773165|FG008|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
8990191|NCT02765165|10053323|FG000|COMPLETED|Treatment Period|Open-ended design for participation until progression or other reason for withdrawal|0
8990192|NCT02765165|10053324|FG001|COMPLETED|Treatment Period|Open-ended design for participation until progression or other reason for withdrawal|0
8990193|NCT02765165|10053325|FG002|COMPLETED|Treatment Period|Open-ended design for participation until progression or other reason for withdrawal|0
8990194|NCT02765165|10053326|FG003|COMPLETED|Treatment Period|Open-ended design for participation until progression or other reason for withdrawal|0
8990195|NCT02765165|10053327|FG004|COMPLETED|Treatment Period|Open-ended design for participation until progression or other reason for withdrawal|0
8990196|NCT02765165|10053328|FG005|COMPLETED|Treatment Period|Open-ended design for participation until progression or other reason for withdrawal|0
8990197|NCT02765165|10053329|FG006|COMPLETED|Treatment Period|Open-ended design for participation until progression or other reason for withdrawal|0
8990198|NCT02765165|10053323|FG000|NOT COMPLETED|Treatment Period||3
8990199|NCT02765165|10053324|FG001|NOT COMPLETED|Treatment Period||4
8990200|NCT02765165|10053325|FG002|NOT COMPLETED|Treatment Period||3
8990201|NCT02765165|10053326|FG003|NOT COMPLETED|Treatment Period||3
8990202|NCT02765165|10053327|FG004|NOT COMPLETED|Treatment Period||6
8990203|NCT02765165|10053328|FG005|NOT COMPLETED|Treatment Period||3
8990204|NCT02765165|10053329|FG006|NOT COMPLETED|Treatment Period||4
8990205|NCT02765165|10053323|FG000|STARTED|Post-treatment Follow-up|Subjects who chose to enter follow-up, including long term follow-up for survival, after discontinuing treatment. Subjects were not required to enter follow-up.|1
8990206|NCT02765165|10053324|FG001|STARTED|Post-treatment Follow-up|Subjects who chose to enter follow-up, including long term follow-up for survival, after discontinuing treatment. Subjects were not required to enter follow-up.|3
8990207|NCT02765165|10053325|FG002|STARTED|Post-treatment Follow-up|Subjects who chose to enter follow-up, including long term follow-up for survival, after discontinuing treatment. Subjects were not required to enter follow-up.|3
8990208|NCT02765165|10053326|FG003|STARTED|Post-treatment Follow-up|Subjects who chose to enter follow-up, including long term follow-up for survival, after discontinuing treatment. Subjects were not required to enter follow-up.|3
8990209|NCT02765165|10053327|FG004|STARTED|Post-treatment Follow-up|Subjects who chose to enter follow-up, including long term follow-up for survival, after discontinuing treatment. Subjects were not required to enter follow-up.|3
8990210|NCT02765165|10053328|FG005|STARTED|Post-treatment Follow-up|Subjects who chose to enter follow-up, including long term follow-up for survival, after discontinuing treatment. Subjects were not required to enter follow-up.|3
8990211|NCT02765165|10053329|FG006|STARTED|Post-treatment Follow-up|Subjects who chose to enter follow-up, including long term follow-up for survival, after discontinuing treatment. Subjects were not required to enter follow-up.|1
8990212|NCT02765165|10053323|FG000|COMPLETED|Post-treatment Follow-up|Open-ended follow-up|0
8990213|NCT02765165|10053324|FG001|COMPLETED|Post-treatment Follow-up||0
8990214|NCT02765165|10053325|FG002|COMPLETED|Post-treatment Follow-up||0
8990215|NCT02765165|10053326|FG003|COMPLETED|Post-treatment Follow-up||0
8990216|NCT02765165|10053327|FG004|COMPLETED|Post-treatment Follow-up|Open-ended follow-up|0
8990217|NCT02765165|10053328|FG005|COMPLETED|Post-treatment Follow-up||0
8990218|NCT02765165|10053329|FG006|COMPLETED|Post-treatment Follow-up||0
8990219|NCT02765165|10053323|FG000|NOT COMPLETED|Post-treatment Follow-up||1
8990220|NCT02765165|10053324|FG001|NOT COMPLETED|Post-treatment Follow-up||3
8990221|NCT02765165|10053325|FG002|NOT COMPLETED|Post-treatment Follow-up||3
8990222|NCT02765165|10053326|FG003|NOT COMPLETED|Post-treatment Follow-up||3
8990223|NCT02765165|10053327|FG004|NOT COMPLETED|Post-treatment Follow-up||3
8990224|NCT02765165|10053328|FG005|NOT COMPLETED|Post-treatment Follow-up||3
8990225|NCT02765165|10053329|FG006|NOT COMPLETED|Post-treatment Follow-up||1
8990226|NCT02765256|10053351|FG000|STARTED|Overall Study||4
8990227|NCT02765256|10053352|FG001|STARTED|Overall Study||4
8990228|NCT02765256|10053351|FG000|COMPLETED|Overall Study||4
8990229|NCT02765256|10053352|FG001|COMPLETED|Overall Study||4
8990230|NCT02765256|10053351|FG000|NOT COMPLETED|Overall Study||0
8990231|NCT02765256|10053352|FG001|NOT COMPLETED|Overall Study||0
8990232|NCT02765269|10053360|FG000|STARTED|Overall Study||25
8990233|NCT02765269|10053361|FG001|STARTED|Overall Study||21
8990234|NCT02765269|10053360|FG000|COMPLETED|Overall Study||25
8990235|NCT02765269|10053361|FG001|COMPLETED|Overall Study||21
8990236|NCT02765269|10053360|FG000|NOT COMPLETED|Overall Study||0
8990237|NCT02765269|10053361|FG001|NOT COMPLETED|Overall Study||0
8990238|NCT02765490|10053369|FG000|STARTED|Overall Study||183
8990239|NCT02765490|10053370|FG001|STARTED|Overall Study||182
8990240|NCT02765490|10053369|FG000|COMPLETED|Overall Study||182
8990241|NCT02765490|10053370|FG001|COMPLETED|Overall Study||179
8990242|NCT02765490|10053369|FG000|NOT COMPLETED|Overall Study||1
8990243|NCT02765490|10053370|FG001|NOT COMPLETED|Overall Study||3
8990244|NCT02766023|10053378|FG000|STARTED|Overall Study||152
8990245|NCT02766023|10053379|FG001|STARTED|Overall Study||76
8990246|NCT02766023|10053378|FG000|COMPLETED|Overall Study||122
8990247|NCT02766023|10053379|FG001|COMPLETED|Overall Study||59
8990248|NCT02766023|10053378|FG000|NOT COMPLETED|Overall Study||30
8990249|NCT02766023|10053379|FG001|NOT COMPLETED|Overall Study||17
8990250|NCT02766088|10053385|FG000|STARTED|Overall Study||850
8725899|NCT01033487|9773166|FG009|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
8806548|NCT01478256|9858777|FG001|COMPLETED|Overall Study||15
8990251|NCT02766088|10053385|FG000|COMPLETED|Overall Study||344
8990252|NCT02766088|10053385|FG000|NOT COMPLETED|Overall Study||506
8990253|NCT02766244|10053389|FG000|STARTED|Overall Study||3
8990254|NCT02766244|10053389|FG000|COMPLETED|Overall Study||3
8990255|NCT02766244|10053389|FG000|NOT COMPLETED|Overall Study||0
8990256|NCT02766283|10053398|FG000|STARTED|Overall Study||843
8990257|NCT02766283|10053398|FG000|COMPLETED|Overall Study||816
8990258|NCT02766283|10053398|FG000|NOT COMPLETED|Overall Study||27
8990259|NCT02766374|10053408|FG000|STARTED|Overall Study||35
8990260|NCT02766374|10053409|FG001|STARTED|Overall Study||33
8990261|NCT02766374|10053408|FG000|COMPLETED|Overall Study||25
8990262|NCT02766374|10053409|FG001|COMPLETED|Overall Study||30
8990263|NCT02766374|10053408|FG000|NOT COMPLETED|Overall Study||10
8990264|NCT02766374|10053409|FG001|NOT COMPLETED|Overall Study||3
8990265|NCT02766400|10053417|FG000|STARTED|Overall Study||21
8990266|NCT02766400|10053418|FG001|STARTED|Overall Study||22
8990267|NCT02766400|10053417|FG000|COMPLETED|Overall Study||19
8990268|NCT02766400|10053418|FG001|COMPLETED|Overall Study||20
8990269|NCT02766400|10053417|FG000|NOT COMPLETED|Overall Study||2
8990270|NCT02766400|10053418|FG001|NOT COMPLETED|Overall Study||2
8990271|NCT02766517|10053427|FG000|STARTED|Overall Study||19
8990272|NCT02766517|10053428|FG001|STARTED|Overall Study||9
8990273|NCT02766517|10053429|FG002|STARTED|Overall Study||9
8990274|NCT02766517|10053427|FG000|COMPLETED|Overall Study||19
8990275|NCT02766517|10053428|FG001|COMPLETED|Overall Study||9
8990276|NCT02766517|10053429|FG002|COMPLETED|Overall Study||9
8990277|NCT02766517|10053427|FG000|NOT COMPLETED|Overall Study||0
8990278|NCT02766517|10053428|FG001|NOT COMPLETED|Overall Study||0
8990279|NCT02766517|10053429|FG002|NOT COMPLETED|Overall Study||0
8990280|NCT02766608|10053442|FG000|STARTED|Overall Study||655
8990281|NCT02766608|10053443|FG001|STARTED|Overall Study||637
8990282|NCT02766608|10053444|FG002|STARTED|Overall Study||644
8990283|NCT02766608|10053445|FG003|STARTED|Overall Study||206
8990284|NCT02766608|10053446|FG004|STARTED|Overall Study||219
8990285|NCT02766608|10053442|FG000|COMPLETED|Overall Study||576
8990286|NCT02766608|10053443|FG001|COMPLETED|Overall Study||567
8990287|NCT02766608|10053444|FG002|COMPLETED|Overall Study||554
8990288|NCT02766608|10053445|FG003|COMPLETED|Overall Study||169
8990289|NCT02766608|10053446|FG004|COMPLETED|Overall Study||190
8990290|NCT02766608|10053442|FG000|NOT COMPLETED|Overall Study||79
8990291|NCT02766608|10053443|FG001|NOT COMPLETED|Overall Study||70
8990292|NCT02766608|10053444|FG002|NOT COMPLETED|Overall Study||90
8990293|NCT02766608|10053445|FG003|NOT COMPLETED|Overall Study||37
8990294|NCT02766608|10053446|FG004|NOT COMPLETED|Overall Study||29
8990295|NCT02766673|10053461|FG000|STARTED|Overall Study||4
8990296|NCT02766673|10053462|FG001|STARTED|Overall Study||4
8990297|NCT02766673|10053463|FG002|STARTED|Overall Study||4
8990298|NCT02766673|10053464|FG003|STARTED|Overall Study||4
8990299|NCT02766673|10053465|FG004|STARTED|Overall Study||4
8990300|NCT02766673|10053466|FG005|STARTED|Overall Study||4
8990301|NCT02766673|10053461|FG000|COMPLETED|Overall Study||3
8990302|NCT02766673|10053462|FG001|COMPLETED|Overall Study||4
8990303|NCT02766673|10053463|FG002|COMPLETED|Overall Study||4
8990304|NCT02766673|10053464|FG003|COMPLETED|Overall Study||4
8990305|NCT02766673|10053465|FG004|COMPLETED|Overall Study||4
8990306|NCT02766673|10053466|FG005|COMPLETED|Overall Study||3
8990307|NCT02766673|10053461|FG000|NOT COMPLETED|Overall Study||1
8990308|NCT02766673|10053462|FG001|NOT COMPLETED|Overall Study||0
8990309|NCT02766673|10053463|FG002|NOT COMPLETED|Overall Study||0
8990310|NCT02766673|10053464|FG003|NOT COMPLETED|Overall Study||0
8990311|NCT02766673|10053465|FG004|NOT COMPLETED|Overall Study||0
8990312|NCT02766673|10053466|FG005|NOT COMPLETED|Overall Study||1
8990313|NCT02766777|10053474|FG000|STARTED|Overall Study||87
8990314|NCT02766777|10053474|FG000|Treated (Safety [SAF] Population)|Overall Study||87
8990315|NCT02766777|10053474|FG000|COMPLETED|Overall Study||53
8990316|NCT02766777|10053474|FG000|NOT COMPLETED|Overall Study||34
8990317|NCT02766907|10053480|FG000|STARTED|Overall Study||10
8990318|NCT02766907|10053481|FG001|STARTED|Overall Study||10
8990319|NCT02766907|10053480|FG000|COMPLETED|Overall Study||9
8990320|NCT02766907|10053481|FG001|COMPLETED|Overall Study||9
8990321|NCT02766907|10053480|FG000|NOT COMPLETED|Overall Study||1
8990322|NCT02766907|10053481|FG001|NOT COMPLETED|Overall Study||1
8990323|NCT02767011|10053489|FG000|STARTED|Overall Study||16
8990324|NCT02767011|10053490|FG001|STARTED|Overall Study||14
8990325|NCT02767011|10053489|FG000|COMPLETED|Overall Study||16
8990326|NCT02767011|10053490|FG001|COMPLETED|Overall Study||14
8990327|NCT02767011|10053489|FG000|NOT COMPLETED|Overall Study||0
8990328|NCT02767011|10053490|FG001|NOT COMPLETED|Overall Study||0
8990329|NCT02767128|10053496|FG000|STARTED|Overall Study||14
8990330|NCT02767128|10053496|FG000|Baseline|Overall Study||14
8990331|NCT02767128|10053496|FG000|Fer-In-Sol|Overall Study||14
8990332|NCT02767128|10053496|FG000|Shohl's + Fer-In-Sol|Overall Study||14
8990333|NCT02767128|10053496|FG000|Triferic|Overall Study||14
8990334|NCT02767128|10053496|FG000|Shohl's + Triferic After 10 Min|Overall Study||14
8990335|NCT02767128|10053496|FG000|Shohl's + Triferic Immediately|Overall Study||14
8990336|NCT02767128|10053496|FG000|COMPLETED|Overall Study||14
8990337|NCT02767128|10053496|FG000|NOT COMPLETED|Overall Study||0
8990338|NCT02767271|10053512|FG000|STARTED|Overall Study||15
8990339|NCT02767271|10053513|FG001|STARTED|Overall Study||15
8990340|NCT02767271|10053512|FG000|Safety Population|Overall Study||15
8990341|NCT02767271|10053513|FG001|Safety Population|Overall Study||15
8990342|NCT02767271|10053512|FG000|Pharmacokinetic Pedis (PKP) Population|Overall Study||15
8990343|NCT02767271|10053513|FG001|Pharmacokinetic Pedis (PKP) Population|Overall Study||0
8990344|NCT02767271|10053512|FG000|Pharmacokinetic Cruris (PKC) Population|Overall Study||0
8990345|NCT02767271|10053513|FG001|Pharmacokinetic Cruris (PKC) Population|Overall Study||15
8990346|NCT02767271|10053512|FG000|COMPLETED|Overall Study||15
8990347|NCT02767271|10053513|FG001|COMPLETED|Overall Study||15
8990348|NCT02767271|10053512|FG000|NOT COMPLETED|Overall Study||0
8990349|NCT02767271|10053513|FG001|NOT COMPLETED|Overall Study||0
8990350|NCT02767323|10053523|FG000|STARTED|Overall Study||83
8990351|NCT02767323|10053524|FG001|STARTED|Overall Study||42
8990352|NCT02767323|10053525|FG002|STARTED|Overall Study||58
8990353|NCT02767323|10053526|FG003|STARTED|Overall Study||1
8990354|NCT02767323|10053523|FG000|COMPLETED|Overall Study||49
8990355|NCT02767323|10053524|FG001|COMPLETED|Overall Study||17
8990356|NCT02767323|10053525|FG002|COMPLETED|Overall Study||28
8990357|NCT02767323|10053526|FG003|COMPLETED|Overall Study||1
8990358|NCT02767323|10053523|FG000|NOT COMPLETED|Overall Study||34
8990359|NCT02767323|10053524|FG001|NOT COMPLETED|Overall Study||25
8990360|NCT02767323|10053525|FG002|NOT COMPLETED|Overall Study||30
8990361|NCT02767323|10053526|FG003|NOT COMPLETED|Overall Study||0
8990362|NCT02767388|10053542|FG000|STARTED|Overall Study||15
8990363|NCT02767388|10053543|FG001|STARTED|Overall Study||15
8990364|NCT02767388|10053544|FG002|STARTED|Overall Study||15
8990365|NCT02767388|10053542|FG000|COMPLETED|Overall Study||8
8990366|NCT02767388|10053543|FG001|COMPLETED|Overall Study||10
8990367|NCT02767388|10053544|FG002|COMPLETED|Overall Study||12
8990368|NCT02767388|10053542|FG000|NOT COMPLETED|Overall Study||7
8990369|NCT02767388|10053543|FG001|NOT COMPLETED|Overall Study||5
8990370|NCT02767388|10053544|FG002|NOT COMPLETED|Overall Study||3
8990371|NCT02767427|10053554|FG000|STARTED|Overall Study||21
8990372|NCT02767427|10053555|FG001|STARTED|Overall Study||19
8990373|NCT02767427|10053554|FG000|COMPLETED|Overall Study||21
8990374|NCT02767427|10053555|FG001|COMPLETED|Overall Study||19
8990375|NCT02767427|10053554|FG000|NOT COMPLETED|Overall Study||0
8990376|NCT02767427|10053555|FG001|NOT COMPLETED|Overall Study||0
8990377|NCT02767492|10053563|FG000|STARTED|Overall Study||45
8990378|NCT02767492|10053564|FG001|STARTED|Overall Study||45
8990379|NCT02767492|10053563|FG000|COMPLETED|Overall Study||35
8990380|NCT02767492|10053564|FG001|COMPLETED|Overall Study||35
8990381|NCT02767492|10053563|FG000|NOT COMPLETED|Overall Study||10
8990382|NCT02767492|10053564|FG001|NOT COMPLETED|Overall Study||10
8990383|NCT02767609|10053570|FG000|STARTED|Overall Study||1
8990384|NCT02767609|10053570|FG000|COMPLETED|Overall Study||1
8990385|NCT02767609|10053570|FG000|NOT COMPLETED|Overall Study||0
8990386|NCT02767765|10053574|FG000|STARTED|Overall Study||61
8990387|NCT02767765|10053574|FG000|COMPLETED|Overall Study||50
8990388|NCT02767765|10053574|FG000|NOT COMPLETED|Overall Study||11
8990389|NCT02767843|10053578|FG000|STARTED|Overall Study||4
8990390|NCT02767843|10053578|FG000|COMPLETED|Overall Study||4
8990391|NCT02767843|10053578|FG000|NOT COMPLETED|Overall Study||0
8990392|NCT02767869|10053586|FG000|STARTED|Overall Study||12
8990393|NCT02767869|10053587|FG001|STARTED|Overall Study||12
8990394|NCT02767869|10053586|FG000|COMPLETED|Overall Study||12
8990395|NCT02767869|10053587|FG001|COMPLETED|Overall Study||12
8990396|NCT02767869|10053586|FG000|NOT COMPLETED|Overall Study||0
8990397|NCT02767869|10053587|FG001|NOT COMPLETED|Overall Study||0
8990398|NCT02767934|10053593|FG000|STARTED|Overall Study||12
8990399|NCT02767934|10053593|FG000|COMPLETED|Overall Study||12
8990400|NCT02767934|10053593|FG000|NOT COMPLETED|Overall Study||0
8990401|NCT02767947|10053600|FG000|STARTED|Overall Study||60
8990402|NCT02767947|10053601|FG001|STARTED|Overall Study||15
8990403|NCT02767947|10053600|FG000|Safety Population|Overall Study||60
8990404|NCT02767947|10053601|FG001|Safety Population|Overall Study||15
8990405|NCT02767947|10053600|FG000|Pharmacokinetic (PK) Population|Overall Study||12
8990406|NCT02767947|10053601|FG001|Pharmacokinetic (PK) Population|Overall Study||3
8990407|NCT02767947|10053600|FG000|COMPLETED|Overall Study||60
8990408|NCT02767947|10053601|FG001|COMPLETED|Overall Study||15
8990409|NCT02767947|10053600|FG000|NOT COMPLETED|Overall Study||0
8990410|NCT02767947|10053601|FG001|NOT COMPLETED|Overall Study||0
8990411|NCT02768103|10053607|FG000|STARTED|Overall Study||5
8990412|NCT02768103|10053607|FG000|COMPLETED|Overall Study||4
8990413|NCT02768103|10053607|FG000|NOT COMPLETED|Overall Study||1
8990414|NCT02768129|10053613|FG000|STARTED|Overall Study||11
8990415|NCT02768129|10053614|FG001|STARTED|Overall Study||10
8990416|NCT02768129|10053613|FG000|COMPLETED|Overall Study||11
8990417|NCT02768129|10053614|FG001|COMPLETED|Overall Study||10
8990418|NCT02768129|10053613|FG000|NOT COMPLETED|Overall Study||0
8990419|NCT02768129|10053614|FG001|NOT COMPLETED|Overall Study||0
8990420|NCT02768194|10053620|FG000|STARTED|Period 1||4
8990421|NCT02768194|10053621|FG001|STARTED|Period 1||4
8990422|NCT02768194|10053622|FG002|STARTED|Period 1||4
8990423|NCT02768194|10053623|FG003|STARTED|Period 1||4
8990424|NCT02768194|10053624|FG004|STARTED|Period 1||4
8990425|NCT02768194|10053625|FG005|STARTED|Period 1||4
8990426|NCT02768194|10053620|FG000|COMPLETED|Period 1||4
8990427|NCT02768194|10053621|FG001|COMPLETED|Period 1||4
8990428|NCT02768194|10053622|FG002|COMPLETED|Period 1||4
8990429|NCT02768194|10053623|FG003|COMPLETED|Period 1||3
8990430|NCT02768194|10053624|FG004|COMPLETED|Period 1||4
8990431|NCT02768194|10053625|FG005|COMPLETED|Period 1||4
8990432|NCT02768194|10053620|FG000|NOT COMPLETED|Period 1||0
8990433|NCT02768194|10053621|FG001|NOT COMPLETED|Period 1||0
8990434|NCT02768194|10053622|FG002|NOT COMPLETED|Period 1||0
8990435|NCT02768194|10053623|FG003|NOT COMPLETED|Period 1||1
8990436|NCT02768194|10053624|FG004|NOT COMPLETED|Period 1||0
8990437|NCT02768194|10053625|FG005|NOT COMPLETED|Period 1||0
8990438|NCT02768194|10053620|FG000|STARTED|Period 2||4
8990439|NCT02768194|10053621|FG001|STARTED|Period 2||4
8990440|NCT02768194|10053622|FG002|STARTED|Period 2||4
8990441|NCT02768194|10053623|FG003|STARTED|Period 2||3
8990442|NCT02768194|10053624|FG004|STARTED|Period 2||4
8990443|NCT02768194|10053625|FG005|STARTED|Period 2||4
8990444|NCT02768194|10053620|FG000|COMPLETED|Period 2||3
8990445|NCT02768194|10053621|FG001|COMPLETED|Period 2||4
8990446|NCT02768194|10053622|FG002|COMPLETED|Period 2||4
8990447|NCT02768194|10053623|FG003|COMPLETED|Period 2||3
8990448|NCT02768194|10053624|FG004|COMPLETED|Period 2||4
8990449|NCT02768194|10053625|FG005|COMPLETED|Period 2||4
8990450|NCT02768194|10053620|FG000|NOT COMPLETED|Period 2||1
8990451|NCT02768194|10053621|FG001|NOT COMPLETED|Period 2||0
8990452|NCT02768194|10053622|FG002|NOT COMPLETED|Period 2||0
8990453|NCT02768194|10053623|FG003|NOT COMPLETED|Period 2||0
8990454|NCT02768194|10053624|FG004|NOT COMPLETED|Period 2||0
8990455|NCT02768194|10053625|FG005|NOT COMPLETED|Period 2||0
8990456|NCT02768194|10053620|FG000|STARTED|Period 3||3
8990457|NCT02768194|10053621|FG001|STARTED|Period 3||4
8990458|NCT02768194|10053622|FG002|STARTED|Period 3||4
8990459|NCT02768194|10053623|FG003|STARTED|Period 3||3
8990460|NCT02768194|10053624|FG004|STARTED|Period 3||4
8990461|NCT02768194|10053625|FG005|STARTED|Period 3||4
8990462|NCT02768194|10053620|FG000|COMPLETED|Period 3||3
8990463|NCT02768194|10053621|FG001|COMPLETED|Period 3||3
8990464|NCT02768194|10053622|FG002|COMPLETED|Period 3||4
8990465|NCT02768194|10053623|FG003|COMPLETED|Period 3||3
8990466|NCT02768194|10053624|FG004|COMPLETED|Period 3||4
8990467|NCT02768194|10053625|FG005|COMPLETED|Period 3||4
8990468|NCT02768194|10053620|FG000|NOT COMPLETED|Period 3||0
8990469|NCT02768194|10053621|FG001|NOT COMPLETED|Period 3||1
8990470|NCT02768194|10053622|FG002|NOT COMPLETED|Period 3||0
8990471|NCT02768194|10053623|FG003|NOT COMPLETED|Period 3||0
8990472|NCT02768194|10053624|FG004|NOT COMPLETED|Period 3||0
8990473|NCT02768194|10053625|FG005|NOT COMPLETED|Period 3||0
8990474|NCT02768298|10053635|FG000|STARTED|Overall Study||103
8990475|NCT02768298|10053636|FG001|STARTED|Overall Study||98
8990476|NCT02768298|10053635|FG000|COMPLETED|Overall Study||99
8990477|NCT02768298|10053636|FG001|COMPLETED|Overall Study||91
8990478|NCT02768298|10053635|FG000|NOT COMPLETED|Overall Study||4
8990479|NCT02768298|10053636|FG001|NOT COMPLETED|Overall Study||7
8990480|NCT02768558|10053644|FG000|STARTED|Overall Study||3
8990481|NCT02768558|10053645|FG001|STARTED|Overall Study||5
8990482|NCT02768558|10053644|FG000|Eligible|Overall Study||3
8990483|NCT02768558|10053645|FG001|Eligible|Overall Study||5
8990484|NCT02768558|10053644|FG000|COMPLETED|Overall Study||3
8990485|NCT02768558|10053645|FG001|COMPLETED|Overall Study||5
8990486|NCT02768558|10053644|FG000|NOT COMPLETED|Overall Study||0
8990487|NCT02768558|10053645|FG001|NOT COMPLETED|Overall Study||0
8990488|NCT02768753|10053653|FG000|STARTED|Overall Study||30
8990489|NCT02768753|10053654|FG001|STARTED|Overall Study||30
8990490|NCT02768753|10053653|FG000|COMPLETED|Overall Study||30
8990491|NCT02768753|10053654|FG001|COMPLETED|Overall Study||30
8990492|NCT02768753|10053653|FG000|NOT COMPLETED|Overall Study||0
8990493|NCT02768753|10053654|FG001|NOT COMPLETED|Overall Study||0
8990494|NCT02768792|10053660|FG000|STARTED|Overall Study||38
8990495|NCT02768792|10053660|FG000|COMPLETED|Overall Study||37
8990496|NCT02768792|10053660|FG000|NOT COMPLETED|Overall Study||1
8990497|NCT02769065|10053694|FG000|STARTED|Overall Study||17
8990498|NCT02769065|10053695|FG001|STARTED|Overall Study||6
8990499|NCT02769065|10053696|FG002|STARTED|Overall Study||6
8990500|NCT02769065|10053697|FG003|STARTED|Overall Study||6
8990501|NCT02769065|10053698|FG004|STARTED|Overall Study||6
8990502|NCT02769065|10053699|FG005|STARTED|Overall Study||6
8990503|NCT02769065|10053700|FG006|STARTED|Overall Study||7
8990504|NCT02769065|10053701|FG007|STARTED|Overall Study||6
8990505|NCT02769065|10053702|FG008|STARTED|Overall Study||6
8990506|NCT02769065|10053703|FG009|STARTED|Overall Study||6
8990507|NCT02769065|10053704|FG010|STARTED|Overall Study||6
8990508|NCT02769065|10053705|FG011|STARTED|Overall Study||6
8990509|NCT02769065|10053706|FG012|STARTED|Overall Study||6
8990510|NCT02769065|10053707|FG013|STARTED|Overall Study||6
8990511|NCT02769065|10053708|FG014|STARTED|Overall Study||6
8990512|NCT02769065|10053709|FG015|STARTED|Overall Study||3
8990513|NCT02769065|10053710|FG016|STARTED|Overall Study||5
8990514|NCT02769065|10053711|FG017|STARTED|Overall Study||5
8990515|NCT02769065|10053712|FG018|STARTED|Overall Study||5
8990516|NCT02769065|10053713|FG019|STARTED|Overall Study||0
8990517|NCT02769065|10053714|FG020|STARTED|Overall Study||4
8990518|NCT02769065|10053715|FG021|STARTED|Overall Study||4
8990519|NCT02769065|10053716|FG022|STARTED|Overall Study||4
8990520|NCT02769065|10053717|FG023|STARTED|Overall Study||6
8990521|NCT02769065|10053718|FG024|STARTED|Overall Study||6
8990522|NCT02769065|10053719|FG025|STARTED|Overall Study||9
8990523|NCT02769065|10053720|FG026|STARTED|Overall Study||9
8990524|NCT02769065|10053721|FG027|STARTED|Overall Study||5
8990525|NCT02769065|10053722|FG028|STARTED|Overall Study||6
8990526|NCT02769065|10053723|FG029|STARTED|Overall Study||6
8990527|NCT02769065|10053694|FG000|COMPLETED|Overall Study||16
8990528|NCT02769065|10053695|FG001|COMPLETED|Overall Study||6
8990529|NCT02769065|10053696|FG002|COMPLETED|Overall Study||6
8990530|NCT02769065|10053697|FG003|COMPLETED|Overall Study||6
8990531|NCT02769065|10053698|FG004|COMPLETED|Overall Study||6
8990532|NCT02769065|10053699|FG005|COMPLETED|Overall Study||6
8990533|NCT02769065|10053700|FG006|COMPLETED|Overall Study||6
8990534|NCT02769065|10053701|FG007|COMPLETED|Overall Study||6
8990535|NCT02769065|10053702|FG008|COMPLETED|Overall Study||6
8990536|NCT02769065|10053703|FG009|COMPLETED|Overall Study||6
8990537|NCT02769065|10053704|FG010|COMPLETED|Overall Study||5
8990538|NCT02769065|10053705|FG011|COMPLETED|Overall Study||6
8990539|NCT02769065|10053706|FG012|COMPLETED|Overall Study||6
8990540|NCT02769065|10053707|FG013|COMPLETED|Overall Study||6
8990541|NCT02769065|10053708|FG014|COMPLETED|Overall Study||6
8990542|NCT02769065|10053709|FG015|COMPLETED|Overall Study||3
8990543|NCT02769065|10053710|FG016|COMPLETED|Overall Study||5
8990544|NCT02769065|10053711|FG017|COMPLETED|Overall Study||5
8990545|NCT02769065|10053712|FG018|COMPLETED|Overall Study||5
8990546|NCT02769065|10053713|FG019|COMPLETED|Overall Study||0
8990547|NCT02769065|10053714|FG020|COMPLETED|Overall Study||4
8990548|NCT02769065|10053715|FG021|COMPLETED|Overall Study||4
8990549|NCT02769065|10053716|FG022|COMPLETED|Overall Study||4
8990550|NCT02769065|10053717|FG023|COMPLETED|Overall Study||6
8990551|NCT02769065|10053718|FG024|COMPLETED|Overall Study||6
8990552|NCT02769065|10053719|FG025|COMPLETED|Overall Study||9
8990553|NCT02769065|10053720|FG026|COMPLETED|Overall Study||9
8990554|NCT02769065|10053721|FG027|COMPLETED|Overall Study||5
8990555|NCT02769065|10053722|FG028|COMPLETED|Overall Study||6
8990556|NCT02769065|10053723|FG029|COMPLETED|Overall Study||6
8990557|NCT02769065|10053694|FG000|NOT COMPLETED|Overall Study||1
8990558|NCT02769065|10053695|FG001|NOT COMPLETED|Overall Study||0
8990559|NCT02769065|10053696|FG002|NOT COMPLETED|Overall Study||0
8990560|NCT02769065|10053697|FG003|NOT COMPLETED|Overall Study||0
8990561|NCT02769065|10053698|FG004|NOT COMPLETED|Overall Study||0
8990562|NCT02769065|10053699|FG005|NOT COMPLETED|Overall Study||0
8990563|NCT02769065|10053700|FG006|NOT COMPLETED|Overall Study||1
8990564|NCT02769065|10053701|FG007|NOT COMPLETED|Overall Study||0
8990565|NCT02769065|10053702|FG008|NOT COMPLETED|Overall Study||0
8990566|NCT02769065|10053703|FG009|NOT COMPLETED|Overall Study||0
8633432|NCT00550745|9673492|FG000|COMPLETED|Overall Study||5913
8990567|NCT02769065|10053704|FG010|NOT COMPLETED|Overall Study||1
8990568|NCT02769065|10053705|FG011|NOT COMPLETED|Overall Study||0
8990569|NCT02769065|10053706|FG012|NOT COMPLETED|Overall Study||0
8990570|NCT02769065|10053707|FG013|NOT COMPLETED|Overall Study||0
8990571|NCT02769065|10053708|FG014|NOT COMPLETED|Overall Study||0
8990572|NCT02769065|10053709|FG015|NOT COMPLETED|Overall Study||0
8990573|NCT02769065|10053710|FG016|NOT COMPLETED|Overall Study||0
8990574|NCT02769065|10053711|FG017|NOT COMPLETED|Overall Study||0
8990575|NCT02769065|10053712|FG018|NOT COMPLETED|Overall Study||0
8990576|NCT02769065|10053713|FG019|NOT COMPLETED|Overall Study||0
8990577|NCT02769065|10053714|FG020|NOT COMPLETED|Overall Study||0
8990578|NCT02769065|10053715|FG021|NOT COMPLETED|Overall Study||0
8990579|NCT02769065|10053716|FG022|NOT COMPLETED|Overall Study||0
8990580|NCT02769065|10053717|FG023|NOT COMPLETED|Overall Study||0
8990581|NCT02769065|10053718|FG024|NOT COMPLETED|Overall Study||0
8990582|NCT02769065|10053719|FG025|NOT COMPLETED|Overall Study||0
8990583|NCT02769065|10053720|FG026|NOT COMPLETED|Overall Study||0
8990584|NCT02769065|10053721|FG027|NOT COMPLETED|Overall Study||0
8990585|NCT02769065|10053722|FG028|NOT COMPLETED|Overall Study||0
8990586|NCT02769065|10053723|FG029|NOT COMPLETED|Overall Study||0
8990587|NCT02769247|10053820|FG000|STARTED|Overall Study||40
8990588|NCT02769247|10053821|FG001|STARTED|Overall Study||40
8990589|NCT02769247|10053822|FG002|STARTED|Overall Study||40
8990590|NCT02769247|10053823|FG003|STARTED|Overall Study||40
8990591|NCT02769247|10053820|FG000|COMPLETED|Overall Study|unable to insert IUD in one patient; 1 pt decided against study participation after enrollment|38
8990592|NCT02769247|10053821|FG001|COMPLETED|Overall Study||40
8990593|NCT02769247|10053822|FG002|COMPLETED|Overall Study|1 took non-study med after enrollment/randomization, before IUD insertion (excluded from study)|39
8990594|NCT02769247|10053823|FG003|COMPLETED|Overall Study|1 patient decided against study participation after enrollment/randomization|39
8990595|NCT02769247|10053820|FG000|NOT COMPLETED|Overall Study||2
8990596|NCT02769247|10053821|FG001|NOT COMPLETED|Overall Study||0
8990597|NCT02769247|10053822|FG002|NOT COMPLETED|Overall Study||1
8990598|NCT02769247|10053823|FG003|NOT COMPLETED|Overall Study||1
8990599|NCT02769312|10053839|FG000|STARTED|Double-Blind (0-2 Weeks)||25
8990600|NCT02769312|10053840|FG001|STARTED|Double-Blind (0-2 Weeks)||25
8990601|NCT02769312|10053839|FG000|COMPLETED|Double-Blind (0-2 Weeks)||23
8990602|NCT02769312|10053840|FG001|COMPLETED|Double-Blind (0-2 Weeks)||24
8990603|NCT02769312|10053839|FG000|NOT COMPLETED|Double-Blind (0-2 Weeks)||2
8990604|NCT02769312|10053840|FG001|NOT COMPLETED|Double-Blind (0-2 Weeks)||1
8990605|NCT02769312|10053839|FG000|STARTED|Unblinded (Optional 2-4 Weeks)|2 participants chose not to continue with the unblinded period.|21
8990606|NCT02769312|10053840|FG001|STARTED|Unblinded (Optional 2-4 Weeks)||24
8990607|NCT02769312|10053839|FG000|COMPLETED|Unblinded (Optional 2-4 Weeks)||20
8990608|NCT02769312|10053840|FG001|COMPLETED|Unblinded (Optional 2-4 Weeks)||23
8990609|NCT02769312|10053839|FG000|NOT COMPLETED|Unblinded (Optional 2-4 Weeks)||1
8990610|NCT02769312|10053840|FG001|NOT COMPLETED|Unblinded (Optional 2-4 Weeks)||1
8990611|NCT02769312|10053839|FG000|STARTED|Follow-up||23
8990612|NCT02769312|10053840|FG001|STARTED|Follow-up||24
8990613|NCT02769312|10053839|FG000|COMPLETED|Follow-up||22
8990614|NCT02769312|10053840|FG001|COMPLETED|Follow-up||23
8990615|NCT02769312|10053839|FG000|NOT COMPLETED|Follow-up||1
8990616|NCT02769312|10053840|FG001|NOT COMPLETED|Follow-up||1
8990617|NCT02769351|10053847|FG000|STARTED|Overall Study|SP|46
8990618|NCT02769351|10053847|FG000|COMPLETED|Overall Study|SP|4
8990619|NCT02769351|10053847|FG000|NOT COMPLETED|Overall Study||42
8990620|NCT02769442|10053854|FG000|STARTED|Overall Study||309
8990621|NCT02769442|10053855|FG001|STARTED|Overall Study||291
8990622|NCT02769442|10053854|FG000|COMPLETED|Overall Study||309
8990623|NCT02769442|10053855|FG001|COMPLETED|Overall Study||291
8990624|NCT02769442|10053854|FG000|NOT COMPLETED|Overall Study||0
8990625|NCT02769442|10053855|FG001|NOT COMPLETED|Overall Study||0
8990626|NCT02769481|10053863|FG000|STARTED|Overall Study||213
8990627|NCT02769481|10053864|FG001|STARTED|Overall Study||213
8990628|NCT02769481|10053863|FG000|Study Complete at Week 60|Overall Study||193
8990629|NCT02769481|10053864|FG001|Study Complete at Week 60|Overall Study||192
8990630|NCT02769481|10053863|FG000|COMPLETED|Overall Study||180
8990631|NCT02769481|10053864|FG001|COMPLETED|Overall Study||177
8990632|NCT02769481|10053863|FG000|NOT COMPLETED|Overall Study||33
8990633|NCT02769481|10053864|FG001|NOT COMPLETED|Overall Study||36
8990634|NCT02769624|10053870|FG000|STARTED|Overall Study||7
8990635|NCT02769624|10053871|FG001|STARTED|Overall Study||8
8990636|NCT02769624|10053870|FG000|COMPLETED|Overall Study||7
8990637|NCT02769624|10053871|FG001|COMPLETED|Overall Study||7
8990638|NCT02769624|10053870|FG000|NOT COMPLETED|Overall Study||0
8990639|NCT02769624|10053871|FG001|NOT COMPLETED|Overall Study||1
8990640|NCT02769702|10053877|FG000|STARTED|Overall Study||2
8990641|NCT02769702|10053877|FG000|COMPLETED|Overall Study||2
8990642|NCT02769702|10053877|FG000|NOT COMPLETED|Overall Study||0
8990643|NCT02769858|10053881|FG000|STARTED|Overall Study||10
8990644|NCT02769858|10053881|FG000|COMPLETED|Overall Study||8
8990645|NCT02769858|10053881|FG000|NOT COMPLETED|Overall Study||2
8990646|NCT02770014|10053885|FG000|STARTED|Plasma Genotyping||43
8990647|NCT02770014|10053885|FG000|COMPLETED|Plasma Genotyping||43
8990648|NCT02770014|10053885|FG000|NOT COMPLETED|Plasma Genotyping||0
8990649|NCT02770014|10053885|FG000|STARTED|EGFR Exon 19 Pos, Treated With Erlotinib|A total of 11 participants were found to have an activating EGFR mutation (exon 19 del or L858R).|11
8990650|NCT02770014|10053885|FG000|COMPLETED|EGFR Exon 19 Pos, Treated With Erlotinib|Of the 11 participants that had an activating EGFR mutation, 6 started erlotinib treatment.|6
8990651|NCT02770014|10053885|FG000|NOT COMPLETED|EGFR Exon 19 Pos, Treated With Erlotinib||5
8990652|NCT02770170|10053894|FG000|STARTED|Overall Study||21
8990653|NCT02770170|10053895|FG001|STARTED|Overall Study||20
8990654|NCT02770170|10053896|FG002|STARTED|Overall Study||40
8990655|NCT02770170|10053897|FG003|STARTED|Overall Study||40
8990656|NCT02770170|10053894|FG000|COMPLETED|Overall Study||14
8990657|NCT02770170|10053895|FG001|COMPLETED|Overall Study||17
8990658|NCT02770170|10053896|FG002|COMPLETED|Overall Study||35
8990659|NCT02770170|10053897|FG003|COMPLETED|Overall Study||33
8990660|NCT02770170|10053894|FG000|NOT COMPLETED|Overall Study||7
8990661|NCT02770170|10053895|FG001|NOT COMPLETED|Overall Study||3
8990662|NCT02770170|10053896|FG002|NOT COMPLETED|Overall Study||5
8990663|NCT02770170|10053897|FG003|NOT COMPLETED|Overall Study||7
8990664|NCT02770248|10053909|FG000|STARTED|Overall Study||62
8990665|NCT02770248|10053910|FG001|STARTED|Overall Study||63
8990666|NCT02770248|10053909|FG000|COMPLETED|Overall Study||62
8990667|NCT02770248|10053910|FG001|COMPLETED|Overall Study||61
8990668|NCT02770248|10053909|FG000|NOT COMPLETED|Overall Study||0
8990669|NCT02770248|10053910|FG001|NOT COMPLETED|Overall Study||2
8990670|NCT02770287|10053916|FG000|STARTED|Overall Study||11
8990671|NCT02770287|10053916|FG000|COMPLETED|Overall Study||11
8990672|NCT02770287|10053916|FG000|NOT COMPLETED|Overall Study||0
8990673|NCT02770365|10053926|FG000|STARTED|Overall Study||277
8990674|NCT02770365|10053927|FG001|STARTED|Overall Study||279
8990675|NCT02770365|10053928|FG002|STARTED|Overall Study||139
8990676|NCT02770365|10053926|FG000|COMPLETED|Overall Study||272
8990677|NCT02770365|10053927|FG001|COMPLETED|Overall Study||275
8990678|NCT02770365|10053928|FG002|COMPLETED|Overall Study||139
8990679|NCT02770365|10053926|FG000|NOT COMPLETED|Overall Study||5
8990680|NCT02770365|10053927|FG001|NOT COMPLETED|Overall Study||4
8990681|NCT02770365|10053928|FG002|NOT COMPLETED|Overall Study||0
8990682|NCT02770521|10053938|FG000|STARTED|Period One||4
8990683|NCT02770521|10053939|FG001|STARTED|Period One||4
8990684|NCT02770521|10053940|FG002|STARTED|Period One||2
8990685|NCT02770521|10053941|FG003|STARTED|Period One||2
8990686|NCT02770521|10053942|FG004|STARTED|Period One||2
8990687|NCT02770521|10053943|FG005|STARTED|Period One||9
8990688|NCT02770521|10053938|FG000|Received Study Drug|Period One||4
8990689|NCT02770521|10053939|FG001|Received Study Drug|Period One||4
8990690|NCT02770521|10053940|FG002|Received Study Drug|Period One||2
8990691|NCT02770521|10053941|FG003|Received Study Drug|Period One||2
8990692|NCT02770521|10053942|FG004|Received Study Drug|Period One||2
8990693|NCT02770521|10053943|FG005|Received Study Drug|Period One||9
8990694|NCT02770521|10053938|FG000|COMPLETED|Period One||4
8990695|NCT02770521|10053939|FG001|COMPLETED|Period One||4
8990696|NCT02770521|10053940|FG002|COMPLETED|Period One||2
8990697|NCT02770521|10053941|FG003|COMPLETED|Period One||2
8990698|NCT02770521|10053942|FG004|COMPLETED|Period One||2
8990699|NCT02770521|10053943|FG005|COMPLETED|Period One||9
8990700|NCT02770521|10053938|FG000|NOT COMPLETED|Period One||0
8990701|NCT02770521|10053939|FG001|NOT COMPLETED|Period One||0
8990702|NCT02770521|10053940|FG002|NOT COMPLETED|Period One||0
8990703|NCT02770521|10053941|FG003|NOT COMPLETED|Period One||0
8990704|NCT02770521|10053942|FG004|NOT COMPLETED|Period One||0
8990705|NCT02770521|10053943|FG005|NOT COMPLETED|Period One||0
8990706|NCT02770521|10053938|FG000|STARTED|Period Two||4
8990707|NCT02770521|10053939|FG001|STARTED|Period Two||4
8571813|NCT00112437|9604139|FG016|COMPLETED|Year 1 (12-Month Base Study)||0
8571814|NCT00112437|9604140|FG017|COMPLETED|Year 1 (12-Month Base Study)||0
8571815|NCT00112437|9604141|FG018|COMPLETED|Year 1 (12-Month Base Study)||0
8571816|NCT00112437|9604142|FG019|COMPLETED|Year 1 (12-Month Base Study)||0
8571817|NCT00112437|9604143|FG020|COMPLETED|Year 1 (12-Month Base Study)||0
8571818|NCT00112437|9604144|FG021|COMPLETED|Year 1 (12-Month Base Study)||0
8571819|NCT00112437|9604145|FG022|COMPLETED|Year 1 (12-Month Base Study)||0
8571820|NCT00112437|9604146|FG023|COMPLETED|Year 1 (12-Month Base Study)||0
8571821|NCT00112437|9604147|FG024|COMPLETED|Year 1 (12-Month Base Study)||0
8571822|NCT00112437|9604148|FG025|COMPLETED|Year 1 (12-Month Base Study)||0
8571823|NCT00112437|9604123|FG000|NOT COMPLETED|Year 1 (12-Month Base Study)||15
8571824|NCT00112437|9604124|FG001|NOT COMPLETED|Year 1 (12-Month Base Study)||18
8571825|NCT00112437|9604125|FG002|NOT COMPLETED|Year 1 (12-Month Base Study)||12
8571826|NCT00112437|9604126|FG003|NOT COMPLETED|Year 1 (12-Month Base Study)||8
8571827|NCT00112437|9604127|FG004|NOT COMPLETED|Year 1 (12-Month Base Study)||12
8571828|NCT00112437|9604128|FG005|NOT COMPLETED|Year 1 (12-Month Base Study)||0
8571829|NCT00112437|9604129|FG006|NOT COMPLETED|Year 1 (12-Month Base Study)||0
8990708|NCT02770521|10053940|FG002|STARTED|Period Two||2
8990709|NCT02770521|10053941|FG003|STARTED|Period Two||2
8990710|NCT02770521|10053942|FG004|STARTED|Period Two||2
8990711|NCT02770521|10053943|FG005|STARTED|Period Two||9
8990712|NCT02770521|10053938|FG000|Received Study Drug|Period Two||4
8990713|NCT02770521|10053939|FG001|Received Study Drug|Period Two||4
8990714|NCT02770521|10053940|FG002|Received Study Drug|Period Two||2
8990715|NCT02770521|10053941|FG003|Received Study Drug|Period Two||2
8990716|NCT02770521|10053942|FG004|Received Study Drug|Period Two||2
8990717|NCT02770521|10053943|FG005|Received Study Drug|Period Two||9
8990718|NCT02770521|10053938|FG000|COMPLETED|Period Two||4
8990719|NCT02770521|10053939|FG001|COMPLETED|Period Two||4
8990720|NCT02770521|10053940|FG002|COMPLETED|Period Two||2
8990721|NCT02770521|10053941|FG003|COMPLETED|Period Two||2
8990722|NCT02770521|10053942|FG004|COMPLETED|Period Two||2
8990723|NCT02770521|10053943|FG005|COMPLETED|Period Two||9
8990724|NCT02770521|10053938|FG000|NOT COMPLETED|Period Two||0
8990725|NCT02770521|10053939|FG001|NOT COMPLETED|Period Two||0
8990726|NCT02770521|10053940|FG002|NOT COMPLETED|Period Two||0
8990727|NCT02770521|10053941|FG003|NOT COMPLETED|Period Two||0
8990728|NCT02770521|10053942|FG004|NOT COMPLETED|Period Two||0
8990729|NCT02770521|10053943|FG005|NOT COMPLETED|Period Two||0
8990730|NCT02770521|10053938|FG000|STARTED|Period Three|Not applicable. Part A only had two periods.|0
8990731|NCT02770521|10053939|FG001|STARTED|Period Three|Not applicable. Part A only had two periods.|0
8990732|NCT02770521|10053940|FG002|STARTED|Period Three||2
8990733|NCT02770521|10053941|FG003|STARTED|Period Three||2
8990734|NCT02770521|10053942|FG004|STARTED|Period Three||2
8990735|NCT02770521|10053943|FG005|STARTED|Period Three||9
8990736|NCT02770521|10053938|FG000|Received Study Drug|Period Three||0
8990737|NCT02770521|10053939|FG001|Received Study Drug|Period Three||0
8990738|NCT02770521|10053940|FG002|Received Study Drug|Period Three||2
8990739|NCT02770521|10053941|FG003|Received Study Drug|Period Three||2
8990740|NCT02770521|10053942|FG004|Received Study Drug|Period Three||2
8990741|NCT02770521|10053943|FG005|Received Study Drug|Period Three||9
8990742|NCT02770521|10053938|FG000|COMPLETED|Period Three||0
8990743|NCT02770521|10053939|FG001|COMPLETED|Period Three||0
8990744|NCT02770521|10053940|FG002|COMPLETED|Period Three||2
8990745|NCT02770521|10053941|FG003|COMPLETED|Period Three||2
8990746|NCT02770521|10053942|FG004|COMPLETED|Period Three||2
8990747|NCT02770521|10053943|FG005|COMPLETED|Period Three||9
8990748|NCT02770521|10053938|FG000|NOT COMPLETED|Period Three||0
8990749|NCT02770521|10053939|FG001|NOT COMPLETED|Period Three||0
8990750|NCT02770521|10053940|FG002|NOT COMPLETED|Period Three||0
8990751|NCT02770521|10053941|FG003|NOT COMPLETED|Period Three||0
8990752|NCT02770521|10053942|FG004|NOT COMPLETED|Period Three||0
8990753|NCT02770521|10053943|FG005|NOT COMPLETED|Period Three||0
8990754|NCT02770547|10053963|FG000|STARTED|Overall Study||16
8990755|NCT02770547|10053964|FG001|STARTED|Overall Study||16
8990756|NCT02770547|10053963|FG000|COMPLETED|Overall Study||15
8990757|NCT02770547|10053964|FG001|COMPLETED|Overall Study||15
8990758|NCT02770547|10053963|FG000|NOT COMPLETED|Overall Study||1
8990759|NCT02770547|10053964|FG001|NOT COMPLETED|Overall Study||1
8990760|NCT02770612|10053970|FG000|STARTED|Overall Study||51
8990761|NCT02770612|10053970|FG000|COMPLETED|Overall Study||50
8990762|NCT02770612|10053970|FG000|NOT COMPLETED|Overall Study||1
8990763|NCT02770625|10053974|FG000|STARTED|Overall Study||8
8990764|NCT02770625|10053974|FG000|COMPLETED|Overall Study||8
8990765|NCT02770625|10053974|FG000|NOT COMPLETED|Overall Study||0
9038997|NCT03334903|10100086|FG000|NOT COMPLETED|Overall Study||4
9038998|NCT03334903|10100087|FG001|NOT COMPLETED|Overall Study||5
9038999|NCT03335150|10100095|FG000|STARTED|Overall Study||55
9039000|NCT03335150|10100096|FG001|STARTED|Overall Study||55
9039001|NCT03335150|10100095|FG000|Enrolled + Assigned Group|Overall Study||54
9039002|NCT03335150|10100096|FG001|Enrolled + Assigned Group|Overall Study||55
9039003|NCT03335150|10100095|FG000|PRE Testing Session|Overall Study||53
9039004|NCT03335150|10100096|FG001|PRE Testing Session|Overall Study||55
9039005|NCT03335150|10100095|FG000|Commenced Group|Overall Study||47
9039006|NCT03335150|10100096|FG001|Commenced Group|Overall Study||52
9039007|NCT03335150|10100095|FG000|POST Testing Session|Overall Study||45
9039008|NCT03335150|10100096|FG001|POST Testing Session|Overall Study||50
9039009|NCT03335150|10100095|FG000|COMPLETED|Overall Study||45
9039010|NCT03335150|10100096|FG001|COMPLETED|Overall Study||50
9039011|NCT03335150|10100095|FG000|NOT COMPLETED|Overall Study||10
9039012|NCT03335150|10100096|FG001|NOT COMPLETED|Overall Study||5
9039013|NCT03335254|10100122|FG000|STARTED|Period 1||9
9039014|NCT03335254|10100123|FG001|STARTED|Period 1||0
9039015|NCT03335254|10100124|FG002|STARTED|Period 1||0
9039016|NCT03335254|10100125|FG003|STARTED|Period 1||0
9039017|NCT03335254|10100126|FG004|STARTED|Period 1||0
9039018|NCT03335254|10100127|FG005|STARTED|Period 1||0
9039019|NCT03335254|10100128|FG006|STARTED|Period 1||0
9039020|NCT03335254|10100129|FG007|STARTED|Period 1||0
9039021|NCT03335254|10100130|FG008|STARTED|Period 1||0
9039022|NCT03335254|10100131|FG009|STARTED|Period 1||0
9039023|NCT03335254|10100132|FG010|STARTED|Period 1||0
9039024|NCT03335254|10100133|FG011|STARTED|Period 1||0
9039025|NCT03335254|10100134|FG012|STARTED|Period 1||0
9039026|NCT03335254|10100135|FG013|STARTED|Period 1||0
9039027|NCT03335254|10100136|FG014|STARTED|Period 1||0
9039028|NCT03335254|10100137|FG015|STARTED|Period 1||0
9039029|NCT03335254|10100138|FG016|STARTED|Period 1||0
9039030|NCT03335254|10100139|FG017|STARTED|Period 1||0
9039031|NCT03335254|10100140|FG018|STARTED|Period 1||0
9039032|NCT03335254|10100141|FG019|STARTED|Period 1||0
9039033|NCT03335254|10100122|FG000|COMPLETED|Period 1||9
9039034|NCT03335254|10100123|FG001|COMPLETED|Period 1||0
9039035|NCT03335254|10100124|FG002|COMPLETED|Period 1||0
9039036|NCT03335254|10100125|FG003|COMPLETED|Period 1||0
9039037|NCT03335254|10100126|FG004|COMPLETED|Period 1||0
9039038|NCT03335254|10100127|FG005|COMPLETED|Period 1||0
8990766|NCT02770820|10053978|FG000|STARTED|Overall Study||7
8990767|NCT02770820|10053978|FG000|COMPLETED|Overall Study||4
8990768|NCT02770820|10053978|FG000|NOT COMPLETED|Overall Study||3
8990769|NCT02770846|10053984|FG000|STARTED|Overall Study||25
8990770|NCT02770846|10053985|FG001|STARTED|Overall Study||25
8990771|NCT02770846|10053984|FG000|COMPLETED|Overall Study||25
8990772|NCT02770846|10053985|FG001|COMPLETED|Overall Study||25
8990773|NCT02770846|10053984|FG000|NOT COMPLETED|Overall Study||0
8990774|NCT02770846|10053985|FG001|NOT COMPLETED|Overall Study||0
8990775|NCT02771093|10053995|FG000|STARTED|Overall Study||13
8990776|NCT02771093|10053996|FG001|STARTED|Overall Study||14
8990777|NCT02771093|10053995|FG000|COMPLETED|Overall Study||13
8990778|NCT02771093|10053996|FG001|COMPLETED|Overall Study||14
8990779|NCT02771093|10053995|FG000|NOT COMPLETED|Overall Study||0
8990780|NCT02771093|10053996|FG001|NOT COMPLETED|Overall Study||0
8990781|NCT02771145|10054002|FG000|STARTED|Overall Study||90
8990782|NCT02771145|10054002|FG000|COMPLETED|Overall Study||86
8990783|NCT02771145|10054002|FG000|NOT COMPLETED|Overall Study||4
8990784|NCT02771210|10054024|FG000|STARTED|Period 1||102
8990785|NCT02771210|10054025|FG001|STARTED|Period 1||102
8990786|NCT02771210|10054024|FG000|COMPLETED|Period 1||91
8990787|NCT02771210|10054025|FG001|COMPLETED|Period 1||84
8990788|NCT02771210|10054024|FG000|NOT COMPLETED|Period 1||11
8990789|NCT02771210|10054025|FG001|NOT COMPLETED|Period 1||18
8990790|NCT02771210|10054024|FG000|STARTED|Period 2||91
8990791|NCT02771210|10054025|FG001|STARTED|Period 2||84
8990792|NCT02771210|10054024|FG000|COMPLETED|Period 2||89
8990793|NCT02771210|10054025|FG001|COMPLETED|Period 2||81
8990794|NCT02771210|10054024|FG000|NOT COMPLETED|Period 2||2
8577905|NCT00165789|9610846|FG000|STARTED|Overall Study||8
8990795|NCT02771210|10054025|FG001|NOT COMPLETED|Period 2||3
8990796|NCT02771340|10054034|FG000|STARTED|Overall Study||2
8990797|NCT02771340|10054035|FG001|STARTED|Overall Study||3
8990798|NCT02771340|10054036|FG002|STARTED|Overall Study||5
8990799|NCT02771340|10054034|FG000|COMPLETED|Overall Study||2
8990800|NCT02771340|10054035|FG001|COMPLETED|Overall Study||3
8990801|NCT02771340|10054036|FG002|COMPLETED|Overall Study||5
8990802|NCT02771340|10054034|FG000|NOT COMPLETED|Overall Study||0
8990803|NCT02771340|10054035|FG001|NOT COMPLETED|Overall Study||0
8990804|NCT02771340|10054036|FG002|NOT COMPLETED|Overall Study||0
8990805|NCT02771366|10054046|FG000|STARTED|Period 1||15
8990806|NCT02771366|10054047|FG001|STARTED|Period 1||15
8990807|NCT02771366|10054046|FG000|COMPLETED|Period 1||15
8990808|NCT02771366|10054047|FG001|COMPLETED|Period 1||13
8990809|NCT02771366|10054046|FG000|NOT COMPLETED|Period 1||0
8990810|NCT02771366|10054047|FG001|NOT COMPLETED|Period 1||2
8990811|NCT02771366|10054046|FG000|STARTED|Period 2 (Crossover)||15
8990812|NCT02771366|10054047|FG001|STARTED|Period 2 (Crossover)||13
8990813|NCT02771366|10054046|FG000|COMPLETED|Period 2 (Crossover)||13
8990814|NCT02771366|10054047|FG001|COMPLETED|Period 2 (Crossover)||13
8990815|NCT02771366|10054046|FG000|NOT COMPLETED|Period 2 (Crossover)||2
8990816|NCT02771366|10054047|FG001|NOT COMPLETED|Period 2 (Crossover)||0
8990817|NCT02771522|10054054|FG000|STARTED|Overall Study|119 teeth imaged with the Calcivis System from 30 patients|30
8990818|NCT02771522|10054054|FG000|COMPLETED|Overall Study|87 teeth imaged with the Calcivis System fro 22 patients|22
8990819|NCT02771522|10054054|FG000|NOT COMPLETED|Overall Study||8
8990820|NCT02771574|10054068|FG000|STARTED|Lyo Avexitide Dose Level 1 (3 Days)||3
8990821|NCT02771574|10054069|FG001|STARTED|Lyo Avexitide Dose Level 1 (3 Days)||0
8990822|NCT02771574|10054070|FG002|STARTED|Lyo Avexitide Dose Level 1 (3 Days)||0
8990823|NCT02771574|10054071|FG003|STARTED|Lyo Avexitide Dose Level 1 (3 Days)||0
8990824|NCT02771574|10054072|FG004|STARTED|Lyo Avexitide Dose Level 1 (3 Days)||0
8990825|NCT02771574|10054068|FG000|COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||3
8990826|NCT02771574|10054069|FG001|COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
8990827|NCT02771574|10054070|FG002|COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
8990828|NCT02771574|10054071|FG003|COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
8990829|NCT02771574|10054072|FG004|COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
8990830|NCT02771574|10054068|FG000|NOT COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
8990831|NCT02771574|10054069|FG001|NOT COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
8990832|NCT02771574|10054070|FG002|NOT COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
8990833|NCT02771574|10054071|FG003|NOT COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
8990834|NCT02771574|10054072|FG004|NOT COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
8990835|NCT02771574|10054068|FG000|STARTED|Lyo Avexitide Dose Level 2 (3 Days)||0
8990836|NCT02771574|10054069|FG001|STARTED|Lyo Avexitide Dose Level 2 (3 Days)||5
8990837|NCT02771574|10054070|FG002|STARTED|Lyo Avexitide Dose Level 2 (3 Days)||0
8990838|NCT02771574|10054071|FG003|STARTED|Lyo Avexitide Dose Level 2 (3 Days)||0
8990839|NCT02771574|10054072|FG004|STARTED|Lyo Avexitide Dose Level 2 (3 Days)||0
8990840|NCT02771574|10054068|FG000|COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
8990841|NCT02771574|10054069|FG001|COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||5
8990842|NCT02771574|10054070|FG002|COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
8990843|NCT02771574|10054071|FG003|COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
8990844|NCT02771574|10054072|FG004|COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
8990845|NCT02771574|10054068|FG000|NOT COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
8990846|NCT02771574|10054069|FG001|NOT COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
8990847|NCT02771574|10054070|FG002|NOT COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
8990848|NCT02771574|10054071|FG003|NOT COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
8990849|NCT02771574|10054072|FG004|NOT COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
8990850|NCT02771574|10054068|FG000|STARTED|Lyo Avexitide Dose Level 3 (3 Days)||0
8990851|NCT02771574|10054069|FG001|STARTED|Lyo Avexitide Dose Level 3 (3 Days)||0
8990852|NCT02771574|10054070|FG002|STARTED|Lyo Avexitide Dose Level 3 (3 Days)||3
8990853|NCT02771574|10054071|FG003|STARTED|Lyo Avexitide Dose Level 3 (3 Days)||0
8990854|NCT02771574|10054072|FG004|STARTED|Lyo Avexitide Dose Level 3 (3 Days)||0
8990855|NCT02771574|10054068|FG000|COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
8990856|NCT02771574|10054069|FG001|COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
8990857|NCT02771574|10054070|FG002|COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||3
8990858|NCT02771574|10054071|FG003|COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
8990859|NCT02771574|10054072|FG004|COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
8990860|NCT02771574|10054068|FG000|NOT COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
8990861|NCT02771574|10054069|FG001|NOT COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
8990862|NCT02771574|10054070|FG002|NOT COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
8990863|NCT02771574|10054071|FG003|NOT COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
8990864|NCT02771574|10054072|FG004|NOT COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
8990865|NCT02771574|10054068|FG000|STARTED|Lyo Avexitide Dose Level 4 (3 Days)||0
8990866|NCT02771574|10054069|FG001|STARTED|Lyo Avexitide Dose Level 4 (3 Days)||0
8990867|NCT02771574|10054070|FG002|STARTED|Lyo Avexitide Dose Level 4 (3 Days)||0
8990868|NCT02771574|10054071|FG003|STARTED|Lyo Avexitide Dose Level 4 (3 Days)||3
8990869|NCT02771574|10054072|FG004|STARTED|Lyo Avexitide Dose Level 4 (3 Days)||0
8990870|NCT02771574|10054068|FG000|COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
8990871|NCT02771574|10054069|FG001|COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
8990872|NCT02771574|10054070|FG002|COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
8990873|NCT02771574|10054071|FG003|COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||3
8990874|NCT02771574|10054072|FG004|COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
8990875|NCT02771574|10054068|FG000|NOT COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
8990876|NCT02771574|10054069|FG001|NOT COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
8990877|NCT02771574|10054070|FG002|NOT COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
8990878|NCT02771574|10054071|FG003|NOT COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
8990879|NCT02771574|10054072|FG004|NOT COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
8990880|NCT02771574|10054068|FG000|STARTED|Liq Avexitide (3 Days)||0
8990881|NCT02771574|10054069|FG001|STARTED|Liq Avexitide (3 Days)||0
8990882|NCT02771574|10054070|FG002|STARTED|Liq Avexitide (3 Days)||0
8990883|NCT02771574|10054071|FG003|STARTED|Liq Avexitide (3 Days)||0
8990884|NCT02771574|10054072|FG004|STARTED|Liq Avexitide (3 Days)||5
8990885|NCT02771574|10054068|FG000|COMPLETED|Liq Avexitide (3 Days)||0
8990886|NCT02771574|10054069|FG001|COMPLETED|Liq Avexitide (3 Days)||0
8633433|NCT00550745|9673493|FG001|COMPLETED|Overall Study||5939
8633434|NCT00550745|9673492|FG000|NOT COMPLETED|Overall Study||87
8633435|NCT00550745|9673493|FG001|NOT COMPLETED|Overall Study||60
8633436|NCT00550771|9673501|FG000|STARTED|Overall Study||121
8633437|NCT00550771|9673502|FG001|STARTED|Overall Study||60
8633438|NCT00550771|9673501|FG000|COMPLETED|Overall Study||104
8990887|NCT02771574|10054070|FG002|COMPLETED|Liq Avexitide (3 Days)||0
8990888|NCT02771574|10054071|FG003|COMPLETED|Liq Avexitide (3 Days)||0
8990889|NCT02771574|10054072|FG004|COMPLETED|Liq Avexitide (3 Days)||5
8990890|NCT02771574|10054068|FG000|NOT COMPLETED|Liq Avexitide (3 Days)||0
8990891|NCT02771574|10054069|FG001|NOT COMPLETED|Liq Avexitide (3 Days)||0
8990892|NCT02771574|10054070|FG002|NOT COMPLETED|Liq Avexitide (3 Days)||0
8990893|NCT02771574|10054071|FG003|NOT COMPLETED|Liq Avexitide (3 Days)||0
8990894|NCT02771574|10054072|FG004|NOT COMPLETED|Liq Avexitide (3 Days)||0
8990895|NCT02772302|10054089|FG000|STARTED|Overall Study||10
8633439|NCT00550771|9673502|FG001|COMPLETED|Overall Study||50
8633440|NCT00550771|9673501|FG000|NOT COMPLETED|Overall Study||17
8990896|NCT02772302|10054090|FG001|STARTED|Overall Study||10
8990897|NCT02772302|10054089|FG000|COMPLETED|Overall Study||10
8990898|NCT02772302|10054090|FG001|COMPLETED|Overall Study||10
8990899|NCT02772302|10054089|FG000|NOT COMPLETED|Overall Study||0
8990900|NCT02772302|10054090|FG001|NOT COMPLETED|Overall Study||0
8990901|NCT02772432|10054098|FG000|STARTED|Overall Study||31
8990902|NCT02772432|10054099|FG001|STARTED|Overall Study||22
8990903|NCT02772432|10054098|FG000|COMPLETED|Overall Study||19
8990904|NCT02772432|10054099|FG001|COMPLETED|Overall Study||21
8990905|NCT02772432|10054098|FG000|NOT COMPLETED|Overall Study||12
8990906|NCT02772432|10054099|FG001|NOT COMPLETED|Overall Study||1
8990907|NCT02772666|10054105|FG000|STARTED|O-Glas Then SFT||44
8990908|NCT02772666|10054105|FG000|COMPLETED|O-Glas Then SFT||44
8990909|NCT02772666|10054105|FG000|NOT COMPLETED|O-Glas Then SFT||0
8990910|NCT02772666|10054105|FG000|STARTED|SFT Then O-Glass||44
8990911|NCT02772666|10054105|FG000|COMPLETED|SFT Then O-Glass||44
8990912|NCT02772666|10054105|FG000|NOT COMPLETED|SFT Then O-Glass||0
8990913|NCT02772757|10054113|FG000|STARTED|Overall Study||22
8990914|NCT02772757|10054114|FG001|STARTED|Overall Study||24
8990915|NCT02772757|10054115|FG002|STARTED|Overall Study||26
8990916|NCT02772757|10054113|FG000|COMPLETED|Overall Study||21
8990917|NCT02772757|10054114|FG001|COMPLETED|Overall Study||21
8990918|NCT02772757|10054115|FG002|COMPLETED|Overall Study||21
8990919|NCT02772757|10054113|FG000|NOT COMPLETED|Overall Study||1
8990920|NCT02772757|10054114|FG001|NOT COMPLETED|Overall Study||3
8990921|NCT02772757|10054115|FG002|NOT COMPLETED|Overall Study||5
8990922|NCT02772783|10054124|FG000|STARTED|Experimental Condition 1, 1 Day||8
8990923|NCT02772783|10054125|FG001|STARTED|Experimental Condition 1, 1 Day||7
8990924|NCT02772783|10054124|FG000|COMPLETED|Experimental Condition 1, 1 Day||8
8990925|NCT02772783|10054125|FG001|COMPLETED|Experimental Condition 1, 1 Day||7
8990926|NCT02772783|10054124|FG000|NOT COMPLETED|Experimental Condition 1, 1 Day||0
8990927|NCT02772783|10054125|FG001|NOT COMPLETED|Experimental Condition 1, 1 Day||0
8990928|NCT02772783|10054124|FG000|STARTED|Wash-out, 1 Week||8
8990929|NCT02772783|10054125|FG001|STARTED|Wash-out, 1 Week||7
8990930|NCT02772783|10054124|FG000|COMPLETED|Wash-out, 1 Week||8
8990931|NCT02772783|10054125|FG001|COMPLETED|Wash-out, 1 Week||7
8990932|NCT02772783|10054124|FG000|NOT COMPLETED|Wash-out, 1 Week||0
8990933|NCT02772783|10054125|FG001|NOT COMPLETED|Wash-out, 1 Week||0
8990934|NCT02772783|10054124|FG000|STARTED|Comparison Condition, 1 Day||8
8990935|NCT02772783|10054125|FG001|STARTED|Comparison Condition, 1 Day||7
8990936|NCT02772783|10054124|FG000|COMPLETED|Comparison Condition, 1 Day||8
8990937|NCT02772783|10054125|FG001|COMPLETED|Comparison Condition, 1 Day||7
8990938|NCT02772783|10054124|FG000|NOT COMPLETED|Comparison Condition, 1 Day||0
8990939|NCT02772783|10054125|FG001|NOT COMPLETED|Comparison Condition, 1 Day||0
8990940|NCT02772783|10054124|FG000|STARTED|Wash-out, 1 Week||8
8990941|NCT02772783|10054125|FG001|STARTED|Wash-out, 1 Week||7
8990942|NCT02772783|10054124|FG000|COMPLETED|Wash-out, 1 Week||8
8990943|NCT02772783|10054125|FG001|COMPLETED|Wash-out, 1 Week||7
8990944|NCT02772783|10054124|FG000|NOT COMPLETED|Wash-out, 1 Week||0
8990945|NCT02772783|10054125|FG001|NOT COMPLETED|Wash-out, 1 Week||0
8990946|NCT02772783|10054124|FG000|STARTED|Experimental Condition 2, 1 Day||8
8990947|NCT02772783|10054125|FG001|STARTED|Experimental Condition 2, 1 Day||7
8990948|NCT02772783|10054124|FG000|COMPLETED|Experimental Condition 2, 1 Day||8
8990949|NCT02772783|10054125|FG001|COMPLETED|Experimental Condition 2, 1 Day||7
8990950|NCT02772783|10054124|FG000|NOT COMPLETED|Experimental Condition 2, 1 Day||0
8990951|NCT02772783|10054125|FG001|NOT COMPLETED|Experimental Condition 2, 1 Day||0
8990952|NCT02772809|10054133|FG000|STARTED|Overall Study||23
8990953|NCT02772809|10054133|FG000|COMPLETED|Overall Study||17
8990954|NCT02772809|10054133|FG000|NOT COMPLETED|Overall Study||6
8990955|NCT02772978|10054142|FG000|STARTED|Overall Study|First participant enrolled|10
8990956|NCT02772978|10054143|FG001|STARTED|Overall Study||9
8633441|NCT00550771|9673502|FG001|NOT COMPLETED|Overall Study||10
8633442|NCT00550836|9673510|FG000|STARTED|Overall Study||49
8990957|NCT02772978|10054142|FG000|COMPLETED|Overall Study|Last participant enrolled|9
8990958|NCT02772978|10054143|FG001|COMPLETED|Overall Study||8
8990959|NCT02772978|10054142|FG000|NOT COMPLETED|Overall Study||1
8990960|NCT02772978|10054143|FG001|NOT COMPLETED|Overall Study||1
8990961|NCT02773368|10054150|FG000|STARTED|Overall Study||210
8990962|NCT02773368|10054151|FG001|STARTED|Overall Study||210
8990963|NCT02773368|10054150|FG000|Exposed|Overall Study||209
8990964|NCT02773368|10054151|FG001|Exposed|Overall Study||210
8990965|NCT02773368|10054150|FG000|COMPLETED|Overall Study||200
8990966|NCT02773368|10054151|FG001|COMPLETED|Overall Study||206
8990967|NCT02773368|10054150|FG000|NOT COMPLETED|Overall Study||10
8990968|NCT02773368|10054151|FG001|NOT COMPLETED|Overall Study||4
8990969|NCT02773446|10054163|FG000|STARTED|First Admission||7
8990970|NCT02773446|10054164|FG001|STARTED|First Admission||7
8990971|NCT02773446|10054165|FG002|STARTED|First Admission||7
8990972|NCT02773446|10054166|FG003|STARTED|First Admission||7
8990973|NCT02773446|10054167|FG004|STARTED|First Admission||0
8990974|NCT02773446|10054168|FG005|STARTED|First Admission||0
8990975|NCT02773446|10054163|FG000|COMPLETED|First Admission||6
8990976|NCT02773446|10054164|FG001|COMPLETED|First Admission||7
8990977|NCT02773446|10054165|FG002|COMPLETED|First Admission||7
8990978|NCT02773446|10054166|FG003|COMPLETED|First Admission||6
8990979|NCT02773446|10054167|FG004|COMPLETED|First Admission||0
8990980|NCT02773446|10054168|FG005|COMPLETED|First Admission||0
8990981|NCT02773446|10054163|FG000|NOT COMPLETED|First Admission||1
8990982|NCT02773446|10054164|FG001|NOT COMPLETED|First Admission||0
8990983|NCT02773446|10054165|FG002|NOT COMPLETED|First Admission||0
8990984|NCT02773446|10054166|FG003|NOT COMPLETED|First Admission||1
8990985|NCT02773446|10054167|FG004|NOT COMPLETED|First Admission||0
8990986|NCT02773446|10054168|FG005|NOT COMPLETED|First Admission||0
8990987|NCT02773446|10054163|FG000|STARTED|Second Admission||0
8990988|NCT02773446|10054164|FG001|STARTED|Second Admission||0
8990989|NCT02773446|10054165|FG002|STARTED|Second Admission||0
8990990|NCT02773446|10054166|FG003|STARTED|Second Admission||0
8990991|NCT02773446|10054167|FG004|STARTED|Second Admission||11
8990992|NCT02773446|10054168|FG005|STARTED|Second Admission||19
8990993|NCT02773446|10054163|FG000|COMPLETED|Second Admission||0
8990994|NCT02773446|10054164|FG001|COMPLETED|Second Admission||0
8990995|NCT02773446|10054165|FG002|COMPLETED|Second Admission||0
8571830|NCT00112437|9604130|FG007|NOT COMPLETED|Year 1 (12-Month Base Study)||0
8571831|NCT00112437|9604131|FG008|NOT COMPLETED|Year 1 (12-Month Base Study)||0
8571832|NCT00112437|9604132|FG009|NOT COMPLETED|Year 1 (12-Month Base Study)||0
8571833|NCT00112437|9604133|FG010|NOT COMPLETED|Year 1 (12-Month Base Study)||0
8571834|NCT00112437|9604134|FG011|NOT COMPLETED|Year 1 (12-Month Base Study)||0
8571835|NCT00112437|9604135|FG012|NOT COMPLETED|Year 1 (12-Month Base Study)||0
8571836|NCT00112437|9604136|FG013|NOT COMPLETED|Year 1 (12-Month Base Study)||0
8571837|NCT00112437|9604137|FG014|NOT COMPLETED|Year 1 (12-Month Base Study)||0
8571838|NCT00112437|9604138|FG015|NOT COMPLETED|Year 1 (12-Month Base Study)||0
8571839|NCT00112437|9604139|FG016|NOT COMPLETED|Year 1 (12-Month Base Study)||0
8571840|NCT00112437|9604140|FG017|NOT COMPLETED|Year 1 (12-Month Base Study)||0
8571841|NCT00112437|9604141|FG018|NOT COMPLETED|Year 1 (12-Month Base Study)||0
8571842|NCT00112437|9604142|FG019|NOT COMPLETED|Year 1 (12-Month Base Study)||0
8571843|NCT00112437|9604143|FG020|NOT COMPLETED|Year 1 (12-Month Base Study)||0
8571844|NCT00112437|9604144|FG021|NOT COMPLETED|Year 1 (12-Month Base Study)||0
8571845|NCT00112437|9604145|FG022|NOT COMPLETED|Year 1 (12-Month Base Study)||0
8571846|NCT00112437|9604146|FG023|NOT COMPLETED|Year 1 (12-Month Base Study)||0
8571847|NCT00112437|9604147|FG024|NOT COMPLETED|Year 1 (12-Month Base Study)||0
8571848|NCT00112437|9604148|FG025|NOT COMPLETED|Year 1 (12-Month Base Study)||0
8633443|NCT00550836|9673511|FG001|STARTED|Overall Study||55
8571849|NCT00112437|9604123|FG000|STARTED|Year 2 (12-Month Extension)||0
8571850|NCT00112437|9604124|FG001|STARTED|Year 2 (12-Month Extension)||0
8571851|NCT00112437|9604125|FG002|STARTED|Year 2 (12-Month Extension)||0
8571852|NCT00112437|9604126|FG003|STARTED|Year 2 (12-Month Extension)||0
8571853|NCT00112437|9604127|FG004|STARTED|Year 2 (12-Month Extension)||0
8571854|NCT00112437|9604128|FG005|STARTED|Year 2 (12-Month Extension)||63
8571855|NCT00112437|9604129|FG006|STARTED|Year 2 (12-Month Extension)||62
8571856|NCT00112437|9604130|FG007|STARTED|Year 2 (12-Month Extension)||63
8633444|NCT00550836|9673510|FG000|COMPLETED|Overall Study||46
8571857|NCT00112437|9604131|FG008|STARTED|Year 2 (12-Month Extension)||69
8633445|NCT00550836|9673511|FG001|COMPLETED|Overall Study||46
8990996|NCT02773446|10054166|FG003|COMPLETED|Second Admission||0
8990997|NCT02773446|10054167|FG004|COMPLETED|Second Admission||11
8990998|NCT02773446|10054168|FG005|COMPLETED|Second Admission||19
8990999|NCT02773446|10054163|FG000|NOT COMPLETED|Second Admission||0
8991000|NCT02773446|10054164|FG001|NOT COMPLETED|Second Admission||0
8991001|NCT02773446|10054165|FG002|NOT COMPLETED|Second Admission||0
8991002|NCT02773446|10054166|FG003|NOT COMPLETED|Second Admission||0
8991003|NCT02773446|10054167|FG004|NOT COMPLETED|Second Admission||0
8571858|NCT00112437|9604132|FG009|STARTED|Year 2 (12-Month Extension)||63
8878987|NCT01931670|9935831|FG002|Completed PTFU Month 6|Post-Treatment Follow-Up (PTFU) Period||18
8878988|NCT01931670|9935829|FG000|Completed PTFU Month 12|Post-Treatment Follow-Up (PTFU) Period||0
8878989|NCT01931670|9935830|FG001|Completed PTFU Month 12|Post-Treatment Follow-Up (PTFU) Period||4
8878990|NCT01931670|9935831|FG002|Completed PTFU Month 12|Post-Treatment Follow-Up (PTFU) Period||15
8878991|NCT01931670|9935829|FG000|COMPLETED|Post-Treatment Follow-Up (PTFU) Period||42
8878992|NCT01931670|9935830|FG001|COMPLETED|Post-Treatment Follow-Up (PTFU) Period||28
8878993|NCT01931670|9935831|FG002|COMPLETED|Post-Treatment Follow-Up (PTFU) Period||33
8878994|NCT01931670|9935829|FG000|NOT COMPLETED|Post-Treatment Follow-Up (PTFU) Period||19
8878995|NCT01931670|9935830|FG001|NOT COMPLETED|Post-Treatment Follow-Up (PTFU) Period||12
8878996|NCT01931670|9935831|FG002|NOT COMPLETED|Post-Treatment Follow-Up (PTFU) Period||21
8878997|NCT01931709|9935839|FG000|STARTED|Overall Study||35
8878998|NCT01931709|9935839|FG000|COMPLETED|Overall Study||35
8878999|NCT01931709|9935839|FG000|NOT COMPLETED|Overall Study||0
8879000|NCT01931735|9935849|FG000|STARTED|Randomized Phase||4
8879001|NCT01931735|9935850|FG001|STARTED|Randomized Phase||3
8879002|NCT01931735|9935851|FG002|STARTED|Randomized Phase||9
8879003|NCT01931735|9935852|FG003|STARTED|Randomized Phase||0
8879004|NCT01931735|9935849|FG000|COMPLETED|Randomized Phase||2
8879005|NCT01931735|9935850|FG001|COMPLETED|Randomized Phase||1
8879006|NCT01931735|9935851|FG002|COMPLETED|Randomized Phase||4
8879007|NCT01931735|9935852|FG003|COMPLETED|Randomized Phase||0
8879008|NCT01931735|9935849|FG000|NOT COMPLETED|Randomized Phase||2
8879009|NCT01931735|9935850|FG001|NOT COMPLETED|Randomized Phase||2
8879010|NCT01931735|9935851|FG002|NOT COMPLETED|Randomized Phase||5
8879011|NCT01931735|9935852|FG003|NOT COMPLETED|Randomized Phase||0
8879012|NCT01931735|9935849|FG000|STARTED|Observational Non-Randomized Phase|Participants continued from the randomized phase|2
8879013|NCT01931735|9935850|FG001|STARTED|Observational Non-Randomized Phase|Participants continued from the randomized phase|1
8879014|NCT01931735|9935851|FG002|STARTED|Observational Non-Randomized Phase||0
8879015|NCT01931735|9935852|FG003|STARTED|Observational Non-Randomized Phase|Participants recruited post-amendment|11
8879016|NCT01931735|9935849|FG000|COMPLETED|Observational Non-Randomized Phase||2
8879017|NCT01931735|9935850|FG001|COMPLETED|Observational Non-Randomized Phase||1
8879018|NCT01931735|9935851|FG002|COMPLETED|Observational Non-Randomized Phase||0
8633446|NCT00550836|9673510|FG000|NOT COMPLETED|Overall Study||3
8633447|NCT00550836|9673511|FG001|NOT COMPLETED|Overall Study||9
8633448|NCT00550862|9673521|FG000|STARTED|Overall Study||38
8633449|NCT00550862|9673522|FG001|STARTED|Overall Study||48
8633450|NCT00550862|9673523|FG002|STARTED|Overall Study||41
8633451|NCT00550862|9673524|FG003|STARTED|Overall Study||38
8633452|NCT00550862|9673521|FG000|COMPLETED|Overall Study||32
8633453|NCT00550862|9673522|FG001|COMPLETED|Overall Study||42
8879019|NCT01931735|9935852|FG003|COMPLETED|Observational Non-Randomized Phase||9
8879020|NCT01931735|9935849|FG000|NOT COMPLETED|Observational Non-Randomized Phase||0
8879021|NCT01931735|9935850|FG001|NOT COMPLETED|Observational Non-Randomized Phase||0
8879022|NCT01931735|9935851|FG002|NOT COMPLETED|Observational Non-Randomized Phase||0
8879023|NCT01931735|9935852|FG003|NOT COMPLETED|Observational Non-Randomized Phase||2
8879024|NCT01931839|9935869|FG000|STARTED|Overall Study||335
8879025|NCT01931839|9935870|FG001|STARTED|Overall Study||178
8879026|NCT01931839|9935871|FG002|STARTED|Overall Study||340
8879027|NCT01931839|9935872|FG003|STARTED|Overall Study||176
8879028|NCT01931839|9935873|FG004|STARTED|Overall Study||19
8879029|NCT01931839|9935874|FG005|STARTED|Overall Study||55
8879030|NCT01931839|9935875|FG006|STARTED|Overall Study||60
8879031|NCT01931839|9935869|FG000|Full Analysis Set (As Randomized)|Overall Study||334
8879032|NCT01931839|9935870|FG001|Full Analysis Set (As Randomized)|Overall Study||179
8879033|NCT01931839|9935871|FG002|Full Analysis Set (As Randomized)|Overall Study||340
8879034|NCT01931839|9935872|FG003|Full Analysis Set (As Randomized)|Overall Study||176
8879035|NCT01931839|9935873|FG004|Full Analysis Set (As Randomized)|Overall Study||19
8879036|NCT01931839|9935874|FG005|Full Analysis Set (As Randomized)|Overall Study||55
8879037|NCT01931839|9935875|FG006|Full Analysis Set (As Randomized)|Overall Study||60
8879038|NCT01931839|9935869|FG000|Safety Analysis Set (As Dosed)|Overall Study||335
8879039|NCT01931839|9935870|FG001|Safety Analysis Set (As Dosed)|Overall Study||178
8879040|NCT01931839|9935871|FG002|Safety Analysis Set (As Dosed)|Overall Study||340
8879041|NCT01931839|9935872|FG003|Safety Analysis Set (As Dosed)|Overall Study||176
8879042|NCT01931839|9935873|FG004|Safety Analysis Set (As Dosed)|Overall Study||19
8879043|NCT01931839|9935874|FG005|Safety Analysis Set (As Dosed)|Overall Study||55
8879044|NCT01931839|9935875|FG006|Safety Analysis Set (As Dosed)|Overall Study||60
8879045|NCT01931839|9935869|FG000|COMPLETED|Overall Study||294
8879046|NCT01931839|9935870|FG001|COMPLETED|Overall Study||152
8879047|NCT01931839|9935871|FG002|COMPLETED|Overall Study||301
8879048|NCT01931839|9935872|FG003|COMPLETED|Overall Study||162
8879049|NCT01931839|9935873|FG004|COMPLETED|Overall Study||18
8879050|NCT01931839|9935874|FG005|COMPLETED|Overall Study||50
8879051|NCT01931839|9935875|FG006|COMPLETED|Overall Study||56
8879052|NCT01931839|9935869|FG000|NOT COMPLETED|Overall Study||41
8879053|NCT01931839|9935870|FG001|NOT COMPLETED|Overall Study||26
8879054|NCT01931839|9935871|FG002|NOT COMPLETED|Overall Study||39
8879055|NCT01931839|9935872|FG003|NOT COMPLETED|Overall Study||14
8879056|NCT01931839|9935873|FG004|NOT COMPLETED|Overall Study||1
8633454|NCT00550862|9673523|FG002|COMPLETED|Overall Study||25
8991004|NCT02773446|10054168|FG005|NOT COMPLETED|Second Admission||0
8991005|NCT02773537|10054188|FG000|STARTED|Overall Study||25
8991006|NCT02773537|10054189|FG001|STARTED|Overall Study||25
8991007|NCT02773537|10054190|FG002|STARTED|Overall Study||25
8991008|NCT02773537|10054188|FG000|COMPLETED|Overall Study||25
8991009|NCT02773537|10054189|FG001|COMPLETED|Overall Study||24
8991010|NCT02773537|10054190|FG002|COMPLETED|Overall Study||21
8991011|NCT02773537|10054188|FG000|NOT COMPLETED|Overall Study||0
8991012|NCT02773537|10054189|FG001|NOT COMPLETED|Overall Study||1
8991013|NCT02773537|10054190|FG002|NOT COMPLETED|Overall Study||4
8991014|NCT02773758|10054200|FG000|STARTED|Overall Study||71
8991015|NCT02773758|10054201|FG001|STARTED|Overall Study||70
8991016|NCT02773758|10054200|FG000|COMPLETED|Overall Study||71
8991017|NCT02773758|10054201|FG001|COMPLETED|Overall Study||70
8991018|NCT02773758|10054200|FG000|NOT COMPLETED|Overall Study||0
8991019|NCT02773758|10054201|FG001|NOT COMPLETED|Overall Study||0
8991020|NCT02773836|10054213|FG000|STARTED|Wave 1- Pre-TPD Implementation||1000
8991021|NCT02773836|10054214|FG001|STARTED|Wave 1- Pre-TPD Implementation||1003
8991022|NCT02773836|10054215|FG002|STARTED|Wave 1- Pre-TPD Implementation||1001
8991023|NCT02773836|10054216|FG003|STARTED|Wave 1- Pre-TPD Implementation||1001
8991024|NCT02773836|10054217|FG004|STARTED|Wave 1- Pre-TPD Implementation||1000
8633455|NCT00550862|9673524|FG003|COMPLETED|Overall Study||37
8633456|NCT00550862|9673521|FG000|NOT COMPLETED|Overall Study||6
8633457|NCT00550862|9673522|FG001|NOT COMPLETED|Overall Study||6
8633458|NCT00550862|9673523|FG002|NOT COMPLETED|Overall Study||16
8879057|NCT01931839|9935874|FG005|NOT COMPLETED|Overall Study||5
8991025|NCT02773836|10054218|FG005|STARTED|Wave 1- Pre-TPD Implementation||1006
8991026|NCT02773836|10054213|FG000|COMPLETED|Wave 1- Pre-TPD Implementation||1000
8991027|NCT02773836|10054214|FG001|COMPLETED|Wave 1- Pre-TPD Implementation||1003
8991028|NCT02773836|10054215|FG002|COMPLETED|Wave 1- Pre-TPD Implementation||1001
8991029|NCT02773836|10054216|FG003|COMPLETED|Wave 1- Pre-TPD Implementation||1001
8991030|NCT02773836|10054217|FG004|COMPLETED|Wave 1- Pre-TPD Implementation||1000
8991031|NCT02773836|10054218|FG005|COMPLETED|Wave 1- Pre-TPD Implementation||1006
8991032|NCT02773836|10054213|FG000|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
8991033|NCT02773836|10054214|FG001|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
8991034|NCT02773836|10054215|FG002|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
8991035|NCT02773836|10054216|FG003|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
8991036|NCT02773836|10054217|FG004|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
8991037|NCT02773836|10054218|FG005|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
8991038|NCT02773836|10054213|FG000|STARTED|Wave 2- Post-TPD Implementation||1010
8991039|NCT02773836|10054214|FG001|STARTED|Wave 2- Post-TPD Implementation||1013
8991040|NCT02773836|10054215|FG002|STARTED|Wave 2- Post-TPD Implementation||1003
8991041|NCT02773836|10054216|FG003|STARTED|Wave 2- Post-TPD Implementation||1010
8991042|NCT02773836|10054217|FG004|STARTED|Wave 2- Post-TPD Implementation||1002
8991043|NCT02773836|10054218|FG005|STARTED|Wave 2- Post-TPD Implementation||998
8633459|NCT00550862|9673524|FG003|NOT COMPLETED|Overall Study||1
8879058|NCT01931839|9935875|FG006|NOT COMPLETED|Overall Study||4
8879059|NCT01931865|9935895|FG000|STARTED|Overall Study||12
8879060|NCT01931865|9935895|FG000|COMPLETED|Overall Study||8
8879061|NCT01931865|9935895|FG000|NOT COMPLETED|Overall Study||4
8879062|NCT01931878|9935900|FG000|STARTED|First Intervention||10
8879063|NCT01931878|9935901|FG001|STARTED|First Intervention||14
8879064|NCT01931878|9935900|FG000|COMPLETED|First Intervention||9
8879065|NCT01931878|9935901|FG001|COMPLETED|First Intervention||14
8879066|NCT01931878|9935900|FG000|NOT COMPLETED|First Intervention||1
8879067|NCT01931878|9935901|FG001|NOT COMPLETED|First Intervention||0
8879068|NCT01931878|9935900|FG000|STARTED|Second Intervention (After 3 Months)||9
8879069|NCT01931878|9935901|FG001|STARTED|Second Intervention (After 3 Months)||14
8879070|NCT01931878|9935900|FG000|COMPLETED|Second Intervention (After 3 Months)||9
8879071|NCT01931878|9935901|FG001|COMPLETED|Second Intervention (After 3 Months)||12
8879072|NCT01931878|9935900|FG000|NOT COMPLETED|Second Intervention (After 3 Months)||0
8879073|NCT01931878|9935901|FG001|NOT COMPLETED|Second Intervention (After 3 Months)||2
8879074|NCT01931956|9935915|FG000|STARTED|Overall Study||59
8879075|NCT01931956|9935916|FG001|STARTED|Overall Study||7
8879076|NCT01931956|9935917|FG002|STARTED|Overall Study||628
8879077|NCT01931956|9935918|FG003|STARTED|Overall Study||271
8879078|NCT01931956|9935915|FG000|COMPLETED|Overall Study||8
8879079|NCT01931956|9935916|FG001|COMPLETED|Overall Study||0
8879080|NCT01931956|9935917|FG002|COMPLETED|Overall Study||141
8879081|NCT01931956|9935918|FG003|COMPLETED|Overall Study||138
8879082|NCT01931956|9935915|FG000|NOT COMPLETED|Overall Study||51
8879083|NCT01931956|9935916|FG001|NOT COMPLETED|Overall Study||7
8879084|NCT01931956|9935917|FG002|NOT COMPLETED|Overall Study||487
8879085|NCT01931956|9935918|FG003|NOT COMPLETED|Overall Study||133
8879086|NCT01931995|9935943|FG000|STARTED|First Intervention (1 Day)||23
8879087|NCT01931995|9935944|FG001|STARTED|First Intervention (1 Day)||22
8879088|NCT01931995|9935943|FG000|COMPLETED|First Intervention (1 Day)||19
8879089|NCT01931995|9935944|FG001|COMPLETED|First Intervention (1 Day)||18
8879090|NCT01931995|9935943|FG000|NOT COMPLETED|First Intervention (1 Day)||4
8991044|NCT02773836|10054213|FG000|COMPLETED|Wave 2- Post-TPD Implementation||1010
8991045|NCT02773836|10054214|FG001|COMPLETED|Wave 2- Post-TPD Implementation||1013
8991046|NCT02773836|10054215|FG002|COMPLETED|Wave 2- Post-TPD Implementation||1003
8991047|NCT02773836|10054216|FG003|COMPLETED|Wave 2- Post-TPD Implementation||1010
8991048|NCT02773836|10054217|FG004|COMPLETED|Wave 2- Post-TPD Implementation||1002
8991049|NCT02773836|10054218|FG005|COMPLETED|Wave 2- Post-TPD Implementation||998
8991050|NCT02773836|10054213|FG000|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
8991051|NCT02773836|10054214|FG001|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
8991052|NCT02773836|10054215|FG002|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
8991053|NCT02773836|10054216|FG003|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
8991054|NCT02773836|10054217|FG004|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
8991055|NCT02773836|10054218|FG005|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
8991056|NCT02774213|10054238|FG000|STARTED|Overall Study||74
8991057|NCT02774213|10054238|FG000|COMPLETED|Overall Study||55
8991058|NCT02774213|10054238|FG000|NOT COMPLETED|Overall Study||19
8991059|NCT02774226|10054244|FG000|STARTED|Overall Study||8
8991060|NCT02774226|10054245|FG001|STARTED|Overall Study||7
8991061|NCT02774226|10054244|FG000|COMPLETED|Overall Study||8
8991062|NCT02774226|10054245|FG001|COMPLETED|Overall Study||7
8991063|NCT02774226|10054244|FG000|NOT COMPLETED|Overall Study||0
8991064|NCT02774226|10054245|FG001|NOT COMPLETED|Overall Study||0
8991065|NCT02774278|10054251|FG000|STARTED|Overall Study||264
8991066|NCT02774278|10054251|FG000|Safety Analysis Population (SAP)|Overall Study|SAP: all participants who received at least 1 dose of trial medication and had a safety follow-up.|261
8991067|NCT02774278|10054251|FG000|COMPLETED|Overall Study||0
8991068|NCT02774278|10054251|FG000|NOT COMPLETED|Overall Study||264
8991069|NCT02774343|10054257|FG000|STARTED|Overall Study||15
8991070|NCT02774343|10054258|FG001|STARTED|Overall Study||15
8633460|NCT00550953|9673536|FG000|STARTED|Overall Study||156
8633461|NCT00550953|9673537|FG001|STARTED|Overall Study||158
8633462|NCT00550953|9673536|FG000|COMPLETED|Overall Study||150
8633463|NCT00550953|9673537|FG001|COMPLETED|Overall Study||152
8633464|NCT00550953|9673536|FG000|NOT COMPLETED|Overall Study||6
8991071|NCT02774343|10054257|FG000|Received at Least One Capsule|Overall Study||12
8991072|NCT02774343|10054258|FG001|Received at Least One Capsule|Overall Study||14
8991073|NCT02774343|10054257|FG000|COMPLETED|Overall Study||9
8991074|NCT02774343|10054258|FG001|COMPLETED|Overall Study||12
8991075|NCT02774343|10054257|FG000|NOT COMPLETED|Overall Study||6
8991076|NCT02774343|10054258|FG001|NOT COMPLETED|Overall Study||3
8991077|NCT02774616|10054267|FG000|STARTED|Overall Study||95
8991078|NCT02774616|10054268|FG001|STARTED|Overall Study||167
8991079|NCT02774616|10054269|FG002|STARTED|Overall Study||16
8991080|NCT02774616|10054267|FG000|Died|Overall Study||6
8991081|NCT02774616|10054268|FG001|Died|Overall Study||3
8991082|NCT02774616|10054269|FG002|Died|Overall Study||1
8991083|NCT02774616|10054267|FG000|Withdrew Consent|Overall Study||3
8991084|NCT02774616|10054268|FG001|Withdrew Consent|Overall Study||3
8991085|NCT02774616|10054269|FG002|Withdrew Consent|Overall Study||0
8991086|NCT02774616|10054267|FG000|Lost to FU|Overall Study||2
8991087|NCT02774616|10054268|FG001|Lost to FU|Overall Study||0
8991088|NCT02774616|10054269|FG002|Lost to FU|Overall Study||0
8991089|NCT02774616|10054267|FG000|Device Explanted|Overall Study||2
8991090|NCT02774616|10054268|FG001|Device Explanted|Overall Study||1
8991091|NCT02774616|10054269|FG002|Device Explanted|Overall Study||1
8991092|NCT02774616|10054267|FG000|Other|Overall Study||2
8991093|NCT02774616|10054268|FG001|Other|Overall Study||4
8991094|NCT02774616|10054269|FG002|Other|Overall Study||1
8991095|NCT02774616|10054267|FG000|COMPLETED|Overall Study||80
8991096|NCT02774616|10054268|FG001|COMPLETED|Overall Study||156
8991097|NCT02774616|10054269|FG002|COMPLETED|Overall Study||13
8991098|NCT02774616|10054267|FG000|NOT COMPLETED|Overall Study||15
8991099|NCT02774616|10054268|FG001|NOT COMPLETED|Overall Study||11
8991100|NCT02774616|10054269|FG002|NOT COMPLETED|Overall Study||3
8991101|NCT02774681|10054279|FG000|STARTED|Treatment on Study||12
8991102|NCT02774681|10054279|FG000|Reached 1st Response/2 Cycles|Treatment on Study||10
8991103|NCT02774681|10054279|FG000|Went on to Start Cycle 3|Treatment on Study||5
8991104|NCT02774681|10054279|FG000|COMPLETED|Treatment on Study||5
8991105|NCT02774681|10054279|FG000|NOT COMPLETED|Treatment on Study||7
8991106|NCT02774681|10054279|FG000|STARTED|Follow-Up for 3 Years||12
8991107|NCT02774681|10054279|FG000|COMPLETED|Follow-Up for 3 Years||0
8991108|NCT02774681|10054279|FG000|NOT COMPLETED|Follow-Up for 3 Years||12
8991109|NCT02774798|10054286|FG000|STARTED|Overall Study||7
8991110|NCT02774798|10054287|FG001|STARTED|Overall Study||17
8991111|NCT02774798|10054288|FG002|STARTED|Overall Study||7
8991112|NCT02774798|10054286|FG000|COMPLETED|Overall Study||7
8991113|NCT02774798|10054287|FG001|COMPLETED|Overall Study||17
8991114|NCT02774798|10054288|FG002|COMPLETED|Overall Study||7
8991115|NCT02774798|10054286|FG000|NOT COMPLETED|Overall Study||0
8991116|NCT02774798|10054287|FG001|NOT COMPLETED|Overall Study||0
8991117|NCT02774798|10054288|FG002|NOT COMPLETED|Overall Study||0
8991118|NCT02774850|10054298|FG000|STARTED|Overall Study||610
8991119|NCT02774850|10054298|FG000|Induction I|Overall Study||585
8991120|NCT02774850|10054298|FG000|Early Discharge Eligible at Induction I|Overall Study|24 of these patients were managed as outpatients. 252 were managed as inpatients.|276
8991121|NCT02774850|10054298|FG000|Induction II|Overall Study||564
8991122|NCT02774850|10054298|FG000|Early Discharge Eligible at Induction II|Overall Study|114 of these patients were managed as outpatients. 379 were managed as inpatients.|493
8991123|NCT02774850|10054298|FG000|Intensification I|Overall Study||476
8991124|NCT02774850|10054298|FG000|Early Discharge Eligible at Int I|Overall Study|104 of these patients were managed as outpatients. 270 were managed as inpatients.|374
8991125|NCT02774850|10054298|FG000|Intensification II|Overall Study||342
9039039|NCT03335254|10100128|FG006|COMPLETED|Period 1||0
9039040|NCT03335254|10100129|FG007|COMPLETED|Period 1||0
8633465|NCT00550953|9673537|FG001|NOT COMPLETED|Overall Study||6
8991126|NCT02774850|10054298|FG000|Early Discharge Eligible at Int II|Overall Study|56 of these patients were managed as outpatients. 229 were managed as inpatients.|285
8991127|NCT02774850|10054298|FG000|Intensification III|Overall Study||48
8991128|NCT02774850|10054298|FG000|Early Discharge Eligible at Int III|Overall Study|7 of these patients were managed as outpatients. 37 were managed as inpatients.|44
8991129|NCT02774850|10054298|FG000|COMPLETED|Overall Study||575
8991130|NCT02774850|10054298|FG000|NOT COMPLETED|Overall Study||35
8991131|NCT02774941|10054306|FG000|STARTED|Overall Study||110
8991132|NCT02774941|10054307|FG001|STARTED|Overall Study||110
8991133|NCT02774941|10054306|FG000|Subjects Excluded|Overall Study||1
8991134|NCT02774941|10054307|FG001|Subjects Excluded|Overall Study||2
8991135|NCT02774941|10054306|FG000|COMPLETED|Overall Study||109
8991136|NCT02774941|10054307|FG001|COMPLETED|Overall Study||108
8991137|NCT02774941|10054306|FG000|NOT COMPLETED|Overall Study||1
8991138|NCT02774941|10054307|FG001|NOT COMPLETED|Overall Study||2
8991139|NCT02775240|10054313|FG000|STARTED|Overall Study||18
8991140|NCT02775240|10054313|FG000|Started Treatment A|Overall Study||18
8991141|NCT02775240|10054313|FG000|Started Treatment B|Overall Study||17
8991142|NCT02775240|10054313|FG000|COMPLETED|Overall Study||17
8991143|NCT02775240|10054313|FG000|NOT COMPLETED|Overall Study||1
8991144|NCT02775344|10054322|FG000|STARTED|Overall Study||40
8991145|NCT02775344|10054323|FG001|STARTED|Overall Study||40
8991146|NCT02775344|10054322|FG000|COMPLETED|Overall Study||37
8991147|NCT02775344|10054323|FG001|COMPLETED|Overall Study||38
8991148|NCT02775344|10054322|FG000|NOT COMPLETED|Overall Study||3
8991149|NCT02775344|10054323|FG001|NOT COMPLETED|Overall Study||2
8991150|NCT02775617|10054331|FG000|STARTED|Overall Study|Participants are seen at via a survey of the community. 92.6% of the resident population|653
8991151|NCT02775617|10054332|FG001|STARTED|Overall Study|Participants are seen at via a survey of the community. 88.9% of the resident population|638
8991152|NCT02775617|10054331|FG000|COMPLETED|Overall Study|Participants are seen at via a survey of the community. 96.3% of the resident population|605
8633466|NCT00551031|9673548|FG000|STARTED|Overall Study||637
8633467|NCT00551031|9673549|FG001|STARTED|Overall Study||636
8633468|NCT00551031|9673550|FG002|STARTED|Overall Study||319
8633469|NCT00551031|9673551|FG003|STARTED|Overall Study||320
8991153|NCT02775617|10054332|FG001|COMPLETED|Overall Study|Participants are seen at via a survey of the community. 76.2% of the resident population|478
8633470|NCT00551031|9673552|FG004|STARTED|Overall Study||186
8991154|NCT02775617|10054331|FG000|NOT COMPLETED|Overall Study||48
8991155|NCT02775617|10054332|FG001|NOT COMPLETED|Overall Study||160
8991156|NCT02775864|10054342|FG000|STARTED|Overall Study||26014
8991157|NCT02775864|10054343|FG001|STARTED|Overall Study||31117
8991158|NCT02775864|10054344|FG002|STARTED|Overall Study||11941
8991159|NCT02775864|10054345|FG003|STARTED|Overall Study||12849
8991160|NCT02775864|10054342|FG000|COMPLETED|Overall Study||22772
8991161|NCT02775864|10054343|FG001|COMPLETED|Overall Study||26218
8991162|NCT02775864|10054344|FG002|COMPLETED|Overall Study||10081
8991163|NCT02775864|10054345|FG003|COMPLETED|Overall Study||10765
8991164|NCT02775864|10054342|FG000|NOT COMPLETED|Overall Study||3242
8991165|NCT02775864|10054343|FG001|NOT COMPLETED|Overall Study||4899
8991166|NCT02775864|10054344|FG002|NOT COMPLETED|Overall Study||1860
8991167|NCT02775864|10054345|FG003|NOT COMPLETED|Overall Study||2084
8991168|NCT02775903|10054360|FG000|STARTED|Overall Study||42
8991169|NCT02775903|10054361|FG001|STARTED|Overall Study||42
8991170|NCT02775903|10054362|FG002|STARTED|Overall Study||64
8991171|NCT02775903|10054363|FG003|STARTED|Overall Study||65
8991172|NCT02775903|10054360|FG000|Received Study Treatment|Overall Study||38
8991173|NCT02775903|10054361|FG001|Received Study Treatment|Overall Study||41
8991174|NCT02775903|10054362|FG002|Received Study Treatment|Overall Study||64
8991175|NCT02775903|10054363|FG003|Received Study Treatment|Overall Study||62
8991176|NCT02775903|10054360|FG000|COMPLETED|Overall Study||0
8991177|NCT02775903|10054361|FG001|COMPLETED|Overall Study||1
8991178|NCT02775903|10054362|FG002|COMPLETED|Overall Study||0
8991179|NCT02775903|10054363|FG003|COMPLETED|Overall Study||0
8991180|NCT02775903|10054360|FG000|NOT COMPLETED|Overall Study||42
8991181|NCT02775903|10054361|FG001|NOT COMPLETED|Overall Study||41
8991182|NCT02775903|10054362|FG002|NOT COMPLETED|Overall Study||64
8991183|NCT02775903|10054363|FG003|NOT COMPLETED|Overall Study||65
8991184|NCT02775916|10054379|FG000|STARTED|Overall Study||20
8571859|NCT00112437|9604133|FG010|STARTED|Year 2 (12-Month Extension)||0
8571860|NCT00112437|9604134|FG011|STARTED|Year 2 (12-Month Extension)||0
8571861|NCT00112437|9604135|FG012|STARTED|Year 2 (12-Month Extension)||0
8571862|NCT00112437|9604136|FG013|STARTED|Year 2 (12-Month Extension)||0
8571863|NCT00112437|9604137|FG014|STARTED|Year 2 (12-Month Extension)||0
8571864|NCT00112437|9604138|FG015|STARTED|Year 2 (12-Month Extension)||0
8571865|NCT00112437|9604139|FG016|STARTED|Year 2 (12-Month Extension)||0
8571866|NCT00112437|9604140|FG017|STARTED|Year 2 (12-Month Extension)||0
8571867|NCT00112437|9604141|FG018|STARTED|Year 2 (12-Month Extension)||0
8571868|NCT00112437|9604142|FG019|STARTED|Year 2 (12-Month Extension)||0
8571869|NCT00112437|9604143|FG020|STARTED|Year 2 (12-Month Extension)||0
8571870|NCT00112437|9604144|FG021|STARTED|Year 2 (12-Month Extension)||0
8571871|NCT00112437|9604145|FG022|STARTED|Year 2 (12-Month Extension)||0
8571872|NCT00112437|9604146|FG023|STARTED|Year 2 (12-Month Extension)||0
8571873|NCT00112437|9604147|FG024|STARTED|Year 2 (12-Month Extension)||0
8571874|NCT00112437|9604148|FG025|STARTED|Year 2 (12-Month Extension)||0
8571875|NCT00112437|9604123|FG000|COMPLETED|Year 2 (12-Month Extension)||0
8571876|NCT00112437|9604124|FG001|COMPLETED|Year 2 (12-Month Extension)||0
8571877|NCT00112437|9604125|FG002|COMPLETED|Year 2 (12-Month Extension)||0
8571878|NCT00112437|9604126|FG003|COMPLETED|Year 2 (12-Month Extension)||0
8571879|NCT00112437|9604127|FG004|COMPLETED|Year 2 (12-Month Extension)||0
8571880|NCT00112437|9604128|FG005|COMPLETED|Year 2 (12-Month Extension)||60
8571881|NCT00112437|9604129|FG006|COMPLETED|Year 2 (12-Month Extension)||53
8571882|NCT00112437|9604130|FG007|COMPLETED|Year 2 (12-Month Extension)||55
8571883|NCT00112437|9604131|FG008|COMPLETED|Year 2 (12-Month Extension)||62
8571884|NCT00112437|9604132|FG009|COMPLETED|Year 2 (12-Month Extension)||50
8571885|NCT00112437|9604133|FG010|COMPLETED|Year 2 (12-Month Extension)||0
8571886|NCT00112437|9604134|FG011|COMPLETED|Year 2 (12-Month Extension)||0
8571887|NCT00112437|9604135|FG012|COMPLETED|Year 2 (12-Month Extension)||0
8571888|NCT00112437|9604136|FG013|COMPLETED|Year 2 (12-Month Extension)||0
8571889|NCT00112437|9604137|FG014|COMPLETED|Year 2 (12-Month Extension)||0
8571890|NCT00112437|9604138|FG015|COMPLETED|Year 2 (12-Month Extension)||0
8571891|NCT00112437|9604139|FG016|COMPLETED|Year 2 (12-Month Extension)||0
8571892|NCT00112437|9604140|FG017|COMPLETED|Year 2 (12-Month Extension)||0
8571893|NCT00112437|9604141|FG018|COMPLETED|Year 2 (12-Month Extension)||0
8571894|NCT00112437|9604142|FG019|COMPLETED|Year 2 (12-Month Extension)||0
8571895|NCT00112437|9604143|FG020|COMPLETED|Year 2 (12-Month Extension)||0
8571896|NCT00112437|9604144|FG021|COMPLETED|Year 2 (12-Month Extension)||0
8571897|NCT00112437|9604145|FG022|COMPLETED|Year 2 (12-Month Extension)||0
8571898|NCT00112437|9604146|FG023|COMPLETED|Year 2 (12-Month Extension)||0
8571899|NCT00112437|9604147|FG024|COMPLETED|Year 2 (12-Month Extension)||0
8571900|NCT00112437|9604148|FG025|COMPLETED|Year 2 (12-Month Extension)||0
8571901|NCT00112437|9604123|FG000|NOT COMPLETED|Year 2 (12-Month Extension)||0
8571902|NCT00112437|9604124|FG001|NOT COMPLETED|Year 2 (12-Month Extension)||0
8571903|NCT00112437|9604125|FG002|NOT COMPLETED|Year 2 (12-Month Extension)||0
8571904|NCT00112437|9604126|FG003|NOT COMPLETED|Year 2 (12-Month Extension)||0
8571905|NCT00112437|9604127|FG004|NOT COMPLETED|Year 2 (12-Month Extension)||0
8571906|NCT00112437|9604128|FG005|NOT COMPLETED|Year 2 (12-Month Extension)||3
8571907|NCT00112437|9604129|FG006|NOT COMPLETED|Year 2 (12-Month Extension)||9
8571908|NCT00112437|9604130|FG007|NOT COMPLETED|Year 2 (12-Month Extension)||8
8571909|NCT00112437|9604131|FG008|NOT COMPLETED|Year 2 (12-Month Extension)||7
8571910|NCT00112437|9604132|FG009|NOT COMPLETED|Year 2 (12-Month Extension)||13
8571911|NCT00112437|9604133|FG010|NOT COMPLETED|Year 2 (12-Month Extension)||0
8571912|NCT00112437|9604134|FG011|NOT COMPLETED|Year 2 (12-Month Extension)||0
8571913|NCT00112437|9604135|FG012|NOT COMPLETED|Year 2 (12-Month Extension)||0
8571914|NCT00112437|9604136|FG013|NOT COMPLETED|Year 2 (12-Month Extension)||0
8991185|NCT02775916|10054380|FG001|STARTED|Overall Study||10
8991186|NCT02775916|10054379|FG000|COMPLETED|Overall Study||17
8991187|NCT02775916|10054380|FG001|COMPLETED|Overall Study||10
8991188|NCT02775916|10054379|FG000|NOT COMPLETED|Overall Study||3
8991189|NCT02775916|10054380|FG001|NOT COMPLETED|Overall Study||0
8991190|NCT02776033|10054389|FG000|STARTED|Overall Study||18
8991191|NCT02776033|10054390|FG001|STARTED|Overall Study||23
8991192|NCT02776033|10054391|FG002|STARTED|Overall Study||24
8991193|NCT02776033|10054389|FG000|COMPLETED|Overall Study||14
8991194|NCT02776033|10054390|FG001|COMPLETED|Overall Study||21
8991195|NCT02776033|10054391|FG002|COMPLETED|Overall Study||22
8991196|NCT02776033|10054389|FG000|NOT COMPLETED|Overall Study||4
8991197|NCT02776033|10054390|FG001|NOT COMPLETED|Overall Study||2
8991198|NCT02776033|10054391|FG002|NOT COMPLETED|Overall Study||2
8991199|NCT02776553|10054407|FG000|STARTED|Overall Study|One subject was eliminated for repeated hospitalizations.|9
8991200|NCT02776553|10054408|FG001|STARTED|Overall Study|Two subjects were eliminated for repeated hospitalizations.|8
8991201|NCT02776553|10054407|FG000|COMPLETED|Overall Study||6
8991202|NCT02776553|10054408|FG001|COMPLETED|Overall Study||5
8991203|NCT02776553|10054407|FG000|NOT COMPLETED|Overall Study||3
8991204|NCT02776553|10054408|FG001|NOT COMPLETED|Overall Study||3
8991205|NCT02776644|10054416|FG000|STARTED|Overall Study||1223
8991206|NCT02776644|10054417|FG001|STARTED|Overall Study||126
8991207|NCT02776644|10054416|FG000|COMPLETED|Overall Study||1223
8991208|NCT02776644|10054417|FG001|COMPLETED|Overall Study||126
8991209|NCT02776644|10054416|FG000|NOT COMPLETED|Overall Study||0
8991210|NCT02776644|10054417|FG001|NOT COMPLETED|Overall Study||0
8991211|NCT02776670|10054425|FG000|STARTED|Overall Study||117
8991212|NCT02776670|10054426|FG001|STARTED|Overall Study||114
8991213|NCT02776670|10054425|FG000|Full Analysis Set (FAS)|Overall Study||117
8991214|NCT02776670|10054426|FG001|Full Analysis Set (FAS)|Overall Study||114
8991215|NCT02776670|10054425|FG000|Per Protocol Analysis Set (PPS)|Overall Study||115
8991216|NCT02776670|10054426|FG001|Per Protocol Analysis Set (PPS)|Overall Study||113
8991217|NCT02776670|10054425|FG000|Safety Analysis Set|Overall Study||117
8991218|NCT02776670|10054426|FG001|Safety Analysis Set|Overall Study||114
8991219|NCT02776670|10054425|FG000|COMPLETED|Overall Study||117
8991220|NCT02776670|10054426|FG001|COMPLETED|Overall Study||108
8991221|NCT02776670|10054425|FG000|NOT COMPLETED|Overall Study||0
8991222|NCT02776670|10054426|FG001|NOT COMPLETED|Overall Study||6
8991223|NCT02776683|10054432|FG000|STARTED|Pre-switch Period|Assigned to trial medication or enrolled/treated|123
8991224|NCT02776683|10054433|FG001|STARTED|Pre-switch Period||0
8991225|NCT02776683|10054432|FG000|COMPLETED|Pre-switch Period|Entered into Switch Set|43
8991226|NCT02776683|10054433|FG001|COMPLETED|Pre-switch Period||0
8991227|NCT02776683|10054432|FG000|NOT COMPLETED|Pre-switch Period||80
8991228|NCT02776683|10054433|FG001|NOT COMPLETED|Pre-switch Period||0
8991229|NCT02776683|10054432|FG000|STARTED|Post-switch Period||0
8991230|NCT02776683|10054433|FG001|STARTED|Post-switch Period|Entered into Switch Set|43
8991231|NCT02776683|10054432|FG000|COMPLETED|Post-switch Period||0
8991232|NCT02776683|10054433|FG001|COMPLETED|Post-switch Period||0
8991233|NCT02776683|10054432|FG000|NOT COMPLETED|Post-switch Period||0
8991234|NCT02776683|10054433|FG001|NOT COMPLETED|Post-switch Period||43
8991235|NCT02776774|10054437|FG000|STARTED|Overall Study||91
8991236|NCT02776774|10054437|FG000|COMPLETED|Overall Study|Total after data cleaning|91
8991237|NCT02776774|10054437|FG000|NOT COMPLETED|Overall Study||0
8991238|NCT02776904|10054443|FG000|STARTED|Overall Study||281
8991239|NCT02776904|10054444|FG001|STARTED|Overall Study||46
8991240|NCT02776904|10054443|FG000|Gait Assessment|Overall Study||178
8991241|NCT02776904|10054444|FG001|Gait Assessment|Overall Study||32
8991242|NCT02776904|10054443|FG000|ImPACT|Overall Study||21
8991243|NCT02776904|10054444|FG001|ImPACT|Overall Study|ImPACT testing for the concussed subjects was completed for the clinical assessment (not research).|46
8991244|NCT02776904|10054443|FG000|COMPLETED|Overall Study||281
8991245|NCT02776904|10054444|FG001|COMPLETED|Overall Study||46
8991246|NCT02776904|10054443|FG000|NOT COMPLETED|Overall Study||0
8991247|NCT02776904|10054444|FG001|NOT COMPLETED|Overall Study||0
8991248|NCT02777021|10054459|FG000|STARTED|Overall Study||60
8991249|NCT02777021|10054460|FG001|STARTED|Overall Study||94
8991250|NCT02777021|10054459|FG000|COMPLETED|Overall Study||43
8991251|NCT02777021|10054460|FG001|COMPLETED|Overall Study||77
8991252|NCT02777021|10054459|FG000|NOT COMPLETED|Overall Study||17
8991253|NCT02777021|10054460|FG001|NOT COMPLETED|Overall Study||17
8991254|NCT02777086|10054468|FG000|STARTED|Overall Study||261
8991255|NCT02777086|10054469|FG001|STARTED|Overall Study||250
8991256|NCT02777086|10054468|FG000|COMPLETED|Overall Study||165
8991257|NCT02777086|10054469|FG001|COMPLETED|Overall Study||151
8633471|NCT00551031|9673548|FG000|COMPLETED|Overall Study||635
8633472|NCT00551031|9673549|FG001|COMPLETED|Overall Study||625
8991258|NCT02777086|10054468|FG000|NOT COMPLETED|Overall Study||96
8991259|NCT02777086|10054469|FG001|NOT COMPLETED|Overall Study||99
8991260|NCT02777125|10054477|FG000|STARTED|Overall Study||488
8991261|NCT02777125|10054478|FG001|STARTED|Overall Study||492
8991262|NCT02777125|10054477|FG000|COMPLETED|Overall Study||445
8991263|NCT02777125|10054478|FG001|COMPLETED|Overall Study||445
8991264|NCT02777125|10054477|FG000|NOT COMPLETED|Overall Study||43
8991265|NCT02777125|10054478|FG001|NOT COMPLETED|Overall Study||47
8991266|NCT02777242|10054485|FG000|STARTED|Overall Study||65
8991267|NCT02777242|10054485|FG000|COMPLETED|Overall Study||59
8991268|NCT02777242|10054485|FG000|NOT COMPLETED|Overall Study||6
8991269|NCT02777268|10054489|FG000|STARTED|Overall Study||16
8991270|NCT02777268|10054489|FG000|COMPLETED|Overall Study||16
8991271|NCT02777268|10054489|FG000|NOT COMPLETED|Overall Study||0
8991272|NCT02777333|10054513|FG000|STARTED|Overall Study||15
8991273|NCT02777333|10054514|FG001|STARTED|Overall Study||15
8991274|NCT02777333|10054513|FG000|COMPLETED|Overall Study||15
8991275|NCT02777333|10054514|FG001|COMPLETED|Overall Study||13
8991276|NCT02777333|10054513|FG000|NOT COMPLETED|Overall Study||0
8991277|NCT02777333|10054514|FG001|NOT COMPLETED|Overall Study||2
9039041|NCT03335254|10100130|FG008|COMPLETED|Period 1||0
9039042|NCT03335254|10100131|FG009|COMPLETED|Period 1||0
9039043|NCT03335254|10100132|FG010|COMPLETED|Period 1||0
9039044|NCT03335254|10100133|FG011|COMPLETED|Period 1||0
9039045|NCT03335254|10100134|FG012|COMPLETED|Period 1||0
9039046|NCT03335254|10100135|FG013|COMPLETED|Period 1||0
9039047|NCT03335254|10100136|FG014|COMPLETED|Period 1||0
9039048|NCT03335254|10100137|FG015|COMPLETED|Period 1||0
9039049|NCT03335254|10100138|FG016|COMPLETED|Period 1||0
9039050|NCT03335254|10100139|FG017|COMPLETED|Period 1||0
9039051|NCT03335254|10100140|FG018|COMPLETED|Period 1||0
9039052|NCT03335254|10100141|FG019|COMPLETED|Period 1||0
9039053|NCT03335254|10100122|FG000|NOT COMPLETED|Period 1||0
9039054|NCT03335254|10100123|FG001|NOT COMPLETED|Period 1||0
9039055|NCT03335254|10100124|FG002|NOT COMPLETED|Period 1||0
9039056|NCT03335254|10100125|FG003|NOT COMPLETED|Period 1||0
9039057|NCT03335254|10100126|FG004|NOT COMPLETED|Period 1||0
9039058|NCT03335254|10100127|FG005|NOT COMPLETED|Period 1||0
9039059|NCT03335254|10100128|FG006|NOT COMPLETED|Period 1||0
9039060|NCT03335254|10100129|FG007|NOT COMPLETED|Period 1||0
9039061|NCT03335254|10100130|FG008|NOT COMPLETED|Period 1||0
9039062|NCT03335254|10100131|FG009|NOT COMPLETED|Period 1||0
9039063|NCT03335254|10100132|FG010|NOT COMPLETED|Period 1||0
9039064|NCT03335254|10100133|FG011|NOT COMPLETED|Period 1||0
9039065|NCT03335254|10100134|FG012|NOT COMPLETED|Period 1||0
9039066|NCT03335254|10100135|FG013|NOT COMPLETED|Period 1||0
9039067|NCT03335254|10100136|FG014|NOT COMPLETED|Period 1||0
9039068|NCT03335254|10100137|FG015|NOT COMPLETED|Period 1||0
8633473|NCT00551031|9673550|FG002|COMPLETED|Overall Study||317
8633474|NCT00551031|9673551|FG003|COMPLETED|Overall Study||317
8633475|NCT00551031|9673552|FG004|COMPLETED|Overall Study||185
8633476|NCT00551031|9673548|FG000|NOT COMPLETED|Overall Study||2
9039069|NCT03335254|10100138|FG016|NOT COMPLETED|Period 1||0
9039070|NCT03335254|10100139|FG017|NOT COMPLETED|Period 1||0
9039071|NCT03335254|10100140|FG018|NOT COMPLETED|Period 1||0
9039072|NCT03335254|10100141|FG019|NOT COMPLETED|Period 1||0
9039073|NCT03335254|10100122|FG000|STARTED|Period 2, Day 1-15||9
9039074|NCT03335254|10100123|FG001|STARTED|Period 2, Day 1-15||0
9039075|NCT03335254|10100124|FG002|STARTED|Period 2, Day 1-15||0
9039076|NCT03335254|10100125|FG003|STARTED|Period 2, Day 1-15||0
9039077|NCT03335254|10100126|FG004|STARTED|Period 2, Day 1-15||0
9039078|NCT03335254|10100127|FG005|STARTED|Period 2, Day 1-15||0
9039079|NCT03335254|10100128|FG006|STARTED|Period 2, Day 1-15||0
9039080|NCT03335254|10100129|FG007|STARTED|Period 2, Day 1-15||0
9039081|NCT03335254|10100130|FG008|STARTED|Period 2, Day 1-15||0
9039082|NCT03335254|10100131|FG009|STARTED|Period 2, Day 1-15||0
9039083|NCT03335254|10100132|FG010|STARTED|Period 2, Day 1-15||0
9039084|NCT03335254|10100133|FG011|STARTED|Period 2, Day 1-15||0
9039085|NCT03335254|10100134|FG012|STARTED|Period 2, Day 1-15||0
9039086|NCT03335254|10100135|FG013|STARTED|Period 2, Day 1-15||0
9039087|NCT03335254|10100136|FG014|STARTED|Period 2, Day 1-15||0
9039088|NCT03335254|10100137|FG015|STARTED|Period 2, Day 1-15||0
9039089|NCT03335254|10100138|FG016|STARTED|Period 2, Day 1-15||0
9039090|NCT03335254|10100139|FG017|STARTED|Period 2, Day 1-15||0
9039091|NCT03335254|10100140|FG018|STARTED|Period 2, Day 1-15||0
9039092|NCT03335254|10100141|FG019|STARTED|Period 2, Day 1-15||0
9039093|NCT03335254|10100122|FG000|COMPLETED|Period 2, Day 1-15||9
9039094|NCT03335254|10100123|FG001|COMPLETED|Period 2, Day 1-15||0
9039095|NCT03335254|10100124|FG002|COMPLETED|Period 2, Day 1-15||0
9039096|NCT03335254|10100125|FG003|COMPLETED|Period 2, Day 1-15||0
9039097|NCT03335254|10100126|FG004|COMPLETED|Period 2, Day 1-15||0
9039098|NCT03335254|10100127|FG005|COMPLETED|Period 2, Day 1-15||0
9039099|NCT03335254|10100128|FG006|COMPLETED|Period 2, Day 1-15||0
9039100|NCT03335254|10100129|FG007|COMPLETED|Period 2, Day 1-15||0
9039101|NCT03335254|10100130|FG008|COMPLETED|Period 2, Day 1-15||0
9039102|NCT03335254|10100131|FG009|COMPLETED|Period 2, Day 1-15||0
9039103|NCT03335254|10100132|FG010|COMPLETED|Period 2, Day 1-15||0
9039104|NCT03335254|10100133|FG011|COMPLETED|Period 2, Day 1-15||0
9039105|NCT03335254|10100134|FG012|COMPLETED|Period 2, Day 1-15||0
9039106|NCT03335254|10100135|FG013|COMPLETED|Period 2, Day 1-15||0
9039107|NCT03335254|10100136|FG014|COMPLETED|Period 2, Day 1-15||0
9039108|NCT03335254|10100137|FG015|COMPLETED|Period 2, Day 1-15||0
9039109|NCT03335254|10100138|FG016|COMPLETED|Period 2, Day 1-15||0
9039110|NCT03335254|10100139|FG017|COMPLETED|Period 2, Day 1-15||0
9039111|NCT03335254|10100140|FG018|COMPLETED|Period 2, Day 1-15||0
9039112|NCT03335254|10100141|FG019|COMPLETED|Period 2, Day 1-15||0
8633477|NCT00551031|9673549|FG001|NOT COMPLETED|Overall Study||11
9039113|NCT03335254|10100122|FG000|NOT COMPLETED|Period 2, Day 1-15||0
9039114|NCT03335254|10100123|FG001|NOT COMPLETED|Period 2, Day 1-15||0
9039115|NCT03335254|10100124|FG002|NOT COMPLETED|Period 2, Day 1-15||0
9039116|NCT03335254|10100125|FG003|NOT COMPLETED|Period 2, Day 1-15||0
9039117|NCT03335254|10100126|FG004|NOT COMPLETED|Period 2, Day 1-15||0
9039118|NCT03335254|10100127|FG005|NOT COMPLETED|Period 2, Day 1-15||0
9039119|NCT03335254|10100128|FG006|NOT COMPLETED|Period 2, Day 1-15||0
9039120|NCT03335254|10100129|FG007|NOT COMPLETED|Period 2, Day 1-15||0
8991278|NCT04952701|10054520|FG000|STARTED|Control Lens||63
8991279|NCT04952701|10054520|FG000|COMPLETED|Control Lens||59
8991280|NCT04952701|10054520|FG000|NOT COMPLETED|Control Lens||4
8991281|NCT04952701|10054520|FG000|STARTED|Test Lens||59
8991282|NCT04952701|10054520|FG000|COMPLETED|Test Lens||58
8991283|NCT04952701|10054520|FG000|NOT COMPLETED|Test Lens||1
8991284|NCT04350606|10054526|FG000|STARTED|Overall Study||3
8991285|NCT04350606|10054526|FG000|Treated|Overall Study||3
8991286|NCT04350606|10054526|FG000|Follow-up|Overall Study||3
8991287|NCT04350606|10054526|FG000|COMPLETED|Overall Study||3
8991288|NCT04350606|10054526|FG000|NOT COMPLETED|Overall Study||0
8991289|NCT04074161|10054533|FG000|STARTED|Overall Study||126
8991290|NCT04074161|10054534|FG001|STARTED|Overall Study||127
8991291|NCT04074161|10054535|FG002|STARTED|Overall Study||85
8991292|NCT04074161|10054533|FG000|Full Analysis Set|Overall Study||126
8991293|NCT04074161|10054534|FG001|Full Analysis Set|Overall Study||127
8991294|NCT04074161|10054535|FG002|Full Analysis Set|Overall Study||85
8991295|NCT04074161|10054533|FG000|Safety Analysis Set|Overall Study||126
8991296|NCT04074161|10054534|FG001|Safety Analysis Set|Overall Study||127
8991297|NCT04074161|10054535|FG002|Safety Analysis Set|Overall Study||85
8991298|NCT04074161|10054533|FG000|COMPLETED|Overall Study||120
8991299|NCT04074161|10054534|FG001|COMPLETED|Overall Study||118
8991300|NCT04074161|10054535|FG002|COMPLETED|Overall Study||81
8991301|NCT04074161|10054533|FG000|NOT COMPLETED|Overall Study||6
8991302|NCT04074161|10054534|FG001|NOT COMPLETED|Overall Study||9
8991303|NCT04074161|10054535|FG002|NOT COMPLETED|Overall Study||4
8991304|NCT04033432|10054543|FG000|STARTED|Overall Study||14
8991305|NCT04033432|10054543|FG000|Registered for Study|Overall Study||14
8991306|NCT04033432|10054543|FG000|Started Cycle 1|Overall Study||14
8991307|NCT04033432|10054543|FG000|Started Cycle 2|Overall Study||13
8991308|NCT04033432|10054543|FG000|Started Cycle 3|Overall Study||10
8991309|NCT04033432|10054543|FG000|Started Cycle 4|Overall Study||7
8991310|NCT04033432|10054543|FG000|Started Cycle 5|Overall Study||1
8991311|NCT04033432|10054543|FG000|Started Cycle 6|Overall Study||1
8991312|NCT04033432|10054543|FG000|Started Cycle 7+|Overall Study||1
8991313|NCT04033432|10054543|FG000|COMPLETED|Overall Study||1
8991314|NCT04033432|10054543|FG000|NOT COMPLETED|Overall Study||13
8991315|NCT04030247|10054548|FG000|STARTED|Overall Study||50
8991316|NCT04030247|10054548|FG000|COMPLETED|Overall Study||33
8991317|NCT04030247|10054548|FG000|NOT COMPLETED|Overall Study||17
8991318|NCT03893565|10054557|FG000|STARTED|Double-blind Induction Phase (10 Weeks)||27
8991319|NCT03893565|10054558|FG001|STARTED|Double-blind Induction Phase (10 Weeks)||48
8991320|NCT03893565|10054559|FG002|STARTED|Double-blind Induction Phase (10 Weeks)||11
8991321|NCT03893565|10054560|FG003|STARTED|Double-blind Induction Phase (10 Weeks)||10
8991322|NCT03893565|10054561|FG004|STARTED|Double-blind Induction Phase (10 Weeks)||8
8991323|NCT03893565|10054562|FG005|STARTED|Double-blind Induction Phase (10 Weeks)||0
8991324|NCT03893565|10054563|FG006|STARTED|Double-blind Induction Phase (10 Weeks)||0
8991325|NCT03893565|10054564|FG007|STARTED|Double-blind Induction Phase (10 Weeks)||0
8991326|NCT03893565|10054565|FG008|STARTED|Double-blind Induction Phase (10 Weeks)||0
8991327|NCT03893565|10054557|FG000|COMPLETED|Double-blind Induction Phase (10 Weeks)||21
8991328|NCT03893565|10054558|FG001|COMPLETED|Double-blind Induction Phase (10 Weeks)||32
8991329|NCT03893565|10054559|FG002|COMPLETED|Double-blind Induction Phase (10 Weeks)||1
8991330|NCT03893565|10054560|FG003|COMPLETED|Double-blind Induction Phase (10 Weeks)||1
8991331|NCT03893565|10054561|FG004|COMPLETED|Double-blind Induction Phase (10 Weeks)||1
8991332|NCT03893565|10054562|FG005|COMPLETED|Double-blind Induction Phase (10 Weeks)||0
8991333|NCT03893565|10054563|FG006|COMPLETED|Double-blind Induction Phase (10 Weeks)||0
8991334|NCT03893565|10054564|FG007|COMPLETED|Double-blind Induction Phase (10 Weeks)||0
8991335|NCT03893565|10054565|FG008|COMPLETED|Double-blind Induction Phase (10 Weeks)||0
8991336|NCT03893565|10054557|FG000|NOT COMPLETED|Double-blind Induction Phase (10 Weeks)||6
8991337|NCT03893565|10054558|FG001|NOT COMPLETED|Double-blind Induction Phase (10 Weeks)||16
8991338|NCT03893565|10054559|FG002|NOT COMPLETED|Double-blind Induction Phase (10 Weeks)||10
8991339|NCT03893565|10054560|FG003|NOT COMPLETED|Double-blind Induction Phase (10 Weeks)||9
8991340|NCT03893565|10054561|FG004|NOT COMPLETED|Double-blind Induction Phase (10 Weeks)||7
8991341|NCT03893565|10054562|FG005|NOT COMPLETED|Double-blind Induction Phase (10 Weeks)||0
8991342|NCT03893565|10054563|FG006|NOT COMPLETED|Double-blind Induction Phase (10 Weeks)||0
8991343|NCT03893565|10054564|FG007|NOT COMPLETED|Double-blind Induction Phase (10 Weeks)||0
8991344|NCT03893565|10054565|FG008|NOT COMPLETED|Double-blind Induction Phase (10 Weeks)||0
8991345|NCT03893565|10054557|FG000|STARTED|Double-blind Extended Treatment(20weeks)||0
8991346|NCT03893565|10054558|FG001|STARTED|Double-blind Extended Treatment(20weeks)||0
8991347|NCT03893565|10054559|FG002|STARTED|Double-blind Extended Treatment(20weeks)||0
8991348|NCT03893565|10054560|FG003|STARTED|Double-blind Extended Treatment(20weeks)||0
8991349|NCT03893565|10054561|FG004|STARTED|Double-blind Extended Treatment(20weeks)||0
8991350|NCT03893565|10054562|FG005|STARTED|Double-blind Extended Treatment(20weeks)||5
8991351|NCT03893565|10054563|FG006|STARTED|Double-blind Extended Treatment(20weeks)||8
8991352|NCT03893565|10054564|FG007|STARTED|Double-blind Extended Treatment(20weeks)||0
8991353|NCT03893565|10054565|FG008|STARTED|Double-blind Extended Treatment(20weeks)||0
8991354|NCT03893565|10054557|FG000|COMPLETED|Double-blind Extended Treatment(20weeks)||0
8991355|NCT03893565|10054558|FG001|COMPLETED|Double-blind Extended Treatment(20weeks)||0
8991356|NCT03893565|10054559|FG002|COMPLETED|Double-blind Extended Treatment(20weeks)||0
8991357|NCT03893565|10054560|FG003|COMPLETED|Double-blind Extended Treatment(20weeks)||0
8991358|NCT03893565|10054561|FG004|COMPLETED|Double-blind Extended Treatment(20weeks)||0
8991359|NCT03893565|10054562|FG005|COMPLETED|Double-blind Extended Treatment(20weeks)||2
8991360|NCT03893565|10054563|FG006|COMPLETED|Double-blind Extended Treatment(20weeks)||4
8991361|NCT03893565|10054564|FG007|COMPLETED|Double-blind Extended Treatment(20weeks)||0
8991362|NCT03893565|10054565|FG008|COMPLETED|Double-blind Extended Treatment(20weeks)||0
8991363|NCT03893565|10054557|FG000|NOT COMPLETED|Double-blind Extended Treatment(20weeks)||0
8991364|NCT03893565|10054558|FG001|NOT COMPLETED|Double-blind Extended Treatment(20weeks)||0
8991365|NCT03893565|10054559|FG002|NOT COMPLETED|Double-blind Extended Treatment(20weeks)||0
8991366|NCT03893565|10054560|FG003|NOT COMPLETED|Double-blind Extended Treatment(20weeks)||0
8991367|NCT03893565|10054561|FG004|NOT COMPLETED|Double-blind Extended Treatment(20weeks)||0
8991368|NCT03893565|10054562|FG005|NOT COMPLETED|Double-blind Extended Treatment(20weeks)||3
8991369|NCT03893565|10054563|FG006|NOT COMPLETED|Double-blind Extended Treatment(20weeks)||4
8991370|NCT03893565|10054564|FG007|NOT COMPLETED|Double-blind Extended Treatment(20weeks)||0
8991371|NCT03893565|10054565|FG008|NOT COMPLETED|Double-blind Extended Treatment(20weeks)||0
8991372|NCT03893565|10054557|FG000|STARTED|Open-label Induction Phase (10 Weeks)||0
8991373|NCT03893565|10054558|FG001|STARTED|Open-label Induction Phase (10 Weeks)||0
8991374|NCT03893565|10054559|FG002|STARTED|Open-label Induction Phase (10 Weeks)||0
8991375|NCT03893565|10054560|FG003|STARTED|Open-label Induction Phase (10 Weeks)||0
8991376|NCT03893565|10054561|FG004|STARTED|Open-label Induction Phase (10 Weeks)||0
8991377|NCT03893565|10054562|FG005|STARTED|Open-label Induction Phase (10 Weeks)||0
8991378|NCT03893565|10054563|FG006|STARTED|Open-label Induction Phase (10 Weeks)||0
8991379|NCT03893565|10054564|FG007|STARTED|Open-label Induction Phase (10 Weeks)||42
8991380|NCT03893565|10054565|FG008|STARTED|Open-label Induction Phase (10 Weeks)||0
8991381|NCT03893565|10054557|FG000|COMPLETED|Open-label Induction Phase (10 Weeks)||0
8991382|NCT03893565|10054558|FG001|COMPLETED|Open-label Induction Phase (10 Weeks)||0
8991383|NCT03893565|10054559|FG002|COMPLETED|Open-label Induction Phase (10 Weeks)||0
8991384|NCT03893565|10054560|FG003|COMPLETED|Open-label Induction Phase (10 Weeks)||0
8991385|NCT03893565|10054561|FG004|COMPLETED|Open-label Induction Phase (10 Weeks)||0
8991386|NCT03893565|10054562|FG005|COMPLETED|Open-label Induction Phase (10 Weeks)||0
8991387|NCT03893565|10054563|FG006|COMPLETED|Open-label Induction Phase (10 Weeks)||0
8633478|NCT00551031|9673550|FG002|NOT COMPLETED|Overall Study||2
8633479|NCT00551031|9673551|FG003|NOT COMPLETED|Overall Study||3
8633480|NCT00551031|9673552|FG004|NOT COMPLETED|Overall Study||1
8633481|NCT00551070|9673564|FG000|STARTED|Overall Study||52
8633482|NCT00551070|9673564|FG000|COMPLETED|Overall Study||52
8991388|NCT03893565|10054564|FG007|COMPLETED|Open-label Induction Phase (10 Weeks)||12
8991389|NCT03893565|10054565|FG008|COMPLETED|Open-label Induction Phase (10 Weeks)||0
8991390|NCT03893565|10054557|FG000|NOT COMPLETED|Open-label Induction Phase (10 Weeks)||0
8991391|NCT03893565|10054558|FG001|NOT COMPLETED|Open-label Induction Phase (10 Weeks)||0
8991392|NCT03893565|10054559|FG002|NOT COMPLETED|Open-label Induction Phase (10 Weeks)||0
8991393|NCT03893565|10054560|FG003|NOT COMPLETED|Open-label Induction Phase (10 Weeks)||0
8991394|NCT03893565|10054561|FG004|NOT COMPLETED|Open-label Induction Phase (10 Weeks)||0
8991395|NCT03893565|10054562|FG005|NOT COMPLETED|Open-label Induction Phase (10 Weeks)||0
8991396|NCT03893565|10054563|FG006|NOT COMPLETED|Open-label Induction Phase (10 Weeks)||0
8991397|NCT03893565|10054564|FG007|NOT COMPLETED|Open-label Induction Phase (10 Weeks)||30
8991398|NCT03893565|10054565|FG008|NOT COMPLETED|Open-label Induction Phase (10 Weeks)||0
8991399|NCT03893565|10054557|FG000|STARTED|Open-label Extended Treatment (20 Weeks)||0
8991400|NCT03893565|10054558|FG001|STARTED|Open-label Extended Treatment (20 Weeks)||0
8991401|NCT03893565|10054559|FG002|STARTED|Open-label Extended Treatment (20 Weeks)||0
8991402|NCT03893565|10054560|FG003|STARTED|Open-label Extended Treatment (20 Weeks)||0
8991403|NCT03893565|10054561|FG004|STARTED|Open-label Extended Treatment (20 Weeks)||0
8991404|NCT03893565|10054562|FG005|STARTED|Open-label Extended Treatment (20 Weeks)||0
8991405|NCT03893565|10054563|FG006|STARTED|Open-label Extended Treatment (20 Weeks)||0
8991406|NCT03893565|10054564|FG007|STARTED|Open-label Extended Treatment (20 Weeks)||0
8991407|NCT03893565|10054565|FG008|STARTED|Open-label Extended Treatment (20 Weeks)||7
8991408|NCT03893565|10054557|FG000|COMPLETED|Open-label Extended Treatment (20 Weeks)||0
8633483|NCT00551070|9673564|FG000|NOT COMPLETED|Overall Study||0
8633484|NCT00551135|9673572|FG000|STARTED|Overall Study||108
8633485|NCT00551135|9673573|FG001|STARTED|Overall Study||106
8633486|NCT00551135|9673574|FG002|STARTED|Overall Study||103
8991409|NCT03893565|10054558|FG001|COMPLETED|Open-label Extended Treatment (20 Weeks)||0
8991410|NCT03893565|10054559|FG002|COMPLETED|Open-label Extended Treatment (20 Weeks)||0
8991411|NCT03893565|10054560|FG003|COMPLETED|Open-label Extended Treatment (20 Weeks)||0
8991412|NCT03893565|10054561|FG004|COMPLETED|Open-label Extended Treatment (20 Weeks)||0
8991413|NCT03893565|10054562|FG005|COMPLETED|Open-label Extended Treatment (20 Weeks)||0
8991414|NCT03893565|10054563|FG006|COMPLETED|Open-label Extended Treatment (20 Weeks)||0
8633487|NCT00551135|9673575|FG003|STARTED|Overall Study||108
8633488|NCT00551135|9673572|FG000|COMPLETED|Overall Study||103
8633489|NCT00551135|9673573|FG001|COMPLETED|Overall Study||104
8633490|NCT00551135|9673574|FG002|COMPLETED|Overall Study||98
8633491|NCT00551135|9673575|FG003|COMPLETED|Overall Study||103
8633492|NCT00551135|9673572|FG000|NOT COMPLETED|Overall Study||5
8991415|NCT03893565|10054564|FG007|COMPLETED|Open-label Extended Treatment (20 Weeks)||0
8991416|NCT03893565|10054565|FG008|COMPLETED|Open-label Extended Treatment (20 Weeks)||3
8991417|NCT03893565|10054557|FG000|NOT COMPLETED|Open-label Extended Treatment (20 Weeks)||0
8991418|NCT03893565|10054558|FG001|NOT COMPLETED|Open-label Extended Treatment (20 Weeks)||0
8991419|NCT03893565|10054559|FG002|NOT COMPLETED|Open-label Extended Treatment (20 Weeks)||0
8991420|NCT03893565|10054560|FG003|NOT COMPLETED|Open-label Extended Treatment (20 Weeks)||0
8991421|NCT03893565|10054561|FG004|NOT COMPLETED|Open-label Extended Treatment (20 Weeks)||0
8991422|NCT03893565|10054562|FG005|NOT COMPLETED|Open-label Extended Treatment (20 Weeks)||0
8991423|NCT03893565|10054563|FG006|NOT COMPLETED|Open-label Extended Treatment (20 Weeks)||0
8991424|NCT03893565|10054564|FG007|NOT COMPLETED|Open-label Extended Treatment (20 Weeks)||0
8991425|NCT03893565|10054565|FG008|NOT COMPLETED|Open-label Extended Treatment (20 Weeks)||4
8991426|NCT03701516|10054584|FG000|STARTED|Period 1||131
8991427|NCT03701516|10054585|FG001|STARTED|Period 1||132
8991428|NCT03701516|10054584|FG000|COMPLETED|Period 1||127
8991429|NCT03701516|10054585|FG001|COMPLETED|Period 1||127
8991430|NCT03701516|10054584|FG000|NOT COMPLETED|Period 1||4
8991431|NCT03701516|10054585|FG001|NOT COMPLETED|Period 1||5
8991432|NCT03701516|10054584|FG000|STARTED|Period 2||127
8991433|NCT03701516|10054585|FG001|STARTED|Period 2||127
8991434|NCT03701516|10054584|FG000|COMPLETED|Period 2||126
8991435|NCT03701516|10054585|FG001|COMPLETED|Period 2||126
8991436|NCT03701516|10054584|FG000|NOT COMPLETED|Period 2||1
8991437|NCT03701516|10054585|FG001|NOT COMPLETED|Period 2||1
8991438|NCT03650556|10054591|FG000|STARTED|Overall Study||224
8991439|NCT03650556|10054591|FG000|Ablation Procedure|Overall Study||223
8991440|NCT03650556|10054591|FG000|Pre-Discharge|Overall Study||223
8991441|NCT03650556|10054591|FG000|7-day Follow-Up|Overall Study||223
8991442|NCT03650556|10054591|FG000|3-month Follow-Up|Overall Study||210
8991443|NCT03650556|10054591|FG000|6-month Follow-up|Overall Study||197
8991444|NCT03650556|10054591|FG000|12-month Follow-Up|Overall Study||189
8991445|NCT03650556|10054591|FG000|15-month Follow-Up|Overall Study||187
8991446|NCT03650556|10054591|FG000|COMPLETED|Overall Study||187
8991447|NCT03650556|10054591|FG000|NOT COMPLETED|Overall Study||37
8991448|NCT03639311|10054598|FG000|STARTED|Overall Study||90
8991449|NCT03639311|10054599|FG001|STARTED|Overall Study||7
8991450|NCT03639311|10054598|FG000|COMPLETED|Overall Study||0
8991451|NCT03639311|10054599|FG001|COMPLETED|Overall Study||7
8991452|NCT03639311|10054598|FG000|NOT COMPLETED|Overall Study||90
8991453|NCT03639311|10054599|FG001|NOT COMPLETED|Overall Study||0
8991454|NCT03628716|10054610|FG000|STARTED|Overall Study||19
8991455|NCT03628716|10054611|FG001|STARTED|Overall Study||24
8991456|NCT03628716|10054610|FG000|COMPLETED|Overall Study||0
8991457|NCT03628716|10054611|FG001|COMPLETED|Overall Study||1
8991458|NCT03628716|10054610|FG000|NOT COMPLETED|Overall Study||19
8991459|NCT03628716|10054611|FG001|NOT COMPLETED|Overall Study||23
9039121|NCT03335254|10100130|FG008|NOT COMPLETED|Period 2, Day 1-15||0
9039122|NCT03335254|10100131|FG009|NOT COMPLETED|Period 2, Day 1-15||0
9039123|NCT03335254|10100132|FG010|NOT COMPLETED|Period 2, Day 1-15||0
9039124|NCT03335254|10100133|FG011|NOT COMPLETED|Period 2, Day 1-15||0
9039125|NCT03335254|10100134|FG012|NOT COMPLETED|Period 2, Day 1-15||0
9039126|NCT03335254|10100135|FG013|NOT COMPLETED|Period 2, Day 1-15||0
9039127|NCT03335254|10100136|FG014|NOT COMPLETED|Period 2, Day 1-15||0
9039128|NCT03335254|10100137|FG015|NOT COMPLETED|Period 2, Day 1-15||0
9039129|NCT03335254|10100138|FG016|NOT COMPLETED|Period 2, Day 1-15||0
9039130|NCT03335254|10100139|FG017|NOT COMPLETED|Period 2, Day 1-15||0
9039131|NCT03335254|10100140|FG018|NOT COMPLETED|Period 2, Day 1-15||0
9039132|NCT03335254|10100141|FG019|NOT COMPLETED|Period 2, Day 1-15||0
9039133|NCT03335254|10100122|FG000|STARTED|Period 3, Day 16-25||9
9039134|NCT03335254|10100123|FG001|STARTED|Period 3, Day 16-25||0
9039135|NCT03335254|10100124|FG002|STARTED|Period 3, Day 16-25||0
9039136|NCT03335254|10100125|FG003|STARTED|Period 3, Day 16-25||0
9039137|NCT03335254|10100126|FG004|STARTED|Period 3, Day 16-25||0
9039138|NCT03335254|10100127|FG005|STARTED|Period 3, Day 16-25||0
9039139|NCT03335254|10100128|FG006|STARTED|Period 3, Day 16-25||0
9039140|NCT03335254|10100129|FG007|STARTED|Period 3, Day 16-25||0
9039141|NCT03335254|10100130|FG008|STARTED|Period 3, Day 16-25||0
9039142|NCT03335254|10100131|FG009|STARTED|Period 3, Day 16-25||0
9039143|NCT03335254|10100132|FG010|STARTED|Period 3, Day 16-25||0
8633493|NCT00551135|9673573|FG001|NOT COMPLETED|Overall Study||2
8633494|NCT00551135|9673574|FG002|NOT COMPLETED|Overall Study||5
8633495|NCT00551135|9673575|FG003|NOT COMPLETED|Overall Study||5
9039144|NCT03335254|10100133|FG011|STARTED|Period 3, Day 16-25||0
9039145|NCT03335254|10100134|FG012|STARTED|Period 3, Day 16-25||0
9039146|NCT03335254|10100135|FG013|STARTED|Period 3, Day 16-25||0
8991460|NCT03377699|10054621|FG000|STARTED|Overall Study||111
8991461|NCT03377699|10054622|FG001|STARTED|Overall Study||114
8991462|NCT03377699|10054621|FG000|Treated|Overall Study||110
8991463|NCT03377699|10054622|FG001|Treated|Overall Study||112
8991464|NCT03377699|10054621|FG000|SASpregnant|Overall Study||91
8991465|NCT03377699|10054622|FG001|SASpregnant|Overall Study||94
8991466|NCT03377699|10054621|FG000|FASpregnant|Overall Study||92
8991467|NCT03377699|10054622|FG001|FASpregnant|Overall Study||96
8991468|NCT03377699|10054621|FG000|COMPLETED|Overall Study||89
8991469|NCT03377699|10054622|FG001|COMPLETED|Overall Study||89
8991470|NCT03377699|10054621|FG000|NOT COMPLETED|Overall Study||22
8991471|NCT03377699|10054622|FG001|NOT COMPLETED|Overall Study||25
8991472|NCT03275350|10054632|FG000|STARTED|Overall Study||55
8991473|NCT03275350|10054633|FG001|STARTED|Overall Study||59
8991474|NCT03275350|10054632|FG000|COMPLETED|Overall Study||47
8991475|NCT03275350|10054633|FG001|COMPLETED|Overall Study||51
8991476|NCT03275350|10054632|FG000|NOT COMPLETED|Overall Study||8
8991477|NCT03275350|10054633|FG001|NOT COMPLETED|Overall Study||8
8991478|NCT03272347|10054644|FG000|STARTED|Overall Study||31
8991479|NCT03272347|10054645|FG001|STARTED|Overall Study||30
8991480|NCT03272347|10054646|FG002|STARTED|Overall Study||31
8991481|NCT03272347|10054647|FG003|STARTED|Overall Study||31
8991482|NCT03272347|10054644|FG000|Treated|Overall Study||29
8991483|NCT03272347|10054645|FG001|Treated|Overall Study||30
8991484|NCT03272347|10054646|FG002|Treated|Overall Study||31
8991485|NCT03272347|10054647|FG003|Treated|Overall Study||31
8991486|NCT03272347|10054644|FG000|COMPLETED|Overall Study||0
8991487|NCT03272347|10054645|FG001|COMPLETED|Overall Study||1
8991488|NCT03272347|10054646|FG002|COMPLETED|Overall Study||0
8991489|NCT03272347|10054647|FG003|COMPLETED|Overall Study||2
8991490|NCT03272347|10054644|FG000|NOT COMPLETED|Overall Study||31
8991491|NCT03272347|10054645|FG001|NOT COMPLETED|Overall Study||29
8991492|NCT03272347|10054646|FG002|NOT COMPLETED|Overall Study||31
8991493|NCT03272347|10054647|FG003|NOT COMPLETED|Overall Study||29
8991494|NCT03138369|10054659|FG000|STARTED|Overall Study||11
8991495|NCT03138369|10054660|FG001|STARTED|Overall Study||11
8991496|NCT03138369|10054659|FG000|COMPLETED|Overall Study||8
8991497|NCT03138369|10054660|FG001|COMPLETED|Overall Study||3
8991498|NCT03138369|10054659|FG000|NOT COMPLETED|Overall Study||3
8991499|NCT03138369|10054660|FG001|NOT COMPLETED|Overall Study||8
8991500|NCT02853305|10054670|FG000|STARTED|Overall Study||351
8991501|NCT02853305|10054671|FG001|STARTED|Overall Study||307
8991502|NCT02853305|10054672|FG002|STARTED|Overall Study||352
8991503|NCT02853305|10054670|FG000|Treated|Overall Study|Includes 2 participants randomized to Pembrolizumab alone|349
8991504|NCT02853305|10054671|FG001|Treated|Overall Study||302
8991505|NCT02853305|10054672|FG002|Treated|Overall Study||342
8991506|NCT02853305|10054670|FG000|COMPLETED|Overall Study||0
8991507|NCT02853305|10054671|FG001|COMPLETED|Overall Study||0
8991508|NCT02853305|10054672|FG002|COMPLETED|Overall Study||0
8991509|NCT02853305|10054670|FG000|NOT COMPLETED|Overall Study||351
8991510|NCT02853305|10054671|FG001|NOT COMPLETED|Overall Study||307
8991511|NCT02853305|10054672|FG002|NOT COMPLETED|Overall Study||352
8991512|NCT02758184|10054682|FG000|STARTED|Overall Study||11
8991513|NCT02758184|10054683|FG001|STARTED|Overall Study||10
8991514|NCT02758184|10054682|FG000|COMPLETED|Overall Study||11
8991515|NCT02758184|10054683|FG001|COMPLETED|Overall Study||10
8991516|NCT02758184|10054682|FG000|NOT COMPLETED|Overall Study||0
8991517|NCT02758184|10054683|FG001|NOT COMPLETED|Overall Study||0
8991518|NCT02677870|10054689|FG000|STARTED|Diet Treatment (4 Weeks)||4
8991519|NCT02677870|10054690|FG001|STARTED|Diet Treatment (4 Weeks)||3
8991520|NCT02677870|10054689|FG000|COMPLETED|Diet Treatment (4 Weeks)||4
8991521|NCT02677870|10054690|FG001|COMPLETED|Diet Treatment (4 Weeks)||3
8991522|NCT02677870|10054689|FG000|NOT COMPLETED|Diet Treatment (4 Weeks)||0
8991523|NCT02677870|10054690|FG001|NOT COMPLETED|Diet Treatment (4 Weeks)||0
8991524|NCT02677870|10054689|FG000|STARTED|First Saproterin Dihydrochloride tx||4
8633496|NCT00551161|9673585|FG000|STARTED|Overall Study||12
8633497|NCT00551161|9673585|FG000|COMPLETED|Overall Study||11
8633498|NCT00551161|9673585|FG000|NOT COMPLETED|Overall Study||1
8633499|NCT00551174|9673591|FG000|STARTED|Overall Study||381
8633500|NCT00551174|9673592|FG001|STARTED|Overall Study||400
8633501|NCT00551174|9673591|FG000|COMPLETED|Overall Study|Intent-to-Treat (ITT) Population|362
8633502|NCT00551174|9673592|FG001|COMPLETED|Overall Study|Intent-to-Treat (ITT) Population|394
8633503|NCT00551174|9673591|FG000|NOT COMPLETED|Overall Study||19
8633504|NCT00551174|9673592|FG001|NOT COMPLETED|Overall Study||6
8633505|NCT00551200|9673598|FG000|STARTED|Overall Study||14
8633506|NCT00551200|9673598|FG000|COMPLETED|Overall Study||10
8633507|NCT00551200|9673598|FG000|NOT COMPLETED|Overall Study||4
8991525|NCT02677870|10054690|FG001|STARTED|First Saproterin Dihydrochloride tx||3
8991526|NCT02677870|10054689|FG000|COMPLETED|First Saproterin Dihydrochloride tx||4
8633508|NCT00551213|9673610|FG000|STARTED|Overall Study||50
8633509|NCT00551213|9673611|FG001|STARTED|Overall Study||17
8633510|NCT00551213|9673610|FG000|Treated|Overall Study||49
8991527|NCT02677870|10054690|FG001|COMPLETED|First Saproterin Dihydrochloride tx||3
8991528|NCT02677870|10054689|FG000|NOT COMPLETED|First Saproterin Dihydrochloride tx||0
8991529|NCT02677870|10054690|FG001|NOT COMPLETED|First Saproterin Dihydrochloride tx||0
8991530|NCT02677870|10054689|FG000|STARTED|Washout (2 Weeks)||4
8991531|NCT02677870|10054690|FG001|STARTED|Washout (2 Weeks)||3
8991532|NCT02677870|10054689|FG000|COMPLETED|Washout (2 Weeks)||4
8991533|NCT02677870|10054690|FG001|COMPLETED|Washout (2 Weeks)||3
8991534|NCT02677870|10054689|FG000|NOT COMPLETED|Washout (2 Weeks)||0
8633511|NCT00551213|9673611|FG001|Treated|Overall Study||15
8991535|NCT02677870|10054690|FG001|NOT COMPLETED|Washout (2 Weeks)||0
8991536|NCT02677870|10054689|FG000|STARTED|Second Saproterin Dihydrochloride tx||4
8991537|NCT02677870|10054690|FG001|STARTED|Second Saproterin Dihydrochloride tx||3
8991538|NCT02677870|10054689|FG000|COMPLETED|Second Saproterin Dihydrochloride tx||4
8991539|NCT02677870|10054690|FG001|COMPLETED|Second Saproterin Dihydrochloride tx||3
8991540|NCT02677870|10054689|FG000|NOT COMPLETED|Second Saproterin Dihydrochloride tx||0
8991541|NCT02677870|10054690|FG001|NOT COMPLETED|Second Saproterin Dihydrochloride tx||0
8991542|NCT02674750|10054701|FG000|STARTED|Overall Study||5
8991543|NCT02674750|10054702|FG001|STARTED|Overall Study||49
8991544|NCT02674750|10054703|FG002|STARTED|Overall Study||16
8991545|NCT02674750|10054701|FG000|COMPLETED|Overall Study||0
8991546|NCT02674750|10054702|FG001|COMPLETED|Overall Study||4
8991547|NCT02674750|10054703|FG002|COMPLETED|Overall Study||4
8991548|NCT02674750|10054701|FG000|NOT COMPLETED|Overall Study||5
8991549|NCT02674750|10054702|FG001|NOT COMPLETED|Overall Study||45
8991550|NCT02674750|10054703|FG002|NOT COMPLETED|Overall Study||12
8991551|NCT02440854|10054710|FG000|STARTED|Overall Study||80
8991552|NCT02440854|10054710|FG000|Analyzed|Overall Study||77
8991553|NCT02440854|10054710|FG000|COMPLETED|Overall Study||0
8991554|NCT02440854|10054710|FG000|NOT COMPLETED|Overall Study||80
8991555|NCT02278185|10054716|FG000|STARTED|Overall Study||10
8991556|NCT02278185|10054717|FG001|STARTED|Overall Study||9
8991557|NCT02278185|10054716|FG000|COMPLETED|Overall Study||7
8991558|NCT02278185|10054717|FG001|COMPLETED|Overall Study||7
8991559|NCT02278185|10054716|FG000|NOT COMPLETED|Overall Study||3
8991560|NCT02278185|10054717|FG001|NOT COMPLETED|Overall Study||2
8991561|NCT02154529|10054729|FG000|STARTED|Overall Study||4
8991562|NCT02154529|10054730|FG001|STARTED|Overall Study||3
8991563|NCT02154529|10054731|FG002|STARTED|Overall Study||8
8991564|NCT02154529|10054732|FG003|STARTED|Overall Study||2
8991565|NCT02154529|10054729|FG000|COMPLETED|Overall Study|Study terminated by sponsor|0
8991566|NCT02154529|10054730|FG001|COMPLETED|Overall Study|Study terminated by sponsor|0
8991567|NCT02154529|10054731|FG002|COMPLETED|Overall Study|Study terminated by sponsor|0
8991568|NCT02154529|10054732|FG003|COMPLETED|Overall Study|Study terminated by sponsor|0
8991569|NCT02154529|10054729|FG000|NOT COMPLETED|Overall Study||4
8991570|NCT02154529|10054730|FG001|NOT COMPLETED|Overall Study||3
8991571|NCT02154529|10054731|FG002|NOT COMPLETED|Overall Study||8
8991572|NCT02154529|10054732|FG003|NOT COMPLETED|Overall Study||2
8991573|NCT00788125|10054744|FG000|STARTED|Overall Study||7
8991574|NCT00788125|10054744|FG000|COMPLETED|Overall Study||1
8991575|NCT00788125|10054744|FG000|NOT COMPLETED|Overall Study||6
9039147|NCT03335254|10100136|FG014|STARTED|Period 3, Day 16-25||0
9039148|NCT03335254|10100137|FG015|STARTED|Period 3, Day 16-25||0
9039149|NCT03335254|10100138|FG016|STARTED|Period 3, Day 16-25||0
9039150|NCT03335254|10100139|FG017|STARTED|Period 3, Day 16-25||0
9039151|NCT03335254|10100140|FG018|STARTED|Period 3, Day 16-25||0
9039152|NCT03335254|10100141|FG019|STARTED|Period 3, Day 16-25||0
9039153|NCT03335254|10100122|FG000|COMPLETED|Period 3, Day 16-25||9
9039154|NCT03335254|10100123|FG001|COMPLETED|Period 3, Day 16-25||0
9039155|NCT03335254|10100124|FG002|COMPLETED|Period 3, Day 16-25||0
9039156|NCT03335254|10100125|FG003|COMPLETED|Period 3, Day 16-25||0
9039157|NCT03335254|10100126|FG004|COMPLETED|Period 3, Day 16-25||0
9039158|NCT03335254|10100127|FG005|COMPLETED|Period 3, Day 16-25||0
9039159|NCT03335254|10100128|FG006|COMPLETED|Period 3, Day 16-25||0
9039160|NCT03335254|10100129|FG007|COMPLETED|Period 3, Day 16-25||0
9039161|NCT03335254|10100130|FG008|COMPLETED|Period 3, Day 16-25||0
9039162|NCT03335254|10100131|FG009|COMPLETED|Period 3, Day 16-25||0
9039163|NCT03335254|10100132|FG010|COMPLETED|Period 3, Day 16-25||0
9039164|NCT03335254|10100133|FG011|COMPLETED|Period 3, Day 16-25||0
9039165|NCT03335254|10100134|FG012|COMPLETED|Period 3, Day 16-25||0
9039166|NCT03335254|10100135|FG013|COMPLETED|Period 3, Day 16-25||0
9039167|NCT03335254|10100136|FG014|COMPLETED|Period 3, Day 16-25||0
9039168|NCT03335254|10100137|FG015|COMPLETED|Period 3, Day 16-25||0
8633512|NCT00551213|9673610|FG000|COMPLETED|Overall Study||0
8633513|NCT00551213|9673611|FG001|COMPLETED|Overall Study||0
8633514|NCT00551213|9673610|FG000|NOT COMPLETED|Overall Study||50
8633515|NCT00551213|9673611|FG001|NOT COMPLETED|Overall Study||17
8633516|NCT00551291|9673617|FG000|STARTED|Overall Study||10
8633517|NCT00551291|9673617|FG000|COMPLETED|Overall Study||9
8633518|NCT00551291|9673617|FG000|NOT COMPLETED|Overall Study||1
8633519|NCT00551369|9673621|FG000|STARTED|Overall Study||33
9039169|NCT03335254|10100138|FG016|COMPLETED|Period 3, Day 16-25||0
9039170|NCT03335254|10100139|FG017|COMPLETED|Period 3, Day 16-25||0
9039171|NCT03335254|10100140|FG018|COMPLETED|Period 3, Day 16-25||0
9039172|NCT03335254|10100141|FG019|COMPLETED|Period 3, Day 16-25||0
9039173|NCT03335254|10100122|FG000|NOT COMPLETED|Period 3, Day 16-25||0
8633520|NCT00551369|9673621|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study|26
9039174|NCT03335254|10100123|FG001|NOT COMPLETED|Period 3, Day 16-25||0
9039175|NCT03335254|10100124|FG002|NOT COMPLETED|Period 3, Day 16-25||0
9039176|NCT03335254|10100125|FG003|NOT COMPLETED|Period 3, Day 16-25||0
9039177|NCT03335254|10100126|FG004|NOT COMPLETED|Period 3, Day 16-25||0
9039178|NCT03335254|10100127|FG005|NOT COMPLETED|Period 3, Day 16-25||0
9039179|NCT03335254|10100128|FG006|NOT COMPLETED|Period 3, Day 16-25||0
9039180|NCT03335254|10100129|FG007|NOT COMPLETED|Period 3, Day 16-25||0
9039181|NCT03335254|10100130|FG008|NOT COMPLETED|Period 3, Day 16-25||0
9039182|NCT03335254|10100131|FG009|NOT COMPLETED|Period 3, Day 16-25||0
8991576|NCT02777554|10054750|FG000|STARTED|Overall Study||62
8991577|NCT02777554|10054751|FG001|STARTED|Overall Study||62
8991578|NCT02777554|10054752|FG002|STARTED|Overall Study||5
8991579|NCT02777554|10054753|FG003|STARTED|Overall Study||5
8991580|NCT02777554|10054754|FG004|STARTED|Overall Study||5
8991581|NCT02777554|10054755|FG005|STARTED|Overall Study||5
8991582|NCT02777554|10054750|FG000|COMPLETED|Overall Study||32
8991583|NCT02777554|10054751|FG001|COMPLETED|Overall Study||37
8991584|NCT02777554|10054752|FG002|COMPLETED|Overall Study||4
8991585|NCT02777554|10054753|FG003|COMPLETED|Overall Study||4
8991586|NCT02777554|10054754|FG004|COMPLETED|Overall Study||5
8991587|NCT02777554|10054755|FG005|COMPLETED|Overall Study||5
8991588|NCT02777554|10054750|FG000|NOT COMPLETED|Overall Study||30
8991589|NCT02777554|10054751|FG001|NOT COMPLETED|Overall Study||25
8991590|NCT02777554|10054752|FG002|NOT COMPLETED|Overall Study||1
8991591|NCT02777554|10054753|FG003|NOT COMPLETED|Overall Study||1
8991592|NCT02777554|10054754|FG004|NOT COMPLETED|Overall Study||0
8991593|NCT02777554|10054755|FG005|NOT COMPLETED|Overall Study||0
8991594|NCT02777749|10054778|FG000|STARTED|Overall Study||53
8991595|NCT02777749|10054779|FG001|STARTED|Overall Study||51
8991596|NCT02777749|10054780|FG002|STARTED|Overall Study||51
8571915|NCT00112437|9604137|FG014|NOT COMPLETED|Year 2 (12-Month Extension)||0
8571916|NCT00112437|9604138|FG015|NOT COMPLETED|Year 2 (12-Month Extension)||0
8571917|NCT00112437|9604139|FG016|NOT COMPLETED|Year 2 (12-Month Extension)||0
8571918|NCT00112437|9604140|FG017|NOT COMPLETED|Year 2 (12-Month Extension)||0
8571919|NCT00112437|9604141|FG018|NOT COMPLETED|Year 2 (12-Month Extension)||0
8571920|NCT00112437|9604142|FG019|NOT COMPLETED|Year 2 (12-Month Extension)||0
8571921|NCT00112437|9604143|FG020|NOT COMPLETED|Year 2 (12-Month Extension)||0
8571922|NCT00112437|9604144|FG021|NOT COMPLETED|Year 2 (12-Month Extension)||0
8571923|NCT00112437|9604145|FG022|NOT COMPLETED|Year 2 (12-Month Extension)||0
8571924|NCT00112437|9604146|FG023|NOT COMPLETED|Year 2 (12-Month Extension)||0
8571925|NCT00112437|9604147|FG024|NOT COMPLETED|Year 2 (12-Month Extension)||0
8571926|NCT00112437|9604148|FG025|NOT COMPLETED|Year 2 (12-Month Extension)||0
8571927|NCT00112437|9604123|FG000|STARTED|Year 3 (12-Month Extension)||0
8571928|NCT00112437|9604124|FG001|STARTED|Year 3 (12-Month Extension)||0
8571929|NCT00112437|9604125|FG002|STARTED|Year 3 (12-Month Extension)||0
8571930|NCT00112437|9604126|FG003|STARTED|Year 3 (12-Month Extension)||0
8571931|NCT00112437|9604127|FG004|STARTED|Year 3 (12-Month Extension)||0
8571932|NCT00112437|9604128|FG005|STARTED|Year 3 (12-Month Extension)||0
8571933|NCT00112437|9604129|FG006|STARTED|Year 3 (12-Month Extension)||0
8571934|NCT00112437|9604130|FG007|STARTED|Year 3 (12-Month Extension)||0
8571935|NCT00112437|9604131|FG008|STARTED|Year 3 (12-Month Extension)||0
8571936|NCT00112437|9604132|FG009|STARTED|Year 3 (12-Month Extension)||0
8571937|NCT00112437|9604133|FG010|STARTED|Year 3 (12-Month Extension)||19
8571938|NCT00112437|9604134|FG011|STARTED|Year 3 (12-Month Extension)||22
8571939|NCT00112437|9604135|FG012|STARTED|Year 3 (12-Month Extension)||18
8571940|NCT00112437|9604136|FG013|STARTED|Year 3 (12-Month Extension)||17
8571941|NCT00112437|9604137|FG014|STARTED|Year 3 (12-Month Extension)||18
8571942|NCT00112437|9604138|FG015|STARTED|Year 3 (12-Month Extension)||17
8571943|NCT00112437|9604139|FG016|STARTED|Year 3 (12-Month Extension)||19
8571944|NCT00112437|9604140|FG017|STARTED|Year 3 (12-Month Extension)||21
8571945|NCT00112437|9604141|FG018|STARTED|Year 3 (12-Month Extension)||18
8571946|NCT00112437|9604142|FG019|STARTED|Year 3 (12-Month Extension)||20
8991597|NCT02777749|10054778|FG000|COMPLETED|Overall Study||53
8991598|NCT02777749|10054779|FG001|COMPLETED|Overall Study||51
8991599|NCT02777749|10054780|FG002|COMPLETED|Overall Study||51
8991600|NCT02777749|10054778|FG000|NOT COMPLETED|Overall Study||0
8991601|NCT02777749|10054779|FG001|NOT COMPLETED|Overall Study||0
8991602|NCT02777749|10054780|FG002|NOT COMPLETED|Overall Study||0
8571947|NCT00112437|9604143|FG020|STARTED|Year 3 (12-Month Extension)||0
8571948|NCT00112437|9604144|FG021|STARTED|Year 3 (12-Month Extension)||0
8571949|NCT00112437|9604145|FG022|STARTED|Year 3 (12-Month Extension)||0
8571950|NCT00112437|9604146|FG023|STARTED|Year 3 (12-Month Extension)||0
8571951|NCT00112437|9604147|FG024|STARTED|Year 3 (12-Month Extension)||0
8571952|NCT00112437|9604148|FG025|STARTED|Year 3 (12-Month Extension)||0
8571953|NCT00112437|9604123|FG000|COMPLETED|Year 3 (12-Month Extension)||0
8571954|NCT00112437|9604124|FG001|COMPLETED|Year 3 (12-Month Extension)||0
8571955|NCT00112437|9604125|FG002|COMPLETED|Year 3 (12-Month Extension)||0
8571956|NCT00112437|9604126|FG003|COMPLETED|Year 3 (12-Month Extension)||0
8571957|NCT00112437|9604127|FG004|COMPLETED|Year 3 (12-Month Extension)||0
8571958|NCT00112437|9604128|FG005|COMPLETED|Year 3 (12-Month Extension)||0
8571959|NCT00112437|9604129|FG006|COMPLETED|Year 3 (12-Month Extension)||0
8991603|NCT02777827|10054792|FG000|STARTED|Treatment Period 1||5
8991604|NCT02777827|10054793|FG001|STARTED|Treatment Period 1||5
8991605|NCT02777827|10054794|FG002|STARTED|Treatment Period 1||5
8991606|NCT02777827|10054795|FG003|STARTED|Treatment Period 1||5
8991607|NCT02777827|10054796|FG004|STARTED|Treatment Period 1||4
8991608|NCT02777827|10054797|FG005|STARTED|Treatment Period 1||6
8991609|NCT02777827|10054792|FG000|COMPLETED|Treatment Period 1||5
8991610|NCT02777827|10054793|FG001|COMPLETED|Treatment Period 1||5
8991611|NCT02777827|10054794|FG002|COMPLETED|Treatment Period 1||5
8991612|NCT02777827|10054795|FG003|COMPLETED|Treatment Period 1||5
8991613|NCT02777827|10054796|FG004|COMPLETED|Treatment Period 1||4
8991614|NCT02777827|10054797|FG005|COMPLETED|Treatment Period 1||6
8991615|NCT02777827|10054792|FG000|NOT COMPLETED|Treatment Period 1||0
8991616|NCT02777827|10054793|FG001|NOT COMPLETED|Treatment Period 1||0
8991617|NCT02777827|10054794|FG002|NOT COMPLETED|Treatment Period 1||0
8991618|NCT02777827|10054795|FG003|NOT COMPLETED|Treatment Period 1||0
8991619|NCT02777827|10054796|FG004|NOT COMPLETED|Treatment Period 1||0
8991620|NCT02777827|10054797|FG005|NOT COMPLETED|Treatment Period 1||0
8991621|NCT02777827|10054792|FG000|STARTED|Washout Between Periods 1 and 2||5
8991622|NCT02777827|10054793|FG001|STARTED|Washout Between Periods 1 and 2||5
8991623|NCT02777827|10054794|FG002|STARTED|Washout Between Periods 1 and 2||5
8991624|NCT02777827|10054795|FG003|STARTED|Washout Between Periods 1 and 2||5
8991625|NCT02777827|10054796|FG004|STARTED|Washout Between Periods 1 and 2||4
8991626|NCT02777827|10054797|FG005|STARTED|Washout Between Periods 1 and 2||6
8991627|NCT02777827|10054792|FG000|COMPLETED|Washout Between Periods 1 and 2||5
8991628|NCT02777827|10054793|FG001|COMPLETED|Washout Between Periods 1 and 2||5
8991629|NCT02777827|10054794|FG002|COMPLETED|Washout Between Periods 1 and 2||5
8991630|NCT02777827|10054795|FG003|COMPLETED|Washout Between Periods 1 and 2||5
8991631|NCT02777827|10054796|FG004|COMPLETED|Washout Between Periods 1 and 2||4
8991632|NCT02777827|10054797|FG005|COMPLETED|Washout Between Periods 1 and 2||6
8991633|NCT02777827|10054792|FG000|NOT COMPLETED|Washout Between Periods 1 and 2||0
8991634|NCT02777827|10054793|FG001|NOT COMPLETED|Washout Between Periods 1 and 2||0
8991635|NCT02777827|10054794|FG002|NOT COMPLETED|Washout Between Periods 1 and 2||0
8991636|NCT02777827|10054795|FG003|NOT COMPLETED|Washout Between Periods 1 and 2||0
8991637|NCT02777827|10054796|FG004|NOT COMPLETED|Washout Between Periods 1 and 2||0
8991638|NCT02777827|10054797|FG005|NOT COMPLETED|Washout Between Periods 1 and 2||0
8991639|NCT02777827|10054792|FG000|STARTED|Treatment Period 2||5
8991640|NCT02777827|10054793|FG001|STARTED|Treatment Period 2||5
8991641|NCT02777827|10054794|FG002|STARTED|Treatment Period 2||5
8991642|NCT02777827|10054795|FG003|STARTED|Treatment Period 2||5
8991643|NCT02777827|10054796|FG004|STARTED|Treatment Period 2||4
8991644|NCT02777827|10054797|FG005|STARTED|Treatment Period 2||6
8991645|NCT02777827|10054792|FG000|COMPLETED|Treatment Period 2||5
8991646|NCT02777827|10054793|FG001|COMPLETED|Treatment Period 2||5
8991647|NCT02777827|10054794|FG002|COMPLETED|Treatment Period 2||5
8991648|NCT02777827|10054795|FG003|COMPLETED|Treatment Period 2||5
8991649|NCT02777827|10054796|FG004|COMPLETED|Treatment Period 2||4
8991650|NCT02777827|10054797|FG005|COMPLETED|Treatment Period 2||6
8991651|NCT02777827|10054792|FG000|NOT COMPLETED|Treatment Period 2||0
8991652|NCT02777827|10054793|FG001|NOT COMPLETED|Treatment Period 2||0
8991653|NCT02777827|10054794|FG002|NOT COMPLETED|Treatment Period 2||0
8991654|NCT02777827|10054795|FG003|NOT COMPLETED|Treatment Period 2||0
8991655|NCT02777827|10054796|FG004|NOT COMPLETED|Treatment Period 2||0
8991656|NCT02777827|10054797|FG005|NOT COMPLETED|Treatment Period 2||0
8991657|NCT02777827|10054792|FG000|STARTED|Washout Between Periods 2 and 3||5
8991658|NCT02777827|10054793|FG001|STARTED|Washout Between Periods 2 and 3||5
8991659|NCT02777827|10054794|FG002|STARTED|Washout Between Periods 2 and 3||5
8991660|NCT02777827|10054795|FG003|STARTED|Washout Between Periods 2 and 3||5
8991661|NCT02777827|10054796|FG004|STARTED|Washout Between Periods 2 and 3||4
8991662|NCT02777827|10054797|FG005|STARTED|Washout Between Periods 2 and 3||6
8991663|NCT02777827|10054792|FG000|COMPLETED|Washout Between Periods 2 and 3||5
8991664|NCT02777827|10054793|FG001|COMPLETED|Washout Between Periods 2 and 3||5
8991665|NCT02777827|10054794|FG002|COMPLETED|Washout Between Periods 2 and 3||5
8991666|NCT02777827|10054795|FG003|COMPLETED|Washout Between Periods 2 and 3||5
8991667|NCT02777827|10054796|FG004|COMPLETED|Washout Between Periods 2 and 3||4
8991668|NCT02777827|10054797|FG005|COMPLETED|Washout Between Periods 2 and 3||6
8991669|NCT02777827|10054792|FG000|NOT COMPLETED|Washout Between Periods 2 and 3||0
8991670|NCT02777827|10054793|FG001|NOT COMPLETED|Washout Between Periods 2 and 3||0
8991671|NCT02777827|10054794|FG002|NOT COMPLETED|Washout Between Periods 2 and 3||0
8991672|NCT02777827|10054795|FG003|NOT COMPLETED|Washout Between Periods 2 and 3||0
8991673|NCT02777827|10054796|FG004|NOT COMPLETED|Washout Between Periods 2 and 3||0
8991674|NCT02777827|10054797|FG005|NOT COMPLETED|Washout Between Periods 2 and 3||0
8991675|NCT02777827|10054792|FG000|STARTED|Treatment Period 3||5
8991676|NCT02777827|10054793|FG001|STARTED|Treatment Period 3||5
8991677|NCT02777827|10054794|FG002|STARTED|Treatment Period 3||5
8991678|NCT02777827|10054795|FG003|STARTED|Treatment Period 3||5
8991679|NCT02777827|10054796|FG004|STARTED|Treatment Period 3||4
8991680|NCT02777827|10054797|FG005|STARTED|Treatment Period 3||6
8991681|NCT02777827|10054792|FG000|COMPLETED|Treatment Period 3||5
8991682|NCT02777827|10054793|FG001|COMPLETED|Treatment Period 3||5
8991683|NCT02777827|10054794|FG002|COMPLETED|Treatment Period 3||5
8991684|NCT02777827|10054795|FG003|COMPLETED|Treatment Period 3||5
8991685|NCT02777827|10054796|FG004|COMPLETED|Treatment Period 3||4
8991686|NCT02777827|10054797|FG005|COMPLETED|Treatment Period 3||6
8991687|NCT02777827|10054792|FG000|NOT COMPLETED|Treatment Period 3||0
8991688|NCT02777827|10054793|FG001|NOT COMPLETED|Treatment Period 3||0
8991689|NCT02777827|10054794|FG002|NOT COMPLETED|Treatment Period 3||0
8633521|NCT00551369|9673621|FG000|NOT COMPLETED|Overall Study||7
8991690|NCT02777827|10054795|FG003|NOT COMPLETED|Treatment Period 3||0
8991691|NCT02777827|10054796|FG004|NOT COMPLETED|Treatment Period 3||0
8991692|NCT02777827|10054797|FG005|NOT COMPLETED|Treatment Period 3||0
8991693|NCT02777827|10054792|FG000|STARTED|Washout Between Periods 3 and 4||5
8991694|NCT02777827|10054793|FG001|STARTED|Washout Between Periods 3 and 4||5
8991695|NCT02777827|10054794|FG002|STARTED|Washout Between Periods 3 and 4||5
8991696|NCT02777827|10054795|FG003|STARTED|Washout Between Periods 3 and 4||5
8991697|NCT02777827|10054796|FG004|STARTED|Washout Between Periods 3 and 4||4
8991698|NCT02777827|10054797|FG005|STARTED|Washout Between Periods 3 and 4||6
8991699|NCT02777827|10054792|FG000|COMPLETED|Washout Between Periods 3 and 4||5
8991700|NCT02777827|10054793|FG001|COMPLETED|Washout Between Periods 3 and 4||5
8991701|NCT02777827|10054794|FG002|COMPLETED|Washout Between Periods 3 and 4||4
8991702|NCT02777827|10054795|FG003|COMPLETED|Washout Between Periods 3 and 4||5
8991703|NCT02777827|10054796|FG004|COMPLETED|Washout Between Periods 3 and 4||4
8991704|NCT02777827|10054797|FG005|COMPLETED|Washout Between Periods 3 and 4||6
8991705|NCT02777827|10054792|FG000|NOT COMPLETED|Washout Between Periods 3 and 4||0
8991706|NCT02777827|10054793|FG001|NOT COMPLETED|Washout Between Periods 3 and 4||0
8991707|NCT02777827|10054794|FG002|NOT COMPLETED|Washout Between Periods 3 and 4||1
8991708|NCT02777827|10054795|FG003|NOT COMPLETED|Washout Between Periods 3 and 4||0
8991709|NCT02777827|10054796|FG004|NOT COMPLETED|Washout Between Periods 3 and 4||0
8991710|NCT02777827|10054797|FG005|NOT COMPLETED|Washout Between Periods 3 and 4||0
8991711|NCT02777827|10054792|FG000|STARTED|Treatment Period 4||5
8991712|NCT02777827|10054793|FG001|STARTED|Treatment Period 4||5
8991713|NCT02777827|10054794|FG002|STARTED|Treatment Period 4||4
8991714|NCT02777827|10054795|FG003|STARTED|Treatment Period 4||5
8991715|NCT02777827|10054796|FG004|STARTED|Treatment Period 4||4
8991716|NCT02777827|10054797|FG005|STARTED|Treatment Period 4||6
8991717|NCT02777827|10054792|FG000|COMPLETED|Treatment Period 4||5
8991718|NCT02777827|10054793|FG001|COMPLETED|Treatment Period 4||5
8991719|NCT02777827|10054794|FG002|COMPLETED|Treatment Period 4||4
8991720|NCT02777827|10054795|FG003|COMPLETED|Treatment Period 4||5
8991721|NCT02777827|10054796|FG004|COMPLETED|Treatment Period 4||4
8991722|NCT02777827|10054797|FG005|COMPLETED|Treatment Period 4||6
8991723|NCT02777827|10054792|FG000|NOT COMPLETED|Treatment Period 4||0
8991724|NCT02777827|10054793|FG001|NOT COMPLETED|Treatment Period 4||0
8991725|NCT02777827|10054794|FG002|NOT COMPLETED|Treatment Period 4||0
8991726|NCT02777827|10054795|FG003|NOT COMPLETED|Treatment Period 4||0
8991727|NCT02777827|10054796|FG004|NOT COMPLETED|Treatment Period 4||0
8991728|NCT02777827|10054797|FG005|NOT COMPLETED|Treatment Period 4||0
8991729|NCT02777827|10054792|FG000|STARTED|Washout Between Periods 4 and 5||5
8991730|NCT02777827|10054793|FG001|STARTED|Washout Between Periods 4 and 5||5
8991731|NCT02777827|10054794|FG002|STARTED|Washout Between Periods 4 and 5||4
8991732|NCT02777827|10054795|FG003|STARTED|Washout Between Periods 4 and 5||5
8991733|NCT02777827|10054796|FG004|STARTED|Washout Between Periods 4 and 5||4
8991734|NCT02777827|10054797|FG005|STARTED|Washout Between Periods 4 and 5||6
8991735|NCT02777827|10054792|FG000|COMPLETED|Washout Between Periods 4 and 5||5
8991736|NCT02777827|10054793|FG001|COMPLETED|Washout Between Periods 4 and 5||5
8991737|NCT02777827|10054794|FG002|COMPLETED|Washout Between Periods 4 and 5||4
8991738|NCT02777827|10054795|FG003|COMPLETED|Washout Between Periods 4 and 5||5
8991739|NCT02777827|10054796|FG004|COMPLETED|Washout Between Periods 4 and 5||4
8991740|NCT02777827|10054797|FG005|COMPLETED|Washout Between Periods 4 and 5||6
8991741|NCT02777827|10054792|FG000|NOT COMPLETED|Washout Between Periods 4 and 5||0
8991742|NCT02777827|10054793|FG001|NOT COMPLETED|Washout Between Periods 4 and 5||0
8991743|NCT02777827|10054794|FG002|NOT COMPLETED|Washout Between Periods 4 and 5||0
8991744|NCT02777827|10054795|FG003|NOT COMPLETED|Washout Between Periods 4 and 5||0
8991745|NCT02777827|10054796|FG004|NOT COMPLETED|Washout Between Periods 4 and 5||0
8991746|NCT02777827|10054797|FG005|NOT COMPLETED|Washout Between Periods 4 and 5||0
8991747|NCT02777827|10054792|FG000|STARTED|Treatment Period 5||5
8991748|NCT02777827|10054793|FG001|STARTED|Treatment Period 5||5
8991749|NCT02777827|10054794|FG002|STARTED|Treatment Period 5||4
8991750|NCT02777827|10054795|FG003|STARTED|Treatment Period 5||5
8991751|NCT02777827|10054796|FG004|STARTED|Treatment Period 5||4
8991752|NCT02777827|10054797|FG005|STARTED|Treatment Period 5||6
8991753|NCT02777827|10054792|FG000|COMPLETED|Treatment Period 5||5
8991754|NCT02777827|10054793|FG001|COMPLETED|Treatment Period 5||5
8991755|NCT02777827|10054794|FG002|COMPLETED|Treatment Period 5||4
8991756|NCT02777827|10054795|FG003|COMPLETED|Treatment Period 5||5
8991757|NCT02777827|10054796|FG004|COMPLETED|Treatment Period 5||4
8991758|NCT02777827|10054797|FG005|COMPLETED|Treatment Period 5||6
8633522|NCT00551421|9673625|FG000|STARTED|Original Protocol, Dose Level 1||3
8991759|NCT02777827|10054792|FG000|NOT COMPLETED|Treatment Period 5||0
8991760|NCT02777827|10054793|FG001|NOT COMPLETED|Treatment Period 5||0
8991761|NCT02777827|10054794|FG002|NOT COMPLETED|Treatment Period 5||0
8991762|NCT02777827|10054795|FG003|NOT COMPLETED|Treatment Period 5||0
8991763|NCT02777827|10054796|FG004|NOT COMPLETED|Treatment Period 5||0
8991764|NCT02777827|10054797|FG005|NOT COMPLETED|Treatment Period 5||0
8991765|NCT02777827|10054792|FG000|STARTED|Washout Between Periods 5 and 6||5
8991766|NCT02777827|10054793|FG001|STARTED|Washout Between Periods 5 and 6||5
8991767|NCT02777827|10054794|FG002|STARTED|Washout Between Periods 5 and 6||4
8991768|NCT02777827|10054795|FG003|STARTED|Washout Between Periods 5 and 6||5
8991769|NCT02777827|10054796|FG004|STARTED|Washout Between Periods 5 and 6||4
8991770|NCT02777827|10054797|FG005|STARTED|Washout Between Periods 5 and 6||6
8991771|NCT02777827|10054792|FG000|COMPLETED|Washout Between Periods 5 and 6||5
8991772|NCT02777827|10054793|FG001|COMPLETED|Washout Between Periods 5 and 6||5
8991773|NCT02777827|10054794|FG002|COMPLETED|Washout Between Periods 5 and 6||4
8991774|NCT02777827|10054795|FG003|COMPLETED|Washout Between Periods 5 and 6||5
8991775|NCT02777827|10054796|FG004|COMPLETED|Washout Between Periods 5 and 6||4
8991776|NCT02777827|10054797|FG005|COMPLETED|Washout Between Periods 5 and 6||6
8991777|NCT02777827|10054792|FG000|NOT COMPLETED|Washout Between Periods 5 and 6||0
8991778|NCT02777827|10054793|FG001|NOT COMPLETED|Washout Between Periods 5 and 6||0
8991779|NCT02777827|10054794|FG002|NOT COMPLETED|Washout Between Periods 5 and 6||0
8991780|NCT02777827|10054795|FG003|NOT COMPLETED|Washout Between Periods 5 and 6||0
8991781|NCT02777827|10054796|FG004|NOT COMPLETED|Washout Between Periods 5 and 6||0
8991782|NCT02777827|10054797|FG005|NOT COMPLETED|Washout Between Periods 5 and 6||0
8991783|NCT02777827|10054792|FG000|STARTED|Treatment Period 6||5
8991784|NCT02777827|10054793|FG001|STARTED|Treatment Period 6||5
8991785|NCT02777827|10054794|FG002|STARTED|Treatment Period 6||4
8991786|NCT02777827|10054795|FG003|STARTED|Treatment Period 6||5
8991787|NCT02777827|10054796|FG004|STARTED|Treatment Period 6||4
8991788|NCT02777827|10054797|FG005|STARTED|Treatment Period 6||6
8991789|NCT02777827|10054792|FG000|COMPLETED|Treatment Period 6||5
8991790|NCT02777827|10054793|FG001|COMPLETED|Treatment Period 6||5
8991791|NCT02777827|10054794|FG002|COMPLETED|Treatment Period 6||4
8991792|NCT02777827|10054795|FG003|COMPLETED|Treatment Period 6||5
8991793|NCT02777827|10054796|FG004|COMPLETED|Treatment Period 6||4
8991794|NCT02777827|10054797|FG005|COMPLETED|Treatment Period 6||6
8991795|NCT02777827|10054792|FG000|NOT COMPLETED|Treatment Period 6||0
8991796|NCT02777827|10054793|FG001|NOT COMPLETED|Treatment Period 6||0
8991797|NCT02777827|10054794|FG002|NOT COMPLETED|Treatment Period 6||0
8991798|NCT02777827|10054795|FG003|NOT COMPLETED|Treatment Period 6||0
8991799|NCT02777827|10054796|FG004|NOT COMPLETED|Treatment Period 6||0
8991800|NCT02777827|10054797|FG005|NOT COMPLETED|Treatment Period 6||0
8991801|NCT02777918|10054813|FG000|STARTED|Overall Study||53
8991802|NCT02777918|10054814|FG001|STARTED|Overall Study||47
8991803|NCT02777918|10054813|FG000|COMPLETED|Overall Study||50
8991804|NCT02777918|10054814|FG001|COMPLETED|Overall Study||43
8991805|NCT02777918|10054813|FG000|NOT COMPLETED|Overall Study||3
8991806|NCT02777918|10054814|FG001|NOT COMPLETED|Overall Study||4
8991807|NCT02777931|10054822|FG000|STARTED|Overall Study||49
8991808|NCT02777931|10054823|FG001|STARTED|Overall Study||52
8991809|NCT02777931|10054822|FG000|Safety Population|Overall Study||47
8991810|NCT02777931|10054823|FG001|Safety Population|Overall Study||50
8991811|NCT02777931|10054822|FG000|Modified Intent to Treat Population|Overall Study||46
8991812|NCT02777931|10054823|FG001|Modified Intent to Treat Population|Overall Study||50
8991813|NCT02777931|10054822|FG000|COMPLETED|Overall Study||37
8991814|NCT02777931|10054823|FG001|COMPLETED|Overall Study||39
8991815|NCT02777931|10054822|FG000|NOT COMPLETED|Overall Study||12
8991816|NCT02777931|10054823|FG001|NOT COMPLETED|Overall Study||13
8991817|NCT02777944|10054831|FG000|STARTED|Overall Study||157
8991818|NCT02777944|10054832|FG001|STARTED|Overall Study||156
8991819|NCT02777944|10054831|FG000|COMPLETED|Overall Study||157
8991820|NCT02777944|10054832|FG001|COMPLETED|Overall Study||156
8991821|NCT02777944|10054831|FG000|NOT COMPLETED|Overall Study||0
8991822|NCT02777944|10054832|FG001|NOT COMPLETED|Overall Study||0
8991823|NCT02777970|10054841|FG000|STARTED|Overall Study||261
8991824|NCT02777970|10054842|FG001|STARTED|Overall Study||262
8991825|NCT02777970|10054843|FG002|STARTED|Overall Study||131
8991826|NCT02777970|10054841|FG000|COMPLETED|Overall Study||260
8991827|NCT02777970|10054842|FG001|COMPLETED|Overall Study||261
8991828|NCT02777970|10054843|FG002|COMPLETED|Overall Study||131
8991829|NCT02777970|10054841|FG000|NOT COMPLETED|Overall Study||1
8991830|NCT02777970|10054842|FG001|NOT COMPLETED|Overall Study||1
8991831|NCT02777970|10054843|FG002|NOT COMPLETED|Overall Study||0
8991832|NCT02778074|10054855|FG000|STARTED|Overall Study||72
8991833|NCT02778074|10054856|FG001|STARTED|Overall Study||72
8991834|NCT02778074|10054855|FG000|COMPLETED|Overall Study||65
8991835|NCT02778074|10054856|FG001|COMPLETED|Overall Study||62
8991836|NCT02778074|10054855|FG000|NOT COMPLETED|Overall Study||7
8991837|NCT02778074|10054856|FG001|NOT COMPLETED|Overall Study||10
8991838|NCT02778100|10054864|FG000|STARTED|Period 1 (Common Cold)||18
8991839|NCT02778100|10054865|FG001|STARTED|Period 1 (Common Cold)||18
8991840|NCT02778100|10054864|FG000|COMPLETED|Period 1 (Common Cold)||17
8991841|NCT02778100|10054865|FG001|COMPLETED|Period 1 (Common Cold)||18
8991842|NCT02778100|10054864|FG000|NOT COMPLETED|Period 1 (Common Cold)||1
8991843|NCT02778100|10054865|FG001|NOT COMPLETED|Period 1 (Common Cold)||0
8991844|NCT02778100|10054864|FG000|STARTED|Period 2 (No Cold Symptoms)||17
8991845|NCT02778100|10054865|FG001|STARTED|Period 2 (No Cold Symptoms)|Cohort 2 only administered NG to participants with a common cold who are taking oxymetazoline.|0
8991846|NCT02778100|10054864|FG000|COMPLETED|Period 2 (No Cold Symptoms)||17
8991847|NCT02778100|10054865|FG001|COMPLETED|Period 2 (No Cold Symptoms)||0
8991848|NCT02778100|10054864|FG000|NOT COMPLETED|Period 2 (No Cold Symptoms)||0
8991849|NCT02778100|10054865|FG001|NOT COMPLETED|Period 2 (No Cold Symptoms)||0
8991850|NCT02778113|10054873|FG000|STARTED|Study Period One||4
8991851|NCT02778113|10054874|FG001|STARTED|Study Period One||4
8991852|NCT02778113|10054875|FG002|STARTED|Study Period One||4
8991853|NCT02778113|10054876|FG003|STARTED|Study Period One||4
8991854|NCT02778113|10054873|FG000|Received Study Drug|Study Period One||4
8991855|NCT02778113|10054874|FG001|Received Study Drug|Study Period One||4
8991856|NCT02778113|10054875|FG002|Received Study Drug|Study Period One||4
8991857|NCT02778113|10054876|FG003|Received Study Drug|Study Period One||4
8991858|NCT02778113|10054873|FG000|COMPLETED|Study Period One||4
8991859|NCT02778113|10054874|FG001|COMPLETED|Study Period One||4
8991860|NCT02778113|10054875|FG002|COMPLETED|Study Period One||4
8991861|NCT02778113|10054876|FG003|COMPLETED|Study Period One||4
8991862|NCT02778113|10054873|FG000|NOT COMPLETED|Study Period One||0
8991863|NCT02778113|10054874|FG001|NOT COMPLETED|Study Period One||0
8991864|NCT02778113|10054875|FG002|NOT COMPLETED|Study Period One||0
8991865|NCT02778113|10054876|FG003|NOT COMPLETED|Study Period One||0
8991866|NCT02778113|10054873|FG000|STARTED|Study Period Two||4
8991867|NCT02778113|10054874|FG001|STARTED|Study Period Two||4
8991868|NCT02778113|10054875|FG002|STARTED|Study Period Two||4
8991869|NCT02778113|10054876|FG003|STARTED|Study Period Two||4
8991870|NCT02778113|10054873|FG000|Received Study Drug|Study Period Two||4
8991871|NCT02778113|10054874|FG001|Received Study Drug|Study Period Two||4
8991872|NCT02778113|10054875|FG002|Received Study Drug|Study Period Two||4
8991873|NCT02778113|10054876|FG003|Received Study Drug|Study Period Two||4
8991874|NCT02778113|10054873|FG000|COMPLETED|Study Period Two||4
8991875|NCT02778113|10054874|FG001|COMPLETED|Study Period Two||4
8991876|NCT02778113|10054875|FG002|COMPLETED|Study Period Two||4
8991877|NCT02778113|10054876|FG003|COMPLETED|Study Period Two||4
8991878|NCT02778113|10054873|FG000|NOT COMPLETED|Study Period Two||0
8991879|NCT02778113|10054874|FG001|NOT COMPLETED|Study Period Two||0
8991880|NCT02778113|10054875|FG002|NOT COMPLETED|Study Period Two||0
8991881|NCT02778113|10054876|FG003|NOT COMPLETED|Study Period Two||0
8991882|NCT02778113|10054873|FG000|STARTED|Study Period Three||4
8991883|NCT02778113|10054874|FG001|STARTED|Study Period Three||4
8991884|NCT02778113|10054875|FG002|STARTED|Study Period Three|One participant completed study period two, but did not enter study period three.|3
8991885|NCT02778113|10054876|FG003|STARTED|Study Period Three||4
8991886|NCT02778113|10054873|FG000|Received Study Drug|Study Period Three||4
8991887|NCT02778113|10054874|FG001|Received Study Drug|Study Period Three||4
8991888|NCT02778113|10054875|FG002|Received Study Drug|Study Period Three||3
8991889|NCT02778113|10054876|FG003|Received Study Drug|Study Period Three||4
8991890|NCT02778113|10054873|FG000|COMPLETED|Study Period Three||4
8991891|NCT02778113|10054874|FG001|COMPLETED|Study Period Three||4
8991892|NCT02778113|10054875|FG002|COMPLETED|Study Period Three||3
8991893|NCT02778113|10054876|FG003|COMPLETED|Study Period Three||4
8991894|NCT02778113|10054873|FG000|NOT COMPLETED|Study Period Three||0
8991895|NCT02778113|10054874|FG001|NOT COMPLETED|Study Period Three||0
8991896|NCT02778113|10054875|FG002|NOT COMPLETED|Study Period Three||0
8991897|NCT02778113|10054876|FG003|NOT COMPLETED|Study Period Three||0
8991898|NCT02778113|10054873|FG000|STARTED|Study Period Four|One participant completed study period three, but did not enter study period four.|3
8991899|NCT02778113|10054874|FG001|STARTED|Study Period Four||4
8991900|NCT02778113|10054875|FG002|STARTED|Study Period Four|One participant completed study period three, but did not enter study period four.|2
8991901|NCT02778113|10054876|FG003|STARTED|Study Period Four||4
8991902|NCT02778113|10054873|FG000|Received Study Drug|Study Period Four||3
8991903|NCT02778113|10054874|FG001|Received Study Drug|Study Period Four||4
8991904|NCT02778113|10054875|FG002|Received Study Drug|Study Period Four||2
8991905|NCT02778113|10054876|FG003|Received Study Drug|Study Period Four||4
8991906|NCT02778113|10054873|FG000|COMPLETED|Study Period Four||3
8991907|NCT02778113|10054874|FG001|COMPLETED|Study Period Four||4
8991908|NCT02778113|10054875|FG002|COMPLETED|Study Period Four||2
8991909|NCT02778113|10054876|FG003|COMPLETED|Study Period Four||4
8991910|NCT02778113|10054873|FG000|NOT COMPLETED|Study Period Four||0
8991911|NCT02778113|10054874|FG001|NOT COMPLETED|Study Period Four||0
8991912|NCT02778113|10054875|FG002|NOT COMPLETED|Study Period Four||0
8991913|NCT02778113|10054876|FG003|NOT COMPLETED|Study Period Four||0
8991914|NCT02778152|10054888|FG000|STARTED|Overall Study||13
8991915|NCT02778152|10054888|FG000|COMPLETED|Overall Study||13
8991916|NCT02778152|10054888|FG000|NOT COMPLETED|Overall Study||0
8991917|NCT02778555|10054895|FG000|STARTED|Overall Study||186
8991918|NCT02778555|10054896|FG001|STARTED|Overall Study||209
8991919|NCT02778555|10054897|FG002|STARTED|Overall Study||318
8991920|NCT02778555|10054895|FG000|COMPLETED|Overall Study||131
8991921|NCT02778555|10054896|FG001|COMPLETED|Overall Study||177
8991922|NCT02778555|10054897|FG002|COMPLETED|Overall Study||211
8991923|NCT02778555|10054895|FG000|NOT COMPLETED|Overall Study||55
8991924|NCT02778555|10054896|FG001|NOT COMPLETED|Overall Study||32
8991925|NCT02778555|10054897|FG002|NOT COMPLETED|Overall Study||107
8991926|NCT02778867|10054907|FG000|STARTED|Phase 1||67
8991927|NCT02778867|10054908|FG001|STARTED|Phase 1||62
8991928|NCT02778867|10054909|FG002|STARTED|Phase 1||0
8991929|NCT02778867|10054910|FG003|STARTED|Phase 1||0
8991930|NCT02778867|10054907|FG000|COMPLETED|Phase 1||65
8991931|NCT02778867|10054908|FG001|COMPLETED|Phase 1||59
8991932|NCT02778867|10054909|FG002|COMPLETED|Phase 1||0
8991933|NCT02778867|10054910|FG003|COMPLETED|Phase 1||0
8991934|NCT02778867|10054907|FG000|NOT COMPLETED|Phase 1||2
8991935|NCT02778867|10054908|FG001|NOT COMPLETED|Phase 1||3
8991936|NCT02778867|10054909|FG002|NOT COMPLETED|Phase 1||0
8991937|NCT02778867|10054910|FG003|NOT COMPLETED|Phase 1||0
8991938|NCT02778867|10054907|FG000|STARTED|Phase 2|1FED non-responders from Phase 1 have the option to undergo 6FED in Phase 2|0
8991939|NCT02778867|10054908|FG001|STARTED|Phase 2|6FED non-responders from Phase 1 have the option to undergo SGC in Phase 2|0
8991940|NCT02778867|10054909|FG002|STARTED|Phase 2|Optional phase for 1FED non-responders|21
8991941|NCT02778867|10054910|FG003|STARTED|Phase 2|Optional phase for 6FED non-responders|11
8991942|NCT02778867|10054907|FG000|COMPLETED|Phase 2||0
8991943|NCT02778867|10054908|FG001|COMPLETED|Phase 2||0
8991944|NCT02778867|10054909|FG002|COMPLETED|Phase 2||20
8991945|NCT02778867|10054910|FG003|COMPLETED|Phase 2||9
8991946|NCT02778867|10054907|FG000|NOT COMPLETED|Phase 2||0
8991947|NCT02778867|10054908|FG001|NOT COMPLETED|Phase 2||0
8991948|NCT02778867|10054909|FG002|NOT COMPLETED|Phase 2||1
8991949|NCT02778867|10054910|FG003|NOT COMPLETED|Phase 2||2
8991950|NCT02778880|10054922|FG000|STARTED|Overall Study||45
8991951|NCT02778880|10054923|FG001|STARTED|Overall Study||45
8991952|NCT02778880|10054922|FG000|COMPLETED|Overall Study||44
8991953|NCT02778880|10054923|FG001|COMPLETED|Overall Study||42
8991954|NCT02778880|10054922|FG000|NOT COMPLETED|Overall Study||1
8991955|NCT02778880|10054923|FG001|NOT COMPLETED|Overall Study||3
8991956|NCT02778932|10054931|FG000|STARTED|Overall Study||74
8991957|NCT02778932|10054932|FG001|STARTED|Overall Study||74
8991958|NCT02778932|10054931|FG000|COMPLETED|Overall Study||74
8991959|NCT02778932|10054932|FG001|COMPLETED|Overall Study||74
8991960|NCT02778932|10054931|FG000|NOT COMPLETED|Overall Study||0
8991961|NCT02778932|10054932|FG001|NOT COMPLETED|Overall Study||0
8991962|NCT02779075|10054940|FG000|STARTED|Overall Study||16
8991963|NCT02779075|10054941|FG001|STARTED|Overall Study||13
8991964|NCT02779075|10054940|FG000|COMPLETED|Overall Study||14
8693638|NCT00867789|9739185|FG000|STARTED|Overall Study||70
8991965|NCT02779075|10054941|FG001|COMPLETED|Overall Study||10
8991966|NCT02779075|10054940|FG000|NOT COMPLETED|Overall Study||2
8991967|NCT02779075|10054941|FG001|NOT COMPLETED|Overall Study||3
8571960|NCT00112437|9604130|FG007|COMPLETED|Year 3 (12-Month Extension)||0
8571961|NCT00112437|9604131|FG008|COMPLETED|Year 3 (12-Month Extension)||0
8571962|NCT00112437|9604132|FG009|COMPLETED|Year 3 (12-Month Extension)||0
8571963|NCT00112437|9604133|FG010|COMPLETED|Year 3 (12-Month Extension)||17
8571964|NCT00112437|9604134|FG011|COMPLETED|Year 3 (12-Month Extension)||17
8571965|NCT00112437|9604135|FG012|COMPLETED|Year 3 (12-Month Extension)||18
8571966|NCT00112437|9604136|FG013|COMPLETED|Year 3 (12-Month Extension)||16
8571967|NCT00112437|9604137|FG014|COMPLETED|Year 3 (12-Month Extension)||17
8571968|NCT00112437|9604138|FG015|COMPLETED|Year 3 (12-Month Extension)||13
8571969|NCT00112437|9604139|FG016|COMPLETED|Year 3 (12-Month Extension)||16
8571970|NCT00112437|9604140|FG017|COMPLETED|Year 3 (12-Month Extension)||20
8571971|NCT00112437|9604141|FG018|COMPLETED|Year 3 (12-Month Extension)||16
8571972|NCT00112437|9604142|FG019|COMPLETED|Year 3 (12-Month Extension)||19
8571973|NCT00112437|9604143|FG020|COMPLETED|Year 3 (12-Month Extension)||0
8571974|NCT00112437|9604144|FG021|COMPLETED|Year 3 (12-Month Extension)||0
8991968|NCT02779166|10054949|FG000|STARTED|Overall Study||50
8991969|NCT02779166|10054950|FG001|STARTED|Overall Study||48
8991970|NCT02779166|10054949|FG000|COMPLETED|Overall Study||50
8991971|NCT02779166|10054950|FG001|COMPLETED|Overall Study||48
8991972|NCT02779166|10054949|FG000|NOT COMPLETED|Overall Study||0
8991973|NCT02779166|10054950|FG001|NOT COMPLETED|Overall Study||0
8991974|NCT02779491|10054960|FG000|STARTED|Overall Study||32
8991975|NCT02779491|10054961|FG001|STARTED|Overall Study||27
8991976|NCT02779491|10054962|FG002|STARTED|Overall Study||18
8991977|NCT02779491|10054963|FG003|STARTED|Overall Study||17
8991978|NCT02779491|10054960|FG000|COMPLETED|Overall Study||32
8991979|NCT02779491|10054961|FG001|COMPLETED|Overall Study||26
8991980|NCT02779491|10054962|FG002|COMPLETED|Overall Study||17
8991981|NCT02779491|10054963|FG003|COMPLETED|Overall Study||15
8991982|NCT02779491|10054960|FG000|NOT COMPLETED|Overall Study||0
8991983|NCT02779491|10054961|FG001|NOT COMPLETED|Overall Study||1
8991984|NCT02779491|10054962|FG002|NOT COMPLETED|Overall Study||1
8991985|NCT02779491|10054963|FG003|NOT COMPLETED|Overall Study||2
8991986|NCT02779543|10054975|FG000|STARTED|Overall Study||100
8991987|NCT02779543|10054976|FG001|STARTED|Overall Study||100
8571975|NCT00112437|9604145|FG022|COMPLETED|Year 3 (12-Month Extension)||0
8571976|NCT00112437|9604146|FG023|COMPLETED|Year 3 (12-Month Extension)||0
8571977|NCT00112437|9604147|FG024|COMPLETED|Year 3 (12-Month Extension)||0
8571978|NCT00112437|9604148|FG025|COMPLETED|Year 3 (12-Month Extension)||0
8571979|NCT00112437|9604123|FG000|NOT COMPLETED|Year 3 (12-Month Extension)||0
8571980|NCT00112437|9604124|FG001|NOT COMPLETED|Year 3 (12-Month Extension)||0
8571981|NCT00112437|9604125|FG002|NOT COMPLETED|Year 3 (12-Month Extension)||0
8571982|NCT00112437|9604126|FG003|NOT COMPLETED|Year 3 (12-Month Extension)||0
8571983|NCT00112437|9604127|FG004|NOT COMPLETED|Year 3 (12-Month Extension)||0
8571984|NCT00112437|9604128|FG005|NOT COMPLETED|Year 3 (12-Month Extension)||0
8571985|NCT00112437|9604129|FG006|NOT COMPLETED|Year 3 (12-Month Extension)||0
8571986|NCT00112437|9604130|FG007|NOT COMPLETED|Year 3 (12-Month Extension)||0
8571987|NCT00112437|9604131|FG008|NOT COMPLETED|Year 3 (12-Month Extension)||0
8571988|NCT00112437|9604132|FG009|NOT COMPLETED|Year 3 (12-Month Extension)||0
8571989|NCT00112437|9604133|FG010|NOT COMPLETED|Year 3 (12-Month Extension)||2
8571990|NCT00112437|9604134|FG011|NOT COMPLETED|Year 3 (12-Month Extension)||5
8571991|NCT00112437|9604135|FG012|NOT COMPLETED|Year 3 (12-Month Extension)||0
8571992|NCT00112437|9604136|FG013|NOT COMPLETED|Year 3 (12-Month Extension)||1
8571993|NCT00112437|9604137|FG014|NOT COMPLETED|Year 3 (12-Month Extension)||1
8571994|NCT00112437|9604138|FG015|NOT COMPLETED|Year 3 (12-Month Extension)||4
8571995|NCT00112437|9604139|FG016|NOT COMPLETED|Year 3 (12-Month Extension)||3
8571996|NCT00112437|9604140|FG017|NOT COMPLETED|Year 3 (12-Month Extension)||1
8571997|NCT00112437|9604141|FG018|NOT COMPLETED|Year 3 (12-Month Extension)||2
8571998|NCT00112437|9604142|FG019|NOT COMPLETED|Year 3 (12-Month Extension)||1
8571999|NCT00112437|9604143|FG020|NOT COMPLETED|Year 3 (12-Month Extension)||0
8572000|NCT00112437|9604144|FG021|NOT COMPLETED|Year 3 (12-Month Extension)||0
8572001|NCT00112437|9604145|FG022|NOT COMPLETED|Year 3 (12-Month Extension)||0
8572002|NCT00112437|9604146|FG023|NOT COMPLETED|Year 3 (12-Month Extension)||0
8572003|NCT00112437|9604147|FG024|NOT COMPLETED|Year 3 (12-Month Extension)||0
8572004|NCT00112437|9604148|FG025|NOT COMPLETED|Year 3 (12-Month Extension)||0
8572005|NCT00112437|9604123|FG000|STARTED|Years 4-5 (24-Month Extension)||0
8572006|NCT00112437|9604124|FG001|STARTED|Years 4-5 (24-Month Extension)||0
8572007|NCT00112437|9604125|FG002|STARTED|Years 4-5 (24-Month Extension)||0
8572008|NCT00112437|9604126|FG003|STARTED|Years 4-5 (24-Month Extension)||0
8572009|NCT00112437|9604127|FG004|STARTED|Years 4-5 (24-Month Extension)||0
8572010|NCT00112437|9604128|FG005|STARTED|Years 4-5 (24-Month Extension)||0
8572011|NCT00112437|9604129|FG006|STARTED|Years 4-5 (24-Month Extension)||0
8572012|NCT00112437|9604130|FG007|STARTED|Years 4-5 (24-Month Extension)||0
8572013|NCT00112437|9604131|FG008|STARTED|Years 4-5 (24-Month Extension)||0
8572014|NCT00112437|9604132|FG009|STARTED|Years 4-5 (24-Month Extension)||0
8572015|NCT00112437|9604133|FG010|STARTED|Years 4-5 (24-Month Extension)||0
8572016|NCT00112437|9604134|FG011|STARTED|Years 4-5 (24-Month Extension)||0
8572017|NCT00112437|9604135|FG012|STARTED|Years 4-5 (24-Month Extension)||0
8572018|NCT00112437|9604136|FG013|STARTED|Years 4-5 (24-Month Extension)||0
8572019|NCT00112437|9604137|FG014|STARTED|Years 4-5 (24-Month Extension)||0
8572020|NCT00112437|9604138|FG015|STARTED|Years 4-5 (24-Month Extension)||0
8572021|NCT00112437|9604139|FG016|STARTED|Years 4-5 (24-Month Extension)||0
8572022|NCT00112437|9604140|FG017|STARTED|Years 4-5 (24-Month Extension)||0
8572023|NCT00112437|9604141|FG018|STARTED|Years 4-5 (24-Month Extension)||0
8572024|NCT00112437|9604142|FG019|STARTED|Years 4-5 (24-Month Extension)||0
8572025|NCT00112437|9604143|FG020|STARTED|Years 4-5 (24-Month Extension)||41
8572026|NCT00112437|9604144|FG021|STARTED|Years 4-5 (24-Month Extension)||100
8991988|NCT02779543|10054975|FG000|COMPLETED|Overall Study||100
8991989|NCT02779543|10054976|FG001|COMPLETED|Overall Study||100
8991990|NCT02779543|10054975|FG000|NOT COMPLETED|Overall Study||0
8991991|NCT02779543|10054976|FG001|NOT COMPLETED|Overall Study||0
8991992|NCT02780115|10054988|FG000|STARTED|Overall Study||28
8991993|NCT02780115|10054989|FG001|STARTED|Overall Study||30
8991994|NCT02780115|10054990|FG002|STARTED|Overall Study||30
8991995|NCT02780115|10054991|FG003|STARTED|Overall Study||32
8991996|NCT02780115|10054992|FG004|STARTED|Overall Study||31
8991997|NCT02780115|10054988|FG000|COMPLETED|Overall Study||28
8991998|NCT02780115|10054989|FG001|COMPLETED|Overall Study||29
8991999|NCT02780115|10054990|FG002|COMPLETED|Overall Study||29
8992000|NCT02780115|10054991|FG003|COMPLETED|Overall Study||31
8992001|NCT02780115|10054992|FG004|COMPLETED|Overall Study||30
8992002|NCT02780115|10054988|FG000|NOT COMPLETED|Overall Study||0
8992003|NCT02780115|10054989|FG001|NOT COMPLETED|Overall Study||1
8992004|NCT02780115|10054990|FG002|NOT COMPLETED|Overall Study||1
8992005|NCT02780115|10054991|FG003|NOT COMPLETED|Overall Study||1
8992006|NCT02780115|10054992|FG004|NOT COMPLETED|Overall Study||1
8992007|NCT02780167|10055009|FG000|STARTED|Overall Study||56
8992008|NCT02780167|10055010|FG001|STARTED|Overall Study||49
8992009|NCT02780167|10055011|FG002|STARTED|Overall Study||51
8992010|NCT02780167|10055012|FG003|STARTED|Overall Study||56
8992011|NCT02780167|10055013|FG004|STARTED|Overall Study||55
8992012|NCT02780167|10055009|FG000|COMPLETED|Overall Study||28
8992013|NCT02780167|10055010|FG001|COMPLETED|Overall Study||27
8992014|NCT02780167|10055011|FG002|COMPLETED|Overall Study||27
8992015|NCT02780167|10055012|FG003|COMPLETED|Overall Study||37
8992016|NCT02780167|10055013|FG004|COMPLETED|Overall Study||38
8992017|NCT02780167|10055009|FG000|NOT COMPLETED|Overall Study||28
8992018|NCT02780167|10055010|FG001|NOT COMPLETED|Overall Study||22
8992019|NCT02780167|10055011|FG002|NOT COMPLETED|Overall Study||24
8992020|NCT02780167|10055012|FG003|NOT COMPLETED|Overall Study||19
8992021|NCT02780167|10055013|FG004|NOT COMPLETED|Overall Study||17
8992022|NCT02780349|10055025|FG000|STARTED|Overall Study||103
8992023|NCT02780349|10055025|FG000|COMPLETED|Overall Study||101
8992024|NCT02780349|10055025|FG000|NOT COMPLETED|Overall Study||2
8992025|NCT02780388|10055034|FG000|STARTED|Overall Study||15
8992026|NCT02780388|10055035|FG001|STARTED|Overall Study||8
8992027|NCT02780388|10055036|FG002|STARTED|Overall Study||10
8992028|NCT02780388|10055037|FG003|STARTED|Overall Study||12
8992029|NCT02780388|10055038|FG004|STARTED|Overall Study||12
8992030|NCT02780388|10055034|FG000|COMPLETED|Overall Study||14
8992031|NCT02780388|10055035|FG001|COMPLETED|Overall Study||6
8992032|NCT02780388|10055036|FG002|COMPLETED|Overall Study||10
8992033|NCT02780388|10055037|FG003|COMPLETED|Overall Study||12
8992034|NCT02780388|10055038|FG004|COMPLETED|Overall Study||12
8992035|NCT02780388|10055034|FG000|NOT COMPLETED|Overall Study||1
8992036|NCT02780388|10055035|FG001|NOT COMPLETED|Overall Study||2
8992037|NCT02780388|10055036|FG002|NOT COMPLETED|Overall Study||0
8992038|NCT02780388|10055037|FG003|NOT COMPLETED|Overall Study||0
8992039|NCT02780388|10055038|FG004|NOT COMPLETED|Overall Study||0
8992040|NCT02780622|10055054|FG000|STARTED|Treatment Period 1||10
8992041|NCT02780622|10055055|FG001|STARTED|Treatment Period 1||10
8992042|NCT02780622|10055054|FG000|COMPLETED|Treatment Period 1||10
8992043|NCT02780622|10055055|FG001|COMPLETED|Treatment Period 1||10
8633523|NCT00551421|9673625|FG000|COMPLETED|Original Protocol, Dose Level 1|1 subject developed Grade 3 diarrhea, all 3 subjects experienced significant skin toxicity.|3
8633524|NCT00551421|9673625|FG000|NOT COMPLETED|Original Protocol, Dose Level 1||0
8992044|NCT02780622|10055054|FG000|NOT COMPLETED|Treatment Period 1||0
8992045|NCT02780622|10055055|FG001|NOT COMPLETED|Treatment Period 1||0
8992046|NCT02780622|10055054|FG000|STARTED|Treatment Period 2||10
8992047|NCT02780622|10055055|FG001|STARTED|Treatment Period 2||10
8992048|NCT02780622|10055054|FG000|COMPLETED|Treatment Period 2||10
8992049|NCT02780622|10055055|FG001|COMPLETED|Treatment Period 2||10
8992050|NCT02780622|10055054|FG000|NOT COMPLETED|Treatment Period 2||0
8992051|NCT02780622|10055055|FG001|NOT COMPLETED|Treatment Period 2||0
8992052|NCT02780661|10055062|FG000|STARTED|Period 1||10
8992053|NCT02780661|10055063|FG001|STARTED|Period 1||9
8992054|NCT02780661|10055062|FG000|COMPLETED|Period 1||10
8992055|NCT02780661|10055063|FG001|COMPLETED|Period 1||9
8992056|NCT02780661|10055062|FG000|NOT COMPLETED|Period 1||0
8992057|NCT02780661|10055063|FG001|NOT COMPLETED|Period 1||0
8992058|NCT02780661|10055062|FG000|STARTED|Wash Out Period||10
8992059|NCT02780661|10055063|FG001|STARTED|Wash Out Period||9
8992060|NCT02780661|10055062|FG000|COMPLETED|Wash Out Period||10
8992061|NCT02780661|10055063|FG001|COMPLETED|Wash Out Period||9
8992062|NCT02780661|10055062|FG000|NOT COMPLETED|Wash Out Period||0
8992063|NCT02780661|10055063|FG001|NOT COMPLETED|Wash Out Period||0
8992064|NCT02780661|10055062|FG000|STARTED|Period 2||10
8992065|NCT02780661|10055063|FG001|STARTED|Period 2||9
8992066|NCT02780661|10055062|FG000|COMPLETED|Period 2||10
8992067|NCT02780661|10055063|FG001|COMPLETED|Period 2||9
8992068|NCT02780661|10055062|FG000|NOT COMPLETED|Period 2||0
8992069|NCT02780661|10055063|FG001|NOT COMPLETED|Period 2||0
8992070|NCT02780687|10055072|FG000|STARTED|Overall Study||34
8992071|NCT02780687|10055073|FG001|STARTED|Overall Study||8
8992072|NCT02780687|10055072|FG000|COMPLETED|Overall Study||0
8992073|NCT02780687|10055073|FG001|COMPLETED|Overall Study||0
8992074|NCT02780687|10055072|FG000|NOT COMPLETED|Overall Study||34
8992075|NCT02780687|10055073|FG001|NOT COMPLETED|Overall Study||8
8992076|NCT02780700|10055078|FG000|STARTED|Overall Study||1
8992077|NCT02780700|10055078|FG000|COMPLETED|Overall Study||0
8992078|NCT02780700|10055078|FG000|NOT COMPLETED|Overall Study||1
9039183|NCT03335254|10100132|FG010|NOT COMPLETED|Period 3, Day 16-25||0
8992079|NCT02780713|10055082|FG000|STARTED|Period 1: Variant A (100mg)|After washout period participants entered Treatment Period 2.|14
8992080|NCT02780713|10055083|FG001|STARTED|Period 1: Variant A (100mg)|After washout period participants entered Treatment Period 3.|0
8992081|NCT02780713|10055084|FG002|STARTED|Period 1: Variant A (100mg)|After washout period participants entered Treatment Period 4.|0
8992082|NCT02780713|10055085|FG003|STARTED|Period 1: Variant A (100mg)|After washout period participants entered Treatment Period 5.|0
8992083|NCT02780713|10055086|FG004|STARTED|Period 1: Variant A (100mg)||0
8992084|NCT02780713|10055082|FG000|COMPLETED|Period 1: Variant A (100mg)||14
8992085|NCT02780713|10055083|FG001|COMPLETED|Period 1: Variant A (100mg)||0
8992086|NCT02780713|10055084|FG002|COMPLETED|Period 1: Variant A (100mg)||0
8992087|NCT02780713|10055085|FG003|COMPLETED|Period 1: Variant A (100mg)||0
8992088|NCT02780713|10055086|FG004|COMPLETED|Period 1: Variant A (100mg)||0
8992089|NCT02780713|10055082|FG000|NOT COMPLETED|Period 1: Variant A (100mg)||0
8992090|NCT02780713|10055083|FG001|NOT COMPLETED|Period 1: Variant A (100mg)||0
8992091|NCT02780713|10055084|FG002|NOT COMPLETED|Period 1: Variant A (100mg)||0
8992092|NCT02780713|10055085|FG003|NOT COMPLETED|Period 1: Variant A (100mg)||0
8992093|NCT02780713|10055086|FG004|NOT COMPLETED|Period 1: Variant A (100mg)||0
8992094|NCT02780713|10055082|FG000|STARTED|Period 2: Reference (100mg)||0
8992095|NCT02780713|10055083|FG001|STARTED|Period 2: Reference (100mg)||14
8992096|NCT02780713|10055084|FG002|STARTED|Period 2: Reference (100mg)||0
8992097|NCT02780713|10055085|FG003|STARTED|Period 2: Reference (100mg)||0
8992098|NCT02780713|10055086|FG004|STARTED|Period 2: Reference (100mg)||0
8992099|NCT02780713|10055082|FG000|COMPLETED|Period 2: Reference (100mg)||0
8992100|NCT02780713|10055083|FG001|COMPLETED|Period 2: Reference (100mg)||14
8992101|NCT02780713|10055084|FG002|COMPLETED|Period 2: Reference (100mg)||0
8992102|NCT02780713|10055085|FG003|COMPLETED|Period 2: Reference (100mg)||0
8992103|NCT02780713|10055086|FG004|COMPLETED|Period 2: Reference (100mg)||0
8992104|NCT02780713|10055082|FG000|NOT COMPLETED|Period 2: Reference (100mg)||0
8992105|NCT02780713|10055083|FG001|NOT COMPLETED|Period 2: Reference (100mg)||0
8992106|NCT02780713|10055084|FG002|NOT COMPLETED|Period 2: Reference (100mg)||0
8992107|NCT02780713|10055085|FG003|NOT COMPLETED|Period 2: Reference (100mg)||0
8992108|NCT02780713|10055086|FG004|NOT COMPLETED|Period 2: Reference (100mg)||0
8992109|NCT02780713|10055082|FG000|STARTED|Period 3: Variant B (100mg)||0
8992110|NCT02780713|10055083|FG001|STARTED|Period 3: Variant B (100mg)||0
8992111|NCT02780713|10055084|FG002|STARTED|Period 3: Variant B (100mg)||14
8992112|NCT02780713|10055085|FG003|STARTED|Period 3: Variant B (100mg)||0
8992113|NCT02780713|10055086|FG004|STARTED|Period 3: Variant B (100mg)||0
8992114|NCT02780713|10055082|FG000|COMPLETED|Period 3: Variant B (100mg)||0
8992115|NCT02780713|10055083|FG001|COMPLETED|Period 3: Variant B (100mg)||0
8992116|NCT02780713|10055084|FG002|COMPLETED|Period 3: Variant B (100mg)||12
8992117|NCT02780713|10055085|FG003|COMPLETED|Period 3: Variant B (100mg)||0
8992118|NCT02780713|10055086|FG004|COMPLETED|Period 3: Variant B (100mg)||0
8992119|NCT02780713|10055082|FG000|NOT COMPLETED|Period 3: Variant B (100mg)||0
8992120|NCT02780713|10055083|FG001|NOT COMPLETED|Period 3: Variant B (100mg)||0
8992121|NCT02780713|10055084|FG002|NOT COMPLETED|Period 3: Variant B (100mg)||2
8992122|NCT02780713|10055085|FG003|NOT COMPLETED|Period 3: Variant B (100mg)||0
8992123|NCT02780713|10055086|FG004|NOT COMPLETED|Period 3: Variant B (100mg)||0
8992124|NCT02780713|10055082|FG000|STARTED|Period 4: Variant C (100mg)||0
8992125|NCT02780713|10055083|FG001|STARTED|Period 4: Variant C (100mg)||0
8992126|NCT02780713|10055084|FG002|STARTED|Period 4: Variant C (100mg)||0
8992127|NCT02780713|10055085|FG003|STARTED|Period 4: Variant C (100mg)||12
8992128|NCT02780713|10055086|FG004|STARTED|Period 4: Variant C (100mg)||0
8992129|NCT02780713|10055082|FG000|COMPLETED|Period 4: Variant C (100mg)||0
8992130|NCT02780713|10055083|FG001|COMPLETED|Period 4: Variant C (100mg)||0
8992131|NCT02780713|10055084|FG002|COMPLETED|Period 4: Variant C (100mg)||0
8992132|NCT02780713|10055085|FG003|COMPLETED|Period 4: Variant C (100mg)||12
8992133|NCT02780713|10055086|FG004|COMPLETED|Period 4: Variant C (100mg)||0
8992134|NCT02780713|10055082|FG000|NOT COMPLETED|Period 4: Variant C (100mg)||0
8992135|NCT02780713|10055083|FG001|NOT COMPLETED|Period 4: Variant C (100mg)||0
8992136|NCT02780713|10055084|FG002|NOT COMPLETED|Period 4: Variant C (100mg)||0
8992137|NCT02780713|10055085|FG003|NOT COMPLETED|Period 4: Variant C (100mg)||0
8992138|NCT02780713|10055086|FG004|NOT COMPLETED|Period 4: Variant C (100mg)||0
8992139|NCT02780713|10055082|FG000|STARTED|Period 5: Variant B (300mg)||0
8992140|NCT02780713|10055083|FG001|STARTED|Period 5: Variant B (300mg)||0
8992141|NCT02780713|10055084|FG002|STARTED|Period 5: Variant B (300mg)||0
8992142|NCT02780713|10055085|FG003|STARTED|Period 5: Variant B (300mg)||0
8992143|NCT02780713|10055086|FG004|STARTED|Period 5: Variant B (300mg)||12
8992144|NCT02780713|10055082|FG000|COMPLETED|Period 5: Variant B (300mg)||0
8992145|NCT02780713|10055083|FG001|COMPLETED|Period 5: Variant B (300mg)||0
8992146|NCT02780713|10055084|FG002|COMPLETED|Period 5: Variant B (300mg)||0
8992147|NCT02780713|10055085|FG003|COMPLETED|Period 5: Variant B (300mg)||0
8992148|NCT02780713|10055086|FG004|COMPLETED|Period 5: Variant B (300mg)||12
8992149|NCT02780713|10055082|FG000|NOT COMPLETED|Period 5: Variant B (300mg)||0
8992150|NCT02780713|10055083|FG001|NOT COMPLETED|Period 5: Variant B (300mg)||0
8992151|NCT02780713|10055084|FG002|NOT COMPLETED|Period 5: Variant B (300mg)||0
8992152|NCT02780713|10055085|FG003|NOT COMPLETED|Period 5: Variant B (300mg)||0
8992153|NCT02780713|10055086|FG004|NOT COMPLETED|Period 5: Variant B (300mg)||0
8992154|NCT02780765|10055107|FG000|STARTED|Overall Study||30
8992155|NCT02780765|10055108|FG001|STARTED|Overall Study||30
8992156|NCT02780765|10055107|FG000|COMPLETED|Overall Study||30
8992157|NCT02780765|10055108|FG001|COMPLETED|Overall Study||30
8992158|NCT02780765|10055107|FG000|NOT COMPLETED|Overall Study||0
8992159|NCT02780765|10055108|FG001|NOT COMPLETED|Overall Study||0
8992160|NCT02780856|10055114|FG000|STARTED|Overall Study||110
8992161|NCT02780856|10055114|FG000|COMPLETED|Overall Study||109
8992162|NCT02780856|10055114|FG000|NOT COMPLETED|Overall Study||1
8992163|NCT02780869|10055123|FG000|STARTED|Overall Study||175
8992164|NCT02780869|10055124|FG001|STARTED|Overall Study||83
8992165|NCT02780869|10055123|FG000|COMPLETED|Overall Study||162
8992166|NCT02780869|10055124|FG001|COMPLETED|Overall Study||74
8992167|NCT02780869|10055123|FG000|NOT COMPLETED|Overall Study||13
8992168|NCT02780869|10055124|FG001|NOT COMPLETED|Overall Study||9
8992169|NCT02781051|10055130|FG000|STARTED|Overall Study||16
8992170|NCT02781051|10055130|FG000|COMPLETED|Overall Study||14
8992171|NCT02781051|10055130|FG000|NOT COMPLETED|Overall Study||2
8992172|NCT02781311|10055138|FG000|STARTED|Overall Study||74
8992173|NCT02781311|10055139|FG001|STARTED|Overall Study||83
8992174|NCT02781311|10055140|FG002|STARTED|Overall Study||12
8992175|NCT02781311|10055138|FG000|Safety Population (Treated)|Overall Study||73
8992176|NCT02781311|10055139|FG001|Safety Population (Treated)|Overall Study||81
8992177|NCT02781311|10055140|FG002|Safety Population (Treated)|Overall Study||12
8992178|NCT02781311|10055138|FG000|mITT Population|Overall Study||70
8992179|NCT02781311|10055139|FG001|mITT Population|Overall Study||78
8992180|NCT02781311|10055140|FG002|mITT Population|Overall Study||11
8992181|NCT02781311|10055138|FG000|COMPLETED|Overall Study||48
8992182|NCT02781311|10055139|FG001|COMPLETED|Overall Study||57
8992183|NCT02781311|10055140|FG002|COMPLETED|Overall Study||8
8992184|NCT02781311|10055138|FG000|NOT COMPLETED|Overall Study||26
8992185|NCT02781311|10055139|FG001|NOT COMPLETED|Overall Study||26
8992186|NCT02781311|10055140|FG002|NOT COMPLETED|Overall Study||4
8992187|NCT02781324|10055149|FG000|STARTED|Overall Study||33
8992188|NCT02781324|10055150|FG001|STARTED|Overall Study||33
8992189|NCT02781324|10055149|FG000|COMPLETED|Overall Study||31
8992190|NCT02781324|10055150|FG001|COMPLETED|Overall Study||31
8992191|NCT02781324|10055149|FG000|NOT COMPLETED|Overall Study||2
8992192|NCT02781324|10055150|FG001|NOT COMPLETED|Overall Study||2
8992193|NCT02781454|10055161|FG000|STARTED|Overall Study||8
8572027|NCT00112437|9604145|FG022|STARTED|Years 4-5 (24-Month Extension)||0
8572028|NCT00112437|9604146|FG023|STARTED|Years 4-5 (24-Month Extension)||0
8572029|NCT00112437|9604147|FG024|STARTED|Years 4-5 (24-Month Extension)||0
8572030|NCT00112437|9604148|FG025|STARTED|Years 4-5 (24-Month Extension)||0
8572031|NCT00112437|9604123|FG000|COMPLETED|Years 4-5 (24-Month Extension)||0
8572032|NCT00112437|9604124|FG001|COMPLETED|Years 4-5 (24-Month Extension)||0
8572033|NCT00112437|9604125|FG002|COMPLETED|Years 4-5 (24-Month Extension)||0
8572034|NCT00112437|9604126|FG003|COMPLETED|Years 4-5 (24-Month Extension)||0
8572035|NCT00112437|9604127|FG004|COMPLETED|Years 4-5 (24-Month Extension)||0
8572036|NCT00112437|9604128|FG005|COMPLETED|Years 4-5 (24-Month Extension)||0
8572037|NCT00112437|9604129|FG006|COMPLETED|Years 4-5 (24-Month Extension)||0
8572038|NCT00112437|9604130|FG007|COMPLETED|Years 4-5 (24-Month Extension)||0
8572039|NCT00112437|9604131|FG008|COMPLETED|Years 4-5 (24-Month Extension)||0
8572040|NCT00112437|9604132|FG009|COMPLETED|Years 4-5 (24-Month Extension)||0
8879091|NCT01931995|9935944|FG001|NOT COMPLETED|First Intervention (1 Day)||4
8879092|NCT01931995|9935943|FG000|STARTED|Washout (at Least 6 Days)||19
8879093|NCT01931995|9935944|FG001|STARTED|Washout (at Least 6 Days)||18
8879094|NCT01931995|9935943|FG000|COMPLETED|Washout (at Least 6 Days)||19
8879095|NCT01931995|9935944|FG001|COMPLETED|Washout (at Least 6 Days)||18
8879096|NCT01931995|9935943|FG000|NOT COMPLETED|Washout (at Least 6 Days)||0
8879097|NCT01931995|9935944|FG001|NOT COMPLETED|Washout (at Least 6 Days)||0
8879098|NCT01931995|9935943|FG000|STARTED|Second Intervention (1 Day)||18
8879099|NCT01931995|9935944|FG001|STARTED|Second Intervention (1 Day)||19
8879100|NCT01931995|9935943|FG000|COMPLETED|Second Intervention (1 Day)||18
8879101|NCT01931995|9935944|FG001|COMPLETED|Second Intervention (1 Day)||19
8879102|NCT01931995|9935943|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
8879103|NCT01931995|9935944|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
8879104|NCT01932060|9935952|FG000|STARTED|Overall Study||27
8879105|NCT01932060|9935953|FG001|STARTED|Overall Study||24
8879106|NCT01932060|9935952|FG000|COMPLETED|Overall Study||27
8879107|NCT01932060|9935953|FG001|COMPLETED|Overall Study||24
8879108|NCT01932060|9935952|FG000|NOT COMPLETED|Overall Study||0
8879109|NCT01932060|9935953|FG001|NOT COMPLETED|Overall Study||0
8879110|NCT01932112|9935959|FG000|STARTED|Overall Study||378
8879111|NCT01932112|9935959|FG000|COMPLETED|Overall Study||378
8879112|NCT01932112|9935959|FG000|NOT COMPLETED|Overall Study||0
8879113|NCT01932164|9935963|FG000|STARTED|Overall Study|It was performed the selection of 5 patients to participate of these study (08/2013)|5
8879114|NCT01932164|9935963|FG000|Cleft Lip and Palate|Overall Study|It was performed de extraction of deciduous teeth of 5 cleft lip/palate patients (09/2013)|5
8879115|NCT01932164|9935963|FG000|Cleft Lip and Palate|Overall Study|Dental pulp was obtained from teeth of 5 different patients (09/2013)|5
8879116|NCT01932164|9935963|FG000|Cleft Lip and Palate|Overall Study|Mesenchymal stem cell obtained from dental pulp of 5patients was obtained, caractherized and frozen|5
8879117|NCT01932164|9935963|FG000|Cleft Lip and Palate|Overall Study|Alveolar bone graft surgeries were did using their dental pulp stem cells with biomaterial|5
8879118|NCT01932164|9935963|FG000|Cleft Lip and Palate|Overall Study|The surgeries were performed between december 2013 and june 2014.|5
8992194|NCT02781454|10055162|FG001|STARTED|Overall Study||6
8992195|NCT02781454|10055163|FG002|STARTED|Overall Study||6
8992196|NCT02781454|10055161|FG000|COMPLETED|Overall Study||8
8992197|NCT02781454|10055162|FG001|COMPLETED|Overall Study||6
8992198|NCT02781454|10055163|FG002|COMPLETED|Overall Study||5
8992199|NCT02781454|10055161|FG000|NOT COMPLETED|Overall Study||0
8992200|NCT02781454|10055162|FG001|NOT COMPLETED|Overall Study||0
8992201|NCT02781454|10055163|FG002|NOT COMPLETED|Overall Study||1
8992202|NCT02781480|10055174|FG000|STARTED|Overall Study||9
8992203|NCT02781480|10055175|FG001|STARTED|Overall Study||3
8992204|NCT02781480|10055176|FG002|STARTED|Overall Study||3
8992205|NCT02781480|10055174|FG000|COMPLETED|Overall Study||9
8992206|NCT02781480|10055175|FG001|COMPLETED|Overall Study||3
8992207|NCT02781480|10055176|FG002|COMPLETED|Overall Study||3
8992208|NCT02781480|10055174|FG000|NOT COMPLETED|Overall Study||0
8992209|NCT02781480|10055175|FG001|NOT COMPLETED|Overall Study||0
8992210|NCT02781480|10055176|FG002|NOT COMPLETED|Overall Study||0
8992211|NCT02781558|10055186|FG000|STARTED|Overall Study||101
8992212|NCT02781558|10055187|FG001|STARTED|Overall Study||103
8992213|NCT02781558|10055186|FG000|COMPLETED|Overall Study||98
8992214|NCT02781558|10055187|FG001|COMPLETED|Overall Study||101
8992215|NCT02781558|10055186|FG000|NOT COMPLETED|Overall Study||3
8992216|NCT02781558|10055187|FG001|NOT COMPLETED|Overall Study||2
8992217|NCT02781571|10055194|FG000|STARTED|Overall Study||79
8992218|NCT02781571|10055194|FG000|COMPLETED|Overall Study||79
8992219|NCT02781571|10055194|FG000|NOT COMPLETED|Overall Study||0
8992220|NCT02781610|10055202|FG000|STARTED|Overall Study||140
8992221|NCT02781610|10055203|FG001|STARTED|Overall Study||137
8992222|NCT02781610|10055204|FG002|STARTED|Overall Study||353
8992223|NCT02781610|10055205|FG003|STARTED|Overall Study||352
8992224|NCT02781610|10055202|FG000|COMPLETED|Overall Study||134
8992225|NCT02781610|10055203|FG001|COMPLETED|Overall Study||130
8992226|NCT02781610|10055204|FG002|COMPLETED|Overall Study||336
8992227|NCT02781610|10055205|FG003|COMPLETED|Overall Study||323
8992228|NCT02781610|10055202|FG000|NOT COMPLETED|Overall Study||6
8992229|NCT02781610|10055203|FG001|NOT COMPLETED|Overall Study||7
8992230|NCT02781610|10055204|FG002|NOT COMPLETED|Overall Study||17
8992231|NCT02781610|10055205|FG003|NOT COMPLETED|Overall Study||29
8992232|NCT02781649|10055218|FG000|STARTED|Overall Study|4 in this group had insufficient viral RNA for genotyping. They were treated as 1a|7
8992233|NCT02781649|10055219|FG001|STARTED|Overall Study||0
8992234|NCT02781649|10055220|FG002|STARTED|Overall Study||3
8992235|NCT02781649|10055218|FG000|COMPLETED|Overall Study||7
8992236|NCT02781649|10055219|FG001|COMPLETED|Overall Study||0
8992237|NCT02781649|10055220|FG002|COMPLETED|Overall Study||3
8992238|NCT02781649|10055218|FG000|NOT COMPLETED|Overall Study||0
8992239|NCT02781649|10055219|FG001|NOT COMPLETED|Overall Study||0
8992240|NCT02781649|10055220|FG002|NOT COMPLETED|Overall Study||0
8992241|NCT02781818|10055231|FG000|STARTED|Overall Study||20
8992242|NCT02781818|10055232|FG001|STARTED|Overall Study||18
8992243|NCT02781818|10055233|FG002|STARTED|Overall Study||17
8992244|NCT02781818|10055231|FG000|COMPLETED|Overall Study||16
8992245|NCT02781818|10055232|FG001|COMPLETED|Overall Study||16
8992246|NCT02781818|10055233|FG002|COMPLETED|Overall Study||16
8992247|NCT02781818|10055231|FG000|NOT COMPLETED|Overall Study||4
8992248|NCT02781818|10055232|FG001|NOT COMPLETED|Overall Study||2
8992249|NCT02781818|10055233|FG002|NOT COMPLETED|Overall Study||1
8992250|NCT02781844|10055245|FG000|STARTED|Treatment Period 1||5
8992251|NCT02781844|10055246|FG001|STARTED|Treatment Period 1||4
8992252|NCT02781844|10055247|FG002|STARTED|Treatment Period 1||4
8992253|NCT02781844|10055248|FG003|STARTED|Treatment Period 1||4
8992254|NCT02781844|10055249|FG004|STARTED|Treatment Period 1||4
8992255|NCT02781844|10055250|FG005|STARTED|Treatment Period 1||5
8992256|NCT02781844|10055251|FG006|STARTED|Treatment Period 1||4
8992257|NCT02781844|10055252|FG007|STARTED|Treatment Period 1||4
8992258|NCT02781844|10055245|FG000|COMPLETED|Treatment Period 1||5
8992259|NCT02781844|10055246|FG001|COMPLETED|Treatment Period 1||4
8992260|NCT02781844|10055247|FG002|COMPLETED|Treatment Period 1||4
8992261|NCT02781844|10055248|FG003|COMPLETED|Treatment Period 1||4
8992262|NCT02781844|10055249|FG004|COMPLETED|Treatment Period 1||4
8992263|NCT02781844|10055250|FG005|COMPLETED|Treatment Period 1||4
8633525|NCT00551421|9673625|FG000|STARTED|Amended Protocol (Cetuximab-refr. mCRC)||14
8633526|NCT00551421|9673625|FG000|COMPLETED|Amended Protocol (Cetuximab-refr. mCRC)||13
8633527|NCT00551421|9673625|FG000|NOT COMPLETED|Amended Protocol (Cetuximab-refr. mCRC)||1
8633528|NCT00551460|9673630|FG000|STARTED|Overall Study||78
8992264|NCT02781844|10055251|FG006|COMPLETED|Treatment Period 1||4
8992265|NCT02781844|10055252|FG007|COMPLETED|Treatment Period 1||4
8992266|NCT02781844|10055245|FG000|NOT COMPLETED|Treatment Period 1||0
8992267|NCT02781844|10055246|FG001|NOT COMPLETED|Treatment Period 1||0
8992268|NCT02781844|10055247|FG002|NOT COMPLETED|Treatment Period 1||0
8992269|NCT02781844|10055248|FG003|NOT COMPLETED|Treatment Period 1||0
8633529|NCT00551460|9673630|FG000|COMPLETED|Overall Study||60
8992270|NCT02781844|10055249|FG004|NOT COMPLETED|Treatment Period 1||0
8992271|NCT02781844|10055250|FG005|NOT COMPLETED|Treatment Period 1||1
8992272|NCT02781844|10055251|FG006|NOT COMPLETED|Treatment Period 1||0
8992273|NCT02781844|10055252|FG007|NOT COMPLETED|Treatment Period 1||0
8992274|NCT02781844|10055245|FG000|STARTED|Treatment Period 2||5
8992275|NCT02781844|10055246|FG001|STARTED|Treatment Period 2||4
8633530|NCT00551460|9673630|FG000|NOT COMPLETED|Overall Study||18
8992276|NCT02781844|10055247|FG002|STARTED|Treatment Period 2||4
8992277|NCT02781844|10055248|FG003|STARTED|Treatment Period 2||4
8992278|NCT02781844|10055249|FG004|STARTED|Treatment Period 2||4
8992279|NCT02781844|10055250|FG005|STARTED|Treatment Period 2||4
8992280|NCT02781844|10055251|FG006|STARTED|Treatment Period 2||4
8992281|NCT02781844|10055252|FG007|STARTED|Treatment Period 2||4
8992282|NCT02781844|10055245|FG000|COMPLETED|Treatment Period 2||5
8992283|NCT02781844|10055246|FG001|COMPLETED|Treatment Period 2||4
8992284|NCT02781844|10055247|FG002|COMPLETED|Treatment Period 2||4
8992285|NCT02781844|10055248|FG003|COMPLETED|Treatment Period 2||4
8992286|NCT02781844|10055249|FG004|COMPLETED|Treatment Period 2||4
8992287|NCT02781844|10055250|FG005|COMPLETED|Treatment Period 2||4
8992288|NCT02781844|10055251|FG006|COMPLETED|Treatment Period 2||4
8992289|NCT02781844|10055252|FG007|COMPLETED|Treatment Period 2||4
8992290|NCT02781844|10055245|FG000|NOT COMPLETED|Treatment Period 2||0
8572041|NCT00112437|9604133|FG010|COMPLETED|Years 4-5 (24-Month Extension)||0
8572042|NCT00112437|9604134|FG011|COMPLETED|Years 4-5 (24-Month Extension)||0
8572043|NCT00112437|9604135|FG012|COMPLETED|Years 4-5 (24-Month Extension)||0
8572044|NCT00112437|9604136|FG013|COMPLETED|Years 4-5 (24-Month Extension)||0
8572045|NCT00112437|9604137|FG014|COMPLETED|Years 4-5 (24-Month Extension)||0
8572046|NCT00112437|9604138|FG015|COMPLETED|Years 4-5 (24-Month Extension)||0
8572047|NCT00112437|9604139|FG016|COMPLETED|Years 4-5 (24-Month Extension)||0
8572048|NCT00112437|9604140|FG017|COMPLETED|Years 4-5 (24-Month Extension)||0
8572049|NCT00112437|9604141|FG018|COMPLETED|Years 4-5 (24-Month Extension)||0
8572050|NCT00112437|9604142|FG019|COMPLETED|Years 4-5 (24-Month Extension)||0
8572051|NCT00112437|9604143|FG020|COMPLETED|Years 4-5 (24-Month Extension)||37
8572052|NCT00112437|9604144|FG021|COMPLETED|Years 4-5 (24-Month Extension)||92
8572053|NCT00112437|9604145|FG022|COMPLETED|Years 4-5 (24-Month Extension)||0
8572054|NCT00112437|9604146|FG023|COMPLETED|Years 4-5 (24-Month Extension)||0
8572055|NCT00112437|9604147|FG024|COMPLETED|Years 4-5 (24-Month Extension)||0
8572056|NCT00112437|9604148|FG025|COMPLETED|Years 4-5 (24-Month Extension)||0
8572057|NCT00112437|9604123|FG000|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
8572058|NCT00112437|9604124|FG001|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
8572059|NCT00112437|9604125|FG002|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
8572060|NCT00112437|9604126|FG003|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
8572061|NCT00112437|9604127|FG004|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
8572062|NCT00112437|9604128|FG005|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
8572063|NCT00112437|9604129|FG006|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
8572064|NCT00112437|9604130|FG007|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
8572065|NCT00112437|9604131|FG008|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
8572066|NCT00112437|9604132|FG009|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
8572067|NCT00112437|9604133|FG010|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
8572068|NCT00112437|9604134|FG011|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
8572069|NCT00112437|9604135|FG012|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
8572070|NCT00112437|9604136|FG013|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
8572071|NCT00112437|9604137|FG014|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
8572072|NCT00112437|9604138|FG015|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
8572073|NCT00112437|9604139|FG016|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
8572074|NCT00112437|9604140|FG017|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
8572075|NCT00112437|9604141|FG018|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
8572076|NCT00112437|9604142|FG019|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
8572077|NCT00112437|9604143|FG020|NOT COMPLETED|Years 4-5 (24-Month Extension)||4
8572078|NCT00112437|9604144|FG021|NOT COMPLETED|Years 4-5 (24-Month Extension)||8
8572079|NCT00112437|9604145|FG022|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
8806549|NCT01478256|9858776|FG000|NOT COMPLETED|Overall Study||0
8992291|NCT02781844|10055246|FG001|NOT COMPLETED|Treatment Period 2||0
8992292|NCT02781844|10055247|FG002|NOT COMPLETED|Treatment Period 2||0
8992293|NCT02781844|10055248|FG003|NOT COMPLETED|Treatment Period 2||0
8992294|NCT02781844|10055249|FG004|NOT COMPLETED|Treatment Period 2||0
8572080|NCT00112437|9604146|FG023|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
8572081|NCT00112437|9604147|FG024|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
8572082|NCT00112437|9604148|FG025|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
8992295|NCT02781844|10055250|FG005|NOT COMPLETED|Treatment Period 2||0
8992296|NCT02781844|10055251|FG006|NOT COMPLETED|Treatment Period 2||0
8992297|NCT02781844|10055252|FG007|NOT COMPLETED|Treatment Period 2||0
8992298|NCT02782065|10055268|FG000|STARTED|Overall Study||58
8992299|NCT02782065|10055268|FG000|COMPLETED|Overall Study||58
8992300|NCT02782065|10055268|FG000|NOT COMPLETED|Overall Study||0
8992301|NCT02782169|10055275|FG000|STARTED|Overall Study||56
8992302|NCT02782169|10055276|FG001|STARTED|Overall Study||54
8992303|NCT02782169|10055275|FG000|COMPLETED|Overall Study||55
8992304|NCT02782169|10055276|FG001|COMPLETED|Overall Study||52
8992305|NCT02782169|10055275|FG000|NOT COMPLETED|Overall Study||1
8992306|NCT02782169|10055276|FG001|NOT COMPLETED|Overall Study||2
8992307|NCT02782325|10055284|FG000|STARTED|Blinded FMT Treatment (up to 24 Weeks)||4
8992308|NCT02782325|10055285|FG001|STARTED|Blinded FMT Treatment (up to 24 Weeks)||2
8992309|NCT02782325|10055286|FG002|STARTED|Blinded FMT Treatment (up to 24 Weeks)||0
8992310|NCT02782325|10055284|FG000|COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||0
8992311|NCT02782325|10055285|FG001|COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||0
8992312|NCT02782325|10055286|FG002|COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||0
8992313|NCT02782325|10055284|FG000|NOT COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||4
8992314|NCT02782325|10055285|FG001|NOT COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||2
8992315|NCT02782325|10055286|FG002|NOT COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||0
8992316|NCT02782325|10055284|FG000|STARTED|Open Label FMT Period (up to 24 Weeks)||0
8992317|NCT02782325|10055285|FG001|STARTED|Open Label FMT Period (up to 24 Weeks)||0
8992318|NCT02782325|10055286|FG002|STARTED|Open Label FMT Period (up to 24 Weeks)|1 participant decided to not participate in the open label period|5
8992319|NCT02782325|10055284|FG000|COMPLETED|Open Label FMT Period (up to 24 Weeks)||0
8992320|NCT02782325|10055285|FG001|COMPLETED|Open Label FMT Period (up to 24 Weeks)||0
8992321|NCT02782325|10055286|FG002|COMPLETED|Open Label FMT Period (up to 24 Weeks)||1
8992322|NCT02782325|10055284|FG000|NOT COMPLETED|Open Label FMT Period (up to 24 Weeks)||0
8992323|NCT02782325|10055285|FG001|NOT COMPLETED|Open Label FMT Period (up to 24 Weeks)||0
8992324|NCT02782325|10055286|FG002|NOT COMPLETED|Open Label FMT Period (up to 24 Weeks)||4
8992325|NCT02782364|10055294|FG000|STARTED|Overall Study||18
8992326|NCT02782364|10055295|FG001|STARTED|Overall Study||18
8992327|NCT02782364|10055294|FG000|COMPLETED|Overall Study||18
8992328|NCT02782364|10055295|FG001|COMPLETED|Overall Study||18
8992329|NCT02782364|10055294|FG000|NOT COMPLETED|Overall Study||0
8992330|NCT02782364|10055295|FG001|NOT COMPLETED|Overall Study||0
8992331|NCT02782377|10055302|FG000|STARTED|Overall Study||40
8992332|NCT02782377|10055302|FG000|COMPLETED|Overall Study|data from five of the patients were excluded due to interpretation difficulties|35
8992333|NCT02782377|10055302|FG000|NOT COMPLETED|Overall Study||5
8992334|NCT02782676|10055307|FG000|STARTED|Overall Study||211
8992335|NCT02782676|10055308|FG001|STARTED|Overall Study||210
8992336|NCT02782676|10055307|FG000|COMPLETED|Overall Study||211
8992337|NCT02782676|10055308|FG001|COMPLETED|Overall Study||209
8992338|NCT02782676|10055307|FG000|NOT COMPLETED|Overall Study||0
8992339|NCT02782676|10055308|FG001|NOT COMPLETED|Overall Study||1
8992340|NCT02782780|10055316|FG000|STARTED|Overall Study||46
8992341|NCT02782780|10055317|FG001|STARTED|Overall Study||39
8992342|NCT02782780|10055316|FG000|COMPLETED|Overall Study||39
8992343|NCT02782780|10055317|FG001|COMPLETED|Overall Study||32
8992344|NCT02782780|10055316|FG000|NOT COMPLETED|Overall Study||7
8992345|NCT02782780|10055317|FG001|NOT COMPLETED|Overall Study||7
8992346|NCT02782923|10055323|FG000|STARTED|Overall Study||19
8992347|NCT02782923|10055323|FG000|COMPLETED|Overall Study||4
8992348|NCT02782923|10055323|FG000|NOT COMPLETED|Overall Study||15
8992349|NCT02783027|10055329|FG000|STARTED|Overall Study||39
8992350|NCT02783027|10055330|FG001|STARTED|Overall Study||44
8992351|NCT02783027|10055329|FG000|COMPLETED|Overall Study||16
8992352|NCT02783027|10055330|FG001|COMPLETED|Overall Study||27
8992353|NCT02783027|10055329|FG000|NOT COMPLETED|Overall Study||23
8992354|NCT02783027|10055330|FG001|NOT COMPLETED|Overall Study||17
8992355|NCT02783066|10055336|FG000|STARTED|Overall Study||16
8992356|NCT02783066|10055336|FG000|COMPLETED|Overall Study|complete 4-week pulseflow offloading wearing test|3
8992357|NCT02783066|10055336|FG000|NOT COMPLETED|Overall Study||13
8992358|NCT02783170|10055343|FG000|STARTED|Overall Study||43
8992359|NCT02783170|10055344|FG001|STARTED|Overall Study||38
8992360|NCT02783170|10055343|FG000|Safety Population|Overall Study|Added subject randomized to sequential but got simultaneous.|42
8992361|NCT02783170|10055344|FG001|Safety Population|Overall Study|Excluded sub. randomized but not vaccinated. Excluded sub. randomized to seq. but got simultaneous.|38
8992362|NCT02783170|10055343|FG000|COMPLETED|Overall Study||42
8992363|NCT02783170|10055344|FG001|COMPLETED|Overall Study||38
8992364|NCT02783170|10055343|FG000|NOT COMPLETED|Overall Study||1
8992365|NCT02783170|10055344|FG001|NOT COMPLETED|Overall Study||0
8992366|NCT02783443|10055353|FG000|STARTED|Overall Study||30
8992367|NCT02783443|10055354|FG001|STARTED|Overall Study||30
8992368|NCT02783443|10055353|FG000|COMPLETED|Overall Study||30
8992369|NCT02783443|10055354|FG001|COMPLETED|Overall Study||30
8992370|NCT02783443|10055353|FG000|NOT COMPLETED|Overall Study||0
8992371|NCT02783443|10055354|FG001|NOT COMPLETED|Overall Study||0
8992372|NCT02783469|10055360|FG000|STARTED|Overall Study||1915
8992373|NCT02783469|10055360|FG000|COMPLETED|Overall Study||1915
8992374|NCT02783469|10055360|FG000|NOT COMPLETED|Overall Study||0
8992375|NCT02783573|10055367|FG000|STARTED|Placebo-Controlled Treatment Period||562
8992376|NCT02783573|10055368|FG001|STARTED|Placebo-Controlled Treatment Period||590
8992377|NCT02783573|10055369|FG002|STARTED|Placebo-Controlled Treatment Period||570
8992378|NCT02783573|10055367|FG000|Received at Least 1 Dose of Study Drug|Placebo-Controlled Treatment Period||558
8992379|NCT02783573|10055368|FG001|Received at Least 1 Dose of Study Drug|Placebo-Controlled Treatment Period||588
8992380|NCT02783573|10055369|FG002|Received at Least 1 Dose of Study Drug|Placebo-Controlled Treatment Period||568
8992381|NCT02783573|10055367|FG000|COMPLETED|Placebo-Controlled Treatment Period||26
8992382|NCT02783573|10055368|FG001|COMPLETED|Placebo-Controlled Treatment Period||28
8992383|NCT02783573|10055369|FG002|COMPLETED|Placebo-Controlled Treatment Period||22
8992384|NCT02783573|10055367|FG000|NOT COMPLETED|Placebo-Controlled Treatment Period||536
8992385|NCT02783573|10055368|FG001|NOT COMPLETED|Placebo-Controlled Treatment Period||562
8992386|NCT02783573|10055369|FG002|NOT COMPLETED|Placebo-Controlled Treatment Period||548
8992387|NCT02783573|10055367|FG000|STARTED|Delayed-Start Period|Participants from placebo group were randomized to Lanabecestat 20 mg and 50 mg.|0
8992388|NCT02783573|10055368|FG001|STARTED|Delayed-Start Period|Participants completed period 1 may not have entered period 2 due to early termination of the study.|17
8992389|NCT02783573|10055369|FG002|STARTED|Delayed-Start Period|Participants completed period 1 may not have entered period 2 due to early termination of the study.|12
8992390|NCT02783573|10055367|FG000|Received at Least 1 Dose of Study Drug|Delayed-Start Period||0
8992391|NCT02783573|10055368|FG001|Received at Least 1 Dose of Study Drug|Delayed-Start Period||14
8992392|NCT02783573|10055369|FG002|Received at Least 1 Dose of Study Drug|Delayed-Start Period||12
8992393|NCT02783573|10055367|FG000|COMPLETED|Delayed-Start Period||0
8992394|NCT02783573|10055368|FG001|COMPLETED|Delayed-Start Period||0
8992395|NCT02783573|10055369|FG002|COMPLETED|Delayed-Start Period||0
8992396|NCT02783573|10055367|FG000|NOT COMPLETED|Delayed-Start Period||0
8992397|NCT02783573|10055368|FG001|NOT COMPLETED|Delayed-Start Period||17
8633531|NCT00551525|9673634|FG000|STARTED|Overall Study||67
8633532|NCT00551525|9673634|FG000|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study|62
8633533|NCT00551525|9673634|FG000|NOT COMPLETED|Overall Study||5
8633534|NCT00551642|9673640|FG000|STARTED|Treatment Period||399
8633535|NCT00551642|9673641|FG001|STARTED|Treatment Period||401
8633536|NCT00551642|9673640|FG000|Safety Population|Treatment Period||395
8633537|NCT00551642|9673641|FG001|Safety Population|Treatment Period||397
8633538|NCT00551642|9673640|FG000|COMPLETED|Treatment Period||338
8992398|NCT02783573|10055369|FG002|NOT COMPLETED|Delayed-Start Period||12
8992399|NCT02783599|10055380|FG000|STARTED|Overall Study||51
8992400|NCT02783599|10055380|FG000|Received At Least One Dose of Study Drug|Overall Study||51
8992401|NCT02783599|10055380|FG000|COMPLETED|Overall Study||11
8992402|NCT02783599|10055380|FG000|NOT COMPLETED|Overall Study||40
8992403|NCT02783729|10055395|FG000|STARTED|Overall Study||208
8992404|NCT02783729|10055396|FG001|STARTED|Overall Study||263
8992405|NCT02783729|10055397|FG002|STARTED|Overall Study||266
8992406|NCT02783729|10055398|FG003|STARTED|Overall Study||269
8992407|NCT02783729|10055395|FG000|COMPLETED|Overall Study||198
8992408|NCT02783729|10055396|FG001|COMPLETED|Overall Study||246
8992409|NCT02783729|10055397|FG002|COMPLETED|Overall Study||258
8633539|NCT00551642|9673641|FG001|COMPLETED|Treatment Period||338
8633540|NCT00551642|9673640|FG000|NOT COMPLETED|Treatment Period||61
8633541|NCT00551642|9673641|FG001|NOT COMPLETED|Treatment Period||63
8633542|NCT00551642|9673640|FG000|STARTED|7-Year Follow-up||152
8633543|NCT00551642|9673641|FG001|STARTED|7-Year Follow-up||153
8633544|NCT00551642|9673640|FG000|COMPLETED|7-Year Follow-up||152
8992410|NCT02783729|10055398|FG003|COMPLETED|Overall Study||260
8992411|NCT02783729|10055395|FG000|NOT COMPLETED|Overall Study||10
8992412|NCT02783729|10055396|FG001|NOT COMPLETED|Overall Study||17
8992413|NCT02783729|10055397|FG002|NOT COMPLETED|Overall Study||8
8992414|NCT02783729|10055398|FG003|NOT COMPLETED|Overall Study||9
8992415|NCT02783768|10055413|FG000|STARTED|Overall Study||6
8992416|NCT02783768|10055414|FG001|STARTED|Overall Study||5
8992417|NCT02783768|10055413|FG000|COMPLETED|Overall Study||5
8992418|NCT02783768|10055414|FG001|COMPLETED|Overall Study||5
8992419|NCT02783768|10055413|FG000|NOT COMPLETED|Overall Study||1
8992420|NCT02783768|10055414|FG001|NOT COMPLETED|Overall Study||0
8992421|NCT02783820|10055424|FG000|STARTED|Overall Study||6
8992422|NCT02783820|10055425|FG001|STARTED|Overall Study||6
8992423|NCT02783820|10055426|FG002|STARTED|Overall Study||6
8992424|NCT02783820|10055427|FG003|STARTED|Overall Study||6
8992425|NCT02783820|10055424|FG000|COMPLETED|Overall Study||6
8992426|NCT02783820|10055425|FG001|COMPLETED|Overall Study||6
8992427|NCT02783820|10055426|FG002|COMPLETED|Overall Study||6
8992428|NCT02783820|10055427|FG003|COMPLETED|Overall Study||6
8992429|NCT02783820|10055424|FG000|NOT COMPLETED|Overall Study||0
8992430|NCT02783820|10055425|FG001|NOT COMPLETED|Overall Study||0
8992431|NCT02783820|10055426|FG002|NOT COMPLETED|Overall Study||0
8992432|NCT02783820|10055427|FG003|NOT COMPLETED|Overall Study||0
8992433|NCT02783898|10055439|FG000|STARTED|Overall Study||125
8992434|NCT02783898|10055440|FG001|STARTED|Overall Study||117
8992435|NCT02783898|10055439|FG000|COMPLETED|Overall Study||124
8992436|NCT02783898|10055440|FG001|COMPLETED|Overall Study||116
8992437|NCT02783898|10055439|FG000|NOT COMPLETED|Overall Study||1
8992438|NCT02783898|10055440|FG001|NOT COMPLETED|Overall Study||1
8992439|NCT02783911|10055450|FG000|STARTED|Overall Study||11
8992440|NCT02783911|10055451|FG001|STARTED|Overall Study||46
8992441|NCT02783911|10055450|FG000|COMPLETED|Overall Study||8
8992442|NCT02783911|10055451|FG001|COMPLETED|Overall Study||14
8992443|NCT02783911|10055450|FG000|NOT COMPLETED|Overall Study||3
8992444|NCT02783911|10055451|FG001|NOT COMPLETED|Overall Study||32
8992445|NCT02783950|10055459|FG000|STARTED|Overall Study||182
8992446|NCT02783950|10055460|FG001|STARTED|Overall Study||174
8633545|NCT00551642|9673641|FG001|COMPLETED|7-Year Follow-up||153
8992447|NCT02783950|10055459|FG000|COMPLETED|Overall Study||175
8992448|NCT02783950|10055460|FG001|COMPLETED|Overall Study||165
8992449|NCT02783950|10055459|FG000|NOT COMPLETED|Overall Study||7
8992450|NCT02783950|10055460|FG001|NOT COMPLETED|Overall Study||9
8992451|NCT02784106|10055468|FG000|STARTED|Double-Blind Treatment Period (12 Weeks)||32
8992452|NCT02784106|10055469|FG001|STARTED|Double-Blind Treatment Period (12 Weeks)||33
8992453|NCT02784106|10055470|FG002|STARTED|Double-Blind Treatment Period (12 Weeks)||0
8992454|NCT02784106|10055471|FG003|STARTED|Double-Blind Treatment Period (12 Weeks)||0
8992455|NCT02784106|10055468|FG000|COMPLETED|Double-Blind Treatment Period (12 Weeks)||24
8992456|NCT02784106|10055469|FG001|COMPLETED|Double-Blind Treatment Period (12 Weeks)||27
8992457|NCT02784106|10055470|FG002|COMPLETED|Double-Blind Treatment Period (12 Weeks)||0
8992458|NCT02784106|10055471|FG003|COMPLETED|Double-Blind Treatment Period (12 Weeks)||0
8992459|NCT02784106|10055468|FG000|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||8
8992460|NCT02784106|10055469|FG001|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||6
8992461|NCT02784106|10055470|FG002|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||0
8992462|NCT02784106|10055471|FG003|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||0
8992463|NCT02784106|10055468|FG000|STARTED|Open-Label Extension Period (26 Weeks)||0
8992464|NCT02784106|10055469|FG001|STARTED|Open-Label Extension Period (26 Weeks)||0
8992465|NCT02784106|10055470|FG002|STARTED|Open-Label Extension Period (26 Weeks)||18
8992466|NCT02784106|10055471|FG003|STARTED|Open-Label Extension Period (26 Weeks)||21
8992467|NCT02784106|10055468|FG000|COMPLETED|Open-Label Extension Period (26 Weeks)||0
8992468|NCT02784106|10055469|FG001|COMPLETED|Open-Label Extension Period (26 Weeks)||0
8992469|NCT02784106|10055470|FG002|COMPLETED|Open-Label Extension Period (26 Weeks)||15
8992470|NCT02784106|10055471|FG003|COMPLETED|Open-Label Extension Period (26 Weeks)||19
8992471|NCT02784106|10055468|FG000|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||0
8992472|NCT02784106|10055469|FG001|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||0
8992473|NCT02784106|10055470|FG002|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||3
8992474|NCT02784106|10055471|FG003|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||2
8992475|NCT02784275|10055484|FG000|STARTED|Overall Study||16
8992476|NCT02784275|10055485|FG001|STARTED|Overall Study||16
8992477|NCT02784275|10055486|FG002|STARTED|Overall Study||17
8992478|NCT02784275|10055487|FG003|STARTED|Overall Study||15
8992479|NCT02784275|10055484|FG000|COMPLETED|Overall Study||15
8992480|NCT02784275|10055485|FG001|COMPLETED|Overall Study||16
8992481|NCT02784275|10055486|FG002|COMPLETED|Overall Study||16
8992482|NCT02784275|10055487|FG003|COMPLETED|Overall Study||14
8992483|NCT02784275|10055484|FG000|NOT COMPLETED|Overall Study||1
8992484|NCT02784275|10055485|FG001|NOT COMPLETED|Overall Study||0
8992485|NCT02784275|10055486|FG002|NOT COMPLETED|Overall Study||1
8992486|NCT02784275|10055487|FG003|NOT COMPLETED|Overall Study||1
8992487|NCT02784431|10055497|FG000|STARTED|Overall Study||20
8992488|NCT02784431|10055497|FG000|COMPLETED|Overall Study||0
8992489|NCT02784431|10055497|FG000|NOT COMPLETED|Overall Study||20
8992490|NCT02784444|10055505|FG000|STARTED|Overall Study||94
8992491|NCT02784444|10055506|FG001|STARTED|Overall Study||99
8992492|NCT02784444|10055507|FG002|STARTED|Overall Study||98
8992493|NCT02784444|10055508|FG003|STARTED|Overall Study||101
8992494|NCT02784444|10055505|FG000|COMPLETED|Overall Study||78
8992495|NCT02784444|10055506|FG001|COMPLETED|Overall Study||90
8992496|NCT02784444|10055507|FG002|COMPLETED|Overall Study||86
8992497|NCT02784444|10055508|FG003|COMPLETED|Overall Study||88
8992498|NCT02784444|10055505|FG000|NOT COMPLETED|Overall Study||16
8992499|NCT02784444|10055506|FG001|NOT COMPLETED|Overall Study||9
8992500|NCT02784444|10055507|FG002|NOT COMPLETED|Overall Study||12
8992501|NCT02784444|10055508|FG003|NOT COMPLETED|Overall Study||13
8992502|NCT02784548|10055518|FG000|STARTED|Overall Study||15
8992503|NCT02784548|10055518|FG000|COMPLETED|Overall Study||15
8992504|NCT02784548|10055518|FG000|NOT COMPLETED|Overall Study||0
8992505|NCT02784587|10055523|FG000|STARTED|Overall Study||25
8992506|NCT02784587|10055523|FG000|COMPLETED|Overall Study||25
8992507|NCT02784587|10055523|FG000|NOT COMPLETED|Overall Study||0
8992508|NCT02784613|10055527|FG000|STARTED|Overall Study||10
8992509|NCT02784613|10055527|FG000|COMPLETED|Overall Study||8
8992510|NCT02784613|10055527|FG000|NOT COMPLETED|Overall Study||2
8992511|NCT02784834|10055531|FG000|STARTED|Overall Study||2
8992512|NCT02784834|10055531|FG000|COMPLETED|Overall Study||1
8992513|NCT02784834|10055531|FG000|NOT COMPLETED|Overall Study||1
8992514|NCT02784925|10055535|FG000|STARTED|Overall Study||30
8992515|NCT02784925|10055535|FG000|COMPLETED|Overall Study||30
8992516|NCT02784925|10055535|FG000|NOT COMPLETED|Overall Study||0
8992517|NCT02785159|10055543|FG000|STARTED|Overall Study||62
8992518|NCT02785159|10055544|FG001|STARTED|Overall Study||58
8992519|NCT02785159|10055545|FG002|STARTED|Overall Study||15
8992520|NCT02785159|10055546|FG003|STARTED|Overall Study||17
8992521|NCT02785159|10055543|FG000|COMPLETED|Overall Study||51
8992522|NCT02785159|10055544|FG001|COMPLETED|Overall Study||45
8992523|NCT02785159|10055545|FG002|COMPLETED|Overall Study||12
8992524|NCT02785159|10055546|FG003|COMPLETED|Overall Study||14
8992525|NCT02785159|10055543|FG000|NOT COMPLETED|Overall Study||11
8992526|NCT02785159|10055544|FG001|NOT COMPLETED|Overall Study||13
8992527|NCT02785159|10055545|FG002|NOT COMPLETED|Overall Study||3
8992528|NCT02785159|10055546|FG003|NOT COMPLETED|Overall Study||3
8992529|NCT02785172|10055560|FG000|STARTED|Overall Study||61
8992530|NCT02785172|10055561|FG001|STARTED|Overall Study||63
8992531|NCT02785172|10055562|FG002|STARTED|Overall Study||16
8992532|NCT02785172|10055563|FG003|STARTED|Overall Study||14
8992533|NCT02785172|10055560|FG000|COMPLETED|Overall Study||61
8992534|NCT02785172|10055561|FG001|COMPLETED|Overall Study||62
8992535|NCT02785172|10055562|FG002|COMPLETED|Overall Study||15
8992536|NCT02785172|10055563|FG003|COMPLETED|Overall Study||14
8992537|NCT02785172|10055560|FG000|NOT COMPLETED|Overall Study||0
8992538|NCT02785172|10055561|FG001|NOT COMPLETED|Overall Study||1
8992539|NCT02785172|10055562|FG002|NOT COMPLETED|Overall Study||1
8992540|NCT02785172|10055563|FG003|NOT COMPLETED|Overall Study||0
8992541|NCT02785185|10055577|FG000|STARTED|Overall Study||60
8992542|NCT02785185|10055578|FG001|STARTED|Overall Study||57
8992543|NCT02785185|10055579|FG002|STARTED|Overall Study||17
8992544|NCT02785185|10055580|FG003|STARTED|Overall Study||16
8992545|NCT02785185|10055577|FG000|COMPLETED|Overall Study||59
8992546|NCT02785185|10055578|FG001|COMPLETED|Overall Study||56
8992547|NCT02785185|10055579|FG002|COMPLETED|Overall Study||15
8992548|NCT02785185|10055580|FG003|COMPLETED|Overall Study||16
8992549|NCT02785185|10055577|FG000|NOT COMPLETED|Overall Study||1
8992550|NCT02785185|10055578|FG001|NOT COMPLETED|Overall Study||1
8992551|NCT02785185|10055579|FG002|NOT COMPLETED|Overall Study||2
8992552|NCT02785185|10055580|FG003|NOT COMPLETED|Overall Study||0
8992553|NCT02785354|10055593|FG000|STARTED|Overall Study||27060
8992554|NCT02785354|10055594|FG001|STARTED|Overall Study||31388
8992555|NCT02785354|10055595|FG002|STARTED|Overall Study||44653
8992556|NCT02785354|10055593|FG000|COMPLETED|Overall Study||27060
8992557|NCT02785354|10055594|FG001|COMPLETED|Overall Study||31388
8992558|NCT02785354|10055595|FG002|COMPLETED|Overall Study||44653
8992559|NCT02785354|10055593|FG000|NOT COMPLETED|Overall Study||0
8992560|NCT02785354|10055594|FG001|NOT COMPLETED|Overall Study||0
8992561|NCT02785354|10055595|FG002|NOT COMPLETED|Overall Study||0
8992562|NCT02785406|10055606|FG000|STARTED|Overall Study||10
8992563|NCT02785406|10055607|FG001|STARTED|Overall Study||10
8992564|NCT02785406|10055606|FG000|Completed First Week|Overall Study||10
8992565|NCT02785406|10055607|FG001|Completed First Week|Overall Study||10
8992566|NCT02785406|10055606|FG000|Completed Second Week|Overall Study||10
8992567|NCT02785406|10055607|FG001|Completed Second Week|Overall Study||10
8992568|NCT02785406|10055606|FG000|COMPLETED|Overall Study||10
8992569|NCT02785406|10055607|FG001|COMPLETED|Overall Study||10
8992570|NCT02785406|10055606|FG000|NOT COMPLETED|Overall Study||0
8992571|NCT02785406|10055607|FG001|NOT COMPLETED|Overall Study||0
8992572|NCT02785432|10055615|FG000|STARTED|Overall Study||4
8992573|NCT02785432|10055616|FG001|STARTED|Overall Study||7
8992574|NCT02785432|10055615|FG000|COMPLETED|Overall Study||4
8992575|NCT02785432|10055616|FG001|COMPLETED|Overall Study||7
8992576|NCT02785432|10055615|FG000|NOT COMPLETED|Overall Study||0
8992577|NCT02785432|10055616|FG001|NOT COMPLETED|Overall Study||0
8992578|NCT02785458|10055624|FG000|STARTED|Baseline||526
8992579|NCT02785458|10055625|FG001|STARTED|Baseline||479
8992580|NCT02785458|10055624|FG000|COMPLETED|Baseline||526
8992581|NCT02785458|10055625|FG001|COMPLETED|Baseline||479
8992582|NCT02785458|10055624|FG000|NOT COMPLETED|Baseline||0
8992583|NCT02785458|10055625|FG001|NOT COMPLETED|Baseline||0
8992584|NCT02785458|10055624|FG000|STARTED|1 Month||526
8992585|NCT02785458|10055625|FG001|STARTED|1 Month||479
8992586|NCT02785458|10055624|FG000|COMPLETED|1 Month||443
8992587|NCT02785458|10055625|FG001|COMPLETED|1 Month||404
8992588|NCT02785458|10055624|FG000|NOT COMPLETED|1 Month||83
8992589|NCT02785458|10055625|FG001|NOT COMPLETED|1 Month||75
8992590|NCT02785458|10055624|FG000|STARTED|3 Months||443
8992591|NCT02785458|10055625|FG001|STARTED|3 Months||404
8992592|NCT02785458|10055624|FG000|COMPLETED|3 Months||315
8992593|NCT02785458|10055625|FG001|COMPLETED|3 Months||293
8992594|NCT02785458|10055624|FG000|NOT COMPLETED|3 Months||128
8992595|NCT02785458|10055625|FG001|NOT COMPLETED|3 Months||111
8992596|NCT02785588|10055631|FG000|STARTED|Phase 1: Initial Feasibility Assessment||49
8992597|NCT02785588|10055631|FG000|COMPLETED|Phase 1: Initial Feasibility Assessment||47
8992598|NCT02785588|10055631|FG000|NOT COMPLETED|Phase 1: Initial Feasibility Assessment||2
8992599|NCT02785588|10055631|FG000|STARTED|Phase2 Controlled Image &Data Collection|Phase 2 participants represent newly enrolled participants.|5
8992600|NCT02785588|10055631|FG000|COMPLETED|Phase2 Controlled Image &Data Collection||5
8992601|NCT02785588|10055631|FG000|NOT COMPLETED|Phase2 Controlled Image &Data Collection||0
8992602|NCT02785770|10055635|FG000|STARTED|Intervention Period 1 (1 Day)||11
8992603|NCT02785770|10055636|FG001|STARTED|Intervention Period 1 (1 Day)||11
8992604|NCT02785770|10055637|FG002|STARTED|Intervention Period 1 (1 Day)||11
8992605|NCT02785770|10055638|FG003|STARTED|Intervention Period 1 (1 Day)||11
8992606|NCT02785770|10055635|FG000|COMPLETED|Intervention Period 1 (1 Day)||11
8992607|NCT02785770|10055636|FG001|COMPLETED|Intervention Period 1 (1 Day)||11
8992608|NCT02785770|10055637|FG002|COMPLETED|Intervention Period 1 (1 Day)||11
8992609|NCT02785770|10055638|FG003|COMPLETED|Intervention Period 1 (1 Day)||11
8992610|NCT02785770|10055635|FG000|NOT COMPLETED|Intervention Period 1 (1 Day)||0
8992611|NCT02785770|10055636|FG001|NOT COMPLETED|Intervention Period 1 (1 Day)||0
8992612|NCT02785770|10055637|FG002|NOT COMPLETED|Intervention Period 1 (1 Day)||0
8992613|NCT02785770|10055638|FG003|NOT COMPLETED|Intervention Period 1 (1 Day)||0
8992614|NCT02785770|10055635|FG000|STARTED|Washout Period 1 (7 Days)||11
8992615|NCT02785770|10055636|FG001|STARTED|Washout Period 1 (7 Days)||11
8992616|NCT02785770|10055637|FG002|STARTED|Washout Period 1 (7 Days)||11
8992617|NCT02785770|10055638|FG003|STARTED|Washout Period 1 (7 Days)||11
8992618|NCT02785770|10055635|FG000|COMPLETED|Washout Period 1 (7 Days)||11
8992619|NCT02785770|10055636|FG001|COMPLETED|Washout Period 1 (7 Days)||11
8992620|NCT02785770|10055637|FG002|COMPLETED|Washout Period 1 (7 Days)||11
8992621|NCT02785770|10055638|FG003|COMPLETED|Washout Period 1 (7 Days)||11
8992622|NCT02785770|10055635|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
8992623|NCT02785770|10055636|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
8992624|NCT02785770|10055637|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
8992625|NCT02785770|10055638|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
8992626|NCT02785770|10055635|FG000|STARTED|Intervention Period 2 (1 Day)||11
8992627|NCT02785770|10055636|FG001|STARTED|Intervention Period 2 (1 Day)||11
8992628|NCT02785770|10055637|FG002|STARTED|Intervention Period 2 (1 Day)||11
8992629|NCT02785770|10055638|FG003|STARTED|Intervention Period 2 (1 Day)||11
8992630|NCT02785770|10055635|FG000|COMPLETED|Intervention Period 2 (1 Day)||11
8992631|NCT02785770|10055636|FG001|COMPLETED|Intervention Period 2 (1 Day)||10
8992632|NCT02785770|10055637|FG002|COMPLETED|Intervention Period 2 (1 Day)||10
8992633|NCT02785770|10055638|FG003|COMPLETED|Intervention Period 2 (1 Day)||11
8992634|NCT02785770|10055635|FG000|NOT COMPLETED|Intervention Period 2 (1 Day)||0
8992635|NCT02785770|10055636|FG001|NOT COMPLETED|Intervention Period 2 (1 Day)||1
8992636|NCT02785770|10055637|FG002|NOT COMPLETED|Intervention Period 2 (1 Day)||1
8992637|NCT02785770|10055638|FG003|NOT COMPLETED|Intervention Period 2 (1 Day)||0
8992638|NCT02785770|10055635|FG000|STARTED|Washout Period 2 (7 Days)||11
8992639|NCT02785770|10055636|FG001|STARTED|Washout Period 2 (7 Days)||10
8992640|NCT02785770|10055637|FG002|STARTED|Washout Period 2 (7 Days)||10
8992641|NCT02785770|10055638|FG003|STARTED|Washout Period 2 (7 Days)||11
8992642|NCT02785770|10055635|FG000|COMPLETED|Washout Period 2 (7 Days)||11
8992643|NCT02785770|10055636|FG001|COMPLETED|Washout Period 2 (7 Days)||10
8992644|NCT02785770|10055637|FG002|COMPLETED|Washout Period 2 (7 Days)||10
8992645|NCT02785770|10055638|FG003|COMPLETED|Washout Period 2 (7 Days)||11
8992646|NCT02785770|10055635|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
8992647|NCT02785770|10055636|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
8992648|NCT02785770|10055637|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
8992649|NCT02785770|10055638|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
8992650|NCT02785770|10055635|FG000|STARTED|Intervention Period 3 (1 Day)||11
8992651|NCT02785770|10055636|FG001|STARTED|Intervention Period 3 (1 Day)||10
8992652|NCT02785770|10055637|FG002|STARTED|Intervention Period 3 (1 Day)||10
8992653|NCT02785770|10055638|FG003|STARTED|Intervention Period 3 (1 Day)||11
8992654|NCT02785770|10055635|FG000|COMPLETED|Intervention Period 3 (1 Day)||11
8992655|NCT02785770|10055636|FG001|COMPLETED|Intervention Period 3 (1 Day)||10
8992656|NCT02785770|10055637|FG002|COMPLETED|Intervention Period 3 (1 Day)||10
8992657|NCT02785770|10055638|FG003|COMPLETED|Intervention Period 3 (1 Day)||10
8992658|NCT02785770|10055635|FG000|NOT COMPLETED|Intervention Period 3 (1 Day)||0
8992659|NCT02785770|10055636|FG001|NOT COMPLETED|Intervention Period 3 (1 Day)||0
8992660|NCT02785770|10055637|FG002|NOT COMPLETED|Intervention Period 3 (1 Day)||0
8992661|NCT02785770|10055638|FG003|NOT COMPLETED|Intervention Period 3 (1 Day)||1
8992662|NCT02785770|10055635|FG000|STARTED|Washout Period 3 (7 Days)||11
8992663|NCT02785770|10055636|FG001|STARTED|Washout Period 3 (7 Days)||10
8992664|NCT02785770|10055637|FG002|STARTED|Washout Period 3 (7 Days)||10
8992665|NCT02785770|10055638|FG003|STARTED|Washout Period 3 (7 Days)||10
8992666|NCT02785770|10055635|FG000|COMPLETED|Washout Period 3 (7 Days)||11
8633546|NCT00551642|9673640|FG000|NOT COMPLETED|7-Year Follow-up||0
8633547|NCT00551642|9673641|FG001|NOT COMPLETED|7-Year Follow-up||0
8691296|NCT00854061|9736531|FG000|Completed 1st Surgery (T-PRED in One Eye and Pred Forte in the Other Eye)|Overall Study||162
8691297|NCT00854061|9736531|FG000|Completed 2nd Surgery (T-PRED and Pred Forte in Opposite Eyes Compared to 1st Surgery)|Overall Study||149
8992667|NCT02785770|10055636|FG001|COMPLETED|Washout Period 3 (7 Days)||10
8992668|NCT02785770|10055637|FG002|COMPLETED|Washout Period 3 (7 Days)||10
8992669|NCT02785770|10055638|FG003|COMPLETED|Washout Period 3 (7 Days)||10
8992670|NCT02785770|10055635|FG000|NOT COMPLETED|Washout Period 3 (7 Days)||0
8992671|NCT02785770|10055636|FG001|NOT COMPLETED|Washout Period 3 (7 Days)||0
8992672|NCT02785770|10055637|FG002|NOT COMPLETED|Washout Period 3 (7 Days)||0
8992673|NCT02785770|10055638|FG003|NOT COMPLETED|Washout Period 3 (7 Days)||0
8992674|NCT02785770|10055635|FG000|STARTED|Intervention Period 4 (1 Day)||11
8992675|NCT02785770|10055636|FG001|STARTED|Intervention Period 4 (1 Day)||10
8992676|NCT02785770|10055637|FG002|STARTED|Intervention Period 4 (1 Day)||10
8992677|NCT02785770|10055638|FG003|STARTED|Intervention Period 4 (1 Day)||10
8992678|NCT02785770|10055635|FG000|COMPLETED|Intervention Period 4 (1 Day)||11
8992679|NCT02785770|10055636|FG001|COMPLETED|Intervention Period 4 (1 Day)||10
8992680|NCT02785770|10055637|FG002|COMPLETED|Intervention Period 4 (1 Day)||10
8992681|NCT02785770|10055638|FG003|COMPLETED|Intervention Period 4 (1 Day)||10
8992682|NCT02785770|10055635|FG000|NOT COMPLETED|Intervention Period 4 (1 Day)||0
8992683|NCT02785770|10055636|FG001|NOT COMPLETED|Intervention Period 4 (1 Day)||0
8992684|NCT02785770|10055637|FG002|NOT COMPLETED|Intervention Period 4 (1 Day)||0
8992685|NCT02785770|10055638|FG003|NOT COMPLETED|Intervention Period 4 (1 Day)||0
8992686|NCT02785900|10055653|FG000|STARTED|Overall Study||117
8992687|NCT02785900|10055654|FG001|STARTED|Overall Study||123
8992688|NCT02785900|10055653|FG000|COMPLETED|Overall Study||0
8992689|NCT02785900|10055654|FG001|COMPLETED|Overall Study||0
8992690|NCT02785900|10055653|FG000|NOT COMPLETED|Overall Study||117
8992691|NCT02785900|10055654|FG001|NOT COMPLETED|Overall Study||123
8992692|NCT02785913|10055660|FG000|STARTED|Overall Study||26
8992693|NCT02785913|10055660|FG000|COMPLETED|Overall Study||0
8992694|NCT02785913|10055660|FG000|NOT COMPLETED|Overall Study||26
8992695|NCT02785939|10055667|FG000|STARTED|Overall Study||31
8992696|NCT02785939|10055668|FG001|STARTED|Overall Study||10
8992697|NCT02785939|10055667|FG000|Participants Re-registered to Palbociclib After Progression on Docetaxel|Overall Study||0
8992698|NCT02785939|10055668|FG001|Participants Re-registered to Palbociclib After Progression on Docetaxel|Overall Study||1
8992699|NCT02785939|10055667|FG000|COMPLETED|Overall Study||0
8992700|NCT02785939|10055668|FG001|COMPLETED|Overall Study||0
8992701|NCT02785939|10055667|FG000|NOT COMPLETED|Overall Study||31
8992702|NCT02785939|10055668|FG001|NOT COMPLETED|Overall Study||10
8992703|NCT02786004|10055676|FG000|STARTED|Overall Study||14
8992704|NCT02786004|10055677|FG001|STARTED|Overall Study||10
8992705|NCT02786004|10055676|FG000|COMPLETED|Overall Study||14
8992706|NCT02786004|10055677|FG001|COMPLETED|Overall Study||9
8992707|NCT02786004|10055676|FG000|NOT COMPLETED|Overall Study||0
8691298|NCT00854061|9736531|FG000|COMPLETED|Overall Study||149
8992708|NCT02786004|10055677|FG001|NOT COMPLETED|Overall Study||1
8992709|NCT02786134|10055687|FG000|STARTED|Overall Study||25
8992710|NCT02786134|10055688|FG001|STARTED|Overall Study||25
8992711|NCT02786134|10055687|FG000|COMPLETED|Overall Study||25
8992712|NCT02786134|10055688|FG001|COMPLETED|Overall Study||25
8992713|NCT02786134|10055687|FG000|NOT COMPLETED|Overall Study||0
8633548|NCT00551707|9673652|FG000|STARTED|Overall Study||4
8633549|NCT00551707|9673653|FG001|STARTED|Overall Study||22
8633550|NCT00551707|9673654|FG002|STARTED|Overall Study||13
8633551|NCT00551707|9673655|FG003|STARTED|Overall Study||8
8633552|NCT00551707|9673656|FG004|STARTED|Overall Study||4
8879119|NCT01932164|9935963|FG000|COMPLETED|Overall Study|In all 5 patients we observed bone formation closing the alveolar cleft after 6 months|5
8879120|NCT01932164|9935963|FG000|NOT COMPLETED|Overall Study||0
8879121|NCT01932242|9935969|FG000|STARTED|Overall Study||35
8879122|NCT01932242|9935970|FG001|STARTED|Overall Study||35
8879123|NCT01932242|9935969|FG000|COMPLETED|Overall Study||30
8879124|NCT01932242|9935970|FG001|COMPLETED|Overall Study||30
8879125|NCT01932242|9935969|FG000|NOT COMPLETED|Overall Study||5
8879126|NCT01932242|9935970|FG001|NOT COMPLETED|Overall Study||5
8879127|NCT01932294|9935976|FG000|STARTED|Overall Study||171
8879128|NCT01932294|9935976|FG000|COMPLETED|Overall Study||72
8879129|NCT01932294|9935976|FG000|NOT COMPLETED|Overall Study||99
8879130|NCT01932437|9935983|FG000|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||1
8879131|NCT01932437|9935984|FG001|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||3
8879132|NCT01932437|9935985|FG002|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
8879133|NCT01932437|9935986|FG003|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
8879134|NCT01932437|9935987|FG004|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
8879135|NCT01932437|9935988|FG005|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
8879136|NCT01932437|9935983|FG000|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||1
8879137|NCT01932437|9935984|FG001|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||3
8879138|NCT01932437|9935985|FG002|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
8879139|NCT01932437|9935986|FG003|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
8879140|NCT01932437|9935987|FG004|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
8879141|NCT01932437|9935988|FG005|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
8879142|NCT01932437|9935983|FG000|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
8879143|NCT01932437|9935984|FG001|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
8879144|NCT01932437|9935985|FG002|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
8879145|NCT01932437|9935986|FG003|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
8879146|NCT01932437|9935987|FG004|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
8879147|NCT01932437|9935988|FG005|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
8879148|NCT01932437|9935983|FG000|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||2
8879149|NCT01932437|9935984|FG001|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
8879150|NCT01932437|9935985|FG002|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||6
8879151|NCT01932437|9935986|FG003|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
8879152|NCT01932437|9935987|FG004|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
8879153|NCT01932437|9935988|FG005|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
8992714|NCT02786134|10055688|FG001|NOT COMPLETED|Overall Study||0
8992715|NCT02786355|10055694|FG000|STARTED|Overall Study||35
8992716|NCT02786355|10055694|FG000|COMPLETED|Overall Study||35
8992717|NCT02786355|10055694|FG000|NOT COMPLETED|Overall Study||0
8992718|NCT02786719|10055701|FG000|STARTED|Overall Study||13
8992719|NCT02786719|10055701|FG000|COMPLETED|Overall Study||12
8992720|NCT02786719|10055701|FG000|NOT COMPLETED|Overall Study||1
8992721|NCT02786771|10055707|FG000|STARTED|Overall Study||63
8992722|NCT02786771|10055708|FG001|STARTED|Overall Study||62
8992723|NCT02786771|10055707|FG000|COMPLETED|Overall Study||53
8992724|NCT02786771|10055708|FG001|COMPLETED|Overall Study||56
8992725|NCT02786771|10055707|FG000|NOT COMPLETED|Overall Study||10
8992726|NCT02786771|10055708|FG001|NOT COMPLETED|Overall Study||6
8992727|NCT02786810|10055714|FG000|STARTED|Overall Study||10
8992728|NCT02786810|10055714|FG000|COMPLETED|Overall Study||10
8992729|NCT02786810|10055714|FG000|NOT COMPLETED|Overall Study||0
8992730|NCT02786836|10055718|FG000|STARTED|Overall Study||76
8992731|NCT02786836|10055718|FG000|Eligible Patients Enrolled Into the Stud|Overall Study||76
8992732|NCT02786836|10055718|FG000|COMPLETED|Overall Study||62
8992733|NCT02786836|10055718|FG000|NOT COMPLETED|Overall Study||14
8992734|NCT02786901|10055726|FG000|STARTED|Overall Study||199
8992735|NCT02786901|10055727|FG001|STARTED|Overall Study||201
8992736|NCT02786901|10055728|FG002|STARTED|Overall Study||200
8992737|NCT02786901|10055726|FG000|COMPLETED|Overall Study||122
8992738|NCT02786901|10055727|FG001|COMPLETED|Overall Study||145
8992739|NCT02786901|10055728|FG002|COMPLETED|Overall Study||159
8992740|NCT02786901|10055726|FG000|NOT COMPLETED|Overall Study||77
8992741|NCT02786901|10055727|FG001|NOT COMPLETED|Overall Study||56
8992742|NCT02786901|10055728|FG002|NOT COMPLETED|Overall Study||41
8992743|NCT02786927|10055736|FG000|STARTED|Overall Study||212
8633553|NCT00551707|9673652|FG000|COMPLETED|Overall Study||4
8633554|NCT00551707|9673653|FG001|COMPLETED|Overall Study||16
8633555|NCT00551707|9673654|FG002|COMPLETED|Overall Study||10
8992744|NCT02786927|10055736|FG000|COMPLETED|Overall Study||207
8992745|NCT02786927|10055736|FG000|NOT COMPLETED|Overall Study||5
8633556|NCT00551707|9673655|FG003|COMPLETED|Overall Study||4
8633557|NCT00551707|9673656|FG004|COMPLETED|Overall Study||3
8633558|NCT00551707|9673652|FG000|NOT COMPLETED|Overall Study||0
8633559|NCT00551707|9673653|FG001|NOT COMPLETED|Overall Study||6
8633560|NCT00551707|9673654|FG002|NOT COMPLETED|Overall Study||3
8633561|NCT00551707|9673655|FG003|NOT COMPLETED|Overall Study||4
8633562|NCT00551707|9673656|FG004|NOT COMPLETED|Overall Study||1
8633563|NCT00551746|9673672|FG000|STARTED|Overall Study||36
8633564|NCT00551746|9673673|FG001|STARTED|Overall Study||34
8633565|NCT00551746|9673672|FG000|COMPLETED|Overall Study||25
8633566|NCT00551746|9673673|FG001|COMPLETED|Overall Study||26
8633567|NCT00551746|9673672|FG000|NOT COMPLETED|Overall Study||11
8992746|NCT02786953|10055743|FG000|STARTED|Overall Study||20
8992747|NCT02786953|10055744|FG001|STARTED|Overall Study||19
8992748|NCT02786953|10055743|FG000|Baseline Teen Survey Data Completed|Overall Study||20
8992749|NCT02786953|10055744|FG001|Baseline Teen Survey Data Completed|Overall Study|One participant withdrawn and data excluded due to becoming ineligible due to a new diagnosis|18
8992750|NCT02786953|10055743|FG000|Baseline Parent Survey Completed|Overall Study||20
8992751|NCT02786953|10055744|FG001|Baseline Parent Survey Completed|Overall Study|One participant withdrawn and data excluded due to becoming ineligible due to a new diagnosis|18
8992752|NCT02786953|10055743|FG000|Actigraph Data Complete|Overall Study||14
8992753|NCT02786953|10055744|FG001|Actigraph Data Complete|Overall Study|One participant withdrawn and data excluded due to becoming ineligible due to a new diagnosis|17
8992754|NCT02786953|10055743|FG000|A1C Data Baseline|Overall Study||20
8992755|NCT02786953|10055744|FG001|A1C Data Baseline|Overall Study|One participant withdrawn and data excluded due to becoming ineligible due to a new diagnosis|18
8992756|NCT02786953|10055743|FG000|Session 1 Completed|Overall Study||17
8992757|NCT02786953|10055744|FG001|Session 1 Completed|Overall Study||0
8992758|NCT02786953|10055743|FG000|Session 2 Completed|Overall Study||16
8992759|NCT02786953|10055744|FG001|Session 2 Completed|Overall Study||0
8992760|NCT02786953|10055743|FG000|Session 3 Completed|Overall Study||16
8992761|NCT02786953|10055744|FG001|Session 3 Completed|Overall Study||0
8992762|NCT02786953|10055743|FG000|3 Month Teen Survey Completed|Overall Study||17
8992763|NCT02786953|10055744|FG001|3 Month Teen Survey Completed|Overall Study||18
8992764|NCT02786953|10055743|FG000|3 Month Parent Survey Completed|Overall Study||17
8992765|NCT02786953|10055744|FG001|3 Month Parent Survey Completed|Overall Study||18
8992766|NCT02786953|10055743|FG000|A1C 3 Month|Overall Study||15
8992767|NCT02786953|10055744|FG001|A1C 3 Month|Overall Study||17
8992768|NCT02786953|10055743|FG000|COMPLETED|Overall Study||17
8992769|NCT02786953|10055744|FG001|COMPLETED|Overall Study||18
8992770|NCT02786953|10055743|FG000|NOT COMPLETED|Overall Study||3
8992771|NCT02786953|10055744|FG001|NOT COMPLETED|Overall Study||1
8992772|NCT02787057|10055752|FG000|STARTED|Overall Study||40
8992773|NCT02787057|10055753|FG001|STARTED|Overall Study||40
8992774|NCT02787057|10055752|FG000|COMPLETED|Overall Study||40
8992775|NCT02787057|10055753|FG001|COMPLETED|Overall Study||40
8992776|NCT02787057|10055752|FG000|NOT COMPLETED|Overall Study||0
8992777|NCT02787057|10055753|FG001|NOT COMPLETED|Overall Study||0
8992778|NCT02787083|10055761|FG000|STARTED|Overall Study||4
8992779|NCT02787083|10055762|FG001|STARTED|Overall Study||5
8992780|NCT02787083|10055761|FG000|COMPLETED|Overall Study||1
8992781|NCT02787083|10055762|FG001|COMPLETED|Overall Study||3
8992782|NCT02787083|10055761|FG000|NOT COMPLETED|Overall Study||3
8992783|NCT02787083|10055762|FG001|NOT COMPLETED|Overall Study||2
8992784|NCT02787291|10055768|FG000|STARTED|Overall Study||227
8992785|NCT02787291|10055768|FG000|COMPLETED|Overall Study||227
8992786|NCT02787291|10055768|FG000|NOT COMPLETED|Overall Study||0
9039184|NCT03335254|10100133|FG011|NOT COMPLETED|Period 3, Day 16-25||0
9039185|NCT03335254|10100134|FG012|NOT COMPLETED|Period 3, Day 16-25||0
9039186|NCT03335254|10100135|FG013|NOT COMPLETED|Period 3, Day 16-25||0
9039187|NCT03335254|10100136|FG014|NOT COMPLETED|Period 3, Day 16-25||0
9039188|NCT03335254|10100137|FG015|NOT COMPLETED|Period 3, Day 16-25||0
8633568|NCT00551746|9673673|FG001|NOT COMPLETED|Overall Study||8
8633569|NCT00551759|9673679|FG000|STARTED|Overall Study||22
8633570|NCT00551759|9673679|FG000|Eligible and Began Treatment|Overall Study||21
8992787|NCT02787304|10055776|FG000|STARTED|Overall Study||49
8992788|NCT02787304|10055777|FG001|STARTED|Overall Study|One subject was randomized and received 1 dose of study drug but withdrew from the study.|50
8992789|NCT02787304|10055778|FG002|STARTED|Overall Study||49
8992790|NCT02787304|10055779|FG003|STARTED|Overall Study||49
8992791|NCT02787304|10055776|FG000|COMPLETED|Overall Study||13
8992792|NCT02787304|10055777|FG001|COMPLETED|Overall Study||12
8992793|NCT02787304|10055778|FG002|COMPLETED|Overall Study||8
8992794|NCT02787304|10055779|FG003|COMPLETED|Overall Study||15
8992795|NCT02787304|10055776|FG000|NOT COMPLETED|Overall Study||36
8992796|NCT02787304|10055777|FG001|NOT COMPLETED|Overall Study||38
8992797|NCT02787304|10055778|FG002|NOT COMPLETED|Overall Study||41
8992798|NCT02787304|10055779|FG003|NOT COMPLETED|Overall Study||34
8992799|NCT02787564|10055791|FG000|STARTED|Overall Study||32
8992800|NCT02787564|10055792|FG001|STARTED|Overall Study||29
8992801|NCT02787564|10055791|FG000|COMPLETED|Overall Study|n=12 food bank users; n=13 non-food bank users|25
8992802|NCT02787564|10055792|FG001|COMPLETED|Overall Study|n=12 food bank users; n=15 non-food bank users|27
8992803|NCT02787564|10055791|FG000|NOT COMPLETED|Overall Study||7
8992804|NCT02787564|10055792|FG001|NOT COMPLETED|Overall Study||2
8992805|NCT02787655|10055800|FG000|STARTED|Overall Study||40
8992806|NCT02787655|10055801|FG001|STARTED|Overall Study||38
8992807|NCT02787655|10055800|FG000|COMPLETED|Overall Study||29
8992808|NCT02787655|10055801|FG001|COMPLETED|Overall Study||26
8992809|NCT02787655|10055800|FG000|NOT COMPLETED|Overall Study||11
8992810|NCT02787655|10055801|FG001|NOT COMPLETED|Overall Study||12
8992811|NCT02787681|10055807|FG000|STARTED|Overall Study||71
8992812|NCT02787681|10055807|FG000|COMPLETED|Overall Study||69
8992813|NCT02787681|10055807|FG000|NOT COMPLETED|Overall Study||2
8992814|NCT02787694|10055811|FG000|STARTED|Overall Study||22
8992815|NCT02787694|10055811|FG000|COMPLETED|Overall Study||17
8992816|NCT02787694|10055811|FG000|NOT COMPLETED|Overall Study||5
8992817|NCT02787863|10055823|FG000|STARTED|Overall Study||33
8992818|NCT02787863|10055824|FG001|STARTED|Overall Study||34
8992819|NCT02787863|10055825|FG002|STARTED|Overall Study||25
8992820|NCT02787863|10055826|FG003|STARTED|Overall Study||25
8992821|NCT02787863|10055827|FG004|STARTED|Overall Study||32
8992822|NCT02787863|10055828|FG005|STARTED|Overall Study||18
8992823|NCT02787863|10055829|FG006|STARTED|Overall Study||25
8992824|NCT02787863|10055830|FG007|STARTED|Overall Study||27
8992825|NCT02787863|10055823|FG000|1 Year After Vaccination|Overall Study||32
8992826|NCT02787863|10055824|FG001|1 Year After Vaccination|Overall Study||33
8992827|NCT02787863|10055825|FG002|1 Year After Vaccination|Overall Study||23
8992828|NCT02787863|10055826|FG003|1 Year After Vaccination|Overall Study||25
8992829|NCT02787863|10055827|FG004|1 Year After Vaccination|Overall Study||32
8992830|NCT02787863|10055828|FG005|1 Year After Vaccination|Overall Study||18
8992831|NCT02787863|10055829|FG006|1 Year After Vaccination|Overall Study||25
8992832|NCT02787863|10055830|FG007|1 Year After Vaccination|Overall Study||27
8992833|NCT02787863|10055823|FG000|4 Years After Vaccination|Overall Study||32
8992834|NCT02787863|10055824|FG001|4 Years After Vaccination|Overall Study||33
8992835|NCT02787863|10055825|FG002|4 Years After Vaccination|Overall Study||23
8992836|NCT02787863|10055826|FG003|4 Years After Vaccination|Overall Study||25
8992837|NCT02787863|10055827|FG004|4 Years After Vaccination|Overall Study||32
8992838|NCT02787863|10055828|FG005|4 Years After Vaccination|Overall Study||18
8572083|NCT00112437|9604123|FG000|STARTED|Years 6-10 (60-Month Extension)||0
8572084|NCT00112437|9604124|FG001|STARTED|Years 6-10 (60-Month Extension)||0
8572085|NCT00112437|9604125|FG002|STARTED|Years 6-10 (60-Month Extension)||0
8572086|NCT00112437|9604126|FG003|STARTED|Years 6-10 (60-Month Extension)||0
8572087|NCT00112437|9604127|FG004|STARTED|Years 6-10 (60-Month Extension)||0
8572088|NCT00112437|9604128|FG005|STARTED|Years 6-10 (60-Month Extension)||0
8572089|NCT00112437|9604129|FG006|STARTED|Years 6-10 (60-Month Extension)||0
8572090|NCT00112437|9604130|FG007|STARTED|Years 6-10 (60-Month Extension)||0
8572091|NCT00112437|9604131|FG008|STARTED|Years 6-10 (60-Month Extension)||0
8572092|NCT00112437|9604132|FG009|STARTED|Years 6-10 (60-Month Extension)||0
8992839|NCT02787863|10055829|FG006|4 Years After Vaccination|Overall Study||25
8992840|NCT02787863|10055830|FG007|4 Years After Vaccination|Overall Study||27
8992841|NCT02787863|10055823|FG000|COMPLETED|Overall Study||32
8572093|NCT00112437|9604133|FG010|STARTED|Years 6-10 (60-Month Extension)||0
8992842|NCT02787863|10055824|FG001|COMPLETED|Overall Study||33
8992843|NCT02787863|10055825|FG002|COMPLETED|Overall Study||23
8992844|NCT02787863|10055826|FG003|COMPLETED|Overall Study||25
8992845|NCT02787863|10055827|FG004|COMPLETED|Overall Study||32
8992846|NCT02787863|10055828|FG005|COMPLETED|Overall Study||18
8992847|NCT02787863|10055829|FG006|COMPLETED|Overall Study||25
8992848|NCT02787863|10055830|FG007|COMPLETED|Overall Study||27
8992849|NCT02787863|10055823|FG000|NOT COMPLETED|Overall Study||1
8992850|NCT02787863|10055824|FG001|NOT COMPLETED|Overall Study||1
8992851|NCT02787863|10055825|FG002|NOT COMPLETED|Overall Study||2
8992852|NCT02787863|10055826|FG003|NOT COMPLETED|Overall Study||0
8992853|NCT02787863|10055827|FG004|NOT COMPLETED|Overall Study||0
8992854|NCT02787863|10055828|FG005|NOT COMPLETED|Overall Study||0
8992855|NCT02787863|10055829|FG006|NOT COMPLETED|Overall Study||0
8992856|NCT02787863|10055830|FG007|NOT COMPLETED|Overall Study||0
8992857|NCT02788019|10055873|FG000|STARTED|Overall Study||27
8992858|NCT02788019|10055874|FG001|STARTED|Overall Study||25
8992859|NCT02788019|10055873|FG000|COMPLETED|Overall Study||23
8992860|NCT02788019|10055874|FG001|COMPLETED|Overall Study||20
8992861|NCT02788019|10055873|FG000|NOT COMPLETED|Overall Study||4
8992862|NCT02788019|10055874|FG001|NOT COMPLETED|Overall Study||5
8992863|NCT02788097|10055882|FG000|STARTED|Overall Study||61
8992864|NCT02788097|10055883|FG001|STARTED|Overall Study||69
8992865|NCT02788097|10055882|FG000|COMPLETED|Overall Study||61
8992866|NCT02788097|10055883|FG001|COMPLETED|Overall Study||69
8992867|NCT02788097|10055882|FG000|NOT COMPLETED|Overall Study||0
8992868|NCT02788097|10055883|FG001|NOT COMPLETED|Overall Study||0
8992869|NCT02788175|10055889|FG000|STARTED|Overall Study||26
8992870|NCT02788175|10055889|FG000|Received Study Agent|Overall Study||20
8992871|NCT02788175|10055889|FG000|COMPLETED|Overall Study||13
8992872|NCT02788175|10055889|FG000|NOT COMPLETED|Overall Study||13
8992873|NCT02788188|10055900|FG000|STARTED|Overall Study||2
8992874|NCT02788188|10055901|FG001|STARTED|Overall Study||2
8992875|NCT02788188|10055902|FG002|STARTED|Overall Study||4
8992876|NCT02788188|10055903|FG003|STARTED|Overall Study||4
8992877|NCT02788188|10055904|FG004|STARTED|Overall Study||8
8992878|NCT02788188|10055905|FG005|STARTED|Overall Study||8
8992879|NCT02788188|10055906|FG006|STARTED|Overall Study||10
8992880|NCT02788188|10055900|FG000|COMPLETED|Overall Study||2
8992881|NCT02788188|10055901|FG001|COMPLETED|Overall Study||2
8992882|NCT02788188|10055902|FG002|COMPLETED|Overall Study||4
8992883|NCT02788188|10055903|FG003|COMPLETED|Overall Study||4
8992884|NCT02788188|10055904|FG004|COMPLETED|Overall Study||8
8572094|NCT00112437|9604134|FG011|STARTED|Years 6-10 (60-Month Extension)||0
8572095|NCT00112437|9604135|FG012|STARTED|Years 6-10 (60-Month Extension)||0
8572096|NCT00112437|9604136|FG013|STARTED|Years 6-10 (60-Month Extension)||0
8572097|NCT00112437|9604137|FG014|STARTED|Years 6-10 (60-Month Extension)||0
8572098|NCT00112437|9604138|FG015|STARTED|Years 6-10 (60-Month Extension)||0
8572099|NCT00112437|9604139|FG016|STARTED|Years 6-10 (60-Month Extension)||0
8572100|NCT00112437|9604140|FG017|STARTED|Years 6-10 (60-Month Extension)||0
8572101|NCT00112437|9604141|FG018|STARTED|Years 6-10 (60-Month Extension)||0
8572102|NCT00112437|9604142|FG019|STARTED|Years 6-10 (60-Month Extension)||0
8572103|NCT00112437|9604143|FG020|STARTED|Years 6-10 (60-Month Extension)||0
8572104|NCT00112437|9604144|FG021|STARTED|Years 6-10 (60-Month Extension)||0
8572105|NCT00112437|9604145|FG022|STARTED|Years 6-10 (60-Month Extension)||28
8572106|NCT00112437|9604146|FG023|STARTED|Years 6-10 (60-Month Extension)||34
8572107|NCT00112437|9604147|FG024|STARTED|Years 6-10 (60-Month Extension)||23
8572108|NCT00112437|9604148|FG025|STARTED|Years 6-10 (60-Month Extension)||32
8572109|NCT00112437|9604123|FG000|COMPLETED|Years 6-10 (60-Month Extension)||0
8572110|NCT00112437|9604124|FG001|COMPLETED|Years 6-10 (60-Month Extension)||0
8572111|NCT00112437|9604125|FG002|COMPLETED|Years 6-10 (60-Month Extension)||0
8572112|NCT00112437|9604126|FG003|COMPLETED|Years 6-10 (60-Month Extension)||0
8572113|NCT00112437|9604127|FG004|COMPLETED|Years 6-10 (60-Month Extension)||0
8572114|NCT00112437|9604128|FG005|COMPLETED|Years 6-10 (60-Month Extension)||0
8992885|NCT02788188|10055905|FG005|COMPLETED|Overall Study||8
8992886|NCT02788188|10055906|FG006|COMPLETED|Overall Study||10
8572115|NCT00112437|9604129|FG006|COMPLETED|Years 6-10 (60-Month Extension)||0
8572116|NCT00112437|9604130|FG007|COMPLETED|Years 6-10 (60-Month Extension)||0
8992887|NCT02788188|10055900|FG000|NOT COMPLETED|Overall Study||0
8992888|NCT02788188|10055901|FG001|NOT COMPLETED|Overall Study||0
8992889|NCT02788188|10055902|FG002|NOT COMPLETED|Overall Study||0
8992890|NCT02788188|10055903|FG003|NOT COMPLETED|Overall Study||0
8992891|NCT02788188|10055904|FG004|NOT COMPLETED|Overall Study||0
8992892|NCT02788188|10055905|FG005|NOT COMPLETED|Overall Study||0
8992893|NCT02788188|10055906|FG006|NOT COMPLETED|Overall Study||0
8992894|NCT02788201|10055928|FG000|STARTED|Overall Study||1
8992895|NCT02788201|10055929|FG001|STARTED|Overall Study||1
8992896|NCT02788201|10055930|FG002|STARTED|Overall Study||1
8992897|NCT02788201|10055931|FG003|STARTED|Overall Study||1
8992898|NCT02788201|10055932|FG004|STARTED|Overall Study||1
8992899|NCT02788201|10055933|FG005|STARTED|Overall Study||3
8992900|NCT02788201|10055928|FG000|Did Not Start Treatment|Overall Study||0
8992901|NCT02788201|10055929|FG001|Did Not Start Treatment|Overall Study||0
8992902|NCT02788201|10055930|FG002|Did Not Start Treatment|Overall Study||0
8992903|NCT02788201|10055931|FG003|Did Not Start Treatment|Overall Study||0
8992904|NCT02788201|10055932|FG004|Did Not Start Treatment|Overall Study||0
8992905|NCT02788201|10055933|FG005|Did Not Start Treatment|Overall Study||3
8992906|NCT02788201|10055928|FG000|COMPLETED|Overall Study||0
8992907|NCT02788201|10055929|FG001|COMPLETED|Overall Study||0
8992908|NCT02788201|10055930|FG002|COMPLETED|Overall Study||0
8992909|NCT02788201|10055931|FG003|COMPLETED|Overall Study||0
8992910|NCT02788201|10055932|FG004|COMPLETED|Overall Study||1
8992911|NCT02788201|10055933|FG005|COMPLETED|Overall Study||0
8992912|NCT02788201|10055928|FG000|NOT COMPLETED|Overall Study||1
8992913|NCT02788201|10055929|FG001|NOT COMPLETED|Overall Study||1
8992914|NCT02788201|10055930|FG002|NOT COMPLETED|Overall Study||1
8992915|NCT02788201|10055931|FG003|NOT COMPLETED|Overall Study||1
8992916|NCT02788201|10055932|FG004|NOT COMPLETED|Overall Study||0
8992917|NCT02788201|10055933|FG005|NOT COMPLETED|Overall Study||3
8992918|NCT02788279|10055952|FG000|STARTED|Overall Study||90
8992919|NCT02788279|10055953|FG001|STARTED|Overall Study||183
8992920|NCT02788279|10055954|FG002|STARTED|Overall Study||90
8992921|NCT02788279|10055952|FG000|Received Treatment (Safety Population)|Overall Study||80
8992922|NCT02788279|10055953|FG001|Received Treatment (Safety Population)|Overall Study||179
8992923|NCT02788279|10055954|FG002|Received Treatment (Safety Population)|Overall Study||90
8992924|NCT02788279|10055952|FG000|Modified ITT Population|Overall Study||57
8992925|NCT02788279|10055953|FG001|Modified ITT Population|Overall Study||125
8992926|NCT02788279|10055954|FG002|Modified ITT Population|Overall Study||61
8992927|NCT02788279|10055952|FG000|COMPLETED|Overall Study||0
8992928|NCT02788279|10055953|FG001|COMPLETED|Overall Study||0
8992929|NCT02788279|10055954|FG002|COMPLETED|Overall Study||0
8992930|NCT02788279|10055952|FG000|NOT COMPLETED|Overall Study||90
8633571|NCT00551759|9673679|FG000|Underwent Surgery|Overall Study||17
8633572|NCT00551759|9673679|FG000|Received Adjuvant Therapy|Overall Study||12
8633573|NCT00551759|9673679|FG000|COMPLETED|Overall Study||9
8633574|NCT00551759|9673679|FG000|NOT COMPLETED|Overall Study||13
8633575|NCT00552058|9673685|FG000|STARTED|Overall Study||223
8633576|NCT00552058|9673686|FG001|STARTED|Overall Study||216
8992931|NCT02788279|10055953|FG001|NOT COMPLETED|Overall Study||183
8992932|NCT02788279|10055954|FG002|NOT COMPLETED|Overall Study||90
8992933|NCT02788357|10055967|FG000|STARTED|Overall Study||6
8633577|NCT00552058|9673685|FG000|COMPLETED|Overall Study||207
8633578|NCT00552058|9673686|FG001|COMPLETED|Overall Study||192
8633579|NCT00552058|9673685|FG000|NOT COMPLETED|Overall Study||16
8633580|NCT00552058|9673686|FG001|NOT COMPLETED|Overall Study||24
8992934|NCT02788357|10055968|FG001|STARTED|Overall Study||6
8992935|NCT02788357|10055967|FG000|COMPLETED|Overall Study||3
8992936|NCT02788357|10055968|FG001|COMPLETED|Overall Study||6
8992937|NCT02788357|10055967|FG000|NOT COMPLETED|Overall Study||3
8992938|NCT02788357|10055968|FG001|NOT COMPLETED|Overall Study||0
8992939|NCT02788474|10055976|FG000|STARTED|Double Blind Treatment Period||231
8992940|NCT02788474|10055977|FG001|STARTED|Double Blind Treatment Period||116
8992941|NCT02788474|10055976|FG000|Treated|Double Blind Treatment Period||230
8992942|NCT02788474|10055977|FG001|Treated|Double Blind Treatment Period||116
8992943|NCT02788474|10055976|FG000|COMPLETED|Double Blind Treatment Period||221
8992944|NCT02788474|10055977|FG001|COMPLETED|Double Blind Treatment Period||112
8992945|NCT02788474|10055976|FG000|NOT COMPLETED|Double Blind Treatment Period||10
8992946|NCT02788474|10055977|FG001|NOT COMPLETED|Double Blind Treatment Period||4
8992947|NCT02788474|10055976|FG000|STARTED|Open Label Treatment Period||221
8992948|NCT02788474|10055977|FG001|STARTED|Open Label Treatment Period||112
8992949|NCT02788474|10055976|FG000|COMPLETED|Open Label Treatment Period||189
8992950|NCT02788474|10055977|FG001|COMPLETED|Open Label Treatment Period||100
8992951|NCT02788474|10055976|FG000|NOT COMPLETED|Open Label Treatment Period||32
8992952|NCT02788474|10055977|FG001|NOT COMPLETED|Open Label Treatment Period||12
8992953|NCT02788513|10055989|FG000|STARTED|Overall Study||123
8992954|NCT02788513|10055990|FG001|STARTED|Overall Study||122
8992955|NCT02788513|10055991|FG002|STARTED|Overall Study||122
8992956|NCT02788513|10055992|FG003|STARTED|Overall Study||123
8992957|NCT02788513|10055993|FG004|STARTED|Overall Study||120
8992958|NCT02788513|10055989|FG000|COMPLETED|Overall Study||114
8992959|NCT02788513|10055990|FG001|COMPLETED|Overall Study||114
8992960|NCT02788513|10055991|FG002|COMPLETED|Overall Study||114
8992961|NCT02788513|10055992|FG003|COMPLETED|Overall Study||117
8992962|NCT02788513|10055993|FG004|COMPLETED|Overall Study||115
8992963|NCT02788513|10055989|FG000|NOT COMPLETED|Overall Study||9
8992964|NCT02788513|10055990|FG001|NOT COMPLETED|Overall Study||8
8992965|NCT02788513|10055991|FG002|NOT COMPLETED|Overall Study||8
8992966|NCT02788513|10055992|FG003|NOT COMPLETED|Overall Study||6
8992967|NCT02788513|10055993|FG004|NOT COMPLETED|Overall Study||5
8992968|NCT02788656|10056007|FG000|STARTED|Overall Study||2
8992969|NCT02788656|10056008|FG001|STARTED|Overall Study||2
8992970|NCT02788656|10056007|FG000|COMPLETED|Overall Study||1
8992971|NCT02788656|10056008|FG001|COMPLETED|Overall Study||2
8992972|NCT02788656|10056007|FG000|NOT COMPLETED|Overall Study||1
8992973|NCT02788656|10056008|FG001|NOT COMPLETED|Overall Study||0
8992974|NCT02788747|10056017|FG000|STARTED|Overall Study||23
8992975|NCT02788747|10056018|FG001|STARTED|Overall Study||24
8992976|NCT02788747|10056019|FG002|STARTED|Overall Study||24
8992977|NCT02788747|10056017|FG000|COMPLETED|Overall Study||22
8992978|NCT02788747|10056018|FG001|COMPLETED|Overall Study||24
8992979|NCT02788747|10056019|FG002|COMPLETED|Overall Study||24
8992980|NCT02788747|10056017|FG000|NOT COMPLETED|Overall Study||1
8992981|NCT02788747|10056018|FG001|NOT COMPLETED|Overall Study||0
8992982|NCT02788747|10056019|FG002|NOT COMPLETED|Overall Study||0
8992983|NCT02788903|10056032|FG000|STARTED|Overall Study||567908
8992984|NCT02788903|10056033|FG001|STARTED|Overall Study||2054256
8992985|NCT02788903|10056032|FG000|COMPLETED|Overall Study||567908
8992986|NCT02788903|10056033|FG001|COMPLETED|Overall Study||2054256
8992987|NCT02788903|10056032|FG000|NOT COMPLETED|Overall Study||0
8992988|NCT02788903|10056033|FG001|NOT COMPLETED|Overall Study||0
8992989|NCT02789033|10056045|FG000|STARTED|Overall Study||17
8992990|NCT02789033|10056046|FG001|STARTED|Overall Study||17
8992991|NCT02789033|10056047|FG002|STARTED|Overall Study||17
8992992|NCT02789033|10056048|FG003|STARTED|Overall Study||17
8992993|NCT02789033|10056045|FG000|COMPLETED|Overall Study||15
8992994|NCT02789033|10056046|FG001|COMPLETED|Overall Study||15
8633581|NCT00552071|9673694|FG000|STARTED|Overall Study||10
8633582|NCT00552071|9673695|FG001|STARTED|Overall Study||11
8633583|NCT00552071|9673694|FG000|COMPLETED|Overall Study||6
8633584|NCT00552071|9673695|FG001|COMPLETED|Overall Study||9
8633585|NCT00552071|9673694|FG000|NOT COMPLETED|Overall Study||4
8992995|NCT02789033|10056047|FG002|COMPLETED|Overall Study||16
8992996|NCT02789033|10056048|FG003|COMPLETED|Overall Study||15
8992997|NCT02789033|10056045|FG000|NOT COMPLETED|Overall Study||2
8992998|NCT02789033|10056046|FG001|NOT COMPLETED|Overall Study||2
8992999|NCT02789033|10056047|FG002|NOT COMPLETED|Overall Study||1
8993000|NCT02789033|10056048|FG003|NOT COMPLETED|Overall Study||2
8993001|NCT02789111|10056060|FG000|STARTED|Overall Study||24
8993002|NCT02789111|10056061|FG001|STARTED|Overall Study||25
8993003|NCT02789111|10056060|FG000|COMPLETED|Overall Study||23
8993004|NCT02789111|10056061|FG001|COMPLETED|Overall Study||21
8993005|NCT02789111|10056060|FG000|NOT COMPLETED|Overall Study||1
8993006|NCT02789111|10056061|FG001|NOT COMPLETED|Overall Study||4
8993007|NCT02789137|10056069|FG000|STARTED|Overall Study||111
8993008|NCT02789137|10056069|FG000|COMPLETED|Overall Study||53
8993009|NCT02789137|10056069|FG000|NOT COMPLETED|Overall Study||58
8993010|NCT02789176|10056078|FG000|STARTED|Overall Study||99
8993011|NCT02789176|10056079|FG001|STARTED|Overall Study||55
8993012|NCT02789176|10056080|FG002|STARTED|Overall Study||95
8993013|NCT02789176|10056081|FG003|STARTED|Overall Study||54
8993014|NCT02789176|10056078|FG000|COMPLETED|Overall Study||91
8993015|NCT02789176|10056079|FG001|COMPLETED|Overall Study||53
8993016|NCT02789176|10056080|FG002|COMPLETED|Overall Study||85
8993017|NCT02789176|10056081|FG003|COMPLETED|Overall Study||53
8993018|NCT02789176|10056078|FG000|NOT COMPLETED|Overall Study||8
8879154|NCT01932437|9935983|FG000|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||2
8879155|NCT01932437|9935984|FG001|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
8879156|NCT01932437|9935985|FG002|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||6
8879157|NCT01932437|9935986|FG003|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
8879158|NCT01932437|9935987|FG004|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
8879159|NCT01932437|9935988|FG005|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
8879160|NCT01932437|9935983|FG000|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
8879161|NCT01932437|9935984|FG001|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
8879162|NCT01932437|9935985|FG002|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
8879163|NCT01932437|9935986|FG003|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
8879164|NCT01932437|9935987|FG004|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
8993019|NCT02789176|10056079|FG001|NOT COMPLETED|Overall Study||2
8993020|NCT02789176|10056080|FG002|NOT COMPLETED|Overall Study||10
8572117|NCT00112437|9604131|FG008|COMPLETED|Years 6-10 (60-Month Extension)||0
8572118|NCT00112437|9604132|FG009|COMPLETED|Years 6-10 (60-Month Extension)||0
8572119|NCT00112437|9604133|FG010|COMPLETED|Years 6-10 (60-Month Extension)||0
8572120|NCT00112437|9604134|FG011|COMPLETED|Years 6-10 (60-Month Extension)||0
8993021|NCT02789176|10056081|FG003|NOT COMPLETED|Overall Study||1
8993022|NCT02789410|10056093|FG000|STARTED|Overall Study||66
8993023|NCT02789410|10056094|FG001|STARTED|Overall Study||68
8993024|NCT02789410|10056093|FG000|COMPLETED|Overall Study||66
8993025|NCT02789410|10056094|FG001|COMPLETED|Overall Study||68
8993026|NCT02789410|10056093|FG000|NOT COMPLETED|Overall Study||0
8993027|NCT02789410|10056094|FG001|NOT COMPLETED|Overall Study||0
8993028|NCT02790073|10056100|FG000|STARTED|Overall Study||14
8993029|NCT02790073|10056100|FG000|COMPLETED|Overall Study||11
8993030|NCT02790073|10056100|FG000|NOT COMPLETED|Overall Study||3
8993031|NCT02790281|10056104|FG000|STARTED|Overall Study||33
8993032|NCT02790281|10056104|FG000|COMPLETED|Overall Study||33
8993033|NCT02790281|10056104|FG000|NOT COMPLETED|Overall Study||0
8993034|NCT02790437|10056110|FG000|STARTED|Overall Study||16
8993035|NCT02790437|10056111|FG001|STARTED|Overall Study||3
8993036|NCT02790437|10056110|FG000|COMPLETED|Overall Study||13
8993037|NCT02790437|10056111|FG001|COMPLETED|Overall Study||3
8993038|NCT02790437|10056110|FG000|NOT COMPLETED|Overall Study||3
8993039|NCT02790437|10056111|FG001|NOT COMPLETED|Overall Study||0
8993040|NCT02790463|10056126|FG000|STARTED|Overall Study||782
8993041|NCT02790463|10056127|FG001|STARTED|Overall Study||681
8993042|NCT02790463|10056126|FG000|COMPLETED|Overall Study||782
8993043|NCT02790463|10056127|FG001|COMPLETED|Overall Study||372
8993044|NCT02790463|10056126|FG000|NOT COMPLETED|Overall Study||0
8993045|NCT02790463|10056127|FG001|NOT COMPLETED|Overall Study||309
8993046|NCT02790606|10056133|FG000|STARTED|Overall Study||110
8993047|NCT02790606|10056133|FG000|COMPLETED|Overall Study||75
8993048|NCT02790606|10056133|FG000|NOT COMPLETED|Overall Study||35
8993049|NCT02790736|10056139|FG000|STARTED|Overall Study||5
8993050|NCT02790736|10056140|FG001|STARTED|Overall Study||1
8993051|NCT02790736|10056139|FG000|COMPLETED|Overall Study||5
8993052|NCT02790736|10056140|FG001|COMPLETED|Overall Study||1
8993053|NCT02790736|10056139|FG000|NOT COMPLETED|Overall Study||0
8993054|NCT02790736|10056140|FG001|NOT COMPLETED|Overall Study||0
8993055|NCT02790788|10056148|FG000|STARTED|Overall Study||46
8993056|NCT02790788|10056149|FG001|STARTED|Overall Study||54
8993057|NCT02790788|10056148|FG000|COMPLETED|Overall Study||46
8993058|NCT02790788|10056149|FG001|COMPLETED|Overall Study||54
8993059|NCT02790788|10056148|FG000|NOT COMPLETED|Overall Study||0
8993060|NCT02790788|10056149|FG001|NOT COMPLETED|Overall Study||0
8993061|NCT02791191|10056160|FG000|STARTED|Overall Study||55
8993062|NCT02791191|10056161|FG001|STARTED|Overall Study||128
8993063|NCT02791191|10056162|FG002|STARTED|Overall Study||133
8993064|NCT02791191|10056160|FG000|Received One Dose of Study Drug|Overall Study||55
8993065|NCT02791191|10056161|FG001|Received One Dose of Study Drug|Overall Study||127
8993066|NCT02791191|10056162|FG002|Received One Dose of Study Drug|Overall Study||133
8993067|NCT02791191|10056160|FG000|COMPLETED|Overall Study||17
8993068|NCT02791191|10056161|FG001|COMPLETED|Overall Study||17
8993069|NCT02791191|10056162|FG002|COMPLETED|Overall Study||13
8993070|NCT02791191|10056160|FG000|NOT COMPLETED|Overall Study||38
8993071|NCT02791191|10056161|FG001|NOT COMPLETED|Overall Study||111
8993072|NCT02791191|10056162|FG002|NOT COMPLETED|Overall Study||120
8993073|NCT02791269|10056172|FG000|STARTED|Overall Study||4
8993074|NCT02791269|10056173|FG001|STARTED|Overall Study||20
8993075|NCT02791269|10056172|FG000|COMPLETED|Overall Study||4
8993076|NCT02791269|10056173|FG001|COMPLETED|Overall Study||19
8993077|NCT02791269|10056172|FG000|NOT COMPLETED|Overall Study||0
8993078|NCT02791269|10056173|FG001|NOT COMPLETED|Overall Study||1
8993079|NCT02791308|10056184|FG000|STARTED|Overall Study||195
8993080|NCT02791308|10056185|FG001|STARTED|Overall Study||196
8993081|NCT02791308|10056186|FG002|STARTED|Overall Study||196
8993082|NCT02791308|10056184|FG000|COMPLETED|Overall Study||185
8993083|NCT02791308|10056185|FG001|COMPLETED|Overall Study||187
8993084|NCT02791308|10056186|FG002|COMPLETED|Overall Study||179
8993085|NCT02791308|10056184|FG000|NOT COMPLETED|Overall Study||10
8993086|NCT02791308|10056185|FG001|NOT COMPLETED|Overall Study||9
8993087|NCT02791308|10056186|FG002|NOT COMPLETED|Overall Study||17
8993088|NCT02791399|10056196|FG000|STARTED|Overall Study||136
8993089|NCT02791399|10056197|FG001|STARTED|Overall Study||150
8993090|NCT02791399|10056196|FG000|COMPLETED|Overall Study||123
8993091|NCT02791399|10056197|FG001|COMPLETED|Overall Study||135
8993092|NCT02791399|10056196|FG000|NOT COMPLETED|Overall Study||13
8993093|NCT02791399|10056197|FG001|NOT COMPLETED|Overall Study||15
8993094|NCT02791438|10056205|FG000|STARTED|Run-In Period||22
8993095|NCT02791438|10056206|FG001|STARTED|Run-In Period||5
8993096|NCT02791438|10056205|FG000|COMPLETED|Run-In Period||22
8993097|NCT02791438|10056206|FG001|COMPLETED|Run-In Period||5
8993098|NCT02791438|10056205|FG000|NOT COMPLETED|Run-In Period||0
8993099|NCT02791438|10056206|FG001|NOT COMPLETED|Run-In Period||0
8993100|NCT02791438|10056205|FG000|STARTED|Treatment Period||22
8993101|NCT02791438|10056206|FG001|STARTED|Treatment Period||5
8993102|NCT02791438|10056205|FG000|COMPLETED|Treatment Period||19
8993103|NCT02791438|10056206|FG001|COMPLETED|Treatment Period||4
8993104|NCT02791438|10056205|FG000|NOT COMPLETED|Treatment Period||3
8993105|NCT02791438|10056206|FG001|NOT COMPLETED|Treatment Period||1
8993106|NCT02791490|10056214|FG000|STARTED|Overall Study||229
8993107|NCT02791490|10056215|FG001|STARTED|Overall Study||229
8993108|NCT02791490|10056214|FG000|COMPLETED|Overall Study||226
8993109|NCT02791490|10056215|FG001|COMPLETED|Overall Study||221
8993110|NCT02791490|10056214|FG000|NOT COMPLETED|Overall Study||3
8993111|NCT02791490|10056215|FG001|NOT COMPLETED|Overall Study||8
8993112|NCT02791516|10056223|FG000|STARTED|Overall Study||33
8993113|NCT02791516|10056224|FG001|STARTED|Overall Study||34
8993114|NCT02791516|10056223|FG000|Completed 6-month Treatment Period|Overall Study||33
8993115|NCT02791516|10056224|FG001|Completed 6-month Treatment Period|Overall Study||33
8993116|NCT02791516|10056223|FG000|COMPLETED|Overall Study||32
8993117|NCT02791516|10056224|FG001|COMPLETED|Overall Study||33
8993118|NCT02791516|10056223|FG000|NOT COMPLETED|Overall Study||1
8993119|NCT02791516|10056224|FG001|NOT COMPLETED|Overall Study||1
8993120|NCT02791659|10056232|FG000|STARTED|Overall Study||27
8993121|NCT02791659|10056233|FG001|STARTED|Overall Study||28
8993122|NCT02791659|10056232|FG000|COMPLETED|Overall Study||27
8993123|NCT02791659|10056233|FG001|COMPLETED|Overall Study||27
8993124|NCT02791659|10056232|FG000|NOT COMPLETED|Overall Study||0
8993125|NCT02791659|10056233|FG001|NOT COMPLETED|Overall Study||1
8993126|NCT02791763|10056242|FG000|STARTED|Overall Study||149
8993127|NCT02791763|10056243|FG001|STARTED|Overall Study||150
8993128|NCT02791763|10056244|FG002|STARTED|Overall Study||56
8993129|NCT02791763|10056242|FG000|COMPLETED|Overall Study||111
8993130|NCT02791763|10056243|FG001|COMPLETED|Overall Study||113
8993131|NCT02791763|10056244|FG002|COMPLETED|Overall Study||43
8993132|NCT02791763|10056242|FG000|NOT COMPLETED|Overall Study||38
8993133|NCT02791763|10056243|FG001|NOT COMPLETED|Overall Study||37
8993134|NCT02791763|10056244|FG002|NOT COMPLETED|Overall Study||13
8993135|NCT02791893|10056263|FG000|STARTED|Blinded Phase||13
8993136|NCT02791893|10056264|FG001|STARTED|Blinded Phase||14
8993137|NCT02791893|10056263|FG000|COMPLETED|Blinded Phase||10
8993138|NCT02791893|10056264|FG001|COMPLETED|Blinded Phase||10
8993139|NCT02791893|10056263|FG000|NOT COMPLETED|Blinded Phase||3
8993140|NCT02791893|10056264|FG001|NOT COMPLETED|Blinded Phase||4
8993141|NCT02791893|10056263|FG000|STARTED|Open Label Phase||10
8993142|NCT02791893|10056264|FG001|STARTED|Open Label Phase||10
8993143|NCT02791893|10056263|FG000|COMPLETED|Open Label Phase||7
8993144|NCT02791893|10056264|FG001|COMPLETED|Open Label Phase||8
8993145|NCT02791893|10056263|FG000|NOT COMPLETED|Open Label Phase||3
8993146|NCT02791893|10056264|FG001|NOT COMPLETED|Open Label Phase||2
8993147|NCT02791906|10056272|FG000|STARTED|Overall Study||4
8993148|NCT02791906|10056273|FG001|STARTED|Overall Study||3
8993149|NCT02791906|10056272|FG000|COMPLETED|Overall Study||2
8993150|NCT02791906|10056273|FG001|COMPLETED|Overall Study||2
8993151|NCT02791906|10056272|FG000|NOT COMPLETED|Overall Study||2
8993152|NCT02791906|10056273|FG001|NOT COMPLETED|Overall Study||1
8993153|NCT02791945|10056283|FG000|STARTED|Overall Study||14
8993154|NCT02791945|10056284|FG001|STARTED|Overall Study||16
8993155|NCT02791945|10056283|FG000|COMPLETED|Overall Study||12
8993156|NCT02791945|10056284|FG001|COMPLETED|Overall Study||14
8993157|NCT02791945|10056283|FG000|NOT COMPLETED|Overall Study||2
8993158|NCT02791945|10056284|FG001|NOT COMPLETED|Overall Study||2
8993159|NCT02792049|10056292|FG000|STARTED|Overall Study||35
8993160|NCT02792049|10056293|FG001|STARTED|Overall Study||35
8993161|NCT02792049|10056292|FG000|COMPLETED|Overall Study||35
8993162|NCT02792049|10056293|FG001|COMPLETED|Overall Study||35
8993163|NCT02792049|10056292|FG000|NOT COMPLETED|Overall Study||0
8993164|NCT02792049|10056293|FG001|NOT COMPLETED|Overall Study||0
8993165|NCT02792062|10056307|FG000|STARTED|Intervention Period 1 (6 Days)||2
8993166|NCT02792062|10056308|FG001|STARTED|Intervention Period 1 (6 Days)||2
8993167|NCT02792062|10056309|FG002|STARTED|Intervention Period 1 (6 Days)||2
8993168|NCT02792062|10056310|FG003|STARTED|Intervention Period 1 (6 Days)||2
8993169|NCT02792062|10056311|FG004|STARTED|Intervention Period 1 (6 Days)||2
8993170|NCT02792062|10056312|FG005|STARTED|Intervention Period 1 (6 Days)||2
8993171|NCT02792062|10056307|FG000|COMPLETED|Intervention Period 1 (6 Days)||2
8993172|NCT02792062|10056308|FG001|COMPLETED|Intervention Period 1 (6 Days)||2
8993173|NCT02792062|10056309|FG002|COMPLETED|Intervention Period 1 (6 Days)||2
8993174|NCT02792062|10056310|FG003|COMPLETED|Intervention Period 1 (6 Days)||2
8993175|NCT02792062|10056311|FG004|COMPLETED|Intervention Period 1 (6 Days)||2
8993176|NCT02792062|10056312|FG005|COMPLETED|Intervention Period 1 (6 Days)||2
8993177|NCT02792062|10056307|FG000|NOT COMPLETED|Intervention Period 1 (6 Days)||0
8993178|NCT02792062|10056308|FG001|NOT COMPLETED|Intervention Period 1 (6 Days)||0
8993179|NCT02792062|10056309|FG002|NOT COMPLETED|Intervention Period 1 (6 Days)||0
8993180|NCT02792062|10056310|FG003|NOT COMPLETED|Intervention Period 1 (6 Days)||0
8993181|NCT02792062|10056311|FG004|NOT COMPLETED|Intervention Period 1 (6 Days)||0
8993182|NCT02792062|10056312|FG005|NOT COMPLETED|Intervention Period 1 (6 Days)||0
8993183|NCT02792062|10056307|FG000|STARTED|Washout Period (at Least 14 Days)||2
8993184|NCT02792062|10056308|FG001|STARTED|Washout Period (at Least 14 Days)||2
8993185|NCT02792062|10056309|FG002|STARTED|Washout Period (at Least 14 Days)||2
8993186|NCT02792062|10056310|FG003|STARTED|Washout Period (at Least 14 Days)||2
8993187|NCT02792062|10056311|FG004|STARTED|Washout Period (at Least 14 Days)||2
8993188|NCT02792062|10056312|FG005|STARTED|Washout Period (at Least 14 Days)||2
8993189|NCT02792062|10056307|FG000|COMPLETED|Washout Period (at Least 14 Days)||2
8993190|NCT02792062|10056308|FG001|COMPLETED|Washout Period (at Least 14 Days)||2
8993191|NCT02792062|10056309|FG002|COMPLETED|Washout Period (at Least 14 Days)||2
8993192|NCT02792062|10056310|FG003|COMPLETED|Washout Period (at Least 14 Days)||2
8993193|NCT02792062|10056311|FG004|COMPLETED|Washout Period (at Least 14 Days)||2
8993194|NCT02792062|10056312|FG005|COMPLETED|Washout Period (at Least 14 Days)||2
8993195|NCT02792062|10056307|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8993196|NCT02792062|10056308|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8993197|NCT02792062|10056309|FG002|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8993198|NCT02792062|10056310|FG003|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8993199|NCT02792062|10056311|FG004|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8993200|NCT02792062|10056312|FG005|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8993201|NCT02792062|10056307|FG000|STARTED|Intervention Period 2 (6 Days)||2
8993202|NCT02792062|10056308|FG001|STARTED|Intervention Period 2 (6 Days)||2
8993203|NCT02792062|10056309|FG002|STARTED|Intervention Period 2 (6 Days)||2
8993204|NCT02792062|10056310|FG003|STARTED|Intervention Period 2 (6 Days)||2
8993205|NCT02792062|10056311|FG004|STARTED|Intervention Period 2 (6 Days)||2
8993206|NCT02792062|10056312|FG005|STARTED|Intervention Period 2 (6 Days)||2
8993207|NCT02792062|10056307|FG000|COMPLETED|Intervention Period 2 (6 Days)||2
8993208|NCT02792062|10056308|FG001|COMPLETED|Intervention Period 2 (6 Days)||2
8993209|NCT02792062|10056309|FG002|COMPLETED|Intervention Period 2 (6 Days)||2
8993210|NCT02792062|10056310|FG003|COMPLETED|Intervention Period 2 (6 Days)||2
8993211|NCT02792062|10056311|FG004|COMPLETED|Intervention Period 2 (6 Days)||2
8993212|NCT02792062|10056312|FG005|COMPLETED|Intervention Period 2 (6 Days)||2
8993213|NCT02792062|10056307|FG000|NOT COMPLETED|Intervention Period 2 (6 Days)||0
8993214|NCT02792062|10056308|FG001|NOT COMPLETED|Intervention Period 2 (6 Days)||0
8993215|NCT02792062|10056309|FG002|NOT COMPLETED|Intervention Period 2 (6 Days)||0
8993216|NCT02792062|10056310|FG003|NOT COMPLETED|Intervention Period 2 (6 Days)||0
8993217|NCT02792062|10056311|FG004|NOT COMPLETED|Intervention Period 2 (6 Days)||0
8993218|NCT02792062|10056312|FG005|NOT COMPLETED|Intervention Period 2 (6 Days)||0
8993219|NCT02792062|10056307|FG000|STARTED|Washout Period (at Least 14 Days)||2
8993220|NCT02792062|10056308|FG001|STARTED|Washout Period (at Least 14 Days)||2
8993221|NCT02792062|10056309|FG002|STARTED|Washout Period (at Least 14 Days)||2
8993222|NCT02792062|10056310|FG003|STARTED|Washout Period (at Least 14 Days)||2
8993223|NCT02792062|10056311|FG004|STARTED|Washout Period (at Least 14 Days)||2
8993224|NCT02792062|10056312|FG005|STARTED|Washout Period (at Least 14 Days)||2
8993225|NCT02792062|10056307|FG000|COMPLETED|Washout Period (at Least 14 Days)||1
8993226|NCT02792062|10056308|FG001|COMPLETED|Washout Period (at Least 14 Days)||2
8993227|NCT02792062|10056309|FG002|COMPLETED|Washout Period (at Least 14 Days)||2
8993228|NCT02792062|10056310|FG003|COMPLETED|Washout Period (at Least 14 Days)||2
8993229|NCT02792062|10056311|FG004|COMPLETED|Washout Period (at Least 14 Days)||2
8993230|NCT02792062|10056312|FG005|COMPLETED|Washout Period (at Least 14 Days)||2
8993231|NCT02792062|10056307|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||1
8993232|NCT02792062|10056308|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8993233|NCT02792062|10056309|FG002|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8993234|NCT02792062|10056310|FG003|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8993235|NCT02792062|10056311|FG004|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8572121|NCT00112437|9604135|FG012|COMPLETED|Years 6-10 (60-Month Extension)||0
8572122|NCT00112437|9604136|FG013|COMPLETED|Years 6-10 (60-Month Extension)||0
8572123|NCT00112437|9604137|FG014|COMPLETED|Years 6-10 (60-Month Extension)||0
8572124|NCT00112437|9604138|FG015|COMPLETED|Years 6-10 (60-Month Extension)||0
8572125|NCT00112437|9604139|FG016|COMPLETED|Years 6-10 (60-Month Extension)||0
8572126|NCT00112437|9604140|FG017|COMPLETED|Years 6-10 (60-Month Extension)||0
8572127|NCT00112437|9604141|FG018|COMPLETED|Years 6-10 (60-Month Extension)||0
8572128|NCT00112437|9604142|FG019|COMPLETED|Years 6-10 (60-Month Extension)||0
8572129|NCT00112437|9604143|FG020|COMPLETED|Years 6-10 (60-Month Extension)||0
8572130|NCT00112437|9604144|FG021|COMPLETED|Years 6-10 (60-Month Extension)||0
8572131|NCT00112437|9604145|FG022|COMPLETED|Years 6-10 (60-Month Extension)||23
8572132|NCT00112437|9604146|FG023|COMPLETED|Years 6-10 (60-Month Extension)||22
8572133|NCT00112437|9604147|FG024|COMPLETED|Years 6-10 (60-Month Extension)||22
8572134|NCT00112437|9604148|FG025|COMPLETED|Years 6-10 (60-Month Extension)||27
8572135|NCT00112437|9604123|FG000|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
8572136|NCT00112437|9604124|FG001|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
8572137|NCT00112437|9604125|FG002|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
8572138|NCT00112437|9604126|FG003|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
8572139|NCT00112437|9604127|FG004|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
8572140|NCT00112437|9604128|FG005|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
8572141|NCT00112437|9604129|FG006|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
8572142|NCT00112437|9604130|FG007|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
8993236|NCT02792062|10056312|FG005|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8993237|NCT02792062|10056307|FG000|STARTED|Intervention Period 3 (6 Days)||1
8993238|NCT02792062|10056308|FG001|STARTED|Intervention Period 3 (6 Days)||2
8993239|NCT02792062|10056309|FG002|STARTED|Intervention Period 3 (6 Days)||2
8993240|NCT02792062|10056310|FG003|STARTED|Intervention Period 3 (6 Days)||2
8993241|NCT02792062|10056311|FG004|STARTED|Intervention Period 3 (6 Days)||2
8993242|NCT02792062|10056312|FG005|STARTED|Intervention Period 3 (6 Days)||2
8993243|NCT02792062|10056307|FG000|COMPLETED|Intervention Period 3 (6 Days)||1
8993244|NCT02792062|10056308|FG001|COMPLETED|Intervention Period 3 (6 Days)||2
8993245|NCT02792062|10056309|FG002|COMPLETED|Intervention Period 3 (6 Days)||2
8993246|NCT02792062|10056310|FG003|COMPLETED|Intervention Period 3 (6 Days)||2
8993247|NCT02792062|10056311|FG004|COMPLETED|Intervention Period 3 (6 Days)||2
8993248|NCT02792062|10056312|FG005|COMPLETED|Intervention Period 3 (6 Days)||2
8993249|NCT02792062|10056307|FG000|NOT COMPLETED|Intervention Period 3 (6 Days)||0
8993250|NCT02792062|10056308|FG001|NOT COMPLETED|Intervention Period 3 (6 Days)||0
8993251|NCT02792062|10056309|FG002|NOT COMPLETED|Intervention Period 3 (6 Days)||0
8993252|NCT02792062|10056310|FG003|NOT COMPLETED|Intervention Period 3 (6 Days)||0
8993253|NCT02792062|10056311|FG004|NOT COMPLETED|Intervention Period 3 (6 Days)||0
8993254|NCT02792062|10056312|FG005|NOT COMPLETED|Intervention Period 3 (6 Days)||0
8993255|NCT02792192|10056324|FG000|STARTED|Overall Study||12
8993256|NCT02792192|10056325|FG001|STARTED|Overall Study||12
8993257|NCT02792192|10056326|FG002|STARTED|Overall Study||0
8993258|NCT02792192|10056327|FG003|STARTED|Overall Study||0
8993259|NCT02792192|10056324|FG000|COMPLETED|Overall Study||0
8993260|NCT02792192|10056325|FG001|COMPLETED|Overall Study||1
8993261|NCT02792192|10056326|FG002|COMPLETED|Overall Study||0
8993262|NCT02792192|10056327|FG003|COMPLETED|Overall Study||0
8993263|NCT02792192|10056324|FG000|NOT COMPLETED|Overall Study||12
8993264|NCT02792192|10056325|FG001|NOT COMPLETED|Overall Study||11
8993265|NCT02792192|10056326|FG002|NOT COMPLETED|Overall Study||0
8993266|NCT02792192|10056327|FG003|NOT COMPLETED|Overall Study||0
8993267|NCT02792218|10056340|FG000|STARTED|Overall Study||465
8993268|NCT02792218|10056341|FG001|STARTED|Overall Study||462
8993269|NCT02792218|10056340|FG000|COMPLETED|Overall Study||416
8993270|NCT02792218|10056341|FG001|COMPLETED|Overall Study||381
8993271|NCT02792218|10056340|FG000|NOT COMPLETED|Overall Study||49
8993272|NCT02792218|10056341|FG001|NOT COMPLETED|Overall Study||81
8993273|NCT02792231|10056349|FG000|STARTED|Overall Study||481
8993274|NCT02792231|10056350|FG001|STARTED|Overall Study||474
8993275|NCT02792231|10056349|FG000|COMPLETED|Overall Study||399
8993276|NCT02792231|10056350|FG001|COMPLETED|Overall Study||390
8993277|NCT02792231|10056349|FG000|NOT COMPLETED|Overall Study||82
8993278|NCT02792231|10056350|FG001|NOT COMPLETED|Overall Study||84
8993279|NCT02792504|10056356|FG000|STARTED|Overall Study||669
8993280|NCT02792504|10056356|FG000|Safety Analysis Set|Overall Study||639
8993281|NCT02792504|10056356|FG000|Efficacy Analysis Set|Overall Study||390
8993282|NCT02792504|10056356|FG000|COMPLETED|Overall Study||639
8993283|NCT02792504|10056356|FG000|NOT COMPLETED|Overall Study||30
8993284|NCT02792517|10056360|FG000|STARTED|Overall Study||41
8993285|NCT02792517|10056360|FG000|Received Erenumab|Overall Study||24
8993286|NCT02792517|10056360|FG000|COMPLETED|Overall Study||21
8993287|NCT02792517|10056360|FG000|NOT COMPLETED|Overall Study||20
8993288|NCT02792699|10056367|FG000|STARTED|Overall Study||104
8993289|NCT02792699|10056368|FG001|STARTED|Overall Study||104
8993290|NCT02792699|10056369|FG002|STARTED|Overall Study||103
8993291|NCT02792699|10056367|FG000|Received First Infusion of First Dose|Overall Study||104
8993292|NCT02792699|10056368|FG001|Received First Infusion of First Dose|Overall Study||104
8993293|NCT02792699|10056369|FG002|Received First Infusion of First Dose|Overall Study||103
8993294|NCT02792699|10056367|FG000|Received Second Infusion of First Dose|Overall Study||102
8993295|NCT02792699|10056368|FG001|Received Second Infusion of First Dose|Overall Study||103
8993296|NCT02792699|10056369|FG002|Received Second Infusion of First Dose|Overall Study||99
8993297|NCT02792699|10056367|FG000|Received First Infusion of Second Dose|Overall Study||97
8993298|NCT02792699|10056368|FG001|Received First Infusion of Second Dose|Overall Study||99
8993299|NCT02792699|10056369|FG002|Received First Infusion of Second Dose|Overall Study||95
8993300|NCT02792699|10056367|FG000|Received Second Infusion of Second Dose|Overall Study||97
8993301|NCT02792699|10056368|FG001|Received Second Infusion of Second Dose|Overall Study||99
8993302|NCT02792699|10056369|FG002|Received Second Infusion of Second Dose|Overall Study||93
8993303|NCT02792699|10056367|FG000|COMPLETED|Overall Study||95
8993304|NCT02792699|10056368|FG001|COMPLETED|Overall Study||94
8993305|NCT02792699|10056369|FG002|COMPLETED|Overall Study||93
8993306|NCT02792699|10056367|FG000|NOT COMPLETED|Overall Study||9
8993307|NCT02792699|10056368|FG001|NOT COMPLETED|Overall Study||10
8993308|NCT02792699|10056369|FG002|NOT COMPLETED|Overall Study||10
8993309|NCT02792777|10056386|FG000|STARTED|Overall Study||96
8993310|NCT02792777|10056387|FG001|STARTED|Overall Study||52
8993311|NCT02792777|10056386|FG000|COMPLETED|Overall Study||89
8993312|NCT02792777|10056387|FG001|COMPLETED|Overall Study||52
8993313|NCT02792777|10056386|FG000|NOT COMPLETED|Overall Study||7
8993314|NCT02792777|10056387|FG001|NOT COMPLETED|Overall Study||0
8993315|NCT02792829|10056402|FG000|STARTED|Treatment Period 1||10
8993316|NCT02792829|10056403|FG001|STARTED|Treatment Period 1||10
8993317|NCT02792829|10056404|FG002|STARTED|Treatment Period 1||5
8993318|NCT02792829|10056405|FG003|STARTED|Treatment Period 1||5
8993319|NCT02792829|10056406|FG004|STARTED|Treatment Period 1||5
8993320|NCT02792829|10056407|FG005|STARTED|Treatment Period 1||5
8993321|NCT02792829|10056408|FG006|STARTED|Treatment Period 1||10
8993322|NCT02792829|10056409|FG007|STARTED|Treatment Period 1||10
8993323|NCT02792829|10056402|FG000|COMPLETED|Treatment Period 1||10
8993324|NCT02792829|10056403|FG001|COMPLETED|Treatment Period 1||10
8993325|NCT02792829|10056404|FG002|COMPLETED|Treatment Period 1||5
8993326|NCT02792829|10056405|FG003|COMPLETED|Treatment Period 1||5
8993327|NCT02792829|10056406|FG004|COMPLETED|Treatment Period 1||5
8993328|NCT02792829|10056407|FG005|COMPLETED|Treatment Period 1||5
8993329|NCT02792829|10056408|FG006|COMPLETED|Treatment Period 1||10
8993330|NCT02792829|10056409|FG007|COMPLETED|Treatment Period 1||10
8993331|NCT02792829|10056402|FG000|NOT COMPLETED|Treatment Period 1||0
8993332|NCT02792829|10056403|FG001|NOT COMPLETED|Treatment Period 1||0
8993333|NCT02792829|10056404|FG002|NOT COMPLETED|Treatment Period 1||0
8993334|NCT02792829|10056405|FG003|NOT COMPLETED|Treatment Period 1||0
8993335|NCT02792829|10056406|FG004|NOT COMPLETED|Treatment Period 1||0
8993336|NCT02792829|10056407|FG005|NOT COMPLETED|Treatment Period 1||0
8993337|NCT02792829|10056408|FG006|NOT COMPLETED|Treatment Period 1||0
8993338|NCT02792829|10056409|FG007|NOT COMPLETED|Treatment Period 1||0
8993339|NCT02792829|10056402|FG000|STARTED|Wash Out Period||10
8993340|NCT02792829|10056403|FG001|STARTED|Wash Out Period||10
8993341|NCT02792829|10056404|FG002|STARTED|Wash Out Period||5
8993342|NCT02792829|10056405|FG003|STARTED|Wash Out Period||5
8993343|NCT02792829|10056406|FG004|STARTED|Wash Out Period||5
8993344|NCT02792829|10056407|FG005|STARTED|Wash Out Period||5
8993345|NCT02792829|10056408|FG006|STARTED|Wash Out Period||10
8993346|NCT02792829|10056409|FG007|STARTED|Wash Out Period||10
8993347|NCT02792829|10056402|FG000|COMPLETED|Wash Out Period||10
8993348|NCT02792829|10056403|FG001|COMPLETED|Wash Out Period||10
8993349|NCT02792829|10056404|FG002|COMPLETED|Wash Out Period||5
8993350|NCT02792829|10056405|FG003|COMPLETED|Wash Out Period||5
8993351|NCT02792829|10056406|FG004|COMPLETED|Wash Out Period||5
8993352|NCT02792829|10056407|FG005|COMPLETED|Wash Out Period||5
8993353|NCT02792829|10056408|FG006|COMPLETED|Wash Out Period||10
8993354|NCT02792829|10056409|FG007|COMPLETED|Wash Out Period||10
8993355|NCT02792829|10056402|FG000|NOT COMPLETED|Wash Out Period||0
8993356|NCT02792829|10056403|FG001|NOT COMPLETED|Wash Out Period||0
8993357|NCT02792829|10056404|FG002|NOT COMPLETED|Wash Out Period||0
8993358|NCT02792829|10056405|FG003|NOT COMPLETED|Wash Out Period||0
8993359|NCT02792829|10056406|FG004|NOT COMPLETED|Wash Out Period||0
8993360|NCT02792829|10056407|FG005|NOT COMPLETED|Wash Out Period||0
8993361|NCT02792829|10056408|FG006|NOT COMPLETED|Wash Out Period||0
8993362|NCT02792829|10056409|FG007|NOT COMPLETED|Wash Out Period||0
8993363|NCT02792829|10056402|FG000|STARTED|Treatment Period 2||10
8993364|NCT02792829|10056403|FG001|STARTED|Treatment Period 2||10
8993365|NCT02792829|10056404|FG002|STARTED|Treatment Period 2||5
8993366|NCT02792829|10056405|FG003|STARTED|Treatment Period 2||5
8993367|NCT02792829|10056406|FG004|STARTED|Treatment Period 2||5
8993368|NCT02792829|10056407|FG005|STARTED|Treatment Period 2||5
8993369|NCT02792829|10056408|FG006|STARTED|Treatment Period 2||10
8993370|NCT02792829|10056409|FG007|STARTED|Treatment Period 2||10
8993371|NCT02792829|10056402|FG000|COMPLETED|Treatment Period 2||10
8993372|NCT02792829|10056403|FG001|COMPLETED|Treatment Period 2||9
8993373|NCT02792829|10056404|FG002|COMPLETED|Treatment Period 2||5
8993374|NCT02792829|10056405|FG003|COMPLETED|Treatment Period 2||5
8993375|NCT02792829|10056406|FG004|COMPLETED|Treatment Period 2||4
8993376|NCT02792829|10056407|FG005|COMPLETED|Treatment Period 2||5
8993377|NCT02792829|10056408|FG006|COMPLETED|Treatment Period 2||9
8993378|NCT02792829|10056409|FG007|COMPLETED|Treatment Period 2||8
8993379|NCT02792829|10056402|FG000|NOT COMPLETED|Treatment Period 2||0
8993380|NCT02792829|10056403|FG001|NOT COMPLETED|Treatment Period 2||1
8993381|NCT02792829|10056404|FG002|NOT COMPLETED|Treatment Period 2||0
8993382|NCT02792829|10056405|FG003|NOT COMPLETED|Treatment Period 2||0
8993383|NCT02792829|10056406|FG004|NOT COMPLETED|Treatment Period 2||1
8993384|NCT02792829|10056407|FG005|NOT COMPLETED|Treatment Period 2||0
8993385|NCT02792829|10056408|FG006|NOT COMPLETED|Treatment Period 2||1
8993386|NCT02792829|10056409|FG007|NOT COMPLETED|Treatment Period 2||2
8993387|NCT02792959|10056435|FG000|STARTED|Overall Study||11
8993388|NCT02792959|10056435|FG000|COMPLETED|Overall Study||10
8993389|NCT02792959|10056435|FG000|NOT COMPLETED|Overall Study||1
8993390|NCT02793128|10056439|FG000|STARTED|Overall Study||71
8993391|NCT02793128|10056439|FG000|COMPLETED|Overall Study||62
8993392|NCT02793128|10056439|FG000|NOT COMPLETED|Overall Study||9
8993393|NCT02793154|10056454|FG000|STARTED|Part A (Single Group-up to 12 Days)||4
8993394|NCT02793154|10056455|FG001|STARTED|Part A (Single Group-up to 12 Days)||0
8993395|NCT02793154|10056456|FG002|STARTED|Part A (Single Group-up to 12 Days)||0
8993396|NCT02793154|10056454|FG000|COMPLETED|Part A (Single Group-up to 12 Days)||4
8993397|NCT02793154|10056455|FG001|COMPLETED|Part A (Single Group-up to 12 Days)||0
8993398|NCT02793154|10056456|FG002|COMPLETED|Part A (Single Group-up to 12 Days)||0
8993399|NCT02793154|10056454|FG000|NOT COMPLETED|Part A (Single Group-up to 12 Days)||0
8993400|NCT02793154|10056455|FG001|NOT COMPLETED|Part A (Single Group-up to 12 Days)||0
8993401|NCT02793154|10056456|FG002|NOT COMPLETED|Part A (Single Group-up to 12 Days)||0
8993402|NCT02793154|10056454|FG000|STARTED|Part B (Parallel Group-up to 84 Days)||0
8993403|NCT02793154|10056455|FG001|STARTED|Part B (Parallel Group-up to 84 Days)||0
8993404|NCT02793154|10056456|FG002|STARTED|Part B (Parallel Group-up to 84 Days)||0
8993405|NCT02793154|10056454|FG000|COMPLETED|Part B (Parallel Group-up to 84 Days)||0
8993406|NCT02793154|10056455|FG001|COMPLETED|Part B (Parallel Group-up to 84 Days)||0
8993407|NCT02793154|10056456|FG002|COMPLETED|Part B (Parallel Group-up to 84 Days)||0
8633586|NCT00552071|9673695|FG001|NOT COMPLETED|Overall Study||2
8633587|NCT00552084|9673705|FG000|STARTED|Overall Study||126
8633588|NCT00552084|9673706|FG001|STARTED|Overall Study||64
8633589|NCT00552084|9673705|FG000|COMPLETED|Overall Study||118
8993408|NCT02793154|10056454|FG000|NOT COMPLETED|Part B (Parallel Group-up to 84 Days)||0
8993409|NCT02793154|10056455|FG001|NOT COMPLETED|Part B (Parallel Group-up to 84 Days)||0
8993410|NCT02793154|10056456|FG002|NOT COMPLETED|Part B (Parallel Group-up to 84 Days)||0
8993411|NCT02793232|10056473|FG000|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
8993412|NCT02793232|10056474|FG001|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
8993413|NCT02793232|10056475|FG002|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
8993414|NCT02793232|10056476|FG003|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
8993415|NCT02793232|10056477|FG004|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||7
8993416|NCT02793232|10056478|FG005|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||12
8993417|NCT02793232|10056479|FG006|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||9
8993418|NCT02793232|10056480|FG007|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
8993419|NCT02793232|10056481|FG008|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||8
8993420|NCT02793232|10056473|FG000|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
8993421|NCT02793232|10056474|FG001|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
8993422|NCT02793232|10056475|FG002|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
8993423|NCT02793232|10056476|FG003|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
8993424|NCT02793232|10056477|FG004|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||6
8993425|NCT02793232|10056478|FG005|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||12
8993426|NCT02793232|10056479|FG006|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||8
8993427|NCT02793232|10056480|FG007|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
8993428|NCT02793232|10056481|FG008|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||8
8993429|NCT02793232|10056473|FG000|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
8993430|NCT02793232|10056474|FG001|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
8993431|NCT02793232|10056475|FG002|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
8993432|NCT02793232|10056476|FG003|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
8993433|NCT02793232|10056477|FG004|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||1
8993434|NCT02793232|10056478|FG005|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
8993435|NCT02793232|10056479|FG006|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||1
8993436|NCT02793232|10056480|FG007|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
8993437|NCT02793232|10056481|FG008|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
8993438|NCT02793232|10056473|FG000|STARTED|Washout Period 1(Part A:at Least 10days)||2
8993439|NCT02793232|10056474|FG001|STARTED|Washout Period 1(Part A:at Least 10days)||2
8993440|NCT02793232|10056475|FG002|STARTED|Washout Period 1(Part A:at Least 10days)||2
8993441|NCT02793232|10056476|FG003|STARTED|Washout Period 1(Part A:at Least 10days)||2
8993442|NCT02793232|10056477|FG004|STARTED|Washout Period 1(Part A:at Least 10days)||0
8993443|NCT02793232|10056478|FG005|STARTED|Washout Period 1(Part A:at Least 10days)||0
8993444|NCT02793232|10056479|FG006|STARTED|Washout Period 1(Part A:at Least 10days)||0
8993445|NCT02793232|10056480|FG007|STARTED|Washout Period 1(Part A:at Least 10days)||0
8993446|NCT02793232|10056481|FG008|STARTED|Washout Period 1(Part A:at Least 10days)||0
8993447|NCT02793232|10056473|FG000|COMPLETED|Washout Period 1(Part A:at Least 10days)||2
8993448|NCT02793232|10056474|FG001|COMPLETED|Washout Period 1(Part A:at Least 10days)||2
8993449|NCT02793232|10056475|FG002|COMPLETED|Washout Period 1(Part A:at Least 10days)||2
8993450|NCT02793232|10056476|FG003|COMPLETED|Washout Period 1(Part A:at Least 10days)||2
8993451|NCT02793232|10056477|FG004|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
8993452|NCT02793232|10056478|FG005|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
8993453|NCT02793232|10056479|FG006|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
8993454|NCT02793232|10056480|FG007|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
8993455|NCT02793232|10056481|FG008|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
8993456|NCT02793232|10056473|FG000|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
8993457|NCT02793232|10056474|FG001|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
8993458|NCT02793232|10056475|FG002|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
8993459|NCT02793232|10056476|FG003|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
8993460|NCT02793232|10056477|FG004|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
8993461|NCT02793232|10056478|FG005|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
8993462|NCT02793232|10056479|FG006|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
8993463|NCT02793232|10056480|FG007|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
8993464|NCT02793232|10056481|FG008|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
8993465|NCT02793232|10056473|FG000|STARTED|Period 2 (Part A: 5 Days)||2
8993466|NCT02793232|10056474|FG001|STARTED|Period 2 (Part A: 5 Days)||2
8993467|NCT02793232|10056475|FG002|STARTED|Period 2 (Part A: 5 Days)||2
8993468|NCT02793232|10056476|FG003|STARTED|Period 2 (Part A: 5 Days)||2
8993469|NCT02793232|10056477|FG004|STARTED|Period 2 (Part A: 5 Days)||0
8993470|NCT02793232|10056478|FG005|STARTED|Period 2 (Part A: 5 Days)||0
8993471|NCT02793232|10056479|FG006|STARTED|Period 2 (Part A: 5 Days)||0
8993472|NCT02793232|10056480|FG007|STARTED|Period 2 (Part A: 5 Days)||0
8993473|NCT02793232|10056481|FG008|STARTED|Period 2 (Part A: 5 Days)||0
8633590|NCT00552084|9673706|FG001|COMPLETED|Overall Study||55
8633591|NCT00552084|9673705|FG000|NOT COMPLETED|Overall Study||8
8633592|NCT00552084|9673706|FG001|NOT COMPLETED|Overall Study||9
8993474|NCT02793232|10056473|FG000|COMPLETED|Period 2 (Part A: 5 Days)||2
8993475|NCT02793232|10056474|FG001|COMPLETED|Period 2 (Part A: 5 Days)||2
8993476|NCT02793232|10056475|FG002|COMPLETED|Period 2 (Part A: 5 Days)||2
8993477|NCT02793232|10056476|FG003|COMPLETED|Period 2 (Part A: 5 Days)||2
8993478|NCT02793232|10056477|FG004|COMPLETED|Period 2 (Part A: 5 Days)||0
8993479|NCT02793232|10056478|FG005|COMPLETED|Period 2 (Part A: 5 Days)||0
8993480|NCT02793232|10056479|FG006|COMPLETED|Period 2 (Part A: 5 Days)||0
8993481|NCT02793232|10056480|FG007|COMPLETED|Period 2 (Part A: 5 Days)||0
8993482|NCT02793232|10056481|FG008|COMPLETED|Period 2 (Part A: 5 Days)||0
8993483|NCT02793232|10056473|FG000|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
8993484|NCT02793232|10056474|FG001|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
8993485|NCT02793232|10056475|FG002|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
8993486|NCT02793232|10056476|FG003|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
8993487|NCT02793232|10056477|FG004|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
8993488|NCT02793232|10056478|FG005|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
8993489|NCT02793232|10056479|FG006|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
8993490|NCT02793232|10056480|FG007|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
8993491|NCT02793232|10056481|FG008|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
8993492|NCT02793232|10056473|FG000|STARTED|Washout Period 2(Part A:at Least 10days)||2
8993493|NCT02793232|10056474|FG001|STARTED|Washout Period 2(Part A:at Least 10days)||2
8993494|NCT02793232|10056475|FG002|STARTED|Washout Period 2(Part A:at Least 10days)||2
8993495|NCT02793232|10056476|FG003|STARTED|Washout Period 2(Part A:at Least 10days)||2
8993496|NCT02793232|10056477|FG004|STARTED|Washout Period 2(Part A:at Least 10days)||0
8993497|NCT02793232|10056478|FG005|STARTED|Washout Period 2(Part A:at Least 10days)||0
8993498|NCT02793232|10056479|FG006|STARTED|Washout Period 2(Part A:at Least 10days)||0
8993499|NCT02793232|10056480|FG007|STARTED|Washout Period 2(Part A:at Least 10days)||0
8993500|NCT02793232|10056481|FG008|STARTED|Washout Period 2(Part A:at Least 10days)||0
8993501|NCT02793232|10056473|FG000|COMPLETED|Washout Period 2(Part A:at Least 10days)||2
8993502|NCT02793232|10056474|FG001|COMPLETED|Washout Period 2(Part A:at Least 10days)||2
8993503|NCT02793232|10056475|FG002|COMPLETED|Washout Period 2(Part A:at Least 10days)||2
8993504|NCT02793232|10056476|FG003|COMPLETED|Washout Period 2(Part A:at Least 10days)||2
8993505|NCT02793232|10056477|FG004|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
8993506|NCT02793232|10056478|FG005|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
8993507|NCT02793232|10056479|FG006|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
8993508|NCT02793232|10056480|FG007|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
8993509|NCT02793232|10056481|FG008|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
8993510|NCT02793232|10056473|FG000|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
8993511|NCT02793232|10056474|FG001|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
8993512|NCT02793232|10056475|FG002|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
8993513|NCT02793232|10056476|FG003|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
8993514|NCT02793232|10056477|FG004|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
8993515|NCT02793232|10056478|FG005|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
8993516|NCT02793232|10056479|FG006|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
8993517|NCT02793232|10056480|FG007|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
8993518|NCT02793232|10056481|FG008|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
8993519|NCT02793232|10056473|FG000|STARTED|Period 3 (Part A: 5 Days)||2
8691299|NCT00854061|9736531|FG000|NOT COMPLETED|Overall Study||23
8993520|NCT02793232|10056474|FG001|STARTED|Period 3 (Part A: 5 Days)||2
8993521|NCT02793232|10056475|FG002|STARTED|Period 3 (Part A: 5 Days)||2
8993522|NCT02793232|10056476|FG003|STARTED|Period 3 (Part A: 5 Days)||2
8993523|NCT02793232|10056477|FG004|STARTED|Period 3 (Part A: 5 Days)||0
8993524|NCT02793232|10056478|FG005|STARTED|Period 3 (Part A: 5 Days)||0
8993525|NCT02793232|10056479|FG006|STARTED|Period 3 (Part A: 5 Days)||0
8993526|NCT02793232|10056480|FG007|STARTED|Period 3 (Part A: 5 Days)||0
8993527|NCT02793232|10056481|FG008|STARTED|Period 3 (Part A: 5 Days)||0
8993528|NCT02793232|10056473|FG000|COMPLETED|Period 3 (Part A: 5 Days)||2
8993529|NCT02793232|10056474|FG001|COMPLETED|Period 3 (Part A: 5 Days)||2
8993530|NCT02793232|10056475|FG002|COMPLETED|Period 3 (Part A: 5 Days)||2
8993531|NCT02793232|10056476|FG003|COMPLETED|Period 3 (Part A: 5 Days)||2
8993532|NCT02793232|10056477|FG004|COMPLETED|Period 3 (Part A: 5 Days)||0
8993533|NCT02793232|10056478|FG005|COMPLETED|Period 3 (Part A: 5 Days)||0
8993534|NCT02793232|10056479|FG006|COMPLETED|Period 3 (Part A: 5 Days)||0
8993535|NCT02793232|10056480|FG007|COMPLETED|Period 3 (Part A: 5 Days)||0
8993536|NCT02793232|10056481|FG008|COMPLETED|Period 3 (Part A: 5 Days)||0
8993537|NCT02793232|10056473|FG000|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
8993538|NCT02793232|10056474|FG001|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
8993539|NCT02793232|10056475|FG002|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
8993540|NCT02793232|10056476|FG003|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
8993541|NCT02793232|10056477|FG004|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
8993542|NCT02793232|10056478|FG005|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
8993543|NCT02793232|10056479|FG006|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
8993544|NCT02793232|10056480|FG007|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
8993545|NCT02793232|10056481|FG008|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
8993546|NCT02793232|10056473|FG000|STARTED|Washout Period 3(Part A:at Least 10days)||2
8993547|NCT02793232|10056474|FG001|STARTED|Washout Period 3(Part A:at Least 10days)||2
8993548|NCT02793232|10056475|FG002|STARTED|Washout Period 3(Part A:at Least 10days)||2
8993549|NCT02793232|10056476|FG003|STARTED|Washout Period 3(Part A:at Least 10days)||2
8993550|NCT02793232|10056477|FG004|STARTED|Washout Period 3(Part A:at Least 10days)||0
8993551|NCT02793232|10056478|FG005|STARTED|Washout Period 3(Part A:at Least 10days)||0
8993552|NCT02793232|10056479|FG006|STARTED|Washout Period 3(Part A:at Least 10days)||0
8993553|NCT02793232|10056480|FG007|STARTED|Washout Period 3(Part A:at Least 10days)||0
8993554|NCT02793232|10056481|FG008|STARTED|Washout Period 3(Part A:at Least 10days)||0
8993555|NCT02793232|10056473|FG000|COMPLETED|Washout Period 3(Part A:at Least 10days)||2
8993556|NCT02793232|10056474|FG001|COMPLETED|Washout Period 3(Part A:at Least 10days)||2
8993557|NCT02793232|10056475|FG002|COMPLETED|Washout Period 3(Part A:at Least 10days)||2
8993558|NCT02793232|10056476|FG003|COMPLETED|Washout Period 3(Part A:at Least 10days)||2
8993559|NCT02793232|10056477|FG004|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
8993560|NCT02793232|10056478|FG005|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
8993561|NCT02793232|10056479|FG006|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
8993562|NCT02793232|10056480|FG007|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
8993563|NCT02793232|10056481|FG008|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
8993564|NCT02793232|10056473|FG000|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
8993565|NCT02793232|10056474|FG001|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
8993566|NCT02793232|10056475|FG002|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
8993567|NCT02793232|10056476|FG003|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
8633593|NCT00552110|9673717|FG000|STARTED|Overall Study|One subject was excluded from the intent to treat population because there was no record of dosing.|146
8633594|NCT00552110|9673718|FG001|STARTED|Overall Study||139
8633595|NCT00552110|9673719|FG002|STARTED|Overall Study||139
8993568|NCT02793232|10056477|FG004|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
8993569|NCT02793232|10056478|FG005|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
8993570|NCT02793232|10056479|FG006|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
8993571|NCT02793232|10056480|FG007|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
8993572|NCT02793232|10056481|FG008|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
8993573|NCT02793232|10056473|FG000|STARTED|Period 4 (Part A: 5 Days)||2
8993574|NCT02793232|10056474|FG001|STARTED|Period 4 (Part A: 5 Days)||2
8993575|NCT02793232|10056475|FG002|STARTED|Period 4 (Part A: 5 Days)||2
8993576|NCT02793232|10056476|FG003|STARTED|Period 4 (Part A: 5 Days)||2
8993577|NCT02793232|10056477|FG004|STARTED|Period 4 (Part A: 5 Days)||0
8993578|NCT02793232|10056478|FG005|STARTED|Period 4 (Part A: 5 Days)||0
8993579|NCT02793232|10056479|FG006|STARTED|Period 4 (Part A: 5 Days)||0
8993580|NCT02793232|10056480|FG007|STARTED|Period 4 (Part A: 5 Days)||0
8993581|NCT02793232|10056481|FG008|STARTED|Period 4 (Part A: 5 Days)||0
8993582|NCT02793232|10056473|FG000|COMPLETED|Period 4 (Part A: 5 Days)||2
8993583|NCT02793232|10056474|FG001|COMPLETED|Period 4 (Part A: 5 Days)||2
8993584|NCT02793232|10056475|FG002|COMPLETED|Period 4 (Part A: 5 Days)||2
8993585|NCT02793232|10056476|FG003|COMPLETED|Period 4 (Part A: 5 Days)||2
8993586|NCT02793232|10056477|FG004|COMPLETED|Period 4 (Part A: 5 Days)||0
8993587|NCT02793232|10056478|FG005|COMPLETED|Period 4 (Part A: 5 Days)||0
8993588|NCT02793232|10056479|FG006|COMPLETED|Period 4 (Part A: 5 Days)||0
8993589|NCT02793232|10056480|FG007|COMPLETED|Period 4 (Part A: 5 Days)||0
8993590|NCT02793232|10056481|FG008|COMPLETED|Period 4 (Part A: 5 Days)||0
8993591|NCT02793232|10056473|FG000|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
8993592|NCT02793232|10056474|FG001|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
8993593|NCT02793232|10056475|FG002|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
8993594|NCT02793232|10056476|FG003|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
8993595|NCT02793232|10056477|FG004|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
8993596|NCT02793232|10056478|FG005|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
8993597|NCT02793232|10056479|FG006|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
8993598|NCT02793232|10056480|FG007|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
8993599|NCT02793232|10056481|FG008|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
8993600|NCT02793622|10056517|FG000|STARTED|Overall Study||391
8993601|NCT02793622|10056518|FG001|STARTED|Overall Study||391
8993602|NCT02793622|10056517|FG000|COMPLETED|Overall Study||338
8993603|NCT02793622|10056518|FG001|COMPLETED|Overall Study||349
8993604|NCT02793622|10056517|FG000|NOT COMPLETED|Overall Study||53
8993605|NCT02793622|10056518|FG001|NOT COMPLETED|Overall Study||42
8993606|NCT02793674|10056526|FG000|STARTED|Overall Study||9
8633596|NCT00552110|9673720|FG003|STARTED|Overall Study|One subject was excluded from the intent to treat population because there was no record of dosing.|141
8633597|NCT00552110|9673721|FG004|STARTED|Overall Study||142
8633598|NCT00552110|9673717|FG000|COMPLETED|Overall Study||142
8633599|NCT00552110|9673718|FG001|COMPLETED|Overall Study||134
8633600|NCT00552110|9673719|FG002|COMPLETED|Overall Study||137
8633601|NCT00552110|9673720|FG003|COMPLETED|Overall Study||133
8633602|NCT00552110|9673721|FG004|COMPLETED|Overall Study||133
8633603|NCT00552110|9673717|FG000|NOT COMPLETED|Overall Study||4
8633604|NCT00552110|9673718|FG001|NOT COMPLETED|Overall Study||5
8993607|NCT02793674|10056527|FG001|STARTED|Overall Study||12
8993608|NCT02793674|10056526|FG000|COMPLETED|Overall Study||9
8993609|NCT02793674|10056527|FG001|COMPLETED|Overall Study||12
8993610|NCT02793674|10056526|FG000|NOT COMPLETED|Overall Study||0
8633605|NCT00552110|9673719|FG002|NOT COMPLETED|Overall Study||2
8725900|NCT01033487|9773157|FG000|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
8993611|NCT02793674|10056527|FG001|NOT COMPLETED|Overall Study||0
8633606|NCT00552110|9673720|FG003|NOT COMPLETED|Overall Study||8
8993612|NCT02793817|10056541|FG000|STARTED|Overall Study||261
8993613|NCT02793817|10056542|FG001|STARTED|Overall Study||259
8993614|NCT02793817|10056541|FG000|COMPLETED|Overall Study||258
8993615|NCT02793817|10056542|FG001|COMPLETED|Overall Study||254
8993616|NCT02793817|10056541|FG000|NOT COMPLETED|Overall Study||3
8993617|NCT02793817|10056542|FG001|NOT COMPLETED|Overall Study||5
8993618|NCT02793856|10056552|FG000|STARTED|Overall Study||2
8993619|NCT02793856|10056553|FG001|STARTED|Overall Study||4
8993620|NCT02793856|10056554|FG002|STARTED|Overall Study||3
8993621|NCT02793856|10056555|FG003|STARTED|Overall Study||3
8993622|NCT02793856|10056552|FG000|COMPLETED|Overall Study||2
8993623|NCT02793856|10056553|FG001|COMPLETED|Overall Study||4
8993624|NCT02793856|10056554|FG002|COMPLETED|Overall Study||3
8993625|NCT02793856|10056555|FG003|COMPLETED|Overall Study||3
8993626|NCT02793856|10056552|FG000|NOT COMPLETED|Overall Study||0
8993627|NCT02793856|10056553|FG001|NOT COMPLETED|Overall Study||0
8993628|NCT02793856|10056554|FG002|NOT COMPLETED|Overall Study||0
8993629|NCT02793856|10056555|FG003|NOT COMPLETED|Overall Study||0
8993630|NCT02793947|10056595|FG000|STARTED|Overall Study||47
8993631|NCT02793947|10056596|FG001|STARTED|Overall Study||55
8993632|NCT02793947|10056595|FG000|COMPLETED|Overall Study||45
8993633|NCT02793947|10056596|FG001|COMPLETED|Overall Study||50
8993634|NCT02793947|10056595|FG000|NOT COMPLETED|Overall Study||2
8993635|NCT02793947|10056596|FG001|NOT COMPLETED|Overall Study||5
8993636|NCT02794103|10056602|FG000|STARTED|Overall Study||18
8993637|NCT02794103|10056602|FG000|COMPLETED|Overall Study||15
8993638|NCT02794103|10056602|FG000|NOT COMPLETED|Overall Study||3
8633607|NCT00552110|9673721|FG004|NOT COMPLETED|Overall Study||9
8633608|NCT00552175|9673736|FG000|STARTED|Overall Study||167
8633609|NCT00552175|9673737|FG001|STARTED|Overall Study||86
8633610|NCT00552175|9673738|FG002|STARTED|Overall Study||86
8993639|NCT02794207|10056608|FG000|STARTED|Overall Study||32
8993640|NCT02794207|10056609|FG001|STARTED|Overall Study||54
8993641|NCT02794207|10056608|FG000|COMPLETED|Overall Study||32
8993642|NCT02794207|10056609|FG001|COMPLETED|Overall Study||54
8993643|NCT02794207|10056608|FG000|NOT COMPLETED|Overall Study||0
8993644|NCT02794207|10056609|FG001|NOT COMPLETED|Overall Study||0
8993645|NCT02794246|10056614|FG000|STARTED|Overall Study||6
8993646|NCT02794246|10056614|FG000|Treated|Overall Study||3
8993647|NCT02794246|10056614|FG000|COMPLETED|Overall Study||0
8993648|NCT02794246|10056614|FG000|NOT COMPLETED|Overall Study||6
8993649|NCT02794441|10056620|FG000|STARTED|Overall Study||7
8993650|NCT02794441|10056621|FG001|STARTED|Overall Study||5
8993651|NCT02794441|10056620|FG000|COMPLETED|Overall Study||6
8993652|NCT02794441|10056621|FG001|COMPLETED|Overall Study||5
8993653|NCT02794441|10056620|FG000|NOT COMPLETED|Overall Study||1
8633611|NCT00552175|9673736|FG000|Full Analysis Set Population|Overall Study||167
8633612|NCT00552175|9673737|FG001|Full Analysis Set Population|Overall Study||85
8633613|NCT00552175|9673738|FG002|Full Analysis Set Population|Overall Study||86
8633614|NCT00552175|9673736|FG000|COMPLETED|Overall Study||150
8633615|NCT00552175|9673737|FG001|COMPLETED|Overall Study||73
8993654|NCT02794441|10056621|FG001|NOT COMPLETED|Overall Study||0
8993655|NCT02794480|10056629|FG000|STARTED|Period 1: Treatment Period 1 (28 Days)||80
8993656|NCT02794480|10056630|FG001|STARTED|Period 1: Treatment Period 1 (28 Days)||82
8993657|NCT02794480|10056631|FG002|STARTED|Period 1: Treatment Period 1 (28 Days)||81
8993658|NCT02794480|10056632|FG003|STARTED|Period 1: Treatment Period 1 (28 Days)||81
8993659|NCT02794480|10056629|FG000|COMPLETED|Period 1: Treatment Period 1 (28 Days)||80
8993660|NCT02794480|10056630|FG001|COMPLETED|Period 1: Treatment Period 1 (28 Days)||80
8993661|NCT02794480|10056631|FG002|COMPLETED|Period 1: Treatment Period 1 (28 Days)||79
8993662|NCT02794480|10056632|FG003|COMPLETED|Period 1: Treatment Period 1 (28 Days)||78
8993663|NCT02794480|10056629|FG000|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||0
8993664|NCT02794480|10056630|FG001|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||2
8993665|NCT02794480|10056631|FG002|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||2
8993666|NCT02794480|10056632|FG003|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||3
8993667|NCT02794480|10056629|FG000|STARTED|Period 2: Treatment Period 2 (28 Days)||80
8993668|NCT02794480|10056630|FG001|STARTED|Period 2: Treatment Period 2 (28 Days)||80
8993669|NCT02794480|10056631|FG002|STARTED|Period 2: Treatment Period 2 (28 Days)||79
8993670|NCT02794480|10056632|FG003|STARTED|Period 2: Treatment Period 2 (28 Days)||78
8993671|NCT02794480|10056629|FG000|COMPLETED|Period 2: Treatment Period 2 (28 Days)||79
8993672|NCT02794480|10056630|FG001|COMPLETED|Period 2: Treatment Period 2 (28 Days)||80
8993673|NCT02794480|10056631|FG002|COMPLETED|Period 2: Treatment Period 2 (28 Days)||79
8993674|NCT02794480|10056632|FG003|COMPLETED|Period 2: Treatment Period 2 (28 Days)||77
8993675|NCT02794480|10056629|FG000|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||1
8993676|NCT02794480|10056630|FG001|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||0
8993677|NCT02794480|10056631|FG002|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||0
8993678|NCT02794480|10056632|FG003|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||1
8993679|NCT02794597|10056642|FG000|STARTED|Overall Study||63
8993680|NCT02794597|10056643|FG001|STARTED|Overall Study||56
8993681|NCT02794597|10056642|FG000|COMPLETED|Overall Study||63
8993682|NCT02794597|10056643|FG001|COMPLETED|Overall Study||56
8993683|NCT02794597|10056642|FG000|NOT COMPLETED|Overall Study||0
8993684|NCT02794597|10056643|FG001|NOT COMPLETED|Overall Study||0
8993685|NCT02794727|10056652|FG000|STARTED|Overall Study||44
8993686|NCT02794727|10056653|FG001|STARTED|Overall Study||46
8993687|NCT02794727|10056654|FG002|STARTED|Overall Study||45
8993688|NCT02794727|10056652|FG000|COMPLETED|Overall Study||44
8993689|NCT02794727|10056653|FG001|COMPLETED|Overall Study||46
8993690|NCT02794727|10056654|FG002|COMPLETED|Overall Study||44
8993691|NCT02794727|10056652|FG000|NOT COMPLETED|Overall Study||0
8993692|NCT02794727|10056653|FG001|NOT COMPLETED|Overall Study||0
8993693|NCT02794727|10056654|FG002|NOT COMPLETED|Overall Study||1
8993694|NCT02794766|10056664|FG000|STARTED|Overall Study||15
8993695|NCT02794766|10056665|FG001|STARTED|Overall Study||15
8993696|NCT02794766|10056666|FG002|STARTED|Overall Study||15
8993697|NCT02794766|10056664|FG000|COMPLETED|Overall Study||15
8993698|NCT02794766|10056665|FG001|COMPLETED|Overall Study||15
8993699|NCT02794766|10056666|FG002|COMPLETED|Overall Study||14
8993700|NCT02794766|10056664|FG000|NOT COMPLETED|Overall Study||0
8993701|NCT02794766|10056665|FG001|NOT COMPLETED|Overall Study||0
8993702|NCT02794766|10056666|FG002|NOT COMPLETED|Overall Study||1
8993703|NCT02794844|10056674|FG000|STARTED|Overall Study||28
8993704|NCT02794844|10056674|FG000|COMPLETED|Overall Study||23
8993705|NCT02794844|10056674|FG000|NOT COMPLETED|Overall Study||5
8993706|NCT02794870|10056680|FG000|STARTED|Overall Study||22
8993707|NCT02794870|10056681|FG001|STARTED|Overall Study||11
8993708|NCT02794870|10056680|FG000|Received Inoculation|Overall Study||21
8993709|NCT02794870|10056681|FG001|Received Inoculation|Overall Study||11
8993710|NCT02794870|10056680|FG000|COMPLETED|Overall Study||20
8993711|NCT02794870|10056681|FG001|COMPLETED|Overall Study||11
8993712|NCT02794870|10056680|FG000|NOT COMPLETED|Overall Study||2
8993713|NCT02794870|10056681|FG001|NOT COMPLETED|Overall Study||0
8993714|NCT02794974|10056689|FG000|STARTED|Overall Study||14
8633616|NCT00552175|9673738|FG002|COMPLETED|Overall Study||72
8633617|NCT00552175|9673736|FG000|NOT COMPLETED|Overall Study||17
8993715|NCT02794974|10056690|FG001|STARTED|Overall Study||15
8993716|NCT02794974|10056689|FG000|COMPLETED|Overall Study||14
8993717|NCT02794974|10056690|FG001|COMPLETED|Overall Study||14
8993718|NCT02794974|10056689|FG000|NOT COMPLETED|Overall Study||0
8993719|NCT02794974|10056690|FG001|NOT COMPLETED|Overall Study||1
8993720|NCT02795117|10056699|FG000|STARTED|Overall Study||193
8993721|NCT02795117|10056700|FG001|STARTED|Overall Study||193
8993722|NCT02795117|10056701|FG002|STARTED|Overall Study||100
8993723|NCT02795117|10056699|FG000|COMPLETED|Overall Study||175
8993724|NCT02795117|10056700|FG001|COMPLETED|Overall Study||166
8993725|NCT02795117|10056701|FG002|COMPLETED|Overall Study||88
8993726|NCT02795117|10056699|FG000|NOT COMPLETED|Overall Study||18
8993727|NCT02795117|10056700|FG001|NOT COMPLETED|Overall Study||27
8993728|NCT02795117|10056701|FG002|NOT COMPLETED|Overall Study||12
8993729|NCT02795767|10056712|FG000|STARTED|Overall Study||68
8633618|NCT00552175|9673737|FG001|NOT COMPLETED|Overall Study||13
8633619|NCT00552175|9673738|FG002|NOT COMPLETED|Overall Study||14
8633620|NCT00552188|9673749|FG000|STARTED|Overall Study||26
8993730|NCT02795767|10056713|FG001|STARTED|Overall Study||10
8993731|NCT02795767|10056714|FG002|STARTED|Overall Study||10
8993732|NCT02795767|10056712|FG000|Received at Least One Dose of Emicizumab|Overall Study||68
8993733|NCT02795767|10056713|FG001|Received at Least One Dose of Emicizumab|Overall Study||10
8993734|NCT02795767|10056714|FG002|Received at Least One Dose of Emicizumab|Overall Study||10
8993735|NCT02795767|10056712|FG000|Dose Up-Titrated to 3 mg/kg QW|Overall Study||0
8993736|NCT02795767|10056713|FG001|Dose Up-Titrated to 3 mg/kg QW|Overall Study||0
8993737|NCT02795767|10056714|FG002|Dose Up-Titrated to 3 mg/kg QW|Overall Study||3
8993738|NCT02795767|10056712|FG000|Completed 52 Weeks in Study|Overall Study||67
8993739|NCT02795767|10056713|FG001|Completed 52 Weeks in Study|Overall Study||10
8993740|NCT02795767|10056714|FG002|Completed 52 Weeks in Study|Overall Study||9
8993741|NCT02795767|10056712|FG000|COMPLETED|Overall Study||67
8993742|NCT02795767|10056713|FG001|COMPLETED|Overall Study||10
8993743|NCT02795767|10056714|FG002|COMPLETED|Overall Study||10
8993744|NCT02795767|10056712|FG000|NOT COMPLETED|Overall Study||1
8993745|NCT02795767|10056713|FG001|NOT COMPLETED|Overall Study||0
8993746|NCT02795767|10056714|FG002|NOT COMPLETED|Overall Study||0
8993747|NCT02795780|10056728|FG000|STARTED|Overall Study||25
8993748|NCT02795780|10056729|FG001|STARTED|Overall Study||54
8993749|NCT02795780|10056728|FG000|COMPLETED|Overall Study||25
8993750|NCT02795780|10056729|FG001|COMPLETED|Overall Study||54
8993751|NCT02795780|10056728|FG000|NOT COMPLETED|Overall Study||0
8993752|NCT02795780|10056729|FG001|NOT COMPLETED|Overall Study||0
8993753|NCT02795819|10056737|FG000|STARTED|Overall Study||0
8633621|NCT00552188|9673750|FG001|STARTED|Overall Study||26
8879165|NCT01932437|9935988|FG005|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
8879166|NCT01932437|9935983|FG000|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||2
8879167|NCT01932437|9935984|FG001|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
8879168|NCT01932437|9935985|FG002|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
8879169|NCT01932437|9935986|FG003|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||6
8879170|NCT01932437|9935987|FG004|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
8879171|NCT01932437|9935988|FG005|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
8879172|NCT01932437|9935983|FG000|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||2
8633622|NCT00552188|9673749|FG000|COMPLETED|Overall Study||24
8633623|NCT00552188|9673750|FG001|COMPLETED|Overall Study||21
8633624|NCT00552188|9673749|FG000|NOT COMPLETED|Overall Study||2
8633625|NCT00552188|9673750|FG001|NOT COMPLETED|Overall Study||5
8633626|NCT00552240|9673758|FG000|STARTED|Overall Study|Number in Full Analysis Set (FAS)|75
8993754|NCT02795819|10056738|FG001|STARTED|Overall Study||6
8993755|NCT02795819|10056739|FG002|STARTED|Overall Study||0
8993756|NCT02795819|10056740|FG003|STARTED|Overall Study||0
8993757|NCT02795819|10056741|FG004|STARTED|Overall Study||0
8993758|NCT02795819|10056742|FG005|STARTED|Overall Study||0
8993759|NCT02795819|10056743|FG006|STARTED|Overall Study||0
8993760|NCT02795819|10056737|FG000|COMPLETED|Overall Study||0
8993761|NCT02795819|10056738|FG001|COMPLETED|Overall Study||6
8993762|NCT02795819|10056739|FG002|COMPLETED|Overall Study||0
8993763|NCT02795819|10056740|FG003|COMPLETED|Overall Study||0
8993764|NCT02795819|10056741|FG004|COMPLETED|Overall Study||0
8993765|NCT02795819|10056742|FG005|COMPLETED|Overall Study||0
8993766|NCT02795819|10056743|FG006|COMPLETED|Overall Study||0
8993767|NCT02795819|10056737|FG000|NOT COMPLETED|Overall Study||0
8993768|NCT02795819|10056738|FG001|NOT COMPLETED|Overall Study||0
8993769|NCT02795819|10056739|FG002|NOT COMPLETED|Overall Study||0
8993770|NCT02795819|10056740|FG003|NOT COMPLETED|Overall Study||0
8993771|NCT02795819|10056741|FG004|NOT COMPLETED|Overall Study||0
8993772|NCT02795819|10056742|FG005|NOT COMPLETED|Overall Study||0
8993773|NCT02795819|10056743|FG006|NOT COMPLETED|Overall Study||0
8993774|NCT02795832|10056759|FG000|STARTED|Overall Study||8
8993775|NCT02795832|10056760|FG001|STARTED|Overall Study||4
8993776|NCT02795832|10056761|FG002|STARTED|Overall Study||8
8993777|NCT02795832|10056762|FG003|STARTED|Overall Study||3
8993778|NCT02795832|10056763|FG004|STARTED|Overall Study||20
8993779|NCT02795832|10056764|FG005|STARTED|Overall Study||10
8993780|NCT02795832|10056759|FG000|COMPLETED|Overall Study||8
8993781|NCT02795832|10056760|FG001|COMPLETED|Overall Study||4
8993782|NCT02795832|10056761|FG002|COMPLETED|Overall Study||8
8993783|NCT02795832|10056762|FG003|COMPLETED|Overall Study||3
8993784|NCT02795832|10056763|FG004|COMPLETED|Overall Study||20
8993785|NCT02795832|10056764|FG005|COMPLETED|Overall Study||7
8993786|NCT02795832|10056759|FG000|NOT COMPLETED|Overall Study||0
8993787|NCT02795832|10056760|FG001|NOT COMPLETED|Overall Study||0
8993788|NCT02795832|10056761|FG002|NOT COMPLETED|Overall Study||0
8993789|NCT02795832|10056762|FG003|NOT COMPLETED|Overall Study||0
8993790|NCT02795832|10056763|FG004|NOT COMPLETED|Overall Study||0
8993791|NCT02795832|10056764|FG005|NOT COMPLETED|Overall Study||3
8993792|NCT02796092|10056788|FG000|STARTED|Overall Study||50
8993793|NCT02796092|10056789|FG001|STARTED|Overall Study||50
8993794|NCT02796092|10056788|FG000|COMPLETED|Overall Study||50
8993795|NCT02796092|10056789|FG001|COMPLETED|Overall Study||50
8993796|NCT02796092|10056788|FG000|NOT COMPLETED|Overall Study||0
8993797|NCT02796092|10056789|FG001|NOT COMPLETED|Overall Study||0
8993798|NCT02796144|10056798|FG000|STARTED|Overall Study||23
8993799|NCT02796144|10056799|FG001|STARTED|Overall Study||24
8993800|NCT02796144|10056800|FG002|STARTED|Overall Study||24
8993801|NCT02796144|10056798|FG000|COMPLETED|Overall Study||18
8993802|NCT02796144|10056799|FG001|COMPLETED|Overall Study||21
8993803|NCT02796144|10056800|FG002|COMPLETED|Overall Study||18
8993804|NCT02796144|10056798|FG000|NOT COMPLETED|Overall Study||5
8993805|NCT02796144|10056799|FG001|NOT COMPLETED|Overall Study||3
8993806|NCT02796144|10056800|FG002|NOT COMPLETED|Overall Study||6
8993807|NCT02796274|10056810|FG000|STARTED|Overall Study||219
8993808|NCT02796274|10056810|FG000|COMPLETED|Overall Study||219
8993809|NCT02796274|10056810|FG000|NOT COMPLETED|Overall Study||0
8993810|NCT02796300|10056816|FG000|STARTED|Overall Study||10
8993811|NCT02796300|10056817|FG001|STARTED|Overall Study||22
8993812|NCT02796300|10056816|FG000|COMPLETED|Overall Study||10
8572143|NCT00112437|9604131|FG008|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
8572144|NCT00112437|9604132|FG009|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
8572145|NCT00112437|9604133|FG010|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
8572146|NCT00112437|9604134|FG011|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
8572147|NCT00112437|9604135|FG012|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
8993813|NCT02796300|10056817|FG001|COMPLETED|Overall Study||22
8993814|NCT02796300|10056816|FG000|NOT COMPLETED|Overall Study||0
8993815|NCT02796300|10056817|FG001|NOT COMPLETED|Overall Study||0
8993816|NCT02796352|10056823|FG000|STARTED|Overall Study||1
8993817|NCT02796352|10056823|FG000|COMPLETED|Overall Study||1
8993818|NCT02796352|10056823|FG000|NOT COMPLETED|Overall Study||0
8993819|NCT02796560|10056829|FG000|STARTED|Overall Study||38
8993820|NCT02796560|10056830|FG001|STARTED|Overall Study||38
8993821|NCT02796560|10056829|FG000|COMPLETED|Overall Study||34
8993822|NCT02796560|10056830|FG001|COMPLETED|Overall Study||36
8993823|NCT02796560|10056829|FG000|NOT COMPLETED|Overall Study||4
8993824|NCT02796560|10056830|FG001|NOT COMPLETED|Overall Study||2
8993825|NCT02796625|10056836|FG000|STARTED|Overall Study||80
8993826|NCT02796625|10056836|FG000|COMPLETED|Overall Study||61
8993827|NCT02796625|10056836|FG000|NOT COMPLETED|Overall Study||19
8993828|NCT02796651|10056840|FG000|STARTED|Overall Study||132
8993829|NCT02796651|10056840|FG000|Formoterol Fumarate (FF) 6 μg|Overall Study||107
8993830|NCT02796651|10056840|FG000|Formoterol Fumarate (FF) 12 μg|Overall Study||121
8993831|NCT02796651|10056840|FG000|Formoterol Fumarate (FF) 24 μg|Overall Study||105
8993832|NCT02796651|10056840|FG000|Perforomist 20 μg|Overall Study||118
8993833|NCT02796651|10056840|FG000|Perforomist 40 μg|Overall Study||108
8993834|NCT02796651|10056840|FG000|Placebo (Lactose Monohydrate)|Overall Study||38
8993835|NCT02796651|10056840|FG000|COMPLETED|Overall Study||106
8993836|NCT02796651|10056840|FG000|NOT COMPLETED|Overall Study||26
8993837|NCT02796664|10056857|FG000|STARTED|Overall Study||29
8993838|NCT02796664|10056858|FG001|STARTED|Overall Study||29
8633627|NCT00552240|9673759|FG001|STARTED|Overall Study|Number in Full Analysis Set (FAS)|77
8633628|NCT00552240|9673758|FG000|COMPLETED|Overall Study||51
8633629|NCT00552240|9673759|FG001|COMPLETED|Overall Study||59
8633630|NCT00552240|9673758|FG000|NOT COMPLETED|Overall Study||24
8993839|NCT02796664|10056857|FG000|COMPLETED|Overall Study||28
8993840|NCT02796664|10056858|FG001|COMPLETED|Overall Study||24
8993841|NCT02796664|10056857|FG000|NOT COMPLETED|Overall Study||1
8993842|NCT02796664|10056858|FG001|NOT COMPLETED|Overall Study||5
8993843|NCT02796677|10056870|FG000|STARTED|Overall Study||317
8993844|NCT02796677|10056871|FG001|STARTED|Overall Study||478
8993845|NCT02796677|10056872|FG002|STARTED|Overall Study||320
8993846|NCT02796677|10056873|FG003|STARTED|Overall Study||479
8993847|NCT02796677|10056870|FG000|Completed Treatment and Follow-up|Overall Study||279
8993848|NCT02796677|10056871|FG001|Completed Treatment and Follow-up|Overall Study||405
8993849|NCT02796677|10056872|FG002|Completed Treatment and Follow-up|Overall Study||267
8993850|NCT02796677|10056873|FG003|Completed Treatment and Follow-up|Overall Study||403
8993851|NCT02796677|10056870|FG000|COMPLETED|Overall Study||279
8993852|NCT02796677|10056871|FG001|COMPLETED|Overall Study||405
8993853|NCT02796677|10056872|FG002|COMPLETED|Overall Study||267
8993854|NCT02796677|10056873|FG003|COMPLETED|Overall Study||405
8993855|NCT02796677|10056870|FG000|NOT COMPLETED|Overall Study||38
8993856|NCT02796677|10056871|FG001|NOT COMPLETED|Overall Study||73
8993857|NCT02796677|10056872|FG002|NOT COMPLETED|Overall Study||53
8993858|NCT02796677|10056873|FG003|NOT COMPLETED|Overall Study||74
8993859|NCT02796755|10056887|FG000|STARTED|Overall Study||15
8993860|NCT02796755|10056888|FG001|STARTED|Overall Study||15
8993861|NCT02796755|10056887|FG000|COMPLETED|Overall Study||13
8993862|NCT02796755|10056888|FG001|COMPLETED|Overall Study||15
8993863|NCT02796755|10056887|FG000|NOT COMPLETED|Overall Study||2
8993864|NCT02796755|10056888|FG001|NOT COMPLETED|Overall Study||0
8993865|NCT02796924|10056894|FG000|STARTED|Overall Study||10
8993866|NCT02796924|10056894|FG000|COMPLETED|Overall Study||10
8993867|NCT02796924|10056894|FG000|NOT COMPLETED|Overall Study||0
8633631|NCT00552240|9673759|FG001|NOT COMPLETED|Overall Study||18
8633632|NCT00552279|9673767|FG000|STARTED|Overall Study||403
8993868|NCT02796963|10056902|FG000|STARTED|Overall Study||383
8993869|NCT02796963|10056903|FG001|STARTED|Overall Study||328
8993870|NCT02796963|10056904|FG002|STARTED|Overall Study||316
8993871|NCT02796963|10056905|FG003|STARTED|Overall Study||354
8993872|NCT02796963|10056902|FG000|First Follow up|Overall Study||293
8993873|NCT02796963|10056903|FG001|First Follow up|Overall Study||279
8993874|NCT02796963|10056904|FG002|First Follow up|Overall Study||257
8993875|NCT02796963|10056905|FG003|First Follow up|Overall Study||291
8993876|NCT02796963|10056902|FG000|Second Follow up|Overall Study||280
8633633|NCT00552279|9673768|FG001|STARTED|Overall Study||401
8993877|NCT02796963|10056903|FG001|Second Follow up|Overall Study||260
8993878|NCT02796963|10056904|FG002|Second Follow up|Overall Study||255
8993879|NCT02796963|10056905|FG003|Second Follow up|Overall Study||293
8993880|NCT02796963|10056902|FG000|Third Follow up|Overall Study||276
8993881|NCT02796963|10056903|FG001|Third Follow up|Overall Study||237
8993882|NCT02796963|10056904|FG002|Third Follow up|Overall Study||245
8993883|NCT02796963|10056905|FG003|Third Follow up|Overall Study||286
8993884|NCT02796963|10056902|FG000|Fourth Follow up|Overall Study||275
8993885|NCT02796963|10056903|FG001|Fourth Follow up|Overall Study||233
8993886|NCT02796963|10056904|FG002|Fourth Follow up|Overall Study||236
8993887|NCT02796963|10056905|FG003|Fourth Follow up|Overall Study||263
8993888|NCT02796963|10056902|FG000|HIV Sero Converted|Overall Study||19
8993889|NCT02796963|10056903|FG001|HIV Sero Converted|Overall Study||19
8993890|NCT02796963|10056904|FG002|HIV Sero Converted|Overall Study||11
8993891|NCT02796963|10056905|FG003|HIV Sero Converted|Overall Study||19
8993892|NCT02796963|10056902|FG000|COMPLETED|Overall Study||294
8993893|NCT02796963|10056903|FG001|COMPLETED|Overall Study||252
8993894|NCT02796963|10056904|FG002|COMPLETED|Overall Study||247
8993895|NCT02796963|10056905|FG003|COMPLETED|Overall Study||282
8993896|NCT02796963|10056902|FG000|NOT COMPLETED|Overall Study||89
8993897|NCT02796963|10056903|FG001|NOT COMPLETED|Overall Study||76
8993898|NCT02796963|10056904|FG002|NOT COMPLETED|Overall Study||69
8993899|NCT02796963|10056905|FG003|NOT COMPLETED|Overall Study||72
8993900|NCT02797054|10056918|FG000|STARTED|Post-test||387
8993901|NCT02797054|10056919|FG001|STARTED|Post-test||383
8993902|NCT02797054|10056920|FG002|STARTED|Post-test||435
8993903|NCT02797054|10056918|FG000|COMPLETED|Post-test||380
8993904|NCT02797054|10056919|FG001|COMPLETED|Post-test||372
8993905|NCT02797054|10056920|FG002|COMPLETED|Post-test||87
8993906|NCT02797054|10056918|FG000|NOT COMPLETED|Post-test||7
8993907|NCT02797054|10056919|FG001|NOT COMPLETED|Post-test||11
8993908|NCT02797054|10056920|FG002|NOT COMPLETED|Post-test||348
8993909|NCT02797054|10056918|FG000|STARTED|Follow-up||387
8993910|NCT02797054|10056919|FG001|STARTED|Follow-up||383
8993911|NCT02797054|10056920|FG002|STARTED|Follow-up||435
8993912|NCT02797054|10056918|FG000|COMPLETED|Follow-up||178
8993913|NCT02797054|10056919|FG001|COMPLETED|Follow-up||155
8993914|NCT02797054|10056920|FG002|COMPLETED|Follow-up||150
8993915|NCT02797054|10056918|FG000|NOT COMPLETED|Follow-up||209
8993916|NCT02797054|10056919|FG001|NOT COMPLETED|Follow-up||228
8993917|NCT02797054|10056920|FG002|NOT COMPLETED|Follow-up||285
8993918|NCT02797080|10056928|FG000|STARTED|Overall Study||38
8993919|NCT02797080|10056928|FG000|COMPLETED|Overall Study||36
8993920|NCT02797080|10056928|FG000|NOT COMPLETED|Overall Study||2
8993921|NCT02797132|10056932|FG000|STARTED|Part A (15 Days)||12
8993922|NCT02797132|10056932|FG000|Part A (<14 kg Weight)|Part A (15 Days)||4
8993923|NCT02797132|10056932|FG000|Part A (>=14 kg Weight)|Part A (15 Days)||8
8993924|NCT02797132|10056932|FG000|COMPLETED|Part A (15 Days)||11
8993925|NCT02797132|10056932|FG000|NOT COMPLETED|Part A (15 Days)||1
8993926|NCT02797132|10056932|FG000|STARTED|Part B (24 Weeks)|Participants from Part A may have participated in Part B.|60
8993927|NCT02797132|10056932|FG000|Part B (<14 kg Weight)|Part B (24 Weeks)||19
8993928|NCT02797132|10056932|FG000|Part B (>=14 kg Weight)|Part B (24 Weeks)||41
8993929|NCT02797132|10056932|FG000|COMPLETED|Part B (24 Weeks)||57
8993930|NCT02797132|10056932|FG000|NOT COMPLETED|Part B (24 Weeks)||3
8993931|NCT02797171|10056951|FG000|STARTED|Overall Study||23
8993932|NCT02797171|10056952|FG001|STARTED|Overall Study||23
8993933|NCT02797171|10056953|FG002|STARTED|Overall Study||7
8993934|NCT02797171|10056954|FG003|STARTED|Overall Study||16
8993935|NCT02797171|10056955|FG004|STARTED|Overall Study||10
8993936|NCT02797171|10056956|FG005|STARTED|Overall Study||1
8993937|NCT02797171|10056951|FG000|Safety Population|Overall Study||23
8993938|NCT02797171|10056952|FG001|Safety Population|Overall Study||23
8993939|NCT02797171|10056953|FG002|Safety Population|Overall Study||7
8993940|NCT02797171|10056954|FG003|Safety Population|Overall Study||16
8993941|NCT02797171|10056955|FG004|Safety Population|Overall Study||10
8993942|NCT02797171|10056956|FG005|Safety Population|Overall Study||1
8993943|NCT02797171|10056951|FG000|COMPLETED|Overall Study||19
8993944|NCT02797171|10056952|FG001|COMPLETED|Overall Study||21
8993945|NCT02797171|10056953|FG002|COMPLETED|Overall Study||5
8993946|NCT02797171|10056954|FG003|COMPLETED|Overall Study||15
8993947|NCT02797171|10056955|FG004|COMPLETED|Overall Study||8
8993948|NCT02797171|10056956|FG005|COMPLETED|Overall Study||0
8993949|NCT02797171|10056951|FG000|NOT COMPLETED|Overall Study||4
8993950|NCT02797171|10056952|FG001|NOT COMPLETED|Overall Study||2
8993951|NCT02797171|10056953|FG002|NOT COMPLETED|Overall Study||2
8993952|NCT02797171|10056954|FG003|NOT COMPLETED|Overall Study||1
8993953|NCT02797171|10056955|FG004|NOT COMPLETED|Overall Study||2
8993954|NCT02797171|10056956|FG005|NOT COMPLETED|Overall Study||1
8993955|NCT02797522|10056981|FG000|STARTED|Overall Study||4
8633634|NCT00552279|9673767|FG000|COMPLETED|Overall Study||389
8633635|NCT00552279|9673768|FG001|COMPLETED|Overall Study||398
8633636|NCT00552279|9673767|FG000|NOT COMPLETED|Overall Study||14
8993956|NCT02797522|10056982|FG001|STARTED|Overall Study||4
8993957|NCT02797522|10056983|FG002|STARTED|Overall Study||4
8993958|NCT02797522|10056984|FG003|STARTED|Overall Study||4
8993959|NCT02797522|10056985|FG004|STARTED|Overall Study||4
8993960|NCT02797522|10056986|FG005|STARTED|Overall Study||4
8993961|NCT02797522|10056987|FG006|STARTED|Overall Study||12
8993962|NCT02797522|10056988|FG007|STARTED|Overall Study||4
8993963|NCT02797522|10056989|FG008|STARTED|Overall Study||2
8633637|NCT00552279|9673768|FG001|NOT COMPLETED|Overall Study||3
8993964|NCT02797522|10056990|FG009|STARTED|Overall Study||4
8993965|NCT02797522|10056991|FG010|STARTED|Overall Study||1
8993966|NCT02797522|10056981|FG000|COMPLETED|Overall Study||4
8993967|NCT02797522|10056982|FG001|COMPLETED|Overall Study||4
8993968|NCT02797522|10056983|FG002|COMPLETED|Overall Study||4
8993969|NCT02797522|10056984|FG003|COMPLETED|Overall Study||4
8993970|NCT02797522|10056985|FG004|COMPLETED|Overall Study||4
8993971|NCT02797522|10056986|FG005|COMPLETED|Overall Study||4
8993972|NCT02797522|10056987|FG006|COMPLETED|Overall Study||12
8993973|NCT02797522|10056988|FG007|COMPLETED|Overall Study||0
8993974|NCT02797522|10056989|FG008|COMPLETED|Overall Study||0
8993975|NCT02797522|10056990|FG009|COMPLETED|Overall Study||0
8993976|NCT02797522|10056991|FG010|COMPLETED|Overall Study||0
8993977|NCT02797522|10056981|FG000|NOT COMPLETED|Overall Study||0
8993978|NCT02797522|10056982|FG001|NOT COMPLETED|Overall Study||0
8993979|NCT02797522|10056983|FG002|NOT COMPLETED|Overall Study||0
8993980|NCT02797522|10056984|FG003|NOT COMPLETED|Overall Study||0
8993981|NCT02797522|10056985|FG004|NOT COMPLETED|Overall Study||0
8993982|NCT02797522|10056986|FG005|NOT COMPLETED|Overall Study||0
8993983|NCT02797522|10056987|FG006|NOT COMPLETED|Overall Study||0
8993984|NCT02797522|10056988|FG007|NOT COMPLETED|Overall Study||4
8993985|NCT02797522|10056989|FG008|NOT COMPLETED|Overall Study||2
8993986|NCT02797522|10056990|FG009|NOT COMPLETED|Overall Study||4
8993987|NCT02797522|10056991|FG010|NOT COMPLETED|Overall Study||1
8993988|NCT02797613|10057021|FG000|STARTED|Overall Study||55
8993989|NCT02797613|10057022|FG001|STARTED|Overall Study||55
8993990|NCT02797613|10057021|FG000|COMPLETED|Overall Study||55
8993991|NCT02797613|10057022|FG001|COMPLETED|Overall Study||55
8993992|NCT02797613|10057021|FG000|NOT COMPLETED|Overall Study||0
8993993|NCT02797613|10057022|FG001|NOT COMPLETED|Overall Study||0
8993994|NCT02797678|10057028|FG000|STARTED|Screening Phase||62
8993995|NCT02797678|10057029|FG001|STARTED|Screening Phase||0
8993996|NCT02797678|10057030|FG002|STARTED|Screening Phase||0
8993997|NCT02797678|10057031|FG003|STARTED|Screening Phase||0
8993998|NCT02797678|10057028|FG000|COMPLETED|Screening Phase||37
8993999|NCT02797678|10057029|FG001|COMPLETED|Screening Phase||0
8994000|NCT02797678|10057030|FG002|COMPLETED|Screening Phase||0
8994001|NCT02797678|10057031|FG003|COMPLETED|Screening Phase||0
8994002|NCT02797678|10057028|FG000|NOT COMPLETED|Screening Phase||25
8994003|NCT02797678|10057029|FG001|NOT COMPLETED|Screening Phase||0
8994004|NCT02797678|10057030|FG002|NOT COMPLETED|Screening Phase||0
8994005|NCT02797678|10057031|FG003|NOT COMPLETED|Screening Phase||0
8994006|NCT02797678|10057028|FG000|STARTED|First Intervention (5 Nights)||0
8994007|NCT02797678|10057029|FG001|STARTED|First Intervention (5 Nights)||20
8994008|NCT02797678|10057030|FG002|STARTED|First Intervention (5 Nights)||17
8994009|NCT02797678|10057031|FG003|STARTED|First Intervention (5 Nights)||0
8994010|NCT02797678|10057028|FG000|COMPLETED|First Intervention (5 Nights)||0
8994011|NCT02797678|10057029|FG001|COMPLETED|First Intervention (5 Nights)||19
8994012|NCT02797678|10057030|FG002|COMPLETED|First Intervention (5 Nights)||17
8994013|NCT02797678|10057031|FG003|COMPLETED|First Intervention (5 Nights)||0
8994014|NCT02797678|10057028|FG000|NOT COMPLETED|First Intervention (5 Nights)||0
8994015|NCT02797678|10057029|FG001|NOT COMPLETED|First Intervention (5 Nights)||1
8994016|NCT02797678|10057030|FG002|NOT COMPLETED|First Intervention (5 Nights)||0
8994017|NCT02797678|10057031|FG003|NOT COMPLETED|First Intervention (5 Nights)||0
8994018|NCT02797678|10057028|FG000|STARTED|Washout||0
8994019|NCT02797678|10057029|FG001|STARTED|Washout||19
8994020|NCT02797678|10057030|FG002|STARTED|Washout||17
8994021|NCT02797678|10057031|FG003|STARTED|Washout||0
8994022|NCT02797678|10057028|FG000|COMPLETED|Washout||0
8994023|NCT02797678|10057029|FG001|COMPLETED|Washout||19
8994024|NCT02797678|10057030|FG002|COMPLETED|Washout||17
8994025|NCT02797678|10057031|FG003|COMPLETED|Washout||0
8994026|NCT02797678|10057028|FG000|NOT COMPLETED|Washout||0
8994027|NCT02797678|10057029|FG001|NOT COMPLETED|Washout||0
8994028|NCT02797678|10057030|FG002|NOT COMPLETED|Washout||0
8994029|NCT02797678|10057031|FG003|NOT COMPLETED|Washout||0
8994030|NCT02797678|10057028|FG000|STARTED|Second Intervention (5 Nights)||0
8994031|NCT02797678|10057029|FG001|STARTED|Second Intervention (5 Nights)||19
8994032|NCT02797678|10057030|FG002|STARTED|Second Intervention (5 Nights)||17
8994033|NCT02797678|10057031|FG003|STARTED|Second Intervention (5 Nights)||0
8994034|NCT02797678|10057028|FG000|COMPLETED|Second Intervention (5 Nights)||0
8994035|NCT02797678|10057029|FG001|COMPLETED|Second Intervention (5 Nights)||19
8994036|NCT02797678|10057030|FG002|COMPLETED|Second Intervention (5 Nights)||16
8994037|NCT02797678|10057031|FG003|COMPLETED|Second Intervention (5 Nights)||0
8994038|NCT02797678|10057028|FG000|NOT COMPLETED|Second Intervention (5 Nights)||0
8994039|NCT02797678|10057029|FG001|NOT COMPLETED|Second Intervention (5 Nights)||0
8994040|NCT02797678|10057030|FG002|NOT COMPLETED|Second Intervention (5 Nights)||1
8994041|NCT02797678|10057031|FG003|NOT COMPLETED|Second Intervention (5 Nights)||0
8994042|NCT02797678|10057028|FG000|STARTED|Sub-Study||0
8994043|NCT02797678|10057029|FG001|STARTED|Sub-Study||0
8994044|NCT02797678|10057030|FG002|STARTED|Sub-Study||0
8633638|NCT00552305|9673774|FG000|STARTED|Overall Study||370
8633639|NCT00552305|9673774|FG000|COMPLETED|Overall Study||120
8633640|NCT00552305|9673774|FG000|NOT COMPLETED|Overall Study||250
8994045|NCT02797678|10057031|FG003|STARTED|Sub-Study||9
8994046|NCT02797678|10057028|FG000|COMPLETED|Sub-Study||0
8994047|NCT02797678|10057029|FG001|COMPLETED|Sub-Study||0
8994048|NCT02797678|10057030|FG002|COMPLETED|Sub-Study||0
8994049|NCT02797678|10057031|FG003|COMPLETED|Sub-Study||9
8994050|NCT02797678|10057028|FG000|NOT COMPLETED|Sub-Study||0
8994051|NCT02797678|10057029|FG001|NOT COMPLETED|Sub-Study||0
8994052|NCT02797678|10057030|FG002|NOT COMPLETED|Sub-Study||0
8994053|NCT02797678|10057031|FG003|NOT COMPLETED|Sub-Study||0
8994054|NCT02797808|10057046|FG000|STARTED|Overall Study||23
8994055|NCT02797808|10057047|FG001|STARTED|Overall Study||18
8994056|NCT02797808|10057046|FG000|COMPLETED|Overall Study||16
8994057|NCT02797808|10057047|FG001|COMPLETED|Overall Study||15
8994058|NCT02797808|10057046|FG000|NOT COMPLETED|Overall Study||7
8994059|NCT02797808|10057047|FG001|NOT COMPLETED|Overall Study||3
8994060|NCT02797821|10057056|FG000|STARTED|Overall Study||8
8994061|NCT02797821|10057057|FG001|STARTED|Overall Study||10
8994062|NCT02797821|10057058|FG002|STARTED|Overall Study||9
8994063|NCT02797821|10057056|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
8994064|NCT02797821|10057057|FG001|Received at Least 1 Dose of Study Drug|Overall Study||10
8994065|NCT02797821|10057058|FG002|Received at Least 1 Dose of Study Drug|Overall Study||9
8994066|NCT02797821|10057056|FG000|COMPLETED|Overall Study||8
8994067|NCT02797821|10057057|FG001|COMPLETED|Overall Study||10
8994068|NCT02797821|10057058|FG002|COMPLETED|Overall Study||9
8994069|NCT02797821|10057056|FG000|NOT COMPLETED|Overall Study||0
8994070|NCT02797821|10057057|FG001|NOT COMPLETED|Overall Study||0
8994071|NCT02797821|10057058|FG002|NOT COMPLETED|Overall Study||0
8994072|NCT02798211|10057069|FG000|STARTED|Period 1||103
8994073|NCT02798211|10057070|FG001|STARTED|Period 1||103
8994074|NCT02798211|10057071|FG002|STARTED|Period 1||52
8994075|NCT02798211|10057072|FG003|STARTED|Period 1||0
8994076|NCT02798211|10057073|FG004|STARTED|Period 1||0
8994077|NCT02798211|10057074|FG005|STARTED|Period 1||0
8994078|NCT02798211|10057069|FG000|COMPLETED|Period 1||97
8994079|NCT02798211|10057070|FG001|COMPLETED|Period 1||93
8994080|NCT02798211|10057071|FG002|COMPLETED|Period 1||46
8994081|NCT02798211|10057072|FG003|COMPLETED|Period 1||0
8994082|NCT02798211|10057073|FG004|COMPLETED|Period 1||0
8994083|NCT02798211|10057074|FG005|COMPLETED|Period 1||0
8994084|NCT02798211|10057069|FG000|NOT COMPLETED|Period 1||6
8994085|NCT02798211|10057070|FG001|NOT COMPLETED|Period 1||10
8994086|NCT02798211|10057071|FG002|NOT COMPLETED|Period 1||6
8994087|NCT02798211|10057072|FG003|NOT COMPLETED|Period 1||0
8994088|NCT02798211|10057073|FG004|NOT COMPLETED|Period 1||0
8994089|NCT02798211|10057074|FG005|NOT COMPLETED|Period 1||0
8994090|NCT02798211|10057069|FG000|STARTED|Period 2||97
8994091|NCT02798211|10057070|FG001|STARTED|Period 2||0
8994092|NCT02798211|10057071|FG002|STARTED|Period 2||0
8994093|NCT02798211|10057072|FG003|STARTED|Period 2||50
8994094|NCT02798211|10057073|FG004|STARTED|Period 2||42
8994095|NCT02798211|10057074|FG005|STARTED|Period 2||46
8994096|NCT02798211|10057069|FG000|COMPLETED|Period 2||83
8994097|NCT02798211|10057070|FG001|COMPLETED|Period 2||0
8994098|NCT02798211|10057071|FG002|COMPLETED|Period 2||0
8994099|NCT02798211|10057072|FG003|COMPLETED|Period 2||43
8994100|NCT02798211|10057073|FG004|COMPLETED|Period 2||34
8994101|NCT02798211|10057074|FG005|COMPLETED|Period 2||40
8994102|NCT02798211|10057069|FG000|NOT COMPLETED|Period 2||14
8994103|NCT02798211|10057070|FG001|NOT COMPLETED|Period 2||0
8994104|NCT02798211|10057071|FG002|NOT COMPLETED|Period 2||0
8994105|NCT02798211|10057072|FG003|NOT COMPLETED|Period 2||7
8994106|NCT02798211|10057073|FG004|NOT COMPLETED|Period 2||8
8994107|NCT02798211|10057074|FG005|NOT COMPLETED|Period 2||6
8633641|NCT00552344|9673778|FG000|STARTED|Overall Study||402
9039189|NCT03335254|10100138|FG016|NOT COMPLETED|Period 3, Day 16-25||0
9039190|NCT03335254|10100139|FG017|NOT COMPLETED|Period 3, Day 16-25||0
9039191|NCT03335254|10100140|FG018|NOT COMPLETED|Period 3, Day 16-25||0
9039192|NCT03335254|10100141|FG019|NOT COMPLETED|Period 3, Day 16-25||0
9039193|NCT03335254|10100122|FG000|STARTED|Period 3, Day 26-30||9
9039194|NCT03335254|10100123|FG001|STARTED|Period 3, Day 26-30||0
9039195|NCT03335254|10100124|FG002|STARTED|Period 3, Day 26-30||0
9039196|NCT03335254|10100125|FG003|STARTED|Period 3, Day 26-30||0
9039197|NCT03335254|10100126|FG004|STARTED|Period 3, Day 26-30||0
9039198|NCT03335254|10100127|FG005|STARTED|Period 3, Day 26-30||0
9039199|NCT03335254|10100128|FG006|STARTED|Period 3, Day 26-30||0
8633642|NCT00552344|9673778|FG000|COMPLETED|Overall Study||87
9039200|NCT03335254|10100129|FG007|STARTED|Period 3, Day 26-30||0
9039201|NCT03335254|10100130|FG008|STARTED|Period 3, Day 26-30||0
9039202|NCT03335254|10100131|FG009|STARTED|Period 3, Day 26-30||0
9039203|NCT03335254|10100132|FG010|STARTED|Period 3, Day 26-30||0
9039204|NCT03335254|10100133|FG011|STARTED|Period 3, Day 26-30||0
9039205|NCT03335254|10100134|FG012|STARTED|Period 3, Day 26-30||0
9039206|NCT03335254|10100135|FG013|STARTED|Period 3, Day 26-30||0
9039207|NCT03335254|10100136|FG014|STARTED|Period 3, Day 26-30||0
9039208|NCT03335254|10100137|FG015|STARTED|Period 3, Day 26-30||0
8994108|NCT02798289|10057086|FG000|STARTED|Overall Study||55
8994109|NCT02798289|10057086|FG000|COMPLETED|Overall Study||55
8994110|NCT02798289|10057086|FG000|NOT COMPLETED|Overall Study||0
8994111|NCT02798315|10057090|FG000|STARTED|Overall Study||40
8994112|NCT02798315|10057090|FG000|COMPLETED|Overall Study||39
8994113|NCT02798315|10057090|FG000|NOT COMPLETED|Overall Study||1
8994114|NCT02798354|10057097|FG000|STARTED|First Intervention Period||1184
8994115|NCT02798354|10057098|FG001|STARTED|First Intervention Period||2176
8994116|NCT02798354|10057099|FG002|STARTED|First Intervention Period||990
8994117|NCT02798354|10057097|FG000|Control Data Error 1|First Intervention Period||440
8994118|NCT02798354|10057098|FG001|Control Data Error 1|First Intervention Period||549
8994119|NCT02798354|10057099|FG002|Control Data Error 1|First Intervention Period||345
8994120|NCT02798354|10057097|FG000|Intervention Data Error 1|First Intervention Period||744
8994121|NCT02798354|10057098|FG001|Intervention Data Error 1|First Intervention Period||1627
8994122|NCT02798354|10057099|FG002|Intervention Data Error 1|First Intervention Period||645
8994123|NCT02798354|10057097|FG000|COMPLETED|First Intervention Period||1184
8994124|NCT02798354|10057098|FG001|COMPLETED|First Intervention Period||2176
8994125|NCT02798354|10057099|FG002|COMPLETED|First Intervention Period||990
8994126|NCT02798354|10057097|FG000|NOT COMPLETED|First Intervention Period||0
8994127|NCT02798354|10057098|FG001|NOT COMPLETED|First Intervention Period||0
8994128|NCT02798354|10057099|FG002|NOT COMPLETED|First Intervention Period||0
8994129|NCT02798354|10057097|FG000|STARTED|Second Intervention Period||2617
8994130|NCT02798354|10057098|FG001|STARTED|Second Intervention Period||1047
8994131|NCT02798354|10057099|FG002|STARTED|Second Intervention Period||1368
8994132|NCT02798354|10057097|FG000|Control Data Error 2|Second Intervention Period||1378
8994133|NCT02798354|10057098|FG001|Control Data Error 2|Second Intervention Period||593
8994134|NCT02798354|10057099|FG002|Control Data Error 2|Second Intervention Period||668
8994135|NCT02798354|10057097|FG000|Intervention Data Error 2|Second Intervention Period||1239
8994136|NCT02798354|10057098|FG001|Intervention Data Error 2|Second Intervention Period||454
8994137|NCT02798354|10057099|FG002|Intervention Data Error 2|Second Intervention Period||700
8994138|NCT02798354|10057097|FG000|COMPLETED|Second Intervention Period||2617
8994139|NCT02798354|10057098|FG001|COMPLETED|Second Intervention Period||1047
8994140|NCT02798354|10057099|FG002|COMPLETED|Second Intervention Period||1368
8994141|NCT02798354|10057097|FG000|NOT COMPLETED|Second Intervention Period||0
8994142|NCT02798354|10057098|FG001|NOT COMPLETED|Second Intervention Period||0
8994143|NCT02798354|10057099|FG002|NOT COMPLETED|Second Intervention Period||0
8994144|NCT02798354|10057097|FG000|STARTED|Third Intervention Period||746
8994145|NCT02798354|10057098|FG001|STARTED|Third Intervention Period||1010
8994146|NCT02798354|10057099|FG002|STARTED|Third Intervention Period||2715
8994147|NCT02798354|10057097|FG000|Control Data Error 3|Third Intervention Period||419
8994148|NCT02798354|10057098|FG001|Control Data Error 3|Third Intervention Period||620
8994149|NCT02798354|10057099|FG002|Control Data Error 3|Third Intervention Period||1467
8994150|NCT02798354|10057097|FG000|Intervention Data Error 3|Third Intervention Period||327
8994151|NCT02798354|10057098|FG001|Intervention Data Error 3|Third Intervention Period||390
8994152|NCT02798354|10057099|FG002|Intervention Data Error 3|Third Intervention Period||1248
8994153|NCT02798354|10057097|FG000|COMPLETED|Third Intervention Period||746
8994154|NCT02798354|10057098|FG001|COMPLETED|Third Intervention Period||1010
8994155|NCT02798354|10057099|FG002|COMPLETED|Third Intervention Period||2715
8994156|NCT02798354|10057097|FG000|NOT COMPLETED|Third Intervention Period||0
8994157|NCT02798354|10057098|FG001|NOT COMPLETED|Third Intervention Period||0
8994158|NCT02798354|10057099|FG002|NOT COMPLETED|Third Intervention Period||0
8994159|NCT02798380|10057113|FG000|STARTED|Overall Study||30
8994160|NCT02798380|10057113|FG000|COMPLETED|Overall Study||30
8994161|NCT02798380|10057113|FG000|NOT COMPLETED|Overall Study||0
8994162|NCT02798627|10057119|FG000|STARTED|Overall Study||27
8994163|NCT02798627|10057120|FG001|STARTED|Overall Study||28
8994164|NCT02798627|10057119|FG000|COMPLETED|Overall Study||27
8994165|NCT02798627|10057120|FG001|COMPLETED|Overall Study||28
8994166|NCT02798627|10057119|FG000|NOT COMPLETED|Overall Study||0
8994167|NCT02798627|10057120|FG001|NOT COMPLETED|Overall Study||0
8994168|NCT02798835|10057129|FG000|STARTED|Overall Study||60
8994169|NCT02798835|10057130|FG001|STARTED|Overall Study||60
8994170|NCT02798835|10057131|FG002|STARTED|Overall Study||60
8994171|NCT02798835|10057129|FG000|COMPLETED|Overall Study||60
8994172|NCT02798835|10057130|FG001|COMPLETED|Overall Study||60
8994173|NCT02798835|10057131|FG002|COMPLETED|Overall Study||57
8994174|NCT02798835|10057129|FG000|NOT COMPLETED|Overall Study||0
8994175|NCT02798835|10057130|FG001|NOT COMPLETED|Overall Study||0
8994176|NCT02798835|10057131|FG002|NOT COMPLETED|Overall Study||3
8994177|NCT02798861|10057139|FG000|STARTED|Overall Study||160
8994178|NCT02798861|10057139|FG000|COMPLETED|Overall Study||137
8994179|NCT02798861|10057139|FG000|NOT COMPLETED|Overall Study||23
8994180|NCT02798952|10057143|FG000|STARTED|Overall Study||302
8994181|NCT02798952|10057143|FG000|COMPLETED|Overall Study||302
8994182|NCT02798952|10057143|FG000|NOT COMPLETED|Overall Study||0
8994183|NCT02798978|10057154|FG000|STARTED|Part 1 (30 Days)||10
8994184|NCT02798978|10057155|FG001|STARTED|Part 1 (30 Days)||6
8994185|NCT02798978|10057156|FG002|STARTED|Part 1 (30 Days)||6
8994186|NCT02798978|10057157|FG003|STARTED|Part 1 (30 Days)||6
8994187|NCT02798978|10057158|FG004|STARTED|Part 1 (30 Days)||6
8994188|NCT02798978|10057159|FG005|STARTED|Part 1 (30 Days)||6
8994189|NCT02798978|10057160|FG006|STARTED|Part 1 (30 Days)||0
8994190|NCT02798978|10057154|FG000|COMPLETED|Part 1 (30 Days)||10
8994191|NCT02798978|10057155|FG001|COMPLETED|Part 1 (30 Days)||6
8994192|NCT02798978|10057156|FG002|COMPLETED|Part 1 (30 Days)||6
8994193|NCT02798978|10057157|FG003|COMPLETED|Part 1 (30 Days)||6
8994194|NCT02798978|10057158|FG004|COMPLETED|Part 1 (30 Days)||6
8994195|NCT02798978|10057159|FG005|COMPLETED|Part 1 (30 Days)||6
8994196|NCT02798978|10057160|FG006|COMPLETED|Part 1 (30 Days)||0
8879173|NCT01932437|9935984|FG001|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
8879174|NCT01932437|9935985|FG002|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
8994197|NCT02798978|10057154|FG000|NOT COMPLETED|Part 1 (30 Days)||0
8994198|NCT02798978|10057155|FG001|NOT COMPLETED|Part 1 (30 Days)||0
8994199|NCT02798978|10057156|FG002|NOT COMPLETED|Part 1 (30 Days)||0
8994200|NCT02798978|10057157|FG003|NOT COMPLETED|Part 1 (30 Days)||0
8994201|NCT02798978|10057158|FG004|NOT COMPLETED|Part 1 (30 Days)||0
8994202|NCT02798978|10057159|FG005|NOT COMPLETED|Part 1 (30 Days)||0
8994203|NCT02798978|10057160|FG006|NOT COMPLETED|Part 1 (30 Days)||0
8994204|NCT02798978|10057154|FG000|STARTED|Part 2 (45 Days)||0
8994205|NCT02798978|10057155|FG001|STARTED|Part 2 (45 Days)||0
8994206|NCT02798978|10057156|FG002|STARTED|Part 2 (45 Days)||0
8994207|NCT02798978|10057157|FG003|STARTED|Part 2 (45 Days)||0
8994208|NCT02798978|10057158|FG004|STARTED|Part 2 (45 Days)||0
8994209|NCT02798978|10057159|FG005|STARTED|Part 2 (45 Days)||0
8994210|NCT02798978|10057160|FG006|STARTED|Part 2 (45 Days)||0
8994211|NCT02798978|10057154|FG000|COMPLETED|Part 2 (45 Days)||0
8994212|NCT02798978|10057155|FG001|COMPLETED|Part 2 (45 Days)||0
8994213|NCT02798978|10057156|FG002|COMPLETED|Part 2 (45 Days)||0
8994214|NCT02798978|10057157|FG003|COMPLETED|Part 2 (45 Days)||0
8994215|NCT02798978|10057158|FG004|COMPLETED|Part 2 (45 Days)||0
8994216|NCT02798978|10057159|FG005|COMPLETED|Part 2 (45 Days)||0
8994217|NCT02798978|10057160|FG006|COMPLETED|Part 2 (45 Days)||0
8994218|NCT02798978|10057154|FG000|NOT COMPLETED|Part 2 (45 Days)||0
8994219|NCT02798978|10057155|FG001|NOT COMPLETED|Part 2 (45 Days)||0
8994220|NCT02798978|10057156|FG002|NOT COMPLETED|Part 2 (45 Days)||0
8994221|NCT02798978|10057157|FG003|NOT COMPLETED|Part 2 (45 Days)||0
8994222|NCT02798978|10057158|FG004|NOT COMPLETED|Part 2 (45 Days)||0
8994223|NCT02798978|10057159|FG005|NOT COMPLETED|Part 2 (45 Days)||0
8994224|NCT02798978|10057160|FG006|NOT COMPLETED|Part 2 (45 Days)||0
8994225|NCT02799069|10057185|FG000|STARTED|Overall Study||76
8994226|NCT02799069|10057186|FG001|STARTED|Overall Study||248
8994227|NCT02799069|10057187|FG002|STARTED|Overall Study||247
8994228|NCT02799069|10057185|FG000|ITT/Safety|Overall Study||76
8994229|NCT02799069|10057186|FG001|ITT/Safety|Overall Study||248
8879175|NCT01932437|9935986|FG003|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||6
8879176|NCT01932437|9935987|FG004|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
8879177|NCT01932437|9935988|FG005|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
8879178|NCT01932437|9935983|FG000|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
8879179|NCT01932437|9935984|FG001|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
8879180|NCT01932437|9935985|FG002|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
8994230|NCT02799069|10057187|FG002|ITT/Safety|Overall Study|1 subject received medication without Illumination and thus was excluded from ITT/safety population|246
8994231|NCT02799069|10057185|FG000|COMPLETED|Overall Study||68
8994232|NCT02799069|10057186|FG001|COMPLETED|Overall Study||241
8994233|NCT02799069|10057187|FG002|COMPLETED|Overall Study||240
8994234|NCT02799069|10057185|FG000|NOT COMPLETED|Overall Study||8
8994235|NCT02799069|10057186|FG001|NOT COMPLETED|Overall Study||7
8994236|NCT02799069|10057187|FG002|NOT COMPLETED|Overall Study||7
8994237|NCT02799082|10057197|FG000|STARTED|Overall Study||41
8994238|NCT02799082|10057198|FG001|STARTED|Overall Study||81
8994239|NCT02799082|10057197|FG000|COMPLETED|Overall Study||37
8994240|NCT02799082|10057198|FG001|COMPLETED|Overall Study||77
8994241|NCT02799082|10057197|FG000|NOT COMPLETED|Overall Study||4
8994242|NCT02799082|10057198|FG001|NOT COMPLETED|Overall Study||4
8994243|NCT02799290|10057207|FG000|STARTED|Overall Study||24
8994244|NCT02799290|10057208|FG001|STARTED|Overall Study||13
8994245|NCT02799290|10057209|FG002|STARTED|Overall Study||11
8994246|NCT02799290|10057207|FG000|COMPLETED|Overall Study||24
8994247|NCT02799290|10057208|FG001|COMPLETED|Overall Study||13
8994248|NCT02799290|10057209|FG002|COMPLETED|Overall Study||11
8994249|NCT02799290|10057207|FG000|NOT COMPLETED|Overall Study||0
8994250|NCT02799290|10057208|FG001|NOT COMPLETED|Overall Study||0
8994251|NCT02799290|10057209|FG002|NOT COMPLETED|Overall Study||0
8994252|NCT02799381|10057223|FG000|STARTED|Overall Study||33
8994253|NCT02799381|10057224|FG001|STARTED|Overall Study||28
8994254|NCT02799381|10057223|FG000|COMPLETED|Overall Study||29
8994255|NCT02799381|10057224|FG001|COMPLETED|Overall Study||25
8994256|NCT02799381|10057223|FG000|NOT COMPLETED|Overall Study||4
8994257|NCT02799381|10057224|FG001|NOT COMPLETED|Overall Study||3
8994258|NCT02799472|10057232|FG000|STARTED|Overall Study||11
8994259|NCT02799472|10057233|FG001|STARTED|Overall Study||28
8994260|NCT02799472|10057232|FG000|COMPLETED|Overall Study||7
8994261|NCT02799472|10057233|FG001|COMPLETED|Overall Study||23
8994262|NCT02799472|10057232|FG000|NOT COMPLETED|Overall Study||4
8994263|NCT02799472|10057233|FG001|NOT COMPLETED|Overall Study||5
8994264|NCT02799667|10057241|FG000|STARTED|Overall Study||55
8994265|NCT02799667|10057242|FG001|STARTED|Overall Study||55
8994266|NCT02799667|10057241|FG000|COMPLETED|Overall Study||54
8994267|NCT02799667|10057242|FG001|COMPLETED|Overall Study||54
8994268|NCT02799667|10057241|FG000|NOT COMPLETED|Overall Study||1
8994269|NCT02799667|10057242|FG001|NOT COMPLETED|Overall Study||1
8725901|NCT01033487|9773158|FG001|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||3
8725902|NCT01033487|9773159|FG002|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
8994270|NCT02799745|10057250|FG000|STARTED|Overall Study||114
8633643|NCT00552344|9673778|FG000|NOT COMPLETED|Overall Study||315
8633644|NCT00552396|9673790|FG000|STARTED|Overall Study||4
8633645|NCT00552396|9673791|FG001|STARTED|Overall Study||3
8633646|NCT00552396|9673792|FG002|STARTED|Overall Study||3
8633647|NCT00552396|9673793|FG003|STARTED|Overall Study||6
8633648|NCT00552396|9673794|FG004|STARTED|Overall Study||3
8633649|NCT00552396|9673795|FG005|STARTED|Overall Study||3
8633650|NCT00552396|9673796|FG006|STARTED|Overall Study||10
8633651|NCT00552396|9673790|FG000|COMPLETED|Overall Study||1
8633652|NCT00552396|9673791|FG001|COMPLETED|Overall Study||0
8633653|NCT00552396|9673792|FG002|COMPLETED|Overall Study||0
8633654|NCT00552396|9673793|FG003|COMPLETED|Overall Study||0
8994271|NCT02799745|10057251|FG001|STARTED|Overall Study||113
8994272|NCT02799745|10057250|FG000|Treated|Overall Study||112
8994273|NCT02799745|10057251|FG001|Treated|Overall Study||113
8633655|NCT00552396|9673794|FG004|COMPLETED|Overall Study||0
8633656|NCT00552396|9673795|FG005|COMPLETED|Overall Study||0
8633657|NCT00552396|9673796|FG006|COMPLETED|Overall Study||1
8633658|NCT00552396|9673790|FG000|NOT COMPLETED|Overall Study||3
8994274|NCT02799745|10057250|FG000|COMPLETED|Overall Study||58
8994275|NCT02799745|10057251|FG001|COMPLETED|Overall Study||42
8994276|NCT02799745|10057250|FG000|NOT COMPLETED|Overall Study||56
8994277|NCT02799745|10057251|FG001|NOT COMPLETED|Overall Study||71
8994278|NCT02799784|10057257|FG000|STARTED|Treatment Period 1 (TP1- 8 Weeks)||117
8994279|NCT02799784|10057258|FG001|STARTED|Treatment Period 1 (TP1- 8 Weeks)||119
8994280|NCT02799784|10057257|FG000|COMPLETED|Treatment Period 1 (TP1- 8 Weeks)||111
8994281|NCT02799784|10057258|FG001|COMPLETED|Treatment Period 1 (TP1- 8 Weeks)||118
8994282|NCT02799784|10057257|FG000|NOT COMPLETED|Treatment Period 1 (TP1- 8 Weeks)||6
8994283|NCT02799784|10057258|FG001|NOT COMPLETED|Treatment Period 1 (TP1- 8 Weeks)||1
8994284|NCT02799784|10057257|FG000|STARTED|Washout Period (3 Weeks)||111
8994285|NCT02799784|10057258|FG001|STARTED|Washout Period (3 Weeks)||118
8633659|NCT00552396|9673791|FG001|NOT COMPLETED|Overall Study||3
8633660|NCT00552396|9673792|FG002|NOT COMPLETED|Overall Study||3
8633661|NCT00552396|9673793|FG003|NOT COMPLETED|Overall Study||6
8633662|NCT00552396|9673794|FG004|NOT COMPLETED|Overall Study||3
8994286|NCT02799784|10057257|FG000|COMPLETED|Washout Period (3 Weeks)||111
8994287|NCT02799784|10057258|FG001|COMPLETED|Washout Period (3 Weeks)||118
8994288|NCT02799784|10057257|FG000|NOT COMPLETED|Washout Period (3 Weeks)||0
8994289|NCT02799784|10057258|FG001|NOT COMPLETED|Washout Period (3 Weeks)||0
8994290|NCT02799784|10057257|FG000|STARTED|Treatment Period 2 (TP2 - 8 Weeks)||111
8994291|NCT02799784|10057258|FG001|STARTED|Treatment Period 2 (TP2 - 8 Weeks)||118
8994292|NCT02799784|10057257|FG000|COMPLETED|Treatment Period 2 (TP2 - 8 Weeks)||110
8994293|NCT02799784|10057258|FG001|COMPLETED|Treatment Period 2 (TP2 - 8 Weeks)||115
8994294|NCT02799784|10057257|FG000|NOT COMPLETED|Treatment Period 2 (TP2 - 8 Weeks)||1
8994295|NCT02799784|10057258|FG001|NOT COMPLETED|Treatment Period 2 (TP2 - 8 Weeks)||3
8994296|NCT02800148|10057267|FG000|STARTED|Overall Study||224
8994297|NCT02800148|10057268|FG001|STARTED|Overall Study||224
8994298|NCT02800148|10057269|FG002|STARTED|Overall Study||219
8994299|NCT02800148|10057267|FG000|COMPLETED|Overall Study||199
8994300|NCT02800148|10057268|FG001|COMPLETED|Overall Study||204
8994301|NCT02800148|10057269|FG002|COMPLETED|Overall Study||194
8994302|NCT02800148|10057267|FG000|NOT COMPLETED|Overall Study||25
8994303|NCT02800148|10057268|FG001|NOT COMPLETED|Overall Study||20
8994304|NCT02800148|10057269|FG002|NOT COMPLETED|Overall Study||25
8994305|NCT02800213|10057279|FG000|STARTED|First Intervention||35
8994306|NCT02800213|10057280|FG001|STARTED|First Intervention||35
8994307|NCT02800213|10057279|FG000|COMPLETED|First Intervention||35
8994308|NCT02800213|10057280|FG001|COMPLETED|First Intervention||35
8994309|NCT02800213|10057279|FG000|NOT COMPLETED|First Intervention||0
8994310|NCT02800213|10057280|FG001|NOT COMPLETED|First Intervention||0
8994311|NCT02800213|10057279|FG000|STARTED|Second Intervention||35
8633663|NCT00552396|9673795|FG005|NOT COMPLETED|Overall Study||3
8633664|NCT00552396|9673796|FG006|NOT COMPLETED|Overall Study||9
8633665|NCT00552409|9673832|FG000|STARTED|Overall Study||11
8633666|NCT00552409|9673833|FG001|STARTED|Overall Study||11
8633667|NCT00552409|9673832|FG000|COMPLETED|Overall Study||10
8994312|NCT02800213|10057280|FG001|STARTED|Second Intervention||35
8994313|NCT02800213|10057279|FG000|COMPLETED|Second Intervention||35
8994314|NCT02800213|10057280|FG001|COMPLETED|Second Intervention||35
8994315|NCT02800213|10057279|FG000|NOT COMPLETED|Second Intervention||0
8994316|NCT02800213|10057280|FG001|NOT COMPLETED|Second Intervention||0
8994317|NCT02800356|10057286|FG000|STARTED|Overall Study||20
8994318|NCT02800356|10057286|FG000|COMPLETED|Overall Study||20
8994319|NCT02800356|10057286|FG000|NOT COMPLETED|Overall Study||0
8994320|NCT02800642|10057290|FG000|STARTED|Overall Study||162
8994321|NCT02800642|10057290|FG000|COMPLETED|Overall Study||137
8994322|NCT02800642|10057290|FG000|NOT COMPLETED|Overall Study||25
8994323|NCT02800928|10057294|FG000|STARTED|Overall Study||9
8994324|NCT02800928|10057295|FG001|STARTED|Overall Study||8
8994325|NCT02800928|10057294|FG000|COMPLETED|Overall Study||7
8994326|NCT02800928|10057295|FG001|COMPLETED|Overall Study||6
8994327|NCT02800928|10057294|FG000|NOT COMPLETED|Overall Study||2
8994328|NCT02800928|10057295|FG001|NOT COMPLETED|Overall Study||2
8994329|NCT02801006|10057301|FG000|STARTED|Lens 1||22
8994330|NCT02801006|10057302|FG001|STARTED|Lens 1||19
8994331|NCT02801006|10057301|FG000|COMPLETED|Lens 1||22
8994332|NCT02801006|10057302|FG001|COMPLETED|Lens 1||19
8994333|NCT02801006|10057301|FG000|NOT COMPLETED|Lens 1||0
8994334|NCT02801006|10057302|FG001|NOT COMPLETED|Lens 1||0
8994335|NCT02801006|10057301|FG000|STARTED|Lens 2||22
8994336|NCT02801006|10057302|FG001|STARTED|Lens 2||19
8994337|NCT02801006|10057301|FG000|COMPLETED|Lens 2||22
8994338|NCT02801006|10057302|FG001|COMPLETED|Lens 2||19
8994339|NCT02801006|10057301|FG000|NOT COMPLETED|Lens 2||0
8994340|NCT02801006|10057302|FG001|NOT COMPLETED|Lens 2||0
8994341|NCT02801370|10057312|FG000|STARTED|Overall Study||130
8994342|NCT02801370|10057313|FG001|STARTED|Overall Study||132
8994343|NCT02801370|10057312|FG000|COMPLETED|Overall Study||123
8994344|NCT02801370|10057313|FG001|COMPLETED|Overall Study||132
8994345|NCT02801370|10057312|FG000|NOT COMPLETED|Overall Study||7
8994346|NCT02801370|10057313|FG001|NOT COMPLETED|Overall Study||0
8994347|NCT02801396|10057320|FG000|STARTED|Period 1||17
8994348|NCT02801396|10057321|FG001|STARTED|Period 1||17
8994349|NCT02801396|10057322|FG002|STARTED|Period 1||17
8994350|NCT02801396|10057323|FG003|STARTED|Period 1||16
8994351|NCT02801396|10057324|FG004|STARTED|Period 1||17
8994352|NCT02801396|10057325|FG005|STARTED|Period 1||17
8994353|NCT02801396|10057320|FG000|COMPLETED|Period 1||17
8994354|NCT02801396|10057321|FG001|COMPLETED|Period 1||17
8994355|NCT02801396|10057322|FG002|COMPLETED|Period 1||17
8994356|NCT02801396|10057323|FG003|COMPLETED|Period 1||16
8994357|NCT02801396|10057324|FG004|COMPLETED|Period 1||16
8994358|NCT02801396|10057325|FG005|COMPLETED|Period 1||17
8994359|NCT02801396|10057320|FG000|NOT COMPLETED|Period 1||0
8994360|NCT02801396|10057321|FG001|NOT COMPLETED|Period 1||0
8994361|NCT02801396|10057322|FG002|NOT COMPLETED|Period 1||0
8994362|NCT02801396|10057323|FG003|NOT COMPLETED|Period 1||0
8994363|NCT02801396|10057324|FG004|NOT COMPLETED|Period 1||1
8633668|NCT00552409|9673833|FG001|COMPLETED|Overall Study||9
8994364|NCT02801396|10057325|FG005|NOT COMPLETED|Period 1||0
8994365|NCT02801396|10057320|FG000|STARTED|Period 2||17
8994366|NCT02801396|10057321|FG001|STARTED|Period 2||17
8994367|NCT02801396|10057322|FG002|STARTED|Period 2||17
8994368|NCT02801396|10057323|FG003|STARTED|Period 2||16
8994369|NCT02801396|10057324|FG004|STARTED|Period 2||16
8994370|NCT02801396|10057325|FG005|STARTED|Period 2||17
8994371|NCT02801396|10057320|FG000|COMPLETED|Period 2||17
8994372|NCT02801396|10057321|FG001|COMPLETED|Period 2||17
8994373|NCT02801396|10057322|FG002|COMPLETED|Period 2||17
8994374|NCT02801396|10057323|FG003|COMPLETED|Period 2||16
8994375|NCT02801396|10057324|FG004|COMPLETED|Period 2||16
8994376|NCT02801396|10057325|FG005|COMPLETED|Period 2||17
8994377|NCT02801396|10057320|FG000|NOT COMPLETED|Period 2||0
8994378|NCT02801396|10057321|FG001|NOT COMPLETED|Period 2||0
8994379|NCT02801396|10057322|FG002|NOT COMPLETED|Period 2||0
8994380|NCT02801396|10057323|FG003|NOT COMPLETED|Period 2||0
8994381|NCT02801396|10057324|FG004|NOT COMPLETED|Period 2||0
8994382|NCT02801396|10057325|FG005|NOT COMPLETED|Period 2||0
8994383|NCT02801396|10057320|FG000|STARTED|Period 3||17
8633669|NCT00552409|9673832|FG000|NOT COMPLETED|Overall Study||1
8633670|NCT00552409|9673833|FG001|NOT COMPLETED|Overall Study||2
8633671|NCT00552422|9673839|FG000|STARTED|Overall Study||6
8994384|NCT02801396|10057321|FG001|STARTED|Period 3||17
8994385|NCT02801396|10057322|FG002|STARTED|Period 3||17
8994386|NCT02801396|10057323|FG003|STARTED|Period 3||16
8994387|NCT02801396|10057324|FG004|STARTED|Period 3||16
8994388|NCT02801396|10057325|FG005|STARTED|Period 3||17
8994389|NCT02801396|10057320|FG000|COMPLETED|Period 3||17
8633672|NCT00552422|9673839|FG000|COMPLETED|Overall Study||6
8633673|NCT00552422|9673839|FG000|NOT COMPLETED|Overall Study||0
8633674|NCT00552448|9673845|FG000|STARTED|Overall Study||20
8633675|NCT00552448|9673846|FG001|STARTED|Overall Study||16
8633676|NCT00552448|9673845|FG000|COMPLETED|Overall Study||19
8633677|NCT00552448|9673846|FG001|COMPLETED|Overall Study||16
8994390|NCT02801396|10057321|FG001|COMPLETED|Period 3||17
8994391|NCT02801396|10057322|FG002|COMPLETED|Period 3||17
8994392|NCT02801396|10057323|FG003|COMPLETED|Period 3||16
8994393|NCT02801396|10057324|FG004|COMPLETED|Period 3||16
8994394|NCT02801396|10057325|FG005|COMPLETED|Period 3||17
8994395|NCT02801396|10057320|FG000|NOT COMPLETED|Period 3||0
8994396|NCT02801396|10057321|FG001|NOT COMPLETED|Period 3||0
8994397|NCT02801396|10057322|FG002|NOT COMPLETED|Period 3||0
8994398|NCT02801396|10057323|FG003|NOT COMPLETED|Period 3||0
8994399|NCT02801396|10057324|FG004|NOT COMPLETED|Period 3||0
8994400|NCT02801396|10057325|FG005|NOT COMPLETED|Period 3||0
8994401|NCT02801578|10057333|FG000|STARTED|Overall Study||11
8994402|NCT02801578|10057333|FG000|COMPLETED|Overall Study||9
8633678|NCT00552448|9673845|FG000|NOT COMPLETED|Overall Study||1
8633679|NCT00552448|9673846|FG001|NOT COMPLETED|Overall Study||0
8994403|NCT02801578|10057333|FG000|NOT COMPLETED|Overall Study||2
8994404|NCT02801617|10057339|FG000|STARTED|Overall Study||51
8994405|NCT02801617|10057340|FG001|STARTED|Overall Study||56
8994406|NCT02801617|10057339|FG000|COMPLETED|Overall Study||49
8994407|NCT02801617|10057340|FG001|COMPLETED|Overall Study||50
8994408|NCT02801617|10057339|FG000|NOT COMPLETED|Overall Study||2
8994409|NCT02801617|10057340|FG001|NOT COMPLETED|Overall Study||6
8994410|NCT02801669|10057352|FG000|STARTED|Overall Study||492
8994411|NCT02801669|10057353|FG001|STARTED|Overall Study||492
8994412|NCT02801669|10057352|FG000|Received at Least 1 Dose of Study Drug|Overall Study||492
8994413|NCT02801669|10057353|FG001|Received at Least 1 Dose of Study Drug|Overall Study||490
8994414|NCT02801669|10057352|FG000|COMPLETED|Overall Study||341
8994415|NCT02801669|10057353|FG001|COMPLETED|Overall Study||340
8994416|NCT02801669|10057352|FG000|NOT COMPLETED|Overall Study||151
8994417|NCT02801669|10057353|FG001|NOT COMPLETED|Overall Study||152
8994418|NCT02801877|10057363|FG000|STARTED|Overall Study||74
8994419|NCT02801877|10057364|FG001|STARTED|Overall Study||75
8994420|NCT02801877|10057365|FG002|STARTED|Overall Study||76
8994421|NCT02801877|10057366|FG003|STARTED|Overall Study||76
8994422|NCT02801877|10057363|FG000|COMPLETED|Overall Study||71
8994423|NCT02801877|10057364|FG001|COMPLETED|Overall Study||74
8994424|NCT02801877|10057365|FG002|COMPLETED|Overall Study||70
8994425|NCT02801877|10057366|FG003|COMPLETED|Overall Study||76
8994426|NCT02801877|10057363|FG000|NOT COMPLETED|Overall Study||3
8994427|NCT02801877|10057364|FG001|NOT COMPLETED|Overall Study||1
8994428|NCT02801877|10057365|FG002|NOT COMPLETED|Overall Study||6
8994429|NCT02801877|10057366|FG003|NOT COMPLETED|Overall Study||0
8994430|NCT02801942|10057378|FG000|STARTED|Overall Study||12
8994431|NCT02801942|10057379|FG001|STARTED|Overall Study||10
8994432|NCT02801942|10057378|FG000|COMPLETED|Overall Study||12
8994433|NCT02801942|10057379|FG001|COMPLETED|Overall Study||10
8994434|NCT02801942|10057378|FG000|NOT COMPLETED|Overall Study||0
8994435|NCT02801942|10057379|FG001|NOT COMPLETED|Overall Study||0
8994436|NCT02802111|10057387|FG000|STARTED|First Intervention (5 Min of Drug)||12
8994437|NCT02802111|10057388|FG001|STARTED|First Intervention (5 Min of Drug)||12
8994438|NCT02802111|10057387|FG000|COMPLETED|First Intervention (5 Min of Drug)||12
8994439|NCT02802111|10057388|FG001|COMPLETED|First Intervention (5 Min of Drug)||12
8994440|NCT02802111|10057387|FG000|NOT COMPLETED|First Intervention (5 Min of Drug)||0
8994441|NCT02802111|10057388|FG001|NOT COMPLETED|First Intervention (5 Min of Drug)||0
8994442|NCT02802111|10057387|FG000|STARTED|Washout (4 Hours)||12
8994443|NCT02802111|10057388|FG001|STARTED|Washout (4 Hours)||12
8994444|NCT02802111|10057387|FG000|COMPLETED|Washout (4 Hours)||12
8994445|NCT02802111|10057388|FG001|COMPLETED|Washout (4 Hours)||12
8994446|NCT02802111|10057387|FG000|NOT COMPLETED|Washout (4 Hours)||0
8994447|NCT02802111|10057388|FG001|NOT COMPLETED|Washout (4 Hours)||0
8994448|NCT02802111|10057387|FG000|STARTED|Second Intervention (5 Min of Drug)||12
8994449|NCT02802111|10057388|FG001|STARTED|Second Intervention (5 Min of Drug)||12
8633680|NCT00552578|9673854|FG000|STARTED|Overall Study||6
8994450|NCT02802111|10057387|FG000|COMPLETED|Second Intervention (5 Min of Drug)||12
8994451|NCT02802111|10057388|FG001|COMPLETED|Second Intervention (5 Min of Drug)||12
8994452|NCT02802111|10057387|FG000|NOT COMPLETED|Second Intervention (5 Min of Drug)||0
8994453|NCT02802111|10057388|FG001|NOT COMPLETED|Second Intervention (5 Min of Drug)||0
8994454|NCT02802241|10057398|FG000|STARTED|Overall Study||97
8994455|NCT02802241|10057399|FG001|STARTED|Overall Study||97
8994456|NCT02802241|10057400|FG002|STARTED|Overall Study||48
8633681|NCT00552578|9673855|FG001|STARTED|Overall Study||6
8994457|NCT02802241|10057401|FG003|STARTED|Overall Study||98
8994458|NCT02802241|10057398|FG000|Planned Analysis|Overall Study||89
8994459|NCT02802241|10057399|FG001|Planned Analysis|Overall Study||86
9039209|NCT03335254|10100138|FG016|STARTED|Period 3, Day 26-30||0
8994460|NCT02802241|10057400|FG002|Planned Analysis|Overall Study|Not included in primary analysis|0
8994461|NCT02802241|10057401|FG003|Planned Analysis|Overall Study||87
8994462|NCT02802241|10057398|FG000|COMPLETED|Overall Study||68
8994463|NCT02802241|10057399|FG001|COMPLETED|Overall Study||71
8994464|NCT02802241|10057400|FG002|COMPLETED|Overall Study|Not included in primary analysis|0
8994465|NCT02802241|10057401|FG003|COMPLETED|Overall Study||72
8994466|NCT02802241|10057398|FG000|NOT COMPLETED|Overall Study||29
8994467|NCT02802241|10057399|FG001|NOT COMPLETED|Overall Study||26
8994468|NCT02802241|10057400|FG002|NOT COMPLETED|Overall Study||48
8994469|NCT02802241|10057401|FG003|NOT COMPLETED|Overall Study||26
8994470|NCT02802319|10057413|FG000|STARTED|Overall Study||22
8994471|NCT02802319|10057414|FG001|STARTED|Overall Study||22
8994472|NCT02802319|10057413|FG000|COMPLETED|Overall Study||20
8994473|NCT02802319|10057414|FG001|COMPLETED|Overall Study||17
8994474|NCT02802319|10057413|FG000|NOT COMPLETED|Overall Study||2
8994475|NCT02802319|10057414|FG001|NOT COMPLETED|Overall Study||5
8994476|NCT02802345|10057422|FG000|STARTED|Overall Study||136
8994477|NCT02802345|10057423|FG001|STARTED|Overall Study||138
8994478|NCT02802345|10057422|FG000|Treated|Overall Study||136
8994479|NCT02802345|10057423|FG001|Treated|Overall Study||137
8994480|NCT02802345|10057422|FG000|COMPLETED|Overall Study||104
8994481|NCT02802345|10057423|FG001|COMPLETED|Overall Study||108
8994482|NCT02802345|10057422|FG000|NOT COMPLETED|Overall Study||32
8994483|NCT02802345|10057423|FG001|NOT COMPLETED|Overall Study||30
8994484|NCT02802449|10057431|FG000|STARTED|Overall Study||111
8994485|NCT02802449|10057432|FG001|STARTED|Overall Study||219
8994486|NCT02802449|10057431|FG000|COMPLETED|Overall Study||102
8994487|NCT02802449|10057432|FG001|COMPLETED|Overall Study||202
8994488|NCT02802449|10057431|FG000|NOT COMPLETED|Overall Study||9
8994489|NCT02802449|10057432|FG001|NOT COMPLETED|Overall Study||17
8994490|NCT02802501|10057441|FG000|STARTED|Double-blind (Up to Day 180)||50
8994491|NCT02802501|10057442|FG001|STARTED|Double-blind (Up to Day 180)||50
8994492|NCT02802501|10057443|FG002|STARTED|Double-blind (Up to Day 180)||50
8994493|NCT02802501|10057441|FG000|COMPLETED|Double-blind (Up to Day 180)||50
8994494|NCT02802501|10057442|FG001|COMPLETED|Double-blind (Up to Day 180)||50
8994495|NCT02802501|10057443|FG002|COMPLETED|Double-blind (Up to Day 180)||50
8994496|NCT02802501|10057441|FG000|NOT COMPLETED|Double-blind (Up to Day 180)||0
8994497|NCT02802501|10057442|FG001|NOT COMPLETED|Double-blind (Up to Day 180)||0
8994498|NCT02802501|10057443|FG002|NOT COMPLETED|Double-blind (Up to Day 180)||0
8994499|NCT02802501|10057441|FG000|STARTED|Open-Label (Day 180 to Day 195)|Participants who had no relapse prior to Day 180 received open-label Primaquine|6
8994500|NCT02802501|10057442|FG001|STARTED|Open-Label (Day 180 to Day 195)|Participants who had no relapse prior to Day 180 received open-label Primaquine|12
8994501|NCT02802501|10057443|FG002|STARTED|Open-Label (Day 180 to Day 195)|Participants who had no relapse prior to Day 180 received open-label Primaquine|26
8994502|NCT02802501|10057441|FG000|COMPLETED|Open-Label (Day 180 to Day 195)||6
8994503|NCT02802501|10057442|FG001|COMPLETED|Open-Label (Day 180 to Day 195)||12
8994504|NCT02802501|10057443|FG002|COMPLETED|Open-Label (Day 180 to Day 195)||26
8994505|NCT02802501|10057441|FG000|NOT COMPLETED|Open-Label (Day 180 to Day 195)||0
8994506|NCT02802501|10057442|FG001|NOT COMPLETED|Open-Label (Day 180 to Day 195)||0
8994507|NCT02802501|10057443|FG002|NOT COMPLETED|Open-Label (Day 180 to Day 195)||0
8994508|NCT02802514|10057456|FG000|STARTED|Session 1 (up to Day 8)||1
8994509|NCT02802514|10057457|FG001|STARTED|Session 1 (up to Day 8)||1
8994510|NCT02802514|10057458|FG002|STARTED|Session 1 (up to Day 8)||1
8994511|NCT02802514|10057459|FG003|STARTED|Session 1 (up to Day 8)||1
8994512|NCT02802514|10057456|FG000|COMPLETED|Session 1 (up to Day 8)||1
8994513|NCT02802514|10057457|FG001|COMPLETED|Session 1 (up to Day 8)||1
8994514|NCT02802514|10057458|FG002|COMPLETED|Session 1 (up to Day 8)||1
8994515|NCT02802514|10057459|FG003|COMPLETED|Session 1 (up to Day 8)||1
8994516|NCT02802514|10057456|FG000|NOT COMPLETED|Session 1 (up to Day 8)||0
8994517|NCT02802514|10057457|FG001|NOT COMPLETED|Session 1 (up to Day 8)||0
8994518|NCT02802514|10057458|FG002|NOT COMPLETED|Session 1 (up to Day 8)||0
8994519|NCT02802514|10057459|FG003|NOT COMPLETED|Session 1 (up to Day 8)||0
8994520|NCT02802514|10057456|FG000|STARTED|Wash Out Period (up to Week 9)||1
8994521|NCT02802514|10057457|FG001|STARTED|Wash Out Period (up to Week 9)||1
8994522|NCT02802514|10057458|FG002|STARTED|Wash Out Period (up to Week 9)||1
8994523|NCT02802514|10057459|FG003|STARTED|Wash Out Period (up to Week 9)||1
8994524|NCT02802514|10057456|FG000|COMPLETED|Wash Out Period (up to Week 9)||1
8994525|NCT02802514|10057457|FG001|COMPLETED|Wash Out Period (up to Week 9)||1
8994526|NCT02802514|10057458|FG002|COMPLETED|Wash Out Period (up to Week 9)||1
8994527|NCT02802514|10057459|FG003|COMPLETED|Wash Out Period (up to Week 9)||1
8994528|NCT02802514|10057456|FG000|NOT COMPLETED|Wash Out Period (up to Week 9)||0
8994529|NCT02802514|10057457|FG001|NOT COMPLETED|Wash Out Period (up to Week 9)||0
8994530|NCT02802514|10057458|FG002|NOT COMPLETED|Wash Out Period (up to Week 9)||0
8994531|NCT02802514|10057459|FG003|NOT COMPLETED|Wash Out Period (up to Week 9)||0
8994532|NCT02802514|10057456|FG000|STARTED|Session 2 (Up to Day 8)||1
8994533|NCT02802514|10057457|FG001|STARTED|Session 2 (Up to Day 8)||1
8994534|NCT02802514|10057458|FG002|STARTED|Session 2 (Up to Day 8)||1
8994535|NCT02802514|10057459|FG003|STARTED|Session 2 (Up to Day 8)||1
8994536|NCT02802514|10057456|FG000|COMPLETED|Session 2 (Up to Day 8)||1
8994537|NCT02802514|10057457|FG001|COMPLETED|Session 2 (Up to Day 8)||1
8994538|NCT02802514|10057458|FG002|COMPLETED|Session 2 (Up to Day 8)||1
8994539|NCT02802514|10057459|FG003|COMPLETED|Session 2 (Up to Day 8)||1
8994540|NCT02802514|10057456|FG000|NOT COMPLETED|Session 2 (Up to Day 8)||0
8994541|NCT02802514|10057457|FG001|NOT COMPLETED|Session 2 (Up to Day 8)||0
8994542|NCT02802514|10057458|FG002|NOT COMPLETED|Session 2 (Up to Day 8)||0
8994543|NCT02802514|10057459|FG003|NOT COMPLETED|Session 2 (Up to Day 8)||0
8994544|NCT02802735|10057475|FG000|STARTED|Overall Study||4
8994545|NCT02802735|10057476|FG001|STARTED|Overall Study||4
8994546|NCT02802735|10057477|FG002|STARTED|Overall Study||4
8994547|NCT02802735|10057478|FG003|STARTED|Overall Study||12
8994548|NCT02802735|10057479|FG004|STARTED|Overall Study||4
8994549|NCT02802735|10057475|FG000|COMPLETED|Overall Study||4
8994550|NCT02802735|10057476|FG001|COMPLETED|Overall Study||3
8994551|NCT02802735|10057477|FG002|COMPLETED|Overall Study||4
8994552|NCT02802735|10057478|FG003|COMPLETED|Overall Study||12
8994553|NCT02802735|10057479|FG004|COMPLETED|Overall Study||4
8994554|NCT02802735|10057475|FG000|NOT COMPLETED|Overall Study||0
8994555|NCT02802735|10057476|FG001|NOT COMPLETED|Overall Study||1
8994556|NCT02802735|10057477|FG002|NOT COMPLETED|Overall Study||0
8994557|NCT02802735|10057478|FG003|NOT COMPLETED|Overall Study||0
8994558|NCT02802735|10057479|FG004|NOT COMPLETED|Overall Study||0
8994559|NCT02802865|10057496|FG000|STARTED|Overall Study||35
8994560|NCT02802865|10057497|FG001|STARTED|Overall Study||35
8994561|NCT02802865|10057496|FG000|COMPLETED|Overall Study||34
8994562|NCT02802865|10057497|FG001|COMPLETED|Overall Study||33
8994563|NCT02802865|10057496|FG000|NOT COMPLETED|Overall Study||1
8994564|NCT02802865|10057497|FG001|NOT COMPLETED|Overall Study||2
8994565|NCT02802878|10057505|FG000|STARTED|Overall Study||21
8994566|NCT02802878|10057506|FG001|STARTED|Overall Study||21
8994567|NCT02802878|10057505|FG000|COMPLETED|Overall Study||17
8994568|NCT02802878|10057506|FG001|COMPLETED|Overall Study||18
8994569|NCT02802878|10057505|FG000|NOT COMPLETED|Overall Study||4
8994570|NCT02802878|10057506|FG001|NOT COMPLETED|Overall Study||3
8994571|NCT02803138|10057512|FG000|STARTED|Overall Study||236
8994572|NCT02803138|10057512|FG000|COMPLETED|Overall Study||166
8994573|NCT02803138|10057512|FG000|NOT COMPLETED|Overall Study||70
8994574|NCT02803164|10057520|FG000|STARTED|Overall Study||10
8994575|NCT02803164|10057521|FG001|STARTED|Overall Study||11
8994576|NCT02803164|10057520|FG000|COMPLETED|Overall Study||10
8994577|NCT02803164|10057521|FG001|COMPLETED|Overall Study||11
8994578|NCT02803164|10057520|FG000|NOT COMPLETED|Overall Study||0
8994579|NCT02803164|10057521|FG001|NOT COMPLETED|Overall Study||0
8994580|NCT02803229|10057531|FG000|STARTED|Overall Study||15
8994581|NCT02803229|10057532|FG001|STARTED|Overall Study||13
8994582|NCT02803229|10057531|FG000|COMPLETED|Overall Study||11
8994583|NCT02803229|10057532|FG001|COMPLETED|Overall Study||7
8994584|NCT02803229|10057531|FG000|NOT COMPLETED|Overall Study||4
8994585|NCT02803229|10057532|FG001|NOT COMPLETED|Overall Study||6
8994586|NCT02803580|10057538|FG000|STARTED|Overall Study||209
8994587|NCT02803580|10057538|FG000|COMPLETED|Overall Study||173
8994588|NCT02803580|10057538|FG000|NOT COMPLETED|Overall Study||36
8994589|NCT02803749|10057544|FG000|STARTED|Overall Study||17
8994590|NCT02803749|10057545|FG001|STARTED|Overall Study||4
8994591|NCT02803749|10057544|FG000|COMPLETED|Overall Study||12
8994592|NCT02803749|10057545|FG001|COMPLETED|Overall Study||4
8994593|NCT02803749|10057544|FG000|NOT COMPLETED|Overall Study||5
8994594|NCT02803749|10057545|FG001|NOT COMPLETED|Overall Study||0
8994595|NCT02804178|10057551|FG000|STARTED|Overall Study||10
8994596|NCT02804178|10057551|FG000|COMPLETED|Overall Study||9
8994597|NCT02804178|10057551|FG000|NOT COMPLETED|Overall Study||1
8994598|NCT02804399|10057555|FG000|STARTED|Period 1||12
8994599|NCT02804399|10057556|FG001|STARTED|Period 1||0
8994600|NCT02804399|10057555|FG000|COMPLETED|Period 1||12
8994601|NCT02804399|10057556|FG001|COMPLETED|Period 1||0
8994602|NCT02804399|10057555|FG000|NOT COMPLETED|Period 1||0
8994603|NCT02804399|10057556|FG001|NOT COMPLETED|Period 1||0
8994604|NCT02804399|10057555|FG000|STARTED|Washout Period at Least 10 Days||12
8994605|NCT02804399|10057556|FG001|STARTED|Washout Period at Least 10 Days||0
8994606|NCT02804399|10057555|FG000|COMPLETED|Washout Period at Least 10 Days||12
8994607|NCT02804399|10057556|FG001|COMPLETED|Washout Period at Least 10 Days||0
8994608|NCT02804399|10057555|FG000|NOT COMPLETED|Washout Period at Least 10 Days||0
8994609|NCT02804399|10057556|FG001|NOT COMPLETED|Washout Period at Least 10 Days||0
8994610|NCT02804399|10057555|FG000|STARTED|Period 2||0
8994611|NCT02804399|10057556|FG001|STARTED|Period 2||12
8994612|NCT02804399|10057555|FG000|COMPLETED|Period 2||0
8994613|NCT02804399|10057556|FG001|COMPLETED|Period 2||11
8994614|NCT02804399|10057555|FG000|NOT COMPLETED|Period 2||0
8994615|NCT02804399|10057556|FG001|NOT COMPLETED|Period 2||1
8994616|NCT02804594|10057567|FG000|STARTED|Overall Study||10
8994617|NCT02804594|10057568|FG001|STARTED|Overall Study||5
8994618|NCT02804594|10057567|FG000|COMPLETED|Overall Study||10
8994619|NCT02804594|10057568|FG001|COMPLETED|Overall Study||5
8994620|NCT02804594|10057567|FG000|NOT COMPLETED|Overall Study||0
8994621|NCT02804594|10057568|FG001|NOT COMPLETED|Overall Study||0
8994622|NCT02804750|10057576|FG000|STARTED|Period 1||17
8994623|NCT02804750|10057577|FG001|STARTED|Period 1||18
8994624|NCT02804750|10057576|FG000|COMPLETED|Period 1||17
8994625|NCT02804750|10057577|FG001|COMPLETED|Period 1||15
8994626|NCT02804750|10057576|FG000|NOT COMPLETED|Period 1||0
8994627|NCT02804750|10057577|FG001|NOT COMPLETED|Period 1||3
8994628|NCT02804750|10057576|FG000|STARTED|Period 2||17
8994629|NCT02804750|10057577|FG001|STARTED|Period 2||15
8994630|NCT02804750|10057576|FG000|COMPLETED|Period 2||16
8994631|NCT02804750|10057577|FG001|COMPLETED|Period 2||15
8994632|NCT02804750|10057576|FG000|NOT COMPLETED|Period 2||1
8994633|NCT02804750|10057577|FG001|NOT COMPLETED|Period 2||0
8994634|NCT02804750|10057576|FG000|STARTED|Period 3||16
8994635|NCT02804750|10057577|FG001|STARTED|Period 3||15
8994636|NCT02804750|10057576|FG000|COMPLETED|Period 3||16
8994637|NCT02804750|10057577|FG001|COMPLETED|Period 3||13
8994638|NCT02804750|10057576|FG000|NOT COMPLETED|Period 3||0
8994639|NCT02804750|10057577|FG001|NOT COMPLETED|Period 3||2
8994640|NCT02804750|10057576|FG000|STARTED|Period 4|Per-protocol, Group 1 did not participate in Period 4.|0
8994641|NCT02804750|10057577|FG001|STARTED|Period 4|One participant completed Period 3 but did not start Period 4 due to a pre-scheduled surgery.|12
8994642|NCT02804750|10057576|FG000|COMPLETED|Period 4||0
8994643|NCT02804750|10057577|FG001|COMPLETED|Period 4||7
8994644|NCT02804750|10057576|FG000|NOT COMPLETED|Period 4||0
8994645|NCT02804750|10057577|FG001|NOT COMPLETED|Period 4||5
8994646|NCT02804763|10057589|FG000|STARTED|Double-Blind Period (Week 1 to Week 24)||45
8994647|NCT02804763|10057590|FG001|STARTED|Double-Blind Period (Week 1 to Week 24)||45
8994648|NCT02804763|10057591|FG002|STARTED|Double-Blind Period (Week 1 to Week 24)||45
8994649|NCT02804763|10057592|FG003|STARTED|Double-Blind Period (Week 1 to Week 24)||47
8994650|NCT02804763|10057589|FG000|Completed Week 24|Double-Blind Period (Week 1 to Week 24)||44
8994651|NCT02804763|10057590|FG001|Completed Week 24|Double-Blind Period (Week 1 to Week 24)||45
8994652|NCT02804763|10057591|FG002|Completed Week 24|Double-Blind Period (Week 1 to Week 24)||44
8994653|NCT02804763|10057592|FG003|Completed Week 24|Double-Blind Period (Week 1 to Week 24)||45
8994654|NCT02804763|10057589|FG000|Finished Wk24 Began Observational Period|Double-Blind Period (Week 1 to Week 24)||44
8994655|NCT02804763|10057590|FG001|Finished Wk24 Began Observational Period|Double-Blind Period (Week 1 to Week 24)||44
8994656|NCT02804763|10057591|FG002|Finished Wk24 Began Observational Period|Double-Blind Period (Week 1 to Week 24)||44
8994657|NCT02804763|10057592|FG003|Finished Wk24 Began Observational Period|Double-Blind Period (Week 1 to Week 24)||45
8994658|NCT02804763|10057589|FG000|COMPLETED|Double-Blind Period (Week 1 to Week 24)||44
8994659|NCT02804763|10057590|FG001|COMPLETED|Double-Blind Period (Week 1 to Week 24)||44
8994660|NCT02804763|10057591|FG002|COMPLETED|Double-Blind Period (Week 1 to Week 24)||44
8994661|NCT02804763|10057592|FG003|COMPLETED|Double-Blind Period (Week 1 to Week 24)||45
8994662|NCT02804763|10057589|FG000|NOT COMPLETED|Double-Blind Period (Week 1 to Week 24)||1
8994663|NCT02804763|10057590|FG001|NOT COMPLETED|Double-Blind Period (Week 1 to Week 24)||1
8994664|NCT02804763|10057591|FG002|NOT COMPLETED|Double-Blind Period (Week 1 to Week 24)||1
8994665|NCT02804763|10057592|FG003|NOT COMPLETED|Double-Blind Period (Week 1 to Week 24)||2
8994666|NCT02804763|10057589|FG000|STARTED|Observational Period (Wk 24 to Wk 48)||44
8994667|NCT02804763|10057590|FG001|STARTED|Observational Period (Wk 24 to Wk 48)||44
8994668|NCT02804763|10057591|FG002|STARTED|Observational Period (Wk 24 to Wk 48)||44
8994669|NCT02804763|10057592|FG003|STARTED|Observational Period (Wk 24 to Wk 48)||45
8994670|NCT02804763|10057589|FG000|COMPLETED|Observational Period (Wk 24 to Wk 48)||38
8994671|NCT02804763|10057590|FG001|COMPLETED|Observational Period (Wk 24 to Wk 48)||43
8994672|NCT02804763|10057591|FG002|COMPLETED|Observational Period (Wk 24 to Wk 48)||41
8994673|NCT02804763|10057592|FG003|COMPLETED|Observational Period (Wk 24 to Wk 48)||42
8994674|NCT02804763|10057589|FG000|NOT COMPLETED|Observational Period (Wk 24 to Wk 48)||6
8994675|NCT02804763|10057590|FG001|NOT COMPLETED|Observational Period (Wk 24 to Wk 48)||1
8994676|NCT02804763|10057591|FG002|NOT COMPLETED|Observational Period (Wk 24 to Wk 48)||3
8994677|NCT02804763|10057592|FG003|NOT COMPLETED|Observational Period (Wk 24 to Wk 48)||3
8994678|NCT02805179|10057606|FG000|STARTED|Overall Study||26
8994679|NCT02805179|10057606|FG000|Eligible Patients That Started Dose-intensified Chemo-radiation|Overall Study||23
8994680|NCT02805179|10057606|FG000|Subset of Participants, Boosted to Both High B-value Diffusion and Perfusion|Overall Study||13
8994681|NCT02805179|10057606|FG000|COMPLETED|Overall Study||23
8994682|NCT02805179|10057606|FG000|NOT COMPLETED|Overall Study||3
8994683|NCT02805309|10057613|FG000|STARTED|Overall Study||18
8994684|NCT02805309|10057614|FG001|STARTED|Overall Study||17
8994685|NCT02805309|10057615|FG002|STARTED|Overall Study||19
8994686|NCT02805309|10057613|FG000|COMPLETED|Overall Study||16
8994687|NCT02805309|10057614|FG001|COMPLETED|Overall Study||13
8994688|NCT02805309|10057615|FG002|COMPLETED|Overall Study||16
8994689|NCT02805309|10057613|FG000|NOT COMPLETED|Overall Study||2
8994690|NCT02805309|10057614|FG001|NOT COMPLETED|Overall Study||4
8994691|NCT02805309|10057615|FG002|NOT COMPLETED|Overall Study||3
8994692|NCT02805647|10057625|FG000|STARTED|Overall Study|at the moment of submision|100
8994693|NCT02805647|10057626|FG001|STARTED|Overall Study|at the moment of submision|122
8994694|NCT02805647|10057625|FG000|COMPLETED|Overall Study|after laboratory tests|100
8994695|NCT02805647|10057626|FG001|COMPLETED|Overall Study|after laboratory tests|122
8994696|NCT02805647|10057625|FG000|NOT COMPLETED|Overall Study||0
8994697|NCT02805647|10057626|FG001|NOT COMPLETED|Overall Study||0
8994698|NCT02805660|10057639|FG000|STARTED|Overall Study||5
8994699|NCT02805660|10057640|FG001|STARTED|Overall Study||4
8994700|NCT02805660|10057641|FG002|STARTED|Overall Study||11
8994701|NCT02805660|10057642|FG003|STARTED|Overall Study||18
8994702|NCT02805660|10057643|FG004|STARTED|Overall Study||3
8994703|NCT02805660|10057644|FG005|STARTED|Overall Study||23
8994704|NCT02805660|10057645|FG006|STARTED|Overall Study||19
8994705|NCT02805660|10057639|FG000|COMPLETED|Overall Study||0
8994706|NCT02805660|10057640|FG001|COMPLETED|Overall Study||0
8994707|NCT02805660|10057641|FG002|COMPLETED|Overall Study||0
8994708|NCT02805660|10057642|FG003|COMPLETED|Overall Study||0
8994709|NCT02805660|10057643|FG004|COMPLETED|Overall Study||0
8994710|NCT02805660|10057644|FG005|COMPLETED|Overall Study||0
8994711|NCT02805660|10057645|FG006|COMPLETED|Overall Study||0
8994712|NCT02805660|10057639|FG000|NOT COMPLETED|Overall Study||5
8994713|NCT02805660|10057640|FG001|NOT COMPLETED|Overall Study||4
8994714|NCT02805660|10057641|FG002|NOT COMPLETED|Overall Study||11
8994715|NCT02805660|10057642|FG003|NOT COMPLETED|Overall Study||18
8994716|NCT02805660|10057643|FG004|NOT COMPLETED|Overall Study||3
8994717|NCT02805660|10057644|FG005|NOT COMPLETED|Overall Study||23
8994718|NCT02805660|10057645|FG006|NOT COMPLETED|Overall Study||19
8994719|NCT02805790|10057676|FG000|STARTED|First Intervention (4 Weeks)||14
8994720|NCT02805790|10057677|FG001|STARTED|First Intervention (4 Weeks)||16
8994721|NCT02805790|10057676|FG000|COMPLETED|First Intervention (4 Weeks)||14
8994722|NCT02805790|10057677|FG001|COMPLETED|First Intervention (4 Weeks)||16
8994723|NCT02805790|10057676|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0
8994724|NCT02805790|10057677|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0
8994725|NCT02805790|10057676|FG000|STARTED|Washout (4 Weeks)||14
8994726|NCT02805790|10057677|FG001|STARTED|Washout (4 Weeks)||16
8994727|NCT02805790|10057676|FG000|COMPLETED|Washout (4 Weeks)||14
8994728|NCT02805790|10057677|FG001|COMPLETED|Washout (4 Weeks)||16
8994729|NCT02805790|10057676|FG000|NOT COMPLETED|Washout (4 Weeks)||0
8994730|NCT02805790|10057677|FG001|NOT COMPLETED|Washout (4 Weeks)||0
8994731|NCT02805790|10057676|FG000|STARTED|Second Intervention (4 Weeks)||14
8994732|NCT02805790|10057677|FG001|STARTED|Second Intervention (4 Weeks)||16
8994733|NCT02805790|10057676|FG000|COMPLETED|Second Intervention (4 Weeks)||14
8994734|NCT02805790|10057677|FG001|COMPLETED|Second Intervention (4 Weeks)||15
8994735|NCT02805790|10057676|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0
8994736|NCT02805790|10057677|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||1
8994737|NCT02805907|10057685|FG000|STARTED|Overall Study||56
8994738|NCT02805907|10057686|FG001|STARTED|Overall Study||56
8994739|NCT02805907|10057685|FG000|COMPLETED|Overall Study||53
8994740|NCT02805907|10057686|FG001|COMPLETED|Overall Study||53
8994741|NCT02805907|10057685|FG000|NOT COMPLETED|Overall Study||3
8994742|NCT02805907|10057686|FG001|NOT COMPLETED|Overall Study||3
8994743|NCT02805972|10057694|FG000|STARTED|Intervention Visit 1||23
8994744|NCT02805972|10057695|FG001|STARTED|Intervention Visit 1||18
8994745|NCT02805972|10057694|FG000|COMPLETED|Intervention Visit 1||23
8994746|NCT02805972|10057695|FG001|COMPLETED|Intervention Visit 1||18
8994747|NCT02805972|10057694|FG000|NOT COMPLETED|Intervention Visit 1||0
8994748|NCT02805972|10057695|FG001|NOT COMPLETED|Intervention Visit 1||0
8994749|NCT02805972|10057694|FG000|STARTED|Washout Period||23
8994750|NCT02805972|10057695|FG001|STARTED|Washout Period||18
8994751|NCT02805972|10057694|FG000|COMPLETED|Washout Period||20
8994752|NCT02805972|10057695|FG001|COMPLETED|Washout Period||18
8994753|NCT02805972|10057694|FG000|NOT COMPLETED|Washout Period||3
8994754|NCT02805972|10057695|FG001|NOT COMPLETED|Washout Period||0
8994755|NCT02805972|10057694|FG000|STARTED|Intervention Visit 2||20
8994756|NCT02805972|10057695|FG001|STARTED|Intervention Visit 2||18
8994757|NCT02805972|10057694|FG000|COMPLETED|Intervention Visit 2||20
8994758|NCT02805972|10057695|FG001|COMPLETED|Intervention Visit 2||18
8994759|NCT02805972|10057694|FG000|NOT COMPLETED|Intervention Visit 2||0
8994760|NCT02805972|10057695|FG001|NOT COMPLETED|Intervention Visit 2||0
8994761|NCT02806024|10057713|FG000|STARTED|Overall Study||7
8994762|NCT02806024|10057714|FG001|STARTED|Overall Study||7
8994763|NCT02806024|10057713|FG000|COMPLETED|Overall Study||6
8994764|NCT02806024|10057714|FG001|COMPLETED|Overall Study||5
8577906|NCT00165789|9610847|FG001|STARTED|Overall Study||20
8994765|NCT02806024|10057713|FG000|NOT COMPLETED|Overall Study||1
8994766|NCT02806024|10057714|FG001|NOT COMPLETED|Overall Study||2
8994767|NCT02806232|10057729|FG000|STARTED|Overall Study||60
8994768|NCT02806232|10057730|FG001|STARTED|Overall Study||60
8994769|NCT02806232|10057731|FG002|STARTED|Overall Study||60
8994770|NCT02806232|10057732|FG003|STARTED|Overall Study||60
8994771|NCT02806232|10057733|FG004|STARTED|Overall Study||60
8994772|NCT02806232|10057734|FG005|STARTED|Overall Study||60
8994773|NCT02806232|10057735|FG006|STARTED|Overall Study||60
8994774|NCT02806232|10057736|FG007|STARTED|Overall Study||20
8994775|NCT02806232|10057737|FG008|STARTED|Overall Study||4
8994776|NCT02806232|10057729|FG000|COMPLETED|Overall Study||59
8994777|NCT02806232|10057730|FG001|COMPLETED|Overall Study||56
8994778|NCT02806232|10057731|FG002|COMPLETED|Overall Study||59
8994779|NCT02806232|10057732|FG003|COMPLETED|Overall Study||60
8994780|NCT02806232|10057733|FG004|COMPLETED|Overall Study||58
8994781|NCT02806232|10057734|FG005|COMPLETED|Overall Study||58
8994782|NCT02806232|10057735|FG006|COMPLETED|Overall Study||60
8994783|NCT02806232|10057736|FG007|COMPLETED|Overall Study||20
8994784|NCT02806232|10057737|FG008|COMPLETED|Overall Study||4
8994785|NCT02806232|10057729|FG000|NOT COMPLETED|Overall Study||1
8994786|NCT02806232|10057730|FG001|NOT COMPLETED|Overall Study||4
8994787|NCT02806232|10057731|FG002|NOT COMPLETED|Overall Study||1
8994788|NCT02806232|10057732|FG003|NOT COMPLETED|Overall Study||0
8994789|NCT02806232|10057733|FG004|NOT COMPLETED|Overall Study||2
8994790|NCT02806232|10057734|FG005|NOT COMPLETED|Overall Study||2
8994791|NCT02806232|10057735|FG006|NOT COMPLETED|Overall Study||0
8994792|NCT02806232|10057736|FG007|NOT COMPLETED|Overall Study||0
8994793|NCT02806232|10057737|FG008|NOT COMPLETED|Overall Study||0
8994794|NCT02806414|10057757|FG000|STARTED|Overall Study||25
8994795|NCT02806414|10057757|FG000|COMPLETED|Overall Study||23
8994796|NCT02806414|10057757|FG000|NOT COMPLETED|Overall Study||2
8994797|NCT02806505|10057763|FG000|STARTED|Overall Study||38
8994798|NCT02806505|10057764|FG001|STARTED|Overall Study||43
8994799|NCT02806505|10057763|FG000|COMPLETED|Overall Study||28
8994800|NCT02806505|10057764|FG001|COMPLETED|Overall Study||32
8994801|NCT02806505|10057763|FG000|NOT COMPLETED|Overall Study||10
8994802|NCT02806505|10057764|FG001|NOT COMPLETED|Overall Study||11
8994803|NCT02806544|10057770|FG000|STARTED|Overall Study||35
8994804|NCT02806544|10057770|FG000|COMPLETED|Overall Study||31
8994805|NCT02806544|10057770|FG000|NOT COMPLETED|Overall Study||4
8994806|NCT02806713|10057776|FG000|STARTED|Overall Study||46
8994807|NCT02806713|10057777|FG001|STARTED|Overall Study||46
8994808|NCT02806713|10057776|FG000|COMPLETED|Overall Study||44
8994809|NCT02806713|10057777|FG001|COMPLETED|Overall Study||44
8572148|NCT00112437|9604136|FG013|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
8572149|NCT00112437|9604137|FG014|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
8572150|NCT00112437|9604138|FG015|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
8572151|NCT00112437|9604139|FG016|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
8572152|NCT00112437|9604140|FG017|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
8572153|NCT00112437|9604141|FG018|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
8572154|NCT00112437|9604142|FG019|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
8572155|NCT00112437|9604143|FG020|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
8572156|NCT00112437|9604144|FG021|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
8572157|NCT00112437|9604145|FG022|NOT COMPLETED|Years 6-10 (60-Month Extension)||5
8572158|NCT00112437|9604146|FG023|NOT COMPLETED|Years 6-10 (60-Month Extension)||12
8572159|NCT00112437|9604147|FG024|NOT COMPLETED|Years 6-10 (60-Month Extension)||1
8572160|NCT00112437|9604148|FG025|NOT COMPLETED|Years 6-10 (60-Month Extension)||5
8572161|NCT00112463|9604202|FG000|STARTED|Overall Study||40
8572162|NCT00112463|9604202|FG000|COMPLETED|Overall Study||1
8572163|NCT00112463|9604202|FG000|NOT COMPLETED|Overall Study||39
8572164|NCT00112489|9604207|FG000|STARTED|Overall Study|All patients enrolled on study|55
8572165|NCT00112489|9604207|FG000|COMPLETED|Overall Study|Completed regimen due to progression|15
8572166|NCT00112489|9604207|FG000|NOT COMPLETED|Overall Study||40
8572167|NCT00112502|9604225|FG000|STARTED|Overall Study||22
8572168|NCT00112502|9604226|FG001|STARTED|Overall Study||22
8572169|NCT00112502|9604227|FG002|STARTED|Overall Study||22
8572170|NCT00112502|9604228|FG003|STARTED|Overall Study||22
8572171|NCT00112502|9604229|FG004|STARTED|Overall Study||23
8572172|NCT00112502|9604230|FG005|STARTED|Overall Study||22
8572173|NCT00112502|9604231|FG006|STARTED|Overall Study||23
8572174|NCT00112502|9604232|FG007|STARTED|Overall Study||22
8572175|NCT00112502|9604225|FG000|COMPLETED|Overall Study||22
8572176|NCT00112502|9604226|FG001|COMPLETED|Overall Study||21
8572177|NCT00112502|9604227|FG002|COMPLETED|Overall Study||21
8572178|NCT00112502|9604228|FG003|COMPLETED|Overall Study||18
8572179|NCT00112502|9604229|FG004|COMPLETED|Overall Study||21
8572180|NCT00112502|9604230|FG005|COMPLETED|Overall Study||17
8994810|NCT02806713|10057776|FG000|NOT COMPLETED|Overall Study||2
8994811|NCT02806713|10057777|FG001|NOT COMPLETED|Overall Study||2
8572181|NCT00112502|9604231|FG006|COMPLETED|Overall Study||20
8572182|NCT00112502|9604232|FG007|COMPLETED|Overall Study||15
8572183|NCT00112502|9604225|FG000|NOT COMPLETED|Overall Study||0
8572184|NCT00112502|9604226|FG001|NOT COMPLETED|Overall Study||1
8572185|NCT00112502|9604227|FG002|NOT COMPLETED|Overall Study||1
8994812|NCT02806726|10057783|FG000|STARTED|Overall Study|Subjects were treated contralaterally|7
8994813|NCT02806726|10057783|FG000|COMPLETED|Overall Study|Subjects were treated contralaterally|6
8994814|NCT02806726|10057783|FG000|NOT COMPLETED|Overall Study||1
8994815|NCT02806869|10057790|FG000|STARTED|First Intervention (1 Day)||24
8994816|NCT02806869|10057791|FG001|STARTED|First Intervention (1 Day)||24
8994817|NCT02806869|10057790|FG000|COMPLETED|First Intervention (1 Day)||13
8994818|NCT02806869|10057791|FG001|COMPLETED|First Intervention (1 Day)||12
8994819|NCT02806869|10057790|FG000|NOT COMPLETED|First Intervention (1 Day)||11
8994820|NCT02806869|10057791|FG001|NOT COMPLETED|First Intervention (1 Day)||12
8994821|NCT02806869|10057790|FG000|STARTED|Washout (7 Days)||7
8994822|NCT02806869|10057791|FG001|STARTED|Washout (7 Days)||7
8994823|NCT02806869|10057790|FG000|COMPLETED|Washout (7 Days)||7
8994824|NCT02806869|10057791|FG001|COMPLETED|Washout (7 Days)||7
8994825|NCT02806869|10057790|FG000|NOT COMPLETED|Washout (7 Days)||0
8994826|NCT02806869|10057791|FG001|NOT COMPLETED|Washout (7 Days)||0
8994827|NCT02806869|10057790|FG000|STARTED|Second Intervention (1 Day)||7
8994828|NCT02806869|10057791|FG001|STARTED|Second Intervention (1 Day)||7
8994829|NCT02806869|10057790|FG000|COMPLETED|Second Intervention (1 Day)||7
8994830|NCT02806869|10057791|FG001|COMPLETED|Second Intervention (1 Day)||5
8994831|NCT02806869|10057790|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
8994832|NCT02806869|10057791|FG001|NOT COMPLETED|Second Intervention (1 Day)||2
8994833|NCT02806895|10057799|FG000|STARTED|Overall Study||17
8994834|NCT02806895|10057800|FG001|STARTED|Overall Study||17
8994835|NCT02806895|10057799|FG000|COMPLETED|Overall Study||16
8994836|NCT02806895|10057800|FG001|COMPLETED|Overall Study||17
8994837|NCT02806895|10057799|FG000|NOT COMPLETED|Overall Study||1
8994838|NCT02806895|10057800|FG001|NOT COMPLETED|Overall Study||0
8994839|NCT02806908|10057809|FG000|STARTED|Overall Study||11
8994840|NCT02806908|10057810|FG001|STARTED|Overall Study||13
8994841|NCT02806908|10057809|FG000|COMPLETED|Overall Study||10
8994842|NCT02806908|10057810|FG001|COMPLETED|Overall Study||12
8994843|NCT02806908|10057809|FG000|NOT COMPLETED|Overall Study||1
8994844|NCT02806908|10057810|FG001|NOT COMPLETED|Overall Study||1
8994845|NCT02806947|10057819|FG000|STARTED|Overall Study||58
8994846|NCT02806947|10057820|FG001|STARTED|Overall Study||64
8994847|NCT02806947|10057819|FG000|COMPLETED|Overall Study||53
8994848|NCT02806947|10057820|FG001|COMPLETED|Overall Study||63
8994849|NCT02806947|10057819|FG000|NOT COMPLETED|Overall Study||5
8994850|NCT02806947|10057820|FG001|NOT COMPLETED|Overall Study||1
8994851|NCT02806973|10057826|FG000|STARTED|Period 1||8
8994852|NCT02806973|10057827|FG001|STARTED|Period 1||8
8994853|NCT02806973|10057828|FG002|STARTED|Period 1||8
8994854|NCT02806973|10057829|FG003|STARTED|Period 1||8
8994855|NCT02806973|10057826|FG000|COMPLETED|Period 1||8
8994856|NCT02806973|10057827|FG001|COMPLETED|Period 1||6
8994857|NCT02806973|10057828|FG002|COMPLETED|Period 1||7
8994858|NCT02806973|10057829|FG003|COMPLETED|Period 1||6
8994859|NCT02806973|10057826|FG000|NOT COMPLETED|Period 1||0
8994860|NCT02806973|10057827|FG001|NOT COMPLETED|Period 1||2
8994861|NCT02806973|10057828|FG002|NOT COMPLETED|Period 1||1
8994862|NCT02806973|10057829|FG003|NOT COMPLETED|Period 1||2
8994863|NCT02806973|10057826|FG000|STARTED|Period 2||8
8994864|NCT02806973|10057827|FG001|STARTED|Period 2||6
8994865|NCT02806973|10057828|FG002|STARTED|Period 2||7
8994866|NCT02806973|10057829|FG003|STARTED|Period 2||6
8994867|NCT02806973|10057826|FG000|COMPLETED|Period 2||8
8994868|NCT02806973|10057827|FG001|COMPLETED|Period 2||6
8994869|NCT02806973|10057828|FG002|COMPLETED|Period 2||7
8994870|NCT02806973|10057829|FG003|COMPLETED|Period 2||6
8994871|NCT02806973|10057826|FG000|NOT COMPLETED|Period 2||0
8994872|NCT02806973|10057827|FG001|NOT COMPLETED|Period 2||0
8994873|NCT02806973|10057828|FG002|NOT COMPLETED|Period 2||0
8994874|NCT02806973|10057829|FG003|NOT COMPLETED|Period 2||0
8994875|NCT02806973|10057826|FG000|STARTED|Period 3||8
8994876|NCT02806973|10057827|FG001|STARTED|Period 3||6
8994877|NCT02806973|10057828|FG002|STARTED|Period 3||7
8994878|NCT02806973|10057829|FG003|STARTED|Period 3||6
8994879|NCT02806973|10057826|FG000|COMPLETED|Period 3||8
8633682|NCT00552578|9673854|FG000|COMPLETED|Overall Study||5
8633683|NCT00552578|9673855|FG001|COMPLETED|Overall Study||5
8633684|NCT00552578|9673854|FG000|NOT COMPLETED|Overall Study||1
8633685|NCT00552578|9673855|FG001|NOT COMPLETED|Overall Study||1
8633686|NCT00552617|9673871|FG000|STARTED|Overall Study||10
8994880|NCT02806973|10057827|FG001|COMPLETED|Period 3||6
8633687|NCT00552617|9673872|FG001|STARTED|Overall Study||10
8994881|NCT02806973|10057828|FG002|COMPLETED|Period 3||6
8994882|NCT02806973|10057829|FG003|COMPLETED|Period 3||3
8994883|NCT02806973|10057826|FG000|NOT COMPLETED|Period 3||0
8994884|NCT02806973|10057827|FG001|NOT COMPLETED|Period 3||0
8994885|NCT02806973|10057828|FG002|NOT COMPLETED|Period 3||1
8994886|NCT02806973|10057829|FG003|NOT COMPLETED|Period 3||3
8994887|NCT02806973|10057826|FG000|STARTED|Period 4||8
8994888|NCT02806973|10057827|FG001|STARTED|Period 4||6
8994889|NCT02806973|10057828|FG002|STARTED|Period 4||6
8994890|NCT02806973|10057829|FG003|STARTED|Period 4||3
8994891|NCT02806973|10057826|FG000|COMPLETED|Period 4||8
8994892|NCT02806973|10057827|FG001|COMPLETED|Period 4||6
8994893|NCT02806973|10057828|FG002|COMPLETED|Period 4||6
8994894|NCT02806973|10057829|FG003|COMPLETED|Period 4||3
8994895|NCT02806973|10057826|FG000|NOT COMPLETED|Period 4||0
8994896|NCT02806973|10057827|FG001|NOT COMPLETED|Period 4||0
8994897|NCT02806973|10057828|FG002|NOT COMPLETED|Period 4||0
8994898|NCT02806973|10057829|FG003|NOT COMPLETED|Period 4||0
8994899|NCT02806986|10057839|FG000|STARTED|Treatment Stage 1||61
8994900|NCT02806986|10057839|FG000|COMPLETED|Treatment Stage 1||60
8994901|NCT02806986|10057839|FG000|NOT COMPLETED|Treatment Stage 1||1
8994902|NCT02806986|10057839|FG000|STARTED|Treatment Stage 2||60
8994903|NCT02806986|10057839|FG000|COMPLETED|Treatment Stage 2||55
8994904|NCT02806986|10057839|FG000|NOT COMPLETED|Treatment Stage 2||5
8994905|NCT02807259|10057849|FG000|STARTED|Baseline (3 Months)||405
8994906|NCT02807259|10057850|FG001|STARTED|Baseline (3 Months)||404
8994907|NCT02807259|10057849|FG000|COMPLETED|Baseline (3 Months)||328
8994908|NCT02807259|10057850|FG001|COMPLETED|Baseline (3 Months)||292
8994909|NCT02807259|10057849|FG000|NOT COMPLETED|Baseline (3 Months)||77
8994910|NCT02807259|10057850|FG001|NOT COMPLETED|Baseline (3 Months)||112
8994911|NCT02807259|10057849|FG000|STARTED|Midline (3 Months)||352
8994912|NCT02807259|10057850|FG001|STARTED|Midline (3 Months)||223
8994913|NCT02807259|10057849|FG000|COMPLETED|Midline (3 Months)||322
8994914|NCT02807259|10057850|FG001|COMPLETED|Midline (3 Months)||189
8994915|NCT02807259|10057849|FG000|NOT COMPLETED|Midline (3 Months)||30
8994916|NCT02807259|10057850|FG001|NOT COMPLETED|Midline (3 Months)||34
8994917|NCT02807259|10057849|FG000|STARTED|Endline (3 Months)||323
8994918|NCT02807259|10057850|FG001|STARTED|Endline (3 Months)||346
8994919|NCT02807259|10057849|FG000|COMPLETED|Endline (3 Months)||288
8994920|NCT02807259|10057850|FG001|COMPLETED|Endline (3 Months)||259
8994921|NCT02807259|10057849|FG000|NOT COMPLETED|Endline (3 Months)||35
8994922|NCT02807259|10057850|FG001|NOT COMPLETED|Endline (3 Months)||87
8994923|NCT02807376|10057860|FG000|STARTED|Overall Study||139
8994924|NCT02807376|10057861|FG001|STARTED|Overall Study||131
8994925|NCT02807376|10057860|FG000|COMPLETED|Overall Study||136
8994926|NCT02807376|10057861|FG001|COMPLETED|Overall Study||130
8994927|NCT02807376|10057860|FG000|NOT COMPLETED|Overall Study||3
8994928|NCT02807376|10057861|FG001|NOT COMPLETED|Overall Study||1
8994929|NCT02807402|10057867|FG000|STARTED|Overall Study||522
8994930|NCT02807402|10057867|FG000|COMPLETED|Overall Study||516
8994931|NCT02807402|10057867|FG000|NOT COMPLETED|Overall Study||6
8994932|NCT02807623|10057882|FG000|STARTED|Overall Study||98
8994933|NCT02807623|10057883|FG001|STARTED|Overall Study||100
8994934|NCT02807623|10057884|FG002|STARTED|Overall Study||102
8994935|NCT02807623|10057882|FG000|COMPLETED|Overall Study||75
8994936|NCT02807623|10057883|FG001|COMPLETED|Overall Study||79
8994937|NCT02807623|10057884|FG002|COMPLETED|Overall Study||79
8994938|NCT02807623|10057882|FG000|NOT COMPLETED|Overall Study||23
8994939|NCT02807623|10057883|FG001|NOT COMPLETED|Overall Study||21
8994940|NCT02807623|10057884|FG002|NOT COMPLETED|Overall Study||23
8994941|NCT02807844|10057911|FG000|STARTED|Overall Study||6
8994942|NCT02807844|10057912|FG001|STARTED|Overall Study||12
8994943|NCT02807844|10057913|FG002|STARTED|Overall Study||12
8994944|NCT02807844|10057914|FG003|STARTED|Overall Study||13
8994945|NCT02807844|10057915|FG004|STARTED|Overall Study||6
8994946|NCT02807844|10057916|FG005|STARTED|Overall Study||11
8994947|NCT02807844|10057917|FG006|STARTED|Overall Study||20
8994948|NCT02807844|10057918|FG007|STARTED|Overall Study||20
8994949|NCT02807844|10057919|FG008|STARTED|Overall Study||21
8994950|NCT02807844|10057920|FG009|STARTED|Overall Study||20
8994951|NCT02807844|10057911|FG000|COMPLETED|Overall Study||0
8994952|NCT02807844|10057912|FG001|COMPLETED|Overall Study||0
8994953|NCT02807844|10057913|FG002|COMPLETED|Overall Study||0
8994954|NCT02807844|10057914|FG003|COMPLETED|Overall Study||0
8994955|NCT02807844|10057915|FG004|COMPLETED|Overall Study||0
8994956|NCT02807844|10057916|FG005|COMPLETED|Overall Study||0
8994957|NCT02807844|10057917|FG006|COMPLETED|Overall Study||0
8994958|NCT02807844|10057918|FG007|COMPLETED|Overall Study||0
8994959|NCT02807844|10057919|FG008|COMPLETED|Overall Study||0
8994960|NCT02807844|10057920|FG009|COMPLETED|Overall Study||0
8994961|NCT02807844|10057911|FG000|NOT COMPLETED|Overall Study||6
8994962|NCT02807844|10057912|FG001|NOT COMPLETED|Overall Study||12
8994963|NCT02807844|10057913|FG002|NOT COMPLETED|Overall Study||12
8994964|NCT02807844|10057914|FG003|NOT COMPLETED|Overall Study||13
8994965|NCT02807844|10057915|FG004|NOT COMPLETED|Overall Study||6
8994966|NCT02807844|10057916|FG005|NOT COMPLETED|Overall Study||11
8994967|NCT02807844|10057917|FG006|NOT COMPLETED|Overall Study||20
8994968|NCT02807844|10057918|FG007|NOT COMPLETED|Overall Study||20
8994969|NCT02807844|10057919|FG008|NOT COMPLETED|Overall Study||21
8994970|NCT02807844|10057920|FG009|NOT COMPLETED|Overall Study||20
8994971|NCT02807857|10057946|FG000|STARTED|Enrolled Set||1415
8994972|NCT02807857|10057946|FG000|COMPLETED|Enrolled Set||864
8994973|NCT02807857|10057946|FG000|NOT COMPLETED|Enrolled Set||551
8994974|NCT02807857|10057946|FG000|STARTED|Follow-Up Set||864
8994975|NCT02807857|10057946|FG000|COMPLETED|Follow-Up Set||680
8994976|NCT02807857|10057946|FG000|NOT COMPLETED|Follow-Up Set||184
8994977|NCT02807948|10057956|FG000|STARTED|Overall Study||132
8994978|NCT02807948|10057957|FG001|STARTED|Overall Study||57
8994979|NCT02807948|10057956|FG000|COMPLETED|Overall Study||131
8994980|NCT02807948|10057957|FG001|COMPLETED|Overall Study||57
8994981|NCT02807948|10057956|FG000|NOT COMPLETED|Overall Study||1
8994982|NCT02807948|10057957|FG001|NOT COMPLETED|Overall Study||0
8994983|NCT02808052|10057965|FG000|STARTED|Overall Study||4
8994984|NCT02808052|10057966|FG001|STARTED|Overall Study||3
8994985|NCT02808052|10057967|FG002|STARTED|Overall Study||2
8994986|NCT02808052|10057965|FG000|COMPLETED|Overall Study||4
8994987|NCT02808052|10057966|FG001|COMPLETED|Overall Study||3
8994988|NCT02808052|10057967|FG002|COMPLETED|Overall Study||2
8994989|NCT02808052|10057965|FG000|NOT COMPLETED|Overall Study||0
8994990|NCT02808052|10057966|FG001|NOT COMPLETED|Overall Study||0
8994991|NCT02808052|10057967|FG002|NOT COMPLETED|Overall Study||0
8994992|NCT02808130|10057981|FG000|STARTED|Overall Study||15
8994993|NCT02808130|10057982|FG001|STARTED|Overall Study||15
8994994|NCT02808130|10057983|FG002|STARTED|Overall Study||15
8994995|NCT02808130|10057984|FG003|STARTED|Overall Study||15
8994996|NCT02808130|10057985|FG004|STARTED|Overall Study||15
8994997|NCT02808130|10057986|FG005|STARTED|Overall Study||15
8994998|NCT02808130|10057981|FG000|COMPLETED|Overall Study||15
8994999|NCT02808130|10057982|FG001|COMPLETED|Overall Study||15
8995000|NCT02808130|10057983|FG002|COMPLETED|Overall Study||15
8995001|NCT02808130|10057984|FG003|COMPLETED|Overall Study||15
8995002|NCT02808130|10057985|FG004|COMPLETED|Overall Study||15
8995003|NCT02808130|10057986|FG005|COMPLETED|Overall Study||15
8995004|NCT02808130|10057981|FG000|NOT COMPLETED|Overall Study||0
8995005|NCT02808130|10057982|FG001|NOT COMPLETED|Overall Study||0
8995006|NCT02808130|10057983|FG002|NOT COMPLETED|Overall Study||0
8995007|NCT02808130|10057984|FG003|NOT COMPLETED|Overall Study||0
8995008|NCT02808130|10057985|FG004|NOT COMPLETED|Overall Study||0
8995009|NCT02808130|10057986|FG005|NOT COMPLETED|Overall Study||0
8995010|NCT02808312|10058008|FG000|STARTED|Overall Study||10
8995011|NCT02808312|10058009|FG001|STARTED|Overall Study||10
8995012|NCT02808312|10058010|FG002|STARTED|Overall Study||17
8995013|NCT02808312|10058011|FG003|STARTED|Overall Study||10
8995014|NCT02808312|10058012|FG004|STARTED|Overall Study||10
8633688|NCT00552617|9673873|FG002|STARTED|Overall Study||10
8633689|NCT00552617|9673874|FG003|STARTED|Overall Study||10
8633690|NCT00552617|9673875|FG004|STARTED|Overall Study||10
8633691|NCT00552617|9673876|FG005|STARTED|Overall Study||10
8633692|NCT00552617|9673877|FG006|STARTED|Overall Study||10
8995015|NCT02808312|10058008|FG000|COMPLETED|Overall Study||10
8995016|NCT02808312|10058009|FG001|COMPLETED|Overall Study||10
8995017|NCT02808312|10058010|FG002|COMPLETED|Overall Study||16
8995018|NCT02808312|10058011|FG003|COMPLETED|Overall Study||10
8995019|NCT02808312|10058012|FG004|COMPLETED|Overall Study||10
8572186|NCT00112502|9604228|FG003|NOT COMPLETED|Overall Study||4
8572187|NCT00112502|9604229|FG004|NOT COMPLETED|Overall Study||2
8572188|NCT00112502|9604230|FG005|NOT COMPLETED|Overall Study||5
8572189|NCT00112502|9604231|FG006|NOT COMPLETED|Overall Study||3
8572190|NCT00112502|9604232|FG007|NOT COMPLETED|Overall Study||7
8572191|NCT00112580|9604262|FG000|STARTED|Overall Study||8
8572192|NCT00112580|9604263|FG001|STARTED|Overall Study||19
8572193|NCT00112580|9604262|FG000|COMPLETED|Overall Study||0
8572194|NCT00112580|9604263|FG001|COMPLETED|Overall Study||0
8572195|NCT00112580|9604262|FG000|NOT COMPLETED|Overall Study||8
8572196|NCT00112580|9604263|FG001|NOT COMPLETED|Overall Study||19
8572197|NCT00112593|9604268|FG000|STARTED|Overall Study||5
8572198|NCT00112593|9604268|FG000|COMPLETED|Overall Study||5
8572199|NCT00112593|9604268|FG000|NOT COMPLETED|Overall Study||0
8572200|NCT00112671|9604272|FG000|STARTED|Overall Study||17
8572201|NCT00112671|9604272|FG000|COMPLETED|Overall Study||17
8572202|NCT00112671|9604272|FG000|NOT COMPLETED|Overall Study||0
8572203|NCT00112723|9604276|FG000|STARTED|Overall Study||13
8572204|NCT00112723|9604277|FG001|STARTED|Overall Study||19
8572205|NCT00112723|9604278|FG002|STARTED|Overall Study||14
8995020|NCT02808312|10058008|FG000|NOT COMPLETED|Overall Study||0
8995021|NCT02808312|10058009|FG001|NOT COMPLETED|Overall Study||0
8995022|NCT02808312|10058010|FG002|NOT COMPLETED|Overall Study||1
8995023|NCT02808312|10058011|FG003|NOT COMPLETED|Overall Study||0
8572206|NCT00112723|9604276|FG000|Patients Evaluable for Toxicity|Overall Study||11
8572207|NCT00112723|9604277|FG001|Patients Evaluable for Toxicity|Overall Study||12
8633693|NCT00552617|9673878|FG007|STARTED|Overall Study||10
8633694|NCT00552617|9673879|FG008|STARTED|Overall Study||10
8995024|NCT02808312|10058012|FG004|NOT COMPLETED|Overall Study||0
8995025|NCT02808338|10058029|FG000|STARTED|Screening||25
8633695|NCT00552617|9673880|FG009|STARTED|Overall Study||10
8995026|NCT02808338|10058029|FG000|COMPLETED|Screening||15
8995027|NCT02808338|10058029|FG000|NOT COMPLETED|Screening||10
8995028|NCT02808338|10058029|FG000|STARTED|Overnight In-lab Polysomonography||15
8995029|NCT02808338|10058029|FG000|Modified Philips BiPAP ASV|Overnight In-lab Polysomonography||13
8995030|NCT02808338|10058029|FG000|ResMed S7 VPAP Adapt|Overnight In-lab Polysomonography||13
8995031|NCT02808338|10058029|FG000|Philips BiPAP AutoSV Advanced System One|Overnight In-lab Polysomonography||12
8995032|NCT02808338|10058029|FG000|ResMed S9 VPAP Adapt|Overnight In-lab Polysomonography||12
8995033|NCT02808338|10058029|FG000|COMPLETED|Overnight In-lab Polysomonography||13
8995034|NCT02808338|10058029|FG000|NOT COMPLETED|Overnight In-lab Polysomonography||2
8995035|NCT02808338|10058029|FG000|STARTED|Take Home Period||13
8995036|NCT02808338|10058029|FG000|COMPLETED|Take Home Period||13
8995037|NCT02808338|10058029|FG000|NOT COMPLETED|Take Home Period||0
8995038|NCT02808429|10058043|FG000|STARTED|Overall Study||5
8995039|NCT02808429|10058044|FG001|STARTED|Overall Study||6
8995040|NCT02808429|10058045|FG002|STARTED|Overall Study||5
8995041|NCT02808429|10058043|FG000|COMPLETED|Overall Study||2
8995042|NCT02808429|10058044|FG001|COMPLETED|Overall Study||5
8995043|NCT02808429|10058045|FG002|COMPLETED|Overall Study||3
8995044|NCT02808429|10058043|FG000|NOT COMPLETED|Overall Study||3
8995045|NCT02808429|10058044|FG001|NOT COMPLETED|Overall Study||1
8995046|NCT02808429|10058045|FG002|NOT COMPLETED|Overall Study||2
8995047|NCT02808819|10058055|FG000|STARTED|Overall Study||220
8995048|NCT02808819|10058056|FG001|STARTED|Overall Study||226
8995049|NCT02808819|10058055|FG000|Treated|Overall Study||220
8995050|NCT02808819|10058056|FG001|Treated|Overall Study||226
8995051|NCT02808819|10058055|FG000|COMPLETED|Overall Study||189
8995052|NCT02808819|10058056|FG001|COMPLETED|Overall Study||195
8995053|NCT02808819|10058055|FG000|NOT COMPLETED|Overall Study||31
8995054|NCT02808819|10058056|FG001|NOT COMPLETED|Overall Study||31
8995055|NCT02808975|10058065|FG000|STARTED|Overall Study||103
8995056|NCT02808975|10058066|FG001|STARTED|Overall Study||103
8995057|NCT02808975|10058065|FG000|COMPLETED|Overall Study||81
8995058|NCT02808975|10058066|FG001|COMPLETED|Overall Study||84
8995059|NCT02808975|10058065|FG000|NOT COMPLETED|Overall Study||22
8995060|NCT02808975|10058066|FG001|NOT COMPLETED|Overall Study||19
8995061|NCT02809053|10058074|FG000|STARTED|Overall Study||157
8995062|NCT02809053|10058075|FG001|STARTED|Overall Study||158
8995063|NCT02809053|10058074|FG000|Completed Treatment|Overall Study||156
8995064|NCT02809053|10058075|FG001|Completed Treatment|Overall Study||156
8995065|NCT02809053|10058074|FG000|COMPLETED|Overall Study||150
8995066|NCT02809053|10058075|FG001|COMPLETED|Overall Study||152
8995067|NCT02809053|10058074|FG000|NOT COMPLETED|Overall Study||7
8995068|NCT02809053|10058075|FG001|NOT COMPLETED|Overall Study||6
8995069|NCT02809183|10058086|FG000|STARTED|Overall Study||25
8995070|NCT02809183|10058087|FG001|STARTED|Overall Study||25
8995071|NCT02809183|10058088|FG002|STARTED|Overall Study||25
8995072|NCT02809183|10058089|FG003|STARTED|Overall Study||26
8995073|NCT02809183|10058090|FG004|STARTED|Overall Study||6
8995074|NCT02809183|10058091|FG005|STARTED|Overall Study||28
8995075|NCT02809183|10058086|FG000|COMPLETED|Overall Study||25
8995076|NCT02809183|10058087|FG001|COMPLETED|Overall Study||25
8995077|NCT02809183|10058088|FG002|COMPLETED|Overall Study||25
8995078|NCT02809183|10058089|FG003|COMPLETED|Overall Study||26
8995079|NCT02809183|10058090|FG004|COMPLETED|Overall Study||6
8995080|NCT02809183|10058091|FG005|COMPLETED|Overall Study||28
8995081|NCT02809183|10058086|FG000|NOT COMPLETED|Overall Study||0
8995082|NCT02809183|10058087|FG001|NOT COMPLETED|Overall Study||0
8995083|NCT02809183|10058088|FG002|NOT COMPLETED|Overall Study||0
8995084|NCT02809183|10058089|FG003|NOT COMPLETED|Overall Study||0
8995085|NCT02809183|10058090|FG004|NOT COMPLETED|Overall Study||0
8995086|NCT02809183|10058091|FG005|NOT COMPLETED|Overall Study||0
8995087|NCT02809430|10058108|FG000|STARTED|Overall Study||90
8995088|NCT02809430|10058108|FG000|Failed 3-night run-in Because no Evidence of Obstructive Sleep Apnea|Overall Study|14 with CPAP < 3 hours, 5 without evidence of OSA, 9 with evidence of central or complex sleep apnea|28
8995089|NCT02809430|10058108|FG000|Stopped CPAP During Inpatient Rehabilitation|Overall Study|10 of 62 participants stopped CPAP after the run-in and prior to discharge from IPR|10
8995090|NCT02809430|10058108|FG000|COMPLETED|Overall Study||52
8995091|NCT02809430|10058108|FG000|NOT COMPLETED|Overall Study||38
8995092|NCT02809833|10058115|FG000|STARTED|Overall Study||850
8995093|NCT02809833|10058115|FG000|COMPLETED|Overall Study||550
8995094|NCT02809833|10058115|FG000|NOT COMPLETED|Overall Study||300
8995095|NCT02809846|10058121|FG000|STARTED|Overall Study||17
8995096|NCT02809846|10058122|FG001|STARTED|Overall Study||16
8995097|NCT02809846|10058121|FG000|COMPLETED|Overall Study||8
8995098|NCT02809846|10058122|FG001|COMPLETED|Overall Study||9
8995099|NCT02809846|10058121|FG000|NOT COMPLETED|Overall Study||9
8995100|NCT02809846|10058122|FG001|NOT COMPLETED|Overall Study||7
8995101|NCT02809859|10058128|FG000|STARTED|Overall Study||139
8995102|NCT02809859|10058128|FG000|COMPLETED|Overall Study||125
8995103|NCT02809859|10058128|FG000|NOT COMPLETED|Overall Study||14
8995104|NCT02809911|10058134|FG000|STARTED|Overall Study|This is the Initial Treatment Population (subjects that started the Enrollment Visit / Visit 2)|22
8995105|NCT02809911|10058135|FG001|STARTED|Overall Study|This is the Initial Treatment Population (subjects that started the Enrollment Visit / Visit 2)|19
8995106|NCT02809911|10058134|FG000|COMPLETED|Overall Study|This is the Initial Treatment Population (subjects that completed the Enrollment Visit / Visit 2)|22
8995107|NCT02809911|10058135|FG001|COMPLETED|Overall Study|This is the Initial Treatment Population (subjects that completed the Enrollment Visit / Visit 2)|19
8995108|NCT02809911|10058134|FG000|NOT COMPLETED|Overall Study||0
8995109|NCT02809911|10058135|FG001|NOT COMPLETED|Overall Study||0
8995110|NCT02809976|10058141|FG000|STARTED|Overall Study||11
8995111|NCT02809976|10058141|FG000|COMPLETED|Overall Study||9
8995112|NCT02809976|10058141|FG000|NOT COMPLETED|Overall Study||2
8995113|NCT02810327|10058147|FG000|STARTED|Overall Study||76
8995114|NCT02810327|10058148|FG001|STARTED|Overall Study||41
8995115|NCT02810327|10058147|FG000|COMPLETED|Overall Study||69
8995116|NCT02810327|10058148|FG001|COMPLETED|Overall Study||34
8995117|NCT02810327|10058147|FG000|NOT COMPLETED|Overall Study||7
8995118|NCT02810327|10058148|FG001|NOT COMPLETED|Overall Study||7
8995119|NCT02810340|10058157|FG000|STARTED|Overall Study||20
8995120|NCT02810340|10058158|FG001|STARTED|Overall Study||20
8995121|NCT02810340|10058159|FG002|STARTED|Overall Study||20
8995122|NCT02810340|10058157|FG000|COMPLETED|Overall Study||19
8995123|NCT02810340|10058158|FG001|COMPLETED|Overall Study||19
8995124|NCT02810340|10058159|FG002|COMPLETED|Overall Study||19
8995125|NCT02810340|10058157|FG000|NOT COMPLETED|Overall Study||1
8995126|NCT02810340|10058158|FG001|NOT COMPLETED|Overall Study||1
8995127|NCT02810340|10058159|FG002|NOT COMPLETED|Overall Study||1
8995128|NCT02810392|10058169|FG000|STARTED|Overall Study||9
8995129|NCT02810392|10058170|FG001|STARTED|Overall Study||10
8995130|NCT02810392|10058169|FG000|COMPLETED|Overall Study||8
8995131|NCT02810392|10058170|FG001|COMPLETED|Overall Study||9
8995132|NCT02810392|10058169|FG000|NOT COMPLETED|Overall Study||1
8995133|NCT02810392|10058170|FG001|NOT COMPLETED|Overall Study||1
8995134|NCT02810509|10058178|FG000|STARTED|Overall Study||584
8995135|NCT02810509|10058179|FG001|STARTED|Overall Study||1230
8995136|NCT02810509|10058178|FG000|COMPLETED|Overall Study||584
8995137|NCT02810509|10058179|FG001|COMPLETED|Overall Study||1230
8995138|NCT02810509|10058178|FG000|NOT COMPLETED|Overall Study||0
8995139|NCT02810509|10058179|FG001|NOT COMPLETED|Overall Study||0
8995140|NCT02810873|10058189|FG000|STARTED|Overall Study||6
8995141|NCT02810873|10058190|FG001|STARTED|Overall Study||13
8995142|NCT02810873|10058189|FG000|COMPLETED|Overall Study||6
8995143|NCT02810873|10058190|FG001|COMPLETED|Overall Study||13
8995144|NCT02810873|10058189|FG000|NOT COMPLETED|Overall Study||0
8995145|NCT02810873|10058190|FG001|NOT COMPLETED|Overall Study||0
8995146|NCT02810951|10058197|FG000|STARTED|Overall Study||6
8633696|NCT00552617|9673871|FG000|Treated|Overall Study||10
8633697|NCT00552617|9673872|FG001|Treated|Overall Study||10
8633698|NCT00552617|9673873|FG002|Treated|Overall Study||9
8633699|NCT00552617|9673874|FG003|Treated|Overall Study||10
8633700|NCT00552617|9673875|FG004|Treated|Overall Study||10
8633701|NCT00552617|9673876|FG005|Treated|Overall Study||10
8633702|NCT00552617|9673877|FG006|Treated|Overall Study||10
8633703|NCT00552617|9673878|FG007|Treated|Overall Study||10
8633704|NCT00552617|9673879|FG008|Treated|Overall Study||10
8995147|NCT02810951|10058197|FG000|FCX-007 Injection|Overall Study||6
8995148|NCT02810951|10058197|FG000|No FCX-007 Injection|Overall Study||6
8995149|NCT02810951|10058197|FG000|COMPLETED|Overall Study||5
8995150|NCT02810951|10058197|FG000|NOT COMPLETED|Overall Study||1
8995151|NCT02810964|10058205|FG000|STARTED|Placebo Run-In Phase (2 Weeks)||32
8995152|NCT02810964|10058206|FG001|STARTED|Placebo Run-In Phase (2 Weeks)||32
8995153|NCT02810964|10058205|FG000|COMPLETED|Placebo Run-In Phase (2 Weeks)||32
8995154|NCT02810964|10058206|FG001|COMPLETED|Placebo Run-In Phase (2 Weeks)||32
8995155|NCT02810964|10058205|FG000|NOT COMPLETED|Placebo Run-In Phase (2 Weeks)||0
8995156|NCT02810964|10058206|FG001|NOT COMPLETED|Placebo Run-In Phase (2 Weeks)||0
8995157|NCT02810964|10058205|FG000|STARTED|Double-Blind Treatment Phase (16 Weeks)||32
8995158|NCT02810964|10058206|FG001|STARTED|Double-Blind Treatment Phase (16 Weeks)||32
8995159|NCT02810964|10058205|FG000|COMPLETED|Double-Blind Treatment Phase (16 Weeks)||29
8995160|NCT02810964|10058206|FG001|COMPLETED|Double-Blind Treatment Phase (16 Weeks)||29
8995161|NCT02810964|10058205|FG000|NOT COMPLETED|Double-Blind Treatment Phase (16 Weeks)||3
8995162|NCT02810964|10058206|FG001|NOT COMPLETED|Double-Blind Treatment Phase (16 Weeks)||3
8995163|NCT02811159|10058212|FG000|STARTED|Treatment Course 1||20
8995164|NCT02811159|10058212|FG000|COMPLETED|Treatment Course 1||19
8995165|NCT02811159|10058212|FG000|NOT COMPLETED|Treatment Course 1||1
8995166|NCT02811159|10058212|FG000|STARTED|Treatment Course 2|Not all participants who completed the Treatment Course 1 entered the Treatment Course 2.|4
8995167|NCT02811159|10058212|FG000|COMPLETED|Treatment Course 2||4
8995168|NCT02811159|10058212|FG000|NOT COMPLETED|Treatment Course 2||0
9039210|NCT03335254|10100139|FG017|STARTED|Period 3, Day 26-30||0
9039211|NCT03335254|10100140|FG018|STARTED|Period 3, Day 26-30||0
9039212|NCT03335254|10100141|FG019|STARTED|Period 3, Day 26-30||0
9039213|NCT03335254|10100122|FG000|COMPLETED|Period 3, Day 26-30||9
9039214|NCT03335254|10100123|FG001|COMPLETED|Period 3, Day 26-30||0
9039215|NCT03335254|10100124|FG002|COMPLETED|Period 3, Day 26-30||0
9039216|NCT03335254|10100125|FG003|COMPLETED|Period 3, Day 26-30||0
9039217|NCT03335254|10100126|FG004|COMPLETED|Period 3, Day 26-30||0
8633705|NCT00552617|9673880|FG009|Treated|Overall Study||9
8633706|NCT00552617|9673871|FG000|COMPLETED|Overall Study||10
8633707|NCT00552617|9673872|FG001|COMPLETED|Overall Study||10
9039218|NCT03335254|10100127|FG005|COMPLETED|Period 3, Day 26-30||0
9039219|NCT03335254|10100128|FG006|COMPLETED|Period 3, Day 26-30||0
9039220|NCT03335254|10100129|FG007|COMPLETED|Period 3, Day 26-30||0
9039221|NCT03335254|10100130|FG008|COMPLETED|Period 3, Day 26-30||0
9039222|NCT03335254|10100131|FG009|COMPLETED|Period 3, Day 26-30||0
9039223|NCT03335254|10100132|FG010|COMPLETED|Period 3, Day 26-30||0
8995169|NCT02811302|10058216|FG000|STARTED|Overall Study||1495
8995170|NCT02811302|10058216|FG000|COMPLETED|Overall Study||1282
8995171|NCT02811302|10058216|FG000|NOT COMPLETED|Overall Study||213
8995172|NCT02811419|10058223|FG000|STARTED|Overall Study||369
8995173|NCT02811419|10058224|FG001|STARTED|Overall Study||371
8995174|NCT02811419|10058223|FG000|COMPLETED|Overall Study||357
8995175|NCT02811419|10058224|FG001|COMPLETED|Overall Study||358
8995176|NCT02811419|10058223|FG000|NOT COMPLETED|Overall Study||12
8995177|NCT02811419|10058224|FG001|NOT COMPLETED|Overall Study||13
8995178|NCT02811445|10058232|FG000|STARTED|Overall Study||18
8995179|NCT02811445|10058233|FG001|STARTED|Overall Study||11
8995180|NCT02811445|10058232|FG000|COMPLETED|Overall Study||18
8995181|NCT02811445|10058233|FG001|COMPLETED|Overall Study||11
8995182|NCT02811445|10058232|FG000|NOT COMPLETED|Overall Study||0
8995183|NCT02811445|10058233|FG001|NOT COMPLETED|Overall Study||0
8995184|NCT02811640|10058239|FG000|STARTED|Overall Study||12
8995185|NCT02811640|10058239|FG000|COMPLETED|Overall Study||10
8995186|NCT02811640|10058239|FG000|NOT COMPLETED|Overall Study||2
8995187|NCT02811965|10058243|FG000|STARTED|Overall Study||21
8995188|NCT02811965|10058243|FG000|COMPLETED|Overall Study||21
8995189|NCT02811965|10058243|FG000|NOT COMPLETED|Overall Study||0
8995190|NCT02812160|10058261|FG000|STARTED|Overall Study||187
8995191|NCT02812160|10058262|FG001|STARTED|Overall Study||101
8995192|NCT02812160|10058261|FG000|COMPLETED|Overall Study||187
8995193|NCT02812160|10058262|FG001|COMPLETED|Overall Study||101
8995194|NCT02812160|10058261|FG000|NOT COMPLETED|Overall Study||0
8995195|NCT02812160|10058262|FG001|NOT COMPLETED|Overall Study||0
8995196|NCT02812186|10058270|FG000|STARTED|Period 1||40
8995197|NCT02812186|10058271|FG001|STARTED|Period 1||39
8995198|NCT02812186|10058270|FG000|COMPLETED|Period 1||29
8995199|NCT02812186|10058271|FG001|COMPLETED|Period 1||24
8995200|NCT02812186|10058270|FG000|NOT COMPLETED|Period 1||11
8995201|NCT02812186|10058271|FG001|NOT COMPLETED|Period 1||15
8995202|NCT02812186|10058270|FG000|STARTED|Period 2||29
8995203|NCT02812186|10058271|FG001|STARTED|Period 2||24
8995204|NCT02812186|10058270|FG000|COMPLETED|Period 2||29
8995205|NCT02812186|10058271|FG001|COMPLETED|Period 2||24
8995206|NCT02812186|10058270|FG000|NOT COMPLETED|Period 2||0
8995207|NCT02812186|10058271|FG001|NOT COMPLETED|Period 2||0
8995208|NCT02812238|10058280|FG000|STARTED|First Intervention||19
8995209|NCT02812238|10058281|FG001|STARTED|First Intervention||19
8995210|NCT02812238|10058280|FG000|COMPLETED|First Intervention||18
8995211|NCT02812238|10058281|FG001|COMPLETED|First Intervention||19
8995212|NCT02812238|10058280|FG000|NOT COMPLETED|First Intervention||1
8995213|NCT02812238|10058281|FG001|NOT COMPLETED|First Intervention||0
8995214|NCT02812238|10058280|FG000|STARTED|Second Intervention||18
8995215|NCT02812238|10058281|FG001|STARTED|Second Intervention||19
8995216|NCT02812238|10058280|FG000|COMPLETED|Second Intervention||18
8995217|NCT02812238|10058281|FG001|COMPLETED|Second Intervention||18
8995218|NCT02812238|10058280|FG000|NOT COMPLETED|Second Intervention||0
8995219|NCT02812238|10058281|FG001|NOT COMPLETED|Second Intervention||1
8995220|NCT02812342|10058287|FG000|STARTED|Overall Study||10
8995221|NCT02812342|10058287|FG000|COMPLETED|Overall Study||10
8995222|NCT02812342|10058287|FG000|NOT COMPLETED|Overall Study||0
8995223|NCT02812771|10058291|FG000|STARTED|Overall Study||62
8995224|NCT02812771|10058291|FG000|COMPLETED|Overall Study||50
8995225|NCT02812771|10058291|FG000|NOT COMPLETED|Overall Study||12
8995226|NCT02813070|10058298|FG000|STARTED|Overall Study||28
8995227|NCT02813070|10058299|FG001|STARTED|Overall Study||23
8995228|NCT02813070|10058300|FG002|STARTED|Overall Study||36
8995229|NCT02813070|10058298|FG000|Treated (Safety Population)|Overall Study||25
8995230|NCT02813070|10058299|FG001|Treated (Safety Population)|Overall Study||20
8995231|NCT02813070|10058300|FG002|Treated (Safety Population)|Overall Study||25
8995232|NCT02813070|10058298|FG000|COMPLETED|Overall Study||25
8995233|NCT02813070|10058299|FG001|COMPLETED|Overall Study||20
8995234|NCT02813070|10058300|FG002|COMPLETED|Overall Study||25
8995235|NCT02813070|10058298|FG000|NOT COMPLETED|Overall Study||3
8995236|NCT02813070|10058299|FG001|NOT COMPLETED|Overall Study||3
8995237|NCT02813070|10058300|FG002|NOT COMPLETED|Overall Study||11
8995238|NCT02813265|10058309|FG000|STARTED|Overall Study||459
8995239|NCT02813265|10058310|FG001|STARTED|Overall Study||456
8995240|NCT02813265|10058309|FG000|COMPLETED|Overall Study||455
8995241|NCT02813265|10058310|FG001|COMPLETED|Overall Study||453
8995242|NCT02813265|10058309|FG000|NOT COMPLETED|Overall Study||4
8995243|NCT02813265|10058310|FG001|NOT COMPLETED|Overall Study||3
8995244|NCT02813421|10058318|FG000|STARTED|Overall Study||5
8995245|NCT02813421|10058319|FG001|STARTED|Overall Study||6
8995246|NCT02813421|10058318|FG000|COMPLETED|Overall Study||3
8995247|NCT02813421|10058319|FG001|COMPLETED|Overall Study||3
8995248|NCT02813421|10058318|FG000|NOT COMPLETED|Overall Study||2
8995249|NCT02813421|10058319|FG001|NOT COMPLETED|Overall Study||3
8995250|NCT02813473|10058325|FG000|STARTED|Overall Study||223
8995251|NCT02813473|10058325|FG000|COMPLETED|Overall Study||223
8995252|NCT02813473|10058325|FG000|NOT COMPLETED|Overall Study||0
8995253|NCT02813551|10058331|FG000|STARTED|Overall Study||59
8995254|NCT02813551|10058332|FG001|STARTED|Overall Study||59
8995255|NCT02813551|10058331|FG000|COMPLETED|Overall Study||58
8995256|NCT02813551|10058332|FG001|COMPLETED|Overall Study||57
8995257|NCT02813551|10058331|FG000|NOT COMPLETED|Overall Study||1
8995258|NCT02813551|10058332|FG001|NOT COMPLETED|Overall Study||2
8995259|NCT02813577|10058338|FG000|STARTED|Overall Study||4
9039224|NCT03335254|10100133|FG011|COMPLETED|Period 3, Day 26-30||0
8995260|NCT02813577|10058338|FG000|COMPLETED|Overall Study|Study was terminated and only some results at 1 month follow up are available.|0
8995261|NCT02813577|10058338|FG000|NOT COMPLETED|Overall Study||4
8995262|NCT02813681|10058345|FG000|STARTED|Overall Study||27
8995263|NCT02813681|10058346|FG001|STARTED|Overall Study||34
8995264|NCT02813681|10058347|FG002|STARTED|Overall Study||19
8995265|NCT02813681|10058345|FG000|COMPLETED|Overall Study||22
8995266|NCT02813681|10058346|FG001|COMPLETED|Overall Study||28
8995267|NCT02813681|10058347|FG002|COMPLETED|Overall Study||19
8995268|NCT02813681|10058345|FG000|NOT COMPLETED|Overall Study||5
8995269|NCT02813681|10058346|FG001|NOT COMPLETED|Overall Study||6
8995270|NCT02813681|10058347|FG002|NOT COMPLETED|Overall Study||0
8995271|NCT02813694|10058359|FG000|STARTED|Overall Study|Intent to Treat Analysis Set|370
8995272|NCT02813694|10058360|FG001|STARTED|Overall Study|Intent to Treat Analysis Set|368
8995273|NCT02813694|10058359|FG000|COMPLETED|Overall Study||353
8995274|NCT02813694|10058360|FG001|COMPLETED|Overall Study|Completed Study (Late Follow Up Assessment)|354
8995275|NCT02813694|10058359|FG000|NOT COMPLETED|Overall Study||17
8995276|NCT02813694|10058360|FG001|NOT COMPLETED|Overall Study||14
8995277|NCT02814175|10058368|FG000|STARTED|Part 1||122
8995278|NCT02814175|10058369|FG001|STARTED|Part 1||123
8995279|NCT02814175|10058370|FG002|STARTED|Part 1||0
8995280|NCT02814175|10058371|FG003|STARTED|Part 1||0
8995281|NCT02814175|10058372|FG004|STARTED|Part 1||0
8995282|NCT02814175|10058373|FG005|STARTED|Part 1||0
8995283|NCT02814175|10058368|FG000|COMPLETED|Part 1||110
8995284|NCT02814175|10058369|FG001|COMPLETED|Part 1||117
8995285|NCT02814175|10058370|FG002|COMPLETED|Part 1||0
8995286|NCT02814175|10058371|FG003|COMPLETED|Part 1||0
8995287|NCT02814175|10058372|FG004|COMPLETED|Part 1||0
8995288|NCT02814175|10058373|FG005|COMPLETED|Part 1||0
8995289|NCT02814175|10058368|FG000|NOT COMPLETED|Part 1||12
8995290|NCT02814175|10058369|FG001|NOT COMPLETED|Part 1||6
8633708|NCT00552617|9673873|FG002|COMPLETED|Overall Study||9
8633709|NCT00552617|9673874|FG003|COMPLETED|Overall Study||9
8633710|NCT00552617|9673875|FG004|COMPLETED|Overall Study||10
8879181|NCT01932437|9935986|FG003|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
8879182|NCT01932437|9935987|FG004|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
8879183|NCT01932437|9935988|FG005|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
8879184|NCT01932437|9935983|FG000|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||2
8879185|NCT01932437|9935984|FG001|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
8879186|NCT01932437|9935985|FG002|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
8879187|NCT01932437|9935986|FG003|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
8879188|NCT01932437|9935987|FG004|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||6
8879189|NCT01932437|9935988|FG005|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
8879190|NCT01932437|9935983|FG000|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||2
8879191|NCT01932437|9935984|FG001|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
8879192|NCT01932437|9935985|FG002|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
8879193|NCT01932437|9935986|FG003|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
8879194|NCT01932437|9935987|FG004|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||6
8879195|NCT01932437|9935988|FG005|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
8879196|NCT01932437|9935983|FG000|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
8879197|NCT01932437|9935984|FG001|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
8879198|NCT01932437|9935985|FG002|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
8879199|NCT01932437|9935986|FG003|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
8879200|NCT01932437|9935987|FG004|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
8879201|NCT01932437|9935988|FG005|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
8879202|NCT01932437|9935983|FG000|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||2
8879203|NCT01932437|9935984|FG001|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
8879204|NCT01932437|9935985|FG002|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
8995291|NCT02814175|10058370|FG002|NOT COMPLETED|Part 1||0
8995292|NCT02814175|10058371|FG003|NOT COMPLETED|Part 1||0
8995293|NCT02814175|10058372|FG004|NOT COMPLETED|Part 1||0
8995294|NCT02814175|10058373|FG005|NOT COMPLETED|Part 1||0
8995295|NCT02814175|10058368|FG000|STARTED|Part 2||0
8995296|NCT02814175|10058369|FG001|STARTED|Part 2||0
8995297|NCT02814175|10058370|FG002|STARTED|Part 2||15
8995298|NCT02814175|10058371|FG003|STARTED|Part 2||95
8995299|NCT02814175|10058372|FG004|STARTED|Part 2||54
8995300|NCT02814175|10058373|FG005|STARTED|Part 2||63
8995301|NCT02814175|10058368|FG000|COMPLETED|Part 2||0
8995302|NCT02814175|10058369|FG001|COMPLETED|Part 2||0
8995303|NCT02814175|10058370|FG002|COMPLETED|Part 2||15
8995304|NCT02814175|10058371|FG003|COMPLETED|Part 2||91
8995305|NCT02814175|10058372|FG004|COMPLETED|Part 2||52
8995306|NCT02814175|10058373|FG005|COMPLETED|Part 2||57
8995307|NCT02814175|10058368|FG000|NOT COMPLETED|Part 2||0
8995308|NCT02814175|10058369|FG001|NOT COMPLETED|Part 2||0
8995309|NCT02814175|10058370|FG002|NOT COMPLETED|Part 2||0
8995310|NCT02814175|10058371|FG003|NOT COMPLETED|Part 2||4
8995311|NCT02814175|10058372|FG004|NOT COMPLETED|Part 2||2
8995312|NCT02814175|10058373|FG005|NOT COMPLETED|Part 2||6
8633711|NCT00552617|9673876|FG005|COMPLETED|Overall Study||8
8995313|NCT02814227|10058387|FG000|STARTED|Overall Study||52
8995314|NCT02814227|10058387|FG000|COMPLETED|Overall Study||52
8995315|NCT02814227|10058387|FG000|NOT COMPLETED|Overall Study||0
8995316|NCT02814279|10058393|FG000|STARTED|Overall Study||21
8995317|NCT02814279|10058394|FG001|STARTED|Overall Study||21
8995318|NCT02814279|10058393|FG000|COMPLETED|Overall Study||21
8995319|NCT02814279|10058394|FG001|COMPLETED|Overall Study||21
8995320|NCT02814279|10058393|FG000|NOT COMPLETED|Overall Study||0
8995321|NCT02814279|10058394|FG001|NOT COMPLETED|Overall Study||0
8995322|NCT02814448|10058405|FG000|STARTED|Overall Study||27
8995323|NCT02814448|10058406|FG001|STARTED|Overall Study||24
8995324|NCT02814448|10058407|FG002|STARTED|Overall Study||26
8995325|NCT02814448|10058408|FG003|STARTED|Overall Study||25
8995326|NCT02814448|10058409|FG004|STARTED|Overall Study||28
8995327|NCT02814448|10058405|FG000|COMPLETED|Overall Study||27
8995328|NCT02814448|10058406|FG001|COMPLETED|Overall Study||24
8995329|NCT02814448|10058407|FG002|COMPLETED|Overall Study||25
8995330|NCT02814448|10058408|FG003|COMPLETED|Overall Study||25
8995331|NCT02814448|10058409|FG004|COMPLETED|Overall Study||26
8995332|NCT02814448|10058405|FG000|NOT COMPLETED|Overall Study||0
8995333|NCT02814448|10058406|FG001|NOT COMPLETED|Overall Study||0
8995334|NCT02814448|10058407|FG002|NOT COMPLETED|Overall Study||1
8995335|NCT02814448|10058408|FG003|NOT COMPLETED|Overall Study||0
8995336|NCT02814448|10058409|FG004|NOT COMPLETED|Overall Study||2
8995337|NCT02814565|10058423|FG000|STARTED|Overall Study||90
8995338|NCT02814565|10058424|FG001|STARTED|Overall Study||90
8995339|NCT02814565|10058423|FG000|COMPLETED|Overall Study||89
8995340|NCT02814565|10058424|FG001|COMPLETED|Overall Study||88
8995341|NCT02814565|10058423|FG000|NOT COMPLETED|Overall Study||1
8995342|NCT02814565|10058424|FG001|NOT COMPLETED|Overall Study||2
8995343|NCT02814643|10058432|FG000|STARTED|Overall Study||51
8995344|NCT02814643|10058433|FG001|STARTED|Overall Study||52
8995345|NCT02814643|10058432|FG000|COMPLETED|Overall Study||50
8995346|NCT02814643|10058433|FG001|COMPLETED|Overall Study||49
8995347|NCT02814643|10058432|FG000|NOT COMPLETED|Overall Study||1
8995348|NCT02814643|10058433|FG001|NOT COMPLETED|Overall Study||3
8995349|NCT02814656|10058443|FG000|STARTED|Overall Study||6
8995350|NCT02814656|10058444|FG001|STARTED|Overall Study||6
8995351|NCT02814656|10058445|FG002|STARTED|Overall Study||6
8995352|NCT02814656|10058446|FG003|STARTED|Overall Study||6
8995353|NCT02814656|10058443|FG000|COMPLETED|Overall Study||6
8995354|NCT02814656|10058444|FG001|COMPLETED|Overall Study||6
8995355|NCT02814656|10058445|FG002|COMPLETED|Overall Study||6
8995356|NCT02814656|10058446|FG003|COMPLETED|Overall Study||6
8995357|NCT02814656|10058443|FG000|NOT COMPLETED|Overall Study||0
8995358|NCT02814656|10058444|FG001|NOT COMPLETED|Overall Study||0
8633712|NCT00552617|9673877|FG006|COMPLETED|Overall Study||10
8633713|NCT00552617|9673878|FG007|COMPLETED|Overall Study||10
8633714|NCT00552617|9673879|FG008|COMPLETED|Overall Study||8
8633715|NCT00552617|9673880|FG009|COMPLETED|Overall Study||9
8633716|NCT00552617|9673871|FG000|NOT COMPLETED|Overall Study||0
8633717|NCT00552617|9673872|FG001|NOT COMPLETED|Overall Study||0
8995359|NCT02814656|10058445|FG002|NOT COMPLETED|Overall Study||0
8995360|NCT02814656|10058446|FG003|NOT COMPLETED|Overall Study||0
8995361|NCT02814838|10058458|FG000|STARTED|Overall Study||50
8995362|NCT02814838|10058459|FG001|STARTED|Overall Study||26
8995363|NCT02814838|10058458|FG000|COMPLETED|Overall Study||48
8995364|NCT02814838|10058459|FG001|COMPLETED|Overall Study||25
8995365|NCT02814838|10058458|FG000|NOT COMPLETED|Overall Study||2
8995366|NCT02814838|10058459|FG001|NOT COMPLETED|Overall Study||1
8995367|NCT02814890|10058467|FG000|STARTED|Overall Study||33
8633718|NCT00552617|9673873|FG002|NOT COMPLETED|Overall Study||1
8633719|NCT00552617|9673874|FG003|NOT COMPLETED|Overall Study||1
8995368|NCT02814890|10058468|FG001|STARTED|Overall Study||32
8995369|NCT02814890|10058467|FG000|COMPLETED|Overall Study||30
8995370|NCT02814890|10058468|FG001|COMPLETED|Overall Study||30
8995371|NCT02814890|10058467|FG000|NOT COMPLETED|Overall Study||3
8995372|NCT02814890|10058468|FG001|NOT COMPLETED|Overall Study||2
8995373|NCT02815293|10058483|FG000|STARTED|Overall Study||10
8995374|NCT02815293|10058484|FG001|STARTED|Overall Study||8
8995375|NCT02815293|10058485|FG002|STARTED|Overall Study||18
8995376|NCT02815293|10058483|FG000|COMPLETED|Overall Study||0
8995377|NCT02815293|10058484|FG001|COMPLETED|Overall Study||0
8995378|NCT02815293|10058485|FG002|COMPLETED|Overall Study||0
8995379|NCT02815293|10058483|FG000|NOT COMPLETED|Overall Study||10
8633720|NCT00552617|9673875|FG004|NOT COMPLETED|Overall Study||0
8633721|NCT00552617|9673876|FG005|NOT COMPLETED|Overall Study||2
8995380|NCT02815293|10058484|FG001|NOT COMPLETED|Overall Study||8
8995381|NCT02815293|10058485|FG002|NOT COMPLETED|Overall Study||18
8995382|NCT02815644|10058493|FG000|STARTED|Treatment Period 1 + Washout||11
8995383|NCT02815644|10058494|FG001|STARTED|Treatment Period 1 + Washout||11
8995384|NCT02815644|10058493|FG000|COMPLETED|Treatment Period 1 + Washout||11
8995385|NCT02815644|10058494|FG001|COMPLETED|Treatment Period 1 + Washout||11
8995386|NCT02815644|10058493|FG000|NOT COMPLETED|Treatment Period 1 + Washout||0
8995387|NCT02815644|10058494|FG001|NOT COMPLETED|Treatment Period 1 + Washout||0
8995388|NCT02815644|10058493|FG000|STARTED|Treatment Period 2||11
8995389|NCT02815644|10058494|FG001|STARTED|Treatment Period 2||11
8995390|NCT02815644|10058493|FG000|COMPLETED|Treatment Period 2||11
8995391|NCT02815644|10058494|FG001|COMPLETED|Treatment Period 2||11
8995392|NCT02815644|10058493|FG000|NOT COMPLETED|Treatment Period 2||0
8995393|NCT02815644|10058494|FG001|NOT COMPLETED|Treatment Period 2||0
8995394|NCT02815670|10058500|FG000|STARTED|Overall Study||1
8995395|NCT02815670|10058500|FG000|COMPLETED|Overall Study||0
8995396|NCT02815670|10058500|FG000|NOT COMPLETED|Overall Study||1
8995397|NCT02815709|10058509|FG000|STARTED|Overall Study||82
8995398|NCT02815709|10058510|FG001|STARTED|Overall Study||86
8995399|NCT02815709|10058511|FG002|STARTED|Overall Study||82
8995400|NCT02815709|10058512|FG003|STARTED|Overall Study||84
8995401|NCT02815709|10058513|FG004|STARTED|Overall Study||84
8995402|NCT02815709|10058509|FG000|Treated With Study Medication|Overall Study||76
8995403|NCT02815709|10058510|FG001|Treated With Study Medication|Overall Study||79
8995404|NCT02815709|10058511|FG002|Treated With Study Medication|Overall Study||79
8995405|NCT02815709|10058512|FG003|Treated With Study Medication|Overall Study||79
8995406|NCT02815709|10058513|FG004|Treated With Study Medication|Overall Study||76
8995407|NCT02815709|10058509|FG000|COMPLETED|Overall Study|Completed Study|75
8995408|NCT02815709|10058510|FG001|COMPLETED|Overall Study|Completed Study|78
8995409|NCT02815709|10058511|FG002|COMPLETED|Overall Study|Completed Study|75
8995410|NCT02815709|10058512|FG003|COMPLETED|Overall Study|Completed Study|76
8995411|NCT02815709|10058513|FG004|COMPLETED|Overall Study|Completed Study|74
8995412|NCT02815709|10058509|FG000|NOT COMPLETED|Overall Study||7
8995413|NCT02815709|10058510|FG001|NOT COMPLETED|Overall Study||8
8995414|NCT02815709|10058511|FG002|NOT COMPLETED|Overall Study||7
8995415|NCT02815709|10058512|FG003|NOT COMPLETED|Overall Study||8
8995416|NCT02815709|10058513|FG004|NOT COMPLETED|Overall Study||10
8995417|NCT02815735|10058526|FG000|STARTED|First Intervention (4 Weeks)||36
8995418|NCT02815735|10058527|FG001|STARTED|First Intervention (4 Weeks)||38
8995419|NCT02815735|10058526|FG000|COMPLETED|First Intervention (4 Weeks)||34
8995420|NCT02815735|10058527|FG001|COMPLETED|First Intervention (4 Weeks)||37
8995421|NCT02815735|10058526|FG000|NOT COMPLETED|First Intervention (4 Weeks)||2
8995422|NCT02815735|10058527|FG001|NOT COMPLETED|First Intervention (4 Weeks)||1
8995423|NCT02815735|10058526|FG000|STARTED|Second Intervention (4 Weeks)||34
8995424|NCT02815735|10058527|FG001|STARTED|Second Intervention (4 Weeks)||37
8995425|NCT02815735|10058526|FG000|COMPLETED|Second Intervention (4 Weeks)||33
8995426|NCT02815735|10058527|FG001|COMPLETED|Second Intervention (4 Weeks)||37
8995427|NCT02815735|10058526|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||1
8995428|NCT02815735|10058527|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||0
8995429|NCT02815982|10058546|FG000|STARTED|Overall Study||27
8995430|NCT02815982|10058547|FG001|STARTED|Overall Study||26
8995431|NCT02815982|10058548|FG002|STARTED|Overall Study||27
8995432|NCT02815982|10058549|FG003|STARTED|Overall Study||26
8995433|NCT02815982|10058546|FG000|COMPLETED|Overall Study||27
8995434|NCT02815982|10058547|FG001|COMPLETED|Overall Study||26
8995435|NCT02815982|10058548|FG002|COMPLETED|Overall Study||27
8995436|NCT02815982|10058549|FG003|COMPLETED|Overall Study||26
8995437|NCT02815982|10058546|FG000|NOT COMPLETED|Overall Study||0
8995438|NCT02815982|10058547|FG001|NOT COMPLETED|Overall Study||0
8995439|NCT02815982|10058548|FG002|NOT COMPLETED|Overall Study||0
8995440|NCT02815982|10058549|FG003|NOT COMPLETED|Overall Study||0
8995441|NCT02816138|10058561|FG000|STARTED|Overall Study||15
8995442|NCT02816138|10058561|FG000|COMPLETED|Overall Study||14
8995443|NCT02816138|10058561|FG000|NOT COMPLETED|Overall Study||1
8995444|NCT02816346|10058570|FG000|STARTED|Overall Study||10
8995445|NCT02816346|10058571|FG001|STARTED|Overall Study||10
8995446|NCT02816346|10058572|FG002|STARTED|Overall Study||10
8995447|NCT02816346|10058573|FG003|STARTED|Overall Study||10
8995448|NCT02816346|10058574|FG004|STARTED|Overall Study||16
8995449|NCT02816346|10058570|FG000|COMPLETED|Overall Study||10
8995450|NCT02816346|10058571|FG001|COMPLETED|Overall Study||10
8995451|NCT02816346|10058572|FG002|COMPLETED|Overall Study||10
8995452|NCT02816346|10058573|FG003|COMPLETED|Overall Study||10
8995453|NCT02816346|10058574|FG004|COMPLETED|Overall Study||16
8995454|NCT02816346|10058570|FG000|NOT COMPLETED|Overall Study||0
8995455|NCT02816346|10058571|FG001|NOT COMPLETED|Overall Study||0
8995456|NCT02816346|10058572|FG002|NOT COMPLETED|Overall Study||0
8995457|NCT02816346|10058573|FG003|NOT COMPLETED|Overall Study||0
8995458|NCT02816346|10058574|FG004|NOT COMPLETED|Overall Study||0
8995459|NCT02816398|10058586|FG000|STARTED|Overall Study||26
8995460|NCT02816398|10058586|FG000|COMPLETED|Overall Study||12
8995461|NCT02816398|10058586|FG000|NOT COMPLETED|Overall Study||14
8995462|NCT02816710|10058593|FG000|STARTED|Overall Study||38
8995463|NCT02816710|10058594|FG001|STARTED|Overall Study||38
8995464|NCT02816710|10058595|FG002|STARTED|Overall Study||36
8995465|NCT02816710|10058593|FG000|COMPLETED|Overall Study||34
8995466|NCT02816710|10058594|FG001|COMPLETED|Overall Study||35
8995467|NCT02816710|10058595|FG002|COMPLETED|Overall Study||29
8995468|NCT02816710|10058593|FG000|NOT COMPLETED|Overall Study||4
8995469|NCT02816710|10058594|FG001|NOT COMPLETED|Overall Study||3
8995470|NCT02816710|10058595|FG002|NOT COMPLETED|Overall Study||7
8995471|NCT02816723|10058608|FG000|STARTED|Overall Study||30
8995472|NCT02816723|10058609|FG001|STARTED|Overall Study||30
8995473|NCT02816723|10058608|FG000|COMPLETED|Overall Study||24
8995474|NCT02816723|10058609|FG001|COMPLETED|Overall Study||28
8995475|NCT02816723|10058608|FG000|NOT COMPLETED|Overall Study||6
8995476|NCT02816723|10058609|FG001|NOT COMPLETED|Overall Study||2
8995477|NCT02817087|10058617|FG000|STARTED|Overall Study||16
8995478|NCT02817087|10058618|FG001|STARTED|Overall Study||15
8995479|NCT02817087|10058617|FG000|COMPLETED|Overall Study|1 pt was withdrawn early d/t concurrent disease. One pt. withdrew ICF d/t transportation concerns|14
8995480|NCT02817087|10058618|FG001|COMPLETED|Overall Study||15
8995481|NCT02817087|10058617|FG000|NOT COMPLETED|Overall Study||2
8995482|NCT02817087|10058618|FG001|NOT COMPLETED|Overall Study||0
8995483|NCT02817516|10058628|FG000|STARTED|Overall Study||6
8995484|NCT02817516|10058629|FG001|STARTED|Overall Study||6
8995485|NCT02817516|10058630|FG002|STARTED|Overall Study||6
8995486|NCT02817516|10058631|FG003|STARTED|Overall Study||6
8995487|NCT02817516|10058628|FG000|COMPLETED|Overall Study||6
8995488|NCT02817516|10058629|FG001|COMPLETED|Overall Study||6
8995489|NCT02817516|10058630|FG002|COMPLETED|Overall Study||5
8995490|NCT02817516|10058631|FG003|COMPLETED|Overall Study||6
8995491|NCT02817516|10058628|FG000|NOT COMPLETED|Overall Study||0
8995492|NCT02817516|10058629|FG001|NOT COMPLETED|Overall Study||0
8995493|NCT02817516|10058630|FG002|NOT COMPLETED|Overall Study||1
8995494|NCT02817516|10058631|FG003|NOT COMPLETED|Overall Study||0
8995495|NCT02817555|10058646|FG000|STARTED|Overall Study||24
8995496|NCT02817555|10058647|FG001|STARTED|Overall Study||26
8995497|NCT02817555|10058646|FG000|COMPLETED|Overall Study||21
8633722|NCT00552617|9673877|FG006|NOT COMPLETED|Overall Study||0
8633723|NCT00552617|9673878|FG007|NOT COMPLETED|Overall Study||0
8633724|NCT00552617|9673879|FG008|NOT COMPLETED|Overall Study||2
8995498|NCT02817555|10058647|FG001|COMPLETED|Overall Study||21
8995499|NCT02817555|10058646|FG000|NOT COMPLETED|Overall Study||3
8995500|NCT02817555|10058647|FG001|NOT COMPLETED|Overall Study||5
8995501|NCT02817594|10058653|FG000|STARTED|Overall Study||51
8995502|NCT02817594|10058653|FG000|Received Treatment|Overall Study||50
8995503|NCT02817594|10058653|FG000|COMPLETED|Overall Study||48
8995504|NCT02817594|10058653|FG000|NOT COMPLETED|Overall Study||3
8995505|NCT02817763|10058663|FG000|STARTED|Overall Study||20
8995506|NCT02817763|10058664|FG001|STARTED|Overall Study||20
8633725|NCT00552617|9673880|FG009|NOT COMPLETED|Overall Study||1
8633726|NCT00552669|9673904|FG000|STARTED|Overall Study|patients|100
8633727|NCT00552669|9673905|FG001|STARTED|Overall Study|patients|100
8995507|NCT02817763|10058663|FG000|COMPLETED|Overall Study||20
8995508|NCT02817763|10058664|FG001|COMPLETED|Overall Study||20
8995509|NCT02817763|10058663|FG000|NOT COMPLETED|Overall Study||0
8995510|NCT02817763|10058664|FG001|NOT COMPLETED|Overall Study||0
8995511|NCT02817776|10058670|FG000|STARTED|Overall Study|33 excluded prior to procedure. 348 had study catheter inserted (Safety Population)|381
8995512|NCT02817776|10058670|FG000|COMPLETED|Overall Study||293
8995513|NCT02817776|10058670|FG000|NOT COMPLETED|Overall Study||88
8995514|NCT02817828|10058674|FG000|STARTED|Overall Study||1553
8995515|NCT02817828|10058674|FG000|COMPLETED|Overall Study||1218
8995516|NCT02817828|10058674|FG000|NOT COMPLETED|Overall Study||335
8995517|NCT02817841|10058683|FG000|STARTED|Overall Study||1864
8995518|NCT02817841|10058683|FG000|COMPLETED|Overall Study||1016
8995519|NCT02817841|10058683|FG000|NOT COMPLETED|Overall Study||848
8995520|NCT02817906|10058693|FG000|STARTED|Overall Study|87 patients were randomized but only 86 received study drug. The number completed and discontinued is based on the 86 patients that received study drug.|86
8995521|NCT02817906|10058694|FG001|STARTED|Overall Study|90 patients were randomized but only 89 received study drug. The number completed and discontinued is based on 89 patients that received study drug.|89
8995522|NCT02817906|10058693|FG000|COMPLETED|Overall Study||70
8995523|NCT02817906|10058694|FG001|COMPLETED|Overall Study||84
8995524|NCT02817906|10058693|FG000|NOT COMPLETED|Overall Study||16
8995525|NCT02817906|10058694|FG001|NOT COMPLETED|Overall Study||5
8995526|NCT02818036|10058702|FG000|STARTED|Overall Study||42
8995527|NCT02818036|10058703|FG001|STARTED|Overall Study||40
8995528|NCT02818036|10058702|FG000|COMPLETED|Overall Study||40
8995529|NCT02818036|10058703|FG001|COMPLETED|Overall Study||40
8995530|NCT02818036|10058702|FG000|NOT COMPLETED|Overall Study||2
8995531|NCT02818036|10058703|FG001|NOT COMPLETED|Overall Study||0
8995532|NCT02818114|10058709|FG000|STARTED|Overall Study||8
8995533|NCT02818114|10058709|FG000|COMPLETED|Overall Study||7
8995534|NCT02818114|10058709|FG000|NOT COMPLETED|Overall Study||1
8995535|NCT02818244|10058718|FG000|STARTED|Overall Study||25
8995536|NCT02818244|10058719|FG001|STARTED|Overall Study||25
8995537|NCT02818244|10058720|FG002|STARTED|Overall Study||25
8995538|NCT02818244|10058721|FG003|STARTED|Overall Study||25
8995539|NCT02818244|10058718|FG000|COMPLETED|Overall Study||25
8995540|NCT02818244|10058719|FG001|COMPLETED|Overall Study||25
8995541|NCT02818244|10058720|FG002|COMPLETED|Overall Study||25
8995542|NCT02818244|10058721|FG003|COMPLETED|Overall Study||25
8995543|NCT02818244|10058718|FG000|NOT COMPLETED|Overall Study||0
8995544|NCT02818244|10058719|FG001|NOT COMPLETED|Overall Study||0
8995545|NCT02818244|10058720|FG002|NOT COMPLETED|Overall Study||0
8995546|NCT02818244|10058721|FG003|NOT COMPLETED|Overall Study||0
8995547|NCT02818569|10058731|FG000|STARTED|Overall Study||8
8995548|NCT02818569|10058732|FG001|STARTED|Overall Study||7
8995549|NCT02818569|10058731|FG000|COMPLETED|Overall Study||8
8995550|NCT02818569|10058732|FG001|COMPLETED|Overall Study||7
8995551|NCT02818569|10058731|FG000|NOT COMPLETED|Overall Study||0
8995552|NCT02818569|10058732|FG001|NOT COMPLETED|Overall Study||0
8995553|NCT02818777|10058741|FG000|STARTED|Overall Study|The number of baseline participants was 13.|13
8995554|NCT02818777|10058741|FG000|COMPLETED|Overall Study||10
8995555|NCT02818777|10058741|FG000|NOT COMPLETED|Overall Study||3
8995556|NCT02818998|10058754|FG000|STARTED|Overall Study||155
8995557|NCT02818998|10058755|FG001|STARTED|Overall Study||154
8995558|NCT02818998|10058756|FG002|STARTED|Overall Study||154
8995559|NCT02818998|10058754|FG000|Completed Week 52 Visit|Overall Study||144
8995560|NCT02818998|10058755|FG001|Completed Week 52 Visit|Overall Study||146
8995561|NCT02818998|10058756|FG002|Completed Week 52 Visit|Overall Study||140
8995562|NCT02818998|10058754|FG000|COMPLETED|Overall Study||137
8995563|NCT02818998|10058755|FG001|COMPLETED|Overall Study||138
8995564|NCT02818998|10058756|FG002|COMPLETED|Overall Study||136
8995565|NCT02818998|10058754|FG000|NOT COMPLETED|Overall Study||18
8995566|NCT02818998|10058755|FG001|NOT COMPLETED|Overall Study||16
8995567|NCT02818998|10058756|FG002|NOT COMPLETED|Overall Study||18
8995568|NCT02819011|10058766|FG000|STARTED|Overall Study||22
8995569|NCT02819011|10058767|FG001|STARTED|Overall Study||22
8995570|NCT02819011|10058766|FG000|COMPLETED|Overall Study||15
8995571|NCT02819011|10058767|FG001|COMPLETED|Overall Study||17
8995572|NCT02819011|10058766|FG000|NOT COMPLETED|Overall Study||7
8995573|NCT02819011|10058767|FG001|NOT COMPLETED|Overall Study||5
8995574|NCT02819284|10058776|FG000|STARTED|Overall Study||452
8995575|NCT02819284|10058777|FG001|STARTED|Overall Study||453
8995576|NCT02819284|10058776|FG000|COMPLETED|Overall Study||447
8995577|NCT02819284|10058777|FG001|COMPLETED|Overall Study||448
8995578|NCT02819284|10058776|FG000|NOT COMPLETED|Overall Study||5
8995579|NCT02819284|10058777|FG001|NOT COMPLETED|Overall Study||5
8995580|NCT02819297|10058785|FG000|STARTED|Overall Study||299
8995581|NCT02819297|10058786|FG001|STARTED|Overall Study||304
8995582|NCT02819297|10058785|FG000|COMPLETED|Overall Study||239
8995583|NCT02819297|10058786|FG001|COMPLETED|Overall Study||252
8995584|NCT02819297|10058785|FG000|NOT COMPLETED|Overall Study||60
8995585|NCT02819297|10058786|FG001|NOT COMPLETED|Overall Study||52
8995586|NCT02819310|10058792|FG000|STARTED|Overall Study||330
8995587|NCT02819310|10058792|FG000|COMPLETED|Overall Study||221
8995588|NCT02819310|10058792|FG000|NOT COMPLETED|Overall Study||109
8995589|NCT02819323|10058799|FG000|STARTED|Overall Study||31
8995590|NCT02819323|10058800|FG001|STARTED|Overall Study||28
8995591|NCT02819323|10058801|FG002|STARTED|Overall Study||32
8995592|NCT02819323|10058799|FG000|COMPLETED|Overall Study||26
8995593|NCT02819323|10058800|FG001|COMPLETED|Overall Study||26
8995594|NCT02819323|10058801|FG002|COMPLETED|Overall Study||31
8995595|NCT02819323|10058799|FG000|NOT COMPLETED|Overall Study||5
8995596|NCT02819323|10058800|FG001|NOT COMPLETED|Overall Study||2
8995597|NCT02819323|10058801|FG002|NOT COMPLETED|Overall Study||1
8995598|NCT02819557|10058809|FG000|STARTED|Overall Study||14
8995599|NCT02819557|10058809|FG000|Safety Population|Overall Study||14
8995600|NCT02819557|10058809|FG000|Pharmacokinetics (PK) Population|Overall Study||14
8995601|NCT02819557|10058809|FG000|Evaluable Population|Overall Study||14
8995602|NCT02819557|10058809|FG000|COMPLETED|Overall Study||14
8995603|NCT02819557|10058809|FG000|NOT COMPLETED|Overall Study||0
8633728|NCT00552669|9673904|FG000|COMPLETED|Overall Study|All patients were followed for 18.3 +/- 7 months.|97
8633729|NCT00552669|9673905|FG001|COMPLETED|Overall Study|All patients were followed for 18.3 +/- 7 months.|93
8633730|NCT00552669|9673904|FG000|NOT COMPLETED|Overall Study||3
8633731|NCT00552669|9673905|FG001|NOT COMPLETED|Overall Study||7
8633732|NCT00552695|9673913|FG000|STARTED|Overall Study|August 2007|22
8633733|NCT00552695|9673914|FG001|STARTED|Overall Study|August 2007|23
8633734|NCT00552695|9673913|FG000|COMPLETED|Overall Study|September 2007|22
8633735|NCT00552695|9673914|FG001|COMPLETED|Overall Study|September 2007|23
8633736|NCT00552695|9673913|FG000|NOT COMPLETED|Overall Study||0
8633737|NCT00552695|9673914|FG001|NOT COMPLETED|Overall Study||0
8995604|NCT02819726|10058816|FG000|STARTED|Part A (All Participants)||98
8995605|NCT02819726|10058817|FG001|STARTED|Part A (All Participants)||98
8995606|NCT02819726|10058818|FG002|STARTED|Part A (All Participants)||98
8995607|NCT02819726|10058819|FG003|STARTED|Part A (All Participants)||0
8995608|NCT02819726|10058816|FG000|COMPLETED|Part A (All Participants)||92
8995609|NCT02819726|10058817|FG001|COMPLETED|Part A (All Participants)||88
8995610|NCT02819726|10058818|FG002|COMPLETED|Part A (All Participants)||87
8995611|NCT02819726|10058819|FG003|COMPLETED|Part A (All Participants)||0
8995612|NCT02819726|10058816|FG000|NOT COMPLETED|Part A (All Participants)||6
8995613|NCT02819726|10058817|FG001|NOT COMPLETED|Part A (All Participants)||10
8995614|NCT02819726|10058818|FG002|NOT COMPLETED|Part A (All Participants)||11
8995615|NCT02819726|10058819|FG003|NOT COMPLETED|Part A (All Participants)||0
8995616|NCT02819726|10058816|FG000|STARTED|Part B (All Participants)|19 participants who completed Part A were not eligible for Part B|73
8995617|NCT02819726|10058817|FG001|STARTED|Part B (All Participants)|18 participants completing Part A were not eligible for Part B|70
8995618|NCT02819726|10058818|FG002|STARTED|Part B (All Participants)|5 participants completing Part A were ineligible for Part B.|39
8995619|NCT02819726|10058819|FG003|STARTED|Part B (All Participants)|5 participants completing Part A were ineligible for Part B.|38
8995620|NCT02819726|10058816|FG000|COMPLETED|Part B (All Participants)||70
8995621|NCT02819726|10058817|FG001|COMPLETED|Part B (All Participants)||68
8995622|NCT02819726|10058818|FG002|COMPLETED|Part B (All Participants)||35
8995623|NCT02819726|10058819|FG003|COMPLETED|Part B (All Participants)||36
8995624|NCT02819726|10058816|FG000|NOT COMPLETED|Part B (All Participants)||3
8995625|NCT02819726|10058817|FG001|NOT COMPLETED|Part B (All Participants)||2
8995626|NCT02819726|10058818|FG002|NOT COMPLETED|Part B (All Participants)||4
8995627|NCT02819726|10058819|FG003|NOT COMPLETED|Part B (All Participants)||2
8995628|NCT02819973|10058830|FG000|STARTED|Overall Study||114
8995629|NCT02819973|10058831|FG001|STARTED|Overall Study||114
8995630|NCT02819973|10058832|FG002|STARTED|Overall Study||115
8995631|NCT02819973|10058830|FG000|COMPLETED|Overall Study|2 withdrawn by request, 4 determined after randomization to be not eligible|108
8995632|NCT02819973|10058831|FG001|COMPLETED|Overall Study|3 determined after randomization to be not eligible|111
8995633|NCT02819973|10058832|FG002|COMPLETED|Overall Study|2 withdrawn by request, 2 determined after randomization to be not eligible|111
8995634|NCT02819973|10058830|FG000|NOT COMPLETED|Overall Study||6
8995635|NCT02819973|10058831|FG001|NOT COMPLETED|Overall Study||3
8995636|NCT02819973|10058832|FG002|NOT COMPLETED|Overall Study||4
8995637|NCT02820038|10058850|FG000|STARTED|Overall Study||78
8995638|NCT02820038|10058851|FG001|STARTED|Overall Study||77
8995639|NCT02820038|10058852|FG002|STARTED|Overall Study||65
8995640|NCT02820038|10058853|FG003|STARTED|Overall Study||66
8995641|NCT02820038|10058850|FG000|COMPLETED|Overall Study||68
8995642|NCT02820038|10058851|FG001|COMPLETED|Overall Study||52
8995643|NCT02820038|10058852|FG002|COMPLETED|Overall Study||60
8995644|NCT02820038|10058853|FG003|COMPLETED|Overall Study||44
8995645|NCT02820038|10058850|FG000|NOT COMPLETED|Overall Study||10
8995646|NCT02820038|10058851|FG001|NOT COMPLETED|Overall Study||25
8995647|NCT02820038|10058852|FG002|NOT COMPLETED|Overall Study||5
8995648|NCT02820038|10058853|FG003|NOT COMPLETED|Overall Study||22
8995649|NCT02820181|10058866|FG000|STARTED|Overall Study||30
8995650|NCT02820181|10058867|FG001|STARTED|Overall Study||30
8995651|NCT02820181|10058866|FG000|COMPLETED|Overall Study||30
8995652|NCT02820181|10058867|FG001|COMPLETED|Overall Study||30
8995653|NCT02820181|10058866|FG000|NOT COMPLETED|Overall Study||0
8995654|NCT02820181|10058867|FG001|NOT COMPLETED|Overall Study||0
8995655|NCT02820298|10058875|FG000|STARTED|Overall Study||13
8995656|NCT02820298|10058876|FG001|STARTED|Overall Study||12
8995657|NCT02820298|10058875|FG000|COMPLETED|Overall Study||12
8995658|NCT02820298|10058876|FG001|COMPLETED|Overall Study||10
8995659|NCT02820298|10058875|FG000|NOT COMPLETED|Overall Study||1
8995660|NCT02820298|10058876|FG001|NOT COMPLETED|Overall Study||2
8995661|NCT02820324|10058893|FG000|STARTED|Overall Study||78
8995662|NCT02820324|10058894|FG001|STARTED|Overall Study||82
8995663|NCT02820324|10058895|FG002|STARTED|Overall Study||82
8995664|NCT02820324|10058896|FG003|STARTED|Overall Study||82
8995665|NCT02820324|10058897|FG004|STARTED|Overall Study||83
8995666|NCT02820324|10058893|FG000|Treated With Study Medication|Overall Study||77
8995667|NCT02820324|10058894|FG001|Treated With Study Medication|Overall Study||80
8995668|NCT02820324|10058895|FG002|Treated With Study Medication|Overall Study||80
8995669|NCT02820324|10058896|FG003|Treated With Study Medication|Overall Study||81
8995670|NCT02820324|10058897|FG004|Treated With Study Medication|Overall Study||83
8995671|NCT02820324|10058893|FG000|COMPLETED|Overall Study||76
8995672|NCT02820324|10058894|FG001|COMPLETED|Overall Study||79
8995673|NCT02820324|10058895|FG002|COMPLETED|Overall Study||79
8995674|NCT02820324|10058896|FG003|COMPLETED|Overall Study||79
8995675|NCT02820324|10058897|FG004|COMPLETED|Overall Study||80
8995676|NCT02820324|10058893|FG000|NOT COMPLETED|Overall Study||2
8995677|NCT02820324|10058894|FG001|NOT COMPLETED|Overall Study||3
8995678|NCT02820324|10058895|FG002|NOT COMPLETED|Overall Study||3
8995679|NCT02820324|10058896|FG003|NOT COMPLETED|Overall Study||3
8995680|NCT02820324|10058897|FG004|NOT COMPLETED|Overall Study||3
8995681|NCT02820597|10058909|FG000|STARTED|Overall Study||27
8995682|NCT02820597|10058909|FG000|1-day Post Treatment|Overall Study||27
8995683|NCT02820597|10058909|FG000|7-day Post Treatment|Overall Study||27
8995684|NCT02820597|10058909|FG000|30-day Post Treatment|Overall Study||27
8995685|NCT02820597|10058909|FG000|90-day Post Treatment|Overall Study|2 participants missed the 90-day visit, 1 participant was lost to follow-up.|24
9039225|NCT03335254|10100134|FG012|COMPLETED|Period 3, Day 26-30||0
8995686|NCT02820597|10058909|FG000|180-day Post Treatment|Overall Study|3 participants missed the 180-day visit, 3 participants were lost to follow-up.|21
8995687|NCT02820597|10058909|FG000|COMPLETED|Overall Study|12 participants were lost to follow-up.|15
8995688|NCT02820597|10058909|FG000|NOT COMPLETED|Overall Study||12
8995689|NCT02820844|10058915|FG000|STARTED|Double-blinded (Up to 48 Weeks)||124
8995690|NCT02820844|10058916|FG001|STARTED|Double-blinded (Up to 48 Weeks)||124
8995691|NCT02820844|10058917|FG002|STARTED|Double-blinded (Up to 48 Weeks)||0
8995692|NCT02820844|10058918|FG003|STARTED|Double-blinded (Up to 48 Weeks)||0
8995693|NCT02820844|10058919|FG004|STARTED|Double-blinded (Up to 48 Weeks)||0
8995694|NCT02820844|10058920|FG005|STARTED|Double-blinded (Up to 48 Weeks)||0
8995695|NCT02820844|10058915|FG000|COMPLETED|Double-blinded (Up to 48 Weeks)||119
8995696|NCT02820844|10058916|FG001|COMPLETED|Double-blinded (Up to 48 Weeks)||115
8995697|NCT02820844|10058917|FG002|COMPLETED|Double-blinded (Up to 48 Weeks)||0
8995698|NCT02820844|10058918|FG003|COMPLETED|Double-blinded (Up to 48 Weeks)||0
8995699|NCT02820844|10058919|FG004|COMPLETED|Double-blinded (Up to 48 Weeks)||0
8995700|NCT02820844|10058920|FG005|COMPLETED|Double-blinded (Up to 48 Weeks)||0
8995701|NCT02820844|10058915|FG000|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||5
8995702|NCT02820844|10058916|FG001|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||9
8995703|NCT02820844|10058917|FG002|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
8995704|NCT02820844|10058918|FG003|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
8995705|NCT02820844|10058919|FG004|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
8995706|NCT02820844|10058920|FG005|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
8995707|NCT02820844|10058915|FG000|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||0
8995708|NCT02820844|10058916|FG001|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||0
8995709|NCT02820844|10058917|FG002|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||108
8995710|NCT02820844|10058918|FG003|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||88
8995711|NCT02820844|10058919|FG004|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||0
8995712|NCT02820844|10058920|FG005|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||0
8995713|NCT02820844|10058915|FG000|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
8995714|NCT02820844|10058916|FG001|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
8995715|NCT02820844|10058917|FG002|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||99
8995716|NCT02820844|10058918|FG003|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||84
8995717|NCT02820844|10058919|FG004|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
8995718|NCT02820844|10058920|FG005|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
8995719|NCT02820844|10058915|FG000|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
8995720|NCT02820844|10058916|FG001|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
8995721|NCT02820844|10058917|FG002|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||9
8995722|NCT02820844|10058918|FG003|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||4
8995723|NCT02820844|10058919|FG004|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
8995724|NCT02820844|10058920|FG005|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
8572208|NCT00112723|9604278|FG002|Patients Evaluable for Toxicity|Overall Study||12
8572209|NCT00112723|9604276|FG000|COMPLETED|Overall Study||11
8572210|NCT00112723|9604277|FG001|COMPLETED|Overall Study||12
8572211|NCT00112723|9604278|FG002|COMPLETED|Overall Study||12
8572212|NCT00112723|9604276|FG000|NOT COMPLETED|Overall Study||2
8572213|NCT00112723|9604277|FG001|NOT COMPLETED|Overall Study||7
8572214|NCT00112723|9604278|FG002|NOT COMPLETED|Overall Study||2
8572215|NCT00112736|9604302|FG000|STARTED|Overall Study||22
8572216|NCT00112736|9604303|FG001|STARTED|Overall Study||47
8572217|NCT00112736|9604302|FG000|COMPLETED|Overall Study|12 of Phase I pts treated at MTD and hence considered part of the Phase II analysis|21
8572218|NCT00112736|9604303|FG001|COMPLETED|Overall Study|12 additional pts from phase 1 study were used in analysis for Phase 2 as they were treated at MTD|47
8572219|NCT00112736|9604302|FG000|NOT COMPLETED|Overall Study||1
8572220|NCT00112736|9604303|FG001|NOT COMPLETED|Overall Study||0
8572221|NCT00112827|9604320|FG000|STARTED|Overall Study||3
8572222|NCT00112827|9604321|FG001|STARTED|Overall Study||4
8572223|NCT00112827|9604322|FG002|STARTED|Overall Study||4
8572224|NCT00112827|9604323|FG003|STARTED|Overall Study||36
8572225|NCT00112827|9604324|FG004|STARTED|Overall Study||7
8572226|NCT00112827|9604320|FG000|COMPLETED|Overall Study||3
8572227|NCT00112827|9604321|FG001|COMPLETED|Overall Study||4
8572228|NCT00112827|9604322|FG002|COMPLETED|Overall Study||4
8572229|NCT00112827|9604323|FG003|COMPLETED|Overall Study||36
8572230|NCT00112827|9604324|FG004|COMPLETED|Overall Study||7
8572231|NCT00112827|9604320|FG000|NOT COMPLETED|Overall Study||0
8572232|NCT00112827|9604321|FG001|NOT COMPLETED|Overall Study||0
8572233|NCT00112827|9604322|FG002|NOT COMPLETED|Overall Study||0
8572234|NCT00112827|9604323|FG003|NOT COMPLETED|Overall Study||0
8572235|NCT00112827|9604324|FG004|NOT COMPLETED|Overall Study||0
8572236|NCT00112866|9604339|FG000|STARTED|Overall Study||15
8572237|NCT00112866|9604340|FG001|STARTED|Overall Study||15
8572238|NCT00112866|9604339|FG000|COMPLETED|Overall Study||13
8572239|NCT00112866|9604340|FG001|COMPLETED|Overall Study||13
8572240|NCT00112866|9604339|FG000|NOT COMPLETED|Overall Study||2
8572241|NCT00112866|9604340|FG001|NOT COMPLETED|Overall Study||2
8633738|NCT00552760|9673922|FG000|STARTED|Overall Study||42
8633739|NCT00552760|9673923|FG001|STARTED|Overall Study||41
8995725|NCT02820844|10058915|FG000|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||0
8995726|NCT02820844|10058916|FG001|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||0
8995727|NCT02820844|10058917|FG002|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||0
8995728|NCT02820844|10058918|FG003|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||0
8995729|NCT02820844|10058919|FG004|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||56
8995730|NCT02820844|10058920|FG005|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||43
8995731|NCT02820844|10058915|FG000|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
8995732|NCT02820844|10058916|FG001|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
8995733|NCT02820844|10058917|FG002|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
8995734|NCT02820844|10058918|FG003|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
8995735|NCT02820844|10058919|FG004|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||54
8995736|NCT02820844|10058920|FG005|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||42
8995737|NCT02820844|10058915|FG000|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
8995738|NCT02820844|10058916|FG001|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
8995739|NCT02820844|10058917|FG002|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
8995740|NCT02820844|10058918|FG003|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
8995741|NCT02820844|10058919|FG004|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||2
8995742|NCT02820844|10058920|FG005|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||1
8995743|NCT02820870|10058939|FG000|STARTED|Before Intervention|These are a separate set of visits from the intervention period and have different visit numbers.|15
8995744|NCT02820870|10058940|FG001|STARTED|Before Intervention|These are a separate set of visits from the intervention period and have different visit numbers.|28
8995745|NCT02820870|10058939|FG000|COMPLETED|Before Intervention||15
8995746|NCT02820870|10058940|FG001|COMPLETED|Before Intervention||28
8995747|NCT02820870|10058939|FG000|NOT COMPLETED|Before Intervention||0
8995748|NCT02820870|10058940|FG001|NOT COMPLETED|Before Intervention||0
8633740|NCT00552760|9673922|FG000|COMPLETED|Overall Study||16
8633741|NCT00552760|9673923|FG001|COMPLETED|Overall Study||8
8633742|NCT00552760|9673922|FG000|NOT COMPLETED|Overall Study||26
8633743|NCT00552760|9673923|FG001|NOT COMPLETED|Overall Study||33
8633744|NCT00552786|9673931|FG000|STARTED|First Intervention||25
8633745|NCT00552786|9673932|FG001|STARTED|First Intervention||28
8633746|NCT00552786|9673931|FG000|Medication and Hearing Evaluation|First Intervention||25
8633747|NCT00552786|9673932|FG001|Medication and Hearing Evaluation|First Intervention||28
8995749|NCT02820870|10058939|FG000|STARTED|Intervention||15
8995750|NCT02820870|10058940|FG001|STARTED|Intervention||28
8995751|NCT02820870|10058939|FG000|COMPLETED|Intervention||15
8995752|NCT02820870|10058940|FG001|COMPLETED|Intervention||28
8995753|NCT02820870|10058939|FG000|NOT COMPLETED|Intervention||0
8995754|NCT02820870|10058940|FG001|NOT COMPLETED|Intervention||0
8995755|NCT02820870|10058939|FG000|STARTED|Post Intervention|These are a separate set of visits from the intervention period and have different visit numbers.|15
8995756|NCT02820870|10058940|FG001|STARTED|Post Intervention|These are a separate set of visits from the intervention period and have different visit numbers.|28
8995757|NCT02820870|10058939|FG000|COMPLETED|Post Intervention||15
8995758|NCT02820870|10058940|FG001|COMPLETED|Post Intervention||28
8995759|NCT02820870|10058939|FG000|NOT COMPLETED|Post Intervention||0
8995760|NCT02820870|10058940|FG001|NOT COMPLETED|Post Intervention||0
8995761|NCT02821104|10058948|FG000|STARTED|Overall Study||77
8995762|NCT02821104|10058948|FG000|COMPLETED|Overall Study||77
8995763|NCT02821104|10058948|FG000|NOT COMPLETED|Overall Study||0
8995764|NCT02821338|10058955|FG000|STARTED|Overall Study||15
8995765|NCT02821338|10058956|FG001|STARTED|Overall Study||15
8995766|NCT02821338|10058955|FG000|COMPLETED|Overall Study|12 out of 15 subjects assigned to Sequence 1 completed the study, and provided two data points.|12
8995767|NCT02821338|10058956|FG001|COMPLETED|Overall Study|13 out of 15 subjects assigned to Sequence 2 completed the study, and provided two data points.|13
8995768|NCT02821338|10058955|FG000|NOT COMPLETED|Overall Study||3
8995769|NCT02821338|10058956|FG001|NOT COMPLETED|Overall Study||2
8995770|NCT02821403|10058964|FG000|STARTED|"First Intervention (1 Month)"||40
8995771|NCT02821403|10058965|FG001|STARTED|"First Intervention (1 Month)"||40
8995772|NCT02821403|10058964|FG000|Used Clear Lens|"First Intervention (1 Month)"||13
8995773|NCT02821403|10058965|FG001|Used Clear Lens|"First Intervention (1 Month)"||13
8995774|NCT02821403|10058964|FG000|Used Yellow Tinted Lens|"First Intervention (1 Month)"||13
8995775|NCT02821403|10058965|FG001|Used Yellow Tinted Lens|"First Intervention (1 Month)"||14
8995776|NCT02821403|10058964|FG000|Used Blue-filtering Coated Lens|"First Intervention (1 Month)"||14
8995777|NCT02821403|10058965|FG001|Used Blue-filtering Coated Lens|"First Intervention (1 Month)"||13
8995778|NCT02821403|10058964|FG000|COMPLETED|"First Intervention (1 Month)"||40
8995779|NCT02821403|10058965|FG001|COMPLETED|"First Intervention (1 Month)"||40
8995780|NCT02821403|10058964|FG000|NOT COMPLETED|"First Intervention (1 Month)"||0
8995781|NCT02821403|10058965|FG001|NOT COMPLETED|"First Intervention (1 Month)"||0
8995782|NCT02821403|10058964|FG000|STARTED|"Second Intervention (1 Month)"||40
8995783|NCT02821403|10058965|FG001|STARTED|"Second Intervention (1 Month)"||40
8995784|NCT02821403|10058964|FG000|Used Clear Lens|"Second Intervention (1 Month)"||13
8995785|NCT02821403|10058965|FG001|Used Clear Lens|"Second Intervention (1 Month)"||14
8995786|NCT02821403|10058964|FG000|Used Yellow Tinted Lens|"Second Intervention (1 Month)"||14
8633748|NCT00552786|9673931|FG000|COMPLETED|First Intervention||25
8633749|NCT00552786|9673932|FG001|COMPLETED|First Intervention||28
8633750|NCT00552786|9673931|FG000|NOT COMPLETED|First Intervention||0
8995787|NCT02821403|10058965|FG001|Used Yellow Tinted Lens|"Second Intervention (1 Month)"||13
8995788|NCT02821403|10058964|FG000|Used Blue-filtering Coated Lens|"Second Intervention (1 Month)"||13
8995789|NCT02821403|10058965|FG001|Used Blue-filtering Coated Lens|"Second Intervention (1 Month)"||13
8995790|NCT02821403|10058964|FG000|COMPLETED|"Second Intervention (1 Month)"||40
8995791|NCT02821403|10058965|FG001|COMPLETED|"Second Intervention (1 Month)"||40
8995792|NCT02821403|10058964|FG000|NOT COMPLETED|"Second Intervention (1 Month)"||0
8995793|NCT02821403|10058965|FG001|NOT COMPLETED|"Second Intervention (1 Month)"||0
8995794|NCT02821403|10058964|FG000|STARTED|"Third Intervention (1 Month)"||40
8995795|NCT02821403|10058965|FG001|STARTED|"Third Intervention (1 Month)"||40
8995796|NCT02821403|10058964|FG000|Used Clear Lens|"Third Intervention (1 Month)"||14
8995797|NCT02821403|10058965|FG001|Used Clear Lens|"Third Intervention (1 Month)"||13
8995798|NCT02821403|10058964|FG000|Used Yellow Tinted Lens|"Third Intervention (1 Month)"||13
8995799|NCT02821403|10058965|FG001|Used Yellow Tinted Lens|"Third Intervention (1 Month)"||13
8995800|NCT02821403|10058964|FG000|Used Blue-filtering Coated Lens|"Third Intervention (1 Month)"||13
8995801|NCT02821403|10058965|FG001|Used Blue-filtering Coated Lens|"Third Intervention (1 Month)"||14
8995802|NCT02821403|10058964|FG000|COMPLETED|"Third Intervention (1 Month)"||40
8995803|NCT02821403|10058965|FG001|COMPLETED|"Third Intervention (1 Month)"||40
8995804|NCT02821403|10058964|FG000|NOT COMPLETED|"Third Intervention (1 Month)"||0
8995805|NCT02821403|10058965|FG001|NOT COMPLETED|"Third Intervention (1 Month)"||0
8995806|NCT02821416|10058979|FG000|STARTED|Overall Study||23
8995807|NCT02821416|10058980|FG001|STARTED|Overall Study||23
8995808|NCT02821416|10058979|FG000|COMPLETED|Overall Study||20
8995809|NCT02821416|10058980|FG001|COMPLETED|Overall Study||22
8995810|NCT02821416|10058979|FG000|NOT COMPLETED|Overall Study||3
8995811|NCT02821416|10058980|FG001|NOT COMPLETED|Overall Study||1
8995812|NCT02821455|10058987|FG000|STARTED|Overall Study||19
8995813|NCT02821455|10058987|FG000|COMPLETED|Overall Study||19
8995814|NCT02821455|10058987|FG000|NOT COMPLETED|Overall Study||0
8995815|NCT02821715|10058991|FG000|STARTED|Overall Study||8
8995816|NCT02821715|10058992|FG001|STARTED|Overall Study||8
8995817|NCT02821715|10058993|FG002|STARTED|Overall Study||8
8995818|NCT02821715|10058994|FG003|STARTED|Overall Study||9
8995819|NCT02821715|10058995|FG004|STARTED|Overall Study||6
8995820|NCT02821715|10058996|FG005|STARTED|Overall Study||9
8995821|NCT02821715|10058991|FG000|COMPLETED|Overall Study||7
8995822|NCT02821715|10058992|FG001|COMPLETED|Overall Study||8
8995823|NCT02821715|10058993|FG002|COMPLETED|Overall Study||8
8995824|NCT02821715|10058994|FG003|COMPLETED|Overall Study||9
8995825|NCT02821715|10058995|FG004|COMPLETED|Overall Study||6
8995826|NCT02821715|10058996|FG005|COMPLETED|Overall Study||9
8995827|NCT02821715|10058991|FG000|NOT COMPLETED|Overall Study||1
8995828|NCT02821715|10058992|FG001|NOT COMPLETED|Overall Study||0
8995829|NCT02821715|10058993|FG002|NOT COMPLETED|Overall Study||0
8995830|NCT02821715|10058994|FG003|NOT COMPLETED|Overall Study||0
8995831|NCT02821715|10058995|FG004|NOT COMPLETED|Overall Study||0
8995832|NCT02821715|10058996|FG005|NOT COMPLETED|Overall Study||0
8995833|NCT02821819|10059004|FG000|STARTED|Overall Study||15
8995834|NCT02821819|10059004|FG000|COMPLETED|Overall Study||14
8995835|NCT02821819|10059004|FG000|NOT COMPLETED|Overall Study||1
8995836|NCT02821910|10059014|FG000|STARTED|Overall Study||7
8995837|NCT02821910|10059015|FG001|STARTED|Overall Study||8
8995838|NCT02821910|10059016|FG002|STARTED|Overall Study||10
8995839|NCT02821910|10059017|FG003|STARTED|Overall Study||10
8995840|NCT02821910|10059018|FG004|STARTED|Overall Study||7
8995841|NCT02821910|10059019|FG005|STARTED|Overall Study||8
8995842|NCT02821910|10059014|FG000|COMPLETED|Overall Study||6
8995843|NCT02821910|10059015|FG001|COMPLETED|Overall Study||8
8995844|NCT02821910|10059016|FG002|COMPLETED|Overall Study||8
8995845|NCT02821910|10059017|FG003|COMPLETED|Overall Study||10
8995846|NCT02821910|10059018|FG004|COMPLETED|Overall Study||7
8995847|NCT02821910|10059019|FG005|COMPLETED|Overall Study||7
8995848|NCT02821910|10059014|FG000|NOT COMPLETED|Overall Study||1
8995849|NCT02821910|10059015|FG001|NOT COMPLETED|Overall Study||0
8995850|NCT02821910|10059016|FG002|NOT COMPLETED|Overall Study||2
8995851|NCT02821910|10059017|FG003|NOT COMPLETED|Overall Study||0
8995852|NCT02821910|10059018|FG004|NOT COMPLETED|Overall Study||0
8995853|NCT02821910|10059019|FG005|NOT COMPLETED|Overall Study||1
8995854|NCT02821962|10059035|FG000|STARTED|Overall Study||19
8995855|NCT02821962|10059036|FG001|STARTED|Overall Study||21
8995856|NCT02821962|10059035|FG000|COMPLETED|Overall Study||17
8995857|NCT02821962|10059036|FG001|COMPLETED|Overall Study||21
8995858|NCT02821962|10059035|FG000|NOT COMPLETED|Overall Study||2
8995859|NCT02821962|10059036|FG001|NOT COMPLETED|Overall Study||0
8995860|NCT02822222|10059044|FG000|STARTED|Overall Study||16
8995861|NCT02822222|10059045|FG001|STARTED|Overall Study||6
8995862|NCT02822222|10059044|FG000|COMPLETED|Overall Study||15
8995863|NCT02822222|10059045|FG001|COMPLETED|Overall Study||6
8995864|NCT02822222|10059044|FG000|NOT COMPLETED|Overall Study||1
8995865|NCT02822222|10059045|FG001|NOT COMPLETED|Overall Study||0
8995866|NCT02822235|10059053|FG000|STARTED|Cross-sectional Phase (Day 1)||264
8995867|NCT02822235|10059054|FG001|STARTED|Cross-sectional Phase (Day 1)||143
8995868|NCT02822235|10059053|FG000|COMPLETED|Cross-sectional Phase (Day 1)||118
8995869|NCT02822235|10059054|FG001|COMPLETED|Cross-sectional Phase (Day 1)||36
8995870|NCT02822235|10059053|FG000|NOT COMPLETED|Cross-sectional Phase (Day 1)||146
8995871|NCT02822235|10059054|FG001|NOT COMPLETED|Cross-sectional Phase (Day 1)||107
8995872|NCT02822235|10059053|FG000|STARTED|Prospective Phase (Day 1 up to Month 12)||118
8995873|NCT02822235|10059054|FG001|STARTED|Prospective Phase (Day 1 up to Month 12)||36
8995874|NCT02822235|10059053|FG000|COMPLETED|Prospective Phase (Day 1 up to Month 12)||107
8995875|NCT02822235|10059054|FG001|COMPLETED|Prospective Phase (Day 1 up to Month 12)||34
8995876|NCT02822235|10059053|FG000|NOT COMPLETED|Prospective Phase (Day 1 up to Month 12)||11
8995877|NCT02822235|10059054|FG001|NOT COMPLETED|Prospective Phase (Day 1 up to Month 12)||2
8995878|NCT02822287|10059067|FG000|STARTED|Overall Study||57
8995879|NCT02822287|10059067|FG000|COMPLETED|Overall Study||57
8995880|NCT02822287|10059067|FG000|NOT COMPLETED|Overall Study||0
8995881|NCT02822599|10059073|FG000|STARTED|Overall Study|First subject enrolled on 6-1-17.|15
8995882|NCT02822599|10059074|FG001|STARTED|Overall Study|First subject enrolled on 6-1-17.|15
8995883|NCT02822599|10059073|FG000|COMPLETED|Overall Study||15
8995884|NCT02822599|10059074|FG001|COMPLETED|Overall Study||15
8995885|NCT02822599|10059073|FG000|NOT COMPLETED|Overall Study||0
8995886|NCT02822599|10059074|FG001|NOT COMPLETED|Overall Study||0
8995887|NCT02822612|10059085|FG000|STARTED|Overall Study||14
8995888|NCT02822612|10059086|FG001|STARTED|Overall Study||13
8995889|NCT02822612|10059087|FG002|STARTED|Overall Study||14
8995890|NCT02822612|10059088|FG003|STARTED|Overall Study||4
8995891|NCT02822612|10059089|FG004|STARTED|Overall Study||15
8995892|NCT02822612|10059085|FG000|COMPLETED|Overall Study||14
8995893|NCT02822612|10059086|FG001|COMPLETED|Overall Study||13
8995894|NCT02822612|10059087|FG002|COMPLETED|Overall Study||14
8995895|NCT02822612|10059088|FG003|COMPLETED|Overall Study||4
8995896|NCT02822612|10059089|FG004|COMPLETED|Overall Study||15
8995897|NCT02822612|10059085|FG000|NOT COMPLETED|Overall Study||0
8995898|NCT02822612|10059086|FG001|NOT COMPLETED|Overall Study||0
8995899|NCT02822612|10059087|FG002|NOT COMPLETED|Overall Study||0
8995900|NCT02822612|10059088|FG003|NOT COMPLETED|Overall Study||0
8995901|NCT02822612|10059089|FG004|NOT COMPLETED|Overall Study||0
8995902|NCT02822794|10059105|FG000|STARTED|Overall Study||57
8995903|NCT02822794|10059106|FG001|STARTED|Overall Study||60
8995904|NCT02822794|10059105|FG000|COMPLETED|Overall Study||56
8995905|NCT02822794|10059106|FG001|COMPLETED|Overall Study||60
8995906|NCT02822794|10059105|FG000|NOT COMPLETED|Overall Study||1
8995907|NCT02822794|10059106|FG001|NOT COMPLETED|Overall Study||0
8995908|NCT02822885|10059119|FG000|STARTED|Overall Study||70
8995909|NCT02822885|10059119|FG000|COMPLETED|Overall Study||70
8995910|NCT02822885|10059119|FG000|NOT COMPLETED|Overall Study||0
8995911|NCT02822950|10059123|FG000|STARTED|Overall Study||10
8995912|NCT02822950|10059123|FG000|COMPLETED|Overall Study||10
8995913|NCT02822950|10059123|FG000|NOT COMPLETED|Overall Study||0
8995914|NCT02823080|10059129|FG000|STARTED|Overall Study||24
8995915|NCT02823080|10059130|FG001|STARTED|Overall Study||24
8995916|NCT02823080|10059129|FG000|COMPLETED|Overall Study||24
8995917|NCT02823080|10059130|FG001|COMPLETED|Overall Study||24
8995918|NCT02823080|10059129|FG000|NOT COMPLETED|Overall Study||0
8995919|NCT02823080|10059130|FG001|NOT COMPLETED|Overall Study||0
8995920|NCT02823431|10059139|FG000|STARTED|Overall Study||11
8995921|NCT02823431|10059140|FG001|STARTED|Overall Study||12
8995922|NCT02823431|10059139|FG000|COMPLETED|Overall Study||11
8995923|NCT02823431|10059140|FG001|COMPLETED|Overall Study||12
8995924|NCT02823431|10059139|FG000|NOT COMPLETED|Overall Study||0
8995925|NCT02823431|10059140|FG001|NOT COMPLETED|Overall Study||0
8995926|NCT02823470|10059148|FG000|STARTED|Overall Study||9
8995927|NCT02823470|10059149|FG001|STARTED|Overall Study||15
8995928|NCT02823470|10059148|FG000|COMPLETED|Overall Study||0
8995929|NCT02823470|10059149|FG001|COMPLETED|Overall Study||0
8995930|NCT02823470|10059148|FG000|NOT COMPLETED|Overall Study||9
8995931|NCT02823470|10059149|FG001|NOT COMPLETED|Overall Study||15
8995932|NCT02823600|10059158|FG000|STARTED|Overall Study||68
8995933|NCT02823600|10059158|FG000|COMPLETED|Overall Study||68
8995934|NCT02823600|10059158|FG000|NOT COMPLETED|Overall Study||0
8995935|NCT02823964|10059164|FG000|STARTED|Overall Study||25
8995936|NCT02823964|10059164|FG000|COMPLETED|Overall Study||20
8995937|NCT02823964|10059164|FG000|NOT COMPLETED|Overall Study||5
8995938|NCT02824224|10059170|FG000|STARTED|Overall Study||19
8995939|NCT02824224|10059171|FG001|STARTED|Overall Study||18
8995940|NCT02824224|10059170|FG000|COMPLETED|Overall Study||17
8995941|NCT02824224|10059171|FG001|COMPLETED|Overall Study||17
8995942|NCT02824224|10059170|FG000|NOT COMPLETED|Overall Study||2
8995943|NCT02824224|10059171|FG001|NOT COMPLETED|Overall Study||1
8995944|NCT02824432|10059179|FG000|STARTED|Overall Study||18
8995945|NCT02824432|10059180|FG001|STARTED|Overall Study||19
8995946|NCT02824432|10059179|FG000|COMPLETED|Overall Study||17
8995947|NCT02824432|10059180|FG001|COMPLETED|Overall Study||19
8995948|NCT02824432|10059179|FG000|NOT COMPLETED|Overall Study||1
8995949|NCT02824432|10059180|FG001|NOT COMPLETED|Overall Study||0
8995950|NCT02824562|10059188|FG000|STARTED|Overall Study||22
8995951|NCT02824562|10059189|FG001|STARTED|Overall Study||22
8995952|NCT02824562|10059188|FG000|COMPLETED|Overall Study||19
8995953|NCT02824562|10059189|FG001|COMPLETED|Overall Study||17
8995954|NCT02824562|10059188|FG000|NOT COMPLETED|Overall Study||3
8995955|NCT02824562|10059189|FG001|NOT COMPLETED|Overall Study||5
8995956|NCT02824913|10059197|FG000|STARTED|First Intervention (1 Day)||1
8995957|NCT02824913|10059198|FG001|STARTED|First Intervention (1 Day)||0
8995958|NCT02824913|10059197|FG000|COMPLETED|First Intervention (1 Day)|Only one subject was enrolled in the study and received both study treatments.|1
8995959|NCT02824913|10059198|FG001|COMPLETED|First Intervention (1 Day)||0
8995960|NCT02824913|10059197|FG000|NOT COMPLETED|First Intervention (1 Day)||0
8995961|NCT02824913|10059198|FG001|NOT COMPLETED|First Intervention (1 Day)||0
8995962|NCT02824913|10059197|FG000|STARTED|Washout (7-14 Days)||1
8995963|NCT02824913|10059198|FG001|STARTED|Washout (7-14 Days)||0
8995964|NCT02824913|10059197|FG000|COMPLETED|Washout (7-14 Days)||1
8995965|NCT02824913|10059198|FG001|COMPLETED|Washout (7-14 Days)||0
8995966|NCT02824913|10059197|FG000|NOT COMPLETED|Washout (7-14 Days)||0
8995967|NCT02824913|10059198|FG001|NOT COMPLETED|Washout (7-14 Days)||0
8995968|NCT02824913|10059197|FG000|STARTED|Second Intervention (1 Day)||1
8995969|NCT02824913|10059198|FG001|STARTED|Second Intervention (1 Day)||0
8995970|NCT02824913|10059197|FG000|COMPLETED|Second Intervention (1 Day)||1
8995971|NCT02824913|10059198|FG001|COMPLETED|Second Intervention (1 Day)||0
8995972|NCT02824913|10059197|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
8995973|NCT02824913|10059198|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
8995974|NCT02825212|10059206|FG000|STARTED|Overall Study||10
8995975|NCT02825212|10059206|FG000|COMPLETED|Overall Study||10
8995976|NCT02825212|10059206|FG000|NOT COMPLETED|Overall Study||0
8995977|NCT02825251|10059212|FG000|STARTED|Overall Study||236
8995978|NCT02825251|10059213|FG001|STARTED|Overall Study||236
8995979|NCT02825251|10059212|FG000|COMPLETED|Overall Study||233
8995980|NCT02825251|10059213|FG001|COMPLETED|Overall Study||230
8995981|NCT02825251|10059212|FG000|NOT COMPLETED|Overall Study||3
8995982|NCT02825251|10059213|FG001|NOT COMPLETED|Overall Study||6
8995983|NCT02825420|10059221|FG000|STARTED|Overall Study||131
8995984|NCT02825420|10059222|FG001|STARTED|Overall Study||89
8995985|NCT02825420|10059221|FG000|COMPLETED|Overall Study||88
8995986|NCT02825420|10059222|FG001|COMPLETED|Overall Study||72
8995987|NCT02825420|10059221|FG000|NOT COMPLETED|Overall Study||43
8995988|NCT02825420|10059222|FG001|NOT COMPLETED|Overall Study||17
8995989|NCT02825550|10059233|FG000|STARTED|Overall Study||13
8995990|NCT02825550|10059233|FG000|COMPLETED|Overall Study||12
8995991|NCT02825550|10059233|FG000|NOT COMPLETED|Overall Study||1
8995992|NCT02825680|10059241|FG000|STARTED|Overall Study||82
8995993|NCT02825680|10059242|FG001|STARTED|Overall Study||55
8995994|NCT02825680|10059241|FG000|COMPLETED|Overall Study||82
8995995|NCT02825680|10059242|FG001|COMPLETED|Overall Study||39
8995996|NCT02825680|10059241|FG000|NOT COMPLETED|Overall Study||0
8995997|NCT02825680|10059242|FG001|NOT COMPLETED|Overall Study||16
8995998|NCT02825849|10059250|FG000|STARTED|Overall Study||22
8995999|NCT02825849|10059251|FG001|STARTED|Overall Study||5
8996000|NCT02825849|10059250|FG000|COMPLETED|Overall Study||22
8996001|NCT02825849|10059251|FG001|COMPLETED|Overall Study||5
8996002|NCT02825849|10059250|FG000|NOT COMPLETED|Overall Study||0
8996003|NCT02825849|10059251|FG001|NOT COMPLETED|Overall Study||0
9039226|NCT03335254|10100135|FG013|COMPLETED|Period 3, Day 26-30||0
9039227|NCT03335254|10100136|FG014|COMPLETED|Period 3, Day 26-30||0
9039228|NCT03335254|10100137|FG015|COMPLETED|Period 3, Day 26-30||0
9039229|NCT03335254|10100138|FG016|COMPLETED|Period 3, Day 26-30||0
9039230|NCT03335254|10100139|FG017|COMPLETED|Period 3, Day 26-30||0
9039231|NCT03335254|10100140|FG018|COMPLETED|Period 3, Day 26-30||0
9039232|NCT03335254|10100141|FG019|COMPLETED|Period 3, Day 26-30||0
9039233|NCT03335254|10100122|FG000|NOT COMPLETED|Period 3, Day 26-30||0
9039234|NCT03335254|10100123|FG001|NOT COMPLETED|Period 3, Day 26-30||0
9039235|NCT03335254|10100124|FG002|NOT COMPLETED|Period 3, Day 26-30||0
9039236|NCT03335254|10100125|FG003|NOT COMPLETED|Period 3, Day 26-30||0
9039237|NCT03335254|10100126|FG004|NOT COMPLETED|Period 3, Day 26-30||0
9039238|NCT03335254|10100127|FG005|NOT COMPLETED|Period 3, Day 26-30||0
9039239|NCT03335254|10100128|FG006|NOT COMPLETED|Period 3, Day 26-30||0
9039240|NCT03335254|10100129|FG007|NOT COMPLETED|Period 3, Day 26-30||0
9039241|NCT03335254|10100130|FG008|NOT COMPLETED|Period 3, Day 26-30||0
9039242|NCT03335254|10100131|FG009|NOT COMPLETED|Period 3, Day 26-30||0
9039243|NCT03335254|10100132|FG010|NOT COMPLETED|Period 3, Day 26-30||0
9039244|NCT03335254|10100133|FG011|NOT COMPLETED|Period 3, Day 26-30||0
9039245|NCT03335254|10100134|FG012|NOT COMPLETED|Period 3, Day 26-30||0
9039246|NCT03335254|10100135|FG013|NOT COMPLETED|Period 3, Day 26-30||0
9039247|NCT03335254|10100136|FG014|NOT COMPLETED|Period 3, Day 26-30||0
9039248|NCT03335254|10100137|FG015|NOT COMPLETED|Period 3, Day 26-30||0
9039249|NCT03335254|10100138|FG016|NOT COMPLETED|Period 3, Day 26-30||0
9039250|NCT03335254|10100139|FG017|NOT COMPLETED|Period 3, Day 26-30||0
9039251|NCT03335254|10100140|FG018|NOT COMPLETED|Period 3, Day 26-30||0
9039252|NCT03335254|10100141|FG019|NOT COMPLETED|Period 3, Day 26-30||0
9039253|NCT03335566|10100172|FG000|STARTED|Overall Study||218
9039254|NCT03335566|10100173|FG001|STARTED|Overall Study||206
9039255|NCT03335566|10100172|FG000|COMPLETED|Overall Study||214
9039256|NCT03335566|10100173|FG001|COMPLETED|Overall Study||203
9039257|NCT03335566|10100172|FG000|NOT COMPLETED|Overall Study||4
9039258|NCT03335566|10100173|FG001|NOT COMPLETED|Overall Study||3
9039259|NCT03335761|10100182|FG000|STARTED|Overall Study||19
9039260|NCT03335761|10100183|FG001|STARTED|Overall Study||14
9039261|NCT03335761|10100184|FG002|STARTED|Overall Study||15
9039262|NCT03335761|10100182|FG000|Implanted With a Neurostimulator Device|Overall Study||18
9039263|NCT03335761|10100183|FG001|Implanted With a Neurostimulator Device|Overall Study||14
9039264|NCT03335761|10100184|FG002|Implanted With a Neurostimulator Device|Overall Study||14
9039265|NCT03335761|10100182|FG000|COMPLETED|Overall Study||17
9039266|NCT03335761|10100183|FG001|COMPLETED|Overall Study||13
9039267|NCT03335761|10100184|FG002|COMPLETED|Overall Study||13
9039268|NCT03335761|10100182|FG000|NOT COMPLETED|Overall Study||2
9039269|NCT03335761|10100183|FG001|NOT COMPLETED|Overall Study||1
9039270|NCT03335761|10100184|FG002|NOT COMPLETED|Overall Study||2
9039271|NCT03335800|10100192|FG000|STARTED|Overall Study||419927
9039272|NCT03335800|10100192|FG000|Received Irregular Pulse Notification|Overall Study||2161
9039273|NCT03335800|10100192|FG000|Attended First Study Visit|Overall Study||945
9039274|NCT03335800|10100192|FG000|ECG Patch Shipped|Overall Study||658
9039275|NCT03335800|10100192|FG000|ECG Patch Returned for Analysis|Overall Study||450
9039276|NCT03335800|10100192|FG000|Attended Second Study Visit|Overall Study||396
9039277|NCT03335800|10100192|FG000|COMPLETED|Overall Study||396
9039278|NCT03335800|10100192|FG000|NOT COMPLETED|Overall Study||419531
9039279|NCT03336450|10100196|FG000|STARTED|Overall Study||3
8996004|NCT02825966|10059257|FG000|STARTED|Overall Study||35
8996005|NCT02825966|10059257|FG000|COMPLETED|Overall Study||35
8996006|NCT02825966|10059257|FG000|NOT COMPLETED|Overall Study||0
8996007|NCT02825992|10059264|FG000|STARTED|Overall Study|The procedure was terminated for clinical reasons in 2 patients, therefore only 127 were treated.|129
8996008|NCT02825992|10059264|FG000|COMPLETED|Overall Study||121
8996009|NCT02825992|10059264|FG000|NOT COMPLETED|Overall Study||8
8996010|NCT02826421|10059278|FG000|STARTED|Overall Study||22
8996011|NCT02826421|10059279|FG001|STARTED|Overall Study||29
8996012|NCT02826421|10059280|FG002|STARTED|Overall Study||28
8996013|NCT02826421|10059281|FG003|STARTED|Overall Study||30
8996014|NCT02826421|10059278|FG000|Treated|Overall Study||19
8996015|NCT02826421|10059279|FG001|Treated|Overall Study||26
8996016|NCT02826421|10059280|FG002|Treated|Overall Study||26
8996017|NCT02826421|10059281|FG003|Treated|Overall Study||28
8996018|NCT02826421|10059278|FG000|COMPLETED|Overall Study||19
8996019|NCT02826421|10059279|FG001|COMPLETED|Overall Study||26
8996020|NCT02826421|10059280|FG002|COMPLETED|Overall Study||26
8996021|NCT02826421|10059281|FG003|COMPLETED|Overall Study||28
8996022|NCT02826421|10059278|FG000|NOT COMPLETED|Overall Study||3
8996023|NCT02826421|10059279|FG001|NOT COMPLETED|Overall Study||3
8996024|NCT02826421|10059280|FG002|NOT COMPLETED|Overall Study||2
8996025|NCT02826421|10059281|FG003|NOT COMPLETED|Overall Study||2
8996026|NCT02826603|10059294|FG000|STARTED|Overall Study||550
8996027|NCT02826603|10059295|FG001|STARTED|Overall Study||552
8996028|NCT02826603|10059294|FG000|COMPLETED|Overall Study||489
8996029|NCT02826603|10059295|FG001|COMPLETED|Overall Study||488
8996030|NCT02826603|10059294|FG000|NOT COMPLETED|Overall Study||61
8996031|NCT02826603|10059295|FG001|NOT COMPLETED|Overall Study||64
8996032|NCT02826694|10059304|FG000|STARTED|Overall Study||61
8996033|NCT02826694|10059305|FG001|STARTED|Overall Study||45
8996034|NCT02826694|10059304|FG000|Decision Group|Overall Study||41
8996035|NCT02826694|10059305|FG001|Decision Group|Overall Study||30
8996036|NCT02826694|10059304|FG000|Control Group|Overall Study||20
8996037|NCT02826694|10059305|FG001|Control Group|Overall Study||15
8996038|NCT02826694|10059304|FG000|COMPLETED|Overall Study||61
8996039|NCT02826694|10059305|FG001|COMPLETED|Overall Study||45
8996040|NCT02826694|10059304|FG000|NOT COMPLETED|Overall Study||0
8996041|NCT02826694|10059305|FG001|NOT COMPLETED|Overall Study||0
8996042|NCT02826798|10059318|FG000|STARTED|Overall Study||25
8996043|NCT02826798|10059319|FG001|STARTED|Overall Study||26
8996044|NCT02826798|10059320|FG002|STARTED|Overall Study||26
8996045|NCT02826798|10059321|FG003|STARTED|Overall Study||25
8996046|NCT02826798|10059322|FG004|STARTED|Overall Study||26
8996047|NCT02826798|10059318|FG000|COMPLETED|Overall Study||25
8996048|NCT02826798|10059319|FG001|COMPLETED|Overall Study||25
8996049|NCT02826798|10059320|FG002|COMPLETED|Overall Study||26
8996050|NCT02826798|10059321|FG003|COMPLETED|Overall Study||24
8996051|NCT02826798|10059322|FG004|COMPLETED|Overall Study||26
8996052|NCT02826798|10059318|FG000|NOT COMPLETED|Overall Study||0
8996053|NCT02826798|10059319|FG001|NOT COMPLETED|Overall Study||1
8996054|NCT02826798|10059320|FG002|NOT COMPLETED|Overall Study||0
8996055|NCT02826798|10059321|FG003|NOT COMPLETED|Overall Study||1
8996056|NCT02826798|10059322|FG004|NOT COMPLETED|Overall Study||0
8996057|NCT02827500|10059336|FG000|STARTED|Overall Study||52
8996058|NCT02827500|10059337|FG001|STARTED|Overall Study||52
8996059|NCT02827500|10059336|FG000|COMPLETED|Overall Study||33
8996060|NCT02827500|10059337|FG001|COMPLETED|Overall Study||45
8996061|NCT02827500|10059336|FG000|NOT COMPLETED|Overall Study||19
8996062|NCT02827500|10059337|FG001|NOT COMPLETED|Overall Study||7
8996063|NCT02827708|10059345|FG000|STARTED|Overall Study||163
8996064|NCT02827708|10059346|FG001|STARTED|Overall Study||161
8996065|NCT02827708|10059345|FG000|Full Analysis Set (FAS)|Overall Study||163
8996066|NCT02827708|10059346|FG001|Full Analysis Set (FAS)|Overall Study||161
8996067|NCT02827708|10059345|FG000|Safety Analysis Set (SAS)|Overall Study||163
8996068|NCT02827708|10059346|FG001|Safety Analysis Set (SAS)|Overall Study||161
8996069|NCT02827708|10059345|FG000|COMPLETED|Overall Study||158
8996070|NCT02827708|10059346|FG001|COMPLETED|Overall Study||156
8996071|NCT02827708|10059345|FG000|NOT COMPLETED|Overall Study||5
8996072|NCT02827708|10059346|FG001|NOT COMPLETED|Overall Study||5
8996073|NCT02828020|10059355|FG000|STARTED|Treatment Period||559
8996074|NCT02828020|10059356|FG001|STARTED|Treatment Period||556
8996075|NCT02828020|10059357|FG002|STARTED|Treatment Period||557
8996076|NCT02828020|10059355|FG000|Safety Population: Received Study Drug|Treatment Period||485
8996077|NCT02828020|10059356|FG001|Safety Population: Received Study Drug|Treatment Period||466
8996078|NCT02828020|10059357|FG002|Safety Population: Received Study Drug|Treatment Period||485
8996079|NCT02828020|10059355|FG000|COMPLETED|Treatment Period||479
8996080|NCT02828020|10059356|FG001|COMPLETED|Treatment Period||457
8996081|NCT02828020|10059357|FG002|COMPLETED|Treatment Period||479
8996082|NCT02828020|10059355|FG000|NOT COMPLETED|Treatment Period||80
8996083|NCT02828020|10059356|FG001|NOT COMPLETED|Treatment Period||99
8996084|NCT02828020|10059357|FG002|NOT COMPLETED|Treatment Period||78
8996085|NCT02828020|10059355|FG000|STARTED|Safety Follow-up Period|1 participant who did not complete the Treatment Period, was counted in the Safety Follow-up Period.|480
8996086|NCT02828020|10059356|FG001|STARTED|Safety Follow-up Period|1 participant who did not complete the Treatment Period, was counted in the Safety Follow-up Period.|458
8996087|NCT02828020|10059357|FG002|STARTED|Safety Follow-up Period|1 participant who did not complete the Treatment Period, was counted in the Safety Follow-up Period.|480
8996088|NCT02828020|10059355|FG000|COMPLETED|Safety Follow-up Period||460
8996089|NCT02828020|10059356|FG001|COMPLETED|Safety Follow-up Period||440
8996090|NCT02828020|10059357|FG002|COMPLETED|Safety Follow-up Period||461
8996091|NCT02828020|10059355|FG000|NOT COMPLETED|Safety Follow-up Period||20
8996092|NCT02828020|10059356|FG001|NOT COMPLETED|Safety Follow-up Period||18
8996093|NCT02828020|10059357|FG002|NOT COMPLETED|Safety Follow-up Period||19
8996094|NCT02828111|10059370|FG000|STARTED|Overall Study||6
8996095|NCT02828111|10059371|FG001|STARTED|Overall Study||6
8996096|NCT02828111|10059372|FG002|STARTED|Overall Study||6
8996097|NCT02828111|10059373|FG003|STARTED|Overall Study||6
8996098|NCT02828111|10059374|FG004|STARTED|Overall Study||12
8996099|NCT02828111|10059370|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
8996100|NCT02828111|10059371|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
8996101|NCT02828111|10059372|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
8996102|NCT02828111|10059373|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
8996103|NCT02828111|10059374|FG004|Received at Least 1 Dose of Study Drug|Overall Study||12
8996104|NCT02828111|10059370|FG000|COMPLETED|Overall Study||6
8996105|NCT02828111|10059371|FG001|COMPLETED|Overall Study||6
8996106|NCT02828111|10059372|FG002|COMPLETED|Overall Study||4
8996107|NCT02828111|10059373|FG003|COMPLETED|Overall Study||5
8996108|NCT02828111|10059374|FG004|COMPLETED|Overall Study||11
8996109|NCT02828111|10059370|FG000|NOT COMPLETED|Overall Study||0
8996110|NCT02828111|10059371|FG001|NOT COMPLETED|Overall Study||0
8996111|NCT02828111|10059372|FG002|NOT COMPLETED|Overall Study||2
8996112|NCT02828111|10059373|FG003|NOT COMPLETED|Overall Study||1
8996113|NCT02828111|10059374|FG004|NOT COMPLETED|Overall Study||1
8996114|NCT02828137|10059398|FG000|STARTED|Overall Study||41
8996115|NCT02828137|10059399|FG001|STARTED|Overall Study||41
8996116|NCT02828137|10059400|FG002|STARTED|Overall Study||41
8996117|NCT02828137|10059398|FG000|COMPLETED|Overall Study||41
8996118|NCT02828137|10059399|FG001|COMPLETED|Overall Study||41
8996119|NCT02828137|10059400|FG002|COMPLETED|Overall Study||41
8996120|NCT02828137|10059398|FG000|NOT COMPLETED|Overall Study||0
8996121|NCT02828137|10059399|FG001|NOT COMPLETED|Overall Study||0
8996122|NCT02828137|10059400|FG002|NOT COMPLETED|Overall Study||0
8996123|NCT02828241|10059410|FG000|STARTED|Overall Study||38
8996124|NCT02828241|10059411|FG001|STARTED|Overall Study||23
8996125|NCT02828241|10059410|FG000|COMPLETED|Overall Study||30
8996126|NCT02828241|10059411|FG001|COMPLETED|Overall Study||21
8996127|NCT02828241|10059410|FG000|NOT COMPLETED|Overall Study||8
8996128|NCT02828241|10059411|FG001|NOT COMPLETED|Overall Study||2
8996129|NCT02828267|10059422|FG000|STARTED|Overall Study||10
8996130|NCT02828267|10059423|FG001|STARTED|Overall Study||21
8996131|NCT02828267|10059424|FG002|STARTED|Overall Study||24
8996132|NCT02828267|10059425|FG003|STARTED|Overall Study||20
8996133|NCT02828267|10059422|FG000|COMPLETED|Overall Study||10
8996134|NCT02828267|10059423|FG001|COMPLETED|Overall Study||21
8996135|NCT02828267|10059424|FG002|COMPLETED|Overall Study||24
8996136|NCT02828267|10059425|FG003|COMPLETED|Overall Study||20
8996137|NCT02828267|10059422|FG000|NOT COMPLETED|Overall Study||0
8996138|NCT02828267|10059423|FG001|NOT COMPLETED|Overall Study||0
8996139|NCT02828267|10059424|FG002|NOT COMPLETED|Overall Study||0
8996140|NCT02828267|10059425|FG003|NOT COMPLETED|Overall Study||0
8996141|NCT02828358|10059439|FG000|STARTED|Overall Study||56
8996142|NCT02828358|10059440|FG001|STARTED|Overall Study||22
8996143|NCT02828358|10059439|FG000|COMPLETED|Overall Study||11
8996144|NCT02828358|10059440|FG001|COMPLETED|Overall Study||0
8996145|NCT02828358|10059439|FG000|NOT COMPLETED|Overall Study||45
8996146|NCT02828358|10059440|FG001|NOT COMPLETED|Overall Study||22
8996147|NCT02828436|10059445|FG000|STARTED|Period 1||0
8996148|NCT02828436|10059446|FG001|STARTED|Period 1||9
8996149|NCT02828436|10059445|FG000|COMPLETED|Period 1||0
8996150|NCT02828436|10059446|FG001|COMPLETED|Period 1||5
8996151|NCT02828436|10059445|FG000|NOT COMPLETED|Period 1||0
8996152|NCT02828436|10059446|FG001|NOT COMPLETED|Period 1||4
8996153|NCT02828436|10059445|FG000|STARTED|Period 2||9
8996154|NCT02828436|10059446|FG001|STARTED|Period 2||0
8996155|NCT02828436|10059445|FG000|COMPLETED|Period 2||1
8996156|NCT02828436|10059446|FG001|COMPLETED|Period 2||0
8996157|NCT02828436|10059445|FG000|NOT COMPLETED|Period 2||8
8996158|NCT02828436|10059446|FG001|NOT COMPLETED|Period 2||0
8996159|NCT02828644|10059454|FG000|STARTED|Overall Study||88
8996160|NCT02828644|10059455|FG001|STARTED|Overall Study||87
8996161|NCT02828644|10059454|FG000|COMPLETED|Overall Study||65
8996162|NCT02828644|10059455|FG001|COMPLETED|Overall Study||65
8996163|NCT02828644|10059454|FG000|NOT COMPLETED|Overall Study||23
8996164|NCT02828644|10059455|FG001|NOT COMPLETED|Overall Study||22
8996165|NCT02829034|10059464|FG000|STARTED|Overall Study||14
8996166|NCT02829034|10059465|FG001|STARTED|Overall Study||8
8996167|NCT02829034|10059464|FG000|COMPLETED|Overall Study||9
8996168|NCT02829034|10059465|FG001|COMPLETED|Overall Study||6
8996169|NCT02829034|10059464|FG000|NOT COMPLETED|Overall Study||5
8996170|NCT02829034|10059465|FG001|NOT COMPLETED|Overall Study||2
8996171|NCT02829138|10059473|FG000|STARTED|Overall Study||29
8996172|NCT02829138|10059474|FG001|STARTED|Overall Study||28
8996173|NCT02829138|10059473|FG000|COMPLETED|Overall Study||28
8996174|NCT02829138|10059474|FG001|COMPLETED|Overall Study||28
8996175|NCT02829138|10059473|FG000|NOT COMPLETED|Overall Study||1
8996176|NCT02829138|10059474|FG001|NOT COMPLETED|Overall Study||0
8996177|NCT02829294|10059480|FG000|STARTED|Overall Study||19
8996178|NCT02829294|10059480|FG000|COMPLETED|Overall Study||19
8996179|NCT02829294|10059480|FG000|NOT COMPLETED|Overall Study||0
8996180|NCT02829307|10059486|FG000|STARTED|Overall Study||8
8996181|NCT02829307|10059486|FG000|COMPLETED|Overall Study||8
8996182|NCT02829307|10059486|FG000|NOT COMPLETED|Overall Study||0
8996183|NCT02829320|10059490|FG000|STARTED|Overall Study||28
8996184|NCT02829320|10059490|FG000|COMPLETED|Overall Study||28
8996185|NCT02829320|10059490|FG000|NOT COMPLETED|Overall Study||0
8996186|NCT02829463|10059503|FG000|STARTED|Overall Study||59
8996187|NCT02829463|10059504|FG001|STARTED|Overall Study||62
8996188|NCT02829463|10059503|FG000|COMPLETED|Overall Study||59
8996189|NCT02829463|10059504|FG001|COMPLETED|Overall Study||62
8996190|NCT02829463|10059503|FG000|NOT COMPLETED|Overall Study||0
8996191|NCT02829463|10059504|FG001|NOT COMPLETED|Overall Study||0
8996192|NCT02829775|10059510|FG000|STARTED|Overall Study||9
8996193|NCT02829775|10059510|FG000|COMPLETED|Overall Study||4
8996194|NCT02829775|10059510|FG000|NOT COMPLETED|Overall Study||5
8996195|NCT02829944|10059517|FG000|STARTED|Overall Study||44
8996196|NCT02829944|10059518|FG001|STARTED|Overall Study||40
8996197|NCT02829944|10059517|FG000|COMPLETED|Overall Study||38
8996198|NCT02829944|10059518|FG001|COMPLETED|Overall Study||33
8996199|NCT02829944|10059517|FG000|NOT COMPLETED|Overall Study||6
8996200|NCT02829944|10059518|FG001|NOT COMPLETED|Overall Study||7
8996201|NCT02829983|10059526|FG000|STARTED|Overall Study||20
8996202|NCT02829983|10059527|FG001|STARTED|Overall Study||20
8996203|NCT02829983|10059526|FG000|COMPLETED|Overall Study||20
8996204|NCT02829983|10059527|FG001|COMPLETED|Overall Study||20
8996205|NCT02829983|10059526|FG000|NOT COMPLETED|Overall Study||0
8996206|NCT02829983|10059527|FG001|NOT COMPLETED|Overall Study||0
8996207|NCT02829996|10059538|FG000|STARTED|Overall Study||39
8996208|NCT02829996|10059539|FG001|STARTED|Overall Study||39
8996209|NCT02829996|10059540|FG002|STARTED|Overall Study||40
8996210|NCT02829996|10059541|FG003|STARTED|Overall Study||41
8996211|NCT02829996|10059542|FG004|STARTED|Overall Study||42
8996212|NCT02829996|10059538|FG000|COMPLETED|Overall Study||38
8996213|NCT02829996|10059539|FG001|COMPLETED|Overall Study||39
8879205|NCT01932437|9935986|FG003|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
8879206|NCT01932437|9935987|FG004|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
8879207|NCT01932437|9935988|FG005|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||6
8879208|NCT01932437|9935983|FG000|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||2
8879209|NCT01932437|9935984|FG001|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
8879210|NCT01932437|9935985|FG002|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
8879211|NCT01932437|9935986|FG003|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
8879212|NCT01932437|9935987|FG004|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
8879213|NCT01932437|9935988|FG005|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||5
8879214|NCT01932437|9935983|FG000|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
8879215|NCT01932437|9935984|FG001|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
8879216|NCT01932437|9935985|FG002|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
8879217|NCT01932437|9935986|FG003|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
8879218|NCT01932437|9935987|FG004|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
8879219|NCT01932437|9935988|FG005|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||1
8879220|NCT01932606|9936011|FG000|STARTED|Overall Study||14
8879221|NCT01932606|9936012|FG001|STARTED|Overall Study||14
8879222|NCT01932606|9936011|FG000|COMPLETED|Overall Study||14
8879223|NCT01932606|9936012|FG001|COMPLETED|Overall Study||14
8879224|NCT01932606|9936011|FG000|NOT COMPLETED|Overall Study||0
8879225|NCT01932606|9936012|FG001|NOT COMPLETED|Overall Study||0
8879226|NCT01932697|9936020|FG000|STARTED|Overall Study||38
8879227|NCT01932697|9936021|FG001|STARTED|Overall Study||43
8879228|NCT01932697|9936020|FG000|COMPLETED|Overall Study||36
8879229|NCT01932697|9936021|FG001|COMPLETED|Overall Study||43
8879230|NCT01932697|9936020|FG000|NOT COMPLETED|Overall Study||2
8879231|NCT01932697|9936021|FG001|NOT COMPLETED|Overall Study||0
8879232|NCT01932762|9936033|FG000|STARTED|Overall Study||30
8879233|NCT01932762|9936034|FG001|STARTED|Overall Study||30
8879234|NCT01932762|9936035|FG002|STARTED|Overall Study||19
8879235|NCT01932762|9936036|FG003|STARTED|Overall Study||19
8879236|NCT01932762|9936033|FG000|COMPLETED|Overall Study||24
8879237|NCT01932762|9936034|FG001|COMPLETED|Overall Study||28
8879238|NCT01932762|9936035|FG002|COMPLETED|Overall Study||19
8879239|NCT01932762|9936036|FG003|COMPLETED|Overall Study||18
8879240|NCT01932762|9936033|FG000|NOT COMPLETED|Overall Study||6
8879241|NCT01932762|9936034|FG001|NOT COMPLETED|Overall Study||2
8879242|NCT01932762|9936035|FG002|NOT COMPLETED|Overall Study||0
8879243|NCT01932762|9936036|FG003|NOT COMPLETED|Overall Study||1
8879244|NCT01932788|9936048|FG000|STARTED|Overall Study||173
8879245|NCT01932788|9936049|FG001|STARTED|Overall Study||169
8879246|NCT01932788|9936048|FG000|COMPLETED|Overall Study||135
8879247|NCT01932788|9936049|FG001|COMPLETED|Overall Study||118
8879248|NCT01932788|9936048|FG000|NOT COMPLETED|Overall Study||38
8879249|NCT01932788|9936049|FG001|NOT COMPLETED|Overall Study||51
8879250|NCT01932970|9936055|FG000|STARTED|Overall Study|Includes all participants who enrolled into the washout period.|158
8879251|NCT01932970|9936055|FG000|Received Treatment|Overall Study|Includes participants who completed the washout period and received etelcalcetide|148
8996214|NCT02829996|10059540|FG002|COMPLETED|Overall Study||40
8996215|NCT02829996|10059541|FG003|COMPLETED|Overall Study||41
8996216|NCT02829996|10059542|FG004|COMPLETED|Overall Study||42
8996217|NCT02829996|10059538|FG000|NOT COMPLETED|Overall Study||1
8996218|NCT02829996|10059539|FG001|NOT COMPLETED|Overall Study||0
8996219|NCT02829996|10059540|FG002|NOT COMPLETED|Overall Study||0
8996220|NCT02829996|10059541|FG003|NOT COMPLETED|Overall Study||0
8996221|NCT02829996|10059542|FG004|NOT COMPLETED|Overall Study||0
8996222|NCT02830074|10059556|FG000|STARTED|Overall Study||32
8996223|NCT02830074|10059557|FG001|STARTED|Overall Study||31
8996224|NCT02830074|10059556|FG000|COMPLETED|Overall Study||32
8996225|NCT02830074|10059557|FG001|COMPLETED|Overall Study||31
8996226|NCT02830074|10059556|FG000|NOT COMPLETED|Overall Study||0
8996227|NCT02830074|10059557|FG001|NOT COMPLETED|Overall Study||0
8996228|NCT02830087|10059570|FG000|STARTED|Overall Study||4
8996229|NCT02830087|10059571|FG001|STARTED|Overall Study||4
8996230|NCT02830087|10059572|FG002|STARTED|Overall Study||4
8996231|NCT02830087|10059573|FG003|STARTED|Overall Study||3
8996232|NCT02830087|10059574|FG004|STARTED|Overall Study||3
8996233|NCT02830087|10059575|FG005|STARTED|Overall Study||3
8996234|NCT02830087|10059570|FG000|COMPLETED|Overall Study||0
8996235|NCT02830087|10059571|FG001|COMPLETED|Overall Study||0
8996236|NCT02830087|10059572|FG002|COMPLETED|Overall Study||0
8996237|NCT02830087|10059573|FG003|COMPLETED|Overall Study||0
8996238|NCT02830087|10059574|FG004|COMPLETED|Overall Study||0
8996239|NCT02830087|10059575|FG005|COMPLETED|Overall Study||0
8996240|NCT02830087|10059570|FG000|NOT COMPLETED|Overall Study||4
8996241|NCT02830087|10059571|FG001|NOT COMPLETED|Overall Study||4
8996242|NCT02830087|10059572|FG002|NOT COMPLETED|Overall Study||4
8996243|NCT02830087|10059573|FG003|NOT COMPLETED|Overall Study||3
8996244|NCT02830087|10059574|FG004|NOT COMPLETED|Overall Study||3
8996245|NCT02830087|10059575|FG005|NOT COMPLETED|Overall Study||3
8996246|NCT02830438|10059589|FG000|STARTED|Overall Study||8
8996247|NCT02830438|10059589|FG000|COMPLETED|Overall Study||8
8996248|NCT02830438|10059589|FG000|NOT COMPLETED|Overall Study||0
8996249|NCT02830776|10059593|FG000|STARTED|Overall Study||15
8996250|NCT02830776|10059593|FG000|COMPLETED|Overall Study||14
8996251|NCT02830776|10059593|FG000|NOT COMPLETED|Overall Study||1
8996252|NCT02830880|10059598|FG000|STARTED|Overall Study||7
8996253|NCT02830880|10059598|FG000|Completed Visit After Cyle 1|Overall Study||7
8996254|NCT02830880|10059598|FG000|COMPLETED|Overall Study||4
8996255|NCT02830880|10059598|FG000|NOT COMPLETED|Overall Study||3
8996256|NCT02830893|10059604|FG000|STARTED|Overall Study||12
8996257|NCT02830893|10059605|FG001|STARTED|Overall Study||11
8996258|NCT02830893|10059604|FG000|COMPLETED|Overall Study||11
8996259|NCT02830893|10059605|FG001|COMPLETED|Overall Study||8
8996260|NCT02830893|10059604|FG000|NOT COMPLETED|Overall Study||1
8996261|NCT02830893|10059605|FG001|NOT COMPLETED|Overall Study||3
8996262|NCT02831257|10059611|FG000|STARTED|Overall Study||18
8996263|NCT02831257|10059611|FG000|COMPLETED|Overall Study||6
8996264|NCT02831257|10059611|FG000|NOT COMPLETED|Overall Study||12
8996265|NCT02831387|10059617|FG000|STARTED|Overall Study||23
8996266|NCT02831387|10059618|FG001|STARTED|Overall Study||24
8996267|NCT02831387|10059617|FG000|COMPLETED|Overall Study||22
8996268|NCT02831387|10059618|FG001|COMPLETED|Overall Study||22
8996269|NCT02831387|10059617|FG000|NOT COMPLETED|Overall Study||1
8996270|NCT02831387|10059618|FG001|NOT COMPLETED|Overall Study||2
8996271|NCT02831569|10059624|FG000|STARTED|Overall Study||80
8996272|NCT02831569|10059624|FG000|COMPLETED|Overall Study||80
8996273|NCT02831569|10059624|FG000|NOT COMPLETED|Overall Study||0
8996274|NCT02831660|10059628|FG000|STARTED|Overall Study||1
8996275|NCT02831660|10059628|FG000|COMPLETED|Overall Study||1
8996276|NCT02831660|10059628|FG000|NOT COMPLETED|Overall Study||0
8996277|NCT02831816|10059632|FG000|STARTED|Overall Study||640
8996278|NCT02831816|10059632|FG000|ZP|Overall Study||589
8996279|NCT02831816|10059632|FG000|CP|Overall Study||590
8633751|NCT00552786|9673932|FG001|NOT COMPLETED|First Intervention||0
8633752|NCT00552786|9673931|FG000|STARTED|Washout Period of 2 Weeks||25
8633753|NCT00552786|9673932|FG001|STARTED|Washout Period of 2 Weeks||28
8633754|NCT00552786|9673931|FG000|COMPLETED|Washout Period of 2 Weeks||25
8633755|NCT00552786|9673932|FG001|COMPLETED|Washout Period of 2 Weeks||28
8633756|NCT00552786|9673931|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
8633757|NCT00552786|9673932|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
8633758|NCT00552786|9673931|FG000|STARTED|Second Intervention||25
8633759|NCT00552786|9673932|FG001|STARTED|Second Intervention||28
8996280|NCT02831816|10059632|FG000|Vehicle|Overall Study||131
8996281|NCT02831816|10059632|FG000|COMPLETED|Overall Study||640
8996282|NCT02831816|10059632|FG000|NOT COMPLETED|Overall Study||0
8996283|NCT02831855|10059643|FG000|STARTED|Open Label Phase (24 Weeks)||694
8996284|NCT02831855|10059644|FG001|STARTED|Open Label Phase (24 Weeks)||0
8996285|NCT02831855|10059645|FG002|STARTED|Open Label Phase (24 Weeks)||0
8996286|NCT02831855|10059643|FG000|COMPLETED|Open Label Phase (24 Weeks)||623
8996287|NCT02831855|10059644|FG001|COMPLETED|Open Label Phase (24 Weeks)||0
8996288|NCT02831855|10059645|FG002|COMPLETED|Open Label Phase (24 Weeks)||0
8996289|NCT02831855|10059643|FG000|NOT COMPLETED|Open Label Phase (24 Weeks)||71
8633760|NCT00552786|9673931|FG000|COMPLETED|Second Intervention||25
8996290|NCT02831855|10059644|FG001|NOT COMPLETED|Open Label Phase (24 Weeks)||0
8996291|NCT02831855|10059645|FG002|NOT COMPLETED|Open Label Phase (24 Weeks)||0
8996292|NCT02831855|10059643|FG000|STARTED|Double Blind Phase (24 Weeks)||0
8996293|NCT02831855|10059644|FG001|STARTED|Double Blind Phase (24 Weeks)|Only eligible participants from open label phase, were randomized into double blind phase.|267
8996294|NCT02831855|10059645|FG002|STARTED|Double Blind Phase (24 Weeks)|Only eligible participants from open label phase, were randomized into double blind phase. .|266
8996295|NCT02831855|10059643|FG000|Treated|Double Blind Phase (24 Weeks)||0
8996296|NCT02831855|10059644|FG001|Treated|Double Blind Phase (24 Weeks)||264
8996297|NCT02831855|10059645|FG002|Treated|Double Blind Phase (24 Weeks)||266
8996298|NCT02831855|10059643|FG000|COMPLETED|Double Blind Phase (24 Weeks)||0
8996299|NCT02831855|10059644|FG001|COMPLETED|Double Blind Phase (24 Weeks)||238
8996300|NCT02831855|10059645|FG002|COMPLETED|Double Blind Phase (24 Weeks)||247
8996301|NCT02831855|10059643|FG000|NOT COMPLETED|Double Blind Phase (24 Weeks)||0
8996302|NCT02831855|10059644|FG001|NOT COMPLETED|Double Blind Phase (24 Weeks)||29
8996303|NCT02831855|10059645|FG002|NOT COMPLETED|Double Blind Phase (24 Weeks)||19
8996304|NCT02831998|10059655|FG000|STARTED|Overall Study||440
8996305|NCT02831998|10059655|FG000|ZP|Overall Study||400
8996306|NCT02831998|10059655|FG000|CP|Overall Study||400
8996307|NCT02831998|10059655|FG000|Vehicle|Overall Study||80
8996308|NCT02831998|10059655|FG000|COMPLETED|Overall Study||440
8996309|NCT02831998|10059655|FG000|NOT COMPLETED|Overall Study||0
8996310|NCT02832037|10059671|FG000|STARTED|Overall Study||85
8996311|NCT02832037|10059672|FG001|STARTED|Overall Study||84
8996312|NCT02832037|10059673|FG002|STARTED|Overall Study||85
8996313|NCT02832037|10059674|FG003|STARTED|Overall Study||85
8996314|NCT02832037|10059675|FG004|STARTED|Overall Study||170
8996315|NCT02832037|10059671|FG000|COMPLETED|Overall Study||66
8996316|NCT02832037|10059672|FG001|COMPLETED|Overall Study||72
8996317|NCT02832037|10059673|FG002|COMPLETED|Overall Study||77
8572242|NCT00112905|9604354|FG000|STARTED|Overall Study||27
8572243|NCT00112905|9604354|FG000|Eligible and Treated|Overall Study||22
8633761|NCT00552786|9673932|FG001|COMPLETED|Second Intervention||28
8633762|NCT00552786|9673931|FG000|NOT COMPLETED|Second Intervention||0
8633763|NCT00552786|9673932|FG001|NOT COMPLETED|Second Intervention||0
8725903|NCT01033487|9773160|FG003|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
8879252|NCT01932970|9936055|FG000|COMPLETED|Overall Study||140
8879253|NCT01932970|9936055|FG000|NOT COMPLETED|Overall Study||18
8879254|NCT01932996|9936061|FG000|STARTED|Overall Study||172
8879255|NCT01932996|9936062|FG001|STARTED|Overall Study||180
8879256|NCT01932996|9936061|FG000|COMPLETED|Overall Study||170
8879257|NCT01932996|9936062|FG001|COMPLETED|Overall Study||180
8879258|NCT01932996|9936061|FG000|NOT COMPLETED|Overall Study||2
8879259|NCT01932996|9936062|FG001|NOT COMPLETED|Overall Study||0
8879260|NCT01933048|9936070|FG000|STARTED|Overall Study||548
8879261|NCT01933048|9936071|FG001|STARTED|Overall Study||529
8879262|NCT01933048|9936070|FG000|COMPLETED|Overall Study||523
8879263|NCT01933048|9936071|FG001|COMPLETED|Overall Study||501
8879264|NCT01933048|9936070|FG000|NOT COMPLETED|Overall Study||25
8879265|NCT01933048|9936071|FG001|NOT COMPLETED|Overall Study||28
8879266|NCT01933113|9936080|FG000|STARTED|Overall Study||3
8879267|NCT01933113|9936080|FG000|COMPLETED|Overall Study||2
8879268|NCT01933113|9936080|FG000|NOT COMPLETED|Overall Study||1
8879269|NCT01933217|9936086|FG000|STARTED|Randomization (4 Weeks)||12
8879270|NCT01933217|9936087|FG001|STARTED|Randomization (4 Weeks)||14
8879271|NCT01933217|9936086|FG000|COMPLETED|Randomization (4 Weeks)||10
8879272|NCT01933217|9936087|FG001|COMPLETED|Randomization (4 Weeks)||10
8879273|NCT01933217|9936086|FG000|NOT COMPLETED|Randomization (4 Weeks)||2
8879274|NCT01933217|9936087|FG001|NOT COMPLETED|Randomization (4 Weeks)||4
8879275|NCT01933217|9936086|FG000|STARTED|Crossover (4 Weeks)||10
8879276|NCT01933217|9936087|FG001|STARTED|Crossover (4 Weeks)||10
8879277|NCT01933217|9936086|FG000|COMPLETED|Crossover (4 Weeks)||10
8879278|NCT01933217|9936087|FG001|COMPLETED|Crossover (4 Weeks)||10
8879279|NCT01933217|9936086|FG000|NOT COMPLETED|Crossover (4 Weeks)||0
8879280|NCT01933217|9936087|FG001|NOT COMPLETED|Crossover (4 Weeks)||0
8879281|NCT01933230|9936095|FG000|STARTED|Overall Study||2
8879282|NCT01933230|9936095|FG000|COMPLETED|Overall Study||2
8879283|NCT01933230|9936095|FG000|NOT COMPLETED|Overall Study||0
8879284|NCT01933243|9936101|FG000|STARTED|Overall Study||12
8879285|NCT01933243|9936102|FG001|STARTED|Overall Study||12
8879286|NCT01933243|9936101|FG000|COMPLETED|Overall Study||10
8879287|NCT01933243|9936102|FG001|COMPLETED|Overall Study||8
8879288|NCT01933243|9936101|FG000|NOT COMPLETED|Overall Study||2
8879289|NCT01933243|9936102|FG001|NOT COMPLETED|Overall Study||4
8879290|NCT01933334|9936110|FG000|STARTED|Overall Study||32
8879291|NCT01933334|9936111|FG001|STARTED|Overall Study||31
8879292|NCT01933334|9936110|FG000|COMPLETED|Overall Study||27
8879293|NCT01933334|9936111|FG001|COMPLETED|Overall Study||29
8879294|NCT01933334|9936110|FG000|NOT COMPLETED|Overall Study||5
8879295|NCT01933334|9936111|FG001|NOT COMPLETED|Overall Study||2
8879296|NCT01933399|9936120|FG000|STARTED|Overall Study||29
8879297|NCT01933399|9936121|FG001|STARTED|Overall Study||32
8879298|NCT01933399|9936122|FG002|STARTED|Overall Study||37
8879299|NCT01933399|9936120|FG000|COMPLETED|Overall Study||29
8879300|NCT01933399|9936121|FG001|COMPLETED|Overall Study||32
8879301|NCT01933399|9936122|FG002|COMPLETED|Overall Study||37
8879302|NCT01933399|9936120|FG000|NOT COMPLETED|Overall Study||0
8879303|NCT01933399|9936121|FG001|NOT COMPLETED|Overall Study||0
8879304|NCT01933399|9936122|FG002|NOT COMPLETED|Overall Study||0
8879305|NCT01933425|9936130|FG000|STARTED|Overall Study||7
8879306|NCT01933425|9936131|FG001|STARTED|Overall Study||7
8879307|NCT01933425|9936130|FG000|COMPLETED|Overall Study||7
8879308|NCT01933425|9936131|FG001|COMPLETED|Overall Study||7
8879309|NCT01933425|9936130|FG000|NOT COMPLETED|Overall Study||0
8879310|NCT01933425|9936131|FG001|NOT COMPLETED|Overall Study||0
8572244|NCT00112905|9604354|FG000|COMPLETED|Overall Study||15
8572245|NCT00112905|9604354|FG000|NOT COMPLETED|Overall Study||12
8572246|NCT00112918|9604361|FG000|STARTED|Overall Study||1151
8572247|NCT00112918|9604362|FG001|STARTED|Overall Study||1155
8879311|NCT01933464|9936141|FG000|STARTED|Overall Study||5
8879312|NCT01933464|9936142|FG001|STARTED|Overall Study||5
8879313|NCT01933464|9936141|FG000|COMPLETED|Overall Study||5
8879314|NCT01933464|9936142|FG001|COMPLETED|Overall Study||5
8996318|NCT02832037|10059674|FG003|COMPLETED|Overall Study||78
8996319|NCT02832037|10059675|FG004|COMPLETED|Overall Study||151
8996320|NCT02832037|10059671|FG000|NOT COMPLETED|Overall Study||19
8996321|NCT02832037|10059672|FG001|NOT COMPLETED|Overall Study||12
8996322|NCT02832037|10059673|FG002|NOT COMPLETED|Overall Study||8
8996323|NCT02832037|10059674|FG003|NOT COMPLETED|Overall Study||7
8996324|NCT02832037|10059675|FG004|NOT COMPLETED|Overall Study||19
8996325|NCT02832115|10059689|FG000|STARTED|Overall Study||48
8996326|NCT02832115|10059690|FG001|STARTED|Overall Study||52
8996327|NCT02832115|10059689|FG000|COMPLETED|Overall Study||48
8996328|NCT02832115|10059690|FG001|COMPLETED|Overall Study||52
8996329|NCT02832115|10059689|FG000|NOT COMPLETED|Overall Study||0
8996330|NCT02832115|10059690|FG001|NOT COMPLETED|Overall Study||0
8996331|NCT02832154|10059696|FG000|STARTED|Overall Study||43
8996332|NCT02832154|10059696|FG000|COMPLETED|Overall Study||43
8996333|NCT02832154|10059696|FG000|NOT COMPLETED|Overall Study||0
8996334|NCT02832284|10059700|FG000|STARTED|Overall Study||23
8996335|NCT02832284|10059700|FG000|COMPLETED|Overall Study||23
8996336|NCT02832284|10059700|FG000|NOT COMPLETED|Overall Study||0
8996337|NCT02832375|10059706|FG000|STARTED|Overall Study||121
8996338|NCT02832375|10059707|FG001|STARTED|Overall Study||121
8996339|NCT02832375|10059706|FG000|COMPLETED|Overall Study||119
8996340|NCT02832375|10059707|FG001|COMPLETED|Overall Study||121
8996341|NCT02832375|10059706|FG000|NOT COMPLETED|Overall Study||2
8996342|NCT02832375|10059707|FG001|NOT COMPLETED|Overall Study||0
8996343|NCT02832622|10059714|FG000|STARTED|Overall Study||2169
8996344|NCT02832622|10059714|FG000|COMPLETED|Overall Study||433
8996345|NCT02832622|10059714|FG000|NOT COMPLETED|Overall Study||1736
8996346|NCT02832674|10059719|FG000|STARTED|Overall Study||72
8996347|NCT02832674|10059719|FG000|COMPLETED|Overall Study||67
8996348|NCT02832674|10059719|FG000|NOT COMPLETED|Overall Study||5
8996349|NCT02833077|10059725|FG000|STARTED|Overall Study||144
8996350|NCT02833077|10059726|FG001|STARTED|Overall Study||48
8996351|NCT02833077|10059725|FG000|Participants Treated|Overall Study||144
8996352|NCT02833077|10059726|FG001|Participants Treated|Overall Study||38
8996353|NCT02833077|10059725|FG000|COMPLETED|Overall Study||127
8996354|NCT02833077|10059726|FG001|COMPLETED|Overall Study|Includes participants who completed the study but did not receive the optional treatment.|40
8996355|NCT02833077|10059725|FG000|NOT COMPLETED|Overall Study||17
8996356|NCT02833077|10059726|FG001|NOT COMPLETED|Overall Study||8
8996357|NCT02833337|10059733|FG000|STARTED|Overall Study||180
8996358|NCT02833337|10059733|FG000|COMPLETED|Overall Study||180
8996359|NCT02833337|10059733|FG000|NOT COMPLETED|Overall Study||0
8996360|NCT02833350|10059744|FG000|STARTED|Overall Study||40
8996361|NCT02833350|10059745|FG001|STARTED|Overall Study||109
8996362|NCT02833350|10059746|FG002|STARTED|Overall Study||110
8996363|NCT02833350|10059747|FG003|STARTED|Overall Study||110
8996364|NCT02833350|10059748|FG004|STARTED|Overall Study||111
8996365|NCT02833350|10059749|FG005|STARTED|Overall Study||49
8996366|NCT02833350|10059750|FG006|STARTED|Overall Study||49
8996367|NCT02833350|10059744|FG000|Randomized|Overall Study||40
8996368|NCT02833350|10059745|FG001|Randomized|Overall Study||109
8996369|NCT02833350|10059746|FG002|Randomized|Overall Study||110
8996370|NCT02833350|10059747|FG003|Randomized|Overall Study||110
8996371|NCT02833350|10059748|FG004|Randomized|Overall Study||111
8996372|NCT02833350|10059749|FG005|Randomized|Overall Study||48
8996373|NCT02833350|10059750|FG006|Randomized|Overall Study||50
8996374|NCT02833350|10059744|FG000|COMPLETED|Overall Study||37
8996375|NCT02833350|10059745|FG001|COMPLETED|Overall Study||100
8996376|NCT02833350|10059746|FG002|COMPLETED|Overall Study||102
8996377|NCT02833350|10059747|FG003|COMPLETED|Overall Study||102
8996378|NCT02833350|10059748|FG004|COMPLETED|Overall Study||108
8996379|NCT02833350|10059749|FG005|COMPLETED|Overall Study||48
8996380|NCT02833350|10059750|FG006|COMPLETED|Overall Study||44
8996381|NCT02833350|10059744|FG000|NOT COMPLETED|Overall Study||3
8996382|NCT02833350|10059745|FG001|NOT COMPLETED|Overall Study||9
8996383|NCT02833350|10059746|FG002|NOT COMPLETED|Overall Study||8
8996384|NCT02833350|10059747|FG003|NOT COMPLETED|Overall Study||8
8996385|NCT02833350|10059748|FG004|NOT COMPLETED|Overall Study||3
8996386|NCT02833350|10059749|FG005|NOT COMPLETED|Overall Study||1
8996387|NCT02833350|10059750|FG006|NOT COMPLETED|Overall Study||5
8996388|NCT02833415|10059771|FG000|STARTED|Overall Study||20
8996389|NCT02833415|10059772|FG001|STARTED|Overall Study||20
8996390|NCT02833415|10059771|FG000|COMPLETED|Overall Study||18
8996391|NCT02833415|10059772|FG001|COMPLETED|Overall Study||17
8996392|NCT02833415|10059771|FG000|NOT COMPLETED|Overall Study||2
8996393|NCT02833415|10059772|FG001|NOT COMPLETED|Overall Study||3
8996394|NCT02833844|10059780|FG000|STARTED|Double-Blind Period||157
8996395|NCT02833844|10059781|FG001|STARTED|Double-Blind Period||310
8996396|NCT02833844|10059780|FG000|Randomized and Treated|Double-Blind Period||157
8996397|NCT02833844|10059781|FG001|Randomized and Treated|Double-Blind Period||307
8996398|NCT02833844|10059780|FG000|COMPLETED|Double-Blind Period|completed double-blind period|155
8996399|NCT02833844|10059781|FG001|COMPLETED|Double-Blind Period|completed double-blind period|303
8996400|NCT02833844|10059780|FG000|NOT COMPLETED|Double-Blind Period||2
8996401|NCT02833844|10059781|FG001|NOT COMPLETED|Double-Blind Period||7
8996402|NCT02833844|10059780|FG000|STARTED|Open-Label Period|3 participants did not continue to open-label period|152
8996403|NCT02833844|10059781|FG001|STARTED|Open-Label Period||303
8996404|NCT02833844|10059780|FG000|Received Open-Label Study Drug|Open-Label Period||152
8996405|NCT02833844|10059781|FG001|Received Open-Label Study Drug|Open-Label Period||299
8996406|NCT02833844|10059780|FG000|COMPLETED|Open-Label Period||150
8996407|NCT02833844|10059781|FG001|COMPLETED|Open-Label Period||301
8996408|NCT02833844|10059780|FG000|NOT COMPLETED|Open-Label Period||2
8996409|NCT02833844|10059781|FG001|NOT COMPLETED|Open-Label Period||2
8996410|NCT02833857|10059789|FG000|STARTED|Overall Study||11
8996411|NCT02833857|10059789|FG000|COMPLETED|Overall Study||11
8996412|NCT02833857|10059789|FG000|NOT COMPLETED|Overall Study||0
8996413|NCT02833922|10059793|FG000|STARTED|Overall Study||718
8996414|NCT02833922|10059793|FG000|COMPLETED|Overall Study||336
8996415|NCT02833922|10059793|FG000|NOT COMPLETED|Overall Study||382
8996416|NCT02833948|10059799|FG000|STARTED|Overall Study||116
8996417|NCT02833948|10059800|FG001|STARTED|Overall Study||115
8996418|NCT02833948|10059799|FG000|COMPLETED|Overall Study||101
8996419|NCT02833948|10059800|FG001|COMPLETED|Overall Study||97
8996420|NCT02833948|10059799|FG000|NOT COMPLETED|Overall Study||15
8996421|NCT02833948|10059800|FG001|NOT COMPLETED|Overall Study||18
8996422|NCT02833974|10059812|FG000|STARTED|Overall Study||14
8996423|NCT02833974|10059813|FG001|STARTED|Overall Study||22
8996424|NCT02833974|10059812|FG000|COMPLETED|Overall Study||13
8996425|NCT02833974|10059813|FG001|COMPLETED|Overall Study||19
8996426|NCT02833974|10059812|FG000|NOT COMPLETED|Overall Study||1
8996427|NCT02833974|10059813|FG001|NOT COMPLETED|Overall Study||3
8996428|NCT02834247|10059823|FG000|STARTED|Dose Escalation Phase||8
8996429|NCT02834247|10059824|FG001|STARTED|Dose Escalation Phase||11
8996430|NCT02834247|10059825|FG002|STARTED|Dose Escalation Phase||5
8996431|NCT02834247|10059826|FG003|STARTED|Dose Escalation Phase||0
8996432|NCT02834247|10059823|FG000|COMPLETED|Dose Escalation Phase||0
8996433|NCT02834247|10059824|FG001|COMPLETED|Dose Escalation Phase||0
8996434|NCT02834247|10059825|FG002|COMPLETED|Dose Escalation Phase||0
8996435|NCT02834247|10059826|FG003|COMPLETED|Dose Escalation Phase||0
8996436|NCT02834247|10059823|FG000|NOT COMPLETED|Dose Escalation Phase||8
8996437|NCT02834247|10059824|FG001|NOT COMPLETED|Dose Escalation Phase||11
8996438|NCT02834247|10059825|FG002|NOT COMPLETED|Dose Escalation Phase||5
8996439|NCT02834247|10059826|FG003|NOT COMPLETED|Dose Escalation Phase||0
8996440|NCT02834247|10059823|FG000|STARTED|Dose Expansion Phase||0
8996441|NCT02834247|10059824|FG001|STARTED|Dose Expansion Phase||0
8996442|NCT02834247|10059825|FG002|STARTED|Dose Expansion Phase||0
8996443|NCT02834247|10059826|FG003|STARTED|Dose Expansion Phase||17
8996444|NCT02834247|10059823|FG000|COMPLETED|Dose Expansion Phase||0
8996445|NCT02834247|10059824|FG001|COMPLETED|Dose Expansion Phase||0
8996446|NCT02834247|10059825|FG002|COMPLETED|Dose Expansion Phase||0
8996447|NCT02834247|10059826|FG003|COMPLETED|Dose Expansion Phase||0
8996448|NCT02834247|10059823|FG000|NOT COMPLETED|Dose Expansion Phase||0
8996449|NCT02834247|10059824|FG001|NOT COMPLETED|Dose Expansion Phase||0
8996450|NCT02834247|10059825|FG002|NOT COMPLETED|Dose Expansion Phase||0
8996451|NCT02834247|10059826|FG003|NOT COMPLETED|Dose Expansion Phase||17
8996452|NCT02834390|10059840|FG000|STARTED|Induction Phase||4
8996453|NCT02834390|10059841|FG001|STARTED|Induction Phase||3
8996454|NCT02834390|10059840|FG000|COMPLETED|Induction Phase||2
8996455|NCT02834390|10059841|FG001|COMPLETED|Induction Phase||1
8996456|NCT02834390|10059840|FG000|NOT COMPLETED|Induction Phase||2
8996457|NCT02834390|10059841|FG001|NOT COMPLETED|Induction Phase||2
8996458|NCT02834390|10059840|FG000|STARTED|Consolidation Phase||2
8996459|NCT02834390|10059841|FG001|STARTED|Consolidation Phase||1
8996460|NCT02834390|10059840|FG000|COMPLETED|Consolidation Phase||1
8996461|NCT02834390|10059841|FG001|COMPLETED|Consolidation Phase||0
8996462|NCT02834390|10059840|FG000|NOT COMPLETED|Consolidation Phase||1
8996463|NCT02834390|10059841|FG001|NOT COMPLETED|Consolidation Phase||1
8996464|NCT02834624|10059849|FG000|STARTED|Overall Study||15
8996465|NCT02834624|10059850|FG001|STARTED|Overall Study||15
8996466|NCT02834624|10059849|FG000|COMPLETED|Overall Study||15
8996467|NCT02834624|10059850|FG001|COMPLETED|Overall Study||15
8996468|NCT02834624|10059849|FG000|NOT COMPLETED|Overall Study||0
8996469|NCT02834624|10059850|FG001|NOT COMPLETED|Overall Study||0
8996470|NCT02834663|10059857|FG000|STARTED|Overall Study|Unit means the eye. One eye was included per patient|25
8996471|NCT02834663|10059857|FG000|COMPLETED|Overall Study|Unit means the eye. One eye was included per patient|25
8996472|NCT02834663|10059857|FG000|NOT COMPLETED|Overall Study||0
8996473|NCT02834806|10059875|FG000|STARTED|Overall Study||58
8996474|NCT02834806|10059875|FG000|COMPLETED|Overall Study||58
8996475|NCT02834806|10059875|FG000|NOT COMPLETED|Overall Study||0
8996476|NCT02834819|10059881|FG000|STARTED|Overall Study||9
8996477|NCT02834819|10059882|FG001|STARTED|Overall Study||9
8996478|NCT02834819|10059881|FG000|COMPLETED|Overall Study||4
8996479|NCT02834819|10059882|FG001|COMPLETED|Overall Study||9
8996480|NCT02834819|10059881|FG000|NOT COMPLETED|Overall Study||5
8996481|NCT02834819|10059882|FG001|NOT COMPLETED|Overall Study||0
8996482|NCT02835092|10059891|FG000|STARTED|Overall Study||66
8996483|NCT02835092|10059892|FG001|STARTED|Overall Study||65
8996484|NCT02835092|10059893|FG002|STARTED|Overall Study||67
8996485|NCT02835092|10059891|FG000|COMPLETED|Overall Study||63
8996486|NCT02835092|10059892|FG001|COMPLETED|Overall Study||57
8996487|NCT02835092|10059893|FG002|COMPLETED|Overall Study||64
8996488|NCT02835092|10059891|FG000|NOT COMPLETED|Overall Study||3
8996489|NCT02835092|10059892|FG001|NOT COMPLETED|Overall Study||8
8996490|NCT02835092|10059893|FG002|NOT COMPLETED|Overall Study||3
8996491|NCT02835274|10059903|FG000|STARTED|Overall Study||6
8996492|NCT02835274|10059904|FG001|STARTED|Overall Study||6
8996493|NCT02835274|10059903|FG000|COMPLETED|Overall Study||6
8996494|NCT02835274|10059904|FG001|COMPLETED|Overall Study||6
8691300|NCT00854087|9736539|FG000|STARTED|Overall Study||59
8996495|NCT02835274|10059903|FG000|NOT COMPLETED|Overall Study||0
8996496|NCT02835274|10059904|FG001|NOT COMPLETED|Overall Study||0
8996497|NCT02835339|10059912|FG000|STARTED|Overall Study||31
8996498|NCT02835339|10059913|FG001|STARTED|Overall Study||35
8996499|NCT02835339|10059912|FG000|COMPLETED|Overall Study||18
8996500|NCT02835339|10059913|FG001|COMPLETED|Overall Study||19
8996501|NCT02835339|10059912|FG000|NOT COMPLETED|Overall Study||13
8996502|NCT02835339|10059913|FG001|NOT COMPLETED|Overall Study||16
8996503|NCT02835495|10059921|FG000|STARTED|Overall Study|26 randomized, however, one had to withdraw pre-intervention initiation due to cancer diagnosis.|26
8996504|NCT02835495|10059922|FG001|STARTED|Overall Study||25
8996505|NCT02835495|10059921|FG000|Intervention Start|Overall Study||25
8996506|NCT02835495|10059922|FG001|Intervention Start|Overall Study||25
8996507|NCT02835495|10059921|FG000|COMPLETED|Overall Study||21
8996508|NCT02835495|10059922|FG001|COMPLETED|Overall Study||23
8996509|NCT02835495|10059921|FG000|NOT COMPLETED|Overall Study||5
8996510|NCT02835495|10059922|FG001|NOT COMPLETED|Overall Study||2
8996511|NCT02835625|10059932|FG000|STARTED|Overall Study||14734
8996512|NCT02835625|10059933|FG001|STARTED|Overall Study||14719
8996513|NCT02835625|10059932|FG000|COMPLETED|Overall Study||14734
8996514|NCT02835625|10059933|FG001|COMPLETED|Overall Study||14719
8996515|NCT02835625|10059932|FG000|NOT COMPLETED|Overall Study||0
8996516|NCT02835625|10059933|FG001|NOT COMPLETED|Overall Study||0
8996517|NCT02835677|10059940|FG000|STARTED|Overall Study||25
8996518|NCT02835677|10059940|FG000|COMPLETED|Overall Study||25
8996519|NCT02835677|10059940|FG000|NOT COMPLETED|Overall Study||0
8996520|NCT02835820|10059946|FG000|STARTED|Overall Study||7
8996521|NCT02835820|10059947|FG001|STARTED|Overall Study||10
8996522|NCT02835820|10059946|FG000|Baseline Screen (OGTT)|Overall Study||7
8996523|NCT02835820|10059947|FG001|Baseline Screen (OGTT)|Overall Study||7
8996524|NCT02835820|10059946|FG000|COMPLETED|Overall Study||7
8996525|NCT02835820|10059947|FG001|COMPLETED|Overall Study||7
8996526|NCT02835820|10059946|FG000|NOT COMPLETED|Overall Study||0
8996527|NCT02835820|10059947|FG001|NOT COMPLETED|Overall Study||3
8996528|NCT02835846|10059953|FG000|STARTED|Overall Study||35
8996529|NCT02835846|10059953|FG000|COMPLETED|Overall Study||24
8996530|NCT02835846|10059953|FG000|NOT COMPLETED|Overall Study||11
8996531|NCT02836496|10059959|FG000|STARTED|Overall Study||54
8996532|NCT02836496|10059960|FG001|STARTED|Overall Study||54
8996533|NCT02836496|10059959|FG000|COMPLETED|Overall Study||52
8996534|NCT02836496|10059960|FG001|COMPLETED|Overall Study||52
8996535|NCT02836496|10059959|FG000|NOT COMPLETED|Overall Study||2
8996536|NCT02836496|10059960|FG001|NOT COMPLETED|Overall Study||2
8996537|NCT02836613|10059968|FG000|STARTED|Overall Study||80
8996538|NCT02836613|10059969|FG001|STARTED|Overall Study||80
8996539|NCT02836613|10059968|FG000|COMPLETED|Overall Study||79
8996540|NCT02836613|10059969|FG001|COMPLETED|Overall Study||77
8996541|NCT02836613|10059968|FG000|NOT COMPLETED|Overall Study||1
8996542|NCT02836613|10059969|FG001|NOT COMPLETED|Overall Study||3
8996543|NCT02836652|10059977|FG000|STARTED|Overall Study||35
8996544|NCT02836652|10059978|FG001|STARTED|Overall Study||37
8996545|NCT02836652|10059977|FG000|As-treated Population|Overall Study||31
8996546|NCT02836652|10059978|FG001|As-treated Population|Overall Study||34
8996547|NCT02836652|10059977|FG000|COMPLETED|Overall Study||17
8996548|NCT02836652|10059978|FG001|COMPLETED|Overall Study||18
8996549|NCT02836652|10059977|FG000|NOT COMPLETED|Overall Study||18
8996550|NCT02836652|10059978|FG001|NOT COMPLETED|Overall Study||19
8996551|NCT02836769|10059984|FG000|STARTED|Overall Study||35
8996552|NCT02836769|10059984|FG000|Received Intervention|Overall Study||30
8996553|NCT02836769|10059984|FG000|Completed Post-test Assessment|Overall Study||21
8996554|NCT02836769|10059984|FG000|COMPLETED|Overall Study||20
8996555|NCT02836769|10059984|FG000|NOT COMPLETED|Overall Study||15
8996556|NCT02836873|10059990|FG000|STARTED|Overall Study||157
8996557|NCT02836873|10059991|FG001|STARTED|Overall Study||155
8996558|NCT02836873|10059990|FG000|COMPLETED|Overall Study||152
8996559|NCT02836873|10059991|FG001|COMPLETED|Overall Study||144
8996560|NCT02836873|10059990|FG000|NOT COMPLETED|Overall Study||5
8996561|NCT02836873|10059991|FG001|NOT COMPLETED|Overall Study||11
8996562|NCT02836990|10059999|FG000|STARTED|Overall Study||50
8996563|NCT02836990|10060000|FG001|STARTED|Overall Study||55
8996564|NCT02836990|10059999|FG000|COMPLETED|Overall Study||50
8996565|NCT02836990|10060000|FG001|COMPLETED|Overall Study||55
8996566|NCT02836990|10059999|FG000|NOT COMPLETED|Overall Study||0
8996567|NCT02836990|10060000|FG001|NOT COMPLETED|Overall Study||0
8996568|NCT02837237|10060008|FG000|STARTED|Overall Study||11
8996569|NCT02837237|10060008|FG000|COMPLETED|Overall Study||11
8996570|NCT02837237|10060008|FG000|NOT COMPLETED|Overall Study||0
8996571|NCT02837328|10060014|FG000|STARTED|Overall Study||29
8996572|NCT02837328|10060015|FG001|STARTED|Overall Study||30
8996573|NCT02837328|10060014|FG000|COMPLETED|Overall Study||29
8996574|NCT02837328|10060015|FG001|COMPLETED|Overall Study||30
8996575|NCT02837328|10060014|FG000|NOT COMPLETED|Overall Study||0
8996576|NCT02837328|10060015|FG001|NOT COMPLETED|Overall Study||0
8996577|NCT02837731|10060023|FG000|STARTED|Allocation||102
8996578|NCT02837731|10060024|FG001|STARTED|Allocation||48
8996579|NCT02837731|10060023|FG000|COMPLETED|Allocation||83
8996580|NCT02837731|10060024|FG001|COMPLETED|Allocation||41
8996581|NCT02837731|10060023|FG000|NOT COMPLETED|Allocation||19
8996582|NCT02837731|10060024|FG001|NOT COMPLETED|Allocation||7
8996583|NCT02837731|10060023|FG000|STARTED|Follow-up||83
8996584|NCT02837731|10060024|FG001|STARTED|Follow-up||41
8996585|NCT02837731|10060023|FG000|COMPLETED|Follow-up||83
8996586|NCT02837731|10060024|FG001|COMPLETED|Follow-up||41
8996587|NCT02837731|10060023|FG000|NOT COMPLETED|Follow-up||0
8996588|NCT02837731|10060024|FG001|NOT COMPLETED|Follow-up||0
8996589|NCT02837731|10060023|FG000|STARTED|Analysis||83
8996590|NCT02837731|10060024|FG001|STARTED|Analysis||41
8996591|NCT02837731|10060023|FG000|COMPLETED|Analysis||83
8996592|NCT02837731|10060024|FG001|COMPLETED|Analysis||41
8996593|NCT02837731|10060023|FG000|NOT COMPLETED|Analysis||0
8996594|NCT02837731|10060024|FG001|NOT COMPLETED|Analysis||0
8996595|NCT02837744|10060030|FG000|STARTED|Overall Study||70
8996596|NCT02837744|10060030|FG000|COMPLETED|Overall Study||70
8996597|NCT02837744|10060030|FG000|NOT COMPLETED|Overall Study||0
8996598|NCT02837913|10060036|FG000|STARTED|Overall Study||10
8996599|NCT02837913|10060037|FG001|STARTED|Overall Study||9
8996600|NCT02837913|10060036|FG000|COMPLETED|Overall Study||10
8996601|NCT02837913|10060037|FG001|COMPLETED|Overall Study||9
8996602|NCT02837913|10060036|FG000|NOT COMPLETED|Overall Study||0
8996603|NCT02837913|10060037|FG001|NOT COMPLETED|Overall Study||0
8996604|NCT02837952|10060045|FG000|STARTED|Overall Study||41
8996605|NCT02837952|10060046|FG001|STARTED|Overall Study||82
8996606|NCT02837952|10060045|FG000|COMPLETED|Overall Study||36
8996607|NCT02837952|10060046|FG001|COMPLETED|Overall Study||76
8996608|NCT02837952|10060045|FG000|NOT COMPLETED|Overall Study||5
8996609|NCT02837952|10060046|FG001|NOT COMPLETED|Overall Study||6
8996610|NCT02838017|10060054|FG000|STARTED|Overall Study||252
8996611|NCT02838017|10060055|FG001|STARTED|Overall Study||252
8996612|NCT02838017|10060054|FG000|COMPLETED|Overall Study||238
8996613|NCT02838017|10060055|FG001|COMPLETED|Overall Study||241
8996614|NCT02838017|10060054|FG000|NOT COMPLETED|Overall Study||14
8996615|NCT02838017|10060055|FG001|NOT COMPLETED|Overall Study||11
8996616|NCT02838134|10060063|FG000|STARTED|Overall Study||50
8996617|NCT02838134|10060064|FG001|STARTED|Overall Study||51
8996618|NCT02838134|10060063|FG000|COMPLETED|Overall Study||48
8996619|NCT02838134|10060064|FG001|COMPLETED|Overall Study||48
8996620|NCT02838134|10060063|FG000|NOT COMPLETED|Overall Study||2
8996621|NCT02838134|10060064|FG001|NOT COMPLETED|Overall Study||3
8996622|NCT02838407|10060070|FG000|STARTED|Overall Study||197
8996623|NCT02838407|10060070|FG000|COMPLETED|Overall Study||197
8996624|NCT02838407|10060070|FG000|NOT COMPLETED|Overall Study||0
8996625|NCT02838420|10060076|FG000|STARTED|Overall Study||125
8996626|NCT02838420|10060077|FG001|STARTED|Overall Study||62
8996627|NCT02838420|10060076|FG000|COMPLETED|Overall Study||0
8996628|NCT02838420|10060077|FG001|COMPLETED|Overall Study||0
8996629|NCT02838420|10060076|FG000|NOT COMPLETED|Overall Study||125
8996630|NCT02838420|10060077|FG001|NOT COMPLETED|Overall Study||62
8996631|NCT02838628|10060085|FG000|STARTED|Treatment and Follow-up Period||84
8996632|NCT02838628|10060086|FG001|STARTED|Treatment and Follow-up Period||84
8996633|NCT02838628|10060085|FG000|COMPLETED|Treatment and Follow-up Period||84
8996634|NCT02838628|10060086|FG001|COMPLETED|Treatment and Follow-up Period||84
8996635|NCT02838628|10060085|FG000|NOT COMPLETED|Treatment and Follow-up Period||0
8996636|NCT02838628|10060086|FG001|NOT COMPLETED|Treatment and Follow-up Period||0
8996637|NCT02838628|10060085|FG000|STARTED|Recurrence Follow-up Period||36
8996638|NCT02838628|10060086|FG001|STARTED|Recurrence Follow-up Period||27
8996639|NCT02838628|10060085|FG000|COMPLETED|Recurrence Follow-up Period||16
8996640|NCT02838628|10060086|FG001|COMPLETED|Recurrence Follow-up Period||10
8996641|NCT02838628|10060085|FG000|NOT COMPLETED|Recurrence Follow-up Period||20
8996642|NCT02838628|10060086|FG001|NOT COMPLETED|Recurrence Follow-up Period||17
8996643|NCT02838901|10060095|FG000|STARTED|Overall Study||9
8996644|NCT02838901|10060096|FG001|STARTED|Overall Study||9
8996645|NCT02838901|10060095|FG000|COMPLETED|Overall Study||7
8996646|NCT02838901|10060096|FG001|COMPLETED|Overall Study||7
8572248|NCT00112918|9604363|FG002|STARTED|Overall Study||1145
8572249|NCT00112918|9604361|FG000|Received Treatment|Overall Study||1126
8572250|NCT00112918|9604362|FG001|Received Treatment|Overall Study|Includes two patients from FOLFOX4 who received Bv and were assigned to FOLFOX4+Bv safety analysis|1145
8572251|NCT00112918|9604363|FG002|Received Treatment|Overall Study||1135
8572252|NCT00112918|9604361|FG000|Stage III Disease Population|Overall Study||955
8572253|NCT00112918|9604362|FG001|Stage III Disease Population|Overall Study||960
8572254|NCT00112918|9604363|FG002|Stage III Disease Population|Overall Study||952
8572255|NCT00112918|9604361|FG000|COMPLETED|Overall Study|Represents patients alive in follow-up at the time of final data cut-off (30 June 2012)|854
8572256|NCT00112918|9604362|FG001|COMPLETED|Overall Study|Represents patients alive in follow-up at the time of final data cut-off (30 June 2012)|810
8572257|NCT00112918|9604363|FG002|COMPLETED|Overall Study|Represents patients alive in follow-up at the time of final data cut-off (30 June 2012)|846
8572258|NCT00112918|9604361|FG000|NOT COMPLETED|Overall Study||297
8572259|NCT00112918|9604362|FG001|NOT COMPLETED|Overall Study||345
8572260|NCT00112918|9604363|FG002|NOT COMPLETED|Overall Study||299
8572261|NCT00112957|9604371|FG000|STARTED|Overall Study||23
8572262|NCT00112957|9604371|FG000|COMPLETED|Overall Study||4
8572263|NCT00112957|9604371|FG000|NOT COMPLETED|Overall Study||19
8572264|NCT00113022|9604377|FG000|STARTED|Overall Study||5
8572265|NCT00113022|9604378|FG001|STARTED|Overall Study||4
8572266|NCT00113022|9604377|FG000|COMPLETED|Overall Study||2
8572267|NCT00113022|9604378|FG001|COMPLETED|Overall Study||2
8572268|NCT00113022|9604377|FG000|NOT COMPLETED|Overall Study||3
8572269|NCT00113022|9604378|FG001|NOT COMPLETED|Overall Study||2
8577577|NCT00159822|9610342|FG000|COMPLETED|Voriconazole Treatment Period|Number of subjects completed treatment: 36 up to month 6 (M6); 26 after M6.|26
8577578|NCT00159822|9610342|FG000|NOT COMPLETED|Voriconazole Treatment Period||22
8577579|NCT00159822|9610342|FG000|STARTED|Post-treatment Follow-up Period||26
8577580|NCT00159822|9610342|FG000|COMPLETED|Post-treatment Follow-up Period||23
8806550|NCT01478256|9858777|FG001|NOT COMPLETED|Overall Study||0
8996647|NCT02838901|10060095|FG000|NOT COMPLETED|Overall Study||2
8996648|NCT02838901|10060096|FG001|NOT COMPLETED|Overall Study||2
8996649|NCT02839200|10060110|FG000|STARTED|Overall Study||60
8996650|NCT02839200|10060111|FG001|STARTED|Overall Study||59
8996651|NCT02839200|10060112|FG002|STARTED|Overall Study||60
8996652|NCT02839200|10060113|FG003|STARTED|Overall Study||61
8996653|NCT02839200|10060114|FG004|STARTED|Overall Study||60
8996654|NCT02839200|10060115|FG005|STARTED|Overall Study||60
8996655|NCT02839200|10060110|FG000|COMPLETED|Overall Study||56
8996656|NCT02839200|10060111|FG001|COMPLETED|Overall Study||58
8996657|NCT02839200|10060112|FG002|COMPLETED|Overall Study||59
8996658|NCT02839200|10060113|FG003|COMPLETED|Overall Study||61
8996659|NCT02839200|10060114|FG004|COMPLETED|Overall Study||58
8996660|NCT02839200|10060115|FG005|COMPLETED|Overall Study||59
8996661|NCT02839200|10060110|FG000|NOT COMPLETED|Overall Study||4
8996662|NCT02839200|10060111|FG001|NOT COMPLETED|Overall Study||1
8996663|NCT02839200|10060112|FG002|NOT COMPLETED|Overall Study||1
8996664|NCT02839200|10060113|FG003|NOT COMPLETED|Overall Study||0
8996665|NCT02839200|10060114|FG004|NOT COMPLETED|Overall Study||2
8996666|NCT02839200|10060115|FG005|NOT COMPLETED|Overall Study||1
8996667|NCT02839330|10060133|FG000|STARTED|Overall Study||804
8996668|NCT02839330|10060134|FG001|STARTED|Overall Study||799
8996669|NCT02839330|10060135|FG002|STARTED|Overall Study||795
8996670|NCT02839330|10060136|FG003|STARTED|Overall Study||798
8996671|NCT02839330|10060133|FG000|Exposed|Overall Study||804
8996672|NCT02839330|10060134|FG001|Exposed|Overall Study||797
8996673|NCT02839330|10060135|FG002|Exposed|Overall Study||793
8996674|NCT02839330|10060136|FG003|Exposed|Overall Study||797
8996675|NCT02839330|10060133|FG000|COMPLETED|Overall Study||746
8996676|NCT02839330|10060134|FG001|COMPLETED|Overall Study||741
8996677|NCT02839330|10060135|FG002|COMPLETED|Overall Study||747
8996678|NCT02839330|10060136|FG003|COMPLETED|Overall Study||747
8996679|NCT02839330|10060133|FG000|NOT COMPLETED|Overall Study||58
8996680|NCT02839330|10060134|FG001|NOT COMPLETED|Overall Study||58
8996681|NCT02839330|10060135|FG002|NOT COMPLETED|Overall Study||48
8996682|NCT02839330|10060136|FG003|NOT COMPLETED|Overall Study||51
8996683|NCT02839681|10060147|FG000|STARTED|Overall Study||2
8996684|NCT02839681|10060147|FG000|COMPLETED|Overall Study||0
8996685|NCT02839681|10060147|FG000|NOT COMPLETED|Overall Study||2
8996686|NCT02839746|10060151|FG000|STARTED|Overall Study||671
8996687|NCT02839746|10060151|FG000|COMPLETED|Overall Study||659
8633764|NCT00552812|9673938|FG000|STARTED|Overall Study|168 consents, 57 failed cath criteria, 5 met criteria but received covered stent, 1 withdrew consent|105
8633765|NCT00552812|9673938|FG000|COMPLETED|Overall Study|Some still remain inside the 2 year follow up window. 2 year follow up data is not yet complete.|85
8996688|NCT02839746|10060151|FG000|NOT COMPLETED|Overall Study||12
8996689|NCT02839772|10060157|FG000|STARTED|Overall Study|Stratification was used. Clinic A enrolled 94 participants and Clinic B 99 participants|97
8996690|NCT02839772|10060158|FG001|STARTED|Overall Study||96
8996691|NCT02839772|10060157|FG000|COMPLETED|Overall Study|1 participant in Clinic B did not return for the 3 months post- intervention data collection.|96
8996692|NCT02839772|10060158|FG001|COMPLETED|Overall Study||96
8996693|NCT02839772|10060157|FG000|NOT COMPLETED|Overall Study||1
8996694|NCT02839772|10060158|FG001|NOT COMPLETED|Overall Study||0
8996695|NCT02839798|10060178|FG000|STARTED|Overall Study||6
8996696|NCT02839798|10060178|FG000|COMPLETED|Overall Study||4
8996697|NCT02839798|10060178|FG000|NOT COMPLETED|Overall Study||2
8996698|NCT02839876|10060184|FG000|STARTED|Overall Study||41
8996699|NCT02839876|10060185|FG001|STARTED|Overall Study||40
8996700|NCT02839876|10060184|FG000|COMPLETED|Overall Study||31
8996701|NCT02839876|10060185|FG001|COMPLETED|Overall Study||29
8996702|NCT02839876|10060184|FG000|NOT COMPLETED|Overall Study||10
8996703|NCT02839876|10060185|FG001|NOT COMPLETED|Overall Study||11
8996704|NCT02839889|10060193|FG000|STARTED|Randomization Period||2
8996705|NCT02839889|10060194|FG001|STARTED|Randomization Period||3
8996706|NCT02839889|10060193|FG000|COMPLETED|Randomization Period||2
8996707|NCT02839889|10060194|FG001|COMPLETED|Randomization Period||3
8996708|NCT02839889|10060193|FG000|NOT COMPLETED|Randomization Period||0
8996709|NCT02839889|10060194|FG001|NOT COMPLETED|Randomization Period||0
8996710|NCT02839889|10060193|FG000|STARTED|Open-Label Period||0
8996711|NCT02839889|10060194|FG001|STARTED|Open-Label Period||5
8996712|NCT02839889|10060193|FG000|COMPLETED|Open-Label Period||0
8996713|NCT02839889|10060194|FG001|COMPLETED|Open-Label Period||4
8996714|NCT02839889|10060193|FG000|NOT COMPLETED|Open-Label Period||0
8996715|NCT02839889|10060194|FG001|NOT COMPLETED|Open-Label Period||1
8996716|NCT02839902|10060202|FG000|STARTED|Overall Study||24
8996717|NCT02839902|10060203|FG001|STARTED|Overall Study||29
8996718|NCT02839902|10060202|FG000|COMPLETED|Overall Study||24
8996719|NCT02839902|10060203|FG001|COMPLETED|Overall Study||29
8996720|NCT02839902|10060202|FG000|NOT COMPLETED|Overall Study||0
8996721|NCT02839902|10060203|FG001|NOT COMPLETED|Overall Study||0
8996722|NCT02840097|10060212|FG000|STARTED|Overall Study||9
8996723|NCT02840097|10060213|FG001|STARTED|Overall Study||10
8996724|NCT02840097|10060214|FG002|STARTED|Overall Study||12
8996725|NCT02840097|10060212|FG000|COMPLETED|Overall Study||9
8996726|NCT02840097|10060213|FG001|COMPLETED|Overall Study||10
8996727|NCT02840097|10060214|FG002|COMPLETED|Overall Study||12
8996728|NCT02840097|10060212|FG000|NOT COMPLETED|Overall Study||0
8996729|NCT02840097|10060213|FG001|NOT COMPLETED|Overall Study||0
8996730|NCT02840097|10060214|FG002|NOT COMPLETED|Overall Study||0
8996731|NCT02840253|10060225|FG000|STARTED|Overall Study||23
8996732|NCT02840253|10060225|FG000|COMPLETED|Overall Study||19
8996733|NCT02840253|10060225|FG000|NOT COMPLETED|Overall Study||4
8996734|NCT02840461|10060232|FG000|STARTED|Overall Study||259
8996735|NCT02840461|10060233|FG001|STARTED|Overall Study||257
8996736|NCT02840461|10060234|FG002|STARTED|Overall Study||114
8996737|NCT02840461|10060232|FG000|COMPLETED|Overall Study||236
8996738|NCT02840461|10060233|FG001|COMPLETED|Overall Study||235
8996739|NCT02840461|10060234|FG002|COMPLETED|Overall Study||100
8996740|NCT02840461|10060232|FG000|NOT COMPLETED|Overall Study||23
8996741|NCT02840461|10060233|FG001|NOT COMPLETED|Overall Study||22
8996742|NCT02840461|10060234|FG002|NOT COMPLETED|Overall Study||14
8996743|NCT02840474|10060245|FG000|STARTED|Overall Study||7
8996744|NCT02840474|10060246|FG001|STARTED|Overall Study||9
8996745|NCT02840474|10060245|FG000|Received Study Product|Overall Study||7
8996746|NCT02840474|10060246|FG001|Received Study Product|Overall Study||9
8996747|NCT02840474|10060245|FG000|COMPLETED|Overall Study||6
8996748|NCT02840474|10060246|FG001|COMPLETED|Overall Study||9
8996749|NCT02840474|10060245|FG000|NOT COMPLETED|Overall Study||1
8996750|NCT02840474|10060246|FG001|NOT COMPLETED|Overall Study||0
9039280|NCT03336450|10100196|FG000|COMPLETED|Overall Study||3
9039281|NCT03336450|10100196|FG000|NOT COMPLETED|Overall Study||0
9039282|NCT03336502|10100202|FG000|STARTED|Overall Study||30
9039283|NCT03336502|10100203|FG001|STARTED|Overall Study||40
9039284|NCT03336502|10100202|FG000|COMPLETED|Overall Study||26
9039285|NCT03336502|10100203|FG001|COMPLETED|Overall Study||31
9039286|NCT03336502|10100202|FG000|NOT COMPLETED|Overall Study||4
9039287|NCT03336502|10100203|FG001|NOT COMPLETED|Overall Study||9
9039288|NCT03336645|10100209|FG000|STARTED|Overall Study||25
9039289|NCT03336645|10100209|FG000|COMPLETED|Overall Study||25
9039290|NCT03336645|10100209|FG000|NOT COMPLETED|Overall Study||0
9039291|NCT03336853|10100215|FG000|STARTED|Overall Study||30
9039292|NCT03336853|10100216|FG001|STARTED|Overall Study||30
9039293|NCT03336853|10100215|FG000|COMPLETED|Overall Study||30
9039294|NCT03336853|10100216|FG001|COMPLETED|Overall Study||30
9039295|NCT03336853|10100215|FG000|NOT COMPLETED|Overall Study||0
9039296|NCT03336853|10100216|FG001|NOT COMPLETED|Overall Study||0
9039297|NCT03337139|10100224|FG000|STARTED|Phase I||87
9039298|NCT03337139|10100225|FG001|STARTED|Phase I|There were not two conditions in Phase I: all participants received standard group LM treatment.|0
9039299|NCT03337139|10100224|FG000|COMPLETED|Phase I||77
9039300|NCT03337139|10100225|FG001|COMPLETED|Phase I||0
9039301|NCT03337139|10100224|FG000|NOT COMPLETED|Phase I||10
9039302|NCT03337139|10100225|FG001|NOT COMPLETED|Phase I||0
9039303|NCT03337139|10100224|FG000|STARTED|Phase II||38
9039304|NCT03337139|10100225|FG001|STARTED|Phase II||39
9039305|NCT03337139|10100224|FG000|26 Week Assessment|Phase II||34
9039306|NCT03337139|10100225|FG001|26 Week Assessment|Phase II||37
9039307|NCT03337139|10100224|FG000|COMPLETED|Phase II||33
9039308|NCT03337139|10100225|FG001|COMPLETED|Phase II||36
9039309|NCT03337139|10100224|FG000|NOT COMPLETED|Phase II||5
9039310|NCT03337139|10100225|FG001|NOT COMPLETED|Phase II||3
9039311|NCT03337152|10100233|FG000|STARTED|Overall Study||24
9039312|NCT03337152|10100234|FG001|STARTED|Overall Study||24
9039313|NCT03337152|10100233|FG000|COMPLETED|Overall Study||13
9039314|NCT03337152|10100234|FG001|COMPLETED|Overall Study||13
9039315|NCT03337152|10100233|FG000|NOT COMPLETED|Overall Study||11
9039316|NCT03337152|10100234|FG001|NOT COMPLETED|Overall Study||11
9039317|NCT03337308|10100246|FG000|STARTED|Overall Study||108
8996751|NCT02840721|10060252|FG000|STARTED|Treatment Period||50
8996752|NCT02840721|10060252|FG000|COMPLETED|Treatment Period||49
8996753|NCT02840721|10060252|FG000|NOT COMPLETED|Treatment Period||1
8996754|NCT02840721|10060252|FG000|STARTED|Follow-Up||49
8996755|NCT02840721|10060252|FG000|COMPLETED|Follow-Up||42
8996756|NCT02840721|10060252|FG000|NOT COMPLETED|Follow-Up||7
8996757|NCT02840916|10060258|FG000|STARTED|Overall Study||33
8996758|NCT02840916|10060259|FG001|STARTED|Overall Study||33
8996759|NCT02840916|10060258|FG000|COMPLETED|Overall Study||32
8996760|NCT02840916|10060259|FG001|COMPLETED|Overall Study||30
8996761|NCT02840916|10060258|FG000|NOT COMPLETED|Overall Study||1
8996762|NCT02840916|10060259|FG001|NOT COMPLETED|Overall Study||3
8996763|NCT02841033|10060265|FG000|STARTED|Overall Study||22
8996764|NCT02841033|10060265|FG000|COMPLETED|Overall Study||22
8996765|NCT02841033|10060265|FG000|NOT COMPLETED|Overall Study||0
8996766|NCT02841046|10060271|FG000|STARTED|Overall Study||25
8996767|NCT02841046|10060272|FG001|STARTED|Overall Study||25
8996768|NCT02841046|10060271|FG000|COMPLETED|Overall Study||25
8996769|NCT02841046|10060272|FG001|COMPLETED|Overall Study||25
8996770|NCT02841046|10060271|FG000|NOT COMPLETED|Overall Study||0
8996771|NCT02841046|10060272|FG001|NOT COMPLETED|Overall Study||0
8996772|NCT02841189|10060278|FG000|STARTED|Overall Study||100
8996773|NCT02841189|10060278|FG000|COMPLETED|Overall Study||65
8996774|NCT02841189|10060278|FG000|NOT COMPLETED|Overall Study||35
8996775|NCT02841241|10060282|FG000|STARTED|Overall Study||7
8996776|NCT02841241|10060282|FG000|COMPLETED|Overall Study||7
8996777|NCT02841241|10060282|FG000|NOT COMPLETED|Overall Study||0
8996778|NCT02841267|10060289|FG000|STARTED|Lead-in (Untreated)||4
8996779|NCT02841267|10060290|FG001|STARTED|Lead-in (Untreated)||7
8996780|NCT02841267|10060291|FG002|STARTED|Lead-in (Untreated)||8
8996781|NCT02841267|10060289|FG000|COMPLETED|Lead-in (Untreated)||4
8996782|NCT02841267|10060290|FG001|COMPLETED|Lead-in (Untreated)||7
8996783|NCT02841267|10060291|FG002|COMPLETED|Lead-in (Untreated)||8
8996784|NCT02841267|10060289|FG000|NOT COMPLETED|Lead-in (Untreated)||0
8996785|NCT02841267|10060290|FG001|NOT COMPLETED|Lead-in (Untreated)||0
8996786|NCT02841267|10060291|FG002|NOT COMPLETED|Lead-in (Untreated)||0
8996787|NCT02841267|10060289|FG000|STARTED|Treatment Period|Cohort 1 was invited to continue receiving 40mg/kg of study drug every 4 weeks for 28 weeks.|4
8996788|NCT02841267|10060290|FG001|STARTED|Treatment Period||7
8996789|NCT02841267|10060291|FG002|STARTED|Treatment Period||8
8996790|NCT02841267|10060289|FG000|COMPLETED|Treatment Period||4
8996791|NCT02841267|10060290|FG001|COMPLETED|Treatment Period||7
8996792|NCT02841267|10060291|FG002|COMPLETED|Treatment Period||8
8996793|NCT02841267|10060289|FG000|NOT COMPLETED|Treatment Period||0
8996794|NCT02841267|10060290|FG001|NOT COMPLETED|Treatment Period||0
8996795|NCT02841267|10060291|FG002|NOT COMPLETED|Treatment Period||0
8996796|NCT02841267|10060289|FG000|STARTED|Extension Study|Cohort 1 was invited to continue receiving 40mg/kg of study drug every 4 weeks for 28 weeks.|4
8996797|NCT02841267|10060290|FG001|STARTED|Extension Study|Cohort 2 was invited to continue receiving 40mg/kg of study drug every 4 weeks for 40 weeks.|6
8996798|NCT02841267|10060291|FG002|STARTED|Extension Study|Cohort 3 was invited to continue receiving 40mg/kg of study drug every 4 weeks for 24 weeks.|6
8996799|NCT02841267|10060289|FG000|COMPLETED|Extension Study||4
8996800|NCT02841267|10060290|FG001|COMPLETED|Extension Study||6
8996801|NCT02841267|10060291|FG002|COMPLETED|Extension Study||6
8996802|NCT02841267|10060289|FG000|NOT COMPLETED|Extension Study||0
8996803|NCT02841267|10060290|FG001|NOT COMPLETED|Extension Study||0
8996804|NCT02841267|10060291|FG002|NOT COMPLETED|Extension Study||0
8996805|NCT02841397|10060307|FG000|STARTED|Overall Study||50
8996806|NCT02841397|10060307|FG000|COMPLETED|Overall Study||48
8996807|NCT02841397|10060307|FG000|NOT COMPLETED|Overall Study||2
8996808|NCT02841449|10060313|FG000|STARTED|Overall Study||7
8996809|NCT02841449|10060314|FG001|STARTED|Overall Study||9
8996810|NCT02841449|10060313|FG000|COMPLETED|Overall Study||7
8996811|NCT02841449|10060314|FG001|COMPLETED|Overall Study||9
8996812|NCT02841449|10060313|FG000|NOT COMPLETED|Overall Study||0
8996813|NCT02841449|10060314|FG001|NOT COMPLETED|Overall Study||0
8996814|NCT02841709|10060320|FG000|STARTED|1st Intervention||12
8996815|NCT02841709|10060321|FG001|STARTED|1st Intervention||11
8996816|NCT02841709|10060322|FG002|STARTED|1st Intervention||12
8572270|NCT00113087|9604386|FG000|STARTED|Overall Study||115
8996817|NCT02841709|10060323|FG003|STARTED|1st Intervention||12
8996818|NCT02841709|10060324|FG004|STARTED|1st Intervention||11
8996819|NCT02841709|10060320|FG000|COMPLETED|1st Intervention||12
8996820|NCT02841709|10060321|FG001|COMPLETED|1st Intervention||11
8996821|NCT02841709|10060322|FG002|COMPLETED|1st Intervention||12
8996822|NCT02841709|10060323|FG003|COMPLETED|1st Intervention||12
8996823|NCT02841709|10060324|FG004|COMPLETED|1st Intervention||11
8996824|NCT02841709|10060320|FG000|NOT COMPLETED|1st Intervention||0
8996825|NCT02841709|10060321|FG001|NOT COMPLETED|1st Intervention||0
8996826|NCT02841709|10060322|FG002|NOT COMPLETED|1st Intervention||0
8996827|NCT02841709|10060323|FG003|NOT COMPLETED|1st Intervention||0
8572271|NCT00113087|9604387|FG001|STARTED|Overall Study||115
8572272|NCT00113087|9604386|FG000|COMPLETED|Overall Study||91
8572273|NCT00113087|9604387|FG001|COMPLETED|Overall Study||94
8572274|NCT00113087|9604386|FG000|NOT COMPLETED|Overall Study||24
8572275|NCT00113087|9604387|FG001|NOT COMPLETED|Overall Study||21
8572276|NCT00113217|9604393|FG000|STARTED|Overall Study||50
8572277|NCT00113217|9604393|FG000|COMPLETED|Overall Study||50
8572278|NCT00113217|9604393|FG000|NOT COMPLETED|Overall Study||0
8572279|NCT00113230|9604397|FG000|STARTED|Overall Study||25
8996828|NCT02841709|10060324|FG004|NOT COMPLETED|1st Intervention||0
8996829|NCT02841709|10060320|FG000|STARTED|Washout Period 1||12
8996830|NCT02841709|10060321|FG001|STARTED|Washout Period 1||11
8996831|NCT02841709|10060322|FG002|STARTED|Washout Period 1||12
8996832|NCT02841709|10060323|FG003|STARTED|Washout Period 1||12
8996833|NCT02841709|10060324|FG004|STARTED|Washout Period 1||11
8996834|NCT02841709|10060320|FG000|COMPLETED|Washout Period 1||12
8996835|NCT02841709|10060321|FG001|COMPLETED|Washout Period 1||11
8996836|NCT02841709|10060322|FG002|COMPLETED|Washout Period 1||12
8996837|NCT02841709|10060323|FG003|COMPLETED|Washout Period 1||12
8996838|NCT02841709|10060324|FG004|COMPLETED|Washout Period 1||11
8996839|NCT02841709|10060320|FG000|NOT COMPLETED|Washout Period 1||0
8996840|NCT02841709|10060321|FG001|NOT COMPLETED|Washout Period 1||0
8996841|NCT02841709|10060322|FG002|NOT COMPLETED|Washout Period 1||0
8996842|NCT02841709|10060323|FG003|NOT COMPLETED|Washout Period 1||0
8996843|NCT02841709|10060324|FG004|NOT COMPLETED|Washout Period 1||0
8996844|NCT02841709|10060320|FG000|STARTED|2nd Intervention||12
8725904|NCT01033487|9773161|FG004|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
8633766|NCT00552812|9673938|FG000|NOT COMPLETED|Overall Study||20
8633767|NCT00552929|9673952|FG000|STARTED|Overall Study||9
8633768|NCT00552929|9673953|FG001|STARTED|Overall Study||10
8633769|NCT00552929|9673954|FG002|STARTED|Overall Study||10
8633770|NCT00552929|9673955|FG003|STARTED|Overall Study||11
8633771|NCT00552929|9673956|FG004|STARTED|Overall Study||10
8633772|NCT00552929|9673957|FG005|STARTED|Overall Study||10
8633773|NCT00552929|9673958|FG006|STARTED|Overall Study||10
8633774|NCT00552929|9673959|FG007|STARTED|Overall Study||11
8633775|NCT00552929|9673960|FG008|STARTED|Overall Study||10
8633776|NCT00552929|9673961|FG009|STARTED|Overall Study||11
8633777|NCT00552929|9673952|FG000|Participants as Treated|Overall Study|One participant randomized to sugammadex 0.5 mg/kg received sugammadex 3.7 mg/kg (4.0 mg\kg group)|9
8996845|NCT02841709|10060321|FG001|STARTED|2nd Intervention||11
8633778|NCT00552929|9673953|FG001|Participants as Treated|Overall Study||10
8633779|NCT00552929|9673954|FG002|Participants as Treated|Overall Study||10
8633780|NCT00552929|9673955|FG003|Participants as Treated|Overall Study|One participant randomized to sugammadex 0.5 mg/kg received sugammadex 3.7 mg/kg (4.0 mg\kg group)|11
8633781|NCT00552929|9673956|FG004|Participants as Treated|Overall Study||10
8633782|NCT00552929|9673957|FG005|Participants as Treated|Overall Study||9
8633783|NCT00552929|9673958|FG006|Participants as Treated|Overall Study||10
8633784|NCT00552929|9673959|FG007|Participants as Treated|Overall Study||11
8633785|NCT00552929|9673960|FG008|Participants as Treated|Overall Study||10
8996846|NCT02841709|10060322|FG002|STARTED|2nd Intervention||12
8996847|NCT02841709|10060323|FG003|STARTED|2nd Intervention||12
8996848|NCT02841709|10060324|FG004|STARTED|2nd Intervention||11
8996849|NCT02841709|10060320|FG000|COMPLETED|2nd Intervention||12
8996850|NCT02841709|10060321|FG001|COMPLETED|2nd Intervention||11
8996851|NCT02841709|10060322|FG002|COMPLETED|2nd Intervention||12
8996852|NCT02841709|10060323|FG003|COMPLETED|2nd Intervention||12
8996853|NCT02841709|10060324|FG004|COMPLETED|2nd Intervention||11
8996854|NCT02841709|10060320|FG000|NOT COMPLETED|2nd Intervention||0
8996855|NCT02841709|10060321|FG001|NOT COMPLETED|2nd Intervention||0
8996856|NCT02841709|10060322|FG002|NOT COMPLETED|2nd Intervention||0
8996857|NCT02841709|10060323|FG003|NOT COMPLETED|2nd Intervention||0
8996858|NCT02841709|10060324|FG004|NOT COMPLETED|2nd Intervention||0
8996859|NCT02841709|10060320|FG000|STARTED|Washout Period 2||12
8996860|NCT02841709|10060321|FG001|STARTED|Washout Period 2||11
8996861|NCT02841709|10060322|FG002|STARTED|Washout Period 2||12
8996862|NCT02841709|10060323|FG003|STARTED|Washout Period 2||12
8996863|NCT02841709|10060324|FG004|STARTED|Washout Period 2||11
8633786|NCT00552929|9673961|FG009|Participants as Treated|Overall Study||11
8633787|NCT00552929|9673952|FG000|COMPLETED|Overall Study||9
8633788|NCT00552929|9673953|FG001|COMPLETED|Overall Study||10
8633789|NCT00552929|9673954|FG002|COMPLETED|Overall Study||10
8879315|NCT01933464|9936141|FG000|NOT COMPLETED|Overall Study||0
8996864|NCT02841709|10060320|FG000|COMPLETED|Washout Period 2||12
8996865|NCT02841709|10060321|FG001|COMPLETED|Washout Period 2||11
8996866|NCT02841709|10060322|FG002|COMPLETED|Washout Period 2||12
8996867|NCT02841709|10060323|FG003|COMPLETED|Washout Period 2||12
8996868|NCT02841709|10060324|FG004|COMPLETED|Washout Period 2||11
8996869|NCT02841709|10060320|FG000|NOT COMPLETED|Washout Period 2||0
8996870|NCT02841709|10060321|FG001|NOT COMPLETED|Washout Period 2||0
8996871|NCT02841709|10060322|FG002|NOT COMPLETED|Washout Period 2||0
8996872|NCT02841709|10060323|FG003|NOT COMPLETED|Washout Period 2||0
8996873|NCT02841709|10060324|FG004|NOT COMPLETED|Washout Period 2||0
8996874|NCT02841709|10060320|FG000|STARTED|3rd Intervention||12
8996875|NCT02841709|10060321|FG001|STARTED|3rd Intervention||11
8996876|NCT02841709|10060322|FG002|STARTED|3rd Intervention||12
8996877|NCT02841709|10060323|FG003|STARTED|3rd Intervention||12
8996878|NCT02841709|10060324|FG004|STARTED|3rd Intervention||11
8996879|NCT02841709|10060320|FG000|COMPLETED|3rd Intervention||12
8996880|NCT02841709|10060321|FG001|COMPLETED|3rd Intervention||11
8996881|NCT02841709|10060322|FG002|COMPLETED|3rd Intervention||12
8996882|NCT02841709|10060323|FG003|COMPLETED|3rd Intervention||12
8996883|NCT02841709|10060324|FG004|COMPLETED|3rd Intervention||11
8996884|NCT02841709|10060320|FG000|NOT COMPLETED|3rd Intervention||0
8996885|NCT02841709|10060321|FG001|NOT COMPLETED|3rd Intervention||0
8996886|NCT02841709|10060322|FG002|NOT COMPLETED|3rd Intervention||0
8996887|NCT02841709|10060323|FG003|NOT COMPLETED|3rd Intervention||0
8996888|NCT02841709|10060324|FG004|NOT COMPLETED|3rd Intervention||0
8996889|NCT02841709|10060320|FG000|STARTED|Washout Period 3||12
8996890|NCT02841709|10060321|FG001|STARTED|Washout Period 3||11
8996891|NCT02841709|10060322|FG002|STARTED|Washout Period 3||12
8996892|NCT02841709|10060323|FG003|STARTED|Washout Period 3||12
8996893|NCT02841709|10060324|FG004|STARTED|Washout Period 3||11
8996894|NCT02841709|10060320|FG000|COMPLETED|Washout Period 3||12
8996895|NCT02841709|10060321|FG001|COMPLETED|Washout Period 3||11
8996896|NCT02841709|10060322|FG002|COMPLETED|Washout Period 3||12
8996897|NCT02841709|10060323|FG003|COMPLETED|Washout Period 3||12
8996898|NCT02841709|10060324|FG004|COMPLETED|Washout Period 3||11
8996899|NCT02841709|10060320|FG000|NOT COMPLETED|Washout Period 3||0
8996900|NCT02841709|10060321|FG001|NOT COMPLETED|Washout Period 3||0
8996901|NCT02841709|10060322|FG002|NOT COMPLETED|Washout Period 3||0
8996902|NCT02841709|10060323|FG003|NOT COMPLETED|Washout Period 3||0
8996903|NCT02841709|10060324|FG004|NOT COMPLETED|Washout Period 3||0
8996904|NCT02841709|10060320|FG000|STARTED|4th Intervention||12
8633790|NCT00552929|9673955|FG003|COMPLETED|Overall Study||11
8879316|NCT01933464|9936142|FG001|NOT COMPLETED|Overall Study||0
8996905|NCT02841709|10060321|FG001|STARTED|4th Intervention||11
8996906|NCT02841709|10060322|FG002|STARTED|4th Intervention||12
8996907|NCT02841709|10060323|FG003|STARTED|4th Intervention||12
8879317|NCT01933594|9936154|FG000|STARTED|Overall Study||12
8879318|NCT01933594|9936155|FG001|STARTED|Overall Study||12
8879319|NCT01933594|9936156|FG002|STARTED|Overall Study||12
8879320|NCT01933594|9936157|FG003|STARTED|Overall Study||7
8879321|NCT01933594|9936158|FG004|STARTED|Overall Study||13
8879322|NCT01933594|9936159|FG005|STARTED|Overall Study||3
8879323|NCT01933594|9936154|FG000|COMPLETED|Overall Study||11
8879324|NCT01933594|9936155|FG001|COMPLETED|Overall Study||12
8879325|NCT01933594|9936156|FG002|COMPLETED|Overall Study||12
8879326|NCT01933594|9936157|FG003|COMPLETED|Overall Study||7
8879327|NCT01933594|9936158|FG004|COMPLETED|Overall Study||11
8879328|NCT01933594|9936159|FG005|COMPLETED|Overall Study||3
8879329|NCT01933594|9936154|FG000|NOT COMPLETED|Overall Study||1
8879330|NCT01933594|9936155|FG001|NOT COMPLETED|Overall Study||0
8879331|NCT01933594|9936156|FG002|NOT COMPLETED|Overall Study||0
8996908|NCT02841709|10060324|FG004|STARTED|4th Intervention||11
8996909|NCT02841709|10060320|FG000|COMPLETED|4th Intervention||12
8996910|NCT02841709|10060321|FG001|COMPLETED|4th Intervention||11
8996911|NCT02841709|10060322|FG002|COMPLETED|4th Intervention||12
8996912|NCT02841709|10060323|FG003|COMPLETED|4th Intervention||12
8996913|NCT02841709|10060324|FG004|COMPLETED|4th Intervention||11
8996914|NCT02841709|10060320|FG000|NOT COMPLETED|4th Intervention||0
8996915|NCT02841709|10060321|FG001|NOT COMPLETED|4th Intervention||0
8996916|NCT02841709|10060322|FG002|NOT COMPLETED|4th Intervention||0
8996917|NCT02841709|10060323|FG003|NOT COMPLETED|4th Intervention||0
8996918|NCT02841709|10060324|FG004|NOT COMPLETED|4th Intervention||0
8996919|NCT02841709|10060320|FG000|STARTED|Washout Period 4||12
8996920|NCT02841709|10060321|FG001|STARTED|Washout Period 4||11
8996921|NCT02841709|10060322|FG002|STARTED|Washout Period 4||12
8996922|NCT02841709|10060323|FG003|STARTED|Washout Period 4||12
8996923|NCT02841709|10060324|FG004|STARTED|Washout Period 4||11
8996924|NCT02841709|10060320|FG000|COMPLETED|Washout Period 4||12
8996925|NCT02841709|10060321|FG001|COMPLETED|Washout Period 4||11
8996926|NCT02841709|10060322|FG002|COMPLETED|Washout Period 4||12
8996927|NCT02841709|10060323|FG003|COMPLETED|Washout Period 4||12
8996928|NCT02841709|10060324|FG004|COMPLETED|Washout Period 4||11
8996929|NCT02841709|10060320|FG000|NOT COMPLETED|Washout Period 4||0
8996930|NCT02841709|10060321|FG001|NOT COMPLETED|Washout Period 4||0
8996931|NCT02841709|10060322|FG002|NOT COMPLETED|Washout Period 4||0
8572280|NCT00113230|9604397|FG000|COMPLETED|Overall Study||25
8572281|NCT00113230|9604397|FG000|NOT COMPLETED|Overall Study||0
8572282|NCT00113269|9604405|FG000|STARTED|Overall Study||76
8572283|NCT00113269|9604406|FG001|STARTED|Overall Study||70
8572284|NCT00113269|9604407|FG002|STARTED|Overall Study||175
8572285|NCT00113269|9604408|FG003|STARTED|Overall Study||180
8572286|NCT00113269|9604405|FG000|Received Treatment|Overall Study||70
8572287|NCT00113269|9604406|FG001|Received Treatment|Overall Study||69
8879332|NCT01933594|9936157|FG003|NOT COMPLETED|Overall Study||0
8879333|NCT01933594|9936158|FG004|NOT COMPLETED|Overall Study||2
8879334|NCT01933594|9936159|FG005|NOT COMPLETED|Overall Study||0
8879335|NCT01933672|9936177|FG000|STARTED|Metformin Run-in Period||43
8879336|NCT01933672|9936178|FG001|STARTED|Metformin Run-in Period||0
8879337|NCT01933672|9936179|FG002|STARTED|Metformin Run-in Period||0
8879338|NCT01933672|9936180|FG003|STARTED|Metformin Run-in Period||0
8879339|NCT01933672|9936181|FG004|STARTED|Metformin Run-in Period||0
8879340|NCT01933672|9936182|FG005|STARTED|Metformin Run-in Period||0
8879341|NCT01933672|9936183|FG006|STARTED|Metformin Run-in Period||0
8879342|NCT01933672|9936177|FG000|Received Treatment|Metformin Run-in Period||43
8879343|NCT01933672|9936178|FG001|Received Treatment|Metformin Run-in Period||0
8879344|NCT01933672|9936179|FG002|Received Treatment|Metformin Run-in Period||0
8879345|NCT01933672|9936180|FG003|Received Treatment|Metformin Run-in Period||0
8879346|NCT01933672|9936181|FG004|Received Treatment|Metformin Run-in Period||0
8879347|NCT01933672|9936182|FG005|Received Treatment|Metformin Run-in Period||0
8879348|NCT01933672|9936183|FG006|Received Treatment|Metformin Run-in Period||0
8879349|NCT01933672|9936177|FG000|COMPLETED|Metformin Run-in Period||33
8879350|NCT01933672|9936178|FG001|COMPLETED|Metformin Run-in Period||0
8879351|NCT01933672|9936179|FG002|COMPLETED|Metformin Run-in Period||0
8879352|NCT01933672|9936180|FG003|COMPLETED|Metformin Run-in Period||0
8879353|NCT01933672|9936181|FG004|COMPLETED|Metformin Run-in Period||0
8879354|NCT01933672|9936182|FG005|COMPLETED|Metformin Run-in Period||0
8879355|NCT01933672|9936183|FG006|COMPLETED|Metformin Run-in Period||0
8879356|NCT01933672|9936177|FG000|NOT COMPLETED|Metformin Run-in Period||10
8879357|NCT01933672|9936178|FG001|NOT COMPLETED|Metformin Run-in Period||0
8879358|NCT01933672|9936179|FG002|NOT COMPLETED|Metformin Run-in Period||0
8879359|NCT01933672|9936180|FG003|NOT COMPLETED|Metformin Run-in Period||0
8879360|NCT01933672|9936181|FG004|NOT COMPLETED|Metformin Run-in Period||0
8879361|NCT01933672|9936182|FG005|NOT COMPLETED|Metformin Run-in Period||0
8879362|NCT01933672|9936183|FG006|NOT COMPLETED|Metformin Run-in Period||0
8996932|NCT02841709|10060323|FG003|NOT COMPLETED|Washout Period 4||0
8996933|NCT02841709|10060324|FG004|NOT COMPLETED|Washout Period 4||0
8996934|NCT02841709|10060320|FG000|STARTED|5th Intervention||12
8572288|NCT00113269|9604407|FG002|Received Treatment|Overall Study||164
8572289|NCT00113269|9604408|FG003|Received Treatment|Overall Study||171
8879363|NCT01933672|9936177|FG000|STARTED|First Intervention Period (12-16 Days)||0
8996935|NCT02841709|10060321|FG001|STARTED|5th Intervention||11
8996936|NCT02841709|10060322|FG002|STARTED|5th Intervention||12
8996937|NCT02841709|10060323|FG003|STARTED|5th Intervention||12
8996938|NCT02841709|10060324|FG004|STARTED|5th Intervention||11
8996939|NCT02841709|10060320|FG000|COMPLETED|5th Intervention|Note: In total, 2 subjects did not complete Sequence 1.|10
8996940|NCT02841709|10060321|FG001|COMPLETED|5th Intervention||11
8996941|NCT02841709|10060322|FG002|COMPLETED|5th Intervention||12
8996942|NCT02841709|10060323|FG003|COMPLETED|5th Intervention||12
8996943|NCT02841709|10060324|FG004|COMPLETED|5th Intervention|Note: In total, 2 subjects did not complete Sequence 5.|9
8996944|NCT02841709|10060320|FG000|NOT COMPLETED|5th Intervention||2
8996945|NCT02841709|10060321|FG001|NOT COMPLETED|5th Intervention||0
8996946|NCT02841709|10060322|FG002|NOT COMPLETED|5th Intervention||0
8996947|NCT02841709|10060323|FG003|NOT COMPLETED|5th Intervention||0
8572290|NCT00113269|9604405|FG000|COMPLETED|Overall Study||51
8572291|NCT00113269|9604406|FG001|COMPLETED|Overall Study||48
8572292|NCT00113269|9604407|FG002|COMPLETED|Overall Study||134
8572293|NCT00113269|9604408|FG003|COMPLETED|Overall Study||140
8572294|NCT00113269|9604405|FG000|NOT COMPLETED|Overall Study||25
8572295|NCT00113269|9604406|FG001|NOT COMPLETED|Overall Study||22
8572296|NCT00113269|9604407|FG002|NOT COMPLETED|Overall Study||41
8572297|NCT00113269|9604408|FG003|NOT COMPLETED|Overall Study||40
8572298|NCT00113295|9604420|FG000|STARTED|Overall Study||11
8572299|NCT00113295|9604421|FG001|STARTED|Overall Study||11
8572300|NCT00113295|9604420|FG000|COMPLETED|Overall Study||6
8572301|NCT00113295|9604421|FG001|COMPLETED|Overall Study||10
8572302|NCT00113295|9604420|FG000|NOT COMPLETED|Overall Study||5
8572303|NCT00113295|9604421|FG001|NOT COMPLETED|Overall Study||1
8572304|NCT00113321|9604429|FG000|STARTED|Overall Study||16
8572305|NCT00113321|9604429|FG000|COMPLETED|Overall Study||16
8572306|NCT00113321|9604429|FG000|NOT COMPLETED|Overall Study||0
8572307|NCT00113334|9604433|FG000|STARTED|Overall Study||6
8572308|NCT00113334|9604433|FG000|COMPLETED|Overall Study||6
8572309|NCT00113334|9604433|FG000|NOT COMPLETED|Overall Study||0
8572310|NCT00113360|9604437|FG000|STARTED|Overall Study|67 participants were enrolled for screening.|67
8572311|NCT00113360|9604437|FG000|COMPLETED|Overall Study||60
8572312|NCT00113360|9604437|FG000|NOT COMPLETED|Overall Study||7
8572313|NCT00113373|9604441|FG000|STARTED|Overall Study||28
8572314|NCT00113373|9604441|FG000|COMPLETED|Overall Study|Eligible and treated patients.|25
8572315|NCT00113373|9604441|FG000|NOT COMPLETED|Overall Study||3
8572316|NCT00113425|9604450|FG000|STARTED|Overall Study||44
8572317|NCT00113425|9604450|FG000|COMPLETED|Overall Study||29
8572318|NCT00113425|9604450|FG000|NOT COMPLETED|Overall Study||15
8572319|NCT00113490|9604457|FG000|STARTED|Overall Study||66
8572320|NCT00113490|9604458|FG001|STARTED|Overall Study||70
8572321|NCT00113490|9604457|FG000|COMPLETED|Overall Study||64
8572322|NCT00113490|9604458|FG001|COMPLETED|Overall Study||67
8572323|NCT00113490|9604457|FG000|NOT COMPLETED|Overall Study||2
8572324|NCT00113490|9604458|FG001|NOT COMPLETED|Overall Study||3
8572325|NCT00113516|9604464|FG000|STARTED|Part 1||84
8572326|NCT00113516|9604465|FG001|STARTED|Part 1||0
8572327|NCT00113516|9604464|FG000|COMPLETED|Part 1|66 subjects continued into Part 2 of the study.|0
8572328|NCT00113516|9604465|FG001|COMPLETED|Part 1||0
8572329|NCT00113516|9604464|FG000|NOT COMPLETED|Part 1||84
8572330|NCT00113516|9604465|FG001|NOT COMPLETED|Part 1||0
8572331|NCT00113516|9604464|FG000|STARTED|Part 2||0
8633791|NCT00552929|9673956|FG004|COMPLETED|Overall Study||10
8572332|NCT00113516|9604465|FG001|STARTED|Part 2||66
8572333|NCT00113516|9604464|FG000|COMPLETED|Part 2||0
8572334|NCT00113516|9604465|FG001|COMPLETED|Part 2||0
8572335|NCT00113516|9604464|FG000|NOT COMPLETED|Part 2||0
8572336|NCT00113516|9604465|FG001|NOT COMPLETED|Part 2||66
8572337|NCT00113529|9604471|FG000|STARTED|Overall Study|Phase 2 included 4 subjects from Phase 1 and 31 from Phase 2, for a total of 35 subjects.|35
8572338|NCT00113529|9604471|FG000|COMPLETED|Overall Study|Subject discontinued from the study and continued treatment on commercially available sunitinib.|1
8572339|NCT00113529|9604471|FG000|NOT COMPLETED|Overall Study||34
8572340|NCT00113555|9604475|FG000|STARTED|Overall Study||221
8572341|NCT00113555|9604475|FG000|TREATED|Overall Study|1 Additional Patient was treated on a compassionate use basis.|162
8996948|NCT02841709|10060324|FG004|NOT COMPLETED|5th Intervention||2
8996949|NCT02841787|10060340|FG000|STARTED|Overall Study||12
8996950|NCT02841787|10060341|FG001|STARTED|Overall Study||23
8996951|NCT02841787|10060342|FG002|STARTED|Overall Study||12
8996952|NCT02841787|10060340|FG000|COMPLETED|Overall Study||9
8996953|NCT02841787|10060341|FG001|COMPLETED|Overall Study||19
8996954|NCT02841787|10060342|FG002|COMPLETED|Overall Study||12
8996955|NCT02841787|10060340|FG000|NOT COMPLETED|Overall Study||3
8996956|NCT02841787|10060341|FG001|NOT COMPLETED|Overall Study||4
8996957|NCT02841787|10060342|FG002|NOT COMPLETED|Overall Study||0
8996958|NCT02842060|10060352|FG000|STARTED|Overall Study||120
8996959|NCT02842060|10060353|FG001|STARTED|Overall Study||60
8996960|NCT02842060|10060352|FG000|COMPLETED|Overall Study||120
8996961|NCT02842060|10060353|FG001|COMPLETED|Overall Study||60
8996962|NCT02842060|10060352|FG000|NOT COMPLETED|Overall Study||0
8996963|NCT02842060|10060353|FG001|NOT COMPLETED|Overall Study||0
8996964|NCT02842073|10060359|FG000|STARTED|Overall Study||12
8996965|NCT02842073|10060359|FG000|COMPLETED|Overall Study||11
8996966|NCT02842073|10060359|FG000|NOT COMPLETED|Overall Study||1
8996967|NCT02842086|10060365|FG000|STARTED|Overall Study||2700
8996968|NCT02842086|10060366|FG001|STARTED|Overall Study||2699
8996969|NCT02842086|10060365|FG000|COMPLETED|Overall Study||2156
8996970|NCT02842086|10060366|FG001|COMPLETED|Overall Study||2206
8996971|NCT02842086|10060365|FG000|NOT COMPLETED|Overall Study||544
8996972|NCT02842086|10060366|FG001|NOT COMPLETED|Overall Study||493
8996973|NCT02842151|10060372|FG000|STARTED|Overall Study||150
8996974|NCT02842151|10060372|FG000|COMPLETED|Overall Study||148
8996975|NCT02842151|10060372|FG000|NOT COMPLETED|Overall Study||2
8996976|NCT02842242|10060380|FG000|STARTED|Overall Study||11
8996977|NCT02842242|10060381|FG001|STARTED|Overall Study||10
8996978|NCT02842242|10060380|FG000|COMPLETED|Overall Study||10
8996979|NCT02842242|10060381|FG001|COMPLETED|Overall Study||10
8996980|NCT02842242|10060380|FG000|NOT COMPLETED|Overall Study||1
8996981|NCT02842242|10060381|FG001|NOT COMPLETED|Overall Study||0
8996982|NCT02842736|10060387|FG000|STARTED|Overall Study|Treated|242
8996983|NCT02842736|10060387|FG000|Known Month 12 Outcome|Overall Study||230
8996984|NCT02842736|10060387|FG000|24 Month Visit Performed|Overall Study||210
8996985|NCT02842736|10060387|FG000|COMPLETED|Overall Study|36 Month Visit Completed|201
8996986|NCT02842736|10060387|FG000|NOT COMPLETED|Overall Study||41
8996987|NCT02843178|10060395|FG000|STARTED|Overall Study||86
8996988|NCT02843178|10060396|FG001|STARTED|Overall Study||90
8996989|NCT02843178|10060397|FG002|STARTED|Overall Study||92
8996990|NCT02843178|10060398|FG003|STARTED|Overall Study||91
8996991|NCT02843178|10060395|FG000|COMPLETED|Overall Study||78
8996992|NCT02843178|10060396|FG001|COMPLETED|Overall Study||82
8996993|NCT02843178|10060397|FG002|COMPLETED|Overall Study||85
8996994|NCT02843178|10060398|FG003|COMPLETED|Overall Study||87
8633792|NCT00552929|9673957|FG005|COMPLETED|Overall Study||9
8996995|NCT02843178|10060395|FG000|NOT COMPLETED|Overall Study||8
8996996|NCT02843178|10060396|FG001|NOT COMPLETED|Overall Study||8
8996997|NCT02843178|10060397|FG002|NOT COMPLETED|Overall Study||7
8996998|NCT02843178|10060398|FG003|NOT COMPLETED|Overall Study||4
8996999|NCT02843529|10060410|FG000|STARTED|Overall Study||244
8997000|NCT02843529|10060411|FG001|STARTED|Overall Study||304
8997001|NCT02843529|10060410|FG000|COMPLETED|Overall Study||213
8997002|NCT02843529|10060411|FG001|COMPLETED|Overall Study||283
8997003|NCT02843529|10060410|FG000|NOT COMPLETED|Overall Study||31
8997004|NCT02843529|10060411|FG001|NOT COMPLETED|Overall Study||21
8997005|NCT02843659|10060420|FG000|STARTED|Overall Study||5
8997006|NCT02843659|10060421|FG001|STARTED|Overall Study||6
8997007|NCT02843659|10060422|FG002|STARTED|Overall Study||7
8997008|NCT02843659|10060420|FG000|COMPLETED|Overall Study||1
8997009|NCT02843659|10060421|FG001|COMPLETED|Overall Study||0
8997010|NCT02843659|10060422|FG002|COMPLETED|Overall Study||2
8997011|NCT02843659|10060420|FG000|NOT COMPLETED|Overall Study||4
8997012|NCT02843659|10060421|FG001|NOT COMPLETED|Overall Study||6
8997013|NCT02843659|10060422|FG002|NOT COMPLETED|Overall Study||5
8997014|NCT02844439|10060430|FG000|STARTED|Overall Study|"All Subjects with Glioblastoma:~24 subjects with EGFR-gene amplified + 16 subjects without EGFR gene-amplified nor EGFRvIII^pos"|40
8997015|NCT02844439|10060430|FG000|Subpopulation A (EGFR Gene Amplified Glioblastoma)|Overall Study||24
8997016|NCT02844439|10060430|FG000|Subpopulation B (EGFRvIII^Pos Glioblastoma)|Overall Study||11
8997017|NCT02844439|10060430|FG000|COMPLETED|Overall Study||0
8997018|NCT02844439|10060430|FG000|NOT COMPLETED|Overall Study||40
8997019|NCT02844543|10060441|FG000|STARTED|Overall Study||155
8997020|NCT02844543|10060441|FG000|COMPLETED|Overall Study||150
8997021|NCT02844543|10060441|FG000|NOT COMPLETED|Overall Study||5
8997022|NCT02844569|10060447|FG000|STARTED|Overall Study||12
8633793|NCT00552929|9673958|FG006|COMPLETED|Overall Study||10
8633794|NCT00552929|9673959|FG007|COMPLETED|Overall Study||11
8997023|NCT02844569|10060448|FG001|STARTED|Overall Study||12
8997024|NCT02844569|10060447|FG000|COMPLETED|Overall Study||12
8997025|NCT02844569|10060448|FG001|COMPLETED|Overall Study||12
8997026|NCT02844569|10060447|FG000|NOT COMPLETED|Overall Study||0
8997027|NCT02844569|10060448|FG001|NOT COMPLETED|Overall Study||0
8997028|NCT02844582|10060454|FG000|STARTED|Overall Study||2
8997029|NCT02844582|10060454|FG000|COMPLETED|Overall Study||2
8997030|NCT02844582|10060454|FG000|NOT COMPLETED|Overall Study||0
8997031|NCT02844920|10060458|FG000|STARTED|Overall Study||37
8997032|NCT02844920|10060458|FG000|Completed Without Evaluable Videos|Overall Study|Participants with completed the follow-up but without evaluable hysteroscopy videos|1
8997033|NCT02844920|10060458|FG000|Completed With Evaluable Videos|Overall Study|Participants with completed the follow-up and evaluable hysteroscopy videos|34
8997034|NCT02844920|10060458|FG000|Completed, Eval. Data, Opposing Fibroids|Overall Study|Participants with completed the follow-up, evaluable hysteroscopy videos, and opposing fibroids|6
8997035|NCT02844920|10060458|FG000|COMPLETED|Overall Study|Participants with completed the follow-up|35
8997036|NCT02844920|10060458|FG000|NOT COMPLETED|Overall Study||2
8997037|NCT02844998|10060465|FG000|STARTED|Overall Study||42
8997038|NCT02844998|10060466|FG001|STARTED|Overall Study||39
8997039|NCT02844998|10060467|FG002|STARTED|Overall Study||39
8997040|NCT02844998|10060465|FG000|COMPLETED|Overall Study||35
8997041|NCT02844998|10060466|FG001|COMPLETED|Overall Study||35
8997042|NCT02844998|10060467|FG002|COMPLETED|Overall Study||35
8997043|NCT02844998|10060465|FG000|NOT COMPLETED|Overall Study||7
8997044|NCT02844998|10060466|FG001|NOT COMPLETED|Overall Study||4
8997045|NCT02844998|10060467|FG002|NOT COMPLETED|Overall Study||4
8997046|NCT02845336|10060477|FG000|STARTED|Overall Study||6
8997047|NCT02845336|10060478|FG001|STARTED|Overall Study||1
8997048|NCT02845336|10060477|FG000|COMPLETED|Overall Study||1
8997049|NCT02845336|10060478|FG001|COMPLETED|Overall Study||0
8997050|NCT02845336|10060477|FG000|NOT COMPLETED|Overall Study||5
8997051|NCT02845336|10060478|FG001|NOT COMPLETED|Overall Study||1
8997052|NCT02845375|10060487|FG000|STARTED|Overall Study||13
8997053|NCT02845375|10060488|FG001|STARTED|Overall Study||14
8997054|NCT02845375|10060489|FG002|STARTED|Overall Study||13
8997055|NCT02845375|10060487|FG000|COMPLETED|Overall Study||12
8997056|NCT02845375|10060488|FG001|COMPLETED|Overall Study||12
8997057|NCT02845375|10060489|FG002|COMPLETED|Overall Study||12
8997058|NCT02845375|10060487|FG000|NOT COMPLETED|Overall Study||1
8997059|NCT02845375|10060488|FG001|NOT COMPLETED|Overall Study||2
8997060|NCT02845375|10060489|FG002|NOT COMPLETED|Overall Study||1
8997061|NCT02845674|10060499|FG000|STARTED|Overall Study||129
8997062|NCT02845674|10060500|FG001|STARTED|Overall Study||129
8997063|NCT02845674|10060499|FG000|COMPLETED|Overall Study||111
8997064|NCT02845674|10060500|FG001|COMPLETED|Overall Study||79
8997065|NCT02845674|10060499|FG000|NOT COMPLETED|Overall Study||18
8997066|NCT02845674|10060500|FG001|NOT COMPLETED|Overall Study||50
8997067|NCT02845700|10060508|FG000|STARTED|Baseline Appointment||6
8997068|NCT02845700|10060509|FG001|STARTED|Baseline Appointment||7
8997069|NCT02845700|10060508|FG000|COMPLETED|Baseline Appointment||6
8997070|NCT02845700|10060509|FG001|COMPLETED|Baseline Appointment||7
8997071|NCT02845700|10060508|FG000|NOT COMPLETED|Baseline Appointment||0
8997072|NCT02845700|10060509|FG001|NOT COMPLETED|Baseline Appointment||0
8997073|NCT02845700|10060508|FG000|STARTED|Intervention Session 1|1 participant withdrew after completing the Baseline Appointment|5
8997074|NCT02845700|10060509|FG001|STARTED|Intervention Session 1|1 participant withdrew after completing the Baseline Appointment|6
8997075|NCT02845700|10060508|FG000|COMPLETED|Intervention Session 1||5
8997076|NCT02845700|10060509|FG001|COMPLETED|Intervention Session 1||6
8997077|NCT02845700|10060508|FG000|NOT COMPLETED|Intervention Session 1||0
8997078|NCT02845700|10060509|FG001|NOT COMPLETED|Intervention Session 1||0
8997079|NCT02845700|10060508|FG000|STARTED|Intervention Session 2||5
8997080|NCT02845700|10060509|FG001|STARTED|Intervention Session 2||6
8997081|NCT02845700|10060508|FG000|COMPLETED|Intervention Session 2||5
8997082|NCT02845700|10060509|FG001|COMPLETED|Intervention Session 2||6
8997083|NCT02845700|10060508|FG000|NOT COMPLETED|Intervention Session 2||0
8997084|NCT02845700|10060509|FG001|NOT COMPLETED|Intervention Session 2||0
8997085|NCT02845700|10060508|FG000|STARTED|Month 1 Follow-Up|3 participants withdrew after completing the Intervention 2 Appointment|2
8997086|NCT02845700|10060509|FG001|STARTED|Month 1 Follow-Up|2 participants withdrew after completing the Intervention 2 Appointment|4
8997087|NCT02845700|10060508|FG000|COMPLETED|Month 1 Follow-Up||2
8997088|NCT02845700|10060509|FG001|COMPLETED|Month 1 Follow-Up||4
8997089|NCT02845700|10060508|FG000|NOT COMPLETED|Month 1 Follow-Up||0
8997090|NCT02845700|10060509|FG001|NOT COMPLETED|Month 1 Follow-Up||0
8997091|NCT02845752|10060517|FG000|STARTED|First Intervention (7 Days)||7
8997092|NCT02845752|10060518|FG001|STARTED|First Intervention (7 Days)||7
8997093|NCT02845752|10060517|FG000|COMPLETED|First Intervention (7 Days)||7
8997094|NCT02845752|10060518|FG001|COMPLETED|First Intervention (7 Days)||7
8997095|NCT02845752|10060517|FG000|NOT COMPLETED|First Intervention (7 Days)||0
8997096|NCT02845752|10060518|FG001|NOT COMPLETED|First Intervention (7 Days)||0
8997097|NCT02845752|10060517|FG000|STARTED|Washout (14 Days)||7
8997098|NCT02845752|10060518|FG001|STARTED|Washout (14 Days)||7
8997099|NCT02845752|10060517|FG000|COMPLETED|Washout (14 Days)||7
8997100|NCT02845752|10060518|FG001|COMPLETED|Washout (14 Days)||7
8997101|NCT02845752|10060517|FG000|NOT COMPLETED|Washout (14 Days)||0
8997102|NCT02845752|10060518|FG001|NOT COMPLETED|Washout (14 Days)||0
8997103|NCT02845752|10060517|FG000|STARTED|Second Intervention (7 Days)||7
8997104|NCT02845752|10060518|FG001|STARTED|Second Intervention (7 Days)||7
8997105|NCT02845752|10060517|FG000|COMPLETED|Second Intervention (7 Days)||7
8997106|NCT02845752|10060518|FG001|COMPLETED|Second Intervention (7 Days)||7
8997107|NCT02845752|10060517|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
8997108|NCT02845752|10060518|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
8997109|NCT02846233|10060526|FG000|STARTED|Overall Study||12
8997110|NCT02846233|10060527|FG001|STARTED|Overall Study||10
8997111|NCT02846233|10060526|FG000|COMPLETED|Overall Study||10
8997112|NCT02846233|10060527|FG001|COMPLETED|Overall Study||8
8997113|NCT02846233|10060526|FG000|NOT COMPLETED|Overall Study||2
8997114|NCT02846233|10060527|FG001|NOT COMPLETED|Overall Study||2
8997115|NCT02846324|10060537|FG000|STARTED|Overall Study||9
8997116|NCT02846324|10060538|FG001|STARTED|Overall Study||6
8997117|NCT02846324|10060539|FG002|STARTED|Overall Study||14
8997118|NCT02846324|10060540|FG003|STARTED|Overall Study||10
8997119|NCT02846324|10060537|FG000|Completed Study Treatment|Overall Study||7
8997120|NCT02846324|10060538|FG001|Completed Study Treatment|Overall Study||5
8997121|NCT02846324|10060539|FG002|Completed Study Treatment|Overall Study||11
8997122|NCT02846324|10060540|FG003|Completed Study Treatment|Overall Study||10
8997123|NCT02846324|10060537|FG000|COMPLETED|Overall Study||7
8997124|NCT02846324|10060538|FG001|COMPLETED|Overall Study||6
8997125|NCT02846324|10060539|FG002|COMPLETED|Overall Study||10
8997126|NCT02846324|10060540|FG003|COMPLETED|Overall Study||10
8997127|NCT02846324|10060537|FG000|NOT COMPLETED|Overall Study||2
8997128|NCT02846324|10060538|FG001|NOT COMPLETED|Overall Study||0
8997129|NCT02846324|10060539|FG002|NOT COMPLETED|Overall Study||4
8997130|NCT02846324|10060540|FG003|NOT COMPLETED|Overall Study||0
8997131|NCT02846415|10060561|FG000|STARTED|Overall Study||18
8997132|NCT02846415|10060562|FG001|STARTED|Overall Study||12
8997133|NCT02846415|10060561|FG000|COMPLETED|Overall Study||15
8997134|NCT02846415|10060562|FG001|COMPLETED|Overall Study||11
8997135|NCT02846415|10060561|FG000|NOT COMPLETED|Overall Study||3
8997136|NCT02846415|10060562|FG001|NOT COMPLETED|Overall Study||1
8997137|NCT02846558|10060572|FG000|STARTED|Overall Study||15
8997138|NCT02846558|10060573|FG001|STARTED|Overall Study||12
8997139|NCT02846558|10060574|FG002|STARTED|Overall Study||14
8997140|NCT02846558|10060575|FG003|STARTED|Overall Study||13
8997141|NCT02846558|10060572|FG000|Baseline Study Visit|Overall Study||10
8997142|NCT02846558|10060573|FG001|Baseline Study Visit|Overall Study||9
8997143|NCT02846558|10060574|FG002|Baseline Study Visit|Overall Study||14
8997144|NCT02846558|10060575|FG003|Baseline Study Visit|Overall Study||12
8997145|NCT02846558|10060572|FG000|3 Month Study Visit|Overall Study||7
8997146|NCT02846558|10060573|FG001|3 Month Study Visit|Overall Study||8
8997147|NCT02846558|10060574|FG002|3 Month Study Visit|Overall Study||12
8997148|NCT02846558|10060575|FG003|3 Month Study Visit|Overall Study||11
8997149|NCT02846558|10060572|FG000|COMPLETED|Overall Study||7
8997150|NCT02846558|10060573|FG001|COMPLETED|Overall Study||8
8997151|NCT02846558|10060574|FG002|COMPLETED|Overall Study||12
8997152|NCT02846558|10060575|FG003|COMPLETED|Overall Study||11
8997153|NCT02846558|10060572|FG000|NOT COMPLETED|Overall Study||8
8997154|NCT02846558|10060573|FG001|NOT COMPLETED|Overall Study||4
8997155|NCT02846558|10060574|FG002|NOT COMPLETED|Overall Study||2
8997156|NCT02846558|10060575|FG003|NOT COMPLETED|Overall Study||2
8997157|NCT02846714|10060592|FG000|STARTED|Overall Study||42
8997158|NCT02846714|10060592|FG000|COMPLETED|Overall Study||36
8997159|NCT02846714|10060592|FG000|NOT COMPLETED|Overall Study||6
8997160|NCT02846740|10060598|FG000|STARTED|Overall Study||15
8997161|NCT02846740|10060599|FG001|STARTED|Overall Study||15
8997162|NCT02846740|10060598|FG000|COMPLETED|Overall Study||15
8997163|NCT02846740|10060599|FG001|COMPLETED|Overall Study||14
8997164|NCT02846740|10060598|FG000|NOT COMPLETED|Overall Study||0
8997165|NCT02846740|10060599|FG001|NOT COMPLETED|Overall Study||1
8997166|NCT02846779|10060608|FG000|STARTED|Overall Study||2000
8997167|NCT02846779|10060609|FG001|STARTED|Overall Study||2000
8997168|NCT02846779|10060610|FG002|STARTED|Overall Study||2000
8997169|NCT02846779|10060608|FG000|COMPLETED|Overall Study||1861
8997170|NCT02846779|10060609|FG001|COMPLETED|Overall Study||1873
8997171|NCT02846779|10060610|FG002|COMPLETED|Overall Study||1862
8997172|NCT02846779|10060608|FG000|NOT COMPLETED|Overall Study||139
8997173|NCT02846779|10060609|FG001|NOT COMPLETED|Overall Study||127
8997174|NCT02846779|10060610|FG002|NOT COMPLETED|Overall Study||138
8997175|NCT02846792|10060618|FG000|STARTED|Overall Study||5
8997176|NCT02846792|10060618|FG000|COMPLETED|Overall Study||5
8997177|NCT02846792|10060618|FG000|NOT COMPLETED|Overall Study||0
8997178|NCT02847169|10060622|FG000|STARTED|First Intervention (1 Week)||15
8997179|NCT02847169|10060623|FG001|STARTED|First Intervention (1 Week)||15
8997180|NCT02847169|10060622|FG000|COMPLETED|First Intervention (1 Week)||15
8997181|NCT02847169|10060623|FG001|COMPLETED|First Intervention (1 Week)||15
8997182|NCT02847169|10060622|FG000|NOT COMPLETED|First Intervention (1 Week)||0
8997183|NCT02847169|10060623|FG001|NOT COMPLETED|First Intervention (1 Week)||0
8997184|NCT02847169|10060622|FG000|STARTED|Second Intervention (1 Week)||15
8997185|NCT02847169|10060623|FG001|STARTED|Second Intervention (1 Week)||15
8997186|NCT02847169|10060622|FG000|COMPLETED|Second Intervention (1 Week)||15
8997187|NCT02847169|10060623|FG001|COMPLETED|Second Intervention (1 Week)||15
8997188|NCT02847169|10060622|FG000|NOT COMPLETED|Second Intervention (1 Week)||0
8997189|NCT02847169|10060623|FG001|NOT COMPLETED|Second Intervention (1 Week)||0
8997190|NCT02847182|10060646|FG000|STARTED|Overall Study||119
8997191|NCT02847182|10060647|FG001|STARTED|Overall Study||61
8997192|NCT02847182|10060646|FG000|First Intervention (6 Months)|Overall Study||119
8997193|NCT02847182|10060647|FG001|First Intervention (6 Months)|Overall Study||61
8997194|NCT02847182|10060646|FG000|Second Intervention (6 Months)|Overall Study||61
8997195|NCT02847182|10060647|FG001|Second Intervention (6 Months)|Overall Study||119
8997196|NCT02847182|10060646|FG000|COMPLETED|Overall Study||119
8997197|NCT02847182|10060647|FG001|COMPLETED|Overall Study||60
8997198|NCT02847182|10060646|FG000|NOT COMPLETED|Overall Study||0
8997199|NCT02847182|10060647|FG001|NOT COMPLETED|Overall Study||1
8997200|NCT02847260|10060659|FG000|STARTED|Overall Study||39
8997201|NCT02847260|10060659|FG000|COMPLETED|Overall Study||32
8997202|NCT02847260|10060659|FG000|NOT COMPLETED|Overall Study||7
8997203|NCT02847494|10060665|FG000|STARTED|Overall Study||109
8997204|NCT02847494|10060666|FG001|STARTED|Overall Study||111
8997205|NCT02847494|10060665|FG000|COMPLETED|Overall Study||101
8997206|NCT02847494|10060666|FG001|COMPLETED|Overall Study||106
8997207|NCT02847494|10060665|FG000|NOT COMPLETED|Overall Study||8
8997208|NCT02847494|10060666|FG001|NOT COMPLETED|Overall Study||5
8997209|NCT02847650|10060674|FG000|STARTED|Overall Study||29
8997210|NCT02847650|10060675|FG001|STARTED|Overall Study||28
8997211|NCT02847650|10060674|FG000|COMPLETED|Overall Study||25
8997212|NCT02847650|10060675|FG001|COMPLETED|Overall Study||22
8997213|NCT02847650|10060674|FG000|NOT COMPLETED|Overall Study||4
8997214|NCT02847650|10060675|FG001|NOT COMPLETED|Overall Study||6
8997215|NCT02847858|10060683|FG000|STARTED|Overall Study||693
8997216|NCT02847858|10060684|FG001|STARTED|Overall Study||667
8997217|NCT02847858|10060683|FG000|COMPLETED|Overall Study||292
8997218|NCT02847858|10060684|FG001|COMPLETED|Overall Study||398
8997219|NCT02847858|10060683|FG000|NOT COMPLETED|Overall Study||401
8997220|NCT02847858|10060684|FG001|NOT COMPLETED|Overall Study||269
8997221|NCT02848079|10060695|FG000|STARTED|Overall Study||41
8997222|NCT02848079|10060695|FG000|Receieved Study Treatment|Overall Study||41
8997223|NCT02848079|10060695|FG000|Discontinued|Overall Study||41
8997224|NCT02848079|10060695|FG000|COMPLETED|Overall Study||41
8997225|NCT02848079|10060695|FG000|NOT COMPLETED|Overall Study||0
8997226|NCT02848222|10060702|FG000|STARTED|Overall Study||25
8997227|NCT02848222|10060703|FG001|STARTED|Overall Study||18
8997228|NCT02848222|10060704|FG002|STARTED|Overall Study||17
8997229|NCT02848222|10060702|FG000|COMPLETED|Overall Study||18
8997230|NCT02848222|10060703|FG001|COMPLETED|Overall Study||17
8997231|NCT02848222|10060704|FG002|COMPLETED|Overall Study||17
8997232|NCT02848222|10060702|FG000|NOT COMPLETED|Overall Study||7
8997233|NCT02848222|10060703|FG001|NOT COMPLETED|Overall Study||1
8997234|NCT02848222|10060704|FG002|NOT COMPLETED|Overall Study||0
8997235|NCT02848313|10060714|FG000|STARTED|Overall Study||21
8997236|NCT02848313|10060715|FG001|STARTED|Overall Study||19
8997237|NCT02848313|10060714|FG000|COMPLETED|Overall Study||18
8997238|NCT02848313|10060715|FG001|COMPLETED|Overall Study||15
8997239|NCT02848313|10060714|FG000|NOT COMPLETED|Overall Study||3
8997240|NCT02848313|10060715|FG001|NOT COMPLETED|Overall Study||4
8997241|NCT02848326|10060727|FG000|STARTED|Treatment Period||186
8997242|NCT02848326|10060728|FG001|STARTED|Treatment Period||94
8997243|NCT02848326|10060729|FG002|STARTED|Treatment Period||185
8997244|NCT02848326|10060730|FG003|STARTED|Treatment Period||187
8997245|NCT02848326|10060731|FG004|STARTED|Treatment Period||89
8997246|NCT02848326|10060732|FG005|STARTED|Treatment Period||93
8997247|NCT02848326|10060727|FG000|Safety Population: Received Study Drug|Treatment Period||186
8997248|NCT02848326|10060728|FG001|Safety Population: Received Study Drug|Treatment Period||93
8997249|NCT02848326|10060729|FG002|Safety Population: Received Study Drug|Treatment Period||183
8997250|NCT02848326|10060730|FG003|Safety Population: Received Study Drug|Treatment Period||186
8997251|NCT02848326|10060731|FG004|Safety Population: Received Study Drug|Treatment Period||86
8997252|NCT02848326|10060732|FG005|Safety Population: Received Study Drug|Treatment Period||91
8997253|NCT02848326|10060727|FG000|COMPLETED|Treatment Period||148
8997254|NCT02848326|10060728|FG001|COMPLETED|Treatment Period||80
8997255|NCT02848326|10060729|FG002|COMPLETED|Treatment Period||149
8997256|NCT02848326|10060730|FG003|COMPLETED|Treatment Period||164
8997257|NCT02848326|10060731|FG004|COMPLETED|Treatment Period||70
8997258|NCT02848326|10060732|FG005|COMPLETED|Treatment Period||73
8997259|NCT02848326|10060727|FG000|NOT COMPLETED|Treatment Period||38
8997260|NCT02848326|10060728|FG001|NOT COMPLETED|Treatment Period||14
8997261|NCT02848326|10060729|FG002|NOT COMPLETED|Treatment Period||36
8997262|NCT02848326|10060730|FG003|NOT COMPLETED|Treatment Period||23
8997263|NCT02848326|10060731|FG004|NOT COMPLETED|Treatment Period||19
8997264|NCT02848326|10060732|FG005|NOT COMPLETED|Treatment Period||20
8997265|NCT02848326|10060727|FG000|STARTED|Safety Follow-up Period||161
8997266|NCT02848326|10060728|FG001|STARTED|Safety Follow-up Period||84
8997267|NCT02848326|10060729|FG002|STARTED|Safety Follow-up Period||156
8997268|NCT02848326|10060730|FG003|STARTED|Safety Follow-up Period||169
8997269|NCT02848326|10060731|FG004|STARTED|Safety Follow-up Period||77
8997270|NCT02848326|10060732|FG005|STARTED|Safety Follow-up Period||82
8997271|NCT02848326|10060727|FG000|COMPLETED|Safety Follow-up Period||157
8997272|NCT02848326|10060728|FG001|COMPLETED|Safety Follow-up Period||83
8997273|NCT02848326|10060729|FG002|COMPLETED|Safety Follow-up Period||153
8997274|NCT02848326|10060730|FG003|COMPLETED|Safety Follow-up Period||169
8997275|NCT02848326|10060731|FG004|COMPLETED|Safety Follow-up Period||76
8997276|NCT02848326|10060732|FG005|COMPLETED|Safety Follow-up Period||77
8997277|NCT02848326|10060727|FG000|NOT COMPLETED|Safety Follow-up Period||4
8997278|NCT02848326|10060728|FG001|NOT COMPLETED|Safety Follow-up Period||1
8997279|NCT02848326|10060729|FG002|NOT COMPLETED|Safety Follow-up Period||3
8997280|NCT02848326|10060730|FG003|NOT COMPLETED|Safety Follow-up Period||0
8997281|NCT02848326|10060731|FG004|NOT COMPLETED|Safety Follow-up Period||1
8997282|NCT02848326|10060732|FG005|NOT COMPLETED|Safety Follow-up Period||5
8997283|NCT02848599|10060748|FG000|STARTED|Overall Study||42
8997284|NCT02848599|10060749|FG001|STARTED|Overall Study||44
8997285|NCT02848599|10060748|FG000|COMPLETED|Overall Study||35
8997286|NCT02848599|10060749|FG001|COMPLETED|Overall Study||35
8997287|NCT02848599|10060748|FG000|NOT COMPLETED|Overall Study||7
8997288|NCT02848599|10060749|FG001|NOT COMPLETED|Overall Study||9
8997289|NCT02848651|10060757|FG000|STARTED|Overall Study||153
8997290|NCT02848651|10060757|FG000|Received Treatment|Overall Study||152
8997291|NCT02848651|10060757|FG000|COMPLETED|Overall Study||47
8997292|NCT02848651|10060757|FG000|NOT COMPLETED|Overall Study||106
8997293|NCT02848664|10060777|FG000|STARTED|Overall Study||11
8997294|NCT02848664|10060777|FG000|COMPLETED|Overall Study||7
8997295|NCT02848664|10060777|FG000|NOT COMPLETED|Overall Study||4
8997296|NCT02848729|10060787|FG000|STARTED|Overall Study||27
8997297|NCT02848729|10060788|FG001|STARTED|Overall Study||23
8997298|NCT02848729|10060787|FG000|Per Protocol Population|Overall Study||11
8997299|NCT02848729|10060788|FG001|Per Protocol Population|Overall Study||11
8879364|NCT01933672|9936178|FG001|STARTED|First Intervention Period (12-16 Days)||7
8879365|NCT01933672|9936179|FG002|STARTED|First Intervention Period (12-16 Days)||3
8879366|NCT01933672|9936180|FG003|STARTED|First Intervention Period (12-16 Days)||5
8879367|NCT01933672|9936181|FG004|STARTED|First Intervention Period (12-16 Days)||7
8879368|NCT01933672|9936182|FG005|STARTED|First Intervention Period (12-16 Days)||5
8879369|NCT01933672|9936183|FG006|STARTED|First Intervention Period (12-16 Days)||6
8879370|NCT01933672|9936177|FG000|COMPLETED|First Intervention Period (12-16 Days)||0
8879371|NCT01933672|9936178|FG001|COMPLETED|First Intervention Period (12-16 Days)||7
8879372|NCT01933672|9936179|FG002|COMPLETED|First Intervention Period (12-16 Days)||2
8879373|NCT01933672|9936180|FG003|COMPLETED|First Intervention Period (12-16 Days)||5
8879374|NCT01933672|9936181|FG004|COMPLETED|First Intervention Period (12-16 Days)||6
8879375|NCT01933672|9936182|FG005|COMPLETED|First Intervention Period (12-16 Days)||4
8879376|NCT01933672|9936183|FG006|COMPLETED|First Intervention Period (12-16 Days)||6
8879377|NCT01933672|9936177|FG000|NOT COMPLETED|First Intervention Period (12-16 Days)||0
8879378|NCT01933672|9936178|FG001|NOT COMPLETED|First Intervention Period (12-16 Days)||0
8879379|NCT01933672|9936179|FG002|NOT COMPLETED|First Intervention Period (12-16 Days)||1
8879380|NCT01933672|9936180|FG003|NOT COMPLETED|First Intervention Period (12-16 Days)||0
8879381|NCT01933672|9936181|FG004|NOT COMPLETED|First Intervention Period (12-16 Days)||1
8879382|NCT01933672|9936182|FG005|NOT COMPLETED|First Intervention Period (12-16 Days)||1
8879383|NCT01933672|9936183|FG006|NOT COMPLETED|First Intervention Period (12-16 Days)||0
8879384|NCT01933672|9936177|FG000|STARTED|First Washout Period (7-14 Days)||0
8879385|NCT01933672|9936178|FG001|STARTED|First Washout Period (7-14 Days)||7
8879386|NCT01933672|9936179|FG002|STARTED|First Washout Period (7-14 Days)||2
8879387|NCT01933672|9936180|FG003|STARTED|First Washout Period (7-14 Days)||5
8879388|NCT01933672|9936181|FG004|STARTED|First Washout Period (7-14 Days)||6
8879389|NCT01933672|9936182|FG005|STARTED|First Washout Period (7-14 Days)||4
8879390|NCT01933672|9936183|FG006|STARTED|First Washout Period (7-14 Days)||6
8879391|NCT01933672|9936177|FG000|COMPLETED|First Washout Period (7-14 Days)||0
8879392|NCT01933672|9936178|FG001|COMPLETED|First Washout Period (7-14 Days)||7
8879393|NCT01933672|9936179|FG002|COMPLETED|First Washout Period (7-14 Days)||2
8879394|NCT01933672|9936180|FG003|COMPLETED|First Washout Period (7-14 Days)||5
8879395|NCT01933672|9936181|FG004|COMPLETED|First Washout Period (7-14 Days)||6
8879396|NCT01933672|9936182|FG005|COMPLETED|First Washout Period (7-14 Days)||4
8879397|NCT01933672|9936183|FG006|COMPLETED|First Washout Period (7-14 Days)||6
8879398|NCT01933672|9936177|FG000|NOT COMPLETED|First Washout Period (7-14 Days)||0
8879399|NCT01933672|9936178|FG001|NOT COMPLETED|First Washout Period (7-14 Days)||0
8879400|NCT01933672|9936179|FG002|NOT COMPLETED|First Washout Period (7-14 Days)||0
8879401|NCT01933672|9936180|FG003|NOT COMPLETED|First Washout Period (7-14 Days)||0
8879402|NCT01933672|9936181|FG004|NOT COMPLETED|First Washout Period (7-14 Days)||0
8879403|NCT01933672|9936182|FG005|NOT COMPLETED|First Washout Period (7-14 Days)||0
8879404|NCT01933672|9936183|FG006|NOT COMPLETED|First Washout Period (7-14 Days)||0
8879405|NCT01933672|9936177|FG000|STARTED|Second Intervention Period (12-16 Days)||0
8879406|NCT01933672|9936178|FG001|STARTED|Second Intervention Period (12-16 Days)||7
8879407|NCT01933672|9936179|FG002|STARTED|Second Intervention Period (12-16 Days)||2
8879408|NCT01933672|9936180|FG003|STARTED|Second Intervention Period (12-16 Days)||5
8879409|NCT01933672|9936181|FG004|STARTED|Second Intervention Period (12-16 Days)||6
8879410|NCT01933672|9936182|FG005|STARTED|Second Intervention Period (12-16 Days)||4
8879411|NCT01933672|9936183|FG006|STARTED|Second Intervention Period (12-16 Days)||6
8879412|NCT01933672|9936177|FG000|COMPLETED|Second Intervention Period (12-16 Days)||0
8879413|NCT01933672|9936178|FG001|COMPLETED|Second Intervention Period (12-16 Days)||6
8879414|NCT01933672|9936179|FG002|COMPLETED|Second Intervention Period (12-16 Days)||1
8879415|NCT01933672|9936180|FG003|COMPLETED|Second Intervention Period (12-16 Days)||5
8997300|NCT02848729|10060787|FG000|Safety Population|Overall Study||27
8997301|NCT02848729|10060788|FG001|Safety Population|Overall Study||23
8997302|NCT02848729|10060787|FG000|COMPLETED|Overall Study||11
8997303|NCT02848729|10060788|FG001|COMPLETED|Overall Study||12
8997304|NCT02848729|10060787|FG000|NOT COMPLETED|Overall Study||16
8997305|NCT02848729|10060788|FG001|NOT COMPLETED|Overall Study||11
8997306|NCT02848833|10060801|FG000|STARTED|Overall Study||3368
8997307|NCT02848833|10060801|FG000|COMPLETED|Overall Study||3231
8997308|NCT02848833|10060801|FG000|NOT COMPLETED|Overall Study||137
8997309|NCT02849080|10060807|FG000|STARTED|Main Phase: 0 - 52 Weeks||253
8997310|NCT02849080|10060808|FG001|STARTED|Main Phase: 0 - 52 Weeks||251
8997311|NCT02849080|10060809|FG002|STARTED|Main Phase: 0 - 52 Weeks||0
8997312|NCT02849080|10060810|FG003|STARTED|Main Phase: 0 - 52 Weeks||0
8997313|NCT02849080|10060807|FG000|Exposed|Main Phase: 0 - 52 Weeks||253
8997314|NCT02849080|10060808|FG001|Exposed|Main Phase: 0 - 52 Weeks||250
8997315|NCT02849080|10060809|FG002|Exposed|Main Phase: 0 - 52 Weeks||0
8997316|NCT02849080|10060810|FG003|Exposed|Main Phase: 0 - 52 Weeks||0
8997317|NCT02849080|10060807|FG000|Full Analysis Set (FAS)|Main Phase: 0 - 52 Weeks||253
8997318|NCT02849080|10060808|FG001|Full Analysis Set (FAS)|Main Phase: 0 - 52 Weeks||251
8997319|NCT02849080|10060809|FG002|Full Analysis Set (FAS)|Main Phase: 0 - 52 Weeks||0
8997320|NCT02849080|10060810|FG003|Full Analysis Set (FAS)|Main Phase: 0 - 52 Weeks||0
9039318|NCT03337308|10100247|FG001|STARTED|Overall Study||110
8997321|NCT02849080|10060807|FG000|Safety Analysis Set (SAS)|Main Phase: 0 - 52 Weeks||253
8997322|NCT02849080|10060808|FG001|Safety Analysis Set (SAS)|Main Phase: 0 - 52 Weeks||250
8997323|NCT02849080|10060809|FG002|Safety Analysis Set (SAS)|Main Phase: 0 - 52 Weeks||0
8997324|NCT02849080|10060810|FG003|Safety Analysis Set (SAS)|Main Phase: 0 - 52 Weeks||0
8997325|NCT02849080|10060807|FG000|COMPLETED|Main Phase: 0 - 52 Weeks||241
8997326|NCT02849080|10060808|FG001|COMPLETED|Main Phase: 0 - 52 Weeks||244
8997327|NCT02849080|10060809|FG002|COMPLETED|Main Phase: 0 - 52 Weeks||0
8997328|NCT02849080|10060810|FG003|COMPLETED|Main Phase: 0 - 52 Weeks||0
8997329|NCT02849080|10060807|FG000|NOT COMPLETED|Main Phase: 0 - 52 Weeks||12
8997330|NCT02849080|10060808|FG001|NOT COMPLETED|Main Phase: 0 - 52 Weeks||7
8997331|NCT02849080|10060809|FG002|NOT COMPLETED|Main Phase: 0 - 52 Weeks||0
8997332|NCT02849080|10060810|FG003|NOT COMPLETED|Main Phase: 0 - 52 Weeks||0
8997333|NCT02849080|10060807|FG000|STARTED|Extension Phase: 53 - 104 Weeks|Participants who had provided consent to continue in the extension phase started in this period.|185
8997334|NCT02849080|10060808|FG001|STARTED|Extension Phase: 53 - 104 Weeks||0
8997335|NCT02849080|10060809|FG002|STARTED|Extension Phase: 53 - 104 Weeks|Participants who had provided consent to continue in the extension phase started in this period.|100
8997336|NCT02849080|10060810|FG003|STARTED|Extension Phase: 53 - 104 Weeks|Participants who had provided consent to continue in the extension phase started in this period.|98
8997337|NCT02849080|10060807|FG000|Exposed|Extension Phase: 53 - 104 Weeks||184
8997338|NCT02849080|10060808|FG001|Exposed|Extension Phase: 53 - 104 Weeks||0
8997339|NCT02849080|10060809|FG002|Exposed|Extension Phase: 53 - 104 Weeks||100
8997340|NCT02849080|10060810|FG003|Exposed|Extension Phase: 53 - 104 Weeks||97
8997341|NCT02849080|10060807|FG000|COMPLETED|Extension Phase: 53 - 104 Weeks||182
8997342|NCT02849080|10060808|FG001|COMPLETED|Extension Phase: 53 - 104 Weeks||0
8997343|NCT02849080|10060809|FG002|COMPLETED|Extension Phase: 53 - 104 Weeks||99
8997344|NCT02849080|10060810|FG003|COMPLETED|Extension Phase: 53 - 104 Weeks||98
8997345|NCT02849080|10060807|FG000|NOT COMPLETED|Extension Phase: 53 - 104 Weeks||3
8997346|NCT02849080|10060808|FG001|NOT COMPLETED|Extension Phase: 53 - 104 Weeks||0
8997347|NCT02849080|10060809|FG002|NOT COMPLETED|Extension Phase: 53 - 104 Weeks||1
8997348|NCT02849080|10060810|FG003|NOT COMPLETED|Extension Phase: 53 - 104 Weeks||0
8997349|NCT02849184|10060824|FG000|STARTED|Overall Study||40
8997350|NCT02849184|10060825|FG001|STARTED|Overall Study||42
8997351|NCT02849184|10060824|FG000|COMPLETED|Overall Study||40
8997352|NCT02849184|10060825|FG001|COMPLETED|Overall Study||42
8997353|NCT02849184|10060824|FG000|NOT COMPLETED|Overall Study||0
8997354|NCT02849184|10060825|FG001|NOT COMPLETED|Overall Study||0
8997355|NCT02849418|10060833|FG000|STARTED|Double-blinded (Up to 48 Weeks)||10
8997356|NCT02849418|10060834|FG001|STARTED|Double-blinded (Up to 48 Weeks)||11
8997357|NCT02849418|10060835|FG002|STARTED|Double-blinded (Up to 48 Weeks)||0
8997358|NCT02849418|10060836|FG003|STARTED|Double-blinded (Up to 48 Weeks)||0
8997359|NCT02849418|10060837|FG004|STARTED|Double-blinded (Up to 48 Weeks)||0
8997360|NCT02849418|10060838|FG005|STARTED|Double-blinded (Up to 48 Weeks)||0
8997361|NCT02849418|10060833|FG000|COMPLETED|Double-blinded (Up to 48 Weeks)||10
8997362|NCT02849418|10060834|FG001|COMPLETED|Double-blinded (Up to 48 Weeks)||11
8997363|NCT02849418|10060835|FG002|COMPLETED|Double-blinded (Up to 48 Weeks)||0
8997364|NCT02849418|10060836|FG003|COMPLETED|Double-blinded (Up to 48 Weeks)||0
8997365|NCT02849418|10060837|FG004|COMPLETED|Double-blinded (Up to 48 Weeks)||0
8997366|NCT02849418|10060838|FG005|COMPLETED|Double-blinded (Up to 48 Weeks)||0
8997367|NCT02849418|10060833|FG000|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
8997368|NCT02849418|10060834|FG001|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
8997369|NCT02849418|10060835|FG002|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
8997370|NCT02849418|10060836|FG003|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
8997371|NCT02849418|10060837|FG004|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
8997372|NCT02849418|10060838|FG005|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
8997373|NCT02849418|10060833|FG000|STARTED|Open-label(2nd Treatment-Week 12 to 48)||0
8997374|NCT02849418|10060834|FG001|STARTED|Open-label(2nd Treatment-Week 12 to 48)||0
8997375|NCT02849418|10060835|FG002|STARTED|Open-label(2nd Treatment-Week 12 to 48)||10
8997376|NCT02849418|10060836|FG003|STARTED|Open-label(2nd Treatment-Week 12 to 48)||6
8997377|NCT02849418|10060837|FG004|STARTED|Open-label(2nd Treatment-Week 12 to 48)||0
8997378|NCT02849418|10060838|FG005|STARTED|Open-label(2nd Treatment-Week 12 to 48)||0
8997379|NCT02849418|10060833|FG000|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
8997380|NCT02849418|10060834|FG001|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
8997381|NCT02849418|10060835|FG002|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||10
8997382|NCT02849418|10060836|FG003|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||6
8997383|NCT02849418|10060837|FG004|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
8997384|NCT02849418|10060838|FG005|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
8997385|NCT02849418|10060833|FG000|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
8997386|NCT02849418|10060834|FG001|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
8997387|NCT02849418|10060835|FG002|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
8997388|NCT02849418|10060836|FG003|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
8997389|NCT02849418|10060837|FG004|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
8997390|NCT02849418|10060838|FG005|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
8997391|NCT02849418|10060833|FG000|STARTED|Open-label(3rd Treatment-Week 12 to 48)||0
8997392|NCT02849418|10060834|FG001|STARTED|Open-label(3rd Treatment-Week 12 to 48)||0
8997393|NCT02849418|10060835|FG002|STARTED|Open-label(3rd Treatment-Week 12 to 48)||0
8997394|NCT02849418|10060836|FG003|STARTED|Open-label(3rd Treatment-Week 12 to 48)||0
8997395|NCT02849418|10060837|FG004|STARTED|Open-label(3rd Treatment-Week 12 to 48)||5
8997396|NCT02849418|10060838|FG005|STARTED|Open-label(3rd Treatment-Week 12 to 48)||3
8997397|NCT02849418|10060833|FG000|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
8997398|NCT02849418|10060834|FG001|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
8997399|NCT02849418|10060835|FG002|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
8997400|NCT02849418|10060836|FG003|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
8997401|NCT02849418|10060837|FG004|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||5
8997402|NCT02849418|10060838|FG005|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||3
8997403|NCT02849418|10060833|FG000|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
8997404|NCT02849418|10060834|FG001|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
8997405|NCT02849418|10060835|FG002|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
8997406|NCT02849418|10060836|FG003|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
8997407|NCT02849418|10060837|FG004|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
8997408|NCT02849418|10060838|FG005|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
8997409|NCT02849509|10060857|FG000|STARTED|Overall Study||379
8997410|NCT02849509|10060858|FG001|STARTED|Overall Study||591
8997411|NCT02849509|10060859|FG002|STARTED|Overall Study||343
8997412|NCT02849509|10060857|FG000|COMPLETED|Overall Study|Not prematurely discontinued from Pradaxa or VKA|289
8997413|NCT02849509|10060858|FG001|COMPLETED|Overall Study|Not prematurely discontinued from Pradaxa or VKA|425
8997414|NCT02849509|10060859|FG002|COMPLETED|Overall Study|Not prematurely discontinued from Pradaxa or VKA|258
8997415|NCT02849509|10060857|FG000|NOT COMPLETED|Overall Study||90
8997416|NCT02849509|10060858|FG001|NOT COMPLETED|Overall Study||166
8997417|NCT02849509|10060859|FG002|NOT COMPLETED|Overall Study||85
8997418|NCT02849678|10060871|FG000|STARTED|Overall Study||20
8997419|NCT02849678|10060872|FG001|STARTED|Overall Study||24
8997420|NCT02849678|10060871|FG000|COMPLETED|Overall Study||17
8997421|NCT02849678|10060872|FG001|COMPLETED|Overall Study||18
8997422|NCT02849678|10060871|FG000|NOT COMPLETED|Overall Study||3
8997423|NCT02849678|10060872|FG001|NOT COMPLETED|Overall Study||6
8997424|NCT02849704|10060880|FG000|STARTED|Washout Period - CP Subj on PERT - 3days||11
8997425|NCT02849704|10060881|FG001|STARTED|Washout Period - CP Subj on PERT - 3days||0
8997426|NCT02849704|10060880|FG000|COMPLETED|Washout Period - CP Subj on PERT - 3days||11
8997427|NCT02849704|10060881|FG001|COMPLETED|Washout Period - CP Subj on PERT - 3days||0
8997428|NCT02849704|10060880|FG000|NOT COMPLETED|Washout Period - CP Subj on PERT - 3days||0
8997429|NCT02849704|10060881|FG001|NOT COMPLETED|Washout Period - CP Subj on PERT - 3days||0
8997430|NCT02849704|10060880|FG000|STARTED|Baseline Assessments - All Subj - 7 Days||24
8572342|NCT00113555|9604475|FG000|COMPLETED|Overall Study|All treated patients were considered in the Intent to Treat analysis.|142
8572343|NCT00113555|9604475|FG000|NOT COMPLETED|Overall Study||79
8572344|NCT00113568|9604480|FG000|STARTED|Overall Study||784
8572345|NCT00113568|9604480|FG000|Intent to Treat Population|Overall Study||723
8997431|NCT02849704|10060881|FG001|STARTED|Baseline Assessments - All Subj - 7 Days||24
8997432|NCT02849704|10060880|FG000|COMPLETED|Baseline Assessments - All Subj - 7 Days||24
8997433|NCT02849704|10060881|FG001|COMPLETED|Baseline Assessments - All Subj - 7 Days||24
8997434|NCT02849704|10060880|FG000|NOT COMPLETED|Baseline Assessments - All Subj - 7 Days||0
8997435|NCT02849704|10060881|FG001|NOT COMPLETED|Baseline Assessments - All Subj - 7 Days||0
8997436|NCT02849704|10060880|FG000|STARTED|Assessment on PERT - CP Subj - 16 Days||24
8997437|NCT02849704|10060881|FG001|STARTED|Assessment on PERT - CP Subj - 16 Days||0
8997438|NCT02849704|10060880|FG000|COMPLETED|Assessment on PERT - CP Subj - 16 Days||21
8997439|NCT02849704|10060881|FG001|COMPLETED|Assessment on PERT - CP Subj - 16 Days||0
8997440|NCT02849704|10060880|FG000|NOT COMPLETED|Assessment on PERT - CP Subj - 16 Days||3
8997441|NCT02849704|10060881|FG001|NOT COMPLETED|Assessment on PERT - CP Subj - 16 Days||0
8997442|NCT02849938|10060893|FG000|STARTED|Overall Study||9
8997443|NCT02849938|10060894|FG001|STARTED|Overall Study||15
8997444|NCT02849938|10060893|FG000|COMPLETED|Overall Study||9
8997445|NCT02849938|10060894|FG001|COMPLETED|Overall Study||15
8997446|NCT02849938|10060893|FG000|NOT COMPLETED|Overall Study||0
8997447|NCT02849938|10060894|FG001|NOT COMPLETED|Overall Study||0
8997448|NCT02850068|10060900|FG000|STARTED|Overall Study||20
8997449|NCT02850068|10060900|FG000|COMPLETED|Overall Study||0
8997450|NCT02850068|10060900|FG000|NOT COMPLETED|Overall Study||20
8997451|NCT02850159|10060906|FG000|STARTED|Overall Study||16
8997452|NCT02850159|10060907|FG001|STARTED|Overall Study||16
8997453|NCT02850159|10060906|FG000|COMPLETED|Overall Study||16
8997454|NCT02850159|10060907|FG001|COMPLETED|Overall Study||16
8997455|NCT02850159|10060906|FG000|NOT COMPLETED|Overall Study||0
8997456|NCT02850159|10060907|FG001|NOT COMPLETED|Overall Study||0
8997457|NCT02850276|10060913|FG000|STARTED|Overall Study||76
8997458|NCT02850276|10060913|FG000|COMPLETED|Overall Study||15
8997459|NCT02850276|10060913|FG000|NOT COMPLETED|Overall Study||61
8997460|NCT02850601|10060920|FG000|STARTED|Overall Study||12
8997461|NCT02850601|10060921|FG001|STARTED|Overall Study||12
8997462|NCT02850601|10060920|FG000|COMPLETED|Overall Study||12
8997463|NCT02850601|10060921|FG001|COMPLETED|Overall Study||12
8997464|NCT02850601|10060920|FG000|NOT COMPLETED|Overall Study||0
8997465|NCT02850601|10060921|FG001|NOT COMPLETED|Overall Study||0
8997466|NCT02850965|10060929|FG000|STARTED|Overall Study||159
8997467|NCT02850965|10060930|FG001|STARTED|Overall Study||159
8997468|NCT02850965|10060929|FG000|Treated|Overall Study||159
8997469|NCT02850965|10060930|FG001|Treated|Overall Study||158
8997470|NCT02850965|10060929|FG000|COMPLETED|Overall Study||141
8997471|NCT02850965|10060930|FG001|COMPLETED|Overall Study||134
8997472|NCT02850965|10060929|FG000|NOT COMPLETED|Overall Study||18
8997473|NCT02850965|10060930|FG001|NOT COMPLETED|Overall Study||25
8997474|NCT02850978|10060936|FG000|STARTED|Overall Study||1335
8997475|NCT02850978|10060936|FG000|Case Report Form (CRF) Collected|Overall Study||1308
8997476|NCT02850978|10060936|FG000|Treated|Overall Study||1308
8997477|NCT02850978|10060936|FG000|COMPLETED|Overall Study||909
8997478|NCT02850978|10060936|FG000|NOT COMPLETED|Overall Study||426
8997479|NCT02851069|10060940|FG000|STARTED|Overall Study||65
8997480|NCT02851069|10060940|FG000|COMPLETED|Overall Study||59
8997481|NCT02851069|10060940|FG000|NOT COMPLETED|Overall Study||6
8997482|NCT02851108|10060947|FG000|STARTED|Overall Study||50
8997483|NCT02851108|10060948|FG001|STARTED|Overall Study||50
8997484|NCT02851108|10060947|FG000|COMPLETED|Overall Study||42
8997485|NCT02851108|10060948|FG001|COMPLETED|Overall Study||49
8997486|NCT02851108|10060947|FG000|NOT COMPLETED|Overall Study||8
8997487|NCT02851108|10060948|FG001|NOT COMPLETED|Overall Study||1
8997488|NCT02851615|10060956|FG000|STARTED|Overall Study||27
8997489|NCT02851615|10060957|FG001|STARTED|Overall Study||31
8997490|NCT02851615|10060956|FG000|COMPLETED|Overall Study||26
8997491|NCT02851615|10060957|FG001|COMPLETED|Overall Study||27
8997492|NCT02851615|10060956|FG000|NOT COMPLETED|Overall Study||1
8997493|NCT02851615|10060957|FG001|NOT COMPLETED|Overall Study||4
8997494|NCT02851823|10060964|FG000|STARTED|Overall Study||25
8997495|NCT02851823|10060964|FG000|1 Month|Overall Study||25
8997496|NCT02851823|10060964|FG000|3 Months|Overall Study||25
8997497|NCT02851823|10060964|FG000|COMPLETED|Overall Study||25
8997498|NCT02851823|10060964|FG000|NOT COMPLETED|Overall Study||0
8997499|NCT02852005|10060975|FG000|STARTED|Overall Study||4
8997500|NCT02852005|10060976|FG001|STARTED|Overall Study||4
8997501|NCT02852005|10060977|FG002|STARTED|Overall Study||6
8997502|NCT02852005|10060978|FG003|STARTED|Overall Study||6
8997503|NCT02852005|10060979|FG004|STARTED|Overall Study||7
8997504|NCT02852005|10060975|FG000|Month 0.5|Overall Study||3
8997505|NCT02852005|10060976|FG001|Month 0.5|Overall Study||4
8997506|NCT02852005|10060977|FG002|Month 0.5|Overall Study||6
8997507|NCT02852005|10060978|FG003|Month 0.5|Overall Study||6
8997508|NCT02852005|10060979|FG004|Month 0.5|Overall Study||7
8997509|NCT02852005|10060975|FG000|Month 4.5|Overall Study||3
8997510|NCT02852005|10060976|FG001|Month 4.5|Overall Study||4
8997511|NCT02852005|10060977|FG002|Month 4.5|Overall Study||6
8997512|NCT02852005|10060978|FG003|Month 4.5|Overall Study||6
8997513|NCT02852005|10060979|FG004|Month 4.5|Overall Study||7
8997514|NCT02852005|10060975|FG000|Month 10|Overall Study||3
8997515|NCT02852005|10060976|FG001|Month 10|Overall Study||3
8997516|NCT02852005|10060977|FG002|Month 10|Overall Study||6
8997517|NCT02852005|10060978|FG003|Month 10|Overall Study||5
8997518|NCT02852005|10060979|FG004|Month 10|Overall Study||7
8997519|NCT02852005|10060975|FG000|COMPLETED|Overall Study||3
8997520|NCT02852005|10060976|FG001|COMPLETED|Overall Study||4
8997521|NCT02852005|10060977|FG002|COMPLETED|Overall Study||6
8997522|NCT02852005|10060978|FG003|COMPLETED|Overall Study||6
8997523|NCT02852005|10060979|FG004|COMPLETED|Overall Study||6
8997524|NCT02852005|10060975|FG000|NOT COMPLETED|Overall Study||1
8997525|NCT02852005|10060976|FG001|NOT COMPLETED|Overall Study||0
8997526|NCT02852005|10060977|FG002|NOT COMPLETED|Overall Study||0
8633795|NCT00552929|9673960|FG008|COMPLETED|Overall Study||9
8633796|NCT00552929|9673961|FG009|COMPLETED|Overall Study||11
8997527|NCT02852005|10060978|FG003|NOT COMPLETED|Overall Study||0
8997528|NCT02852005|10060979|FG004|NOT COMPLETED|Overall Study||1
8997529|NCT02852265|10060995|FG000|STARTED|1-month Follow-up||10
8997530|NCT02852265|10060996|FG001|STARTED|1-month Follow-up||10
8997531|NCT02852265|10060995|FG000|COMPLETED|1-month Follow-up||10
8997532|NCT02852265|10060996|FG001|COMPLETED|1-month Follow-up||10
8997533|NCT02852265|10060995|FG000|NOT COMPLETED|1-month Follow-up||0
8997534|NCT02852265|10060996|FG001|NOT COMPLETED|1-month Follow-up||0
8997535|NCT02852265|10060995|FG000|STARTED|3-month Follow-up||10
8997536|NCT02852265|10060996|FG001|STARTED|3-month Follow-up||10
8997537|NCT02852265|10060995|FG000|COMPLETED|3-month Follow-up||9
8997538|NCT02852265|10060996|FG001|COMPLETED|3-month Follow-up||9
8997539|NCT02852265|10060995|FG000|NOT COMPLETED|3-month Follow-up||1
8997540|NCT02852265|10060996|FG001|NOT COMPLETED|3-month Follow-up||1
8997541|NCT02852265|10060995|FG000|STARTED|6-month Follow-up||9
8997542|NCT02852265|10060996|FG001|STARTED|6-month Follow-up||9
8997543|NCT02852265|10060995|FG000|COMPLETED|6-month Follow-up||9
8997544|NCT02852265|10060996|FG001|COMPLETED|6-month Follow-up||9
8997545|NCT02852265|10060995|FG000|NOT COMPLETED|6-month Follow-up||0
8997546|NCT02852265|10060996|FG001|NOT COMPLETED|6-month Follow-up||0
8997547|NCT02852330|10061006|FG000|STARTED|Overall Study||20
8997548|NCT02852330|10061006|FG000|COMPLETED|Overall Study||20
8997549|NCT02852330|10061006|FG000|NOT COMPLETED|Overall Study||0
8997550|NCT02852434|10061012|FG000|STARTED|Overall Study||36
8997551|NCT02852434|10061013|FG001|STARTED|Overall Study||36
8997552|NCT02852434|10061012|FG000|COMPLETED|Overall Study||34
8997553|NCT02852434|10061013|FG001|COMPLETED|Overall Study||35
8997554|NCT02852434|10061012|FG000|NOT COMPLETED|Overall Study||2
8997555|NCT02852434|10061013|FG001|NOT COMPLETED|Overall Study||1
8997556|NCT02853032|10061021|FG000|STARTED|Overall Study||60
8997557|NCT02853032|10061022|FG001|STARTED|Overall Study||59
8997558|NCT02853032|10061021|FG000|COMPLETED|Overall Study|"Evaluable = 10 or more irTMS sessions Completers = 15 or more irTMS sessions"|51
8997559|NCT02853032|10061022|FG001|COMPLETED|Overall Study|"Evaluable = 10 or more irTMS sessions Completers = 15 or more irTMS sessions"|56
8997560|NCT02853032|10061021|FG000|NOT COMPLETED|Overall Study||9
8997561|NCT02853032|10061022|FG001|NOT COMPLETED|Overall Study||3
8997562|NCT02853123|10061030|FG000|STARTED|Treatment Period 1||52
8997563|NCT02853123|10061031|FG001|STARTED|Treatment Period 1||54
8997564|NCT02853123|10061030|FG000|COMPLETED|Treatment Period 1||52
8997565|NCT02853123|10061031|FG001|COMPLETED|Treatment Period 1||51
8997566|NCT02853123|10061030|FG000|NOT COMPLETED|Treatment Period 1||0
8997567|NCT02853123|10061031|FG001|NOT COMPLETED|Treatment Period 1||3
8997568|NCT02853123|10061030|FG000|STARTED|Washout Period||52
8997569|NCT02853123|10061031|FG001|STARTED|Washout Period||51
8997570|NCT02853123|10061030|FG000|COMPLETED|Washout Period||51
8997571|NCT02853123|10061031|FG001|COMPLETED|Washout Period||48
8997572|NCT02853123|10061030|FG000|NOT COMPLETED|Washout Period||1
8997573|NCT02853123|10061031|FG001|NOT COMPLETED|Washout Period||3
8997574|NCT02853123|10061030|FG000|STARTED|Treatment Period 2||51
8997575|NCT02853123|10061031|FG001|STARTED|Treatment Period 2||48
8997576|NCT02853123|10061030|FG000|COMPLETED|Treatment Period 2||51
8997577|NCT02853123|10061031|FG001|COMPLETED|Treatment Period 2||48
8997578|NCT02853123|10061030|FG000|NOT COMPLETED|Treatment Period 2||0
8997579|NCT02853123|10061031|FG001|NOT COMPLETED|Treatment Period 2||0
8997580|NCT02853318|10061038|FG000|STARTED|Overall Study||40
8997581|NCT02853318|10061038|FG000|COMPLETED|Overall Study||39
8997582|NCT02853318|10061038|FG000|NOT COMPLETED|Overall Study||1
8997583|NCT02853435|10061045|FG000|STARTED|Part 1a, Period 1 (3 Days)||9
8997584|NCT02853435|10061046|FG001|STARTED|Part 1a, Period 1 (3 Days)||9
8997585|NCT02853435|10061047|FG002|STARTED|Part 1a, Period 1 (3 Days)||8
8997586|NCT02853435|10061048|FG003|STARTED|Part 1a, Period 1 (3 Days)||0
8997587|NCT02853435|10061049|FG004|STARTED|Part 1a, Period 1 (3 Days)||0
8997588|NCT02853435|10061050|FG005|STARTED|Part 1a, Period 1 (3 Days)||0
8997589|NCT02853435|10061045|FG000|COMPLETED|Part 1a, Period 1 (3 Days)||9
8997590|NCT02853435|10061046|FG001|COMPLETED|Part 1a, Period 1 (3 Days)||9
8997591|NCT02853435|10061047|FG002|COMPLETED|Part 1a, Period 1 (3 Days)||8
8997592|NCT02853435|10061048|FG003|COMPLETED|Part 1a, Period 1 (3 Days)||0
8997593|NCT02853435|10061049|FG004|COMPLETED|Part 1a, Period 1 (3 Days)||0
8633797|NCT00552929|9673952|FG000|NOT COMPLETED|Overall Study||0
8997594|NCT02853435|10061050|FG005|COMPLETED|Part 1a, Period 1 (3 Days)||0
8997595|NCT02853435|10061045|FG000|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
8997596|NCT02853435|10061046|FG001|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
8997597|NCT02853435|10061047|FG002|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
8997598|NCT02853435|10061048|FG003|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
8997599|NCT02853435|10061049|FG004|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
8997600|NCT02853435|10061050|FG005|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
8997601|NCT02853435|10061045|FG000|STARTED|Part 1a, Washout Period 1 (3 Days)||9
8997602|NCT02853435|10061046|FG001|STARTED|Part 1a, Washout Period 1 (3 Days)||9
8997603|NCT02853435|10061047|FG002|STARTED|Part 1a, Washout Period 1 (3 Days)||8
8997604|NCT02853435|10061048|FG003|STARTED|Part 1a, Washout Period 1 (3 Days)||0
8997605|NCT02853435|10061049|FG004|STARTED|Part 1a, Washout Period 1 (3 Days)||0
8997606|NCT02853435|10061050|FG005|STARTED|Part 1a, Washout Period 1 (3 Days)||0
8997607|NCT02853435|10061045|FG000|COMPLETED|Part 1a, Washout Period 1 (3 Days)||9
8997608|NCT02853435|10061046|FG001|COMPLETED|Part 1a, Washout Period 1 (3 Days)||9
8997609|NCT02853435|10061047|FG002|COMPLETED|Part 1a, Washout Period 1 (3 Days)||8
9039319|NCT03337308|10100248|FG002|STARTED|Overall Study||109
8572346|NCT00113568|9604480|FG000|COMPLETED|Overall Study||239
8572347|NCT00113568|9604480|FG000|NOT COMPLETED|Overall Study||545
8572348|NCT00113607|9604486|FG000|STARTED|Overall Study|Number of randomized participants|335
8572349|NCT00113607|9604487|FG001|STARTED|Overall Study|Number of randomized participants|337
8572350|NCT00113607|9604486|FG000|COMPLETED|Overall Study||0
9039320|NCT03337308|10100249|FG003|STARTED|Overall Study||55
8572351|NCT00113607|9604487|FG001|COMPLETED|Overall Study||0
8572352|NCT00113607|9604486|FG000|NOT COMPLETED|Overall Study||335
9039321|NCT03337308|10100246|FG000|COMPLETED|Overall Study||103
9039322|NCT03337308|10100247|FG001|COMPLETED|Overall Study||103
9039323|NCT03337308|10100248|FG002|COMPLETED|Overall Study||104
9039324|NCT03337308|10100249|FG003|COMPLETED|Overall Study||53
9039325|NCT03337308|10100246|FG000|NOT COMPLETED|Overall Study||5
9039326|NCT03337308|10100247|FG001|NOT COMPLETED|Overall Study||7
9039327|NCT03337308|10100248|FG002|NOT COMPLETED|Overall Study||5
9039328|NCT03337308|10100249|FG003|NOT COMPLETED|Overall Study||2
9039329|NCT03337477|10100261|FG000|STARTED|Overall Study||33
9039330|NCT03337477|10100262|FG001|STARTED|Overall Study||37
9039331|NCT03337477|10100261|FG000|COMPLETED|Overall Study||22
9039332|NCT03337477|10100262|FG001|COMPLETED|Overall Study||24
9039333|NCT03337477|10100261|FG000|NOT COMPLETED|Overall Study||11
9039334|NCT03337477|10100262|FG001|NOT COMPLETED|Overall Study||13
8997610|NCT02853435|10061048|FG003|COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
8997611|NCT02853435|10061049|FG004|COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
8997612|NCT02853435|10061050|FG005|COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
8997613|NCT02853435|10061045|FG000|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
8997614|NCT02853435|10061046|FG001|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
8997615|NCT02853435|10061047|FG002|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
8997616|NCT02853435|10061048|FG003|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
8997617|NCT02853435|10061049|FG004|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
8997618|NCT02853435|10061050|FG005|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
8997619|NCT02853435|10061045|FG000|STARTED|Part 1a, Period 2 (3 Days)||9
8997620|NCT02853435|10061046|FG001|STARTED|Part 1a, Period 2 (3 Days)||9
8997621|NCT02853435|10061047|FG002|STARTED|Part 1a, Period 2 (3 Days)||8
8997622|NCT02853435|10061048|FG003|STARTED|Part 1a, Period 2 (3 Days)||0
8997623|NCT02853435|10061049|FG004|STARTED|Part 1a, Period 2 (3 Days)||0
8997624|NCT02853435|10061050|FG005|STARTED|Part 1a, Period 2 (3 Days)||0
8997625|NCT02853435|10061045|FG000|COMPLETED|Part 1a, Period 2 (3 Days)||9
8997626|NCT02853435|10061046|FG001|COMPLETED|Part 1a, Period 2 (3 Days)||9
8997627|NCT02853435|10061047|FG002|COMPLETED|Part 1a, Period 2 (3 Days)||8
8997628|NCT02853435|10061048|FG003|COMPLETED|Part 1a, Period 2 (3 Days)||0
8997629|NCT02853435|10061049|FG004|COMPLETED|Part 1a, Period 2 (3 Days)||0
8997630|NCT02853435|10061050|FG005|COMPLETED|Part 1a, Period 2 (3 Days)||0
8997631|NCT02853435|10061045|FG000|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
8997632|NCT02853435|10061046|FG001|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
8997633|NCT02853435|10061047|FG002|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
8997634|NCT02853435|10061048|FG003|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
8997635|NCT02853435|10061049|FG004|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
8997636|NCT02853435|10061050|FG005|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
8997637|NCT02853435|10061045|FG000|STARTED|Part 1a, Washout Period 2 (3 Days)||9
8997638|NCT02853435|10061046|FG001|STARTED|Part 1a, Washout Period 2 (3 Days)||9
8997639|NCT02853435|10061047|FG002|STARTED|Part 1a, Washout Period 2 (3 Days)||8
8997640|NCT02853435|10061048|FG003|STARTED|Part 1a, Washout Period 2 (3 Days)||0
8997641|NCT02853435|10061049|FG004|STARTED|Part 1a, Washout Period 2 (3 Days)||0
8997642|NCT02853435|10061050|FG005|STARTED|Part 1a, Washout Period 2 (3 Days)||0
8997643|NCT02853435|10061045|FG000|COMPLETED|Part 1a, Washout Period 2 (3 Days)||9
8997644|NCT02853435|10061046|FG001|COMPLETED|Part 1a, Washout Period 2 (3 Days)||9
8997645|NCT02853435|10061047|FG002|COMPLETED|Part 1a, Washout Period 2 (3 Days)||8
8572353|NCT00113607|9604487|FG001|NOT COMPLETED|Overall Study||337
8572354|NCT00113763|9604496|FG000|STARTED|Overall Study||231
8572355|NCT00113763|9604497|FG001|STARTED|Overall Study||232
8572356|NCT00113763|9604496|FG000|Received Study Drug|Overall Study||229
8572357|NCT00113763|9604497|FG001|Received Study Drug|Overall Study||0
8572358|NCT00113763|9604496|FG000|COMPLETED|Overall Study|Defined as participants who completed safety follow-up visit or who died.|158
8572359|NCT00113763|9604497|FG001|COMPLETED|Overall Study|Defined as participants who completed safety follow-up visit or who died.|206
8572360|NCT00113763|9604496|FG000|NOT COMPLETED|Overall Study||73
8572361|NCT00113763|9604497|FG001|NOT COMPLETED|Overall Study||26
8633798|NCT00552929|9673953|FG001|NOT COMPLETED|Overall Study||0
8633799|NCT00552929|9673954|FG002|NOT COMPLETED|Overall Study||0
8633800|NCT00552929|9673955|FG003|NOT COMPLETED|Overall Study||0
8633801|NCT00552929|9673956|FG004|NOT COMPLETED|Overall Study||0
8633802|NCT00552929|9673957|FG005|NOT COMPLETED|Overall Study||1
8633803|NCT00552929|9673958|FG006|NOT COMPLETED|Overall Study||0
8633804|NCT00552929|9673959|FG007|NOT COMPLETED|Overall Study||0
8633805|NCT00552929|9673960|FG008|NOT COMPLETED|Overall Study||1
8633806|NCT00552929|9673961|FG009|NOT COMPLETED|Overall Study||0
8633807|NCT00553059|9673985|FG000|STARTED|Overall Study||31
8633808|NCT00553059|9673986|FG001|STARTED|Overall Study||31
8633809|NCT00553059|9673985|FG000|COMPLETED|Overall Study||30
8633810|NCT00553059|9673986|FG001|COMPLETED|Overall Study||29
8997646|NCT02853435|10061048|FG003|COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
8997647|NCT02853435|10061049|FG004|COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
8997648|NCT02853435|10061050|FG005|COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
8997649|NCT02853435|10061045|FG000|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
8997650|NCT02853435|10061046|FG001|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
8997651|NCT02853435|10061047|FG002|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
8997652|NCT02853435|10061048|FG003|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
8572362|NCT00113841|9604506|FG000|STARTED|Overall Study||16
8633811|NCT00553059|9673985|FG000|NOT COMPLETED|Overall Study||1
8633812|NCT00553059|9673986|FG001|NOT COMPLETED|Overall Study||2
8633813|NCT00553098|9673992|FG000|STARTED|Overall Study||29
8633814|NCT00553098|9673992|FG000|COMPLETED|Overall Study||28
8633815|NCT00553098|9673992|FG000|NOT COMPLETED|Overall Study||1
8633816|NCT00553150|9674002|FG000|STARTED|Overall Study||6
8997653|NCT02853435|10061049|FG004|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
8997654|NCT02853435|10061050|FG005|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
8997655|NCT02853435|10061045|FG000|STARTED|Part 1a, Period 3 (3 Days)||9
8997656|NCT02853435|10061046|FG001|STARTED|Part 1a, Period 3 (3 Days)||9
8997657|NCT02853435|10061047|FG002|STARTED|Part 1a, Period 3 (3 Days)||8
8997658|NCT02853435|10061048|FG003|STARTED|Part 1a, Period 3 (3 Days)||0
8997659|NCT02853435|10061049|FG004|STARTED|Part 1a, Period 3 (3 Days)||0
8997660|NCT02853435|10061050|FG005|STARTED|Part 1a, Period 3 (3 Days)||0
8997661|NCT02853435|10061045|FG000|COMPLETED|Part 1a, Period 3 (3 Days)||9
8997662|NCT02853435|10061046|FG001|COMPLETED|Part 1a, Period 3 (3 Days)||9
8997663|NCT02853435|10061047|FG002|COMPLETED|Part 1a, Period 3 (3 Days)||8
8997664|NCT02853435|10061048|FG003|COMPLETED|Part 1a, Period 3 (3 Days)||0
8997665|NCT02853435|10061049|FG004|COMPLETED|Part 1a, Period 3 (3 Days)||0
8997666|NCT02853435|10061050|FG005|COMPLETED|Part 1a, Period 3 (3 Days)||0
8997667|NCT02853435|10061045|FG000|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
8997668|NCT02853435|10061046|FG001|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
8997669|NCT02853435|10061047|FG002|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
8997670|NCT02853435|10061048|FG003|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
8997671|NCT02853435|10061049|FG004|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
8997672|NCT02853435|10061050|FG005|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
8997673|NCT02853435|10061045|FG000|STARTED|Part 2, Period 1 (3 Days)||0
8997674|NCT02853435|10061046|FG001|STARTED|Part 2, Period 1 (3 Days)||0
8997675|NCT02853435|10061047|FG002|STARTED|Part 2, Period 1 (3 Days)||0
8997676|NCT02853435|10061048|FG003|STARTED|Part 2, Period 1 (3 Days)||10
8997677|NCT02853435|10061049|FG004|STARTED|Part 2, Period 1 (3 Days)||0
8997678|NCT02853435|10061050|FG005|STARTED|Part 2, Period 1 (3 Days)||0
8997679|NCT02853435|10061045|FG000|COMPLETED|Part 2, Period 1 (3 Days)||0
8997680|NCT02853435|10061046|FG001|COMPLETED|Part 2, Period 1 (3 Days)||0
8633817|NCT00553150|9674003|FG001|STARTED|Overall Study||6
8997681|NCT02853435|10061047|FG002|COMPLETED|Part 2, Period 1 (3 Days)||0
8997682|NCT02853435|10061048|FG003|COMPLETED|Part 2, Period 1 (3 Days)||10
8997683|NCT02853435|10061049|FG004|COMPLETED|Part 2, Period 1 (3 Days)||0
8997684|NCT02853435|10061050|FG005|COMPLETED|Part 2, Period 1 (3 Days)||0
8997685|NCT02853435|10061045|FG000|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
8997686|NCT02853435|10061046|FG001|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
8997687|NCT02853435|10061047|FG002|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
8997688|NCT02853435|10061048|FG003|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
8997689|NCT02853435|10061049|FG004|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
8997690|NCT02853435|10061050|FG005|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
8997691|NCT02853435|10061045|FG000|STARTED|Part 2, Washout Period 1 (3 Days)||0
8997692|NCT02853435|10061046|FG001|STARTED|Part 2, Washout Period 1 (3 Days)||0
8997693|NCT02853435|10061047|FG002|STARTED|Part 2, Washout Period 1 (3 Days)||0
8997694|NCT02853435|10061048|FG003|STARTED|Part 2, Washout Period 1 (3 Days)||10
8997695|NCT02853435|10061049|FG004|STARTED|Part 2, Washout Period 1 (3 Days)||0
8997696|NCT02853435|10061050|FG005|STARTED|Part 2, Washout Period 1 (3 Days)||0
8997697|NCT02853435|10061045|FG000|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
8997698|NCT02853435|10061046|FG001|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
8997699|NCT02853435|10061047|FG002|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
8997700|NCT02853435|10061048|FG003|COMPLETED|Part 2, Washout Period 1 (3 Days)||10
8997701|NCT02853435|10061049|FG004|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
8997702|NCT02853435|10061050|FG005|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
8997703|NCT02853435|10061045|FG000|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
8997704|NCT02853435|10061046|FG001|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
8997705|NCT02853435|10061047|FG002|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
8997706|NCT02853435|10061048|FG003|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
8997707|NCT02853435|10061049|FG004|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
8997708|NCT02853435|10061050|FG005|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
8997709|NCT02853435|10061045|FG000|STARTED|Part 2, Period 2 (3 Days)||0
8997710|NCT02853435|10061046|FG001|STARTED|Part 2, Period 2 (3 Days)||0
8997711|NCT02853435|10061047|FG002|STARTED|Part 2, Period 2 (3 Days)||0
8997712|NCT02853435|10061048|FG003|STARTED|Part 2, Period 2 (3 Days)||10
8633818|NCT00553150|9674004|FG002|STARTED|Overall Study||6
8997713|NCT02853435|10061049|FG004|STARTED|Part 2, Period 2 (3 Days)||0
8997714|NCT02853435|10061050|FG005|STARTED|Part 2, Period 2 (3 Days)||0
8997715|NCT02853435|10061045|FG000|COMPLETED|Part 2, Period 2 (3 Days)||0
8997716|NCT02853435|10061046|FG001|COMPLETED|Part 2, Period 2 (3 Days)||0
8997717|NCT02853435|10061047|FG002|COMPLETED|Part 2, Period 2 (3 Days)||0
8997718|NCT02853435|10061048|FG003|COMPLETED|Part 2, Period 2 (3 Days)||10
8997719|NCT02853435|10061049|FG004|COMPLETED|Part 2, Period 2 (3 Days)||0
8997720|NCT02853435|10061050|FG005|COMPLETED|Part 2, Period 2 (3 Days)||0
8997721|NCT02853435|10061045|FG000|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
8997722|NCT02853435|10061046|FG001|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
8997723|NCT02853435|10061047|FG002|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
8997724|NCT02853435|10061048|FG003|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
8997725|NCT02853435|10061049|FG004|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
8997726|NCT02853435|10061050|FG005|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
8997727|NCT02853435|10061045|FG000|STARTED|Part 3, Period 1 (3 Days)||0
8997728|NCT02853435|10061046|FG001|STARTED|Part 3, Period 1 (3 Days)||0
8997729|NCT02853435|10061047|FG002|STARTED|Part 3, Period 1 (3 Days)||0
8997730|NCT02853435|10061048|FG003|STARTED|Part 3, Period 1 (3 Days)||0
8997731|NCT02853435|10061049|FG004|STARTED|Part 3, Period 1 (3 Days)||10
8997732|NCT02853435|10061050|FG005|STARTED|Part 3, Period 1 (3 Days)||2
8997733|NCT02853435|10061045|FG000|COMPLETED|Part 3, Period 1 (3 Days)||0
8997734|NCT02853435|10061046|FG001|COMPLETED|Part 3, Period 1 (3 Days)||0
8997735|NCT02853435|10061047|FG002|COMPLETED|Part 3, Period 1 (3 Days)||0
8997736|NCT02853435|10061048|FG003|COMPLETED|Part 3, Period 1 (3 Days)||0
8997737|NCT02853435|10061049|FG004|COMPLETED|Part 3, Period 1 (3 Days)||10
8997738|NCT02853435|10061050|FG005|COMPLETED|Part 3, Period 1 (3 Days)||2
8997739|NCT02853435|10061045|FG000|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
8997740|NCT02853435|10061046|FG001|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
8997741|NCT02853435|10061047|FG002|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
8997742|NCT02853435|10061048|FG003|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
8997743|NCT02853435|10061049|FG004|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
8997744|NCT02853435|10061050|FG005|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
8997745|NCT02853435|10061045|FG000|STARTED|Part 3, Washout Period 1 (3 Days)||0
8997746|NCT02853435|10061046|FG001|STARTED|Part 3, Washout Period 1 (3 Days)||0
8997747|NCT02853435|10061047|FG002|STARTED|Part 3, Washout Period 1 (3 Days)||0
8997748|NCT02853435|10061048|FG003|STARTED|Part 3, Washout Period 1 (3 Days)||0
8997749|NCT02853435|10061049|FG004|STARTED|Part 3, Washout Period 1 (3 Days)||10
8997750|NCT02853435|10061050|FG005|STARTED|Part 3, Washout Period 1 (3 Days)||2
8997751|NCT02853435|10061045|FG000|COMPLETED|Part 3, Washout Period 1 (3 Days)||0
8997752|NCT02853435|10061046|FG001|COMPLETED|Part 3, Washout Period 1 (3 Days)||0
8997753|NCT02853435|10061047|FG002|COMPLETED|Part 3, Washout Period 1 (3 Days)||0
8997754|NCT02853435|10061048|FG003|COMPLETED|Part 3, Washout Period 1 (3 Days)||0
8997755|NCT02853435|10061049|FG004|COMPLETED|Part 3, Washout Period 1 (3 Days)||10
8997756|NCT02853435|10061050|FG005|COMPLETED|Part 3, Washout Period 1 (3 Days)||2
8997757|NCT02853435|10061045|FG000|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
8997758|NCT02853435|10061046|FG001|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
8997759|NCT02853435|10061047|FG002|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
8997760|NCT02853435|10061048|FG003|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
8997761|NCT02853435|10061049|FG004|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
8997762|NCT02853435|10061050|FG005|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
8997763|NCT02853435|10061045|FG000|STARTED|Part 3, Period 2 (3 Days)||0
8997764|NCT02853435|10061046|FG001|STARTED|Part 3, Period 2 (3 Days)||0
8997765|NCT02853435|10061047|FG002|STARTED|Part 3, Period 2 (3 Days)||0
8997766|NCT02853435|10061048|FG003|STARTED|Part 3, Period 2 (3 Days)||0
8997767|NCT02853435|10061049|FG004|STARTED|Part 3, Period 2 (3 Days)||10
8633819|NCT00553150|9674005|FG003|STARTED|Overall Study||104
8879416|NCT01933672|9936181|FG004|COMPLETED|Second Intervention Period (12-16 Days)||6
8997768|NCT02853435|10061050|FG005|STARTED|Part 3, Period 2 (3 Days)||2
8997769|NCT02853435|10061045|FG000|COMPLETED|Part 3, Period 2 (3 Days)||0
8997770|NCT02853435|10061046|FG001|COMPLETED|Part 3, Period 2 (3 Days)||0
8997771|NCT02853435|10061047|FG002|COMPLETED|Part 3, Period 2 (3 Days)||0
8997772|NCT02853435|10061048|FG003|COMPLETED|Part 3, Period 2 (3 Days)||0
8997773|NCT02853435|10061049|FG004|COMPLETED|Part 3, Period 2 (3 Days)||10
8997774|NCT02853435|10061050|FG005|COMPLETED|Part 3, Period 2 (3 Days)||2
8997775|NCT02853435|10061045|FG000|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
8997776|NCT02853435|10061046|FG001|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
8997777|NCT02853435|10061047|FG002|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
8997778|NCT02853435|10061048|FG003|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
8997779|NCT02853435|10061049|FG004|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
8997780|NCT02853435|10061050|FG005|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
8997781|NCT02853435|10061045|FG000|STARTED|Part 3, Washout Period 2 (3 Days)||0
8997782|NCT02853435|10061046|FG001|STARTED|Part 3, Washout Period 2 (3 Days)||0
8997783|NCT02853435|10061047|FG002|STARTED|Part 3, Washout Period 2 (3 Days)||0
8997784|NCT02853435|10061048|FG003|STARTED|Part 3, Washout Period 2 (3 Days)||0
8997785|NCT02853435|10061049|FG004|STARTED|Part 3, Washout Period 2 (3 Days)||10
8997786|NCT02853435|10061050|FG005|STARTED|Part 3, Washout Period 2 (3 Days)||2
8997787|NCT02853435|10061045|FG000|COMPLETED|Part 3, Washout Period 2 (3 Days)||0
8997788|NCT02853435|10061046|FG001|COMPLETED|Part 3, Washout Period 2 (3 Days)||0
8997789|NCT02853435|10061047|FG002|COMPLETED|Part 3, Washout Period 2 (3 Days)||0
8997790|NCT02853435|10061048|FG003|COMPLETED|Part 3, Washout Period 2 (3 Days)||0
8997791|NCT02853435|10061049|FG004|COMPLETED|Part 3, Washout Period 2 (3 Days)||9
8997792|NCT02853435|10061050|FG005|COMPLETED|Part 3, Washout Period 2 (3 Days)||2
8997793|NCT02853435|10061045|FG000|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
8997794|NCT02853435|10061046|FG001|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
8997795|NCT02853435|10061047|FG002|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
8997796|NCT02853435|10061048|FG003|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
8997797|NCT02853435|10061049|FG004|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||1
8997798|NCT02853435|10061050|FG005|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
8997799|NCT02853435|10061045|FG000|STARTED|Part 3, Period 3 (3 Days)||0
8997800|NCT02853435|10061046|FG001|STARTED|Part 3, Period 3 (3 Days)||0
8997801|NCT02853435|10061047|FG002|STARTED|Part 3, Period 3 (3 Days)||0
8997802|NCT02853435|10061048|FG003|STARTED|Part 3, Period 3 (3 Days)||0
8997803|NCT02853435|10061049|FG004|STARTED|Part 3, Period 3 (3 Days)||9
8997804|NCT02853435|10061050|FG005|STARTED|Part 3, Period 3 (3 Days)||2
8997805|NCT02853435|10061045|FG000|COMPLETED|Part 3, Period 3 (3 Days)||0
8997806|NCT02853435|10061046|FG001|COMPLETED|Part 3, Period 3 (3 Days)||0
8997807|NCT02853435|10061047|FG002|COMPLETED|Part 3, Period 3 (3 Days)||0
8997808|NCT02853435|10061048|FG003|COMPLETED|Part 3, Period 3 (3 Days)||0
8997809|NCT02853435|10061049|FG004|COMPLETED|Part 3, Period 3 (3 Days)||9
8997810|NCT02853435|10061050|FG005|COMPLETED|Part 3, Period 3 (3 Days)||2
8997811|NCT02853435|10061045|FG000|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
8997812|NCT02853435|10061046|FG001|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
8997813|NCT02853435|10061047|FG002|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
8997814|NCT02853435|10061048|FG003|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
8997815|NCT02853435|10061049|FG004|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
8997816|NCT02853435|10061050|FG005|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
8997817|NCT02853929|10061082|FG000|STARTED|Overall Study||270
8997818|NCT02853929|10061083|FG001|STARTED|Overall Study||281
8572363|NCT00113841|9604507|FG001|STARTED|Overall Study||17
8572364|NCT00113841|9604506|FG000|COMPLETED|Overall Study||15
8572365|NCT00113841|9604507|FG001|COMPLETED|Overall Study||15
8633820|NCT00553150|9674002|FG000|COMPLETED|Overall Study||6
8633821|NCT00553150|9674003|FG001|COMPLETED|Overall Study||6
8572366|NCT00113841|9604506|FG000|NOT COMPLETED|Overall Study||1
8572367|NCT00113841|9604507|FG001|NOT COMPLETED|Overall Study||2
8572368|NCT00113880|9604516|FG000|STARTED|Overall Study||63061
8572369|NCT00113880|9604517|FG001|STARTED|Overall Study||71949
8572370|NCT00113880|9604518|FG002|STARTED|Overall Study||62492
8572371|NCT00113880|9604516|FG000|COMPLETED|Overall Study||63061
8572372|NCT00113880|9604517|FG001|COMPLETED|Overall Study||71949
8572373|NCT00113880|9604518|FG002|COMPLETED|Overall Study||62492
8572374|NCT00113880|9604516|FG000|NOT COMPLETED|Overall Study||0
8572375|NCT00113880|9604517|FG001|NOT COMPLETED|Overall Study||0
8572376|NCT00113880|9604518|FG002|NOT COMPLETED|Overall Study||0
8572377|NCT00114114|9604539|FG000|STARTED|Overall Study||26
8572378|NCT00114114|9604540|FG001|STARTED|Overall Study||25
8572379|NCT00114114|9604541|FG002|STARTED|Overall Study||31
8633822|NCT00553150|9674004|FG002|COMPLETED|Overall Study||6
8633823|NCT00553150|9674005|FG003|COMPLETED|Overall Study||100
8997819|NCT02853929|10061082|FG000|Vaccinated|Overall Study||263
8997820|NCT02853929|10061083|FG001|Vaccinated|Overall Study||277
8997821|NCT02853929|10061082|FG000|COMPLETED|Overall Study||259
8997822|NCT02853929|10061083|FG001|COMPLETED|Overall Study||277
8997823|NCT02853929|10061082|FG000|NOT COMPLETED|Overall Study||11
8997824|NCT02853929|10061083|FG001|NOT COMPLETED|Overall Study||4
8997825|NCT02854059|10061091|FG000|STARTED|Overall Study||2
8997826|NCT02854059|10061092|FG001|STARTED|Overall Study||0
8997827|NCT02854059|10061091|FG000|COMPLETED|Overall Study||2
8997828|NCT02854059|10061092|FG001|COMPLETED|Overall Study||0
8997829|NCT02854059|10061091|FG000|NOT COMPLETED|Overall Study||0
8997830|NCT02854059|10061092|FG001|NOT COMPLETED|Overall Study||0
8725905|NCT01033487|9773162|FG005|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
8997831|NCT02854527|10061108|FG000|STARTED|Overall Study||3
8997832|NCT02854527|10061109|FG001|STARTED|Overall Study||3
8997833|NCT02854527|10061110|FG002|STARTED|Overall Study||3
8997834|NCT02854527|10061111|FG003|STARTED|Overall Study||3
8997835|NCT02854527|10061112|FG004|STARTED|Overall Study||3
8997836|NCT02854527|10061113|FG005|STARTED|Overall Study||3
8997837|NCT02854527|10061114|FG006|STARTED|Overall Study||3
8997838|NCT02854527|10061115|FG007|STARTED|Overall Study||3
8997839|NCT02854527|10061116|FG008|STARTED|Overall Study||3
8997840|NCT02854527|10061117|FG009|STARTED|Overall Study||3
8997841|NCT02854527|10061108|FG000|Received R1|Overall Study||3
8997842|NCT02854527|10061109|FG001|Received R1|Overall Study||3
8997843|NCT02854527|10061110|FG002|Received R1|Overall Study||3
8997844|NCT02854527|10061111|FG003|Received R1|Overall Study||2
8997845|NCT02854527|10061112|FG004|Received R1|Overall Study||2
8997846|NCT02854527|10061113|FG005|Received R1|Overall Study||3
8997847|NCT02854527|10061114|FG006|Received R1|Overall Study||3
8997848|NCT02854527|10061115|FG007|Received R1|Overall Study||3
8997849|NCT02854527|10061116|FG008|Received R1|Overall Study||3
8997850|NCT02854527|10061117|FG009|Received R1|Overall Study||3
8997851|NCT02854527|10061108|FG000|Received R2|Overall Study||3
8997852|NCT02854527|10061109|FG001|Received R2|Overall Study||3
8997853|NCT02854527|10061110|FG002|Received R2|Overall Study||3
8997854|NCT02854527|10061111|FG003|Received R2|Overall Study||3
8997855|NCT02854527|10061112|FG004|Received R2|Overall Study||3
8997856|NCT02854527|10061113|FG005|Received R2|Overall Study||3
8997857|NCT02854527|10061114|FG006|Received R2|Overall Study||3
8997858|NCT02854527|10061115|FG007|Received R2|Overall Study||3
8997859|NCT02854527|10061116|FG008|Received R2|Overall Study||3
8997860|NCT02854527|10061117|FG009|Received R2|Overall Study||3
8997861|NCT02854527|10061108|FG000|Received R3|Overall Study||3
8997862|NCT02854527|10061109|FG001|Received R3|Overall Study||3
8997863|NCT02854527|10061110|FG002|Received R3|Overall Study||3
8997864|NCT02854527|10061111|FG003|Received R3|Overall Study||2
8997865|NCT02854527|10061112|FG004|Received R3|Overall Study||3
8997866|NCT02854527|10061113|FG005|Received R3|Overall Study||3
8997867|NCT02854527|10061114|FG006|Received R3|Overall Study||3
8997868|NCT02854527|10061115|FG007|Received R3|Overall Study||3
8997869|NCT02854527|10061116|FG008|Received R3|Overall Study||3
8997870|NCT02854527|10061117|FG009|Received R3|Overall Study||3
8997871|NCT02854527|10061108|FG000|Received R4|Overall Study||3
8997872|NCT02854527|10061109|FG001|Received R4|Overall Study||3
8997873|NCT02854527|10061110|FG002|Received R4|Overall Study||3
8997874|NCT02854527|10061111|FG003|Received R4|Overall Study||2
8997875|NCT02854527|10061112|FG004|Received R4|Overall Study||3
8997876|NCT02854527|10061113|FG005|Received R4|Overall Study||3
8997877|NCT02854527|10061114|FG006|Received R4|Overall Study||3
8997878|NCT02854527|10061115|FG007|Received R4|Overall Study||3
8997879|NCT02854527|10061116|FG008|Received R4|Overall Study||3
8997880|NCT02854527|10061117|FG009|Received R4|Overall Study||3
8997881|NCT02854527|10061108|FG000|Received T|Overall Study||3
8997882|NCT02854527|10061109|FG001|Received T|Overall Study||3
8997883|NCT02854527|10061110|FG002|Received T|Overall Study||3
8997884|NCT02854527|10061111|FG003|Received T|Overall Study||2
8997885|NCT02854527|10061112|FG004|Received T|Overall Study||2
8997886|NCT02854527|10061113|FG005|Received T|Overall Study||3
8997887|NCT02854527|10061114|FG006|Received T|Overall Study||3
8997888|NCT02854527|10061115|FG007|Received T|Overall Study||3
8997889|NCT02854527|10061116|FG008|Received T|Overall Study||3
8997890|NCT02854527|10061117|FG009|Received T|Overall Study||3
8997891|NCT02854527|10061108|FG000|COMPLETED|Overall Study||3
8997892|NCT02854527|10061109|FG001|COMPLETED|Overall Study||3
8997893|NCT02854527|10061110|FG002|COMPLETED|Overall Study||3
8997894|NCT02854527|10061111|FG003|COMPLETED|Overall Study||2
8997895|NCT02854527|10061112|FG004|COMPLETED|Overall Study||2
8997896|NCT02854527|10061113|FG005|COMPLETED|Overall Study||3
8997897|NCT02854527|10061114|FG006|COMPLETED|Overall Study||3
8997898|NCT02854527|10061115|FG007|COMPLETED|Overall Study||3
8997899|NCT02854527|10061116|FG008|COMPLETED|Overall Study||3
8997900|NCT02854527|10061117|FG009|COMPLETED|Overall Study||3
8997901|NCT02854527|10061108|FG000|NOT COMPLETED|Overall Study||0
8997902|NCT02854527|10061109|FG001|NOT COMPLETED|Overall Study||0
8997903|NCT02854527|10061110|FG002|NOT COMPLETED|Overall Study||0
8997904|NCT02854527|10061111|FG003|NOT COMPLETED|Overall Study||1
8997905|NCT02854527|10061112|FG004|NOT COMPLETED|Overall Study||1
8997906|NCT02854527|10061113|FG005|NOT COMPLETED|Overall Study||0
8997907|NCT02854527|10061114|FG006|NOT COMPLETED|Overall Study||0
8997908|NCT02854527|10061115|FG007|NOT COMPLETED|Overall Study||0
8997909|NCT02854527|10061116|FG008|NOT COMPLETED|Overall Study||0
8997910|NCT02854527|10061117|FG009|NOT COMPLETED|Overall Study||0
8997911|NCT02854540|10061129|FG000|STARTED|Overall Study||13
8997912|NCT02854540|10061129|FG000|COMPLETED|Overall Study||11
8997913|NCT02854540|10061129|FG000|NOT COMPLETED|Overall Study||2
8997914|NCT02854605|10061138|FG000|STARTED|Overall Study||56
8997915|NCT02854605|10061139|FG001|STARTED|Overall Study||56
8997916|NCT02854605|10061140|FG002|STARTED|Overall Study||28
8997917|NCT02854605|10061138|FG000|COMPLETED|Overall Study||53
8997918|NCT02854605|10061139|FG001|COMPLETED|Overall Study||49
8997919|NCT02854605|10061140|FG002|COMPLETED|Overall Study||24
8997920|NCT02854605|10061138|FG000|NOT COMPLETED|Overall Study||3
8997921|NCT02854605|10061139|FG001|NOT COMPLETED|Overall Study||7
8997922|NCT02854605|10061140|FG002|NOT COMPLETED|Overall Study||4
8997923|NCT02854631|10061150|FG000|STARTED|Overall Study||52
8997924|NCT02854631|10061151|FG001|STARTED|Overall Study||52
8997925|NCT02854631|10061150|FG000|COMPLETED|Overall Study||26
8997926|NCT02854631|10061151|FG001|COMPLETED|Overall Study||37
8997927|NCT02854631|10061150|FG000|NOT COMPLETED|Overall Study||26
8997928|NCT02854631|10061151|FG001|NOT COMPLETED|Overall Study||15
8997929|NCT02854800|10061160|FG000|STARTED|Overall Study||32
8997930|NCT02854800|10061161|FG001|STARTED|Overall Study||28
8997931|NCT02854800|10061162|FG002|STARTED|Overall Study||14
8997932|NCT02854800|10061160|FG000|COMPLETED|Overall Study||12
8997933|NCT02854800|10061161|FG001|COMPLETED|Overall Study||15
8997934|NCT02854800|10061162|FG002|COMPLETED|Overall Study||8
8997935|NCT02854800|10061160|FG000|NOT COMPLETED|Overall Study||20
8997936|NCT02854800|10061161|FG001|NOT COMPLETED|Overall Study||13
8997937|NCT02854800|10061162|FG002|NOT COMPLETED|Overall Study||6
8997938|NCT02855086|10061175|FG000|STARTED|Overall Study||2
8997939|NCT02855086|10061176|FG001|STARTED|Overall Study||1
8997940|NCT02855086|10061175|FG000|COMPLETED|Overall Study||2
8997941|NCT02855086|10061176|FG001|COMPLETED|Overall Study||1
8997942|NCT02855086|10061175|FG000|NOT COMPLETED|Overall Study||0
8997943|NCT02855086|10061176|FG001|NOT COMPLETED|Overall Study||0
8997944|NCT02855164|10061190|FG000|STARTED|Parts A + B (Randomized Set)||14
8997945|NCT02855164|10061191|FG001|STARTED|Parts A + B (Randomized Set)||16
8997946|NCT02855164|10061192|FG002|STARTED|Parts A + B (Randomized Set)||37
8997947|NCT02855164|10061193|FG003|STARTED|Parts A + B (Randomized Set)||85
8997948|NCT02855164|10061194|FG004|STARTED|Parts A + B (Randomized Set)||46
8997949|NCT02855164|10061195|FG005|STARTED|Parts A + B (Randomized Set)||0
8997950|NCT02855164|10061196|FG006|STARTED|Parts A + B (Randomized Set)||0
8997951|NCT02855164|10061197|FG007|STARTED|Parts A + B (Randomized Set)||0
8997952|NCT02855164|10061190|FG000|COMPLETED|Parts A + B (Randomized Set)||14
8997953|NCT02855164|10061191|FG001|COMPLETED|Parts A + B (Randomized Set)||16
8997954|NCT02855164|10061192|FG002|COMPLETED|Parts A + B (Randomized Set)||36
8997955|NCT02855164|10061193|FG003|COMPLETED|Parts A + B (Randomized Set)||77
8997956|NCT02855164|10061194|FG004|COMPLETED|Parts A + B (Randomized Set)||45
8997957|NCT02855164|10061195|FG005|COMPLETED|Parts A + B (Randomized Set)||0
8997958|NCT02855164|10061196|FG006|COMPLETED|Parts A + B (Randomized Set)||0
8997959|NCT02855164|10061197|FG007|COMPLETED|Parts A + B (Randomized Set)||0
8997960|NCT02855164|10061190|FG000|NOT COMPLETED|Parts A + B (Randomized Set)||0
8997961|NCT02855164|10061191|FG001|NOT COMPLETED|Parts A + B (Randomized Set)||0
8997962|NCT02855164|10061192|FG002|NOT COMPLETED|Parts A + B (Randomized Set)||1
8997963|NCT02855164|10061193|FG003|NOT COMPLETED|Parts A + B (Randomized Set)||8
8997964|NCT02855164|10061194|FG004|NOT COMPLETED|Parts A + B (Randomized Set)||1
8997965|NCT02855164|10061195|FG005|NOT COMPLETED|Parts A + B (Randomized Set)||0
8997966|NCT02855164|10061196|FG006|NOT COMPLETED|Parts A + B (Randomized Set)||0
8997967|NCT02855164|10061197|FG007|NOT COMPLETED|Parts A + B (Randomized Set)||0
8997968|NCT02855164|10061190|FG000|STARTED|Part C (Randomized Set)||0
8997969|NCT02855164|10061191|FG001|STARTED|Part C (Randomized Set)||0
8997970|NCT02855164|10061192|FG002|STARTED|Part C (Randomized Set)||0
8997971|NCT02855164|10061193|FG003|STARTED|Part C (Randomized Set)||0
8997972|NCT02855164|10061194|FG004|STARTED|Part C (Randomized Set)||0
8997973|NCT02855164|10061195|FG005|STARTED|Part C (Randomized Set)||50
8997974|NCT02855164|10061196|FG006|STARTED|Part C (Randomized Set)||51
8997975|NCT02855164|10061197|FG007|STARTED|Part C (Randomized Set)||51
8997976|NCT02855164|10061190|FG000|COMPLETED|Part C (Randomized Set)||0
8997977|NCT02855164|10061191|FG001|COMPLETED|Part C (Randomized Set)||0
8997978|NCT02855164|10061192|FG002|COMPLETED|Part C (Randomized Set)||0
8997979|NCT02855164|10061193|FG003|COMPLETED|Part C (Randomized Set)||0
8997980|NCT02855164|10061194|FG004|COMPLETED|Part C (Randomized Set)||0
8997981|NCT02855164|10061195|FG005|COMPLETED|Part C (Randomized Set)||38
8997982|NCT02855164|10061196|FG006|COMPLETED|Part C (Randomized Set)||37
8997983|NCT02855164|10061197|FG007|COMPLETED|Part C (Randomized Set)||44
8997984|NCT02855164|10061190|FG000|NOT COMPLETED|Part C (Randomized Set)||0
8997985|NCT02855164|10061191|FG001|NOT COMPLETED|Part C (Randomized Set)||0
8997986|NCT02855164|10061192|FG002|NOT COMPLETED|Part C (Randomized Set)||0
8997987|NCT02855164|10061193|FG003|NOT COMPLETED|Part C (Randomized Set)||0
8997988|NCT02855164|10061194|FG004|NOT COMPLETED|Part C (Randomized Set)||0
8997989|NCT02855164|10061195|FG005|NOT COMPLETED|Part C (Randomized Set)||12
8997990|NCT02855164|10061196|FG006|NOT COMPLETED|Part C (Randomized Set)||14
8997991|NCT02855164|10061197|FG007|NOT COMPLETED|Part C (Randomized Set)||7
8997992|NCT02855281|10061235|FG000|STARTED|Overall Study||50
8997993|NCT02855281|10061235|FG000|COMPLETED|Overall Study||50
8997994|NCT02855281|10061235|FG000|NOT COMPLETED|Overall Study||0
8997995|NCT02855359|10061245|FG000|STARTED|Overall Study||11
8997996|NCT02855359|10061246|FG001|STARTED|Overall Study||13
8997997|NCT02855359|10061247|FG002|STARTED|Overall Study||0
8997998|NCT02855359|10061248|FG003|STARTED|Overall Study||0
8997999|NCT02855359|10061245|FG000|COMPLETED|Overall Study||0
8998000|NCT02855359|10061246|FG001|COMPLETED|Overall Study||0
8998001|NCT02855359|10061247|FG002|COMPLETED|Overall Study||0
8998002|NCT02855359|10061248|FG003|COMPLETED|Overall Study||0
8998003|NCT02855359|10061245|FG000|NOT COMPLETED|Overall Study||11
8998004|NCT02855359|10061246|FG001|NOT COMPLETED|Overall Study||13
8998005|NCT02855359|10061247|FG002|NOT COMPLETED|Overall Study||0
8998006|NCT02855359|10061248|FG003|NOT COMPLETED|Overall Study||0
8998007|NCT02855437|10061256|FG000|STARTED|Phase 1||23
8998008|NCT02855437|10061257|FG001|STARTED|Phase 1||21
8998009|NCT02855437|10061256|FG000|COMPLETED|Phase 1||21
8998010|NCT02855437|10061257|FG001|COMPLETED|Phase 1||19
8998011|NCT02855437|10061256|FG000|NOT COMPLETED|Phase 1||2
8998012|NCT02855437|10061257|FG001|NOT COMPLETED|Phase 1||2
8998013|NCT02855437|10061256|FG000|STARTED|Crossover Period (Same Day)||21
8998014|NCT02855437|10061257|FG001|STARTED|Crossover Period (Same Day)||19
8998015|NCT02855437|10061256|FG000|COMPLETED|Crossover Period (Same Day)||21
8998016|NCT02855437|10061257|FG001|COMPLETED|Crossover Period (Same Day)||19
8998017|NCT02855437|10061256|FG000|NOT COMPLETED|Crossover Period (Same Day)||0
8998018|NCT02855437|10061257|FG001|NOT COMPLETED|Crossover Period (Same Day)||0
8998019|NCT02855437|10061256|FG000|STARTED|Phase 2||21
8998020|NCT02855437|10061257|FG001|STARTED|Phase 2||19
8998021|NCT02855437|10061256|FG000|COMPLETED|Phase 2||20
8998022|NCT02855437|10061257|FG001|COMPLETED|Phase 2||18
8998023|NCT02855437|10061256|FG000|NOT COMPLETED|Phase 2||1
8998024|NCT02855437|10061257|FG001|NOT COMPLETED|Phase 2||1
8998025|NCT02855450|10061266|FG000|STARTED|Overall Study||40
8998026|NCT02855450|10061267|FG001|STARTED|Overall Study||20
8998027|NCT02855450|10061266|FG000|COMPLETED|Overall Study||35
8998028|NCT02855450|10061267|FG001|COMPLETED|Overall Study||20
8998029|NCT02855450|10061266|FG000|NOT COMPLETED|Overall Study||5
8572380|NCT00114114|9604542|FG003|STARTED|Overall Study||35
8998030|NCT02855450|10061267|FG001|NOT COMPLETED|Overall Study||0
8998031|NCT02855541|10061273|FG000|STARTED|Overall Study||25
8998032|NCT02855541|10061273|FG000|COMPLETED|Overall Study||21
8998033|NCT02855541|10061273|FG000|NOT COMPLETED|Overall Study||4
8998034|NCT02855567|10061279|FG000|STARTED|Overall Study||54
8998035|NCT02855567|10061280|FG001|STARTED|Overall Study||56
8998036|NCT02855567|10061279|FG000|COMPLETED|Overall Study||54
8572381|NCT00114114|9604543|FG004|STARTED|Overall Study||29
8572382|NCT00114114|9604544|FG005|STARTED|Overall Study||31
8572383|NCT00114114|9604539|FG000|COMPLETED|Overall Study||21
8572384|NCT00114114|9604540|FG001|COMPLETED|Overall Study||24
8572385|NCT00114114|9604541|FG002|COMPLETED|Overall Study||30
8572386|NCT00114114|9604542|FG003|COMPLETED|Overall Study||31
8998037|NCT02855567|10061280|FG001|COMPLETED|Overall Study||56
8998038|NCT02855567|10061279|FG000|NOT COMPLETED|Overall Study||0
8998039|NCT02855567|10061280|FG001|NOT COMPLETED|Overall Study||0
8998040|NCT02856035|10061286|FG000|STARTED|Overall Study||4
8998041|NCT02856035|10061286|FG000|COMPLETED|Overall Study||4
8998042|NCT02856035|10061286|FG000|NOT COMPLETED|Overall Study||0
8998043|NCT02856282|10061290|FG000|STARTED|Overall Study||46
8998044|NCT02856282|10061290|FG000|COMPLETED|Overall Study||45
8998045|NCT02856282|10061290|FG000|NOT COMPLETED|Overall Study||1
8998046|NCT02856490|10061297|FG000|STARTED|Overall Study||2
8998047|NCT02856490|10061298|FG001|STARTED|Overall Study||2
8998048|NCT02856490|10061299|FG002|STARTED|Overall Study||2
8998049|NCT02856490|10061297|FG000|COMPLETED|Overall Study||2
8998050|NCT02856490|10061298|FG001|COMPLETED|Overall Study||2
8998051|NCT02856490|10061299|FG002|COMPLETED|Overall Study||2
8998052|NCT02856490|10061297|FG000|NOT COMPLETED|Overall Study||0
8998053|NCT02856490|10061298|FG001|NOT COMPLETED|Overall Study||0
8998054|NCT02856490|10061299|FG002|NOT COMPLETED|Overall Study||0
8998055|NCT02856555|10061310|FG000|STARTED|Overall Study||51
8998056|NCT02856555|10061311|FG001|STARTED|Overall Study||50
8998057|NCT02856555|10061312|FG002|STARTED|Overall Study||26
8998058|NCT02856555|10061310|FG000|COMPLETED|Overall Study||46
8998059|NCT02856555|10061311|FG001|COMPLETED|Overall Study||46
8998060|NCT02856555|10061312|FG002|COMPLETED|Overall Study||26
8998061|NCT02856555|10061310|FG000|NOT COMPLETED|Overall Study||5
8998062|NCT02856555|10061311|FG001|NOT COMPLETED|Overall Study||4
8998063|NCT02856555|10061312|FG002|NOT COMPLETED|Overall Study||0
8998064|NCT02856802|10061322|FG000|STARTED|Double-Blind Treatment Period 1|4 of 54 randomized subjects did not start; 2 had no migraines, 1 withdrew, 1 lost to follow-up.|50
8998065|NCT02856802|10061323|FG001|STARTED|Double-Blind Treatment Period 1|10 of 53 randomized subjects did not start; 6 had no migraines, 3 withdrew, 1 sponsor terminated.|43
8998066|NCT02856802|10061322|FG000|COMPLETED|Double-Blind Treatment Period 1||48
8998067|NCT02856802|10061323|FG001|COMPLETED|Double-Blind Treatment Period 1||38
8998068|NCT02856802|10061322|FG000|NOT COMPLETED|Double-Blind Treatment Period 1||2
8998069|NCT02856802|10061323|FG001|NOT COMPLETED|Double-Blind Treatment Period 1||5
8998070|NCT02856802|10061322|FG000|STARTED|Double-Blind Treatment Period 2|6 of 43 re-randomized subjects did not start; 5 had no migraines, for 1 protocol deviation.|37
8998071|NCT02856802|10061323|FG001|STARTED|Double-Blind Treatment Period 2|5 of 43 re-randomized subjects did not start; 4 had no migraines, for 1 prohibited drug use.|38
8998072|NCT02856802|10061322|FG000|COMPLETED|Double-Blind Treatment Period 2||36
8998073|NCT02856802|10061323|FG001|COMPLETED|Double-Blind Treatment Period 2||38
8998074|NCT02856802|10061322|FG000|NOT COMPLETED|Double-Blind Treatment Period 2||1
8998075|NCT02856802|10061323|FG001|NOT COMPLETED|Double-Blind Treatment Period 2||0
8998076|NCT02856828|10061335|FG000|STARTED|Overall Study||2
8998077|NCT02856828|10061336|FG001|STARTED|Overall Study||3
8998078|NCT02856828|10061335|FG000|COMPLETED|Overall Study||2
8998079|NCT02856828|10061336|FG001|COMPLETED|Overall Study||3
8998080|NCT02856828|10061335|FG000|NOT COMPLETED|Overall Study||0
8998081|NCT02856828|10061336|FG001|NOT COMPLETED|Overall Study||0
9039335|NCT03337490|10100273|FG000|STARTED|Overall Study||128
9039336|NCT03337490|10100274|FG001|STARTED|Overall Study||126
9039337|NCT03337490|10100275|FG002|STARTED|Overall Study||42
9039338|NCT03337490|10100273|FG000|COMPLETED|Overall Study||117
9039339|NCT03337490|10100274|FG001|COMPLETED|Overall Study||112
9039340|NCT03337490|10100275|FG002|COMPLETED|Overall Study||7
9039341|NCT03337490|10100273|FG000|NOT COMPLETED|Overall Study||11
9039342|NCT03337490|10100274|FG001|NOT COMPLETED|Overall Study||14
9039343|NCT03337490|10100275|FG002|NOT COMPLETED|Overall Study||35
9039344|NCT03337542|10100283|FG000|STARTED|Overall Study||243
9039345|NCT03337542|10100283|FG000|Safety Population|Overall Study||242
9039346|NCT03337542|10100283|FG000|COMPLETED|Overall Study||222
9039347|NCT03337542|10100283|FG000|NOT COMPLETED|Overall Study||21
9039348|NCT03338010|10100290|FG000|STARTED|Overall Study||359
9039349|NCT03338010|10100291|FG001|STARTED|Overall Study||177
9039350|NCT03338010|10100290|FG000|Received at Least One Dose of Study Drug|Overall Study||359
9039351|NCT03338010|10100291|FG001|Received at Least One Dose of Study Drug|Overall Study||177
9039352|NCT03338010|10100290|FG000|COMPLETED|Overall Study||336
9039353|NCT03338010|10100291|FG001|COMPLETED|Overall Study||159
9039354|NCT03338010|10100290|FG000|NOT COMPLETED|Overall Study||23
9039355|NCT03338010|10100291|FG001|NOT COMPLETED|Overall Study||18
9039356|NCT03338023|10100299|FG000|STARTED|Overall Study||137
9039357|NCT03338023|10100300|FG001|STARTED|Overall Study||135
9039358|NCT03338023|10100299|FG000|Received at Least One Dose of Study Drug|Overall Study||137
9039359|NCT03338023|10100300|FG001|Received at Least One Dose of Study Drug|Overall Study||135
9039360|NCT03338023|10100299|FG000|COMPLETED|Overall Study||128
9039361|NCT03338023|10100300|FG001|COMPLETED|Overall Study||125
9039362|NCT03338023|10100299|FG000|NOT COMPLETED|Overall Study||9
9039363|NCT03338023|10100300|FG001|NOT COMPLETED|Overall Study||10
9039364|NCT03338036|10100310|FG000|STARTED|Overall Study||0
9039365|NCT03338036|10100311|FG001|STARTED|Overall Study||11
9039366|NCT03338036|10100312|FG002|STARTED|Overall Study||12
9039367|NCT03338036|10100313|FG003|STARTED|Overall Study||8
9039368|NCT03338036|10100310|FG000|COMPLETED|Overall Study||0
9039369|NCT03338036|10100311|FG001|COMPLETED|Overall Study||7
9039370|NCT03338036|10100312|FG002|COMPLETED|Overall Study||9
9039371|NCT03338036|10100313|FG003|COMPLETED|Overall Study||8
9039372|NCT03338036|10100310|FG000|NOT COMPLETED|Overall Study||0
9039373|NCT03338036|10100311|FG001|NOT COMPLETED|Overall Study||4
9039374|NCT03338036|10100312|FG002|NOT COMPLETED|Overall Study||3
8998082|NCT02856880|10061350|FG000|STARTED|Overall Study||45
8998083|NCT02856880|10061350|FG000|Received Test Zinc-IPMP|Overall Study||44
8998084|NCT02856880|10061350|FG000|Received Test Zinc Non-IPMP|Overall Study||44
8998085|NCT02856880|10061350|FG000|Received Positive Control|Overall Study||45
8998086|NCT02856880|10061350|FG000|Received Non-SLS Negative Control|Overall Study||44
8998087|NCT02856880|10061350|FG000|Received SLS Negative Control|Overall Study||44
8998088|NCT02856880|10061350|FG000|COMPLETED|Overall Study||44
8998089|NCT02856880|10061350|FG000|NOT COMPLETED|Overall Study||1
8998090|NCT02857283|10061371|FG000|STARTED|First Exposure||8
8998091|NCT02857283|10061372|FG001|STARTED|First Exposure||7
8998092|NCT02857283|10061371|FG000|COMPLETED|First Exposure||7
8998093|NCT02857283|10061372|FG001|COMPLETED|First Exposure||7
8998094|NCT02857283|10061371|FG000|NOT COMPLETED|First Exposure||1
8998095|NCT02857283|10061372|FG001|NOT COMPLETED|First Exposure||0
8998096|NCT02857283|10061371|FG000|STARTED|Washout (2 Weeks)||7
8998097|NCT02857283|10061372|FG001|STARTED|Washout (2 Weeks)||7
8998098|NCT02857283|10061371|FG000|COMPLETED|Washout (2 Weeks)||7
8998099|NCT02857283|10061372|FG001|COMPLETED|Washout (2 Weeks)||7
8998100|NCT02857283|10061371|FG000|NOT COMPLETED|Washout (2 Weeks)||0
8998101|NCT02857283|10061372|FG001|NOT COMPLETED|Washout (2 Weeks)||0
8998102|NCT02857283|10061371|FG000|STARTED|Second Exposure||7
8998103|NCT02857283|10061372|FG001|STARTED|Second Exposure||7
8998104|NCT02857283|10061371|FG000|COMPLETED|Second Exposure||7
8998105|NCT02857283|10061372|FG001|COMPLETED|Second Exposure||7
8998106|NCT02857283|10061371|FG000|NOT COMPLETED|Second Exposure||0
8998107|NCT02857283|10061372|FG001|NOT COMPLETED|Second Exposure||0
8998108|NCT02857816|10061379|FG000|STARTED|Overall Study||154
8998109|NCT02857816|10061379|FG000|Subjects Qualified and Treated With PTNM|Overall Study||120
8998110|NCT02857816|10061379|FG000|COMPLETED|Overall Study||116
8998111|NCT02857816|10061379|FG000|NOT COMPLETED|Overall Study||38
8998112|NCT02858050|10061386|FG000|STARTED|Overall Study||20
8998113|NCT02858050|10061387|FG001|STARTED|Overall Study||20
8998114|NCT02858050|10061386|FG000|COMPLETED|Overall Study||20
8998115|NCT02858050|10061387|FG001|COMPLETED|Overall Study||20
8998116|NCT02858050|10061386|FG000|NOT COMPLETED|Overall Study||0
8998117|NCT02858050|10061387|FG001|NOT COMPLETED|Overall Study||0
8998118|NCT02858076|10061395|FG000|STARTED|Overall Study||100
8998119|NCT02858076|10061396|FG001|STARTED|Overall Study||105
8998120|NCT02858076|10061395|FG000|COMPLETED|Overall Study||90
8998121|NCT02858076|10061396|FG001|COMPLETED|Overall Study||87
8998122|NCT02858076|10061395|FG000|NOT COMPLETED|Overall Study||10
8998123|NCT02858076|10061396|FG001|NOT COMPLETED|Overall Study||18
8998124|NCT02858180|10061406|FG000|STARTED|Overall Study||10
8998125|NCT02858180|10061407|FG001|STARTED|Overall Study||5
8998126|NCT02858180|10061406|FG000|COMPLETED|Overall Study|Completed a 12-week course of therapy.|10
8998127|NCT02858180|10061407|FG001|COMPLETED|Overall Study|Completed a 12-week course of therapy.|3
8998128|NCT02858180|10061406|FG000|NOT COMPLETED|Overall Study||0
8998129|NCT02858180|10061407|FG001|NOT COMPLETED|Overall Study||2
8998130|NCT02858349|10061413|FG000|STARTED|Overall Study||10
8998131|NCT02858349|10061413|FG000|COMPLETED|Overall Study||10
8998132|NCT02858349|10061413|FG000|NOT COMPLETED|Overall Study||0
8998133|NCT02858362|10061420|FG000|STARTED|Overall Study||30
8998134|NCT02858362|10061421|FG001|STARTED|Overall Study||10
8998135|NCT02858362|10061422|FG002|STARTED|Overall Study||3
8998136|NCT02858362|10061420|FG000|Did Not Enter Extension Phase|Overall Study||1
8998137|NCT02858362|10061421|FG001|Did Not Enter Extension Phase|Overall Study||2
8998138|NCT02858362|10061422|FG002|Did Not Enter Extension Phase|Overall Study||0
8998139|NCT02858362|10061420|FG000|COMPLETED|Overall Study||28
8998140|NCT02858362|10061421|FG001|COMPLETED|Overall Study||9
8998141|NCT02858362|10061422|FG002|COMPLETED|Overall Study||0
8998142|NCT02858362|10061420|FG000|NOT COMPLETED|Overall Study||2
8998143|NCT02858362|10061421|FG001|NOT COMPLETED|Overall Study||1
8998144|NCT02858362|10061422|FG002|NOT COMPLETED|Overall Study||3
8998145|NCT02858401|10061442|FG000|STARTED|Overall Study||6
8998146|NCT02858401|10061443|FG001|STARTED|Overall Study||6
8998147|NCT02858401|10061444|FG002|STARTED|Overall Study||6
8998148|NCT02858401|10061445|FG003|STARTED|Overall Study||6
8998149|NCT02858401|10061446|FG004|STARTED|Overall Study||6
8998150|NCT02858401|10061447|FG005|STARTED|Overall Study||6
8998151|NCT02858401|10061448|FG006|STARTED|Overall Study||12
8998152|NCT02858401|10061442|FG000|COMPLETED|Overall Study||6
8998153|NCT02858401|10061443|FG001|COMPLETED|Overall Study||5
8998154|NCT02858401|10061444|FG002|COMPLETED|Overall Study||6
8998155|NCT02858401|10061445|FG003|COMPLETED|Overall Study||6
8998156|NCT02858401|10061446|FG004|COMPLETED|Overall Study||6
8998157|NCT02858401|10061447|FG005|COMPLETED|Overall Study||5
8998158|NCT02858401|10061448|FG006|COMPLETED|Overall Study||12
8998159|NCT02858401|10061442|FG000|NOT COMPLETED|Overall Study||0
8998160|NCT02858401|10061443|FG001|NOT COMPLETED|Overall Study||1
8998161|NCT02858401|10061444|FG002|NOT COMPLETED|Overall Study||0
8998162|NCT02858401|10061445|FG003|NOT COMPLETED|Overall Study||0
8998163|NCT02858401|10061446|FG004|NOT COMPLETED|Overall Study||0
8998164|NCT02858401|10061447|FG005|NOT COMPLETED|Overall Study||1
8998165|NCT02858401|10061448|FG006|NOT COMPLETED|Overall Study||0
8998166|NCT02858440|10061473|FG000|STARTED|Overall Study||235
8998167|NCT02858440|10061473|FG000|COMPLETED|Overall Study||223
8998168|NCT02858440|10061473|FG000|NOT COMPLETED|Overall Study||12
8998169|NCT02858492|10061481|FG000|STARTED|Overall Study||3
8998170|NCT02858492|10061482|FG001|STARTED|Overall Study||15
8998171|NCT02858492|10061483|FG002|STARTED|Overall Study||5
8998172|NCT02858492|10061484|FG003|STARTED|Overall Study||28
8998173|NCT02858492|10061481|FG000|COMPLETED|Overall Study||3
8998174|NCT02858492|10061482|FG001|COMPLETED|Overall Study||14
8998175|NCT02858492|10061483|FG002|COMPLETED|Overall Study||5
8998176|NCT02858492|10061484|FG003|COMPLETED|Overall Study||22
8998177|NCT02858492|10061481|FG000|NOT COMPLETED|Overall Study||0
8998178|NCT02858492|10061482|FG001|NOT COMPLETED|Overall Study||1
8998179|NCT02858492|10061483|FG002|NOT COMPLETED|Overall Study||0
8998180|NCT02858492|10061484|FG003|NOT COMPLETED|Overall Study||6
8998181|NCT02858713|10061498|FG000|STARTED|Overall Study||68
8998182|NCT02858713|10061499|FG001|STARTED|Overall Study||66
8998183|NCT02858713|10061498|FG000|COMPLETED|Overall Study||61
8998184|NCT02858713|10061499|FG001|COMPLETED|Overall Study||61
8998185|NCT02858713|10061498|FG000|NOT COMPLETED|Overall Study||7
8998186|NCT02858713|10061499|FG001|NOT COMPLETED|Overall Study||5
8998187|NCT02858726|10061513|FG000|STARTED|Overall Study||44
8998188|NCT02858726|10061514|FG001|STARTED|Overall Study||42
8998189|NCT02858726|10061515|FG002|STARTED|Overall Study||44
8998190|NCT02858726|10061516|FG003|STARTED|Overall Study||45
8998191|NCT02858726|10061513|FG000|COMPLETED|Overall Study||39
8998192|NCT02858726|10061514|FG001|COMPLETED|Overall Study||35
8998193|NCT02858726|10061515|FG002|COMPLETED|Overall Study||33
8998194|NCT02858726|10061516|FG003|COMPLETED|Overall Study||42
8998195|NCT02858726|10061513|FG000|NOT COMPLETED|Overall Study||5
8998196|NCT02858726|10061514|FG001|NOT COMPLETED|Overall Study||7
8998197|NCT02858726|10061515|FG002|NOT COMPLETED|Overall Study||11
8998198|NCT02858726|10061516|FG003|NOT COMPLETED|Overall Study||3
8998199|NCT02859142|10061532|FG000|STARTED|Overall Study||61
8998200|NCT02859142|10061533|FG001|STARTED|Overall Study||61
8998201|NCT02859142|10061532|FG000|COMPLETED|Overall Study||57
8998202|NCT02859142|10061533|FG001|COMPLETED|Overall Study||52
8998203|NCT02859142|10061532|FG000|NOT COMPLETED|Overall Study||4
8998204|NCT02859142|10061533|FG001|NOT COMPLETED|Overall Study||9
8998205|NCT02859246|10061539|FG000|STARTED|Overall Study|15 subjects were enrolled into study|15
8998206|NCT02859246|10061539|FG000|COMPLETED|Overall Study|10 subjects completed the study|10
8998207|NCT02859246|10061539|FG000|NOT COMPLETED|Overall Study||5
8998208|NCT02859324|10061547|FG000|STARTED|Overall Study||7
8998209|NCT02859324|10061548|FG001|STARTED|Overall Study||9
8998210|NCT02859324|10061549|FG002|STARTED|Overall Study||5
8998211|NCT02859324|10061547|FG000|COMPLETED|Overall Study||0
8998212|NCT02859324|10061548|FG001|COMPLETED|Overall Study||0
8998213|NCT02859324|10061549|FG002|COMPLETED|Overall Study||0
8998214|NCT02859324|10061547|FG000|NOT COMPLETED|Overall Study||7
8998215|NCT02859324|10061548|FG001|NOT COMPLETED|Overall Study||9
8998216|NCT02859324|10061549|FG002|NOT COMPLETED|Overall Study||5
8998217|NCT02859441|10061557|FG000|STARTED|Overall Study||3
8998218|NCT02859441|10061557|FG000|COMPLETED|Overall Study||3
8998219|NCT02859441|10061557|FG000|NOT COMPLETED|Overall Study||0
8998220|NCT02859454|10061578|FG000|STARTED|Overall Study||13
8998221|NCT02859454|10061578|FG000|COMPLETED|Overall Study||12
8725906|NCT01033487|9773163|FG006|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
8725907|NCT01033487|9773164|FG007|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||3
8725908|NCT01033487|9773165|FG008|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
8725909|NCT01033487|9773166|FG009|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
8998222|NCT02859454|10061578|FG000|NOT COMPLETED|Overall Study||1
8998223|NCT02859597|10061587|FG000|STARTED|Overall Study|started Dec 2016|22
8998224|NCT02859597|10061588|FG001|STARTED|Overall Study|Started Dec 2016|19
8998225|NCT02859597|10061587|FG000|COMPLETED|Overall Study|September 2018|22
8998226|NCT02859597|10061588|FG001|COMPLETED|Overall Study|September 2018|19
8998227|NCT02859597|10061587|FG000|NOT COMPLETED|Overall Study||0
8998228|NCT02859597|10061588|FG001|NOT COMPLETED|Overall Study||0
8998229|NCT02860130|10061598|FG000|STARTED|Overall Study||17
8998230|NCT02860130|10061599|FG001|STARTED|Overall Study||17
8998231|NCT02860130|10061598|FG000|COMPLETED|Overall Study||10
8998232|NCT02860130|10061599|FG001|COMPLETED|Overall Study||8
8998233|NCT02860130|10061598|FG000|NOT COMPLETED|Overall Study||7
8998234|NCT02860130|10061599|FG001|NOT COMPLETED|Overall Study||9
8998235|NCT02860286|10061607|FG000|STARTED|Overall Study||13
8998236|NCT02860286|10061608|FG001|STARTED|Overall Study||61
8998237|NCT02860286|10061607|FG000|COMPLETED|Overall Study||13
8998238|NCT02860286|10061608|FG001|COMPLETED|Overall Study||61
8998239|NCT02860286|10061607|FG000|NOT COMPLETED|Overall Study||0
8998240|NCT02860286|10061608|FG001|NOT COMPLETED|Overall Study||0
8998241|NCT02860507|10061625|FG000|STARTED|Overall Study||25
8998242|NCT02860507|10061626|FG001|STARTED|Overall Study||25
8998243|NCT02860507|10061625|FG000|COMPLETED|Overall Study||25
8725910|NCT01033487|9773157|FG000|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
8725911|NCT01033487|9773158|FG001|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
8725912|NCT01033487|9773159|FG002|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
8998244|NCT02860507|10061626|FG001|COMPLETED|Overall Study||25
8998245|NCT02860507|10061625|FG000|NOT COMPLETED|Overall Study||0
8998246|NCT02860507|10061626|FG001|NOT COMPLETED|Overall Study||0
8998247|NCT02860546|10061632|FG000|STARTED|Overall Study||18
8998248|NCT02860546|10061632|FG000|COMPLETED|Overall Study||0
8998249|NCT02860546|10061632|FG000|NOT COMPLETED|Overall Study||18
8998250|NCT02860845|10061638|FG000|STARTED|Overall Study||24
8998251|NCT02860845|10061639|FG001|STARTED|Overall Study||24
8998252|NCT02860845|10061638|FG000|Analyzed Patients|Overall Study||22
8998253|NCT02860845|10061639|FG001|Analyzed Patients|Overall Study||23
8998254|NCT02860845|10061638|FG000|COMPLETED|Overall Study||22
8998255|NCT02860845|10061639|FG001|COMPLETED|Overall Study||23
8998256|NCT02860845|10061638|FG000|NOT COMPLETED|Overall Study||2
8998257|NCT02860845|10061639|FG001|NOT COMPLETED|Overall Study||1
8998258|NCT02860988|10061651|FG000|STARTED|Overall Study||201
8998259|NCT02860988|10061652|FG001|STARTED|Overall Study||200
8998260|NCT02860988|10061651|FG000|COMPLETED|Overall Study||117
8998261|NCT02860988|10061652|FG001|COMPLETED|Overall Study||94
8998262|NCT02860988|10061651|FG000|NOT COMPLETED|Overall Study||84
8998263|NCT02860988|10061652|FG001|NOT COMPLETED|Overall Study||106
8633824|NCT00553150|9674002|FG000|NOT COMPLETED|Overall Study||0
8633825|NCT00553150|9674003|FG001|NOT COMPLETED|Overall Study||0
8633826|NCT00553150|9674004|FG002|NOT COMPLETED|Overall Study||0
8633827|NCT00553150|9674005|FG003|NOT COMPLETED|Overall Study||4
8633828|NCT00553163|9674015|FG000|STARTED|Overall Study||16
8633829|NCT00553163|9674016|FG001|STARTED|Overall Study||10
8633830|NCT00553163|9674015|FG000|COMPLETED|Overall Study||16
8633831|NCT00553163|9674016|FG001|COMPLETED|Overall Study||10
8633832|NCT00553163|9674015|FG000|NOT COMPLETED|Overall Study||0
8633833|NCT00553163|9674016|FG001|NOT COMPLETED|Overall Study||0
8633834|NCT00553202|9674027|FG000|STARTED|Overall Study||158
8633835|NCT00553202|9674027|FG000|COMPLETED|Overall Study||90
8633836|NCT00553202|9674027|FG000|NOT COMPLETED|Overall Study||68
8633837|NCT00553254|9674034|FG000|STARTED|Overall Study||6
8633838|NCT00553254|9674035|FG001|STARTED|Overall Study||6
8633839|NCT00553254|9674036|FG002|STARTED|Overall Study||43
8633840|NCT00553254|9674034|FG000|COMPLETED|Overall Study||0
8633841|NCT00553254|9674035|FG001|COMPLETED|Overall Study||0
8633842|NCT00553254|9674036|FG002|COMPLETED|Overall Study||0
8633843|NCT00553254|9674034|FG000|NOT COMPLETED|Overall Study||6
8633844|NCT00553254|9674035|FG001|NOT COMPLETED|Overall Study||6
8633845|NCT00553254|9674036|FG002|NOT COMPLETED|Overall Study||43
8633846|NCT00553267|9674051|FG000|STARTED|Overall Study||315
8633847|NCT00553267|9674052|FG001|STARTED|Overall Study||315
8633848|NCT00553267|9674053|FG002|STARTED|Overall Study||317
8633849|NCT00553267|9674051|FG000|COMPLETED|Overall Study||301
8633850|NCT00553267|9674052|FG001|COMPLETED|Overall Study||297
8633851|NCT00553267|9674053|FG002|COMPLETED|Overall Study||307
8633852|NCT00553267|9674051|FG000|NOT COMPLETED|Overall Study||14
8633853|NCT00553267|9674052|FG001|NOT COMPLETED|Overall Study||18
8633854|NCT00553267|9674053|FG002|NOT COMPLETED|Overall Study||10
8633855|NCT00553280|9674061|FG000|STARTED|Overall Study||123
8633856|NCT00553280|9674061|FG000|COMPLETED|Overall Study||97
8633857|NCT00553280|9674061|FG000|NOT COMPLETED|Overall Study||26
8633858|NCT00553319|9674068|FG000|STARTED|Overall Study||43
8633859|NCT00553319|9674069|FG001|STARTED|Overall Study||40
8633860|NCT00553319|9674070|FG002|STARTED|Overall Study||43
8633861|NCT00553319|9674068|FG000|COMPLETED|Overall Study||29
8633862|NCT00553319|9674069|FG001|COMPLETED|Overall Study||30
8633863|NCT00553319|9674070|FG002|COMPLETED|Overall Study||34
8633864|NCT00553319|9674068|FG000|NOT COMPLETED|Overall Study||14
8633865|NCT00553319|9674069|FG001|NOT COMPLETED|Overall Study||10
8633866|NCT00553319|9674070|FG002|NOT COMPLETED|Overall Study||9
8633867|NCT00553332|9674078|FG000|STARTED|Overall Study||29
8633868|NCT00553332|9674078|FG000|COMPLETED|Overall Study|evaluable for response|28
8633869|NCT00553332|9674078|FG000|NOT COMPLETED|Overall Study||1
8633870|NCT00553358|9674085|FG000|STARTED|Overall Study||152
8633871|NCT00553358|9674086|FG001|STARTED|Overall Study||154
8633872|NCT00553358|9674087|FG002|STARTED|Overall Study||149
8633873|NCT00553358|9674085|FG000|COMPLETED|Overall Study||73
8633874|NCT00553358|9674086|FG001|COMPLETED|Overall Study||58
8998264|NCT02861118|10061660|FG000|STARTED|Overall Study||194
8998265|NCT02861118|10061661|FG001|STARTED|Overall Study||116
8998266|NCT02861118|10061660|FG000|COMPLETED|Overall Study||194
8998267|NCT02861118|10061661|FG001|COMPLETED|Overall Study||116
8998268|NCT02861118|10061660|FG000|NOT COMPLETED|Overall Study||0
8998269|NCT02861118|10061661|FG001|NOT COMPLETED|Overall Study||0
8998270|NCT02861131|10061671|FG000|STARTED|Overall Study||100
8998271|NCT02861131|10061672|FG001|STARTED|Overall Study||100
8998272|NCT02861131|10061671|FG000|COMPLETED|Overall Study||100
8998273|NCT02861131|10061672|FG001|COMPLETED|Overall Study||100
8633875|NCT00553358|9674087|FG002|COMPLETED|Overall Study||61
8633876|NCT00553358|9674085|FG000|NOT COMPLETED|Overall Study||79
8633877|NCT00553358|9674086|FG001|NOT COMPLETED|Overall Study||96
8633878|NCT00553358|9674087|FG002|NOT COMPLETED|Overall Study||88
8633879|NCT00553410|9674103|FG000|STARTED|Overall Study||2441
8633880|NCT00553410|9674104|FG001|STARTED|Overall Study||2443
8633881|NCT00553410|9674103|FG000|COMPLETED|Overall Study||2426
8633882|NCT00553410|9674104|FG001|COMPLETED|Overall Study||2425
8633883|NCT00553410|9674103|FG000|NOT COMPLETED|Overall Study||15
8998274|NCT02861131|10061671|FG000|NOT COMPLETED|Overall Study||0
8998275|NCT02861131|10061672|FG001|NOT COMPLETED|Overall Study||0
8998276|NCT02861534|10061680|FG000|STARTED|Overall Study||2526
8998277|NCT02861534|10061681|FG001|STARTED|Overall Study||2524
8998278|NCT02861534|10061680|FG000|Treated|Overall Study||2519
8998279|NCT02861534|10061681|FG001|Treated|Overall Study||2515
8998280|NCT02861534|10061680|FG000|COMPLETED|Overall Study||1952
8998281|NCT02861534|10061681|FG001|COMPLETED|Overall Study||1937
8998282|NCT02861534|10061680|FG000|NOT COMPLETED|Overall Study||574
8998283|NCT02861534|10061681|FG001|NOT COMPLETED|Overall Study||587
8998284|NCT02861586|10061695|FG000|STARTED|Overall Study||51
8998285|NCT02861586|10061696|FG001|STARTED|Overall Study||18
8998286|NCT02861586|10061697|FG002|STARTED|Overall Study||47
8998287|NCT02861586|10061698|FG003|STARTED|Overall Study||16
8998288|NCT02861586|10061699|FG004|STARTED|Overall Study||47
8998289|NCT02861586|10061700|FG005|STARTED|Overall Study||50
8998290|NCT02861586|10061701|FG006|STARTED|Overall Study||18
8998291|NCT02861586|10061702|FG007|STARTED|Overall Study||16
8998292|NCT02861586|10061695|FG000|COMPLETED|Overall Study||47
8998293|NCT02861586|10061696|FG001|COMPLETED|Overall Study||15
8998294|NCT02861586|10061697|FG002|COMPLETED|Overall Study||46
8998295|NCT02861586|10061698|FG003|COMPLETED|Overall Study||16
8998296|NCT02861586|10061699|FG004|COMPLETED|Overall Study||47
8998297|NCT02861586|10061700|FG005|COMPLETED|Overall Study||45
8998298|NCT02861586|10061701|FG006|COMPLETED|Overall Study||17
8998299|NCT02861586|10061702|FG007|COMPLETED|Overall Study||16
8998300|NCT02861586|10061695|FG000|NOT COMPLETED|Overall Study||4
8998301|NCT02861586|10061696|FG001|NOT COMPLETED|Overall Study||3
8998302|NCT02861586|10061697|FG002|NOT COMPLETED|Overall Study||1
8998303|NCT02861586|10061698|FG003|NOT COMPLETED|Overall Study||0
8998304|NCT02861586|10061699|FG004|NOT COMPLETED|Overall Study||0
8998305|NCT02861586|10061700|FG005|NOT COMPLETED|Overall Study||5
8998306|NCT02861586|10061701|FG006|NOT COMPLETED|Overall Study||1
8998307|NCT02861586|10061702|FG007|NOT COMPLETED|Overall Study||0
8998308|NCT02861664|10061727|FG000|STARTED|Overall Study||67
8998309|NCT02861664|10061728|FG001|STARTED|Overall Study||68
8998310|NCT02861664|10061727|FG000|COMPLETED|Overall Study||67
8998311|NCT02861664|10061728|FG001|COMPLETED|Overall Study||67
8998312|NCT02861664|10061727|FG000|NOT COMPLETED|Overall Study||0
8998313|NCT02861664|10061728|FG001|NOT COMPLETED|Overall Study||1
8998314|NCT02861807|10061736|FG000|STARTED|Overall Study||47
8998315|NCT02861807|10061737|FG001|STARTED|Overall Study||37
8998316|NCT02861807|10061736|FG000|Attended Post-treatment Assessment|Overall Study||34
8572387|NCT00114114|9604543|FG004|COMPLETED|Overall Study||27
8572388|NCT00114114|9604544|FG005|COMPLETED|Overall Study||30
8572389|NCT00114114|9604539|FG000|NOT COMPLETED|Overall Study||5
8572390|NCT00114114|9604540|FG001|NOT COMPLETED|Overall Study||1
8572391|NCT00114114|9604541|FG002|NOT COMPLETED|Overall Study||1
8572392|NCT00114114|9604542|FG003|NOT COMPLETED|Overall Study||4
8572393|NCT00114114|9604543|FG004|NOT COMPLETED|Overall Study||2
8572394|NCT00114114|9604544|FG005|NOT COMPLETED|Overall Study||1
8572395|NCT00114127|9604562|FG000|STARTED|Overall Study||13
8572396|NCT00114127|9604563|FG001|STARTED|Overall Study||15
8572397|NCT00114127|9604562|FG000|COMPLETED|Overall Study||9
8572398|NCT00114127|9604563|FG001|COMPLETED|Overall Study||11
8572399|NCT00114127|9604562|FG000|NOT COMPLETED|Overall Study||4
8998317|NCT02861807|10061737|FG001|Attended Post-treatment Assessment|Overall Study||18
8998318|NCT02861807|10061736|FG000|Attended 2-month Follow-up|Overall Study||32
8998319|NCT02861807|10061737|FG001|Attended 2-month Follow-up|Overall Study||20
8998320|NCT02861807|10061736|FG000|COMPLETED|Overall Study||35
8998321|NCT02861807|10061737|FG001|COMPLETED|Overall Study||23
8998322|NCT02861807|10061736|FG000|NOT COMPLETED|Overall Study||12
8998323|NCT02861807|10061737|FG001|NOT COMPLETED|Overall Study||14
8998324|NCT02861937|10061746|FG000|STARTED|Overall Study||10
8998325|NCT02861937|10061747|FG001|STARTED|Overall Study||12
8998326|NCT02861937|10061748|FG002|STARTED|Overall Study||12
8998327|NCT02861937|10061746|FG000|COMPLETED|Overall Study||10
8998328|NCT02861937|10061747|FG001|COMPLETED|Overall Study||12
8998329|NCT02861937|10061748|FG002|COMPLETED|Overall Study||12
8998330|NCT02861937|10061746|FG000|NOT COMPLETED|Overall Study||0
8998331|NCT02861937|10061747|FG001|NOT COMPLETED|Overall Study||0
8998332|NCT02861937|10061748|FG002|NOT COMPLETED|Overall Study||0
8998333|NCT02862080|10061759|FG000|STARTED|7 Days Before Any Intervention||1
8998334|NCT02862080|10061760|FG001|STARTED|7 Days Before Any Intervention||1
8998335|NCT02862080|10061761|FG002|STARTED|7 Days Before Any Intervention||1
8998336|NCT02862080|10061762|FG003|STARTED|7 Days Before Any Intervention||1
8998337|NCT02862080|10061759|FG000|COMPLETED|7 Days Before Any Intervention||1
8998338|NCT02862080|10061760|FG001|COMPLETED|7 Days Before Any Intervention||1
8998339|NCT02862080|10061761|FG002|COMPLETED|7 Days Before Any Intervention||1
8998340|NCT02862080|10061762|FG003|COMPLETED|7 Days Before Any Intervention||1
8998341|NCT02862080|10061759|FG000|NOT COMPLETED|7 Days Before Any Intervention||0
8998342|NCT02862080|10061760|FG001|NOT COMPLETED|7 Days Before Any Intervention||0
8998343|NCT02862080|10061761|FG002|NOT COMPLETED|7 Days Before Any Intervention||0
8998344|NCT02862080|10061762|FG003|NOT COMPLETED|7 Days Before Any Intervention||0
8998345|NCT02862080|10061759|FG000|STARTED|3 Days Before Any Intervention||1
8998346|NCT02862080|10061760|FG001|STARTED|3 Days Before Any Intervention||1
8998347|NCT02862080|10061761|FG002|STARTED|3 Days Before Any Intervention||1
8998348|NCT02862080|10061762|FG003|STARTED|3 Days Before Any Intervention||1
8998349|NCT02862080|10061759|FG000|COMPLETED|3 Days Before Any Intervention||1
8998350|NCT02862080|10061760|FG001|COMPLETED|3 Days Before Any Intervention||1
8998351|NCT02862080|10061761|FG002|COMPLETED|3 Days Before Any Intervention||1
8998352|NCT02862080|10061762|FG003|COMPLETED|3 Days Before Any Intervention||1
8998353|NCT02862080|10061759|FG000|NOT COMPLETED|3 Days Before Any Intervention||0
8998354|NCT02862080|10061760|FG001|NOT COMPLETED|3 Days Before Any Intervention||0
8998355|NCT02862080|10061761|FG002|NOT COMPLETED|3 Days Before Any Intervention||0
8998356|NCT02862080|10061762|FG003|NOT COMPLETED|3 Days Before Any Intervention||0
8998357|NCT02862080|10061759|FG000|STARTED|Intervention 1 (1 Week)||1
8998358|NCT02862080|10061760|FG001|STARTED|Intervention 1 (1 Week)||1
8998359|NCT02862080|10061761|FG002|STARTED|Intervention 1 (1 Week)||1
8998360|NCT02862080|10061762|FG003|STARTED|Intervention 1 (1 Week)||1
8998361|NCT02862080|10061759|FG000|COMPLETED|Intervention 1 (1 Week)||1
8998362|NCT02862080|10061760|FG001|COMPLETED|Intervention 1 (1 Week)||1
8998363|NCT02862080|10061761|FG002|COMPLETED|Intervention 1 (1 Week)||1
8998364|NCT02862080|10061762|FG003|COMPLETED|Intervention 1 (1 Week)||1
8998365|NCT02862080|10061759|FG000|NOT COMPLETED|Intervention 1 (1 Week)||0
8998366|NCT02862080|10061760|FG001|NOT COMPLETED|Intervention 1 (1 Week)||0
8998367|NCT02862080|10061761|FG002|NOT COMPLETED|Intervention 1 (1 Week)||0
8998368|NCT02862080|10061762|FG003|NOT COMPLETED|Intervention 1 (1 Week)||0
8998369|NCT02862080|10061759|FG000|STARTED|Washout (1 Week)||1
8998370|NCT02862080|10061760|FG001|STARTED|Washout (1 Week)||1
8998371|NCT02862080|10061761|FG002|STARTED|Washout (1 Week)||1
8998372|NCT02862080|10061762|FG003|STARTED|Washout (1 Week)||1
8998373|NCT02862080|10061759|FG000|COMPLETED|Washout (1 Week)||1
8998374|NCT02862080|10061760|FG001|COMPLETED|Washout (1 Week)||1
8998375|NCT02862080|10061761|FG002|COMPLETED|Washout (1 Week)||1
8998376|NCT02862080|10061762|FG003|COMPLETED|Washout (1 Week)||1
8998377|NCT02862080|10061759|FG000|NOT COMPLETED|Washout (1 Week)||0
8998378|NCT02862080|10061760|FG001|NOT COMPLETED|Washout (1 Week)||0
8998379|NCT02862080|10061761|FG002|NOT COMPLETED|Washout (1 Week)||0
8998380|NCT02862080|10061762|FG003|NOT COMPLETED|Washout (1 Week)||0
8998381|NCT02862080|10061759|FG000|STARTED|Intervention 2 (1 Week)||1
8998382|NCT02862080|10061760|FG001|STARTED|Intervention 2 (1 Week)||1
8998383|NCT02862080|10061761|FG002|STARTED|Intervention 2 (1 Week)||1
8998384|NCT02862080|10061762|FG003|STARTED|Intervention 2 (1 Week)||1
8998385|NCT02862080|10061759|FG000|COMPLETED|Intervention 2 (1 Week)||1
8998386|NCT02862080|10061760|FG001|COMPLETED|Intervention 2 (1 Week)||1
8998387|NCT02862080|10061761|FG002|COMPLETED|Intervention 2 (1 Week)||1
8998388|NCT02862080|10061762|FG003|COMPLETED|Intervention 2 (1 Week)||1
8998389|NCT02862080|10061759|FG000|NOT COMPLETED|Intervention 2 (1 Week)||0
8998390|NCT02862080|10061760|FG001|NOT COMPLETED|Intervention 2 (1 Week)||0
8998391|NCT02862080|10061761|FG002|NOT COMPLETED|Intervention 2 (1 Week)||0
8998392|NCT02862080|10061762|FG003|NOT COMPLETED|Intervention 2 (1 Week)||0
8998393|NCT02862080|10061759|FG000|STARTED|Washout (1 Week)||1
8998394|NCT02862080|10061760|FG001|STARTED|Washout (1 Week)||1
8633884|NCT00553410|9674104|FG001|NOT COMPLETED|Overall Study||18
8633885|NCT00553436|9674110|FG000|STARTED|Overall Study|20 August 2007|7
8633886|NCT00553436|9674110|FG000|COMPLETED|Overall Study|09 April 2009|6
8633887|NCT00553436|9674110|FG000|NOT COMPLETED|Overall Study||1
8633888|NCT00553462|9674114|FG000|STARTED|Overall Study||75
8998395|NCT02862080|10061761|FG002|STARTED|Washout (1 Week)||1
8998396|NCT02862080|10061762|FG003|STARTED|Washout (1 Week)||1
8633889|NCT00553462|9674114|FG000|COMPLETED|Overall Study||61
8633890|NCT00553462|9674114|FG000|NOT COMPLETED|Overall Study||14
8633891|NCT00553475|9674121|FG000|STARTED|Overall Study||135
8998397|NCT02862080|10061759|FG000|COMPLETED|Washout (1 Week)||1
8998398|NCT02862080|10061760|FG001|COMPLETED|Washout (1 Week)||1
8998399|NCT02862080|10061761|FG002|COMPLETED|Washout (1 Week)||1
8998400|NCT02862080|10061762|FG003|COMPLETED|Washout (1 Week)||1
8998401|NCT02862080|10061759|FG000|NOT COMPLETED|Washout (1 Week)||0
8998402|NCT02862080|10061760|FG001|NOT COMPLETED|Washout (1 Week)||0
8998403|NCT02862080|10061761|FG002|NOT COMPLETED|Washout (1 Week)||0
8998404|NCT02862080|10061762|FG003|NOT COMPLETED|Washout (1 Week)||0
8998405|NCT02862080|10061759|FG000|STARTED|Intervention 1 Again (1 Week)||1
8633892|NCT00553475|9674122|FG001|STARTED|Overall Study||134
8633893|NCT00553475|9674123|FG002|STARTED|Overall Study||45
8633894|NCT00553475|9674121|FG000|COMPLETED|Overall Study||119
8998406|NCT02862080|10061760|FG001|STARTED|Intervention 1 Again (1 Week)||1
8998407|NCT02862080|10061761|FG002|STARTED|Intervention 1 Again (1 Week)||1
8998408|NCT02862080|10061762|FG003|STARTED|Intervention 1 Again (1 Week)||1
8998409|NCT02862080|10061759|FG000|COMPLETED|Intervention 1 Again (1 Week)||1
8998410|NCT02862080|10061760|FG001|COMPLETED|Intervention 1 Again (1 Week)||1
8998411|NCT02862080|10061761|FG002|COMPLETED|Intervention 1 Again (1 Week)||1
8998412|NCT02862080|10061762|FG003|COMPLETED|Intervention 1 Again (1 Week)||1
8998413|NCT02862080|10061759|FG000|NOT COMPLETED|Intervention 1 Again (1 Week)||0
8998414|NCT02862080|10061760|FG001|NOT COMPLETED|Intervention 1 Again (1 Week)||0
8998415|NCT02862080|10061761|FG002|NOT COMPLETED|Intervention 1 Again (1 Week)||0
8998416|NCT02862080|10061762|FG003|NOT COMPLETED|Intervention 1 Again (1 Week)||0
8998417|NCT02862106|10061778|FG000|STARTED|Overall Study||183
8998418|NCT02862106|10061779|FG001|STARTED|Overall Study||26
8998419|NCT02862106|10061778|FG000|COMPLETED|Overall Study||145
8998420|NCT02862106|10061779|FG001|COMPLETED|Overall Study||20
8998421|NCT02862106|10061778|FG000|NOT COMPLETED|Overall Study||38
8998422|NCT02862106|10061779|FG001|NOT COMPLETED|Overall Study||6
8998423|NCT02862535|10061795|FG000|STARTED|Overall Study||9
8998424|NCT02862535|10061796|FG001|STARTED|Overall Study||6
8998425|NCT02862535|10061797|FG002|STARTED|Overall Study||10
8998426|NCT02862535|10061798|FG003|STARTED|Overall Study||11
8998427|NCT02862535|10061795|FG000|COMPLETED|Overall Study||0
8998428|NCT02862535|10061796|FG001|COMPLETED|Overall Study||0
8998429|NCT02862535|10061797|FG002|COMPLETED|Overall Study||0
8998430|NCT02862535|10061798|FG003|COMPLETED|Overall Study||0
8998431|NCT02862535|10061795|FG000|NOT COMPLETED|Overall Study||9
8998432|NCT02862535|10061796|FG001|NOT COMPLETED|Overall Study||6
8998433|NCT02862535|10061797|FG002|NOT COMPLETED|Overall Study||10
8998434|NCT02862535|10061798|FG003|NOT COMPLETED|Overall Study||11
8998435|NCT02862548|10061810|FG000|STARTED|Open-Label Phase||26
8998436|NCT02862548|10061811|FG001|STARTED|Open-Label Phase||25
8998437|NCT02862548|10061810|FG000|COMPLETED|Open-Label Phase||26
8998438|NCT02862548|10061811|FG001|COMPLETED|Open-Label Phase||24
8998439|NCT02862548|10061810|FG000|NOT COMPLETED|Open-Label Phase||0
8998440|NCT02862548|10061811|FG001|NOT COMPLETED|Open-Label Phase||1
8998441|NCT02862548|10061810|FG000|STARTED|Open-Label Extension Phase||26
8998442|NCT02862548|10061811|FG001|STARTED|Open-Label Extension Phase||24
8998443|NCT02862548|10061810|FG000|COMPLETED|Open-Label Extension Phase||0
8998444|NCT02862548|10061811|FG001|COMPLETED|Open-Label Extension Phase||0
8998445|NCT02862548|10061810|FG000|NOT COMPLETED|Open-Label Extension Phase||26
8998446|NCT02862548|10061811|FG001|NOT COMPLETED|Open-Label Extension Phase||24
8998447|NCT02862574|10061820|FG000|STARTED|Double-Blind Treatment Period||5
8998448|NCT02862574|10061821|FG001|STARTED|Double-Blind Treatment Period||5
8998449|NCT02862574|10061822|FG002|STARTED|Double-Blind Treatment Period||5
8998450|NCT02862574|10061820|FG000|COMPLETED|Double-Blind Treatment Period||2
8998451|NCT02862574|10061821|FG001|COMPLETED|Double-Blind Treatment Period||3
8998452|NCT02862574|10061822|FG002|COMPLETED|Double-Blind Treatment Period||1
8998453|NCT02862574|10061820|FG000|NOT COMPLETED|Double-Blind Treatment Period||3
8998454|NCT02862574|10061821|FG001|NOT COMPLETED|Double-Blind Treatment Period||2
8998455|NCT02862574|10061822|FG002|NOT COMPLETED|Double-Blind Treatment Period||4
8998456|NCT02862574|10061820|FG000|STARTED|Open-Label Treatment Period||2
8998457|NCT02862574|10061821|FG001|STARTED|Open-Label Treatment Period||3
8998458|NCT02862574|10061822|FG002|STARTED|Open-Label Treatment Period||1
8998459|NCT02862574|10061820|FG000|COMPLETED|Open-Label Treatment Period||0
8998460|NCT02862574|10061821|FG001|COMPLETED|Open-Label Treatment Period||0
8998461|NCT02862574|10061822|FG002|COMPLETED|Open-Label Treatment Period||0
8998462|NCT02862574|10061820|FG000|NOT COMPLETED|Open-Label Treatment Period||2
8998463|NCT02862574|10061821|FG001|NOT COMPLETED|Open-Label Treatment Period||3
8998464|NCT02862574|10061822|FG002|NOT COMPLETED|Open-Label Treatment Period||1
8998465|NCT02862600|10061831|FG000|STARTED|Period 1--Perhexiline-low Target Range|First subject underwent baseline functional assessment and perhexiline dosing on August 22, 2016|35
8998466|NCT02862600|10061831|FG000|COMPLETED|Period 1--Perhexiline-low Target Range|Study terminated on April 26, 2017 due to lack of efficacy.|22
8998467|NCT02862600|10061831|FG000|NOT COMPLETED|Period 1--Perhexiline-low Target Range||13
8998468|NCT02862600|10061831|FG000|STARTED|Period 2--Perhexiline-high Target Range|First subject completed Period 1 and moved into Period 2 perhexiline dosing on October 17, 2016|22
8998469|NCT02862600|10061831|FG000|COMPLETED|Period 2--Perhexiline-high Target Range|Study terminated on April 26, 2017 due to lack of efficacy in first 15 subjects completing Period 2.|15
8998470|NCT02862600|10061831|FG000|NOT COMPLETED|Period 2--Perhexiline-high Target Range||7
8998471|NCT02862730|10061837|FG000|STARTED|Tslim Training Visit (2 Weeks)||4
8998472|NCT02862730|10061838|FG001|STARTED|Tslim Training Visit (2 Weeks)||1
8998473|NCT02862730|10061839|FG002|STARTED|Tslim Training Visit (2 Weeks)||8
8998474|NCT02862730|10061840|FG003|STARTED|Tslim Training Visit (2 Weeks)||5
8998475|NCT02862730|10061841|FG004|STARTED|Tslim Training Visit (2 Weeks)||5
8998476|NCT02862730|10061842|FG005|STARTED|Tslim Training Visit (2 Weeks)||1
8998477|NCT02862730|10061843|FG006|STARTED|Tslim Training Visit (2 Weeks)||1
8998478|NCT02862730|10061837|FG000|COMPLETED|Tslim Training Visit (2 Weeks)||4
8633895|NCT00553475|9674122|FG001|COMPLETED|Overall Study||114
8998479|NCT02862730|10061838|FG001|COMPLETED|Tslim Training Visit (2 Weeks)||1
8633896|NCT00553475|9674123|FG002|COMPLETED|Overall Study||32
8633897|NCT00553475|9674121|FG000|NOT COMPLETED|Overall Study||16
8633898|NCT00553475|9674122|FG001|NOT COMPLETED|Overall Study||20
8633899|NCT00553475|9674123|FG002|NOT COMPLETED|Overall Study||13
8633900|NCT00553501|9674133|FG000|STARTED|Overall Study||59
8633901|NCT00553501|9674133|FG000|COMPLETED|Overall Study||55
8998480|NCT02862730|10061839|FG002|COMPLETED|Tslim Training Visit (2 Weeks)||7
8998481|NCT02862730|10061840|FG003|COMPLETED|Tslim Training Visit (2 Weeks)||5
8998482|NCT02862730|10061841|FG004|COMPLETED|Tslim Training Visit (2 Weeks)||5
8998483|NCT02862730|10061842|FG005|COMPLETED|Tslim Training Visit (2 Weeks)||1
8998484|NCT02862730|10061843|FG006|COMPLETED|Tslim Training Visit (2 Weeks)||1
8998485|NCT02862730|10061837|FG000|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
8998486|NCT02862730|10061838|FG001|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
8998487|NCT02862730|10061839|FG002|NOT COMPLETED|Tslim Training Visit (2 Weeks)||1
8998488|NCT02862730|10061840|FG003|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
8998489|NCT02862730|10061841|FG004|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
8998490|NCT02862730|10061842|FG005|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
8998491|NCT02862730|10061843|FG006|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
8998492|NCT02862730|10061837|FG000|STARTED|First Rest Period (1-12 Weeks)||4
8998493|NCT02862730|10061838|FG001|STARTED|First Rest Period (1-12 Weeks)||1
8998494|NCT02862730|10061839|FG002|STARTED|First Rest Period (1-12 Weeks)||7
8998495|NCT02862730|10061840|FG003|STARTED|First Rest Period (1-12 Weeks)||5
8998496|NCT02862730|10061841|FG004|STARTED|First Rest Period (1-12 Weeks)||5
8998497|NCT02862730|10061842|FG005|STARTED|First Rest Period (1-12 Weeks)||1
8998498|NCT02862730|10061843|FG006|STARTED|First Rest Period (1-12 Weeks)||1
8998499|NCT02862730|10061837|FG000|COMPLETED|First Rest Period (1-12 Weeks)||4
8998500|NCT02862730|10061838|FG001|COMPLETED|First Rest Period (1-12 Weeks)||1
8998501|NCT02862730|10061839|FG002|COMPLETED|First Rest Period (1-12 Weeks)||7
8998502|NCT02862730|10061840|FG003|COMPLETED|First Rest Period (1-12 Weeks)||5
8998503|NCT02862730|10061841|FG004|COMPLETED|First Rest Period (1-12 Weeks)||5
8998504|NCT02862730|10061842|FG005|COMPLETED|First Rest Period (1-12 Weeks)||1
8998505|NCT02862730|10061843|FG006|COMPLETED|First Rest Period (1-12 Weeks)||1
8998506|NCT02862730|10061837|FG000|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
8998507|NCT02862730|10061838|FG001|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
8998508|NCT02862730|10061839|FG002|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
8998509|NCT02862730|10061840|FG003|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
8998510|NCT02862730|10061841|FG004|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
8998511|NCT02862730|10061842|FG005|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
8998512|NCT02862730|10061843|FG006|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
8998513|NCT02862730|10061837|FG000|STARTED|First Intervention (84 Hours)||4
8998514|NCT02862730|10061838|FG001|STARTED|First Intervention (84 Hours)||1
8998515|NCT02862730|10061839|FG002|STARTED|First Intervention (84 Hours)||7
8998516|NCT02862730|10061840|FG003|STARTED|First Intervention (84 Hours)||5
8998517|NCT02862730|10061841|FG004|STARTED|First Intervention (84 Hours)||5
8998518|NCT02862730|10061842|FG005|STARTED|First Intervention (84 Hours)||1
8998519|NCT02862730|10061843|FG006|STARTED|First Intervention (84 Hours)||1
8998520|NCT02862730|10061837|FG000|COMPLETED|First Intervention (84 Hours)||4
8998521|NCT02862730|10061838|FG001|COMPLETED|First Intervention (84 Hours)||1
8998522|NCT02862730|10061839|FG002|COMPLETED|First Intervention (84 Hours)||7
8998523|NCT02862730|10061840|FG003|COMPLETED|First Intervention (84 Hours)||5
8998524|NCT02862730|10061841|FG004|COMPLETED|First Intervention (84 Hours)||5
8998525|NCT02862730|10061842|FG005|COMPLETED|First Intervention (84 Hours)||1
8998526|NCT02862730|10061843|FG006|COMPLETED|First Intervention (84 Hours)||1
8998527|NCT02862730|10061837|FG000|NOT COMPLETED|First Intervention (84 Hours)||0
8998528|NCT02862730|10061838|FG001|NOT COMPLETED|First Intervention (84 Hours)||0
8998529|NCT02862730|10061839|FG002|NOT COMPLETED|First Intervention (84 Hours)||0
8998530|NCT02862730|10061840|FG003|NOT COMPLETED|First Intervention (84 Hours)||0
8998531|NCT02862730|10061841|FG004|NOT COMPLETED|First Intervention (84 Hours)||0
8998532|NCT02862730|10061842|FG005|NOT COMPLETED|First Intervention (84 Hours)||0
8998533|NCT02862730|10061843|FG006|NOT COMPLETED|First Intervention (84 Hours)||0
8998534|NCT02862730|10061837|FG000|STARTED|Second Rest Period (7-45 Days)||4
8998535|NCT02862730|10061838|FG001|STARTED|Second Rest Period (7-45 Days)||1
8998536|NCT02862730|10061839|FG002|STARTED|Second Rest Period (7-45 Days)||7
8998537|NCT02862730|10061840|FG003|STARTED|Second Rest Period (7-45 Days)||5
8998538|NCT02862730|10061841|FG004|STARTED|Second Rest Period (7-45 Days)||5
8998539|NCT02862730|10061842|FG005|STARTED|Second Rest Period (7-45 Days)||1
8998540|NCT02862730|10061843|FG006|STARTED|Second Rest Period (7-45 Days)||1
8998541|NCT02862730|10061837|FG000|COMPLETED|Second Rest Period (7-45 Days)||4
8998542|NCT02862730|10061838|FG001|COMPLETED|Second Rest Period (7-45 Days)||1
8998543|NCT02862730|10061839|FG002|COMPLETED|Second Rest Period (7-45 Days)||7
8998544|NCT02862730|10061840|FG003|COMPLETED|Second Rest Period (7-45 Days)||5
8998545|NCT02862730|10061841|FG004|COMPLETED|Second Rest Period (7-45 Days)||5
8998546|NCT02862730|10061842|FG005|COMPLETED|Second Rest Period (7-45 Days)||1
8998547|NCT02862730|10061843|FG006|COMPLETED|Second Rest Period (7-45 Days)||1
8998548|NCT02862730|10061837|FG000|NOT COMPLETED|Second Rest Period (7-45 Days)||0
8998549|NCT02862730|10061838|FG001|NOT COMPLETED|Second Rest Period (7-45 Days)||0
8998550|NCT02862730|10061839|FG002|NOT COMPLETED|Second Rest Period (7-45 Days)||0
8998551|NCT02862730|10061840|FG003|NOT COMPLETED|Second Rest Period (7-45 Days)||0
8633902|NCT00553501|9674133|FG000|NOT COMPLETED|Overall Study||4
8998552|NCT02862730|10061841|FG004|NOT COMPLETED|Second Rest Period (7-45 Days)||0
8998553|NCT02862730|10061842|FG005|NOT COMPLETED|Second Rest Period (7-45 Days)||0
8998554|NCT02862730|10061843|FG006|NOT COMPLETED|Second Rest Period (7-45 Days)||0
8998555|NCT02862730|10061837|FG000|STARTED|Second Intervention (84 Hours)||4
8998556|NCT02862730|10061838|FG001|STARTED|Second Intervention (84 Hours)||1
8998557|NCT02862730|10061839|FG002|STARTED|Second Intervention (84 Hours)||7
8998558|NCT02862730|10061840|FG003|STARTED|Second Intervention (84 Hours)||5
8998559|NCT02862730|10061841|FG004|STARTED|Second Intervention (84 Hours)||5
8998560|NCT02862730|10061842|FG005|STARTED|Second Intervention (84 Hours)||1
8998561|NCT02862730|10061843|FG006|STARTED|Second Intervention (84 Hours)||1
8998562|NCT02862730|10061837|FG000|COMPLETED|Second Intervention (84 Hours)||3
8998563|NCT02862730|10061838|FG001|COMPLETED|Second Intervention (84 Hours)||1
8998564|NCT02862730|10061839|FG002|COMPLETED|Second Intervention (84 Hours)||7
8998565|NCT02862730|10061840|FG003|COMPLETED|Second Intervention (84 Hours)||5
8998566|NCT02862730|10061841|FG004|COMPLETED|Second Intervention (84 Hours)||5
8998567|NCT02862730|10061842|FG005|COMPLETED|Second Intervention (84 Hours)||1
8998568|NCT02862730|10061843|FG006|COMPLETED|Second Intervention (84 Hours)||1
8998569|NCT02862730|10061837|FG000|NOT COMPLETED|Second Intervention (84 Hours)||1
8998570|NCT02862730|10061838|FG001|NOT COMPLETED|Second Intervention (84 Hours)||0
8998571|NCT02862730|10061839|FG002|NOT COMPLETED|Second Intervention (84 Hours)||0
8998572|NCT02862730|10061840|FG003|NOT COMPLETED|Second Intervention (84 Hours)||0
8998573|NCT02862730|10061841|FG004|NOT COMPLETED|Second Intervention (84 Hours)||0
8998574|NCT02862730|10061842|FG005|NOT COMPLETED|Second Intervention (84 Hours)||0
8998575|NCT02862730|10061843|FG006|NOT COMPLETED|Second Intervention (84 Hours)||0
8998576|NCT02862730|10061837|FG000|STARTED|Third Rest Period (7-45 Days)||3
8998577|NCT02862730|10061838|FG001|STARTED|Third Rest Period (7-45 Days)||1
8998578|NCT02862730|10061839|FG002|STARTED|Third Rest Period (7-45 Days)||7
8998579|NCT02862730|10061840|FG003|STARTED|Third Rest Period (7-45 Days)||5
8998580|NCT02862730|10061841|FG004|STARTED|Third Rest Period (7-45 Days)||5
8998581|NCT02862730|10061842|FG005|STARTED|Third Rest Period (7-45 Days)||1
8998582|NCT02862730|10061843|FG006|STARTED|Third Rest Period (7-45 Days)||1
8998583|NCT02862730|10061837|FG000|COMPLETED|Third Rest Period (7-45 Days)||3
8998584|NCT02862730|10061838|FG001|COMPLETED|Third Rest Period (7-45 Days)||1
8633903|NCT00553514|9674142|FG000|STARTED|Overall Study||14
8633904|NCT00553514|9674143|FG001|STARTED|Overall Study||14
8633905|NCT00553514|9674144|FG002|STARTED|Overall Study||15
8633906|NCT00553514|9674145|FG003|STARTED|Overall Study||13
8633907|NCT00553514|9674146|FG004|STARTED|Overall Study||15
8998585|NCT02862730|10061839|FG002|COMPLETED|Third Rest Period (7-45 Days)||6
8998586|NCT02862730|10061840|FG003|COMPLETED|Third Rest Period (7-45 Days)||5
8998587|NCT02862730|10061841|FG004|COMPLETED|Third Rest Period (7-45 Days)||4
8998588|NCT02862730|10061842|FG005|COMPLETED|Third Rest Period (7-45 Days)||1
8998589|NCT02862730|10061843|FG006|COMPLETED|Third Rest Period (7-45 Days)||1
8998590|NCT02862730|10061837|FG000|NOT COMPLETED|Third Rest Period (7-45 Days)||0
8998591|NCT02862730|10061838|FG001|NOT COMPLETED|Third Rest Period (7-45 Days)||0
8998592|NCT02862730|10061839|FG002|NOT COMPLETED|Third Rest Period (7-45 Days)||1
8998593|NCT02862730|10061840|FG003|NOT COMPLETED|Third Rest Period (7-45 Days)||0
8998594|NCT02862730|10061841|FG004|NOT COMPLETED|Third Rest Period (7-45 Days)||1
8998595|NCT02862730|10061842|FG005|NOT COMPLETED|Third Rest Period (7-45 Days)||0
8998596|NCT02862730|10061843|FG006|NOT COMPLETED|Third Rest Period (7-45 Days)||0
8998597|NCT02862730|10061837|FG000|STARTED|Third Intervention (84 Hours)||3
8998598|NCT02862730|10061838|FG001|STARTED|Third Intervention (84 Hours)||1
8998599|NCT02862730|10061839|FG002|STARTED|Third Intervention (84 Hours)||6
8998600|NCT02862730|10061840|FG003|STARTED|Third Intervention (84 Hours)||5
8998601|NCT02862730|10061841|FG004|STARTED|Third Intervention (84 Hours)||4
8998602|NCT02862730|10061842|FG005|STARTED|Third Intervention (84 Hours)||1
8998603|NCT02862730|10061843|FG006|STARTED|Third Intervention (84 Hours)||1
8998604|NCT02862730|10061837|FG000|COMPLETED|Third Intervention (84 Hours)||3
8998605|NCT02862730|10061838|FG001|COMPLETED|Third Intervention (84 Hours)||1
8998606|NCT02862730|10061839|FG002|COMPLETED|Third Intervention (84 Hours)||6
8998607|NCT02862730|10061840|FG003|COMPLETED|Third Intervention (84 Hours)||4
8998608|NCT02862730|10061841|FG004|COMPLETED|Third Intervention (84 Hours)||4
8998609|NCT02862730|10061842|FG005|COMPLETED|Third Intervention (84 Hours)||1
8998610|NCT02862730|10061843|FG006|COMPLETED|Third Intervention (84 Hours)||1
8998611|NCT02862730|10061837|FG000|NOT COMPLETED|Third Intervention (84 Hours)||0
8998612|NCT02862730|10061838|FG001|NOT COMPLETED|Third Intervention (84 Hours)||0
8998613|NCT02862730|10061839|FG002|NOT COMPLETED|Third Intervention (84 Hours)||0
8998614|NCT02862730|10061840|FG003|NOT COMPLETED|Third Intervention (84 Hours)||1
8998615|NCT02862730|10061841|FG004|NOT COMPLETED|Third Intervention (84 Hours)||0
8998616|NCT02862730|10061842|FG005|NOT COMPLETED|Third Intervention (84 Hours)||0
8998617|NCT02862730|10061843|FG006|NOT COMPLETED|Third Intervention (84 Hours)||0
8998618|NCT02862730|10061837|FG000|STARTED|Fourth Rest Period (7-45 Days)||3
8998619|NCT02862730|10061838|FG001|STARTED|Fourth Rest Period (7-45 Days)||1
8998620|NCT02862730|10061839|FG002|STARTED|Fourth Rest Period (7-45 Days)||6
8998621|NCT02862730|10061840|FG003|STARTED|Fourth Rest Period (7-45 Days)||4
8998622|NCT02862730|10061841|FG004|STARTED|Fourth Rest Period (7-45 Days)||4
8998623|NCT02862730|10061842|FG005|STARTED|Fourth Rest Period (7-45 Days)||1
8998624|NCT02862730|10061843|FG006|STARTED|Fourth Rest Period (7-45 Days)||1
8998625|NCT02862730|10061837|FG000|COMPLETED|Fourth Rest Period (7-45 Days)||3
8998626|NCT02862730|10061838|FG001|COMPLETED|Fourth Rest Period (7-45 Days)||1
8998627|NCT02862730|10061839|FG002|COMPLETED|Fourth Rest Period (7-45 Days)||6
8998628|NCT02862730|10061840|FG003|COMPLETED|Fourth Rest Period (7-45 Days)||4
8998629|NCT02862730|10061841|FG004|COMPLETED|Fourth Rest Period (7-45 Days)||4
8998630|NCT02862730|10061842|FG005|COMPLETED|Fourth Rest Period (7-45 Days)||1
8998631|NCT02862730|10061843|FG006|COMPLETED|Fourth Rest Period (7-45 Days)||1
8998632|NCT02862730|10061837|FG000|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
8998633|NCT02862730|10061838|FG001|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
8998634|NCT02862730|10061839|FG002|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
8998635|NCT02862730|10061840|FG003|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
8998636|NCT02862730|10061841|FG004|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
8998637|NCT02862730|10061842|FG005|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
8998638|NCT02862730|10061843|FG006|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
8998639|NCT02862730|10061837|FG000|STARTED|Fourth Intervention (84 Hours)||3
8998640|NCT02862730|10061838|FG001|STARTED|Fourth Intervention (84 Hours)||1
8998641|NCT02862730|10061839|FG002|STARTED|Fourth Intervention (84 Hours)||6
8998642|NCT02862730|10061840|FG003|STARTED|Fourth Intervention (84 Hours)||4
8998643|NCT02862730|10061841|FG004|STARTED|Fourth Intervention (84 Hours)||4
8998644|NCT02862730|10061842|FG005|STARTED|Fourth Intervention (84 Hours)||1
8998645|NCT02862730|10061843|FG006|STARTED|Fourth Intervention (84 Hours)||1
8998646|NCT02862730|10061837|FG000|COMPLETED|Fourth Intervention (84 Hours)||3
8998647|NCT02862730|10061838|FG001|COMPLETED|Fourth Intervention (84 Hours)||1
8998648|NCT02862730|10061839|FG002|COMPLETED|Fourth Intervention (84 Hours)||6
8998649|NCT02862730|10061840|FG003|COMPLETED|Fourth Intervention (84 Hours)||4
8998650|NCT02862730|10061841|FG004|COMPLETED|Fourth Intervention (84 Hours)||4
8998651|NCT02862730|10061842|FG005|COMPLETED|Fourth Intervention (84 Hours)||1
8998652|NCT02862730|10061843|FG006|COMPLETED|Fourth Intervention (84 Hours)||1
8998653|NCT02862730|10061837|FG000|NOT COMPLETED|Fourth Intervention (84 Hours)||0
8998654|NCT02862730|10061838|FG001|NOT COMPLETED|Fourth Intervention (84 Hours)||0
8998655|NCT02862730|10061839|FG002|NOT COMPLETED|Fourth Intervention (84 Hours)||0
8998656|NCT02862730|10061840|FG003|NOT COMPLETED|Fourth Intervention (84 Hours)||0
8998657|NCT02862730|10061841|FG004|NOT COMPLETED|Fourth Intervention (84 Hours)||0
8998658|NCT02862730|10061842|FG005|NOT COMPLETED|Fourth Intervention (84 Hours)||0
8998659|NCT02862730|10061843|FG006|NOT COMPLETED|Fourth Intervention (84 Hours)||0
8998660|NCT02862912|10061860|FG000|STARTED|Overall Study||23
8998661|NCT02862912|10061861|FG001|STARTED|Overall Study||20
8998662|NCT02862912|10061860|FG000|COMPLETED|Overall Study||22
8998663|NCT02862912|10061861|FG001|COMPLETED|Overall Study||20
8998664|NCT02862912|10061860|FG000|NOT COMPLETED|Overall Study||1
8998665|NCT02862912|10061861|FG001|NOT COMPLETED|Overall Study||0
8998666|NCT02863198|10061871|FG000|STARTED|Overall Study||60
8998667|NCT02863198|10061872|FG001|STARTED|Overall Study||60
8998668|NCT02863198|10061871|FG000|COMPLETED|Overall Study||60
8998669|NCT02863198|10061872|FG001|COMPLETED|Overall Study||60
8998670|NCT02863198|10061871|FG000|NOT COMPLETED|Overall Study||0
8998671|NCT02863198|10061872|FG001|NOT COMPLETED|Overall Study||0
8998672|NCT02863263|10061880|FG000|STARTED|Overall Study||3
8998673|NCT02863263|10061881|FG001|STARTED|Overall Study||2
8998674|NCT02863263|10061880|FG000|COMPLETED|Overall Study||2
8998675|NCT02863263|10061881|FG001|COMPLETED|Overall Study||1
8998676|NCT02863263|10061880|FG000|NOT COMPLETED|Overall Study||1
8998677|NCT02863263|10061881|FG001|NOT COMPLETED|Overall Study||1
8572400|NCT00114127|9604563|FG001|NOT COMPLETED|Overall Study||4
8572401|NCT00114140|9604569|FG000|STARTED|Overall Study||136
8572402|NCT00114140|9604569|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|129
8572403|NCT00114140|9604569|FG000|NOT COMPLETED|Overall Study||7
8572404|NCT00114166|9604582|FG000|STARTED|Overall Study||15
8572405|NCT00114166|9604583|FG001|STARTED|Overall Study||66
8572406|NCT00114166|9604582|FG000|COMPLETED|Overall Study||15
8572407|NCT00114166|9604583|FG001|COMPLETED|Overall Study||65
8572408|NCT00114166|9604582|FG000|NOT COMPLETED|Overall Study||0
8572409|NCT00114166|9604583|FG001|NOT COMPLETED|Overall Study||1
8572410|NCT00114218|9604591|FG000|STARTED|Overall Study||28
8572411|NCT00114218|9604591|FG000|COMPLETED|Overall Study||24
8572412|NCT00114218|9604591|FG000|NOT COMPLETED|Overall Study||4
8572413|NCT00114231|9604597|FG000|STARTED|Overall Study||62
8572414|NCT00114231|9604598|FG001|STARTED|Overall Study||28
8572415|NCT00114231|9604597|FG000|COMPLETED|Overall Study||53
8572416|NCT00114231|9604598|FG001|COMPLETED|Overall Study||26
8572417|NCT00114231|9604597|FG000|NOT COMPLETED|Overall Study||9
8572418|NCT00114231|9604598|FG001|NOT COMPLETED|Overall Study||2
8572419|NCT00114244|9604605|FG000|STARTED|Overall Study||15
8572420|NCT00114244|9604606|FG001|STARTED|Overall Study||37
8572421|NCT00114244|9604605|FG000|COMPLETED|Overall Study||13
8572422|NCT00114244|9604606|FG001|COMPLETED|Overall Study||30
8572423|NCT00114244|9604605|FG000|NOT COMPLETED|Overall Study||2
8572424|NCT00114244|9604606|FG001|NOT COMPLETED|Overall Study||7
8572425|NCT00114504|9604614|FG000|STARTED|Overall Study||21
8572426|NCT00114504|9604615|FG001|STARTED|Overall Study||22
8572427|NCT00114504|9604614|FG000|COMPLETED|Overall Study||21
8572428|NCT00114504|9604615|FG001|COMPLETED|Overall Study||22
8572429|NCT00114504|9604614|FG000|NOT COMPLETED|Overall Study||0
8572430|NCT00114504|9604615|FG001|NOT COMPLETED|Overall Study||0
8572431|NCT00114517|9604629|FG000|STARTED|Overall Study||137
8572432|NCT00114517|9604630|FG001|STARTED|Overall Study||134
8572433|NCT00114517|9604631|FG002|STARTED|Overall Study||186
8572434|NCT00114517|9604632|FG003|STARTED|Overall Study||186
8572435|NCT00114517|9604629|FG000|COMPLETED|Overall Study||125
8572436|NCT00114517|9604630|FG001|COMPLETED|Overall Study||123
8572437|NCT00114517|9604631|FG002|COMPLETED|Overall Study||172
8572438|NCT00114517|9604632|FG003|COMPLETED|Overall Study||176
8572439|NCT00114517|9604629|FG000|NOT COMPLETED|Overall Study||12
8572440|NCT00114517|9604630|FG001|NOT COMPLETED|Overall Study||11
8572441|NCT00114517|9604631|FG002|NOT COMPLETED|Overall Study||14
8572442|NCT00114517|9604632|FG003|NOT COMPLETED|Overall Study||10
8572443|NCT00114530|9604640|FG000|STARTED|Overall Study||36
8572444|NCT00114530|9604641|FG001|STARTED|Overall Study||39
8572445|NCT00114530|9604640|FG000|COMPLETED|Overall Study|Completed 72 mo, 54 mo after failure, or at least 54 mo at study end (last patient's 54 mo visit)|27
8572446|NCT00114530|9604641|FG001|COMPLETED|Overall Study|Completed 72 mo, 54 mo after failure, or at least 54 mo at study end (last patient's 54 mo visit)|19
8572447|NCT00114530|9604640|FG000|NOT COMPLETED|Overall Study||9
8572448|NCT00114530|9604641|FG001|NOT COMPLETED|Overall Study||20
8572449|NCT00114634|9604651|FG000|STARTED|Overall Study||13
8572450|NCT00114634|9604651|FG000|COMPLETED|Overall Study|Assessment forms lost by one failure to complete and return forms by two|10
8572451|NCT00114634|9604651|FG000|NOT COMPLETED|Overall Study||3
8572452|NCT00114738|9604657|FG000|STARTED|Bortezomib Then Bortezomib + Induction||53
8572453|NCT00114738|9604658|FG001|STARTED|Bortezomib Then Bortezomib + Induction||0
8998678|NCT02863289|10061887|FG000|STARTED|Overall Study|Study started on 01/11/2016, with 118 study participants.|118
8998679|NCT02863289|10061887|FG000|COMPLETED|Overall Study|Study completed on 01/03/2017, 35 study participants have returned the questionnaire.|35
8998680|NCT02863289|10061887|FG000|NOT COMPLETED|Overall Study||83
8998681|NCT02863328|10061894|FG000|STARTED|Overall Study||411
8998682|NCT02863328|10061895|FG001|STARTED|Overall Study||410
8998683|NCT02863328|10061894|FG000|Full Analysis Set (FAS)|Overall Study||411
8998684|NCT02863328|10061895|FG001|Full Analysis Set (FAS)|Overall Study||410
8998685|NCT02863328|10061894|FG000|Safety Analysis Set (SAS)|Overall Study||410
8998686|NCT02863328|10061895|FG001|Safety Analysis Set (SAS)|Overall Study||409
8998687|NCT02863328|10061894|FG000|COMPLETED|Overall Study||400
8998688|NCT02863328|10061895|FG001|COMPLETED|Overall Study||387
8998689|NCT02863328|10061894|FG000|NOT COMPLETED|Overall Study||11
8998690|NCT02863328|10061895|FG001|NOT COMPLETED|Overall Study||23
8998691|NCT02863354|10061903|FG000|STARTED|Year 1||23
8998692|NCT02863354|10061904|FG001|STARTED|Year 1||20
8998693|NCT02863354|10061903|FG000|COMPLETED|Year 1||19
8998694|NCT02863354|10061904|FG001|COMPLETED|Year 1||18
8998695|NCT02863354|10061903|FG000|NOT COMPLETED|Year 1||4
8998696|NCT02863354|10061904|FG001|NOT COMPLETED|Year 1||2
8998697|NCT02863354|10061903|FG000|STARTED|Year 2||19
8998698|NCT02863354|10061904|FG001|STARTED|Year 2||18
8998699|NCT02863354|10061903|FG000|COMPLETED|Year 2||17
8998700|NCT02863354|10061904|FG001|COMPLETED|Year 2||16
8998701|NCT02863354|10061903|FG000|NOT COMPLETED|Year 2||2
8998702|NCT02863354|10061904|FG001|NOT COMPLETED|Year 2||2
8998703|NCT02863419|10061913|FG000|STARTED|Overall Study||285
8998704|NCT02863419|10061914|FG001|STARTED|Overall Study||284
8998705|NCT02863419|10061915|FG002|STARTED|Overall Study||142
8998706|NCT02863419|10061913|FG000|Full Analysis Set (FAS)|Overall Study||285
8998707|NCT02863419|10061914|FG001|Full Analysis Set (FAS)|Overall Study||284
8998708|NCT02863419|10061915|FG002|Full Analysis Set (FAS)|Overall Study||142
8998709|NCT02863419|10061913|FG000|Safety Analysis Set (SAS)|Overall Study||285
8998710|NCT02863419|10061914|FG001|Safety Analysis Set (SAS)|Overall Study||284
8998711|NCT02863419|10061915|FG002|Safety Analysis Set (SAS)|Overall Study||142
8998712|NCT02863419|10061913|FG000|COMPLETED|Overall Study||277
8998713|NCT02863419|10061914|FG001|COMPLETED|Overall Study||274
8998714|NCT02863419|10061915|FG002|COMPLETED|Overall Study||134
8998715|NCT02863419|10061913|FG000|NOT COMPLETED|Overall Study||8
8998716|NCT02863419|10061914|FG001|NOT COMPLETED|Overall Study||10
8998717|NCT02863419|10061915|FG002|NOT COMPLETED|Overall Study||8
8998718|NCT02863575|10061926|FG000|STARTED|Overall Study||161
8998719|NCT02863575|10061927|FG001|STARTED|Overall Study||161
8998720|NCT02863575|10061928|FG002|STARTED|Overall Study||52
8998721|NCT02863575|10061926|FG000|COMPLETED|Overall Study||160
8998722|NCT02863575|10061927|FG001|COMPLETED|Overall Study||159
8998723|NCT02863575|10061928|FG002|COMPLETED|Overall Study||51
8998724|NCT02863575|10061926|FG000|NOT COMPLETED|Overall Study||1
8998725|NCT02863575|10061927|FG001|NOT COMPLETED|Overall Study||2
8998726|NCT02863575|10061928|FG002|NOT COMPLETED|Overall Study||1
8998727|NCT02864069|10061939|FG000|STARTED|Overall Study||18
8998728|NCT02864069|10061940|FG001|STARTED|Overall Study||13
8998729|NCT02864069|10061941|FG002|STARTED|Overall Study||21
8998730|NCT02864069|10061939|FG000|COMPLETED|Overall Study||12
8998731|NCT02864069|10061940|FG001|COMPLETED|Overall Study||5
8998732|NCT02864069|10061941|FG002|COMPLETED|Overall Study||13
8998733|NCT02864069|10061939|FG000|NOT COMPLETED|Overall Study||6
8998734|NCT02864069|10061940|FG001|NOT COMPLETED|Overall Study||8
8998735|NCT02864069|10061941|FG002|NOT COMPLETED|Overall Study||8
8998736|NCT02864082|10061951|FG000|STARTED|Overall Study||10
8998737|NCT02864082|10061952|FG001|STARTED|Overall Study||9
8998738|NCT02864082|10061951|FG000|COMPLETED|Overall Study||7
8998739|NCT02864082|10061952|FG001|COMPLETED|Overall Study||5
8998740|NCT02864082|10061951|FG000|NOT COMPLETED|Overall Study||3
8998741|NCT02864082|10061952|FG001|NOT COMPLETED|Overall Study||4
8998742|NCT02864316|10061974|FG000|STARTED|Overall Study||2
8998743|NCT02864316|10061975|FG001|STARTED|Overall Study||2
8998744|NCT02864316|10061974|FG000|COMPLETED|Overall Study||0
8998745|NCT02864316|10061975|FG001|COMPLETED|Overall Study||0
8998746|NCT02864316|10061974|FG000|NOT COMPLETED|Overall Study||2
8998747|NCT02864316|10061975|FG001|NOT COMPLETED|Overall Study||2
8998748|NCT02864342|10061983|FG000|STARTED|Overall Study||70
8998749|NCT02864342|10061984|FG001|STARTED|Overall Study||68
8998750|NCT02864342|10061983|FG000|Full Analysis Set (FAS)|Overall Study||70
8998751|NCT02864342|10061984|FG001|Full Analysis Set (FAS)|Overall Study||67
8998752|NCT02864342|10061983|FG000|COMPLETED|Overall Study||55
8998753|NCT02864342|10061984|FG001|COMPLETED|Overall Study||49
8998754|NCT02864342|10061983|FG000|NOT COMPLETED|Overall Study||15
8998755|NCT02864342|10061984|FG001|NOT COMPLETED|Overall Study||19
8998756|NCT02864355|10061993|FG000|STARTED|Overall Study||25
8998757|NCT02864355|10061994|FG001|STARTED|Overall Study||28
8998758|NCT02864355|10061993|FG000|COMPLETED|Overall Study||23
8998759|NCT02864355|10061994|FG001|COMPLETED|Overall Study||25
8998760|NCT02864355|10061993|FG000|NOT COMPLETED|Overall Study||2
8998761|NCT02864355|10061994|FG001|NOT COMPLETED|Overall Study||3
8998762|NCT02864368|10062005|FG000|STARTED|Overall Study||4
8998763|NCT02864368|10062006|FG001|STARTED|Overall Study||1
8998764|NCT02864368|10062007|FG002|STARTED|Overall Study||6
8998765|NCT02864368|10062008|FG003|STARTED|Overall Study||8
8998766|NCT02864368|10062009|FG004|STARTED|Overall Study||8
8998767|NCT02864368|10062005|FG000|COMPLETED|Overall Study||4
8998768|NCT02864368|10062006|FG001|COMPLETED|Overall Study||1
8998769|NCT02864368|10062007|FG002|COMPLETED|Overall Study||6
8998770|NCT02864368|10062008|FG003|COMPLETED|Overall Study||8
8998771|NCT02864368|10062009|FG004|COMPLETED|Overall Study||8
8998772|NCT02864368|10062005|FG000|NOT COMPLETED|Overall Study||0
8998773|NCT02864368|10062006|FG001|NOT COMPLETED|Overall Study||0
8998774|NCT02864368|10062007|FG002|NOT COMPLETED|Overall Study||0
8998775|NCT02864368|10062008|FG003|NOT COMPLETED|Overall Study||0
8998776|NCT02864368|10062009|FG004|NOT COMPLETED|Overall Study||0
8998777|NCT02864381|10062028|FG000|STARTED|Overall Study||72
8998778|NCT02864381|10062029|FG001|STARTED|Overall Study||72
8998779|NCT02864381|10062028|FG000|COMPLETED|Overall Study||0
8998780|NCT02864381|10062029|FG001|COMPLETED|Overall Study||0
8998781|NCT02864381|10062028|FG000|NOT COMPLETED|Overall Study||72
8998782|NCT02864381|10062029|FG001|NOT COMPLETED|Overall Study||72
8998783|NCT02864394|10062037|FG000|STARTED|Overall Study||213
8998784|NCT02864394|10062038|FG001|STARTED|Overall Study||212
8998785|NCT02864394|10062037|FG000|Treated|Overall Study||213
8998786|NCT02864394|10062038|FG001|Treated|Overall Study||198
8998787|NCT02864394|10062037|FG000|COMPLETED|Overall Study||0
8998788|NCT02864394|10062038|FG001|COMPLETED|Overall Study||0
8998789|NCT02864394|10062037|FG000|NOT COMPLETED|Overall Study||213
8998790|NCT02864394|10062038|FG001|NOT COMPLETED|Overall Study||212
8998791|NCT02864706|10062046|FG000|STARTED|Overall Study||48
8998792|NCT02864706|10062047|FG001|STARTED|Overall Study||47
8998793|NCT02864706|10062046|FG000|Safety Set|Overall Study||48
8998794|NCT02864706|10062047|FG001|Safety Set|Overall Study||47
8998795|NCT02864706|10062046|FG000|Intent to Treat|Overall Study||46
8998796|NCT02864706|10062047|FG001|Intent to Treat|Overall Study||47
8998797|NCT02864706|10062046|FG000|COMPLETED|Overall Study||48
8998798|NCT02864706|10062047|FG001|COMPLETED|Overall Study||47
8998799|NCT02864706|10062046|FG000|NOT COMPLETED|Overall Study||0
8998800|NCT02864706|10062047|FG001|NOT COMPLETED|Overall Study||0
8998801|NCT02864732|10062055|FG000|STARTED|Overall Study||15
8998802|NCT02864732|10062056|FG001|STARTED|Overall Study||15
8998803|NCT02864732|10062055|FG000|COMPLETED|Overall Study||13
8998804|NCT02864732|10062056|FG001|COMPLETED|Overall Study||13
8633908|NCT00553514|9674142|FG000|COMPLETED|Overall Study||6
8633909|NCT00553514|9674143|FG001|COMPLETED|Overall Study||6
8998805|NCT02864732|10062055|FG000|NOT COMPLETED|Overall Study||2
8998806|NCT02864732|10062056|FG001|NOT COMPLETED|Overall Study||2
8998807|NCT02865343|10062065|FG000|STARTED|Overall Study||6
8998808|NCT02865343|10062066|FG001|STARTED|Overall Study||5
8998809|NCT02865343|10062065|FG000|COMPLETED|Overall Study||6
8998810|NCT02865343|10062066|FG001|COMPLETED|Overall Study||3
8998811|NCT02865343|10062065|FG000|NOT COMPLETED|Overall Study||0
8998812|NCT02865343|10062066|FG001|NOT COMPLETED|Overall Study||2
8998813|NCT02865434|10062085|FG000|STARTED|Overall Study||3
8998814|NCT02865434|10062086|FG001|STARTED|Overall Study||3
8998815|NCT02865434|10062087|FG002|STARTED|Overall Study||3
8998816|NCT02865434|10062088|FG003|STARTED|Overall Study||3
8998817|NCT02865434|10062089|FG004|STARTED|Overall Study||3
8998818|NCT02865434|10062090|FG005|STARTED|Overall Study||3
8998819|NCT02865434|10062091|FG006|STARTED|Overall Study||3
8998820|NCT02865434|10062092|FG007|STARTED|Overall Study||3
8998821|NCT02865434|10062093|FG008|STARTED|Overall Study||3
8998822|NCT02865434|10062094|FG009|STARTED|Overall Study||6
8998823|NCT02865434|10062095|FG010|STARTED|Overall Study||6
8998824|NCT02865434|10062085|FG000|COMPLETED|Overall Study||3
8998825|NCT02865434|10062086|FG001|COMPLETED|Overall Study||3
8998826|NCT02865434|10062087|FG002|COMPLETED|Overall Study||3
8998827|NCT02865434|10062088|FG003|COMPLETED|Overall Study||3
8998828|NCT02865434|10062089|FG004|COMPLETED|Overall Study||3
8998829|NCT02865434|10062090|FG005|COMPLETED|Overall Study||3
8998830|NCT02865434|10062091|FG006|COMPLETED|Overall Study||3
8998831|NCT02865434|10062092|FG007|COMPLETED|Overall Study||3
8998832|NCT02865434|10062093|FG008|COMPLETED|Overall Study||3
8998833|NCT02865434|10062094|FG009|COMPLETED|Overall Study||6
8998834|NCT02865434|10062095|FG010|COMPLETED|Overall Study||6
8998835|NCT02865434|10062085|FG000|NOT COMPLETED|Overall Study||0
8998836|NCT02865434|10062086|FG001|NOT COMPLETED|Overall Study||0
8998837|NCT02865434|10062087|FG002|NOT COMPLETED|Overall Study||0
8998838|NCT02865434|10062088|FG003|NOT COMPLETED|Overall Study||0
8998839|NCT02865434|10062089|FG004|NOT COMPLETED|Overall Study||0
8998840|NCT02865434|10062090|FG005|NOT COMPLETED|Overall Study||0
8998841|NCT02865434|10062091|FG006|NOT COMPLETED|Overall Study||0
8998842|NCT02865434|10062092|FG007|NOT COMPLETED|Overall Study||0
8998843|NCT02865434|10062093|FG008|NOT COMPLETED|Overall Study||0
8998844|NCT02865434|10062094|FG009|NOT COMPLETED|Overall Study||0
8998845|NCT02865434|10062095|FG010|NOT COMPLETED|Overall Study||0
8633910|NCT00553514|9674144|FG002|COMPLETED|Overall Study||9
8633911|NCT00553514|9674145|FG003|COMPLETED|Overall Study||6
8998846|NCT02865499|10062125|FG000|STARTED|Baseline||8
8998847|NCT02865499|10062125|FG000|COMPLETED|Baseline||6
8998848|NCT02865499|10062125|FG000|NOT COMPLETED|Baseline||2
8998849|NCT02865499|10062125|FG000|STARTED|8 Weeks||6
8998850|NCT02865499|10062125|FG000|COMPLETED|8 Weeks||6
8998851|NCT02865499|10062125|FG000|NOT COMPLETED|8 Weeks||0
8998852|NCT02865499|10062125|FG000|STARTED|12 Weeks||6
8998853|NCT02865499|10062125|FG000|COMPLETED|12 Weeks||6
8998854|NCT02865499|10062125|FG000|NOT COMPLETED|12 Weeks||0
8998855|NCT02865538|10062134|FG000|STARTED|Overall Study||18
8998856|NCT02865538|10062135|FG001|STARTED|Overall Study||15
8998857|NCT02865538|10062136|FG002|STARTED|Overall Study||15
8998858|NCT02865538|10062137|FG003|STARTED|Overall Study||15
8998859|NCT02865538|10062138|FG004|STARTED|Overall Study||13
8998860|NCT02865538|10062134|FG000|COMPLETED|Overall Study||17
8998861|NCT02865538|10062135|FG001|COMPLETED|Overall Study||15
8998862|NCT02865538|10062136|FG002|COMPLETED|Overall Study||14
8998863|NCT02865538|10062137|FG003|COMPLETED|Overall Study||15
8998864|NCT02865538|10062138|FG004|COMPLETED|Overall Study||13
8998865|NCT02865538|10062134|FG000|NOT COMPLETED|Overall Study||1
8998866|NCT02865538|10062135|FG001|NOT COMPLETED|Overall Study||0
8998867|NCT02865538|10062136|FG002|NOT COMPLETED|Overall Study||1
8998868|NCT02865538|10062137|FG003|NOT COMPLETED|Overall Study||0
8998869|NCT02865538|10062138|FG004|NOT COMPLETED|Overall Study||0
8998870|NCT02865590|10062152|FG000|STARTED|Overall Study||8
8998871|NCT02865590|10062153|FG001|STARTED|Overall Study||8
8998872|NCT02865590|10062152|FG000|COMPLETED|Overall Study||8
8998873|NCT02865590|10062153|FG001|COMPLETED|Overall Study||8
8998874|NCT02865590|10062152|FG000|NOT COMPLETED|Overall Study||0
8998875|NCT02865590|10062153|FG001|NOT COMPLETED|Overall Study||0
8998876|NCT02865720|10062161|FG000|STARTED|Overall Study||0
8998877|NCT02865720|10062162|FG001|STARTED|Overall Study||8
8998878|NCT02865720|10062161|FG000|COMPLETED|Overall Study||0
8998879|NCT02865720|10062162|FG001|COMPLETED|Overall Study||8
8998880|NCT02865720|10062161|FG000|NOT COMPLETED|Overall Study||0
8998881|NCT02865720|10062162|FG001|NOT COMPLETED|Overall Study||0
8998882|NCT02865811|10062167|FG000|STARTED|Overall Study||26
8998883|NCT02865811|10062167|FG000|COMPLETED|Overall Study||26
8998884|NCT02865811|10062167|FG000|NOT COMPLETED|Overall Study||0
8998885|NCT02866175|10062174|FG000|STARTED|Overall Study||751
8998886|NCT02866175|10062175|FG001|STARTED|Overall Study||755
8998887|NCT02866175|10062174|FG000|COMPLETED|Overall Study||616
8998888|NCT02866175|10062175|FG001|COMPLETED|Overall Study||580
8998889|NCT02866175|10062174|FG000|NOT COMPLETED|Overall Study||135
8998890|NCT02866175|10062175|FG001|NOT COMPLETED|Overall Study||175
8998891|NCT02866643|10062184|FG000|STARTED|Overall Study||48
8998892|NCT02866643|10062185|FG001|STARTED|Overall Study||47
8998893|NCT02866643|10062184|FG000|Intent-to-Treat (ITT) Population|Overall Study||38
8998894|NCT02866643|10062185|FG001|Intent-to-Treat (ITT) Population|Overall Study||39
8998895|NCT02866643|10062184|FG000|Per Protocol Population|Overall Study||35
8998896|NCT02866643|10062185|FG001|Per Protocol Population|Overall Study||35
8998897|NCT02866643|10062184|FG000|COMPLETED|Overall Study||35
8998898|NCT02866643|10062185|FG001|COMPLETED|Overall Study||35
8998899|NCT02866643|10062184|FG000|NOT COMPLETED|Overall Study||13
8998900|NCT02866643|10062185|FG001|NOT COMPLETED|Overall Study||12
8998901|NCT02866942|10062191|FG000|STARTED|Overall Study||479
8998902|NCT02866942|10062191|FG000|COMPLETED|Overall Study||478
8998903|NCT02866942|10062191|FG000|NOT COMPLETED|Overall Study||1
8998904|NCT02867059|10062197|FG000|STARTED|Overall Study||7
8998905|NCT02867059|10062198|FG001|STARTED|Overall Study||10
8998906|NCT02867059|10062197|FG000|COMPLETED|Overall Study||7
8998907|NCT02867059|10062198|FG001|COMPLETED|Overall Study||8
8998908|NCT02867059|10062197|FG000|NOT COMPLETED|Overall Study||0
8998909|NCT02867059|10062198|FG001|NOT COMPLETED|Overall Study||2
8998910|NCT02867150|10062204|FG000|STARTED|Overall Study||58
8998911|NCT02867150|10062204|FG000|COMPLETED|Overall Study||58
8998912|NCT02867150|10062204|FG000|NOT COMPLETED|Overall Study||0
8998913|NCT02867163|10062208|FG000|STARTED|Overall Study||25
8998914|NCT02867163|10062208|FG000|COMPLETED|Overall Study||25
8998915|NCT02867163|10062208|FG000|NOT COMPLETED|Overall Study||0
8998916|NCT02867202|10062214|FG000|STARTED|Overall Study||83
8998917|NCT02867202|10062215|FG001|STARTED|Overall Study||88
8998918|NCT02867202|10062214|FG000|COMPLETED|Overall Study||62
8998919|NCT02867202|10062215|FG001|COMPLETED|Overall Study||56
8998920|NCT02867202|10062214|FG000|NOT COMPLETED|Overall Study||21
8998921|NCT02867202|10062215|FG001|NOT COMPLETED|Overall Study||32
8998922|NCT02867605|10062221|FG000|STARTED|Overall Study||20
8998923|NCT02867605|10062221|FG000|COMPLETED|Overall Study||20
8998924|NCT02867605|10062221|FG000|NOT COMPLETED|Overall Study||0
8998925|NCT02867618|10062238|FG000|STARTED|Overall Study||11
8998926|NCT02867618|10062238|FG000|COMPLETED|Overall Study||11
8998927|NCT02867618|10062238|FG000|NOT COMPLETED|Overall Study||0
8998928|NCT02867709|10062245|FG000|STARTED|Treatment Period||563
8998929|NCT02867709|10062246|FG001|STARTED|Treatment Period||561
8998930|NCT02867709|10062247|FG002|STARTED|Treatment Period||562
8879417|NCT01933672|9936182|FG005|COMPLETED|Second Intervention Period (12-16 Days)||4
8879418|NCT01933672|9936183|FG006|COMPLETED|Second Intervention Period (12-16 Days)||6
8879419|NCT01933672|9936177|FG000|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
8879420|NCT01933672|9936178|FG001|NOT COMPLETED|Second Intervention Period (12-16 Days)||1
8879421|NCT01933672|9936179|FG002|NOT COMPLETED|Second Intervention Period (12-16 Days)||1
8879422|NCT01933672|9936180|FG003|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
8879423|NCT01933672|9936181|FG004|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
8879424|NCT01933672|9936182|FG005|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
8879425|NCT01933672|9936183|FG006|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
8879426|NCT01933672|9936177|FG000|STARTED|Second Washout Period (7-14 Days)||0
8998931|NCT02867709|10062245|FG000|Safety Population: Received Study Drug|Treatment Period||499
8998932|NCT02867709|10062246|FG001|Safety Population: Received Study Drug|Treatment Period||478
8998933|NCT02867709|10062247|FG002|Safety Population: Received Study Drug|Treatment Period||488
8998934|NCT02867709|10062245|FG000|COMPLETED|Treatment Period||493
8998935|NCT02867709|10062246|FG001|COMPLETED|Treatment Period||474
8998936|NCT02867709|10062247|FG002|COMPLETED|Treatment Period||487
8998937|NCT02867709|10062245|FG000|NOT COMPLETED|Treatment Period||70
8998938|NCT02867709|10062246|FG001|NOT COMPLETED|Treatment Period||87
8998939|NCT02867709|10062247|FG002|NOT COMPLETED|Treatment Period||75
8998940|NCT02867709|10062245|FG000|STARTED|Safety Follow-up Period||493
8998941|NCT02867709|10062246|FG001|STARTED|Safety Follow-up Period||474
8998942|NCT02867709|10062247|FG002|STARTED|Safety Follow-up Period||487
8998943|NCT02867709|10062245|FG000|COMPLETED|Safety Follow-up Period||482
8998944|NCT02867709|10062246|FG001|COMPLETED|Safety Follow-up Period||459
8998945|NCT02867709|10062247|FG002|COMPLETED|Safety Follow-up Period||473
8998946|NCT02867709|10062245|FG000|NOT COMPLETED|Safety Follow-up Period||11
8998947|NCT02867709|10062246|FG001|NOT COMPLETED|Safety Follow-up Period||15
8998948|NCT02867709|10062247|FG002|NOT COMPLETED|Safety Follow-up Period||14
8998949|NCT02867995|10062257|FG000|STARTED|Overall Study|Total patients consented|9
8998950|NCT02867995|10062258|FG001|STARTED|Overall Study|Total patients consented|30
8998951|NCT02867995|10062257|FG000|COMPLETED|Overall Study|Total patients completed|9
8998952|NCT02867995|10062258|FG001|COMPLETED|Overall Study|Total patients completed|27
8998953|NCT02867995|10062257|FG000|NOT COMPLETED|Overall Study||0
8998954|NCT02867995|10062258|FG001|NOT COMPLETED|Overall Study||3
8998955|NCT02868216|10062270|FG000|STARTED|Overall Study||43
8633912|NCT00553514|9674146|FG004|COMPLETED|Overall Study||8
8633913|NCT00553514|9674142|FG000|NOT COMPLETED|Overall Study||8
8998956|NCT02868216|10062271|FG001|STARTED|Overall Study||47
8998957|NCT02868216|10062270|FG000|COMPLETED|Overall Study||35
8998958|NCT02868216|10062271|FG001|COMPLETED|Overall Study||41
8998959|NCT02868216|10062270|FG000|NOT COMPLETED|Overall Study||8
8998960|NCT02868216|10062271|FG001|NOT COMPLETED|Overall Study||6
8998961|NCT02868229|10062281|FG000|STARTED|Overall Study||12
8998962|NCT02868229|10062282|FG001|STARTED|Overall Study||16
8998963|NCT02868229|10062283|FG002|STARTED|Overall Study||16
8998964|NCT02868229|10062284|FG003|STARTED|Overall Study||17
8998965|NCT02868229|10062281|FG000|Intent to Treat (ITT) Population|Overall Study||12
8998966|NCT02868229|10062282|FG001|Intent to Treat (ITT) Population|Overall Study||16
8998967|NCT02868229|10062283|FG002|Intent to Treat (ITT) Population|Overall Study||16
8998968|NCT02868229|10062284|FG003|Intent to Treat (ITT) Population|Overall Study||17
8998969|NCT02868229|10062281|FG000|Pharmacodynamic (PD) Population|Overall Study||12
8998970|NCT02868229|10062282|FG001|Pharmacodynamic (PD) Population|Overall Study||16
8998971|NCT02868229|10062283|FG002|Pharmacodynamic (PD) Population|Overall Study||13
8998972|NCT02868229|10062284|FG003|Pharmacodynamic (PD) Population|Overall Study||12
8998973|NCT02868229|10062281|FG000|Pharmacokinetic (PK) Population|Overall Study||12
8998974|NCT02868229|10062282|FG001|Pharmacokinetic (PK) Population|Overall Study||16
8998975|NCT02868229|10062283|FG002|Pharmacokinetic (PK) Population|Overall Study||16
8998976|NCT02868229|10062284|FG003|Pharmacokinetic (PK) Population|Overall Study||17
8998977|NCT02868229|10062281|FG000|Safety Analysis Population|Overall Study||12
8998978|NCT02868229|10062282|FG001|Safety Analysis Population|Overall Study||16
8998979|NCT02868229|10062283|FG002|Safety Analysis Population|Overall Study||16
8998980|NCT02868229|10062284|FG003|Safety Analysis Population|Overall Study||17
8998981|NCT02868229|10062281|FG000|Maximum Tolerated Dose (MTD) Population|Overall Study||12
8998982|NCT02868229|10062282|FG001|Maximum Tolerated Dose (MTD) Population|Overall Study||16
8998983|NCT02868229|10062283|FG002|Maximum Tolerated Dose (MTD) Population|Overall Study||16
8998984|NCT02868229|10062284|FG003|Maximum Tolerated Dose (MTD) Population|Overall Study||16
8998985|NCT02868229|10062281|FG000|COMPLETED|Overall Study||11
8998986|NCT02868229|10062282|FG001|COMPLETED|Overall Study||16
8998987|NCT02868229|10062283|FG002|COMPLETED|Overall Study||15
8998988|NCT02868229|10062284|FG003|COMPLETED|Overall Study||12
8998989|NCT02868229|10062281|FG000|NOT COMPLETED|Overall Study||1
8998990|NCT02868229|10062282|FG001|NOT COMPLETED|Overall Study||0
8998991|NCT02868229|10062283|FG002|NOT COMPLETED|Overall Study||1
8998992|NCT02868229|10062284|FG003|NOT COMPLETED|Overall Study||5
8998993|NCT02868242|10062299|FG000|STARTED|Overall Study||19
8998994|NCT02868242|10062299|FG000|COMPLETED|Overall Study||19
8998995|NCT02868242|10062299|FG000|NOT COMPLETED|Overall Study||0
8998996|NCT02868281|10062307|FG000|STARTED|Overall Study||252
8998997|NCT02868281|10062308|FG001|STARTED|Overall Study||278
8998998|NCT02868281|10062307|FG000|COMPLETED|Overall Study||209
8998999|NCT02868281|10062308|FG001|COMPLETED|Overall Study||234
8999000|NCT02868281|10062307|FG000|NOT COMPLETED|Overall Study||43
8999001|NCT02868281|10062308|FG001|NOT COMPLETED|Overall Study||44
8999002|NCT02868554|10062317|FG000|STARTED|Overall Study||10
8999003|NCT02868554|10062318|FG001|STARTED|Overall Study||12
8999004|NCT02868554|10062319|FG002|STARTED|Overall Study||12
8999005|NCT02868554|10062317|FG000|COMPLETED|Overall Study||7
8999006|NCT02868554|10062318|FG001|COMPLETED|Overall Study||12
8999007|NCT02868554|10062319|FG002|COMPLETED|Overall Study||11
8999008|NCT02868554|10062317|FG000|NOT COMPLETED|Overall Study||3
8999009|NCT02868554|10062318|FG001|NOT COMPLETED|Overall Study||0
8999010|NCT02868554|10062319|FG002|NOT COMPLETED|Overall Study||1
8999011|NCT02869295|10062332|FG000|STARTED|Overall Study||4
8999012|NCT02869295|10062333|FG001|STARTED|Overall Study||11
8999013|NCT02869295|10062334|FG002|STARTED|Overall Study||6
8572454|NCT00114738|9604659|FG002|STARTED|Bortezomib Then Bortezomib + Induction||0
8572455|NCT00114738|9604657|FG000|Started With Bortezomib Alone|Bortezomib Then Bortezomib + Induction||47
8572456|NCT00114738|9604658|FG001|Started With Bortezomib Alone|Bortezomib Then Bortezomib + Induction||0
8572457|NCT00114738|9604659|FG002|Started With Bortezomib Alone|Bortezomib Then Bortezomib + Induction||0
8572458|NCT00114738|9604657|FG000|Skipped Bortezomib Alone|Bortezomib Then Bortezomib + Induction||6
8572459|NCT00114738|9604658|FG001|Skipped Bortezomib Alone|Bortezomib Then Bortezomib + Induction||0
8577907|NCT00165789|9610848|FG002|STARTED|Overall Study||12
8999014|NCT02869295|10062335|FG003|STARTED|Overall Study||6
8999015|NCT02869295|10062336|FG004|STARTED|Overall Study||1
8999016|NCT02869295|10062332|FG000|COMPLETED|Overall Study||0
8999017|NCT02869295|10062333|FG001|COMPLETED|Overall Study||0
8999018|NCT02869295|10062334|FG002|COMPLETED|Overall Study||0
8999019|NCT02869295|10062335|FG003|COMPLETED|Overall Study||0
8999020|NCT02869295|10062336|FG004|COMPLETED|Overall Study||0
8999021|NCT02869295|10062332|FG000|NOT COMPLETED|Overall Study||4
8999022|NCT02869295|10062333|FG001|NOT COMPLETED|Overall Study||11
8999023|NCT02869295|10062334|FG002|NOT COMPLETED|Overall Study||6
8999024|NCT02869295|10062335|FG003|NOT COMPLETED|Overall Study||6
8999025|NCT02869295|10062336|FG004|NOT COMPLETED|Overall Study||1
8999026|NCT02869334|10062350|FG000|STARTED|Overall Study||10
8999027|NCT02869334|10062351|FG001|STARTED|Overall Study||10
8999028|NCT02869334|10062350|FG000|COMPLETED|Overall Study||2
8999029|NCT02869334|10062351|FG001|COMPLETED|Overall Study||3
8999030|NCT02869334|10062350|FG000|NOT COMPLETED|Overall Study||8
8999031|NCT02869334|10062351|FG001|NOT COMPLETED|Overall Study||7
8999032|NCT02869438|10062359|FG000|STARTED|Overall Study||118
8999033|NCT02869438|10062360|FG001|STARTED|Overall Study||115
8999034|NCT02869438|10062359|FG000|COMPLETED|Overall Study||115
8999035|NCT02869438|10062360|FG001|COMPLETED|Overall Study||113
8999036|NCT02869438|10062359|FG000|NOT COMPLETED|Overall Study||3
8999037|NCT02869438|10062360|FG001|NOT COMPLETED|Overall Study||2
8999038|NCT02869451|10062366|FG000|STARTED|Overall Study||5
8999039|NCT02869451|10062366|FG000|COMPLETED|Overall Study||5
8999040|NCT02869451|10062366|FG000|NOT COMPLETED|Overall Study||0
8999041|NCT02869893|10062370|FG000|STARTED|Overall Study||57
8999042|NCT02869893|10062370|FG000|COMPLETED|Overall Study||50
8999043|NCT02869893|10062370|FG000|NOT COMPLETED|Overall Study||7
8999044|NCT02870101|10062375|FG000|STARTED|Overall Study||2767
8999045|NCT02870101|10062375|FG000|COMPLETED|Overall Study||2598
8999046|NCT02870101|10062375|FG000|NOT COMPLETED|Overall Study||169
8999047|NCT02870205|10062394|FG000|STARTED|Overall Study||294
8999048|NCT02870205|10062395|FG001|STARTED|Overall Study||294
8999049|NCT02870205|10062396|FG002|STARTED|Overall Study||294
8999050|NCT02870205|10062397|FG003|STARTED|Overall Study||294
8999051|NCT02870205|10062394|FG000|COMPLETED|Overall Study||284
8999052|NCT02870205|10062395|FG001|COMPLETED|Overall Study||289
8999053|NCT02870205|10062396|FG002|COMPLETED|Overall Study||287
8999054|NCT02870205|10062397|FG003|COMPLETED|Overall Study||287
8999055|NCT02870205|10062394|FG000|NOT COMPLETED|Overall Study||10
8999056|NCT02870205|10062395|FG001|NOT COMPLETED|Overall Study||5
8999057|NCT02870205|10062396|FG002|NOT COMPLETED|Overall Study||7
8999058|NCT02870205|10062397|FG003|NOT COMPLETED|Overall Study||7
8999059|NCT02870283|10062410|FG000|STARTED|Overall Study||38
8999060|NCT02870283|10062411|FG001|STARTED|Overall Study||35
8999061|NCT02870283|10062412|FG002|STARTED|Overall Study||34
8999062|NCT02870283|10062410|FG000|COMPLETED|Overall Study||35
8999063|NCT02870283|10062411|FG001|COMPLETED|Overall Study||26
8999064|NCT02870283|10062412|FG002|COMPLETED|Overall Study||15
8999065|NCT02870283|10062410|FG000|NOT COMPLETED|Overall Study||3
8999066|NCT02870283|10062411|FG001|NOT COMPLETED|Overall Study||9
8999067|NCT02870283|10062412|FG002|NOT COMPLETED|Overall Study||19
8999068|NCT02870309|10062420|FG000|STARTED|Overall Study||4
8999069|NCT02870309|10062420|FG000|COMPLETED|Overall Study||4
8999070|NCT02870309|10062420|FG000|NOT COMPLETED|Overall Study||0
8999071|NCT02870933|10062426|FG000|STARTED|Overall Study||15
8999072|NCT02870933|10062427|FG001|STARTED|Overall Study||15
8999073|NCT02870933|10062426|FG000|COMPLETED|Overall Study||13
8999074|NCT02870933|10062427|FG001|COMPLETED|Overall Study||13
8999075|NCT02870933|10062426|FG000|NOT COMPLETED|Overall Study||2
8879427|NCT01933672|9936178|FG001|STARTED|Second Washout Period (7-14 Days)||6
8879428|NCT01933672|9936179|FG002|STARTED|Second Washout Period (7-14 Days)||1
8879429|NCT01933672|9936180|FG003|STARTED|Second Washout Period (7-14 Days)||5
8879430|NCT01933672|9936181|FG004|STARTED|Second Washout Period (7-14 Days)||6
8879431|NCT01933672|9936182|FG005|STARTED|Second Washout Period (7-14 Days)||4
8879432|NCT01933672|9936183|FG006|STARTED|Second Washout Period (7-14 Days)||6
8879433|NCT01933672|9936177|FG000|COMPLETED|Second Washout Period (7-14 Days)||0
8879434|NCT01933672|9936178|FG001|COMPLETED|Second Washout Period (7-14 Days)||6
8879435|NCT01933672|9936179|FG002|COMPLETED|Second Washout Period (7-14 Days)||1
8879436|NCT01933672|9936180|FG003|COMPLETED|Second Washout Period (7-14 Days)||5
8879437|NCT01933672|9936181|FG004|COMPLETED|Second Washout Period (7-14 Days)||6
8999076|NCT02870933|10062427|FG001|NOT COMPLETED|Overall Study||2
8999077|NCT02870972|10062439|FG000|STARTED|Overall Study||18
8999078|NCT02870972|10062440|FG001|STARTED|Overall Study||14
8879438|NCT01933672|9936182|FG005|COMPLETED|Second Washout Period (7-14 Days)||4
8999079|NCT02870972|10062441|FG002|STARTED|Overall Study||14
8999080|NCT02870972|10062442|FG003|STARTED|Overall Study||7
8999081|NCT02870972|10062443|FG004|STARTED|Overall Study||22
8999082|NCT02870972|10062439|FG000|COMPLETED|Overall Study||17
8999083|NCT02870972|10062440|FG001|COMPLETED|Overall Study||14
8999084|NCT02870972|10062441|FG002|COMPLETED|Overall Study||14
8999085|NCT02870972|10062442|FG003|COMPLETED|Overall Study||7
8999086|NCT02870972|10062443|FG004|COMPLETED|Overall Study||22
8999087|NCT02870972|10062439|FG000|NOT COMPLETED|Overall Study||1
8999088|NCT02870972|10062440|FG001|NOT COMPLETED|Overall Study||0
8999089|NCT02870972|10062441|FG002|NOT COMPLETED|Overall Study||0
8999090|NCT02870972|10062442|FG003|NOT COMPLETED|Overall Study||0
8999091|NCT02870972|10062443|FG004|NOT COMPLETED|Overall Study||0
8999092|NCT02871011|10062459|FG000|STARTED|Overall Study||7
8999093|NCT02871011|10062460|FG001|STARTED|Overall Study||13
8999094|NCT02871011|10062459|FG000|COMPLETED|Overall Study||7
8999095|NCT02871011|10062460|FG001|COMPLETED|Overall Study||13
8999096|NCT02871011|10062459|FG000|NOT COMPLETED|Overall Study||0
8999097|NCT02871011|10062460|FG001|NOT COMPLETED|Overall Study||0
8999098|NCT02871128|10062469|FG000|STARTED|Overall Study||20
8999099|NCT02871128|10062470|FG001|STARTED|Overall Study||20
8999100|NCT02871128|10062471|FG002|STARTED|Overall Study||16
8999101|NCT02871128|10062469|FG000|COMPLETED|Overall Study||20
8999102|NCT02871128|10062470|FG001|COMPLETED|Overall Study||19
8999103|NCT02871128|10062471|FG002|COMPLETED|Overall Study||15
8999104|NCT02871128|10062469|FG000|NOT COMPLETED|Overall Study||0
8999105|NCT02871128|10062470|FG001|NOT COMPLETED|Overall Study||1
8999106|NCT02871128|10062471|FG002|NOT COMPLETED|Overall Study||1
8999107|NCT02871375|10062479|FG000|STARTED|Period 1, First 14 Days of Wear||89
8999108|NCT02871375|10062480|FG001|STARTED|Period 1, First 14 Days of Wear||77
8999109|NCT02871375|10062479|FG000|COMPLETED|Period 1, First 14 Days of Wear||89
8999110|NCT02871375|10062480|FG001|COMPLETED|Period 1, First 14 Days of Wear||76
8999111|NCT02871375|10062479|FG000|NOT COMPLETED|Period 1, First 14 Days of Wear||0
8999112|NCT02871375|10062480|FG001|NOT COMPLETED|Period 1, First 14 Days of Wear||1
8999113|NCT02871375|10062479|FG000|STARTED|Period 2, Second 14 Days of Wear||89
8999114|NCT02871375|10062480|FG001|STARTED|Period 2, Second 14 Days of Wear||76
8999115|NCT02871375|10062479|FG000|COMPLETED|Period 2, Second 14 Days of Wear||89
8999116|NCT02871375|10062480|FG001|COMPLETED|Period 2, Second 14 Days of Wear||76
8999117|NCT02871375|10062479|FG000|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
8999118|NCT02871375|10062480|FG001|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
8999119|NCT02871440|10062491|FG000|STARTED|Overall Study||12
8999120|NCT02871440|10062492|FG001|STARTED|Overall Study||13
8999121|NCT02871440|10062493|FG002|STARTED|Overall Study||15
8999122|NCT02871440|10062491|FG000|COMPLETED|Overall Study||12
8999123|NCT02871440|10062492|FG001|COMPLETED|Overall Study||13
8999124|NCT02871440|10062493|FG002|COMPLETED|Overall Study||15
8999125|NCT02871440|10062491|FG000|NOT COMPLETED|Overall Study||0
8999126|NCT02871440|10062492|FG001|NOT COMPLETED|Overall Study||0
8999127|NCT02871440|10062493|FG002|NOT COMPLETED|Overall Study||0
8999128|NCT02871479|10062507|FG000|STARTED|Overall Study||36
8999129|NCT02871479|10062508|FG001|STARTED|Overall Study||24
8999130|NCT02871479|10062509|FG002|STARTED|Overall Study||11
8999131|NCT02871479|10062507|FG000|COMPLETED|Overall Study||33
8999132|NCT02871479|10062508|FG001|COMPLETED|Overall Study||21
8999133|NCT02871479|10062509|FG002|COMPLETED|Overall Study||11
8999134|NCT02871479|10062507|FG000|NOT COMPLETED|Overall Study||3
8999135|NCT02871479|10062508|FG001|NOT COMPLETED|Overall Study||3
8999136|NCT02871479|10062509|FG002|NOT COMPLETED|Overall Study||0
8999137|NCT02871492|10062520|FG000|STARTED|Overall Study||73
8999138|NCT02871492|10062521|FG001|STARTED|Overall Study||73
8999139|NCT02871492|10062522|FG002|STARTED|Overall Study||77
8999140|NCT02871492|10062520|FG000|COMPLETED|Overall Study||67
8999141|NCT02871492|10062521|FG001|COMPLETED|Overall Study||70
8999142|NCT02871492|10062522|FG002|COMPLETED|Overall Study||71
8999143|NCT02871492|10062520|FG000|NOT COMPLETED|Overall Study||6
8999144|NCT02871492|10062521|FG001|NOT COMPLETED|Overall Study||3
8999145|NCT02871492|10062522|FG002|NOT COMPLETED|Overall Study||6
8999146|NCT02871570|10062532|FG000|STARTED|Overall Study||8
8999147|NCT02871570|10062533|FG001|STARTED|Overall Study||8
8999148|NCT02871570|10062532|FG000|COMPLETED|Overall Study||8
8999149|NCT02871570|10062533|FG001|COMPLETED|Overall Study||8
8999150|NCT02871570|10062532|FG000|NOT COMPLETED|Overall Study||0
8999151|NCT02871570|10062533|FG001|NOT COMPLETED|Overall Study||0
8999152|NCT02871635|10062541|FG000|STARTED|Overall Study||72
8999153|NCT02871635|10062542|FG001|STARTED|Overall Study||75
8999154|NCT02871635|10062541|FG000|COMPLETED|Overall Study||54
8999155|NCT02871635|10062542|FG001|COMPLETED|Overall Study||56
8999156|NCT02871635|10062541|FG000|NOT COMPLETED|Overall Study||18
8999157|NCT02871635|10062542|FG001|NOT COMPLETED|Overall Study||19
8999158|NCT02871739|10062554|FG000|STARTED|Overall Study||6
8999159|NCT02871739|10062555|FG001|STARTED|Overall Study||6
8999160|NCT02871739|10062556|FG002|STARTED|Overall Study||4
8999161|NCT02871739|10062557|FG003|STARTED|Overall Study||7
8999162|NCT02871739|10062554|FG000|Completed First SPI|Overall Study||3
8999163|NCT02871739|10062555|FG001|Completed First SPI|Overall Study||5
8999164|NCT02871739|10062556|FG002|Completed First SPI|Overall Study||4
8999165|NCT02871739|10062557|FG003|Completed First SPI|Overall Study||6
8999166|NCT02871739|10062554|FG000|Completed Second SPI|Overall Study||3
8999167|NCT02871739|10062555|FG001|Completed Second SPI|Overall Study||4
8999168|NCT02871739|10062556|FG002|Completed Second SPI|Overall Study||4
8999169|NCT02871739|10062557|FG003|Completed Second SPI|Overall Study||5
8999170|NCT02871739|10062554|FG000|Complete Final Survey|Overall Study||3
8999171|NCT02871739|10062555|FG001|Complete Final Survey|Overall Study||4
8999172|NCT02871739|10062556|FG002|Complete Final Survey|Overall Study||4
8999173|NCT02871739|10062557|FG003|Complete Final Survey|Overall Study||5
8999174|NCT02871739|10062554|FG000|COMPLETED|Overall Study||3
8999175|NCT02871739|10062555|FG001|COMPLETED|Overall Study||4
8999176|NCT02871739|10062556|FG002|COMPLETED|Overall Study||4
8999177|NCT02871739|10062557|FG003|COMPLETED|Overall Study||5
8999178|NCT02871739|10062554|FG000|NOT COMPLETED|Overall Study||3
8999179|NCT02871739|10062555|FG001|NOT COMPLETED|Overall Study||2
8999180|NCT02871739|10062556|FG002|NOT COMPLETED|Overall Study||0
8999181|NCT02871739|10062557|FG003|NOT COMPLETED|Overall Study||2
9039375|NCT03338036|10100313|FG003|NOT COMPLETED|Overall Study||0
8999182|NCT02872012|10062572|FG000|STARTED|Overall Study||4
8999183|NCT02872012|10062573|FG001|STARTED|Overall Study||7
8999184|NCT02872012|10062574|FG002|STARTED|Overall Study||4
8999185|NCT02872012|10062575|FG003|STARTED|Overall Study||3
8999186|NCT02872012|10062576|FG004|STARTED|Overall Study||5
8999187|NCT02872012|10062572|FG000|COMPLETED|Overall Study||3
8999188|NCT02872012|10062573|FG001|COMPLETED|Overall Study||7
8999189|NCT02872012|10062574|FG002|COMPLETED|Overall Study||4
8999190|NCT02872012|10062575|FG003|COMPLETED|Overall Study||3
8999191|NCT02872012|10062576|FG004|COMPLETED|Overall Study||5
8999192|NCT02872012|10062572|FG000|NOT COMPLETED|Overall Study||1
8999193|NCT02872012|10062573|FG001|NOT COMPLETED|Overall Study||0
8999194|NCT02872012|10062574|FG002|NOT COMPLETED|Overall Study||0
8999195|NCT02872012|10062575|FG003|NOT COMPLETED|Overall Study||0
8999196|NCT02872012|10062576|FG004|NOT COMPLETED|Overall Study||0
8999197|NCT02872103|10062592|FG000|STARTED|Cycle 1||83
8999198|NCT02872103|10062593|FG001|STARTED|Cycle 1||39
8999199|NCT02872103|10062592|FG000|COMPLETED|Cycle 1||83
8999200|NCT02872103|10062593|FG001|COMPLETED|Cycle 1||38
8999201|NCT02872103|10062592|FG000|NOT COMPLETED|Cycle 1||0
8999202|NCT02872103|10062593|FG001|NOT COMPLETED|Cycle 1||1
8999203|NCT02872103|10062592|FG000|STARTED|Cycle 2-4||83
8999204|NCT02872103|10062593|FG001|STARTED|Cycle 2-4|1 subject withdrawn in Cycle 1|38
8999205|NCT02872103|10062592|FG000|COMPLETED|Cycle 2-4||81
8999206|NCT02872103|10062593|FG001|COMPLETED|Cycle 2-4||37
8999207|NCT02872103|10062592|FG000|NOT COMPLETED|Cycle 2-4||2
8999208|NCT02872103|10062593|FG001|NOT COMPLETED|Cycle 2-4||1
8999209|NCT02872142|10062601|FG000|STARTED|Overall Study||12
8999210|NCT02872142|10062601|FG000|COMPLETED|Overall Study||6
8999211|NCT02872142|10062601|FG000|NOT COMPLETED|Overall Study||6
8999212|NCT02872285|10062607|FG000|STARTED|Overall Study||22
8879439|NCT01933672|9936183|FG006|COMPLETED|Second Washout Period (7-14 Days)||6
8879440|NCT01933672|9936177|FG000|NOT COMPLETED|Second Washout Period (7-14 Days)||0
8879441|NCT01933672|9936178|FG001|NOT COMPLETED|Second Washout Period (7-14 Days)||0
8879442|NCT01933672|9936179|FG002|NOT COMPLETED|Second Washout Period (7-14 Days)||0
8879443|NCT01933672|9936180|FG003|NOT COMPLETED|Second Washout Period (7-14 Days)||0
8879444|NCT01933672|9936181|FG004|NOT COMPLETED|Second Washout Period (7-14 Days)||0
8879445|NCT01933672|9936182|FG005|NOT COMPLETED|Second Washout Period (7-14 Days)||0
8879446|NCT01933672|9936183|FG006|NOT COMPLETED|Second Washout Period (7-14 Days)||0
8879447|NCT01933672|9936177|FG000|STARTED|Third Intervention Period (12-16 Days)||0
8879448|NCT01933672|9936178|FG001|STARTED|Third Intervention Period (12-16 Days)||6
8999213|NCT02872285|10062608|FG001|STARTED|Overall Study||11
8999214|NCT02872285|10062607|FG000|COMPLETED|Overall Study||17
8999215|NCT02872285|10062608|FG001|COMPLETED|Overall Study||9
8999216|NCT02872285|10062607|FG000|NOT COMPLETED|Overall Study||5
8999217|NCT02872285|10062608|FG001|NOT COMPLETED|Overall Study||2
8999218|NCT02872311|10062619|FG000|STARTED|Overall Study||59
8999219|NCT02872311|10062620|FG001|STARTED|Overall Study||60
8999220|NCT02872311|10062621|FG002|STARTED|Overall Study||20
8999221|NCT02872311|10062622|FG003|STARTED|Overall Study||20
8999222|NCT02872311|10062623|FG004|STARTED|Overall Study||20
8999223|NCT02872311|10062619|FG000|COMPLETED|Overall Study||55
8999224|NCT02872311|10062620|FG001|COMPLETED|Overall Study||58
8999225|NCT02872311|10062621|FG002|COMPLETED|Overall Study||19
8999226|NCT02872311|10062622|FG003|COMPLETED|Overall Study||20
8999227|NCT02872311|10062623|FG004|COMPLETED|Overall Study||20
8999228|NCT02872311|10062619|FG000|NOT COMPLETED|Overall Study||4
8999229|NCT02872311|10062620|FG001|NOT COMPLETED|Overall Study||2
8999230|NCT02872311|10062621|FG002|NOT COMPLETED|Overall Study||1
8999231|NCT02872311|10062622|FG003|NOT COMPLETED|Overall Study||0
8999232|NCT02872311|10062623|FG004|NOT COMPLETED|Overall Study||0
8999233|NCT02872857|10062653|FG000|STARTED|Phase 1||15
8999234|NCT02872857|10062654|FG001|STARTED|Phase 1||15
8999235|NCT02872857|10062655|FG002|STARTED|Phase 1||0
8999236|NCT02872857|10062656|FG003|STARTED|Phase 1||0
8999237|NCT02872857|10062653|FG000|COMPLETED|Phase 1||15
8999238|NCT02872857|10062654|FG001|COMPLETED|Phase 1||15
8999239|NCT02872857|10062655|FG002|COMPLETED|Phase 1||0
8999240|NCT02872857|10062656|FG003|COMPLETED|Phase 1||0
8999241|NCT02872857|10062653|FG000|NOT COMPLETED|Phase 1||0
8999242|NCT02872857|10062654|FG001|NOT COMPLETED|Phase 1||0
8999243|NCT02872857|10062655|FG002|NOT COMPLETED|Phase 1||0
8999244|NCT02872857|10062656|FG003|NOT COMPLETED|Phase 1||0
8999245|NCT02872857|10062653|FG000|STARTED|Phase 2||0
8999246|NCT02872857|10062654|FG001|STARTED|Phase 2||0
8999247|NCT02872857|10062655|FG002|STARTED|Phase 2||15
8999248|NCT02872857|10062656|FG003|STARTED|Phase 2||15
8999249|NCT02872857|10062653|FG000|COMPLETED|Phase 2||0
8999250|NCT02872857|10062654|FG001|COMPLETED|Phase 2||0
8999251|NCT02872857|10062655|FG002|COMPLETED|Phase 2||15
8999252|NCT02872857|10062656|FG003|COMPLETED|Phase 2||15
8999253|NCT02872857|10062653|FG000|NOT COMPLETED|Phase 2||0
8999254|NCT02872857|10062654|FG001|NOT COMPLETED|Phase 2||0
8999255|NCT02872857|10062655|FG002|NOT COMPLETED|Phase 2||0
8999256|NCT02872857|10062656|FG003|NOT COMPLETED|Phase 2||0
8999257|NCT02872909|10062664|FG000|STARTED|Overall Study||32
8999258|NCT02872909|10062665|FG001|STARTED|Overall Study||18
8999259|NCT02872909|10062664|FG000|COMPLETED|Overall Study||32
8999260|NCT02872909|10062665|FG001|COMPLETED|Overall Study||18
8999261|NCT02872909|10062664|FG000|NOT COMPLETED|Overall Study||0
8999262|NCT02872909|10062665|FG001|NOT COMPLETED|Overall Study||0
8999263|NCT02872935|10062673|FG000|STARTED|Overall Study||11
8999264|NCT02872935|10062674|FG001|STARTED|Overall Study||11
8999265|NCT02872935|10062673|FG000|COMPLETED|Overall Study||11
8999266|NCT02872935|10062674|FG001|COMPLETED|Overall Study|One subject consented but did no proceed with the study.|10
8999267|NCT02872935|10062673|FG000|NOT COMPLETED|Overall Study||0
8999268|NCT02872935|10062674|FG001|NOT COMPLETED|Overall Study||1
8999269|NCT02873104|10062682|FG000|STARTED|Overall Study||47
8999270|NCT02873104|10062683|FG001|STARTED|Overall Study||23
8999271|NCT02873104|10062682|FG000|COMPLETED|Overall Study||46
8999272|NCT02873104|10062683|FG001|COMPLETED|Overall Study||23
8999273|NCT02873104|10062682|FG000|NOT COMPLETED|Overall Study||1
8999274|NCT02873104|10062683|FG001|NOT COMPLETED|Overall Study||0
8999275|NCT02873208|10062689|FG000|STARTED|Overall Study||265
8999276|NCT02873208|10062689|FG000|COMPLETED|Overall Study||167
8999277|NCT02873208|10062689|FG000|NOT COMPLETED|Overall Study||98
8572460|NCT00114738|9604659|FG002|Skipped Bortezomib Alone|Bortezomib Then Bortezomib + Induction||0
8999278|NCT02873221|10062696|FG000|STARTED|Treatment Period||417
8999279|NCT02873221|10062697|FG001|STARTED|Treatment Period||417
8999280|NCT02873221|10062698|FG002|STARTED|Treatment Period||420
8999281|NCT02873221|10062696|FG000|Safety Population: Received Study Drug|Treatment Period||417
8999282|NCT02873221|10062697|FG001|Safety Population: Received Study Drug|Treatment Period||404
8999283|NCT02873221|10062698|FG002|Safety Population: Received Study Drug|Treatment Period||409
8999284|NCT02873221|10062696|FG000|COMPLETED|Treatment Period||329
8999285|NCT02873221|10062697|FG001|COMPLETED|Treatment Period||291
8999286|NCT02873221|10062698|FG002|COMPLETED|Treatment Period||315
8999287|NCT02873221|10062696|FG000|NOT COMPLETED|Treatment Period||88
8999288|NCT02873221|10062697|FG001|NOT COMPLETED|Treatment Period||126
8999289|NCT02873221|10062698|FG002|NOT COMPLETED|Treatment Period||105
8999290|NCT02873221|10062696|FG000|STARTED|Safety Follow-up Period||350
8999291|NCT02873221|10062697|FG001|STARTED|Safety Follow-up Period||356
8999292|NCT02873221|10062698|FG002|STARTED|Safety Follow-up Period||364
8999293|NCT02873221|10062696|FG000|COMPLETED|Safety Follow-up Period||343
8999294|NCT02873221|10062697|FG001|COMPLETED|Safety Follow-up Period||339
8999295|NCT02873221|10062698|FG002|COMPLETED|Safety Follow-up Period||350
8999296|NCT02873221|10062696|FG000|NOT COMPLETED|Safety Follow-up Period||7
8999297|NCT02873221|10062697|FG001|NOT COMPLETED|Safety Follow-up Period||17
8999298|NCT02873221|10062698|FG002|NOT COMPLETED|Safety Follow-up Period||14
8999299|NCT02873286|10062711|FG000|STARTED|Main Study||78
8633914|NCT00553514|9674143|FG001|NOT COMPLETED|Overall Study||8
8633915|NCT00553514|9674144|FG002|NOT COMPLETED|Overall Study||6
8633916|NCT00553514|9674145|FG003|NOT COMPLETED|Overall Study||7
8633917|NCT00553514|9674146|FG004|NOT COMPLETED|Overall Study||7
8633918|NCT00553540|9674160|FG000|STARTED|Overall Study||25
8879449|NCT01933672|9936179|FG002|STARTED|Third Intervention Period (12-16 Days)||1
8879450|NCT01933672|9936180|FG003|STARTED|Third Intervention Period (12-16 Days)||5
8879451|NCT01933672|9936181|FG004|STARTED|Third Intervention Period (12-16 Days)||6
8879452|NCT01933672|9936182|FG005|STARTED|Third Intervention Period (12-16 Days)||4
8879453|NCT01933672|9936183|FG006|STARTED|Third Intervention Period (12-16 Days)||6
8879454|NCT01933672|9936177|FG000|COMPLETED|Third Intervention Period (12-16 Days)||0
8879455|NCT01933672|9936178|FG001|COMPLETED|Third Intervention Period (12-16 Days)||5
8879456|NCT01933672|9936179|FG002|COMPLETED|Third Intervention Period (12-16 Days)||1
8879457|NCT01933672|9936180|FG003|COMPLETED|Third Intervention Period (12-16 Days)||4
8879458|NCT01933672|9936181|FG004|COMPLETED|Third Intervention Period (12-16 Days)||6
8879459|NCT01933672|9936182|FG005|COMPLETED|Third Intervention Period (12-16 Days)||4
8879460|NCT01933672|9936183|FG006|COMPLETED|Third Intervention Period (12-16 Days)||6
8879461|NCT01933672|9936177|FG000|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
8999300|NCT02873286|10062712|FG001|STARTED|Main Study||89
8999301|NCT02873286|10062713|FG002|STARTED|Main Study||80
8999302|NCT02873286|10062714|FG003|STARTED|Main Study||90
8999303|NCT02873286|10062715|FG004|STARTED|Main Study||83
8999304|NCT02873286|10062711|FG000|COMPLETED|Main Study||76
8999305|NCT02873286|10062712|FG001|COMPLETED|Main Study||84
8999306|NCT02873286|10062713|FG002|COMPLETED|Main Study||78
8999307|NCT02873286|10062714|FG003|COMPLETED|Main Study||89
8999308|NCT02873286|10062715|FG004|COMPLETED|Main Study||81
8999309|NCT02873286|10062711|FG000|NOT COMPLETED|Main Study||2
8999310|NCT02873286|10062712|FG001|NOT COMPLETED|Main Study||5
8999311|NCT02873286|10062713|FG002|NOT COMPLETED|Main Study||2
8999312|NCT02873286|10062714|FG003|NOT COMPLETED|Main Study||1
8999313|NCT02873286|10062715|FG004|NOT COMPLETED|Main Study||2
8999314|NCT02873286|10062711|FG000|STARTED|Booster Substudy||43
8999315|NCT02873286|10062712|FG001|STARTED|Booster Substudy||0
8999316|NCT02873286|10062713|FG002|STARTED|Booster Substudy||45
8999317|NCT02873286|10062714|FG003|STARTED|Booster Substudy||0
8999318|NCT02873286|10062715|FG004|STARTED|Booster Substudy||0
8999319|NCT02873286|10062711|FG000|COMPLETED|Booster Substudy||43
8633919|NCT00553540|9674161|FG001|STARTED|Overall Study||25
8633920|NCT00553540|9674160|FG000|COMPLETED|Overall Study||23
8633921|NCT00553540|9674161|FG001|COMPLETED|Overall Study||20
8999320|NCT02873286|10062712|FG001|COMPLETED|Booster Substudy||0
8999321|NCT02873286|10062713|FG002|COMPLETED|Booster Substudy||45
8999322|NCT02873286|10062714|FG003|COMPLETED|Booster Substudy||0
8633922|NCT00553540|9674160|FG000|NOT COMPLETED|Overall Study||2
8879462|NCT01933672|9936178|FG001|NOT COMPLETED|Third Intervention Period (12-16 Days)||1
8999323|NCT02873286|10062715|FG004|COMPLETED|Booster Substudy||0
8999324|NCT02873286|10062711|FG000|NOT COMPLETED|Booster Substudy||0
8999325|NCT02873286|10062712|FG001|NOT COMPLETED|Booster Substudy||0
8999326|NCT02873286|10062713|FG002|NOT COMPLETED|Booster Substudy||0
8999327|NCT02873286|10062714|FG003|NOT COMPLETED|Booster Substudy||0
8999328|NCT02873286|10062715|FG004|NOT COMPLETED|Booster Substudy||0
8999329|NCT02873338|10062730|FG000|STARTED|Overall Study||26
8999330|NCT02873338|10062731|FG001|STARTED|Overall Study||25
8999331|NCT02873338|10062732|FG002|STARTED|Overall Study||24
8999332|NCT02873338|10062730|FG000|COMPLETED|Overall Study||8
8999333|NCT02873338|10062731|FG001|COMPLETED|Overall Study||4
8999334|NCT02873338|10062732|FG002|COMPLETED|Overall Study||6
8999335|NCT02873338|10062730|FG000|NOT COMPLETED|Overall Study||18
8999336|NCT02873338|10062731|FG001|NOT COMPLETED|Overall Study||21
8999337|NCT02873338|10062732|FG002|NOT COMPLETED|Overall Study||18
8999338|NCT02873377|10062742|FG000|STARTED|Period 1: Enrollment||65
8999339|NCT02873377|10062743|FG001|STARTED|Period 1: Enrollment||69
8999340|NCT02873377|10062742|FG000|COMPLETED|Period 1: Enrollment||65
8999341|NCT02873377|10062743|FG001|COMPLETED|Period 1: Enrollment||69
8999342|NCT02873377|10062742|FG000|NOT COMPLETED|Period 1: Enrollment||0
8999343|NCT02873377|10062743|FG001|NOT COMPLETED|Period 1: Enrollment||0
8999344|NCT02873377|10062742|FG000|STARTED|Period Title 2: 3 Months Follow up||65
8999345|NCT02873377|10062743|FG001|STARTED|Period Title 2: 3 Months Follow up||69
8999346|NCT02873377|10062742|FG000|COMPLETED|Period Title 2: 3 Months Follow up||43
8999347|NCT02873377|10062743|FG001|COMPLETED|Period Title 2: 3 Months Follow up||47
8999348|NCT02873377|10062742|FG000|NOT COMPLETED|Period Title 2: 3 Months Follow up||22
8999349|NCT02873377|10062743|FG001|NOT COMPLETED|Period Title 2: 3 Months Follow up||22
8999350|NCT02873377|10062742|FG000|STARTED|Period Title 3: 6 Months Follow up||65
8999351|NCT02873377|10062743|FG001|STARTED|Period Title 3: 6 Months Follow up||69
8999352|NCT02873377|10062742|FG000|COMPLETED|Period Title 3: 6 Months Follow up||50
8999353|NCT02873377|10062743|FG001|COMPLETED|Period Title 3: 6 Months Follow up||46
8999354|NCT02873377|10062742|FG000|NOT COMPLETED|Period Title 3: 6 Months Follow up||15
8999355|NCT02873377|10062743|FG001|NOT COMPLETED|Period Title 3: 6 Months Follow up||23
8999356|NCT02873429|10062752|FG000|STARTED|Baseline||109
8999357|NCT02873429|10062753|FG001|STARTED|Baseline||100
8999358|NCT02873429|10062752|FG000|COMPLETED|Baseline||109
8999359|NCT02873429|10062753|FG001|COMPLETED|Baseline||100
8999360|NCT02873429|10062752|FG000|NOT COMPLETED|Baseline||0
8633923|NCT00553540|9674161|FG001|NOT COMPLETED|Overall Study||5
8633924|NCT00553605|9674169|FG000|STARTED|Overall Study||176
8999361|NCT02873429|10062753|FG001|NOT COMPLETED|Baseline||0
8999362|NCT02873429|10062752|FG000|STARTED|6-8 Weeks|4 CAM participants not eligible to complete follow ups because they did not continue treatment.|105
8999363|NCT02873429|10062753|FG001|STARTED|6-8 Weeks|2 Con. participants not eligible to complete follow ups because they did not continue treatment.|98
8999364|NCT02873429|10062752|FG000|COMPLETED|6-8 Weeks||95
8999365|NCT02873429|10062753|FG001|COMPLETED|6-8 Weeks||97
8999366|NCT02873429|10062752|FG000|NOT COMPLETED|6-8 Weeks||10
8999367|NCT02873429|10062753|FG001|NOT COMPLETED|6-8 Weeks||1
8999368|NCT02873429|10062752|FG000|STARTED|16 Weeks|10 CAM participants Missed 6-8 week but are eligible for 16 week|105
8999369|NCT02873429|10062753|FG001|STARTED|16 Weeks|1 Conv. participant Missed 6-8 week but was eligible for 16 week|98
8999370|NCT02873429|10062752|FG000|COMPLETED|16 Weeks||100
8999371|NCT02873429|10062753|FG001|COMPLETED|16 Weeks||96
8999372|NCT02873429|10062752|FG000|NOT COMPLETED|16 Weeks||5
8999373|NCT02873429|10062753|FG001|NOT COMPLETED|16 Weeks||2
8999374|NCT02873481|10062761|FG000|STARTED|Overall Study||15
8999375|NCT02873481|10062762|FG001|STARTED|Overall Study||17
8999376|NCT02873481|10062761|FG000|COMPLETED|Overall Study||15
8999377|NCT02873481|10062762|FG001|COMPLETED|Overall Study||17
8999378|NCT02873481|10062761|FG000|NOT COMPLETED|Overall Study||0
8999379|NCT02873481|10062762|FG001|NOT COMPLETED|Overall Study||0
8999380|NCT02873585|10062768|FG000|STARTED|Overall Study||32
8999381|NCT02873585|10062768|FG000|COMPLETED|Overall Study||32
8999382|NCT02873585|10062768|FG000|NOT COMPLETED|Overall Study||0
8999383|NCT02873689|10062778|FG000|STARTED|Overall Study||109
8999384|NCT02873689|10062779|FG001|STARTED|Overall Study||108
8999385|NCT02873689|10062778|FG000|Treated|Overall Study||108
8999386|NCT02873689|10062779|FG001|Treated|Overall Study||107
8999387|NCT02873689|10062778|FG000|COMPLETED|Overall Study||102
8999388|NCT02873689|10062779|FG001|COMPLETED|Overall Study||103
8999389|NCT02873689|10062778|FG000|NOT COMPLETED|Overall Study||7
8999390|NCT02873689|10062779|FG001|NOT COMPLETED|Overall Study||5
8999391|NCT02873702|10062787|FG000|STARTED|Healing Period (up to Week 8)||20
8999392|NCT02873702|10062788|FG001|STARTED|Healing Period (up to Week 8)||17
8999393|NCT02873702|10062789|FG002|STARTED|Healing Period (up to Week 8)||0
8999394|NCT02873702|10062790|FG003|STARTED|Healing Period (up to Week 8)||0
8999395|NCT02873702|10062787|FG000|COMPLETED|Healing Period (up to Week 8)||19
8999396|NCT02873702|10062788|FG001|COMPLETED|Healing Period (up to Week 8)||16
8999397|NCT02873702|10062789|FG002|COMPLETED|Healing Period (up to Week 8)||0
8999398|NCT02873702|10062790|FG003|COMPLETED|Healing Period (up to Week 8)||0
8999399|NCT02873702|10062787|FG000|NOT COMPLETED|Healing Period (up to Week 8)||1
8999400|NCT02873702|10062788|FG001|NOT COMPLETED|Healing Period (up to Week 8)||1
8999401|NCT02873702|10062789|FG002|NOT COMPLETED|Healing Period (up to Week 8)||0
8999402|NCT02873702|10062790|FG003|NOT COMPLETED|Healing Period (up to Week 8)||0
8999403|NCT02873702|10062787|FG000|STARTED|Maintenance Period (up to Month 6)||0
8999404|NCT02873702|10062788|FG001|STARTED|Maintenance Period (up to Month 6)||0
8999405|NCT02873702|10062789|FG002|STARTED|Maintenance Period (up to Month 6)||8
8999406|NCT02873702|10062790|FG003|STARTED|Maintenance Period (up to Month 6)||8
8999407|NCT02873702|10062787|FG000|COMPLETED|Maintenance Period (up to Month 6)||0
8999408|NCT02873702|10062788|FG001|COMPLETED|Maintenance Period (up to Month 6)||0
8999409|NCT02873702|10062789|FG002|COMPLETED|Maintenance Period (up to Month 6)||1
8999410|NCT02873702|10062790|FG003|COMPLETED|Maintenance Period (up to Month 6)||6
8633925|NCT00553605|9674170|FG001|STARTED|Overall Study||164
8999411|NCT02873702|10062787|FG000|NOT COMPLETED|Maintenance Period (up to Month 6)||0
8999412|NCT02873702|10062788|FG001|NOT COMPLETED|Maintenance Period (up to Month 6)||0
8999413|NCT02873702|10062789|FG002|NOT COMPLETED|Maintenance Period (up to Month 6)||7
8999414|NCT02873702|10062790|FG003|NOT COMPLETED|Maintenance Period (up to Month 6)||2
8999415|NCT02873754|10062800|FG000|STARTED|Overall Study||11
8999416|NCT02873754|10062800|FG000|COMPLETED|Overall Study||5
8999417|NCT02873754|10062800|FG000|NOT COMPLETED|Overall Study||6
8999418|NCT02873923|10062804|FG000|STARTED|Overall Study||2846
8999419|NCT02873923|10062804|FG000|COMPLETED|Overall Study||2846
8999420|NCT02873923|10062804|FG000|NOT COMPLETED|Overall Study||0
8999421|NCT02873936|10062811|FG000|STARTED|Overall Study||148
8999422|NCT02873936|10062812|FG001|STARTED|Overall Study||153
8999423|NCT02873936|10062813|FG002|STARTED|Overall Study||148
8999424|NCT02873936|10062811|FG000|COMPLETED|Overall Study||135
8999425|NCT02873936|10062812|FG001|COMPLETED|Overall Study||130
8999426|NCT02873936|10062813|FG002|COMPLETED|Overall Study||116
8999427|NCT02873936|10062811|FG000|NOT COMPLETED|Overall Study||13
8999428|NCT02873936|10062812|FG001|NOT COMPLETED|Overall Study||23
8999429|NCT02873936|10062813|FG002|NOT COMPLETED|Overall Study||32
8999430|NCT02874066|10062821|FG000|STARTED|Overall Study||46
8999431|NCT02874066|10062821|FG000|COMPLETED|Overall Study||46
8999432|NCT02874066|10062821|FG000|NOT COMPLETED|Overall Study||0
8999433|NCT02874092|10062827|FG000|STARTED|Overall Study||7
8999434|NCT02874092|10062828|FG001|STARTED|Overall Study||2
8999435|NCT02874092|10062827|FG000|COMPLETED|Overall Study||7
8999436|NCT02874092|10062828|FG001|COMPLETED|Overall Study||2
8999437|NCT02874092|10062827|FG000|NOT COMPLETED|Overall Study||0
8999438|NCT02874092|10062828|FG001|NOT COMPLETED|Overall Study||0
8999439|NCT02874404|10062833|FG000|STARTED|Overall Study||13
8999440|NCT02874404|10062833|FG000|COMPLETED|Overall Study||13
8999441|NCT02874404|10062833|FG000|NOT COMPLETED|Overall Study||0
8999442|NCT02874534|10062840|FG000|STARTED|Overall Study||31
8999443|NCT02874534|10062841|FG001|STARTED|Overall Study||26
8999444|NCT02874534|10062840|FG000|COMPLETED|Overall Study||23
8999445|NCT02874534|10062841|FG001|COMPLETED|Overall Study||15
8999446|NCT02874534|10062840|FG000|NOT COMPLETED|Overall Study||8
8999447|NCT02874534|10062841|FG001|NOT COMPLETED|Overall Study||11
8999448|NCT02874794|10062849|FG000|STARTED|Overall Study||233
8999449|NCT02874794|10062850|FG001|STARTED|Overall Study||232
8999450|NCT02874794|10062849|FG000|COMPLETED|Overall Study||226
8999451|NCT02874794|10062850|FG001|COMPLETED|Overall Study||221
8999452|NCT02874794|10062849|FG000|NOT COMPLETED|Overall Study||7
8999453|NCT02874794|10062850|FG001|NOT COMPLETED|Overall Study||11
8999454|NCT02874846|10062861|FG000|STARTED|Overall Study||8
8999455|NCT02874846|10062862|FG001|STARTED|Overall Study||4
8999456|NCT02874846|10062861|FG000|COMPLETED|Overall Study||8
8999457|NCT02874846|10062862|FG001|COMPLETED|Overall Study||4
8999458|NCT02874846|10062861|FG000|NOT COMPLETED|Overall Study||0
8999459|NCT02874846|10062862|FG001|NOT COMPLETED|Overall Study||0
8999460|NCT02874924|10062872|FG000|STARTED|Overall Study||14
8999461|NCT02874924|10062873|FG001|STARTED|Overall Study||14
8999462|NCT02874924|10062874|FG002|STARTED|Overall Study||6
8999463|NCT02874924|10062872|FG000|COMPLETED|Overall Study||11
8999464|NCT02874924|10062873|FG001|COMPLETED|Overall Study||14
8999465|NCT02874924|10062874|FG002|COMPLETED|Overall Study||6
8999466|NCT02874924|10062872|FG000|NOT COMPLETED|Overall Study||3
8999467|NCT02874924|10062873|FG001|NOT COMPLETED|Overall Study||0
8999468|NCT02874924|10062874|FG002|NOT COMPLETED|Overall Study||0
8999469|NCT02875028|10062884|FG000|STARTED|First Intervention (24 Hours)||8
8999470|NCT02875028|10062885|FG001|STARTED|First Intervention (24 Hours)||8
8999471|NCT02875028|10062884|FG000|COMPLETED|First Intervention (24 Hours)||8
8999472|NCT02875028|10062885|FG001|COMPLETED|First Intervention (24 Hours)||8
8999473|NCT02875028|10062884|FG000|NOT COMPLETED|First Intervention (24 Hours)||0
8999474|NCT02875028|10062885|FG001|NOT COMPLETED|First Intervention (24 Hours)||0
8999475|NCT02875028|10062884|FG000|STARTED|Washout Period||8
8999476|NCT02875028|10062885|FG001|STARTED|Washout Period||8
8999477|NCT02875028|10062884|FG000|COMPLETED|Washout Period||8
8577908|NCT00165789|9610849|FG003|STARTED|Overall Study||35
8577909|NCT00165789|9610846|FG000|COMPLETED|Overall Study||8
8577910|NCT00165789|9610847|FG001|COMPLETED|Overall Study||16
8577911|NCT00165789|9610848|FG002|COMPLETED|Overall Study||11
8577912|NCT00165789|9610849|FG003|COMPLETED|Overall Study||21
8577913|NCT00165789|9610846|FG000|NOT COMPLETED|Overall Study||0
8999478|NCT02875028|10062885|FG001|COMPLETED|Washout Period||7
8999479|NCT02875028|10062884|FG000|NOT COMPLETED|Washout Period||0
8999480|NCT02875028|10062885|FG001|NOT COMPLETED|Washout Period||1
8999481|NCT02875028|10062884|FG000|STARTED|Second Intervention (24 Hours)||8
8999482|NCT02875028|10062885|FG001|STARTED|Second Intervention (24 Hours)||7
8999483|NCT02875028|10062884|FG000|COMPLETED|Second Intervention (24 Hours)||8
8999484|NCT02875028|10062885|FG001|COMPLETED|Second Intervention (24 Hours)||7
8999485|NCT02875028|10062884|FG000|NOT COMPLETED|Second Intervention (24 Hours)||0
8999486|NCT02875028|10062885|FG001|NOT COMPLETED|Second Intervention (24 Hours)||0
8999487|NCT02875080|10062896|FG000|STARTED|Overall Study||6
8999488|NCT02875080|10062897|FG001|STARTED|Overall Study||6
8999489|NCT02875080|10062898|FG002|STARTED|Overall Study||6
8999490|NCT02875080|10062896|FG000|COMPLETED|Overall Study||4
8999491|NCT02875080|10062897|FG001|COMPLETED|Overall Study||6
8999492|NCT02875080|10062898|FG002|COMPLETED|Overall Study||6
8999493|NCT02875080|10062896|FG000|NOT COMPLETED|Overall Study||2
8999494|NCT02875080|10062897|FG001|NOT COMPLETED|Overall Study||0
8999495|NCT02875080|10062898|FG002|NOT COMPLETED|Overall Study||0
8999496|NCT02875340|10062906|FG000|STARTED|Overall Study||8
8999497|NCT02875340|10062906|FG000|COMPLETED|Overall Study|No patients completed 6 months of continuous treatment|0
8999498|NCT02875340|10062906|FG000|NOT COMPLETED|Overall Study||8
8999499|NCT02875366|10062918|FG000|STARTED|Overall Study||36
8999500|NCT02875366|10062919|FG001|STARTED|Overall Study||34
8999501|NCT02875366|10062918|FG000|COMPLETED|Overall Study||36
8999502|NCT02875366|10062919|FG001|COMPLETED|Overall Study||31
8999503|NCT02875366|10062918|FG000|NOT COMPLETED|Overall Study||0
8999504|NCT02875366|10062919|FG001|NOT COMPLETED|Overall Study||3
8999505|NCT02875392|10062927|FG000|STARTED|Overall Study||28
8999506|NCT02875392|10062928|FG001|STARTED|Overall Study||29
8999507|NCT02875392|10062927|FG000|COMPLETED|Overall Study||21
8999508|NCT02875392|10062928|FG001|COMPLETED|Overall Study||21
8999509|NCT02875392|10062927|FG000|NOT COMPLETED|Overall Study||7
8999510|NCT02875392|10062928|FG001|NOT COMPLETED|Overall Study||8
8999511|NCT02875613|10062934|FG000|STARTED|Overall Study||5
8999512|NCT02875613|10062934|FG000|COMPLETED|Overall Study||4
8999513|NCT02875613|10062934|FG000|NOT COMPLETED|Overall Study||1
8999514|NCT02875834|10062942|FG000|STARTED|Open-label Phase||267
8999515|NCT02875834|10062943|FG001|STARTED|Open-label Phase||0
8999516|NCT02875834|10062944|FG002|STARTED|Open-label Phase||0
8999517|NCT02875834|10062945|FG003|STARTED|Open-label Phase||0
8999518|NCT02875834|10062942|FG000|COMPLETED|Open-label Phase||260
8999519|NCT02875834|10062943|FG001|COMPLETED|Open-label Phase||0
8999520|NCT02875834|10062944|FG002|COMPLETED|Open-label Phase||0
8999521|NCT02875834|10062945|FG003|COMPLETED|Open-label Phase||0
8999522|NCT02875834|10062942|FG000|NOT COMPLETED|Open-label Phase||7
8999523|NCT02875834|10062943|FG001|NOT COMPLETED|Open-label Phase||0
8999524|NCT02875834|10062944|FG002|NOT COMPLETED|Open-label Phase||0
8999525|NCT02875834|10062945|FG003|NOT COMPLETED|Open-label Phase||0
8999526|NCT02875834|10062942|FG000|STARTED|Randomized Treatment Phase|No subjects were randomized in 10g TID group in RTP.|0
8999527|NCT02875834|10062943|FG001|STARTED|Randomized Treatment Phase|99 subjects were randomized in 5g QD group in RTP.|99
8999528|NCT02875834|10062944|FG002|STARTED|Randomized Treatment Phase|99 subjects were randomized in 10g QD group in RTP.|99
8999529|NCT02875834|10062945|FG003|STARTED|Randomized Treatment Phase|50 subjects were randomized in placebo group in RTP.|50
8999530|NCT02875834|10062942|FG000|COMPLETED|Randomized Treatment Phase||0
8999531|NCT02875834|10062943|FG001|COMPLETED|Randomized Treatment Phase||85
8999532|NCT02875834|10062944|FG002|COMPLETED|Randomized Treatment Phase||88
8999533|NCT02875834|10062945|FG003|COMPLETED|Randomized Treatment Phase||41
8999534|NCT02875834|10062942|FG000|NOT COMPLETED|Randomized Treatment Phase||0
8999535|NCT02875834|10062943|FG001|NOT COMPLETED|Randomized Treatment Phase||14
8999536|NCT02875834|10062944|FG002|NOT COMPLETED|Randomized Treatment Phase||11
8999537|NCT02875834|10062945|FG003|NOT COMPLETED|Randomized Treatment Phase||9
8999538|NCT02875977|10062957|FG000|STARTED|Overall Study||100
8999539|NCT02875977|10062958|FG001|STARTED|Overall Study||100
8999540|NCT02875977|10062957|FG000|COMPLETED|Overall Study||58
8999541|NCT02875977|10062958|FG001|COMPLETED|Overall Study||71
8999542|NCT02875977|10062957|FG000|NOT COMPLETED|Overall Study||42
8999543|NCT02875977|10062958|FG001|NOT COMPLETED|Overall Study||29
8999544|NCT02876055|10062967|FG000|STARTED|Overall Study||42
8999545|NCT02876055|10062968|FG001|STARTED|Overall Study||41
8999546|NCT02876055|10062969|FG002|STARTED|Overall Study||42
8999547|NCT02876055|10062967|FG000|COMPLETED|Overall Study||42
8999548|NCT02876055|10062968|FG001|COMPLETED|Overall Study||41
8999549|NCT02876055|10062969|FG002|COMPLETED|Overall Study||42
8999550|NCT02876055|10062967|FG000|NOT COMPLETED|Overall Study||0
8999551|NCT02876055|10062968|FG001|NOT COMPLETED|Overall Study||0
8999552|NCT02876055|10062969|FG002|NOT COMPLETED|Overall Study||0
8999553|NCT02876159|10062979|FG000|STARTED|Overall Study||10
8999554|NCT02876159|10062980|FG001|STARTED|Overall Study||10
8999555|NCT02876159|10062979|FG000|COMPLETED|Overall Study||10
8999556|NCT02876159|10062980|FG001|COMPLETED|Overall Study||10
8999557|NCT02876159|10062979|FG000|NOT COMPLETED|Overall Study||0
8999558|NCT02876159|10062980|FG001|NOT COMPLETED|Overall Study||0
8999559|NCT02876575|10062989|FG000|STARTED|Overall Study||48
8999560|NCT02876575|10062989|FG000|COMPLETED|Overall Study||48
8999561|NCT02876575|10062989|FG000|NOT COMPLETED|Overall Study||0
8999562|NCT02876601|10062998|FG000|STARTED|First Intervention (24 Hours)||8
8999563|NCT02876601|10062999|FG001|STARTED|First Intervention (24 Hours)||8
8999564|NCT02876601|10063000|FG002|STARTED|First Intervention (24 Hours)||2
8999565|NCT02876601|10063001|FG003|STARTED|First Intervention (24 Hours)||2
8999566|NCT02876601|10062998|FG000|COMPLETED|First Intervention (24 Hours)||8
8999567|NCT02876601|10062999|FG001|COMPLETED|First Intervention (24 Hours)||8
8999568|NCT02876601|10063000|FG002|COMPLETED|First Intervention (24 Hours)||2
8999569|NCT02876601|10063001|FG003|COMPLETED|First Intervention (24 Hours)||2
8999570|NCT02876601|10062998|FG000|NOT COMPLETED|First Intervention (24 Hours)||0
8999571|NCT02876601|10062999|FG001|NOT COMPLETED|First Intervention (24 Hours)||0
8999572|NCT02876601|10063000|FG002|NOT COMPLETED|First Intervention (24 Hours)||0
8999573|NCT02876601|10063001|FG003|NOT COMPLETED|First Intervention (24 Hours)||0
8999574|NCT02876601|10062998|FG000|STARTED|Washout (Minimum of 6 Weeks)||8
8999575|NCT02876601|10062999|FG001|STARTED|Washout (Minimum of 6 Weeks)||8
8999576|NCT02876601|10063000|FG002|STARTED|Washout (Minimum of 6 Weeks)||2
8999577|NCT02876601|10063001|FG003|STARTED|Washout (Minimum of 6 Weeks)||2
8999578|NCT02876601|10062998|FG000|COMPLETED|Washout (Minimum of 6 Weeks)||8
8999579|NCT02876601|10062999|FG001|COMPLETED|Washout (Minimum of 6 Weeks)||8
8999580|NCT02876601|10063000|FG002|COMPLETED|Washout (Minimum of 6 Weeks)||1
8999581|NCT02876601|10063001|FG003|COMPLETED|Washout (Minimum of 6 Weeks)||2
8999582|NCT02876601|10062998|FG000|NOT COMPLETED|Washout (Minimum of 6 Weeks)||0
8999583|NCT02876601|10062999|FG001|NOT COMPLETED|Washout (Minimum of 6 Weeks)||0
8999584|NCT02876601|10063000|FG002|NOT COMPLETED|Washout (Minimum of 6 Weeks)||1
8999585|NCT02876601|10063001|FG003|NOT COMPLETED|Washout (Minimum of 6 Weeks)||0
8999586|NCT02876601|10062998|FG000|STARTED|Second Intervention (24 Hours)||8
8999587|NCT02876601|10062999|FG001|STARTED|Second Intervention (24 Hours)||8
8999588|NCT02876601|10063000|FG002|STARTED|Second Intervention (24 Hours)||1
8999589|NCT02876601|10063001|FG003|STARTED|Second Intervention (24 Hours)||2
8999590|NCT02876601|10062998|FG000|COMPLETED|Second Intervention (24 Hours)||8
8999591|NCT02876601|10062999|FG001|COMPLETED|Second Intervention (24 Hours)||8
8999592|NCT02876601|10063000|FG002|COMPLETED|Second Intervention (24 Hours)||1
8999593|NCT02876601|10063001|FG003|COMPLETED|Second Intervention (24 Hours)||2
8999594|NCT02876601|10062998|FG000|NOT COMPLETED|Second Intervention (24 Hours)||0
8999595|NCT02876601|10062999|FG001|NOT COMPLETED|Second Intervention (24 Hours)||0
8999596|NCT02876601|10063000|FG002|NOT COMPLETED|Second Intervention (24 Hours)||0
8999597|NCT02876601|10063001|FG003|NOT COMPLETED|Second Intervention (24 Hours)||0
8999598|NCT02876757|10063048|FG000|STARTED|Overall Study||93197
8999599|NCT02876757|10063049|FG001|STARTED|Overall Study||93197
8999600|NCT02876757|10063048|FG000|COMPLETED|Overall Study||93197
8999601|NCT02876757|10063049|FG001|COMPLETED|Overall Study||93197
8999602|NCT02876757|10063048|FG000|NOT COMPLETED|Overall Study||0
8999603|NCT02876757|10063049|FG001|NOT COMPLETED|Overall Study||0
8999604|NCT02876887|10063057|FG000|STARTED|Overall Study||23
8999605|NCT02876887|10063058|FG001|STARTED|Overall Study||21
8999606|NCT02876887|10063057|FG000|COMPLETED|Overall Study||19
8999607|NCT02876887|10063058|FG001|COMPLETED|Overall Study||21
8999608|NCT02876887|10063057|FG000|NOT COMPLETED|Overall Study||4
8999609|NCT02876887|10063058|FG001|NOT COMPLETED|Overall Study||0
8999610|NCT02876900|10063067|FG000|STARTED|Overall Study||205
8633926|NCT00553605|9674169|FG000|Treated|Overall Study||174
8633927|NCT00553605|9674170|FG001|Treated|Overall Study||164
8999611|NCT02876900|10063068|FG001|STARTED|Overall Study||206
8999612|NCT02876900|10063069|FG002|STARTED|Overall Study||206
8999613|NCT02876900|10063067|FG000|COMPLETED|Overall Study||166
8999614|NCT02876900|10063068|FG001|COMPLETED|Overall Study||158
8999615|NCT02876900|10063069|FG002|COMPLETED|Overall Study||162
8999616|NCT02876900|10063067|FG000|NOT COMPLETED|Overall Study||39
8999617|NCT02876900|10063068|FG001|NOT COMPLETED|Overall Study||48
8999618|NCT02876900|10063069|FG002|NOT COMPLETED|Overall Study||44
8999619|NCT02876926|10063080|FG000|STARTED|Overall Study||21
8999620|NCT02876926|10063081|FG001|STARTED|Overall Study||22
8999621|NCT02876926|10063082|FG002|STARTED|Overall Study||22
8999622|NCT02876926|10063080|FG000|COMPLETED|Overall Study||3
8999623|NCT02876926|10063081|FG001|COMPLETED|Overall Study||3
8999624|NCT02876926|10063082|FG002|COMPLETED|Overall Study||2
8999625|NCT02876926|10063080|FG000|NOT COMPLETED|Overall Study||18
8999626|NCT02876926|10063081|FG001|NOT COMPLETED|Overall Study||19
8999627|NCT02876926|10063082|FG002|NOT COMPLETED|Overall Study||20
8999628|NCT02877004|10063093|FG000|STARTED|Overall Study||20
8999629|NCT02877004|10063094|FG001|STARTED|Overall Study||20
8999630|NCT02877004|10063095|FG002|STARTED|Overall Study||20
8999631|NCT02877004|10063093|FG000|COMPLETED|Overall Study||20
8633928|NCT00553605|9674169|FG000|COMPLETED|Overall Study||172
8999632|NCT02877004|10063094|FG001|COMPLETED|Overall Study||20
8999633|NCT02877004|10063095|FG002|COMPLETED|Overall Study||19
8999634|NCT02877004|10063093|FG000|NOT COMPLETED|Overall Study||0
8999635|NCT02877004|10063094|FG001|NOT COMPLETED|Overall Study||0
8999636|NCT02877004|10063095|FG002|NOT COMPLETED|Overall Study||1
8999637|NCT02877082|10063103|FG000|STARTED|Overall Study||5
8999638|NCT02877082|10063103|FG000|COMPLETED|Overall Study||0
8999639|NCT02877082|10063103|FG000|NOT COMPLETED|Overall Study||5
9039376|NCT03338062|10100323|FG000|STARTED|Overall Study||10
8999640|NCT02877095|10063109|FG000|STARTED|Overall Study|First patient enrolled 1/9/17.|20
8999641|NCT02877095|10063110|FG001|STARTED|Overall Study||20
8999642|NCT02877095|10063109|FG000|COMPLETED|Overall Study||20
8999643|NCT02877095|10063110|FG001|COMPLETED|Overall Study||20
8999644|NCT02877095|10063109|FG000|NOT COMPLETED|Overall Study||0
8999645|NCT02877095|10063110|FG001|NOT COMPLETED|Overall Study||0
8999646|NCT02877485|10063118|FG000|STARTED|Overall Study||22
8999647|NCT02877485|10063119|FG001|STARTED|Overall Study||20
8999648|NCT02877485|10063118|FG000|COMPLETED|Overall Study||22
8999649|NCT02877485|10063119|FG001|COMPLETED|Overall Study||20
8999650|NCT02877485|10063118|FG000|NOT COMPLETED|Overall Study||0
8999651|NCT02877485|10063119|FG001|NOT COMPLETED|Overall Study||0
8999652|NCT02877680|10063128|FG000|STARTED|Overall Study||55
8999653|NCT02877680|10063129|FG001|STARTED|Overall Study||25
8999654|NCT02877680|10063128|FG000|COMPLETED|Overall Study||54
8999655|NCT02877680|10063129|FG001|COMPLETED|Overall Study||24
8999656|NCT02877680|10063128|FG000|NOT COMPLETED|Overall Study||1
8999657|NCT02877680|10063129|FG001|NOT COMPLETED|Overall Study||1
8999658|NCT02877927|10063141|FG000|STARTED|Overall Study||368
8999659|NCT02877927|10063142|FG001|STARTED|Overall Study||367
8999660|NCT02877927|10063141|FG000|COMPLETED|Overall Study||314
8999661|NCT02877927|10063142|FG001|COMPLETED|Overall Study||310
8999662|NCT02877927|10063141|FG000|NOT COMPLETED|Overall Study||54
8999663|NCT02877927|10063142|FG001|NOT COMPLETED|Overall Study||57
8999664|NCT02878057|10063148|FG000|STARTED|Overall Study||30
8999665|NCT02878057|10063148|FG000|COMPLETED|Overall Study||26
8999666|NCT02878057|10063148|FG000|NOT COMPLETED|Overall Study||4
8999667|NCT02878213|10063152|FG000|STARTED|Overall Study||39
8999668|NCT02878213|10063152|FG000|COMPLETED|Overall Study||36
8999669|NCT02878213|10063152|FG000|NOT COMPLETED|Overall Study||3
8999670|NCT02878330|10063159|FG000|STARTED|Overall Study||484
8999671|NCT02878330|10063160|FG001|STARTED|Overall Study||969
8999672|NCT02878330|10063159|FG000|COMPLETED|Overall Study||455
8999673|NCT02878330|10063160|FG001|COMPLETED|Overall Study||913
8999674|NCT02878330|10063159|FG000|NOT COMPLETED|Overall Study||29
8999675|NCT02878330|10063160|FG001|NOT COMPLETED|Overall Study||56
8999676|NCT02878382|10063167|FG000|STARTED|Overall Study|total 20 patients.split-scalp: 20 split -scalp received CAL-PDT and the other 20 received C-PDT|20
8999677|NCT02878382|10063168|FG001|STARTED|Overall Study|otal 20 patients.split-scalp: 20 split -scalp received CAL-PDT and the other 20 received C-PDT|20
8999678|NCT02878382|10063167|FG000|COMPLETED|Overall Study||20
8999679|NCT02878382|10063168|FG001|COMPLETED|Overall Study||20
8999680|NCT02878382|10063167|FG000|NOT COMPLETED|Overall Study||0
8999681|NCT02878382|10063168|FG001|NOT COMPLETED|Overall Study||0
8999682|NCT02878486|10063178|FG000|STARTED|Overall Study||3
8999683|NCT02878486|10063179|FG001|STARTED|Overall Study||3
8999684|NCT02878486|10063178|FG000|COMPLETED|Overall Study||3
8999685|NCT02878486|10063179|FG001|COMPLETED|Overall Study||3
8999686|NCT02878486|10063178|FG000|NOT COMPLETED|Overall Study||0
8999687|NCT02878486|10063179|FG001|NOT COMPLETED|Overall Study||0
8999688|NCT02878590|10063185|FG000|STARTED|Overall Study||12
8999689|NCT02878590|10063185|FG000|COMPLETED|Overall Study||10
8999690|NCT02878590|10063185|FG000|NOT COMPLETED|Overall Study||2
8999691|NCT02879032|10063189|FG000|STARTED|Overall Study||130
8999692|NCT02879032|10063189|FG000|COMPLETED|Overall Study||130
8999693|NCT02879032|10063189|FG000|NOT COMPLETED|Overall Study||0
8999694|NCT02879383|10063199|FG000|STARTED|First 24 Weeks||39
8999695|NCT02879383|10063200|FG001|STARTED|First 24 Weeks||37
8999696|NCT02879383|10063201|FG002|STARTED|First 24 Weeks||17
8999697|NCT02879383|10063202|FG003|STARTED|First 24 Weeks||16
8999698|NCT02879383|10063199|FG000|COMPLETED|First 24 Weeks||39
8999699|NCT02879383|10063200|FG001|COMPLETED|First 24 Weeks||36
8999700|NCT02879383|10063201|FG002|COMPLETED|First 24 Weeks||17
8999701|NCT02879383|10063202|FG003|COMPLETED|First 24 Weeks||16
8999702|NCT02879383|10063199|FG000|NOT COMPLETED|First 24 Weeks||0
8999703|NCT02879383|10063200|FG001|NOT COMPLETED|First 24 Weeks||1
8999704|NCT02879383|10063201|FG002|NOT COMPLETED|First 24 Weeks||0
8999705|NCT02879383|10063202|FG003|NOT COMPLETED|First 24 Weeks||0
8999706|NCT02879383|10063199|FG000|STARTED|Second 24 Weeks (Crossover for Sham)||33
8999707|NCT02879383|10063200|FG001|STARTED|Second 24 Weeks (Crossover for Sham)||0
8999708|NCT02879383|10063201|FG002|STARTED|Second 24 Weeks (Crossover for Sham)||4
8999709|NCT02879383|10063202|FG003|STARTED|Second 24 Weeks (Crossover for Sham)||0
8999710|NCT02879383|10063199|FG000|COMPLETED|Second 24 Weeks (Crossover for Sham)||33
8999711|NCT02879383|10063200|FG001|COMPLETED|Second 24 Weeks (Crossover for Sham)||0
8999712|NCT02879383|10063201|FG002|COMPLETED|Second 24 Weeks (Crossover for Sham)||4
8999713|NCT02879383|10063202|FG003|COMPLETED|Second 24 Weeks (Crossover for Sham)||0
8999714|NCT02879383|10063199|FG000|NOT COMPLETED|Second 24 Weeks (Crossover for Sham)||0
8999715|NCT02879383|10063200|FG001|NOT COMPLETED|Second 24 Weeks (Crossover for Sham)||0
8999716|NCT02879383|10063201|FG002|NOT COMPLETED|Second 24 Weeks (Crossover for Sham)||0
8999717|NCT02879383|10063202|FG003|NOT COMPLETED|Second 24 Weeks (Crossover for Sham)||0
8999718|NCT02879578|10063217|FG000|STARTED|Overall Study||33
8999719|NCT02879578|10063218|FG001|STARTED|Overall Study||41
8999720|NCT02879578|10063219|FG002|STARTED|Overall Study||81
8999721|NCT02879578|10063217|FG000|Safety Analysis Set|Overall Study||33
8999722|NCT02879578|10063218|FG001|Safety Analysis Set|Overall Study||40
8999723|NCT02879578|10063219|FG002|Safety Analysis Set|Overall Study||79
8999724|NCT02879578|10063217|FG000|COMPLETED|Overall Study||23
8999725|NCT02879578|10063218|FG001|COMPLETED|Overall Study||32
8999726|NCT02879578|10063219|FG002|COMPLETED|Overall Study||49
8999727|NCT02879578|10063217|FG000|NOT COMPLETED|Overall Study||10
8999728|NCT02879578|10063218|FG001|NOT COMPLETED|Overall Study||9
8999729|NCT02879578|10063219|FG002|NOT COMPLETED|Overall Study||32
8999730|NCT02879747|10063230|FG000|STARTED|Overall Study||27
8999731|NCT02879747|10063231|FG001|STARTED|Overall Study||38
8999732|NCT02879747|10063232|FG002|STARTED|Overall Study||33
8999733|NCT02879747|10063230|FG000|COMPLETED|Overall Study||23
8999734|NCT02879747|10063231|FG001|COMPLETED|Overall Study||32
8999735|NCT02879747|10063232|FG002|COMPLETED|Overall Study||31
8999736|NCT02879747|10063230|FG000|NOT COMPLETED|Overall Study||4
8999737|NCT02879747|10063231|FG001|NOT COMPLETED|Overall Study||6
8999738|NCT02879747|10063232|FG002|NOT COMPLETED|Overall Study||2
8999739|NCT02879812|10063251|FG000|STARTED|Overall Study||23370
8999740|NCT02879812|10063252|FG001|STARTED|Overall Study||22480
8999741|NCT02879812|10063251|FG000|COMPLETED|Overall Study||22153
8999742|NCT02879812|10063252|FG001|COMPLETED|Overall Study||21029
8999743|NCT02879812|10063251|FG000|NOT COMPLETED|Overall Study||1217
8999744|NCT02879812|10063252|FG001|NOT COMPLETED|Overall Study||1451
8999745|NCT02879994|10063258|FG000|STARTED|Overall Study||11
8999746|NCT02879994|10063258|FG000|COMPLETED|Overall Study||0
8999747|NCT02879994|10063258|FG000|NOT COMPLETED|Overall Study||11
8999748|NCT02880137|10063262|FG000|STARTED|Overall Study||36
8999749|NCT02880137|10063262|FG000|COMPLETED|Overall Study||36
8999750|NCT02880137|10063262|FG000|NOT COMPLETED|Overall Study||0
8999751|NCT02880176|10063268|FG000|STARTED|Overall Study||23
8999752|NCT02880176|10063269|FG001|STARTED|Overall Study||11
8999753|NCT02880176|10063268|FG000|Underwent Cystectomy|Overall Study||22
8999754|NCT02880176|10063269|FG001|Underwent Cystectomy|Overall Study||11
8999755|NCT02880176|10063268|FG000|Collected Postop Step Data|Overall Study||22
8999756|NCT02880176|10063269|FG001|Collected Postop Step Data|Overall Study||11
8999757|NCT02880176|10063268|FG000|Responded to 30 Day Survey|Overall Study||20
8999758|NCT02880176|10063269|FG001|Responded to 30 Day Survey|Overall Study||9
8999759|NCT02880176|10063268|FG000|COMPLETED|Overall Study||20
8999760|NCT02880176|10063269|FG001|COMPLETED|Overall Study||9
8999761|NCT02880176|10063268|FG000|NOT COMPLETED|Overall Study||3
8999762|NCT02880176|10063269|FG001|NOT COMPLETED|Overall Study||2
8999763|NCT02880189|10063275|FG000|STARTED|Overall Study||21
8999764|NCT02880189|10063275|FG000|COMPLETED|Overall Study||21
8999765|NCT02880189|10063275|FG000|NOT COMPLETED|Overall Study||0
8999766|NCT02880228|10063279|FG000|STARTED|Overall Study||11
8999767|NCT02880228|10063279|FG000|COMPLETED|Overall Study||11
8999768|NCT02880228|10063279|FG000|NOT COMPLETED|Overall Study||0
8999769|NCT02880254|10063285|FG000|STARTED|Overall Study||13
8999770|NCT02880254|10063286|FG001|STARTED|Overall Study||14
8999771|NCT02880254|10063285|FG000|COMPLETED|Overall Study||4
8999772|NCT02880254|10063286|FG001|COMPLETED|Overall Study||4
8999773|NCT02880254|10063285|FG000|NOT COMPLETED|Overall Study||9
8999774|NCT02880254|10063286|FG001|NOT COMPLETED|Overall Study||10
8999775|NCT02880475|10063294|FG000|STARTED|Overall Study||13
8999776|NCT02880475|10063295|FG001|STARTED|Overall Study||17
8999777|NCT02880475|10063294|FG000|COMPLETED|Overall Study||13
8999778|NCT02880475|10063295|FG001|COMPLETED|Overall Study||17
8999779|NCT02880475|10063294|FG000|NOT COMPLETED|Overall Study||0
8999780|NCT02880475|10063295|FG001|NOT COMPLETED|Overall Study||0
8999781|NCT02880514|10063303|FG000|STARTED|Overall Study|A total of 50 subjects with one sinus side assigned to the treatment group|50
8999782|NCT02880514|10063304|FG001|STARTED|Overall Study|A total of 50 subjects with one sinus side assigned to the control group|50
8999783|NCT02880514|10063303|FG000|COMPLETED|Overall Study||50
8999784|NCT02880514|10063304|FG001|COMPLETED|Overall Study||50
8999785|NCT02880514|10063303|FG000|NOT COMPLETED|Overall Study||0
8999786|NCT02880514|10063304|FG001|NOT COMPLETED|Overall Study||0
8999787|NCT02880761|10063313|FG000|STARTED|Overall Study||103
8999788|NCT02880761|10063314|FG001|STARTED|Overall Study||106
8999789|NCT02880761|10063313|FG000|COMPLETED|Overall Study||87
8999790|NCT02880761|10063314|FG001|COMPLETED|Overall Study||85
8999791|NCT02880761|10063313|FG000|NOT COMPLETED|Overall Study||16
8999792|NCT02880761|10063314|FG001|NOT COMPLETED|Overall Study||21
8999793|NCT02880852|10063320|FG000|STARTED|Overall Study||20
8999794|NCT02880852|10063320|FG000|COMPLETED|Overall Study||20
8999795|NCT02880852|10063320|FG000|NOT COMPLETED|Overall Study||0
8999796|NCT02880865|10063326|FG000|STARTED|Overall Study||314
8999797|NCT02880865|10063327|FG001|STARTED|Overall Study||314
8999798|NCT02880865|10063326|FG000|Received MMR Dose 1|Overall Study||314
8999799|NCT02880865|10063327|FG001|Received MMR Dose 1|Overall Study||314
8999800|NCT02880865|10063326|FG000|Received CD-JEV|Overall Study||314
8999801|NCT02880865|10063327|FG001|Received CD-JEV|Overall Study||309
8999802|NCT02880865|10063326|FG000|Received MMR Dose 2|Overall Study||313
8999803|NCT02880865|10063327|FG001|Received MMR Dose 2|Overall Study||311
8999804|NCT02880865|10063326|FG000|COMPLETED|Overall Study||313
8999805|NCT02880865|10063327|FG001|COMPLETED|Overall Study||311
8999806|NCT02880865|10063326|FG000|NOT COMPLETED|Overall Study||1
8999807|NCT02880865|10063327|FG001|NOT COMPLETED|Overall Study||3
8999808|NCT02881008|10063360|FG000|STARTED|Overall Study||8
8999809|NCT02881008|10063361|FG001|STARTED|Overall Study||8
8999810|NCT02881008|10063362|FG002|STARTED|Overall Study||8
8999811|NCT02881008|10063363|FG003|STARTED|Overall Study||8
8999812|NCT02881008|10063364|FG004|STARTED|Overall Study||8
8999813|NCT02881008|10063365|FG005|STARTED|Overall Study||8
8999814|NCT02881008|10063360|FG000|COMPLETED|Overall Study||8
8999815|NCT02881008|10063361|FG001|COMPLETED|Overall Study||8
8999816|NCT02881008|10063362|FG002|COMPLETED|Overall Study||8
8999817|NCT02881008|10063363|FG003|COMPLETED|Overall Study||8
8999818|NCT02881008|10063364|FG004|COMPLETED|Overall Study||8
8999819|NCT02881008|10063365|FG005|COMPLETED|Overall Study||8
8999820|NCT02881008|10063360|FG000|NOT COMPLETED|Overall Study||0
8999821|NCT02881008|10063361|FG001|NOT COMPLETED|Overall Study||0
8999822|NCT02881008|10063362|FG002|NOT COMPLETED|Overall Study||0
8999823|NCT02881008|10063363|FG003|NOT COMPLETED|Overall Study||0
8999824|NCT02881008|10063364|FG004|NOT COMPLETED|Overall Study||0
8999825|NCT02881008|10063365|FG005|NOT COMPLETED|Overall Study||0
8999826|NCT02881047|10063382|FG000|STARTED|Overall Study||8
8999827|NCT02881047|10063382|FG000|COMPLETED|Overall Study||6
8999828|NCT02881047|10063382|FG000|NOT COMPLETED|Overall Study||2
8999829|NCT02881112|10063386|FG000|STARTED|Overall Study||180
8999830|NCT02881112|10063386|FG000|COMPLETED|Overall Study||152
8999831|NCT02881112|10063386|FG000|NOT COMPLETED|Overall Study||28
8999832|NCT02881567|10063390|FG000|STARTED|Overall Study||41
8999833|NCT02881567|10063390|FG000|COMPLETED|Overall Study||23
8999834|NCT02881567|10063390|FG000|NOT COMPLETED|Overall Study||18
8999835|NCT02881658|10063396|FG000|STARTED|Overall Study||100
8999836|NCT02881658|10063397|FG001|STARTED|Overall Study||101
8999837|NCT02881658|10063396|FG000|COMPLETED|Overall Study||98
8999838|NCT02881658|10063397|FG001|COMPLETED|Overall Study||96
8999839|NCT02881658|10063396|FG000|NOT COMPLETED|Overall Study||2
8999840|NCT02881658|10063397|FG001|NOT COMPLETED|Overall Study||5
8999841|NCT02881775|10063405|FG000|STARTED|Baseline||11
8999842|NCT02881775|10063406|FG001|STARTED|Baseline||9
8999843|NCT02881775|10063405|FG000|COMPLETED|Baseline||11
8999844|NCT02881775|10063406|FG001|COMPLETED|Baseline||9
8999845|NCT02881775|10063405|FG000|NOT COMPLETED|Baseline||0
8999846|NCT02881775|10063406|FG001|NOT COMPLETED|Baseline||0
8999847|NCT02881775|10063405|FG000|STARTED|First Intervention (1-hr Session)|Two participants dropped out prior to First Intervention (1-hr Session).|9
8999848|NCT02881775|10063406|FG001|STARTED|First Intervention (1-hr Session)|Two participants dropped out prior to First Intervention (1-hr Session).|7
8999849|NCT02881775|10063405|FG000|COMPLETED|First Intervention (1-hr Session)||9
8999850|NCT02881775|10063406|FG001|COMPLETED|First Intervention (1-hr Session)||7
8999851|NCT02881775|10063405|FG000|NOT COMPLETED|First Intervention (1-hr Session)||0
8999852|NCT02881775|10063406|FG001|NOT COMPLETED|First Intervention (1-hr Session)||0
8999853|NCT02881775|10063405|FG000|STARTED|Washout (1 Week)||9
8999854|NCT02881775|10063406|FG001|STARTED|Washout (1 Week)||7
8999855|NCT02881775|10063405|FG000|COMPLETED|Washout (1 Week)||9
8999856|NCT02881775|10063406|FG001|COMPLETED|Washout (1 Week)||7
8999857|NCT02881775|10063405|FG000|NOT COMPLETED|Washout (1 Week)||0
8999858|NCT02881775|10063406|FG001|NOT COMPLETED|Washout (1 Week)||0
8999859|NCT02881775|10063405|FG000|STARTED|Second Intervention (1-Hour Session)||9
8999860|NCT02881775|10063406|FG001|STARTED|Second Intervention (1-Hour Session)||7
8999861|NCT02881775|10063405|FG000|COMPLETED|Second Intervention (1-Hour Session)||9
8999862|NCT02881775|10063406|FG001|COMPLETED|Second Intervention (1-Hour Session)||7
8999863|NCT02881775|10063405|FG000|NOT COMPLETED|Second Intervention (1-Hour Session)||0
8999864|NCT02881775|10063406|FG001|NOT COMPLETED|Second Intervention (1-Hour Session)||0
8999865|NCT02881840|10063412|FG000|STARTED|Overall Study||6
8999866|NCT02881840|10063412|FG000|COMPLETED|Overall Study||6
8999867|NCT02881840|10063412|FG000|NOT COMPLETED|Overall Study||0
8999868|NCT02881957|10063418|FG000|STARTED|Overall Study||136
8999869|NCT02881957|10063419|FG001|STARTED|Overall Study||138
8999870|NCT02881957|10063418|FG000|COMPLETED|Overall Study||133
8999871|NCT02881957|10063419|FG001|COMPLETED|Overall Study||134
8999872|NCT02881957|10063418|FG000|NOT COMPLETED|Overall Study||3
8999873|NCT02881957|10063419|FG001|NOT COMPLETED|Overall Study||4
8999874|NCT02881996|10063427|FG000|STARTED|Overall Study||45
8999875|NCT02881996|10063428|FG001|STARTED|Overall Study||45
8999876|NCT02881996|10063427|FG000|COMPLETED|Overall Study||39
8999877|NCT02881996|10063428|FG001|COMPLETED|Overall Study||43
8999878|NCT02881996|10063427|FG000|NOT COMPLETED|Overall Study||6
8999879|NCT02881996|10063428|FG001|NOT COMPLETED|Overall Study||2
8999880|NCT02882152|10063436|FG000|STARTED|Overall Study||20
8633929|NCT00553605|9674170|FG001|COMPLETED|Overall Study||161
8633930|NCT00553605|9674169|FG000|NOT COMPLETED|Overall Study||4
8633931|NCT00553605|9674170|FG001|NOT COMPLETED|Overall Study||3
8633932|NCT00553631|9674178|FG000|STARTED|Overall Study|Intent-to-treat (ITT) population|17
8879463|NCT01933672|9936179|FG002|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
8999881|NCT02882152|10063437|FG001|STARTED|Overall Study||20
8879464|NCT01933672|9936180|FG003|NOT COMPLETED|Third Intervention Period (12-16 Days)||1
8879465|NCT01933672|9936181|FG004|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
8879466|NCT01933672|9936182|FG005|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
8879467|NCT01933672|9936183|FG006|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
8879468|NCT01933776|9936198|FG000|STARTED|Overall Study||20
8879469|NCT01933776|9936199|FG001|STARTED|Overall Study||20
8879470|NCT01933776|9936198|FG000|COMPLETED|Overall Study||20
8879471|NCT01933776|9936199|FG001|COMPLETED|Overall Study||20
8879472|NCT01933776|9936198|FG000|NOT COMPLETED|Overall Study||0
8879473|NCT01933776|9936199|FG001|NOT COMPLETED|Overall Study||0
8879474|NCT01933789|9936214|FG000|STARTED|Overall Study||65
8879475|NCT01933789|9936215|FG001|STARTED|Overall Study||67
8879476|NCT01933789|9936216|FG002|STARTED|Overall Study||2
8879477|NCT01933789|9936217|FG003|STARTED|Overall Study||2
8879478|NCT01933789|9936218|FG004|STARTED|Overall Study||249
8879479|NCT01933789|9936219|FG005|STARTED|Overall Study||288
8879480|NCT01933789|9936220|FG006|STARTED|Overall Study||58
8879481|NCT01933789|9936221|FG007|STARTED|Overall Study||61
8879482|NCT01933789|9936222|FG008|STARTED|Overall Study||25
8879483|NCT01933789|9936214|FG000|Had Target Visit|Overall Study|Had target visit(s) completed before clinician or patient withdrawal|61
8879484|NCT01933789|9936215|FG001|Had Target Visit|Overall Study|Had target visit(s) completed before clinician or patient withdrawal|65
8879485|NCT01933789|9936216|FG002|Had Target Visit|Overall Study||2
8879486|NCT01933789|9936217|FG003|Had Target Visit|Overall Study||2
8879487|NCT01933789|9936218|FG004|Had Target Visit|Overall Study||228
8879488|NCT01933789|9936219|FG005|Had Target Visit|Overall Study||266
8879489|NCT01933789|9936220|FG006|Had Target Visit|Overall Study||0
8999882|NCT02882152|10063436|FG000|COMPLETED|Overall Study||19
8999883|NCT02882152|10063437|FG001|COMPLETED|Overall Study||20
8999884|NCT02882152|10063436|FG000|NOT COMPLETED|Overall Study||1
8999885|NCT02882152|10063437|FG001|NOT COMPLETED|Overall Study||0
8999886|NCT02882178|10063443|FG000|STARTED|Overall Study||18
8999887|NCT02882178|10063443|FG000|COMPLETED|Overall Study||18
8999888|NCT02882178|10063443|FG000|NOT COMPLETED|Overall Study||0
8999889|NCT02882633|10063449|FG000|STARTED|Overall Study||25
8999890|NCT02882633|10063450|FG001|STARTED|Overall Study||25
8999891|NCT02882633|10063449|FG000|COMPLETED|Overall Study||23
8999892|NCT02882633|10063450|FG001|COMPLETED|Overall Study||25
8633933|NCT00553631|9674179|FG001|STARTED|Overall Study|Intent-to-treat (ITT) population|17
8999893|NCT02882633|10063449|FG000|NOT COMPLETED|Overall Study||2
8999894|NCT02882633|10063450|FG001|NOT COMPLETED|Overall Study||0
8999895|NCT02882711|10063456|FG000|STARTED|Overall Study||6
8999896|NCT02882711|10063456|FG000|COMPLETED|Overall Study||2
8999897|NCT02882711|10063456|FG000|NOT COMPLETED|Overall Study||4
8999898|NCT02882854|10063462|FG000|STARTED|Overall Study||40
8999899|NCT02882854|10063463|FG001|STARTED|Overall Study||44
8999900|NCT02882854|10063462|FG000|COMPLETED|Overall Study||39
8999901|NCT02882854|10063463|FG001|COMPLETED|Overall Study||41
8999902|NCT02882854|10063462|FG000|NOT COMPLETED|Overall Study||1
8999903|NCT02882854|10063463|FG001|NOT COMPLETED|Overall Study||3
8999904|NCT02883244|10063471|FG000|STARTED|Overall Study||24
8999905|NCT02883244|10063472|FG001|STARTED|Overall Study||26
8999906|NCT02883244|10063471|FG000|COMPLETED|Overall Study||24
8999907|NCT02883244|10063472|FG001|COMPLETED|Overall Study||25
8999908|NCT02883244|10063471|FG000|NOT COMPLETED|Overall Study||0
8999909|NCT02883244|10063472|FG001|NOT COMPLETED|Overall Study||1
8999910|NCT02883452|10063484|FG000|STARTED|Overall Study|This cohort is only for Part 1.|13
8999911|NCT02883452|10063485|FG001|STARTED|Overall Study|This cohort is only for Part 1.|11
8999912|NCT02883452|10063486|FG002|STARTED|Overall Study|This cohort is only for Part 1.|12
8999913|NCT02883452|10063487|FG003|STARTED|Overall Study|This cohort is only for Part 1.|8
8999914|NCT02883452|10063488|FG004|STARTED|Overall Study|This arm is for Part 2. All of the patients in Part 2 were screened only for Part 2.|66
8999915|NCT02883452|10063489|FG005|STARTED|Overall Study|This arm is for Part 2. All of the patients in Part 2 were screened only for Part 2.|65
8999916|NCT02883452|10063484|FG000|COMPLETED|Overall Study||8
8999917|NCT02883452|10063485|FG001|COMPLETED|Overall Study||9
8999918|NCT02883452|10063486|FG002|COMPLETED|Overall Study||7
8999919|NCT02883452|10063487|FG003|COMPLETED|Overall Study||6
8999920|NCT02883452|10063488|FG004|COMPLETED|Overall Study||55
8999921|NCT02883452|10063489|FG005|COMPLETED|Overall Study||50
8999922|NCT02883452|10063484|FG000|NOT COMPLETED|Overall Study||5
8999923|NCT02883452|10063485|FG001|NOT COMPLETED|Overall Study||2
8999924|NCT02883452|10063486|FG002|NOT COMPLETED|Overall Study||5
8999925|NCT02883452|10063487|FG003|NOT COMPLETED|Overall Study||2
8999926|NCT02883452|10063488|FG004|NOT COMPLETED|Overall Study||11
8999927|NCT02883452|10063489|FG005|NOT COMPLETED|Overall Study||15
8999928|NCT02884089|10063504|FG000|STARTED|Period 1||11
8999929|NCT02884089|10063505|FG001|STARTED|Period 1||11
8999930|NCT02884089|10063506|FG002|STARTED|Period 1||9
8999931|NCT02884089|10063507|FG003|STARTED|Period 1||9
8999932|NCT02884089|10063504|FG000|Received at Least One Dose of Study Drug|Period 1||11
8999933|NCT02884089|10063505|FG001|Received at Least One Dose of Study Drug|Period 1||11
8999934|NCT02884089|10063506|FG002|Received at Least One Dose of Study Drug|Period 1||9
8999935|NCT02884089|10063507|FG003|Received at Least One Dose of Study Drug|Period 1||9
8999936|NCT02884089|10063504|FG000|COMPLETED|Period 1||9
8999937|NCT02884089|10063505|FG001|COMPLETED|Period 1||9
8999938|NCT02884089|10063506|FG002|COMPLETED|Period 1||9
8999939|NCT02884089|10063507|FG003|COMPLETED|Period 1||9
8999940|NCT02884089|10063504|FG000|NOT COMPLETED|Period 1||2
8999941|NCT02884089|10063505|FG001|NOT COMPLETED|Period 1||2
8999942|NCT02884089|10063506|FG002|NOT COMPLETED|Period 1||0
8999943|NCT02884089|10063507|FG003|NOT COMPLETED|Period 1||0
8999944|NCT02884089|10063504|FG000|STARTED|Washout Period 1||9
8999945|NCT02884089|10063505|FG001|STARTED|Washout Period 1||9
8999946|NCT02884089|10063506|FG002|STARTED|Washout Period 1||9
8999947|NCT02884089|10063507|FG003|STARTED|Washout Period 1||9
8999948|NCT02884089|10063504|FG000|COMPLETED|Washout Period 1||9
8999949|NCT02884089|10063505|FG001|COMPLETED|Washout Period 1||7
8999950|NCT02884089|10063506|FG002|COMPLETED|Washout Period 1||9
8999951|NCT02884089|10063507|FG003|COMPLETED|Washout Period 1||8
8999952|NCT02884089|10063504|FG000|NOT COMPLETED|Washout Period 1||0
8999953|NCT02884089|10063505|FG001|NOT COMPLETED|Washout Period 1||2
8999954|NCT02884089|10063506|FG002|NOT COMPLETED|Washout Period 1||0
8999955|NCT02884089|10063507|FG003|NOT COMPLETED|Washout Period 1||1
8999956|NCT02884089|10063504|FG000|STARTED|Period 2||9
8999957|NCT02884089|10063505|FG001|STARTED|Period 2||7
8999958|NCT02884089|10063506|FG002|STARTED|Period 2||9
8999959|NCT02884089|10063507|FG003|STARTED|Period 2||8
8999960|NCT02884089|10063504|FG000|COMPLETED|Period 2||8
8999961|NCT02884089|10063505|FG001|COMPLETED|Period 2||7
8999962|NCT02884089|10063506|FG002|COMPLETED|Period 2||9
8999963|NCT02884089|10063507|FG003|COMPLETED|Period 2||8
8999964|NCT02884089|10063504|FG000|NOT COMPLETED|Period 2||1
8999965|NCT02884089|10063505|FG001|NOT COMPLETED|Period 2||0
8999966|NCT02884089|10063506|FG002|NOT COMPLETED|Period 2||0
8999967|NCT02884089|10063507|FG003|NOT COMPLETED|Period 2||0
8999968|NCT02884089|10063504|FG000|STARTED|Washout Period 2||8
8999969|NCT02884089|10063505|FG001|STARTED|Washout Period 2||7
8999970|NCT02884089|10063506|FG002|STARTED|Washout Period 2||9
8999971|NCT02884089|10063507|FG003|STARTED|Washout Period 2||8
8999972|NCT02884089|10063504|FG000|COMPLETED|Washout Period 2||8
8999973|NCT02884089|10063505|FG001|COMPLETED|Washout Period 2||7
8999974|NCT02884089|10063506|FG002|COMPLETED|Washout Period 2||9
8999975|NCT02884089|10063507|FG003|COMPLETED|Washout Period 2||8
8999976|NCT02884089|10063504|FG000|NOT COMPLETED|Washout Period 2||0
8999977|NCT02884089|10063505|FG001|NOT COMPLETED|Washout Period 2||0
8999978|NCT02884089|10063506|FG002|NOT COMPLETED|Washout Period 2||0
8999979|NCT02884089|10063507|FG003|NOT COMPLETED|Washout Period 2||0
8999980|NCT02884089|10063504|FG000|STARTED|Period 3||8
8999981|NCT02884089|10063505|FG001|STARTED|Period 3||7
8999982|NCT02884089|10063506|FG002|STARTED|Period 3||9
8999983|NCT02884089|10063507|FG003|STARTED|Period 3||8
8999984|NCT02884089|10063504|FG000|COMPLETED|Period 3||8
8999985|NCT02884089|10063505|FG001|COMPLETED|Period 3||7
8999986|NCT02884089|10063506|FG002|COMPLETED|Period 3||8
8999987|NCT02884089|10063507|FG003|COMPLETED|Period 3||8
8999988|NCT02884089|10063504|FG000|NOT COMPLETED|Period 3||0
8999989|NCT02884089|10063505|FG001|NOT COMPLETED|Period 3||0
8999990|NCT02884089|10063506|FG002|NOT COMPLETED|Period 3||1
8999991|NCT02884089|10063507|FG003|NOT COMPLETED|Period 3||0
8999992|NCT02884089|10063504|FG000|STARTED|Washout Period 3||8
8999993|NCT02884089|10063505|FG001|STARTED|Washout Period 3||7
8999994|NCT02884089|10063506|FG002|STARTED|Washout Period 3||8
8999995|NCT02884089|10063507|FG003|STARTED|Washout Period 3||8
8999996|NCT02884089|10063504|FG000|COMPLETED|Washout Period 3||8
8999997|NCT02884089|10063505|FG001|COMPLETED|Washout Period 3||7
8999998|NCT02884089|10063506|FG002|COMPLETED|Washout Period 3||7
8999999|NCT02884089|10063507|FG003|COMPLETED|Washout Period 3||7
9000000|NCT02884089|10063504|FG000|NOT COMPLETED|Washout Period 3||0
9000001|NCT02884089|10063505|FG001|NOT COMPLETED|Washout Period 3||0
9000002|NCT02884089|10063506|FG002|NOT COMPLETED|Washout Period 3||1
9000003|NCT02884089|10063507|FG003|NOT COMPLETED|Washout Period 3||1
9000004|NCT02884089|10063504|FG000|STARTED|Period 4||8
9000005|NCT02884089|10063505|FG001|STARTED|Period 4||7
9000006|NCT02884089|10063506|FG002|STARTED|Period 4||7
9000007|NCT02884089|10063507|FG003|STARTED|Period 4||7
9000008|NCT02884089|10063504|FG000|COMPLETED|Period 4||7
9000009|NCT02884089|10063505|FG001|COMPLETED|Period 4||6
9000010|NCT02884089|10063506|FG002|COMPLETED|Period 4||7
9000011|NCT02884089|10063507|FG003|COMPLETED|Period 4||7
9000012|NCT02884089|10063504|FG000|NOT COMPLETED|Period 4||1
9000013|NCT02884089|10063505|FG001|NOT COMPLETED|Period 4||1
8572461|NCT00114738|9604657|FG000|COMPLETED|Bortezomib Then Bortezomib + Induction||51
8572462|NCT00114738|9604658|FG001|COMPLETED|Bortezomib Then Bortezomib + Induction||0
8572463|NCT00114738|9604659|FG002|COMPLETED|Bortezomib Then Bortezomib + Induction||0
8572464|NCT00114738|9604657|FG000|NOT COMPLETED|Bortezomib Then Bortezomib + Induction||2
8572465|NCT00114738|9604658|FG001|NOT COMPLETED|Bortezomib Then Bortezomib + Induction||0
8572466|NCT00114738|9604659|FG002|NOT COMPLETED|Bortezomib Then Bortezomib + Induction||0
8572467|NCT00114738|9604657|FG000|STARTED|Screening for Randomization||51
8572468|NCT00114738|9604658|FG001|STARTED|Screening for Randomization||0
8572469|NCT00114738|9604659|FG002|STARTED|Screening for Randomization||0
8572470|NCT00114738|9604657|FG000|COMPLETED|Screening for Randomization||30
8572471|NCT00114738|9604658|FG001|COMPLETED|Screening for Randomization||0
8572472|NCT00114738|9604659|FG002|COMPLETED|Screening for Randomization||0
8572473|NCT00114738|9604657|FG000|NOT COMPLETED|Screening for Randomization||21
9000014|NCT02884089|10063506|FG002|NOT COMPLETED|Period 4||0
9000015|NCT02884089|10063507|FG003|NOT COMPLETED|Period 4||0
9000016|NCT02884089|10063504|FG000|STARTED|Follow-up Visit||7
9000017|NCT02884089|10063505|FG001|STARTED|Follow-up Visit||6
9000018|NCT02884089|10063506|FG002|STARTED|Follow-up Visit||7
9000019|NCT02884089|10063507|FG003|STARTED|Follow-up Visit||7
9000020|NCT02884089|10063504|FG000|COMPLETED|Follow-up Visit||6
9000021|NCT02884089|10063505|FG001|COMPLETED|Follow-up Visit||6
9000022|NCT02884089|10063506|FG002|COMPLETED|Follow-up Visit||7
9000023|NCT02884089|10063507|FG003|COMPLETED|Follow-up Visit||6
9000024|NCT02884089|10063504|FG000|NOT COMPLETED|Follow-up Visit||1
9000025|NCT02884089|10063505|FG001|NOT COMPLETED|Follow-up Visit||0
9000026|NCT02884089|10063506|FG002|NOT COMPLETED|Follow-up Visit||0
9000027|NCT02884089|10063507|FG003|NOT COMPLETED|Follow-up Visit||1
9000028|NCT02884414|10063517|FG000|STARTED|Overall Study||56
9000029|NCT02884414|10063517|FG000|COMPLETED|Overall Study||56
9000030|NCT02884414|10063517|FG000|NOT COMPLETED|Overall Study||0
9000031|NCT02884427|10063524|FG000|STARTED|Overall Study||48
9000032|NCT02884427|10063525|FG001|STARTED|Overall Study||52
9000033|NCT02884427|10063526|FG002|STARTED|Overall Study||50
9000034|NCT02884427|10063524|FG000|COMPLETED|Overall Study||48
9000035|NCT02884427|10063525|FG001|COMPLETED|Overall Study||52
9000036|NCT02884427|10063526|FG002|COMPLETED|Overall Study||50
9000037|NCT02884427|10063524|FG000|NOT COMPLETED|Overall Study||0
9000038|NCT02884427|10063525|FG001|NOT COMPLETED|Overall Study||0
9000039|NCT02884427|10063526|FG002|NOT COMPLETED|Overall Study||0
9000040|NCT02884492|10063536|FG000|STARTED|Overall Study||7
9000041|NCT02884492|10063537|FG001|STARTED|Overall Study||10
9000042|NCT02884492|10063536|FG000|COMPLETED|Overall Study||7
9000043|NCT02884492|10063537|FG001|COMPLETED|Overall Study||10
9000044|NCT02884492|10063536|FG000|NOT COMPLETED|Overall Study||0
9000045|NCT02884492|10063537|FG001|NOT COMPLETED|Overall Study||0
9000046|NCT02885012|10063545|FG000|STARTED|Overall Study||1
9000047|NCT02885012|10063546|FG001|STARTED|Overall Study||2
9000048|NCT02885012|10063545|FG000|COMPLETED|Overall Study||1
9000049|NCT02885012|10063546|FG001|COMPLETED|Overall Study||2
9000050|NCT02885012|10063545|FG000|NOT COMPLETED|Overall Study||0
9000051|NCT02885012|10063546|FG001|NOT COMPLETED|Overall Study||0
9000052|NCT02885025|10063556|FG000|STARTED|Overall Study||16
9000053|NCT02885025|10063557|FG001|STARTED|Overall Study||14
9000054|NCT02885025|10063558|FG002|STARTED|Overall Study||9
9000055|NCT02885025|10063559|FG003|STARTED|Overall Study||8
9000056|NCT02885025|10063556|FG000|COMPLETED|Overall Study||16
9000057|NCT02885025|10063557|FG001|COMPLETED|Overall Study||12
9000058|NCT02885025|10063558|FG002|COMPLETED|Overall Study||9
9000059|NCT02885025|10063559|FG003|COMPLETED|Overall Study||8
9000060|NCT02885025|10063556|FG000|NOT COMPLETED|Overall Study||0
9000061|NCT02885025|10063557|FG001|NOT COMPLETED|Overall Study||2
9000062|NCT02885025|10063558|FG002|NOT COMPLETED|Overall Study||0
9000063|NCT02885025|10063559|FG003|NOT COMPLETED|Overall Study||0
9000064|NCT02885181|10063577|FG000|STARTED|Overall Study||20
9000065|NCT02885181|10063578|FG001|STARTED|Overall Study||20
9000066|NCT02885181|10063579|FG002|STARTED|Overall Study||21
9000067|NCT02885181|10063580|FG003|STARTED|Overall Study||22
9000068|NCT02885181|10063577|FG000|COMPLETED|Overall Study||20
9000069|NCT02885181|10063578|FG001|COMPLETED|Overall Study||19
9000070|NCT02885181|10063579|FG002|COMPLETED|Overall Study||21
9000071|NCT02885181|10063580|FG003|COMPLETED|Overall Study||19
9000072|NCT02885181|10063577|FG000|NOT COMPLETED|Overall Study||0
9000073|NCT02885181|10063578|FG001|NOT COMPLETED|Overall Study||1
9000074|NCT02885181|10063579|FG002|NOT COMPLETED|Overall Study||0
9000075|NCT02885181|10063580|FG003|NOT COMPLETED|Overall Study||3
9000076|NCT02885246|10063594|FG000|STARTED|Overall Study||1839
9000077|NCT02885246|10063594|FG000|COMPLETED|Overall Study||1839
9000078|NCT02885246|10063594|FG000|NOT COMPLETED|Overall Study||0
9000079|NCT02885350|10063602|FG000|STARTED|Overall Study||20
9000080|NCT02885350|10063603|FG001|STARTED|Overall Study||20
9000081|NCT02885350|10063604|FG002|STARTED|Overall Study||20
9000082|NCT02885350|10063605|FG003|STARTED|Overall Study||20
9000083|NCT02885350|10063602|FG000|COMPLETED|Overall Study||20
9000084|NCT02885350|10063603|FG001|COMPLETED|Overall Study||20
9000085|NCT02885350|10063604|FG002|COMPLETED|Overall Study||20
9000086|NCT02885350|10063605|FG003|COMPLETED|Overall Study||20
8633934|NCT00553631|9674178|FG000|COMPLETED|Overall Study||16
8633935|NCT00553631|9674179|FG001|COMPLETED|Overall Study||16
8879490|NCT01933789|9936221|FG007|Had Target Visit|Overall Study||0
8879491|NCT01933789|9936222|FG008|Had Target Visit|Overall Study||0
8879492|NCT01933789|9936214|FG000|Completed After-visit Survey|Overall Study|Number reflects individual clinicians who returned surveys for up to 6 enrolled patients|57
8879493|NCT01933789|9936215|FG001|Completed After-visit Survey|Overall Study|Number reflects individual clinicians who returned surveys for up to 6 enrolled patients|64
8879494|NCT01933789|9936216|FG002|Completed After-visit Survey|Overall Study|Number reflects individual IP Team members who returned surveys for up to 6 enrolled patients|2
8879495|NCT01933789|9936217|FG003|Completed After-visit Survey|Overall Study|Number reflects individual IP Team members who returned surveys for up to 6 enrolled patients|1
9000087|NCT02885350|10063602|FG000|NOT COMPLETED|Overall Study||0
9000088|NCT02885350|10063603|FG001|NOT COMPLETED|Overall Study||0
9000089|NCT02885350|10063604|FG002|NOT COMPLETED|Overall Study||0
9000090|NCT02885350|10063605|FG003|NOT COMPLETED|Overall Study||0
9000091|NCT02885506|10063625|FG000|STARTED|Part A||6
9000092|NCT02885506|10063626|FG001|STARTED|Part A||6
9000093|NCT02885506|10063627|FG002|STARTED|Part A||6
9000094|NCT02885506|10063628|FG003|STARTED|Part A||6
9000095|NCT02885506|10063629|FG004|STARTED|Part A||6
9000096|NCT02885506|10063630|FG005|STARTED|Part A||6
9000097|NCT02885506|10063631|FG006|STARTED|Part A||6
9000098|NCT02885506|10063632|FG007|STARTED|Part A||14
9000099|NCT02885506|10063633|FG008|STARTED|Part A||0
9000100|NCT02885506|10063634|FG009|STARTED|Part A||0
9000101|NCT02885506|10063625|FG000|COMPLETED|Part A||6
9000102|NCT02885506|10063626|FG001|COMPLETED|Part A||6
9000103|NCT02885506|10063627|FG002|COMPLETED|Part A||6
9000104|NCT02885506|10063628|FG003|COMPLETED|Part A||6
9000105|NCT02885506|10063629|FG004|COMPLETED|Part A||6
9000106|NCT02885506|10063630|FG005|COMPLETED|Part A||6
9000107|NCT02885506|10063631|FG006|COMPLETED|Part A||6
8633936|NCT00553631|9674178|FG000|NOT COMPLETED|Overall Study||1
9000108|NCT02885506|10063632|FG007|COMPLETED|Part A||14
9000109|NCT02885506|10063633|FG008|COMPLETED|Part A||0
9000110|NCT02885506|10063634|FG009|COMPLETED|Part A||0
9000111|NCT02885506|10063625|FG000|NOT COMPLETED|Part A||0
9000112|NCT02885506|10063626|FG001|NOT COMPLETED|Part A||0
9000113|NCT02885506|10063627|FG002|NOT COMPLETED|Part A||0
9000114|NCT02885506|10063628|FG003|NOT COMPLETED|Part A||0
9000115|NCT02885506|10063629|FG004|NOT COMPLETED|Part A||0
9000116|NCT02885506|10063630|FG005|NOT COMPLETED|Part A||0
9000117|NCT02885506|10063631|FG006|NOT COMPLETED|Part A||0
9000118|NCT02885506|10063632|FG007|NOT COMPLETED|Part A||0
9000119|NCT02885506|10063633|FG008|NOT COMPLETED|Part A||0
9000120|NCT02885506|10063634|FG009|NOT COMPLETED|Part A||0
9000121|NCT02885506|10063625|FG000|STARTED|Part B||0
9000122|NCT02885506|10063626|FG001|STARTED|Part B||0
9000123|NCT02885506|10063627|FG002|STARTED|Part B||0
9000124|NCT02885506|10063628|FG003|STARTED|Part B||0
9000125|NCT02885506|10063629|FG004|STARTED|Part B||0
9000126|NCT02885506|10063630|FG005|STARTED|Part B||0
9000127|NCT02885506|10063631|FG006|STARTED|Part B||0
9000128|NCT02885506|10063632|FG007|STARTED|Part B||0
9000129|NCT02885506|10063633|FG008|STARTED|Part B||4
9000130|NCT02885506|10063634|FG009|STARTED|Part B||4
9000131|NCT02885506|10063625|FG000|COMPLETED|Part B||0
9000132|NCT02885506|10063626|FG001|COMPLETED|Part B||0
9000133|NCT02885506|10063627|FG002|COMPLETED|Part B||0
9000134|NCT02885506|10063628|FG003|COMPLETED|Part B||0
9000135|NCT02885506|10063629|FG004|COMPLETED|Part B||0
9000136|NCT02885506|10063630|FG005|COMPLETED|Part B||0
9000137|NCT02885506|10063631|FG006|COMPLETED|Part B||0
9000138|NCT02885506|10063632|FG007|COMPLETED|Part B||0
9000139|NCT02885506|10063633|FG008|COMPLETED|Part B||4
9000140|NCT02885506|10063634|FG009|COMPLETED|Part B||4
9000141|NCT02885506|10063625|FG000|NOT COMPLETED|Part B||0
9000142|NCT02885506|10063626|FG001|NOT COMPLETED|Part B||0
9000143|NCT02885506|10063627|FG002|NOT COMPLETED|Part B||0
9000144|NCT02885506|10063628|FG003|NOT COMPLETED|Part B||0
8725913|NCT01033487|9773160|FG003|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
8725914|NCT01033487|9773161|FG004|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
8725915|NCT01033487|9773162|FG005|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
8725916|NCT01033487|9773163|FG006|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
8725917|NCT01033487|9773164|FG007|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
8725918|NCT01033487|9773165|FG008|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
8725919|NCT01033487|9773166|FG009|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
8725920|NCT01033487|9773157|FG000|STARTED|Third Intervention Period||2
8725921|NCT01033487|9773158|FG001|STARTED|Third Intervention Period||3
8725922|NCT01033487|9773159|FG002|STARTED|Third Intervention Period||2
8725923|NCT01033487|9773160|FG003|STARTED|Third Intervention Period||2
9000145|NCT02885506|10063629|FG004|NOT COMPLETED|Part B||0
9000146|NCT02885506|10063630|FG005|NOT COMPLETED|Part B||0
9000147|NCT02885506|10063631|FG006|NOT COMPLETED|Part B||0
9000148|NCT02885506|10063632|FG007|NOT COMPLETED|Part B||0
9000149|NCT02885506|10063633|FG008|NOT COMPLETED|Part B||0
9000150|NCT02885506|10063634|FG009|NOT COMPLETED|Part B||0
9000151|NCT02885636|10063660|FG000|STARTED|Overall Study||15
9000152|NCT02885636|10063661|FG001|STARTED|Overall Study||15
9000153|NCT02885636|10063660|FG000|COMPLETED|Overall Study||15
9000154|NCT02885636|10063661|FG001|COMPLETED|Overall Study||15
9000155|NCT02885636|10063660|FG000|NOT COMPLETED|Overall Study||0
9000156|NCT02885636|10063661|FG001|NOT COMPLETED|Overall Study||0
9039377|NCT03338062|10100324|FG001|STARTED|Overall Study||5
9039378|NCT03338062|10100323|FG000|COMPLETED|Overall Study||9
9039379|NCT03338062|10100324|FG001|COMPLETED|Overall Study||5
9039380|NCT03338062|10100323|FG000|NOT COMPLETED|Overall Study||1
9039381|NCT03338062|10100324|FG001|NOT COMPLETED|Overall Study||0
9039382|NCT03338296|10100333|FG000|STARTED|Overall Study||139
9039383|NCT03338296|10100334|FG001|STARTED|Overall Study||139
9039384|NCT03338296|10100333|FG000|Safety Analysis Set|Overall Study||139
9039385|NCT03338296|10100334|FG001|Safety Analysis Set|Overall Study||136
9039386|NCT03338296|10100333|FG000|COMPLETED|Overall Study||36
9039387|NCT03338296|10100334|FG001|COMPLETED|Overall Study||31
9039388|NCT03338296|10100333|FG000|NOT COMPLETED|Overall Study||103
9039389|NCT03338296|10100334|FG001|NOT COMPLETED|Overall Study||108
9039390|NCT03338400|10100342|FG000|STARTED|Overall Study||25
9039391|NCT03338400|10100343|FG001|STARTED|Overall Study||26
9039392|NCT03338400|10100342|FG000|COMPLETED|Overall Study||24
9039393|NCT03338400|10100343|FG001|COMPLETED|Overall Study||24
9039394|NCT03338400|10100342|FG000|NOT COMPLETED|Overall Study||1
9000157|NCT02886234|10063669|FG000|STARTED|Overall Study||20
9000158|NCT02886234|10063670|FG001|STARTED|Overall Study||24
9000159|NCT02886234|10063669|FG000|COMPLETED|Overall Study||20
9000160|NCT02886234|10063670|FG001|COMPLETED|Overall Study||22
9000161|NCT02886234|10063669|FG000|NOT COMPLETED|Overall Study||0
9000162|NCT02886234|10063670|FG001|NOT COMPLETED|Overall Study||2
9000163|NCT02886338|10063676|FG000|STARTED|Overall Study||10
9000164|NCT02886338|10063676|FG000|COMPLETED|Overall Study||9
9000165|NCT02886338|10063676|FG000|NOT COMPLETED|Overall Study||1
9000166|NCT02886494|10063682|FG000|STARTED|Overall Study||60
9000167|NCT02886494|10063683|FG001|STARTED|Overall Study||20
9000168|NCT02886494|10063682|FG000|COMPLETED|Overall Study||43
9000169|NCT02886494|10063683|FG001|COMPLETED|Overall Study||16
9000170|NCT02886494|10063682|FG000|NOT COMPLETED|Overall Study||17
9000171|NCT02886494|10063683|FG001|NOT COMPLETED|Overall Study||4
9000172|NCT02886624|10063692|FG000|STARTED|8-week Treatment||30
9000173|NCT02886624|10063692|FG000|COMPLETED|8-week Treatment||30
9000174|NCT02886624|10063692|FG000|NOT COMPLETED|8-week Treatment||0
9000175|NCT02886624|10063692|FG000|STARTED|12-week Post Treatment Follow-up||30
9000176|NCT02886624|10063692|FG000|COMPLETED|12-week Post Treatment Follow-up||29
9000177|NCT02886624|10063692|FG000|NOT COMPLETED|12-week Post Treatment Follow-up||1
9000178|NCT02886624|10063692|FG000|STARTED|48-week Post Treatment Follow-up||29
9000179|NCT02886624|10063692|FG000|COMPLETED|48-week Post Treatment Follow-up||28
9000180|NCT02886624|10063692|FG000|NOT COMPLETED|48-week Post Treatment Follow-up||1
8879496|NCT01933789|9936218|FG004|Completed After-visit Survey|Overall Study||0
8879497|NCT01933789|9936219|FG005|Completed After-visit Survey|Overall Study||0
8879498|NCT01933789|9936220|FG006|Completed After-visit Survey|Overall Study||0
8879499|NCT01933789|9936221|FG007|Completed After-visit Survey|Overall Study||0
8879500|NCT01933789|9936222|FG008|Completed After-visit Survey|Overall Study||0
8879501|NCT01933789|9936214|FG000|Completed 2-Week Survey|Overall Study||0
8879502|NCT01933789|9936215|FG001|Completed 2-Week Survey|Overall Study||0
8879503|NCT01933789|9936216|FG002|Completed 2-Week Survey|Overall Study||0
8879504|NCT01933789|9936217|FG003|Completed 2-Week Survey|Overall Study||0
8879505|NCT01933789|9936218|FG004|Completed 2-Week Survey|Overall Study||184
9000181|NCT02886702|10063699|FG000|STARTED|Overall Study||284
9000182|NCT02886702|10063700|FG001|STARTED|Overall Study||286
9000183|NCT02886702|10063701|FG002|STARTED|Overall Study||285
9000184|NCT02886702|10063699|FG000|Modified Intent-to Treat (mITT)|Overall Study||263
9000185|NCT02886702|10063700|FG001|Modified Intent-to Treat (mITT)|Overall Study||266
9000186|NCT02886702|10063701|FG002|Modified Intent-to Treat (mITT)|Overall Study||275
9000187|NCT02886702|10063699|FG000|Per-Protocol Population (PP)|Overall Study||208
9000188|NCT02886702|10063700|FG001|Per-Protocol Population (PP)|Overall Study||209
9000189|NCT02886702|10063701|FG002|Per-Protocol Population (PP)|Overall Study||201
9000190|NCT02886702|10063699|FG000|COMPLETED|Overall Study||236
9000191|NCT02886702|10063700|FG001|COMPLETED|Overall Study||235
9000192|NCT02886702|10063701|FG002|COMPLETED|Overall Study||232
9000193|NCT02886702|10063699|FG000|NOT COMPLETED|Overall Study||48
9000194|NCT02886702|10063700|FG001|NOT COMPLETED|Overall Study||51
9000195|NCT02886702|10063701|FG002|NOT COMPLETED|Overall Study||53
9000196|NCT02886715|10063712|FG000|STARTED|Overall Study||442
9000197|NCT02886715|10063713|FG001|STARTED|Overall Study||445
9000198|NCT02886715|10063714|FG002|STARTED|Overall Study||223
9000199|NCT02886715|10063712|FG000|Modified ITT (mITT)|Overall Study||421
9000200|NCT02886715|10063713|FG001|Modified ITT (mITT)|Overall Study||418
9000201|NCT02886715|10063714|FG002|Modified ITT (mITT)|Overall Study||217
9000202|NCT02886715|10063712|FG000|Per Protocol (PP) Population|Overall Study||346
9000203|NCT02886715|10063713|FG001|Per Protocol (PP) Population|Overall Study||351
9000204|NCT02886715|10063714|FG002|Per Protocol (PP) Population|Overall Study||176
9000205|NCT02886715|10063712|FG000|COMPLETED|Overall Study||378
9000206|NCT02886715|10063713|FG001|COMPLETED|Overall Study||390
9000207|NCT02886715|10063714|FG002|COMPLETED|Overall Study||203
9000208|NCT02886715|10063712|FG000|NOT COMPLETED|Overall Study||64
9000209|NCT02886715|10063713|FG001|NOT COMPLETED|Overall Study||55
9000210|NCT02886715|10063714|FG002|NOT COMPLETED|Overall Study||20
9000211|NCT02886728|10063726|FG000|STARTED|Overall Study||417
9000212|NCT02886728|10063727|FG001|STARTED|Overall Study||207
9000213|NCT02886728|10063728|FG002|STARTED|Overall Study||210
9000214|NCT02886728|10063729|FG003|STARTED|Overall Study||418
9000215|NCT02886728|10063726|FG000|COMPLETED|Overall Study||345
9000216|NCT02886728|10063727|FG001|COMPLETED|Overall Study||175
9000217|NCT02886728|10063728|FG002|COMPLETED|Overall Study||174
9000218|NCT02886728|10063729|FG003|COMPLETED|Overall Study||331
9000219|NCT02886728|10063726|FG000|NOT COMPLETED|Overall Study||72
9000220|NCT02886728|10063727|FG001|NOT COMPLETED|Overall Study||32
9000221|NCT02886728|10063728|FG002|NOT COMPLETED|Overall Study||36
9000222|NCT02886728|10063729|FG003|NOT COMPLETED|Overall Study||87
9000223|NCT02886923|10063739|FG000|STARTED|Period 1||12
9000224|NCT02886923|10063740|FG001|STARTED|Period 1||11
9000225|NCT02886923|10063739|FG000|COMPLETED|Period 1||12
9000226|NCT02886923|10063740|FG001|COMPLETED|Period 1||11
9000227|NCT02886923|10063739|FG000|NOT COMPLETED|Period 1||0
9000228|NCT02886923|10063740|FG001|NOT COMPLETED|Period 1||0
9000229|NCT02886923|10063739|FG000|STARTED|Period 2||12
9000230|NCT02886923|10063740|FG001|STARTED|Period 2||11
9000231|NCT02886923|10063739|FG000|COMPLETED|Period 2||12
9000232|NCT02886923|10063740|FG001|COMPLETED|Period 2||11
9000233|NCT02886923|10063739|FG000|NOT COMPLETED|Period 2||0
8879506|NCT01933789|9936219|FG005|Completed 2-Week Survey|Overall Study||215
8879507|NCT01933789|9936220|FG006|Completed 2-Week Survey|Overall Study||0
8879508|NCT01933789|9936221|FG007|Completed 2-Week Survey|Overall Study||0
8879509|NCT01933789|9936222|FG008|Completed 2-Week Survey|Overall Study||0
8879510|NCT01933789|9936214|FG000|Completed 3-Month Survey|Overall Study||0
8879511|NCT01933789|9936215|FG001|Completed 3-Month Survey|Overall Study||0
8879512|NCT01933789|9936216|FG002|Completed 3-Month Survey|Overall Study||0
8879513|NCT01933789|9936217|FG003|Completed 3-Month Survey|Overall Study||0
8879514|NCT01933789|9936218|FG004|Completed 3-Month Survey|Overall Study||176
8879515|NCT01933789|9936219|FG005|Completed 3-Month Survey|Overall Study||211
8879516|NCT01933789|9936220|FG006|Completed 3-Month Survey|Overall Study||37
8879517|NCT01933789|9936221|FG007|Completed 3-Month Survey|Overall Study||43
8879518|NCT01933789|9936222|FG008|Completed 3-Month Survey|Overall Study||0
8879519|NCT01933789|9936214|FG000|Completed 6-Month Survey|Overall Study||0
8879520|NCT01933789|9936215|FG001|Completed 6-Month Survey|Overall Study||0
8879521|NCT01933789|9936216|FG002|Completed 6-Month Survey|Overall Study||0
9000234|NCT02886923|10063740|FG001|NOT COMPLETED|Period 2||0
9000235|NCT02887183|10063746|FG000|STARTED|Overall Study||795
9000236|NCT02887183|10063746|FG000|Full Analysis Set|Overall Study||794
9000237|NCT02887183|10063746|FG000|COMPLETED|Overall Study||654
9000238|NCT02887183|10063746|FG000|NOT COMPLETED|Overall Study||141
9000239|NCT02887404|10063752|FG000|STARTED|Overall Study||150
9000240|NCT02887404|10063753|FG001|STARTED|Overall Study||149
9000241|NCT02887404|10063752|FG000|COMPLETED|Overall Study||150
9000242|NCT02887404|10063753|FG001|COMPLETED|Overall Study||149
9000243|NCT02887404|10063752|FG000|NOT COMPLETED|Overall Study||0
9000244|NCT02887404|10063753|FG001|NOT COMPLETED|Overall Study||0
9000245|NCT02887521|10063762|FG000|STARTED|Overall Study||4
9000246|NCT02887521|10063763|FG001|STARTED|Overall Study||5
9000247|NCT02887521|10063762|FG000|COMPLETED|Overall Study||4
9000248|NCT02887521|10063763|FG001|COMPLETED|Overall Study||2
9000249|NCT02887521|10063762|FG000|NOT COMPLETED|Overall Study||0
9000250|NCT02887521|10063763|FG001|NOT COMPLETED|Overall Study||3
8879522|NCT01933789|9936217|FG003|Completed 6-Month Survey|Overall Study||0
8879523|NCT01933789|9936218|FG004|Completed 6-Month Survey|Overall Study||160
8879524|NCT01933789|9936219|FG005|Completed 6-Month Survey|Overall Study||188
9000251|NCT02887989|10063771|FG000|STARTED|Overall Study||70
9000252|NCT02887989|10063772|FG001|STARTED|Overall Study||70
9000253|NCT02887989|10063771|FG000|COMPLETED|Overall Study||61
9000254|NCT02887989|10063772|FG001|COMPLETED|Overall Study||59
9000255|NCT02887989|10063771|FG000|NOT COMPLETED|Overall Study||9
9000256|NCT02887989|10063772|FG001|NOT COMPLETED|Overall Study||11
9000257|NCT02888080|10063780|FG000|STARTED|Overall Study||20
9000258|NCT02888080|10063781|FG001|STARTED|Overall Study||20
9000259|NCT02888080|10063780|FG000|COMPLETED|Overall Study||18
9000260|NCT02888080|10063781|FG001|COMPLETED|Overall Study||15
9000261|NCT02888080|10063780|FG000|NOT COMPLETED|Overall Study||2
9000262|NCT02888080|10063781|FG001|NOT COMPLETED|Overall Study||5
9000263|NCT02888093|10063789|FG000|STARTED|Overall Study||22
9000264|NCT02888093|10063790|FG001|STARTED|Overall Study||22
9000265|NCT02888093|10063789|FG000|COMPLETED|Overall Study||20
9000266|NCT02888093|10063790|FG001|COMPLETED|Overall Study||20
9000267|NCT02888093|10063789|FG000|NOT COMPLETED|Overall Study||2
9000268|NCT02888093|10063790|FG001|NOT COMPLETED|Overall Study||2
9000269|NCT02888106|10063804|FG000|STARTED|Overall Study||15
9000270|NCT02888106|10063805|FG001|STARTED|Overall Study||15
9000271|NCT02888106|10063806|FG002|STARTED|Overall Study||15
9000272|NCT02888106|10063807|FG003|STARTED|Overall Study||15
9000273|NCT02888106|10063808|FG004|STARTED|Overall Study||15
9000274|NCT02888106|10063809|FG005|STARTED|Overall Study||15
9000275|NCT02888106|10063804|FG000|COMPLETED|Overall Study||10
9000276|NCT02888106|10063805|FG001|COMPLETED|Overall Study||13
9000277|NCT02888106|10063806|FG002|COMPLETED|Overall Study||15
9000278|NCT02888106|10063807|FG003|COMPLETED|Overall Study||13
9000279|NCT02888106|10063808|FG004|COMPLETED|Overall Study||14
9000280|NCT02888106|10063809|FG005|COMPLETED|Overall Study||14
9000281|NCT02888106|10063804|FG000|NOT COMPLETED|Overall Study||5
9000282|NCT02888106|10063805|FG001|NOT COMPLETED|Overall Study||2
9000283|NCT02888106|10063806|FG002|NOT COMPLETED|Overall Study||0
9000284|NCT02888106|10063807|FG003|NOT COMPLETED|Overall Study||2
9000285|NCT02888106|10063808|FG004|NOT COMPLETED|Overall Study||1
9000286|NCT02888106|10063809|FG005|NOT COMPLETED|Overall Study||1
9000287|NCT02888171|10063831|FG000|STARTED|Overall Study||30
9000288|NCT02888171|10063832|FG001|STARTED|Overall Study||30
8633937|NCT00553631|9674179|FG001|NOT COMPLETED|Overall Study||1
8633938|NCT00553644|9674185|FG000|STARTED|Overall Study||53
8633939|NCT00553644|9674185|FG000|COMPLETED|Overall Study||25
8633940|NCT00553644|9674185|FG000|NOT COMPLETED|Overall Study||28
8633941|NCT00553696|9674193|FG000|STARTED|Overall Study||4
8633942|NCT00553696|9674194|FG001|STARTED|Overall Study||16
8633943|NCT00553696|9674195|FG002|STARTED|Overall Study||6
8633944|NCT00553696|9674196|FG003|STARTED|Overall Study||1
8633945|NCT00553696|9674193|FG000|COMPLETED|Overall Study||0
8879525|NCT01933789|9936220|FG006|Completed 6-Month Survey|Overall Study||35
8879526|NCT01933789|9936221|FG007|Completed 6-Month Survey|Overall Study||40
8879527|NCT01933789|9936222|FG008|Completed 6-Month Survey|Overall Study||0
8879528|NCT01933789|9936214|FG000|Qualitative Interviews|Overall Study||0
8879529|NCT01933789|9936215|FG001|Qualitative Interviews|Overall Study||0
8879530|NCT01933789|9936216|FG002|Qualitative Interviews|Overall Study||0
8879531|NCT01933789|9936217|FG003|Qualitative Interviews|Overall Study||0
8879532|NCT01933789|9936218|FG004|Qualitative Interviews|Overall Study||0
8879533|NCT01933789|9936219|FG005|Qualitative Interviews|Overall Study||0
8879534|NCT01933789|9936220|FG006|Qualitative Interviews|Overall Study||0
8879535|NCT01933789|9936221|FG007|Qualitative Interviews|Overall Study||0
8879536|NCT01933789|9936222|FG008|Qualitative Interviews|Overall Study||25
8879537|NCT01933789|9936214|FG000|COMPLETED|Overall Study||59
8879538|NCT01933789|9936215|FG001|COMPLETED|Overall Study||66
8879539|NCT01933789|9936216|FG002|COMPLETED|Overall Study||2
8879540|NCT01933789|9936217|FG003|COMPLETED|Overall Study||1
8879541|NCT01933789|9936218|FG004|COMPLETED|Overall Study||190
8879542|NCT01933789|9936219|FG005|COMPLETED|Overall Study||221
8879543|NCT01933789|9936220|FG006|COMPLETED|Overall Study||43
8879544|NCT01933789|9936221|FG007|COMPLETED|Overall Study||47
8879545|NCT01933789|9936222|FG008|COMPLETED|Overall Study||25
8879546|NCT01933789|9936214|FG000|NOT COMPLETED|Overall Study||6
8879547|NCT01933789|9936215|FG001|NOT COMPLETED|Overall Study||1
8879548|NCT01933789|9936216|FG002|NOT COMPLETED|Overall Study||0
8879549|NCT01933789|9936217|FG003|NOT COMPLETED|Overall Study||1
8879550|NCT01933789|9936218|FG004|NOT COMPLETED|Overall Study||59
8879551|NCT01933789|9936219|FG005|NOT COMPLETED|Overall Study||67
9000289|NCT02888171|10063831|FG000|COMPLETED|Overall Study||25
9000290|NCT02888171|10063832|FG001|COMPLETED|Overall Study||26
9000291|NCT02888171|10063831|FG000|NOT COMPLETED|Overall Study||5
9000292|NCT02888171|10063832|FG001|NOT COMPLETED|Overall Study||4
9000293|NCT02888665|10063841|FG000|STARTED|Overall Study||3
9000294|NCT02888665|10063842|FG001|STARTED|Overall Study||3
9000295|NCT02888665|10063843|FG002|STARTED|Overall Study||31
9000296|NCT02888665|10063841|FG000|COMPLETED|Overall Study||3
9000297|NCT02888665|10063842|FG001|COMPLETED|Overall Study||3
9000298|NCT02888665|10063843|FG002|COMPLETED|Overall Study||31
9000299|NCT02888665|10063841|FG000|NOT COMPLETED|Overall Study||0
9000300|NCT02888665|10063842|FG001|NOT COMPLETED|Overall Study||0
9000301|NCT02888665|10063843|FG002|NOT COMPLETED|Overall Study||0
9000302|NCT02888691|10063852|FG000|STARTED|First Intervention Period||7
9000303|NCT02888691|10063853|FG001|STARTED|First Intervention Period||7
8633946|NCT00553696|9674194|FG001|COMPLETED|Overall Study||0
8633947|NCT00553696|9674195|FG002|COMPLETED|Overall Study||0
9000304|NCT02888691|10063852|FG000|COMPLETED|First Intervention Period||6
9000305|NCT02888691|10063853|FG001|COMPLETED|First Intervention Period||7
9000306|NCT02888691|10063852|FG000|NOT COMPLETED|First Intervention Period||1
9000307|NCT02888691|10063853|FG001|NOT COMPLETED|First Intervention Period||0
9000308|NCT02888691|10063852|FG000|STARTED|Second Intervention Period|This is a cross-over study. Therefore starters does not necessarily equal completers of period 1.|7
9000309|NCT02888691|10063853|FG001|STARTED|Second Intervention Period||5
9000310|NCT02888691|10063852|FG000|COMPLETED|Second Intervention Period||7
9000311|NCT02888691|10063853|FG001|COMPLETED|Second Intervention Period||3
9000312|NCT02888691|10063852|FG000|NOT COMPLETED|Second Intervention Period||0
9000313|NCT02888691|10063853|FG001|NOT COMPLETED|Second Intervention Period||2
9000314|NCT02888756|10063862|FG000|STARTED|Vaccination Period||16
9000315|NCT02888756|10063863|FG001|STARTED|Vaccination Period||9
9000316|NCT02888756|10063864|FG002|STARTED|Vaccination Period||8
9000317|NCT02888756|10063862|FG000|COMPLETED|Vaccination Period||16
9000318|NCT02888756|10063863|FG001|COMPLETED|Vaccination Period||9
9000319|NCT02888756|10063864|FG002|COMPLETED|Vaccination Period||8
9000320|NCT02888756|10063862|FG000|NOT COMPLETED|Vaccination Period||0
9000321|NCT02888756|10063863|FG001|NOT COMPLETED|Vaccination Period||0
9000322|NCT02888756|10063864|FG002|NOT COMPLETED|Vaccination Period||0
9000323|NCT02888756|10063862|FG000|STARTED|Analytical Treatment Interruption||15
9000324|NCT02888756|10063863|FG001|STARTED|Analytical Treatment Interruption||9
9000325|NCT02888756|10063864|FG002|STARTED|Analytical Treatment Interruption||8
9000326|NCT02888756|10063862|FG000|COMPLETED|Analytical Treatment Interruption||5
9000327|NCT02888756|10063863|FG001|COMPLETED|Analytical Treatment Interruption||3
9000328|NCT02888756|10063864|FG002|COMPLETED|Analytical Treatment Interruption||3
9000329|NCT02888756|10063862|FG000|NOT COMPLETED|Analytical Treatment Interruption||10
9000330|NCT02888756|10063863|FG001|NOT COMPLETED|Analytical Treatment Interruption||6
9000331|NCT02888756|10063864|FG002|NOT COMPLETED|Analytical Treatment Interruption||5
9000332|NCT02889289|10063872|FG000|STARTED|Overall Study||1
9000333|NCT02889289|10063872|FG000|COMPLETED|Overall Study||1
9000334|NCT02889289|10063872|FG000|NOT COMPLETED|Overall Study||0
9000335|NCT02889393|10063878|FG000|STARTED|Overall Study||3
9000336|NCT02889393|10063879|FG001|STARTED|Overall Study||3
9000337|NCT02889393|10063878|FG000|COMPLETED|Overall Study||3
9000338|NCT02889393|10063879|FG001|COMPLETED|Overall Study||3
9000339|NCT02889393|10063878|FG000|NOT COMPLETED|Overall Study||0
9000340|NCT02889393|10063879|FG001|NOT COMPLETED|Overall Study||0
9000341|NCT02889510|10063886|FG000|STARTED|Overall Study||35
9000342|NCT02889510|10063887|FG001|STARTED|Overall Study||37
9000343|NCT02889510|10063886|FG000|COMPLETED|Overall Study||27
9000344|NCT02889510|10063887|FG001|COMPLETED|Overall Study||32
9000345|NCT02889510|10063886|FG000|NOT COMPLETED|Overall Study||8
9000346|NCT02889510|10063887|FG001|NOT COMPLETED|Overall Study||5
9000347|NCT02889562|10063895|FG000|STARTED|Overall Study||28
9000348|NCT02889562|10063896|FG001|STARTED|Overall Study||28
9000349|NCT02889562|10063895|FG000|COMPLETED|Overall Study||28
9000350|NCT02889562|10063896|FG001|COMPLETED|Overall Study||26
9000351|NCT02889562|10063895|FG000|NOT COMPLETED|Overall Study||0
9000352|NCT02889562|10063896|FG001|NOT COMPLETED|Overall Study||2
9000353|NCT02889796|10063906|FG000|STARTED|Overall Study||477
9000354|NCT02889796|10063907|FG001|STARTED|Overall Study||480
9000355|NCT02889796|10063908|FG002|STARTED|Overall Study||325
9000356|NCT02889796|10063909|FG003|STARTED|Overall Study||190
9000357|NCT02889796|10063910|FG004|STARTED|Overall Study||191
9000358|NCT02889796|10063911|FG005|STARTED|Overall Study||96
9000359|NCT02889796|10063906|FG000|COMPLETED|Overall Study||424
9000360|NCT02889796|10063907|FG001|COMPLETED|Overall Study||422
9000361|NCT02889796|10063908|FG002|COMPLETED|Overall Study||281
9000362|NCT02889796|10063909|FG003|COMPLETED|Overall Study||181
9000363|NCT02889796|10063910|FG004|COMPLETED|Overall Study||185
9000364|NCT02889796|10063911|FG005|COMPLETED|Overall Study|Completed 24 weeks of placebo treatment and not rerandomized to Filgotinib 200 mg or 100 mg groups|24
8633948|NCT00553696|9674196|FG003|COMPLETED|Overall Study||0
8633949|NCT00553696|9674193|FG000|NOT COMPLETED|Overall Study||4
8633950|NCT00553696|9674194|FG001|NOT COMPLETED|Overall Study||16
8633951|NCT00553696|9674195|FG002|NOT COMPLETED|Overall Study||6
8633952|NCT00553696|9674196|FG003|NOT COMPLETED|Overall Study||1
9000365|NCT02889796|10063906|FG000|NOT COMPLETED|Overall Study||53
9000366|NCT02889796|10063907|FG001|NOT COMPLETED|Overall Study||58
9000367|NCT02889796|10063908|FG002|NOT COMPLETED|Overall Study||44
9000368|NCT02889796|10063909|FG003|NOT COMPLETED|Overall Study||9
9000369|NCT02889796|10063910|FG004|NOT COMPLETED|Overall Study||6
9000370|NCT02889796|10063911|FG005|NOT COMPLETED|Overall Study||72
9000371|NCT02889861|10063934|FG000|STARTED|Overall Study||3
9000372|NCT02889861|10063934|FG000|COMPLETED|Overall Study||1
9000373|NCT02889861|10063934|FG000|NOT COMPLETED|Overall Study||2
9000374|NCT02890303|10063943|FG000|STARTED|Overall Study||100
9000375|NCT02890303|10063943|FG000|COMPLETED|Overall Study||100
9000376|NCT02890303|10063943|FG000|NOT COMPLETED|Overall Study||0
9000377|NCT02890381|10063949|FG000|STARTED|Overall Study||11
9000378|NCT02890381|10063950|FG001|STARTED|Overall Study||6
9000379|NCT02890381|10063949|FG000|COMPLETED|Overall Study||11
9000380|NCT02890381|10063950|FG001|COMPLETED|Overall Study||6
9000381|NCT02890381|10063949|FG000|NOT COMPLETED|Overall Study||0
9000382|NCT02890381|10063950|FG001|NOT COMPLETED|Overall Study||0
9000383|NCT02890992|10063964|FG000|STARTED|12 Weeks Open-Label Dose Finding Period||4
9039395|NCT03338400|10100343|FG001|NOT COMPLETED|Overall Study||2
8633953|NCT00553735|9674209|FG000|STARTED|Overall Study||8
9000384|NCT02890992|10063965|FG001|STARTED|12 Weeks Open-Label Dose Finding Period||6
9000385|NCT02890992|10063966|FG002|STARTED|12 Weeks Open-Label Dose Finding Period||4
9000386|NCT02890992|10063967|FG003|STARTED|12 Weeks Open-Label Dose Finding Period||6
9000387|NCT02890992|10063968|FG004|STARTED|12 Weeks Open-Label Dose Finding Period||6
9000388|NCT02890992|10063969|FG005|STARTED|12 Weeks Open-Label Dose Finding Period||5
9000389|NCT02890992|10063970|FG006|STARTED|12 Weeks Open-Label Dose Finding Period||6
9000390|NCT02890992|10063971|FG007|STARTED|12 Weeks Open-Label Dose Finding Period||5
9000391|NCT02890992|10063964|FG000|Treated|12 Weeks Open-Label Dose Finding Period||4
9000392|NCT02890992|10063965|FG001|Treated|12 Weeks Open-Label Dose Finding Period||6
9000393|NCT02890992|10063966|FG002|Treated|12 Weeks Open-Label Dose Finding Period||4
9000394|NCT02890992|10063967|FG003|Treated|12 Weeks Open-Label Dose Finding Period||6
9000395|NCT02890992|10063968|FG004|Treated|12 Weeks Open-Label Dose Finding Period||6
9000396|NCT02890992|10063969|FG005|Treated|12 Weeks Open-Label Dose Finding Period||5
9000397|NCT02890992|10063970|FG006|Treated|12 Weeks Open-Label Dose Finding Period||6
9000398|NCT02890992|10063971|FG007|Treated|12 Weeks Open-Label Dose Finding Period||5
9000399|NCT02890992|10063964|FG000|COMPLETED|12 Weeks Open-Label Dose Finding Period|Out of 4 participants, 3 participants entered into the open-label extension (OLE) period.|4
9000400|NCT02890992|10063965|FG001|COMPLETED|12 Weeks Open-Label Dose Finding Period||6
9000401|NCT02890992|10063966|FG002|COMPLETED|12 Weeks Open-Label Dose Finding Period||4
9000402|NCT02890992|10063967|FG003|COMPLETED|12 Weeks Open-Label Dose Finding Period||6
9000403|NCT02890992|10063968|FG004|COMPLETED|12 Weeks Open-Label Dose Finding Period||6
9000404|NCT02890992|10063969|FG005|COMPLETED|12 Weeks Open-Label Dose Finding Period||5
9000405|NCT02890992|10063970|FG006|COMPLETED|12 Weeks Open-Label Dose Finding Period||6
9000406|NCT02890992|10063971|FG007|COMPLETED|12 Weeks Open-Label Dose Finding Period||5
9000407|NCT02890992|10063964|FG000|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
9000408|NCT02890992|10063965|FG001|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
9000409|NCT02890992|10063966|FG002|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
9000410|NCT02890992|10063967|FG003|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
9000411|NCT02890992|10063968|FG004|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
9000412|NCT02890992|10063969|FG005|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
9000413|NCT02890992|10063970|FG006|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
9000414|NCT02890992|10063971|FG007|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
9000415|NCT02890992|10063964|FG000|STARTED|130 Weeks Open-Label Extension Period|3 participants from Open-Label Dose Finding Period (OLDFI) entered in OLE period.|3
9000416|NCT02890992|10063965|FG001|STARTED|130 Weeks Open-Label Extension Period||6
9000417|NCT02890992|10063966|FG002|STARTED|130 Weeks Open-Label Extension Period||4
9000418|NCT02890992|10063967|FG003|STARTED|130 Weeks Open-Label Extension Period||6
9000419|NCT02890992|10063968|FG004|STARTED|130 Weeks Open-Label Extension Period||6
9000420|NCT02890992|10063969|FG005|STARTED|130 Weeks Open-Label Extension Period||5
9000421|NCT02890992|10063970|FG006|STARTED|130 Weeks Open-Label Extension Period||6
9000422|NCT02890992|10063971|FG007|STARTED|130 Weeks Open-Label Extension Period||5
9000423|NCT02890992|10063964|FG000|Treated|130 Weeks Open-Label Extension Period||3
9000424|NCT02890992|10063965|FG001|Treated|130 Weeks Open-Label Extension Period||6
9000425|NCT02890992|10063966|FG002|Treated|130 Weeks Open-Label Extension Period||4
9000426|NCT02890992|10063967|FG003|Treated|130 Weeks Open-Label Extension Period||6
9000427|NCT02890992|10063968|FG004|Treated|130 Weeks Open-Label Extension Period||6
9000428|NCT02890992|10063969|FG005|Treated|130 Weeks Open-Label Extension Period||5
9000429|NCT02890992|10063970|FG006|Treated|130 Weeks Open-Label Extension Period||5
9000430|NCT02890992|10063971|FG007|Treated|130 Weeks Open-Label Extension Period||4
9000431|NCT02890992|10063964|FG000|COMPLETED|130 Weeks Open-Label Extension Period||3
9000432|NCT02890992|10063965|FG001|COMPLETED|130 Weeks Open-Label Extension Period||3
9000433|NCT02890992|10063966|FG002|COMPLETED|130 Weeks Open-Label Extension Period||4
9000434|NCT02890992|10063967|FG003|COMPLETED|130 Weeks Open-Label Extension Period||6
9000435|NCT02890992|10063968|FG004|COMPLETED|130 Weeks Open-Label Extension Period||6
9000436|NCT02890992|10063969|FG005|COMPLETED|130 Weeks Open-Label Extension Period||5
9000437|NCT02890992|10063970|FG006|COMPLETED|130 Weeks Open-Label Extension Period||5
9000438|NCT02890992|10063971|FG007|COMPLETED|130 Weeks Open-Label Extension Period||4
9000439|NCT02890992|10063964|FG000|NOT COMPLETED|130 Weeks Open-Label Extension Period||0
9000440|NCT02890992|10063965|FG001|NOT COMPLETED|130 Weeks Open-Label Extension Period||3
9000441|NCT02890992|10063966|FG002|NOT COMPLETED|130 Weeks Open-Label Extension Period||0
9000442|NCT02890992|10063967|FG003|NOT COMPLETED|130 Weeks Open-Label Extension Period||0
9000443|NCT02890992|10063968|FG004|NOT COMPLETED|130 Weeks Open-Label Extension Period||0
9000444|NCT02890992|10063969|FG005|NOT COMPLETED|130 Weeks Open-Label Extension Period||0
9000445|NCT02890992|10063970|FG006|NOT COMPLETED|130 Weeks Open-Label Extension Period||1
9000446|NCT02890992|10063971|FG007|NOT COMPLETED|130 Weeks Open-Label Extension Period||1
9000447|NCT02891070|10063998|FG000|STARTED|Overall Study||110
9000448|NCT02891070|10063999|FG001|STARTED|Overall Study||114
9000449|NCT02891070|10063998|FG000|COMPLETED|Overall Study||100
9000450|NCT02891070|10063999|FG001|COMPLETED|Overall Study||106
8633954|NCT00553735|9674209|FG000|COMPLETED|Overall Study||1
8633955|NCT00553735|9674209|FG000|NOT COMPLETED|Overall Study||7
9000451|NCT02891070|10063998|FG000|NOT COMPLETED|Overall Study||10
9000452|NCT02891070|10063999|FG001|NOT COMPLETED|Overall Study||8
9000453|NCT02891174|10064007|FG000|STARTED|First Intervention (24 Hours)||20
8633956|NCT00553787|9674219|FG000|STARTED|Overall Study||994
9000454|NCT02891174|10064008|FG001|STARTED|First Intervention (24 Hours)||23
9000455|NCT02891174|10064007|FG000|Received First Intervention|First Intervention (24 Hours)||19
9000456|NCT02891174|10064008|FG001|Received First Intervention|First Intervention (24 Hours)||18
9000457|NCT02891174|10064007|FG000|COMPLETED|First Intervention (24 Hours)||17
9000458|NCT02891174|10064008|FG001|COMPLETED|First Intervention (24 Hours)||10
9000459|NCT02891174|10064007|FG000|NOT COMPLETED|First Intervention (24 Hours)||3
9000460|NCT02891174|10064008|FG001|NOT COMPLETED|First Intervention (24 Hours)||13
9000461|NCT02891174|10064007|FG000|STARTED|Second Intervention (24 Hours)||17
9000462|NCT02891174|10064008|FG001|STARTED|Second Intervention (24 Hours)||10
9000463|NCT02891174|10064007|FG000|COMPLETED|Second Intervention (24 Hours)||11
9000464|NCT02891174|10064008|FG001|COMPLETED|Second Intervention (24 Hours)||3
9000465|NCT02891174|10064007|FG000|NOT COMPLETED|Second Intervention (24 Hours)||6
9000466|NCT02891174|10064008|FG001|NOT COMPLETED|Second Intervention (24 Hours)||7
9000467|NCT02891200|10064020|FG000|STARTED|Overall Study||145
9000468|NCT02891200|10064021|FG001|STARTED|Overall Study||147
9000469|NCT02891200|10064020|FG000|COMPLETED|Overall Study||103
9000470|NCT02891200|10064021|FG001|COMPLETED|Overall Study||98
8633957|NCT00553787|9674220|FG001|STARTED|Overall Study||498
8633958|NCT00553787|9674221|FG002|STARTED|Overall Study||995
8633959|NCT00553787|9674219|FG000|COMPLETED|Overall Study||616
8633960|NCT00553787|9674220|FG001|COMPLETED|Overall Study||374
8633961|NCT00553787|9674221|FG002|COMPLETED|Overall Study||733
8633962|NCT00553787|9674219|FG000|NOT COMPLETED|Overall Study||378
8633963|NCT00553787|9674220|FG001|NOT COMPLETED|Overall Study||124
8633964|NCT00553787|9674221|FG002|NOT COMPLETED|Overall Study||262
8633965|NCT00553839|9674229|FG000|STARTED|Overall Study||21
8633966|NCT00553839|9674229|FG000|COMPLETED|Overall Study||21
8633967|NCT00553839|9674229|FG000|NOT COMPLETED|Overall Study||0
8633968|NCT00553969|9674237|FG000|STARTED|Overall Study||31
8633969|NCT00553969|9674238|FG001|STARTED|Overall Study||24
8633970|NCT00553969|9674239|FG002|STARTED|Overall Study||22
8633971|NCT00553969|9674240|FG003|STARTED|Overall Study||24
8633972|NCT00553969|9674237|FG000|COMPLETED|Overall Study||23
8633973|NCT00553969|9674238|FG001|COMPLETED|Overall Study||24
8633974|NCT00553969|9674239|FG002|COMPLETED|Overall Study||21
8725924|NCT01033487|9773161|FG004|STARTED|Third Intervention Period||2
9000471|NCT02891200|10064020|FG000|NOT COMPLETED|Overall Study||42
9000472|NCT02891200|10064021|FG001|NOT COMPLETED|Overall Study||49
9000473|NCT02891408|10064034|FG000|STARTED|Overall Study||10
9000474|NCT02891408|10064035|FG001|STARTED|Overall Study||10
9000475|NCT02891408|10064036|FG002|STARTED|Overall Study||14
9000476|NCT02891408|10064037|FG003|STARTED|Overall Study||10
9000477|NCT02891408|10064038|FG004|STARTED|Overall Study||10
9000478|NCT02891408|10064039|FG005|STARTED|Overall Study||10
9000479|NCT02891408|10064040|FG006|STARTED|Overall Study||10
9000480|NCT02891408|10064034|FG000|COMPLETED|Overall Study||10
9000481|NCT02891408|10064035|FG001|COMPLETED|Overall Study||10
9000482|NCT02891408|10064036|FG002|COMPLETED|Overall Study||13
9000483|NCT02891408|10064037|FG003|COMPLETED|Overall Study||10
9000484|NCT02891408|10064038|FG004|COMPLETED|Overall Study||10
9000485|NCT02891408|10064039|FG005|COMPLETED|Overall Study||10
9000486|NCT02891408|10064040|FG006|COMPLETED|Overall Study||10
9000487|NCT02891408|10064034|FG000|NOT COMPLETED|Overall Study||0
8572474|NCT00114738|9604658|FG001|NOT COMPLETED|Screening for Randomization||0
8572475|NCT00114738|9604659|FG002|NOT COMPLETED|Screening for Randomization||0
8572476|NCT00114738|9604657|FG000|STARTED|Randomization||0
8572477|NCT00114738|9604658|FG001|STARTED|Randomization||14
8572478|NCT00114738|9604659|FG002|STARTED|Randomization||16
8572479|NCT00114738|9604657|FG000|COMPLETED|Randomization||0
8572480|NCT00114738|9604658|FG001|COMPLETED|Randomization||14
8572481|NCT00114738|9604659|FG002|COMPLETED|Randomization||16
8572482|NCT00114738|9604657|FG000|NOT COMPLETED|Randomization||0
8572483|NCT00114738|9604658|FG001|NOT COMPLETED|Randomization||0
8633975|NCT00553969|9674240|FG003|COMPLETED|Overall Study||23
9000488|NCT02891408|10064035|FG001|NOT COMPLETED|Overall Study||0
9000489|NCT02891408|10064036|FG002|NOT COMPLETED|Overall Study||1
9000490|NCT02891408|10064037|FG003|NOT COMPLETED|Overall Study||0
9000491|NCT02891408|10064038|FG004|NOT COMPLETED|Overall Study||0
9000492|NCT02891408|10064039|FG005|NOT COMPLETED|Overall Study||0
9000493|NCT02891408|10064040|FG006|NOT COMPLETED|Overall Study||0
9000494|NCT02891629|10064068|FG000|STARTED|Overall Study||10
9000495|NCT02891629|10064069|FG001|STARTED|Overall Study||5
8633976|NCT00553969|9674237|FG000|NOT COMPLETED|Overall Study||8
8633977|NCT00553969|9674238|FG001|NOT COMPLETED|Overall Study||0
8633978|NCT00553969|9674239|FG002|NOT COMPLETED|Overall Study||1
8633979|NCT00553969|9674240|FG003|NOT COMPLETED|Overall Study||1
8633980|NCT00554099|9674253|FG000|STARTED|Treatment Period (12 Weeks)||41
9000496|NCT02891629|10064068|FG000|COMPLETED|Overall Study||10
9000497|NCT02891629|10064069|FG001|COMPLETED|Overall Study||4
9000498|NCT02891629|10064068|FG000|NOT COMPLETED|Overall Study||0
9000499|NCT02891629|10064069|FG001|NOT COMPLETED|Overall Study||1
9000500|NCT02891681|10064078|FG000|STARTED|Overall Study||39
9000501|NCT02891681|10064079|FG001|STARTED|Overall Study||1
9000502|NCT02891681|10064080|FG002|STARTED|Overall Study||1
9000503|NCT02891681|10064078|FG000|COMPLETED|Overall Study||36
9000504|NCT02891681|10064079|FG001|COMPLETED|Overall Study||1
9000505|NCT02891681|10064080|FG002|COMPLETED|Overall Study||0
9000506|NCT02891681|10064078|FG000|NOT COMPLETED|Overall Study||3
9000507|NCT02891681|10064079|FG001|NOT COMPLETED|Overall Study||0
9000508|NCT02891681|10064080|FG002|NOT COMPLETED|Overall Study||1
9000509|NCT02891850|10064090|FG000|STARTED|Overall Study||111
9000510|NCT02891850|10064091|FG001|STARTED|Overall Study||114
9000511|NCT02891850|10064090|FG000|COMPLETED|Overall Study||104
9000512|NCT02891850|10064091|FG001|COMPLETED|Overall Study||107
9000513|NCT02891850|10064090|FG000|NOT COMPLETED|Overall Study||7
9000514|NCT02891850|10064091|FG001|NOT COMPLETED|Overall Study||7
9000515|NCT02891863|10064097|FG000|STARTED|Overall Study||9
9000516|NCT02891863|10064097|FG000|COMPLETED|Overall Study||9
9000517|NCT02891863|10064097|FG000|NOT COMPLETED|Overall Study||0
9000518|NCT02891915|10064103|FG000|STARTED|Overall Study||192
9000519|NCT02891915|10064104|FG001|STARTED|Overall Study||193
9000520|NCT02891915|10064103|FG000|COMPLETED|Overall Study||179
9000521|NCT02891915|10064104|FG001|COMPLETED|Overall Study||181
9000522|NCT02891915|10064103|FG000|NOT COMPLETED|Overall Study||13
9000523|NCT02891915|10064104|FG001|NOT COMPLETED|Overall Study||12
9000524|NCT02892019|10064112|FG000|STARTED|Overall Study||41
9000525|NCT02892019|10064113|FG001|STARTED|Overall Study||39
9000526|NCT02892019|10064112|FG000|COMPLETED|Overall Study||40
9000527|NCT02892019|10064113|FG001|COMPLETED|Overall Study||36
9000528|NCT02892019|10064112|FG000|NOT COMPLETED|Overall Study||1
9000529|NCT02892019|10064113|FG001|NOT COMPLETED|Overall Study||3
9000530|NCT02892110|10064121|FG000|STARTED|Overall Study||35
9000531|NCT02892110|10064122|FG001|STARTED|Overall Study||37
9000532|NCT02892110|10064121|FG000|COMPLETED|Overall Study||22
9000533|NCT02892110|10064122|FG001|COMPLETED|Overall Study||25
9000534|NCT02892110|10064121|FG000|NOT COMPLETED|Overall Study||13
9000535|NCT02892110|10064122|FG001|NOT COMPLETED|Overall Study||12
9000536|NCT02892344|10064130|FG000|STARTED|Overall Study||398
9000537|NCT02892344|10064131|FG001|STARTED|Overall Study||404
9000538|NCT02892344|10064130|FG000|Full Analysis Set|Overall Study||395
9000539|NCT02892344|10064131|FG001|Full Analysis Set|Overall Study||399
9000540|NCT02892344|10064130|FG000|COMPLETED|Overall Study||394
9000541|NCT02892344|10064131|FG001|COMPLETED|Overall Study||383
9000542|NCT02892344|10064130|FG000|NOT COMPLETED|Overall Study||4
9000543|NCT02892344|10064131|FG001|NOT COMPLETED|Overall Study||21
9000544|NCT02892409|10064139|FG000|STARTED|Overall Study||15
9000545|NCT02892409|10064140|FG001|STARTED|Overall Study||15
9000546|NCT02892409|10064139|FG000|COMPLETED|Overall Study||12
9000547|NCT02892409|10064140|FG001|COMPLETED|Overall Study||14
9000548|NCT02892409|10064139|FG000|NOT COMPLETED|Overall Study||3
9000549|NCT02892409|10064140|FG001|NOT COMPLETED|Overall Study||1
9000550|NCT02892422|10064146|FG000|STARTED|Overall Study|528 participants were enrolled, 524 from study 16159A and 4 from study 16323A|528
8633981|NCT00554099|9674254|FG001|STARTED|Treatment Period (12 Weeks)||40
8879552|NCT01933789|9936220|FG006|NOT COMPLETED|Overall Study||15
8879553|NCT01933789|9936221|FG007|NOT COMPLETED|Overall Study||14
8879554|NCT01933789|9936222|FG008|NOT COMPLETED|Overall Study||0
8879555|NCT01933880|9936244|FG000|STARTED|Overall Study||153
8879556|NCT01933880|9936245|FG001|STARTED|Overall Study||41
8879557|NCT01933880|9936244|FG000|COMPLETED|Overall Study||123
8879558|NCT01933880|9936245|FG001|COMPLETED|Overall Study||40
8879559|NCT01933880|9936244|FG000|NOT COMPLETED|Overall Study||30
8879560|NCT01933880|9936245|FG001|NOT COMPLETED|Overall Study||1
8879561|NCT01933919|9936258|FG000|STARTED|Double-blind Placebo-controlled Phase||19
8879562|NCT01933919|9936259|FG001|STARTED|Double-blind Placebo-controlled Phase||19
8879563|NCT01933919|9936258|FG000|Received Study Drug|Double-blind Placebo-controlled Phase||19
8879564|NCT01933919|9936259|FG001|Received Study Drug|Double-blind Placebo-controlled Phase||19
8879565|NCT01933919|9936258|FG000|COMPLETED|Double-blind Placebo-controlled Phase||19
8879566|NCT01933919|9936259|FG001|COMPLETED|Double-blind Placebo-controlled Phase||15
8879567|NCT01933919|9936258|FG000|NOT COMPLETED|Double-blind Placebo-controlled Phase||0
8879568|NCT01933919|9936259|FG001|NOT COMPLETED|Double-blind Placebo-controlled Phase||4
8879569|NCT01933919|9936258|FG000|STARTED|Open-label Long-term Phase||19
8879570|NCT01933919|9936259|FG001|STARTED|Open-label Long-term Phase||15
8879571|NCT01933919|9936258|FG000|COMPLETED|Open-label Long-term Phase||12
9000551|NCT02892422|10064146|FG000|COMPLETED|Overall Study||318
9000552|NCT02892422|10064146|FG000|NOT COMPLETED|Overall Study||210
9000553|NCT02892448|10064153|FG000|STARTED|Overall Study||12
9000554|NCT02892448|10064154|FG001|STARTED|Overall Study||12
9000555|NCT02892448|10064155|FG002|STARTED|Overall Study||11
9000556|NCT02892448|10064153|FG000|COMPLETED|Overall Study||10
9000557|NCT02892448|10064154|FG001|COMPLETED|Overall Study||10
9000558|NCT02892448|10064155|FG002|COMPLETED|Overall Study||10
8633982|NCT00554099|9674255|FG002|STARTED|Treatment Period (12 Weeks)||36
9000559|NCT02892448|10064153|FG000|NOT COMPLETED|Overall Study||2
9000560|NCT02892448|10064154|FG001|NOT COMPLETED|Overall Study||2
9000561|NCT02892448|10064155|FG002|NOT COMPLETED|Overall Study||1
8633983|NCT00554099|9674253|FG000|COMPLETED|Treatment Period (12 Weeks)||29
8633984|NCT00554099|9674254|FG001|COMPLETED|Treatment Period (12 Weeks)||32
9000562|NCT02892513|10064165|FG000|STARTED|Overall Study||28
9000563|NCT02892513|10064166|FG001|STARTED|Overall Study|did not receive allocated intervention = 1 (withdrew per participant request)|25
9000564|NCT02892513|10064165|FG000|COMPLETED|Overall Study|Discontinued intervention early = 5; excluded from analysis = 0|28
9000565|NCT02892513|10064166|FG001|COMPLETED|Overall Study|Discontinued intervention early = 6; excluded from analysis = 1|24
9000566|NCT02892513|10064165|FG000|NOT COMPLETED|Overall Study||0
9000567|NCT02892513|10064166|FG001|NOT COMPLETED|Overall Study||1
9000568|NCT02892734|10064172|FG000|STARTED|Treatment on Study||3
9000569|NCT02892734|10064172|FG000|Completed 1st Cycle/Response at 12 Weeks|Treatment on Study||1
9000570|NCT02892734|10064172|FG000|Went on to Start Cycle 2|Treatment on Study||1
9000571|NCT02892734|10064172|FG000|COMPLETED|Treatment on Study||1
9000572|NCT02892734|10064172|FG000|NOT COMPLETED|Treatment on Study||2
9000573|NCT02892734|10064172|FG000|STARTED|Follow up for 2 Years||3
9000574|NCT02892734|10064172|FG000|COMPLETED|Follow up for 2 Years||0
9000575|NCT02892734|10064172|FG000|NOT COMPLETED|Follow up for 2 Years||3
9000576|NCT02892760|10064176|FG000|STARTED|Overall Study||17
9000577|NCT02892760|10064176|FG000|Received Intervention|Overall Study||15
9000578|NCT02892760|10064176|FG000|COMPLETED|Overall Study||14
9000579|NCT02892760|10064176|FG000|NOT COMPLETED|Overall Study||3
9000580|NCT02893878|10064183|FG000|STARTED|Overall Study||13861
9000581|NCT02893878|10064184|FG001|STARTED|Overall Study||2295
9000582|NCT02893878|10064185|FG002|STARTED|Overall Study||3178
9000583|NCT02893878|10064183|FG000|COMPLETED|Overall Study||13861
9000584|NCT02893878|10064184|FG001|COMPLETED|Overall Study||2295
9000585|NCT02893878|10064185|FG002|COMPLETED|Overall Study||3178
9000586|NCT02893878|10064183|FG000|NOT COMPLETED|Overall Study||0
9000587|NCT02893878|10064184|FG001|NOT COMPLETED|Overall Study||0
9000588|NCT02893878|10064185|FG002|NOT COMPLETED|Overall Study||0
9000589|NCT02894502|10064199|FG000|STARTED|Baseline||155
9000590|NCT02894502|10064200|FG001|STARTED|Baseline||177
9000591|NCT02894502|10064201|FG002|STARTED|Baseline||178
9000592|NCT02894502|10064199|FG000|COMPLETED|Baseline||128
9000593|NCT02894502|10064200|FG001|COMPLETED|Baseline||145
9000594|NCT02894502|10064201|FG002|COMPLETED|Baseline||133
9000595|NCT02894502|10064199|FG000|NOT COMPLETED|Baseline||27
9000596|NCT02894502|10064200|FG001|NOT COMPLETED|Baseline||32
9000597|NCT02894502|10064201|FG002|NOT COMPLETED|Baseline||45
9000598|NCT02894502|10064199|FG000|STARTED|First Follow up||128
9000599|NCT02894502|10064200|FG001|STARTED|First Follow up||145
9000600|NCT02894502|10064201|FG002|STARTED|First Follow up||133
9000601|NCT02894502|10064199|FG000|COMPLETED|First Follow up||94
9000602|NCT02894502|10064200|FG001|COMPLETED|First Follow up||114
9000603|NCT02894502|10064201|FG002|COMPLETED|First Follow up||93
9000604|NCT02894502|10064199|FG000|NOT COMPLETED|First Follow up||34
9000605|NCT02894502|10064200|FG001|NOT COMPLETED|First Follow up||31
9000606|NCT02894502|10064201|FG002|NOT COMPLETED|First Follow up||40
9000607|NCT02894502|10064199|FG000|STARTED|Second Follow up||94
9000608|NCT02894502|10064200|FG001|STARTED|Second Follow up||114
9000609|NCT02894502|10064201|FG002|STARTED|Second Follow up||93
9000610|NCT02894502|10064199|FG000|COMPLETED|Second Follow up||79
9000611|NCT02894502|10064200|FG001|COMPLETED|Second Follow up||96
9000612|NCT02894502|10064201|FG002|COMPLETED|Second Follow up||79
9000613|NCT02894502|10064199|FG000|NOT COMPLETED|Second Follow up||15
9000614|NCT02894502|10064200|FG001|NOT COMPLETED|Second Follow up||18
8879572|NCT01933919|9936259|FG001|COMPLETED|Open-label Long-term Phase||9
8879573|NCT01933919|9936258|FG000|NOT COMPLETED|Open-label Long-term Phase||7
8879574|NCT01933919|9936259|FG001|NOT COMPLETED|Open-label Long-term Phase||6
8879575|NCT01933984|9936279|FG000|STARTED|Overall Study||26
8879576|NCT01933984|9936280|FG001|STARTED|Overall Study||25
8879577|NCT01933984|9936279|FG000|COMPLETED|Overall Study||26
8879578|NCT01933984|9936280|FG001|COMPLETED|Overall Study||25
8879579|NCT01933984|9936279|FG000|NOT COMPLETED|Overall Study||0
8879580|NCT01933984|9936280|FG001|NOT COMPLETED|Overall Study||0
8879581|NCT01934010|9936293|FG000|STARTED|Overall Study||114
8879582|NCT01934010|9936294|FG001|STARTED|Overall Study||67
8879583|NCT01934010|9936295|FG002|STARTED|Overall Study||76
9000615|NCT02894502|10064201|FG002|NOT COMPLETED|Second Follow up||14
9000616|NCT02894502|10064199|FG000|STARTED|Third Follow up||79
9000617|NCT02894502|10064200|FG001|STARTED|Third Follow up||96
9000618|NCT02894502|10064201|FG002|STARTED|Third Follow up||79
9000619|NCT02894502|10064199|FG000|COMPLETED|Third Follow up||73
9000620|NCT02894502|10064200|FG001|COMPLETED|Third Follow up||89
9000621|NCT02894502|10064201|FG002|COMPLETED|Third Follow up||76
9000622|NCT02894502|10064199|FG000|NOT COMPLETED|Third Follow up||6
9000623|NCT02894502|10064200|FG001|NOT COMPLETED|Third Follow up||7
9000624|NCT02894502|10064201|FG002|NOT COMPLETED|Third Follow up||3
9000625|NCT02894840|10064216|FG000|STARTED|Overall Study||20
9000626|NCT02894840|10064217|FG001|STARTED|Overall Study||20
9000627|NCT02894840|10064218|FG002|STARTED|Overall Study||200
9000628|NCT02894840|10064219|FG003|STARTED|Overall Study||100
9000629|NCT02894840|10064216|FG000|COMPLETED|Overall Study||19
8633985|NCT00554099|9674255|FG002|COMPLETED|Treatment Period (12 Weeks)||27
9000630|NCT02894840|10064217|FG001|COMPLETED|Overall Study||20
8633986|NCT00554099|9674253|FG000|NOT COMPLETED|Treatment Period (12 Weeks)||12
8879584|NCT01934010|9936293|FG000|COMPLETED|Overall Study||91
8879585|NCT01934010|9936294|FG001|COMPLETED|Overall Study||56
9000631|NCT02894840|10064218|FG002|COMPLETED|Overall Study||197
9000632|NCT02894840|10064219|FG003|COMPLETED|Overall Study||100
9000633|NCT02894840|10064216|FG000|NOT COMPLETED|Overall Study||1
9000634|NCT02894840|10064217|FG001|NOT COMPLETED|Overall Study||0
9000635|NCT02894840|10064218|FG002|NOT COMPLETED|Overall Study||3
9000636|NCT02894840|10064219|FG003|NOT COMPLETED|Overall Study||0
9000637|NCT02895035|10064234|FG000|STARTED|Overall Study||23
9000638|NCT02895035|10064235|FG001|STARTED|Overall Study||36
9000639|NCT02895035|10064234|FG000|COMPLETED|Overall Study||18
9000640|NCT02895035|10064235|FG001|COMPLETED|Overall Study||24
9000641|NCT02895035|10064234|FG000|NOT COMPLETED|Overall Study||5
9000642|NCT02895035|10064235|FG001|NOT COMPLETED|Overall Study||12
9000643|NCT02895100|10064245|FG000|STARTED|Overall Study||25
9000644|NCT02895100|10064246|FG001|STARTED|Overall Study||25
9000645|NCT02895100|10064247|FG002|STARTED|Overall Study||23
9000646|NCT02895100|10064248|FG003|STARTED|Overall Study||25
9000647|NCT02895100|10064245|FG000|COMPLETED|Overall Study||14
9000648|NCT02895100|10064246|FG001|COMPLETED|Overall Study||14
9000649|NCT02895100|10064247|FG002|COMPLETED|Overall Study||15
9000650|NCT02895100|10064248|FG003|COMPLETED|Overall Study||15
9000651|NCT02895100|10064245|FG000|NOT COMPLETED|Overall Study||11
9000652|NCT02895100|10064246|FG001|NOT COMPLETED|Overall Study||11
9000653|NCT02895100|10064247|FG002|NOT COMPLETED|Overall Study||8
9000654|NCT02895100|10064248|FG003|NOT COMPLETED|Overall Study||10
9000655|NCT02895295|10064261|FG000|STARTED|Overall Study||384
9000656|NCT02895295|10064262|FG001|STARTED|Overall Study||410
9000657|NCT02895295|10064263|FG002|STARTED|Overall Study||391
9000658|NCT02895295|10064261|FG000|COMPLETED|Overall Study||313
9000659|NCT02895295|10064262|FG001|COMPLETED|Overall Study||316
9000660|NCT02895295|10064263|FG002|COMPLETED|Overall Study||299
9000661|NCT02895295|10064261|FG000|NOT COMPLETED|Overall Study||71
9000662|NCT02895295|10064262|FG001|NOT COMPLETED|Overall Study||94
9000663|NCT02895295|10064263|FG002|NOT COMPLETED|Overall Study||92
9000664|NCT02895347|10064273|FG000|STARTED|Overall Study||20
9000665|NCT02895347|10064274|FG001|STARTED|Overall Study||20
9000666|NCT02895347|10064273|FG000|COMPLETED|Overall Study||17
9000667|NCT02895347|10064274|FG001|COMPLETED|Overall Study||19
9000668|NCT02895347|10064273|FG000|NOT COMPLETED|Overall Study||3
9000669|NCT02895347|10064274|FG001|NOT COMPLETED|Overall Study||1
9000670|NCT02895360|10064287|FG000|STARTED|Phase 1 - 30 mg/m² Cohort||4
9000671|NCT02895360|10064288|FG001|STARTED|Phase 1 - 30 mg/m² Cohort||0
9000672|NCT02895360|10064289|FG002|STARTED|Phase 1 - 30 mg/m² Cohort||0
9000673|NCT02895360|10064290|FG003|STARTED|Phase 1 - 30 mg/m² Cohort||0
9000674|NCT02895360|10064291|FG004|STARTED|Phase 1 - 30 mg/m² Cohort||0
9000675|NCT02895360|10064292|FG005|STARTED|Phase 1 - 30 mg/m² Cohort||0
9000676|NCT02895360|10064287|FG000|COMPLETED|Phase 1 - 30 mg/m² Cohort||0
9000677|NCT02895360|10064288|FG001|COMPLETED|Phase 1 - 30 mg/m² Cohort||0
9000678|NCT02895360|10064289|FG002|COMPLETED|Phase 1 - 30 mg/m² Cohort||0
9000679|NCT02895360|10064290|FG003|COMPLETED|Phase 1 - 30 mg/m² Cohort||0
9000680|NCT02895360|10064291|FG004|COMPLETED|Phase 1 - 30 mg/m² Cohort||0
9000681|NCT02895360|10064292|FG005|COMPLETED|Phase 1 - 30 mg/m² Cohort||0
8572484|NCT00114738|9604659|FG002|NOT COMPLETED|Randomization||0
8572485|NCT00114777|9604669|FG000|STARTED|Randomization to Month 36||184
8633987|NCT00554099|9674254|FG001|NOT COMPLETED|Treatment Period (12 Weeks)||8
8879586|NCT01934010|9936295|FG002|COMPLETED|Overall Study||74
8879587|NCT01934010|9936293|FG000|NOT COMPLETED|Overall Study||23
8879588|NCT01934010|9936294|FG001|NOT COMPLETED|Overall Study||11
8879589|NCT01934010|9936295|FG002|NOT COMPLETED|Overall Study||2
8879590|NCT01934140|9936314|FG000|STARTED|Persistence Phase (Year 6-10)||235
8879591|NCT01934140|9936315|FG001|STARTED|Persistence Phase (Year 6-10)||76
8879592|NCT01934140|9936314|FG000|COMPLETED|Persistence Phase (Year 6-10)|Participants completed all persistence phase visits|152
9000682|NCT02895360|10064287|FG000|NOT COMPLETED|Phase 1 - 30 mg/m² Cohort||4
9000683|NCT02895360|10064288|FG001|NOT COMPLETED|Phase 1 - 30 mg/m² Cohort||0
9000684|NCT02895360|10064289|FG002|NOT COMPLETED|Phase 1 - 30 mg/m² Cohort||0
9000685|NCT02895360|10064290|FG003|NOT COMPLETED|Phase 1 - 30 mg/m² Cohort||0
9000686|NCT02895360|10064291|FG004|NOT COMPLETED|Phase 1 - 30 mg/m² Cohort||0
9000687|NCT02895360|10064292|FG005|NOT COMPLETED|Phase 1 - 30 mg/m² Cohort||0
9000688|NCT02895360|10064287|FG000|STARTED|Phase 1 - 45 mg/m² Cohort||0
9000689|NCT02895360|10064288|FG001|STARTED|Phase 1 - 45 mg/m² Cohort||3
9000690|NCT02895360|10064289|FG002|STARTED|Phase 1 - 45 mg/m² Cohort||0
9000691|NCT02895360|10064290|FG003|STARTED|Phase 1 - 45 mg/m² Cohort||0
9000692|NCT02895360|10064291|FG004|STARTED|Phase 1 - 45 mg/m² Cohort||0
9000693|NCT02895360|10064292|FG005|STARTED|Phase 1 - 45 mg/m² Cohort||0
9000694|NCT02895360|10064287|FG000|COMPLETED|Phase 1 - 45 mg/m² Cohort||0
9000695|NCT02895360|10064288|FG001|COMPLETED|Phase 1 - 45 mg/m² Cohort||0
9000696|NCT02895360|10064289|FG002|COMPLETED|Phase 1 - 45 mg/m² Cohort||0
9000697|NCT02895360|10064290|FG003|COMPLETED|Phase 1 - 45 mg/m² Cohort||0
9000698|NCT02895360|10064291|FG004|COMPLETED|Phase 1 - 45 mg/m² Cohort||0
9000699|NCT02895360|10064292|FG005|COMPLETED|Phase 1 - 45 mg/m² Cohort||0
9000700|NCT02895360|10064287|FG000|NOT COMPLETED|Phase 1 - 45 mg/m² Cohort||0
9000701|NCT02895360|10064288|FG001|NOT COMPLETED|Phase 1 - 45 mg/m² Cohort||3
9000702|NCT02895360|10064289|FG002|NOT COMPLETED|Phase 1 - 45 mg/m² Cohort||0
9000703|NCT02895360|10064290|FG003|NOT COMPLETED|Phase 1 - 45 mg/m² Cohort||0
9000704|NCT02895360|10064291|FG004|NOT COMPLETED|Phase 1 - 45 mg/m² Cohort||0
9000705|NCT02895360|10064292|FG005|NOT COMPLETED|Phase 1 - 45 mg/m² Cohort||0
9000706|NCT02895360|10064287|FG000|STARTED|Phase 1 - 70 mg/m² Cohort||0
9000707|NCT02895360|10064288|FG001|STARTED|Phase 1 - 70 mg/m² Cohort||0
8633988|NCT00554099|9674255|FG002|NOT COMPLETED|Treatment Period (12 Weeks)||9
8633989|NCT00554099|9674253|FG000|STARTED|Non-Treatment Phase (9 Months)||29
8633990|NCT00554099|9674254|FG001|STARTED|Non-Treatment Phase (9 Months)||32
9000708|NCT02895360|10064289|FG002|STARTED|Phase 1 - 70 mg/m² Cohort||9
9000709|NCT02895360|10064290|FG003|STARTED|Phase 1 - 70 mg/m² Cohort||0
8572486|NCT00114777|9604670|FG001|STARTED|Randomization to Month 36||175
8572487|NCT00114777|9604671|FG002|STARTED|Randomization to Month 36||184
8572488|NCT00114777|9604669|FG000|COMPLETED|Randomization to Month 36||109
8572489|NCT00114777|9604670|FG001|COMPLETED|Randomization to Month 36||114
8572490|NCT00114777|9604671|FG002|COMPLETED|Randomization to Month 36||100
8572491|NCT00114777|9604669|FG000|NOT COMPLETED|Randomization to Month 36||75
9000710|NCT02895360|10064291|FG004|STARTED|Phase 1 - 70 mg/m² Cohort||0
9000711|NCT02895360|10064292|FG005|STARTED|Phase 1 - 70 mg/m² Cohort||0
9000712|NCT02895360|10064287|FG000|COMPLETED|Phase 1 - 70 mg/m² Cohort||0
9000713|NCT02895360|10064288|FG001|COMPLETED|Phase 1 - 70 mg/m² Cohort||0
9000714|NCT02895360|10064289|FG002|COMPLETED|Phase 1 - 70 mg/m² Cohort||0
9000715|NCT02895360|10064290|FG003|COMPLETED|Phase 1 - 70 mg/m² Cohort||0
9000716|NCT02895360|10064291|FG004|COMPLETED|Phase 1 - 70 mg/m² Cohort||0
9000717|NCT02895360|10064292|FG005|COMPLETED|Phase 1 - 70 mg/m² Cohort||0
9000718|NCT02895360|10064287|FG000|NOT COMPLETED|Phase 1 - 70 mg/m² Cohort||0
9000719|NCT02895360|10064288|FG001|NOT COMPLETED|Phase 1 - 70 mg/m² Cohort||0
9000720|NCT02895360|10064289|FG002|NOT COMPLETED|Phase 1 - 70 mg/m² Cohort||9
9000721|NCT02895360|10064290|FG003|NOT COMPLETED|Phase 1 - 70 mg/m² Cohort||0
9000722|NCT02895360|10064291|FG004|NOT COMPLETED|Phase 1 - 70 mg/m² Cohort||0
9000723|NCT02895360|10064292|FG005|NOT COMPLETED|Phase 1 - 70 mg/m² Cohort||0
9000724|NCT02895360|10064287|FG000|STARTED|Phase 1 - 90 mg/m² Cohort||0
9000725|NCT02895360|10064288|FG001|STARTED|Phase 1 - 90 mg/m² Cohort||0
9000726|NCT02895360|10064289|FG002|STARTED|Phase 1 - 90 mg/m² Cohort||0
9000727|NCT02895360|10064290|FG003|STARTED|Phase 1 - 90 mg/m² Cohort||4
9000728|NCT02895360|10064291|FG004|STARTED|Phase 1 - 90 mg/m² Cohort||0
9000729|NCT02895360|10064292|FG005|STARTED|Phase 1 - 90 mg/m² Cohort||0
9000730|NCT02895360|10064287|FG000|COMPLETED|Phase 1 - 90 mg/m² Cohort||0
9000731|NCT02895360|10064288|FG001|COMPLETED|Phase 1 - 90 mg/m² Cohort||0
8633991|NCT00554099|9674255|FG002|STARTED|Non-Treatment Phase (9 Months)||27
8633992|NCT00554099|9674253|FG000|COMPLETED|Non-Treatment Phase (9 Months)||22
8633993|NCT00554099|9674254|FG001|COMPLETED|Non-Treatment Phase (9 Months)||27
8879593|NCT01934140|9936315|FG001|COMPLETED|Persistence Phase (Year 6-10)|Participants completed all persistence phase visits|51
8879594|NCT01934140|9936314|FG000|NOT COMPLETED|Persistence Phase (Year 6-10)||83
8879595|NCT01934140|9936315|FG001|NOT COMPLETED|Persistence Phase (Year 6-10)||25
8572492|NCT00114777|9604670|FG001|NOT COMPLETED|Randomization to Month 36||61
8572493|NCT00114777|9604671|FG002|NOT COMPLETED|Randomization to Month 36||84
8572494|NCT00114777|9604669|FG000|STARTED|Long-Term Extension to Month 84||104
8879596|NCT01934140|9936314|FG000|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent, were enrolled in booster phase.|164
8879597|NCT01934140|9936315|FG001|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent, were enrolled in booster phase.|56
8879598|NCT01934140|9936314|FG000|Vaccinated|Booster Phase (6 Months)||164
8879599|NCT01934140|9936315|FG001|Vaccinated|Booster Phase (6 Months)||56
8879600|NCT01934140|9936314|FG000|COMPLETED|Booster Phase (6 Months)||159
8879601|NCT01934140|9936315|FG001|COMPLETED|Booster Phase (6 Months)||53
8879602|NCT01934140|9936314|FG000|NOT COMPLETED|Booster Phase (6 Months)||5
8879603|NCT01934140|9936315|FG001|NOT COMPLETED|Booster Phase (6 Months)||3
8879604|NCT01934192|9936327|FG000|STARTED|Overall Study||40
8879605|NCT01934192|9936328|FG001|STARTED|Overall Study||44
8879606|NCT01934192|9936329|FG002|STARTED|Overall Study||4
8879607|NCT01934192|9936330|FG003|STARTED|Overall Study||4
8879608|NCT01934192|9936327|FG000|COMPLETED|Overall Study||31
8879609|NCT01934192|9936328|FG001|COMPLETED|Overall Study||37
8879610|NCT01934192|9936329|FG002|COMPLETED|Overall Study||3
8879611|NCT01934192|9936330|FG003|COMPLETED|Overall Study||3
8879612|NCT01934192|9936327|FG000|NOT COMPLETED|Overall Study||9
8879613|NCT01934192|9936328|FG001|NOT COMPLETED|Overall Study||7
8879614|NCT01934192|9936329|FG002|NOT COMPLETED|Overall Study||1
8879615|NCT01934192|9936330|FG003|NOT COMPLETED|Overall Study||1
8879616|NCT01934218|9936353|FG000|STARTED|Double-blind Phase||404
9000732|NCT02895360|10064289|FG002|COMPLETED|Phase 1 - 90 mg/m² Cohort||0
9000733|NCT02895360|10064290|FG003|COMPLETED|Phase 1 - 90 mg/m² Cohort||0
9000734|NCT02895360|10064291|FG004|COMPLETED|Phase 1 - 90 mg/m² Cohort||0
9000735|NCT02895360|10064292|FG005|COMPLETED|Phase 1 - 90 mg/m² Cohort||0
9000736|NCT02895360|10064287|FG000|NOT COMPLETED|Phase 1 - 90 mg/m² Cohort||0
8572495|NCT00114777|9604670|FG001|STARTED|Long-Term Extension to Month 84||113
8572496|NCT00114777|9604671|FG002|STARTED|Long-Term Extension to Month 84||87
8633994|NCT00554099|9674255|FG002|COMPLETED|Non-Treatment Phase (9 Months)||24
8633995|NCT00554099|9674253|FG000|NOT COMPLETED|Non-Treatment Phase (9 Months)||7
9000737|NCT02895360|10064288|FG001|NOT COMPLETED|Phase 1 - 90 mg/m² Cohort||0
9000738|NCT02895360|10064289|FG002|NOT COMPLETED|Phase 1 - 90 mg/m² Cohort||0
9000739|NCT02895360|10064290|FG003|NOT COMPLETED|Phase 1 - 90 mg/m² Cohort||4
9000740|NCT02895360|10064291|FG004|NOT COMPLETED|Phase 1 - 90 mg/m² Cohort||0
9000741|NCT02895360|10064292|FG005|NOT COMPLETED|Phase 1 - 90 mg/m² Cohort||0
9000742|NCT02895360|10064287|FG000|STARTED|Phase 2a||0
9000743|NCT02895360|10064288|FG001|STARTED|Phase 2a||0
9000744|NCT02895360|10064289|FG002|STARTED|Phase 2a||0
9000745|NCT02895360|10064290|FG003|STARTED|Phase 2a||0
9000746|NCT02895360|10064291|FG004|STARTED|Phase 2a||11
9000747|NCT02895360|10064292|FG005|STARTED|Phase 2a||12
8633996|NCT00554099|9674254|FG001|NOT COMPLETED|Non-Treatment Phase (9 Months)||5
8633997|NCT00554099|9674255|FG002|NOT COMPLETED|Non-Treatment Phase (9 Months)||3
8633998|NCT00554216|9674266|FG000|STARTED|Overall Study||514
8633999|NCT00554216|9674267|FG001|STARTED|Overall Study||241
8634000|NCT00554216|9674268|FG002|STARTED|Overall Study||512
8634001|NCT00554216|9674266|FG000|COMPLETED|Overall Study||272
8634002|NCT00554216|9674267|FG001|COMPLETED|Overall Study||147
8634003|NCT00554216|9674268|FG002|COMPLETED|Overall Study||340
8634004|NCT00554216|9674266|FG000|NOT COMPLETED|Overall Study||242
8879617|NCT01934218|9936354|FG001|STARTED|Double-blind Phase||410
8879618|NCT01934218|9936353|FG000|Analyzed Participants|Double-blind Phase||402
8879619|NCT01934218|9936354|FG001|Analyzed Participants|Double-blind Phase||407
9000748|NCT02895360|10064287|FG000|COMPLETED|Phase 2a||0
9000749|NCT02895360|10064288|FG001|COMPLETED|Phase 2a||0
9000750|NCT02895360|10064289|FG002|COMPLETED|Phase 2a||0
9000751|NCT02895360|10064290|FG003|COMPLETED|Phase 2a||0
9000752|NCT02895360|10064291|FG004|COMPLETED|Phase 2a||0
9000753|NCT02895360|10064292|FG005|COMPLETED|Phase 2a||0
9000754|NCT02895360|10064287|FG000|NOT COMPLETED|Phase 2a||0
9000755|NCT02895360|10064288|FG001|NOT COMPLETED|Phase 2a||0
9000756|NCT02895360|10064289|FG002|NOT COMPLETED|Phase 2a||0
9000757|NCT02895360|10064290|FG003|NOT COMPLETED|Phase 2a||0
9000758|NCT02895360|10064291|FG004|NOT COMPLETED|Phase 2a||11
8879620|NCT01934218|9936353|FG000|COMPLETED|Double-blind Phase||356
8879621|NCT01934218|9936354|FG001|COMPLETED|Double-blind Phase||356
8879622|NCT01934218|9936353|FG000|NOT COMPLETED|Double-blind Phase||48
8879623|NCT01934218|9936354|FG001|NOT COMPLETED|Double-blind Phase||54
8879624|NCT01934218|9936353|FG000|STARTED|Open-Label Phase||316
8879625|NCT01934218|9936354|FG001|STARTED|Open-Label Phase||328
8879626|NCT01934218|9936353|FG000|COMPLETED|Open-Label Phase||290
8879627|NCT01934218|9936354|FG001|COMPLETED|Open-Label Phase||304
8879628|NCT01934218|9936353|FG000|NOT COMPLETED|Open-Label Phase||26
8879629|NCT01934218|9936354|FG001|NOT COMPLETED|Open-Label Phase||24
8879630|NCT01934231|9936360|FG000|STARTED|Overall Study||27
8879631|NCT01934231|9936360|FG000|COMPLETED|Overall Study||27
8879632|NCT01934231|9936360|FG000|NOT COMPLETED|Overall Study||0
8879633|NCT01934335|9936366|FG000|STARTED|Overall Study||7
8879634|NCT01934335|9936367|FG001|STARTED|Overall Study||5
8879635|NCT01934335|9936366|FG000|COMPLETED|Overall Study||6
8879636|NCT01934335|9936367|FG001|COMPLETED|Overall Study||4
8879637|NCT01934335|9936366|FG000|NOT COMPLETED|Overall Study||1
8879638|NCT01934335|9936367|FG001|NOT COMPLETED|Overall Study||1
8879639|NCT01934517|9936373|FG000|STARTED|Overall Study||25
8879640|NCT01934517|9936373|FG000|COMPLETED|Overall Study||25
8879641|NCT01934517|9936373|FG000|NOT COMPLETED|Overall Study||0
8879642|NCT01934556|9936384|FG000|STARTED|Overall Study||30
8879643|NCT01934556|9936385|FG001|STARTED|Overall Study||60
8879644|NCT01934556|9936386|FG002|STARTED|Overall Study||60
8879645|NCT01934556|9936384|FG000|COMPLETED|Overall Study||25
8879646|NCT01934556|9936385|FG001|COMPLETED|Overall Study||44
8879647|NCT01934556|9936386|FG002|COMPLETED|Overall Study||50
8879648|NCT01934556|9936384|FG000|NOT COMPLETED|Overall Study||5
8879649|NCT01934556|9936385|FG001|NOT COMPLETED|Overall Study||16
8879650|NCT01934556|9936386|FG002|NOT COMPLETED|Overall Study||10
8879651|NCT01934582|9936394|FG000|STARTED|Overall Study||13
8879652|NCT01934582|9936394|FG000|COMPLETED|Overall Study||13
8879653|NCT01934582|9936394|FG000|NOT COMPLETED|Overall Study||0
8879654|NCT01934790|9936400|FG000|STARTED|Treatment|Eligible for treatment|45
8879655|NCT01934790|9936400|FG000|Participants Received Study Treatment|Treatment||44
8879656|NCT01934790|9936400|FG000|COMPLETED|Treatment||29
8879657|NCT01934790|9936400|FG000|NOT COMPLETED|Treatment||16
8879658|NCT01934790|9936400|FG000|STARTED|Active Follow up||34
8879659|NCT01934790|9936400|FG000|COMPLETED|Active Follow up||10
8879660|NCT01934790|9936400|FG000|NOT COMPLETED|Active Follow up||24
8879661|NCT01934790|9936400|FG000|STARTED|Long Term Follow up||12
8879662|NCT01934790|9936400|FG000|COMPLETED|Long Term Follow up||12
8879663|NCT01934790|9936400|FG000|NOT COMPLETED|Long Term Follow up||0
8879664|NCT01934894|9936406|FG000|STARTED|Overall Study||6
9000759|NCT02895360|10064292|FG005|NOT COMPLETED|Phase 2a||12
9000760|NCT02895945|10064326|FG000|STARTED|Overall Study||7
9000761|NCT02895945|10064327|FG001|STARTED|Overall Study||1
8634005|NCT00554216|9674267|FG001|NOT COMPLETED|Overall Study||94
8634006|NCT00554216|9674268|FG002|NOT COMPLETED|Overall Study||172
8634007|NCT00554229|9674278|FG000|STARTED|Overall Study||299
8879665|NCT01934894|9936407|FG001|STARTED|Overall Study||5
8879666|NCT01934894|9936406|FG000|COMPLETED|Overall Study||0
9000762|NCT02895945|10064326|FG000|SAS|Overall Study||7
9000763|NCT02895945|10064327|FG001|SAS|Overall Study||1
9000764|NCT02895945|10064326|FG000|FAS|Overall Study||7
9000765|NCT02895945|10064327|FG001|FAS|Overall Study||0
9000766|NCT02895945|10064326|FG000|COMPLETED|Overall Study||5
9000767|NCT02895945|10064327|FG001|COMPLETED|Overall Study||0
8879667|NCT01934894|9936407|FG001|COMPLETED|Overall Study||0
8879668|NCT01934894|9936406|FG000|NOT COMPLETED|Overall Study||6
8879669|NCT01934894|9936407|FG001|NOT COMPLETED|Overall Study||5
8879670|NCT01934972|9936418|FG000|STARTED|Overall Study||13
8879671|NCT01934972|9936419|FG001|STARTED|Overall Study||11
8879672|NCT01934972|9936418|FG000|COMPLETED|Overall Study||4
8879673|NCT01934972|9936419|FG001|COMPLETED|Overall Study||5
8879674|NCT01934972|9936418|FG000|NOT COMPLETED|Overall Study||9
8879675|NCT01934972|9936419|FG001|NOT COMPLETED|Overall Study||6
9000768|NCT02895945|10064326|FG000|NOT COMPLETED|Overall Study||2
9000769|NCT02895945|10064327|FG001|NOT COMPLETED|Overall Study||1
9000770|NCT02896075|10064333|FG000|STARTED|Overall Study||40
9000771|NCT02896075|10064333|FG000|Leg Soreness|Overall Study||40
9000772|NCT02896075|10064333|FG000|COMPLETED|Overall Study||40
9000773|NCT02896075|10064333|FG000|NOT COMPLETED|Overall Study||0
9000774|NCT02896127|10064342|FG000|STARTED|COMPLETED WEEK 52||305
9000775|NCT02896127|10064343|FG001|STARTED|COMPLETED WEEK 52|Includes participants originally assigned to placebo and switched to AIN457150 mg after Wk 16.|153
9000776|NCT02896127|10064342|FG000|COMPLETED|COMPLETED WEEK 52||278
9000777|NCT02896127|10064343|FG001|COMPLETED|COMPLETED WEEK 52||142
9000778|NCT02896127|10064342|FG000|NOT COMPLETED|COMPLETED WEEK 52||27
9000779|NCT02896127|10064343|FG001|NOT COMPLETED|COMPLETED WEEK 52||11
9000780|NCT02896127|10064342|FG000|STARTED|COMPLETED POST-TREATMENT FOLLOW UP|Participants enter follow-up if they exited before Wk 52 Thus numbers different from previous period|280
9000781|NCT02896127|10064343|FG001|STARTED|COMPLETED POST-TREATMENT FOLLOW UP|Participants enter follow-up if they exited before Wk 52 Thus numbers different from previous period|139
9000782|NCT02896127|10064342|FG000|COMPLETED|COMPLETED POST-TREATMENT FOLLOW UP|Participants enter follow-up if they exited before Wk 52 Thus numbers different from previous period|276
9000783|NCT02896127|10064343|FG001|COMPLETED|COMPLETED POST-TREATMENT FOLLOW UP|Participants enter follow-up if they exited before Wk 52 Thus numbers different from previous period|134
9000784|NCT02896127|10064342|FG000|NOT COMPLETED|COMPLETED POST-TREATMENT FOLLOW UP||4
9000785|NCT02896127|10064343|FG001|NOT COMPLETED|COMPLETED POST-TREATMENT FOLLOW UP||5
9000786|NCT02896296|10064349|FG000|STARTED|Overall Study||208
9000787|NCT02896296|10064349|FG000|COMPLETED|Overall Study||166
9000788|NCT02896296|10064349|FG000|NOT COMPLETED|Overall Study||42
9000789|NCT02896361|10064353|FG000|STARTED|First Intervention (2 Weeks)||9
9000790|NCT02896361|10064354|FG001|STARTED|First Intervention (2 Weeks)||10
9000791|NCT02896361|10064355|FG002|STARTED|First Intervention (2 Weeks)||8
9000792|NCT02896361|10064353|FG000|COMPLETED|First Intervention (2 Weeks)||9
9000793|NCT02896361|10064354|FG001|COMPLETED|First Intervention (2 Weeks)||10
9000794|NCT02896361|10064355|FG002|COMPLETED|First Intervention (2 Weeks)||8
9000795|NCT02896361|10064353|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0
9000796|NCT02896361|10064354|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0
9000797|NCT02896361|10064355|FG002|NOT COMPLETED|First Intervention (2 Weeks)||0
9000798|NCT02896361|10064353|FG000|STARTED|Second Intervention (2 Weeks)||9
9000799|NCT02896361|10064354|FG001|STARTED|Second Intervention (2 Weeks)||10
9000800|NCT02896361|10064355|FG002|STARTED|Second Intervention (2 Weeks)||8
9000801|NCT02896361|10064353|FG000|COMPLETED|Second Intervention (2 Weeks)||9
9000802|NCT02896361|10064354|FG001|COMPLETED|Second Intervention (2 Weeks)||10
9000803|NCT02896361|10064355|FG002|COMPLETED|Second Intervention (2 Weeks)||8
9000804|NCT02896361|10064353|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0
9000805|NCT02896361|10064354|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0
9000806|NCT02896361|10064355|FG002|NOT COMPLETED|Second Intervention (2 Weeks)||0
9000807|NCT02896361|10064353|FG000|STARTED|Third Intervention (2 Weeks)||9
9000808|NCT02896361|10064354|FG001|STARTED|Third Intervention (2 Weeks)||10
9000809|NCT02896361|10064355|FG002|STARTED|Third Intervention (2 Weeks)||8
9000810|NCT02896361|10064353|FG000|COMPLETED|Third Intervention (2 Weeks)||8
9000811|NCT02896361|10064354|FG001|COMPLETED|Third Intervention (2 Weeks)||9
9000812|NCT02896361|10064355|FG002|COMPLETED|Third Intervention (2 Weeks)||8
9000813|NCT02896361|10064353|FG000|NOT COMPLETED|Third Intervention (2 Weeks)||1
9000814|NCT02896361|10064354|FG001|NOT COMPLETED|Third Intervention (2 Weeks)||1
9000815|NCT02896361|10064355|FG002|NOT COMPLETED|Third Intervention (2 Weeks)||0
9000816|NCT02896400|10064383|FG000|STARTED|Baseline||66
9000817|NCT02896400|10064384|FG001|STARTED|Baseline||66
9000818|NCT02896400|10064385|FG002|STARTED|Baseline||66
9000819|NCT02896400|10064386|FG003|STARTED|Baseline||66
9000820|NCT02896400|10064387|FG004|STARTED|Baseline||66
9000821|NCT02896400|10064388|FG005|STARTED|Baseline||66
9000822|NCT02896400|10064389|FG006|STARTED|Baseline||66
9000823|NCT02896400|10064390|FG007|STARTED|Baseline||66
9000824|NCT02896400|10064391|FG008|STARTED|Baseline||66
9000825|NCT02896400|10064392|FG009|STARTED|Baseline||66
9000826|NCT02896400|10064393|FG010|STARTED|Baseline||66
9000827|NCT02896400|10064394|FG011|STARTED|Baseline||66
9000828|NCT02896400|10064395|FG012|STARTED|Baseline||66
9000829|NCT02896400|10064396|FG013|STARTED|Baseline||66
9000830|NCT02896400|10064397|FG014|STARTED|Baseline||66
9000831|NCT02896400|10064398|FG015|STARTED|Baseline||66
9000832|NCT02896400|10064383|FG000|COMPLETED|Baseline||66
9000833|NCT02896400|10064384|FG001|COMPLETED|Baseline||66
9000834|NCT02896400|10064385|FG002|COMPLETED|Baseline||66
9000835|NCT02896400|10064386|FG003|COMPLETED|Baseline||66
9000836|NCT02896400|10064387|FG004|COMPLETED|Baseline||66
9000837|NCT02896400|10064388|FG005|COMPLETED|Baseline||66
9000838|NCT02896400|10064389|FG006|COMPLETED|Baseline||66
9000839|NCT02896400|10064390|FG007|COMPLETED|Baseline||66
9000840|NCT02896400|10064391|FG008|COMPLETED|Baseline||66
9000841|NCT02896400|10064392|FG009|COMPLETED|Baseline||66
9000842|NCT02896400|10064393|FG010|COMPLETED|Baseline||66
8879676|NCT01935180|9936427|FG000|STARTED|Overall Study||573
8879677|NCT01935180|9936428|FG001|STARTED|Overall Study||575
8879678|NCT01935180|9936427|FG000|COMPLETED|Overall Study||552
8879679|NCT01935180|9936428|FG001|COMPLETED|Overall Study||561
8879680|NCT01935180|9936427|FG000|NOT COMPLETED|Overall Study||21
8879681|NCT01935180|9936428|FG001|NOT COMPLETED|Overall Study||14
9000843|NCT02896400|10064394|FG011|COMPLETED|Baseline||66
9000844|NCT02896400|10064395|FG012|COMPLETED|Baseline||66
9000845|NCT02896400|10064396|FG013|COMPLETED|Baseline||66
9000846|NCT02896400|10064397|FG014|COMPLETED|Baseline||66
9000847|NCT02896400|10064398|FG015|COMPLETED|Baseline||66
9000848|NCT02896400|10064383|FG000|NOT COMPLETED|Baseline||0
9000849|NCT02896400|10064384|FG001|NOT COMPLETED|Baseline||0
9000850|NCT02896400|10064385|FG002|NOT COMPLETED|Baseline||0
9000851|NCT02896400|10064386|FG003|NOT COMPLETED|Baseline||0
9000852|NCT02896400|10064387|FG004|NOT COMPLETED|Baseline||0
9000853|NCT02896400|10064388|FG005|NOT COMPLETED|Baseline||0
9000854|NCT02896400|10064389|FG006|NOT COMPLETED|Baseline||0
9000855|NCT02896400|10064390|FG007|NOT COMPLETED|Baseline||0
9000856|NCT02896400|10064391|FG008|NOT COMPLETED|Baseline||0
9000857|NCT02896400|10064392|FG009|NOT COMPLETED|Baseline||0
8879682|NCT01935622|9936437|FG000|STARTED|Overall Study||3
8879683|NCT01935622|9936438|FG001|STARTED|Overall Study||3
8879684|NCT01935622|9936439|FG002|STARTED|Overall Study||4
8879685|NCT01935622|9936437|FG000|COMPLETED|Overall Study||1
8879686|NCT01935622|9936438|FG001|COMPLETED|Overall Study||1
8879687|NCT01935622|9936439|FG002|COMPLETED|Overall Study||4
8879688|NCT01935622|9936437|FG000|NOT COMPLETED|Overall Study||2
8879689|NCT01935622|9936438|FG001|NOT COMPLETED|Overall Study||2
8879690|NCT01935622|9936439|FG002|NOT COMPLETED|Overall Study||0
8879691|NCT01935700|9936449|FG000|STARTED|Overall Study||14
8879692|NCT01935700|9936450|FG001|STARTED|Overall Study||86
8879693|NCT01935700|9936449|FG000|COMPLETED|Overall Study||9
8879694|NCT01935700|9936450|FG001|COMPLETED|Overall Study||86
8879695|NCT01935700|9936449|FG000|NOT COMPLETED|Overall Study||5
9000858|NCT02896400|10064393|FG010|NOT COMPLETED|Baseline||0
9000859|NCT02896400|10064394|FG011|NOT COMPLETED|Baseline||0
9000860|NCT02896400|10064395|FG012|NOT COMPLETED|Baseline||0
9000861|NCT02896400|10064396|FG013|NOT COMPLETED|Baseline||0
9000862|NCT02896400|10064397|FG014|NOT COMPLETED|Baseline||0
9000863|NCT02896400|10064398|FG015|NOT COMPLETED|Baseline||0
9000864|NCT02896400|10064383|FG000|STARTED|1 Month Follow-up||66
9000865|NCT02896400|10064384|FG001|STARTED|1 Month Follow-up||66
9000866|NCT02896400|10064385|FG002|STARTED|1 Month Follow-up||66
9000867|NCT02896400|10064386|FG003|STARTED|1 Month Follow-up||66
9000868|NCT02896400|10064387|FG004|STARTED|1 Month Follow-up||66
9000869|NCT02896400|10064388|FG005|STARTED|1 Month Follow-up||66
9000870|NCT02896400|10064389|FG006|STARTED|1 Month Follow-up||66
9000871|NCT02896400|10064390|FG007|STARTED|1 Month Follow-up||66
9000872|NCT02896400|10064391|FG008|STARTED|1 Month Follow-up||66
9000873|NCT02896400|10064392|FG009|STARTED|1 Month Follow-up||66
9000874|NCT02896400|10064393|FG010|STARTED|1 Month Follow-up||66
9000875|NCT02896400|10064394|FG011|STARTED|1 Month Follow-up||66
9000876|NCT02896400|10064395|FG012|STARTED|1 Month Follow-up||66
9000877|NCT02896400|10064396|FG013|STARTED|1 Month Follow-up||66
9000878|NCT02896400|10064397|FG014|STARTED|1 Month Follow-up||66
9000879|NCT02896400|10064398|FG015|STARTED|1 Month Follow-up||66
9000880|NCT02896400|10064383|FG000|COMPLETED|1 Month Follow-up||59
9000881|NCT02896400|10064384|FG001|COMPLETED|1 Month Follow-up||59
9000882|NCT02896400|10064385|FG002|COMPLETED|1 Month Follow-up||61
9000883|NCT02896400|10064386|FG003|COMPLETED|1 Month Follow-up||58
9000884|NCT02896400|10064387|FG004|COMPLETED|1 Month Follow-up||57
9000885|NCT02896400|10064388|FG005|COMPLETED|1 Month Follow-up||60
9000886|NCT02896400|10064389|FG006|COMPLETED|1 Month Follow-up||61
8572497|NCT00114777|9604669|FG000|COMPLETED|Long-Term Extension to Month 84||74
8572498|NCT00114777|9604670|FG001|COMPLETED|Long-Term Extension to Month 84||84
8572499|NCT00114777|9604671|FG002|COMPLETED|Long-Term Extension to Month 84||57
8572500|NCT00114777|9604669|FG000|NOT COMPLETED|Long-Term Extension to Month 84||30
8572501|NCT00114777|9604670|FG001|NOT COMPLETED|Long-Term Extension to Month 84||29
8572502|NCT00114777|9604671|FG002|NOT COMPLETED|Long-Term Extension to Month 84||30
8572503|NCT00114959|9604680|FG000|STARTED|Overall Study||15
8572504|NCT00114959|9604680|FG000|COMPLETED|Overall Study|protocol definition of completed study is having received >= 4 cycles of treatment|7
8572505|NCT00114959|9604680|FG000|NOT COMPLETED|Overall Study||8
8879696|NCT01935700|9936450|FG001|NOT COMPLETED|Overall Study||0
8879697|NCT01935791|9936458|FG000|STARTED|Period 1||4
8879698|NCT01935791|9936459|FG001|STARTED|Period 1||4
8879699|NCT01935791|9936460|FG002|STARTED|Period 1||3
8879700|NCT01935791|9936461|FG003|STARTED|Period 1||0
8879701|NCT01935791|9936462|FG004|STARTED|Period 1||0
8879702|NCT01935791|9936463|FG005|STARTED|Period 1||0
8879703|NCT01935791|9936464|FG006|STARTED|Period 1||0
8879704|NCT01935791|9936465|FG007|STARTED|Period 1||0
9000887|NCT02896400|10064390|FG007|COMPLETED|1 Month Follow-up||60
9000888|NCT02896400|10064391|FG008|COMPLETED|1 Month Follow-up||62
9000889|NCT02896400|10064392|FG009|COMPLETED|1 Month Follow-up||59
9000890|NCT02896400|10064393|FG010|COMPLETED|1 Month Follow-up||61
9000891|NCT02896400|10064394|FG011|COMPLETED|1 Month Follow-up||61
9000892|NCT02896400|10064395|FG012|COMPLETED|1 Month Follow-up||63
9000893|NCT02896400|10064396|FG013|COMPLETED|1 Month Follow-up||62
9000894|NCT02896400|10064397|FG014|COMPLETED|1 Month Follow-up||65
9000895|NCT02896400|10064398|FG015|COMPLETED|1 Month Follow-up||63
9000896|NCT02896400|10064383|FG000|NOT COMPLETED|1 Month Follow-up||7
9000897|NCT02896400|10064384|FG001|NOT COMPLETED|1 Month Follow-up||7
9000898|NCT02896400|10064385|FG002|NOT COMPLETED|1 Month Follow-up||5
9000899|NCT02896400|10064386|FG003|NOT COMPLETED|1 Month Follow-up||8
9000900|NCT02896400|10064387|FG004|NOT COMPLETED|1 Month Follow-up||9
9000901|NCT02896400|10064388|FG005|NOT COMPLETED|1 Month Follow-up||6
9000902|NCT02896400|10064389|FG006|NOT COMPLETED|1 Month Follow-up||5
9000903|NCT02896400|10064390|FG007|NOT COMPLETED|1 Month Follow-up||6
9000904|NCT02896400|10064391|FG008|NOT COMPLETED|1 Month Follow-up||4
9000905|NCT02896400|10064392|FG009|NOT COMPLETED|1 Month Follow-up||7
9000906|NCT02896400|10064393|FG010|NOT COMPLETED|1 Month Follow-up||5
9000907|NCT02896400|10064394|FG011|NOT COMPLETED|1 Month Follow-up||5
9000908|NCT02896400|10064395|FG012|NOT COMPLETED|1 Month Follow-up||3
9000909|NCT02896400|10064396|FG013|NOT COMPLETED|1 Month Follow-up||4
9000910|NCT02896400|10064397|FG014|NOT COMPLETED|1 Month Follow-up||1
9000911|NCT02896400|10064398|FG015|NOT COMPLETED|1 Month Follow-up||3
9000912|NCT02896400|10064383|FG000|STARTED|3 Month Follow-up||66
9000913|NCT02896400|10064384|FG001|STARTED|3 Month Follow-up||66
9000914|NCT02896400|10064385|FG002|STARTED|3 Month Follow-up||66
9000915|NCT02896400|10064386|FG003|STARTED|3 Month Follow-up||66
9000916|NCT02896400|10064387|FG004|STARTED|3 Month Follow-up||66
8634008|NCT00554229|9674279|FG001|STARTED|Overall Study||295
8634009|NCT00554229|9674278|FG000|Patients Who Received Treatment|Overall Study||298
8634010|NCT00554229|9674279|FG001|Patients Who Received Treatment|Overall Study||295
8634011|NCT00554229|9674278|FG000|COMPLETED|Overall Study||73
8879705|NCT01935791|9936466|FG008|STARTED|Period 1||0
8879706|NCT01935791|9936458|FG000|COMPLETED|Period 1||4
9000917|NCT02896400|10064388|FG005|STARTED|3 Month Follow-up||66
9000918|NCT02896400|10064389|FG006|STARTED|3 Month Follow-up||66
9000919|NCT02896400|10064390|FG007|STARTED|3 Month Follow-up||66
9000920|NCT02896400|10064391|FG008|STARTED|3 Month Follow-up||66
9000921|NCT02896400|10064392|FG009|STARTED|3 Month Follow-up||66
9000922|NCT02896400|10064393|FG010|STARTED|3 Month Follow-up||66
9000923|NCT02896400|10064394|FG011|STARTED|3 Month Follow-up||66
9000924|NCT02896400|10064395|FG012|STARTED|3 Month Follow-up||66
9000925|NCT02896400|10064396|FG013|STARTED|3 Month Follow-up||66
9000926|NCT02896400|10064397|FG014|STARTED|3 Month Follow-up||66
9000927|NCT02896400|10064398|FG015|STARTED|3 Month Follow-up||65
9000928|NCT02896400|10064383|FG000|COMPLETED|3 Month Follow-up||60
9000929|NCT02896400|10064384|FG001|COMPLETED|3 Month Follow-up||63
9000930|NCT02896400|10064385|FG002|COMPLETED|3 Month Follow-up||60
9000931|NCT02896400|10064386|FG003|COMPLETED|3 Month Follow-up||55
9000932|NCT02896400|10064387|FG004|COMPLETED|3 Month Follow-up||54
9000933|NCT02896400|10064388|FG005|COMPLETED|3 Month Follow-up||60
9000934|NCT02896400|10064389|FG006|COMPLETED|3 Month Follow-up||62
9000935|NCT02896400|10064390|FG007|COMPLETED|3 Month Follow-up||63
8879707|NCT01935791|9936459|FG001|COMPLETED|Period 1||4
8879708|NCT01935791|9936460|FG002|COMPLETED|Period 1||3
8879709|NCT01935791|9936461|FG003|COMPLETED|Period 1||0
8879710|NCT01935791|9936462|FG004|COMPLETED|Period 1||0
8879711|NCT01935791|9936463|FG005|COMPLETED|Period 1||0
8879712|NCT01935791|9936464|FG006|COMPLETED|Period 1||0
8879713|NCT01935791|9936465|FG007|COMPLETED|Period 1||0
8879714|NCT01935791|9936466|FG008|COMPLETED|Period 1||0
8879715|NCT01935791|9936458|FG000|NOT COMPLETED|Period 1||0
8879716|NCT01935791|9936459|FG001|NOT COMPLETED|Period 1||0
8879717|NCT01935791|9936460|FG002|NOT COMPLETED|Period 1||0
8879718|NCT01935791|9936461|FG003|NOT COMPLETED|Period 1||0
8879719|NCT01935791|9936462|FG004|NOT COMPLETED|Period 1||0
8879720|NCT01935791|9936463|FG005|NOT COMPLETED|Period 1||0
8879721|NCT01935791|9936464|FG006|NOT COMPLETED|Period 1||0
8879722|NCT01935791|9936465|FG007|NOT COMPLETED|Period 1||0
8879723|NCT01935791|9936466|FG008|NOT COMPLETED|Period 1||0
8879724|NCT01935791|9936458|FG000|STARTED|Period 2||0
8879725|NCT01935791|9936459|FG001|STARTED|Period 2||0
8879726|NCT01935791|9936460|FG002|STARTED|Period 2||0
8879727|NCT01935791|9936461|FG003|STARTED|Period 2||2
8879728|NCT01935791|9936462|FG004|STARTED|Period 2||3
8879729|NCT01935791|9936463|FG005|STARTED|Period 2||1
8879730|NCT01935791|9936464|FG006|STARTED|Period 2||1
8879731|NCT01935791|9936465|FG007|STARTED|Period 2||3
8879732|NCT01935791|9936466|FG008|STARTED|Period 2||1
8879733|NCT01935791|9936458|FG000|COMPLETED|Period 2||0
8879734|NCT01935791|9936459|FG001|COMPLETED|Period 2||0
9000936|NCT02896400|10064391|FG008|COMPLETED|3 Month Follow-up||60
9000937|NCT02896400|10064392|FG009|COMPLETED|3 Month Follow-up||61
9000938|NCT02896400|10064393|FG010|COMPLETED|3 Month Follow-up||60
8634012|NCT00554229|9674279|FG001|COMPLETED|Overall Study||70
8879735|NCT01935791|9936460|FG002|COMPLETED|Period 2||0
8879736|NCT01935791|9936461|FG003|COMPLETED|Period 2||2
8879737|NCT01935791|9936462|FG004|COMPLETED|Period 2||3
8879738|NCT01935791|9936463|FG005|COMPLETED|Period 2||1
8879739|NCT01935791|9936464|FG006|COMPLETED|Period 2||1
8879740|NCT01935791|9936465|FG007|COMPLETED|Period 2||3
8879741|NCT01935791|9936466|FG008|COMPLETED|Period 2||1
8879742|NCT01935791|9936458|FG000|NOT COMPLETED|Period 2||0
8879743|NCT01935791|9936459|FG001|NOT COMPLETED|Period 2||0
8879744|NCT01935791|9936460|FG002|NOT COMPLETED|Period 2||0
8879745|NCT01935791|9936461|FG003|NOT COMPLETED|Period 2||0
8879746|NCT01935791|9936462|FG004|NOT COMPLETED|Period 2||0
8879747|NCT01935791|9936463|FG005|NOT COMPLETED|Period 2||0
9000939|NCT02896400|10064394|FG011|COMPLETED|3 Month Follow-up||60
9000940|NCT02896400|10064395|FG012|COMPLETED|3 Month Follow-up||63
9000941|NCT02896400|10064396|FG013|COMPLETED|3 Month Follow-up||60
9000942|NCT02896400|10064397|FG014|COMPLETED|3 Month Follow-up||62
9000943|NCT02896400|10064398|FG015|COMPLETED|3 Month Follow-up||63
9000944|NCT02896400|10064383|FG000|NOT COMPLETED|3 Month Follow-up||6
9000945|NCT02896400|10064384|FG001|NOT COMPLETED|3 Month Follow-up||3
9000946|NCT02896400|10064385|FG002|NOT COMPLETED|3 Month Follow-up||6
9000947|NCT02896400|10064386|FG003|NOT COMPLETED|3 Month Follow-up||11
9000948|NCT02896400|10064387|FG004|NOT COMPLETED|3 Month Follow-up||12
9000949|NCT02896400|10064388|FG005|NOT COMPLETED|3 Month Follow-up||6
9000950|NCT02896400|10064389|FG006|NOT COMPLETED|3 Month Follow-up||4
9000951|NCT02896400|10064390|FG007|NOT COMPLETED|3 Month Follow-up||3
9000952|NCT02896400|10064391|FG008|NOT COMPLETED|3 Month Follow-up||6
9000953|NCT02896400|10064392|FG009|NOT COMPLETED|3 Month Follow-up||5
8572506|NCT00114972|9604686|FG000|STARTED|Overall Study||897
8572507|NCT00114972|9604687|FG001|STARTED|Overall Study||903
8572508|NCT00114972|9604686|FG000|COMPLETED|Overall Study||849
8572509|NCT00114972|9604687|FG001|COMPLETED|Overall Study||891
8572510|NCT00114972|9604686|FG000|NOT COMPLETED|Overall Study||48
8572511|NCT00114972|9604687|FG001|NOT COMPLETED|Overall Study||12
8572512|NCT00115037|9604695|FG000|STARTED|Phase1||152
8572513|NCT00115037|9604696|FG001|STARTED|Phase1||150
8572514|NCT00115037|9604697|FG002|STARTED|Phase1||0
8572515|NCT00115037|9604698|FG003|STARTED|Phase1||0
8572516|NCT00115037|9604699|FG004|STARTED|Phase1||0
8572517|NCT00115037|9604700|FG005|STARTED|Phase1||0
8572518|NCT00115037|9604695|FG000|COMPLETED|Phase1||127
8572519|NCT00115037|9604696|FG001|COMPLETED|Phase1||123
8572520|NCT00115037|9604697|FG002|COMPLETED|Phase1||0
8572521|NCT00115037|9604698|FG003|COMPLETED|Phase1||0
8572522|NCT00115037|9604699|FG004|COMPLETED|Phase1||0
8572523|NCT00115037|9604700|FG005|COMPLETED|Phase1||0
8572524|NCT00115037|9604695|FG000|NOT COMPLETED|Phase1||25
8572525|NCT00115037|9604696|FG001|NOT COMPLETED|Phase1||27
8572526|NCT00115037|9604697|FG002|NOT COMPLETED|Phase1||0
8572527|NCT00115037|9604698|FG003|NOT COMPLETED|Phase1||0
8572528|NCT00115037|9604699|FG004|NOT COMPLETED|Phase1||0
8572529|NCT00115037|9604700|FG005|NOT COMPLETED|Phase1||0
8572530|NCT00115037|9604695|FG000|STARTED|Phase2||0
8572531|NCT00115037|9604696|FG001|STARTED|Phase2||0
8572532|NCT00115037|9604697|FG002|STARTED|Phase2||91
8572533|NCT00115037|9604698|FG003|STARTED|Phase2||92
8572534|NCT00115037|9604699|FG004|STARTED|Phase2||34
8572535|NCT00115037|9604700|FG005|STARTED|Phase2||33
8572536|NCT00115037|9604695|FG000|COMPLETED|Phase2||0
8572537|NCT00115037|9604696|FG001|COMPLETED|Phase2||0
8572538|NCT00115037|9604697|FG002|COMPLETED|Phase2||76
8572539|NCT00115037|9604698|FG003|COMPLETED|Phase2||77
8572540|NCT00115037|9604699|FG004|COMPLETED|Phase2||28
8572541|NCT00115037|9604700|FG005|COMPLETED|Phase2||21
8572542|NCT00115037|9604695|FG000|NOT COMPLETED|Phase2||0
8572543|NCT00115037|9604696|FG001|NOT COMPLETED|Phase2||0
8572544|NCT00115037|9604697|FG002|NOT COMPLETED|Phase2||15
8572545|NCT00115037|9604698|FG003|NOT COMPLETED|Phase2||15
8572546|NCT00115037|9604699|FG004|NOT COMPLETED|Phase2||6
8572547|NCT00115037|9604700|FG005|NOT COMPLETED|Phase2||12
8572548|NCT00115063|9604716|FG000|STARTED|Overall Study||200
8572549|NCT00115063|9604717|FG001|STARTED|Overall Study||190
8572550|NCT00115063|9604716|FG000|COMPLETED|Overall Study||101
8572551|NCT00115063|9604717|FG001|COMPLETED|Overall Study||86
8572552|NCT00115063|9604716|FG000|NOT COMPLETED|Overall Study||99
8572553|NCT00115063|9604717|FG001|NOT COMPLETED|Overall Study||104
8572554|NCT00115076|9604723|FG000|STARTED|Overall Study||30
8572555|NCT00115076|9604723|FG000|COMPLETED|Overall Study||30
8572556|NCT00115076|9604723|FG000|NOT COMPLETED|Overall Study||0
8572557|NCT00115297|9604729|FG000|STARTED|Overall Study||30
8572558|NCT00115297|9604730|FG001|STARTED|Overall Study||32
8572559|NCT00115297|9604729|FG000|COMPLETED|Overall Study||30
8572560|NCT00115297|9604730|FG001|COMPLETED|Overall Study||32
8572561|NCT00115297|9604729|FG000|NOT COMPLETED|Overall Study||0
9000954|NCT02896400|10064393|FG010|NOT COMPLETED|3 Month Follow-up||6
9000955|NCT02896400|10064394|FG011|NOT COMPLETED|3 Month Follow-up||6
8572562|NCT00115297|9604730|FG001|NOT COMPLETED|Overall Study||0
8572563|NCT00115336|9604741|FG000|STARTED|Overall Study||6
8572564|NCT00115336|9604742|FG001|STARTED|Overall Study||4
8572565|NCT00115336|9604741|FG000|COMPLETED|Overall Study||6
8572566|NCT00115336|9604742|FG001|COMPLETED|Overall Study||3
9000956|NCT02896400|10064395|FG012|NOT COMPLETED|3 Month Follow-up||3
8572567|NCT00115336|9604741|FG000|NOT COMPLETED|Overall Study||0
8572568|NCT00115336|9604742|FG001|NOT COMPLETED|Overall Study||1
8572569|NCT00115349|9604752|FG000|STARTED|Overall Study|Target was 43 subjects in this arm.|11
9000957|NCT02896400|10064396|FG013|NOT COMPLETED|3 Month Follow-up||6
8634013|NCT00554229|9674278|FG000|NOT COMPLETED|Overall Study||226
8634014|NCT00554229|9674279|FG001|NOT COMPLETED|Overall Study||225
8634015|NCT00554372|9674287|FG000|STARTED|Overall Study||14
8634016|NCT00554372|9674288|FG001|STARTED|Overall Study||16
8634017|NCT00554372|9674287|FG000|COMPLETED|Overall Study||14
8634018|NCT00554372|9674288|FG001|COMPLETED|Overall Study||16
9000958|NCT02896400|10064397|FG014|NOT COMPLETED|3 Month Follow-up||4
9000959|NCT02896400|10064398|FG015|NOT COMPLETED|3 Month Follow-up||2
9000960|NCT02896400|10064383|FG000|STARTED|Biochemical Verification at 3 Months||60
9000961|NCT02896400|10064384|FG001|STARTED|Biochemical Verification at 3 Months||63
9000962|NCT02896400|10064385|FG002|STARTED|Biochemical Verification at 3 Months||60
9000963|NCT02896400|10064386|FG003|STARTED|Biochemical Verification at 3 Months||55
9000964|NCT02896400|10064387|FG004|STARTED|Biochemical Verification at 3 Months||54
9000965|NCT02896400|10064388|FG005|STARTED|Biochemical Verification at 3 Months||60
9000966|NCT02896400|10064389|FG006|STARTED|Biochemical Verification at 3 Months||62
9000967|NCT02896400|10064390|FG007|STARTED|Biochemical Verification at 3 Months||63
9000968|NCT02896400|10064391|FG008|STARTED|Biochemical Verification at 3 Months||60
9000969|NCT02896400|10064392|FG009|STARTED|Biochemical Verification at 3 Months||61
9000970|NCT02896400|10064393|FG010|STARTED|Biochemical Verification at 3 Months||60
9000971|NCT02896400|10064394|FG011|STARTED|Biochemical Verification at 3 Months||60
9000972|NCT02896400|10064395|FG012|STARTED|Biochemical Verification at 3 Months||63
9000973|NCT02896400|10064396|FG013|STARTED|Biochemical Verification at 3 Months||60
9000974|NCT02896400|10064397|FG014|STARTED|Biochemical Verification at 3 Months||62
9000975|NCT02896400|10064398|FG015|STARTED|Biochemical Verification at 3 Months||63
9000976|NCT02896400|10064383|FG000|COMPLETED|Biochemical Verification at 3 Months||14
9000977|NCT02896400|10064384|FG001|COMPLETED|Biochemical Verification at 3 Months||15
9000978|NCT02896400|10064385|FG002|COMPLETED|Biochemical Verification at 3 Months||13
9000979|NCT02896400|10064386|FG003|COMPLETED|Biochemical Verification at 3 Months||14
9000980|NCT02896400|10064387|FG004|COMPLETED|Biochemical Verification at 3 Months||9
9000981|NCT02896400|10064388|FG005|COMPLETED|Biochemical Verification at 3 Months||11
9000982|NCT02896400|10064389|FG006|COMPLETED|Biochemical Verification at 3 Months||11
9000983|NCT02896400|10064390|FG007|COMPLETED|Biochemical Verification at 3 Months||14
9000984|NCT02896400|10064391|FG008|COMPLETED|Biochemical Verification at 3 Months||15
9000985|NCT02896400|10064392|FG009|COMPLETED|Biochemical Verification at 3 Months||8
9000986|NCT02896400|10064393|FG010|COMPLETED|Biochemical Verification at 3 Months||5
9000987|NCT02896400|10064394|FG011|COMPLETED|Biochemical Verification at 3 Months||19
9000988|NCT02896400|10064395|FG012|COMPLETED|Biochemical Verification at 3 Months||10
9000989|NCT02896400|10064396|FG013|COMPLETED|Biochemical Verification at 3 Months||12
9000990|NCT02896400|10064397|FG014|COMPLETED|Biochemical Verification at 3 Months||7
9000991|NCT02896400|10064398|FG015|COMPLETED|Biochemical Verification at 3 Months||6
8879748|NCT01935791|9936464|FG006|NOT COMPLETED|Period 2||0
8879749|NCT01935791|9936465|FG007|NOT COMPLETED|Period 2||0
8879750|NCT01935791|9936466|FG008|NOT COMPLETED|Period 2||0
9000992|NCT02896400|10064383|FG000|NOT COMPLETED|Biochemical Verification at 3 Months||46
9000993|NCT02896400|10064384|FG001|NOT COMPLETED|Biochemical Verification at 3 Months||48
9000994|NCT02896400|10064385|FG002|NOT COMPLETED|Biochemical Verification at 3 Months||47
9000995|NCT02896400|10064386|FG003|NOT COMPLETED|Biochemical Verification at 3 Months||41
9000996|NCT02896400|10064387|FG004|NOT COMPLETED|Biochemical Verification at 3 Months||45
9000997|NCT02896400|10064388|FG005|NOT COMPLETED|Biochemical Verification at 3 Months||49
9000998|NCT02896400|10064389|FG006|NOT COMPLETED|Biochemical Verification at 3 Months||51
9000999|NCT02896400|10064390|FG007|NOT COMPLETED|Biochemical Verification at 3 Months||49
9001000|NCT02896400|10064391|FG008|NOT COMPLETED|Biochemical Verification at 3 Months||45
9001001|NCT02896400|10064392|FG009|NOT COMPLETED|Biochemical Verification at 3 Months||53
9001002|NCT02896400|10064393|FG010|NOT COMPLETED|Biochemical Verification at 3 Months||55
8725925|NCT01033487|9773162|FG005|STARTED|Third Intervention Period||2
8879751|NCT01936181|9936482|FG000|STARTED|Randomised, Double-blind||291
8879752|NCT01936181|9936483|FG001|STARTED|Randomised, Double-blind||293
8879753|NCT01936181|9936484|FG002|STARTED|Randomised, Double-blind||0
8879754|NCT01936181|9936485|FG003|STARTED|Randomised, Double-blind||0
8879755|NCT01936181|9936482|FG000|COMPLETED|Randomised, Double-blind||227
8879756|NCT01936181|9936483|FG001|COMPLETED|Randomised, Double-blind||225
8879757|NCT01936181|9936484|FG002|COMPLETED|Randomised, Double-blind||0
8879758|NCT01936181|9936485|FG003|COMPLETED|Randomised, Double-blind||0
8879759|NCT01936181|9936482|FG000|NOT COMPLETED|Randomised, Double-blind||64
8879760|NCT01936181|9936483|FG001|NOT COMPLETED|Randomised, Double-blind||68
8879761|NCT01936181|9936484|FG002|NOT COMPLETED|Randomised, Double-blind||0
8879762|NCT01936181|9936485|FG003|NOT COMPLETED|Randomised, Double-blind||0
8879763|NCT01936181|9936482|FG000|STARTED|Transition-extension||201
8879764|NCT01936181|9936483|FG001|STARTED|Transition-extension||0
8634019|NCT00554372|9674287|FG000|NOT COMPLETED|Overall Study||0
8634020|NCT00554372|9674288|FG001|NOT COMPLETED|Overall Study||0
8634021|NCT00554463|9674296|FG000|STARTED|Overall Study||5
8634022|NCT00554463|9674296|FG000|COMPLETED|Overall Study||5
8879765|NCT01936181|9936484|FG002|STARTED|Transition-extension||94
8879766|NCT01936181|9936485|FG003|STARTED|Transition-extension||101
8879767|NCT01936181|9936482|FG000|COMPLETED|Transition-extension||186
8879768|NCT01936181|9936483|FG001|COMPLETED|Transition-extension||0
8879769|NCT01936181|9936484|FG002|COMPLETED|Transition-extension||88
9001003|NCT02896400|10064394|FG011|NOT COMPLETED|Biochemical Verification at 3 Months||41
9001004|NCT02896400|10064395|FG012|NOT COMPLETED|Biochemical Verification at 3 Months||53
9001005|NCT02896400|10064396|FG013|NOT COMPLETED|Biochemical Verification at 3 Months||48
9001006|NCT02896400|10064397|FG014|NOT COMPLETED|Biochemical Verification at 3 Months||55
9001007|NCT02896400|10064398|FG015|NOT COMPLETED|Biochemical Verification at 3 Months||57
9001008|NCT02896569|10064426|FG000|STARTED|Overall Study||25
9001009|NCT02896569|10064427|FG001|STARTED|Overall Study||24
9001010|NCT02896569|10064426|FG000|COMPLETED|Overall Study||21
9001011|NCT02896569|10064427|FG001|COMPLETED|Overall Study||19
9001012|NCT02896569|10064426|FG000|NOT COMPLETED|Overall Study||4
9001013|NCT02896569|10064427|FG001|NOT COMPLETED|Overall Study||5
9001014|NCT02896595|10064435|FG000|STARTED|Overall Study||50
9001015|NCT02896595|10064436|FG001|STARTED|Overall Study||50
9001016|NCT02896595|10064435|FG000|COMPLETED|Overall Study||50
9001017|NCT02896595|10064436|FG001|COMPLETED|Overall Study||50
9001018|NCT02896595|10064435|FG000|NOT COMPLETED|Overall Study||0
9001019|NCT02896595|10064436|FG001|NOT COMPLETED|Overall Study||0
9001020|NCT02896907|10064442|FG000|STARTED|Overall Study||8
9001021|NCT02896907|10064442|FG000|COMPLETED|Overall Study||8
9001022|NCT02896907|10064442|FG000|NOT COMPLETED|Overall Study||0
9001023|NCT02897115|10064448|FG000|STARTED|Overall Study||14
9001024|NCT02897115|10064449|FG001|STARTED|Overall Study||8
9001025|NCT02897115|10064448|FG000|COMPLETED|Overall Study||3
9001026|NCT02897115|10064449|FG001|COMPLETED|Overall Study||0
9001027|NCT02897115|10064448|FG000|NOT COMPLETED|Overall Study||11
9001028|NCT02897115|10064449|FG001|NOT COMPLETED|Overall Study||8
9001029|NCT02897141|10064457|FG000|STARTED|Overall Study||40
9001030|NCT02897141|10064458|FG001|STARTED|Overall Study||40
9001031|NCT02897141|10064457|FG000|COMPLETED|Overall Study||38
9001032|NCT02897141|10064458|FG001|COMPLETED|Overall Study||39
9001033|NCT02897141|10064457|FG000|NOT COMPLETED|Overall Study||2
9001034|NCT02897141|10064458|FG001|NOT COMPLETED|Overall Study||1
9001035|NCT02897349|10064477|FG000|STARTED|Overall Study||102
9001036|NCT02897349|10064478|FG001|STARTED|Overall Study||104
9001037|NCT02897349|10064477|FG000|COMPLETED|Overall Study||97
9001038|NCT02897349|10064478|FG001|COMPLETED|Overall Study||98
9001039|NCT02897349|10064477|FG000|NOT COMPLETED|Overall Study||5
9001040|NCT02897349|10064478|FG001|NOT COMPLETED|Overall Study||6
9001041|NCT02898077|10064486|FG000|STARTED|Overall Study||294
9001042|NCT02898077|10064487|FG001|STARTED|Overall Study||146
9001043|NCT02898077|10064486|FG000|Received at Least 1 Dose of Study Drug|Overall Study||293
9001044|NCT02898077|10064487|FG001|Received at Least 1 Dose of Study Drug|Overall Study||145
9001045|NCT02898077|10064486|FG000|COMPLETED|Overall Study||199
9001046|NCT02898077|10064487|FG001|COMPLETED|Overall Study||116
9001047|NCT02898077|10064486|FG000|NOT COMPLETED|Overall Study||95
9001048|NCT02898077|10064487|FG001|NOT COMPLETED|Overall Study||30
9001049|NCT02898103|10064495|FG000|STARTED|Overall Study||4
9001050|NCT02898103|10064496|FG001|STARTED|Overall Study||3
9001051|NCT02898103|10064495|FG000|COMPLETED|Overall Study||4
9001052|NCT02898103|10064496|FG001|COMPLETED|Overall Study||3
9001053|NCT02898103|10064495|FG000|NOT COMPLETED|Overall Study||0
9001054|NCT02898103|10064496|FG001|NOT COMPLETED|Overall Study||0
9001055|NCT02898116|10064506|FG000|STARTED|Overall Study||2
9001056|NCT02898116|10064506|FG000|COMPLETED|Overall Study||0
9001057|NCT02898116|10064506|FG000|NOT COMPLETED|Overall Study||2
9001058|NCT02898454|10064513|FG000|STARTED|Overall Study||153
9001059|NCT02898454|10064514|FG001|STARTED|Overall Study||145
9001060|NCT02898454|10064515|FG002|STARTED|Overall Study||150
9001061|NCT02898454|10064513|FG000|Intent-to-Treat (ITT) Population|Overall Study||153
9001062|NCT02898454|10064514|FG001|Intent-to-Treat (ITT) Population|Overall Study||145
9001063|NCT02898454|10064515|FG002|Intent-to-Treat (ITT) Population|Overall Study||150
9001064|NCT02898454|10064513|FG000|Treated|Overall Study||152
9001065|NCT02898454|10064514|FG001|Treated|Overall Study||145
9001066|NCT02898454|10064515|FG002|Treated|Overall Study||150
9001067|NCT02898454|10064513|FG000|Safety Population|Overall Study|2 participants randomized to placebo received 1 dose of dupilumab:counted in 300 mg q2w then q4w arm|150
9001068|NCT02898454|10064514|FG001|Safety Population|Overall Study|1 randomized to dupilumab q2w arm received 1dose of placebo: counted in 300 mg q2w then q4w arm.|148
9001069|NCT02898454|10064515|FG002|Safety Population|Overall Study||149
9001070|NCT02898454|10064513|FG000|COMPLETED|Overall Study||136
9001071|NCT02898454|10064514|FG001|COMPLETED|Overall Study||140
9001072|NCT02898454|10064515|FG002|COMPLETED|Overall Study||144
9001073|NCT02898454|10064513|FG000|NOT COMPLETED|Overall Study||17
9001074|NCT02898454|10064514|FG001|NOT COMPLETED|Overall Study||5
9001075|NCT02898454|10064515|FG002|NOT COMPLETED|Overall Study||6
9001076|NCT02898597|10064530|FG000|STARTED|Overall Study||25
9001077|NCT02898597|10064531|FG001|STARTED|Overall Study||24
9001078|NCT02898597|10064530|FG000|COMPLETED|Overall Study||21
9001079|NCT02898597|10064531|FG001|COMPLETED|Overall Study||12
9001080|NCT02898597|10064530|FG000|NOT COMPLETED|Overall Study||4
9001081|NCT02898597|10064531|FG001|NOT COMPLETED|Overall Study||12
9001082|NCT02898662|10064539|FG000|STARTED|Overall Study||40
9001083|NCT02898662|10064540|FG001|STARTED|Overall Study||41
9001084|NCT02898662|10064539|FG000|Completed Treatment|Overall Study||25
9001085|NCT02898662|10064540|FG001|Completed Treatment|Overall Study||29
9001086|NCT02898662|10064539|FG000|COMPLETED|Overall Study||11
9001087|NCT02898662|10064540|FG001|COMPLETED|Overall Study||13
9001088|NCT02898662|10064539|FG000|NOT COMPLETED|Overall Study||29
9001089|NCT02898662|10064540|FG001|NOT COMPLETED|Overall Study||28
9001090|NCT02898740|10064548|FG000|STARTED|Overall Study||21
9001091|NCT02898740|10064549|FG001|STARTED|Overall Study||19
9001092|NCT02898740|10064548|FG000|COMPLETED|Overall Study||21
9001093|NCT02898740|10064549|FG001|COMPLETED|Overall Study||19
9001094|NCT02898740|10064548|FG000|NOT COMPLETED|Overall Study||0
9001095|NCT02898740|10064549|FG001|NOT COMPLETED|Overall Study||0
9001096|NCT02898974|10064557|FG000|STARTED|Overall Study||13
9001097|NCT02898974|10064558|FG001|STARTED|Overall Study||9
9001098|NCT02898974|10064557|FG000|COMPLETED|Overall Study||13
9001099|NCT02898974|10064558|FG001|COMPLETED|Overall Study||9
9001100|NCT02898974|10064557|FG000|NOT COMPLETED|Overall Study||0
9001101|NCT02898974|10064558|FG001|NOT COMPLETED|Overall Study||0
9001102|NCT02899156|10064566|FG000|STARTED|Overall Study||11
9001103|NCT02899156|10064567|FG001|STARTED|Overall Study||11
9001104|NCT02899156|10064566|FG000|COMPLETED|Overall Study||10
9001105|NCT02899156|10064567|FG001|COMPLETED|Overall Study||10
9001106|NCT02899156|10064566|FG000|NOT COMPLETED|Overall Study||1
9001107|NCT02899156|10064567|FG001|NOT COMPLETED|Overall Study||1
9001108|NCT02899195|10064573|FG000|STARTED|Concurrent Durvalumab||55
9001109|NCT02899195|10064573|FG000|COMPLETED|Concurrent Durvalumab||44
9001110|NCT02899195|10064573|FG000|NOT COMPLETED|Concurrent Durvalumab||11
9001111|NCT02899195|10064573|FG000|STARTED|Maintenance Durvalumab||44
9001112|NCT02899195|10064573|FG000|COMPLETED|Maintenance Durvalumab||10
9001113|NCT02899195|10064573|FG000|NOT COMPLETED|Maintenance Durvalumab||34
9001114|NCT02899338|10064579|FG000|STARTED|Overall Study||81
9001115|NCT02899338|10064580|FG001|STARTED|Overall Study||81
9001116|NCT02899338|10064579|FG000|COMPLETED|Overall Study||78
9001117|NCT02899338|10064580|FG001|COMPLETED|Overall Study||79
9001118|NCT02899338|10064579|FG000|NOT COMPLETED|Overall Study||3
9001119|NCT02899338|10064580|FG001|NOT COMPLETED|Overall Study||2
9001120|NCT02899377|10064588|FG000|STARTED|Overall Study||13
9001121|NCT02899377|10064589|FG001|STARTED|Overall Study||12
9001122|NCT02899377|10064588|FG000|COMPLETED|Overall Study||12
9001123|NCT02899377|10064589|FG001|COMPLETED|Overall Study||12
9001124|NCT02899377|10064588|FG000|NOT COMPLETED|Overall Study||1
9001125|NCT02899377|10064589|FG001|NOT COMPLETED|Overall Study||0
9001126|NCT02899650|10064600|FG000|STARTED|Overall Study||15
9001127|NCT02899650|10064601|FG001|STARTED|Overall Study||10
9001128|NCT02899650|10064602|FG002|STARTED|Overall Study||14
9001129|NCT02899650|10064603|FG003|STARTED|Overall Study|We were not able to recruit older unfit adults so this group was dropped from the study.|0
9001130|NCT02899650|10064600|FG000|COMPLETED|Overall Study||15
9001131|NCT02899650|10064601|FG001|COMPLETED|Overall Study||10
9001132|NCT02899650|10064602|FG002|COMPLETED|Overall Study||14
9001133|NCT02899650|10064603|FG003|COMPLETED|Overall Study||0
9001134|NCT02899650|10064600|FG000|NOT COMPLETED|Overall Study||0
9001135|NCT02899650|10064601|FG001|NOT COMPLETED|Overall Study||0
9001136|NCT02899650|10064602|FG002|NOT COMPLETED|Overall Study||0
9001137|NCT02899650|10064603|FG003|NOT COMPLETED|Overall Study||0
9001138|NCT02899689|10064614|FG000|STARTED|Overall Study||209
9001139|NCT02899689|10064615|FG001|STARTED|Overall Study||210
9001140|NCT02899689|10064614|FG000|COMPLETED|Overall Study||209
9001141|NCT02899689|10064615|FG001|COMPLETED|Overall Study||208
9001142|NCT02899689|10064614|FG000|NOT COMPLETED|Overall Study||0
9001143|NCT02899689|10064615|FG001|NOT COMPLETED|Overall Study||2
9001144|NCT02899884|10064621|FG000|STARTED|Overall Study||3765
8634023|NCT00554463|9674296|FG000|NOT COMPLETED|Overall Study||0
8879770|NCT01936181|9936485|FG003|COMPLETED|Transition-extension||96
8879771|NCT01936181|9936482|FG000|NOT COMPLETED|Transition-extension||15
9001145|NCT02899884|10064621|FG000|COMPLETED|Overall Study||3765
8634024|NCT00554515|9674300|FG000|STARTED|Overall Study||123
8879772|NCT01936181|9936483|FG001|NOT COMPLETED|Transition-extension||0
8879773|NCT01936181|9936484|FG002|NOT COMPLETED|Transition-extension||6
8879774|NCT01936181|9936485|FG003|NOT COMPLETED|Transition-extension||5
8879775|NCT01936259|9936498|FG000|STARTED|Overall Study||130
8879776|NCT01936259|9936499|FG001|STARTED|Overall Study||131
8879777|NCT01936259|9936498|FG000|COMPLETED|Overall Study||118
8879778|NCT01936259|9936499|FG001|COMPLETED|Overall Study||111
8879779|NCT01936259|9936498|FG000|NOT COMPLETED|Overall Study||12
8879780|NCT01936259|9936499|FG001|NOT COMPLETED|Overall Study||20
8879781|NCT01936324|9936508|FG000|STARTED|Overall Study||6
8879782|NCT01936324|9936509|FG001|STARTED|Overall Study||53
9001146|NCT02899884|10064621|FG000|NOT COMPLETED|Overall Study||0
9001147|NCT02899962|10064625|FG000|STARTED|Open-label Phase||650
9001148|NCT02899962|10064626|FG001|STARTED|Open-label Phase||0
9001149|NCT02899962|10064627|FG002|STARTED|Open-label Phase||0
9001150|NCT02899962|10064625|FG000|COMPLETED|Open-label Phase||623
9001151|NCT02899962|10064626|FG001|COMPLETED|Open-label Phase||0
9001152|NCT02899962|10064627|FG002|COMPLETED|Open-label Phase||0
9001153|NCT02899962|10064625|FG000|NOT COMPLETED|Open-label Phase||27
9001154|NCT02899962|10064626|FG001|NOT COMPLETED|Open-label Phase||0
9001155|NCT02899962|10064627|FG002|NOT COMPLETED|Open-label Phase||0
9001156|NCT02899962|10064625|FG000|STARTED|Maintenance Phase||0
9001157|NCT02899962|10064626|FG001|STARTED|Maintenance Phase||272
9001158|NCT02899962|10064627|FG002|STARTED|Maintenance Phase||273
9001159|NCT02899962|10064625|FG000|COMPLETED|Maintenance Phase||0
9001160|NCT02899962|10064626|FG001|COMPLETED|Maintenance Phase||131
9001161|NCT02899962|10064627|FG002|COMPLETED|Maintenance Phase||120
9001162|NCT02899962|10064625|FG000|NOT COMPLETED|Maintenance Phase||0
9001163|NCT02899962|10064626|FG001|NOT COMPLETED|Maintenance Phase||141
9001164|NCT02899962|10064627|FG002|NOT COMPLETED|Maintenance Phase||153
8634025|NCT00554515|9674300|FG000|Treated|Overall Study||120
8879783|NCT01936324|9936510|FG002|STARTED|Overall Study||55
9001165|NCT02899988|10064638|FG000|STARTED|Induction Period (16 Weeks)||52
9001166|NCT02899988|10064639|FG001|STARTED|Induction Period (16 Weeks)||51
9001167|NCT02899988|10064640|FG002|STARTED|Induction Period (16 Weeks)||51
9001168|NCT02899988|10064641|FG003|STARTED|Induction Period (16 Weeks)||51
9001169|NCT02899988|10064642|FG004|STARTED|Induction Period (16 Weeks)||0
9001170|NCT02899988|10064643|FG005|STARTED|Induction Period (16 Weeks)||0
9001171|NCT02899988|10064644|FG006|STARTED|Induction Period (16 Weeks)||0
9001172|NCT02899988|10064645|FG007|STARTED|Induction Period (16 Weeks)||0
9001173|NCT02899988|10064646|FG008|STARTED|Induction Period (16 Weeks)||0
9001174|NCT02899988|10064647|FG009|STARTED|Induction Period (16 Weeks)||0
9001175|NCT02899988|10064648|FG010|STARTED|Induction Period (16 Weeks)||0
9001176|NCT02899988|10064638|FG000|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||52
9001177|NCT02899988|10064639|FG001|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||51
9001178|NCT02899988|10064640|FG002|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||51
9001179|NCT02899988|10064641|FG003|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||51
9001180|NCT02899988|10064642|FG004|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
9001181|NCT02899988|10064643|FG005|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
9001182|NCT02899988|10064644|FG006|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
9001183|NCT02899988|10064645|FG007|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
9001184|NCT02899988|10064646|FG008|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
9001185|NCT02899988|10064647|FG009|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
9001186|NCT02899988|10064648|FG010|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
9001187|NCT02899988|10064638|FG000|COMPLETED|Induction Period (16 Weeks)||50
9001188|NCT02899988|10064639|FG001|COMPLETED|Induction Period (16 Weeks)||49
9001189|NCT02899988|10064640|FG002|COMPLETED|Induction Period (16 Weeks)||51
9001190|NCT02899988|10064641|FG003|COMPLETED|Induction Period (16 Weeks)||49
9001191|NCT02899988|10064642|FG004|COMPLETED|Induction Period (16 Weeks)||0
9001192|NCT02899988|10064643|FG005|COMPLETED|Induction Period (16 Weeks)||0
9001193|NCT02899988|10064644|FG006|COMPLETED|Induction Period (16 Weeks)||0
9001194|NCT02899988|10064645|FG007|COMPLETED|Induction Period (16 Weeks)||0
9001195|NCT02899988|10064646|FG008|COMPLETED|Induction Period (16 Weeks)||0
9001196|NCT02899988|10064647|FG009|COMPLETED|Induction Period (16 Weeks)||0
9001197|NCT02899988|10064648|FG010|COMPLETED|Induction Period (16 Weeks)||0
9001198|NCT02899988|10064638|FG000|NOT COMPLETED|Induction Period (16 Weeks)||2
9001199|NCT02899988|10064639|FG001|NOT COMPLETED|Induction Period (16 Weeks)||2
9001200|NCT02899988|10064640|FG002|NOT COMPLETED|Induction Period (16 Weeks)||0
9001201|NCT02899988|10064641|FG003|NOT COMPLETED|Induction Period (16 Weeks)||2
8879784|NCT01936324|9936508|FG000|COMPLETED|Overall Study||6
8879785|NCT01936324|9936509|FG001|COMPLETED|Overall Study||47
8879786|NCT01936324|9936510|FG002|COMPLETED|Overall Study||50
8879787|NCT01936324|9936508|FG000|NOT COMPLETED|Overall Study||0
8879788|NCT01936324|9936509|FG001|NOT COMPLETED|Overall Study||6
8879789|NCT01936324|9936510|FG002|NOT COMPLETED|Overall Study||5
8879790|NCT01936363|9936519|FG000|STARTED|Overall Study||32
8879791|NCT01936363|9936520|FG001|STARTED|Overall Study||33
8879792|NCT01936363|9936519|FG000|COMPLETED|Overall Study||32
8879793|NCT01936363|9936520|FG001|COMPLETED|Overall Study||33
8879794|NCT01936363|9936519|FG000|NOT COMPLETED|Overall Study||0
8879795|NCT01936363|9936520|FG001|NOT COMPLETED|Overall Study||0
8879796|NCT01936389|9936528|FG000|STARTED|Overall Study||5
8879797|NCT01936389|9936529|FG001|STARTED|Overall Study||5
8879798|NCT01936389|9936528|FG000|COMPLETED|Overall Study||4
8879799|NCT01936389|9936529|FG001|COMPLETED|Overall Study||5
8879800|NCT01936389|9936528|FG000|NOT COMPLETED|Overall Study||1
8879801|NCT01936389|9936529|FG001|NOT COMPLETED|Overall Study||0
8879802|NCT01936467|9936537|FG000|STARTED|Overall Study||60
8879803|NCT01936467|9936538|FG001|STARTED|Overall Study||61
8879804|NCT01936467|9936537|FG000|COMPLETED|Overall Study||60
8879805|NCT01936467|9936538|FG001|COMPLETED|Overall Study||61
8879806|NCT01936467|9936537|FG000|NOT COMPLETED|Overall Study||0
8879807|NCT01936467|9936538|FG001|NOT COMPLETED|Overall Study||0
9001202|NCT02899988|10064642|FG004|NOT COMPLETED|Induction Period (16 Weeks)||0
9001203|NCT02899988|10064643|FG005|NOT COMPLETED|Induction Period (16 Weeks)||0
9001204|NCT02899988|10064644|FG006|NOT COMPLETED|Induction Period (16 Weeks)||0
9001205|NCT02899988|10064645|FG007|NOT COMPLETED|Induction Period (16 Weeks)||0
8572570|NCT00115349|9604753|FG001|STARTED|Overall Study|Target was 43 subjects in this arm.|9
8572571|NCT00115349|9604752|FG000|COMPLETED|Overall Study|Study closed due to low enrollment.|0
8572572|NCT00115349|9604753|FG001|COMPLETED|Overall Study|study closed due to low enrollment.|0
8572573|NCT00115349|9604752|FG000|NOT COMPLETED|Overall Study||11
8572574|NCT00115349|9604753|FG001|NOT COMPLETED|Overall Study||9
8572575|NCT00115739|9604759|FG000|STARTED|Overall Study||11
8572576|NCT00115739|9604759|FG000|COMPLETED|Overall Study||8
8572577|NCT00115739|9604759|FG000|NOT COMPLETED|Overall Study||3
8572578|NCT00115765|9604769|FG000|STARTED|Overall Study||115
8572579|NCT00115765|9604770|FG001|STARTED|Overall Study||413
8572580|NCT00115765|9604771|FG002|STARTED|Overall Study||410
8572581|NCT00115765|9604772|FG003|STARTED|Overall Study||115
8572582|NCT00115765|9604769|FG000|COMPLETED|Overall Study|Participants who were on study at closure or died|80
8572583|NCT00115765|9604770|FG001|COMPLETED|Overall Study|Participants who were on study at closure or died|313
8572584|NCT00115765|9604771|FG002|COMPLETED|Overall Study|Participants who were on study at closure or died|289
8879808|NCT01936519|9936550|FG000|STARTED|Overall Study||12
8879809|NCT01936519|9936551|FG001|STARTED|Overall Study||12
8879810|NCT01936519|9936550|FG000|COMPLETED|Overall Study||11
8879811|NCT01936519|9936551|FG001|COMPLETED|Overall Study||8
8879812|NCT01936519|9936550|FG000|NOT COMPLETED|Overall Study||1
8879813|NCT01936519|9936551|FG001|NOT COMPLETED|Overall Study||4
8879814|NCT01936623|9936562|FG000|STARTED|Overall Study||40
8879815|NCT01936623|9936563|FG001|STARTED|Overall Study||40
8879816|NCT01936623|9936562|FG000|COMPLETED|Overall Study||40
8879817|NCT01936623|9936563|FG001|COMPLETED|Overall Study||35
8879818|NCT01936623|9936562|FG000|NOT COMPLETED|Overall Study||0
9001206|NCT02899988|10064646|FG008|NOT COMPLETED|Induction Period (16 Weeks)||0
8879819|NCT01936623|9936563|FG001|NOT COMPLETED|Overall Study||5
8879820|NCT01936649|9936569|FG000|STARTED|Overall Study||63
8879821|NCT01936649|9936569|FG000|Treated|Overall Study||51
8879822|NCT01936649|9936569|FG000|COMPLETED|Overall Study||50
8879823|NCT01936649|9936569|FG000|NOT COMPLETED|Overall Study||13
8879824|NCT01936662|9936575|FG000|STARTED|Overall Study||42
8879825|NCT01936662|9936576|FG001|STARTED|Overall Study||42
8879826|NCT01936662|9936575|FG000|COMPLETED|Overall Study||42
8879827|NCT01936662|9936576|FG001|COMPLETED|Overall Study||42
8879828|NCT01936662|9936575|FG000|NOT COMPLETED|Overall Study||0
9001207|NCT02899988|10064647|FG009|NOT COMPLETED|Induction Period (16 Weeks)||0
9001208|NCT02899988|10064648|FG010|NOT COMPLETED|Induction Period (16 Weeks)||0
9001209|NCT02899988|10064638|FG000|STARTED|Maintenance Period (88 Weeks)|No participants received placebo during maintenance period.|0
9001210|NCT02899988|10064639|FG001|STARTED|Maintenance Period (88 Weeks)|No participants received 30 mg mirikizumab Q8W in both induction and maintenance.|0
9001211|NCT02899988|10064640|FG002|STARTED|Maintenance Period (88 Weeks)|No participants received 100 mg mirikizumab Q8W in both induction and maintenance.|0
9001212|NCT02899988|10064641|FG003|STARTED|Maintenance Period (88 Weeks)||0
9001213|NCT02899988|10064642|FG004|STARTED|Maintenance Period (88 Weeks)|Participants received 30 mg mirikizumab Q8W during induction period.|15
9001214|NCT02899988|10064643|FG005|STARTED|Maintenance Period (88 Weeks)|Participants received 100 mg mirikizumab Q8W during induction period.|30
9001215|NCT02899988|10064644|FG006|STARTED|Maintenance Period (88 Weeks)|Participants received 300 mg mirikizumab Q8W during induction period.|34
9001216|NCT02899988|10064645|FG007|STARTED|Maintenance Period (88 Weeks)|Participants received placebo during induction period.|50
9001217|NCT02899988|10064646|FG008|STARTED|Maintenance Period (88 Weeks)|Participants received 30 mg mirikizumab Q8W during induction arm.|34
9001218|NCT02899988|10064647|FG009|STARTED|Maintenance Period (88 Weeks)|Participants received 100 mg mirikizumab Q8W during induction arm.|21
9001219|NCT02899988|10064648|FG010|STARTED|Maintenance Period (88 Weeks)|Participants received 300 mg mirikizumab Q8W during induction arm.|15
9001220|NCT02899988|10064638|FG000|Rescue Participants|Maintenance Period (88 Weeks)||0
9001221|NCT02899988|10064639|FG001|Rescue Participants|Maintenance Period (88 Weeks)||0
9001222|NCT02899988|10064640|FG002|Rescue Participants|Maintenance Period (88 Weeks)||0
9001223|NCT02899988|10064641|FG003|Rescue Participants|Maintenance Period (88 Weeks)|In PRN not regaining ≥ PASI 90 after 3 consecutive doses of drug or have < PASI 50 after 1 dose.|10
9001224|NCT02899988|10064642|FG004|Rescue Participants|Maintenance Period (88 Weeks)||0
9001225|NCT02899988|10064643|FG005|Rescue Participants|Maintenance Period (88 Weeks)||0
9001226|NCT02899988|10064644|FG006|Rescue Participants|Maintenance Period (88 Weeks)||0
9001227|NCT02899988|10064645|FG007|Rescue Participants|Maintenance Period (88 Weeks)||0
9001228|NCT02899988|10064646|FG008|Rescue Participants|Maintenance Period (88 Weeks)||0
9001229|NCT02899988|10064647|FG009|Rescue Participants|Maintenance Period (88 Weeks)||0
9001230|NCT02899988|10064648|FG010|Rescue Participants|Maintenance Period (88 Weeks)||0
9001231|NCT02899988|10064638|FG000|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||0
9001232|NCT02899988|10064639|FG001|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||0
9001233|NCT02899988|10064640|FG002|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||0
8879829|NCT01936662|9936576|FG001|NOT COMPLETED|Overall Study||0
8879830|NCT01936844|9936586|FG000|STARTED|Overall Study||15
8879831|NCT01936844|9936587|FG001|STARTED|Overall Study||15
8879832|NCT01936844|9936586|FG000|COMPLETED|Overall Study||9
8879833|NCT01936844|9936587|FG001|COMPLETED|Overall Study||8
8879834|NCT01936844|9936586|FG000|NOT COMPLETED|Overall Study||6
8879835|NCT01936844|9936587|FG001|NOT COMPLETED|Overall Study||7
8879836|NCT01936870|9936593|FG000|STARTED|Overall Study||2492
8879837|NCT01936870|9936593|FG000|COMPLETED|Overall Study||2303
8879838|NCT01936870|9936593|FG000|NOT COMPLETED|Overall Study||189
8879839|NCT01936896|9936597|FG000|STARTED|Overall Study||10
8879840|NCT01936896|9936597|FG000|COMPLETED|Overall Study||10
8879841|NCT01936896|9936597|FG000|NOT COMPLETED|Overall Study||0
9001234|NCT02899988|10064641|FG003|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||13
9001235|NCT02899988|10064642|FG004|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||9
9001236|NCT02899988|10064643|FG005|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||18
9001237|NCT02899988|10064644|FG006|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||26
9001238|NCT02899988|10064645|FG007|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||42
9001239|NCT02899988|10064646|FG008|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||24
9001240|NCT02899988|10064647|FG009|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||17
9001241|NCT02899988|10064648|FG010|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||0
9001242|NCT02899988|10064638|FG000|COMPLETED|Maintenance Period (88 Weeks)||0
9001243|NCT02899988|10064639|FG001|COMPLETED|Maintenance Period (88 Weeks)||0
9001244|NCT02899988|10064640|FG002|COMPLETED|Maintenance Period (88 Weeks)||0
9001245|NCT02899988|10064641|FG003|COMPLETED|Maintenance Period (88 Weeks)||0
9001246|NCT02899988|10064642|FG004|COMPLETED|Maintenance Period (88 Weeks)||13
9001247|NCT02899988|10064643|FG005|COMPLETED|Maintenance Period (88 Weeks)||27
9001248|NCT02899988|10064644|FG006|COMPLETED|Maintenance Period (88 Weeks)||30
9001249|NCT02899988|10064645|FG007|COMPLETED|Maintenance Period (88 Weeks)||45
9001250|NCT02899988|10064646|FG008|COMPLETED|Maintenance Period (88 Weeks)||30
9001251|NCT02899988|10064647|FG009|COMPLETED|Maintenance Period (88 Weeks)||19
9001252|NCT02899988|10064648|FG010|COMPLETED|Maintenance Period (88 Weeks)||13
9001253|NCT02899988|10064638|FG000|NOT COMPLETED|Maintenance Period (88 Weeks)||0
9001254|NCT02899988|10064639|FG001|NOT COMPLETED|Maintenance Period (88 Weeks)||0
9001255|NCT02899988|10064640|FG002|NOT COMPLETED|Maintenance Period (88 Weeks)||0
9001256|NCT02899988|10064641|FG003|NOT COMPLETED|Maintenance Period (88 Weeks)||0
9001257|NCT02899988|10064642|FG004|NOT COMPLETED|Maintenance Period (88 Weeks)||2
9001258|NCT02899988|10064643|FG005|NOT COMPLETED|Maintenance Period (88 Weeks)||3
9001259|NCT02899988|10064644|FG006|NOT COMPLETED|Maintenance Period (88 Weeks)||4
9001260|NCT02899988|10064645|FG007|NOT COMPLETED|Maintenance Period (88 Weeks)||5
9001261|NCT02899988|10064646|FG008|NOT COMPLETED|Maintenance Period (88 Weeks)||4
9001262|NCT02899988|10064647|FG009|NOT COMPLETED|Maintenance Period (88 Weeks)||2
9001263|NCT02899988|10064648|FG010|NOT COMPLETED|Maintenance Period (88 Weeks)||2
9001264|NCT02899988|10064638|FG000|STARTED|Follow-Up (16 Weeks)||0
9001265|NCT02899988|10064639|FG001|STARTED|Follow-Up (16 Weeks)||0
9001266|NCT02899988|10064640|FG002|STARTED|Follow-Up (16 Weeks)||0
9001267|NCT02899988|10064641|FG003|STARTED|Follow-Up (16 Weeks)||0
9001268|NCT02899988|10064642|FG004|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|2
9001269|NCT02899988|10064643|FG005|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|4
9001270|NCT02899988|10064644|FG006|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|3
9001271|NCT02899988|10064645|FG007|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|3
9001272|NCT02899988|10064646|FG008|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|6
9001273|NCT02899988|10064647|FG009|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|2
9001274|NCT02899988|10064648|FG010|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|0
9001275|NCT02899988|10064638|FG000|COMPLETED|Follow-Up (16 Weeks)||0
9001276|NCT02899988|10064639|FG001|COMPLETED|Follow-Up (16 Weeks)||0
9001277|NCT02899988|10064640|FG002|COMPLETED|Follow-Up (16 Weeks)||0
9001278|NCT02899988|10064641|FG003|COMPLETED|Follow-Up (16 Weeks)||0
8879842|NCT01936909|9936604|FG000|STARTED|Overall Study||20
8879843|NCT01936909|9936605|FG001|STARTED|Overall Study||20
8879844|NCT01936909|9936606|FG002|STARTED|Overall Study||20
8879845|NCT01936909|9936604|FG000|COMPLETED|Overall Study||10
8879846|NCT01936909|9936605|FG001|COMPLETED|Overall Study||12
8879847|NCT01936909|9936606|FG002|COMPLETED|Overall Study||14
8879848|NCT01936909|9936604|FG000|NOT COMPLETED|Overall Study||10
8879849|NCT01936909|9936605|FG001|NOT COMPLETED|Overall Study||8
8879850|NCT01936909|9936606|FG002|NOT COMPLETED|Overall Study||6
8879851|NCT01936948|9936618|FG000|STARTED|Overall Study||227
8879852|NCT01936948|9936619|FG001|STARTED|Overall Study||231
8879853|NCT01936948|9936620|FG002|STARTED|Overall Study||237
8879854|NCT01936948|9936621|FG003|STARTED|Overall Study||233
8879855|NCT01936948|9936618|FG000|Crossover|Overall Study||31
8879856|NCT01936948|9936619|FG001|Crossover|Overall Study||27
8879857|NCT01936948|9936620|FG002|Crossover|Overall Study||22
8879858|NCT01936948|9936621|FG003|Crossover|Overall Study||25
8879859|NCT01936948|9936618|FG000|COMPLETED|Overall Study||227
8879860|NCT01936948|9936619|FG001|COMPLETED|Overall Study||228
8879861|NCT01936948|9936620|FG002|COMPLETED|Overall Study||234
8879862|NCT01936948|9936621|FG003|COMPLETED|Overall Study||230
8879863|NCT01936948|9936618|FG000|NOT COMPLETED|Overall Study||0
8879864|NCT01936948|9936619|FG001|NOT COMPLETED|Overall Study||3
8879865|NCT01936948|9936620|FG002|NOT COMPLETED|Overall Study||3
8879866|NCT01936948|9936621|FG003|NOT COMPLETED|Overall Study||3
8879867|NCT01937026|9936629|FG000|STARTED|Period 1 (Day 1 Through Predose Day 3)||18
8879868|NCT01937026|9936629|FG000|Received Baricitinib|Period 1 (Day 1 Through Predose Day 3)||18
8879869|NCT01937026|9936629|FG000|COMPLETED|Period 1 (Day 1 Through Predose Day 3)||18
8879870|NCT01937026|9936629|FG000|NOT COMPLETED|Period 1 (Day 1 Through Predose Day 3)||0
8879871|NCT01937026|9936629|FG000|STARTED|Period 2 (At Dosing Day 3 Through Day 8)||18
9001279|NCT02899988|10064642|FG004|COMPLETED|Follow-Up (16 Weeks)||2
9001280|NCT02899988|10064643|FG005|COMPLETED|Follow-Up (16 Weeks)||4
9001281|NCT02899988|10064644|FG006|COMPLETED|Follow-Up (16 Weeks)||3
9001282|NCT02899988|10064645|FG007|COMPLETED|Follow-Up (16 Weeks)||3
9001283|NCT02899988|10064646|FG008|COMPLETED|Follow-Up (16 Weeks)||6
9001284|NCT02899988|10064647|FG009|COMPLETED|Follow-Up (16 Weeks)||2
9001285|NCT02899988|10064648|FG010|COMPLETED|Follow-Up (16 Weeks)||0
9001286|NCT02899988|10064638|FG000|NOT COMPLETED|Follow-Up (16 Weeks)||0
9001287|NCT02899988|10064639|FG001|NOT COMPLETED|Follow-Up (16 Weeks)||0
9001288|NCT02899988|10064640|FG002|NOT COMPLETED|Follow-Up (16 Weeks)||0
9001289|NCT02899988|10064641|FG003|NOT COMPLETED|Follow-Up (16 Weeks)||0
9001290|NCT02899988|10064642|FG004|NOT COMPLETED|Follow-Up (16 Weeks)||0
9001291|NCT02899988|10064643|FG005|NOT COMPLETED|Follow-Up (16 Weeks)||0
9001292|NCT02899988|10064644|FG006|NOT COMPLETED|Follow-Up (16 Weeks)||0
9001293|NCT02899988|10064645|FG007|NOT COMPLETED|Follow-Up (16 Weeks)||0
9001294|NCT02899988|10064646|FG008|NOT COMPLETED|Follow-Up (16 Weeks)||0
9001295|NCT02899988|10064647|FG009|NOT COMPLETED|Follow-Up (16 Weeks)||0
9001296|NCT02899988|10064648|FG010|NOT COMPLETED|Follow-Up (16 Weeks)||0
9001297|NCT02900092|10064680|FG000|STARTED|Overall Study||10
9001298|NCT02900092|10064680|FG000|COMPLETED|Overall Study||9
9001299|NCT02900092|10064680|FG000|NOT COMPLETED|Overall Study||1
9001300|NCT02900170|10064684|FG000|STARTED|Overall Study||8
9001301|NCT02900170|10064684|FG000|COMPLETED|Overall Study||0
9001302|NCT02900170|10064684|FG000|NOT COMPLETED|Overall Study||8
9001303|NCT02900378|10064690|FG000|STARTED|Randomization (Visit 2)||310
9001304|NCT02900378|10064691|FG001|STARTED|Randomization (Visit 2)||311
9001305|NCT02900378|10064690|FG000|COMPLETED|Randomization (Visit 2)||287
9001306|NCT02900378|10064691|FG001|COMPLETED|Randomization (Visit 2)||283
9001307|NCT02900378|10064690|FG000|NOT COMPLETED|Randomization (Visit 2)||23
9001308|NCT02900378|10064691|FG001|NOT COMPLETED|Randomization (Visit 2)||28
9001309|NCT02900378|10064690|FG000|STARTED|Treatment Phase||309
9001310|NCT02900378|10064691|FG001|STARTED|Treatment Phase||310
9001311|NCT02900378|10064690|FG000|Full Analysis Set|Treatment Phase||302
9001312|NCT02900378|10064691|FG001|Full Analysis Set|Treatment Phase||302
9001313|NCT02900378|10064690|FG000|COMPLETED|Treatment Phase||309
9001314|NCT02900378|10064691|FG001|COMPLETED|Treatment Phase||310
9001315|NCT02900378|10064690|FG000|NOT COMPLETED|Treatment Phase||0
9001316|NCT02900378|10064691|FG001|NOT COMPLETED|Treatment Phase||0
9001317|NCT02901054|10064697|FG000|STARTED|Overall Study|19 consented, 3 withdrew prior to intervention, 1 received study drug but surgery was cancelled.|19
9001318|NCT02901054|10064697|FG000|COMPLETED|Overall Study||15
9001319|NCT02901054|10064697|FG000|NOT COMPLETED|Overall Study||4
9001320|NCT02901080|10064701|FG000|STARTED|Overall Study||161
9001321|NCT02901080|10064701|FG000|COMPLETED|Overall Study||112
9001322|NCT02901080|10064701|FG000|NOT COMPLETED|Overall Study||49
9001323|NCT02901249|10064707|FG000|STARTED|Overall Study||68
9001324|NCT02901249|10064707|FG000|COMPLETED|Overall Study|Primary and secondary outcomes are assessed just at the end of the protocol, not at each step|43
9001325|NCT02901249|10064707|FG000|NOT COMPLETED|Overall Study||25
9001326|NCT02901275|10064711|FG000|STARTED|Overall Study||29
9001327|NCT02901275|10064711|FG000|Placebo + Placebo|Overall Study||29
9001328|NCT02901275|10064711|FG000|Hydromorphone (Oral) 4mg + Placebo|Overall Study||29
9001329|NCT02901275|10064711|FG000|Hydromorphone (Oral) 4mg + Dronabinol (Oral) 2.5mg|Overall Study||29
9001330|NCT02901275|10064711|FG000|Hydromorphone (Oral) 4mg + Dronabinol (Oral) 5mg|Overall Study||29
9001331|NCT02901275|10064711|FG000|Hydromorphone (Oral) 4mg + Dronabinol (Oral) 10mg|Overall Study||29
9001332|NCT02901275|10064711|FG000|COMPLETED|Overall Study||29
9001333|NCT02901275|10064711|FG000|NOT COMPLETED|Overall Study||0
9001334|NCT02901431|10064731|FG000|STARTED|PK Part||12
9001335|NCT02901431|10064732|FG001|STARTED|PK Part||11
9001336|NCT02901431|10064733|FG002|STARTED|PK Part||15
9001337|NCT02901431|10064734|FG003|STARTED|PK Part||0
9001338|NCT02901431|10064735|FG004|STARTED|PK Part||0
9001339|NCT02901431|10064736|FG005|STARTED|PK Part||0
8879872|NCT01937026|9936629|FG000|Received Baricitinib|Period 2 (At Dosing Day 3 Through Day 8)||18
8879873|NCT01937026|9936629|FG000|Received Probenecid on Days 3 Through 7|Period 2 (At Dosing Day 3 Through Day 8)||18
8879874|NCT01937026|9936629|FG000|COMPLETED|Period 2 (At Dosing Day 3 Through Day 8)||18
8879875|NCT01937026|9936629|FG000|NOT COMPLETED|Period 2 (At Dosing Day 3 Through Day 8)||0
8879876|NCT01937117|9936636|FG000|STARTED|Overall Study||88
8879877|NCT01937117|9936636|FG000|COMPLETED|Overall Study||75
8879878|NCT01937117|9936636|FG000|NOT COMPLETED|Overall Study||13
8879879|NCT01937130|9936644|FG000|STARTED|Overall Study||5
8879880|NCT01937130|9936645|FG001|STARTED|Overall Study||7
8879881|NCT01937130|9936646|FG002|STARTED|Overall Study||5
8879882|NCT01937130|9936647|FG003|STARTED|Overall Study||4
8879883|NCT01937130|9936644|FG000|COMPLETED|Overall Study||0
8879884|NCT01937130|9936645|FG001|COMPLETED|Overall Study||3
8879885|NCT01937130|9936646|FG002|COMPLETED|Overall Study||2
8879886|NCT01937130|9936647|FG003|COMPLETED|Overall Study||2
9001340|NCT02901431|10064737|FG006|STARTED|PK Part||0
9001341|NCT02901431|10064738|FG007|STARTED|PK Part||0
9001342|NCT02901431|10064739|FG008|STARTED|PK Part||0
8879887|NCT01937130|9936644|FG000|NOT COMPLETED|Overall Study||5
8879888|NCT01937130|9936645|FG001|NOT COMPLETED|Overall Study||4
8879889|NCT01937130|9936646|FG002|NOT COMPLETED|Overall Study||3
8879890|NCT01937130|9936647|FG003|NOT COMPLETED|Overall Study||2
8879891|NCT01937195|9936657|FG000|STARTED|Overall Study||95
9001343|NCT02901431|10064740|FG009|STARTED|PK Part||0
9001344|NCT02901431|10064741|FG010|STARTED|PK Part||0
9001345|NCT02901431|10064742|FG011|STARTED|PK Part||0
9001346|NCT02901431|10064743|FG012|STARTED|PK Part||0
9001347|NCT02901431|10064731|FG000|COMPLETED|PK Part||5
9001348|NCT02901431|10064732|FG001|COMPLETED|PK Part||5
9001349|NCT02901431|10064733|FG002|COMPLETED|PK Part||6
9001350|NCT02901431|10064734|FG003|COMPLETED|PK Part||0
9001351|NCT02901431|10064735|FG004|COMPLETED|PK Part||0
9001352|NCT02901431|10064736|FG005|COMPLETED|PK Part||0
8634026|NCT00554515|9674300|FG000|COMPLETED|Overall Study||5
8634027|NCT00554515|9674300|FG000|NOT COMPLETED|Overall Study||118
8634028|NCT00554619|9674325|FG000|STARTED|Overall Study||21
8634029|NCT00554619|9674325|FG000|COMPLETED|Overall Study||18
8634030|NCT00554619|9674325|FG000|NOT COMPLETED|Overall Study||3
8879892|NCT01937195|9936657|FG000|COMPLETED|Overall Study||95
9001353|NCT02901431|10064737|FG006|COMPLETED|PK Part||0
9001354|NCT02901431|10064738|FG007|COMPLETED|PK Part||0
9001355|NCT02901431|10064739|FG008|COMPLETED|PK Part||0
9001356|NCT02901431|10064740|FG009|COMPLETED|PK Part||0
8634031|NCT00554671|9674331|FG000|STARTED|Overall Study||117
8879893|NCT01937195|9936657|FG000|NOT COMPLETED|Overall Study||0
8879894|NCT01937260|9936663|FG000|STARTED|Overall Study||21
8879895|NCT01937260|9936664|FG001|STARTED|Overall Study||10
8879896|NCT01937260|9936663|FG000|COMPLETED|Overall Study||20
8879897|NCT01937260|9936664|FG001|COMPLETED|Overall Study||10
8879898|NCT01937260|9936663|FG000|NOT COMPLETED|Overall Study||1
8879899|NCT01937260|9936664|FG001|NOT COMPLETED|Overall Study||0
8879900|NCT01937299|9936672|FG000|STARTED|Overall Study||117
8879901|NCT01937299|9936673|FG001|STARTED|Overall Study||116
8879902|NCT01937299|9936672|FG000|COMPLETED|Overall Study||103
8879903|NCT01937299|9936673|FG001|COMPLETED|Overall Study||112
8879904|NCT01937299|9936672|FG000|NOT COMPLETED|Overall Study||14
8879905|NCT01937299|9936673|FG001|NOT COMPLETED|Overall Study||4
8879906|NCT01937312|9936682|FG000|STARTED|Overall Study||94
8879907|NCT01937312|9936683|FG001|STARTED|Overall Study||95
8879908|NCT01937312|9936682|FG000|Treated|Overall Study||93
8879909|NCT01937312|9936683|FG001|Treated|Overall Study||95
8879910|NCT01937312|9936682|FG000|COMPLETED|Overall Study||83
8879911|NCT01937312|9936683|FG001|COMPLETED|Overall Study||92
8879912|NCT01937312|9936682|FG000|NOT COMPLETED|Overall Study||11
8879913|NCT01937312|9936683|FG001|NOT COMPLETED|Overall Study||3
8879914|NCT01937351|9936692|FG000|STARTED|Overall Study||134
8879915|NCT01937351|9936693|FG001|STARTED|Overall Study||28
8879916|NCT01937351|9936692|FG000|Treated w Study Device|Overall Study||130
8879917|NCT01937351|9936693|FG001|Treated w Study Device|Overall Study||28
8879918|NCT01937351|9936692|FG000|30-Day Follow-up|Overall Study||128
8879919|NCT01937351|9936693|FG001|30-Day Follow-up|Overall Study||27
8879920|NCT01937351|9936692|FG000|6-Month Follow-up|Overall Study||125
8879921|NCT01937351|9936693|FG001|6-Month Follow-up|Overall Study||26
8879922|NCT01937351|9936692|FG000|COMPLETED|Overall Study||125
8879923|NCT01937351|9936693|FG001|COMPLETED|Overall Study||26
8879924|NCT01937351|9936692|FG000|NOT COMPLETED|Overall Study||9
8879925|NCT01937351|9936693|FG001|NOT COMPLETED|Overall Study||2
8879926|NCT01937364|9936700|FG000|STARTED|Overall Study||9
8879927|NCT01937364|9936701|FG001|STARTED|Overall Study||8
8879928|NCT01937364|9936700|FG000|COMPLETED|Overall Study||7
8879929|NCT01937364|9936701|FG001|COMPLETED|Overall Study||7
8879930|NCT01937364|9936700|FG000|NOT COMPLETED|Overall Study||2
8879931|NCT01937364|9936701|FG001|NOT COMPLETED|Overall Study||1
8879932|NCT01937390|9936707|FG000|STARTED|Overall Study||585
8879933|NCT01937390|9936707|FG000|COMPLETED|Overall Study||550
8879934|NCT01937390|9936707|FG000|NOT COMPLETED|Overall Study||35
8879935|NCT01937520|9936713|FG000|STARTED|Overall Study||11
8879936|NCT01937520|9936714|FG001|STARTED|Overall Study||9
8879937|NCT01937520|9936713|FG000|COMPLETED|Overall Study||11
8879938|NCT01937520|9936714|FG001|COMPLETED|Overall Study||9
8879939|NCT01937520|9936713|FG000|NOT COMPLETED|Overall Study||0
8634032|NCT00554671|9674332|FG001|STARTED|Overall Study||133
8879940|NCT01937520|9936714|FG001|NOT COMPLETED|Overall Study||0
8879941|NCT01937559|9936724|FG000|STARTED|Overall Study||61
8879942|NCT01937559|9936725|FG001|STARTED|Overall Study||61
8879943|NCT01937559|9936726|FG002|STARTED|Overall Study||66
8879944|NCT01937559|9936724|FG000|COMPLETED|Overall Study||50
8879945|NCT01937559|9936725|FG001|COMPLETED|Overall Study||50
8879946|NCT01937559|9936726|FG002|COMPLETED|Overall Study||66
8879947|NCT01937559|9936724|FG000|NOT COMPLETED|Overall Study||11
8879948|NCT01937559|9936725|FG001|NOT COMPLETED|Overall Study||11
8879949|NCT01937559|9936726|FG002|NOT COMPLETED|Overall Study||0
8879950|NCT01937598|9936738|FG000|STARTED|Overall Study||8
8879951|NCT01937598|9936739|FG001|STARTED|Overall Study||8
9001357|NCT02901431|10064741|FG010|COMPLETED|PK Part||0
8634033|NCT00554671|9674331|FG000|COMPLETED|Overall Study||97
8634034|NCT00554671|9674332|FG001|COMPLETED|Overall Study||117
9001358|NCT02901431|10064742|FG011|COMPLETED|PK Part||0
9001359|NCT02901431|10064743|FG012|COMPLETED|PK Part||0
9001360|NCT02901431|10064731|FG000|NOT COMPLETED|PK Part||7
9001361|NCT02901431|10064732|FG001|NOT COMPLETED|PK Part||6
9001362|NCT02901431|10064733|FG002|NOT COMPLETED|PK Part||9
9001363|NCT02901431|10064734|FG003|NOT COMPLETED|PK Part||0
9001364|NCT02901431|10064735|FG004|NOT COMPLETED|PK Part||0
9001365|NCT02901431|10064736|FG005|NOT COMPLETED|PK Part||0
9001366|NCT02901431|10064737|FG006|NOT COMPLETED|PK Part||0
9001367|NCT02901431|10064738|FG007|NOT COMPLETED|PK Part||0
9001368|NCT02901431|10064739|FG008|NOT COMPLETED|PK Part||0
9001369|NCT02901431|10064740|FG009|NOT COMPLETED|PK Part||0
9001370|NCT02901431|10064741|FG010|NOT COMPLETED|PK Part||0
9001371|NCT02901431|10064742|FG011|NOT COMPLETED|PK Part||0
9001372|NCT02901431|10064743|FG012|NOT COMPLETED|PK Part||0
9001373|NCT02901431|10064731|FG000|STARTED|Main Treatment Part||0
9001374|NCT02901431|10064732|FG001|STARTED|Main Treatment Part||0
9001375|NCT02901431|10064733|FG002|STARTED|Main Treatment Part||0
9001376|NCT02901431|10064734|FG003|STARTED|Main Treatment Part||112
9001377|NCT02901431|10064735|FG004|STARTED|Main Treatment Part||57
9001378|NCT02901431|10064736|FG005|STARTED|Main Treatment Part||66
9001379|NCT02901431|10064737|FG006|STARTED|Main Treatment Part||66
9001380|NCT02901431|10064738|FG007|STARTED|Main Treatment Part||7
9001381|NCT02901431|10064739|FG008|STARTED|Main Treatment Part||0
9001382|NCT02901431|10064740|FG009|STARTED|Main Treatment Part||0
9001383|NCT02901431|10064741|FG010|STARTED|Main Treatment Part||0
9001384|NCT02901431|10064742|FG011|STARTED|Main Treatment Part||0
9001385|NCT02901431|10064743|FG012|STARTED|Main Treatment Part||0
9001386|NCT02901431|10064731|FG000|COMPLETED|Main Treatment Part||0
9001387|NCT02901431|10064732|FG001|COMPLETED|Main Treatment Part||0
9001388|NCT02901431|10064733|FG002|COMPLETED|Main Treatment Part||0
9001389|NCT02901431|10064734|FG003|COMPLETED|Main Treatment Part||86
9001390|NCT02901431|10064735|FG004|COMPLETED|Main Treatment Part||50
9001391|NCT02901431|10064736|FG005|COMPLETED|Main Treatment Part||54
9001392|NCT02901431|10064737|FG006|COMPLETED|Main Treatment Part||55
9001393|NCT02901431|10064738|FG007|COMPLETED|Main Treatment Part||7
9001394|NCT02901431|10064739|FG008|COMPLETED|Main Treatment Part||0
9001395|NCT02901431|10064740|FG009|COMPLETED|Main Treatment Part||0
9001396|NCT02901431|10064741|FG010|COMPLETED|Main Treatment Part||0
9001397|NCT02901431|10064742|FG011|COMPLETED|Main Treatment Part||0
9001398|NCT02901431|10064743|FG012|COMPLETED|Main Treatment Part||0
9001399|NCT02901431|10064731|FG000|NOT COMPLETED|Main Treatment Part||0
8634035|NCT00554671|9674331|FG000|NOT COMPLETED|Overall Study||20
8879952|NCT01937598|9936738|FG000|COMPLETED|Overall Study||8
8879953|NCT01937598|9936739|FG001|COMPLETED|Overall Study||8
8879954|NCT01937598|9936738|FG000|NOT COMPLETED|Overall Study||0
8879955|NCT01937598|9936739|FG001|NOT COMPLETED|Overall Study||0
8879956|NCT01937624|9936745|FG000|STARTED|Overall Study||51
8879957|NCT01937624|9936745|FG000|COMPLETED|Overall Study||51
8879958|NCT01937624|9936745|FG000|NOT COMPLETED|Overall Study||0
8879959|NCT01937715|9936754|FG000|STARTED|Overall Study||3
8879960|NCT01937715|9936755|FG001|STARTED|Overall Study||4
8879961|NCT01937715|9936756|FG002|STARTED|Overall Study||3
8879962|NCT01937715|9936757|FG003|STARTED|Overall Study||5
8879963|NCT01937715|9936758|FG004|STARTED|Overall Study||3
8879964|NCT01937715|9936754|FG000|COMPLETED|Overall Study||3
8879965|NCT01937715|9936755|FG001|COMPLETED|Overall Study||3
8879966|NCT01937715|9936756|FG002|COMPLETED|Overall Study||3
8879967|NCT01937715|9936757|FG003|COMPLETED|Overall Study||1
8879968|NCT01937715|9936758|FG004|COMPLETED|Overall Study||1
8879969|NCT01937715|9936754|FG000|NOT COMPLETED|Overall Study||0
8879970|NCT01937715|9936755|FG001|NOT COMPLETED|Overall Study||1
8879971|NCT01937715|9936756|FG002|NOT COMPLETED|Overall Study||0
8879972|NCT01937715|9936757|FG003|NOT COMPLETED|Overall Study||4
8879973|NCT01937715|9936758|FG004|NOT COMPLETED|Overall Study||2
9001400|NCT02901431|10064732|FG001|NOT COMPLETED|Main Treatment Part||0
9001401|NCT02901431|10064733|FG002|NOT COMPLETED|Main Treatment Part||0
9001402|NCT02901431|10064734|FG003|NOT COMPLETED|Main Treatment Part||26
9001403|NCT02901431|10064735|FG004|NOT COMPLETED|Main Treatment Part||7
9001404|NCT02901431|10064736|FG005|NOT COMPLETED|Main Treatment Part||12
9001405|NCT02901431|10064737|FG006|NOT COMPLETED|Main Treatment Part||11
9001406|NCT02901431|10064738|FG007|NOT COMPLETED|Main Treatment Part||0
9001407|NCT02901431|10064739|FG008|NOT COMPLETED|Main Treatment Part||0
9001408|NCT02901431|10064740|FG009|NOT COMPLETED|Main Treatment Part||0
9001409|NCT02901431|10064741|FG010|NOT COMPLETED|Main Treatment Part||0
9001410|NCT02901431|10064742|FG011|NOT COMPLETED|Main Treatment Part||0
9001411|NCT02901431|10064743|FG012|NOT COMPLETED|Main Treatment Part||0
9001412|NCT02901431|10064731|FG000|STARTED|Open Label Part||0
9001413|NCT02901431|10064732|FG001|STARTED|Open Label Part||0
9001414|NCT02901431|10064733|FG002|STARTED|Open Label Part||0
9001415|NCT02901431|10064734|FG003|STARTED|Open Label Part||0
9001416|NCT02901431|10064735|FG004|STARTED|Open Label Part||0
9001417|NCT02901431|10064736|FG005|STARTED|Open Label Part||0
9001418|NCT02901431|10064737|FG006|STARTED|Open Label Part||0
9001419|NCT02901431|10064738|FG007|STARTED|Open Label Part||0
9001420|NCT02901431|10064739|FG008|STARTED|Open Label Part||68
9001421|NCT02901431|10064740|FG009|STARTED|Open Label Part||35
9001422|NCT02901431|10064741|FG010|STARTED|Open Label Part||40
9001423|NCT02901431|10064742|FG011|STARTED|Open Label Part||46
9001424|NCT02901431|10064743|FG012|STARTED|Open Label Part||5
9001425|NCT02901431|10064731|FG000|COMPLETED|Open Label Part||0
9001426|NCT02901431|10064732|FG001|COMPLETED|Open Label Part||0
9001427|NCT02901431|10064733|FG002|COMPLETED|Open Label Part||0
9001428|NCT02901431|10064734|FG003|COMPLETED|Open Label Part||0
9001429|NCT02901431|10064735|FG004|COMPLETED|Open Label Part||0
9001430|NCT02901431|10064736|FG005|COMPLETED|Open Label Part||0
9001431|NCT02901431|10064737|FG006|COMPLETED|Open Label Part||0
9001432|NCT02901431|10064738|FG007|COMPLETED|Open Label Part||0
9001433|NCT02901431|10064739|FG008|COMPLETED|Open Label Part||20
9001434|NCT02901431|10064740|FG009|COMPLETED|Open Label Part||11
9001435|NCT02901431|10064741|FG010|COMPLETED|Open Label Part||11
9001436|NCT02901431|10064742|FG011|COMPLETED|Open Label Part||7
9001437|NCT02901431|10064743|FG012|COMPLETED|Open Label Part||2
9001438|NCT02901431|10064731|FG000|NOT COMPLETED|Open Label Part||0
9001439|NCT02901431|10064732|FG001|NOT COMPLETED|Open Label Part||0
9001440|NCT02901431|10064733|FG002|NOT COMPLETED|Open Label Part||0
9001441|NCT02901431|10064734|FG003|NOT COMPLETED|Open Label Part||0
9001442|NCT02901431|10064735|FG004|NOT COMPLETED|Open Label Part||0
9001443|NCT02901431|10064736|FG005|NOT COMPLETED|Open Label Part||0
9001444|NCT02901431|10064737|FG006|NOT COMPLETED|Open Label Part||0
9001445|NCT02901431|10064738|FG007|NOT COMPLETED|Open Label Part||0
9001446|NCT02901431|10064739|FG008|NOT COMPLETED|Open Label Part||48
9001447|NCT02901431|10064740|FG009|NOT COMPLETED|Open Label Part||24
9001448|NCT02901431|10064741|FG010|NOT COMPLETED|Open Label Part||29
9001449|NCT02901431|10064742|FG011|NOT COMPLETED|Open Label Part||39
9001450|NCT02901431|10064743|FG012|NOT COMPLETED|Open Label Part||3
9001451|NCT02901899|10064768|FG000|STARTED|Reached 1st Response Assessment||45
9001452|NCT02901899|10064768|FG000|Registered|Reached 1st Response Assessment||45
9001453|NCT02901899|10064768|FG000|Started Treatment|Reached 1st Response Assessment||43
9001454|NCT02901899|10064768|FG000|Attempted 2 Cycles of Treatment/Reached First Response|Reached 1st Response Assessment||37
9001455|NCT02901899|10064768|FG000|COMPLETED|Reached 1st Response Assessment||37
9001456|NCT02901899|10064768|FG000|NOT COMPLETED|Reached 1st Response Assessment||8
9001457|NCT02901899|10064768|FG000|STARTED|Continued Treatment After 1st Response||37
9001458|NCT02901899|10064768|FG000|Went on to Start Cycle 3|Continued Treatment After 1st Response||21
9001459|NCT02901899|10064768|FG000|COMPLETED|Continued Treatment After 1st Response||21
9001460|NCT02901899|10064768|FG000|NOT COMPLETED|Continued Treatment After 1st Response||16
9001461|NCT02901899|10064768|FG000|STARTED|Follow up|All patients who receive at least one dose of study drug go into the follow up period.|43
9001462|NCT02901899|10064768|FG000|COMPLETED|Follow up||27
9001463|NCT02901899|10064768|FG000|NOT COMPLETED|Follow up||16
9001464|NCT02901951|10064772|FG000|STARTED|Overall Study||103
9001465|NCT02901951|10064772|FG000|COMPLETED|Overall Study||103
9001466|NCT02901951|10064772|FG000|NOT COMPLETED|Overall Study||0
9001467|NCT02902081|10064776|FG000|STARTED|Overall Study||38
9001468|NCT02902081|10064776|FG000|COMPLETED|Overall Study||38
9001469|NCT02902081|10064776|FG000|NOT COMPLETED|Overall Study||0
9001470|NCT02902146|10064786|FG000|STARTED|Overall Study||381
9001471|NCT02902146|10064787|FG001|STARTED|Overall Study||376
9001472|NCT02902146|10064786|FG000|COMPLETED|Overall Study||381
9001473|NCT02902146|10064787|FG001|COMPLETED|Overall Study||376
9001474|NCT02902146|10064786|FG000|NOT COMPLETED|Overall Study||0
9001475|NCT02902146|10064787|FG001|NOT COMPLETED|Overall Study||0
9001476|NCT02902172|10064795|FG000|STARTED|Overall Study||16
9001477|NCT02902172|10064796|FG001|STARTED|Overall Study||20
9001478|NCT02902172|10064795|FG000|COMPLETED|Overall Study||16
8879974|NCT01937871|9936773|FG000|STARTED|Overall Study||361
8879975|NCT01937871|9936774|FG001|STARTED|Overall Study||363
8879976|NCT01937871|9936775|FG002|STARTED|Overall Study||185
8879977|NCT01937871|9936773|FG000|Received at Least One Dose of Study Drug|Overall Study||361
8879978|NCT01937871|9936774|FG001|Received at Least One Dose of Study Drug|Overall Study||362
8879979|NCT01937871|9936775|FG002|Received at Least One Dose of Study Drug|Overall Study||185
8879980|NCT01937871|9936773|FG000|COMPLETED|Overall Study||337
8879981|NCT01937871|9936774|FG001|COMPLETED|Overall Study||346
8879982|NCT01937871|9936775|FG002|COMPLETED|Overall Study||174
8879983|NCT01937871|9936773|FG000|NOT COMPLETED|Overall Study||24
8879984|NCT01937871|9936774|FG001|NOT COMPLETED|Overall Study||17
8879985|NCT01937871|9936775|FG002|NOT COMPLETED|Overall Study||11
8879986|NCT01937884|9936788|FG000|STARTED|Overall Study||7
8879987|NCT01937884|9936789|FG001|STARTED|Overall Study||11
8879988|NCT01937884|9936788|FG000|COMPLETED|Overall Study||6
8879989|NCT01937884|9936789|FG001|COMPLETED|Overall Study||11
8879990|NCT01937884|9936788|FG000|NOT COMPLETED|Overall Study||1
8879991|NCT01937884|9936789|FG001|NOT COMPLETED|Overall Study||0
8879992|NCT01937975|9936800|FG000|STARTED|Overall Study||8
8879993|NCT01937975|9936801|FG001|STARTED|Overall Study||8
9001479|NCT02902172|10064796|FG001|COMPLETED|Overall Study||20
9001480|NCT02902172|10064795|FG000|NOT COMPLETED|Overall Study||0
9001481|NCT02902172|10064796|FG001|NOT COMPLETED|Overall Study||0
9001482|NCT02902237|10064803|FG000|STARTED|Overall Study||17
9001483|NCT02902237|10064803|FG000|COMPLETED|Overall Study|STUDY INITIATION: 2017 03 29, 1st Patient In, STUDY COMPLETION: 2019 11 05, Date of Study End|17
9001484|NCT02902237|10064803|FG000|NOT COMPLETED|Overall Study||0
9001485|NCT02902770|10064817|FG000|STARTED|Overall Study||50
9001486|NCT02902770|10064818|FG001|STARTED|Overall Study||50
9001487|NCT02902770|10064819|FG002|STARTED|Overall Study||50
9001488|NCT02902770|10064817|FG000|COMPLETED|Overall Study||50
9001489|NCT02902770|10064818|FG001|COMPLETED|Overall Study||50
9001490|NCT02902770|10064819|FG002|COMPLETED|Overall Study||50
9001491|NCT02902770|10064817|FG000|NOT COMPLETED|Overall Study||0
9001492|NCT02902770|10064818|FG001|NOT COMPLETED|Overall Study||0
9001493|NCT02902770|10064819|FG002|NOT COMPLETED|Overall Study||0
9001494|NCT02902809|10064827|FG000|STARTED|Overall Study||28
9001495|NCT02902809|10064827|FG000|Treatment Received|Overall Study||28
9001496|NCT02902809|10064827|FG000|Treatment Completed|Overall Study||2
9001497|NCT02902809|10064827|FG000|COMPLETED|Overall Study||0
9001498|NCT02902809|10064827|FG000|NOT COMPLETED|Overall Study||28
9001499|NCT02902913|10064831|FG000|STARTED|Overall Study||9
9001500|NCT02902913|10064831|FG000|First Intervention (1 Day)|Overall Study||9
9001501|NCT02902913|10064831|FG000|Washout (7 Days)|Overall Study||9
9001502|NCT02902913|10064831|FG000|Second Intervention (1 Day)|Overall Study||9
9001503|NCT02902913|10064831|FG000|Washout (7 Days)|Overall Study||9
9001504|NCT02902913|10064831|FG000|Third Intervention (1 Day)|Overall Study||9
9001505|NCT02902913|10064831|FG000|Washout (7 Days)|Overall Study||9
9001506|NCT02902913|10064831|FG000|Ibuprofen (400mg)|Overall Study||9
9001507|NCT02902913|10064831|FG000|COMPLETED|Overall Study||9
9001508|NCT02902913|10064831|FG000|NOT COMPLETED|Overall Study||0
9039396|NCT03338556|10100361|FG000|STARTED|Overall Study||25
9039397|NCT03338556|10100362|FG001|STARTED|Overall Study||27
9039398|NCT03338556|10100363|FG002|STARTED|Overall Study||24
9039399|NCT03338556|10100364|FG003|STARTED|Overall Study||26
9039400|NCT03338556|10100361|FG000|COMPLETED|Overall Study||23
9039401|NCT03338556|10100362|FG001|COMPLETED|Overall Study||23
9039402|NCT03338556|10100363|FG002|COMPLETED|Overall Study||22
9039403|NCT03338556|10100364|FG003|COMPLETED|Overall Study||24
9039404|NCT03338556|10100361|FG000|NOT COMPLETED|Overall Study||2
9039405|NCT03338556|10100362|FG001|NOT COMPLETED|Overall Study||4
8572585|NCT00115765|9604772|FG003|COMPLETED|Overall Study|Participants who were on study at closure or died|84
8572586|NCT00115765|9604769|FG000|NOT COMPLETED|Overall Study||35
8572587|NCT00115765|9604770|FG001|NOT COMPLETED|Overall Study||100
8572588|NCT00115765|9604771|FG002|NOT COMPLETED|Overall Study||121
8572589|NCT00115765|9604772|FG003|NOT COMPLETED|Overall Study||31
8572590|NCT00115778|9604780|FG000|STARTED|Overall Study||6
8572591|NCT00115778|9604781|FG001|STARTED|Overall Study||5
8572592|NCT00115778|9604780|FG000|COMPLETED|Overall Study||6
8572593|NCT00115778|9604781|FG001|COMPLETED|Overall Study||4
8572594|NCT00115778|9604780|FG000|NOT COMPLETED|Overall Study||0
8572595|NCT00115778|9604781|FG001|NOT COMPLETED|Overall Study||1
8572596|NCT00115804|9604787|FG000|STARTED|Overall Study||6
8572597|NCT00115804|9604787|FG000|COMPLETED|Overall Study||4
8572598|NCT00115804|9604787|FG000|NOT COMPLETED|Overall Study||2
8572599|NCT00115869|9604795|FG000|STARTED|Overall Study||4211
8572600|NCT00115869|9604796|FG001|STARTED|Overall Study||4177
8572601|NCT00115869|9604795|FG000|Completed Data Collection at 12th Grade|Overall Study||3876
8572602|NCT00115869|9604796|FG001|Completed Data Collection at 12th Grade|Overall Study||3847
8572603|NCT00115869|9604795|FG000|COMPLETED|Overall Study||3894
8572604|NCT00115869|9604796|FG001|COMPLETED|Overall Study|Follow-up at two years post high school.|3881
8572605|NCT00115869|9604795|FG000|NOT COMPLETED|Overall Study||317
8572606|NCT00115869|9604796|FG001|NOT COMPLETED|Overall Study||296
9039406|NCT03338556|10100363|FG002|NOT COMPLETED|Overall Study||2
9039407|NCT03338556|10100364|FG003|NOT COMPLETED|Overall Study||2
9039408|NCT03338569|10100376|FG000|STARTED|Overall Study||64
9039409|NCT03338569|10100377|FG001|STARTED|Overall Study||61
9039410|NCT03338569|10100376|FG000|COMPLETED|Overall Study||56
9001509|NCT02902965|10064839|FG000|STARTED|Overall Study||74
9001510|NCT02902965|10064839|FG000|COMPLETED|Overall Study||64
9001511|NCT02902965|10064839|FG000|NOT COMPLETED|Overall Study||10
9001512|NCT02903030|10064846|FG000|STARTED|First Intervention (8 Weeks)||8
9001513|NCT02903030|10064847|FG001|STARTED|First Intervention (8 Weeks)||5
9001514|NCT02903030|10064846|FG000|Received Intervention|First Intervention (8 Weeks)||6
9001515|NCT02903030|10064847|FG001|Received Intervention|First Intervention (8 Weeks)||4
9001516|NCT02903030|10064846|FG000|COMPLETED|First Intervention (8 Weeks)||6
9001517|NCT02903030|10064847|FG001|COMPLETED|First Intervention (8 Weeks)||4
9001518|NCT02903030|10064846|FG000|NOT COMPLETED|First Intervention (8 Weeks)||2
9001519|NCT02903030|10064847|FG001|NOT COMPLETED|First Intervention (8 Weeks)||1
9001520|NCT02903030|10064846|FG000|STARTED|Washout (3 Weeks)||6
9001521|NCT02903030|10064847|FG001|STARTED|Washout (3 Weeks)||4
9001522|NCT02903030|10064846|FG000|COMPLETED|Washout (3 Weeks)||6
9001523|NCT02903030|10064847|FG001|COMPLETED|Washout (3 Weeks)||4
9001524|NCT02903030|10064846|FG000|NOT COMPLETED|Washout (3 Weeks)||0
9001525|NCT02903030|10064847|FG001|NOT COMPLETED|Washout (3 Weeks)||0
9001526|NCT02903030|10064846|FG000|STARTED|Second Intervention (8 Weeks)||6
9001527|NCT02903030|10064847|FG001|STARTED|Second Intervention (8 Weeks)||4
9001528|NCT02903030|10064846|FG000|COMPLETED|Second Intervention (8 Weeks)||6
9001529|NCT02903030|10064847|FG001|COMPLETED|Second Intervention (8 Weeks)||4
9001530|NCT02903030|10064846|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||0
9001531|NCT02903030|10064847|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||0
9001532|NCT02903121|10064858|FG000|STARTED|Overall Study||57
9001533|NCT02903121|10064859|FG001|STARTED|Overall Study||52
9001534|NCT02903121|10064858|FG000|COMPLETED|Overall Study||34
9001535|NCT02903121|10064859|FG001|COMPLETED|Overall Study||38
9001536|NCT02903121|10064858|FG000|NOT COMPLETED|Overall Study||23
9001537|NCT02903121|10064859|FG001|NOT COMPLETED|Overall Study||14
9001538|NCT02903238|10064865|FG000|STARTED|Overall Study||21
9001539|NCT02903238|10064865|FG000|COMPLETED|Overall Study||17
9001540|NCT02903238|10064865|FG000|NOT COMPLETED|Overall Study||4
9001541|NCT02903368|10064872|FG000|STARTED|Overall Study||59
9001542|NCT02903368|10064873|FG001|STARTED|Overall Study||59
9001543|NCT02903368|10064872|FG000|COMPLETED|Overall Study||55
9001544|NCT02903368|10064873|FG001|COMPLETED|Overall Study||59
9001545|NCT02903368|10064872|FG000|NOT COMPLETED|Overall Study||4
9001546|NCT02903368|10064873|FG001|NOT COMPLETED|Overall Study||0
9001547|NCT02903394|10064884|FG000|STARTED|Overall Study||5
9001548|NCT02903394|10064885|FG001|STARTED|Overall Study||50
9001549|NCT02903394|10064884|FG000|COMPLETED|Overall Study||5
9001550|NCT02903394|10064885|FG001|COMPLETED|Overall Study||50
9001551|NCT02903394|10064884|FG000|NOT COMPLETED|Overall Study||0
9001552|NCT02903394|10064885|FG001|NOT COMPLETED|Overall Study||0
9001553|NCT02903407|10064894|FG000|STARTED|Overall Study||4
9001554|NCT02903407|10064895|FG001|STARTED|Overall Study||3
9001555|NCT02903407|10064894|FG000|COMPLETED|Overall Study||4
9001556|NCT02903407|10064895|FG001|COMPLETED|Overall Study||3
9001557|NCT02903407|10064894|FG000|NOT COMPLETED|Overall Study||0
9001558|NCT02903407|10064895|FG001|NOT COMPLETED|Overall Study||0
9001559|NCT02903420|10064901|FG000|STARTED|Overall Study||28
9001560|NCT02903420|10064901|FG000|COMPLETED|Overall Study||25
9001561|NCT02903420|10064901|FG000|NOT COMPLETED|Overall Study||3
9001562|NCT02903446|10064907|FG000|STARTED|Overall Study||10
9001563|NCT02903446|10064908|FG001|STARTED|Overall Study||10
9001564|NCT02903446|10064907|FG000|COMPLETED|Overall Study||10
9001565|NCT02903446|10064908|FG001|COMPLETED|Overall Study||10
9001566|NCT02903446|10064907|FG000|NOT COMPLETED|Overall Study||0
9001567|NCT02903446|10064908|FG001|NOT COMPLETED|Overall Study||0
9001568|NCT02903511|10064916|FG000|STARTED|Overall Study||26
9001569|NCT02903511|10064917|FG001|STARTED|Overall Study||25
9001570|NCT02903511|10064916|FG000|Received Intervention|Overall Study||25
9001571|NCT02903511|10064917|FG001|Received Intervention|Overall Study||25
9001572|NCT02903511|10064916|FG000|COMPLETED|Overall Study||22
9001573|NCT02903511|10064917|FG001|COMPLETED|Overall Study||23
9001574|NCT02903511|10064916|FG000|NOT COMPLETED|Overall Study||4
9001575|NCT02903511|10064917|FG001|NOT COMPLETED|Overall Study||2
9001576|NCT02903836|10064926|FG000|STARTED|Overall Study||74
9001577|NCT02903836|10064927|FG001|STARTED|Overall Study||73
9001578|NCT02903836|10064928|FG002|STARTED|Overall Study||77
9001579|NCT02903836|10064926|FG000|COMPLETED|Overall Study||71
9001580|NCT02903836|10064927|FG001|COMPLETED|Overall Study||69
9001581|NCT02903836|10064928|FG002|COMPLETED|Overall Study||73
9001582|NCT02903836|10064926|FG000|NOT COMPLETED|Overall Study||3
9001583|NCT02903836|10064927|FG001|NOT COMPLETED|Overall Study||4
9001584|NCT02903836|10064928|FG002|NOT COMPLETED|Overall Study||4
9001585|NCT02903966|10064938|FG000|STARTED|Part A (Day 1 to 43)||12
9001586|NCT02903966|10064939|FG001|STARTED|Part A (Day 1 to 43)||24
9001587|NCT02903966|10064938|FG000|COMPLETED|Part A (Day 1 to 43)||11
9001588|NCT02903966|10064939|FG001|COMPLETED|Part A (Day 1 to 43)||24
9001589|NCT02903966|10064938|FG000|NOT COMPLETED|Part A (Day 1 to 43)||1
9001590|NCT02903966|10064939|FG001|NOT COMPLETED|Part A (Day 1 to 43)||0
9001591|NCT02903966|10064938|FG000|STARTED|Part B (Day 44 to 112)||11
9001592|NCT02903966|10064939|FG001|STARTED|Part B (Day 44 to 112)||24
9001593|NCT02903966|10064938|FG000|COMPLETED|Part B (Day 44 to 112)||11
9001594|NCT02903966|10064939|FG001|COMPLETED|Part B (Day 44 to 112)||22
9001595|NCT02903966|10064938|FG000|NOT COMPLETED|Part B (Day 44 to 112)||0
9001596|NCT02903966|10064939|FG001|NOT COMPLETED|Part B (Day 44 to 112)||2
9001597|NCT02904057|10064953|FG000|STARTED|Overall Study||19
9001598|NCT02904057|10064954|FG001|STARTED|Overall Study||10
9001599|NCT02904057|10064953|FG000|COMPLETED|Overall Study||19
9001600|NCT02904057|10064954|FG001|COMPLETED|Overall Study||10
9001601|NCT02904057|10064953|FG000|NOT COMPLETED|Overall Study||0
9001602|NCT02904057|10064954|FG001|NOT COMPLETED|Overall Study||0
9001603|NCT02904096|10064962|FG000|STARTED|Overall Study||130
9001604|NCT02904096|10064963|FG001|STARTED|Overall Study||126
9001605|NCT02904096|10064962|FG000|COMPLETED|Overall Study||111
9001606|NCT02904096|10064963|FG001|COMPLETED|Overall Study||105
9001607|NCT02904096|10064962|FG000|NOT COMPLETED|Overall Study||19
9001608|NCT02904096|10064963|FG001|NOT COMPLETED|Overall Study||21
9001609|NCT02904200|10064969|FG000|STARTED|Overall Study|One pat. early terminated on own decision, due to travelling distance between home and hospital.|2
9001610|NCT02904200|10064970|FG001|STARTED|Overall Study|No statistical evaluation was performed because only 2 subjects were included in one arm.|0
9001611|NCT02904200|10064969|FG000|COMPLETED|Overall Study||1
9001612|NCT02904200|10064970|FG001|COMPLETED|Overall Study||0
9001613|NCT02904200|10064969|FG000|NOT COMPLETED|Overall Study||1
9001614|NCT02904200|10064970|FG001|NOT COMPLETED|Overall Study||0
9001615|NCT02904226|10064982|FG000|STARTED|Overall Study||40
9001616|NCT02904226|10064983|FG001|STARTED|Overall Study||31
9001617|NCT02904226|10064984|FG002|STARTED|Overall Study||30
9001618|NCT02904226|10064985|FG003|STARTED|Overall Study||100
9001619|NCT02904226|10064986|FG004|STARTED|Overall Study||11
9001620|NCT02904226|10064987|FG005|STARTED|Overall Study||0
9001621|NCT02904226|10064988|FG006|STARTED|Overall Study||6
9001622|NCT02904226|10064989|FG007|STARTED|Overall Study||0
9001623|NCT02904226|10064982|FG000|COMPLETED|Overall Study||0
8634036|NCT00554671|9674332|FG001|NOT COMPLETED|Overall Study||16
8634037|NCT00554749|9674339|FG000|STARTED|Overall Study||7
8879994|NCT01937975|9936802|FG002|STARTED|Overall Study||8
8879995|NCT01937975|9936800|FG000|COMPLETED|Overall Study||8
8879996|NCT01937975|9936801|FG001|COMPLETED|Overall Study||8
8879997|NCT01937975|9936802|FG002|COMPLETED|Overall Study||8
9001624|NCT02904226|10064983|FG001|COMPLETED|Overall Study||2
9001625|NCT02904226|10064984|FG002|COMPLETED|Overall Study||0
9001626|NCT02904226|10064985|FG003|COMPLETED|Overall Study||4
9001627|NCT02904226|10064986|FG004|COMPLETED|Overall Study||0
9001628|NCT02904226|10064987|FG005|COMPLETED|Overall Study||0
9001629|NCT02904226|10064988|FG006|COMPLETED|Overall Study||0
8879998|NCT01937975|9936800|FG000|NOT COMPLETED|Overall Study||0
8879999|NCT01937975|9936801|FG001|NOT COMPLETED|Overall Study||0
8880000|NCT01937975|9936802|FG002|NOT COMPLETED|Overall Study||0
8880001|NCT01938001|9936816|FG000|STARTED|Overall Study||178
8880002|NCT01938001|9936817|FG001|STARTED|Overall Study||180
8880003|NCT01938001|9936816|FG000|Participants Received Treatment|Overall Study||176
8880004|NCT01938001|9936817|FG001|Participants Received Treatment|Overall Study||180
8880005|NCT01938001|9936816|FG000|Completed Treatment|Overall Study||124
8880006|NCT01938001|9936817|FG001|Completed Treatment|Overall Study||110
8880007|NCT01938001|9936816|FG000|COMPLETED|Overall Study||135
8880008|NCT01938001|9936817|FG001|COMPLETED|Overall Study||133
8880009|NCT01938001|9936816|FG000|NOT COMPLETED|Overall Study||43
8880010|NCT01938001|9936817|FG001|NOT COMPLETED|Overall Study||47
8880011|NCT01938040|9936825|FG000|STARTED|Overall Study||28
8880012|NCT01938040|9936826|FG001|STARTED|Overall Study||27
8880013|NCT01938040|9936825|FG000|Plasma Analysis|Overall Study|complete set of blood samples could not be obtained|24
8880014|NCT01938040|9936826|FG001|Plasma Analysis|Overall Study|complete set of blood samples could not be obtained|25
8880015|NCT01938040|9936825|FG000|Behavior Metrics|Overall Study||28
8880016|NCT01938040|9936826|FG001|Behavior Metrics|Overall Study||27
8880017|NCT01938040|9936825|FG000|COMPLETED|Overall Study||28
8880018|NCT01938040|9936826|FG001|COMPLETED|Overall Study||27
8880019|NCT01938040|9936825|FG000|NOT COMPLETED|Overall Study||0
8880020|NCT01938040|9936826|FG001|NOT COMPLETED|Overall Study||0
9001630|NCT02904226|10064989|FG007|COMPLETED|Overall Study||0
9001631|NCT02904226|10064982|FG000|NOT COMPLETED|Overall Study||40
9001632|NCT02904226|10064983|FG001|NOT COMPLETED|Overall Study||29
9001633|NCT02904226|10064984|FG002|NOT COMPLETED|Overall Study||30
9001634|NCT02904226|10064985|FG003|NOT COMPLETED|Overall Study||96
9001635|NCT02904226|10064986|FG004|NOT COMPLETED|Overall Study||11
9001636|NCT02904226|10064987|FG005|NOT COMPLETED|Overall Study||0
9001637|NCT02904226|10064988|FG006|NOT COMPLETED|Overall Study||6
8634038|NCT00554749|9674339|FG000|COMPLETED|Overall Study||7
8634039|NCT00554749|9674339|FG000|NOT COMPLETED|Overall Study||0
9001638|NCT02904226|10064989|FG007|NOT COMPLETED|Overall Study||0
9001639|NCT02904265|10065007|FG000|STARTED|Overall Study|Study closed due to only 3 participants recruited|1
9001640|NCT02904265|10065008|FG001|STARTED|Overall Study|Study closed due to only 3 participants recruited|2
9001641|NCT02904265|10065007|FG000|COMPLETED|Overall Study||0
9001642|NCT02904265|10065008|FG001|COMPLETED|Overall Study||0
9001643|NCT02904265|10065007|FG000|NOT COMPLETED|Overall Study||1
9001644|NCT02904265|10065008|FG001|NOT COMPLETED|Overall Study||2
9001645|NCT02904512|10065016|FG000|STARTED|Overall Study||9
9001646|NCT02904512|10065017|FG001|STARTED|Overall Study||7
9001647|NCT02904512|10065016|FG000|COMPLETED|Overall Study||6
9001648|NCT02904512|10065017|FG001|COMPLETED|Overall Study||7
9001649|NCT02904512|10065016|FG000|NOT COMPLETED|Overall Study||3
9001650|NCT02904512|10065017|FG001|NOT COMPLETED|Overall Study||0
9001651|NCT02904902|10065023|FG000|STARTED|Overall Study||15
9001652|NCT02904902|10065023|FG000|COMPLETED|Overall Study||14
9001653|NCT02904902|10065023|FG000|NOT COMPLETED|Overall Study||1
9001654|NCT02904915|10065029|FG000|STARTED|Overall Study||25
9001655|NCT02904915|10065030|FG001|STARTED|Overall Study||25
9001656|NCT02904915|10065029|FG000|COMPLETED|Overall Study||25
9001657|NCT02904915|10065030|FG001|COMPLETED|Overall Study||25
9001658|NCT02904915|10065029|FG000|NOT COMPLETED|Overall Study||0
9001659|NCT02904915|10065030|FG001|NOT COMPLETED|Overall Study||0
9001660|NCT02904954|10065038|FG000|STARTED|Neoadjuvant (Preoperative) to Surgery||30
9001661|NCT02904954|10065039|FG001|STARTED|Neoadjuvant (Preoperative) to Surgery||30
9001662|NCT02904954|10065038|FG000|COMPLETED|Neoadjuvant (Preoperative) to Surgery|30 participants completed 2 neoadjuvant cycles. Surgical resection was not performed in 4 participants.|26
9001663|NCT02904954|10065039|FG001|COMPLETED|Neoadjuvant (Preoperative) to Surgery|30 participants completed the first neoadjuvant Durvalumab cycle combined with SBRT. Three subjects did not receive the 2nd cycle. Surgical resection was not performed in 4 participants.|26
9001664|NCT02904954|10065038|FG000|NOT COMPLETED|Neoadjuvant (Preoperative) to Surgery||4
9001665|NCT02904954|10065039|FG001|NOT COMPLETED|Neoadjuvant (Preoperative) to Surgery||4
9001666|NCT02904954|10065038|FG000|STARTED|Adjuvant Durvalumab||26
9001667|NCT02904954|10065039|FG001|STARTED|Adjuvant Durvalumab||26
9001668|NCT02904954|10065038|FG000|COMPLETED|Adjuvant Durvalumab||5
9001669|NCT02904954|10065039|FG001|COMPLETED|Adjuvant Durvalumab||10
9001670|NCT02904954|10065038|FG000|NOT COMPLETED|Adjuvant Durvalumab||21
9001671|NCT02904954|10065039|FG001|NOT COMPLETED|Adjuvant Durvalumab||16
9001672|NCT02905006|10065053|FG000|STARTED|Overall Study||42
9001673|NCT02905006|10065054|FG001|STARTED|Overall Study||39
9001674|NCT02905006|10065055|FG002|STARTED|Overall Study||43
9001675|NCT02905006|10065056|FG003|STARTED|Overall Study||40
9001676|NCT02905006|10065057|FG004|STARTED|Overall Study||43
9001677|NCT02905006|10065058|FG005|STARTED|Overall Study||43
9001678|NCT02905006|10065053|FG000|Completed Treatment Period|Overall Study||37
9001679|NCT02905006|10065054|FG001|Completed Treatment Period|Overall Study||36
9001680|NCT02905006|10065055|FG002|Completed Treatment Period|Overall Study||38
9001681|NCT02905006|10065056|FG003|Completed Treatment Period|Overall Study||34
8880021|NCT01938066|9936840|FG000|STARTED|Overall Study||15
8880022|NCT01938066|9936841|FG001|STARTED|Overall Study||15
8880023|NCT01938066|9936840|FG000|COMPLETED|Overall Study||14
8880024|NCT01938066|9936841|FG001|COMPLETED|Overall Study||13
8880025|NCT01938066|9936840|FG000|NOT COMPLETED|Overall Study||1
8880026|NCT01938066|9936841|FG001|NOT COMPLETED|Overall Study||2
8880027|NCT01938079|9936849|FG000|STARTED|Overall Study||10
8880028|NCT01938079|9936850|FG001|STARTED|Overall Study||10
8880029|NCT01938079|9936849|FG000|COMPLETED|Overall Study||10
9001682|NCT02905006|10065057|FG004|Completed Treatment Period|Overall Study||40
9001683|NCT02905006|10065058|FG005|Completed Treatment Period|Overall Study||39
9001684|NCT02905006|10065053|FG000|Enrolled in Extension Study (PS0011)|Overall Study||38
9001685|NCT02905006|10065054|FG001|Enrolled in Extension Study (PS0011)|Overall Study||35
9001686|NCT02905006|10065055|FG002|Enrolled in Extension Study (PS0011)|Overall Study||39
9001687|NCT02905006|10065056|FG003|Enrolled in Extension Study (PS0011)|Overall Study||38
9039411|NCT03338569|10100377|FG001|COMPLETED|Overall Study||56
8880030|NCT01938079|9936850|FG001|COMPLETED|Overall Study||10
8880031|NCT01938079|9936849|FG000|NOT COMPLETED|Overall Study||0
8880032|NCT01938079|9936850|FG001|NOT COMPLETED|Overall Study||0
8880033|NCT01938170|9936856|FG000|STARTED|Overall Study||41
8880034|NCT01938170|9936856|FG000|COMPLETED|Overall Study||41
8880035|NCT01938170|9936856|FG000|NOT COMPLETED|Overall Study||0
8880036|NCT01938378|9936863|FG000|STARTED|Overall Study||41
8880037|NCT01938378|9936863|FG000|COMPLETED|Overall Study||41
8880038|NCT01938378|9936863|FG000|NOT COMPLETED|Overall Study||0
8880039|NCT01938391|9936881|FG000|STARTED|Baseline||25
8880040|NCT01938391|9936881|FG000|COMPLETED|Baseline||25
8880041|NCT01938391|9936881|FG000|NOT COMPLETED|Baseline||0
8880042|NCT01938391|9936881|FG000|STARTED|2 Week Follow up||25
8880043|NCT01938391|9936881|FG000|COMPLETED|2 Week Follow up||25
8880044|NCT01938391|9936881|FG000|NOT COMPLETED|2 Week Follow up||0
8880045|NCT01938391|9936881|FG000|STARTED|6 Month Follow up||25
8880046|NCT01938391|9936881|FG000|COMPLETED|6 Month Follow up||24
8880047|NCT01938391|9936881|FG000|NOT COMPLETED|6 Month Follow up||1
8880048|NCT01938391|9936881|FG000|STARTED|12 Month Follow up||24
8880049|NCT01938391|9936881|FG000|COMPLETED|12 Month Follow up||22
8880050|NCT01938391|9936881|FG000|NOT COMPLETED|12 Month Follow up||2
8880051|NCT01938430|9936899|FG000|STARTED|Overall Study||30
8880052|NCT01938430|9936900|FG001|STARTED|Overall Study||29
8880053|NCT01938430|9936901|FG002|STARTED|Overall Study||23
8880054|NCT01938430|9936902|FG003|STARTED|Overall Study||26
9001688|NCT02905006|10065057|FG004|Enrolled in Extension Study (PS0011)|Overall Study||42
9001689|NCT02905006|10065058|FG005|Enrolled in Extension Study (PS0011)|Overall Study||40
9001690|NCT02905006|10065053|FG000|Entered Safety Follow-up Period|Overall Study||4
9001691|NCT02905006|10065054|FG001|Entered Safety Follow-up Period|Overall Study||4
9001692|NCT02905006|10065055|FG002|Entered Safety Follow-up Period|Overall Study||4
9001693|NCT02905006|10065056|FG003|Entered Safety Follow-up Period|Overall Study||2
9001694|NCT02905006|10065057|FG004|Entered Safety Follow-up Period|Overall Study||1
9001695|NCT02905006|10065058|FG005|Entered Safety Follow-up Period|Overall Study||3
9001696|NCT02905006|10065053|FG000|COMPLETED|Overall Study||37
9001697|NCT02905006|10065054|FG001|COMPLETED|Overall Study||36
9001698|NCT02905006|10065055|FG002|COMPLETED|Overall Study||38
9001699|NCT02905006|10065056|FG003|COMPLETED|Overall Study||34
9001700|NCT02905006|10065057|FG004|COMPLETED|Overall Study||40
9001701|NCT02905006|10065058|FG005|COMPLETED|Overall Study||39
9001702|NCT02905006|10065053|FG000|NOT COMPLETED|Overall Study||5
9001703|NCT02905006|10065054|FG001|NOT COMPLETED|Overall Study||3
9001704|NCT02905006|10065055|FG002|NOT COMPLETED|Overall Study||5
9001705|NCT02905006|10065056|FG003|NOT COMPLETED|Overall Study||6
9001706|NCT02905006|10065057|FG004|NOT COMPLETED|Overall Study||3
9001707|NCT02905006|10065058|FG005|NOT COMPLETED|Overall Study||4
9001708|NCT02905149|10065098|FG000|STARTED|Overall Study||30
9001709|NCT02905149|10065099|FG001|STARTED|Overall Study||30
9001710|NCT02905149|10065098|FG000|COMPLETED|Overall Study||28
9001711|NCT02905149|10065099|FG001|COMPLETED|Overall Study||30
9001712|NCT02905149|10065098|FG000|NOT COMPLETED|Overall Study||2
9001713|NCT02905149|10065099|FG001|NOT COMPLETED|Overall Study||0
9001714|NCT02905266|10065107|FG000|STARTED|Treatment Phase Part 1||53
9001715|NCT02905266|10065108|FG001|STARTED|Treatment Phase Part 1||53
9001716|NCT02905266|10065107|FG000|COMPLETED|Treatment Phase Part 1||24
9001717|NCT02905266|10065108|FG001|COMPLETED|Treatment Phase Part 1||30
9001718|NCT02905266|10065107|FG000|NOT COMPLETED|Treatment Phase Part 1||29
9001719|NCT02905266|10065108|FG001|NOT COMPLETED|Treatment Phase Part 1||23
8880055|NCT01938430|9936903|FG004|STARTED|Overall Study||55
8880056|NCT01938430|9936904|FG005|STARTED|Overall Study||56
8880057|NCT01938430|9936905|FG006|STARTED|Overall Study||26
8880058|NCT01938430|9936906|FG007|STARTED|Overall Study||25
8880059|NCT01938430|9936907|FG008|STARTED|Overall Study||26
8880060|NCT01938430|9936908|FG009|STARTED|Overall Study||26
8880061|NCT01938430|9936909|FG010|STARTED|Overall Study||6
8880062|NCT01938430|9936910|FG011|STARTED|Overall Study||4
8880063|NCT01938430|9936911|FG012|STARTED|Overall Study||4
8880064|NCT01938430|9936912|FG013|STARTED|Overall Study||3
8880065|NCT01938430|9936899|FG000|COMPLETED|Overall Study||26
8880066|NCT01938430|9936900|FG001|COMPLETED|Overall Study||26
8880067|NCT01938430|9936901|FG002|COMPLETED|Overall Study||18
8880068|NCT01938430|9936902|FG003|COMPLETED|Overall Study||24
8880069|NCT01938430|9936903|FG004|COMPLETED|Overall Study||55
8880070|NCT01938430|9936904|FG005|COMPLETED|Overall Study||55
8880071|NCT01938430|9936905|FG006|COMPLETED|Overall Study||24
8880072|NCT01938430|9936906|FG007|COMPLETED|Overall Study||24
8880073|NCT01938430|9936907|FG008|COMPLETED|Overall Study||22
8880074|NCT01938430|9936908|FG009|COMPLETED|Overall Study||23
8880075|NCT01938430|9936909|FG010|COMPLETED|Overall Study||3
8880076|NCT01938430|9936910|FG011|COMPLETED|Overall Study||3
8880077|NCT01938430|9936911|FG012|COMPLETED|Overall Study||4
8880078|NCT01938430|9936912|FG013|COMPLETED|Overall Study||2
8880079|NCT01938430|9936899|FG000|NOT COMPLETED|Overall Study||4
8880080|NCT01938430|9936900|FG001|NOT COMPLETED|Overall Study||3
8880081|NCT01938430|9936901|FG002|NOT COMPLETED|Overall Study||5
8880082|NCT01938430|9936902|FG003|NOT COMPLETED|Overall Study||2
8880083|NCT01938430|9936903|FG004|NOT COMPLETED|Overall Study||0
8880084|NCT01938430|9936904|FG005|NOT COMPLETED|Overall Study||1
8880085|NCT01938430|9936905|FG006|NOT COMPLETED|Overall Study||2
8880086|NCT01938430|9936906|FG007|NOT COMPLETED|Overall Study||1
8880087|NCT01938430|9936907|FG008|NOT COMPLETED|Overall Study||4
8880088|NCT01938430|9936908|FG009|NOT COMPLETED|Overall Study||3
8880089|NCT01938430|9936909|FG010|NOT COMPLETED|Overall Study||3
8880090|NCT01938430|9936910|FG011|NOT COMPLETED|Overall Study||1
8880091|NCT01938430|9936911|FG012|NOT COMPLETED|Overall Study||0
8880092|NCT01938430|9936912|FG013|NOT COMPLETED|Overall Study||1
8880093|NCT01938573|9936967|FG000|STARTED|Overall Study||15
8880094|NCT01938573|9936968|FG001|STARTED|Overall Study||6
8880095|NCT01938573|9936967|FG000|COMPLETED|Overall Study||13
8880096|NCT01938573|9936968|FG001|COMPLETED|Overall Study||6
8880097|NCT01938573|9936967|FG000|NOT COMPLETED|Overall Study||2
8880098|NCT01938573|9936968|FG001|NOT COMPLETED|Overall Study||0
8880099|NCT01938625|9936975|FG000|STARTED|Overall Study||10
8880100|NCT01938625|9936976|FG001|STARTED|Overall Study||25
8880101|NCT01938625|9936975|FG000|COMPLETED|Overall Study||10
8880102|NCT01938625|9936976|FG001|COMPLETED|Overall Study||23
8880103|NCT01938625|9936975|FG000|NOT COMPLETED|Overall Study||0
8880104|NCT01938625|9936976|FG001|NOT COMPLETED|Overall Study||2
8880105|NCT01938664|9936984|FG000|STARTED|Overall Study||20
8880106|NCT01938664|9936985|FG001|STARTED|Overall Study||10
8880107|NCT01938664|9936984|FG000|COMPLETED|Overall Study||5
8880108|NCT01938664|9936985|FG001|COMPLETED|Overall Study||0
8880109|NCT01938664|9936984|FG000|NOT COMPLETED|Overall Study||15
9001720|NCT02905266|10065107|FG000|STARTED|Transition From Part 1 to Part 2||24
9001721|NCT02905266|10065108|FG001|STARTED|Transition From Part 1 to Part 2||30
9001722|NCT02905266|10065107|FG000|COMPLETED|Transition From Part 1 to Part 2||20
9001723|NCT02905266|10065108|FG001|COMPLETED|Transition From Part 1 to Part 2||22
9001724|NCT02905266|10065107|FG000|NOT COMPLETED|Transition From Part 1 to Part 2||4
9001725|NCT02905266|10065108|FG001|NOT COMPLETED|Transition From Part 1 to Part 2||8
9001726|NCT02905266|10065107|FG000|STARTED|Maintenance Phase Part 2||20
9001727|NCT02905266|10065108|FG001|STARTED|Maintenance Phase Part 2||22
9001728|NCT02905266|10065107|FG000|COMPLETED|Maintenance Phase Part 2||8
9001729|NCT02905266|10065108|FG001|COMPLETED|Maintenance Phase Part 2||14
9001730|NCT02905266|10065107|FG000|NOT COMPLETED|Maintenance Phase Part 2||12
9001731|NCT02905266|10065108|FG001|NOT COMPLETED|Maintenance Phase Part 2||8
9001732|NCT02905331|10065116|FG000|STARTED|Placebo Controlled Period(Week[wk] 0-16)||16
9001733|NCT02905331|10065117|FG001|STARTED|Placebo Controlled Period(Week[wk] 0-16)||62
9001734|NCT02905331|10065118|FG002|STARTED|Placebo Controlled Period(Week[wk] 0-16)||0
9001735|NCT02905331|10065116|FG000|COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||13
9001736|NCT02905331|10065117|FG001|COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||61
9001737|NCT02905331|10065118|FG002|COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||0
9001738|NCT02905331|10065116|FG000|NOT COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||3
9001739|NCT02905331|10065117|FG001|NOT COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||1
9001740|NCT02905331|10065118|FG002|NOT COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||0
9001741|NCT02905331|10065116|FG000|STARTED|Active Treatment and Follow up (wk16-40)||0
9001742|NCT02905331|10065117|FG001|STARTED|Active Treatment and Follow up (wk16-40)||61
9001743|NCT02905331|10065118|FG002|STARTED|Active Treatment and Follow up (wk16-40)||13
9001744|NCT02905331|10065116|FG000|COMPLETED|Active Treatment and Follow up (wk16-40)||0
9001745|NCT02905331|10065117|FG001|COMPLETED|Active Treatment and Follow up (wk16-40)||53
9001746|NCT02905331|10065118|FG002|COMPLETED|Active Treatment and Follow up (wk16-40)||13
9001747|NCT02905331|10065116|FG000|NOT COMPLETED|Active Treatment and Follow up (wk16-40)||0
9001748|NCT02905331|10065117|FG001|NOT COMPLETED|Active Treatment and Follow up (wk16-40)||8
9001749|NCT02905331|10065118|FG002|NOT COMPLETED|Active Treatment and Follow up (wk16-40)||0
9001750|NCT02905435|10065126|FG000|STARTED|Overall Study||14
9001751|NCT02905435|10065126|FG000|COMPLETED|Overall Study||7
9001752|NCT02905435|10065126|FG000|NOT COMPLETED|Overall Study||7
9001753|NCT02905825|10065131|FG000|STARTED|Overall Study||53
9001754|NCT02905825|10065131|FG000|COMPLETED|Overall Study||41
9001755|NCT02905825|10065131|FG000|NOT COMPLETED|Overall Study||12
9001756|NCT02905981|10065135|FG000|STARTED|Overall Study||1
9001757|NCT02905981|10065135|FG000|COMPLETED|Overall Study||0
9001758|NCT02905981|10065135|FG000|NOT COMPLETED|Overall Study||1
9001759|NCT02906358|10065141|FG000|STARTED|Overall Study||58
9001760|NCT02906358|10065142|FG001|STARTED|Overall Study||53
9001761|NCT02906358|10065141|FG000|Completed 3 Month Measures|Overall Study||36
9001762|NCT02906358|10065142|FG001|Completed 3 Month Measures|Overall Study||33
9001763|NCT02906358|10065141|FG000|COMPLETED|Overall Study||36
9001764|NCT02906358|10065142|FG001|COMPLETED|Overall Study||31
9001765|NCT02906358|10065141|FG000|NOT COMPLETED|Overall Study||22
9001766|NCT02906358|10065142|FG001|NOT COMPLETED|Overall Study||22
9001767|NCT02906566|10065150|FG000|STARTED|Overall Study||24
9001768|NCT02906566|10065151|FG001|STARTED|Overall Study||10
9001769|NCT02906566|10065150|FG000|COMPLETED|Overall Study||21
9001770|NCT02906566|10065151|FG001|COMPLETED|Overall Study||10
9001771|NCT02906566|10065150|FG000|NOT COMPLETED|Overall Study||3
9001772|NCT02906566|10065151|FG001|NOT COMPLETED|Overall Study||0
9001773|NCT02906579|10065159|FG000|STARTED|Overall Study||11
9001774|NCT02906579|10065159|FG000|Completed Cycle 1 (Placebo)|Overall Study||11
9001775|NCT02906579|10065159|FG000|Completed Cycle 2 (10 mg IW-1973)|Overall Study||11
9001776|NCT02906579|10065159|FG000|Completed Cycle 3 (20 mg IW-1973)|Overall Study||11
9001777|NCT02906579|10065159|FG000|Completed Cycle 4 (30 mg IW-1973)|Overall Study||10
8634040|NCT00554788|9674346|FG000|STARTED|Overall Study||21
8634041|NCT00554788|9674347|FG001|STARTED|Overall Study||18
8634042|NCT00554788|9674348|FG002|STARTED|Overall Study||21
8880110|NCT01938664|9936985|FG001|NOT COMPLETED|Overall Study||10
8880111|NCT01938846|9936994|FG000|STARTED|Overall Study||41
8880112|NCT01938846|9936995|FG001|STARTED|Overall Study||25
8880113|NCT01938846|9936996|FG002|STARTED|Overall Study||24
8880114|NCT01938846|9936994|FG000|COMPLETED|Overall Study||0
8880115|NCT01938846|9936995|FG001|COMPLETED|Overall Study||0
8880116|NCT01938846|9936996|FG002|COMPLETED|Overall Study||0
8880117|NCT01938846|9936994|FG000|NOT COMPLETED|Overall Study||41
8880118|NCT01938846|9936995|FG001|NOT COMPLETED|Overall Study||25
8880119|NCT01938846|9936996|FG002|NOT COMPLETED|Overall Study||24
8880120|NCT01938989|9937037|FG000|STARTED|Overall Study||77
8880121|NCT01938989|9937038|FG001|STARTED|Overall Study||77
8880122|NCT01938989|9937037|FG000|COMPLETED|Overall Study||77
8880123|NCT01938989|9937038|FG001|COMPLETED|Overall Study||77
8880124|NCT01938989|9937037|FG000|NOT COMPLETED|Overall Study||0
8880125|NCT01938989|9937038|FG001|NOT COMPLETED|Overall Study||0
8880126|NCT01939002|9937046|FG000|STARTED|Overall Study||103
8880127|NCT01939002|9937047|FG001|STARTED|Overall Study||98
8880128|NCT01939002|9937046|FG000|COMPLETED|Overall Study||84
8880129|NCT01939002|9937047|FG001|COMPLETED|Overall Study||80
8880130|NCT01939002|9937046|FG000|NOT COMPLETED|Overall Study||19
8880131|NCT01939002|9937047|FG001|NOT COMPLETED|Overall Study||18
8880132|NCT01939028|9937058|FG000|STARTED|Overall Study||58
8880133|NCT01939028|9937058|FG000|COMPLETED|Overall Study||46
8880134|NCT01939028|9937058|FG000|NOT COMPLETED|Overall Study||12
8880135|NCT01939145|9937064|FG000|STARTED|Overall Study||49
9001778|NCT02906579|10065159|FG000|Completed Cycle 5 (40 mg IW-1973)|Overall Study||9
9001779|NCT02906579|10065159|FG000|Completed Cycle 6 (50 mg IW-1973)|Overall Study||9
9001780|NCT02906579|10065159|FG000|COMPLETED|Overall Study||9
9001781|NCT02906579|10065159|FG000|NOT COMPLETED|Overall Study||2
9001782|NCT02906644|10065181|FG000|STARTED|First 2 Weeks||31
9001783|NCT02906644|10065182|FG001|STARTED|First 2 Weeks||30
9001784|NCT02906644|10065181|FG000|COMPLETED|First 2 Weeks||30
9001785|NCT02906644|10065182|FG001|COMPLETED|First 2 Weeks||27
9001786|NCT02906644|10065181|FG000|NOT COMPLETED|First 2 Weeks||1
9001787|NCT02906644|10065182|FG001|NOT COMPLETED|First 2 Weeks||3
9001788|NCT02906644|10065181|FG000|STARTED|Weeks 3 to 14|All participants receiving active Lorcaserin plus nicotine patches starting at the 2nd study visit.|30
9001789|NCT02906644|10065182|FG001|STARTED|Weeks 3 to 14|All participants receiving active Lorcaserin plus nicotine patches starting at the 2nd study visit.|27
9001790|NCT02906644|10065181|FG000|Final Study Visit|Weeks 3 to 14|All participants receiving only 1 week of 14mg & 1 week of 7mg nicotine patches at this visit.|17
8572607|NCT00115934|9604806|FG000|STARTED|Overall Study|279 randomized to MBTS, but 3 did not have a Norwood surgery; one was withdrawn-with limited data.|279
8572608|NCT00115934|9604807|FG001|STARTED|Overall Study|276 randomized to RVPAS, but 2 did not have a Norwood surgery and were excluded from analyses.|276
8572609|NCT00115934|9604806|FG000|COMPLETED|Overall Study||275
8572610|NCT00115934|9604807|FG001|COMPLETED|Overall Study||274
8572611|NCT00115934|9604806|FG000|NOT COMPLETED|Overall Study||4
8572612|NCT00115934|9604807|FG001|NOT COMPLETED|Overall Study||2
8572613|NCT00116168|9604817|FG000|STARTED|Overall Study||6
8572614|NCT00116168|9604818|FG001|STARTED|Overall Study||11
8572615|NCT00116168|9604819|FG002|STARTED|Overall Study||6
8572616|NCT00116168|9604820|FG003|STARTED|Overall Study||6
8572617|NCT00116168|9604817|FG000|COMPLETED|Overall Study||0
8572618|NCT00116168|9604818|FG001|COMPLETED|Overall Study||6
8572619|NCT00116168|9604819|FG002|COMPLETED|Overall Study||6
9001791|NCT02906644|10065182|FG001|Final Study Visit|Weeks 3 to 14|All participants receiving only 1 week of 14mg & 1 week of 7mg nicotine patches at this visit.|20
9001792|NCT02906644|10065181|FG000|Follow-up (6 Months Post Quit Day)|Weeks 3 to 14||14
9001793|NCT02906644|10065182|FG001|Follow-up (6 Months Post Quit Day)|Weeks 3 to 14||16
9001794|NCT02906644|10065181|FG000|COMPLETED|Weeks 3 to 14||14
9001795|NCT02906644|10065182|FG001|COMPLETED|Weeks 3 to 14||16
9001796|NCT02906644|10065181|FG000|NOT COMPLETED|Weeks 3 to 14||16
9001797|NCT02906644|10065182|FG001|NOT COMPLETED|Weeks 3 to 14||11
9001798|NCT02906670|10065199|FG000|STARTED|Cohort 1, QW||1
9001799|NCT02906670|10065200|FG001|STARTED|Cohort 1, QW||0
9001800|NCT02906670|10065201|FG002|STARTED|Cohort 1, QW||0
9001801|NCT02906670|10065202|FG003|STARTED|Cohort 1, QW||0
9001802|NCT02906670|10065203|FG004|STARTED|Cohort 1, QW||0
9001803|NCT02906670|10065204|FG005|STARTED|Cohort 1, QW||0
9001804|NCT02906670|10065205|FG006|STARTED|Cohort 1, QW||0
9001805|NCT02906670|10065206|FG007|STARTED|Cohort 1, QW||0
9001806|NCT02906670|10065207|FG008|STARTED|Cohort 1, QW||0
9001807|NCT02906670|10065208|FG009|STARTED|Cohort 1, QW||0
9001808|NCT02906670|10065199|FG000|COMPLETED|Cohort 1, QW||0
9001809|NCT02906670|10065200|FG001|COMPLETED|Cohort 1, QW||0
9001810|NCT02906670|10065201|FG002|COMPLETED|Cohort 1, QW||0
9001811|NCT02906670|10065202|FG003|COMPLETED|Cohort 1, QW||0
9001812|NCT02906670|10065203|FG004|COMPLETED|Cohort 1, QW||0
9001813|NCT02906670|10065204|FG005|COMPLETED|Cohort 1, QW||0
9001814|NCT02906670|10065205|FG006|COMPLETED|Cohort 1, QW||0
9001815|NCT02906670|10065206|FG007|COMPLETED|Cohort 1, QW||0
9001816|NCT02906670|10065207|FG008|COMPLETED|Cohort 1, QW||0
9001817|NCT02906670|10065208|FG009|COMPLETED|Cohort 1, QW||0
9001818|NCT02906670|10065199|FG000|NOT COMPLETED|Cohort 1, QW||1
9001819|NCT02906670|10065200|FG001|NOT COMPLETED|Cohort 1, QW||0
9001820|NCT02906670|10065201|FG002|NOT COMPLETED|Cohort 1, QW||0
9001821|NCT02906670|10065202|FG003|NOT COMPLETED|Cohort 1, QW||0
9001822|NCT02906670|10065203|FG004|NOT COMPLETED|Cohort 1, QW||0
9001823|NCT02906670|10065204|FG005|NOT COMPLETED|Cohort 1, QW||0
9001824|NCT02906670|10065205|FG006|NOT COMPLETED|Cohort 1, QW||0
9001825|NCT02906670|10065206|FG007|NOT COMPLETED|Cohort 1, QW||0
9001826|NCT02906670|10065207|FG008|NOT COMPLETED|Cohort 1, QW||0
9001827|NCT02906670|10065208|FG009|NOT COMPLETED|Cohort 1, QW||0
9001828|NCT02906670|10065199|FG000|STARTED|Cohort 2, QW||0
9001829|NCT02906670|10065200|FG001|STARTED|Cohort 2, QW||1
9001830|NCT02906670|10065201|FG002|STARTED|Cohort 2, QW||0
9001831|NCT02906670|10065202|FG003|STARTED|Cohort 2, QW||0
9001832|NCT02906670|10065203|FG004|STARTED|Cohort 2, QW||0
9001833|NCT02906670|10065204|FG005|STARTED|Cohort 2, QW||0
9001834|NCT02906670|10065205|FG006|STARTED|Cohort 2, QW||0
9001835|NCT02906670|10065206|FG007|STARTED|Cohort 2, QW||0
9001836|NCT02906670|10065207|FG008|STARTED|Cohort 2, QW||0
9001837|NCT02906670|10065208|FG009|STARTED|Cohort 2, QW||0
9001838|NCT02906670|10065199|FG000|COMPLETED|Cohort 2, QW||0
9001839|NCT02906670|10065200|FG001|COMPLETED|Cohort 2, QW||0
8880136|NCT01939145|9937065|FG001|STARTED|Overall Study||51
8880137|NCT01939145|9937064|FG000|COMPLETED|Overall Study||47
8880138|NCT01939145|9937065|FG001|COMPLETED|Overall Study||44
9001840|NCT02906670|10065201|FG002|COMPLETED|Cohort 2, QW||0
9001841|NCT02906670|10065202|FG003|COMPLETED|Cohort 2, QW||0
9001842|NCT02906670|10065203|FG004|COMPLETED|Cohort 2, QW||0
9001843|NCT02906670|10065204|FG005|COMPLETED|Cohort 2, QW||0
9001844|NCT02906670|10065205|FG006|COMPLETED|Cohort 2, QW||0
9001845|NCT02906670|10065206|FG007|COMPLETED|Cohort 2, QW||0
9001846|NCT02906670|10065207|FG008|COMPLETED|Cohort 2, QW||0
8634043|NCT00554788|9674346|FG000|COMPLETED|Overall Study||14
8634044|NCT00554788|9674347|FG001|COMPLETED|Overall Study||12
8880139|NCT01939145|9937064|FG000|NOT COMPLETED|Overall Study||2
8880140|NCT01939145|9937065|FG001|NOT COMPLETED|Overall Study||7
8880141|NCT01939158|9937075|FG000|STARTED|Overall Study||203
8880142|NCT01939158|9937076|FG001|STARTED|Overall Study||198
8880143|NCT01939158|9937077|FG002|STARTED|Overall Study||201
8880144|NCT01939158|9937078|FG003|STARTED|Overall Study||201
8880145|NCT01939158|9937075|FG000|Vaccinated|Overall Study||203
8880146|NCT01939158|9937076|FG001|Vaccinated|Overall Study||197
8880147|NCT01939158|9937077|FG002|Vaccinated|Overall Study||201
8880148|NCT01939158|9937078|FG003|Vaccinated|Overall Study||201
8880149|NCT01939158|9937075|FG000|COMPLETED|Overall Study||156
8880150|NCT01939158|9937076|FG001|COMPLETED|Overall Study||146
8880151|NCT01939158|9937077|FG002|COMPLETED|Overall Study||160
9001847|NCT02906670|10065208|FG009|COMPLETED|Cohort 2, QW||0
9001848|NCT02906670|10065199|FG000|NOT COMPLETED|Cohort 2, QW||0
9001849|NCT02906670|10065200|FG001|NOT COMPLETED|Cohort 2, QW||1
9001850|NCT02906670|10065201|FG002|NOT COMPLETED|Cohort 2, QW||0
9001851|NCT02906670|10065202|FG003|NOT COMPLETED|Cohort 2, QW||0
9001852|NCT02906670|10065203|FG004|NOT COMPLETED|Cohort 2, QW||0
8880152|NCT01939158|9937078|FG003|COMPLETED|Overall Study||157
8880153|NCT01939158|9937075|FG000|NOT COMPLETED|Overall Study||47
8880154|NCT01939158|9937076|FG001|NOT COMPLETED|Overall Study||52
8880155|NCT01939158|9937077|FG002|NOT COMPLETED|Overall Study||41
9001853|NCT02906670|10065204|FG005|NOT COMPLETED|Cohort 2, QW||0
9001854|NCT02906670|10065205|FG006|NOT COMPLETED|Cohort 2, QW||0
9001855|NCT02906670|10065206|FG007|NOT COMPLETED|Cohort 2, QW||0
9001856|NCT02906670|10065207|FG008|NOT COMPLETED|Cohort 2, QW||0
9001857|NCT02906670|10065208|FG009|NOT COMPLETED|Cohort 2, QW||0
9001858|NCT02906670|10065199|FG000|STARTED|Cohort 3, QW||0
9001859|NCT02906670|10065200|FG001|STARTED|Cohort 3, QW||0
9001860|NCT02906670|10065201|FG002|STARTED|Cohort 3, QW||4
9001861|NCT02906670|10065202|FG003|STARTED|Cohort 3, QW||0
9001862|NCT02906670|10065203|FG004|STARTED|Cohort 3, QW||0
9001863|NCT02906670|10065204|FG005|STARTED|Cohort 3, QW||0
9001864|NCT02906670|10065205|FG006|STARTED|Cohort 3, QW||0
9001865|NCT02906670|10065206|FG007|STARTED|Cohort 3, QW||0
9001866|NCT02906670|10065207|FG008|STARTED|Cohort 3, QW||0
9001867|NCT02906670|10065208|FG009|STARTED|Cohort 3, QW||0
9001868|NCT02906670|10065199|FG000|COMPLETED|Cohort 3, QW||0
9001869|NCT02906670|10065200|FG001|COMPLETED|Cohort 3, QW||0
9001870|NCT02906670|10065201|FG002|COMPLETED|Cohort 3, QW||0
9001871|NCT02906670|10065202|FG003|COMPLETED|Cohort 3, QW||0
9001872|NCT02906670|10065203|FG004|COMPLETED|Cohort 3, QW||0
9001873|NCT02906670|10065204|FG005|COMPLETED|Cohort 3, QW||0
9001874|NCT02906670|10065205|FG006|COMPLETED|Cohort 3, QW||0
9001875|NCT02906670|10065206|FG007|COMPLETED|Cohort 3, QW||0
9001876|NCT02906670|10065207|FG008|COMPLETED|Cohort 3, QW||0
9001877|NCT02906670|10065208|FG009|COMPLETED|Cohort 3, QW||0
9001878|NCT02906670|10065199|FG000|NOT COMPLETED|Cohort 3, QW||0
9001879|NCT02906670|10065200|FG001|NOT COMPLETED|Cohort 3, QW||0
9001880|NCT02906670|10065201|FG002|NOT COMPLETED|Cohort 3, QW||4
8634045|NCT00554788|9674348|FG002|COMPLETED|Overall Study||7
8634046|NCT00554788|9674346|FG000|NOT COMPLETED|Overall Study||7
8634047|NCT00554788|9674347|FG001|NOT COMPLETED|Overall Study||6
8634048|NCT00554788|9674348|FG002|NOT COMPLETED|Overall Study||14
8634049|NCT00554801|9674359|FG000|STARTED|Overall Study||55
8634050|NCT00554801|9674360|FG001|STARTED|Overall Study||29
9001881|NCT02906670|10065202|FG003|NOT COMPLETED|Cohort 3, QW||0
9001882|NCT02906670|10065203|FG004|NOT COMPLETED|Cohort 3, QW||0
9001883|NCT02906670|10065204|FG005|NOT COMPLETED|Cohort 3, QW||0
9001884|NCT02906670|10065205|FG006|NOT COMPLETED|Cohort 3, QW||0
9001885|NCT02906670|10065206|FG007|NOT COMPLETED|Cohort 3, QW||0
9001886|NCT02906670|10065207|FG008|NOT COMPLETED|Cohort 3, QW||0
9001887|NCT02906670|10065208|FG009|NOT COMPLETED|Cohort 3, QW||0
8634051|NCT00554801|9674359|FG000|COMPLETED|Overall Study||36
8880156|NCT01939158|9937078|FG003|NOT COMPLETED|Overall Study||44
8880157|NCT01939197|9937099|FG000|STARTED|Overall Study||31
8880158|NCT01939197|9937100|FG001|STARTED|Overall Study||32
8880159|NCT01939197|9937101|FG002|STARTED|Overall Study||10
8880160|NCT01939197|9937102|FG003|STARTED|Overall Study||12
8880161|NCT01939197|9937103|FG004|STARTED|Overall Study||200
8880162|NCT01939197|9937104|FG005|STARTED|Overall Study||5
8880163|NCT01939197|9937105|FG006|STARTED|Overall Study||28
8880164|NCT01939197|9937099|FG000|COMPLETED|Overall Study||30
8880165|NCT01939197|9937100|FG001|COMPLETED|Overall Study||31
8880166|NCT01939197|9937101|FG002|COMPLETED|Overall Study||10
8880167|NCT01939197|9937102|FG003|COMPLETED|Overall Study||11
8880168|NCT01939197|9937103|FG004|COMPLETED|Overall Study||196
8880169|NCT01939197|9937104|FG005|COMPLETED|Overall Study||4
8880170|NCT01939197|9937105|FG006|COMPLETED|Overall Study||26
8880171|NCT01939197|9937099|FG000|NOT COMPLETED|Overall Study||1
8880172|NCT01939197|9937100|FG001|NOT COMPLETED|Overall Study||1
8880173|NCT01939197|9937101|FG002|NOT COMPLETED|Overall Study||0
8880174|NCT01939197|9937102|FG003|NOT COMPLETED|Overall Study||1
8880175|NCT01939197|9937103|FG004|NOT COMPLETED|Overall Study||4
8880176|NCT01939197|9937104|FG005|NOT COMPLETED|Overall Study||1
8880177|NCT01939197|9937105|FG006|NOT COMPLETED|Overall Study||2
8880178|NCT01939288|9937137|FG000|STARTED|Overall Study||5
8880179|NCT01939288|9937138|FG001|STARTED|Overall Study||5
8880180|NCT01939288|9937137|FG000|COMPLETED|Overall Study||5
8880181|NCT01939288|9937138|FG001|COMPLETED|Overall Study||5
8880182|NCT01939288|9937137|FG000|NOT COMPLETED|Overall Study||0
8880183|NCT01939288|9937138|FG001|NOT COMPLETED|Overall Study||0
8880184|NCT01939301|9937145|FG000|STARTED|Overall Study||39
8880185|NCT01939301|9937146|FG001|STARTED|Overall Study||39
8880186|NCT01939301|9937145|FG000|COMPLETED|Overall Study||38
8880187|NCT01939301|9937146|FG001|COMPLETED|Overall Study||38
8880188|NCT01939301|9937145|FG000|NOT COMPLETED|Overall Study||1
8880189|NCT01939301|9937146|FG001|NOT COMPLETED|Overall Study||1
8880190|NCT01939314|9937154|FG000|STARTED|Overall Study||45
8880191|NCT01939314|9937155|FG001|STARTED|Overall Study||48
8880192|NCT01939314|9937154|FG000|15 Minute Endpoint|Overall Study||41
8880193|NCT01939314|9937155|FG001|15 Minute Endpoint|Overall Study||46
8880194|NCT01939314|9937154|FG000|24 Hour Endpoint|Overall Study||36
8880195|NCT01939314|9937155|FG001|24 Hour Endpoint|Overall Study||40
9001888|NCT02906670|10065199|FG000|STARTED|Cohort 4, Q2W||0
9001889|NCT02906670|10065200|FG001|STARTED|Cohort 4, Q2W||0
9001890|NCT02906670|10065201|FG002|STARTED|Cohort 4, Q2W||0
9001891|NCT02906670|10065202|FG003|STARTED|Cohort 4, Q2W||0
9001892|NCT02906670|10065203|FG004|STARTED|Cohort 4, Q2W||0
9001893|NCT02906670|10065204|FG005|STARTED|Cohort 4, Q2W||3
8634052|NCT00554801|9674360|FG001|COMPLETED|Overall Study||29
8634053|NCT00554801|9674359|FG000|NOT COMPLETED|Overall Study||19
8634054|NCT00554801|9674360|FG001|NOT COMPLETED|Overall Study||0
8880196|NCT01939314|9937154|FG000|COMPLETED|Overall Study||36
8880197|NCT01939314|9937155|FG001|COMPLETED|Overall Study||40
8880198|NCT01939314|9937154|FG000|NOT COMPLETED|Overall Study||9
8880199|NCT01939314|9937155|FG001|NOT COMPLETED|Overall Study||8
8880200|NCT01939353|9937163|FG000|STARTED|Placebo Run-in (1 Week)||45
9001894|NCT02906670|10065205|FG006|STARTED|Cohort 4, Q2W||0
9001895|NCT02906670|10065206|FG007|STARTED|Cohort 4, Q2W||0
9001896|NCT02906670|10065207|FG008|STARTED|Cohort 4, Q2W||0
9001897|NCT02906670|10065208|FG009|STARTED|Cohort 4, Q2W||0
9001898|NCT02906670|10065199|FG000|COMPLETED|Cohort 4, Q2W||0
9001899|NCT02906670|10065200|FG001|COMPLETED|Cohort 4, Q2W||0
9001900|NCT02906670|10065201|FG002|COMPLETED|Cohort 4, Q2W||0
9001901|NCT02906670|10065202|FG003|COMPLETED|Cohort 4, Q2W||0
9001902|NCT02906670|10065203|FG004|COMPLETED|Cohort 4, Q2W||0
9001903|NCT02906670|10065204|FG005|COMPLETED|Cohort 4, Q2W||0
9001904|NCT02906670|10065205|FG006|COMPLETED|Cohort 4, Q2W||0
9001905|NCT02906670|10065206|FG007|COMPLETED|Cohort 4, Q2W||0
9001906|NCT02906670|10065207|FG008|COMPLETED|Cohort 4, Q2W||0
9001907|NCT02906670|10065208|FG009|COMPLETED|Cohort 4, Q2W||0
9001908|NCT02906670|10065199|FG000|NOT COMPLETED|Cohort 4, Q2W||0
9001909|NCT02906670|10065200|FG001|NOT COMPLETED|Cohort 4, Q2W||0
9001910|NCT02906670|10065201|FG002|NOT COMPLETED|Cohort 4, Q2W||0
9001911|NCT02906670|10065202|FG003|NOT COMPLETED|Cohort 4, Q2W||0
9001912|NCT02906670|10065203|FG004|NOT COMPLETED|Cohort 4, Q2W||0
9001913|NCT02906670|10065204|FG005|NOT COMPLETED|Cohort 4, Q2W||3
9001914|NCT02906670|10065205|FG006|NOT COMPLETED|Cohort 4, Q2W||0
9001915|NCT02906670|10065206|FG007|NOT COMPLETED|Cohort 4, Q2W||0
9001916|NCT02906670|10065207|FG008|NOT COMPLETED|Cohort 4, Q2W||0
9001917|NCT02906670|10065208|FG009|NOT COMPLETED|Cohort 4, Q2W||0
8634055|NCT00554853|9674370|FG000|STARTED|First Arm of Study||72
8880201|NCT01939353|9937163|FG000|COMPLETED|Placebo Run-in (1 Week)||41
8880202|NCT01939353|9937163|FG000|NOT COMPLETED|Placebo Run-in (1 Week)||4
8880203|NCT01939353|9937163|FG000|STARTED|CTN SR Treatment Phase (4 Weeks)||41
8880204|NCT01939353|9937163|FG000|COMPLETED|CTN SR Treatment Phase (4 Weeks)||37
8880205|NCT01939353|9937163|FG000|NOT COMPLETED|CTN SR Treatment Phase (4 Weeks)||4
8880206|NCT01939366|9937172|FG000|STARTED|Overall Study||66
8880207|NCT01939366|9937173|FG001|STARTED|Overall Study||64
8880208|NCT01939366|9937174|FG002|STARTED|Overall Study||65
8880209|NCT01939366|9937175|FG003|STARTED|Overall Study||68
8880210|NCT01939366|9937176|FG004|STARTED|Overall Study||66
8880211|NCT01939366|9937172|FG000|Allocated Set Excl. Non-compliant Sites|Overall Study||64
8880212|NCT01939366|9937173|FG001|Allocated Set Excl. Non-compliant Sites|Overall Study||61
8880213|NCT01939366|9937174|FG002|Allocated Set Excl. Non-compliant Sites|Overall Study||63
8880214|NCT01939366|9937175|FG003|Allocated Set Excl. Non-compliant Sites|Overall Study||65
8880215|NCT01939366|9937176|FG004|Allocated Set Excl. Non-compliant Sites|Overall Study||63
8880216|NCT01939366|9937172|FG000|Safety Set|Overall Study||64
8880217|NCT01939366|9937173|FG001|Safety Set|Overall Study||61
8880218|NCT01939366|9937174|FG002|Safety Set|Overall Study||62
8880219|NCT01939366|9937175|FG003|Safety Set|Overall Study||65
8880220|NCT01939366|9937176|FG004|Safety Set|Overall Study||62
8880221|NCT01939366|9937172|FG000|Full Analysis Set|Overall Study||64
8880222|NCT01939366|9937173|FG001|Full Analysis Set|Overall Study||60
8880223|NCT01939366|9937174|FG002|Full Analysis Set|Overall Study||61
8880224|NCT01939366|9937175|FG003|Full Analysis Set|Overall Study||65
8880225|NCT01939366|9937176|FG004|Full Analysis Set|Overall Study||62
9001918|NCT02906670|10065199|FG000|STARTED|Cohort 5, Q2W||0
9001919|NCT02906670|10065200|FG001|STARTED|Cohort 5, Q2W||0
9001920|NCT02906670|10065201|FG002|STARTED|Cohort 5, Q2W||0
9001921|NCT02906670|10065202|FG003|STARTED|Cohort 5, Q2W||0
9001922|NCT02906670|10065203|FG004|STARTED|Cohort 5, Q2W||0
9001923|NCT02906670|10065204|FG005|STARTED|Cohort 5, Q2W||0
9001924|NCT02906670|10065205|FG006|STARTED|Cohort 5, Q2W||7
9001925|NCT02906670|10065206|FG007|STARTED|Cohort 5, Q2W||0
9001926|NCT02906670|10065207|FG008|STARTED|Cohort 5, Q2W||0
9001927|NCT02906670|10065208|FG009|STARTED|Cohort 5, Q2W||0
9001928|NCT02906670|10065199|FG000|COMPLETED|Cohort 5, Q2W||0
9001929|NCT02906670|10065200|FG001|COMPLETED|Cohort 5, Q2W||0
9001930|NCT02906670|10065201|FG002|COMPLETED|Cohort 5, Q2W||0
9001931|NCT02906670|10065202|FG003|COMPLETED|Cohort 5, Q2W||0
9001932|NCT02906670|10065203|FG004|COMPLETED|Cohort 5, Q2W||0
9001933|NCT02906670|10065204|FG005|COMPLETED|Cohort 5, Q2W||0
9001934|NCT02906670|10065205|FG006|COMPLETED|Cohort 5, Q2W||0
9001935|NCT02906670|10065206|FG007|COMPLETED|Cohort 5, Q2W||0
9001936|NCT02906670|10065207|FG008|COMPLETED|Cohort 5, Q2W||0
9001937|NCT02906670|10065208|FG009|COMPLETED|Cohort 5, Q2W||0
9001938|NCT02906670|10065199|FG000|NOT COMPLETED|Cohort 5, Q2W||0
9001939|NCT02906670|10065200|FG001|NOT COMPLETED|Cohort 5, Q2W||0
9001940|NCT02906670|10065201|FG002|NOT COMPLETED|Cohort 5, Q2W||0
9001941|NCT02906670|10065202|FG003|NOT COMPLETED|Cohort 5, Q2W||0
9001942|NCT02906670|10065203|FG004|NOT COMPLETED|Cohort 5, Q2W||0
9001943|NCT02906670|10065204|FG005|NOT COMPLETED|Cohort 5, Q2W||0
9001944|NCT02906670|10065205|FG006|NOT COMPLETED|Cohort 5, Q2W||7
9001945|NCT02906670|10065206|FG007|NOT COMPLETED|Cohort 5, Q2W||0
9001946|NCT02906670|10065207|FG008|NOT COMPLETED|Cohort 5, Q2W||0
9001947|NCT02906670|10065208|FG009|NOT COMPLETED|Cohort 5, Q2W||0
9001948|NCT02906670|10065199|FG000|STARTED|Cohort 5P, Q2W||0
9001949|NCT02906670|10065200|FG001|STARTED|Cohort 5P, Q2W||0
9001950|NCT02906670|10065201|FG002|STARTED|Cohort 5P, Q2W||0
9001951|NCT02906670|10065202|FG003|STARTED|Cohort 5P, Q2W||0
9001952|NCT02906670|10065203|FG004|STARTED|Cohort 5P, Q2W||0
9001953|NCT02906670|10065204|FG005|STARTED|Cohort 5P, Q2W||0
9001954|NCT02906670|10065205|FG006|STARTED|Cohort 5P, Q2W||0
8880226|NCT01939366|9937172|FG000|Per Protocol Set|Overall Study||58
8880227|NCT01939366|9937173|FG001|Per Protocol Set|Overall Study||55
9001955|NCT02906670|10065206|FG007|STARTED|Cohort 5P, Q2W||3
9001956|NCT02906670|10065207|FG008|STARTED|Cohort 5P, Q2W||0
8880228|NCT01939366|9937174|FG002|Per Protocol Set|Overall Study||50
9001957|NCT02906670|10065208|FG009|STARTED|Cohort 5P, Q2W||0
9001958|NCT02906670|10065199|FG000|COMPLETED|Cohort 5P, Q2W||0
9001959|NCT02906670|10065200|FG001|COMPLETED|Cohort 5P, Q2W||0
9001960|NCT02906670|10065201|FG002|COMPLETED|Cohort 5P, Q2W||0
9001961|NCT02906670|10065202|FG003|COMPLETED|Cohort 5P, Q2W||0
9001962|NCT02906670|10065203|FG004|COMPLETED|Cohort 5P, Q2W||0
8880229|NCT01939366|9937175|FG003|Per Protocol Set|Overall Study||51
8880230|NCT01939366|9937176|FG004|Per Protocol Set|Overall Study||49
8880231|NCT01939366|9937172|FG000|COMPLETED|Overall Study||52
8880232|NCT01939366|9937173|FG001|COMPLETED|Overall Study||41
8880233|NCT01939366|9937174|FG002|COMPLETED|Overall Study||27
8880234|NCT01939366|9937175|FG003|COMPLETED|Overall Study||51
8880235|NCT01939366|9937176|FG004|COMPLETED|Overall Study||48
8880236|NCT01939366|9937172|FG000|NOT COMPLETED|Overall Study||14
8880237|NCT01939366|9937173|FG001|NOT COMPLETED|Overall Study||23
8880238|NCT01939366|9937174|FG002|NOT COMPLETED|Overall Study||38
8880239|NCT01939366|9937175|FG003|NOT COMPLETED|Overall Study||17
8880240|NCT01939366|9937176|FG004|NOT COMPLETED|Overall Study||18
8880241|NCT01939405|9937190|FG000|STARTED|Overall Study||30
8880242|NCT01939405|9937191|FG001|STARTED|Overall Study||30
8880243|NCT01939405|9937190|FG000|COMPLETED|Overall Study||27
8880244|NCT01939405|9937191|FG001|COMPLETED|Overall Study||28
8880245|NCT01939405|9937190|FG000|NOT COMPLETED|Overall Study||3
8880246|NCT01939405|9937191|FG001|NOT COMPLETED|Overall Study||2
8880247|NCT01939496|9937200|FG000|STARTED|Overall Study||56
8880248|NCT01939496|9937201|FG001|STARTED|Overall Study||57
8880249|NCT01939496|9937202|FG002|STARTED|Overall Study||56
8880250|NCT01939496|9937200|FG000|COMPLETED|Overall Study||47
8880251|NCT01939496|9937201|FG001|COMPLETED|Overall Study||54
8880252|NCT01939496|9937202|FG002|COMPLETED|Overall Study||54
8880253|NCT01939496|9937200|FG000|NOT COMPLETED|Overall Study||9
8880254|NCT01939496|9937201|FG001|NOT COMPLETED|Overall Study||3
8880255|NCT01939496|9937202|FG002|NOT COMPLETED|Overall Study||2
8880256|NCT01939548|9937213|FG000|STARTED|Overall Study||78
8880257|NCT01939548|9937214|FG001|STARTED|Overall Study||82
8880258|NCT01939548|9937215|FG002|STARTED|Overall Study||80
8880259|NCT01939548|9937213|FG000|COMPLETED|Overall Study||41
8880260|NCT01939548|9937214|FG001|COMPLETED|Overall Study||33
8880261|NCT01939548|9937215|FG002|COMPLETED|Overall Study||50
8880262|NCT01939548|9937213|FG000|NOT COMPLETED|Overall Study||37
8880263|NCT01939548|9937214|FG001|NOT COMPLETED|Overall Study||49
8880264|NCT01939548|9937215|FG002|NOT COMPLETED|Overall Study||30
8880265|NCT01939899|9937228|FG000|STARTED|Lead-in Dose Finding Phase||3
8880266|NCT01939899|9937229|FG001|STARTED|Lead-in Dose Finding Phase||7
8880267|NCT01939899|9937230|FG002|STARTED|Lead-in Dose Finding Phase||6
8880268|NCT01939899|9937231|FG003|STARTED|Lead-in Dose Finding Phase||0
8880269|NCT01939899|9937232|FG004|STARTED|Lead-in Dose Finding Phase||0
8880270|NCT01939899|9937228|FG000|COMPLETED|Lead-in Dose Finding Phase||1
8880271|NCT01939899|9937229|FG001|COMPLETED|Lead-in Dose Finding Phase||0
8880272|NCT01939899|9937230|FG002|COMPLETED|Lead-in Dose Finding Phase||1
8880273|NCT01939899|9937231|FG003|COMPLETED|Lead-in Dose Finding Phase||0
8880274|NCT01939899|9937232|FG004|COMPLETED|Lead-in Dose Finding Phase||0
8880275|NCT01939899|9937228|FG000|NOT COMPLETED|Lead-in Dose Finding Phase||2
8880276|NCT01939899|9937229|FG001|NOT COMPLETED|Lead-in Dose Finding Phase||7
8880277|NCT01939899|9937230|FG002|NOT COMPLETED|Lead-in Dose Finding Phase||5
8880278|NCT01939899|9937231|FG003|NOT COMPLETED|Lead-in Dose Finding Phase||0
8880279|NCT01939899|9937232|FG004|NOT COMPLETED|Lead-in Dose Finding Phase||0
8880280|NCT01939899|9937228|FG000|STARTED|Phase 2||0
8880281|NCT01939899|9937229|FG001|STARTED|Phase 2||0
8880282|NCT01939899|9937230|FG002|STARTED|Phase 2||0
8880283|NCT01939899|9937231|FG003|STARTED|Phase 2||12
8880284|NCT01939899|9937232|FG004|STARTED|Phase 2||1
8880285|NCT01939899|9937228|FG000|COMPLETED|Phase 2||0
8880286|NCT01939899|9937229|FG001|COMPLETED|Phase 2||0
8880287|NCT01939899|9937230|FG002|COMPLETED|Phase 2||0
8880288|NCT01939899|9937231|FG003|COMPLETED|Phase 2||1
8880289|NCT01939899|9937232|FG004|COMPLETED|Phase 2||0
8880290|NCT01939899|9937228|FG000|NOT COMPLETED|Phase 2||0
8880291|NCT01939899|9937229|FG001|NOT COMPLETED|Phase 2||0
8880292|NCT01939899|9937230|FG002|NOT COMPLETED|Phase 2||0
8880293|NCT01939899|9937231|FG003|NOT COMPLETED|Phase 2||11
8880294|NCT01939899|9937232|FG004|NOT COMPLETED|Phase 2||1
8880295|NCT01939938|9937250|FG000|STARTED|Overall Study||10
9001963|NCT02906670|10065204|FG005|COMPLETED|Cohort 5P, Q2W||0
9001964|NCT02906670|10065205|FG006|COMPLETED|Cohort 5P, Q2W||0
8880296|NCT01939938|9937250|FG000|COMPLETED|Overall Study||10
8880297|NCT01939938|9937250|FG000|NOT COMPLETED|Overall Study||0
8880298|NCT01939977|9937258|FG000|STARTED|Overall Study||46
8880299|NCT01939977|9937259|FG001|STARTED|Overall Study|48 patients randomized but 1 did not meet inclusion criteria. 47 patients analyzed.|48
8880300|NCT01939977|9937258|FG000|COMPLETED|Overall Study||37
8880301|NCT01939977|9937259|FG001|COMPLETED|Overall Study||41
8880302|NCT01939977|9937258|FG000|NOT COMPLETED|Overall Study||9
8880303|NCT01939977|9937259|FG001|NOT COMPLETED|Overall Study||7
8880304|NCT01940120|9937265|FG000|STARTED|Overall Study||78
8880305|NCT01940120|9937265|FG000|COMPLETED|Overall Study||30
8880306|NCT01940120|9937265|FG000|NOT COMPLETED|Overall Study||48
8880307|NCT01940146|9937274|FG000|STARTED|Overall Study||56
8880308|NCT01940146|9937275|FG001|STARTED|Overall Study||55
8880309|NCT01940146|9937276|FG002|STARTED|Overall Study||56
8880310|NCT01940146|9937277|FG003|STARTED|Overall Study||55
8880311|NCT01940146|9937274|FG000|COMPLETED|Overall Study||55
8880312|NCT01940146|9937275|FG001|COMPLETED|Overall Study||55
8880313|NCT01940146|9937276|FG002|COMPLETED|Overall Study||55
8880314|NCT01940146|9937277|FG003|COMPLETED|Overall Study||53
9001965|NCT02906670|10065206|FG007|COMPLETED|Cohort 5P, Q2W||0
9001966|NCT02906670|10065207|FG008|COMPLETED|Cohort 5P, Q2W||0
9001967|NCT02906670|10065208|FG009|COMPLETED|Cohort 5P, Q2W||0
9001968|NCT02906670|10065199|FG000|NOT COMPLETED|Cohort 5P, Q2W||0
9001969|NCT02906670|10065200|FG001|NOT COMPLETED|Cohort 5P, Q2W||0
9001970|NCT02906670|10065201|FG002|NOT COMPLETED|Cohort 5P, Q2W||0
9001971|NCT02906670|10065202|FG003|NOT COMPLETED|Cohort 5P, Q2W||0
9001972|NCT02906670|10065203|FG004|NOT COMPLETED|Cohort 5P, Q2W||0
8880315|NCT01940146|9937274|FG000|NOT COMPLETED|Overall Study||1
8880316|NCT01940146|9937275|FG001|NOT COMPLETED|Overall Study||0
8880317|NCT01940146|9937276|FG002|NOT COMPLETED|Overall Study||1
8880318|NCT01940146|9937277|FG003|NOT COMPLETED|Overall Study||2
8880319|NCT01940276|9937289|FG000|STARTED|Overall Study||50
8880320|NCT01940276|9937290|FG001|STARTED|Overall Study||50
8880321|NCT01940276|9937289|FG000|COMPLETED|Overall Study||50
8880322|NCT01940276|9937290|FG001|COMPLETED|Overall Study||50
8880323|NCT01940276|9937289|FG000|NOT COMPLETED|Overall Study||0
8880324|NCT01940276|9937290|FG001|NOT COMPLETED|Overall Study||0
8880325|NCT01940354|9937298|FG000|STARTED|Overall Study||110
8880326|NCT01940354|9937299|FG001|STARTED|Overall Study||110
8880327|NCT01940354|9937298|FG000|COMPLETED|Overall Study||106
8880328|NCT01940354|9937299|FG001|COMPLETED|Overall Study||108
8880329|NCT01940354|9937298|FG000|NOT COMPLETED|Overall Study||4
8880330|NCT01940354|9937299|FG001|NOT COMPLETED|Overall Study||2
8880331|NCT01940484|9937305|FG000|STARTED|Overall Study||98
8880332|NCT01940484|9937305|FG000|COMPLETED|Overall Study||88
8880333|NCT01940484|9937305|FG000|NOT COMPLETED|Overall Study||10
8880334|NCT01940497|9937311|FG000|STARTED|Overall Study||121
8880335|NCT01940497|9937312|FG001|STARTED|Overall Study||119
8880336|NCT01940497|9937311|FG000|Treated|Overall Study||115
8880337|NCT01940497|9937312|FG001|Treated|Overall Study||113
8880338|NCT01940497|9937311|FG000|Treated: Adjuvant|Overall Study||95
8880339|NCT01940497|9937312|FG001|Treated: Adjuvant|Overall Study||92
8880340|NCT01940497|9937311|FG000|Treated: Neoadjuvant|Overall Study||20
8880341|NCT01940497|9937312|FG001|Treated: Neoadjuvant|Overall Study||21
8880342|NCT01940497|9937311|FG000|COMPLETED|Overall Study||100
8880343|NCT01940497|9937312|FG001|COMPLETED|Overall Study||101
8880344|NCT01940497|9937311|FG000|NOT COMPLETED|Overall Study||21
8880345|NCT01940497|9937312|FG001|NOT COMPLETED|Overall Study||18
8880346|NCT01940510|9937329|FG000|STARTED|Overall Study||24
8880347|NCT01940510|9937329|FG000|COMPLETED|Overall Study||24
8880348|NCT01940510|9937329|FG000|NOT COMPLETED|Overall Study||0
8880349|NCT01940523|9937338|FG000|STARTED|Overall Study||320
8880350|NCT01940523|9937339|FG001|STARTED|Overall Study||320
8880351|NCT01940523|9937338|FG000|COMPLETED|Overall Study||320
8880352|NCT01940523|9937339|FG001|COMPLETED|Overall Study||320
8880353|NCT01940523|9937338|FG000|NOT COMPLETED|Overall Study||0
8880354|NCT01940523|9937339|FG001|NOT COMPLETED|Overall Study||0
8880355|NCT01940705|9937351|FG000|STARTED|Overall Study||66
8880356|NCT01940705|9937352|FG001|STARTED|Overall Study||67
8880357|NCT01940705|9937353|FG002|STARTED|Overall Study||69
8880358|NCT01940705|9937354|FG003|STARTED|Overall Study||67
8880359|NCT01940705|9937351|FG000|COMPLETED|Overall Study||62
8880360|NCT01940705|9937352|FG001|COMPLETED|Overall Study||59
8880361|NCT01940705|9937353|FG002|COMPLETED|Overall Study||61
8880362|NCT01940705|9937354|FG003|COMPLETED|Overall Study||63
8880363|NCT01940705|9937351|FG000|NOT COMPLETED|Overall Study||4
8880364|NCT01940705|9937352|FG001|NOT COMPLETED|Overall Study||8
8880365|NCT01940705|9937353|FG002|NOT COMPLETED|Overall Study||8
8880366|NCT01940705|9937354|FG003|NOT COMPLETED|Overall Study||4
8880367|NCT01940887|9937369|FG000|STARTED|Year 1||322
8880368|NCT01940887|9937370|FG001|STARTED|Year 1||320
8880369|NCT01940887|9937369|FG000|COMPLETED|Year 1||283
8880370|NCT01940887|9937370|FG001|COMPLETED|Year 1||297
8880371|NCT01940887|9937369|FG000|NOT COMPLETED|Year 1||39
8880372|NCT01940887|9937370|FG001|NOT COMPLETED|Year 1||23
8880373|NCT01940887|9937369|FG000|STARTED|Year 2||283
8880374|NCT01940887|9937370|FG001|STARTED|Year 2||297
8880375|NCT01940887|9937369|FG000|COMPLETED|Year 2||66
8880376|NCT01940887|9937370|FG001|COMPLETED|Year 2||75
8880377|NCT01940887|9937369|FG000|NOT COMPLETED|Year 2||217
8880378|NCT01940887|9937370|FG001|NOT COMPLETED|Year 2||222
8880379|NCT01940900|9937378|FG000|STARTED|Overall Study||311
8880380|NCT01940900|9937379|FG001|STARTED|Overall Study||315
8880381|NCT01940900|9937378|FG000|COMPLETED|Overall Study||282
8880382|NCT01940900|9937379|FG001|COMPLETED|Overall Study||284
9001973|NCT02906670|10065204|FG005|NOT COMPLETED|Cohort 5P, Q2W||0
9001974|NCT02906670|10065205|FG006|NOT COMPLETED|Cohort 5P, Q2W||0
9001975|NCT02906670|10065206|FG007|NOT COMPLETED|Cohort 5P, Q2W||3
8880383|NCT01940900|9937378|FG000|NOT COMPLETED|Overall Study||29
8880384|NCT01940900|9937379|FG001|NOT COMPLETED|Overall Study||31
8880385|NCT01940939|9937387|FG000|STARTED|Overall Study||35
8880386|NCT01940939|9937388|FG001|STARTED|Overall Study||35
8880387|NCT01940939|9937387|FG000|COMPLETED|Overall Study||33
8880388|NCT01940939|9937388|FG001|COMPLETED|Overall Study||27
8880389|NCT01940939|9937387|FG000|NOT COMPLETED|Overall Study||2
8880390|NCT01940939|9937388|FG001|NOT COMPLETED|Overall Study||8
8880391|NCT01941030|9937396|FG000|STARTED|Overall Study||25
8880392|NCT01941030|9937397|FG001|STARTED|Overall Study||26
8880393|NCT01941030|9937396|FG000|COMPLETED|Overall Study||12
8880394|NCT01941030|9937397|FG001|COMPLETED|Overall Study||13
8880395|NCT01941030|9937396|FG000|NOT COMPLETED|Overall Study||13
8880396|NCT01941030|9937397|FG001|NOT COMPLETED|Overall Study||13
9001976|NCT02906670|10065207|FG008|NOT COMPLETED|Cohort 5P, Q2W||0
9001977|NCT02906670|10065208|FG009|NOT COMPLETED|Cohort 5P, Q2W||0
9001978|NCT02906670|10065199|FG000|STARTED|Cohort 6P, Q2W||0
9001979|NCT02906670|10065200|FG001|STARTED|Cohort 6P, Q2W||0
9001980|NCT02906670|10065201|FG002|STARTED|Cohort 6P, Q2W||0
9001981|NCT02906670|10065202|FG003|STARTED|Cohort 6P, Q2W||0
9001982|NCT02906670|10065203|FG004|STARTED|Cohort 6P, Q2W||0
9001983|NCT02906670|10065204|FG005|STARTED|Cohort 6P, Q2W||0
9001984|NCT02906670|10065205|FG006|STARTED|Cohort 6P, Q2W||0
9001985|NCT02906670|10065206|FG007|STARTED|Cohort 6P, Q2W||0
9001986|NCT02906670|10065207|FG008|STARTED|Cohort 6P, Q2W||4
9001987|NCT02906670|10065208|FG009|STARTED|Cohort 6P, Q2W||0
9001988|NCT02906670|10065199|FG000|COMPLETED|Cohort 6P, Q2W||0
9001989|NCT02906670|10065200|FG001|COMPLETED|Cohort 6P, Q2W||0
9001990|NCT02906670|10065201|FG002|COMPLETED|Cohort 6P, Q2W||0
9001991|NCT02906670|10065202|FG003|COMPLETED|Cohort 6P, Q2W||0
9001992|NCT02906670|10065203|FG004|COMPLETED|Cohort 6P, Q2W||0
8634056|NCT00554853|9674371|FG001|STARTED|First Arm of Study||71
8725926|NCT01033487|9773163|FG006|STARTED|Third Intervention Period||2
8880397|NCT01941095|9937403|FG000|STARTED|Overall Study||97
8880398|NCT01941095|9937403|FG000|COMPLETED|Overall Study||41
8880399|NCT01941095|9937403|FG000|NOT COMPLETED|Overall Study||56
8880400|NCT01941186|9937410|FG000|STARTED|Randomization/Allocation to Study Group||31
8880401|NCT01941186|9937411|FG001|STARTED|Randomization/Allocation to Study Group||33
8880402|NCT01941186|9937410|FG000|COMPLETED|Randomization/Allocation to Study Group||31
8880403|NCT01941186|9937411|FG001|COMPLETED|Randomization/Allocation to Study Group||33
8880404|NCT01941186|9937410|FG000|NOT COMPLETED|Randomization/Allocation to Study Group||0
8880405|NCT01941186|9937411|FG001|NOT COMPLETED|Randomization/Allocation to Study Group||0
8880406|NCT01941186|9937410|FG000|STARTED|Follow-up||31
8880407|NCT01941186|9937411|FG001|STARTED|Follow-up||33
8880408|NCT01941186|9937410|FG000|COMPLETED|Follow-up||30
8880409|NCT01941186|9937411|FG001|COMPLETED|Follow-up||33
8880410|NCT01941186|9937410|FG000|NOT COMPLETED|Follow-up||1
8880411|NCT01941186|9937411|FG001|NOT COMPLETED|Follow-up||0
8880412|NCT01941472|9937430|FG000|STARTED|Overall Study||40
8880413|NCT01941472|9937430|FG000|COMPLETED|Overall Study||40
8880414|NCT01941472|9937430|FG000|NOT COMPLETED|Overall Study||0
8880415|NCT01941485|9937434|FG000|STARTED|Overall Study||59
8880416|NCT01941485|9937434|FG000|COMPLETED|Overall Study||59
8880417|NCT01941485|9937434|FG000|NOT COMPLETED|Overall Study||0
8880418|NCT01941498|9937456|FG000|STARTED|Overall Study||97
8880419|NCT01941498|9937456|FG000|COMPLETED|Overall Study||96
8880420|NCT01941498|9937456|FG000|NOT COMPLETED|Overall Study||1
8880421|NCT01941537|9937477|FG000|STARTED|Overall Study||40
8880422|NCT01941537|9937478|FG001|STARTED|Overall Study||20
8880423|NCT01941537|9937477|FG000|COMPLETED|Overall Study||36
8880424|NCT01941537|9937478|FG001|COMPLETED|Overall Study||17
8880425|NCT01941537|9937477|FG000|NOT COMPLETED|Overall Study||4
8880426|NCT01941537|9937478|FG001|NOT COMPLETED|Overall Study||3
8880427|NCT01941628|9937487|FG000|STARTED|Overall Study||46
8880428|NCT01941628|9937488|FG001|STARTED|Overall Study||45
8880429|NCT01941628|9937487|FG000|COMPLETED|Overall Study||45
8880430|NCT01941628|9937488|FG001|COMPLETED|Overall Study||45
8880431|NCT01941628|9937487|FG000|NOT COMPLETED|Overall Study||1
8880432|NCT01941628|9937488|FG001|NOT COMPLETED|Overall Study||0
8880433|NCT01941745|9937498|FG000|STARTED|Overall Study||22
8880434|NCT01941745|9937499|FG001|STARTED|Overall Study||22
8880435|NCT01941745|9937500|FG002|STARTED|Overall Study||21
8880436|NCT01941745|9937501|FG003|STARTED|Overall Study||23
8880437|NCT01941745|9937498|FG000|COMPLETED|Overall Study||22
8880438|NCT01941745|9937499|FG001|COMPLETED|Overall Study||22
8880439|NCT01941745|9937500|FG002|COMPLETED|Overall Study||21
8880440|NCT01941745|9937501|FG003|COMPLETED|Overall Study||23
8880441|NCT01941745|9937498|FG000|NOT COMPLETED|Overall Study||0
8880442|NCT01941745|9937499|FG001|NOT COMPLETED|Overall Study||0
8880443|NCT01941745|9937500|FG002|NOT COMPLETED|Overall Study||0
8880444|NCT01941745|9937501|FG003|NOT COMPLETED|Overall Study||0
8880445|NCT01941927|9937516|FG000|STARTED|Overall Study||10
8880446|NCT01941927|9937517|FG001|STARTED|Overall Study||10
8880447|NCT01941927|9937516|FG000|COMPLETED|Overall Study||10
8880448|NCT01941927|9937517|FG001|COMPLETED|Overall Study||10
8880449|NCT01941927|9937516|FG000|NOT COMPLETED|Overall Study||0
8880450|NCT01941927|9937517|FG001|NOT COMPLETED|Overall Study||0
8880451|NCT01941940|9937523|FG000|STARTED|Overall Study||227
8880452|NCT01941940|9937523|FG000|COMPLETED|Overall Study||194
8880453|NCT01941940|9937523|FG000|NOT COMPLETED|Overall Study||33
8880454|NCT01942148|9937527|FG000|STARTED|Overall Study||68
8880455|NCT01942148|9937527|FG000|COMPLETED|Overall Study||41
8880456|NCT01942148|9937527|FG000|NOT COMPLETED|Overall Study||27
8880457|NCT01942161|9937534|FG000|STARTED|Overall Study||35
8880458|NCT01942161|9937535|FG001|STARTED|Overall Study||30
8880459|NCT01942161|9937536|FG002|STARTED|Overall Study||41
8880460|NCT01942161|9937534|FG000|COMPLETED|Overall Study||27
8880461|NCT01942161|9937535|FG001|COMPLETED|Overall Study||24
8880462|NCT01942161|9937536|FG002|COMPLETED|Overall Study||35
8880463|NCT01942161|9937534|FG000|NOT COMPLETED|Overall Study||8
8880464|NCT01942161|9937535|FG001|NOT COMPLETED|Overall Study||6
9001993|NCT02906670|10065204|FG005|COMPLETED|Cohort 6P, Q2W||0
9001994|NCT02906670|10065205|FG006|COMPLETED|Cohort 6P, Q2W||0
9001995|NCT02906670|10065206|FG007|COMPLETED|Cohort 6P, Q2W||0
9001996|NCT02906670|10065207|FG008|COMPLETED|Cohort 6P, Q2W||0
9001997|NCT02906670|10065208|FG009|COMPLETED|Cohort 6P, Q2W||0
9001998|NCT02906670|10065199|FG000|NOT COMPLETED|Cohort 6P, Q2W||0
9001999|NCT02906670|10065200|FG001|NOT COMPLETED|Cohort 6P, Q2W||0
9002000|NCT02906670|10065201|FG002|NOT COMPLETED|Cohort 6P, Q2W||0
9002001|NCT02906670|10065202|FG003|NOT COMPLETED|Cohort 6P, Q2W||0
9002002|NCT02906670|10065203|FG004|NOT COMPLETED|Cohort 6P, Q2W||0
9002003|NCT02906670|10065204|FG005|NOT COMPLETED|Cohort 6P, Q2W||0
9002004|NCT02906670|10065205|FG006|NOT COMPLETED|Cohort 6P, Q2W||0
9002005|NCT02906670|10065206|FG007|NOT COMPLETED|Cohort 6P, Q2W||0
9002006|NCT02906670|10065207|FG008|NOT COMPLETED|Cohort 6P, Q2W||4
9002007|NCT02906670|10065208|FG009|NOT COMPLETED|Cohort 6P, Q2W||0
9002008|NCT02906670|10065199|FG000|STARTED|Cohort 4P, QW||0
9002009|NCT02906670|10065200|FG001|STARTED|Cohort 4P, QW||0
9002010|NCT02906670|10065201|FG002|STARTED|Cohort 4P, QW||0
9002011|NCT02906670|10065202|FG003|STARTED|Cohort 4P, QW||3
9002012|NCT02906670|10065203|FG004|STARTED|Cohort 4P, QW||0
9002013|NCT02906670|10065204|FG005|STARTED|Cohort 4P, QW||0
9002014|NCT02906670|10065205|FG006|STARTED|Cohort 4P, QW||0
9002015|NCT02906670|10065206|FG007|STARTED|Cohort 4P, QW||0
9002016|NCT02906670|10065207|FG008|STARTED|Cohort 4P, QW||0
9002017|NCT02906670|10065208|FG009|STARTED|Cohort 4P, QW||0
9002018|NCT02906670|10065199|FG000|COMPLETED|Cohort 4P, QW||0
9002019|NCT02906670|10065200|FG001|COMPLETED|Cohort 4P, QW||0
9002020|NCT02906670|10065201|FG002|COMPLETED|Cohort 4P, QW||0
9002021|NCT02906670|10065202|FG003|COMPLETED|Cohort 4P, QW||0
9002022|NCT02906670|10065203|FG004|COMPLETED|Cohort 4P, QW||0
9002023|NCT02906670|10065204|FG005|COMPLETED|Cohort 4P, QW||0
9002024|NCT02906670|10065205|FG006|COMPLETED|Cohort 4P, QW||0
9002025|NCT02906670|10065206|FG007|COMPLETED|Cohort 4P, QW||0
9002026|NCT02906670|10065207|FG008|COMPLETED|Cohort 4P, QW||0
9002027|NCT02906670|10065208|FG009|COMPLETED|Cohort 4P, QW||0
9002028|NCT02906670|10065199|FG000|NOT COMPLETED|Cohort 4P, QW||0
9002029|NCT02906670|10065200|FG001|NOT COMPLETED|Cohort 4P, QW||0
9002030|NCT02906670|10065201|FG002|NOT COMPLETED|Cohort 4P, QW||0
9002031|NCT02906670|10065202|FG003|NOT COMPLETED|Cohort 4P, QW||3
9002032|NCT02906670|10065203|FG004|NOT COMPLETED|Cohort 4P, QW||0
9002033|NCT02906670|10065204|FG005|NOT COMPLETED|Cohort 4P, QW||0
8634057|NCT00554853|9674370|FG000|COMPLETED|First Arm of Study||56
8880465|NCT01942161|9937536|FG002|NOT COMPLETED|Overall Study||6
8880466|NCT01942486|9937544|FG000|STARTED|Overall Study||35
8880467|NCT01942486|9937544|FG000|COMPLETED|Overall Study||8
8880468|NCT01942486|9937544|FG000|NOT COMPLETED|Overall Study||27
8880469|NCT01942590|9937550|FG000|STARTED|Overall Study||8
8880470|NCT01942590|9937551|FG001|STARTED|Overall Study||5
8880471|NCT01942590|9937550|FG000|COMPLETED|Overall Study||7
8880472|NCT01942590|9937551|FG001|COMPLETED|Overall Study||4
8880473|NCT01942590|9937550|FG000|NOT COMPLETED|Overall Study||1
8880474|NCT01942590|9937551|FG001|NOT COMPLETED|Overall Study||1
8880475|NCT01942668|9937563|FG000|STARTED|Overall Study||418
8880476|NCT01942668|9937564|FG001|STARTED|Overall Study||426
8880477|NCT01942668|9937565|FG002|STARTED|Overall Study||422
8880478|NCT01942668|9937566|FG003|STARTED|Overall Study||427
8880479|NCT01942668|9937567|FG004|STARTED|Overall Study||152
8880480|NCT01942668|9937563|FG000|COMPLETED|Overall Study||284
8880481|NCT01942668|9937564|FG001|COMPLETED|Overall Study||305
8880482|NCT01942668|9937565|FG002|COMPLETED|Overall Study||312
8880483|NCT01942668|9937566|FG003|COMPLETED|Overall Study||281
8880484|NCT01942668|9937567|FG004|COMPLETED|Overall Study||93
8880485|NCT01942668|9937563|FG000|NOT COMPLETED|Overall Study||134
8880486|NCT01942668|9937564|FG001|NOT COMPLETED|Overall Study||121
8880487|NCT01942668|9937565|FG002|NOT COMPLETED|Overall Study||110
8880488|NCT01942668|9937566|FG003|NOT COMPLETED|Overall Study||146
8880489|NCT01942668|9937567|FG004|NOT COMPLETED|Overall Study||59
8880490|NCT01942694|9937586|FG000|STARTED|Overall Study||1212
8880491|NCT01942694|9937587|FG001|STARTED|Overall Study||1211
8880492|NCT01942694|9937586|FG000|COMPLETED|Overall Study||1211
8880493|NCT01942694|9937587|FG001|COMPLETED|Overall Study||1211
8880494|NCT01942694|9937586|FG000|NOT COMPLETED|Overall Study||1
8880495|NCT01942694|9937587|FG001|NOT COMPLETED|Overall Study||0
8880496|NCT01942707|9937595|FG000|STARTED|Overall Study||23
8880497|NCT01942707|9937596|FG001|STARTED|Overall Study||23
8880498|NCT01942707|9937595|FG000|COMPLETED|Overall Study||23
8880499|NCT01942707|9937596|FG001|COMPLETED|Overall Study||23
8880500|NCT01942707|9937595|FG000|NOT COMPLETED|Overall Study||0
8880501|NCT01942707|9937596|FG001|NOT COMPLETED|Overall Study||0
9002034|NCT02906670|10065205|FG006|NOT COMPLETED|Cohort 4P, QW||0
9002035|NCT02906670|10065206|FG007|NOT COMPLETED|Cohort 4P, QW||0
9002036|NCT02906670|10065207|FG008|NOT COMPLETED|Cohort 4P, QW||0
9002037|NCT02906670|10065208|FG009|NOT COMPLETED|Cohort 4P, QW||0
9002038|NCT02906670|10065199|FG000|STARTED|Cohort 7P, Q2W||0
9002039|NCT02906670|10065200|FG001|STARTED|Cohort 7P, Q2W||0
9002040|NCT02906670|10065201|FG002|STARTED|Cohort 7P, Q2W||0
9002041|NCT02906670|10065202|FG003|STARTED|Cohort 7P, Q2W||0
8880502|NCT01942720|9937602|FG000|STARTED|Overall Study||74
8880503|NCT01942720|9937602|FG000|COMPLETED|Overall Study||53
8880504|NCT01942720|9937602|FG000|NOT COMPLETED|Overall Study||21
8880505|NCT01942733|9937606|FG000|STARTED|Overall Study||44
8880506|NCT01942733|9937606|FG000|COMPLETED|Overall Study||41
8880507|NCT01942733|9937606|FG000|NOT COMPLETED|Overall Study||3
8880508|NCT01942785|9937610|FG000|STARTED|Overall Study||54
8880509|NCT01942785|9937610|FG000|COMPLETED|Overall Study||50
9002042|NCT02906670|10065203|FG004|STARTED|Cohort 7P, Q2W||0
8880510|NCT01942785|9937610|FG000|NOT COMPLETED|Overall Study||4
8880511|NCT01942993|9937616|FG000|STARTED|Overall Study||3
8880512|NCT01942993|9937616|FG000|COMPLETED|Overall Study||1
8880513|NCT01942993|9937616|FG000|NOT COMPLETED|Overall Study||2
9002043|NCT02906670|10065204|FG005|STARTED|Cohort 7P, Q2W||0
9002044|NCT02906670|10065205|FG006|STARTED|Cohort 7P, Q2W||0
9002045|NCT02906670|10065206|FG007|STARTED|Cohort 7P, Q2W||0
9002046|NCT02906670|10065207|FG008|STARTED|Cohort 7P, Q2W||0
9002047|NCT02906670|10065208|FG009|STARTED|Cohort 7P, Q2W||3
8880514|NCT01943110|9937620|FG000|STARTED|Overall Study||30
8880515|NCT01943110|9937620|FG000|COMPLETED|Overall Study||30
8880516|NCT01943110|9937620|FG000|NOT COMPLETED|Overall Study||0
9002048|NCT02906670|10065199|FG000|COMPLETED|Cohort 7P, Q2W||0
9002049|NCT02906670|10065200|FG001|COMPLETED|Cohort 7P, Q2W||0
9002050|NCT02906670|10065201|FG002|COMPLETED|Cohort 7P, Q2W||0
9002051|NCT02906670|10065202|FG003|COMPLETED|Cohort 7P, Q2W||0
9002052|NCT02906670|10065203|FG004|COMPLETED|Cohort 7P, Q2W||0
9002053|NCT02906670|10065204|FG005|COMPLETED|Cohort 7P, Q2W||0
9002054|NCT02906670|10065205|FG006|COMPLETED|Cohort 7P, Q2W||0
9002055|NCT02906670|10065206|FG007|COMPLETED|Cohort 7P, Q2W||0
9002056|NCT02906670|10065207|FG008|COMPLETED|Cohort 7P, Q2W||0
9002057|NCT02906670|10065208|FG009|COMPLETED|Cohort 7P, Q2W||0
9002058|NCT02906670|10065199|FG000|NOT COMPLETED|Cohort 7P, Q2W||0
9002059|NCT02906670|10065200|FG001|NOT COMPLETED|Cohort 7P, Q2W||0
9002060|NCT02906670|10065201|FG002|NOT COMPLETED|Cohort 7P, Q2W||0
9002061|NCT02906670|10065202|FG003|NOT COMPLETED|Cohort 7P, Q2W||0
9002062|NCT02906670|10065203|FG004|NOT COMPLETED|Cohort 7P, Q2W||0
9002063|NCT02906670|10065204|FG005|NOT COMPLETED|Cohort 7P, Q2W||0
9002064|NCT02906670|10065205|FG006|NOT COMPLETED|Cohort 7P, Q2W||0
9002065|NCT02906670|10065206|FG007|NOT COMPLETED|Cohort 7P, Q2W||0
9002066|NCT02906670|10065207|FG008|NOT COMPLETED|Cohort 7P, Q2W||0
9002067|NCT02906670|10065208|FG009|NOT COMPLETED|Cohort 7P, Q2W||3
9002068|NCT02906670|10065199|FG000|STARTED|Cohort 5P, QW||0
9002069|NCT02906670|10065200|FG001|STARTED|Cohort 5P, QW||0
9002070|NCT02906670|10065201|FG002|STARTED|Cohort 5P, QW||0
9002071|NCT02906670|10065202|FG003|STARTED|Cohort 5P, QW||0
9002072|NCT02906670|10065203|FG004|STARTED|Cohort 5P, QW||3
9002073|NCT02906670|10065204|FG005|STARTED|Cohort 5P, QW||0
9002074|NCT02906670|10065205|FG006|STARTED|Cohort 5P, QW||0
9002075|NCT02906670|10065206|FG007|STARTED|Cohort 5P, QW||0
9002076|NCT02906670|10065207|FG008|STARTED|Cohort 5P, QW||0
9002077|NCT02906670|10065208|FG009|STARTED|Cohort 5P, QW||0
9002078|NCT02906670|10065199|FG000|COMPLETED|Cohort 5P, QW||0
9002079|NCT02906670|10065200|FG001|COMPLETED|Cohort 5P, QW||0
9002080|NCT02906670|10065201|FG002|COMPLETED|Cohort 5P, QW||0
9002081|NCT02906670|10065202|FG003|COMPLETED|Cohort 5P, QW||0
9002082|NCT02906670|10065203|FG004|COMPLETED|Cohort 5P, QW||0
9002083|NCT02906670|10065204|FG005|COMPLETED|Cohort 5P, QW||0
9002084|NCT02906670|10065205|FG006|COMPLETED|Cohort 5P, QW||0
9002085|NCT02906670|10065206|FG007|COMPLETED|Cohort 5P, QW||0
9002086|NCT02906670|10065207|FG008|COMPLETED|Cohort 5P, QW||0
9002087|NCT02906670|10065208|FG009|COMPLETED|Cohort 5P, QW||0
9002088|NCT02906670|10065199|FG000|NOT COMPLETED|Cohort 5P, QW||0
9002089|NCT02906670|10065200|FG001|NOT COMPLETED|Cohort 5P, QW||0
9002090|NCT02906670|10065201|FG002|NOT COMPLETED|Cohort 5P, QW||0
9002091|NCT02906670|10065202|FG003|NOT COMPLETED|Cohort 5P, QW||0
9002092|NCT02906670|10065203|FG004|NOT COMPLETED|Cohort 5P, QW||3
9002093|NCT02906670|10065204|FG005|NOT COMPLETED|Cohort 5P, QW||0
9002094|NCT02906670|10065205|FG006|NOT COMPLETED|Cohort 5P, QW||0
9002095|NCT02906670|10065206|FG007|NOT COMPLETED|Cohort 5P, QW||0
9002096|NCT02906670|10065207|FG008|NOT COMPLETED|Cohort 5P, QW||0
9002097|NCT02906670|10065208|FG009|NOT COMPLETED|Cohort 5P, QW||0
9002098|NCT02906696|10065258|FG000|STARTED|Overall Study||8
9002099|NCT02906696|10065258|FG000|COMPLETED|Overall Study||8
9002100|NCT02906696|10065258|FG000|NOT COMPLETED|Overall Study||0
9002101|NCT02906709|10065264|FG000|STARTED|Phase A (Week 0 to Week 16)||123
9002102|NCT02906709|10065265|FG001|STARTED|Phase A (Week 0 to Week 16)||61
9002103|NCT02906709|10065264|FG000|COMPLETED|Phase A (Week 0 to Week 16)||122
9002104|NCT02906709|10065265|FG001|COMPLETED|Phase A (Week 0 to Week 16)||58
9002105|NCT02906709|10065264|FG000|NOT COMPLETED|Phase A (Week 0 to Week 16)||1
9002106|NCT02906709|10065265|FG001|NOT COMPLETED|Phase A (Week 0 to Week 16)||3
9002107|NCT02906709|10065264|FG000|STARTED|Phase B (Extension, Week 17 to Week 52)||122
9002108|NCT02906709|10065265|FG001|STARTED|Phase B (Extension, Week 17 to Week 52)||58
9002109|NCT02906709|10065264|FG000|COMPLETED|Phase B (Extension, Week 17 to Week 52)||117
9002110|NCT02906709|10065265|FG001|COMPLETED|Phase B (Extension, Week 17 to Week 52)||58
9002111|NCT02906709|10065264|FG000|NOT COMPLETED|Phase B (Extension, Week 17 to Week 52)||5
9002112|NCT02906709|10065265|FG001|NOT COMPLETED|Phase B (Extension, Week 17 to Week 52)||0
9002113|NCT02906813|10065280|FG000|STARTED|Intervention Period 1 (3 Days)||3
9002114|NCT02906813|10065281|FG001|STARTED|Intervention Period 1 (3 Days)||3
9002115|NCT02906813|10065282|FG002|STARTED|Intervention Period 1 (3 Days)||3
9002116|NCT02906813|10065280|FG000|COMPLETED|Intervention Period 1 (3 Days)||3
9002117|NCT02906813|10065281|FG001|COMPLETED|Intervention Period 1 (3 Days)||3
9002118|NCT02906813|10065282|FG002|COMPLETED|Intervention Period 1 (3 Days)||3
9002119|NCT02906813|10065280|FG000|NOT COMPLETED|Intervention Period 1 (3 Days)||0
9002120|NCT02906813|10065281|FG001|NOT COMPLETED|Intervention Period 1 (3 Days)||0
9002121|NCT02906813|10065282|FG002|NOT COMPLETED|Intervention Period 1 (3 Days)||0
9002122|NCT02906813|10065280|FG000|STARTED|Washout Period 1 (at Least 3 Days)||3
9002123|NCT02906813|10065281|FG001|STARTED|Washout Period 1 (at Least 3 Days)||3
9002124|NCT02906813|10065282|FG002|STARTED|Washout Period 1 (at Least 3 Days)||3
9002125|NCT02906813|10065280|FG000|COMPLETED|Washout Period 1 (at Least 3 Days)||3
8880517|NCT01943227|9937638|FG000|STARTED|Overall Study||10
9002126|NCT02906813|10065281|FG001|COMPLETED|Washout Period 1 (at Least 3 Days)||3
9002127|NCT02906813|10065282|FG002|COMPLETED|Washout Period 1 (at Least 3 Days)||3
9002128|NCT02906813|10065280|FG000|NOT COMPLETED|Washout Period 1 (at Least 3 Days)||0
9002129|NCT02906813|10065281|FG001|NOT COMPLETED|Washout Period 1 (at Least 3 Days)||0
9002130|NCT02906813|10065282|FG002|NOT COMPLETED|Washout Period 1 (at Least 3 Days)||0
9002131|NCT02906813|10065280|FG000|STARTED|Intervention Period 2 (3 Days)||3
9002132|NCT02906813|10065281|FG001|STARTED|Intervention Period 2 (3 Days)||3
9002133|NCT02906813|10065282|FG002|STARTED|Intervention Period 2 (3 Days)||3
9002134|NCT02906813|10065280|FG000|COMPLETED|Intervention Period 2 (3 Days)||3
9002135|NCT02906813|10065281|FG001|COMPLETED|Intervention Period 2 (3 Days)||3
9002136|NCT02906813|10065282|FG002|COMPLETED|Intervention Period 2 (3 Days)||3
8880518|NCT01943227|9937639|FG001|STARTED|Overall Study||10
8880519|NCT01943227|9937638|FG000|COMPLETED|Overall Study||10
8880520|NCT01943227|9937639|FG001|COMPLETED|Overall Study||10
8880521|NCT01943227|9937638|FG000|NOT COMPLETED|Overall Study||0
8880522|NCT01943227|9937639|FG001|NOT COMPLETED|Overall Study||0
8880523|NCT01943292|9937648|FG000|STARTED|Overall Study||3
8880524|NCT01943292|9937649|FG001|STARTED|Overall Study||3
8880525|NCT01943292|9937650|FG002|STARTED|Overall Study||3
8880526|NCT01943292|9937648|FG000|Completed Cycle 1|Overall Study||3
8880527|NCT01943292|9937649|FG001|Completed Cycle 1|Overall Study||3
8880528|NCT01943292|9937650|FG002|Completed Cycle 1|Overall Study||3
8880529|NCT01943292|9937648|FG000|Completed Treatment|Overall Study||3
8880530|NCT01943292|9937649|FG001|Completed Treatment|Overall Study||3
8880531|NCT01943292|9937650|FG002|Completed Treatment|Overall Study||3
8880532|NCT01943292|9937648|FG000|Completed Follow-Up|Overall Study||2
8880533|NCT01943292|9937649|FG001|Completed Follow-Up|Overall Study||3
8880534|NCT01943292|9937650|FG002|Completed Follow-Up|Overall Study||3
8880535|NCT01943292|9937648|FG000|COMPLETED|Overall Study||2
8880536|NCT01943292|9937649|FG001|COMPLETED|Overall Study||3
8880537|NCT01943292|9937650|FG002|COMPLETED|Overall Study||3
8880538|NCT01943292|9937648|FG000|NOT COMPLETED|Overall Study||1
8880539|NCT01943292|9937649|FG001|NOT COMPLETED|Overall Study||0
8880540|NCT01943292|9937650|FG002|NOT COMPLETED|Overall Study||0
8880541|NCT01943344|9937658|FG000|STARTED|Overall Study||12
8880542|NCT01943344|9937658|FG000|COMPLETED|Overall Study||9
8880543|NCT01943344|9937658|FG000|NOT COMPLETED|Overall Study||3
8880544|NCT01943435|9937667|FG000|STARTED|Baseline Eligibility and Randomization||88
8880545|NCT01943435|9937668|FG001|STARTED|Baseline Eligibility and Randomization||84
8880546|NCT01943435|9937669|FG002|STARTED|Baseline Eligibility and Randomization||87
8880547|NCT01943435|9937667|FG000|COMPLETED|Baseline Eligibility and Randomization||84
8880548|NCT01943435|9937668|FG001|COMPLETED|Baseline Eligibility and Randomization||72
8880549|NCT01943435|9937669|FG002|COMPLETED|Baseline Eligibility and Randomization||84
8880550|NCT01943435|9937667|FG000|NOT COMPLETED|Baseline Eligibility and Randomization||4
8880551|NCT01943435|9937668|FG001|NOT COMPLETED|Baseline Eligibility and Randomization||12
8880552|NCT01943435|9937669|FG002|NOT COMPLETED|Baseline Eligibility and Randomization||3
8880553|NCT01943435|9937667|FG000|STARTED|Intervention Period||84
8880554|NCT01943435|9937668|FG001|STARTED|Intervention Period||72
8880555|NCT01943435|9937669|FG002|STARTED|Intervention Period||84
8880556|NCT01943435|9937667|FG000|COMPLETED|Intervention Period||81
8880557|NCT01943435|9937668|FG001|COMPLETED|Intervention Period||69
8880558|NCT01943435|9937669|FG002|COMPLETED|Intervention Period||80
8880559|NCT01943435|9937667|FG000|NOT COMPLETED|Intervention Period||3
8880560|NCT01943435|9937668|FG001|NOT COMPLETED|Intervention Period||3
8880561|NCT01943435|9937669|FG002|NOT COMPLETED|Intervention Period||4
8880562|NCT01943435|9937667|FG000|STARTED|2 Month Follow up||81
8880563|NCT01943435|9937668|FG001|STARTED|2 Month Follow up||69
8880564|NCT01943435|9937669|FG002|STARTED|2 Month Follow up||80
8880565|NCT01943435|9937667|FG000|COMPLETED|2 Month Follow up||79
8880566|NCT01943435|9937668|FG001|COMPLETED|2 Month Follow up||66
8880567|NCT01943435|9937669|FG002|COMPLETED|2 Month Follow up||80
8880568|NCT01943435|9937667|FG000|NOT COMPLETED|2 Month Follow up||2
8880569|NCT01943435|9937668|FG001|NOT COMPLETED|2 Month Follow up||3
8880570|NCT01943435|9937669|FG002|NOT COMPLETED|2 Month Follow up||0
8880571|NCT01943435|9937667|FG000|STARTED|6 Month Follow up||79
8880572|NCT01943435|9937668|FG001|STARTED|6 Month Follow up||66
8880573|NCT01943435|9937669|FG002|STARTED|6 Month Follow up||80
8880574|NCT01943435|9937667|FG000|COMPLETED|6 Month Follow up||67
8880575|NCT01943435|9937668|FG001|COMPLETED|6 Month Follow up||59
8880576|NCT01943435|9937669|FG002|COMPLETED|6 Month Follow up||65
8880577|NCT01943435|9937667|FG000|NOT COMPLETED|6 Month Follow up||12
8880578|NCT01943435|9937668|FG001|NOT COMPLETED|6 Month Follow up||7
8880579|NCT01943435|9937669|FG002|NOT COMPLETED|6 Month Follow up||15
8880580|NCT01943461|9937681|FG000|STARTED|Overall Study||5
8880581|NCT01943461|9937682|FG001|STARTED|Overall Study||6
8880582|NCT01943461|9937683|FG002|STARTED|Overall Study||6
8880583|NCT01943461|9937684|FG003|STARTED|Overall Study||40
8880584|NCT01943461|9937681|FG000|COMPLETED|Overall Study||5
8880585|NCT01943461|9937682|FG001|COMPLETED|Overall Study||6
8880586|NCT01943461|9937683|FG002|COMPLETED|Overall Study||6
8880587|NCT01943461|9937684|FG003|COMPLETED|Overall Study||40
8880588|NCT01943461|9937681|FG000|NOT COMPLETED|Overall Study||0
8880589|NCT01943461|9937682|FG001|NOT COMPLETED|Overall Study||0
8880590|NCT01943461|9937683|FG002|NOT COMPLETED|Overall Study||0
8880591|NCT01943461|9937684|FG003|NOT COMPLETED|Overall Study||0
9002137|NCT02906813|10065280|FG000|NOT COMPLETED|Intervention Period 2 (3 Days)||0
8880592|NCT01943474|9937696|FG000|STARTED|Overall Study||123
8880593|NCT01943474|9937697|FG001|STARTED|Overall Study||125
8880594|NCT01943474|9937696|FG000|COMPLETED|Overall Study||123
8880595|NCT01943474|9937697|FG001|COMPLETED|Overall Study||125
8880596|NCT01943474|9937696|FG000|NOT COMPLETED|Overall Study||0
8880597|NCT01943474|9937697|FG001|NOT COMPLETED|Overall Study||0
8634058|NCT00554853|9674371|FG001|COMPLETED|First Arm of Study||64
8880598|NCT01943539|9937703|FG000|STARTED|Overall Study||44
8880599|NCT01943539|9937704|FG001|STARTED|Overall Study||40
8880600|NCT01943539|9937703|FG000|COMPLETED|Overall Study||40
8880601|NCT01943539|9937704|FG001|COMPLETED|Overall Study||40
8880602|NCT01943539|9937703|FG000|NOT COMPLETED|Overall Study||4
8880603|NCT01943539|9937704|FG001|NOT COMPLETED|Overall Study||0
8880604|NCT01943552|9937713|FG000|STARTED|Overall Study|One patient was randomised to the placebo group, but received nebulized ipratropium bromide.|96
8880605|NCT01943552|9937714|FG001|STARTED|Overall Study||94
8880606|NCT01943552|9937713|FG000|COMPLETED|Overall Study||71
8880607|NCT01943552|9937714|FG001|COMPLETED|Overall Study||69
8880608|NCT01943552|9937713|FG000|NOT COMPLETED|Overall Study||25
8880609|NCT01943552|9937714|FG001|NOT COMPLETED|Overall Study||25
8880610|NCT01943565|9937723|FG000|STARTED|Overall Study||11
8880611|NCT01943565|9937724|FG001|STARTED|Overall Study||9
8880612|NCT01943565|9937725|FG002|STARTED|Overall Study||9
8880613|NCT01943565|9937723|FG000|COMPLETED|Overall Study||11
8880614|NCT01943565|9937724|FG001|COMPLETED|Overall Study||9
8880615|NCT01943565|9937725|FG002|COMPLETED|Overall Study||9
8880616|NCT01943565|9937723|FG000|NOT COMPLETED|Overall Study||0
8880617|NCT01943565|9937724|FG001|NOT COMPLETED|Overall Study||0
8880618|NCT01943565|9937725|FG002|NOT COMPLETED|Overall Study||0
8880619|NCT01943591|9937735|FG000|STARTED|Overall Study||104
8880620|NCT01943591|9937736|FG001|STARTED|Overall Study||106
8880621|NCT01943591|9937735|FG000|COMPLETED|Overall Study||99
8880622|NCT01943591|9937736|FG001|COMPLETED|Overall Study||95
8880623|NCT01943591|9937735|FG000|NOT COMPLETED|Overall Study||5
8880624|NCT01943591|9937736|FG001|NOT COMPLETED|Overall Study||11
8880625|NCT01943799|9937746|FG000|STARTED|Overall Study||27
8880626|NCT01943799|9937747|FG001|STARTED|Overall Study||50
8880627|NCT01943799|9937748|FG002|STARTED|Overall Study|1 participant was randomized to OAV + GS-4774 2 YU but received OAV + GS-4774 10 YU.|51
8880628|NCT01943799|9937749|FG003|STARTED|Overall Study||50
8880629|NCT01943799|9937746|FG000|COMPLETED|Overall Study||22
8880630|NCT01943799|9937747|FG001|COMPLETED|Overall Study||47
8880631|NCT01943799|9937748|FG002|COMPLETED|Overall Study||49
8880632|NCT01943799|9937749|FG003|COMPLETED|Overall Study||50
8880633|NCT01943799|9937746|FG000|NOT COMPLETED|Overall Study||5
8880634|NCT01943799|9937747|FG001|NOT COMPLETED|Overall Study||3
8880635|NCT01943799|9937748|FG002|NOT COMPLETED|Overall Study||2
8880636|NCT01943799|9937749|FG003|NOT COMPLETED|Overall Study||0
8880637|NCT01943851|9937777|FG000|STARTED|Part 1 (Up to 86.9 Weeks)||1
8880638|NCT01943851|9937778|FG001|STARTED|Part 1 (Up to 86.9 Weeks)||1
8880639|NCT01943851|9937779|FG002|STARTED|Part 1 (Up to 86.9 Weeks)||1
8880640|NCT01943851|9937780|FG003|STARTED|Part 1 (Up to 86.9 Weeks)||5
8880641|NCT01943851|9937781|FG004|STARTED|Part 1 (Up to 86.9 Weeks)||1
8880642|NCT01943851|9937782|FG005|STARTED|Part 1 (Up to 86.9 Weeks)||4
8880643|NCT01943851|9937783|FG006|STARTED|Part 1 (Up to 86.9 Weeks)||8
8880644|NCT01943851|9937784|FG007|STARTED|Part 1 (Up to 86.9 Weeks)||18
8880645|NCT01943851|9937785|FG008|STARTED|Part 1 (Up to 86.9 Weeks)||3
8880646|NCT01943851|9937786|FG009|STARTED|Part 1 (Up to 86.9 Weeks)||8
8880647|NCT01943851|9937787|FG010|STARTED|Part 1 (Up to 86.9 Weeks)||1
8880648|NCT01943851|9937788|FG011|STARTED|Part 1 (Up to 86.9 Weeks)||7
8880649|NCT01943851|9937789|FG012|STARTED|Part 1 (Up to 86.9 Weeks)||7
8880650|NCT01943851|9937790|FG013|STARTED|Part 1 (Up to 86.9 Weeks)||16
8880651|NCT01943851|9937791|FG014|STARTED|Part 1 (Up to 86.9 Weeks)||6
8880652|NCT01943851|9937792|FG015|STARTED|Part 1 (Up to 86.9 Weeks)||0
8880653|NCT01943851|9937793|FG016|STARTED|Part 1 (Up to 86.9 Weeks)||0
8880654|NCT01943851|9937794|FG017|STARTED|Part 1 (Up to 86.9 Weeks)||0
8880655|NCT01943851|9937777|FG000|COMPLETED|Part 1 (Up to 86.9 Weeks)||1
8880656|NCT01943851|9937778|FG001|COMPLETED|Part 1 (Up to 86.9 Weeks)||1
8880657|NCT01943851|9937779|FG002|COMPLETED|Part 1 (Up to 86.9 Weeks)||1
8880658|NCT01943851|9937780|FG003|COMPLETED|Part 1 (Up to 86.9 Weeks)||4
8880659|NCT01943851|9937781|FG004|COMPLETED|Part 1 (Up to 86.9 Weeks)||0
8880660|NCT01943851|9937782|FG005|COMPLETED|Part 1 (Up to 86.9 Weeks)||4
8880661|NCT01943851|9937783|FG006|COMPLETED|Part 1 (Up to 86.9 Weeks)||7
8880662|NCT01943851|9937784|FG007|COMPLETED|Part 1 (Up to 86.9 Weeks)||16
8880663|NCT01943851|9937785|FG008|COMPLETED|Part 1 (Up to 86.9 Weeks)||2
8880664|NCT01943851|9937786|FG009|COMPLETED|Part 1 (Up to 86.9 Weeks)||8
8880665|NCT01943851|9937787|FG010|COMPLETED|Part 1 (Up to 86.9 Weeks)||1
8880666|NCT01943851|9937788|FG011|COMPLETED|Part 1 (Up to 86.9 Weeks)||7
8880667|NCT01943851|9937789|FG012|COMPLETED|Part 1 (Up to 86.9 Weeks)||7
8880668|NCT01943851|9937790|FG013|COMPLETED|Part 1 (Up to 86.9 Weeks)||15
8880669|NCT01943851|9937791|FG014|COMPLETED|Part 1 (Up to 86.9 Weeks)||6
8880670|NCT01943851|9937792|FG015|COMPLETED|Part 1 (Up to 86.9 Weeks)||0
8880671|NCT01943851|9937793|FG016|COMPLETED|Part 1 (Up to 86.9 Weeks)||0
8880672|NCT01943851|9937794|FG017|COMPLETED|Part 1 (Up to 86.9 Weeks)||0
8880673|NCT01943851|9937777|FG000|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
8880674|NCT01943851|9937778|FG001|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
8880675|NCT01943851|9937779|FG002|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
8880676|NCT01943851|9937780|FG003|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||1
8880677|NCT01943851|9937781|FG004|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||1
8880678|NCT01943851|9937782|FG005|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
8880679|NCT01943851|9937783|FG006|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||1
8880680|NCT01943851|9937784|FG007|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||2
8880681|NCT01943851|9937785|FG008|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||1
8880682|NCT01943851|9937786|FG009|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
8880683|NCT01943851|9937787|FG010|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
8880684|NCT01943851|9937788|FG011|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
8880685|NCT01943851|9937789|FG012|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
8880686|NCT01943851|9937790|FG013|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||1
8880687|NCT01943851|9937791|FG014|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
8880688|NCT01943851|9937792|FG015|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
8880689|NCT01943851|9937793|FG016|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
8880690|NCT01943851|9937794|FG017|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
8880691|NCT01943851|9937777|FG000|STARTED|Part 2 (Up to 36.4 Weeks)||0
8880692|NCT01943851|9937778|FG001|STARTED|Part 2 (Up to 36.4 Weeks)||0
8880693|NCT01943851|9937779|FG002|STARTED|Part 2 (Up to 36.4 Weeks)||0
8880694|NCT01943851|9937780|FG003|STARTED|Part 2 (Up to 36.4 Weeks)||0
8880695|NCT01943851|9937781|FG004|STARTED|Part 2 (Up to 36.4 Weeks)||0
8880696|NCT01943851|9937782|FG005|STARTED|Part 2 (Up to 36.4 Weeks)||0
8634059|NCT00554853|9674370|FG000|NOT COMPLETED|First Arm of Study||16
8634060|NCT00554853|9674371|FG001|NOT COMPLETED|First Arm of Study||7
8634061|NCT00554853|9674370|FG000|STARTED|Washout Period (2 Weeks)||56
8634062|NCT00554853|9674371|FG001|STARTED|Washout Period (2 Weeks)||64
8634063|NCT00554853|9674370|FG000|COMPLETED|Washout Period (2 Weeks)||56
8634064|NCT00554853|9674371|FG001|COMPLETED|Washout Period (2 Weeks)||57
8634065|NCT00554853|9674370|FG000|NOT COMPLETED|Washout Period (2 Weeks)||0
8634066|NCT00554853|9674371|FG001|NOT COMPLETED|Washout Period (2 Weeks)||7
8880697|NCT01943851|9937783|FG006|STARTED|Part 2 (Up to 36.4 Weeks)||0
8880698|NCT01943851|9937784|FG007|STARTED|Part 2 (Up to 36.4 Weeks)||0
8880699|NCT01943851|9937785|FG008|STARTED|Part 2 (Up to 36.4 Weeks)||0
9002138|NCT02906813|10065281|FG001|NOT COMPLETED|Intervention Period 2 (3 Days)||0
8880700|NCT01943851|9937786|FG009|STARTED|Part 2 (Up to 36.4 Weeks)||0
8880701|NCT01943851|9937787|FG010|STARTED|Part 2 (Up to 36.4 Weeks)||0
8880702|NCT01943851|9937788|FG011|STARTED|Part 2 (Up to 36.4 Weeks)||0
8880703|NCT01943851|9937789|FG012|STARTED|Part 2 (Up to 36.4 Weeks)||0
8880704|NCT01943851|9937790|FG013|STARTED|Part 2 (Up to 36.4 Weeks)||0
8880705|NCT01943851|9937791|FG014|STARTED|Part 2 (Up to 36.4 Weeks)||0
8880706|NCT01943851|9937792|FG015|STARTED|Part 2 (Up to 36.4 Weeks)||7
8880707|NCT01943851|9937793|FG016|STARTED|Part 2 (Up to 36.4 Weeks)||16
8880708|NCT01943851|9937794|FG017|STARTED|Part 2 (Up to 36.4 Weeks)||1
8880709|NCT01943851|9937777|FG000|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
8880710|NCT01943851|9937778|FG001|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
8880711|NCT01943851|9937779|FG002|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
8880712|NCT01943851|9937780|FG003|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
8880713|NCT01943851|9937781|FG004|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
9002139|NCT02906813|10065282|FG002|NOT COMPLETED|Intervention Period 2 (3 Days)||0
9002140|NCT02906813|10065280|FG000|STARTED|Washout Period 2 (at Least 3 Days)||3
9002141|NCT02906813|10065281|FG001|STARTED|Washout Period 2 (at Least 3 Days)||3
8880714|NCT01943851|9937782|FG005|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
8880715|NCT01943851|9937783|FG006|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
8880716|NCT01943851|9937784|FG007|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
8880717|NCT01943851|9937785|FG008|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
8880718|NCT01943851|9937786|FG009|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
8880719|NCT01943851|9937787|FG010|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
8880720|NCT01943851|9937788|FG011|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
8880721|NCT01943851|9937789|FG012|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
8880722|NCT01943851|9937790|FG013|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
8880723|NCT01943851|9937791|FG014|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
8880724|NCT01943851|9937792|FG015|COMPLETED|Part 2 (Up to 36.4 Weeks)||1
8880725|NCT01943851|9937793|FG016|COMPLETED|Part 2 (Up to 36.4 Weeks)||13
8880726|NCT01943851|9937794|FG017|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
8880727|NCT01943851|9937777|FG000|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
8880728|NCT01943851|9937778|FG001|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
8880729|NCT01943851|9937779|FG002|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
8880730|NCT01943851|9937780|FG003|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
8880731|NCT01943851|9937781|FG004|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
8880732|NCT01943851|9937782|FG005|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
8880733|NCT01943851|9937783|FG006|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
8880734|NCT01943851|9937784|FG007|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
8880735|NCT01943851|9937785|FG008|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
8880736|NCT01943851|9937786|FG009|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
8880737|NCT01943851|9937787|FG010|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
8880738|NCT01943851|9937788|FG011|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
8880739|NCT01943851|9937789|FG012|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
8880740|NCT01943851|9937790|FG013|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
8880741|NCT01943851|9937791|FG014|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
8880742|NCT01943851|9937792|FG015|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||6
8880743|NCT01943851|9937793|FG016|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||3
8880744|NCT01943851|9937794|FG017|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||1
8634067|NCT00554853|9674370|FG000|STARTED|Crossover Arm (3 Months)||56
8880745|NCT01943864|9937835|FG000|STARTED|Overall Study||20
9002142|NCT02906813|10065282|FG002|STARTED|Washout Period 2 (at Least 3 Days)||3
8634068|NCT00554853|9674371|FG001|STARTED|Crossover Arm (3 Months)||57
8880746|NCT01943864|9937835|FG000|COMPLETED|Overall Study|Death or 1 year from randomization after progression was considered completion; 20 participants died|20
8880747|NCT01943864|9937835|FG000|NOT COMPLETED|Overall Study||0
8880748|NCT01943916|9937839|FG000|STARTED|Overall Study||2105
8880749|NCT01943916|9937839|FG000|COMPLETED|Overall Study||1739
8880750|NCT01943916|9937839|FG000|NOT COMPLETED|Overall Study||366
8880751|NCT01944046|9937850|FG000|STARTED|Randomized to DB||146
8880752|NCT01944046|9937851|FG001|STARTED|Randomized to DB||144
8880753|NCT01944046|9937850|FG000|COMPLETED|Randomized to DB||125
8880754|NCT01944046|9937851|FG001|COMPLETED|Randomized to DB||125
8880755|NCT01944046|9937850|FG000|NOT COMPLETED|Randomized to DB||21
8880756|NCT01944046|9937851|FG001|NOT COMPLETED|Randomized to DB||19
8880757|NCT01944046|9937850|FG000|STARTED|Open Label Eligible and Consented||124
8880758|NCT01944046|9937851|FG001|STARTED|Open Label Eligible and Consented||124
8880759|NCT01944046|9937850|FG000|COMPLETED|Open Label Eligible and Consented||110
8880760|NCT01944046|9937851|FG001|COMPLETED|Open Label Eligible and Consented||116
8880761|NCT01944046|9937850|FG000|NOT COMPLETED|Open Label Eligible and Consented||14
8880762|NCT01944046|9937851|FG001|NOT COMPLETED|Open Label Eligible and Consented||8
8880763|NCT01944098|9937863|FG000|STARTED|Overall Study||10
8880764|NCT01944098|9937864|FG001|STARTED|Overall Study||10
8880765|NCT01944098|9937863|FG000|COMPLETED|Overall Study||9
8880766|NCT01944098|9937864|FG001|COMPLETED|Overall Study||10
8880767|NCT01944098|9937863|FG000|NOT COMPLETED|Overall Study||1
8880768|NCT01944098|9937864|FG001|NOT COMPLETED|Overall Study||0
8880769|NCT01944293|9937872|FG000|STARTED|Overall Study||7
8880770|NCT01944293|9937873|FG001|STARTED|Overall Study||9
8880771|NCT01944293|9937872|FG000|COMPLETED|Overall Study||7
8880772|NCT01944293|9937873|FG001|COMPLETED|Overall Study||9
8880773|NCT01944293|9937872|FG000|NOT COMPLETED|Overall Study||0
8880774|NCT01944293|9937873|FG001|NOT COMPLETED|Overall Study||0
8880775|NCT01944319|9937881|FG000|STARTED|Overall Study||40
9002143|NCT02906813|10065280|FG000|COMPLETED|Washout Period 2 (at Least 3 Days)||3
9002144|NCT02906813|10065281|FG001|COMPLETED|Washout Period 2 (at Least 3 Days)||3
9002145|NCT02906813|10065282|FG002|COMPLETED|Washout Period 2 (at Least 3 Days)||3
9002146|NCT02906813|10065280|FG000|NOT COMPLETED|Washout Period 2 (at Least 3 Days)||0
9002147|NCT02906813|10065281|FG001|NOT COMPLETED|Washout Period 2 (at Least 3 Days)||0
9002148|NCT02906813|10065282|FG002|NOT COMPLETED|Washout Period 2 (at Least 3 Days)||0
9002149|NCT02906813|10065280|FG000|STARTED|Intervention Period 3 (3 Days)||3
8634069|NCT00554853|9674370|FG000|COMPLETED|Crossover Arm (3 Months)||53
8634070|NCT00554853|9674371|FG001|COMPLETED|Crossover Arm (3 Months)||55
8880776|NCT01944319|9937882|FG001|STARTED|Overall Study||39
8880777|NCT01944319|9937881|FG000|COMPLETED|Overall Study||40
8880778|NCT01944319|9937882|FG001|COMPLETED|Overall Study||39
8880779|NCT01944319|9937881|FG000|NOT COMPLETED|Overall Study||0
8880780|NCT01944319|9937882|FG001|NOT COMPLETED|Overall Study||0
8880781|NCT01944345|9937889|FG000|STARTED|Overall Study||69
8880782|NCT01944345|9937889|FG000|COMPLETED|Overall Study||69
8880783|NCT01944345|9937889|FG000|NOT COMPLETED|Overall Study||0
8880784|NCT01944371|9937896|FG000|STARTED|Overall Study||10
8880785|NCT01944371|9937897|FG001|STARTED|Overall Study||10
9002150|NCT02906813|10065281|FG001|STARTED|Intervention Period 3 (3 Days)||3
9002151|NCT02906813|10065282|FG002|STARTED|Intervention Period 3 (3 Days)||3
9002152|NCT02906813|10065280|FG000|COMPLETED|Intervention Period 3 (3 Days)||3
9002153|NCT02906813|10065281|FG001|COMPLETED|Intervention Period 3 (3 Days)||3
9002154|NCT02906813|10065282|FG002|COMPLETED|Intervention Period 3 (3 Days)||3
9002155|NCT02906813|10065280|FG000|NOT COMPLETED|Intervention Period 3 (3 Days)||0
9002156|NCT02906813|10065281|FG001|NOT COMPLETED|Intervention Period 3 (3 Days)||0
9002157|NCT02906813|10065282|FG002|NOT COMPLETED|Intervention Period 3 (3 Days)||0
9002158|NCT02906917|10065292|FG000|STARTED|Initiation Period (Week 0-26)||267
9002159|NCT02906917|10065293|FG001|STARTED|Initiation Period (Week 0-26)||265
9002160|NCT02906917|10065292|FG000|Exposed|Initiation Period (Week 0-26)||265
9002161|NCT02906917|10065293|FG001|Exposed|Initiation Period (Week 0-26)||263
9002162|NCT02906917|10065292|FG000|COMPLETED|Initiation Period (Week 0-26)||261
9002163|NCT02906917|10065293|FG001|COMPLETED|Initiation Period (Week 0-26)||254
9002164|NCT02906917|10065292|FG000|NOT COMPLETED|Initiation Period (Week 0-26)||6
9002165|NCT02906917|10065293|FG001|NOT COMPLETED|Initiation Period (Week 0-26)||11
9002166|NCT02906917|10065292|FG000|STARTED|Intensification Period (Week 26-38)||261
9002167|NCT02906917|10065293|FG001|STARTED|Intensification Period (Week 26-38)||254
9002168|NCT02906917|10065292|FG000|COMPLETED|Intensification Period (Week 26-38)||252
9002169|NCT02906917|10065293|FG001|COMPLETED|Intensification Period (Week 26-38)||247
9002170|NCT02906917|10065292|FG000|NOT COMPLETED|Intensification Period (Week 26-38)||9
9002171|NCT02906917|10065293|FG001|NOT COMPLETED|Intensification Period (Week 26-38)||7
8634071|NCT00554853|9674370|FG000|NOT COMPLETED|Crossover Arm (3 Months)||3
8880786|NCT01944371|9937898|FG002|STARTED|Overall Study||10
8880787|NCT01944371|9937896|FG000|COMPLETED|Overall Study||10
8880788|NCT01944371|9937897|FG001|COMPLETED|Overall Study||10
8880789|NCT01944371|9937898|FG002|COMPLETED|Overall Study||10
8880790|NCT01944371|9937896|FG000|NOT COMPLETED|Overall Study||0
8880791|NCT01944371|9937897|FG001|NOT COMPLETED|Overall Study||0
8880792|NCT01944371|9937898|FG002|NOT COMPLETED|Overall Study||0
8880793|NCT01944423|9937908|FG000|STARTED|Overall Study||27
8880794|NCT01944423|9937909|FG001|STARTED|Overall Study||26
8880795|NCT01944423|9937908|FG000|End of Treatment|Overall Study||21
8880796|NCT01944423|9937909|FG001|End of Treatment|Overall Study||20
8880797|NCT01944423|9937908|FG000|1-month Follow-up|Overall Study||22
8880798|NCT01944423|9937909|FG001|1-month Follow-up|Overall Study||19
8880799|NCT01944423|9937908|FG000|4-month Follow-up|Overall Study||19
8880800|NCT01944423|9937909|FG001|4-month Follow-up|Overall Study||16
8880801|NCT01944423|9937908|FG000|COMPLETED|Overall Study|6-month follow-up|19
8880802|NCT01944423|9937909|FG001|COMPLETED|Overall Study|6-month follow-up|17
8880803|NCT01944423|9937908|FG000|NOT COMPLETED|Overall Study||8
8880804|NCT01944423|9937909|FG001|NOT COMPLETED|Overall Study||9
8880805|NCT01944462|9937915|FG000|STARTED|PPPP Educational Program||203
8880806|NCT01944462|9937915|FG000|Baseline|PPPP Educational Program||203
8880807|NCT01944462|9937915|FG000|Post-Test|PPPP Educational Program||187
8880808|NCT01944462|9937915|FG000|3 Month Follow-Up|PPPP Educational Program||143
8880809|NCT01944462|9937915|FG000|COMPLETED|PPPP Educational Program||143
8880810|NCT01944462|9937915|FG000|NOT COMPLETED|PPPP Educational Program||60
8880811|NCT01944462|9937915|FG000|STARTED|Optional Vaccination||20
8880812|NCT01944462|9937915|FG000|COMPLETED|Optional Vaccination||20
8880813|NCT01944462|9937915|FG000|NOT COMPLETED|Optional Vaccination||0
8880814|NCT01944631|9937922|FG000|STARTED|Overall Study||100
8880815|NCT01944631|9937923|FG001|STARTED|Overall Study||100
8880816|NCT01944631|9937922|FG000|COMPLETED|Overall Study||96
9002172|NCT02906930|10065303|FG000|STARTED|Overall Study||175
9002173|NCT02906930|10065304|FG001|STARTED|Overall Study||175
9002174|NCT02906930|10065305|FG002|STARTED|Overall Study||175
9002175|NCT02906930|10065306|FG003|STARTED|Overall Study||178
9002176|NCT02906930|10065303|FG000|Full Analysis Set (FAS)|Overall Study||175
9002177|NCT02906930|10065304|FG001|Full Analysis Set (FAS)|Overall Study||175
9002178|NCT02906930|10065305|FG002|Full Analysis Set (FAS)|Overall Study||175
9002179|NCT02906930|10065306|FG003|Full Analysis Set (FAS)|Overall Study||178
9002180|NCT02906930|10065303|FG000|Safety Analysis Set (SAS)|Overall Study||175
9002181|NCT02906930|10065304|FG001|Safety Analysis Set (SAS)|Overall Study||175
9002182|NCT02906930|10065305|FG002|Safety Analysis Set (SAS)|Overall Study||175
9002183|NCT02906930|10065306|FG003|Safety Analysis Set (SAS)|Overall Study||178
9002184|NCT02906930|10065303|FG000|COMPLETED|Overall Study||169
9002185|NCT02906930|10065304|FG001|COMPLETED|Overall Study||161
9002186|NCT02906930|10065305|FG002|COMPLETED|Overall Study||163
9002187|NCT02906930|10065306|FG003|COMPLETED|Overall Study||170
9002188|NCT02906930|10065303|FG000|NOT COMPLETED|Overall Study||6
9002189|NCT02906930|10065304|FG001|NOT COMPLETED|Overall Study||14
9002190|NCT02906930|10065305|FG002|NOT COMPLETED|Overall Study||12
9002191|NCT02906930|10065306|FG003|NOT COMPLETED|Overall Study||8
9002192|NCT02907073|10065319|FG000|STARTED|Overall Study||8
9002193|NCT02907073|10065320|FG001|STARTED|Overall Study||0
9002194|NCT02907073|10065321|FG002|STARTED|Overall Study||0
9002195|NCT02907073|10065319|FG000|COMPLETED|Overall Study||8
9002196|NCT02907073|10065320|FG001|COMPLETED|Overall Study||0
9002197|NCT02907073|10065321|FG002|COMPLETED|Overall Study||0
8634072|NCT00554853|9674371|FG001|NOT COMPLETED|Crossover Arm (3 Months)||2
8634073|NCT00554970|9674387|FG000|STARTED|Period 1||8
8634074|NCT00554970|9674388|FG001|STARTED|Period 1||8
8634075|NCT00554970|9674389|FG002|STARTED|Period 1||8
8634076|NCT00554970|9674390|FG003|STARTED|Period 1||8
8634077|NCT00554970|9674387|FG000|COMPLETED|Period 1||7
9002198|NCT02907073|10065319|FG000|NOT COMPLETED|Overall Study||0
9002199|NCT02907073|10065320|FG001|NOT COMPLETED|Overall Study||0
9002200|NCT02907073|10065321|FG002|NOT COMPLETED|Overall Study||0
9002201|NCT02907177|10065331|FG000|STARTED|Overall Study||68
9002202|NCT02907177|10065332|FG001|STARTED|Overall Study||68
9002203|NCT02907177|10065331|FG000|Treated|Overall Study||67
9002204|NCT02907177|10065332|FG001|Treated|Overall Study||68
9002205|NCT02907177|10065331|FG000|Randomized Analysis Set|Overall Study||68
9002206|NCT02907177|10065332|FG001|Randomized Analysis Set|Overall Study||68
9002207|NCT02907177|10065331|FG000|COMPLETED|Overall Study||0
9002208|NCT02907177|10065332|FG001|COMPLETED|Overall Study||0
9002209|NCT02907177|10065331|FG000|NOT COMPLETED|Overall Study||68
9002210|NCT02907177|10065332|FG001|NOT COMPLETED|Overall Study||68
9002211|NCT02907216|10065340|FG000|STARTED|Overall Study||147
8880817|NCT01944631|9937923|FG001|COMPLETED|Overall Study||98
8880818|NCT01944631|9937922|FG000|NOT COMPLETED|Overall Study||4
8880819|NCT01944631|9937923|FG001|NOT COMPLETED|Overall Study||2
8880820|NCT01944644|9937931|FG000|STARTED|Overall Study||34
8634078|NCT00554970|9674388|FG001|COMPLETED|Period 1||8
8634079|NCT00554970|9674389|FG002|COMPLETED|Period 1||8
8634080|NCT00554970|9674390|FG003|COMPLETED|Period 1||8
8880821|NCT01944644|9937932|FG001|STARTED|Overall Study||32
8880822|NCT01944644|9937931|FG000|COMPLETED|Overall Study||34
8880823|NCT01944644|9937932|FG001|COMPLETED|Overall Study||32
8880824|NCT01944644|9937931|FG000|NOT COMPLETED|Overall Study||0
8880825|NCT01944644|9937932|FG001|NOT COMPLETED|Overall Study||0
8880826|NCT01944670|9937938|FG000|STARTED|Overall Study||26
8880827|NCT01944670|9937938|FG000|COMPLETED|Overall Study||24
8880828|NCT01944670|9937938|FG000|NOT COMPLETED|Overall Study||2
8880829|NCT01944722|9937944|FG000|STARTED|Overall Study||33858
8880830|NCT01944722|9937944|FG000|COMPLETED|Overall Study||24343
8880831|NCT01944722|9937944|FG000|NOT COMPLETED|Overall Study||9515
8880832|NCT01944774|9937956|FG000|STARTED|Overall Study||69
8880833|NCT01944774|9937957|FG001|STARTED|Overall Study||68
8880834|NCT01944774|9937958|FG002|STARTED|Overall Study||70
8880835|NCT01944774|9937956|FG000|Received Treatment|Overall Study||68
8880836|NCT01944774|9937957|FG001|Received Treatment|Overall Study||67
8880837|NCT01944774|9937958|FG002|Received Treatment|Overall Study||70
8880838|NCT01944774|9937956|FG000|COMPLETED|Overall Study||63
8880839|NCT01944774|9937957|FG001|COMPLETED|Overall Study||60
8880840|NCT01944774|9937958|FG002|COMPLETED|Overall Study||62
8880841|NCT01944774|9937956|FG000|NOT COMPLETED|Overall Study||6
8880842|NCT01944774|9937957|FG001|NOT COMPLETED|Overall Study||8
8880843|NCT01944774|9937958|FG002|NOT COMPLETED|Overall Study||8
8880844|NCT01944839|9937971|FG000|STARTED|Overall Study||309
8880845|NCT01944839|9937972|FG001|STARTED|Overall Study||310
8880846|NCT01944839|9937971|FG000|COMPLETED|Overall Study||287
8880847|NCT01944839|9937972|FG001|COMPLETED|Overall Study||282
8880848|NCT01944839|9937971|FG000|NOT COMPLETED|Overall Study||22
8880849|NCT01944839|9937972|FG001|NOT COMPLETED|Overall Study||28
8880850|NCT01944878|9937980|FG000|STARTED|Overall Study||127
8880851|NCT01944878|9937981|FG001|STARTED|Overall Study||328
8880852|NCT01944878|9937980|FG000|COMPLETED|Overall Study||127
8880853|NCT01944878|9937981|FG001|COMPLETED|Overall Study||328
8880854|NCT01944878|9937980|FG000|NOT COMPLETED|Overall Study||0
8880855|NCT01944878|9937981|FG001|NOT COMPLETED|Overall Study||0
8880856|NCT01944930|9937991|FG000|STARTED|Overall Study||12
8880857|NCT01944930|9937992|FG001|STARTED|Overall Study||11
8880858|NCT01944930|9937991|FG000|COMPLETED|Overall Study||10
8880859|NCT01944930|9937992|FG001|COMPLETED|Overall Study||10
8880860|NCT01944930|9937991|FG000|NOT COMPLETED|Overall Study||2
8880861|NCT01944930|9937992|FG001|NOT COMPLETED|Overall Study||1
8880862|NCT01944969|9937998|FG000|STARTED|Overall Study||26
8880863|NCT01944969|9937998|FG000|COMPLETED|Overall Study||0
8880864|NCT01944969|9937998|FG000|NOT COMPLETED|Overall Study||26
8880865|NCT01945034|9938007|FG000|STARTED|Overall Study||67
8880866|NCT01945034|9938008|FG001|STARTED|Overall Study||85
8634081|NCT00554970|9674387|FG000|NOT COMPLETED|Period 1||1
8634082|NCT00554970|9674388|FG001|NOT COMPLETED|Period 1||0
8634083|NCT00554970|9674389|FG002|NOT COMPLETED|Period 1||0
8634084|NCT00554970|9674390|FG003|NOT COMPLETED|Period 1||0
8880867|NCT01945034|9938009|FG002|STARTED|Overall Study||152
8880868|NCT01945034|9938007|FG000|COMPLETED|Overall Study||66
8880869|NCT01945034|9938008|FG001|COMPLETED|Overall Study||80
8880870|NCT01945034|9938009|FG002|COMPLETED|Overall Study||145
8880871|NCT01945034|9938007|FG000|NOT COMPLETED|Overall Study||1
8880872|NCT01945034|9938008|FG001|NOT COMPLETED|Overall Study||5
8880873|NCT01945034|9938009|FG002|NOT COMPLETED|Overall Study||7
8880874|NCT01945086|9938020|FG000|STARTED|Overall Study||27
8880875|NCT01945086|9938021|FG001|STARTED|Overall Study||24
8880876|NCT01945086|9938022|FG002|STARTED|Overall Study||28
9002212|NCT02907216|10065341|FG001|STARTED|Overall Study||145
9002213|NCT02907216|10065340|FG000|COMPLETED|Overall Study||146
9002214|NCT02907216|10065341|FG001|COMPLETED|Overall Study||144
9002215|NCT02907216|10065340|FG000|NOT COMPLETED|Overall Study||1
9002216|NCT02907216|10065341|FG001|NOT COMPLETED|Overall Study||1
9002217|NCT02907268|10065349|FG000|STARTED|Overall Study||5
9002218|NCT02907268|10065350|FG001|STARTED|Overall Study||5
9002219|NCT02907268|10065349|FG000|COMPLETED|Overall Study||5
9002220|NCT02907268|10065350|FG001|COMPLETED|Overall Study||5
9002221|NCT02907268|10065349|FG000|NOT COMPLETED|Overall Study||0
9002222|NCT02907268|10065350|FG001|NOT COMPLETED|Overall Study||0
9002223|NCT02907463|10065355|FG000|STARTED|Overall Study||280
9002224|NCT02907463|10065355|FG000|Enrolled Cohort|Overall Study||280
9002225|NCT02907463|10065355|FG000|Per Protocol Cohort|Overall Study||276
9002226|NCT02907463|10065355|FG000|COMPLETED|Overall Study||243
8880877|NCT01945086|9938020|FG000|COMPLETED|Overall Study||26
8880878|NCT01945086|9938021|FG001|COMPLETED|Overall Study||24
8880879|NCT01945086|9938022|FG002|COMPLETED|Overall Study||26
8880880|NCT01945086|9938020|FG000|NOT COMPLETED|Overall Study||1
8880881|NCT01945086|9938021|FG001|NOT COMPLETED|Overall Study||0
8880882|NCT01945086|9938022|FG002|NOT COMPLETED|Overall Study||2
9002227|NCT02907463|10065355|FG000|NOT COMPLETED|Overall Study||37
9002228|NCT02907489|10065369|FG000|STARTED|Overall Study||42
9002229|NCT02907489|10065370|FG001|STARTED|Overall Study||42
9002230|NCT02907489|10065369|FG000|COMPLETED|Overall Study||40
8634085|NCT00554970|9674387|FG000|STARTED|Period 2||7
9002231|NCT02907489|10065370|FG001|COMPLETED|Overall Study||41
9002232|NCT02907489|10065369|FG000|NOT COMPLETED|Overall Study||2
9002233|NCT02907489|10065370|FG001|NOT COMPLETED|Overall Study||1
9002234|NCT02907619|10065379|FG000|STARTED|Overall Study||19
9002235|NCT02907619|10065380|FG001|STARTED|Overall Study||20
9002236|NCT02907619|10065381|FG002|STARTED|Overall Study||20
9002237|NCT02907619|10065379|FG000|Received Treatment|Overall Study||19
9002238|NCT02907619|10065380|FG001|Received Treatment|Overall Study||20
8880883|NCT01945112|9938030|FG000|STARTED|Overall Study|total number of sites where tape was applied|77
8880884|NCT01945112|9938031|FG001|STARTED|Overall Study|total number of sites where tape was applied|51
8880885|NCT01945112|9938030|FG000|COMPLETED|Overall Study||77
8880886|NCT01945112|9938031|FG001|COMPLETED|Overall Study||51
8880887|NCT01945112|9938030|FG000|NOT COMPLETED|Overall Study||0
8880888|NCT01945112|9938031|FG001|NOT COMPLETED|Overall Study||0
8880889|NCT01945138|9938038|FG000|STARTED|Overall Study||7
8880890|NCT01945138|9938039|FG001|STARTED|Overall Study||7
8880891|NCT01945138|9938038|FG000|COMPLETED|Overall Study||7
9002239|NCT02907619|10065381|FG002|Received Treatment|Overall Study||20
9002240|NCT02907619|10065379|FG000|COMPLETED|Overall Study||0
9002241|NCT02907619|10065380|FG001|COMPLETED|Overall Study||0
9002242|NCT02907619|10065381|FG002|COMPLETED|Overall Study||0
9002243|NCT02907619|10065379|FG000|NOT COMPLETED|Overall Study||19
9002244|NCT02907619|10065380|FG001|NOT COMPLETED|Overall Study||20
9002245|NCT02907619|10065381|FG002|NOT COMPLETED|Overall Study||20
9002246|NCT02907814|10065393|FG000|STARTED|Overall Study||6
9002247|NCT02907814|10065394|FG001|STARTED|Overall Study||0
9002248|NCT02907814|10065393|FG000|COMPLETED|Overall Study||0
9002249|NCT02907814|10065394|FG001|COMPLETED|Overall Study||0
9002250|NCT02907814|10065393|FG000|NOT COMPLETED|Overall Study||6
9002251|NCT02907814|10065394|FG001|NOT COMPLETED|Overall Study||0
9002252|NCT02907892|10065402|FG000|STARTED|Overall Study||277
9002253|NCT02907892|10065403|FG001|STARTED|Overall Study||276
9002254|NCT02907892|10065402|FG000|COMPLETED|Overall Study||250
9002255|NCT02907892|10065403|FG001|COMPLETED|Overall Study||236
9002256|NCT02907892|10065402|FG000|NOT COMPLETED|Overall Study||27
9002257|NCT02907892|10065403|FG001|NOT COMPLETED|Overall Study||40
9002258|NCT02907918|10065409|FG000|STARTED|Overall Study||26
9002259|NCT02907918|10065409|FG000|COMPLETED|Overall Study||26
9002260|NCT02907918|10065409|FG000|NOT COMPLETED|Overall Study||0
9002261|NCT02908100|10065419|FG000|STARTED|Overall Study||86
9002262|NCT02908100|10065420|FG001|STARTED|Overall Study||87
9002263|NCT02908100|10065421|FG002|STARTED|Overall Study||87
9002264|NCT02908100|10065419|FG000|COMPLETED|Overall Study||63
9002265|NCT02908100|10065420|FG001|COMPLETED|Overall Study||66
9002266|NCT02908100|10065421|FG002|COMPLETED|Overall Study||66
9002267|NCT02908100|10065419|FG000|NOT COMPLETED|Overall Study||23
9002268|NCT02908100|10065420|FG001|NOT COMPLETED|Overall Study||21
9002269|NCT02908100|10065421|FG002|NOT COMPLETED|Overall Study||21
9002270|NCT02908178|10065435|FG000|STARTED|Overall Study|The sample prior to Mahalanobis matching.|2409
9002271|NCT02908178|10065436|FG001|STARTED|Overall Study|The sample prior to Mahalanobis matching.|13106
9002272|NCT02908178|10065437|FG002|STARTED|Overall Study|The sample prior to Mahalanobis matching.|1992
8880892|NCT01945138|9938039|FG001|COMPLETED|Overall Study||7
8880893|NCT01945138|9938038|FG000|NOT COMPLETED|Overall Study||0
8880894|NCT01945138|9938039|FG001|NOT COMPLETED|Overall Study||0
8880895|NCT01945216|9938048|FG000|STARTED|Overall Study||3317
8880896|NCT01945216|9938048|FG000|COMPLETED|Overall Study||3218
8880897|NCT01945216|9938048|FG000|NOT COMPLETED|Overall Study||99
8880898|NCT01945242|9938058|FG000|STARTED|Overall Study||1251
8880899|NCT01945242|9938059|FG001|STARTED|Overall Study||123
8880900|NCT01945242|9938058|FG000|COMPLETED|Overall Study||1248
8880901|NCT01945242|9938059|FG001|COMPLETED|Overall Study||120
8880902|NCT01945242|9938058|FG000|NOT COMPLETED|Overall Study||3
8880903|NCT01945242|9938059|FG001|NOT COMPLETED|Overall Study||3
8880904|NCT01945281|9938068|FG000|STARTED|Overall Study||34
8880905|NCT01945281|9938069|FG001|STARTED|Overall Study||17
8880906|NCT01945281|9938068|FG000|Treated|Overall Study||33
8880907|NCT01945281|9938069|FG001|Treated|Overall Study||16
8880908|NCT01945281|9938068|FG000|COMPLETED|Overall Study||28
8880909|NCT01945281|9938069|FG001|COMPLETED|Overall Study||13
8880910|NCT01945281|9938068|FG000|NOT COMPLETED|Overall Study||6
8880911|NCT01945281|9938069|FG001|NOT COMPLETED|Overall Study||4
8880912|NCT01945294|9938078|FG000|STARTED|Period 1: 12-Week PR + BOC Lead-In||257
8880913|NCT01945294|9938079|FG001|STARTED|Period 1: 12-Week PR + BOC Lead-In||0
8880914|NCT01945294|9938080|FG002|STARTED|Period 1: 12-Week PR + BOC Lead-In||0
8880915|NCT01945294|9938081|FG003|STARTED|Period 1: 12-Week PR + BOC Lead-In||0
8880916|NCT01945294|9938078|FG000|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||236
8880917|NCT01945294|9938079|FG001|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
8880918|NCT01945294|9938080|FG002|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
8880919|NCT01945294|9938081|FG003|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
8880920|NCT01945294|9938078|FG000|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||21
8880921|NCT01945294|9938079|FG001|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
8880922|NCT01945294|9938080|FG002|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
8880923|NCT01945294|9938081|FG003|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
8880924|NCT01945294|9938078|FG000|STARTED|Period 2: BOC+ PR Treatment & Follow-up|Participants were assigned to 1 of the 3 arms after upon the 12-week BOC + PR lead-in.|0
8880925|NCT01945294|9938079|FG001|STARTED|Period 2: BOC+ PR Treatment & Follow-up||102
9002273|NCT02908178|10065438|FG003|STARTED|Overall Study|The sample prior to Mahalanobis matching.|10784
9002274|NCT02908178|10065435|FG000|COMPLETED|Overall Study|The sample after Mahalanobis matching; that is, the number in the main analyses.|2409
9002275|NCT02908178|10065436|FG001|COMPLETED|Overall Study|The sample after Mahalanobis matching; that is, the number in the main analyses.|4718
9002276|NCT02908178|10065437|FG002|COMPLETED|Overall Study|The sample after Mahalanobis matching; that is, the number in the main analyses.|1992
8880926|NCT01945294|9938080|FG002|STARTED|Period 2: BOC+ PR Treatment & Follow-up||105
8880927|NCT01945294|9938081|FG003|STARTED|Period 2: BOC+ PR Treatment & Follow-up||29
8880928|NCT01945294|9938078|FG000|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||0
8880929|NCT01945294|9938079|FG001|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||97
8880930|NCT01945294|9938080|FG002|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||97
8880931|NCT01945294|9938081|FG003|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||23
8880932|NCT01945294|9938078|FG000|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||0
8880933|NCT01945294|9938079|FG001|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||5
8880934|NCT01945294|9938080|FG002|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||8
8880935|NCT01945294|9938081|FG003|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||6
8880936|NCT01945489|9938092|FG000|STARTED|Cycle 1||129
8880937|NCT01945489|9938093|FG001|STARTED|Cycle 1||125
8880938|NCT01945489|9938092|FG000|COMPLETED|Cycle 1||116
8880939|NCT01945489|9938093|FG001|COMPLETED|Cycle 1||121
8880940|NCT01945489|9938092|FG000|NOT COMPLETED|Cycle 1||13
8880941|NCT01945489|9938093|FG001|NOT COMPLETED|Cycle 1||4
8880942|NCT01945489|9938092|FG000|STARTED|Cycle 2|Not all participants participated in Cycle 2.|88
8880943|NCT01945489|9938093|FG001|STARTED|Cycle 2||107
8880944|NCT01945489|9938092|FG000|COMPLETED|Cycle 2||87
8880945|NCT01945489|9938093|FG001|COMPLETED|Cycle 2||106
8880946|NCT01945489|9938092|FG000|NOT COMPLETED|Cycle 2||1
8880947|NCT01945489|9938093|FG001|NOT COMPLETED|Cycle 2||1
8880948|NCT01945580|9938102|FG000|STARTED|Overall Study||228
8880949|NCT01945580|9938103|FG001|STARTED|Overall Study||485
8880950|NCT01945580|9938102|FG000|COMPLETED|Overall Study||176
8880951|NCT01945580|9938103|FG001|COMPLETED|Overall Study||401
8880952|NCT01945580|9938102|FG000|NOT COMPLETED|Overall Study||52
8880953|NCT01945580|9938103|FG001|NOT COMPLETED|Overall Study||84
8880954|NCT01945593|9938117|FG000|STARTED|Overall Study||3
8880955|NCT01945593|9938118|FG001|STARTED|Overall Study||64
8880956|NCT01945593|9938119|FG002|STARTED|Overall Study||26
8880957|NCT01945593|9938120|FG003|STARTED|Overall Study||125
8880958|NCT01945593|9938117|FG000|COMPLETED|Overall Study||3
8880959|NCT01945593|9938118|FG001|COMPLETED|Overall Study||56
8880960|NCT01945593|9938119|FG002|COMPLETED|Overall Study||23
8880961|NCT01945593|9938120|FG003|COMPLETED|Overall Study||105
8880962|NCT01945593|9938117|FG000|NOT COMPLETED|Overall Study||0
8880963|NCT01945593|9938118|FG001|NOT COMPLETED|Overall Study||8
8880964|NCT01945593|9938119|FG002|NOT COMPLETED|Overall Study||3
8880965|NCT01945593|9938120|FG003|NOT COMPLETED|Overall Study||20
8880966|NCT01945710|9938142|FG000|STARTED|Overall Study||7
8880967|NCT01945710|9938143|FG001|STARTED|Overall Study||6
8880968|NCT01945710|9938144|FG002|STARTED|Overall Study||7
8880969|NCT01945710|9938145|FG003|STARTED|Overall Study||3
8880970|NCT01945710|9938146|FG004|STARTED|Overall Study||9
8880971|NCT01945710|9938147|FG005|STARTED|Overall Study||3
8880972|NCT01945710|9938148|FG006|STARTED|Overall Study||23
8880973|NCT01945710|9938142|FG000|COMPLETED|Overall Study||0
8880974|NCT01945710|9938143|FG001|COMPLETED|Overall Study||0
8880975|NCT01945710|9938144|FG002|COMPLETED|Overall Study||0
8880976|NCT01945710|9938145|FG003|COMPLETED|Overall Study||0
8880977|NCT01945710|9938146|FG004|COMPLETED|Overall Study||0
8880978|NCT01945710|9938147|FG005|COMPLETED|Overall Study||0
8880979|NCT01945710|9938148|FG006|COMPLETED|Overall Study||0
8880980|NCT01945710|9938142|FG000|NOT COMPLETED|Overall Study||7
8880981|NCT01945710|9938143|FG001|NOT COMPLETED|Overall Study||6
8880982|NCT01945710|9938144|FG002|NOT COMPLETED|Overall Study||7
8880983|NCT01945710|9938145|FG003|NOT COMPLETED|Overall Study||3
8880984|NCT01945710|9938146|FG004|NOT COMPLETED|Overall Study||9
8880985|NCT01945710|9938147|FG005|NOT COMPLETED|Overall Study||3
8880986|NCT01945710|9938148|FG006|NOT COMPLETED|Overall Study||23
8880987|NCT01945866|9938168|FG000|STARTED|Overall Study||65
9002277|NCT02908178|10065438|FG003|COMPLETED|Overall Study|The sample after Mahalanobis matching; that is, the number in the main analyses.|3965
9002278|NCT02908178|10065435|FG000|NOT COMPLETED|Overall Study||0
9002279|NCT02908178|10065436|FG001|NOT COMPLETED|Overall Study||8388
8634086|NCT00554970|9674388|FG001|STARTED|Period 2||8
8634087|NCT00554970|9674389|FG002|STARTED|Period 2||8
8880988|NCT01945866|9938169|FG001|STARTED|Overall Study||64
8880989|NCT01945866|9938168|FG000|COMPLETED|Overall Study||63
8880990|NCT01945866|9938169|FG001|COMPLETED|Overall Study||64
8880991|NCT01945866|9938168|FG000|NOT COMPLETED|Overall Study||2
8880992|NCT01945866|9938169|FG001|NOT COMPLETED|Overall Study||0
8880993|NCT01945944|9938178|FG000|STARTED|Overall Study||9
8880994|NCT01945944|9938179|FG001|STARTED|Overall Study||9
8880995|NCT01945944|9938178|FG000|COMPLETED|Overall Study||8
8880996|NCT01945944|9938179|FG001|COMPLETED|Overall Study||6
8880997|NCT01945944|9938178|FG000|NOT COMPLETED|Overall Study||1
8880998|NCT01945944|9938179|FG001|NOT COMPLETED|Overall Study||3
8880999|NCT01945970|9938187|FG000|STARTED|Overall Study||5
8881000|NCT01945970|9938188|FG001|STARTED|Overall Study||5
8881001|NCT01945970|9938189|FG002|STARTED|Overall Study||5
8881002|NCT01945970|9938190|FG003|STARTED|Overall Study||5
8881003|NCT01945970|9938191|FG004|STARTED|Overall Study||5
8881004|NCT01945970|9938192|FG005|STARTED|Overall Study||5
8881005|NCT01945970|9938187|FG000|COMPLETED|Overall Study||5
8881006|NCT01945970|9938188|FG001|COMPLETED|Overall Study||5
8881007|NCT01945970|9938189|FG002|COMPLETED|Overall Study||5
8881008|NCT01945970|9938190|FG003|COMPLETED|Overall Study||5
8881009|NCT01945970|9938191|FG004|COMPLETED|Overall Study||5
8881010|NCT01945970|9938192|FG005|COMPLETED|Overall Study||5
8634088|NCT00554970|9674390|FG003|STARTED|Period 2||8
8881011|NCT01945970|9938187|FG000|NOT COMPLETED|Overall Study||0
8881012|NCT01945970|9938188|FG001|NOT COMPLETED|Overall Study||0
8881013|NCT01945970|9938189|FG002|NOT COMPLETED|Overall Study||0
8881014|NCT01945970|9938190|FG003|NOT COMPLETED|Overall Study||0
8881015|NCT01945970|9938191|FG004|NOT COMPLETED|Overall Study||0
8881016|NCT01945970|9938192|FG005|NOT COMPLETED|Overall Study||0
8881017|NCT01945996|9938204|FG000|STARTED|Overall Study||22
8881018|NCT01945996|9938205|FG001|STARTED|Overall Study||22
8881019|NCT01945996|9938204|FG000|COMPLETED|Overall Study||19
8881020|NCT01945996|9938205|FG001|COMPLETED|Overall Study||17
8881021|NCT01945996|9938204|FG000|NOT COMPLETED|Overall Study||3
9002280|NCT02908178|10065437|FG002|NOT COMPLETED|Overall Study||0
9002281|NCT02908178|10065438|FG003|NOT COMPLETED|Overall Study||6819
9002282|NCT02908347|10065449|FG000|STARTED|Overall Study||23
9002283|NCT02908347|10065450|FG001|STARTED|Overall Study||23
9002284|NCT02908347|10065449|FG000|COMPLETED|Overall Study||22
9002285|NCT02908347|10065450|FG001|COMPLETED|Overall Study||22
9002286|NCT02908347|10065449|FG000|NOT COMPLETED|Overall Study||1
9002287|NCT02908347|10065450|FG001|NOT COMPLETED|Overall Study||1
9002288|NCT02908464|10065472|FG000|STARTED|Overall Study||22
9002289|NCT02908464|10065473|FG001|STARTED|Overall Study||23
9002290|NCT02908464|10065472|FG000|COMPLETED|Overall Study||20
9002291|NCT02908464|10065473|FG001|COMPLETED|Overall Study||20
9002292|NCT02908464|10065472|FG000|NOT COMPLETED|Overall Study||2
9002293|NCT02908464|10065473|FG001|NOT COMPLETED|Overall Study||3
9002294|NCT02908490|10065482|FG000|STARTED|Overall Study||12
9002295|NCT02908490|10065483|FG001|STARTED|Overall Study||13
9002296|NCT02908490|10065482|FG000|COMPLETED|Overall Study||10
9002297|NCT02908490|10065483|FG001|COMPLETED|Overall Study||11
9002298|NCT02908490|10065482|FG000|NOT COMPLETED|Overall Study||2
9002299|NCT02908490|10065483|FG001|NOT COMPLETED|Overall Study||2
9002300|NCT02908529|10065489|FG000|STARTED|Overall Study||10
9002301|NCT02908529|10065490|FG001|STARTED|Overall Study||12
9002302|NCT02908529|10065489|FG000|COMPLETED|Overall Study||10
9002303|NCT02908529|10065490|FG001|COMPLETED|Overall Study||10
9002304|NCT02908529|10065489|FG000|NOT COMPLETED|Overall Study||0
9002305|NCT02908529|10065490|FG001|NOT COMPLETED|Overall Study||2
9002306|NCT02908620|10065502|FG000|STARTED|Overall Study||10
9002307|NCT02908620|10065503|FG001|STARTED|Overall Study||10
9002308|NCT02908620|10065504|FG002|STARTED|Overall Study||10
9002309|NCT02908620|10065505|FG003|STARTED|Overall Study||10
9002310|NCT02908620|10065502|FG000|COMPLETED|Overall Study||10
9002311|NCT02908620|10065503|FG001|COMPLETED|Overall Study||10
9002312|NCT02908620|10065504|FG002|COMPLETED|Overall Study||10
9002313|NCT02908620|10065505|FG003|COMPLETED|Overall Study||10
9002314|NCT02908620|10065502|FG000|NOT COMPLETED|Overall Study||0
9002315|NCT02908620|10065503|FG001|NOT COMPLETED|Overall Study||0
9002316|NCT02908620|10065504|FG002|NOT COMPLETED|Overall Study||0
9002317|NCT02908620|10065505|FG003|NOT COMPLETED|Overall Study||0
9002318|NCT02908841|10065521|FG000|STARTED|Overall Study||10
9002319|NCT02908841|10065522|FG001|STARTED|Overall Study||12
9002320|NCT02908841|10065521|FG000|COMPLETED|Overall Study||6
9002321|NCT02908841|10065522|FG001|COMPLETED|Overall Study||12
9002322|NCT02908841|10065521|FG000|NOT COMPLETED|Overall Study||4
9002323|NCT02908841|10065522|FG001|NOT COMPLETED|Overall Study||0
9002324|NCT02908880|10065528|FG000|STARTED|Overall Study|Subjects within the Primary Analysis Cohort that received the MANTA Device|263
9002325|NCT02908880|10065528|FG000|COMPLETED|Overall Study|Subjects within the Primary Analysis Cohort that completed all follow-up time points.|236
9002326|NCT02908880|10065528|FG000|NOT COMPLETED|Overall Study||27
9002327|NCT02909101|10065534|FG000|STARTED|Overall Study||29
9002328|NCT02909101|10065535|FG001|STARTED|Overall Study||29
9002329|NCT02909101|10065534|FG000|COMPLETED|Overall Study||28
9002330|NCT02909101|10065535|FG001|COMPLETED|Overall Study||28
9002331|NCT02909101|10065534|FG000|NOT COMPLETED|Overall Study||1
9002332|NCT02909101|10065535|FG001|NOT COMPLETED|Overall Study||1
9002333|NCT02909140|10065544|FG000|STARTED|Overall Study||0
9002334|NCT02909140|10065545|FG001|STARTED|Overall Study||2
9002335|NCT02909140|10065546|FG002|STARTED|Overall Study||0
9002336|NCT02909140|10065544|FG000|COMPLETED|Overall Study||0
9002337|NCT02909140|10065545|FG001|COMPLETED|Overall Study||2
9002338|NCT02909140|10065546|FG002|COMPLETED|Overall Study||0
9002339|NCT02909140|10065544|FG000|NOT COMPLETED|Overall Study||0
9002340|NCT02909140|10065545|FG001|NOT COMPLETED|Overall Study||0
9002341|NCT02909140|10065546|FG002|NOT COMPLETED|Overall Study||0
9002342|NCT02909153|10065559|FG000|STARTED|Overall Study||6
9002343|NCT02909153|10065560|FG001|STARTED|Overall Study||6
9002344|NCT02909153|10065561|FG002|STARTED|Overall Study||6
9002345|NCT02909153|10065562|FG003|STARTED|Overall Study||6
9002346|NCT02909153|10065563|FG004|STARTED|Overall Study||6
9002347|NCT02909153|10065559|FG000|Triferic in Dianeal PD Solution|Overall Study||6
9002348|NCT02909153|10065560|FG001|Triferic in Dianeal PD Solution|Overall Study||6
9002349|NCT02909153|10065561|FG002|Triferic in Dianeal PD Solution|Overall Study||6
9002350|NCT02909153|10065562|FG003|Triferic in Dianeal PD Solution|Overall Study||0
9002351|NCT02909153|10065563|FG004|Triferic in Dianeal PD Solution|Overall Study||0
9002352|NCT02909153|10065559|FG000|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||6
9002353|NCT02909153|10065560|FG001|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||5
9002354|NCT02909153|10065561|FG002|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||6
9002355|NCT02909153|10065562|FG003|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||6
8881022|NCT01945996|9938205|FG001|NOT COMPLETED|Overall Study||5
8881023|NCT01946126|9938215|FG000|STARTED|Overall Study||184
8881024|NCT01946126|9938216|FG001|STARTED|Overall Study||275
8881025|NCT01946126|9938215|FG000|COMPLETED|Overall Study||184
8881026|NCT01946126|9938216|FG001|COMPLETED|Overall Study||275
8881027|NCT01946126|9938215|FG000|NOT COMPLETED|Overall Study||0
8881028|NCT01946126|9938216|FG001|NOT COMPLETED|Overall Study||0
8881029|NCT01946152|9938226|FG000|STARTED|Overall Study||3
8881030|NCT01946152|9938227|FG001|STARTED|Overall Study||3
8881031|NCT01946152|9938228|FG002|STARTED|Overall Study||6
8881032|NCT01946152|9938229|FG003|STARTED|Overall Study||8
8881033|NCT01946152|9938226|FG000|COMPLETED|Overall Study||2
8881034|NCT01946152|9938227|FG001|COMPLETED|Overall Study||0
8881035|NCT01946152|9938228|FG002|COMPLETED|Overall Study||0
8881036|NCT01946152|9938229|FG003|COMPLETED|Overall Study||0
8881037|NCT01946152|9938226|FG000|NOT COMPLETED|Overall Study||1
8881038|NCT01946152|9938227|FG001|NOT COMPLETED|Overall Study||3
8881039|NCT01946152|9938228|FG002|NOT COMPLETED|Overall Study||6
8881040|NCT01946152|9938229|FG003|NOT COMPLETED|Overall Study||8
8881041|NCT01946165|9938243|FG000|STARTED|Overall Study||45
8881042|NCT01946165|9938244|FG001|STARTED|Overall Study||23
8881043|NCT01946165|9938243|FG000|COMPLETED|Overall Study||43
8881044|NCT01946165|9938244|FG001|COMPLETED|Overall Study||21
8881045|NCT01946165|9938243|FG000|NOT COMPLETED|Overall Study||2
8881046|NCT01946165|9938244|FG001|NOT COMPLETED|Overall Study||2
8881047|NCT01946178|9938251|FG000|STARTED|Overall Study||73
8881048|NCT01946178|9938251|FG000|COMPLETED|Overall Study||71
8881049|NCT01946178|9938251|FG000|NOT COMPLETED|Overall Study||2
8881050|NCT01946191|9938261|FG000|STARTED|Allocation||98
8881051|NCT01946191|9938262|FG001|STARTED|Allocation||96
8881052|NCT01946191|9938261|FG000|COMPLETED|Allocation||97
8881053|NCT01946191|9938262|FG001|COMPLETED|Allocation||95
8881054|NCT01946191|9938261|FG000|NOT COMPLETED|Allocation||1
8881055|NCT01946191|9938262|FG001|NOT COMPLETED|Allocation||1
8881056|NCT01946191|9938261|FG000|STARTED|Follow-Up, 24-mo Endpoint||97
8881057|NCT01946191|9938262|FG001|STARTED|Follow-Up, 24-mo Endpoint||95
8881058|NCT01946191|9938261|FG000|COMPLETED|Follow-Up, 24-mo Endpoint||80
8881059|NCT01946191|9938262|FG001|COMPLETED|Follow-Up, 24-mo Endpoint||77
8881060|NCT01946191|9938261|FG000|NOT COMPLETED|Follow-Up, 24-mo Endpoint||17
8881061|NCT01946191|9938262|FG001|NOT COMPLETED|Follow-Up, 24-mo Endpoint||18
8881062|NCT01946191|9938261|FG000|STARTED|Primary Outcome Analysis||98
8881063|NCT01946191|9938262|FG001|STARTED|Primary Outcome Analysis||95
8881064|NCT01946191|9938261|FG000|COMPLETED|Primary Outcome Analysis|Weight data at 24 months|80
8881065|NCT01946191|9938262|FG001|COMPLETED|Primary Outcome Analysis|Weight data at 24 months|77
8881066|NCT01946191|9938261|FG000|NOT COMPLETED|Primary Outcome Analysis||18
8881067|NCT01946191|9938262|FG001|NOT COMPLETED|Primary Outcome Analysis||18
8881068|NCT01946243|9938269|FG000|STARTED|Overall Study||96
8881069|NCT01946243|9938269|FG000|COMPLETED|Overall Study||96
8881070|NCT01946243|9938269|FG000|NOT COMPLETED|Overall Study||0
8881071|NCT01946282|9938278|FG000|STARTED|Year 1||6565
8881072|NCT01946282|9938279|FG001|STARTED|Year 1||1000
8881073|NCT01946282|9938280|FG002|STARTED|Year 1||1000
8881074|NCT01946282|9938278|FG000|COMPLETED|Year 1||2379
8881075|NCT01946282|9938279|FG001|COMPLETED|Year 1||392
8881076|NCT01946282|9938280|FG002|COMPLETED|Year 1||346
8881077|NCT01946282|9938278|FG000|NOT COMPLETED|Year 1||4186
8881078|NCT01946282|9938279|FG001|NOT COMPLETED|Year 1||608
8881079|NCT01946282|9938280|FG002|NOT COMPLETED|Year 1||654
8881080|NCT01946282|9938278|FG000|STARTED|Year 2|Patients are those with Year 1 negative FIT results, or no longer met inclusion criteria.|2051
8881081|NCT01946282|9938279|FG001|STARTED|Year 2|Patients are those with Year 1 negative FIT results, or no longer met inclusion criteria.|341
8881082|NCT01946282|9938280|FG002|STARTED|Year 2|Patients are those with Year 1 negative FIT results, or no longer met inclusion criteria.|299
8881083|NCT01946282|9938278|FG000|COMPLETED|Year 2||1248
8881084|NCT01946282|9938279|FG001|COMPLETED|Year 2||210
8881085|NCT01946282|9938280|FG002|COMPLETED|Year 2||184
8881086|NCT01946282|9938278|FG000|NOT COMPLETED|Year 2||803
8881087|NCT01946282|9938279|FG001|NOT COMPLETED|Year 2||131
8881088|NCT01946282|9938280|FG002|NOT COMPLETED|Year 2||115
8881089|NCT01946282|9938278|FG000|STARTED|Year 3|Patients are those with Year 2 negative FIT results, or no longer met inclusion criteria.|1144
8881090|NCT01946282|9938279|FG001|STARTED|Year 3|Patients are those with Year 2 negative FIT results, or no longer met inclusion criteria.|184
8881091|NCT01946282|9938280|FG002|STARTED|Year 3|Patients are those with Year 2 negative FIT results, or no longer met inclusion criteria.|170
8881092|NCT01946282|9938278|FG000|COMPLETED|Year 3||856
8881093|NCT01946282|9938279|FG001|COMPLETED|Year 3||141
8881094|NCT01946282|9938280|FG002|COMPLETED|Year 3||140
8881095|NCT01946282|9938278|FG000|NOT COMPLETED|Year 3||288
8881096|NCT01946282|9938279|FG001|NOT COMPLETED|Year 3||43
8881097|NCT01946282|9938280|FG002|NOT COMPLETED|Year 3||30
8881098|NCT01946412|9938290|FG000|STARTED|Overall Study||33
8881099|NCT01946412|9938290|FG000|COMPLETED|Overall Study||28
8881100|NCT01946412|9938290|FG000|NOT COMPLETED|Overall Study||5
8881101|NCT01946425|9938298|FG000|STARTED|Overall Study||30
8881102|NCT01946425|9938299|FG001|STARTED|Overall Study||30
8881103|NCT01946425|9938298|FG000|COMPLETED|Overall Study||28
8881104|NCT01946425|9938299|FG001|COMPLETED|Overall Study||30
9039412|NCT03338569|10100376|FG000|NOT COMPLETED|Overall Study||8
8881105|NCT01946425|9938298|FG000|NOT COMPLETED|Overall Study||2
8881106|NCT01946425|9938299|FG001|NOT COMPLETED|Overall Study||0
8881107|NCT01946438|9938310|FG000|STARTED|Overall Study||52
8881108|NCT01946438|9938311|FG001|STARTED|Overall Study||52
8881109|NCT01946438|9938312|FG002|STARTED|Overall Study||52
8881110|NCT01946438|9938313|FG003|STARTED|Overall Study||52
8881111|NCT01946438|9938310|FG000|COMPLETED|Overall Study||50
8881112|NCT01946438|9938311|FG001|COMPLETED|Overall Study||52
8881113|NCT01946438|9938312|FG002|COMPLETED|Overall Study||51
8881114|NCT01946438|9938313|FG003|COMPLETED|Overall Study||51
8881115|NCT01946438|9938310|FG000|NOT COMPLETED|Overall Study||2
8881116|NCT01946438|9938311|FG001|NOT COMPLETED|Overall Study||0
8881117|NCT01946438|9938312|FG002|NOT COMPLETED|Overall Study||1
8881118|NCT01946438|9938313|FG003|NOT COMPLETED|Overall Study||1
8881119|NCT01946529|9938332|FG000|STARTED|End of Window Therapy (2 Courses)||1
8881120|NCT01946529|9938333|FG001|STARTED|End of Window Therapy (2 Courses)||17
8881121|NCT01946529|9938334|FG002|STARTED|End of Window Therapy (2 Courses)||6
8881122|NCT01946529|9938332|FG000|COMPLETED|End of Window Therapy (2 Courses)||1
8881123|NCT01946529|9938333|FG001|COMPLETED|End of Window Therapy (2 Courses)||16
8881124|NCT01946529|9938334|FG002|COMPLETED|End of Window Therapy (2 Courses)||6
8881125|NCT01946529|9938332|FG000|NOT COMPLETED|End of Window Therapy (2 Courses)||0
8881126|NCT01946529|9938333|FG001|NOT COMPLETED|End of Window Therapy (2 Courses)||1
8881127|NCT01946529|9938334|FG002|NOT COMPLETED|End of Window Therapy (2 Courses)||0
8881128|NCT01946529|9938332|FG000|STARTED|Completion of All Therapy||1
8881129|NCT01946529|9938333|FG001|STARTED|Completion of All Therapy||16
8881130|NCT01946529|9938334|FG002|STARTED|Completion of All Therapy||6
8881131|NCT01946529|9938332|FG000|COMPLETED|Completion of All Therapy||0
8881132|NCT01946529|9938333|FG001|COMPLETED|Completion of All Therapy||0
8881133|NCT01946529|9938334|FG002|COMPLETED|Completion of All Therapy||0
8881134|NCT01946529|9938332|FG000|NOT COMPLETED|Completion of All Therapy||1
8881135|NCT01946529|9938333|FG001|NOT COMPLETED|Completion of All Therapy||16
8881136|NCT01946529|9938334|FG002|NOT COMPLETED|Completion of All Therapy||6
8881137|NCT01946802|9938341|FG000|STARTED|Overall Study||44
8881138|NCT01946802|9938341|FG000|COMPLETED|Overall Study||39
8881139|NCT01946802|9938341|FG000|NOT COMPLETED|Overall Study||5
8881140|NCT01946880|9938347|FG000|STARTED|Overall Study||50
8881141|NCT01946880|9938348|FG001|STARTED|Overall Study||52
8881142|NCT01946880|9938347|FG000|COMPLETED|Overall Study||43
8881143|NCT01946880|9938348|FG001|COMPLETED|Overall Study||49
8881144|NCT01946880|9938347|FG000|NOT COMPLETED|Overall Study||7
8881145|NCT01946880|9938348|FG001|NOT COMPLETED|Overall Study||3
8881146|NCT01947127|9938356|FG000|STARTED|Overall Study||166
8881147|NCT01947127|9938357|FG001|STARTED|Overall Study||292
8881148|NCT01947127|9938356|FG000|COMPLETED|Overall Study||143
8881149|NCT01947127|9938357|FG001|COMPLETED|Overall Study||249
8881150|NCT01947127|9938356|FG000|NOT COMPLETED|Overall Study||23
8881151|NCT01947127|9938357|FG001|NOT COMPLETED|Overall Study||43
8881152|NCT01947153|9938363|FG000|STARTED|Test Period 1||18
8881153|NCT01947153|9938364|FG001|STARTED|Test Period 1||18
8881154|NCT01947153|9938363|FG000|COMPLETED|Test Period 1||18
8881155|NCT01947153|9938364|FG001|COMPLETED|Test Period 1||18
8881156|NCT01947153|9938363|FG000|NOT COMPLETED|Test Period 1||0
8881157|NCT01947153|9938364|FG001|NOT COMPLETED|Test Period 1||0
8881158|NCT01947153|9938363|FG000|STARTED|Test Period 2||18
8881159|NCT01947153|9938364|FG001|STARTED|Test Period 2||18
8881160|NCT01947153|9938363|FG000|COMPLETED|Test Period 2||18
8881161|NCT01947153|9938364|FG001|COMPLETED|Test Period 2||18
8881162|NCT01947153|9938363|FG000|NOT COMPLETED|Test Period 2||0
8881163|NCT01947153|9938364|FG001|NOT COMPLETED|Test Period 2||0
8881164|NCT01947283|9938377|FG000|STARTED|Overall Study||89
8881165|NCT01947283|9938378|FG001|STARTED|Overall Study||68
8881166|NCT01947283|9938379|FG002|STARTED|Overall Study||83
8881167|NCT01947283|9938380|FG003|STARTED|Overall Study||72
8881168|NCT01947283|9938381|FG004|STARTED|Overall Study||95
8881169|NCT01947283|9938382|FG005|STARTED|Overall Study||34
8881170|NCT01947283|9938383|FG006|STARTED|Overall Study||40
8634089|NCT00554970|9674387|FG000|COMPLETED|Period 2||7
8634090|NCT00554970|9674388|FG001|COMPLETED|Period 2||8
8634091|NCT00554970|9674389|FG002|COMPLETED|Period 2||7
8634092|NCT00554970|9674390|FG003|COMPLETED|Period 2||8
8634093|NCT00554970|9674387|FG000|NOT COMPLETED|Period 2||0
8634094|NCT00554970|9674388|FG001|NOT COMPLETED|Period 2||0
8634095|NCT00554970|9674389|FG002|NOT COMPLETED|Period 2||1
8881171|NCT01947283|9938377|FG000|Baseline Assessment|Overall Study||89
8881172|NCT01947283|9938378|FG001|Baseline Assessment|Overall Study||68
8881173|NCT01947283|9938379|FG002|Baseline Assessment|Overall Study||83
8881174|NCT01947283|9938380|FG003|Baseline Assessment|Overall Study||72
8881175|NCT01947283|9938381|FG004|Baseline Assessment|Overall Study||0
8881176|NCT01947283|9938382|FG005|Baseline Assessment|Overall Study||34
8881177|NCT01947283|9938383|FG006|Baseline Assessment|Overall Study||40
8881178|NCT01947283|9938377|FG000|Follow-up Assessment|Overall Study||64
8881179|NCT01947283|9938378|FG001|Follow-up Assessment|Overall Study||51
8881180|NCT01947283|9938379|FG002|Follow-up Assessment|Overall Study||65
8881181|NCT01947283|9938380|FG003|Follow-up Assessment|Overall Study||59
8881182|NCT01947283|9938381|FG004|Follow-up Assessment|Overall Study||0
8881183|NCT01947283|9938382|FG005|Follow-up Assessment|Overall Study||27
8881184|NCT01947283|9938383|FG006|Follow-up Assessment|Overall Study||36
8881185|NCT01947283|9938377|FG000|Clinical Recording|Overall Study||65
8881186|NCT01947283|9938378|FG001|Clinical Recording|Overall Study||54
8881187|NCT01947283|9938379|FG002|Clinical Recording|Overall Study||68
8634096|NCT00554970|9674390|FG003|NOT COMPLETED|Period 2||0
8634097|NCT00554996|9674400|FG000|STARTED|Overall Study||10
8881188|NCT01947283|9938380|FG003|Clinical Recording|Overall Study||57
8881189|NCT01947283|9938381|FG004|Clinical Recording|Overall Study||0
8881190|NCT01947283|9938382|FG005|Clinical Recording|Overall Study||0
8881191|NCT01947283|9938383|FG006|Clinical Recording|Overall Study||0
8881192|NCT01947283|9938377|FG000|End-of-Intervention Assessment|Overall Study||74
8881193|NCT01947283|9938378|FG001|End-of-Intervention Assessment|Overall Study||53
8881194|NCT01947283|9938379|FG002|End-of-Intervention Assessment|Overall Study||73
8881195|NCT01947283|9938380|FG003|End-of-Intervention Assessment|Overall Study||66
8881196|NCT01947283|9938381|FG004|End-of-Intervention Assessment|Overall Study||0
8881197|NCT01947283|9938382|FG005|End-of-Intervention Assessment|Overall Study||32
8881198|NCT01947283|9938383|FG006|End-of-Intervention Assessment|Overall Study||33
8881199|NCT01947283|9938377|FG000|In Analysis|Overall Study||89
8881200|NCT01947283|9938378|FG001|In Analysis|Overall Study||68
8881201|NCT01947283|9938379|FG002|In Analysis|Overall Study||83
8881202|NCT01947283|9938380|FG003|In Analysis|Overall Study||72
8881203|NCT01947283|9938381|FG004|In Analysis|Overall Study||95
8881204|NCT01947283|9938382|FG005|In Analysis|Overall Study||30
8881205|NCT01947283|9938383|FG006|In Analysis|Overall Study||38
8881206|NCT01947283|9938377|FG000|Completed NRCT Baseline Assessment|Overall Study||0
8881207|NCT01947283|9938378|FG001|Completed NRCT Baseline Assessment|Overall Study||0
8881208|NCT01947283|9938379|FG002|Completed NRCT Baseline Assessment|Overall Study||0
8881209|NCT01947283|9938380|FG003|Completed NRCT Baseline Assessment|Overall Study||0
8881210|NCT01947283|9938381|FG004|Completed NRCT Baseline Assessment|Overall Study||95
8881211|NCT01947283|9938382|FG005|Completed NRCT Baseline Assessment|Overall Study||0
8881212|NCT01947283|9938383|FG006|Completed NRCT Baseline Assessment|Overall Study||0
8881213|NCT01947283|9938377|FG000|COMPLETED|Overall Study||60
8881214|NCT01947283|9938378|FG001|COMPLETED|Overall Study||45
8881215|NCT01947283|9938379|FG002|COMPLETED|Overall Study||62
8881216|NCT01947283|9938380|FG003|COMPLETED|Overall Study||55
8881217|NCT01947283|9938381|FG004|COMPLETED|Overall Study||95
8881218|NCT01947283|9938382|FG005|COMPLETED|Overall Study||27
8881219|NCT01947283|9938383|FG006|COMPLETED|Overall Study||32
8881220|NCT01947283|9938377|FG000|NOT COMPLETED|Overall Study||29
8881221|NCT01947283|9938378|FG001|NOT COMPLETED|Overall Study||23
8881222|NCT01947283|9938379|FG002|NOT COMPLETED|Overall Study||21
8881223|NCT01947283|9938380|FG003|NOT COMPLETED|Overall Study||17
8881224|NCT01947283|9938381|FG004|NOT COMPLETED|Overall Study||0
8881225|NCT01947283|9938382|FG005|NOT COMPLETED|Overall Study||7
8881226|NCT01947283|9938383|FG006|NOT COMPLETED|Overall Study||8
8881227|NCT01947335|9938402|FG000|STARTED|Overall Study||42
8881228|NCT01947335|9938403|FG001|STARTED|Overall Study||41
8881229|NCT01947335|9938402|FG000|COMPLETED|Overall Study||42
8881230|NCT01947335|9938403|FG001|COMPLETED|Overall Study||41
8881231|NCT01947335|9938402|FG000|NOT COMPLETED|Overall Study||0
8881232|NCT01947335|9938403|FG001|NOT COMPLETED|Overall Study||0
8881233|NCT01947491|9938413|FG000|STARTED|Overall Study||174
8881234|NCT01947491|9938414|FG001|STARTED|Overall Study||87
8881235|NCT01947491|9938415|FG002|STARTED|Overall Study||90
8881236|NCT01947491|9938416|FG003|STARTED|Overall Study||43
8881237|NCT01947491|9938413|FG000|COMPLETED|Overall Study||166
8881238|NCT01947491|9938414|FG001|COMPLETED|Overall Study||81
8881239|NCT01947491|9938415|FG002|COMPLETED|Overall Study||88
8881240|NCT01947491|9938416|FG003|COMPLETED|Overall Study||38
8881241|NCT01947491|9938413|FG000|NOT COMPLETED|Overall Study||8
8881242|NCT01947491|9938414|FG001|NOT COMPLETED|Overall Study||6
8881243|NCT01947491|9938415|FG002|NOT COMPLETED|Overall Study||2
8881244|NCT01947491|9938416|FG003|NOT COMPLETED|Overall Study||5
8881245|NCT01947517|9938428|FG000|STARTED|Overall Study||26
8881246|NCT01947517|9938429|FG001|STARTED|Overall Study||26
8881247|NCT01947517|9938428|FG000|COMPLETED|Overall Study||25
8881248|NCT01947517|9938429|FG001|COMPLETED|Overall Study||25
8881249|NCT01947517|9938428|FG000|NOT COMPLETED|Overall Study||1
8881250|NCT01947517|9938429|FG001|NOT COMPLETED|Overall Study||1
8881251|NCT01947582|9938435|FG000|STARTED|Overall Study||2
8881252|NCT01947582|9938435|FG000|COMPLETED|Overall Study||1
8881253|NCT01947582|9938435|FG000|NOT COMPLETED|Overall Study||1
8881254|NCT01947647|9938441|FG000|STARTED|Treatment Phase||46
8881255|NCT01947647|9938442|FG001|STARTED|Treatment Phase||47
8881256|NCT01947647|9938441|FG000|COMPLETED|Treatment Phase||29
8881257|NCT01947647|9938442|FG001|COMPLETED|Treatment Phase||21
8881258|NCT01947647|9938441|FG000|NOT COMPLETED|Treatment Phase||17
8881259|NCT01947647|9938442|FG001|NOT COMPLETED|Treatment Phase||26
8881260|NCT01947647|9938441|FG000|STARTED|6-month Followup Phase||29
8881261|NCT01947647|9938442|FG001|STARTED|6-month Followup Phase||21
8881262|NCT01947647|9938441|FG000|COMPLETED|6-month Followup Phase||20
8881263|NCT01947647|9938442|FG001|COMPLETED|6-month Followup Phase||13
8881264|NCT01947647|9938441|FG000|NOT COMPLETED|6-month Followup Phase||9
8881265|NCT01947647|9938442|FG001|NOT COMPLETED|6-month Followup Phase||8
8881266|NCT01947816|9938448|FG000|STARTED|Overall Study||1593
8881267|NCT01947816|9938448|FG000|COMPLETED|Overall Study||1523
8881268|NCT01947816|9938448|FG000|NOT COMPLETED|Overall Study||70
8881269|NCT01947855|9938455|FG000|STARTED|Overall Study||21
8881270|NCT01947855|9938456|FG001|STARTED|Overall Study||20
8881271|NCT01947855|9938457|FG002|STARTED|Overall Study||19
8881272|NCT01947855|9938455|FG000|COMPLETED|Overall Study||20
8881273|NCT01947855|9938456|FG001|COMPLETED|Overall Study||20
8881274|NCT01947855|9938457|FG002|COMPLETED|Overall Study||19
8881275|NCT01947855|9938455|FG000|NOT COMPLETED|Overall Study||1
8881276|NCT01947855|9938456|FG001|NOT COMPLETED|Overall Study||0
8881277|NCT01947855|9938457|FG002|NOT COMPLETED|Overall Study||0
8881278|NCT01947894|9938468|FG000|STARTED|Overall Study||247
8881279|NCT01947894|9938469|FG001|STARTED|Overall Study||42
8881280|NCT01947894|9938470|FG002|STARTED|Overall Study||88
8881281|NCT01947894|9938468|FG000|Treated|Overall Study||246
8881282|NCT01947894|9938469|FG001|Treated|Overall Study||41
8881283|NCT01947894|9938470|FG002|Treated|Overall Study||87
8881284|NCT01947894|9938468|FG000|COMPLETED|Overall Study||160
8881285|NCT01947894|9938469|FG001|COMPLETED|Overall Study||24
8881286|NCT01947894|9938470|FG002|COMPLETED|Overall Study||61
8881287|NCT01947894|9938468|FG000|NOT COMPLETED|Overall Study||87
8881288|NCT01947894|9938469|FG001|NOT COMPLETED|Overall Study||18
8881289|NCT01947894|9938470|FG002|NOT COMPLETED|Overall Study||27
8881290|NCT01947907|9938482|FG000|STARTED|Overall Study||12
8881291|NCT01947907|9938483|FG001|STARTED|Overall Study||14
8881292|NCT01947907|9938484|FG002|STARTED|Overall Study||14
8881293|NCT01947907|9938485|FG003|STARTED|Overall Study||13
8881294|NCT01947907|9938482|FG000|COMPLETED|Overall Study||12
8881295|NCT01947907|9938483|FG001|COMPLETED|Overall Study||14
8881296|NCT01947907|9938484|FG002|COMPLETED|Overall Study||14
8881297|NCT01947907|9938485|FG003|COMPLETED|Overall Study||13
8881298|NCT01947907|9938482|FG000|NOT COMPLETED|Overall Study||0
8881299|NCT01947907|9938483|FG001|NOT COMPLETED|Overall Study||0
8881300|NCT01947907|9938484|FG002|NOT COMPLETED|Overall Study||0
8881301|NCT01947907|9938485|FG003|NOT COMPLETED|Overall Study||0
8881302|NCT01947946|9938498|FG000|STARTED|Overall Study||3
8881303|NCT01947946|9938499|FG001|STARTED|Overall Study||5
8881304|NCT01947946|9938500|FG002|STARTED|Overall Study||5
8881305|NCT01947946|9938498|FG000|COMPLETED|Overall Study|Study Stopped|0
8881306|NCT01947946|9938499|FG001|COMPLETED|Overall Study||0
8881307|NCT01947946|9938500|FG002|COMPLETED|Overall Study||0
8881308|NCT01947946|9938498|FG000|NOT COMPLETED|Overall Study||3
8881309|NCT01947946|9938499|FG001|NOT COMPLETED|Overall Study||5
8881310|NCT01947946|9938500|FG002|NOT COMPLETED|Overall Study||5
8881311|NCT01948050|9938510|FG000|STARTED|Overall Study||16
8881312|NCT01948050|9938511|FG001|STARTED|Overall Study||8
8881313|NCT01948050|9938510|FG000|COMPLETED|Overall Study||16
8881314|NCT01948050|9938511|FG001|COMPLETED|Overall Study||7
8881315|NCT01948050|9938510|FG000|NOT COMPLETED|Overall Study||0
8881316|NCT01948050|9938511|FG001|NOT COMPLETED|Overall Study||1
8881317|NCT01948063|9938519|FG000|STARTED|Overall Study||20
8881318|NCT01948063|9938520|FG001|STARTED|Overall Study||21
8881319|NCT01948063|9938519|FG000|COMPLETED|Overall Study||19
8881320|NCT01948063|9938520|FG001|COMPLETED|Overall Study||19
8881321|NCT01948063|9938519|FG000|NOT COMPLETED|Overall Study||1
8881322|NCT01948063|9938520|FG001|NOT COMPLETED|Overall Study||2
8881323|NCT01948076|9938528|FG000|STARTED|Overall Study||20
8881324|NCT01948076|9938529|FG001|STARTED|Overall Study||20
8881325|NCT01948076|9938528|FG000|COMPLETED|Overall Study||20
8881326|NCT01948076|9938529|FG001|COMPLETED|Overall Study||19
8881327|NCT01948076|9938528|FG000|NOT COMPLETED|Overall Study||0
8881328|NCT01948076|9938529|FG001|NOT COMPLETED|Overall Study||1
8881329|NCT01948141|9938537|FG000|STARTED|Overall Study||6
8881330|NCT01948141|9938537|FG000|COMPLETED|Overall Study||6
8881331|NCT01948141|9938537|FG000|NOT COMPLETED|Overall Study||0
8881332|NCT01948193|9938541|FG000|STARTED|Overall Study||177
8881333|NCT01948193|9938541|FG000|COMPLETED|Overall Study||168
8881334|NCT01948193|9938541|FG000|NOT COMPLETED|Overall Study||9
8881335|NCT01948258|9938546|FG000|STARTED|Overall Study||395
8881336|NCT01948258|9938546|FG000|COMPLETED|Overall Study||233
8881337|NCT01948258|9938546|FG000|NOT COMPLETED|Overall Study||162
8881338|NCT01948310|9938552|FG000|STARTED|Overall Study||19
8881339|NCT01948310|9938553|FG001|STARTED|Overall Study||18
8881340|NCT01948310|9938552|FG000|COMPLETED|Overall Study||16
8881341|NCT01948310|9938553|FG001|COMPLETED|Overall Study||13
8881342|NCT01948310|9938552|FG000|NOT COMPLETED|Overall Study||3
8881343|NCT01948310|9938553|FG001|NOT COMPLETED|Overall Study||5
8881344|NCT01948375|9938561|FG000|STARTED|Overall Study||30
8881345|NCT01948375|9938562|FG001|STARTED|Overall Study||30
8881346|NCT01948375|9938561|FG000|COMPLETED|Overall Study||30
8881347|NCT01948375|9938562|FG001|COMPLETED|Overall Study||30
8881348|NCT01948375|9938561|FG000|NOT COMPLETED|Overall Study||0
8881349|NCT01948375|9938562|FG001|NOT COMPLETED|Overall Study||0
8881350|NCT01948388|9938572|FG000|STARTED|Overall Study||10
8881351|NCT01948388|9938573|FG001|STARTED|Overall Study||10
8881352|NCT01948388|9938572|FG000|COMPLETED|Overall Study||8
8881353|NCT01948388|9938573|FG001|COMPLETED|Overall Study||9
8881354|NCT01948388|9938572|FG000|NOT COMPLETED|Overall Study||2
8881355|NCT01948388|9938573|FG001|NOT COMPLETED|Overall Study||1
8881356|NCT01948427|9938586|FG000|STARTED|Overall Study||49
8881357|NCT01948427|9938587|FG001|STARTED|Overall Study||89
8881358|NCT01948427|9938588|FG002|STARTED|Overall Study||4
8881359|NCT01948427|9938589|FG003|STARTED|Overall Study||1
8881360|NCT01948427|9938590|FG004|STARTED|Overall Study||60
8881361|NCT01948427|9938586|FG000|COMPLETED|Overall Study||42
8881362|NCT01948427|9938587|FG001|COMPLETED|Overall Study||72
8881363|NCT01948427|9938588|FG002|COMPLETED|Overall Study||4
8881364|NCT01948427|9938589|FG003|COMPLETED|Overall Study||1
8881365|NCT01948427|9938590|FG004|COMPLETED|Overall Study||46
8881366|NCT01948427|9938586|FG000|NOT COMPLETED|Overall Study||7
8881367|NCT01948427|9938587|FG001|NOT COMPLETED|Overall Study||17
8881368|NCT01948427|9938588|FG002|NOT COMPLETED|Overall Study||0
8881369|NCT01948427|9938589|FG003|NOT COMPLETED|Overall Study||0
8881370|NCT01948427|9938590|FG004|NOT COMPLETED|Overall Study||14
8881371|NCT01948518|9938607|FG000|STARTED|Overall Study||15
8881372|NCT01948518|9938607|FG000|COMPLETED|Overall Study||15
8881373|NCT01948518|9938607|FG000|NOT COMPLETED|Overall Study||0
8881374|NCT01948739|9938611|FG000|STARTED|Overall Study||18
8881375|NCT01948739|9938611|FG000|Received Intervention|Overall Study||10
8881376|NCT01948739|9938611|FG000|COMPLETED|Overall Study||10
8881377|NCT01948739|9938611|FG000|NOT COMPLETED|Overall Study||8
8881378|NCT01948791|9938615|FG000|STARTED|Overall Study||222
8881379|NCT01948791|9938615|FG000|COMPLETED|Overall Study||151
8881380|NCT01948791|9938615|FG000|NOT COMPLETED|Overall Study||71
8881381|NCT01948830|9938621|FG000|STARTED|Overall Study||323
8881382|NCT01948830|9938622|FG001|STARTED|Overall Study||327
8881383|NCT01948830|9938621|FG000|Safety Set|Overall Study||323
8881384|NCT01948830|9938622|FG001|Safety Set|Overall Study||326
8881385|NCT01948830|9938621|FG000|COMPLETED|Overall Study||290
8881386|NCT01948830|9938622|FG001|COMPLETED|Overall Study||295
8881387|NCT01948830|9938621|FG000|NOT COMPLETED|Overall Study||33
8881388|NCT01948830|9938622|FG001|NOT COMPLETED|Overall Study||32
8881389|NCT01948908|9938631|FG000|STARTED|Overall Study||33
8881390|NCT01948908|9938632|FG001|STARTED|Overall Study||33
8881391|NCT01948908|9938633|FG002|STARTED|Overall Study||33
8881392|NCT01948908|9938631|FG000|COMPLETED|Overall Study||32
8881393|NCT01948908|9938632|FG001|COMPLETED|Overall Study||33
8881394|NCT01948908|9938633|FG002|COMPLETED|Overall Study||31
8881395|NCT01948908|9938631|FG000|NOT COMPLETED|Overall Study||1
8881396|NCT01948908|9938632|FG001|NOT COMPLETED|Overall Study||0
8881397|NCT01948908|9938633|FG002|NOT COMPLETED|Overall Study||2
8881398|NCT01948947|9938643|FG000|STARTED|Overall Study||14
8881399|NCT01948947|9938644|FG001|STARTED|Overall Study||15
8881400|NCT01948947|9938643|FG000|COMPLETED|Overall Study||14
8881401|NCT01948947|9938644|FG001|COMPLETED|Overall Study||15
8881402|NCT01948947|9938643|FG000|NOT COMPLETED|Overall Study||0
8881403|NCT01948947|9938644|FG001|NOT COMPLETED|Overall Study||0
8881404|NCT01948986|9938655|FG000|STARTED|Overall Study||6
8881405|NCT01948986|9938656|FG001|STARTED|Overall Study||8
8881406|NCT01948986|9938657|FG002|STARTED|Overall Study||8
8881407|NCT01948986|9938658|FG003|STARTED|Overall Study||6
8881408|NCT01948986|9938659|FG004|STARTED|Overall Study||8
8881409|NCT01948986|9938655|FG000|COMPLETED|Overall Study||6
8881410|NCT01948986|9938656|FG001|COMPLETED|Overall Study||8
8881411|NCT01948986|9938657|FG002|COMPLETED|Overall Study||8
8881412|NCT01948986|9938658|FG003|COMPLETED|Overall Study||6
8881413|NCT01948986|9938659|FG004|COMPLETED|Overall Study||8
8881414|NCT01948986|9938655|FG000|NOT COMPLETED|Overall Study||0
8881415|NCT01948986|9938656|FG001|NOT COMPLETED|Overall Study||0
8881416|NCT01948986|9938657|FG002|NOT COMPLETED|Overall Study||0
8881417|NCT01948986|9938658|FG003|NOT COMPLETED|Overall Study||0
8881418|NCT01948986|9938659|FG004|NOT COMPLETED|Overall Study||0
8881419|NCT01949051|9938671|FG000|STARTED|Treatment Period 1 (7 Days)||13
8881420|NCT01949051|9938672|FG001|STARTED|Treatment Period 1 (7 Days)||13
8881421|NCT01949051|9938673|FG002|STARTED|Treatment Period 1 (7 Days)||13
8881422|NCT01949051|9938674|FG003|STARTED|Treatment Period 1 (7 Days)||13
8881423|NCT01949051|9938675|FG004|STARTED|Treatment Period 1 (7 Days)||13
8881424|NCT01949051|9938676|FG005|STARTED|Treatment Period 1 (7 Days)||13
8881425|NCT01949051|9938671|FG000|COMPLETED|Treatment Period 1 (7 Days)||11
8881426|NCT01949051|9938672|FG001|COMPLETED|Treatment Period 1 (7 Days)||13
8881427|NCT01949051|9938673|FG002|COMPLETED|Treatment Period 1 (7 Days)||13
8881428|NCT01949051|9938674|FG003|COMPLETED|Treatment Period 1 (7 Days)||12
8881429|NCT01949051|9938675|FG004|COMPLETED|Treatment Period 1 (7 Days)||13
8881430|NCT01949051|9938676|FG005|COMPLETED|Treatment Period 1 (7 Days)||13
8881431|NCT01949051|9938671|FG000|NOT COMPLETED|Treatment Period 1 (7 Days)||2
8881432|NCT01949051|9938672|FG001|NOT COMPLETED|Treatment Period 1 (7 Days)||0
8881433|NCT01949051|9938673|FG002|NOT COMPLETED|Treatment Period 1 (7 Days)||0
8881434|NCT01949051|9938674|FG003|NOT COMPLETED|Treatment Period 1 (7 Days)||1
8881435|NCT01949051|9938675|FG004|NOT COMPLETED|Treatment Period 1 (7 Days)||0
8881436|NCT01949051|9938676|FG005|NOT COMPLETED|Treatment Period 1 (7 Days)||0
8881437|NCT01949051|9938671|FG000|STARTED|Washout Period 1 (14 to 20 Days)||11
8881438|NCT01949051|9938672|FG001|STARTED|Washout Period 1 (14 to 20 Days)||13
8881439|NCT01949051|9938673|FG002|STARTED|Washout Period 1 (14 to 20 Days)||13
8881440|NCT01949051|9938674|FG003|STARTED|Washout Period 1 (14 to 20 Days)||12
8881441|NCT01949051|9938675|FG004|STARTED|Washout Period 1 (14 to 20 Days)||13
8881442|NCT01949051|9938676|FG005|STARTED|Washout Period 1 (14 to 20 Days)||13
8881443|NCT01949051|9938671|FG000|COMPLETED|Washout Period 1 (14 to 20 Days)||11
8881444|NCT01949051|9938672|FG001|COMPLETED|Washout Period 1 (14 to 20 Days)||13
8881445|NCT01949051|9938673|FG002|COMPLETED|Washout Period 1 (14 to 20 Days)||13
8881446|NCT01949051|9938674|FG003|COMPLETED|Washout Period 1 (14 to 20 Days)||12
8881447|NCT01949051|9938675|FG004|COMPLETED|Washout Period 1 (14 to 20 Days)||13
8881448|NCT01949051|9938676|FG005|COMPLETED|Washout Period 1 (14 to 20 Days)||13
8881449|NCT01949051|9938671|FG000|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
8881450|NCT01949051|9938672|FG001|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
8881451|NCT01949051|9938673|FG002|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
8881452|NCT01949051|9938674|FG003|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
8881453|NCT01949051|9938675|FG004|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
8881454|NCT01949051|9938676|FG005|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
8881455|NCT01949051|9938671|FG000|STARTED|Treatment Period 2 (7 Days)||11
8881456|NCT01949051|9938672|FG001|STARTED|Treatment Period 2 (7 Days)||13
8881457|NCT01949051|9938673|FG002|STARTED|Treatment Period 2 (7 Days)||13
8881458|NCT01949051|9938674|FG003|STARTED|Treatment Period 2 (7 Days)||12
8881459|NCT01949051|9938675|FG004|STARTED|Treatment Period 2 (7 Days)||13
8881460|NCT01949051|9938676|FG005|STARTED|Treatment Period 2 (7 Days)||13
8881461|NCT01949051|9938671|FG000|COMPLETED|Treatment Period 2 (7 Days)||11
8881462|NCT01949051|9938672|FG001|COMPLETED|Treatment Period 2 (7 Days)||12
8881463|NCT01949051|9938673|FG002|COMPLETED|Treatment Period 2 (7 Days)||12
8881464|NCT01949051|9938674|FG003|COMPLETED|Treatment Period 2 (7 Days)||12
8881465|NCT01949051|9938675|FG004|COMPLETED|Treatment Period 2 (7 Days)||13
8881466|NCT01949051|9938676|FG005|COMPLETED|Treatment Period 2 (7 Days)||12
8881467|NCT01949051|9938671|FG000|NOT COMPLETED|Treatment Period 2 (7 Days)||0
8881468|NCT01949051|9938672|FG001|NOT COMPLETED|Treatment Period 2 (7 Days)||1
8881469|NCT01949051|9938673|FG002|NOT COMPLETED|Treatment Period 2 (7 Days)||1
8881470|NCT01949051|9938674|FG003|NOT COMPLETED|Treatment Period 2 (7 Days)||0
8881471|NCT01949051|9938675|FG004|NOT COMPLETED|Treatment Period 2 (7 Days)||0
8881472|NCT01949051|9938676|FG005|NOT COMPLETED|Treatment Period 2 (7 Days)||1
8881473|NCT01949051|9938671|FG000|STARTED|Washout Period 2 (14 to 20 Days)||11
8881474|NCT01949051|9938672|FG001|STARTED|Washout Period 2 (14 to 20 Days)||12
8881475|NCT01949051|9938673|FG002|STARTED|Washout Period 2 (14 to 20 Days)||12
8881476|NCT01949051|9938674|FG003|STARTED|Washout Period 2 (14 to 20 Days)||12
9002356|NCT02909153|10065563|FG004|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||6
9002357|NCT02909153|10065559|FG000|Triferic in Extraneal PD Solution|Overall Study||0
9002358|NCT02909153|10065560|FG001|Triferic in Extraneal PD Solution|Overall Study||0
9002359|NCT02909153|10065561|FG002|Triferic in Extraneal PD Solution|Overall Study||0
9002360|NCT02909153|10065562|FG003|Triferic in Extraneal PD Solution|Overall Study||6
9002361|NCT02909153|10065563|FG004|Triferic in Extraneal PD Solution|Overall Study||6
9002362|NCT02909153|10065559|FG000|COMPLETED|Overall Study||6
9002363|NCT02909153|10065560|FG001|COMPLETED|Overall Study||5
9002364|NCT02909153|10065561|FG002|COMPLETED|Overall Study||6
9002365|NCT02909153|10065562|FG003|COMPLETED|Overall Study||6
9002366|NCT02909153|10065563|FG004|COMPLETED|Overall Study||6
9002367|NCT02909153|10065559|FG000|NOT COMPLETED|Overall Study||0
9002368|NCT02909153|10065560|FG001|NOT COMPLETED|Overall Study||1
9002369|NCT02909153|10065561|FG002|NOT COMPLETED|Overall Study||0
9002370|NCT02909153|10065562|FG003|NOT COMPLETED|Overall Study||0
9002371|NCT02909153|10065563|FG004|NOT COMPLETED|Overall Study||0
9002372|NCT02909439|10065577|FG000|STARTED|Overall Study||31
9002373|NCT02909439|10065578|FG001|STARTED|Overall Study||31
9002374|NCT02909439|10065577|FG000|COMPLETED|Overall Study||31
9002375|NCT02909439|10065578|FG001|COMPLETED|Overall Study||31
9002376|NCT02909439|10065577|FG000|NOT COMPLETED|Overall Study||0
9002377|NCT02909439|10065578|FG001|NOT COMPLETED|Overall Study||0
9002378|NCT02909504|10065584|FG000|STARTED|Overall Study||24
9002379|NCT02909504|10065584|FG000|COMPLETED|Overall Study||12
9002380|NCT02909504|10065584|FG000|NOT COMPLETED|Overall Study||12
9002381|NCT02909764|10065591|FG000|STARTED|Overall Study||19
9002382|NCT02909764|10065592|FG001|STARTED|Overall Study||20
9002383|NCT02909764|10065591|FG000|COMPLETED|Overall Study||19
9002384|NCT02909764|10065592|FG001|COMPLETED|Overall Study||20
9002385|NCT02909764|10065591|FG000|NOT COMPLETED|Overall Study||0
9002386|NCT02909764|10065592|FG001|NOT COMPLETED|Overall Study||0
9002387|NCT02909907|10065603|FG000|STARTED|Overall Study||10
9002388|NCT02909907|10065604|FG001|STARTED|Overall Study||10
9002389|NCT02909907|10065603|FG000|COMPLETED|Overall Study||10
9002390|NCT02909907|10065604|FG001|COMPLETED|Overall Study||9
9002391|NCT02909907|10065603|FG000|NOT COMPLETED|Overall Study||0
9002392|NCT02909907|10065604|FG001|NOT COMPLETED|Overall Study||1
9002393|NCT02909959|10065612|FG000|STARTED|Overall Study||24
9002394|NCT02909959|10065613|FG001|STARTED|Overall Study||24
9002395|NCT02909959|10065612|FG000|COMPLETED|Overall Study||24
9002396|NCT02909959|10065613|FG001|COMPLETED|Overall Study||24
8881477|NCT01949051|9938675|FG004|STARTED|Washout Period 2 (14 to 20 Days)||13
8881478|NCT01949051|9938676|FG005|STARTED|Washout Period 2 (14 to 20 Days)||12
9002397|NCT02909959|10065612|FG000|NOT COMPLETED|Overall Study||0
9002398|NCT02909959|10065613|FG001|NOT COMPLETED|Overall Study||0
9002399|NCT02910011|10065619|FG000|STARTED|Overall Study||15
9002400|NCT02910011|10065619|FG000|COMPLETED|Overall Study||13
9002401|NCT02910011|10065619|FG000|NOT COMPLETED|Overall Study||2
9002402|NCT02910037|10065625|FG000|STARTED|Overall Study||214
8881479|NCT01949051|9938671|FG000|COMPLETED|Washout Period 2 (14 to 20 Days)||11
8881480|NCT01949051|9938672|FG001|COMPLETED|Washout Period 2 (14 to 20 Days)||12
8881481|NCT01949051|9938673|FG002|COMPLETED|Washout Period 2 (14 to 20 Days)||12
8881482|NCT01949051|9938674|FG003|COMPLETED|Washout Period 2 (14 to 20 Days)||12
8881483|NCT01949051|9938675|FG004|COMPLETED|Washout Period 2 (14 to 20 Days)||13
8881484|NCT01949051|9938676|FG005|COMPLETED|Washout Period 2 (14 to 20 Days)||12
8881485|NCT01949051|9938671|FG000|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
8881486|NCT01949051|9938672|FG001|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
8881487|NCT01949051|9938673|FG002|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
8881488|NCT01949051|9938674|FG003|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
8881489|NCT01949051|9938675|FG004|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
8881490|NCT01949051|9938676|FG005|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
8881491|NCT01949051|9938671|FG000|STARTED|Treatment Period 3 (7 Days)||11
8881492|NCT01949051|9938672|FG001|STARTED|Treatment Period 3 (7 Days)||12
8881493|NCT01949051|9938673|FG002|STARTED|Treatment Period 3 (7 Days)||12
8881494|NCT01949051|9938674|FG003|STARTED|Treatment Period 3 (7 Days)||12
8881495|NCT01949051|9938675|FG004|STARTED|Treatment Period 3 (7 Days)||13
8881496|NCT01949051|9938676|FG005|STARTED|Treatment Period 3 (7 Days)||12
8881497|NCT01949051|9938671|FG000|COMPLETED|Treatment Period 3 (7 Days)||11
8881498|NCT01949051|9938672|FG001|COMPLETED|Treatment Period 3 (7 Days)||12
8881499|NCT01949051|9938673|FG002|COMPLETED|Treatment Period 3 (7 Days)||12
8881500|NCT01949051|9938674|FG003|COMPLETED|Treatment Period 3 (7 Days)||12
8881501|NCT01949051|9938675|FG004|COMPLETED|Treatment Period 3 (7 Days)||13
8881502|NCT01949051|9938676|FG005|COMPLETED|Treatment Period 3 (7 Days)||12
8881503|NCT01949051|9938671|FG000|NOT COMPLETED|Treatment Period 3 (7 Days)||0
8881504|NCT01949051|9938672|FG001|NOT COMPLETED|Treatment Period 3 (7 Days)||0
8881505|NCT01949051|9938673|FG002|NOT COMPLETED|Treatment Period 3 (7 Days)||0
9002403|NCT02910037|10065625|FG000|COMPLETED|Overall Study||204
9002404|NCT02910037|10065625|FG000|NOT COMPLETED|Overall Study||10
9002405|NCT02910063|10065645|FG000|STARTED|Phase 2||41
9002406|NCT02910063|10065646|FG001|STARTED|Phase 2|Participants in this Phase 3 arm were not included in the Phase 2 period.|0
9002407|NCT02910063|10065647|FG002|STARTED|Phase 2|Participants in this Phase 3 arm were not included in the Phase 2 period.|0
9002408|NCT02910063|10065645|FG000|Started Cycle 1|Phase 2||41
9002409|NCT02910063|10065646|FG001|Started Cycle 1|Phase 2||0
9002410|NCT02910063|10065647|FG002|Started Cycle 1|Phase 2||0
9002411|NCT02910063|10065645|FG000|Started Optional Cycle 2|Phase 2||4
8881506|NCT01949051|9938674|FG003|NOT COMPLETED|Treatment Period 3 (7 Days)||0
8881507|NCT01949051|9938675|FG004|NOT COMPLETED|Treatment Period 3 (7 Days)||0
8881508|NCT01949051|9938676|FG005|NOT COMPLETED|Treatment Period 3 (7 Days)||0
8881509|NCT01949090|9938689|FG000|STARTED|Overall Study||60
8881510|NCT01949090|9938690|FG001|STARTED|Overall Study||60
8881511|NCT01949090|9938691|FG002|STARTED|Overall Study||60
8881512|NCT01949090|9938692|FG003|STARTED|Overall Study||60
8881513|NCT01949090|9938693|FG004|STARTED|Overall Study||120
8881514|NCT01949090|9938689|FG000|COMPLETED|Overall Study||56
8881515|NCT01949090|9938690|FG001|COMPLETED|Overall Study||58
8881516|NCT01949090|9938691|FG002|COMPLETED|Overall Study||58
8881517|NCT01949090|9938692|FG003|COMPLETED|Overall Study||59
8881518|NCT01949090|9938693|FG004|COMPLETED|Overall Study||116
8881519|NCT01949090|9938689|FG000|NOT COMPLETED|Overall Study||4
8881520|NCT01949090|9938690|FG001|NOT COMPLETED|Overall Study||2
8881521|NCT01949090|9938691|FG002|NOT COMPLETED|Overall Study||2
8881522|NCT01949090|9938692|FG003|NOT COMPLETED|Overall Study||1
8881523|NCT01949090|9938693|FG004|NOT COMPLETED|Overall Study||4
8881524|NCT01949116|9938708|FG000|STARTED|Overall Study||86
8881525|NCT01949116|9938709|FG001|STARTED|Overall Study||90
8881526|NCT01949116|9938708|FG000|COMPLETED|Overall Study||78
8881527|NCT01949116|9938709|FG001|COMPLETED|Overall Study||84
8881528|NCT01949116|9938708|FG000|NOT COMPLETED|Overall Study||8
8881529|NCT01949116|9938709|FG001|NOT COMPLETED|Overall Study||6
8881530|NCT01949142|9938721|FG000|STARTED|Overall Study||179
8881531|NCT01949142|9938722|FG001|STARTED|Overall Study||87
8881532|NCT01949142|9938721|FG000|COMPLETED|Overall Study||176
8881533|NCT01949142|9938722|FG001|COMPLETED|Overall Study||86
8881534|NCT01949142|9938721|FG000|NOT COMPLETED|Overall Study||3
8881535|NCT01949142|9938722|FG001|NOT COMPLETED|Overall Study||1
9002412|NCT02910063|10065646|FG001|Started Optional Cycle 2|Phase 2||0
9002413|NCT02910063|10065647|FG002|Started Optional Cycle 2|Phase 2||0
9002414|NCT02910063|10065645|FG000|COMPLETED|Phase 2||13
9002415|NCT02910063|10065646|FG001|COMPLETED|Phase 2||0
9002416|NCT02910063|10065647|FG002|COMPLETED|Phase 2||0
9002417|NCT02910063|10065645|FG000|NOT COMPLETED|Phase 2||28
9002418|NCT02910063|10065646|FG001|NOT COMPLETED|Phase 2||0
9002419|NCT02910063|10065647|FG002|NOT COMPLETED|Phase 2||0
9002420|NCT02910063|10065645|FG000|STARTED|Phase 3|Participants in this Phase 2 arm were not included in the Phase 3 period.|0
9002421|NCT02910063|10065646|FG001|STARTED|Phase 3||0
9002422|NCT02910063|10065647|FG002|STARTED|Phase 3||0
9002423|NCT02910063|10065645|FG000|COMPLETED|Phase 3||0
8881536|NCT01949155|9938731|FG000|STARTED|Overall Study||178
8881537|NCT01949155|9938732|FG001|STARTED|Overall Study||88
8881538|NCT01949155|9938731|FG000|COMPLETED|Overall Study||176
8881539|NCT01949155|9938732|FG001|COMPLETED|Overall Study||88
8881540|NCT01949155|9938731|FG000|NOT COMPLETED|Overall Study||2
9002424|NCT02910063|10065646|FG001|COMPLETED|Phase 3||0
9002425|NCT02910063|10065647|FG002|COMPLETED|Phase 3||0
9002426|NCT02910063|10065645|FG000|NOT COMPLETED|Phase 3||0
9002427|NCT02910063|10065646|FG001|NOT COMPLETED|Phase 3||0
8881541|NCT01949155|9938732|FG001|NOT COMPLETED|Overall Study||0
8881542|NCT01949337|9938741|FG000|STARTED|Overall Study||657
8881543|NCT01949337|9938742|FG001|STARTED|Overall Study||654
8881544|NCT01949337|9938741|FG000|COMPLETED|Overall Study||657
8881545|NCT01949337|9938742|FG001|COMPLETED|Overall Study||654
8881546|NCT01949337|9938741|FG000|NOT COMPLETED|Overall Study||0
8881547|NCT01949337|9938742|FG001|NOT COMPLETED|Overall Study||0
8881548|NCT01949389|9938748|FG000|STARTED|Overall Study||51
8881549|NCT01949389|9938748|FG000|COMPLETED|Overall Study||51
8881550|NCT01949389|9938748|FG000|NOT COMPLETED|Overall Study||0
8881551|NCT01949480|9938754|FG000|STARTED|Overall Study||20
8881552|NCT01949480|9938755|FG001|STARTED|Overall Study||22
8881553|NCT01949480|9938754|FG000|COMPLETED|Overall Study||15
8881554|NCT01949480|9938755|FG001|COMPLETED|Overall Study||14
8881555|NCT01949480|9938754|FG000|NOT COMPLETED|Overall Study||5
8881556|NCT01949480|9938755|FG001|NOT COMPLETED|Overall Study||8
9002428|NCT02910063|10065647|FG002|NOT COMPLETED|Phase 3||0
9002429|NCT02910089|10065658|FG000|STARTED|Overall Study|Patients allocated to intervention|700
9002430|NCT02910089|10065659|FG001|STARTED|Overall Study|Patients allocated to control|700
9002431|NCT02910089|10065658|FG000|COMPLETED|Overall Study|22 patients ineligible (3.1%)|678
9002432|NCT02910089|10065659|FG001|COMPLETED|Overall Study|16 Patients ineligible (2.3%)|684
9002433|NCT02910089|10065658|FG000|NOT COMPLETED|Overall Study||22
9002434|NCT02910089|10065659|FG001|NOT COMPLETED|Overall Study||16
9002435|NCT02910102|10065667|FG000|STARTED|Overall Study||21
9002436|NCT02910102|10065668|FG001|STARTED|Overall Study||17
9002437|NCT02910102|10065667|FG000|Safety Population|Overall Study||21
9002438|NCT02910102|10065668|FG001|Safety Population|Overall Study||17
9002439|NCT02910102|10065667|FG000|Intent to Treat (ITT) Population|Overall Study||21
9002440|NCT02910102|10065668|FG001|Intent to Treat (ITT) Population|Overall Study||17
8881557|NCT01949532|9938763|FG000|STARTED|Overall Study||15
8881558|NCT01949532|9938764|FG001|STARTED|Overall Study||11
8881559|NCT01949532|9938763|FG000|COMPLETED|Overall Study||12
8881560|NCT01949532|9938764|FG001|COMPLETED|Overall Study||8
8881561|NCT01949532|9938763|FG000|NOT COMPLETED|Overall Study||3
8881562|NCT01949532|9938764|FG001|NOT COMPLETED|Overall Study||3
8881563|NCT01949545|9938774|FG000|STARTED|Overall Study||11
8881564|NCT01949545|9938775|FG001|STARTED|Overall Study||17
8881565|NCT01949545|9938776|FG002|STARTED|Overall Study||14
8881566|NCT01949545|9938777|FG003|STARTED|Overall Study||4
8881567|NCT01949545|9938774|FG000|COMPLETED|Overall Study||11
8881568|NCT01949545|9938775|FG001|COMPLETED|Overall Study||17
8881569|NCT01949545|9938776|FG002|COMPLETED|Overall Study||14
8881570|NCT01949545|9938777|FG003|COMPLETED|Overall Study||4
8881571|NCT01949545|9938774|FG000|NOT COMPLETED|Overall Study||0
8881572|NCT01949545|9938775|FG001|NOT COMPLETED|Overall Study||0
8634098|NCT00554996|9674400|FG000|COMPLETED|Overall Study||10
8634099|NCT00554996|9674400|FG000|NOT COMPLETED|Overall Study||0
8634100|NCT00555048|9674404|FG000|STARTED|Overall Study||1
8634101|NCT00555048|9674404|FG000|COMPLETED|Overall Study||1
8881573|NCT01949545|9938776|FG002|NOT COMPLETED|Overall Study||0
8881574|NCT01949545|9938777|FG003|NOT COMPLETED|Overall Study||0
8881575|NCT01949662|9938789|FG000|STARTED|Overall Study||47
8881576|NCT01949662|9938790|FG001|STARTED|Overall Study||43
8881577|NCT01949662|9938789|FG000|COMPLETED|Overall Study||29
8881578|NCT01949662|9938790|FG001|COMPLETED|Overall Study||29
8881579|NCT01949662|9938789|FG000|NOT COMPLETED|Overall Study||18
8881580|NCT01949662|9938790|FG001|NOT COMPLETED|Overall Study||14
8881581|NCT01949779|9938796|FG000|STARTED|Overall Study||81
8881582|NCT01949779|9938796|FG000|COMPLETED|Overall Study||79
8881583|NCT01949779|9938796|FG000|NOT COMPLETED|Overall Study||2
8881584|NCT01949844|9938800|FG000|STARTED|Overall Study||44
8881585|NCT01949844|9938800|FG000|COMPLETED|Overall Study||44
8881586|NCT01949844|9938800|FG000|NOT COMPLETED|Overall Study||0
8881587|NCT01949870|9938804|FG000|STARTED|Overall Study||6
8634102|NCT00555048|9674404|FG000|NOT COMPLETED|Overall Study||0
8634103|NCT00555061|9674408|FG000|STARTED|Overall Study|One participant did not receive study medication and was not included in the analysis population.|87
8881588|NCT01949870|9938804|FG000|Received Treatment|Overall Study||4
8881589|NCT01949870|9938804|FG000|COMPLETED|Overall Study||0
8881590|NCT01949870|9938804|FG000|NOT COMPLETED|Overall Study||6
8881591|NCT01950013|9938811|FG000|STARTED|Overall Study||15
8881592|NCT01950013|9938812|FG001|STARTED|Overall Study||15
8881593|NCT01950013|9938813|FG002|STARTED|Overall Study||15
8881594|NCT01950013|9938811|FG000|COMPLETED|Overall Study||15
8881595|NCT01950013|9938812|FG001|COMPLETED|Overall Study||13
8881596|NCT01950013|9938813|FG002|COMPLETED|Overall Study||15
8881597|NCT01950013|9938811|FG000|NOT COMPLETED|Overall Study||0
8881598|NCT01950013|9938812|FG001|NOT COMPLETED|Overall Study||2
8881599|NCT01950013|9938813|FG002|NOT COMPLETED|Overall Study||0
8881600|NCT01950039|9938823|FG000|STARTED|Overall Study||15
8881601|NCT01950039|9938824|FG001|STARTED|Overall Study||13
8881602|NCT01950039|9938823|FG000|Study Drug Initiated|Overall Study||14
8881603|NCT01950039|9938824|FG001|Study Drug Initiated|Overall Study||13
8881604|NCT01950039|9938823|FG000|Completed Clamp|Overall Study||13
8881605|NCT01950039|9938824|FG001|Completed Clamp|Overall Study||12
8881606|NCT01950039|9938823|FG000|Completed MRI|Overall Study||13
8881607|NCT01950039|9938824|FG001|Completed MRI|Overall Study||12
8881608|NCT01950039|9938823|FG000|Completed Endothelial Evaluation|Overall Study||14
8881609|NCT01950039|9938824|FG001|Completed Endothelial Evaluation|Overall Study||12
8881610|NCT01950039|9938823|FG000|COMPLETED|Overall Study||14
8881611|NCT01950039|9938824|FG001|COMPLETED|Overall Study||13
8881612|NCT01950039|9938823|FG000|NOT COMPLETED|Overall Study||1
8881613|NCT01950039|9938824|FG001|NOT COMPLETED|Overall Study||0
8881614|NCT01950078|9938832|FG000|STARTED|Overall Study||1025
8881615|NCT01950078|9938833|FG001|STARTED|Overall Study||508
8881616|NCT01950078|9938832|FG000|COMPLETED|Overall Study||1005
8881617|NCT01950078|9938833|FG001|COMPLETED|Overall Study||496
8881618|NCT01950078|9938832|FG000|NOT COMPLETED|Overall Study||20
8881619|NCT01950078|9938833|FG001|NOT COMPLETED|Overall Study||12
8881620|NCT01950169|9938842|FG000|STARTED|Overall Study||28
8881621|NCT01950169|9938843|FG001|STARTED|Overall Study||26
8881622|NCT01950169|9938844|FG002|STARTED|Overall Study||25
8881623|NCT01950169|9938842|FG000|COMPLETED|Overall Study||25
8881624|NCT01950169|9938843|FG001|COMPLETED|Overall Study||18
8881625|NCT01950169|9938844|FG002|COMPLETED|Overall Study||24
8881626|NCT01950169|9938842|FG000|NOT COMPLETED|Overall Study||3
8881627|NCT01950169|9938843|FG001|NOT COMPLETED|Overall Study||8
8881628|NCT01950169|9938844|FG002|NOT COMPLETED|Overall Study||1
8881629|NCT01950260|9938855|FG000|STARTED|Overall Study||30
8881630|NCT01950260|9938856|FG001|STARTED|Overall Study||31
8881631|NCT01950260|9938855|FG000|COMPLETED|Overall Study||30
8881632|NCT01950260|9938856|FG001|COMPLETED|Overall Study||31
9002441|NCT02910102|10065667|FG000|Per-Protocol Population|Overall Study||20
9002442|NCT02910102|10065668|FG001|Per-Protocol Population|Overall Study||17
9002443|NCT02910102|10065667|FG000|COMPLETED|Overall Study||21
9002444|NCT02910102|10065668|FG001|COMPLETED|Overall Study||17
9002445|NCT02910102|10065667|FG000|NOT COMPLETED|Overall Study||0
9002446|NCT02910102|10065668|FG001|NOT COMPLETED|Overall Study||0
9002447|NCT02910167|10065679|FG000|STARTED|Overall Study||360
9002448|NCT02910167|10065679|FG000|COMPLETED|Overall Study||341
9002449|NCT02910167|10065679|FG000|NOT COMPLETED|Overall Study||19
9002450|NCT02910362|10065685|FG000|STARTED|Overall Study||8
9002451|NCT02910362|10065686|FG001|STARTED|Overall Study||7
9002452|NCT02910362|10065685|FG000|COMPLETED|Overall Study||8
8634104|NCT00555061|9674408|FG000|COMPLETED|Overall Study||78
8634105|NCT00555061|9674408|FG000|NOT COMPLETED|Overall Study||9
8634106|NCT00555152|9674416|FG000|STARTED|Period Open at BCM: 1/17/08-3/8/10||2
8634107|NCT00555152|9674417|FG001|STARTED|Period Open at BCM: 1/17/08-3/8/10|Participants in initial and second study registration periods reported separately.|0
8634108|NCT00555152|9674418|FG002|STARTED|Period Open at BCM: 1/17/08-3/8/10||0
8634109|NCT00555152|9674419|FG003|STARTED|Period Open at BCM: 1/17/08-3/8/10||1
8634110|NCT00555152|9674416|FG000|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||2
8634111|NCT00555152|9674417|FG001|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
8634112|NCT00555152|9674418|FG002|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
8634113|NCT00555152|9674419|FG003|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||1
8634114|NCT00555152|9674416|FG000|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
8634115|NCT00555152|9674417|FG001|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
8634116|NCT00555152|9674418|FG002|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
8634117|NCT00555152|9674419|FG003|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
8634118|NCT00555152|9674416|FG000|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14|Participants in initial and second study registration periods reported separately.|0
8634119|NCT00555152|9674417|FG001|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14||10
8634120|NCT00555152|9674418|FG002|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14||0
8634121|NCT00555152|9674419|FG003|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14||9
8634122|NCT00555152|9674416|FG000|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
8634123|NCT00555152|9674417|FG001|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||10
8725927|NCT01033487|9773164|FG007|STARTED|Third Intervention Period||3
8881633|NCT01950260|9938855|FG000|NOT COMPLETED|Overall Study||0
8881634|NCT01950260|9938856|FG001|NOT COMPLETED|Overall Study||0
8881635|NCT01950273|9938864|FG000|STARTED|Overall Study||49
8881636|NCT01950273|9938865|FG001|STARTED|Overall Study||46
8881637|NCT01950273|9938864|FG000|COMPLETED|Overall Study||45
8881638|NCT01950273|9938865|FG001|COMPLETED|Overall Study||46
8881639|NCT01950273|9938864|FG000|NOT COMPLETED|Overall Study||4
9002453|NCT02910362|10065686|FG001|COMPLETED|Overall Study||7
9002454|NCT02910362|10065685|FG000|NOT COMPLETED|Overall Study||0
9002455|NCT02910362|10065686|FG001|NOT COMPLETED|Overall Study||0
9002456|NCT02910466|10065692|FG000|STARTED|Overall Study||39
9002457|NCT02910466|10065692|FG000|Safety Set|Overall Study||39
9002458|NCT02910466|10065692|FG000|Treated|Overall Study||36
9002459|NCT02910466|10065692|FG000|COMPLETED|Overall Study||0
9002460|NCT02910466|10065692|FG000|NOT COMPLETED|Overall Study||39
9002461|NCT02910674|10065696|FG000|STARTED|Overall Study||102
9002462|NCT02910674|10065696|FG000|COMPLETED|Overall Study||102
9002463|NCT02910674|10065696|FG000|NOT COMPLETED|Overall Study||0
9002464|NCT02910713|10065701|FG000|STARTED|Overall Study||185
9002465|NCT02910713|10065701|FG000|Safety Population: Entered CAE|Overall Study||171
9002466|NCT02910713|10065701|FG000|COMPLETED|Overall Study|Completed=Completed both Intranasal and Extranasal applications.|143
9002467|NCT02910713|10065701|FG000|NOT COMPLETED|Overall Study||42
9002468|NCT02910739|10065708|FG000|STARTED|Overall Study||8
9002469|NCT02910739|10065709|FG001|STARTED|Overall Study||8
9002470|NCT02910739|10065710|FG002|STARTED|Overall Study|Participants were not enrolled in Part II as the PK criterion from the Part I IA was not met.|0
9002471|NCT02910739|10065711|FG003|STARTED|Overall Study|Participants were not enrolled in Part II as the PK criterion from the Part I IA was not met.|0
8881640|NCT01950273|9938865|FG001|NOT COMPLETED|Overall Study||0
8881641|NCT01950299|9938874|FG000|STARTED|Overall Study||33
8881642|NCT01950299|9938875|FG001|STARTED|Overall Study||31
8881643|NCT01950299|9938876|FG002|STARTED|Overall Study||35
8881644|NCT01950299|9938874|FG000|COMPLETED|Overall Study||22
8881645|NCT01950299|9938875|FG001|COMPLETED|Overall Study||27
8881646|NCT01950299|9938876|FG002|COMPLETED|Overall Study||28
8881647|NCT01950299|9938874|FG000|NOT COMPLETED|Overall Study||11
8881648|NCT01950299|9938875|FG001|NOT COMPLETED|Overall Study||4
8881649|NCT01950299|9938876|FG002|NOT COMPLETED|Overall Study||7
8881650|NCT01950364|9938886|FG000|STARTED|Overall Study||10
8881651|NCT01950364|9938887|FG001|STARTED|Overall Study||10
8881652|NCT01950364|9938886|FG000|COMPLETED|Overall Study||0
8881653|NCT01950364|9938887|FG001|COMPLETED|Overall Study||0
8881654|NCT01950364|9938886|FG000|NOT COMPLETED|Overall Study||10
8881655|NCT01950364|9938887|FG001|NOT COMPLETED|Overall Study||10
8881656|NCT01950663|9938893|FG000|STARTED|Overall Study||468
9002472|NCT02910739|10065708|FG000|COMPLETED|Overall Study||7
9002473|NCT02910739|10065709|FG001|COMPLETED|Overall Study||8
9002474|NCT02910739|10065710|FG002|COMPLETED|Overall Study|Participants were not enrolled in Part II as the PK criterion from the Part I IA was not met.|0
9002475|NCT02910739|10065711|FG003|COMPLETED|Overall Study|Participants were not enrolled in Part II as the PK criterion from the Part I IA was not met.|0
9002476|NCT02910739|10065708|FG000|NOT COMPLETED|Overall Study||1
9002477|NCT02910739|10065709|FG001|NOT COMPLETED|Overall Study||0
9002478|NCT02910739|10065710|FG002|NOT COMPLETED|Overall Study||0
9002479|NCT02910739|10065711|FG003|NOT COMPLETED|Overall Study||0
9002480|NCT02911025|10065717|FG000|STARTED|Overall Study||13
9002481|NCT02911025|10065717|FG000|COMPLETED|Overall Study||10
8634124|NCT00555152|9674418|FG002|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
8634125|NCT00555152|9674419|FG003|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||9
8634126|NCT00555152|9674416|FG000|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
8881657|NCT01950663|9938893|FG000|COMPLETED|Overall Study||467
9002482|NCT02911025|10065717|FG000|NOT COMPLETED|Overall Study||3
9002483|NCT02911116|10065723|FG000|STARTED|Overall Study||5
9002484|NCT02911116|10065724|FG001|STARTED|Overall Study||3
9002485|NCT02911116|10065723|FG000|COMPLETED|Overall Study||4
9002486|NCT02911116|10065724|FG001|COMPLETED|Overall Study||2
9002487|NCT02911116|10065723|FG000|NOT COMPLETED|Overall Study||1
9002488|NCT02911116|10065724|FG001|NOT COMPLETED|Overall Study||1
9002489|NCT02911285|10065732|FG000|STARTED|Overall Study||49
9002490|NCT02911285|10065733|FG001|STARTED|Overall Study||41
8634127|NCT00555152|9674417|FG001|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
8881658|NCT01950663|9938893|FG000|NOT COMPLETED|Overall Study||1
8881659|NCT01950741|9938897|FG000|STARTED|Overall Study||48
8881660|NCT01950741|9938897|FG000|COMPLETED|Overall Study||45
8881661|NCT01950741|9938897|FG000|NOT COMPLETED|Overall Study||3
8881662|NCT01950780|9938901|FG000|STARTED|Overall Study||12
8881663|NCT01950780|9938901|FG000|COMPLETED|Overall Study||12
8881664|NCT01950780|9938901|FG000|NOT COMPLETED|Overall Study||0
8881665|NCT01950819|9938908|FG000|STARTED|Overall Study||1022
8881666|NCT01950819|9938909|FG001|STARTED|Overall Study||1015
8881667|NCT01950819|9938908|FG000|COMPLETED|Overall Study||893
8881668|NCT01950819|9938909|FG001|COMPLETED|Overall Study||881
8881669|NCT01950819|9938908|FG000|NOT COMPLETED|Overall Study||129
8881670|NCT01950819|9938909|FG001|NOT COMPLETED|Overall Study||134
8881671|NCT01951066|9938915|FG000|STARTED|First Intervention (Baseline to Week 16)||10
8881672|NCT01951066|9938916|FG001|STARTED|First Intervention (Baseline to Week 16)||10
8881673|NCT01951066|9938915|FG000|COMPLETED|First Intervention (Baseline to Week 16)||10
8881674|NCT01951066|9938916|FG001|COMPLETED|First Intervention (Baseline to Week 16)||10
8881675|NCT01951066|9938915|FG000|NOT COMPLETED|First Intervention (Baseline to Week 16)||0
8881676|NCT01951066|9938916|FG001|NOT COMPLETED|First Intervention (Baseline to Week 16)||0
8881677|NCT01951066|9938915|FG000|STARTED|Second Intervention (Week 16 to Week 32)||10
8881678|NCT01951066|9938916|FG001|STARTED|Second Intervention (Week 16 to Week 32)||10
8881679|NCT01951066|9938915|FG000|COMPLETED|Second Intervention (Week 16 to Week 32)||10
8881680|NCT01951066|9938916|FG001|COMPLETED|Second Intervention (Week 16 to Week 32)||10
8881681|NCT01951066|9938915|FG000|NOT COMPLETED|Second Intervention (Week 16 to Week 32)||0
8881682|NCT01951066|9938916|FG001|NOT COMPLETED|Second Intervention (Week 16 to Week 32)||0
8881683|NCT01951092|9938921|FG000|STARTED|Overall Study||32
8881684|NCT01951092|9938921|FG000|COMPLETED|Overall Study||20
8881685|NCT01951092|9938921|FG000|NOT COMPLETED|Overall Study||12
8881686|NCT01951105|9938928|FG000|STARTED|Overall Study||11
8881687|NCT01951105|9938929|FG001|STARTED|Overall Study||31
8881688|NCT01951105|9938930|FG002|STARTED|Overall Study||30
8634128|NCT00555152|9674418|FG002|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
8634129|NCT00555152|9674419|FG003|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
8881689|NCT01951105|9938928|FG000|Completed 12 Weeks Treatment|Overall Study||10
8881690|NCT01951105|9938929|FG001|Completed 12 Weeks Treatment|Overall Study||24
8881691|NCT01951105|9938930|FG002|Completed 12 Weeks Treatment|Overall Study||28
8881692|NCT01951105|9938928|FG000|COMPLETED|Overall Study||10
8881693|NCT01951105|9938929|FG001|COMPLETED|Overall Study||21
8881694|NCT01951105|9938930|FG002|COMPLETED|Overall Study||28
8881695|NCT01951105|9938928|FG000|NOT COMPLETED|Overall Study||1
8881696|NCT01951105|9938929|FG001|NOT COMPLETED|Overall Study||10
8881697|NCT01951105|9938930|FG002|NOT COMPLETED|Overall Study||2
8881698|NCT01951118|9938944|FG000|STARTED|Overall Study||121
8881699|NCT01951118|9938944|FG000|COMPLETED|Overall Study||94
8881700|NCT01951118|9938944|FG000|NOT COMPLETED|Overall Study||27
8881701|NCT01951157|9938956|FG000|STARTED|Overall Study||22
8881702|NCT01951157|9938957|FG001|STARTED|Overall Study||22
8881703|NCT01951157|9938958|FG002|STARTED|Overall Study||25
8881704|NCT01951157|9938956|FG000|COMPLETED|Overall Study||0
8881705|NCT01951157|9938957|FG001|COMPLETED|Overall Study||0
8881706|NCT01951157|9938958|FG002|COMPLETED|Overall Study||0
8881707|NCT01951157|9938956|FG000|NOT COMPLETED|Overall Study||22
8881708|NCT01951157|9938957|FG001|NOT COMPLETED|Overall Study||22
8881709|NCT01951157|9938958|FG002|NOT COMPLETED|Overall Study||25
8881710|NCT01951170|9938967|FG000|STARTED|Overall Study||52
8881711|NCT01951170|9938967|FG000|COMPLETED|Overall Study||51
8881712|NCT01951170|9938967|FG000|NOT COMPLETED|Overall Study||1
8881713|NCT01951261|9938973|FG000|STARTED|Overall Study||58
8881714|NCT01951261|9938974|FG001|STARTED|Overall Study||58
8881715|NCT01951261|9938973|FG000|Discontinued|Overall Study|"2-readmission when was at home~1-monitor failure~1-new home hospitalitation 4-missing~1-death"|9
8881716|NCT01951261|9938974|FG001|Discontinued|Overall Study|"2-readmission when was at home~1-new home hospitalitation 3-missing"|6
8881717|NCT01951261|9938973|FG000|COMPLETED|Overall Study||49
8881718|NCT01951261|9938974|FG001|COMPLETED|Overall Study||52
8881719|NCT01951261|9938973|FG000|NOT COMPLETED|Overall Study||9
9002491|NCT02911285|10065732|FG000|COMPLETED|Overall Study||40
9002492|NCT02911285|10065733|FG001|COMPLETED|Overall Study||36
9002493|NCT02911285|10065732|FG000|NOT COMPLETED|Overall Study||9
9002494|NCT02911285|10065733|FG001|NOT COMPLETED|Overall Study||5
9002495|NCT02911324|10065745|FG000|STARTED|Overall Study||9
9002496|NCT02911324|10065746|FG001|STARTED|Overall Study||7
9002497|NCT02911324|10065745|FG000|COMPLETED|Overall Study||6
9002498|NCT02911324|10065746|FG001|COMPLETED|Overall Study||6
9002499|NCT02911324|10065745|FG000|NOT COMPLETED|Overall Study||3
9002500|NCT02911324|10065746|FG001|NOT COMPLETED|Overall Study||1
9002501|NCT02911519|10065755|FG000|STARTED|Overall Study||90
9002502|NCT02911519|10065756|FG001|STARTED|Overall Study||86
9002503|NCT02911519|10065755|FG000|COMPLETED|Overall Study||88
9002504|NCT02911519|10065756|FG001|COMPLETED|Overall Study||82
9002505|NCT02911519|10065755|FG000|NOT COMPLETED|Overall Study||2
9002506|NCT02911519|10065756|FG001|NOT COMPLETED|Overall Study||4
9002507|NCT02911688|10065764|FG000|STARTED|First Intervention||9
9002508|NCT02911688|10065765|FG001|STARTED|First Intervention||9
8634130|NCT00555217|9674431|FG000|STARTED|Overall Study||724
8634131|NCT00555217|9674432|FG001|STARTED|Overall Study||724
8634132|NCT00555217|9674431|FG000|COMPLETED|Overall Study||649
8634133|NCT00555217|9674432|FG001|COMPLETED|Overall Study||656
8881720|NCT01951261|9938974|FG001|NOT COMPLETED|Overall Study||6
8881721|NCT01951326|9938982|FG000|STARTED|Overall Study||166
9002509|NCT02911688|10065764|FG000|Received Intervention|First Intervention||9
9002510|NCT02911688|10065765|FG001|Received Intervention|First Intervention||9
9002511|NCT02911688|10065764|FG000|COMPLETED|First Intervention||9
9002512|NCT02911688|10065765|FG001|COMPLETED|First Intervention||9
8881722|NCT01951326|9938983|FG001|STARTED|Overall Study||165
8881723|NCT01951326|9938982|FG000|COMPLETED|Overall Study||87
8881724|NCT01951326|9938983|FG001|COMPLETED|Overall Study||87
8881725|NCT01951326|9938982|FG000|NOT COMPLETED|Overall Study||79
8881726|NCT01951326|9938983|FG001|NOT COMPLETED|Overall Study||78
8881727|NCT01951339|9938992|FG000|STARTED|Overall Study||15
8881728|NCT01951339|9938993|FG001|STARTED|Overall Study||15
8881729|NCT01951339|9938992|FG000|COMPLETED|Overall Study||13
8881730|NCT01951339|9938993|FG001|COMPLETED|Overall Study||14
8881731|NCT01951339|9938992|FG000|NOT COMPLETED|Overall Study||2
8881732|NCT01951339|9938993|FG001|NOT COMPLETED|Overall Study||1
8881733|NCT01951352|9938999|FG000|STARTED|Overall Study||10
8881734|NCT01951352|9938999|FG000|COMPLETED|Overall Study||10
8881735|NCT01951352|9938999|FG000|NOT COMPLETED|Overall Study||0
8881736|NCT01951391|9939005|FG000|STARTED|Overall Study||5
8881737|NCT01951391|9939006|FG001|STARTED|Overall Study||5
8881738|NCT01951391|9939005|FG000|COMPLETED|Overall Study||5
8881739|NCT01951391|9939006|FG001|COMPLETED|Overall Study||5
8881740|NCT01951391|9939005|FG000|NOT COMPLETED|Overall Study||0
8881741|NCT01951391|9939006|FG001|NOT COMPLETED|Overall Study||0
8881742|NCT01951417|9939014|FG000|STARTED|Overall Study||81
8881743|NCT01951417|9939014|FG000|COMPLETED|Overall Study||72
8881744|NCT01951417|9939014|FG000|NOT COMPLETED|Overall Study||9
8881745|NCT01951573|9939022|FG000|STARTED|Period 1, First 9 Hours of Wear||17
8881746|NCT01951573|9939023|FG001|STARTED|Period 1, First 9 Hours of Wear||17
8881747|NCT01951573|9939022|FG000|COMPLETED|Period 1, First 9 Hours of Wear||17
8881748|NCT01951573|9939023|FG001|COMPLETED|Period 1, First 9 Hours of Wear||17
8881749|NCT01951573|9939022|FG000|NOT COMPLETED|Period 1, First 9 Hours of Wear||0
8881750|NCT01951573|9939023|FG001|NOT COMPLETED|Period 1, First 9 Hours of Wear||0
8881751|NCT01951573|9939022|FG000|STARTED|Washout Period||17
8881752|NCT01951573|9939023|FG001|STARTED|Washout Period||17
8881753|NCT01951573|9939022|FG000|COMPLETED|Washout Period||17
8881754|NCT01951573|9939023|FG001|COMPLETED|Washout Period||16
8881755|NCT01951573|9939022|FG000|NOT COMPLETED|Washout Period||0
8881756|NCT01951573|9939023|FG001|NOT COMPLETED|Washout Period||1
8881757|NCT01951573|9939022|FG000|STARTED|Period 2, Second 9 Hours of Wear||17
8881758|NCT01951573|9939023|FG001|STARTED|Period 2, Second 9 Hours of Wear||16
8881759|NCT01951573|9939022|FG000|COMPLETED|Period 2, Second 9 Hours of Wear||17
8881760|NCT01951573|9939023|FG001|COMPLETED|Period 2, Second 9 Hours of Wear||16
8881761|NCT01951573|9939022|FG000|NOT COMPLETED|Period 2, Second 9 Hours of Wear||0
8881762|NCT01951573|9939023|FG001|NOT COMPLETED|Period 2, Second 9 Hours of Wear||0
8881763|NCT01951586|9939031|FG000|STARTED|Overall Study||78
8881764|NCT01951586|9939032|FG001|STARTED|Overall Study||148
8881765|NCT01951586|9939031|FG000|Received Study Drug|Overall Study||76
8881766|NCT01951586|9939032|FG001|Received Study Drug|Overall Study||145
8881767|NCT01951586|9939031|FG000|COMPLETED|Overall Study||0
8881768|NCT01951586|9939032|FG001|COMPLETED|Overall Study||0
8881769|NCT01951586|9939031|FG000|NOT COMPLETED|Overall Study||78
8881770|NCT01951586|9939032|FG001|NOT COMPLETED|Overall Study||148
8881771|NCT01951625|9939044|FG000|STARTED|Treatment Period||92
8881772|NCT01951625|9939045|FG001|STARTED|Treatment Period||91
8881773|NCT01951625|9939046|FG002|STARTED|Treatment Period||91
8881774|NCT01951625|9939047|FG003|STARTED|Treatment Period||91
8881775|NCT01951625|9939048|FG004|STARTED|Treatment Period||91
8881776|NCT01951625|9939044|FG000|COMPLETED|Treatment Period||73
8881777|NCT01951625|9939045|FG001|COMPLETED|Treatment Period||70
8881778|NCT01951625|9939046|FG002|COMPLETED|Treatment Period||76
8881779|NCT01951625|9939047|FG003|COMPLETED|Treatment Period||69
8881780|NCT01951625|9939048|FG004|COMPLETED|Treatment Period||74
8881781|NCT01951625|9939044|FG000|NOT COMPLETED|Treatment Period||19
8881782|NCT01951625|9939045|FG001|NOT COMPLETED|Treatment Period||21
8881783|NCT01951625|9939046|FG002|NOT COMPLETED|Treatment Period||15
8881784|NCT01951625|9939047|FG003|NOT COMPLETED|Treatment Period||22
8881785|NCT01951625|9939048|FG004|NOT COMPLETED|Treatment Period||17
8881786|NCT01951625|9939044|FG000|STARTED|Follow Up Period||87
8881787|NCT01951625|9939045|FG001|STARTED|Follow Up Period||88
8881788|NCT01951625|9939046|FG002|STARTED|Follow Up Period||88
8881789|NCT01951625|9939047|FG003|STARTED|Follow Up Period||87
8881790|NCT01951625|9939048|FG004|STARTED|Follow Up Period||88
8881791|NCT01951625|9939044|FG000|COMPLETED|Follow Up Period||79
8881792|NCT01951625|9939045|FG001|COMPLETED|Follow Up Period||79
8881793|NCT01951625|9939046|FG002|COMPLETED|Follow Up Period||84
8881794|NCT01951625|9939047|FG003|COMPLETED|Follow Up Period||76
8881795|NCT01951625|9939048|FG004|COMPLETED|Follow Up Period||78
8881796|NCT01951625|9939044|FG000|NOT COMPLETED|Follow Up Period||8
8881797|NCT01951625|9939045|FG001|NOT COMPLETED|Follow Up Period||9
8881798|NCT01951625|9939046|FG002|NOT COMPLETED|Follow Up Period||4
8725928|NCT01033487|9773165|FG008|STARTED|Third Intervention Period||2
8881799|NCT01951625|9939047|FG003|NOT COMPLETED|Follow Up Period||11
8881800|NCT01951625|9939048|FG004|NOT COMPLETED|Follow Up Period||10
8881801|NCT01951638|9939066|FG000|STARTED|Treatment Period||93
8881802|NCT01951638|9939067|FG001|STARTED|Treatment Period||96
8881803|NCT01951638|9939068|FG002|STARTED|Treatment Period||96
8881804|NCT01951638|9939069|FG003|STARTED|Treatment Period||96
8725929|NCT01033487|9773166|FG009|STARTED|Third Intervention Period||2
8725930|NCT01033487|9773157|FG000|COMPLETED|Third Intervention Period||2
8881805|NCT01951638|9939070|FG004|STARTED|Treatment Period||96
8881806|NCT01951638|9939066|FG000|COMPLETED|Treatment Period||80
8881807|NCT01951638|9939067|FG001|COMPLETED|Treatment Period||82
8881808|NCT01951638|9939068|FG002|COMPLETED|Treatment Period||83
8881809|NCT01951638|9939069|FG003|COMPLETED|Treatment Period||80
8881810|NCT01951638|9939070|FG004|COMPLETED|Treatment Period||86
8881811|NCT01951638|9939066|FG000|NOT COMPLETED|Treatment Period||13
8881812|NCT01951638|9939067|FG001|NOT COMPLETED|Treatment Period||14
8881813|NCT01951638|9939068|FG002|NOT COMPLETED|Treatment Period||13
8881814|NCT01951638|9939069|FG003|NOT COMPLETED|Treatment Period||16
8881815|NCT01951638|9939070|FG004|NOT COMPLETED|Treatment Period||10
8881816|NCT01951638|9939066|FG000|STARTED|Follow-up Period||89
9002513|NCT02911688|10065764|FG000|NOT COMPLETED|First Intervention||0
9002514|NCT02911688|10065765|FG001|NOT COMPLETED|First Intervention||0
9002515|NCT02911688|10065764|FG000|STARTED|Washout||9
9002516|NCT02911688|10065765|FG001|STARTED|Washout||9
9002517|NCT02911688|10065764|FG000|COMPLETED|Washout||8
9002518|NCT02911688|10065765|FG001|COMPLETED|Washout||7
9002519|NCT02911688|10065764|FG000|NOT COMPLETED|Washout||1
9002520|NCT02911688|10065765|FG001|NOT COMPLETED|Washout||2
9002521|NCT02911688|10065764|FG000|STARTED|Second Intervention||8
9002522|NCT02911688|10065765|FG001|STARTED|Second Intervention||7
9002523|NCT02911688|10065764|FG000|COMPLETED|Second Intervention||8
9002524|NCT02911688|10065765|FG001|COMPLETED|Second Intervention||7
9002525|NCT02911688|10065764|FG000|NOT COMPLETED|Second Intervention||0
9002526|NCT02911688|10065765|FG001|NOT COMPLETED|Second Intervention||0
9002527|NCT02911753|10065776|FG000|STARTED|Overall Study||21
9002528|NCT02911753|10065777|FG001|STARTED|Overall Study||19
9002529|NCT02911753|10065778|FG002|STARTED|Overall Study||10
9002530|NCT02911753|10065776|FG000|COMPLETED|Overall Study||18
8634134|NCT00555217|9674431|FG000|NOT COMPLETED|Overall Study||75
8634135|NCT00555217|9674432|FG001|NOT COMPLETED|Overall Study||68
8634136|NCT00555321|9674443|FG000|STARTED|Treatment Phase up to 12-months||52
8634137|NCT00555321|9674444|FG001|STARTED|Treatment Phase up to 12-months||51
8725931|NCT01033487|9773158|FG001|COMPLETED|Third Intervention Period||3
9002531|NCT02911753|10065777|FG001|COMPLETED|Overall Study||16
9002532|NCT02911753|10065778|FG002|COMPLETED|Overall Study||10
9002533|NCT02911753|10065776|FG000|NOT COMPLETED|Overall Study||3
9002534|NCT02911753|10065777|FG001|NOT COMPLETED|Overall Study||3
9002535|NCT02911753|10065778|FG002|NOT COMPLETED|Overall Study||0
9002536|NCT02911818|10065807|FG000|STARTED|52 Week Study||50
9002537|NCT02911818|10065808|FG001|STARTED|52 Week Study||50
9002538|NCT02911818|10065809|FG002|STARTED|52 Week Study||50
9002539|NCT02911818|10065810|FG003|STARTED|52 Week Study||0
9002540|NCT02911818|10065811|FG004|STARTED|52 Week Study||0
9002541|NCT02911818|10065807|FG000|COMPLETED|52 Week Study||46
9002542|NCT02911818|10065808|FG001|COMPLETED|52 Week Study||45
9002543|NCT02911818|10065809|FG002|COMPLETED|52 Week Study||46
9002544|NCT02911818|10065810|FG003|COMPLETED|52 Week Study||0
9002545|NCT02911818|10065811|FG004|COMPLETED|52 Week Study||0
9002546|NCT02911818|10065807|FG000|NOT COMPLETED|52 Week Study||4
9002547|NCT02911818|10065808|FG001|NOT COMPLETED|52 Week Study||5
9002548|NCT02911818|10065809|FG002|NOT COMPLETED|52 Week Study||4
9002549|NCT02911818|10065810|FG003|NOT COMPLETED|52 Week Study||0
9002550|NCT02911818|10065811|FG004|NOT COMPLETED|52 Week Study||0
9002551|NCT02911818|10065807|FG000|STARTED|12 Week Extension Study||0
9002552|NCT02911818|10065808|FG001|STARTED|12 Week Extension Study||0
9002553|NCT02911818|10065809|FG002|STARTED|12 Week Extension Study||0
9002554|NCT02911818|10065810|FG003|STARTED|12 Week Extension Study||22
9002555|NCT02911818|10065811|FG004|STARTED|12 Week Extension Study||23
9002556|NCT02911818|10065807|FG000|COMPLETED|12 Week Extension Study||0
9002557|NCT02911818|10065808|FG001|COMPLETED|12 Week Extension Study||0
9002558|NCT02911818|10065809|FG002|COMPLETED|12 Week Extension Study||0
9002559|NCT02911818|10065810|FG003|COMPLETED|12 Week Extension Study||22
9002560|NCT02911818|10065811|FG004|COMPLETED|12 Week Extension Study||22
9002561|NCT02911818|10065807|FG000|NOT COMPLETED|12 Week Extension Study||0
9002562|NCT02911818|10065808|FG001|NOT COMPLETED|12 Week Extension Study||0
9002563|NCT02911818|10065809|FG002|NOT COMPLETED|12 Week Extension Study||0
8725932|NCT01033487|9773159|FG002|COMPLETED|Third Intervention Period||2
8725933|NCT01033487|9773160|FG003|COMPLETED|Third Intervention Period||2
8725934|NCT01033487|9773161|FG004|COMPLETED|Third Intervention Period||2
8881817|NCT01951638|9939067|FG001|STARTED|Follow-up Period||95
8881818|NCT01951638|9939068|FG002|STARTED|Follow-up Period||95
8881819|NCT01951638|9939069|FG003|STARTED|Follow-up Period||88
9002564|NCT02911818|10065810|FG003|NOT COMPLETED|12 Week Extension Study||0
9002565|NCT02911818|10065811|FG004|NOT COMPLETED|12 Week Extension Study||1
9002566|NCT02911844|10065825|FG000|STARTED|Overall Study||5
8634138|NCT00555321|9674445|FG002|STARTED|Treatment Phase up to 12-months||50
8634139|NCT00555321|9674446|FG003|STARTED|Treatment Phase up to 12-months||53
8634140|NCT00555321|9674447|FG004|STARTED|Treatment Phase up to 12-months||54
8634141|NCT00555321|9674443|FG000|Received Transplant and Treated|Treatment Phase up to 12-months||50
8634142|NCT00555321|9674444|FG001|Received Transplant and Treated|Treatment Phase up to 12-months||48
8881820|NCT01951638|9939070|FG004|STARTED|Follow-up Period||94
8634143|NCT00555321|9674445|FG002|Received Transplant and Treated|Treatment Phase up to 12-months||49
9002567|NCT02911844|10065825|FG000|COMPLETED|Overall Study||5
9002568|NCT02911844|10065825|FG000|NOT COMPLETED|Overall Study||0
9002569|NCT02911857|10065832|FG000|STARTED|Overall Study||2
9002570|NCT02911857|10065833|FG001|STARTED|Overall Study||1
9002571|NCT02911857|10065834|FG002|STARTED|Overall Study||1
9002572|NCT02911857|10065832|FG000|COMPLETED|Overall Study||2
9002573|NCT02911857|10065833|FG001|COMPLETED|Overall Study||1
9002574|NCT02911857|10065834|FG002|COMPLETED|Overall Study||1
9002575|NCT02911857|10065832|FG000|NOT COMPLETED|Overall Study||0
8881821|NCT01951638|9939066|FG000|COMPLETED|Follow-up Period||87
8881822|NCT01951638|9939067|FG001|COMPLETED|Follow-up Period||86
8881823|NCT01951638|9939068|FG002|COMPLETED|Follow-up Period||90
8881824|NCT01951638|9939069|FG003|COMPLETED|Follow-up Period||80
8881825|NCT01951638|9939070|FG004|COMPLETED|Follow-up Period||89
8881826|NCT01951638|9939066|FG000|NOT COMPLETED|Follow-up Period||2
8881827|NCT01951638|9939067|FG001|NOT COMPLETED|Follow-up Period||9
8881828|NCT01951638|9939068|FG002|NOT COMPLETED|Follow-up Period||5
8881829|NCT01951638|9939069|FG003|NOT COMPLETED|Follow-up Period||8
8881830|NCT01951638|9939070|FG004|NOT COMPLETED|Follow-up Period||5
8881831|NCT01951651|9939084|FG000|STARTED|Overall Study||12
8881832|NCT01951651|9939085|FG001|STARTED|Overall Study||12
8881833|NCT01951651|9939084|FG000|COMPLETED|Overall Study||8
8881834|NCT01951651|9939085|FG001|COMPLETED|Overall Study||10
8881835|NCT01951651|9939084|FG000|NOT COMPLETED|Overall Study||4
8881836|NCT01951651|9939085|FG001|NOT COMPLETED|Overall Study||2
9002576|NCT02911857|10065833|FG001|NOT COMPLETED|Overall Study||0
9002577|NCT02911857|10065834|FG002|NOT COMPLETED|Overall Study||0
9002578|NCT02911909|10065844|FG000|STARTED|Overall Study||4
9002579|NCT02911909|10065845|FG001|STARTED|Overall Study||3
9002580|NCT02911909|10065844|FG000|COMPLETED|Overall Study||2
9002581|NCT02911909|10065845|FG001|COMPLETED|Overall Study|No Data was obtained in the study group.|0
9002582|NCT02911909|10065844|FG000|NOT COMPLETED|Overall Study||2
9002583|NCT02911909|10065845|FG001|NOT COMPLETED|Overall Study||3
9002584|NCT02911922|10065853|FG000|STARTED|Overall Study||1
9002585|NCT02911922|10065854|FG001|STARTED|Overall Study||0
9002586|NCT02911922|10065853|FG000|COMPLETED|Overall Study||1
9002587|NCT02911922|10065854|FG001|COMPLETED|Overall Study||0
9002588|NCT02911922|10065853|FG000|NOT COMPLETED|Overall Study||0
9002589|NCT02911922|10065854|FG001|NOT COMPLETED|Overall Study||0
9002590|NCT02911948|10065864|FG000|STARTED|Overall Study||105
9002591|NCT02911948|10065865|FG001|STARTED|Overall Study||105
9002592|NCT02911948|10065864|FG000|COMPLETED|Overall Study||105
9002593|NCT02911948|10065865|FG001|COMPLETED|Overall Study||98
9002594|NCT02911948|10065864|FG000|NOT COMPLETED|Overall Study||0
9002595|NCT02911948|10065865|FG001|NOT COMPLETED|Overall Study||7
9002596|NCT02912195|10065873|FG000|STARTED|Overall Study||16
9002597|NCT02912195|10065874|FG001|STARTED|Overall Study||16
9002598|NCT02912195|10065873|FG000|COMPLETED|Overall Study||16
9002599|NCT02912195|10065874|FG001|COMPLETED|Overall Study||16
9002600|NCT02912195|10065873|FG000|NOT COMPLETED|Overall Study||0
9002601|NCT02912195|10065874|FG001|NOT COMPLETED|Overall Study||0
9002602|NCT02912364|10065880|FG000|STARTED|Treatment 1||23
9002603|NCT02912364|10065881|FG001|STARTED|Treatment 1||23
9002604|NCT02912364|10065880|FG000|Received Intervention|Treatment 1||18
9002605|NCT02912364|10065881|FG001|Received Intervention|Treatment 1||18
9002606|NCT02912364|10065880|FG000|COMPLETED|Treatment 1||13
9002607|NCT02912364|10065881|FG001|COMPLETED|Treatment 1||11
9002608|NCT02912364|10065880|FG000|NOT COMPLETED|Treatment 1||10
9002609|NCT02912364|10065881|FG001|NOT COMPLETED|Treatment 1||12
9002610|NCT02912364|10065880|FG000|STARTED|Washout Period||13
9002611|NCT02912364|10065881|FG001|STARTED|Washout Period||11
9002612|NCT02912364|10065880|FG000|COMPLETED|Washout Period||13
9002613|NCT02912364|10065881|FG001|COMPLETED|Washout Period||11
9002614|NCT02912364|10065880|FG000|NOT COMPLETED|Washout Period||0
9002615|NCT02912364|10065881|FG001|NOT COMPLETED|Washout Period||0
9002616|NCT02912364|10065880|FG000|STARTED|Treatment 2||13
9002617|NCT02912364|10065881|FG001|STARTED|Treatment 2||11
9002618|NCT02912364|10065880|FG000|Received Intervention|Treatment 2||12
9002619|NCT02912364|10065881|FG001|Received Intervention|Treatment 2||11
9002620|NCT02912364|10065880|FG000|COMPLETED|Treatment 2||12
9002621|NCT02912364|10065881|FG001|COMPLETED|Treatment 2||11
9002622|NCT02912364|10065880|FG000|NOT COMPLETED|Treatment 2||1
9002623|NCT02912364|10065881|FG001|NOT COMPLETED|Treatment 2||0
9002624|NCT02912455|10065892|FG000|STARTED|Overall Study||11
9002625|NCT02912455|10065893|FG001|STARTED|Overall Study||5
9002626|NCT02912455|10065892|FG000|COMPLETED|Overall Study||9
9002627|NCT02912455|10065893|FG001|COMPLETED|Overall Study||2
9002628|NCT02912455|10065892|FG000|NOT COMPLETED|Overall Study||2
9002629|NCT02912455|10065893|FG001|NOT COMPLETED|Overall Study||3
9002630|NCT02912468|10065901|FG000|STARTED|Overall Study||133
9002631|NCT02912468|10065902|FG001|STARTED|Overall Study||143
9002632|NCT02912468|10065901|FG000|Treated|Overall Study||133
9002633|NCT02912468|10065902|FG001|Treated|Overall Study||142
9002634|NCT02912468|10065901|FG000|Safety Population|Overall Study||132
9002635|NCT02912468|10065902|FG001|Safety Population|Overall Study||143
9002636|NCT02912468|10065901|FG000|COMPLETED|Overall Study||124
9002637|NCT02912468|10065902|FG001|COMPLETED|Overall Study||138
9002638|NCT02912468|10065901|FG000|NOT COMPLETED|Overall Study||9
9002639|NCT02912468|10065902|FG001|NOT COMPLETED|Overall Study||5
9002640|NCT02912650|10065913|FG000|STARTED|Overall Study||56
9002641|NCT02912650|10065914|FG001|STARTED|Overall Study||172
9002642|NCT02912650|10065915|FG002|STARTED|Overall Study||175
9002643|NCT02912650|10065916|FG003|STARTED|Overall Study||165
9002644|NCT02912650|10065913|FG000|COMPLETED|Overall Study||55
9002645|NCT02912650|10065914|FG001|COMPLETED|Overall Study||172
9002646|NCT02912650|10065915|FG002|COMPLETED|Overall Study||173
9002647|NCT02912650|10065916|FG003|COMPLETED|Overall Study||160
9002648|NCT02912650|10065913|FG000|NOT COMPLETED|Overall Study||1
9002649|NCT02912650|10065914|FG001|NOT COMPLETED|Overall Study||0
9002650|NCT02912650|10065915|FG002|NOT COMPLETED|Overall Study||2
9002651|NCT02912650|10065916|FG003|NOT COMPLETED|Overall Study||5
9002652|NCT02913105|10065929|FG000|STARTED|Overall Study||37
8881837|NCT01951703|9939093|FG000|STARTED|First Intervention||64
8881838|NCT01951703|9939094|FG001|STARTED|First Intervention||63
8881839|NCT01951703|9939093|FG000|COMPLETED|First Intervention||61
8881840|NCT01951703|9939094|FG001|COMPLETED|First Intervention||62
8881841|NCT01951703|9939093|FG000|NOT COMPLETED|First Intervention||3
8881842|NCT01951703|9939094|FG001|NOT COMPLETED|First Intervention||1
8881843|NCT01951703|9939093|FG000|STARTED|Second Intervention||61
8881844|NCT01951703|9939094|FG001|STARTED|Second Intervention||62
8881845|NCT01951703|9939093|FG000|COMPLETED|Second Intervention||61
8881846|NCT01951703|9939094|FG001|COMPLETED|Second Intervention||60
8881847|NCT01951703|9939093|FG000|NOT COMPLETED|Second Intervention||0
8881848|NCT01951703|9939094|FG001|NOT COMPLETED|Second Intervention||2
8881849|NCT01951768|9939103|FG000|STARTED|Overall Study||43
8881850|NCT01951768|9939104|FG001|STARTED|Overall Study||45
8881851|NCT01951768|9939103|FG000|COMPLETED|Overall Study|43 patients|43
8881852|NCT01951768|9939104|FG001|COMPLETED|Overall Study|45 patients|45
8881853|NCT01951768|9939103|FG000|NOT COMPLETED|Overall Study||0
8881854|NCT01951768|9939104|FG001|NOT COMPLETED|Overall Study||0
8881855|NCT01951820|9939112|FG000|STARTED|Overall Study||34
8881856|NCT01951820|9939113|FG001|STARTED|Overall Study||30
8881857|NCT01951820|9939112|FG000|COMPLETED|Overall Study||34
8881858|NCT01951820|9939113|FG001|COMPLETED|Overall Study||30
8881859|NCT01951820|9939112|FG000|NOT COMPLETED|Overall Study||0
8881860|NCT01951820|9939113|FG001|NOT COMPLETED|Overall Study||0
8881861|NCT01951950|9939121|FG000|STARTED|Overall Study||26
8881862|NCT01951950|9939122|FG001|STARTED|Overall Study||26
8881863|NCT01951950|9939121|FG000|COMPLETED|Overall Study||20
8881864|NCT01951950|9939122|FG001|COMPLETED|Overall Study||20
8881865|NCT01951950|9939121|FG000|NOT COMPLETED|Overall Study||6
8881866|NCT01951950|9939122|FG001|NOT COMPLETED|Overall Study||6
8881867|NCT01951963|9939130|FG000|STARTED|Overall Study||31
8881868|NCT01951963|9939131|FG001|STARTED|Overall Study||32
8881869|NCT01951963|9939130|FG000|COMPLETED|Overall Study||31
8881870|NCT01951963|9939131|FG001|COMPLETED|Overall Study||32
8881871|NCT01951963|9939130|FG000|NOT COMPLETED|Overall Study||0
8881872|NCT01951963|9939131|FG001|NOT COMPLETED|Overall Study||0
8881873|NCT01952015|9939141|FG000|STARTED|Induction||12
8881874|NCT01952015|9939141|FG000|COMPLETED|Induction||11
8881875|NCT01952015|9939141|FG000|NOT COMPLETED|Induction||1
8881876|NCT01952015|9939141|FG000|STARTED|Maintenance||11
8881877|NCT01952015|9939141|FG000|COMPLETED|Maintenance||9
8881878|NCT01952015|9939141|FG000|NOT COMPLETED|Maintenance||2
8881879|NCT01952015|9939141|FG000|STARTED|Treatment Period 3||9
8881880|NCT01952015|9939141|FG000|COMPLETED|Treatment Period 3||0
8881881|NCT01952015|9939141|FG000|NOT COMPLETED|Treatment Period 3||9
8881882|NCT01952041|9939159|FG000|STARTED|Overall Study||62
8881883|NCT01952041|9939160|FG001|STARTED|Overall Study||64
8881884|NCT01952041|9939159|FG000|COMPLETED|Overall Study||45
8881885|NCT01952041|9939160|FG001|COMPLETED|Overall Study||43
8881886|NCT01952041|9939159|FG000|NOT COMPLETED|Overall Study||17
8881887|NCT01952041|9939160|FG001|NOT COMPLETED|Overall Study||21
8881888|NCT01952054|9939166|FG000|STARTED|Overall Study||6
8881889|NCT01952054|9939166|FG000|COMPLETED|Overall Study||5
8881890|NCT01952054|9939166|FG000|NOT COMPLETED|Overall Study||1
8881891|NCT01952080|9939174|FG000|STARTED|Overall Study||5
8881892|NCT01952080|9939175|FG001|STARTED|Overall Study||8
8881893|NCT01952080|9939176|FG002|STARTED|Overall Study||14
8881894|NCT01952080|9939177|FG003|STARTED|Overall Study||15
8881895|NCT01952080|9939174|FG000|Treated|Overall Study||5
8881896|NCT01952080|9939175|FG001|Treated|Overall Study||8
8881897|NCT01952080|9939176|FG002|Treated|Overall Study||14
8881898|NCT01952080|9939177|FG003|Treated|Overall Study||15
8881899|NCT01952080|9939174|FG000|COMPLETED|Overall Study||5
8881900|NCT01952080|9939175|FG001|COMPLETED|Overall Study||7
8881901|NCT01952080|9939176|FG002|COMPLETED|Overall Study||14
8881902|NCT01952080|9939177|FG003|COMPLETED|Overall Study||14
8881903|NCT01952080|9939174|FG000|NOT COMPLETED|Overall Study||0
8881904|NCT01952080|9939175|FG001|NOT COMPLETED|Overall Study||1
8881905|NCT01952080|9939176|FG002|NOT COMPLETED|Overall Study||0
8881906|NCT01952080|9939177|FG003|NOT COMPLETED|Overall Study||1
8881907|NCT01952145|9939189|FG000|STARTED|Overall Study||278
8881908|NCT01952145|9939190|FG001|STARTED|Overall Study||279
9002653|NCT02913105|10065930|FG001|STARTED|Overall Study||44
9002654|NCT02913105|10065931|FG002|STARTED|Overall Study||40
9002655|NCT02913105|10065929|FG000|COMPLETED|Overall Study||22
9002656|NCT02913105|10065930|FG001|COMPLETED|Overall Study||39
8572620|NCT00116168|9604820|FG003|COMPLETED|Overall Study||6
8881909|NCT01952145|9939189|FG000|COMPLETED|Overall Study||250
8881910|NCT01952145|9939190|FG001|COMPLETED|Overall Study||265
8881911|NCT01952145|9939189|FG000|NOT COMPLETED|Overall Study||28
8881912|NCT01952145|9939190|FG001|NOT COMPLETED|Overall Study||14
8881913|NCT01952301|9939196|FG000|STARTED|Overall Study|We designed and implemented a single-blind, randomized, controlled, split-mouth study of 30 subjects|30
8881914|NCT01952301|9939196|FG000|COMPLETED|Overall Study||30
8881915|NCT01952301|9939196|FG000|NOT COMPLETED|Overall Study||0
8881916|NCT01952366|9939202|FG000|STARTED|Overall Study||169
8881917|NCT01952366|9939202|FG000|COMPLETED|Overall Study||138
8881918|NCT01952366|9939202|FG000|NOT COMPLETED|Overall Study||31
8881919|NCT01952418|9939211|FG000|STARTED|Overall Study||910
9002657|NCT02913105|10065931|FG002|COMPLETED|Overall Study||33
8881920|NCT01952418|9939212|FG001|STARTED|Overall Study||895
8881921|NCT01952418|9939211|FG000|COMPLETED|Overall Study||910
8881922|NCT01952418|9939212|FG001|COMPLETED|Overall Study||895
8881923|NCT01952418|9939211|FG000|NOT COMPLETED|Overall Study||0
8881924|NCT01952418|9939212|FG001|NOT COMPLETED|Overall Study||0
8881925|NCT01952444|9939220|FG000|STARTED|Overall Study||20
8881926|NCT01952444|9939221|FG001|STARTED|Overall Study||20
8881927|NCT01952444|9939220|FG000|COMPLETED|Overall Study||20
8881928|NCT01952444|9939221|FG001|COMPLETED|Overall Study||19
8881929|NCT01952444|9939220|FG000|NOT COMPLETED|Overall Study||0
8881930|NCT01952444|9939221|FG001|NOT COMPLETED|Overall Study||1
8881931|NCT01952470|9939234|FG000|STARTED|Overall Study||16
8881932|NCT01952470|9939235|FG001|STARTED|Overall Study||16
8881933|NCT01952470|9939234|FG000|ITT Analysis|Overall Study||16
8881934|NCT01952470|9939235|FG001|ITT Analysis|Overall Study||16
9002658|NCT02913105|10065929|FG000|NOT COMPLETED|Overall Study||15
9002659|NCT02913105|10065930|FG001|NOT COMPLETED|Overall Study||5
9002660|NCT02913105|10065931|FG002|NOT COMPLETED|Overall Study||7
9002661|NCT02913326|10065942|FG000|STARTED|Overall Study||60
9002662|NCT02913326|10065943|FG001|STARTED|Overall Study||60
9002663|NCT02913326|10065942|FG000|COMPLETED|Overall Study||59
9002664|NCT02913326|10065943|FG001|COMPLETED|Overall Study||58
9002665|NCT02913326|10065942|FG000|NOT COMPLETED|Overall Study||1
9002666|NCT02913326|10065943|FG001|NOT COMPLETED|Overall Study||2
9002667|NCT02913521|10065952|FG000|STARTED|Overall Study||316
9002668|NCT02913521|10065953|FG001|STARTED|Overall Study||312
9002669|NCT02913521|10065954|FG002|STARTED|Overall Study||306
9002670|NCT02913521|10065952|FG000|COMPLETED|Overall Study||263
9002671|NCT02913521|10065953|FG001|COMPLETED|Overall Study||262
9002672|NCT02913521|10065954|FG002|COMPLETED|Overall Study||261
9002673|NCT02913521|10065952|FG000|NOT COMPLETED|Overall Study||53
9002674|NCT02913521|10065953|FG001|NOT COMPLETED|Overall Study||50
9002675|NCT02913521|10065954|FG002|NOT COMPLETED|Overall Study||45
9002676|NCT02913924|10065964|FG000|STARTED|Overall Study||34
9002677|NCT02913924|10065965|FG001|STARTED|Overall Study||34
9002678|NCT02913924|10065964|FG000|COMPLETED|Overall Study||21
9002679|NCT02913924|10065965|FG001|COMPLETED|Overall Study||21
9002680|NCT02913924|10065964|FG000|NOT COMPLETED|Overall Study||13
9002681|NCT02913924|10065965|FG001|NOT COMPLETED|Overall Study||13
9002682|NCT02914119|10065971|FG000|STARTED|Overall Study||30430
9002683|NCT02914119|10065971|FG000|COMPLETED|Overall Study||30430
9002684|NCT02914119|10065971|FG000|NOT COMPLETED|Overall Study||0
9002685|NCT02914132|10065975|FG000|STARTED|Overall Study||15
9002686|NCT02914132|10065975|FG000|COMPLETED|Overall Study||15
9002687|NCT02914132|10065975|FG000|NOT COMPLETED|Overall Study||0
9039413|NCT03338569|10100377|FG001|NOT COMPLETED|Overall Study||5
9039414|NCT03338673|10100385|FG000|STARTED|Overall Study||6
9039415|NCT03338673|10100386|FG001|STARTED|Overall Study||6
9039416|NCT03338673|10100385|FG000|COMPLETED|Overall Study||5
9039417|NCT03338673|10100386|FG001|COMPLETED|Overall Study||5
9039418|NCT03338673|10100385|FG000|NOT COMPLETED|Overall Study||1
9039419|NCT03338673|10100386|FG001|NOT COMPLETED|Overall Study||1
9039420|NCT03338686|10100395|FG000|STARTED|Overall Study||2
9039421|NCT03338686|10100396|FG001|STARTED|Overall Study||5
9039422|NCT03338686|10100397|FG002|STARTED|Overall Study|12 FGG implant sites and 7 CTG implant sites for this Arm/Group|7
9039423|NCT03338686|10100395|FG000|COMPLETED|Overall Study||2
9039424|NCT03338686|10100396|FG001|COMPLETED|Overall Study||5
9039425|NCT03338686|10100397|FG002|COMPLETED|Overall Study||7
9039426|NCT03338686|10100395|FG000|NOT COMPLETED|Overall Study||0
9039427|NCT03338686|10100396|FG001|NOT COMPLETED|Overall Study||0
9039428|NCT03338686|10100397|FG002|NOT COMPLETED|Overall Study||0
9039429|NCT03338803|10100404|FG000|STARTED|Overall Study||11001
9039430|NCT03338803|10100404|FG000|COMPLETED|Overall Study||11001
9039431|NCT03338803|10100404|FG000|NOT COMPLETED|Overall Study||0
9039432|NCT03338816|10100410|FG000|STARTED|6-Month Double-blind Period||46
9039433|NCT03338816|10100411|FG001|STARTED|6-Month Double-blind Period||48
9039434|NCT03338816|10100410|FG000|COMPLETED|6-Month Double-blind Period||46
9039435|NCT03338816|10100411|FG001|COMPLETED|6-Month Double-blind Period|1 participant discontinued treatment during the 6-month DB period but completed the 6-month DB Visit|47
9039436|NCT03338816|10100410|FG000|NOT COMPLETED|6-Month Double-blind Period||0
9039437|NCT03338816|10100411|FG001|NOT COMPLETED|6-Month Double-blind Period||1
9039438|NCT03338816|10100410|FG000|STARTED|Open-Label Extension Period||46
9039439|NCT03338816|10100411|FG001|STARTED|Open-Label Extension Period||47
9039440|NCT03338816|10100410|FG000|COMPLETED|Open-Label Extension Period||0
9039441|NCT03338816|10100411|FG001|COMPLETED|Open-Label Extension Period||0
9039442|NCT03338816|10100410|FG000|NOT COMPLETED|Open-Label Extension Period||46
9039443|NCT03338816|10100411|FG001|NOT COMPLETED|Open-Label Extension Period||47
9039444|NCT03338855|10100419|FG000|STARTED|Overall Study||12
9039445|NCT03338855|10100420|FG001|STARTED|Overall Study||14
9039446|NCT03338855|10100419|FG000|Received Treatment in Period 1|Overall Study||12
9039447|NCT03338855|10100420|FG001|Received Treatment in Period 1|Overall Study||14
9039448|NCT03338855|10100419|FG000|Received Treatment in Period 2|Overall Study||11
9039449|NCT03338855|10100420|FG001|Received Treatment in Period 2|Overall Study||14
9039450|NCT03338855|10100419|FG000|COMPLETED|Overall Study||11
9039451|NCT03338855|10100420|FG001|COMPLETED|Overall Study||14
9039452|NCT03338855|10100419|FG000|NOT COMPLETED|Overall Study||1
9039453|NCT03338855|10100420|FG001|NOT COMPLETED|Overall Study||0
9039454|NCT03338894|10100426|FG000|STARTED|Overall Study||66
9039455|NCT03338894|10100426|FG000|COMPLETED|Overall Study||56
9039456|NCT03338894|10100426|FG000|NOT COMPLETED|Overall Study||10
9039457|NCT03338998|10100432|FG000|STARTED|Treatment Period||16
8881935|NCT01952470|9939234|FG000|Discontinued Intervention|Overall Study||2
8881936|NCT01952470|9939235|FG001|Discontinued Intervention|Overall Study||1
8881937|NCT01952470|9939234|FG000|Death|Overall Study||1
8881938|NCT01952470|9939235|FG001|Death|Overall Study||1
8881939|NCT01952470|9939234|FG000|Missing Baseline LCI 2% Data.|Overall Study||0
8881940|NCT01952470|9939235|FG001|Missing Baseline LCI 2% Data.|Overall Study||2
8881941|NCT01952470|9939234|FG000|Missing 1+3 Month LCI 2% Data.|Overall Study||2
8881942|NCT01952470|9939235|FG001|Missing 1+3 Month LCI 2% Data.|Overall Study||1
8881943|NCT01952470|9939234|FG000|Missing 3 Month LCI 2% Data.|Overall Study||1
8881944|NCT01952470|9939235|FG001|Missing 3 Month LCI 2% Data.|Overall Study||0
8881945|NCT01952470|9939234|FG000|COMPLETED|Overall Study||13
8881946|NCT01952470|9939235|FG001|COMPLETED|Overall Study||13
8881947|NCT01952470|9939234|FG000|NOT COMPLETED|Overall Study||3
8881948|NCT01952470|9939235|FG001|NOT COMPLETED|Overall Study||3
8881949|NCT01952600|9939244|FG000|STARTED|Overall Study||80
8881950|NCT01952600|9939245|FG001|STARTED|Overall Study||90
8881951|NCT01952600|9939246|FG002|STARTED|Overall Study||45
8881952|NCT01952600|9939244|FG000|COMPLETED|Overall Study||65
8881953|NCT01952600|9939245|FG001|COMPLETED|Overall Study||77
8881954|NCT01952600|9939246|FG002|COMPLETED|Overall Study||38
8881955|NCT01952600|9939244|FG000|NOT COMPLETED|Overall Study||15
8881956|NCT01952600|9939245|FG001|NOT COMPLETED|Overall Study||13
8881957|NCT01952600|9939246|FG002|NOT COMPLETED|Overall Study||7
8881958|NCT01952665|9939256|FG000|STARTED|Overall Study||37
8881959|NCT01952665|9939257|FG001|STARTED|Overall Study||26
8881960|NCT01952665|9939256|FG000|COMPLETED|Overall Study||31
8881961|NCT01952665|9939257|FG001|COMPLETED|Overall Study||20
8881962|NCT01952665|9939256|FG000|NOT COMPLETED|Overall Study||6
8881963|NCT01952665|9939257|FG001|NOT COMPLETED|Overall Study||6
8881964|NCT01952678|9939268|FG000|STARTED|Overall Study||102
8881965|NCT01952678|9939269|FG001|STARTED|Overall Study||102
8881966|NCT01952678|9939268|FG000|COMPLETED|Overall Study||102
8881967|NCT01952678|9939269|FG001|COMPLETED|Overall Study||102
8881968|NCT01952678|9939268|FG000|NOT COMPLETED|Overall Study||0
8881969|NCT01952678|9939269|FG001|NOT COMPLETED|Overall Study||0
8881970|NCT01952691|9939285|FG000|STARTED|Overall Study||22
8881971|NCT01952691|9939285|FG000|COMPLETED|Overall Study||20
8881972|NCT01952691|9939285|FG000|NOT COMPLETED|Overall Study||2
8881973|NCT01952834|9939289|FG000|STARTED|Overall Study||21
8881974|NCT01952834|9939289|FG000|COMPLETED|Overall Study||20
8881975|NCT01952834|9939289|FG000|NOT COMPLETED|Overall Study||1
8881976|NCT01953003|9939296|FG000|STARTED|Overall Study||56
8881977|NCT01953003|9939297|FG001|STARTED|Overall Study||56
8881978|NCT01953003|9939296|FG000|COMPLETED|Overall Study||0
8881979|NCT01953003|9939297|FG001|COMPLETED|Overall Study||1
8881980|NCT01953003|9939296|FG000|NOT COMPLETED|Overall Study||56
8881981|NCT01953003|9939297|FG001|NOT COMPLETED|Overall Study||55
8881982|NCT01953081|9939305|FG000|STARTED|Overall Study||7
8881983|NCT01953081|9939306|FG001|STARTED|Overall Study||6
8881984|NCT01953081|9939305|FG000|COMPLETED|Overall Study||5
8881985|NCT01953081|9939306|FG001|COMPLETED|Overall Study||3
8881986|NCT01953081|9939305|FG000|NOT COMPLETED|Overall Study||2
8881987|NCT01953081|9939306|FG001|NOT COMPLETED|Overall Study||3
8881988|NCT01953211|9939312|FG000|STARTED|Overall Study|completed prior to clinical trials submission|64
8881989|NCT01953211|9939312|FG000|COMPLETED|Overall Study|completed prior to clinical trials submission|64
8881990|NCT01953211|9939312|FG000|NOT COMPLETED|Overall Study||0
9002688|NCT02914184|10065983|FG000|STARTED|Overall Study||400
9002689|NCT02914184|10065984|FG001|STARTED|Overall Study||396
9002690|NCT02914184|10065985|FG002|STARTED|Overall Study||402
9002691|NCT02914184|10065986|FG003|STARTED|Overall Study||402
9002692|NCT02914184|10065983|FG000|COMPLETED|Overall Study||386
9002693|NCT02914184|10065984|FG001|COMPLETED|Overall Study||383
9002694|NCT02914184|10065985|FG002|COMPLETED|Overall Study||385
9002695|NCT02914184|10065986|FG003|COMPLETED|Overall Study||391
9002696|NCT02914184|10065983|FG000|NOT COMPLETED|Overall Study||14
9002697|NCT02914184|10065984|FG001|NOT COMPLETED|Overall Study||13
9002698|NCT02914184|10065985|FG002|NOT COMPLETED|Overall Study||17
9002699|NCT02914184|10065986|FG003|NOT COMPLETED|Overall Study||11
9002700|NCT02914210|10066000|FG000|STARTED|Overall Study||153
9002701|NCT02914210|10066001|FG001|STARTED|Overall Study||153
9002702|NCT02914210|10066000|FG000|COMPLETED|Overall Study||143
9002703|NCT02914210|10066001|FG001|COMPLETED|Overall Study||144
9002704|NCT02914210|10066000|FG000|NOT COMPLETED|Overall Study||10
8572621|NCT00116168|9604817|FG000|NOT COMPLETED|Overall Study||6
8725935|NCT01033487|9773162|FG005|COMPLETED|Third Intervention Period||2
8725936|NCT01033487|9773163|FG006|COMPLETED|Third Intervention Period||2
8881991|NCT01953224|9939320|FG000|STARTED|Overall Study||20
8881992|NCT01953224|9939321|FG001|STARTED|Overall Study||20
8881993|NCT01953224|9939320|FG000|COMPLETED|Overall Study||18
8881994|NCT01953224|9939321|FG001|COMPLETED|Overall Study||17
8881995|NCT01953224|9939320|FG000|NOT COMPLETED|Overall Study||2
8881996|NCT01953224|9939321|FG001|NOT COMPLETED|Overall Study||3
8881997|NCT01953237|9939329|FG000|STARTED|Overall Study||10
8881998|NCT01953237|9939330|FG001|STARTED|Overall Study||21
8881999|NCT01953237|9939329|FG000|COMPLETED|Overall Study||10
8882000|NCT01953237|9939330|FG001|COMPLETED|Overall Study||21
8882001|NCT01953237|9939329|FG000|NOT COMPLETED|Overall Study||0
8882002|NCT01953237|9939330|FG001|NOT COMPLETED|Overall Study||0
8882003|NCT01953328|9939344|FG000|STARTED|Overall Study||49
8882004|NCT01953328|9939345|FG001|STARTED|Overall Study||50
9002705|NCT02914210|10066001|FG001|NOT COMPLETED|Overall Study||9
9002706|NCT02914236|10066007|FG000|STARTED|Overall Study||50
8882005|NCT01953328|9939346|FG002|STARTED|Overall Study||50
8882006|NCT01953328|9939347|FG003|STARTED|Overall Study||50
8882007|NCT01953328|9939348|FG004|STARTED|Overall Study||52
8882008|NCT01953328|9939349|FG005|STARTED|Overall Study||51
8882009|NCT01953328|9939350|FG006|STARTED|Overall Study||51
8882010|NCT01953328|9939351|FG007|STARTED|Overall Study||51
8882011|NCT01953328|9939344|FG000|Received Treatment|Overall Study||49
8882012|NCT01953328|9939345|FG001|Received Treatment|Overall Study||50
8882013|NCT01953328|9939346|FG002|Received Treatment|Overall Study||50
8634144|NCT00555321|9674446|FG003|Received Transplant and Treated|Treatment Phase up to 12-months||53
8634145|NCT00555321|9674447|FG004|Received Transplant and Treated|Treatment Phase up to 12-months||50
8634146|NCT00555321|9674443|FG000|COMPLETED|Treatment Phase up to 12-months||31
8882014|NCT01953328|9939347|FG003|Received Treatment|Overall Study||50
8882015|NCT01953328|9939348|FG004|Received Treatment|Overall Study||52
8882016|NCT01953328|9939349|FG005|Received Treatment|Overall Study||51
8882017|NCT01953328|9939350|FG006|Received Treatment|Overall Study||51
8882018|NCT01953328|9939351|FG007|Received Treatment|Overall Study||51
8882019|NCT01953328|9939344|FG000|COMPLETED|Overall Study||49
8882020|NCT01953328|9939345|FG001|COMPLETED|Overall Study||50
8882021|NCT01953328|9939346|FG002|COMPLETED|Overall Study||50
8882022|NCT01953328|9939347|FG003|COMPLETED|Overall Study||50
8882023|NCT01953328|9939348|FG004|COMPLETED|Overall Study||50
8882024|NCT01953328|9939349|FG005|COMPLETED|Overall Study||51
8882025|NCT01953328|9939350|FG006|COMPLETED|Overall Study||51
8882026|NCT01953328|9939351|FG007|COMPLETED|Overall Study||51
8882027|NCT01953328|9939344|FG000|NOT COMPLETED|Overall Study||0
8882028|NCT01953328|9939345|FG001|NOT COMPLETED|Overall Study||0
8882029|NCT01953328|9939346|FG002|NOT COMPLETED|Overall Study||0
8882030|NCT01953328|9939347|FG003|NOT COMPLETED|Overall Study||0
8882031|NCT01953328|9939348|FG004|NOT COMPLETED|Overall Study||2
8882032|NCT01953328|9939349|FG005|NOT COMPLETED|Overall Study||0
8882033|NCT01953328|9939350|FG006|NOT COMPLETED|Overall Study||0
8882034|NCT01953328|9939351|FG007|NOT COMPLETED|Overall Study||0
8882035|NCT01953354|9939371|FG000|STARTED|Overall Study||9
8882036|NCT01953354|9939372|FG001|STARTED|Overall Study||7
8882037|NCT01953354|9939371|FG000|COMPLETED|Overall Study||8
8882038|NCT01953354|9939372|FG001|COMPLETED|Overall Study||5
8882039|NCT01953354|9939371|FG000|NOT COMPLETED|Overall Study||1
8882040|NCT01953354|9939372|FG001|NOT COMPLETED|Overall Study||2
8882041|NCT01953432|9939380|FG000|STARTED|Overall Study||22
8882042|NCT01953432|9939381|FG001|STARTED|Overall Study||21
8882043|NCT01953432|9939380|FG000|COMPLETED|Overall Study||8
8882044|NCT01953432|9939381|FG001|COMPLETED|Overall Study||6
8882045|NCT01953432|9939380|FG000|NOT COMPLETED|Overall Study||14
8882046|NCT01953432|9939381|FG001|NOT COMPLETED|Overall Study||15
8882047|NCT01953575|9939390|FG000|STARTED|Overall Study||10
8882048|NCT01953575|9939391|FG001|STARTED|Overall Study||10
8882049|NCT01953575|9939392|FG002|STARTED|Overall Study||10
8882050|NCT01953575|9939390|FG000|COMPLETED|Overall Study||10
8882051|NCT01953575|9939391|FG001|COMPLETED|Overall Study||10
8882052|NCT01953575|9939392|FG002|COMPLETED|Overall Study||10
8882053|NCT01953575|9939390|FG000|NOT COMPLETED|Overall Study||0
8882054|NCT01953575|9939391|FG001|NOT COMPLETED|Overall Study||0
8882055|NCT01953575|9939392|FG002|NOT COMPLETED|Overall Study||0
8882056|NCT01953601|9939403|FG000|STARTED|Part 1 (Base Study)||485
8882057|NCT01953601|9939404|FG001|STARTED|Part 1 (Base Study)||484
8882058|NCT01953601|9939405|FG002|STARTED|Part 1 (Base Study)||485
8882059|NCT01953601|9939403|FG000|Treated|Part 1 (Base Study)||483
8882060|NCT01953601|9939404|FG001|Treated|Part 1 (Base Study)||484
8882061|NCT01953601|9939405|FG002|Treated|Part 1 (Base Study)||484
8882062|NCT01953601|9939403|FG000|COMPLETED|Part 1 (Base Study)||234
8882063|NCT01953601|9939404|FG001|COMPLETED|Part 1 (Base Study)||231
8882064|NCT01953601|9939405|FG002|COMPLETED|Part 1 (Base Study)||239
8882065|NCT01953601|9939403|FG000|NOT COMPLETED|Part 1 (Base Study)||251
8882066|NCT01953601|9939404|FG001|NOT COMPLETED|Part 1 (Base Study)||253
8882067|NCT01953601|9939405|FG002|NOT COMPLETED|Part 1 (Base Study)||246
8882068|NCT01953601|9939403|FG000|STARTED|Part 2 (Extension Study)|Number started refers only to participants completing Part 1, volunteering to continue to Part 2.|198
8882069|NCT01953601|9939404|FG001|STARTED|Part 2 (Extension Study)|Number started refers only to participants completing Part 1, volunteering to continue to Part 2.|191
8882070|NCT01953601|9939405|FG002|STARTED|Part 2 (Extension Study)|Number started refers only to participants completing Part 1, volunteering to continue to Part 2.|204
8882071|NCT01953601|9939403|FG000|Treated|Part 2 (Extension Study)||197
8882072|NCT01953601|9939404|FG001|Treated|Part 2 (Extension Study)||191
8882073|NCT01953601|9939405|FG002|Treated|Part 2 (Extension Study)||204
8882074|NCT01953601|9939403|FG000|COMPLETED|Part 2 (Extension Study)||0
8882075|NCT01953601|9939404|FG001|COMPLETED|Part 2 (Extension Study)||0
8882076|NCT01953601|9939405|FG002|COMPLETED|Part 2 (Extension Study)||0
8882077|NCT01953601|9939403|FG000|NOT COMPLETED|Part 2 (Extension Study)||198
8882078|NCT01953601|9939404|FG001|NOT COMPLETED|Part 2 (Extension Study)||191
8882079|NCT01953601|9939405|FG002|NOT COMPLETED|Part 2 (Extension Study)||204
8882080|NCT01953692|9939425|FG000|STARTED|Overall Study||28
8882081|NCT01953692|9939426|FG001|STARTED|Overall Study||30
8882082|NCT01953692|9939427|FG002|STARTED|Overall Study||31
8882083|NCT01953692|9939428|FG003|STARTED|Overall Study||21
8634147|NCT00555321|9674444|FG001|COMPLETED|Treatment Phase up to 12-months||29
8634148|NCT00555321|9674445|FG002|COMPLETED|Treatment Phase up to 12-months||26
8634149|NCT00555321|9674446|FG003|COMPLETED|Treatment Phase up to 12-months||46
8634150|NCT00555321|9674447|FG004|COMPLETED|Treatment Phase up to 12-months||32
8882084|NCT01953692|9939429|FG004|STARTED|Overall Study||4
8882085|NCT01953692|9939430|FG005|STARTED|Overall Study||22
8882086|NCT01953692|9939431|FG006|STARTED|Overall Study||42
8882087|NCT01953692|9939432|FG007|STARTED|Overall Study||13
8882088|NCT01953692|9939433|FG008|STARTED|Overall Study||6
8882089|NCT01953692|9939425|FG000|COMPLETED|Overall Study||1
8882090|NCT01953692|9939426|FG001|COMPLETED|Overall Study||5
8882091|NCT01953692|9939427|FG002|COMPLETED|Overall Study||11
8882092|NCT01953692|9939428|FG003|COMPLETED|Overall Study||7
8882093|NCT01953692|9939429|FG004|COMPLETED|Overall Study||1
8882094|NCT01953692|9939430|FG005|COMPLETED|Overall Study||4
8882095|NCT01953692|9939431|FG006|COMPLETED|Overall Study||10
8882096|NCT01953692|9939432|FG007|COMPLETED|Overall Study||3
8634151|NCT00555321|9674443|FG000|NOT COMPLETED|Treatment Phase up to 12-months||21
8634152|NCT00555321|9674444|FG001|NOT COMPLETED|Treatment Phase up to 12-months||22
8634153|NCT00555321|9674445|FG002|NOT COMPLETED|Treatment Phase up to 12-months||24
8634154|NCT00555321|9674446|FG003|NOT COMPLETED|Treatment Phase up to 12-months||7
8634155|NCT00555321|9674447|FG004|NOT COMPLETED|Treatment Phase up to 12-months||22
8634156|NCT00555321|9674443|FG000|STARTED|Long-term Extension Phase|1 participant did not enter LTE|30
8634157|NCT00555321|9674444|FG001|STARTED|Long-term Extension Phase|2 participants did not enter LTE|27
8634158|NCT00555321|9674445|FG002|STARTED|Long-term Extension Phase|2 participants did not enter LTE|24
8634159|NCT00555321|9674446|FG003|STARTED|Long-term Extension Phase|8 participants did not enter LTE|38
8882097|NCT01953692|9939433|FG008|COMPLETED|Overall Study||1
8882098|NCT01953692|9939425|FG000|NOT COMPLETED|Overall Study||27
8882099|NCT01953692|9939426|FG001|NOT COMPLETED|Overall Study||25
8882100|NCT01953692|9939427|FG002|NOT COMPLETED|Overall Study||20
8882101|NCT01953692|9939428|FG003|NOT COMPLETED|Overall Study||14
8882102|NCT01953692|9939429|FG004|NOT COMPLETED|Overall Study||3
8882103|NCT01953692|9939430|FG005|NOT COMPLETED|Overall Study||18
8882104|NCT01953692|9939431|FG006|NOT COMPLETED|Overall Study||32
8882105|NCT01953692|9939432|FG007|NOT COMPLETED|Overall Study||10
8882106|NCT01953692|9939433|FG008|NOT COMPLETED|Overall Study||5
8882107|NCT01953783|9939463|FG000|STARTED|Overall Study||7
8882108|NCT01953783|9939463|FG000|COMPLETED|Overall Study||5
8882109|NCT01953783|9939463|FG000|NOT COMPLETED|Overall Study||2
8882110|NCT01953874|9939469|FG000|STARTED|Overall Study||65
8882111|NCT01953874|9939470|FG001|STARTED|Overall Study||61
8882112|NCT01953874|9939469|FG000|COMPLETED|Overall Study||65
8882113|NCT01953874|9939470|FG001|COMPLETED|Overall Study||61
8882114|NCT01953874|9939469|FG000|NOT COMPLETED|Overall Study||0
8882115|NCT01953874|9939470|FG001|NOT COMPLETED|Overall Study||0
8882116|NCT01953913|9939477|FG000|STARTED|Overall Study||542
8882117|NCT01953913|9939477|FG000|Treated|Overall Study||541
8882118|NCT01953913|9939477|FG000|COMPLETED|Overall Study||0
8882119|NCT01953913|9939477|FG000|NOT COMPLETED|Overall Study||542
8882120|NCT01954017|9939484|FG000|STARTED|Overall Study||36
8882121|NCT01954017|9939485|FG001|STARTED|Overall Study||33
8882122|NCT01954017|9939486|FG002|STARTED|Overall Study||34
8882123|NCT01954017|9939484|FG000|COMPLETED|Overall Study||31
8882124|NCT01954017|9939485|FG001|COMPLETED|Overall Study||25
8882125|NCT01954017|9939486|FG002|COMPLETED|Overall Study||21
8882126|NCT01954017|9939484|FG000|NOT COMPLETED|Overall Study||5
8882127|NCT01954017|9939485|FG001|NOT COMPLETED|Overall Study||8
8882128|NCT01954017|9939486|FG002|NOT COMPLETED|Overall Study||13
8882129|NCT01954056|9939522|FG000|STARTED|Birth to 60 Days of Life||6
8882130|NCT01954056|9939523|FG001|STARTED|Birth to 60 Days of Life||6
8882131|NCT01954056|9939522|FG000|COMPLETED|Birth to 60 Days of Life||6
8882132|NCT01954056|9939523|FG001|COMPLETED|Birth to 60 Days of Life||6
8882133|NCT01954056|9939522|FG000|NOT COMPLETED|Birth to 60 Days of Life||0
8882134|NCT01954056|9939523|FG001|NOT COMPLETED|Birth to 60 Days of Life||0
8882135|NCT01954056|9939522|FG000|STARTED|Birth to 22-26 Mos. Corrected GA||6
8882136|NCT01954056|9939523|FG001|STARTED|Birth to 22-26 Mos. Corrected GA||6
8882137|NCT01954056|9939522|FG000|COMPLETED|Birth to 22-26 Mos. Corrected GA||5
8634160|NCT00555321|9674447|FG004|STARTED|Long-term Extension Phase|6 participants did not enter LTE|26
8634161|NCT00555321|9674443|FG000|COMPLETED|Long-term Extension Phase||0
8634162|NCT00555321|9674444|FG001|COMPLETED|Long-term Extension Phase||0
8634163|NCT00555321|9674445|FG002|COMPLETED|Long-term Extension Phase||0
8634164|NCT00555321|9674446|FG003|COMPLETED|Long-term Extension Phase||0
8634165|NCT00555321|9674447|FG004|COMPLETED|Long-term Extension Phase||0
8634166|NCT00555321|9674443|FG000|NOT COMPLETED|Long-term Extension Phase||30
8634167|NCT00555321|9674444|FG001|NOT COMPLETED|Long-term Extension Phase||27
8882138|NCT01954056|9939523|FG001|COMPLETED|Birth to 22-26 Mos. Corrected GA||6
8882139|NCT01954056|9939522|FG000|NOT COMPLETED|Birth to 22-26 Mos. Corrected GA||1
8882140|NCT01954056|9939523|FG001|NOT COMPLETED|Birth to 22-26 Mos. Corrected GA||0
8882141|NCT01954082|9939531|FG000|STARTED|Overall Study||317
8882142|NCT01954082|9939532|FG001|STARTED|Overall Study||321
8882143|NCT01954082|9939531|FG000|Treated|Overall Study|The 4 participants who were not treated either died (3) or withdrew before treatment start (1).|313
8882144|NCT01954082|9939532|FG001|Treated|Overall Study|The 2 participants who were not treated died before treatment start.|319
8882145|NCT01954082|9939531|FG000|COMPLETED|Overall Study|There were 22 infants that received more doses than intended per protocol.|249
8882146|NCT01954082|9939532|FG001|COMPLETED|Overall Study|There were 27 infants that received more doses than intended per protocol.|264
8882147|NCT01954082|9939531|FG000|NOT COMPLETED|Overall Study||68
8882148|NCT01954082|9939532|FG001|NOT COMPLETED|Overall Study||57
8882149|NCT01954121|9939540|FG000|STARTED|Overall Study||220
8882150|NCT01954121|9939541|FG001|STARTED|Overall Study||216
8882151|NCT01954121|9939540|FG000|COMPLETED|Overall Study||93
8882152|NCT01954121|9939541|FG001|COMPLETED|Overall Study||125
8882153|NCT01954121|9939540|FG000|NOT COMPLETED|Overall Study||127
8882154|NCT01954121|9939541|FG001|NOT COMPLETED|Overall Study||91
8882155|NCT01954251|9939549|FG000|STARTED|Overall Study||413
8882156|NCT01954251|9939550|FG001|STARTED|Overall Study||415
8882157|NCT01954251|9939549|FG000|COMPLETED|Overall Study||400
8882158|NCT01954251|9939550|FG001|COMPLETED|Overall Study||396
8882159|NCT01954251|9939549|FG000|NOT COMPLETED|Overall Study||13
8882160|NCT01954251|9939550|FG001|NOT COMPLETED|Overall Study||19
8882161|NCT01954264|9939557|FG000|STARTED|Overall Study||2421
8882162|NCT01954264|9939557|FG000|COMPLETED|Overall Study||2421
8882163|NCT01954264|9939557|FG000|NOT COMPLETED|Overall Study||0
8882164|NCT01954342|9939578|FG000|STARTED|Overall Study||36
8882165|NCT01954342|9939579|FG001|STARTED|Overall Study||8
8882166|NCT01954342|9939580|FG002|STARTED|Overall Study||10
8882167|NCT01954342|9939581|FG003|STARTED|Overall Study||18
8882168|NCT01954342|9939578|FG000|COMPLETED|Overall Study||36
8882169|NCT01954342|9939579|FG001|COMPLETED|Overall Study||8
8882170|NCT01954342|9939580|FG002|COMPLETED|Overall Study||10
8882171|NCT01954342|9939581|FG003|COMPLETED|Overall Study||0
8882172|NCT01954342|9939578|FG000|NOT COMPLETED|Overall Study||0
8882173|NCT01954342|9939579|FG001|NOT COMPLETED|Overall Study||0
8634168|NCT00555321|9674445|FG002|NOT COMPLETED|Long-term Extension Phase||24
8634169|NCT00555321|9674446|FG003|NOT COMPLETED|Long-term Extension Phase||38
8634170|NCT00555321|9674447|FG004|NOT COMPLETED|Long-term Extension Phase||26
8634171|NCT00555360|9674466|FG000|STARTED|Overall Study||183
8634172|NCT00555360|9674467|FG001|STARTED|Overall Study||189
8882174|NCT01954342|9939580|FG002|NOT COMPLETED|Overall Study||0
8882175|NCT01954342|9939581|FG003|NOT COMPLETED|Overall Study||18
8882176|NCT01954394|9939593|FG000|STARTED|Overall Study|Enrolled|331
8882177|NCT01954394|9939594|FG001|STARTED|Overall Study|Enrolled|655
8882178|NCT01954394|9939593|FG000|Treated|Overall Study|Safety population|330
8882179|NCT01954394|9939594|FG001|Treated|Overall Study|Safety population|655
8882180|NCT01954394|9939593|FG000|COMPLETED|Overall Study||301
8882181|NCT01954394|9939594|FG001|COMPLETED|Overall Study||598
8882182|NCT01954394|9939593|FG000|NOT COMPLETED|Overall Study||30
8882183|NCT01954394|9939594|FG001|NOT COMPLETED|Overall Study||57
8882184|NCT01954628|9939604|FG000|STARTED|Overall Study||200
8882185|NCT01954628|9939605|FG001|STARTED|Overall Study||200
8882186|NCT01954628|9939604|FG000|Full Analysis Set (FAS)|Overall Study||200
8882187|NCT01954628|9939605|FG001|Full Analysis Set (FAS)|Overall Study||198
8882188|NCT01954628|9939604|FG000|Safety Set|Overall Study||200
8882189|NCT01954628|9939605|FG001|Safety Set|Overall Study||200
8882190|NCT01954628|9939604|FG000|Pharmacokinetic Population|Overall Study||181
8882191|NCT01954628|9939605|FG001|Pharmacokinetic Population|Overall Study||0
8882192|NCT01954628|9939604|FG000|US 6 Month Ophthalmology Safety Visit|Overall Study||37
8882193|NCT01954628|9939605|FG001|US 6 Month Ophthalmology Safety Visit|Overall Study||32
8882194|NCT01954628|9939604|FG000|COMPLETED|Overall Study||169
8882195|NCT01954628|9939605|FG001|COMPLETED|Overall Study||173
8882196|NCT01954628|9939604|FG000|NOT COMPLETED|Overall Study||31
8882197|NCT01954628|9939605|FG001|NOT COMPLETED|Overall Study||27
8882198|NCT01954745|9939615|FG000|STARTED|Overall Study||19
8882199|NCT01954745|9939615|FG000|COMPLETED|Overall Study||0
8882200|NCT01954745|9939615|FG000|NOT COMPLETED|Overall Study||19
8882201|NCT01954771|9939622|FG000|STARTED|Overall Study||29
8882202|NCT01954771|9939623|FG001|STARTED|Overall Study||32
8882203|NCT01954771|9939624|FG002|STARTED|Overall Study||28
8882204|NCT01954771|9939622|FG000|COMPLETED|Overall Study||22
8882205|NCT01954771|9939623|FG001|COMPLETED|Overall Study||29
8882206|NCT01954771|9939624|FG002|COMPLETED|Overall Study||25
8882207|NCT01954771|9939622|FG000|NOT COMPLETED|Overall Study||7
8882208|NCT01954771|9939623|FG001|NOT COMPLETED|Overall Study||3
8882209|NCT01954771|9939624|FG002|NOT COMPLETED|Overall Study||3
8882210|NCT01954927|9939637|FG000|STARTED|Overall Study||45
8882211|NCT01954927|9939638|FG001|STARTED|Overall Study||45
8882212|NCT01954927|9939637|FG000|COMPLETED|Overall Study||42
8882213|NCT01954927|9939638|FG001|COMPLETED|Overall Study||44
8882214|NCT01954927|9939637|FG000|NOT COMPLETED|Overall Study||3
8882215|NCT01954927|9939638|FG001|NOT COMPLETED|Overall Study||1
8882216|NCT01955005|9939646|FG000|STARTED|Overall Study||30
8882217|NCT01955005|9939647|FG001|STARTED|Overall Study||30
8882218|NCT01955005|9939646|FG000|COMPLETED|Overall Study||27
8882219|NCT01955005|9939647|FG001|COMPLETED|Overall Study||25
8882220|NCT01955005|9939646|FG000|NOT COMPLETED|Overall Study||3
8882221|NCT01955005|9939647|FG001|NOT COMPLETED|Overall Study||5
8882222|NCT01955044|9939656|FG000|STARTED|Overall Study||10
8882223|NCT01955044|9939657|FG001|STARTED|Overall Study||10
8882224|NCT01955044|9939658|FG002|STARTED|Overall Study||10
8882225|NCT01955044|9939656|FG000|COMPLETED|Overall Study||9
8882226|NCT01955044|9939657|FG001|COMPLETED|Overall Study||9
8882227|NCT01955044|9939658|FG002|COMPLETED|Overall Study||10
8882228|NCT01955044|9939656|FG000|NOT COMPLETED|Overall Study||1
8634173|NCT00555360|9674466|FG000|COMPLETED|Overall Study||156
8634174|NCT00555360|9674467|FG001|COMPLETED|Overall Study||153
8882229|NCT01955044|9939657|FG001|NOT COMPLETED|Overall Study||1
8882230|NCT01955044|9939658|FG002|NOT COMPLETED|Overall Study||0
8882231|NCT01955083|9939668|FG000|STARTED|Overall Study||15
8882232|NCT01955083|9939669|FG001|STARTED|Overall Study||15
8882233|NCT01955083|9939668|FG000|COMPLETED|Overall Study||14
8882234|NCT01955083|9939669|FG001|COMPLETED|Overall Study||14
8882235|NCT01955083|9939668|FG000|NOT COMPLETED|Overall Study||1
8882236|NCT01955083|9939669|FG001|NOT COMPLETED|Overall Study||1
8882237|NCT01955122|9939701|FG000|STARTED|Overall Study|"Excluded (n = 5)~Included in analysis (n = 59)"|64
8882238|NCT01955122|9939702|FG001|STARTED|Overall Study|"Excluded (n = 5)~Included in analysis (n = 57)"|62
8882239|NCT01955122|9939701|FG000|No.Patients Enrolled|Overall Study||64
8882240|NCT01955122|9939702|FG001|No.Patients Enrolled|Overall Study||62
8882241|NCT01955122|9939701|FG000|No. Patients Completed Double Procedure|Overall Study||59
8882242|NCT01955122|9939702|FG001|No. Patients Completed Double Procedure|Overall Study||57
8882243|NCT01955122|9939701|FG000|COMPLETED|Overall Study||59
8882244|NCT01955122|9939702|FG001|COMPLETED|Overall Study||57
8882245|NCT01955122|9939701|FG000|NOT COMPLETED|Overall Study||5
8882246|NCT01955122|9939702|FG001|NOT COMPLETED|Overall Study||5
8882247|NCT01955161|9939717|FG000|STARTED|Overall Study||310
8882248|NCT01955161|9939718|FG001|STARTED|Overall Study||313
8882249|NCT01955161|9939719|FG002|STARTED|Overall Study||310
8882250|NCT01955161|9939717|FG000|Treated|Overall Study||308
8882251|NCT01955161|9939718|FG001|Treated|Overall Study||313
8882252|NCT01955161|9939719|FG002|Treated|Overall Study||309
8882253|NCT01955161|9939717|FG000|COMPLETED|Overall Study||283
8882254|NCT01955161|9939718|FG001|COMPLETED|Overall Study||288
8882255|NCT01955161|9939719|FG002|COMPLETED|Overall Study||275
8882256|NCT01955161|9939717|FG000|NOT COMPLETED|Overall Study||27
8882257|NCT01955161|9939718|FG001|NOT COMPLETED|Overall Study||25
8882258|NCT01955161|9939719|FG002|NOT COMPLETED|Overall Study||35
8882259|NCT01955369|9939727|FG000|STARTED|Overall Study||200
8882260|NCT01955369|9939727|FG000|COMPLETED|Overall Study||200
8882261|NCT01955369|9939727|FG000|NOT COMPLETED|Overall Study||0
8882262|NCT01955382|9939733|FG000|STARTED|Overall Study||35
8882263|NCT01955382|9939734|FG001|STARTED|Overall Study||35
8882264|NCT01955382|9939733|FG000|COMPLETED|Overall Study||35
8882265|NCT01955382|9939734|FG001|COMPLETED|Overall Study||35
8882266|NCT01955382|9939733|FG000|NOT COMPLETED|Overall Study||0
8882267|NCT01955382|9939734|FG001|NOT COMPLETED|Overall Study||0
8882268|NCT01955434|9939741|FG000|STARTED|Overall Study||25
8882269|NCT01955434|9939741|FG000|COMPLETED|Overall Study||25
8882270|NCT01955434|9939741|FG000|NOT COMPLETED|Overall Study||0
8882271|NCT01955473|9939750|FG000|STARTED|Overall Study||3
8882272|NCT01955473|9939751|FG001|STARTED|Overall Study||6
8882273|NCT01955473|9939752|FG002|STARTED|Overall Study||6
8882274|NCT01955473|9939753|FG003|STARTED|Overall Study||6
8882275|NCT01955473|9939754|FG004|STARTED|Overall Study||30
8882276|NCT01955473|9939750|FG000|COMPLETED|Overall Study||3
8882277|NCT01955473|9939751|FG001|COMPLETED|Overall Study||6
8882278|NCT01955473|9939752|FG002|COMPLETED|Overall Study||6
8882279|NCT01955473|9939753|FG003|COMPLETED|Overall Study||6
9002707|NCT02914236|10066007|FG000|4-week Follow-up Visit|Overall Study||50
9002708|NCT02914236|10066007|FG000|12-week Follow-up Visit|Overall Study||50
9002709|NCT02914236|10066007|FG000|26-week Follow-up Visit|Overall Study||49
9002710|NCT02914236|10066007|FG000|COMPLETED|Overall Study||49
9002711|NCT02914236|10066007|FG000|NOT COMPLETED|Overall Study||1
9002712|NCT02914275|10066013|FG000|STARTED|Overall Study||1687
9002713|NCT02914275|10066014|FG001|STARTED|Overall Study||563
9002714|NCT02914275|10066013|FG000|Included in Clinical Database / FAS|Overall Study||1684
9002715|NCT02914275|10066014|FG001|Included in Clinical Database / FAS|Overall Study||563
9002716|NCT02914275|10066013|FG000|COMPLETED|Overall Study||1566
9002717|NCT02914275|10066014|FG001|COMPLETED|Overall Study||521
9002718|NCT02914275|10066013|FG000|NOT COMPLETED|Overall Study||121
9002719|NCT02914275|10066014|FG001|NOT COMPLETED|Overall Study||42
9002720|NCT02914457|10066024|FG000|STARTED|Overall Study||31
9002721|NCT02914457|10066024|FG000|COMPLETED|Overall Study|Subjects who completed electrophysiological study with analyzable data|25
9002722|NCT02914457|10066024|FG000|NOT COMPLETED|Overall Study||6
9002723|NCT02914509|10066030|FG000|STARTED|Overall Study||348
9002724|NCT02914509|10066031|FG001|STARTED|Overall Study||217
9002725|NCT02914509|10066030|FG000|COMPLETED|Overall Study||343
9002726|NCT02914509|10066031|FG001|COMPLETED|Overall Study||211
9002727|NCT02914509|10066030|FG000|NOT COMPLETED|Overall Study||5
9002728|NCT02914509|10066031|FG001|NOT COMPLETED|Overall Study||6
9002729|NCT02914522|10066045|FG000|STARTED|Induction Study: Up to Week 11||245
9002730|NCT02914522|10066046|FG001|STARTED|Induction Study: Up to Week 11||278
9002731|NCT02914522|10066047|FG002|STARTED|Induction Study: Up to Week 11||137
9002732|NCT02914522|10066048|FG003|STARTED|Induction Study: Up to Week 11||262
9002733|NCT02914522|10066049|FG004|STARTED|Induction Study: Up to Week 11||286
9002734|NCT02914522|10066050|FG005|STARTED|Induction Study: Up to Week 11||143
8572622|NCT00116168|9604818|FG001|NOT COMPLETED|Overall Study||5
8572623|NCT00116168|9604819|FG002|NOT COMPLETED|Overall Study||0
8882280|NCT01955473|9939754|FG004|COMPLETED|Overall Study||30
8882281|NCT01955473|9939750|FG000|NOT COMPLETED|Overall Study||0
8882282|NCT01955473|9939751|FG001|NOT COMPLETED|Overall Study||0
8882283|NCT01955473|9939752|FG002|NOT COMPLETED|Overall Study||0
8882284|NCT01955473|9939753|FG003|NOT COMPLETED|Overall Study||0
8882285|NCT01955473|9939754|FG004|NOT COMPLETED|Overall Study||0
8882286|NCT01955564|9939777|FG000|STARTED|Overall Study||18
8882287|NCT01955564|9939778|FG001|STARTED|Overall Study||6
8882288|NCT01955564|9939779|FG002|STARTED|Overall Study||6
8882289|NCT01955564|9939780|FG003|STARTED|Overall Study||6
8882290|NCT01955564|9939781|FG004|STARTED|Overall Study||6
8882291|NCT01955564|9939782|FG005|STARTED|Overall Study||6
9002735|NCT02914522|10066051|FG006|STARTED|Induction Study: Up to Week 11||0
8882292|NCT01955564|9939783|FG006|STARTED|Overall Study||6
8882293|NCT01955564|9939777|FG000|COMPLETED|Overall Study||18
8882294|NCT01955564|9939778|FG001|COMPLETED|Overall Study||6
8882295|NCT01955564|9939779|FG002|COMPLETED|Overall Study||6
8882296|NCT01955564|9939780|FG003|COMPLETED|Overall Study||6
8882297|NCT01955564|9939781|FG004|COMPLETED|Overall Study||6
8882298|NCT01955564|9939782|FG005|COMPLETED|Overall Study||6
8882299|NCT01955564|9939783|FG006|COMPLETED|Overall Study||6
8882300|NCT01955564|9939777|FG000|NOT COMPLETED|Overall Study||0
8882301|NCT01955564|9939778|FG001|NOT COMPLETED|Overall Study||0
8882302|NCT01955564|9939779|FG002|NOT COMPLETED|Overall Study||0
8882303|NCT01955564|9939780|FG003|NOT COMPLETED|Overall Study||0
8882304|NCT01955564|9939781|FG004|NOT COMPLETED|Overall Study||0
8882305|NCT01955564|9939782|FG005|NOT COMPLETED|Overall Study||0
8882306|NCT01955564|9939783|FG006|NOT COMPLETED|Overall Study||0
8882307|NCT01955629|9939805|FG000|STARTED|Overall Study||4
8882308|NCT01955629|9939805|FG000|COMPLETED|Overall Study|1 participant with DP and 3 with unacceptable toxicity were considered completed as per protocol.|4
8882309|NCT01955629|9939805|FG000|NOT COMPLETED|Overall Study||0
8882310|NCT01955707|9939811|FG000|STARTED|Overall Study||82
8882311|NCT01955707|9939812|FG001|STARTED|Overall Study||79
8882312|NCT01955707|9939811|FG000|Withdrew Prior to Dosing|Overall Study||0
8882313|NCT01955707|9939812|FG001|Withdrew Prior to Dosing|Overall Study||1
8882314|NCT01955707|9939811|FG000|Dosed|Overall Study||82
8882315|NCT01955707|9939812|FG001|Dosed|Overall Study||78
9002736|NCT02914522|10066052|FG007|STARTED|Induction Study: Up to Week 11||0
9002737|NCT02914522|10066053|FG008|STARTED|Induction Study: Up to Week 11||0
9002738|NCT02914522|10066054|FG009|STARTED|Induction Study: Up to Week 11||0
9002739|NCT02914522|10066055|FG010|STARTED|Induction Study: Up to Week 11||0
9002740|NCT02914522|10066045|FG000|COMPLETED|Induction Study: Up to Week 11||235
9002741|NCT02914522|10066046|FG001|COMPLETED|Induction Study: Up to Week 11||256
9002742|NCT02914522|10066047|FG002|COMPLETED|Induction Study: Up to Week 11||127
9002743|NCT02914522|10066048|FG003|COMPLETED|Induction Study: Up to Week 11||234
9002744|NCT02914522|10066049|FG004|COMPLETED|Induction Study: Up to Week 11||262
9002745|NCT02914522|10066050|FG005|COMPLETED|Induction Study: Up to Week 11||127
9002746|NCT02914522|10066051|FG006|COMPLETED|Induction Study: Up to Week 11||0
9002747|NCT02914522|10066052|FG007|COMPLETED|Induction Study: Up to Week 11||0
9002748|NCT02914522|10066053|FG008|COMPLETED|Induction Study: Up to Week 11||0
9002749|NCT02914522|10066054|FG009|COMPLETED|Induction Study: Up to Week 11||0
9002750|NCT02914522|10066055|FG010|COMPLETED|Induction Study: Up to Week 11||0
9002751|NCT02914522|10066045|FG000|NOT COMPLETED|Induction Study: Up to Week 11||10
9002752|NCT02914522|10066046|FG001|NOT COMPLETED|Induction Study: Up to Week 11||22
9002753|NCT02914522|10066047|FG002|NOT COMPLETED|Induction Study: Up to Week 11||10
9002754|NCT02914522|10066048|FG003|NOT COMPLETED|Induction Study: Up to Week 11||28
9002755|NCT02914522|10066049|FG004|NOT COMPLETED|Induction Study: Up to Week 11||24
9002756|NCT02914522|10066050|FG005|NOT COMPLETED|Induction Study: Up to Week 11||16
9002757|NCT02914522|10066051|FG006|NOT COMPLETED|Induction Study: Up to Week 11||0
9002758|NCT02914522|10066052|FG007|NOT COMPLETED|Induction Study: Up to Week 11||0
9002759|NCT02914522|10066053|FG008|NOT COMPLETED|Induction Study: Up to Week 11||0
9002760|NCT02914522|10066054|FG009|NOT COMPLETED|Induction Study: Up to Week 11||0
9002761|NCT02914522|10066055|FG010|NOT COMPLETED|Induction Study: Up to Week 11||0
9002762|NCT02914522|10066045|FG000|STARTED|Maintenance Study: Week 11 to Week 58|Participants achieved either EBS remission/MCS response at Week 10 continued into Maintenance Study.|0
9002763|NCT02914522|10066046|FG001|STARTED|Maintenance Study: Week 11 to Week 58|Participants achieved either EBS remission/MCS response at Week 10 continued into Maintenance Study.|0
9002764|NCT02914522|10066047|FG002|STARTED|Maintenance Study: Week 11 to Week 58|Participants achieved either EBS remission/MCS response at Week 10 continued into Maintenance Study.|0
9002765|NCT02914522|10066048|FG003|STARTED|Maintenance Study: Week 11 to Week 58||0
9002766|NCT02914522|10066049|FG004|STARTED|Maintenance Study: Week 11 to Week 58||0
9002767|NCT02914522|10066050|FG005|STARTED|Maintenance Study: Week 11 to Week 58|Participants achieved either EBS remission/MCS response at Week 10 continued into Maintenance Study.|0
9002768|NCT02914522|10066051|FG006|STARTED|Maintenance Study: Week 11 to Week 58|Participants achieved either EBS remission/MCS response at Week 10 continued into Maintenance Study.|202
9002769|NCT02914522|10066052|FG007|STARTED|Maintenance Study: Week 11 to Week 58|Participants achieved either EBS remission/MCS response at Week 10 continued into Maintenance Study.|99
8634175|NCT00555360|9674466|FG000|NOT COMPLETED|Overall Study||27
8634176|NCT00555360|9674467|FG001|NOT COMPLETED|Overall Study||36
9002770|NCT02914522|10066053|FG008|STARTED|Maintenance Study: Week 11 to Week 58|Participants achieved either EBS remission/MCS response at Week 10 continued into Maintenance Study.|179
9002771|NCT02914522|10066054|FG009|STARTED|Maintenance Study: Week 11 to Week 58|Participants achieved either EBS remission/MCS response at Week 10 continued into Maintenance Study.|91
9002772|NCT02914522|10066055|FG010|STARTED|Maintenance Study: Week 11 to Week 58||93
9002773|NCT02914522|10066045|FG000|COMPLETED|Maintenance Study: Week 11 to Week 58||0
9002774|NCT02914522|10066046|FG001|COMPLETED|Maintenance Study: Week 11 to Week 58||0
9002775|NCT02914522|10066047|FG002|COMPLETED|Maintenance Study: Week 11 to Week 58||0
9002776|NCT02914522|10066048|FG003|COMPLETED|Maintenance Study: Week 11 to Week 58||0
8882316|NCT01955707|9939811|FG000|Received Total Volume of Study Drug|Overall Study||82
8634177|NCT00555425|9674476|FG000|STARTED|Overall Study||57
8882317|NCT01955707|9939812|FG001|Received Total Volume of Study Drug|Overall Study||77
8882318|NCT01955707|9939811|FG000|COMPLETED|Overall Study||62
8882319|NCT01955707|9939812|FG001|COMPLETED|Overall Study||57
8882320|NCT01955707|9939811|FG000|NOT COMPLETED|Overall Study||20
8882321|NCT01955707|9939812|FG001|NOT COMPLETED|Overall Study||22
8882322|NCT01955720|9939818|FG000|STARTED|Overall Study||13
8882323|NCT01955720|9939819|FG001|STARTED|Overall Study||13
8882324|NCT01955720|9939820|FG002|STARTED|Overall Study||3
8882325|NCT01955720|9939821|FG003|STARTED|Overall Study||3
8882326|NCT01955720|9939822|FG004|STARTED|Overall Study||7
8882327|NCT01955720|9939823|FG005|STARTED|Overall Study||7
8882328|NCT01955720|9939818|FG000|Healthy Subjects Aged 45-64|Overall Study||3
8882329|NCT01955720|9939819|FG001|Healthy Subjects Aged 45-64|Overall Study||3
8882330|NCT01955720|9939820|FG002|Healthy Subjects Aged 45-64|Overall Study||3
8882331|NCT01955720|9939821|FG003|Healthy Subjects Aged 45-64|Overall Study||3
8882332|NCT01955720|9939822|FG004|Healthy Subjects Aged 45-64|Overall Study||0
8882333|NCT01955720|9939823|FG005|Healthy Subjects Aged 45-64|Overall Study||0
8882334|NCT01955720|9939818|FG000|Healthy Subjects Aged 65-80|Overall Study||4
8882335|NCT01955720|9939819|FG001|Healthy Subjects Aged 65-80|Overall Study||4
8882336|NCT01955720|9939820|FG002|Healthy Subjects Aged 65-80|Overall Study||0
8882337|NCT01955720|9939821|FG003|Healthy Subjects Aged 65-80|Overall Study||0
8882338|NCT01955720|9939822|FG004|Healthy Subjects Aged 65-80|Overall Study||4
8882339|NCT01955720|9939823|FG005|Healthy Subjects Aged 65-80|Overall Study||4
8882340|NCT01955720|9939818|FG000|Subjects With Mild Renal Impairment|Overall Study||3
8882341|NCT01955720|9939819|FG001|Subjects With Mild Renal Impairment|Overall Study||3
8882342|NCT01955720|9939820|FG002|Subjects With Mild Renal Impairment|Overall Study||0
8882343|NCT01955720|9939821|FG003|Subjects With Mild Renal Impairment|Overall Study||0
8882344|NCT01955720|9939822|FG004|Subjects With Mild Renal Impairment|Overall Study||3
8882345|NCT01955720|9939823|FG005|Subjects With Mild Renal Impairment|Overall Study||3
8882346|NCT01955720|9939818|FG000|Subjects With Moderate Renal Impairment|Overall Study||3
8882347|NCT01955720|9939819|FG001|Subjects With Moderate Renal Impairment|Overall Study||3
8882348|NCT01955720|9939820|FG002|Subjects With Moderate Renal Impairment|Overall Study||0
8882349|NCT01955720|9939821|FG003|Subjects With Moderate Renal Impairment|Overall Study||0
8882350|NCT01955720|9939822|FG004|Subjects With Moderate Renal Impairment|Overall Study||0
8882351|NCT01955720|9939823|FG005|Subjects With Moderate Renal Impairment|Overall Study||0
8882352|NCT01955720|9939818|FG000|COMPLETED|Overall Study||13
8882353|NCT01955720|9939819|FG001|COMPLETED|Overall Study||13
8882354|NCT01955720|9939820|FG002|COMPLETED|Overall Study||3
8882355|NCT01955720|9939821|FG003|COMPLETED|Overall Study||3
8882356|NCT01955720|9939822|FG004|COMPLETED|Overall Study||7
8882357|NCT01955720|9939823|FG005|COMPLETED|Overall Study||7
8882358|NCT01955720|9939818|FG000|NOT COMPLETED|Overall Study||0
8882359|NCT01955720|9939819|FG001|NOT COMPLETED|Overall Study||0
8882360|NCT01955720|9939820|FG002|NOT COMPLETED|Overall Study||0
8882361|NCT01955720|9939821|FG003|NOT COMPLETED|Overall Study||0
8882362|NCT01955720|9939822|FG004|NOT COMPLETED|Overall Study||0
8882363|NCT01955720|9939823|FG005|NOT COMPLETED|Overall Study||0
8882364|NCT01955733|9939872|FG000|STARTED|Period 1||33
8882365|NCT01955733|9939873|FG001|STARTED|Period 1||29
8882366|NCT01955733|9939874|FG002|STARTED|Period 1||29
8882367|NCT01955733|9939872|FG000|COMPLETED|Period 1||32
8882368|NCT01955733|9939873|FG001|COMPLETED|Period 1||29
8882369|NCT01955733|9939874|FG002|COMPLETED|Period 1||29
8882370|NCT01955733|9939872|FG000|NOT COMPLETED|Period 1||1
8882371|NCT01955733|9939873|FG001|NOT COMPLETED|Period 1||0
8882372|NCT01955733|9939874|FG002|NOT COMPLETED|Period 1||0
8882373|NCT01955733|9939872|FG000|STARTED|Period 2||32
8882374|NCT01955733|9939873|FG001|STARTED|Period 2||29
8882375|NCT01955733|9939874|FG002|STARTED|Period 2||29
8882376|NCT01955733|9939872|FG000|COMPLETED|Period 2||20
8882377|NCT01955733|9939873|FG001|COMPLETED|Period 2||10
8882378|NCT01955733|9939874|FG002|COMPLETED|Period 2||8
8882379|NCT01955733|9939872|FG000|NOT COMPLETED|Period 2||12
8882380|NCT01955733|9939873|FG001|NOT COMPLETED|Period 2||19
8882381|NCT01955733|9939874|FG002|NOT COMPLETED|Period 2||21
8882382|NCT01955837|9939884|FG000|STARTED|Overall Study||271
8882383|NCT01955837|9939885|FG001|STARTED|Overall Study||135
8882384|NCT01955837|9939884|FG000|COMPLETED|Overall Study||271
8882385|NCT01955837|9939885|FG001|COMPLETED|Overall Study||135
8882386|NCT01955837|9939884|FG000|NOT COMPLETED|Overall Study||0
8882387|NCT01955837|9939885|FG001|NOT COMPLETED|Overall Study||0
8882388|NCT01955954|9939891|FG000|STARTED|Overall Study||69
8882389|NCT01955954|9939891|FG000|Received Treatment|Overall Study||66
8882390|NCT01955954|9939891|FG000|Completed Treatment|Overall Study||53
8882391|NCT01955954|9939891|FG000|Completed Post-treatment Assessement|Overall Study||48
8882392|NCT01955954|9939891|FG000|Completed 2-month Assessment|Overall Study|Primary endpoint|46
8882393|NCT01955954|9939891|FG000|Completed 6-month Assessement|Overall Study||42
8882394|NCT01955954|9939891|FG000|COMPLETED|Overall Study|12-months|33
8882395|NCT01955954|9939891|FG000|NOT COMPLETED|Overall Study||36
8882396|NCT01956032|9939895|FG000|STARTED|Overall Study||15
8882397|NCT01956032|9939895|FG000|COMPLETED|Overall Study||15
8882398|NCT01956032|9939895|FG000|NOT COMPLETED|Overall Study||0
8882399|NCT01956071|9939899|FG000|STARTED|Overall Study||44
8882400|NCT01956071|9939899|FG000|COMPLETED|Overall Study||44
8882401|NCT01956071|9939899|FG000|NOT COMPLETED|Overall Study||0
8882402|NCT01956097|9939906|FG000|STARTED|Overall Study||30
8882403|NCT01956097|9939907|FG001|STARTED|Overall Study||30
8882404|NCT01956097|9939908|FG002|STARTED|Overall Study||15
8882405|NCT01956097|9939906|FG000|COMPLETED|Overall Study||24
8882406|NCT01956097|9939907|FG001|COMPLETED|Overall Study||28
8882407|NCT01956097|9939908|FG002|COMPLETED|Overall Study||15
8882408|NCT01956097|9939906|FG000|NOT COMPLETED|Overall Study||6
8882409|NCT01956097|9939907|FG001|NOT COMPLETED|Overall Study||2
8634178|NCT00555425|9674477|FG001|STARTED|Overall Study||56
8634179|NCT00555425|9674476|FG000|COMPLETED|Overall Study||6
8634180|NCT00555425|9674477|FG001|COMPLETED|Overall Study||37
8634181|NCT00555425|9674476|FG000|NOT COMPLETED|Overall Study||51
8634182|NCT00555425|9674477|FG001|NOT COMPLETED|Overall Study||19
8634183|NCT00555438|9674483|FG000|STARTED|10 Days Post-operative||442
8634184|NCT00555438|9674483|FG000|COMPLETED|10 Days Post-operative|438 patients attended the day 10 visit (four patients died during hospitalization)|438
8634185|NCT00555438|9674483|FG000|NOT COMPLETED|10 Days Post-operative||4
8634186|NCT00555438|9674483|FG000|STARTED|Between 10 Days and 30 Days Postoperativ||438
8634187|NCT00555438|9674483|FG000|COMPLETED|Between 10 Days and 30 Days Postoperativ||433
8634188|NCT00555438|9674483|FG000|NOT COMPLETED|Between 10 Days and 30 Days Postoperativ||5
8634189|NCT00555464|9674489|FG000|STARTED|Overall Study||4
8634190|NCT00555464|9674490|FG001|STARTED|Overall Study||4
8634191|NCT00555464|9674489|FG000|COMPLETED|Overall Study||4
8634192|NCT00555464|9674490|FG001|COMPLETED|Overall Study||1
8634193|NCT00555464|9674489|FG000|NOT COMPLETED|Overall Study||0
8634194|NCT00555464|9674490|FG001|NOT COMPLETED|Overall Study||3
8691301|NCT00854087|9736540|FG001|STARTED|Overall Study||59
8691302|NCT00854087|9736539|FG000|COMPLETED|Overall Study||40
8691303|NCT00854087|9736540|FG001|COMPLETED|Overall Study||40
8691304|NCT00854087|9736539|FG000|NOT COMPLETED|Overall Study||19
8882410|NCT01956097|9939908|FG002|NOT COMPLETED|Overall Study||0
8882411|NCT01956123|9939918|FG000|STARTED|COS Cycle 2||252
8882412|NCT01956123|9939919|FG001|STARTED|COS Cycle 2||261
8882413|NCT01956123|9939920|FG002|STARTED|COS Cycle 2||0
8882414|NCT01956123|9939921|FG003|STARTED|COS Cycle 2||0
8882415|NCT01956123|9939918|FG000|COMPLETED|COS Cycle 2||238
8882416|NCT01956123|9939919|FG001|COMPLETED|COS Cycle 2||254
8882417|NCT01956123|9939920|FG002|COMPLETED|COS Cycle 2||0
8882418|NCT01956123|9939921|FG003|COMPLETED|COS Cycle 2||0
8882419|NCT01956123|9939918|FG000|NOT COMPLETED|COS Cycle 2||14
8882420|NCT01956123|9939919|FG001|NOT COMPLETED|COS Cycle 2||7
8882421|NCT01956123|9939920|FG002|NOT COMPLETED|COS Cycle 2||0
8882422|NCT01956123|9939921|FG003|NOT COMPLETED|COS Cycle 2||0
8882423|NCT01956123|9939918|FG000|STARTED|COS Cycle 3||0
8882424|NCT01956123|9939919|FG001|STARTED|COS Cycle 3||0
8882425|NCT01956123|9939920|FG002|STARTED|COS Cycle 3|Subjects in COS cycle 2 who failed to achieve an ongoing pregnancy could undergo COS cycle 3|95
8882426|NCT01956123|9939921|FG003|STARTED|COS Cycle 3|Subjects in COS cycle 2 who failed to achieve an ongoing pregnancy could undergo COS cycle 3|93
8882427|NCT01956123|9939918|FG000|COMPLETED|COS Cycle 3||0
8882428|NCT01956123|9939919|FG001|COMPLETED|COS Cycle 3||0
8882429|NCT01956123|9939920|FG002|COMPLETED|COS Cycle 3||89
8882430|NCT01956123|9939921|FG003|COMPLETED|COS Cycle 3||91
8882431|NCT01956123|9939918|FG000|NOT COMPLETED|COS Cycle 3||0
8882432|NCT01956123|9939919|FG001|NOT COMPLETED|COS Cycle 3||0
8882433|NCT01956123|9939920|FG002|NOT COMPLETED|COS Cycle 3||6
8882434|NCT01956123|9939921|FG003|NOT COMPLETED|COS Cycle 3||2
8882435|NCT01956240|9939934|FG000|STARTED|Overall Study||48
8882436|NCT01956240|9939935|FG001|STARTED|Overall Study||49
8882437|NCT01956240|9939934|FG000|COMPLETED|Overall Study||25
8882438|NCT01956240|9939935|FG001|COMPLETED|Overall Study||25
8882439|NCT01956240|9939934|FG000|NOT COMPLETED|Overall Study||23
8882440|NCT01956240|9939935|FG001|NOT COMPLETED|Overall Study||24
8882441|NCT01956279|9939943|FG000|STARTED|Overall Study||82
8882442|NCT01956279|9939944|FG001|STARTED|Overall Study||88
8882443|NCT01956279|9939943|FG000|COMPLETED|Overall Study||68
8882444|NCT01956279|9939944|FG001|COMPLETED|Overall Study||74
8882445|NCT01956279|9939943|FG000|NOT COMPLETED|Overall Study||14
8882446|NCT01956279|9939944|FG001|NOT COMPLETED|Overall Study||14
8882447|NCT01956435|9939950|FG000|STARTED|Overall Study||3
8882448|NCT01956435|9939951|FG001|STARTED|Overall Study||3
8882449|NCT01956435|9939950|FG000|COMPLETED|Overall Study||3
8882450|NCT01956435|9939951|FG001|COMPLETED|Overall Study||3
8882451|NCT01956435|9939950|FG000|NOT COMPLETED|Overall Study||0
8882452|NCT01956435|9939951|FG001|NOT COMPLETED|Overall Study||0
8882453|NCT01956773|9939960|FG000|STARTED|Overall Study||2520
8882454|NCT01956773|9939961|FG001|STARTED|Overall Study||100
8882455|NCT01956773|9939960|FG000|COMPLETED|Overall Study||1892
8882456|NCT01956773|9939961|FG001|COMPLETED|Overall Study||99
8882457|NCT01956773|9939960|FG000|NOT COMPLETED|Overall Study||628
8882458|NCT01956773|9939961|FG001|NOT COMPLETED|Overall Study||1
8882459|NCT01957085|9939967|FG000|STARTED|Overall Study|Per Institutional Review Board requirements, exact dates are not to be reported|366
8882460|NCT01957085|9939967|FG000|COMPLETED|Overall Study|Per Institutional Review Board, exact dates are not to be reported|366
8882461|NCT01957085|9939967|FG000|NOT COMPLETED|Overall Study||0
8882462|NCT01957111|9939974|FG000|STARTED|Overall Study||16
8882463|NCT01957111|9939975|FG001|STARTED|Overall Study||16
8882464|NCT01957111|9939974|FG000|COMPLETED|Overall Study||15
8882465|NCT01957111|9939975|FG001|COMPLETED|Overall Study||15
8882466|NCT01957111|9939974|FG000|NOT COMPLETED|Overall Study||1
8882467|NCT01957111|9939975|FG001|NOT COMPLETED|Overall Study||1
8882468|NCT01957137|9939981|FG000|STARTED|Randomized Portion||30
8882469|NCT01957137|9939981|FG000|Continuous Stimulation|Randomized Portion|Subjects received continuous stimulation for approximately 4 weeks.|29
8882470|NCT01957137|9939981|FG000|Cycling Parameter #1|Randomized Portion|Subjects received Cycling Parameter #1 for approximately 4 weeks.|30
9039458|NCT03338998|10100433|FG001|STARTED|Treatment Period||13
8691305|NCT00854087|9736540|FG001|NOT COMPLETED|Overall Study||19
8882471|NCT01957137|9939981|FG000|Cycling Parameter #2|Randomized Portion|Subjects received Cycling Parameter #2 for approximately 4 weeks.|28
8882472|NCT01957137|9939981|FG000|Cycling Parameter #3|Randomized Portion|Subjects received Cycling Parameter #3 for approximately 4 weeks.|28
8882473|NCT01957137|9939981|FG000|COMPLETED|Randomized Portion||28
8882474|NCT01957137|9939981|FG000|NOT COMPLETED|Randomized Portion||2
8882475|NCT01957137|9939981|FG000|STARTED|No Stimulation|Following randomized portion, all subjects went through no stimulation for approximately 4 weeks.|28
8882476|NCT01957137|9939981|FG000|COMPLETED|No Stimulation||28
8882477|NCT01957137|9939981|FG000|NOT COMPLETED|No Stimulation||0
8882478|NCT01957150|9939995|FG000|STARTED|Overall Study||142
8882479|NCT01957150|9939996|FG001|STARTED|Overall Study||141
8882480|NCT01957150|9939995|FG000|COMPLETED|Overall Study||87
8882481|NCT01957150|9939996|FG001|COMPLETED|Overall Study||83
8882482|NCT01957150|9939995|FG000|NOT COMPLETED|Overall Study||55
8882483|NCT01957150|9939996|FG001|NOT COMPLETED|Overall Study||58
8882484|NCT01957163|9940005|FG000|STARTED|Overall Study||206
8882485|NCT01957163|9940006|FG001|STARTED|Overall Study||206
8882486|NCT01957163|9940007|FG002|STARTED|Overall Study||207
8882487|NCT01957163|9940005|FG000|COMPLETED|Overall Study||191
8882488|NCT01957163|9940006|FG001|COMPLETED|Overall Study||195
8882489|NCT01957163|9940007|FG002|COMPLETED|Overall Study||189
8882490|NCT01957163|9940005|FG000|NOT COMPLETED|Overall Study||15
8882491|NCT01957163|9940006|FG001|NOT COMPLETED|Overall Study||11
8882492|NCT01957163|9940007|FG002|NOT COMPLETED|Overall Study||18
9002777|NCT02914522|10066049|FG004|COMPLETED|Maintenance Study: Week 11 to Week 58||0
9002778|NCT02914522|10066050|FG005|COMPLETED|Maintenance Study: Week 11 to Week 58||0
9002779|NCT02914522|10066051|FG006|COMPLETED|Maintenance Study: Week 11 to Week 58||150
9002780|NCT02914522|10066052|FG007|COMPLETED|Maintenance Study: Week 11 to Week 58||41
9002781|NCT02914522|10066053|FG008|COMPLETED|Maintenance Study: Week 11 to Week 58||104
9002782|NCT02914522|10066054|FG009|COMPLETED|Maintenance Study: Week 11 to Week 58||42
9002783|NCT02914522|10066055|FG010|COMPLETED|Maintenance Study: Week 11 to Week 58||64
9002784|NCT02914522|10066045|FG000|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||0
9002785|NCT02914522|10066046|FG001|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||0
9002786|NCT02914522|10066047|FG002|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||0
9002787|NCT02914522|10066048|FG003|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||0
9002788|NCT02914522|10066049|FG004|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||0
9002789|NCT02914522|10066050|FG005|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||0
9002790|NCT02914522|10066051|FG006|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||52
9002791|NCT02914522|10066052|FG007|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||58
9002792|NCT02914522|10066053|FG008|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||75
9002793|NCT02914522|10066054|FG009|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||49
9002794|NCT02914522|10066055|FG010|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||29
8882493|NCT01957202|9940015|FG000|STARTED|Treatment Period 1 (8 Days)||3
8882494|NCT01957202|9940016|FG001|STARTED|Treatment Period 1 (8 Days)||6
8882495|NCT01957202|9940017|FG002|STARTED|Treatment Period 1 (8 Days)||6
8882496|NCT01957202|9940018|FG003|STARTED|Treatment Period 1 (8 Days)||3
8882497|NCT01957202|9940019|FG004|STARTED|Treatment Period 1 (8 Days)||3
8882498|NCT01957202|9940020|FG005|STARTED|Treatment Period 1 (8 Days)||2
8882499|NCT01957202|9940021|FG006|STARTED|Treatment Period 1 (8 Days)||3
8882500|NCT01957202|9940022|FG007|STARTED|Treatment Period 1 (8 Days)||3
8882501|NCT01957202|9940023|FG008|STARTED|Treatment Period 1 (8 Days)||3
8882502|NCT01957202|9940024|FG009|STARTED|Treatment Period 1 (8 Days)||6
8882503|NCT01957202|9940025|FG010|STARTED|Treatment Period 1 (8 Days)||3
8882504|NCT01957202|9940026|FG011|STARTED|Treatment Period 1 (8 Days)||6
8882505|NCT01957202|9940027|FG012|STARTED|Treatment Period 1 (8 Days)||3
8882506|NCT01957202|9940028|FG013|STARTED|Treatment Period 1 (8 Days)||3
8882507|NCT01957202|9940029|FG014|STARTED|Treatment Period 1 (8 Days)||6
8882508|NCT01957202|9940030|FG015|STARTED|Treatment Period 1 (8 Days)||3
8882509|NCT01957202|9940031|FG016|STARTED|Treatment Period 1 (8 Days)||6
8882510|NCT01957202|9940032|FG017|STARTED|Treatment Period 1 (8 Days)||3
8882511|NCT01957202|9940015|FG000|COMPLETED|Treatment Period 1 (8 Days)||3
8882512|NCT01957202|9940016|FG001|COMPLETED|Treatment Period 1 (8 Days)||6
8882513|NCT01957202|9940017|FG002|COMPLETED|Treatment Period 1 (8 Days)||6
8882514|NCT01957202|9940018|FG003|COMPLETED|Treatment Period 1 (8 Days)||3
8882515|NCT01957202|9940019|FG004|COMPLETED|Treatment Period 1 (8 Days)||3
8882516|NCT01957202|9940020|FG005|COMPLETED|Treatment Period 1 (8 Days)||2
8882517|NCT01957202|9940021|FG006|COMPLETED|Treatment Period 1 (8 Days)||3
8882518|NCT01957202|9940022|FG007|COMPLETED|Treatment Period 1 (8 Days)||3
8882519|NCT01957202|9940023|FG008|COMPLETED|Treatment Period 1 (8 Days)||3
8882520|NCT01957202|9940024|FG009|COMPLETED|Treatment Period 1 (8 Days)||6
8882521|NCT01957202|9940025|FG010|COMPLETED|Treatment Period 1 (8 Days)||3
8882522|NCT01957202|9940026|FG011|COMPLETED|Treatment Period 1 (8 Days)||6
8882523|NCT01957202|9940027|FG012|COMPLETED|Treatment Period 1 (8 Days)||3
8882524|NCT01957202|9940028|FG013|COMPLETED|Treatment Period 1 (8 Days)||3
8882525|NCT01957202|9940029|FG014|COMPLETED|Treatment Period 1 (8 Days)||6
8882526|NCT01957202|9940030|FG015|COMPLETED|Treatment Period 1 (8 Days)||3
8882527|NCT01957202|9940031|FG016|COMPLETED|Treatment Period 1 (8 Days)||6
8882528|NCT01957202|9940032|FG017|COMPLETED|Treatment Period 1 (8 Days)||3
8882529|NCT01957202|9940015|FG000|NOT COMPLETED|Treatment Period 1 (8 Days)||0
8882530|NCT01957202|9940016|FG001|NOT COMPLETED|Treatment Period 1 (8 Days)||0
8882531|NCT01957202|9940017|FG002|NOT COMPLETED|Treatment Period 1 (8 Days)||0
8882532|NCT01957202|9940018|FG003|NOT COMPLETED|Treatment Period 1 (8 Days)||0
8882533|NCT01957202|9940019|FG004|NOT COMPLETED|Treatment Period 1 (8 Days)||0
8882534|NCT01957202|9940020|FG005|NOT COMPLETED|Treatment Period 1 (8 Days)||0
8882535|NCT01957202|9940021|FG006|NOT COMPLETED|Treatment Period 1 (8 Days)||0
8882536|NCT01957202|9940022|FG007|NOT COMPLETED|Treatment Period 1 (8 Days)||0
8882537|NCT01957202|9940023|FG008|NOT COMPLETED|Treatment Period 1 (8 Days)||0
8882538|NCT01957202|9940024|FG009|NOT COMPLETED|Treatment Period 1 (8 Days)||0
8882539|NCT01957202|9940025|FG010|NOT COMPLETED|Treatment Period 1 (8 Days)||0
8882540|NCT01957202|9940026|FG011|NOT COMPLETED|Treatment Period 1 (8 Days)||0
8882541|NCT01957202|9940027|FG012|NOT COMPLETED|Treatment Period 1 (8 Days)||0
8882542|NCT01957202|9940028|FG013|NOT COMPLETED|Treatment Period 1 (8 Days)||0
8882543|NCT01957202|9940029|FG014|NOT COMPLETED|Treatment Period 1 (8 Days)||0
8882544|NCT01957202|9940030|FG015|NOT COMPLETED|Treatment Period 1 (8 Days)||0
8882545|NCT01957202|9940031|FG016|NOT COMPLETED|Treatment Period 1 (8 Days)||0
8882546|NCT01957202|9940032|FG017|NOT COMPLETED|Treatment Period 1 (8 Days)||0
8882547|NCT01957202|9940015|FG000|STARTED|Washout Period 1 (14 to 28 Days)||3
8882548|NCT01957202|9940016|FG001|STARTED|Washout Period 1 (14 to 28 Days)||6
8882549|NCT01957202|9940017|FG002|STARTED|Washout Period 1 (14 to 28 Days)||6
8882550|NCT01957202|9940018|FG003|STARTED|Washout Period 1 (14 to 28 Days)||3
8882551|NCT01957202|9940019|FG004|STARTED|Washout Period 1 (14 to 28 Days)||3
8882552|NCT01957202|9940020|FG005|STARTED|Washout Period 1 (14 to 28 Days)||2
8882553|NCT01957202|9940021|FG006|STARTED|Washout Period 1 (14 to 28 Days)||3
8882554|NCT01957202|9940022|FG007|STARTED|Washout Period 1 (14 to 28 Days)||3
8882555|NCT01957202|9940023|FG008|STARTED|Washout Period 1 (14 to 28 Days)||3
8882556|NCT01957202|9940024|FG009|STARTED|Washout Period 1 (14 to 28 Days)||6
8882557|NCT01957202|9940025|FG010|STARTED|Washout Period 1 (14 to 28 Days)||3
8882558|NCT01957202|9940026|FG011|STARTED|Washout Period 1 (14 to 28 Days)||6
8882559|NCT01957202|9940027|FG012|STARTED|Washout Period 1 (14 to 28 Days)||3
8882560|NCT01957202|9940028|FG013|STARTED|Washout Period 1 (14 to 28 Days)||3
8882561|NCT01957202|9940029|FG014|STARTED|Washout Period 1 (14 to 28 Days)||6
8882562|NCT01957202|9940030|FG015|STARTED|Washout Period 1 (14 to 28 Days)||3
8882563|NCT01957202|9940031|FG016|STARTED|Washout Period 1 (14 to 28 Days)||6
8882564|NCT01957202|9940032|FG017|STARTED|Washout Period 1 (14 to 28 Days)||3
8882565|NCT01957202|9940015|FG000|COMPLETED|Washout Period 1 (14 to 28 Days)||3
8882566|NCT01957202|9940016|FG001|COMPLETED|Washout Period 1 (14 to 28 Days)||6
8882567|NCT01957202|9940017|FG002|COMPLETED|Washout Period 1 (14 to 28 Days)||6
8882568|NCT01957202|9940018|FG003|COMPLETED|Washout Period 1 (14 to 28 Days)||3
8882569|NCT01957202|9940019|FG004|COMPLETED|Washout Period 1 (14 to 28 Days)||3
8882570|NCT01957202|9940020|FG005|COMPLETED|Washout Period 1 (14 to 28 Days)||2
8882571|NCT01957202|9940021|FG006|COMPLETED|Washout Period 1 (14 to 28 Days)||3
8882572|NCT01957202|9940022|FG007|COMPLETED|Washout Period 1 (14 to 28 Days)||3
9002795|NCT02914548|10066085|FG000|STARTED|Overall Study||67
9002796|NCT02914548|10066086|FG001|STARTED|Overall Study||67
9002797|NCT02914548|10066087|FG002|STARTED|Overall Study||66
9002798|NCT02914548|10066085|FG000|COMPLETED|Overall Study||46
8882573|NCT01957202|9940023|FG008|COMPLETED|Washout Period 1 (14 to 28 Days)||3
8882574|NCT01957202|9940024|FG009|COMPLETED|Washout Period 1 (14 to 28 Days)||6
8882575|NCT01957202|9940025|FG010|COMPLETED|Washout Period 1 (14 to 28 Days)||3
8882576|NCT01957202|9940026|FG011|COMPLETED|Washout Period 1 (14 to 28 Days)||6
8882577|NCT01957202|9940027|FG012|COMPLETED|Washout Period 1 (14 to 28 Days)||3
8882578|NCT01957202|9940028|FG013|COMPLETED|Washout Period 1 (14 to 28 Days)||3
8882579|NCT01957202|9940029|FG014|COMPLETED|Washout Period 1 (14 to 28 Days)||6
8882580|NCT01957202|9940030|FG015|COMPLETED|Washout Period 1 (14 to 28 Days)||3
8882581|NCT01957202|9940031|FG016|COMPLETED|Washout Period 1 (14 to 28 Days)||6
8882582|NCT01957202|9940032|FG017|COMPLETED|Washout Period 1 (14 to 28 Days)||3
8882583|NCT01957202|9940015|FG000|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
8882584|NCT01957202|9940016|FG001|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
8882585|NCT01957202|9940017|FG002|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
8882586|NCT01957202|9940018|FG003|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
8882587|NCT01957202|9940019|FG004|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
8882588|NCT01957202|9940020|FG005|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
8882589|NCT01957202|9940021|FG006|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
8882590|NCT01957202|9940022|FG007|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
8882591|NCT01957202|9940023|FG008|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
8882592|NCT01957202|9940024|FG009|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
8882593|NCT01957202|9940025|FG010|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
8882594|NCT01957202|9940026|FG011|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
8882595|NCT01957202|9940027|FG012|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
8882596|NCT01957202|9940028|FG013|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
8882597|NCT01957202|9940029|FG014|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
8882598|NCT01957202|9940030|FG015|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
8882599|NCT01957202|9940031|FG016|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
8882600|NCT01957202|9940032|FG017|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
8882601|NCT01957202|9940015|FG000|STARTED|Treatment Period 2 (8 Days)||3
8882602|NCT01957202|9940016|FG001|STARTED|Treatment Period 2 (8 Days)||6
8882603|NCT01957202|9940017|FG002|STARTED|Treatment Period 2 (8 Days)||6
8882604|NCT01957202|9940018|FG003|STARTED|Treatment Period 2 (8 Days)||3
8882605|NCT01957202|9940019|FG004|STARTED|Treatment Period 2 (8 Days)||3
8882606|NCT01957202|9940020|FG005|STARTED|Treatment Period 2 (8 Days)||2
8882607|NCT01957202|9940021|FG006|STARTED|Treatment Period 2 (8 Days)||3
8882608|NCT01957202|9940022|FG007|STARTED|Treatment Period 2 (8 Days)||3
8882609|NCT01957202|9940023|FG008|STARTED|Treatment Period 2 (8 Days)||3
8882610|NCT01957202|9940024|FG009|STARTED|Treatment Period 2 (8 Days)||6
8882611|NCT01957202|9940025|FG010|STARTED|Treatment Period 2 (8 Days)||3
8882612|NCT01957202|9940026|FG011|STARTED|Treatment Period 2 (8 Days)||6
8882613|NCT01957202|9940027|FG012|STARTED|Treatment Period 2 (8 Days)||3
8882614|NCT01957202|9940028|FG013|STARTED|Treatment Period 2 (8 Days)||3
8882615|NCT01957202|9940029|FG014|STARTED|Treatment Period 2 (8 Days)||6
8882616|NCT01957202|9940030|FG015|STARTED|Treatment Period 2 (8 Days)||3
8882617|NCT01957202|9940031|FG016|STARTED|Treatment Period 2 (8 Days)||6
8882618|NCT01957202|9940032|FG017|STARTED|Treatment Period 2 (8 Days)||3
8882619|NCT01957202|9940015|FG000|COMPLETED|Treatment Period 2 (8 Days)||3
8882620|NCT01957202|9940016|FG001|COMPLETED|Treatment Period 2 (8 Days)||5
8882621|NCT01957202|9940017|FG002|COMPLETED|Treatment Period 2 (8 Days)||6
8882622|NCT01957202|9940018|FG003|COMPLETED|Treatment Period 2 (8 Days)||3
8882623|NCT01957202|9940019|FG004|COMPLETED|Treatment Period 2 (8 Days)||3
8882624|NCT01957202|9940020|FG005|COMPLETED|Treatment Period 2 (8 Days)||2
8882625|NCT01957202|9940021|FG006|COMPLETED|Treatment Period 2 (8 Days)||3
8882626|NCT01957202|9940022|FG007|COMPLETED|Treatment Period 2 (8 Days)||3
8882627|NCT01957202|9940023|FG008|COMPLETED|Treatment Period 2 (8 Days)||3
8882628|NCT01957202|9940024|FG009|COMPLETED|Treatment Period 2 (8 Days)||6
8882629|NCT01957202|9940025|FG010|COMPLETED|Treatment Period 2 (8 Days)||3
8882630|NCT01957202|9940026|FG011|COMPLETED|Treatment Period 2 (8 Days)||6
8882631|NCT01957202|9940027|FG012|COMPLETED|Treatment Period 2 (8 Days)||3
8882632|NCT01957202|9940028|FG013|COMPLETED|Treatment Period 2 (8 Days)||3
8882633|NCT01957202|9940029|FG014|COMPLETED|Treatment Period 2 (8 Days)||6
8882634|NCT01957202|9940030|FG015|COMPLETED|Treatment Period 2 (8 Days)||3
8882635|NCT01957202|9940031|FG016|COMPLETED|Treatment Period 2 (8 Days)||5
9002799|NCT02914548|10066086|FG001|COMPLETED|Overall Study||53
9002800|NCT02914548|10066087|FG002|COMPLETED|Overall Study||46
9002801|NCT02914548|10066085|FG000|NOT COMPLETED|Overall Study||21
9002802|NCT02914548|10066086|FG001|NOT COMPLETED|Overall Study||14
9002803|NCT02914548|10066087|FG002|NOT COMPLETED|Overall Study||20
9002804|NCT02914795|10066097|FG000|STARTED|Overall Study||77
9002805|NCT02914795|10066098|FG001|STARTED|Overall Study||22
9002806|NCT02914795|10066097|FG000|COMPLETED|Overall Study||77
9002807|NCT02914795|10066098|FG001|COMPLETED|Overall Study||22
9002808|NCT02914795|10066097|FG000|NOT COMPLETED|Overall Study||0
9002809|NCT02914795|10066098|FG001|NOT COMPLETED|Overall Study||0
9002810|NCT02914834|10066108|FG000|STARTED|Overall Study||12
9002811|NCT02914834|10066109|FG001|STARTED|Overall Study||15
9002812|NCT02914834|10066108|FG000|COMPLETED|Overall Study||11
9002813|NCT02914834|10066109|FG001|COMPLETED|Overall Study||13
9002814|NCT02914834|10066108|FG000|NOT COMPLETED|Overall Study||1
9002815|NCT02914834|10066109|FG001|NOT COMPLETED|Overall Study||2
9002816|NCT02915029|10066117|FG000|STARTED|Overall Study||63
8882636|NCT01957202|9940032|FG017|COMPLETED|Treatment Period 2 (8 Days)||3
8882637|NCT01957202|9940015|FG000|NOT COMPLETED|Treatment Period 2 (8 Days)||0
8882638|NCT01957202|9940016|FG001|NOT COMPLETED|Treatment Period 2 (8 Days)||1
8882639|NCT01957202|9940017|FG002|NOT COMPLETED|Treatment Period 2 (8 Days)||0
8882640|NCT01957202|9940018|FG003|NOT COMPLETED|Treatment Period 2 (8 Days)||0
8882641|NCT01957202|9940019|FG004|NOT COMPLETED|Treatment Period 2 (8 Days)||0
8882642|NCT01957202|9940020|FG005|NOT COMPLETED|Treatment Period 2 (8 Days)||0
8882643|NCT01957202|9940021|FG006|NOT COMPLETED|Treatment Period 2 (8 Days)||0
8882644|NCT01957202|9940022|FG007|NOT COMPLETED|Treatment Period 2 (8 Days)||0
8882645|NCT01957202|9940023|FG008|NOT COMPLETED|Treatment Period 2 (8 Days)||0
8882646|NCT01957202|9940024|FG009|NOT COMPLETED|Treatment Period 2 (8 Days)||0
8882647|NCT01957202|9940025|FG010|NOT COMPLETED|Treatment Period 2 (8 Days)||0
8882648|NCT01957202|9940026|FG011|NOT COMPLETED|Treatment Period 2 (8 Days)||0
8882649|NCT01957202|9940027|FG012|NOT COMPLETED|Treatment Period 2 (8 Days)||0
8882650|NCT01957202|9940028|FG013|NOT COMPLETED|Treatment Period 2 (8 Days)||0
8882651|NCT01957202|9940029|FG014|NOT COMPLETED|Treatment Period 2 (8 Days)||0
8882652|NCT01957202|9940030|FG015|NOT COMPLETED|Treatment Period 2 (8 Days)||0
8882653|NCT01957202|9940031|FG016|NOT COMPLETED|Treatment Period 2 (8 Days)||1
8882654|NCT01957202|9940032|FG017|NOT COMPLETED|Treatment Period 2 (8 Days)||0
8882655|NCT01957202|9940015|FG000|STARTED|Washout Period 2 (14 to 28 Days)||3
8882656|NCT01957202|9940016|FG001|STARTED|Washout Period 2 (14 to 28 Days)||5
8882657|NCT01957202|9940017|FG002|STARTED|Washout Period 2 (14 to 28 Days)||6
8882658|NCT01957202|9940018|FG003|STARTED|Washout Period 2 (14 to 28 Days)||3
8882659|NCT01957202|9940019|FG004|STARTED|Washout Period 2 (14 to 28 Days)||3
8882660|NCT01957202|9940020|FG005|STARTED|Washout Period 2 (14 to 28 Days)||2
8882661|NCT01957202|9940021|FG006|STARTED|Washout Period 2 (14 to 28 Days)||3
8882662|NCT01957202|9940022|FG007|STARTED|Washout Period 2 (14 to 28 Days)||3
8882663|NCT01957202|9940023|FG008|STARTED|Washout Period 2 (14 to 28 Days)||3
8882664|NCT01957202|9940024|FG009|STARTED|Washout Period 2 (14 to 28 Days)||6
8882665|NCT01957202|9940025|FG010|STARTED|Washout Period 2 (14 to 28 Days)||3
8882666|NCT01957202|9940026|FG011|STARTED|Washout Period 2 (14 to 28 Days)||6
8882667|NCT01957202|9940027|FG012|STARTED|Washout Period 2 (14 to 28 Days)||3
8882668|NCT01957202|9940028|FG013|STARTED|Washout Period 2 (14 to 28 Days)||3
8882669|NCT01957202|9940029|FG014|STARTED|Washout Period 2 (14 to 28 Days)||6
8882670|NCT01957202|9940030|FG015|STARTED|Washout Period 2 (14 to 28 Days)||3
8882671|NCT01957202|9940031|FG016|STARTED|Washout Period 2 (14 to 28 Days)||5
8882672|NCT01957202|9940032|FG017|STARTED|Washout Period 2 (14 to 28 Days)||3
8882673|NCT01957202|9940015|FG000|COMPLETED|Washout Period 2 (14 to 28 Days)||3
8882674|NCT01957202|9940016|FG001|COMPLETED|Washout Period 2 (14 to 28 Days)||5
8882675|NCT01957202|9940017|FG002|COMPLETED|Washout Period 2 (14 to 28 Days)||6
8882676|NCT01957202|9940018|FG003|COMPLETED|Washout Period 2 (14 to 28 Days)||3
8882677|NCT01957202|9940019|FG004|COMPLETED|Washout Period 2 (14 to 28 Days)||3
8882678|NCT01957202|9940020|FG005|COMPLETED|Washout Period 2 (14 to 28 Days)||2
8882679|NCT01957202|9940021|FG006|COMPLETED|Washout Period 2 (14 to 28 Days)||3
8882680|NCT01957202|9940022|FG007|COMPLETED|Washout Period 2 (14 to 28 Days)||3
8882681|NCT01957202|9940023|FG008|COMPLETED|Washout Period 2 (14 to 28 Days)||3
8882682|NCT01957202|9940024|FG009|COMPLETED|Washout Period 2 (14 to 28 Days)||6
8882683|NCT01957202|9940025|FG010|COMPLETED|Washout Period 2 (14 to 28 Days)||3
8882684|NCT01957202|9940026|FG011|COMPLETED|Washout Period 2 (14 to 28 Days)||6
8882685|NCT01957202|9940027|FG012|COMPLETED|Washout Period 2 (14 to 28 Days)||3
8882686|NCT01957202|9940028|FG013|COMPLETED|Washout Period 2 (14 to 28 Days)||3
8634195|NCT00555477|9674498|FG000|STARTED|Overall Study||14
8634196|NCT00555477|9674499|FG001|STARTED|Overall Study||45
8634197|NCT00555477|9674498|FG000|COMPLETED|Overall Study||12
8634198|NCT00555477|9674499|FG001|COMPLETED|Overall Study||32
8634199|NCT00555477|9674498|FG000|NOT COMPLETED|Overall Study||2
8634200|NCT00555477|9674499|FG001|NOT COMPLETED|Overall Study||13
8634201|NCT00555568|9674507|FG000|STARTED|Overall Study||100
8634202|NCT00555568|9674508|FG001|STARTED|Overall Study||98
8634203|NCT00555568|9674509|FG002|STARTED|Overall Study||100
8634204|NCT00555568|9674507|FG000|COMPLETED|Overall Study||74
8634205|NCT00555568|9674508|FG001|COMPLETED|Overall Study||82
8634206|NCT00555568|9674509|FG002|COMPLETED|Overall Study||84
8634207|NCT00555568|9674507|FG000|NOT COMPLETED|Overall Study||26
8634208|NCT00555568|9674508|FG001|NOT COMPLETED|Overall Study||16
8634209|NCT00555568|9674509|FG002|NOT COMPLETED|Overall Study||16
8634210|NCT00555581|9674517|FG000|STARTED|Overall Study||30
8634211|NCT00555581|9674517|FG000|COMPLETED|Overall Study||24
8634212|NCT00555581|9674517|FG000|NOT COMPLETED|Overall Study||6
8634213|NCT00555620|9674527|FG000|STARTED|Overall Study||6
8634214|NCT00555620|9674528|FG001|STARTED|Overall Study||7
8634215|NCT00555620|9674529|FG002|STARTED|Overall Study||15
8634216|NCT00555620|9674530|FG003|STARTED|Overall Study||23
8634217|NCT00555620|9674531|FG004|STARTED|Overall Study||3
8882687|NCT01957202|9940029|FG014|COMPLETED|Washout Period 2 (14 to 28 Days)||6
8882688|NCT01957202|9940030|FG015|COMPLETED|Washout Period 2 (14 to 28 Days)||3
8882689|NCT01957202|9940031|FG016|COMPLETED|Washout Period 2 (14 to 28 Days)||5
8882690|NCT01957202|9940032|FG017|COMPLETED|Washout Period 2 (14 to 28 Days)||3
8634218|NCT00555620|9674532|FG005|STARTED|Overall Study||22
8634219|NCT00555620|9674527|FG000|COMPLETED|Overall Study||0
8634220|NCT00555620|9674528|FG001|COMPLETED|Overall Study||0
8634221|NCT00555620|9674529|FG002|COMPLETED|Overall Study||0
8634222|NCT00555620|9674530|FG003|COMPLETED|Overall Study||0
8634223|NCT00555620|9674531|FG004|COMPLETED|Overall Study||0
8882691|NCT01957202|9940015|FG000|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
8882692|NCT01957202|9940016|FG001|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
8882693|NCT01957202|9940017|FG002|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
8882694|NCT01957202|9940018|FG003|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
8882695|NCT01957202|9940019|FG004|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
8882696|NCT01957202|9940020|FG005|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
8882697|NCT01957202|9940021|FG006|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
8882698|NCT01957202|9940022|FG007|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
8882699|NCT01957202|9940023|FG008|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
8882700|NCT01957202|9940024|FG009|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
8882701|NCT01957202|9940025|FG010|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
8882702|NCT01957202|9940026|FG011|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
8634224|NCT00555620|9674532|FG005|COMPLETED|Overall Study||0
8634225|NCT00555620|9674527|FG000|NOT COMPLETED|Overall Study||6
8634226|NCT00555620|9674528|FG001|NOT COMPLETED|Overall Study||7
8634227|NCT00555620|9674529|FG002|NOT COMPLETED|Overall Study||15
8634228|NCT00555620|9674530|FG003|NOT COMPLETED|Overall Study||23
8634229|NCT00555620|9674531|FG004|NOT COMPLETED|Overall Study||3
8634230|NCT00555620|9674532|FG005|NOT COMPLETED|Overall Study||22
8634231|NCT00555672|9674552|FG000|STARTED|Overall Study||24
8634232|NCT00555672|9674553|FG001|STARTED|Overall Study||10
8634233|NCT00555672|9674552|FG000|COMPLETED|Overall Study||0
8634234|NCT00555672|9674553|FG001|COMPLETED|Overall Study||0
8634235|NCT00555672|9674552|FG000|NOT COMPLETED|Overall Study||24
8634236|NCT00555672|9674553|FG001|NOT COMPLETED|Overall Study||10
8634237|NCT00555750|9674561|FG000|STARTED|Overall Study||10
8634238|NCT00555750|9674562|FG001|STARTED|Overall Study||10
8634239|NCT00555750|9674561|FG000|COMPLETED|Overall Study||10
8634240|NCT00555750|9674562|FG001|COMPLETED|Overall Study||10
8634241|NCT00555750|9674561|FG000|NOT COMPLETED|Overall Study||0
8634242|NCT00555750|9674562|FG001|NOT COMPLETED|Overall Study||0
8634243|NCT00555880|9674570|FG000|STARTED|Treatment Period 1 (1 Day)||13
8634244|NCT00555880|9674571|FG001|STARTED|Treatment Period 1 (1 Day)||11
8634245|NCT00555880|9674570|FG000|COMPLETED|Treatment Period 1 (1 Day)||13
8634246|NCT00555880|9674571|FG001|COMPLETED|Treatment Period 1 (1 Day)||11
8634247|NCT00555880|9674570|FG000|NOT COMPLETED|Treatment Period 1 (1 Day)||0
8882703|NCT01957202|9940027|FG012|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
8882704|NCT01957202|9940028|FG013|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
8882705|NCT01957202|9940029|FG014|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
8882706|NCT01957202|9940030|FG015|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
8882707|NCT01957202|9940031|FG016|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
8882708|NCT01957202|9940032|FG017|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
8882709|NCT01957202|9940015|FG000|STARTED|Treatment Period 3 (8 Days)||3
8882710|NCT01957202|9940016|FG001|STARTED|Treatment Period 3 (8 Days)||5
8882711|NCT01957202|9940017|FG002|STARTED|Treatment Period 3 (8 Days)||6
8882712|NCT01957202|9940018|FG003|STARTED|Treatment Period 3 (8 Days)||3
8882713|NCT01957202|9940019|FG004|STARTED|Treatment Period 3 (8 Days)||3
8882714|NCT01957202|9940020|FG005|STARTED|Treatment Period 3 (8 Days)||2
8882715|NCT01957202|9940021|FG006|STARTED|Treatment Period 3 (8 Days)||3
8882716|NCT01957202|9940022|FG007|STARTED|Treatment Period 3 (8 Days)||3
8882717|NCT01957202|9940023|FG008|STARTED|Treatment Period 3 (8 Days)||3
8882718|NCT01957202|9940024|FG009|STARTED|Treatment Period 3 (8 Days)||6
8882719|NCT01957202|9940025|FG010|STARTED|Treatment Period 3 (8 Days)||3
8882720|NCT01957202|9940026|FG011|STARTED|Treatment Period 3 (8 Days)||6
8882721|NCT01957202|9940027|FG012|STARTED|Treatment Period 3 (8 Days)||3
8882722|NCT01957202|9940028|FG013|STARTED|Treatment Period 3 (8 Days)||3
8882723|NCT01957202|9940029|FG014|STARTED|Treatment Period 3 (8 Days)||6
8882724|NCT01957202|9940030|FG015|STARTED|Treatment Period 3 (8 Days)||3
8882725|NCT01957202|9940031|FG016|STARTED|Treatment Period 3 (8 Days)||5
8882726|NCT01957202|9940032|FG017|STARTED|Treatment Period 3 (8 Days)||3
8882727|NCT01957202|9940015|FG000|COMPLETED|Treatment Period 3 (8 Days)||3
8882728|NCT01957202|9940016|FG001|COMPLETED|Treatment Period 3 (8 Days)||5
8882729|NCT01957202|9940017|FG002|COMPLETED|Treatment Period 3 (8 Days)||6
8634248|NCT00555880|9674571|FG001|NOT COMPLETED|Treatment Period 1 (1 Day)||0
8634249|NCT00555880|9674570|FG000|STARTED|Washout (1 Day)||13
8634250|NCT00555880|9674571|FG001|STARTED|Washout (1 Day)||11
8634251|NCT00555880|9674570|FG000|COMPLETED|Washout (1 Day)||13
8634252|NCT00555880|9674571|FG001|COMPLETED|Washout (1 Day)||11
8634253|NCT00555880|9674570|FG000|NOT COMPLETED|Washout (1 Day)||0
8634254|NCT00555880|9674571|FG001|NOT COMPLETED|Washout (1 Day)||0
8634255|NCT00555880|9674570|FG000|STARTED|Treatment Period 2 (1 Day)||13
8634256|NCT00555880|9674571|FG001|STARTED|Treatment Period 2 (1 Day)||11
8634257|NCT00555880|9674570|FG000|COMPLETED|Treatment Period 2 (1 Day)||13
8634258|NCT00555880|9674571|FG001|COMPLETED|Treatment Period 2 (1 Day)||11
8634259|NCT00555880|9674570|FG000|NOT COMPLETED|Treatment Period 2 (1 Day)||0
8634260|NCT00555880|9674571|FG001|NOT COMPLETED|Treatment Period 2 (1 Day)||0
8634261|NCT00555893|9674580|FG000|STARTED|Overall Study||130
8634262|NCT00555893|9674581|FG001|STARTED|Overall Study||63
8634263|NCT00555893|9674580|FG000|Final Analysis|Overall Study|n=16 excluded from number started because >119 hrs|114
8634264|NCT00555893|9674581|FG001|Final Analysis|Overall Study|n=12 excluded from number started because >119 hrs|51
9002817|NCT02915029|10066118|FG001|STARTED|Overall Study||62
9002818|NCT02915029|10066117|FG000|COMPLETED|Overall Study||50
9002819|NCT02915029|10066118|FG001|COMPLETED|Overall Study||48
9002820|NCT02915029|10066117|FG000|NOT COMPLETED|Overall Study||13
9002821|NCT02915029|10066118|FG001|NOT COMPLETED|Overall Study||14
9002822|NCT02915159|10066126|FG000|STARTED|Overall Study||92
9002823|NCT02915159|10066127|FG001|STARTED|Overall Study||95
9002824|NCT02915159|10066126|FG000|COMPLETED|Overall Study||81
9002825|NCT02915159|10066127|FG001|COMPLETED|Overall Study||87
9002826|NCT02915159|10066126|FG000|NOT COMPLETED|Overall Study||11
9002827|NCT02915159|10066127|FG001|NOT COMPLETED|Overall Study||8
9002828|NCT02915705|10066139|FG000|STARTED|Treatment Period||32
9002829|NCT02915705|10066140|FG001|STARTED|Treatment Period||29
9002830|NCT02915705|10066139|FG000|Completed Week 40|Treatment Period||32
9002831|NCT02915705|10066140|FG001|Completed Week 40|Treatment Period||29
9002832|NCT02915705|10066139|FG000|Completed Week 64|Treatment Period||32
9002833|NCT02915705|10066140|FG001|Completed Week 64|Treatment Period||29
9002834|NCT02915705|10066139|FG000|COMPLETED|Treatment Period||32
9002835|NCT02915705|10066140|FG001|COMPLETED|Treatment Period||29
9002836|NCT02915705|10066139|FG000|NOT COMPLETED|Treatment Period||0
9002837|NCT02915705|10066140|FG001|NOT COMPLETED|Treatment Period||0
9002838|NCT02915705|10066139|FG000|STARTED|Long Term Extension Period|6 participants did not enter the extension period|26
9002839|NCT02915705|10066140|FG001|STARTED|Long Term Extension Period|4 participants did not enter the extension period|25
9002840|NCT02915705|10066139|FG000|COMPLETED|Long Term Extension Period||26
9002841|NCT02915705|10066140|FG001|COMPLETED|Long Term Extension Period||25
9002842|NCT02915705|10066139|FG000|NOT COMPLETED|Long Term Extension Period||0
9002843|NCT02915705|10066140|FG001|NOT COMPLETED|Long Term Extension Period||0
9002844|NCT02915744|10066151|FG000|STARTED|Overall Study||92
9002845|NCT02915744|10066152|FG001|STARTED|Overall Study||86
9002846|NCT02915744|10066151|FG000|COMPLETED|Overall Study||13
9002847|NCT02915744|10066152|FG001|COMPLETED|Overall Study||9
9002848|NCT02915744|10066151|FG000|NOT COMPLETED|Overall Study||79
9002849|NCT02915744|10066152|FG001|NOT COMPLETED|Overall Study||77
9002850|NCT02915835|10066162|FG000|STARTED|Overall Study||9
9002851|NCT02915835|10066163|FG001|STARTED|Overall Study||8
9002852|NCT02915835|10066162|FG000|COMPLETED|Overall Study||8
9002853|NCT02915835|10066163|FG001|COMPLETED|Overall Study||7
9002854|NCT02915835|10066162|FG000|NOT COMPLETED|Overall Study||1
9002855|NCT02915835|10066163|FG001|NOT COMPLETED|Overall Study||1
9002856|NCT02915874|10066171|FG000|STARTED|Overall Study||44
9002857|NCT02915874|10066172|FG001|STARTED|Overall Study||28
9002858|NCT02915874|10066171|FG000|Week 6 Follow Up|Overall Study||41
9002859|NCT02915874|10066172|FG001|Week 6 Follow Up|Overall Study||26
9002860|NCT02915874|10066171|FG000|COMPLETED|Overall Study||38
9002861|NCT02915874|10066172|FG001|COMPLETED|Overall Study||22
9002862|NCT02915874|10066171|FG000|NOT COMPLETED|Overall Study||6
9002863|NCT02915874|10066172|FG001|NOT COMPLETED|Overall Study||6
9002864|NCT02915978|10066181|FG000|STARTED|Overall Study||15
9002865|NCT02915978|10066182|FG001|STARTED|Overall Study||15
9002866|NCT02915978|10066183|FG002|STARTED|Overall Study||15
9002867|NCT02915978|10066181|FG000|COMPLETED|Overall Study||13
9002868|NCT02915978|10066182|FG001|COMPLETED|Overall Study||14
9002869|NCT02915978|10066183|FG002|COMPLETED|Overall Study||15
9002870|NCT02915978|10066181|FG000|NOT COMPLETED|Overall Study||2
9002871|NCT02915978|10066182|FG001|NOT COMPLETED|Overall Study||1
9002872|NCT02915978|10066183|FG002|NOT COMPLETED|Overall Study||0
9002873|NCT02916056|10066191|FG000|STARTED|Overall Study||297
9002874|NCT02916056|10066191|FG000|COMPLETED|Overall Study||0
9002875|NCT02916056|10066191|FG000|NOT COMPLETED|Overall Study||297
9002876|NCT02916407|10066197|FG000|STARTED|Overall Study||28
9002877|NCT02916407|10066198|FG001|STARTED|Overall Study||28
9002878|NCT02916407|10066197|FG000|COMPLETED|Overall Study||28
9002879|NCT02916407|10066198|FG001|COMPLETED|Overall Study||28
9002880|NCT02916407|10066197|FG000|NOT COMPLETED|Overall Study||0
9002881|NCT02916407|10066198|FG001|NOT COMPLETED|Overall Study||0
9002882|NCT02916433|10066206|FG000|STARTED|Overall Study||3
9002883|NCT02916433|10066207|FG001|STARTED|Overall Study||2
9002884|NCT02916433|10066206|FG000|COMPLETED|Overall Study||1
9002885|NCT02916433|10066207|FG001|COMPLETED|Overall Study||2
9002886|NCT02916433|10066206|FG000|NOT COMPLETED|Overall Study||2
9002887|NCT02916433|10066207|FG001|NOT COMPLETED|Overall Study||0
9002888|NCT02916498|10066218|FG000|STARTED|First Intervention, 21 Days||2
9002889|NCT02916498|10066219|FG001|STARTED|First Intervention, 21 Days||4
9002890|NCT02916498|10066218|FG000|COMPLETED|First Intervention, 21 Days||2
9002891|NCT02916498|10066219|FG001|COMPLETED|First Intervention, 21 Days||4
9002892|NCT02916498|10066218|FG000|NOT COMPLETED|First Intervention, 21 Days||0
9002893|NCT02916498|10066219|FG001|NOT COMPLETED|First Intervention, 21 Days||0
9002894|NCT02916498|10066218|FG000|STARTED|Second Intervention, 21 Days||2
8882730|NCT01957202|9940018|FG003|COMPLETED|Treatment Period 3 (8 Days)||3
9002895|NCT02916498|10066219|FG001|STARTED|Second Intervention, 21 Days||4
9002896|NCT02916498|10066218|FG000|COMPLETED|Second Intervention, 21 Days||2
9002897|NCT02916498|10066219|FG001|COMPLETED|Second Intervention, 21 Days||4
9002898|NCT02916498|10066218|FG000|NOT COMPLETED|Second Intervention, 21 Days||0
9002899|NCT02916498|10066219|FG001|NOT COMPLETED|Second Intervention, 21 Days||0
9002900|NCT02916563|10066225|FG000|STARTED|Overall Study||50
9002901|NCT02916563|10066225|FG000|COMPLETED|Overall Study||50
9002902|NCT02916563|10066225|FG000|NOT COMPLETED|Overall Study||0
9002903|NCT02916693|10066229|FG000|STARTED|Overall Study||20
8882731|NCT01957202|9940019|FG004|COMPLETED|Treatment Period 3 (8 Days)||3
8882732|NCT01957202|9940020|FG005|COMPLETED|Treatment Period 3 (8 Days)||2
8882733|NCT01957202|9940021|FG006|COMPLETED|Treatment Period 3 (8 Days)||3
8882734|NCT01957202|9940022|FG007|COMPLETED|Treatment Period 3 (8 Days)||3
8882735|NCT01957202|9940023|FG008|COMPLETED|Treatment Period 3 (8 Days)||3
8882736|NCT01957202|9940024|FG009|COMPLETED|Treatment Period 3 (8 Days)||6
8882737|NCT01957202|9940025|FG010|COMPLETED|Treatment Period 3 (8 Days)||3
8882738|NCT01957202|9940026|FG011|COMPLETED|Treatment Period 3 (8 Days)||6
8882739|NCT01957202|9940027|FG012|COMPLETED|Treatment Period 3 (8 Days)||3
8882740|NCT01957202|9940028|FG013|COMPLETED|Treatment Period 3 (8 Days)||3
8882741|NCT01957202|9940029|FG014|COMPLETED|Treatment Period 3 (8 Days)||6
8882742|NCT01957202|9940030|FG015|COMPLETED|Treatment Period 3 (8 Days)||3
8882743|NCT01957202|9940031|FG016|COMPLETED|Treatment Period 3 (8 Days)||4
8882744|NCT01957202|9940032|FG017|COMPLETED|Treatment Period 3 (8 Days)||3
8882745|NCT01957202|9940015|FG000|NOT COMPLETED|Treatment Period 3 (8 Days)||0
8882746|NCT01957202|9940016|FG001|NOT COMPLETED|Treatment Period 3 (8 Days)||0
8882747|NCT01957202|9940017|FG002|NOT COMPLETED|Treatment Period 3 (8 Days)||0
8882748|NCT01957202|9940018|FG003|NOT COMPLETED|Treatment Period 3 (8 Days)||0
8882749|NCT01957202|9940019|FG004|NOT COMPLETED|Treatment Period 3 (8 Days)||0
8882750|NCT01957202|9940020|FG005|NOT COMPLETED|Treatment Period 3 (8 Days)||0
8882751|NCT01957202|9940021|FG006|NOT COMPLETED|Treatment Period 3 (8 Days)||0
8882752|NCT01957202|9940022|FG007|NOT COMPLETED|Treatment Period 3 (8 Days)||0
8882753|NCT01957202|9940023|FG008|NOT COMPLETED|Treatment Period 3 (8 Days)||0
8882754|NCT01957202|9940024|FG009|NOT COMPLETED|Treatment Period 3 (8 Days)||0
8882755|NCT01957202|9940025|FG010|NOT COMPLETED|Treatment Period 3 (8 Days)||0
9002904|NCT02916693|10066229|FG000|COMPLETED|Overall Study||13
9002905|NCT02916693|10066229|FG000|NOT COMPLETED|Overall Study||7
9002906|NCT02916745|10066237|FG000|STARTED|Overall Study||5
9002907|NCT02916745|10066237|FG000|COMPLETED|Overall Study||5
9002908|NCT02916745|10066237|FG000|NOT COMPLETED|Overall Study||0
9002909|NCT02916927|10066243|FG000|STARTED|Overall Study||31
9002910|NCT02916927|10066244|FG001|STARTED|Overall Study||31
9002911|NCT02916927|10066243|FG000|Received Study Drug|Overall Study||31
9002912|NCT02916927|10066244|FG001|Received Study Drug|Overall Study||29
9002913|NCT02916927|10066243|FG000|COMPLETED|Overall Study||30
9002914|NCT02916927|10066244|FG001|COMPLETED|Overall Study|1 participant was in radiology for the 45 and 60 minute time points.|28
9002915|NCT02916927|10066243|FG000|NOT COMPLETED|Overall Study||1
9002916|NCT02916927|10066244|FG001|NOT COMPLETED|Overall Study||3
9002917|NCT02917031|10066253|FG000|STARTED|Overall Study||112
9002918|NCT02917031|10066254|FG001|STARTED|Overall Study||115
9002919|NCT02917031|10066255|FG002|STARTED|Overall Study||120
9002920|NCT02917031|10066253|FG000|COMPLETED|Overall Study||94
9002921|NCT02917031|10066254|FG001|COMPLETED|Overall Study||102
9002922|NCT02917031|10066255|FG002|COMPLETED|Overall Study||105
9002923|NCT02917031|10066253|FG000|NOT COMPLETED|Overall Study||18
9002924|NCT02917031|10066254|FG001|NOT COMPLETED|Overall Study||13
9002925|NCT02917031|10066255|FG002|NOT COMPLETED|Overall Study||15
9002926|NCT02917122|10066266|FG000|STARTED|Overall Study||8
9002927|NCT02917122|10066267|FG001|STARTED|Overall Study||7
9002928|NCT02917122|10066266|FG000|COMPLETED|Overall Study||8
9002929|NCT02917122|10066267|FG001|COMPLETED|Overall Study||7
9002930|NCT02917122|10066266|FG000|NOT COMPLETED|Overall Study||0
9002931|NCT02917122|10066267|FG001|NOT COMPLETED|Overall Study||0
9002932|NCT02917265|10066275|FG000|STARTED|Overall Study||5
9002933|NCT02917265|10066276|FG001|STARTED|Overall Study||2
8882756|NCT01957202|9940026|FG011|NOT COMPLETED|Treatment Period 3 (8 Days)||0
8882757|NCT01957202|9940027|FG012|NOT COMPLETED|Treatment Period 3 (8 Days)||0
8882758|NCT01957202|9940028|FG013|NOT COMPLETED|Treatment Period 3 (8 Days)||0
8882759|NCT01957202|9940029|FG014|NOT COMPLETED|Treatment Period 3 (8 Days)||0
8882760|NCT01957202|9940030|FG015|NOT COMPLETED|Treatment Period 3 (8 Days)||0
8882761|NCT01957202|9940031|FG016|NOT COMPLETED|Treatment Period 3 (8 Days)||1
8882762|NCT01957202|9940032|FG017|NOT COMPLETED|Treatment Period 3 (8 Days)||0
8882763|NCT01957215|9940044|FG000|STARTED|Overall Study||135
8882764|NCT01957215|9940045|FG001|STARTED|Overall Study||135
8882765|NCT01957215|9940044|FG000|COMPLETED|Overall Study||122
8882766|NCT01957215|9940045|FG001|COMPLETED|Overall Study||123
8882767|NCT01957215|9940044|FG000|NOT COMPLETED|Overall Study||13
8882768|NCT01957215|9940045|FG001|NOT COMPLETED|Overall Study||12
8882769|NCT01957384|9940055|FG000|STARTED|Test Period 1 (14 Days)||4
8882770|NCT01957384|9940056|FG001|STARTED|Test Period 1 (14 Days)||4
8882771|NCT01957384|9940057|FG002|STARTED|Test Period 1 (14 Days)||4
8882772|NCT01957384|9940058|FG003|STARTED|Test Period 1 (14 Days)||4
8882773|NCT01957384|9940059|FG004|STARTED|Test Period 1 (14 Days)||3
8882774|NCT01957384|9940060|FG005|STARTED|Test Period 1 (14 Days)||3
8882775|NCT01957384|9940055|FG000|COMPLETED|Test Period 1 (14 Days)||4
8882776|NCT01957384|9940056|FG001|COMPLETED|Test Period 1 (14 Days)||4
8882777|NCT01957384|9940057|FG002|COMPLETED|Test Period 1 (14 Days)||4
8882778|NCT01957384|9940058|FG003|COMPLETED|Test Period 1 (14 Days)||4
8882779|NCT01957384|9940059|FG004|COMPLETED|Test Period 1 (14 Days)||3
9002934|NCT02917265|10066275|FG000|COMPLETED|Overall Study||3
9002935|NCT02917265|10066276|FG001|COMPLETED|Overall Study||2
9002936|NCT02917265|10066275|FG000|NOT COMPLETED|Overall Study||2
9002937|NCT02917265|10066276|FG001|NOT COMPLETED|Overall Study||0
9002938|NCT02917278|10066286|FG000|STARTED|Overall Study||10
9002939|NCT02917278|10066287|FG001|STARTED|Overall Study||9
8882780|NCT01957384|9940060|FG005|COMPLETED|Test Period 1 (14 Days)||3
8882781|NCT01957384|9940055|FG000|NOT COMPLETED|Test Period 1 (14 Days)||0
8882782|NCT01957384|9940056|FG001|NOT COMPLETED|Test Period 1 (14 Days)||0
8882783|NCT01957384|9940057|FG002|NOT COMPLETED|Test Period 1 (14 Days)||0
8882784|NCT01957384|9940058|FG003|NOT COMPLETED|Test Period 1 (14 Days)||0
8882785|NCT01957384|9940059|FG004|NOT COMPLETED|Test Period 1 (14 Days)||0
8882786|NCT01957384|9940060|FG005|NOT COMPLETED|Test Period 1 (14 Days)||0
8882787|NCT01957384|9940055|FG000|STARTED|Test Period 2 (14 Days)||4
8882788|NCT01957384|9940056|FG001|STARTED|Test Period 2 (14 Days)||4
8882789|NCT01957384|9940057|FG002|STARTED|Test Period 2 (14 Days)||4
8882790|NCT01957384|9940058|FG003|STARTED|Test Period 2 (14 Days)||4
8882791|NCT01957384|9940059|FG004|STARTED|Test Period 2 (14 Days)||3
8882792|NCT01957384|9940060|FG005|STARTED|Test Period 2 (14 Days)||3
8882793|NCT01957384|9940055|FG000|COMPLETED|Test Period 2 (14 Days)||4
8882794|NCT01957384|9940056|FG001|COMPLETED|Test Period 2 (14 Days)||4
8882795|NCT01957384|9940057|FG002|COMPLETED|Test Period 2 (14 Days)||4
8882796|NCT01957384|9940058|FG003|COMPLETED|Test Period 2 (14 Days)||4
8882797|NCT01957384|9940059|FG004|COMPLETED|Test Period 2 (14 Days)||3
8882798|NCT01957384|9940060|FG005|COMPLETED|Test Period 2 (14 Days)||3
8882799|NCT01957384|9940055|FG000|NOT COMPLETED|Test Period 2 (14 Days)||0
8882800|NCT01957384|9940056|FG001|NOT COMPLETED|Test Period 2 (14 Days)||0
8882801|NCT01957384|9940057|FG002|NOT COMPLETED|Test Period 2 (14 Days)||0
8882802|NCT01957384|9940058|FG003|NOT COMPLETED|Test Period 2 (14 Days)||0
8882803|NCT01957384|9940059|FG004|NOT COMPLETED|Test Period 2 (14 Days)||0
8882804|NCT01957384|9940060|FG005|NOT COMPLETED|Test Period 2 (14 Days)||0
8882805|NCT01957384|9940055|FG000|STARTED|Test Period 3 (14 Days)||4
8882806|NCT01957384|9940056|FG001|STARTED|Test Period 3 (14 Days)||4
8882807|NCT01957384|9940057|FG002|STARTED|Test Period 3 (14 Days)||4
8882808|NCT01957384|9940058|FG003|STARTED|Test Period 3 (14 Days)||4
8882809|NCT01957384|9940059|FG004|STARTED|Test Period 3 (14 Days)||3
8882810|NCT01957384|9940060|FG005|STARTED|Test Period 3 (14 Days)||3
8882811|NCT01957384|9940055|FG000|COMPLETED|Test Period 3 (14 Days)||4
8882812|NCT01957384|9940056|FG001|COMPLETED|Test Period 3 (14 Days)||4
8882813|NCT01957384|9940057|FG002|COMPLETED|Test Period 3 (14 Days)||4
8882814|NCT01957384|9940058|FG003|COMPLETED|Test Period 3 (14 Days)||4
8882815|NCT01957384|9940059|FG004|COMPLETED|Test Period 3 (14 Days)||3
9002940|NCT02917278|10066286|FG000|COMPLETED|Overall Study||9
9002941|NCT02917278|10066287|FG001|COMPLETED|Overall Study||9
9002942|NCT02917278|10066286|FG000|NOT COMPLETED|Overall Study||1
9002943|NCT02917278|10066287|FG001|NOT COMPLETED|Overall Study||0
9002944|NCT02917447|10066295|FG000|STARTED|Overall Study||51
9002945|NCT02917447|10066296|FG001|STARTED|Overall Study||51
9002946|NCT02917447|10066295|FG000|COMPLETED|Overall Study||44
9002947|NCT02917447|10066296|FG001|COMPLETED|Overall Study||48
9002948|NCT02917447|10066295|FG000|NOT COMPLETED|Overall Study||7
9002949|NCT02917447|10066296|FG001|NOT COMPLETED|Overall Study||3
9002950|NCT02917603|10066304|FG000|STARTED|Overall Study||20
9002951|NCT02917603|10066305|FG001|STARTED|Overall Study||20
9002952|NCT02917603|10066304|FG000|COMPLETED|Overall Study||19
9002953|NCT02917603|10066305|FG001|COMPLETED|Overall Study||16
9002954|NCT02917603|10066304|FG000|NOT COMPLETED|Overall Study||1
9002955|NCT02917603|10066305|FG001|NOT COMPLETED|Overall Study||4
9002956|NCT02917642|10066314|FG000|STARTED|Overall Study||25
9002957|NCT02917642|10066315|FG001|STARTED|Overall Study||25
9002958|NCT02917642|10066314|FG000|COMPLETED|Overall Study||25
9002959|NCT02917642|10066315|FG001|COMPLETED|Overall Study||25
9002960|NCT02917642|10066314|FG000|NOT COMPLETED|Overall Study||0
9002961|NCT02917642|10066315|FG001|NOT COMPLETED|Overall Study||0
9002962|NCT02917941|10066321|FG000|STARTED|Treatment Period||34
9002963|NCT02917941|10066321|FG000|COMPLETED|Treatment Period||10
9002964|NCT02917941|10066321|FG000|NOT COMPLETED|Treatment Period||24
9002965|NCT02917941|10066321|FG000|STARTED|Survival Follow-up Period||31
9002966|NCT02917941|10066321|FG000|COMPLETED|Survival Follow-up Period||26
9002967|NCT02917941|10066321|FG000|NOT COMPLETED|Survival Follow-up Period||5
9002968|NCT02918071|10066325|FG000|STARTED|Overall Study||121
9002969|NCT02918071|10066325|FG000|COMPLETED|Overall Study||118
9002970|NCT02918071|10066325|FG000|NOT COMPLETED|Overall Study||3
9002971|NCT02918097|10066329|FG000|STARTED|Overall Study||78
9002972|NCT02918097|10066329|FG000|COMPLETED|Overall Study|Primary and secondary outcomes are assessed just at the end of the protocol, not at each step|58
9002973|NCT02918097|10066329|FG000|NOT COMPLETED|Overall Study||20
9002974|NCT02918266|10066344|FG000|STARTED|Part 1||6
9002975|NCT02918266|10066345|FG001|STARTED|Part 1||0
9002976|NCT02918266|10066346|FG002|STARTED|Part 1||0
9002977|NCT02918266|10066347|FG003|STARTED|Part 1||0
9002978|NCT02918266|10066348|FG004|STARTED|Part 1||0
9002979|NCT02918266|10066349|FG005|STARTED|Part 1||0
9002980|NCT02918266|10066350|FG006|STARTED|Part 1||0
9002981|NCT02918266|10066351|FG007|STARTED|Part 1||0
8882816|NCT01957384|9940060|FG005|COMPLETED|Test Period 3 (14 Days)||3
8882817|NCT01957384|9940055|FG000|NOT COMPLETED|Test Period 3 (14 Days)||0
8882818|NCT01957384|9940056|FG001|NOT COMPLETED|Test Period 3 (14 Days)||0
9002982|NCT02918266|10066352|FG008|STARTED|Part 1||0
9002983|NCT02918266|10066353|FG009|STARTED|Part 1||0
9002984|NCT02918266|10066354|FG010|STARTED|Part 1||0
9002985|NCT02918266|10066344|FG000|COMPLETED|Part 1||6
9002986|NCT02918266|10066345|FG001|COMPLETED|Part 1||0
9002987|NCT02918266|10066346|FG002|COMPLETED|Part 1||0
8882819|NCT01957384|9940057|FG002|NOT COMPLETED|Test Period 3 (14 Days)||0
9002988|NCT02918266|10066347|FG003|COMPLETED|Part 1||0
9002989|NCT02918266|10066348|FG004|COMPLETED|Part 1||0
8882820|NCT01957384|9940058|FG003|NOT COMPLETED|Test Period 3 (14 Days)||0
8882821|NCT01957384|9940059|FG004|NOT COMPLETED|Test Period 3 (14 Days)||0
8882822|NCT01957384|9940060|FG005|NOT COMPLETED|Test Period 3 (14 Days)||0
8882823|NCT01957397|9940068|FG000|STARTED|Baseline Own Product||13
8882824|NCT01957397|9940069|FG001|STARTED|Baseline Own Product||13
8882825|NCT01957397|9940068|FG000|COMPLETED|Baseline Own Product||13
8882826|NCT01957397|9940069|FG001|COMPLETED|Baseline Own Product||13
8882827|NCT01957397|9940068|FG000|NOT COMPLETED|Baseline Own Product||0
8882828|NCT01957397|9940069|FG001|NOT COMPLETED|Baseline Own Product||0
8882829|NCT01957397|9940068|FG000|STARTED|Test Period 1||13
8882830|NCT01957397|9940069|FG001|STARTED|Test Period 1||13
8882831|NCT01957397|9940068|FG000|COMPLETED|Test Period 1||11
8882832|NCT01957397|9940069|FG001|COMPLETED|Test Period 1||12
8882833|NCT01957397|9940068|FG000|NOT COMPLETED|Test Period 1||2
8882834|NCT01957397|9940069|FG001|NOT COMPLETED|Test Period 1||1
8882835|NCT01957397|9940068|FG000|STARTED|Test Period 2||11
8882836|NCT01957397|9940069|FG001|STARTED|Test Period 2||12
8882837|NCT01957397|9940068|FG000|COMPLETED|Test Period 2||11
8882838|NCT01957397|9940069|FG001|COMPLETED|Test Period 2||11
8882839|NCT01957397|9940068|FG000|NOT COMPLETED|Test Period 2||0
8882840|NCT01957397|9940069|FG001|NOT COMPLETED|Test Period 2||1
8882841|NCT01957397|9940068|FG000|STARTED|Test Period 3||11
8882842|NCT01957397|9940069|FG001|STARTED|Test Period 3||11
8882843|NCT01957397|9940068|FG000|COMPLETED|Test Period 3||9
8882844|NCT01957397|9940069|FG001|COMPLETED|Test Period 3||9
8882845|NCT01957397|9940068|FG000|NOT COMPLETED|Test Period 3||2
8882846|NCT01957397|9940069|FG001|NOT COMPLETED|Test Period 3||2
8882847|NCT01957410|9940079|FG000|STARTED|Open Label||13
9002990|NCT02918266|10066349|FG005|COMPLETED|Part 1||0
9002991|NCT02918266|10066350|FG006|COMPLETED|Part 1||0
9002992|NCT02918266|10066351|FG007|COMPLETED|Part 1||0
9002993|NCT02918266|10066352|FG008|COMPLETED|Part 1||0
9002994|NCT02918266|10066353|FG009|COMPLETED|Part 1||0
9002995|NCT02918266|10066354|FG010|COMPLETED|Part 1||0
9002996|NCT02918266|10066344|FG000|NOT COMPLETED|Part 1||0
9002997|NCT02918266|10066345|FG001|NOT COMPLETED|Part 1||0
9002998|NCT02918266|10066346|FG002|NOT COMPLETED|Part 1||0
9002999|NCT02918266|10066347|FG003|NOT COMPLETED|Part 1||0
9003000|NCT02918266|10066348|FG004|NOT COMPLETED|Part 1||0
9003001|NCT02918266|10066349|FG005|NOT COMPLETED|Part 1||0
9003002|NCT02918266|10066350|FG006|NOT COMPLETED|Part 1||0
9003003|NCT02918266|10066351|FG007|NOT COMPLETED|Part 1||0
9003004|NCT02918266|10066352|FG008|NOT COMPLETED|Part 1||0
9003005|NCT02918266|10066353|FG009|NOT COMPLETED|Part 1||0
9003006|NCT02918266|10066354|FG010|NOT COMPLETED|Part 1||0
9003007|NCT02918266|10066344|FG000|STARTED|Part 2: Intervention Period 1 (2 Days)||0
9003008|NCT02918266|10066345|FG001|STARTED|Part 2: Intervention Period 1 (2 Days)||1
9003009|NCT02918266|10066346|FG002|STARTED|Part 2: Intervention Period 1 (2 Days)||1
9003010|NCT02918266|10066347|FG003|STARTED|Part 2: Intervention Period 1 (2 Days)||1
9003011|NCT02918266|10066348|FG004|STARTED|Part 2: Intervention Period 1 (2 Days)||1
9003012|NCT02918266|10066349|FG005|STARTED|Part 2: Intervention Period 1 (2 Days)||1
9003013|NCT02918266|10066350|FG006|STARTED|Part 2: Intervention Period 1 (2 Days)||2
9003014|NCT02918266|10066351|FG007|STARTED|Part 2: Intervention Period 1 (2 Days)||1
9003015|NCT02918266|10066352|FG008|STARTED|Part 2: Intervention Period 1 (2 Days)||2
9003016|NCT02918266|10066353|FG009|STARTED|Part 2: Intervention Period 1 (2 Days)||1
9003017|NCT02918266|10066354|FG010|STARTED|Part 2: Intervention Period 1 (2 Days)||1
9003018|NCT02918266|10066344|FG000|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
9003019|NCT02918266|10066345|FG001|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
9003020|NCT02918266|10066346|FG002|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
8882848|NCT01957410|9940079|FG000|COMPLETED|Open Label||13
8882849|NCT01957410|9940079|FG000|NOT COMPLETED|Open Label||0
8882850|NCT01957410|9940079|FG000|STARTED|Optional Open Label||13
9003021|NCT02918266|10066347|FG003|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
9003022|NCT02918266|10066348|FG004|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
9003023|NCT02918266|10066349|FG005|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
9003024|NCT02918266|10066350|FG006|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
9003025|NCT02918266|10066351|FG007|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
9003026|NCT02918266|10066352|FG008|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
9003027|NCT02918266|10066353|FG009|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
9003028|NCT02918266|10066354|FG010|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
9003029|NCT02918266|10066344|FG000|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
9003030|NCT02918266|10066345|FG001|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
9003031|NCT02918266|10066346|FG002|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
9003032|NCT02918266|10066347|FG003|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
9003033|NCT02918266|10066348|FG004|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
9003034|NCT02918266|10066349|FG005|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
9003035|NCT02918266|10066350|FG006|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||2
9003036|NCT02918266|10066351|FG007|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
9003037|NCT02918266|10066352|FG008|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||2
9003038|NCT02918266|10066353|FG009|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
9003039|NCT02918266|10066354|FG010|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
9003040|NCT02918266|10066344|FG000|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
9003041|NCT02918266|10066345|FG001|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
8882851|NCT01957410|9940079|FG000|COMPLETED|Optional Open Label||13
8882852|NCT01957410|9940079|FG000|NOT COMPLETED|Optional Open Label||0
8882853|NCT01957462|9940083|FG000|STARTED|Test Period 1||16
8882854|NCT01957462|9940084|FG001|STARTED|Test Period 1||15
8882855|NCT01957462|9940083|FG000|COMPLETED|Test Period 1||14
8882856|NCT01957462|9940084|FG001|COMPLETED|Test Period 1||15
8882857|NCT01957462|9940083|FG000|NOT COMPLETED|Test Period 1||2
8882858|NCT01957462|9940084|FG001|NOT COMPLETED|Test Period 1||0
8882859|NCT01957462|9940083|FG000|STARTED|Test Period 2||14
8882860|NCT01957462|9940084|FG001|STARTED|Test Period 2||15
8882861|NCT01957462|9940083|FG000|COMPLETED|Test Period 2||14
8882862|NCT01957462|9940084|FG001|COMPLETED|Test Period 2||15
8882863|NCT01957462|9940083|FG000|NOT COMPLETED|Test Period 2||0
8882864|NCT01957462|9940084|FG001|NOT COMPLETED|Test Period 2||0
8882865|NCT01957475|9940090|FG000|STARTED|Test Period 1||10
8882866|NCT01957475|9940091|FG001|STARTED|Test Period 1||10
8882867|NCT01957475|9940090|FG000|COMPLETED|Test Period 1||8
8882868|NCT01957475|9940091|FG001|COMPLETED|Test Period 1||9
8882869|NCT01957475|9940090|FG000|NOT COMPLETED|Test Period 1||2
8882870|NCT01957475|9940091|FG001|NOT COMPLETED|Test Period 1||1
8882871|NCT01957475|9940090|FG000|STARTED|Test Period 2||9
8882872|NCT01957475|9940091|FG001|STARTED|Test Period 2||8
8882873|NCT01957475|9940090|FG000|COMPLETED|Test Period 2||8
8882874|NCT01957475|9940091|FG001|COMPLETED|Test Period 2||8
8882875|NCT01957475|9940090|FG000|NOT COMPLETED|Test Period 2||1
8882876|NCT01957475|9940091|FG001|NOT COMPLETED|Test Period 2||0
8882877|NCT01957488|9940097|FG000|STARTED|Test Period 1 (2 Weeks)||30
8882878|NCT01957488|9940098|FG001|STARTED|Test Period 1 (2 Weeks)||31
8882879|NCT01957488|9940099|FG002|STARTED|Test Period 1 (2 Weeks)||30
8882880|NCT01957488|9940100|FG003|STARTED|Test Period 1 (2 Weeks)||32
8882881|NCT01957488|9940101|FG004|STARTED|Test Period 1 (2 Weeks)||30
8882882|NCT01957488|9940102|FG005|STARTED|Test Period 1 (2 Weeks)||30
8882883|NCT01957488|9940097|FG000|COMPLETED|Test Period 1 (2 Weeks)||27
8882884|NCT01957488|9940098|FG001|COMPLETED|Test Period 1 (2 Weeks)||28
8882885|NCT01957488|9940099|FG002|COMPLETED|Test Period 1 (2 Weeks)||26
8882886|NCT01957488|9940100|FG003|COMPLETED|Test Period 1 (2 Weeks)||29
8882887|NCT01957488|9940101|FG004|COMPLETED|Test Period 1 (2 Weeks)||27
8882888|NCT01957488|9940102|FG005|COMPLETED|Test Period 1 (2 Weeks)||24
8882889|NCT01957488|9940097|FG000|NOT COMPLETED|Test Period 1 (2 Weeks)||3
8882890|NCT01957488|9940098|FG001|NOT COMPLETED|Test Period 1 (2 Weeks)||3
8882891|NCT01957488|9940099|FG002|NOT COMPLETED|Test Period 1 (2 Weeks)||4
8882892|NCT01957488|9940100|FG003|NOT COMPLETED|Test Period 1 (2 Weeks)||3
8882893|NCT01957488|9940101|FG004|NOT COMPLETED|Test Period 1 (2 Weeks)||3
8882894|NCT01957488|9940102|FG005|NOT COMPLETED|Test Period 1 (2 Weeks)||6
8882895|NCT01957488|9940097|FG000|STARTED|Test Period 2 (2 Weeks)||27
8882896|NCT01957488|9940098|FG001|STARTED|Test Period 2 (2 Weeks)||28
8882897|NCT01957488|9940099|FG002|STARTED|Test Period 2 (2 Weeks)||26
8882898|NCT01957488|9940100|FG003|STARTED|Test Period 2 (2 Weeks)||29
8882899|NCT01957488|9940101|FG004|STARTED|Test Period 2 (2 Weeks)||27
8882900|NCT01957488|9940102|FG005|STARTED|Test Period 2 (2 Weeks)||24
8882901|NCT01957488|9940097|FG000|COMPLETED|Test Period 2 (2 Weeks)||24
8882902|NCT01957488|9940098|FG001|COMPLETED|Test Period 2 (2 Weeks)||27
8882903|NCT01957488|9940099|FG002|COMPLETED|Test Period 2 (2 Weeks)||25
8882904|NCT01957488|9940100|FG003|COMPLETED|Test Period 2 (2 Weeks)||28
8882905|NCT01957488|9940101|FG004|COMPLETED|Test Period 2 (2 Weeks)||25
9003042|NCT02918266|10066346|FG002|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
9003043|NCT02918266|10066347|FG003|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
9003044|NCT02918266|10066348|FG004|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
9003045|NCT02918266|10066349|FG005|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
9003046|NCT02918266|10066350|FG006|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
9003047|NCT02918266|10066351|FG007|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
9003048|NCT02918266|10066352|FG008|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
9003049|NCT02918266|10066353|FG009|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
9003050|NCT02918266|10066354|FG010|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
9003051|NCT02918266|10066344|FG000|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
9003052|NCT02918266|10066345|FG001|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
9003053|NCT02918266|10066346|FG002|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
9003054|NCT02918266|10066347|FG003|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
9003055|NCT02918266|10066348|FG004|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
9003056|NCT02918266|10066349|FG005|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
9003057|NCT02918266|10066350|FG006|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
9003058|NCT02918266|10066351|FG007|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
9003059|NCT02918266|10066352|FG008|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
9003060|NCT02918266|10066353|FG009|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
9003061|NCT02918266|10066354|FG010|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
8882906|NCT01957488|9940102|FG005|COMPLETED|Test Period 2 (2 Weeks)||23
8882907|NCT01957488|9940097|FG000|NOT COMPLETED|Test Period 2 (2 Weeks)||3
8882908|NCT01957488|9940098|FG001|NOT COMPLETED|Test Period 2 (2 Weeks)||1
8882909|NCT01957488|9940099|FG002|NOT COMPLETED|Test Period 2 (2 Weeks)||1
8882910|NCT01957488|9940100|FG003|NOT COMPLETED|Test Period 2 (2 Weeks)||1
8882911|NCT01957488|9940101|FG004|NOT COMPLETED|Test Period 2 (2 Weeks)||2
8882912|NCT01957488|9940102|FG005|NOT COMPLETED|Test Period 2 (2 Weeks)||1
8882913|NCT01957488|9940097|FG000|STARTED|Test Period 3 (2 Weeks)||24
8882914|NCT01957488|9940098|FG001|STARTED|Test Period 3 (2 Weeks)||27
8882915|NCT01957488|9940099|FG002|STARTED|Test Period 3 (2 Weeks)||25
8882916|NCT01957488|9940100|FG003|STARTED|Test Period 3 (2 Weeks)||28
8882917|NCT01957488|9940101|FG004|STARTED|Test Period 3 (2 Weeks)||25
8882918|NCT01957488|9940102|FG005|STARTED|Test Period 3 (2 Weeks)||23
8882919|NCT01957488|9940097|FG000|COMPLETED|Test Period 3 (2 Weeks)||23
8882920|NCT01957488|9940098|FG001|COMPLETED|Test Period 3 (2 Weeks)||26
8882921|NCT01957488|9940099|FG002|COMPLETED|Test Period 3 (2 Weeks)||25
8882922|NCT01957488|9940100|FG003|COMPLETED|Test Period 3 (2 Weeks)||28
8882923|NCT01957488|9940101|FG004|COMPLETED|Test Period 3 (2 Weeks)||25
8882924|NCT01957488|9940102|FG005|COMPLETED|Test Period 3 (2 Weeks)||23
8882925|NCT01957488|9940097|FG000|NOT COMPLETED|Test Period 3 (2 Weeks)||1
8882926|NCT01957488|9940098|FG001|NOT COMPLETED|Test Period 3 (2 Weeks)||1
8882927|NCT01957488|9940099|FG002|NOT COMPLETED|Test Period 3 (2 Weeks)||0
8882928|NCT01957488|9940100|FG003|NOT COMPLETED|Test Period 3 (2 Weeks)||0
8882929|NCT01957488|9940101|FG004|NOT COMPLETED|Test Period 3 (2 Weeks)||0
8882930|NCT01957488|9940102|FG005|NOT COMPLETED|Test Period 3 (2 Weeks)||0
8882931|NCT01957553|9940110|FG000|STARTED|Test Period 1 (21 +- 1 Days)||61
8882932|NCT01957553|9940111|FG001|STARTED|Test Period 1 (21 +- 1 Days)||66
8882933|NCT01957553|9940110|FG000|COMPLETED|Test Period 1 (21 +- 1 Days)||54
8882934|NCT01957553|9940111|FG001|COMPLETED|Test Period 1 (21 +- 1 Days)||63
8882935|NCT01957553|9940110|FG000|NOT COMPLETED|Test Period 1 (21 +- 1 Days)||7
8882936|NCT01957553|9940111|FG001|NOT COMPLETED|Test Period 1 (21 +- 1 Days)||3
8882937|NCT01957553|9940110|FG000|STARTED|Test Period 2 (21 +- 1 Days)||54
8882938|NCT01957553|9940111|FG001|STARTED|Test Period 2 (21 +- 1 Days)||63
8882939|NCT01957553|9940110|FG000|COMPLETED|Test Period 2 (21 +- 1 Days)||51
8882940|NCT01957553|9940111|FG001|COMPLETED|Test Period 2 (21 +- 1 Days)||56
8882941|NCT01957553|9940110|FG000|NOT COMPLETED|Test Period 2 (21 +- 1 Days)||3
8882942|NCT01957553|9940111|FG001|NOT COMPLETED|Test Period 2 (21 +- 1 Days)||7
8882943|NCT01957579|9940121|FG000|STARTED|Overall Study||3
8882944|NCT01957579|9940122|FG001|STARTED|Overall Study||7
8882945|NCT01957579|9940123|FG002|STARTED|Overall Study||4
8882946|NCT01957579|9940124|FG003|STARTED|Overall Study||6
8882947|NCT01957579|9940121|FG000|COMPLETED|Overall Study||3
8882948|NCT01957579|9940122|FG001|COMPLETED|Overall Study||6
8882949|NCT01957579|9940123|FG002|COMPLETED|Overall Study||2
8882950|NCT01957579|9940124|FG003|COMPLETED|Overall Study||6
8882951|NCT01957579|9940121|FG000|NOT COMPLETED|Overall Study||0
8882952|NCT01957579|9940122|FG001|NOT COMPLETED|Overall Study||1
8882953|NCT01957579|9940123|FG002|NOT COMPLETED|Overall Study||2
8882954|NCT01957579|9940124|FG003|NOT COMPLETED|Overall Study||0
8882955|NCT01957644|9940156|FG000|STARTED|Overall Study||6
8882956|NCT01957644|9940157|FG001|STARTED|Overall Study||6
8882957|NCT01957644|9940158|FG002|STARTED|Overall Study||1
8882958|NCT01957644|9940159|FG003|STARTED|Overall Study||2
8882959|NCT01957644|9940160|FG004|STARTED|Overall Study||1
8882960|NCT01957644|9940156|FG000|COMPLETED|Overall Study||0
8882961|NCT01957644|9940157|FG001|COMPLETED|Overall Study||0
8882962|NCT01957644|9940158|FG002|COMPLETED|Overall Study||0
8882963|NCT01957644|9940159|FG003|COMPLETED|Overall Study||0
8882964|NCT01957644|9940160|FG004|COMPLETED|Overall Study||0
8882965|NCT01957644|9940156|FG000|NOT COMPLETED|Overall Study||6
8882966|NCT01957644|9940157|FG001|NOT COMPLETED|Overall Study||6
8882967|NCT01957644|9940158|FG002|NOT COMPLETED|Overall Study||1
8882968|NCT01957644|9940159|FG003|NOT COMPLETED|Overall Study||2
8882969|NCT01957644|9940160|FG004|NOT COMPLETED|Overall Study||1
8882970|NCT01957657|9940174|FG000|STARTED|Overall Study||4
8882971|NCT01957657|9940174|FG000|COMPLETED|Overall Study||4
8882972|NCT01957657|9940174|FG000|NOT COMPLETED|Overall Study||0
8882973|NCT01957709|9940178|FG000|STARTED|Overall Study||8
8882974|NCT01957709|9940178|FG000|COMPLETED|Overall Study||7
8882975|NCT01957709|9940178|FG000|NOT COMPLETED|Overall Study||1
8882976|NCT01957761|9940182|FG000|STARTED|Overall Study||189
8882977|NCT01957761|9940182|FG000|COMPLETED|Overall Study||189
8882978|NCT01957761|9940182|FG000|NOT COMPLETED|Overall Study||0
8882979|NCT01957787|9940186|FG000|STARTED|Overall Study|Participant who was withdrawn prior to study treatment was not included in Number of Index Tumors.|131
8882980|NCT01957787|9940186|FG000|Intent-to-Treat (ITT) Population|Overall Study||130
8882981|NCT01957787|9940186|FG000|Modified ITT (mITT) Population|Overall Study||128
8882982|NCT01957787|9940186|FG000|COMPLETED|Overall Study||95
8882983|NCT01957787|9940186|FG000|NOT COMPLETED|Overall Study||36
8882984|NCT01957865|9940193|FG000|STARTED|Overall Study||21
8882985|NCT01957865|9940194|FG001|STARTED|Overall Study||20
8882986|NCT01957865|9940195|FG002|STARTED|Overall Study||22
8882987|NCT01957865|9940193|FG000|COMPLETED|Overall Study||21
8882988|NCT01957865|9940194|FG001|COMPLETED|Overall Study||18
8882989|NCT01957865|9940195|FG002|COMPLETED|Overall Study||19
8882990|NCT01957865|9940193|FG000|NOT COMPLETED|Overall Study||0
8882991|NCT01957865|9940194|FG001|NOT COMPLETED|Overall Study||2
8882992|NCT01957865|9940195|FG002|NOT COMPLETED|Overall Study||3
8882993|NCT01957930|9940207|FG000|STARTED|Overall Study||35
8882994|NCT01957930|9940208|FG001|STARTED|Overall Study||37
8882995|NCT01957930|9940209|FG002|STARTED|Overall Study||19
8882996|NCT01957930|9940207|FG000|COMPLETED|Overall Study||35
8882997|NCT01957930|9940208|FG001|COMPLETED|Overall Study||37
8882998|NCT01957930|9940209|FG002|COMPLETED|Overall Study||19
8882999|NCT01957930|9940207|FG000|NOT COMPLETED|Overall Study||0
8883000|NCT01957930|9940208|FG001|NOT COMPLETED|Overall Study||0
8883001|NCT01957930|9940209|FG002|NOT COMPLETED|Overall Study||0
8883002|NCT01958008|9940220|FG000|STARTED|Overall Study||21
8883003|NCT01958008|9940221|FG001|STARTED|Overall Study||21
8883004|NCT01958008|9940222|FG002|STARTED|Overall Study||21
8883005|NCT01958008|9940223|FG003|STARTED|Overall Study||21
8883006|NCT01958008|9940220|FG000|COMPLETED|Overall Study||20
8883007|NCT01958008|9940221|FG001|COMPLETED|Overall Study||21
8883008|NCT01958008|9940222|FG002|COMPLETED|Overall Study||20
8883009|NCT01958008|9940223|FG003|COMPLETED|Overall Study||21
8883010|NCT01958008|9940220|FG000|NOT COMPLETED|Overall Study||1
9003062|NCT02918266|10066344|FG000|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
8725937|NCT01033487|9773164|FG007|COMPLETED|Third Intervention Period||3
8725938|NCT01033487|9773165|FG008|COMPLETED|Third Intervention Period||2
8725939|NCT01033487|9773166|FG009|COMPLETED|Third Intervention Period||2
8883011|NCT01958008|9940221|FG001|NOT COMPLETED|Overall Study||0
8883012|NCT01958008|9940222|FG002|NOT COMPLETED|Overall Study||1
8883013|NCT01958008|9940223|FG003|NOT COMPLETED|Overall Study||0
8883014|NCT01958060|9940242|FG000|STARTED|Overall Study||10
8883015|NCT01958060|9940243|FG001|STARTED|Overall Study||6
8883016|NCT01958060|9940244|FG002|STARTED|Overall Study||6
8883017|NCT01958060|9940245|FG003|STARTED|Overall Study||5
8634265|NCT00555893|9674580|FG000|COMPLETED|Overall Study||130
8634266|NCT00555893|9674581|FG001|COMPLETED|Overall Study||63
8634267|NCT00555893|9674580|FG000|NOT COMPLETED|Overall Study||0
8883018|NCT01958060|9940246|FG004|STARTED|Overall Study||7
8883019|NCT01958060|9940247|FG005|STARTED|Overall Study||1
8883020|NCT01958060|9940242|FG000|COMPLETED|Overall Study||8
8883021|NCT01958060|9940243|FG001|COMPLETED|Overall Study||6
8883022|NCT01958060|9940244|FG002|COMPLETED|Overall Study||6
8883023|NCT01958060|9940245|FG003|COMPLETED|Overall Study||5
8883024|NCT01958060|9940246|FG004|COMPLETED|Overall Study|One subject in the 50 mg iv dose group did not receive complete dose of trial medication.|6
8883025|NCT01958060|9940247|FG005|COMPLETED|Overall Study|One subject in the 100 mg iv dose group did not receive complete dose of trial medication.|1
8883026|NCT01958060|9940242|FG000|NOT COMPLETED|Overall Study||2
8883027|NCT01958060|9940243|FG001|NOT COMPLETED|Overall Study||0
8883028|NCT01958060|9940244|FG002|NOT COMPLETED|Overall Study||0
8883029|NCT01958060|9940245|FG003|NOT COMPLETED|Overall Study||0
8883030|NCT01958060|9940246|FG004|NOT COMPLETED|Overall Study||1
8883031|NCT01958060|9940247|FG005|NOT COMPLETED|Overall Study||0
8883032|NCT01958073|9940268|FG000|STARTED|Randomized Period||9
8883033|NCT01958073|9940269|FG001|STARTED|Randomized Period||9
8883034|NCT01958073|9940270|FG002|STARTED|Randomized Period||17
8883035|NCT01958073|9940271|FG003|STARTED|Randomized Period||0
8883036|NCT01958073|9940272|FG004|STARTED|Randomized Period||0
8883037|NCT01958073|9940268|FG000|COMPLETED|Randomized Period||7
8883038|NCT01958073|9940269|FG001|COMPLETED|Randomized Period||8
8883039|NCT01958073|9940270|FG002|COMPLETED|Randomized Period||11
8883040|NCT01958073|9940271|FG003|COMPLETED|Randomized Period||0
8883041|NCT01958073|9940272|FG004|COMPLETED|Randomized Period||0
8883042|NCT01958073|9940268|FG000|NOT COMPLETED|Randomized Period||2
8883043|NCT01958073|9940269|FG001|NOT COMPLETED|Randomized Period||1
8634268|NCT00555893|9674581|FG001|NOT COMPLETED|Overall Study||0
8634269|NCT00555906|9674590|FG000|STARTED|Phase 1||3
8634270|NCT00555906|9674591|FG001|STARTED|Phase 1||6
8634271|NCT00555906|9674592|FG002|STARTED|Phase 1||7
8634272|NCT00555906|9674593|FG003|STARTED|Phase 1||5
8634273|NCT00555906|9674594|FG004|STARTED|Phase 1||0
8634274|NCT00555906|9674590|FG000|COMPLETED|Phase 1||0
8634275|NCT00555906|9674591|FG001|COMPLETED|Phase 1||0
8634276|NCT00555906|9674592|FG002|COMPLETED|Phase 1||0
8883044|NCT01958073|9940270|FG002|NOT COMPLETED|Randomized Period||6
8883045|NCT01958073|9940271|FG003|NOT COMPLETED|Randomized Period||0
8883046|NCT01958073|9940272|FG004|NOT COMPLETED|Randomized Period||0
8883047|NCT01958073|9940268|FG000|STARTED|Open Label Period||0
8883048|NCT01958073|9940269|FG001|STARTED|Open Label Period||0
8883049|NCT01958073|9940270|FG002|STARTED|Open Label Period||0
8883050|NCT01958073|9940271|FG003|STARTED|Open Label Period||5
8883051|NCT01958073|9940272|FG004|STARTED|Open Label Period||17
8883052|NCT01958073|9940268|FG000|COMPLETED|Open Label Period||0
8883053|NCT01958073|9940269|FG001|COMPLETED|Open Label Period||0
8883054|NCT01958073|9940270|FG002|COMPLETED|Open Label Period||0
8883055|NCT01958073|9940271|FG003|COMPLETED|Open Label Period||5
8883056|NCT01958073|9940272|FG004|COMPLETED|Open Label Period||17
8883057|NCT01958073|9940268|FG000|NOT COMPLETED|Open Label Period||0
8883058|NCT01958073|9940269|FG001|NOT COMPLETED|Open Label Period||0
8883059|NCT01958073|9940270|FG002|NOT COMPLETED|Open Label Period||0
8883060|NCT01958073|9940271|FG003|NOT COMPLETED|Open Label Period||0
8883061|NCT01958073|9940272|FG004|NOT COMPLETED|Open Label Period||0
8883062|NCT01958112|9940288|FG000|STARTED|Overall Study||14
8883063|NCT01958112|9940288|FG000|COMPLETED|Overall Study||14
8883064|NCT01958112|9940288|FG000|NOT COMPLETED|Overall Study||0
8883065|NCT01958125|9940294|FG000|STARTED|Overall Study||50
8883066|NCT01958125|9940295|FG001|STARTED|Overall Study||52
8883067|NCT01958125|9940294|FG000|COMPLETED|Overall Study||48
8883068|NCT01958125|9940295|FG001|COMPLETED|Overall Study||44
8883069|NCT01958125|9940294|FG000|NOT COMPLETED|Overall Study||2
8883070|NCT01958125|9940295|FG001|NOT COMPLETED|Overall Study||8
8883071|NCT01958164|9940303|FG000|STARTED|Overall Study|Randomised and treated|6
8883072|NCT01958164|9940304|FG001|STARTED|Overall Study|Randomised and treated|10
8883073|NCT01958164|9940303|FG000|COMPLETED|Overall Study||4
8883074|NCT01958164|9940304|FG001|COMPLETED|Overall Study||5
8883075|NCT01958164|9940303|FG000|NOT COMPLETED|Overall Study||2
8883076|NCT01958164|9940304|FG001|NOT COMPLETED|Overall Study||5
8883077|NCT01958281|9940313|FG000|STARTED|Overall Study||10
8883078|NCT01958281|9940314|FG001|STARTED|Overall Study||10
8883079|NCT01958281|9940315|FG002|STARTED|Overall Study||18
8883080|NCT01958281|9940313|FG000|COMPLETED|Overall Study||4
8883081|NCT01958281|9940314|FG001|COMPLETED|Overall Study||6
8883082|NCT01958281|9940315|FG002|COMPLETED|Overall Study||18
8883083|NCT01958281|9940313|FG000|NOT COMPLETED|Overall Study||6
8634277|NCT00555906|9674593|FG003|COMPLETED|Phase 1||0
8634278|NCT00555906|9674594|FG004|COMPLETED|Phase 1||0
8634279|NCT00555906|9674590|FG000|NOT COMPLETED|Phase 1||3
8634280|NCT00555906|9674591|FG001|NOT COMPLETED|Phase 1||6
8883084|NCT01958281|9940314|FG001|NOT COMPLETED|Overall Study||4
8883085|NCT01958281|9940315|FG002|NOT COMPLETED|Overall Study||0
8883086|NCT01958294|9940324|FG000|STARTED|Overall Study||12
8883087|NCT01958294|9940324|FG000|COMPLETED|Overall Study||10
8883088|NCT01958294|9940324|FG000|NOT COMPLETED|Overall Study||2
9003063|NCT02918266|10066345|FG001|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
9003064|NCT02918266|10066346|FG002|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
8883089|NCT01958320|9940330|FG000|STARTED|Overall Study||104
8883090|NCT01958320|9940331|FG001|STARTED|Overall Study||98
8883091|NCT01958320|9940330|FG000|COMPLETED|Overall Study||104
8883092|NCT01958320|9940331|FG001|COMPLETED|Overall Study||98
8883093|NCT01958320|9940330|FG000|NOT COMPLETED|Overall Study||0
8883094|NCT01958320|9940331|FG001|NOT COMPLETED|Overall Study||0
8883095|NCT01958346|9940341|FG000|STARTED|Overall Study||39
8883096|NCT01958346|9940342|FG001|STARTED|Overall Study||39
8883097|NCT01958346|9940341|FG000|COMPLETED|Overall Study||39
8883098|NCT01958346|9940342|FG001|COMPLETED|Overall Study||39
8883099|NCT01958346|9940341|FG000|NOT COMPLETED|Overall Study||0
8883100|NCT01958346|9940342|FG001|NOT COMPLETED|Overall Study||0
8883101|NCT01958437|9940350|FG000|STARTED|Overall Study||11
8883102|NCT01958437|9940351|FG001|STARTED|Overall Study||11
8883103|NCT01958437|9940352|FG002|STARTED|Overall Study||11
8883104|NCT01958437|9940353|FG003|STARTED|Overall Study||11
8883105|NCT01958437|9940350|FG000|COMPLETED|Overall Study||11
8883106|NCT01958437|9940351|FG001|COMPLETED|Overall Study||11
8883107|NCT01958437|9940352|FG002|COMPLETED|Overall Study||10
8883108|NCT01958437|9940353|FG003|COMPLETED|Overall Study||10
8883109|NCT01958437|9940350|FG000|NOT COMPLETED|Overall Study||0
8883110|NCT01958437|9940351|FG001|NOT COMPLETED|Overall Study||0
8883111|NCT01958437|9940352|FG002|NOT COMPLETED|Overall Study||1
8883112|NCT01958437|9940353|FG003|NOT COMPLETED|Overall Study||1
8883113|NCT01958476|9940372|FG000|STARTED|Overall Study||59
8883114|NCT01958476|9940373|FG001|STARTED|Overall Study||58
8883115|NCT01958476|9940372|FG000|COMPLETED|Overall Study||58
8883116|NCT01958476|9940373|FG001|COMPLETED|Overall Study||58
8883117|NCT01958476|9940372|FG000|NOT COMPLETED|Overall Study||1
8883118|NCT01958476|9940373|FG001|NOT COMPLETED|Overall Study||0
8883119|NCT01958489|9940379|FG000|STARTED|Period 1||24
8883120|NCT01958489|9940380|FG001|STARTED|Period 1||0
8883121|NCT01958489|9940379|FG000|Received at Least 1 Dose of Study Drug|Period 1||24
8883122|NCT01958489|9940380|FG001|Received at Least 1 Dose of Study Drug|Period 1||0
8883123|NCT01958489|9940379|FG000|COMPLETED|Period 1||24
8883124|NCT01958489|9940380|FG001|COMPLETED|Period 1||0
8883125|NCT01958489|9940379|FG000|NOT COMPLETED|Period 1||0
8883126|NCT01958489|9940380|FG001|NOT COMPLETED|Period 1||0
8883127|NCT01958489|9940379|FG000|STARTED|Period 2|Participants who completed Period 1 treatment crossed over to Period 2 treatment|0
8883128|NCT01958489|9940380|FG001|STARTED|Period 2|Participants who started Period 2 treatment crossed over from Period 1 treatment|24
8883129|NCT01958489|9940379|FG000|Received at Least 1 Dose of Study Drug|Period 2||0
8883130|NCT01958489|9940380|FG001|Received at Least 1 Dose of Study Drug|Period 2||24
8883131|NCT01958489|9940379|FG000|COMPLETED|Period 2||0
8883132|NCT01958489|9940380|FG001|COMPLETED|Period 2||23
8883133|NCT01958489|9940379|FG000|NOT COMPLETED|Period 2||0
8883134|NCT01958489|9940380|FG001|NOT COMPLETED|Period 2||1
8883135|NCT01958606|9940393|FG000|STARTED|Overall Study||13
8883136|NCT01958606|9940394|FG001|STARTED|Overall Study||5
8883137|NCT01958606|9940393|FG000|COMPLETED|Overall Study||11
8883138|NCT01958606|9940394|FG001|COMPLETED|Overall Study||5
8883139|NCT01958606|9940393|FG000|NOT COMPLETED|Overall Study||2
8883140|NCT01958606|9940394|FG001|NOT COMPLETED|Overall Study||0
8883141|NCT01958619|9940404|FG000|STARTED|Overall Study||15
8883142|NCT01958619|9940405|FG001|STARTED|Overall Study||14
8883143|NCT01958619|9940406|FG002|STARTED|Overall Study||14
8883144|NCT01958619|9940407|FG003|STARTED|Overall Study||12
8883145|NCT01958619|9940404|FG000|COMPLETED|Overall Study||13
8883146|NCT01958619|9940405|FG001|COMPLETED|Overall Study||14
8883147|NCT01958619|9940406|FG002|COMPLETED|Overall Study||13
8883148|NCT01958619|9940407|FG003|COMPLETED|Overall Study||12
8883149|NCT01958619|9940404|FG000|NOT COMPLETED|Overall Study||2
8883150|NCT01958619|9940405|FG001|NOT COMPLETED|Overall Study||0
8883151|NCT01958619|9940406|FG002|NOT COMPLETED|Overall Study||1
8883152|NCT01958619|9940407|FG003|NOT COMPLETED|Overall Study||0
8883153|NCT01958645|9940420|FG000|STARTED|Overall Study||4
8883154|NCT01958645|9940421|FG001|STARTED|Overall Study||4
8883155|NCT01958645|9940422|FG002|STARTED|Overall Study||4
8883156|NCT01958645|9940420|FG000|COMPLETED|Overall Study||4
8883157|NCT01958645|9940421|FG001|COMPLETED|Overall Study||4
8883158|NCT01958645|9940422|FG002|COMPLETED|Overall Study||4
8883159|NCT01958645|9940420|FG000|NOT COMPLETED|Overall Study||0
8883160|NCT01958645|9940421|FG001|NOT COMPLETED|Overall Study||0
8883161|NCT01958645|9940422|FG002|NOT COMPLETED|Overall Study||0
8883162|NCT01958671|9940435|FG000|STARTED|Overall Study||156
8883163|NCT01958671|9940436|FG001|STARTED|Overall Study||152
8883164|NCT01958671|9940437|FG002|STARTED|Overall Study||153
8883165|NCT01958671|9940435|FG000|COMPLETED|Overall Study||137
8883166|NCT01958671|9940436|FG001|COMPLETED|Overall Study||128
8883167|NCT01958671|9940437|FG002|COMPLETED|Overall Study||121
8883168|NCT01958671|9940435|FG000|NOT COMPLETED|Overall Study||19
8883169|NCT01958671|9940436|FG001|NOT COMPLETED|Overall Study||24
8883170|NCT01958671|9940437|FG002|NOT COMPLETED|Overall Study||32
8883171|NCT01958788|9940449|FG000|STARTED|Overall Study||7
8883172|NCT01958788|9940449|FG000|COMPLETED|Overall Study||7
8883173|NCT01958788|9940449|FG000|NOT COMPLETED|Overall Study||0
8883174|NCT01958827|9940453|FG000|STARTED|Overall Study||28
8883175|NCT01958827|9940453|FG000|COMPLETED|Overall Study||18
8883176|NCT01958827|9940453|FG000|NOT COMPLETED|Overall Study||10
8883177|NCT01958918|9940459|FG000|STARTED|Overall Study||356
8883178|NCT01958918|9940460|FG001|STARTED|Overall Study||356
8883179|NCT01958918|9940459|FG000|Full Analysis Set|Overall Study||353
8883180|NCT01958918|9940460|FG001|Full Analysis Set|Overall Study||354
8883181|NCT01958918|9940459|FG000|COMPLETED|Overall Study||313
8883182|NCT01958918|9940460|FG001|COMPLETED|Overall Study||314
8883183|NCT01958918|9940459|FG000|NOT COMPLETED|Overall Study||43
8883184|NCT01958918|9940460|FG001|NOT COMPLETED|Overall Study||42
8883185|NCT01959035|9940466|FG000|STARTED|Overall Study||88
8883186|NCT01959035|9940466|FG000|COMPLETED|Overall Study||77
8883187|NCT01959035|9940466|FG000|NOT COMPLETED|Overall Study||11
8883188|NCT01959048|9940470|FG000|STARTED|Overall Study||3
8883189|NCT01959048|9940470|FG000|COMPLETED|Overall Study||3
8883190|NCT01959048|9940470|FG000|NOT COMPLETED|Overall Study||0
8883191|NCT01959113|9940474|FG000|STARTED|Overall Study||5
8883192|NCT01959113|9940474|FG000|COMPLETED|Overall Study||5
8883193|NCT01959113|9940474|FG000|NOT COMPLETED|Overall Study||0
8883194|NCT01959165|9940484|FG000|STARTED|Overall Study||13
8883195|NCT01959165|9940485|FG001|STARTED|Overall Study|1 patient discontinued the study without any treatment out of 11 patients.|11
8883196|NCT01959165|9940486|FG002|STARTED|Overall Study||12
8883197|NCT01959165|9940487|FG003|STARTED|Overall Study||9
8883198|NCT01959165|9940484|FG000|COMPLETED|Overall Study||12
8883199|NCT01959165|9940485|FG001|COMPLETED|Overall Study||10
8883200|NCT01959165|9940486|FG002|COMPLETED|Overall Study||12
8883201|NCT01959165|9940487|FG003|COMPLETED|Overall Study||7
8883202|NCT01959165|9940484|FG000|NOT COMPLETED|Overall Study||1
8883203|NCT01959165|9940485|FG001|NOT COMPLETED|Overall Study||1
9003065|NCT02918266|10066347|FG003|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
9003066|NCT02918266|10066348|FG004|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
9003067|NCT02918266|10066349|FG005|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
9003068|NCT02918266|10066350|FG006|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
9003069|NCT02918266|10066351|FG007|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
8883204|NCT01959165|9940486|FG002|NOT COMPLETED|Overall Study||0
8883205|NCT01959165|9940487|FG003|NOT COMPLETED|Overall Study||2
8883206|NCT01959178|9940497|FG000|STARTED|Overall Study||73
8883207|NCT01959178|9940498|FG001|STARTED|Overall Study||73
8883208|NCT01959178|9940497|FG000|COMPLETED|Overall Study||71
8883209|NCT01959178|9940498|FG001|COMPLETED|Overall Study||71
8883210|NCT01959178|9940497|FG000|NOT COMPLETED|Overall Study||2
8883211|NCT01959178|9940498|FG001|NOT COMPLETED|Overall Study||2
8883212|NCT01959230|9940506|FG000|STARTED|Overall Study||40
8883213|NCT01959230|9940507|FG001|STARTED|Overall Study||20
8883214|NCT01959230|9940506|FG000|Received at Least 1 Dose of Study Drug|Overall Study||40
8883215|NCT01959230|9940507|FG001|Received at Least 1 Dose of Study Drug|Overall Study||20
8883216|NCT01959230|9940506|FG000|COMPLETED|Overall Study||36
8883217|NCT01959230|9940507|FG001|COMPLETED|Overall Study||19
8883218|NCT01959230|9940506|FG000|NOT COMPLETED|Overall Study||4
8883219|NCT01959230|9940507|FG001|NOT COMPLETED|Overall Study||1
8883220|NCT01959243|9940515|FG000|STARTED|Overall Study||337
8883221|NCT01959243|9940516|FG001|STARTED|Overall Study||170
8883222|NCT01959243|9940515|FG000|Received at Least 1 Dose of Study Drug|Overall Study||337
8883223|NCT01959243|9940516|FG001|Received at Least 1 Dose of Study Drug|Overall Study||170
8883224|NCT01959243|9940515|FG000|COMPLETED|Overall Study||324
8883225|NCT01959243|9940516|FG001|COMPLETED|Overall Study||166
8883226|NCT01959243|9940515|FG000|NOT COMPLETED|Overall Study||13
8883227|NCT01959243|9940516|FG001|NOT COMPLETED|Overall Study||4
8883228|NCT01959334|9940524|FG000|STARTED|First Dose||26
8883229|NCT01959334|9940525|FG001|STARTED|First Dose||49
8883230|NCT01959334|9940524|FG000|COMPLETED|First Dose|Each Dosing Period separated by at least 7 calendar days.|26
8883231|NCT01959334|9940525|FG001|COMPLETED|First Dose|Each Dosing Period is separated by at least 7 calendar days.|49
8883232|NCT01959334|9940524|FG000|NOT COMPLETED|First Dose||0
8883233|NCT01959334|9940525|FG001|NOT COMPLETED|First Dose||0
8883234|NCT01959334|9940524|FG000|STARTED|Second Dose||26
8883235|NCT01959334|9940525|FG001|STARTED|Second Dose||49
8883236|NCT01959334|9940524|FG000|COMPLETED|Second Dose||25
8883237|NCT01959334|9940525|FG001|COMPLETED|Second Dose||49
8883238|NCT01959334|9940524|FG000|NOT COMPLETED|Second Dose||1
8883239|NCT01959334|9940525|FG001|NOT COMPLETED|Second Dose||0
8883240|NCT01959334|9940524|FG000|STARTED|Third Dose||25
8883241|NCT01959334|9940525|FG001|STARTED|Third Dose||49
8883242|NCT01959334|9940524|FG000|COMPLETED|Third Dose||25
8883243|NCT01959334|9940525|FG001|COMPLETED|Third Dose||48
8883244|NCT01959334|9940524|FG000|NOT COMPLETED|Third Dose||0
8883245|NCT01959334|9940525|FG001|NOT COMPLETED|Third Dose||1
8883246|NCT01959347|9940533|FG000|STARTED|Overall Study||238
8883247|NCT01959347|9940534|FG001|STARTED|Overall Study||242
8883248|NCT01959347|9940533|FG000|COMPLETED|Overall Study||229
8883249|NCT01959347|9940534|FG001|COMPLETED|Overall Study||235
8883250|NCT01959347|9940533|FG000|NOT COMPLETED|Overall Study||9
8883251|NCT01959347|9940534|FG001|NOT COMPLETED|Overall Study||7
8883252|NCT01959412|9940540|FG000|STARTED|Overall Study||15
8883253|NCT01959412|9940541|FG001|STARTED|Overall Study||15
9003070|NCT02918266|10066352|FG008|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
8883254|NCT01959412|9940542|FG002|STARTED|Overall Study||15
8883255|NCT01959412|9940543|FG003|STARTED|Overall Study||15
8883256|NCT01959412|9940544|FG004|STARTED|Overall Study||16
8883257|NCT01959412|9940545|FG005|STARTED|Overall Study||15
8883258|NCT01959412|9940540|FG000|COMPLETED|Overall Study||14
8883259|NCT01959412|9940541|FG001|COMPLETED|Overall Study||14
8883260|NCT01959412|9940542|FG002|COMPLETED|Overall Study||15
8883261|NCT01959412|9940543|FG003|COMPLETED|Overall Study||13
8883262|NCT01959412|9940544|FG004|COMPLETED|Overall Study||13
8883263|NCT01959412|9940545|FG005|COMPLETED|Overall Study||15
8883264|NCT01959412|9940540|FG000|NOT COMPLETED|Overall Study||1
8883265|NCT01959412|9940541|FG001|NOT COMPLETED|Overall Study||1
8883266|NCT01959412|9940542|FG002|NOT COMPLETED|Overall Study||0
8883267|NCT01959412|9940543|FG003|NOT COMPLETED|Overall Study||2
8883268|NCT01959412|9940544|FG004|NOT COMPLETED|Overall Study||3
8883269|NCT01959412|9940545|FG005|NOT COMPLETED|Overall Study||0
9003071|NCT02918266|10066353|FG009|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
9003072|NCT02918266|10066354|FG010|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
9003073|NCT02918266|10066344|FG000|STARTED|Part 2: Intervention Period 2 (2 Days)||0
9003074|NCT02918266|10066345|FG001|STARTED|Part 2: Intervention Period 2 (2 Days)||0
9003075|NCT02918266|10066346|FG002|STARTED|Part 2: Intervention Period 2 (2 Days)||0
9003076|NCT02918266|10066347|FG003|STARTED|Part 2: Intervention Period 2 (2 Days)||0
9003077|NCT02918266|10066348|FG004|STARTED|Part 2: Intervention Period 2 (2 Days)||0
9003078|NCT02918266|10066349|FG005|STARTED|Part 2: Intervention Period 2 (2 Days)||0
9003079|NCT02918266|10066350|FG006|STARTED|Part 2: Intervention Period 2 (2 Days)||0
9003080|NCT02918266|10066351|FG007|STARTED|Part 2: Intervention Period 2 (2 Days)||0
9003081|NCT02918266|10066352|FG008|STARTED|Part 2: Intervention Period 2 (2 Days)||0
9003082|NCT02918266|10066353|FG009|STARTED|Part 2: Intervention Period 2 (2 Days)||0
9003083|NCT02918266|10066354|FG010|STARTED|Part 2: Intervention Period 2 (2 Days)||0
9003084|NCT02918266|10066344|FG000|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
9003085|NCT02918266|10066345|FG001|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
9003086|NCT02918266|10066346|FG002|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
9003087|NCT02918266|10066347|FG003|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
9003088|NCT02918266|10066348|FG004|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
9003089|NCT02918266|10066349|FG005|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
9003090|NCT02918266|10066350|FG006|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
9003091|NCT02918266|10066351|FG007|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
9003092|NCT02918266|10066352|FG008|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
9003093|NCT02918266|10066353|FG009|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
9003094|NCT02918266|10066354|FG010|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
9003095|NCT02918266|10066344|FG000|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
9003096|NCT02918266|10066345|FG001|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
9003097|NCT02918266|10066346|FG002|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
9003098|NCT02918266|10066347|FG003|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
9003099|NCT02918266|10066348|FG004|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
9003100|NCT02918266|10066349|FG005|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
9003101|NCT02918266|10066350|FG006|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
9003102|NCT02918266|10066351|FG007|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
9003103|NCT02918266|10066352|FG008|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
9003104|NCT02918266|10066353|FG009|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
9003105|NCT02918266|10066354|FG010|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
9003106|NCT02918266|10066344|FG000|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
9003107|NCT02918266|10066345|FG001|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
9003108|NCT02918266|10066346|FG002|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
9003109|NCT02918266|10066347|FG003|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
8634281|NCT00555906|9674592|FG002|NOT COMPLETED|Phase 1||7
8634282|NCT00555906|9674593|FG003|NOT COMPLETED|Phase 1||5
8634283|NCT00555906|9674594|FG004|NOT COMPLETED|Phase 1||0
8634284|NCT00555906|9674590|FG000|STARTED|Phase 2||0
8634285|NCT00555906|9674591|FG001|STARTED|Phase 2||0
8634286|NCT00555906|9674592|FG002|STARTED|Phase 2||0
9003110|NCT02918266|10066348|FG004|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
9003111|NCT02918266|10066349|FG005|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
9003112|NCT02918266|10066350|FG006|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
9003113|NCT02918266|10066351|FG007|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
9003114|NCT02918266|10066352|FG008|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
9003115|NCT02918266|10066353|FG009|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
9003116|NCT02918266|10066354|FG010|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
9003117|NCT02918266|10066344|FG000|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
9003118|NCT02918266|10066345|FG001|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
9003119|NCT02918266|10066346|FG002|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
9003120|NCT02918266|10066347|FG003|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
9003121|NCT02918266|10066348|FG004|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
9003122|NCT02918266|10066349|FG005|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
9003123|NCT02918266|10066350|FG006|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
9003124|NCT02918266|10066351|FG007|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
9003125|NCT02918266|10066352|FG008|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
9003126|NCT02918266|10066353|FG009|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
9003127|NCT02918266|10066354|FG010|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
9003128|NCT02918266|10066344|FG000|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
9003129|NCT02918266|10066345|FG001|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
9003130|NCT02918266|10066346|FG002|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
8634287|NCT00555906|9674593|FG003|STARTED|Phase 2||0
8634288|NCT00555906|9674594|FG004|STARTED|Phase 2||32
8634289|NCT00555906|9674590|FG000|Treated|Phase 2||0
8883270|NCT01959425|9940561|FG000|STARTED|Overall Study||32
8883271|NCT01959425|9940562|FG001|STARTED|Overall Study||31
8634290|NCT00555906|9674591|FG001|Treated|Phase 2||0
8883272|NCT01959425|9940561|FG000|COMPLETED|Overall Study||20
8883273|NCT01959425|9940562|FG001|COMPLETED|Overall Study||23
8883274|NCT01959425|9940561|FG000|NOT COMPLETED|Overall Study||12
8883275|NCT01959425|9940562|FG001|NOT COMPLETED|Overall Study||8
8883276|NCT01959490|9940571|FG000|STARTED|Overall Study||5
8883277|NCT01959490|9940572|FG001|STARTED|Overall Study||6
8883278|NCT01959490|9940573|FG002|STARTED|Overall Study||5
8883279|NCT01959490|9940571|FG000|COMPLETED|Overall Study||5
8883280|NCT01959490|9940572|FG001|COMPLETED|Overall Study||6
8883281|NCT01959490|9940573|FG002|COMPLETED|Overall Study||5
8883282|NCT01959490|9940571|FG000|NOT COMPLETED|Overall Study||0
8883283|NCT01959490|9940572|FG001|NOT COMPLETED|Overall Study||0
8883284|NCT01959490|9940573|FG002|NOT COMPLETED|Overall Study||0
8883285|NCT01959503|9940583|FG000|STARTED|Overall Study||107
8883286|NCT01959503|9940584|FG001|STARTED|Overall Study||51
8883287|NCT01959503|9940583|FG000|COMPLETED|Overall Study||104
8883288|NCT01959503|9940584|FG001|COMPLETED|Overall Study||49
8634291|NCT00555906|9674592|FG002|Treated|Phase 2||0
8634292|NCT00555906|9674593|FG003|Treated|Phase 2||0
8883289|NCT01959503|9940583|FG000|NOT COMPLETED|Overall Study||3
8883290|NCT01959503|9940584|FG001|NOT COMPLETED|Overall Study||2
8883291|NCT01959516|9940590|FG000|STARTED|Epoch 1||63
8883292|NCT01959516|9940591|FG001|STARTED|Epoch 1||63
8883293|NCT01959516|9940590|FG000|Safety Population|Epoch 1||62
8883294|NCT01959516|9940591|FG001|Safety Population|Epoch 1||62
8883295|NCT01959516|9940590|FG000|ITT Population|Epoch 1||62
8883296|NCT01959516|9940591|FG001|ITT Population|Epoch 1||62
8883297|NCT01959516|9940590|FG000|COMPLETED|Epoch 1||53
8883298|NCT01959516|9940591|FG001|COMPLETED|Epoch 1||58
8883299|NCT01959516|9940590|FG000|NOT COMPLETED|Epoch 1||10
8883300|NCT01959516|9940591|FG001|NOT COMPLETED|Epoch 1||5
8883301|NCT01959516|9940590|FG000|STARTED|Epoch 2||63
8883302|NCT01959516|9940591|FG001|STARTED|Epoch 2||63
8883303|NCT01959516|9940590|FG000|COMPLETED|Epoch 2||61
8883304|NCT01959516|9940591|FG001|COMPLETED|Epoch 2||62
8883305|NCT01959516|9940590|FG000|NOT COMPLETED|Epoch 2||2
8883306|NCT01959516|9940591|FG001|NOT COMPLETED|Epoch 2||1
8883307|NCT01959529|9940599|FG000|STARTED|Overall Study||3818
8883308|NCT01959529|9940600|FG001|STARTED|Overall Study||3819
8883309|NCT01959529|9940599|FG000|Exposed|Overall Study||3809
8883310|NCT01959529|9940600|FG001|Exposed|Overall Study||3806
8883311|NCT01959529|9940599|FG000|COMPLETED|Overall Study||3742
8883312|NCT01959529|9940600|FG001|COMPLETED|Overall Study||3747
8883313|NCT01959529|9940599|FG000|NOT COMPLETED|Overall Study||76
8883314|NCT01959529|9940600|FG001|NOT COMPLETED|Overall Study||72
8883315|NCT01959542|9940606|FG000|STARTED|Overall Study||15
8883316|NCT01959542|9940606|FG000|Evaluable at Visit 1|Overall Study||12
8883317|NCT01959542|9940606|FG000|Evaluable at Visit 2|Overall Study||12
8883318|NCT01959542|9940606|FG000|COMPLETED|Overall Study||12
8883319|NCT01959542|9940606|FG000|NOT COMPLETED|Overall Study||3
8883320|NCT01959581|9940611|FG000|STARTED|Overall Study||30
8883321|NCT01959581|9940611|FG000|COMPLETED|Overall Study||25
8883322|NCT01959581|9940611|FG000|NOT COMPLETED|Overall Study||5
8883323|NCT01959607|9940617|FG000|STARTED|Washout Period of 1 Day (Day 0)||22
8883324|NCT01959607|9940618|FG001|STARTED|Washout Period of 1 Day (Day 0)||22
8883325|NCT01959607|9940619|FG002|STARTED|Washout Period of 1 Day (Day 0)||9
8883326|NCT01959607|9940620|FG003|STARTED|Washout Period of 1 Day (Day 0)||9
8883327|NCT01959607|9940617|FG000|COMPLETED|Washout Period of 1 Day (Day 0)||22
8883328|NCT01959607|9940618|FG001|COMPLETED|Washout Period of 1 Day (Day 0)||22
8883329|NCT01959607|9940619|FG002|COMPLETED|Washout Period of 1 Day (Day 0)||9
8883330|NCT01959607|9940620|FG003|COMPLETED|Washout Period of 1 Day (Day 0)||9
8883331|NCT01959607|9940617|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
8883332|NCT01959607|9940618|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
8883333|NCT01959607|9940619|FG002|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
8883334|NCT01959607|9940620|FG003|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
8883335|NCT01959607|9940617|FG000|STARTED|First Intervention (Day 1)||22
8883336|NCT01959607|9940618|FG001|STARTED|First Intervention (Day 1)||22
8883337|NCT01959607|9940619|FG002|STARTED|First Intervention (Day 1)||9
8883338|NCT01959607|9940620|FG003|STARTED|First Intervention (Day 1)||9
8883339|NCT01959607|9940617|FG000|COMPLETED|First Intervention (Day 1)||21
8883340|NCT01959607|9940618|FG001|COMPLETED|First Intervention (Day 1)||21
8883341|NCT01959607|9940619|FG002|COMPLETED|First Intervention (Day 1)||9
8883342|NCT01959607|9940620|FG003|COMPLETED|First Intervention (Day 1)||9
8883343|NCT01959607|9940617|FG000|NOT COMPLETED|First Intervention (Day 1)||1
8883344|NCT01959607|9940618|FG001|NOT COMPLETED|First Intervention (Day 1)||1
8883345|NCT01959607|9940619|FG002|NOT COMPLETED|First Intervention (Day 1)||0
8883346|NCT01959607|9940620|FG003|NOT COMPLETED|First Intervention (Day 1)||0
9003131|NCT02918266|10066347|FG003|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
9003132|NCT02918266|10066348|FG004|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
8634293|NCT00555906|9674594|FG004|Treated|Phase 2||30
8883347|NCT01959607|9940617|FG000|STARTED|Washout Period of 1 Day (Day 2)||21
8883348|NCT01959607|9940618|FG001|STARTED|Washout Period of 1 Day (Day 2)||21
8883349|NCT01959607|9940619|FG002|STARTED|Washout Period of 1 Day (Day 2)||9
8883350|NCT01959607|9940620|FG003|STARTED|Washout Period of 1 Day (Day 2)||9
8883351|NCT01959607|9940617|FG000|COMPLETED|Washout Period of 1 Day (Day 2)||21
8634294|NCT00555906|9674590|FG000|COMPLETED|Phase 2||0
8883352|NCT01959607|9940618|FG001|COMPLETED|Washout Period of 1 Day (Day 2)||21
8883353|NCT01959607|9940619|FG002|COMPLETED|Washout Period of 1 Day (Day 2)||9
8883354|NCT01959607|9940620|FG003|COMPLETED|Washout Period of 1 Day (Day 2)||9
8883355|NCT01959607|9940617|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
8883356|NCT01959607|9940618|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
8883357|NCT01959607|9940619|FG002|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
8883358|NCT01959607|9940620|FG003|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
8883359|NCT01959607|9940617|FG000|STARTED|Second Intervention (Day 3)||21
8883360|NCT01959607|9940618|FG001|STARTED|Second Intervention (Day 3)||21
8883361|NCT01959607|9940619|FG002|STARTED|Second Intervention (Day 3)||9
8883362|NCT01959607|9940620|FG003|STARTED|Second Intervention (Day 3)||9
8883363|NCT01959607|9940617|FG000|COMPLETED|Second Intervention (Day 3)||21
8883364|NCT01959607|9940618|FG001|COMPLETED|Second Intervention (Day 3)||21
8883365|NCT01959607|9940619|FG002|COMPLETED|Second Intervention (Day 3)||9
8883366|NCT01959607|9940620|FG003|COMPLETED|Second Intervention (Day 3)||9
8883367|NCT01959607|9940617|FG000|NOT COMPLETED|Second Intervention (Day 3)||0
8883368|NCT01959607|9940618|FG001|NOT COMPLETED|Second Intervention (Day 3)||0
8883369|NCT01959607|9940619|FG002|NOT COMPLETED|Second Intervention (Day 3)||0
8883370|NCT01959607|9940620|FG003|NOT COMPLETED|Second Intervention (Day 3)||0
8883371|NCT01959672|9940629|FG000|STARTED|Overall Study||11
8883372|NCT01959672|9940629|FG000|COMPLETED|Overall Study||10
8883373|NCT01959672|9940629|FG000|NOT COMPLETED|Overall Study||1
8883374|NCT01959685|9940636|FG000|STARTED|Overall Study||9
8883375|NCT01959685|9940636|FG000|COMPLETED|Overall Study||9
8883376|NCT01959685|9940636|FG000|NOT COMPLETED|Overall Study||0
8883377|NCT01959698|9940647|FG000|STARTED|Overall Study||3
8883378|NCT01959698|9940648|FG001|STARTED|Overall Study||3
8883379|NCT01959698|9940649|FG002|STARTED|Overall Study||3
8883380|NCT01959698|9940650|FG003|STARTED|Overall Study||3
8883381|NCT01959698|9940651|FG004|STARTED|Overall Study||3
8883382|NCT01959698|9940652|FG005|STARTED|Overall Study||6
8883383|NCT01959698|9940653|FG006|STARTED|Overall Study||8
8883384|NCT01959698|9940647|FG000|COMPLETED|Overall Study||2
8883385|NCT01959698|9940648|FG001|COMPLETED|Overall Study||3
8883386|NCT01959698|9940649|FG002|COMPLETED|Overall Study||2
8883387|NCT01959698|9940650|FG003|COMPLETED|Overall Study||1
8883388|NCT01959698|9940651|FG004|COMPLETED|Overall Study||3
8883389|NCT01959698|9940652|FG005|COMPLETED|Overall Study||3
8883390|NCT01959698|9940653|FG006|COMPLETED|Overall Study||4
8883391|NCT01959698|9940647|FG000|NOT COMPLETED|Overall Study||1
8883392|NCT01959698|9940648|FG001|NOT COMPLETED|Overall Study||0
8883393|NCT01959698|9940649|FG002|NOT COMPLETED|Overall Study||1
8883394|NCT01959698|9940650|FG003|NOT COMPLETED|Overall Study||2
8883395|NCT01959698|9940651|FG004|NOT COMPLETED|Overall Study||0
8883396|NCT01959698|9940652|FG005|NOT COMPLETED|Overall Study||3
8883397|NCT01959698|9940653|FG006|NOT COMPLETED|Overall Study||4
8883398|NCT01959841|9940673|FG000|STARTED|Overall Study||252
8883399|NCT01959841|9940674|FG001|STARTED|Overall Study||250
8883400|NCT01959841|9940675|FG002|STARTED|Overall Study||249
8725940|NCT01033487|9773157|FG000|NOT COMPLETED|Third Intervention Period||0
8725941|NCT01033487|9773158|FG001|NOT COMPLETED|Third Intervention Period||0
8883401|NCT01959841|9940673|FG000|Full Analysis Set Included|Overall Study||247
8883402|NCT01959841|9940674|FG001|Full Analysis Set Included|Overall Study||243
8883403|NCT01959841|9940675|FG002|Full Analysis Set Included|Overall Study||245
8883404|NCT01959841|9940673|FG000|Full Analysis Set Excluded|Overall Study||5
8883405|NCT01959841|9940674|FG001|Full Analysis Set Excluded|Overall Study||7
8883406|NCT01959841|9940675|FG002|Full Analysis Set Excluded|Overall Study||4
8883407|NCT01959841|9940673|FG000|Reason FAS Excluding 1|Overall Study||5
8883408|NCT01959841|9940674|FG001|Reason FAS Excluding 1|Overall Study||5
8883409|NCT01959841|9940675|FG002|Reason FAS Excluding 1|Overall Study||4
8883410|NCT01959841|9940673|FG000|Reason FAS Excluding 2|Overall Study||0
8883411|NCT01959841|9940674|FG001|Reason FAS Excluding 2|Overall Study||1
8883412|NCT01959841|9940675|FG002|Reason FAS Excluding 2|Overall Study||0
8883413|NCT01959841|9940673|FG000|Reason FAS Excluding 3|Overall Study||0
8883414|NCT01959841|9940674|FG001|Reason FAS Excluding 3|Overall Study||1
8883415|NCT01959841|9940675|FG002|Reason FAS Excluding 3|Overall Study||0
8883416|NCT01959841|9940673|FG000|COMPLETED|Overall Study||209
8883417|NCT01959841|9940674|FG001|COMPLETED|Overall Study||193
8883418|NCT01959841|9940675|FG002|COMPLETED|Overall Study||206
8883419|NCT01959841|9940673|FG000|NOT COMPLETED|Overall Study||43
8883420|NCT01959841|9940674|FG001|NOT COMPLETED|Overall Study||57
8883421|NCT01959841|9940675|FG002|NOT COMPLETED|Overall Study||43
8883422|NCT01959880|9940687|FG000|STARTED|Overall Study||1132
8883423|NCT01959880|9940688|FG001|STARTED|Overall Study||369
8883424|NCT01959880|9940689|FG002|STARTED|Overall Study||209
8883425|NCT01959880|9940690|FG003|STARTED|Overall Study||181
8883426|NCT01959880|9940687|FG000|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|0
8883427|NCT01959880|9940688|FG001|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|0
8883428|NCT01959880|9940689|FG002|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|1
8883429|NCT01959880|9940690|FG003|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|0
8883430|NCT01959880|9940687|FG000|NOT COMPLETED|Overall Study||1132
8725942|NCT01033487|9773159|FG002|NOT COMPLETED|Third Intervention Period||0
8725943|NCT01033487|9773160|FG003|NOT COMPLETED|Third Intervention Period||0
8725944|NCT01033487|9773161|FG004|NOT COMPLETED|Third Intervention Period||0
8725945|NCT01033487|9773162|FG005|NOT COMPLETED|Third Intervention Period||0
8634295|NCT00555906|9674591|FG001|COMPLETED|Phase 2||0
8634296|NCT00555906|9674592|FG002|COMPLETED|Phase 2||0
8634297|NCT00555906|9674593|FG003|COMPLETED|Phase 2||0
8883431|NCT01959880|9940688|FG001|NOT COMPLETED|Overall Study||369
8883432|NCT01959880|9940689|FG002|NOT COMPLETED|Overall Study||208
8883433|NCT01959880|9940690|FG003|NOT COMPLETED|Overall Study||181
8883434|NCT01959919|9940700|FG000|STARTED|Overall Study||86
8883435|NCT01959919|9940700|FG000|COMPLETED|Overall Study||84
8883436|NCT01959919|9940700|FG000|NOT COMPLETED|Overall Study||2
8883437|NCT01959932|9940707|FG000|STARTED|Overall Study||80
8883438|NCT01959932|9940708|FG001|STARTED|Overall Study||41
8883439|NCT01959932|9940709|FG002|STARTED|Overall Study||39
8883440|NCT01959932|9940707|FG000|COMPLETED|Overall Study||79
8883441|NCT01959932|9940708|FG001|COMPLETED|Overall Study||41
8883442|NCT01959932|9940709|FG002|COMPLETED|Overall Study||39
8883443|NCT01959932|9940707|FG000|NOT COMPLETED|Overall Study||1
8883444|NCT01959932|9940708|FG001|NOT COMPLETED|Overall Study||0
8883445|NCT01959932|9940709|FG002|NOT COMPLETED|Overall Study||0
8883446|NCT01959945|9940722|FG000|STARTED|Overall Study||80
8883447|NCT01959945|9940723|FG001|STARTED|Overall Study||78
8883448|NCT01959945|9940724|FG002|STARTED|Overall Study||28
8883449|NCT01959945|9940725|FG003|STARTED|Overall Study||31
8883450|NCT01959945|9940722|FG000|COMPLETED|Overall Study||76
8883451|NCT01959945|9940723|FG001|COMPLETED|Overall Study||75
8883452|NCT01959945|9940724|FG002|COMPLETED|Overall Study||9
8883453|NCT01959945|9940725|FG003|COMPLETED|Overall Study||15
8883454|NCT01959945|9940722|FG000|NOT COMPLETED|Overall Study||4
8883455|NCT01959945|9940723|FG001|NOT COMPLETED|Overall Study||3
8883456|NCT01959945|9940724|FG002|NOT COMPLETED|Overall Study||19
8883457|NCT01959945|9940725|FG003|NOT COMPLETED|Overall Study||16
8883458|NCT01960075|9940740|FG000|STARTED|Overall Study||149
8883459|NCT01960075|9940741|FG001|STARTED|Overall Study||149
8883460|NCT01960075|9940742|FG002|STARTED|Overall Study||180
8883461|NCT01960075|9940740|FG000|COMPLETED|Overall Study||141
8883462|NCT01960075|9940741|FG001|COMPLETED|Overall Study||146
8883463|NCT01960075|9940742|FG002|COMPLETED|Overall Study||173
8883464|NCT01960075|9940740|FG000|NOT COMPLETED|Overall Study||8
8883465|NCT01960075|9940741|FG001|NOT COMPLETED|Overall Study||3
8883466|NCT01960075|9940742|FG002|NOT COMPLETED|Overall Study||7
9003133|NCT02918266|10066349|FG005|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
9003134|NCT02918266|10066350|FG006|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
9003135|NCT02918266|10066351|FG007|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
8634298|NCT00555906|9674594|FG004|COMPLETED|Phase 2||0
8634299|NCT00555906|9674590|FG000|NOT COMPLETED|Phase 2||0
8634300|NCT00555906|9674591|FG001|NOT COMPLETED|Phase 2||0
9003136|NCT02918266|10066352|FG008|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
9003137|NCT02918266|10066353|FG009|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
9003138|NCT02918266|10066354|FG010|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
9003139|NCT02918266|10066344|FG000|STARTED|Part 2: Intervention Period 3 (2 Days)||0
9003140|NCT02918266|10066345|FG001|STARTED|Part 2: Intervention Period 3 (2 Days)||0
9003141|NCT02918266|10066346|FG002|STARTED|Part 2: Intervention Period 3 (2 Days)||0
9003142|NCT02918266|10066347|FG003|STARTED|Part 2: Intervention Period 3 (2 Days)||0
9003143|NCT02918266|10066348|FG004|STARTED|Part 2: Intervention Period 3 (2 Days)||0
9003144|NCT02918266|10066349|FG005|STARTED|Part 2: Intervention Period 3 (2 Days)||0
9003145|NCT02918266|10066350|FG006|STARTED|Part 2: Intervention Period 3 (2 Days)||0
9003146|NCT02918266|10066351|FG007|STARTED|Part 2: Intervention Period 3 (2 Days)||0
9003147|NCT02918266|10066352|FG008|STARTED|Part 2: Intervention Period 3 (2 Days)||0
9003148|NCT02918266|10066353|FG009|STARTED|Part 2: Intervention Period 3 (2 Days)||0
9003149|NCT02918266|10066354|FG010|STARTED|Part 2: Intervention Period 3 (2 Days)||0
9003150|NCT02918266|10066344|FG000|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
9003151|NCT02918266|10066345|FG001|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
9003152|NCT02918266|10066346|FG002|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
9003153|NCT02918266|10066347|FG003|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
9003154|NCT02918266|10066348|FG004|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
9003155|NCT02918266|10066349|FG005|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
9003156|NCT02918266|10066350|FG006|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
9003157|NCT02918266|10066351|FG007|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
9003158|NCT02918266|10066352|FG008|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
9003159|NCT02918266|10066353|FG009|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
9003160|NCT02918266|10066354|FG010|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
9003161|NCT02918266|10066344|FG000|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
9003162|NCT02918266|10066345|FG001|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
9003163|NCT02918266|10066346|FG002|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
9003164|NCT02918266|10066347|FG003|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
8634301|NCT00555906|9674592|FG002|NOT COMPLETED|Phase 2||0
8634302|NCT00555906|9674593|FG003|NOT COMPLETED|Phase 2||0
8883467|NCT01960114|9940752|FG000|STARTED|Overall Study||134
8883468|NCT01960114|9940753|FG001|STARTED|Overall Study||269
8883469|NCT01960114|9940752|FG000|COMPLETED|Overall Study||133
8883470|NCT01960114|9940753|FG001|COMPLETED|Overall Study||268
8883471|NCT01960114|9940752|FG000|NOT COMPLETED|Overall Study||1
8883472|NCT01960114|9940753|FG001|NOT COMPLETED|Overall Study||1
8883473|NCT01960140|9940759|FG000|STARTED|Period 1 (Days 1-2)||40
8634303|NCT00555906|9674594|FG004|NOT COMPLETED|Phase 2||32
8634304|NCT00555971|9674611|FG000|STARTED|Overall Study||5
8634305|NCT00555971|9674612|FG001|STARTED|Overall Study||8
8883474|NCT01960140|9940759|FG000|Received Simvastatin|Period 1 (Days 1-2)||40
8883475|NCT01960140|9940759|FG000|COMPLETED|Period 1 (Days 1-2)||40
8883476|NCT01960140|9940759|FG000|NOT COMPLETED|Period 1 (Days 1-2)||0
8883477|NCT01960140|9940759|FG000|STARTED|Period 2 (Days 3-18)||40
8883478|NCT01960140|9940759|FG000|Received At Least 1 Dose of Baricitinib|Period 2 (Days 3-18)||40
8883479|NCT01960140|9940759|FG000|Received Simvastatin|Period 2 (Days 3-18)||38
8883480|NCT01960140|9940759|FG000|COMPLETED|Period 2 (Days 3-18)||38
8883481|NCT01960140|9940759|FG000|NOT COMPLETED|Period 2 (Days 3-18)||2
8634306|NCT00555971|9674611|FG000|COMPLETED|Overall Study||4
8634307|NCT00555971|9674612|FG001|COMPLETED|Overall Study||7
8634308|NCT00555971|9674611|FG000|NOT COMPLETED|Overall Study||1
8634309|NCT00555971|9674612|FG001|NOT COMPLETED|Overall Study||1
8634310|NCT00555997|9674621|FG000|STARTED|Phase 1 SPCD||29
8634311|NCT00555997|9674622|FG001|STARTED|Phase 1 SPCD||91
8634312|NCT00555997|9674623|FG002|STARTED|Phase 1 SPCD||0
8634313|NCT00555997|9674624|FG003|STARTED|Phase 1 SPCD||0
8634314|NCT00555997|9674621|FG000|COMPLETED|Phase 1 SPCD||17
8634315|NCT00555997|9674622|FG001|COMPLETED|Phase 1 SPCD||76
8634316|NCT00555997|9674623|FG002|COMPLETED|Phase 1 SPCD||0
8634317|NCT00555997|9674624|FG003|COMPLETED|Phase 1 SPCD||0
8634318|NCT00555997|9674621|FG000|NOT COMPLETED|Phase 1 SPCD||12
8634319|NCT00555997|9674622|FG001|NOT COMPLETED|Phase 1 SPCD||15
8634320|NCT00555997|9674623|FG002|NOT COMPLETED|Phase 1 SPCD||0
8634321|NCT00555997|9674624|FG003|NOT COMPLETED|Phase 1 SPCD||0
8725946|NCT01033487|9773163|FG006|NOT COMPLETED|Third Intervention Period||0
8725947|NCT01033487|9773164|FG007|NOT COMPLETED|Third Intervention Period||0
8725948|NCT01033487|9773165|FG008|NOT COMPLETED|Third Intervention Period||0
8725949|NCT01033487|9773166|FG009|NOT COMPLETED|Third Intervention Period||0
8725950|NCT01033487|9773157|FG000|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
8725951|NCT01033487|9773158|FG001|STARTED|Between Period 3 and 4 (At Least 7 Days)||3
8725952|NCT01033487|9773159|FG002|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
8725953|NCT01033487|9773160|FG003|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
8725954|NCT01033487|9773161|FG004|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
8725955|NCT01033487|9773162|FG005|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
8725956|NCT01033487|9773163|FG006|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
8725957|NCT01033487|9773164|FG007|STARTED|Between Period 3 and 4 (At Least 7 Days)||3
8725958|NCT01033487|9773165|FG008|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
8725959|NCT01033487|9773166|FG009|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
8725960|NCT01033487|9773157|FG000|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
8725961|NCT01033487|9773158|FG001|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||3
8725962|NCT01033487|9773159|FG002|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
8725963|NCT01033487|9773160|FG003|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
8725964|NCT01033487|9773161|FG004|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
8725965|NCT01033487|9773162|FG005|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
8725966|NCT01033487|9773163|FG006|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
8725967|NCT01033487|9773164|FG007|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||3
8725968|NCT01033487|9773165|FG008|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
8725969|NCT01033487|9773166|FG009|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
8725970|NCT01033487|9773157|FG000|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
8725971|NCT01033487|9773158|FG001|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
8725972|NCT01033487|9773159|FG002|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
8725973|NCT01033487|9773160|FG003|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
8725974|NCT01033487|9773161|FG004|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
8725975|NCT01033487|9773162|FG005|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
8725976|NCT01033487|9773163|FG006|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
8725977|NCT01033487|9773164|FG007|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
8725978|NCT01033487|9773165|FG008|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
8725979|NCT01033487|9773166|FG009|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
8725980|NCT01033487|9773157|FG000|STARTED|Fourth Intervention Period||2
8725981|NCT01033487|9773158|FG001|STARTED|Fourth Intervention Period||3
8725982|NCT01033487|9773159|FG002|STARTED|Fourth Intervention Period||2
8725983|NCT01033487|9773160|FG003|STARTED|Fourth Intervention Period||2
8725984|NCT01033487|9773161|FG004|STARTED|Fourth Intervention Period||2
8725985|NCT01033487|9773162|FG005|STARTED|Fourth Intervention Period||2
8725986|NCT01033487|9773163|FG006|STARTED|Fourth Intervention Period||2
8725987|NCT01033487|9773164|FG007|STARTED|Fourth Intervention Period||3
8725988|NCT01033487|9773165|FG008|STARTED|Fourth Intervention Period||2
8725989|NCT01033487|9773166|FG009|STARTED|Fourth Intervention Period||2
8725990|NCT01033487|9773157|FG000|COMPLETED|Fourth Intervention Period||2
8725991|NCT01033487|9773158|FG001|COMPLETED|Fourth Intervention Period||3
8725992|NCT01033487|9773159|FG002|COMPLETED|Fourth Intervention Period||2
8725993|NCT01033487|9773160|FG003|COMPLETED|Fourth Intervention Period||2
8725994|NCT01033487|9773161|FG004|COMPLETED|Fourth Intervention Period||2
8725995|NCT01033487|9773162|FG005|COMPLETED|Fourth Intervention Period||2
8725996|NCT01033487|9773163|FG006|COMPLETED|Fourth Intervention Period||2
8883482|NCT01960257|9940767|FG000|STARTED|Stage 1 (1-3 Weeks)||77
8634322|NCT00555997|9674621|FG000|STARTED|Phase 2 SPCD||0
8883483|NCT01960257|9940768|FG001|STARTED|Stage 1 (1-3 Weeks)||0
8883484|NCT01960257|9940769|FG002|STARTED|Stage 1 (1-3 Weeks)||0
8883485|NCT01960257|9940767|FG000|COMPLETED|Stage 1 (1-3 Weeks)||61
8634323|NCT00555997|9674622|FG001|STARTED|Phase 2 SPCD||0
8634324|NCT00555997|9674623|FG002|STARTED|Phase 2 SPCD||38
8883486|NCT01960257|9940768|FG001|COMPLETED|Stage 1 (1-3 Weeks)||0
8883487|NCT01960257|9940769|FG002|COMPLETED|Stage 1 (1-3 Weeks)||0
8883488|NCT01960257|9940767|FG000|NOT COMPLETED|Stage 1 (1-3 Weeks)||16
8883489|NCT01960257|9940768|FG001|NOT COMPLETED|Stage 1 (1-3 Weeks)||0
8883490|NCT01960257|9940769|FG002|NOT COMPLETED|Stage 1 (1-3 Weeks)||0
8883491|NCT01960257|9940767|FG000|STARTED|Stage 2(1-4 Months, Not to Exceed 12wks)||0
8883492|NCT01960257|9940768|FG001|STARTED|Stage 2(1-4 Months, Not to Exceed 12wks)||41
8883493|NCT01960257|9940769|FG002|STARTED|Stage 2(1-4 Months, Not to Exceed 12wks)||20
8883494|NCT01960257|9940767|FG000|COMPLETED|Stage 2(1-4 Months, Not to Exceed 12wks)||0
8883495|NCT01960257|9940768|FG001|COMPLETED|Stage 2(1-4 Months, Not to Exceed 12wks)||41
8883496|NCT01960257|9940769|FG002|COMPLETED|Stage 2(1-4 Months, Not to Exceed 12wks)||20
8883497|NCT01960257|9940767|FG000|NOT COMPLETED|Stage 2(1-4 Months, Not to Exceed 12wks)||0
8883498|NCT01960257|9940768|FG001|NOT COMPLETED|Stage 2(1-4 Months, Not to Exceed 12wks)||0
8883499|NCT01960257|9940769|FG002|NOT COMPLETED|Stage 2(1-4 Months, Not to Exceed 12wks)||0
8883500|NCT01960296|9940781|FG000|STARTED|Overall Study||23
8883501|NCT01960296|9940782|FG001|STARTED|Overall Study||25
8883502|NCT01960296|9940781|FG000|COMPLETED|Overall Study||21
8883503|NCT01960296|9940782|FG001|COMPLETED|Overall Study||22
8883504|NCT01960296|9940781|FG000|NOT COMPLETED|Overall Study||2
8883505|NCT01960296|9940782|FG001|NOT COMPLETED|Overall Study||3
8883506|NCT01960348|9940790|FG000|STARTED|Overall Study||148
8883507|NCT01960348|9940791|FG001|STARTED|Overall Study||77
8883508|NCT01960348|9940790|FG000|COMPLETED|Overall Study||138
8883509|NCT01960348|9940791|FG001|COMPLETED|Overall Study||55
8883510|NCT01960348|9940790|FG000|NOT COMPLETED|Overall Study||10
8883511|NCT01960348|9940791|FG001|NOT COMPLETED|Overall Study||22
8883512|NCT01960387|9940797|FG000|STARTED|Overall Study||2
8883513|NCT01960387|9940797|FG000|COMPLETED|Overall Study||2
8883514|NCT01960387|9940797|FG000|NOT COMPLETED|Overall Study||0
8883515|NCT01960400|9940803|FG000|STARTED|Overall Study||11
8883516|NCT01960400|9940804|FG001|STARTED|Overall Study||11
8883517|NCT01960400|9940803|FG000|COMPLETED|Overall Study||11
8883518|NCT01960400|9940804|FG001|COMPLETED|Overall Study||11
8883519|NCT01960400|9940803|FG000|NOT COMPLETED|Overall Study||0
8883520|NCT01960400|9940804|FG001|NOT COMPLETED|Overall Study||0
8883521|NCT01960413|9940812|FG000|STARTED|Overall Study||24
8883522|NCT01960413|9940813|FG001|STARTED|Overall Study||22
8883523|NCT01960413|9940812|FG000|COMPLETED|Overall Study||20
8883524|NCT01960413|9940813|FG001|COMPLETED|Overall Study||21
8883525|NCT01960413|9940812|FG000|NOT COMPLETED|Overall Study||4
8883526|NCT01960413|9940813|FG001|NOT COMPLETED|Overall Study||1
8883527|NCT01960465|9940821|FG000|STARTED|Overall Study||138
8883528|NCT01960465|9940822|FG001|STARTED|Overall Study||82
8883529|NCT01960465|9940821|FG000|COMPLETED|Overall Study||118
8883530|NCT01960465|9940822|FG001|COMPLETED|Overall Study||73
8883531|NCT01960465|9940821|FG000|NOT COMPLETED|Overall Study||20
8883532|NCT01960465|9940822|FG001|NOT COMPLETED|Overall Study||9
8883533|NCT01960725|9940830|FG000|STARTED|Overall Study||33
8883534|NCT01960725|9940831|FG001|STARTED|Overall Study||33
8883535|NCT01960725|9940830|FG000|Received First Vaccine|Overall Study||33
8883536|NCT01960725|9940831|FG001|Received First Vaccine|Overall Study||33
8883537|NCT01960725|9940830|FG000|Recieved Second Vaccine|Overall Study||33
8883538|NCT01960725|9940831|FG001|Recieved Second Vaccine|Overall Study||33
8883539|NCT01960725|9940830|FG000|Received Third Vaccine|Overall Study||32
8883540|NCT01960725|9940831|FG001|Received Third Vaccine|Overall Study||32
8883541|NCT01960725|9940830|FG000|COMPLETED|Overall Study||27
8883542|NCT01960725|9940831|FG001|COMPLETED|Overall Study||28
8883543|NCT01960725|9940830|FG000|NOT COMPLETED|Overall Study||6
8883544|NCT01960725|9940831|FG001|NOT COMPLETED|Overall Study||5
8883545|NCT01960790|9940837|FG000|STARTED|Overall Study||473
8883546|NCT01960790|9940837|FG000|COMPLETED|Overall Study||462
8883547|NCT01960790|9940837|FG000|NOT COMPLETED|Overall Study||11
8883548|NCT01960816|9940841|FG000|STARTED|Overall Study||33
8883549|NCT01960816|9940841|FG000|COMPLETED|Overall Study||32
8883550|NCT01960816|9940841|FG000|NOT COMPLETED|Overall Study||1
8883551|NCT01960842|9940845|FG000|STARTED|Overall Study||31
8883552|NCT01960842|9940845|FG000|COMPLETED|Overall Study||28
8883553|NCT01960842|9940845|FG000|NOT COMPLETED|Overall Study||3
8883554|NCT01960855|9940854|FG000|STARTED|Overall Study||56
8883555|NCT01960855|9940855|FG001|STARTED|Overall Study||55
8883556|NCT01960855|9940856|FG002|STARTED|Overall Study||55
8883557|NCT01960855|9940857|FG003|STARTED|Overall Study||55
8883558|NCT01960855|9940858|FG004|STARTED|Overall Study||55
8883559|NCT01960855|9940854|FG000|COMPLETED|Overall Study||45
8883560|NCT01960855|9940855|FG001|COMPLETED|Overall Study||51
8883561|NCT01960855|9940856|FG002|COMPLETED|Overall Study||46
8883562|NCT01960855|9940857|FG003|COMPLETED|Overall Study||51
8883563|NCT01960855|9940858|FG004|COMPLETED|Overall Study||50
8883564|NCT01960855|9940854|FG000|NOT COMPLETED|Overall Study||11
8883565|NCT01960855|9940855|FG001|NOT COMPLETED|Overall Study||4
8883566|NCT01960855|9940856|FG002|NOT COMPLETED|Overall Study||9
8883567|NCT01960855|9940857|FG003|NOT COMPLETED|Overall Study||4
8883568|NCT01960855|9940858|FG004|NOT COMPLETED|Overall Study||5
8634325|NCT00555997|9674624|FG003|STARTED|Phase 2 SPCD||25
8883569|NCT01960907|9940872|FG000|STARTED|Overall Study||158
8883570|NCT01960907|9940873|FG001|STARTED|Overall Study||154
8883571|NCT01960907|9940872|FG000|COMPLETED|Overall Study||122
8883572|NCT01960907|9940873|FG001|COMPLETED|Overall Study||109
8883573|NCT01960907|9940872|FG000|NOT COMPLETED|Overall Study||36
8883574|NCT01960907|9940873|FG001|NOT COMPLETED|Overall Study||45
8883575|NCT01960998|9940884|FG000|STARTED|Overall Study||101
8883576|NCT01960998|9940885|FG001|STARTED|Overall Study||96
8883577|NCT01960998|9940884|FG000|COMPLETED|Overall Study||90
8883578|NCT01960998|9940885|FG001|COMPLETED|Overall Study||85
8883579|NCT01960998|9940884|FG000|NOT COMPLETED|Overall Study||11
8883580|NCT01960998|9940885|FG001|NOT COMPLETED|Overall Study||11
8883581|NCT01961089|9940893|FG000|STARTED|Overall Study||40
8883582|NCT01961089|9940893|FG000|COMPLETED|Overall Study||40
8883583|NCT01961089|9940893|FG000|NOT COMPLETED|Overall Study||0
8883584|NCT01961115|9940900|FG000|STARTED|Overall Study||2
8883585|NCT01961115|9940901|FG001|STARTED|Overall Study||0
8883586|NCT01961115|9940902|FG002|STARTED|Overall Study||9
8883587|NCT01961115|9940900|FG000|COMPLETED|Overall Study||0
8883588|NCT01961115|9940901|FG001|COMPLETED|Overall Study||0
8883589|NCT01961115|9940902|FG002|COMPLETED|Overall Study||5
8883590|NCT01961115|9940900|FG000|NOT COMPLETED|Overall Study||2
8883591|NCT01961115|9940901|FG001|NOT COMPLETED|Overall Study||0
8883592|NCT01961115|9940902|FG002|NOT COMPLETED|Overall Study||4
8883593|NCT01961167|9940910|FG000|STARTED|Overall Study||27
8883594|NCT01961167|9940910|FG000|COMPLETED|Overall Study||27
9003165|NCT02918266|10066348|FG004|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
9003166|NCT02918266|10066349|FG005|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
9003167|NCT02918266|10066350|FG006|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
9003168|NCT02918266|10066351|FG007|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
9003169|NCT02918266|10066352|FG008|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
9003170|NCT02918266|10066353|FG009|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
9003171|NCT02918266|10066354|FG010|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
9003172|NCT02918266|10066344|FG000|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
9003173|NCT02918266|10066345|FG001|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
9003174|NCT02918266|10066346|FG002|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
9003175|NCT02918266|10066347|FG003|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
9003176|NCT02918266|10066348|FG004|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
9003177|NCT02918266|10066349|FG005|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
9003178|NCT02918266|10066350|FG006|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
9003179|NCT02918266|10066351|FG007|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
9003180|NCT02918266|10066352|FG008|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
9003181|NCT02918266|10066353|FG009|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
9003182|NCT02918266|10066354|FG010|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
9003183|NCT02918266|10066344|FG000|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
9003184|NCT02918266|10066345|FG001|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
9003185|NCT02918266|10066346|FG002|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
9003186|NCT02918266|10066347|FG003|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
9003187|NCT02918266|10066348|FG004|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
9003188|NCT02918266|10066349|FG005|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
9003189|NCT02918266|10066350|FG006|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
9003190|NCT02918266|10066351|FG007|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
9003191|NCT02918266|10066352|FG008|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
9003192|NCT02918266|10066353|FG009|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
9003193|NCT02918266|10066354|FG010|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
9003194|NCT02918266|10066344|FG000|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
9003195|NCT02918266|10066345|FG001|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
9003196|NCT02918266|10066346|FG002|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
8883595|NCT01961167|9940910|FG000|NOT COMPLETED|Overall Study||0
8883596|NCT01961271|9940914|FG000|STARTED|Overall Study||114
8883597|NCT01961271|9940914|FG000|COMPLETED|Overall Study||64
8883598|NCT01961271|9940914|FG000|NOT COMPLETED|Overall Study||50
8883599|NCT01961297|9940920|FG000|STARTED|Overall Study||30
8883600|NCT01961297|9940921|FG001|STARTED|Overall Study||23
8883601|NCT01961297|9940920|FG000|COMPLETED|Overall Study||28
8883602|NCT01961297|9940921|FG001|COMPLETED|Overall Study||22
8883603|NCT01961297|9940920|FG000|NOT COMPLETED|Overall Study||2
8883604|NCT01961297|9940921|FG001|NOT COMPLETED|Overall Study||1
8883605|NCT01961323|9940927|FG000|STARTED|Overall Study||70
8883606|NCT01961323|9940927|FG000|COMPLETED|Overall Study||21
8883607|NCT01961323|9940927|FG000|NOT COMPLETED|Overall Study||49
8883608|NCT01961349|9940934|FG000|STARTED|Overall Study||54
8883609|NCT01961349|9940935|FG001|STARTED|Overall Study||107
8883610|NCT01961349|9940936|FG002|STARTED|Overall Study||111
8883611|NCT01961349|9940934|FG000|COMPLETED|Overall Study||51
8883612|NCT01961349|9940935|FG001|COMPLETED|Overall Study||101
8883613|NCT01961349|9940936|FG002|COMPLETED|Overall Study||109
8883614|NCT01961349|9940934|FG000|NOT COMPLETED|Overall Study||3
8883615|NCT01961349|9940935|FG001|NOT COMPLETED|Overall Study||6
8883616|NCT01961349|9940936|FG002|NOT COMPLETED|Overall Study||2
8883617|NCT01961362|9940944|FG000|STARTED|Overall Study||19
8883618|NCT01961362|9940944|FG000|COMPLETED|Overall Study||19
8883619|NCT01961362|9940944|FG000|NOT COMPLETED|Overall Study||0
8883620|NCT01961544|9940948|FG000|STARTED|Overall Study||101
8883621|NCT01961544|9940948|FG000|COMPLETED|Overall Study||88
8883622|NCT01961544|9940948|FG000|NOT COMPLETED|Overall Study||13
8883623|NCT01961609|9940954|FG000|STARTED|Initiation||119
8883624|NCT01961609|9940955|FG001|STARTED|Initiation||116
8883625|NCT01961609|9940956|FG002|STARTED|Initiation||0
8883626|NCT01961609|9940957|FG003|STARTED|Initiation||0
8883627|NCT01961609|9940954|FG000|Safety Set|Initiation||118
8883628|NCT01961609|9940955|FG001|Safety Set|Initiation||115
8883629|NCT01961609|9940956|FG002|Safety Set|Initiation||0
8883630|NCT01961609|9940957|FG003|Safety Set|Initiation||0
8883631|NCT01961609|9940954|FG000|Full Analysis Set|Initiation||118
8883632|NCT01961609|9940955|FG001|Full Analysis Set|Initiation||115
8883633|NCT01961609|9940956|FG002|Full Analysis Set|Initiation||0
8883634|NCT01961609|9940957|FG003|Full Analysis Set|Initiation||0
8883635|NCT01961609|9940954|FG000|COMPLETED|Initiation||107
8883636|NCT01961609|9940955|FG001|COMPLETED|Initiation||103
8883637|NCT01961609|9940956|FG002|COMPLETED|Initiation||0
8883638|NCT01961609|9940957|FG003|COMPLETED|Initiation||0
8883639|NCT01961609|9940954|FG000|NOT COMPLETED|Initiation||12
8883640|NCT01961609|9940955|FG001|NOT COMPLETED|Initiation||13
8883641|NCT01961609|9940956|FG002|NOT COMPLETED|Initiation||0
8883642|NCT01961609|9940957|FG003|NOT COMPLETED|Initiation||0
8883643|NCT01961609|9940954|FG000|STARTED|Maintenance 1 (Weeks 17 - 48)||107
8883644|NCT01961609|9940955|FG001|STARTED|Maintenance 1 (Weeks 17 - 48)||66
8883645|NCT01961609|9940956|FG002|STARTED|Maintenance 1 (Weeks 17 - 48)||37
8883646|NCT01961609|9940957|FG003|STARTED|Maintenance 1 (Weeks 17 - 48)||0
8883647|NCT01961609|9940954|FG000|Full Analysis Set|Maintenance 1 (Weeks 17 - 48)||107
8883648|NCT01961609|9940955|FG001|Full Analysis Set|Maintenance 1 (Weeks 17 - 48)||66
8883649|NCT01961609|9940956|FG002|Full Analysis Set|Maintenance 1 (Weeks 17 - 48)||37
8883650|NCT01961609|9940957|FG003|Full Analysis Set|Maintenance 1 (Weeks 17 - 48)||0
8883651|NCT01961609|9940954|FG000|Safety Set|Maintenance 1 (Weeks 17 - 48)||107
8883652|NCT01961609|9940955|FG001|Safety Set|Maintenance 1 (Weeks 17 - 48)||66
8883653|NCT01961609|9940956|FG002|Safety Set|Maintenance 1 (Weeks 17 - 48)||37
8883654|NCT01961609|9940957|FG003|Safety Set|Maintenance 1 (Weeks 17 - 48)||0
8883655|NCT01961609|9940954|FG000|COMPLETED|Maintenance 1 (Weeks 17 - 48)||84
8883656|NCT01961609|9940955|FG001|COMPLETED|Maintenance 1 (Weeks 17 - 48)||55
8883657|NCT01961609|9940956|FG002|COMPLETED|Maintenance 1 (Weeks 17 - 48)||18
8883658|NCT01961609|9940957|FG003|COMPLETED|Maintenance 1 (Weeks 17 - 48)||0
8883659|NCT01961609|9940954|FG000|NOT COMPLETED|Maintenance 1 (Weeks 17 - 48)||23
8883660|NCT01961609|9940955|FG001|NOT COMPLETED|Maintenance 1 (Weeks 17 - 48)||11
8883661|NCT01961609|9940956|FG002|NOT COMPLETED|Maintenance 1 (Weeks 17 - 48)||19
8883662|NCT01961609|9940957|FG003|NOT COMPLETED|Maintenance 1 (Weeks 17 - 48)||0
9003197|NCT02918266|10066347|FG003|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
9003198|NCT02918266|10066348|FG004|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
9003199|NCT02918266|10066349|FG005|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
9003200|NCT02918266|10066350|FG006|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
9003201|NCT02918266|10066351|FG007|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
9003202|NCT02918266|10066352|FG008|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
9003203|NCT02918266|10066353|FG009|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
9003204|NCT02918266|10066354|FG010|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
8883663|NCT01961609|9940954|FG000|STARTED|Maintanence 2 (Weeks 49 - 72)||83
8883664|NCT01961609|9940955|FG001|STARTED|Maintanence 2 (Weeks 49 - 72)||31
8883665|NCT01961609|9940956|FG002|STARTED|Maintanence 2 (Weeks 49 - 72)||16
8883666|NCT01961609|9940957|FG003|STARTED|Maintanence 2 (Weeks 49 - 72)||24
8883667|NCT01961609|9940954|FG000|Safety Set|Maintanence 2 (Weeks 49 - 72)||83
8883668|NCT01961609|9940955|FG001|Safety Set|Maintanence 2 (Weeks 49 - 72)||31
8883669|NCT01961609|9940956|FG002|Safety Set|Maintanence 2 (Weeks 49 - 72)||16
8883670|NCT01961609|9940957|FG003|Safety Set|Maintanence 2 (Weeks 49 - 72)||24
8883671|NCT01961609|9940954|FG000|Full Analysis Set|Maintanence 2 (Weeks 49 - 72)||83
8883672|NCT01961609|9940955|FG001|Full Analysis Set|Maintanence 2 (Weeks 49 - 72)||31
8883673|NCT01961609|9940956|FG002|Full Analysis Set|Maintanence 2 (Weeks 49 - 72)||16
8883674|NCT01961609|9940957|FG003|Full Analysis Set|Maintanence 2 (Weeks 49 - 72)||24
8883675|NCT01961609|9940954|FG000|COMPLETED|Maintanence 2 (Weeks 49 - 72)||71
8883676|NCT01961609|9940955|FG001|COMPLETED|Maintanence 2 (Weeks 49 - 72)||25
8883677|NCT01961609|9940956|FG002|COMPLETED|Maintanence 2 (Weeks 49 - 72)||12
8883678|NCT01961609|9940957|FG003|COMPLETED|Maintanence 2 (Weeks 49 - 72)||17
8883679|NCT01961609|9940954|FG000|NOT COMPLETED|Maintanence 2 (Weeks 49 - 72)||12
8883680|NCT01961609|9940955|FG001|NOT COMPLETED|Maintanence 2 (Weeks 49 - 72)||6
8883681|NCT01961609|9940956|FG002|NOT COMPLETED|Maintanence 2 (Weeks 49 - 72)||4
8883682|NCT01961609|9940957|FG003|NOT COMPLETED|Maintanence 2 (Weeks 49 - 72)||7
8883683|NCT01961687|9940974|FG000|STARTED|Overall Study||121
8883684|NCT01961687|9940974|FG000|COMPLETED|Overall Study||60
8883685|NCT01961687|9940974|FG000|NOT COMPLETED|Overall Study||61
8883686|NCT01961882|9940980|FG000|STARTED|Overall Study||69
8883687|NCT01961882|9940981|FG001|STARTED|Overall Study||65
8883688|NCT01961882|9940980|FG000|COMPLETED|Overall Study||19
8883689|NCT01961882|9940981|FG001|COMPLETED|Overall Study||23
8883690|NCT01961882|9940980|FG000|NOT COMPLETED|Overall Study||50
8883691|NCT01961882|9940981|FG001|NOT COMPLETED|Overall Study||42
8883692|NCT01961921|9940987|FG000|STARTED|Overall Study||27
8883693|NCT01961921|9940987|FG000|COMPLETED|Overall Study||25
9003205|NCT02918266|10066344|FG000|STARTED|Part 2: Intervention Period 4 (2 Days)||0
9003206|NCT02918266|10066345|FG001|STARTED|Part 2: Intervention Period 4 (2 Days)||0
9003207|NCT02918266|10066346|FG002|STARTED|Part 2: Intervention Period 4 (2 Days)||0
9003208|NCT02918266|10066347|FG003|STARTED|Part 2: Intervention Period 4 (2 Days)||0
9003209|NCT02918266|10066348|FG004|STARTED|Part 2: Intervention Period 4 (2 Days)||0
9003210|NCT02918266|10066349|FG005|STARTED|Part 2: Intervention Period 4 (2 Days)||0
9003211|NCT02918266|10066350|FG006|STARTED|Part 2: Intervention Period 4 (2 Days)||0
9003212|NCT02918266|10066351|FG007|STARTED|Part 2: Intervention Period 4 (2 Days)||0
9003213|NCT02918266|10066352|FG008|STARTED|Part 2: Intervention Period 4 (2 Days)||0
9003214|NCT02918266|10066353|FG009|STARTED|Part 2: Intervention Period 4 (2 Days)||0
9003215|NCT02918266|10066354|FG010|STARTED|Part 2: Intervention Period 4 (2 Days)||0
9003216|NCT02918266|10066344|FG000|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
9003217|NCT02918266|10066345|FG001|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
9003218|NCT02918266|10066346|FG002|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
9003219|NCT02918266|10066347|FG003|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
9003220|NCT02918266|10066348|FG004|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
9003221|NCT02918266|10066349|FG005|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
9003222|NCT02918266|10066350|FG006|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
9003223|NCT02918266|10066351|FG007|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
9003224|NCT02918266|10066352|FG008|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
9003225|NCT02918266|10066353|FG009|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
9003226|NCT02918266|10066354|FG010|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
9003227|NCT02918266|10066344|FG000|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
9003228|NCT02918266|10066345|FG001|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
9003229|NCT02918266|10066346|FG002|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
9003230|NCT02918266|10066347|FG003|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
9003231|NCT02918266|10066348|FG004|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
9003232|NCT02918266|10066349|FG005|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
9003233|NCT02918266|10066350|FG006|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
9003234|NCT02918266|10066351|FG007|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
9003235|NCT02918266|10066352|FG008|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
9003236|NCT02918266|10066353|FG009|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
9003237|NCT02918266|10066354|FG010|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
9003238|NCT02918266|10066344|FG000|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
9003239|NCT02918266|10066345|FG001|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
9003240|NCT02918266|10066346|FG002|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
9003241|NCT02918266|10066347|FG003|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
9003242|NCT02918266|10066348|FG004|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
9003243|NCT02918266|10066349|FG005|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
9003244|NCT02918266|10066350|FG006|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
9003245|NCT02918266|10066351|FG007|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
9003246|NCT02918266|10066352|FG008|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
9003247|NCT02918266|10066353|FG009|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
9003248|NCT02918266|10066354|FG010|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
9003249|NCT02918266|10066344|FG000|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
9003250|NCT02918266|10066345|FG001|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
9003251|NCT02918266|10066346|FG002|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
9003252|NCT02918266|10066347|FG003|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
9003253|NCT02918266|10066348|FG004|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
9039459|NCT03338998|10100432|FG000|COMPLETED|Treatment Period||8
8883694|NCT01961921|9940987|FG000|NOT COMPLETED|Overall Study||2
8883695|NCT01962025|9940993|FG000|STARTED|Overall Study||8
8883696|NCT01962025|9940994|FG001|STARTED|Overall Study||6
8883697|NCT01962025|9940993|FG000|COMPLETED|Overall Study||8
8883698|NCT01962025|9940994|FG001|COMPLETED|Overall Study||6
8883699|NCT01962025|9940993|FG000|NOT COMPLETED|Overall Study||0
8883700|NCT01962025|9940994|FG001|NOT COMPLETED|Overall Study||0
8883701|NCT01962103|9941011|FG000|STARTED|Phase 1||16
8883702|NCT01962103|9941012|FG001|STARTED|Phase 1||8
8883703|NCT01962103|9941013|FG002|STARTED|Phase 1||14
8883704|NCT01962103|9941014|FG003|STARTED|Phase 1||11
8883705|NCT01962103|9941015|FG004|STARTED|Phase 1||8
8883706|NCT01962103|9941016|FG005|STARTED|Phase 1||7
8883707|NCT01962103|9941017|FG006|STARTED|Phase 1||0
8883708|NCT01962103|9941018|FG007|STARTED|Phase 1||0
8883709|NCT01962103|9941019|FG008|STARTED|Phase 1||0
8883710|NCT01962103|9941011|FG000|COMPLETED|Phase 1||0
8883711|NCT01962103|9941012|FG001|COMPLETED|Phase 1||0
8883712|NCT01962103|9941013|FG002|COMPLETED|Phase 1||0
8883713|NCT01962103|9941014|FG003|COMPLETED|Phase 1||0
8883714|NCT01962103|9941015|FG004|COMPLETED|Phase 1||0
8883715|NCT01962103|9941016|FG005|COMPLETED|Phase 1||0
8883716|NCT01962103|9941017|FG006|COMPLETED|Phase 1||0
8883717|NCT01962103|9941018|FG007|COMPLETED|Phase 1||0
8883718|NCT01962103|9941019|FG008|COMPLETED|Phase 1||0
8883719|NCT01962103|9941011|FG000|NOT COMPLETED|Phase 1||16
8883720|NCT01962103|9941012|FG001|NOT COMPLETED|Phase 1||8
8883721|NCT01962103|9941013|FG002|NOT COMPLETED|Phase 1||14
8883722|NCT01962103|9941014|FG003|NOT COMPLETED|Phase 1||11
8883723|NCT01962103|9941015|FG004|NOT COMPLETED|Phase 1||8
8883724|NCT01962103|9941016|FG005|NOT COMPLETED|Phase 1||7
8883725|NCT01962103|9941017|FG006|NOT COMPLETED|Phase 1||0
8883726|NCT01962103|9941018|FG007|NOT COMPLETED|Phase 1||0
8883727|NCT01962103|9941019|FG008|NOT COMPLETED|Phase 1||0
8883728|NCT01962103|9941011|FG000|STARTED|Phase 2||0
8883729|NCT01962103|9941012|FG001|STARTED|Phase 2||0
8883730|NCT01962103|9941013|FG002|STARTED|Phase 2||0
8883731|NCT01962103|9941014|FG003|STARTED|Phase 2||0
8883732|NCT01962103|9941015|FG004|STARTED|Phase 2||0
8883733|NCT01962103|9941016|FG005|STARTED|Phase 2||0
8883734|NCT01962103|9941017|FG006|STARTED|Phase 2||14
8883735|NCT01962103|9941018|FG007|STARTED|Phase 2||14
8883736|NCT01962103|9941019|FG008|STARTED|Phase 2||14
8883737|NCT01962103|9941011|FG000|COMPLETED|Phase 2||0
8883738|NCT01962103|9941012|FG001|COMPLETED|Phase 2||0
8883739|NCT01962103|9941013|FG002|COMPLETED|Phase 2||0
8883740|NCT01962103|9941014|FG003|COMPLETED|Phase 2||0
8883741|NCT01962103|9941015|FG004|COMPLETED|Phase 2||0
8883742|NCT01962103|9941016|FG005|COMPLETED|Phase 2||0
8883743|NCT01962103|9941017|FG006|COMPLETED|Phase 2|completed treatment|0
8883744|NCT01962103|9941018|FG007|COMPLETED|Phase 2|completed treatment|0
8883745|NCT01962103|9941019|FG008|COMPLETED|Phase 2|completed treatment|0
9003254|NCT02918266|10066349|FG005|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
9003255|NCT02918266|10066350|FG006|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
9003256|NCT02918266|10066351|FG007|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
9003257|NCT02918266|10066352|FG008|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
9003258|NCT02918266|10066353|FG009|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
9003259|NCT02918266|10066354|FG010|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
9003260|NCT02918266|10066344|FG000|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
9003261|NCT02918266|10066345|FG001|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
9003262|NCT02918266|10066346|FG002|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
9003263|NCT02918266|10066347|FG003|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
9003264|NCT02918266|10066348|FG004|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
9003265|NCT02918266|10066349|FG005|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
9003266|NCT02918266|10066350|FG006|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
9003267|NCT02918266|10066351|FG007|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
9003268|NCT02918266|10066352|FG008|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
9003269|NCT02918266|10066353|FG009|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
9003270|NCT02918266|10066354|FG010|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
9003271|NCT02918266|10066344|FG000|STARTED|Part 2: Intervention Period 5 (2 Days)||0
9003272|NCT02918266|10066345|FG001|STARTED|Part 2: Intervention Period 5 (2 Days)||0
9003273|NCT02918266|10066346|FG002|STARTED|Part 2: Intervention Period 5 (2 Days)||0
9003274|NCT02918266|10066347|FG003|STARTED|Part 2: Intervention Period 5 (2 Days)||0
9003275|NCT02918266|10066348|FG004|STARTED|Part 2: Intervention Period 5 (2 Days)||0
9003276|NCT02918266|10066349|FG005|STARTED|Part 2: Intervention Period 5 (2 Days)||0
9003277|NCT02918266|10066350|FG006|STARTED|Part 2: Intervention Period 5 (2 Days)||0
9003278|NCT02918266|10066351|FG007|STARTED|Part 2: Intervention Period 5 (2 Days)||0
9003279|NCT02918266|10066352|FG008|STARTED|Part 2: Intervention Period 5 (2 Days)||0
9003280|NCT02918266|10066353|FG009|STARTED|Part 2: Intervention Period 5 (2 Days)||0
9003281|NCT02918266|10066354|FG010|STARTED|Part 2: Intervention Period 5 (2 Days)||0
9003282|NCT02918266|10066344|FG000|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
9003283|NCT02918266|10066345|FG001|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
8572624|NCT00116168|9604820|FG003|NOT COMPLETED|Overall Study||0
9003284|NCT02918266|10066346|FG002|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
9039460|NCT03338998|10100433|FG001|COMPLETED|Treatment Period||10
8883746|NCT01962103|9941011|FG000|NOT COMPLETED|Phase 2||0
8883747|NCT01962103|9941012|FG001|NOT COMPLETED|Phase 2||0
8883748|NCT01962103|9941013|FG002|NOT COMPLETED|Phase 2||0
8883749|NCT01962103|9941014|FG003|NOT COMPLETED|Phase 2||0
8883750|NCT01962103|9941015|FG004|NOT COMPLETED|Phase 2||0
8883751|NCT01962103|9941016|FG005|NOT COMPLETED|Phase 2||0
8883752|NCT01962103|9941017|FG006|NOT COMPLETED|Phase 2||14
8883753|NCT01962103|9941018|FG007|NOT COMPLETED|Phase 2||14
8883754|NCT01962103|9941019|FG008|NOT COMPLETED|Phase 2||14
8883755|NCT01962207|9941043|FG000|STARTED|Persistence Phase (5 Years)||76
8883756|NCT01962207|9941044|FG001|STARTED|Persistence Phase (5 Years)||23
8883757|NCT01962207|9941045|FG002|STARTED|Persistence Phase (5 Years)||115
8883758|NCT01962207|9941046|FG003|STARTED|Persistence Phase (5 Years)||29
8883759|NCT01962207|9941043|FG000|COMPLETED|Persistence Phase (5 Years)||47
8883760|NCT01962207|9941044|FG001|COMPLETED|Persistence Phase (5 Years)||10
8883761|NCT01962207|9941045|FG002|COMPLETED|Persistence Phase (5 Years)||71
8883762|NCT01962207|9941046|FG003|COMPLETED|Persistence Phase (5 Years)||17
8883763|NCT01962207|9941043|FG000|NOT COMPLETED|Persistence Phase (5 Years)||29
8883764|NCT01962207|9941044|FG001|NOT COMPLETED|Persistence Phase (5 Years)||13
8883765|NCT01962207|9941045|FG002|NOT COMPLETED|Persistence Phase (5 Years)||44
8883766|NCT01962207|9941046|FG003|NOT COMPLETED|Persistence Phase (5 Years)||12
8883767|NCT01962207|9941043|FG000|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent to get enrolled in booster phase.|67
8883768|NCT01962207|9941044|FG001|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent to get enrolled in booster phase.|16
8883769|NCT01962207|9941045|FG002|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent to get enrolled in booster phase.|77
8883770|NCT01962207|9941046|FG003|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent to get enrolled in booster phase.|21
8883771|NCT01962207|9941043|FG000|COMPLETED|Booster Phase (6 Months)||67
8883772|NCT01962207|9941044|FG001|COMPLETED|Booster Phase (6 Months)||16
8883773|NCT01962207|9941045|FG002|COMPLETED|Booster Phase (6 Months)||77
8883774|NCT01962207|9941046|FG003|COMPLETED|Booster Phase (6 Months)||21
8883775|NCT01962207|9941043|FG000|NOT COMPLETED|Booster Phase (6 Months)||0
8883776|NCT01962207|9941044|FG001|NOT COMPLETED|Booster Phase (6 Months)||0
8883777|NCT01962207|9941045|FG002|NOT COMPLETED|Booster Phase (6 Months)||0
8883778|NCT01962207|9941046|FG003|NOT COMPLETED|Booster Phase (6 Months)||0
8883779|NCT01962298|9941065|FG000|STARTED|Overall Study||15
8883780|NCT01962298|9941066|FG001|STARTED|Overall Study||15
8883781|NCT01962298|9941067|FG002|STARTED|Overall Study||15
9003285|NCT02918266|10066347|FG003|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
9003286|NCT02918266|10066348|FG004|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
9003287|NCT02918266|10066349|FG005|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
9003288|NCT02918266|10066350|FG006|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
9003289|NCT02918266|10066351|FG007|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
9003290|NCT02918266|10066352|FG008|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
9003291|NCT02918266|10066353|FG009|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
9003292|NCT02918266|10066354|FG010|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
9003293|NCT02918266|10066344|FG000|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
9003294|NCT02918266|10066345|FG001|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
9003295|NCT02918266|10066346|FG002|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
9003296|NCT02918266|10066347|FG003|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
9003297|NCT02918266|10066348|FG004|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
9003298|NCT02918266|10066349|FG005|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
9003299|NCT02918266|10066350|FG006|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
9003300|NCT02918266|10066351|FG007|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
9003301|NCT02918266|10066352|FG008|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
9003302|NCT02918266|10066353|FG009|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
9003303|NCT02918266|10066354|FG010|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
9003304|NCT02918279|10066376|FG000|STARTED|Overall Study||125
9003305|NCT02918279|10066377|FG001|STARTED|Overall Study||126
9003306|NCT02918279|10066376|FG000|Full Analysis Set|Overall Study||125
9003307|NCT02918279|10066377|FG001|Full Analysis Set|Overall Study||126
9003308|NCT02918279|10066376|FG000|Safety Analysis Set|Overall Study||125
9003309|NCT02918279|10066377|FG001|Safety Analysis Set|Overall Study||126
9003310|NCT02918279|10066376|FG000|COMPLETED|Overall Study||112
9003311|NCT02918279|10066377|FG001|COMPLETED|Overall Study||103
9003312|NCT02918279|10066376|FG000|NOT COMPLETED|Overall Study||13
9003313|NCT02918279|10066377|FG001|NOT COMPLETED|Overall Study||23
9003314|NCT02918318|10066387|FG000|STARTED|Double-blind Induction Phase: 4 Weeks||41
9003315|NCT02918318|10066388|FG001|STARTED|Double-blind Induction Phase: 4 Weeks||40
9003316|NCT02918318|10066389|FG002|STARTED|Double-blind Induction Phase: 4 Weeks||41
9003317|NCT02918318|10066390|FG003|STARTED|Double-blind Induction Phase: 4 Weeks||80
9003318|NCT02918318|10066391|FG004|STARTED|Double-blind Induction Phase: 4 Weeks||0
9003319|NCT02918318|10066387|FG000|Responders|Double-blind Induction Phase: 4 Weeks||13
9003320|NCT02918318|10066388|FG001|Responders|Double-blind Induction Phase: 4 Weeks||11
9003321|NCT02918318|10066389|FG002|Responders|Double-blind Induction Phase: 4 Weeks||17
9003322|NCT02918318|10066390|FG003|Responders|Double-blind Induction Phase: 4 Weeks||27
9003323|NCT02918318|10066391|FG004|Responders|Double-blind Induction Phase: 4 Weeks||0
9003324|NCT02918318|10066387|FG000|COMPLETED|Double-blind Induction Phase: 4 Weeks||39
9003325|NCT02918318|10066388|FG001|COMPLETED|Double-blind Induction Phase: 4 Weeks||33
9003326|NCT02918318|10066389|FG002|COMPLETED|Double-blind Induction Phase: 4 Weeks||39
9003327|NCT02918318|10066390|FG003|COMPLETED|Double-blind Induction Phase: 4 Weeks||72
9003328|NCT02918318|10066391|FG004|COMPLETED|Double-blind Induction Phase: 4 Weeks||0
8634326|NCT00555997|9674621|FG000|COMPLETED|Phase 2 SPCD||0
8634327|NCT00555997|9674622|FG001|COMPLETED|Phase 2 SPCD||0
8634328|NCT00555997|9674623|FG002|COMPLETED|Phase 2 SPCD||31
8634329|NCT00555997|9674624|FG003|COMPLETED|Phase 2 SPCD||22
8634330|NCT00555997|9674621|FG000|NOT COMPLETED|Phase 2 SPCD||0
8634331|NCT00555997|9674622|FG001|NOT COMPLETED|Phase 2 SPCD||0
8634332|NCT00555997|9674623|FG002|NOT COMPLETED|Phase 2 SPCD||7
8634333|NCT00555997|9674624|FG003|NOT COMPLETED|Phase 2 SPCD||3
8634334|NCT00556049|9674636|FG000|STARTED|Overall Study||72
8634335|NCT00556049|9674636|FG000|COMPLETED|Overall Study||72
8883782|NCT01962298|9941068|FG003|STARTED|Overall Study||15
8883783|NCT01962298|9941069|FG004|STARTED|Overall Study||15
8883784|NCT01962298|9941065|FG000|Received Intervention|Overall Study|1 subject did not receive the planned intervention and received a different one for clinical reasons|14
8883785|NCT01962298|9941066|FG001|Received Intervention|Overall Study||15
8883786|NCT01962298|9941067|FG002|Received Intervention|Overall Study||15
8883787|NCT01962298|9941068|FG003|Received Intervention|Overall Study||15
8883788|NCT01962298|9941069|FG004|Received Intervention|Overall Study||15
8883789|NCT01962298|9941065|FG000|COMPLETED|Overall Study||12
8883790|NCT01962298|9941066|FG001|COMPLETED|Overall Study||11
8883791|NCT01962298|9941067|FG002|COMPLETED|Overall Study||10
8883792|NCT01962298|9941068|FG003|COMPLETED|Overall Study||13
8883793|NCT01962298|9941069|FG004|COMPLETED|Overall Study||9
8883794|NCT01962298|9941065|FG000|NOT COMPLETED|Overall Study||3
8634336|NCT00556049|9674636|FG000|NOT COMPLETED|Overall Study||0
8634337|NCT00556140|9674640|FG000|STARTED|Overall Study||16
8883795|NCT01962298|9941066|FG001|NOT COMPLETED|Overall Study||4
8883796|NCT01962298|9941067|FG002|NOT COMPLETED|Overall Study||5
8883797|NCT01962298|9941068|FG003|NOT COMPLETED|Overall Study||2
8883798|NCT01962298|9941069|FG004|NOT COMPLETED|Overall Study||6
8883799|NCT01962428|9941083|FG000|STARTED|Overall Study||139
8883800|NCT01962428|9941084|FG001|STARTED|Overall Study||139
8883801|NCT01962428|9941083|FG000|COMPLETED|Overall Study||129
8883802|NCT01962428|9941084|FG001|COMPLETED|Overall Study||133
8883803|NCT01962428|9941083|FG000|NOT COMPLETED|Overall Study||10
8883804|NCT01962428|9941084|FG001|NOT COMPLETED|Overall Study||6
8883805|NCT01962441|9941093|FG000|STARTED|Randomized Period||200
8883806|NCT01962441|9941094|FG001|STARTED|Randomized Period||201
8883807|NCT01962441|9941095|FG002|STARTED|Randomized Period||200
8883808|NCT01962441|9941093|FG000|COMPLETED|Randomized Period||190
8883809|NCT01962441|9941094|FG001|COMPLETED|Randomized Period||190
8883810|NCT01962441|9941095|FG002|COMPLETED|Randomized Period||189
8883811|NCT01962441|9941093|FG000|NOT COMPLETED|Randomized Period||10
8883812|NCT01962441|9941094|FG001|NOT COMPLETED|Randomized Period||11
8883813|NCT01962441|9941095|FG002|NOT COMPLETED|Randomized Period||11
8883814|NCT01962441|9941093|FG000|STARTED|Retreatment Substudy|20 participants who experienced virologic failure enrolled into the Retreatment Substudy.|20
8883815|NCT01962441|9941094|FG001|STARTED|Retreatment Substudy|10 participants who experienced virologic failure enrolled into the Retreatment Substudy.|10
8883816|NCT01962441|9941095|FG002|STARTED|Retreatment Substudy|Participants in the SOF+RBV+Peg-IFN group were not eligible to enroll in the Retreatment Substudy.|0
8883817|NCT01962441|9941093|FG000|COMPLETED|Retreatment Substudy||18
8883818|NCT01962441|9941094|FG001|COMPLETED|Retreatment Substudy||10
8883819|NCT01962441|9941095|FG002|COMPLETED|Retreatment Substudy||0
8883820|NCT01962441|9941093|FG000|NOT COMPLETED|Retreatment Substudy||2
8883821|NCT01962441|9941094|FG001|NOT COMPLETED|Retreatment Substudy||0
8883822|NCT01962441|9941095|FG002|NOT COMPLETED|Retreatment Substudy||0
8883823|NCT01962493|9941106|FG000|STARTED|Overall Study||78
8883824|NCT01962493|9941107|FG001|STARTED|Overall Study||82
8883825|NCT01962493|9941106|FG000|COMPLETED|Overall Study||73
8883826|NCT01962493|9941107|FG001|COMPLETED|Overall Study||77
8883827|NCT01962493|9941106|FG000|NOT COMPLETED|Overall Study||5
8883828|NCT01962493|9941107|FG001|NOT COMPLETED|Overall Study||5
8883829|NCT01962558|9941115|FG000|STARTED|Overall Study||16
8883830|NCT01962558|9941116|FG001|STARTED|Overall Study||14
8883831|NCT01962558|9941115|FG000|Acute Study|Overall Study||16
8883832|NCT01962558|9941116|FG001|Acute Study|Overall Study||14
8883833|NCT01962558|9941115|FG000|12-Weeks|Overall Study||16
9003329|NCT02918318|10066387|FG000|NOT COMPLETED|Double-blind Induction Phase: 4 Weeks||2
9003330|NCT02918318|10066388|FG001|NOT COMPLETED|Double-blind Induction Phase: 4 Weeks||7
9003331|NCT02918318|10066389|FG002|NOT COMPLETED|Double-blind Induction Phase: 4 Weeks||2
9003332|NCT02918318|10066390|FG003|NOT COMPLETED|Double-blind Induction Phase: 4 Weeks||8
9003333|NCT02918318|10066391|FG004|NOT COMPLETED|Double-blind Induction Phase: 4 Weeks||0
9003334|NCT02918318|10066387|FG000|STARTED|Double-blind Follow-up Phase: 4 Weeks||27
9003335|NCT02918318|10066388|FG001|STARTED|Double-blind Follow-up Phase: 4 Weeks||28
9003336|NCT02918318|10066389|FG002|STARTED|Double-blind Follow-up Phase: 4 Weeks||24
9003337|NCT02918318|10066390|FG003|STARTED|Double-blind Follow-up Phase: 4 Weeks||53
9003338|NCT02918318|10066391|FG004|STARTED|Double-blind Follow-up Phase: 4 Weeks||0
9003339|NCT02918318|10066387|FG000|COMPLETED|Double-blind Follow-up Phase: 4 Weeks||26
9003340|NCT02918318|10066388|FG001|COMPLETED|Double-blind Follow-up Phase: 4 Weeks||28
9003341|NCT02918318|10066389|FG002|COMPLETED|Double-blind Follow-up Phase: 4 Weeks||23
9003342|NCT02918318|10066390|FG003|COMPLETED|Double-blind Follow-up Phase: 4 Weeks||50
9003343|NCT02918318|10066391|FG004|COMPLETED|Double-blind Follow-up Phase: 4 Weeks||0
9003344|NCT02918318|10066387|FG000|NOT COMPLETED|Double-blind Follow-up Phase: 4 Weeks||1
9003345|NCT02918318|10066388|FG001|NOT COMPLETED|Double-blind Follow-up Phase: 4 Weeks||0
9003346|NCT02918318|10066389|FG002|NOT COMPLETED|Double-blind Follow-up Phase: 4 Weeks||1
9003347|NCT02918318|10066390|FG003|NOT COMPLETED|Double-blind Follow-up Phase: 4 Weeks||3
9003348|NCT02918318|10066391|FG004|NOT COMPLETED|Double-blind Follow-up Phase: 4 Weeks||0
9003349|NCT02918318|10066387|FG000|STARTED|Posttreatment Phase: Up to 24 Weeks||13
8634338|NCT00556140|9674640|FG000|COMPLETED|Overall Study||13
8883834|NCT01962558|9941116|FG001|12-Weeks|Overall Study||14
8883835|NCT01962558|9941115|FG000|COMPLETED|Overall Study||16
8883836|NCT01962558|9941116|FG001|COMPLETED|Overall Study||14
8883837|NCT01962558|9941115|FG000|NOT COMPLETED|Overall Study||0
8634339|NCT00556140|9674640|FG000|NOT COMPLETED|Overall Study||3
8883838|NCT01962558|9941116|FG001|NOT COMPLETED|Overall Study||0
8883839|NCT01962688|9941124|FG000|STARTED|Overall Study||19
8883840|NCT01962688|9941125|FG001|STARTED|Overall Study||18
8883841|NCT01962688|9941124|FG000|COMPLETED|Overall Study||19
8883842|NCT01962688|9941125|FG001|COMPLETED|Overall Study||18
8883843|NCT01962688|9941124|FG000|NOT COMPLETED|Overall Study||0
8883844|NCT01962688|9941125|FG001|NOT COMPLETED|Overall Study||0
8883845|NCT01962714|9941133|FG000|STARTED|Overall Study||91
8883846|NCT01962714|9941134|FG001|STARTED|Overall Study||93
8883847|NCT01962714|9941133|FG000|Immediate Post-treatment Assessment|Overall Study||63
8883848|NCT01962714|9941134|FG001|Immediate Post-treatment Assessment|Overall Study||57
8883849|NCT01962714|9941133|FG000|3-month Follow-up|Overall Study||58
8883850|NCT01962714|9941134|FG001|3-month Follow-up|Overall Study||56
8883851|NCT01962714|9941133|FG000|COMPLETED|Overall Study||61
8883852|NCT01962714|9941134|FG001|COMPLETED|Overall Study||60
8883853|NCT01962714|9941133|FG000|NOT COMPLETED|Overall Study||30
8883854|NCT01962714|9941134|FG001|NOT COMPLETED|Overall Study||33
8883855|NCT01962870|9941142|FG000|STARTED|Overall Study||13
8883856|NCT01962870|9941143|FG001|STARTED|Overall Study||17
8883857|NCT01962870|9941142|FG000|COMPLETED|Overall Study||13
8883858|NCT01962870|9941143|FG001|COMPLETED|Overall Study||17
8883859|NCT01962870|9941142|FG000|NOT COMPLETED|Overall Study||0
8883860|NCT01962870|9941143|FG001|NOT COMPLETED|Overall Study||0
8883861|NCT01962896|9941149|FG000|STARTED|Overall Study||4
8883862|NCT01962896|9941149|FG000|COMPLETED|Overall Study||0
8883863|NCT01962896|9941149|FG000|NOT COMPLETED|Overall Study||4
8883864|NCT01962922|9941156|FG000|STARTED|PK Portion Day 7||27
8883865|NCT01962922|9941157|FG001|STARTED|PK Portion Day 7||23
8883866|NCT01962922|9941156|FG000|COMPLETED|PK Portion Day 7||23
8883867|NCT01962922|9941157|FG001|COMPLETED|PK Portion Day 7||23
8883868|NCT01962922|9941156|FG000|NOT COMPLETED|PK Portion Day 7||4
8883869|NCT01962922|9941157|FG001|NOT COMPLETED|PK Portion Day 7||0
8883870|NCT01962922|9941156|FG000|STARTED|PK Portion Day 14||23
8883871|NCT01962922|9941157|FG001|STARTED|PK Portion Day 14||23
8883872|NCT01962922|9941156|FG000|COMPLETED|PK Portion Day 14||23
8883873|NCT01962922|9941157|FG001|COMPLETED|PK Portion Day 14||23
8883874|NCT01962922|9941156|FG000|NOT COMPLETED|PK Portion Day 14||0
8883875|NCT01962922|9941157|FG001|NOT COMPLETED|PK Portion Day 14||0
8883876|NCT01962922|9941156|FG000|STARTED|PK Portion Day 21||23
8883877|NCT01962922|9941157|FG001|STARTED|PK Portion Day 21||23
8883878|NCT01962922|9941156|FG000|COMPLETED|PK Portion Day 21||23
8883879|NCT01962922|9941157|FG001|COMPLETED|PK Portion Day 21||23
8883880|NCT01962922|9941156|FG000|NOT COMPLETED|PK Portion Day 21||0
8883881|NCT01962922|9941157|FG001|NOT COMPLETED|PK Portion Day 21||0
8883882|NCT01962922|9941156|FG000|STARTED|Extendion Portion (up to Month 6)||23
8883883|NCT01962922|9941157|FG001|STARTED|Extendion Portion (up to Month 6)||23
8883884|NCT01962922|9941156|FG000|COMPLETED|Extendion Portion (up to Month 6)||18
8883885|NCT01962922|9941157|FG001|COMPLETED|Extendion Portion (up to Month 6)||20
8883886|NCT01962922|9941156|FG000|NOT COMPLETED|Extendion Portion (up to Month 6)||5
8883887|NCT01962922|9941157|FG001|NOT COMPLETED|Extendion Portion (up to Month 6)||3
8883888|NCT01962961|9941166|FG000|STARTED|Overall Study||9
8883889|NCT01962961|9941167|FG001|STARTED|Overall Study||8
8883890|NCT01962961|9941168|FG002|STARTED|Overall Study||7
8883891|NCT01962961|9941166|FG000|COMPLETED|Overall Study||9
8883892|NCT01962961|9941167|FG001|COMPLETED|Overall Study||7
8883893|NCT01962961|9941168|FG002|COMPLETED|Overall Study||6
8883894|NCT01962961|9941166|FG000|NOT COMPLETED|Overall Study||0
8883895|NCT01962961|9941167|FG001|NOT COMPLETED|Overall Study||1
8883896|NCT01962961|9941168|FG002|NOT COMPLETED|Overall Study||1
8883897|NCT01962987|9941179|FG000|STARTED|Overall Study||190
8883898|NCT01962987|9941180|FG001|STARTED|Overall Study||191
8883899|NCT01962987|9941181|FG002|STARTED|Overall Study||95
8883900|NCT01962987|9941179|FG000|COMPLETED|Overall Study||160
8883901|NCT01962987|9941180|FG001|COMPLETED|Overall Study||163
8883902|NCT01962987|9941181|FG002|COMPLETED|Overall Study||83
8883903|NCT01962987|9941179|FG000|NOT COMPLETED|Overall Study||30
8883904|NCT01962987|9941180|FG001|NOT COMPLETED|Overall Study||28
8883905|NCT01962987|9941181|FG002|NOT COMPLETED|Overall Study||12
8883906|NCT01963078|9941193|FG000|STARTED|Overall Study||9
8883907|NCT01963078|9941194|FG001|STARTED|Overall Study||10
8883908|NCT01963078|9941195|FG002|STARTED|Overall Study||10
9003350|NCT02918318|10066388|FG001|STARTED|Posttreatment Phase: Up to 24 Weeks||11
9003351|NCT02918318|10066389|FG002|STARTED|Posttreatment Phase: Up to 24 Weeks||17
9003352|NCT02918318|10066390|FG003|STARTED|Posttreatment Phase: Up to 24 Weeks||27
9003353|NCT02918318|10066391|FG004|STARTED|Posttreatment Phase: Up to 24 Weeks||0
9003354|NCT02918318|10066387|FG000|COMPLETED|Posttreatment Phase: Up to 24 Weeks||12
9003355|NCT02918318|10066388|FG001|COMPLETED|Posttreatment Phase: Up to 24 Weeks||8
9003356|NCT02918318|10066389|FG002|COMPLETED|Posttreatment Phase: Up to 24 Weeks||16
9003357|NCT02918318|10066390|FG003|COMPLETED|Posttreatment Phase: Up to 24 Weeks||25
8883909|NCT01963078|9941196|FG003|STARTED|Overall Study||9
8883910|NCT01963078|9941193|FG000|COMPLETED|Overall Study||8
8883911|NCT01963078|9941194|FG001|COMPLETED|Overall Study||9
8883912|NCT01963078|9941195|FG002|COMPLETED|Overall Study||9
8883913|NCT01963078|9941196|FG003|COMPLETED|Overall Study||7
8883914|NCT01963078|9941193|FG000|NOT COMPLETED|Overall Study||1
8883915|NCT01963078|9941194|FG001|NOT COMPLETED|Overall Study||1
8883916|NCT01963078|9941195|FG002|NOT COMPLETED|Overall Study||1
8883917|NCT01963078|9941196|FG003|NOT COMPLETED|Overall Study||2
8883918|NCT01963091|9941208|FG000|STARTED|Overall Study||17
8883919|NCT01963091|9941209|FG001|STARTED|Overall Study||16
8883920|NCT01963091|9941208|FG000|COMPLETED|Overall Study||17
8883921|NCT01963091|9941209|FG001|COMPLETED|Overall Study||16
8883922|NCT01963091|9941208|FG000|NOT COMPLETED|Overall Study||0
8883923|NCT01963091|9941209|FG001|NOT COMPLETED|Overall Study||0
8883924|NCT01963117|9941215|FG000|STARTED|Overall Study||11
8883925|NCT01963117|9941215|FG000|COMPLETED|Overall Study||10
8883926|NCT01963117|9941215|FG000|NOT COMPLETED|Overall Study||1
8883927|NCT01963143|9941222|FG000|STARTED|Overall Study||14
8883928|NCT01963143|9941223|FG001|STARTED|Overall Study||19
8883929|NCT01963143|9941224|FG002|STARTED|Overall Study||15
8883930|NCT01963143|9941222|FG000|COMPLETED|Overall Study||14
8883931|NCT01963143|9941223|FG001|COMPLETED|Overall Study||18
8883932|NCT01963143|9941224|FG002|COMPLETED|Overall Study||14
8883933|NCT01963143|9941222|FG000|NOT COMPLETED|Overall Study||0
8883934|NCT01963143|9941223|FG001|NOT COMPLETED|Overall Study||1
8883935|NCT01963143|9941224|FG002|NOT COMPLETED|Overall Study||1
8883936|NCT01963169|9941233|FG000|STARTED|Overall Study||301
8883937|NCT01963169|9941234|FG001|STARTED|Overall Study||302
8883938|NCT01963169|9941235|FG002|STARTED|Overall Study||263
8883939|NCT01963169|9941233|FG000|COMPLETED|Overall Study||242
8883940|NCT01963169|9941234|FG001|COMPLETED|Overall Study||220
8883941|NCT01963169|9941235|FG002|COMPLETED|Overall Study||237
8883942|NCT01963169|9941233|FG000|NOT COMPLETED|Overall Study||59
8883943|NCT01963169|9941234|FG001|NOT COMPLETED|Overall Study||82
8883944|NCT01963169|9941235|FG002|NOT COMPLETED|Overall Study||26
8883945|NCT01963234|9941246|FG000|STARTED|Overall Study||268
8883946|NCT01963234|9941247|FG001|STARTED|Overall Study||171
8883947|NCT01963234|9941246|FG000|COMPLETED|Overall Study||207
8883948|NCT01963234|9941247|FG001|COMPLETED|Overall Study||171
8883949|NCT01963234|9941246|FG000|NOT COMPLETED|Overall Study||61
8883950|NCT01963234|9941247|FG001|NOT COMPLETED|Overall Study||0
8883951|NCT01963260|9941269|FG000|STARTED|Overall Study||6
8883952|NCT01963260|9941270|FG001|STARTED|Overall Study||6
8883953|NCT01963260|9941271|FG002|STARTED|Overall Study||6
8883954|NCT01963260|9941272|FG003|STARTED|Overall Study||6
8883955|NCT01963260|9941273|FG004|STARTED|Overall Study||6
8883956|NCT01963260|9941274|FG005|STARTED|Overall Study||10
8883957|NCT01963260|9941275|FG006|STARTED|Overall Study||3
8883958|NCT01963260|9941276|FG007|STARTED|Overall Study||2
8883959|NCT01963260|9941277|FG008|STARTED|Overall Study||1
8883960|NCT01963260|9941278|FG009|STARTED|Overall Study||4
8883961|NCT01963260|9941269|FG000|Treated|Overall Study||6
8883962|NCT01963260|9941270|FG001|Treated|Overall Study||6
8883963|NCT01963260|9941271|FG002|Treated|Overall Study||6
8883964|NCT01963260|9941272|FG003|Treated|Overall Study||6
8883965|NCT01963260|9941273|FG004|Treated|Overall Study||6
8883966|NCT01963260|9941274|FG005|Treated|Overall Study||10
8883967|NCT01963260|9941275|FG006|Treated|Overall Study||3
8883968|NCT01963260|9941276|FG007|Treated|Overall Study||2
8883969|NCT01963260|9941277|FG008|Treated|Overall Study||1
8883970|NCT01963260|9941278|FG009|Treated|Overall Study||4
8883971|NCT01963260|9941269|FG000|COMPLETED|Overall Study||4
8883972|NCT01963260|9941270|FG001|COMPLETED|Overall Study||6
8883973|NCT01963260|9941271|FG002|COMPLETED|Overall Study||6
8883974|NCT01963260|9941272|FG003|COMPLETED|Overall Study||5
8883975|NCT01963260|9941273|FG004|COMPLETED|Overall Study||4
8634340|NCT00556322|9674646|FG000|STARTED|Overall Study||221
8634341|NCT00556322|9674647|FG001|STARTED|Overall Study||203
8883976|NCT01963260|9941274|FG005|COMPLETED|Overall Study||10
8883977|NCT01963260|9941275|FG006|COMPLETED|Overall Study||3
8883978|NCT01963260|9941276|FG007|COMPLETED|Overall Study||2
8883979|NCT01963260|9941277|FG008|COMPLETED|Overall Study||1
8883980|NCT01963260|9941278|FG009|COMPLETED|Overall Study||4
8883981|NCT01963260|9941269|FG000|NOT COMPLETED|Overall Study||2
8883982|NCT01963260|9941270|FG001|NOT COMPLETED|Overall Study||0
8883983|NCT01963260|9941271|FG002|NOT COMPLETED|Overall Study||0
8883984|NCT01963260|9941272|FG003|NOT COMPLETED|Overall Study||1
8883985|NCT01963260|9941273|FG004|NOT COMPLETED|Overall Study||2
8883986|NCT01963260|9941274|FG005|NOT COMPLETED|Overall Study||0
8883987|NCT01963260|9941275|FG006|NOT COMPLETED|Overall Study||0
8883988|NCT01963260|9941276|FG007|NOT COMPLETED|Overall Study||0
8883989|NCT01963260|9941277|FG008|NOT COMPLETED|Overall Study||0
8883990|NCT01963260|9941278|FG009|NOT COMPLETED|Overall Study||0
8883991|NCT01963403|9941309|FG000|STARTED|Overall Study||13
8883992|NCT01963403|9941310|FG001|STARTED|Overall Study||13
8883993|NCT01963403|9941309|FG000|COMPLETED|Overall Study|Follow-up over three months|11
8883994|NCT01963403|9941310|FG001|COMPLETED|Overall Study|Follow-up over three months|9
8883995|NCT01963403|9941309|FG000|NOT COMPLETED|Overall Study||2
8883996|NCT01963403|9941310|FG001|NOT COMPLETED|Overall Study||4
8883997|NCT01963481|9941318|FG000|STARTED|Overall Study||23
8883998|NCT01963481|9941318|FG000|COMPLETED|Overall Study||23
8883999|NCT01963481|9941318|FG000|NOT COMPLETED|Overall Study||0
8884000|NCT01963611|9941327|FG000|STARTED|Overall Study||51
8884001|NCT01963611|9941328|FG001|STARTED|Overall Study||49
8884002|NCT01963611|9941329|FG002|STARTED|Overall Study||52
8634342|NCT00556322|9674646|FG000|COMPLETED|Overall Study|Data cutoff was 01 August 2010|0
8884003|NCT01963611|9941330|FG003|STARTED|Overall Study||52
8884004|NCT01963611|9941331|FG004|STARTED|Overall Study||51
8884005|NCT01963611|9941327|FG000|Safety Analysis Set|Overall Study||51
8884006|NCT01963611|9941328|FG001|Safety Analysis Set|Overall Study||49
8884007|NCT01963611|9941329|FG002|Safety Analysis Set|Overall Study||52
8884008|NCT01963611|9941330|FG003|Safety Analysis Set|Overall Study||52
8884009|NCT01963611|9941331|FG004|Safety Analysis Set|Overall Study||50
8884010|NCT01963611|9941327|FG000|COMPLETED|Overall Study||0
8884011|NCT01963611|9941328|FG001|COMPLETED|Overall Study||0
8884012|NCT01963611|9941329|FG002|COMPLETED|Overall Study||0
8884013|NCT01963611|9941330|FG003|COMPLETED|Overall Study||0
8884014|NCT01963611|9941331|FG004|COMPLETED|Overall Study||0
8884015|NCT01963611|9941327|FG000|NOT COMPLETED|Overall Study||51
8884016|NCT01963611|9941328|FG001|NOT COMPLETED|Overall Study||49
8884017|NCT01963611|9941329|FG002|NOT COMPLETED|Overall Study||52
8884018|NCT01963611|9941330|FG003|NOT COMPLETED|Overall Study||52
8884019|NCT01963611|9941331|FG004|NOT COMPLETED|Overall Study||51
8884020|NCT01963676|9941346|FG000|STARTED|Overall Study||14
8884021|NCT01963676|9941347|FG001|STARTED|Overall Study||13
8884022|NCT01963676|9941346|FG000|COMPLETED|Overall Study||13
8884023|NCT01963676|9941347|FG001|COMPLETED|Overall Study||13
8884024|NCT01963676|9941346|FG000|NOT COMPLETED|Overall Study||1
8884025|NCT01963676|9941347|FG001|NOT COMPLETED|Overall Study||0
8884026|NCT01963767|9941355|FG000|STARTED|Overall Study||58
8884027|NCT01963767|9941356|FG001|STARTED|Overall Study||55
8884028|NCT01963767|9941355|FG000|COMPLETED|Overall Study||52
8884029|NCT01963767|9941356|FG001|COMPLETED|Overall Study||53
8884030|NCT01963767|9941355|FG000|NOT COMPLETED|Overall Study||6
8884031|NCT01963767|9941356|FG001|NOT COMPLETED|Overall Study||2
8884032|NCT01963793|9941362|FG000|STARTED|Overall Study||20
8884033|NCT01963793|9941362|FG000|COMPLETED|Overall Study||20
8884034|NCT01963793|9941362|FG000|NOT COMPLETED|Overall Study||0
8725997|NCT01033487|9773164|FG007|COMPLETED|Fourth Intervention Period||3
8725998|NCT01033487|9773165|FG008|COMPLETED|Fourth Intervention Period||1
8884035|NCT01963845|9941379|FG000|STARTED|Overall Study||25
8884036|NCT01963845|9941380|FG001|STARTED|Overall Study||25
8634343|NCT00556322|9674647|FG001|COMPLETED|Overall Study|Data cutoff was 01 August 2010|0
8634344|NCT00556322|9674646|FG000|NOT COMPLETED|Overall Study||221
8634345|NCT00556322|9674647|FG001|NOT COMPLETED|Overall Study||203
8634346|NCT00556374|9674658|FG000|STARTED|Overall Study||1709
8634347|NCT00556374|9674659|FG001|STARTED|Overall Study||1711
8634348|NCT00556374|9674658|FG000|Received Study Drug|Overall Study||1699
8634349|NCT00556374|9674659|FG001|Received Study Drug|Overall Study||1700
8884037|NCT01963845|9941379|FG000|COMPLETED|Overall Study||25
8884038|NCT01963845|9941380|FG001|COMPLETED|Overall Study||25
8884039|NCT01963845|9941379|FG000|NOT COMPLETED|Overall Study||0
8884040|NCT01963845|9941380|FG001|NOT COMPLETED|Overall Study||0
8884041|NCT01963923|9941388|FG000|STARTED|3 Weeks Post-surgery||20
8884042|NCT01963923|9941389|FG001|STARTED|3 Weeks Post-surgery||20
8884043|NCT01963923|9941388|FG000|COMPLETED|3 Weeks Post-surgery||12
8884044|NCT01963923|9941389|FG001|COMPLETED|3 Weeks Post-surgery||10
8884045|NCT01963923|9941388|FG000|NOT COMPLETED|3 Weeks Post-surgery||8
8884046|NCT01963923|9941389|FG001|NOT COMPLETED|3 Weeks Post-surgery||10
8884047|NCT01963923|9941388|FG000|STARTED|3 Months Post-surgery||12
8884048|NCT01963923|9941389|FG001|STARTED|3 Months Post-surgery||10
8884049|NCT01963923|9941388|FG000|COMPLETED|3 Months Post-surgery||10
8884050|NCT01963923|9941389|FG001|COMPLETED|3 Months Post-surgery||9
8884051|NCT01963923|9941388|FG000|NOT COMPLETED|3 Months Post-surgery||2
8884052|NCT01963923|9941389|FG001|NOT COMPLETED|3 Months Post-surgery||1
8884053|NCT01964092|9941404|FG000|STARTED|Overall Study||229
8884054|NCT01964092|9941405|FG001|STARTED|Overall Study||181
8884055|NCT01964092|9941404|FG000|COMPLETED|Overall Study||227
8884056|NCT01964092|9941405|FG001|COMPLETED|Overall Study||181
8884057|NCT01964092|9941404|FG000|NOT COMPLETED|Overall Study||2
8884058|NCT01964092|9941405|FG001|NOT COMPLETED|Overall Study||0
8884059|NCT01964105|9941414|FG000|STARTED|Overall Study||15
8884060|NCT01964105|9941415|FG001|STARTED|Overall Study||75
8884061|NCT01964105|9941416|FG002|STARTED|Overall Study||10
8884062|NCT01964105|9941414|FG000|COMPLETED|Overall Study||13
8884063|NCT01964105|9941415|FG001|COMPLETED|Overall Study||62
8884064|NCT01964105|9941416|FG002|COMPLETED|Overall Study||10
8884065|NCT01964105|9941414|FG000|NOT COMPLETED|Overall Study||2
8884066|NCT01964105|9941415|FG001|NOT COMPLETED|Overall Study||13
8884067|NCT01964105|9941416|FG002|NOT COMPLETED|Overall Study||0
9003358|NCT02918318|10066391|FG004|COMPLETED|Posttreatment Phase: Up to 24 Weeks||0
9003359|NCT02918318|10066387|FG000|NOT COMPLETED|Posttreatment Phase: Up to 24 Weeks||1
9003360|NCT02918318|10066388|FG001|NOT COMPLETED|Posttreatment Phase: Up to 24 Weeks||3
9003361|NCT02918318|10066389|FG002|NOT COMPLETED|Posttreatment Phase: Up to 24 Weeks||1
9003362|NCT02918318|10066390|FG003|NOT COMPLETED|Posttreatment Phase: Up to 24 Weeks||2
9003363|NCT02918318|10066391|FG004|NOT COMPLETED|Posttreatment Phase: Up to 24 Weeks||0
9003364|NCT02918318|10066387|FG000|STARTED|Open Label Treatment Phase: 4 Weeks||0
9003365|NCT02918318|10066388|FG001|STARTED|Open Label Treatment Phase: 4 Weeks||0
9003366|NCT02918318|10066389|FG002|STARTED|Open Label Treatment Phase: 4 Weeks||0
9003367|NCT02918318|10066390|FG003|STARTED|Open Label Treatment Phase: 4 Weeks||0
9003368|NCT02918318|10066391|FG004|STARTED|Open Label Treatment Phase: 4 Weeks||48
9003369|NCT02918318|10066387|FG000|COMPLETED|Open Label Treatment Phase: 4 Weeks||0
9003370|NCT02918318|10066388|FG001|COMPLETED|Open Label Treatment Phase: 4 Weeks||0
9003371|NCT02918318|10066389|FG002|COMPLETED|Open Label Treatment Phase: 4 Weeks||0
8634350|NCT00556374|9674658|FG000|COMPLETED|Overall Study|Indicates participants continuing study|1462
9003372|NCT02918318|10066390|FG003|COMPLETED|Open Label Treatment Phase: 4 Weeks||0
9003373|NCT02918318|10066391|FG004|COMPLETED|Open Label Treatment Phase: 4 Weeks||47
8634351|NCT00556374|9674659|FG001|COMPLETED|Overall Study|Indicates participants continuing study|1491
8884068|NCT01964222|9941426|FG000|STARTED|Overall Study||101
8884069|NCT01964222|9941427|FG001|STARTED|Overall Study||100
8884070|NCT01964222|9941426|FG000|COMPLETED|Overall Study||86
8884071|NCT01964222|9941427|FG001|COMPLETED|Overall Study||89
8884072|NCT01964222|9941426|FG000|NOT COMPLETED|Overall Study||15
8884073|NCT01964222|9941427|FG001|NOT COMPLETED|Overall Study||11
8884074|NCT01964300|9941435|FG000|STARTED|Overall Study||7
8884075|NCT01964300|9941436|FG001|STARTED|Overall Study||12
8884076|NCT01964300|9941435|FG000|COMPLETED|Overall Study||1
8884077|NCT01964300|9941436|FG001|COMPLETED|Overall Study||1
8884078|NCT01964300|9941435|FG000|NOT COMPLETED|Overall Study||6
8884079|NCT01964300|9941436|FG001|NOT COMPLETED|Overall Study||11
8884080|NCT01964326|9941442|FG000|STARTED|Overall Study||1311
8884081|NCT01964326|9941442|FG000|COMPLETED|Overall Study||1014
8884082|NCT01964326|9941442|FG000|NOT COMPLETED|Overall Study||297
8884083|NCT01964352|9941450|FG000|STARTED|Overall Study||204
8884084|NCT01964352|9941451|FG001|STARTED|Overall Study||203
8884085|NCT01964352|9941452|FG002|STARTED|Overall Study||202
8884086|NCT01964352|9941453|FG003|STARTED|Overall Study||203
8884087|NCT01964352|9941450|FG000|COMPLETED|Overall Study||178
8884088|NCT01964352|9941451|FG001|COMPLETED|Overall Study||192
8884089|NCT01964352|9941452|FG002|COMPLETED|Overall Study||196
8884090|NCT01964352|9941453|FG003|COMPLETED|Overall Study||195
8884091|NCT01964352|9941450|FG000|NOT COMPLETED|Overall Study||26
8884092|NCT01964352|9941451|FG001|NOT COMPLETED|Overall Study||11
8884093|NCT01964352|9941452|FG002|NOT COMPLETED|Overall Study||6
8884094|NCT01964352|9941453|FG003|NOT COMPLETED|Overall Study||8
8884095|NCT01964378|9941465|FG000|STARTED|Overall Study||66
8884096|NCT01964378|9941466|FG001|STARTED|Overall Study||66
8884097|NCT01964378|9941465|FG000|Participants Treated (Safety Set)|Overall Study||65
8884098|NCT01964378|9941466|FG001|Participants Treated (Safety Set)|Overall Study|"4 Participants died during treatment, hereof 2 with withdrawal... as primary reason for discont."|61
8884099|NCT01964378|9941465|FG000|COMPLETED|Overall Study||41
8884100|NCT01964378|9941466|FG001|COMPLETED|Overall Study||45
8884101|NCT01964378|9941465|FG000|NOT COMPLETED|Overall Study||25
8884102|NCT01964378|9941466|FG001|NOT COMPLETED|Overall Study||21
8884103|NCT01964430|9941474|FG000|STARTED|Overall Study||432
8884104|NCT01964430|9941475|FG001|STARTED|Overall Study||434
8884105|NCT01964430|9941474|FG000|Treated Population|Overall Study||429
8884106|NCT01964430|9941475|FG001|Treated Population|Overall Study||423
8884107|NCT01964430|9941474|FG000|COMPLETED|Overall Study||287
8884108|NCT01964430|9941475|FG001|COMPLETED|Overall Study||310
8884109|NCT01964430|9941474|FG000|NOT COMPLETED|Overall Study||145
8884110|NCT01964430|9941475|FG001|NOT COMPLETED|Overall Study||124
8884111|NCT01964521|9941481|FG000|STARTED|Overall Study||24
8884112|NCT01964521|9941481|FG000|COMPLETED|Overall Study||20
8884113|NCT01964521|9941481|FG000|NOT COMPLETED|Overall Study||4
8884114|NCT01964547|9941488|FG000|STARTED|Overall Study||62
8884115|NCT01964547|9941489|FG001|STARTED|Overall Study||59
8884116|NCT01964547|9941488|FG000|COMPLETED|Overall Study||50
8884117|NCT01964547|9941489|FG001|COMPLETED|Overall Study||48
8884118|NCT01964547|9941488|FG000|NOT COMPLETED|Overall Study||12
8884119|NCT01964547|9941489|FG001|NOT COMPLETED|Overall Study||11
8884120|NCT01964716|9941497|FG000|STARTED|Overall Study||250
8884121|NCT01964716|9941498|FG001|STARTED|Overall Study||250
8884122|NCT01964716|9941497|FG000|Vaccinated Dose 1|Overall Study||250
8884123|NCT01964716|9941498|FG001|Vaccinated Dose 1|Overall Study||250
8884124|NCT01964716|9941497|FG000|Vaccinated Dose 2|Overall Study||249
8884125|NCT01964716|9941498|FG001|Vaccinated Dose 2|Overall Study||248
8884126|NCT01964716|9941497|FG000|Vaccinated Dose 3|Overall Study||247
8884127|NCT01964716|9941498|FG001|Vaccinated Dose 3|Overall Study||244
8884128|NCT01964716|9941497|FG000|COMPLETED|Overall Study||245
8884129|NCT01964716|9941498|FG001|COMPLETED|Overall Study||244
8884130|NCT01964716|9941497|FG000|NOT COMPLETED|Overall Study||5
8884131|NCT01964716|9941498|FG001|NOT COMPLETED|Overall Study||6
8884132|NCT01964755|9941512|FG000|STARTED|Overall Study||6
8884133|NCT01964755|9941512|FG000|Cycle 2|Overall Study||5
8884134|NCT01964755|9941512|FG000|Cycle 3|Overall Study||4
8884135|NCT01964755|9941512|FG000|Cycle 4|Overall Study||4
8884136|NCT01964755|9941512|FG000|Cycle 5|Overall Study||4
8884137|NCT01964755|9941512|FG000|COMPLETED|Overall Study||4
8884138|NCT01964755|9941512|FG000|NOT COMPLETED|Overall Study||2
8884139|NCT01964898|9941518|FG000|STARTED|Overall Study||31
8884140|NCT01964898|9941519|FG001|STARTED|Overall Study||33
8884141|NCT01964898|9941518|FG000|12 Week Assessment|Overall Study||25
8884142|NCT01964898|9941519|FG001|12 Week Assessment|Overall Study||30
8884143|NCT01964898|9941518|FG000|COMPLETED|Overall Study||24
8884144|NCT01964898|9941519|FG001|COMPLETED|Overall Study||26
8884145|NCT01964898|9941518|FG000|NOT COMPLETED|Overall Study||7
8884146|NCT01964898|9941519|FG001|NOT COMPLETED|Overall Study||7
8884147|NCT01964924|9941525|FG000|STARTED|Trametinib Monotherapy||37
8884148|NCT01964924|9941526|FG001|STARTED|Trametinib Monotherapy||0
8884149|NCT01964924|9941525|FG000|COMPLETED|Trametinib Monotherapy||18
8884150|NCT01964924|9941526|FG001|COMPLETED|Trametinib Monotherapy||0
8884151|NCT01964924|9941525|FG000|NOT COMPLETED|Trametinib Monotherapy||19
8884152|NCT01964924|9941526|FG001|NOT COMPLETED|Trametinib Monotherapy||0
8884153|NCT01964924|9941525|FG000|STARTED|Trametinib + GSK2141||0
8884154|NCT01964924|9941526|FG001|STARTED|Trametinib + GSK2141|Progressed in Part 1 and therefore initiated combination treatment in Part 2|19
8884155|NCT01964924|9941525|FG000|COMPLETED|Trametinib + GSK2141||0
8884156|NCT01964924|9941526|FG001|COMPLETED|Trametinib + GSK2141||19
8884157|NCT01964924|9941525|FG000|NOT COMPLETED|Trametinib + GSK2141||0
8884158|NCT01964924|9941526|FG001|NOT COMPLETED|Trametinib + GSK2141||0
9003374|NCT02918318|10066387|FG000|NOT COMPLETED|Open Label Treatment Phase: 4 Weeks||0
9003375|NCT02918318|10066388|FG001|NOT COMPLETED|Open Label Treatment Phase: 4 Weeks||0
9003376|NCT02918318|10066389|FG002|NOT COMPLETED|Open Label Treatment Phase: 4 Weeks||0
9003377|NCT02918318|10066390|FG003|NOT COMPLETED|Open Label Treatment Phase: 4 Weeks||0
9003378|NCT02918318|10066391|FG004|NOT COMPLETED|Open Label Treatment Phase: 4 Weeks||1
9003379|NCT02918318|10066387|FG000|STARTED|Open Label Follow-up Phase: 4 Weeks||0
9003380|NCT02918318|10066388|FG001|STARTED|Open Label Follow-up Phase: 4 Weeks||0
9003381|NCT02918318|10066389|FG002|STARTED|Open Label Follow-up Phase: 4 Weeks||0
9003382|NCT02918318|10066390|FG003|STARTED|Open Label Follow-up Phase: 4 Weeks||0
9003383|NCT02918318|10066391|FG004|STARTED|Open Label Follow-up Phase: 4 Weeks||48
9003384|NCT02918318|10066387|FG000|COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
9003385|NCT02918318|10066388|FG001|COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
9003386|NCT02918318|10066389|FG002|COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
9003387|NCT02918318|10066390|FG003|COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
9003388|NCT02918318|10066391|FG004|COMPLETED|Open Label Follow-up Phase: 4 Weeks||47
9003389|NCT02918318|10066387|FG000|NOT COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
9003390|NCT02918318|10066388|FG001|NOT COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
9003391|NCT02918318|10066389|FG002|NOT COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
9003392|NCT02918318|10066390|FG003|NOT COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
9003393|NCT02918318|10066391|FG004|NOT COMPLETED|Open Label Follow-up Phase: 4 Weeks||1
9003394|NCT02918357|10066412|FG000|STARTED|Overall Study||385
9003395|NCT02918357|10066412|FG000|Investigational Drug Administration|Overall Study||385
9003396|NCT02918357|10066412|FG000|PET/CT Scan|Overall Study||385
9003397|NCT02918357|10066412|FG000|COMPLETED|Overall Study||385
9003398|NCT02918357|10066412|FG000|NOT COMPLETED|Overall Study||0
9003399|NCT02918396|10066437|FG000|STARTED|Overall Study||2
9003400|NCT02918396|10066438|FG001|STARTED|Overall Study||1
9003401|NCT02918396|10066439|FG002|STARTED|Overall Study||2
9003402|NCT02918396|10066437|FG000|COMPLETED|Overall Study||2
9003403|NCT02918396|10066438|FG001|COMPLETED|Overall Study||1
9003404|NCT02918396|10066439|FG002|COMPLETED|Overall Study||2
8634352|NCT00556374|9674658|FG000|NOT COMPLETED|Overall Study||247
8634353|NCT00556374|9674659|FG001|NOT COMPLETED|Overall Study||220
8634354|NCT00556426|9674665|FG000|STARTED|Overall Study||100
9003405|NCT02918396|10066437|FG000|NOT COMPLETED|Overall Study||0
9003406|NCT02918396|10066438|FG001|NOT COMPLETED|Overall Study||0
9003407|NCT02918396|10066439|FG002|NOT COMPLETED|Overall Study||0
9003408|NCT02918552|10066449|FG000|STARTED|Overall Study||7
9003409|NCT02918552|10066450|FG001|STARTED|Overall Study||8
9003410|NCT02918552|10066449|FG000|COMPLETED|Overall Study||6
9003411|NCT02918552|10066450|FG001|COMPLETED|Overall Study||6
9003412|NCT02918552|10066449|FG000|NOT COMPLETED|Overall Study||1
9003413|NCT02918552|10066450|FG001|NOT COMPLETED|Overall Study||2
9003414|NCT02918617|10066465|FG000|STARTED|Overall Study||21
9003415|NCT02918617|10066466|FG001|STARTED|Overall Study||20
9003416|NCT02918617|10066467|FG002|STARTED|Overall Study||22
9003417|NCT02918617|10066468|FG003|STARTED|Overall Study||22
9003418|NCT02918617|10066469|FG004|STARTED|Overall Study||24
9003419|NCT02918617|10066470|FG005|STARTED|Overall Study||20
9003420|NCT02918617|10066471|FG006|STARTED|Overall Study||22
9003421|NCT02918617|10066472|FG007|STARTED|Overall Study||26
9003422|NCT02918617|10066473|FG008|STARTED|Overall Study||26
9003423|NCT02918617|10066465|FG000|COMPLETED|Overall Study||20
9003424|NCT02918617|10066466|FG001|COMPLETED|Overall Study||20
9003425|NCT02918617|10066467|FG002|COMPLETED|Overall Study||19
9003426|NCT02918617|10066468|FG003|COMPLETED|Overall Study||22
9003427|NCT02918617|10066469|FG004|COMPLETED|Overall Study||24
9003428|NCT02918617|10066470|FG005|COMPLETED|Overall Study||20
9003429|NCT02918617|10066471|FG006|COMPLETED|Overall Study||22
9003430|NCT02918617|10066472|FG007|COMPLETED|Overall Study||25
9003431|NCT02918617|10066473|FG008|COMPLETED|Overall Study||26
8634355|NCT00556426|9674665|FG000|COMPLETED|Overall Study||91
8634356|NCT00556426|9674665|FG000|NOT COMPLETED|Overall Study||9
8634357|NCT00556439|9674674|FG000|STARTED|Study Entry to Week 12|58 signed informed consent with 9 not being eligible. The remaining 49 received study drug.|49
8884159|NCT01964950|9941537|FG000|STARTED|Overall Study|Data reports overall population,since data not collected separately per arm as specified in protocol|1101
8884160|NCT01964950|9941537|FG000|COMPLETED|Overall Study||1076
9003432|NCT02918617|10066465|FG000|NOT COMPLETED|Overall Study||1
9003433|NCT02918617|10066466|FG001|NOT COMPLETED|Overall Study||0
9003434|NCT02918617|10066467|FG002|NOT COMPLETED|Overall Study||3
9003435|NCT02918617|10066468|FG003|NOT COMPLETED|Overall Study||0
9003436|NCT02918617|10066469|FG004|NOT COMPLETED|Overall Study||0
9003437|NCT02918617|10066470|FG005|NOT COMPLETED|Overall Study||0
9003438|NCT02918617|10066471|FG006|NOT COMPLETED|Overall Study||0
8884161|NCT01964950|9941537|FG000|NOT COMPLETED|Overall Study||25
8884162|NCT01964963|9941544|FG000|STARTED|Overall Study||19192
8884163|NCT01964963|9941544|FG000|COMPLETED|Overall Study||18249
9003439|NCT02918617|10066472|FG007|NOT COMPLETED|Overall Study||1
9003440|NCT02918617|10066473|FG008|NOT COMPLETED|Overall Study||0
9003441|NCT02918630|10066495|FG000|STARTED|Overall Study||4
9003442|NCT02918630|10066496|FG001|STARTED|Overall Study||3
9003443|NCT02918630|10066495|FG000|COMPLETED|Overall Study||4
9003444|NCT02918630|10066496|FG001|COMPLETED|Overall Study||3
8884164|NCT01964963|9941544|FG000|NOT COMPLETED|Overall Study||943
8725999|NCT01033487|9773166|FG009|COMPLETED|Fourth Intervention Period||2
8884165|NCT01964976|9941550|FG000|STARTED|Overall Study|Data reports overall population,since data not collected separately per arm as specified in protocol|1096
8884166|NCT01964976|9941550|FG000|COMPLETED|Overall Study||1065
8884167|NCT01964976|9941550|FG000|NOT COMPLETED|Overall Study||31
8884168|NCT01965002|9941557|FG000|STARTED|Overall Study||5
8884169|NCT01965002|9941557|FG000|COMPLETED|Overall Study||5
8884170|NCT01965002|9941557|FG000|NOT COMPLETED|Overall Study||0
8884171|NCT01965067|9941565|FG000|STARTED|Overall Study||30
8884172|NCT01965067|9941566|FG001|STARTED|Overall Study||30
8884173|NCT01965067|9941565|FG000|COMPLETED|Overall Study||30
8884174|NCT01965067|9941566|FG001|COMPLETED|Overall Study||30
8884175|NCT01965067|9941565|FG000|NOT COMPLETED|Overall Study||0
8884176|NCT01965067|9941566|FG001|NOT COMPLETED|Overall Study||0
8884177|NCT01965158|9941574|FG000|STARTED|Overall Study|Includes 1 participant enrolled at 2 different sites simultaneously|274
8884178|NCT01965158|9941575|FG001|STARTED|Overall Study|Includes 1 participant enrolled at 2 different sites simultaneously|273
8884179|NCT01965158|9941574|FG000|Received Treatment|Overall Study||272
8884180|NCT01965158|9941575|FG001|Received Treatment|Overall Study||273
8884181|NCT01965158|9941574|FG000|COMPLETED|Overall Study||233
8884182|NCT01965158|9941575|FG001|COMPLETED|Overall Study||238
8884183|NCT01965158|9941574|FG000|NOT COMPLETED|Overall Study||41
8884184|NCT01965158|9941575|FG001|NOT COMPLETED|Overall Study||35
8884185|NCT01965262|9941581|FG000|STARTED|First Intervention (7 Days)||15
8884186|NCT01965262|9941582|FG001|STARTED|First Intervention (7 Days)||15
8884187|NCT01965262|9941581|FG000|COMPLETED|First Intervention (7 Days)||15
8884188|NCT01965262|9941582|FG001|COMPLETED|First Intervention (7 Days)||15
8884189|NCT01965262|9941581|FG000|NOT COMPLETED|First Intervention (7 Days)||0
8884190|NCT01965262|9941582|FG001|NOT COMPLETED|First Intervention (7 Days)||0
8884191|NCT01965262|9941581|FG000|STARTED|Second Intervention (7 Days)||15
8884192|NCT01965262|9941582|FG001|STARTED|Second Intervention (7 Days)||15
8884193|NCT01965262|9941581|FG000|COMPLETED|Second Intervention (7 Days)||14
8884194|NCT01965262|9941582|FG001|COMPLETED|Second Intervention (7 Days)||5
8884195|NCT01965262|9941581|FG000|NOT COMPLETED|Second Intervention (7 Days)||1
8884196|NCT01965262|9941582|FG001|NOT COMPLETED|Second Intervention (7 Days)||10
8884197|NCT01965288|9941590|FG000|STARTED|Overall Study||30
8884198|NCT01965288|9941591|FG001|STARTED|Overall Study||30
8884199|NCT01965288|9941590|FG000|COMPLETED|Overall Study||30
8884200|NCT01965288|9941591|FG001|COMPLETED|Overall Study||30
8884201|NCT01965288|9941590|FG000|NOT COMPLETED|Overall Study||0
8884202|NCT01965288|9941591|FG001|NOT COMPLETED|Overall Study||0
8884203|NCT01965327|9941609|FG000|STARTED|Overall Study||12
8884204|NCT01965327|9941609|FG000|COMPLETED|Overall Study|Prior to completion, 2 subjects were withdrawn by the PI for failure to adhere to study protocol.|10
8884205|NCT01965327|9941609|FG000|NOT COMPLETED|Overall Study||2
8884206|NCT01965366|9941615|FG000|STARTED|Overall Study||13
8884207|NCT01965366|9941616|FG001|STARTED|Overall Study||14
8884208|NCT01965366|9941615|FG000|COMPLETED|Overall Study||3
8884209|NCT01965366|9941616|FG001|COMPLETED|Overall Study||9
8884210|NCT01965366|9941615|FG000|NOT COMPLETED|Overall Study||10
8884211|NCT01965366|9941616|FG001|NOT COMPLETED|Overall Study||5
8884212|NCT01965431|9941622|FG000|STARTED|Overall Study|Started are actually Treated subjects|8
8884213|NCT01965431|9941623|FG001|STARTED|Overall Study||8
8884214|NCT01965431|9941624|FG002|STARTED|Overall Study||8
8884215|NCT01965431|9941625|FG003|STARTED|Overall Study||8
8884216|NCT01965431|9941626|FG004|STARTED|Overall Study||8
8884217|NCT01965431|9941627|FG005|STARTED|Overall Study||8
8884218|NCT01965431|9941622|FG000|COMPLETED|Overall Study||2
8884219|NCT01965431|9941623|FG001|COMPLETED|Overall Study||2
8884220|NCT01965431|9941624|FG002|COMPLETED|Overall Study||2
8884221|NCT01965431|9941625|FG003|COMPLETED|Overall Study||2
8884222|NCT01965431|9941626|FG004|COMPLETED|Overall Study||2
8884223|NCT01965431|9941627|FG005|COMPLETED|Overall Study||2
8884224|NCT01965431|9941622|FG000|NOT COMPLETED|Overall Study||6
8884225|NCT01965431|9941623|FG001|NOT COMPLETED|Overall Study||6
8884226|NCT01965431|9941624|FG002|NOT COMPLETED|Overall Study||6
8884227|NCT01965431|9941625|FG003|NOT COMPLETED|Overall Study||6
8884228|NCT01965431|9941626|FG004|NOT COMPLETED|Overall Study||6
8884229|NCT01965431|9941627|FG005|NOT COMPLETED|Overall Study||6
8884230|NCT01965535|9941639|FG000|STARTED|Overall Study||78
8884231|NCT01965535|9941640|FG001|STARTED|Overall Study||77
8884232|NCT01965535|9941639|FG000|COMPLETED|Overall Study||76
8884233|NCT01965535|9941640|FG001|COMPLETED|Overall Study||76
8884234|NCT01965535|9941639|FG000|NOT COMPLETED|Overall Study||2
8884235|NCT01965535|9941640|FG001|NOT COMPLETED|Overall Study||1
8884236|NCT01965561|9941646|FG000|STARTED|Overall Study||10
8884237|NCT01965561|9941646|FG000|COMPLETED|Overall Study||10
8884238|NCT01965561|9941646|FG000|NOT COMPLETED|Overall Study||0
8884239|NCT01965600|9941653|FG000|STARTED|First Intervention||6
8884240|NCT01965600|9941654|FG001|STARTED|First Intervention||8
8884241|NCT01965600|9941655|FG002|STARTED|First Intervention||5
8884242|NCT01965600|9941656|FG003|STARTED|First Intervention||4
8884243|NCT01965600|9941653|FG000|Received at Least One Dose of Drug|First Intervention||6
8884244|NCT01965600|9941654|FG001|Received at Least One Dose of Drug|First Intervention||8
8884245|NCT01965600|9941655|FG002|Received at Least One Dose of Drug|First Intervention||5
8884246|NCT01965600|9941656|FG003|Received at Least One Dose of Drug|First Intervention||4
8884247|NCT01965600|9941653|FG000|COMPLETED|First Intervention||6
8884248|NCT01965600|9941654|FG001|COMPLETED|First Intervention||8
8884249|NCT01965600|9941655|FG002|COMPLETED|First Intervention||5
8884250|NCT01965600|9941656|FG003|COMPLETED|First Intervention||4
8884251|NCT01965600|9941653|FG000|NOT COMPLETED|First Intervention||0
8884252|NCT01965600|9941654|FG001|NOT COMPLETED|First Intervention||0
8884253|NCT01965600|9941655|FG002|NOT COMPLETED|First Intervention||0
8884254|NCT01965600|9941656|FG003|NOT COMPLETED|First Intervention||0
8884255|NCT01965600|9941653|FG000|STARTED|Washout Period of Approximately 15 Days||6
8884256|NCT01965600|9941654|FG001|STARTED|Washout Period of Approximately 15 Days||8
8884257|NCT01965600|9941655|FG002|STARTED|Washout Period of Approximately 15 Days||5
8884258|NCT01965600|9941656|FG003|STARTED|Washout Period of Approximately 15 Days||4
8884259|NCT01965600|9941653|FG000|COMPLETED|Washout Period of Approximately 15 Days||4
8884260|NCT01965600|9941654|FG001|COMPLETED|Washout Period of Approximately 15 Days||4
8884261|NCT01965600|9941655|FG002|COMPLETED|Washout Period of Approximately 15 Days||3
8884262|NCT01965600|9941656|FG003|COMPLETED|Washout Period of Approximately 15 Days||2
8884263|NCT01965600|9941653|FG000|NOT COMPLETED|Washout Period of Approximately 15 Days||2
8884264|NCT01965600|9941654|FG001|NOT COMPLETED|Washout Period of Approximately 15 Days||4
8884265|NCT01965600|9941655|FG002|NOT COMPLETED|Washout Period of Approximately 15 Days||2
8884266|NCT01965600|9941656|FG003|NOT COMPLETED|Washout Period of Approximately 15 Days||2
8884267|NCT01965600|9941653|FG000|STARTED|Second Intervention||4
8884268|NCT01965600|9941654|FG001|STARTED|Second Intervention||4
8884269|NCT01965600|9941655|FG002|STARTED|Second Intervention||3
8884270|NCT01965600|9941656|FG003|STARTED|Second Intervention||2
8884271|NCT01965600|9941653|FG000|COMPLETED|Second Intervention||4
8884272|NCT01965600|9941654|FG001|COMPLETED|Second Intervention||4
8884273|NCT01965600|9941655|FG002|COMPLETED|Second Intervention||1
8884274|NCT01965600|9941656|FG003|COMPLETED|Second Intervention||0
8884275|NCT01965600|9941653|FG000|NOT COMPLETED|Second Intervention||0
8884276|NCT01965600|9941654|FG001|NOT COMPLETED|Second Intervention||0
8884277|NCT01965600|9941655|FG002|NOT COMPLETED|Second Intervention||2
8884278|NCT01965600|9941656|FG003|NOT COMPLETED|Second Intervention||2
8884279|NCT01965652|9941666|FG000|STARTED|Overall Study|Includes two participants who each enrolled at two different sites|623
8884280|NCT01965652|9941667|FG001|STARTED|Overall Study|Includes three participants who each enrolled at two different sites|623
8884281|NCT01965652|9941666|FG000|Received Treatment|Overall Study||622
8884282|NCT01965652|9941667|FG001|Received Treatment|Overall Study||623
8884283|NCT01965652|9941666|FG000|COMPLETED|Overall Study||413
8884284|NCT01965652|9941667|FG001|COMPLETED|Overall Study||413
8884285|NCT01965652|9941666|FG000|NOT COMPLETED|Overall Study||210
8884286|NCT01965652|9941667|FG001|NOT COMPLETED|Overall Study||210
8884287|NCT01965665|9941673|FG000|STARTED|Overall Study||20
8884288|NCT01965665|9941673|FG000|COMPLETED|Overall Study||19
8884289|NCT01965665|9941673|FG000|NOT COMPLETED|Overall Study||1
8884290|NCT01965756|9941679|FG000|STARTED|Overall Study||10
8884291|NCT01965756|9941680|FG001|STARTED|Overall Study||10
8884292|NCT01965756|9941679|FG000|COMPLETED|Overall Study||10
8884293|NCT01965756|9941680|FG001|COMPLETED|Overall Study||10
8884294|NCT01965756|9941679|FG000|NOT COMPLETED|Overall Study||0
8884295|NCT01965756|9941680|FG001|NOT COMPLETED|Overall Study||0
8884296|NCT01965834|9941690|FG000|STARTED|Overall Study||6
8884297|NCT01965834|9941690|FG000|COMPLETED|Overall Study||2
8884298|NCT01965834|9941690|FG000|NOT COMPLETED|Overall Study||4
8884299|NCT01965860|9941697|FG000|STARTED|Overall Study||11
8884300|NCT01965860|9941698|FG001|STARTED|Overall Study||10
8884301|NCT01965860|9941699|FG002|STARTED|Overall Study||11
8884302|NCT01965860|9941697|FG000|COMPLETED|Overall Study||9
8884303|NCT01965860|9941698|FG001|COMPLETED|Overall Study||10
8884304|NCT01965860|9941699|FG002|COMPLETED|Overall Study||10
8884305|NCT01965860|9941697|FG000|NOT COMPLETED|Overall Study||2
8884306|NCT01965860|9941698|FG001|NOT COMPLETED|Overall Study||0
8884307|NCT01965860|9941699|FG002|NOT COMPLETED|Overall Study||1
8884308|NCT01965899|9941707|FG000|STARTED|Overall Study||151
8884309|NCT01965899|9941707|FG000|COMPLETED|Overall Study||145
8884310|NCT01965899|9941707|FG000|NOT COMPLETED|Overall Study||6
8884311|NCT01965938|9941714|FG000|STARTED|Overall Study||21
8884312|NCT01965938|9941715|FG001|STARTED|Overall Study||20
8884313|NCT01965938|9941714|FG000|COMPLETED|Overall Study||20
8884314|NCT01965938|9941715|FG001|COMPLETED|Overall Study||20
8884315|NCT01965938|9941714|FG000|NOT COMPLETED|Overall Study||1
8884316|NCT01965938|9941715|FG001|NOT COMPLETED|Overall Study||0
8884317|NCT01966003|9941725|FG000|STARTED|Overall Study||328
8884318|NCT01966003|9941726|FG001|STARTED|Overall Study||314
8884319|NCT01966003|9941725|FG000|Received Study Drug|Overall Study||324
8884320|NCT01966003|9941726|FG001|Received Study Drug|Overall Study||309
8884321|NCT01966003|9941725|FG000|COMPLETED|Overall Study||58
8884322|NCT01966003|9941726|FG001|COMPLETED|Overall Study||44
8884323|NCT01966003|9941725|FG000|NOT COMPLETED|Overall Study||270
8884324|NCT01966003|9941726|FG001|NOT COMPLETED|Overall Study||270
8884325|NCT01966042|9941732|FG000|STARTED|Overall Study||13
8884326|NCT01966042|9941732|FG000|COMPLETED|Overall Study||11
8884327|NCT01966042|9941732|FG000|NOT COMPLETED|Overall Study||2
8884328|NCT01966068|9941738|FG000|STARTED|Overall Study||294
8884329|NCT01966068|9941738|FG000|Used the MyAsthma Portal at Least Once|Overall Study||237
8884330|NCT01966068|9941738|FG000|Use the MyAsthma Portal More Than Once|Overall Study||156
8884331|NCT01966068|9941738|FG000|COMPLETED|Overall Study||156
8884332|NCT01966068|9941738|FG000|NOT COMPLETED|Overall Study||138
8884333|NCT01966107|9941745|FG000|STARTED|Overall Study||1812
8884334|NCT01966107|9941746|FG001|STARTED|Overall Study||1818
8884335|NCT01966107|9941745|FG000|Full Analysis Set|Overall Study||1791
8884336|NCT01966107|9941746|FG001|Full Analysis Set|Overall Study||1798
8884337|NCT01966107|9941745|FG000|COMPLETED|Overall Study||1010
8884338|NCT01966107|9941746|FG001|COMPLETED|Overall Study||937
8884339|NCT01966107|9941745|FG000|NOT COMPLETED|Overall Study||802
8884340|NCT01966107|9941746|FG001|NOT COMPLETED|Overall Study||881
8884341|NCT01966120|9941754|FG000|STARTED|Overall Study||55
8884342|NCT01966120|9941755|FG001|STARTED|Overall Study||32
8884343|NCT01966120|9941754|FG000|COMPLETED|Overall Study||54
8884344|NCT01966120|9941755|FG001|COMPLETED|Overall Study||26
8884345|NCT01966120|9941754|FG000|NOT COMPLETED|Overall Study||1
8884346|NCT01966120|9941755|FG001|NOT COMPLETED|Overall Study||6
8884347|NCT01966159|9941763|FG000|STARTED|Overall Study||205
8884348|NCT01966159|9941764|FG001|STARTED|Overall Study||207
8884349|NCT01966159|9941763|FG000|COMPLETED|Overall Study||205
8884350|NCT01966159|9941764|FG001|COMPLETED|Overall Study||207
8884351|NCT01966159|9941763|FG000|NOT COMPLETED|Overall Study||0
8884352|NCT01966159|9941764|FG001|NOT COMPLETED|Overall Study||0
8884353|NCT01966354|9941773|FG000|STARTED|Overall Study||75
8884354|NCT01966354|9941774|FG001|STARTED|Overall Study||73
8884355|NCT01966354|9941775|FG002|STARTED|Overall Study||72
8884356|NCT01966354|9941773|FG000|COMPLETED|Overall Study||75
8884357|NCT01966354|9941774|FG001|COMPLETED|Overall Study||73
8884358|NCT01966354|9941775|FG002|COMPLETED|Overall Study||72
8884359|NCT01966354|9941773|FG000|NOT COMPLETED|Overall Study||0
8884360|NCT01966354|9941774|FG001|NOT COMPLETED|Overall Study||0
8884361|NCT01966354|9941775|FG002|NOT COMPLETED|Overall Study||0
8884362|NCT01966380|9941783|FG000|STARTED|Overall Study||3
8884363|NCT01966380|9941784|FG001|STARTED|Overall Study||3
8884364|NCT01966380|9941783|FG000|COMPLETED|Overall Study||3
8884365|NCT01966380|9941784|FG001|COMPLETED|Overall Study||2
8884366|NCT01966380|9941783|FG000|NOT COMPLETED|Overall Study||0
8884367|NCT01966380|9941784|FG001|NOT COMPLETED|Overall Study||1
8884368|NCT01966419|9941792|FG000|STARTED|Overall Study||115
8884369|NCT01966419|9941793|FG001|STARTED|Overall Study||116
8884370|NCT01966419|9941792|FG000|Intent to Treat Population (ITT)T)115|Overall Study||115
8884371|NCT01966419|9941793|FG001|Intent to Treat Population (ITT)T)115|Overall Study||116
8884372|NCT01966419|9941792|FG000|Safety Analysis Set (SAS)|Overall Study||112
8884373|NCT01966419|9941793|FG001|Safety Analysis Set (SAS)|Overall Study||114
8884374|NCT01966419|9941792|FG000|COMPLETED|Overall Study||74
8884375|NCT01966419|9941793|FG001|COMPLETED|Overall Study||80
8884376|NCT01966419|9941792|FG000|NOT COMPLETED|Overall Study||41
8884377|NCT01966419|9941793|FG001|NOT COMPLETED|Overall Study||36
8884378|NCT01966432|9941802|FG000|STARTED|Overall Study||10
8884379|NCT01966432|9941803|FG001|STARTED|Overall Study||34
9003445|NCT02918630|10066495|FG000|NOT COMPLETED|Overall Study||0
9003446|NCT02918630|10066496|FG001|NOT COMPLETED|Overall Study||0
9003447|NCT02918656|10066505|FG000|STARTED|Overall Study||54
9003448|NCT02918656|10066506|FG001|STARTED|Overall Study||60
9003449|NCT02918656|10066507|FG002|STARTED|Overall Study||57
9003450|NCT02918656|10066505|FG000|COMPLETED|Overall Study||54
9003451|NCT02918656|10066506|FG001|COMPLETED|Overall Study||60
9003452|NCT02918656|10066507|FG002|COMPLETED|Overall Study||57
9003453|NCT02918656|10066505|FG000|NOT COMPLETED|Overall Study||0
9003454|NCT02918656|10066506|FG001|NOT COMPLETED|Overall Study||0
9003455|NCT02918656|10066507|FG002|NOT COMPLETED|Overall Study||0
9003456|NCT02918669|10066515|FG000|STARTED|Overall Study||12
9003457|NCT02918669|10066515|FG000|COMPLETED|Overall Study||8
9003458|NCT02918669|10066515|FG000|NOT COMPLETED|Overall Study||4
9003459|NCT02918721|10066519|FG000|STARTED|Overall Study||70
9003460|NCT02918721|10066519|FG000|COMPLETED|Overall Study||70
9003461|NCT02918721|10066519|FG000|NOT COMPLETED|Overall Study||0
9003462|NCT02918773|10066526|FG000|STARTED|Overall Study||11
8572625|NCT00116207|9604832|FG000|STARTED|Overall Study||22
8572626|NCT00116207|9604833|FG001|STARTED|Overall Study||22
8572627|NCT00116207|9604832|FG000|COMPLETED|Overall Study||13
8572628|NCT00116207|9604833|FG001|COMPLETED|Overall Study||18
8572629|NCT00116207|9604832|FG000|NOT COMPLETED|Overall Study||9
8884380|NCT01966432|9941804|FG002|STARTED|Overall Study||54
8884381|NCT01966432|9941802|FG000|COMPLETED|Overall Study||5
8884382|NCT01966432|9941803|FG001|COMPLETED|Overall Study||21
8884383|NCT01966432|9941804|FG002|COMPLETED|Overall Study||28
8884384|NCT01966432|9941802|FG000|NOT COMPLETED|Overall Study||5
9003463|NCT02918773|10066527|FG001|STARTED|Overall Study||11
8572630|NCT00116207|9604833|FG001|NOT COMPLETED|Overall Study||4
8884385|NCT01966432|9941803|FG001|NOT COMPLETED|Overall Study||13
8884386|NCT01966432|9941804|FG002|NOT COMPLETED|Overall Study||26
8884387|NCT01966445|9941820|FG000|STARTED|Part1 (Median Exposure of 6.143 Weeks)||1
8884388|NCT01966445|9941821|FG001|STARTED|Part1 (Median Exposure of 6.143 Weeks)||3
8884389|NCT01966445|9941822|FG002|STARTED|Part1 (Median Exposure of 6.143 Weeks)||2
8884390|NCT01966445|9941823|FG003|STARTED|Part1 (Median Exposure of 6.143 Weeks)||5
8884391|NCT01966445|9941824|FG004|STARTED|Part1 (Median Exposure of 6.143 Weeks)||4
8884392|NCT01966445|9941825|FG005|STARTED|Part1 (Median Exposure of 6.143 Weeks)||5
8884393|NCT01966445|9941826|FG006|STARTED|Part1 (Median Exposure of 6.143 Weeks)||0
8884394|NCT01966445|9941820|FG000|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
8884395|NCT01966445|9941821|FG001|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
9003464|NCT02918773|10066526|FG000|COMPLETED|Overall Study||11
9003465|NCT02918773|10066527|FG001|COMPLETED|Overall Study||11
8884396|NCT01966445|9941822|FG002|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
8884397|NCT01966445|9941823|FG003|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||2
8572631|NCT00116272|9604841|FG000|STARTED|Overall Study||370
8572632|NCT00116272|9604842|FG001|STARTED|Overall Study||164
8572633|NCT00116272|9604841|FG000|COMPLETED|Overall Study|Indicates participants with a known outcome of pregnancy|359
8884398|NCT01966445|9941824|FG004|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
8884399|NCT01966445|9941825|FG005|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||4
8884400|NCT01966445|9941826|FG006|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||0
8884401|NCT01966445|9941820|FG000|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||0
8884402|NCT01966445|9941821|FG001|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||2
8884403|NCT01966445|9941822|FG002|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
8884404|NCT01966445|9941823|FG003|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||3
8884405|NCT01966445|9941824|FG004|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||3
8884406|NCT01966445|9941825|FG005|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
8884407|NCT01966445|9941826|FG006|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||0
8884408|NCT01966445|9941820|FG000|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
8884409|NCT01966445|9941821|FG001|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
8884410|NCT01966445|9941822|FG002|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
8884411|NCT01966445|9941823|FG003|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
8884412|NCT01966445|9941824|FG004|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
8884413|NCT01966445|9941825|FG005|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
8884414|NCT01966445|9941826|FG006|STARTED|Part2 (Median Exposure of 7.143 Weeks)||9
8884415|NCT01966445|9941820|FG000|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
8884416|NCT01966445|9941821|FG001|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
8884417|NCT01966445|9941822|FG002|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
8884418|NCT01966445|9941823|FG003|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
8884419|NCT01966445|9941824|FG004|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
8884420|NCT01966445|9941825|FG005|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
8884421|NCT01966445|9941826|FG006|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||4
8884422|NCT01966445|9941820|FG000|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
8884423|NCT01966445|9941821|FG001|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
8884424|NCT01966445|9941822|FG002|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
8884425|NCT01966445|9941823|FG003|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
8884426|NCT01966445|9941824|FG004|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
8884427|NCT01966445|9941825|FG005|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
8884428|NCT01966445|9941826|FG006|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||5
8884429|NCT01966458|9941844|FG000|STARTED|Overall Study||308
8884430|NCT01966458|9941845|FG001|STARTED|Overall Study||157
8884431|NCT01966458|9941844|FG000|COMPLETED|Overall Study||304
8884432|NCT01966458|9941845|FG001|COMPLETED|Overall Study||155
8884433|NCT01966458|9941844|FG000|NOT COMPLETED|Overall Study||4
8884434|NCT01966458|9941845|FG001|NOT COMPLETED|Overall Study||2
8884435|NCT01966718|9941851|FG000|STARTED|Overall Study||8
8884436|NCT01966718|9941851|FG000|COMPLETED|Overall Study||8
8884437|NCT01966718|9941851|FG000|NOT COMPLETED|Overall Study||0
8884438|NCT01966770|9941857|FG000|STARTED|Overall Study||20
8884439|NCT01966770|9941857|FG000|COMPLETED|Overall Study||20
8884440|NCT01966770|9941857|FG000|NOT COMPLETED|Overall Study||0
8884441|NCT01966796|9941895|FG000|STARTED|Overall Study||15
8884442|NCT01966796|9941896|FG001|STARTED|Overall Study||51
8884443|NCT01966796|9941897|FG002|STARTED|Overall Study||195
8884444|NCT01966796|9941898|FG003|STARTED|Overall Study||269
8884445|NCT01966796|9941895|FG000|COMPLETED|Overall Study||15
8884446|NCT01966796|9941896|FG001|COMPLETED|Overall Study||51
8884447|NCT01966796|9941897|FG002|COMPLETED|Overall Study||195
8884448|NCT01966796|9941898|FG003|COMPLETED|Overall Study||269
8884449|NCT01966796|9941895|FG000|NOT COMPLETED|Overall Study||0
8884450|NCT01966796|9941896|FG001|NOT COMPLETED|Overall Study||0
8884451|NCT01966796|9941897|FG002|NOT COMPLETED|Overall Study||0
8884452|NCT01966796|9941898|FG003|NOT COMPLETED|Overall Study||0
8884453|NCT01966809|9941912|FG000|STARTED|Overall Study||1
8884454|NCT01966809|9941912|FG000|COMPLETED|Overall Study||1
8884455|NCT01966809|9941912|FG000|NOT COMPLETED|Overall Study||0
8884456|NCT01966900|9941918|FG000|STARTED|Overall Study||8
8884457|NCT01966900|9941919|FG001|STARTED|Overall Study||6
8884458|NCT01966900|9941918|FG000|COMPLETED|Overall Study||6
8884459|NCT01966900|9941919|FG001|COMPLETED|Overall Study||6
8884460|NCT01966900|9941918|FG000|NOT COMPLETED|Overall Study||2
8884461|NCT01966900|9941919|FG001|NOT COMPLETED|Overall Study||0
8884462|NCT01966926|9941927|FG000|STARTED|Overall Study||15
8884463|NCT01966926|9941928|FG001|STARTED|Overall Study||15
8884464|NCT01966926|9941927|FG000|COMPLETED|Overall Study||15
8884465|NCT01966926|9941928|FG001|COMPLETED|Overall Study||15
8884466|NCT01966926|9941927|FG000|NOT COMPLETED|Overall Study||0
8884467|NCT01966926|9941928|FG001|NOT COMPLETED|Overall Study||0
8884468|NCT01966978|9941936|FG000|STARTED|Overall Study||61
8884469|NCT01966978|9941937|FG001|STARTED|Overall Study||59
8884470|NCT01966978|9941936|FG000|COMPLETED|Overall Study||44
8884471|NCT01966978|9941937|FG001|COMPLETED|Overall Study||46
8884472|NCT01966978|9941936|FG000|NOT COMPLETED|Overall Study||17
8884473|NCT01966978|9941937|FG001|NOT COMPLETED|Overall Study||13
8884474|NCT01967069|9941945|FG000|STARTED|Overall Study||182
8884475|NCT01967069|9941946|FG001|STARTED|Overall Study||95
8884476|NCT01967069|9941945|FG000|COMPLETED|Overall Study||174
8884477|NCT01967069|9941946|FG001|COMPLETED|Overall Study||87
8884478|NCT01967069|9941945|FG000|NOT COMPLETED|Overall Study||8
8884479|NCT01967069|9941946|FG001|NOT COMPLETED|Overall Study||8
8884480|NCT01967121|9941955|FG000|STARTED|Overall Study||25
8884481|NCT01967121|9941956|FG001|STARTED|Overall Study||25
8884482|NCT01967121|9941957|FG002|STARTED|Overall Study||25
8884483|NCT01967121|9941955|FG000|COMPLETED|Overall Study||25
8884484|NCT01967121|9941956|FG001|COMPLETED|Overall Study||25
8884485|NCT01967121|9941957|FG002|COMPLETED|Overall Study||25
8884486|NCT01967121|9941955|FG000|NOT COMPLETED|Overall Study||0
8884487|NCT01967121|9941956|FG001|NOT COMPLETED|Overall Study||0
8884488|NCT01967121|9941957|FG002|NOT COMPLETED|Overall Study||0
8884489|NCT01967134|9941968|FG000|STARTED|Overall Study||8
8884490|NCT01967134|9941969|FG001|STARTED|Overall Study||8
8884491|NCT01967134|9941970|FG002|STARTED|Overall Study||9
8884492|NCT01967134|9941968|FG000|COMPLETED|Overall Study||8
8884493|NCT01967134|9941969|FG001|COMPLETED|Overall Study||7
8884494|NCT01967134|9941970|FG002|COMPLETED|Overall Study||9
8884495|NCT01967134|9941968|FG000|NOT COMPLETED|Overall Study||0
8884496|NCT01967134|9941969|FG001|NOT COMPLETED|Overall Study||1
8884497|NCT01967134|9941970|FG002|NOT COMPLETED|Overall Study||0
8884498|NCT01967147|9941980|FG000|STARTED|Overall Study||112
8884499|NCT01967147|9941981|FG001|STARTED|Overall Study||102
8884500|NCT01967147|9941980|FG000|COMPLETED|Overall Study||99
8884501|NCT01967147|9941981|FG001|COMPLETED|Overall Study||82
8884502|NCT01967147|9941980|FG000|NOT COMPLETED|Overall Study||13
8884503|NCT01967147|9941981|FG001|NOT COMPLETED|Overall Study||20
8884504|NCT01967173|9941996|FG000|STARTED|Overall Study||69
8884505|NCT01967173|9941997|FG001|STARTED|Overall Study||69
8884506|NCT01967173|9941998|FG002|STARTED|Overall Study||71
8884507|NCT01967173|9941999|FG003|STARTED|Overall Study||71
8884508|NCT01967173|9942000|FG004|STARTED|Overall Study||73
8884509|NCT01967173|9942001|FG005|STARTED|Overall Study||72
8884510|NCT01967173|9942002|FG006|STARTED|Overall Study||75
8884511|NCT01967173|9942003|FG007|STARTED|Overall Study||74
8884512|NCT01967173|9941996|FG000|Completed 1st Period|Overall Study||58
8884513|NCT01967173|9941997|FG001|Completed 1st Period|Overall Study||60
8884514|NCT01967173|9941998|FG002|Completed 1st Period|Overall Study||67
9003466|NCT02918773|10066526|FG000|NOT COMPLETED|Overall Study||0
9003467|NCT02918773|10066527|FG001|NOT COMPLETED|Overall Study||0
9003468|NCT02918851|10066537|FG000|STARTED|Overall Study||14
9003469|NCT02918851|10066538|FG001|STARTED|Overall Study||14
9003470|NCT02918851|10066539|FG002|STARTED|Overall Study||14
9003471|NCT02918851|10066537|FG000|COMPLETED|Overall Study||10
9003472|NCT02918851|10066538|FG001|COMPLETED|Overall Study||10
9003473|NCT02918851|10066539|FG002|COMPLETED|Overall Study||10
9003474|NCT02918851|10066537|FG000|NOT COMPLETED|Overall Study||4
9003475|NCT02918851|10066538|FG001|NOT COMPLETED|Overall Study||4
9003476|NCT02918851|10066539|FG002|NOT COMPLETED|Overall Study||4
9003477|NCT02918877|10066549|FG000|STARTED|Overall Study||24
9003478|NCT02918877|10066550|FG001|STARTED|Overall Study||25
9003479|NCT02918877|10066549|FG000|COMPLETED|Overall Study||18
9003480|NCT02918877|10066550|FG001|COMPLETED|Overall Study||22
9003481|NCT02918877|10066549|FG000|NOT COMPLETED|Overall Study||6
9003482|NCT02918877|10066550|FG001|NOT COMPLETED|Overall Study||3
8634358|NCT00556439|9674675|FG001|STARTED|Study Entry to Week 12|No participants received placebo until the Week 12 Randomization|0
8634359|NCT00556439|9674676|FG002|STARTED|Study Entry to Week 12|39 signed informed consent with 5 not being eligible. The remaining 34 received study drug.|34
8634360|NCT00556439|9674677|FG003|STARTED|Study Entry to Week 12|No participants received placebo until the Week 12 Randomization|0
8634361|NCT00556439|9674674|FG000|COMPLETED|Study Entry to Week 12||41
8634362|NCT00556439|9674675|FG001|COMPLETED|Study Entry to Week 12||0
8634363|NCT00556439|9674676|FG002|COMPLETED|Study Entry to Week 12||26
9003483|NCT02918968|10066558|FG000|STARTED|1st Line AAT||102
8634364|NCT00556439|9674677|FG003|COMPLETED|Study Entry to Week 12||0
8634365|NCT00556439|9674674|FG000|NOT COMPLETED|Study Entry to Week 12||8
8634366|NCT00556439|9674675|FG001|NOT COMPLETED|Study Entry to Week 12||0
8634367|NCT00556439|9674676|FG002|NOT COMPLETED|Study Entry to Week 12||8
8634368|NCT00556439|9674677|FG003|NOT COMPLETED|Study Entry to Week 12||0
8634369|NCT00556439|9674674|FG000|STARTED|After Week 12 (Randomized Study Period)||20
8634370|NCT00556439|9674675|FG001|STARTED|After Week 12 (Randomized Study Period)||21
8634371|NCT00556439|9674676|FG002|STARTED|After Week 12 (Randomized Study Period)||11
8884515|NCT01967173|9941999|FG003|Completed 1st Period|Overall Study||65
9003484|NCT02918968|10066559|FG001|STARTED|1st Line AAT||104
9003485|NCT02918968|10066558|FG000|Maintained 1st Line AAT Without Progression|1st Line AAT||25
9003486|NCT02918968|10066559|FG001|Maintained 1st Line AAT Without Progression|1st Line AAT||8
9003487|NCT02918968|10066558|FG000|COMPLETED|1st Line AAT||73
9003488|NCT02918968|10066559|FG001|COMPLETED|1st Line AAT||93
9003489|NCT02918968|10066558|FG000|NOT COMPLETED|1st Line AAT||29
9003490|NCT02918968|10066559|FG001|NOT COMPLETED|1st Line AAT||11
8884516|NCT01967173|9942000|FG004|Completed 1st Period|Overall Study||64
8884517|NCT01967173|9942001|FG005|Completed 1st Period|Overall Study||62
8884518|NCT01967173|9942002|FG006|Completed 1st Period|Overall Study||67
8884519|NCT01967173|9942003|FG007|Completed 1st Period|Overall Study||69
8884520|NCT01967173|9941996|FG000|Completed 2nd Period|Overall Study||52
8884521|NCT01967173|9941997|FG001|Completed 2nd Period|Overall Study||58
8884522|NCT01967173|9941998|FG002|Completed 2nd Period|Overall Study||63
8884523|NCT01967173|9941999|FG003|Completed 2nd Period|Overall Study||62
8884524|NCT01967173|9942000|FG004|Completed 2nd Period|Overall Study||63
8884525|NCT01967173|9942001|FG005|Completed 2nd Period|Overall Study||57
8884526|NCT01967173|9942002|FG006|Completed 2nd Period|Overall Study||63
8884527|NCT01967173|9942003|FG007|Completed 2nd Period|Overall Study||61
8884528|NCT01967173|9941996|FG000|Completed 3rd Period|Overall Study||48
8884529|NCT01967173|9941997|FG001|Completed 3rd Period|Overall Study||54
8884530|NCT01967173|9941998|FG002|Completed 3rd Period|Overall Study||60
8884531|NCT01967173|9941999|FG003|Completed 3rd Period|Overall Study||61
8884532|NCT01967173|9942000|FG004|Completed 3rd Period|Overall Study||59
8884533|NCT01967173|9942001|FG005|Completed 3rd Period|Overall Study||56
8884534|NCT01967173|9942002|FG006|Completed 3rd Period|Overall Study||59
8884535|NCT01967173|9942003|FG007|Completed 3rd Period|Overall Study||56
8884536|NCT01967173|9941996|FG000|Completed 4th Period|Overall Study||45
8884537|NCT01967173|9941997|FG001|Completed 4th Period|Overall Study||52
8884538|NCT01967173|9941998|FG002|Completed 4th Period|Overall Study||55
8884539|NCT01967173|9941999|FG003|Completed 4th Period|Overall Study||57
8634372|NCT00556439|9674677|FG003|STARTED|After Week 12 (Randomized Study Period)||15
8634373|NCT00556439|9674674|FG000|COMPLETED|After Week 12 (Randomized Study Period)||17
8634374|NCT00556439|9674675|FG001|COMPLETED|After Week 12 (Randomized Study Period)||17
8634375|NCT00556439|9674676|FG002|COMPLETED|After Week 12 (Randomized Study Period)||11
8634376|NCT00556439|9674677|FG003|COMPLETED|After Week 12 (Randomized Study Period)||14
8634377|NCT00556439|9674674|FG000|NOT COMPLETED|After Week 12 (Randomized Study Period)||3
8884540|NCT01967173|9942000|FG004|Completed 4th Period|Overall Study||56
8884541|NCT01967173|9942001|FG005|Completed 4th Period|Overall Study||49
8884542|NCT01967173|9942002|FG006|Completed 4th Period|Overall Study||57
8884543|NCT01967173|9942003|FG007|Completed 4th Period|Overall Study||50
8884544|NCT01967173|9941996|FG000|COMPLETED|Overall Study||45
8884545|NCT01967173|9941997|FG001|COMPLETED|Overall Study||52
8884546|NCT01967173|9941998|FG002|COMPLETED|Overall Study||55
8884547|NCT01967173|9941999|FG003|COMPLETED|Overall Study||57
8884548|NCT01967173|9942000|FG004|COMPLETED|Overall Study||56
8884549|NCT01967173|9942001|FG005|COMPLETED|Overall Study||49
8884550|NCT01967173|9942002|FG006|COMPLETED|Overall Study||57
8884551|NCT01967173|9942003|FG007|COMPLETED|Overall Study||50
8884552|NCT01967173|9941996|FG000|NOT COMPLETED|Overall Study||24
8884553|NCT01967173|9941997|FG001|NOT COMPLETED|Overall Study||17
8884554|NCT01967173|9941998|FG002|NOT COMPLETED|Overall Study||16
8884555|NCT01967173|9941999|FG003|NOT COMPLETED|Overall Study||14
8884556|NCT01967173|9942000|FG004|NOT COMPLETED|Overall Study||17
8884557|NCT01967173|9942001|FG005|NOT COMPLETED|Overall Study||23
8884558|NCT01967173|9942002|FG006|NOT COMPLETED|Overall Study||18
8884559|NCT01967173|9942003|FG007|NOT COMPLETED|Overall Study||24
8884560|NCT01967225|9942019|FG000|STARTED|Overall Study||84
8884561|NCT01967225|9942020|FG001|STARTED|Overall Study||41
8884562|NCT01967225|9942019|FG000|Participants Received Treatment|Overall Study||83
8884563|NCT01967225|9942020|FG001|Participants Received Treatment|Overall Study||41
8884564|NCT01967225|9942019|FG000|COMPLETED|Overall Study||72
8884565|NCT01967225|9942020|FG001|COMPLETED|Overall Study||38
8884566|NCT01967225|9942019|FG000|NOT COMPLETED|Overall Study||12
8884567|NCT01967225|9942020|FG001|NOT COMPLETED|Overall Study||3
8884568|NCT01967277|9942030|FG000|STARTED|Overall Study||22
8884569|NCT01967277|9942031|FG001|STARTED|Overall Study||22
8884570|NCT01967277|9942030|FG000|COMPLETED|Overall Study||21
8884571|NCT01967277|9942031|FG001|COMPLETED|Overall Study||19
8634378|NCT00556439|9674675|FG001|NOT COMPLETED|After Week 12 (Randomized Study Period)||4
8634379|NCT00556439|9674676|FG002|NOT COMPLETED|After Week 12 (Randomized Study Period)||0
8634380|NCT00556439|9674677|FG003|NOT COMPLETED|After Week 12 (Randomized Study Period)||1
8634381|NCT00556452|9674690|FG000|STARTED|Overall Study||6
8634382|NCT00556452|9674691|FG001|STARTED|Overall Study||21
8634383|NCT00556452|9674692|FG002|STARTED|Overall Study||19
8634384|NCT00556452|9674690|FG000|COMPLETED|Overall Study||6
8634385|NCT00556452|9674691|FG001|COMPLETED|Overall Study||21
8634386|NCT00556452|9674692|FG002|COMPLETED|Overall Study||19
8634387|NCT00556452|9674690|FG000|NOT COMPLETED|Overall Study||0
8634388|NCT00556452|9674691|FG001|NOT COMPLETED|Overall Study||0
8634389|NCT00556452|9674692|FG002|NOT COMPLETED|Overall Study||0
8634390|NCT00556478|9674699|FG000|STARTED|Double-blind Phase||171
8634391|NCT00556478|9674700|FG001|STARTED|Double-blind Phase||85
8634392|NCT00556478|9674699|FG000|ITT|Double-blind Phase||167
8634393|NCT00556478|9674700|FG001|ITT|Double-blind Phase||82
8634394|NCT00556478|9674699|FG000|COMPLETED|Double-blind Phase||150
8634395|NCT00556478|9674700|FG001|COMPLETED|Double-blind Phase||77
8634396|NCT00556478|9674699|FG000|NOT COMPLETED|Double-blind Phase||21
8884572|NCT01967277|9942030|FG000|NOT COMPLETED|Overall Study||1
8884573|NCT01967277|9942031|FG001|NOT COMPLETED|Overall Study||3
8884574|NCT01967342|9942040|FG000|STARTED|Overall Study||98
8884575|NCT01967342|9942041|FG001|STARTED|Overall Study||95
8884576|NCT01967342|9942042|FG002|STARTED|Overall Study||97
8884577|NCT01967342|9942040|FG000|5-week Follow-up|Overall Study||83
8884578|NCT01967342|9942041|FG001|5-week Follow-up|Overall Study||78
8884579|NCT01967342|9942042|FG002|5-week Follow-up|Overall Study||76
8884580|NCT01967342|9942040|FG000|10-week Follow-up|Overall Study||78
8884581|NCT01967342|9942041|FG001|10-week Follow-up|Overall Study||83
8884582|NCT01967342|9942042|FG002|10-week Follow-up|Overall Study||80
8884583|NCT01967342|9942040|FG000|COMPLETED|Overall Study||71
8884584|NCT01967342|9942041|FG001|COMPLETED|Overall Study||70
8634397|NCT00556478|9674700|FG001|NOT COMPLETED|Double-blind Phase||8
8634398|NCT00556478|9674699|FG000|STARTED|Open-Label Phase||146
8634399|NCT00556478|9674700|FG001|STARTED|Open-Label Phase||77
8884585|NCT01967342|9942042|FG002|COMPLETED|Overall Study||68
8884586|NCT01967342|9942040|FG000|NOT COMPLETED|Overall Study||27
9003491|NCT02918968|10066558|FG000|STARTED|2nd Line AAT|Participants who maintained 1st line AAT without progression did not enter 2nd line AAT|48
9003492|NCT02918968|10066559|FG001|STARTED|2nd Line AAT|Participants who maintained 1st line AAT without progression did not enter 2nd line AAT|85
9003493|NCT02918968|10066558|FG000|COMPLETED|2nd Line AAT||23
9003494|NCT02918968|10066559|FG001|COMPLETED|2nd Line AAT||73
9003495|NCT02918968|10066558|FG000|NOT COMPLETED|2nd Line AAT||25
9003496|NCT02918968|10066559|FG001|NOT COMPLETED|2nd Line AAT||12
9003497|NCT02919007|10066567|FG000|STARTED|Overall Study||25
9003498|NCT02919007|10066567|FG000|COMPLETED|Overall Study||25
9003499|NCT02919007|10066567|FG000|NOT COMPLETED|Overall Study||0
9003500|NCT02919111|10066571|FG000|STARTED|Overall Study||299
9003501|NCT02919111|10066571|FG000|COMPLETED|Overall Study||299
9003502|NCT02919111|10066571|FG000|NOT COMPLETED|Overall Study||0
9003503|NCT02919267|10066579|FG000|STARTED|Overall Study||10
9003504|NCT02919267|10066580|FG001|STARTED|Overall Study||12
9003505|NCT02919267|10066581|FG002|STARTED|Overall Study||13
9003506|NCT02919267|10066582|FG003|STARTED|Overall Study||14
9003507|NCT02919267|10066579|FG000|COMPLETED|Overall Study||10
9003508|NCT02919267|10066580|FG001|COMPLETED|Overall Study||9
9003509|NCT02919267|10066581|FG002|COMPLETED|Overall Study||10
9003510|NCT02919267|10066582|FG003|COMPLETED|Overall Study||10
9003511|NCT02919267|10066579|FG000|NOT COMPLETED|Overall Study||0
9003512|NCT02919267|10066580|FG001|NOT COMPLETED|Overall Study||3
9003513|NCT02919267|10066581|FG002|NOT COMPLETED|Overall Study||3
9003514|NCT02919267|10066582|FG003|NOT COMPLETED|Overall Study||4
9003515|NCT02919423|10066594|FG000|STARTED|Overall Study||6
9003516|NCT02919423|10066595|FG001|STARTED|Overall Study||25
9003517|NCT02919423|10066594|FG000|COMPLETED|Overall Study||4
9003518|NCT02919423|10066595|FG001|COMPLETED|Overall Study||16
9003519|NCT02919423|10066594|FG000|NOT COMPLETED|Overall Study||2
9003520|NCT02919423|10066595|FG001|NOT COMPLETED|Overall Study||9
9003521|NCT02919475|10066606|FG000|STARTED|Overall Study||52
9003522|NCT02919475|10066607|FG001|STARTED|Overall Study||52
9003523|NCT02919475|10066608|FG002|STARTED|Overall Study||52
9003524|NCT02919475|10066609|FG003|STARTED|Overall Study||51
9003525|NCT02919475|10066610|FG004|STARTED|Overall Study||52
9003526|NCT02919475|10066606|FG000|Started Dosing|Overall Study||51
9003527|NCT02919475|10066607|FG001|Started Dosing|Overall Study||52
9003528|NCT02919475|10066608|FG002|Started Dosing|Overall Study||52
9003529|NCT02919475|10066609|FG003|Started Dosing|Overall Study||51
9003530|NCT02919475|10066610|FG004|Started Dosing|Overall Study||52
9003531|NCT02919475|10066606|FG000|COMPLETED|Overall Study||46
9003532|NCT02919475|10066607|FG001|COMPLETED|Overall Study||44
9003533|NCT02919475|10066608|FG002|COMPLETED|Overall Study||47
9003534|NCT02919475|10066609|FG003|COMPLETED|Overall Study||38
9003535|NCT02919475|10066610|FG004|COMPLETED|Overall Study||48
9003536|NCT02919475|10066606|FG000|NOT COMPLETED|Overall Study||6
9003537|NCT02919475|10066607|FG001|NOT COMPLETED|Overall Study||8
9003538|NCT02919475|10066608|FG002|NOT COMPLETED|Overall Study||5
9003539|NCT02919475|10066609|FG003|NOT COMPLETED|Overall Study||13
8634400|NCT00556478|9674699|FG000|Treated in Open-label|Open-Label Phase||142
8634401|NCT00556478|9674700|FG001|Treated in Open-label|Open-Label Phase||71
8634402|NCT00556478|9674699|FG000|COMPLETED|Open-Label Phase||132
8634403|NCT00556478|9674700|FG001|COMPLETED|Open-Label Phase||67
8634404|NCT00556478|9674699|FG000|NOT COMPLETED|Open-Label Phase||14
8634405|NCT00556478|9674700|FG001|NOT COMPLETED|Open-Label Phase||10
8634406|NCT00556491|9674711|FG000|STARTED|Overall Study|January 2008|20
8634407|NCT00556491|9674712|FG001|STARTED|Overall Study||20
8634408|NCT00556491|9674711|FG000|COMPLETED|Overall Study||19
8634409|NCT00556491|9674712|FG001|COMPLETED|Overall Study||19
8634410|NCT00556491|9674711|FG000|NOT COMPLETED|Overall Study||1
8634411|NCT00556491|9674712|FG001|NOT COMPLETED|Overall Study||1
8634412|NCT00556504|9674730|FG000|STARTED|Overall Study||42
8634413|NCT00556504|9674731|FG001|STARTED|Overall Study||42
8634414|NCT00556504|9674730|FG000|Intend-to Treat Population|Overall Study||42
8634415|NCT00556504|9674731|FG001|Intend-to Treat Population|Overall Study||42
8634416|NCT00556504|9674730|FG000|Safety Population|Overall Study||41
8634417|NCT00556504|9674731|FG001|Safety Population|Overall Study||42
8634418|NCT00556504|9674730|FG000|COMPLETED|Overall Study||34
8634419|NCT00556504|9674731|FG001|COMPLETED|Overall Study||33
8884587|NCT01967342|9942041|FG001|NOT COMPLETED|Overall Study||25
8884588|NCT01967342|9942042|FG002|NOT COMPLETED|Overall Study||29
8884589|NCT01967433|9942052|FG000|STARTED|Overall Study||61
8884590|NCT01967433|9942053|FG001|STARTED|Overall Study||59
8884591|NCT01967433|9942052|FG000|COMPLETED|Overall Study||61
8884592|NCT01967433|9942053|FG001|COMPLETED|Overall Study||58
8884593|NCT01967433|9942052|FG000|NOT COMPLETED|Overall Study||0
8884594|NCT01967433|9942053|FG001|NOT COMPLETED|Overall Study||1
8884595|NCT01967537|9942065|FG000|STARTED|Overall Study||341
8884596|NCT01967537|9942065|FG000|COMPLETED|Overall Study||281
8884597|NCT01967537|9942065|FG000|NOT COMPLETED|Overall Study||60
9003540|NCT02919475|10066610|FG004|NOT COMPLETED|Overall Study||4
9003541|NCT02919657|10066622|FG000|STARTED|Overall Study|10 Participants|10
8634420|NCT00556504|9674730|FG000|NOT COMPLETED|Overall Study||8
8634421|NCT00556504|9674731|FG001|NOT COMPLETED|Overall Study||9
8634422|NCT00556543|9674737|FG000|STARTED|Overall Study||10
8634423|NCT00556543|9674737|FG000|COMPLETED|Overall Study|Subjects completed 180 days of study enrollment|10
8634424|NCT00556543|9674737|FG000|NOT COMPLETED|Overall Study||0
8884598|NCT01967550|9942071|FG000|STARTED|Overall Study||153
8884599|NCT01967550|9942072|FG001|STARTED|Overall Study||151
8884600|NCT01967550|9942071|FG000|COMPLETED|Overall Study||148
8884601|NCT01967550|9942072|FG001|COMPLETED|Overall Study||149
8884602|NCT01967550|9942071|FG000|NOT COMPLETED|Overall Study||5
8884603|NCT01967550|9942072|FG001|NOT COMPLETED|Overall Study||2
8884604|NCT01967576|9942078|FG000|STARTED|Overall Study||14
8884605|NCT01967576|9942078|FG000|COMPLETED|Overall Study||7
8884606|NCT01967576|9942078|FG000|NOT COMPLETED|Overall Study||7
8884607|NCT01967628|9942084|FG000|STARTED|Overall Study||48
8884608|NCT01967628|9942085|FG001|STARTED|Overall Study||50
8884609|NCT01967628|9942084|FG000|COMPLETED|Overall Study||21
8884610|NCT01967628|9942085|FG001|COMPLETED|Overall Study||19
8884611|NCT01967628|9942084|FG000|NOT COMPLETED|Overall Study||27
8884612|NCT01967628|9942085|FG001|NOT COMPLETED|Overall Study||31
8884613|NCT01967641|9942091|FG000|STARTED|Randomized||51
8884614|NCT01967641|9942091|FG000|COMPLETED|Randomized|Completed week 12|43
8884615|NCT01967641|9942091|FG000|NOT COMPLETED|Randomized||8
8884616|NCT01967641|9942091|FG000|STARTED|Admission to Inpatient Phase||43
8884617|NCT01967641|9942091|FG000|COMPLETED|Admission to Inpatient Phase|Completed 7 week inpatient phase|31
8884618|NCT01967641|9942091|FG000|NOT COMPLETED|Admission to Inpatient Phase||12
8884619|NCT01967641|9942091|FG000|STARTED|12-week Outpatient Phase||31
8884620|NCT01967641|9942091|FG000|COMPLETED|12-week Outpatient Phase|Completed week 12 of outpatient phase|18
8884621|NCT01967641|9942091|FG000|NOT COMPLETED|12-week Outpatient Phase||13
8884622|NCT01967706|9942098|FG000|STARTED|Washout Period of 1 Day (Day 0)||22
8884623|NCT01967706|9942099|FG001|STARTED|Washout Period of 1 Day (Day 0)||22
8884624|NCT01967706|9942100|FG002|STARTED|Washout Period of 1 Day (Day 0)||9
8884625|NCT01967706|9942101|FG003|STARTED|Washout Period of 1 Day (Day 0)||9
8884626|NCT01967706|9942098|FG000|COMPLETED|Washout Period of 1 Day (Day 0)||22
8884627|NCT01967706|9942099|FG001|COMPLETED|Washout Period of 1 Day (Day 0)||22
8884628|NCT01967706|9942100|FG002|COMPLETED|Washout Period of 1 Day (Day 0)||9
8884629|NCT01967706|9942101|FG003|COMPLETED|Washout Period of 1 Day (Day 0)||9
8884630|NCT01967706|9942098|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
8884631|NCT01967706|9942099|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
8884632|NCT01967706|9942100|FG002|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
8884633|NCT01967706|9942101|FG003|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
8884634|NCT01967706|9942098|FG000|STARTED|First Intervention (Day 1)||22
8884635|NCT01967706|9942099|FG001|STARTED|First Intervention (Day 1)||22
8884636|NCT01967706|9942100|FG002|STARTED|First Intervention (Day 1)||9
8884637|NCT01967706|9942101|FG003|STARTED|First Intervention (Day 1)||9
8884638|NCT01967706|9942098|FG000|COMPLETED|First Intervention (Day 1)||21
8884639|NCT01967706|9942099|FG001|COMPLETED|First Intervention (Day 1)||22
8884640|NCT01967706|9942100|FG002|COMPLETED|First Intervention (Day 1)||9
8884641|NCT01967706|9942101|FG003|COMPLETED|First Intervention (Day 1)||9
8884642|NCT01967706|9942098|FG000|NOT COMPLETED|First Intervention (Day 1)||1
8884643|NCT01967706|9942099|FG001|NOT COMPLETED|First Intervention (Day 1)||0
8884644|NCT01967706|9942100|FG002|NOT COMPLETED|First Intervention (Day 1)||0
8884645|NCT01967706|9942101|FG003|NOT COMPLETED|First Intervention (Day 1)||0
8884646|NCT01967706|9942098|FG000|STARTED|Washout Period of 1 Day (Day 2)||21
8884647|NCT01967706|9942099|FG001|STARTED|Washout Period of 1 Day (Day 2)||22
8884648|NCT01967706|9942100|FG002|STARTED|Washout Period of 1 Day (Day 2)||9
8884649|NCT01967706|9942101|FG003|STARTED|Washout Period of 1 Day (Day 2)||9
8884650|NCT01967706|9942098|FG000|COMPLETED|Washout Period of 1 Day (Day 2)||21
8884651|NCT01967706|9942099|FG001|COMPLETED|Washout Period of 1 Day (Day 2)||22
8884652|NCT01967706|9942100|FG002|COMPLETED|Washout Period of 1 Day (Day 2)||9
8884653|NCT01967706|9942101|FG003|COMPLETED|Washout Period of 1 Day (Day 2)||9
8884654|NCT01967706|9942098|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
8884655|NCT01967706|9942099|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
8884656|NCT01967706|9942100|FG002|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
8884657|NCT01967706|9942101|FG003|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
8884658|NCT01967706|9942098|FG000|STARTED|Second Intervention (Day 3)||21
8884659|NCT01967706|9942099|FG001|STARTED|Second Intervention (Day 3)||22
8884660|NCT01967706|9942100|FG002|STARTED|Second Intervention (Day 3)||9
8884661|NCT01967706|9942101|FG003|STARTED|Second Intervention (Day 3)||9
8884662|NCT01967706|9942098|FG000|COMPLETED|Second Intervention (Day 3)||21
8884663|NCT01967706|9942099|FG001|COMPLETED|Second Intervention (Day 3)||22
9003542|NCT02919657|10066623|FG001|STARTED|Overall Study|10 Participants|10
9003543|NCT02919657|10066622|FG000|COMPLETED|Overall Study|completed with the same initial 10 participants|10
8884664|NCT01967706|9942100|FG002|COMPLETED|Second Intervention (Day 3)||9
8884665|NCT01967706|9942101|FG003|COMPLETED|Second Intervention (Day 3)||9
8884666|NCT01967706|9942098|FG000|NOT COMPLETED|Second Intervention (Day 3)||0
8884667|NCT01967706|9942099|FG001|NOT COMPLETED|Second Intervention (Day 3)||0
8884668|NCT01967706|9942100|FG002|NOT COMPLETED|Second Intervention (Day 3)||0
8884669|NCT01967706|9942101|FG003|NOT COMPLETED|Second Intervention (Day 3)||0
8884670|NCT01967719|9942112|FG000|STARTED|Washout Period of 1 Day (Day 0)||22
8884671|NCT01967719|9942113|FG001|STARTED|Washout Period of 1 Day (Day 0)||22
8884672|NCT01967719|9942114|FG002|STARTED|Washout Period of 1 Day (Day 0)||9
8884673|NCT01967719|9942115|FG003|STARTED|Washout Period of 1 Day (Day 0)||9
8884674|NCT01967719|9942112|FG000|COMPLETED|Washout Period of 1 Day (Day 0)||22
8884675|NCT01967719|9942113|FG001|COMPLETED|Washout Period of 1 Day (Day 0)||22
8884676|NCT01967719|9942114|FG002|COMPLETED|Washout Period of 1 Day (Day 0)||9
8884677|NCT01967719|9942115|FG003|COMPLETED|Washout Period of 1 Day (Day 0)||9
8884678|NCT01967719|9942112|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
8884679|NCT01967719|9942113|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
8884680|NCT01967719|9942114|FG002|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
8884681|NCT01967719|9942115|FG003|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
8634425|NCT00556673|9674746|FG000|STARTED|Overall Study||16
8634426|NCT00556673|9674747|FG001|STARTED|Overall Study||15
8634427|NCT00556673|9674746|FG000|Pharmacodynamic (PD) Population|Overall Study|4 patients inadvertently unblinded were not included in PD analysis population.|12
8634428|NCT00556673|9674747|FG001|Pharmacodynamic (PD) Population|Overall Study|3 patients inadvertently unblinded were not included in PD analysis population.|12
8634429|NCT00556673|9674746|FG000|COMPLETED|Overall Study||13
8634430|NCT00556673|9674747|FG001|COMPLETED|Overall Study||13
8634431|NCT00556673|9674746|FG000|NOT COMPLETED|Overall Study||3
8634432|NCT00556673|9674747|FG001|NOT COMPLETED|Overall Study||2
8634433|NCT00556712|9674757|FG000|STARTED|Overall Study||451
8884682|NCT01967719|9942112|FG000|STARTED|First Intervention (Day 1)||22
8884683|NCT01967719|9942113|FG001|STARTED|First Intervention (Day 1)||22
8884684|NCT01967719|9942114|FG002|STARTED|First Intervention (Day 1)||9
8884685|NCT01967719|9942115|FG003|STARTED|First Intervention (Day 1)||9
8884686|NCT01967719|9942112|FG000|COMPLETED|First Intervention (Day 1)||22
8884687|NCT01967719|9942113|FG001|COMPLETED|First Intervention (Day 1)||21
8884688|NCT01967719|9942114|FG002|COMPLETED|First Intervention (Day 1)||9
8884689|NCT01967719|9942115|FG003|COMPLETED|First Intervention (Day 1)||8
8884690|NCT01967719|9942112|FG000|NOT COMPLETED|First Intervention (Day 1)||0
8884691|NCT01967719|9942113|FG001|NOT COMPLETED|First Intervention (Day 1)||1
8884692|NCT01967719|9942114|FG002|NOT COMPLETED|First Intervention (Day 1)||0
8884693|NCT01967719|9942115|FG003|NOT COMPLETED|First Intervention (Day 1)||1
8884694|NCT01967719|9942112|FG000|STARTED|Washout Period of 1 Day (Day 2)||22
8884695|NCT01967719|9942113|FG001|STARTED|Washout Period of 1 Day (Day 2)||21
8884696|NCT01967719|9942114|FG002|STARTED|Washout Period of 1 Day (Day 2)||9
8634434|NCT00556712|9674758|FG001|STARTED|Overall Study||438
8634435|NCT00556712|9674757|FG000|COMPLETED|Overall Study|Data cutoff date: 17 May 2008|0
8634436|NCT00556712|9674758|FG001|COMPLETED|Overall Study|Data cutoff date: 17 May 2008|0
8634437|NCT00556712|9674757|FG000|NOT COMPLETED|Overall Study||451
8634438|NCT00556712|9674758|FG001|NOT COMPLETED|Overall Study||438
8634439|NCT00556842|9674766|FG000|STARTED|Overall Study||749
8884697|NCT01967719|9942115|FG003|STARTED|Washout Period of 1 Day (Day 2)||8
8884698|NCT01967719|9942112|FG000|COMPLETED|Washout Period of 1 Day (Day 2)||22
8884699|NCT01967719|9942113|FG001|COMPLETED|Washout Period of 1 Day (Day 2)||21
8884700|NCT01967719|9942114|FG002|COMPLETED|Washout Period of 1 Day (Day 2)||9
8884701|NCT01967719|9942115|FG003|COMPLETED|Washout Period of 1 Day (Day 2)||8
8884702|NCT01967719|9942112|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
8634440|NCT00556842|9674767|FG001|STARTED|Overall Study||746
8634441|NCT00556842|9674766|FG000|COMPLETED|Overall Study||718
8634442|NCT00556842|9674767|FG001|COMPLETED|Overall Study||723
8634443|NCT00556842|9674766|FG000|NOT COMPLETED|Overall Study||31
8884703|NCT01967719|9942113|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
8884704|NCT01967719|9942114|FG002|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
8884705|NCT01967719|9942115|FG003|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
8884706|NCT01967719|9942112|FG000|STARTED|Second Intervention (Day 3)||22
8884707|NCT01967719|9942113|FG001|STARTED|Second Intervention (Day 3)||21
8884708|NCT01967719|9942114|FG002|STARTED|Second Intervention (Day 3)||9
8884709|NCT01967719|9942115|FG003|STARTED|Second Intervention (Day 3)||8
8884710|NCT01967719|9942112|FG000|COMPLETED|Second Intervention (Day 3)||22
8884711|NCT01967719|9942113|FG001|COMPLETED|Second Intervention (Day 3)||20
8884712|NCT01967719|9942114|FG002|COMPLETED|Second Intervention (Day 3)||9
8884713|NCT01967719|9942115|FG003|COMPLETED|Second Intervention (Day 3)||8
8884714|NCT01967719|9942112|FG000|NOT COMPLETED|Second Intervention (Day 3)||0
8884715|NCT01967719|9942113|FG001|NOT COMPLETED|Second Intervention (Day 3)||1
8884716|NCT01967719|9942114|FG002|NOT COMPLETED|Second Intervention (Day 3)||0
8884717|NCT01967719|9942115|FG003|NOT COMPLETED|Second Intervention (Day 3)||0
8884718|NCT01967732|9942127|FG000|STARTED|Washout Period of 1 Day (Day 0)||22
8884719|NCT01967732|9942128|FG001|STARTED|Washout Period of 1 Day (Day 0)||22
8884720|NCT01967732|9942129|FG002|STARTED|Washout Period of 1 Day (Day 0)||9
8884721|NCT01967732|9942130|FG003|STARTED|Washout Period of 1 Day (Day 0)||9
8884722|NCT01967732|9942127|FG000|COMPLETED|Washout Period of 1 Day (Day 0)||22
8884723|NCT01967732|9942128|FG001|COMPLETED|Washout Period of 1 Day (Day 0)||21
8884724|NCT01967732|9942129|FG002|COMPLETED|Washout Period of 1 Day (Day 0)||9
8884725|NCT01967732|9942130|FG003|COMPLETED|Washout Period of 1 Day (Day 0)||9
8884726|NCT01967732|9942127|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
8884727|NCT01967732|9942128|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 0)||1
8884728|NCT01967732|9942129|FG002|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
8884729|NCT01967732|9942130|FG003|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
8634444|NCT00556842|9674767|FG001|NOT COMPLETED|Overall Study||23
8634445|NCT00556894|9674784|FG000|STARTED|Overall Study||82
8634446|NCT00556894|9674785|FG001|STARTED|Overall Study||87
8634447|NCT00556894|9674786|FG002|STARTED|Overall Study||84
8634448|NCT00556894|9674784|FG000|COMPLETED|Overall Study||66
8884730|NCT01967732|9942127|FG000|STARTED|First Intervention (Day 1)||22
8884731|NCT01967732|9942128|FG001|STARTED|First Intervention (Day 1)||21
8884732|NCT01967732|9942129|FG002|STARTED|First Intervention (Day 1)||9
8884733|NCT01967732|9942130|FG003|STARTED|First Intervention (Day 1)||9
8884734|NCT01967732|9942127|FG000|COMPLETED|First Intervention (Day 1)||22
8884735|NCT01967732|9942128|FG001|COMPLETED|First Intervention (Day 1)|Subject discontinued from the study prior to product use|20
8884736|NCT01967732|9942129|FG002|COMPLETED|First Intervention (Day 1)||9
8884737|NCT01967732|9942130|FG003|COMPLETED|First Intervention (Day 1)||9
8884738|NCT01967732|9942127|FG000|NOT COMPLETED|First Intervention (Day 1)||0
8884739|NCT01967732|9942128|FG001|NOT COMPLETED|First Intervention (Day 1)||1
8884740|NCT01967732|9942129|FG002|NOT COMPLETED|First Intervention (Day 1)||0
8884741|NCT01967732|9942130|FG003|NOT COMPLETED|First Intervention (Day 1)||0
8884742|NCT01967732|9942127|FG000|STARTED|Washout Period of 1 Day (Day 2)||22
8884743|NCT01967732|9942128|FG001|STARTED|Washout Period of 1 Day (Day 2)||20
8884744|NCT01967732|9942129|FG002|STARTED|Washout Period of 1 Day (Day 2)||9
8884745|NCT01967732|9942130|FG003|STARTED|Washout Period of 1 Day (Day 2)||9
8884746|NCT01967732|9942127|FG000|COMPLETED|Washout Period of 1 Day (Day 2)||22
8884747|NCT01967732|9942128|FG001|COMPLETED|Washout Period of 1 Day (Day 2)||20
8884748|NCT01967732|9942129|FG002|COMPLETED|Washout Period of 1 Day (Day 2)||9
8884749|NCT01967732|9942130|FG003|COMPLETED|Washout Period of 1 Day (Day 2)||9
8884750|NCT01967732|9942127|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
8884751|NCT01967732|9942128|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
8884752|NCT01967732|9942129|FG002|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
8884753|NCT01967732|9942130|FG003|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
8884754|NCT01967732|9942127|FG000|STARTED|Second Intervention (Day 3)||22
8884755|NCT01967732|9942128|FG001|STARTED|Second Intervention (Day 3)||20
8884756|NCT01967732|9942129|FG002|STARTED|Second Intervention (Day 3)||9
8884757|NCT01967732|9942130|FG003|STARTED|Second Intervention (Day 3)||9
8884758|NCT01967732|9942127|FG000|COMPLETED|Second Intervention (Day 3)||22
8884759|NCT01967732|9942128|FG001|COMPLETED|Second Intervention (Day 3)||20
8884760|NCT01967732|9942129|FG002|COMPLETED|Second Intervention (Day 3)||9
8884761|NCT01967732|9942130|FG003|COMPLETED|Second Intervention (Day 3)||9
8884762|NCT01967732|9942127|FG000|NOT COMPLETED|Second Intervention (Day 3)||0
8884763|NCT01967732|9942128|FG001|NOT COMPLETED|Second Intervention (Day 3)||0
8884764|NCT01967732|9942129|FG002|NOT COMPLETED|Second Intervention (Day 3)||0
8884765|NCT01967732|9942130|FG003|NOT COMPLETED|Second Intervention (Day 3)||0
8884766|NCT01967784|9942138|FG000|STARTED|Overall Study||100
8884767|NCT01967784|9942138|FG000|COMPLETED|Overall Study||100
8884768|NCT01967784|9942138|FG000|NOT COMPLETED|Overall Study||0
8884769|NCT01967836|9942142|FG000|STARTED|Overall Study||20
8884770|NCT01967836|9942142|FG000|COMPLETED|Overall Study||11
8884771|NCT01967836|9942142|FG000|NOT COMPLETED|Overall Study||9
9003544|NCT02919657|10066623|FG001|COMPLETED|Overall Study|completed with the same initial 10 participants|10
9003545|NCT02919657|10066622|FG000|NOT COMPLETED|Overall Study||0
9003546|NCT02919657|10066623|FG001|NOT COMPLETED|Overall Study||0
9003547|NCT02919696|10066631|FG000|STARTED|Overall Study||12
9003548|NCT02919696|10066632|FG001|STARTED|Overall Study||14
9003549|NCT02919696|10066631|FG000|Received at Least One Dose of Study Drug|Overall Study||12
9003550|NCT02919696|10066632|FG001|Received at Least One Dose of Study Drug|Overall Study||13
9003551|NCT02919696|10066631|FG000|PK 100 mg Abemaciclib Dose|Overall Study||5
9003552|NCT02919696|10066632|FG001|PK 100 mg Abemaciclib Dose|Overall Study||0
9003553|NCT02919696|10066631|FG000|PK 150 mg Abemaciclib Dose|Overall Study||0
9003554|NCT02919696|10066632|FG001|PK 150 mg Abemaciclib Dose|Overall Study||2
8634449|NCT00556894|9674785|FG001|COMPLETED|Overall Study||68
8634450|NCT00556894|9674786|FG002|COMPLETED|Overall Study||65
8634451|NCT00556894|9674784|FG000|NOT COMPLETED|Overall Study||16
8634452|NCT00556894|9674785|FG001|NOT COMPLETED|Overall Study||19
8884772|NCT01967862|9942147|FG000|STARTED|Overall Study||54
8884773|NCT01967862|9942147|FG000|COMPLETED|Overall Study||54
9003555|NCT02919696|10066631|FG000|Death On Treatment|Overall Study||1
9003556|NCT02919696|10066632|FG001|Death On Treatment|Overall Study||0
9003557|NCT02919696|10066631|FG000|Progressive Disease|Overall Study||7
9003558|NCT02919696|10066632|FG001|Progressive Disease|Overall Study||9
9003559|NCT02919696|10066631|FG000|COMPLETED|Overall Study||8
9003560|NCT02919696|10066632|FG001|COMPLETED|Overall Study||9
9003561|NCT02919696|10066631|FG000|NOT COMPLETED|Overall Study||4
9003562|NCT02919696|10066632|FG001|NOT COMPLETED|Overall Study||5
9003563|NCT02919761|10066644|FG000|STARTED|Part 1: Open Label||259
9003564|NCT02919761|10066645|FG001|STARTED|Part 1: Open Label|Part 2 Blinded groups were not evaluated as such during Part 1|0
9003565|NCT02919761|10066646|FG002|STARTED|Part 1: Open Label||0
9003566|NCT02919761|10066644|FG000|mITT Population|Part 1: Open Label||259
9003567|NCT02919761|10066645|FG001|mITT Population|Part 1: Open Label||0
9003568|NCT02919761|10066646|FG002|mITT Population|Part 1: Open Label||0
9003569|NCT02919761|10066644|FG000|Safety Population|Part 1: Open Label||259
9003570|NCT02919761|10066645|FG001|Safety Population|Part 1: Open Label||0
9003571|NCT02919761|10066646|FG002|Safety Population|Part 1: Open Label||0
9003572|NCT02919761|10066644|FG000|Per Protocol Population|Part 1: Open Label||236
8884774|NCT01967862|9942147|FG000|NOT COMPLETED|Overall Study||0
8884775|NCT01967888|9942153|FG000|STARTED|Overall Study||52
8884776|NCT01967888|9942154|FG001|STARTED|Overall Study||52
8884777|NCT01967888|9942153|FG000|COMPLETED|Overall Study||42
8884778|NCT01967888|9942154|FG001|COMPLETED|Overall Study||45
8884779|NCT01967888|9942153|FG000|NOT COMPLETED|Overall Study||10
9003573|NCT02919761|10066645|FG001|Per Protocol Population|Part 1: Open Label||0
8634453|NCT00556894|9674786|FG002|NOT COMPLETED|Overall Study||19
8884780|NCT01967888|9942154|FG001|NOT COMPLETED|Overall Study||7
8884781|NCT01967940|9942163|FG000|STARTED|Part 1||12
8884782|NCT01967940|9942164|FG001|STARTED|Part 1||28
8884783|NCT01967940|9942165|FG002|STARTED|Part 1||15
8884784|NCT01967940|9942166|FG003|STARTED|Part 1||0
8884785|NCT01967940|9942163|FG000|COMPLETED|Part 1||12
8884786|NCT01967940|9942164|FG001|COMPLETED|Part 1||28
8884787|NCT01967940|9942165|FG002|COMPLETED|Part 1||15
8884788|NCT01967940|9942166|FG003|COMPLETED|Part 1||0
8884789|NCT01967940|9942163|FG000|NOT COMPLETED|Part 1||0
9003574|NCT02919761|10066646|FG002|Per Protocol Population|Part 1: Open Label||0
9003575|NCT02919761|10066644|FG000|COMPLETED|Part 1: Open Label||235
9003576|NCT02919761|10066645|FG001|COMPLETED|Part 1: Open Label||0
9003577|NCT02919761|10066646|FG002|COMPLETED|Part 1: Open Label||0
9003578|NCT02919761|10066644|FG000|NOT COMPLETED|Part 1: Open Label||24
9003579|NCT02919761|10066645|FG001|NOT COMPLETED|Part 1: Open Label||0
9003580|NCT02919761|10066646|FG002|NOT COMPLETED|Part 1: Open Label||0
9003581|NCT02919761|10066644|FG000|STARTED|Part 2: Double-blind|154 of the original Part 1 participants continued to Part 2, randomized to Acthar or placebo|0
9003582|NCT02919761|10066645|FG001|STARTED|Part 2: Double-blind|77 participants who completed Part 1 were to receive Acthar for an additional 12 weeks in Part 2|77
9003583|NCT02919761|10066646|FG002|STARTED|Part 2: Double-blind|77 participants who completed Part 1 were to receive placebo for an additional 12 weeks in Part 2|77
9003584|NCT02919761|10066644|FG000|Safety Population|Part 2: Double-blind||0
9003585|NCT02919761|10066645|FG001|Safety Population|Part 2: Double-blind||77
9003586|NCT02919761|10066646|FG002|Safety Population|Part 2: Double-blind||77
9003587|NCT02919761|10066644|FG000|mITT Population|Part 2: Double-blind||0
9003588|NCT02919761|10066645|FG001|mITT Population|Part 2: Double-blind||77
9003589|NCT02919761|10066646|FG002|mITT Population|Part 2: Double-blind||76
9003590|NCT02919761|10066644|FG000|Per Protocol Population|Part 2: Double-blind||0
9003591|NCT02919761|10066645|FG001|Per Protocol Population|Part 2: Double-blind||76
9003592|NCT02919761|10066646|FG002|Per Protocol Population|Part 2: Double-blind||73
9003593|NCT02919761|10066644|FG000|COMPLETED|Part 2: Double-blind||0
9003594|NCT02919761|10066645|FG001|COMPLETED|Part 2: Double-blind||71
9003595|NCT02919761|10066646|FG002|COMPLETED|Part 2: Double-blind||56
9003596|NCT02919761|10066644|FG000|NOT COMPLETED|Part 2: Double-blind||0
9003597|NCT02919761|10066645|FG001|NOT COMPLETED|Part 2: Double-blind||6
9003598|NCT02919761|10066646|FG002|NOT COMPLETED|Part 2: Double-blind||21
9003599|NCT02919813|10066659|FG000|STARTED|Overall Study||14
9003600|NCT02919813|10066660|FG001|STARTED|Overall Study||17
9003601|NCT02919813|10066659|FG000|COMPLETED|Overall Study||14
9003602|NCT02919813|10066660|FG001|COMPLETED|Overall Study||17
9003603|NCT02919813|10066659|FG000|NOT COMPLETED|Overall Study||0
9003604|NCT02919813|10066660|FG001|NOT COMPLETED|Overall Study||0
9003605|NCT02919826|10066668|FG000|STARTED|Overall Study||10
9003606|NCT02919826|10066669|FG001|STARTED|Overall Study||10
9003607|NCT02919826|10066668|FG000|COMPLETED|Overall Study||10
9003608|NCT02919826|10066669|FG001|COMPLETED|Overall Study||8
9003609|NCT02919826|10066668|FG000|NOT COMPLETED|Overall Study||0
9003610|NCT02919826|10066669|FG001|NOT COMPLETED|Overall Study||2
9003611|NCT02919995|10066683|FG000|STARTED|Overall Study||1
9003612|NCT02919995|10066684|FG001|STARTED|Overall Study||2
9003613|NCT02919995|10066685|FG002|STARTED|Overall Study||2
9003614|NCT02919995|10066686|FG003|STARTED|Overall Study||2
9003615|NCT02919995|10066687|FG004|STARTED|Overall Study||1
9003616|NCT02919995|10066688|FG005|STARTED|Overall Study||2
9003617|NCT02919995|10066683|FG000|COMPLETED|Overall Study||1
9003618|NCT02919995|10066684|FG001|COMPLETED|Overall Study||2
9003619|NCT02919995|10066685|FG002|COMPLETED|Overall Study||2
9003620|NCT02919995|10066686|FG003|COMPLETED|Overall Study||2
9003621|NCT02919995|10066687|FG004|COMPLETED|Overall Study||1
9003622|NCT02919995|10066688|FG005|COMPLETED|Overall Study||1
9003623|NCT02919995|10066683|FG000|NOT COMPLETED|Overall Study||0
9003624|NCT02919995|10066684|FG001|NOT COMPLETED|Overall Study||0
9003625|NCT02919995|10066685|FG002|NOT COMPLETED|Overall Study||0
9003626|NCT02919995|10066686|FG003|NOT COMPLETED|Overall Study||0
9003627|NCT02919995|10066687|FG004|NOT COMPLETED|Overall Study||0
9003628|NCT02919995|10066688|FG005|NOT COMPLETED|Overall Study||1
9003629|NCT02920476|10066696|FG000|STARTED|Overall Study||4
9003630|NCT02920476|10066696|FG000|COMPLETED|Overall Study||3
9003631|NCT02920476|10066696|FG000|NOT COMPLETED|Overall Study||1
9003632|NCT02920528|10066703|FG000|STARTED|Overall Study||35
9003633|NCT02920528|10066704|FG001|STARTED|Overall Study||36
9003634|NCT02920528|10066705|FG002|STARTED|Overall Study||35
9003635|NCT02920528|10066703|FG000|COMPLETED|Overall Study||32
9003636|NCT02920528|10066704|FG001|COMPLETED|Overall Study||35
9003637|NCT02920528|10066705|FG002|COMPLETED|Overall Study||30
9003638|NCT02920528|10066703|FG000|NOT COMPLETED|Overall Study||3
9003639|NCT02920528|10066704|FG001|NOT COMPLETED|Overall Study||1
9003640|NCT02920528|10066705|FG002|NOT COMPLETED|Overall Study||5
9003641|NCT02920749|10066717|FG000|STARTED|Overall Study||30
9003642|NCT02920749|10066718|FG001|STARTED|Overall Study||30
9003643|NCT02920749|10066719|FG002|STARTED|Overall Study||30
9003644|NCT02920749|10066720|FG003|STARTED|Overall Study||30
9003645|NCT02920749|10066717|FG000|COMPLETED|Overall Study||30
9003646|NCT02920749|10066718|FG001|COMPLETED|Overall Study||30
9003647|NCT02920749|10066719|FG002|COMPLETED|Overall Study||30
9003648|NCT02920749|10066720|FG003|COMPLETED|Overall Study||30
8884790|NCT01967940|9942164|FG001|NOT COMPLETED|Part 1||0
8884791|NCT01967940|9942165|FG002|NOT COMPLETED|Part 1||0
8884792|NCT01967940|9942166|FG003|NOT COMPLETED|Part 1||0
8884793|NCT01967940|9942163|FG000|STARTED|Part 2|4 participants completed Part 1 and did not enter Part 2; 8 participants moved to the Part 2 group|0
8884794|NCT01967940|9942164|FG001|STARTED|Part 2|12 participants completed Part 1 and did not enter Part 2; 16 participants moved to the Part 2 group|0
8884795|NCT01967940|9942165|FG002|STARTED|Part 2|1 participant completed Part 1 and did not enter Part 2; 14 participants moved to the Part 2 group|0
8884796|NCT01967940|9942166|FG003|STARTED|Part 2|38 participants from the Part 1 groups moved to this Part 2 E/C/F/TAF + ATV group|38
8884797|NCT01967940|9942163|FG000|COMPLETED|Part 2||0
8884798|NCT01967940|9942164|FG001|COMPLETED|Part 2||0
8884799|NCT01967940|9942165|FG002|COMPLETED|Part 2||0
8884800|NCT01967940|9942166|FG003|COMPLETED|Part 2||35
8884801|NCT01967940|9942163|FG000|NOT COMPLETED|Part 2||0
8884802|NCT01967940|9942164|FG001|NOT COMPLETED|Part 2||0
8884803|NCT01967940|9942165|FG002|NOT COMPLETED|Part 2||0
8884804|NCT01967940|9942166|FG003|NOT COMPLETED|Part 2||3
8884805|NCT01968031|9942179|FG000|STARTED|Overall Study||204
8884806|NCT01968031|9942180|FG001|STARTED|Overall Study||202
8884807|NCT01968031|9942181|FG002|STARTED|Overall Study||207
8884808|NCT01968031|9942179|FG000|Completed Week 2|Overall Study||197
8884809|NCT01968031|9942180|FG001|Completed Week 2|Overall Study||190
8884810|NCT01968031|9942181|FG002|Completed Week 2|Overall Study||199
8884811|NCT01968031|9942179|FG000|Completed Week 6|Overall Study||191
8884812|NCT01968031|9942180|FG001|Completed Week 6|Overall Study||183
8884813|NCT01968031|9942181|FG002|Completed Week 6|Overall Study||187
8884814|NCT01968031|9942179|FG000|Completed Week 10|Overall Study||187
8884815|NCT01968031|9942180|FG001|Completed Week 10|Overall Study||181
8884816|NCT01968031|9942181|FG002|Completed Week 10|Overall Study||181
8884817|NCT01968031|9942179|FG000|COMPLETED|Overall Study||186
8884818|NCT01968031|9942180|FG001|COMPLETED|Overall Study||182
8884819|NCT01968031|9942181|FG002|COMPLETED|Overall Study||178
8884820|NCT01968031|9942179|FG000|NOT COMPLETED|Overall Study||18
8884821|NCT01968031|9942180|FG001|NOT COMPLETED|Overall Study||20
8884822|NCT01968031|9942181|FG002|NOT COMPLETED|Overall Study||29
8884823|NCT01968057|9942189|FG000|STARTED|Period 1 (Day 1 to Predosing Day 4)||18
8884824|NCT01968057|9942189|FG000|Received Baricitinib|Period 1 (Day 1 to Predosing Day 4)||18
8884825|NCT01968057|9942189|FG000|COMPLETED|Period 1 (Day 1 to Predosing Day 4)||18
8884826|NCT01968057|9942189|FG000|NOT COMPLETED|Period 1 (Day 1 to Predosing Day 4)||0
8884827|NCT01968057|9942189|FG000|STARTED|Period 2 (At Dosing Day 4 to Day 7)||18
8884828|NCT01968057|9942189|FG000|Received Baricitinib + Ciclosporin|Period 2 (At Dosing Day 4 to Day 7)||18
8884829|NCT01968057|9942189|FG000|COMPLETED|Period 2 (At Dosing Day 4 to Day 7)||18
8884830|NCT01968057|9942189|FG000|NOT COMPLETED|Period 2 (At Dosing Day 4 to Day 7)||0
8884831|NCT01968070|9942213|FG000|STARTED|Period 1||4
8884832|NCT01968070|9942214|FG001|STARTED|Period 1||4
8884833|NCT01968070|9942215|FG002|STARTED|Period 1||4
8884834|NCT01968070|9942216|FG003|STARTED|Period 1||4
8884835|NCT01968070|9942217|FG004|STARTED|Period 1||4
8884836|NCT01968070|9942218|FG005|STARTED|Period 1||4
8884837|NCT01968070|9942219|FG006|STARTED|Period 1||10
8884838|NCT01968070|9942220|FG007|STARTED|Period 1||2
8884839|NCT01968070|9942221|FG008|STARTED|Period 1||2
8884840|NCT01968070|9942222|FG009|STARTED|Period 1||9
8884841|NCT01968070|9942223|FG010|STARTED|Period 1||2
8884842|NCT01968070|9942224|FG011|STARTED|Period 1||2
9003649|NCT02920749|10066717|FG000|NOT COMPLETED|Overall Study||0
9003650|NCT02920749|10066718|FG001|NOT COMPLETED|Overall Study||0
9003651|NCT02920749|10066719|FG002|NOT COMPLETED|Overall Study||0
9003652|NCT02920749|10066720|FG003|NOT COMPLETED|Overall Study||0
9003653|NCT02920918|10066736|FG000|STARTED|Overall Study||17
9003654|NCT02920918|10066737|FG001|STARTED|Overall Study||19
9003655|NCT02920918|10066736|FG000|COMPLETED|Overall Study||17
9003656|NCT02920918|10066737|FG001|COMPLETED|Overall Study||19
9003657|NCT02920918|10066736|FG000|NOT COMPLETED|Overall Study||0
9003658|NCT02920918|10066737|FG001|NOT COMPLETED|Overall Study||0
9003659|NCT02920957|10066743|FG000|STARTED|First Intervention : 1 Month||46
9003660|NCT02920957|10066744|FG001|STARTED|First Intervention : 1 Month||41
9003661|NCT02920957|10066743|FG000|COMPLETED|First Intervention : 1 Month||42
9003662|NCT02920957|10066744|FG001|COMPLETED|First Intervention : 1 Month||41
9003663|NCT02920957|10066743|FG000|NOT COMPLETED|First Intervention : 1 Month||4
9003664|NCT02920957|10066744|FG001|NOT COMPLETED|First Intervention : 1 Month||0
9003665|NCT02920957|10066743|FG000|STARTED|Second Intervention: 1 Month||42
9003666|NCT02920957|10066744|FG001|STARTED|Second Intervention: 1 Month||41
8884843|NCT01968070|9942225|FG012|STARTED|Period 1||9
8884844|NCT01968070|9942226|FG013|STARTED|Period 1||2
8884845|NCT01968070|9942227|FG014|STARTED|Period 1||2
8884846|NCT01968070|9942228|FG015|STARTED|Period 1||9
8884847|NCT01968070|9942229|FG016|STARTED|Period 1||2
8884848|NCT01968070|9942230|FG017|STARTED|Period 1||2
8884849|NCT01968070|9942213|FG000|COMPLETED|Period 1||4
8884850|NCT01968070|9942214|FG001|COMPLETED|Period 1||3
8884851|NCT01968070|9942215|FG002|COMPLETED|Period 1||4
8884852|NCT01968070|9942216|FG003|COMPLETED|Period 1||2
8884853|NCT01968070|9942217|FG004|COMPLETED|Period 1||3
8884854|NCT01968070|9942218|FG005|COMPLETED|Period 1||4
8884855|NCT01968070|9942219|FG006|COMPLETED|Period 1||8
8884856|NCT01968070|9942220|FG007|COMPLETED|Period 1||2
8884857|NCT01968070|9942221|FG008|COMPLETED|Period 1||2
8884858|NCT01968070|9942222|FG009|COMPLETED|Period 1||9
8884859|NCT01968070|9942223|FG010|COMPLETED|Period 1||2
8884860|NCT01968070|9942224|FG011|COMPLETED|Period 1||1
8884861|NCT01968070|9942225|FG012|COMPLETED|Period 1||9
8884862|NCT01968070|9942226|FG013|COMPLETED|Period 1||2
8884863|NCT01968070|9942227|FG014|COMPLETED|Period 1||2
8884864|NCT01968070|9942228|FG015|COMPLETED|Period 1||8
8884865|NCT01968070|9942229|FG016|COMPLETED|Period 1||2
8884866|NCT01968070|9942230|FG017|COMPLETED|Period 1||2
8884867|NCT01968070|9942213|FG000|NOT COMPLETED|Period 1||0
8884868|NCT01968070|9942214|FG001|NOT COMPLETED|Period 1||1
8884869|NCT01968070|9942215|FG002|NOT COMPLETED|Period 1||0
8884870|NCT01968070|9942216|FG003|NOT COMPLETED|Period 1||2
8884871|NCT01968070|9942217|FG004|NOT COMPLETED|Period 1||1
8884872|NCT01968070|9942218|FG005|NOT COMPLETED|Period 1||0
8884873|NCT01968070|9942219|FG006|NOT COMPLETED|Period 1||2
8884874|NCT01968070|9942220|FG007|NOT COMPLETED|Period 1||0
8884875|NCT01968070|9942221|FG008|NOT COMPLETED|Period 1||0
8884876|NCT01968070|9942222|FG009|NOT COMPLETED|Period 1||0
8884877|NCT01968070|9942223|FG010|NOT COMPLETED|Period 1||0
8884878|NCT01968070|9942224|FG011|NOT COMPLETED|Period 1||1
8884879|NCT01968070|9942225|FG012|NOT COMPLETED|Period 1||0
8884880|NCT01968070|9942226|FG013|NOT COMPLETED|Period 1||0
8884881|NCT01968070|9942227|FG014|NOT COMPLETED|Period 1||0
8884882|NCT01968070|9942228|FG015|NOT COMPLETED|Period 1||1
8884883|NCT01968070|9942229|FG016|NOT COMPLETED|Period 1||0
8884884|NCT01968070|9942230|FG017|NOT COMPLETED|Period 1||0
8884885|NCT01968070|9942213|FG000|STARTED|Period 2||4
8884886|NCT01968070|9942214|FG001|STARTED|Period 2|1 participant was added to replace the participant who discontinued the period 1.|4
8884887|NCT01968070|9942215|FG002|STARTED|Period 2||4
8884888|NCT01968070|9942216|FG003|STARTED|Period 2|2 participants were added to replace the 2 participants who discontinued the period 1.|4
8884889|NCT01968070|9942217|FG004|STARTED|Period 2||3
8884890|NCT01968070|9942218|FG005|STARTED|Period 2||4
8884891|NCT01968070|9942219|FG006|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
8884892|NCT01968070|9942220|FG007|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
8884893|NCT01968070|9942221|FG008|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
8884894|NCT01968070|9942222|FG009|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
8884895|NCT01968070|9942223|FG010|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
8884896|NCT01968070|9942224|FG011|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
8884897|NCT01968070|9942225|FG012|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
8884898|NCT01968070|9942226|FG013|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
8884899|NCT01968070|9942227|FG014|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
8884900|NCT01968070|9942228|FG015|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
8884901|NCT01968070|9942229|FG016|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
8884902|NCT01968070|9942230|FG017|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
8884903|NCT01968070|9942213|FG000|COMPLETED|Period 2||4
8884904|NCT01968070|9942214|FG001|COMPLETED|Period 2||4
8884905|NCT01968070|9942215|FG002|COMPLETED|Period 2||4
8884906|NCT01968070|9942216|FG003|COMPLETED|Period 2||4
8884907|NCT01968070|9942217|FG004|COMPLETED|Period 2||2
8884908|NCT01968070|9942218|FG005|COMPLETED|Period 2||4
8884909|NCT01968070|9942219|FG006|COMPLETED|Period 2||0
8884910|NCT01968070|9942220|FG007|COMPLETED|Period 2||0
8884911|NCT01968070|9942221|FG008|COMPLETED|Period 2||0
8884912|NCT01968070|9942222|FG009|COMPLETED|Period 2||0
8884913|NCT01968070|9942223|FG010|COMPLETED|Period 2||0
8884914|NCT01968070|9942224|FG011|COMPLETED|Period 2||0
8884915|NCT01968070|9942225|FG012|COMPLETED|Period 2||0
8884916|NCT01968070|9942226|FG013|COMPLETED|Period 2||0
8884917|NCT01968070|9942227|FG014|COMPLETED|Period 2||0
8884918|NCT01968070|9942228|FG015|COMPLETED|Period 2||0
8884919|NCT01968070|9942229|FG016|COMPLETED|Period 2||0
8884920|NCT01968070|9942230|FG017|COMPLETED|Period 2||0
8884921|NCT01968070|9942213|FG000|NOT COMPLETED|Period 2||0
8884922|NCT01968070|9942214|FG001|NOT COMPLETED|Period 2||0
8884923|NCT01968070|9942215|FG002|NOT COMPLETED|Period 2||0
8884924|NCT01968070|9942216|FG003|NOT COMPLETED|Period 2||0
8884925|NCT01968070|9942217|FG004|NOT COMPLETED|Period 2||1
8884926|NCT01968070|9942218|FG005|NOT COMPLETED|Period 2||0
8884927|NCT01968070|9942219|FG006|NOT COMPLETED|Period 2||0
8884928|NCT01968070|9942220|FG007|NOT COMPLETED|Period 2||0
8884929|NCT01968070|9942221|FG008|NOT COMPLETED|Period 2||0
8884930|NCT01968070|9942222|FG009|NOT COMPLETED|Period 2||0
8884931|NCT01968070|9942223|FG010|NOT COMPLETED|Period 2||0
8884932|NCT01968070|9942224|FG011|NOT COMPLETED|Period 2||0
8884933|NCT01968070|9942225|FG012|NOT COMPLETED|Period 2||0
8884934|NCT01968070|9942226|FG013|NOT COMPLETED|Period 2||0
8884935|NCT01968070|9942227|FG014|NOT COMPLETED|Period 2||0
8884936|NCT01968070|9942228|FG015|NOT COMPLETED|Period 2||0
8884937|NCT01968070|9942229|FG016|NOT COMPLETED|Period 2||0
8884938|NCT01968070|9942230|FG017|NOT COMPLETED|Period 2||0
8884939|NCT01968070|9942213|FG000|STARTED|Period 3||4
8884940|NCT01968070|9942214|FG001|STARTED|Period 3||4
8884941|NCT01968070|9942215|FG002|STARTED|Period 3||4
8884942|NCT01968070|9942216|FG003|STARTED|Period 3||4
8884943|NCT01968070|9942217|FG004|STARTED|Period 3||3
8884944|NCT01968070|9942218|FG005|STARTED|Period 3||4
8884945|NCT01968070|9942219|FG006|STARTED|Period 3||0
8884946|NCT01968070|9942220|FG007|STARTED|Period 3||0
8884947|NCT01968070|9942221|FG008|STARTED|Period 3||0
8884948|NCT01968070|9942222|FG009|STARTED|Period 3||0
8884949|NCT01968070|9942223|FG010|STARTED|Period 3||0
8884950|NCT01968070|9942224|FG011|STARTED|Period 3||0
8884951|NCT01968070|9942225|FG012|STARTED|Period 3||0
8884952|NCT01968070|9942226|FG013|STARTED|Period 3||0
8884953|NCT01968070|9942227|FG014|STARTED|Period 3||0
8884954|NCT01968070|9942228|FG015|STARTED|Period 3||0
8884955|NCT01968070|9942229|FG016|STARTED|Period 3||0
8884956|NCT01968070|9942230|FG017|STARTED|Period 3||0
8884957|NCT01968070|9942213|FG000|COMPLETED|Period 3||4
8884958|NCT01968070|9942214|FG001|COMPLETED|Period 3||4
8884959|NCT01968070|9942215|FG002|COMPLETED|Period 3||4
8884960|NCT01968070|9942216|FG003|COMPLETED|Period 3||4
8884961|NCT01968070|9942217|FG004|COMPLETED|Period 3||3
8884962|NCT01968070|9942218|FG005|COMPLETED|Period 3||4
8884963|NCT01968070|9942219|FG006|COMPLETED|Period 3||0
8884964|NCT01968070|9942220|FG007|COMPLETED|Period 3||0
8884965|NCT01968070|9942221|FG008|COMPLETED|Period 3||0
8884966|NCT01968070|9942222|FG009|COMPLETED|Period 3||0
8884967|NCT01968070|9942223|FG010|COMPLETED|Period 3||0
8884968|NCT01968070|9942224|FG011|COMPLETED|Period 3||0
8884969|NCT01968070|9942225|FG012|COMPLETED|Period 3||0
8884970|NCT01968070|9942226|FG013|COMPLETED|Period 3||0
8884971|NCT01968070|9942227|FG014|COMPLETED|Period 3||0
8884972|NCT01968070|9942228|FG015|COMPLETED|Period 3||0
9003667|NCT02920957|10066743|FG000|COMPLETED|Second Intervention: 1 Month||42
9003668|NCT02920957|10066744|FG001|COMPLETED|Second Intervention: 1 Month||40
9003669|NCT02920957|10066743|FG000|NOT COMPLETED|Second Intervention: 1 Month||0
9003670|NCT02920957|10066744|FG001|NOT COMPLETED|Second Intervention: 1 Month||1
9003671|NCT02920970|10066761|FG000|STARTED|First Intervention||38
9003672|NCT02920970|10066762|FG001|STARTED|First Intervention||32
9003673|NCT02920970|10066761|FG000|COMPLETED|First Intervention||38
9003674|NCT02920970|10066762|FG001|COMPLETED|First Intervention||30
9003675|NCT02920970|10066761|FG000|NOT COMPLETED|First Intervention||0
9003676|NCT02920970|10066762|FG001|NOT COMPLETED|First Intervention||2
9003677|NCT02920970|10066761|FG000|STARTED|Second Intervention||38
9003678|NCT02920970|10066762|FG001|STARTED|Second Intervention||30
9003679|NCT02920970|10066761|FG000|COMPLETED|Second Intervention||37
9003680|NCT02920970|10066762|FG001|COMPLETED|Second Intervention||30
9003681|NCT02920970|10066761|FG000|NOT COMPLETED|Second Intervention||1
9003682|NCT02920970|10066762|FG001|NOT COMPLETED|Second Intervention||0
9003683|NCT02920983|10066770|FG000|STARTED|Dispense 1||8
9003684|NCT02920983|10066771|FG001|STARTED|Dispense 1||10
9003685|NCT02920983|10066772|FG002|STARTED|Dispense 1||7
9003686|NCT02920983|10066773|FG003|STARTED|Dispense 1||6
9003687|NCT02920983|10066774|FG004|STARTED|Dispense 1||13
9003688|NCT02920983|10066775|FG005|STARTED|Dispense 1||7
9003689|NCT02920983|10066770|FG000|COMPLETED|Dispense 1||8
9003690|NCT02920983|10066771|FG001|COMPLETED|Dispense 1||10
9003691|NCT02920983|10066772|FG002|COMPLETED|Dispense 1||7
9003692|NCT02920983|10066773|FG003|COMPLETED|Dispense 1||6
9003693|NCT02920983|10066774|FG004|COMPLETED|Dispense 1||12
9003694|NCT02920983|10066775|FG005|COMPLETED|Dispense 1||7
9003695|NCT02920983|10066770|FG000|NOT COMPLETED|Dispense 1||0
9003696|NCT02920983|10066771|FG001|NOT COMPLETED|Dispense 1||0
9003697|NCT02920983|10066772|FG002|NOT COMPLETED|Dispense 1||0
9003698|NCT02920983|10066773|FG003|NOT COMPLETED|Dispense 1||0
9003699|NCT02920983|10066774|FG004|NOT COMPLETED|Dispense 1||1
9003700|NCT02920983|10066775|FG005|NOT COMPLETED|Dispense 1||0
9003701|NCT02920983|10066770|FG000|STARTED|Dispense 2||8
9003702|NCT02920983|10066771|FG001|STARTED|Dispense 2||10
9003703|NCT02920983|10066772|FG002|STARTED|Dispense 2||7
9003704|NCT02920983|10066773|FG003|STARTED|Dispense 2||6
9003705|NCT02920983|10066774|FG004|STARTED|Dispense 2||13
9003706|NCT02920983|10066775|FG005|STARTED|Dispense 2||7
9003707|NCT02920983|10066770|FG000|COMPLETED|Dispense 2||7
9003708|NCT02920983|10066771|FG001|COMPLETED|Dispense 2||10
9003709|NCT02920983|10066772|FG002|COMPLETED|Dispense 2||7
9003710|NCT02920983|10066773|FG003|COMPLETED|Dispense 2||6
9003711|NCT02920983|10066774|FG004|COMPLETED|Dispense 2||12
9003712|NCT02920983|10066775|FG005|COMPLETED|Dispense 2||7
9003713|NCT02920983|10066770|FG000|NOT COMPLETED|Dispense 2||1
9003714|NCT02920983|10066771|FG001|NOT COMPLETED|Dispense 2||0
9003715|NCT02920983|10066772|FG002|NOT COMPLETED|Dispense 2||0
9003716|NCT02920983|10066773|FG003|NOT COMPLETED|Dispense 2||0
9003717|NCT02920983|10066774|FG004|NOT COMPLETED|Dispense 2||1
8634454|NCT00556933|9674798|FG000|STARTED|Single vs. Divided-dose rATG Induction||45
9003718|NCT02920983|10066775|FG005|NOT COMPLETED|Dispense 2||0
9003719|NCT02920983|10066770|FG000|STARTED|Dispense 3||8
9003720|NCT02920983|10066771|FG001|STARTED|Dispense 3||10
9003721|NCT02920983|10066772|FG002|STARTED|Dispense 3||7
9003722|NCT02920983|10066773|FG003|STARTED|Dispense 3||6
9003723|NCT02920983|10066774|FG004|STARTED|Dispense 3||13
9003724|NCT02920983|10066775|FG005|STARTED|Dispense 3||7
9003725|NCT02920983|10066770|FG000|COMPLETED|Dispense 3||7
9003726|NCT02920983|10066771|FG001|COMPLETED|Dispense 3||9
8884973|NCT01968070|9942229|FG016|COMPLETED|Period 3||0
8884974|NCT01968070|9942230|FG017|COMPLETED|Period 3||0
8884975|NCT01968070|9942213|FG000|NOT COMPLETED|Period 3||0
8884976|NCT01968070|9942214|FG001|NOT COMPLETED|Period 3||0
8884977|NCT01968070|9942215|FG002|NOT COMPLETED|Period 3||0
8884978|NCT01968070|9942216|FG003|NOT COMPLETED|Period 3||0
8884979|NCT01968070|9942217|FG004|NOT COMPLETED|Period 3||0
8884980|NCT01968070|9942218|FG005|NOT COMPLETED|Period 3||0
8884981|NCT01968070|9942219|FG006|NOT COMPLETED|Period 3||0
8884982|NCT01968070|9942220|FG007|NOT COMPLETED|Period 3||0
8884983|NCT01968070|9942221|FG008|NOT COMPLETED|Period 3||0
8884984|NCT01968070|9942222|FG009|NOT COMPLETED|Period 3||0
8884985|NCT01968070|9942223|FG010|NOT COMPLETED|Period 3||0
8884986|NCT01968070|9942224|FG011|NOT COMPLETED|Period 3||0
8884987|NCT01968070|9942225|FG012|NOT COMPLETED|Period 3||0
8884988|NCT01968070|9942226|FG013|NOT COMPLETED|Period 3||0
8884989|NCT01968070|9942227|FG014|NOT COMPLETED|Period 3||0
8884990|NCT01968070|9942228|FG015|NOT COMPLETED|Period 3||0
8884991|NCT01968070|9942229|FG016|NOT COMPLETED|Period 3||0
8884992|NCT01968070|9942230|FG017|NOT COMPLETED|Period 3||0
8884993|NCT01968135|9942270|FG000|STARTED|Overall Study||16
8884994|NCT01968135|9942271|FG001|STARTED|Overall Study||16
8884995|NCT01968135|9942270|FG000|COMPLETED|Overall Study||16
8884996|NCT01968135|9942271|FG001|COMPLETED|Overall Study||16
8884997|NCT01968135|9942270|FG000|NOT COMPLETED|Overall Study||0
8884998|NCT01968135|9942271|FG001|NOT COMPLETED|Overall Study||0
8884999|NCT01968213|9942279|FG000|STARTED|Overall Study||375
8885000|NCT01968213|9942280|FG001|STARTED|Overall Study||189
8885001|NCT01968213|9942279|FG000|COMPLETED|Overall Study||285
8885002|NCT01968213|9942280|FG001|COMPLETED|Overall Study||180
8885003|NCT01968213|9942279|FG000|NOT COMPLETED|Overall Study||90
8885004|NCT01968213|9942280|FG001|NOT COMPLETED|Overall Study||9
8885005|NCT01968317|9942288|FG000|STARTED|Overall Study||76
8885006|NCT01968317|9942289|FG001|STARTED|Overall Study||74
8885007|NCT01968317|9942288|FG000|COMPLETED|Overall Study||76
8885008|NCT01968317|9942289|FG001|COMPLETED|Overall Study||74
8885009|NCT01968317|9942288|FG000|NOT COMPLETED|Overall Study||0
8885010|NCT01968317|9942289|FG001|NOT COMPLETED|Overall Study||0
8885011|NCT01968356|9942303|FG000|STARTED|Overall Study||101
8885012|NCT01968356|9942304|FG001|STARTED|Overall Study||93
8885013|NCT01968356|9942305|FG002|STARTED|Overall Study||96
8885014|NCT01968356|9942306|FG003|STARTED|Overall Study||32
8885015|NCT01968356|9942307|FG004|STARTED|Overall Study||97
8885016|NCT01968356|9942308|FG005|STARTED|Overall Study||99
8885017|NCT01968356|9942309|FG006|STARTED|Overall Study||97
8885018|NCT01968356|9942310|FG007|STARTED|Overall Study||31
8885019|NCT01968356|9942303|FG000|COMPLETED|Overall Study||101
9003727|NCT02920983|10066772|FG002|COMPLETED|Dispense 3||7
9003728|NCT02920983|10066773|FG003|COMPLETED|Dispense 3||6
9003729|NCT02920983|10066774|FG004|COMPLETED|Dispense 3||12
9003730|NCT02920983|10066775|FG005|COMPLETED|Dispense 3||7
9003731|NCT02920983|10066770|FG000|NOT COMPLETED|Dispense 3||1
9003732|NCT02920983|10066771|FG001|NOT COMPLETED|Dispense 3||1
9003733|NCT02920983|10066772|FG002|NOT COMPLETED|Dispense 3||0
9003734|NCT02920983|10066773|FG003|NOT COMPLETED|Dispense 3||0
9003735|NCT02920983|10066774|FG004|NOT COMPLETED|Dispense 3||1
9003736|NCT02920983|10066775|FG005|NOT COMPLETED|Dispense 3||0
9003737|NCT02921061|10066783|FG000|STARTED|Overall Study||28
9003738|NCT02921061|10066783|FG000|COMPLETED|Overall Study||28
9003739|NCT02921061|10066783|FG000|NOT COMPLETED|Overall Study||0
9003740|NCT02921087|10066789|FG000|STARTED|Overall Study||12
9003741|NCT02921087|10066790|FG001|STARTED|Overall Study||11
9003742|NCT02921087|10066789|FG000|COMPLETED|Overall Study||12
9003743|NCT02921087|10066790|FG001|COMPLETED|Overall Study|One subject dropped out prior to 1 week of lens wear while wearing the control lens (lens 1).|10
9003744|NCT02921087|10066789|FG000|NOT COMPLETED|Overall Study||0
9003745|NCT02921087|10066790|FG001|NOT COMPLETED|Overall Study||1
9003746|NCT02921295|10066806|FG000|STARTED|Sidekicks||1
9003747|NCT02921295|10066806|FG000|COMPLETED|Sidekicks||1
9003748|NCT02921295|10066806|FG000|NOT COMPLETED|Sidekicks||0
9003749|NCT02921295|10066806|FG000|STARTED|Conventional Prostheses||1
8634455|NCT00556933|9674799|FG001|STARTED|Single vs. Divided-dose rATG Induction||45
8634456|NCT00556933|9674800|FG002|STARTED|Single vs. Divided-dose rATG Induction||45
9003750|NCT02921295|10066806|FG000|COMPLETED|Conventional Prostheses||1
9003751|NCT02921295|10066806|FG000|NOT COMPLETED|Conventional Prostheses||0
9003752|NCT02921386|10066815|FG000|STARTED|Sequence A: Fasting||18
9003753|NCT02921386|10066815|FG000|COMPLETED|Sequence A: Fasting||18
9003754|NCT02921386|10066815|FG000|NOT COMPLETED|Sequence A: Fasting||0
9003755|NCT02921386|10066815|FG000|STARTED|Sequence B: 15 g Fat Breakfast||18
9003756|NCT02921386|10066815|FG000|COMPLETED|Sequence B: 15 g Fat Breakfast||18
9003757|NCT02921386|10066815|FG000|NOT COMPLETED|Sequence B: 15 g Fat Breakfast||0
9003758|NCT02921386|10066815|FG000|STARTED|Sequence C: 30 g Fat Breakfast||18
9003759|NCT02921386|10066815|FG000|COMPLETED|Sequence C: 30 g Fat Breakfast||18
9003760|NCT02921386|10066815|FG000|NOT COMPLETED|Sequence C: 30 g Fat Breakfast||0
9003761|NCT02921386|10066815|FG000|STARTED|Sequence D: 45 g Fat Breakfast||18
9003762|NCT02921386|10066815|FG000|COMPLETED|Sequence D: 45 g Fat Breakfast||18
9003763|NCT02921386|10066815|FG000|NOT COMPLETED|Sequence D: 45 g Fat Breakfast||0
9003764|NCT02921386|10066815|FG000|STARTED|Sequence E: FDA High Fat Breakfast||18
9003765|NCT02921386|10066815|FG000|COMPLETED|Sequence E: FDA High Fat Breakfast||18
9003766|NCT02921386|10066815|FG000|NOT COMPLETED|Sequence E: FDA High Fat Breakfast||0
9003767|NCT02921412|10066823|FG000|STARTED|Overall Study||36
9003768|NCT02921412|10066823|FG000|COMPLETED|Overall Study||36
9003769|NCT02921412|10066823|FG000|NOT COMPLETED|Overall Study||0
9003770|NCT02921425|10066834|FG000|STARTED|Overall Study||47
9003771|NCT02921425|10066834|FG000|Second Visit|Overall Study|Participants had to wear an accelerometer and make entries into their PHR over the previous 7 days.|47
8885020|NCT01968356|9942304|FG001|COMPLETED|Overall Study||93
8885021|NCT01968356|9942305|FG002|COMPLETED|Overall Study||96
8885022|NCT01968356|9942306|FG003|COMPLETED|Overall Study||32
8885023|NCT01968356|9942307|FG004|COMPLETED|Overall Study||97
8885024|NCT01968356|9942308|FG005|COMPLETED|Overall Study||99
8885025|NCT01968356|9942309|FG006|COMPLETED|Overall Study||97
8885026|NCT01968356|9942310|FG007|COMPLETED|Overall Study||31
8885027|NCT01968356|9942303|FG000|NOT COMPLETED|Overall Study||0
8885028|NCT01968356|9942304|FG001|NOT COMPLETED|Overall Study||0
8885029|NCT01968356|9942305|FG002|NOT COMPLETED|Overall Study||0
8885030|NCT01968356|9942306|FG003|NOT COMPLETED|Overall Study||0
8885031|NCT01968356|9942307|FG004|NOT COMPLETED|Overall Study||0
8885032|NCT01968356|9942308|FG005|NOT COMPLETED|Overall Study||0
8885033|NCT01968356|9942309|FG006|NOT COMPLETED|Overall Study||0
8885034|NCT01968356|9942310|FG007|NOT COMPLETED|Overall Study||0
8885035|NCT01968382|9942339|FG000|STARTED|Overall Study||18
8885036|NCT01968382|9942340|FG001|STARTED|Overall Study||19
8885037|NCT01968382|9942341|FG002|STARTED|Overall Study||20
8885038|NCT01968382|9942339|FG000|COMPLETED|Overall Study||18
8885039|NCT01968382|9942340|FG001|COMPLETED|Overall Study||19
8885040|NCT01968382|9942341|FG002|COMPLETED|Overall Study||20
8885041|NCT01968382|9942339|FG000|NOT COMPLETED|Overall Study||0
8885042|NCT01968382|9942340|FG001|NOT COMPLETED|Overall Study||0
8885043|NCT01968382|9942341|FG002|NOT COMPLETED|Overall Study||0
8885044|NCT01968421|9942351|FG000|STARTED|Overall Study|March 1, 2015 was the date for recruiting patients|99
8885045|NCT01968421|9942352|FG001|STARTED|Overall Study|March 1, 2015 was the date for recruiting controls|97
8885046|NCT01968421|9942351|FG000|Starting Trial|Overall Study||99
8885047|NCT01968421|9942352|FG001|Starting Trial|Overall Study||97
8885048|NCT01968421|9942351|FG000|COMPLETED|Overall Study|Nov. 23, 2018 is the date for completing the trial|99
8885049|NCT01968421|9942352|FG001|COMPLETED|Overall Study|Nov. 23, 2018 is the date for completing the trial|97
8885050|NCT01968421|9942351|FG000|NOT COMPLETED|Overall Study||0
8885051|NCT01968421|9942352|FG001|NOT COMPLETED|Overall Study||0
8885052|NCT01968434|9942360|FG000|STARTED|Overall Study||78
8885053|NCT01968434|9942361|FG001|STARTED|Overall Study||72
8885054|NCT01968434|9942360|FG000|COMPLETED|Overall Study||75
8885055|NCT01968434|9942361|FG001|COMPLETED|Overall Study||66
8885056|NCT01968434|9942360|FG000|NOT COMPLETED|Overall Study||3
8885057|NCT01968434|9942361|FG001|NOT COMPLETED|Overall Study||6
8885058|NCT01968447|9942369|FG000|STARTED|Overall Study||20
8885059|NCT01968447|9942370|FG001|STARTED|Overall Study||20
8885060|NCT01968447|9942369|FG000|COMPLETED|Overall Study||20
8885061|NCT01968447|9942370|FG001|COMPLETED|Overall Study||20
8885062|NCT01968447|9942369|FG000|NOT COMPLETED|Overall Study||0
8885063|NCT01968447|9942370|FG001|NOT COMPLETED|Overall Study||0
8885064|NCT01968551|9942379|FG000|STARTED|Open Label Phase (48 Weeks)||22
8885065|NCT01968551|9942380|FG001|STARTED|Open Label Phase (48 Weeks)||90
8885066|NCT01968551|9942381|FG002|STARTED|Open Label Phase (48 Weeks)||46
8885067|NCT01968551|9942379|FG000|COMPLETED|Open Label Phase (48 Weeks)||20
8885068|NCT01968551|9942380|FG001|COMPLETED|Open Label Phase (48 Weeks)||87
8885069|NCT01968551|9942381|FG002|COMPLETED|Open Label Phase (48 Weeks)||41
8885070|NCT01968551|9942379|FG000|NOT COMPLETED|Open Label Phase (48 Weeks)||2
8885071|NCT01968551|9942380|FG001|NOT COMPLETED|Open Label Phase (48 Weeks)||3
8885072|NCT01968551|9942381|FG002|NOT COMPLETED|Open Label Phase (48 Weeks)||5
8885073|NCT01968551|9942379|FG000|STARTED|Extension Phase||20
8885074|NCT01968551|9942380|FG001|STARTED|Extension Phase||87
8885075|NCT01968551|9942381|FG002|STARTED|Extension Phase|7 participant completed the Open-Label Phase, but did not enter in the Extension Phase|34
8885076|NCT01968551|9942379|FG000|COMPLETED|Extension Phase||19
8885077|NCT01968551|9942380|FG001|COMPLETED|Extension Phase||86
8885078|NCT01968551|9942381|FG002|COMPLETED|Extension Phase||30
8885079|NCT01968551|9942379|FG000|NOT COMPLETED|Extension Phase||1
8885080|NCT01968551|9942380|FG001|NOT COMPLETED|Extension Phase||1
8885081|NCT01968551|9942381|FG002|NOT COMPLETED|Extension Phase||4
8885082|NCT01968694|9942395|FG000|STARTED|Visit 1 (1 Day)||10
8885083|NCT01968694|9942396|FG001|STARTED|Visit 1 (1 Day)||9
8885084|NCT01968694|9942395|FG000|COMPLETED|Visit 1 (1 Day)||10
8885085|NCT01968694|9942396|FG001|COMPLETED|Visit 1 (1 Day)||9
8885086|NCT01968694|9942395|FG000|NOT COMPLETED|Visit 1 (1 Day)||0
8885087|NCT01968694|9942396|FG001|NOT COMPLETED|Visit 1 (1 Day)||0
8885088|NCT01968694|9942395|FG000|STARTED|Washout (1 Month)||10
8885089|NCT01968694|9942396|FG001|STARTED|Washout (1 Month)||9
8885090|NCT01968694|9942395|FG000|COMPLETED|Washout (1 Month)||10
8885091|NCT01968694|9942396|FG001|COMPLETED|Washout (1 Month)||8
8885092|NCT01968694|9942395|FG000|NOT COMPLETED|Washout (1 Month)||0
8885093|NCT01968694|9942396|FG001|NOT COMPLETED|Washout (1 Month)||1
8885094|NCT01968694|9942395|FG000|STARTED|Visit 2 (1 Day)||10
8885095|NCT01968694|9942396|FG001|STARTED|Visit 2 (1 Day)||8
8885096|NCT01968694|9942395|FG000|COMPLETED|Visit 2 (1 Day)||10
8885097|NCT01968694|9942396|FG001|COMPLETED|Visit 2 (1 Day)||8
8885098|NCT01968694|9942395|FG000|NOT COMPLETED|Visit 2 (1 Day)||0
8885099|NCT01968694|9942396|FG001|NOT COMPLETED|Visit 2 (1 Day)||0
8885100|NCT01968707|9942412|FG000|STARTED|Overall Study||247
8885101|NCT01968707|9942413|FG001|STARTED|Overall Study||74
8885102|NCT01968707|9942414|FG002|STARTED|Overall Study||246
8885103|NCT01968707|9942415|FG003|STARTED|Overall Study||245
8885104|NCT01968707|9942416|FG004|STARTED|Overall Study||236
8885105|NCT01968707|9942417|FG005|STARTED|Overall Study||70
8885106|NCT01968707|9942418|FG006|STARTED|Overall Study||238
8885107|NCT01968707|9942419|FG007|STARTED|Overall Study||238
8885108|NCT01968707|9942412|FG000|COMPLETED|Overall Study||198
8885109|NCT01968707|9942413|FG001|COMPLETED|Overall Study||62
8885110|NCT01968707|9942414|FG002|COMPLETED|Overall Study||205
8885111|NCT01968707|9942415|FG003|COMPLETED|Overall Study||201
8885112|NCT01968707|9942416|FG004|COMPLETED|Overall Study||200
8885113|NCT01968707|9942417|FG005|COMPLETED|Overall Study||59
8885114|NCT01968707|9942418|FG006|COMPLETED|Overall Study||204
8885115|NCT01968707|9942419|FG007|COMPLETED|Overall Study||203
8885116|NCT01968707|9942412|FG000|NOT COMPLETED|Overall Study||49
8885117|NCT01968707|9942413|FG001|NOT COMPLETED|Overall Study||12
8885118|NCT01968707|9942414|FG002|NOT COMPLETED|Overall Study||41
8885119|NCT01968707|9942415|FG003|NOT COMPLETED|Overall Study||44
8885120|NCT01968707|9942416|FG004|NOT COMPLETED|Overall Study||36
8885121|NCT01968707|9942417|FG005|NOT COMPLETED|Overall Study||11
8885122|NCT01968707|9942418|FG006|NOT COMPLETED|Overall Study||34
8885123|NCT01968707|9942419|FG007|NOT COMPLETED|Overall Study||35
8885124|NCT01968811|9942452|FG000|STARTED|Overall Study||10
8885125|NCT01968811|9942452|FG000|COMPLETED|Overall Study||5
8885126|NCT01968811|9942452|FG000|NOT COMPLETED|Overall Study||5
8885127|NCT01968954|9942458|FG000|STARTED|Overall Study||354
8885128|NCT01968954|9942459|FG001|STARTED|Overall Study||357
8885129|NCT01968954|9942458|FG000|Treated|Overall Study||353
8885130|NCT01968954|9942459|FG001|Treated|Overall Study||356
8885131|NCT01968954|9942458|FG000|COMPLETED|Overall Study||314
8885132|NCT01968954|9942459|FG001|COMPLETED|Overall Study||314
8885133|NCT01968954|9942458|FG000|NOT COMPLETED|Overall Study||40
8885134|NCT01968954|9942459|FG001|NOT COMPLETED|Overall Study||43
8885135|NCT01968967|9942468|FG000|STARTED|Treatment Period||1071
8885136|NCT01968967|9942469|FG001|STARTED|Treatment Period||1068
8885137|NCT01968967|9942470|FG002|STARTED|Treatment Period||0
8885138|NCT01968967|9942471|FG003|STARTED|Treatment Period||0
8885139|NCT01968967|9942472|FG004|STARTED|Treatment Period||0
8885140|NCT01968967|9942468|FG000|Treated|Treatment Period||1065
8885141|NCT01968967|9942469|FG001|Treated|Treatment Period||1063
8885142|NCT01968967|9942470|FG002|Treated|Treatment Period||0
8885143|NCT01968967|9942471|FG003|Treated|Treatment Period||0
8885144|NCT01968967|9942472|FG004|Treated|Treatment Period||0
8885145|NCT01968967|9942468|FG000|COMPLETED|Treatment Period||925
8885146|NCT01968967|9942469|FG001|COMPLETED|Treatment Period||934
8885147|NCT01968967|9942470|FG002|COMPLETED|Treatment Period||0
8885148|NCT01968967|9942471|FG003|COMPLETED|Treatment Period||0
8885149|NCT01968967|9942472|FG004|COMPLETED|Treatment Period||0
8885150|NCT01968967|9942468|FG000|NOT COMPLETED|Treatment Period||146
8885151|NCT01968967|9942469|FG001|NOT COMPLETED|Treatment Period||134
8885152|NCT01968967|9942470|FG002|NOT COMPLETED|Treatment Period||0
8885153|NCT01968967|9942471|FG003|NOT COMPLETED|Treatment Period||0
8885154|NCT01968967|9942472|FG004|NOT COMPLETED|Treatment Period||0
8885155|NCT01968967|9942468|FG000|STARTED|Extension Period||0
8885156|NCT01968967|9942469|FG001|STARTED|Extension Period||0
8885157|NCT01968967|9942470|FG002|STARTED|Extension Period||47
8885158|NCT01968967|9942471|FG003|STARTED|Extension Period||19
8885159|NCT01968967|9942472|FG004|STARTED|Extension Period||39
8885160|NCT01968967|9942468|FG000|COMPLETED|Extension Period||0
8885161|NCT01968967|9942469|FG001|COMPLETED|Extension Period||0
8885162|NCT01968967|9942470|FG002|COMPLETED|Extension Period||45
8885163|NCT01968967|9942471|FG003|COMPLETED|Extension Period||19
8885164|NCT01968967|9942472|FG004|COMPLETED|Extension Period||34
8885165|NCT01968967|9942468|FG000|NOT COMPLETED|Extension Period||0
8885166|NCT01968967|9942469|FG001|NOT COMPLETED|Extension Period||0
8885167|NCT01968967|9942470|FG002|NOT COMPLETED|Extension Period||2
8885168|NCT01968967|9942471|FG003|NOT COMPLETED|Extension Period||0
8885169|NCT01968967|9942472|FG004|NOT COMPLETED|Extension Period||5
8885170|NCT01968980|9942488|FG000|STARTED|Overall Study||185
8885171|NCT01968980|9942489|FG001|STARTED|Overall Study||185
8885172|NCT01968980|9942488|FG000|COMPLETED|Overall Study||169
9003772|NCT02921425|10066834|FG000|COMPLETED|Overall Study||38
9003773|NCT02921425|10066834|FG000|NOT COMPLETED|Overall Study||9
9003774|NCT02921490|10066838|FG000|STARTED|Overall Study||10
9003775|NCT02921490|10066838|FG000|COMPLETED|Overall Study||10
9003776|NCT02921490|10066838|FG000|NOT COMPLETED|Overall Study||0
9003777|NCT02921737|10066842|FG000|STARTED|Overall Study||7
9003778|NCT02921737|10066842|FG000|COMPLETED|Overall Study||7
9003779|NCT02921737|10066842|FG000|NOT COMPLETED|Overall Study||0
9003780|NCT02921750|10066848|FG000|STARTED|Overall Study||124
9003781|NCT02921750|10066849|FG001|STARTED|Overall Study||124
9003782|NCT02921750|10066848|FG000|Intention to Treat (ITT)|Overall Study||122
9003783|NCT02921750|10066849|FG001|Intention to Treat (ITT)|Overall Study||123
9003784|NCT02921750|10066848|FG000|Per Protocol (PP)|Overall Study||100
9003785|NCT02921750|10066849|FG001|Per Protocol (PP)|Overall Study||107
9003786|NCT02921750|10066848|FG000|Completed 6 Weeks Follow-up (PP)|Overall Study||97
9003787|NCT02921750|10066849|FG001|Completed 6 Weeks Follow-up (PP)|Overall Study||104
9003788|NCT02921750|10066848|FG000|Subgroup Followed for 24 Weeks (ITT)|Overall Study||35
9003789|NCT02921750|10066849|FG001|Subgroup Followed for 24 Weeks (ITT)|Overall Study||40
9003790|NCT02921750|10066848|FG000|Subgroup Followed for 24 Weeks (PP)|Overall Study||19
9003791|NCT02921750|10066849|FG001|Subgroup Followed for 24 Weeks (PP)|Overall Study||36
9003792|NCT02921750|10066848|FG000|COMPLETED|Overall Study||115
9003793|NCT02921750|10066849|FG001|COMPLETED|Overall Study||113
9003794|NCT02921750|10066848|FG000|NOT COMPLETED|Overall Study||9
9003795|NCT02921750|10066849|FG001|NOT COMPLETED|Overall Study||11
9003796|NCT02921841|10066860|FG000|STARTED|Overall Study||68
9003797|NCT02921841|10066861|FG001|STARTED|Overall Study||57
8885173|NCT01968980|9942489|FG001|COMPLETED|Overall Study||171
8885174|NCT01968980|9942488|FG000|NOT COMPLETED|Overall Study||16
8885175|NCT01968980|9942489|FG001|NOT COMPLETED|Overall Study||14
9003798|NCT02921841|10066860|FG000|COMPLETED|Overall Study||52
9003799|NCT02921841|10066861|FG001|COMPLETED|Overall Study||44
8885176|NCT01969058|9942498|FG000|STARTED|Overall Study||50
8885177|NCT01969058|9942499|FG001|STARTED|Overall Study||26
8885178|NCT01969058|9942498|FG000|COMPLETED|Overall Study||47
8885179|NCT01969058|9942499|FG001|COMPLETED|Overall Study||26
8885180|NCT01969058|9942498|FG000|NOT COMPLETED|Overall Study||3
8885181|NCT01969058|9942499|FG001|NOT COMPLETED|Overall Study||0
8885182|NCT01969084|9942507|FG000|STARTED|Overall Study||19
8885183|NCT01969084|9942508|FG001|STARTED|Overall Study||22
8885184|NCT01969084|9942507|FG000|COMPLETED|Overall Study||19
8885185|NCT01969084|9942508|FG001|COMPLETED|Overall Study|One subject withdrew due to unrelated serious adverse event|21
8885186|NCT01969084|9942507|FG000|NOT COMPLETED|Overall Study||0
8885187|NCT01969084|9942508|FG001|NOT COMPLETED|Overall Study||1
8885188|NCT01969162|9942518|FG000|STARTED|Overall Study||35
8885189|NCT01969162|9942518|FG000|COMPLETED|Overall Study||35
8885190|NCT01969162|9942518|FG000|NOT COMPLETED|Overall Study||0
8885191|NCT01969201|9942524|FG000|STARTED|Overall Study||352
8885192|NCT01969201|9942525|FG001|STARTED|Overall Study||358
8885193|NCT01969201|9942524|FG000|COMPLETED|Overall Study||307
8885194|NCT01969201|9942525|FG001|COMPLETED|Overall Study||313
8885195|NCT01969201|9942524|FG000|NOT COMPLETED|Overall Study||45
8885196|NCT01969201|9942525|FG001|NOT COMPLETED|Overall Study||45
8885197|NCT01969214|9942531|FG000|STARTED|Overall Study||101
8885198|NCT01969214|9942531|FG000|COMPLETED|Overall Study||86
8885199|NCT01969214|9942531|FG000|NOT COMPLETED|Overall Study||15
8885200|NCT01969240|9942537|FG000|STARTED|Overall Study||451
8885201|NCT01969240|9942538|FG001|STARTED|Overall Study||447
8885202|NCT01969240|9942537|FG000|COMPLETED|Overall Study||451
8885203|NCT01969240|9942538|FG001|COMPLETED|Overall Study||447
8885204|NCT01969240|9942537|FG000|NOT COMPLETED|Overall Study||0
8885205|NCT01969240|9942538|FG001|NOT COMPLETED|Overall Study||0
8885206|NCT01969435|9942546|FG000|STARTED|Overall Study||50
8885207|NCT01969435|9942546|FG000|COMPLETED|Overall Study||50
8885208|NCT01969435|9942546|FG000|NOT COMPLETED|Overall Study||0
8885209|NCT01969448|9942553|FG000|STARTED|Overall Study||55
8885210|NCT01969448|9942554|FG001|STARTED|Overall Study||24
8885211|NCT01969448|9942555|FG002|STARTED|Overall Study||0
8885212|NCT01969448|9942553|FG000|COMPLETED|Overall Study||55
8885213|NCT01969448|9942554|FG001|COMPLETED|Overall Study||24
8885214|NCT01969448|9942555|FG002|COMPLETED|Overall Study||0
8885215|NCT01969448|9942553|FG000|NOT COMPLETED|Overall Study||0
8885216|NCT01969448|9942554|FG001|NOT COMPLETED|Overall Study||0
8885217|NCT01969448|9942555|FG002|NOT COMPLETED|Overall Study||0
9003800|NCT02921841|10066860|FG000|NOT COMPLETED|Overall Study||16
9003801|NCT02921841|10066861|FG001|NOT COMPLETED|Overall Study||13
9003802|NCT02922153|10066869|FG000|STARTED|Overall Study||65
9003803|NCT02922153|10066870|FG001|STARTED|Overall Study||19
9003804|NCT02922153|10066869|FG000|COMPLETED|Overall Study||55
9003805|NCT02922153|10066870|FG001|COMPLETED|Overall Study||17
9003806|NCT02922153|10066869|FG000|NOT COMPLETED|Overall Study||10
9003807|NCT02922153|10066870|FG001|NOT COMPLETED|Overall Study||2
9003808|NCT02922582|10066880|FG000|STARTED|Overall Study||4
9003809|NCT02922582|10066881|FG001|STARTED|Overall Study||4
9003810|NCT02922582|10066882|FG002|STARTED|Overall Study||4
9003811|NCT02922582|10066883|FG003|STARTED|Overall Study||4
9003812|NCT02922582|10066880|FG000|COMPLETED|Overall Study||4
9003813|NCT02922582|10066881|FG001|COMPLETED|Overall Study||3
9003814|NCT02922582|10066882|FG002|COMPLETED|Overall Study||4
9003815|NCT02922582|10066883|FG003|COMPLETED|Overall Study||4
9003816|NCT02922582|10066880|FG000|NOT COMPLETED|Overall Study||0
9003817|NCT02922582|10066881|FG001|NOT COMPLETED|Overall Study||1
9003818|NCT02922582|10066882|FG002|NOT COMPLETED|Overall Study||0
9003819|NCT02922582|10066883|FG003|NOT COMPLETED|Overall Study||0
9003820|NCT02922634|10066893|FG000|STARTED|Overall Study||229
9003821|NCT02922634|10066893|FG000|COMPLETED|Overall Study||219
9003822|NCT02922634|10066893|FG000|NOT COMPLETED|Overall Study||10
9003823|NCT02922738|10066906|FG000|STARTED|Overall Study|158 patients and 17 providers|175
9003824|NCT02922738|10066907|FG001|STARTED|Overall Study|275 patients and 15 providers|290
8634457|NCT00556933|9674801|FG003|STARTED|Single vs. Divided-dose rATG Induction||45
8634458|NCT00556933|9674798|FG000|COMPLETED|Single vs. Divided-dose rATG Induction||43
8634459|NCT00556933|9674799|FG001|COMPLETED|Single vs. Divided-dose rATG Induction||37
8634460|NCT00556933|9674800|FG002|COMPLETED|Single vs. Divided-dose rATG Induction||39
8634461|NCT00556933|9674801|FG003|COMPLETED|Single vs. Divided-dose rATG Induction||43
9003825|NCT02922738|10066906|FG000|COMPLETED|Overall Study||175
9003826|NCT02922738|10066907|FG001|COMPLETED|Overall Study||290
9003827|NCT02922738|10066906|FG000|NOT COMPLETED|Overall Study||0
9003828|NCT02922738|10066907|FG001|NOT COMPLETED|Overall Study||0
9003829|NCT02922868|10066917|FG000|STARTED|Overall Study||30
9003830|NCT02922868|10066918|FG001|STARTED|Overall Study||30
9003831|NCT02922868|10066917|FG000|COMPLETED|Overall Study||30
9003832|NCT02922868|10066918|FG001|COMPLETED|Overall Study||30
9003833|NCT02922868|10066917|FG000|NOT COMPLETED|Overall Study||0
9003834|NCT02922868|10066918|FG001|NOT COMPLETED|Overall Study||0
9003835|NCT02922959|10066926|FG000|STARTED|Overall Study||40
9003836|NCT02922959|10066927|FG001|STARTED|Overall Study||40
9003837|NCT02922959|10066926|FG000|3 Weeks|Overall Study|n=38 (95.0%)|38
9003838|NCT02922959|10066927|FG001|3 Weeks|Overall Study|n=36 (90.0%)|36
9003839|NCT02922959|10066926|FG000|3 Months|Overall Study|n=35 (87.5%)|35
9003840|NCT02922959|10066927|FG001|3 Months|Overall Study|n=31 (77.5%)|31
9003841|NCT02922959|10066926|FG000|6 Months|Overall Study|n=28 (70.0%)|28
9003842|NCT02922959|10066927|FG001|6 Months|Overall Study|n=30 (75.0%)|30
9003843|NCT02922959|10066926|FG000|12 Months|Overall Study|n=21 (52.5%)|21
9003844|NCT02922959|10066927|FG001|12 Months|Overall Study|n=23 (57.5%)|23
8885218|NCT01969500|9942565|FG000|STARTED|Overall Study||25
8885219|NCT01969500|9942566|FG001|STARTED|Overall Study||26
8885220|NCT01969500|9942565|FG000|COMPLETED|Overall Study||24
8885221|NCT01969500|9942566|FG001|COMPLETED|Overall Study||24
8885222|NCT01969500|9942565|FG000|NOT COMPLETED|Overall Study||1
8885223|NCT01969500|9942566|FG001|NOT COMPLETED|Overall Study||2
8885224|NCT01969539|9942572|FG000|STARTED|Overall Study||11
8885225|NCT01969539|9942572|FG000|COMPLETED|Overall Study||11
8885226|NCT01969539|9942572|FG000|NOT COMPLETED|Overall Study||0
8885227|NCT01969708|9942578|FG000|STARTED|Overall Study||180
8885228|NCT01969708|9942579|FG001|STARTED|Overall Study||182
8885229|NCT01969708|9942578|FG000|COMPLETED|Overall Study||175
8885230|NCT01969708|9942579|FG001|COMPLETED|Overall Study||173
8885231|NCT01969708|9942578|FG000|NOT COMPLETED|Overall Study||5
8885232|NCT01969708|9942579|FG001|NOT COMPLETED|Overall Study||9
8885233|NCT01969721|9942585|FG000|STARTED|Overall Study||58
8885234|NCT01969721|9942586|FG001|STARTED|Overall Study||69
8885235|NCT01969721|9942587|FG002|STARTED|Overall Study||50
8885236|NCT01969721|9942588|FG003|STARTED|Overall Study||52
8885237|NCT01969721|9942585|FG000|COMPLETED|Overall Study||54
8885238|NCT01969721|9942586|FG001|COMPLETED|Overall Study||57
8885239|NCT01969721|9942587|FG002|COMPLETED|Overall Study||45
8885240|NCT01969721|9942588|FG003|COMPLETED|Overall Study||46
8885241|NCT01969721|9942585|FG000|NOT COMPLETED|Overall Study||4
8885242|NCT01969721|9942586|FG001|NOT COMPLETED|Overall Study||12
8885243|NCT01969721|9942587|FG002|NOT COMPLETED|Overall Study||5
8885244|NCT01969721|9942588|FG003|NOT COMPLETED|Overall Study||6
8885245|NCT01969747|9942602|FG000|STARTED|Overall Study||19
8885246|NCT01969747|9942603|FG001|STARTED|Overall Study||19
8885247|NCT01969747|9942604|FG002|STARTED|Overall Study||19
8885248|NCT01969747|9942605|FG003|STARTED|Overall Study||18
8885249|NCT01969747|9942602|FG000|COMPLETED|Overall Study||19
8885250|NCT01969747|9942603|FG001|COMPLETED|Overall Study||19
8885251|NCT01969747|9942604|FG002|COMPLETED|Overall Study||19
8885252|NCT01969747|9942605|FG003|COMPLETED|Overall Study||18
8885253|NCT01969747|9942602|FG000|NOT COMPLETED|Overall Study||0
8885254|NCT01969747|9942603|FG001|NOT COMPLETED|Overall Study||0
8885255|NCT01969747|9942604|FG002|NOT COMPLETED|Overall Study||0
8885256|NCT01969747|9942605|FG003|NOT COMPLETED|Overall Study||0
8885257|NCT01969799|9942617|FG000|STARTED|Overall Study||71
8885258|NCT01969799|9942618|FG001|STARTED|Overall Study||72
8885259|NCT01969799|9942617|FG000|COMPLETED|Overall Study||54
8885260|NCT01969799|9942618|FG001|COMPLETED|Overall Study||58
8885261|NCT01969799|9942617|FG000|NOT COMPLETED|Overall Study||17
8885262|NCT01969799|9942618|FG001|NOT COMPLETED|Overall Study||14
8885263|NCT01969851|9942627|FG000|STARTED|Overall Study||10
8885264|NCT01969851|9942628|FG001|STARTED|Overall Study||24
8885265|NCT01969851|9942629|FG002|STARTED|Overall Study||21
8885266|NCT01969851|9942627|FG000|COMPLETED|Overall Study||9
8885267|NCT01969851|9942628|FG001|COMPLETED|Overall Study||21
8885268|NCT01969851|9942629|FG002|COMPLETED|Overall Study||14
8885269|NCT01969851|9942627|FG000|NOT COMPLETED|Overall Study||1
8885270|NCT01969851|9942628|FG001|NOT COMPLETED|Overall Study||3
8885271|NCT01969851|9942629|FG002|NOT COMPLETED|Overall Study||7
8885272|NCT01969916|9942637|FG000|STARTED|Overall Study||150
8885273|NCT01969916|9942637|FG000|COMPLETED|Overall Study||105
8885274|NCT01969916|9942637|FG000|NOT COMPLETED|Overall Study||45
8885275|NCT01970007|9942641|FG000|STARTED|Overall Study||243
8885276|NCT01970007|9942641|FG000|COMPLETED|Overall Study||188
8885277|NCT01970007|9942641|FG000|NOT COMPLETED|Overall Study||55
8885278|NCT01970176|9942647|FG000|STARTED|Overall Study||14
8885279|NCT01970176|9942648|FG001|STARTED|Overall Study||6
8885280|NCT01970176|9942647|FG000|COMPLETED|Overall Study||14
8885281|NCT01970176|9942648|FG001|COMPLETED|Overall Study||6
8885282|NCT01970176|9942647|FG000|NOT COMPLETED|Overall Study||0
8885283|NCT01970176|9942648|FG001|NOT COMPLETED|Overall Study||0
8885284|NCT01970241|9942656|FG000|STARTED|Overall Study||46
8885285|NCT01970241|9942657|FG001|STARTED|Overall Study||39
8885286|NCT01970241|9942656|FG000|COMPLETED|Overall Study||29
8885287|NCT01970241|9942657|FG001|COMPLETED|Overall Study||31
8885288|NCT01970241|9942656|FG000|NOT COMPLETED|Overall Study||17
8885289|NCT01970241|9942657|FG001|NOT COMPLETED|Overall Study||8
8885290|NCT01970371|9942668|FG000|STARTED|Overall Study||18
8885291|NCT01970371|9942669|FG001|STARTED|Overall Study||21
8885292|NCT01970371|9942670|FG002|STARTED|Overall Study||30
8885293|NCT01970371|9942668|FG000|COMPLETED|Overall Study||10
8885294|NCT01970371|9942669|FG001|COMPLETED|Overall Study||8
8885295|NCT01970371|9942670|FG002|COMPLETED|Overall Study||17
8885296|NCT01970371|9942668|FG000|NOT COMPLETED|Overall Study||8
8885297|NCT01970371|9942669|FG001|NOT COMPLETED|Overall Study||13
8885298|NCT01970371|9942670|FG002|NOT COMPLETED|Overall Study||13
8885299|NCT01970397|9942682|FG000|STARTED|Overall Study||69
8885300|NCT01970397|9942683|FG001|STARTED|Overall Study||69
8885301|NCT01970397|9942682|FG000|COMPLETED|Overall Study||67
8885302|NCT01970397|9942683|FG001|COMPLETED|Overall Study||64
8885303|NCT01970397|9942682|FG000|NOT COMPLETED|Overall Study||2
8885304|NCT01970397|9942683|FG001|NOT COMPLETED|Overall Study||5
8885305|NCT01970475|9942691|FG000|STARTED|Overall Study||264
8885306|NCT01970475|9942692|FG001|STARTED|Overall Study||262
8885307|NCT01970475|9942691|FG000|COMPLETED|Overall Study||243
8885308|NCT01970475|9942692|FG001|COMPLETED|Overall Study||251
8885309|NCT01970475|9942691|FG000|NOT COMPLETED|Overall Study||21
8885310|NCT01970475|9942692|FG001|NOT COMPLETED|Overall Study||11
8885311|NCT01970488|9942700|FG000|STARTED|Part 1: Through Week 16||175
8885312|NCT01970488|9942701|FG001|STARTED|Part 1: Through Week 16||175
8885313|NCT01970488|9942702|FG002|STARTED|Part 1: Through Week 16||0
8885314|NCT01970488|9942703|FG003|STARTED|Part 1: Through Week 16||0
8885315|NCT01970488|9942704|FG004|STARTED|Part 1: Through Week 16||0
8885316|NCT01970488|9942700|FG000|Received Treatment|Part 1: Through Week 16||174
8885317|NCT01970488|9942701|FG001|Received Treatment|Part 1: Through Week 16||173
8885318|NCT01970488|9942702|FG002|Received Treatment|Part 1: Through Week 16||0
8885319|NCT01970488|9942703|FG003|Received Treatment|Part 1: Through Week 16||0
9003845|NCT02922959|10066926|FG000|COMPLETED|Overall Study||21
9003846|NCT02922959|10066927|FG001|COMPLETED|Overall Study||23
9003847|NCT02922959|10066926|FG000|NOT COMPLETED|Overall Study||19
9003848|NCT02922959|10066927|FG001|NOT COMPLETED|Overall Study||17
9003849|NCT02923115|10066939|FG000|STARTED|Overall Study||12
9003850|NCT02923115|10066940|FG001|STARTED|Overall Study||16
9003851|NCT02923115|10066941|FG002|STARTED|Overall Study||23
9003852|NCT02923115|10066942|FG003|STARTED|Overall Study||23
9003853|NCT02923115|10066943|FG004|STARTED|Overall Study||22
9003854|NCT02923115|10066944|FG005|STARTED|Overall Study||38
9003855|NCT02923115|10066939|FG000|Treated|Overall Study||12
8634462|NCT00556933|9674798|FG000|NOT COMPLETED|Single vs. Divided-dose rATG Induction||2
8634463|NCT00556933|9674799|FG001|NOT COMPLETED|Single vs. Divided-dose rATG Induction||8
8634464|NCT00556933|9674800|FG002|NOT COMPLETED|Single vs. Divided-dose rATG Induction||6
9003856|NCT02923115|10066940|FG001|Treated|Overall Study||16
9003857|NCT02923115|10066941|FG002|Treated|Overall Study||20
9003858|NCT02923115|10066942|FG003|Treated|Overall Study||22
9003859|NCT02923115|10066943|FG004|Treated|Overall Study||17
9003860|NCT02923115|10066944|FG005|Treated|Overall Study||38
9003861|NCT02923115|10066939|FG000|COMPLETED|Overall Study||12
9003862|NCT02923115|10066940|FG001|COMPLETED|Overall Study||15
9003863|NCT02923115|10066941|FG002|COMPLETED|Overall Study||20
9003864|NCT02923115|10066942|FG003|COMPLETED|Overall Study||21
9003865|NCT02923115|10066943|FG004|COMPLETED|Overall Study||17
9003866|NCT02923115|10066944|FG005|COMPLETED|Overall Study||38
9003867|NCT02923115|10066939|FG000|NOT COMPLETED|Overall Study||0
9003868|NCT02923115|10066940|FG001|NOT COMPLETED|Overall Study||1
9003869|NCT02923115|10066941|FG002|NOT COMPLETED|Overall Study||3
9003870|NCT02923115|10066942|FG003|NOT COMPLETED|Overall Study||2
9003871|NCT02923115|10066943|FG004|NOT COMPLETED|Overall Study||5
9003872|NCT02923115|10066944|FG005|NOT COMPLETED|Overall Study||0
9003873|NCT02923167|10066958|FG000|STARTED|Overall Study||6
9003874|NCT02923167|10066958|FG000|COMPLETED|Overall Study||4
9003875|NCT02923167|10066958|FG000|NOT COMPLETED|Overall Study||2
9003876|NCT02923180|10066963|FG000|STARTED|Overall Study||32
9003877|NCT02923180|10066963|FG000|COMPLETED|Overall Study||6
9003878|NCT02923180|10066963|FG000|NOT COMPLETED|Overall Study||26
9003879|NCT02923245|10066969|FG000|STARTED|Overall Study||60
9003880|NCT02923245|10066970|FG001|STARTED|Overall Study||60
9003881|NCT02923245|10066969|FG000|COMPLETED|Overall Study||58
9003882|NCT02923245|10066970|FG001|COMPLETED|Overall Study||59
9003883|NCT02923245|10066969|FG000|NOT COMPLETED|Overall Study||2
9003884|NCT02923245|10066970|FG001|NOT COMPLETED|Overall Study||1
9003885|NCT02923271|10066979|FG000|STARTED|Overall Study||18
8634465|NCT00556933|9674801|FG003|NOT COMPLETED|Single vs. Divided-dose rATG Induction||2
8634466|NCT00556933|9674798|FG000|STARTED|CNI Withdrawal vs. Minimization||43
8634467|NCT00556933|9674799|FG001|STARTED|CNI Withdrawal vs. Minimization||37
8634468|NCT00556933|9674800|FG002|STARTED|CNI Withdrawal vs. Minimization||39
8634469|NCT00556933|9674801|FG003|STARTED|CNI Withdrawal vs. Minimization||43
9003886|NCT02923271|10066980|FG001|STARTED|Overall Study||16
9003887|NCT02923271|10066979|FG000|COMPLETED|Overall Study||10
9003888|NCT02923271|10066980|FG001|COMPLETED|Overall Study||14
9003889|NCT02923271|10066979|FG000|NOT COMPLETED|Overall Study||8
9003890|NCT02923271|10066980|FG001|NOT COMPLETED|Overall Study||2
9003891|NCT02923349|10066993|FG000|STARTED|Overall Study||4
9003892|NCT02923349|10066994|FG001|STARTED|Overall Study||4
9003893|NCT02923349|10066995|FG002|STARTED|Overall Study||22
9003894|NCT02923349|10066996|FG003|STARTED|Overall Study||18
9003895|NCT02923349|10066997|FG004|STARTED|Overall Study||23
9003896|NCT02923349|10066998|FG005|STARTED|Overall Study||12
9003897|NCT02923349|10066999|FG006|STARTED|Overall Study||4
9003898|NCT02923349|10066993|FG000|COMPLETED|Overall Study||0
9003899|NCT02923349|10066994|FG001|COMPLETED|Overall Study||0
9003900|NCT02923349|10066995|FG002|COMPLETED|Overall Study||5
9003901|NCT02923349|10066996|FG003|COMPLETED|Overall Study||2
9003902|NCT02923349|10066997|FG004|COMPLETED|Overall Study||4
9003903|NCT02923349|10066998|FG005|COMPLETED|Overall Study||5
9003904|NCT02923349|10066999|FG006|COMPLETED|Overall Study||1
9003905|NCT02923349|10066993|FG000|NOT COMPLETED|Overall Study||4
9003906|NCT02923349|10066994|FG001|NOT COMPLETED|Overall Study||4
9003907|NCT02923349|10066995|FG002|NOT COMPLETED|Overall Study||17
9003908|NCT02923349|10066996|FG003|NOT COMPLETED|Overall Study||16
9003909|NCT02923349|10066997|FG004|NOT COMPLETED|Overall Study||19
9003910|NCT02923349|10066998|FG005|NOT COMPLETED|Overall Study||7
9003911|NCT02923349|10066999|FG006|NOT COMPLETED|Overall Study||3
8885320|NCT01970488|9942704|FG004|Received Treatment|Part 1: Through Week 16||0
9003912|NCT02923427|10067017|FG000|STARTED|Overall Study||55
9003913|NCT02923427|10067018|FG001|STARTED|Overall Study||57
9003914|NCT02923427|10067017|FG000|COMPLETED|Overall Study|"The reasons:~n= 2 Convert to Laparotomy n=1 Desaturation n=1 LMA-S can not be placed"|51
9003915|NCT02923427|10067018|FG001|COMPLETED|Overall Study|"The reasons:~n = 2 Convert to Laparotomy"|55
9003916|NCT02923427|10067017|FG000|NOT COMPLETED|Overall Study||4
8885321|NCT01970488|9942700|FG000|COMPLETED|Part 1: Through Week 16||164
8885322|NCT01970488|9942701|FG001|COMPLETED|Part 1: Through Week 16||162
8885323|NCT01970488|9942702|FG002|COMPLETED|Part 1: Through Week 16||0
8885324|NCT01970488|9942703|FG003|COMPLETED|Part 1: Through Week 16||0
8885325|NCT01970488|9942704|FG004|COMPLETED|Part 1: Through Week 16||0
8885326|NCT01970488|9942700|FG000|NOT COMPLETED|Part 1: Through Week 16||11
8885327|NCT01970488|9942701|FG001|NOT COMPLETED|Part 1: Through Week 16||13
8885328|NCT01970488|9942702|FG002|NOT COMPLETED|Part 1: Through Week 16||0
8885329|NCT01970488|9942703|FG003|NOT COMPLETED|Part 1: Through Week 16||0
8885330|NCT01970488|9942704|FG004|NOT COMPLETED|Part 1: Through Week 16||0
8885331|NCT01970488|9942700|FG000|STARTED|Part 2: Post Week 16||0
8885332|NCT01970488|9942701|FG001|STARTED|Part 2: Post Week 16||0
8885333|NCT01970488|9942702|FG002|STARTED|Part 2: Post Week 16|Only participants who completed week 16 and with a PASI 50 response continued in Part 2|152
8885334|NCT01970488|9942703|FG003|STARTED|Part 2: Post Week 16|Only participants who completed week 16 and with a PASI 50 response continued in Part 2|79
8885335|NCT01970488|9942704|FG004|STARTED|Part 2: Post Week 16|Only participants who completed week 16 and with a PASI 50 response continued in Part 2|77
8885336|NCT01970488|9942700|FG000|COMPLETED|Part 2: Post Week 16||0
8885337|NCT01970488|9942701|FG001|COMPLETED|Part 2: Post Week 16||0
8885338|NCT01970488|9942702|FG002|COMPLETED|Part 2: Post Week 16||135
8885339|NCT01970488|9942703|FG003|COMPLETED|Part 2: Post Week 16||71
8885340|NCT01970488|9942704|FG004|COMPLETED|Part 2: Post Week 16||69
8885341|NCT01970488|9942700|FG000|NOT COMPLETED|Part 2: Post Week 16||0
8885342|NCT01970488|9942701|FG001|NOT COMPLETED|Part 2: Post Week 16||0
8885343|NCT01970488|9942702|FG002|NOT COMPLETED|Part 2: Post Week 16||17
8885344|NCT01970488|9942703|FG003|NOT COMPLETED|Part 2: Post Week 16||8
8885345|NCT01970488|9942704|FG004|NOT COMPLETED|Part 2: Post Week 16||8
8885346|NCT01970527|9942721|FG000|STARTED|Pre-treatment/Baseline||9
8885347|NCT01970527|9942722|FG001|STARTED|Pre-treatment/Baseline||14
8885348|NCT01970527|9942721|FG000|COMPLETED|Pre-treatment/Baseline||8
8885349|NCT01970527|9942722|FG001|COMPLETED|Pre-treatment/Baseline||14
8885350|NCT01970527|9942721|FG000|NOT COMPLETED|Pre-treatment/Baseline||1
8885351|NCT01970527|9942722|FG001|NOT COMPLETED|Pre-treatment/Baseline||0
8885352|NCT01970527|9942721|FG000|STARTED|Treatment||8
8885353|NCT01970527|9942722|FG001|STARTED|Treatment||14
8885354|NCT01970527|9942721|FG000|COMPLETED|Treatment||8
8885355|NCT01970527|9942722|FG001|COMPLETED|Treatment||11
8885356|NCT01970527|9942721|FG000|NOT COMPLETED|Treatment||0
8634470|NCT00556933|9674798|FG000|COMPLETED|CNI Withdrawal vs. Minimization||42
8634471|NCT00556933|9674799|FG001|COMPLETED|CNI Withdrawal vs. Minimization||33
8634472|NCT00556933|9674800|FG002|COMPLETED|CNI Withdrawal vs. Minimization||36
8885357|NCT01970527|9942722|FG001|NOT COMPLETED|Treatment||3
8885358|NCT01970527|9942721|FG000|STARTED|Follow-up Clinic Visit||8
8885359|NCT01970527|9942722|FG001|STARTED|Follow-up Clinic Visit||11
8885360|NCT01970527|9942721|FG000|COMPLETED|Follow-up Clinic Visit||7
8885361|NCT01970527|9942722|FG001|COMPLETED|Follow-up Clinic Visit||8
8885362|NCT01970527|9942721|FG000|NOT COMPLETED|Follow-up Clinic Visit||1
8885363|NCT01970527|9942722|FG001|NOT COMPLETED|Follow-up Clinic Visit||3
8885364|NCT01970540|9942734|FG000|STARTED|Overall Study||73
8885365|NCT01970540|9942735|FG001|STARTED|Overall Study||28
8885366|NCT01970540|9942736|FG002|STARTED|Overall Study||19
8885367|NCT01970540|9942734|FG000|COMPLETED|Overall Study||0
8885368|NCT01970540|9942735|FG001|COMPLETED|Overall Study||0
8885369|NCT01970540|9942736|FG002|COMPLETED|Overall Study||0
8885370|NCT01970540|9942734|FG000|NOT COMPLETED|Overall Study||73
8885371|NCT01970540|9942735|FG001|NOT COMPLETED|Overall Study||28
8885372|NCT01970540|9942736|FG002|NOT COMPLETED|Overall Study||19
8885373|NCT01970592|9942755|FG000|STARTED|Overall Study|Completed all training sessions|56
8885374|NCT01970592|9942755|FG000|COMPLETED|Overall Study||50
8885375|NCT01970592|9942755|FG000|NOT COMPLETED|Overall Study||6
8885376|NCT01970787|9942759|FG000|STARTED|Overall Study||22
8885377|NCT01970787|9942759|FG000|COMPLETED|Overall Study||21
8885378|NCT01970787|9942759|FG000|NOT COMPLETED|Overall Study||1
8885379|NCT01970878|9942767|FG000|STARTED|Overall Study||290
8885380|NCT01970878|9942768|FG001|STARTED|Overall Study|218 subjects were reported in the CSR, 1 had no completion status|218
8885381|NCT01970878|9942769|FG002|STARTED|Overall Study||213
8885382|NCT01970878|9942770|FG003|STARTED|Overall Study||171
8885383|NCT01970878|9942767|FG000|COMPLETED|Overall Study||253
8885384|NCT01970878|9942768|FG001|COMPLETED|Overall Study||191
8885385|NCT01970878|9942769|FG002|COMPLETED|Overall Study||187
8885386|NCT01970878|9942770|FG003|COMPLETED|Overall Study||147
8885387|NCT01970878|9942767|FG000|NOT COMPLETED|Overall Study||37
8885388|NCT01970878|9942768|FG001|NOT COMPLETED|Overall Study||27
8885389|NCT01970878|9942769|FG002|NOT COMPLETED|Overall Study||26
8885390|NCT01970878|9942770|FG003|NOT COMPLETED|Overall Study||24
8885391|NCT01970943|9942780|FG000|STARTED|Overall Study||11
8885392|NCT01970943|9942781|FG001|STARTED|Overall Study||12
8885393|NCT01970943|9942780|FG000|COMPLETED|Overall Study||8
8885394|NCT01970943|9942781|FG001|COMPLETED|Overall Study||11
8885395|NCT01970943|9942780|FG000|NOT COMPLETED|Overall Study||3
8885396|NCT01970943|9942781|FG001|NOT COMPLETED|Overall Study||1
8885397|NCT01970982|9942790|FG000|STARTED|Overall Study||80
8885398|NCT01970982|9942791|FG001|STARTED|Overall Study||40
8885399|NCT01970982|9942792|FG002|STARTED|Overall Study||40
8634473|NCT00556933|9674801|FG003|COMPLETED|CNI Withdrawal vs. Minimization||41
8885400|NCT01970982|9942790|FG000|COMPLETED|Overall Study||80
8885401|NCT01970982|9942791|FG001|COMPLETED|Overall Study||40
8885402|NCT01970982|9942792|FG002|COMPLETED|Overall Study||38
8634474|NCT00556933|9674798|FG000|NOT COMPLETED|CNI Withdrawal vs. Minimization||1
8634475|NCT00556933|9674799|FG001|NOT COMPLETED|CNI Withdrawal vs. Minimization||4
8634476|NCT00556933|9674800|FG002|NOT COMPLETED|CNI Withdrawal vs. Minimization||3
8634477|NCT00556933|9674801|FG003|NOT COMPLETED|CNI Withdrawal vs. Minimization||2
8634478|NCT00556946|9674820|FG000|STARTED|Overall Study||17
8634479|NCT00556946|9674820|FG000|COMPLETED|Overall Study||16
8634480|NCT00556946|9674820|FG000|NOT COMPLETED|Overall Study||1
8634481|NCT00556972|9674824|FG000|STARTED|Overall Study||4
8634482|NCT00556972|9674824|FG000|COMPLETED|Overall Study||4
8885403|NCT01970982|9942790|FG000|NOT COMPLETED|Overall Study||0
8885404|NCT01970982|9942791|FG001|NOT COMPLETED|Overall Study||0
8885405|NCT01970982|9942792|FG002|NOT COMPLETED|Overall Study||2
8885406|NCT01970995|9942804|FG000|STARTED|Confinement Period (Population at Day 5)||78
8885407|NCT01970995|9942805|FG001|STARTED|Confinement Period (Population at Day 5)||42
8885408|NCT01970995|9942806|FG002|STARTED|Confinement Period (Population at Day 5)||40
8885409|NCT01970995|9942804|FG000|COMPLETED|Confinement Period (Population at Day 5)||77
8885410|NCT01970995|9942805|FG001|COMPLETED|Confinement Period (Population at Day 5)||41
8885411|NCT01970995|9942806|FG002|COMPLETED|Confinement Period (Population at Day 5)||39
8885412|NCT01970995|9942804|FG000|NOT COMPLETED|Confinement Period (Population at Day 5)||1
8885413|NCT01970995|9942805|FG001|NOT COMPLETED|Confinement Period (Population at Day 5)||1
8885414|NCT01970995|9942806|FG002|NOT COMPLETED|Confinement Period (Population at Day 5)||1
8885415|NCT01970995|9942804|FG000|STARTED|End of Study (Population at Day 90)||77
8885416|NCT01970995|9942805|FG001|STARTED|End of Study (Population at Day 90)||41
8885417|NCT01970995|9942806|FG002|STARTED|End of Study (Population at Day 90)||39
8885418|NCT01970995|9942804|FG000|COMPLETED|End of Study (Population at Day 90)||76
8885419|NCT01970995|9942805|FG001|COMPLETED|End of Study (Population at Day 90)||41
8885420|NCT01970995|9942806|FG002|COMPLETED|End of Study (Population at Day 90)||38
8885421|NCT01970995|9942804|FG000|NOT COMPLETED|End of Study (Population at Day 90)||1
8885422|NCT01970995|9942805|FG001|NOT COMPLETED|End of Study (Population at Day 90)||0
8885423|NCT01970995|9942806|FG002|NOT COMPLETED|End of Study (Population at Day 90)||1
8885424|NCT01971086|9942814|FG000|STARTED|Overall Study||300
8885425|NCT01971086|9942814|FG000|COMPLETED|Overall Study||300
8885426|NCT01971086|9942814|FG000|NOT COMPLETED|Overall Study||0
8885427|NCT01971203|9942821|FG000|STARTED|Overall Study||26
8885428|NCT01971203|9942822|FG001|STARTED|Overall Study||29
9003917|NCT02923427|10067018|FG001|NOT COMPLETED|Overall Study||2
9003918|NCT02923895|10067026|FG000|STARTED|Overall Study||97
9003919|NCT02923895|10067027|FG001|STARTED|Overall Study||95
9003920|NCT02923895|10067026|FG000|COMPLETED|Overall Study||97
9003921|NCT02923895|10067027|FG001|COMPLETED|Overall Study||95
9003922|NCT02923895|10067026|FG000|NOT COMPLETED|Overall Study||0
9003923|NCT02923895|10067027|FG001|NOT COMPLETED|Overall Study||0
9003924|NCT02923921|10067035|FG000|STARTED|Overall Study||283
9003925|NCT02923921|10067036|FG001|STARTED|Overall Study||284
9003926|NCT02923921|10067035|FG000|Received at Least 1 Dose of Study Drug|Overall Study||278
9003927|NCT02923921|10067036|FG001|Received at Least 1 Dose of Study Drug|Overall Study||251
9003928|NCT02923921|10067035|FG000|Safety Population|Overall Study||278
9003929|NCT02923921|10067036|FG001|Safety Population|Overall Study||251
9003930|NCT02923921|10067035|FG000|COMPLETED|Overall Study||230
9003931|NCT02923921|10067036|FG001|COMPLETED|Overall Study||227
9003932|NCT02923921|10067035|FG000|NOT COMPLETED|Overall Study||53
9003933|NCT02923921|10067036|FG001|NOT COMPLETED|Overall Study||57
9003934|NCT02924051|10067044|FG000|STARTED|Overall Study||82
9003935|NCT02924051|10067045|FG001|STARTED|Overall Study||106
9003936|NCT02924051|10067044|FG000|COMPLETED|Overall Study||81
9003937|NCT02924051|10067045|FG001|COMPLETED|Overall Study||97
9003938|NCT02924051|10067044|FG000|NOT COMPLETED|Overall Study||1
9003939|NCT02924051|10067045|FG001|NOT COMPLETED|Overall Study||9
9003940|NCT02924350|10067055|FG000|STARTED|Overall Study||102
9003941|NCT02924350|10067056|FG001|STARTED|Overall Study||102
9003942|NCT02924350|10067055|FG000|COMPLETED|Overall Study||102
9003943|NCT02924350|10067056|FG001|COMPLETED|Overall Study||100
9003944|NCT02924350|10067055|FG000|NOT COMPLETED|Overall Study||0
9003945|NCT02924350|10067056|FG001|NOT COMPLETED|Overall Study||2
9003946|NCT02924428|10067064|FG000|STARTED|Overall Study||20
9003947|NCT02924428|10067065|FG001|STARTED|Overall Study||19
9003948|NCT02924428|10067064|FG000|COMPLETED|Overall Study||16
9003949|NCT02924428|10067065|FG001|COMPLETED|Overall Study||14
9003950|NCT02924428|10067064|FG000|NOT COMPLETED|Overall Study||4
9003951|NCT02924428|10067065|FG001|NOT COMPLETED|Overall Study||5
9003952|NCT02924688|10067077|FG000|STARTED|Overall Study||407
9003953|NCT02924688|10067078|FG001|STARTED|Overall Study||405
9003954|NCT02924688|10067079|FG002|STARTED|Overall Study||406
9003955|NCT02924688|10067080|FG003|STARTED|Overall Study||406
9003956|NCT02924688|10067081|FG004|STARTED|Overall Study||404
9003957|NCT02924688|10067082|FG005|STARTED|Overall Study||408
9003958|NCT02924688|10067077|FG000|COMPLETED|Overall Study||374
9003959|NCT02924688|10067078|FG001|COMPLETED|Overall Study||374
9003960|NCT02924688|10067079|FG002|COMPLETED|Overall Study||383
9003961|NCT02924688|10067080|FG003|COMPLETED|Overall Study||378
9003962|NCT02924688|10067081|FG004|COMPLETED|Overall Study||381
9003963|NCT02924688|10067082|FG005|COMPLETED|Overall Study||384
9003964|NCT02924688|10067077|FG000|NOT COMPLETED|Overall Study||33
9003965|NCT02924688|10067078|FG001|NOT COMPLETED|Overall Study||31
8634483|NCT00556972|9674824|FG000|NOT COMPLETED|Overall Study||0
8634484|NCT00556998|9674828|FG000|STARTED|Voriconazole Intravenous (IV)||26
8885429|NCT01971203|9942821|FG000|COMPLETED|Overall Study||17
8885430|NCT01971203|9942822|FG001|COMPLETED|Overall Study||21
8885431|NCT01971203|9942821|FG000|NOT COMPLETED|Overall Study||9
8885432|NCT01971203|9942822|FG001|NOT COMPLETED|Overall Study||8
8885433|NCT01971255|9942830|FG000|STARTED|Overall Study||32
8885434|NCT01971255|9942831|FG001|STARTED|Overall Study||42
8885435|NCT01971255|9942830|FG000|COMPLETED|Overall Study||31
8885436|NCT01971255|9942831|FG001|COMPLETED|Overall Study||40
8885437|NCT01971255|9942830|FG000|NOT COMPLETED|Overall Study||1
8885438|NCT01971255|9942831|FG001|NOT COMPLETED|Overall Study||2
8885439|NCT01971346|9942837|FG000|STARTED|Overall Study|Four subjects signed the informed consent and terminated the study before beginning.|50
8885440|NCT01971346|9942837|FG000|COMPLETED|Overall Study||42
8885441|NCT01971346|9942837|FG000|NOT COMPLETED|Overall Study||8
8885442|NCT01971385|9942852|FG000|STARTED|Overall Study||17
8885443|NCT01971385|9942853|FG001|STARTED|Overall Study||18
8885444|NCT01971385|9942854|FG002|STARTED|Overall Study||19
8885445|NCT01971385|9942852|FG000|COMPLETED|Overall Study||14
8885446|NCT01971385|9942853|FG001|COMPLETED|Overall Study||13
8885447|NCT01971385|9942854|FG002|COMPLETED|Overall Study||15
8885448|NCT01971385|9942852|FG000|NOT COMPLETED|Overall Study||3
8885449|NCT01971385|9942853|FG001|NOT COMPLETED|Overall Study||5
8885450|NCT01971385|9942854|FG002|NOT COMPLETED|Overall Study||4
8885451|NCT01971463|9942861|FG000|STARTED|Overall Study||81
8885452|NCT01971463|9942861|FG000|COMPLETED|Overall Study||81
8885453|NCT01971463|9942861|FG000|NOT COMPLETED|Overall Study||0
8885454|NCT01971476|9942868|FG000|STARTED|Cohort 1: 2 to <12 Years||3
8885455|NCT01971476|9942869|FG001|STARTED|Cohort 1: 2 to <12 Years||3
8885456|NCT01971476|9942870|FG002|STARTED|Cohort 1: 2 to <12 Years||6
8885457|NCT01971476|9942868|FG000|COMPLETED|Cohort 1: 2 to <12 Years||0
8885458|NCT01971476|9942869|FG001|COMPLETED|Cohort 1: 2 to <12 Years||0
8885459|NCT01971476|9942870|FG002|COMPLETED|Cohort 1: 2 to <12 Years||0
8885460|NCT01971476|9942868|FG000|NOT COMPLETED|Cohort 1: 2 to <12 Years||3
8885461|NCT01971476|9942869|FG001|NOT COMPLETED|Cohort 1: 2 to <12 Years||3
8885462|NCT01971476|9942870|FG002|NOT COMPLETED|Cohort 1: 2 to <12 Years||6
8885463|NCT01971476|9942868|FG000|STARTED|Cohort 2: 12 to <18 Years||6
8885464|NCT01971476|9942869|FG001|STARTED|Cohort 2: 12 to <18 Years||4
8885465|NCT01971476|9942870|FG002|STARTED|Cohort 2: 12 to <18 Years||0
8885466|NCT01971476|9942868|FG000|COMPLETED|Cohort 2: 12 to <18 Years||0
8885467|NCT01971476|9942869|FG001|COMPLETED|Cohort 2: 12 to <18 Years||0
8885468|NCT01971476|9942870|FG002|COMPLETED|Cohort 2: 12 to <18 Years||0
8885469|NCT01971476|9942868|FG000|NOT COMPLETED|Cohort 2: 12 to <18 Years||6
8885470|NCT01971476|9942869|FG001|NOT COMPLETED|Cohort 2: 12 to <18 Years||4
8885471|NCT01971476|9942870|FG002|NOT COMPLETED|Cohort 2: 12 to <18 Years||0
8885472|NCT01971554|9942891|FG000|STARTED|Overall Study||9
8885473|NCT01971554|9942892|FG001|STARTED|Overall Study||18
8885474|NCT01971554|9942893|FG002|STARTED|Overall Study||18
8885475|NCT01971554|9942894|FG003|STARTED|Overall Study||18
8885476|NCT01971554|9942891|FG000|COMPLETED|Overall Study||8
8885477|NCT01971554|9942892|FG001|COMPLETED|Overall Study||18
8885478|NCT01971554|9942893|FG002|COMPLETED|Overall Study||18
8885479|NCT01971554|9942894|FG003|COMPLETED|Overall Study||18
8885480|NCT01971554|9942891|FG000|NOT COMPLETED|Overall Study||1
8885481|NCT01971554|9942892|FG001|NOT COMPLETED|Overall Study||0
8885482|NCT01971554|9942893|FG002|NOT COMPLETED|Overall Study||0
8885483|NCT01971554|9942894|FG003|NOT COMPLETED|Overall Study||0
8885484|NCT01971567|9942906|FG000|STARTED|Overall Study||56
8885485|NCT01971567|9942907|FG001|STARTED|Overall Study||51
8885486|NCT01971567|9942906|FG000|COMPLETED|Overall Study||52
8885487|NCT01971567|9942907|FG001|COMPLETED|Overall Study||49
8885488|NCT01971567|9942906|FG000|NOT COMPLETED|Overall Study||4
8885489|NCT01971567|9942907|FG001|NOT COMPLETED|Overall Study||2
8885490|NCT01971580|9942915|FG000|STARTED|Overall Study||14
8885491|NCT01971580|9942916|FG001|STARTED|Overall Study||14
8885492|NCT01971580|9942915|FG000|COMPLETED|Overall Study||10
8885493|NCT01971580|9942916|FG001|COMPLETED|Overall Study||9
8885494|NCT01971580|9942915|FG000|NOT COMPLETED|Overall Study||4
8885495|NCT01971580|9942916|FG001|NOT COMPLETED|Overall Study||5
8885496|NCT01971593|9942924|FG000|STARTED|Overall Study||14
8885497|NCT01971593|9942925|FG001|STARTED|Overall Study||12
8885498|NCT01971593|9942924|FG000|COMPLETED|Overall Study||9
8885499|NCT01971593|9942925|FG001|COMPLETED|Overall Study||8
8885500|NCT01971593|9942924|FG000|NOT COMPLETED|Overall Study||5
8885501|NCT01971593|9942925|FG001|NOT COMPLETED|Overall Study||4
8885502|NCT01971645|9942932|FG000|STARTED|Overall Study||25
8885503|NCT01971645|9942933|FG001|STARTED|Overall Study||27
8885504|NCT01971645|9942934|FG002|STARTED|Overall Study||25
8885505|NCT01971645|9942932|FG000|COMPLETED|Overall Study||23
8885506|NCT01971645|9942933|FG001|COMPLETED|Overall Study||27
8885507|NCT01971645|9942934|FG002|COMPLETED|Overall Study||23
8885508|NCT01971645|9942932|FG000|NOT COMPLETED|Overall Study||2
8885509|NCT01971645|9942933|FG001|NOT COMPLETED|Overall Study||0
8885510|NCT01971645|9942934|FG002|NOT COMPLETED|Overall Study||2
8885511|NCT01971723|9942944|FG000|STARTED|Overall Study||16
8885512|NCT01971723|9942945|FG001|STARTED|Overall Study||16
8885513|NCT01971723|9942944|FG000|COMPLETED|Overall Study||14
8885514|NCT01971723|9942945|FG001|COMPLETED|Overall Study||13
8885515|NCT01971723|9942944|FG000|NOT COMPLETED|Overall Study||2
8885516|NCT01971723|9942945|FG001|NOT COMPLETED|Overall Study||3
8885517|NCT01972061|9942954|FG000|STARTED|Overall Study||1
8885518|NCT01972061|9942955|FG001|STARTED|Overall Study||23
8885519|NCT01972061|9942956|FG002|STARTED|Overall Study||20
8885520|NCT01972061|9942954|FG000|COMPLETED|Overall Study||1
8885521|NCT01972061|9942955|FG001|COMPLETED|Overall Study||23
8885522|NCT01972061|9942956|FG002|COMPLETED|Overall Study||20
8885523|NCT01972061|9942954|FG000|NOT COMPLETED|Overall Study||0
8885524|NCT01972061|9942955|FG001|NOT COMPLETED|Overall Study||0
8885525|NCT01972061|9942956|FG002|NOT COMPLETED|Overall Study||0
8885526|NCT01972074|9942967|FG000|STARTED|Overall Study||22
8885527|NCT01972074|9942968|FG001|STARTED|Overall Study||21
8885528|NCT01972074|9942969|FG002|STARTED|Overall Study||18
8885529|NCT01972074|9942967|FG000|COMPLETED|Overall Study||16
8885530|NCT01972074|9942968|FG001|COMPLETED|Overall Study||17
8885531|NCT01972074|9942969|FG002|COMPLETED|Overall Study||15
8885532|NCT01972074|9942967|FG000|NOT COMPLETED|Overall Study||6
8885533|NCT01972074|9942968|FG001|NOT COMPLETED|Overall Study||4
8885534|NCT01972074|9942969|FG002|NOT COMPLETED|Overall Study||3
8885535|NCT01972152|9942976|FG000|STARTED|First Treatment Visit||5
8885536|NCT01972152|9942977|FG001|STARTED|First Treatment Visit||5
8885537|NCT01972152|9942978|FG002|STARTED|First Treatment Visit||5
8885538|NCT01972152|9942979|FG003|STARTED|First Treatment Visit||5
8885539|NCT01972152|9942980|FG004|STARTED|First Treatment Visit||5
8885540|NCT01972152|9942981|FG005|STARTED|First Treatment Visit||5
8885541|NCT01972152|9942976|FG000|COMPLETED|First Treatment Visit||5
8885542|NCT01972152|9942977|FG001|COMPLETED|First Treatment Visit||4
8885543|NCT01972152|9942978|FG002|COMPLETED|First Treatment Visit||5
8885544|NCT01972152|9942979|FG003|COMPLETED|First Treatment Visit||5
8885545|NCT01972152|9942980|FG004|COMPLETED|First Treatment Visit||5
8885546|NCT01972152|9942981|FG005|COMPLETED|First Treatment Visit||5
8885547|NCT01972152|9942976|FG000|NOT COMPLETED|First Treatment Visit||0
8885548|NCT01972152|9942977|FG001|NOT COMPLETED|First Treatment Visit||1
8885549|NCT01972152|9942978|FG002|NOT COMPLETED|First Treatment Visit||0
8885550|NCT01972152|9942979|FG003|NOT COMPLETED|First Treatment Visit||0
8885551|NCT01972152|9942980|FG004|NOT COMPLETED|First Treatment Visit||0
8885552|NCT01972152|9942981|FG005|NOT COMPLETED|First Treatment Visit||0
8885553|NCT01972152|9942976|FG000|STARTED|Second Treatment Visit||5
8885554|NCT01972152|9942977|FG001|STARTED|Second Treatment Visit||4
8885555|NCT01972152|9942978|FG002|STARTED|Second Treatment Visit||5
8885556|NCT01972152|9942979|FG003|STARTED|Second Treatment Visit||5
8885557|NCT01972152|9942980|FG004|STARTED|Second Treatment Visit||5
8885558|NCT01972152|9942981|FG005|STARTED|Second Treatment Visit||5
8885559|NCT01972152|9942976|FG000|COMPLETED|Second Treatment Visit||5
8885560|NCT01972152|9942977|FG001|COMPLETED|Second Treatment Visit||3
8885561|NCT01972152|9942978|FG002|COMPLETED|Second Treatment Visit||5
8885562|NCT01972152|9942979|FG003|COMPLETED|Second Treatment Visit||5
8885563|NCT01972152|9942980|FG004|COMPLETED|Second Treatment Visit||5
8885564|NCT01972152|9942981|FG005|COMPLETED|Second Treatment Visit||5
8885565|NCT01972152|9942976|FG000|NOT COMPLETED|Second Treatment Visit||0
8885566|NCT01972152|9942977|FG001|NOT COMPLETED|Second Treatment Visit||1
8885567|NCT01972152|9942978|FG002|NOT COMPLETED|Second Treatment Visit||0
8885568|NCT01972152|9942979|FG003|NOT COMPLETED|Second Treatment Visit||0
8885569|NCT01972152|9942980|FG004|NOT COMPLETED|Second Treatment Visit||0
8885570|NCT01972152|9942981|FG005|NOT COMPLETED|Second Treatment Visit||0
8885571|NCT01972152|9942976|FG000|STARTED|Third Treatment Visit||5
8885572|NCT01972152|9942977|FG001|STARTED|Third Treatment Visit||3
8885573|NCT01972152|9942978|FG002|STARTED|Third Treatment Visit||5
8885574|NCT01972152|9942979|FG003|STARTED|Third Treatment Visit||5
8885575|NCT01972152|9942980|FG004|STARTED|Third Treatment Visit||5
8885576|NCT01972152|9942981|FG005|STARTED|Third Treatment Visit||5
8885577|NCT01972152|9942976|FG000|COMPLETED|Third Treatment Visit||5
8885578|NCT01972152|9942977|FG001|COMPLETED|Third Treatment Visit||3
8885579|NCT01972152|9942978|FG002|COMPLETED|Third Treatment Visit||5
8885580|NCT01972152|9942979|FG003|COMPLETED|Third Treatment Visit||5
8885581|NCT01972152|9942980|FG004|COMPLETED|Third Treatment Visit||5
8885582|NCT01972152|9942981|FG005|COMPLETED|Third Treatment Visit||5
8885583|NCT01972152|9942976|FG000|NOT COMPLETED|Third Treatment Visit||0
8885584|NCT01972152|9942977|FG001|NOT COMPLETED|Third Treatment Visit||0
8885585|NCT01972152|9942978|FG002|NOT COMPLETED|Third Treatment Visit||0
8885586|NCT01972152|9942979|FG003|NOT COMPLETED|Third Treatment Visit||0
8885587|NCT01972152|9942980|FG004|NOT COMPLETED|Third Treatment Visit||0
8885588|NCT01972152|9942981|FG005|NOT COMPLETED|Third Treatment Visit||0
8885589|NCT01972204|9942994|FG000|STARTED|Overall Study||62
8885590|NCT01972204|9942995|FG001|STARTED|Overall Study||63
8885591|NCT01972204|9942994|FG000|COMPLETED|Overall Study||58
8885592|NCT01972204|9942995|FG001|COMPLETED|Overall Study||59
8885593|NCT01972204|9942994|FG000|NOT COMPLETED|Overall Study||4
8885594|NCT01972204|9942995|FG001|NOT COMPLETED|Overall Study||4
8885595|NCT01972282|9943001|FG000|STARTED|Overall Study||1020
8885596|NCT01972282|9943001|FG000|COMPLETED|Overall Study||1005
8885597|NCT01972282|9943001|FG000|NOT COMPLETED|Overall Study||15
8885598|NCT01972308|9943007|FG000|STARTED|Overall Study||156
8885599|NCT01972308|9943008|FG001|STARTED|Overall Study||156
8885600|NCT01972308|9943007|FG000|COMPLETED|Overall Study||148
8885601|NCT01972308|9943008|FG001|COMPLETED|Overall Study||148
8885602|NCT01972308|9943007|FG000|NOT COMPLETED|Overall Study||8
8885603|NCT01972308|9943008|FG001|NOT COMPLETED|Overall Study||8
8885604|NCT01972438|9943018|FG000|STARTED|Baseline-Month 3 Crossover Period|Two participants never started IP: one died and one did not meet the inclusion criteria|9
9003966|NCT02924688|10067079|FG002|NOT COMPLETED|Overall Study||23
8885605|NCT01972438|9943019|FG001|STARTED|Baseline-Month 3 Crossover Period|One participant never started IP, as unable to donate blood for preparation of ASEDs|9
8885606|NCT01972438|9943018|FG000|COMPLETED|Baseline-Month 3 Crossover Period||6
8885607|NCT01972438|9943019|FG001|COMPLETED|Baseline-Month 3 Crossover Period||6
8885608|NCT01972438|9943018|FG000|NOT COMPLETED|Baseline-Month 3 Crossover Period||3
8885609|NCT01972438|9943019|FG001|NOT COMPLETED|Baseline-Month 3 Crossover Period||3
8885610|NCT01972438|9943018|FG000|STARTED|Months 3-6 Crossover Period||6
8885611|NCT01972438|9943019|FG001|STARTED|Months 3-6 Crossover Period|Two participants who missed Month 3 visit completed this pd but one who completed Month 3 didn't|7
9003967|NCT02924688|10067080|FG003|NOT COMPLETED|Overall Study||28
9003968|NCT02924688|10067081|FG004|NOT COMPLETED|Overall Study||23
9003969|NCT02924688|10067082|FG005|NOT COMPLETED|Overall Study||24
9003970|NCT02924883|10067101|FG000|STARTED|Overall Study||133
9003971|NCT02924883|10067102|FG001|STARTED|Overall Study||69
9003972|NCT02924883|10067101|FG000|COMPLETED|Overall Study||0
9003973|NCT02924883|10067102|FG001|COMPLETED|Overall Study||0
9003974|NCT02924883|10067101|FG000|NOT COMPLETED|Overall Study||133
9003975|NCT02924883|10067102|FG001|NOT COMPLETED|Overall Study||69
9003976|NCT02925078|10067112|FG000|STARTED|Overall Study||14
9003977|NCT02925078|10067113|FG001|STARTED|Overall Study||16
9003978|NCT02925078|10067112|FG000|COMPLETED|Overall Study||13
9003979|NCT02925078|10067113|FG001|COMPLETED|Overall Study||13
9003980|NCT02925078|10067112|FG000|NOT COMPLETED|Overall Study||1
9003981|NCT02925078|10067113|FG001|NOT COMPLETED|Overall Study||3
9003982|NCT02925117|10067123|FG000|STARTED|Period 1 (Weeks 0 - 16)||41
9003983|NCT02925117|10067124|FG001|STARTED|Period 1 (Weeks 0 - 16)||42
9003984|NCT02925117|10067125|FG002|STARTED|Period 1 (Weeks 0 - 16)||42
9003985|NCT02925117|10067126|FG003|STARTED|Period 1 (Weeks 0 - 16)||42
9003986|NCT02925117|10067127|FG004|STARTED|Period 1 (Weeks 0 - 16)||0
9003987|NCT02925117|10067128|FG005|STARTED|Period 1 (Weeks 0 - 16)||0
9003988|NCT02925117|10067129|FG006|STARTED|Period 1 (Weeks 0 - 16)||0
9003989|NCT02925117|10067130|FG007|STARTED|Period 1 (Weeks 0 - 16)||0
9003990|NCT02925117|10067131|FG008|STARTED|Period 1 (Weeks 0 - 16)||0
9003991|NCT02925117|10067132|FG009|STARTED|Period 1 (Weeks 0 - 16)||0
9003992|NCT02925117|10067133|FG010|STARTED|Period 1 (Weeks 0 - 16)||0
9003993|NCT02925117|10067134|FG011|STARTED|Period 1 (Weeks 0 - 16)||0
9003994|NCT02925117|10067123|FG000|Received Treatment|Period 1 (Weeks 0 - 16)||40
9003995|NCT02925117|10067124|FG001|Received Treatment|Period 1 (Weeks 0 - 16)||42
9003996|NCT02925117|10067125|FG002|Received Treatment|Period 1 (Weeks 0 - 16)||42
9003997|NCT02925117|10067126|FG003|Received Treatment|Period 1 (Weeks 0 - 16)||42
9003998|NCT02925117|10067127|FG004|Received Treatment|Period 1 (Weeks 0 - 16)||0
8572634|NCT00116272|9604842|FG001|COMPLETED|Overall Study|Indicates participants with a known outcome of pregnancy|158
8885612|NCT01972438|9943018|FG000|COMPLETED|Months 3-6 Crossover Period||6
8885613|NCT01972438|9943019|FG001|COMPLETED|Months 3-6 Crossover Period||6
8885614|NCT01972438|9943018|FG000|NOT COMPLETED|Months 3-6 Crossover Period||0
8885615|NCT01972438|9943019|FG001|NOT COMPLETED|Months 3-6 Crossover Period||1
8885616|NCT01972438|9943018|FG000|STARTED|Months 6-12 Study Period||6
8885617|NCT01972438|9943019|FG001|STARTED|Months 6-12 Study Period||6
8885618|NCT01972438|9943018|FG000|COMPLETED|Months 6-12 Study Period||3
8885619|NCT01972438|9943019|FG001|COMPLETED|Months 6-12 Study Period||4
8885620|NCT01972438|9943018|FG000|NOT COMPLETED|Months 6-12 Study Period||3
8885621|NCT01972438|9943019|FG001|NOT COMPLETED|Months 6-12 Study Period||2
8885622|NCT01972438|9943018|FG000|STARTED|Post Month 12 Study Period||3
8885623|NCT01972438|9943019|FG001|STARTED|Post Month 12 Study Period||4
8885624|NCT01972438|9943018|FG000|COMPLETED|Post Month 12 Study Period||0
8885625|NCT01972438|9943019|FG001|COMPLETED|Post Month 12 Study Period||0
8885626|NCT01972438|9943018|FG000|NOT COMPLETED|Post Month 12 Study Period||3
8885627|NCT01972438|9943019|FG001|NOT COMPLETED|Post Month 12 Study Period||4
8885628|NCT01972464|9943029|FG000|STARTED|Treatment Period (Week 1 Through Week 8)||19
8885629|NCT01972464|9943030|FG001|STARTED|Treatment Period (Week 1 Through Week 8)||22
8885630|NCT01972464|9943029|FG000|COMPLETED|Treatment Period (Week 1 Through Week 8)||16
8885631|NCT01972464|9943030|FG001|COMPLETED|Treatment Period (Week 1 Through Week 8)||18
8885632|NCT01972464|9943029|FG000|NOT COMPLETED|Treatment Period (Week 1 Through Week 8)||3
8885633|NCT01972464|9943030|FG001|NOT COMPLETED|Treatment Period (Week 1 Through Week 8)||4
8885634|NCT01972464|9943029|FG000|STARTED|3-Month Follow-Up (Week 20)||16
8885635|NCT01972464|9943030|FG001|STARTED|3-Month Follow-Up (Week 20)||18
8885636|NCT01972464|9943029|FG000|COMPLETED|3-Month Follow-Up (Week 20)||15
8885637|NCT01972464|9943030|FG001|COMPLETED|3-Month Follow-Up (Week 20)||17
8885638|NCT01972464|9943029|FG000|NOT COMPLETED|3-Month Follow-Up (Week 20)||1
8885639|NCT01972464|9943030|FG001|NOT COMPLETED|3-Month Follow-Up (Week 20)||1
8885640|NCT01972516|9943039|FG000|STARTED|Overall Study||3
8885641|NCT01972516|9943040|FG001|STARTED|Overall Study||1
8885642|NCT01972516|9943039|FG000|COMPLETED|Overall Study||3
8885643|NCT01972516|9943040|FG001|COMPLETED|Overall Study||1
8885644|NCT01972516|9943039|FG000|NOT COMPLETED|Overall Study||0
8885645|NCT01972516|9943040|FG001|NOT COMPLETED|Overall Study||0
8885646|NCT01972529|9943050|FG000|STARTED|Overall Study||48
8885647|NCT01972529|9943051|FG001|STARTED|Overall Study||90
8885648|NCT01972529|9943052|FG002|STARTED|Overall Study||34
8885649|NCT01972529|9943053|FG003|STARTED|Overall Study||59
8885650|NCT01972529|9943050|FG000|COMPLETED|Overall Study||46
8885651|NCT01972529|9943051|FG001|COMPLETED|Overall Study||85
8885652|NCT01972529|9943052|FG002|COMPLETED|Overall Study||32
8885653|NCT01972529|9943053|FG003|COMPLETED|Overall Study||55
8885654|NCT01972529|9943050|FG000|NOT COMPLETED|Overall Study||2
8885655|NCT01972529|9943051|FG001|NOT COMPLETED|Overall Study||5
8885656|NCT01972529|9943052|FG002|NOT COMPLETED|Overall Study||2
8885657|NCT01972529|9943053|FG003|NOT COMPLETED|Overall Study||4
8885658|NCT01972568|9943067|FG000|STARTED|Overall Study||102
8885659|NCT01972568|9943068|FG001|STARTED|Overall Study||104
8885660|NCT01972568|9943069|FG002|STARTED|Overall Study||100
8885661|NCT01972568|9943067|FG000|COMPLETED|Overall Study||86
8885662|NCT01972568|9943068|FG001|COMPLETED|Overall Study||92
9003999|NCT02925117|10067128|FG005|Received Treatment|Period 1 (Weeks 0 - 16)||0
9004000|NCT02925117|10067129|FG006|Received Treatment|Period 1 (Weeks 0 - 16)||0
9004001|NCT02925117|10067130|FG007|Received Treatment|Period 1 (Weeks 0 - 16)||0
9004002|NCT02925117|10067131|FG008|Received Treatment|Period 1 (Weeks 0 - 16)||0
9004003|NCT02925117|10067132|FG009|Received Treatment|Period 1 (Weeks 0 - 16)||0
9004004|NCT02925117|10067133|FG010|Received Treatment|Period 1 (Weeks 0 - 16)||0
9004005|NCT02925117|10067134|FG011|Received Treatment|Period 1 (Weeks 0 - 16)||0
9004006|NCT02925117|10067123|FG000|COMPLETED|Period 1 (Weeks 0 - 16)||23
9004007|NCT02925117|10067124|FG001|COMPLETED|Period 1 (Weeks 0 - 16)||31
9004008|NCT02925117|10067125|FG002|COMPLETED|Period 1 (Weeks 0 - 16)||37
9004009|NCT02925117|10067126|FG003|COMPLETED|Period 1 (Weeks 0 - 16)||39
9004010|NCT02925117|10067127|FG004|COMPLETED|Period 1 (Weeks 0 - 16)||0
9004011|NCT02925117|10067128|FG005|COMPLETED|Period 1 (Weeks 0 - 16)||0
9004012|NCT02925117|10067129|FG006|COMPLETED|Period 1 (Weeks 0 - 16)||0
9004013|NCT02925117|10067130|FG007|COMPLETED|Period 1 (Weeks 0 - 16)||0
9004014|NCT02925117|10067131|FG008|COMPLETED|Period 1 (Weeks 0 - 16)||0
9004015|NCT02925117|10067132|FG009|COMPLETED|Period 1 (Weeks 0 - 16)||0
9004016|NCT02925117|10067133|FG010|COMPLETED|Period 1 (Weeks 0 - 16)||0
9004017|NCT02925117|10067134|FG011|COMPLETED|Period 1 (Weeks 0 - 16)||0
9004018|NCT02925117|10067123|FG000|NOT COMPLETED|Period 1 (Weeks 0 - 16)||18
9004019|NCT02925117|10067124|FG001|NOT COMPLETED|Period 1 (Weeks 0 - 16)||11
9004020|NCT02925117|10067125|FG002|NOT COMPLETED|Period 1 (Weeks 0 - 16)||5
9004021|NCT02925117|10067126|FG003|NOT COMPLETED|Period 1 (Weeks 0 - 16)||3
8885663|NCT01972568|9943069|FG002|COMPLETED|Overall Study||84
8885664|NCT01972568|9943067|FG000|NOT COMPLETED|Overall Study||16
8885665|NCT01972568|9943068|FG001|NOT COMPLETED|Overall Study||12
8885666|NCT01972568|9943069|FG002|NOT COMPLETED|Overall Study||16
8885667|NCT01972659|9943079|FG000|STARTED|Overall Study||40
8885668|NCT01972659|9943080|FG001|STARTED|Overall Study||40
8885669|NCT01972659|9943079|FG000|COMPLETED|Overall Study||36
8885670|NCT01972659|9943080|FG001|COMPLETED|Overall Study||37
8885671|NCT01972659|9943079|FG000|NOT COMPLETED|Overall Study||4
8885672|NCT01972659|9943080|FG001|NOT COMPLETED|Overall Study||3
8885673|NCT01972724|9943089|FG000|STARTED|Double-Blind||19
8885674|NCT01972724|9943090|FG001|STARTED|Double-Blind||18
8885675|NCT01972724|9943091|FG002|STARTED|Double-Blind||0
8885676|NCT01972724|9943089|FG000|Intent-to-treat:Received Study Drug|Double-Blind||17
8885677|NCT01972724|9943090|FG001|Intent-to-treat:Received Study Drug|Double-Blind||17
8885678|NCT01972724|9943091|FG002|Intent-to-treat:Received Study Drug|Double-Blind||0
8885679|NCT01972724|9943089|FG000|COMPLETED|Double-Blind||10
8885680|NCT01972724|9943090|FG001|COMPLETED|Double-Blind||9
8885681|NCT01972724|9943091|FG002|COMPLETED|Double-Blind||0
8885682|NCT01972724|9943089|FG000|NOT COMPLETED|Double-Blind||9
8885683|NCT01972724|9943090|FG001|NOT COMPLETED|Double-Blind||9
8885684|NCT01972724|9943091|FG002|NOT COMPLETED|Double-Blind||0
8885685|NCT01972724|9943089|FG000|STARTED|Open-Label||0
8885686|NCT01972724|9943090|FG001|STARTED|Open-Label||0
8885687|NCT01972724|9943091|FG002|STARTED|Open-Label||77
8885688|NCT01972724|9943089|FG000|COMPLETED|Open-Label||0
8885689|NCT01972724|9943090|FG001|COMPLETED|Open-Label||0
8885690|NCT01972724|9943091|FG002|COMPLETED|Open-Label||72
8885691|NCT01972724|9943089|FG000|NOT COMPLETED|Open-Label||0
8885692|NCT01972724|9943090|FG001|NOT COMPLETED|Open-Label||0
8885693|NCT01972724|9943091|FG002|NOT COMPLETED|Open-Label||5
8885694|NCT01972776|9943105|FG000|STARTED|Part 1||6
8885695|NCT01972776|9943106|FG001|STARTED|Part 1||6
8885696|NCT01972776|9943107|FG002|STARTED|Part 1||8
8885697|NCT01972776|9943108|FG003|STARTED|Part 1||7
8885698|NCT01972776|9943109|FG004|STARTED|Part 1||0
8885699|NCT01972776|9943110|FG005|STARTED|Part 1||0
8885700|NCT01972776|9943105|FG000|COMPLETED|Part 1||6
8885701|NCT01972776|9943106|FG001|COMPLETED|Part 1||6
8885702|NCT01972776|9943107|FG002|COMPLETED|Part 1||6
8885703|NCT01972776|9943108|FG003|COMPLETED|Part 1||6
8885704|NCT01972776|9943109|FG004|COMPLETED|Part 1||0
8885705|NCT01972776|9943110|FG005|COMPLETED|Part 1||0
8885706|NCT01972776|9943105|FG000|NOT COMPLETED|Part 1||0
8885707|NCT01972776|9943106|FG001|NOT COMPLETED|Part 1||0
8885708|NCT01972776|9943107|FG002|NOT COMPLETED|Part 1||2
8885709|NCT01972776|9943108|FG003|NOT COMPLETED|Part 1||1
8885710|NCT01972776|9943109|FG004|NOT COMPLETED|Part 1||0
8885711|NCT01972776|9943110|FG005|NOT COMPLETED|Part 1||0
8885712|NCT01972776|9943105|FG000|STARTED|Part 2||0
8885713|NCT01972776|9943106|FG001|STARTED|Part 2||0
8885714|NCT01972776|9943107|FG002|STARTED|Part 2||0
8885715|NCT01972776|9943108|FG003|STARTED|Part 2||0
8885716|NCT01972776|9943109|FG004|STARTED|Part 2||14
8885717|NCT01972776|9943110|FG005|STARTED|Part 2||7
8885718|NCT01972776|9943105|FG000|COMPLETED|Part 2||0
8885719|NCT01972776|9943106|FG001|COMPLETED|Part 2||0
8885720|NCT01972776|9943107|FG002|COMPLETED|Part 2||0
8885721|NCT01972776|9943108|FG003|COMPLETED|Part 2||0
8885722|NCT01972776|9943109|FG004|COMPLETED|Part 2||1
8885723|NCT01972776|9943110|FG005|COMPLETED|Part 2||0
8885724|NCT01972776|9943105|FG000|NOT COMPLETED|Part 2||0
8885725|NCT01972776|9943106|FG001|NOT COMPLETED|Part 2||0
8885726|NCT01972776|9943107|FG002|NOT COMPLETED|Part 2||0
8634485|NCT00556998|9674828|FG000|Treated|Voriconazole Intravenous (IV)||26
8634486|NCT00556998|9674828|FG000|COMPLETED|Voriconazole Intravenous (IV)|One participant received 2 days of oral; then received IV again before discontinuing from study.|21
8634487|NCT00556998|9674828|FG000|NOT COMPLETED|Voriconazole Intravenous (IV)||5
8634488|NCT00556998|9674828|FG000|STARTED|Voriconazole Oral|One participant received voriconazole 150 mg every 12 hours during oral phase.|22
8634489|NCT00556998|9674828|FG000|COMPLETED|Voriconazole Oral||20
8634490|NCT00556998|9674828|FG000|NOT COMPLETED|Voriconazole Oral||2
8634491|NCT00557076|9674838|FG000|STARTED|Overall Study||8
8634492|NCT00557076|9674839|FG001|STARTED|Overall Study||8
8634493|NCT00557076|9674838|FG000|COMPLETED|Overall Study||8
8634494|NCT00557076|9674839|FG001|COMPLETED|Overall Study|One participant was withdrawn due to unblinding|7
8634495|NCT00557076|9674838|FG000|NOT COMPLETED|Overall Study||0
8634496|NCT00557076|9674839|FG001|NOT COMPLETED|Overall Study||1
8634497|NCT00557245|9674848|FG000|STARTED|Overall Study||1589
8634498|NCT00557245|9674849|FG001|STARTED|Overall Study||1583
8634499|NCT00557245|9674850|FG002|STARTED|Overall Study||1586
8634500|NCT00557245|9674848|FG000|COMPLETED|Overall Study||1577
8634501|NCT00557245|9674849|FG001|COMPLETED|Overall Study||1571
8634502|NCT00557245|9674850|FG002|COMPLETED|Overall Study||1574
8634503|NCT00557245|9674848|FG000|NOT COMPLETED|Overall Study||12
8634504|NCT00557245|9674849|FG001|NOT COMPLETED|Overall Study||12
8634505|NCT00557245|9674850|FG002|NOT COMPLETED|Overall Study||12
8634506|NCT00557284|9674863|FG000|STARTED|Overall Study||9
8885727|NCT01972776|9943108|FG003|NOT COMPLETED|Part 2||0
8885728|NCT01972776|9943109|FG004|NOT COMPLETED|Part 2||13
8885729|NCT01972776|9943110|FG005|NOT COMPLETED|Part 2||7
8885730|NCT01972789|9943126|FG000|STARTED|Overall Study||174
8885731|NCT01972789|9943127|FG001|STARTED|Overall Study||175
8885732|NCT01972789|9943126|FG000|COMPLETED|Overall Study||134
8885733|NCT01972789|9943127|FG001|COMPLETED|Overall Study||145
8885734|NCT01972789|9943126|FG000|NOT COMPLETED|Overall Study||40
8885735|NCT01972789|9943127|FG001|NOT COMPLETED|Overall Study||30
8885736|NCT01972841|9943139|FG000|STARTED|Overall Study||447
8885737|NCT01972841|9943140|FG001|STARTED|Overall Study||441
8885738|NCT01972841|9943141|FG002|STARTED|Overall Study||437
8885739|NCT01972841|9943142|FG003|STARTED|Overall Study||434
8885740|NCT01972841|9943143|FG004|STARTED|Overall Study||885
8885741|NCT01972841|9943144|FG005|STARTED|Overall Study||883
8885742|NCT01972841|9943139|FG000|COMPLETED|Overall Study||404
8634507|NCT00557284|9674864|FG001|STARTED|Overall Study||11
8634508|NCT00557284|9674863|FG000|COMPLETED|Overall Study||9
8634509|NCT00557284|9674864|FG001|COMPLETED|Overall Study||11
8634510|NCT00557284|9674863|FG000|NOT COMPLETED|Overall Study||0
8634511|NCT00557284|9674864|FG001|NOT COMPLETED|Overall Study||0
8885743|NCT01972841|9943140|FG001|COMPLETED|Overall Study||397
8885744|NCT01972841|9943141|FG002|COMPLETED|Overall Study||387
8885745|NCT01972841|9943142|FG003|COMPLETED|Overall Study||397
8885746|NCT01972841|9943143|FG004|COMPLETED|Overall Study||802
8885747|NCT01972841|9943144|FG005|COMPLETED|Overall Study||798
8885748|NCT01972841|9943139|FG000|NOT COMPLETED|Overall Study||43
8885749|NCT01972841|9943140|FG001|NOT COMPLETED|Overall Study||44
8885750|NCT01972841|9943141|FG002|NOT COMPLETED|Overall Study||50
8885751|NCT01972841|9943142|FG003|NOT COMPLETED|Overall Study||37
8885752|NCT01972841|9943143|FG004|NOT COMPLETED|Overall Study||83
8885753|NCT01972841|9943144|FG005|NOT COMPLETED|Overall Study||85
8885754|NCT01973036|9943160|FG000|STARTED|Overall Study||108
8885755|NCT01973036|9943161|FG001|STARTED|Overall Study||93
8885756|NCT01973036|9943160|FG000|Received Assigned Intervention|Overall Study||113
8885757|NCT01973036|9943161|FG001|Received Assigned Intervention|Overall Study||88
8885758|NCT01973036|9943160|FG000|COMPLETED|Overall Study||108
8885759|NCT01973036|9943161|FG001|COMPLETED|Overall Study||93
8885760|NCT01973036|9943160|FG000|NOT COMPLETED|Overall Study||0
8885761|NCT01973036|9943161|FG001|NOT COMPLETED|Overall Study||0
8885762|NCT01973205|9943170|FG000|STARTED|Overall Study||453
8885763|NCT01973205|9943171|FG001|STARTED|Overall Study||447
8885764|NCT01973205|9943170|FG000|COMPLETED|Overall Study||423
8885765|NCT01973205|9943171|FG001|COMPLETED|Overall Study||425
8885766|NCT01973205|9943170|FG000|NOT COMPLETED|Overall Study||30
8885767|NCT01973205|9943171|FG001|NOT COMPLETED|Overall Study||22
8885768|NCT01973218|9943179|FG000|STARTED|Overall Study||176
8885769|NCT01973218|9943180|FG001|STARTED|Overall Study||88
8885770|NCT01973218|9943179|FG000|COMPLETED|Overall Study||174
8885771|NCT01973218|9943180|FG001|COMPLETED|Overall Study||88
8885772|NCT01973218|9943179|FG000|NOT COMPLETED|Overall Study||2
8885773|NCT01973218|9943180|FG001|NOT COMPLETED|Overall Study||0
9004022|NCT02925117|10067127|FG004|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
9004023|NCT02925117|10067128|FG005|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
9004024|NCT02925117|10067129|FG006|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
9004025|NCT02925117|10067130|FG007|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
9004026|NCT02925117|10067131|FG008|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
9004027|NCT02925117|10067132|FG009|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
9004028|NCT02925117|10067133|FG010|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
9004029|NCT02925117|10067134|FG011|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
9004030|NCT02925117|10067123|FG000|STARTED|Period 2 (Weeks 16 - 88)||0
9004031|NCT02925117|10067124|FG001|STARTED|Period 2 (Weeks 16 - 88)||0
9004032|NCT02925117|10067125|FG002|STARTED|Period 2 (Weeks 16 - 88)||0
9004033|NCT02925117|10067126|FG003|STARTED|Period 2 (Weeks 16 - 88)||0
9004034|NCT02925117|10067127|FG004|STARTED|Period 2 (Weeks 16 - 88)||10
9004035|NCT02925117|10067128|FG005|STARTED|Period 2 (Weeks 16 - 88)||10
9004036|NCT02925117|10067129|FG006|STARTED|Period 2 (Weeks 16 - 88)||15
9004037|NCT02925117|10067130|FG007|STARTED|Period 2 (Weeks 16 - 88)||16
9004038|NCT02925117|10067131|FG008|STARTED|Period 2 (Weeks 16 - 88)||19
9004039|NCT02925117|10067132|FG009|STARTED|Period 2 (Weeks 16 - 88)||18
9004040|NCT02925117|10067133|FG010|STARTED|Period 2 (Weeks 16 - 88)||19
9004041|NCT02925117|10067134|FG011|STARTED|Period 2 (Weeks 16 - 88)||19
9004042|NCT02925117|10067123|FG000|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||0
9004043|NCT02925117|10067124|FG001|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||0
9004044|NCT02925117|10067125|FG002|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||0
9004045|NCT02925117|10067126|FG003|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||0
9004046|NCT02925117|10067127|FG004|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||8
9004047|NCT02925117|10067128|FG005|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||1
9004048|NCT02925117|10067129|FG006|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||13
9004049|NCT02925117|10067130|FG007|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||12
9004050|NCT02925117|10067131|FG008|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||17
9004051|NCT02925117|10067132|FG009|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||12
9004052|NCT02925117|10067133|FG010|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||14
8726000|NCT01033487|9773157|FG000|NOT COMPLETED|Fourth Intervention Period||0
8726001|NCT01033487|9773158|FG001|NOT COMPLETED|Fourth Intervention Period||0
8726002|NCT01033487|9773159|FG002|NOT COMPLETED|Fourth Intervention Period||0
8726003|NCT01033487|9773160|FG003|NOT COMPLETED|Fourth Intervention Period||0
8726004|NCT01033487|9773161|FG004|NOT COMPLETED|Fourth Intervention Period||0
8726005|NCT01033487|9773162|FG005|NOT COMPLETED|Fourth Intervention Period||0
8885774|NCT01973231|9943190|FG000|STARTED|Overall Study||202
8885775|NCT01973231|9943191|FG001|STARTED|Overall Study||202
8885776|NCT01973231|9943190|FG000|COMPLETED|Overall Study||191
8885777|NCT01973231|9943191|FG001|COMPLETED|Overall Study||190
8885778|NCT01973231|9943190|FG000|NOT COMPLETED|Overall Study||11
8885779|NCT01973231|9943191|FG001|NOT COMPLETED|Overall Study||12
8885780|NCT01973283|9943197|FG000|STARTED|Overall Study||100
8885781|NCT01973283|9943197|FG000|COMPLETED|Overall Study||96
8885782|NCT01973283|9943197|FG000|NOT COMPLETED|Overall Study||4
8885783|NCT01973335|9943207|FG000|STARTED|Overall Study||9
8885784|NCT01973335|9943208|FG001|STARTED|Overall Study||7
8885785|NCT01973335|9943209|FG002|STARTED|Overall Study||9
8885786|NCT01973335|9943210|FG003|STARTED|Overall Study||9
8885787|NCT01973335|9943207|FG000|COMPLETED|Overall Study||9
8885788|NCT01973335|9943208|FG001|COMPLETED|Overall Study||7
8885789|NCT01973335|9943209|FG002|COMPLETED|Overall Study||9
8885790|NCT01973335|9943210|FG003|COMPLETED|Overall Study||9
8885791|NCT01973335|9943207|FG000|NOT COMPLETED|Overall Study||0
8885792|NCT01973335|9943208|FG001|NOT COMPLETED|Overall Study||0
8885793|NCT01973335|9943209|FG002|NOT COMPLETED|Overall Study||0
8885794|NCT01973335|9943210|FG003|NOT COMPLETED|Overall Study||0
8885795|NCT01973348|9943224|FG000|STARTED|Overall Study||27
8885796|NCT01973348|9943225|FG001|STARTED|Overall Study||18
8885797|NCT01973348|9943226|FG002|STARTED|Overall Study||0
8885798|NCT01973348|9943227|FG003|STARTED|Overall Study||0
8885799|NCT01973348|9943224|FG000|COMPLETED|Overall Study||19
8885800|NCT01973348|9943225|FG001|COMPLETED|Overall Study||15
8885801|NCT01973348|9943226|FG002|COMPLETED|Overall Study||0
8885802|NCT01973348|9943227|FG003|COMPLETED|Overall Study||0
8885803|NCT01973348|9943224|FG000|NOT COMPLETED|Overall Study||8
8885804|NCT01973348|9943225|FG001|NOT COMPLETED|Overall Study||3
8885805|NCT01973348|9943226|FG002|NOT COMPLETED|Overall Study||0
8885806|NCT01973348|9943227|FG003|NOT COMPLETED|Overall Study||0
8885807|NCT01973387|9943239|FG000|STARTED|Overall Study||106
8885808|NCT01973387|9943240|FG001|STARTED|Overall Study||54
8885809|NCT01973387|9943239|FG000|Treated|Overall Study||104
8885810|NCT01973387|9943240|FG001|Treated|Overall Study||52
8885811|NCT01973387|9943239|FG000|COMPLETED|Overall Study||0
8885812|NCT01973387|9943240|FG001|COMPLETED|Overall Study||36
8885813|NCT01973387|9943239|FG000|NOT COMPLETED|Overall Study||106
8885814|NCT01973387|9943240|FG001|NOT COMPLETED|Overall Study||18
8885815|NCT01973413|9943248|FG000|STARTED|Overall Study||12
8885816|NCT01973413|9943249|FG001|STARTED|Overall Study||20
8885817|NCT01973413|9943248|FG000|COMPLETED|Overall Study||11
8885818|NCT01973413|9943249|FG001|COMPLETED|Overall Study||20
8885819|NCT01973413|9943248|FG000|NOT COMPLETED|Overall Study||1
8885820|NCT01973413|9943249|FG001|NOT COMPLETED|Overall Study||0
8885821|NCT01973439|9943256|FG000|STARTED|Overall Study||23
8885822|NCT01973439|9943256|FG000|Two Evaluable PK Days|Overall Study|18 Children had two evaluable PK days|18
8885823|NCT01973439|9943256|FG000|One Evaluable PK Day Only|Overall Study|5 children had only one evaluable PK day.|5
8885824|NCT01973439|9943256|FG000|COMPLETED|Overall Study||18
8885825|NCT01973439|9943256|FG000|NOT COMPLETED|Overall Study||5
8885826|NCT01973491|9943260|FG000|STARTED|Baseline Control Period (8 Weeks)||37
8885827|NCT01973491|9943260|FG000|COMPLETED|Baseline Control Period (8 Weeks)||19
8885828|NCT01973491|9943260|FG000|NOT COMPLETED|Baseline Control Period (8 Weeks)||18
8885829|NCT01973491|9943260|FG000|STARTED|Titration Period(4 Weeks)||19
8885830|NCT01973491|9943260|FG000|COMPLETED|Titration Period(4 Weeks)||19
8885831|NCT01973491|9943260|FG000|NOT COMPLETED|Titration Period(4 Weeks)||0
8885832|NCT01973491|9943260|FG000|STARTED|Treatment Period (16 Weeks)||19
8885833|NCT01973491|9943260|FG000|COMPLETED|Treatment Period (16 Weeks)||18
8885834|NCT01973491|9943260|FG000|NOT COMPLETED|Treatment Period (16 Weeks)||1
8885835|NCT01973569|9943267|FG000|STARTED|Overall Study||228
8885836|NCT01973569|9943268|FG001|STARTED|Overall Study||225
8885837|NCT01973569|9943269|FG002|STARTED|Overall Study||226
8885838|NCT01973569|9943267|FG000|Received Study Drug|Overall Study||222
8885839|NCT01973569|9943268|FG001|Received Study Drug|Overall Study||222
8885840|NCT01973569|9943269|FG002|Received Study Drug|Overall Study||223
8885841|NCT01973569|9943267|FG000|Did Not Receive Study Drug|Overall Study||6
8885842|NCT01973569|9943268|FG001|Did Not Receive Study Drug|Overall Study||3
8634512|NCT00557310|9674870|FG000|STARTED|Main Study (0 - 18 Months)||35
8634513|NCT00557310|9674870|FG000|COMPLETED|Main Study (0 - 18 Months)|One had a metal hip implant, a protocol violation, and was excluded from efficacy analyses.|30
8634514|NCT00557310|9674870|FG000|NOT COMPLETED|Main Study (0 - 18 Months)||5
8634515|NCT00557310|9674870|FG000|STARTED|Extension Phase (18 - 24 Months)||30
8634516|NCT00557310|9674870|FG000|COMPLETED|Extension Phase (18 - 24 Months)|One had a metal hip implant, a protocol violation, and was excluded from efficacy analyses.|25
8726006|NCT01033487|9773163|FG006|NOT COMPLETED|Fourth Intervention Period||0
8726007|NCT01033487|9773164|FG007|NOT COMPLETED|Fourth Intervention Period||0
8726008|NCT01033487|9773165|FG008|NOT COMPLETED|Fourth Intervention Period||1
8726009|NCT01033487|9773166|FG009|NOT COMPLETED|Fourth Intervention Period||0
8726010|NCT01033487|9773157|FG000|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
8726011|NCT01033487|9773158|FG001|STARTED|Between Period 4 and 5 (At Least 7 Days)||3
8634517|NCT00557310|9674870|FG000|NOT COMPLETED|Extension Phase (18 - 24 Months)||5
8634518|NCT00557323|9674874|FG000|STARTED|Overall Study||34
8634519|NCT00557323|9674874|FG000|COMPLETED|Overall Study||27
8634520|NCT00557323|9674874|FG000|NOT COMPLETED|Overall Study||7
8726012|NCT01033487|9773159|FG002|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
8726013|NCT01033487|9773160|FG003|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
8885843|NCT01973569|9943269|FG002|Did Not Receive Study Drug|Overall Study||3
8885844|NCT01973569|9943267|FG000|Discontinued Study Treatment|Overall Study||23
8885845|NCT01973569|9943268|FG001|Discontinued Study Treatment|Overall Study||22
8885846|NCT01973569|9943269|FG002|Discontinued Study Treatment|Overall Study||15
8885847|NCT01973569|9943267|FG000|Discontinued Study|Overall Study||23
8885848|NCT01973569|9943268|FG001|Discontinued Study|Overall Study||22
8885849|NCT01973569|9943269|FG002|Discontinued Study|Overall Study||15
8885850|NCT01973569|9943267|FG000|COMPLETED|Overall Study||199
8885851|NCT01973569|9943268|FG001|COMPLETED|Overall Study||200
8885852|NCT01973569|9943269|FG002|COMPLETED|Overall Study||208
8885853|NCT01973569|9943267|FG000|NOT COMPLETED|Overall Study||29
8726014|NCT01033487|9773161|FG004|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
8726015|NCT01033487|9773162|FG005|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
8726016|NCT01033487|9773163|FG006|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
8726017|NCT01033487|9773164|FG007|STARTED|Between Period 4 and 5 (At Least 7 Days)||3
8726018|NCT01033487|9773165|FG008|STARTED|Between Period 4 and 5 (At Least 7 Days)||1
8726019|NCT01033487|9773166|FG009|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
8726020|NCT01033487|9773157|FG000|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
8726021|NCT01033487|9773158|FG001|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||3
8726022|NCT01033487|9773159|FG002|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
8726023|NCT01033487|9773160|FG003|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
8726024|NCT01033487|9773161|FG004|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
8726025|NCT01033487|9773162|FG005|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
8726026|NCT01033487|9773163|FG006|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
8726027|NCT01033487|9773164|FG007|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||3
8885854|NCT01973569|9943268|FG001|NOT COMPLETED|Overall Study||25
8885855|NCT01973569|9943269|FG002|NOT COMPLETED|Overall Study||18
8885856|NCT01973595|9943281|FG000|STARTED|Intervention Phase 1||15
8885857|NCT01973595|9943282|FG001|STARTED|Intervention Phase 1||14
8885858|NCT01973595|9943283|FG002|STARTED|Intervention Phase 1||15
8885859|NCT01973595|9943284|FG003|STARTED|Intervention Phase 1||14
8885860|NCT01973595|9943281|FG000|COMPLETED|Intervention Phase 1||15
8885861|NCT01973595|9943282|FG001|COMPLETED|Intervention Phase 1||14
8885862|NCT01973595|9943283|FG002|COMPLETED|Intervention Phase 1||15
8885863|NCT01973595|9943284|FG003|COMPLETED|Intervention Phase 1||14
8885864|NCT01973595|9943281|FG000|NOT COMPLETED|Intervention Phase 1||0
8885865|NCT01973595|9943282|FG001|NOT COMPLETED|Intervention Phase 1||0
8885866|NCT01973595|9943283|FG002|NOT COMPLETED|Intervention Phase 1||0
8885867|NCT01973595|9943284|FG003|NOT COMPLETED|Intervention Phase 1||0
8885868|NCT01973595|9943281|FG000|STARTED|Washout||15
8885869|NCT01973595|9943282|FG001|STARTED|Washout||14
8885870|NCT01973595|9943283|FG002|STARTED|Washout||15
8885871|NCT01973595|9943284|FG003|STARTED|Washout||14
8885872|NCT01973595|9943281|FG000|COMPLETED|Washout||14
8885873|NCT01973595|9943282|FG001|COMPLETED|Washout||14
8885874|NCT01973595|9943283|FG002|COMPLETED|Washout||14
9004053|NCT02925117|10067134|FG011|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||4
9004054|NCT02925117|10067123|FG000|COMPLETED|Period 2 (Weeks 16 - 88)||0
9004055|NCT02925117|10067124|FG001|COMPLETED|Period 2 (Weeks 16 - 88)||0
9004056|NCT02925117|10067125|FG002|COMPLETED|Period 2 (Weeks 16 - 88)||0
9004057|NCT02925117|10067126|FG003|COMPLETED|Period 2 (Weeks 16 - 88)||0
9004058|NCT02925117|10067127|FG004|COMPLETED|Period 2 (Weeks 16 - 88)||8
9004059|NCT02925117|10067128|FG005|COMPLETED|Period 2 (Weeks 16 - 88)||5
9004060|NCT02925117|10067129|FG006|COMPLETED|Period 2 (Weeks 16 - 88)||9
9004061|NCT02925117|10067130|FG007|COMPLETED|Period 2 (Weeks 16 - 88)||11
9004062|NCT02925117|10067131|FG008|COMPLETED|Period 2 (Weeks 16 - 88)||13
9004063|NCT02925117|10067132|FG009|COMPLETED|Period 2 (Weeks 16 - 88)||12
9004064|NCT02925117|10067133|FG010|COMPLETED|Period 2 (Weeks 16 - 88)||11
9004065|NCT02925117|10067134|FG011|COMPLETED|Period 2 (Weeks 16 - 88)||14
9004066|NCT02925117|10067123|FG000|NOT COMPLETED|Period 2 (Weeks 16 - 88)||0
9004067|NCT02925117|10067124|FG001|NOT COMPLETED|Period 2 (Weeks 16 - 88)||0
9004068|NCT02925117|10067125|FG002|NOT COMPLETED|Period 2 (Weeks 16 - 88)||0
9004069|NCT02925117|10067126|FG003|NOT COMPLETED|Period 2 (Weeks 16 - 88)||0
9004070|NCT02925117|10067127|FG004|NOT COMPLETED|Period 2 (Weeks 16 - 88)||2
9004071|NCT02925117|10067128|FG005|NOT COMPLETED|Period 2 (Weeks 16 - 88)||5
9004072|NCT02925117|10067129|FG006|NOT COMPLETED|Period 2 (Weeks 16 - 88)||6
9004073|NCT02925117|10067130|FG007|NOT COMPLETED|Period 2 (Weeks 16 - 88)||5
9004074|NCT02925117|10067131|FG008|NOT COMPLETED|Period 2 (Weeks 16 - 88)||6
8634521|NCT00557349|9674880|FG000|STARTED|Overall Study|omeprazole/bicarb|22
8634522|NCT00557349|9674881|FG001|STARTED|Overall Study||18
8634523|NCT00557349|9674880|FG000|COMPLETED|Overall Study||17
8634524|NCT00557349|9674881|FG001|COMPLETED|Overall Study||13
8634525|NCT00557349|9674880|FG000|NOT COMPLETED|Overall Study||5
8634526|NCT00557349|9674881|FG001|NOT COMPLETED|Overall Study||5
8634527|NCT00557362|9674891|FG000|STARTED|Overall Study||30
8634528|NCT00557362|9674892|FG001|STARTED|Overall Study||30
8634529|NCT00557362|9674893|FG002|STARTED|Overall Study||30
8634530|NCT00557362|9674894|FG003|STARTED|Overall Study||30
8634531|NCT00557362|9674891|FG000|COMPLETED|Overall Study||28
8885875|NCT01973595|9943284|FG003|COMPLETED|Washout||14
8885876|NCT01973595|9943281|FG000|NOT COMPLETED|Washout||1
8885877|NCT01973595|9943282|FG001|NOT COMPLETED|Washout||0
8885878|NCT01973595|9943283|FG002|NOT COMPLETED|Washout||1
8885879|NCT01973595|9943284|FG003|NOT COMPLETED|Washout||0
8885880|NCT01973595|9943281|FG000|STARTED|Intervention Phase 2||14
8885881|NCT01973595|9943282|FG001|STARTED|Intervention Phase 2||14
8885882|NCT01973595|9943283|FG002|STARTED|Intervention Phase 2||14
8885883|NCT01973595|9943284|FG003|STARTED|Intervention Phase 2||14
8885884|NCT01973595|9943281|FG000|COMPLETED|Intervention Phase 2||14
8885885|NCT01973595|9943282|FG001|COMPLETED|Intervention Phase 2||14
8885886|NCT01973595|9943283|FG002|COMPLETED|Intervention Phase 2||14
8885887|NCT01973595|9943284|FG003|COMPLETED|Intervention Phase 2||14
8885888|NCT01973595|9943281|FG000|NOT COMPLETED|Intervention Phase 2||0
8885889|NCT01973595|9943282|FG001|NOT COMPLETED|Intervention Phase 2||0
8885890|NCT01973595|9943283|FG002|NOT COMPLETED|Intervention Phase 2||0
9004075|NCT02925117|10067132|FG009|NOT COMPLETED|Period 2 (Weeks 16 - 88)||6
9004076|NCT02925117|10067133|FG010|NOT COMPLETED|Period 2 (Weeks 16 - 88)||8
9004077|NCT02925117|10067134|FG011|NOT COMPLETED|Period 2 (Weeks 16 - 88)||5
9039461|NCT03338998|10100432|FG000|NOT COMPLETED|Treatment Period||8
9039462|NCT03338998|10100433|FG001|NOT COMPLETED|Treatment Period||3
9039463|NCT03338998|10100432|FG000|STARTED|Safety Follow-Up Period||16
9039464|NCT03338998|10100433|FG001|STARTED|Safety Follow-Up Period||13
9039465|NCT03338998|10100432|FG000|COMPLETED|Safety Follow-Up Period||14
9039466|NCT03338998|10100433|FG001|COMPLETED|Safety Follow-Up Period||12
9039467|NCT03338998|10100432|FG000|NOT COMPLETED|Safety Follow-Up Period||2
9039468|NCT03338998|10100433|FG001|NOT COMPLETED|Safety Follow-Up Period||1
9039469|NCT03339206|10100443|FG000|STARTED|Overall Study||262
9039470|NCT03339206|10100444|FG001|STARTED|Overall Study||263
9039471|NCT03339206|10100445|FG002|STARTED|Overall Study||264
9039472|NCT03339206|10100443|FG000|COMPLETED|Overall Study||262
9039473|NCT03339206|10100444|FG001|COMPLETED|Overall Study||263
9039474|NCT03339206|10100445|FG002|COMPLETED|Overall Study||264
9039475|NCT03339206|10100443|FG000|NOT COMPLETED|Overall Study||0
9039476|NCT03339206|10100444|FG001|NOT COMPLETED|Overall Study||0
9039477|NCT03339206|10100445|FG002|NOT COMPLETED|Overall Study||0
9039478|NCT03339219|10100453|FG000|STARTED|Overall Study||35
9039479|NCT03339219|10100453|FG000|COMPLETED|Overall Study||0
9039480|NCT03339219|10100453|FG000|NOT COMPLETED|Overall Study||35
9039481|NCT03339297|10100459|FG000|STARTED|Overall Study||79
9039482|NCT03339297|10100460|FG001|STARTED|Overall Study||73
9039483|NCT03339297|10100459|FG000|COMPLETED|Overall Study||56
9039484|NCT03339297|10100460|FG001|COMPLETED|Overall Study||59
9039485|NCT03339297|10100459|FG000|NOT COMPLETED|Overall Study||23
9039486|NCT03339297|10100460|FG001|NOT COMPLETED|Overall Study||14
8885891|NCT01973595|9943284|FG003|NOT COMPLETED|Intervention Phase 2||0
8885892|NCT01973608|9943299|FG000|STARTED|Overall Study||2
8885893|NCT01973608|9943300|FG001|STARTED|Overall Study||2
8885894|NCT01973608|9943301|FG002|STARTED|Overall Study||6
8885895|NCT01973608|9943302|FG003|STARTED|Overall Study||2
8885896|NCT01973608|9943299|FG000|COMPLETED|Overall Study||2
8885897|NCT01973608|9943300|FG001|COMPLETED|Overall Study||2
8885898|NCT01973608|9943301|FG002|COMPLETED|Overall Study||6
8885899|NCT01973608|9943302|FG003|COMPLETED|Overall Study||2
8885900|NCT01973608|9943299|FG000|NOT COMPLETED|Overall Study||0
8885901|NCT01973608|9943300|FG001|NOT COMPLETED|Overall Study||0
8885902|NCT01973608|9943301|FG002|NOT COMPLETED|Overall Study||0
8885903|NCT01973608|9943302|FG003|NOT COMPLETED|Overall Study||0
8885904|NCT01973777|9943316|FG000|STARTED|Overall Study|January 2014|51
8885905|NCT01973777|9943316|FG000|One Year Follow-up|Overall Study||44
8885906|NCT01973777|9943316|FG000|COMPLETED|Overall Study||44
8885907|NCT01973777|9943316|FG000|NOT COMPLETED|Overall Study||7
8885908|NCT01973972|9943322|FG000|STARTED|Overall Study||127
8885909|NCT01973972|9943323|FG001|STARTED|Overall Study||136
8885910|NCT01973972|9943322|FG000|COMPLETED|Overall Study||109
8885911|NCT01973972|9943323|FG001|COMPLETED|Overall Study||117
8885912|NCT01973972|9943322|FG000|NOT COMPLETED|Overall Study||18
8885913|NCT01973972|9943323|FG001|NOT COMPLETED|Overall Study||19
8885914|NCT01973998|9943331|FG000|STARTED|Overall Study||33
8885915|NCT01973998|9943332|FG001|STARTED|Overall Study||35
8885916|NCT01973998|9943331|FG000|COMPLETED|Overall Study||31
8885917|NCT01973998|9943332|FG001|COMPLETED|Overall Study||33
8885918|NCT01973998|9943331|FG000|NOT COMPLETED|Overall Study||2
8885919|NCT01973998|9943332|FG001|NOT COMPLETED|Overall Study||2
8885920|NCT01974050|9943338|FG000|STARTED|Overall Study||166
8885921|NCT01974050|9943338|FG000|COMPLETED|Overall Study||141
8885922|NCT01974050|9943338|FG000|NOT COMPLETED|Overall Study||25
8885923|NCT01974089|9943344|FG000|STARTED|Overall Study||53
8885924|NCT01974089|9943345|FG001|STARTED|Overall Study||101
8885925|NCT01974089|9943344|FG000|COMPLETED|Overall Study||53
8885926|NCT01974089|9943345|FG001|COMPLETED|Overall Study||101
8885927|NCT01974089|9943344|FG000|NOT COMPLETED|Overall Study||0
8885928|NCT01974089|9943345|FG001|NOT COMPLETED|Overall Study||0
8885929|NCT01974102|9943355|FG000|STARTED|Overall Study||22
8885930|NCT01974102|9943356|FG001|STARTED|Overall Study||20
8885931|NCT01974102|9943355|FG000|COMPLETED|Overall Study||15
8885932|NCT01974102|9943356|FG001|COMPLETED|Overall Study||19
8885933|NCT01974102|9943355|FG000|NOT COMPLETED|Overall Study||7
8885934|NCT01974102|9943356|FG001|NOT COMPLETED|Overall Study||1
8885935|NCT01974141|9943366|FG000|STARTED|Overall Study||1044
8885936|NCT01974141|9943367|FG001|STARTED|Overall Study||1058
8885937|NCT01974141|9943366|FG000|COMPLETED|Overall Study||948
8885938|NCT01974141|9943367|FG001|COMPLETED|Overall Study||976
8885939|NCT01974141|9943366|FG000|NOT COMPLETED|Overall Study||96
8885940|NCT01974141|9943367|FG001|NOT COMPLETED|Overall Study||82
8885941|NCT01974245|9943375|FG000|STARTED|Overall Study||27
8885942|NCT01974245|9943376|FG001|STARTED|Overall Study||28
8885943|NCT01974245|9943375|FG000|COMPLETED|Overall Study||18
8885944|NCT01974245|9943376|FG001|COMPLETED|Overall Study||20
9039487|NCT03339453|10100468|FG000|STARTED|First Visit of Glucagon Treatment||35
9039488|NCT03339453|10100469|FG001|STARTED|First Visit of Glucagon Treatment||35
9039489|NCT03339453|10100468|FG000|Received at Least 1 Dose of Study Drug|First Visit of Glucagon Treatment||35
8885945|NCT01974245|9943375|FG000|NOT COMPLETED|Overall Study||9
8885946|NCT01974245|9943376|FG001|NOT COMPLETED|Overall Study||8
8885947|NCT01974323|9943384|FG000|STARTED|Overall Study||1118
8885948|NCT01974323|9943385|FG001|STARTED|Overall Study||1120
8885949|NCT01974323|9943384|FG000|COMPLETED|Overall Study||1026
8885950|NCT01974323|9943385|FG001|COMPLETED|Overall Study||1027
8885951|NCT01974323|9943384|FG000|NOT COMPLETED|Overall Study||92
8885952|NCT01974323|9943385|FG001|NOT COMPLETED|Overall Study||93
8885953|NCT01974687|9943416|FG000|STARTED|Overall Study||6
8885954|NCT01974687|9943417|FG001|STARTED|Overall Study||6
8885955|NCT01974687|9943418|FG002|STARTED|Overall Study||6
8885956|NCT01974687|9943419|FG003|STARTED|Overall Study||6
8885957|NCT01974687|9943420|FG004|STARTED|Overall Study||2
8885958|NCT01974687|9943421|FG005|STARTED|Overall Study||6
8885959|NCT01974687|9943422|FG006|STARTED|Overall Study||3
8885960|NCT01974687|9943423|FG007|STARTED|Overall Study||3
8885961|NCT01974687|9943424|FG008|STARTED|Overall Study||3
8885962|NCT01974687|9943425|FG009|STARTED|Overall Study||3
8885963|NCT01974687|9943426|FG010|STARTED|Overall Study||3
8885964|NCT01974687|9943427|FG011|STARTED|Overall Study||13
8885965|NCT01974687|9943428|FG012|STARTED|Overall Study||13
8885966|NCT01974687|9943429|FG013|STARTED|Overall Study||10
8885967|NCT01974687|9943430|FG014|STARTED|Overall Study||19
8885968|NCT01974687|9943431|FG015|STARTED|Overall Study||9
8885969|NCT01974687|9943432|FG016|STARTED|Overall Study||9
8885970|NCT01974687|9943433|FG017|STARTED|Overall Study||11
8885971|NCT01974687|9943434|FG018|STARTED|Overall Study||9
8885972|NCT01974687|9943435|FG019|STARTED|Overall Study||3
8885973|NCT01974687|9943436|FG020|STARTED|Overall Study||3
9004078|NCT02925143|10067156|FG000|STARTED|Overall Study||6525
9004079|NCT02925143|10067156|FG000|Participants Receiving Depolarizing Neuromuscular Blocking Agent (NMBA) (Succinylcholine)|Overall Study||3099
9004080|NCT02925143|10067156|FG000|Participants Receiving Non-depolarizing Neuromuscular Blocking Agent (NMBA)|Overall Study||3426
9004081|NCT02925143|10067156|FG000|COMPLETED|Overall Study||6525
9004082|NCT02925143|10067156|FG000|NOT COMPLETED|Overall Study||0
9004083|NCT02925312|10067162|FG000|STARTED|Overall Study||125
9004084|NCT02925312|10067163|FG001|STARTED|Overall Study||294
8572635|NCT00116272|9604841|FG000|NOT COMPLETED|Overall Study||11
8572636|NCT00116272|9604842|FG001|NOT COMPLETED|Overall Study||6
8885974|NCT01974687|9943437|FG021|STARTED|Overall Study||8
8885975|NCT01974687|9943438|FG022|STARTED|Overall Study||8
8885976|NCT01974687|9943439|FG023|STARTED|Overall Study||6
8885977|NCT01974687|9943440|FG024|STARTED|Overall Study||10
9004085|NCT02925312|10067162|FG000|COMPLETED|Overall Study||98
8885978|NCT01974687|9943416|FG000|Treated|Overall Study||6
8885979|NCT01974687|9943417|FG001|Treated|Overall Study||6
8885980|NCT01974687|9943418|FG002|Treated|Overall Study||6
8885981|NCT01974687|9943419|FG003|Treated|Overall Study||6
8885982|NCT01974687|9943420|FG004|Treated|Overall Study||2
8885983|NCT01974687|9943421|FG005|Treated|Overall Study||6
8885984|NCT01974687|9943422|FG006|Treated|Overall Study||3
8885985|NCT01974687|9943423|FG007|Treated|Overall Study||3
8885986|NCT01974687|9943424|FG008|Treated|Overall Study||3
8885987|NCT01974687|9943425|FG009|Treated|Overall Study||3
8885988|NCT01974687|9943426|FG010|Treated|Overall Study||3
8885989|NCT01974687|9943427|FG011|Treated|Overall Study|2 participants discontinued prior to receiving study drug|11
8885990|NCT01974687|9943428|FG012|Treated|Overall Study|3 participants discontinued prior to receiving study drug|10
8885991|NCT01974687|9943429|FG013|Treated|Overall Study|2 participants discontinued prior to receiving study drug|8
8885992|NCT01974687|9943430|FG014|Treated|Overall Study|1 participant discontinued prior to receiving study drug|18
8885993|NCT01974687|9943431|FG015|Treated|Overall Study|1 participant discontinued prior to receiving study drug|8
8885994|NCT01974687|9943432|FG016|Treated|Overall Study|1 participant discontinued prior to receiving study drug|8
8885995|NCT01974687|9943433|FG017|Treated|Overall Study|3 participants discontinued prior to receiving study drug|8
8885996|NCT01974687|9943434|FG018|Treated|Overall Study||9
8885997|NCT01974687|9943435|FG019|Treated|Overall Study||3
8885998|NCT01974687|9943436|FG020|Treated|Overall Study||3
8885999|NCT01974687|9943437|FG021|Treated|Overall Study||8
8886000|NCT01974687|9943438|FG022|Treated|Overall Study||8
8886001|NCT01974687|9943439|FG023|Treated|Overall Study||6
8886002|NCT01974687|9943440|FG024|Treated|Overall Study||10
8886003|NCT01974687|9943416|FG000|COMPLETED|Overall Study||6
8886004|NCT01974687|9943417|FG001|COMPLETED|Overall Study||6
8886005|NCT01974687|9943418|FG002|COMPLETED|Overall Study||6
8886006|NCT01974687|9943419|FG003|COMPLETED|Overall Study||6
8886007|NCT01974687|9943420|FG004|COMPLETED|Overall Study||2
8886008|NCT01974687|9943421|FG005|COMPLETED|Overall Study||6
8886009|NCT01974687|9943422|FG006|COMPLETED|Overall Study||3
8886010|NCT01974687|9943423|FG007|COMPLETED|Overall Study||3
8886011|NCT01974687|9943424|FG008|COMPLETED|Overall Study||3
8886012|NCT01974687|9943425|FG009|COMPLETED|Overall Study||3
8886013|NCT01974687|9943426|FG010|COMPLETED|Overall Study||3
8886014|NCT01974687|9943427|FG011|COMPLETED|Overall Study||11
8886015|NCT01974687|9943428|FG012|COMPLETED|Overall Study||10
8886016|NCT01974687|9943429|FG013|COMPLETED|Overall Study||8
8886017|NCT01974687|9943430|FG014|COMPLETED|Overall Study||18
8886018|NCT01974687|9943431|FG015|COMPLETED|Overall Study||8
8886019|NCT01974687|9943432|FG016|COMPLETED|Overall Study||8
8886020|NCT01974687|9943433|FG017|COMPLETED|Overall Study||8
8886021|NCT01974687|9943434|FG018|COMPLETED|Overall Study||9
8886022|NCT01974687|9943435|FG019|COMPLETED|Overall Study||3
8886023|NCT01974687|9943436|FG020|COMPLETED|Overall Study||3
8886024|NCT01974687|9943437|FG021|COMPLETED|Overall Study||8
8886025|NCT01974687|9943438|FG022|COMPLETED|Overall Study||8
8886026|NCT01974687|9943439|FG023|COMPLETED|Overall Study||6
8886027|NCT01974687|9943440|FG024|COMPLETED|Overall Study||10
8886028|NCT01974687|9943416|FG000|NOT COMPLETED|Overall Study||0
8886029|NCT01974687|9943417|FG001|NOT COMPLETED|Overall Study||0
8886030|NCT01974687|9943418|FG002|NOT COMPLETED|Overall Study||0
8886031|NCT01974687|9943419|FG003|NOT COMPLETED|Overall Study||0
8886032|NCT01974687|9943420|FG004|NOT COMPLETED|Overall Study||0
8886033|NCT01974687|9943421|FG005|NOT COMPLETED|Overall Study||0
8886034|NCT01974687|9943422|FG006|NOT COMPLETED|Overall Study||0
8886035|NCT01974687|9943423|FG007|NOT COMPLETED|Overall Study||0
8886036|NCT01974687|9943424|FG008|NOT COMPLETED|Overall Study||0
8886037|NCT01974687|9943425|FG009|NOT COMPLETED|Overall Study||0
8886038|NCT01974687|9943426|FG010|NOT COMPLETED|Overall Study||0
8886039|NCT01974687|9943427|FG011|NOT COMPLETED|Overall Study||2
8886040|NCT01974687|9943428|FG012|NOT COMPLETED|Overall Study||3
8886041|NCT01974687|9943429|FG013|NOT COMPLETED|Overall Study||2
8886042|NCT01974687|9943430|FG014|NOT COMPLETED|Overall Study||1
8886043|NCT01974687|9943431|FG015|NOT COMPLETED|Overall Study||1
8886044|NCT01974687|9943432|FG016|NOT COMPLETED|Overall Study||1
8886045|NCT01974687|9943433|FG017|NOT COMPLETED|Overall Study||3
8886046|NCT01974687|9943434|FG018|NOT COMPLETED|Overall Study||0
8886047|NCT01974687|9943435|FG019|NOT COMPLETED|Overall Study||0
8886048|NCT01974687|9943436|FG020|NOT COMPLETED|Overall Study||0
8886049|NCT01974687|9943437|FG021|NOT COMPLETED|Overall Study||0
8886050|NCT01974687|9943438|FG022|NOT COMPLETED|Overall Study||0
8886051|NCT01974687|9943439|FG023|NOT COMPLETED|Overall Study||0
8886052|NCT01974687|9943440|FG024|NOT COMPLETED|Overall Study||0
8886053|NCT01974700|9943522|FG000|STARTED|Overall Study||5
8886054|NCT01974700|9943523|FG001|STARTED|Overall Study||3
8886055|NCT01974700|9943522|FG000|COMPLETED|Overall Study||5
8886056|NCT01974700|9943523|FG001|COMPLETED|Overall Study||3
8886057|NCT01974700|9943522|FG000|NOT COMPLETED|Overall Study||0
8886058|NCT01974700|9943523|FG001|NOT COMPLETED|Overall Study||0
8886059|NCT01974752|9943531|FG000|STARTED|Overall Study||97
8886060|NCT01974752|9943532|FG001|STARTED|Overall Study||32
8886061|NCT01974752|9943531|FG000|COMPLETED|Overall Study||60
8886062|NCT01974752|9943532|FG001|COMPLETED|Overall Study||17
8886063|NCT01974752|9943531|FG000|NOT COMPLETED|Overall Study||37
8886064|NCT01974752|9943532|FG001|NOT COMPLETED|Overall Study||15
8886065|NCT01974817|9943538|FG000|STARTED|Overall Study||25
8886066|NCT01974817|9943538|FG000|COMPLETED|Overall Study||17
8886067|NCT01974817|9943538|FG000|NOT COMPLETED|Overall Study||8
8886068|NCT01974895|9943544|FG000|STARTED|Overall Study||158
8886069|NCT01974895|9943545|FG001|STARTED|Overall Study||156
8886070|NCT01974895|9943544|FG000|COMPLETED|Overall Study||143
8886071|NCT01974895|9943545|FG001|COMPLETED|Overall Study||141
8886072|NCT01974895|9943544|FG000|NOT COMPLETED|Overall Study||15
8886073|NCT01974895|9943545|FG001|NOT COMPLETED|Overall Study||15
8886074|NCT01975090|9943551|FG000|STARTED|Overall Study||129
8886075|NCT01975090|9943551|FG000|6-month Follow-up|Overall Study||117
8886076|NCT01975090|9943551|FG000|COMPLETED|Overall Study||117
8886077|NCT01975090|9943551|FG000|NOT COMPLETED|Overall Study||12
8886078|NCT01975220|9943564|FG000|STARTED|Test Period 1||12
8886079|NCT01975220|9943565|FG001|STARTED|Test Period 1||12
8886080|NCT01975220|9943566|FG002|STARTED|Test Period 1||12
8886081|NCT01975220|9943567|FG003|STARTED|Test Period 1||12
8886082|NCT01975220|9943568|FG004|STARTED|Test Period 1||12
8886083|NCT01975220|9943569|FG005|STARTED|Test Period 1||12
8886084|NCT01975220|9943564|FG000|COMPLETED|Test Period 1||12
8886085|NCT01975220|9943565|FG001|COMPLETED|Test Period 1||11
8886086|NCT01975220|9943566|FG002|COMPLETED|Test Period 1||12
8886087|NCT01975220|9943567|FG003|COMPLETED|Test Period 1||12
8886088|NCT01975220|9943568|FG004|COMPLETED|Test Period 1||12
8886089|NCT01975220|9943569|FG005|COMPLETED|Test Period 1||12
8886090|NCT01975220|9943564|FG000|NOT COMPLETED|Test Period 1||0
8886091|NCT01975220|9943565|FG001|NOT COMPLETED|Test Period 1||1
8886092|NCT01975220|9943566|FG002|NOT COMPLETED|Test Period 1||0
8886093|NCT01975220|9943567|FG003|NOT COMPLETED|Test Period 1||0
8886094|NCT01975220|9943568|FG004|NOT COMPLETED|Test Period 1||0
8886095|NCT01975220|9943569|FG005|NOT COMPLETED|Test Period 1||0
8886096|NCT01975220|9943564|FG000|STARTED|Test Period 2||12
8886097|NCT01975220|9943565|FG001|STARTED|Test Period 2||11
8886098|NCT01975220|9943566|FG002|STARTED|Test Period 2||12
8886099|NCT01975220|9943567|FG003|STARTED|Test Period 2||12
8886100|NCT01975220|9943568|FG004|STARTED|Test Period 2||12
8634532|NCT00557362|9674892|FG001|COMPLETED|Overall Study||28
8634533|NCT00557362|9674893|FG002|COMPLETED|Overall Study||26
8634534|NCT00557362|9674894|FG003|COMPLETED|Overall Study||27
8886101|NCT01975220|9943569|FG005|STARTED|Test Period 2||12
8886102|NCT01975220|9943564|FG000|COMPLETED|Test Period 2||12
8886103|NCT01975220|9943565|FG001|COMPLETED|Test Period 2||11
8886104|NCT01975220|9943566|FG002|COMPLETED|Test Period 2||12
8886105|NCT01975220|9943567|FG003|COMPLETED|Test Period 2||12
8886106|NCT01975220|9943568|FG004|COMPLETED|Test Period 2||12
8886107|NCT01975220|9943569|FG005|COMPLETED|Test Period 2||12
8886108|NCT01975220|9943564|FG000|NOT COMPLETED|Test Period 2||0
8886109|NCT01975220|9943565|FG001|NOT COMPLETED|Test Period 2||0
8886110|NCT01975220|9943566|FG002|NOT COMPLETED|Test Period 2||0
8886111|NCT01975220|9943567|FG003|NOT COMPLETED|Test Period 2||0
8886112|NCT01975220|9943568|FG004|NOT COMPLETED|Test Period 2||0
8886113|NCT01975220|9943569|FG005|NOT COMPLETED|Test Period 2||0
8886114|NCT01975246|9943586|FG000|STARTED|Overall Study||149
8886115|NCT01975246|9943587|FG001|STARTED|Overall Study||160
8886116|NCT01975246|9943586|FG000|COMPLETED|Overall Study||145
8886117|NCT01975246|9943587|FG001|COMPLETED|Overall Study||158
8886118|NCT01975246|9943586|FG000|NOT COMPLETED|Overall Study||4
8886119|NCT01975246|9943587|FG001|NOT COMPLETED|Overall Study||2
8886120|NCT01975285|9943595|FG000|STARTED|Overall Study||30
8886121|NCT01975285|9943596|FG001|STARTED|Overall Study||30
8886122|NCT01975285|9943595|FG000|COMPLETED|Overall Study||28
8886123|NCT01975285|9943596|FG001|COMPLETED|Overall Study||28
8886124|NCT01975285|9943595|FG000|NOT COMPLETED|Overall Study||2
8886125|NCT01975285|9943596|FG001|NOT COMPLETED|Overall Study||2
8886126|NCT01975376|9943604|FG000|STARTED|Overall Study||8390
8886127|NCT01975376|9943605|FG001|STARTED|Overall Study||8394
8886128|NCT01975376|9943604|FG000|Treated|Overall Study||8374
8886129|NCT01975376|9943605|FG001|Treated|Overall Study||8386
8886130|NCT01975376|9943604|FG000|COMPLETED|Overall Study||8164
8886131|NCT01975376|9943605|FG001|COMPLETED|Overall Study||8177
8886132|NCT01975376|9943604|FG000|NOT COMPLETED|Overall Study||226
8886133|NCT01975376|9943605|FG001|NOT COMPLETED|Overall Study||217
8886134|NCT01975389|9943613|FG000|STARTED|Overall Study||5283
8886135|NCT01975389|9943614|FG001|STARTED|Overall Study||5281
8886136|NCT01975389|9943613|FG000|Treated|Overall Study||5279
8886137|NCT01975389|9943614|FG001|Treated|Overall Study||5276
8886138|NCT01975389|9943613|FG000|COMPLETED|Overall Study||5031
8886139|NCT01975389|9943614|FG001|COMPLETED|Overall Study||5045
8886140|NCT01975389|9943613|FG000|NOT COMPLETED|Overall Study||252
8634535|NCT00557362|9674891|FG000|NOT COMPLETED|Overall Study||2
8634536|NCT00557362|9674892|FG001|NOT COMPLETED|Overall Study||2
8886141|NCT01975389|9943614|FG001|NOT COMPLETED|Overall Study||236
8886142|NCT01975428|9943622|FG000|STARTED|Overall Study||85
8886143|NCT01975428|9943623|FG001|STARTED|Overall Study||97
8886144|NCT01975428|9943622|FG000|COMPLETED|Overall Study||65
8886145|NCT01975428|9943623|FG001|COMPLETED|Overall Study||83
8634537|NCT00557362|9674893|FG002|NOT COMPLETED|Overall Study||4
8886146|NCT01975428|9943622|FG000|NOT COMPLETED|Overall Study||20
8886147|NCT01975428|9943623|FG001|NOT COMPLETED|Overall Study||14
8886148|NCT01975519|9943631|FG000|STARTED|Overall Study||3
8886149|NCT01975519|9943632|FG001|STARTED|Overall Study||108
8634538|NCT00557362|9674894|FG003|NOT COMPLETED|Overall Study||3
8886150|NCT01975519|9943631|FG000|Phase 1b|Overall Study||3
8886151|NCT01975519|9943632|FG001|Phase 1b|Overall Study||23
8886152|NCT01975519|9943631|FG000|Phase 2a Soft Tissue Sarcoma|Overall Study||0
8886153|NCT01975519|9943632|FG001|Phase 2a Soft Tissue Sarcoma|Overall Study||63
8886154|NCT01975519|9943631|FG000|Phase 2a Angiosarcoma Cohort|Overall Study||0
8886155|NCT01975519|9943632|FG001|Phase 2a Angiosarcoma Cohort|Overall Study||22
8886156|NCT01975519|9943631|FG000|COMPLETED|Overall Study||3
8886157|NCT01975519|9943632|FG001|COMPLETED|Overall Study||108
8886158|NCT01975519|9943631|FG000|NOT COMPLETED|Overall Study||0
8886159|NCT01975519|9943632|FG001|NOT COMPLETED|Overall Study||0
8886160|NCT01975675|9943650|FG000|STARTED|Overall Study||83
8886161|NCT01975675|9943651|FG001|STARTED|Overall Study||83
8886162|NCT01975675|9943652|FG002|STARTED|Overall Study||88
8886163|NCT01975675|9943653|FG003|STARTED|Overall Study||87
8886164|NCT01975675|9943650|FG000|COMPLETED|Overall Study||83
8886165|NCT01975675|9943651|FG001|COMPLETED|Overall Study||82
8886166|NCT01975675|9943652|FG002|COMPLETED|Overall Study||88
8886167|NCT01975675|9943653|FG003|COMPLETED|Overall Study||87
8886168|NCT01975675|9943650|FG000|NOT COMPLETED|Overall Study||0
8886169|NCT01975675|9943651|FG001|NOT COMPLETED|Overall Study||1
8886170|NCT01975675|9943652|FG002|NOT COMPLETED|Overall Study||0
8886171|NCT01975675|9943653|FG003|NOT COMPLETED|Overall Study||0
8886172|NCT01975701|9943663|FG000|STARTED|Overall Study||26
8886173|NCT01975701|9943663|FG000|COMPLETED|Overall Study||1
8886174|NCT01975701|9943663|FG000|NOT COMPLETED|Overall Study||25
8886175|NCT01975831|9943676|FG000|STARTED|Overall Study||3
8886176|NCT01975831|9943677|FG001|STARTED|Overall Study||11
8886177|NCT01975831|9943678|FG002|STARTED|Overall Study||4
8886178|NCT01975831|9943679|FG003|STARTED|Overall Study||4
8886179|NCT01975831|9943680|FG004|STARTED|Overall Study||19
8886180|NCT01975831|9943681|FG005|STARTED|Overall Study||16
8886181|NCT01975831|9943682|FG006|STARTED|Overall Study||16
8886182|NCT01975831|9943683|FG007|STARTED|Overall Study||16
8886183|NCT01975831|9943684|FG008|STARTED|Overall Study||15
8886184|NCT01975831|9943676|FG000|COMPLETED|Overall Study||0
8886185|NCT01975831|9943677|FG001|COMPLETED|Overall Study||2
8886186|NCT01975831|9943678|FG002|COMPLETED|Overall Study||0
8886187|NCT01975831|9943679|FG003|COMPLETED|Overall Study||0
8886188|NCT01975831|9943680|FG004|COMPLETED|Overall Study||1
8886189|NCT01975831|9943681|FG005|COMPLETED|Overall Study||2
8886190|NCT01975831|9943682|FG006|COMPLETED|Overall Study||0
8886191|NCT01975831|9943683|FG007|COMPLETED|Overall Study||1
8886192|NCT01975831|9943684|FG008|COMPLETED|Overall Study||3
9004086|NCT02925312|10067163|FG001|COMPLETED|Overall Study||294
9004087|NCT02925312|10067162|FG000|NOT COMPLETED|Overall Study||27
9004088|NCT02925312|10067163|FG001|NOT COMPLETED|Overall Study||0
8886193|NCT01975831|9943676|FG000|NOT COMPLETED|Overall Study||3
8886194|NCT01975831|9943677|FG001|NOT COMPLETED|Overall Study||9
8886195|NCT01975831|9943678|FG002|NOT COMPLETED|Overall Study||4
8886196|NCT01975831|9943679|FG003|NOT COMPLETED|Overall Study||4
8886197|NCT01975831|9943680|FG004|NOT COMPLETED|Overall Study||18
8886198|NCT01975831|9943681|FG005|NOT COMPLETED|Overall Study||14
8886199|NCT01975831|9943682|FG006|NOT COMPLETED|Overall Study||16
8886200|NCT01975831|9943683|FG007|NOT COMPLETED|Overall Study||15
8886201|NCT01975831|9943684|FG008|NOT COMPLETED|Overall Study||12
8886202|NCT01975909|9943706|FG000|STARTED|Overall Study||10
8886203|NCT01975909|9943707|FG001|STARTED|Overall Study||10
8886204|NCT01975909|9943706|FG000|COMPLETED|Overall Study||10
8886205|NCT01975909|9943707|FG001|COMPLETED|Overall Study||10
8886206|NCT01975909|9943706|FG000|NOT COMPLETED|Overall Study||0
8886207|NCT01975909|9943707|FG001|NOT COMPLETED|Overall Study||0
8886208|NCT01975922|9943715|FG000|STARTED|Overall Study||45
8886209|NCT01975922|9943716|FG001|STARTED|Overall Study||52
8886210|NCT01975922|9943715|FG000|COMPLETED|Overall Study||45
8886211|NCT01975922|9943716|FG001|COMPLETED|Overall Study||43
8886212|NCT01975922|9943715|FG000|NOT COMPLETED|Overall Study||0
8886213|NCT01975922|9943716|FG001|NOT COMPLETED|Overall Study||9
8886214|NCT01975935|9943724|FG000|STARTED|Overall Study||21
8886215|NCT01975935|9943725|FG001|STARTED|Overall Study||21
8886216|NCT01975935|9943724|FG000|COMPLETED|Overall Study||18
8886217|NCT01975935|9943725|FG001|COMPLETED|Overall Study||20
8886218|NCT01975935|9943724|FG000|NOT COMPLETED|Overall Study||3
8886219|NCT01975935|9943725|FG001|NOT COMPLETED|Overall Study||1
8886220|NCT01975948|9943735|FG000|STARTED|Overall Study||56
8886221|NCT01975948|9943736|FG001|STARTED|Overall Study||55
8886222|NCT01975948|9943737|FG002|STARTED|Overall Study||72
8886223|NCT01975948|9943738|FG003|STARTED|Overall Study||57
8886224|NCT01975948|9943735|FG000|COMPLETED|Overall Study||39
8886225|NCT01975948|9943736|FG001|COMPLETED|Overall Study||34
8886226|NCT01975948|9943737|FG002|COMPLETED|Overall Study||65
8886227|NCT01975948|9943738|FG003|COMPLETED|Overall Study||51
8886228|NCT01975948|9943735|FG000|NOT COMPLETED|Overall Study||17
8886229|NCT01975948|9943736|FG001|NOT COMPLETED|Overall Study||21
8886230|NCT01975948|9943737|FG002|NOT COMPLETED|Overall Study||7
8886231|NCT01975948|9943738|FG003|NOT COMPLETED|Overall Study||6
8886232|NCT01975974|9943748|FG000|STARTED|Overall Study||100
9004089|NCT02925403|10067171|FG000|STARTED|Overall Study||8
8886233|NCT01975974|9943748|FG000|COMPLETED|Overall Study||100
8886234|NCT01975974|9943748|FG000|NOT COMPLETED|Overall Study||0
8886235|NCT01976104|9943756|FG000|STARTED|Overall Study||43
8886236|NCT01976104|9943757|FG001|STARTED|Overall Study||70
8886237|NCT01976104|9943758|FG002|STARTED|Overall Study||33
8886238|NCT01976104|9943759|FG003|STARTED|Overall Study||58
8886239|NCT01976104|9943756|FG000|COMPLETED|Overall Study||37
8886240|NCT01976104|9943757|FG001|COMPLETED|Overall Study||68
8886241|NCT01976104|9943758|FG002|COMPLETED|Overall Study||31
8886242|NCT01976104|9943759|FG003|COMPLETED|Overall Study||55
8886243|NCT01976104|9943756|FG000|NOT COMPLETED|Overall Study||6
8886244|NCT01976104|9943757|FG001|NOT COMPLETED|Overall Study||2
8886245|NCT01976104|9943758|FG002|NOT COMPLETED|Overall Study||2
8886246|NCT01976104|9943759|FG003|NOT COMPLETED|Overall Study||3
8634539|NCT00557440|9674910|FG000|STARTED|Treatment Period 1||12
8634540|NCT00557440|9674911|FG001|STARTED|Treatment Period 1||12
8634541|NCT00557440|9674912|FG002|STARTED|Treatment Period 1||13
8634542|NCT00557440|9674910|FG000|COMPLETED|Treatment Period 1||12
8634543|NCT00557440|9674911|FG001|COMPLETED|Treatment Period 1||12
8634544|NCT00557440|9674912|FG002|COMPLETED|Treatment Period 1||12
8634545|NCT00557440|9674910|FG000|NOT COMPLETED|Treatment Period 1||0
8634546|NCT00557440|9674911|FG001|NOT COMPLETED|Treatment Period 1||0
8634547|NCT00557440|9674912|FG002|NOT COMPLETED|Treatment Period 1||1
8634548|NCT00557440|9674910|FG000|STARTED|Treatment Period 2||12
8634549|NCT00557440|9674911|FG001|STARTED|Treatment Period 2||12
8634550|NCT00557440|9674912|FG002|STARTED|Treatment Period 2||12
8634551|NCT00557440|9674910|FG000|COMPLETED|Treatment Period 2||12
8634552|NCT00557440|9674911|FG001|COMPLETED|Treatment Period 2||12
8634553|NCT00557440|9674912|FG002|COMPLETED|Treatment Period 2||12
8634554|NCT00557440|9674910|FG000|NOT COMPLETED|Treatment Period 2||0
8634555|NCT00557440|9674911|FG001|NOT COMPLETED|Treatment Period 2||0
8886247|NCT01976299|9943772|FG000|STARTED|Overall Study||292
8886248|NCT01976299|9943773|FG001|STARTED|Overall Study||286
8886249|NCT01976299|9943772|FG000|Completed Procedure|Overall Study||283
8886250|NCT01976299|9943773|FG001|Completed Procedure|Overall Study||284
8886251|NCT01976299|9943772|FG000|COMPLETED|Overall Study|9 subjects did not proceed onto procedure in this arm.|269
8886252|NCT01976299|9943773|FG001|COMPLETED|Overall Study|2 subjects did not proceed onto procedure in this arm.|280
8634556|NCT00557440|9674912|FG002|NOT COMPLETED|Treatment Period 2||0
8634557|NCT00557440|9674910|FG000|STARTED|Treatment Period 3||12
8634558|NCT00557440|9674911|FG001|STARTED|Treatment Period 3||12
8634559|NCT00557440|9674912|FG002|STARTED|Treatment Period 3||12
8634560|NCT00557440|9674910|FG000|COMPLETED|Treatment Period 3||12
8634561|NCT00557440|9674911|FG001|COMPLETED|Treatment Period 3||12
8634562|NCT00557440|9674912|FG002|COMPLETED|Treatment Period 3||12
8886253|NCT01976299|9943772|FG000|NOT COMPLETED|Overall Study||23
8886254|NCT01976299|9943773|FG001|NOT COMPLETED|Overall Study||6
8886255|NCT01976312|9943781|FG000|STARTED|Overall Study||190
8886256|NCT01976312|9943782|FG001|STARTED|Overall Study||62
8886257|NCT01976312|9943781|FG000|Completed 3 Months|Overall Study||186
8886258|NCT01976312|9943782|FG001|Completed 3 Months|Overall Study||60
8886259|NCT01976312|9943781|FG000|Discontinued Study Prior to 3 Months|Overall Study||4
8886260|NCT01976312|9943782|FG001|Discontinued Study Prior to 3 Months|Overall Study||2
8886261|NCT01976312|9943781|FG000|COMPLETED|Overall Study|Completed study at 12 months|173
8886262|NCT01976312|9943782|FG001|COMPLETED|Overall Study|Completed study at 12 months|53
8886263|NCT01976312|9943781|FG000|NOT COMPLETED|Overall Study||17
8886264|NCT01976312|9943782|FG001|NOT COMPLETED|Overall Study||9
8886265|NCT01976338|9943791|FG000|STARTED|Overall Study||190
8886266|NCT01976338|9943792|FG001|STARTED|Overall Study||93
8886267|NCT01976338|9943791|FG000|Completed 6 Months|Overall Study||185
8886268|NCT01976338|9943792|FG001|Completed 6 Months|Overall Study||91
8886269|NCT01976338|9943791|FG000|Discontinued Study Prior to 6 Months|Overall Study||5
8886270|NCT01976338|9943792|FG001|Discontinued Study Prior to 6 Months|Overall Study||2
8886271|NCT01976338|9943791|FG000|COMPLETED|Overall Study|12 months|177
8886272|NCT01976338|9943792|FG001|COMPLETED|Overall Study|12 months|89
8886273|NCT01976338|9943791|FG000|NOT COMPLETED|Overall Study||13
8886274|NCT01976338|9943792|FG001|NOT COMPLETED|Overall Study||4
9004090|NCT02925403|10067172|FG001|STARTED|Overall Study||5
9004091|NCT02925403|10067171|FG000|COMPLETED|Overall Study||8
9004092|NCT02925403|10067172|FG001|COMPLETED|Overall Study||4
9004093|NCT02925403|10067171|FG000|NOT COMPLETED|Overall Study||0
9004094|NCT02925403|10067172|FG001|NOT COMPLETED|Overall Study||1
9004095|NCT02925455|10067180|FG000|STARTED|Overall Study||9
9004096|NCT02925455|10067181|FG001|STARTED|Overall Study||6
9004097|NCT02925455|10067180|FG000|COMPLETED|Overall Study||7
9004098|NCT02925455|10067181|FG001|COMPLETED|Overall Study||6
9004099|NCT02925455|10067180|FG000|NOT COMPLETED|Overall Study||2
9004100|NCT02925455|10067181|FG001|NOT COMPLETED|Overall Study||0
9004101|NCT02925494|10067191|FG000|STARTED|Treatment Period||59
9004102|NCT02925494|10067192|FG001|STARTED|Treatment Period||58
9004103|NCT02925494|10067193|FG002|STARTED|Treatment Period||98
9004104|NCT02925494|10067194|FG003|STARTED|Treatment Period||218
9004105|NCT02925494|10067191|FG000|COMPLETED|Treatment Period||50
9004106|NCT02925494|10067192|FG001|COMPLETED|Treatment Period||43
9004107|NCT02925494|10067193|FG002|COMPLETED|Treatment Period||79
9004108|NCT02925494|10067194|FG003|COMPLETED|Treatment Period||182
9004109|NCT02925494|10067191|FG000|NOT COMPLETED|Treatment Period||9
9004110|NCT02925494|10067192|FG001|NOT COMPLETED|Treatment Period||15
9004111|NCT02925494|10067193|FG002|NOT COMPLETED|Treatment Period||19
9004112|NCT02925494|10067194|FG003|NOT COMPLETED|Treatment Period||36
9004113|NCT02925494|10067191|FG000|STARTED|Post-Treatment Follow-Up Period||54
9004114|NCT02925494|10067192|FG001|STARTED|Post-Treatment Follow-Up Period||47
9004115|NCT02925494|10067193|FG002|STARTED|Post-Treatment Follow-Up Period||88
8634563|NCT00557440|9674910|FG000|NOT COMPLETED|Treatment Period 3||0
8634564|NCT00557440|9674911|FG001|NOT COMPLETED|Treatment Period 3||0
9004116|NCT02925494|10067194|FG003|STARTED|Post-Treatment Follow-Up Period||184
9004117|NCT02925494|10067191|FG000|COMPLETED|Post-Treatment Follow-Up Period||40
9004118|NCT02925494|10067192|FG001|COMPLETED|Post-Treatment Follow-Up Period||37
9004119|NCT02925494|10067193|FG002|COMPLETED|Post-Treatment Follow-Up Period||64
9004120|NCT02925494|10067194|FG003|COMPLETED|Post-Treatment Follow-Up Period||134
8634565|NCT00557440|9674912|FG002|NOT COMPLETED|Treatment Period 3||0
8886275|NCT01976364|9943799|FG000|STARTED|Main Study (36 Months)||686
8886276|NCT01976364|9943800|FG001|STARTED|Main Study (36 Months)||0
8886277|NCT01976364|9943801|FG002|STARTED|Main Study (36 Months)||0
8886278|NCT01976364|9943799|FG000|COMPLETED|Main Study (36 Months)||465
8886279|NCT01976364|9943800|FG001|COMPLETED|Main Study (36 Months)||0
8886280|NCT01976364|9943801|FG002|COMPLETED|Main Study (36 Months)||0
8886281|NCT01976364|9943799|FG000|NOT COMPLETED|Main Study (36 Months)||221
8886282|NCT01976364|9943800|FG001|NOT COMPLETED|Main Study (36 Months)||0
8886283|NCT01976364|9943801|FG002|NOT COMPLETED|Main Study (36 Months)||0
8886284|NCT01976364|9943799|FG000|STARTED|Sub-study (12 Months)||0
8886285|NCT01976364|9943800|FG001|STARTED|Sub-study (12 Months)|Participants from main study who consented to take part in sub-study, continued into sub-study.|89
8886286|NCT01976364|9943801|FG002|STARTED|Sub-study (12 Months)|Participants from main study who consented to take part in sub-study, continued into sub-study.|90
8886287|NCT01976364|9943799|FG000|COMPLETED|Sub-study (12 Months)||0
8886288|NCT01976364|9943800|FG001|COMPLETED|Sub-study (12 Months)||83
8886289|NCT01976364|9943801|FG002|COMPLETED|Sub-study (12 Months)||85
8886290|NCT01976364|9943799|FG000|NOT COMPLETED|Sub-study (12 Months)||0
8886291|NCT01976364|9943800|FG001|NOT COMPLETED|Sub-study (12 Months)||6
8886292|NCT01976364|9943801|FG002|NOT COMPLETED|Sub-study (12 Months)||5
8886293|NCT01976390|9943812|FG000|STARTED|Overall Study||41
8886294|NCT01976390|9943813|FG001|STARTED|Overall Study||19
8886295|NCT01976390|9943812|FG000|COMPLETED|Overall Study||41
8886296|NCT01976390|9943813|FG001|COMPLETED|Overall Study||19
8886297|NCT01976390|9943812|FG000|NOT COMPLETED|Overall Study||0
8886298|NCT01976390|9943813|FG001|NOT COMPLETED|Overall Study||0
8886299|NCT01976416|9943821|FG000|STARTED|Overall Study||104
8886300|NCT01976416|9943822|FG001|STARTED|Overall Study||104
8886301|NCT01976416|9943821|FG000|COMPLETED|Overall Study||102
8886302|NCT01976416|9943822|FG001|COMPLETED|Overall Study||102
8886303|NCT01976416|9943821|FG000|NOT COMPLETED|Overall Study||2
8886304|NCT01976416|9943822|FG001|NOT COMPLETED|Overall Study||2
8886305|NCT01976442|9943830|FG000|STARTED|Overall Study||69
8886306|NCT01976442|9943831|FG001|STARTED|Overall Study||31
8886307|NCT01976442|9943830|FG000|COMPLETED|Overall Study||69
8886308|NCT01976442|9943831|FG001|COMPLETED|Overall Study||31
8886309|NCT01976442|9943830|FG000|NOT COMPLETED|Overall Study||0
8886310|NCT01976442|9943831|FG001|NOT COMPLETED|Overall Study||0
8886311|NCT01976507|9943837|FG000|STARTED|Overall Study||101
8886312|NCT01976507|9943837|FG000|Received Initial Dose of Dabigatran|Overall Study||100
8886313|NCT01976507|9943837|FG000|COMPLETED|Overall Study||94
8886314|NCT01976507|9943837|FG000|NOT COMPLETED|Overall Study||7
8886315|NCT01976572|9943841|FG000|STARTED|Overall Study||6
8886316|NCT01976572|9943842|FG001|STARTED|Overall Study||6
8634566|NCT00557466|9674926|FG000|STARTED|Overall Study||98
8634567|NCT00557466|9674927|FG001|STARTED|Overall Study||92
8634568|NCT00557466|9674928|FG002|STARTED|Overall Study||101
8634569|NCT00557466|9674929|FG003|STARTED|Overall Study||96
8634570|NCT00557466|9674930|FG004|STARTED|Overall Study||90
8634571|NCT00557466|9674931|FG005|STARTED|Overall Study||91
8886317|NCT01976572|9943843|FG002|STARTED|Overall Study||6
8886318|NCT01976572|9943841|FG000|COMPLETED|Overall Study||6
8886319|NCT01976572|9943842|FG001|COMPLETED|Overall Study||6
8886320|NCT01976572|9943843|FG002|COMPLETED|Overall Study||6
8886321|NCT01976572|9943841|FG000|NOT COMPLETED|Overall Study||0
8886322|NCT01976572|9943842|FG001|NOT COMPLETED|Overall Study||0
8886323|NCT01976572|9943843|FG002|NOT COMPLETED|Overall Study||0
8886324|NCT01976624|9943852|FG000|STARTED|Overall Study||756
8886325|NCT01976624|9943852|FG000|COMPLETED|Overall Study||742
8886326|NCT01976624|9943852|FG000|NOT COMPLETED|Overall Study||14
8886327|NCT01976650|9943856|FG000|STARTED|Overall Study||724
8886328|NCT01976650|9943856|FG000|COMPLETED|Overall Study||718
8886329|NCT01976650|9943856|FG000|NOT COMPLETED|Overall Study||6
8886330|NCT01976663|9943860|FG000|STARTED|Overall Study||126
8886331|NCT01976663|9943860|FG000|Received Touch-up Treatment|Overall Study||63
8886332|NCT01976663|9943860|FG000|Received Asymmetry Correction|Overall Study||45
8886333|NCT01976663|9943860|FG000|Received Repeat Treatment|Overall Study||85
8886334|NCT01976663|9943860|FG000|COMPLETED|Overall Study||84
8886335|NCT01976663|9943860|FG000|NOT COMPLETED|Overall Study||42
8886336|NCT01976728|9943872|FG000|STARTED|Overall Study||10
8886337|NCT01976728|9943873|FG001|STARTED|Overall Study||9
8886338|NCT01976728|9943874|FG002|STARTED|Overall Study||10
8886339|NCT01976728|9943875|FG003|STARTED|Overall Study||10
8886340|NCT01976728|9943872|FG000|Dosed|Overall Study||10
8886341|NCT01976728|9943873|FG001|Dosed|Overall Study||9
8886342|NCT01976728|9943874|FG002|Dosed|Overall Study||10
8726028|NCT01033487|9773165|FG008|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||1
8886343|NCT01976728|9943875|FG003|Dosed|Overall Study||10
8886344|NCT01976728|9943872|FG000|COMPLETED|Overall Study||9
8634572|NCT00557466|9674926|FG000|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|98
8886345|NCT01976728|9943873|FG001|COMPLETED|Overall Study||9
8886346|NCT01976728|9943874|FG002|COMPLETED|Overall Study||10
8886347|NCT01976728|9943875|FG003|COMPLETED|Overall Study||10
8886348|NCT01976728|9943872|FG000|NOT COMPLETED|Overall Study||1
8886349|NCT01976728|9943873|FG001|NOT COMPLETED|Overall Study||0
8886350|NCT01976728|9943874|FG002|NOT COMPLETED|Overall Study||0
8886351|NCT01976728|9943875|FG003|NOT COMPLETED|Overall Study||0
8886352|NCT01976741|9943911|FG000|STARTED|Overall Study||4
8886353|NCT01976741|9943912|FG001|STARTED|Overall Study||4
8886354|NCT01976741|9943913|FG002|STARTED|Overall Study||4
8886355|NCT01976741|9943914|FG003|STARTED|Overall Study||3
8886356|NCT01976741|9943915|FG004|STARTED|Overall Study||4
8886357|NCT01976741|9943916|FG005|STARTED|Overall Study||4
8886358|NCT01976741|9943917|FG006|STARTED|Overall Study||23
8886359|NCT01976741|9943918|FG007|STARTED|Overall Study||74
8886360|NCT01976741|9943919|FG008|STARTED|Overall Study||8
8886361|NCT01976741|9943920|FG009|STARTED|Overall Study||40
8886362|NCT01976741|9943911|FG000|COMPLETED|Overall Study||3
8886363|NCT01976741|9943912|FG001|COMPLETED|Overall Study||4
8886364|NCT01976741|9943913|FG002|COMPLETED|Overall Study||1
8886365|NCT01976741|9943914|FG003|COMPLETED|Overall Study||2
8886366|NCT01976741|9943915|FG004|COMPLETED|Overall Study||4
8886367|NCT01976741|9943916|FG005|COMPLETED|Overall Study||4
8886368|NCT01976741|9943917|FG006|COMPLETED|Overall Study||19
8886369|NCT01976741|9943918|FG007|COMPLETED|Overall Study||62
8886370|NCT01976741|9943919|FG008|COMPLETED|Overall Study||7
8886371|NCT01976741|9943920|FG009|COMPLETED|Overall Study||36
8886372|NCT01976741|9943911|FG000|NOT COMPLETED|Overall Study||1
8886373|NCT01976741|9943912|FG001|NOT COMPLETED|Overall Study||0
8886374|NCT01976741|9943913|FG002|NOT COMPLETED|Overall Study||3
8886375|NCT01976741|9943914|FG003|NOT COMPLETED|Overall Study||1
8886376|NCT01976741|9943915|FG004|NOT COMPLETED|Overall Study||0
8886377|NCT01976741|9943916|FG005|NOT COMPLETED|Overall Study||0
8886378|NCT01976741|9943917|FG006|NOT COMPLETED|Overall Study||4
8886379|NCT01976741|9943918|FG007|NOT COMPLETED|Overall Study||12
8886380|NCT01976741|9943919|FG008|NOT COMPLETED|Overall Study||1
8886381|NCT01976741|9943920|FG009|NOT COMPLETED|Overall Study||4
8886382|NCT01976806|9943956|FG000|STARTED|Overall Study||27
8886383|NCT01976806|9943957|FG001|STARTED|Overall Study||28
8886384|NCT01976806|9943956|FG000|COMPLETED|Overall Study||24
8886385|NCT01976806|9943957|FG001|COMPLETED|Overall Study||22
8886386|NCT01976806|9943956|FG000|NOT COMPLETED|Overall Study||3
8886387|NCT01976806|9943957|FG001|NOT COMPLETED|Overall Study||6
8886388|NCT01976819|9943963|FG000|STARTED|Overall Study||16
8886389|NCT01976819|9943963|FG000|COMPLETED|Overall Study||11
8886390|NCT01976819|9943963|FG000|NOT COMPLETED|Overall Study||5
8886391|NCT01976845|9943975|FG000|STARTED|Overall Study||48
8886392|NCT01976845|9943976|FG001|STARTED|Overall Study||48
8886393|NCT01976845|9943977|FG002|STARTED|Overall Study||43
8886394|NCT01976845|9943975|FG000|COMPLETED|Overall Study||40
8886395|NCT01976845|9943976|FG001|COMPLETED|Overall Study||40
8886396|NCT01976845|9943977|FG002|COMPLETED|Overall Study||40
8886397|NCT01976845|9943975|FG000|NOT COMPLETED|Overall Study||8
8886398|NCT01976845|9943976|FG001|NOT COMPLETED|Overall Study||8
8886399|NCT01976845|9943977|FG002|NOT COMPLETED|Overall Study||3
8886400|NCT01976871|9943985|FG000|STARTED|Overall Study||21
8886401|NCT01976871|9943985|FG000|COMPLETED|Overall Study||20
8886402|NCT01976871|9943985|FG000|NOT COMPLETED|Overall Study||1
9004121|NCT02925494|10067191|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||14
9004122|NCT02925494|10067192|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||10
9004123|NCT02925494|10067193|FG002|NOT COMPLETED|Post-Treatment Follow-Up Period||24
9004124|NCT02925494|10067194|FG003|NOT COMPLETED|Post-Treatment Follow-Up Period||50
9004125|NCT02925611|10067207|FG000|STARTED|Overall Study||30
9004126|NCT02925611|10067208|FG001|STARTED|Overall Study||30
9004127|NCT02925611|10067207|FG000|COMPLETED|Overall Study||30
9004128|NCT02925611|10067208|FG001|COMPLETED|Overall Study||30
9004129|NCT02925611|10067207|FG000|NOT COMPLETED|Overall Study||0
9004130|NCT02925611|10067208|FG001|NOT COMPLETED|Overall Study||0
9004131|NCT02925741|10067216|FG000|STARTED|Overall Study||1637
9004132|NCT02925741|10067217|FG001|STARTED|Overall Study||1706
9004133|NCT02925741|10067216|FG000|COMPLETED|Overall Study||1626
9004134|NCT02925741|10067217|FG001|COMPLETED|Overall Study||1706
9004135|NCT02925741|10067216|FG000|NOT COMPLETED|Overall Study||11
9004136|NCT02925741|10067217|FG001|NOT COMPLETED|Overall Study||0
9004137|NCT02925858|10067228|FG000|STARTED|Overall Study||42
9004138|NCT02925858|10067229|FG001|STARTED|Overall Study||38
9004139|NCT02925858|10067228|FG000|COMPLETED|Overall Study||42
9004140|NCT02925858|10067229|FG001|COMPLETED|Overall Study||38
9004141|NCT02925858|10067228|FG000|NOT COMPLETED|Overall Study||0
9004142|NCT02925858|10067229|FG001|NOT COMPLETED|Overall Study||0
9004143|NCT02925923|10067237|FG000|STARTED|Overall Study||50
9004144|NCT02925923|10067238|FG001|STARTED|Overall Study||50
9004145|NCT02925923|10067237|FG000|COMPLETED|Overall Study||50
9004146|NCT02925923|10067238|FG001|COMPLETED|Overall Study||48
9004147|NCT02925923|10067237|FG000|NOT COMPLETED|Overall Study||0
9004148|NCT02925923|10067238|FG001|NOT COMPLETED|Overall Study||2
9004149|NCT02926027|10067246|FG000|STARTED|Overall Study||40
9004150|NCT02926027|10067247|FG001|STARTED|Overall Study||40
9004151|NCT02926027|10067246|FG000|COMPLETED|Overall Study||31
9004152|NCT02926027|10067247|FG001|COMPLETED|Overall Study||37
9004153|NCT02926027|10067246|FG000|NOT COMPLETED|Overall Study||9
9004154|NCT02926027|10067247|FG001|NOT COMPLETED|Overall Study||3
9004155|NCT02926209|10067253|FG000|STARTED|Study Cohort|Training cohort patients Aer-O-Scope as first followed by a conventional colonoscopy|42
9004156|NCT02926209|10067254|FG001|STARTED|Study Cohort||37
8886403|NCT01976975|9943991|FG000|STARTED|Overall Study||226
8886404|NCT01976975|9943992|FG001|STARTED|Overall Study||44
9004157|NCT02926209|10067253|FG000|COMPLETED|Study Cohort||41
9004158|NCT02926209|10067254|FG001|COMPLETED|Study Cohort||37
8886405|NCT01976975|9943991|FG000|COMPLETED|Overall Study||79
8886406|NCT01976975|9943992|FG001|COMPLETED|Overall Study||32
8886407|NCT01976975|9943991|FG000|NOT COMPLETED|Overall Study||147
8886408|NCT01976975|9943992|FG001|NOT COMPLETED|Overall Study||12
8886409|NCT01976988|9944000|FG000|STARTED|Overall Study||208
8886410|NCT01976988|9944001|FG001|STARTED|Overall Study||202
8886411|NCT01976988|9944000|FG000|COMPLETED|Overall Study||192
8886412|NCT01976988|9944001|FG001|COMPLETED|Overall Study||184
8886413|NCT01976988|9944000|FG000|NOT COMPLETED|Overall Study||16
8886414|NCT01976988|9944001|FG001|NOT COMPLETED|Overall Study||18
8886415|NCT01977040|9944009|FG000|STARTED|Overall Study||68
8886416|NCT01977040|9944009|FG000|COMPLETED|Overall Study||66
8886417|NCT01977040|9944009|FG000|NOT COMPLETED|Overall Study||2
8886418|NCT01977092|9944019|FG000|STARTED|Overall Study||149
8886419|NCT01977092|9944020|FG001|STARTED|Overall Study||181
8886420|NCT01977092|9944019|FG000|COMPLETED|Overall Study||118
8886421|NCT01977092|9944020|FG001|COMPLETED|Overall Study||151
8886422|NCT01977092|9944019|FG000|NOT COMPLETED|Overall Study||31
8886423|NCT01977092|9944020|FG001|NOT COMPLETED|Overall Study||30
8886424|NCT01977222|9944026|FG000|STARTED|Overall Study||12
8886425|NCT01977222|9944026|FG000|COMPLETED|Overall Study||11
8886426|NCT01977222|9944026|FG000|NOT COMPLETED|Overall Study||1
8886427|NCT01977352|9944032|FG000|STARTED|Overall Study||21
8886428|NCT01977352|9944033|FG001|STARTED|Overall Study||21
8886429|NCT01977352|9944032|FG000|COMPLETED|Overall Study||20
8886430|NCT01977352|9944033|FG001|COMPLETED|Overall Study||19
8886431|NCT01977352|9944032|FG000|NOT COMPLETED|Overall Study||1
8886432|NCT01977352|9944033|FG001|NOT COMPLETED|Overall Study||2
8886433|NCT01977456|9944039|FG000|STARTED|Overall Study||27
8634573|NCT00557466|9674927|FG001|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|92
8634574|NCT00557466|9674928|FG002|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|101
8634575|NCT00557466|9674929|FG003|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|96
8886434|NCT01977456|9944039|FG000|COMPLETED|Overall Study||22
8886435|NCT01977456|9944039|FG000|NOT COMPLETED|Overall Study||5
8886436|NCT01977482|9944049|FG000|STARTED|Overall Study||39
8886437|NCT01977482|9944050|FG001|STARTED|Overall Study||39
8886438|NCT01977482|9944051|FG002|STARTED|Overall Study||40
8886439|NCT01977482|9944052|FG003|STARTED|Overall Study||39
8886440|NCT01977482|9944053|FG004|STARTED|Overall Study||40
8886441|NCT01977482|9944054|FG005|STARTED|Overall Study||19
8886442|NCT01977482|9944049|FG000|COMPLETED|Overall Study||36
8886443|NCT01977482|9944050|FG001|COMPLETED|Overall Study||30
8886444|NCT01977482|9944051|FG002|COMPLETED|Overall Study||35
8886445|NCT01977482|9944052|FG003|COMPLETED|Overall Study||35
8886446|NCT01977482|9944053|FG004|COMPLETED|Overall Study||37
8886447|NCT01977482|9944054|FG005|COMPLETED|Overall Study||14
8572637|NCT00116337|9604850|FG000|STARTED|Overall Study||17
8572638|NCT00116337|9604850|FG000|COMPLETED|Overall Study||17
8572639|NCT00116337|9604850|FG000|NOT COMPLETED|Overall Study||0
8572640|NCT00116428|9604863|FG000|STARTED|Overall Study||106
8572641|NCT00116428|9604864|FG001|STARTED|Overall Study||61
8572642|NCT00116428|9604863|FG000|Underwent Study Ablation Procedure|Overall Study||103
8572643|NCT00116428|9604864|FG001|Underwent Study Ablation Procedure|Overall Study||36
8572644|NCT00116428|9604863|FG000|COMPLETED|Overall Study||103
8572645|NCT00116428|9604864|FG001|COMPLETED|Overall Study||56
8572646|NCT00116428|9604863|FG000|NOT COMPLETED|Overall Study||3
8572647|NCT00116428|9604864|FG001|NOT COMPLETED|Overall Study||5
8572648|NCT00116558|9604876|FG000|STARTED|Overall Study||80
8572649|NCT00116558|9604877|FG001|STARTED|Overall Study||26
8634576|NCT00557466|9674930|FG004|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|90
8634577|NCT00557466|9674931|FG005|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|91
8634578|NCT00557466|9674926|FG000|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|98
8886448|NCT01977482|9944049|FG000|NOT COMPLETED|Overall Study||3
8886449|NCT01977482|9944050|FG001|NOT COMPLETED|Overall Study||9
8886450|NCT01977482|9944051|FG002|NOT COMPLETED|Overall Study||5
8886451|NCT01977482|9944052|FG003|NOT COMPLETED|Overall Study||4
8886452|NCT01977482|9944053|FG004|NOT COMPLETED|Overall Study||3
8886453|NCT01977482|9944054|FG005|NOT COMPLETED|Overall Study||5
8886454|NCT01977547|9944075|FG000|STARTED|Overall Study||768
8886455|NCT01977547|9944076|FG001|STARTED|Overall Study||770
8886456|NCT01977547|9944075|FG000|COMPLETED|Overall Study||728
8886457|NCT01977547|9944076|FG001|COMPLETED|Overall Study||733
8886458|NCT01977547|9944075|FG000|NOT COMPLETED|Overall Study||40
8886459|NCT01977547|9944076|FG001|NOT COMPLETED|Overall Study||37
8886460|NCT01977573|9944086|FG000|STARTED|Overall Study||136
8886461|NCT01977573|9944087|FG001|STARTED|Overall Study||44
8886462|NCT01977573|9944088|FG002|STARTED|Overall Study||36
8886463|NCT01977573|9944089|FG003|STARTED|Overall Study||36
8886464|NCT01977573|9944086|FG000|COMPLETED|Overall Study||116
8886465|NCT01977573|9944087|FG001|COMPLETED|Overall Study||41
8886466|NCT01977573|9944088|FG002|COMPLETED|Overall Study||32
8886467|NCT01977573|9944089|FG003|COMPLETED|Overall Study||33
8886468|NCT01977573|9944086|FG000|NOT COMPLETED|Overall Study||20
8886469|NCT01977573|9944087|FG001|NOT COMPLETED|Overall Study||3
8886470|NCT01977573|9944088|FG002|NOT COMPLETED|Overall Study||4
8886471|NCT01977573|9944089|FG003|NOT COMPLETED|Overall Study||3
8886472|NCT01977599|9944102|FG000|STARTED|Overall Study||1118
8886473|NCT01977599|9944103|FG001|STARTED|Overall Study||1122
8886474|NCT01977599|9944102|FG000|COMPLETED|Overall Study||1118
8886475|NCT01977599|9944103|FG001|COMPLETED|Overall Study||1122
8886476|NCT01977599|9944102|FG000|NOT COMPLETED|Overall Study||0
8886477|NCT01977599|9944103|FG001|NOT COMPLETED|Overall Study||0
8886478|NCT01977612|9944111|FG000|STARTED|Overall Study||85
8886479|NCT01977612|9944112|FG001|STARTED|Overall Study||80
8886480|NCT01977612|9944111|FG000|COMPLETED|Overall Study||84
8886481|NCT01977612|9944112|FG001|COMPLETED|Overall Study||79
8886482|NCT01977612|9944111|FG000|NOT COMPLETED|Overall Study||1
8886483|NCT01977612|9944112|FG001|NOT COMPLETED|Overall Study||1
8886484|NCT01977625|9944118|FG000|STARTED|First Intervention (4 Weeks)||11
8886485|NCT01977625|9944119|FG001|STARTED|First Intervention (4 Weeks)||7
8886486|NCT01977625|9944118|FG000|COMPLETED|First Intervention (4 Weeks)||8
8886487|NCT01977625|9944119|FG001|COMPLETED|First Intervention (4 Weeks)||7
8886488|NCT01977625|9944118|FG000|NOT COMPLETED|First Intervention (4 Weeks)||3
8886489|NCT01977625|9944119|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0
8886490|NCT01977625|9944118|FG000|STARTED|Washout (2 Weeks)||8
8886491|NCT01977625|9944119|FG001|STARTED|Washout (2 Weeks)||7
8886492|NCT01977625|9944118|FG000|COMPLETED|Washout (2 Weeks)||8
8886493|NCT01977625|9944119|FG001|COMPLETED|Washout (2 Weeks)||7
8886494|NCT01977625|9944118|FG000|NOT COMPLETED|Washout (2 Weeks)||0
8886495|NCT01977625|9944119|FG001|NOT COMPLETED|Washout (2 Weeks)||0
8886496|NCT01977625|9944118|FG000|STARTED|Second Intervention (4 Weeks)||8
8886497|NCT01977625|9944119|FG001|STARTED|Second Intervention (4 Weeks)||7
8886498|NCT01977625|9944118|FG000|COMPLETED|Second Intervention (4 Weeks)||7
8886499|NCT01977625|9944119|FG001|COMPLETED|Second Intervention (4 Weeks)||7
8886500|NCT01977625|9944118|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||1
8886501|NCT01977625|9944119|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||0
8886502|NCT01977651|9944127|FG000|STARTED|4 Month Treatment Period||423
8886503|NCT01977651|9944127|FG000|COMPLETED|4 Month Treatment Period||322
8886504|NCT01977651|9944127|FG000|NOT COMPLETED|4 Month Treatment Period||101
8886505|NCT01977651|9944127|FG000|STARTED|1 Year Extension Period|Participants who benefited from enzalutamide treatment continued in the 1 year extension period|287
8886506|NCT01977651|9944127|FG000|COMPLETED|1 Year Extension Period||157
8886507|NCT01977651|9944127|FG000|NOT COMPLETED|1 Year Extension Period||130
8886508|NCT01977651|9944127|FG000|STARTED|Post 1 Year Extension Period|Participants who benefited from enzalutamide treatment continued in the post 1 year extension period|145
8886509|NCT01977651|9944127|FG000|COMPLETED|Post 1 Year Extension Period||1
8886510|NCT01977651|9944127|FG000|NOT COMPLETED|Post 1 Year Extension Period||144
8886511|NCT01977677|9944134|FG000|STARTED|Overall Study||3
8886512|NCT01977677|9944135|FG001|STARTED|Overall Study||6
8886513|NCT01977677|9944136|FG002|STARTED|Overall Study||21
8886514|NCT01977677|9944134|FG000|COMPLETED|Overall Study||3
8886515|NCT01977677|9944135|FG001|COMPLETED|Overall Study||6
8886516|NCT01977677|9944136|FG002|COMPLETED|Overall Study||20
8886517|NCT01977677|9944134|FG000|NOT COMPLETED|Overall Study||0
8886518|NCT01977677|9944135|FG001|NOT COMPLETED|Overall Study||0
8886519|NCT01977677|9944136|FG002|NOT COMPLETED|Overall Study||1
8886520|NCT01977690|9944146|FG000|STARTED|Overall Study||15
9004159|NCT02926209|10067253|FG000|NOT COMPLETED|Study Cohort||1
9004160|NCT02926209|10067254|FG001|NOT COMPLETED|Study Cohort||0
9004161|NCT02926209|10067253|FG000|STARTED|Training Cohort - First Patients||20
9004162|NCT02926209|10067254|FG001|STARTED|Training Cohort - First Patients||0
9004163|NCT02926209|10067253|FG000|COMPLETED|Training Cohort - First Patients||20
9004164|NCT02926209|10067254|FG001|COMPLETED|Training Cohort - First Patients||0
9004165|NCT02926209|10067253|FG000|NOT COMPLETED|Training Cohort - First Patients||0
9004166|NCT02926209|10067254|FG001|NOT COMPLETED|Training Cohort - First Patients||0
9004167|NCT02926573|10067263|FG000|STARTED|Overall Study||55
9004168|NCT02926573|10067264|FG001|STARTED|Overall Study||55
9004169|NCT02926573|10067263|FG000|COMPLETED|Overall Study||44
9004170|NCT02926573|10067264|FG001|COMPLETED|Overall Study||46
9004171|NCT02926573|10067263|FG000|NOT COMPLETED|Overall Study||11
9004172|NCT02926573|10067264|FG001|NOT COMPLETED|Overall Study||9
9004173|NCT02926677|10067273|FG000|STARTED|Overall Study||25
9004174|NCT02926677|10067274|FG001|STARTED|Overall Study||22
9004175|NCT02926677|10067275|FG002|STARTED|Overall Study||26
9004176|NCT02926677|10067273|FG000|COMPLETED|Overall Study||8
8886521|NCT01977690|9944147|FG001|STARTED|Overall Study||15
8886522|NCT01977690|9944146|FG000|COMPLETED|Overall Study||15
8886523|NCT01977690|9944147|FG001|COMPLETED|Overall Study||11
8886524|NCT01977690|9944146|FG000|NOT COMPLETED|Overall Study||0
8886525|NCT01977690|9944147|FG001|NOT COMPLETED|Overall Study||4
8886526|NCT01977781|9944155|FG000|STARTED|Overall Study||24
8886527|NCT01977781|9944156|FG001|STARTED|Overall Study||16
8886528|NCT01977781|9944155|FG000|COMPLETED|Overall Study||18
8886529|NCT01977781|9944156|FG001|COMPLETED|Overall Study||15
8886530|NCT01977781|9944155|FG000|NOT COMPLETED|Overall Study||6
8886531|NCT01977781|9944156|FG001|NOT COMPLETED|Overall Study||1
8886532|NCT01977794|9944164|FG000|STARTED|Overall Study||100
8886533|NCT01977794|9944165|FG001|STARTED|Overall Study||100
8886534|NCT01977794|9944164|FG000|COMPLETED|Overall Study||92
8886535|NCT01977794|9944165|FG001|COMPLETED|Overall Study||94
8886536|NCT01977794|9944164|FG000|NOT COMPLETED|Overall Study||8
8886537|NCT01977794|9944165|FG001|NOT COMPLETED|Overall Study||6
8886538|NCT01977820|9944173|FG000|STARTED|Overall Study||1
8886539|NCT01977820|9944174|FG001|STARTED|Overall Study||1
8886540|NCT01977820|9944173|FG000|COMPLETED|Overall Study||0
8886541|NCT01977820|9944174|FG001|COMPLETED|Overall Study||0
8886542|NCT01977820|9944173|FG000|NOT COMPLETED|Overall Study||1
8886543|NCT01977820|9944174|FG001|NOT COMPLETED|Overall Study||1
8886544|NCT01977846|9944182|FG000|STARTED|Total Study - Retrospective||251
8886545|NCT01977846|9944183|FG001|STARTED|Total Study - Retrospective||0
8886546|NCT01977846|9944182|FG000|COMPLETED|Total Study - Retrospective||251
8886547|NCT01977846|9944183|FG001|COMPLETED|Total Study - Retrospective||0
8886548|NCT01977846|9944182|FG000|NOT COMPLETED|Total Study - Retrospective||0
8886549|NCT01977846|9944183|FG001|NOT COMPLETED|Total Study - Retrospective||0
8886550|NCT01977846|9944182|FG000|STARTED|Total Study - Prospective||0
8886551|NCT01977846|9944183|FG001|STARTED|Total Study - Prospective||259
8886552|NCT01977846|9944182|FG000|COMPLETED|Total Study - Prospective||0
8886553|NCT01977846|9944183|FG001|COMPLETED|Total Study - Prospective||230
8886554|NCT01977846|9944182|FG000|NOT COMPLETED|Total Study - Prospective||0
8886555|NCT01977846|9944183|FG001|NOT COMPLETED|Total Study - Prospective||29
8886556|NCT01977898|9944192|FG000|STARTED|Overall Study||28
8886557|NCT01977898|9944193|FG001|STARTED|Overall Study||35
8886558|NCT01977898|9944192|FG000|COMPLETED|Overall Study||27
8886559|NCT01977898|9944193|FG001|COMPLETED|Overall Study||34
8886560|NCT01977898|9944192|FG000|NOT COMPLETED|Overall Study||1
8886561|NCT01977898|9944193|FG001|NOT COMPLETED|Overall Study||1
8886562|NCT01977937|9944201|FG000|STARTED|Overall Study||27
8886563|NCT01977937|9944202|FG001|STARTED|Overall Study||28
8886564|NCT01977937|9944201|FG000|COMPLETED|Overall Study||24
8886565|NCT01977937|9944202|FG001|COMPLETED|Overall Study||26
8886566|NCT01977937|9944201|FG000|NOT COMPLETED|Overall Study||3
8886567|NCT01977937|9944202|FG001|NOT COMPLETED|Overall Study||2
8886568|NCT01978093|9944210|FG000|STARTED|Overall Study||297
8886569|NCT01978093|9944211|FG001|STARTED|Overall Study||303
8886570|NCT01978093|9944210|FG000|COMPLETED|Overall Study||232
8886571|NCT01978093|9944211|FG001|COMPLETED|Overall Study||230
8886572|NCT01978093|9944210|FG000|NOT COMPLETED|Overall Study||65
8886573|NCT01978093|9944211|FG001|NOT COMPLETED|Overall Study||73
8886574|NCT01978119|9944220|FG000|STARTED|Treatment Period 1 (12 Weeks)||40
8886575|NCT01978119|9944221|FG001|STARTED|Treatment Period 1 (12 Weeks)||42
8886576|NCT01978119|9944220|FG000|COMPLETED|Treatment Period 1 (12 Weeks)||38
8886577|NCT01978119|9944221|FG001|COMPLETED|Treatment Period 1 (12 Weeks)||42
8886578|NCT01978119|9944220|FG000|NOT COMPLETED|Treatment Period 1 (12 Weeks)||2
8886579|NCT01978119|9944221|FG001|NOT COMPLETED|Treatment Period 1 (12 Weeks)||0
8886580|NCT01978119|9944220|FG000|STARTED|Washout Period 1 (3 Weeks)||38
8886581|NCT01978119|9944221|FG001|STARTED|Washout Period 1 (3 Weeks)||42
8886582|NCT01978119|9944220|FG000|COMPLETED|Washout Period 1 (3 Weeks)||38
8886583|NCT01978119|9944221|FG001|COMPLETED|Washout Period 1 (3 Weeks)||42
8886584|NCT01978119|9944220|FG000|NOT COMPLETED|Washout Period 1 (3 Weeks)||0
8886585|NCT01978119|9944221|FG001|NOT COMPLETED|Washout Period 1 (3 Weeks)||0
8886586|NCT01978119|9944220|FG000|STARTED|Treatment Period 2 (12 Weeks)||38
9004177|NCT02926677|10067274|FG001|COMPLETED|Overall Study||8
9004178|NCT02926677|10067275|FG002|COMPLETED|Overall Study||6
9004179|NCT02926677|10067273|FG000|NOT COMPLETED|Overall Study||17
9004180|NCT02926677|10067274|FG001|NOT COMPLETED|Overall Study||14
9004181|NCT02926677|10067275|FG002|NOT COMPLETED|Overall Study||20
9004182|NCT02926937|10067287|FG000|STARTED|Overall Study||150
9004183|NCT02926937|10067288|FG001|STARTED|Overall Study||142
9004184|NCT02926937|10067289|FG002|STARTED|Overall Study||107
9004185|NCT02926937|10067287|FG000|COMPLETED|Overall Study||131
9004186|NCT02926937|10067288|FG001|COMPLETED|Overall Study||127
9004187|NCT02926937|10067289|FG002|COMPLETED|Overall Study||96
9004188|NCT02926937|10067287|FG000|NOT COMPLETED|Overall Study||19
9004189|NCT02926937|10067288|FG001|NOT COMPLETED|Overall Study||15
9004190|NCT02926937|10067289|FG002|NOT COMPLETED|Overall Study||11
9004191|NCT02926950|10067300|FG000|STARTED|Overall Study||259
9004192|NCT02926950|10067301|FG001|STARTED|Overall Study||259
9004193|NCT02926950|10067300|FG000|COMPLETED|Overall Study||210
9004194|NCT02926950|10067301|FG001|COMPLETED|Overall Study||211
9004195|NCT02926950|10067300|FG000|NOT COMPLETED|Overall Study||49
9004196|NCT02926950|10067301|FG001|NOT COMPLETED|Overall Study||48
9004197|NCT02927080|10067318|FG000|STARTED|Overall Study||6
9004198|NCT02927080|10067319|FG001|STARTED|Overall Study||6
9004199|NCT02927080|10067320|FG002|STARTED|Overall Study||6
9004200|NCT02927080|10067321|FG003|STARTED|Overall Study||6
9004201|NCT02927080|10067322|FG004|STARTED|Overall Study||7
9004202|NCT02927080|10067323|FG005|STARTED|Overall Study||6
9004203|NCT02927080|10067324|FG006|STARTED|Overall Study||15
9004204|NCT02927080|10067325|FG007|STARTED|Overall Study||14
9004205|NCT02927080|10067326|FG008|STARTED|Overall Study||15
9004206|NCT02927080|10067327|FG009|STARTED|Overall Study||14
9004207|NCT02927080|10067318|FG000|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||0
9004208|NCT02927080|10067319|FG001|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||0
9004209|NCT02927080|10067320|FG002|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||0
9004210|NCT02927080|10067321|FG003|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||0
9004211|NCT02927080|10067322|FG004|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||0
8886587|NCT01978119|9944221|FG001|STARTED|Treatment Period 2 (12 Weeks)||42
8886588|NCT01978119|9944220|FG000|COMPLETED|Treatment Period 2 (12 Weeks)||38
8886589|NCT01978119|9944221|FG001|COMPLETED|Treatment Period 2 (12 Weeks)||40
8886590|NCT01978119|9944220|FG000|NOT COMPLETED|Treatment Period 2 (12 Weeks)||0
8886591|NCT01978119|9944221|FG001|NOT COMPLETED|Treatment Period 2 (12 Weeks)||2
8886592|NCT01978145|9944227|FG000|STARTED|Treatment Period 1||214
8886593|NCT01978145|9944228|FG001|STARTED|Treatment Period 1||212
8886594|NCT01978145|9944227|FG000|COMPLETED|Treatment Period 1||205
8886595|NCT01978145|9944228|FG001|COMPLETED|Treatment Period 1||196
8886596|NCT01978145|9944227|FG000|NOT COMPLETED|Treatment Period 1||9
8886597|NCT01978145|9944228|FG001|NOT COMPLETED|Treatment Period 1||16
8886598|NCT01978145|9944227|FG000|STARTED|Washout Period 1||205
8886599|NCT01978145|9944228|FG001|STARTED|Washout Period 1||196
8886600|NCT01978145|9944227|FG000|COMPLETED|Washout Period 1||204
8886601|NCT01978145|9944228|FG001|COMPLETED|Washout Period 1||193
8886602|NCT01978145|9944227|FG000|NOT COMPLETED|Washout Period 1||1
8886603|NCT01978145|9944228|FG001|NOT COMPLETED|Washout Period 1||3
8886604|NCT01978145|9944227|FG000|STARTED|Treatment Period 2||204
8886605|NCT01978145|9944228|FG001|STARTED|Treatment Period 2||193
8886606|NCT01978145|9944227|FG000|COMPLETED|Treatment Period 2||185
8886607|NCT01978145|9944228|FG001|COMPLETED|Treatment Period 2||179
8886608|NCT01978145|9944227|FG000|NOT COMPLETED|Treatment Period 2||19
8886609|NCT01978145|9944228|FG001|NOT COMPLETED|Treatment Period 2||14
8886610|NCT01978184|9944236|FG000|STARTED|Overall Study||43
8886611|NCT01978184|9944237|FG001|STARTED|Overall Study||61
8886612|NCT01978184|9944236|FG000|COMPLETED|Overall Study||30
8886613|NCT01978184|9944237|FG001|COMPLETED|Overall Study||41
8886614|NCT01978184|9944236|FG000|NOT COMPLETED|Overall Study||13
8886615|NCT01978184|9944237|FG001|NOT COMPLETED|Overall Study||20
8886616|NCT01978236|9944243|FG000|STARTED|Overall Study||6
8886617|NCT01978236|9944243|FG000|COMPLETED|Overall Study||4
8886618|NCT01978236|9944243|FG000|NOT COMPLETED|Overall Study||2
8886619|NCT01978262|9944247|FG000|STARTED|Overall Study||103
8886620|NCT01978262|9944247|FG000|COMPLETED|Overall Study||92
8886621|NCT01978262|9944247|FG000|NOT COMPLETED|Overall Study||11
8886622|NCT01978314|9944257|FG000|STARTED|Overall Study||8
8886623|NCT01978314|9944258|FG001|STARTED|Overall Study||8
8886624|NCT01978314|9944259|FG002|STARTED|Overall Study||8
8886625|NCT01978314|9944260|FG003|STARTED|Overall Study||1
8886626|NCT01978314|9944261|FG004|STARTED|Overall Study||8
8886627|NCT01978314|9944257|FG000|COMPLETED|Overall Study||8
8886628|NCT01978314|9944258|FG001|COMPLETED|Overall Study||8
8886629|NCT01978314|9944259|FG002|COMPLETED|Overall Study||8
8886630|NCT01978314|9944260|FG003|COMPLETED|Overall Study||1
8886631|NCT01978314|9944261|FG004|COMPLETED|Overall Study||8
8886632|NCT01978314|9944257|FG000|NOT COMPLETED|Overall Study||0
8886633|NCT01978314|9944258|FG001|NOT COMPLETED|Overall Study||0
8886634|NCT01978314|9944259|FG002|NOT COMPLETED|Overall Study||0
8886635|NCT01978314|9944260|FG003|NOT COMPLETED|Overall Study||0
8886636|NCT01978314|9944261|FG004|NOT COMPLETED|Overall Study||0
8886637|NCT01978509|9944287|FG000|STARTED|Overall Study||10
8886638|NCT01978509|9944288|FG001|STARTED|Overall Study||13
8886639|NCT01978509|9944289|FG002|STARTED|Overall Study||9
8886640|NCT01978509|9944287|FG000|COMPLETED|Overall Study||8
8886641|NCT01978509|9944288|FG001|COMPLETED|Overall Study||8
8886642|NCT01978509|9944289|FG002|COMPLETED|Overall Study||9
8886643|NCT01978509|9944287|FG000|NOT COMPLETED|Overall Study||2
8886644|NCT01978509|9944288|FG001|NOT COMPLETED|Overall Study||5
8886645|NCT01978509|9944289|FG002|NOT COMPLETED|Overall Study||0
8886646|NCT01978600|9944299|FG000|STARTED|Overall Study||44
8886647|NCT01978600|9944300|FG001|STARTED|Overall Study||42
8886648|NCT01978600|9944299|FG000|COMPLETED|Overall Study||44
8886649|NCT01978600|9944300|FG001|COMPLETED|Overall Study||42
8886650|NCT01978600|9944299|FG000|NOT COMPLETED|Overall Study||0
8886651|NCT01978600|9944300|FG001|NOT COMPLETED|Overall Study||0
8634579|NCT00557466|9674927|FG001|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|91
8634580|NCT00557466|9674928|FG002|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|98
8634581|NCT00557466|9674929|FG003|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|93
8634582|NCT00557466|9674930|FG004|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|87
8634583|NCT00557466|9674931|FG005|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|89
8886652|NCT01978743|9944306|FG000|STARTED|Overall Study||10
8886653|NCT01978743|9944306|FG000|COMPLETED|Overall Study||10
8886654|NCT01978743|9944306|FG000|NOT COMPLETED|Overall Study||0
8886655|NCT01978912|9944315|FG000|STARTED|Overall Study||6
8886656|NCT01978912|9944316|FG001|STARTED|Overall Study||6
8886657|NCT01978912|9944317|FG002|STARTED|Overall Study||6
8886658|NCT01978912|9944318|FG003|STARTED|Overall Study||6
8886659|NCT01978912|9944315|FG000|COMPLETED|Overall Study||3
8886660|NCT01978912|9944316|FG001|COMPLETED|Overall Study||3
8886661|NCT01978912|9944317|FG002|COMPLETED|Overall Study||3
8886662|NCT01978912|9944318|FG003|COMPLETED|Overall Study||3
8886663|NCT01978912|9944315|FG000|NOT COMPLETED|Overall Study||3
8886664|NCT01978912|9944316|FG001|NOT COMPLETED|Overall Study||3
8886665|NCT01978912|9944317|FG002|NOT COMPLETED|Overall Study||3
8886666|NCT01978912|9944318|FG003|NOT COMPLETED|Overall Study||3
8886667|NCT01979016|9944330|FG000|STARTED|Overall Study||27
8886668|NCT01979016|9944331|FG001|STARTED|Overall Study||27
8886669|NCT01979016|9944330|FG000|COMPLETED|Overall Study||25
8886670|NCT01979016|9944331|FG001|COMPLETED|Overall Study||26
8886671|NCT01979016|9944330|FG000|NOT COMPLETED|Overall Study||2
8886672|NCT01979016|9944331|FG001|NOT COMPLETED|Overall Study||1
9004212|NCT02927080|10067323|FG005|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||0
9004213|NCT02927080|10067324|FG006|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||14
9004214|NCT02927080|10067325|FG007|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||13
9004215|NCT02927080|10067326|FG008|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||14
9004216|NCT02927080|10067327|FG009|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||12
9004217|NCT02927080|10067318|FG000|COMPLETED|Overall Study||6
9004218|NCT02927080|10067319|FG001|COMPLETED|Overall Study||5
9004219|NCT02927080|10067320|FG002|COMPLETED|Overall Study||6
8634584|NCT00557466|9674926|FG000|COMPLETED|Overall Study||94
8634585|NCT00557466|9674927|FG001|COMPLETED|Overall Study||87
8634586|NCT00557466|9674928|FG002|COMPLETED|Overall Study||95
8634587|NCT00557466|9674929|FG003|COMPLETED|Overall Study||92
8634588|NCT00557466|9674930|FG004|COMPLETED|Overall Study||87
8634589|NCT00557466|9674931|FG005|COMPLETED|Overall Study||85
8634590|NCT00557466|9674926|FG000|NOT COMPLETED|Overall Study||4
8634591|NCT00557466|9674927|FG001|NOT COMPLETED|Overall Study||5
8634592|NCT00557466|9674928|FG002|NOT COMPLETED|Overall Study||6
8726029|NCT01033487|9773166|FG009|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
8726030|NCT01033487|9773157|FG000|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
8726031|NCT01033487|9773158|FG001|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
8726032|NCT01033487|9773159|FG002|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
8726033|NCT01033487|9773160|FG003|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
8726034|NCT01033487|9773161|FG004|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
8726035|NCT01033487|9773162|FG005|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
8726036|NCT01033487|9773163|FG006|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
8726037|NCT01033487|9773164|FG007|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
8726038|NCT01033487|9773165|FG008|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
8726039|NCT01033487|9773166|FG009|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
8726040|NCT01033487|9773157|FG000|STARTED|Fifth Intervention Period||2
8726041|NCT01033487|9773158|FG001|STARTED|Fifth Intervention Period||3
8726042|NCT01033487|9773159|FG002|STARTED|Fifth Intervention Period||2
8726043|NCT01033487|9773160|FG003|STARTED|Fifth Intervention Period||2
8726044|NCT01033487|9773161|FG004|STARTED|Fifth Intervention Period||2
8726045|NCT01033487|9773162|FG005|STARTED|Fifth Intervention Period||2
8726046|NCT01033487|9773163|FG006|STARTED|Fifth Intervention Period||2
8726047|NCT01033487|9773164|FG007|STARTED|Fifth Intervention Period||3
8726048|NCT01033487|9773165|FG008|STARTED|Fifth Intervention Period||1
8726049|NCT01033487|9773166|FG009|STARTED|Fifth Intervention Period||2
8634593|NCT00557466|9674929|FG003|NOT COMPLETED|Overall Study||4
8634594|NCT00557466|9674930|FG004|NOT COMPLETED|Overall Study||3
8634595|NCT00557466|9674931|FG005|NOT COMPLETED|Overall Study||6
8634596|NCT00557492|9674945|FG000|STARTED|Overall Study||59
8634597|NCT00557492|9674945|FG000|COMPLETED|Overall Study|Evaluable for outcomes|58
8634598|NCT00557492|9674945|FG000|NOT COMPLETED|Overall Study||1
8634599|NCT00557505|9674958|FG000|STARTED|Overall Study||3
8634600|NCT00557505|9674959|FG001|STARTED|Overall Study||3
8634601|NCT00557505|9674960|FG002|STARTED|Overall Study||4
8634602|NCT00557505|9674961|FG003|STARTED|Overall Study||3
8634603|NCT00557505|9674962|FG004|STARTED|Overall Study||2
8634604|NCT00557505|9674963|FG005|STARTED|Overall Study||3
8634605|NCT00557505|9674964|FG006|STARTED|Overall Study||3
8634606|NCT00557505|9674965|FG007|STARTED|Overall Study||5
8634607|NCT00557505|9674966|FG008|STARTED|Overall Study||17
8634608|NCT00557505|9674958|FG000|COMPLETED|Overall Study||0
8634609|NCT00557505|9674959|FG001|COMPLETED|Overall Study||0
8634610|NCT00557505|9674960|FG002|COMPLETED|Overall Study||0
8634611|NCT00557505|9674961|FG003|COMPLETED|Overall Study||0
8634612|NCT00557505|9674962|FG004|COMPLETED|Overall Study||0
8634613|NCT00557505|9674963|FG005|COMPLETED|Overall Study||0
8634614|NCT00557505|9674964|FG006|COMPLETED|Overall Study||0
8634615|NCT00557505|9674965|FG007|COMPLETED|Overall Study||0
8634616|NCT00557505|9674966|FG008|COMPLETED|Overall Study||0
8634617|NCT00557505|9674958|FG000|NOT COMPLETED|Overall Study||3
8634618|NCT00557505|9674959|FG001|NOT COMPLETED|Overall Study||3
8634619|NCT00557505|9674960|FG002|NOT COMPLETED|Overall Study||4
8634620|NCT00557505|9674961|FG003|NOT COMPLETED|Overall Study||3
8634621|NCT00557505|9674962|FG004|NOT COMPLETED|Overall Study||2
8634622|NCT00557505|9674963|FG005|NOT COMPLETED|Overall Study||3
8634623|NCT00557505|9674964|FG006|NOT COMPLETED|Overall Study||3
8634624|NCT00557505|9674965|FG007|NOT COMPLETED|Overall Study||5
8634625|NCT00557505|9674966|FG008|NOT COMPLETED|Overall Study||17
8634626|NCT00557622|9674991|FG000|STARTED|4-Week Run-in Phase||5
8634627|NCT00557622|9674992|FG001|STARTED|4-Week Run-in Phase||0
8634628|NCT00557622|9674991|FG000|COMPLETED|4-Week Run-in Phase||3
8634629|NCT00557622|9674992|FG001|COMPLETED|4-Week Run-in Phase||0
8634630|NCT00557622|9674991|FG000|NOT COMPLETED|4-Week Run-in Phase||2
8634631|NCT00557622|9674992|FG001|NOT COMPLETED|4-Week Run-in Phase||0
8634632|NCT00557622|9674991|FG000|STARTED|12-Week Treatment Phase||1
8634633|NCT00557622|9674992|FG001|STARTED|12-Week Treatment Phase||2
8634634|NCT00557622|9674991|FG000|COMPLETED|12-Week Treatment Phase||1
8634635|NCT00557622|9674992|FG001|COMPLETED|12-Week Treatment Phase||1
8886673|NCT01979029|9944339|FG000|STARTED|Overall Study||29
8886674|NCT01979029|9944340|FG001|STARTED|Overall Study||28
8886675|NCT01979029|9944339|FG000|COMPLETED|Overall Study||29
8886676|NCT01979029|9944340|FG001|COMPLETED|Overall Study||28
9004220|NCT02927080|10067321|FG003|COMPLETED|Overall Study||6
9004221|NCT02927080|10067322|FG004|COMPLETED|Overall Study||6
9004222|NCT02927080|10067323|FG005|COMPLETED|Overall Study||6
9004223|NCT02927080|10067324|FG006|COMPLETED|Overall Study||7
9004224|NCT02927080|10067325|FG007|COMPLETED|Overall Study||5
9004225|NCT02927080|10067326|FG008|COMPLETED|Overall Study||12
9004226|NCT02927080|10067327|FG009|COMPLETED|Overall Study||7
9004227|NCT02927080|10067318|FG000|NOT COMPLETED|Overall Study||0
9004228|NCT02927080|10067319|FG001|NOT COMPLETED|Overall Study||1
9004229|NCT02927080|10067320|FG002|NOT COMPLETED|Overall Study||0
9004230|NCT02927080|10067321|FG003|NOT COMPLETED|Overall Study||0
9004231|NCT02927080|10067322|FG004|NOT COMPLETED|Overall Study||1
9004232|NCT02927080|10067323|FG005|NOT COMPLETED|Overall Study||0
9004233|NCT02927080|10067324|FG006|NOT COMPLETED|Overall Study||8
9004234|NCT02927080|10067325|FG007|NOT COMPLETED|Overall Study||9
9004235|NCT02927080|10067326|FG008|NOT COMPLETED|Overall Study||3
9004236|NCT02927080|10067327|FG009|NOT COMPLETED|Overall Study||7
9004237|NCT02927171|10067374|FG000|STARTED|Overall Study||53
9004238|NCT02927171|10067375|FG001|STARTED|Overall Study||51
9004239|NCT02927171|10067374|FG000|COMPLETED|Overall Study||53
9004240|NCT02927171|10067375|FG001|COMPLETED|Overall Study||50
9004241|NCT02927171|10067374|FG000|NOT COMPLETED|Overall Study||0
9004242|NCT02927171|10067375|FG001|NOT COMPLETED|Overall Study||1
9004243|NCT02927223|10067381|FG000|STARTED|Overall Study||6
8634636|NCT00557622|9674991|FG000|NOT COMPLETED|12-Week Treatment Phase||0
8634637|NCT00557622|9674992|FG001|NOT COMPLETED|12-Week Treatment Phase||1
8634638|NCT00557830|9675001|FG000|STARTED|Screening Treatment Phase||12
8634639|NCT00557830|9675002|FG001|STARTED|Screening Treatment Phase||0
8634640|NCT00557830|9675003|FG002|STARTED|Screening Treatment Phase||0
8634641|NCT00557830|9675001|FG000|COMPLETED|Screening Treatment Phase||6
9004244|NCT02927223|10067381|FG000|COMPLETED|Overall Study||6
9004245|NCT02927223|10067381|FG000|NOT COMPLETED|Overall Study||0
9004246|NCT02927301|10067387|FG000|STARTED|Overall Study||181
9004247|NCT02927301|10067387|FG000|COMPLETED|Overall Study||171
9004248|NCT02927301|10067387|FG000|NOT COMPLETED|Overall Study||10
9004249|NCT02927327|10067393|FG000|STARTED|Overall Study||30
9004250|NCT02927327|10067394|FG001|STARTED|Overall Study||31
9004251|NCT02927327|10067393|FG000|COMPLETED|Overall Study||30
9004252|NCT02927327|10067394|FG001|COMPLETED|Overall Study||31
9004253|NCT02927327|10067393|FG000|NOT COMPLETED|Overall Study||0
9004254|NCT02927327|10067394|FG001|NOT COMPLETED|Overall Study||0
9004255|NCT02927366|10067402|FG000|STARTED|Overall Study||6
9004256|NCT02927366|10067403|FG001|STARTED|Overall Study||2
9004257|NCT02927366|10067402|FG000|Pharmacodynamic (PD) Analysis Set|Overall Study||6
9004258|NCT02927366|10067403|FG001|Pharmacodynamic (PD) Analysis Set|Overall Study||2
9004259|NCT02927366|10067402|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||4
9004260|NCT02927366|10067403|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||0
9004261|NCT02927366|10067402|FG000|COMPLETED|Overall Study||4
9004262|NCT02927366|10067403|FG001|COMPLETED|Overall Study||2
9004263|NCT02927366|10067402|FG000|NOT COMPLETED|Overall Study||2
9004264|NCT02927366|10067403|FG001|NOT COMPLETED|Overall Study||0
9004265|NCT02927431|10067412|FG000|STARTED|Overall Study||2
9004266|NCT02927431|10067413|FG001|STARTED|Overall Study||4
9004267|NCT02927431|10067414|FG002|STARTED|Overall Study||4
9004268|NCT02927431|10067412|FG000|COMPLETED|Overall Study||2
9004269|NCT02927431|10067413|FG001|COMPLETED|Overall Study||4
9004270|NCT02927431|10067414|FG002|COMPLETED|Overall Study||3
9004271|NCT02927431|10067412|FG000|NOT COMPLETED|Overall Study||0
9004272|NCT02927431|10067413|FG001|NOT COMPLETED|Overall Study||0
9004273|NCT02927431|10067414|FG002|NOT COMPLETED|Overall Study||1
9004274|NCT02927457|10067426|FG000|STARTED|Overall Study||0
9004275|NCT02927457|10067427|FG001|STARTED|Overall Study||11
9004276|NCT02927457|10067426|FG000|COMPLETED|Overall Study||0
9004277|NCT02927457|10067427|FG001|COMPLETED|Overall Study||11
9004278|NCT02927457|10067426|FG000|NOT COMPLETED|Overall Study||0
9004279|NCT02927457|10067427|FG001|NOT COMPLETED|Overall Study||0
9004280|NCT02927639|10067439|FG000|STARTED|Overall Study||83
9004281|NCT02927639|10067440|FG001|STARTED|Overall Study|1 subj was inadvertently enrolled in another interventional study just before enrolling so removed.|82
9004282|NCT02927639|10067439|FG000|COMPLETED|Overall Study||10
9004283|NCT02927639|10067440|FG001|COMPLETED|Overall Study||13
9004284|NCT02927639|10067439|FG000|NOT COMPLETED|Overall Study||73
9004285|NCT02927639|10067440|FG001|NOT COMPLETED|Overall Study||69
9004286|NCT02927795|10067446|FG000|STARTED|Overall Study||257
8634642|NCT00557830|9675002|FG001|COMPLETED|Screening Treatment Phase||0
8886677|NCT01979029|9944339|FG000|NOT COMPLETED|Overall Study||0
9004287|NCT02927795|10067446|FG000|Treated|Overall Study||253
9004288|NCT02927795|10067446|FG000|COMPLETED|Overall Study||234
9004289|NCT02927795|10067446|FG000|NOT COMPLETED|Overall Study||23
9004290|NCT02927834|10067453|FG000|STARTED|Overall Study||8
9004291|NCT02927834|10067454|FG001|STARTED|Overall Study||8
9004292|NCT02927834|10067455|FG002|STARTED|Overall Study||8
9004293|NCT02927834|10067453|FG000|COMPLETED|Overall Study||7
9004294|NCT02927834|10067454|FG001|COMPLETED|Overall Study||6
9004295|NCT02927834|10067455|FG002|COMPLETED|Overall Study||6
9004296|NCT02927834|10067453|FG000|NOT COMPLETED|Overall Study||1
9004297|NCT02927834|10067454|FG001|NOT COMPLETED|Overall Study||2
8886678|NCT01979029|9944340|FG001|NOT COMPLETED|Overall Study||0
8886679|NCT01979133|9944346|FG000|STARTED|Overall Study||10
8886680|NCT01979133|9944346|FG000|COMPLETED|Overall Study||7
8886681|NCT01979133|9944346|FG000|NOT COMPLETED|Overall Study||3
8886682|NCT01979159|9944363|FG000|STARTED|Overall Study||4
8886683|NCT01979159|9944363|FG000|COMPLETED|Overall Study||4
8886684|NCT01979159|9944363|FG000|NOT COMPLETED|Overall Study||0
8886685|NCT01979185|9944371|FG000|STARTED|Period 1||15
8886686|NCT01979185|9944372|FG001|STARTED|Period 1||15
8886687|NCT01979185|9944371|FG000|COMPLETED|Period 1||15
8886688|NCT01979185|9944372|FG001|COMPLETED|Period 1||15
8886689|NCT01979185|9944371|FG000|NOT COMPLETED|Period 1||0
8886690|NCT01979185|9944372|FG001|NOT COMPLETED|Period 1||0
8886691|NCT01979185|9944371|FG000|STARTED|Period 2||15
8886692|NCT01979185|9944372|FG001|STARTED|Period 2||15
8886693|NCT01979185|9944371|FG000|COMPLETED|Period 2||15
8886694|NCT01979185|9944372|FG001|COMPLETED|Period 2|1 subject discontinued due to a positive drug test prior to receiving Simvastatin alone in Period 2.|14
8886695|NCT01979185|9944371|FG000|NOT COMPLETED|Period 2||0
8886696|NCT01979185|9944372|FG001|NOT COMPLETED|Period 2||1
8886697|NCT01979276|9944378|FG000|STARTED|Overall Study||2
8886698|NCT01979276|9944378|FG000|COMPLETED|Overall Study||2
8886699|NCT01979276|9944378|FG000|NOT COMPLETED|Overall Study||0
8886700|NCT01979445|9944384|FG000|STARTED|Overall Study||3
8886701|NCT01979445|9944385|FG001|STARTED|Overall Study||3
8886702|NCT01979445|9944386|FG002|STARTED|Overall Study||6
8886703|NCT01979445|9944387|FG003|STARTED|Overall Study||3
8886704|NCT01979445|9944384|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
8886705|NCT01979445|9944385|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
8886706|NCT01979445|9944386|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
8886707|NCT01979445|9944387|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
8886708|NCT01979445|9944384|FG000|ITT Population|Overall Study||3
8886709|NCT01979445|9944385|FG001|ITT Population|Overall Study||3
8886710|NCT01979445|9944386|FG002|ITT Population|Overall Study||6
8886711|NCT01979445|9944387|FG003|ITT Population|Overall Study||3
8886712|NCT01979445|9944384|FG000|COMPLETED|Overall Study||3
8886713|NCT01979445|9944385|FG001|COMPLETED|Overall Study||3
8886714|NCT01979445|9944386|FG002|COMPLETED|Overall Study||6
8886715|NCT01979445|9944387|FG003|COMPLETED|Overall Study||3
8886716|NCT01979445|9944384|FG000|NOT COMPLETED|Overall Study||0
8886717|NCT01979445|9944385|FG001|NOT COMPLETED|Overall Study||0
8886718|NCT01979445|9944386|FG002|NOT COMPLETED|Overall Study||0
8886719|NCT01979445|9944387|FG003|NOT COMPLETED|Overall Study||0
8886720|NCT01979523|9944407|FG000|STARTED|Overall Study||21
8886721|NCT01979523|9944408|FG001|STARTED|Overall Study||21
8886722|NCT01979523|9944407|FG000|COMPLETED|Overall Study||20
8886723|NCT01979523|9944408|FG001|COMPLETED|Overall Study||21
8634643|NCT00557830|9675003|FG002|COMPLETED|Screening Treatment Phase||0
8634644|NCT00557830|9675001|FG000|NOT COMPLETED|Screening Treatment Phase||6
8886724|NCT01979523|9944407|FG000|NOT COMPLETED|Overall Study||1
8886725|NCT01979523|9944408|FG001|NOT COMPLETED|Overall Study||0
8886726|NCT01979614|9944417|FG000|STARTED|Overall Study||30
8886727|NCT01979614|9944418|FG001|STARTED|Overall Study||28
8886728|NCT01979614|9944417|FG000|Safety Analysis Set|Overall Study||30
8886729|NCT01979614|9944418|FG001|Safety Analysis Set|Overall Study||28
8886730|NCT01979614|9944417|FG000|PK Analysis Set|Overall Study||30
8886731|NCT01979614|9944418|FG001|PK Analysis Set|Overall Study||0
9004298|NCT02927834|10067455|FG002|NOT COMPLETED|Overall Study||2
9004299|NCT02927873|10067469|FG000|STARTED|Overall Study||11
9004300|NCT02927873|10067470|FG001|STARTED|Overall Study||14
9004301|NCT02927873|10067471|FG002|STARTED|Overall Study||18
9004302|NCT02927873|10067472|FG003|STARTED|Overall Study||11
9004303|NCT02927873|10067473|FG004|STARTED|Overall Study||11
9004304|NCT02927873|10067474|FG005|STARTED|Overall Study||17
9004305|NCT02927873|10067469|FG000|COMPLETED|Overall Study||9
9004306|NCT02927873|10067470|FG001|COMPLETED|Overall Study||11
9004307|NCT02927873|10067471|FG002|COMPLETED|Overall Study||18
9004308|NCT02927873|10067472|FG003|COMPLETED|Overall Study||11
9004309|NCT02927873|10067473|FG004|COMPLETED|Overall Study||11
9004310|NCT02927873|10067474|FG005|COMPLETED|Overall Study||16
9004311|NCT02927873|10067469|FG000|NOT COMPLETED|Overall Study||2
9004312|NCT02927873|10067470|FG001|NOT COMPLETED|Overall Study||3
9004313|NCT02927873|10067471|FG002|NOT COMPLETED|Overall Study||0
9004314|NCT02927873|10067472|FG003|NOT COMPLETED|Overall Study||0
9004315|NCT02927873|10067473|FG004|NOT COMPLETED|Overall Study||0
8886732|NCT01979614|9944417|FG000|PD Analysis Set|Overall Study||25
8886733|NCT01979614|9944418|FG001|PD Analysis Set|Overall Study||26
8886734|NCT01979614|9944417|FG000|COMPLETED|Overall Study||29
8886735|NCT01979614|9944418|FG001|COMPLETED|Overall Study||27
8886736|NCT01979614|9944417|FG000|NOT COMPLETED|Overall Study||1
8886737|NCT01979614|9944418|FG001|NOT COMPLETED|Overall Study||1
8886738|NCT01979835|9944424|FG000|STARTED|Primary Outcome SA Measurment||1030
8886739|NCT01979835|9944424|FG000|COMPLETED|Primary Outcome SA Measurment||1012
8886740|NCT01979835|9944424|FG000|NOT COMPLETED|Primary Outcome SA Measurment||18
9004316|NCT02927873|10067474|FG005|NOT COMPLETED|Overall Study||1
9004317|NCT02927925|10067488|FG000|STARTED|Overall Study||32
9004318|NCT02927925|10067488|FG000|COMPLETED|Overall Study||0
9004319|NCT02927925|10067488|FG000|NOT COMPLETED|Overall Study||32
9004320|NCT02928029|10067494|FG000|STARTED|Overall Study||3
9004321|NCT02928029|10067495|FG001|STARTED|Overall Study||4
9004322|NCT02928029|10067494|FG000|COMPLETED|Overall Study||0
8886741|NCT01979835|9944424|FG000|STARTED|Follow-up||1012
8886742|NCT01979835|9944424|FG000|COMPLETED|Follow-up||980
8886743|NCT01979835|9944424|FG000|NOT COMPLETED|Follow-up||32
8886744|NCT01979952|9944430|FG000|STARTED|Overall Study||56
8886745|NCT01979952|9944431|FG001|STARTED|Overall Study||57
8886746|NCT01979952|9944430|FG000|COMPLETED|Overall Study||48
8886747|NCT01979952|9944431|FG001|COMPLETED|Overall Study||51
8886748|NCT01979952|9944430|FG000|NOT COMPLETED|Overall Study||8
8886749|NCT01979952|9944431|FG001|NOT COMPLETED|Overall Study||6
8886750|NCT01980056|9944440|FG000|STARTED|Overall Study||4
8886751|NCT01980056|9944441|FG001|STARTED|Overall Study||4
8886752|NCT01980056|9944442|FG002|STARTED|Overall Study||2
8886753|NCT01980056|9944440|FG000|COMPLETED|Overall Study||3
8886754|NCT01980056|9944441|FG001|COMPLETED|Overall Study||3
8886755|NCT01980056|9944442|FG002|COMPLETED|Overall Study||2
8886756|NCT01980056|9944440|FG000|NOT COMPLETED|Overall Study||1
8886757|NCT01980056|9944441|FG001|NOT COMPLETED|Overall Study||1
8886758|NCT01980056|9944442|FG002|NOT COMPLETED|Overall Study||0
8886759|NCT01980095|9944456|FG000|STARTED|Overall Study|Protocol planned for 90 patients, protocol amendment increase up to 120 patients.|78
8886760|NCT01980095|9944457|FG001|STARTED|Overall Study|Protocol planned for 90 patients, protocol amendment increase up to 120 patients.|41
8886761|NCT01980095|9944456|FG000|Treated|Overall Study|Of 78 patients randomized, 1 patient erroneously randomized and not treated|77
8886762|NCT01980095|9944457|FG001|Treated|Overall Study||41
8886763|NCT01980095|9944456|FG000|COMPLETED|Overall Study||63
8886764|NCT01980095|9944457|FG001|COMPLETED|Overall Study||30
8634645|NCT00557830|9675002|FG001|NOT COMPLETED|Screening Treatment Phase||0
8634646|NCT00557830|9675003|FG002|NOT COMPLETED|Screening Treatment Phase||0
8634647|NCT00557830|9675001|FG000|STARTED|Treatment Phase||0
8634648|NCT00557830|9675002|FG001|STARTED|Treatment Phase||4
8634649|NCT00557830|9675003|FG002|STARTED|Treatment Phase||2
8634650|NCT00557830|9675001|FG000|COMPLETED|Treatment Phase||0
8886765|NCT01980095|9944456|FG000|NOT COMPLETED|Overall Study||15
8886766|NCT01980095|9944457|FG001|NOT COMPLETED|Overall Study||11
8886767|NCT01980485|9944467|FG000|STARTED|Overall Study||120
8886768|NCT01980485|9944468|FG001|STARTED|Overall Study||105
8886769|NCT01980485|9944467|FG000|COMPLETED|Overall Study||84
8886770|NCT01980485|9944468|FG001|COMPLETED|Overall Study||80
8886771|NCT01980485|9944467|FG000|NOT COMPLETED|Overall Study||36
8886772|NCT01980485|9944468|FG001|NOT COMPLETED|Overall Study||25
8886773|NCT01980524|9944476|FG000|STARTED|Study Day 1||4
8886774|NCT01980524|9944477|FG001|STARTED|Study Day 1||4
8886775|NCT01980524|9944476|FG000|COMPLETED|Study Day 1||4
8886776|NCT01980524|9944477|FG001|COMPLETED|Study Day 1||4
8886777|NCT01980524|9944476|FG000|NOT COMPLETED|Study Day 1||0
8886778|NCT01980524|9944477|FG001|NOT COMPLETED|Study Day 1||0
8886779|NCT01980524|9944476|FG000|STARTED|Washout (at Least 2 Weeks)||4
8886780|NCT01980524|9944477|FG001|STARTED|Washout (at Least 2 Weeks)||4
8886781|NCT01980524|9944476|FG000|COMPLETED|Washout (at Least 2 Weeks)||4
8886782|NCT01980524|9944477|FG001|COMPLETED|Washout (at Least 2 Weeks)||4
8886783|NCT01980524|9944476|FG000|NOT COMPLETED|Washout (at Least 2 Weeks)||0
8886784|NCT01980524|9944477|FG001|NOT COMPLETED|Washout (at Least 2 Weeks)||0
8886785|NCT01980524|9944476|FG000|STARTED|Study Day 2||4
8886786|NCT01980524|9944477|FG001|STARTED|Study Day 2||4
8886787|NCT01980524|9944476|FG000|COMPLETED|Study Day 2||4
8886788|NCT01980524|9944477|FG001|COMPLETED|Study Day 2||4
8886789|NCT01980524|9944476|FG000|NOT COMPLETED|Study Day 2||0
8886790|NCT01980524|9944477|FG001|NOT COMPLETED|Study Day 2||0
8886791|NCT01980589|9944486|FG000|STARTED|Overall Study||3
8886792|NCT01980589|9944487|FG001|STARTED|Overall Study||3
8886793|NCT01980589|9944488|FG002|STARTED|Overall Study||16
8886794|NCT01980589|9944486|FG000|COMPLETED|Overall Study||3
8886795|NCT01980589|9944487|FG001|COMPLETED|Overall Study||3
8886796|NCT01980589|9944488|FG002|COMPLETED|Overall Study||16
8886797|NCT01980589|9944486|FG000|NOT COMPLETED|Overall Study||0
8886798|NCT01980589|9944487|FG001|NOT COMPLETED|Overall Study||0
8886799|NCT01980589|9944488|FG002|NOT COMPLETED|Overall Study||0
8886800|NCT01980628|9944496|FG000|STARTED|Overall Study|Total number of patients enrolled to the study and received study treatment|63
8886801|NCT01980628|9944496|FG000|COMPLETED|Overall Study|Participants who remain on treatment at Final Analysis.|0
8886802|NCT01980628|9944496|FG000|NOT COMPLETED|Overall Study||63
8886803|NCT01980654|9944503|FG000|STARTED|Overall Study||60
8886804|NCT01980654|9944504|FG001|STARTED|Overall Study||20
8886805|NCT01980654|9944503|FG000|COMPLETED|Overall Study||60
8886806|NCT01980654|9944504|FG001|COMPLETED|Overall Study||20
8886807|NCT01980654|9944503|FG000|NOT COMPLETED|Overall Study||0
8886808|NCT01980654|9944504|FG001|NOT COMPLETED|Overall Study||0
8886809|NCT01980706|9944513|FG000|STARTED|Overall Study||40
8886810|NCT01980706|9944514|FG001|STARTED|Overall Study||43
9004323|NCT02928029|10067495|FG001|COMPLETED|Overall Study||0
8886811|NCT01980706|9944515|FG002|STARTED|Overall Study||37
8886812|NCT01980706|9944513|FG000|COMPLETED|Overall Study||23
8886813|NCT01980706|9944514|FG001|COMPLETED|Overall Study||26
8886814|NCT01980706|9944515|FG002|COMPLETED|Overall Study||24
8886815|NCT01980706|9944513|FG000|NOT COMPLETED|Overall Study||17
8886816|NCT01980706|9944514|FG001|NOT COMPLETED|Overall Study||17
8886817|NCT01980706|9944515|FG002|NOT COMPLETED|Overall Study||13
8886818|NCT01980771|9944525|FG000|STARTED|Overall Study||436
8886819|NCT01980771|9944526|FG001|STARTED|Overall Study||424
8886820|NCT01980771|9944525|FG000|COMPLETED|Overall Study||352
8634651|NCT00557830|9675002|FG001|COMPLETED|Treatment Phase||4
8634652|NCT00557830|9675003|FG002|COMPLETED|Treatment Phase||2
8886821|NCT01980771|9944526|FG001|COMPLETED|Overall Study||305
8886822|NCT01980771|9944525|FG000|NOT COMPLETED|Overall Study||84
8886823|NCT01980771|9944526|FG001|NOT COMPLETED|Overall Study||119
8886824|NCT01980888|9944534|FG000|STARTED|Overall Study||157
8886825|NCT01980888|9944535|FG001|STARTED|Overall Study||154
8886826|NCT01980888|9944534|FG000|COMPLETED|Overall Study|Completed = reached primary efficacy endpoint of progressive disease or death.|13
8886827|NCT01980888|9944535|FG001|COMPLETED|Overall Study|Completed = reached primary efficacy endpoint of progressive disease or death.|21
8886828|NCT01980888|9944534|FG000|NOT COMPLETED|Overall Study||144
8886829|NCT01980888|9944535|FG001|NOT COMPLETED|Overall Study||133
8886830|NCT01980914|9944541|FG000|STARTED|Overall Study||11
8886831|NCT01980914|9944541|FG000|COMPLETED|Overall Study||11
8886832|NCT01980914|9944541|FG000|NOT COMPLETED|Overall Study||0
8886833|NCT01980992|9944548|FG000|STARTED|52 Weeks Blinded Study Treatment||23
8886834|NCT01980992|9944549|FG001|STARTED|52 Weeks Blinded Study Treatment||23
8886835|NCT01980992|9944548|FG000|COMPLETED|52 Weeks Blinded Study Treatment||21
8886836|NCT01980992|9944549|FG001|COMPLETED|52 Weeks Blinded Study Treatment||19
8886837|NCT01980992|9944548|FG000|NOT COMPLETED|52 Weeks Blinded Study Treatment||2
8886838|NCT01980992|9944549|FG001|NOT COMPLETED|52 Weeks Blinded Study Treatment||4
8886839|NCT01980992|9944548|FG000|STARTED|52 Weeks Open Label Active Wheat OIT||21
8886840|NCT01980992|9944549|FG001|STARTED|52 Weeks Open Label Active Wheat OIT||19
8886841|NCT01980992|9944548|FG000|COMPLETED|52 Weeks Open Label Active Wheat OIT||18
8886842|NCT01980992|9944549|FG001|COMPLETED|52 Weeks Open Label Active Wheat OIT||18
8886843|NCT01980992|9944548|FG000|NOT COMPLETED|52 Weeks Open Label Active Wheat OIT||3
8886844|NCT01980992|9944549|FG001|NOT COMPLETED|52 Weeks Open Label Active Wheat OIT||1
8886845|NCT01981057|9944564|FG000|STARTED|Overall Study||50
8886846|NCT01981057|9944565|FG001|STARTED|Overall Study||50
8886847|NCT01981057|9944564|FG000|COMPLETED|Overall Study||50
8886848|NCT01981057|9944565|FG001|COMPLETED|Overall Study||50
8886849|NCT01981057|9944564|FG000|NOT COMPLETED|Overall Study||0
8886850|NCT01981057|9944565|FG001|NOT COMPLETED|Overall Study||0
8886851|NCT01981109|9944571|FG000|STARTED|Overall Study||225
8886852|NCT01981109|9944571|FG000|COMPLETED|Overall Study||1
8886853|NCT01981109|9944571|FG000|NOT COMPLETED|Overall Study||224
8886854|NCT01981122|9944578|FG000|STARTED|Overall Study||25
8886855|NCT01981122|9944579|FG001|STARTED|Overall Study||27
8886856|NCT01981122|9944578|FG000|COMPLETED|Overall Study||11
8886857|NCT01981122|9944579|FG001|COMPLETED|Overall Study||7
8886858|NCT01981122|9944578|FG000|NOT COMPLETED|Overall Study||14
8886859|NCT01981122|9944579|FG001|NOT COMPLETED|Overall Study||20
8886860|NCT01981187|9944585|FG000|STARTED|Overall Study||12
8886861|NCT01981187|9944585|FG000|COMPLETED|Overall Study||0
8886862|NCT01981187|9944585|FG000|NOT COMPLETED|Overall Study||12
8886863|NCT01981356|9944591|FG000|STARTED|Overall Study||12
8886864|NCT01981356|9944592|FG001|STARTED|Overall Study||6
8886865|NCT01981356|9944591|FG000|COMPLETED|Overall Study||5
8886866|NCT01981356|9944592|FG001|COMPLETED|Overall Study||4
8886867|NCT01981356|9944591|FG000|NOT COMPLETED|Overall Study||7
8886868|NCT01981356|9944592|FG001|NOT COMPLETED|Overall Study||2
8886869|NCT01981473|9944602|FG000|STARTED|Overall Study||202
8886870|NCT01981473|9944603|FG001|STARTED|Overall Study||199
8886871|NCT01981473|9944604|FG002|STARTED|Overall Study||204
8886872|NCT01981473|9944602|FG000|COMPLETED|Overall Study||200
8886873|NCT01981473|9944603|FG001|COMPLETED|Overall Study||199
8886874|NCT01981473|9944604|FG002|COMPLETED|Overall Study||196
8886875|NCT01981473|9944602|FG000|NOT COMPLETED|Overall Study||2
8886876|NCT01981473|9944603|FG001|NOT COMPLETED|Overall Study||0
8886877|NCT01981473|9944604|FG002|NOT COMPLETED|Overall Study||8
8886878|NCT01981564|9944617|FG000|STARTED|Overall Study||107
8886879|NCT01981564|9944618|FG001|STARTED|Overall Study||115
8886880|NCT01981564|9944617|FG000|COMPLETED|Overall Study||98
8886881|NCT01981564|9944618|FG001|COMPLETED|Overall Study||106
8886882|NCT01981564|9944617|FG000|NOT COMPLETED|Overall Study||9
8886883|NCT01981564|9944618|FG001|NOT COMPLETED|Overall Study||9
8886884|NCT01981590|9944625|FG000|STARTED|Overall Study||15
8886885|NCT01981590|9944625|FG000|COMPLETED|Overall Study||15
8886886|NCT01981590|9944625|FG000|NOT COMPLETED|Overall Study||0
8886887|NCT01981616|9944632|FG000|STARTED|Overall Study||64
8886888|NCT01981616|9944633|FG001|STARTED|Overall Study||63
8886889|NCT01981616|9944632|FG000|COMPLETED|Overall Study||63
8886890|NCT01981616|9944633|FG001|COMPLETED|Overall Study||62
8886891|NCT01981616|9944632|FG000|NOT COMPLETED|Overall Study||1
8886892|NCT01981616|9944633|FG001|NOT COMPLETED|Overall Study||1
8886893|NCT01981759|9944641|FG000|STARTED|Overall Study||28
8886894|NCT01981759|9944642|FG001|STARTED|Overall Study||30
8886895|NCT01981759|9944641|FG000|Baseline (Week 1)|Overall Study||28
8886896|NCT01981759|9944642|FG001|Baseline (Week 1)|Overall Study||30
8886897|NCT01981759|9944641|FG000|Randomization (Week 3)|Overall Study||28
8886898|NCT01981759|9944642|FG001|Randomization (Week 3)|Overall Study||30
8886899|NCT01981759|9944641|FG000|Completed Week 12|Overall Study||22
8886900|NCT01981759|9944642|FG001|Completed Week 12|Overall Study||22
8886901|NCT01981759|9944641|FG000|COMPLETED|Overall Study||21
8886902|NCT01981759|9944642|FG001|COMPLETED|Overall Study||19
8886903|NCT01981759|9944641|FG000|NOT COMPLETED|Overall Study||7
8886904|NCT01981759|9944642|FG001|NOT COMPLETED|Overall Study||11
8886905|NCT01981772|9944650|FG000|STARTED|Overall Study||45
8886906|NCT01981772|9944651|FG001|STARTED|Overall Study||43
8886907|NCT01981772|9944650|FG000|COMPLETED|Overall Study||45
8886908|NCT01981772|9944651|FG001|COMPLETED|Overall Study||43
8886909|NCT01981772|9944650|FG000|NOT COMPLETED|Overall Study||0
8886910|NCT01981772|9944651|FG001|NOT COMPLETED|Overall Study||0
8886911|NCT01981863|9944659|FG000|STARTED|Overall Study||20
8886912|NCT01981863|9944660|FG001|STARTED|Overall Study||20
8886913|NCT01981863|9944659|FG000|COMPLETED|Overall Study||20
8886914|NCT01981863|9944660|FG001|COMPLETED|Overall Study||20
8886915|NCT01981863|9944659|FG000|NOT COMPLETED|Overall Study||0
8886916|NCT01981863|9944660|FG001|NOT COMPLETED|Overall Study||0
8886917|NCT01981954|9944666|FG000|STARTED|Titration Period||23
8886918|NCT01981954|9944666|FG000|Treated|Titration Period||23
8886919|NCT01981954|9944666|FG000|COMPLETED|Titration Period||22
8886920|NCT01981954|9944666|FG000|NOT COMPLETED|Titration Period||1
8886921|NCT01981954|9944666|FG000|STARTED|Fixed-Dose Assessment Period||22
8886922|NCT01981954|9944666|FG000|Treated|Fixed-Dose Assessment Period||22
8886923|NCT01981954|9944666|FG000|COMPLETED|Fixed-Dose Assessment Period||21
8886924|NCT01981954|9944666|FG000|NOT COMPLETED|Fixed-Dose Assessment Period||1
8886925|NCT01981967|9944672|FG000|STARTED|Overall Study||6851
8886926|NCT01981967|9944673|FG001|STARTED|Overall Study||3149
8886927|NCT01981967|9944672|FG000|COMPLETED|Overall Study||6851
8886928|NCT01981967|9944673|FG001|COMPLETED|Overall Study||3149
8886929|NCT01981967|9944672|FG000|NOT COMPLETED|Overall Study||0
8886930|NCT01981967|9944673|FG001|NOT COMPLETED|Overall Study||0
8886931|NCT01982123|9944679|FG000|STARTED|Overall Study||12
8886932|NCT01982123|9944679|FG000|COMPLETED|Overall Study||12
8886933|NCT01982123|9944679|FG000|NOT COMPLETED|Overall Study||0
8886934|NCT01982240|9944686|FG000|STARTED|Overall Study||452
8886935|NCT01982240|9944687|FG001|STARTED|Overall Study||453
8886936|NCT01982240|9944688|FG002|STARTED|Overall Study||441
8886937|NCT01982240|9944686|FG000|COMPLETED|Overall Study||385
8886938|NCT01982240|9944687|FG001|COMPLETED|Overall Study||384
8886939|NCT01982240|9944688|FG002|COMPLETED|Overall Study||371
8886940|NCT01982240|9944686|FG000|NOT COMPLETED|Overall Study||67
8886941|NCT01982240|9944687|FG001|NOT COMPLETED|Overall Study||69
8886942|NCT01982240|9944688|FG002|NOT COMPLETED|Overall Study||70
8886943|NCT01982292|9944702|FG000|STARTED|Overall Study|"Started indicates Randomized set"|215
8886944|NCT01982292|9944703|FG001|STARTED|Overall Study||108
8886945|NCT01982292|9944702|FG000|Full Analaysis Set (FAS)|Overall Study|FAS excludes mis-randomized patients|213
8886946|NCT01982292|9944703|FG001|Full Analaysis Set (FAS)|Overall Study||108
8886947|NCT01982292|9944702|FG000|Safety Set|Overall Study||212
8886948|NCT01982292|9944703|FG001|Safety Set|Overall Study||108
8886949|NCT01982292|9944702|FG000|COMPLETED|Overall Study||203
8886950|NCT01982292|9944703|FG001|COMPLETED|Overall Study||107
8886951|NCT01982292|9944702|FG000|NOT COMPLETED|Overall Study||12
8886952|NCT01982292|9944703|FG001|NOT COMPLETED|Overall Study||1
8886953|NCT01982331|9944711|FG000|STARTED|Received Vaccination 1||28
8886954|NCT01982331|9944712|FG001|STARTED|Received Vaccination 1||10
8886955|NCT01982331|9944711|FG000|COMPLETED|Received Vaccination 1||28
8886956|NCT01982331|9944712|FG001|COMPLETED|Received Vaccination 1||10
8886957|NCT01982331|9944711|FG000|NOT COMPLETED|Received Vaccination 1||0
8886958|NCT01982331|9944712|FG001|NOT COMPLETED|Received Vaccination 1||0
8886959|NCT01982331|9944711|FG000|STARTED|Received Vaccination 2||28
8886960|NCT01982331|9944712|FG001|STARTED|Received Vaccination 2||10
8886961|NCT01982331|9944711|FG000|COMPLETED|Received Vaccination 2||27
8886962|NCT01982331|9944712|FG001|COMPLETED|Received Vaccination 2||7
8886963|NCT01982331|9944711|FG000|NOT COMPLETED|Received Vaccination 2||1
8886964|NCT01982331|9944712|FG001|NOT COMPLETED|Received Vaccination 2||3
8886965|NCT01982331|9944711|FG000|STARTED|Completed Study (Day 112)||27
8886966|NCT01982331|9944712|FG001|STARTED|Completed Study (Day 112)||7
8886967|NCT01982331|9944711|FG000|COMPLETED|Completed Study (Day 112)||25
8886968|NCT01982331|9944712|FG001|COMPLETED|Completed Study (Day 112)||7
8886969|NCT01982331|9944711|FG000|NOT COMPLETED|Completed Study (Day 112)||2
8886970|NCT01982331|9944712|FG001|NOT COMPLETED|Completed Study (Day 112)||0
8886971|NCT01982435|9944720|FG000|STARTED|Overall Study||15
8886972|NCT01982435|9944721|FG001|STARTED|Overall Study||12
8886973|NCT01982435|9944720|FG000|COMPLETED|Overall Study||14
8886974|NCT01982435|9944721|FG001|COMPLETED|Overall Study||12
8886975|NCT01982435|9944720|FG000|NOT COMPLETED|Overall Study||1
8886976|NCT01982435|9944721|FG001|NOT COMPLETED|Overall Study||0
8886977|NCT01982539|9944727|FG000|STARTED|Overall Study||25
8886978|NCT01982539|9944727|FG000|COMPLETED|Overall Study||25
8886979|NCT01982539|9944727|FG000|NOT COMPLETED|Overall Study||0
8886980|NCT01982643|9944731|FG000|STARTED|Overall Study||49
8634653|NCT00557830|9675001|FG000|NOT COMPLETED|Treatment Phase||0
8634654|NCT00557830|9675002|FG001|NOT COMPLETED|Treatment Phase||0
8634655|NCT00557830|9675003|FG002|NOT COMPLETED|Treatment Phase||0
8886981|NCT01982643|9944731|FG000|COMPLETED|Overall Study||37
8886982|NCT01982643|9944731|FG000|NOT COMPLETED|Overall Study||12
8886983|NCT01982682|9944735|FG000|STARTED|Overall Study||41
8886984|NCT01982682|9944735|FG000|COMPLETED|Overall Study||40
8886985|NCT01982682|9944735|FG000|NOT COMPLETED|Overall Study||1
8886986|NCT01982695|9944742|FG000|STARTED|Overall Study||12
8886987|NCT01982695|9944743|FG001|STARTED|Overall Study||11
8886988|NCT01982695|9944742|FG000|COMPLETED|Overall Study||12
8886989|NCT01982695|9944743|FG001|COMPLETED|Overall Study||10
8886990|NCT01982695|9944742|FG000|NOT COMPLETED|Overall Study||0
8886991|NCT01982695|9944743|FG001|NOT COMPLETED|Overall Study||1
8886992|NCT01982773|9944751|FG000|STARTED|Overall Study||58
8886993|NCT01982773|9944752|FG001|STARTED|Overall Study||60
8886994|NCT01982773|9944751|FG000|COMPLETED|Overall Study||50
8886995|NCT01982773|9944752|FG001|COMPLETED|Overall Study||56
8886996|NCT01982773|9944751|FG000|NOT COMPLETED|Overall Study||8
8886997|NCT01982773|9944752|FG001|NOT COMPLETED|Overall Study||4
8886998|NCT01982786|9944760|FG000|STARTED|Overall Study||29
8886999|NCT01982786|9944761|FG001|STARTED|Overall Study||28
8887000|NCT01982786|9944760|FG000|COMPLETED|Overall Study||29
8887001|NCT01982786|9944761|FG001|COMPLETED|Overall Study||28
8887002|NCT01982786|9944760|FG000|NOT COMPLETED|Overall Study||0
8887003|NCT01982786|9944761|FG001|NOT COMPLETED|Overall Study||0
8887004|NCT01982812|9944769|FG000|STARTED|Overall Study||23
8887005|NCT01982812|9944770|FG001|STARTED|Overall Study||21
8887006|NCT01982812|9944769|FG000|COMPLETED|Overall Study||22
8887007|NCT01982812|9944770|FG001|COMPLETED|Overall Study||11
8887008|NCT01982812|9944769|FG000|NOT COMPLETED|Overall Study||1
8887009|NCT01982812|9944770|FG001|NOT COMPLETED|Overall Study||10
8887010|NCT01982942|9944778|FG000|STARTED|Overall Study||129
8887011|NCT01982942|9944779|FG001|STARTED|Overall Study||126
8887012|NCT01982942|9944778|FG000|COMPLETED|Overall Study||108
8887013|NCT01982942|9944779|FG001|COMPLETED|Overall Study||112
8887014|NCT01982942|9944778|FG000|NOT COMPLETED|Overall Study||21
8887015|NCT01982942|9944779|FG001|NOT COMPLETED|Overall Study||14
8887016|NCT01982955|9944790|FG000|STARTED|Overall Study||6
8887017|NCT01982955|9944791|FG001|STARTED|Overall Study||12
8887018|NCT01982955|9944792|FG002|STARTED|Overall Study||31
8887019|NCT01982955|9944793|FG003|STARTED|Overall Study||24
8887020|NCT01982955|9944794|FG004|STARTED|Overall Study||15
8887021|NCT01982955|9944790|FG000|Treated|Overall Study||6
8887022|NCT01982955|9944791|FG001|Treated|Overall Study||12
8887023|NCT01982955|9944792|FG002|Treated|Overall Study||31
8887024|NCT01982955|9944793|FG003|Treated|Overall Study||23
8887025|NCT01982955|9944794|FG004|Treated|Overall Study||15
8887026|NCT01982955|9944790|FG000|COMPLETED|Overall Study||6
8887027|NCT01982955|9944791|FG001|COMPLETED|Overall Study||12
8887028|NCT01982955|9944792|FG002|COMPLETED|Overall Study||27
8887029|NCT01982955|9944793|FG003|COMPLETED|Overall Study||23
8887030|NCT01982955|9944794|FG004|COMPLETED|Overall Study||15
8887031|NCT01982955|9944790|FG000|NOT COMPLETED|Overall Study||0
8887032|NCT01982955|9944791|FG001|NOT COMPLETED|Overall Study||0
8887033|NCT01982955|9944792|FG002|NOT COMPLETED|Overall Study||4
8887034|NCT01982955|9944793|FG003|NOT COMPLETED|Overall Study||1
8887035|NCT01982955|9944794|FG004|NOT COMPLETED|Overall Study||0
8887036|NCT01982968|9944809|FG000|STARTED|Overall Study||29
8887037|NCT01982968|9944810|FG001|STARTED|Overall Study||29
8887038|NCT01982968|9944809|FG000|COMPLETED|Overall Study||21
8887039|NCT01982968|9944810|FG001|COMPLETED|Overall Study||27
8887040|NCT01982968|9944809|FG000|NOT COMPLETED|Overall Study||8
8887041|NCT01982968|9944810|FG001|NOT COMPLETED|Overall Study||2
9004324|NCT02928029|10067494|FG000|NOT COMPLETED|Overall Study||3
9004325|NCT02928029|10067495|FG001|NOT COMPLETED|Overall Study||4
9004326|NCT02928055|10067504|FG000|STARTED|Overall Study||8
9004327|NCT02928055|10067505|FG001|STARTED|Overall Study||8
9004328|NCT02928055|10067506|FG002|STARTED|Overall Study||7
9004329|NCT02928055|10067504|FG000|End of Treatment|Overall Study||8
9004330|NCT02928055|10067505|FG001|End of Treatment|Overall Study||8
8634656|NCT00557856|9675011|FG000|STARTED|Part 1: Dose Escalation Phase||7
8634657|NCT00557856|9675012|FG001|STARTED|Part 1: Dose Escalation Phase||5
8634658|NCT00557856|9675013|FG002|STARTED|Part 1: Dose Escalation Phase||6
8634659|NCT00557856|9675014|FG003|STARTED|Part 1: Dose Escalation Phase||3
8634660|NCT00557856|9675015|FG004|STARTED|Part 1: Dose Escalation Phase||4
8634661|NCT00557856|9675016|FG005|STARTED|Part 1: Dose Escalation Phase||8
8634662|NCT00557856|9675017|FG006|STARTED|Part 1: Dose Escalation Phase||7
8634663|NCT00557856|9675018|FG007|STARTED|Part 1: Dose Escalation Phase||6
8634664|NCT00557856|9675019|FG008|STARTED|Part 1: Dose Escalation Phase||0
8726050|NCT01033487|9773157|FG000|COMPLETED|Fifth Intervention Period||2
8726051|NCT01033487|9773158|FG001|COMPLETED|Fifth Intervention Period||3
8726052|NCT01033487|9773159|FG002|COMPLETED|Fifth Intervention Period||2
8726053|NCT01033487|9773160|FG003|COMPLETED|Fifth Intervention Period||2
8726054|NCT01033487|9773161|FG004|COMPLETED|Fifth Intervention Period||2
8726055|NCT01033487|9773162|FG005|COMPLETED|Fifth Intervention Period||2
8726056|NCT01033487|9773163|FG006|COMPLETED|Fifth Intervention Period||2
8726057|NCT01033487|9773164|FG007|COMPLETED|Fifth Intervention Period||3
8726058|NCT01033487|9773165|FG008|COMPLETED|Fifth Intervention Period||1
9004331|NCT02928055|10067506|FG002|End of Treatment|Overall Study||6
9004332|NCT02928055|10067504|FG000|1 Month Follow up|Overall Study||7
9004333|NCT02928055|10067505|FG001|1 Month Follow up|Overall Study||7
9004334|NCT02928055|10067506|FG002|1 Month Follow up|Overall Study||6
9004335|NCT02928055|10067504|FG000|2 Month Follow up|Overall Study||6
9004336|NCT02928055|10067505|FG001|2 Month Follow up|Overall Study||7
9004337|NCT02928055|10067506|FG002|2 Month Follow up|Overall Study||5
9004338|NCT02928055|10067504|FG000|3 Month Follow up|Overall Study||5
9004339|NCT02928055|10067505|FG001|3 Month Follow up|Overall Study||6
9004340|NCT02928055|10067506|FG002|3 Month Follow up|Overall Study||5
9004341|NCT02928055|10067504|FG000|COMPLETED|Overall Study||5
9004342|NCT02928055|10067505|FG001|COMPLETED|Overall Study||6
9004343|NCT02928055|10067506|FG002|COMPLETED|Overall Study||5
9004344|NCT02928055|10067504|FG000|NOT COMPLETED|Overall Study||3
9004345|NCT02928055|10067505|FG001|NOT COMPLETED|Overall Study||2
9004346|NCT02928055|10067506|FG002|NOT COMPLETED|Overall Study||2
9004347|NCT02928380|10067514|FG000|STARTED|Period 1||13
9004348|NCT02928380|10067515|FG001|STARTED|Period 1||14
9004349|NCT02928380|10067516|FG002|STARTED|Period 1||14
8887042|NCT01983020|9944820|FG000|STARTED|Overall Study||12
8887043|NCT01983020|9944821|FG001|STARTED|Overall Study||11
8887044|NCT01983020|9944822|FG002|STARTED|Overall Study||12
8887045|NCT01983020|9944823|FG003|STARTED|Overall Study||11
8887046|NCT01983020|9944820|FG000|COMPLETED|Overall Study||12
8887047|NCT01983020|9944821|FG001|COMPLETED|Overall Study||11
8887048|NCT01983020|9944822|FG002|COMPLETED|Overall Study||12
8887049|NCT01983020|9944823|FG003|COMPLETED|Overall Study||11
8887050|NCT01983020|9944820|FG000|NOT COMPLETED|Overall Study||0
8887051|NCT01983020|9944821|FG001|NOT COMPLETED|Overall Study||0
8887052|NCT01983020|9944822|FG002|NOT COMPLETED|Overall Study||0
8887053|NCT01983020|9944823|FG003|NOT COMPLETED|Overall Study||0
8887054|NCT01983111|9944835|FG000|STARTED|Overall Study||70
8887055|NCT01983111|9944836|FG001|STARTED|Overall Study||66
8887056|NCT01983111|9944835|FG000|COMPLETED|Overall Study||58
8887057|NCT01983111|9944836|FG001|COMPLETED|Overall Study||59
8887058|NCT01983111|9944835|FG000|NOT COMPLETED|Overall Study||12
8887059|NCT01983111|9944836|FG001|NOT COMPLETED|Overall Study||7
8887060|NCT01983228|9944844|FG000|STARTED|Overall Study||249
8887061|NCT01983228|9944845|FG001|STARTED|Overall Study||251
8887062|NCT01983228|9944844|FG000|COMPLETED|Overall Study||211
8887063|NCT01983228|9944845|FG001|COMPLETED|Overall Study||189
8887064|NCT01983228|9944844|FG000|NOT COMPLETED|Overall Study||38
8887065|NCT01983228|9944845|FG001|NOT COMPLETED|Overall Study||62
8887066|NCT01983254|9944855|FG000|STARTED|Overall Study|86 patients, 39 caregivers|125
8887067|NCT01983254|9944856|FG001|STARTED|Overall Study|89 patients, 47 caregivers|136
8887068|NCT01983254|9944855|FG000|Interview 1|Overall Study|86 patients, 39 caregivers|125
8887069|NCT01983254|9944856|FG001|Interview 1|Overall Study|89 patients, 47 caregivers|136
8887070|NCT01983254|9944855|FG000|Interview 2|Overall Study|65 patients, 30 caregivers|95
8887071|NCT01983254|9944856|FG001|Interview 2|Overall Study|71 patients, 39 caregivers|110
8887072|NCT01983254|9944855|FG000|Interview 3|Overall Study|62 patients, 29 caregivers|91
8887073|NCT01983254|9944856|FG001|Interview 3|Overall Study|69 patients, 37 caregivers|106
8887074|NCT01983254|9944855|FG000|COMPLETED|Overall Study|62 patients, 29 caregivers|91
8887075|NCT01983254|9944856|FG001|COMPLETED|Overall Study|69 patients, 37 caregivers|106
8887076|NCT01983254|9944855|FG000|NOT COMPLETED|Overall Study||34
8887077|NCT01983254|9944856|FG001|NOT COMPLETED|Overall Study||30
8887078|NCT01983293|9944864|FG000|STARTED|Overall Study||161
8887079|NCT01983293|9944865|FG001|STARTED|Overall Study||81
8887080|NCT01983293|9944864|FG000|COMPLETED|Overall Study||128
8634665|NCT00557856|9675011|FG000|Treated|Part 1: Dose Escalation Phase||5
8634666|NCT00557856|9675012|FG001|Treated|Part 1: Dose Escalation Phase||5
8634667|NCT00557856|9675013|FG002|Treated|Part 1: Dose Escalation Phase||6
8634668|NCT00557856|9675014|FG003|Treated|Part 1: Dose Escalation Phase||3
8887081|NCT01983293|9944865|FG001|COMPLETED|Overall Study||62
8887082|NCT01983293|9944864|FG000|NOT COMPLETED|Overall Study||33
8887083|NCT01983293|9944865|FG001|NOT COMPLETED|Overall Study||19
8887084|NCT01983566|9944875|FG000|STARTED|Test Period 1||4
8887085|NCT01983566|9944876|FG001|STARTED|Test Period 1||4
8887086|NCT01983566|9944877|FG002|STARTED|Test Period 1||4
8887087|NCT01983566|9944878|FG003|STARTED|Test Period 1||4
8887088|NCT01983566|9944875|FG000|COMPLETED|Test Period 1||4
8887089|NCT01983566|9944876|FG001|COMPLETED|Test Period 1||4
9004350|NCT02928380|10067517|FG003|STARTED|Period 1||14
9004351|NCT02928380|10067518|FG004|STARTED|Period 1||14
9004352|NCT02928380|10067519|FG005|STARTED|Period 1||14
9004353|NCT02928380|10067514|FG000|COMPLETED|Period 1||13
9004354|NCT02928380|10067515|FG001|COMPLETED|Period 1||14
9004355|NCT02928380|10067516|FG002|COMPLETED|Period 1||14
9004356|NCT02928380|10067517|FG003|COMPLETED|Period 1||14
9004357|NCT02928380|10067518|FG004|COMPLETED|Period 1||14
9004358|NCT02928380|10067519|FG005|COMPLETED|Period 1||14
9004359|NCT02928380|10067514|FG000|NOT COMPLETED|Period 1||0
9004360|NCT02928380|10067515|FG001|NOT COMPLETED|Period 1||0
9004361|NCT02928380|10067516|FG002|NOT COMPLETED|Period 1||0
9004362|NCT02928380|10067517|FG003|NOT COMPLETED|Period 1||0
9004363|NCT02928380|10067518|FG004|NOT COMPLETED|Period 1||0
9004364|NCT02928380|10067519|FG005|NOT COMPLETED|Period 1||0
9004365|NCT02928380|10067514|FG000|STARTED|Wash Out Period 1||13
9004366|NCT02928380|10067515|FG001|STARTED|Wash Out Period 1||14
9004367|NCT02928380|10067516|FG002|STARTED|Wash Out Period 1||14
9004368|NCT02928380|10067517|FG003|STARTED|Wash Out Period 1||14
9004369|NCT02928380|10067518|FG004|STARTED|Wash Out Period 1||14
9004370|NCT02928380|10067519|FG005|STARTED|Wash Out Period 1||14
9004371|NCT02928380|10067514|FG000|COMPLETED|Wash Out Period 1||13
9004372|NCT02928380|10067515|FG001|COMPLETED|Wash Out Period 1||14
9004373|NCT02928380|10067516|FG002|COMPLETED|Wash Out Period 1||14
9004374|NCT02928380|10067517|FG003|COMPLETED|Wash Out Period 1||14
9004375|NCT02928380|10067518|FG004|COMPLETED|Wash Out Period 1||14
8887090|NCT01983566|9944877|FG002|COMPLETED|Test Period 1||4
8887091|NCT01983566|9944878|FG003|COMPLETED|Test Period 1||4
9004376|NCT02928380|10067519|FG005|COMPLETED|Wash Out Period 1||14
9004377|NCT02928380|10067514|FG000|NOT COMPLETED|Wash Out Period 1||0
9004378|NCT02928380|10067515|FG001|NOT COMPLETED|Wash Out Period 1||0
9004379|NCT02928380|10067516|FG002|NOT COMPLETED|Wash Out Period 1||0
9004380|NCT02928380|10067517|FG003|NOT COMPLETED|Wash Out Period 1||0
9004381|NCT02928380|10067518|FG004|NOT COMPLETED|Wash Out Period 1||0
9004382|NCT02928380|10067519|FG005|NOT COMPLETED|Wash Out Period 1||0
9004383|NCT02928380|10067514|FG000|STARTED|Period 2||13
9004384|NCT02928380|10067515|FG001|STARTED|Period 2||14
9004385|NCT02928380|10067516|FG002|STARTED|Period 2||14
9004386|NCT02928380|10067517|FG003|STARTED|Period 2||14
8887092|NCT01983566|9944875|FG000|NOT COMPLETED|Test Period 1||0
8887093|NCT01983566|9944876|FG001|NOT COMPLETED|Test Period 1||0
8887094|NCT01983566|9944877|FG002|NOT COMPLETED|Test Period 1||0
8887095|NCT01983566|9944878|FG003|NOT COMPLETED|Test Period 1||0
8887096|NCT01983566|9944875|FG000|STARTED|Wash-Out 1||4
8887097|NCT01983566|9944876|FG001|STARTED|Wash-Out 1||4
8887098|NCT01983566|9944877|FG002|STARTED|Wash-Out 1||4
8887099|NCT01983566|9944878|FG003|STARTED|Wash-Out 1||4
8887100|NCT01983566|9944875|FG000|COMPLETED|Wash-Out 1||4
8887101|NCT01983566|9944876|FG001|COMPLETED|Wash-Out 1||4
8887102|NCT01983566|9944877|FG002|COMPLETED|Wash-Out 1||4
8887103|NCT01983566|9944878|FG003|COMPLETED|Wash-Out 1||4
8887104|NCT01983566|9944875|FG000|NOT COMPLETED|Wash-Out 1||0
8887105|NCT01983566|9944876|FG001|NOT COMPLETED|Wash-Out 1||0
8887106|NCT01983566|9944877|FG002|NOT COMPLETED|Wash-Out 1||0
8887107|NCT01983566|9944878|FG003|NOT COMPLETED|Wash-Out 1||0
8887108|NCT01983566|9944875|FG000|STARTED|Test Period 2||4
8887109|NCT01983566|9944876|FG001|STARTED|Test Period 2||4
8887110|NCT01983566|9944877|FG002|STARTED|Test Period 2||4
8887111|NCT01983566|9944878|FG003|STARTED|Test Period 2||4
8887112|NCT01983566|9944875|FG000|COMPLETED|Test Period 2||4
8887113|NCT01983566|9944876|FG001|COMPLETED|Test Period 2||4
8887114|NCT01983566|9944877|FG002|COMPLETED|Test Period 2||4
8887115|NCT01983566|9944878|FG003|COMPLETED|Test Period 2||4
8887116|NCT01983566|9944875|FG000|NOT COMPLETED|Test Period 2||0
8887117|NCT01983566|9944876|FG001|NOT COMPLETED|Test Period 2||0
8887118|NCT01983566|9944877|FG002|NOT COMPLETED|Test Period 2||0
8887119|NCT01983566|9944878|FG003|NOT COMPLETED|Test Period 2||0
8887120|NCT01983566|9944875|FG000|STARTED|Wash-Out 2|Subjects starting may not equal number completing the previous period due to early study termination|2
8887121|NCT01983566|9944876|FG001|STARTED|Wash-Out 2|Subjects starting may not equal number completing the previous period due to early study termination|3
8887122|NCT01983566|9944877|FG002|STARTED|Wash-Out 2|Subjects starting may not equal number completing the previous period due to early study termination|2
8887123|NCT01983566|9944878|FG003|STARTED|Wash-Out 2||4
8887124|NCT01983566|9944875|FG000|COMPLETED|Wash-Out 2||2
8887125|NCT01983566|9944876|FG001|COMPLETED|Wash-Out 2||3
8887126|NCT01983566|9944877|FG002|COMPLETED|Wash-Out 2||2
8887127|NCT01983566|9944878|FG003|COMPLETED|Wash-Out 2||4
8887128|NCT01983566|9944875|FG000|NOT COMPLETED|Wash-Out 2||0
8887129|NCT01983566|9944876|FG001|NOT COMPLETED|Wash-Out 2||0
8887130|NCT01983566|9944877|FG002|NOT COMPLETED|Wash-Out 2||0
8887131|NCT01983566|9944878|FG003|NOT COMPLETED|Wash-Out 2||0
8887132|NCT01983566|9944875|FG000|STARTED|Test Period 3||2
8887133|NCT01983566|9944876|FG001|STARTED|Test Period 3||3
8887134|NCT01983566|9944877|FG002|STARTED|Test Period 3||2
8887135|NCT01983566|9944878|FG003|STARTED|Test Period 3||4
8887136|NCT01983566|9944875|FG000|COMPLETED|Test Period 3||2
8887137|NCT01983566|9944876|FG001|COMPLETED|Test Period 3||3
8887138|NCT01983566|9944877|FG002|COMPLETED|Test Period 3||2
8887139|NCT01983566|9944878|FG003|COMPLETED|Test Period 3||4
8887140|NCT01983566|9944875|FG000|NOT COMPLETED|Test Period 3||0
8887141|NCT01983566|9944876|FG001|NOT COMPLETED|Test Period 3||0
8887142|NCT01983566|9944877|FG002|NOT COMPLETED|Test Period 3||0
8887143|NCT01983566|9944878|FG003|NOT COMPLETED|Test Period 3||0
8887144|NCT01983566|9944875|FG000|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
8887145|NCT01983566|9944876|FG001|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
8887146|NCT01983566|9944877|FG002|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
8887147|NCT01983566|9944878|FG003|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
8887148|NCT01983566|9944875|FG000|COMPLETED|Wash-Out 3||0
8887149|NCT01983566|9944876|FG001|COMPLETED|Wash-Out 3||0
8887150|NCT01983566|9944877|FG002|COMPLETED|Wash-Out 3||0
8887151|NCT01983566|9944878|FG003|COMPLETED|Wash-Out 3||0
8887152|NCT01983566|9944875|FG000|NOT COMPLETED|Wash-Out 3||0
8887153|NCT01983566|9944876|FG001|NOT COMPLETED|Wash-Out 3||0
8887154|NCT01983566|9944877|FG002|NOT COMPLETED|Wash-Out 3||0
8887155|NCT01983566|9944878|FG003|NOT COMPLETED|Wash-Out 3||0
8887156|NCT01983566|9944875|FG000|STARTED|Test Period 4||0
8887157|NCT01983566|9944876|FG001|STARTED|Test Period 4||0
8887158|NCT01983566|9944877|FG002|STARTED|Test Period 4||0
8887159|NCT01983566|9944878|FG003|STARTED|Test Period 4||0
8887160|NCT01983566|9944875|FG000|COMPLETED|Test Period 4||0
8887161|NCT01983566|9944876|FG001|COMPLETED|Test Period 4||0
8887162|NCT01983566|9944877|FG002|COMPLETED|Test Period 4||0
8887163|NCT01983566|9944878|FG003|COMPLETED|Test Period 4||0
8887164|NCT01983566|9944875|FG000|NOT COMPLETED|Test Period 4||0
8887165|NCT01983566|9944876|FG001|NOT COMPLETED|Test Period 4||0
8887166|NCT01983566|9944877|FG002|NOT COMPLETED|Test Period 4||0
8887167|NCT01983566|9944878|FG003|NOT COMPLETED|Test Period 4||0
8887168|NCT01983683|9944891|FG000|STARTED|Overall Study||298
8887169|NCT01983683|9944892|FG001|STARTED|Overall Study||311
8887170|NCT01983683|9944891|FG000|COMPLETED|Overall Study||260
8887171|NCT01983683|9944892|FG001|COMPLETED|Overall Study||260
8887172|NCT01983683|9944891|FG000|NOT COMPLETED|Overall Study||38
8887173|NCT01983683|9944892|FG001|NOT COMPLETED|Overall Study||51
8887174|NCT01983787|9944898|FG000|STARTED|Overall Study||10
8887175|NCT01983787|9944898|FG000|COMPLETED|Overall Study||10
8887176|NCT01983787|9944898|FG000|NOT COMPLETED|Overall Study||0
8887177|NCT01983826|9944923|FG000|STARTED|Overall Study||13
8887178|NCT01983826|9944924|FG001|STARTED|Overall Study||8
8887179|NCT01983826|9944923|FG000|COMPLETED|Overall Study||13
8887180|NCT01983826|9944924|FG001|COMPLETED|Overall Study||8
8887181|NCT01983826|9944923|FG000|NOT COMPLETED|Overall Study||0
8887182|NCT01983826|9944924|FG001|NOT COMPLETED|Overall Study||0
8887183|NCT01983839|9944934|FG000|STARTED|Overall Study||18
8887184|NCT01983839|9944934|FG000|COMPLETED|Overall Study||18
8887185|NCT01983839|9944934|FG000|NOT COMPLETED|Overall Study||0
8887186|NCT01983878|9944938|FG000|STARTED|Overall Study||36
8887187|NCT01983878|9944938|FG000|Received At Least One Dose of Study Drug|Overall Study||36
8887188|NCT01983878|9944938|FG000|COMPLETED|Overall Study||36
8634669|NCT00557856|9675015|FG004|Treated|Part 1: Dose Escalation Phase||4
8887189|NCT01983878|9944938|FG000|NOT COMPLETED|Overall Study||0
8887190|NCT01983930|9944945|FG000|STARTED|Overall Study||41
8887191|NCT01983930|9944946|FG001|STARTED|Overall Study||38
8887192|NCT01983930|9944945|FG000|COMPLETED|Overall Study||32
8887193|NCT01983930|9944946|FG001|COMPLETED|Overall Study||29
8887194|NCT01983930|9944945|FG000|NOT COMPLETED|Overall Study||9
8887195|NCT01983930|9944946|FG001|NOT COMPLETED|Overall Study||9
8887196|NCT01983969|9944956|FG000|STARTED|Overall Study||37
8887197|NCT01983969|9944957|FG001|STARTED|Overall Study||19
8887198|NCT01983969|9944958|FG002|STARTED|Overall Study||5
8887199|NCT01983969|9944956|FG000|COMPLETED|Overall Study||37
8887200|NCT01983969|9944957|FG001|COMPLETED|Overall Study||18
8887201|NCT01983969|9944958|FG002|COMPLETED|Overall Study||5
8887202|NCT01983969|9944956|FG000|NOT COMPLETED|Overall Study||0
8887203|NCT01983969|9944957|FG001|NOT COMPLETED|Overall Study||1
8887204|NCT01983969|9944958|FG002|NOT COMPLETED|Overall Study||0
8887205|NCT01984164|9944972|FG000|STARTED|Overall Study||87
8887206|NCT01984164|9944973|FG001|STARTED|Overall Study||89
8887207|NCT01984164|9944972|FG000|COMPLETED|Overall Study||77
8887208|NCT01984164|9944973|FG001|COMPLETED|Overall Study||64
8887209|NCT01984164|9944972|FG000|NOT COMPLETED|Overall Study||10
8887210|NCT01984164|9944973|FG001|NOT COMPLETED|Overall Study||25
8887211|NCT01984229|9944981|FG000|STARTED|Period 1||6
8887212|NCT01984229|9944982|FG001|STARTED|Period 1||17
8887213|NCT01984229|9944981|FG000|COMPLETED|Period 1||6
9004387|NCT02928380|10067518|FG004|STARTED|Period 2||14
9004388|NCT02928380|10067519|FG005|STARTED|Period 2||14
9004389|NCT02928380|10067514|FG000|COMPLETED|Period 2||13
9004390|NCT02928380|10067515|FG001|COMPLETED|Period 2||14
9004391|NCT02928380|10067516|FG002|COMPLETED|Period 2||14
9004392|NCT02928380|10067517|FG003|COMPLETED|Period 2||14
9004393|NCT02928380|10067518|FG004|COMPLETED|Period 2||14
9004394|NCT02928380|10067519|FG005|COMPLETED|Period 2||14
9004395|NCT02928380|10067514|FG000|NOT COMPLETED|Period 2||0
8887214|NCT01984229|9944982|FG001|COMPLETED|Period 1||17
8887215|NCT01984229|9944981|FG000|NOT COMPLETED|Period 1||0
8887216|NCT01984229|9944982|FG001|NOT COMPLETED|Period 1||0
8887217|NCT01984229|9944981|FG000|STARTED|Period 2||6
8887218|NCT01984229|9944982|FG001|STARTED|Period 2||17
8887219|NCT01984229|9944981|FG000|COMPLETED|Period 2||6
8887220|NCT01984229|9944982|FG001|COMPLETED|Period 2||17
8887221|NCT01984229|9944981|FG000|NOT COMPLETED|Period 2||0
8887222|NCT01984229|9944982|FG001|NOT COMPLETED|Period 2||0
8887223|NCT01984229|9944981|FG000|STARTED|Period 3||6
8887224|NCT01984229|9944982|FG001|STARTED|Period 3||17
8887225|NCT01984229|9944981|FG000|COMPLETED|Period 3||6
8887226|NCT01984229|9944982|FG001|COMPLETED|Period 3||17
8887227|NCT01984229|9944981|FG000|NOT COMPLETED|Period 3||0
8887228|NCT01984229|9944982|FG001|NOT COMPLETED|Period 3||0
8887229|NCT01984229|9944981|FG000|STARTED|Safety Follow-up Period||6
8887230|NCT01984229|9944982|FG001|STARTED|Safety Follow-up Period||17
8887231|NCT01984229|9944981|FG000|COMPLETED|Safety Follow-up Period||4
8887232|NCT01984229|9944982|FG001|COMPLETED|Safety Follow-up Period||16
8887233|NCT01984229|9944981|FG000|NOT COMPLETED|Safety Follow-up Period||2
8887234|NCT01984229|9944982|FG001|NOT COMPLETED|Safety Follow-up Period||1
8887235|NCT01984242|9944997|FG000|STARTED|Overall Study||101
8887236|NCT01984242|9944998|FG001|STARTED|Overall Study||103
8887237|NCT01984242|9944999|FG002|STARTED|Overall Study||101
8887238|NCT01984242|9944997|FG000|Treated|Overall Study||101
8887239|NCT01984242|9944998|FG001|Treated|Overall Study||103
8887240|NCT01984242|9944999|FG002|Treated|Overall Study||100
9004396|NCT02928380|10067515|FG001|NOT COMPLETED|Period 2||0
9004397|NCT02928380|10067516|FG002|NOT COMPLETED|Period 2||0
9004398|NCT02928380|10067517|FG003|NOT COMPLETED|Period 2||0
9004399|NCT02928380|10067518|FG004|NOT COMPLETED|Period 2||0
9004400|NCT02928380|10067519|FG005|NOT COMPLETED|Period 2||0
9004401|NCT02928380|10067514|FG000|STARTED|Wash Out Period 2||13
9004402|NCT02928380|10067515|FG001|STARTED|Wash Out Period 2||14
9004403|NCT02928380|10067516|FG002|STARTED|Wash Out Period 2||14
9004404|NCT02928380|10067517|FG003|STARTED|Wash Out Period 2||14
9004405|NCT02928380|10067518|FG004|STARTED|Wash Out Period 2||14
9004406|NCT02928380|10067519|FG005|STARTED|Wash Out Period 2||14
9004407|NCT02928380|10067514|FG000|COMPLETED|Wash Out Period 2||13
9004408|NCT02928380|10067515|FG001|COMPLETED|Wash Out Period 2||14
9004409|NCT02928380|10067516|FG002|COMPLETED|Wash Out Period 2||14
9004410|NCT02928380|10067517|FG003|COMPLETED|Wash Out Period 2||14
9004411|NCT02928380|10067518|FG004|COMPLETED|Wash Out Period 2||14
9004412|NCT02928380|10067519|FG005|COMPLETED|Wash Out Period 2||14
9004413|NCT02928380|10067514|FG000|NOT COMPLETED|Wash Out Period 2||0
9004414|NCT02928380|10067515|FG001|NOT COMPLETED|Wash Out Period 2||0
9004415|NCT02928380|10067516|FG002|NOT COMPLETED|Wash Out Period 2||0
9004416|NCT02928380|10067517|FG003|NOT COMPLETED|Wash Out Period 2||0
8887241|NCT01984242|9944997|FG000|COMPLETED|Overall Study||0
8634670|NCT00557856|9675016|FG005|Treated|Part 1: Dose Escalation Phase||8
8634671|NCT00557856|9675017|FG006|Treated|Part 1: Dose Escalation Phase||7
8887242|NCT01984242|9944998|FG001|COMPLETED|Overall Study||0
8887243|NCT01984242|9944999|FG002|COMPLETED|Overall Study||0
8887244|NCT01984242|9944997|FG000|NOT COMPLETED|Overall Study||101
8887245|NCT01984242|9944998|FG001|NOT COMPLETED|Overall Study||103
8887246|NCT01984242|9944999|FG002|NOT COMPLETED|Overall Study||101
8887247|NCT01984294|9945018|FG000|STARTED|Overall Study||35
8887248|NCT01984294|9945019|FG001|STARTED|Overall Study||32
8887249|NCT01984294|9945020|FG002|STARTED|Overall Study||34
8887250|NCT01984294|9945018|FG000|COMPLETED|Overall Study||31
8887251|NCT01984294|9945019|FG001|COMPLETED|Overall Study||29
8887252|NCT01984294|9945020|FG002|COMPLETED|Overall Study||27
8887253|NCT01984294|9945018|FG000|NOT COMPLETED|Overall Study||4
8887254|NCT01984294|9945019|FG001|NOT COMPLETED|Overall Study||3
8887255|NCT01984294|9945020|FG002|NOT COMPLETED|Overall Study||7
8887256|NCT01984398|9945030|FG000|STARTED|Treatment Period 1||4
8887257|NCT01984398|9945031|FG001|STARTED|Treatment Period 1||4
8887258|NCT01984398|9945032|FG002|STARTED|Treatment Period 1||4
8887259|NCT01984398|9945033|FG003|STARTED|Treatment Period 1||4
8887260|NCT01984398|9945030|FG000|COMPLETED|Treatment Period 1||4
8887261|NCT01984398|9945031|FG001|COMPLETED|Treatment Period 1||4
8887262|NCT01984398|9945032|FG002|COMPLETED|Treatment Period 1||4
8887263|NCT01984398|9945033|FG003|COMPLETED|Treatment Period 1||4
8887264|NCT01984398|9945030|FG000|NOT COMPLETED|Treatment Period 1||0
8887265|NCT01984398|9945031|FG001|NOT COMPLETED|Treatment Period 1||0
8887266|NCT01984398|9945032|FG002|NOT COMPLETED|Treatment Period 1||0
8887267|NCT01984398|9945033|FG003|NOT COMPLETED|Treatment Period 1||0
8887268|NCT01984398|9945030|FG000|STARTED|Washout Period of 5 to 7 Days||4
8887269|NCT01984398|9945031|FG001|STARTED|Washout Period of 5 to 7 Days||4
8887270|NCT01984398|9945032|FG002|STARTED|Washout Period of 5 to 7 Days||4
8887271|NCT01984398|9945033|FG003|STARTED|Washout Period of 5 to 7 Days||4
8887272|NCT01984398|9945030|FG000|COMPLETED|Washout Period of 5 to 7 Days||4
8887273|NCT01984398|9945031|FG001|COMPLETED|Washout Period of 5 to 7 Days||4
8887274|NCT01984398|9945032|FG002|COMPLETED|Washout Period of 5 to 7 Days||4
8887275|NCT01984398|9945033|FG003|COMPLETED|Washout Period of 5 to 7 Days||4
8887276|NCT01984398|9945030|FG000|NOT COMPLETED|Washout Period of 5 to 7 Days||0
8887277|NCT01984398|9945031|FG001|NOT COMPLETED|Washout Period of 5 to 7 Days||0
8887278|NCT01984398|9945032|FG002|NOT COMPLETED|Washout Period of 5 to 7 Days||0
8887279|NCT01984398|9945033|FG003|NOT COMPLETED|Washout Period of 5 to 7 Days||0
8887280|NCT01984398|9945030|FG000|STARTED|Treatment Period 2||4
8887281|NCT01984398|9945031|FG001|STARTED|Treatment Period 2||4
8887282|NCT01984398|9945032|FG002|STARTED|Treatment Period 2||4
8887283|NCT01984398|9945033|FG003|STARTED|Treatment Period 2||4
8887284|NCT01984398|9945030|FG000|COMPLETED|Treatment Period 2||4
8887285|NCT01984398|9945031|FG001|COMPLETED|Treatment Period 2||4
8887286|NCT01984398|9945032|FG002|COMPLETED|Treatment Period 2||4
8887287|NCT01984398|9945033|FG003|COMPLETED|Treatment Period 2||4
9004417|NCT02928380|10067518|FG004|NOT COMPLETED|Wash Out Period 2||0
9004418|NCT02928380|10067519|FG005|NOT COMPLETED|Wash Out Period 2||0
9004419|NCT02928380|10067514|FG000|STARTED|Period 3||13
9004420|NCT02928380|10067515|FG001|STARTED|Period 3||14
9004421|NCT02928380|10067516|FG002|STARTED|Period 3||14
9004422|NCT02928380|10067517|FG003|STARTED|Period 3||14
9004423|NCT02928380|10067518|FG004|STARTED|Period 3||14
9004424|NCT02928380|10067519|FG005|STARTED|Period 3||14
9004425|NCT02928380|10067514|FG000|COMPLETED|Period 3||13
9004426|NCT02928380|10067515|FG001|COMPLETED|Period 3||14
9004427|NCT02928380|10067516|FG002|COMPLETED|Period 3||14
9004428|NCT02928380|10067517|FG003|COMPLETED|Period 3||14
9004429|NCT02928380|10067518|FG004|COMPLETED|Period 3||14
9004430|NCT02928380|10067519|FG005|COMPLETED|Period 3||14
9004431|NCT02928380|10067514|FG000|NOT COMPLETED|Period 3||0
9004432|NCT02928380|10067515|FG001|NOT COMPLETED|Period 3||0
9004433|NCT02928380|10067516|FG002|NOT COMPLETED|Period 3||0
9004434|NCT02928380|10067517|FG003|NOT COMPLETED|Period 3||0
9004435|NCT02928380|10067518|FG004|NOT COMPLETED|Period 3||0
9004436|NCT02928380|10067519|FG005|NOT COMPLETED|Period 3||0
9004437|NCT02928536|10067530|FG000|STARTED|Overall Study||11902
9004438|NCT02928536|10067530|FG000|COMPLETED|Overall Study||11902
9004439|NCT02928536|10067530|FG000|NOT COMPLETED|Overall Study||0
9004440|NCT02928770|10067534|FG000|STARTED|Overall Study||32
9004441|NCT02928770|10067534|FG000|COMPLETED|Overall Study||30
9004442|NCT02928770|10067534|FG000|NOT COMPLETED|Overall Study||2
9004443|NCT02928848|10067540|FG000|STARTED|Arm 1||9
9004444|NCT02928848|10067541|FG001|STARTED|Arm 1||7
9004445|NCT02928848|10067540|FG000|COMPLETED|Arm 1||9
9004446|NCT02928848|10067541|FG001|COMPLETED|Arm 1||6
9004447|NCT02928848|10067540|FG000|NOT COMPLETED|Arm 1||0
9004448|NCT02928848|10067541|FG001|NOT COMPLETED|Arm 1||1
8634672|NCT00557856|9675018|FG007|Treated|Part 1: Dose Escalation Phase||6
8634673|NCT00557856|9675019|FG008|Treated|Part 1: Dose Escalation Phase||0
8887288|NCT01984398|9945030|FG000|NOT COMPLETED|Treatment Period 2||0
8887289|NCT01984398|9945031|FG001|NOT COMPLETED|Treatment Period 2||0
8887290|NCT01984398|9945032|FG002|NOT COMPLETED|Treatment Period 2||0
9004449|NCT02928848|10067540|FG000|STARTED|Arm 2||9
9004450|NCT02928848|10067541|FG001|STARTED|Arm 2||6
9004451|NCT02928848|10067540|FG000|COMPLETED|Arm 2||8
9004452|NCT02928848|10067541|FG001|COMPLETED|Arm 2||6
9004453|NCT02928848|10067540|FG000|NOT COMPLETED|Arm 2||1
8887291|NCT01984398|9945033|FG003|NOT COMPLETED|Treatment Period 2||0
8887292|NCT01984424|9945045|FG000|STARTED|Overall Study||73
8887293|NCT01984424|9945046|FG001|STARTED|Overall Study||145
8887294|NCT01984424|9945045|FG000|COMPLETED|Overall Study||70
8887295|NCT01984424|9945046|FG001|COMPLETED|Overall Study||138
8887296|NCT01984424|9945045|FG000|NOT COMPLETED|Overall Study||3
8887297|NCT01984424|9945046|FG001|NOT COMPLETED|Overall Study||7
8887298|NCT01984515|9945052|FG000|STARTED|Overall Study||59
8887299|NCT01984515|9945052|FG000|Received CBT Session|Overall Study||40
8887300|NCT01984515|9945052|FG000|COMPLETED|Overall Study||40
8887301|NCT01984515|9945052|FG000|NOT COMPLETED|Overall Study||19
8887302|NCT01984684|9945058|FG000|STARTED|Overall Study||423
8887303|NCT01984684|9945059|FG001|STARTED|Overall Study||427
8887304|NCT01984684|9945058|FG000|COMPLETED|Overall Study||366
8887305|NCT01984684|9945059|FG001|COMPLETED|Overall Study||368
8887306|NCT01984684|9945058|FG000|NOT COMPLETED|Overall Study||57
8887307|NCT01984684|9945059|FG001|NOT COMPLETED|Overall Study||59
8887308|NCT01984697|9945070|FG000|STARTED|Overall Study||301
8887309|NCT01984697|9945071|FG001|STARTED|Overall Study||301
8887310|NCT01984697|9945072|FG002|STARTED|Overall Study||301
8887311|NCT01984697|9945073|FG003|STARTED|Overall Study||301
8887312|NCT01984697|9945074|FG004|STARTED|Overall Study||314
8887313|NCT01984697|9945070|FG000|Vaccination 1|Overall Study||301
8887314|NCT01984697|9945071|FG001|Vaccination 1|Overall Study||301
8887315|NCT01984697|9945072|FG002|Vaccination 1|Overall Study||300
8887316|NCT01984697|9945073|FG003|Vaccination 1|Overall Study||300
8887317|NCT01984697|9945074|FG004|Vaccination 1|Overall Study||314
8887318|NCT01984697|9945070|FG000|Vaccination 2|Overall Study||293
8887319|NCT01984697|9945071|FG001|Vaccination 2|Overall Study||296
8887320|NCT01984697|9945072|FG002|Vaccination 2|Overall Study||291
8887321|NCT01984697|9945073|FG003|Vaccination 2|Overall Study||298
8887322|NCT01984697|9945074|FG004|Vaccination 2|Overall Study||313
8887323|NCT01984697|9945070|FG000|Vaccination 3|Overall Study||0
8887324|NCT01984697|9945071|FG001|Vaccination 3|Overall Study||0
8887325|NCT01984697|9945072|FG002|Vaccination 3|Overall Study||0
8887326|NCT01984697|9945073|FG003|Vaccination 3|Overall Study||293
8887327|NCT01984697|9945074|FG004|Vaccination 3|Overall Study||311
8887328|NCT01984697|9945070|FG000|Month 36 Vaccination|Overall Study||270
8634674|NCT00557856|9675011|FG000|COMPLETED|Part 1: Dose Escalation Phase||0
8634675|NCT00557856|9675012|FG001|COMPLETED|Part 1: Dose Escalation Phase||0
8634676|NCT00557856|9675013|FG002|COMPLETED|Part 1: Dose Escalation Phase||0
8634677|NCT00557856|9675014|FG003|COMPLETED|Part 1: Dose Escalation Phase||0
8634678|NCT00557856|9675015|FG004|COMPLETED|Part 1: Dose Escalation Phase||0
8634679|NCT00557856|9675016|FG005|COMPLETED|Part 1: Dose Escalation Phase||0
8887329|NCT01984697|9945071|FG001|Month 36 Vaccination|Overall Study||281
8887330|NCT01984697|9945072|FG002|Month 36 Vaccination|Overall Study||280
8887331|NCT01984697|9945073|FG003|Month 36 Vaccination|Overall Study||9
8887332|NCT01984697|9945074|FG004|Month 36 Vaccination|Overall Study||31
8887333|NCT01984697|9945070|FG000|COMPLETED|Overall Study||258
8634680|NCT00557856|9675017|FG006|COMPLETED|Part 1: Dose Escalation Phase||0
8634681|NCT00557856|9675018|FG007|COMPLETED|Part 1: Dose Escalation Phase||0
8634682|NCT00557856|9675019|FG008|COMPLETED|Part 1: Dose Escalation Phase||0
8634683|NCT00557856|9675011|FG000|NOT COMPLETED|Part 1: Dose Escalation Phase||7
8634684|NCT00557856|9675012|FG001|NOT COMPLETED|Part 1: Dose Escalation Phase||5
8634685|NCT00557856|9675013|FG002|NOT COMPLETED|Part 1: Dose Escalation Phase||6
8634686|NCT00557856|9675014|FG003|NOT COMPLETED|Part 1: Dose Escalation Phase||3
8634687|NCT00557856|9675015|FG004|NOT COMPLETED|Part 1: Dose Escalation Phase||4
8634688|NCT00557856|9675016|FG005|NOT COMPLETED|Part 1: Dose Escalation Phase||8
8634689|NCT00557856|9675017|FG006|NOT COMPLETED|Part 1: Dose Escalation Phase||7
8634690|NCT00557856|9675018|FG007|NOT COMPLETED|Part 1: Dose Escalation Phase||6
8634691|NCT00557856|9675019|FG008|NOT COMPLETED|Part 1: Dose Escalation Phase||0
8634692|NCT00557856|9675011|FG000|STARTED|Part 2: Exploratory Phase||0
8634693|NCT00557856|9675012|FG001|STARTED|Part 2: Exploratory Phase||0
8634694|NCT00557856|9675013|FG002|STARTED|Part 2: Exploratory Phase||0
8634695|NCT00557856|9675014|FG003|STARTED|Part 2: Exploratory Phase||0
8634696|NCT00557856|9675015|FG004|STARTED|Part 2: Exploratory Phase||0
8634697|NCT00557856|9675016|FG005|STARTED|Part 2: Exploratory Phase||0
8634698|NCT00557856|9675017|FG006|STARTED|Part 2: Exploratory Phase||0
8634699|NCT00557856|9675018|FG007|STARTED|Part 2: Exploratory Phase||0
8634700|NCT00557856|9675019|FG008|STARTED|Part 2: Exploratory Phase||24
8634701|NCT00557856|9675011|FG000|COMPLETED|Part 2: Exploratory Phase||0
8634702|NCT00557856|9675012|FG001|COMPLETED|Part 2: Exploratory Phase||0
8634703|NCT00557856|9675013|FG002|COMPLETED|Part 2: Exploratory Phase||0
8634704|NCT00557856|9675014|FG003|COMPLETED|Part 2: Exploratory Phase||0
8634705|NCT00557856|9675015|FG004|COMPLETED|Part 2: Exploratory Phase||0
8634706|NCT00557856|9675016|FG005|COMPLETED|Part 2: Exploratory Phase||0
8634707|NCT00557856|9675017|FG006|COMPLETED|Part 2: Exploratory Phase||0
8634708|NCT00557856|9675018|FG007|COMPLETED|Part 2: Exploratory Phase||0
8634709|NCT00557856|9675019|FG008|COMPLETED|Part 2: Exploratory Phase||0
8634710|NCT00557856|9675011|FG000|NOT COMPLETED|Part 2: Exploratory Phase||0
8634711|NCT00557856|9675012|FG001|NOT COMPLETED|Part 2: Exploratory Phase||0
8634712|NCT00557856|9675013|FG002|NOT COMPLETED|Part 2: Exploratory Phase||0
8634713|NCT00557856|9675014|FG003|NOT COMPLETED|Part 2: Exploratory Phase||0
8634714|NCT00557856|9675015|FG004|NOT COMPLETED|Part 2: Exploratory Phase||0
8887334|NCT01984697|9945071|FG001|COMPLETED|Overall Study||270
8887335|NCT01984697|9945072|FG002|COMPLETED|Overall Study||272
8887336|NCT01984697|9945073|FG003|COMPLETED|Overall Study||280
8887337|NCT01984697|9945074|FG004|COMPLETED|Overall Study||279
8887338|NCT01984697|9945070|FG000|NOT COMPLETED|Overall Study||43
8887339|NCT01984697|9945071|FG001|NOT COMPLETED|Overall Study||31
8887340|NCT01984697|9945072|FG002|NOT COMPLETED|Overall Study||29
8887341|NCT01984697|9945073|FG003|NOT COMPLETED|Overall Study||21
8887342|NCT01984697|9945074|FG004|NOT COMPLETED|Overall Study||35
8887343|NCT01984892|9945086|FG000|STARTED|Overall Study||8
8887344|NCT01984892|9945086|FG000|COMPLETED|Overall Study|1 completed all study visits up until the termination of the study, last study visit not done.|1
8887345|NCT01984892|9945086|FG000|NOT COMPLETED|Overall Study||7
8887346|NCT01985126|9945092|FG000|STARTED|Overall Study||18
8887347|NCT01985126|9945093|FG001|STARTED|Overall Study||106
8887348|NCT01985126|9945092|FG000|COMPLETED|Overall Study||0
8887349|NCT01985126|9945093|FG001|COMPLETED|Overall Study||0
8887350|NCT01985126|9945092|FG000|NOT COMPLETED|Overall Study||18
8887351|NCT01985126|9945093|FG001|NOT COMPLETED|Overall Study||106
8887352|NCT01985321|9945101|FG000|STARTED|Overall Study|This is Treatment Eligible Subjects only|90
8887353|NCT01985321|9945102|FG001|STARTED|Overall Study|This is treatment eligible subjects only|83
8887354|NCT01985321|9945101|FG000|COMPLETED|Overall Study||79
8887355|NCT01985321|9945102|FG001|COMPLETED|Overall Study||78
8887356|NCT01985321|9945101|FG000|NOT COMPLETED|Overall Study||11
8887357|NCT01985321|9945102|FG001|NOT COMPLETED|Overall Study||5
8887358|NCT01985334|9945116|FG000|STARTED|Overall Study||130
8887359|NCT01985334|9945117|FG001|STARTED|Overall Study||387
8887360|NCT01985334|9945118|FG002|STARTED|Overall Study||420
8887361|NCT01985334|9945119|FG003|STARTED|Overall Study||1262
8887362|NCT01985334|9945120|FG004|STARTED|Overall Study||274
8887363|NCT01985334|9945121|FG005|STARTED|Overall Study||822
8887364|NCT01985334|9945122|FG006|STARTED|Overall Study||274
8887365|NCT01985334|9945123|FG007|STARTED|Overall Study||820
8887366|NCT01985334|9945116|FG000|The Intention-to-treat (ITT) Population|Overall Study||122
8887367|NCT01985334|9945117|FG001|The Intention-to-treat (ITT) Population|Overall Study||369
8887368|NCT01985334|9945118|FG002|The Intention-to-treat (ITT) Population|Overall Study||420
8887369|NCT01985334|9945119|FG003|The Intention-to-treat (ITT) Population|Overall Study||1254
8887370|NCT01985334|9945120|FG004|The Intention-to-treat (ITT) Population|Overall Study||269
8887371|NCT01985334|9945121|FG005|The Intention-to-treat (ITT) Population|Overall Study||811
8887372|NCT01985334|9945122|FG006|The Intention-to-treat (ITT) Population|Overall Study||268
8887373|NCT01985334|9945123|FG007|The Intention-to-treat (ITT) Population|Overall Study||811
8887374|NCT01985334|9945116|FG000|COMPLETED|Overall Study||107
8887375|NCT01985334|9945117|FG001|COMPLETED|Overall Study||303
8887376|NCT01985334|9945118|FG002|COMPLETED|Overall Study||367
8887377|NCT01985334|9945119|FG003|COMPLETED|Overall Study||1033
8887378|NCT01985334|9945120|FG004|COMPLETED|Overall Study||234
8572650|NCT00116558|9604878|FG002|STARTED|Overall Study||47
8887379|NCT01985334|9945121|FG005|COMPLETED|Overall Study||666
8572651|NCT00116558|9604876|FG000|COMPLETED|Overall Study||49
8572652|NCT00116558|9604877|FG001|COMPLETED|Overall Study||11
8572653|NCT00116558|9604878|FG002|COMPLETED|Overall Study||14
8887380|NCT01985334|9945122|FG006|COMPLETED|Overall Study||237
8887381|NCT01985334|9945123|FG007|COMPLETED|Overall Study||699
8887382|NCT01985334|9945116|FG000|NOT COMPLETED|Overall Study||23
8887383|NCT01985334|9945117|FG001|NOT COMPLETED|Overall Study||84
8887384|NCT01985334|9945118|FG002|NOT COMPLETED|Overall Study||53
8887385|NCT01985334|9945119|FG003|NOT COMPLETED|Overall Study||229
8887386|NCT01985334|9945120|FG004|NOT COMPLETED|Overall Study||40
8887387|NCT01985334|9945121|FG005|NOT COMPLETED|Overall Study||156
8887388|NCT01985334|9945122|FG006|NOT COMPLETED|Overall Study||37
8887389|NCT01985334|9945123|FG007|NOT COMPLETED|Overall Study||121
8887390|NCT01985360|9945157|FG000|STARTED|Overall Study||388
8887391|NCT01985360|9945158|FG001|STARTED|Overall Study||389
8887392|NCT01985360|9945157|FG000|COMPLETED|Overall Study||379
8887393|NCT01985360|9945158|FG001|COMPLETED|Overall Study||386
8887394|NCT01985360|9945157|FG000|NOT COMPLETED|Overall Study||9
8887395|NCT01985360|9945158|FG001|NOT COMPLETED|Overall Study||3
8887396|NCT01985425|9945166|FG000|STARTED|Overall Study||49
8887397|NCT01985425|9945167|FG001|STARTED|Overall Study||51
8887398|NCT01985425|9945166|FG000|COMPLETED|Overall Study||49
8887399|NCT01985425|9945167|FG001|COMPLETED|Overall Study||51
8887400|NCT01985425|9945166|FG000|NOT COMPLETED|Overall Study||0
8887401|NCT01985425|9945167|FG001|NOT COMPLETED|Overall Study||0
8887402|NCT01985542|9945175|FG000|STARTED|Overall Study||7
8887403|NCT01985542|9945176|FG001|STARTED|Overall Study||9
8887404|NCT01985542|9945175|FG000|COMPLETED|Overall Study||3
8887405|NCT01985542|9945176|FG001|COMPLETED|Overall Study||3
8887406|NCT01985542|9945175|FG000|NOT COMPLETED|Overall Study||4
8887407|NCT01985542|9945176|FG001|NOT COMPLETED|Overall Study||6
8887408|NCT01985581|9945185|FG000|STARTED|First Intervention||25
8887409|NCT01985581|9945186|FG001|STARTED|First Intervention||25
8887410|NCT01985581|9945185|FG000|COMPLETED|First Intervention||22
8887411|NCT01985581|9945186|FG001|COMPLETED|First Intervention||23
8887412|NCT01985581|9945185|FG000|NOT COMPLETED|First Intervention||3
8887413|NCT01985581|9945186|FG001|NOT COMPLETED|First Intervention||2
8887414|NCT01985581|9945185|FG000|STARTED|Second Intervention||22
8887415|NCT01985581|9945186|FG001|STARTED|Second Intervention||23
8887416|NCT01985581|9945185|FG000|COMPLETED|Second Intervention||20
8887417|NCT01985581|9945186|FG001|COMPLETED|Second Intervention||19
9004454|NCT02928848|10067541|FG001|NOT COMPLETED|Arm 2||0
9004455|NCT02928952|10067551|FG000|STARTED|Overall Study||65
9004456|NCT02928952|10067552|FG001|STARTED|Overall Study||67
9004457|NCT02928952|10067551|FG000|COMPLETED|Overall Study||55
9004458|NCT02928952|10067552|FG001|COMPLETED|Overall Study||60
9004459|NCT02928952|10067551|FG000|NOT COMPLETED|Overall Study||10
9004460|NCT02928952|10067552|FG001|NOT COMPLETED|Overall Study||7
9004461|NCT02929329|10067560|FG000|STARTED|Overall Study||4112
9004462|NCT02929329|10067561|FG001|STARTED|Overall Study||4120
8887418|NCT01985581|9945185|FG000|NOT COMPLETED|Second Intervention||2
8887419|NCT01985581|9945186|FG001|NOT COMPLETED|Second Intervention||4
8887420|NCT01985685|9945205|FG000|STARTED|Overall Study||27
8887421|NCT01985685|9945206|FG001|STARTED|Overall Study||29
8887422|NCT01985685|9945205|FG000|COMPLETED|Overall Study||27
8887423|NCT01985685|9945206|FG001|COMPLETED|Overall Study||29
8887424|NCT01985685|9945205|FG000|NOT COMPLETED|Overall Study||0
9004463|NCT02929329|10067560|FG000|Received Treatment|Overall Study||4101
8887425|NCT01985685|9945206|FG001|NOT COMPLETED|Overall Study||0
8887426|NCT01985763|9945212|FG000|STARTED|Overall Study||13
8887427|NCT01985763|9945212|FG000|COMPLETED|Overall Study||13
8887428|NCT01985763|9945212|FG000|NOT COMPLETED|Overall Study||0
9004464|NCT02929329|10067561|FG001|Received Treatment|Overall Study||4110
9004465|NCT02929329|10067560|FG000|COMPLETED|Overall Study|7 participants in this group who discontinued the study had unknown vital status at the end of study|3008
9004466|NCT02929329|10067561|FG001|COMPLETED|Overall Study|9 participants in this group who discontinued the study had unknown vital status at the end of study|3028
9004467|NCT02929329|10067560|FG000|NOT COMPLETED|Overall Study||1104
9004468|NCT02929329|10067561|FG001|NOT COMPLETED|Overall Study||1092
9004469|NCT02929407|10067571|FG000|STARTED|Overall Study||4
9004470|NCT02929407|10067571|FG000|COMPLETED|Overall Study||3
9004471|NCT02929407|10067571|FG000|NOT COMPLETED|Overall Study||1
9004472|NCT02929498|10067578|FG000|STARTED|Part 1: Dose Confirmation (Upto 2 Years)||5
9004473|NCT02929498|10067579|FG001|STARTED|Part 1: Dose Confirmation (Upto 2 Years)||0
9004474|NCT02929498|10067580|FG002|STARTED|Part 1: Dose Confirmation (Upto 2 Years)||0
9004475|NCT02929498|10067578|FG000|COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0
9004476|NCT02929498|10067579|FG001|COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0
9004477|NCT02929498|10067580|FG002|COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0
9004478|NCT02929498|10067578|FG000|NOT COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||5
9004479|NCT02929498|10067579|FG001|NOT COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0
9004480|NCT02929498|10067580|FG002|NOT COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0
9004481|NCT02929498|10067578|FG000|STARTED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
9004482|NCT02929498|10067579|FG001|STARTED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
9004483|NCT02929498|10067580|FG002|STARTED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
9004484|NCT02929498|10067578|FG000|COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
9004485|NCT02929498|10067579|FG001|COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
9004486|NCT02929498|10067580|FG002|COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
9004487|NCT02929498|10067578|FG000|NOT COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
9004488|NCT02929498|10067579|FG001|NOT COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
9004489|NCT02929498|10067580|FG002|NOT COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
9004490|NCT02929667|10067588|FG000|STARTED|Overall Study||11
9004491|NCT02929667|10067589|FG001|STARTED|Overall Study||11
9004492|NCT02929667|10067588|FG000|COMPLETED|Overall Study||11
9004493|NCT02929667|10067589|FG001|COMPLETED|Overall Study||11
9004494|NCT02929667|10067588|FG000|NOT COMPLETED|Overall Study||0
9004495|NCT02929667|10067589|FG001|NOT COMPLETED|Overall Study||0
9004496|NCT02929823|10067600|FG000|STARTED|Overall Study||42
9004497|NCT02929823|10067601|FG001|STARTED|Overall Study||46
9004498|NCT02929823|10067602|FG002|STARTED|Overall Study||42
9004499|NCT02929823|10067600|FG000|COMPLETED|Overall Study||39
9004500|NCT02929823|10067601|FG001|COMPLETED|Overall Study||40
9004501|NCT02929823|10067602|FG002|COMPLETED|Overall Study||38
9004502|NCT02929823|10067600|FG000|NOT COMPLETED|Overall Study||3
9004503|NCT02929823|10067601|FG001|NOT COMPLETED|Overall Study||6
9004504|NCT02929823|10067602|FG002|NOT COMPLETED|Overall Study||4
9004505|NCT02929979|10067612|FG000|STARTED|Overall Study||52
9004506|NCT02929979|10067613|FG001|STARTED|Overall Study||38
9004507|NCT02929979|10067612|FG000|COMPLETED|Overall Study||25
9004508|NCT02929979|10067613|FG001|COMPLETED|Overall Study||28
9004509|NCT02929979|10067612|FG000|NOT COMPLETED|Overall Study||27
9004510|NCT02929979|10067613|FG001|NOT COMPLETED|Overall Study||10
9004511|NCT02930005|10067622|FG000|STARTED|Overall Study||2
9004512|NCT02930005|10067623|FG001|STARTED|Overall Study||6
9004513|NCT02930005|10067622|FG000|Completed 2 Weeks|Overall Study||2
9004514|NCT02930005|10067623|FG001|Completed 2 Weeks|Overall Study||2
9004515|NCT02930005|10067622|FG000|COMPLETED|Overall Study||1
9004516|NCT02930005|10067623|FG001|COMPLETED|Overall Study||1
9004517|NCT02930005|10067622|FG000|NOT COMPLETED|Overall Study||1
9004518|NCT02930005|10067623|FG001|NOT COMPLETED|Overall Study||5
9004519|NCT02930018|10067631|FG000|STARTED|Overall Study||556
9004520|NCT02930018|10067632|FG001|STARTED|Overall Study||549
9004521|NCT02930018|10067631|FG000|COMPLETED|Overall Study||550
9004522|NCT02930018|10067632|FG001|COMPLETED|Overall Study||546
9004523|NCT02930018|10067631|FG000|NOT COMPLETED|Overall Study||6
9004524|NCT02930018|10067632|FG001|NOT COMPLETED|Overall Study||3
9004525|NCT02930174|10067640|FG000|STARTED|Overall Study||12
9004526|NCT02930174|10067641|FG001|STARTED|Overall Study||8
9004527|NCT02930174|10067640|FG000|COMPLETED|Overall Study||12
9004528|NCT02930174|10067641|FG001|COMPLETED|Overall Study||8
9004529|NCT02930174|10067640|FG000|NOT COMPLETED|Overall Study||0
8887429|NCT01985932|9945217|FG000|STARTED|Overall Study||15
8887430|NCT01985932|9945217|FG000|COMPLETED|Overall Study||15
8887431|NCT01985932|9945217|FG000|NOT COMPLETED|Overall Study||0
8887432|NCT01985958|9945221|FG000|STARTED|Overall Study||4
8887433|NCT01985958|9945221|FG000|COMPLETED|Overall Study||3
8887434|NCT01985958|9945221|FG000|NOT COMPLETED|Overall Study||1
8887435|NCT01985971|9945225|FG000|STARTED|Overall Study||2
8887436|NCT01985971|9945225|FG000|COMPLETED|Overall Study||1
8887437|NCT01985971|9945225|FG000|NOT COMPLETED|Overall Study||1
8887438|NCT01986010|9945246|FG000|STARTED|Overall Study||13
8887439|NCT01986010|9945247|FG001|STARTED|Overall Study||14
8887440|NCT01986010|9945248|FG002|STARTED|Overall Study||14
8887441|NCT01986010|9945249|FG003|STARTED|Overall Study||10
8887442|NCT01986010|9945250|FG004|STARTED|Overall Study||11
8887443|NCT01986010|9945251|FG005|STARTED|Overall Study||19
8887444|NCT01986010|9945252|FG006|STARTED|Overall Study||10
8887445|NCT01986010|9945253|FG007|STARTED|Overall Study||4
8887446|NCT01986010|9945254|FG008|STARTED|Overall Study||12
8887447|NCT01986010|9945255|FG009|STARTED|Overall Study||10
8887448|NCT01986010|9945256|FG010|STARTED|Overall Study||10
8887449|NCT01986010|9945257|FG011|STARTED|Overall Study||11
8887450|NCT01986010|9945258|FG012|STARTED|Overall Study||10
8887451|NCT01986010|9945259|FG013|STARTED|Overall Study||11
8887452|NCT01986010|9945260|FG014|STARTED|Overall Study||16
8887453|NCT01986010|9945261|FG015|STARTED|Overall Study||11
8887454|NCT01986010|9945262|FG016|STARTED|Overall Study||4
8887455|NCT01986010|9945246|FG000|Vaccination 1|Overall Study||13
8887456|NCT01986010|9945247|FG001|Vaccination 1|Overall Study||14
8887457|NCT01986010|9945248|FG002|Vaccination 1|Overall Study||14
8887458|NCT01986010|9945249|FG003|Vaccination 1|Overall Study||10
8887459|NCT01986010|9945250|FG004|Vaccination 1|Overall Study||11
8887460|NCT01986010|9945251|FG005|Vaccination 1|Overall Study||19
8887461|NCT01986010|9945252|FG006|Vaccination 1|Overall Study||10
8887462|NCT01986010|9945253|FG007|Vaccination 1|Overall Study||4
8887463|NCT01986010|9945254|FG008|Vaccination 1|Overall Study||12
8887464|NCT01986010|9945255|FG009|Vaccination 1|Overall Study||10
8887465|NCT01986010|9945256|FG010|Vaccination 1|Overall Study||10
8887466|NCT01986010|9945257|FG011|Vaccination 1|Overall Study||11
8887467|NCT01986010|9945258|FG012|Vaccination 1|Overall Study||10
8887468|NCT01986010|9945259|FG013|Vaccination 1|Overall Study||11
8887469|NCT01986010|9945260|FG014|Vaccination 1|Overall Study||16
8887470|NCT01986010|9945261|FG015|Vaccination 1|Overall Study||11
8887471|NCT01986010|9945262|FG016|Vaccination 1|Overall Study||4
8887472|NCT01986010|9945246|FG000|Vaccination 2|Overall Study||12
8887473|NCT01986010|9945247|FG001|Vaccination 2|Overall Study||13
8887474|NCT01986010|9945248|FG002|Vaccination 2|Overall Study||12
8887475|NCT01986010|9945249|FG003|Vaccination 2|Overall Study||10
8887476|NCT01986010|9945250|FG004|Vaccination 2|Overall Study||9
8887477|NCT01986010|9945251|FG005|Vaccination 2|Overall Study||19
8887478|NCT01986010|9945252|FG006|Vaccination 2|Overall Study||10
8887479|NCT01986010|9945253|FG007|Vaccination 2|Overall Study||4
8887480|NCT01986010|9945254|FG008|Vaccination 2|Overall Study||11
8887481|NCT01986010|9945255|FG009|Vaccination 2|Overall Study||10
8887482|NCT01986010|9945256|FG010|Vaccination 2|Overall Study||10
8887483|NCT01986010|9945257|FG011|Vaccination 2|Overall Study||10
8887484|NCT01986010|9945258|FG012|Vaccination 2|Overall Study||10
8887485|NCT01986010|9945259|FG013|Vaccination 2|Overall Study||9
8887486|NCT01986010|9945260|FG014|Vaccination 2|Overall Study||16
8887487|NCT01986010|9945261|FG015|Vaccination 2|Overall Study||10
8887488|NCT01986010|9945262|FG016|Vaccination 2|Overall Study||4
8887489|NCT01986010|9945246|FG000|Vaccination 3|Overall Study||10
8887490|NCT01986010|9945247|FG001|Vaccination 3|Overall Study||10
8887491|NCT01986010|9945248|FG002|Vaccination 3|Overall Study||9
8887492|NCT01986010|9945249|FG003|Vaccination 3|Overall Study||10
8887493|NCT01986010|9945250|FG004|Vaccination 3|Overall Study||9
8887494|NCT01986010|9945251|FG005|Vaccination 3|Overall Study||15
8887495|NCT01986010|9945252|FG006|Vaccination 3|Overall Study||10
8887496|NCT01986010|9945253|FG007|Vaccination 3|Overall Study||4
8887497|NCT01986010|9945254|FG008|Vaccination 3|Overall Study||10
8887498|NCT01986010|9945255|FG009|Vaccination 3|Overall Study||10
8887499|NCT01986010|9945256|FG010|Vaccination 3|Overall Study||10
8887500|NCT01986010|9945257|FG011|Vaccination 3|Overall Study||8
8887501|NCT01986010|9945258|FG012|Vaccination 3|Overall Study||10
9004530|NCT02930174|10067641|FG001|NOT COMPLETED|Overall Study||0
9004531|NCT02930226|10067655|FG000|STARTED|Overall Study||4
9004532|NCT02930226|10067656|FG001|STARTED|Overall Study||4
9004533|NCT02930226|10067657|FG002|STARTED|Overall Study||4
9004534|NCT02930226|10067658|FG003|STARTED|Overall Study||4
9004535|NCT02930226|10067659|FG004|STARTED|Overall Study||4
9004536|NCT02930226|10067660|FG005|STARTED|Overall Study||4
9004537|NCT02930226|10067655|FG000|COMPLETED|Overall Study||4
9004538|NCT02930226|10067656|FG001|COMPLETED|Overall Study||4
9004539|NCT02930226|10067657|FG002|COMPLETED|Overall Study||4
9004540|NCT02930226|10067658|FG003|COMPLETED|Overall Study||4
9004541|NCT02930226|10067659|FG004|COMPLETED|Overall Study||3
9004542|NCT02930226|10067660|FG005|COMPLETED|Overall Study||4
9004543|NCT02930226|10067655|FG000|NOT COMPLETED|Overall Study||0
9004544|NCT02930226|10067656|FG001|NOT COMPLETED|Overall Study||0
9004545|NCT02930226|10067657|FG002|NOT COMPLETED|Overall Study||0
9004546|NCT02930226|10067658|FG003|NOT COMPLETED|Overall Study||0
8634715|NCT00557856|9675016|FG005|NOT COMPLETED|Part 2: Exploratory Phase||0
8887502|NCT01986010|9945259|FG013|Vaccination 3|Overall Study||9
8887503|NCT01986010|9945260|FG014|Vaccination 3|Overall Study||13
8887504|NCT01986010|9945261|FG015|Vaccination 3|Overall Study||10
8887505|NCT01986010|9945262|FG016|Vaccination 3|Overall Study||4
8887506|NCT01986010|9945246|FG000|COMPLETED|Overall Study||7
8887507|NCT01986010|9945247|FG001|COMPLETED|Overall Study||6
8887508|NCT01986010|9945248|FG002|COMPLETED|Overall Study||7
8887509|NCT01986010|9945249|FG003|COMPLETED|Overall Study||8
8887510|NCT01986010|9945250|FG004|COMPLETED|Overall Study||6
9004547|NCT02930226|10067659|FG004|NOT COMPLETED|Overall Study||1
9004548|NCT02930226|10067660|FG005|NOT COMPLETED|Overall Study||0
8887511|NCT01986010|9945251|FG005|COMPLETED|Overall Study||11
8887512|NCT01986010|9945252|FG006|COMPLETED|Overall Study||10
8887513|NCT01986010|9945253|FG007|COMPLETED|Overall Study||4
8887514|NCT01986010|9945254|FG008|COMPLETED|Overall Study||6
8887515|NCT01986010|9945255|FG009|COMPLETED|Overall Study||7
8887516|NCT01986010|9945256|FG010|COMPLETED|Overall Study||3
8887517|NCT01986010|9945257|FG011|COMPLETED|Overall Study||1
8887518|NCT01986010|9945258|FG012|COMPLETED|Overall Study||0
8887519|NCT01986010|9945259|FG013|COMPLETED|Overall Study||0
8887520|NCT01986010|9945260|FG014|COMPLETED|Overall Study||6
8887521|NCT01986010|9945261|FG015|COMPLETED|Overall Study||0
8887522|NCT01986010|9945262|FG016|COMPLETED|Overall Study||0
8887523|NCT01986010|9945246|FG000|NOT COMPLETED|Overall Study||6
8887524|NCT01986010|9945247|FG001|NOT COMPLETED|Overall Study||8
9004549|NCT02930343|10067678|FG000|STARTED|Overall Study||68
8887525|NCT01986010|9945248|FG002|NOT COMPLETED|Overall Study||7
8887526|NCT01986010|9945249|FG003|NOT COMPLETED|Overall Study||2
8887527|NCT01986010|9945250|FG004|NOT COMPLETED|Overall Study||5
9004550|NCT02930343|10067679|FG001|STARTED|Overall Study||68
9004551|NCT02930343|10067678|FG000|COMPLETED|Overall Study||59
9004552|NCT02930343|10067679|FG001|COMPLETED|Overall Study||61
9004553|NCT02930343|10067678|FG000|NOT COMPLETED|Overall Study||9
9004554|NCT02930343|10067679|FG001|NOT COMPLETED|Overall Study||7
9004555|NCT02930590|10067685|FG000|STARTED|First Intervention (2 Hours)||3
9004556|NCT02930590|10067686|FG001|STARTED|First Intervention (2 Hours)||3
9004557|NCT02930590|10067687|FG002|STARTED|First Intervention (2 Hours)||3
9004558|NCT02930590|10067688|FG003|STARTED|First Intervention (2 Hours)||2
9004559|NCT02930590|10067689|FG004|STARTED|First Intervention (2 Hours)||2
9004560|NCT02930590|10067690|FG005|STARTED|First Intervention (2 Hours)||2
9004561|NCT02930590|10067685|FG000|COMPLETED|First Intervention (2 Hours)||3
9004562|NCT02930590|10067686|FG001|COMPLETED|First Intervention (2 Hours)||3
9004563|NCT02930590|10067687|FG002|COMPLETED|First Intervention (2 Hours)||3
9004564|NCT02930590|10067688|FG003|COMPLETED|First Intervention (2 Hours)||2
9004565|NCT02930590|10067689|FG004|COMPLETED|First Intervention (2 Hours)||2
9004566|NCT02930590|10067690|FG005|COMPLETED|First Intervention (2 Hours)||2
9004567|NCT02930590|10067685|FG000|NOT COMPLETED|First Intervention (2 Hours)||0
9004568|NCT02930590|10067686|FG001|NOT COMPLETED|First Intervention (2 Hours)||0
9004569|NCT02930590|10067687|FG002|NOT COMPLETED|First Intervention (2 Hours)||0
9004570|NCT02930590|10067688|FG003|NOT COMPLETED|First Intervention (2 Hours)||0
9004571|NCT02930590|10067689|FG004|NOT COMPLETED|First Intervention (2 Hours)||0
9004572|NCT02930590|10067690|FG005|NOT COMPLETED|First Intervention (2 Hours)||0
9004573|NCT02930590|10067685|FG000|STARTED|Second Intervention (2 Hours)||3
9004574|NCT02930590|10067686|FG001|STARTED|Second Intervention (2 Hours)||3
9004575|NCT02930590|10067687|FG002|STARTED|Second Intervention (2 Hours)||3
9004576|NCT02930590|10067688|FG003|STARTED|Second Intervention (2 Hours)||2
9004577|NCT02930590|10067689|FG004|STARTED|Second Intervention (2 Hours)||2
9004578|NCT02930590|10067690|FG005|STARTED|Second Intervention (2 Hours)||2
9004579|NCT02930590|10067685|FG000|COMPLETED|Second Intervention (2 Hours)||3
9004580|NCT02930590|10067686|FG001|COMPLETED|Second Intervention (2 Hours)||3
9004581|NCT02930590|10067687|FG002|COMPLETED|Second Intervention (2 Hours)||3
9004582|NCT02930590|10067688|FG003|COMPLETED|Second Intervention (2 Hours)||2
9004583|NCT02930590|10067689|FG004|COMPLETED|Second Intervention (2 Hours)||2
9004584|NCT02930590|10067690|FG005|COMPLETED|Second Intervention (2 Hours)||2
9004585|NCT02930590|10067685|FG000|NOT COMPLETED|Second Intervention (2 Hours)||0
9004586|NCT02930590|10067686|FG001|NOT COMPLETED|Second Intervention (2 Hours)||0
9004587|NCT02930590|10067687|FG002|NOT COMPLETED|Second Intervention (2 Hours)||0
9004588|NCT02930590|10067688|FG003|NOT COMPLETED|Second Intervention (2 Hours)||0
9004589|NCT02930590|10067689|FG004|NOT COMPLETED|Second Intervention (2 Hours)||0
9004590|NCT02930590|10067690|FG005|NOT COMPLETED|Second Intervention (2 Hours)||0
9004591|NCT02930590|10067685|FG000|STARTED|Third Intervention (2 Hours)||3
9004592|NCT02930590|10067686|FG001|STARTED|Third Intervention (2 Hours)||3
9004593|NCT02930590|10067687|FG002|STARTED|Third Intervention (2 Hours)||3
9004594|NCT02930590|10067688|FG003|STARTED|Third Intervention (2 Hours)||2
9004595|NCT02930590|10067689|FG004|STARTED|Third Intervention (2 Hours)||2
9004596|NCT02930590|10067690|FG005|STARTED|Third Intervention (2 Hours)||2
9004597|NCT02930590|10067685|FG000|COMPLETED|Third Intervention (2 Hours)||3
9004598|NCT02930590|10067686|FG001|COMPLETED|Third Intervention (2 Hours)||3
9004599|NCT02930590|10067687|FG002|COMPLETED|Third Intervention (2 Hours)||3
9004600|NCT02930590|10067688|FG003|COMPLETED|Third Intervention (2 Hours)||2
9004601|NCT02930590|10067689|FG004|COMPLETED|Third Intervention (2 Hours)||2
9004602|NCT02930590|10067690|FG005|COMPLETED|Third Intervention (2 Hours)||2
9004603|NCT02930590|10067685|FG000|NOT COMPLETED|Third Intervention (2 Hours)||0
9004604|NCT02930590|10067686|FG001|NOT COMPLETED|Third Intervention (2 Hours)||0
9004605|NCT02930590|10067687|FG002|NOT COMPLETED|Third Intervention (2 Hours)||0
9004606|NCT02930590|10067688|FG003|NOT COMPLETED|Third Intervention (2 Hours)||0
9004607|NCT02930590|10067689|FG004|NOT COMPLETED|Third Intervention (2 Hours)||0
9004608|NCT02930590|10067690|FG005|NOT COMPLETED|Third Intervention (2 Hours)||0
9004609|NCT02930824|10067704|FG000|STARTED|Overall Study||62
9004610|NCT02930824|10067705|FG001|STARTED|Overall Study||63
9004611|NCT02930824|10067706|FG002|STARTED|Overall Study||30
9004612|NCT02930824|10067707|FG003|STARTED|Overall Study||30
9004613|NCT02930824|10067704|FG000|COMPLETED|Overall Study||56
9004614|NCT02930824|10067705|FG001|COMPLETED|Overall Study||57
9004615|NCT02930824|10067706|FG002|COMPLETED|Overall Study||20
8634716|NCT00557856|9675017|FG006|NOT COMPLETED|Part 2: Exploratory Phase||0
8634717|NCT00557856|9675018|FG007|NOT COMPLETED|Part 2: Exploratory Phase||0
8887528|NCT01986010|9945251|FG005|NOT COMPLETED|Overall Study||8
8887529|NCT01986010|9945252|FG006|NOT COMPLETED|Overall Study||0
8887530|NCT01986010|9945253|FG007|NOT COMPLETED|Overall Study||0
8887531|NCT01986010|9945254|FG008|NOT COMPLETED|Overall Study||6
8887532|NCT01986010|9945255|FG009|NOT COMPLETED|Overall Study||3
8887533|NCT01986010|9945256|FG010|NOT COMPLETED|Overall Study||7
8887534|NCT01986010|9945257|FG011|NOT COMPLETED|Overall Study||10
8887535|NCT01986010|9945258|FG012|NOT COMPLETED|Overall Study||10
8887536|NCT01986010|9945259|FG013|NOT COMPLETED|Overall Study||11
8887537|NCT01986010|9945260|FG014|NOT COMPLETED|Overall Study||10
8887538|NCT01986010|9945261|FG015|NOT COMPLETED|Overall Study||11
9004616|NCT02930824|10067707|FG003|COMPLETED|Overall Study||23
9004617|NCT02930824|10067704|FG000|NOT COMPLETED|Overall Study||6
9004618|NCT02930824|10067705|FG001|NOT COMPLETED|Overall Study||6
9004619|NCT02930824|10067706|FG002|NOT COMPLETED|Overall Study||10
9004620|NCT02930824|10067707|FG003|NOT COMPLETED|Overall Study||7
9004621|NCT02930837|10067723|FG000|STARTED|Overall Study|Started are treated patients|120
9004622|NCT02930837|10067723|FG000|COMPLETED|Overall Study|Completed the trial|108
9004623|NCT02930837|10067723|FG000|NOT COMPLETED|Overall Study||12
9004624|NCT02930941|10067729|FG000|STARTED|Overall Study||17
9004625|NCT02930941|10067730|FG001|STARTED|Overall Study||18
9004626|NCT02930941|10067729|FG000|COMPLETED|Overall Study||16
8634718|NCT00557856|9675019|FG008|NOT COMPLETED|Part 2: Exploratory Phase||24
8887539|NCT01986010|9945262|FG016|NOT COMPLETED|Overall Study||4
8887540|NCT01986062|9945310|FG000|STARTED|Overall Study||47
8887541|NCT01986062|9945311|FG001|STARTED|Overall Study||50
8887542|NCT01986062|9945310|FG000|COMPLETED|Overall Study||46
8887543|NCT01986062|9945311|FG001|COMPLETED|Overall Study||49
8887544|NCT01986062|9945310|FG000|NOT COMPLETED|Overall Study||1
8887545|NCT01986062|9945311|FG001|NOT COMPLETED|Overall Study||1
8887546|NCT01986140|9945319|FG000|STARTED|Overall Study||157
8887547|NCT01986140|9945320|FG001|STARTED|Overall Study||79
8887548|NCT01986140|9945319|FG000|COMPLETED|Overall Study||122
8887549|NCT01986140|9945320|FG001|COMPLETED|Overall Study||51
8887550|NCT01986140|9945319|FG000|NOT COMPLETED|Overall Study||35
8887551|NCT01986140|9945320|FG001|NOT COMPLETED|Overall Study||28
8887552|NCT01986231|9945326|FG000|STARTED|Overall Study||12
8887553|NCT01986231|9945326|FG000|COMPLETED|Overall Study||11
8887554|NCT01986231|9945326|FG000|NOT COMPLETED|Overall Study||1
8887555|NCT01986348|9945334|FG000|STARTED|Overall Study||8
8887556|NCT01986348|9945335|FG001|STARTED|Overall Study||24
8887557|NCT01986348|9945336|FG002|STARTED|Overall Study||14
8887558|NCT01986348|9945337|FG003|STARTED|Overall Study||30
8887559|NCT01986348|9945334|FG000|COMPLETED|Overall Study||0
8887560|NCT01986348|9945335|FG001|COMPLETED|Overall Study||0
8887561|NCT01986348|9945336|FG002|COMPLETED|Overall Study||0
8887562|NCT01986348|9945337|FG003|COMPLETED|Overall Study||0
8887563|NCT01986348|9945334|FG000|NOT COMPLETED|Overall Study||8
8887564|NCT01986348|9945335|FG001|NOT COMPLETED|Overall Study||24
8887565|NCT01986348|9945336|FG002|NOT COMPLETED|Overall Study||14
8887566|NCT01986348|9945337|FG003|NOT COMPLETED|Overall Study||30
8887567|NCT01986361|9945352|FG000|STARTED|Overall Study||101
8887568|NCT01986361|9945353|FG001|STARTED|Overall Study||21
8887569|NCT01986361|9945352|FG000|COMPLETED|Overall Study||101
8887570|NCT01986361|9945353|FG001|COMPLETED|Overall Study||21
8887571|NCT01986361|9945352|FG000|NOT COMPLETED|Overall Study||0
8887572|NCT01986361|9945353|FG001|NOT COMPLETED|Overall Study||0
8887573|NCT01986647|9945363|FG000|STARTED|Overall Study||152
8887574|NCT01986647|9945364|FG001|STARTED|Overall Study||146
8887575|NCT01986647|9945365|FG002|STARTED|Overall Study||49
8887576|NCT01986647|9945366|FG003|STARTED|Overall Study||77
8887577|NCT01986647|9945363|FG000|COMPLETED|Overall Study||142
8887578|NCT01986647|9945364|FG001|COMPLETED|Overall Study||139
8887579|NCT01986647|9945365|FG002|COMPLETED|Overall Study||37
8887580|NCT01986647|9945366|FG003|COMPLETED|Overall Study||66
8887581|NCT01986647|9945363|FG000|NOT COMPLETED|Overall Study||10
8887582|NCT01986647|9945364|FG001|NOT COMPLETED|Overall Study||7
8887583|NCT01986647|9945365|FG002|NOT COMPLETED|Overall Study||12
8887584|NCT01986647|9945366|FG003|NOT COMPLETED|Overall Study||11
8887585|NCT01986686|9945382|FG000|STARTED|Overall Study||81
8887586|NCT01986686|9945383|FG001|STARTED|Overall Study||26
8887587|NCT01986686|9945382|FG000|COMPLETED|Overall Study||81
8887588|NCT01986686|9945383|FG001|COMPLETED|Overall Study||26
8887589|NCT01986686|9945382|FG000|NOT COMPLETED|Overall Study||0
8887590|NCT01986686|9945383|FG001|NOT COMPLETED|Overall Study||0
8887591|NCT01986790|9945392|FG000|STARTED|Overall Study||91
8887592|NCT01986790|9945393|FG001|STARTED|Overall Study||154
8887593|NCT01986790|9945394|FG002|STARTED|Overall Study||98
8887594|NCT01986790|9945392|FG000|COMPLETED|Overall Study||91
8887595|NCT01986790|9945393|FG001|COMPLETED|Overall Study||154
8887596|NCT01986790|9945394|FG002|COMPLETED|Overall Study||98
8887597|NCT01986790|9945392|FG000|NOT COMPLETED|Overall Study||0
8887598|NCT01986790|9945393|FG001|NOT COMPLETED|Overall Study||0
8887599|NCT01986790|9945394|FG002|NOT COMPLETED|Overall Study||0
8887600|NCT01986829|9945402|FG000|STARTED|Overall Study||9
8887601|NCT01986829|9945402|FG000|COMPLETED|Overall Study||8
8887602|NCT01986829|9945402|FG000|NOT COMPLETED|Overall Study||1
8887603|NCT01986855|9945412|FG000|STARTED|Overall Study||158
8887604|NCT01986855|9945413|FG001|STARTED|Overall Study||156
8887605|NCT01986855|9945414|FG002|STARTED|Overall Study||154
8887606|NCT01986855|9945412|FG000|Treated|Overall Study||158
8887607|NCT01986855|9945413|FG001|Treated|Overall Study||155
8887608|NCT01986855|9945414|FG002|Treated|Overall Study||154
8887609|NCT01986855|9945412|FG000|COMPLETED|Overall Study||145
8887610|NCT01986855|9945413|FG001|COMPLETED|Overall Study||142
8887611|NCT01986855|9945414|FG002|COMPLETED|Overall Study||143
8887612|NCT01986855|9945412|FG000|NOT COMPLETED|Overall Study||13
8887613|NCT01986855|9945413|FG001|NOT COMPLETED|Overall Study||14
8887614|NCT01986855|9945414|FG002|NOT COMPLETED|Overall Study||11
8887615|NCT01986881|9945425|FG000|STARTED|Overall Study||2752
8887616|NCT01986881|9945426|FG001|STARTED|Overall Study||2747
8887617|NCT01986881|9945427|FG002|STARTED|Overall Study||2747
9004627|NCT02930941|10067730|FG001|COMPLETED|Overall Study||16
9004628|NCT02930941|10067729|FG000|NOT COMPLETED|Overall Study||1
9004629|NCT02930941|10067730|FG001|NOT COMPLETED|Overall Study||2
9004630|NCT02930980|10067740|FG000|STARTED|Overall Study||43
9004631|NCT02930980|10067740|FG000|COMPLETED|Overall Study||43
9004632|NCT02930980|10067740|FG000|NOT COMPLETED|Overall Study||0
9004633|NCT02931045|10067746|FG000|STARTED|Overall Study||30
9004634|NCT02931045|10067747|FG001|STARTED|Overall Study||30
9004635|NCT02931045|10067746|FG000|COMPLETED|Overall Study||27
9004636|NCT02931045|10067747|FG001|COMPLETED|Overall Study||28
9004637|NCT02931045|10067746|FG000|NOT COMPLETED|Overall Study||3
9004638|NCT02931045|10067747|FG001|NOT COMPLETED|Overall Study||2
9004639|NCT02931253|10067755|FG000|STARTED|Overall Study||2
9004640|NCT02931253|10067756|FG001|STARTED|Overall Study||4
9004641|NCT02931253|10067755|FG000|COMPLETED|Overall Study||2
9004642|NCT02931253|10067756|FG001|COMPLETED|Overall Study||4
9004643|NCT02931253|10067755|FG000|NOT COMPLETED|Overall Study||0
8887618|NCT01986881|9945425|FG000|Treated|Overall Study||2746
8887619|NCT01986881|9945426|FG001|Treated|Overall Study||2747
8887620|NCT01986881|9945427|FG002|Treated|Overall Study||2745
8887621|NCT01986881|9945425|FG000|Participants Enrolled in the Insulin +/- Metformin Glycemic Sub-Study|Overall Study||348
8887622|NCT01986881|9945426|FG001|Participants Enrolled in the Insulin +/- Metformin Glycemic Sub-Study|Overall Study||370
8887623|NCT01986881|9945427|FG002|Participants Enrolled in the Insulin +/- Metformin Glycemic Sub-Study|Overall Study||347
8887624|NCT01986881|9945425|FG000|Participants Enrolled in the Sulfonylurea Monotherapy Glycemic Sub-Study|Overall Study||55
8887625|NCT01986881|9945426|FG001|Participants Enrolled in the Sulfonylurea Monotherapy Glycemic Sub-Study|Overall Study||54
8887626|NCT01986881|9945427|FG002|Participants Enrolled in the Sulfonylurea Monotherapy Glycemic Sub-Study|Overall Study||48
8887627|NCT01986881|9945425|FG000|Participants Enrolled in the Metformin With Sulfonylurea Glycemic Sub-Study|Overall Study||100
8887628|NCT01986881|9945426|FG001|Participants Enrolled in the Metformin With Sulfonylurea Glycemic Sub-Study|Overall Study||113
8887629|NCT01986881|9945427|FG002|Participants Enrolled in the Metformin With Sulfonylurea Glycemic Sub-Study|Overall Study||117
8887630|NCT01986881|9945425|FG000|COMPLETED|Overall Study||2422
8887631|NCT01986881|9945426|FG001|COMPLETED|Overall Study||2401
8887632|NCT01986881|9945427|FG002|COMPLETED|Overall Study||2389
8887633|NCT01986881|9945425|FG000|NOT COMPLETED|Overall Study||330
8887634|NCT01986881|9945426|FG001|NOT COMPLETED|Overall Study||346
8887635|NCT01986881|9945427|FG002|NOT COMPLETED|Overall Study||358
8887636|NCT01986907|9945458|FG000|STARTED|Overall Study||936
8887637|NCT01986907|9945458|FG000|COMPLETED|Overall Study||774
8887638|NCT01986907|9945458|FG000|NOT COMPLETED|Overall Study||162
8887639|NCT01986920|9945465|FG000|STARTED|A- 101 25%||35
8887640|NCT01986920|9945466|FG001|STARTED|A- 101 25%||0
8887641|NCT01986920|9945467|FG002|STARTED|A- 101 25%||0
8887642|NCT01986920|9945468|FG003|STARTED|A- 101 25%||0
8887643|NCT01986920|9945465|FG000|COMPLETED|A- 101 25%||34
8887644|NCT01986920|9945466|FG001|COMPLETED|A- 101 25%||0
8887645|NCT01986920|9945467|FG002|COMPLETED|A- 101 25%||0
8887646|NCT01986920|9945468|FG003|COMPLETED|A- 101 25%||0
8887647|NCT01986920|9945465|FG000|NOT COMPLETED|A- 101 25%||1
8887648|NCT01986920|9945466|FG001|NOT COMPLETED|A- 101 25%||0
8887649|NCT01986920|9945467|FG002|NOT COMPLETED|A- 101 25%||0
8887650|NCT01986920|9945468|FG003|NOT COMPLETED|A- 101 25%||0
8887651|NCT01986920|9945465|FG000|STARTED|A-101 32.5%||0
8887652|NCT01986920|9945466|FG001|STARTED|A-101 32.5%||35
8887653|NCT01986920|9945467|FG002|STARTED|A-101 32.5%||0
8887654|NCT01986920|9945468|FG003|STARTED|A-101 32.5%||0
8887655|NCT01986920|9945465|FG000|COMPLETED|A-101 32.5%||0
8887656|NCT01986920|9945466|FG001|COMPLETED|A-101 32.5%||34
8887657|NCT01986920|9945467|FG002|COMPLETED|A-101 32.5%||0
8887658|NCT01986920|9945468|FG003|COMPLETED|A-101 32.5%||0
8887659|NCT01986920|9945465|FG000|NOT COMPLETED|A-101 32.5%||0
8887660|NCT01986920|9945466|FG001|NOT COMPLETED|A-101 32.5%||1
8887661|NCT01986920|9945467|FG002|NOT COMPLETED|A-101 32.5%||0
8887662|NCT01986920|9945468|FG003|NOT COMPLETED|A-101 32.5%||0
8887663|NCT01986920|9945465|FG000|STARTED|A-101 40%||0
8887664|NCT01986920|9945466|FG001|STARTED|A-101 40%||0
8887665|NCT01986920|9945467|FG002|STARTED|A-101 40%||35
8887666|NCT01986920|9945468|FG003|STARTED|A-101 40%||0
8887667|NCT01986920|9945465|FG000|COMPLETED|A-101 40%||0
8887668|NCT01986920|9945466|FG001|COMPLETED|A-101 40%||0
8887669|NCT01986920|9945467|FG002|COMPLETED|A-101 40%||34
8887670|NCT01986920|9945468|FG003|COMPLETED|A-101 40%||0
8887671|NCT01986920|9945465|FG000|NOT COMPLETED|A-101 40%||0
8887672|NCT01986920|9945466|FG001|NOT COMPLETED|A-101 40%||0
8887673|NCT01986920|9945467|FG002|NOT COMPLETED|A-101 40%||1
8887674|NCT01986920|9945468|FG003|NOT COMPLETED|A-101 40%||0
8887675|NCT01986920|9945465|FG000|STARTED|Placebo||0
8887676|NCT01986920|9945466|FG001|STARTED|Placebo||0
8887677|NCT01986920|9945467|FG002|STARTED|Placebo||0
8887678|NCT01986920|9945468|FG003|STARTED|Placebo||35
8887679|NCT01986920|9945465|FG000|COMPLETED|Placebo||0
8887680|NCT01986920|9945466|FG001|COMPLETED|Placebo||0
8887681|NCT01986920|9945467|FG002|COMPLETED|Placebo||0
8887682|NCT01986920|9945468|FG003|COMPLETED|Placebo||34
8887683|NCT01986920|9945465|FG000|NOT COMPLETED|Placebo||0
8887684|NCT01986920|9945466|FG001|NOT COMPLETED|Placebo||0
8887685|NCT01986920|9945467|FG002|NOT COMPLETED|Placebo||0
8887686|NCT01986920|9945468|FG003|NOT COMPLETED|Placebo||1
8887687|NCT01986946|9945480|FG000|STARTED|Overall Study||5
8887688|NCT01986946|9945481|FG001|STARTED|Overall Study||9
8887689|NCT01986946|9945480|FG000|COMPLETED|Overall Study||5
8887690|NCT01986946|9945481|FG001|COMPLETED|Overall Study||9
8887691|NCT01986946|9945480|FG000|NOT COMPLETED|Overall Study||0
8887692|NCT01986946|9945481|FG001|NOT COMPLETED|Overall Study||0
8887693|NCT01986985|9945487|FG000|STARTED|Overall Study||58
8887694|NCT01986985|9945487|FG000|COMPLETED|Overall Study||51
8887695|NCT01986985|9945487|FG000|NOT COMPLETED|Overall Study||7
8887696|NCT01987089|9945493|FG000|STARTED|Overall Study||31
8887697|NCT01987089|9945494|FG001|STARTED|Overall Study||32
8887698|NCT01987089|9945493|FG000|COMPLETED|Overall Study||30
8887699|NCT01987089|9945494|FG001|COMPLETED|Overall Study||28
8887700|NCT01987089|9945493|FG000|NOT COMPLETED|Overall Study||1
8887701|NCT01987089|9945494|FG001|NOT COMPLETED|Overall Study||4
8887702|NCT01987102|9945502|FG000|STARTED|2 Courses of HDMTX With SOC Rescue||8
8887703|NCT01987102|9945503|FG001|STARTED|2 Courses of HDMTX With SOC Rescue||10
8887704|NCT01987102|9945502|FG000|COMPLETED|2 Courses of HDMTX With SOC Rescue||4
8634719|NCT00557882|9675036|FG000|STARTED|Overall Study||32
8634720|NCT00557882|9675037|FG001|STARTED|Overall Study||33
8634721|NCT00557882|9675036|FG000|COMPLETED|Overall Study||27
8634722|NCT00557882|9675037|FG001|COMPLETED|Overall Study||33
8634723|NCT00557882|9675036|FG000|NOT COMPLETED|Overall Study||5
8634724|NCT00557882|9675037|FG001|NOT COMPLETED|Overall Study||0
8634725|NCT00557947|9675043|FG000|STARTED|Overall Study||83
8634726|NCT00557947|9675043|FG000|COMPLETED|Overall Study||83
8634727|NCT00557947|9675043|FG000|NOT COMPLETED|Overall Study||0
8634728|NCT00558012|9675053|FG000|STARTED|Overall Study||89
8634729|NCT00558012|9675054|FG001|STARTED|Overall Study||92
8634730|NCT00558012|9675053|FG000|COMPLETED|Overall Study||64
8634731|NCT00558012|9675054|FG001|COMPLETED|Overall Study||74
8634732|NCT00558012|9675053|FG000|NOT COMPLETED|Overall Study||25
8634733|NCT00558012|9675054|FG001|NOT COMPLETED|Overall Study||18
8634734|NCT00558025|9675062|FG000|STARTED|Overall Study||104
8634735|NCT00558025|9675063|FG001|STARTED|Overall Study||52
8634736|NCT00558025|9675062|FG000|COMPLETED|Overall Study||100
8634737|NCT00558025|9675063|FG001|COMPLETED|Overall Study||49
8634738|NCT00558025|9675062|FG000|NOT COMPLETED|Overall Study||4
8634739|NCT00558025|9675063|FG001|NOT COMPLETED|Overall Study||3
8634740|NCT00558064|9675071|FG000|STARTED|Overall Study||269
8634741|NCT00558064|9675072|FG001|STARTED|Overall Study||262
8634742|NCT00558064|9675071|FG000|COMPLETED|Overall Study||264
8634743|NCT00558064|9675072|FG001|COMPLETED|Overall Study||257
8634744|NCT00558064|9675071|FG000|NOT COMPLETED|Overall Study||5
8634745|NCT00558064|9675072|FG001|NOT COMPLETED|Overall Study||5
8887705|NCT01987102|9945503|FG001|COMPLETED|2 Courses of HDMTX With SOC Rescue||4
8887706|NCT01987102|9945502|FG000|NOT COMPLETED|2 Courses of HDMTX With SOC Rescue||4
8887707|NCT01987102|9945503|FG001|NOT COMPLETED|2 Courses of HDMTX With SOC Rescue||6
8887708|NCT01987102|9945502|FG000|STARTED|2 Courses of HDMTX With MOD Rescue||4
8887709|NCT01987102|9945503|FG001|STARTED|2 Courses of HDMTX With MOD Rescue||4
8887710|NCT01987102|9945502|FG000|COMPLETED|2 Courses of HDMTX With MOD Rescue||4
8887711|NCT01987102|9945503|FG001|COMPLETED|2 Courses of HDMTX With MOD Rescue||3
8887712|NCT01987102|9945502|FG000|NOT COMPLETED|2 Courses of HDMTX With MOD Rescue||0
8887713|NCT01987102|9945503|FG001|NOT COMPLETED|2 Courses of HDMTX With MOD Rescue||1
8887714|NCT01987219|9945516|FG000|STARTED|Overall Study||2
8887715|NCT01987219|9945517|FG001|STARTED|Overall Study||2
8887716|NCT01987219|9945518|FG002|STARTED|Overall Study||7
8887717|NCT01987219|9945519|FG003|STARTED|Overall Study||2
8887718|NCT01987219|9945520|FG004|STARTED|Overall Study||1
8887719|NCT01987219|9945521|FG005|STARTED|Overall Study||1
8887720|NCT01987219|9945516|FG000|COMPLETED|Overall Study||2
8634746|NCT00558103|9675083|FG000|STARTED|Randomized Treatment Phase||38
8887721|NCT01987219|9945517|FG001|COMPLETED|Overall Study||2
8887722|NCT01987219|9945518|FG002|COMPLETED|Overall Study||6
8887723|NCT01987219|9945519|FG003|COMPLETED|Overall Study||2
8887724|NCT01987219|9945520|FG004|COMPLETED|Overall Study||1
8634747|NCT00558103|9675084|FG001|STARTED|Randomized Treatment Phase||38
8634748|NCT00558103|9675085|FG002|STARTED|Randomized Treatment Phase||36
8634749|NCT00558103|9675086|FG003|STARTED|Randomized Treatment Phase||13
8634750|NCT00558103|9675087|FG004|STARTED|Randomized Treatment Phase||38
8634751|NCT00558103|9675088|FG005|STARTED|Randomized Treatment Phase||0
8634752|NCT00558103|9675083|FG000|COMPLETED|Randomized Treatment Phase||33
8634753|NCT00558103|9675084|FG001|COMPLETED|Randomized Treatment Phase||34
8634754|NCT00558103|9675085|FG002|COMPLETED|Randomized Treatment Phase||33
8887725|NCT01987219|9945521|FG005|COMPLETED|Overall Study||1
8887726|NCT01987219|9945516|FG000|NOT COMPLETED|Overall Study||0
8887727|NCT01987219|9945517|FG001|NOT COMPLETED|Overall Study||0
8887728|NCT01987219|9945518|FG002|NOT COMPLETED|Overall Study||1
8887729|NCT01987219|9945519|FG003|NOT COMPLETED|Overall Study||0
8887730|NCT01987219|9945520|FG004|NOT COMPLETED|Overall Study||0
8887731|NCT01987219|9945521|FG005|NOT COMPLETED|Overall Study||0
8887732|NCT01987232|9945534|FG000|STARTED|Overall Study||5
8887733|NCT01987232|9945535|FG001|STARTED|Overall Study||3
8887734|NCT01987232|9945536|FG002|STARTED|Overall Study||3
8887735|NCT01987232|9945537|FG003|STARTED|Overall Study||15
8887736|NCT01987232|9945538|FG004|STARTED|Overall Study||6
8887737|NCT01987232|9945534|FG000|COMPLETED|Overall Study||5
8887738|NCT01987232|9945535|FG001|COMPLETED|Overall Study||3
8887739|NCT01987232|9945536|FG002|COMPLETED|Overall Study||3
8887740|NCT01987232|9945537|FG003|COMPLETED|Overall Study||14
8887741|NCT01987232|9945538|FG004|COMPLETED|Overall Study||6
8887742|NCT01987232|9945534|FG000|NOT COMPLETED|Overall Study||0
8887743|NCT01987232|9945535|FG001|NOT COMPLETED|Overall Study||0
8887744|NCT01987232|9945536|FG002|NOT COMPLETED|Overall Study||0
8887745|NCT01987232|9945537|FG003|NOT COMPLETED|Overall Study||1
8887746|NCT01987232|9945538|FG004|NOT COMPLETED|Overall Study||0
8887747|NCT01987349|9945560|FG000|STARTED|Overall Study||6
8887748|NCT01987349|9945561|FG001|STARTED|Overall Study||6
8887749|NCT01987349|9945562|FG002|STARTED|Overall Study||8
8887750|NCT01987349|9945563|FG003|STARTED|Overall Study||6
8887751|NCT01987349|9945564|FG004|STARTED|Overall Study||6
8887752|NCT01987349|9945565|FG005|STARTED|Overall Study||6
8887753|NCT01987349|9945566|FG006|STARTED|Overall Study||10
8887754|NCT01987349|9945567|FG007|STARTED|Overall Study||25
8887755|NCT01987349|9945560|FG000|COMPLETED|Overall Study||6
8887756|NCT01987349|9945561|FG001|COMPLETED|Overall Study||6
8887757|NCT01987349|9945562|FG002|COMPLETED|Overall Study||8
8887758|NCT01987349|9945563|FG003|COMPLETED|Overall Study||6
8887759|NCT01987349|9945564|FG004|COMPLETED|Overall Study||6
8887760|NCT01987349|9945565|FG005|COMPLETED|Overall Study||6
8887761|NCT01987349|9945566|FG006|COMPLETED|Overall Study||10
8887762|NCT01987349|9945567|FG007|COMPLETED|Overall Study||24
8887763|NCT01987349|9945560|FG000|NOT COMPLETED|Overall Study||0
8887764|NCT01987349|9945561|FG001|NOT COMPLETED|Overall Study||0
8887765|NCT01987349|9945562|FG002|NOT COMPLETED|Overall Study||0
8887766|NCT01987349|9945563|FG003|NOT COMPLETED|Overall Study||0
8887767|NCT01987349|9945564|FG004|NOT COMPLETED|Overall Study||0
8887768|NCT01987349|9945565|FG005|NOT COMPLETED|Overall Study||0
8887769|NCT01987349|9945566|FG006|NOT COMPLETED|Overall Study||0
8887770|NCT01987349|9945567|FG007|NOT COMPLETED|Overall Study||1
8887771|NCT01987401|9945592|FG000|STARTED|Overall Study||591
8887772|NCT01987401|9945593|FG001|STARTED|Overall Study||591
8887773|NCT01987401|9945594|FG002|STARTED|Overall Study||60
8887774|NCT01987401|9945592|FG000|COMPLETED|Overall Study||137
8887775|NCT01987401|9945593|FG001|COMPLETED|Overall Study||121
8887776|NCT01987401|9945594|FG002|COMPLETED|Overall Study||16
8887777|NCT01987401|9945592|FG000|NOT COMPLETED|Overall Study||454
8887778|NCT01987401|9945593|FG001|NOT COMPLETED|Overall Study||470
9004644|NCT02931253|10067756|FG001|NOT COMPLETED|Overall Study||0
9004645|NCT02931396|10067764|FG000|STARTED|Overall Study||10
9004646|NCT02931396|10067765|FG001|STARTED|Overall Study||10
9004647|NCT02931396|10067764|FG000|COMPLETED|Overall Study||5
9004648|NCT02931396|10067765|FG001|COMPLETED|Overall Study||10
9004649|NCT02931396|10067764|FG000|NOT COMPLETED|Overall Study||5
9004650|NCT02931396|10067765|FG001|NOT COMPLETED|Overall Study||0
9004651|NCT02931539|10067773|FG000|STARTED|Period 1: Treatment Phase||117
9004652|NCT02931539|10067774|FG001|STARTED|Period 1: Treatment Phase||235
9004653|NCT02931539|10067775|FG002|STARTED|Period 1: Treatment Phase||0
9004654|NCT02931539|10067773|FG000|Treated Participants|Period 1: Treatment Phase||116
9004655|NCT02931539|10067774|FG001|Treated Participants|Period 1: Treatment Phase||234
9004656|NCT02931539|10067775|FG002|Treated Participants|Period 1: Treatment Phase||0
9004657|NCT02931539|10067773|FG000|IAT (Ganciclovir/ Valganciclovir)|Period 1: Treatment Phase||56
9004658|NCT02931539|10067774|FG001|IAT (Ganciclovir/ Valganciclovir)|Period 1: Treatment Phase||0
9004659|NCT02931539|10067775|FG002|IAT (Ganciclovir/ Valganciclovir)|Period 1: Treatment Phase||0
9004660|NCT02931539|10067773|FG000|IAT (Foscarnet)|Period 1: Treatment Phase||47
9004661|NCT02931539|10067774|FG001|IAT (Foscarnet)|Period 1: Treatment Phase||0
9004662|NCT02931539|10067775|FG002|IAT (Foscarnet)|Period 1: Treatment Phase||0
9004663|NCT02931539|10067773|FG000|IAT (Cidofovir)|Period 1: Treatment Phase||6
9004664|NCT02931539|10067774|FG001|IAT (Cidofovir)|Period 1: Treatment Phase||0
9004665|NCT02931539|10067775|FG002|IAT (Cidofovir)|Period 1: Treatment Phase||0
9004666|NCT02931539|10067773|FG000|IAT (Foscarnet + Valganciclovir/Ganciclovir)|Period 1: Treatment Phase||7
9004667|NCT02931539|10067774|FG001|IAT (Foscarnet + Valganciclovir/Ganciclovir)|Period 1: Treatment Phase||0
9004668|NCT02931539|10067775|FG002|IAT (Foscarnet + Valganciclovir/Ganciclovir)|Period 1: Treatment Phase||0
8887779|NCT01987401|9945594|FG002|NOT COMPLETED|Overall Study||44
8887780|NCT01987414|9945604|FG000|STARTED|Overall Study||10
8887781|NCT01987414|9945605|FG001|STARTED|Overall Study||8
9004669|NCT02931539|10067773|FG000|COMPLETED|Period 1: Treatment Phase||58
9004670|NCT02931539|10067774|FG001|COMPLETED|Period 1: Treatment Phase||199
9004671|NCT02931539|10067775|FG002|COMPLETED|Period 1: Treatment Phase||0
9004672|NCT02931539|10067773|FG000|NOT COMPLETED|Period 1: Treatment Phase||59
8887782|NCT01987414|9945604|FG000|COMPLETED|Overall Study||8
8887783|NCT01987414|9945605|FG001|COMPLETED|Overall Study||6
8887784|NCT01987414|9945604|FG000|NOT COMPLETED|Overall Study||2
8887785|NCT01987414|9945605|FG001|NOT COMPLETED|Overall Study||2
8887786|NCT01987427|9945614|FG000|STARTED|Overall Study||78
8887787|NCT01987427|9945615|FG001|STARTED|Overall Study||78
8887788|NCT01987427|9945616|FG002|STARTED|Overall Study||79
8887789|NCT01987427|9945614|FG000|COMPLETED|Overall Study||64
8887790|NCT01987427|9945615|FG001|COMPLETED|Overall Study||68
8887791|NCT01987427|9945616|FG002|COMPLETED|Overall Study||59
8887792|NCT01987427|9945614|FG000|NOT COMPLETED|Overall Study||14
8887793|NCT01987427|9945615|FG001|NOT COMPLETED|Overall Study||10
8887794|NCT01987427|9945616|FG002|NOT COMPLETED|Overall Study||20
8887795|NCT01987453|9945627|FG000|STARTED|Overall Study||51
8887796|NCT01987453|9945628|FG001|STARTED|Overall Study||41
8887797|NCT01987453|9945629|FG002|STARTED|Overall Study||8
8887798|NCT01987453|9945627|FG000|COMPLETED|Overall Study||50
8887799|NCT01987453|9945628|FG001|COMPLETED|Overall Study||29
8887800|NCT01987453|9945629|FG002|COMPLETED|Overall Study||7
8887801|NCT01987453|9945627|FG000|NOT COMPLETED|Overall Study||1
8887802|NCT01987453|9945628|FG001|NOT COMPLETED|Overall Study||12
8887803|NCT01987453|9945629|FG002|NOT COMPLETED|Overall Study||1
8887804|NCT01987479|9945641|FG000|STARTED|Overall Study||150
8887805|NCT01987479|9945641|FG000|COMPLETED|Overall Study||133
8887806|NCT01987479|9945641|FG000|NOT COMPLETED|Overall Study||17
8887807|NCT01987505|9945647|FG000|STARTED|Overall Study||140
8887808|NCT01987505|9945647|FG000|COMPLETED|Overall Study||106
8887809|NCT01987505|9945647|FG000|NOT COMPLETED|Overall Study||34
8887810|NCT01987557|9945656|FG000|STARTED|Overall Study||16
8887811|NCT01987557|9945657|FG001|STARTED|Overall Study||16
8887812|NCT01987557|9945658|FG002|STARTED|Overall Study||16
8887813|NCT01987557|9945656|FG000|COMPLETED|Overall Study||13
8887814|NCT01987557|9945657|FG001|COMPLETED|Overall Study||13
8887815|NCT01987557|9945658|FG002|COMPLETED|Overall Study||13
8887816|NCT01987557|9945656|FG000|NOT COMPLETED|Overall Study||3
8887817|NCT01987557|9945657|FG001|NOT COMPLETED|Overall Study||3
8887818|NCT01987557|9945658|FG002|NOT COMPLETED|Overall Study||3
8887819|NCT01987583|9945668|FG000|STARTED|Overall Study||40
8887820|NCT01987583|9945669|FG001|STARTED|Overall Study||40
8887821|NCT01987583|9945668|FG000|COMPLETED|Overall Study||37
8887822|NCT01987583|9945669|FG001|COMPLETED|Overall Study||38
8887823|NCT01987583|9945668|FG000|NOT COMPLETED|Overall Study||3
8887824|NCT01987583|9945669|FG001|NOT COMPLETED|Overall Study||2
8887825|NCT01987596|9945677|FG000|STARTED|Overall Study||12
8887826|NCT01987596|9945678|FG001|STARTED|Overall Study||11
8887827|NCT01987596|9945677|FG000|COMPLETED|Overall Study||11
8887828|NCT01987596|9945678|FG001|COMPLETED|Overall Study||10
8887829|NCT01987596|9945677|FG000|NOT COMPLETED|Overall Study||1
8887830|NCT01987596|9945678|FG001|NOT COMPLETED|Overall Study||1
8887831|NCT01987609|9945690|FG000|STARTED|Overall Study|one arm on one patient|7
8887832|NCT01987609|9945690|FG000|Hylenex Injected in Arm|Overall Study||6
8887833|NCT01987609|9945690|FG000|Normal Saline Injected in Arm|Overall Study||6
8887834|NCT01987609|9945690|FG000|COMPLETED|Overall Study||6
8887835|NCT01987609|9945690|FG000|NOT COMPLETED|Overall Study||1
8887836|NCT01987752|9945704|FG000|STARTED|Overall Study||732
8887837|NCT01987752|9945704|FG000|COMPLETED|Overall Study||732
8887838|NCT01987752|9945704|FG000|NOT COMPLETED|Overall Study||0
8887839|NCT01987765|9945708|FG000|STARTED|Overall Study||847
8887840|NCT01987765|9945708|FG000|COMPLETED|Overall Study||745
8887841|NCT01987765|9945708|FG000|NOT COMPLETED|Overall Study||102
8887842|NCT01987817|9945714|FG000|STARTED|Overall Study||29
8887843|NCT01987817|9945715|FG001|STARTED|Overall Study||27
8887844|NCT01987817|9945714|FG000|COMPLETED|Overall Study||23
8887845|NCT01987817|9945715|FG001|COMPLETED|Overall Study||26
8887846|NCT01987817|9945714|FG000|NOT COMPLETED|Overall Study||6
8887847|NCT01987817|9945715|FG001|NOT COMPLETED|Overall Study||1
8887848|NCT01987830|9945722|FG000|STARTED|Overall Study||13
8887849|NCT01987830|9945722|FG000|COMPLETED|Overall Study||12
8887850|NCT01987830|9945722|FG000|NOT COMPLETED|Overall Study||1
8887851|NCT01987895|9945728|FG000|STARTED|Overall Study||306
8887852|NCT01987895|9945729|FG001|STARTED|Overall Study||326
8887853|NCT01987895|9945728|FG000|COMPLETED|Overall Study||276
8887854|NCT01987895|9945729|FG001|COMPLETED|Overall Study||296
8887855|NCT01987895|9945728|FG000|NOT COMPLETED|Overall Study||30
8887856|NCT01987895|9945729|FG001|NOT COMPLETED|Overall Study||30
8887857|NCT01987908|9945735|FG000|STARTED|Placebo Lead-in Period||23
8887858|NCT01987908|9945736|FG001|STARTED|Placebo Lead-in Period||0
8887859|NCT01987908|9945737|FG002|STARTED|Placebo Lead-in Period||0
8887860|NCT01987908|9945735|FG000|COMPLETED|Placebo Lead-in Period||14
8887861|NCT01987908|9945736|FG001|COMPLETED|Placebo Lead-in Period||0
8887862|NCT01987908|9945737|FG002|COMPLETED|Placebo Lead-in Period||0
9004673|NCT02931539|10067774|FG001|NOT COMPLETED|Period 1: Treatment Phase||36
8887863|NCT01987908|9945735|FG000|NOT COMPLETED|Placebo Lead-in Period||9
8887864|NCT01987908|9945736|FG001|NOT COMPLETED|Placebo Lead-in Period||0
8887865|NCT01987908|9945737|FG002|NOT COMPLETED|Placebo Lead-in Period||0
9004674|NCT02931539|10067775|FG002|NOT COMPLETED|Period 1: Treatment Phase||0
8887866|NCT01987908|9945735|FG000|STARTED|Treatment Period||0
8887867|NCT01987908|9945736|FG001|STARTED|Treatment Period||11
8887868|NCT01987908|9945737|FG002|STARTED|Treatment Period||3
8887869|NCT01987908|9945735|FG000|COMPLETED|Treatment Period||0
8887870|NCT01987908|9945736|FG001|COMPLETED|Treatment Period||10
8887871|NCT01987908|9945737|FG002|COMPLETED|Treatment Period||2
8887872|NCT01987908|9945735|FG000|NOT COMPLETED|Treatment Period||0
8887873|NCT01987908|9945736|FG001|NOT COMPLETED|Treatment Period||1
8887874|NCT01987908|9945737|FG002|NOT COMPLETED|Treatment Period||1
8634755|NCT00558103|9675086|FG003|COMPLETED|Randomized Treatment Phase||11
8634756|NCT00558103|9675087|FG004|COMPLETED|Randomized Treatment Phase||33
8634757|NCT00558103|9675088|FG005|COMPLETED|Randomized Treatment Phase||0
8634758|NCT00558103|9675083|FG000|NOT COMPLETED|Randomized Treatment Phase||5
8634759|NCT00558103|9675084|FG001|NOT COMPLETED|Randomized Treatment Phase||4
8634760|NCT00558103|9675085|FG002|NOT COMPLETED|Randomized Treatment Phase||3
8634761|NCT00558103|9675086|FG003|NOT COMPLETED|Randomized Treatment Phase||2
8634762|NCT00558103|9675087|FG004|NOT COMPLETED|Randomized Treatment Phase||5
8634763|NCT00558103|9675088|FG005|NOT COMPLETED|Randomized Treatment Phase||0
8887875|NCT01987908|9945735|FG000|STARTED|Post-Treatment Observation Period||0
8887876|NCT01987908|9945736|FG001|STARTED|Post-Treatment Observation Period||10
8887877|NCT01987908|9945737|FG002|STARTED|Post-Treatment Observation Period||2
8887878|NCT01987908|9945735|FG000|COMPLETED|Post-Treatment Observation Period||0
8887879|NCT01987908|9945736|FG001|COMPLETED|Post-Treatment Observation Period||7
8887880|NCT01987908|9945737|FG002|COMPLETED|Post-Treatment Observation Period||2
8887881|NCT01987908|9945735|FG000|NOT COMPLETED|Post-Treatment Observation Period||0
8887882|NCT01987908|9945736|FG001|NOT COMPLETED|Post-Treatment Observation Period||3
8887883|NCT01987908|9945737|FG002|NOT COMPLETED|Post-Treatment Observation Period||0
8887884|NCT01987960|9945763|FG000|STARTED|Period 1||417
8887885|NCT01987960|9945764|FG001|STARTED|Period 1||0
8887886|NCT01987960|9945765|FG002|STARTED|Period 1||0
8887887|NCT01987960|9945766|FG003|STARTED|Period 1||0
8887888|NCT01987960|9945763|FG000|COMPLETED|Period 1||231
8887889|NCT01987960|9945764|FG001|COMPLETED|Period 1||0
8887890|NCT01987960|9945765|FG002|COMPLETED|Period 1||0
8887891|NCT01987960|9945766|FG003|COMPLETED|Period 1||0
8887892|NCT01987960|9945763|FG000|NOT COMPLETED|Period 1||186
8887893|NCT01987960|9945764|FG001|NOT COMPLETED|Period 1||0
8887894|NCT01987960|9945765|FG002|NOT COMPLETED|Period 1||0
8887895|NCT01987960|9945766|FG003|NOT COMPLETED|Period 1||0
8887896|NCT01987960|9945763|FG000|STARTED|Period 2||0
8887897|NCT01987960|9945764|FG001|STARTED|Period 2||17
8887898|NCT01987960|9945765|FG002|STARTED|Period 2||23
8887899|NCT01987960|9945766|FG003|STARTED|Period 2||0
8887900|NCT01987960|9945763|FG000|COMPLETED|Period 2||0
8887901|NCT01987960|9945764|FG001|COMPLETED|Period 2||12
8887902|NCT01987960|9945765|FG002|COMPLETED|Period 2||14
8887903|NCT01987960|9945766|FG003|COMPLETED|Period 2||0
8887904|NCT01987960|9945763|FG000|NOT COMPLETED|Period 2||0
8887905|NCT01987960|9945764|FG001|NOT COMPLETED|Period 2||5
8887906|NCT01987960|9945765|FG002|NOT COMPLETED|Period 2||9
8887907|NCT01987960|9945766|FG003|NOT COMPLETED|Period 2||0
8887908|NCT01987960|9945763|FG000|STARTED|Period 3||0
8887909|NCT01987960|9945764|FG001|STARTED|Period 3||0
8887910|NCT01987960|9945765|FG002|STARTED|Period 3||0
8887911|NCT01987960|9945766|FG003|STARTED|Period 3||190
8887912|NCT01987960|9945763|FG000|COMPLETED|Period 3||0
8887913|NCT01987960|9945764|FG001|COMPLETED|Period 3||0
8726059|NCT01033487|9773166|FG009|COMPLETED|Fifth Intervention Period||2
8726060|NCT01033487|9773157|FG000|NOT COMPLETED|Fifth Intervention Period||0
8726061|NCT01033487|9773158|FG001|NOT COMPLETED|Fifth Intervention Period||0
8726062|NCT01033487|9773159|FG002|NOT COMPLETED|Fifth Intervention Period||0
8726063|NCT01033487|9773160|FG003|NOT COMPLETED|Fifth Intervention Period||0
8726064|NCT01033487|9773161|FG004|NOT COMPLETED|Fifth Intervention Period||0
8887914|NCT01987960|9945765|FG002|COMPLETED|Period 3||0
8887915|NCT01987960|9945766|FG003|COMPLETED|Period 3||119
8887916|NCT01987960|9945763|FG000|NOT COMPLETED|Period 3||0
8887917|NCT01987960|9945764|FG001|NOT COMPLETED|Period 3||0
8887918|NCT01987960|9945765|FG002|NOT COMPLETED|Period 3||0
8887919|NCT01987960|9945766|FG003|NOT COMPLETED|Period 3||71
8887920|NCT01987986|9945780|FG000|STARTED|Overall Study||43
8887921|NCT01987986|9945781|FG001|STARTED|Overall Study||43
8887922|NCT01987986|9945782|FG002|STARTED|Overall Study||40
8634764|NCT00558103|9675083|FG000|STARTED|Monotherapy Extension Phase||0
8634765|NCT00558103|9675084|FG001|STARTED|Monotherapy Extension Phase||0
8634766|NCT00558103|9675085|FG002|STARTED|Monotherapy Extension Phase||0
8887923|NCT01987986|9945783|FG003|STARTED|Overall Study||24
8887924|NCT01987986|9945780|FG000|COMPLETED|Overall Study||41
8887925|NCT01987986|9945781|FG001|COMPLETED|Overall Study||43
8887926|NCT01987986|9945782|FG002|COMPLETED|Overall Study||38
8887927|NCT01987986|9945783|FG003|COMPLETED|Overall Study||24
8887928|NCT01987986|9945780|FG000|NOT COMPLETED|Overall Study||2
8887929|NCT01987986|9945781|FG001|NOT COMPLETED|Overall Study||0
8887930|NCT01987986|9945782|FG002|NOT COMPLETED|Overall Study||2
8887931|NCT01987986|9945783|FG003|NOT COMPLETED|Overall Study||0
8887932|NCT01988012|9945793|FG000|STARTED|Overall Study||100
8887933|NCT01988012|9945793|FG000|COMPLETED|Overall Study||85
8634767|NCT00558103|9675086|FG003|STARTED|Monotherapy Extension Phase||0
8726065|NCT01033487|9773162|FG005|NOT COMPLETED|Fifth Intervention Period||0
8887934|NCT01988012|9945793|FG000|NOT COMPLETED|Overall Study||15
8887935|NCT01988090|9945799|FG000|STARTED|Start Treament After Randomization||46
8887936|NCT01988090|9945800|FG001|STARTED|Start Treament After Randomization||47
8887937|NCT01988090|9945799|FG000|COMPLETED|Start Treament After Randomization||44
8887938|NCT01988090|9945800|FG001|COMPLETED|Start Treament After Randomization||43
8887939|NCT01988090|9945799|FG000|NOT COMPLETED|Start Treament After Randomization||2
8887940|NCT01988090|9945800|FG001|NOT COMPLETED|Start Treament After Randomization||4
8887941|NCT01988090|9945799|FG000|STARTED|Complete Study After Start||44
8887942|NCT01988090|9945800|FG001|STARTED|Complete Study After Start||43
8634768|NCT00558103|9675087|FG004|STARTED|Monotherapy Extension Phase||0
8887943|NCT01988090|9945799|FG000|COMPLETED|Complete Study After Start||41
8887944|NCT01988090|9945800|FG001|COMPLETED|Complete Study After Start||42
8887945|NCT01988090|9945799|FG000|NOT COMPLETED|Complete Study After Start||3
8887946|NCT01988090|9945800|FG001|NOT COMPLETED|Complete Study After Start||1
8887947|NCT01988103|9945809|FG000|STARTED|Placebo-Controlled Phase Week 0-16||84
8887948|NCT01988103|9945810|FG001|STARTED|Placebo-Controlled Phase Week 0-16||85
8887949|NCT01988103|9945811|FG002|STARTED|Placebo-Controlled Phase Week 0-16||85
8887950|NCT01988103|9945812|FG003|STARTED|Placebo-Controlled Phase Week 0-16||0
8887951|NCT01988103|9945813|FG004|STARTED|Placebo-Controlled Phase Week 0-16||0
8887952|NCT01988103|9945809|FG000|COMPLETED|Placebo-Controlled Phase Week 0-16||72
8887953|NCT01988103|9945810|FG001|COMPLETED|Placebo-Controlled Phase Week 0-16||69
8887954|NCT01988103|9945811|FG002|COMPLETED|Placebo-Controlled Phase Week 0-16||76
8887955|NCT01988103|9945812|FG003|COMPLETED|Placebo-Controlled Phase Week 0-16||0
8887956|NCT01988103|9945813|FG004|COMPLETED|Placebo-Controlled Phase Week 0-16||0
8887957|NCT01988103|9945809|FG000|NOT COMPLETED|Placebo-Controlled Phase Week 0-16||12
8887958|NCT01988103|9945810|FG001|NOT COMPLETED|Placebo-Controlled Phase Week 0-16||16
8887959|NCT01988103|9945811|FG002|NOT COMPLETED|Placebo-Controlled Phase Week 0-16||9
8887960|NCT01988103|9945812|FG003|NOT COMPLETED|Placebo-Controlled Phase Week 0-16||0
8887961|NCT01988103|9945813|FG004|NOT COMPLETED|Placebo-Controlled Phase Week 0-16||0
8887962|NCT01988103|9945809|FG000|STARTED|Active Treatment Phase (Weeks 16-68)||0
8887963|NCT01988103|9945810|FG001|STARTED|Active Treatment Phase (Weeks 16-68)||69
8887964|NCT01988103|9945811|FG002|STARTED|Active Treatment Phase (Weeks 16-68)||76
8887965|NCT01988103|9945812|FG003|STARTED|Active Treatment Phase (Weeks 16-68)||36
8887966|NCT01988103|9945813|FG004|STARTED|Active Treatment Phase (Weeks 16-68)||35
8887967|NCT01988103|9945809|FG000|COMPLETED|Active Treatment Phase (Weeks 16-68)||0
8887968|NCT01988103|9945810|FG001|COMPLETED|Active Treatment Phase (Weeks 16-68)||56
8887969|NCT01988103|9945811|FG002|COMPLETED|Active Treatment Phase (Weeks 16-68)||65
8887970|NCT01988103|9945812|FG003|COMPLETED|Active Treatment Phase (Weeks 16-68)||33
8887971|NCT01988103|9945813|FG004|COMPLETED|Active Treatment Phase (Weeks 16-68)||30
8887972|NCT01988103|9945809|FG000|NOT COMPLETED|Active Treatment Phase (Weeks 16-68)||0
8887973|NCT01988103|9945810|FG001|NOT COMPLETED|Active Treatment Phase (Weeks 16-68)||13
8887974|NCT01988103|9945811|FG002|NOT COMPLETED|Active Treatment Phase (Weeks 16-68)||11
8887975|NCT01988103|9945812|FG003|NOT COMPLETED|Active Treatment Phase (Weeks 16-68)||3
8887976|NCT01988103|9945813|FG004|NOT COMPLETED|Active Treatment Phase (Weeks 16-68)||5
8887977|NCT01988103|9945809|FG000|STARTED|Observational Follow-up Phase||12
8887978|NCT01988103|9945810|FG001|STARTED|Observational Follow-up Phase||82
8887979|NCT01988103|9945811|FG002|STARTED|Observational Follow-up Phase||83
8887980|NCT01988103|9945812|FG003|STARTED|Observational Follow-up Phase||36
8887981|NCT01988103|9945813|FG004|STARTED|Observational Follow-up Phase||33
8887982|NCT01988103|9945809|FG000|COMPLETED|Observational Follow-up Phase||12
8887983|NCT01988103|9945810|FG001|COMPLETED|Observational Follow-up Phase||79
8887984|NCT01988103|9945811|FG002|COMPLETED|Observational Follow-up Phase||82
8887985|NCT01988103|9945812|FG003|COMPLETED|Observational Follow-up Phase||36
8887986|NCT01988103|9945813|FG004|COMPLETED|Observational Follow-up Phase||33
8887987|NCT01988103|9945809|FG000|NOT COMPLETED|Observational Follow-up Phase||0
8887988|NCT01988103|9945810|FG001|NOT COMPLETED|Observational Follow-up Phase||3
8887989|NCT01988103|9945811|FG002|NOT COMPLETED|Observational Follow-up Phase||1
8887990|NCT01988103|9945812|FG003|NOT COMPLETED|Observational Follow-up Phase||0
8887991|NCT01988103|9945813|FG004|NOT COMPLETED|Observational Follow-up Phase||0
8887992|NCT01988129|9945830|FG000|STARTED|Overall Study|Intervention participant data obtained from department. Individuals not enrolled for primary aim.|601
8887993|NCT01988129|9945831|FG001|STARTED|Overall Study|Control participant data obtained from department. Individuals were not enrolled.|588
8887994|NCT01988129|9945830|FG000|Attended Education Session|Overall Study||542
8887995|NCT01988129|9945831|FG001|Attended Education Session|Overall Study||18
8887996|NCT01988129|9945830|FG000|Screened for Sleep Disorders|Overall Study||416
8887997|NCT01988129|9945831|FG001|Screened for Sleep Disorders|Overall Study||15
8887998|NCT01988129|9945830|FG000|Completed 1-year Follow-up Survey|Overall Study||100
8887999|NCT01988129|9945831|FG001|Completed 1-year Follow-up Survey|Overall Study||4
8888000|NCT01988129|9945830|FG000|COMPLETED|Overall Study||601
8888001|NCT01988129|9945831|FG001|COMPLETED|Overall Study||588
8888002|NCT01988129|9945830|FG000|NOT COMPLETED|Overall Study||0
8888003|NCT01988129|9945831|FG001|NOT COMPLETED|Overall Study||0
8888004|NCT01988246|9945842|FG000|STARTED|Overall Study||15
8888005|NCT01988246|9945843|FG001|STARTED|Overall Study||15
8888006|NCT01988246|9945842|FG000|COMPLETED|Overall Study||14
8888007|NCT01988246|9945843|FG001|COMPLETED|Overall Study||15
8888008|NCT01988246|9945842|FG000|NOT COMPLETED|Overall Study||1
8888009|NCT01988246|9945843|FG001|NOT COMPLETED|Overall Study||0
8888010|NCT01988376|9945851|FG000|STARTED|Overall Study||129
8888011|NCT01988376|9945852|FG001|STARTED|Overall Study||129
8888012|NCT01988376|9945851|FG000|COMPLETED|Overall Study||129
8888013|NCT01988376|9945852|FG001|COMPLETED|Overall Study||129
8888014|NCT01988376|9945851|FG000|NOT COMPLETED|Overall Study||0
8888015|NCT01988376|9945852|FG001|NOT COMPLETED|Overall Study||0
8888016|NCT01988402|9945860|FG000|STARTED|Overall Study||16
8888017|NCT01988402|9945861|FG001|STARTED|Overall Study||19
8888018|NCT01988402|9945860|FG000|COMPLETED|Overall Study||14
8888019|NCT01988402|9945861|FG001|COMPLETED|Overall Study||17
8888020|NCT01988402|9945860|FG000|NOT COMPLETED|Overall Study||2
8888021|NCT01988402|9945861|FG001|NOT COMPLETED|Overall Study||2
8634769|NCT00558103|9675088|FG005|STARTED|Monotherapy Extension Phase|9/11 participants completing pazopanib monotherapy elected to receive lapatinib monotherapy.|9
8634770|NCT00558103|9675083|FG000|COMPLETED|Monotherapy Extension Phase||0
8634771|NCT00558103|9675084|FG001|COMPLETED|Monotherapy Extension Phase||0
8634772|NCT00558103|9675085|FG002|COMPLETED|Monotherapy Extension Phase||0
8634773|NCT00558103|9675086|FG003|COMPLETED|Monotherapy Extension Phase||0
8634774|NCT00558103|9675087|FG004|COMPLETED|Monotherapy Extension Phase||0
8634775|NCT00558103|9675088|FG005|COMPLETED|Monotherapy Extension Phase||0
8634776|NCT00558103|9675083|FG000|NOT COMPLETED|Monotherapy Extension Phase||0
8634777|NCT00558103|9675084|FG001|NOT COMPLETED|Monotherapy Extension Phase||0
8634778|NCT00558103|9675085|FG002|NOT COMPLETED|Monotherapy Extension Phase||0
8634779|NCT00558103|9675086|FG003|NOT COMPLETED|Monotherapy Extension Phase||0
8634780|NCT00558103|9675087|FG004|NOT COMPLETED|Monotherapy Extension Phase||0
8634781|NCT00558103|9675088|FG005|NOT COMPLETED|Monotherapy Extension Phase||9
8634782|NCT00558246|9675101|FG000|STARTED|Overall Study||79
8634783|NCT00558246|9675101|FG000|COMPLETED|Overall Study||79
8634784|NCT00558246|9675101|FG000|NOT COMPLETED|Overall Study||0
8634785|NCT00558259|9675110|FG000|STARTED|Overall Study|Number who started treatment. There were 4 patients randomised to Dabigatran and not treated.|681
8634786|NCT00558259|9675111|FG001|STARTED|Overall Study|Number who started treatment. There were 6 patients randomised to placebo and not treated.|662
8634787|NCT00558259|9675110|FG000|COMPLETED|Overall Study|Completed treatment.|610
8634788|NCT00558259|9675111|FG001|COMPLETED|Overall Study|Completed treatment.|563
8634789|NCT00558259|9675110|FG000|NOT COMPLETED|Overall Study||71
8634790|NCT00558259|9675111|FG001|NOT COMPLETED|Overall Study||99
8634791|NCT00558272|9675119|FG000|STARTED|Overall Study|Randomised|69
8726066|NCT01033487|9773163|FG006|NOT COMPLETED|Fifth Intervention Period||0
8726067|NCT01033487|9773164|FG007|NOT COMPLETED|Fifth Intervention Period||0
8726068|NCT01033487|9773165|FG008|NOT COMPLETED|Fifth Intervention Period||0
8726069|NCT01033487|9773166|FG009|NOT COMPLETED|Fifth Intervention Period||0
8726070|NCT01033565|9773180|FG000|STARTED|Overall Study||1
8726071|NCT01033565|9773180|FG000|COMPLETED|Overall Study||1
8726072|NCT01033565|9773180|FG000|NOT COMPLETED|Overall Study||0
8726073|NCT01033643|9773189|FG000|STARTED|Overall Study||6
8726074|NCT01033643|9773190|FG001|STARTED|Overall Study||6
8726075|NCT01033643|9773191|FG002|STARTED|Overall Study||6
8726076|NCT01033643|9773192|FG003|STARTED|Overall Study||4
8726077|NCT01033643|9773193|FG004|STARTED|Overall Study||0
8726078|NCT01033643|9773194|FG005|STARTED|Overall Study||8
8726079|NCT01033643|9773189|FG000|COMPLETED|Overall Study||6
8726080|NCT01033643|9773190|FG001|COMPLETED|Overall Study||3
8726081|NCT01033643|9773191|FG002|COMPLETED|Overall Study||6
8726082|NCT01033643|9773192|FG003|COMPLETED|Overall Study||4
8726083|NCT01033643|9773193|FG004|COMPLETED|Overall Study||0
8726084|NCT01033643|9773194|FG005|COMPLETED|Overall Study||7
8726085|NCT01033643|9773189|FG000|NOT COMPLETED|Overall Study||0
8726086|NCT01033643|9773190|FG001|NOT COMPLETED|Overall Study||3
8726087|NCT01033643|9773191|FG002|NOT COMPLETED|Overall Study||0
8726088|NCT01033643|9773192|FG003|NOT COMPLETED|Overall Study||0
8726089|NCT01033643|9773193|FG004|NOT COMPLETED|Overall Study||0
8726090|NCT01033643|9773194|FG005|NOT COMPLETED|Overall Study||1
8726091|NCT01033734|9773208|FG000|STARTED|Overall Study||8
8726092|NCT01033734|9773208|FG000|COMPLETED|Overall Study||7
8726093|NCT01033734|9773208|FG000|NOT COMPLETED|Overall Study||1
8726094|NCT01033747|9773223|FG000|STARTED|Overall Study||51
8726095|NCT01033747|9773224|FG001|STARTED|Overall Study||19
8726096|NCT01033747|9773223|FG000|COMPLETED|Overall Study||14
8726097|NCT01033747|9773224|FG001|COMPLETED|Overall Study||4
8726098|NCT01033747|9773223|FG000|NOT COMPLETED|Overall Study||37
8726099|NCT01033747|9773224|FG001|NOT COMPLETED|Overall Study||15
8726100|NCT01033773|9773230|FG000|STARTED|Overall Study||86
8726101|NCT01033773|9773230|FG000|COMPLETED|Overall Study||51
8726102|NCT01033773|9773230|FG000|NOT COMPLETED|Overall Study||35
8726103|NCT01033825|9773241|FG000|STARTED|Overall Study||51
8726104|NCT01033825|9773242|FG001|STARTED|Overall Study||60
8726105|NCT01033825|9773243|FG002|STARTED|Overall Study||57
8726106|NCT01033825|9773244|FG003|STARTED|Overall Study||48
8726107|NCT01033825|9773245|FG004|STARTED|Overall Study||58
8726108|NCT01033825|9773246|FG005|STARTED|Overall Study||18
8888022|NCT01988415|9945867|FG000|STARTED|Overall Study|52 eyes of 26 subjects (paired-eyes: commercial and investigational software)|26
8888023|NCT01988415|9945867|FG000|COMPLETED|Overall Study||26
8888024|NCT01988415|9945867|FG000|NOT COMPLETED|Overall Study||0
8888025|NCT01988662|9945875|FG000|STARTED|Overall Study||104
8888026|NCT01988662|9945876|FG001|STARTED|Overall Study||101
8634792|NCT00558272|9675120|FG001|STARTED|Overall Study|Randomised|70
8726109|NCT01033825|9773247|FG006|STARTED|Overall Study||18
8726110|NCT01033825|9773241|FG000|COMPLETED|Overall Study||48
8726111|NCT01033825|9773242|FG001|COMPLETED|Overall Study||57
8726112|NCT01033825|9773243|FG002|COMPLETED|Overall Study||55
8726113|NCT01033825|9773244|FG003|COMPLETED|Overall Study||46
8726114|NCT01033825|9773245|FG004|COMPLETED|Overall Study||56
8634793|NCT00558272|9675119|FG000|30 Days Follow-up|Overall Study|30 days after last dose|41
8726115|NCT01033825|9773246|FG005|COMPLETED|Overall Study||18
8726116|NCT01033825|9773247|FG006|COMPLETED|Overall Study||18
8726117|NCT01033825|9773241|FG000|NOT COMPLETED|Overall Study||3
8726118|NCT01033825|9773242|FG001|NOT COMPLETED|Overall Study||3
8888027|NCT01988662|9945875|FG000|COMPLETED|Overall Study||100
8888028|NCT01988662|9945876|FG001|COMPLETED|Overall Study||99
8888029|NCT01988662|9945875|FG000|NOT COMPLETED|Overall Study||4
8888030|NCT01988662|9945876|FG001|NOT COMPLETED|Overall Study||2
8888031|NCT01988779|9945885|FG000|STARTED|Overall Study||12
8888032|NCT01988779|9945886|FG001|STARTED|Overall Study||13
8888033|NCT01988779|9945885|FG000|COMPLETED|Overall Study||9
8888034|NCT01988779|9945886|FG001|COMPLETED|Overall Study||11
8888035|NCT01988779|9945885|FG000|NOT COMPLETED|Overall Study||3
8888036|NCT01988779|9945886|FG001|NOT COMPLETED|Overall Study||2
8888037|NCT01988857|9945892|FG000|STARTED|Overall Study||300
8888038|NCT01988857|9945892|FG000|COMPLETED|Overall Study||300
8888039|NCT01988857|9945892|FG000|NOT COMPLETED|Overall Study||0
8888040|NCT01988922|9945899|FG000|STARTED|Overall Study||10
8888041|NCT01988922|9945900|FG001|STARTED|Overall Study||10
8888042|NCT01988922|9945901|FG002|STARTED|Overall Study||10
8888043|NCT01988922|9945899|FG000|COMPLETED|Overall Study||10
8888044|NCT01988922|9945900|FG001|COMPLETED|Overall Study||10
8888045|NCT01988922|9945901|FG002|COMPLETED|Overall Study||10
8888046|NCT01988922|9945899|FG000|NOT COMPLETED|Overall Study||0
8888047|NCT01988922|9945900|FG001|NOT COMPLETED|Overall Study||0
8888048|NCT01988922|9945901|FG002|NOT COMPLETED|Overall Study||0
8888049|NCT01989130|9945914|FG000|STARTED|Overall Study||43
8888050|NCT01989130|9945915|FG001|STARTED|Overall Study||27
8888051|NCT01989130|9945914|FG000|COMPLETED|Overall Study||43
8888052|NCT01989130|9945915|FG001|COMPLETED|Overall Study||27
8888053|NCT01989130|9945914|FG000|NOT COMPLETED|Overall Study||0
8888054|NCT01989130|9945915|FG001|NOT COMPLETED|Overall Study||0
8888055|NCT01989156|9945924|FG000|STARTED|Confinement Period (Population at Day 5)||80
8888056|NCT01989156|9945925|FG001|STARTED|Confinement Period (Population at Day 5)||41
8888057|NCT01989156|9945926|FG002|STARTED|Confinement Period (Population at Day 5)||39
8888058|NCT01989156|9945924|FG000|COMPLETED|Confinement Period (Population at Day 5)||80
8888059|NCT01989156|9945925|FG001|COMPLETED|Confinement Period (Population at Day 5)||40
8888060|NCT01989156|9945926|FG002|COMPLETED|Confinement Period (Population at Day 5)||34
8888061|NCT01989156|9945924|FG000|NOT COMPLETED|Confinement Period (Population at Day 5)||0
8888062|NCT01989156|9945925|FG001|NOT COMPLETED|Confinement Period (Population at Day 5)||1
8888063|NCT01989156|9945926|FG002|NOT COMPLETED|Confinement Period (Population at Day 5)||5
8888064|NCT01989156|9945924|FG000|STARTED|End of Study (Population at Day 90)||80
8888065|NCT01989156|9945925|FG001|STARTED|End of Study (Population at Day 90)||40
8888066|NCT01989156|9945926|FG002|STARTED|End of Study (Population at Day 90)||34
8888067|NCT01989156|9945924|FG000|COMPLETED|End of Study (Population at Day 90)||73
8888068|NCT01989156|9945925|FG001|COMPLETED|End of Study (Population at Day 90)||35
8888069|NCT01989156|9945926|FG002|COMPLETED|End of Study (Population at Day 90)||31
8888070|NCT01989156|9945924|FG000|NOT COMPLETED|End of Study (Population at Day 90)||7
8888071|NCT01989156|9945925|FG001|NOT COMPLETED|End of Study (Population at Day 90)||5
8888072|NCT01989156|9945926|FG002|NOT COMPLETED|End of Study (Population at Day 90)||3
8888073|NCT01989169|9945936|FG000|STARTED|Period 1||15
8888074|NCT01989169|9945937|FG001|STARTED|Period 1||15
8888075|NCT01989169|9945936|FG000|COMPLETED|Period 1||15
8888076|NCT01989169|9945937|FG001|COMPLETED|Period 1||15
8888077|NCT01989169|9945936|FG000|NOT COMPLETED|Period 1||0
8888078|NCT01989169|9945937|FG001|NOT COMPLETED|Period 1||0
8888079|NCT01989169|9945936|FG000|STARTED|Period 2||15
8888080|NCT01989169|9945937|FG001|STARTED|Period 2||15
8888081|NCT01989169|9945936|FG000|COMPLETED|Period 2||15
8888082|NCT01989169|9945937|FG001|COMPLETED|Period 2||14
8888083|NCT01989169|9945936|FG000|NOT COMPLETED|Period 2||0
8888084|NCT01989169|9945937|FG001|NOT COMPLETED|Period 2||1
8888085|NCT01989195|9945943|FG000|STARTED|Overall Study||6
8888086|NCT01989195|9945943|FG000|COMPLETED|Overall Study||6
8888087|NCT01989195|9945943|FG000|NOT COMPLETED|Overall Study||0
8888088|NCT01989208|9945952|FG000|STARTED|200 mg (7 Days)||4
8888089|NCT01989208|9945953|FG001|STARTED|200 mg (7 Days)||12
8888090|NCT01989208|9945952|FG000|COMPLETED|200 mg (7 Days)||4
8888091|NCT01989208|9945953|FG001|COMPLETED|200 mg (7 Days)||11
8888092|NCT01989208|9945952|FG000|NOT COMPLETED|200 mg (7 Days)||0
8888093|NCT01989208|9945953|FG001|NOT COMPLETED|200 mg (7 Days)||1
8888094|NCT01989208|9945952|FG000|STARTED|400 mg (7 Days)||4
8888095|NCT01989208|9945953|FG001|STARTED|400 mg (7 Days)||11
8888096|NCT01989208|9945952|FG000|COMPLETED|400 mg (7 Days)||4
8888097|NCT01989208|9945953|FG001|COMPLETED|400 mg (7 Days)||11
8888098|NCT01989208|9945952|FG000|NOT COMPLETED|400 mg (7 Days)||0
8888099|NCT01989208|9945953|FG001|NOT COMPLETED|400 mg (7 Days)||0
8888100|NCT01989208|9945952|FG000|STARTED|800 mg (7 Days)||4
8888101|NCT01989208|9945953|FG001|STARTED|800 mg (7 Days)||11
8888102|NCT01989208|9945952|FG000|COMPLETED|800 mg (7 Days)||4
8888103|NCT01989208|9945953|FG001|COMPLETED|800 mg (7 Days)||11
8888104|NCT01989208|9945952|FG000|NOT COMPLETED|800 mg (7 Days)||0
8888105|NCT01989208|9945953|FG001|NOT COMPLETED|800 mg (7 Days)||0
8888106|NCT01989221|9945971|FG000|STARTED|Overall Study||14
8888107|NCT01989221|9945971|FG000|COMPLETED|Overall Study||14
8888108|NCT01989221|9945971|FG000|NOT COMPLETED|Overall Study||0
8888109|NCT01989455|9945980|FG000|STARTED|Overall Study||14
8888110|NCT01989455|9945981|FG001|STARTED|Overall Study||14
8888111|NCT01989455|9945982|FG002|STARTED|Overall Study||14
8888112|NCT01989455|9945983|FG003|STARTED|Overall Study||14
9004675|NCT02931539|10067773|FG000|STARTED|Period 2: Maribavir Rescue Therapy||0
9004676|NCT02931539|10067774|FG001|STARTED|Period 2: Maribavir Rescue Therapy||0
9004677|NCT02931539|10067775|FG002|STARTED|Period 2: Maribavir Rescue Therapy||22
8888113|NCT01989455|9945984|FG004|STARTED|Overall Study||8
8888114|NCT01989455|9945980|FG000|COMPLETED|Overall Study||14
8888115|NCT01989455|9945981|FG001|COMPLETED|Overall Study||12
8888116|NCT01989455|9945982|FG002|COMPLETED|Overall Study||13
8888117|NCT01989455|9945983|FG003|COMPLETED|Overall Study||14
8888118|NCT01989455|9945984|FG004|COMPLETED|Overall Study||7
8888119|NCT01989455|9945980|FG000|NOT COMPLETED|Overall Study||0
8888120|NCT01989455|9945981|FG001|NOT COMPLETED|Overall Study||2
8888121|NCT01989455|9945982|FG002|NOT COMPLETED|Overall Study||1
8888122|NCT01989455|9945983|FG003|NOT COMPLETED|Overall Study||0
8888123|NCT01989455|9945984|FG004|NOT COMPLETED|Overall Study||1
8888124|NCT01989468|9946003|FG000|STARTED|Overall Study||138
8888125|NCT01989468|9946004|FG001|STARTED|Overall Study||139
8888126|NCT01989468|9946005|FG002|STARTED|Overall Study||64
8888127|NCT01989468|9946006|FG003|STARTED|Overall Study||65
8888128|NCT01989468|9946007|FG004|STARTED|Overall Study||8
8888129|NCT01989468|9946003|FG000|COMPLETED|Overall Study||91
8888130|NCT01989468|9946004|FG001|COMPLETED|Overall Study||102
8888131|NCT01989468|9946005|FG002|COMPLETED|Overall Study||45
8888132|NCT01989468|9946006|FG003|COMPLETED|Overall Study||49
8888133|NCT01989468|9946007|FG004|COMPLETED|Overall Study||0
8888134|NCT01989468|9946003|FG000|NOT COMPLETED|Overall Study||47
8888135|NCT01989468|9946004|FG001|NOT COMPLETED|Overall Study||37
8888136|NCT01989468|9946005|FG002|NOT COMPLETED|Overall Study||19
8888137|NCT01989468|9946006|FG003|NOT COMPLETED|Overall Study||16
8888138|NCT01989468|9946007|FG004|NOT COMPLETED|Overall Study||8
8888139|NCT01989546|9946020|FG000|STARTED|Overall Study||9
8634794|NCT00558272|9675120|FG001|30 Days Follow-up|Overall Study|30 days after last dose|67
8634795|NCT00558272|9675119|FG000|COMPLETED|Overall Study|4-week treatment period|56
8634796|NCT00558272|9675120|FG001|COMPLETED|Overall Study|4-week treatment period|68
8634797|NCT00558272|9675119|FG000|NOT COMPLETED|Overall Study||13
8888140|NCT01989546|9946020|FG000|COMPLETED|Overall Study||0
8888141|NCT01989546|9946020|FG000|NOT COMPLETED|Overall Study||9
8888142|NCT01989572|9946030|FG000|STARTED|Overall Study||109
8888143|NCT01989572|9946031|FG001|STARTED|Overall Study||111
8888144|NCT01989572|9946032|FG002|STARTED|Overall Study||109
8888145|NCT01989572|9946033|FG003|STARTED|Overall Study||107
8888146|NCT01989572|9946034|FG004|STARTED|Overall Study||190
8888147|NCT01989572|9946035|FG005|STARTED|Overall Study||189
8888148|NCT01989572|9946030|FG000|Treated|Overall Study||104
8888149|NCT01989572|9946031|FG001|Treated|Overall Study||110
8888150|NCT01989572|9946032|FG002|Treated|Overall Study||107
8888151|NCT01989572|9946033|FG003|Treated|Overall Study||104
8888152|NCT01989572|9946034|FG004|Treated|Overall Study||186
8888153|NCT01989572|9946035|FG005|Treated|Overall Study||171
8888154|NCT01989572|9946030|FG000|COMPLETED|Overall Study||54
8888155|NCT01989572|9946031|FG001|COMPLETED|Overall Study||53
8888156|NCT01989572|9946032|FG002|COMPLETED|Overall Study||47
8888157|NCT01989572|9946033|FG003|COMPLETED|Overall Study||56
8888158|NCT01989572|9946034|FG004|COMPLETED|Overall Study||92
8888159|NCT01989572|9946035|FG005|COMPLETED|Overall Study||79
8888160|NCT01989572|9946030|FG000|NOT COMPLETED|Overall Study||55
8888161|NCT01989572|9946031|FG001|NOT COMPLETED|Overall Study||58
8888162|NCT01989572|9946032|FG002|NOT COMPLETED|Overall Study||62
8888163|NCT01989572|9946033|FG003|NOT COMPLETED|Overall Study||51
8888164|NCT01989572|9946034|FG004|NOT COMPLETED|Overall Study||98
8888165|NCT01989572|9946035|FG005|NOT COMPLETED|Overall Study||110
8888166|NCT01989689|9946055|FG000|STARTED|Baseline||11
8888167|NCT01989689|9946056|FG001|STARTED|Baseline||13
8888168|NCT01989689|9946055|FG000|COMPLETED|Baseline||11
8888169|NCT01989689|9946056|FG001|COMPLETED|Baseline||13
8888170|NCT01989689|9946055|FG000|NOT COMPLETED|Baseline||0
8888171|NCT01989689|9946056|FG001|NOT COMPLETED|Baseline||0
8888172|NCT01989689|9946055|FG000|STARTED|Treatment Period 1 ( 3 Months)||11
8888173|NCT01989689|9946056|FG001|STARTED|Treatment Period 1 ( 3 Months)||13
8888174|NCT01989689|9946055|FG000|COMPLETED|Treatment Period 1 ( 3 Months)||11
8888175|NCT01989689|9946056|FG001|COMPLETED|Treatment Period 1 ( 3 Months)||10
8888176|NCT01989689|9946055|FG000|NOT COMPLETED|Treatment Period 1 ( 3 Months)||0
8888177|NCT01989689|9946056|FG001|NOT COMPLETED|Treatment Period 1 ( 3 Months)||3
8888178|NCT01989689|9946055|FG000|STARTED|Treatment Period ( 3 Months)||11
8888179|NCT01989689|9946056|FG001|STARTED|Treatment Period ( 3 Months)||10
8888180|NCT01989689|9946055|FG000|COMPLETED|Treatment Period ( 3 Months)||11
8888181|NCT01989689|9946056|FG001|COMPLETED|Treatment Period ( 3 Months)||10
8888182|NCT01989689|9946055|FG000|NOT COMPLETED|Treatment Period ( 3 Months)||0
8888183|NCT01989689|9946056|FG001|NOT COMPLETED|Treatment Period ( 3 Months)||0
8888184|NCT01989754|9946066|FG000|STARTED|Overall Study||2905
8634798|NCT00558272|9675120|FG001|NOT COMPLETED|Overall Study||2
8888185|NCT01989754|9946067|FG001|STARTED|Overall Study||2907
8888186|NCT01989754|9946066|FG000|Treated|Overall Study||2903
8888187|NCT01989754|9946067|FG001|Treated|Overall Study||2904
8888188|NCT01989754|9946066|FG000|COMPLETED|Overall Study|Participants who died are included in this category.|2866
8888189|NCT01989754|9946067|FG001|COMPLETED|Overall Study|Participants who died are included in this category.|2872
8888190|NCT01989754|9946066|FG000|NOT COMPLETED|Overall Study||39
8634799|NCT00558285|9675131|FG000|STARTED|Overall Study||50
8888191|NCT01989754|9946067|FG001|NOT COMPLETED|Overall Study||35
8888192|NCT01989793|9946075|FG000|STARTED|Overall Study||18
8888193|NCT01989793|9946076|FG001|STARTED|Overall Study||19
8888194|NCT01989793|9946075|FG000|COMPLETED|Overall Study||10
8888195|NCT01989793|9946076|FG001|COMPLETED|Overall Study||15
8888196|NCT01989793|9946075|FG000|NOT COMPLETED|Overall Study||8
8888197|NCT01989793|9946076|FG001|NOT COMPLETED|Overall Study||4
8888198|NCT01989910|9946084|FG000|STARTED|Overall Study||53
8888199|NCT01989910|9946085|FG001|STARTED|Overall Study||54
8888200|NCT01989910|9946084|FG000|COMPLETED|Overall Study||51
8888201|NCT01989910|9946085|FG001|COMPLETED|Overall Study||54
8888202|NCT01989910|9946084|FG000|NOT COMPLETED|Overall Study||2
8888203|NCT01989910|9946085|FG001|NOT COMPLETED|Overall Study||0
9004678|NCT02931539|10067773|FG000|COMPLETED|Period 2: Maribavir Rescue Therapy||0
9004679|NCT02931539|10067774|FG001|COMPLETED|Period 2: Maribavir Rescue Therapy||0
9004680|NCT02931539|10067775|FG002|COMPLETED|Period 2: Maribavir Rescue Therapy||20
9004681|NCT02931539|10067773|FG000|NOT COMPLETED|Period 2: Maribavir Rescue Therapy||0
9004682|NCT02931539|10067774|FG001|NOT COMPLETED|Period 2: Maribavir Rescue Therapy||0
9004683|NCT02931539|10067775|FG002|NOT COMPLETED|Period 2: Maribavir Rescue Therapy||2
9004684|NCT02931565|10067790|FG000|STARTED|Overall Study||2
9004685|NCT02931565|10067791|FG001|STARTED|Overall Study||7
8634800|NCT00558285|9675132|FG001|STARTED|Overall Study||51
8634801|NCT00558285|9675133|FG002|STARTED|Overall Study||51
9004686|NCT02931565|10067790|FG000|COMPLETED|Overall Study||2
9004687|NCT02931565|10067791|FG001|COMPLETED|Overall Study||7
9004688|NCT02931565|10067790|FG000|NOT COMPLETED|Overall Study||0
9004689|NCT02931565|10067791|FG001|NOT COMPLETED|Overall Study||0
9004690|NCT02931838|10067804|FG000|STARTED|Overall Study||45
9004691|NCT02931838|10067805|FG001|STARTED|Overall Study||44
9004692|NCT02931838|10067806|FG002|STARTED|Overall Study||44
9004693|NCT02931838|10067807|FG003|STARTED|Overall Study||45
9004694|NCT02931838|10067808|FG004|STARTED|Overall Study||45
9004695|NCT02931838|10067809|FG005|STARTED|Overall Study||44
9004696|NCT02931838|10067804|FG000|COMPLETED|Overall Study||31
9004697|NCT02931838|10067805|FG001|COMPLETED|Overall Study||34
9004698|NCT02931838|10067806|FG002|COMPLETED|Overall Study||36
9004699|NCT02931838|10067807|FG003|COMPLETED|Overall Study||42
9004700|NCT02931838|10067808|FG004|COMPLETED|Overall Study||39
9004701|NCT02931838|10067809|FG005|COMPLETED|Overall Study||42
9004702|NCT02931838|10067804|FG000|NOT COMPLETED|Overall Study||14
9004703|NCT02931838|10067805|FG001|NOT COMPLETED|Overall Study||10
9004704|NCT02931838|10067806|FG002|NOT COMPLETED|Overall Study||8
9004705|NCT02931838|10067807|FG003|NOT COMPLETED|Overall Study||3
9004706|NCT02931838|10067808|FG004|NOT COMPLETED|Overall Study||6
9004707|NCT02931838|10067809|FG005|NOT COMPLETED|Overall Study||2
9004708|NCT02932228|10067830|FG000|STARTED|Overall Study||150
9004709|NCT02932228|10067831|FG001|STARTED|Overall Study||433
9004710|NCT02932228|10067830|FG000|COMPLETED|Overall Study||140
9004711|NCT02932228|10067831|FG001|COMPLETED|Overall Study||405
9004712|NCT02932228|10067830|FG000|NOT COMPLETED|Overall Study||10
9004713|NCT02932228|10067831|FG001|NOT COMPLETED|Overall Study||28
9004714|NCT02932267|10067839|FG000|STARTED|Overall Study||50
9004715|NCT02932267|10067839|FG000|COMPLETED|Overall Study||42
9004716|NCT02932267|10067839|FG000|NOT COMPLETED|Overall Study||8
9004717|NCT02932306|10067845|FG000|STARTED|Overall Study||406
9004718|NCT02932306|10067846|FG001|STARTED|Overall Study||414
9004719|NCT02932306|10067845|FG000|Intent-to-treat (ITT) Population|Overall Study||406
9004720|NCT02932306|10067846|FG001|Intent-to-treat (ITT) Population|Overall Study||414
9004721|NCT02932306|10067845|FG000|Safety Population|Overall Study||378
9004722|NCT02932306|10067846|FG001|Safety Population|Overall Study||385
9004723|NCT02932306|10067845|FG000|COMPLETED|Overall Study||338
9004724|NCT02932306|10067846|FG001|COMPLETED|Overall Study||337
9004725|NCT02932306|10067845|FG000|NOT COMPLETED|Overall Study||68
9004726|NCT02932306|10067846|FG001|NOT COMPLETED|Overall Study||77
9004727|NCT02932462|10067854|FG000|STARTED|Overall Study||184
9004728|NCT02932462|10067855|FG001|STARTED|Overall Study||189
9004729|NCT02932462|10067854|FG000|COMPLETED|Overall Study||177
9004730|NCT02932462|10067855|FG001|COMPLETED|Overall Study||176
9004731|NCT02932462|10067854|FG000|NOT COMPLETED|Overall Study||7
9004732|NCT02932462|10067855|FG001|NOT COMPLETED|Overall Study||13
9004733|NCT02932787|10067863|FG000|STARTED|Overall Study||22
9004734|NCT02932787|10067864|FG001|STARTED|Overall Study||9
9004735|NCT02932787|10067863|FG000|COMPLETED|Overall Study||22
9004736|NCT02932787|10067864|FG001|COMPLETED|Overall Study||9
9004737|NCT02932787|10067863|FG000|NOT COMPLETED|Overall Study||0
8634802|NCT00558285|9675134|FG003|STARTED|Overall Study||52
9004738|NCT02932787|10067864|FG001|NOT COMPLETED|Overall Study||0
9004739|NCT02932878|10067875|FG000|STARTED|Overall Study||15
9004740|NCT02932878|10067876|FG001|STARTED|Overall Study||1
9004741|NCT02932878|10067875|FG000|COMPLETED|Overall Study||13
9004742|NCT02932878|10067876|FG001|COMPLETED|Overall Study||0
9004743|NCT02932878|10067875|FG000|NOT COMPLETED|Overall Study||2
9004744|NCT02932878|10067876|FG001|NOT COMPLETED|Overall Study||1
9004745|NCT02932891|10067882|FG000|STARTED|Overall Study||28
9004746|NCT02932891|10067882|FG000|COMPLETED|Overall Study||24
9004747|NCT02932891|10067882|FG000|NOT COMPLETED|Overall Study||4
9004748|NCT02932904|10067890|FG000|STARTED|Overall Study||92
9004749|NCT02932904|10067891|FG001|STARTED|Overall Study||85
9004750|NCT02932904|10067892|FG002|STARTED|Overall Study||91
9004751|NCT02932904|10067893|FG003|STARTED|Overall Study||93
8634803|NCT00558285|9675135|FG004|STARTED|Overall Study||53
9004752|NCT02932904|10067890|FG000|Treated|Overall Study||91
9004753|NCT02932904|10067891|FG001|Treated|Overall Study||84
9004754|NCT02932904|10067892|FG002|Treated|Overall Study||91
9004755|NCT02932904|10067893|FG003|Treated|Overall Study||91
9004756|NCT02932904|10067890|FG000|COMPLETED|Overall Study||76
9004757|NCT02932904|10067891|FG001|COMPLETED|Overall Study||67
8888204|NCT01989975|9946091|FG000|STARTED|Overall Study||40
8888205|NCT01989975|9946091|FG000|COMPLETED|Overall Study||40
8888206|NCT01989975|9946091|FG000|NOT COMPLETED|Overall Study||0
8888207|NCT01990261|9946095|FG000|STARTED|Overall Study||33
8888208|NCT01990261|9946095|FG000|Treated|Overall Study||29
8888209|NCT01990261|9946095|FG000|COMPLETED|Overall Study||8
8888210|NCT01990261|9946095|FG000|NOT COMPLETED|Overall Study||25
8888211|NCT01990300|9946099|FG000|STARTED|Overall Study||3281
8888212|NCT01990300|9946099|FG000|COMPLETED|Overall Study||3139
8888213|NCT01990300|9946099|FG000|NOT COMPLETED|Overall Study||142
8888214|NCT01990313|9946103|FG000|STARTED|Overall Study||15
8888215|NCT01990313|9946103|FG000|COMPLETED|Overall Study||14
8888216|NCT01990313|9946103|FG000|NOT COMPLETED|Overall Study||1
8888217|NCT01990339|9946107|FG000|STARTED|Overall Study||14965
8888218|NCT01990339|9946107|FG000|COMPLETED|Overall Study||12653
8888219|NCT01990339|9946107|FG000|NOT COMPLETED|Overall Study||2312
8888220|NCT01990495|9946113|FG000|STARTED|Overall Study||18
8888221|NCT01990495|9946114|FG001|STARTED|Overall Study||19
8888222|NCT01990495|9946113|FG000|COMPLETED|Overall Study||13
8888223|NCT01990495|9946114|FG001|COMPLETED|Overall Study||15
8888224|NCT01990495|9946113|FG000|NOT COMPLETED|Overall Study||5
8888225|NCT01990495|9946114|FG001|NOT COMPLETED|Overall Study||4
8888226|NCT01990534|9946122|FG000|STARTED|Overall Study||60
8888227|NCT01990534|9946122|FG000|COMPLETED|Overall Study||25
8888228|NCT01990534|9946122|FG000|NOT COMPLETED|Overall Study||35
8888229|NCT01990560|9946126|FG000|STARTED|Overall Study||8
8888230|NCT01990560|9946126|FG000|COMPLETED|Overall Study||7
8888231|NCT01990560|9946126|FG000|NOT COMPLETED|Overall Study||1
8888232|NCT01990573|9946133|FG000|STARTED|Overall Study||20
8888233|NCT01990573|9946134|FG001|STARTED|Overall Study||14
8888234|NCT01990573|9946135|FG002|STARTED|Overall Study||17
8888235|NCT01990573|9946133|FG000|COMPLETED|Overall Study||20
8888236|NCT01990573|9946134|FG001|COMPLETED|Overall Study||14
8888237|NCT01990573|9946135|FG002|COMPLETED|Overall Study||16
8888238|NCT01990573|9946133|FG000|NOT COMPLETED|Overall Study||0
8888239|NCT01990573|9946134|FG001|NOT COMPLETED|Overall Study||0
8888240|NCT01990573|9946135|FG002|NOT COMPLETED|Overall Study||1
8888241|NCT01990612|9946145|FG000|STARTED|Overall Study||3044
8888242|NCT01990612|9946146|FG001|STARTED|Overall Study||3062
8888243|NCT01990612|9946145|FG000|COMPLETED|Overall Study||3037
8888244|NCT01990612|9946146|FG001|COMPLETED|Overall Study||3059
8888245|NCT01990612|9946145|FG000|NOT COMPLETED|Overall Study||7
8888246|NCT01990612|9946146|FG001|NOT COMPLETED|Overall Study||3
8888247|NCT01990664|9946154|FG000|STARTED|Overall Study||102
8888248|NCT01990664|9946155|FG001|STARTED|Overall Study||90
8888249|NCT01990664|9946154|FG000|COMPLETED|Overall Study||95
8888250|NCT01990664|9946155|FG001|COMPLETED|Overall Study||79
8888251|NCT01990664|9946154|FG000|NOT COMPLETED|Overall Study||7
8888252|NCT01990664|9946155|FG001|NOT COMPLETED|Overall Study||11
8888253|NCT01990677|9946163|FG000|STARTED|Overall Study||12
8888254|NCT01990677|9946164|FG001|STARTED|Overall Study||6
8888255|NCT01990677|9946163|FG000|COMPLETED|Overall Study||10
8888256|NCT01990677|9946164|FG001|COMPLETED|Overall Study||5
8888257|NCT01990677|9946163|FG000|NOT COMPLETED|Overall Study||2
8888258|NCT01990677|9946164|FG001|NOT COMPLETED|Overall Study||1
8888259|NCT01990703|9946172|FG000|STARTED|Overall Study||147
8888260|NCT01990703|9946173|FG001|STARTED|Overall Study||138
8888261|NCT01990703|9946172|FG000|COMPLETED|Overall Study||108
8888262|NCT01990703|9946173|FG001|COMPLETED|Overall Study||93
8888263|NCT01990703|9946172|FG000|NOT COMPLETED|Overall Study||39
8888264|NCT01990703|9946173|FG001|NOT COMPLETED|Overall Study||45
8888265|NCT01990742|9946181|FG000|STARTED|Overall Study|This is a facility-level intervention, access to individual level records occurred via MDS data only|3259
8888266|NCT01990742|9946182|FG001|STARTED|Overall Study|This is a facility-level control , access to individual participants occurred only via MDS records.|4331
8888267|NCT01990742|9946181|FG000|COMPLETED|Overall Study|Fourteen facilities completed the intervention.|2852
8888268|NCT01990742|9946182|FG001|COMPLETED|Overall Study|Eleven nursing homes completed the control group /usual care allocation.|2978
8888269|NCT01990742|9946181|FG000|NOT COMPLETED|Overall Study||407
8888270|NCT01990742|9946182|FG001|NOT COMPLETED|Overall Study||1353
8888271|NCT01990768|9946191|FG000|STARTED|Intervention Started||345
8888272|NCT01990768|9946192|FG001|STARTED|Intervention Started||345
8888273|NCT01990768|9946193|FG002|STARTED|Intervention Started||373
8888274|NCT01990768|9946191|FG000|COMPLETED|Intervention Started||309
8888275|NCT01990768|9946192|FG001|COMPLETED|Intervention Started||312
8888276|NCT01990768|9946193|FG002|COMPLETED|Intervention Started||346
8888277|NCT01990768|9946191|FG000|NOT COMPLETED|Intervention Started||36
8888278|NCT01990768|9946192|FG001|NOT COMPLETED|Intervention Started||33
8888279|NCT01990768|9946193|FG002|NOT COMPLETED|Intervention Started||27
8888280|NCT01990768|9946191|FG000|STARTED|Prehospital Study Drug Infusion||309
8888281|NCT01990768|9946192|FG001|STARTED|Prehospital Study Drug Infusion||312
8888282|NCT01990768|9946193|FG002|STARTED|Prehospital Study Drug Infusion||346
8888283|NCT01990768|9946191|FG000|COMPLETED|Prehospital Study Drug Infusion||290
8888284|NCT01990768|9946192|FG001|COMPLETED|Prehospital Study Drug Infusion||285
8888285|NCT01990768|9946193|FG002|COMPLETED|Prehospital Study Drug Infusion||327
8888286|NCT01990768|9946191|FG000|NOT COMPLETED|Prehospital Study Drug Infusion||19
8888287|NCT01990768|9946192|FG001|NOT COMPLETED|Prehospital Study Drug Infusion||27
8888288|NCT01990768|9946193|FG002|NOT COMPLETED|Prehospital Study Drug Infusion||19
8888289|NCT01990768|9946191|FG000|STARTED|In-Hospital Study Drug Infusion||309
8888290|NCT01990768|9946192|FG001|STARTED|In-Hospital Study Drug Infusion||312
8888291|NCT01990768|9946193|FG002|STARTED|In-Hospital Study Drug Infusion||346
8888292|NCT01990768|9946191|FG000|COMPLETED|In-Hospital Study Drug Infusion||214
8888293|NCT01990768|9946192|FG001|COMPLETED|In-Hospital Study Drug Infusion||229
9004758|NCT02932904|10067892|FG002|COMPLETED|Overall Study||68
9004759|NCT02932904|10067893|FG003|COMPLETED|Overall Study||79
9004760|NCT02932904|10067890|FG000|NOT COMPLETED|Overall Study||16
9004761|NCT02932904|10067891|FG001|NOT COMPLETED|Overall Study||18
9004762|NCT02932904|10067892|FG002|NOT COMPLETED|Overall Study||23
9004763|NCT02932904|10067893|FG003|NOT COMPLETED|Overall Study||14
9004764|NCT02932943|10067908|FG000|STARTED|Overall Study||227
9004765|NCT02932943|10067909|FG001|STARTED|Overall Study||231
9004766|NCT02932943|10067908|FG000|COMPLETED|Overall Study||222
9004767|NCT02932943|10067909|FG001|COMPLETED|Overall Study||224
9004768|NCT02932943|10067908|FG000|NOT COMPLETED|Overall Study||5
9004769|NCT02932943|10067909|FG001|NOT COMPLETED|Overall Study||7
9004770|NCT02933034|10067915|FG000|STARTED|Overall Study||33
9004771|NCT02933034|10067915|FG000|Received Both MEMRI and DEMRI Scans|Overall Study||24
9004772|NCT02933034|10067915|FG000|COMPLETED|Overall Study||24
9004773|NCT02933034|10067915|FG000|NOT COMPLETED|Overall Study||9
9004774|NCT02933060|10067921|FG000|STARTED|Overall Study||25
9004775|NCT02933060|10067922|FG001|STARTED|Overall Study||25
9004776|NCT02933060|10067921|FG000|COMPLETED|Overall Study||25
9004777|NCT02933060|10067922|FG001|COMPLETED|Overall Study||24
9004778|NCT02933060|10067921|FG000|NOT COMPLETED|Overall Study||0
9004779|NCT02933060|10067922|FG001|NOT COMPLETED|Overall Study||1
9004780|NCT02933320|10067932|FG000|STARTED|Overall Study||13
9004781|NCT02933320|10067933|FG001|STARTED|Overall Study||1
9004782|NCT02933320|10067934|FG002|STARTED|Overall Study|Trial terminated early|0
9004783|NCT02933320|10067935|FG003|STARTED|Overall Study|Trial terminated early|0
9004784|NCT02933320|10067932|FG000|COMPLETED|Overall Study||13
9004785|NCT02933320|10067933|FG001|COMPLETED|Overall Study||1
9004786|NCT02933320|10067934|FG002|COMPLETED|Overall Study||0
9004787|NCT02933320|10067935|FG003|COMPLETED|Overall Study||0
9004788|NCT02933320|10067932|FG000|NOT COMPLETED|Overall Study||0
9004789|NCT02933320|10067933|FG001|NOT COMPLETED|Overall Study||0
9004790|NCT02933320|10067934|FG002|NOT COMPLETED|Overall Study||0
9004791|NCT02933320|10067935|FG003|NOT COMPLETED|Overall Study||0
9004792|NCT02933372|10067947|FG000|STARTED|Overall Study||15
9004793|NCT02933372|10067948|FG001|STARTED|Overall Study||10
9004794|NCT02933372|10067947|FG000|COMPLETED|Overall Study||15
9004795|NCT02933372|10067948|FG001|COMPLETED|Overall Study||10
9004796|NCT02933372|10067947|FG000|NOT COMPLETED|Overall Study||0
9004797|NCT02933372|10067948|FG001|NOT COMPLETED|Overall Study||0
9004798|NCT02933450|10067956|FG000|STARTED|Overall Study||20
9004799|NCT02933450|10067957|FG001|STARTED|Overall Study||23
9004800|NCT02933450|10067956|FG000|COMPLETED|Overall Study||15
9004801|NCT02933450|10067957|FG001|COMPLETED|Overall Study||15
9004802|NCT02933450|10067956|FG000|NOT COMPLETED|Overall Study||5
9004803|NCT02933450|10067957|FG001|NOT COMPLETED|Overall Study||8
9004804|NCT02933476|10067963|FG000|STARTED|Overall Study||5
9004805|NCT02933476|10067963|FG000|COMPLETED|Overall Study||5
9004806|NCT02933476|10067963|FG000|NOT COMPLETED|Overall Study||0
9004807|NCT02933489|10067969|FG000|STARTED|Overall Study||757
8888294|NCT01990768|9946193|FG002|COMPLETED|In-Hospital Study Drug Infusion||266
8888295|NCT01990768|9946191|FG000|NOT COMPLETED|In-Hospital Study Drug Infusion||95
9004808|NCT02933489|10067970|FG001|STARTED|Overall Study||759
9004809|NCT02933489|10067969|FG000|DBTperformed|Overall Study||726
9004810|NCT02933489|10067970|FG001|DBTperformed|Overall Study||737
9004811|NCT02933489|10067969|FG000|AB MR Performed|Overall Study||713
9004812|NCT02933489|10067970|FG001|AB MR Performed|Overall Study||733
9004813|NCT02933489|10067969|FG000|COMPLETED|Overall Study||713
9004814|NCT02933489|10067970|FG001|COMPLETED|Overall Study||731
8888296|NCT01990768|9946192|FG001|NOT COMPLETED|In-Hospital Study Drug Infusion||83
8888297|NCT01990768|9946193|FG002|NOT COMPLETED|In-Hospital Study Drug Infusion||80
8888298|NCT01990768|9946191|FG000|STARTED|6-Month Follow-up||309
8888299|NCT01990768|9946192|FG001|STARTED|6-Month Follow-up||312
8888300|NCT01990768|9946193|FG002|STARTED|6-Month Follow-up||346
8888301|NCT01990768|9946191|FG000|COMPLETED|6-Month Follow-up||270
8888302|NCT01990768|9946192|FG001|COMPLETED|6-Month Follow-up||261
8888303|NCT01990768|9946193|FG002|COMPLETED|6-Month Follow-up||288
8888304|NCT01990768|9946191|FG000|NOT COMPLETED|6-Month Follow-up||39
8888305|NCT01990768|9946192|FG001|NOT COMPLETED|6-Month Follow-up||51
8888306|NCT01990768|9946193|FG002|NOT COMPLETED|6-Month Follow-up||58
8888307|NCT01990794|9946202|FG000|STARTED|Overall Study||13
8888308|NCT01990794|9946202|FG000|One Month Into Study|Overall Study||10
8888309|NCT01990794|9946202|FG000|COMPLETED|Overall Study||10
8888310|NCT01990794|9946202|FG000|NOT COMPLETED|Overall Study||3
8888311|NCT01990820|9946291|FG000|STARTED|Overall Study||13
8888312|NCT01990820|9946292|FG001|STARTED|Overall Study||12
8888313|NCT01990820|9946291|FG000|COMPLETED|Overall Study||13
8888314|NCT01990820|9946292|FG001|COMPLETED|Overall Study||12
8888315|NCT01990820|9946291|FG000|NOT COMPLETED|Overall Study||0
8888316|NCT01990820|9946292|FG001|NOT COMPLETED|Overall Study||0
8888317|NCT01990859|9946298|FG000|STARTED|Treatment (4 Doses Over 12 Weeks)||20
8888318|NCT01990859|9946298|FG000|COMPLETED|Treatment (4 Doses Over 12 Weeks)||15
8888319|NCT01990859|9946298|FG000|NOT COMPLETED|Treatment (4 Doses Over 12 Weeks)||5
8888320|NCT01990859|9946298|FG000|STARTED|Week 12 to Week 24 Post Dosing Follow Up|All were entered into follow-up whether dosing was completed or not.|20
8888321|NCT01990859|9946298|FG000|COMPLETED|Week 12 to Week 24 Post Dosing Follow Up||3
8888322|NCT01990859|9946298|FG000|NOT COMPLETED|Week 12 to Week 24 Post Dosing Follow Up||17
8888323|NCT01990859|9946298|FG000|STARTED|90 Day Follow Up for All Participants|All entered into 90 day follow-up whether treatment and/or post dose follow up was completed or not.|20
8888324|NCT01990859|9946298|FG000|COMPLETED|90 Day Follow Up for All Participants||20
8888325|NCT01990859|9946298|FG000|NOT COMPLETED|90 Day Follow Up for All Participants||0
8888326|NCT01990898|9946303|FG000|STARTED|Overall Study||26
8888327|NCT01990898|9946303|FG000|3 Months|Overall Study||22
8888328|NCT01990898|9946303|FG000|COMPLETED|Overall Study||22
8888329|NCT01990898|9946303|FG000|NOT COMPLETED|Overall Study||4
8888330|NCT01990950|9946307|FG000|STARTED|Overall Study||21
8888331|NCT01990950|9946307|FG000|COMPLETED|Overall Study||10
8888332|NCT01990950|9946307|FG000|NOT COMPLETED|Overall Study||11
8888333|NCT01991197|9946313|FG000|STARTED|Overall Study||9
8888334|NCT01991197|9946314|FG001|STARTED|Overall Study||11
8888335|NCT01991197|9946313|FG000|COMPLETED|Overall Study||6
8888336|NCT01991197|9946314|FG001|COMPLETED|Overall Study||8
8888337|NCT01991197|9946313|FG000|NOT COMPLETED|Overall Study||3
8888338|NCT01991197|9946314|FG001|NOT COMPLETED|Overall Study||3
8888339|NCT01991314|9946327|FG000|STARTED|Overall Study||45
8888340|NCT01991314|9946328|FG001|STARTED|Overall Study||43
8888341|NCT01991314|9946327|FG000|COMPLETED|Overall Study||34
8634804|NCT00558285|9675131|FG000|Safety: Received Study Drug|Overall Study||49
8634805|NCT00558285|9675132|FG001|Safety: Received Study Drug|Overall Study||51
8634806|NCT00558285|9675133|FG002|Safety: Received Study Drug|Overall Study||51
8634807|NCT00558285|9675134|FG003|Safety: Received Study Drug|Overall Study||51
8634808|NCT00558285|9675135|FG004|Safety: Received Study Drug|Overall Study||53
8888342|NCT01991314|9946328|FG001|COMPLETED|Overall Study||32
8888343|NCT01991314|9946327|FG000|NOT COMPLETED|Overall Study||11
8888344|NCT01991314|9946328|FG001|NOT COMPLETED|Overall Study||11
8888345|NCT01991470|9946334|FG000|STARTED|Enlite 1 Period||161
8888346|NCT01991470|9946334|FG000|COMPLETED|Enlite 1 Period||141
8888347|NCT01991470|9946334|FG000|NOT COMPLETED|Enlite 1 Period||20
8888348|NCT01991470|9946334|FG000|STARTED|Enlite 3 Period|Additional 25 subjects who participated only Enlite 3 phase|158
8888349|NCT01991470|9946334|FG000|COMPLETED|Enlite 3 Period||146
8888350|NCT01991470|9946334|FG000|NOT COMPLETED|Enlite 3 Period||12
8888351|NCT01991483|9946350|FG000|STARTED|Dose Level: Placebo||7
8888352|NCT01991483|9946351|FG001|STARTED|Dose Level: Placebo||0
8888353|NCT01991483|9946352|FG002|STARTED|Dose Level: Placebo||0
8888354|NCT01991483|9946353|FG003|STARTED|Dose Level: Placebo||0
8888355|NCT01991483|9946350|FG000|Received at Least One Dose of Study Drug|Dose Level: Placebo||7
8888356|NCT01991483|9946351|FG001|Received at Least One Dose of Study Drug|Dose Level: Placebo||0
8888357|NCT01991483|9946352|FG002|Received at Least One Dose of Study Drug|Dose Level: Placebo||0
8888358|NCT01991483|9946353|FG003|Received at Least One Dose of Study Drug|Dose Level: Placebo||0
8888359|NCT01991483|9946350|FG000|COMPLETED|Dose Level: Placebo||7
8888360|NCT01991483|9946351|FG001|COMPLETED|Dose Level: Placebo||0
8888361|NCT01991483|9946352|FG002|COMPLETED|Dose Level: Placebo||0
8888362|NCT01991483|9946353|FG003|COMPLETED|Dose Level: Placebo||0
8888363|NCT01991483|9946350|FG000|NOT COMPLETED|Dose Level: Placebo||0
8888364|NCT01991483|9946351|FG001|NOT COMPLETED|Dose Level: Placebo||0
8888365|NCT01991483|9946352|FG002|NOT COMPLETED|Dose Level: Placebo||0
8888366|NCT01991483|9946353|FG003|NOT COMPLETED|Dose Level: Placebo||0
8888367|NCT01991483|9946350|FG000|STARTED|Dose Level 300 mg|Multiple periods were added for each dose level to represent dose escalation.|0
8888368|NCT01991483|9946351|FG001|STARTED|Dose Level 300 mg|Multiple periods were added for each dose level to represent dose escalation.|6
8888369|NCT01991483|9946352|FG002|STARTED|Dose Level 300 mg||0
8888370|NCT01991483|9946353|FG003|STARTED|Dose Level 300 mg||0
8634809|NCT00558285|9675131|FG000|COMPLETED|Overall Study||44
8634810|NCT00558285|9675132|FG001|COMPLETED|Overall Study||48
8888371|NCT01991483|9946350|FG000|Received at Least One Dose of Study Drug|Dose Level 300 mg||0
8888372|NCT01991483|9946351|FG001|Received at Least One Dose of Study Drug|Dose Level 300 mg||6
8888373|NCT01991483|9946352|FG002|Received at Least One Dose of Study Drug|Dose Level 300 mg||0
8888374|NCT01991483|9946353|FG003|Received at Least One Dose of Study Drug|Dose Level 300 mg||0
8888375|NCT01991483|9946350|FG000|COMPLETED|Dose Level 300 mg||0
8888376|NCT01991483|9946351|FG001|COMPLETED|Dose Level 300 mg||6
8888377|NCT01991483|9946352|FG002|COMPLETED|Dose Level 300 mg||0
8888378|NCT01991483|9946353|FG003|COMPLETED|Dose Level 300 mg||0
8888379|NCT01991483|9946350|FG000|NOT COMPLETED|Dose Level 300 mg||0
8888380|NCT01991483|9946351|FG001|NOT COMPLETED|Dose Level 300 mg||0
8888381|NCT01991483|9946352|FG002|NOT COMPLETED|Dose Level 300 mg||0
8888382|NCT01991483|9946353|FG003|NOT COMPLETED|Dose Level 300 mg||0
8888383|NCT01991483|9946350|FG000|STARTED|Dose Level 600 mg||0
8888384|NCT01991483|9946351|FG001|STARTED|Dose Level 600 mg|Multiple periods were added for each dose level to represent dose escalation.|0
8888385|NCT01991483|9946352|FG002|STARTED|Dose Level 600 mg|Multiple periods were added for each dose level to represent dose escalation.|11
8888386|NCT01991483|9946353|FG003|STARTED|Dose Level 600 mg||0
8888387|NCT01991483|9946350|FG000|Receive at Least One Dose of Study Drug|Dose Level 600 mg||0
8888388|NCT01991483|9946351|FG001|Receive at Least One Dose of Study Drug|Dose Level 600 mg||0
8888389|NCT01991483|9946352|FG002|Receive at Least One Dose of Study Drug|Dose Level 600 mg||11
8888390|NCT01991483|9946353|FG003|Receive at Least One Dose of Study Drug|Dose Level 600 mg||0
8888391|NCT01991483|9946350|FG000|COMPLETED|Dose Level 600 mg||0
8888392|NCT01991483|9946351|FG001|COMPLETED|Dose Level 600 mg||0
8888393|NCT01991483|9946352|FG002|COMPLETED|Dose Level 600 mg||9
8888394|NCT01991483|9946353|FG003|COMPLETED|Dose Level 600 mg||0
8888395|NCT01991483|9946350|FG000|NOT COMPLETED|Dose Level 600 mg||0
8888396|NCT01991483|9946351|FG001|NOT COMPLETED|Dose Level 600 mg||0
8888397|NCT01991483|9946352|FG002|NOT COMPLETED|Dose Level 600 mg||2
8888398|NCT01991483|9946353|FG003|NOT COMPLETED|Dose Level 600 mg||0
8888399|NCT01991483|9946350|FG000|STARTED|Dose Level 1000 mg||0
8888400|NCT01991483|9946351|FG001|STARTED|Dose Level 1000 mg||0
8888401|NCT01991483|9946352|FG002|STARTED|Dose Level 1000 mg|Multiple periods were added for each dose level to represent dose escalation.|0
8888402|NCT01991483|9946353|FG003|STARTED|Dose Level 1000 mg|Multiple periods were added for each dose level to represent dose escalation.|4
8888403|NCT01991483|9946350|FG000|Received at Least One Dose of Study Drug|Dose Level 1000 mg||0
8888404|NCT01991483|9946351|FG001|Received at Least One Dose of Study Drug|Dose Level 1000 mg||0
8888405|NCT01991483|9946352|FG002|Received at Least One Dose of Study Drug|Dose Level 1000 mg||0
8888406|NCT01991483|9946353|FG003|Received at Least One Dose of Study Drug|Dose Level 1000 mg||4
8888407|NCT01991483|9946350|FG000|COMPLETED|Dose Level 1000 mg||0
8888408|NCT01991483|9946351|FG001|COMPLETED|Dose Level 1000 mg||0
8888409|NCT01991483|9946352|FG002|COMPLETED|Dose Level 1000 mg||0
8888410|NCT01991483|9946353|FG003|COMPLETED|Dose Level 1000 mg||3
8888411|NCT01991483|9946350|FG000|NOT COMPLETED|Dose Level 1000 mg||0
8888412|NCT01991483|9946351|FG001|NOT COMPLETED|Dose Level 1000 mg||0
8888413|NCT01991483|9946352|FG002|NOT COMPLETED|Dose Level 1000 mg||0
8888414|NCT01991483|9946353|FG003|NOT COMPLETED|Dose Level 1000 mg||1
8888415|NCT01991522|9946368|FG000|STARTED|Overall Study||16
8888416|NCT01991522|9946369|FG001|STARTED|Overall Study||17
8888417|NCT01991522|9946368|FG000|COMPLETED|Overall Study||16
8888418|NCT01991522|9946369|FG001|COMPLETED|Overall Study||17
8888419|NCT01991522|9946368|FG000|NOT COMPLETED|Overall Study||0
8888420|NCT01991522|9946369|FG001|NOT COMPLETED|Overall Study||0
8888421|NCT01991548|9946375|FG000|STARTED|Overall Study||40
8888422|NCT01991548|9946375|FG000|COMPLETED|Overall Study||39
8888423|NCT01991548|9946375|FG000|NOT COMPLETED|Overall Study||1
8888424|NCT01991743|9946383|FG000|STARTED|Overall Study||60
9004815|NCT02933489|10067969|FG000|NOT COMPLETED|Overall Study||44
9004816|NCT02933489|10067970|FG001|NOT COMPLETED|Overall Study||28
9004817|NCT02933502|10067981|FG000|STARTED|Overall Study||3
9004818|NCT02933502|10067981|FG000|COMPLETED|Overall Study||3
9004819|NCT02933502|10067981|FG000|NOT COMPLETED|Overall Study||0
9004820|NCT02933528|10067985|FG000|STARTED|Overall Study||24
9004821|NCT02933528|10067985|FG000|COMPLETED|Overall Study||22
9004822|NCT02933528|10067985|FG000|NOT COMPLETED|Overall Study||2
9004823|NCT02933866|10067991|FG000|STARTED|Overall Study||186
9004824|NCT02933866|10067992|FG001|STARTED|Overall Study||185
9004825|NCT02933866|10067991|FG000|COMPLETED|Overall Study||174
9004826|NCT02933866|10067992|FG001|COMPLETED|Overall Study||176
9004827|NCT02933866|10067991|FG000|NOT COMPLETED|Overall Study||12
9004828|NCT02933866|10067992|FG001|NOT COMPLETED|Overall Study||9
9004829|NCT02933879|10068001|FG000|STARTED|Overall Study||64
9004830|NCT02933879|10068002|FG001|STARTED|Overall Study||62
9004831|NCT02933879|10068003|FG002|STARTED|Overall Study||58
8888425|NCT01991743|9946384|FG001|STARTED|Overall Study||60
8888426|NCT01991743|9946385|FG002|STARTED|Overall Study||60
9004832|NCT02933879|10068001|FG000|COMPLETED|Overall Study||48
8888427|NCT01991743|9946386|FG003|STARTED|Overall Study||60
8888428|NCT01991743|9946383|FG000|COMPLETED|Overall Study||60
8888429|NCT01991743|9946384|FG001|COMPLETED|Overall Study||60
8888430|NCT01991743|9946385|FG002|COMPLETED|Overall Study||59
8888431|NCT01991743|9946386|FG003|COMPLETED|Overall Study||60
9004833|NCT02933879|10068002|FG001|COMPLETED|Overall Study||48
9004834|NCT02933879|10068003|FG002|COMPLETED|Overall Study||41
9004835|NCT02933879|10068001|FG000|NOT COMPLETED|Overall Study||16
9004836|NCT02933879|10068002|FG001|NOT COMPLETED|Overall Study||14
8888432|NCT01991743|9946383|FG000|NOT COMPLETED|Overall Study||0
8888433|NCT01991743|9946384|FG001|NOT COMPLETED|Overall Study||0
8888434|NCT01991743|9946385|FG002|NOT COMPLETED|Overall Study||1
8888435|NCT01991743|9946386|FG003|NOT COMPLETED|Overall Study||0
8888436|NCT01991795|9946398|FG000|STARTED|Overall Study||9645
8888437|NCT01991795|9946399|FG001|STARTED|Overall Study||9626
8888438|NCT01991795|9946398|FG000|COMPLETED|Overall Study||9496
8888439|NCT01991795|9946399|FG001|COMPLETED|Overall Study||9503
8888440|NCT01991795|9946398|FG000|NOT COMPLETED|Overall Study||149
8888441|NCT01991795|9946399|FG001|NOT COMPLETED|Overall Study||123
8888442|NCT01991808|9946405|FG000|STARTED|Overall Study||16
8888443|NCT01991808|9946405|FG000|COMPLETED|Overall Study||16
8888444|NCT01991808|9946405|FG000|NOT COMPLETED|Overall Study||0
8888445|NCT01991821|9946411|FG000|STARTED|Overall Study||169
8888446|NCT01991821|9946412|FG001|STARTED|Overall Study||178
8888447|NCT01991821|9946411|FG000|COMPLETED|Overall Study||6
8888448|NCT01991821|9946412|FG001|COMPLETED|Overall Study||11
8888449|NCT01991821|9946411|FG000|NOT COMPLETED|Overall Study||163
8888450|NCT01991821|9946412|FG001|NOT COMPLETED|Overall Study||167
8888451|NCT01991860|9946422|FG000|STARTED|Overall Study||176
8888452|NCT01991860|9946423|FG001|STARTED|Overall Study||166
8888453|NCT01991860|9946422|FG000|COMPLETED|Overall Study||172
8888454|NCT01991860|9946423|FG001|COMPLETED|Overall Study||164
8888455|NCT01991860|9946422|FG000|NOT COMPLETED|Overall Study||4
8888456|NCT01991860|9946423|FG001|NOT COMPLETED|Overall Study||2
8888457|NCT01991977|9946429|FG000|STARTED|Overall Study||91
8888458|NCT01991977|9946429|FG000|Received PET Tracer|Overall Study||84
8888459|NCT01991977|9946429|FG000|Received IMRT Treatment|Overall Study||79
8888460|NCT01991977|9946429|FG000|Evaluable for the Primary Outcome|Overall Study||39
9004837|NCT02933879|10068003|FG002|NOT COMPLETED|Overall Study||17
9004838|NCT02934178|10068015|FG000|STARTED|Received Vaccination 1||12
9004839|NCT02934178|10068016|FG001|STARTED|Received Vaccination 1||4
9004840|NCT02934178|10068015|FG000|COMPLETED|Received Vaccination 1||12
9004841|NCT02934178|10068016|FG001|COMPLETED|Received Vaccination 1||4
9004842|NCT02934178|10068015|FG000|NOT COMPLETED|Received Vaccination 1||0
9004843|NCT02934178|10068016|FG001|NOT COMPLETED|Received Vaccination 1||0
9004844|NCT02934178|10068015|FG000|STARTED|Received Vaccination 2||12
9004845|NCT02934178|10068016|FG001|STARTED|Received Vaccination 2||4
9004846|NCT02934178|10068015|FG000|COMPLETED|Received Vaccination 2||12
9004847|NCT02934178|10068016|FG001|COMPLETED|Received Vaccination 2||3
9004848|NCT02934178|10068015|FG000|NOT COMPLETED|Received Vaccination 2||0
9004849|NCT02934178|10068016|FG001|NOT COMPLETED|Received Vaccination 2||1
9004850|NCT02934178|10068015|FG000|STARTED|Received Vaccination 3||12
9004851|NCT02934178|10068016|FG001|STARTED|Received Vaccination 3||3
9004852|NCT02934178|10068015|FG000|COMPLETED|Received Vaccination 3||11
9004853|NCT02934178|10068016|FG001|COMPLETED|Received Vaccination 3||3
9004854|NCT02934178|10068015|FG000|NOT COMPLETED|Received Vaccination 3||1
9004855|NCT02934178|10068016|FG001|NOT COMPLETED|Received Vaccination 3||0
9004856|NCT02934191|10068025|FG000|STARTED|Overall Study||87
9004857|NCT02934191|10068026|FG001|STARTED|Overall Study||85
9004858|NCT02934191|10068025|FG000|COMPLETED|Overall Study||87
9004859|NCT02934191|10068026|FG001|COMPLETED|Overall Study||85
9004860|NCT02934191|10068025|FG000|NOT COMPLETED|Overall Study||0
9004861|NCT02934191|10068026|FG001|NOT COMPLETED|Overall Study||0
9004862|NCT02934347|10068034|FG000|STARTED|Overall Study||374
9004863|NCT02934347|10068035|FG001|STARTED|Overall Study||407
9004864|NCT02934347|10068034|FG000|COMPLETED|Overall Study||374
9004865|NCT02934347|10068035|FG001|COMPLETED|Overall Study||407
9004866|NCT02934347|10068034|FG000|NOT COMPLETED|Overall Study||0
9004867|NCT02934347|10068035|FG001|NOT COMPLETED|Overall Study||0
9004868|NCT02934555|10068043|FG000|STARTED|Overall Study||23
9004869|NCT02934555|10068044|FG001|STARTED|Overall Study||25
9004870|NCT02934555|10068043|FG000|COMPLETED|Overall Study||21
9004871|NCT02934555|10068044|FG001|COMPLETED|Overall Study||22
9004872|NCT02934555|10068043|FG000|NOT COMPLETED|Overall Study||2
9004873|NCT02934555|10068044|FG001|NOT COMPLETED|Overall Study||3
9004874|NCT02934698|10068050|FG000|STARTED|Overall Study||2
9004875|NCT02934698|10068050|FG000|COMPLETED|Overall Study||2
9004876|NCT02934698|10068050|FG000|NOT COMPLETED|Overall Study||0
9004877|NCT02935036|10068056|FG000|STARTED|Overall Study||147
9004878|NCT02935036|10068057|FG001|STARTED|Overall Study||147
9004879|NCT02935036|10068056|FG000|COMPLETED|Overall Study||137
9004880|NCT02935036|10068057|FG001|COMPLETED|Overall Study||136
9004881|NCT02935036|10068056|FG000|NOT COMPLETED|Overall Study||10
9004882|NCT02935036|10068057|FG001|NOT COMPLETED|Overall Study||11
9004883|NCT02935062|10068066|FG000|STARTED|Overall Study||8
9004884|NCT02935062|10068067|FG001|STARTED|Overall Study||8
9004885|NCT02935062|10068068|FG002|STARTED|Overall Study||8
9004886|NCT02935062|10068066|FG000|COMPLETED|Overall Study||8
9004887|NCT02935062|10068067|FG001|COMPLETED|Overall Study||8
9004888|NCT02935062|10068068|FG002|COMPLETED|Overall Study||8
9004889|NCT02935062|10068066|FG000|NOT COMPLETED|Overall Study||0
9004890|NCT02935062|10068067|FG001|NOT COMPLETED|Overall Study||0
9004891|NCT02935062|10068068|FG002|NOT COMPLETED|Overall Study||0
9004892|NCT02935088|10068076|FG000|STARTED|Overall Study||2217
9004893|NCT02935088|10068076|FG000|COMPLETED|Overall Study||2115
9004894|NCT02935088|10068076|FG000|NOT COMPLETED|Overall Study||102
9004895|NCT02935179|10068089|FG000|STARTED|Overall Study||30
9004896|NCT02935179|10068090|FG001|STARTED|Overall Study||30
9004897|NCT02935179|10068089|FG000|COMPLETED|Overall Study||29
8888461|NCT01991977|9946429|FG000|COMPLETED|Overall Study||79
8888462|NCT01991977|9946429|FG000|NOT COMPLETED|Overall Study||12
8888463|NCT01991990|9946435|FG000|STARTED|Overall Study||6
8888464|NCT01991990|9946436|FG001|STARTED|Overall Study||12
8888465|NCT01991990|9946435|FG000|COMPLETED|Overall Study||6
8888466|NCT01991990|9946436|FG001|COMPLETED|Overall Study||12
8888467|NCT01991990|9946435|FG000|NOT COMPLETED|Overall Study||0
8888468|NCT01991990|9946436|FG001|NOT COMPLETED|Overall Study||0
8888469|NCT01992016|9946448|FG000|STARTED|Overall Study||4
8888470|NCT01992016|9946449|FG001|STARTED|Overall Study||7
8888471|NCT01992016|9946448|FG000|COMPLETED|Overall Study||4
8888472|NCT01992016|9946449|FG001|COMPLETED|Overall Study||7
9004898|NCT02935179|10068090|FG001|COMPLETED|Overall Study||29
9004899|NCT02935179|10068089|FG000|NOT COMPLETED|Overall Study||1
9004900|NCT02935179|10068090|FG001|NOT COMPLETED|Overall Study||1
9004901|NCT02935192|10068098|FG000|STARTED|Overall Study|312 subjects were included in the Full Protocol Analysis because 8 withdrew without getting product.|320
9004902|NCT02935192|10068099|FG001|STARTED|Overall Study|156 subjects were included in the Full Protocol Analysis because 4 withdrew without getting product.|160
9004903|NCT02935192|10068098|FG000|Received Vaccine/Placebo|Overall Study||312
9004904|NCT02935192|10068099|FG001|Received Vaccine/Placebo|Overall Study||156
9004905|NCT02935192|10068098|FG000|COMPLETED|Overall Study||312
9004906|NCT02935192|10068099|FG001|COMPLETED|Overall Study||156
9004907|NCT02935192|10068098|FG000|NOT COMPLETED|Overall Study||8
9004908|NCT02935192|10068099|FG001|NOT COMPLETED|Overall Study||4
9004909|NCT02935452|10068107|FG000|STARTED|Overall Study||30
9004910|NCT02935452|10068108|FG001|STARTED|Overall Study||30
9004911|NCT02935452|10068107|FG000|COMPLETED|Overall Study||27
9004912|NCT02935452|10068108|FG001|COMPLETED|Overall Study||29
9004913|NCT02935452|10068107|FG000|NOT COMPLETED|Overall Study||3
9004914|NCT02935452|10068108|FG001|NOT COMPLETED|Overall Study||1
9004915|NCT02935543|10068114|FG000|STARTED|Overall Study||1
9004916|NCT02935543|10068114|FG000|COMPLETED|Overall Study||1
9004917|NCT02935543|10068114|FG000|NOT COMPLETED|Overall Study||0
9004918|NCT02935673|10068121|FG000|STARTED|Overall Study||16
9004919|NCT02935673|10068122|FG001|STARTED|Overall Study||27
9004920|NCT02935673|10068123|FG002|STARTED|Overall Study||6
9004921|NCT02935673|10068121|FG000|COMPLETED|Overall Study||15
9004922|NCT02935673|10068122|FG001|COMPLETED|Overall Study||24
9004923|NCT02935673|10068123|FG002|COMPLETED|Overall Study||6
9004924|NCT02935673|10068121|FG000|NOT COMPLETED|Overall Study||1
9004925|NCT02935673|10068122|FG001|NOT COMPLETED|Overall Study||3
9004926|NCT02935673|10068123|FG002|NOT COMPLETED|Overall Study||0
9004927|NCT02935699|10068135|FG000|STARTED|Overall Study||127
9004928|NCT02935699|10068136|FG001|STARTED|Overall Study||135
9004929|NCT02935699|10068135|FG000|COMPLETED|Overall Study||127
9004930|NCT02935699|10068136|FG001|COMPLETED|Overall Study||135
9004931|NCT02935699|10068135|FG000|NOT COMPLETED|Overall Study||0
9004932|NCT02935699|10068136|FG001|NOT COMPLETED|Overall Study||0
9004933|NCT02935738|10068146|FG000|STARTED|Overall Study||67
9004934|NCT02935738|10068147|FG001|STARTED|Overall Study||74
9004935|NCT02935738|10068148|FG002|STARTED|Overall Study||47
9004936|NCT02935738|10068149|FG003|STARTED|Overall Study||53
9004937|NCT02935738|10068146|FG000|COMPLETED|Overall Study||50
9004938|NCT02935738|10068147|FG001|COMPLETED|Overall Study||53
9004939|NCT02935738|10068148|FG002|COMPLETED|Overall Study||46
9004940|NCT02935738|10068149|FG003|COMPLETED|Overall Study||48
9004941|NCT02935738|10068146|FG000|NOT COMPLETED|Overall Study||17
9004942|NCT02935738|10068147|FG001|NOT COMPLETED|Overall Study||21
9004943|NCT02935738|10068148|FG002|NOT COMPLETED|Overall Study||1
9004944|NCT02935738|10068149|FG003|NOT COMPLETED|Overall Study||5
9004945|NCT02935842|10068163|FG000|STARTED|Testing and Therapy Period 1||8
9004946|NCT02935842|10068164|FG001|STARTED|Testing and Therapy Period 1||6
9004947|NCT02935842|10068165|FG002|STARTED|Testing and Therapy Period 1||6
9004948|NCT02935842|10068166|FG003|STARTED|Testing and Therapy Period 1|Due to limited staff capacity, HC have only been included in the final tranche.|0
9004949|NCT02935842|10068163|FG000|COMPLETED|Testing and Therapy Period 1||8
9004950|NCT02935842|10068164|FG001|COMPLETED|Testing and Therapy Period 1||6
9004951|NCT02935842|10068165|FG002|COMPLETED|Testing and Therapy Period 1||6
9004952|NCT02935842|10068166|FG003|COMPLETED|Testing and Therapy Period 1||0
9004953|NCT02935842|10068163|FG000|NOT COMPLETED|Testing and Therapy Period 1||0
9004954|NCT02935842|10068164|FG001|NOT COMPLETED|Testing and Therapy Period 1||0
9004955|NCT02935842|10068165|FG002|NOT COMPLETED|Testing and Therapy Period 1||0
9004956|NCT02935842|10068166|FG003|NOT COMPLETED|Testing and Therapy Period 1||0
9004957|NCT02935842|10068163|FG000|STARTED|Testing and Therapy Period 2||8
9004958|NCT02935842|10068164|FG001|STARTED|Testing and Therapy Period 2||6
9004959|NCT02935842|10068165|FG002|STARTED|Testing and Therapy Period 2||6
9004960|NCT02935842|10068166|FG003|STARTED|Testing and Therapy Period 2|Due to limited staff capacity, HC have only been included in the final tranche.|0
9004961|NCT02935842|10068163|FG000|COMPLETED|Testing and Therapy Period 2||6
9004962|NCT02935842|10068164|FG001|COMPLETED|Testing and Therapy Period 2||6
9004963|NCT02935842|10068165|FG002|COMPLETED|Testing and Therapy Period 2||6
9004964|NCT02935842|10068166|FG003|COMPLETED|Testing and Therapy Period 2||0
9004965|NCT02935842|10068163|FG000|NOT COMPLETED|Testing and Therapy Period 2||2
9004966|NCT02935842|10068164|FG001|NOT COMPLETED|Testing and Therapy Period 2||0
9004967|NCT02935842|10068165|FG002|NOT COMPLETED|Testing and Therapy Period 2||0
9004968|NCT02935842|10068166|FG003|NOT COMPLETED|Testing and Therapy Period 2||0
9004969|NCT02935842|10068163|FG000|STARTED|Testing and Therapy Period 3||6
8888473|NCT01992016|9946448|FG000|NOT COMPLETED|Overall Study||0
9004970|NCT02935842|10068164|FG001|STARTED|Testing and Therapy Period 3||6
9004971|NCT02935842|10068165|FG002|STARTED|Testing and Therapy Period 3||6
9004972|NCT02935842|10068166|FG003|STARTED|Testing and Therapy Period 3|HC received no interventions. They have only been tested at BL, 4 Weeks and 6 Months.|18
9004973|NCT02935842|10068163|FG000|COMPLETED|Testing and Therapy Period 3||3
9004974|NCT02935842|10068164|FG001|COMPLETED|Testing and Therapy Period 3||2
9004975|NCT02935842|10068165|FG002|COMPLETED|Testing and Therapy Period 3||1
9004976|NCT02935842|10068166|FG003|COMPLETED|Testing and Therapy Period 3||17
9004977|NCT02935842|10068163|FG000|NOT COMPLETED|Testing and Therapy Period 3||3
9004978|NCT02935842|10068164|FG001|NOT COMPLETED|Testing and Therapy Period 3||4
9004979|NCT02935842|10068165|FG002|NOT COMPLETED|Testing and Therapy Period 3||5
9004980|NCT02935842|10068166|FG003|NOT COMPLETED|Testing and Therapy Period 3||1
9004981|NCT02935894|10068183|FG000|STARTED|Overall Study||14
9004982|NCT02935894|10068183|FG000|COMPLETED|Overall Study||13
9004983|NCT02935894|10068183|FG000|NOT COMPLETED|Overall Study||1
9004984|NCT02936037|10068189|FG000|STARTED|Double-Blind Treatment Period||316
9004985|NCT02936037|10068190|FG001|STARTED|Double-Blind Treatment Period||326
9004986|NCT02936037|10068189|FG000|COMPLETED|Double-Blind Treatment Period||267
9004987|NCT02936037|10068190|FG001|COMPLETED|Double-Blind Treatment Period||261
9004988|NCT02936037|10068189|FG000|NOT COMPLETED|Double-Blind Treatment Period||49
9004989|NCT02936037|10068190|FG001|NOT COMPLETED|Double-Blind Treatment Period||65
9004990|NCT02936037|10068189|FG000|STARTED|Open Label Extension||0
9004991|NCT02936037|10068190|FG001|STARTED|Open Label Extension||528
9004992|NCT02936037|10068189|FG000|COMPLETED|Open Label Extension||0
9004993|NCT02936037|10068190|FG001|COMPLETED|Open Label Extension||518
9004994|NCT02936037|10068189|FG000|NOT COMPLETED|Open Label Extension||0
9004995|NCT02936037|10068190|FG001|NOT COMPLETED|Open Label Extension||10
9004996|NCT02936076|10068198|FG000|STARTED|Overall Study||25
9004997|NCT02936076|10068199|FG001|STARTED|Overall Study||24
9004998|NCT02936076|10068198|FG000|COMPLETED|Overall Study||19
9004999|NCT02936076|10068199|FG001|COMPLETED|Overall Study||20
9005000|NCT02936076|10068198|FG000|NOT COMPLETED|Overall Study||6
9005001|NCT02936076|10068199|FG001|NOT COMPLETED|Overall Study||4
9005002|NCT02936479|10068205|FG000|STARTED|Overall Study||1
9005003|NCT02936479|10068205|FG000|COMPLETED|Overall Study||1
9005004|NCT02936479|10068205|FG000|NOT COMPLETED|Overall Study||0
9005005|NCT02936635|10068211|FG000|STARTED|Overall Study||115
9005006|NCT02936635|10068212|FG001|STARTED|Overall Study||165
9005007|NCT02936635|10068211|FG000|COMPLETED|Overall Study||0
9005008|NCT02936635|10068212|FG001|COMPLETED|Overall Study||0
9005009|NCT02936635|10068211|FG000|NOT COMPLETED|Overall Study||115
9005010|NCT02936635|10068212|FG001|NOT COMPLETED|Overall Study||165
9005011|NCT02936648|10068218|FG000|STARTED|Overall Study||2209
9005012|NCT02936648|10068218|FG000|COMPLETED|Overall Study||2209
9005013|NCT02936648|10068218|FG000|NOT COMPLETED|Overall Study||0
9005014|NCT02936869|10068224|FG000|STARTED|Overall Study||104
9005015|NCT02936869|10068225|FG001|STARTED|Overall Study||103
9005016|NCT02936869|10068224|FG000|COMPLETED|Overall Study||102
9005017|NCT02936869|10068225|FG001|COMPLETED|Overall Study||98
9005018|NCT02936869|10068224|FG000|NOT COMPLETED|Overall Study||2
9005019|NCT02936869|10068225|FG001|NOT COMPLETED|Overall Study||5
9039490|NCT03339453|10100469|FG001|Received at Least 1 Dose of Study Drug|First Visit of Glucagon Treatment||35
9039491|NCT03339453|10100468|FG000|COMPLETED|First Visit of Glucagon Treatment||35
9039492|NCT03339453|10100469|FG001|COMPLETED|First Visit of Glucagon Treatment||34
9039493|NCT03339453|10100468|FG000|NOT COMPLETED|First Visit of Glucagon Treatment||0
9039494|NCT03339453|10100469|FG001|NOT COMPLETED|First Visit of Glucagon Treatment||1
9039495|NCT03339453|10100468|FG000|STARTED|Second Visit for Alternate Glucagon||35
9039496|NCT03339453|10100469|FG001|STARTED|Second Visit for Alternate Glucagon||34
9039497|NCT03339453|10100468|FG000|COMPLETED|Second Visit for Alternate Glucagon||35
9039498|NCT03339453|10100469|FG001|COMPLETED|Second Visit for Alternate Glucagon||34
9039499|NCT03339453|10100468|FG000|NOT COMPLETED|Second Visit for Alternate Glucagon||0
9039500|NCT03339453|10100469|FG001|NOT COMPLETED|Second Visit for Alternate Glucagon||0
9039501|NCT03339570|10100475|FG000|STARTED|Overall Study||20
9039502|NCT03339570|10100475|FG000|COMPLETED|Overall Study||16
9039503|NCT03339570|10100475|FG000|NOT COMPLETED|Overall Study||4
9039504|NCT03339583|10100490|FG000|STARTED|First Intervention (14 Days)||19
9039505|NCT03339583|10100491|FG001|STARTED|First Intervention (14 Days)||23
9039506|NCT03339583|10100490|FG000|COMPLETED|First Intervention (14 Days)||18
8634811|NCT00558285|9675133|FG002|COMPLETED|Overall Study||46
8634812|NCT00558285|9675134|FG003|COMPLETED|Overall Study||48
8634813|NCT00558285|9675135|FG004|COMPLETED|Overall Study||49
9039507|NCT03339583|10100491|FG001|COMPLETED|First Intervention (14 Days)||23
9039508|NCT03339583|10100490|FG000|NOT COMPLETED|First Intervention (14 Days)||1
9039509|NCT03339583|10100491|FG001|NOT COMPLETED|First Intervention (14 Days)||0
9039510|NCT03339583|10100490|FG000|STARTED|Washout (14 Days)||18
9039511|NCT03339583|10100491|FG001|STARTED|Washout (14 Days)||23
9039512|NCT03339583|10100490|FG000|COMPLETED|Washout (14 Days)||18
9039513|NCT03339583|10100491|FG001|COMPLETED|Washout (14 Days)||23
8634814|NCT00558285|9675131|FG000|NOT COMPLETED|Overall Study||6
8634815|NCT00558285|9675132|FG001|NOT COMPLETED|Overall Study||3
9039514|NCT03339583|10100490|FG000|NOT COMPLETED|Washout (14 Days)||0
9039515|NCT03339583|10100491|FG001|NOT COMPLETED|Washout (14 Days)||0
9039516|NCT03339583|10100490|FG000|STARTED|Second Intervention (14 Days)||18
9039517|NCT03339583|10100491|FG001|STARTED|Second Intervention (14 Days)||23
9039518|NCT03339583|10100490|FG000|COMPLETED|Second Intervention (14 Days)||18
9005020|NCT02937116|10068244|FG000|STARTED|Overall Study||3
9005021|NCT02937116|10068245|FG001|STARTED|Overall Study||3
9005022|NCT02937116|10068246|FG002|STARTED|Overall Study||3
9005023|NCT02937116|10068247|FG003|STARTED|Overall Study||3
9005024|NCT02937116|10068248|FG004|STARTED|Overall Study||22
9005025|NCT02937116|10068249|FG005|STARTED|Overall Study||87
9005026|NCT02937116|10068250|FG006|STARTED|Overall Study||37
9005027|NCT02937116|10068251|FG007|STARTED|Overall Study||21
9005028|NCT02937116|10068252|FG008|STARTED|Overall Study||20
9005029|NCT02937116|10068253|FG009|STARTED|Overall Study||20
9005030|NCT02937116|10068254|FG010|STARTED|Overall Study||7
9005031|NCT02937116|10068255|FG011|STARTED|Overall Study||7
9005032|NCT02937116|10068244|FG000|COMPLETED|Overall Study||0
9005033|NCT02937116|10068245|FG001|COMPLETED|Overall Study||0
9005034|NCT02937116|10068246|FG002|COMPLETED|Overall Study||0
9005035|NCT02937116|10068247|FG003|COMPLETED|Overall Study||0
9005036|NCT02937116|10068248|FG004|COMPLETED|Overall Study||0
9005037|NCT02937116|10068249|FG005|COMPLETED|Overall Study||0
9005038|NCT02937116|10068250|FG006|COMPLETED|Overall Study||0
9005039|NCT02937116|10068251|FG007|COMPLETED|Overall Study||0
9005040|NCT02937116|10068252|FG008|COMPLETED|Overall Study||0
9005041|NCT02937116|10068253|FG009|COMPLETED|Overall Study||0
9005042|NCT02937116|10068254|FG010|COMPLETED|Overall Study||0
9005043|NCT02937116|10068255|FG011|COMPLETED|Overall Study||0
9005044|NCT02937116|10068244|FG000|NOT COMPLETED|Overall Study||3
9005045|NCT02937116|10068245|FG001|NOT COMPLETED|Overall Study||3
9005046|NCT02937116|10068246|FG002|NOT COMPLETED|Overall Study||3
9005047|NCT02937116|10068247|FG003|NOT COMPLETED|Overall Study||3
9005048|NCT02937116|10068248|FG004|NOT COMPLETED|Overall Study||22
9005049|NCT02937116|10068249|FG005|NOT COMPLETED|Overall Study||87
9005050|NCT02937116|10068250|FG006|NOT COMPLETED|Overall Study||37
9005051|NCT02937116|10068251|FG007|NOT COMPLETED|Overall Study||21
9005052|NCT02937116|10068252|FG008|NOT COMPLETED|Overall Study||20
9005053|NCT02937116|10068253|FG009|NOT COMPLETED|Overall Study||20
9005054|NCT02937116|10068254|FG010|NOT COMPLETED|Overall Study||7
9005055|NCT02937116|10068255|FG011|NOT COMPLETED|Overall Study||7
9005056|NCT02937168|10068281|FG000|STARTED|PET/CT Screening Period (21 Days)||5
9005057|NCT02937168|10068282|FG001|STARTED|PET/CT Screening Period (21 Days)||0
9005058|NCT02937168|10068283|FG002|STARTED|PET/CT Screening Period (21 Days)||0
9005059|NCT02937168|10068281|FG000|COMPLETED|PET/CT Screening Period (21 Days)||5
9005060|NCT02937168|10068282|FG001|COMPLETED|PET/CT Screening Period (21 Days)||0
9005061|NCT02937168|10068283|FG002|COMPLETED|PET/CT Screening Period (21 Days)||0
9005062|NCT02937168|10068281|FG000|NOT COMPLETED|PET/CT Screening Period (21 Days)||0
9005063|NCT02937168|10068282|FG001|NOT COMPLETED|PET/CT Screening Period (21 Days)||0
9005064|NCT02937168|10068283|FG002|NOT COMPLETED|PET/CT Screening Period (21 Days)||0
9005065|NCT02937168|10068281|FG000|STARTED|Double-Blind Treatment Period (6 Weeks)||0
9005066|NCT02937168|10068282|FG001|STARTED|Double-Blind Treatment Period (6 Weeks)||0
9005067|NCT02937168|10068283|FG002|STARTED|Double-Blind Treatment Period (6 Weeks)||0
9005068|NCT02937168|10068281|FG000|COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
9005069|NCT02937168|10068282|FG001|COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
9005070|NCT02937168|10068283|FG002|COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
9005071|NCT02937168|10068281|FG000|NOT COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
9005072|NCT02937168|10068282|FG001|NOT COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
9005073|NCT02937168|10068283|FG002|NOT COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
9005074|NCT02937194|10068291|FG000|STARTED|1-year Followup||294
9005075|NCT02937194|10068292|FG001|STARTED|1-year Followup||286
9005076|NCT02937194|10068291|FG000|COMPLETED|1-year Followup||223
9005077|NCT02937194|10068292|FG001|COMPLETED|1-year Followup||218
9005078|NCT02937194|10068291|FG000|NOT COMPLETED|1-year Followup||71
9005079|NCT02937194|10068292|FG001|NOT COMPLETED|1-year Followup||68
9005080|NCT02937194|10068291|FG000|STARTED|2-years Followup|The researchers contacted all the participants recruited/enrolled at baseline at each follow-up regardless if they had participated in the previous follow-up or not. So the number started equals 294 for each follow-up.|294
9005081|NCT02937194|10068292|FG001|STARTED|2-years Followup|The researchers contacted all the participants recruited/enrolled at baseline at each follow-up regardless if they had participated in the previous follow-up or not. So the number started equals 286 for each follow-up.|286
9005082|NCT02937194|10068291|FG000|COMPLETED|2-years Followup||216
9005083|NCT02937194|10068292|FG001|COMPLETED|2-years Followup||208
9005084|NCT02937194|10068291|FG000|NOT COMPLETED|2-years Followup||78
9005085|NCT02937194|10068292|FG001|NOT COMPLETED|2-years Followup||78
9005086|NCT02937194|10068291|FG000|STARTED|3-years Followup|The researchers contacted all the participants recruited/enrolled at baseline at each follow-up regardless if they had participated in the previous follow-up or not. So the number started equals 294 for each follow-up.|294
9005087|NCT02937194|10068292|FG001|STARTED|3-years Followup|The researchers contacted all the participants recruited/enrolled at baseline at each follow-up regardless if they had participated in the previous follow-up or not. So the number started equals 286 for each follow-up.|286
9005088|NCT02937194|10068291|FG000|COMPLETED|3-years Followup||228
9005089|NCT02937194|10068292|FG001|COMPLETED|3-years Followup||208
9005090|NCT02937194|10068291|FG000|NOT COMPLETED|3-years Followup||66
9005091|NCT02937194|10068292|FG001|NOT COMPLETED|3-years Followup||78
9005092|NCT02937350|10068301|FG000|STARTED|Overall Study||43
9005093|NCT02937350|10068302|FG001|STARTED|Overall Study||25
9005094|NCT02937350|10068303|FG002|STARTED|Overall Study||20
9005095|NCT02937350|10068301|FG000|COMPLETED|Overall Study||43
9005096|NCT02937350|10068302|FG001|COMPLETED|Overall Study||24
9005097|NCT02937350|10068303|FG002|COMPLETED|Overall Study||20
9005098|NCT02937350|10068301|FG000|NOT COMPLETED|Overall Study||0
9005099|NCT02937350|10068302|FG001|NOT COMPLETED|Overall Study||1
9005100|NCT02937350|10068303|FG002|NOT COMPLETED|Overall Study||0
9005101|NCT02937454|10068311|FG000|STARTED|Overall Study||567
9005102|NCT02937454|10068312|FG001|STARTED|Overall Study||565
9005103|NCT02937454|10068311|FG000|Started Treatment|Overall Study||559
9005104|NCT02937454|10068312|FG001|Started Treatment|Overall Study||551
9005105|NCT02937454|10068311|FG000|COMPLETED|Overall Study||427
9005106|NCT02937454|10068312|FG001|COMPLETED|Overall Study||437
9005107|NCT02937454|10068311|FG000|NOT COMPLETED|Overall Study||140
9005108|NCT02937454|10068312|FG001|NOT COMPLETED|Overall Study||128
9005109|NCT02937506|10068321|FG000|STARTED|Overall Study||300
9005110|NCT02937506|10068322|FG001|STARTED|Overall Study||300
9005111|NCT02937506|10068321|FG000|COMPLETED|Overall Study||300
9005112|NCT02937506|10068322|FG001|COMPLETED|Overall Study||300
9005113|NCT02937506|10068321|FG000|NOT COMPLETED|Overall Study||0
9005114|NCT02937506|10068322|FG001|NOT COMPLETED|Overall Study||0
9005115|NCT02937545|10068330|FG000|STARTED|Overall Study||69
9005116|NCT02937545|10068331|FG001|STARTED|Overall Study||85
9005117|NCT02937545|10068332|FG002|STARTED|Overall Study||15
9005118|NCT02937545|10068333|FG003|STARTED|Overall Study||21
9005119|NCT02937545|10068330|FG000|COMPLETED|Overall Study||67
9005120|NCT02937545|10068331|FG001|COMPLETED|Overall Study||83
9005121|NCT02937545|10068332|FG002|COMPLETED|Overall Study||9
9005122|NCT02937545|10068333|FG003|COMPLETED|Overall Study||14
9005123|NCT02937545|10068330|FG000|NOT COMPLETED|Overall Study||2
9005124|NCT02937545|10068331|FG001|NOT COMPLETED|Overall Study||2
9005125|NCT02937545|10068332|FG002|NOT COMPLETED|Overall Study||6
9005126|NCT02937545|10068333|FG003|NOT COMPLETED|Overall Study||7
9005127|NCT02937558|10068346|FG000|STARTED|Double-blind Phase||3
9005128|NCT02937558|10068347|FG001|STARTED|Double-blind Phase||2
9005129|NCT02937558|10068346|FG000|COMPLETED|Double-blind Phase||3
9005130|NCT02937558|10068347|FG001|COMPLETED|Double-blind Phase||2
9005131|NCT02937558|10068346|FG000|NOT COMPLETED|Double-blind Phase||0
9005132|NCT02937558|10068347|FG001|NOT COMPLETED|Double-blind Phase||0
9005133|NCT02937558|10068346|FG000|STARTED|Open-label Phase||5
9005134|NCT02937558|10068347|FG001|STARTED|Open-label Phase||0
9005135|NCT02937558|10068346|FG000|COMPLETED|Open-label Phase||5
9005136|NCT02937558|10068347|FG001|COMPLETED|Open-label Phase||0
9005137|NCT02937558|10068346|FG000|NOT COMPLETED|Open-label Phase||0
9005138|NCT02937558|10068347|FG001|NOT COMPLETED|Open-label Phase||0
9005139|NCT02937584|10068354|FG000|STARTED|Period 1||11
9005140|NCT02937584|10068355|FG001|STARTED|Period 1||12
9005141|NCT02937584|10068354|FG000|COMPLETED|Period 1||10
9005142|NCT02937584|10068355|FG001|COMPLETED|Period 1||10
9005143|NCT02937584|10068354|FG000|NOT COMPLETED|Period 1||1
9005144|NCT02937584|10068355|FG001|NOT COMPLETED|Period 1||2
9005145|NCT02937584|10068354|FG000|STARTED|Washout||10
9005146|NCT02937584|10068355|FG001|STARTED|Washout||10
9005147|NCT02937584|10068354|FG000|COMPLETED|Washout||10
9005148|NCT02937584|10068355|FG001|COMPLETED|Washout||9
9005149|NCT02937584|10068354|FG000|NOT COMPLETED|Washout||0
9005150|NCT02937584|10068355|FG001|NOT COMPLETED|Washout||1
9005151|NCT02937584|10068354|FG000|STARTED|Period 2||10
9005152|NCT02937584|10068355|FG001|STARTED|Period 2||9
9005153|NCT02937584|10068354|FG000|COMPLETED|Period 2||10
9005154|NCT02937584|10068355|FG001|COMPLETED|Period 2||9
9005155|NCT02937584|10068354|FG000|NOT COMPLETED|Period 2||0
9005156|NCT02937584|10068355|FG001|NOT COMPLETED|Period 2||0
9005157|NCT02937623|10068363|FG000|STARTED|Overall Study||60
9005158|NCT02937623|10068364|FG001|STARTED|Overall Study||60
9005159|NCT02937623|10068363|FG000|COMPLETED|Overall Study||60
9005160|NCT02937623|10068364|FG001|COMPLETED|Overall Study||60
9005161|NCT02937623|10068363|FG000|NOT COMPLETED|Overall Study||0
9005162|NCT02937623|10068364|FG001|NOT COMPLETED|Overall Study||0
9005163|NCT02937636|10068372|FG000|STARTED|Overall Study||63
9005164|NCT02937636|10068373|FG001|STARTED|Overall Study||65
9005165|NCT02937636|10068372|FG000|COMPLETED|Overall Study||60
9005166|NCT02937636|10068373|FG001|COMPLETED|Overall Study||63
9005167|NCT02937636|10068372|FG000|NOT COMPLETED|Overall Study||3
9005168|NCT02937636|10068373|FG001|NOT COMPLETED|Overall Study||2
9005169|NCT02937701|10068382|FG000|STARTED|Day 1 to Week 22||279
9005170|NCT02937701|10068383|FG001|STARTED|Day 1 to Week 22||279
9005171|NCT02937701|10068384|FG002|STARTED|Day 1 to Week 22||0
9005172|NCT02937701|10068385|FG003|STARTED|Day 1 to Week 22||0
9005173|NCT02937701|10068386|FG004|STARTED|Day 1 to Week 22||0
9005174|NCT02937701|10068382|FG000|Received Treatment|Day 1 to Week 22||278
9005175|NCT02937701|10068383|FG001|Received Treatment|Day 1 to Week 22||278
9005176|NCT02937701|10068384|FG002|Received Treatment|Day 1 to Week 22||0
9005177|NCT02937701|10068385|FG003|Received Treatment|Day 1 to Week 22||0
9005178|NCT02937701|10068386|FG004|Received Treatment|Day 1 to Week 22||0
9005179|NCT02937701|10068382|FG000|COMPLETED|Day 1 to Week 22||244
9005180|NCT02937701|10068383|FG001|COMPLETED|Day 1 to Week 22||240
9005181|NCT02937701|10068384|FG002|COMPLETED|Day 1 to Week 22||0
9005182|NCT02937701|10068385|FG003|COMPLETED|Day 1 to Week 22||0
9005183|NCT02937701|10068386|FG004|COMPLETED|Day 1 to Week 22||0
9005184|NCT02937701|10068382|FG000|NOT COMPLETED|Day 1 to Week 22||35
9005185|NCT02937701|10068383|FG001|NOT COMPLETED|Day 1 to Week 22||39
9005186|NCT02937701|10068384|FG002|NOT COMPLETED|Day 1 to Week 22||0
9005187|NCT02937701|10068385|FG003|NOT COMPLETED|Day 1 to Week 22||0
9005188|NCT02937701|10068386|FG004|NOT COMPLETED|Day 1 to Week 22||0
9005189|NCT02937701|10068382|FG000|STARTED|Week 22 to Week 50||0
9005190|NCT02937701|10068383|FG001|STARTED|Week 22 to Week 50||0
9005191|NCT02937701|10068384|FG002|STARTED|Week 22 to Week 50||244
9005192|NCT02937701|10068385|FG003|STARTED|Week 22 to Week 50||121
9005193|NCT02937701|10068386|FG004|STARTED|Week 22 to Week 50||119
9005194|NCT02937701|10068382|FG000|COMPLETED|Week 22 to Week 50||0
9005195|NCT02937701|10068383|FG001|COMPLETED|Week 22 to Week 50||0
9005196|NCT02937701|10068384|FG002|COMPLETED|Week 22 to Week 50||212
9005197|NCT02937701|10068385|FG003|COMPLETED|Week 22 to Week 50||113
9005198|NCT02937701|10068386|FG004|COMPLETED|Week 22 to Week 50||110
9005199|NCT02937701|10068382|FG000|NOT COMPLETED|Week 22 to Week 50||0
9005200|NCT02937701|10068383|FG001|NOT COMPLETED|Week 22 to Week 50||0
9005201|NCT02937701|10068384|FG002|NOT COMPLETED|Week 22 to Week 50||32
9005202|NCT02937701|10068385|FG003|NOT COMPLETED|Week 22 to Week 50||8
9005203|NCT02937701|10068386|FG004|NOT COMPLETED|Week 22 to Week 50||9
9005204|NCT02937740|10068400|FG000|STARTED|BID for 90 Days, 22 mg/Day||24
9005205|NCT02937740|10068401|FG001|STARTED|BID for 90 Days, 22 mg/Day||93
9005206|NCT02937740|10068400|FG000|COMPLETED|BID for 90 Days, 22 mg/Day||19
9005207|NCT02937740|10068401|FG001|COMPLETED|BID for 90 Days, 22 mg/Day||62
9005208|NCT02937740|10068400|FG000|NOT COMPLETED|BID for 90 Days, 22 mg/Day||5
9005209|NCT02937740|10068401|FG001|NOT COMPLETED|BID for 90 Days, 22 mg/Day||31
9005210|NCT02937740|10068400|FG000|STARTED|Uptitrated to TID on Day 90 for 30 Days||13
9005211|NCT02937740|10068401|FG001|STARTED|Uptitrated to TID on Day 90 for 30 Days||17
9005212|NCT02937740|10068400|FG000|COMPLETED|Uptitrated to TID on Day 90 for 30 Days||12
9005213|NCT02937740|10068401|FG001|COMPLETED|Uptitrated to TID on Day 90 for 30 Days||15
9005214|NCT02937740|10068400|FG000|NOT COMPLETED|Uptitrated to TID on Day 90 for 30 Days||1
9005215|NCT02937740|10068401|FG001|NOT COMPLETED|Uptitrated to TID on Day 90 for 30 Days||2
9005216|NCT02937870|10068413|FG000|STARTED|Overall Study||23
9005217|NCT02937870|10068413|FG000|Received Test Adhesive 1|Overall Study||21
9005218|NCT02937870|10068413|FG000|Received Test Adhesive 2|Overall Study||22
9005219|NCT02937870|10068413|FG000|Received Positive Control Adhesive|Overall Study||21
9005220|NCT02937870|10068413|FG000|Received no Adhesive|Overall Study||20
9005221|NCT02937870|10068413|FG000|COMPLETED|Overall Study||20
9005222|NCT02937870|10068413|FG000|NOT COMPLETED|Overall Study||3
9005223|NCT02938052|10068427|FG000|STARTED|Overall Study||10
9005224|NCT02938052|10068427|FG000|COMPLETED|Overall Study||10
9005225|NCT02938052|10068427|FG000|NOT COMPLETED|Overall Study||0
9005226|NCT02938169|10068436|FG000|STARTED|Overall Study||15
9005227|NCT02938169|10068437|FG001|STARTED|Overall Study||15
9005228|NCT02938169|10068438|FG002|STARTED|Overall Study||15
9005229|NCT02938169|10068439|FG003|STARTED|Overall Study||15
9005230|NCT02938169|10068436|FG000|COMPLETED|Overall Study||13
9005231|NCT02938169|10068437|FG001|COMPLETED|Overall Study||13
9005232|NCT02938169|10068438|FG002|COMPLETED|Overall Study||10
9005233|NCT02938169|10068439|FG003|COMPLETED|Overall Study||12
9005234|NCT02938169|10068436|FG000|NOT COMPLETED|Overall Study||2
9005235|NCT02938169|10068437|FG001|NOT COMPLETED|Overall Study||2
9005236|NCT02938169|10068438|FG002|NOT COMPLETED|Overall Study||5
9005237|NCT02938169|10068439|FG003|NOT COMPLETED|Overall Study||3
9005238|NCT02938494|10068460|FG000|STARTED|Overall Study||69
9005239|NCT02938494|10068461|FG001|STARTED|Overall Study||72
9005240|NCT02938494|10068462|FG002|STARTED|Overall Study||34
9005241|NCT02938494|10068463|FG003|STARTED|Overall Study||35
9005242|NCT02938494|10068460|FG000|COMPLETED|Overall Study||65
9005243|NCT02938494|10068461|FG001|COMPLETED|Overall Study||63
9005244|NCT02938494|10068462|FG002|COMPLETED|Overall Study||30
9005245|NCT02938494|10068463|FG003|COMPLETED|Overall Study||31
9005246|NCT02938494|10068460|FG000|NOT COMPLETED|Overall Study||4
9005247|NCT02938494|10068461|FG001|NOT COMPLETED|Overall Study||9
8634816|NCT00558285|9675133|FG002|NOT COMPLETED|Overall Study||5
8634817|NCT00558285|9675134|FG003|NOT COMPLETED|Overall Study||4
9005248|NCT02938494|10068462|FG002|NOT COMPLETED|Overall Study||4
9005249|NCT02938494|10068463|FG003|NOT COMPLETED|Overall Study||4
9005250|NCT02938520|10068474|FG000|STARTED|Overall Study||283
9005251|NCT02938520|10068475|FG001|STARTED|Overall Study||283
9005252|NCT02938520|10068474|FG000|COMPLETED|Overall Study||0
9005253|NCT02938520|10068475|FG001|COMPLETED|Overall Study||0
9005254|NCT02938520|10068474|FG000|NOT COMPLETED|Overall Study||283
9005255|NCT02938520|10068475|FG001|NOT COMPLETED|Overall Study||283
9005256|NCT02938585|10068488|FG000|STARTED|Overall Study||9
9005257|NCT02938585|10068489|FG001|STARTED|Overall Study||33
9005258|NCT02938585|10068490|FG002|STARTED|Overall Study||11
9005259|NCT02938585|10068491|FG003|STARTED|Overall Study||15
9005260|NCT02938585|10068488|FG000|Exposed to Prophylaxis Regimen|Overall Study||9
9005261|NCT02938585|10068489|FG001|Exposed to Prophylaxis Regimen|Overall Study||31
9005262|NCT02938585|10068490|FG002|Exposed to Prophylaxis Regimen|Overall Study||11
9005263|NCT02938585|10068491|FG003|Exposed to Prophylaxis Regimen|Overall Study||12
9005264|NCT02938585|10068488|FG000|Exposed to On-demand Regimen|Overall Study||1
9005265|NCT02938585|10068489|FG001|Exposed to On-demand Regimen|Overall Study||7
9005266|NCT02938585|10068490|FG002|Exposed to On-demand Regimen|Overall Study||1
9005267|NCT02938585|10068491|FG003|Exposed to On-demand Regimen|Overall Study||8
9005268|NCT02938585|10068488|FG000|COMPLETED|Overall Study||9
9005269|NCT02938585|10068489|FG001|COMPLETED|Overall Study||32
9005270|NCT02938585|10068490|FG002|COMPLETED|Overall Study||11
9005271|NCT02938585|10068491|FG003|COMPLETED|Overall Study||10
9005272|NCT02938585|10068488|FG000|NOT COMPLETED|Overall Study||0
9005273|NCT02938585|10068489|FG001|NOT COMPLETED|Overall Study||1
8634818|NCT00558285|9675135|FG004|NOT COMPLETED|Overall Study||4
9005274|NCT02938585|10068490|FG002|NOT COMPLETED|Overall Study||0
9005275|NCT02938585|10068491|FG003|NOT COMPLETED|Overall Study||5
9005276|NCT02938949|10068517|FG000|STARTED|Overall Study||10
9005277|NCT02938949|10068518|FG001|STARTED|Overall Study||10
9005278|NCT02938949|10068517|FG000|COMPLETED|Overall Study||10
9005279|NCT02938949|10068518|FG001|COMPLETED|Overall Study||10
9005280|NCT02938949|10068517|FG000|NOT COMPLETED|Overall Study||0
9005281|NCT02938949|10068518|FG001|NOT COMPLETED|Overall Study||0
9005282|NCT02939014|10068526|FG000|STARTED|Overall Study||30
9005283|NCT02939014|10068527|FG001|STARTED|Overall Study||9
9005284|NCT02939014|10068526|FG000|COMPLETED|Overall Study||25
9005285|NCT02939014|10068527|FG001|COMPLETED|Overall Study||6
9005286|NCT02939014|10068526|FG000|NOT COMPLETED|Overall Study||5
9005287|NCT02939014|10068527|FG001|NOT COMPLETED|Overall Study||3
9005288|NCT02939079|10068536|FG000|STARTED|Overall Study||25
9005289|NCT02939079|10068537|FG001|STARTED|Overall Study||25
9005290|NCT02939079|10068536|FG000|COMPLETED|Overall Study||21
9005291|NCT02939079|10068537|FG001|COMPLETED|Overall Study||20
9005292|NCT02939079|10068536|FG000|NOT COMPLETED|Overall Study||4
9005293|NCT02939079|10068537|FG001|NOT COMPLETED|Overall Study||5
9005294|NCT02939105|10068543|FG000|STARTED|Overall Study||15
9005295|NCT02939105|10068543|FG000|COMPLETED|Overall Study||15
9005296|NCT02939105|10068543|FG000|NOT COMPLETED|Overall Study||0
9005297|NCT02939131|10068550|FG000|STARTED|Overall Study|One additional site in the COMB-R group withdrew prior to the start of participant enrollment.|81
9005298|NCT02939131|10068551|FG001|STARTED|Overall Study||75
9005299|NCT02939131|10068550|FG000|Week 24 Visit|Overall Study|These are the numbers still on study at week 24|74
9005300|NCT02939131|10068551|FG001|Week 24 Visit|Overall Study||72
9005301|NCT02939131|10068550|FG000|COMPLETED|Overall Study||70
9005302|NCT02939131|10068551|FG001|COMPLETED|Overall Study||66
9005303|NCT02939131|10068550|FG000|NOT COMPLETED|Overall Study||11
9005304|NCT02939131|10068551|FG001|NOT COMPLETED|Overall Study||9
9005305|NCT02939170|10068560|FG000|STARTED|Overall Study||40
9005306|NCT02939170|10068561|FG001|STARTED|Overall Study||40
9005307|NCT02939170|10068560|FG000|COMPLETED|Overall Study||40
9005308|NCT02939170|10068561|FG001|COMPLETED|Overall Study||40
9005309|NCT02939170|10068560|FG000|NOT COMPLETED|Overall Study||0
9005310|NCT02939170|10068561|FG001|NOT COMPLETED|Overall Study||0
9005311|NCT02939326|10068576|FG000|STARTED|Overall Study||7
9005312|NCT02939326|10068577|FG001|STARTED|Overall Study||5
9005313|NCT02939326|10068578|FG002|STARTED|Overall Study||5
9005314|NCT02939326|10068579|FG003|STARTED|Overall Study||5
9005315|NCT02939326|10068580|FG004|STARTED|Overall Study||5
9005316|NCT02939326|10068581|FG005|STARTED|Overall Study||5
9005317|NCT02939326|10068582|FG006|STARTED|Overall Study||5
9005318|NCT02939326|10068583|FG007|STARTED|Overall Study||5
9005319|NCT02939326|10068576|FG000|COMPLETED|Overall Study||7
9005320|NCT02939326|10068577|FG001|COMPLETED|Overall Study||5
9005321|NCT02939326|10068578|FG002|COMPLETED|Overall Study||5
9005322|NCT02939326|10068579|FG003|COMPLETED|Overall Study||5
9005323|NCT02939326|10068580|FG004|COMPLETED|Overall Study||5
9005324|NCT02939326|10068581|FG005|COMPLETED|Overall Study||5
9005325|NCT02939326|10068582|FG006|COMPLETED|Overall Study||5
9005326|NCT02939326|10068583|FG007|COMPLETED|Overall Study||5
9005327|NCT02939326|10068576|FG000|NOT COMPLETED|Overall Study||0
9005328|NCT02939326|10068577|FG001|NOT COMPLETED|Overall Study||0
9005329|NCT02939326|10068578|FG002|NOT COMPLETED|Overall Study||0
9005330|NCT02939326|10068579|FG003|NOT COMPLETED|Overall Study||0
9005331|NCT02939326|10068580|FG004|NOT COMPLETED|Overall Study||0
9005332|NCT02939326|10068581|FG005|NOT COMPLETED|Overall Study||0
9005333|NCT02939326|10068582|FG006|NOT COMPLETED|Overall Study||0
9005334|NCT02939326|10068583|FG007|NOT COMPLETED|Overall Study||0
9005335|NCT02939560|10068601|FG000|STARTED|Overall Study||13
9005336|NCT02939560|10068601|FG000|COMPLETED|Overall Study||10
9005337|NCT02939560|10068601|FG000|NOT COMPLETED|Overall Study||3
9005338|NCT02939599|10068607|FG000|STARTED|Overall Study||3
9005339|NCT02939599|10068608|FG001|STARTED|Overall Study||2
9005340|NCT02939599|10068607|FG000|COMPLETED|Overall Study||0
9005341|NCT02939599|10068608|FG001|COMPLETED|Overall Study||0
9005342|NCT02939599|10068607|FG000|NOT COMPLETED|Overall Study||3
9005343|NCT02939599|10068608|FG001|NOT COMPLETED|Overall Study||2
9005344|NCT02939651|10068615|FG000|STARTED|Overall Study||21
9005345|NCT02939651|10068615|FG000|COMPLETED|Overall Study||21
9005346|NCT02939651|10068615|FG000|NOT COMPLETED|Overall Study||0
9005347|NCT02939716|10068619|FG000|STARTED|Overall Study||3
9005348|NCT02939716|10068620|FG001|STARTED|Overall Study||3
9005349|NCT02939716|10068621|FG002|STARTED|Overall Study||3
9005350|NCT02939716|10068622|FG003|STARTED|Overall Study||3
9005351|NCT02939716|10068623|FG004|STARTED|Overall Study||3
9005352|NCT02939716|10068624|FG005|STARTED|Overall Study||3
9005353|NCT02939716|10068619|FG000|COMPLETED|Overall Study||3
9005354|NCT02939716|10068620|FG001|COMPLETED|Overall Study||3
9005355|NCT02939716|10068621|FG002|COMPLETED|Overall Study||3
9005356|NCT02939716|10068622|FG003|COMPLETED|Overall Study||2
9005357|NCT02939716|10068623|FG004|COMPLETED|Overall Study||2
9005358|NCT02939716|10068624|FG005|COMPLETED|Overall Study||2
9005359|NCT02939716|10068619|FG000|NOT COMPLETED|Overall Study||0
9005360|NCT02939716|10068620|FG001|NOT COMPLETED|Overall Study||0
9005361|NCT02939716|10068621|FG002|NOT COMPLETED|Overall Study||0
9005362|NCT02939716|10068622|FG003|NOT COMPLETED|Overall Study||1
9005363|NCT02939716|10068623|FG004|NOT COMPLETED|Overall Study||1
9005364|NCT02939716|10068624|FG005|NOT COMPLETED|Overall Study||1
9005365|NCT02939781|10068641|FG000|STARTED|Overall Study||12
9005366|NCT02939781|10068641|FG000|COMPLETED|Overall Study||3
9005367|NCT02939781|10068641|FG000|NOT COMPLETED|Overall Study||9
9039519|NCT03339583|10100491|FG001|COMPLETED|Second Intervention (14 Days)||21
9005368|NCT02939937|10068648|FG000|STARTED|Overall Study|5 patients had drug reaction and 1 patient excluded from study,|21
9005369|NCT02939937|10068649|FG001|STARTED|Overall Study|3 patients excluded from study|50
9005370|NCT02939937|10068648|FG000|COMPLETED|Overall Study||15
9005371|NCT02939937|10068649|FG001|COMPLETED|Overall Study||47
9005372|NCT02939937|10068648|FG000|NOT COMPLETED|Overall Study||6
9005373|NCT02939937|10068649|FG001|NOT COMPLETED|Overall Study||3
9005374|NCT02939950|10068657|FG000|STARTED|Overall Study||406
9005375|NCT02939950|10068658|FG001|STARTED|Overall Study||410
9005376|NCT02939950|10068657|FG000|Dispensed the Assigned Lenses|Overall Study||405
9005377|NCT02939950|10068658|FG001|Dispensed the Assigned Lenses|Overall Study||410
9005378|NCT02939950|10068657|FG000|Eligible at Baseline|Overall Study||403
9005379|NCT02939950|10068658|FG001|Eligible at Baseline|Overall Study||402
9005380|NCT02939950|10068657|FG000|COMPLETED|Overall Study||340
9005381|NCT02939950|10068658|FG001|COMPLETED|Overall Study||329
9005382|NCT02939950|10068657|FG000|NOT COMPLETED|Overall Study||66
9005383|NCT02939950|10068658|FG001|NOT COMPLETED|Overall Study||81
9005384|NCT02940249|10068664|FG000|STARTED|Overall Study||34
9005385|NCT02940249|10068664|FG000|COMPLETED|Overall Study||30
9005386|NCT02940249|10068664|FG000|NOT COMPLETED|Overall Study||4
9005387|NCT02940327|10068674|FG000|STARTED|Overall Study||24
9005388|NCT02940327|10068674|FG000|COMPLETED|Overall Study||24
9005389|NCT02940327|10068674|FG000|NOT COMPLETED|Overall Study||0
9005390|NCT02940392|10068679|FG000|STARTED|Overall Study||15
9005391|NCT02940392|10068679|FG000|COMPLETED|Overall Study||7
9005392|NCT02940392|10068679|FG000|NOT COMPLETED|Overall Study||8
9005393|NCT02940574|10068685|FG000|STARTED|From Study Start to 1-month Follow-up||22
9005394|NCT02940574|10068686|FG001|STARTED|From Study Start to 1-month Follow-up||18
9005395|NCT02940574|10068685|FG000|COMPLETED|From Study Start to 1-month Follow-up|Discontinued intervention (N=1): self-termination unrelated to treatment|21
9005396|NCT02940574|10068686|FG001|COMPLETED|From Study Start to 1-month Follow-up|All participants completed, but data from 1 participant was not included in analyses.|18
9005397|NCT02940574|10068685|FG000|NOT COMPLETED|From Study Start to 1-month Follow-up||1
9005398|NCT02940574|10068686|FG001|NOT COMPLETED|From Study Start to 1-month Follow-up||0
9005399|NCT02940574|10068685|FG000|STARTED|1-year Follow-up||21
9005400|NCT02940574|10068686|FG001|STARTED|1-year Follow-up||18
9005401|NCT02940574|10068685|FG000|COMPLETED|1-year Follow-up||18
9005402|NCT02940574|10068686|FG001|COMPLETED|1-year Follow-up||14
9005403|NCT02940574|10068685|FG000|NOT COMPLETED|1-year Follow-up||3
9005404|NCT02940574|10068686|FG001|NOT COMPLETED|1-year Follow-up||4
9005405|NCT02940626|10068698|FG000|STARTED|Overall Study||77
9005406|NCT02940626|10068699|FG001|STARTED|Overall Study||78
9005407|NCT02940626|10068698|FG000|Randomized Into Primary Prevention Study|Overall Study||77
9005408|NCT02940626|10068699|FG001|Randomized Into Primary Prevention Study|Overall Study||77
9005409|NCT02940626|10068698|FG000|Randomized Into Treatment Sub-study|Overall Study||0
9005410|NCT02940626|10068699|FG001|Randomized Into Treatment Sub-study|Overall Study||1
9005411|NCT02940626|10068698|FG000|Received Study Treatment|Overall Study||77
9005412|NCT02940626|10068699|FG001|Received Study Treatment|Overall Study||77
9005413|NCT02940626|10068698|FG000|Completed Through Study Day 22|Overall Study||42
9005414|NCT02940626|10068699|FG001|Completed Through Study Day 22|Overall Study||49
9005415|NCT02940626|10068698|FG000|COMPLETED|Overall Study||30
9005416|NCT02940626|10068699|FG001|COMPLETED|Overall Study||43
9005417|NCT02940626|10068698|FG000|NOT COMPLETED|Overall Study||47
9005418|NCT02940626|10068699|FG001|NOT COMPLETED|Overall Study||35
9005419|NCT02940691|10068707|FG000|STARTED|Overall Study||32
9005420|NCT02940691|10068707|FG000|COMPLETED|Overall Study||26
9005421|NCT02940691|10068707|FG000|NOT COMPLETED|Overall Study||6
9005422|NCT02940730|10068714|FG000|STARTED|Intervention 1||10
9005423|NCT02940730|10068715|FG001|STARTED|Intervention 1||0
9005424|NCT02940730|10068714|FG000|Received Intervention|Intervention 1||10
9005425|NCT02940730|10068715|FG001|Received Intervention|Intervention 1||0
9005426|NCT02940730|10068714|FG000|COMPLETED|Intervention 1||10
9005427|NCT02940730|10068715|FG001|COMPLETED|Intervention 1||0
8634819|NCT00558363|9675149|FG000|STARTED|Overall Study||147
9005428|NCT02940730|10068714|FG000|NOT COMPLETED|Intervention 1||0
9005429|NCT02940730|10068715|FG001|NOT COMPLETED|Intervention 1||0
9005430|NCT02940730|10068714|FG000|STARTED|Intervention 2||10
9005431|NCT02940730|10068715|FG001|STARTED|Intervention 2||0
9005432|NCT02940730|10068714|FG000|Received Intervention|Intervention 2||3
9005433|NCT02940730|10068715|FG001|Received Intervention|Intervention 2||0
9005434|NCT02940730|10068714|FG000|COMPLETED|Intervention 2||3
9005435|NCT02940730|10068715|FG001|COMPLETED|Intervention 2||0
9005436|NCT02940730|10068714|FG000|NOT COMPLETED|Intervention 2||7
9005437|NCT02940730|10068715|FG001|NOT COMPLETED|Intervention 2||0
9005438|NCT02940860|10068723|FG000|STARTED|Overall Study||1027
9005439|NCT02940860|10068724|FG001|STARTED|Overall Study||511
9005440|NCT02940860|10068723|FG000|COMPLETED|Overall Study||971
9005441|NCT02940860|10068724|FG001|COMPLETED|Overall Study||476
9005442|NCT02940860|10068723|FG000|NOT COMPLETED|Overall Study||56
9005443|NCT02940860|10068724|FG001|NOT COMPLETED|Overall Study||35
9005444|NCT02940886|10068734|FG000|STARTED|Overall Study|Intention-to-treat analysis set included 1009 subjects, safety analysis set included 989 subjects.|1009
9005445|NCT02940886|10068735|FG001|STARTED|Overall Study|Intention-to-treat analysis set included 503 subjects, safety analysis set included 494 subjects.|503
9005446|NCT02940886|10068734|FG000|Safety Analysis Set|Overall Study||989
9005447|NCT02940886|10068735|FG001|Safety Analysis Set|Overall Study||494
9005448|NCT02940886|10068734|FG000|COMPLETED|Overall Study||907
8634820|NCT00558363|9675150|FG001|STARTED|Overall Study||147
9005449|NCT02940886|10068735|FG001|COMPLETED|Overall Study||449
9005450|NCT02940886|10068734|FG000|NOT COMPLETED|Overall Study||102
9005451|NCT02940886|10068735|FG001|NOT COMPLETED|Overall Study||54
9005452|NCT02941523|10068745|FG000|STARTED|Monotherapy|8 received NOX66 400 mg monotherapy and combination therapy with carboplatin.|8
9005453|NCT02941523|10068746|FG001|STARTED|Monotherapy||8
9005454|NCT02941523|10068745|FG000|COMPLETED|Monotherapy||8
9005455|NCT02941523|10068746|FG001|COMPLETED|Monotherapy||7
9005456|NCT02941523|10068745|FG000|NOT COMPLETED|Monotherapy||0
9005457|NCT02941523|10068746|FG001|NOT COMPLETED|Monotherapy||1
8572654|NCT00116558|9604876|FG000|NOT COMPLETED|Overall Study||31
8572655|NCT00116558|9604877|FG001|NOT COMPLETED|Overall Study||15
8572656|NCT00116558|9604878|FG002|NOT COMPLETED|Overall Study||33
8572657|NCT00116584|9604887|FG000|STARTED|Overall Study||36
8572658|NCT00116584|9604888|FG001|STARTED|Overall Study||36
8572659|NCT00116584|9604887|FG000|COMPLETED|Overall Study||34
8572660|NCT00116584|9604888|FG001|COMPLETED|Overall Study||35
8572661|NCT00116584|9604887|FG000|NOT COMPLETED|Overall Study||2
8572662|NCT00116584|9604888|FG001|NOT COMPLETED|Overall Study||1
8572663|NCT00116649|9604894|FG000|STARTED|Overall Study|586 screened (34 not eligible) 552 enrolled 551 study population (1 subject not treated)|551
8634821|NCT00558363|9675149|FG000|COMPLETED|Overall Study||76
8634822|NCT00558363|9675150|FG001|COMPLETED|Overall Study||111
8572664|NCT00116649|9604894|FG000|COMPLETED|Overall Study||396
8572665|NCT00116649|9604894|FG000|NOT COMPLETED|Overall Study||155
8572666|NCT00116688|9604900|FG000|STARTED|Overall Study||292
8572667|NCT00116688|9604901|FG001|STARTED|Overall Study||21
8572668|NCT00116688|9604900|FG000|Received Study Medication|Overall Study||291
8572669|NCT00116688|9604901|FG001|Received Study Medication|Overall Study||20
8572670|NCT00116688|9604900|FG000|COMPLETED|Overall Study||200
8572671|NCT00116688|9604901|FG001|COMPLETED|Overall Study||17
8572672|NCT00116688|9604900|FG000|NOT COMPLETED|Overall Study||92
8572673|NCT00116688|9604901|FG001|NOT COMPLETED|Overall Study||4
8572674|NCT00116753|9604910|FG000|STARTED|Overall Study|Randomised.|153
8572675|NCT00116753|9604911|FG001|STARTED|Overall Study||155
8572676|NCT00116753|9604912|FG002|STARTED|Overall Study||152
8572677|NCT00116753|9604910|FG000|ITT Population|Overall Study||150
8572678|NCT00116753|9604911|FG001|ITT Population|Overall Study||150
8572679|NCT00116753|9604912|FG002|ITT Population|Overall Study||147
8572680|NCT00116753|9604910|FG000|COMPLETED|Overall Study||121
8572681|NCT00116753|9604911|FG001|COMPLETED|Overall Study||125
8572682|NCT00116753|9604912|FG002|COMPLETED|Overall Study||128
8572683|NCT00116753|9604910|FG000|NOT COMPLETED|Overall Study||32
8572684|NCT00116753|9604911|FG001|NOT COMPLETED|Overall Study||30
8572685|NCT00116753|9604912|FG002|NOT COMPLETED|Overall Study||24
8572686|NCT00116779|9604922|FG000|STARTED|Overall Study|Randomized and treated; Intent-to-treat population|63
8572687|NCT00116779|9604923|FG001|STARTED|Overall Study|Randomized and treated; intent-to-treat population|64
8572688|NCT00116779|9604922|FG000|COMPLETED|Overall Study||42
8572689|NCT00116779|9604923|FG001|COMPLETED|Overall Study||45
8572690|NCT00116779|9604922|FG000|NOT COMPLETED|Overall Study||21
8572691|NCT00116779|9604923|FG001|NOT COMPLETED|Overall Study||19
8572692|NCT00116805|9604931|FG000|STARTED|Double-blind Period Through Week 48||176
8572693|NCT00116805|9604932|FG001|STARTED|Double-blind Period Through Week 48||90
8572694|NCT00116805|9604931|FG000|COMPLETED|Double-blind Period Through Week 48||165
8572695|NCT00116805|9604932|FG001|COMPLETED|Double-blind Period Through Week 48||85
8572696|NCT00116805|9604931|FG000|NOT COMPLETED|Double-blind Period Through Week 48||11
8572697|NCT00116805|9604932|FG001|NOT COMPLETED|Double-blind Period Through Week 48||5
8572698|NCT00116805|9604931|FG000|STARTED|Open-label Period Weeks 49 - 96|11 participants completed 48 weeks but did not continue on study.|154
8572699|NCT00116805|9604932|FG001|STARTED|Open-label Period Weeks 49 - 96|1 participant completed 48 weeks but did not continue on study.|84
8572700|NCT00116805|9604931|FG000|COMPLETED|Open-label Period Weeks 49 - 96||144
8572701|NCT00116805|9604932|FG001|COMPLETED|Open-label Period Weeks 49 - 96||83
8572702|NCT00116805|9604931|FG000|NOT COMPLETED|Open-label Period Weeks 49 - 96||10
8572703|NCT00116805|9604932|FG001|NOT COMPLETED|Open-label Period Weeks 49 - 96||1
8572704|NCT00116805|9604931|FG000|STARTED|Open-label Period Weeks 97 - 144||144
8572705|NCT00116805|9604932|FG001|STARTED|Open-label Period Weeks 97 - 144||83
8572706|NCT00116805|9604931|FG000|COMPLETED|Open-label Period Weeks 97 - 144||133
8634823|NCT00558363|9675149|FG000|NOT COMPLETED|Overall Study||71
8572707|NCT00116805|9604932|FG001|COMPLETED|Open-label Period Weeks 97 - 144||74
8572708|NCT00116805|9604931|FG000|NOT COMPLETED|Open-label Period Weeks 97 - 144||11
8572709|NCT00116805|9604932|FG001|NOT COMPLETED|Open-label Period Weeks 97 - 144||9
8572710|NCT00116805|9604931|FG000|STARTED|Open-label Period Weeks 145 - 192||133
8572711|NCT00116805|9604932|FG001|STARTED|Open-label Period Weeks 145 - 192||74
9005458|NCT02941523|10068745|FG000|STARTED|Carboplatin Combination Therapy|All continued to combination therapy|8
9005459|NCT02941523|10068746|FG001|STARTED|Carboplatin Combination Therapy|7 continued to combination therapy; 3 started combination therapy only|10
9005460|NCT02941523|10068745|FG000|COMPLETED|Carboplatin Combination Therapy||3
9005461|NCT02941523|10068746|FG001|COMPLETED|Carboplatin Combination Therapy||6
9005462|NCT02941523|10068745|FG000|NOT COMPLETED|Carboplatin Combination Therapy||5
9005463|NCT02941523|10068746|FG001|NOT COMPLETED|Carboplatin Combination Therapy||4
9005464|NCT02941614|10068762|FG000|STARTED|Overall Study||744
9005465|NCT02941614|10068763|FG001|STARTED|Overall Study||692
8634824|NCT00558363|9675150|FG001|NOT COMPLETED|Overall Study||36
8634825|NCT00558428|9675160|FG000|STARTED|Overall Study||267
8634826|NCT00558428|9675161|FG001|STARTED|Overall Study||276
8634827|NCT00558428|9675162|FG002|STARTED|Overall Study||277
8634828|NCT00558428|9675163|FG003|STARTED|Overall Study||277
8634829|NCT00558428|9675160|FG000|COMPLETED|Overall Study||255
8634830|NCT00558428|9675161|FG001|COMPLETED|Overall Study||252
8634831|NCT00558428|9675162|FG002|COMPLETED|Overall Study||273
8634832|NCT00558428|9675163|FG003|COMPLETED|Overall Study||266
8634833|NCT00558428|9675160|FG000|NOT COMPLETED|Overall Study||12
8634834|NCT00558428|9675161|FG001|NOT COMPLETED|Overall Study||24
8634835|NCT00558428|9675162|FG002|NOT COMPLETED|Overall Study||4
8634836|NCT00558428|9675163|FG003|NOT COMPLETED|Overall Study||11
8634837|NCT00558467|9675175|FG000|STARTED|Overall Study||20
8634838|NCT00558467|9675176|FG001|STARTED|Overall Study||43
8888474|NCT01992016|9946449|FG001|NOT COMPLETED|Overall Study||0
8888475|NCT01992094|9946458|FG000|STARTED|Overall Study||1335
8888476|NCT01992094|9946459|FG001|STARTED|Overall Study||676
8888477|NCT01992094|9946460|FG002|STARTED|Overall Study||669
8888478|NCT01992094|9946458|FG000|COMPLETED|Overall Study||1285
8888479|NCT01992094|9946459|FG001|COMPLETED|Overall Study||652
8888480|NCT01992094|9946460|FG002|COMPLETED|Overall Study||648
8888481|NCT01992094|9946458|FG000|NOT COMPLETED|Overall Study||50
8888482|NCT01992094|9946459|FG001|NOT COMPLETED|Overall Study||24
8888483|NCT01992094|9946460|FG002|NOT COMPLETED|Overall Study||21
8888484|NCT01992107|9946487|FG000|STARTED|Overall Study||1159
8888485|NCT01992107|9946488|FG001|STARTED|Overall Study||593
8888486|NCT01992107|9946489|FG002|STARTED|Overall Study||581
8888487|NCT01992107|9946487|FG000|COMPLETED|Overall Study||1091
8888488|NCT01992107|9946488|FG001|COMPLETED|Overall Study||560
8888489|NCT01992107|9946489|FG002|COMPLETED|Overall Study||545
8888490|NCT01992107|9946487|FG000|NOT COMPLETED|Overall Study||68
8888491|NCT01992107|9946488|FG001|NOT COMPLETED|Overall Study||33
8888492|NCT01992107|9946489|FG002|NOT COMPLETED|Overall Study||36
8888493|NCT01992159|9946518|FG000|STARTED|Overall Study||63
8888494|NCT01992159|9946519|FG001|STARTED|Overall Study||63
8888495|NCT01992159|9946520|FG002|STARTED|Overall Study||63
8888496|NCT01992159|9946521|FG003|STARTED|Overall Study||63
8888497|NCT01992159|9946518|FG000|Received Treatment|Overall Study||63
8888498|NCT01992159|9946519|FG001|Received Treatment|Overall Study||63
8888499|NCT01992159|9946520|FG002|Received Treatment|Overall Study||63
8634839|NCT00558467|9675175|FG000|COMPLETED|Overall Study||19
8634840|NCT00558467|9675176|FG001|COMPLETED|Overall Study||39
8634841|NCT00558467|9675175|FG000|NOT COMPLETED|Overall Study||1
8634842|NCT00558467|9675176|FG001|NOT COMPLETED|Overall Study||4
8634843|NCT00558519|9675182|FG000|STARTED|Overall Study||318
8634844|NCT00558519|9675182|FG000|COMPLETED|Overall Study||295
8634845|NCT00558519|9675182|FG000|NOT COMPLETED|Overall Study||23
8634846|NCT00558571|9675190|FG000|STARTED|Overall Study||16
8634847|NCT00558571|9675191|FG001|STARTED|Overall Study||16
8888500|NCT01992159|9946521|FG003|Received Treatment|Overall Study||63
8888501|NCT01992159|9946518|FG000|Completed First 12 Months of Study|Overall Study||59
8888502|NCT01992159|9946519|FG001|Completed First 12 Months of Study|Overall Study||56
8888503|NCT01992159|9946520|FG002|Completed First 12 Months of Study|Overall Study||63
8888504|NCT01992159|9946521|FG003|Completed First 12 Months of Study|Overall Study||59
8888505|NCT01992159|9946518|FG000|COMPLETED|Overall Study||59
8888506|NCT01992159|9946519|FG001|COMPLETED|Overall Study||55
8888507|NCT01992159|9946520|FG002|COMPLETED|Overall Study||62
8888508|NCT01992159|9946521|FG003|COMPLETED|Overall Study||59
8888509|NCT01992159|9946518|FG000|NOT COMPLETED|Overall Study||4
8888510|NCT01992159|9946519|FG001|NOT COMPLETED|Overall Study||8
8888511|NCT01992159|9946520|FG002|NOT COMPLETED|Overall Study||1
8888512|NCT01992159|9946521|FG003|NOT COMPLETED|Overall Study||4
8888513|NCT01992172|9946533|FG000|STARTED|Overall Study||7
8888514|NCT01992172|9946534|FG001|STARTED|Overall Study||0
8888515|NCT01992172|9946533|FG000|COMPLETED|Overall Study||7
8888516|NCT01992172|9946534|FG001|COMPLETED|Overall Study||0
8888517|NCT01992172|9946533|FG000|NOT COMPLETED|Overall Study||0
8888518|NCT01992172|9946534|FG001|NOT COMPLETED|Overall Study||0
8888519|NCT01992185|9946542|FG000|STARTED|Overall Study||7
8888520|NCT01992185|9946543|FG001|STARTED|Overall Study||8
8888521|NCT01992185|9946542|FG000|COMPLETED|Overall Study||7
8888522|NCT01992185|9946543|FG001|COMPLETED|Overall Study||8
8888523|NCT01992185|9946542|FG000|NOT COMPLETED|Overall Study||0
8888524|NCT01992185|9946543|FG001|NOT COMPLETED|Overall Study||0
8888525|NCT01992354|9946549|FG000|STARTED|Overall Study||4
8888526|NCT01992354|9946549|FG000|COMPLETED|Overall Study||4
8888527|NCT01992354|9946549|FG000|NOT COMPLETED|Overall Study||0
8888528|NCT01992380|9946557|FG000|STARTED|Overall Study||6
8888529|NCT01992380|9946558|FG001|STARTED|Overall Study||8
8888530|NCT01992380|9946559|FG002|STARTED|Overall Study||10
8888531|NCT01992380|9946557|FG000|COMPLETED|Overall Study||6
8888532|NCT01992380|9946558|FG001|COMPLETED|Overall Study||8
8888533|NCT01992380|9946559|FG002|COMPLETED|Overall Study||10
8888534|NCT01992380|9946557|FG000|NOT COMPLETED|Overall Study||0
8888535|NCT01992380|9946558|FG001|NOT COMPLETED|Overall Study||0
8888536|NCT01992380|9946559|FG002|NOT COMPLETED|Overall Study||0
8888537|NCT01992523|9946567|FG000|STARTED|Overall Study||41
8888538|NCT01992523|9946568|FG001|STARTED|Overall Study||41
8888539|NCT01992523|9946567|FG000|COMPLETED|Overall Study||41
8888540|NCT01992523|9946568|FG001|COMPLETED|Overall Study||41
8888541|NCT01992523|9946567|FG000|NOT COMPLETED|Overall Study||0
8888542|NCT01992523|9946568|FG001|NOT COMPLETED|Overall Study||0
8888543|NCT01992536|9946586|FG000|STARTED|Overall Study||26
8888544|NCT01992536|9946587|FG001|STARTED|Overall Study||25
8888545|NCT01992536|9946588|FG002|STARTED|Overall Study||17
8888546|NCT01992536|9946589|FG003|STARTED|Overall Study||24
8888547|NCT01992536|9946590|FG004|STARTED|Overall Study||11
8888548|NCT01992536|9946591|FG005|STARTED|Overall Study||21
8888549|NCT01992536|9946592|FG006|STARTED|Overall Study||7
8888550|NCT01992536|9946593|FG007|STARTED|Overall Study||21
8888551|NCT01992536|9946594|FG008|STARTED|Overall Study||19
8888552|NCT01992536|9946595|FG009|STARTED|Overall Study||19
8888553|NCT01992536|9946586|FG000|COMPLETED|Overall Study||22
8888554|NCT01992536|9946587|FG001|COMPLETED|Overall Study||22
8888555|NCT01992536|9946588|FG002|COMPLETED|Overall Study||16
8888556|NCT01992536|9946589|FG003|COMPLETED|Overall Study||22
8888557|NCT01992536|9946590|FG004|COMPLETED|Overall Study||11
8888558|NCT01992536|9946591|FG005|COMPLETED|Overall Study||20
8888559|NCT01992536|9946592|FG006|COMPLETED|Overall Study||0
8888560|NCT01992536|9946593|FG007|COMPLETED|Overall Study||21
8888561|NCT01992536|9946594|FG008|COMPLETED|Overall Study||18
8888562|NCT01992536|9946595|FG009|COMPLETED|Overall Study||18
8888563|NCT01992536|9946586|FG000|NOT COMPLETED|Overall Study||4
8888564|NCT01992536|9946587|FG001|NOT COMPLETED|Overall Study||3
8888565|NCT01992536|9946588|FG002|NOT COMPLETED|Overall Study||1
8888566|NCT01992536|9946589|FG003|NOT COMPLETED|Overall Study||2
8888567|NCT01992536|9946590|FG004|NOT COMPLETED|Overall Study||0
8888568|NCT01992536|9946591|FG005|NOT COMPLETED|Overall Study||1
8888569|NCT01992536|9946592|FG006|NOT COMPLETED|Overall Study||7
8888570|NCT01992536|9946593|FG007|NOT COMPLETED|Overall Study||0
8888571|NCT01992536|9946594|FG008|NOT COMPLETED|Overall Study||1
8888572|NCT01992536|9946595|FG009|NOT COMPLETED|Overall Study||1
8888573|NCT01992549|9946637|FG000|STARTED|Overall Study||48
8888574|NCT01992549|9946637|FG000|SAF Population|Overall Study||48
8888575|NCT01992549|9946637|FG000|ITT Population|Overall Study||47
8888576|NCT01992549|9946637|FG000|PROPH Population|Overall Study||47
8888577|NCT01992549|9946637|FG000|BLEED Population|Overall Study||29
8888578|NCT01992549|9946637|FG000|SURG Population|Overall Study||3
8888579|NCT01992549|9946637|FG000|COMPLETED|Overall Study||44
8888580|NCT01992549|9946637|FG000|NOT COMPLETED|Overall Study||4
8888581|NCT01992757|9946647|FG000|STARTED|Overall Study||51
8888582|NCT01992757|9946647|FG000|COMPLETED|Overall Study||49
8888583|NCT01992757|9946647|FG000|NOT COMPLETED|Overall Study||2
8888584|NCT01992874|9946652|FG000|STARTED|Part A||21
8888585|NCT01992874|9946653|FG001|STARTED|Part A||17
8888586|NCT01992874|9946654|FG002|STARTED|Part A||0
8888587|NCT01992874|9946652|FG000|COMPLETED|Part A||21
8888588|NCT01992874|9946653|FG001|COMPLETED|Part A||17
8888589|NCT01992874|9946654|FG002|COMPLETED|Part A||0
8888590|NCT01992874|9946652|FG000|NOT COMPLETED|Part A||0
8888591|NCT01992874|9946653|FG001|NOT COMPLETED|Part A||0
8888592|NCT01992874|9946654|FG002|NOT COMPLETED|Part A||0
8888593|NCT01992874|9946652|FG000|STARTED|Part B||0
8888594|NCT01992874|9946653|FG001|STARTED|Part B||0
8888595|NCT01992874|9946654|FG002|STARTED|Part B||38
8888596|NCT01992874|9946652|FG000|COMPLETED|Part B||0
8888597|NCT01992874|9946653|FG001|COMPLETED|Part B||0
8888598|NCT01992874|9946654|FG002|COMPLETED|Part B||38
8888599|NCT01992874|9946652|FG000|NOT COMPLETED|Part B||0
8888600|NCT01992874|9946653|FG001|NOT COMPLETED|Part B||0
8888601|NCT01992874|9946654|FG002|NOT COMPLETED|Part B||0
8888602|NCT01993017|9946667|FG000|STARTED|Overall Study||499
8888603|NCT01993017|9946668|FG001|STARTED|Overall Study||501
8888604|NCT01993017|9946669|FG002|STARTED|Overall Study||500
8888605|NCT01993017|9946667|FG000|COMPLETED|Overall Study||393
8888606|NCT01993017|9946668|FG001|COMPLETED|Overall Study||411
8888607|NCT01993017|9946669|FG002|COMPLETED|Overall Study||421
8888608|NCT01993017|9946667|FG000|NOT COMPLETED|Overall Study||106
8888609|NCT01993017|9946668|FG001|NOT COMPLETED|Overall Study||90
8888610|NCT01993017|9946669|FG002|NOT COMPLETED|Overall Study||79
8888611|NCT01993030|9946680|FG000|STARTED|Overall Study||36
8888612|NCT01993030|9946681|FG001|STARTED|Overall Study||35
8888613|NCT01993030|9946680|FG000|COMPLETED|Overall Study||36
8888614|NCT01993030|9946681|FG001|COMPLETED|Overall Study||31
8888615|NCT01993030|9946680|FG000|NOT COMPLETED|Overall Study||0
8888616|NCT01993030|9946681|FG001|NOT COMPLETED|Overall Study||4
8888617|NCT01993108|9946689|FG000|STARTED|Overall Study||11
8888618|NCT01993108|9946690|FG001|STARTED|Overall Study||12
8888619|NCT01993108|9946689|FG000|COMPLETED|Overall Study||11
8888620|NCT01993108|9946690|FG001|COMPLETED|Overall Study||12
8888621|NCT01993108|9946689|FG000|NOT COMPLETED|Overall Study||0
8888622|NCT01993108|9946690|FG001|NOT COMPLETED|Overall Study||0
8888623|NCT01993186|9946710|FG000|STARTED|Double-Blind Placebo-Controlled Period||25
8888624|NCT01993186|9946711|FG001|STARTED|Double-Blind Placebo-Controlled Period||11
8888625|NCT01993186|9946710|FG000|COMPLETED|Double-Blind Placebo-Controlled Period||23
8888626|NCT01993186|9946711|FG001|COMPLETED|Double-Blind Placebo-Controlled Period||11
8888627|NCT01993186|9946710|FG000|NOT COMPLETED|Double-Blind Placebo-Controlled Period||2
8888628|NCT01993186|9946711|FG001|NOT COMPLETED|Double-Blind Placebo-Controlled Period||0
8888629|NCT01993186|9946710|FG000|STARTED|Open-Label Extension Period||23
8888630|NCT01993186|9946711|FG001|STARTED|Open-Label Extension Period||11
8888631|NCT01993186|9946710|FG000|COMPLETED|Open-Label Extension Period||16
8888632|NCT01993186|9946711|FG001|COMPLETED|Open-Label Extension Period||5
8888633|NCT01993186|9946710|FG000|NOT COMPLETED|Open-Label Extension Period||7
8888634|NCT01993186|9946711|FG001|NOT COMPLETED|Open-Label Extension Period||6
8888635|NCT01993238|9946718|FG000|STARTED|Overall Study||11
8888636|NCT01993238|9946718|FG000|COMPLETED|Overall Study||11
8888637|NCT01993238|9946718|FG000|NOT COMPLETED|Overall Study||0
8888638|NCT01993329|9946728|FG000|STARTED|Period 1||3
8888639|NCT01993329|9946729|FG001|STARTED|Period 1||4
8888640|NCT01993329|9946730|FG002|STARTED|Period 1||3
8888641|NCT01993329|9946731|FG003|STARTED|Period 1||3
8888642|NCT01993329|9946732|FG004|STARTED|Period 1||3
8888643|NCT01993329|9946733|FG005|STARTED|Period 1||4
8888644|NCT01993329|9946728|FG000|COMPLETED|Period 1||3
8888645|NCT01993329|9946729|FG001|COMPLETED|Period 1||4
8888646|NCT01993329|9946730|FG002|COMPLETED|Period 1||3
8888647|NCT01993329|9946731|FG003|COMPLETED|Period 1||3
8888648|NCT01993329|9946732|FG004|COMPLETED|Period 1||3
8888649|NCT01993329|9946733|FG005|COMPLETED|Period 1||4
8888650|NCT01993329|9946728|FG000|NOT COMPLETED|Period 1||0
8888651|NCT01993329|9946729|FG001|NOT COMPLETED|Period 1||0
8888652|NCT01993329|9946730|FG002|NOT COMPLETED|Period 1||0
8888653|NCT01993329|9946731|FG003|NOT COMPLETED|Period 1||0
8888654|NCT01993329|9946732|FG004|NOT COMPLETED|Period 1||0
8888655|NCT01993329|9946733|FG005|NOT COMPLETED|Period 1||0
8888656|NCT01993329|9946728|FG000|STARTED|Wash-out||3
8888657|NCT01993329|9946729|FG001|STARTED|Wash-out||4
8888658|NCT01993329|9946730|FG002|STARTED|Wash-out||3
8888659|NCT01993329|9946731|FG003|STARTED|Wash-out||3
8888660|NCT01993329|9946732|FG004|STARTED|Wash-out||3
8888661|NCT01993329|9946733|FG005|STARTED|Wash-out||4
8888662|NCT01993329|9946728|FG000|COMPLETED|Wash-out||3
8888663|NCT01993329|9946729|FG001|COMPLETED|Wash-out||4
8888664|NCT01993329|9946730|FG002|COMPLETED|Wash-out||3
8888665|NCT01993329|9946731|FG003|COMPLETED|Wash-out||3
8888666|NCT01993329|9946732|FG004|COMPLETED|Wash-out||3
8888667|NCT01993329|9946733|FG005|COMPLETED|Wash-out||4
8888668|NCT01993329|9946728|FG000|NOT COMPLETED|Wash-out||0
8888669|NCT01993329|9946729|FG001|NOT COMPLETED|Wash-out||0
8888670|NCT01993329|9946730|FG002|NOT COMPLETED|Wash-out||0
8888671|NCT01993329|9946731|FG003|NOT COMPLETED|Wash-out||0
8888672|NCT01993329|9946732|FG004|NOT COMPLETED|Wash-out||0
8888673|NCT01993329|9946733|FG005|NOT COMPLETED|Wash-out||0
8888674|NCT01993329|9946728|FG000|STARTED|Period 2||3
8888675|NCT01993329|9946729|FG001|STARTED|Period 2||4
8888676|NCT01993329|9946730|FG002|STARTED|Period 2||3
8888677|NCT01993329|9946731|FG003|STARTED|Period 2||3
8888678|NCT01993329|9946732|FG004|STARTED|Period 2||3
8888679|NCT01993329|9946733|FG005|STARTED|Period 2||4
8888680|NCT01993329|9946728|FG000|COMPLETED|Period 2||3
8888681|NCT01993329|9946729|FG001|COMPLETED|Period 2||4
8888682|NCT01993329|9946730|FG002|COMPLETED|Period 2||3
8888683|NCT01993329|9946731|FG003|COMPLETED|Period 2||3
8888684|NCT01993329|9946732|FG004|COMPLETED|Period 2||3
8888685|NCT01993329|9946733|FG005|COMPLETED|Period 2||3
8888686|NCT01993329|9946728|FG000|NOT COMPLETED|Period 2||0
8888687|NCT01993329|9946729|FG001|NOT COMPLETED|Period 2||0
8888688|NCT01993329|9946730|FG002|NOT COMPLETED|Period 2||0
8888689|NCT01993329|9946731|FG003|NOT COMPLETED|Period 2||0
8888690|NCT01993329|9946732|FG004|NOT COMPLETED|Period 2||0
8888691|NCT01993329|9946733|FG005|NOT COMPLETED|Period 2||1
8888692|NCT01993329|9946728|FG000|STARTED|Wash-out||3
8888693|NCT01993329|9946729|FG001|STARTED|Wash-out||4
8888694|NCT01993329|9946730|FG002|STARTED|Wash-out||3
8888695|NCT01993329|9946731|FG003|STARTED|Wash-out||3
8888696|NCT01993329|9946732|FG004|STARTED|Wash-out||3
8888697|NCT01993329|9946733|FG005|STARTED|Wash-out||3
8888698|NCT01993329|9946728|FG000|COMPLETED|Wash-out||3
8888699|NCT01993329|9946729|FG001|COMPLETED|Wash-out||3
8888700|NCT01993329|9946730|FG002|COMPLETED|Wash-out||3
8888701|NCT01993329|9946731|FG003|COMPLETED|Wash-out||3
8888702|NCT01993329|9946732|FG004|COMPLETED|Wash-out||3
8888703|NCT01993329|9946733|FG005|COMPLETED|Wash-out||3
8888704|NCT01993329|9946728|FG000|NOT COMPLETED|Wash-out||0
8888705|NCT01993329|9946729|FG001|NOT COMPLETED|Wash-out||1
8888706|NCT01993329|9946730|FG002|NOT COMPLETED|Wash-out||0
8888707|NCT01993329|9946731|FG003|NOT COMPLETED|Wash-out||0
8888708|NCT01993329|9946732|FG004|NOT COMPLETED|Wash-out||0
8888709|NCT01993329|9946733|FG005|NOT COMPLETED|Wash-out||0
8888710|NCT01993329|9946728|FG000|STARTED|Period 3||3
8888711|NCT01993329|9946729|FG001|STARTED|Period 3||3
8888712|NCT01993329|9946730|FG002|STARTED|Period 3||3
8888713|NCT01993329|9946731|FG003|STARTED|Period 3||3
8888714|NCT01993329|9946732|FG004|STARTED|Period 3||3
8888715|NCT01993329|9946733|FG005|STARTED|Period 3||3
8888716|NCT01993329|9946728|FG000|COMPLETED|Period 3||3
8888717|NCT01993329|9946729|FG001|COMPLETED|Period 3||3
8888718|NCT01993329|9946730|FG002|COMPLETED|Period 3||3
8888719|NCT01993329|9946731|FG003|COMPLETED|Period 3||3
8888720|NCT01993329|9946732|FG004|COMPLETED|Period 3||3
8888721|NCT01993329|9946733|FG005|COMPLETED|Period 3||3
8888722|NCT01993329|9946728|FG000|NOT COMPLETED|Period 3||0
8888723|NCT01993329|9946729|FG001|NOT COMPLETED|Period 3||0
8888724|NCT01993329|9946730|FG002|NOT COMPLETED|Period 3||0
8888725|NCT01993329|9946731|FG003|NOT COMPLETED|Period 3||0
8888726|NCT01993329|9946732|FG004|NOT COMPLETED|Period 3||0
8888727|NCT01993329|9946733|FG005|NOT COMPLETED|Period 3||0
8888728|NCT01993615|9946747|FG000|STARTED|Overall Study||40
8888729|NCT01993615|9946748|FG001|STARTED|Overall Study||40
8888730|NCT01993615|9946747|FG000|COMPLETED|Overall Study||39
8888731|NCT01993615|9946748|FG001|COMPLETED|Overall Study||40
8888732|NCT01993615|9946747|FG000|NOT COMPLETED|Overall Study||1
8888733|NCT01993615|9946748|FG001|NOT COMPLETED|Overall Study||0
8888734|NCT01993667|9946756|FG000|STARTED|Overall Study||64
8888735|NCT01993667|9946757|FG001|STARTED|Overall Study||66
8888736|NCT01993667|9946756|FG000|COMPLETED|Overall Study||43
8888737|NCT01993667|9946757|FG001|COMPLETED|Overall Study||47
8888738|NCT01993667|9946756|FG000|NOT COMPLETED|Overall Study||21
8888739|NCT01993667|9946757|FG001|NOT COMPLETED|Overall Study||19
8888740|NCT01993823|9946765|FG000|STARTED|Overall Study||95
8888741|NCT01993823|9946766|FG001|STARTED|Overall Study||95
8888742|NCT01993823|9946765|FG000|COMPLETED|Overall Study||88
8888743|NCT01993823|9946766|FG001|COMPLETED|Overall Study||79
8888744|NCT01993823|9946765|FG000|NOT COMPLETED|Overall Study||7
8888745|NCT01993823|9946766|FG001|NOT COMPLETED|Overall Study||16
8888746|NCT01993836|9946775|FG000|STARTED|Overall Study|This represents the number of enrolled patients who completed baseline cognitive testing|72
8888747|NCT01993836|9946776|FG001|STARTED|Overall Study||68
8888748|NCT01993836|9946777|FG002|STARTED|Overall Study||51
8888749|NCT01993836|9946775|FG000|COMPLETED|Overall Study||55
8888750|NCT01993836|9946776|FG001|COMPLETED|Overall Study||55
8888751|NCT01993836|9946777|FG002|COMPLETED|Overall Study||46
8888752|NCT01993836|9946775|FG000|NOT COMPLETED|Overall Study||17
8888753|NCT01993836|9946776|FG001|NOT COMPLETED|Overall Study||13
8888754|NCT01993836|9946777|FG002|NOT COMPLETED|Overall Study||5
8888755|NCT01993849|9946787|FG000|STARTED|Overall Study||12
8888756|NCT01993849|9946788|FG001|STARTED|Overall Study||11
8888757|NCT01993849|9946787|FG000|COMPLETED|Overall Study||9
8888758|NCT01993849|9946788|FG001|COMPLETED|Overall Study||9
8888759|NCT01993849|9946787|FG000|NOT COMPLETED|Overall Study||3
8888760|NCT01993849|9946788|FG001|NOT COMPLETED|Overall Study||2
8888761|NCT01993875|9946798|FG000|STARTED|Overall Study||82
8888762|NCT01993875|9946799|FG001|STARTED|Overall Study||82
8888763|NCT01993875|9946798|FG000|COMPLETED|Overall Study||75
8888764|NCT01993875|9946799|FG001|COMPLETED|Overall Study||76
8888765|NCT01993875|9946798|FG000|NOT COMPLETED|Overall Study||7
8888766|NCT01993875|9946799|FG001|NOT COMPLETED|Overall Study||6
8888767|NCT01993888|9946808|FG000|STARTED|Overall Study||50
8888768|NCT01993888|9946809|FG001|STARTED|Overall Study||52
8888769|NCT01993888|9946808|FG000|COMPLETED|Overall Study||48
8888770|NCT01993888|9946809|FG001|COMPLETED|Overall Study||49
8888771|NCT01993888|9946808|FG000|NOT COMPLETED|Overall Study||2
8888772|NCT01993888|9946809|FG001|NOT COMPLETED|Overall Study||3
8888773|NCT01993927|9946815|FG000|STARTED|Overall Study||742
8888774|NCT01993927|9946815|FG000|COMPLETED|Overall Study||713
8888775|NCT01993927|9946815|FG000|NOT COMPLETED|Overall Study||29
8888776|NCT01993940|9946821|FG000|STARTED|Overall Study|Includes one participant who enrolled at two different sites|277
8888777|NCT01993940|9946822|FG001|STARTED|Overall Study|Includes two participants who each enrolled at two different sites|276
8888778|NCT01993940|9946821|FG000|Received Treatment|Overall Study||272
8888779|NCT01993940|9946822|FG001|Received Treatment|Overall Study||276
8888780|NCT01993940|9946821|FG000|COMPLETED|Overall Study||237
8888781|NCT01993940|9946822|FG001|COMPLETED|Overall Study||232
8888782|NCT01993940|9946821|FG000|NOT COMPLETED|Overall Study||40
8888783|NCT01993940|9946822|FG001|NOT COMPLETED|Overall Study||44
8888784|NCT01994109|9946831|FG000|STARTED|Double-blind Phase (Part A)||63
8888785|NCT01994109|9946832|FG001|STARTED|Double-blind Phase (Part A)||64
8888786|NCT01994109|9946833|FG002|STARTED|Double-blind Phase (Part A)||60
8888787|NCT01994109|9946834|FG003|STARTED|Double-blind Phase (Part A)||0
8888788|NCT01994109|9946831|FG000|COMPLETED|Double-blind Phase (Part A)||62
8888789|NCT01994109|9946832|FG001|COMPLETED|Double-blind Phase (Part A)||61
8888790|NCT01994109|9946833|FG002|COMPLETED|Double-blind Phase (Part A)||53
8888791|NCT01994109|9946834|FG003|COMPLETED|Double-blind Phase (Part A)||0
8888792|NCT01994109|9946831|FG000|NOT COMPLETED|Double-blind Phase (Part A)||1
8888793|NCT01994109|9946832|FG001|NOT COMPLETED|Double-blind Phase (Part A)||3
8888794|NCT01994109|9946833|FG002|NOT COMPLETED|Double-blind Phase (Part A)||7
8888795|NCT01994109|9946834|FG003|NOT COMPLETED|Double-blind Phase (Part A)||0
8888796|NCT01994109|9946831|FG000|STARTED|Open-label Phase (Part B)||0
8888797|NCT01994109|9946832|FG001|STARTED|Open-label Phase (Part B)||0
8888798|NCT01994109|9946833|FG002|STARTED|Open-label Phase (Part B)|No placebo group in Part B.|0
8888799|NCT01994109|9946834|FG003|STARTED|Open-label Phase (Part B)|61 from 2500 U group, 57 from 3500 U group, 52 from Placebo group continued to Part B|170
8888800|NCT01994109|9946831|FG000|COMPLETED|Open-label Phase (Part B)||0
8888801|NCT01994109|9946832|FG001|COMPLETED|Open-label Phase (Part B)||0
8888802|NCT01994109|9946833|FG002|COMPLETED|Open-label Phase (Part B)|No placebo group in Part B.|0
8888803|NCT01994109|9946834|FG003|COMPLETED|Open-label Phase (Part B)||128
8888804|NCT01994109|9946831|FG000|NOT COMPLETED|Open-label Phase (Part B)||0
8888805|NCT01994109|9946832|FG001|NOT COMPLETED|Open-label Phase (Part B)||0
8888806|NCT01994109|9946833|FG002|NOT COMPLETED|Open-label Phase (Part B)||0
8888807|NCT01994109|9946834|FG003|NOT COMPLETED|Open-label Phase (Part B)||42
8888808|NCT01994226|9946846|FG000|STARTED|Overall Study||199
8888809|NCT01994226|9946847|FG001|STARTED|Overall Study||200
8888810|NCT01994226|9946846|FG000|COMPLETED|Overall Study||180
8888811|NCT01994226|9946847|FG001|COMPLETED|Overall Study||179
8888812|NCT01994226|9946846|FG000|NOT COMPLETED|Overall Study||19
8888813|NCT01994226|9946847|FG001|NOT COMPLETED|Overall Study||21
8888814|NCT01994291|9946856|FG000|STARTED|Overall Study||99
8888815|NCT01994291|9946857|FG001|STARTED|Overall Study||43
8888816|NCT01994291|9946858|FG002|STARTED|Overall Study||56
8888817|NCT01994291|9946856|FG000|Received Treatment|Overall Study||99
8888818|NCT01994291|9946857|FG001|Received Treatment|Overall Study||43
9005466|NCT02941614|10068762|FG000|COMPLETED|Overall Study||603
9005467|NCT02941614|10068763|FG001|COMPLETED|Overall Study||446
9005468|NCT02941614|10068762|FG000|NOT COMPLETED|Overall Study||141
9005469|NCT02941614|10068763|FG001|NOT COMPLETED|Overall Study||246
9005470|NCT02941627|10068771|FG000|STARTED|Overall Study|Among 53 patients enrolled: 1 passed away after the informed consent completion, 1 was not implanted for surgical failure, and 1 for cholesteatoma discovered during surgical procedure. This last patient was included in safety analysis as defined in the protocol. Therefore, among 53 patients enrolled 51 were evaluated for safety outcomes, and 50 were successfully implanted and complete the study.|53
9005471|NCT02941627|10068771|FG000|Clinical Safety on Overall Participants|Overall Study||51
9005472|NCT02941627|10068771|FG000|Clinical Efficiency on English Speaking Participants|Overall Study|Among the 50 patients successfully implanted 33 English speaking participant complete speech performance measure.|33
9005473|NCT02941627|10068771|FG000|COMPLETED|Overall Study||50
9005474|NCT02941627|10068771|FG000|NOT COMPLETED|Overall Study||3
9005475|NCT02941640|10068785|FG000|STARTED|Overall Study||30
9005476|NCT02941640|10068786|FG001|STARTED|Overall Study||30
9005477|NCT02941640|10068787|FG002|STARTED|Overall Study||30
9005478|NCT02941640|10068788|FG003|STARTED|Overall Study||30
9005479|NCT02941640|10068785|FG000|COMPLETED|Overall Study||30
9005480|NCT02941640|10068786|FG001|COMPLETED|Overall Study||30
9005481|NCT02941640|10068787|FG002|COMPLETED|Overall Study||30
9005482|NCT02941640|10068788|FG003|COMPLETED|Overall Study||30
9005483|NCT02941640|10068785|FG000|NOT COMPLETED|Overall Study||0
9005484|NCT02941640|10068786|FG001|NOT COMPLETED|Overall Study||0
9005485|NCT02941640|10068787|FG002|NOT COMPLETED|Overall Study||0
9005486|NCT02941640|10068788|FG003|NOT COMPLETED|Overall Study||0
9005487|NCT02941692|10068800|FG000|STARTED|Overall Study||32
9005488|NCT02941692|10068801|FG001|STARTED|Overall Study||34
9005489|NCT02941692|10068800|FG000|COMPLETED|Overall Study||32
9005490|NCT02941692|10068801|FG001|COMPLETED|Overall Study||34
9005491|NCT02941692|10068800|FG000|NOT COMPLETED|Overall Study||0
9005492|NCT02941692|10068801|FG001|NOT COMPLETED|Overall Study||0
9005493|NCT02942160|10068807|FG000|STARTED|Overall Study|Observation Phase prior to open-label treatment phase|259
9005494|NCT02942160|10068807|FG000|EN3835-202 Participants|Overall Study|Observation Phase Completed|222
9005495|NCT02942160|10068807|FG000|EN3835 Treated Subjects in EN3835-202|Overall Study|EN3835 Treated Participants in EN3835-202 Started|200
9005496|NCT02942160|10068807|FG000|COMPLETED|Overall Study|EN3835 Treated Participants in EN3835-202 Completed|156
9005497|NCT02942160|10068807|FG000|NOT COMPLETED|Overall Study||103
9005498|NCT02942264|10068824|FG000|STARTED|Phase 1 MTD Finding Stage||6
9005499|NCT02942264|10068825|FG001|STARTED|Phase 1 MTD Finding Stage||13
9005500|NCT02942264|10068826|FG002|STARTED|Phase 1 MTD Finding Stage||3
9005501|NCT02942264|10068827|FG003|STARTED|Phase 1 MTD Finding Stage||6
9005502|NCT02942264|10068828|FG004|STARTED|Phase 1 MTD Finding Stage||3
9005503|NCT02942264|10068829|FG005|STARTED|Phase 1 MTD Finding Stage||2
9005504|NCT02942264|10068830|FG006|STARTED|Phase 1 MTD Finding Stage||7
9005505|NCT02942264|10068831|FG007|STARTED|Phase 1 MTD Finding Stage||0
9005506|NCT02942264|10068832|FG008|STARTED|Phase 1 MTD Finding Stage||0
9005507|NCT02942264|10068824|FG000|COMPLETED|Phase 1 MTD Finding Stage||6
9005508|NCT02942264|10068825|FG001|COMPLETED|Phase 1 MTD Finding Stage||12
9005509|NCT02942264|10068826|FG002|COMPLETED|Phase 1 MTD Finding Stage||3
9005510|NCT02942264|10068827|FG003|COMPLETED|Phase 1 MTD Finding Stage||6
9005511|NCT02942264|10068828|FG004|COMPLETED|Phase 1 MTD Finding Stage||3
9005512|NCT02942264|10068829|FG005|COMPLETED|Phase 1 MTD Finding Stage||2
9005513|NCT02942264|10068830|FG006|COMPLETED|Phase 1 MTD Finding Stage||6
9005514|NCT02942264|10068831|FG007|COMPLETED|Phase 1 MTD Finding Stage||0
9005515|NCT02942264|10068832|FG008|COMPLETED|Phase 1 MTD Finding Stage||0
9005516|NCT02942264|10068824|FG000|NOT COMPLETED|Phase 1 MTD Finding Stage||0
9005517|NCT02942264|10068825|FG001|NOT COMPLETED|Phase 1 MTD Finding Stage||1
9005518|NCT02942264|10068826|FG002|NOT COMPLETED|Phase 1 MTD Finding Stage||0
9005519|NCT02942264|10068827|FG003|NOT COMPLETED|Phase 1 MTD Finding Stage||0
9005520|NCT02942264|10068828|FG004|NOT COMPLETED|Phase 1 MTD Finding Stage||0
9005521|NCT02942264|10068829|FG005|NOT COMPLETED|Phase 1 MTD Finding Stage||0
9005522|NCT02942264|10068830|FG006|NOT COMPLETED|Phase 1 MTD Finding Stage||1
9005523|NCT02942264|10068831|FG007|NOT COMPLETED|Phase 1 MTD Finding Stage||0
9005524|NCT02942264|10068832|FG008|NOT COMPLETED|Phase 1 MTD Finding Stage||0
9005525|NCT02942264|10068824|FG000|STARTED|Phase 1 Cohort Expansion Stage||0
8577914|NCT00165789|9610847|FG001|NOT COMPLETED|Overall Study||4
8577915|NCT00165789|9610848|FG002|NOT COMPLETED|Overall Study||1
8577916|NCT00165789|9610849|FG003|NOT COMPLETED|Overall Study||14
8577917|NCT00165841|9610861|FG000|STARTED|Overall Study||103
8577918|NCT00165841|9610862|FG001|STARTED|Overall Study||97
8577919|NCT00165841|9610861|FG000|COMPLETED|Overall Study||73
8888819|NCT01994291|9946858|FG002|Received Treatment|Overall Study||56
8888820|NCT01994291|9946856|FG000|COMPLETED|Overall Study||84
8888821|NCT01994291|9946857|FG001|COMPLETED|Overall Study||36
8888822|NCT01994291|9946858|FG002|COMPLETED|Overall Study||47
8888823|NCT01994291|9946856|FG000|NOT COMPLETED|Overall Study||15
8888824|NCT01994291|9946857|FG001|NOT COMPLETED|Overall Study||7
8888825|NCT01994291|9946858|FG002|NOT COMPLETED|Overall Study||9
8888826|NCT01994395|9946869|FG000|STARTED|Overall Study||26
8888827|NCT01994395|9946870|FG001|STARTED|Overall Study||27
8888828|NCT01994395|9946869|FG000|COMPLETED|Overall Study||25
8888829|NCT01994395|9946870|FG001|COMPLETED|Overall Study||25
8888830|NCT01994395|9946869|FG000|NOT COMPLETED|Overall Study||1
8888831|NCT01994395|9946870|FG001|NOT COMPLETED|Overall Study||2
8888832|NCT01994486|9946876|FG000|STARTED|Overall Study||20
8888833|NCT01994486|9946876|FG000|COMPLETED|Overall Study||20
8888834|NCT01994486|9946876|FG000|NOT COMPLETED|Overall Study||0
8888835|NCT01994538|9946884|FG000|STARTED|Overall Study||136
8888836|NCT01994538|9946885|FG001|STARTED|Overall Study||136
8888837|NCT01994538|9946884|FG000|COMPLETED|Overall Study||136
8888838|NCT01994538|9946885|FG001|COMPLETED|Overall Study||136
8888839|NCT01994538|9946884|FG000|NOT COMPLETED|Overall Study||0
8888840|NCT01994538|9946885|FG001|NOT COMPLETED|Overall Study||0
8888841|NCT01994590|9946891|FG000|STARTED|Overall Study||4
8888842|NCT01994590|9946891|FG000|COMPLETED|Overall Study||2
8888843|NCT01994590|9946891|FG000|NOT COMPLETED|Overall Study||2
8888844|NCT01994629|9946897|FG000|STARTED|Overall Study||100
8888845|NCT01994629|9946898|FG001|STARTED|Overall Study||102
8888846|NCT01994629|9946897|FG000|COMPLETED|Overall Study||99
8888847|NCT01994629|9946898|FG001|COMPLETED|Overall Study||99
8888848|NCT01994629|9946897|FG000|NOT COMPLETED|Overall Study||1
8888849|NCT01994629|9946898|FG001|NOT COMPLETED|Overall Study||3
8888850|NCT01994720|9946906|FG000|STARTED|Overall Study||6589
8888851|NCT01994720|9946907|FG001|STARTED|Overall Study||6610
8888852|NCT01994720|9946906|FG000|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the Study Closure Visit|6543
8888853|NCT01994720|9946907|FG001|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the Study Closure Visit|6554
8888854|NCT01994720|9946906|FG000|NOT COMPLETED|Overall Study||46
8888855|NCT01994720|9946907|FG001|NOT COMPLETED|Overall Study||56
8888856|NCT01994746|9946913|FG000|STARTED|First Visit||39
8888857|NCT01994746|9946914|FG001|STARTED|First Visit||38
8888858|NCT01994746|9946913|FG000|Received At Least 1 Dose|First Visit||39
8888859|NCT01994746|9946914|FG001|Received At Least 1 Dose|First Visit||38
8888860|NCT01994746|9946913|FG000|COMPLETED|First Visit||39
8888861|NCT01994746|9946914|FG001|COMPLETED|First Visit||38
8888862|NCT01994746|9946913|FG000|NOT COMPLETED|First Visit||0
8888863|NCT01994746|9946914|FG001|NOT COMPLETED|First Visit||0
8888864|NCT01994746|9946913|FG000|STARTED|Second Visit|One participant requested to withdraw after completing the first dosing visit.|38
8888865|NCT01994746|9946914|FG001|STARTED|Second Visit||38
8888866|NCT01994746|9946913|FG000|Completed Both Dosing Visits|Second Visit||38
8888867|NCT01994746|9946914|FG001|Completed Both Dosing Visits|Second Visit||38
8888868|NCT01994746|9946913|FG000|COMPLETED|Second Visit||38
8888869|NCT01994746|9946914|FG001|COMPLETED|Second Visit||38
8888870|NCT01994746|9946913|FG000|NOT COMPLETED|Second Visit||0
8888871|NCT01994746|9946914|FG001|NOT COMPLETED|Second Visit||0
8888872|NCT01994785|9946924|FG000|STARTED|Overall Study||109
8888873|NCT01994785|9946925|FG001|STARTED|Overall Study||109
8888874|NCT01994785|9946926|FG002|STARTED|Overall Study||117
8888875|NCT01994785|9946927|FG003|STARTED|Overall Study||117
8888876|NCT01994785|9946924|FG000|COMPLETED|Overall Study||101
8888877|NCT01994785|9946925|FG001|COMPLETED|Overall Study||108
8888878|NCT01994785|9946926|FG002|COMPLETED|Overall Study||117
8888879|NCT01994785|9946927|FG003|COMPLETED|Overall Study||114
8888880|NCT01994785|9946924|FG000|NOT COMPLETED|Overall Study||8
8888881|NCT01994785|9946925|FG001|NOT COMPLETED|Overall Study||1
8888882|NCT01994785|9946926|FG002|NOT COMPLETED|Overall Study||0
8888883|NCT01994785|9946927|FG003|NOT COMPLETED|Overall Study||3
8888884|NCT01994837|9946937|FG000|STARTED|Overall Study||32
8888885|NCT01994837|9946937|FG000|Treated|Overall Study||32
8888886|NCT01994837|9946937|FG000|COMPLETED|Overall Study||0
8888887|NCT01994837|9946937|FG000|NOT COMPLETED|Overall Study||32
8888888|NCT01994850|9946941|FG000|STARTED|Overall Study||32
8888889|NCT01994850|9946941|FG000|COMPLETED|Overall Study||30
8888890|NCT01994850|9946941|FG000|NOT COMPLETED|Overall Study||2
8888891|NCT01994863|9946945|FG000|STARTED|Period 1||11
8888892|NCT01994863|9946946|FG001|STARTED|Period 1||12
8888893|NCT01994863|9946945|FG000|COMPLETED|Period 1||4
8888894|NCT01994863|9946946|FG001|COMPLETED|Period 1||9
8888895|NCT01994863|9946945|FG000|NOT COMPLETED|Period 1||7
8888896|NCT01994863|9946946|FG001|NOT COMPLETED|Period 1||3
8888897|NCT01994863|9946945|FG000|STARTED|Period 2||8
8888898|NCT01994863|9946946|FG001|STARTED|Period 2||9
8888899|NCT01994863|9946945|FG000|COMPLETED|Period 2||7
8888900|NCT01994863|9946946|FG001|COMPLETED|Period 2||5
8888901|NCT01994863|9946945|FG000|NOT COMPLETED|Period 2||1
8888902|NCT01994863|9946946|FG001|NOT COMPLETED|Period 2||4
8888903|NCT01994876|9946952|FG000|STARTED|Baseline - Own Product||9
8888904|NCT01994876|9946953|FG001|STARTED|Baseline - Own Product||9
8888905|NCT01994876|9946952|FG000|COMPLETED|Baseline - Own Product||9
8888906|NCT01994876|9946953|FG001|COMPLETED|Baseline - Own Product||9
8888907|NCT01994876|9946952|FG000|NOT COMPLETED|Baseline - Own Product||0
8888908|NCT01994876|9946953|FG001|NOT COMPLETED|Baseline - Own Product||0
8888909|NCT01994876|9946952|FG000|STARTED|Test Period 1||9
8888910|NCT01994876|9946953|FG001|STARTED|Test Period 1||9
8888911|NCT01994876|9946952|FG000|COMPLETED|Test Period 1||9
8888912|NCT01994876|9946953|FG001|COMPLETED|Test Period 1||7
8888913|NCT01994876|9946952|FG000|NOT COMPLETED|Test Period 1||0
8888914|NCT01994876|9946953|FG001|NOT COMPLETED|Test Period 1||2
8888915|NCT01994876|9946952|FG000|STARTED|Test Period 2||9
8888916|NCT01994876|9946953|FG001|STARTED|Test Period 2||7
8888917|NCT01994876|9946952|FG000|COMPLETED|Test Period 2||8
8888918|NCT01994876|9946953|FG001|COMPLETED|Test Period 2||6
8888919|NCT01994876|9946952|FG000|NOT COMPLETED|Test Period 2||1
8888920|NCT01994876|9946953|FG001|NOT COMPLETED|Test Period 2||1
8888921|NCT01994889|9946964|FG000|STARTED|Overall Study||88
8888922|NCT01994889|9946965|FG001|STARTED|Overall Study||176
8888923|NCT01994889|9946966|FG002|STARTED|Overall Study||177
8888924|NCT01994889|9946964|FG000|COMPLETED|Overall Study||60
8888925|NCT01994889|9946965|FG001|COMPLETED|Overall Study||113
8888926|NCT01994889|9946966|FG002|COMPLETED|Overall Study||85
8888927|NCT01994889|9946964|FG000|NOT COMPLETED|Overall Study||28
8888928|NCT01994889|9946965|FG001|NOT COMPLETED|Overall Study||63
8888929|NCT01994889|9946966|FG002|NOT COMPLETED|Overall Study||92
8888930|NCT01994902|9946973|FG000|STARTED|Test Period 1||63
8888931|NCT01994902|9946974|FG001|STARTED|Test Period 1|Randomisation mistake:a subject randomised to SenSura Convex Light but tested Coloplast test product|64
8888932|NCT01994902|9946973|FG000|COMPLETED|Test Period 1||57
8888933|NCT01994902|9946974|FG001|COMPLETED|Test Period 1|The subject testing Coloplast test product discontinued due to device deficiency with adverse event|61
8888934|NCT01994902|9946973|FG000|NOT COMPLETED|Test Period 1||6
8888935|NCT01994902|9946974|FG001|NOT COMPLETED|Test Period 1||3
8888936|NCT01994902|9946973|FG000|STARTED|Test Period 2||57
8888937|NCT01994902|9946974|FG001|STARTED|Test Period 2||61
8888938|NCT01994902|9946973|FG000|COMPLETED|Test Period 2||57
8888939|NCT01994902|9946974|FG001|COMPLETED|Test Period 2||55
8888940|NCT01994902|9946973|FG000|NOT COMPLETED|Test Period 2||0
8888941|NCT01994902|9946974|FG001|NOT COMPLETED|Test Period 2||6
8888942|NCT01994954|9946982|FG000|STARTED|Overall Study||99
8888943|NCT01994954|9946983|FG001|STARTED|Overall Study||97
8888944|NCT01994954|9946982|FG000|COMPLETED|Overall Study||74
8888945|NCT01994954|9946983|FG001|COMPLETED|Overall Study||67
8888946|NCT01994954|9946982|FG000|NOT COMPLETED|Overall Study||25
8888947|NCT01994954|9946983|FG001|NOT COMPLETED|Overall Study||30
8888948|NCT01994993|9947000|FG000|STARTED|Overall Study||63
8888949|NCT01994993|9947001|FG001|STARTED|Overall Study||47
8888950|NCT01994993|9947002|FG002|STARTED|Overall Study||70
8888951|NCT01994993|9947003|FG003|STARTED|Overall Study||55
8888952|NCT01994993|9947004|FG004|STARTED|Overall Study||24
8888953|NCT01994993|9947000|FG000|COMPLETED|Overall Study||28
8888954|NCT01994993|9947001|FG001|COMPLETED|Overall Study||12
8888955|NCT01994993|9947002|FG002|COMPLETED|Overall Study||23
8888956|NCT01994993|9947003|FG003|COMPLETED|Overall Study||9
8888957|NCT01994993|9947004|FG004|COMPLETED|Overall Study||22
8888958|NCT01994993|9947000|FG000|NOT COMPLETED|Overall Study||35
8888959|NCT01994993|9947001|FG001|NOT COMPLETED|Overall Study||35
8888960|NCT01994993|9947002|FG002|NOT COMPLETED|Overall Study||47
8888961|NCT01994993|9947003|FG003|NOT COMPLETED|Overall Study||46
8888962|NCT01994993|9947004|FG004|NOT COMPLETED|Overall Study||2
8888963|NCT01995045|9947018|FG000|STARTED|Overall Study||29
8888964|NCT01995045|9947019|FG001|STARTED|Overall Study||28
8888965|NCT01995045|9947018|FG000|COMPLETED|Overall Study||29
8888966|NCT01995045|9947019|FG001|COMPLETED|Overall Study||28
8888967|NCT01995045|9947018|FG000|NOT COMPLETED|Overall Study||0
8888968|NCT01995045|9947019|FG001|NOT COMPLETED|Overall Study||0
8888969|NCT01995071|9947037|FG000|STARTED|Overall Study||8
8888970|NCT01995071|9947038|FG001|STARTED|Overall Study||8
8888971|NCT01995071|9947039|FG002|STARTED|Overall Study||9
8888972|NCT01995071|9947040|FG003|STARTED|Overall Study||8
8888973|NCT01995071|9947041|FG004|STARTED|Overall Study||8
8888974|NCT01995071|9947042|FG005|STARTED|Overall Study||8
8888975|NCT01995071|9947043|FG006|STARTED|Overall Study||8
8888976|NCT01995071|9947044|FG007|STARTED|Overall Study||8
8888977|NCT01995071|9947045|FG008|STARTED|Overall Study||8
8888978|NCT01995071|9947046|FG009|STARTED|Overall Study||8
8888979|NCT01995071|9947047|FG010|STARTED|Overall Study||8
8888980|NCT01995071|9947048|FG011|STARTED|Overall Study||0
8888981|NCT01995071|9947037|FG000|COMPLETED|Overall Study||7
8888982|NCT01995071|9947038|FG001|COMPLETED|Overall Study||8
8888983|NCT01995071|9947039|FG002|COMPLETED|Overall Study||8
8888984|NCT01995071|9947040|FG003|COMPLETED|Overall Study||8
8888985|NCT01995071|9947041|FG004|COMPLETED|Overall Study||7
8888986|NCT01995071|9947042|FG005|COMPLETED|Overall Study||8
8888987|NCT01995071|9947043|FG006|COMPLETED|Overall Study||7
8888988|NCT01995071|9947044|FG007|COMPLETED|Overall Study||6
8888989|NCT01995071|9947045|FG008|COMPLETED|Overall Study||7
8888990|NCT01995071|9947046|FG009|COMPLETED|Overall Study||8
8888991|NCT01995071|9947047|FG010|COMPLETED|Overall Study||7
8888992|NCT01995071|9947048|FG011|COMPLETED|Overall Study||0
8888993|NCT01995071|9947037|FG000|NOT COMPLETED|Overall Study||1
8888994|NCT01995071|9947038|FG001|NOT COMPLETED|Overall Study||0
8888995|NCT01995071|9947039|FG002|NOT COMPLETED|Overall Study||1
8888996|NCT01995071|9947040|FG003|NOT COMPLETED|Overall Study||0
8888997|NCT01995071|9947041|FG004|NOT COMPLETED|Overall Study||1
8888998|NCT01995071|9947042|FG005|NOT COMPLETED|Overall Study||0
8888999|NCT01995071|9947043|FG006|NOT COMPLETED|Overall Study||1
8889000|NCT01995071|9947044|FG007|NOT COMPLETED|Overall Study||2
8889001|NCT01995071|9947045|FG008|NOT COMPLETED|Overall Study||1
8889002|NCT01995071|9947046|FG009|NOT COMPLETED|Overall Study||0
9005526|NCT02942264|10068825|FG001|STARTED|Phase 1 Cohort Expansion Stage||0
9005527|NCT02942264|10068826|FG002|STARTED|Phase 1 Cohort Expansion Stage||0
9005528|NCT02942264|10068827|FG003|STARTED|Phase 1 Cohort Expansion Stage||0
9005529|NCT02942264|10068828|FG004|STARTED|Phase 1 Cohort Expansion Stage||0
9005530|NCT02942264|10068829|FG005|STARTED|Phase 1 Cohort Expansion Stage||0
9005531|NCT02942264|10068830|FG006|STARTED|Phase 1 Cohort Expansion Stage||0
9005532|NCT02942264|10068831|FG007|STARTED|Phase 1 Cohort Expansion Stage||6
9005533|NCT02942264|10068832|FG008|STARTED|Phase 1 Cohort Expansion Stage||7
9005534|NCT02942264|10068824|FG000|COMPLETED|Phase 1 Cohort Expansion Stage||0
9005535|NCT02942264|10068825|FG001|COMPLETED|Phase 1 Cohort Expansion Stage||0
9005536|NCT02942264|10068826|FG002|COMPLETED|Phase 1 Cohort Expansion Stage||0
9005537|NCT02942264|10068827|FG003|COMPLETED|Phase 1 Cohort Expansion Stage||0
9005538|NCT02942264|10068828|FG004|COMPLETED|Phase 1 Cohort Expansion Stage||0
9005539|NCT02942264|10068829|FG005|COMPLETED|Phase 1 Cohort Expansion Stage||0
9005540|NCT02942264|10068830|FG006|COMPLETED|Phase 1 Cohort Expansion Stage||0
9005541|NCT02942264|10068831|FG007|COMPLETED|Phase 1 Cohort Expansion Stage||6
8889003|NCT01995071|9947047|FG010|NOT COMPLETED|Overall Study||1
8889004|NCT01995071|9947048|FG011|NOT COMPLETED|Overall Study||0
8889005|NCT01995123|9947082|FG000|STARTED|Overall Study||63
8889006|NCT01995123|9947083|FG001|STARTED|Overall Study||61
8889007|NCT01995123|9947082|FG000|COMPLETED|Overall Study||45
9005542|NCT02942264|10068832|FG008|COMPLETED|Phase 1 Cohort Expansion Stage||6
9005543|NCT02942264|10068824|FG000|NOT COMPLETED|Phase 1 Cohort Expansion Stage||0
9005544|NCT02942264|10068825|FG001|NOT COMPLETED|Phase 1 Cohort Expansion Stage||0
9005545|NCT02942264|10068826|FG002|NOT COMPLETED|Phase 1 Cohort Expansion Stage||0
9005546|NCT02942264|10068827|FG003|NOT COMPLETED|Phase 1 Cohort Expansion Stage||0
9005547|NCT02942264|10068828|FG004|NOT COMPLETED|Phase 1 Cohort Expansion Stage||0
9005548|NCT02942264|10068829|FG005|NOT COMPLETED|Phase 1 Cohort Expansion Stage||0
9005549|NCT02942264|10068830|FG006|NOT COMPLETED|Phase 1 Cohort Expansion Stage||0
9005550|NCT02942264|10068831|FG007|NOT COMPLETED|Phase 1 Cohort Expansion Stage||0
9005551|NCT02942264|10068832|FG008|NOT COMPLETED|Phase 1 Cohort Expansion Stage||1
8572712|NCT00116805|9604931|FG000|COMPLETED|Open-label Period Weeks 145 - 192||123
8572713|NCT00116805|9604932|FG001|COMPLETED|Open-label Period Weeks 145 - 192||68
8572714|NCT00116805|9604931|FG000|NOT COMPLETED|Open-label Period Weeks 145 - 192||10
8572715|NCT00116805|9604932|FG001|NOT COMPLETED|Open-label Period Weeks 145 - 192||6
8572716|NCT00116805|9604931|FG000|STARTED|Open-label Period Weeks 193 - 240||123
8889008|NCT01995123|9947083|FG001|COMPLETED|Overall Study||46
8889009|NCT01995123|9947082|FG000|NOT COMPLETED|Overall Study||18
8889010|NCT01995123|9947083|FG001|NOT COMPLETED|Overall Study||15
8889011|NCT01995136|9947089|FG000|STARTED|Overall Study||32
9005552|NCT02942407|10068859|FG000|STARTED|Overall Study||82
9005553|NCT02942407|10068860|FG001|STARTED|Overall Study||72
9005554|NCT02942407|10068859|FG000|COMPLETED|Overall Study||56
9005555|NCT02942407|10068860|FG001|COMPLETED|Overall Study||48
9005556|NCT02942407|10068859|FG000|NOT COMPLETED|Overall Study||26
9005557|NCT02942407|10068860|FG001|NOT COMPLETED|Overall Study||24
9005558|NCT02942485|10068876|FG000|STARTED|Overall Study||7
9005559|NCT02942485|10068877|FG001|STARTED|Overall Study||1
9005560|NCT02942485|10068876|FG000|COMPLETED|Overall Study||6
9005561|NCT02942485|10068877|FG001|COMPLETED|Overall Study||1
9005562|NCT02942485|10068876|FG000|NOT COMPLETED|Overall Study||1
9005563|NCT02942485|10068877|FG001|NOT COMPLETED|Overall Study||0
9005564|NCT02942576|10068885|FG000|STARTED|Overall Study||405
9005565|NCT02942576|10068886|FG001|STARTED|Overall Study||197
9005566|NCT02942576|10068885|FG000|COMPLETED|Overall Study||359
9005567|NCT02942576|10068886|FG001|COMPLETED|Overall Study||174
8572717|NCT00116805|9604932|FG001|STARTED|Open-label Period Weeks 193 - 240||68
8889012|NCT01995136|9947089|FG000|COMPLETED|Overall Study||31
8889013|NCT01995136|9947089|FG000|NOT COMPLETED|Overall Study||1
8889014|NCT01995201|9947095|FG000|STARTED|From Baseline Until Week 24||74
9005568|NCT02942576|10068885|FG000|NOT COMPLETED|Overall Study||46
8889015|NCT01995201|9947096|FG001|STARTED|From Baseline Until Week 24||327
8889016|NCT01995201|9947097|FG002|STARTED|From Baseline Until Week 24||0
8889017|NCT01995201|9947098|FG003|STARTED|From Baseline Until Week 24||0
8889018|NCT01995201|9947099|FG004|STARTED|From Baseline Until Week 24||0
8889019|NCT01995201|9947100|FG005|STARTED|From Baseline Until Week 24||0
8889020|NCT01995201|9947101|FG006|STARTED|From Baseline Until Week 24||0
8889021|NCT01995201|9947095|FG000|COMPLETED|From Baseline Until Week 24||64
8889022|NCT01995201|9947096|FG001|COMPLETED|From Baseline Until Week 24||281
8889023|NCT01995201|9947097|FG002|COMPLETED|From Baseline Until Week 24||0
8889024|NCT01995201|9947098|FG003|COMPLETED|From Baseline Until Week 24||0
8889025|NCT01995201|9947099|FG004|COMPLETED|From Baseline Until Week 24||0
8889026|NCT01995201|9947100|FG005|COMPLETED|From Baseline Until Week 24||0
8889027|NCT01995201|9947101|FG006|COMPLETED|From Baseline Until Week 24||0
8889028|NCT01995201|9947095|FG000|NOT COMPLETED|From Baseline Until Week 24||10
8889029|NCT01995201|9947096|FG001|NOT COMPLETED|From Baseline Until Week 24||46
8889030|NCT01995201|9947097|FG002|NOT COMPLETED|From Baseline Until Week 24||0
8889031|NCT01995201|9947098|FG003|NOT COMPLETED|From Baseline Until Week 24||0
8889032|NCT01995201|9947099|FG004|NOT COMPLETED|From Baseline Until Week 24||0
8889033|NCT01995201|9947100|FG005|NOT COMPLETED|From Baseline Until Week 24||0
8889034|NCT01995201|9947101|FG006|NOT COMPLETED|From Baseline Until Week 24||0
8889035|NCT01995201|9947095|FG000|STARTED|From Week 24 Until Week 48||0
8889036|NCT01995201|9947096|FG001|STARTED|From Week 24 Until Week 48||0
8889037|NCT01995201|9947097|FG002|STARTED|From Week 24 Until Week 48||89
8889038|NCT01995201|9947098|FG003|STARTED|From Week 24 Until Week 48||90
8889039|NCT01995201|9947099|FG004|STARTED|From Week 24 Until Week 48||95
8889040|NCT01995201|9947100|FG005|STARTED|From Week 24 Until Week 48||67
8889041|NCT01995201|9947101|FG006|STARTED|From Week 24 Until Week 48||2
8889042|NCT01995201|9947095|FG000|COMPLETED|From Week 24 Until Week 48||0
8889043|NCT01995201|9947096|FG001|COMPLETED|From Week 24 Until Week 48||0
8889044|NCT01995201|9947097|FG002|COMPLETED|From Week 24 Until Week 48||84
8889045|NCT01995201|9947098|FG003|COMPLETED|From Week 24 Until Week 48||89
8889046|NCT01995201|9947099|FG004|COMPLETED|From Week 24 Until Week 48||89
8889047|NCT01995201|9947100|FG005|COMPLETED|From Week 24 Until Week 48||59
8889048|NCT01995201|9947101|FG006|COMPLETED|From Week 24 Until Week 48||0
8889049|NCT01995201|9947095|FG000|NOT COMPLETED|From Week 24 Until Week 48||0
8889050|NCT01995201|9947096|FG001|NOT COMPLETED|From Week 24 Until Week 48||0
8889051|NCT01995201|9947097|FG002|NOT COMPLETED|From Week 24 Until Week 48||5
8889052|NCT01995201|9947098|FG003|NOT COMPLETED|From Week 24 Until Week 48||1
8889053|NCT01995201|9947099|FG004|NOT COMPLETED|From Week 24 Until Week 48||6
8889054|NCT01995201|9947100|FG005|NOT COMPLETED|From Week 24 Until Week 48||8
8889055|NCT01995201|9947101|FG006|NOT COMPLETED|From Week 24 Until Week 48||2
8889056|NCT01995266|9947122|FG000|STARTED|Overall Study||159
8889057|NCT01995266|9947122|FG000|COMPLETED|Overall Study||150
8889058|NCT01995266|9947122|FG000|NOT COMPLETED|Overall Study||9
8889059|NCT01995357|9947126|FG000|STARTED|Period 1||4
8889060|NCT01995357|9947127|FG001|STARTED|Period 1||3
8889061|NCT01995357|9947128|FG002|STARTED|Period 1||4
8889062|NCT01995357|9947129|FG003|STARTED|Period 1||3
8889063|NCT01995357|9947130|FG004|STARTED|Period 1||4
8889064|NCT01995357|9947131|FG005|STARTED|Period 1||4
8889065|NCT01995357|9947126|FG000|COMPLETED|Period 1||4
8889066|NCT01995357|9947127|FG001|COMPLETED|Period 1||3
8889067|NCT01995357|9947128|FG002|COMPLETED|Period 1||4
8889068|NCT01995357|9947129|FG003|COMPLETED|Period 1||3
8889069|NCT01995357|9947130|FG004|COMPLETED|Period 1||4
8889070|NCT01995357|9947131|FG005|COMPLETED|Period 1||4
8889071|NCT01995357|9947126|FG000|NOT COMPLETED|Period 1||0
8889072|NCT01995357|9947127|FG001|NOT COMPLETED|Period 1||0
8726119|NCT01033825|9773243|FG002|NOT COMPLETED|Overall Study||2
8726120|NCT01033825|9773244|FG003|NOT COMPLETED|Overall Study||2
8726121|NCT01033825|9773245|FG004|NOT COMPLETED|Overall Study||2
8889073|NCT01995357|9947128|FG002|NOT COMPLETED|Period 1||0
8889074|NCT01995357|9947129|FG003|NOT COMPLETED|Period 1||0
8889075|NCT01995357|9947130|FG004|NOT COMPLETED|Period 1||0
8889076|NCT01995357|9947131|FG005|NOT COMPLETED|Period 1||0
8889077|NCT01995357|9947126|FG000|STARTED|Period 2||4
8889078|NCT01995357|9947127|FG001|STARTED|Period 2||3
8889079|NCT01995357|9947128|FG002|STARTED|Period 2||4
8572718|NCT00116805|9604931|FG000|COMPLETED|Open-label Period Weeks 193 - 240||110
8572719|NCT00116805|9604932|FG001|COMPLETED|Open-label Period Weeks 193 - 240||64
8572720|NCT00116805|9604931|FG000|NOT COMPLETED|Open-label Period Weeks 193 - 240||13
8572721|NCT00116805|9604932|FG001|NOT COMPLETED|Open-label Period Weeks 193 - 240||4
8572722|NCT00116805|9604931|FG000|STARTED|Open-label Period Weeks 241 - 288||110
8572723|NCT00116805|9604932|FG001|STARTED|Open-label Period Weeks 241 - 288||64
8726122|NCT01033825|9773246|FG005|NOT COMPLETED|Overall Study||0
8889080|NCT01995357|9947129|FG003|STARTED|Period 2||3
8889081|NCT01995357|9947130|FG004|STARTED|Period 2||4
8889082|NCT01995357|9947131|FG005|STARTED|Period 2||4
8889083|NCT01995357|9947126|FG000|COMPLETED|Period 2||4
8889084|NCT01995357|9947127|FG001|COMPLETED|Period 2||3
8889085|NCT01995357|9947128|FG002|COMPLETED|Period 2||4
8889086|NCT01995357|9947129|FG003|COMPLETED|Period 2||3
8889087|NCT01995357|9947130|FG004|COMPLETED|Period 2||4
8889088|NCT01995357|9947131|FG005|COMPLETED|Period 2||4
8889089|NCT01995357|9947126|FG000|NOT COMPLETED|Period 2||0
8889090|NCT01995357|9947127|FG001|NOT COMPLETED|Period 2||0
8889091|NCT01995357|9947128|FG002|NOT COMPLETED|Period 2||0
8889092|NCT01995357|9947129|FG003|NOT COMPLETED|Period 2||0
8889093|NCT01995357|9947130|FG004|NOT COMPLETED|Period 2||0
8889094|NCT01995357|9947131|FG005|NOT COMPLETED|Period 2||0
8889095|NCT01995357|9947126|FG000|STARTED|Period 3||4
8889096|NCT01995357|9947127|FG001|STARTED|Period 3||3
8889097|NCT01995357|9947128|FG002|STARTED|Period 3||4
8889098|NCT01995357|9947129|FG003|STARTED|Period 3||3
8889099|NCT01995357|9947130|FG004|STARTED|Period 3||4
8889100|NCT01995357|9947131|FG005|STARTED|Period 3||4
8889101|NCT01995357|9947126|FG000|COMPLETED|Period 3||4
8889102|NCT01995357|9947127|FG001|COMPLETED|Period 3||3
8889103|NCT01995357|9947128|FG002|COMPLETED|Period 3||4
8889104|NCT01995357|9947129|FG003|COMPLETED|Period 3||3
8889105|NCT01995357|9947130|FG004|COMPLETED|Period 3||4
8889106|NCT01995357|9947131|FG005|COMPLETED|Period 3||4
8889107|NCT01995357|9947126|FG000|NOT COMPLETED|Period 3||0
8889108|NCT01995357|9947127|FG001|NOT COMPLETED|Period 3||0
8889109|NCT01995357|9947128|FG002|NOT COMPLETED|Period 3||0
8889110|NCT01995357|9947129|FG003|NOT COMPLETED|Period 3||0
8889111|NCT01995357|9947130|FG004|NOT COMPLETED|Period 3||0
8889112|NCT01995357|9947131|FG005|NOT COMPLETED|Period 3||0
8889113|NCT01995357|9947126|FG000|STARTED|Period 4||4
8889114|NCT01995357|9947127|FG001|STARTED|Period 4||3
8889115|NCT01995357|9947128|FG002|STARTED|Period 4|The subject who did not complete period 5, erroneously used product A when B should have been used.|4
8889116|NCT01995357|9947129|FG003|STARTED|Period 4||3
8889117|NCT01995357|9947130|FG004|STARTED|Period 4||4
8889118|NCT01995357|9947131|FG005|STARTED|Period 4||4
8889119|NCT01995357|9947126|FG000|COMPLETED|Period 4||4
8889120|NCT01995357|9947127|FG001|COMPLETED|Period 4||3
8889121|NCT01995357|9947128|FG002|COMPLETED|Period 4||4
8889122|NCT01995357|9947129|FG003|COMPLETED|Period 4||3
8889123|NCT01995357|9947130|FG004|COMPLETED|Period 4||4
8889124|NCT01995357|9947131|FG005|COMPLETED|Period 4||4
8889125|NCT01995357|9947126|FG000|NOT COMPLETED|Period 4||0
8889126|NCT01995357|9947127|FG001|NOT COMPLETED|Period 4||0
8889127|NCT01995357|9947128|FG002|NOT COMPLETED|Period 4||0
8889128|NCT01995357|9947129|FG003|NOT COMPLETED|Period 4||0
8889129|NCT01995357|9947130|FG004|NOT COMPLETED|Period 4||0
8889130|NCT01995357|9947131|FG005|NOT COMPLETED|Period 4||0
8889131|NCT01995357|9947126|FG000|STARTED|Period 5|The two discontinued subjects tested zero planned B products in period 5.|4
8889132|NCT01995357|9947127|FG001|STARTED|Period 5||3
8889133|NCT01995357|9947128|FG002|STARTED|Period 5||4
8889134|NCT01995357|9947129|FG003|STARTED|Period 5||3
8889135|NCT01995357|9947130|FG004|STARTED|Period 5|1 subject terminated due to an adverse event. Subject counted as completed as some B products tested|4
8889136|NCT01995357|9947131|FG005|STARTED|Period 5||4
8889137|NCT01995357|9947126|FG000|COMPLETED|Period 5||2
8889138|NCT01995357|9947127|FG001|COMPLETED|Period 5||3
8889139|NCT01995357|9947128|FG002|COMPLETED|Period 5||3
8889140|NCT01995357|9947129|FG003|COMPLETED|Period 5||3
8889141|NCT01995357|9947130|FG004|COMPLETED|Period 5||4
8889142|NCT01995357|9947131|FG005|COMPLETED|Period 5||4
8889143|NCT01995357|9947126|FG000|NOT COMPLETED|Period 5||2
8889144|NCT01995357|9947127|FG001|NOT COMPLETED|Period 5||0
8889145|NCT01995357|9947128|FG002|NOT COMPLETED|Period 5||1
8889146|NCT01995357|9947129|FG003|NOT COMPLETED|Period 5||0
8889147|NCT01995357|9947130|FG004|NOT COMPLETED|Period 5||0
8889148|NCT01995357|9947131|FG005|NOT COMPLETED|Period 5||0
8889149|NCT01995461|9947147|FG000|STARTED|Overall Study||26
8889150|NCT01995461|9947147|FG000|COMPLETED|Overall Study||21
8889151|NCT01995461|9947147|FG000|NOT COMPLETED|Overall Study||5
8889152|NCT01995487|9947153|FG000|STARTED|Overall Study||958
8889153|NCT01995487|9947154|FG001|STARTED|Overall Study||961
8889154|NCT01995487|9947153|FG000|COMPLETED|Overall Study||884
8889155|NCT01995487|9947154|FG001|COMPLETED|Overall Study||878
8889156|NCT01995487|9947153|FG000|NOT COMPLETED|Overall Study||74
8889157|NCT01995487|9947154|FG001|NOT COMPLETED|Overall Study||83
8889158|NCT01995513|9947160|FG000|STARTED|Open Label Treatment Period||509
8889159|NCT01995513|9947161|FG001|STARTED|Open Label Treatment Period||0
8889160|NCT01995513|9947162|FG002|STARTED|Open Label Treatment Period||0
8889161|NCT01995513|9947160|FG000|COMPLETED|Open Label Treatment Period||251
8889162|NCT01995513|9947161|FG001|COMPLETED|Open Label Treatment Period||0
8889163|NCT01995513|9947162|FG002|COMPLETED|Open Label Treatment Period||0
8889164|NCT01995513|9947160|FG000|NOT COMPLETED|Open Label Treatment Period||258
8889165|NCT01995513|9947161|FG001|NOT COMPLETED|Open Label Treatment Period||0
8889166|NCT01995513|9947162|FG002|NOT COMPLETED|Open Label Treatment Period||0
8889167|NCT01995513|9947160|FG000|STARTED|Double Blind Treatment Period||0
8889168|NCT01995513|9947161|FG001|STARTED|Double Blind Treatment Period||126
8889169|NCT01995513|9947162|FG002|STARTED|Double Blind Treatment Period||125
8889170|NCT01995513|9947160|FG000|Treated|Double Blind Treatment Period||0
8889171|NCT01995513|9947161|FG001|Treated|Double Blind Treatment Period||125
8889172|NCT01995513|9947162|FG002|Treated|Double Blind Treatment Period||124
8889173|NCT01995513|9947160|FG000|COMPLETED|Double Blind Treatment Period||0
8889174|NCT01995513|9947161|FG001|COMPLETED|Double Blind Treatment Period||0
8889175|NCT01995513|9947162|FG002|COMPLETED|Double Blind Treatment Period||0
8889176|NCT01995513|9947160|FG000|NOT COMPLETED|Double Blind Treatment Period||0
8889177|NCT01995513|9947161|FG001|NOT COMPLETED|Double Blind Treatment Period||126
8889178|NCT01995513|9947162|FG002|NOT COMPLETED|Double Blind Treatment Period||125
8889179|NCT01995526|9947172|FG000|STARTED|Overall Study||11
8889180|NCT01995526|9947172|FG000|Received One Dose of Study Drug|Overall Study||11
8889181|NCT01995526|9947172|FG000|COMPLETED|Overall Study||10
8889182|NCT01995526|9947172|FG000|NOT COMPLETED|Overall Study||1
8889183|NCT01995539|9947176|FG000|STARTED|Overall Study||181
8889184|NCT01995539|9947176|FG000|COMPLETED|Overall Study||148
8889185|NCT01995539|9947176|FG000|NOT COMPLETED|Overall Study||33
8889186|NCT01995552|9947180|FG000|STARTED|Overall Study|There were 249 patients were included for Baseline cohort and 233 in analysis cohort|250
8889187|NCT01995552|9947180|FG000|COMPLETED|Overall Study|There were 233 patients who were eligible for primary objective analysis|233
8889188|NCT01995552|9947180|FG000|NOT COMPLETED|Overall Study||17
8889189|NCT01995825|9947188|FG000|STARTED|Overall Study||18
8889190|NCT01995825|9947189|FG001|STARTED|Overall Study||17
8889191|NCT01995825|9947188|FG000|COMPLETED|Overall Study||17
8889192|NCT01995825|9947189|FG001|COMPLETED|Overall Study||17
8889193|NCT01995825|9947188|FG000|NOT COMPLETED|Overall Study||1
8889194|NCT01995825|9947189|FG001|NOT COMPLETED|Overall Study||0
8889195|NCT01995838|9947202|FG000|STARTED|Overall Study||56
8889196|NCT01995838|9947203|FG001|STARTED|Overall Study||32
8889197|NCT01995838|9947204|FG002|STARTED|Overall Study||27
8889198|NCT01995838|9947205|FG003|STARTED|Overall Study||38
8889199|NCT01995838|9947206|FG004|STARTED|Overall Study||32
8889200|NCT01995838|9947207|FG005|STARTED|Overall Study||56
8889201|NCT01995838|9947208|FG006|STARTED|Overall Study||50
8889202|NCT01995838|9947202|FG000|COMPLETED|Overall Study||51
8889203|NCT01995838|9947203|FG001|COMPLETED|Overall Study||30
8889204|NCT01995838|9947204|FG002|COMPLETED|Overall Study||27
8889205|NCT01995838|9947205|FG003|COMPLETED|Overall Study||36
8889206|NCT01995838|9947206|FG004|COMPLETED|Overall Study||30
8889207|NCT01995838|9947207|FG005|COMPLETED|Overall Study||54
8889208|NCT01995838|9947208|FG006|COMPLETED|Overall Study||45
8889209|NCT01995838|9947202|FG000|NOT COMPLETED|Overall Study||5
8889210|NCT01995838|9947203|FG001|NOT COMPLETED|Overall Study||2
8889211|NCT01995838|9947204|FG002|NOT COMPLETED|Overall Study||0
8889212|NCT01995838|9947205|FG003|NOT COMPLETED|Overall Study||2
8889213|NCT01995838|9947206|FG004|NOT COMPLETED|Overall Study||2
8889214|NCT01995838|9947207|FG005|NOT COMPLETED|Overall Study||2
8889215|NCT01995838|9947208|FG006|NOT COMPLETED|Overall Study||5
8889216|NCT01996033|9947225|FG000|STARTED|Overall Study||25
8889217|NCT01996033|9947225|FG000|COMPLETED|Overall Study||16
8889218|NCT01996033|9947225|FG000|NOT COMPLETED|Overall Study||9
8889219|NCT01996241|9947231|FG000|STARTED|Overall Study||1164
8889220|NCT01996241|9947232|FG001|STARTED|Overall Study||1111
8889221|NCT01996241|9947231|FG000|COMPLETED|Overall Study||912
8889222|NCT01996241|9947232|FG001|COMPLETED|Overall Study||876
8889223|NCT01996241|9947231|FG000|NOT COMPLETED|Overall Study||252
8889224|NCT01996241|9947232|FG001|NOT COMPLETED|Overall Study||235
8889225|NCT01996254|9947242|FG000|STARTED|Overall Study||5
8889226|NCT01996254|9947243|FG001|STARTED|Overall Study||14
8889227|NCT01996254|9947244|FG002|STARTED|Overall Study||14
8889228|NCT01996254|9947242|FG000|Safety Set|Overall Study||5
8889229|NCT01996254|9947243|FG001|Safety Set|Overall Study||14
8889230|NCT01996254|9947244|FG002|Safety Set|Overall Study||14
8889231|NCT01996254|9947242|FG000|Full Analysis Set|Overall Study||0
8889232|NCT01996254|9947243|FG001|Full Analysis Set|Overall Study||12
8889233|NCT01996254|9947244|FG002|Full Analysis Set|Overall Study||14
8889234|NCT01996254|9947242|FG000|Long Term Analysis Set|Overall Study||0
8889235|NCT01996254|9947243|FG001|Long Term Analysis Set|Overall Study||12
8889236|NCT01996254|9947244|FG002|Long Term Analysis Set|Overall Study||14
8889237|NCT01996254|9947242|FG000|Per Protocol Set|Overall Study||0
8889238|NCT01996254|9947243|FG001|Per Protocol Set|Overall Study||10
8889239|NCT01996254|9947244|FG002|Per Protocol Set|Overall Study||13
8889240|NCT01996254|9947242|FG000|COMPLETED|Overall Study||4
8889241|NCT01996254|9947243|FG001|COMPLETED|Overall Study||9
8889242|NCT01996254|9947244|FG002|COMPLETED|Overall Study||6
8889243|NCT01996254|9947242|FG000|NOT COMPLETED|Overall Study||1
8889244|NCT01996254|9947243|FG001|NOT COMPLETED|Overall Study||5
8889245|NCT01996254|9947244|FG002|NOT COMPLETED|Overall Study||8
8889246|NCT01996319|9947256|FG000|STARTED|Overall Study||96
8889247|NCT01996319|9947257|FG001|STARTED|Overall Study||98
8889248|NCT01996319|9947256|FG000|COMPLETED|Overall Study||88
8889249|NCT01996319|9947257|FG001|COMPLETED|Overall Study||95
8889250|NCT01996319|9947256|FG000|NOT COMPLETED|Overall Study||8
8889251|NCT01996319|9947257|FG001|NOT COMPLETED|Overall Study||3
8889252|NCT01996332|9947263|FG000|STARTED|Overall Study||1805
8889253|NCT01996332|9947263|FG000|COMPLETED|Overall Study||0
8889254|NCT01996332|9947263|FG000|NOT COMPLETED|Overall Study||1805
9005569|NCT02942576|10068886|FG001|NOT COMPLETED|Overall Study||23
9005570|NCT02942654|10068892|FG000|STARTED|Period 1||16
9005571|NCT02942654|10068893|FG001|STARTED|Period 1||16
9005572|NCT02942654|10068892|FG000|Received at Least 1 Dose of Study Drug|Period 1||16
9005573|NCT02942654|10068893|FG001|Received at Least 1 Dose of Study Drug|Period 1||16
9005574|NCT02942654|10068892|FG000|COMPLETED|Period 1||16
9005575|NCT02942654|10068893|FG001|COMPLETED|Period 1||16
9005576|NCT02942654|10068892|FG000|NOT COMPLETED|Period 1||0
9005577|NCT02942654|10068893|FG001|NOT COMPLETED|Period 1||0
9005578|NCT02942654|10068892|FG000|STARTED|Washout||16
9005579|NCT02942654|10068893|FG001|STARTED|Washout||16
9005580|NCT02942654|10068892|FG000|COMPLETED|Washout||16
9005581|NCT02942654|10068893|FG001|COMPLETED|Washout||16
9005582|NCT02942654|10068892|FG000|NOT COMPLETED|Washout||0
9005583|NCT02942654|10068893|FG001|NOT COMPLETED|Washout||0
9005584|NCT02942654|10068892|FG000|STARTED|Period 2||16
9005585|NCT02942654|10068893|FG001|STARTED|Period 2||16
9005586|NCT02942654|10068892|FG000|COMPLETED|Period 2||16
9005587|NCT02942654|10068893|FG001|COMPLETED|Period 2||16
9005588|NCT02942654|10068892|FG000|NOT COMPLETED|Period 2||0
8889255|NCT01996592|9947267|FG000|STARTED|Overall Study||575
8889256|NCT01996592|9947267|FG000|COMPLETED|Overall Study||530
8889257|NCT01996592|9947267|FG000|NOT COMPLETED|Overall Study||45
8889258|NCT01996644|9947278|FG000|STARTED|Overall Study||20
8889259|NCT01996644|9947279|FG001|STARTED|Overall Study||16
8889260|NCT01996644|9947278|FG000|COMPLETED|Overall Study||20
8889261|NCT01996644|9947279|FG001|COMPLETED|Overall Study||16
8889262|NCT01996644|9947278|FG000|NOT COMPLETED|Overall Study||0
8889263|NCT01996644|9947279|FG001|NOT COMPLETED|Overall Study||0
8634848|NCT00558571|9675192|FG002|STARTED|Overall Study||16
8634849|NCT00558571|9675193|FG003|STARTED|Overall Study||30
8634850|NCT00558571|9675190|FG000|COMPLETED|Overall Study||16
8889264|NCT01996657|9947291|FG000|STARTED|Overall Study||250
8889265|NCT01996657|9947292|FG001|STARTED|Overall Study||250
8889266|NCT01996657|9947293|FG002|STARTED|Overall Study||248
8889267|NCT01996657|9947291|FG000|COMPLETED|Overall Study||237
9005589|NCT02942654|10068893|FG001|NOT COMPLETED|Period 2||0
9005590|NCT02942771|10068904|FG000|STARTED|Overall Study||9
9005591|NCT02942771|10068905|FG001|STARTED|Overall Study||6
9005592|NCT02942771|10068906|FG002|STARTED|Overall Study||6
9005593|NCT02942771|10068907|FG003|STARTED|Overall Study||6
9005594|NCT02942771|10068908|FG004|STARTED|Overall Study||8
9005595|NCT02942771|10068904|FG000|COMPLETED|Overall Study||6
9005596|NCT02942771|10068905|FG001|COMPLETED|Overall Study||6
9005597|NCT02942771|10068906|FG002|COMPLETED|Overall Study||6
9005598|NCT02942771|10068907|FG003|COMPLETED|Overall Study||6
9005599|NCT02942771|10068908|FG004|COMPLETED|Overall Study||4
9005600|NCT02942771|10068904|FG000|NOT COMPLETED|Overall Study||3
9005601|NCT02942771|10068905|FG001|NOT COMPLETED|Overall Study||0
9005602|NCT02942771|10068906|FG002|NOT COMPLETED|Overall Study||0
9005603|NCT02942771|10068907|FG003|NOT COMPLETED|Overall Study||0
9005604|NCT02942771|10068908|FG004|NOT COMPLETED|Overall Study||4
9005605|NCT02942979|10068922|FG000|STARTED|Step 0||108
9005606|NCT02942979|10068923|FG001|STARTED|Step 0||0
9005607|NCT02942979|10068922|FG000|COMPLETED|Step 0||108
9005608|NCT02942979|10068923|FG001|COMPLETED|Step 0|This is a stepped wedge design - all participants received both MISSION Implementation as Usual and Facilitation|0
9005609|NCT02942979|10068922|FG000|NOT COMPLETED|Step 0||0
9005610|NCT02942979|10068923|FG001|NOT COMPLETED|Step 0||0
9005611|NCT02942979|10068922|FG000|STARTED|Step 1||15
9005612|NCT02942979|10068923|FG001|STARTED|Step 1||93
9005613|NCT02942979|10068922|FG000|COMPLETED|Step 1||15
9005614|NCT02942979|10068923|FG001|COMPLETED|Step 1||93
9005615|NCT02942979|10068922|FG000|NOT COMPLETED|Step 1||0
9005616|NCT02942979|10068923|FG001|NOT COMPLETED|Step 1||0
9005617|NCT02942979|10068922|FG000|STARTED|Step 2||0
9005618|NCT02942979|10068923|FG001|STARTED|Step 2||108
9005619|NCT02942979|10068922|FG000|COMPLETED|Step 2||0
9005620|NCT02942979|10068923|FG001|COMPLETED|Step 2||108
9005621|NCT02942979|10068922|FG000|NOT COMPLETED|Step 2||0
9005622|NCT02942979|10068923|FG001|NOT COMPLETED|Step 2||0
9005623|NCT02943070|10068929|FG000|STARTED|Overall Study||50
9005624|NCT02943070|10068929|FG000|COMPLETED|Overall Study||7
9005625|NCT02943070|10068929|FG000|NOT COMPLETED|Overall Study||43
9005626|NCT02943096|10068942|FG000|STARTED|Overall Study||3
9005627|NCT02943096|10068943|FG001|STARTED|Overall Study||3
9005628|NCT02943096|10068942|FG000|COMPLETED|Overall Study||3
9005629|NCT02943096|10068943|FG001|COMPLETED|Overall Study||2
9005630|NCT02943096|10068942|FG000|NOT COMPLETED|Overall Study||0
9005631|NCT02943096|10068943|FG001|NOT COMPLETED|Overall Study||1
9005632|NCT02943213|10068949|FG000|STARTED|Treatment Period 1||20
9005633|NCT02943213|10068949|FG000|COMPLETED|Treatment Period 1||20
9005634|NCT02943213|10068949|FG000|NOT COMPLETED|Treatment Period 1||0
9005635|NCT02943213|10068949|FG000|STARTED|Treatment Period 2||20
9005636|NCT02943213|10068949|FG000|COMPLETED|Treatment Period 2||20
9005637|NCT02943213|10068949|FG000|NOT COMPLETED|Treatment Period 2||0
9005638|NCT02943226|10068957|FG000|STARTED|Overall Study||31
9005639|NCT02943226|10068958|FG001|STARTED|Overall Study||30
9005640|NCT02943226|10068957|FG000|COMPLETED|Overall Study||31
9005641|NCT02943226|10068958|FG001|COMPLETED|Overall Study||30
9005642|NCT02943226|10068957|FG000|NOT COMPLETED|Overall Study||0
9005643|NCT02943226|10068958|FG001|NOT COMPLETED|Overall Study||0
9005644|NCT02943447|10068967|FG000|STARTED|Blinded Study Phase||28
9005645|NCT02943447|10068968|FG001|STARTED|Blinded Study Phase||30
9005646|NCT02943447|10068969|FG002|STARTED|Blinded Study Phase||13
9005647|NCT02943447|10068967|FG000|COMPLETED|Blinded Study Phase||23
9005648|NCT02943447|10068968|FG001|COMPLETED|Blinded Study Phase||28
9005649|NCT02943447|10068969|FG002|COMPLETED|Blinded Study Phase||12
9005650|NCT02943447|10068967|FG000|NOT COMPLETED|Blinded Study Phase||5
9005651|NCT02943447|10068968|FG001|NOT COMPLETED|Blinded Study Phase||2
9005652|NCT02943447|10068969|FG002|NOT COMPLETED|Blinded Study Phase||1
9005653|NCT02943447|10068967|FG000|STARTED|Open-Label Extension Phase||23
9005654|NCT02943447|10068968|FG001|STARTED|Open-Label Extension Phase||28
9005655|NCT02943447|10068969|FG002|STARTED|Open-Label Extension Phase||12
9005656|NCT02943447|10068967|FG000|COMPLETED|Open-Label Extension Phase||5
9005657|NCT02943447|10068968|FG001|COMPLETED|Open-Label Extension Phase||3
9005658|NCT02943447|10068969|FG002|COMPLETED|Open-Label Extension Phase||2
9005659|NCT02943447|10068967|FG000|NOT COMPLETED|Open-Label Extension Phase||18
9005660|NCT02943447|10068968|FG001|NOT COMPLETED|Open-Label Extension Phase||25
8634851|NCT00558571|9675191|FG001|COMPLETED|Overall Study||16
8634852|NCT00558571|9675192|FG002|COMPLETED|Overall Study||16
8889268|NCT01996657|9947292|FG001|COMPLETED|Overall Study||239
8889269|NCT01996657|9947293|FG002|COMPLETED|Overall Study||234
8889270|NCT01996657|9947291|FG000|NOT COMPLETED|Overall Study||13
8889271|NCT01996657|9947292|FG001|NOT COMPLETED|Overall Study||11
8889272|NCT01996657|9947293|FG002|NOT COMPLETED|Overall Study||14
8889273|NCT01996709|9947303|FG000|STARTED|Overall Study||66
8889274|NCT01996709|9947304|FG001|STARTED|Overall Study||68
8889275|NCT01996709|9947303|FG000|COMPLETED|Overall Study||61
8889276|NCT01996709|9947304|FG001|COMPLETED|Overall Study||67
8889277|NCT01996709|9947303|FG000|NOT COMPLETED|Overall Study||5
8889278|NCT01996709|9947304|FG001|NOT COMPLETED|Overall Study||1
8889279|NCT01996748|9947316|FG000|STARTED|Overall Study||66
8889280|NCT01996748|9947317|FG001|STARTED|Overall Study||69
8889281|NCT01996748|9947316|FG000|COMPLETED|Overall Study||58
8889282|NCT01996748|9947317|FG001|COMPLETED|Overall Study||63
8889283|NCT01996748|9947316|FG000|NOT COMPLETED|Overall Study||8
8889284|NCT01996748|9947317|FG001|NOT COMPLETED|Overall Study||6
8889285|NCT01996813|9947327|FG000|STARTED|Overall Study||23
8889286|NCT01996813|9947328|FG001|STARTED|Overall Study||24
8889287|NCT01996813|9947327|FG000|COMPLETED|Overall Study||23
8889288|NCT01996813|9947328|FG001|COMPLETED|Overall Study||24
8889289|NCT01996813|9947327|FG000|NOT COMPLETED|Overall Study||0
8889290|NCT01996813|9947328|FG001|NOT COMPLETED|Overall Study||0
8889291|NCT01996826|9947336|FG000|STARTED|Overall Study||39
8889292|NCT01996826|9947337|FG001|STARTED|Overall Study||36
8889293|NCT01996826|9947336|FG000|COMPLETED|Overall Study||32
8889294|NCT01996826|9947337|FG001|COMPLETED|Overall Study||33
8889295|NCT01996826|9947336|FG000|NOT COMPLETED|Overall Study||7
8889296|NCT01996826|9947337|FG001|NOT COMPLETED|Overall Study||3
8889297|NCT01996839|9947346|FG000|STARTED|Overall Study||172
8889298|NCT01996839|9947347|FG001|STARTED|Overall Study||171
8889299|NCT01996839|9947348|FG002|STARTED|Overall Study||171
8889300|NCT01996839|9947346|FG000|COMPLETED|Overall Study||80
8889301|NCT01996839|9947347|FG001|COMPLETED|Overall Study||133
9005661|NCT02943447|10068969|FG002|NOT COMPLETED|Open-Label Extension Phase||10
9005662|NCT02943460|10068989|FG000|STARTED|Blinded Study Phase||22
9005663|NCT02943460|10068990|FG001|STARTED|Blinded Study Phase||20
9005664|NCT02943460|10068991|FG002|STARTED|Blinded Study Phase||10
9005665|NCT02943460|10068989|FG000|COMPLETED|Blinded Study Phase||19
9005666|NCT02943460|10068990|FG001|COMPLETED|Blinded Study Phase||19
9005667|NCT02943460|10068991|FG002|COMPLETED|Blinded Study Phase||10
9005668|NCT02943460|10068989|FG000|NOT COMPLETED|Blinded Study Phase||3
9005669|NCT02943460|10068990|FG001|NOT COMPLETED|Blinded Study Phase||1
9005670|NCT02943460|10068991|FG002|NOT COMPLETED|Blinded Study Phase||0
9005671|NCT02943460|10068989|FG000|STARTED|Open Label Extension (OLE) Phase||19
9005672|NCT02943460|10068990|FG001|STARTED|Open Label Extension (OLE) Phase|1 participant completed the Blinded Study Phase, but did not continue in the OLE Phase.|18
9005673|NCT02943460|10068991|FG002|STARTED|Open Label Extension (OLE) Phase||10
9005674|NCT02943460|10068989|FG000|COMPLETED|Open Label Extension (OLE) Phase||14
9005675|NCT02943460|10068990|FG001|COMPLETED|Open Label Extension (OLE) Phase||11
9005676|NCT02943460|10068991|FG002|COMPLETED|Open Label Extension (OLE) Phase||8
9005677|NCT02943460|10068989|FG000|NOT COMPLETED|Open Label Extension (OLE) Phase||5
9005678|NCT02943460|10068990|FG001|NOT COMPLETED|Open Label Extension (OLE) Phase||7
9005679|NCT02943460|10068991|FG002|NOT COMPLETED|Open Label Extension (OLE) Phase||2
9005680|NCT02943473|10069000|FG000|STARTED|Overall Study||9
9005681|NCT02943473|10069000|FG000|COMPLETED|Overall Study||3
9005682|NCT02943473|10069000|FG000|NOT COMPLETED|Overall Study||6
9005683|NCT02943499|10069006|FG000|STARTED|Overall Study||41
9005684|NCT02943499|10069007|FG001|STARTED|Overall Study||39
9005685|NCT02943499|10069006|FG000|COMPLETED|Overall Study||34
9005686|NCT02943499|10069007|FG001|COMPLETED|Overall Study||34
9005687|NCT02943499|10069006|FG000|NOT COMPLETED|Overall Study||7
9005688|NCT02943499|10069007|FG001|NOT COMPLETED|Overall Study||5
9005689|NCT02943564|10069016|FG000|STARTED|Overall Study||217
9005690|NCT02943564|10069017|FG001|STARTED|Overall Study||211
9005691|NCT02943564|10069018|FG002|STARTED|Overall Study||210
9005692|NCT02943564|10069016|FG000|Responder|Overall Study||83
9005693|NCT02943564|10069017|FG001|Responder|Overall Study||77
9005694|NCT02943564|10069018|FG002|Responder|Overall Study||77
9005695|NCT02943564|10069016|FG000|Non-Responder|Overall Study||134
9005696|NCT02943564|10069017|FG001|Non-Responder|Overall Study||134
9005697|NCT02943564|10069018|FG002|Non-Responder|Overall Study||133
9005698|NCT02943564|10069016|FG000|COMPLETED|Overall Study||207
9005699|NCT02943564|10069017|FG001|COMPLETED|Overall Study||198
9005700|NCT02943564|10069018|FG002|COMPLETED|Overall Study||201
9005701|NCT02943564|10069016|FG000|NOT COMPLETED|Overall Study||10
9005702|NCT02943564|10069017|FG001|NOT COMPLETED|Overall Study||13
9005703|NCT02943564|10069018|FG002|NOT COMPLETED|Overall Study||9
9005704|NCT02943577|10069028|FG000|STARTED|Overall Study||209
9005705|NCT02943577|10069029|FG001|STARTED|Overall Study||206
9005706|NCT02943577|10069028|FG000|COMPLETED|Overall Study||204
9005707|NCT02943577|10069029|FG001|COMPLETED|Overall Study||201
9005708|NCT02943577|10069028|FG000|NOT COMPLETED|Overall Study||5
9005709|NCT02943577|10069029|FG001|NOT COMPLETED|Overall Study||5
9005710|NCT02943668|10069035|FG000|STARTED|Overall Study||2
9005711|NCT02943668|10069035|FG000|COMPLETED|Overall Study||1
9005712|NCT02943668|10069035|FG000|NOT COMPLETED|Overall Study||1
8889302|NCT01996839|9947348|FG002|COMPLETED|Overall Study||139
8889303|NCT01996839|9947346|FG000|NOT COMPLETED|Overall Study||92
8889304|NCT01996839|9947347|FG001|NOT COMPLETED|Overall Study||38
8889305|NCT01996839|9947348|FG002|NOT COMPLETED|Overall Study||32
8889306|NCT01996904|9947358|FG000|STARTED|Overall Study||139
8889307|NCT01996904|9947359|FG001|STARTED|Overall Study||117
8889308|NCT01996904|9947358|FG000|COMPLETED|Overall Study||101
8889309|NCT01996904|9947359|FG001|COMPLETED|Overall Study||90
8726123|NCT01033825|9773247|FG006|NOT COMPLETED|Overall Study||0
8726124|NCT01033851|9773267|FG000|STARTED|Overall Study||48
8726125|NCT01033851|9773268|FG001|STARTED|Overall Study||41
8726126|NCT01033851|9773267|FG000|COMPLETED|Overall Study||45
8726127|NCT01033851|9773268|FG001|COMPLETED|Overall Study||34
8889310|NCT01996904|9947358|FG000|NOT COMPLETED|Overall Study||38
8889311|NCT01996904|9947359|FG001|NOT COMPLETED|Overall Study||27
8889312|NCT01996917|9947365|FG000|STARTED|Overall Study||21
8889313|NCT01996917|9947365|FG000|COMPLETED|Overall Study||21
8889314|NCT01996917|9947365|FG000|NOT COMPLETED|Overall Study||0
8889315|NCT01996943|9947372|FG000|STARTED|Overall Study||50
8889316|NCT01996943|9947373|FG001|STARTED|Overall Study||50
8889317|NCT01996943|9947372|FG000|COMPLETED|Overall Study||50
8889318|NCT01996943|9947373|FG001|COMPLETED|Overall Study||50
9005713|NCT02943941|10069042|FG000|STARTED|Overall Study||16
8572724|NCT00116805|9604931|FG000|COMPLETED|Open-label Period Weeks 241 - 288||104
8572725|NCT00116805|9604932|FG001|COMPLETED|Open-label Period Weeks 241 - 288||64
8572726|NCT00116805|9604931|FG000|NOT COMPLETED|Open-label Period Weeks 241 - 288||6
8572727|NCT00116805|9604932|FG001|NOT COMPLETED|Open-label Period Weeks 241 - 288||0
8572728|NCT00116805|9604931|FG000|STARTED|Open-label Period Weeks 289 - 336||104
8726128|NCT01033851|9773267|FG000|NOT COMPLETED|Overall Study||3
8889319|NCT01996943|9947372|FG000|NOT COMPLETED|Overall Study||0
8889320|NCT01996943|9947373|FG001|NOT COMPLETED|Overall Study||0
8889321|NCT01997125|9947379|FG000|STARTED|Overall Study||1
8889322|NCT01997125|9947379|FG000|COMPLETED|Overall Study||1
8889323|NCT01997125|9947379|FG000|NOT COMPLETED|Overall Study||0
8889324|NCT01997216|9947383|FG000|STARTED|First 9 Hours||18
8889325|NCT01997216|9947384|FG001|STARTED|First 9 Hours||21
8889326|NCT01997216|9947383|FG000|COMPLETED|First 9 Hours||18
8889327|NCT01997216|9947384|FG001|COMPLETED|First 9 Hours||21
8889328|NCT01997216|9947383|FG000|NOT COMPLETED|First 9 Hours||0
8889329|NCT01997216|9947384|FG001|NOT COMPLETED|First 9 Hours||0
8889330|NCT01997216|9947383|FG000|STARTED|Second 9 Hours|One participant was not exposed to Pair 1 due to product unavailability, but was exposed to Pair 2.|19
8889331|NCT01997216|9947384|FG001|STARTED|Second 9 Hours||21
8889332|NCT01997216|9947383|FG000|COMPLETED|Second 9 Hours||19
8889333|NCT01997216|9947384|FG001|COMPLETED|Second 9 Hours||21
8889334|NCT01997216|9947383|FG000|NOT COMPLETED|Second 9 Hours||0
8889335|NCT01997216|9947384|FG001|NOT COMPLETED|Second 9 Hours||0
8889336|NCT01997229|9947392|FG000|STARTED|Overall Study||62
8889337|NCT01997229|9947393|FG001|STARTED|Overall Study||63
8889338|NCT01997229|9947392|FG000|COMPLETED|Overall Study||57
8889339|NCT01997229|9947393|FG001|COMPLETED|Overall Study||61
8889340|NCT01997229|9947392|FG000|NOT COMPLETED|Overall Study||5
8889341|NCT01997229|9947393|FG001|NOT COMPLETED|Overall Study||2
8889342|NCT01997281|9947401|FG000|STARTED|Overall Study||7
8889343|NCT01997281|9947402|FG001|STARTED|Overall Study||7
8889344|NCT01997281|9947401|FG000|Withdrawal|Overall Study||1
8889345|NCT01997281|9947402|FG001|Withdrawal|Overall Study||0
8889346|NCT01997281|9947401|FG000|COMPLETED|Overall Study||6
8889347|NCT01997281|9947402|FG001|COMPLETED|Overall Study||7
8889348|NCT01997281|9947401|FG000|NOT COMPLETED|Overall Study||1
8889349|NCT01997281|9947402|FG001|NOT COMPLETED|Overall Study||0
8889350|NCT01997333|9947410|FG000|STARTED|Randomization and Treatment||109
8889351|NCT01997333|9947411|FG001|STARTED|Randomization and Treatment||218
8889352|NCT01997333|9947410|FG000|COMPLETED|Randomization and Treatment||6
8889353|NCT01997333|9947411|FG001|COMPLETED|Randomization and Treatment||15
8889354|NCT01997333|9947410|FG000|NOT COMPLETED|Randomization and Treatment||103
8889355|NCT01997333|9947411|FG001|NOT COMPLETED|Randomization and Treatment||203
8889356|NCT01997333|9947410|FG000|STARTED|Survival Follow up||92
8889357|NCT01997333|9947411|FG001|STARTED|Survival Follow up||213
8889358|NCT01997333|9947410|FG000|COMPLETED|Survival Follow up||76
8889359|NCT01997333|9947411|FG001|COMPLETED|Survival Follow up||199
8889360|NCT01997333|9947410|FG000|NOT COMPLETED|Survival Follow up||16
8889361|NCT01997333|9947411|FG001|NOT COMPLETED|Survival Follow up||14
8889362|NCT01997398|9947419|FG000|STARTED|Overall Study||35
8889363|NCT01997398|9947419|FG000|COMPLETED|Overall Study|One patient took PD meds 3 hours prior to 6 mo. UPDRS testing and was excluded from the analysis.|34
8889364|NCT01997398|9947419|FG000|NOT COMPLETED|Overall Study||1
8889365|NCT01997411|9947433|FG000|STARTED|Overall Study||6
8889366|NCT01997411|9947434|FG001|STARTED|Overall Study||6
8889367|NCT01997411|9947435|FG002|STARTED|Overall Study||6
8889368|NCT01997411|9947436|FG003|STARTED|Overall Study||6
8889369|NCT01997411|9947437|FG004|STARTED|Overall Study||6
8889370|NCT01997411|9947438|FG005|STARTED|Overall Study||6
8889371|NCT01997411|9947439|FG006|STARTED|Overall Study||6
8889372|NCT01997411|9947440|FG007|STARTED|Overall Study||6
8889373|NCT01997411|9947433|FG000|COMPLETED|Overall Study||6
8889374|NCT01997411|9947434|FG001|COMPLETED|Overall Study||6
8889375|NCT01997411|9947435|FG002|COMPLETED|Overall Study||6
8889376|NCT01997411|9947436|FG003|COMPLETED|Overall Study||6
8889377|NCT01997411|9947437|FG004|COMPLETED|Overall Study||6
8889378|NCT01997411|9947438|FG005|COMPLETED|Overall Study||5
8889379|NCT01997411|9947439|FG006|COMPLETED|Overall Study||6
8889380|NCT01997411|9947440|FG007|COMPLETED|Overall Study||6
8889381|NCT01997411|9947433|FG000|NOT COMPLETED|Overall Study||0
8889382|NCT01997411|9947434|FG001|NOT COMPLETED|Overall Study||0
8889383|NCT01997411|9947435|FG002|NOT COMPLETED|Overall Study||0
8889384|NCT01997411|9947436|FG003|NOT COMPLETED|Overall Study||0
8889385|NCT01997411|9947437|FG004|NOT COMPLETED|Overall Study||0
8889386|NCT01997411|9947438|FG005|NOT COMPLETED|Overall Study||1
8889387|NCT01997411|9947439|FG006|NOT COMPLETED|Overall Study||0
8889388|NCT01997411|9947440|FG007|NOT COMPLETED|Overall Study||0
8889389|NCT01997437|9947458|FG000|STARTED|Overall Study||6
8889390|NCT01997437|9947458|FG000|COMPLETED|Overall Study||6
8889391|NCT01997437|9947458|FG000|NOT COMPLETED|Overall Study||0
8889392|NCT01997515|9947464|FG000|STARTED|Overall Study||40
8889393|NCT01997515|9947465|FG001|STARTED|Overall Study||40
8889394|NCT01997515|9947464|FG000|COMPLETED|Overall Study||36
8889395|NCT01997515|9947465|FG001|COMPLETED|Overall Study||35
8889396|NCT01997515|9947464|FG000|NOT COMPLETED|Overall Study||4
8889397|NCT01997515|9947465|FG001|NOT COMPLETED|Overall Study||5
8889398|NCT01997723|9947471|FG000|STARTED|Overall Study||75
8889399|NCT01997723|9947471|FG000|COMPLETED|Overall Study||75
8889400|NCT01997723|9947471|FG000|NOT COMPLETED|Overall Study||0
8889401|NCT01997892|9947475|FG000|STARTED|Overall Study||1027
8889402|NCT01997892|9947475|FG000|Received Darbepoetin Alfa|Overall Study||987
8889403|NCT01997892|9947475|FG000|COMPLETED|Overall Study||959
8889404|NCT01997892|9947475|FG000|NOT COMPLETED|Overall Study||68
8889405|NCT01997905|9947484|FG000|STARTED|Overall Study||13
8889406|NCT01997905|9947484|FG000|Baseline Completed|Overall Study||11
8889407|NCT01997905|9947484|FG000|COMPLETED|Overall Study||10
8889408|NCT01997905|9947484|FG000|NOT COMPLETED|Overall Study||3
8889409|NCT01998243|9947490|FG000|STARTED|Overall Study||42
8889410|NCT01998243|9947491|FG001|STARTED|Overall Study||39
8889411|NCT01998243|9947490|FG000|COMPLETED|Overall Study||34
8889412|NCT01998243|9947491|FG001|COMPLETED|Overall Study||32
8889413|NCT01998243|9947490|FG000|NOT COMPLETED|Overall Study||8
8889414|NCT01998243|9947491|FG001|NOT COMPLETED|Overall Study||7
9005714|NCT02943941|10069042|FG000|COMPLETED|Overall Study||16
9005715|NCT02943941|10069042|FG000|NOT COMPLETED|Overall Study||0
9005716|NCT02944383|10069050|FG000|STARTED|Overall Study||30
9005717|NCT02944383|10069051|FG001|STARTED|Overall Study||30
9005718|NCT02944383|10069052|FG002|STARTED|Overall Study||31
9005719|NCT02944383|10069050|FG000|COMPLETED|Overall Study||29
9005720|NCT02944383|10069051|FG001|COMPLETED|Overall Study||30
9005721|NCT02944383|10069052|FG002|COMPLETED|Overall Study||30
9005722|NCT02944383|10069050|FG000|NOT COMPLETED|Overall Study||1
9005723|NCT02944383|10069051|FG001|NOT COMPLETED|Overall Study||0
9005724|NCT02944383|10069052|FG002|NOT COMPLETED|Overall Study||1
9005725|NCT02944448|10069064|FG000|STARTED|Overall Study||316
9005726|NCT02944448|10069065|FG001|STARTED|Overall Study||160
9005727|NCT02944448|10069064|FG000|COMPLETED|Overall Study||227
9005728|NCT02944448|10069065|FG001|COMPLETED|Overall Study||136
9005729|NCT02944448|10069064|FG000|NOT COMPLETED|Overall Study||89
9005730|NCT02944448|10069065|FG001|NOT COMPLETED|Overall Study||24
9005731|NCT02944461|10069072|FG000|STARTED|Overall Study||20
9005732|NCT02944461|10069072|FG000|COMPLETED|Overall Study||15
9005733|NCT02944461|10069072|FG000|NOT COMPLETED|Overall Study||5
9005734|NCT02944565|10069076|FG000|STARTED|Overall Study||28
9005735|NCT02944565|10069076|FG000|COMPLETED|Overall Study||28
9005736|NCT02944565|10069076|FG000|NOT COMPLETED|Overall Study||0
9005737|NCT02944656|10069083|FG000|STARTED|Overall Study||57
9005738|NCT02944656|10069084|FG001|STARTED|Overall Study||57
9005739|NCT02944656|10069083|FG000|Completed Procedure Day|Overall Study||54
9005740|NCT02944656|10069084|FG001|Completed Procedure Day|Overall Study||57
9005741|NCT02944656|10069083|FG000|Completed Day 1 Follow up|Overall Study||47
9005742|NCT02944656|10069084|FG001|Completed Day 1 Follow up|Overall Study||47
9005743|NCT02944656|10069083|FG000|COMPLETED|Overall Study||47
9005744|NCT02944656|10069084|FG001|COMPLETED|Overall Study||47
9005745|NCT02944656|10069083|FG000|NOT COMPLETED|Overall Study||10
9005746|NCT02944656|10069084|FG001|NOT COMPLETED|Overall Study||10
9005747|NCT02944968|10069090|FG000|STARTED|Overall Study||51
9005748|NCT02944968|10069090|FG000|COMPLETED|Overall Study||48
9005749|NCT02944968|10069090|FG000|NOT COMPLETED|Overall Study||3
9005750|NCT02945046|10069097|FG000|STARTED|Overall Study||59
9005751|NCT02945046|10069098|FG001|STARTED|Overall Study||55
9005752|NCT02945046|10069099|FG002|STARTED|Overall Study||55
9005753|NCT02945046|10069097|FG000|Safety Analysis Set|Overall Study||59
9005754|NCT02945046|10069098|FG001|Safety Analysis Set|Overall Study||55
9005755|NCT02945046|10069099|FG002|Safety Analysis Set|Overall Study||55
9005756|NCT02945046|10069097|FG000|Full Analysis Set|Overall Study||57
8889415|NCT01998269|9947499|FG000|STARTED|Overall Study||193
8889416|NCT01998269|9947499|FG000|COMPLETED|Overall Study||193
8889417|NCT01998269|9947499|FG000|NOT COMPLETED|Overall Study||0
8889418|NCT01998360|9947505|FG000|STARTED|Overall Study||50
8889419|NCT01998360|9947506|FG001|STARTED|Overall Study||50
8889420|NCT01998360|9947505|FG000|COMPLETED|Overall Study||50
8889421|NCT01998360|9947506|FG001|COMPLETED|Overall Study||50
8889422|NCT01998360|9947505|FG000|NOT COMPLETED|Overall Study||0
8889423|NCT01998360|9947506|FG001|NOT COMPLETED|Overall Study||0
8889424|NCT01998399|9947514|FG000|STARTED|Overall Study||12
8889425|NCT01998399|9947515|FG001|STARTED|Overall Study||13
8889426|NCT01998399|9947514|FG000|COMPLETED|Overall Study||4
8889427|NCT01998399|9947515|FG001|COMPLETED|Overall Study||4
9005757|NCT02945046|10069098|FG001|Full Analysis Set|Overall Study||53
9005758|NCT02945046|10069099|FG002|Full Analysis Set|Overall Study||55
9005759|NCT02945046|10069097|FG000|COMPLETED|Overall Study||46
8889428|NCT01998399|9947514|FG000|NOT COMPLETED|Overall Study||8
8889429|NCT01998399|9947515|FG001|NOT COMPLETED|Overall Study||9
8889430|NCT01998438|9947524|FG000|STARTED|Overall Study||319
8889431|NCT01998438|9947525|FG001|STARTED|Overall Study||318
8889432|NCT01998438|9947526|FG002|STARTED|Overall Study||318
8889433|NCT01998438|9947524|FG000|COMPLETED|Overall Study||319
8889434|NCT01998438|9947525|FG001|COMPLETED|Overall Study||318
8889435|NCT01998438|9947526|FG002|COMPLETED|Overall Study||318
8889436|NCT01998438|9947524|FG000|NOT COMPLETED|Overall Study||0
8889437|NCT01998438|9947525|FG001|NOT COMPLETED|Overall Study||0
8889438|NCT01998438|9947526|FG002|NOT COMPLETED|Overall Study||0
8889439|NCT01998477|9947536|FG000|STARTED|Overall Study||282
8889440|NCT01998477|9947537|FG001|STARTED|Overall Study||148
8889441|NCT01998477|9947536|FG000|COMPLETED|Overall Study||272
8889442|NCT01998477|9947537|FG001|COMPLETED|Overall Study||143
8889443|NCT01998477|9947536|FG000|NOT COMPLETED|Overall Study||10
8889444|NCT01998477|9947537|FG001|NOT COMPLETED|Overall Study||5
8889445|NCT01998581|9947570|FG000|STARTED|Overall Study||169
8889446|NCT01998581|9947571|FG001|STARTED|Overall Study||56
8889447|NCT01998581|9947570|FG000|COMPLETED|Overall Study||123
8889448|NCT01998581|9947571|FG001|COMPLETED|Overall Study||44
8889449|NCT01998581|9947570|FG000|NOT COMPLETED|Overall Study||46
8889450|NCT01998581|9947571|FG001|NOT COMPLETED|Overall Study||12
8889451|NCT01998633|9947580|FG000|STARTED|Overall Study||47
8889452|NCT01998633|9947580|FG000|COMPLETED|Overall Study||46
8889453|NCT01998633|9947580|FG000|NOT COMPLETED|Overall Study||1
8889454|NCT01998737|9947590|FG000|STARTED|Overall Study||911
8889455|NCT01998737|9947591|FG001|STARTED|Overall Study||100
8889456|NCT01998737|9947590|FG000|COMPLETED|Overall Study||888
8889457|NCT01998737|9947591|FG001|COMPLETED|Overall Study||100
8889458|NCT01998737|9947590|FG000|NOT COMPLETED|Overall Study||23
8889459|NCT01998737|9947591|FG001|NOT COMPLETED|Overall Study||0
8889460|NCT01998880|9947599|FG000|STARTED|Overall Study||233
8889461|NCT01998880|9947600|FG001|STARTED|Overall Study||118
8889462|NCT01998880|9947599|FG000|Received Study Drug|Overall Study||230
8889463|NCT01998880|9947600|FG001|Received Study Drug|Overall Study||116
8889464|NCT01998880|9947599|FG000|COMPLETED|Overall Study|Completed=Completed treatment.|205
8889465|NCT01998880|9947600|FG001|COMPLETED|Overall Study||78
8889466|NCT01998880|9947599|FG000|NOT COMPLETED|Overall Study||28
8889467|NCT01998880|9947600|FG001|NOT COMPLETED|Overall Study||40
8889468|NCT01998893|9947606|FG000|STARTED|Overall Study||38
8889469|NCT01998893|9947606|FG000|1st Treatment Cycle Completed Until PD|Overall Study|Progressive disease (PD)|30
8889470|NCT01998893|9947606|FG000|2nd Treatment Cycle Started|Overall Study||5
8889471|NCT01998893|9947606|FG000|2nd Treatment Cycle Completed Until PD|Overall Study||3
8889472|NCT01998893|9947606|FG000|COMPLETED|Overall Study||21
8889473|NCT01998893|9947606|FG000|NOT COMPLETED|Overall Study||17
8889474|NCT01998906|9947613|FG000|STARTED|Overall Study||115
8889475|NCT01998906|9947614|FG001|STARTED|Overall Study||116
8889476|NCT01998906|9947615|FG002|STARTED|Overall Study||99
8889477|NCT01998906|9947613|FG000|COMPLETED|Overall Study||1
8889478|NCT01998906|9947614|FG001|COMPLETED|Overall Study||2
8889479|NCT01998906|9947615|FG002|COMPLETED|Overall Study||1
8889480|NCT01998906|9947613|FG000|NOT COMPLETED|Overall Study||114
8889481|NCT01998906|9947614|FG001|NOT COMPLETED|Overall Study||114
8889482|NCT01998906|9947615|FG002|NOT COMPLETED|Overall Study||98
8889483|NCT01998919|9947628|FG000|STARTED|Overall Study||79
8889484|NCT01998919|9947629|FG001|STARTED|Overall Study||74
8889485|NCT01998919|9947628|FG000|Randomized|Overall Study|1 participant randomized to erlotinib didn't receive study drug; analyzed in placebo for safety|78
8889486|NCT01998919|9947629|FG001|Randomized|Overall Study|One participant withdrew consent prior to 1st dose and was excluded from safety analysis population.|76
8889487|NCT01998919|9947628|FG000|COMPLETED|Overall Study||37
8889488|NCT01998919|9947629|FG001|COMPLETED|Overall Study||39
8889489|NCT01998919|9947628|FG000|NOT COMPLETED|Overall Study||42
8889490|NCT01998919|9947629|FG001|NOT COMPLETED|Overall Study||35
8889491|NCT01998958|9947642|FG000|STARTED|Period 1 (Panel A and B)||33
8889492|NCT01998958|9947643|FG001|STARTED|Period 1 (Panel A and B)||11
8889493|NCT01998958|9947644|FG002|STARTED|Period 1 (Panel A and B)||11
8889494|NCT01998958|9947645|FG003|STARTED|Period 1 (Panel A and B)||12
8889495|NCT01998958|9947646|FG004|STARTED|Period 1 (Panel A and B)||21
8889496|NCT01998958|9947647|FG005|STARTED|Period 1 (Panel A and B)||11
8889497|NCT01998958|9947648|FG006|STARTED|Period 1 (Panel A and B)||9
8889498|NCT01998958|9947649|FG007|STARTED|Period 1 (Panel A and B)||0
8889499|NCT01998958|9947650|FG008|STARTED|Period 1 (Panel A and B)||0
8889500|NCT01998958|9947651|FG009|STARTED|Period 1 (Panel A and B)||0
8889501|NCT01998958|9947652|FG010|STARTED|Period 1 (Panel A and B)||0
8889502|NCT01998958|9947653|FG011|STARTED|Period 1 (Panel A and B)||0
8889503|NCT01998958|9947654|FG012|STARTED|Period 1 (Panel A and B)||0
8889504|NCT01998958|9947655|FG013|STARTED|Period 1 (Panel A and B)||0
8726129|NCT01033851|9773268|FG001|NOT COMPLETED|Overall Study||7
8889505|NCT01998958|9947656|FG014|STARTED|Period 1 (Panel A and B)||0
8889506|NCT01998958|9947657|FG015|STARTED|Period 1 (Panel A and B)||0
8889507|NCT01998958|9947658|FG016|STARTED|Period 1 (Panel A and B)||0
8889508|NCT01998958|9947659|FG017|STARTED|Period 1 (Panel A and B)||0
8889509|NCT01998958|9947660|FG018|STARTED|Period 1 (Panel A and B)||0
8889510|NCT01998958|9947661|FG019|STARTED|Period 1 (Panel A and B)||0
8889511|NCT01998958|9947662|FG020|STARTED|Period 1 (Panel A and B)||0
8889512|NCT01998958|9947663|FG021|STARTED|Period 1 (Panel A and B)||0
8889513|NCT01998958|9947664|FG022|STARTED|Period 1 (Panel A and B)||0
8889514|NCT01998958|9947665|FG023|STARTED|Period 1 (Panel A and B)||0
8889515|NCT01998958|9947666|FG024|STARTED|Period 1 (Panel A and B)||0
8889516|NCT01998958|9947667|FG025|STARTED|Period 1 (Panel A and B)||0
8889517|NCT01998958|9947668|FG026|STARTED|Period 1 (Panel A and B)||0
8889518|NCT01998958|9947669|FG027|STARTED|Period 1 (Panel A and B)||0
8889519|NCT01998958|9947670|FG028|STARTED|Period 1 (Panel A and B)||0
8889520|NCT01998958|9947671|FG029|STARTED|Period 1 (Panel A and B)||0
8889521|NCT01998958|9947672|FG030|STARTED|Period 1 (Panel A and B)||0
8889522|NCT01998958|9947673|FG031|STARTED|Period 1 (Panel A and B)||0
8889523|NCT01998958|9947642|FG000|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||9
8889524|NCT01998958|9947643|FG001|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8889525|NCT01998958|9947644|FG002|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8889526|NCT01998958|9947645|FG003|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8889527|NCT01998958|9947646|FG004|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8889528|NCT01998958|9947647|FG005|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8889529|NCT01998958|9947648|FG006|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8889530|NCT01998958|9947649|FG007|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8889531|NCT01998958|9947650|FG008|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8889532|NCT01998958|9947651|FG009|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8889533|NCT01998958|9947652|FG010|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8889534|NCT01998958|9947653|FG011|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8889535|NCT01998958|9947654|FG012|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8889536|NCT01998958|9947655|FG013|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8889537|NCT01998958|9947656|FG014|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8889538|NCT01998958|9947657|FG015|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8889539|NCT01998958|9947658|FG016|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8889540|NCT01998958|9947659|FG017|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8889541|NCT01998958|9947660|FG018|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8889542|NCT01998958|9947661|FG019|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8889543|NCT01998958|9947662|FG020|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8889544|NCT01998958|9947663|FG021|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8889545|NCT01998958|9947664|FG022|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8889546|NCT01998958|9947665|FG023|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8889547|NCT01998958|9947666|FG024|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8889548|NCT01998958|9947667|FG025|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8889549|NCT01998958|9947668|FG026|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8889550|NCT01998958|9947669|FG027|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8889551|NCT01998958|9947670|FG028|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8889552|NCT01998958|9947671|FG029|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8889553|NCT01998958|9947672|FG030|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8889554|NCT01998958|9947673|FG031|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8889555|NCT01998958|9947642|FG000|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||8
8889556|NCT01998958|9947643|FG001|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8889557|NCT01998958|9947644|FG002|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8889558|NCT01998958|9947645|FG003|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8889559|NCT01998958|9947646|FG004|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8634853|NCT00558571|9675193|FG003|COMPLETED|Overall Study||30
8634854|NCT00558571|9675190|FG000|NOT COMPLETED|Overall Study||0
8634855|NCT00558571|9675191|FG001|NOT COMPLETED|Overall Study||0
8889560|NCT01998958|9947647|FG005|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8889561|NCT01998958|9947648|FG006|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8889562|NCT01998958|9947649|FG007|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8889563|NCT01998958|9947650|FG008|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8889564|NCT01998958|9947651|FG009|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8889565|NCT01998958|9947652|FG010|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8889566|NCT01998958|9947653|FG011|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8889567|NCT01998958|9947654|FG012|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8889568|NCT01998958|9947655|FG013|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8634856|NCT00558571|9675192|FG002|NOT COMPLETED|Overall Study||0
8634857|NCT00558571|9675193|FG003|NOT COMPLETED|Overall Study||0
8634858|NCT00558636|9675216|FG000|STARTED|Treatment|up to 6 cycles of combination therapy|47
8634859|NCT00558636|9675217|FG001|STARTED|Treatment||44
8889569|NCT01998958|9947656|FG014|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8889570|NCT01998958|9947657|FG015|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8889571|NCT01998958|9947658|FG016|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8634860|NCT00558636|9675216|FG000|Start of Maintenance Monotherapy|Treatment|Sorafenib taken as the single agent in the Maintenance Phase|2
8634861|NCT00558636|9675217|FG001|Start of Maintenance Monotherapy|Treatment|Placebo taken as the single agent in the Maintenance Phase|2
8889572|NCT01998958|9947659|FG017|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8889573|NCT01998958|9947660|FG018|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8889574|NCT01998958|9947661|FG019|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8889575|NCT01998958|9947662|FG020|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8889576|NCT01998958|9947663|FG021|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8889577|NCT01998958|9947664|FG022|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8889578|NCT01998958|9947665|FG023|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8889579|NCT01998958|9947666|FG024|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8889580|NCT01998958|9947667|FG025|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8889581|NCT01998958|9947668|FG026|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8889582|NCT01998958|9947669|FG027|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
9005760|NCT02945046|10069098|FG001|COMPLETED|Overall Study||42
9005761|NCT02945046|10069099|FG002|COMPLETED|Overall Study||40
9005762|NCT02945046|10069097|FG000|NOT COMPLETED|Overall Study||13
9005763|NCT02945046|10069098|FG001|NOT COMPLETED|Overall Study||13
9005764|NCT02945046|10069099|FG002|NOT COMPLETED|Overall Study||15
9005765|NCT02945150|10069107|FG000|STARTED|Overall Study||8
9005766|NCT02945150|10069107|FG000|SVR12|Overall Study||8
9005767|NCT02945150|10069107|FG000|COMPLETED|Overall Study||8
9005768|NCT02945150|10069107|FG000|NOT COMPLETED|Overall Study||0
9005769|NCT02945254|10069113|FG000|STARTED|Overall Study||10
9005770|NCT02945254|10069114|FG001|STARTED|Overall Study||10
9005771|NCT02945254|10069113|FG000|COMPLETED|Overall Study||8
9005772|NCT02945254|10069114|FG001|COMPLETED|Overall Study||10
9005773|NCT02945254|10069113|FG000|NOT COMPLETED|Overall Study||2
9005774|NCT02945254|10069114|FG001|NOT COMPLETED|Overall Study||0
9005775|NCT02945410|10069126|FG000|STARTED|Intervention 1 (5 Days)||3
9005776|NCT02945410|10069127|FG001|STARTED|Intervention 1 (5 Days)||4
9005777|NCT02945410|10069128|FG002|STARTED|Intervention 1 (5 Days)||2
9005778|NCT02945410|10069129|FG003|STARTED|Intervention 1 (5 Days)||3
9005779|NCT02945410|10069130|FG004|STARTED|Intervention 1 (5 Days)||2
9005780|NCT02945410|10069131|FG005|STARTED|Intervention 1 (5 Days)||1
9005781|NCT02945410|10069126|FG000|COMPLETED|Intervention 1 (5 Days)||2
9005782|NCT02945410|10069127|FG001|COMPLETED|Intervention 1 (5 Days)||1
9005783|NCT02945410|10069128|FG002|COMPLETED|Intervention 1 (5 Days)||2
9005784|NCT02945410|10069129|FG003|COMPLETED|Intervention 1 (5 Days)||3
9005785|NCT02945410|10069130|FG004|COMPLETED|Intervention 1 (5 Days)||2
9005786|NCT02945410|10069131|FG005|COMPLETED|Intervention 1 (5 Days)||0
9005787|NCT02945410|10069126|FG000|NOT COMPLETED|Intervention 1 (5 Days)||1
9005788|NCT02945410|10069127|FG001|NOT COMPLETED|Intervention 1 (5 Days)||3
9005789|NCT02945410|10069128|FG002|NOT COMPLETED|Intervention 1 (5 Days)||0
9005790|NCT02945410|10069129|FG003|NOT COMPLETED|Intervention 1 (5 Days)||0
9005791|NCT02945410|10069130|FG004|NOT COMPLETED|Intervention 1 (5 Days)||0
9005792|NCT02945410|10069131|FG005|NOT COMPLETED|Intervention 1 (5 Days)||1
8889583|NCT01998958|9947670|FG028|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8889584|NCT01998958|9947671|FG029|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8889585|NCT01998958|9947672|FG030|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8889586|NCT01998958|9947673|FG031|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8889587|NCT01998958|9947642|FG000|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||5
8889588|NCT01998958|9947643|FG001|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8889589|NCT01998958|9947644|FG002|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8889590|NCT01998958|9947645|FG003|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8889591|NCT01998958|9947646|FG004|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8889592|NCT01998958|9947647|FG005|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8889593|NCT01998958|9947648|FG006|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8889594|NCT01998958|9947649|FG007|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8889595|NCT01998958|9947650|FG008|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8889596|NCT01998958|9947651|FG009|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8889597|NCT01998958|9947652|FG010|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8889598|NCT01998958|9947653|FG011|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8889599|NCT01998958|9947654|FG012|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8889600|NCT01998958|9947655|FG013|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8889601|NCT01998958|9947656|FG014|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8889602|NCT01998958|9947657|FG015|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8889603|NCT01998958|9947658|FG016|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8889604|NCT01998958|9947659|FG017|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8889605|NCT01998958|9947660|FG018|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8889606|NCT01998958|9947661|FG019|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8889607|NCT01998958|9947662|FG020|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8889608|NCT01998958|9947663|FG021|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8889609|NCT01998958|9947664|FG022|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8889610|NCT01998958|9947665|FG023|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
9005793|NCT02945410|10069126|FG000|STARTED|Washout 1 (14 Days)||2
9005794|NCT02945410|10069127|FG001|STARTED|Washout 1 (14 Days)||1
9005795|NCT02945410|10069128|FG002|STARTED|Washout 1 (14 Days)||2
9005796|NCT02945410|10069129|FG003|STARTED|Washout 1 (14 Days)||3
9005797|NCT02945410|10069130|FG004|STARTED|Washout 1 (14 Days)||2
9005798|NCT02945410|10069131|FG005|STARTED|Washout 1 (14 Days)||0
9005799|NCT02945410|10069126|FG000|COMPLETED|Washout 1 (14 Days)||2
9005800|NCT02945410|10069127|FG001|COMPLETED|Washout 1 (14 Days)||1
9005801|NCT02945410|10069128|FG002|COMPLETED|Washout 1 (14 Days)||0
9005802|NCT02945410|10069129|FG003|COMPLETED|Washout 1 (14 Days)||3
8889611|NCT01998958|9947666|FG024|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8889612|NCT01998958|9947667|FG025|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8889613|NCT01998958|9947668|FG026|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8889614|NCT01998958|9947669|FG027|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8889615|NCT01998958|9947670|FG028|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8889616|NCT01998958|9947671|FG029|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8889617|NCT01998958|9947672|FG030|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8889618|NCT01998958|9947673|FG031|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8889619|NCT01998958|9947642|FG000|COMPLETED|Period 1 (Panel A and B)||32
8889620|NCT01998958|9947643|FG001|COMPLETED|Period 1 (Panel A and B)||8
9005803|NCT02945410|10069130|FG004|COMPLETED|Washout 1 (14 Days)||1
9005804|NCT02945410|10069131|FG005|COMPLETED|Washout 1 (14 Days)||0
9005805|NCT02945410|10069126|FG000|NOT COMPLETED|Washout 1 (14 Days)||0
9005806|NCT02945410|10069127|FG001|NOT COMPLETED|Washout 1 (14 Days)||0
9005807|NCT02945410|10069128|FG002|NOT COMPLETED|Washout 1 (14 Days)||2
9005808|NCT02945410|10069129|FG003|NOT COMPLETED|Washout 1 (14 Days)||0
9005809|NCT02945410|10069130|FG004|NOT COMPLETED|Washout 1 (14 Days)||1
9005810|NCT02945410|10069131|FG005|NOT COMPLETED|Washout 1 (14 Days)||0
9005811|NCT02945410|10069126|FG000|STARTED|Intervention 2 (5 Days)||2
9005812|NCT02945410|10069127|FG001|STARTED|Intervention 2 (5 Days)||1
9005813|NCT02945410|10069128|FG002|STARTED|Intervention 2 (5 Days)||0
9005814|NCT02945410|10069129|FG003|STARTED|Intervention 2 (5 Days)||3
9005815|NCT02945410|10069130|FG004|STARTED|Intervention 2 (5 Days)||1
9005816|NCT02945410|10069131|FG005|STARTED|Intervention 2 (5 Days)||0
9005817|NCT02945410|10069126|FG000|COMPLETED|Intervention 2 (5 Days)||2
9005818|NCT02945410|10069127|FG001|COMPLETED|Intervention 2 (5 Days)||1
9005819|NCT02945410|10069128|FG002|COMPLETED|Intervention 2 (5 Days)||0
9005820|NCT02945410|10069129|FG003|COMPLETED|Intervention 2 (5 Days)||3
9005821|NCT02945410|10069130|FG004|COMPLETED|Intervention 2 (5 Days)||1
9005822|NCT02945410|10069131|FG005|COMPLETED|Intervention 2 (5 Days)||0
9005823|NCT02945410|10069126|FG000|NOT COMPLETED|Intervention 2 (5 Days)||0
9005824|NCT02945410|10069127|FG001|NOT COMPLETED|Intervention 2 (5 Days)||0
9005825|NCT02945410|10069128|FG002|NOT COMPLETED|Intervention 2 (5 Days)||0
9005826|NCT02945410|10069129|FG003|NOT COMPLETED|Intervention 2 (5 Days)||0
9005827|NCT02945410|10069130|FG004|NOT COMPLETED|Intervention 2 (5 Days)||0
9005828|NCT02945410|10069131|FG005|NOT COMPLETED|Intervention 2 (5 Days)||0
9005829|NCT02945410|10069126|FG000|STARTED|Washout 2 (14 Days)||2
9005830|NCT02945410|10069127|FG001|STARTED|Washout 2 (14 Days)||1
9005831|NCT02945410|10069128|FG002|STARTED|Washout 2 (14 Days)||0
9005832|NCT02945410|10069129|FG003|STARTED|Washout 2 (14 Days)||3
9005833|NCT02945410|10069130|FG004|STARTED|Washout 2 (14 Days)||1
9005834|NCT02945410|10069131|FG005|STARTED|Washout 2 (14 Days)||0
9005835|NCT02945410|10069126|FG000|COMPLETED|Washout 2 (14 Days)||2
9005836|NCT02945410|10069127|FG001|COMPLETED|Washout 2 (14 Days)||1
9005837|NCT02945410|10069128|FG002|COMPLETED|Washout 2 (14 Days)||0
9005838|NCT02945410|10069129|FG003|COMPLETED|Washout 2 (14 Days)||3
9005839|NCT02945410|10069130|FG004|COMPLETED|Washout 2 (14 Days)||1
9005840|NCT02945410|10069131|FG005|COMPLETED|Washout 2 (14 Days)||0
9005841|NCT02945410|10069126|FG000|NOT COMPLETED|Washout 2 (14 Days)||0
9005842|NCT02945410|10069127|FG001|NOT COMPLETED|Washout 2 (14 Days)||0
9005843|NCT02945410|10069128|FG002|NOT COMPLETED|Washout 2 (14 Days)||0
9005844|NCT02945410|10069129|FG003|NOT COMPLETED|Washout 2 (14 Days)||0
9005845|NCT02945410|10069130|FG004|NOT COMPLETED|Washout 2 (14 Days)||0
9005846|NCT02945410|10069131|FG005|NOT COMPLETED|Washout 2 (14 Days)||0
9005847|NCT02945410|10069126|FG000|STARTED|Intervention 3 (5 Days)||2
9005848|NCT02945410|10069127|FG001|STARTED|Intervention 3 (5 Days)||1
9005849|NCT02945410|10069128|FG002|STARTED|Intervention 3 (5 Days)||0
9005850|NCT02945410|10069129|FG003|STARTED|Intervention 3 (5 Days)||3
9005851|NCT02945410|10069130|FG004|STARTED|Intervention 3 (5 Days)||1
9005852|NCT02945410|10069131|FG005|STARTED|Intervention 3 (5 Days)||0
9005853|NCT02945410|10069126|FG000|COMPLETED|Intervention 3 (5 Days)||2
9005854|NCT02945410|10069127|FG001|COMPLETED|Intervention 3 (5 Days)||1
9005855|NCT02945410|10069128|FG002|COMPLETED|Intervention 3 (5 Days)||0
9005856|NCT02945410|10069129|FG003|COMPLETED|Intervention 3 (5 Days)||3
9005857|NCT02945410|10069130|FG004|COMPLETED|Intervention 3 (5 Days)||1
9005858|NCT02945410|10069131|FG005|COMPLETED|Intervention 3 (5 Days)||0
9005859|NCT02945410|10069126|FG000|NOT COMPLETED|Intervention 3 (5 Days)||0
9005860|NCT02945410|10069127|FG001|NOT COMPLETED|Intervention 3 (5 Days)||0
9005861|NCT02945410|10069128|FG002|NOT COMPLETED|Intervention 3 (5 Days)||0
9005862|NCT02945410|10069129|FG003|NOT COMPLETED|Intervention 3 (5 Days)||0
9005863|NCT02945410|10069130|FG004|NOT COMPLETED|Intervention 3 (5 Days)||0
9005864|NCT02945410|10069131|FG005|NOT COMPLETED|Intervention 3 (5 Days)||0
9005865|NCT02945553|10069141|FG000|STARTED|Overall Study||14
9005866|NCT02945553|10069142|FG001|STARTED|Overall Study||11
9005867|NCT02945553|10069141|FG000|COMPLETED|Overall Study|Included in analysis for primary aim.|11
9005868|NCT02945553|10069142|FG001|COMPLETED|Overall Study|Included in analysis for primary aim.|9
9005869|NCT02945553|10069141|FG000|NOT COMPLETED|Overall Study||3
9005870|NCT02945553|10069142|FG001|NOT COMPLETED|Overall Study||2
9005871|NCT02945657|10069152|FG000|STARTED|Overall Study||32
9005872|NCT02945657|10069152|FG000|COMPLETED|Overall Study||28
9005873|NCT02945657|10069152|FG000|NOT COMPLETED|Overall Study||4
9005874|NCT02946021|10069159|FG000|STARTED|Overall Study||6
9005875|NCT02946021|10069160|FG001|STARTED|Overall Study||5
9005876|NCT02946021|10069159|FG000|COMPLETED|Overall Study||6
9005877|NCT02946021|10069160|FG001|COMPLETED|Overall Study||5
8889621|NCT01998958|9947644|FG002|COMPLETED|Period 1 (Panel A and B)||11
8889622|NCT01998958|9947645|FG003|COMPLETED|Period 1 (Panel A and B)||12
8889623|NCT01998958|9947646|FG004|COMPLETED|Period 1 (Panel A and B)||21
8889624|NCT01998958|9947647|FG005|COMPLETED|Period 1 (Panel A and B)||11
8889625|NCT01998958|9947648|FG006|COMPLETED|Period 1 (Panel A and B)||9
8889626|NCT01998958|9947649|FG007|COMPLETED|Period 1 (Panel A and B)||0
8889627|NCT01998958|9947650|FG008|COMPLETED|Period 1 (Panel A and B)||0
8889628|NCT01998958|9947651|FG009|COMPLETED|Period 1 (Panel A and B)||0
8889629|NCT01998958|9947652|FG010|COMPLETED|Period 1 (Panel A and B)||0
8889630|NCT01998958|9947653|FG011|COMPLETED|Period 1 (Panel A and B)||0
8889631|NCT01998958|9947654|FG012|COMPLETED|Period 1 (Panel A and B)||0
8889632|NCT01998958|9947655|FG013|COMPLETED|Period 1 (Panel A and B)||0
8889633|NCT01998958|9947656|FG014|COMPLETED|Period 1 (Panel A and B)||0
8889634|NCT01998958|9947657|FG015|COMPLETED|Period 1 (Panel A and B)||0
8889635|NCT01998958|9947658|FG016|COMPLETED|Period 1 (Panel A and B)||0
8889636|NCT01998958|9947659|FG017|COMPLETED|Period 1 (Panel A and B)||0
8889637|NCT01998958|9947660|FG018|COMPLETED|Period 1 (Panel A and B)||0
8889638|NCT01998958|9947661|FG019|COMPLETED|Period 1 (Panel A and B)||0
8889639|NCT01998958|9947662|FG020|COMPLETED|Period 1 (Panel A and B)||0
8889640|NCT01998958|9947663|FG021|COMPLETED|Period 1 (Panel A and B)||0
8889641|NCT01998958|9947664|FG022|COMPLETED|Period 1 (Panel A and B)||0
8889642|NCT01998958|9947665|FG023|COMPLETED|Period 1 (Panel A and B)||0
8889643|NCT01998958|9947666|FG024|COMPLETED|Period 1 (Panel A and B)||0
8889644|NCT01998958|9947667|FG025|COMPLETED|Period 1 (Panel A and B)||0
8889645|NCT01998958|9947668|FG026|COMPLETED|Period 1 (Panel A and B)||0
8889646|NCT01998958|9947669|FG027|COMPLETED|Period 1 (Panel A and B)||0
8889647|NCT01998958|9947670|FG028|COMPLETED|Period 1 (Panel A and B)||0
8889648|NCT01998958|9947671|FG029|COMPLETED|Period 1 (Panel A and B)||0
8889649|NCT01998958|9947672|FG030|COMPLETED|Period 1 (Panel A and B)||0
8889650|NCT01998958|9947673|FG031|COMPLETED|Period 1 (Panel A and B)||0
8889651|NCT01998958|9947642|FG000|NOT COMPLETED|Period 1 (Panel A and B)||1
8889652|NCT01998958|9947643|FG001|NOT COMPLETED|Period 1 (Panel A and B)||3
8889653|NCT01998958|9947644|FG002|NOT COMPLETED|Period 1 (Panel A and B)||0
8889654|NCT01998958|9947645|FG003|NOT COMPLETED|Period 1 (Panel A and B)||0
8889655|NCT01998958|9947646|FG004|NOT COMPLETED|Period 1 (Panel A and B)||0
8889656|NCT01998958|9947647|FG005|NOT COMPLETED|Period 1 (Panel A and B)||0
8889657|NCT01998958|9947648|FG006|NOT COMPLETED|Period 1 (Panel A and B)||0
8889658|NCT01998958|9947649|FG007|NOT COMPLETED|Period 1 (Panel A and B)||0
8889659|NCT01998958|9947650|FG008|NOT COMPLETED|Period 1 (Panel A and B)||0
8889660|NCT01998958|9947651|FG009|NOT COMPLETED|Period 1 (Panel A and B)||0
8889661|NCT01998958|9947652|FG010|NOT COMPLETED|Period 1 (Panel A and B)||0
8889662|NCT01998958|9947653|FG011|NOT COMPLETED|Period 1 (Panel A and B)||0
8889663|NCT01998958|9947654|FG012|NOT COMPLETED|Period 1 (Panel A and B)||0
8889664|NCT01998958|9947655|FG013|NOT COMPLETED|Period 1 (Panel A and B)||0
8889665|NCT01998958|9947656|FG014|NOT COMPLETED|Period 1 (Panel A and B)||0
8889666|NCT01998958|9947657|FG015|NOT COMPLETED|Period 1 (Panel A and B)||0
8889667|NCT01998958|9947658|FG016|NOT COMPLETED|Period 1 (Panel A and B)||0
8889668|NCT01998958|9947659|FG017|NOT COMPLETED|Period 1 (Panel A and B)||0
8889669|NCT01998958|9947660|FG018|NOT COMPLETED|Period 1 (Panel A and B)||0
8889670|NCT01998958|9947661|FG019|NOT COMPLETED|Period 1 (Panel A and B)||0
8889671|NCT01998958|9947662|FG020|NOT COMPLETED|Period 1 (Panel A and B)||0
8889672|NCT01998958|9947663|FG021|NOT COMPLETED|Period 1 (Panel A and B)||0
8889673|NCT01998958|9947664|FG022|NOT COMPLETED|Period 1 (Panel A and B)||0
8889674|NCT01998958|9947665|FG023|NOT COMPLETED|Period 1 (Panel A and B)||0
8889675|NCT01998958|9947666|FG024|NOT COMPLETED|Period 1 (Panel A and B)||0
8889676|NCT01998958|9947667|FG025|NOT COMPLETED|Period 1 (Panel A and B)||0
8889677|NCT01998958|9947668|FG026|NOT COMPLETED|Period 1 (Panel A and B)||0
8889678|NCT01998958|9947669|FG027|NOT COMPLETED|Period 1 (Panel A and B)||0
8889679|NCT01998958|9947670|FG028|NOT COMPLETED|Period 1 (Panel A and B)||0
8889680|NCT01998958|9947671|FG029|NOT COMPLETED|Period 1 (Panel A and B)||0
8889681|NCT01998958|9947672|FG030|NOT COMPLETED|Period 1 (Panel A and B)||0
8889682|NCT01998958|9947673|FG031|NOT COMPLETED|Period 1 (Panel A and B)||0
8889683|NCT01998958|9947642|FG000|STARTED|Period 2 (Panel A and B)||0
8889684|NCT01998958|9947643|FG001|STARTED|Period 2 (Panel A and B)||0
8889685|NCT01998958|9947644|FG002|STARTED|Period 2 (Panel A and B)||0
8889686|NCT01998958|9947645|FG003|STARTED|Period 2 (Panel A and B)||0
8889687|NCT01998958|9947646|FG004|STARTED|Period 2 (Panel A and B)||0
8889688|NCT01998958|9947647|FG005|STARTED|Period 2 (Panel A and B)||0
8889689|NCT01998958|9947648|FG006|STARTED|Period 2 (Panel A and B)||0
8889690|NCT01998958|9947649|FG007|STARTED|Period 2 (Panel A and B)||6
8889691|NCT01998958|9947650|FG008|STARTED|Period 2 (Panel A and B)||4
8889692|NCT01998958|9947651|FG009|STARTED|Period 2 (Panel A and B)||8
8889693|NCT01998958|9947652|FG010|STARTED|Period 2 (Panel A and B)||9
8889694|NCT01998958|9947653|FG011|STARTED|Period 2 (Panel A and B)||5
8889695|NCT01998958|9947654|FG012|STARTED|Period 2 (Panel A and B)||8
8889696|NCT01998958|9947655|FG013|STARTED|Period 2 (Panel A and B)||11
8889697|NCT01998958|9947656|FG014|STARTED|Period 2 (Panel A and B)||12
8889698|NCT01998958|9947657|FG015|STARTED|Period 2 (Panel A and B)||5
8889699|NCT01998958|9947658|FG016|STARTED|Period 2 (Panel A and B)||8
8889700|NCT01998958|9947659|FG017|STARTED|Period 2 (Panel A and B)||5
8889701|NCT01998958|9947660|FG018|STARTED|Period 2 (Panel A and B)||3
8889702|NCT01998958|9947661|FG019|STARTED|Period 2 (Panel A and B)||11
8889703|NCT01998958|9947662|FG020|STARTED|Period 2 (Panel A and B)||9
8889704|NCT01998958|9947663|FG021|STARTED|Period 2 (Panel A and B)||0
8889705|NCT01998958|9947664|FG022|STARTED|Period 2 (Panel A and B)||0
8889706|NCT01998958|9947665|FG023|STARTED|Period 2 (Panel A and B)||0
8889707|NCT01998958|9947666|FG024|STARTED|Period 2 (Panel A and B)||0
8889708|NCT01998958|9947667|FG025|STARTED|Period 2 (Panel A and B)||0
8889709|NCT01998958|9947668|FG026|STARTED|Period 2 (Panel A and B)||0
8889710|NCT01998958|9947669|FG027|STARTED|Period 2 (Panel A and B)||0
8889711|NCT01998958|9947670|FG028|STARTED|Period 2 (Panel A and B)||0
8889712|NCT01998958|9947671|FG029|STARTED|Period 2 (Panel A and B)||0
8889713|NCT01998958|9947672|FG030|STARTED|Period 2 (Panel A and B)||0
8889714|NCT01998958|9947673|FG031|STARTED|Period 2 (Panel A and B)||0
8889715|NCT01998958|9947642|FG000|COMPLETED|Period 2 (Panel A and B)||0
8889716|NCT01998958|9947643|FG001|COMPLETED|Period 2 (Panel A and B)||0
8889717|NCT01998958|9947644|FG002|COMPLETED|Period 2 (Panel A and B)||0
8889718|NCT01998958|9947645|FG003|COMPLETED|Period 2 (Panel A and B)||0
8889719|NCT01998958|9947646|FG004|COMPLETED|Period 2 (Panel A and B)||0
8889720|NCT01998958|9947647|FG005|COMPLETED|Period 2 (Panel A and B)||0
8889721|NCT01998958|9947648|FG006|COMPLETED|Period 2 (Panel A and B)||0
8889722|NCT01998958|9947649|FG007|COMPLETED|Period 2 (Panel A and B)||6
8889723|NCT01998958|9947650|FG008|COMPLETED|Period 2 (Panel A and B)||4
8889724|NCT01998958|9947651|FG009|COMPLETED|Period 2 (Panel A and B)||8
8889725|NCT01998958|9947652|FG010|COMPLETED|Period 2 (Panel A and B)||8
8889726|NCT01998958|9947653|FG011|COMPLETED|Period 2 (Panel A and B)||5
9005878|NCT02946021|10069159|FG000|NOT COMPLETED|Overall Study||0
9005879|NCT02946021|10069160|FG001|NOT COMPLETED|Overall Study||0
9005880|NCT02946034|10069166|FG000|STARTED|Overall Study||10
9005881|NCT02946034|10069166|FG000|COMPLETED|Overall Study||10
9005882|NCT02946034|10069166|FG000|NOT COMPLETED|Overall Study||0
9005883|NCT02946073|10069176|FG000|STARTED|Titration Phase||811
9005884|NCT02946073|10069177|FG001|STARTED|Titration Phase||0
9005885|NCT02946073|10069178|FG002|STARTED|Titration Phase||98
9005886|NCT02946073|10069179|FG003|STARTED|Titration Phase||0
9005887|NCT02946073|10069176|FG000|COMPLETED|Titration Phase||222
9005888|NCT02946073|10069177|FG001|COMPLETED|Titration Phase||0
9005889|NCT02946073|10069178|FG002|COMPLETED|Titration Phase||75
9005890|NCT02946073|10069179|FG003|COMPLETED|Titration Phase||0
9005891|NCT02946073|10069176|FG000|NOT COMPLETED|Titration Phase||589
9005892|NCT02946073|10069177|FG001|NOT COMPLETED|Titration Phase||0
9005893|NCT02946073|10069178|FG002|NOT COMPLETED|Titration Phase||23
9005894|NCT02946073|10069179|FG003|NOT COMPLETED|Titration Phase||0
9005895|NCT02946073|10069176|FG000|STARTED|Double Blind Phase||112
9005896|NCT02946073|10069177|FG001|STARTED|Double Blind Phase||110
9005897|NCT02946073|10069178|FG002|STARTED|Double Blind Phase||0
9005898|NCT02946073|10069179|FG003|STARTED|Double Blind Phase||0
9005899|NCT02946073|10069176|FG000|COMPLETED|Double Blind Phase||88
9005900|NCT02946073|10069177|FG001|COMPLETED|Double Blind Phase||70
9005901|NCT02946073|10069178|FG002|COMPLETED|Double Blind Phase||0
9005902|NCT02946073|10069179|FG003|COMPLETED|Double Blind Phase||0
9005903|NCT02946073|10069176|FG000|NOT COMPLETED|Double Blind Phase||24
9005904|NCT02946073|10069177|FG001|NOT COMPLETED|Double Blind Phase||40
9005905|NCT02946073|10069178|FG002|NOT COMPLETED|Double Blind Phase||0
9005906|NCT02946073|10069179|FG003|NOT COMPLETED|Double Blind Phase||0
9005907|NCT02946073|10069176|FG000|STARTED|Open Label Phase||0
9005908|NCT02946073|10069177|FG001|STARTED|Open Label Phase||0
9005909|NCT02946073|10069178|FG002|STARTED|Open Label Phase||75
9005910|NCT02946073|10069179|FG003|STARTED|Open Label Phase||57
9005911|NCT02946073|10069176|FG000|COMPLETED|Open Label Phase||0
9005912|NCT02946073|10069177|FG001|COMPLETED|Open Label Phase||0
9005913|NCT02946073|10069178|FG002|COMPLETED|Open Label Phase||54
9005914|NCT02946073|10069179|FG003|COMPLETED|Open Label Phase||44
9005915|NCT02946073|10069176|FG000|NOT COMPLETED|Open Label Phase||0
9005916|NCT02946073|10069177|FG001|NOT COMPLETED|Open Label Phase||0
9005917|NCT02946073|10069178|FG002|NOT COMPLETED|Open Label Phase||21
9005918|NCT02946073|10069179|FG003|NOT COMPLETED|Open Label Phase||13
9005919|NCT02946229|10069198|FG000|STARTED|Overall Study||142
9005920|NCT02946229|10069198|FG000|COMPLETED|Overall Study||142
9005921|NCT02946229|10069198|FG000|NOT COMPLETED|Overall Study||0
9005922|NCT02946385|10069208|FG000|STARTED|Overall Study||126
9005923|NCT02946385|10069209|FG001|STARTED|Overall Study||127
9005924|NCT02946385|10069210|FG002|STARTED|Overall Study||99
9005925|NCT02946385|10069211|FG003|STARTED|Overall Study||74
9005926|NCT02946385|10069212|FG004|STARTED|Overall Study||101
9005927|NCT02946385|10069213|FG005|STARTED|Overall Study||77
9005928|NCT02946385|10069208|FG000|COMPLETED|Overall Study||126
9005929|NCT02946385|10069209|FG001|COMPLETED|Overall Study||127
9005930|NCT02946385|10069210|FG002|COMPLETED|Overall Study||96
9005931|NCT02946385|10069211|FG003|COMPLETED|Overall Study||74
9005932|NCT02946385|10069212|FG004|COMPLETED|Overall Study||99
9005933|NCT02946385|10069213|FG005|COMPLETED|Overall Study||76
9005934|NCT02946385|10069208|FG000|NOT COMPLETED|Overall Study||0
8889727|NCT01998958|9947654|FG012|COMPLETED|Period 2 (Panel A and B)||8
8889728|NCT01998958|9947655|FG013|COMPLETED|Period 2 (Panel A and B)||11
8889729|NCT01998958|9947656|FG014|COMPLETED|Period 2 (Panel A and B)||10
9005935|NCT02946385|10069209|FG001|NOT COMPLETED|Overall Study||0
9005936|NCT02946385|10069210|FG002|NOT COMPLETED|Overall Study||3
9005937|NCT02946385|10069211|FG003|NOT COMPLETED|Overall Study||0
8889730|NCT01998958|9947657|FG015|COMPLETED|Period 2 (Panel A and B)||5
9005938|NCT02946385|10069212|FG004|NOT COMPLETED|Overall Study||2
8889731|NCT01998958|9947658|FG016|COMPLETED|Period 2 (Panel A and B)||8
8889732|NCT01998958|9947659|FG017|COMPLETED|Period 2 (Panel A and B)||5
8889733|NCT01998958|9947660|FG018|COMPLETED|Period 2 (Panel A and B)||2
8889734|NCT01998958|9947661|FG019|COMPLETED|Period 2 (Panel A and B)||11
8889735|NCT01998958|9947662|FG020|COMPLETED|Period 2 (Panel A and B)||9
8889736|NCT01998958|9947663|FG021|COMPLETED|Period 2 (Panel A and B)||0
8889737|NCT01998958|9947664|FG022|COMPLETED|Period 2 (Panel A and B)||0
8889738|NCT01998958|9947665|FG023|COMPLETED|Period 2 (Panel A and B)||0
8889739|NCT01998958|9947666|FG024|COMPLETED|Period 2 (Panel A and B)||0
8889740|NCT01998958|9947667|FG025|COMPLETED|Period 2 (Panel A and B)||0
8889741|NCT01998958|9947668|FG026|COMPLETED|Period 2 (Panel A and B)||0
8889742|NCT01998958|9947669|FG027|COMPLETED|Period 2 (Panel A and B)||0
8889743|NCT01998958|9947670|FG028|COMPLETED|Period 2 (Panel A and B)||0
8889744|NCT01998958|9947671|FG029|COMPLETED|Period 2 (Panel A and B)||0
8889745|NCT01998958|9947672|FG030|COMPLETED|Period 2 (Panel A and B)||0
8889746|NCT01998958|9947673|FG031|COMPLETED|Period 2 (Panel A and B)||0
8889747|NCT01998958|9947642|FG000|NOT COMPLETED|Period 2 (Panel A and B)||0
8889748|NCT01998958|9947643|FG001|NOT COMPLETED|Period 2 (Panel A and B)||0
9005939|NCT02946385|10069213|FG005|NOT COMPLETED|Overall Study||1
9005940|NCT02946463|10069235|FG000|STARTED|Primary Evaluation Period||125
9005941|NCT02946463|10069236|FG001|STARTED|Primary Evaluation Period||121
9005942|NCT02946463|10069235|FG000|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||125
9005943|NCT02946463|10069236|FG001|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||121
9005944|NCT02946463|10069235|FG000|COMPLETED|Primary Evaluation Period||125
9005945|NCT02946463|10069236|FG001|COMPLETED|Primary Evaluation Period||119
9005946|NCT02946463|10069235|FG000|NOT COMPLETED|Primary Evaluation Period||0
9005947|NCT02946463|10069236|FG001|NOT COMPLETED|Primary Evaluation Period||2
9005948|NCT02946463|10069235|FG000|STARTED|Extension Period||124
9005949|NCT02946463|10069236|FG001|STARTED|Extension Period||119
9005950|NCT02946463|10069235|FG000|Received at Least 1 Dose of Ravulizumab|Extension Period||124
9005951|NCT02946463|10069236|FG001|Received at Least 1 Dose of Ravulizumab|Extension Period||119
9005952|NCT02946463|10069235|FG000|COMPLETED|Extension Period||0
9005953|NCT02946463|10069236|FG001|COMPLETED|Extension Period||0
9005954|NCT02946463|10069235|FG000|NOT COMPLETED|Extension Period||124
9005955|NCT02946463|10069236|FG001|NOT COMPLETED|Extension Period||119
9005956|NCT02946489|10069242|FG000|STARTED|Overall Study||8
9005957|NCT02946489|10069242|FG000|COMPLETED|Overall Study||8
9005958|NCT02946489|10069242|FG000|NOT COMPLETED|Overall Study||0
9005959|NCT02946515|10069248|FG000|STARTED|Overall Study||22
9005960|NCT02946515|10069249|FG001|STARTED|Overall Study||22
9005961|NCT02946515|10069248|FG000|COMPLETED|Overall Study||20
8634862|NCT00558636|9675216|FG000|COMPLETED|Treatment|Patients still on treatment did not enter follow-up because the study was prematurely terminated|0
8634863|NCT00558636|9675217|FG001|COMPLETED|Treatment|Patients still on treatment did not enter follow-up because the study was prematurely terminated|0
8634864|NCT00558636|9675216|FG000|NOT COMPLETED|Treatment||47
8634865|NCT00558636|9675217|FG001|NOT COMPLETED|Treatment||44
9005962|NCT02946515|10069249|FG001|COMPLETED|Overall Study||21
9005963|NCT02946515|10069248|FG000|NOT COMPLETED|Overall Study||2
8572729|NCT00116805|9604932|FG001|STARTED|Open-label Period Weeks 289 - 336||64
8572730|NCT00116805|9604931|FG000|COMPLETED|Open-label Period Weeks 289 - 336||98
8572731|NCT00116805|9604932|FG001|COMPLETED|Open-label Period Weeks 289 - 336||57
8572732|NCT00116805|9604931|FG000|NOT COMPLETED|Open-label Period Weeks 289 - 336||6
8572733|NCT00116805|9604932|FG001|NOT COMPLETED|Open-label Period Weeks 289 - 336||7
8572734|NCT00116805|9604931|FG000|STARTED|Open-label Period Weeks 337 - 384||98
8572735|NCT00116805|9604932|FG001|STARTED|Open-label Period Weeks 337 - 384||57
8572736|NCT00116805|9604931|FG000|COMPLETED|Open-label Period Weeks 337 - 384||90
8572737|NCT00116805|9604932|FG001|COMPLETED|Open-label Period Weeks 337 - 384||56
8572738|NCT00116805|9604931|FG000|NOT COMPLETED|Open-label Period Weeks 337 - 384||8
8572739|NCT00116805|9604932|FG001|NOT COMPLETED|Open-label Period Weeks 337 - 384||1
8572740|NCT00116805|9604931|FG000|STARTED|Open-label Period Weeks 385 - 432|31 participants completed 384 weeks but did not continue on study.|59
8572741|NCT00116805|9604932|FG001|STARTED|Open-label Period Weeks 385 - 432|26 participants completed 384 weeks but did not continue on study.|30
8572742|NCT00116805|9604931|FG000|COMPLETED|Open-label Period Weeks 385 - 432||57
8889749|NCT01998958|9947644|FG002|NOT COMPLETED|Period 2 (Panel A and B)||0
8889750|NCT01998958|9947645|FG003|NOT COMPLETED|Period 2 (Panel A and B)||0
8889751|NCT01998958|9947646|FG004|NOT COMPLETED|Period 2 (Panel A and B)||0
8889752|NCT01998958|9947647|FG005|NOT COMPLETED|Period 2 (Panel A and B)||0
8889753|NCT01998958|9947648|FG006|NOT COMPLETED|Period 2 (Panel A and B)||0
8889754|NCT01998958|9947649|FG007|NOT COMPLETED|Period 2 (Panel A and B)||0
8889755|NCT01998958|9947650|FG008|NOT COMPLETED|Period 2 (Panel A and B)||0
8889756|NCT01998958|9947651|FG009|NOT COMPLETED|Period 2 (Panel A and B)||0
8889757|NCT01998958|9947652|FG010|NOT COMPLETED|Period 2 (Panel A and B)||1
8889758|NCT01998958|9947653|FG011|NOT COMPLETED|Period 2 (Panel A and B)||0
8889759|NCT01998958|9947654|FG012|NOT COMPLETED|Period 2 (Panel A and B)||0
8889760|NCT01998958|9947655|FG013|NOT COMPLETED|Period 2 (Panel A and B)||0
8889761|NCT01998958|9947656|FG014|NOT COMPLETED|Period 2 (Panel A and B)||2
8889762|NCT01998958|9947657|FG015|NOT COMPLETED|Period 2 (Panel A and B)||0
8889763|NCT01998958|9947658|FG016|NOT COMPLETED|Period 2 (Panel A and B)||0
8726130|NCT01033864|9773276|FG000|STARTED|Overall Study||12
8726131|NCT01033864|9773277|FG001|STARTED|Overall Study||11
8889764|NCT01998958|9947659|FG017|NOT COMPLETED|Period 2 (Panel A and B)||0
8889765|NCT01998958|9947660|FG018|NOT COMPLETED|Period 2 (Panel A and B)||1
8889766|NCT01998958|9947661|FG019|NOT COMPLETED|Period 2 (Panel A and B)||0
8889767|NCT01998958|9947662|FG020|NOT COMPLETED|Period 2 (Panel A and B)||0
8889768|NCT01998958|9947663|FG021|NOT COMPLETED|Period 2 (Panel A and B)||0
8889769|NCT01998958|9947664|FG022|NOT COMPLETED|Period 2 (Panel A and B)||0
8889770|NCT01998958|9947665|FG023|NOT COMPLETED|Period 2 (Panel A and B)||0
8889771|NCT01998958|9947666|FG024|NOT COMPLETED|Period 2 (Panel A and B)||0
8889772|NCT01998958|9947667|FG025|NOT COMPLETED|Period 2 (Panel A and B)||0
8889773|NCT01998958|9947668|FG026|NOT COMPLETED|Period 2 (Panel A and B)||0
8889774|NCT01998958|9947669|FG027|NOT COMPLETED|Period 2 (Panel A and B)||0
8889775|NCT01998958|9947670|FG028|NOT COMPLETED|Period 2 (Panel A and B)||0
8889776|NCT01998958|9947671|FG029|NOT COMPLETED|Period 2 (Panel A and B)||0
8889777|NCT01998958|9947672|FG030|NOT COMPLETED|Period 2 (Panel A and B)||0
8889778|NCT01998958|9947673|FG031|NOT COMPLETED|Period 2 (Panel A and B)||0
8889779|NCT01998958|9947642|FG000|STARTED|Open Label Phase (Optional)||0
8889780|NCT01998958|9947643|FG001|STARTED|Open Label Phase (Optional)||0
8889781|NCT01998958|9947644|FG002|STARTED|Open Label Phase (Optional)||0
8889782|NCT01998958|9947645|FG003|STARTED|Open Label Phase (Optional)||0
8889783|NCT01998958|9947646|FG004|STARTED|Open Label Phase (Optional)||0
8889784|NCT01998958|9947647|FG005|STARTED|Open Label Phase (Optional)||0
8889785|NCT01998958|9947648|FG006|STARTED|Open Label Phase (Optional)||0
8889786|NCT01998958|9947649|FG007|STARTED|Open Label Phase (Optional)||0
8889787|NCT01998958|9947650|FG008|STARTED|Open Label Phase (Optional)||0
8889788|NCT01998958|9947651|FG009|STARTED|Open Label Phase (Optional)||0
8889789|NCT01998958|9947652|FG010|STARTED|Open Label Phase (Optional)||0
8889790|NCT01998958|9947653|FG011|STARTED|Open Label Phase (Optional)||0
8889791|NCT01998958|9947654|FG012|STARTED|Open Label Phase (Optional)||0
8889792|NCT01998958|9947655|FG013|STARTED|Open Label Phase (Optional)||0
8889793|NCT01998958|9947656|FG014|STARTED|Open Label Phase (Optional)||0
8889794|NCT01998958|9947657|FG015|STARTED|Open Label Phase (Optional)||0
8889795|NCT01998958|9947658|FG016|STARTED|Open Label Phase (Optional)||0
8889796|NCT01998958|9947659|FG017|STARTED|Open Label Phase (Optional)||0
8889797|NCT01998958|9947660|FG018|STARTED|Open Label Phase (Optional)||0
8889798|NCT01998958|9947661|FG019|STARTED|Open Label Phase (Optional)||0
8889799|NCT01998958|9947662|FG020|STARTED|Open Label Phase (Optional)||0
8889800|NCT01998958|9947663|FG021|STARTED|Open Label Phase (Optional)||10
8889801|NCT01998958|9947664|FG022|STARTED|Open Label Phase (Optional)||20
8889802|NCT01998958|9947665|FG023|STARTED|Open Label Phase (Optional)||27
8889803|NCT01998958|9947666|FG024|STARTED|Open Label Phase (Optional)||13
8889804|NCT01998958|9947667|FG025|STARTED|Open Label Phase (Optional)||7
8889805|NCT01998958|9947668|FG026|STARTED|Open Label Phase (Optional)||19
8889806|NCT01998958|9947669|FG027|STARTED|Open Label Phase (Optional)||0
8889807|NCT01998958|9947670|FG028|STARTED|Open Label Phase (Optional)||0
8889808|NCT01998958|9947671|FG029|STARTED|Open Label Phase (Optional)||0
8889809|NCT01998958|9947672|FG030|STARTED|Open Label Phase (Optional)||0
8889810|NCT01998958|9947673|FG031|STARTED|Open Label Phase (Optional)||0
8889811|NCT01998958|9947642|FG000|COMPLETED|Open Label Phase (Optional)||0
8889812|NCT01998958|9947643|FG001|COMPLETED|Open Label Phase (Optional)||0
8889813|NCT01998958|9947644|FG002|COMPLETED|Open Label Phase (Optional)||0
8889814|NCT01998958|9947645|FG003|COMPLETED|Open Label Phase (Optional)||0
8889815|NCT01998958|9947646|FG004|COMPLETED|Open Label Phase (Optional)||0
8889816|NCT01998958|9947647|FG005|COMPLETED|Open Label Phase (Optional)||0
8889817|NCT01998958|9947648|FG006|COMPLETED|Open Label Phase (Optional)||0
8889818|NCT01998958|9947649|FG007|COMPLETED|Open Label Phase (Optional)||0
8889819|NCT01998958|9947650|FG008|COMPLETED|Open Label Phase (Optional)||0
8889820|NCT01998958|9947651|FG009|COMPLETED|Open Label Phase (Optional)||0
8889821|NCT01998958|9947652|FG010|COMPLETED|Open Label Phase (Optional)||0
8889822|NCT01998958|9947653|FG011|COMPLETED|Open Label Phase (Optional)||0
8889823|NCT01998958|9947654|FG012|COMPLETED|Open Label Phase (Optional)||0
8889824|NCT01998958|9947655|FG013|COMPLETED|Open Label Phase (Optional)||0
8889825|NCT01998958|9947656|FG014|COMPLETED|Open Label Phase (Optional)||0
8889826|NCT01998958|9947657|FG015|COMPLETED|Open Label Phase (Optional)||0
8889827|NCT01998958|9947658|FG016|COMPLETED|Open Label Phase (Optional)||0
8889828|NCT01998958|9947659|FG017|COMPLETED|Open Label Phase (Optional)||0
8726132|NCT01033864|9773276|FG000|COMPLETED|Overall Study||12
8726133|NCT01033864|9773277|FG001|COMPLETED|Overall Study||11
8889829|NCT01998958|9947660|FG018|COMPLETED|Open Label Phase (Optional)||0
8889830|NCT01998958|9947661|FG019|COMPLETED|Open Label Phase (Optional)||0
8889831|NCT01998958|9947662|FG020|COMPLETED|Open Label Phase (Optional)||0
8889832|NCT01998958|9947663|FG021|COMPLETED|Open Label Phase (Optional)||7
8889833|NCT01998958|9947664|FG022|COMPLETED|Open Label Phase (Optional)||11
8889834|NCT01998958|9947665|FG023|COMPLETED|Open Label Phase (Optional)||23
8889835|NCT01998958|9947666|FG024|COMPLETED|Open Label Phase (Optional)||13
8889836|NCT01998958|9947667|FG025|COMPLETED|Open Label Phase (Optional)||7
8889837|NCT01998958|9947668|FG026|COMPLETED|Open Label Phase (Optional)||19
8889838|NCT01998958|9947669|FG027|COMPLETED|Open Label Phase (Optional)||0
8889839|NCT01998958|9947670|FG028|COMPLETED|Open Label Phase (Optional)||0
8889840|NCT01998958|9947671|FG029|COMPLETED|Open Label Phase (Optional)||0
8889841|NCT01998958|9947672|FG030|COMPLETED|Open Label Phase (Optional)||0
8889842|NCT01998958|9947673|FG031|COMPLETED|Open Label Phase (Optional)||0
8889843|NCT01998958|9947642|FG000|NOT COMPLETED|Open Label Phase (Optional)||0
8889844|NCT01998958|9947643|FG001|NOT COMPLETED|Open Label Phase (Optional)||0
8889845|NCT01998958|9947644|FG002|NOT COMPLETED|Open Label Phase (Optional)||0
8889846|NCT01998958|9947645|FG003|NOT COMPLETED|Open Label Phase (Optional)||0
8889847|NCT01998958|9947646|FG004|NOT COMPLETED|Open Label Phase (Optional)||0
8889848|NCT01998958|9947647|FG005|NOT COMPLETED|Open Label Phase (Optional)||0
8889849|NCT01998958|9947648|FG006|NOT COMPLETED|Open Label Phase (Optional)||0
8889850|NCT01998958|9947649|FG007|NOT COMPLETED|Open Label Phase (Optional)||0
8889851|NCT01998958|9947650|FG008|NOT COMPLETED|Open Label Phase (Optional)||0
8889852|NCT01998958|9947651|FG009|NOT COMPLETED|Open Label Phase (Optional)||0
8889853|NCT01998958|9947652|FG010|NOT COMPLETED|Open Label Phase (Optional)||0
8889854|NCT01998958|9947653|FG011|NOT COMPLETED|Open Label Phase (Optional)||0
8889855|NCT01998958|9947654|FG012|NOT COMPLETED|Open Label Phase (Optional)||0
8889856|NCT01998958|9947655|FG013|NOT COMPLETED|Open Label Phase (Optional)||0
8889857|NCT01998958|9947656|FG014|NOT COMPLETED|Open Label Phase (Optional)||0
8889858|NCT01998958|9947657|FG015|NOT COMPLETED|Open Label Phase (Optional)||0
8889859|NCT01998958|9947658|FG016|NOT COMPLETED|Open Label Phase (Optional)||0
8889860|NCT01998958|9947659|FG017|NOT COMPLETED|Open Label Phase (Optional)||0
8889861|NCT01998958|9947660|FG018|NOT COMPLETED|Open Label Phase (Optional)||0
8889862|NCT01998958|9947661|FG019|NOT COMPLETED|Open Label Phase (Optional)||0
8889863|NCT01998958|9947662|FG020|NOT COMPLETED|Open Label Phase (Optional)||0
8889864|NCT01998958|9947663|FG021|NOT COMPLETED|Open Label Phase (Optional)||3
8889865|NCT01998958|9947664|FG022|NOT COMPLETED|Open Label Phase (Optional)||9
8889866|NCT01998958|9947665|FG023|NOT COMPLETED|Open Label Phase (Optional)||4
8889867|NCT01998958|9947666|FG024|NOT COMPLETED|Open Label Phase (Optional)||0
8889868|NCT01998958|9947667|FG025|NOT COMPLETED|Open Label Phase (Optional)||0
8889869|NCT01998958|9947668|FG026|NOT COMPLETED|Open Label Phase (Optional)||0
8889870|NCT01998958|9947669|FG027|NOT COMPLETED|Open Label Phase (Optional)||0
8889871|NCT01998958|9947670|FG028|NOT COMPLETED|Open Label Phase (Optional)||0
8889872|NCT01998958|9947671|FG029|NOT COMPLETED|Open Label Phase (Optional)||0
8889873|NCT01998958|9947672|FG030|NOT COMPLETED|Open Label Phase (Optional)||0
8889874|NCT01998958|9947673|FG031|NOT COMPLETED|Open Label Phase (Optional)||0
8889875|NCT01998958|9947642|FG000|STARTED|Follow-up Phase||0
8889876|NCT01998958|9947643|FG001|STARTED|Follow-up Phase||0
8889877|NCT01998958|9947644|FG002|STARTED|Follow-up Phase||0
8889878|NCT01998958|9947645|FG003|STARTED|Follow-up Phase||0
8889879|NCT01998958|9947646|FG004|STARTED|Follow-up Phase||0
8889880|NCT01998958|9947647|FG005|STARTED|Follow-up Phase||0
8889881|NCT01998958|9947648|FG006|STARTED|Follow-up Phase||0
8889882|NCT01998958|9947649|FG007|STARTED|Follow-up Phase||0
8889883|NCT01998958|9947650|FG008|STARTED|Follow-up Phase||0
8889884|NCT01998958|9947651|FG009|STARTED|Follow-up Phase||0
8889885|NCT01998958|9947652|FG010|STARTED|Follow-up Phase||0
8889886|NCT01998958|9947653|FG011|STARTED|Follow-up Phase||0
8889887|NCT01998958|9947654|FG012|STARTED|Follow-up Phase||0
8889888|NCT01998958|9947655|FG013|STARTED|Follow-up Phase||0
8889889|NCT01998958|9947656|FG014|STARTED|Follow-up Phase||0
8889890|NCT01998958|9947657|FG015|STARTED|Follow-up Phase||0
9005964|NCT02946515|10069249|FG001|NOT COMPLETED|Overall Study||1
9005965|NCT02946580|10069257|FG000|STARTED|Overall Study||28
9005966|NCT02946580|10069258|FG001|STARTED|Overall Study||25
9005967|NCT02946580|10069257|FG000|COMPLETED|Overall Study||27
8889891|NCT01998958|9947658|FG016|STARTED|Follow-up Phase||0
8889892|NCT01998958|9947659|FG017|STARTED|Follow-up Phase||0
8889893|NCT01998958|9947660|FG018|STARTED|Follow-up Phase||0
8889894|NCT01998958|9947661|FG019|STARTED|Follow-up Phase||0
8889895|NCT01998958|9947662|FG020|STARTED|Follow-up Phase||0
8889896|NCT01998958|9947663|FG021|STARTED|Follow-up Phase||0
8889897|NCT01998958|9947664|FG022|STARTED|Follow-up Phase||0
8889898|NCT01998958|9947665|FG023|STARTED|Follow-up Phase||0
8889899|NCT01998958|9947666|FG024|STARTED|Follow-up Phase||0
8889900|NCT01998958|9947667|FG025|STARTED|Follow-up Phase||0
8889901|NCT01998958|9947668|FG026|STARTED|Follow-up Phase||0
8889902|NCT01998958|9947669|FG027|STARTED|Follow-up Phase||1
8889903|NCT01998958|9947670|FG028|STARTED|Follow-up Phase||4
8889904|NCT01998958|9947671|FG029|STARTED|Follow-up Phase||12
9005968|NCT02946580|10069258|FG001|COMPLETED|Overall Study||20
8889905|NCT01998958|9947672|FG030|STARTED|Follow-up Phase||39
8889906|NCT01998958|9947673|FG031|STARTED|Follow-up Phase||42
8889907|NCT01998958|9947642|FG000|COMPLETED|Follow-up Phase||0
8889908|NCT01998958|9947643|FG001|COMPLETED|Follow-up Phase||0
8889909|NCT01998958|9947644|FG002|COMPLETED|Follow-up Phase||0
8889910|NCT01998958|9947645|FG003|COMPLETED|Follow-up Phase||0
8889911|NCT01998958|9947646|FG004|COMPLETED|Follow-up Phase||0
8889912|NCT01998958|9947647|FG005|COMPLETED|Follow-up Phase||0
8889913|NCT01998958|9947648|FG006|COMPLETED|Follow-up Phase||0
8889914|NCT01998958|9947649|FG007|COMPLETED|Follow-up Phase||0
8889915|NCT01998958|9947650|FG008|COMPLETED|Follow-up Phase||0
8889916|NCT01998958|9947651|FG009|COMPLETED|Follow-up Phase||0
8889917|NCT01998958|9947652|FG010|COMPLETED|Follow-up Phase||0
8889918|NCT01998958|9947653|FG011|COMPLETED|Follow-up Phase||0
8889919|NCT01998958|9947654|FG012|COMPLETED|Follow-up Phase||0
8889920|NCT01998958|9947655|FG013|COMPLETED|Follow-up Phase||0
8889921|NCT01998958|9947656|FG014|COMPLETED|Follow-up Phase||0
8889922|NCT01998958|9947657|FG015|COMPLETED|Follow-up Phase||0
8889923|NCT01998958|9947658|FG016|COMPLETED|Follow-up Phase||0
8889924|NCT01998958|9947659|FG017|COMPLETED|Follow-up Phase||0
8889925|NCT01998958|9947660|FG018|COMPLETED|Follow-up Phase||0
8889926|NCT01998958|9947661|FG019|COMPLETED|Follow-up Phase||0
8889927|NCT01998958|9947662|FG020|COMPLETED|Follow-up Phase||0
8889928|NCT01998958|9947663|FG021|COMPLETED|Follow-up Phase||0
8889929|NCT01998958|9947664|FG022|COMPLETED|Follow-up Phase||0
8889930|NCT01998958|9947665|FG023|COMPLETED|Follow-up Phase||0
8889931|NCT01998958|9947666|FG024|COMPLETED|Follow-up Phase||0
8889932|NCT01998958|9947667|FG025|COMPLETED|Follow-up Phase||0
8889933|NCT01998958|9947668|FG026|COMPLETED|Follow-up Phase||0
8889934|NCT01998958|9947669|FG027|COMPLETED|Follow-up Phase||1
8889935|NCT01998958|9947670|FG028|COMPLETED|Follow-up Phase||4
8889936|NCT01998958|9947671|FG029|COMPLETED|Follow-up Phase||12
8889937|NCT01998958|9947672|FG030|COMPLETED|Follow-up Phase||39
8889938|NCT01998958|9947673|FG031|COMPLETED|Follow-up Phase||42
8889939|NCT01998958|9947642|FG000|NOT COMPLETED|Follow-up Phase||0
8889940|NCT01998958|9947643|FG001|NOT COMPLETED|Follow-up Phase||0
8889941|NCT01998958|9947644|FG002|NOT COMPLETED|Follow-up Phase||0
8889942|NCT01998958|9947645|FG003|NOT COMPLETED|Follow-up Phase||0
8889943|NCT01998958|9947646|FG004|NOT COMPLETED|Follow-up Phase||0
8889944|NCT01998958|9947647|FG005|NOT COMPLETED|Follow-up Phase||0
8889945|NCT01998958|9947648|FG006|NOT COMPLETED|Follow-up Phase||0
8889946|NCT01998958|9947649|FG007|NOT COMPLETED|Follow-up Phase||0
8889947|NCT01998958|9947650|FG008|NOT COMPLETED|Follow-up Phase||0
9005969|NCT02946580|10069257|FG000|NOT COMPLETED|Overall Study||1
9005970|NCT02946580|10069258|FG001|NOT COMPLETED|Overall Study||5
9005971|NCT02946892|10069264|FG000|STARTED|First Intervention (12 Weeks)||11
9005972|NCT02946892|10069265|FG001|STARTED|First Intervention (12 Weeks)||15
9005973|NCT02946892|10069264|FG000|COMPLETED|First Intervention (12 Weeks)||11
9005974|NCT02946892|10069265|FG001|COMPLETED|First Intervention (12 Weeks)||14
9005975|NCT02946892|10069264|FG000|NOT COMPLETED|First Intervention (12 Weeks)||0
9005976|NCT02946892|10069265|FG001|NOT COMPLETED|First Intervention (12 Weeks)||1
9005977|NCT02946892|10069264|FG000|STARTED|Washout (6 Weeks)||11
9005978|NCT02946892|10069265|FG001|STARTED|Washout (6 Weeks)||14
9005979|NCT02946892|10069264|FG000|COMPLETED|Washout (6 Weeks)||9
9005980|NCT02946892|10069265|FG001|COMPLETED|Washout (6 Weeks)||14
9005981|NCT02946892|10069264|FG000|NOT COMPLETED|Washout (6 Weeks)||2
9005982|NCT02946892|10069265|FG001|NOT COMPLETED|Washout (6 Weeks)||0
9005983|NCT02946892|10069264|FG000|STARTED|Second Intervention||9
9005984|NCT02946892|10069265|FG001|STARTED|Second Intervention||14
9005985|NCT02946892|10069264|FG000|COMPLETED|Second Intervention||9
9005986|NCT02946892|10069265|FG001|COMPLETED|Second Intervention||14
9005987|NCT02946892|10069264|FG000|NOT COMPLETED|Second Intervention||0
9005988|NCT02946892|10069265|FG001|NOT COMPLETED|Second Intervention||0
9005989|NCT02946918|10069273|FG000|STARTED|Overall Study||6
9005990|NCT02946918|10069274|FG001|STARTED|Overall Study||8
8634866|NCT00558636|9675216|FG000|STARTED|Follow-up|12 subjects entered Follow-up phase before they completed the treatment phase|12
8634867|NCT00558636|9675217|FG001|STARTED|Follow-up|7 subjects entered Follow-up phase before they completed the treatment phase|7
8634868|NCT00558636|9675216|FG000|COMPLETED|Follow-up|Study was prematurely terminated|0
8634869|NCT00558636|9675217|FG001|COMPLETED|Follow-up|Study was prematurely terminated|0
8634870|NCT00558636|9675216|FG000|NOT COMPLETED|Follow-up||12
8634871|NCT00558636|9675217|FG001|NOT COMPLETED|Follow-up||7
8634872|NCT00558701|9675225|FG000|STARTED|Overall Study||15
8634873|NCT00558701|9675226|FG001|STARTED|Overall Study||15
8634874|NCT00558701|9675225|FG000|COMPLETED|Overall Study||14
8634875|NCT00558701|9675226|FG001|COMPLETED|Overall Study||11
8634876|NCT00558701|9675225|FG000|NOT COMPLETED|Overall Study||1
8634877|NCT00558701|9675226|FG001|NOT COMPLETED|Overall Study||4
8634878|NCT00558753|9675234|FG000|STARTED|Overall Study||120
9005991|NCT02946918|10069273|FG000|COMPLETED|Overall Study||5
9005992|NCT02946918|10069274|FG001|COMPLETED|Overall Study||5
9005993|NCT02946918|10069273|FG000|NOT COMPLETED|Overall Study||1
9005994|NCT02946918|10069274|FG001|NOT COMPLETED|Overall Study||3
9005995|NCT02947984|10069282|FG000|STARTED|Overall Study||22
9005996|NCT02947984|10069283|FG001|STARTED|Overall Study||22
9005997|NCT02947984|10069282|FG000|COMPLETED|Overall Study||22
9005998|NCT02947984|10069283|FG001|COMPLETED|Overall Study||22
8634879|NCT00558753|9675235|FG001|STARTED|Overall Study||120
8634880|NCT00558753|9675234|FG000|COMPLETED|Overall Study||115
8634881|NCT00558753|9675235|FG001|COMPLETED|Overall Study||113
8889948|NCT01998958|9947651|FG009|NOT COMPLETED|Follow-up Phase||0
8889949|NCT01998958|9947652|FG010|NOT COMPLETED|Follow-up Phase||0
8889950|NCT01998958|9947653|FG011|NOT COMPLETED|Follow-up Phase||0
8889951|NCT01998958|9947654|FG012|NOT COMPLETED|Follow-up Phase||0
8889952|NCT01998958|9947655|FG013|NOT COMPLETED|Follow-up Phase||0
8889953|NCT01998958|9947656|FG014|NOT COMPLETED|Follow-up Phase||0
9005999|NCT02947984|10069282|FG000|NOT COMPLETED|Overall Study||0
9006000|NCT02947984|10069283|FG001|NOT COMPLETED|Overall Study||0
9006001|NCT02947997|10069289|FG000|STARTED|Overall Study||4
8889954|NCT01998958|9947657|FG015|NOT COMPLETED|Follow-up Phase||0
8889955|NCT01998958|9947658|FG016|NOT COMPLETED|Follow-up Phase||0
8889956|NCT01998958|9947659|FG017|NOT COMPLETED|Follow-up Phase||0
8889957|NCT01998958|9947660|FG018|NOT COMPLETED|Follow-up Phase||0
8889958|NCT01998958|9947661|FG019|NOT COMPLETED|Follow-up Phase||0
8889959|NCT01998958|9947662|FG020|NOT COMPLETED|Follow-up Phase||0
8889960|NCT01998958|9947663|FG021|NOT COMPLETED|Follow-up Phase||0
8889961|NCT01998958|9947664|FG022|NOT COMPLETED|Follow-up Phase||0
8889962|NCT01998958|9947665|FG023|NOT COMPLETED|Follow-up Phase||0
8889963|NCT01998958|9947666|FG024|NOT COMPLETED|Follow-up Phase||0
8889964|NCT01998958|9947667|FG025|NOT COMPLETED|Follow-up Phase||0
8889965|NCT01998958|9947668|FG026|NOT COMPLETED|Follow-up Phase||0
8889966|NCT01998958|9947669|FG027|NOT COMPLETED|Follow-up Phase||0
8889967|NCT01998958|9947670|FG028|NOT COMPLETED|Follow-up Phase||0
8889968|NCT01998958|9947671|FG029|NOT COMPLETED|Follow-up Phase||0
8889969|NCT01998958|9947672|FG030|NOT COMPLETED|Follow-up Phase||0
8889970|NCT01998958|9947673|FG031|NOT COMPLETED|Follow-up Phase||0
8889971|NCT01998984|9947727|FG000|STARTED|Overall Study||55
8889972|NCT01998984|9947728|FG001|STARTED|Overall Study||59
8889973|NCT01998984|9947729|FG002|STARTED|Overall Study||49
8889974|NCT01998984|9947730|FG003|STARTED|Overall Study||61
8889975|NCT01998984|9947727|FG000|COMPLETED|Overall Study||55
8889976|NCT01998984|9947728|FG001|COMPLETED|Overall Study||58
8889977|NCT01998984|9947729|FG002|COMPLETED|Overall Study||48
8889978|NCT01998984|9947730|FG003|COMPLETED|Overall Study||58
8889979|NCT01998984|9947727|FG000|NOT COMPLETED|Overall Study||0
8889980|NCT01998984|9947728|FG001|NOT COMPLETED|Overall Study||1
8889981|NCT01998984|9947729|FG002|NOT COMPLETED|Overall Study||1
8889982|NCT01998984|9947730|FG003|NOT COMPLETED|Overall Study||3
8889983|NCT01999114|9947745|FG000|STARTED|Overall Study||66
8889984|NCT01999114|9947746|FG001|STARTED|Overall Study||66
8889985|NCT01999114|9947747|FG002|STARTED|Overall Study||66
8889986|NCT01999114|9947748|FG003|STARTED|Overall Study||65
8889987|NCT01999114|9947749|FG004|STARTED|Overall Study||65
8889988|NCT01999114|9947745|FG000|COMPLETED|Overall Study||58
8889989|NCT01999114|9947746|FG001|COMPLETED|Overall Study||59
8889990|NCT01999114|9947747|FG002|COMPLETED|Overall Study||61
8889991|NCT01999114|9947748|FG003|COMPLETED|Overall Study||62
8889992|NCT01999114|9947749|FG004|COMPLETED|Overall Study||61
8889993|NCT01999114|9947745|FG000|NOT COMPLETED|Overall Study||8
8889994|NCT01999114|9947746|FG001|NOT COMPLETED|Overall Study||7
8889995|NCT01999114|9947747|FG002|NOT COMPLETED|Overall Study||5
8889996|NCT01999114|9947748|FG003|NOT COMPLETED|Overall Study||3
8889997|NCT01999114|9947749|FG004|NOT COMPLETED|Overall Study||4
8889998|NCT01999192|9947779|FG000|STARTED|Main Phase I||83
8889999|NCT01999192|9947780|FG001|STARTED|Main Phase I||80
8890000|NCT01999192|9947781|FG002|STARTED|Main Phase I||78
8890001|NCT01999192|9947782|FG003|STARTED|Main Phase I||80
8890002|NCT01999192|9947779|FG000|COMPLETED|Main Phase I||72
8890003|NCT01999192|9947780|FG001|COMPLETED|Main Phase I||70
8890004|NCT01999192|9947781|FG002|COMPLETED|Main Phase I||70
8890005|NCT01999192|9947782|FG003|COMPLETED|Main Phase I||72
8890006|NCT01999192|9947779|FG000|NOT COMPLETED|Main Phase I||11
8890007|NCT01999192|9947780|FG001|NOT COMPLETED|Main Phase I||10
8890008|NCT01999192|9947781|FG002|NOT COMPLETED|Main Phase I||8
8890009|NCT01999192|9947782|FG003|NOT COMPLETED|Main Phase I||8
8890010|NCT01999192|9947779|FG000|STARTED|Main Phase II|Non-responders were switched to higher dose Level after Main Phase 1, started = completed -switched.|64
8890011|NCT01999192|9947780|FG001|STARTED|Main Phase II|started Patient = completed patients + switched patients (non-responder) from other arms.|75
8890012|NCT01999192|9947781|FG002|STARTED|Main Phase II|started Patient = completed patients + switched patients (non-responder) from other arms.|98
8890013|NCT01999192|9947782|FG003|STARTED|Main Phase II|non-responders were switched to higher dose Level after Main Phase 1, started = completed -switched|44
8890014|NCT01999192|9947779|FG000|COMPLETED|Main Phase II||55
8890015|NCT01999192|9947780|FG001|COMPLETED|Main Phase II||66
8890016|NCT01999192|9947781|FG002|COMPLETED|Main Phase II||76
8890017|NCT01999192|9947782|FG003|COMPLETED|Main Phase II||43
8890018|NCT01999192|9947779|FG000|NOT COMPLETED|Main Phase II||9
8890019|NCT01999192|9947780|FG001|NOT COMPLETED|Main Phase II||9
8890020|NCT01999192|9947781|FG002|NOT COMPLETED|Main Phase II||22
8890021|NCT01999192|9947782|FG003|NOT COMPLETED|Main Phase II||1
8890022|NCT01999192|9947779|FG000|STARTED|Extension Phase|Some patients terminated or were switched to higher dose Level after Main Phase 2.|54
8890023|NCT01999192|9947780|FG001|STARTED|Extension Phase|Some patients terminated or were switched to higher dose Level after Main Phase 2.|56
8890024|NCT01999192|9947781|FG002|STARTED|Extension Phase|Some patients terminated after Main Phase 2.|68
8890025|NCT01999192|9947782|FG003|STARTED|Extension Phase|No Placebo arm for Extension Phase, all patients terminated or were switched to tregalizumab Groups.|0
8890026|NCT01999192|9947779|FG000|COMPLETED|Extension Phase||41
8890027|NCT01999192|9947780|FG001|COMPLETED|Extension Phase||38
8890028|NCT01999192|9947781|FG002|COMPLETED|Extension Phase||44
8890029|NCT01999192|9947782|FG003|COMPLETED|Extension Phase||0
8890030|NCT01999192|9947779|FG000|NOT COMPLETED|Extension Phase||13
8890031|NCT01999192|9947780|FG001|NOT COMPLETED|Extension Phase||18
8890032|NCT01999192|9947781|FG002|NOT COMPLETED|Extension Phase||24
8890033|NCT01999192|9947782|FG003|NOT COMPLETED|Extension Phase||0
8890034|NCT01999218|9947795|FG000|STARTED|Overall Study||448
8890035|NCT01999218|9947796|FG001|STARTED|Overall Study||441
8890036|NCT01999218|9947797|FG002|STARTED|Overall Study||437
8890037|NCT01999218|9947795|FG000|Treated|Overall Study||448
8890038|NCT01999218|9947796|FG001|Treated|Overall Study||440
8890039|NCT01999218|9947797|FG002|Treated|Overall Study||437
8890040|NCT01999218|9947795|FG000|Site Issue|Overall Study||445
8890041|NCT01999218|9947796|FG001|Site Issue|Overall Study||435
8890042|NCT01999218|9947797|FG002|Site Issue|Overall Study||435
8890043|NCT01999218|9947795|FG000|COMPLETED|Overall Study||339
8890044|NCT01999218|9947796|FG001|COMPLETED|Overall Study||340
8890045|NCT01999218|9947797|FG002|COMPLETED|Overall Study||327
8890046|NCT01999218|9947795|FG000|NOT COMPLETED|Overall Study||109
8890047|NCT01999218|9947796|FG001|NOT COMPLETED|Overall Study||101
8890048|NCT01999218|9947797|FG002|NOT COMPLETED|Overall Study||110
8890049|NCT01999231|9947809|FG000|STARTED|Overall Study||6
8890050|NCT01999231|9947810|FG001|STARTED|Overall Study||6
8890051|NCT01999231|9947811|FG002|STARTED|Overall Study||6
8890052|NCT01999231|9947812|FG003|STARTED|Overall Study||6
8890053|NCT01999231|9947809|FG000|COMPLETED|Overall Study||6
8890054|NCT01999231|9947810|FG001|COMPLETED|Overall Study||6
8890055|NCT01999231|9947811|FG002|COMPLETED|Overall Study||6
8890056|NCT01999231|9947812|FG003|COMPLETED|Overall Study||6
8890057|NCT01999231|9947809|FG000|NOT COMPLETED|Overall Study||0
8890058|NCT01999231|9947810|FG001|NOT COMPLETED|Overall Study||0
8890059|NCT01999231|9947811|FG002|NOT COMPLETED|Overall Study||0
8890060|NCT01999231|9947812|FG003|NOT COMPLETED|Overall Study||0
8890061|NCT01999322|9947826|FG000|STARTED|Overall Study||25
8890062|NCT01999322|9947827|FG001|STARTED|Overall Study||12
8890063|NCT01999322|9947826|FG000|COMPLETED|Overall Study||24
8890064|NCT01999322|9947827|FG001|COMPLETED|Overall Study||12
8890065|NCT01999322|9947826|FG000|NOT COMPLETED|Overall Study||1
8890066|NCT01999322|9947827|FG001|NOT COMPLETED|Overall Study||0
8890067|NCT01999335|9947838|FG000|STARTED|Overall Study||3
8890068|NCT01999335|9947839|FG001|STARTED|Overall Study||1
8890069|NCT01999335|9947840|FG002|STARTED|Overall Study||7
8890070|NCT01999335|9947841|FG003|STARTED|Overall Study||10
8890071|NCT01999335|9947842|FG004|STARTED|Overall Study||12
8890072|NCT01999335|9947838|FG000|Received Study Treatment|Overall Study||3
8890073|NCT01999335|9947839|FG001|Received Study Treatment|Overall Study||1
8890074|NCT01999335|9947840|FG002|Received Study Treatment|Overall Study||7
8890075|NCT01999335|9947841|FG003|Received Study Treatment|Overall Study||10
8890076|NCT01999335|9947842|FG004|Received Study Treatment|Overall Study||10
8890077|NCT01999335|9947838|FG000|COMPLETED|Overall Study||3
8890078|NCT01999335|9947839|FG001|COMPLETED|Overall Study||1
8890079|NCT01999335|9947840|FG002|COMPLETED|Overall Study||7
8890080|NCT01999335|9947841|FG003|COMPLETED|Overall Study||10
8890081|NCT01999335|9947842|FG004|COMPLETED|Overall Study||10
8890082|NCT01999335|9947838|FG000|NOT COMPLETED|Overall Study||0
8890083|NCT01999335|9947839|FG001|NOT COMPLETED|Overall Study||0
8890084|NCT01999335|9947840|FG002|NOT COMPLETED|Overall Study||0
8890085|NCT01999335|9947841|FG003|NOT COMPLETED|Overall Study||0
8890086|NCT01999335|9947842|FG004|NOT COMPLETED|Overall Study||2
8890087|NCT01999348|9947857|FG000|STARTED|Overall Study||1553
8890088|NCT01999348|9947857|FG000|COMPLETED|Overall Study||1433
8890089|NCT01999348|9947857|FG000|NOT COMPLETED|Overall Study||120
8890090|NCT01999400|9947861|FG000|STARTED|First Intervention (1 Day)||6
8890091|NCT01999400|9947862|FG001|STARTED|First Intervention (1 Day)||6
8890092|NCT01999400|9947863|FG002|STARTED|First Intervention (1 Day)||5
8890093|NCT01999400|9947864|FG003|STARTED|First Intervention (1 Day)||5
8890094|NCT01999400|9947865|FG004|STARTED|First Intervention (1 Day)||4
8890095|NCT01999400|9947866|FG005|STARTED|First Intervention (1 Day)||4
8890096|NCT01999400|9947861|FG000|COMPLETED|First Intervention (1 Day)||4
8890097|NCT01999400|9947862|FG001|COMPLETED|First Intervention (1 Day)||4
8890098|NCT01999400|9947863|FG002|COMPLETED|First Intervention (1 Day)||3
8890099|NCT01999400|9947864|FG003|COMPLETED|First Intervention (1 Day)||2
9006002|NCT02947997|10069289|FG000|COMPLETED|Overall Study||4
9006003|NCT02947997|10069289|FG000|NOT COMPLETED|Overall Study||0
8890100|NCT01999400|9947865|FG004|COMPLETED|First Intervention (1 Day)||4
8890101|NCT01999400|9947866|FG005|COMPLETED|First Intervention (1 Day)||3
8890102|NCT01999400|9947861|FG000|NOT COMPLETED|First Intervention (1 Day)||2
8890103|NCT01999400|9947862|FG001|NOT COMPLETED|First Intervention (1 Day)||2
8890104|NCT01999400|9947863|FG002|NOT COMPLETED|First Intervention (1 Day)||2
8890105|NCT01999400|9947864|FG003|NOT COMPLETED|First Intervention (1 Day)||3
8890106|NCT01999400|9947865|FG004|NOT COMPLETED|First Intervention (1 Day)||0
8890107|NCT01999400|9947866|FG005|NOT COMPLETED|First Intervention (1 Day)||1
8890108|NCT01999400|9947861|FG000|STARTED|Washout (10 Days)||5
8890109|NCT01999400|9947862|FG001|STARTED|Washout (10 Days)||4
8890110|NCT01999400|9947863|FG002|STARTED|Washout (10 Days)||3
8890111|NCT01999400|9947864|FG003|STARTED|Washout (10 Days)||2
8890112|NCT01999400|9947865|FG004|STARTED|Washout (10 Days)||3
8890113|NCT01999400|9947866|FG005|STARTED|Washout (10 Days)||3
8890114|NCT01999400|9947861|FG000|COMPLETED|Washout (10 Days)||5
8890115|NCT01999400|9947862|FG001|COMPLETED|Washout (10 Days)||4
8890116|NCT01999400|9947863|FG002|COMPLETED|Washout (10 Days)||3
8890117|NCT01999400|9947864|FG003|COMPLETED|Washout (10 Days)||2
8890118|NCT01999400|9947865|FG004|COMPLETED|Washout (10 Days)||3
8890119|NCT01999400|9947866|FG005|COMPLETED|Washout (10 Days)||3
8890120|NCT01999400|9947861|FG000|NOT COMPLETED|Washout (10 Days)||0
8890121|NCT01999400|9947862|FG001|NOT COMPLETED|Washout (10 Days)||0
8890122|NCT01999400|9947863|FG002|NOT COMPLETED|Washout (10 Days)||0
8890123|NCT01999400|9947864|FG003|NOT COMPLETED|Washout (10 Days)||0
8890124|NCT01999400|9947865|FG004|NOT COMPLETED|Washout (10 Days)||0
9006004|NCT02948257|10069293|FG000|STARTED|Overall Study||52
8890125|NCT01999400|9947866|FG005|NOT COMPLETED|Washout (10 Days)||0
8890126|NCT01999400|9947861|FG000|STARTED|Second Intervention (1 Day)||5
8890127|NCT01999400|9947862|FG001|STARTED|Second Intervention (1 Day)||4
8890128|NCT01999400|9947863|FG002|STARTED|Second Intervention (1 Day)||3
8890129|NCT01999400|9947864|FG003|STARTED|Second Intervention (1 Day)||2
8890130|NCT01999400|9947865|FG004|STARTED|Second Intervention (1 Day)||3
8890131|NCT01999400|9947866|FG005|STARTED|Second Intervention (1 Day)||3
8890132|NCT01999400|9947861|FG000|COMPLETED|Second Intervention (1 Day)||5
8890133|NCT01999400|9947862|FG001|COMPLETED|Second Intervention (1 Day)||4
8890134|NCT01999400|9947863|FG002|COMPLETED|Second Intervention (1 Day)||3
8890135|NCT01999400|9947864|FG003|COMPLETED|Second Intervention (1 Day)||2
8890136|NCT01999400|9947865|FG004|COMPLETED|Second Intervention (1 Day)||3
8890137|NCT01999400|9947866|FG005|COMPLETED|Second Intervention (1 Day)||3
8890138|NCT01999400|9947861|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
8890139|NCT01999400|9947862|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
8890140|NCT01999400|9947863|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
8890141|NCT01999400|9947864|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
8890142|NCT01999400|9947865|FG004|NOT COMPLETED|Second Intervention (1 Day)||0
8890143|NCT01999400|9947866|FG005|NOT COMPLETED|Second Intervention (1 Day)||0
8890144|NCT01999400|9947861|FG000|STARTED|Washout (10 Days)||2
8890145|NCT01999400|9947862|FG001|STARTED|Washout (10 Days)||0
8890146|NCT01999400|9947863|FG002|STARTED|Washout (10 Days)||1
8890147|NCT01999400|9947864|FG003|STARTED|Washout (10 Days)||1
8890148|NCT01999400|9947865|FG004|STARTED|Washout (10 Days)||1
8890149|NCT01999400|9947866|FG005|STARTED|Washout (10 Days)||1
8890150|NCT01999400|9947861|FG000|COMPLETED|Washout (10 Days)||2
8890151|NCT01999400|9947862|FG001|COMPLETED|Washout (10 Days)||0
8890152|NCT01999400|9947863|FG002|COMPLETED|Washout (10 Days)||1
8890153|NCT01999400|9947864|FG003|COMPLETED|Washout (10 Days)||1
8890154|NCT01999400|9947865|FG004|COMPLETED|Washout (10 Days)||1
8890155|NCT01999400|9947866|FG005|COMPLETED|Washout (10 Days)||1
8890156|NCT01999400|9947861|FG000|NOT COMPLETED|Washout (10 Days)||0
8890157|NCT01999400|9947862|FG001|NOT COMPLETED|Washout (10 Days)||0
8890158|NCT01999400|9947863|FG002|NOT COMPLETED|Washout (10 Days)||0
8890159|NCT01999400|9947864|FG003|NOT COMPLETED|Washout (10 Days)||0
8890160|NCT01999400|9947865|FG004|NOT COMPLETED|Washout (10 Days)||0
8890161|NCT01999400|9947866|FG005|NOT COMPLETED|Washout (10 Days)||0
8890162|NCT01999400|9947861|FG000|STARTED|Third Intervention (1 Day)||2
8890163|NCT01999400|9947862|FG001|STARTED|Third Intervention (1 Day)||0
8890164|NCT01999400|9947863|FG002|STARTED|Third Intervention (1 Day)||1
8890165|NCT01999400|9947864|FG003|STARTED|Third Intervention (1 Day)||1
8890166|NCT01999400|9947865|FG004|STARTED|Third Intervention (1 Day)||1
8890167|NCT01999400|9947866|FG005|STARTED|Third Intervention (1 Day)||1
8890168|NCT01999400|9947861|FG000|COMPLETED|Third Intervention (1 Day)||2
8890169|NCT01999400|9947862|FG001|COMPLETED|Third Intervention (1 Day)||0
8890170|NCT01999400|9947863|FG002|COMPLETED|Third Intervention (1 Day)||1
8890171|NCT01999400|9947864|FG003|COMPLETED|Third Intervention (1 Day)||1
8890172|NCT01999400|9947865|FG004|COMPLETED|Third Intervention (1 Day)||1
8890173|NCT01999400|9947866|FG005|COMPLETED|Third Intervention (1 Day)||0
8890174|NCT01999400|9947861|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
8890175|NCT01999400|9947862|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
8890176|NCT01999400|9947863|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
8890177|NCT01999400|9947864|FG003|NOT COMPLETED|Third Intervention (1 Day)||0
8890178|NCT01999400|9947865|FG004|NOT COMPLETED|Third Intervention (1 Day)||0
8890179|NCT01999400|9947866|FG005|NOT COMPLETED|Third Intervention (1 Day)||1
8890180|NCT01999400|9947861|FG000|STARTED|Washout (10 Days)||1
8890181|NCT01999400|9947862|FG001|STARTED|Washout (10 Days)||0
8890182|NCT01999400|9947863|FG002|STARTED|Washout (10 Days)||1
8890183|NCT01999400|9947864|FG003|STARTED|Washout (10 Days)||0
8890184|NCT01999400|9947865|FG004|STARTED|Washout (10 Days)||0
8890185|NCT01999400|9947866|FG005|STARTED|Washout (10 Days)||0
8890186|NCT01999400|9947861|FG000|COMPLETED|Washout (10 Days)||1
8890187|NCT01999400|9947862|FG001|COMPLETED|Washout (10 Days)||0
8890188|NCT01999400|9947863|FG002|COMPLETED|Washout (10 Days)||1
8890189|NCT01999400|9947864|FG003|COMPLETED|Washout (10 Days)||0
8890190|NCT01999400|9947865|FG004|COMPLETED|Washout (10 Days)||0
8890191|NCT01999400|9947866|FG005|COMPLETED|Washout (10 Days)||0
8890192|NCT01999400|9947861|FG000|NOT COMPLETED|Washout (10 Days)||0
8890193|NCT01999400|9947862|FG001|NOT COMPLETED|Washout (10 Days)||0
8890194|NCT01999400|9947863|FG002|NOT COMPLETED|Washout (10 Days)||0
8890195|NCT01999400|9947864|FG003|NOT COMPLETED|Washout (10 Days)||0
9006005|NCT02948257|10069293|FG000|COMPLETED|Overall Study||52
8890196|NCT01999400|9947865|FG004|NOT COMPLETED|Washout (10 Days)||0
8890197|NCT01999400|9947866|FG005|NOT COMPLETED|Washout (10 Days)||0
8890198|NCT01999400|9947861|FG000|STARTED|Fourth Intervention (1 Day)||1
8890199|NCT01999400|9947862|FG001|STARTED|Fourth Intervention (1 Day)||0
8890200|NCT01999400|9947863|FG002|STARTED|Fourth Intervention (1 Day)||1
8890201|NCT01999400|9947864|FG003|STARTED|Fourth Intervention (1 Day)||0
8890202|NCT01999400|9947865|FG004|STARTED|Fourth Intervention (1 Day)||0
8890203|NCT01999400|9947866|FG005|STARTED|Fourth Intervention (1 Day)||0
8890204|NCT01999400|9947861|FG000|COMPLETED|Fourth Intervention (1 Day)||1
8890205|NCT01999400|9947862|FG001|COMPLETED|Fourth Intervention (1 Day)||0
8890206|NCT01999400|9947863|FG002|COMPLETED|Fourth Intervention (1 Day)||1
8890207|NCT01999400|9947864|FG003|COMPLETED|Fourth Intervention (1 Day)||0
9006006|NCT02948257|10069293|FG000|NOT COMPLETED|Overall Study||0
8890208|NCT01999400|9947865|FG004|COMPLETED|Fourth Intervention (1 Day)||0
8890209|NCT01999400|9947866|FG005|COMPLETED|Fourth Intervention (1 Day)||0
8890210|NCT01999400|9947861|FG000|NOT COMPLETED|Fourth Intervention (1 Day)||0
8890211|NCT01999400|9947862|FG001|NOT COMPLETED|Fourth Intervention (1 Day)||0
8890212|NCT01999400|9947863|FG002|NOT COMPLETED|Fourth Intervention (1 Day)||0
8890213|NCT01999400|9947864|FG003|NOT COMPLETED|Fourth Intervention (1 Day)||0
8890214|NCT01999400|9947865|FG004|NOT COMPLETED|Fourth Intervention (1 Day)||0
8890215|NCT01999400|9947866|FG005|NOT COMPLETED|Fourth Intervention (1 Day)||0
8890216|NCT01999465|9947878|FG000|STARTED|Overall Study||10
8890217|NCT01999465|9947879|FG001|STARTED|Overall Study||10
8890218|NCT01999465|9947878|FG000|COMPLETED|Overall Study||10
8890219|NCT01999465|9947879|FG001|COMPLETED|Overall Study||7
8890220|NCT01999465|9947878|FG000|NOT COMPLETED|Overall Study||0
8890221|NCT01999465|9947879|FG001|NOT COMPLETED|Overall Study||3
8890222|NCT01999517|9947887|FG000|STARTED|Overall Study||68
8890223|NCT01999517|9947888|FG001|STARTED|Overall Study||54
8890224|NCT01999517|9947887|FG000|COMPLETED|Overall Study||68
8890225|NCT01999517|9947888|FG001|COMPLETED|Overall Study||54
8890226|NCT01999517|9947887|FG000|NOT COMPLETED|Overall Study||0
8890227|NCT01999517|9947888|FG001|NOT COMPLETED|Overall Study||0
8890228|NCT01999530|9947894|FG000|STARTED|Overall Study||20
8890229|NCT01999530|9947894|FG000|COMPLETED|Overall Study||7
9006007|NCT02948426|10069301|FG000|STARTED|Overall Study||3
9006008|NCT02948426|10069302|FG001|STARTED|Overall Study||6
9006009|NCT02948426|10069303|FG002|STARTED|Overall Study||3
9006010|NCT02948426|10069304|FG003|STARTED|Overall Study||6
9006011|NCT02948426|10069301|FG000|COMPLETED|Overall Study||3
9006012|NCT02948426|10069302|FG001|COMPLETED|Overall Study||6
9006013|NCT02948426|10069303|FG002|COMPLETED|Overall Study||3
9006014|NCT02948426|10069304|FG003|COMPLETED|Overall Study||6
9006015|NCT02948426|10069301|FG000|NOT COMPLETED|Overall Study||0
9006016|NCT02948426|10069302|FG001|NOT COMPLETED|Overall Study||0
9006017|NCT02948426|10069303|FG002|NOT COMPLETED|Overall Study||0
9006018|NCT02948426|10069304|FG003|NOT COMPLETED|Overall Study||0
9006019|NCT02948582|10069316|FG000|STARTED|Treatment Period 1||7
9006020|NCT02948582|10069317|FG001|STARTED|Treatment Period 1||7
9006021|NCT02948582|10069318|FG002|STARTED|Treatment Period 1||7
9006022|NCT02948582|10069319|FG003|STARTED|Treatment Period 1||7
9006023|NCT02948582|10069320|FG004|STARTED|Treatment Period 1||7
9006024|NCT02948582|10069321|FG005|STARTED|Treatment Period 1||7
9006025|NCT02948582|10069316|FG000|COMPLETED|Treatment Period 1||7
9006026|NCT02948582|10069317|FG001|COMPLETED|Treatment Period 1||7
9006027|NCT02948582|10069318|FG002|COMPLETED|Treatment Period 1||7
9006028|NCT02948582|10069319|FG003|COMPLETED|Treatment Period 1||7
9006029|NCT02948582|10069320|FG004|COMPLETED|Treatment Period 1||7
9006030|NCT02948582|10069321|FG005|COMPLETED|Treatment Period 1||7
9006031|NCT02948582|10069316|FG000|NOT COMPLETED|Treatment Period 1||0
9006032|NCT02948582|10069317|FG001|NOT COMPLETED|Treatment Period 1||0
9006033|NCT02948582|10069318|FG002|NOT COMPLETED|Treatment Period 1||0
9006034|NCT02948582|10069319|FG003|NOT COMPLETED|Treatment Period 1||0
9006035|NCT02948582|10069320|FG004|NOT COMPLETED|Treatment Period 1||0
9006036|NCT02948582|10069321|FG005|NOT COMPLETED|Treatment Period 1||0
9006037|NCT02948582|10069316|FG000|STARTED|Washout Period 1||7
9006038|NCT02948582|10069317|FG001|STARTED|Washout Period 1||7
9006039|NCT02948582|10069318|FG002|STARTED|Washout Period 1||7
9006040|NCT02948582|10069319|FG003|STARTED|Washout Period 1||7
8572743|NCT00116805|9604932|FG001|COMPLETED|Open-label Period Weeks 385 - 432||30
8572744|NCT00116805|9604931|FG000|NOT COMPLETED|Open-label Period Weeks 385 - 432||2
8572745|NCT00116805|9604932|FG001|NOT COMPLETED|Open-label Period Weeks 385 - 432||0
8572746|NCT00116805|9604931|FG000|STARTED|Open-label Period Weeks 433 - 480||57
8572747|NCT00116805|9604932|FG001|STARTED|Open-label Period Weeks 433 - 480|1 participant completed 432 weeks but did not continue on study.|29
8572748|NCT00116805|9604931|FG000|COMPLETED|Open-label Period Weeks 433 - 480||53
8572749|NCT00116805|9604932|FG001|COMPLETED|Open-label Period Weeks 433 - 480||29
8572750|NCT00116805|9604931|FG000|NOT COMPLETED|Open-label Period Weeks 433 - 480||4
8572751|NCT00116805|9604932|FG001|NOT COMPLETED|Open-label Period Weeks 433 - 480||0
8572752|NCT00116831|9604949|FG000|STARTED|Overall Study||337
8572753|NCT00116831|9604950|FG001|STARTED|Overall Study||331
8572754|NCT00116831|9604949|FG000|COMPLETED|Overall Study||264
8890230|NCT01999530|9947894|FG000|NOT COMPLETED|Overall Study||13
9006041|NCT02948582|10069320|FG004|STARTED|Washout Period 1||7
8890231|NCT01999777|9947900|FG000|STARTED|Overall Study||31
8890232|NCT01999777|9947901|FG001|STARTED|Overall Study||31
8890233|NCT01999777|9947900|FG000|COMPLETED|Overall Study||31
8890234|NCT01999777|9947901|FG001|COMPLETED|Overall Study||31
8890235|NCT01999777|9947900|FG000|NOT COMPLETED|Overall Study||0
8890236|NCT01999777|9947901|FG001|NOT COMPLETED|Overall Study||0
8890237|NCT01999868|9947910|FG000|STARTED|Lead-in Phase (Week 0 - 12)||45
8890238|NCT01999868|9947911|FG001|STARTED|Lead-in Phase (Week 0 - 12)||46
8890239|NCT01999868|9947912|FG002|STARTED|Lead-in Phase (Week 0 - 12)||17
8890240|NCT01999868|9947910|FG000|COMPLETED|Lead-in Phase (Week 0 - 12)||45
8890241|NCT01999868|9947911|FG001|COMPLETED|Lead-in Phase (Week 0 - 12)||46
8890242|NCT01999868|9947912|FG002|COMPLETED|Lead-in Phase (Week 0 - 12)||12
8890243|NCT01999868|9947910|FG000|NOT COMPLETED|Lead-in Phase (Week 0 - 12)||0
8890244|NCT01999868|9947911|FG001|NOT COMPLETED|Lead-in Phase (Week 0 - 12)||0
8890245|NCT01999868|9947912|FG002|NOT COMPLETED|Lead-in Phase (Week 0 - 12)||5
8890246|NCT01999868|9947910|FG000|STARTED|Blinded Treatment Phase (Week 12 - 40)||45
8890247|NCT01999868|9947911|FG001|STARTED|Blinded Treatment Phase (Week 12 - 40)||46
8890248|NCT01999868|9947912|FG002|STARTED|Blinded Treatment Phase (Week 12 - 40)|Participants didn't meet eligibility requirements for randomization or withdrew prior to Week 12.|0
8890249|NCT01999868|9947910|FG000|COMPLETED|Blinded Treatment Phase (Week 12 - 40)||27
8890250|NCT01999868|9947911|FG001|COMPLETED|Blinded Treatment Phase (Week 12 - 40)||35
8890251|NCT01999868|9947912|FG002|COMPLETED|Blinded Treatment Phase (Week 12 - 40)||0
8890252|NCT01999868|9947910|FG000|NOT COMPLETED|Blinded Treatment Phase (Week 12 - 40)||18
8890253|NCT01999868|9947911|FG001|NOT COMPLETED|Blinded Treatment Phase (Week 12 - 40)||11
8890254|NCT01999868|9947912|FG002|NOT COMPLETED|Blinded Treatment Phase (Week 12 - 40)||0
8890255|NCT01999868|9947910|FG000|STARTED|Blinded Observation Phase (Week 40 - 88)||27
8890256|NCT01999868|9947911|FG001|STARTED|Blinded Observation Phase (Week 40 - 88)||35
8890257|NCT01999868|9947912|FG002|STARTED|Blinded Observation Phase (Week 40 - 88)||0
8890258|NCT01999868|9947910|FG000|COMPLETED|Blinded Observation Phase (Week 40 - 88)||4
8890259|NCT01999868|9947911|FG001|COMPLETED|Blinded Observation Phase (Week 40 - 88)||6
8890260|NCT01999868|9947912|FG002|COMPLETED|Blinded Observation Phase (Week 40 - 88)||0
8890261|NCT01999868|9947910|FG000|NOT COMPLETED|Blinded Observation Phase (Week 40 - 88)||23
8890262|NCT01999868|9947911|FG001|NOT COMPLETED|Blinded Observation Phase (Week 40 - 88)||29
8890263|NCT01999868|9947912|FG002|NOT COMPLETED|Blinded Observation Phase (Week 40 - 88)||0
8890264|NCT01999894|9947920|FG000|STARTED|Overall Study||102
8890265|NCT01999894|9947920|FG000|COMPLETED|Overall Study||66
8890266|NCT01999894|9947920|FG000|NOT COMPLETED|Overall Study||36
8890267|NCT01999920|9947927|FG000|STARTED|Overall Study||13
8890268|NCT01999920|9947928|FG001|STARTED|Overall Study||11
8890269|NCT01999920|9947927|FG000|COMPLETED|Overall Study||7
8890270|NCT01999920|9947928|FG001|COMPLETED|Overall Study||9
8890271|NCT01999920|9947927|FG000|NOT COMPLETED|Overall Study||6
8890272|NCT01999920|9947928|FG001|NOT COMPLETED|Overall Study||2
8890273|NCT01999946|9947937|FG000|STARTED|Overall Study||61
8890274|NCT01999946|9947938|FG001|STARTED|Overall Study||58
8890275|NCT01999946|9947939|FG002|STARTED|Overall Study||79
8890276|NCT01999946|9947937|FG000|COMPLETED|Overall Study||59
8890277|NCT01999946|9947938|FG001|COMPLETED|Overall Study||56
8890278|NCT01999946|9947939|FG002|COMPLETED|Overall Study||0
8890279|NCT01999946|9947937|FG000|NOT COMPLETED|Overall Study||2
8890280|NCT01999946|9947938|FG001|NOT COMPLETED|Overall Study||2
8890281|NCT01999946|9947939|FG002|NOT COMPLETED|Overall Study||79
8890282|NCT01999972|9947952|FG000|STARTED|Dose Escalation Part||5
8890283|NCT01999972|9947953|FG001|STARTED|Dose Escalation Part||3
8890284|NCT01999972|9947954|FG002|STARTED|Dose Escalation Part||5
8890285|NCT01999972|9947955|FG003|STARTED|Dose Escalation Part||11
8890286|NCT01999972|9947956|FG004|STARTED|Dose Escalation Part||0
8890287|NCT01999972|9947957|FG005|STARTED|Dose Escalation Part||0
8890288|NCT01999972|9947952|FG000|Treated|Dose Escalation Part||5
8890289|NCT01999972|9947953|FG001|Treated|Dose Escalation Part||3
8890290|NCT01999972|9947954|FG002|Treated|Dose Escalation Part||4
8890291|NCT01999972|9947955|FG003|Treated|Dose Escalation Part||10
8890292|NCT01999972|9947956|FG004|Treated|Dose Escalation Part||0
8890293|NCT01999972|9947957|FG005|Treated|Dose Escalation Part||0
8890294|NCT01999972|9947952|FG000|COMPLETED|Dose Escalation Part||0
8890295|NCT01999972|9947953|FG001|COMPLETED|Dose Escalation Part||0
8890296|NCT01999972|9947954|FG002|COMPLETED|Dose Escalation Part||0
8890297|NCT01999972|9947955|FG003|COMPLETED|Dose Escalation Part||0
8890298|NCT01999972|9947956|FG004|COMPLETED|Dose Escalation Part||0
8890299|NCT01999972|9947957|FG005|COMPLETED|Dose Escalation Part||0
8890300|NCT01999972|9947952|FG000|NOT COMPLETED|Dose Escalation Part||5
8890301|NCT01999972|9947953|FG001|NOT COMPLETED|Dose Escalation Part||3
8890302|NCT01999972|9947954|FG002|NOT COMPLETED|Dose Escalation Part||5
8890303|NCT01999972|9947955|FG003|NOT COMPLETED|Dose Escalation Part||11
8890304|NCT01999972|9947956|FG004|NOT COMPLETED|Dose Escalation Part||0
8890305|NCT01999972|9947957|FG005|NOT COMPLETED|Dose Escalation Part||0
8890306|NCT01999972|9947952|FG000|STARTED|Dose Expansion Part||0
8890307|NCT01999972|9947953|FG001|STARTED|Dose Expansion Part||0
8890308|NCT01999972|9947954|FG002|STARTED|Dose Expansion Part||0
8890309|NCT01999972|9947955|FG003|STARTED|Dose Expansion Part||0
8890310|NCT01999972|9947956|FG004|STARTED|Dose Expansion Part||21
8890311|NCT01999972|9947957|FG005|STARTED|Dose Expansion Part||7
8890312|NCT01999972|9947952|FG000|Treated|Dose Expansion Part||0
8890313|NCT01999972|9947953|FG001|Treated|Dose Expansion Part||0
8890314|NCT01999972|9947954|FG002|Treated|Dose Expansion Part||0
8890315|NCT01999972|9947955|FG003|Treated|Dose Expansion Part||0
8890316|NCT01999972|9947956|FG004|Treated|Dose Expansion Part||21
8890317|NCT01999972|9947957|FG005|Treated|Dose Expansion Part||7
8890318|NCT01999972|9947952|FG000|COMPLETED|Dose Expansion Part||0
8890319|NCT01999972|9947953|FG001|COMPLETED|Dose Expansion Part||0
8890320|NCT01999972|9947954|FG002|COMPLETED|Dose Expansion Part||0
8890321|NCT01999972|9947955|FG003|COMPLETED|Dose Expansion Part||0
8890322|NCT01999972|9947956|FG004|COMPLETED|Dose Expansion Part||0
8890323|NCT01999972|9947957|FG005|COMPLETED|Dose Expansion Part||0
8890324|NCT01999972|9947952|FG000|NOT COMPLETED|Dose Expansion Part||0
8890325|NCT01999972|9947953|FG001|NOT COMPLETED|Dose Expansion Part||0
8890326|NCT01999972|9947954|FG002|NOT COMPLETED|Dose Expansion Part||0
8890327|NCT01999972|9947955|FG003|NOT COMPLETED|Dose Expansion Part||0
8890328|NCT01999972|9947956|FG004|NOT COMPLETED|Dose Expansion Part||21
8890329|NCT01999972|9947957|FG005|NOT COMPLETED|Dose Expansion Part||7
8890330|NCT01999985|9947973|FG000|STARTED|Overall Study||8
8890331|NCT01999985|9947974|FG001|STARTED|Overall Study||3
8890332|NCT01999985|9947975|FG002|STARTED|Overall Study||14
8890333|NCT01999985|9947973|FG000|COMPLETED|Overall Study||8
8890334|NCT01999985|9947974|FG001|COMPLETED|Overall Study||3
8890335|NCT01999985|9947975|FG002|COMPLETED|Overall Study||14
8890336|NCT01999985|9947973|FG000|NOT COMPLETED|Overall Study||0
8890337|NCT01999985|9947974|FG001|NOT COMPLETED|Overall Study||0
8890338|NCT01999985|9947975|FG002|NOT COMPLETED|Overall Study||0
8890339|NCT02000154|9947981|FG000|STARTED|Overall Study||1
8890340|NCT02000154|9947981|FG000|COMPLETED|Overall Study||1
8890341|NCT02000154|9947981|FG000|NOT COMPLETED|Overall Study||0
8890342|NCT02000180|9947987|FG000|STARTED|Overall Study||18
8890343|NCT02000180|9947988|FG001|STARTED|Overall Study||19
8890344|NCT02000180|9947987|FG000|COMPLETED|Overall Study||18
8890345|NCT02000180|9947988|FG001|COMPLETED|Overall Study||19
8890346|NCT02000180|9947987|FG000|NOT COMPLETED|Overall Study||0
8890347|NCT02000180|9947988|FG001|NOT COMPLETED|Overall Study||0
8890348|NCT02000440|9947994|FG000|STARTED|Overall Study||17
8890349|NCT02000440|9947994|FG000|COMPLETED|Overall Study||13
8890350|NCT02000440|9947994|FG000|NOT COMPLETED|Overall Study||4
8890351|NCT02000531|9948000|FG000|STARTED|Overall Study||21
8890352|NCT02000531|9948001|FG001|STARTED|Overall Study||24
8890353|NCT02000531|9948000|FG000|Safety Population|Overall Study||21
8890354|NCT02000531|9948001|FG001|Safety Population|Overall Study||24
8890355|NCT02000531|9948000|FG000|COMPLETED|Overall Study||17
8890356|NCT02000531|9948001|FG001|COMPLETED|Overall Study||16
8890357|NCT02000531|9948000|FG000|NOT COMPLETED|Overall Study||4
8890358|NCT02000531|9948001|FG001|NOT COMPLETED|Overall Study||8
8890359|NCT02000583|9948009|FG000|STARTED|Overall Study||78
8890360|NCT02000583|9948010|FG001|STARTED|Overall Study||39
8890361|NCT02000583|9948009|FG000|COMPLETED|Overall Study||75
8890362|NCT02000583|9948010|FG001|COMPLETED|Overall Study||34
8890363|NCT02000583|9948009|FG000|NOT COMPLETED|Overall Study||3
8890364|NCT02000583|9948010|FG001|NOT COMPLETED|Overall Study||5
8890365|NCT02000752|9948018|FG000|STARTED|Overall Study||60
8890366|NCT02000752|9948019|FG001|STARTED|Overall Study||60
8890367|NCT02000752|9948018|FG000|COMPLETED|Overall Study||29
8890368|NCT02000752|9948019|FG001|COMPLETED|Overall Study||47
8890369|NCT02000752|9948018|FG000|NOT COMPLETED|Overall Study||31
8890370|NCT02000752|9948019|FG001|NOT COMPLETED|Overall Study||13
8890371|NCT02000817|9948029|FG000|STARTED|Overall Study||6
8890372|NCT02000817|9948030|FG001|STARTED|Overall Study||9
8890373|NCT02000817|9948031|FG002|STARTED|Overall Study||8
8890374|NCT02000817|9948032|FG003|STARTED|Overall Study||7
8890375|NCT02000817|9948029|FG000|COMPLETED|Overall Study||4
8890376|NCT02000817|9948030|FG001|COMPLETED|Overall Study||8
8890377|NCT02000817|9948031|FG002|COMPLETED|Overall Study||7
8890378|NCT02000817|9948032|FG003|COMPLETED|Overall Study||7
8890379|NCT02000817|9948029|FG000|NOT COMPLETED|Overall Study||2
8890380|NCT02000817|9948030|FG001|NOT COMPLETED|Overall Study||1
8890381|NCT02000817|9948031|FG002|NOT COMPLETED|Overall Study||1
8890382|NCT02000817|9948032|FG003|NOT COMPLETED|Overall Study||0
8890383|NCT02000908|9948047|FG000|STARTED|Overall Study||30
8890384|NCT02000908|9948048|FG001|STARTED|Overall Study||40
8634882|NCT00558753|9675234|FG000|NOT COMPLETED|Overall Study||5
8890385|NCT02000908|9948047|FG000|COMPLETED|Overall Study||28
8890386|NCT02000908|9948048|FG001|COMPLETED|Overall Study||36
8890387|NCT02000908|9948047|FG000|NOT COMPLETED|Overall Study||2
8890388|NCT02000908|9948048|FG001|NOT COMPLETED|Overall Study||4
8890389|NCT02000921|9948057|FG000|STARTED|Overall Study||27
8634883|NCT00558753|9675235|FG001|NOT COMPLETED|Overall Study||7
8634884|NCT00558792|9675244|FG000|STARTED|Overall Study||68
8890390|NCT02000921|9948058|FG001|STARTED|Overall Study||53
8890391|NCT02000921|9948059|FG002|STARTED|Overall Study||56
8890392|NCT02000921|9948057|FG000|COMPLETED|Overall Study||22
8890393|NCT02000921|9948058|FG001|COMPLETED|Overall Study||37
8890394|NCT02000921|9948059|FG002|COMPLETED|Overall Study||46
8890395|NCT02000921|9948057|FG000|NOT COMPLETED|Overall Study||5
8890396|NCT02000921|9948058|FG001|NOT COMPLETED|Overall Study||16
8890397|NCT02000921|9948059|FG002|NOT COMPLETED|Overall Study||10
8890398|NCT02000973|9948071|FG000|STARTED|Overall Study||20
8890399|NCT02000973|9948072|FG001|STARTED|Overall Study||20
8890400|NCT02000973|9948073|FG002|STARTED|Overall Study||20
8890401|NCT02000973|9948074|FG003|STARTED|Overall Study||20
8890402|NCT02000973|9948071|FG000|COMPLETED|Overall Study||20
8890403|NCT02000973|9948072|FG001|COMPLETED|Overall Study||20
8890404|NCT02000973|9948073|FG002|COMPLETED|Overall Study||20
8890405|NCT02000973|9948074|FG003|COMPLETED|Overall Study||20
8890406|NCT02000973|9948071|FG000|NOT COMPLETED|Overall Study||0
8890407|NCT02000973|9948072|FG001|NOT COMPLETED|Overall Study||0
8890408|NCT02000973|9948073|FG002|NOT COMPLETED|Overall Study||0
8890409|NCT02000973|9948074|FG003|NOT COMPLETED|Overall Study||0
8890410|NCT02001051|9948086|FG000|STARTED|Overall Study||2
8890411|NCT02001051|9948087|FG001|STARTED|Overall Study||2
8890412|NCT02001051|9948086|FG000|COMPLETED|Overall Study||2
8890413|NCT02001051|9948087|FG001|COMPLETED|Overall Study||1
8890414|NCT02001051|9948086|FG000|NOT COMPLETED|Overall Study||0
8890415|NCT02001051|9948087|FG001|NOT COMPLETED|Overall Study||1
8890416|NCT02001064|9948095|FG000|STARTED|Overall Study||30
8890417|NCT02001064|9948096|FG001|STARTED|Overall Study||30
8890418|NCT02001064|9948095|FG000|COMPLETED|Overall Study||28
8890419|NCT02001064|9948096|FG001|COMPLETED|Overall Study||29
8890420|NCT02001064|9948095|FG000|NOT COMPLETED|Overall Study||2
8890421|NCT02001064|9948096|FG001|NOT COMPLETED|Overall Study||1
8890422|NCT02001181|9948104|FG000|STARTED|Overall Study||35
8890423|NCT02001181|9948105|FG001|STARTED|Overall Study||34
8890424|NCT02001181|9948104|FG000|COMPLETED|Overall Study||34
8890425|NCT02001181|9948105|FG001|COMPLETED|Overall Study||31
8890426|NCT02001181|9948104|FG000|NOT COMPLETED|Overall Study||1
8890427|NCT02001181|9948105|FG001|NOT COMPLETED|Overall Study||3
9006042|NCT02948582|10069321|FG005|STARTED|Washout Period 1||7
9006043|NCT02948582|10069316|FG000|COMPLETED|Washout Period 1||7
9006044|NCT02948582|10069317|FG001|COMPLETED|Washout Period 1||5
9006045|NCT02948582|10069318|FG002|COMPLETED|Washout Period 1||7
9006046|NCT02948582|10069319|FG003|COMPLETED|Washout Period 1||7
9006047|NCT02948582|10069320|FG004|COMPLETED|Washout Period 1||7
9006048|NCT02948582|10069321|FG005|COMPLETED|Washout Period 1||6
9006049|NCT02948582|10069316|FG000|NOT COMPLETED|Washout Period 1||0
9006050|NCT02948582|10069317|FG001|NOT COMPLETED|Washout Period 1||2
9006051|NCT02948582|10069318|FG002|NOT COMPLETED|Washout Period 1||0
9006052|NCT02948582|10069319|FG003|NOT COMPLETED|Washout Period 1||0
9006053|NCT02948582|10069320|FG004|NOT COMPLETED|Washout Period 1||0
9006054|NCT02948582|10069321|FG005|NOT COMPLETED|Washout Period 1||1
9006055|NCT02948582|10069316|FG000|STARTED|Treatment Period 2||7
9006056|NCT02948582|10069317|FG001|STARTED|Treatment Period 2||5
9006057|NCT02948582|10069318|FG002|STARTED|Treatment Period 2||7
9006058|NCT02948582|10069319|FG003|STARTED|Treatment Period 2||7
9006059|NCT02948582|10069320|FG004|STARTED|Treatment Period 2||7
9006060|NCT02948582|10069321|FG005|STARTED|Treatment Period 2||6
9006061|NCT02948582|10069316|FG000|COMPLETED|Treatment Period 2||7
9006062|NCT02948582|10069317|FG001|COMPLETED|Treatment Period 2||5
9006063|NCT02948582|10069318|FG002|COMPLETED|Treatment Period 2||7
9006064|NCT02948582|10069319|FG003|COMPLETED|Treatment Period 2||7
9006065|NCT02948582|10069320|FG004|COMPLETED|Treatment Period 2||7
9006066|NCT02948582|10069321|FG005|COMPLETED|Treatment Period 2||6
9006067|NCT02948582|10069316|FG000|NOT COMPLETED|Treatment Period 2||0
9006068|NCT02948582|10069317|FG001|NOT COMPLETED|Treatment Period 2||0
9006069|NCT02948582|10069318|FG002|NOT COMPLETED|Treatment Period 2||0
9006070|NCT02948582|10069319|FG003|NOT COMPLETED|Treatment Period 2||0
9006071|NCT02948582|10069320|FG004|NOT COMPLETED|Treatment Period 2||0
9006072|NCT02948582|10069321|FG005|NOT COMPLETED|Treatment Period 2||0
9006073|NCT02948582|10069316|FG000|STARTED|Washout Period 2||7
9006074|NCT02948582|10069317|FG001|STARTED|Washout Period 2||5
9006075|NCT02948582|10069318|FG002|STARTED|Washout Period 2||7
9006076|NCT02948582|10069319|FG003|STARTED|Washout Period 2||7
9006077|NCT02948582|10069320|FG004|STARTED|Washout Period 2||7
9006078|NCT02948582|10069321|FG005|STARTED|Washout Period 2||6
9006079|NCT02948582|10069316|FG000|COMPLETED|Washout Period 2||7
9006080|NCT02948582|10069317|FG001|COMPLETED|Washout Period 2||4
9006081|NCT02948582|10069318|FG002|COMPLETED|Washout Period 2||7
9006082|NCT02948582|10069319|FG003|COMPLETED|Washout Period 2||6
9006083|NCT02948582|10069320|FG004|COMPLETED|Washout Period 2||7
9006084|NCT02948582|10069321|FG005|COMPLETED|Washout Period 2||6
9006085|NCT02948582|10069316|FG000|NOT COMPLETED|Washout Period 2||0
9006086|NCT02948582|10069317|FG001|NOT COMPLETED|Washout Period 2||1
9006087|NCT02948582|10069318|FG002|NOT COMPLETED|Washout Period 2||0
9006088|NCT02948582|10069319|FG003|NOT COMPLETED|Washout Period 2||1
9006089|NCT02948582|10069320|FG004|NOT COMPLETED|Washout Period 2||0
8890428|NCT02001194|9948115|FG000|STARTED|Intervention Period (13 Weeks)|17 teams|68
8890429|NCT02001194|9948116|FG001|STARTED|Intervention Period (13 Weeks)|20 teams|80
8890430|NCT02001194|9948117|FG002|STARTED|Intervention Period (13 Weeks)|19 teams|76
8890431|NCT02001194|9948118|FG003|STARTED|Intervention Period (13 Weeks)|20 teams|80
9006090|NCT02948582|10069321|FG005|NOT COMPLETED|Washout Period 2||0
9006091|NCT02948582|10069316|FG000|STARTED|Treatment Period 3||7
9006092|NCT02948582|10069317|FG001|STARTED|Treatment Period 3||4
9006093|NCT02948582|10069318|FG002|STARTED|Treatment Period 3||7
9006094|NCT02948582|10069319|FG003|STARTED|Treatment Period 3||6
9006095|NCT02948582|10069320|FG004|STARTED|Treatment Period 3||7
9006096|NCT02948582|10069321|FG005|STARTED|Treatment Period 3||6
9006097|NCT02948582|10069316|FG000|COMPLETED|Treatment Period 3||7
9006098|NCT02948582|10069317|FG001|COMPLETED|Treatment Period 3||4
9006099|NCT02948582|10069318|FG002|COMPLETED|Treatment Period 3||7
9006100|NCT02948582|10069319|FG003|COMPLETED|Treatment Period 3||6
8890432|NCT02001194|9948115|FG000|COMPLETED|Intervention Period (13 Weeks)|16 teams|67
8890433|NCT02001194|9948116|FG001|COMPLETED|Intervention Period (13 Weeks)|20 teams|80
8890434|NCT02001194|9948117|FG002|COMPLETED|Intervention Period (13 Weeks)|19 teams|74
8890435|NCT02001194|9948118|FG003|COMPLETED|Intervention Period (13 Weeks)|20 teams|78
8890436|NCT02001194|9948115|FG000|NOT COMPLETED|Intervention Period (13 Weeks)||1
8890437|NCT02001194|9948116|FG001|NOT COMPLETED|Intervention Period (13 Weeks)||0
8890438|NCT02001194|9948117|FG002|NOT COMPLETED|Intervention Period (13 Weeks)||2
8890439|NCT02001194|9948118|FG003|NOT COMPLETED|Intervention Period (13 Weeks)||2
8634885|NCT00558792|9675245|FG001|STARTED|Overall Study||63
8634886|NCT00558792|9675246|FG002|STARTED|Overall Study||60
8634887|NCT00558792|9675244|FG000|COMPLETED|Overall Study||68
8890440|NCT02001194|9948115|FG000|STARTED|Follow-Up Period (13 Weeks)||67
8890441|NCT02001194|9948116|FG001|STARTED|Follow-Up Period (13 Weeks)||80
8890442|NCT02001194|9948117|FG002|STARTED|Follow-Up Period (13 Weeks)||74
8890443|NCT02001194|9948118|FG003|STARTED|Follow-Up Period (13 Weeks)||78
8890444|NCT02001194|9948115|FG000|COMPLETED|Follow-Up Period (13 Weeks)||64
8890445|NCT02001194|9948116|FG001|COMPLETED|Follow-Up Period (13 Weeks)||78
8890446|NCT02001194|9948117|FG002|COMPLETED|Follow-Up Period (13 Weeks)||73
8890447|NCT02001194|9948118|FG003|COMPLETED|Follow-Up Period (13 Weeks)||78
8890448|NCT02001194|9948115|FG000|NOT COMPLETED|Follow-Up Period (13 Weeks)||3
8890449|NCT02001194|9948116|FG001|NOT COMPLETED|Follow-Up Period (13 Weeks)||2
8890450|NCT02001194|9948117|FG002|NOT COMPLETED|Follow-Up Period (13 Weeks)||1
8890451|NCT02001194|9948118|FG003|NOT COMPLETED|Follow-Up Period (13 Weeks)||0
8890452|NCT02001558|9948130|FG000|STARTED|Overall Study||32
8890453|NCT02001558|9948131|FG001|STARTED|Overall Study||33
8890454|NCT02001558|9948130|FG000|COMPLETED|Overall Study||24
8890455|NCT02001558|9948131|FG001|COMPLETED|Overall Study||19
8890456|NCT02001558|9948130|FG000|NOT COMPLETED|Overall Study||8
8890457|NCT02001558|9948131|FG001|NOT COMPLETED|Overall Study||14
8890458|NCT02001688|9948140|FG000|STARTED|Overall Study||12
8890459|NCT02001688|9948141|FG001|STARTED|Overall Study||12
8890460|NCT02001688|9948142|FG002|STARTED|Overall Study||12
8890461|NCT02001688|9948140|FG000|COMPLETED|Overall Study||12
8890462|NCT02001688|9948141|FG001|COMPLETED|Overall Study||11
8890463|NCT02001688|9948142|FG002|COMPLETED|Overall Study||11
8634888|NCT00558792|9675245|FG001|COMPLETED|Overall Study||63
8634889|NCT00558792|9675246|FG002|COMPLETED|Overall Study||60
8634890|NCT00558792|9675244|FG000|NOT COMPLETED|Overall Study||0
8634891|NCT00558792|9675245|FG001|NOT COMPLETED|Overall Study||0
8634892|NCT00558792|9675246|FG002|NOT COMPLETED|Overall Study||0
8634893|NCT00558831|9675257|FG000|STARTED|Overall Study||11
8634894|NCT00558831|9675257|FG000|COMPLETED|Overall Study||10
8634895|NCT00558831|9675257|FG000|NOT COMPLETED|Overall Study||1
8890464|NCT02001688|9948140|FG000|NOT COMPLETED|Overall Study||0
8890465|NCT02001688|9948141|FG001|NOT COMPLETED|Overall Study||1
8890466|NCT02001688|9948142|FG002|NOT COMPLETED|Overall Study||1
8890467|NCT02001714|9948153|FG000|STARTED|Overall Study||232
8890468|NCT02001714|9948154|FG001|STARTED|Overall Study||231
8890469|NCT02001714|9948153|FG000|COMPLETED|Overall Study||210
8890470|NCT02001714|9948154|FG001|COMPLETED|Overall Study||219
8890471|NCT02001714|9948153|FG000|NOT COMPLETED|Overall Study||22
8890472|NCT02001714|9948154|FG001|NOT COMPLETED|Overall Study||12
8890473|NCT02001987|9948160|FG000|STARTED|Core Study Period (24 Weeks)||139
8890474|NCT02001987|9948160|FG000|COMPLETED|Core Study Period (24 Weeks)||116
8890475|NCT02001987|9948160|FG000|NOT COMPLETED|Core Study Period (24 Weeks)||23
8890476|NCT02001987|9948160|FG000|STARTED|LTE Period (52 Weeks)||116
8890477|NCT02001987|9948160|FG000|COMPLETED|LTE Period (52 Weeks)||107
8890478|NCT02001987|9948160|FG000|NOT COMPLETED|LTE Period (52 Weeks)||9
8890479|NCT02002091|9948171|FG000|STARTED|Screening||122
8890480|NCT02002091|9948172|FG001|STARTED|Screening||205
8890481|NCT02002091|9948171|FG000|COMPLETED|Screening||109
8890482|NCT02002091|9948172|FG001|COMPLETED|Screening||191
8890483|NCT02002091|9948171|FG000|NOT COMPLETED|Screening||13
8890484|NCT02002091|9948172|FG001|NOT COMPLETED|Screening||14
8890485|NCT02002091|9948171|FG000|STARTED|One Year Follow up||109
8890486|NCT02002091|9948172|FG001|STARTED|One Year Follow up||191
8890487|NCT02002091|9948171|FG000|COMPLETED|One Year Follow up||109
8890488|NCT02002091|9948172|FG001|COMPLETED|One Year Follow up||191
8890489|NCT02002091|9948171|FG000|NOT COMPLETED|One Year Follow up||0
8890490|NCT02002091|9948172|FG001|NOT COMPLETED|One Year Follow up||0
8890491|NCT02002182|9948209|FG000|STARTED|Overall Study||9
8890492|NCT02002182|9948210|FG001|STARTED|Overall Study||6
8890493|NCT02002182|9948209|FG000|COMPLETED|Overall Study||4
8634896|NCT00558844|9675268|FG000|STARTED|Overall Study||15
8634897|NCT00558844|9675269|FG001|STARTED|Overall Study||7
8634898|NCT00558844|9675270|FG002|STARTED|Overall Study||7
8890494|NCT02002182|9948210|FG001|COMPLETED|Overall Study||5
8890495|NCT02002182|9948209|FG000|NOT COMPLETED|Overall Study||5
8890496|NCT02002182|9948210|FG001|NOT COMPLETED|Overall Study||1
8890497|NCT02002208|9948218|FG000|STARTED|Overall Study||69
8890498|NCT02002208|9948219|FG001|STARTED|Overall Study||70
8890499|NCT02002208|9948218|FG000|COMPLETED|Overall Study||32
8890500|NCT02002208|9948219|FG001|COMPLETED|Overall Study||30
8890501|NCT02002208|9948218|FG000|NOT COMPLETED|Overall Study||37
8890502|NCT02002208|9948219|FG001|NOT COMPLETED|Overall Study||40
8890503|NCT02002221|9948227|FG000|STARTED|Overall Study||78
8890504|NCT02002221|9948228|FG001|STARTED|Overall Study||78
8890505|NCT02002221|9948227|FG000|COMPLETED|Overall Study||76
8890506|NCT02002221|9948228|FG001|COMPLETED|Overall Study||75
8890507|NCT02002221|9948227|FG000|NOT COMPLETED|Overall Study||2
8890508|NCT02002221|9948228|FG001|NOT COMPLETED|Overall Study||3
8890509|NCT02002494|9948234|FG000|STARTED|Overall Study||27
8890510|NCT02002494|9948234|FG000|COMPLETED|Overall Study||27
8890511|NCT02002494|9948234|FG000|NOT COMPLETED|Overall Study||0
8890512|NCT02002533|9948251|FG000|STARTED|Overall Study||34
8890513|NCT02002533|9948252|FG001|STARTED|Overall Study||37
8890514|NCT02002533|9948251|FG000|COMPLETED|Overall Study||28
8890515|NCT02002533|9948252|FG001|COMPLETED|Overall Study||19
8890516|NCT02002533|9948251|FG000|NOT COMPLETED|Overall Study||6
8890517|NCT02002533|9948252|FG001|NOT COMPLETED|Overall Study||18
8890518|NCT02002650|9948261|FG000|STARTED|Overall Study||1297
8890519|NCT02002650|9948262|FG001|STARTED|Overall Study||1303
9006101|NCT02948582|10069320|FG004|COMPLETED|Treatment Period 3||7
9006102|NCT02948582|10069321|FG005|COMPLETED|Treatment Period 3||6
9006103|NCT02948582|10069316|FG000|NOT COMPLETED|Treatment Period 3||0
9006104|NCT02948582|10069317|FG001|NOT COMPLETED|Treatment Period 3||0
9006105|NCT02948582|10069318|FG002|NOT COMPLETED|Treatment Period 3||0
9006106|NCT02948582|10069319|FG003|NOT COMPLETED|Treatment Period 3||0
9006107|NCT02948582|10069320|FG004|NOT COMPLETED|Treatment Period 3||0
9006108|NCT02948582|10069321|FG005|NOT COMPLETED|Treatment Period 3||0
9006109|NCT02948582|10069316|FG000|STARTED|Washout Period 3||7
9006110|NCT02948582|10069317|FG001|STARTED|Washout Period 3||4
9006111|NCT02948582|10069318|FG002|STARTED|Washout Period 3||7
9006112|NCT02948582|10069319|FG003|STARTED|Washout Period 3||6
9006113|NCT02948582|10069320|FG004|STARTED|Washout Period 3||7
9006114|NCT02948582|10069321|FG005|STARTED|Washout Period 3||6
9006115|NCT02948582|10069316|FG000|COMPLETED|Washout Period 3||7
9006116|NCT02948582|10069317|FG001|COMPLETED|Washout Period 3||4
9006117|NCT02948582|10069318|FG002|COMPLETED|Washout Period 3||7
9006118|NCT02948582|10069319|FG003|COMPLETED|Washout Period 3||6
9006119|NCT02948582|10069320|FG004|COMPLETED|Washout Period 3||7
9006120|NCT02948582|10069321|FG005|COMPLETED|Washout Period 3||6
9006121|NCT02948582|10069316|FG000|NOT COMPLETED|Washout Period 3||0
9006122|NCT02948582|10069317|FG001|NOT COMPLETED|Washout Period 3||0
9006123|NCT02948582|10069318|FG002|NOT COMPLETED|Washout Period 3||0
9006124|NCT02948582|10069319|FG003|NOT COMPLETED|Washout Period 3||0
9006125|NCT02948582|10069320|FG004|NOT COMPLETED|Washout Period 3||0
9006126|NCT02948582|10069321|FG005|NOT COMPLETED|Washout Period 3||0
9006127|NCT02948582|10069316|FG000|STARTED|Treatment Period 4||7
9006128|NCT02948582|10069317|FG001|STARTED|Treatment Period 4||4
9006129|NCT02948582|10069318|FG002|STARTED|Treatment Period 4||7
9006130|NCT02948582|10069319|FG003|STARTED|Treatment Period 4||6
9006131|NCT02948582|10069320|FG004|STARTED|Treatment Period 4||7
9006132|NCT02948582|10069321|FG005|STARTED|Treatment Period 4||6
9006133|NCT02948582|10069316|FG000|COMPLETED|Treatment Period 4||7
9006134|NCT02948582|10069317|FG001|COMPLETED|Treatment Period 4||4
9006135|NCT02948582|10069318|FG002|COMPLETED|Treatment Period 4||7
9006136|NCT02948582|10069319|FG003|COMPLETED|Treatment Period 4||6
9006137|NCT02948582|10069320|FG004|COMPLETED|Treatment Period 4||7
9006138|NCT02948582|10069321|FG005|COMPLETED|Treatment Period 4||6
9006139|NCT02948582|10069316|FG000|NOT COMPLETED|Treatment Period 4||0
9006140|NCT02948582|10069317|FG001|NOT COMPLETED|Treatment Period 4||0
9006141|NCT02948582|10069318|FG002|NOT COMPLETED|Treatment Period 4||0
9006142|NCT02948582|10069319|FG003|NOT COMPLETED|Treatment Period 4||0
9006143|NCT02948582|10069320|FG004|NOT COMPLETED|Treatment Period 4||0
9006144|NCT02948582|10069321|FG005|NOT COMPLETED|Treatment Period 4||0
9006145|NCT02948582|10069316|FG000|STARTED|Washout Period 4||7
9006146|NCT02948582|10069317|FG001|STARTED|Washout Period 4||4
9006147|NCT02948582|10069318|FG002|STARTED|Washout Period 4||7
9006148|NCT02948582|10069319|FG003|STARTED|Washout Period 4||6
9006149|NCT02948582|10069320|FG004|STARTED|Washout Period 4||7
9006150|NCT02948582|10069321|FG005|STARTED|Washout Period 4||6
9006151|NCT02948582|10069316|FG000|COMPLETED|Washout Period 4||6
9006152|NCT02948582|10069317|FG001|COMPLETED|Washout Period 4||4
9006153|NCT02948582|10069318|FG002|COMPLETED|Washout Period 4||6
9006154|NCT02948582|10069319|FG003|COMPLETED|Washout Period 4||6
9006155|NCT02948582|10069320|FG004|COMPLETED|Washout Period 4||7
9006156|NCT02948582|10069321|FG005|COMPLETED|Washout Period 4||6
9006157|NCT02948582|10069316|FG000|NOT COMPLETED|Washout Period 4||1
9006158|NCT02948582|10069317|FG001|NOT COMPLETED|Washout Period 4||0
9006159|NCT02948582|10069318|FG002|NOT COMPLETED|Washout Period 4||1
9006160|NCT02948582|10069319|FG003|NOT COMPLETED|Washout Period 4||0
9006161|NCT02948582|10069320|FG004|NOT COMPLETED|Washout Period 4||0
8726134|NCT01033864|9773276|FG000|NOT COMPLETED|Overall Study||0
8890520|NCT02002650|9948261|FG000|COMPLETED|Overall Study||1297
8890521|NCT02002650|9948262|FG001|COMPLETED|Overall Study||1303
8890522|NCT02002650|9948261|FG000|NOT COMPLETED|Overall Study||0
9006162|NCT02948582|10069321|FG005|NOT COMPLETED|Washout Period 4||0
9006163|NCT02948582|10069316|FG000|STARTED|Treatment Period 5||6
9006164|NCT02948582|10069317|FG001|STARTED|Treatment Period 5||4
9006165|NCT02948582|10069318|FG002|STARTED|Treatment Period 5||6
9006166|NCT02948582|10069319|FG003|STARTED|Treatment Period 5||6
9006167|NCT02948582|10069320|FG004|STARTED|Treatment Period 5||7
9006168|NCT02948582|10069321|FG005|STARTED|Treatment Period 5||6
9006169|NCT02948582|10069316|FG000|COMPLETED|Treatment Period 5||6
9006170|NCT02948582|10069317|FG001|COMPLETED|Treatment Period 5||4
9006171|NCT02948582|10069318|FG002|COMPLETED|Treatment Period 5||6
9006172|NCT02948582|10069319|FG003|COMPLETED|Treatment Period 5||6
9006173|NCT02948582|10069320|FG004|COMPLETED|Treatment Period 5||7
9006174|NCT02948582|10069321|FG005|COMPLETED|Treatment Period 5||6
8890523|NCT02002650|9948262|FG001|NOT COMPLETED|Overall Study||0
8890524|NCT02002689|9948269|FG000|STARTED|Overall Study||10
9006175|NCT02948582|10069316|FG000|NOT COMPLETED|Treatment Period 5||0
9006176|NCT02948582|10069317|FG001|NOT COMPLETED|Treatment Period 5||0
9006177|NCT02948582|10069318|FG002|NOT COMPLETED|Treatment Period 5||0
9006178|NCT02948582|10069319|FG003|NOT COMPLETED|Treatment Period 5||0
9006179|NCT02948582|10069320|FG004|NOT COMPLETED|Treatment Period 5||0
9006180|NCT02948582|10069321|FG005|NOT COMPLETED|Treatment Period 5||0
9006181|NCT02948582|10069316|FG000|STARTED|Washout Period 5||6
9006182|NCT02948582|10069317|FG001|STARTED|Washout Period 5||4
9006183|NCT02948582|10069318|FG002|STARTED|Washout Period 5||6
9006184|NCT02948582|10069319|FG003|STARTED|Washout Period 5||6
9006185|NCT02948582|10069320|FG004|STARTED|Washout Period 5||7
9006186|NCT02948582|10069321|FG005|STARTED|Washout Period 5||6
9006187|NCT02948582|10069316|FG000|COMPLETED|Washout Period 5||6
9006188|NCT02948582|10069317|FG001|COMPLETED|Washout Period 5||4
9006189|NCT02948582|10069318|FG002|COMPLETED|Washout Period 5||6
9006190|NCT02948582|10069319|FG003|COMPLETED|Washout Period 5||6
9006191|NCT02948582|10069320|FG004|COMPLETED|Washout Period 5||7
9006192|NCT02948582|10069321|FG005|COMPLETED|Washout Period 5||6
9006193|NCT02948582|10069316|FG000|NOT COMPLETED|Washout Period 5||0
9006194|NCT02948582|10069317|FG001|NOT COMPLETED|Washout Period 5||0
9006195|NCT02948582|10069318|FG002|NOT COMPLETED|Washout Period 5||0
9006196|NCT02948582|10069319|FG003|NOT COMPLETED|Washout Period 5||0
9006197|NCT02948582|10069320|FG004|NOT COMPLETED|Washout Period 5||0
9006198|NCT02948582|10069321|FG005|NOT COMPLETED|Washout Period 5||0
9006199|NCT02948582|10069316|FG000|STARTED|Treatment Period 6||6
9006200|NCT02948582|10069317|FG001|STARTED|Treatment Period 6||4
9006201|NCT02948582|10069318|FG002|STARTED|Treatment Period 6||6
9006202|NCT02948582|10069319|FG003|STARTED|Treatment Period 6||6
9006203|NCT02948582|10069320|FG004|STARTED|Treatment Period 6||7
9006204|NCT02948582|10069321|FG005|STARTED|Treatment Period 6||6
9006205|NCT02948582|10069316|FG000|COMPLETED|Treatment Period 6||6
9006206|NCT02948582|10069317|FG001|COMPLETED|Treatment Period 6||4
9006207|NCT02948582|10069318|FG002|COMPLETED|Treatment Period 6||6
9006208|NCT02948582|10069319|FG003|COMPLETED|Treatment Period 6||6
9006209|NCT02948582|10069320|FG004|COMPLETED|Treatment Period 6||7
9006210|NCT02948582|10069321|FG005|COMPLETED|Treatment Period 6||6
8634899|NCT00558844|9675271|FG003|STARTED|Overall Study||5
8634900|NCT00558844|9675272|FG004|STARTED|Overall Study||7
8634901|NCT00558844|9675268|FG000|COMPLETED|Overall Study||12
8890525|NCT02002689|9948269|FG000|COMPLETED|Overall Study||0
9006211|NCT02948582|10069316|FG000|NOT COMPLETED|Treatment Period 6||0
9006212|NCT02948582|10069317|FG001|NOT COMPLETED|Treatment Period 6||0
9006213|NCT02948582|10069318|FG002|NOT COMPLETED|Treatment Period 6||0
9006214|NCT02948582|10069319|FG003|NOT COMPLETED|Treatment Period 6||0
9006215|NCT02948582|10069320|FG004|NOT COMPLETED|Treatment Period 6||0
9006216|NCT02948582|10069321|FG005|NOT COMPLETED|Treatment Period 6||0
9006217|NCT02948582|10069316|FG000|STARTED|Wshout Period 6||6
9006218|NCT02948582|10069317|FG001|STARTED|Wshout Period 6||4
9006219|NCT02948582|10069318|FG002|STARTED|Wshout Period 6||6
9006220|NCT02948582|10069319|FG003|STARTED|Wshout Period 6||6
9006221|NCT02948582|10069320|FG004|STARTED|Wshout Period 6||7
9006222|NCT02948582|10069321|FG005|STARTED|Wshout Period 6||6
9006223|NCT02948582|10069316|FG000|COMPLETED|Wshout Period 6||6
9006224|NCT02948582|10069317|FG001|COMPLETED|Wshout Period 6||4
9006225|NCT02948582|10069318|FG002|COMPLETED|Wshout Period 6||6
9006226|NCT02948582|10069319|FG003|COMPLETED|Wshout Period 6||6
9006227|NCT02948582|10069320|FG004|COMPLETED|Wshout Period 6||7
9006228|NCT02948582|10069321|FG005|COMPLETED|Wshout Period 6||6
8634902|NCT00558844|9675269|FG001|COMPLETED|Overall Study||7
8634903|NCT00558844|9675270|FG002|COMPLETED|Overall Study||6
8634904|NCT00558844|9675271|FG003|COMPLETED|Overall Study||5
8634905|NCT00558844|9675272|FG004|COMPLETED|Overall Study||6
8634906|NCT00558844|9675268|FG000|NOT COMPLETED|Overall Study||3
8634907|NCT00558844|9675269|FG001|NOT COMPLETED|Overall Study||0
8634908|NCT00558844|9675270|FG002|NOT COMPLETED|Overall Study||1
8634909|NCT00558844|9675271|FG003|NOT COMPLETED|Overall Study||0
8634910|NCT00558844|9675272|FG004|NOT COMPLETED|Overall Study||1
8890526|NCT02002689|9948269|FG000|NOT COMPLETED|Overall Study||10
8890527|NCT02002702|9948276|FG000|STARTED|Overall Study||16
8890528|NCT02002702|9948277|FG001|STARTED|Overall Study||15
8890529|NCT02002702|9948278|FG002|STARTED|Overall Study||15
8890530|NCT02002702|9948276|FG000|COMPLETED|Overall Study||16
9006229|NCT02948582|10069316|FG000|NOT COMPLETED|Wshout Period 6||0
9006230|NCT02948582|10069317|FG001|NOT COMPLETED|Wshout Period 6||0
9006231|NCT02948582|10069318|FG002|NOT COMPLETED|Wshout Period 6||0
9006232|NCT02948582|10069319|FG003|NOT COMPLETED|Wshout Period 6||0
9006233|NCT02948582|10069320|FG004|NOT COMPLETED|Wshout Period 6||0
9006234|NCT02948582|10069321|FG005|NOT COMPLETED|Wshout Period 6||0
9006235|NCT02948634|10069337|FG000|STARTED|Overall Study||17
9006236|NCT02948634|10069338|FG001|STARTED|Overall Study||11
9006237|NCT02948634|10069337|FG000|COMPLETED|Overall Study||7
9006238|NCT02948634|10069338|FG001|COMPLETED|Overall Study||9
9006239|NCT02948634|10069337|FG000|NOT COMPLETED|Overall Study||10
9006240|NCT02948634|10069338|FG001|NOT COMPLETED|Overall Study||2
8634911|NCT00558896|9675292|FG000|STARTED|Overall Study||60
8634912|NCT00558896|9675293|FG001|STARTED|Overall Study||34
8634913|NCT00558896|9675294|FG002|STARTED|Overall Study||35
8890531|NCT02002702|9948277|FG001|COMPLETED|Overall Study||15
8890532|NCT02002702|9948278|FG002|COMPLETED|Overall Study||15
8890533|NCT02002702|9948276|FG000|NOT COMPLETED|Overall Study||0
8890534|NCT02002702|9948277|FG001|NOT COMPLETED|Overall Study||0
8890535|NCT02002702|9948278|FG002|NOT COMPLETED|Overall Study||0
8890536|NCT02002767|9948288|FG000|STARTED|Overall Study||9
8890537|NCT02002767|9948289|FG001|STARTED|Overall Study||10
8890538|NCT02002767|9948288|FG000|COMPLETED|Overall Study||9
8890539|NCT02002767|9948289|FG001|COMPLETED|Overall Study||10
8890540|NCT02002767|9948288|FG000|NOT COMPLETED|Overall Study||0
8890541|NCT02002767|9948289|FG001|NOT COMPLETED|Overall Study||0
8890542|NCT02002832|9948297|FG000|STARTED|Overall Study||194
8890543|NCT02002832|9948298|FG001|STARTED|Overall Study||194
8890544|NCT02002832|9948297|FG000|COMPLETED|Overall Study||166
8890545|NCT02002832|9948298|FG001|COMPLETED|Overall Study||168
8890546|NCT02002832|9948297|FG000|NOT COMPLETED|Overall Study||28
8890547|NCT02002832|9948298|FG001|NOT COMPLETED|Overall Study||26
8890548|NCT02002871|9948305|FG000|STARTED|Overall Study||21
8890549|NCT02002871|9948305|FG000|COMPLETED|Overall Study||20
8890550|NCT02002871|9948305|FG000|NOT COMPLETED|Overall Study||1
8890551|NCT02002884|9948313|FG000|STARTED|Main Period (MP)||87
8890552|NCT02002884|9948314|FG001|STARTED|Main Period (MP)||88
8890553|NCT02002884|9948315|FG002|STARTED|Main Period (MP)||176
8890554|NCT02002884|9948316|FG003|STARTED|Main Period (MP)||0
8890555|NCT02002884|9948313|FG000|Treated|Main Period (MP)||87
8890556|NCT02002884|9948314|FG001|Treated|Main Period (MP)||87
8890557|NCT02002884|9948315|FG002|Treated|Main Period (MP)||176
8890558|NCT02002884|9948316|FG003|Treated|Main Period (MP)||0
8890559|NCT02002884|9948313|FG000|COMPLETED|Main Period (MP)||81
8890560|NCT02002884|9948314|FG001|COMPLETED|Main Period (MP)||82
8890561|NCT02002884|9948315|FG002|COMPLETED|Main Period (MP)||168
8890562|NCT02002884|9948316|FG003|COMPLETED|Main Period (MP)||0
8890563|NCT02002884|9948313|FG000|NOT COMPLETED|Main Period (MP)||6
8890564|NCT02002884|9948314|FG001|NOT COMPLETED|Main Period (MP)||6
8890565|NCT02002884|9948315|FG002|NOT COMPLETED|Main Period (MP)||8
8890566|NCT02002884|9948316|FG003|NOT COMPLETED|Main Period (MP)||0
8890567|NCT02002884|9948313|FG000|STARTED|Open-Label Extension Period (OLEX)||0
8890568|NCT02002884|9948314|FG001|STARTED|Open-Label Extension Period (OLEX)||0
8890569|NCT02002884|9948315|FG002|STARTED|Open-Label Extension Period (OLEX)||0
8890570|NCT02002884|9948316|FG003|STARTED|Open-Label Extension Period (OLEX)||331
8890571|NCT02002884|9948313|FG000|COMPLETED|Open-Label Extension Period (OLEX)||0
8890572|NCT02002884|9948314|FG001|COMPLETED|Open-Label Extension Period (OLEX)||0
8890573|NCT02002884|9948315|FG002|COMPLETED|Open-Label Extension Period (OLEX)||0
8890574|NCT02002884|9948316|FG003|COMPLETED|Open-Label Extension Period (OLEX)||281
8890575|NCT02002884|9948313|FG000|NOT COMPLETED|Open-Label Extension Period (OLEX)||0
8890576|NCT02002884|9948314|FG001|NOT COMPLETED|Open-Label Extension Period (OLEX)||0
8890577|NCT02002884|9948315|FG002|NOT COMPLETED|Open-Label Extension Period (OLEX)||0
8890578|NCT02002884|9948316|FG003|NOT COMPLETED|Open-Label Extension Period (OLEX)||50
8890579|NCT02002936|9948326|FG000|STARTED|Overall Study||1
8890580|NCT02002936|9948326|FG000|COMPLETED|Overall Study||1
8890581|NCT02002936|9948326|FG000|NOT COMPLETED|Overall Study||0
8890582|NCT02002975|9948330|FG000|STARTED|Overall Study||18223
8890583|NCT02002975|9948330|FG000|COMPLETED|Overall Study||17651
8890584|NCT02002975|9948330|FG000|NOT COMPLETED|Overall Study||572
8890585|NCT02003014|9948334|FG000|STARTED|Overall Study||899
8890586|NCT02003014|9948334|FG000|COMPLETED|Overall Study||880
8890587|NCT02003014|9948334|FG000|NOT COMPLETED|Overall Study||19
8890588|NCT02003053|9948340|FG000|STARTED|Overall Study||4
8890589|NCT02003053|9948341|FG001|STARTED|Overall Study||3
8890590|NCT02003053|9948340|FG000|COMPLETED|Overall Study||4
9006241|NCT02948777|10069344|FG000|STARTED|Overall Study||14
9006242|NCT02948777|10069344|FG000|COMPLETED|Overall Study||13
9006243|NCT02948777|10069344|FG000|NOT COMPLETED|Overall Study||1
9006244|NCT02948829|10069349|FG000|STARTED|Overall Study||200
9006245|NCT02948829|10069349|FG000|COMPLETED|Overall Study||0
9006246|NCT02948829|10069349|FG000|NOT COMPLETED|Overall Study||200
9006247|NCT02949011|10069371|FG000|STARTED|Overall Study||730
9006248|NCT02949011|10069372|FG001|STARTED|Overall Study||729
9006249|NCT02949011|10069373|FG002|STARTED|Overall Study||725
9006250|NCT02949011|10069371|FG000|Received Study Drug|Overall Study||728
8634914|NCT00558896|9675295|FG003|STARTED|Overall Study||35
8634915|NCT00558896|9675296|FG004|STARTED|Overall Study||60
8634916|NCT00558896|9675297|FG005|STARTED|Overall Study||120
8634917|NCT00558896|9675298|FG006|STARTED|Overall Study||33
8634918|NCT00558896|9675292|FG000|COMPLETED|Overall Study||39
8634919|NCT00558896|9675293|FG001|COMPLETED|Overall Study||27
8634920|NCT00558896|9675294|FG002|COMPLETED|Overall Study||30
8634921|NCT00558896|9675295|FG003|COMPLETED|Overall Study||23
8634922|NCT00558896|9675296|FG004|COMPLETED|Overall Study||37
8634923|NCT00558896|9675297|FG005|COMPLETED|Overall Study||68
8890591|NCT02003053|9948341|FG001|COMPLETED|Overall Study||3
8890592|NCT02003053|9948340|FG000|NOT COMPLETED|Overall Study||0
8890593|NCT02003053|9948341|FG001|NOT COMPLETED|Overall Study||0
8890594|NCT02003183|9948349|FG000|STARTED|Overall Study||7
8890595|NCT02003183|9948350|FG001|STARTED|Overall Study||17
8890596|NCT02003183|9948349|FG000|COMPLETED|Overall Study||7
8890597|NCT02003183|9948350|FG001|COMPLETED|Overall Study||15
8890598|NCT02003183|9948349|FG000|NOT COMPLETED|Overall Study||0
8634924|NCT00558896|9675298|FG006|COMPLETED|Overall Study||9
8890599|NCT02003183|9948350|FG001|NOT COMPLETED|Overall Study||2
8890600|NCT02003352|9948356|FG000|STARTED|Overall Study||98
8890601|NCT02003352|9948356|FG000|COMPLETED|Overall Study||98
8890602|NCT02003352|9948356|FG000|NOT COMPLETED|Overall Study||0
8890603|NCT02003365|9948363|FG000|STARTED|Overall Study||10
8890604|NCT02003365|9948364|FG001|STARTED|Overall Study||30
8890605|NCT02003365|9948365|FG002|STARTED|Overall Study||10
8890606|NCT02003365|9948363|FG000|COMPLETED|Overall Study||10
8890607|NCT02003365|9948364|FG001|COMPLETED|Overall Study||30
8890608|NCT02003365|9948365|FG002|COMPLETED|Overall Study||9
8890609|NCT02003365|9948363|FG000|NOT COMPLETED|Overall Study||0
8890610|NCT02003365|9948364|FG001|NOT COMPLETED|Overall Study||0
8890611|NCT02003365|9948365|FG002|NOT COMPLETED|Overall Study||1
8890612|NCT02003391|9948375|FG000|STARTED|Overall Study||81
8890613|NCT02003391|9948376|FG001|STARTED|Overall Study||75
8890614|NCT02003391|9948375|FG000|Safety Population|Overall Study||81
8890615|NCT02003391|9948376|FG001|Safety Population|Overall Study||75
8890616|NCT02003391|9948375|FG000|Intent to Treat Population|Overall Study||78
8890617|NCT02003391|9948376|FG001|Intent to Treat Population|Overall Study||73
8890618|NCT02003391|9948375|FG000|COMPLETED|Overall Study||78
8890619|NCT02003391|9948376|FG001|COMPLETED|Overall Study||73
8890620|NCT02003391|9948375|FG000|NOT COMPLETED|Overall Study||3
8890621|NCT02003391|9948376|FG001|NOT COMPLETED|Overall Study||2
8890622|NCT02003404|9948382|FG000|STARTED|Overall Study||17
8890623|NCT02003404|9948382|FG000|COMPLETED|Overall Study||17
8890624|NCT02003404|9948382|FG000|NOT COMPLETED|Overall Study||0
8890625|NCT02003508|9948390|FG000|STARTED|Overall Study||179
8890626|NCT02003508|9948391|FG001|STARTED|Overall Study||166
8890627|NCT02003508|9948390|FG000|COMPLETED|Overall Study||179
8890628|NCT02003508|9948391|FG001|COMPLETED|Overall Study||166
8890629|NCT02003508|9948390|FG000|NOT COMPLETED|Overall Study||0
8890630|NCT02003508|9948391|FG001|NOT COMPLETED|Overall Study||0
8890631|NCT02003534|9948397|FG000|STARTED|Overall Study||376
8890632|NCT02003534|9948397|FG000|COMPLETED|Overall Study||329
8890633|NCT02003534|9948397|FG000|NOT COMPLETED|Overall Study||47
8890634|NCT02003573|9948404|FG000|STARTED|Overall Study|Started are treated patients|3
8890635|NCT02003573|9948405|FG001|STARTED|Overall Study|Started are treated patients|4
8890636|NCT02003573|9948406|FG002|STARTED|Overall Study|Started are treated patients|6
8890637|NCT02003573|9948404|FG000|COMPLETED|Overall Study||0
8890638|NCT02003573|9948405|FG001|COMPLETED|Overall Study||0
8890639|NCT02003573|9948406|FG002|COMPLETED|Overall Study||0
8890640|NCT02003573|9948404|FG000|NOT COMPLETED|Overall Study||3
8890641|NCT02003573|9948405|FG001|NOT COMPLETED|Overall Study||4
8890642|NCT02003573|9948406|FG002|NOT COMPLETED|Overall Study||6
8890643|NCT02003625|9948418|FG000|STARTED|Overall Study||15
8890644|NCT02003625|9948419|FG001|STARTED|Overall Study||15
8890645|NCT02003625|9948418|FG000|Received Transplant|Overall Study||14
8890646|NCT02003625|9948419|FG001|Received Transplant|Overall Study||12
8890647|NCT02003625|9948418|FG000|COMPLETED|Overall Study||14
8890648|NCT02003625|9948419|FG001|COMPLETED|Overall Study||12
8890649|NCT02003625|9948418|FG000|NOT COMPLETED|Overall Study||1
8890650|NCT02003625|9948419|FG001|NOT COMPLETED|Overall Study||3
9006251|NCT02949011|10069372|FG001|Received Study Drug|Overall Study|Includes one participant who received baloxavir marboxil in error|728
9006252|NCT02949011|10069373|FG002|Received Study Drug|Overall Study|Includes one participant who received baloxavir marboxil in error|722
9006253|NCT02949011|10069371|FG000|Intention to Treat Infected Population|Overall Study||388
9006254|NCT02949011|10069372|FG001|Intention to Treat Infected Population|Overall Study||386
9006255|NCT02949011|10069373|FG002|Intention to Treat Infected Population|Overall Study||389
9006256|NCT02949011|10069371|FG000|COMPLETED|Overall Study||697
9006257|NCT02949011|10069372|FG001|COMPLETED|Overall Study||695
9006258|NCT02949011|10069373|FG002|COMPLETED|Overall Study||683
9006259|NCT02949011|10069371|FG000|NOT COMPLETED|Overall Study||33
9006260|NCT02949011|10069372|FG001|NOT COMPLETED|Overall Study||34
9006261|NCT02949011|10069373|FG002|NOT COMPLETED|Overall Study||42
9006262|NCT02949024|10069383|FG000|STARTED|Overall Study||10
9006263|NCT02949024|10069384|FG001|STARTED|Overall Study||10
9006264|NCT02949024|10069383|FG000|COMPLETED|Overall Study||10
9006265|NCT02949024|10069384|FG001|COMPLETED|Overall Study||9
9006266|NCT02949024|10069383|FG000|NOT COMPLETED|Overall Study||0
9006267|NCT02949024|10069384|FG001|NOT COMPLETED|Overall Study||1
9039520|NCT03339583|10100490|FG000|NOT COMPLETED|Second Intervention (14 Days)||0
9039521|NCT03339583|10100491|FG001|NOT COMPLETED|Second Intervention (14 Days)||2
9039522|NCT03339583|10100490|FG000|STARTED|Follow-up (14 Days)||18
9039523|NCT03339583|10100491|FG001|STARTED|Follow-up (14 Days)||21
9039524|NCT03339583|10100490|FG000|COMPLETED|Follow-up (14 Days)||12
9039525|NCT03339583|10100491|FG001|COMPLETED|Follow-up (14 Days)||18
9039526|NCT03339583|10100490|FG000|NOT COMPLETED|Follow-up (14 Days)||6
9039527|NCT03339583|10100491|FG001|NOT COMPLETED|Follow-up (14 Days)||3
9039528|NCT03339713|10100501|FG000|STARTED|Overall Study||90
9039529|NCT03339713|10100502|FG001|STARTED|Overall Study||90
9039530|NCT03339713|10100501|FG000|COMPLETED|Overall Study||86
9039531|NCT03339713|10100502|FG001|COMPLETED|Overall Study||88
9039532|NCT03339713|10100501|FG000|NOT COMPLETED|Overall Study||4
9039533|NCT03339713|10100502|FG001|NOT COMPLETED|Overall Study||2
9039534|NCT03339726|10100513|FG000|STARTED|Overall Study||64
9039535|NCT03339726|10100514|FG001|STARTED|Overall Study||66
9039536|NCT03339726|10100515|FG002|STARTED|Overall Study||63
9039537|NCT03339726|10100513|FG000|COMPLETED|Overall Study||63
9039538|NCT03339726|10100514|FG001|COMPLETED|Overall Study||65
9039539|NCT03339726|10100515|FG002|COMPLETED|Overall Study||63
9039540|NCT03339726|10100513|FG000|NOT COMPLETED|Overall Study||1
9039541|NCT03339726|10100514|FG001|NOT COMPLETED|Overall Study||1
9039542|NCT03339726|10100515|FG002|NOT COMPLETED|Overall Study||0
9039543|NCT03339999|10100527|FG000|STARTED|Overall Study||7
8890651|NCT02003638|9948427|FG000|STARTED|Overall Study||6
8890652|NCT02003638|9948428|FG001|STARTED|Overall Study||3
8890653|NCT02003638|9948427|FG000|COMPLETED|Overall Study|1 withdrew after developing bacterial pharyngitis. Not considered treatment-emergent.|5
8890654|NCT02003638|9948428|FG001|COMPLETED|Overall Study||3
8890655|NCT02003638|9948427|FG000|NOT COMPLETED|Overall Study||1
8890656|NCT02003638|9948428|FG001|NOT COMPLETED|Overall Study||0
8890657|NCT02003898|9948434|FG000|STARTED|Overall Study||372
8890658|NCT02003898|9948434|FG000|COMPLETED|Overall Study||305
8890659|NCT02003898|9948434|FG000|NOT COMPLETED|Overall Study||67
8890660|NCT02003911|9948440|FG000|STARTED|Overall Study||80
8890661|NCT02003911|9948441|FG001|STARTED|Overall Study||79
8890662|NCT02003911|9948440|FG000|COMPLETED|Overall Study||78
8890663|NCT02003911|9948441|FG001|COMPLETED|Overall Study||72
8890664|NCT02003911|9948440|FG000|NOT COMPLETED|Overall Study||2
8890665|NCT02003911|9948441|FG001|NOT COMPLETED|Overall Study||7
8890666|NCT02003963|9948449|FG000|STARTED|Overall Study||22
8890667|NCT02003963|9948450|FG001|STARTED|Overall Study||19
8890668|NCT02003963|9948449|FG000|COMPLETED|Overall Study|2 participants dropped out: 1 due to lack of interest and 1 due to a mental health hospitalization.|20
8890669|NCT02003963|9948450|FG001|COMPLETED|Overall Study|1 participant was removed from analysis for completing final visit outside of visit window.|18
8890670|NCT02003963|9948449|FG000|NOT COMPLETED|Overall Study||2
8890671|NCT02003963|9948450|FG001|NOT COMPLETED|Overall Study||1
8890672|NCT02004093|9948460|FG000|STARTED|Overall Study|Includes 1 participant who was randomized to chemotherapy group but received pertuzumab+chemotherapy|75
8890673|NCT02004093|9948461|FG001|STARTED|Overall Study||74
8890674|NCT02004093|9948460|FG000|COMPLETED|Overall Study||1
8890675|NCT02004093|9948461|FG001|COMPLETED|Overall Study||1
8890676|NCT02004093|9948460|FG000|NOT COMPLETED|Overall Study||74
8890677|NCT02004093|9948461|FG001|NOT COMPLETED|Overall Study||73
8890678|NCT02004132|9948470|FG000|STARTED|Overall Study||12
8890679|NCT02004132|9948470|FG000|Received Study Drug|Overall Study||12
8890680|NCT02004132|9948470|FG000|COMPLETED|Overall Study||12
8890681|NCT02004132|9948470|FG000|NOT COMPLETED|Overall Study||0
8890682|NCT02004158|9948474|FG000|STARTED|Overall Study||23
8890683|NCT02004158|9948474|FG000|COMPLETED|Overall Study||20
8890684|NCT02004158|9948474|FG000|NOT COMPLETED|Overall Study||3
8890685|NCT02004236|9948483|FG000|STARTED|Overall Study||75
8890686|NCT02004236|9948484|FG001|STARTED|Overall Study||75
8890687|NCT02004236|9948485|FG002|STARTED|Overall Study||75
8890688|NCT02004236|9948483|FG000|COMPLETED|Overall Study||75
8890689|NCT02004236|9948484|FG001|COMPLETED|Overall Study||75
8890690|NCT02004236|9948485|FG002|COMPLETED|Overall Study|Leave the group because the parents does't find any clinical improvement.|59
8890691|NCT02004236|9948483|FG000|NOT COMPLETED|Overall Study||0
8890692|NCT02004236|9948484|FG001|NOT COMPLETED|Overall Study||0
8890693|NCT02004236|9948485|FG002|NOT COMPLETED|Overall Study||16
8890694|NCT02004262|9948500|FG000|STARTED|Overall Study||73
8890695|NCT02004262|9948501|FG001|STARTED|Overall Study||68
8890696|NCT02004262|9948502|FG002|STARTED|Overall Study||72
8890697|NCT02004262|9948503|FG003|STARTED|Overall Study||29
8890698|NCT02004262|9948504|FG004|STARTED|Overall Study||31
8890699|NCT02004262|9948505|FG005|STARTED|Overall Study||30
8890700|NCT02004262|9948500|FG000|Treated|Overall Study||68
8890701|NCT02004262|9948501|FG001|Treated|Overall Study||58
8890702|NCT02004262|9948502|FG002|Treated|Overall Study||43
8890703|NCT02004262|9948503|FG003|Treated|Overall Study||26
8890704|NCT02004262|9948504|FG004|Treated|Overall Study||29
8890705|NCT02004262|9948505|FG005|Treated|Overall Study||11
8890706|NCT02004262|9948500|FG000|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
8890707|NCT02004262|9948501|FG001|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
8890708|NCT02004262|9948502|FG002|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
8890709|NCT02004262|9948503|FG003|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
8890710|NCT02004262|9948504|FG004|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
8890711|NCT02004262|9948505|FG005|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
8890712|NCT02004262|9948500|FG000|NOT COMPLETED|Overall Study||73
8890713|NCT02004262|9948501|FG001|NOT COMPLETED|Overall Study||68
8890714|NCT02004262|9948502|FG002|NOT COMPLETED|Overall Study||72
8890715|NCT02004262|9948503|FG003|NOT COMPLETED|Overall Study||29
8890716|NCT02004262|9948504|FG004|NOT COMPLETED|Overall Study||31
8890717|NCT02004262|9948505|FG005|NOT COMPLETED|Overall Study||30
8890718|NCT02004288|9948521|FG000|STARTED|Overall Study||15
8890719|NCT02004288|9948522|FG001|STARTED|Overall Study||16
8890720|NCT02004288|9948521|FG000|COMPLETED|Overall Study||14
8890721|NCT02004288|9948522|FG001|COMPLETED|Overall Study||15
8890722|NCT02004288|9948521|FG000|NOT COMPLETED|Overall Study||1
8890723|NCT02004288|9948522|FG001|NOT COMPLETED|Overall Study||1
8890724|NCT02004353|9948528|FG000|STARTED|Overall Study||1518
8890725|NCT02004353|9948528|FG000|COMPLETED|Overall Study||184
8890726|NCT02004353|9948528|FG000|NOT COMPLETED|Overall Study||1334
8890727|NCT02004366|9948537|FG000|STARTED|In-hospital||128
8890728|NCT02004366|9948538|FG001|STARTED|In-hospital||122
8890729|NCT02004366|9948539|FG002|STARTED|In-hospital||0
8890730|NCT02004366|9948540|FG003|STARTED|In-hospital||0
8890731|NCT02004366|9948541|FG004|STARTED|In-hospital||0
8890732|NCT02004366|9948537|FG000|COMPLETED|In-hospital||128
8890733|NCT02004366|9948538|FG001|COMPLETED|In-hospital||122
8890734|NCT02004366|9948539|FG002|COMPLETED|In-hospital||0
8890735|NCT02004366|9948540|FG003|COMPLETED|In-hospital||0
8890736|NCT02004366|9948541|FG004|COMPLETED|In-hospital||0
8890737|NCT02004366|9948537|FG000|NOT COMPLETED|In-hospital||0
8890738|NCT02004366|9948538|FG001|NOT COMPLETED|In-hospital||0
8890739|NCT02004366|9948539|FG002|NOT COMPLETED|In-hospital||0
8890740|NCT02004366|9948540|FG003|NOT COMPLETED|In-hospital||0
8890741|NCT02004366|9948541|FG004|NOT COMPLETED|In-hospital||0
8890742|NCT02004366|9948537|FG000|STARTED|On Discharge||0
8890743|NCT02004366|9948538|FG001|STARTED|On Discharge||0
8890744|NCT02004366|9948539|FG002|STARTED|On Discharge||92
8890745|NCT02004366|9948540|FG003|STARTED|On Discharge||93
8890746|NCT02004366|9948541|FG004|STARTED|On Discharge||39
8890747|NCT02004366|9948537|FG000|COMPLETED|On Discharge||0
8890748|NCT02004366|9948538|FG001|COMPLETED|On Discharge||0
8890749|NCT02004366|9948539|FG002|COMPLETED|On Discharge||92
8890750|NCT02004366|9948540|FG003|COMPLETED|On Discharge||93
8890751|NCT02004366|9948541|FG004|COMPLETED|On Discharge||39
8890752|NCT02004366|9948537|FG000|NOT COMPLETED|On Discharge||0
8890753|NCT02004366|9948538|FG001|NOT COMPLETED|On Discharge||0
8890754|NCT02004366|9948539|FG002|NOT COMPLETED|On Discharge||0
8890755|NCT02004366|9948540|FG003|NOT COMPLETED|On Discharge||0
8890756|NCT02004366|9948541|FG004|NOT COMPLETED|On Discharge||0
8890757|NCT02004613|9948556|FG000|STARTED|Overall Study||400
8890758|NCT02004613|9948557|FG001|STARTED|Overall Study||398
8890759|NCT02004613|9948556|FG000|COMPLETED|Overall Study||398
8890760|NCT02004613|9948557|FG001|COMPLETED|Overall Study||396
8890761|NCT02004613|9948556|FG000|NOT COMPLETED|Overall Study||2
8890762|NCT02004613|9948557|FG001|NOT COMPLETED|Overall Study||2
8890763|NCT02004847|9948565|FG000|STARTED|Overall Study||24
8890764|NCT02004847|9948566|FG001|STARTED|Overall Study||23
8890765|NCT02004847|9948565|FG000|COMPLETED|Overall Study||23
8634925|NCT00558896|9675292|FG000|NOT COMPLETED|Overall Study||21
8634926|NCT00558896|9675293|FG001|NOT COMPLETED|Overall Study||7
8634927|NCT00558896|9675294|FG002|NOT COMPLETED|Overall Study||5
8634928|NCT00558896|9675295|FG003|NOT COMPLETED|Overall Study||12
8890766|NCT02004847|9948566|FG001|COMPLETED|Overall Study||22
8890767|NCT02004847|9948565|FG000|NOT COMPLETED|Overall Study||1
8890768|NCT02004847|9948566|FG001|NOT COMPLETED|Overall Study||1
8890769|NCT02004873|9948581|FG000|STARTED|Overall Study|Micra Implant Attempt|725
8890770|NCT02004873|9948581|FG000|Micra Implant Success|Overall Study||719
8890771|NCT02004873|9948581|FG000|COMPLETED|Overall Study|6-Month Follow-up|301
8890772|NCT02004873|9948581|FG000|NOT COMPLETED|Overall Study||424
8890773|NCT02004886|9948592|FG000|STARTED|Overall Study||19
8890774|NCT02004886|9948593|FG001|STARTED|Overall Study||18
8890775|NCT02004886|9948594|FG002|STARTED|Overall Study||18
8890776|NCT02004886|9948595|FG003|STARTED|Overall Study||19
8890777|NCT02004886|9948592|FG000|COMPLETED|Overall Study||18
9006268|NCT02949141|10069392|FG000|STARTED|Overall Study||62
9006269|NCT02949141|10069392|FG000|COMPLETED|Overall Study||62
9006270|NCT02949141|10069392|FG000|NOT COMPLETED|Overall Study||0
9006271|NCT02949271|10069401|FG000|STARTED|Overall Study||90
9006272|NCT02949271|10069402|FG001|STARTED|Overall Study||89
9006273|NCT02949271|10069401|FG000|COMPLETED|Overall Study||61
9006274|NCT02949271|10069402|FG001|COMPLETED|Overall Study||59
8634929|NCT00558896|9675296|FG004|NOT COMPLETED|Overall Study||23
8890778|NCT02004886|9948593|FG001|COMPLETED|Overall Study||17
8890779|NCT02004886|9948594|FG002|COMPLETED|Overall Study||18
8890780|NCT02004886|9948595|FG003|COMPLETED|Overall Study||19
8890781|NCT02004886|9948592|FG000|NOT COMPLETED|Overall Study||1
8890782|NCT02004886|9948593|FG001|NOT COMPLETED|Overall Study||1
8890783|NCT02004886|9948594|FG002|NOT COMPLETED|Overall Study||0
8890784|NCT02004886|9948595|FG003|NOT COMPLETED|Overall Study||0
8634930|NCT00558896|9675297|FG005|NOT COMPLETED|Overall Study||52
8634931|NCT00558896|9675298|FG006|NOT COMPLETED|Overall Study||24
8634932|NCT00559013|9675314|FG000|STARTED|Overall Study||38
8890785|NCT02004977|9948607|FG000|STARTED|Overall Study||463
8890786|NCT02004977|9948608|FG001|STARTED|Overall Study||441
8890787|NCT02004977|9948607|FG000|COMPLETED|Overall Study||409
8890788|NCT02004977|9948608|FG001|COMPLETED|Overall Study||436
8890789|NCT02004977|9948607|FG000|NOT COMPLETED|Overall Study||54
8890790|NCT02004977|9948608|FG001|NOT COMPLETED|Overall Study||5
8890791|NCT02004990|9948614|FG000|STARTED|Overall Study||12
8890792|NCT02004990|9948614|FG000|COMPLETED|Overall Study||12
8890793|NCT02004990|9948614|FG000|NOT COMPLETED|Overall Study||0
9006275|NCT02949271|10069401|FG000|NOT COMPLETED|Overall Study||29
8634933|NCT00559013|9675314|FG000|COMPLETED|Overall Study||38
8890794|NCT02005016|9948618|FG000|STARTED|Overall Study||46
8890795|NCT02005016|9948618|FG000|COMPLETED|Overall Study||44
8890796|NCT02005016|9948618|FG000|NOT COMPLETED|Overall Study||2
8890797|NCT02005029|9948624|FG000|STARTED|First Intervention (1 Day)||5
8890798|NCT02005029|9948625|FG001|STARTED|First Intervention (1 Day)||5
8890799|NCT02005029|9948624|FG000|COMPLETED|First Intervention (1 Day)||4
8890800|NCT02005029|9948625|FG001|COMPLETED|First Intervention (1 Day)||5
8890801|NCT02005029|9948624|FG000|NOT COMPLETED|First Intervention (1 Day)||1
8890802|NCT02005029|9948625|FG001|NOT COMPLETED|First Intervention (1 Day)||0
8890803|NCT02005029|9948624|FG000|STARTED|Washout (2 Weeks)||4
8890804|NCT02005029|9948625|FG001|STARTED|Washout (2 Weeks)||5
8890805|NCT02005029|9948624|FG000|COMPLETED|Washout (2 Weeks)||4
8890806|NCT02005029|9948625|FG001|COMPLETED|Washout (2 Weeks)||5
8890807|NCT02005029|9948624|FG000|NOT COMPLETED|Washout (2 Weeks)||0
8890808|NCT02005029|9948625|FG001|NOT COMPLETED|Washout (2 Weeks)||0
8890809|NCT02005029|9948624|FG000|STARTED|Second Intervention (1 Day)||4
8890810|NCT02005029|9948625|FG001|STARTED|Second Intervention (1 Day)||5
8890811|NCT02005029|9948624|FG000|COMPLETED|Second Intervention (1 Day)||4
8890812|NCT02005029|9948625|FG001|COMPLETED|Second Intervention (1 Day)||5
8890813|NCT02005029|9948624|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
8890814|NCT02005029|9948625|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
8890815|NCT02005211|9948656|FG000|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
8890816|NCT02005211|9948657|FG001|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
8890817|NCT02005211|9948658|FG002|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
8890818|NCT02005211|9948659|FG003|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
8890819|NCT02005211|9948660|FG004|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||0
8890820|NCT02005211|9948661|FG005|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||0
8890821|NCT02005211|9948662|FG006|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||0
8890822|NCT02005211|9948656|FG000|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
8890823|NCT02005211|9948657|FG001|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
8890824|NCT02005211|9948658|FG002|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
8890825|NCT02005211|9948659|FG003|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
8890826|NCT02005211|9948660|FG004|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
8890827|NCT02005211|9948661|FG005|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
8890828|NCT02005211|9948662|FG006|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
8890829|NCT02005211|9948656|FG000|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
8890830|NCT02005211|9948657|FG001|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
8890831|NCT02005211|9948658|FG002|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
8890832|NCT02005211|9948659|FG003|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
8890833|NCT02005211|9948660|FG004|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
8890834|NCT02005211|9948661|FG005|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
8890835|NCT02005211|9948662|FG006|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
8890836|NCT02005211|9948656|FG000|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
8890837|NCT02005211|9948657|FG001|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
8890838|NCT02005211|9948658|FG002|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
8890839|NCT02005211|9948659|FG003|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
8890840|NCT02005211|9948660|FG004|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||6
8890841|NCT02005211|9948661|FG005|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||6
8890842|NCT02005211|9948662|FG006|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||4
8890843|NCT02005211|9948656|FG000|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
8890844|NCT02005211|9948657|FG001|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
8890845|NCT02005211|9948658|FG002|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
8890846|NCT02005211|9948659|FG003|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
8890847|NCT02005211|9948660|FG004|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||5
8890848|NCT02005211|9948661|FG005|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||6
8890849|NCT02005211|9948662|FG006|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||4
8890850|NCT02005211|9948656|FG000|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
8890851|NCT02005211|9948657|FG001|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
8890852|NCT02005211|9948658|FG002|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
8890853|NCT02005211|9948659|FG003|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
8890854|NCT02005211|9948660|FG004|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||1
8890855|NCT02005211|9948661|FG005|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
8890856|NCT02005211|9948662|FG006|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
8890857|NCT02005250|9948687|FG000|STARTED|Overall Study||61
8890858|NCT02005250|9948688|FG001|STARTED|Overall Study||32
8890859|NCT02005250|9948687|FG000|COMPLETED|Overall Study||46
8890860|NCT02005250|9948688|FG001|COMPLETED|Overall Study||27
8890861|NCT02005250|9948687|FG000|NOT COMPLETED|Overall Study||15
8890862|NCT02005250|9948688|FG001|NOT COMPLETED|Overall Study||5
8890863|NCT02005276|9948698|FG000|STARTED|Overall Study||65
8890864|NCT02005276|9948699|FG001|STARTED|Overall Study||41
8890865|NCT02005276|9948700|FG002|STARTED|Overall Study||59
8890866|NCT02005276|9948701|FG003|STARTED|Overall Study||44
8890867|NCT02005276|9948698|FG000|Completed Intervention|Overall Study||61
8890868|NCT02005276|9948699|FG001|Completed Intervention|Overall Study||39
8890869|NCT02005276|9948700|FG002|Completed Intervention|Overall Study||56
8890870|NCT02005276|9948701|FG003|Completed Intervention|Overall Study||42
8890871|NCT02005276|9948698|FG000|COMPLETED|Overall Study||60
8634934|NCT00559013|9675314|FG000|NOT COMPLETED|Overall Study||0
8634935|NCT00559104|9675320|FG000|STARTED|Overall Study||55
8634936|NCT00559104|9675321|FG001|STARTED|Overall Study||5
8634937|NCT00559104|9675320|FG000|COMPLETED|Overall Study|Progression was the reason for off-treatment for 9 of 9 patients who went off of treatment.|46
8634938|NCT00559104|9675321|FG001|COMPLETED|Overall Study||5
8890872|NCT02005276|9948699|FG001|COMPLETED|Overall Study||39
8890873|NCT02005276|9948700|FG002|COMPLETED|Overall Study||56
8890874|NCT02005276|9948701|FG003|COMPLETED|Overall Study||41
8890875|NCT02005276|9948698|FG000|NOT COMPLETED|Overall Study||5
9006276|NCT02949271|10069402|FG001|NOT COMPLETED|Overall Study||30
8890876|NCT02005276|9948699|FG001|NOT COMPLETED|Overall Study||2
8890877|NCT02005276|9948700|FG002|NOT COMPLETED|Overall Study||3
8890878|NCT02005276|9948701|FG003|NOT COMPLETED|Overall Study||3
8890879|NCT02005354|9948715|FG000|STARTED|Overall Study||35
8890880|NCT02005354|9948716|FG001|STARTED|Overall Study||35
8890881|NCT02005354|9948715|FG000|COMPLETED|Overall Study||35
8890882|NCT02005354|9948716|FG001|COMPLETED|Overall Study||35
8890883|NCT02005354|9948715|FG000|NOT COMPLETED|Overall Study||0
8890884|NCT02005354|9948716|FG001|NOT COMPLETED|Overall Study||0
8890885|NCT02005393|9948722|FG000|STARTED|Overall Study||20
8890886|NCT02005393|9948722|FG000|COMPLETED|Overall Study||20
8890887|NCT02005393|9948722|FG000|NOT COMPLETED|Overall Study||0
8890888|NCT02005484|9948726|FG000|STARTED|Overall Study||6
8890889|NCT02005484|9948726|FG000|COMPLETED|Overall Study||2
8890890|NCT02005484|9948726|FG000|NOT COMPLETED|Overall Study||4
8890891|NCT02005510|9948732|FG000|STARTED|Randomized (Round 1)|Excludes 163 determined to be ineligible post-randomization due to delays in data warehouse update.|8120
8890892|NCT02005510|9948733|FG001|STARTED|Randomized (Round 1)|Excludes 196 determined to be ineligible post-randomization due to delays in data warehouse update.|8111
8890893|NCT02005510|9948732|FG000|COMPLETED|Randomized (Round 1)||8120
8890894|NCT02005510|9948733|FG001|COMPLETED|Randomized (Round 1)||8111
8890895|NCT02005510|9948732|FG000|NOT COMPLETED|Randomized (Round 1)||0
8890896|NCT02005510|9948733|FG001|NOT COMPLETED|Randomized (Round 1)||0
8890897|NCT02005510|9948732|FG000|STARTED|Rerandomized (Round 2)|Excludes 10 determined to be ineligible post-randomization due to delays in data warehouse update.|1631
8890898|NCT02005510|9948733|FG001|STARTED|Rerandomized (Round 2)|Excludes 5 determined to be ineligible post-randomization due to delays in data warehouse update.|1585
8890899|NCT02005510|9948732|FG000|COMPLETED|Rerandomized (Round 2)||1631
8890900|NCT02005510|9948733|FG001|COMPLETED|Rerandomized (Round 2)||1585
8890901|NCT02005510|9948732|FG000|NOT COMPLETED|Rerandomized (Round 2)||0
8890902|NCT02005510|9948733|FG001|NOT COMPLETED|Rerandomized (Round 2)||0
8890903|NCT02005510|9948732|FG000|STARTED|Rerandomized (Round 3)|Excludes 5 determined to be ineligible post-randomization due to delays in data warehouse update.|209
8890904|NCT02005510|9948733|FG001|STARTED|Rerandomized (Round 3)||195
8890905|NCT02005510|9948732|FG000|COMPLETED|Rerandomized (Round 3)||209
8890906|NCT02005510|9948733|FG001|COMPLETED|Rerandomized (Round 3)||195
8890907|NCT02005510|9948732|FG000|NOT COMPLETED|Rerandomized (Round 3)||0
8890908|NCT02005510|9948733|FG001|NOT COMPLETED|Rerandomized (Round 3)||0
8890909|NCT02005536|9948739|FG000|STARTED|Overall Study||60
9006277|NCT02949362|10069410|FG000|STARTED|Retrospective Period||24
9006278|NCT02949362|10069411|FG001|STARTED|Retrospective Period||5
9006279|NCT02949362|10069412|FG002|STARTED|Retrospective Period||0
9006280|NCT02949362|10069413|FG003|STARTED|Retrospective Period||0
9006281|NCT02949362|10069410|FG000|COMPLETED|Retrospective Period||20
9006282|NCT02949362|10069411|FG001|COMPLETED|Retrospective Period||4
9006283|NCT02949362|10069412|FG002|COMPLETED|Retrospective Period||0
9006284|NCT02949362|10069413|FG003|COMPLETED|Retrospective Period||0
9006285|NCT02949362|10069410|FG000|NOT COMPLETED|Retrospective Period||4
9006286|NCT02949362|10069411|FG001|NOT COMPLETED|Retrospective Period||1
9006287|NCT02949362|10069412|FG002|NOT COMPLETED|Retrospective Period||0
9006288|NCT02949362|10069413|FG003|NOT COMPLETED|Retrospective Period||0
9006289|NCT02949362|10069410|FG000|STARTED|Prospective Period||0
9006290|NCT02949362|10069411|FG001|STARTED|Prospective Period||0
9006291|NCT02949362|10069412|FG002|STARTED|Prospective Period|Participants were enrolled from retrospective period.|5
9006292|NCT02949362|10069413|FG003|STARTED|Prospective Period|Participants were enrolled from retrospective period.|19
9006293|NCT02949362|10069410|FG000|COMPLETED|Prospective Period||0
9006294|NCT02949362|10069411|FG001|COMPLETED|Prospective Period||0
9006295|NCT02949362|10069412|FG002|COMPLETED|Prospective Period||4
9006296|NCT02949362|10069413|FG003|COMPLETED|Prospective Period||15
9006297|NCT02949362|10069410|FG000|NOT COMPLETED|Prospective Period||0
9006298|NCT02949362|10069411|FG001|NOT COMPLETED|Prospective Period||0
9006299|NCT02949362|10069412|FG002|NOT COMPLETED|Prospective Period||1
9006300|NCT02949362|10069413|FG003|NOT COMPLETED|Prospective Period||4
9006301|NCT02949518|10069427|FG000|STARTED|Overall Study||28
8890910|NCT02005536|9948739|FG000|COMPLETED|Overall Study||60
8890911|NCT02005536|9948739|FG000|NOT COMPLETED|Overall Study||0
8890912|NCT02005549|9948743|FG000|STARTED|Overall Study||18
8890913|NCT02005549|9948743|FG000|COMPLETED|Overall Study||18
8890914|NCT02005549|9948743|FG000|NOT COMPLETED|Overall Study||0
8890915|NCT02005562|9948749|FG000|STARTED|Overall Study||127
8890916|NCT02005562|9948750|FG001|STARTED|Overall Study||125
8890917|NCT02005562|9948749|FG000|Transplanted|Overall Study||126
8890918|NCT02005562|9948750|FG001|Transplanted|Overall Study||121
8890919|NCT02005562|9948749|FG000|COMPLETED|Overall Study||115
8890920|NCT02005562|9948750|FG001|COMPLETED|Overall Study||110
8890921|NCT02005562|9948749|FG000|NOT COMPLETED|Overall Study||12
8890922|NCT02005562|9948750|FG001|NOT COMPLETED|Overall Study||15
8890923|NCT02005601|9948758|FG000|STARTED|Overall Study||53
8890924|NCT02005601|9948759|FG001|STARTED|Overall Study||53
8890925|NCT02005601|9948758|FG000|COMPLETED|Overall Study||53
8890926|NCT02005601|9948759|FG001|COMPLETED|Overall Study||53
8890927|NCT02005601|9948758|FG000|NOT COMPLETED|Overall Study||0
8890928|NCT02005601|9948759|FG001|NOT COMPLETED|Overall Study||0
8890929|NCT02005627|9948767|FG000|STARTED|Overall Study||23
8890930|NCT02005627|9948768|FG001|STARTED|Overall Study||23
8890931|NCT02005627|9948767|FG000|COMPLETED|Overall Study||21
8890932|NCT02005627|9948768|FG001|COMPLETED|Overall Study||19
8890933|NCT02005627|9948767|FG000|NOT COMPLETED|Overall Study||2
8890934|NCT02005627|9948768|FG001|NOT COMPLETED|Overall Study||4
8890935|NCT02005666|9948778|FG000|STARTED|Overall Study||338
8890936|NCT02005666|9948779|FG001|STARTED|Overall Study||343
8890937|NCT02005666|9948780|FG002|STARTED|Overall Study||169
8890938|NCT02005666|9948778|FG000|COMPLETED|Overall Study||311
8890939|NCT02005666|9948779|FG001|COMPLETED|Overall Study||299
8890940|NCT02005666|9948780|FG002|COMPLETED|Overall Study||160
8890941|NCT02005666|9948778|FG000|NOT COMPLETED|Overall Study||27
8890942|NCT02005666|9948779|FG001|NOT COMPLETED|Overall Study||44
8890943|NCT02005666|9948780|FG002|NOT COMPLETED|Overall Study||9
8890944|NCT02005692|9948788|FG000|STARTED|Overall Study||70
8890945|NCT02005692|9948788|FG000|COMPLETED|Overall Study||63
8890946|NCT02005692|9948788|FG000|NOT COMPLETED|Overall Study||7
8890947|NCT02005887|9948795|FG000|STARTED|Overall Study||26
8890948|NCT02005887|9948796|FG001|STARTED|Overall Study||25
8890949|NCT02005887|9948795|FG000|COMPLETED|Overall Study||26
8890950|NCT02005887|9948796|FG001|COMPLETED|Overall Study||23
8890951|NCT02005887|9948795|FG000|NOT COMPLETED|Overall Study||0
8890952|NCT02005887|9948796|FG001|NOT COMPLETED|Overall Study||2
8890953|NCT02006056|9948804|FG000|STARTED|Overall Study||26
8890954|NCT02006056|9948805|FG001|STARTED|Overall Study||4
8890955|NCT02006056|9948804|FG000|COMPLETED|Overall Study||26
8890956|NCT02006056|9948805|FG001|COMPLETED|Overall Study||4
8890957|NCT02006056|9948804|FG000|NOT COMPLETED|Overall Study||0
8890958|NCT02006056|9948805|FG001|NOT COMPLETED|Overall Study||0
8890959|NCT02006108|9948811|FG000|STARTED|Overall Study||21
8890960|NCT02006108|9948811|FG000|MR Imaging|Overall Study||19
8890961|NCT02006108|9948811|FG000|COMPLETED|Overall Study||19
8890962|NCT02006108|9948811|FG000|NOT COMPLETED|Overall Study||2
8890963|NCT02006121|9948817|FG000|STARTED|Double Blind Phase||54
8890964|NCT02006121|9948818|FG001|STARTED|Double Blind Phase||53
8890965|NCT02006121|9948817|FG000|COMPLETED|Double Blind Phase|Early switching to open label: 1 for lack of efficacy, 1 could not tolerate 3 mg/hour minimum rate|42
8890966|NCT02006121|9948818|FG001|COMPLETED|Double Blind Phase|16 placebo-treated patients early switched to open label phase due to lack of efficacy|29
8890967|NCT02006121|9948817|FG000|NOT COMPLETED|Double Blind Phase||12
8890968|NCT02006121|9948818|FG001|NOT COMPLETED|Double Blind Phase||24
8890969|NCT02006121|9948817|FG000|STARTED|Open Label Phase|From Apo: 38 completers and 2 early switched; From Placebo: 28 completers and 16 early switched|84
8890970|NCT02006121|9948818|FG001|STARTED|Open Label Phase|No patients received placebo in the open label phase|0
8890971|NCT02006121|9948817|FG000|COMPLETED|Open Label Phase|30 who continued on apomorphine from blinded phase, 29 who switched to apomorphine from placebo|59
8890972|NCT02006121|9948818|FG001|COMPLETED|Open Label Phase||0
8890973|NCT02006121|9948817|FG000|NOT COMPLETED|Open Label Phase||25
8890974|NCT02006121|9948818|FG001|NOT COMPLETED|Open Label Phase||0
8890975|NCT02006160|9948830|FG000|STARTED|Overall Study||45
8890976|NCT02006160|9948831|FG001|STARTED|Overall Study||16
8890977|NCT02006160|9948830|FG000|COMPLETED|Overall Study||41
8890978|NCT02006160|9948831|FG001|COMPLETED|Overall Study||16
8890979|NCT02006160|9948830|FG000|NOT COMPLETED|Overall Study||4
8890980|NCT02006160|9948831|FG001|NOT COMPLETED|Overall Study||0
8890981|NCT02006264|9948839|FG000|STARTED|Overall Study||15
8890982|NCT02006264|9948840|FG001|STARTED|Overall Study||15
8890983|NCT02006264|9948839|FG000|COMPLETED|Overall Study||14
8890984|NCT02006264|9948840|FG001|COMPLETED|Overall Study||15
8890985|NCT02006264|9948839|FG000|NOT COMPLETED|Overall Study||1
8890986|NCT02006264|9948840|FG001|NOT COMPLETED|Overall Study||0
8890987|NCT02006342|9948848|FG000|STARTED|Overall Study||20
8890988|NCT02006342|9948849|FG001|STARTED|Overall Study||20
8890989|NCT02006342|9948848|FG000|COMPLETED|Overall Study||19
8890990|NCT02006342|9948849|FG001|COMPLETED|Overall Study||20
8890991|NCT02006342|9948848|FG000|NOT COMPLETED|Overall Study||1
8890992|NCT02006342|9948849|FG001|NOT COMPLETED|Overall Study||0
8890993|NCT02006420|9948857|FG000|STARTED|Overall Study||24
8890994|NCT02006420|9948858|FG001|STARTED|Overall Study||21
8890995|NCT02006420|9948857|FG000|COMPLETED|Overall Study||24
8890996|NCT02006420|9948858|FG001|COMPLETED|Overall Study||21
8890997|NCT02006420|9948857|FG000|NOT COMPLETED|Overall Study||0
8890998|NCT02006420|9948858|FG001|NOT COMPLETED|Overall Study||0
8890999|NCT02006472|9948875|FG000|STARTED|Period 1 (Through Week 26)||82
8891000|NCT02006472|9948876|FG001|STARTED|Period 1 (Through Week 26)||81
8891001|NCT02006472|9948877|FG002|STARTED|Period 1 (Through Week 26)||82
8891002|NCT02006472|9948878|FG003|STARTED|Period 1 (Through Week 26)||81
8891003|NCT02006472|9948879|FG004|STARTED|Period 1 (Through Week 26)||82
8891004|NCT02006472|9948875|FG000|ITT|Period 1 (Through Week 26)||82
8891005|NCT02006472|9948876|FG001|ITT|Period 1 (Through Week 26)||81
8891006|NCT02006472|9948877|FG002|ITT|Period 1 (Through Week 26)||82
8891007|NCT02006472|9948878|FG003|ITT|Period 1 (Through Week 26)||81
8891008|NCT02006472|9948879|FG004|ITT|Period 1 (Through Week 26)||82
8891009|NCT02006472|9948875|FG000|FAS|Period 1 (Through Week 26)||81
8891010|NCT02006472|9948876|FG001|FAS|Period 1 (Through Week 26)||75
8891011|NCT02006472|9948877|FG002|FAS|Period 1 (Through Week 26)||79
8891012|NCT02006472|9948878|FG003|FAS|Period 1 (Through Week 26)||81
8891013|NCT02006472|9948879|FG004|FAS|Period 1 (Through Week 26)||81
8891014|NCT02006472|9948875|FG000|Safety Set|Period 1 (Through Week 26)||82
8891015|NCT02006472|9948876|FG001|Safety Set|Period 1 (Through Week 26)||81
8891016|NCT02006472|9948877|FG002|Safety Set|Period 1 (Through Week 26)||82
8891017|NCT02006472|9948878|FG003|Safety Set|Period 1 (Through Week 26)||81
8891018|NCT02006472|9948879|FG004|Safety Set|Period 1 (Through Week 26)||82
8891019|NCT02006472|9948875|FG000|COMPLETED|Period 1 (Through Week 26)||70
8891020|NCT02006472|9948876|FG001|COMPLETED|Period 1 (Through Week 26)||59
8891021|NCT02006472|9948877|FG002|COMPLETED|Period 1 (Through Week 26)||65
8891022|NCT02006472|9948878|FG003|COMPLETED|Period 1 (Through Week 26)||67
8891023|NCT02006472|9948879|FG004|COMPLETED|Period 1 (Through Week 26)||62
8891024|NCT02006472|9948875|FG000|NOT COMPLETED|Period 1 (Through Week 26)||12
8891025|NCT02006472|9948876|FG001|NOT COMPLETED|Period 1 (Through Week 26)||22
8891026|NCT02006472|9948877|FG002|NOT COMPLETED|Period 1 (Through Week 26)||17
8891027|NCT02006472|9948878|FG003|NOT COMPLETED|Period 1 (Through Week 26)||14
8891028|NCT02006472|9948879|FG004|NOT COMPLETED|Period 1 (Through Week 26)||20
8891029|NCT02006472|9948875|FG000|STARTED|Period 2 (Through Week 52)||57
8891030|NCT02006472|9948876|FG001|STARTED|Period 2 (Through Week 52)||49
8891031|NCT02006472|9948877|FG002|STARTED|Period 2 (Through Week 52)||54
8891032|NCT02006472|9948878|FG003|STARTED|Period 2 (Through Week 52)||56
8891033|NCT02006472|9948879|FG004|STARTED|Period 2 (Through Week 52)||46
8891034|NCT02006472|9948875|FG000|Started Treatment in Period 2|Period 2 (Through Week 52)||57
8891035|NCT02006472|9948876|FG001|Started Treatment in Period 2|Period 2 (Through Week 52)||49
8891036|NCT02006472|9948877|FG002|Started Treatment in Period 2|Period 2 (Through Week 52)||52
8891037|NCT02006472|9948878|FG003|Started Treatment in Period 2|Period 2 (Through Week 52)||56
8891038|NCT02006472|9948879|FG004|Started Treatment in Period 2|Period 2 (Through Week 52)||46
8891039|NCT02006472|9948875|FG000|COMPLETED|Period 2 (Through Week 52)||52
8891040|NCT02006472|9948876|FG001|COMPLETED|Period 2 (Through Week 52)||43
8891041|NCT02006472|9948877|FG002|COMPLETED|Period 2 (Through Week 52)||44
8891042|NCT02006472|9948878|FG003|COMPLETED|Period 2 (Through Week 52)||53
8891043|NCT02006472|9948879|FG004|COMPLETED|Period 2 (Through Week 52)||44
8891044|NCT02006472|9948875|FG000|NOT COMPLETED|Period 2 (Through Week 52)||5
8891045|NCT02006472|9948876|FG001|NOT COMPLETED|Period 2 (Through Week 52)||6
8891046|NCT02006472|9948877|FG002|NOT COMPLETED|Period 2 (Through Week 52)||10
8891047|NCT02006472|9948878|FG003|NOT COMPLETED|Period 2 (Through Week 52)||3
8891048|NCT02006472|9948879|FG004|NOT COMPLETED|Period 2 (Through Week 52)||2
8891049|NCT02006576|9948899|FG000|STARTED|Overall Study||35
8891050|NCT02006576|9948900|FG001|STARTED|Overall Study||51
8891051|NCT02006576|9948901|FG002|STARTED|Overall Study||32
8891052|NCT02006576|9948899|FG000|COMPLETED|Overall Study||17
8891053|NCT02006576|9948900|FG001|COMPLETED|Overall Study||44
8891054|NCT02006576|9948901|FG002|COMPLETED|Overall Study||15
8891055|NCT02006576|9948899|FG000|NOT COMPLETED|Overall Study||18
8891056|NCT02006576|9948900|FG001|NOT COMPLETED|Overall Study||7
8891057|NCT02006576|9948901|FG002|NOT COMPLETED|Overall Study||17
8891058|NCT02006628|9948911|FG000|STARTED|Overall Study||43
8891059|NCT02006628|9948912|FG001|STARTED|Overall Study||45
8891060|NCT02006628|9948911|FG000|Received at Least 1 Dose of Study Drug|Overall Study||43
8891061|NCT02006628|9948912|FG001|Received at Least 1 Dose of Study Drug|Overall Study||45
8891062|NCT02006628|9948911|FG000|Intention to Treat (ITT) Analysis Set|Overall Study||42
8891063|NCT02006628|9948912|FG001|Intention to Treat (ITT) Analysis Set|Overall Study||44
8891064|NCT02006628|9948911|FG000|COMPLETED|Overall Study||40
8891065|NCT02006628|9948912|FG001|COMPLETED|Overall Study||43
8891066|NCT02006628|9948911|FG000|NOT COMPLETED|Overall Study||3
8891067|NCT02006628|9948912|FG001|NOT COMPLETED|Overall Study||2
8891068|NCT02006641|9948921|FG000|STARTED|Overall Study||284
8891069|NCT02006641|9948922|FG001|STARTED|Overall Study||290
8891070|NCT02006641|9948923|FG002|STARTED|Overall Study||284
8891071|NCT02006641|9948921|FG000|Treated|Overall Study||282
8891072|NCT02006641|9948922|FG001|Treated|Overall Study||285
8891073|NCT02006641|9948923|FG002|Treated|Overall Study||281
8891074|NCT02006641|9948921|FG000|COMPLETED|Overall Study||258
8891075|NCT02006641|9948922|FG001|COMPLETED|Overall Study||257
8891076|NCT02006641|9948923|FG002|COMPLETED|Overall Study||248
8891077|NCT02006641|9948921|FG000|NOT COMPLETED|Overall Study||26
8891078|NCT02006641|9948922|FG001|NOT COMPLETED|Overall Study||33
8891079|NCT02006641|9948923|FG002|NOT COMPLETED|Overall Study||36
8891080|NCT02006654|9948933|FG000|STARTED|Overall Study||369
8891081|NCT02006654|9948934|FG001|STARTED|Overall Study||365
8891082|NCT02006654|9948933|FG000|Treated|Overall Study||365
8891083|NCT02006654|9948934|FG001|Treated|Overall Study||363
8891084|NCT02006654|9948933|FG000|COMPLETED|Overall Study||324
8891085|NCT02006654|9948934|FG001|COMPLETED|Overall Study||321
8891086|NCT02006654|9948933|FG000|NOT COMPLETED|Overall Study||45
8891087|NCT02006654|9948934|FG001|NOT COMPLETED|Overall Study||44
9006302|NCT02949518|10069428|FG001|STARTED|Overall Study||28
9006303|NCT02949518|10069427|FG000|COMPLETED|Overall Study||25
9006304|NCT02949518|10069428|FG001|COMPLETED|Overall Study||26
9006305|NCT02949518|10069427|FG000|NOT COMPLETED|Overall Study||3
9006306|NCT02949518|10069428|FG001|NOT COMPLETED|Overall Study||2
9006307|NCT02949674|10069439|FG000|STARTED|Overall Study||31
9006308|NCT02949674|10069440|FG001|STARTED|Overall Study||31
9006309|NCT02949674|10069441|FG002|STARTED|Overall Study||31
9006310|NCT02949674|10069439|FG000|COMPLETED|Overall Study||31
9006311|NCT02949674|10069440|FG001|COMPLETED|Overall Study||31
9006312|NCT02949674|10069441|FG002|COMPLETED|Overall Study||31
9006313|NCT02949674|10069439|FG000|NOT COMPLETED|Overall Study||0
9006314|NCT02949674|10069440|FG001|NOT COMPLETED|Overall Study||0
9006315|NCT02949674|10069441|FG002|NOT COMPLETED|Overall Study||0
9006316|NCT02949908|10069449|FG000|STARTED|Overall Study||2
9006317|NCT02949908|10069449|FG000|COMPLETED|Overall Study||0
8634939|NCT00559104|9675320|FG000|NOT COMPLETED|Overall Study||9
8634940|NCT00559104|9675321|FG001|NOT COMPLETED|Overall Study||0
8634941|NCT00559273|9675329|FG000|STARTED|Correction Period (20 Weeks)||153
9006318|NCT02949908|10069449|FG000|NOT COMPLETED|Overall Study||2
9006319|NCT02949921|10069455|FG000|STARTED|Overall Study||10
9006320|NCT02949921|10069456|FG001|STARTED|Overall Study||10
9006321|NCT02949921|10069455|FG000|COMPLETED|Overall Study||10
9006322|NCT02949921|10069456|FG001|COMPLETED|Overall Study||10
9006323|NCT02949921|10069455|FG000|NOT COMPLETED|Overall Study||0
9006324|NCT02949921|10069456|FG001|NOT COMPLETED|Overall Study||0
9006325|NCT02949973|10069462|FG000|STARTED|Overall Study||10
9006326|NCT02949973|10069462|FG000|COMPLETED|Overall Study||9
9006327|NCT02949973|10069462|FG000|NOT COMPLETED|Overall Study||1
9006328|NCT02950025|10069468|FG000|STARTED|Overall Study||2
9006329|NCT02950025|10069469|FG001|STARTED|Overall Study||3
9006330|NCT02950025|10069468|FG000|COMPLETED|Overall Study||2
9006331|NCT02950025|10069469|FG001|COMPLETED|Overall Study||3
9006332|NCT02950025|10069468|FG000|NOT COMPLETED|Overall Study||0
9006333|NCT02950025|10069469|FG001|NOT COMPLETED|Overall Study||0
9006334|NCT02950467|10069475|FG000|STARTED|Open-label Treatment||18
9006335|NCT02950467|10069475|FG000|COMPLETED|Open-label Treatment|1 participant completed study period but missed some visits due to an adverse event (AE).|18
9006336|NCT02950467|10069475|FG000|NOT COMPLETED|Open-label Treatment||0
9006337|NCT02950467|10069475|FG000|STARTED|3-month Follow-up||18
9006338|NCT02950467|10069475|FG000|COMPLETED|3-month Follow-up|All participants completed the safety follow-up assessment, but not all completed outcomes measures.|18
9006339|NCT02950467|10069475|FG000|NOT COMPLETED|3-month Follow-up||0
9006340|NCT02950545|10069485|FG000|STARTED|Session 1 (70 Minutes)||9
9006341|NCT02950545|10069486|FG001|STARTED|Session 1 (70 Minutes)||9
9006342|NCT02950545|10069487|FG002|STARTED|Session 1 (70 Minutes)||7
9006343|NCT02950545|10069488|FG003|STARTED|Session 1 (70 Minutes)||8
9006344|NCT02950545|10069489|FG004|STARTED|Session 1 (70 Minutes)||8
9006345|NCT02950545|10069490|FG005|STARTED|Session 1 (70 Minutes)||10
9006346|NCT02950545|10069485|FG000|COMPLETED|Session 1 (70 Minutes)||9
9006347|NCT02950545|10069486|FG001|COMPLETED|Session 1 (70 Minutes)||9
9006348|NCT02950545|10069487|FG002|COMPLETED|Session 1 (70 Minutes)||7
9006349|NCT02950545|10069488|FG003|COMPLETED|Session 1 (70 Minutes)||8
9006350|NCT02950545|10069489|FG004|COMPLETED|Session 1 (70 Minutes)||8
9006351|NCT02950545|10069490|FG005|COMPLETED|Session 1 (70 Minutes)||9
9006352|NCT02950545|10069485|FG000|NOT COMPLETED|Session 1 (70 Minutes)||0
9006353|NCT02950545|10069486|FG001|NOT COMPLETED|Session 1 (70 Minutes)||0
9006354|NCT02950545|10069487|FG002|NOT COMPLETED|Session 1 (70 Minutes)||0
9006355|NCT02950545|10069488|FG003|NOT COMPLETED|Session 1 (70 Minutes)||0
9006356|NCT02950545|10069489|FG004|NOT COMPLETED|Session 1 (70 Minutes)||0
9006357|NCT02950545|10069490|FG005|NOT COMPLETED|Session 1 (70 Minutes)||1
9006358|NCT02950545|10069485|FG000|STARTED|Washout 1 (5 Minutes)||9
9006359|NCT02950545|10069486|FG001|STARTED|Washout 1 (5 Minutes)||9
8634942|NCT00559273|9675330|FG001|STARTED|Correction Period (20 Weeks)||154
8634943|NCT00559273|9675329|FG000|Treated|Correction Period (20 Weeks)||151
8634944|NCT00559273|9675330|FG001|Treated|Correction Period (20 Weeks)||154
8634945|NCT00559273|9675329|FG000|COMPLETED|Correction Period (20 Weeks)||144
8634946|NCT00559273|9675330|FG001|COMPLETED|Correction Period (20 Weeks)||142
8634947|NCT00559273|9675329|FG000|NOT COMPLETED|Correction Period (20 Weeks)||9
8634948|NCT00559273|9675330|FG001|NOT COMPLETED|Correction Period (20 Weeks)||12
8726135|NCT01033864|9773277|FG001|NOT COMPLETED|Overall Study||0
8726136|NCT01033942|9773286|FG000|STARTED|Overall Study||20
8891088|NCT02006667|9948941|FG000|STARTED|Overall Study||13
8891089|NCT02006667|9948941|FG000|COMPLETED|Overall Study||7
8891090|NCT02006667|9948941|FG000|NOT COMPLETED|Overall Study||6
9006360|NCT02950545|10069487|FG002|STARTED|Washout 1 (5 Minutes)||7
9006361|NCT02950545|10069488|FG003|STARTED|Washout 1 (5 Minutes)||8
9006362|NCT02950545|10069489|FG004|STARTED|Washout 1 (5 Minutes)||8
9006363|NCT02950545|10069490|FG005|STARTED|Washout 1 (5 Minutes)||9
9006364|NCT02950545|10069485|FG000|COMPLETED|Washout 1 (5 Minutes)||8
8726137|NCT01033942|9773287|FG001|STARTED|Overall Study||19
8891091|NCT02006693|9948947|FG000|STARTED|Overall Study||112
8891092|NCT02006693|9948948|FG001|STARTED|Overall Study||87
8891093|NCT02006693|9948947|FG000|COMPLETED|Overall Study||84
8891094|NCT02006693|9948948|FG001|COMPLETED|Overall Study||74
8891095|NCT02006693|9948947|FG000|NOT COMPLETED|Overall Study||28
8891096|NCT02006693|9948948|FG001|NOT COMPLETED|Overall Study||13
8891097|NCT02006706|9948954|FG000|STARTED|Overall Study||15
8891098|NCT02006706|9948954|FG000|COMPLETED|Overall Study||14
8891099|NCT02006706|9948954|FG000|NOT COMPLETED|Overall Study||1
8891100|NCT02006719|9948960|FG000|STARTED|Overall Study||237
8891101|NCT02006719|9948961|FG001|STARTED|Overall Study||85
8891102|NCT02006719|9948960|FG000|COMPLETED|Overall Study||219
8891103|NCT02006719|9948961|FG001|COMPLETED|Overall Study||80
8891104|NCT02006719|9948960|FG000|NOT COMPLETED|Overall Study||18
8891105|NCT02006719|9948961|FG001|NOT COMPLETED|Overall Study||5
8891106|NCT02006732|9948971|FG000|STARTED|Overall Study||202
8891107|NCT02006732|9948972|FG001|STARTED|Overall Study||203
8891108|NCT02006732|9948973|FG002|STARTED|Overall Study||202
8891109|NCT02006732|9948974|FG003|STARTED|Overall Study||202
8891110|NCT02006732|9948971|FG000|COMPLETED|Overall Study||182
8891111|NCT02006732|9948972|FG001|COMPLETED|Overall Study||191
8891112|NCT02006732|9948973|FG002|COMPLETED|Overall Study||193
8891113|NCT02006732|9948974|FG003|COMPLETED|Overall Study||198
9006365|NCT02950545|10069486|FG001|COMPLETED|Washout 1 (5 Minutes)||9
9006366|NCT02950545|10069487|FG002|COMPLETED|Washout 1 (5 Minutes)||7
9006367|NCT02950545|10069488|FG003|COMPLETED|Washout 1 (5 Minutes)||7
9006368|NCT02950545|10069489|FG004|COMPLETED|Washout 1 (5 Minutes)||8
9006369|NCT02950545|10069490|FG005|COMPLETED|Washout 1 (5 Minutes)||8
9006370|NCT02950545|10069485|FG000|NOT COMPLETED|Washout 1 (5 Minutes)||1
9006371|NCT02950545|10069486|FG001|NOT COMPLETED|Washout 1 (5 Minutes)||0
9006372|NCT02950545|10069487|FG002|NOT COMPLETED|Washout 1 (5 Minutes)||0
9006373|NCT02950545|10069488|FG003|NOT COMPLETED|Washout 1 (5 Minutes)||1
9006374|NCT02950545|10069489|FG004|NOT COMPLETED|Washout 1 (5 Minutes)||0
9006375|NCT02950545|10069490|FG005|NOT COMPLETED|Washout 1 (5 Minutes)||1
9006376|NCT02950545|10069485|FG000|STARTED|Session 2 (70 Minutes)||8
9006377|NCT02950545|10069486|FG001|STARTED|Session 2 (70 Minutes)||9
9006378|NCT02950545|10069487|FG002|STARTED|Session 2 (70 Minutes)||7
9006379|NCT02950545|10069488|FG003|STARTED|Session 2 (70 Minutes)||7
9006380|NCT02950545|10069489|FG004|STARTED|Session 2 (70 Minutes)||8
9006381|NCT02950545|10069490|FG005|STARTED|Session 2 (70 Minutes)||8
9006382|NCT02950545|10069485|FG000|COMPLETED|Session 2 (70 Minutes)||8
9006383|NCT02950545|10069486|FG001|COMPLETED|Session 2 (70 Minutes)||9
9006384|NCT02950545|10069487|FG002|COMPLETED|Session 2 (70 Minutes)||7
9006385|NCT02950545|10069488|FG003|COMPLETED|Session 2 (70 Minutes)||7
9006386|NCT02950545|10069489|FG004|COMPLETED|Session 2 (70 Minutes)||7
9006387|NCT02950545|10069490|FG005|COMPLETED|Session 2 (70 Minutes)||8
9006388|NCT02950545|10069485|FG000|NOT COMPLETED|Session 2 (70 Minutes)||0
9006389|NCT02950545|10069486|FG001|NOT COMPLETED|Session 2 (70 Minutes)||0
9006390|NCT02950545|10069487|FG002|NOT COMPLETED|Session 2 (70 Minutes)||0
9006391|NCT02950545|10069488|FG003|NOT COMPLETED|Session 2 (70 Minutes)||0
9006392|NCT02950545|10069489|FG004|NOT COMPLETED|Session 2 (70 Minutes)||1
9006393|NCT02950545|10069490|FG005|NOT COMPLETED|Session 2 (70 Minutes)||0
9006394|NCT02950545|10069485|FG000|STARTED|Washout 2 (5 Minutes)||8
9006395|NCT02950545|10069486|FG001|STARTED|Washout 2 (5 Minutes)||9
9006396|NCT02950545|10069487|FG002|STARTED|Washout 2 (5 Minutes)||7
9006397|NCT02950545|10069488|FG003|STARTED|Washout 2 (5 Minutes)||7
9006398|NCT02950545|10069489|FG004|STARTED|Washout 2 (5 Minutes)||7
9006399|NCT02950545|10069490|FG005|STARTED|Washout 2 (5 Minutes)||8
9006400|NCT02950545|10069485|FG000|COMPLETED|Washout 2 (5 Minutes)||7
9006401|NCT02950545|10069486|FG001|COMPLETED|Washout 2 (5 Minutes)||9
9006402|NCT02950545|10069487|FG002|COMPLETED|Washout 2 (5 Minutes)||7
9006403|NCT02950545|10069488|FG003|COMPLETED|Washout 2 (5 Minutes)||7
9006404|NCT02950545|10069489|FG004|COMPLETED|Washout 2 (5 Minutes)||7
9006405|NCT02950545|10069490|FG005|COMPLETED|Washout 2 (5 Minutes)||8
9006406|NCT02950545|10069485|FG000|NOT COMPLETED|Washout 2 (5 Minutes)||1
9006407|NCT02950545|10069486|FG001|NOT COMPLETED|Washout 2 (5 Minutes)||0
9006408|NCT02950545|10069487|FG002|NOT COMPLETED|Washout 2 (5 Minutes)||0
9006409|NCT02950545|10069488|FG003|NOT COMPLETED|Washout 2 (5 Minutes)||0
9006410|NCT02950545|10069489|FG004|NOT COMPLETED|Washout 2 (5 Minutes)||0
9006411|NCT02950545|10069490|FG005|NOT COMPLETED|Washout 2 (5 Minutes)||0
9006412|NCT02950545|10069485|FG000|STARTED|Session 3 (70 Minutes)||7
9006413|NCT02950545|10069486|FG001|STARTED|Session 3 (70 Minutes)||9
9006414|NCT02950545|10069487|FG002|STARTED|Session 3 (70 Minutes)||7
9006415|NCT02950545|10069488|FG003|STARTED|Session 3 (70 Minutes)||7
9006416|NCT02950545|10069489|FG004|STARTED|Session 3 (70 Minutes)||7
9006417|NCT02950545|10069490|FG005|STARTED|Session 3 (70 Minutes)||8
9006418|NCT02950545|10069485|FG000|COMPLETED|Session 3 (70 Minutes)||7
9006419|NCT02950545|10069486|FG001|COMPLETED|Session 3 (70 Minutes)||9
9006420|NCT02950545|10069487|FG002|COMPLETED|Session 3 (70 Minutes)||7
9006421|NCT02950545|10069488|FG003|COMPLETED|Session 3 (70 Minutes)||7
9006422|NCT02950545|10069489|FG004|COMPLETED|Session 3 (70 Minutes)||7
9006423|NCT02950545|10069490|FG005|COMPLETED|Session 3 (70 Minutes)||7
9006424|NCT02950545|10069485|FG000|NOT COMPLETED|Session 3 (70 Minutes)||0
9006425|NCT02950545|10069486|FG001|NOT COMPLETED|Session 3 (70 Minutes)||0
9006426|NCT02950545|10069487|FG002|NOT COMPLETED|Session 3 (70 Minutes)||0
9006427|NCT02950545|10069488|FG003|NOT COMPLETED|Session 3 (70 Minutes)||0
9006428|NCT02950545|10069489|FG004|NOT COMPLETED|Session 3 (70 Minutes)||0
8891114|NCT02006732|9948971|FG000|NOT COMPLETED|Overall Study||20
8891115|NCT02006732|9948972|FG001|NOT COMPLETED|Overall Study||12
8891116|NCT02006732|9948973|FG002|NOT COMPLETED|Overall Study||9
8891117|NCT02006732|9948974|FG003|NOT COMPLETED|Overall Study||4
8891118|NCT02006758|9948984|FG000|STARTED|Overall Study|Total number of enrolled participants|68
8891119|NCT02006758|9948984|FG000|Underwent Renal Denervation|Overall Study|Underwent renal denervation|67
8891120|NCT02006758|9948984|FG000|1-month Follow up|Overall Study|1-month follow up completed|66
8891121|NCT02006758|9948984|FG000|6-month Follow up|Overall Study|6-month follow up completed|60
8891122|NCT02006758|9948984|FG000|12-month Follow up|Overall Study|12-month follow up completed|55
8891123|NCT02006758|9948984|FG000|COMPLETED|Overall Study||55
8891124|NCT02006758|9948984|FG000|NOT COMPLETED|Overall Study||13
8891125|NCT02006836|9948992|FG000|STARTED|Case-control Period: Month 1- Month 6||20
8891126|NCT02006836|9948993|FG001|STARTED|Case-control Period: Month 1- Month 6||20
8891127|NCT02006836|9948994|FG002|STARTED|Case-control Period: Month 1- Month 6||0
8891128|NCT02006836|9948992|FG000|COMPLETED|Case-control Period: Month 1- Month 6||20
8891129|NCT02006836|9948993|FG001|COMPLETED|Case-control Period: Month 1- Month 6||20
8891130|NCT02006836|9948994|FG002|COMPLETED|Case-control Period: Month 1- Month 6||0
8891131|NCT02006836|9948992|FG000|NOT COMPLETED|Case-control Period: Month 1- Month 6||0
8891132|NCT02006836|9948993|FG001|NOT COMPLETED|Case-control Period: Month 1- Month 6||0
8891133|NCT02006836|9948994|FG002|NOT COMPLETED|Case-control Period: Month 1- Month 6||0
8891134|NCT02006836|9948992|FG000|STARTED|Self-control Period: Month 7-month 12||0
8891135|NCT02006836|9948993|FG001|STARTED|Self-control Period: Month 7-month 12||0
8891136|NCT02006836|9948994|FG002|STARTED|Self-control Period: Month 7-month 12||19
8891137|NCT02006836|9948992|FG000|COMPLETED|Self-control Period: Month 7-month 12||0
8891138|NCT02006836|9948993|FG001|COMPLETED|Self-control Period: Month 7-month 12||0
8891139|NCT02006836|9948994|FG002|COMPLETED|Self-control Period: Month 7-month 12||19
8891140|NCT02006836|9948992|FG000|NOT COMPLETED|Self-control Period: Month 7-month 12||0
8891141|NCT02006836|9948993|FG001|NOT COMPLETED|Self-control Period: Month 7-month 12||0
8634949|NCT00559273|9675329|FG000|STARTED|Evaluation Period (8 Weeks)||144
8634950|NCT00559273|9675330|FG001|STARTED|Evaluation Period (8 Weeks)||142
8634951|NCT00559273|9675329|FG000|COMPLETED|Evaluation Period (8 Weeks)||141
8891142|NCT02006836|9948994|FG002|NOT COMPLETED|Self-control Period: Month 7-month 12||0
8891143|NCT02006888|9949007|FG000|STARTED|Overall Study||158
8891144|NCT02006888|9949008|FG001|STARTED|Overall Study||156
8891145|NCT02006888|9949009|FG002|STARTED|Overall Study||80
8891146|NCT02006888|9949007|FG000|COMPLETED|Overall Study||122
8891147|NCT02006888|9949008|FG001|COMPLETED|Overall Study||122
8891148|NCT02006888|9949009|FG002|COMPLETED|Overall Study||58
8891149|NCT02006888|9949007|FG000|NOT COMPLETED|Overall Study||36
8891150|NCT02006888|9949008|FG001|NOT COMPLETED|Overall Study||34
8891151|NCT02006888|9949009|FG002|NOT COMPLETED|Overall Study||22
8891152|NCT02006979|9949019|FG000|STARTED|Overall Study||14
8634952|NCT00559273|9675330|FG001|COMPLETED|Evaluation Period (8 Weeks)||137
8634953|NCT00559273|9675329|FG000|NOT COMPLETED|Evaluation Period (8 Weeks)||3
8634954|NCT00559273|9675330|FG001|NOT COMPLETED|Evaluation Period (8 Weeks)||5
8634955|NCT00559364|9675338|FG000|STARTED|Overall Study||30
8634956|NCT00559364|9675339|FG001|STARTED|Overall Study||20
8634957|NCT00559364|9675338|FG000|COMPLETED|Overall Study||29
8634958|NCT00559364|9675339|FG001|COMPLETED|Overall Study||20
8634959|NCT00559364|9675338|FG000|NOT COMPLETED|Overall Study||1
8634960|NCT00559364|9675339|FG001|NOT COMPLETED|Overall Study||0
8634961|NCT00559377|9675345|FG000|STARTED|Overall Study||16
8634962|NCT00559377|9675345|FG000|COMPLETED|Overall Study||7
8726138|NCT01033942|9773288|FG002|STARTED|Overall Study||19
8726139|NCT01033942|9773286|FG000|COMPLETED|Overall Study||18
8726140|NCT01033942|9773287|FG001|COMPLETED|Overall Study||15
8726141|NCT01033942|9773288|FG002|COMPLETED|Overall Study||18
8726142|NCT01033942|9773286|FG000|NOT COMPLETED|Overall Study||2
8726143|NCT01033942|9773287|FG001|NOT COMPLETED|Overall Study||4
8726144|NCT01033942|9773288|FG002|NOT COMPLETED|Overall Study||1
8726145|NCT01034111|9773298|FG000|STARTED|Overall Study||30
8726146|NCT01034111|9773298|FG000|COMPLETED|Overall Study||30
8726147|NCT01034111|9773298|FG000|NOT COMPLETED|Overall Study||0
8726148|NCT01034137|9773305|FG000|STARTED|Overall Study||106
8726149|NCT01034137|9773306|FG001|STARTED|Overall Study||103
8726150|NCT01034137|9773307|FG002|STARTED|Overall Study||108
8726151|NCT01034137|9773305|FG000|COMPLETED|Overall Study||78
8726152|NCT01034137|9773306|FG001|COMPLETED|Overall Study||81
8726153|NCT01034137|9773307|FG002|COMPLETED|Overall Study||78
8726154|NCT01034137|9773305|FG000|NOT COMPLETED|Overall Study||28
8726155|NCT01034137|9773306|FG001|NOT COMPLETED|Overall Study||22
8726156|NCT01034137|9773307|FG002|NOT COMPLETED|Overall Study||30
8634963|NCT00559377|9675345|FG000|NOT COMPLETED|Overall Study||9
8726157|NCT01034163|9773318|FG000|STARTED|Overall Study||27
8726158|NCT01034163|9773319|FG001|STARTED|Overall Study||14
8634964|NCT00559468|9675354|FG000|STARTED|Overall Study||26
8634965|NCT00559468|9675355|FG001|STARTED|Overall Study||26
8806551|NCT01478321|9858785|FG000|STARTED|Concurrent Therapy (5 Weeks)||54
8806552|NCT01478321|9858785|FG000|COMPLETED|Concurrent Therapy (5 Weeks)||38
8806553|NCT01478321|9858785|FG000|NOT COMPLETED|Concurrent Therapy (5 Weeks)||16
8806554|NCT01478321|9858785|FG000|STARTED|Started Adjuvant Therapy||38
8806555|NCT01478321|9858785|FG000|Completed First Cycle|Started Adjuvant Therapy||37
8806556|NCT01478321|9858785|FG000|COMPLETED|Started Adjuvant Therapy||37
8806557|NCT01478321|9858785|FG000|NOT COMPLETED|Started Adjuvant Therapy||1
8806558|NCT01478321|9858785|FG000|STARTED|Adjuvant Therapy Until PD or Toxicity||37
8891153|NCT02006979|9949020|FG001|STARTED|Overall Study||13
8891154|NCT02006979|9949019|FG000|COMPLETED|Overall Study||13
8891155|NCT02006979|9949020|FG001|COMPLETED|Overall Study||11
8891156|NCT02006979|9949019|FG000|NOT COMPLETED|Overall Study||1
8891157|NCT02006979|9949020|FG001|NOT COMPLETED|Overall Study||2
8891158|NCT02007070|9949026|FG000|STARTED|Overall Study||38
8891159|NCT02007070|9949026|FG000|COMPLETED|Overall Study|Completed 2 years of treatment.|5
8891160|NCT02007070|9949026|FG000|NOT COMPLETED|Overall Study||33
8891161|NCT02007096|9949032|FG000|STARTED|Overall Study||63
8891162|NCT02007096|9949033|FG001|STARTED|Overall Study||64
8891163|NCT02007096|9949032|FG000|COMPLETED|Overall Study||52
8891164|NCT02007096|9949033|FG001|COMPLETED|Overall Study||48
8726159|NCT01034163|9773318|FG000|Untreated (Not in Safety Set)|Overall Study||1
8726160|NCT01034163|9773319|FG001|Untreated (Not in Safety Set)|Overall Study||2
8726161|NCT01034163|9773318|FG000|Safety Set|Overall Study||26
8726162|NCT01034163|9773319|FG001|Safety Set|Overall Study||12
8726163|NCT01034163|9773318|FG000|In Open Label Phase After Unblinding|Overall Study||5
8726164|NCT01034163|9773319|FG001|In Open Label Phase After Unblinding|Overall Study||0
8891165|NCT02007096|9949032|FG000|NOT COMPLETED|Overall Study||11
8891166|NCT02007096|9949033|FG001|NOT COMPLETED|Overall Study||16
8891167|NCT02007109|9949039|FG000|STARTED|Overall Study||193
8891168|NCT02007109|9949039|FG000|PACU Analysis|Overall Study||184
8891169|NCT02007109|9949039|FG000|COMPLETED|Overall Study||82
8891170|NCT02007109|9949039|FG000|NOT COMPLETED|Overall Study||111
8891171|NCT02007200|9949046|FG000|STARTED|Overall Study||55
8891172|NCT02007200|9949046|FG000|COMPLETED|Overall Study||55
8891173|NCT02007200|9949046|FG000|NOT COMPLETED|Overall Study||0
9006429|NCT02950545|10069490|FG005|NOT COMPLETED|Session 3 (70 Minutes)||1
9006430|NCT02950558|10069498|FG000|STARTED|Overall Study||8
9006431|NCT02950558|10069499|FG001|STARTED|Overall Study||6
9006432|NCT02950558|10069498|FG000|12 Month Pain Questionnaire|Overall Study||6
9006433|NCT02950558|10069499|FG001|12 Month Pain Questionnaire|Overall Study||6
9006434|NCT02950558|10069498|FG000|COMPLETED|Overall Study||6
9006435|NCT02950558|10069499|FG001|COMPLETED|Overall Study||6
9006436|NCT02950558|10069498|FG000|NOT COMPLETED|Overall Study||2
9006437|NCT02950558|10069499|FG001|NOT COMPLETED|Overall Study||0
9006438|NCT02950753|10069508|FG000|STARTED|Overall Study||15
9006439|NCT02950753|10069509|FG001|STARTED|Overall Study||15
9006440|NCT02950753|10069508|FG000|COMPLETED|Overall Study||15
9006441|NCT02950753|10069509|FG001|COMPLETED|Overall Study||15
9006442|NCT02950753|10069508|FG000|NOT COMPLETED|Overall Study||0
9006443|NCT02950753|10069509|FG001|NOT COMPLETED|Overall Study||0
8726165|NCT01034163|9773318|FG000|COMPLETED|Overall Study||0
8891174|NCT02007252|9949052|FG000|STARTED|Overall Study||31
8891175|NCT02007252|9949053|FG001|STARTED|Overall Study||33
9006444|NCT02950831|10069515|FG000|STARTED|Overall Study||27
9006445|NCT02950831|10069515|FG000|Complete Trial|Overall Study||26
9006446|NCT02950831|10069515|FG000|Permanent Implant|Overall Study||20
9006447|NCT02950831|10069515|FG000|4 Week Follow up|Overall Study||20
9006448|NCT02950831|10069515|FG000|8 Weeks Follow up|Overall Study||19
9006449|NCT02950831|10069515|FG000|COMPLETED|Overall Study||18
9006450|NCT02950831|10069515|FG000|NOT COMPLETED|Overall Study||9
9006451|NCT02951143|10069525|FG000|STARTED|Overall Study||97
9006452|NCT02951143|10069526|FG001|STARTED|Overall Study||41
9006453|NCT02951143|10069527|FG002|STARTED|Overall Study||47
9006454|NCT02951143|10069528|FG003|STARTED|Overall Study||39
9006455|NCT02951143|10069529|FG004|STARTED|Overall Study||37
9006456|NCT02951143|10069530|FG005|STARTED|Overall Study||44
9006457|NCT02951143|10069525|FG000|COMPLETED|Overall Study||36
9006458|NCT02951143|10069526|FG001|COMPLETED|Overall Study||32
9006459|NCT02951143|10069527|FG002|COMPLETED|Overall Study||29
9006460|NCT02951143|10069528|FG003|COMPLETED|Overall Study||30
9006461|NCT02951143|10069529|FG004|COMPLETED|Overall Study||31
9006462|NCT02951143|10069530|FG005|COMPLETED|Overall Study||29
9006463|NCT02951143|10069525|FG000|NOT COMPLETED|Overall Study||61
9006464|NCT02951143|10069526|FG001|NOT COMPLETED|Overall Study||9
9006465|NCT02951143|10069527|FG002|NOT COMPLETED|Overall Study||18
9006466|NCT02951143|10069528|FG003|NOT COMPLETED|Overall Study||9
9006467|NCT02951143|10069529|FG004|NOT COMPLETED|Overall Study||6
8891176|NCT02007252|9949052|FG000|Safety Analysis Set|Overall Study||31
8891177|NCT02007252|9949053|FG001|Safety Analysis Set|Overall Study||33
8891178|NCT02007252|9949052|FG000|Pharmacodynamic Analysis Set|Overall Study||31
8891179|NCT02007252|9949053|FG001|Pharmacodynamic Analysis Set|Overall Study||33
8891180|NCT02007252|9949052|FG000|COMPLETED|Overall Study||20
9006468|NCT02951143|10069530|FG005|NOT COMPLETED|Overall Study||15
9006469|NCT02951156|10069547|FG000|STARTED|Overall Study||9
9006470|NCT02951156|10069548|FG001|STARTED|Overall Study||9
8891181|NCT02007252|9949053|FG001|COMPLETED|Overall Study||22
8891182|NCT02007252|9949052|FG000|NOT COMPLETED|Overall Study||11
8891183|NCT02007252|9949053|FG001|NOT COMPLETED|Overall Study||11
8891184|NCT02007278|9949061|FG000|STARTED|Overall Study||20
8891185|NCT02007278|9949062|FG001|STARTED|Overall Study||20
8891186|NCT02007278|9949061|FG000|COMPLETED|Overall Study||18
8891187|NCT02007278|9949062|FG001|COMPLETED|Overall Study||17
8891188|NCT02007278|9949061|FG000|NOT COMPLETED|Overall Study||2
8891189|NCT02007278|9949062|FG001|NOT COMPLETED|Overall Study||3
9006471|NCT02951156|10069549|FG002|STARTED|Overall Study||11
9006472|NCT02951156|10069547|FG000|COMPLETED|Overall Study||0
9006473|NCT02951156|10069548|FG001|COMPLETED|Overall Study||0
9006474|NCT02951156|10069549|FG002|COMPLETED|Overall Study||1
9006475|NCT02951156|10069547|FG000|NOT COMPLETED|Overall Study||9
8891190|NCT02007291|9949068|FG000|STARTED|Overall Study||48
8891191|NCT02007291|9949069|FG001|STARTED|Overall Study||23
8891192|NCT02007291|9949068|FG000|COMPLETED|Overall Study||48
8891193|NCT02007291|9949069|FG001|COMPLETED|Overall Study||23
8891194|NCT02007291|9949068|FG000|NOT COMPLETED|Overall Study||0
8891195|NCT02007291|9949069|FG001|NOT COMPLETED|Overall Study||0
8891196|NCT02007369|9949078|FG000|STARTED|Overall Study||42
8891197|NCT02007369|9949079|FG001|STARTED|Overall Study||40
8891198|NCT02007369|9949080|FG002|STARTED|Overall Study||54
8891199|NCT02007369|9949078|FG000|COMPLETED|Overall Study||42
8891200|NCT02007369|9949079|FG001|COMPLETED|Overall Study||40
8891201|NCT02007369|9949080|FG002|COMPLETED|Overall Study||54
8891202|NCT02007369|9949078|FG000|NOT COMPLETED|Overall Study||0
8891203|NCT02007369|9949079|FG001|NOT COMPLETED|Overall Study||0
8891204|NCT02007369|9949080|FG002|NOT COMPLETED|Overall Study||0
8891205|NCT02007434|9949096|FG000|STARTED|Overall Study||17
8891206|NCT02007434|9949097|FG001|STARTED|Overall Study||4
8891207|NCT02007434|9949098|FG002|STARTED|Overall Study||17
8891208|NCT02007434|9949099|FG003|STARTED|Overall Study||4
8891209|NCT02007434|9949100|FG004|STARTED|Overall Study||16
8891210|NCT02007434|9949101|FG005|STARTED|Overall Study||4
8891211|NCT02007434|9949102|FG006|STARTED|Overall Study||18
8891212|NCT02007434|9949103|FG007|STARTED|Overall Study||4
8891213|NCT02007434|9949096|FG000|Received Treatment|Overall Study||17
8891214|NCT02007434|9949097|FG001|Received Treatment|Overall Study||3
8891215|NCT02007434|9949098|FG002|Received Treatment|Overall Study||17
8891216|NCT02007434|9949099|FG003|Received Treatment|Overall Study||4
8891217|NCT02007434|9949100|FG004|Received Treatment|Overall Study||16
8891218|NCT02007434|9949101|FG005|Received Treatment|Overall Study||4
8891219|NCT02007434|9949102|FG006|Received Treatment|Overall Study||18
8891220|NCT02007434|9949103|FG007|Received Treatment|Overall Study||4
8891221|NCT02007434|9949096|FG000|COMPLETED|Overall Study||16
8891222|NCT02007434|9949097|FG001|COMPLETED|Overall Study||3
8891223|NCT02007434|9949098|FG002|COMPLETED|Overall Study||16
8891224|NCT02007434|9949099|FG003|COMPLETED|Overall Study||4
8891225|NCT02007434|9949100|FG004|COMPLETED|Overall Study||16
8891226|NCT02007434|9949101|FG005|COMPLETED|Overall Study||4
8891227|NCT02007434|9949102|FG006|COMPLETED|Overall Study||18
8891228|NCT02007434|9949103|FG007|COMPLETED|Overall Study||4
8891229|NCT02007434|9949096|FG000|NOT COMPLETED|Overall Study||1
9006476|NCT02951156|10069548|FG001|NOT COMPLETED|Overall Study||9
9006477|NCT02951156|10069549|FG002|NOT COMPLETED|Overall Study||10
9006478|NCT02951182|10069564|FG000|STARTED|Overall Study||11
9006479|NCT02951182|10069565|FG001|STARTED|Overall Study||9
9006480|NCT02951182|10069566|FG002|STARTED|Overall Study||9
9006481|NCT02951182|10069567|FG003|STARTED|Overall Study||18
9006482|NCT02951182|10069568|FG004|STARTED|Overall Study||6
9006483|NCT02951182|10069569|FG005|STARTED|Overall Study||20
9006484|NCT02951182|10069564|FG000|COMPLETED|Overall Study||11
8634966|NCT00559468|9675354|FG000|Treated|Overall Study||26
8634967|NCT00559468|9675355|FG001|Treated|Overall Study||25
8634968|NCT00559468|9675354|FG000|COMPLETED|Overall Study||26
8634969|NCT00559468|9675355|FG001|COMPLETED|Overall Study||25
8634970|NCT00559468|9675354|FG000|NOT COMPLETED|Overall Study||0
8634971|NCT00559468|9675355|FG001|NOT COMPLETED|Overall Study||1
8634972|NCT00559507|9675361|FG000|STARTED|Overall Study||12
8634973|NCT00559507|9675361|FG000|COMPLETED|Overall Study||9
8634974|NCT00559507|9675361|FG000|NOT COMPLETED|Overall Study||3
8634975|NCT00559585|9675367|FG000|STARTED|Double Blind ST Period Main Study|Randomized and treated|736
8634976|NCT00559585|9675368|FG001|STARTED|Double Blind ST Period Main Study|Randomized and treated|721
8634977|NCT00559585|9675367|FG000|COMPLETED|Double Blind ST Period Main Study||693
8634978|NCT00559585|9675368|FG001|COMPLETED|Double Blind ST Period Main Study||676
8634979|NCT00559585|9675367|FG000|NOT COMPLETED|Double Blind ST Period Main Study||43
8634980|NCT00559585|9675368|FG001|NOT COMPLETED|Double Blind ST Period Main Study||45
8634981|NCT00559585|9675367|FG000|STARTED|Anti-TNF Sub-Study in ST Period|7 completed Sub-Study ST period and 6 chose to roll over into LT Period.|8
8634982|NCT00559585|9675368|FG001|STARTED|Anti-TNF Sub-Study in ST Period|9 completed Sub-Study ST Period and 9 chose to over into the LT Period.|10
8634983|NCT00559585|9675367|FG000|COMPLETED|Anti-TNF Sub-Study in ST Period||7
8634984|NCT00559585|9675368|FG001|COMPLETED|Anti-TNF Sub-Study in ST Period||9
8634985|NCT00559585|9675367|FG000|NOT COMPLETED|Anti-TNF Sub-Study in ST Period||1
8634986|NCT00559585|9675368|FG001|NOT COMPLETED|Anti-TNF Sub-Study in ST Period||1
8634987|NCT00559585|9675367|FG000|STARTED|Open Label LT Period Main + Sub-Study|1373 includes 15 participants from ST Period Sub-Study who rolled over into LT Period (6 SC + 9 IV).|1373
8634988|NCT00559585|9675368|FG001|STARTED|Open Label LT Period Main + Sub-Study|IV administration was discontinued and abatacept was only administered SC during LT Period.|0
8634989|NCT00559585|9675367|FG000|COMPLETED|Open Label LT Period Main + Sub-Study||945
8891230|NCT02007434|9949097|FG001|NOT COMPLETED|Overall Study||1
8891231|NCT02007434|9949098|FG002|NOT COMPLETED|Overall Study||1
8891232|NCT02007434|9949099|FG003|NOT COMPLETED|Overall Study||0
8891233|NCT02007434|9949100|FG004|NOT COMPLETED|Overall Study||0
8891234|NCT02007434|9949101|FG005|NOT COMPLETED|Overall Study||0
8891235|NCT02007434|9949102|FG006|NOT COMPLETED|Overall Study||0
9006485|NCT02951182|10069565|FG001|COMPLETED|Overall Study||9
9006486|NCT02951182|10069566|FG002|COMPLETED|Overall Study||9
8891236|NCT02007434|9949103|FG007|NOT COMPLETED|Overall Study||0
8891237|NCT02007577|9949124|FG000|STARTED|Overall Study||27
8891238|NCT02007577|9949125|FG001|STARTED|Overall Study||14
9006487|NCT02951182|10069567|FG003|COMPLETED|Overall Study||18
8891239|NCT02007577|9949124|FG000|COMPLETED|Overall Study||26
8891240|NCT02007577|9949125|FG001|COMPLETED|Overall Study||13
8891241|NCT02007577|9949124|FG000|NOT COMPLETED|Overall Study||1
8891242|NCT02007577|9949125|FG001|NOT COMPLETED|Overall Study||1
8891243|NCT02007720|9949133|FG000|STARTED|Overall Study||436
8891244|NCT02007720|9949134|FG001|STARTED|Overall Study||440
8891245|NCT02007720|9949133|FG000|Full Analysis Set|Overall Study||433
8891246|NCT02007720|9949134|FG001|Full Analysis Set|Overall Study||437
8891247|NCT02007720|9949133|FG000|Safety Set|Overall Study||426
8891248|NCT02007720|9949134|FG001|Safety Set|Overall Study||432
8891249|NCT02007720|9949133|FG000|COMPLETED|Overall Study||354
8891250|NCT02007720|9949134|FG001|COMPLETED|Overall Study||368
8891251|NCT02007720|9949133|FG000|NOT COMPLETED|Overall Study||82
8891252|NCT02007720|9949134|FG001|NOT COMPLETED|Overall Study||72
8891253|NCT02007863|9949141|FG000|STARTED|Overall Study||2
8891254|NCT02007863|9949141|FG000|COMPLETED|Overall Study||2
8891255|NCT02007863|9949141|FG000|NOT COMPLETED|Overall Study||0
8891256|NCT02007954|9949145|FG000|STARTED|Overall Study|A total of 32 participants were consented, with 8 patients screened out prior to treatment.|24
8891257|NCT02007954|9949145|FG000|Completed First TACE|Overall Study||24
8891258|NCT02007954|9949145|FG000|Completed First Clinical and Imaging|Overall Study|1 patient exited prior to first imaging follow-up due to unrelated serious adverse event and death|23
8891259|NCT02007954|9949145|FG000|COMPLETED|Overall Study||17
8891260|NCT02007954|9949145|FG000|NOT COMPLETED|Overall Study||7
8891261|NCT02008149|9949152|FG000|STARTED|Overall Study||7
8891262|NCT02008149|9949153|FG001|STARTED|Overall Study||1
8891263|NCT02008149|9949154|FG002|STARTED|Overall Study||1
8891264|NCT02008149|9949152|FG000|COMPLETED|Overall Study||4
8891265|NCT02008149|9949153|FG001|COMPLETED|Overall Study||0
8891266|NCT02008149|9949154|FG002|COMPLETED|Overall Study||1
8891267|NCT02008149|9949152|FG000|NOT COMPLETED|Overall Study||3
8891268|NCT02008149|9949153|FG001|NOT COMPLETED|Overall Study||1
8891269|NCT02008149|9949154|FG002|NOT COMPLETED|Overall Study||0
8891270|NCT02008227|9949164|FG000|STARTED|Overall Study||612
8891271|NCT02008227|9949165|FG001|STARTED|Overall Study||613
8891272|NCT02008227|9949164|FG000|Treated|Overall Study||579
8891273|NCT02008227|9949165|FG001|Treated|Overall Study||608
8891274|NCT02008227|9949164|FG000|COMPLETED|Overall Study||0
8891275|NCT02008227|9949165|FG001|COMPLETED|Overall Study||0
8891276|NCT02008227|9949164|FG000|NOT COMPLETED|Overall Study||612
8891277|NCT02008227|9949165|FG001|NOT COMPLETED|Overall Study||613
8891278|NCT02008318|9949174|FG000|STARTED|Overall Study||41
8891279|NCT02008318|9949175|FG001|STARTED|Overall Study||2
8891280|NCT02008318|9949174|FG000|Received At Least 1 Dose of Study Drug|Overall Study||41
8891281|NCT02008318|9949175|FG001|Received At Least 1 Dose of Study Drug|Overall Study||2
8891282|NCT02008318|9949174|FG000|COMPLETED|Overall Study||29
8891283|NCT02008318|9949175|FG001|COMPLETED|Overall Study||1
8891284|NCT02008318|9949174|FG000|NOT COMPLETED|Overall Study||12
8891285|NCT02008318|9949175|FG001|NOT COMPLETED|Overall Study||1
8891286|NCT02008526|9949187|FG000|STARTED|Overall Study||94
8891287|NCT02008526|9949188|FG001|STARTED|Overall Study||99
8891288|NCT02008526|9949189|FG002|STARTED|Overall Study||93
8891289|NCT02008526|9949187|FG000|COMPLETED|Overall Study||86
8891290|NCT02008526|9949188|FG001|COMPLETED|Overall Study||85
8891291|NCT02008526|9949189|FG002|COMPLETED|Overall Study||84
8891292|NCT02008526|9949187|FG000|NOT COMPLETED|Overall Study||8
8891293|NCT02008526|9949188|FG001|NOT COMPLETED|Overall Study||14
8891294|NCT02008526|9949189|FG002|NOT COMPLETED|Overall Study||9
8891295|NCT02008565|9949201|FG000|STARTED|Overall Study||86
8891296|NCT02008565|9949202|FG001|STARTED|Overall Study||84
8891297|NCT02008565|9949203|FG002|STARTED|Overall Study||88
8891298|NCT02008565|9949204|FG003|STARTED|Overall Study||42
8891299|NCT02008565|9949201|FG000|COMPLETED|Overall Study||85
8891300|NCT02008565|9949202|FG001|COMPLETED|Overall Study||83
8891301|NCT02008565|9949203|FG002|COMPLETED|Overall Study||86
8891302|NCT02008565|9949204|FG003|COMPLETED|Overall Study||42
8891303|NCT02008565|9949201|FG000|NOT COMPLETED|Overall Study||1
8891304|NCT02008565|9949202|FG001|NOT COMPLETED|Overall Study||1
8891305|NCT02008565|9949203|FG002|NOT COMPLETED|Overall Study||2
8891306|NCT02008565|9949204|FG003|NOT COMPLETED|Overall Study||0
8891307|NCT02008617|9949218|FG000|STARTED|Overall Study||8
8891308|NCT02008617|9949219|FG001|STARTED|Overall Study||10
8891309|NCT02008617|9949218|FG000|COMPLETED|Overall Study||8
8891310|NCT02008617|9949219|FG001|COMPLETED|Overall Study||10
8891311|NCT02008617|9949218|FG000|NOT COMPLETED|Overall Study||0
8891312|NCT02008617|9949219|FG001|NOT COMPLETED|Overall Study||0
8891313|NCT02008682|9949227|FG000|STARTED|Overall Study||184
8891314|NCT02008682|9949228|FG001|STARTED|Overall Study||184
8891315|NCT02008682|9949227|FG000|Exposed|Overall Study|1 subject withdrawn before exposure to trial product|183
8891316|NCT02008682|9949228|FG001|Exposed|Overall Study||184
8891317|NCT02008682|9949227|FG000|COMPLETED|Overall Study|Completed without discontinuation of trial product|157
8891318|NCT02008682|9949228|FG001|COMPLETED|Overall Study|Completed without discontinuation of trial product|170
8891319|NCT02008682|9949227|FG000|NOT COMPLETED|Overall Study||27
8891320|NCT02008682|9949228|FG001|NOT COMPLETED|Overall Study||14
8891321|NCT02008773|9949238|FG000|STARTED|Overall Study||40
8891322|NCT02008773|9949239|FG001|STARTED|Overall Study||34
8891323|NCT02008773|9949240|FG002|STARTED|Overall Study||46
8891324|NCT02008773|9949241|FG003|STARTED|Overall Study||50
8891325|NCT02008773|9949238|FG000|COMPLETED|Overall Study||27
8891326|NCT02008773|9949239|FG001|COMPLETED|Overall Study||25
8891327|NCT02008773|9949240|FG002|COMPLETED|Overall Study||32
8891328|NCT02008773|9949241|FG003|COMPLETED|Overall Study||38
8891329|NCT02008773|9949238|FG000|NOT COMPLETED|Overall Study||13
8891330|NCT02008773|9949239|FG001|NOT COMPLETED|Overall Study||9
8891331|NCT02008773|9949240|FG002|NOT COMPLETED|Overall Study||14
8891332|NCT02008773|9949241|FG003|NOT COMPLETED|Overall Study||12
8891333|NCT02008877|9949249|FG000|STARTED|Overall Study||3
8891334|NCT02008877|9949250|FG001|STARTED|Overall Study||7
8891335|NCT02008877|9949251|FG002|STARTED|Overall Study||10
8891336|NCT02008877|9949249|FG000|COMPLETED|Overall Study||3
8891337|NCT02008877|9949250|FG001|COMPLETED|Overall Study||6
8891338|NCT02008877|9949251|FG002|COMPLETED|Overall Study||10
8891339|NCT02008877|9949249|FG000|NOT COMPLETED|Overall Study||0
8891340|NCT02008877|9949250|FG001|NOT COMPLETED|Overall Study||1
8891341|NCT02008877|9949251|FG002|NOT COMPLETED|Overall Study||0
8891342|NCT02008890|9949263|FG000|STARTED|Period 1||80
8891343|NCT02008890|9949264|FG001|STARTED|Period 1||79
8891344|NCT02008890|9949265|FG002|STARTED|Period 1||78
8891345|NCT02008890|9949266|FG003|STARTED|Period 1||0
8891346|NCT02008890|9949267|FG004|STARTED|Period 1||0
8891347|NCT02008890|9949263|FG000|COMPLETED|Period 1||65
8891348|NCT02008890|9949264|FG001|COMPLETED|Period 1||64
8891349|NCT02008890|9949265|FG002|COMPLETED|Period 1||66
8891350|NCT02008890|9949266|FG003|COMPLETED|Period 1||0
9006488|NCT02951182|10069568|FG004|COMPLETED|Overall Study||6
9006489|NCT02951182|10069569|FG005|COMPLETED|Overall Study||20
9006490|NCT02951182|10069564|FG000|NOT COMPLETED|Overall Study||0
9006491|NCT02951182|10069565|FG001|NOT COMPLETED|Overall Study||0
9006492|NCT02951182|10069566|FG002|NOT COMPLETED|Overall Study||0
9006493|NCT02951182|10069567|FG003|NOT COMPLETED|Overall Study||0
8634990|NCT00559585|9675368|FG001|COMPLETED|Open Label LT Period Main + Sub-Study||0
8891351|NCT02008890|9949267|FG004|COMPLETED|Period 1||0
9006494|NCT02951182|10069568|FG004|NOT COMPLETED|Overall Study||0
9006495|NCT02951182|10069569|FG005|NOT COMPLETED|Overall Study||0
9006496|NCT02951195|10069597|FG000|STARTED|Overall Study||8
9006497|NCT02951195|10069598|FG001|STARTED|Overall Study||6
9006498|NCT02951195|10069599|FG002|STARTED|Overall Study||10
9006499|NCT02951195|10069600|FG003|STARTED|Overall Study||10
9006500|NCT02951195|10069601|FG004|STARTED|Overall Study||4
9006501|NCT02951195|10069602|FG005|STARTED|Overall Study||10
9006502|NCT02951195|10069603|FG006|STARTED|Overall Study||7
9006503|NCT02951195|10069604|FG007|STARTED|Overall Study||21
9006504|NCT02951195|10069597|FG000|COMPLETED|Overall Study||8
9006505|NCT02951195|10069598|FG001|COMPLETED|Overall Study||6
9006506|NCT02951195|10069599|FG002|COMPLETED|Overall Study||10
9006507|NCT02951195|10069600|FG003|COMPLETED|Overall Study||10
9006508|NCT02951195|10069601|FG004|COMPLETED|Overall Study||4
9006509|NCT02951195|10069602|FG005|COMPLETED|Overall Study||10
9006510|NCT02951195|10069603|FG006|COMPLETED|Overall Study||7
9006511|NCT02951195|10069604|FG007|COMPLETED|Overall Study||21
9006512|NCT02951195|10069597|FG000|NOT COMPLETED|Overall Study||0
9006513|NCT02951195|10069598|FG001|NOT COMPLETED|Overall Study||0
8691306|NCT00854100|9736549|FG000|STARTED|Overall Study||81
8891352|NCT02008890|9949263|FG000|NOT COMPLETED|Period 1||15
8891353|NCT02008890|9949264|FG001|NOT COMPLETED|Period 1||15
8891354|NCT02008890|9949265|FG002|NOT COMPLETED|Period 1||12
8891355|NCT02008890|9949266|FG003|NOT COMPLETED|Period 1||0
8891356|NCT02008890|9949267|FG004|NOT COMPLETED|Period 1||0
8891357|NCT02008890|9949263|FG000|STARTED|Period 2||65
8891358|NCT02008890|9949264|FG001|STARTED|Period 2||64
8891359|NCT02008890|9949265|FG002|STARTED|Period 2||10
8891360|NCT02008890|9949266|FG003|STARTED|Period 2||27
8891361|NCT02008890|9949267|FG004|STARTED|Period 2||28
8891362|NCT02008890|9949263|FG000|COMPLETED|Period 2||38
8891363|NCT02008890|9949264|FG001|COMPLETED|Period 2||49
8891364|NCT02008890|9949265|FG002|COMPLETED|Period 2||9
9006514|NCT02951195|10069599|FG002|NOT COMPLETED|Overall Study||0
9006515|NCT02951195|10069600|FG003|NOT COMPLETED|Overall Study||0
9006516|NCT02951195|10069601|FG004|NOT COMPLETED|Overall Study||0
9006517|NCT02951195|10069602|FG005|NOT COMPLETED|Overall Study||0
9006518|NCT02951195|10069603|FG006|NOT COMPLETED|Overall Study||0
9006519|NCT02951195|10069604|FG007|NOT COMPLETED|Overall Study||0
9006520|NCT02951273|10069632|FG000|STARTED|Overall Study||30
8891365|NCT02008890|9949266|FG003|COMPLETED|Period 2||13
8891366|NCT02008890|9949267|FG004|COMPLETED|Period 2||20
8891367|NCT02008890|9949263|FG000|NOT COMPLETED|Period 2||27
8891368|NCT02008890|9949264|FG001|NOT COMPLETED|Period 2||15
8891369|NCT02008890|9949265|FG002|NOT COMPLETED|Period 2||1
8891370|NCT02008890|9949266|FG003|NOT COMPLETED|Period 2||14
8891371|NCT02008890|9949267|FG004|NOT COMPLETED|Period 2||8
8891372|NCT02008890|9949263|FG000|STARTED|Extension Period||31
8891373|NCT02008890|9949264|FG001|STARTED|Extension Period||36
8891374|NCT02008890|9949265|FG002|STARTED|Extension Period||0
8891375|NCT02008890|9949266|FG003|STARTED|Extension Period||10
8891376|NCT02008890|9949267|FG004|STARTED|Extension Period||17
8891377|NCT02008890|9949263|FG000|COMPLETED|Extension Period||26
8891378|NCT02008890|9949264|FG001|COMPLETED|Extension Period||31
8891379|NCT02008890|9949265|FG002|COMPLETED|Extension Period||0
8891380|NCT02008890|9949266|FG003|COMPLETED|Extension Period||6
8891381|NCT02008890|9949267|FG004|COMPLETED|Extension Period||13
8891382|NCT02008890|9949263|FG000|NOT COMPLETED|Extension Period||5
8891383|NCT02008890|9949264|FG001|NOT COMPLETED|Extension Period||5
8634991|NCT00559585|9675367|FG000|NOT COMPLETED|Open Label LT Period Main + Sub-Study||428
8634992|NCT00559585|9675368|FG001|NOT COMPLETED|Open Label LT Period Main + Sub-Study||0
8634993|NCT00559637|9675385|FG000|STARTED|Overall Study||184
8634994|NCT00559637|9675385|FG000|COMPLETED|Overall Study||130
8634995|NCT00559637|9675385|FG000|NOT COMPLETED|Overall Study||54
8891384|NCT02008890|9949265|FG002|NOT COMPLETED|Extension Period||0
8891385|NCT02008890|9949266|FG003|NOT COMPLETED|Extension Period||4
8891386|NCT02008890|9949267|FG004|NOT COMPLETED|Extension Period||4
8891387|NCT02008916|9949285|FG000|STARTED|Primary Assessment (up to Week 16)||74
8891388|NCT02008916|9949286|FG001|STARTED|Primary Assessment (up to Week 16)||76
8891389|NCT02008916|9949287|FG002|STARTED|Primary Assessment (up to Week 16)||76
8891390|NCT02008916|9949285|FG000|FAS|Primary Assessment (up to Week 16)||74
8891391|NCT02008916|9949286|FG001|FAS|Primary Assessment (up to Week 16)||76
8891392|NCT02008916|9949287|FG002|FAS|Primary Assessment (up to Week 16)||76
8891393|NCT02008916|9949285|FG000|Safety Set|Primary Assessment (up to Week 16)||74
8891394|NCT02008916|9949286|FG001|Safety Set|Primary Assessment (up to Week 16)||76
8891395|NCT02008916|9949287|FG002|Safety Set|Primary Assessment (up to Week 16)||75
8891396|NCT02008916|9949285|FG000|COMPLETED|Primary Assessment (up to Week 16)||74
8891397|NCT02008916|9949286|FG001|COMPLETED|Primary Assessment (up to Week 16)||75
8891398|NCT02008916|9949287|FG002|COMPLETED|Primary Assessment (up to Week 16)||73
8891399|NCT02008916|9949285|FG000|NOT COMPLETED|Primary Assessment (up to Week 16)||0
8891400|NCT02008916|9949286|FG001|NOT COMPLETED|Primary Assessment (up to Week 16)||1
8891401|NCT02008916|9949287|FG002|NOT COMPLETED|Primary Assessment (up to Week 16)||3
8891402|NCT02008916|9949285|FG000|STARTED|Week 16 - 156||74
8891403|NCT02008916|9949286|FG001|STARTED|Week 16 - 156||75
8891404|NCT02008916|9949287|FG002|STARTED|Week 16 - 156||73
8891405|NCT02008916|9949285|FG000|COMPLETED|Week 16 - 156||55
8891406|NCT02008916|9949286|FG001|COMPLETED|Week 16 - 156||62
8891407|NCT02008916|9949287|FG002|COMPLETED|Week 16 - 156||63
8891408|NCT02008916|9949285|FG000|NOT COMPLETED|Week 16 - 156||19
8891409|NCT02008916|9949286|FG001|NOT COMPLETED|Week 16 - 156||13
8891410|NCT02008916|9949287|FG002|NOT COMPLETED|Week 16 - 156||10
8891411|NCT02008942|9949296|FG000|STARTED|First Intervention||27
8891412|NCT02008942|9949297|FG001|STARTED|First Intervention||30
8891413|NCT02008942|9949296|FG000|COMPLETED|First Intervention||27
8891414|NCT02008942|9949297|FG001|COMPLETED|First Intervention||30
8891415|NCT02008942|9949296|FG000|NOT COMPLETED|First Intervention||0
9006521|NCT02951273|10069632|FG000|COMPLETED|Overall Study||27
9006522|NCT02951273|10069632|FG000|NOT COMPLETED|Overall Study||3
9006523|NCT02951312|10069640|FG000|STARTED|Study Part 1||6
9006524|NCT02951312|10069641|FG001|STARTED|Study Part 1||6
9006525|NCT02951312|10069642|FG002|STARTED|Study Part 1||0
9006526|NCT02951312|10069643|FG003|STARTED|Study Part 1||0
9006527|NCT02951312|10069640|FG000|COMPLETED|Study Part 1||6
9006528|NCT02951312|10069641|FG001|COMPLETED|Study Part 1||6
9006529|NCT02951312|10069642|FG002|COMPLETED|Study Part 1||0
9006530|NCT02951312|10069643|FG003|COMPLETED|Study Part 1||0
9006531|NCT02951312|10069640|FG000|NOT COMPLETED|Study Part 1||0
9006532|NCT02951312|10069641|FG001|NOT COMPLETED|Study Part 1||0
9006533|NCT02951312|10069642|FG002|NOT COMPLETED|Study Part 1||0
9006534|NCT02951312|10069643|FG003|NOT COMPLETED|Study Part 1||0
9006535|NCT02951312|10069640|FG000|STARTED|Study Part 2||0
9006536|NCT02951312|10069641|FG001|STARTED|Study Part 2||0
9006537|NCT02951312|10069642|FG002|STARTED|Study Part 2||6
9006538|NCT02951312|10069643|FG003|STARTED|Study Part 2||6
9006539|NCT02951312|10069640|FG000|COMPLETED|Study Part 2||0
8634996|NCT00559754|9675389|FG000|STARTED|Overall Study||72
8634997|NCT00559754|9675389|FG000|COMPLETED|Overall Study||61
8891416|NCT02008942|9949297|FG001|NOT COMPLETED|First Intervention||0
8891417|NCT02008942|9949296|FG000|STARTED|Second Intervention||26
8891418|NCT02008942|9949297|FG001|STARTED|Second Intervention||30
8891419|NCT02008942|9949296|FG000|COMPLETED|Second Intervention||25
8891420|NCT02008942|9949297|FG001|COMPLETED|Second Intervention||30
9006540|NCT02951312|10069641|FG001|COMPLETED|Study Part 2||0
9006541|NCT02951312|10069642|FG002|COMPLETED|Study Part 2||6
9006542|NCT02951312|10069643|FG003|COMPLETED|Study Part 2||6
9006543|NCT02951312|10069640|FG000|NOT COMPLETED|Study Part 2||0
9006544|NCT02951312|10069641|FG001|NOT COMPLETED|Study Part 2||0
9006545|NCT02951312|10069642|FG002|NOT COMPLETED|Study Part 2||0
8891421|NCT02008942|9949296|FG000|NOT COMPLETED|Second Intervention||1
8891422|NCT02008942|9949297|FG001|NOT COMPLETED|Second Intervention||0
8891423|NCT02009046|9949305|FG000|STARTED|Overall Study||1025
8891424|NCT02009046|9949306|FG001|STARTED|Overall Study||884
8891425|NCT02009046|9949305|FG000|SEI Curriculum Only|Overall Study||461
8891426|NCT02009046|9949306|FG001|SEI Curriculum Only|Overall Study||0
8891427|NCT02009046|9949305|FG000|SEI Curriculum + 3 SchoolWide Components|Overall Study||544
8891428|NCT02009046|9949306|FG001|SEI Curriculum + 3 SchoolWide Components|Overall Study||0
8891429|NCT02009046|9949305|FG000|Ctrl Curriculum Only|Overall Study||0
8891430|NCT02009046|9949306|FG001|Ctrl Curriculum Only|Overall Study||456
8891431|NCT02009046|9949305|FG000|Ctrl Curriculm +1 SchoolWide Component|Overall Study||0
8891432|NCT02009046|9949306|FG001|Ctrl Curriculm +1 SchoolWide Component|Overall Study||428
8891433|NCT02009046|9949305|FG000|COMPLETED|Overall Study||769
8891434|NCT02009046|9949306|FG001|COMPLETED|Overall Study||678
8891435|NCT02009046|9949305|FG000|NOT COMPLETED|Overall Study||256
8891436|NCT02009046|9949306|FG001|NOT COMPLETED|Overall Study||206
8891437|NCT02009163|9949320|FG000|STARTED|Open-label Period (Non-randomized)||418
8891438|NCT02009163|9949321|FG001|STARTED|Open-label Period (Non-randomized)||0
8891439|NCT02009163|9949322|FG002|STARTED|Open-label Period (Non-randomized)||0
8891440|NCT02009163|9949320|FG000|COMPLETED|Open-label Period (Non-randomized)||275
8891441|NCT02009163|9949321|FG001|COMPLETED|Open-label Period (Non-randomized)||0
8891442|NCT02009163|9949322|FG002|COMPLETED|Open-label Period (Non-randomized)||0
8891443|NCT02009163|9949320|FG000|NOT COMPLETED|Open-label Period (Non-randomized)||143
8891444|NCT02009163|9949321|FG001|NOT COMPLETED|Open-label Period (Non-randomized)||0
8891445|NCT02009163|9949322|FG002|NOT COMPLETED|Open-label Period (Non-randomized)||0
8891446|NCT02009163|9949320|FG000|STARTED|Randomized-withdrawal Period|The open-label treatment group is not an arm of the randomized-withdrawal period.|0
8891447|NCT02009163|9949321|FG001|STARTED|Randomized-withdrawal Period|The total who started the Placebo and SPD489 arms equals those who completed the open-label period.|138
9006546|NCT02951312|10069643|FG003|NOT COMPLETED|Study Part 2||0
9006547|NCT02951351|10069665|FG000|STARTED|Overall Study||19
9006548|NCT02951351|10069666|FG001|STARTED|Overall Study||17
9006549|NCT02951351|10069665|FG000|COMPLETED|Overall Study||19
9006550|NCT02951351|10069666|FG001|COMPLETED|Overall Study||17
9006551|NCT02951351|10069665|FG000|NOT COMPLETED|Overall Study||0
9006552|NCT02951351|10069666|FG001|NOT COMPLETED|Overall Study||0
9006553|NCT02951429|10069674|FG000|STARTED|Overall Study||88
9006554|NCT02951429|10069675|FG001|STARTED|Overall Study||89
9006555|NCT02951429|10069674|FG000|COMPLETED|Overall Study||16
9006556|NCT02951429|10069675|FG001|COMPLETED|Overall Study||6
9006557|NCT02951429|10069674|FG000|NOT COMPLETED|Overall Study||72
9006558|NCT02951429|10069675|FG001|NOT COMPLETED|Overall Study||83
9006559|NCT02951533|10069683|FG000|STARTED|Part I (Week 0 Through Week 24)||60
9006560|NCT02951533|10069684|FG001|STARTED|Part I (Week 0 Through Week 24)||59
9006561|NCT02951533|10069685|FG002|STARTED|Part I (Week 0 Through Week 24)||0
9006562|NCT02951533|10069683|FG000|Treated|Part I (Week 0 Through Week 24)||60
9006563|NCT02951533|10069684|FG001|Treated|Part I (Week 0 Through Week 24)||58
9006564|NCT02951533|10069685|FG002|Treated|Part I (Week 0 Through Week 24)||0
9006565|NCT02951533|10069683|FG000|COMPLETED|Part I (Week 0 Through Week 24)||56
9006566|NCT02951533|10069684|FG001|COMPLETED|Part I (Week 0 Through Week 24)||36
9006567|NCT02951533|10069685|FG002|COMPLETED|Part I (Week 0 Through Week 24)||0
9006568|NCT02951533|10069683|FG000|NOT COMPLETED|Part I (Week 0 Through Week 24)||4
9006569|NCT02951533|10069684|FG001|NOT COMPLETED|Part I (Week 0 Through Week 24)||23
9006570|NCT02951533|10069685|FG002|NOT COMPLETED|Part I (Week 0 Through Week 24)||0
9006571|NCT02951533|10069683|FG000|STARTED|Part IIa (Week 24 Through Week 32)||56
9006572|NCT02951533|10069684|FG001|STARTED|Part IIa (Week 24 Through Week 32)|1 participant did not sign informed consent form (ICF) for Study Part II but completed Study Part I.|35
9006573|NCT02951533|10069685|FG002|STARTED|Part IIa (Week 24 Through Week 32)||0
9006574|NCT02951533|10069683|FG000|PASI 75 Responder at Week 32|Part IIa (Week 24 Through Week 32)||54
9006575|NCT02951533|10069684|FG001|PASI 75 Responder at Week 32|Part IIa (Week 24 Through Week 32)||14
9006576|NCT02951533|10069685|FG002|PASI 75 Responder at Week 32|Part IIa (Week 24 Through Week 32)||0
9006577|NCT02951533|10069683|FG000|PASI 75 Non-responder at Week 32|Part IIa (Week 24 Through Week 32)||1
9006578|NCT02951533|10069684|FG001|PASI 75 Non-responder at Week 32|Part IIa (Week 24 Through Week 32)||20
9006579|NCT02951533|10069685|FG002|PASI 75 Non-responder at Week 32|Part IIa (Week 24 Through Week 32)||0
9006580|NCT02951533|10069683|FG000|COMPLETED|Part IIa (Week 24 Through Week 32)||55
9006581|NCT02951533|10069684|FG001|COMPLETED|Part IIa (Week 24 Through Week 32)||34
9006582|NCT02951533|10069685|FG002|COMPLETED|Part IIa (Week 24 Through Week 32)||0
9006583|NCT02951533|10069683|FG000|NOT COMPLETED|Part IIa (Week 24 Through Week 32)||1
9006584|NCT02951533|10069684|FG001|NOT COMPLETED|Part IIa (Week 24 Through Week 32)||1
9006585|NCT02951533|10069685|FG002|NOT COMPLETED|Part IIa (Week 24 Through Week 32)||0
9006586|NCT02951533|10069683|FG000|STARTED|Part IIb (Week 32 Through Week 56)||55
9006587|NCT02951533|10069684|FG001|STARTED|Part IIb (Week 32 Through Week 56)|Out of 34 participants in the FAE group, 14 PASI 75 responders remained on FAE treatment.|14
9006588|NCT02951533|10069685|FG002|STARTED|Part IIb (Week 32 Through Week 56)|Out of 34 participants in FAE group, 20 PASI 75 non-responders switched to GUS group.|20
9006589|NCT02951533|10069683|FG000|COMPLETED|Part IIb (Week 32 Through Week 56)||54
9006590|NCT02951533|10069684|FG001|COMPLETED|Part IIb (Week 32 Through Week 56)||10
9006591|NCT02951533|10069685|FG002|COMPLETED|Part IIb (Week 32 Through Week 56)||20
9006592|NCT02951533|10069683|FG000|NOT COMPLETED|Part IIb (Week 32 Through Week 56)||1
8891448|NCT02009163|9949322|FG002|STARTED|Randomized-withdrawal Period|The total who started the Placebo and SPD489 arms equals those who completed the open-label period.|137
8891449|NCT02009163|9949320|FG000|COMPLETED|Randomized-withdrawal Period||0
8891450|NCT02009163|9949321|FG001|COMPLETED|Randomized-withdrawal Period||50
8891451|NCT02009163|9949322|FG002|COMPLETED|Randomized-withdrawal Period||102
8891452|NCT02009163|9949320|FG000|NOT COMPLETED|Randomized-withdrawal Period||0
8891453|NCT02009163|9949321|FG001|NOT COMPLETED|Randomized-withdrawal Period||88
8891454|NCT02009163|9949322|FG002|NOT COMPLETED|Randomized-withdrawal Period||35
8891455|NCT02009332|9949338|FG000|STARTED|Phase 1: Dose Level 1 (Weeks 1-10)||3
8634998|NCT00559754|9675389|FG000|NOT COMPLETED|Overall Study||11
8634999|NCT00559845|9675393|FG000|STARTED|Overall Study||56
8635000|NCT00559845|9675393|FG000|COMPLETED|Overall Study||49
8891456|NCT02009332|9949339|FG001|STARTED|Phase 1: Dose Level 1 (Weeks 1-10)||0
8891457|NCT02009332|9949340|FG002|STARTED|Phase 1: Dose Level 1 (Weeks 1-10)||0
8891458|NCT02009332|9949341|FG003|STARTED|Phase 1: Dose Level 1 (Weeks 1-10)||0
8891459|NCT02009332|9949342|FG004|STARTED|Phase 1: Dose Level 1 (Weeks 1-10)||0
8891460|NCT02009332|9949343|FG005|STARTED|Phase 1: Dose Level 1 (Weeks 1-10)||0
8891461|NCT02009332|9949338|FG000|COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)|Cohort 1 completed 6-week treatment.|3
8891462|NCT02009332|9949339|FG001|COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
8891463|NCT02009332|9949340|FG002|COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
8891464|NCT02009332|9949341|FG003|COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
8891465|NCT02009332|9949342|FG004|COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
8891466|NCT02009332|9949343|FG005|COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
8891467|NCT02009332|9949338|FG000|NOT COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
8891468|NCT02009332|9949339|FG001|NOT COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
8891469|NCT02009332|9949340|FG002|NOT COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
8891470|NCT02009332|9949341|FG003|NOT COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
8891471|NCT02009332|9949342|FG004|NOT COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
8891472|NCT02009332|9949343|FG005|NOT COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
8891473|NCT02009332|9949338|FG000|STARTED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
8891474|NCT02009332|9949339|FG001|STARTED|Phase 1: Dose Level 2/2b (Wks 11-29)||4
8891475|NCT02009332|9949340|FG002|STARTED|Phase 1: Dose Level 2/2b (Wks 11-29)||1
8891476|NCT02009332|9949341|FG003|STARTED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
8891477|NCT02009332|9949342|FG004|STARTED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
8891478|NCT02009332|9949343|FG005|STARTED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
8891479|NCT02009332|9949338|FG000|COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
8891480|NCT02009332|9949339|FG001|COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)|Cohort 2 completed 6-week treatment.|3
8891481|NCT02009332|9949340|FG002|COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)|Cohort 2b stopped due to lack of enrollment.|1
8891482|NCT02009332|9949341|FG003|COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
8635001|NCT00559845|9675393|FG000|NOT COMPLETED|Overall Study||7
8635002|NCT00559949|9675397|FG000|STARTED|Overall Study||39
8891483|NCT02009332|9949342|FG004|COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
8891484|NCT02009332|9949343|FG005|COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
8891485|NCT02009332|9949338|FG000|NOT COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
8891486|NCT02009332|9949339|FG001|NOT COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||1
8891487|NCT02009332|9949340|FG002|NOT COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
8891488|NCT02009332|9949341|FG003|NOT COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
8891489|NCT02009332|9949342|FG004|NOT COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
8891490|NCT02009332|9949343|FG005|NOT COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
9006593|NCT02951533|10069684|FG001|NOT COMPLETED|Part IIb (Week 32 Through Week 56)||4
9006594|NCT02951533|10069685|FG002|NOT COMPLETED|Part IIb (Week 32 Through Week 56)||0
9006595|NCT02951533|10069683|FG000|STARTED|Part III (Week 64 Through Week 100)|18 participants were not eligible to enter Part III.|36
9006596|NCT02951533|10069684|FG001|STARTED|Part III (Week 64 Through Week 100)|10 participants in the FAE group were not eligible to enter Part III.|0
9006597|NCT02951533|10069685|FG002|STARTED|Part III (Week 64 Through Week 100)|8 participants were not eligible to enter Part III.|12
9006598|NCT02951533|10069683|FG000|COMPLETED|Part III (Week 64 Through Week 100)||32
9006599|NCT02951533|10069684|FG001|COMPLETED|Part III (Week 64 Through Week 100)||0
9006600|NCT02951533|10069685|FG002|COMPLETED|Part III (Week 64 Through Week 100)||10
9006601|NCT02951533|10069683|FG000|NOT COMPLETED|Part III (Week 64 Through Week 100)||4
9006602|NCT02951533|10069684|FG001|NOT COMPLETED|Part III (Week 64 Through Week 100)||0
9006603|NCT02951533|10069685|FG002|NOT COMPLETED|Part III (Week 64 Through Week 100)||2
9006604|NCT02951702|10069704|FG000|STARTED|Overall Study||34
9006605|NCT02951702|10069705|FG001|STARTED|Overall Study||17
9006606|NCT02951702|10069704|FG000|COMPLETED|Overall Study||34
9006607|NCT02951702|10069705|FG001|COMPLETED|Overall Study||17
9006608|NCT02951702|10069704|FG000|NOT COMPLETED|Overall Study||0
9006609|NCT02951702|10069705|FG001|NOT COMPLETED|Overall Study||0
9006610|NCT02951780|10069720|FG000|STARTED|Period 1||3
9006611|NCT02951780|10069721|FG001|STARTED|Period 1||2
9006612|NCT02951780|10069722|FG002|STARTED|Period 1||3
9006613|NCT02951780|10069723|FG003|STARTED|Period 1||3
9006614|NCT02951780|10069724|FG004|STARTED|Period 1||2
9006615|NCT02951780|10069725|FG005|STARTED|Period 1||3
9006616|NCT02951780|10069726|FG006|STARTED|Period 1||2
9006617|NCT02951780|10069727|FG007|STARTED|Period 1||3
8635003|NCT00559949|9675397|FG000|COMPLETED|Overall Study||32
8635004|NCT00559949|9675397|FG000|NOT COMPLETED|Overall Study||7
8891491|NCT02009332|9949338|FG000|STARTED|Phase 1: Dose Level 3 (Weeks 30-47)||0
8891492|NCT02009332|9949339|FG001|STARTED|Phase 1: Dose Level 3 (Weeks 30-47)||0
8891493|NCT02009332|9949340|FG002|STARTED|Phase 1: Dose Level 3 (Weeks 30-47)||0
8891494|NCT02009332|9949341|FG003|STARTED|Phase 1: Dose Level 3 (Weeks 30-47)||3
8891495|NCT02009332|9949342|FG004|STARTED|Phase 1: Dose Level 3 (Weeks 30-47)||0
8891496|NCT02009332|9949343|FG005|STARTED|Phase 1: Dose Level 3 (Weeks 30-47)||0
8891497|NCT02009332|9949338|FG000|COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
8891498|NCT02009332|9949339|FG001|COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
8891499|NCT02009332|9949340|FG002|COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
8891500|NCT02009332|9949341|FG003|COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)|Cohort 3 completed 6-week treatment.|3
8891501|NCT02009332|9949342|FG004|COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
8891502|NCT02009332|9949343|FG005|COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
8891503|NCT02009332|9949338|FG000|NOT COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
8891504|NCT02009332|9949339|FG001|NOT COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
8891505|NCT02009332|9949340|FG002|NOT COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
8891506|NCT02009332|9949341|FG003|NOT COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
8891507|NCT02009332|9949342|FG004|NOT COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
8891508|NCT02009332|9949343|FG005|NOT COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
8891509|NCT02009332|9949338|FG000|STARTED|Phase 1: Dose Level 4 (Weeks 48-77)||0
8891510|NCT02009332|9949339|FG001|STARTED|Phase 1: Dose Level 4 (Weeks 48-77)||0
8891511|NCT02009332|9949340|FG002|STARTED|Phase 1: Dose Level 4 (Weeks 48-77)||0
8891512|NCT02009332|9949341|FG003|STARTED|Phase 1: Dose Level 4 (Weeks 48-77)||0
8891513|NCT02009332|9949342|FG004|STARTED|Phase 1: Dose Level 4 (Weeks 48-77)||4
8891514|NCT02009332|9949343|FG005|STARTED|Phase 1: Dose Level 4 (Weeks 48-77)||0
8891515|NCT02009332|9949338|FG000|COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
8891516|NCT02009332|9949339|FG001|COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
8891517|NCT02009332|9949340|FG002|COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
8891518|NCT02009332|9949341|FG003|COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
8891519|NCT02009332|9949342|FG004|COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)|Cohort 4 completed 6-week treatment.|3
9006618|NCT02951780|10069728|FG008|STARTED|Period 1||2
9006619|NCT02951780|10069720|FG000|COMPLETED|Period 1||3
9006620|NCT02951780|10069721|FG001|COMPLETED|Period 1||2
9006621|NCT02951780|10069722|FG002|COMPLETED|Period 1||3
9006622|NCT02951780|10069723|FG003|COMPLETED|Period 1||2
9006623|NCT02951780|10069724|FG004|COMPLETED|Period 1||2
8635005|NCT00559962|9675409|FG000|STARTED|Overall Study||33
8635006|NCT00559962|9675410|FG001|STARTED|Overall Study||34
8635007|NCT00559962|9675411|FG002|STARTED|Overall Study||34
9006624|NCT02951780|10069725|FG005|COMPLETED|Period 1||3
9006625|NCT02951780|10069726|FG006|COMPLETED|Period 1||2
9006626|NCT02951780|10069727|FG007|COMPLETED|Period 1||2
9006627|NCT02951780|10069728|FG008|COMPLETED|Period 1||2
9006628|NCT02951780|10069720|FG000|NOT COMPLETED|Period 1||0
9006629|NCT02951780|10069721|FG001|NOT COMPLETED|Period 1||0
9006630|NCT02951780|10069722|FG002|NOT COMPLETED|Period 1||0
9006631|NCT02951780|10069723|FG003|NOT COMPLETED|Period 1||1
9006632|NCT02951780|10069724|FG004|NOT COMPLETED|Period 1||0
9006633|NCT02951780|10069725|FG005|NOT COMPLETED|Period 1||0
9006634|NCT02951780|10069726|FG006|NOT COMPLETED|Period 1||0
9006635|NCT02951780|10069727|FG007|NOT COMPLETED|Period 1||1
9006636|NCT02951780|10069728|FG008|NOT COMPLETED|Period 1||0
9006637|NCT02951780|10069720|FG000|STARTED|Period 2||3
9006638|NCT02951780|10069721|FG001|STARTED|Period 2||2
9006639|NCT02951780|10069722|FG002|STARTED|Period 2||3
9006640|NCT02951780|10069723|FG003|STARTED|Period 2||2
9006641|NCT02951780|10069724|FG004|STARTED|Period 2||2
8891520|NCT02009332|9949343|FG005|COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
8891521|NCT02009332|9949338|FG000|NOT COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
8891522|NCT02009332|9949339|FG001|NOT COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
8891523|NCT02009332|9949340|FG002|NOT COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
8891524|NCT02009332|9949341|FG003|NOT COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
8891525|NCT02009332|9949342|FG004|NOT COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||1
8891526|NCT02009332|9949343|FG005|NOT COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
8891527|NCT02009332|9949338|FG000|STARTED|Phase 2 (Weeks 206-252)||0
8891528|NCT02009332|9949339|FG001|STARTED|Phase 2 (Weeks 206-252)||0
8891529|NCT02009332|9949340|FG002|STARTED|Phase 2 (Weeks 206-252)||0
8891530|NCT02009332|9949341|FG003|STARTED|Phase 2 (Weeks 206-252)||0
8891531|NCT02009332|9949342|FG004|STARTED|Phase 2 (Weeks 206-252)||0
8891532|NCT02009332|9949343|FG005|STARTED|Phase 2 (Weeks 206-252)||6
8891533|NCT02009332|9949338|FG000|COMPLETED|Phase 2 (Weeks 206-252)||0
8891534|NCT02009332|9949339|FG001|COMPLETED|Phase 2 (Weeks 206-252)||0
8891535|NCT02009332|9949340|FG002|COMPLETED|Phase 2 (Weeks 206-252)||0
8891536|NCT02009332|9949341|FG003|COMPLETED|Phase 2 (Weeks 206-252)||0
9006642|NCT02951780|10069725|FG005|STARTED|Period 2||3
8635008|NCT00559962|9675412|FG003|STARTED|Overall Study||34
8635009|NCT00559962|9675413|FG004|STARTED|Overall Study||35
8891537|NCT02009332|9949342|FG004|COMPLETED|Phase 2 (Weeks 206-252)||0
8891538|NCT02009332|9949343|FG005|COMPLETED|Phase 2 (Weeks 206-252)|Phase 2 stopped due to lack of efficacy.|5
9006643|NCT02951780|10069726|FG006|STARTED|Period 2||2
9006644|NCT02951780|10069727|FG007|STARTED|Period 2||2
9006645|NCT02951780|10069728|FG008|STARTED|Period 2||2
9006646|NCT02951780|10069720|FG000|COMPLETED|Period 2||3
9006647|NCT02951780|10069721|FG001|COMPLETED|Period 2||2
9006648|NCT02951780|10069722|FG002|COMPLETED|Period 2||3
8891539|NCT02009332|9949338|FG000|NOT COMPLETED|Phase 2 (Weeks 206-252)||0
8891540|NCT02009332|9949339|FG001|NOT COMPLETED|Phase 2 (Weeks 206-252)||0
8891541|NCT02009332|9949340|FG002|NOT COMPLETED|Phase 2 (Weeks 206-252)||0
9006649|NCT02951780|10069723|FG003|COMPLETED|Period 2||2
9006650|NCT02951780|10069724|FG004|COMPLETED|Period 2||2
9006651|NCT02951780|10069725|FG005|COMPLETED|Period 2||3
9006652|NCT02951780|10069726|FG006|COMPLETED|Period 2||2
9006653|NCT02951780|10069727|FG007|COMPLETED|Period 2||1
9006654|NCT02951780|10069728|FG008|COMPLETED|Period 2||2
9006655|NCT02951780|10069720|FG000|NOT COMPLETED|Period 2||0
9006656|NCT02951780|10069721|FG001|NOT COMPLETED|Period 2||0
9006657|NCT02951780|10069722|FG002|NOT COMPLETED|Period 2||0
9006658|NCT02951780|10069723|FG003|NOT COMPLETED|Period 2||0
9006659|NCT02951780|10069724|FG004|NOT COMPLETED|Period 2||0
9006660|NCT02951780|10069725|FG005|NOT COMPLETED|Period 2||0
8891542|NCT02009332|9949341|FG003|NOT COMPLETED|Phase 2 (Weeks 206-252)||0
8891543|NCT02009332|9949342|FG004|NOT COMPLETED|Phase 2 (Weeks 206-252)||0
9006661|NCT02951780|10069726|FG006|NOT COMPLETED|Period 2||0
9006662|NCT02951780|10069727|FG007|NOT COMPLETED|Period 2||1
9006663|NCT02951780|10069728|FG008|NOT COMPLETED|Period 2||0
9006664|NCT02951780|10069720|FG000|STARTED|Period 3||3
9006665|NCT02951780|10069721|FG001|STARTED|Period 3||2
9006666|NCT02951780|10069722|FG002|STARTED|Period 3||3
9006667|NCT02951780|10069723|FG003|STARTED|Period 3||2
9006668|NCT02951780|10069724|FG004|STARTED|Period 3||2
9006669|NCT02951780|10069725|FG005|STARTED|Period 3||3
9006670|NCT02951780|10069726|FG006|STARTED|Period 3||2
9006671|NCT02951780|10069727|FG007|STARTED|Period 3||1
9006672|NCT02951780|10069728|FG008|STARTED|Period 3||2
9006673|NCT02951780|10069720|FG000|COMPLETED|Period 3||3
9006674|NCT02951780|10069721|FG001|COMPLETED|Period 3||2
9006675|NCT02951780|10069722|FG002|COMPLETED|Period 3||3
9006676|NCT02951780|10069723|FG003|COMPLETED|Period 3||2
9006677|NCT02951780|10069724|FG004|COMPLETED|Period 3||2
9006678|NCT02951780|10069725|FG005|COMPLETED|Period 3||3
9006679|NCT02951780|10069726|FG006|COMPLETED|Period 3||2
9006680|NCT02951780|10069727|FG007|COMPLETED|Period 3||1
9006681|NCT02951780|10069728|FG008|COMPLETED|Period 3||2
9006682|NCT02951780|10069720|FG000|NOT COMPLETED|Period 3||0
9006683|NCT02951780|10069721|FG001|NOT COMPLETED|Period 3||0
9006684|NCT02951780|10069722|FG002|NOT COMPLETED|Period 3||0
9006685|NCT02951780|10069723|FG003|NOT COMPLETED|Period 3||0
9006686|NCT02951780|10069724|FG004|NOT COMPLETED|Period 3||0
9006687|NCT02951780|10069725|FG005|NOT COMPLETED|Period 3||0
9006688|NCT02951780|10069726|FG006|NOT COMPLETED|Period 3||0
9006689|NCT02951780|10069727|FG007|NOT COMPLETED|Period 3||0
9006690|NCT02951780|10069728|FG008|NOT COMPLETED|Period 3||0
9006691|NCT02951819|10069750|FG000|STARTED|Overall Study||87
9006692|NCT02951819|10069751|FG001|STARTED|Overall Study||14
9006693|NCT02951819|10069750|FG000|Treated|Overall Study||86
9006694|NCT02951819|10069751|FG001|Treated|Overall Study||14
9006695|NCT02951819|10069750|FG000|COMPLETED|Overall Study||59
9006696|NCT02951819|10069751|FG001|COMPLETED|Overall Study||7
9006697|NCT02951819|10069750|FG000|NOT COMPLETED|Overall Study||28
9006698|NCT02951819|10069751|FG001|NOT COMPLETED|Overall Study||7
9006699|NCT02951884|10069760|FG000|STARTED|Overall Study||0
9006700|NCT02951884|10069761|FG001|STARTED|Overall Study||1
9006701|NCT02951884|10069762|FG002|STARTED|Overall Study||1
9006702|NCT02951884|10069760|FG000|COMPLETED|Overall Study||0
9006703|NCT02951884|10069761|FG001|COMPLETED|Overall Study||1
9006704|NCT02951884|10069762|FG002|COMPLETED|Overall Study||1
9006705|NCT02951884|10069760|FG000|NOT COMPLETED|Overall Study||0
9006706|NCT02951884|10069761|FG001|NOT COMPLETED|Overall Study||0
9006707|NCT02951884|10069762|FG002|NOT COMPLETED|Overall Study||0
9006708|NCT02951988|10069773|FG000|STARTED|Open-Label Treatment Period||1304
9006709|NCT02951988|10069774|FG001|STARTED|Open-Label Treatment Period||0
9006710|NCT02951988|10069775|FG002|STARTED|Open-Label Treatment Period||0
9006711|NCT02951988|10069776|FG003|STARTED|Open-Label Treatment Period||0
9006712|NCT02951988|10069773|FG000|COMPLETED|Open-Label Treatment Period||1056
9006713|NCT02951988|10069774|FG001|COMPLETED|Open-Label Treatment Period||0
9006714|NCT02951988|10069775|FG002|COMPLETED|Open-Label Treatment Period||0
8891544|NCT02009332|9949343|FG005|NOT COMPLETED|Phase 2 (Weeks 206-252)||1
8891545|NCT02009397|9949357|FG000|STARTED|Overall Study||26
8891546|NCT02009397|9949357|FG000|COMPLETED|Overall Study||6
8891547|NCT02009397|9949357|FG000|NOT COMPLETED|Overall Study||20
8891548|NCT02009501|9949363|FG000|STARTED|Overall Study||9
8891549|NCT02009501|9949364|FG001|STARTED|Overall Study||11
8891550|NCT02009501|9949363|FG000|COMPLETED|Overall Study||9
8891551|NCT02009501|9949364|FG001|COMPLETED|Overall Study||11
8891552|NCT02009501|9949363|FG000|NOT COMPLETED|Overall Study||0
8891553|NCT02009501|9949364|FG001|NOT COMPLETED|Overall Study||0
8891554|NCT02009696|9949370|FG000|STARTED|Overall Study||221
8891555|NCT02009696|9949370|FG000|COMPLETED|Overall Study||219
8891556|NCT02009696|9949370|FG000|NOT COMPLETED|Overall Study||2
8891557|NCT02009722|9949376|FG000|STARTED|Overall Study||41
9006715|NCT02951988|10069776|FG003|COMPLETED|Open-Label Treatment Period||0
9006716|NCT02951988|10069773|FG000|NOT COMPLETED|Open-Label Treatment Period||248
9006717|NCT02951988|10069774|FG001|NOT COMPLETED|Open-Label Treatment Period||0
9006718|NCT02951988|10069775|FG002|NOT COMPLETED|Open-Label Treatment Period||0
9006719|NCT02951988|10069776|FG003|NOT COMPLETED|Open-Label Treatment Period||0
9006720|NCT02951988|10069773|FG000|STARTED|Double-Blind Treatment Period||0
9006721|NCT02951988|10069774|FG001|STARTED|Double-Blind Treatment Period||202
8891558|NCT02009722|9949377|FG001|STARTED|Overall Study||43
8891559|NCT02009722|9949376|FG000|Received Intervention|Overall Study||41
8891560|NCT02009722|9949377|FG001|Received Intervention|Overall Study||42
8891561|NCT02009722|9949376|FG000|COMPLETED|Overall Study||40
8891562|NCT02009722|9949377|FG001|COMPLETED|Overall Study||40
8891563|NCT02009722|9949376|FG000|NOT COMPLETED|Overall Study||1
8891564|NCT02009722|9949377|FG001|NOT COMPLETED|Overall Study||3
8891565|NCT02009865|9949385|FG000|STARTED|Overall Study||81
8891566|NCT02009865|9949386|FG001|STARTED|Overall Study||81
8891567|NCT02009865|9949385|FG000|COMPLETED|Overall Study||80
8891568|NCT02009865|9949386|FG001|COMPLETED|Overall Study||76
8891569|NCT02009865|9949385|FG000|NOT COMPLETED|Overall Study||1
8891570|NCT02009865|9949386|FG001|NOT COMPLETED|Overall Study||5
8891571|NCT02009878|9949395|FG000|STARTED|Overall Study||10
8891572|NCT02009878|9949396|FG001|STARTED|Overall Study||11
8891573|NCT02009878|9949397|FG002|STARTED|Overall Study||9
8891574|NCT02009878|9949395|FG000|COMPLETED|Overall Study||10
8891575|NCT02009878|9949396|FG001|COMPLETED|Overall Study||10
8891576|NCT02009878|9949397|FG002|COMPLETED|Overall Study||9
8891577|NCT02009878|9949395|FG000|NOT COMPLETED|Overall Study||0
8891578|NCT02009878|9949396|FG001|NOT COMPLETED|Overall Study||1
8891579|NCT02009878|9949397|FG002|NOT COMPLETED|Overall Study||0
8891580|NCT02009930|9949405|FG000|STARTED|Overall Study|5 withdrawn|112
8891581|NCT02009930|9949405|FG000|COMPLETED|Overall Study||107
8891582|NCT02009930|9949405|FG000|NOT COMPLETED|Overall Study||5
8891583|NCT02010021|9949418|FG000|STARTED|Overall Study||10
8891584|NCT02010021|9949419|FG001|STARTED|Overall Study||7
8891585|NCT02010021|9949418|FG000|COMPLETED|Overall Study||10
8891586|NCT02010021|9949419|FG001|COMPLETED|Overall Study||7
8891587|NCT02010021|9949418|FG000|NOT COMPLETED|Overall Study||0
8891588|NCT02010021|9949419|FG001|NOT COMPLETED|Overall Study||0
8891589|NCT02010151|9949427|FG000|STARTED|Overall Study|January 2013 to December 2017|1498
8891590|NCT02010151|9949428|FG001|STARTED|Overall Study|January 2013 to December 2017|1696
8891591|NCT02010151|9949427|FG000|COMPLETED|Overall Study|Text message (TM) sent: 0|1498
8891592|NCT02010151|9949428|FG001|COMPLETED|Overall Study|TM sent: 598|1696
8891593|NCT02010151|9949427|FG000|NOT COMPLETED|Overall Study||0
8891594|NCT02010151|9949428|FG001|NOT COMPLETED|Overall Study||0
8891595|NCT02010203|9949439|FG000|STARTED|Overall Study||10
8891596|NCT02010203|9949440|FG001|STARTED|Overall Study||26
8891597|NCT02010203|9949441|FG002|STARTED|Overall Study||26
8891598|NCT02010203|9949442|FG003|STARTED|Overall Study||26
8891599|NCT02010203|9949443|FG004|STARTED|Overall Study||16
8891600|NCT02010203|9949439|FG000|COMPLETED|Overall Study||10
8891601|NCT02010203|9949440|FG001|COMPLETED|Overall Study||17
8891602|NCT02010203|9949441|FG002|COMPLETED|Overall Study||16
8891603|NCT02010203|9949442|FG003|COMPLETED|Overall Study||23
8891604|NCT02010203|9949443|FG004|COMPLETED|Overall Study||3
8891605|NCT02010203|9949439|FG000|NOT COMPLETED|Overall Study||0
8891606|NCT02010203|9949440|FG001|NOT COMPLETED|Overall Study||9
8891607|NCT02010203|9949441|FG002|NOT COMPLETED|Overall Study||10
8891608|NCT02010203|9949442|FG003|NOT COMPLETED|Overall Study||3
8891609|NCT02010203|9949443|FG004|NOT COMPLETED|Overall Study||13
8891610|NCT02010216|9949455|FG000|STARTED|Overall Study||23
8891611|NCT02010216|9949455|FG000|COMPLETED|Overall Study||23
8891612|NCT02010216|9949455|FG000|NOT COMPLETED|Overall Study||0
8891613|NCT02010255|9949473|FG000|STARTED|Overall Study||28
8891614|NCT02010255|9949474|FG001|STARTED|Overall Study||28
8891615|NCT02010255|9949475|FG002|STARTED|Overall Study||25
8891616|NCT02010255|9949476|FG003|STARTED|Overall Study||26
8891617|NCT02010255|9949477|FG004|STARTED|Overall Study||52
8635010|NCT00559962|9675414|FG005|STARTED|Overall Study||28
8891618|NCT02010255|9949478|FG005|STARTED|Overall Study||49
8891619|NCT02010255|9949479|FG006|STARTED|Overall Study||34
8891620|NCT02010255|9949480|FG007|STARTED|Overall Study||33
8891621|NCT02010255|9949481|FG008|STARTED|Overall Study||22
8891622|NCT02010255|9949482|FG009|STARTED|Overall Study||23
8891623|NCT02010255|9949483|FG010|STARTED|Overall Study||3
8891624|NCT02010255|9949484|FG011|STARTED|Overall Study||5
8891625|NCT02010255|9949485|FG012|STARTED|Overall Study||3
8891626|NCT02010255|9949486|FG013|STARTED|Overall Study||3
8891627|NCT02010255|9949473|FG000|COMPLETED|Overall Study||22
8891628|NCT02010255|9949474|FG001|COMPLETED|Overall Study||26
8891629|NCT02010255|9949475|FG002|COMPLETED|Overall Study||18
8891630|NCT02010255|9949476|FG003|COMPLETED|Overall Study||20
8891631|NCT02010255|9949477|FG004|COMPLETED|Overall Study||48
8891632|NCT02010255|9949478|FG005|COMPLETED|Overall Study||49
8891633|NCT02010255|9949479|FG006|COMPLETED|Overall Study||33
8891634|NCT02010255|9949480|FG007|COMPLETED|Overall Study||32
8891635|NCT02010255|9949481|FG008|COMPLETED|Overall Study||21
8891636|NCT02010255|9949482|FG009|COMPLETED|Overall Study||23
8891637|NCT02010255|9949483|FG010|COMPLETED|Overall Study||1
8891638|NCT02010255|9949484|FG011|COMPLETED|Overall Study||4
8891639|NCT02010255|9949485|FG012|COMPLETED|Overall Study||3
8891640|NCT02010255|9949486|FG013|COMPLETED|Overall Study||2
8891641|NCT02010255|9949473|FG000|NOT COMPLETED|Overall Study||6
8891642|NCT02010255|9949474|FG001|NOT COMPLETED|Overall Study||2
8891643|NCT02010255|9949475|FG002|NOT COMPLETED|Overall Study||7
8635011|NCT00559962|9675415|FG006|STARTED|Overall Study||33
8891644|NCT02010255|9949476|FG003|NOT COMPLETED|Overall Study||6
8891645|NCT02010255|9949477|FG004|NOT COMPLETED|Overall Study||4
8891646|NCT02010255|9949478|FG005|NOT COMPLETED|Overall Study||0
8891647|NCT02010255|9949479|FG006|NOT COMPLETED|Overall Study||1
8891648|NCT02010255|9949480|FG007|NOT COMPLETED|Overall Study||1
8891649|NCT02010255|9949481|FG008|NOT COMPLETED|Overall Study||1
8891650|NCT02010255|9949482|FG009|NOT COMPLETED|Overall Study||0
8891651|NCT02010255|9949483|FG010|NOT COMPLETED|Overall Study||2
8891652|NCT02010255|9949484|FG011|NOT COMPLETED|Overall Study||1
8891653|NCT02010255|9949485|FG012|NOT COMPLETED|Overall Study||0
8891654|NCT02010255|9949486|FG013|NOT COMPLETED|Overall Study||1
8891655|NCT02010359|9949543|FG000|STARTED|Overall Study||15
8891656|NCT02010359|9949544|FG001|STARTED|Overall Study||14
8891657|NCT02010359|9949543|FG000|COMPLETED|Overall Study||13
8891658|NCT02010359|9949544|FG001|COMPLETED|Overall Study||12
8891659|NCT02010359|9949543|FG000|NOT COMPLETED|Overall Study||2
8891660|NCT02010359|9949544|FG001|NOT COMPLETED|Overall Study||2
8891661|NCT02010567|9949555|FG000|STARTED|Overall Study||3
8891662|NCT02010567|9949556|FG001|STARTED|Overall Study||6
8891663|NCT02010567|9949557|FG002|STARTED|Overall Study||14
8891664|NCT02010567|9949558|FG003|STARTED|Overall Study||3
8891665|NCT02010567|9949559|FG004|STARTED|Overall Study||6
8891666|NCT02010567|9949555|FG000|COMPLETED|Overall Study||3
8891667|NCT02010567|9949556|FG001|COMPLETED|Overall Study||6
8891668|NCT02010567|9949557|FG002|COMPLETED|Overall Study||13
8891669|NCT02010567|9949558|FG003|COMPLETED|Overall Study||3
8891670|NCT02010567|9949559|FG004|COMPLETED|Overall Study||5
8891671|NCT02010567|9949555|FG000|NOT COMPLETED|Overall Study||0
8891672|NCT02010567|9949556|FG001|NOT COMPLETED|Overall Study||0
8891673|NCT02010567|9949557|FG002|NOT COMPLETED|Overall Study||1
8891674|NCT02010567|9949558|FG003|NOT COMPLETED|Overall Study||0
8891675|NCT02010567|9949559|FG004|NOT COMPLETED|Overall Study||1
8891676|NCT02010632|9949569|FG000|STARTED|First Intervention (7 Days)||16
8891677|NCT02010632|9949570|FG001|STARTED|First Intervention (7 Days)||16
8891678|NCT02010632|9949569|FG000|COMPLETED|First Intervention (7 Days)||16
8891679|NCT02010632|9949570|FG001|COMPLETED|First Intervention (7 Days)||16
8891680|NCT02010632|9949569|FG000|NOT COMPLETED|First Intervention (7 Days)||0
8891681|NCT02010632|9949570|FG001|NOT COMPLETED|First Intervention (7 Days)||0
8891682|NCT02010632|9949569|FG000|STARTED|Wash Out Period (14 Days)||16
8891683|NCT02010632|9949570|FG001|STARTED|Wash Out Period (14 Days)||16
8891684|NCT02010632|9949569|FG000|COMPLETED|Wash Out Period (14 Days)||16
8891685|NCT02010632|9949570|FG001|COMPLETED|Wash Out Period (14 Days)||16
8891686|NCT02010632|9949569|FG000|NOT COMPLETED|Wash Out Period (14 Days)||0
8891687|NCT02010632|9949570|FG001|NOT COMPLETED|Wash Out Period (14 Days)||0
8891688|NCT02010632|9949569|FG000|STARTED|Second Intervention (7 Days)||16
8891689|NCT02010632|9949570|FG001|STARTED|Second Intervention (7 Days)||16
8891690|NCT02010632|9949569|FG000|COMPLETED|Second Intervention (7 Days)||15
8891691|NCT02010632|9949570|FG001|COMPLETED|Second Intervention (7 Days)||16
8891692|NCT02010632|9949569|FG000|NOT COMPLETED|Second Intervention (7 Days)||1
8891693|NCT02010632|9949570|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
8891694|NCT02010645|9949576|FG000|STARTED|Overall Study||6
8891695|NCT02010645|9949576|FG000|COMPLETED|Overall Study||6
8891696|NCT02010645|9949576|FG000|NOT COMPLETED|Overall Study||0
9006722|NCT02951988|10069775|FG002|STARTED|Double-Blind Treatment Period||202
9006723|NCT02951988|10069776|FG003|STARTED|Double-Blind Treatment Period||200
9006724|NCT02951988|10069773|FG000|COMPLETED|Double-Blind Treatment Period||0
9006725|NCT02951988|10069774|FG001|COMPLETED|Double-Blind Treatment Period||101
9006726|NCT02951988|10069775|FG002|COMPLETED|Double-Blind Treatment Period||101
9006727|NCT02951988|10069776|FG003|COMPLETED|Double-Blind Treatment Period||85
9006728|NCT02951988|10069773|FG000|NOT COMPLETED|Double-Blind Treatment Period||0
9006729|NCT02951988|10069774|FG001|NOT COMPLETED|Double-Blind Treatment Period||101
9006730|NCT02951988|10069775|FG002|NOT COMPLETED|Double-Blind Treatment Period||101
9006731|NCT02951988|10069776|FG003|NOT COMPLETED|Double-Blind Treatment Period||115
9006732|NCT02952001|10069788|FG000|STARTED|Overall Study||28
9006733|NCT02952001|10069789|FG001|STARTED|Overall Study||5
9006734|NCT02952001|10069788|FG000|COMPLETED|Overall Study||14
9006735|NCT02952001|10069789|FG001|COMPLETED|Overall Study||2
9006736|NCT02952001|10069788|FG000|NOT COMPLETED|Overall Study||14
9006737|NCT02952001|10069789|FG001|NOT COMPLETED|Overall Study||3
9006738|NCT02952261|10069798|FG000|STARTED|Overall Study||100
9006739|NCT02952261|10069799|FG001|STARTED|Overall Study||100
9006740|NCT02952261|10069798|FG000|COMPLETED|Overall Study||95
9006741|NCT02952261|10069799|FG001|COMPLETED|Overall Study||95
9006742|NCT02952261|10069798|FG000|NOT COMPLETED|Overall Study||5
9006743|NCT02952261|10069799|FG001|NOT COMPLETED|Overall Study||5
9006744|NCT02952313|10069805|FG000|STARTED|Primary Endpoint||113
9006745|NCT02952313|10069805|FG000|6 Months|Primary Endpoint||106
9006746|NCT02952313|10069805|FG000|COMPLETED|Primary Endpoint||106
9006747|NCT02952313|10069805|FG000|NOT COMPLETED|Primary Endpoint||7
9006748|NCT02952313|10069805|FG000|STARTED|Long-term Follow-up||107
9006749|NCT02952313|10069805|FG000|12-Month|Long-term Follow-up||93
9006750|NCT02952313|10069805|FG000|18-Month|Long-term Follow-up||79
9006751|NCT02952313|10069805|FG000|COMPLETED|Long-term Follow-up||75
9006752|NCT02952313|10069805|FG000|NOT COMPLETED|Long-term Follow-up||32
9006753|NCT02952586|10069812|FG000|STARTED|Lead-In Phase (7 Days)||350
9006754|NCT02952586|10069813|FG001|STARTED|Lead-In Phase (7 Days)||347
9006755|NCT02952586|10069812|FG000|Safety Analysis Set|Lead-In Phase (7 Days)||348
9006756|NCT02952586|10069813|FG001|Safety Analysis Set|Lead-In Phase (7 Days)||344
9006757|NCT02952586|10069812|FG000|COMPLETED|Lead-In Phase (7 Days)||345
9006758|NCT02952586|10069813|FG001|COMPLETED|Lead-In Phase (7 Days)||343
9006759|NCT02952586|10069812|FG000|NOT COMPLETED|Lead-In Phase (7 Days)||5
9006760|NCT02952586|10069813|FG001|NOT COMPLETED|Lead-In Phase (7 Days)||4
8891697|NCT02010684|9949582|FG000|STARTED|Overall Study||39
8891698|NCT02010684|9949583|FG001|STARTED|Overall Study||82
8891699|NCT02010684|9949582|FG000|COMPLETED|Overall Study||27
8891700|NCT02010684|9949583|FG001|COMPLETED|Overall Study||59
8891701|NCT02010684|9949582|FG000|NOT COMPLETED|Overall Study||12
8891702|NCT02010684|9949583|FG001|NOT COMPLETED|Overall Study||23
8635012|NCT00559962|9675416|FG007|STARTED|Overall Study||29
8635013|NCT00559962|9675409|FG000|COMPLETED|Overall Study||31
8635014|NCT00559962|9675410|FG001|COMPLETED|Overall Study||25
8635015|NCT00559962|9675411|FG002|COMPLETED|Overall Study||24
8635016|NCT00559962|9675412|FG003|COMPLETED|Overall Study||29
8891703|NCT02010697|9949592|FG000|STARTED|Overall Study||1044
8891704|NCT02010697|9949593|FG001|STARTED|Overall Study||1038
8891705|NCT02010697|9949594|FG002|STARTED|Overall Study||1043
8891706|NCT02010697|9949592|FG000|COMPLETED|Overall Study||1044
8891707|NCT02010697|9949593|FG001|COMPLETED|Overall Study||1038
8891708|NCT02010697|9949594|FG002|COMPLETED|Overall Study||1043
8891709|NCT02010697|9949592|FG000|NOT COMPLETED|Overall Study||0
8891710|NCT02010697|9949593|FG001|NOT COMPLETED|Overall Study||0
8891711|NCT02010697|9949594|FG002|NOT COMPLETED|Overall Study||0
8891712|NCT02010775|9949607|FG000|STARTED|Overall Study||38
8891713|NCT02010775|9949608|FG001|STARTED|Overall Study||38
8891714|NCT02010775|9949609|FG002|STARTED|Overall Study||37
8891715|NCT02010775|9949610|FG003|STARTED|Overall Study||37
8891716|NCT02010775|9949611|FG004|STARTED|Overall Study||37
8891717|NCT02010775|9949607|FG000|COMPLETED|Overall Study||33
8891718|NCT02010775|9949608|FG001|COMPLETED|Overall Study||35
8891719|NCT02010775|9949609|FG002|COMPLETED|Overall Study||34
8891720|NCT02010775|9949610|FG003|COMPLETED|Overall Study||34
8891721|NCT02010775|9949611|FG004|COMPLETED|Overall Study||31
8891722|NCT02010775|9949607|FG000|NOT COMPLETED|Overall Study||5
8891723|NCT02010775|9949608|FG001|NOT COMPLETED|Overall Study||3
8891724|NCT02010775|9949609|FG002|NOT COMPLETED|Overall Study||3
8891725|NCT02010775|9949610|FG003|NOT COMPLETED|Overall Study||3
8891726|NCT02010775|9949611|FG004|NOT COMPLETED|Overall Study||6
8891727|NCT02010996|9949625|FG000|STARTED|Overall Study||36
8891728|NCT02010996|9949626|FG001|STARTED|Overall Study||36
8891729|NCT02010996|9949625|FG000|COMPLETED|Overall Study||36
8891730|NCT02010996|9949626|FG001|COMPLETED|Overall Study||36
8891731|NCT02010996|9949625|FG000|NOT COMPLETED|Overall Study||0
8891732|NCT02010996|9949626|FG001|NOT COMPLETED|Overall Study||0
8891733|NCT02011113|9949636|FG000|STARTED|Overall Study||36
8891734|NCT02011113|9949636|FG000|COMPLETED|Overall Study|Completed = participants with progressive disease were considered as completed.|0
8891735|NCT02011113|9949636|FG000|NOT COMPLETED|Overall Study||36
8891736|NCT02011386|9949641|FG000|STARTED|Overall Study||53
8891737|NCT02011386|9949641|FG000|COMPLETED|Overall Study||48
8891738|NCT02011386|9949641|FG000|NOT COMPLETED|Overall Study||5
8891739|NCT02011464|9949647|FG000|STARTED|Overall Study||10
8891740|NCT02011464|9949648|FG001|STARTED|Overall Study||10
8891741|NCT02011464|9949647|FG000|COMPLETED|Overall Study||10
8891742|NCT02011464|9949648|FG001|COMPLETED|Overall Study||10
8891743|NCT02011464|9949647|FG000|NOT COMPLETED|Overall Study||0
8891744|NCT02011464|9949648|FG001|NOT COMPLETED|Overall Study||0
8891745|NCT02011490|9949669|FG000|STARTED|Part 1||8
8891746|NCT02011490|9949670|FG001|STARTED|Part 1||8
8891747|NCT02011490|9949671|FG002|STARTED|Part 1||8
8891748|NCT02011490|9949672|FG003|STARTED|Part 1||0
8891749|NCT02011490|9949673|FG004|STARTED|Part 1||0
8891750|NCT02011490|9949674|FG005|STARTED|Part 1||0
8891751|NCT02011490|9949669|FG000|COMPLETED|Part 1||8
8891752|NCT02011490|9949670|FG001|COMPLETED|Part 1||8
8891753|NCT02011490|9949671|FG002|COMPLETED|Part 1||8
8891754|NCT02011490|9949672|FG003|COMPLETED|Part 1||0
8891755|NCT02011490|9949673|FG004|COMPLETED|Part 1||0
8891756|NCT02011490|9949674|FG005|COMPLETED|Part 1||0
8891757|NCT02011490|9949669|FG000|NOT COMPLETED|Part 1||0
8891758|NCT02011490|9949670|FG001|NOT COMPLETED|Part 1||0
8891759|NCT02011490|9949671|FG002|NOT COMPLETED|Part 1||0
8891760|NCT02011490|9949672|FG003|NOT COMPLETED|Part 1||0
8891761|NCT02011490|9949673|FG004|NOT COMPLETED|Part 1||0
8891762|NCT02011490|9949674|FG005|NOT COMPLETED|Part 1||0
8891763|NCT02011490|9949669|FG000|STARTED|Part 2||0
8891764|NCT02011490|9949670|FG001|STARTED|Part 2||0
8891765|NCT02011490|9949671|FG002|STARTED|Part 2||0
9006761|NCT02952586|10069812|FG000|STARTED|CRT for Avelumab or Placebo (63 Days)||345
8891766|NCT02011490|9949672|FG003|STARTED|Part 2|4 had also participated in Part 1 (all in severe group)|6
8891767|NCT02011490|9949673|FG004|STARTED|Part 2|3 had also participated in Part 1 (2 in moderate, 1 in severe groups)|6
8891768|NCT02011490|9949674|FG005|STARTED|Part 2|2 had also participated in Part 1 (both in healthy group)|6
8891769|NCT02011490|9949669|FG000|COMPLETED|Part 2||0
8891770|NCT02011490|9949670|FG001|COMPLETED|Part 2||0
8891771|NCT02011490|9949671|FG002|COMPLETED|Part 2||0
8891772|NCT02011490|9949672|FG003|COMPLETED|Part 2||6
8891773|NCT02011490|9949673|FG004|COMPLETED|Part 2||6
8635017|NCT00559962|9675413|FG004|COMPLETED|Overall Study||21
8635018|NCT00559962|9675414|FG005|COMPLETED|Overall Study||23
8891774|NCT02011490|9949674|FG005|COMPLETED|Part 2||6
8891775|NCT02011490|9949669|FG000|NOT COMPLETED|Part 2||0
8891776|NCT02011490|9949670|FG001|NOT COMPLETED|Part 2||0
8891777|NCT02011490|9949671|FG002|NOT COMPLETED|Part 2||0
8891778|NCT02011490|9949672|FG003|NOT COMPLETED|Part 2||0
8891779|NCT02011490|9949673|FG004|NOT COMPLETED|Part 2||0
8891780|NCT02011490|9949674|FG005|NOT COMPLETED|Part 2||0
8635019|NCT00559962|9675415|FG006|COMPLETED|Overall Study||28
8635020|NCT00559962|9675416|FG007|COMPLETED|Overall Study||25
8891781|NCT02011516|9949690|FG000|STARTED|Overall Study||8
8891782|NCT02011516|9949691|FG001|STARTED|Overall Study||8
8891783|NCT02011516|9949690|FG000|COMPLETED|Overall Study||4
8891784|NCT02011516|9949691|FG001|COMPLETED|Overall Study||6
8891785|NCT02011516|9949690|FG000|NOT COMPLETED|Overall Study||4
8891786|NCT02011516|9949691|FG001|NOT COMPLETED|Overall Study||2
8891787|NCT02011893|9949697|FG000|STARTED|Enrollment to Randomization||173
8891788|NCT02011893|9949698|FG001|STARTED|Enrollment to Randomization||0
8891789|NCT02011893|9949699|FG002|STARTED|Enrollment to Randomization||0
8891790|NCT02011893|9949697|FG000|Baseline|Enrollment to Randomization||141
8891791|NCT02011893|9949698|FG001|Baseline|Enrollment to Randomization||0
8891792|NCT02011893|9949699|FG002|Baseline|Enrollment to Randomization||0
8891793|NCT02011893|9949697|FG000|Trial Stimulation Implant|Enrollment to Randomization||121
8891794|NCT02011893|9949698|FG001|Trial Stimulation Implant|Enrollment to Randomization||0
8891795|NCT02011893|9949699|FG002|Trial Stimulation Implant|Enrollment to Randomization||0
8891796|NCT02011893|9949697|FG000|Permanent Stimulation Implant|Enrollment to Randomization||101
8891797|NCT02011893|9949698|FG001|Permanent Stimulation Implant|Enrollment to Randomization||0
8891798|NCT02011893|9949699|FG002|Permanent Stimulation Implant|Enrollment to Randomization||0
8891799|NCT02011893|9949697|FG000|Randomization|Enrollment to Randomization||100
8891800|NCT02011893|9949698|FG001|Randomization|Enrollment to Randomization||0
8891801|NCT02011893|9949699|FG002|Randomization|Enrollment to Randomization||0
8891802|NCT02011893|9949697|FG000|COMPLETED|Enrollment to Randomization||100
8891803|NCT02011893|9949698|FG001|COMPLETED|Enrollment to Randomization||0
9006762|NCT02952586|10069813|FG001|STARTED|CRT for Avelumab or Placebo (63 Days)|All participants who did not withdraw from study after Lead-In phase, entered into CRT phase.|340
9006763|NCT02952586|10069812|FG000|COMPLETED|CRT for Avelumab or Placebo (63 Days)||312
9006764|NCT02952586|10069813|FG001|COMPLETED|CRT for Avelumab or Placebo (63 Days)||313
9006765|NCT02952586|10069812|FG000|NOT COMPLETED|CRT for Avelumab or Placebo (63 Days)||33
9006766|NCT02952586|10069813|FG001|NOT COMPLETED|CRT for Avelumab or Placebo (63 Days)||27
9006767|NCT02952586|10069812|FG000|STARTED|CRT for Cisplatin (63 Days)|Avelumab, Cisplatin, and IMRT were treatments in CRT phase.|345
9006768|NCT02952586|10069813|FG001|STARTED|CRT for Cisplatin (63 Days)|Placebo, Cisplatin, and IMRT were treatments in CRT phase.|340
9006769|NCT02952586|10069812|FG000|COMPLETED|CRT for Cisplatin (63 Days)||234
9006770|NCT02952586|10069813|FG001|COMPLETED|CRT for Cisplatin (63 Days)||236
9006771|NCT02952586|10069812|FG000|NOT COMPLETED|CRT for Cisplatin (63 Days)||111
9006772|NCT02952586|10069813|FG001|NOT COMPLETED|CRT for Cisplatin (63 Days)||104
9006773|NCT02952586|10069812|FG000|STARTED|CRT for IMRT (63 Days)|Avelumab, Cisplatin, and IMRT were treatments in CRT phase.|345
9006774|NCT02952586|10069813|FG001|STARTED|CRT for IMRT (63 Days)|Placebo, Cisplatin, and IMRT were treatments in CRT phase.|340
9006775|NCT02952586|10069812|FG000|COMPLETED|CRT for IMRT (63 Days)||322
9006776|NCT02952586|10069813|FG001|COMPLETED|CRT for IMRT (63 Days)||320
9006777|NCT02952586|10069812|FG000|NOT COMPLETED|CRT for IMRT (63 Days)||23
9006778|NCT02952586|10069813|FG001|NOT COMPLETED|CRT for IMRT (63 Days)||20
9006779|NCT02952586|10069812|FG000|STARTED|Maintenance Phase (12 Months)|All participants who did not withdraw from study after CRT phases, entered into maintenance phase.|291
9006780|NCT02952586|10069813|FG001|STARTED|Maintenance Phase (12 Months)|All participants who did not withdraw from study after CRT phases, entered into maintenance phase.|304
9006781|NCT02952586|10069812|FG000|COMPLETED|Maintenance Phase (12 Months)||139
9006782|NCT02952586|10069813|FG001|COMPLETED|Maintenance Phase (12 Months)||177
9006783|NCT02952586|10069812|FG000|NOT COMPLETED|Maintenance Phase (12 Months)||152
9006784|NCT02952586|10069813|FG001|NOT COMPLETED|Maintenance Phase (12 Months)||127
9006785|NCT02952586|10069812|FG000|STARTED|Follow-Up Phase (90 Days)|Participants who did not withdraw study after previous phases, entered in short-term follow up phase.|266
9006786|NCT02952586|10069813|FG001|STARTED|Follow-Up Phase (90 Days)|Participants who did not withdraw study after previous phases, entered in short-term follow up phase.|284
9006787|NCT02952586|10069812|FG000|COMPLETED|Follow-Up Phase (90 Days)||208
9006788|NCT02952586|10069813|FG001|COMPLETED|Follow-Up Phase (90 Days)||216
9006789|NCT02952586|10069812|FG000|NOT COMPLETED|Follow-Up Phase (90 Days)||58
8635021|NCT00559962|9675409|FG000|NOT COMPLETED|Overall Study||2
8635022|NCT00559962|9675410|FG001|NOT COMPLETED|Overall Study||9
9006790|NCT02952586|10069813|FG001|NOT COMPLETED|Follow-Up Phase (90 Days)||68
9006791|NCT02952586|10069812|FG000|STARTED|LT Follow-up (up to 45 Months)|Participants who did not withdraw study after previous phases, entered in long-term follow up phase.|247
9006792|NCT02952586|10069813|FG001|STARTED|LT Follow-up (up to 45 Months)|Participants who did not withdraw study after previous phases, entered in long-term follow up phase.|237
9006793|NCT02952586|10069812|FG000|COMPLETED|LT Follow-up (up to 45 Months)||0
9006794|NCT02952586|10069813|FG001|COMPLETED|LT Follow-up (up to 45 Months)||0
9006795|NCT02952586|10069812|FG000|NOT COMPLETED|LT Follow-up (up to 45 Months)||247
9006796|NCT02952586|10069813|FG001|NOT COMPLETED|LT Follow-up (up to 45 Months)||237
9006797|NCT02952820|10069823|FG000|STARTED|Placebo-Controlled Treatment (6 Months)||325
9006798|NCT02952820|10069824|FG001|STARTED|Placebo-Controlled Treatment (6 Months)||323
8635023|NCT00559962|9675411|FG002|NOT COMPLETED|Overall Study||10
8891804|NCT02011893|9949699|FG002|COMPLETED|Enrollment to Randomization||0
8891805|NCT02011893|9949697|FG000|NOT COMPLETED|Enrollment to Randomization||73
8891806|NCT02011893|9949698|FG001|NOT COMPLETED|Enrollment to Randomization||0
8891807|NCT02011893|9949699|FG002|NOT COMPLETED|Enrollment to Randomization||0
8891808|NCT02011893|9949697|FG000|STARTED|Period 1 (Randomization to 12 Weeks)||0
8891809|NCT02011893|9949698|FG001|STARTED|Period 1 (Randomization to 12 Weeks)||45
8891810|NCT02011893|9949699|FG002|STARTED|Period 1 (Randomization to 12 Weeks)||55
8891811|NCT02011893|9949697|FG000|6 Week Follow-up|Period 1 (Randomization to 12 Weeks)||0
8891812|NCT02011893|9949698|FG001|6 Week Follow-up|Period 1 (Randomization to 12 Weeks)||45
8891813|NCT02011893|9949699|FG002|6 Week Follow-up|Period 1 (Randomization to 12 Weeks)||52
9006799|NCT02952820|10069825|FG002|STARTED|Placebo-Controlled Treatment (6 Months)||323
9006800|NCT02952820|10069823|FG000|Treated|Placebo-Controlled Treatment (6 Months)||321
9006801|NCT02952820|10069824|FG001|Treated|Placebo-Controlled Treatment (6 Months)||319
9006802|NCT02952820|10069825|FG002|Treated|Placebo-Controlled Treatment (6 Months)||319
9006803|NCT02952820|10069823|FG000|Safety Analysis Set|Placebo-Controlled Treatment (6 Months)||319
9006804|NCT02952820|10069824|FG001|Safety Analysis Set|Placebo-Controlled Treatment (6 Months)||314
9006805|NCT02952820|10069825|FG002|Safety Analysis Set|Placebo-Controlled Treatment (6 Months)||314
9006806|NCT02952820|10069823|FG000|COMPLETED|Placebo-Controlled Treatment (6 Months)||261
9006807|NCT02952820|10069824|FG001|COMPLETED|Placebo-Controlled Treatment (6 Months)||254
9006808|NCT02952820|10069825|FG002|COMPLETED|Placebo-Controlled Treatment (6 Months)||235
9006809|NCT02952820|10069823|FG000|NOT COMPLETED|Placebo-Controlled Treatment (6 Months)||64
9006810|NCT02952820|10069824|FG001|NOT COMPLETED|Placebo-Controlled Treatment (6 Months)||69
9006811|NCT02952820|10069825|FG002|NOT COMPLETED|Placebo-Controlled Treatment (6 Months)||88
9006812|NCT02952820|10069823|FG000|STARTED|Active Treatment Period (6 Months)|Participants from Placebo were re-randomized to Lemborexant 5 mg and Lemborexant 10 mg.|0
9006813|NCT02952820|10069824|FG001|STARTED|Active Treatment Period (6 Months)||384
9006814|NCT02952820|10069825|FG002|STARTED|Active Treatment Period (6 Months)||352
9006815|NCT02952820|10069823|FG000|COMPLETED|Active Treatment Period (6 Months)||0
9006816|NCT02952820|10069824|FG001|COMPLETED|Active Treatment Period (6 Months)||346
9006817|NCT02952820|10069825|FG002|COMPLETED|Active Treatment Period (6 Months)||321
9006818|NCT02952820|10069823|FG000|NOT COMPLETED|Active Treatment Period (6 Months)||0
9006819|NCT02952820|10069824|FG001|NOT COMPLETED|Active Treatment Period (6 Months)||38
9006820|NCT02952820|10069825|FG002|NOT COMPLETED|Active Treatment Period (6 Months)||31
9006821|NCT02952872|10069852|FG000|STARTED|Overall Study||22
9006822|NCT02952872|10069853|FG001|STARTED|Overall Study||22
9006823|NCT02952872|10069854|FG002|STARTED|Overall Study||22
8635024|NCT00559962|9675412|FG003|NOT COMPLETED|Overall Study||5
8635025|NCT00559962|9675413|FG004|NOT COMPLETED|Overall Study||14
8635026|NCT00559962|9675414|FG005|NOT COMPLETED|Overall Study||5
8635027|NCT00559962|9675415|FG006|NOT COMPLETED|Overall Study||5
8635028|NCT00559962|9675416|FG007|NOT COMPLETED|Overall Study||4
9006824|NCT02952872|10069855|FG003|STARTED|Overall Study||22
9006825|NCT02952872|10069856|FG004|STARTED|Overall Study||22
9006826|NCT02952872|10069857|FG005|STARTED|Overall Study||21
9006827|NCT02952872|10069858|FG006|STARTED|Overall Study||22
9006828|NCT02952872|10069859|FG007|STARTED|Overall Study||21
9006829|NCT02952872|10069860|FG008|STARTED|Overall Study||22
9006830|NCT02952872|10069861|FG009|STARTED|Overall Study||22
9006831|NCT02952872|10069862|FG010|STARTED|Overall Study||23
9006832|NCT02952872|10069863|FG011|STARTED|Overall Study||22
9006833|NCT02952872|10069864|FG012|STARTED|Overall Study||22
9006834|NCT02952872|10069865|FG013|STARTED|Overall Study||22
9006835|NCT02952872|10069866|FG014|STARTED|Overall Study||22
9006836|NCT02952872|10069867|FG015|STARTED|Overall Study||23
9006837|NCT02952872|10069852|FG000|COMPLETED|Overall Study||22
9006838|NCT02952872|10069853|FG001|COMPLETED|Overall Study||22
9006839|NCT02952872|10069854|FG002|COMPLETED|Overall Study||22
9006840|NCT02952872|10069855|FG003|COMPLETED|Overall Study||22
9006841|NCT02952872|10069856|FG004|COMPLETED|Overall Study||22
9006842|NCT02952872|10069857|FG005|COMPLETED|Overall Study||21
9006843|NCT02952872|10069858|FG006|COMPLETED|Overall Study||22
9006844|NCT02952872|10069859|FG007|COMPLETED|Overall Study||21
9006845|NCT02952872|10069860|FG008|COMPLETED|Overall Study||22
9006846|NCT02952872|10069861|FG009|COMPLETED|Overall Study||22
9006847|NCT02952872|10069862|FG010|COMPLETED|Overall Study||23
9006848|NCT02952872|10069863|FG011|COMPLETED|Overall Study||22
9006849|NCT02952872|10069864|FG012|COMPLETED|Overall Study||22
9006850|NCT02952872|10069865|FG013|COMPLETED|Overall Study||22
9006851|NCT02952872|10069866|FG014|COMPLETED|Overall Study||22
9006852|NCT02952872|10069867|FG015|COMPLETED|Overall Study||23
9006853|NCT02952872|10069852|FG000|NOT COMPLETED|Overall Study||0
9006854|NCT02952872|10069853|FG001|NOT COMPLETED|Overall Study||0
9006855|NCT02952872|10069854|FG002|NOT COMPLETED|Overall Study||0
9006856|NCT02952872|10069855|FG003|NOT COMPLETED|Overall Study||0
9006857|NCT02952872|10069856|FG004|NOT COMPLETED|Overall Study||0
9006858|NCT02952872|10069857|FG005|NOT COMPLETED|Overall Study||0
9006859|NCT02952872|10069858|FG006|NOT COMPLETED|Overall Study||0
8635029|NCT00559988|9675437|FG000|STARTED|Overall Study||1357
8891814|NCT02011893|9949697|FG000|12 Week Follow-up|Period 1 (Randomization to 12 Weeks)||0
8891815|NCT02011893|9949698|FG001|12 Week Follow-up|Period 1 (Randomization to 12 Weeks)||45
8891816|NCT02011893|9949699|FG002|12 Week Follow-up|Period 1 (Randomization to 12 Weeks)||52
8891817|NCT02011893|9949697|FG000|COMPLETED|Period 1 (Randomization to 12 Weeks)||0
8891818|NCT02011893|9949698|FG001|COMPLETED|Period 1 (Randomization to 12 Weeks)||45
8891819|NCT02011893|9949699|FG002|COMPLETED|Period 1 (Randomization to 12 Weeks)||52
8891820|NCT02011893|9949697|FG000|NOT COMPLETED|Period 1 (Randomization to 12 Weeks)||0
8891821|NCT02011893|9949698|FG001|NOT COMPLETED|Period 1 (Randomization to 12 Weeks)||0
9006860|NCT02952872|10069859|FG007|NOT COMPLETED|Overall Study||0
9006861|NCT02952872|10069860|FG008|NOT COMPLETED|Overall Study||0
8635030|NCT00559988|9675438|FG001|STARTED|Overall Study||1361
9006862|NCT02952872|10069861|FG009|NOT COMPLETED|Overall Study||0
8891822|NCT02011893|9949699|FG002|NOT COMPLETED|Period 1 (Randomization to 12 Weeks)||3
8891823|NCT02011893|9949697|FG000|STARTED|Period 2 (12 Weeks to 24 Weeks)||0
8891824|NCT02011893|9949698|FG001|STARTED|Period 2 (12 Weeks to 24 Weeks)||45
8891825|NCT02011893|9949699|FG002|STARTED|Period 2 (12 Weeks to 24 Weeks)||52
8891826|NCT02011893|9949697|FG000|18 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||0
8891827|NCT02011893|9949698|FG001|18 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||44
8891828|NCT02011893|9949699|FG002|18 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||51
8891829|NCT02011893|9949697|FG000|24 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||0
8891830|NCT02011893|9949698|FG001|24 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||45
8891831|NCT02011893|9949699|FG002|24 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||51
8891832|NCT02011893|9949697|FG000|COMPLETED|Period 2 (12 Weeks to 24 Weeks)||0
8891833|NCT02011893|9949698|FG001|COMPLETED|Period 2 (12 Weeks to 24 Weeks)||45
8891834|NCT02011893|9949699|FG002|COMPLETED|Period 2 (12 Weeks to 24 Weeks)||51
8891835|NCT02011893|9949697|FG000|NOT COMPLETED|Period 2 (12 Weeks to 24 Weeks)||0
8891836|NCT02011893|9949698|FG001|NOT COMPLETED|Period 2 (12 Weeks to 24 Weeks)||0
9006863|NCT02952872|10069862|FG010|NOT COMPLETED|Overall Study||0
9006864|NCT02952872|10069863|FG011|NOT COMPLETED|Overall Study||0
9006865|NCT02952872|10069864|FG012|NOT COMPLETED|Overall Study||0
9006866|NCT02952872|10069865|FG013|NOT COMPLETED|Overall Study||0
9006867|NCT02952872|10069866|FG014|NOT COMPLETED|Overall Study||0
9006868|NCT02952872|10069867|FG015|NOT COMPLETED|Overall Study||0
9006869|NCT02952898|10069904|FG000|STARTED|Overall Study||220
9006870|NCT02952898|10069905|FG001|STARTED|Overall Study||221
9006871|NCT02952898|10069906|FG002|STARTED|Overall Study||224
9006872|NCT02952898|10069904|FG000|COMPLETED|Overall Study||198
9006873|NCT02952898|10069905|FG001|COMPLETED|Overall Study||202
9006874|NCT02952898|10069906|FG002|COMPLETED|Overall Study||209
9006875|NCT02952898|10069904|FG000|NOT COMPLETED|Overall Study||22
9006876|NCT02952898|10069905|FG001|NOT COMPLETED|Overall Study||19
9006877|NCT02952898|10069906|FG002|NOT COMPLETED|Overall Study||15
9006878|NCT02953262|10069918|FG000|STARTED|Overall Study||68
9006879|NCT02953262|10069919|FG001|STARTED|Overall Study||69
9006880|NCT02953262|10069920|FG002|STARTED|Overall Study||68
9006881|NCT02953262|10069921|FG003|STARTED|Overall Study||70
9006882|NCT02953262|10069918|FG000|COMPLETED|Overall Study||65
9006883|NCT02953262|10069919|FG001|COMPLETED|Overall Study||63
9006884|NCT02953262|10069920|FG002|COMPLETED|Overall Study||65
9006885|NCT02953262|10069921|FG003|COMPLETED|Overall Study||67
9006886|NCT02953262|10069918|FG000|NOT COMPLETED|Overall Study||3
9006887|NCT02953262|10069919|FG001|NOT COMPLETED|Overall Study||6
9006888|NCT02953262|10069920|FG002|NOT COMPLETED|Overall Study||3
9006889|NCT02953262|10069921|FG003|NOT COMPLETED|Overall Study||3
9006890|NCT02953314|10069937|FG000|STARTED|Overall Study||13
9006891|NCT02953314|10069938|FG001|STARTED|Overall Study||70
9006892|NCT02953314|10069937|FG000|COMPLETED|Overall Study||13
9006893|NCT02953314|10069938|FG001|COMPLETED|Overall Study||67
9006894|NCT02953314|10069937|FG000|NOT COMPLETED|Overall Study||0
9006895|NCT02953314|10069938|FG001|NOT COMPLETED|Overall Study||3
9006896|NCT02953418|10069944|FG000|STARTED|Overall Study||34
9006897|NCT02953418|10069944|FG000|COMPLETED|Overall Study||34
9006898|NCT02953418|10069944|FG000|NOT COMPLETED|Overall Study||0
9006899|NCT02953548|10069948|FG000|STARTED|Overall Study||5
9006900|NCT02953548|10069949|FG001|STARTED|Overall Study||4
9006901|NCT02953548|10069948|FG000|COMPLETED|Overall Study||5
9006902|NCT02953548|10069949|FG001|COMPLETED|Overall Study||4
9006903|NCT02953548|10069948|FG000|NOT COMPLETED|Overall Study||0
9006904|NCT02953548|10069949|FG001|NOT COMPLETED|Overall Study||0
9006905|NCT02953561|10069956|FG000|STARTED|Overall Study||19
9006906|NCT02953561|10069956|FG000|COMPLETED|Overall Study||19
9006907|NCT02953561|10069956|FG000|NOT COMPLETED|Overall Study||0
9006908|NCT02953639|10069963|FG000|STARTED|Overall Study||81
9006909|NCT02953639|10069964|FG001|STARTED|Overall Study||54
9006910|NCT02953639|10069965|FG002|STARTED|Overall Study||78
9006911|NCT02953639|10069963|FG000|COMPLETED|Overall Study||61
9006912|NCT02953639|10069964|FG001|COMPLETED|Overall Study||40
9006913|NCT02953639|10069965|FG002|COMPLETED|Overall Study||62
9006914|NCT02953639|10069963|FG000|NOT COMPLETED|Overall Study||20
9006915|NCT02953639|10069964|FG001|NOT COMPLETED|Overall Study||14
9006916|NCT02953639|10069965|FG002|NOT COMPLETED|Overall Study||16
9006917|NCT02953678|10069975|FG000|STARTED|Overall Study||71
9006918|NCT02953678|10069975|FG000|COMPLETED|Overall Study||0
9006919|NCT02953678|10069975|FG000|NOT COMPLETED|Overall Study||71
9006920|NCT02953782|10069988|FG000|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||6
9006921|NCT02953782|10069989|FG001|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||3
9006922|NCT02953782|10069990|FG002|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||9
8891837|NCT02011893|9949699|FG002|NOT COMPLETED|Period 2 (12 Weeks to 24 Weeks)||1
8891838|NCT02011945|9949707|FG000|STARTED|Overall Study||2
8891839|NCT02011945|9949708|FG001|STARTED|Overall Study||13
8891840|NCT02011945|9949709|FG002|STARTED|Overall Study||16
8891841|NCT02011945|9949707|FG000|COMPLETED|Overall Study||0
8891842|NCT02011945|9949708|FG001|COMPLETED|Overall Study||3
8891843|NCT02011945|9949709|FG002|COMPLETED|Overall Study||6
9006923|NCT02953782|10069991|FG003|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||8
9006924|NCT02953782|10069992|FG004|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||6
9006925|NCT02953782|10069993|FG005|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||0
9006926|NCT02953782|10069994|FG006|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||0
9006927|NCT02953782|10069995|FG007|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||0
8891844|NCT02011945|9949707|FG000|NOT COMPLETED|Overall Study||2
8891845|NCT02011945|9949708|FG001|NOT COMPLETED|Overall Study||10
8891846|NCT02011945|9949709|FG002|NOT COMPLETED|Overall Study||10
8891847|NCT02012192|9949719|FG000|STARTED|Overall Study||90
8891848|NCT02012192|9949720|FG001|STARTED|Overall Study||43
8891849|NCT02012192|9949719|FG000|COMPLETED|Overall Study||63
8891850|NCT02012192|9949720|FG001|COMPLETED|Overall Study||43
8891851|NCT02012192|9949719|FG000|NOT COMPLETED|Overall Study||27
8891852|NCT02012192|9949720|FG001|NOT COMPLETED|Overall Study||0
8891853|NCT02012218|9949731|FG000|STARTED|Overall Study||12
8891854|NCT02012218|9949732|FG001|STARTED|Overall Study||11
8891855|NCT02012218|9949733|FG002|STARTED|Overall Study||13
8891856|NCT02012218|9949734|FG003|STARTED|Overall Study||19
8891857|NCT02012218|9949735|FG004|STARTED|Overall Study||6
8891858|NCT02012218|9949731|FG000|COMPLETED|Overall Study||8
8891859|NCT02012218|9949732|FG001|COMPLETED|Overall Study||10
8891860|NCT02012218|9949733|FG002|COMPLETED|Overall Study||11
8891861|NCT02012218|9949734|FG003|COMPLETED|Overall Study||17
8891862|NCT02012218|9949735|FG004|COMPLETED|Overall Study||5
8891863|NCT02012218|9949731|FG000|NOT COMPLETED|Overall Study||4
8891864|NCT02012218|9949732|FG001|NOT COMPLETED|Overall Study||1
8891865|NCT02012218|9949733|FG002|NOT COMPLETED|Overall Study||2
8891866|NCT02012218|9949734|FG003|NOT COMPLETED|Overall Study||2
8891867|NCT02012218|9949735|FG004|NOT COMPLETED|Overall Study||1
8891868|NCT02012283|9949749|FG000|STARTED|First Intervention||10
8891869|NCT02012283|9949750|FG001|STARTED|First Intervention||10
8891870|NCT02012283|9949749|FG000|COMPLETED|First Intervention||10
8891871|NCT02012283|9949750|FG001|COMPLETED|First Intervention||10
8891872|NCT02012283|9949749|FG000|NOT COMPLETED|First Intervention||0
8891873|NCT02012283|9949750|FG001|NOT COMPLETED|First Intervention||0
8891874|NCT02012283|9949749|FG000|STARTED|Second Intervention||10
8891875|NCT02012283|9949750|FG001|STARTED|Second Intervention||10
8891876|NCT02012283|9949749|FG000|COMPLETED|Second Intervention||10
8891877|NCT02012283|9949750|FG001|COMPLETED|Second Intervention||10
8891878|NCT02012283|9949749|FG000|NOT COMPLETED|Second Intervention||0
8891879|NCT02012283|9949750|FG001|NOT COMPLETED|Second Intervention||0
8891880|NCT02012283|9949749|FG000|STARTED|Third Intervention||10
8891881|NCT02012283|9949750|FG001|STARTED|Third Intervention||10
8891882|NCT02012283|9949749|FG000|COMPLETED|Third Intervention||10
8891883|NCT02012283|9949750|FG001|COMPLETED|Third Intervention||10
8891884|NCT02012283|9949749|FG000|NOT COMPLETED|Third Intervention||0
8891885|NCT02012283|9949750|FG001|NOT COMPLETED|Third Intervention||0
8891886|NCT02012348|9949764|FG000|STARTED|Overall Study||10
8891887|NCT02012348|9949765|FG001|STARTED|Overall Study||10
8891888|NCT02012348|9949766|FG002|STARTED|Overall Study||10
8891889|NCT02012348|9949764|FG000|COMPLETED|Overall Study||10
8891890|NCT02012348|9949765|FG001|COMPLETED|Overall Study||10
8891891|NCT02012348|9949766|FG002|COMPLETED|Overall Study||10
8891892|NCT02012348|9949764|FG000|NOT COMPLETED|Overall Study||0
8891893|NCT02012348|9949765|FG001|NOT COMPLETED|Overall Study||0
8891894|NCT02012348|9949766|FG002|NOT COMPLETED|Overall Study||0
8891895|NCT02012452|9949776|FG000|STARTED|Overall Study||7
8891896|NCT02012452|9949777|FG001|STARTED|Overall Study||2
8891897|NCT02012452|9949776|FG000|COMPLETED|Overall Study||1
8891898|NCT02012452|9949777|FG001|COMPLETED|Overall Study||1
8891899|NCT02012452|9949776|FG000|NOT COMPLETED|Overall Study||6
8891900|NCT02012452|9949777|FG001|NOT COMPLETED|Overall Study||1
8891901|NCT02012491|9949785|FG000|STARTED|Overall Study||151
8891902|NCT02012491|9949786|FG001|STARTED|Overall Study||149
8891903|NCT02012491|9949785|FG000|COMPLETED|Overall Study||149
8891904|NCT02012491|9949786|FG001|COMPLETED|Overall Study||148
8891905|NCT02012491|9949785|FG000|NOT COMPLETED|Overall Study||2
8891906|NCT02012491|9949786|FG001|NOT COMPLETED|Overall Study||1
8891907|NCT02012582|9949796|FG000|STARTED|Overall Study||8
8891908|NCT02012582|9949797|FG001|STARTED|Overall Study||8
8891909|NCT02012582|9949798|FG002|STARTED|Overall Study||8
8891910|NCT02012582|9949799|FG003|STARTED|Overall Study||8
8891911|NCT02012582|9949796|FG000|COMPLETED|Overall Study||8
8891912|NCT02012582|9949797|FG001|COMPLETED|Overall Study||8
8891913|NCT02012582|9949798|FG002|COMPLETED|Overall Study||8
8891914|NCT02012582|9949799|FG003|COMPLETED|Overall Study||7
8891915|NCT02012582|9949796|FG000|NOT COMPLETED|Overall Study||0
9006928|NCT02953782|10069988|FG000|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
9006929|NCT02953782|10069989|FG001|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
9006930|NCT02953782|10069990|FG002|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
9006931|NCT02953782|10069991|FG003|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
8891916|NCT02012582|9949797|FG001|NOT COMPLETED|Overall Study||0
8891917|NCT02012582|9949798|FG002|NOT COMPLETED|Overall Study||0
8891918|NCT02012582|9949799|FG003|NOT COMPLETED|Overall Study||1
8891919|NCT02012621|9949809|FG000|STARTED|Overall Study||807
8891920|NCT02012621|9949809|FG000|Visit 1 Completed|Overall Study||807
8891921|NCT02012621|9949809|FG000|Visit 2 Completed|Overall Study||688
8891922|NCT02012621|9949809|FG000|Visit 3 Completed|Overall Study||444
8891923|NCT02012621|9949809|FG000|COMPLETED|Overall Study||807
8891924|NCT02012621|9949809|FG000|NOT COMPLETED|Overall Study||0
8891925|NCT02012686|9949815|FG000|STARTED|Overall Study||50
8891926|NCT02012686|9949816|FG001|STARTED|Overall Study||50
8891927|NCT02012686|9949815|FG000|COMPLETED|Overall Study||50
8891928|NCT02012686|9949816|FG001|COMPLETED|Overall Study||48
8891929|NCT02012686|9949815|FG000|NOT COMPLETED|Overall Study||0
8891930|NCT02012686|9949816|FG001|NOT COMPLETED|Overall Study||2
8891931|NCT02012959|9949822|FG000|STARTED|Treatment Phase A||9
8891932|NCT02012959|9949823|FG001|STARTED|Treatment Phase A|Zero participants noted because participants did not start Phase B yet|0
8891933|NCT02012959|9949824|FG002|STARTED|Treatment Phase A|Zero participants noted because participants did not start Phase B yet|0
8891934|NCT02012959|9949825|FG003|STARTED|Treatment Phase A|Zero participants noted because participants did not start Phase B yet|0
8891935|NCT02012959|9949826|FG004|STARTED|Treatment Phase A|Zero participants noted because participants did not start Phase B yet|0
8891936|NCT02012959|9949822|FG000|Received At Least 1 Dose of Study Drug|Treatment Phase A||9
8891937|NCT02012959|9949823|FG001|Received At Least 1 Dose of Study Drug|Treatment Phase A||0
8891938|NCT02012959|9949824|FG002|Received At Least 1 Dose of Study Drug|Treatment Phase A||0
8891939|NCT02012959|9949825|FG003|Received At Least 1 Dose of Study Drug|Treatment Phase A||0
8891940|NCT02012959|9949826|FG004|Received At Least 1 Dose of Study Drug|Treatment Phase A||0
8891941|NCT02012959|9949822|FG000|COMPLETED|Treatment Phase A||7
8891942|NCT02012959|9949823|FG001|COMPLETED|Treatment Phase A||0
8891943|NCT02012959|9949824|FG002|COMPLETED|Treatment Phase A||0
8891944|NCT02012959|9949825|FG003|COMPLETED|Treatment Phase A||0
8891945|NCT02012959|9949826|FG004|COMPLETED|Treatment Phase A||0
8891946|NCT02012959|9949822|FG000|NOT COMPLETED|Treatment Phase A||2
8891947|NCT02012959|9949823|FG001|NOT COMPLETED|Treatment Phase A||0
8891948|NCT02012959|9949824|FG002|NOT COMPLETED|Treatment Phase A||0
8891949|NCT02012959|9949825|FG003|NOT COMPLETED|Treatment Phase A||0
8891950|NCT02012959|9949826|FG004|NOT COMPLETED|Treatment Phase A||0
8891951|NCT02012959|9949822|FG000|STARTED|Treatment Phase B|Zero participants noted because participants had completed Phase A|0
8891952|NCT02012959|9949823|FG001|STARTED|Treatment Phase B|Participants in this group continued treatment with the study drug|2
8891953|NCT02012959|9949824|FG002|STARTED|Treatment Phase B|Participants in this group did not receive additional study drug after Phase A|3
8891954|NCT02012959|9949825|FG003|STARTED|Treatment Phase B|Participants in this group could continue study drug treatment, per the investigator's discretion|1
8891955|NCT02012959|9949826|FG004|STARTED|Treatment Phase B|Participants in this group could receive the investigator's preferred standard of care|1
8891956|NCT02012959|9949822|FG000|Received At Least 1 Dose of Study Drug|Treatment Phase B||0
8891957|NCT02012959|9949823|FG001|Received At Least 1 Dose of Study Drug|Treatment Phase B||2
8891958|NCT02012959|9949824|FG002|Received At Least 1 Dose of Study Drug|Treatment Phase B||3
8891959|NCT02012959|9949825|FG003|Received At Least 1 Dose of Study Drug|Treatment Phase B||1
8891960|NCT02012959|9949826|FG004|Received At Least 1 Dose of Study Drug|Treatment Phase B||1
8891961|NCT02012959|9949822|FG000|COMPLETED|Treatment Phase B||0
8891962|NCT02012959|9949823|FG001|COMPLETED|Treatment Phase B||2
8891963|NCT02012959|9949824|FG002|COMPLETED|Treatment Phase B||3
8891964|NCT02012959|9949825|FG003|COMPLETED|Treatment Phase B||1
8891965|NCT02012959|9949826|FG004|COMPLETED|Treatment Phase B||1
8891966|NCT02012959|9949822|FG000|NOT COMPLETED|Treatment Phase B||0
8891967|NCT02012959|9949823|FG001|NOT COMPLETED|Treatment Phase B||0
8891968|NCT02012959|9949824|FG002|NOT COMPLETED|Treatment Phase B||0
8891969|NCT02012959|9949825|FG003|NOT COMPLETED|Treatment Phase B||0
8891970|NCT02012959|9949826|FG004|NOT COMPLETED|Treatment Phase B||0
8891971|NCT02013037|9949836|FG000|STARTED|Overall Study||36
8891972|NCT02013037|9949836|FG000|COMPLETED|Overall Study||20
8891973|NCT02013037|9949836|FG000|NOT COMPLETED|Overall Study||16
8891974|NCT02013050|9949845|FG000|STARTED|Overall Study||42
8891975|NCT02013050|9949846|FG001|STARTED|Overall Study||41
8891976|NCT02013050|9949847|FG002|STARTED|Overall Study||3
8891977|NCT02013050|9949848|FG003|STARTED|Overall Study||23
8891978|NCT02013050|9949845|FG000|COMPLETED|Overall Study||38
8891979|NCT02013050|9949846|FG001|COMPLETED|Overall Study||36
8891980|NCT02013050|9949847|FG002|COMPLETED|Overall Study||3
8891981|NCT02013050|9949848|FG003|COMPLETED|Overall Study||19
8891982|NCT02013050|9949845|FG000|NOT COMPLETED|Overall Study||4
8891983|NCT02013050|9949846|FG001|NOT COMPLETED|Overall Study||5
8891984|NCT02013050|9949847|FG002|NOT COMPLETED|Overall Study||0
8891985|NCT02013050|9949848|FG003|NOT COMPLETED|Overall Study||4
8891986|NCT02013180|9949860|FG000|STARTED|Overall Study||119
8891987|NCT02013180|9949861|FG001|STARTED|Overall Study||361
8891988|NCT02013180|9949860|FG000|COMPLETED|Overall Study||119
9006932|NCT02953782|10069992|FG004|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
9006933|NCT02953782|10069993|FG005|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
9006934|NCT02953782|10069994|FG006|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
9006935|NCT02953782|10069995|FG007|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
9006936|NCT02953782|10069988|FG000|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||6
9006937|NCT02953782|10069989|FG001|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||3
9006938|NCT02953782|10069990|FG002|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||9
9006939|NCT02953782|10069991|FG003|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||8
9006940|NCT02953782|10069992|FG004|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||6
9006941|NCT02953782|10069993|FG005|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
9006942|NCT02953782|10069994|FG006|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
9006943|NCT02953782|10069995|FG007|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
9006944|NCT02953782|10069988|FG000|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||0
9006945|NCT02953782|10069989|FG001|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||0
9006946|NCT02953782|10069990|FG002|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||0
9006947|NCT02953782|10069991|FG003|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||0
8891989|NCT02013180|9949861|FG001|COMPLETED|Overall Study||361
8891990|NCT02013180|9949860|FG000|NOT COMPLETED|Overall Study||0
8891991|NCT02013180|9949861|FG001|NOT COMPLETED|Overall Study||0
8891992|NCT02013206|9949869|FG000|STARTED|Overall Study||29
8891993|NCT02013206|9949870|FG001|STARTED|Overall Study||23
8891994|NCT02013206|9949869|FG000|Received Study Drug|Overall Study||26
8891995|NCT02013206|9949870|FG001|Received Study Drug|Overall Study||23
8891996|NCT02013206|9949869|FG000|COMPLETED|Overall Study|3 Patients were on-going at clinical cut-off. Not Completed=patients who discontinued treatment.|2
8891997|NCT02013206|9949870|FG001|COMPLETED|Overall Study||1
8891998|NCT02013206|9949869|FG000|NOT COMPLETED|Overall Study||27
8891999|NCT02013206|9949870|FG001|NOT COMPLETED|Overall Study||22
8892000|NCT02013245|9949880|FG000|STARTED|Overall Study||9
8892001|NCT02013245|9949881|FG001|STARTED|Overall Study||9
8892002|NCT02013245|9949882|FG002|STARTED|Overall Study||9
8892003|NCT02013245|9949883|FG003|STARTED|Overall Study||9
8892004|NCT02013245|9949880|FG000|COMPLETED|Overall Study||9
8892005|NCT02013245|9949881|FG001|COMPLETED|Overall Study||8
8892006|NCT02013245|9949882|FG002|COMPLETED|Overall Study||9
8892007|NCT02013245|9949883|FG003|COMPLETED|Overall Study||9
8892008|NCT02013245|9949880|FG000|NOT COMPLETED|Overall Study||0
8892009|NCT02013245|9949881|FG001|NOT COMPLETED|Overall Study||1
8892010|NCT02013245|9949882|FG002|NOT COMPLETED|Overall Study||0
8892011|NCT02013245|9949883|FG003|NOT COMPLETED|Overall Study||0
8892012|NCT02013375|9949893|FG000|STARTED|Overall Study||2
8892013|NCT02013375|9949893|FG000|COMPLETED|Overall Study||0
8892014|NCT02013375|9949893|FG000|NOT COMPLETED|Overall Study||2
8892015|NCT02013388|9949906|FG000|STARTED|Overall Study||9
8892016|NCT02013388|9949907|FG001|STARTED|Overall Study||6
8892017|NCT02013388|9949908|FG002|STARTED|Overall Study||6
8892018|NCT02013388|9949909|FG003|STARTED|Overall Study||6
8892019|NCT02013388|9949910|FG004|STARTED|Overall Study||6
8892020|NCT02013388|9949911|FG005|STARTED|Overall Study||6
8892021|NCT02013388|9949912|FG006|STARTED|Overall Study||6
8892022|NCT02013388|9949913|FG007|STARTED|Overall Study||4
8892023|NCT02013388|9949906|FG000|COMPLETED|Overall Study||8
8892024|NCT02013388|9949907|FG001|COMPLETED|Overall Study||6
8892025|NCT02013388|9949908|FG002|COMPLETED|Overall Study||6
8892026|NCT02013388|9949909|FG003|COMPLETED|Overall Study||6
8892027|NCT02013388|9949910|FG004|COMPLETED|Overall Study||5
8892028|NCT02013388|9949911|FG005|COMPLETED|Overall Study||6
8892029|NCT02013388|9949912|FG006|COMPLETED|Overall Study||6
8892030|NCT02013388|9949913|FG007|COMPLETED|Overall Study||4
8892031|NCT02013388|9949906|FG000|NOT COMPLETED|Overall Study||1
8892032|NCT02013388|9949907|FG001|NOT COMPLETED|Overall Study||0
8892033|NCT02013388|9949908|FG002|NOT COMPLETED|Overall Study||0
8892034|NCT02013388|9949909|FG003|NOT COMPLETED|Overall Study||0
8892035|NCT02013388|9949910|FG004|NOT COMPLETED|Overall Study||1
8892036|NCT02013388|9949911|FG005|NOT COMPLETED|Overall Study||0
8892037|NCT02013388|9949912|FG006|NOT COMPLETED|Overall Study||0
8892038|NCT02013388|9949913|FG007|NOT COMPLETED|Overall Study||0
8892039|NCT02013531|9949935|FG000|STARTED|Overall Study||37
8892040|NCT02013531|9949935|FG000|COMPLETED|Overall Study||32
8892041|NCT02013531|9949935|FG000|NOT COMPLETED|Overall Study||5
8892042|NCT02013544|9949941|FG000|STARTED|Overall Study||182
8892043|NCT02013544|9949942|FG001|STARTED|Overall Study||376
8892044|NCT02013544|9949941|FG000|Safety Population|Overall Study||180
8892045|NCT02013544|9949942|FG001|Safety Population|Overall Study||374
8892046|NCT02013544|9949941|FG000|ITT Population|Overall Study||157
8892047|NCT02013544|9949942|FG001|ITT Population|Overall Study||325
8892048|NCT02013544|9949941|FG000|COMPLETED|Overall Study||171
8892049|NCT02013544|9949942|FG001|COMPLETED|Overall Study||356
8892050|NCT02013544|9949941|FG000|NOT COMPLETED|Overall Study||11
8892051|NCT02013544|9949942|FG001|NOT COMPLETED|Overall Study||20
8892052|NCT02013609|9949948|FG000|STARTED|Overall Study|One participant out of 48 participants enrolled had discontinued before receiving study medication.|47
8892053|NCT02013609|9949948|FG000|COMPLETED|Overall Study||29
8892054|NCT02013609|9949948|FG000|NOT COMPLETED|Overall Study||18
8892055|NCT02013622|9949952|FG000|STARTED|Overall Study||49
8892056|NCT02013622|9949952|FG000|COMPLETED|Overall Study||25
8892057|NCT02013622|9949952|FG000|NOT COMPLETED|Overall Study||24
8892058|NCT02013674|9949958|FG000|STARTED|Overall Study||15
8892059|NCT02013674|9949959|FG001|STARTED|Overall Study||15
8892060|NCT02013674|9949958|FG000|COMPLETED|Overall Study||14
8892061|NCT02013674|9949959|FG001|COMPLETED|Overall Study||14
8892062|NCT02013674|9949958|FG000|NOT COMPLETED|Overall Study||1
8892063|NCT02013674|9949959|FG001|NOT COMPLETED|Overall Study||1
8892064|NCT02013687|9949969|FG000|STARTED|Overall Study||6
8892065|NCT02013687|9949970|FG001|STARTED|Overall Study||6
8892066|NCT02013687|9949971|FG002|STARTED|Overall Study||16
8892067|NCT02013687|9949972|FG003|STARTED|Overall Study||16
8892068|NCT02013687|9949969|FG000|COMPLETED|Overall Study||6
8892069|NCT02013687|9949970|FG001|COMPLETED|Overall Study||6
8892070|NCT02013687|9949971|FG002|COMPLETED|Overall Study||14
8892071|NCT02013687|9949972|FG003|COMPLETED|Overall Study||14
8892072|NCT02013687|9949969|FG000|NOT COMPLETED|Overall Study||0
8892073|NCT02013687|9949970|FG001|NOT COMPLETED|Overall Study||0
8892074|NCT02013687|9949971|FG002|NOT COMPLETED|Overall Study||2
8892075|NCT02013687|9949972|FG003|NOT COMPLETED|Overall Study||2
8892076|NCT02013765|9949986|FG000|STARTED|Overall Study||5
8892077|NCT02013765|9949986|FG000|COMPLETED|Overall Study||4
8635031|NCT00559988|9675437|FG000|COMPLETED|Overall Study||1006
8635032|NCT00559988|9675438|FG001|COMPLETED|Overall Study||1009
8892078|NCT02013765|9949986|FG000|NOT COMPLETED|Overall Study||1
8892079|NCT02013778|9949990|FG000|STARTED|Overall Study||8
8892080|NCT02013778|9949990|FG000|COMPLETED|Overall Study||1
8892081|NCT02013778|9949990|FG000|NOT COMPLETED|Overall Study||7
8892082|NCT02013791|9950003|FG000|STARTED|Period 1||8
8892083|NCT02013791|9950004|FG001|STARTED|Period 1||8
8892084|NCT02013791|9950005|FG002|STARTED|Period 1||4
8892085|NCT02013791|9950006|FG003|STARTED|Period 1||8
8892086|NCT02013791|9950007|FG004|STARTED|Period 1||4
8892087|NCT02013791|9950008|FG005|STARTED|Period 1||8
8892088|NCT02013791|9950009|FG006|STARTED|Period 1||4
8892089|NCT02013791|9950010|FG007|STARTED|Period 1||8
8892090|NCT02013791|9950011|FG008|STARTED|Period 1||3
8892091|NCT02013791|9950003|FG000|COMPLETED|Period 1||8
8892092|NCT02013791|9950004|FG001|COMPLETED|Period 1||6
8892093|NCT02013791|9950005|FG002|COMPLETED|Period 1||4
8892094|NCT02013791|9950006|FG003|COMPLETED|Period 1||7
8892095|NCT02013791|9950007|FG004|COMPLETED|Period 1||4
8892096|NCT02013791|9950008|FG005|COMPLETED|Period 1||8
8892097|NCT02013791|9950009|FG006|COMPLETED|Period 1||3
8892098|NCT02013791|9950010|FG007|COMPLETED|Period 1||7
8892099|NCT02013791|9950011|FG008|COMPLETED|Period 1||3
8892100|NCT02013791|9950003|FG000|NOT COMPLETED|Period 1||0
8892101|NCT02013791|9950004|FG001|NOT COMPLETED|Period 1||2
8892102|NCT02013791|9950005|FG002|NOT COMPLETED|Period 1||0
8892103|NCT02013791|9950006|FG003|NOT COMPLETED|Period 1||1
8892104|NCT02013791|9950007|FG004|NOT COMPLETED|Period 1||0
8892105|NCT02013791|9950008|FG005|NOT COMPLETED|Period 1||0
8892106|NCT02013791|9950009|FG006|NOT COMPLETED|Period 1||1
8892107|NCT02013791|9950010|FG007|NOT COMPLETED|Period 1||1
8892108|NCT02013791|9950011|FG008|NOT COMPLETED|Period 1||0
8892109|NCT02013791|9950003|FG000|STARTED|Period 2||0
8892110|NCT02013791|9950004|FG001|STARTED|Period 2||0
8892111|NCT02013791|9950005|FG002|STARTED|Period 2||2
8892112|NCT02013791|9950006|FG003|STARTED|Period 2||0
8635033|NCT00559988|9675437|FG000|NOT COMPLETED|Overall Study||351
8892113|NCT02013791|9950007|FG004|STARTED|Period 2||0
8892114|NCT02013791|9950008|FG005|STARTED|Period 2||0
8635034|NCT00559988|9675438|FG001|NOT COMPLETED|Overall Study||352
8635035|NCT00560066|9675446|FG000|STARTED|Overall Study||396
8635036|NCT00560066|9675447|FG001|STARTED|Overall Study||1002
8635037|NCT00560066|9675446|FG000|COMPLETED|Overall Study||390
8892115|NCT02013791|9950009|FG006|STARTED|Period 2||3
8892116|NCT02013791|9950010|FG007|STARTED|Period 2||0
8892117|NCT02013791|9950011|FG008|STARTED|Period 2||0
8892118|NCT02013791|9950003|FG000|COMPLETED|Period 2||0
8892119|NCT02013791|9950004|FG001|COMPLETED|Period 2||0
8892120|NCT02013791|9950005|FG002|COMPLETED|Period 2||2
8892121|NCT02013791|9950006|FG003|COMPLETED|Period 2||0
8892122|NCT02013791|9950007|FG004|COMPLETED|Period 2||0
8892123|NCT02013791|9950008|FG005|COMPLETED|Period 2||0
8892124|NCT02013791|9950009|FG006|COMPLETED|Period 2||3
8892125|NCT02013791|9950010|FG007|COMPLETED|Period 2||0
8892126|NCT02013791|9950011|FG008|COMPLETED|Period 2||0
8892127|NCT02013791|9950003|FG000|NOT COMPLETED|Period 2||0
8892128|NCT02013791|9950004|FG001|NOT COMPLETED|Period 2||0
8892129|NCT02013791|9950005|FG002|NOT COMPLETED|Period 2||0
8892130|NCT02013791|9950006|FG003|NOT COMPLETED|Period 2||0
8892131|NCT02013791|9950007|FG004|NOT COMPLETED|Period 2||0
8892132|NCT02013791|9950008|FG005|NOT COMPLETED|Period 2||0
8635038|NCT00560066|9675447|FG001|COMPLETED|Overall Study||980
8892133|NCT02013791|9950009|FG006|NOT COMPLETED|Period 2||0
8892134|NCT02013791|9950010|FG007|NOT COMPLETED|Period 2||0
8892135|NCT02013791|9950011|FG008|NOT COMPLETED|Period 2||0
8892136|NCT02013817|9950032|FG000|STARTED|Overall Study||43
8892137|NCT02013817|9950032|FG000|COMPLETED|Overall Study||16
8892138|NCT02013817|9950032|FG000|NOT COMPLETED|Overall Study||27
8892139|NCT02013830|9950036|FG000|STARTED|Overall Study||45
8892140|NCT02013830|9950036|FG000|COMPLETED|Overall Study||15
9039544|NCT03339999|10100528|FG001|STARTED|Overall Study||6
8892141|NCT02013830|9950036|FG000|NOT COMPLETED|Overall Study||30
8892142|NCT02014051|9950040|FG000|STARTED|Overall Study||3
8892143|NCT02014051|9950041|FG001|STARTED|Overall Study||6
8892144|NCT02014051|9950040|FG000|COMPLETED|Overall Study||2
8892145|NCT02014051|9950041|FG001|COMPLETED|Overall Study||5
8892146|NCT02014051|9950040|FG000|NOT COMPLETED|Overall Study||1
8892147|NCT02014051|9950041|FG001|NOT COMPLETED|Overall Study||1
8892148|NCT02014116|9950057|FG000|STARTED|Overall Study||3
8892149|NCT02014116|9950058|FG001|STARTED|Overall Study||4
8635039|NCT00560066|9675446|FG000|NOT COMPLETED|Overall Study||6
8635040|NCT00560066|9675447|FG001|NOT COMPLETED|Overall Study||22
8892150|NCT02014116|9950059|FG002|STARTED|Overall Study||3
8892151|NCT02014116|9950060|FG003|STARTED|Overall Study||7
8892152|NCT02014116|9950061|FG004|STARTED|Overall Study||2
8892153|NCT02014116|9950062|FG005|STARTED|Overall Study||16
8892154|NCT02014116|9950063|FG006|STARTED|Overall Study||1
8892155|NCT02014116|9950064|FG007|STARTED|Overall Study||5
8892156|NCT02014116|9950065|FG008|STARTED|Overall Study||10
8892157|NCT02014116|9950057|FG000|Received at Least One Dose of Study Drug|Overall Study||3
9039545|NCT03339999|10100529|FG002|STARTED|Overall Study||6
9039546|NCT03339999|10100530|FG003|STARTED|Overall Study||5
9039547|NCT03339999|10100527|FG000|Modified Intent-to-Treat Population|Overall Study||7
8892158|NCT02014116|9950058|FG001|Received at Least One Dose of Study Drug|Overall Study||4
8892159|NCT02014116|9950059|FG002|Received at Least One Dose of Study Drug|Overall Study||3
8892160|NCT02014116|9950060|FG003|Received at Least One Dose of Study Drug|Overall Study||7
8892161|NCT02014116|9950061|FG004|Received at Least One Dose of Study Drug|Overall Study||2
8892162|NCT02014116|9950062|FG005|Received at Least One Dose of Study Drug|Overall Study||16
8892163|NCT02014116|9950063|FG006|Received at Least One Dose of Study Drug|Overall Study||1
8892164|NCT02014116|9950064|FG007|Received at Least One Dose of Study Drug|Overall Study||5
8635041|NCT00560105|9675460|FG000|STARTED|Overall Study||20
8635042|NCT00560105|9675461|FG001|STARTED|Overall Study||20
8635043|NCT00560105|9675460|FG000|COMPLETED|Overall Study||19
8635044|NCT00560105|9675461|FG001|COMPLETED|Overall Study||18
8635045|NCT00560105|9675460|FG000|NOT COMPLETED|Overall Study||1
8635046|NCT00560105|9675461|FG001|NOT COMPLETED|Overall Study||2
8635047|NCT00560235|9675470|FG000|STARTED|Phase 1||10
8892165|NCT02014116|9950065|FG008|Received at Least One Dose of Study Drug|Overall Study||10
8892166|NCT02014116|9950057|FG000|COMPLETED|Overall Study||0
8892167|NCT02014116|9950058|FG001|COMPLETED|Overall Study||0
8892168|NCT02014116|9950059|FG002|COMPLETED|Overall Study||0
8892169|NCT02014116|9950060|FG003|COMPLETED|Overall Study||0
8892170|NCT02014116|9950061|FG004|COMPLETED|Overall Study||0
8892171|NCT02014116|9950062|FG005|COMPLETED|Overall Study||0
8892172|NCT02014116|9950063|FG006|COMPLETED|Overall Study||0
8892173|NCT02014116|9950064|FG007|COMPLETED|Overall Study||0
8892174|NCT02014116|9950065|FG008|COMPLETED|Overall Study||0
8892175|NCT02014116|9950057|FG000|NOT COMPLETED|Overall Study||3
8892176|NCT02014116|9950058|FG001|NOT COMPLETED|Overall Study||4
8892177|NCT02014116|9950059|FG002|NOT COMPLETED|Overall Study||3
8892178|NCT02014116|9950060|FG003|NOT COMPLETED|Overall Study||7
8892179|NCT02014116|9950061|FG004|NOT COMPLETED|Overall Study||2
8635048|NCT00560235|9675471|FG001|STARTED|Phase 1||0
8635049|NCT00560235|9675472|FG002|STARTED|Phase 1||0
8635050|NCT00560235|9675470|FG000|COMPLETED|Phase 1||2
8635051|NCT00560235|9675471|FG001|COMPLETED|Phase 1||0
8635052|NCT00560235|9675472|FG002|COMPLETED|Phase 1||0
8635053|NCT00560235|9675470|FG000|NOT COMPLETED|Phase 1||8
8635054|NCT00560235|9675471|FG001|NOT COMPLETED|Phase 1||0
8635055|NCT00560235|9675472|FG002|NOT COMPLETED|Phase 1||0
8635056|NCT00560235|9675470|FG000|STARTED|Phase 1B||0
8892180|NCT02014116|9950062|FG005|NOT COMPLETED|Overall Study||16
8892181|NCT02014116|9950063|FG006|NOT COMPLETED|Overall Study||1
8892182|NCT02014116|9950064|FG007|NOT COMPLETED|Overall Study||5
8892183|NCT02014116|9950065|FG008|NOT COMPLETED|Overall Study||10
8892184|NCT02014129|9950091|FG000|STARTED|Overall Study||3
8892185|NCT02014129|9950092|FG001|STARTED|Overall Study||3
8892186|NCT02014129|9950093|FG002|STARTED|Overall Study||6
8892187|NCT02014129|9950091|FG000|Received at Least One Dose of Study Drug|Overall Study||3
8892188|NCT02014129|9950092|FG001|Received at Least One Dose of Study Drug|Overall Study||3
8892189|NCT02014129|9950093|FG002|Received at Least One Dose of Study Drug|Overall Study||6
8892190|NCT02014129|9950091|FG000|COMPLETED|Overall Study||3
8892191|NCT02014129|9950092|FG001|COMPLETED|Overall Study||3
8892192|NCT02014129|9950093|FG002|COMPLETED|Overall Study||6
8892193|NCT02014129|9950091|FG000|NOT COMPLETED|Overall Study||0
8892194|NCT02014129|9950092|FG001|NOT COMPLETED|Overall Study||0
8892195|NCT02014129|9950093|FG002|NOT COMPLETED|Overall Study||0
8892196|NCT02014272|9950101|FG000|STARTED|Intervention Period 1||14
8892197|NCT02014272|9950102|FG001|STARTED|Intervention Period 1||14
8892198|NCT02014272|9950101|FG000|COMPLETED|Intervention Period 1||13
8892199|NCT02014272|9950102|FG001|COMPLETED|Intervention Period 1||13
8892200|NCT02014272|9950101|FG000|NOT COMPLETED|Intervention Period 1||1
8892201|NCT02014272|9950102|FG001|NOT COMPLETED|Intervention Period 1||1
8892202|NCT02014272|9950101|FG000|STARTED|Washout Period 1 (7 Days)||13
8892203|NCT02014272|9950102|FG001|STARTED|Washout Period 1 (7 Days)||13
8892204|NCT02014272|9950101|FG000|COMPLETED|Washout Period 1 (7 Days)||13
8892205|NCT02014272|9950102|FG001|COMPLETED|Washout Period 1 (7 Days)||13
8892206|NCT02014272|9950101|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
8892207|NCT02014272|9950102|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
8892208|NCT02014272|9950101|FG000|STARTED|Intervention Period 2||13
8892209|NCT02014272|9950102|FG001|STARTED|Intervention Period 2||13
8892210|NCT02014272|9950101|FG000|COMPLETED|Intervention Period 2||13
8892211|NCT02014272|9950102|FG001|COMPLETED|Intervention Period 2||13
8892212|NCT02014272|9950101|FG000|NOT COMPLETED|Intervention Period 2||0
8892213|NCT02014272|9950102|FG001|NOT COMPLETED|Intervention Period 2||0
8892214|NCT02014363|9950111|FG000|STARTED|Overall Study||55
8892215|NCT02014363|9950112|FG001|STARTED|Overall Study||54
8892216|NCT02014363|9950113|FG002|STARTED|Overall Study||55
8892217|NCT02014363|9950111|FG000|COMPLETED|Overall Study||38
8892218|NCT02014363|9950112|FG001|COMPLETED|Overall Study||35
8892219|NCT02014363|9950113|FG002|COMPLETED|Overall Study||31
8892220|NCT02014363|9950111|FG000|NOT COMPLETED|Overall Study||17
8892221|NCT02014363|9950112|FG001|NOT COMPLETED|Overall Study||19
8892222|NCT02014363|9950113|FG002|NOT COMPLETED|Overall Study||24
8892223|NCT02014376|9950124|FG000|STARTED|Overall Study||15
8635057|NCT00560235|9675471|FG001|STARTED|Phase 1B||21
8635058|NCT00560235|9675472|FG002|STARTED|Phase 1B||0
8635059|NCT00560235|9675470|FG000|COMPLETED|Phase 1B||0
8635060|NCT00560235|9675471|FG001|COMPLETED|Phase 1B||2
8635061|NCT00560235|9675472|FG002|COMPLETED|Phase 1B||0
8635062|NCT00560235|9675470|FG000|NOT COMPLETED|Phase 1B||0
8892224|NCT02014376|9950125|FG001|STARTED|Overall Study||16
8892225|NCT02014376|9950126|FG002|STARTED|Overall Study||17
8892226|NCT02014376|9950124|FG000|Received at Least 1 Dose of Study Drug|Overall Study||15
8892227|NCT02014376|9950125|FG001|Received at Least 1 Dose of Study Drug|Overall Study||16
8892228|NCT02014376|9950126|FG002|Received at Least 1 Dose of Study Drug|Overall Study||17
8892229|NCT02014376|9950124|FG000|COMPLETED|Overall Study||12
8892230|NCT02014376|9950125|FG001|COMPLETED|Overall Study||15
8892231|NCT02014376|9950126|FG002|COMPLETED|Overall Study||17
8892232|NCT02014376|9950124|FG000|NOT COMPLETED|Overall Study||3
8892233|NCT02014376|9950125|FG001|NOT COMPLETED|Overall Study||1
8892234|NCT02014376|9950126|FG002|NOT COMPLETED|Overall Study||0
8892235|NCT02014402|9950138|FG000|STARTED|Overall Study||31
8892236|NCT02014402|9950139|FG001|STARTED|Overall Study||30
8892237|NCT02014402|9950140|FG002|STARTED|Overall Study||35
8892238|NCT02014402|9950141|FG003|STARTED|Overall Study||85
8892239|NCT02014402|9950138|FG000|Human Thrombin|Overall Study||20
8892240|NCT02014402|9950139|FG001|Human Thrombin|Overall Study||20
8892241|NCT02014402|9950140|FG002|Human Thrombin|Overall Study||23
8892242|NCT02014402|9950141|FG003|Human Thrombin|Overall Study||57
9006948|NCT02953782|10069992|FG004|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||0
9006949|NCT02953782|10069993|FG005|STARTED|Phase 2 (Maximum Duration: 11.1 Months)|11 participants were included in safety run-in to evaluate DLT. 9 out of 11 were evaluable for DLT.|16
9006950|NCT02953782|10069994|FG006|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||15
9006951|NCT02953782|10069995|FG007|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||15
9006952|NCT02953782|10069988|FG000|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
9006953|NCT02953782|10069989|FG001|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
9006954|NCT02953782|10069990|FG002|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
9006955|NCT02953782|10069991|FG003|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
9006956|NCT02953782|10069992|FG004|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
9006957|NCT02953782|10069993|FG005|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
9006958|NCT02953782|10069994|FG006|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
9006959|NCT02953782|10069995|FG007|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
9006960|NCT02953782|10069988|FG000|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
9006961|NCT02953782|10069989|FG001|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
9006962|NCT02953782|10069990|FG002|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
9006963|NCT02953782|10069991|FG003|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
9006964|NCT02953782|10069992|FG004|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
9006965|NCT02953782|10069993|FG005|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||16
9006966|NCT02953782|10069994|FG006|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||15
9006967|NCT02953782|10069995|FG007|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||15
9006968|NCT02953821|10070018|FG000|STARTED|Overall Study||86
9006969|NCT02953821|10070019|FG001|STARTED|Overall Study||86
9006970|NCT02953821|10070018|FG000|Safety Population|Overall Study||86
9006971|NCT02953821|10070019|FG001|Safety Population|Overall Study||86
9006972|NCT02953821|10070018|FG000|Modified Intent to Treat (mITT) Populati|Overall Study||85
9006973|NCT02953821|10070019|FG001|Modified Intent to Treat (mITT) Populati|Overall Study||84
9006974|NCT02953821|10070018|FG000|Per Protocol (PP) Population|Overall Study||72
9006975|NCT02953821|10070019|FG001|Per Protocol (PP) Population|Overall Study||75
9006976|NCT02953821|10070018|FG000|Completed Week 16 Visit|Overall Study||76
9006977|NCT02953821|10070019|FG001|Completed Week 16 Visit|Overall Study||77
9006978|NCT02953821|10070018|FG000|Completed Study Treatment (Week 24)|Overall Study||73
9006979|NCT02953821|10070019|FG001|Completed Study Treatment (Week 24)|Overall Study||76
9006980|NCT02953821|10070018|FG000|COMPLETED|Overall Study||71
9006981|NCT02953821|10070019|FG001|COMPLETED|Overall Study||73
9006982|NCT02953821|10070018|FG000|NOT COMPLETED|Overall Study||15
9006983|NCT02953821|10070019|FG001|NOT COMPLETED|Overall Study||13
9006984|NCT02953860|10070027|FG000|STARTED|Overall Study||32
9006985|NCT02953860|10070027|FG000|COMPLETED|Overall Study||32
9006986|NCT02953860|10070027|FG000|NOT COMPLETED|Overall Study||0
9006987|NCT02953873|10070031|FG000|STARTED|Overall Study||25
9006988|NCT02953873|10070031|FG000|COMPLETED|Overall Study||25
9006989|NCT02953873|10070031|FG000|NOT COMPLETED|Overall Study||0
9006990|NCT02953886|10070035|FG000|STARTED|Overall Study||20
9006991|NCT02953886|10070035|FG000|COMPLETED|Overall Study||20
9006992|NCT02953886|10070035|FG000|NOT COMPLETED|Overall Study||0
9006993|NCT02953938|10070041|FG000|STARTED|Overall Study||29
9006994|NCT02953938|10070042|FG001|STARTED|Overall Study||30
9006995|NCT02953938|10070041|FG000|COMPLETED|Overall Study||28
8892243|NCT02014402|9950138|FG000|Bovine Thrombin|Overall Study||11
8892244|NCT02014402|9950139|FG001|Bovine Thrombin|Overall Study||10
8892245|NCT02014402|9950140|FG002|Bovine Thrombin|Overall Study||12
8892246|NCT02014402|9950141|FG003|Bovine Thrombin|Overall Study||28
9006996|NCT02953938|10070042|FG001|COMPLETED|Overall Study||28
9006997|NCT02953938|10070041|FG000|NOT COMPLETED|Overall Study||1
9006998|NCT02953938|10070042|FG001|NOT COMPLETED|Overall Study||2
9006999|NCT02954172|10070051|FG000|STARTED|Overall Study||226
8892247|NCT02014402|9950138|FG000|COMPLETED|Overall Study||29
8892248|NCT02014402|9950139|FG001|COMPLETED|Overall Study||27
8892249|NCT02014402|9950140|FG002|COMPLETED|Overall Study||32
8892250|NCT02014402|9950141|FG003|COMPLETED|Overall Study||82
8892251|NCT02014402|9950138|FG000|NOT COMPLETED|Overall Study||2
8892252|NCT02014402|9950139|FG001|NOT COMPLETED|Overall Study||3
8892253|NCT02014402|9950140|FG002|NOT COMPLETED|Overall Study||3
8892254|NCT02014402|9950141|FG003|NOT COMPLETED|Overall Study||3
8892255|NCT02014441|9950158|FG000|STARTED|Overall Study||61
8892256|NCT02014441|9950158|FG000|Received Treatment|Overall Study||60
8892257|NCT02014441|9950158|FG000|COMPLETED|Overall Study||49
8892258|NCT02014441|9950158|FG000|NOT COMPLETED|Overall Study||12
8892259|NCT02014467|9950166|FG000|STARTED|Overall Study||365
8892260|NCT02014467|9950167|FG001|STARTED|Overall Study||119
8892261|NCT02014467|9950166|FG000|COMPLETED|Overall Study||340
8892262|NCT02014467|9950167|FG001|COMPLETED|Overall Study||112
8892263|NCT02014467|9950166|FG000|NOT COMPLETED|Overall Study||25
8892264|NCT02014467|9950167|FG001|NOT COMPLETED|Overall Study||7
8892265|NCT02014480|9950173|FG000|STARTED|Treatment Period 1 (14 Days)||35
8892266|NCT02014480|9950174|FG001|STARTED|Treatment Period 1 (14 Days)||35
8892267|NCT02014480|9950175|FG002|STARTED|Treatment Period 1 (14 Days)||34
8892268|NCT02014480|9950176|FG003|STARTED|Treatment Period 1 (14 Days)||34
8892269|NCT02014480|9950177|FG004|STARTED|Treatment Period 1 (14 Days)||35
8892270|NCT02014480|9950178|FG005|STARTED|Treatment Period 1 (14 Days)|One participant randomized to Sequence 6 actually received UMEC in Treatment Periods 2 and 3.|34
8892271|NCT02014480|9950173|FG000|COMPLETED|Treatment Period 1 (14 Days)||35
8892272|NCT02014480|9950174|FG001|COMPLETED|Treatment Period 1 (14 Days)||34
8892273|NCT02014480|9950175|FG002|COMPLETED|Treatment Period 1 (14 Days)||33
8892274|NCT02014480|9950176|FG003|COMPLETED|Treatment Period 1 (14 Days)||32
8892275|NCT02014480|9950177|FG004|COMPLETED|Treatment Period 1 (14 Days)||34
8892276|NCT02014480|9950178|FG005|COMPLETED|Treatment Period 1 (14 Days)||34
8892277|NCT02014480|9950173|FG000|NOT COMPLETED|Treatment Period 1 (14 Days)||0
8892278|NCT02014480|9950174|FG001|NOT COMPLETED|Treatment Period 1 (14 Days)||1
8892279|NCT02014480|9950175|FG002|NOT COMPLETED|Treatment Period 1 (14 Days)||1
8892280|NCT02014480|9950176|FG003|NOT COMPLETED|Treatment Period 1 (14 Days)||2
8892281|NCT02014480|9950177|FG004|NOT COMPLETED|Treatment Period 1 (14 Days)||1
8892282|NCT02014480|9950178|FG005|NOT COMPLETED|Treatment Period 1 (14 Days)||0
8892283|NCT02014480|9950173|FG000|STARTED|Washout Period 1 (10 to 14 Days)||35
8892284|NCT02014480|9950174|FG001|STARTED|Washout Period 1 (10 to 14 Days)||34
8892285|NCT02014480|9950175|FG002|STARTED|Washout Period 1 (10 to 14 Days)||33
8892286|NCT02014480|9950176|FG003|STARTED|Washout Period 1 (10 to 14 Days)||32
8892287|NCT02014480|9950177|FG004|STARTED|Washout Period 1 (10 to 14 Days)||34
8892288|NCT02014480|9950178|FG005|STARTED|Washout Period 1 (10 to 14 Days)||34
8892289|NCT02014480|9950173|FG000|COMPLETED|Washout Period 1 (10 to 14 Days)||35
8892290|NCT02014480|9950174|FG001|COMPLETED|Washout Period 1 (10 to 14 Days)||34
8892291|NCT02014480|9950175|FG002|COMPLETED|Washout Period 1 (10 to 14 Days)||32
8892292|NCT02014480|9950176|FG003|COMPLETED|Washout Period 1 (10 to 14 Days)||32
8892293|NCT02014480|9950177|FG004|COMPLETED|Washout Period 1 (10 to 14 Days)||34
8892294|NCT02014480|9950178|FG005|COMPLETED|Washout Period 1 (10 to 14 Days)||34
8892295|NCT02014480|9950173|FG000|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
8892296|NCT02014480|9950174|FG001|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
8892297|NCT02014480|9950175|FG002|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||1
8892298|NCT02014480|9950176|FG003|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
8892299|NCT02014480|9950177|FG004|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
8892300|NCT02014480|9950178|FG005|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
8892301|NCT02014480|9950173|FG000|STARTED|Treatment Period 2 (14 Days)||35
8892302|NCT02014480|9950174|FG001|STARTED|Treatment Period 2 (14 Days)||34
8892303|NCT02014480|9950175|FG002|STARTED|Treatment Period 2 (14 Days)||32
8892304|NCT02014480|9950176|FG003|STARTED|Treatment Period 2 (14 Days)||32
8892305|NCT02014480|9950177|FG004|STARTED|Treatment Period 2 (14 Days)||34
8892306|NCT02014480|9950178|FG005|STARTED|Treatment Period 2 (14 Days)||34
8892307|NCT02014480|9950173|FG000|COMPLETED|Treatment Period 2 (14 Days)||34
8892308|NCT02014480|9950174|FG001|COMPLETED|Treatment Period 2 (14 Days)||33
8892309|NCT02014480|9950175|FG002|COMPLETED|Treatment Period 2 (14 Days)||30
8892310|NCT02014480|9950176|FG003|COMPLETED|Treatment Period 2 (14 Days)||31
8892311|NCT02014480|9950177|FG004|COMPLETED|Treatment Period 2 (14 Days)||34
8892312|NCT02014480|9950178|FG005|COMPLETED|Treatment Period 2 (14 Days)||34
8892313|NCT02014480|9950173|FG000|NOT COMPLETED|Treatment Period 2 (14 Days)||1
8892314|NCT02014480|9950174|FG001|NOT COMPLETED|Treatment Period 2 (14 Days)||1
8892315|NCT02014480|9950175|FG002|NOT COMPLETED|Treatment Period 2 (14 Days)||2
8892316|NCT02014480|9950176|FG003|NOT COMPLETED|Treatment Period 2 (14 Days)||1
8892317|NCT02014480|9950177|FG004|NOT COMPLETED|Treatment Period 2 (14 Days)||0
8892318|NCT02014480|9950178|FG005|NOT COMPLETED|Treatment Period 2 (14 Days)||0
8892319|NCT02014480|9950173|FG000|STARTED|Washout Period 2 (10 to 14 Days)||34
8892320|NCT02014480|9950174|FG001|STARTED|Washout Period 2 (10 to 14 Days)||33
8892321|NCT02014480|9950175|FG002|STARTED|Washout Period 2 (10 to 14 Days)||30
8892322|NCT02014480|9950176|FG003|STARTED|Washout Period 2 (10 to 14 Days)||31
8892323|NCT02014480|9950177|FG004|STARTED|Washout Period 2 (10 to 14 Days)||34
8892324|NCT02014480|9950178|FG005|STARTED|Washout Period 2 (10 to 14 Days)||34
8892325|NCT02014480|9950173|FG000|COMPLETED|Washout Period 2 (10 to 14 Days)||34
8892326|NCT02014480|9950174|FG001|COMPLETED|Washout Period 2 (10 to 14 Days)||33
8892327|NCT02014480|9950175|FG002|COMPLETED|Washout Period 2 (10 to 14 Days)||30
8892328|NCT02014480|9950176|FG003|COMPLETED|Washout Period 2 (10 to 14 Days)||31
8892329|NCT02014480|9950177|FG004|COMPLETED|Washout Period 2 (10 to 14 Days)||34
8892330|NCT02014480|9950178|FG005|COMPLETED|Washout Period 2 (10 to 14 Days)||34
8892331|NCT02014480|9950173|FG000|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
8892332|NCT02014480|9950174|FG001|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
8892333|NCT02014480|9950175|FG002|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
8892334|NCT02014480|9950176|FG003|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
8892335|NCT02014480|9950177|FG004|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
8892336|NCT02014480|9950178|FG005|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
8892337|NCT02014480|9950173|FG000|STARTED|Treatment Period 3 (14 Days)||34
8892338|NCT02014480|9950174|FG001|STARTED|Treatment Period 3 (14 Days)||33
8892339|NCT02014480|9950175|FG002|STARTED|Treatment Period 3 (14 Days)||30
8892340|NCT02014480|9950176|FG003|STARTED|Treatment Period 3 (14 Days)||31
8892341|NCT02014480|9950177|FG004|STARTED|Treatment Period 3 (14 Days)||34
8892342|NCT02014480|9950178|FG005|STARTED|Treatment Period 3 (14 Days)||34
8892343|NCT02014480|9950173|FG000|COMPLETED|Treatment Period 3 (14 Days)||34
8892344|NCT02014480|9950174|FG001|COMPLETED|Treatment Period 3 (14 Days)||32
8892345|NCT02014480|9950175|FG002|COMPLETED|Treatment Period 3 (14 Days)||29
8892346|NCT02014480|9950176|FG003|COMPLETED|Treatment Period 3 (14 Days)||31
8892347|NCT02014480|9950177|FG004|COMPLETED|Treatment Period 3 (14 Days)||34
8892348|NCT02014480|9950178|FG005|COMPLETED|Treatment Period 3 (14 Days)||32
8892349|NCT02014480|9950173|FG000|NOT COMPLETED|Treatment Period 3 (14 Days)||0
8892350|NCT02014480|9950174|FG001|NOT COMPLETED|Treatment Period 3 (14 Days)||1
8892351|NCT02014480|9950175|FG002|NOT COMPLETED|Treatment Period 3 (14 Days)||1
8892352|NCT02014480|9950176|FG003|NOT COMPLETED|Treatment Period 3 (14 Days)||0
8892353|NCT02014480|9950177|FG004|NOT COMPLETED|Treatment Period 3 (14 Days)||0
8892354|NCT02014480|9950178|FG005|NOT COMPLETED|Treatment Period 3 (14 Days)||2
8892355|NCT02014519|9950186|FG000|STARTED|Overall Study||2000
8892356|NCT02014519|9950186|FG000|COMPLETED|Overall Study||2000
8892357|NCT02014519|9950186|FG000|NOT COMPLETED|Overall Study||0
8892358|NCT02014584|9950200|FG000|STARTED|Double-Blind Period (24 Weeks)||59
8892359|NCT02014584|9950201|FG001|STARTED|Double-Blind Period (24 Weeks)||58
8892360|NCT02014584|9950202|FG002|STARTED|Double-Blind Period (24 Weeks)||0
8892361|NCT02014584|9950203|FG003|STARTED|Double-Blind Period (24 Weeks)||0
8892362|NCT02014584|9950204|FG004|STARTED|Double-Blind Period (24 Weeks)||0
8892363|NCT02014584|9950205|FG005|STARTED|Double-Blind Period (24 Weeks)||0
8892364|NCT02014584|9950200|FG000|COMPLETED|Double-Blind Period (24 Weeks)||57
8892365|NCT02014584|9950201|FG001|COMPLETED|Double-Blind Period (24 Weeks)||52
8892366|NCT02014584|9950202|FG002|COMPLETED|Double-Blind Period (24 Weeks)||0
8892367|NCT02014584|9950203|FG003|COMPLETED|Double-Blind Period (24 Weeks)||0
8892368|NCT02014584|9950204|FG004|COMPLETED|Double-Blind Period (24 Weeks)||0
8892369|NCT02014584|9950205|FG005|COMPLETED|Double-Blind Period (24 Weeks)||0
8892370|NCT02014584|9950200|FG000|NOT COMPLETED|Double-Blind Period (24 Weeks)||2
8892371|NCT02014584|9950201|FG001|NOT COMPLETED|Double-Blind Period (24 Weeks)||6
8892372|NCT02014584|9950202|FG002|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
8892373|NCT02014584|9950203|FG003|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
8892374|NCT02014584|9950204|FG004|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
8892375|NCT02014584|9950205|FG005|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
8892376|NCT02014584|9950200|FG000|STARTED|Open-Label Period (24 Weeks)||0
8892377|NCT02014584|9950201|FG001|STARTED|Open-Label Period (24 Weeks)||0
8892378|NCT02014584|9950202|FG002|STARTED|Open-Label Period (24 Weeks)||49
8892379|NCT02014584|9950203|FG003|STARTED|Open-Label Period (24 Weeks)||48
8892380|NCT02014584|9950204|FG004|STARTED|Open-Label Period (24 Weeks)||0
8892381|NCT02014584|9950205|FG005|STARTED|Open-Label Period (24 Weeks)||0
8892382|NCT02014584|9950200|FG000|COMPLETED|Open-Label Period (24 Weeks)||0
8892383|NCT02014584|9950201|FG001|COMPLETED|Open-Label Period (24 Weeks)||0
8892384|NCT02014584|9950202|FG002|COMPLETED|Open-Label Period (24 Weeks)||44
8892385|NCT02014584|9950203|FG003|COMPLETED|Open-Label Period (24 Weeks)||47
8892386|NCT02014584|9950204|FG004|COMPLETED|Open-Label Period (24 Weeks)||0
8892387|NCT02014584|9950205|FG005|COMPLETED|Open-Label Period (24 Weeks)||0
8892388|NCT02014584|9950200|FG000|NOT COMPLETED|Open-Label Period (24 Weeks)||0
8892389|NCT02014584|9950201|FG001|NOT COMPLETED|Open-Label Period (24 Weeks)||0
8892390|NCT02014584|9950202|FG002|NOT COMPLETED|Open-Label Period (24 Weeks)||5
8892391|NCT02014584|9950203|FG003|NOT COMPLETED|Open-Label Period (24 Weeks)||1
8892392|NCT02014584|9950204|FG004|NOT COMPLETED|Open-Label Period (24 Weeks)||0
8892393|NCT02014584|9950205|FG005|NOT COMPLETED|Open-Label Period (24 Weeks)||0
8892394|NCT02014584|9950200|FG000|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
8892395|NCT02014584|9950201|FG001|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
8892396|NCT02014584|9950202|FG002|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
8892397|NCT02014584|9950203|FG003|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
8892398|NCT02014584|9950204|FG004|STARTED|Target Follow-up (F/U) Period (24 Weeks)||3
8892399|NCT02014584|9950205|FG005|STARTED|Target Follow-up (F/U) Period (24 Weeks)||2
8892400|NCT02014584|9950200|FG000|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
9007000|NCT02954172|10070052|FG001|STARTED|Overall Study||224
8892401|NCT02014584|9950201|FG001|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
8892402|NCT02014584|9950202|FG002|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
8892403|NCT02014584|9950203|FG003|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
8892404|NCT02014584|9950204|FG004|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||2
8892405|NCT02014584|9950205|FG005|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||2
8892406|NCT02014584|9950200|FG000|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
8892407|NCT02014584|9950201|FG001|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
8892408|NCT02014584|9950202|FG002|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
9007001|NCT02954172|10070051|FG000|COMPLETED|Overall Study||220
8892409|NCT02014584|9950203|FG003|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
8892410|NCT02014584|9950204|FG004|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||1
8892411|NCT02014584|9950205|FG005|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
8892412|NCT02014597|9950219|FG000|STARTED|Overall Study||12
8892413|NCT02014597|9950220|FG001|STARTED|Overall Study||11
8892414|NCT02014597|9950219|FG000|COMPLETED|Overall Study||10
8892415|NCT02014597|9950220|FG001|COMPLETED|Overall Study||10
8892416|NCT02014597|9950219|FG000|NOT COMPLETED|Overall Study||2
8892417|NCT02014597|9950220|FG001|NOT COMPLETED|Overall Study||1
8892418|NCT02014740|9950228|FG000|STARTED|Overall Study||55
8892419|NCT02014740|9950229|FG001|STARTED|Overall Study||45
8892420|NCT02014740|9950228|FG000|COMPLETED|Overall Study||49
8892421|NCT02014740|9950229|FG001|COMPLETED|Overall Study||40
8892422|NCT02014740|9950228|FG000|NOT COMPLETED|Overall Study||6
8892423|NCT02014740|9950229|FG001|NOT COMPLETED|Overall Study||5
8892424|NCT02015039|9950237|FG000|STARTED|Overall Study||6
8892425|NCT02015039|9950238|FG001|STARTED|Overall Study||7
8892426|NCT02015039|9950237|FG000|COMPLETED|Overall Study||6
8892427|NCT02015039|9950238|FG001|COMPLETED|Overall Study||6
8892428|NCT02015039|9950237|FG000|NOT COMPLETED|Overall Study||0
8892429|NCT02015039|9950238|FG001|NOT COMPLETED|Overall Study||1
8892430|NCT02015065|9950247|FG000|STARTED|Overall Study||2
8892431|NCT02015065|9950248|FG001|STARTED|Overall Study||5
8892432|NCT02015065|9950249|FG002|STARTED|Overall Study||2
8892433|NCT02015065|9950247|FG000|COMPLETED|Overall Study||1
8892434|NCT02015065|9950248|FG001|COMPLETED|Overall Study||3
8892435|NCT02015065|9950249|FG002|COMPLETED|Overall Study||1
8892436|NCT02015065|9950247|FG000|NOT COMPLETED|Overall Study||1
8892437|NCT02015065|9950248|FG001|NOT COMPLETED|Overall Study||2
8892438|NCT02015065|9950249|FG002|NOT COMPLETED|Overall Study||1
8892439|NCT02015104|9950259|FG000|STARTED|Overall Study||16
8892440|NCT02015104|9950260|FG001|STARTED|Overall Study||16
8892441|NCT02015104|9950259|FG000|COMPLETED|Overall Study||15
8892442|NCT02015104|9950260|FG001|COMPLETED|Overall Study||15
8892443|NCT02015104|9950259|FG000|NOT COMPLETED|Overall Study||1
8892444|NCT02015104|9950260|FG001|NOT COMPLETED|Overall Study||1
8892445|NCT02015195|9950276|FG000|STARTED|Overall Study||16
8892446|NCT02015195|9950277|FG001|STARTED|Overall Study||16
8892447|NCT02015195|9950278|FG002|STARTED|Overall Study||16
8892448|NCT02015195|9950279|FG003|STARTED|Overall Study||1
8892449|NCT02015195|9950280|FG004|STARTED|Overall Study||16
8892450|NCT02015195|9950281|FG005|STARTED|Overall Study||16
8892451|NCT02015195|9950282|FG006|STARTED|Overall Study||16
8892452|NCT02015195|9950276|FG000|COMPLETED|Overall Study||16
8892453|NCT02015195|9950277|FG001|COMPLETED|Overall Study||16
8892454|NCT02015195|9950278|FG002|COMPLETED|Overall Study||16
8892455|NCT02015195|9950279|FG003|COMPLETED|Overall Study||0
8892456|NCT02015195|9950280|FG004|COMPLETED|Overall Study||16
8892457|NCT02015195|9950281|FG005|COMPLETED|Overall Study||16
8892458|NCT02015195|9950282|FG006|COMPLETED|Overall Study||16
8892459|NCT02015195|9950276|FG000|NOT COMPLETED|Overall Study||0
8892460|NCT02015195|9950277|FG001|NOT COMPLETED|Overall Study||0
8892461|NCT02015195|9950278|FG002|NOT COMPLETED|Overall Study||0
8892462|NCT02015195|9950279|FG003|NOT COMPLETED|Overall Study||1
8892463|NCT02015195|9950280|FG004|NOT COMPLETED|Overall Study||0
8892464|NCT02015195|9950281|FG005|NOT COMPLETED|Overall Study||0
8892465|NCT02015195|9950282|FG006|NOT COMPLETED|Overall Study||0
8892466|NCT02015221|9950299|FG000|STARTED|Overall Study||41
8892467|NCT02015221|9950300|FG001|STARTED|Overall Study||40
8892468|NCT02015221|9950299|FG000|COMPLETED|Overall Study||32
8892469|NCT02015221|9950300|FG001|COMPLETED|Overall Study||34
8892470|NCT02015221|9950299|FG000|NOT COMPLETED|Overall Study||9
8892471|NCT02015221|9950300|FG001|NOT COMPLETED|Overall Study||6
8892472|NCT02015234|9950308|FG000|STARTED|Overall Study||79
8892473|NCT02015234|9950309|FG001|STARTED|Overall Study||79
8892474|NCT02015234|9950308|FG000|COMPLETED|Overall Study||43
8892475|NCT02015234|9950309|FG001|COMPLETED|Overall Study||54
8892476|NCT02015234|9950308|FG000|NOT COMPLETED|Overall Study||36
8892477|NCT02015234|9950309|FG001|NOT COMPLETED|Overall Study||25
8892478|NCT02015390|9950319|FG000|STARTED|Overall Study||9
8892479|NCT02015390|9950320|FG001|STARTED|Overall Study||7
8892480|NCT02015390|9950319|FG000|COMPLETED|Overall Study||8
8892481|NCT02015390|9950320|FG001|COMPLETED|Overall Study||3
8892482|NCT02015390|9950319|FG000|NOT COMPLETED|Overall Study||1
8892483|NCT02015390|9950320|FG001|NOT COMPLETED|Overall Study||4
9007002|NCT02954172|10070052|FG001|COMPLETED|Overall Study||221
8572755|NCT00116831|9604950|FG001|COMPLETED|Overall Study||259
8726166|NCT01034163|9773319|FG001|COMPLETED|Overall Study||0
8892484|NCT02015442|9950327|FG000|STARTED|First Intervention (7 Days)||5
8892485|NCT02015442|9950328|FG001|STARTED|First Intervention (7 Days)||4
8892486|NCT02015442|9950327|FG000|COMPLETED|First Intervention (7 Days)||5
8892487|NCT02015442|9950328|FG001|COMPLETED|First Intervention (7 Days)||4
8892488|NCT02015442|9950327|FG000|NOT COMPLETED|First Intervention (7 Days)||0
8892489|NCT02015442|9950328|FG001|NOT COMPLETED|First Intervention (7 Days)||0
8892490|NCT02015442|9950327|FG000|STARTED|Wash-out (4 Weeks)||5
8892491|NCT02015442|9950328|FG001|STARTED|Wash-out (4 Weeks)||4
8892492|NCT02015442|9950327|FG000|COMPLETED|Wash-out (4 Weeks)||5
8892493|NCT02015442|9950328|FG001|COMPLETED|Wash-out (4 Weeks)||4
8892494|NCT02015442|9950327|FG000|NOT COMPLETED|Wash-out (4 Weeks)||0
8892495|NCT02015442|9950328|FG001|NOT COMPLETED|Wash-out (4 Weeks)||0
8892496|NCT02015442|9950327|FG000|STARTED|Second Intervention (7 Days)||5
8892497|NCT02015442|9950328|FG001|STARTED|Second Intervention (7 Days)||4
8892498|NCT02015442|9950327|FG000|COMPLETED|Second Intervention (7 Days)||5
8892499|NCT02015442|9950328|FG001|COMPLETED|Second Intervention (7 Days)||4
8892500|NCT02015442|9950327|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
8892501|NCT02015442|9950328|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
8892502|NCT02015481|9950334|FG000|STARTED|Overall Study||25
8892503|NCT02015481|9950334|FG000|COMPLETED|Overall Study||24
8892504|NCT02015481|9950334|FG000|NOT COMPLETED|Overall Study||1
8892505|NCT02015520|9950343|FG000|STARTED|Overall Study||40
8892506|NCT02015520|9950344|FG001|STARTED|Overall Study||21
8892507|NCT02015520|9950345|FG002|STARTED|Overall Study||42
8892508|NCT02015520|9950346|FG003|STARTED|Overall Study||40
8892509|NCT02015520|9950343|FG000|COMPLETED|Overall Study||35
8892510|NCT02015520|9950344|FG001|COMPLETED|Overall Study||17
8892511|NCT02015520|9950345|FG002|COMPLETED|Overall Study||35
8892512|NCT02015520|9950346|FG003|COMPLETED|Overall Study||36
8892513|NCT02015520|9950343|FG000|NOT COMPLETED|Overall Study||5
8892514|NCT02015520|9950344|FG001|NOT COMPLETED|Overall Study||4
8892515|NCT02015520|9950345|FG002|NOT COMPLETED|Overall Study||7
8892516|NCT02015520|9950346|FG003|NOT COMPLETED|Overall Study||4
8892517|NCT02015546|9950359|FG000|STARTED|Overall Study||23
8892518|NCT02015546|9950360|FG001|STARTED|Overall Study||21
8892519|NCT02015546|9950361|FG002|STARTED|Overall Study||26
8892520|NCT02015546|9950359|FG000|COMPLETED|Overall Study||20
8892521|NCT02015546|9950360|FG001|COMPLETED|Overall Study||19
8892522|NCT02015546|9950361|FG002|COMPLETED|Overall Study||22
8892523|NCT02015546|9950359|FG000|NOT COMPLETED|Overall Study||3
8892524|NCT02015546|9950360|FG001|NOT COMPLETED|Overall Study||2
8892525|NCT02015546|9950361|FG002|NOT COMPLETED|Overall Study||4
8892526|NCT02015637|9950371|FG000|STARTED|Overall Study||306
8892527|NCT02015637|9950372|FG001|STARTED|Overall Study||154
8892528|NCT02015637|9950371|FG000|COMPLETED|Overall Study||298
8892529|NCT02015637|9950372|FG001|COMPLETED|Overall Study||149
8892530|NCT02015637|9950371|FG000|NOT COMPLETED|Overall Study||8
8892531|NCT02015637|9950372|FG001|NOT COMPLETED|Overall Study||5
8892532|NCT02015676|9950381|FG000|STARTED|Overall Study||15
8892533|NCT02015676|9950382|FG001|STARTED|Overall Study||48
8892534|NCT02015676|9950383|FG002|STARTED|Overall Study||6
8892535|NCT02015676|9950381|FG000|COMPLETED|Overall Study||6
8892536|NCT02015676|9950382|FG001|COMPLETED|Overall Study||14
8892537|NCT02015676|9950383|FG002|COMPLETED|Overall Study||3
8892538|NCT02015676|9950381|FG000|NOT COMPLETED|Overall Study||9
8635063|NCT00560235|9675471|FG001|NOT COMPLETED|Phase 1B||19
8635064|NCT00560235|9675472|FG002|NOT COMPLETED|Phase 1B||0
8635065|NCT00560235|9675470|FG000|STARTED|Phase 2||0
8635066|NCT00560235|9675471|FG001|STARTED|Phase 2||0
8635067|NCT00560235|9675472|FG002|STARTED|Phase 2||107
8635068|NCT00560235|9675470|FG000|COMPLETED|Phase 2||0
8892539|NCT02015676|9950382|FG001|NOT COMPLETED|Overall Study||34
8892540|NCT02015676|9950383|FG002|NOT COMPLETED|Overall Study||3
8892541|NCT02015754|9950387|FG000|STARTED|Overall Study|17 participants were consented, but 3 participants were screened out prior to treatment|14
8892542|NCT02015754|9950387|FG000|Completed First TACE|Overall Study||14
8892543|NCT02015754|9950387|FG000|Completed First Clinical and Imaging|Overall Study|1 patient exited prior to follow-up|13
8892544|NCT02015754|9950387|FG000|COMPLETED|Overall Study||3
8892545|NCT02015754|9950387|FG000|NOT COMPLETED|Overall Study||11
8892546|NCT02015793|9950393|FG000|STARTED|Overall Study||15
8892547|NCT02015793|9950394|FG001|STARTED|Overall Study||15
8892548|NCT02015793|9950393|FG000|Completed Double-Blind Period|Overall Study||14
8892549|NCT02015793|9950394|FG001|Completed Double-Blind Period|Overall Study||14
8892550|NCT02015793|9950393|FG000|Entered Open-label Extension Period|Overall Study||13
8892551|NCT02015793|9950394|FG001|Entered Open-label Extension Period|Overall Study||14
8892552|NCT02015793|9950393|FG000|COMPLETED|Overall Study||11
8892553|NCT02015793|9950394|FG001|COMPLETED|Overall Study||11
8892554|NCT02015793|9950393|FG000|NOT COMPLETED|Overall Study||4
8892555|NCT02015793|9950394|FG001|NOT COMPLETED|Overall Study||4
8892556|NCT02015819|9950410|FG000|STARTED|Overall Study||3
8892557|NCT02015819|9950411|FG001|STARTED|Overall Study||3
8892558|NCT02015819|9950412|FG002|STARTED|Overall Study||3
8892559|NCT02015819|9950413|FG003|STARTED|Overall Study||7
8892560|NCT02015819|9950410|FG000|COMPLETED|Overall Study||3
8892561|NCT02015819|9950411|FG001|COMPLETED|Overall Study||3
8892562|NCT02015819|9950412|FG002|COMPLETED|Overall Study||3
8892563|NCT02015819|9950413|FG003|COMPLETED|Overall Study||6
8892564|NCT02015819|9950410|FG000|NOT COMPLETED|Overall Study||0
8892565|NCT02015819|9950411|FG001|NOT COMPLETED|Overall Study||0
8892566|NCT02015819|9950412|FG002|NOT COMPLETED|Overall Study||0
8892567|NCT02015819|9950413|FG003|NOT COMPLETED|Overall Study||1
8892568|NCT02016105|9950429|FG000|STARTED|TREATMENT PERIOD 1||231
8892569|NCT02016105|9950430|FG001|STARTED|TREATMENT PERIOD 1||234
8892570|NCT02016105|9950431|FG002|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
8892571|NCT02016105|9950432|FG003|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
8892572|NCT02016105|9950433|FG004|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
8892573|NCT02016105|9950434|FG005|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
9007003|NCT02954172|10070051|FG000|NOT COMPLETED|Overall Study||6
8635069|NCT00560235|9675471|FG001|COMPLETED|Phase 2||0
8635070|NCT00560235|9675472|FG002|COMPLETED|Phase 2||10
8635071|NCT00560235|9675470|FG000|NOT COMPLETED|Phase 2||0
8892574|NCT02016105|9950429|FG000|COMPLETED|TREATMENT PERIOD 1|12 patients did not proceed into Treatment Period 2|201
8892575|NCT02016105|9950430|FG001|COMPLETED|TREATMENT PERIOD 1|11 patients did not proceed into Treatment Period 2|201
8892576|NCT02016105|9950431|FG002|COMPLETED|TREATMENT PERIOD 1||0
8892577|NCT02016105|9950432|FG003|COMPLETED|TREATMENT PERIOD 1||0
8892578|NCT02016105|9950433|FG004|COMPLETED|TREATMENT PERIOD 1||0
8892579|NCT02016105|9950434|FG005|COMPLETED|TREATMENT PERIOD 1||0
8892580|NCT02016105|9950429|FG000|NOT COMPLETED|TREATMENT PERIOD 1||30
8892581|NCT02016105|9950430|FG001|NOT COMPLETED|TREATMENT PERIOD 1||33
8892582|NCT02016105|9950431|FG002|NOT COMPLETED|TREATMENT PERIOD 1||0
8892583|NCT02016105|9950432|FG003|NOT COMPLETED|TREATMENT PERIOD 1||0
8892584|NCT02016105|9950433|FG004|NOT COMPLETED|TREATMENT PERIOD 1||0
8892585|NCT02016105|9950434|FG005|NOT COMPLETED|TREATMENT PERIOD 1||0
8892586|NCT02016105|9950429|FG000|STARTED|TREATMENT PERIOD 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
8892587|NCT02016105|9950430|FG001|STARTED|TREATMENT PERIOD 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
8892588|NCT02016105|9950431|FG002|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from Humira ® adalimumab treatment arm in Treatment Period 1"|63
8892589|NCT02016105|9950432|FG003|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from Humira ® adalimumab treatment arm in Treatment Period 1"|127
8892590|NCT02016105|9950433|FG004|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from GP2017 adalimumab treatment arm in Treatment Period 1"|63
8892591|NCT02016105|9950434|FG005|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from GP2017 adalimumab treatment arm in Treatment Period 1"|126
8892592|NCT02016105|9950429|FG000|COMPLETED|TREATMENT PERIOD 2||0
8892593|NCT02016105|9950430|FG001|COMPLETED|TREATMENT PERIOD 2||0
8892594|NCT02016105|9950431|FG002|COMPLETED|TREATMENT PERIOD 2||57
8892595|NCT02016105|9950432|FG003|COMPLETED|TREATMENT PERIOD 2||116
8892596|NCT02016105|9950433|FG004|COMPLETED|TREATMENT PERIOD 2||59
8892597|NCT02016105|9950434|FG005|COMPLETED|TREATMENT PERIOD 2||112
8892598|NCT02016105|9950429|FG000|NOT COMPLETED|TREATMENT PERIOD 2||0
8892599|NCT02016105|9950430|FG001|NOT COMPLETED|TREATMENT PERIOD 2||0
9007004|NCT02954172|10070052|FG001|NOT COMPLETED|Overall Study||3
9007005|NCT02954198|10070061|FG000|STARTED|Overall Study||20
9007006|NCT02954198|10070062|FG001|STARTED|Overall Study||20
9007007|NCT02954198|10070061|FG000|COMPLETED|Overall Study||20
9007008|NCT02954198|10070062|FG001|COMPLETED|Overall Study||20
9007009|NCT02954198|10070061|FG000|NOT COMPLETED|Overall Study||0
9007010|NCT02954198|10070062|FG001|NOT COMPLETED|Overall Study||0
8892600|NCT02016105|9950431|FG002|NOT COMPLETED|TREATMENT PERIOD 2||6
8892601|NCT02016105|9950432|FG003|NOT COMPLETED|TREATMENT PERIOD 2||11
8892602|NCT02016105|9950433|FG004|NOT COMPLETED|TREATMENT PERIOD 2||4
8892603|NCT02016105|9950434|FG005|NOT COMPLETED|TREATMENT PERIOD 2||14
8892604|NCT02016105|9950429|FG000|STARTED|EXTENSION PERIOD||0
8892605|NCT02016105|9950430|FG001|STARTED|EXTENSION PERIOD||0
8892606|NCT02016105|9950431|FG002|STARTED|EXTENSION PERIOD|5 patients did not proceed from Treatment Period 2 into Extension Period|52
8892607|NCT02016105|9950432|FG003|STARTED|EXTENSION PERIOD|7 patients did not proceed from Treatment Period 2 into Extension Period|109
8892608|NCT02016105|9950433|FG004|STARTED|EXTENSION PERIOD|3 patients did not proceed from Treatment Period 2 into Extension Period|56
8892609|NCT02016105|9950434|FG005|STARTED|EXTENSION PERIOD|6 patients did not proceed from Treatment Period 2 into Extension Period|106
8892610|NCT02016105|9950429|FG000|COMPLETED|EXTENSION PERIOD||0
8892611|NCT02016105|9950430|FG001|COMPLETED|EXTENSION PERIOD||0
8892612|NCT02016105|9950431|FG002|COMPLETED|EXTENSION PERIOD||47
8892613|NCT02016105|9950432|FG003|COMPLETED|EXTENSION PERIOD||104
8892614|NCT02016105|9950433|FG004|COMPLETED|EXTENSION PERIOD||50
8892615|NCT02016105|9950434|FG005|COMPLETED|EXTENSION PERIOD||100
8892616|NCT02016105|9950429|FG000|NOT COMPLETED|EXTENSION PERIOD||0
8892617|NCT02016105|9950430|FG001|NOT COMPLETED|EXTENSION PERIOD||0
8892618|NCT02016105|9950431|FG002|NOT COMPLETED|EXTENSION PERIOD||5
8892619|NCT02016105|9950432|FG003|NOT COMPLETED|EXTENSION PERIOD||5
8892620|NCT02016105|9950433|FG004|NOT COMPLETED|EXTENSION PERIOD||6
8892621|NCT02016105|9950434|FG005|NOT COMPLETED|EXTENSION PERIOD||6
8892622|NCT02016170|9950451|FG000|STARTED|Overall Study||27
8892623|NCT02016170|9950452|FG001|STARTED|Overall Study||28
8892624|NCT02016170|9950453|FG002|STARTED|Overall Study||27
8892625|NCT02016170|9950451|FG000|COMPLETED|Overall Study||25
8892626|NCT02016170|9950452|FG001|COMPLETED|Overall Study||27
8892627|NCT02016170|9950453|FG002|COMPLETED|Overall Study||27
8892628|NCT02016170|9950451|FG000|NOT COMPLETED|Overall Study||2
8892629|NCT02016170|9950452|FG001|NOT COMPLETED|Overall Study||1
8892630|NCT02016170|9950453|FG002|NOT COMPLETED|Overall Study||0
8892631|NCT02016183|9950460|FG000|STARTED|Overall Study||3222
8892632|NCT02016183|9950460|FG000|COMPLETED|Overall Study||3157
8892633|NCT02016183|9950460|FG000|NOT COMPLETED|Overall Study||65
8892634|NCT02016235|9950467|FG000|STARTED|Overall Study||10
8892635|NCT02016235|9950468|FG001|STARTED|Overall Study||10
8892636|NCT02016235|9950469|FG002|STARTED|Overall Study||10
8892637|NCT02016235|9950467|FG000|COMPLETED|Overall Study||10
8892638|NCT02016235|9950468|FG001|COMPLETED|Overall Study||10
8892639|NCT02016235|9950469|FG002|COMPLETED|Overall Study||10
8892640|NCT02016235|9950467|FG000|NOT COMPLETED|Overall Study||0
8892641|NCT02016235|9950468|FG001|NOT COMPLETED|Overall Study||0
8892642|NCT02016235|9950469|FG002|NOT COMPLETED|Overall Study||0
8892643|NCT02016300|9950479|FG000|STARTED|Overall Study||12
8892644|NCT02016300|9950480|FG001|STARTED|Overall Study||12
9007011|NCT02954354|10070071|FG000|STARTED|Overall Study||612
8892645|NCT02016300|9950479|FG000|COMPLETED|Overall Study||12
8892646|NCT02016300|9950480|FG001|COMPLETED|Overall Study||9
8892647|NCT02016300|9950479|FG000|NOT COMPLETED|Overall Study||0
8892648|NCT02016300|9950480|FG001|NOT COMPLETED|Overall Study||3
8892649|NCT02016482|9950488|FG000|STARTED|Period A||108
8892650|NCT02016482|9950489|FG001|STARTED|Period A||109
8892651|NCT02016482|9950488|FG000|COMPLETED|Period A|56 participants early escaped to the end of Period A and 38 continued to the end of Period A.|94
8892652|NCT02016482|9950489|FG001|COMPLETED|Period A|8 participants early escaped to the end of Period A and 86 continued to the end of Period A.|94
8892653|NCT02016482|9950488|FG000|NOT COMPLETED|Period A||14
8892654|NCT02016482|9950489|FG001|NOT COMPLETED|Period A||15
8892655|NCT02016482|9950488|FG000|STARTED|Period B||94
8892656|NCT02016482|9950489|FG001|STARTED|Period B||94
8892657|NCT02016482|9950488|FG000|COMPLETED|Period B||81
8892658|NCT02016482|9950489|FG001|COMPLETED|Period B||87
8892659|NCT02016482|9950488|FG000|NOT COMPLETED|Period B||13
8892660|NCT02016482|9950489|FG001|NOT COMPLETED|Period B||7
8892661|NCT02016560|9950503|FG000|STARTED|Exploratory Phase||16
8892662|NCT02016560|9950504|FG001|STARTED|Exploratory Phase||58
8892663|NCT02016560|9950505|FG002|STARTED|Exploratory Phase||98
8892664|NCT02016560|9950506|FG003|STARTED|Exploratory Phase||51
8892665|NCT02016560|9950507|FG004|STARTED|Exploratory Phase||0
8892666|NCT02016560|9950508|FG005|STARTED|Exploratory Phase||0
8892667|NCT02016560|9950503|FG000|COMPLETED|Exploratory Phase||16
8892668|NCT02016560|9950504|FG001|COMPLETED|Exploratory Phase||54
8892669|NCT02016560|9950505|FG002|COMPLETED|Exploratory Phase||62
8892670|NCT02016560|9950506|FG003|COMPLETED|Exploratory Phase||35
8892671|NCT02016560|9950507|FG004|COMPLETED|Exploratory Phase||0
8892672|NCT02016560|9950508|FG005|COMPLETED|Exploratory Phase||0
8892673|NCT02016560|9950503|FG000|NOT COMPLETED|Exploratory Phase||0
8892674|NCT02016560|9950504|FG001|NOT COMPLETED|Exploratory Phase||4
8892675|NCT02016560|9950505|FG002|NOT COMPLETED|Exploratory Phase||36
8892676|NCT02016560|9950506|FG003|NOT COMPLETED|Exploratory Phase||16
8892677|NCT02016560|9950507|FG004|NOT COMPLETED|Exploratory Phase||0
8892678|NCT02016560|9950508|FG005|NOT COMPLETED|Exploratory Phase||0
8892679|NCT02016560|9950503|FG000|STARTED|Confirmatory Phase||0
8892680|NCT02016560|9950504|FG001|STARTED|Confirmatory Phase||0
8892681|NCT02016560|9950505|FG002|STARTED|Confirmatory Phase||0
8892682|NCT02016560|9950506|FG003|STARTED|Confirmatory Phase||0
8892683|NCT02016560|9950507|FG004|STARTED|Confirmatory Phase||98
8892684|NCT02016560|9950508|FG005|STARTED|Confirmatory Phase||62
8892685|NCT02016560|9950503|FG000|COMPLETED|Confirmatory Phase||0
8892686|NCT02016560|9950504|FG001|COMPLETED|Confirmatory Phase||0
8892687|NCT02016560|9950505|FG002|COMPLETED|Confirmatory Phase||0
8892688|NCT02016560|9950506|FG003|COMPLETED|Confirmatory Phase||0
8892689|NCT02016560|9950507|FG004|COMPLETED|Confirmatory Phase||76
8892690|NCT02016560|9950508|FG005|COMPLETED|Confirmatory Phase||35
8892691|NCT02016560|9950503|FG000|NOT COMPLETED|Confirmatory Phase||0
8892692|NCT02016560|9950504|FG001|NOT COMPLETED|Confirmatory Phase||0
8892693|NCT02016560|9950505|FG002|NOT COMPLETED|Confirmatory Phase||0
8892694|NCT02016560|9950506|FG003|NOT COMPLETED|Confirmatory Phase||0
8892695|NCT02016560|9950507|FG004|NOT COMPLETED|Confirmatory Phase||22
8892696|NCT02016560|9950508|FG005|NOT COMPLETED|Confirmatory Phase||27
8892697|NCT02016612|9950534|FG000|STARTED|Overall Study||25
8892698|NCT02016612|9950535|FG001|STARTED|Overall Study||25
8892699|NCT02016612|9950536|FG002|STARTED|Overall Study||26
8892700|NCT02016612|9950537|FG003|STARTED|Overall Study||61
8892701|NCT02016612|9950534|FG000|COMPLETED|Overall Study||25
8892702|NCT02016612|9950535|FG001|COMPLETED|Overall Study||25
8892703|NCT02016612|9950536|FG002|COMPLETED|Overall Study||26
8892704|NCT02016612|9950537|FG003|COMPLETED|Overall Study||61
8892705|NCT02016612|9950534|FG000|NOT COMPLETED|Overall Study||0
8892706|NCT02016612|9950535|FG001|NOT COMPLETED|Overall Study||0
8892707|NCT02016612|9950536|FG002|NOT COMPLETED|Overall Study||0
8892708|NCT02016612|9950537|FG003|NOT COMPLETED|Overall Study||0
8892709|NCT02016625|9950549|FG000|STARTED|Cyclo or Tac (Single Dose, Day 1)||16
8892710|NCT02016625|9950550|FG001|STARTED|Cyclo or Tac (Single Dose, Day 1)||16
8892711|NCT02016625|9950549|FG000|COMPLETED|Cyclo or Tac (Single Dose, Day 1)||16
9007012|NCT02954354|10070072|FG001|STARTED|Overall Study||310
8892712|NCT02016625|9950550|FG001|COMPLETED|Cyclo or Tac (Single Dose, Day 1)||15
8892713|NCT02016625|9950549|FG000|NOT COMPLETED|Cyclo or Tac (Single Dose, Day 1)||0
8892714|NCT02016625|9950550|FG001|NOT COMPLETED|Cyclo or Tac (Single Dose, Day 1)||1
8892715|NCT02016625|9950549|FG000|STARTED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||16
8892716|NCT02016625|9950550|FG001|STARTED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||15
8892717|NCT02016625|9950549|FG000|COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||13
8892718|NCT02016625|9950550|FG001|COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||15
8892719|NCT02016625|9950549|FG000|NOT COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||3
8892720|NCT02016625|9950550|FG001|NOT COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||0
8892721|NCT02016690|9950566|FG000|STARTED|Overall Study||312
8892722|NCT02016690|9950566|FG000|Treated|Overall Study||312
8892723|NCT02016690|9950566|FG000|Safety Analysis Set (SAS)|Overall Study||304
8892724|NCT02016690|9950566|FG000|COMPLETED|Overall Study|(Effectiveness analysis set)|288
8892725|NCT02016690|9950566|FG000|NOT COMPLETED|Overall Study||24
8892726|NCT02016716|9950573|FG000|STARTED|Overall Study||53
8892727|NCT02016716|9950574|FG001|STARTED|Overall Study||118
8892728|NCT02016716|9950575|FG002|STARTED|Overall Study||123
8892729|NCT02016716|9950573|FG000|Received Study Treatment|Overall Study||53
8892730|NCT02016716|9950574|FG001|Received Study Treatment|Overall Study||118
8892731|NCT02016716|9950575|FG002|Received Study Treatment|Overall Study||123
8892732|NCT02016716|9950573|FG000|COMPLETED|Overall Study||47
8892733|NCT02016716|9950574|FG001|COMPLETED|Overall Study||110
8892734|NCT02016716|9950575|FG002|COMPLETED|Overall Study||117
8892735|NCT02016716|9950573|FG000|NOT COMPLETED|Overall Study||6
8892736|NCT02016716|9950574|FG001|NOT COMPLETED|Overall Study||8
8892737|NCT02016716|9950575|FG002|NOT COMPLETED|Overall Study||6
8892738|NCT02016755|9950584|FG000|STARTED|Overall Study||10
8892739|NCT02016755|9950584|FG000|Completed Month 18 Clinic Visit|Overall Study||5
8635072|NCT00560235|9675471|FG001|NOT COMPLETED|Phase 2||0
8635073|NCT00560235|9675472|FG002|NOT COMPLETED|Phase 2||97
8635074|NCT00560313|9675490|FG000|STARTED|Overall Study||54
8635075|NCT00560313|9675490|FG000|COMPLETED|Overall Study||48
8635076|NCT00560313|9675490|FG000|NOT COMPLETED|Overall Study||6
8892740|NCT02016755|9950584|FG000|Completed Month 36 LTFU Questionnaire|Overall Study||3
8892741|NCT02016755|9950584|FG000|COMPLETED|Overall Study||3
8892742|NCT02016755|9950584|FG000|NOT COMPLETED|Overall Study||7
8892743|NCT02016885|9950593|FG000|STARTED|Overall Study||38
8892744|NCT02016885|9950594|FG001|STARTED|Overall Study||40
8892745|NCT02016885|9950595|FG002|STARTED|Overall Study||40
8892746|NCT02016885|9950596|FG003|STARTED|Overall Study||40
8892747|NCT02016885|9950597|FG004|STARTED|Overall Study||40
8892748|NCT02016885|9950593|FG000|COMPLETED|Overall Study||34
8892749|NCT02016885|9950594|FG001|COMPLETED|Overall Study||36
8892750|NCT02016885|9950595|FG002|COMPLETED|Overall Study||39
8892751|NCT02016885|9950596|FG003|COMPLETED|Overall Study||30
8892752|NCT02016885|9950597|FG004|COMPLETED|Overall Study||39
8892753|NCT02016885|9950593|FG000|NOT COMPLETED|Overall Study||4
8892754|NCT02016885|9950594|FG001|NOT COMPLETED|Overall Study||4
8892755|NCT02016885|9950595|FG002|NOT COMPLETED|Overall Study||1
8892756|NCT02016885|9950596|FG003|NOT COMPLETED|Overall Study||10
8892757|NCT02016885|9950597|FG004|NOT COMPLETED|Overall Study||1
8892758|NCT02016898|9950611|FG000|STARTED|Overall Study||50
8892759|NCT02016898|9950612|FG001|STARTED|Overall Study||45
8892760|NCT02016898|9950611|FG000|COMPLETED|Overall Study||45
8892761|NCT02016898|9950612|FG001|COMPLETED|Overall Study||40
8892762|NCT02016898|9950611|FG000|NOT COMPLETED|Overall Study||5
8892763|NCT02016898|9950612|FG001|NOT COMPLETED|Overall Study||5
8892764|NCT02016963|9950618|FG000|STARTED|Overall Study||20
8892765|NCT02016963|9950618|FG000|COMPLETED|Overall Study||20
8892766|NCT02016963|9950618|FG000|NOT COMPLETED|Overall Study||0
8892767|NCT02017015|9950623|FG000|STARTED|Overall Study||83
8892768|NCT02017015|9950623|FG000|Safety Population|Overall Study||83
8892769|NCT02017015|9950623|FG000|COMPLETED|Overall Study|Completed = Participants remaining on treatment at the time of the data cut-off of 01 Jun 2015|14
8892770|NCT02017015|9950623|FG000|NOT COMPLETED|Overall Study||69
8892771|NCT02017093|9950630|FG000|STARTED|Overall Study||4
8892772|NCT02017093|9950631|FG001|STARTED|Overall Study||3
9007013|NCT02954354|10070073|FG002|STARTED|Overall Study||514
9007014|NCT02954354|10070071|FG000|Received Study Drug|Overall Study||610
9007015|NCT02954354|10070072|FG001|Received Study Drug|Overall Study||309
9007016|NCT02954354|10070073|FG002|Received Study Drug|Overall Study||513
9007017|NCT02954354|10070071|FG000|Intention to Treat Infected Population|Overall Study||456
9007018|NCT02954354|10070072|FG001|Intention to Treat Infected Population|Overall Study||231
9007019|NCT02954354|10070073|FG002|Intention to Treat Infected Population|Overall Study||377
9007020|NCT02954354|10070071|FG000|COMPLETED|Overall Study||578
9007021|NCT02954354|10070072|FG001|COMPLETED|Overall Study||290
9007022|NCT02954354|10070073|FG002|COMPLETED|Overall Study||498
9007023|NCT02954354|10070071|FG000|NOT COMPLETED|Overall Study||34
9007024|NCT02954354|10070072|FG001|NOT COMPLETED|Overall Study||20
9007025|NCT02954354|10070073|FG002|NOT COMPLETED|Overall Study||16
9007026|NCT02954458|10070087|FG000|STARTED|Overall Study||7
9007027|NCT02954458|10070088|FG001|STARTED|Overall Study||3
9007028|NCT02954458|10070089|FG002|STARTED|Overall Study||1
9007029|NCT02954458|10070090|FG003|STARTED|Overall Study||50
9007030|NCT02954458|10070087|FG000|COMPLETED|Overall Study||6
9007031|NCT02954458|10070088|FG001|COMPLETED|Overall Study||3
9007032|NCT02954458|10070089|FG002|COMPLETED|Overall Study||0
9007033|NCT02954458|10070090|FG003|COMPLETED|Overall Study||38
9007034|NCT02954458|10070087|FG000|NOT COMPLETED|Overall Study||1
9007035|NCT02954458|10070088|FG001|NOT COMPLETED|Overall Study||0
9007036|NCT02954458|10070089|FG002|NOT COMPLETED|Overall Study||1
9007037|NCT02954458|10070090|FG003|NOT COMPLETED|Overall Study||12
9007038|NCT02954575|10070104|FG000|STARTED|Overall Study||57
9007039|NCT02954575|10070104|FG000|Received Treatment|Overall Study||55
8635077|NCT00560352|9675512|FG000|STARTED|Overall Study||7
8635078|NCT00560352|9675513|FG001|STARTED|Overall Study||3
8635079|NCT00560352|9675514|FG002|STARTED|Overall Study||4
8892773|NCT02017093|9950630|FG000|COMPLETED|Overall Study||4
8892774|NCT02017093|9950631|FG001|COMPLETED|Overall Study||3
8892775|NCT02017093|9950630|FG000|NOT COMPLETED|Overall Study||0
8892776|NCT02017093|9950631|FG001|NOT COMPLETED|Overall Study||0
8892777|NCT02017171|9950641|FG000|STARTED|Overall Study||267
8635080|NCT00560352|9675512|FG000|COMPLETED|Overall Study||0
8892778|NCT02017171|9950642|FG001|STARTED|Overall Study||263
8892779|NCT02017171|9950641|FG000|COMPLETED|Overall Study||205
8892780|NCT02017171|9950642|FG001|COMPLETED|Overall Study||217
8892781|NCT02017171|9950641|FG000|NOT COMPLETED|Overall Study||62
9007040|NCT02954575|10070104|FG000|SAF Population|Overall Study||55
9007041|NCT02954575|10070104|FG000|FAS Population|Overall Study||55
9007042|NCT02954575|10070104|FG000|PP Population|Overall Study||52
8892782|NCT02017171|9950642|FG001|NOT COMPLETED|Overall Study||46
8892783|NCT02017210|9950652|FG000|STARTED|Overall Study||17
8892784|NCT02017210|9950653|FG001|STARTED|Overall Study||20
8892785|NCT02017210|9950654|FG002|STARTED|Overall Study||20
8892786|NCT02017210|9950652|FG000|COMPLETED|Overall Study||17
8892787|NCT02017210|9950653|FG001|COMPLETED|Overall Study||20
8892788|NCT02017210|9950654|FG002|COMPLETED|Overall Study||20
8892789|NCT02017210|9950652|FG000|NOT COMPLETED|Overall Study||0
8892790|NCT02017210|9950653|FG001|NOT COMPLETED|Overall Study||0
8892791|NCT02017210|9950654|FG002|NOT COMPLETED|Overall Study||0
8892792|NCT02017223|9950665|FG000|STARTED|Overall Study||12
8892793|NCT02017223|9950665|FG000|COMPLETED|Overall Study||10
8892794|NCT02017223|9950665|FG000|NOT COMPLETED|Overall Study||2
8892795|NCT02017327|9950672|FG000|STARTED|Overall Study||122
8892796|NCT02017327|9950673|FG001|STARTED|Overall Study||125
8892797|NCT02017327|9950674|FG002|STARTED|Overall Study||132
8892798|NCT02017327|9950672|FG000|COMPLETED|Overall Study||106
8892799|NCT02017327|9950673|FG001|COMPLETED|Overall Study||113
8892800|NCT02017327|9950674|FG002|COMPLETED|Overall Study||117
8892801|NCT02017327|9950672|FG000|NOT COMPLETED|Overall Study||16
8892802|NCT02017327|9950673|FG001|NOT COMPLETED|Overall Study||12
8892803|NCT02017327|9950674|FG002|NOT COMPLETED|Overall Study||15
8892804|NCT02017444|9950684|FG000|STARTED|Overall Study||14
8892805|NCT02017444|9950685|FG001|STARTED|Overall Study||17
8892806|NCT02017444|9950684|FG000|COMPLETED|Overall Study||12
8892807|NCT02017444|9950685|FG001|COMPLETED|Overall Study|NB: One participant did not complete primary outcome.|17
8892808|NCT02017444|9950684|FG000|NOT COMPLETED|Overall Study||2
8892809|NCT02017444|9950685|FG001|NOT COMPLETED|Overall Study||0
9007043|NCT02954575|10070104|FG000|PK Population|Overall Study||21
9007044|NCT02954575|10070104|FG000|SURG Population|Overall Study||1
9007045|NCT02954575|10070104|FG000|COMPLETED|Overall Study||54
9007046|NCT02954575|10070104|FG000|NOT COMPLETED|Overall Study||3
9007047|NCT02954601|10070116|FG000|STARTED|First Intervention (Five Days)||11
9007048|NCT02954601|10070117|FG001|STARTED|First Intervention (Five Days)||6
9007049|NCT02954601|10070118|FG002|STARTED|First Intervention (Five Days)||8
9007050|NCT02954601|10070119|FG003|STARTED|First Intervention (Five Days)||7
9007051|NCT02954601|10070116|FG000|COMPLETED|First Intervention (Five Days)||11
9007052|NCT02954601|10070117|FG001|COMPLETED|First Intervention (Five Days)||6
9007053|NCT02954601|10070118|FG002|COMPLETED|First Intervention (Five Days)||7
9007054|NCT02954601|10070119|FG003|COMPLETED|First Intervention (Five Days)||7
9007055|NCT02954601|10070116|FG000|NOT COMPLETED|First Intervention (Five Days)||0
9007056|NCT02954601|10070117|FG001|NOT COMPLETED|First Intervention (Five Days)||0
9007057|NCT02954601|10070118|FG002|NOT COMPLETED|First Intervention (Five Days)||1
9007058|NCT02954601|10070119|FG003|NOT COMPLETED|First Intervention (Five Days)||0
9007059|NCT02954601|10070116|FG000|STARTED|Second Intervention (Five Days)||11
9007060|NCT02954601|10070117|FG001|STARTED|Second Intervention (Five Days)||6
9007061|NCT02954601|10070118|FG002|STARTED|Second Intervention (Five Days)||8
9007062|NCT02954601|10070119|FG003|STARTED|Second Intervention (Five Days)||6
9007063|NCT02954601|10070116|FG000|COMPLETED|Second Intervention (Five Days)||11
9007064|NCT02954601|10070117|FG001|COMPLETED|Second Intervention (Five Days)||6
8892810|NCT02017535|9950695|FG000|STARTED|Overall Study||9
8892811|NCT02017535|9950696|FG001|STARTED|Overall Study||3
8892812|NCT02017535|9950697|FG002|STARTED|Overall Study||2
8892813|NCT02017535|9950698|FG003|STARTED|Overall Study||1
8892814|NCT02017535|9950695|FG000|COMPLETED|Overall Study||8
8892815|NCT02017535|9950696|FG001|COMPLETED|Overall Study||3
8892816|NCT02017535|9950697|FG002|COMPLETED|Overall Study||2
8892817|NCT02017535|9950698|FG003|COMPLETED|Overall Study||1
8892818|NCT02017535|9950695|FG000|NOT COMPLETED|Overall Study||1
8892819|NCT02017535|9950696|FG001|NOT COMPLETED|Overall Study||0
8892820|NCT02017535|9950697|FG002|NOT COMPLETED|Overall Study||0
8892821|NCT02017535|9950698|FG003|NOT COMPLETED|Overall Study||0
8892822|NCT02017574|9950710|FG000|STARTED|Overall Study||12
8892823|NCT02017574|9950711|FG001|STARTED|Overall Study||12
8892824|NCT02017574|9950710|FG000|COMPLETED|Overall Study||12
8892825|NCT02017574|9950711|FG001|COMPLETED|Overall Study||12
8892826|NCT02017574|9950710|FG000|NOT COMPLETED|Overall Study||0
9007065|NCT02954601|10070118|FG002|COMPLETED|Second Intervention (Five Days)||8
9007066|NCT02954601|10070119|FG003|COMPLETED|Second Intervention (Five Days)||6
9007067|NCT02954601|10070116|FG000|NOT COMPLETED|Second Intervention (Five Days)||0
9007068|NCT02954601|10070117|FG001|NOT COMPLETED|Second Intervention (Five Days)||0
9007069|NCT02954601|10070118|FG002|NOT COMPLETED|Second Intervention (Five Days)||0
9007070|NCT02954601|10070119|FG003|NOT COMPLETED|Second Intervention (Five Days)||0
8892827|NCT02017574|9950711|FG001|NOT COMPLETED|Overall Study||0
8892828|NCT02017860|9950717|FG000|STARTED|Overall Study||4
8892829|NCT02017860|9950717|FG000|COMPLETED|Overall Study||2
8892830|NCT02017860|9950717|FG000|NOT COMPLETED|Overall Study||2
8892831|NCT02017899|9950727|FG000|STARTED|Overall Study||8
8892832|NCT02017899|9950728|FG001|STARTED|Overall Study||9
8892833|NCT02017899|9950729|FG002|STARTED|Overall Study||8
8892834|NCT02017899|9950730|FG003|STARTED|Overall Study||8
8892835|NCT02017899|9950731|FG004|STARTED|Overall Study||9
8892836|NCT02017899|9950732|FG005|STARTED|Overall Study||8
8892837|NCT02017899|9950727|FG000|COMPLETED|Overall Study||8
8892838|NCT02017899|9950728|FG001|COMPLETED|Overall Study||9
8892839|NCT02017899|9950729|FG002|COMPLETED|Overall Study||8
8892840|NCT02017899|9950730|FG003|COMPLETED|Overall Study||7
8892841|NCT02017899|9950731|FG004|COMPLETED|Overall Study||8
8892842|NCT02017899|9950732|FG005|COMPLETED|Overall Study||8
8892843|NCT02017899|9950727|FG000|NOT COMPLETED|Overall Study||0
8892844|NCT02017899|9950728|FG001|NOT COMPLETED|Overall Study||0
8892845|NCT02017899|9950729|FG002|NOT COMPLETED|Overall Study||0
8892846|NCT02017899|9950730|FG003|NOT COMPLETED|Overall Study||1
8892847|NCT02017899|9950731|FG004|NOT COMPLETED|Overall Study||1
8892848|NCT02017899|9950732|FG005|NOT COMPLETED|Overall Study||0
8892849|NCT02018042|9950746|FG000|STARTED|Overall Study||15
8892850|NCT02018042|9950746|FG000|COMPLETED|Overall Study||14
8892851|NCT02018042|9950746|FG000|NOT COMPLETED|Overall Study||1
8892852|NCT02018107|9950750|FG000|STARTED|Overall Study||27
8892853|NCT02018107|9950750|FG000|COMPLETED|Overall Study||27
8892854|NCT02018107|9950750|FG000|NOT COMPLETED|Overall Study||0
8892855|NCT02018315|9950754|FG000|STARTED|Overall Study||14
8892856|NCT02018315|9950754|FG000|COMPLETED|Overall Study||14
8892857|NCT02018315|9950754|FG000|NOT COMPLETED|Overall Study||0
8892858|NCT02018445|9950758|FG000|STARTED|Overall Study||36
8892859|NCT02018445|9950758|FG000|COMPLETED|Overall Study||29
8892860|NCT02018445|9950758|FG000|NOT COMPLETED|Overall Study||7
8892861|NCT02018458|9950765|FG000|STARTED|Overall Study||10
8892862|NCT02018458|9950765|FG000|COMPLETED|Overall Study||6
8892863|NCT02018458|9950765|FG000|NOT COMPLETED|Overall Study||4
9007071|NCT02954601|10070116|FG000|STARTED|Third Intervention (Five Days)||9
9007072|NCT02954601|10070117|FG001|STARTED|Third Intervention (Five Days)||8
9007073|NCT02954601|10070118|FG002|STARTED|Third Intervention (Five Days)||6
9007074|NCT02954601|10070119|FG003|STARTED|Third Intervention (Five Days)||8
9007075|NCT02954601|10070116|FG000|COMPLETED|Third Intervention (Five Days)||9
9007076|NCT02954601|10070117|FG001|COMPLETED|Third Intervention (Five Days)||8
9007077|NCT02954601|10070118|FG002|COMPLETED|Third Intervention (Five Days)||6
9007078|NCT02954601|10070119|FG003|COMPLETED|Third Intervention (Five Days)||8
9007079|NCT02954601|10070116|FG000|NOT COMPLETED|Third Intervention (Five Days)||0
9007080|NCT02954601|10070117|FG001|NOT COMPLETED|Third Intervention (Five Days)||0
9007081|NCT02954601|10070118|FG002|NOT COMPLETED|Third Intervention (Five Days)||0
9007082|NCT02954601|10070119|FG003|NOT COMPLETED|Third Intervention (Five Days)||0
9007083|NCT02954653|10070131|FG000|STARTED|Overall Study||4
9007084|NCT02954653|10070132|FG001|STARTED|Overall Study||4
9007085|NCT02954653|10070133|FG002|STARTED|Overall Study|No participants were enrolled in this arm.|0
9007086|NCT02954653|10070134|FG003|STARTED|Overall Study|No participants were enrolled in this arm.|0
9007087|NCT02954653|10070135|FG004|STARTED|Overall Study|No participants were enrolled in this arm.|0
9007088|NCT02954653|10070136|FG005|STARTED|Overall Study|No participants were enrolled in this arm.|0
9007089|NCT02954653|10070137|FG006|STARTED|Overall Study|No participants were enrolled in this arm.|0
9007090|NCT02954653|10070138|FG007|STARTED|Overall Study|No participants were enrolled in this arm.|0
9007091|NCT02954653|10070139|FG008|STARTED|Overall Study|No participants were enrolled in this arm.|0
9007092|NCT02954653|10070131|FG000|Received Treatment|Overall Study||3
9007093|NCT02954653|10070132|FG001|Received Treatment|Overall Study||4
9007094|NCT02954653|10070133|FG002|Received Treatment|Overall Study||0
9007095|NCT02954653|10070134|FG003|Received Treatment|Overall Study||0
9007096|NCT02954653|10070135|FG004|Received Treatment|Overall Study||0
9007097|NCT02954653|10070136|FG005|Received Treatment|Overall Study||0
9007098|NCT02954653|10070137|FG006|Received Treatment|Overall Study||0
9007099|NCT02954653|10070138|FG007|Received Treatment|Overall Study||0
9007100|NCT02954653|10070139|FG008|Received Treatment|Overall Study||0
9007101|NCT02954653|10070131|FG000|COMPLETED|Overall Study||0
9007102|NCT02954653|10070132|FG001|COMPLETED|Overall Study||1
9007103|NCT02954653|10070133|FG002|COMPLETED|Overall Study||0
9007104|NCT02954653|10070134|FG003|COMPLETED|Overall Study||0
9007105|NCT02954653|10070135|FG004|COMPLETED|Overall Study||0
9007106|NCT02954653|10070136|FG005|COMPLETED|Overall Study||0
9007107|NCT02954653|10070137|FG006|COMPLETED|Overall Study||0
9007108|NCT02954653|10070138|FG007|COMPLETED|Overall Study||0
9007109|NCT02954653|10070139|FG008|COMPLETED|Overall Study||0
9007110|NCT02954653|10070131|FG000|NOT COMPLETED|Overall Study||4
9007111|NCT02954653|10070132|FG001|NOT COMPLETED|Overall Study||3
9007112|NCT02954653|10070133|FG002|NOT COMPLETED|Overall Study||0
9007113|NCT02954653|10070134|FG003|NOT COMPLETED|Overall Study||0
9007114|NCT02954653|10070135|FG004|NOT COMPLETED|Overall Study||0
9007115|NCT02954653|10070136|FG005|NOT COMPLETED|Overall Study||0
9007116|NCT02954653|10070137|FG006|NOT COMPLETED|Overall Study||0
9007117|NCT02954653|10070138|FG007|NOT COMPLETED|Overall Study||0
9007118|NCT02954653|10070139|FG008|NOT COMPLETED|Overall Study||0
9007119|NCT02954848|10070153|FG000|STARTED|Overall Study||245
9007120|NCT02954848|10070154|FG001|STARTED|Overall Study||239
9007121|NCT02954848|10070153|FG000|Treated|Overall Study||245
9007122|NCT02954848|10070154|FG001|Treated|Overall Study||238
9007123|NCT02954848|10070153|FG000|COMPLETED|Overall Study||243
9007124|NCT02954848|10070154|FG001|COMPLETED|Overall Study||234
9007125|NCT02954848|10070153|FG000|NOT COMPLETED|Overall Study||2
9007126|NCT02954848|10070154|FG001|NOT COMPLETED|Overall Study||5
9007127|NCT02954887|10070160|FG000|STARTED|Overall Study||9
9007128|NCT02954887|10070160|FG000|COMPLETED|Overall Study||2
9007129|NCT02954887|10070160|FG000|NOT COMPLETED|Overall Study||7
9007130|NCT02955069|10070166|FG000|STARTED|Overall Study||95
9007131|NCT02955069|10070167|FG001|STARTED|Overall Study||21
9007132|NCT02955069|10070166|FG000|Full Analysis Set (FAS)|Overall Study||95
9007133|NCT02955069|10070167|FG001|Full Analysis Set (FAS)|Overall Study||21
9007134|NCT02955069|10070166|FG000|Safety Set|Overall Study||95
9007135|NCT02955069|10070167|FG001|Safety Set|Overall Study||21
8892864|NCT02018562|9950771|FG000|STARTED|Overall Study||25
8892865|NCT02018562|9950772|FG001|STARTED|Overall Study||25
8892866|NCT02018562|9950771|FG000|COMPLETED|Overall Study||22
8892867|NCT02018562|9950772|FG001|COMPLETED|Overall Study||25
8892868|NCT02018562|9950771|FG000|NOT COMPLETED|Overall Study||3
8892869|NCT02018562|9950772|FG001|NOT COMPLETED|Overall Study||0
8892870|NCT02018627|9950780|FG000|STARTED|Overall Study||7
8892871|NCT02018627|9950781|FG001|STARTED|Overall Study||6
8892872|NCT02018627|9950780|FG000|COMPLETED|Overall Study||7
8892873|NCT02018627|9950781|FG001|COMPLETED|Overall Study||6
8892874|NCT02018627|9950780|FG000|NOT COMPLETED|Overall Study||0
8892875|NCT02018627|9950781|FG001|NOT COMPLETED|Overall Study||0
8892876|NCT02018653|9950789|FG000|STARTED|Overall Study||1
8892877|NCT02018653|9950790|FG001|STARTED|Overall Study||1
8892878|NCT02018653|9950789|FG000|COMPLETED|Overall Study||1
8892879|NCT02018653|9950790|FG001|COMPLETED|Overall Study||0
8892880|NCT02018653|9950789|FG000|NOT COMPLETED|Overall Study||0
8892881|NCT02018653|9950790|FG001|NOT COMPLETED|Overall Study||1
8892882|NCT02018809|9950800|FG000|STARTED|Overall Study||50
8892883|NCT02018809|9950801|FG001|STARTED|Overall Study||50
8892884|NCT02018809|9950802|FG002|STARTED|Overall Study||50
8892885|NCT02018809|9950803|FG003|STARTED|Overall Study||50
8892886|NCT02018809|9950800|FG000|COMPLETED|Overall Study||50
8892887|NCT02018809|9950801|FG001|COMPLETED|Overall Study||50
8892888|NCT02018809|9950802|FG002|COMPLETED|Overall Study||50
8892889|NCT02018809|9950803|FG003|COMPLETED|Overall Study||50
8892890|NCT02018809|9950800|FG000|NOT COMPLETED|Overall Study||0
8892891|NCT02018809|9950801|FG001|NOT COMPLETED|Overall Study||0
8892892|NCT02018809|9950802|FG002|NOT COMPLETED|Overall Study||0
8892893|NCT02018809|9950803|FG003|NOT COMPLETED|Overall Study||0
8892894|NCT02018822|9950815|FG000|STARTED|Overall Study||50
8892895|NCT02018822|9950816|FG001|STARTED|Overall Study||50
8892896|NCT02018822|9950817|FG002|STARTED|Overall Study||35
8892897|NCT02018822|9950815|FG000|COMPLETED|Overall Study||44
8892898|NCT02018822|9950816|FG001|COMPLETED|Overall Study||42
8892899|NCT02018822|9950817|FG002|COMPLETED|Overall Study||29
8892900|NCT02018822|9950815|FG000|NOT COMPLETED|Overall Study||6
8892901|NCT02018822|9950816|FG001|NOT COMPLETED|Overall Study||8
8892902|NCT02018822|9950817|FG002|NOT COMPLETED|Overall Study||6
8892903|NCT02018887|9950836|FG000|STARTED|Part A: Cohorts 1-2: Period 1||9
8892904|NCT02018887|9950837|FG001|STARTED|Part A: Cohorts 1-2: Period 1||9
8892905|NCT02018887|9950838|FG002|STARTED|Part A: Cohorts 1-2: Period 1|Placebo was not administered in this period.|0
8892906|NCT02018887|9950839|FG003|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
8892907|NCT02018887|9950840|FG004|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
8892908|NCT02018887|9950841|FG005|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
8892909|NCT02018887|9950842|FG006|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
8892910|NCT02018887|9950843|FG007|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
8892911|NCT02018887|9950844|FG008|STARTED|Part A: Cohorts 1-2: Period 1|Placebo was not administered in this period.|0
8892912|NCT02018887|9950845|FG009|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
8892913|NCT02018887|9950846|FG010|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
8892914|NCT02018887|9950836|FG000|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||9
8892915|NCT02018887|9950837|FG001|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||9
8892916|NCT02018887|9950838|FG002|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
8892917|NCT02018887|9950839|FG003|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
8892918|NCT02018887|9950840|FG004|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
8892919|NCT02018887|9950841|FG005|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
8892920|NCT02018887|9950842|FG006|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
8892921|NCT02018887|9950843|FG007|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
8892922|NCT02018887|9950844|FG008|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
8892923|NCT02018887|9950845|FG009|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
8892924|NCT02018887|9950846|FG010|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
8892925|NCT02018887|9950836|FG000|COMPLETED|Part A: Cohorts 1-2: Period 1||9
8892926|NCT02018887|9950837|FG001|COMPLETED|Part A: Cohorts 1-2: Period 1||9
8892927|NCT02018887|9950838|FG002|COMPLETED|Part A: Cohorts 1-2: Period 1||0
8892928|NCT02018887|9950839|FG003|COMPLETED|Part A: Cohorts 1-2: Period 1||0
8892929|NCT02018887|9950840|FG004|COMPLETED|Part A: Cohorts 1-2: Period 1||0
8892930|NCT02018887|9950841|FG005|COMPLETED|Part A: Cohorts 1-2: Period 1||0
8892931|NCT02018887|9950842|FG006|COMPLETED|Part A: Cohorts 1-2: Period 1||0
8892932|NCT02018887|9950843|FG007|COMPLETED|Part A: Cohorts 1-2: Period 1||0
8892933|NCT02018887|9950844|FG008|COMPLETED|Part A: Cohorts 1-2: Period 1||0
8892934|NCT02018887|9950845|FG009|COMPLETED|Part A: Cohorts 1-2: Period 1||0
8892935|NCT02018887|9950846|FG010|COMPLETED|Part A: Cohorts 1-2: Period 1||0
8892936|NCT02018887|9950836|FG000|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
8892937|NCT02018887|9950837|FG001|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
8892938|NCT02018887|9950838|FG002|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
8892939|NCT02018887|9950839|FG003|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
8892940|NCT02018887|9950840|FG004|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
8892941|NCT02018887|9950841|FG005|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
8892942|NCT02018887|9950842|FG006|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
8892943|NCT02018887|9950843|FG007|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
8892944|NCT02018887|9950844|FG008|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
8892945|NCT02018887|9950845|FG009|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
8892946|NCT02018887|9950846|FG010|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
8892947|NCT02018887|9950836|FG000|STARTED|Part A: Cohorts 1-2: Period 2||9
8892948|NCT02018887|9950837|FG001|STARTED|Part A: Cohorts 1-2: Period 2||9
8892949|NCT02018887|9950838|FG002|STARTED|Part A: Cohorts 1-2: Period 2|Placebo was not administered in this period.|0
8892950|NCT02018887|9950839|FG003|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
9007136|NCT02955069|10070166|FG000|Pharmacokinetic Analysis Set (PAS)|Overall Study||94
9007137|NCT02955069|10070167|FG001|Pharmacokinetic Analysis Set (PAS)|Overall Study||18
9007138|NCT02955069|10070166|FG000|Immunogenicity (IG) Prevalence Set|Overall Study||94
9007139|NCT02955069|10070167|FG001|Immunogenicity (IG) Prevalence Set|Overall Study||21
9007140|NCT02955069|10070166|FG000|IG Incidence Set|Overall Study||84
9007141|NCT02955069|10070167|FG001|IG Incidence Set|Overall Study||17
9007142|NCT02955069|10070166|FG000|COMPLETED|Overall Study||0
9007143|NCT02955069|10070167|FG001|COMPLETED|Overall Study||0
9007144|NCT02955069|10070166|FG000|NOT COMPLETED|Overall Study||95
9007145|NCT02955069|10070167|FG001|NOT COMPLETED|Overall Study||21
9007146|NCT02955147|10070175|FG000|STARTED|Overall Study||13
9007147|NCT02955147|10070175|FG000|COMPLETED|Overall Study||13
9007148|NCT02955147|10070175|FG000|NOT COMPLETED|Overall Study||0
9007149|NCT02955186|10070181|FG000|STARTED|Overall Study||33
9007150|NCT02955186|10070182|FG001|STARTED|Overall Study||17
9007151|NCT02955186|10070181|FG000|COMPLETED|Overall Study||26
9007152|NCT02955186|10070182|FG001|COMPLETED|Overall Study||15
9007153|NCT02955186|10070181|FG000|NOT COMPLETED|Overall Study||7
9007154|NCT02955186|10070182|FG001|NOT COMPLETED|Overall Study||2
9007155|NCT02955212|10070190|FG000|STARTED|Period 1: Double-blind Treatment Period||169
9007156|NCT02955212|10070191|FG001|STARTED|Period 1: Double-blind Treatment Period||169
9007157|NCT02955212|10070190|FG000|COMPLETED|Period 1: Double-blind Treatment Period||153
9007158|NCT02955212|10070191|FG001|COMPLETED|Period 1: Double-blind Treatment Period||157
9007159|NCT02955212|10070190|FG000|NOT COMPLETED|Period 1: Double-blind Treatment Period||16
9007160|NCT02955212|10070191|FG001|NOT COMPLETED|Period 1: Double-blind Treatment Period||12
9007161|NCT02955212|10070190|FG000|STARTED|Period 2: Open-label Extension||153
9007162|NCT02955212|10070191|FG001|STARTED|Period 2: Open-label Extension||157
9007163|NCT02955212|10070190|FG000|COMPLETED|Period 2: Open-label Extension||136
9007164|NCT02955212|10070191|FG001|COMPLETED|Period 2: Open-label Extension||139
9007165|NCT02955212|10070190|FG000|NOT COMPLETED|Period 2: Open-label Extension||17
9007166|NCT02955212|10070191|FG001|NOT COMPLETED|Period 2: Open-label Extension||18
9007167|NCT02955329|10070198|FG000|STARTED|Tobacco Arm||8
9007168|NCT02955329|10070198|FG000|COMPLETED|Tobacco Arm||8
9007169|NCT02955329|10070198|FG000|NOT COMPLETED|Tobacco Arm||0
9007170|NCT02955329|10070198|FG000|STARTED|Cannabis Arm||8
9007171|NCT02955329|10070198|FG000|COMPLETED|Cannabis Arm||8
9007172|NCT02955329|10070198|FG000|NOT COMPLETED|Cannabis Arm||0
9007173|NCT02955329|10070198|FG000|STARTED|Combined Cannabis and Tobacco Arm||8
9007174|NCT02955329|10070198|FG000|COMPLETED|Combined Cannabis and Tobacco Arm||8
9007175|NCT02955329|10070198|FG000|NOT COMPLETED|Combined Cannabis and Tobacco Arm||0
9007176|NCT02956044|10070209|FG000|STARTED|Overall Study||18
9007177|NCT02956044|10070210|FG001|STARTED|Overall Study||18
9007178|NCT02956044|10070211|FG002|STARTED|Overall Study||18
9007179|NCT02956044|10070209|FG000|COMPLETED|Overall Study||18
9007180|NCT02956044|10070210|FG001|COMPLETED|Overall Study||18
9007181|NCT02956044|10070211|FG002|COMPLETED|Overall Study||18
9007182|NCT02956044|10070209|FG000|NOT COMPLETED|Overall Study||0
9007183|NCT02956044|10070210|FG001|NOT COMPLETED|Overall Study||0
9007184|NCT02956044|10070211|FG002|NOT COMPLETED|Overall Study||0
9007185|NCT02956057|10070239|FG000|STARTED|Overall Study||174
9007186|NCT02956057|10070240|FG001|STARTED|Overall Study||174
9007187|NCT02956057|10070241|FG002|STARTED|Overall Study||174
9007188|NCT02956057|10070242|FG003|STARTED|Overall Study||174
9007189|NCT02956057|10070243|FG004|STARTED|Overall Study||174
9007190|NCT02956057|10070244|FG005|STARTED|Overall Study||174
9007191|NCT02956057|10070239|FG000|COMPLETED|Overall Study||160
9007192|NCT02956057|10070240|FG001|COMPLETED|Overall Study||162
9007193|NCT02956057|10070241|FG002|COMPLETED|Overall Study||166
9007194|NCT02956057|10070242|FG003|COMPLETED|Overall Study||159
9007195|NCT02956057|10070243|FG004|COMPLETED|Overall Study||169
9007196|NCT02956057|10070244|FG005|COMPLETED|Overall Study||157
9007197|NCT02956057|10070239|FG000|NOT COMPLETED|Overall Study||14
9007198|NCT02956057|10070240|FG001|NOT COMPLETED|Overall Study||12
9007199|NCT02956057|10070241|FG002|NOT COMPLETED|Overall Study||8
9007200|NCT02956057|10070242|FG003|NOT COMPLETED|Overall Study||15
9007201|NCT02956057|10070243|FG004|NOT COMPLETED|Overall Study||5
9007202|NCT02956057|10070244|FG005|NOT COMPLETED|Overall Study||17
9007203|NCT02956070|10070260|FG000|STARTED|Overall Study||35
9007204|NCT02956070|10070261|FG001|STARTED|Overall Study||35
9007205|NCT02956070|10070260|FG000|COMPLETED|Overall Study||35
8892951|NCT02018887|9950840|FG004|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
8892952|NCT02018887|9950841|FG005|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
8892953|NCT02018887|9950842|FG006|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
8892954|NCT02018887|9950843|FG007|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
8892955|NCT02018887|9950844|FG008|STARTED|Part A: Cohorts 1-2: Period 2|Placebo was not administered in this period.|0
8892956|NCT02018887|9950845|FG009|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
8892957|NCT02018887|9950846|FG010|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
8892958|NCT02018887|9950836|FG000|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||9
8892959|NCT02018887|9950837|FG001|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||9
8892960|NCT02018887|9950838|FG002|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
8892961|NCT02018887|9950839|FG003|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
8892962|NCT02018887|9950840|FG004|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
8892963|NCT02018887|9950841|FG005|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
8892964|NCT02018887|9950842|FG006|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
8892965|NCT02018887|9950843|FG007|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
8892966|NCT02018887|9950844|FG008|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
8892967|NCT02018887|9950845|FG009|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
8892968|NCT02018887|9950846|FG010|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
8892969|NCT02018887|9950836|FG000|COMPLETED|Part A: Cohorts 1-2: Period 2||9
8892970|NCT02018887|9950837|FG001|COMPLETED|Part A: Cohorts 1-2: Period 2||9
8892971|NCT02018887|9950838|FG002|COMPLETED|Part A: Cohorts 1-2: Period 2||0
8892972|NCT02018887|9950839|FG003|COMPLETED|Part A: Cohorts 1-2: Period 2||0
8892973|NCT02018887|9950840|FG004|COMPLETED|Part A: Cohorts 1-2: Period 2||0
8892974|NCT02018887|9950841|FG005|COMPLETED|Part A: Cohorts 1-2: Period 2||0
8892975|NCT02018887|9950842|FG006|COMPLETED|Part A: Cohorts 1-2: Period 2||0
8892976|NCT02018887|9950843|FG007|COMPLETED|Part A: Cohorts 1-2: Period 2||0
8892977|NCT02018887|9950844|FG008|COMPLETED|Part A: Cohorts 1-2: Period 2||0
8892978|NCT02018887|9950845|FG009|COMPLETED|Part A: Cohorts 1-2: Period 2||0
8892979|NCT02018887|9950846|FG010|COMPLETED|Part A: Cohorts 1-2: Period 2||0
8892980|NCT02018887|9950836|FG000|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
8892981|NCT02018887|9950837|FG001|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
8892982|NCT02018887|9950838|FG002|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
8892983|NCT02018887|9950839|FG003|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
8892984|NCT02018887|9950840|FG004|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
8892985|NCT02018887|9950841|FG005|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
8892986|NCT02018887|9950842|FG006|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
8892987|NCT02018887|9950843|FG007|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
8892988|NCT02018887|9950844|FG008|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
8892989|NCT02018887|9950845|FG009|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
8892990|NCT02018887|9950846|FG010|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
8892991|NCT02018887|9950836|FG000|STARTED|Part A: Cohorts 1-2: Period 3||9
8892992|NCT02018887|9950837|FG001|STARTED|Part A: Cohorts 1-2: Period 3||9
8892993|NCT02018887|9950838|FG002|STARTED|Part A: Cohorts 1-2: Period 3|Placebo was not administered in this period.|0
8892994|NCT02018887|9950839|FG003|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
8892995|NCT02018887|9950840|FG004|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
8892996|NCT02018887|9950841|FG005|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
8892997|NCT02018887|9950842|FG006|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
8892998|NCT02018887|9950843|FG007|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
8892999|NCT02018887|9950844|FG008|STARTED|Part A: Cohorts 1-2: Period 3|Placebo was not administered in this period.|0
8893000|NCT02018887|9950845|FG009|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
8893001|NCT02018887|9950846|FG010|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
8893002|NCT02018887|9950836|FG000|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||8
8893003|NCT02018887|9950837|FG001|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||9
8893004|NCT02018887|9950838|FG002|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
8893005|NCT02018887|9950839|FG003|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
8893006|NCT02018887|9950840|FG004|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
8893007|NCT02018887|9950841|FG005|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
8893008|NCT02018887|9950842|FG006|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
8893009|NCT02018887|9950843|FG007|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
8893010|NCT02018887|9950844|FG008|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
8893011|NCT02018887|9950845|FG009|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
8893012|NCT02018887|9950846|FG010|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
8893013|NCT02018887|9950836|FG000|COMPLETED|Part A: Cohorts 1-2: Period 3||8
8893014|NCT02018887|9950837|FG001|COMPLETED|Part A: Cohorts 1-2: Period 3||9
8893015|NCT02018887|9950838|FG002|COMPLETED|Part A: Cohorts 1-2: Period 3||0
8893016|NCT02018887|9950839|FG003|COMPLETED|Part A: Cohorts 1-2: Period 3||0
8893017|NCT02018887|9950840|FG004|COMPLETED|Part A: Cohorts 1-2: Period 3||0
8893018|NCT02018887|9950841|FG005|COMPLETED|Part A: Cohorts 1-2: Period 3||0
9007206|NCT02956070|10070261|FG001|COMPLETED|Overall Study||35
9007207|NCT02956070|10070260|FG000|NOT COMPLETED|Overall Study||0
9007208|NCT02956070|10070261|FG001|NOT COMPLETED|Overall Study||0
9007209|NCT02956122|10070267|FG000|STARTED|Overall Study||1
9007210|NCT02956122|10070267|FG000|COMPLETED|Overall Study||1
9007211|NCT02956122|10070267|FG000|NOT COMPLETED|Overall Study||0
9007212|NCT02956278|10070281|FG000|STARTED|Overall Study||15
9007213|NCT02956278|10070282|FG001|STARTED|Overall Study||9
9007214|NCT02956278|10070283|FG002|STARTED|Overall Study||3
9007215|NCT02956278|10070281|FG000|COMPLETED|Overall Study||9
9007216|NCT02956278|10070282|FG001|COMPLETED|Overall Study||7
9007217|NCT02956278|10070283|FG002|COMPLETED|Overall Study||3
9007218|NCT02956278|10070281|FG000|NOT COMPLETED|Overall Study||6
9007219|NCT02956278|10070282|FG001|NOT COMPLETED|Overall Study||2
9007220|NCT02956278|10070283|FG002|NOT COMPLETED|Overall Study||0
9007221|NCT02956460|10070293|FG000|STARTED|Lens 1||30
9007222|NCT02956460|10070294|FG001|STARTED|Lens 1||34
9007223|NCT02956460|10070293|FG000|COMPLETED|Lens 1||29
9007224|NCT02956460|10070294|FG001|COMPLETED|Lens 1||34
9007225|NCT02956460|10070293|FG000|NOT COMPLETED|Lens 1||1
9007226|NCT02956460|10070294|FG001|NOT COMPLETED|Lens 1||0
9007227|NCT02956460|10070293|FG000|STARTED|Lens 2||29
9007228|NCT02956460|10070294|FG001|STARTED|Lens 2||34
9007229|NCT02956460|10070293|FG000|COMPLETED|Lens 2||29
9007230|NCT02956460|10070294|FG001|COMPLETED|Lens 2||34
9007231|NCT02956460|10070293|FG000|NOT COMPLETED|Lens 2||0
9007232|NCT02956460|10070294|FG001|NOT COMPLETED|Lens 2||0
9007233|NCT02956486|10070302|FG000|STARTED|Core Phase||1108
9007234|NCT02956486|10070303|FG001|STARTED|Core Phase||1104
9007235|NCT02956486|10070304|FG002|STARTED|Core Phase||0
9007236|NCT02956486|10070302|FG000|Treated|Core Phase||1108
9007237|NCT02956486|10070303|FG001|Treated|Core Phase||1101
9007238|NCT02956486|10070304|FG002|Treated|Core Phase||0
9007239|NCT02956486|10070302|FG000|Safety Analysis Set (SAS)|Core Phase||1105
9007240|NCT02956486|10070303|FG001|Safety Analysis Set (SAS)|Core Phase||1099
9007241|NCT02956486|10070304|FG002|Safety Analysis Set (SAS)|Core Phase||0
9007242|NCT02956486|10070302|FG000|Full Analysis Set (FAS)|Core Phase||1084
9007243|NCT02956486|10070303|FG001|Full Analysis Set (FAS)|Core Phase||1062
9007244|NCT02956486|10070304|FG002|Full Analysis Set (FAS)|Core Phase||0
9007245|NCT02956486|10070302|FG000|COMPLETED|Core Phase||29
9007246|NCT02956486|10070303|FG001|COMPLETED|Core Phase||32
9007247|NCT02956486|10070304|FG002|COMPLETED|Core Phase||0
9007248|NCT02956486|10070302|FG000|NOT COMPLETED|Core Phase||1079
9007249|NCT02956486|10070303|FG001|NOT COMPLETED|Core Phase||1072
9007250|NCT02956486|10070304|FG002|NOT COMPLETED|Core Phase||0
9007251|NCT02956486|10070302|FG000|STARTED|Extension Phase||0
9007252|NCT02956486|10070303|FG001|STARTED|Extension Phase||0
9007253|NCT02956486|10070304|FG002|STARTED|Extension Phase|Eligible participants who completed core and consented for extension phase, entered extension phase.|19
8893019|NCT02018887|9950842|FG006|COMPLETED|Part A: Cohorts 1-2: Period 3||0
8893020|NCT02018887|9950843|FG007|COMPLETED|Part A: Cohorts 1-2: Period 3||0
8893021|NCT02018887|9950844|FG008|COMPLETED|Part A: Cohorts 1-2: Period 3||0
8893022|NCT02018887|9950845|FG009|COMPLETED|Part A: Cohorts 1-2: Period 3||0
8893023|NCT02018887|9950846|FG010|COMPLETED|Part A: Cohorts 1-2: Period 3||0
8893024|NCT02018887|9950836|FG000|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||1
8893025|NCT02018887|9950837|FG001|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
8893026|NCT02018887|9950838|FG002|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
8893027|NCT02018887|9950839|FG003|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
8893028|NCT02018887|9950840|FG004|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
8893029|NCT02018887|9950841|FG005|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
8893030|NCT02018887|9950842|FG006|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
8893031|NCT02018887|9950843|FG007|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
8893032|NCT02018887|9950844|FG008|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
8893033|NCT02018887|9950845|FG009|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
8893034|NCT02018887|9950846|FG010|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
8893035|NCT02018887|9950836|FG000|STARTED|Part B: Cohorts 3-7 Overall|Column for Part A data only.|0
8893036|NCT02018887|9950837|FG001|STARTED|Part B: Cohorts 3-7 Overall|Column for Part A data only.|0
8893037|NCT02018887|9950838|FG002|STARTED|Part B: Cohorts 3-7 Overall||15
8893038|NCT02018887|9950839|FG003|STARTED|Part B: Cohorts 3-7 Overall||9
8893039|NCT02018887|9950840|FG004|STARTED|Part B: Cohorts 3-7 Overall||9
8893040|NCT02018887|9950841|FG005|STARTED|Part B: Cohorts 3-7 Overall||9
8893041|NCT02018887|9950842|FG006|STARTED|Part B: Cohorts 3-7 Overall||9
8893042|NCT02018887|9950843|FG007|STARTED|Part B: Cohorts 3-7 Overall||9
8893043|NCT02018887|9950844|FG008|STARTED|Part B: Cohorts 3-7 Overall|Placebo was not administered in this period.|0
8893044|NCT02018887|9950845|FG009|STARTED|Part B: Cohorts 3-7 Overall|This dose was not administered in this period.|0
8893045|NCT02018887|9950846|FG010|STARTED|Part B: Cohorts 3-7 Overall|This dose was not administered in this period.|0
8893046|NCT02018887|9950836|FG000|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0
8893047|NCT02018887|9950837|FG001|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0
9007254|NCT02956486|10070302|FG000|Treated|Extension Phase||0
9007255|NCT02956486|10070303|FG001|Treated|Extension Phase||0
9007256|NCT02956486|10070304|FG002|Treated|Extension Phase||18
9007257|NCT02956486|10070302|FG000|Safety Analysis Set (SAS)|Extension Phase||0
8893048|NCT02018887|9950838|FG002|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||15
8893049|NCT02018887|9950839|FG003|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9
8893050|NCT02018887|9950840|FG004|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9
8893051|NCT02018887|9950841|FG005|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9
8893052|NCT02018887|9950842|FG006|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9
8893053|NCT02018887|9950843|FG007|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9
8893054|NCT02018887|9950844|FG008|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0
8893055|NCT02018887|9950845|FG009|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0
8893056|NCT02018887|9950846|FG010|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0
8893057|NCT02018887|9950836|FG000|COMPLETED|Part B: Cohorts 3-7 Overall||0
8635081|NCT00560352|9675513|FG001|COMPLETED|Overall Study||0
8635082|NCT00560352|9675514|FG002|COMPLETED|Overall Study||0
8635083|NCT00560352|9675512|FG000|NOT COMPLETED|Overall Study||7
8635084|NCT00560352|9675513|FG001|NOT COMPLETED|Overall Study||3
8635085|NCT00560352|9675514|FG002|NOT COMPLETED|Overall Study||4
8635086|NCT00560391|9675531|FG000|STARTED|Overall Study|Participants who received treatment|6
8635087|NCT00560391|9675532|FG001|STARTED|Overall Study|Participants who received treatment|3
8635088|NCT00560391|9675533|FG002|STARTED|Overall Study|Participants who received treatment|3
8635089|NCT00560391|9675534|FG003|STARTED|Overall Study|Participants who received treatment|6
8893058|NCT02018887|9950837|FG001|COMPLETED|Part B: Cohorts 3-7 Overall||0
8893059|NCT02018887|9950838|FG002|COMPLETED|Part B: Cohorts 3-7 Overall||15
8893060|NCT02018887|9950839|FG003|COMPLETED|Part B: Cohorts 3-7 Overall||9
8893061|NCT02018887|9950840|FG004|COMPLETED|Part B: Cohorts 3-7 Overall||8
8635090|NCT00560391|9675535|FG004|STARTED|Overall Study|Participants who received treatment|17
8635091|NCT00560391|9675531|FG000|COMPLETED|Overall Study|Completed=off treatment;Disease progression-1;Death-1;Max. clinical benefit-2;Study drug toxicity-2|6
8635092|NCT00560391|9675532|FG001|COMPLETED|Overall Study|Completed=off treatment; Disease progression-1;Death-1; Unrelated AE-1|3
8691307|NCT00854100|9736550|FG001|STARTED|Overall Study||76
8893062|NCT02018887|9950841|FG005|COMPLETED|Part B: Cohorts 3-7 Overall||9
8893063|NCT02018887|9950842|FG006|COMPLETED|Part B: Cohorts 3-7 Overall||8
8893064|NCT02018887|9950843|FG007|COMPLETED|Part B: Cohorts 3-7 Overall||5
8893065|NCT02018887|9950844|FG008|COMPLETED|Part B: Cohorts 3-7 Overall||0
8893066|NCT02018887|9950845|FG009|COMPLETED|Part B: Cohorts 3-7 Overall||0
8893067|NCT02018887|9950846|FG010|COMPLETED|Part B: Cohorts 3-7 Overall||0
8893068|NCT02018887|9950836|FG000|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
8893069|NCT02018887|9950837|FG001|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
8893070|NCT02018887|9950838|FG002|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
8893071|NCT02018887|9950839|FG003|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
8893072|NCT02018887|9950840|FG004|NOT COMPLETED|Part B: Cohorts 3-7 Overall||1
8893073|NCT02018887|9950841|FG005|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
8893074|NCT02018887|9950842|FG006|NOT COMPLETED|Part B: Cohorts 3-7 Overall||1
8893075|NCT02018887|9950843|FG007|NOT COMPLETED|Part B: Cohorts 3-7 Overall||4
8893076|NCT02018887|9950844|FG008|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
9007258|NCT02956486|10070303|FG001|Safety Analysis Set (SAS)|Extension Phase||0
9007259|NCT02956486|10070304|FG002|Safety Analysis Set (SAS)|Extension Phase||18
9007260|NCT02956486|10070302|FG000|COMPLETED|Extension Phase||0
9007261|NCT02956486|10070303|FG001|COMPLETED|Extension Phase||0
9007262|NCT02956486|10070304|FG002|COMPLETED|Extension Phase||0
9007263|NCT02956486|10070302|FG000|NOT COMPLETED|Extension Phase||0
9007264|NCT02956486|10070303|FG001|NOT COMPLETED|Extension Phase||0
9007265|NCT02956486|10070304|FG002|NOT COMPLETED|Extension Phase||19
9007266|NCT02956616|10070315|FG000|STARTED|Overall Study||58
9007267|NCT02956616|10070316|FG001|STARTED|Overall Study||60
9007268|NCT02956616|10070315|FG000|COMPLETED|Overall Study||58
9007269|NCT02956616|10070316|FG001|COMPLETED|Overall Study||60
9007270|NCT02956616|10070315|FG000|NOT COMPLETED|Overall Study||0
9007271|NCT02956616|10070316|FG001|NOT COMPLETED|Overall Study||0
9007272|NCT02956629|10070328|FG000|STARTED|Overall Study||78
9007273|NCT02956629|10070329|FG001|STARTED|Overall Study||47
9007274|NCT02956629|10070330|FG002|STARTED|Overall Study||61
9007275|NCT02956629|10070331|FG003|STARTED|Overall Study||56
9007276|NCT02956629|10070332|FG004|STARTED|Overall Study||18
9007277|NCT02956629|10070333|FG005|STARTED|Overall Study||22
9007278|NCT02956629|10070328|FG000|COMPLETED|Overall Study||73
9007279|NCT02956629|10070329|FG001|COMPLETED|Overall Study||41
9007280|NCT02956629|10070330|FG002|COMPLETED|Overall Study||57
9007281|NCT02956629|10070331|FG003|COMPLETED|Overall Study||55
9007282|NCT02956629|10070332|FG004|COMPLETED|Overall Study||18
9007283|NCT02956629|10070333|FG005|COMPLETED|Overall Study||21
9007284|NCT02956629|10070328|FG000|NOT COMPLETED|Overall Study||5
9007285|NCT02956629|10070329|FG001|NOT COMPLETED|Overall Study||6
9007286|NCT02956629|10070330|FG002|NOT COMPLETED|Overall Study||4
9007287|NCT02956629|10070331|FG003|NOT COMPLETED|Overall Study||1
9007288|NCT02956629|10070332|FG004|NOT COMPLETED|Overall Study||0
9007289|NCT02956629|10070333|FG005|NOT COMPLETED|Overall Study||1
9007290|NCT02956746|10070351|FG000|STARTED|Overall Study||40
9007291|NCT02956746|10070352|FG001|STARTED|Overall Study||40
9007292|NCT02956746|10070353|FG002|STARTED|Overall Study||42
9007293|NCT02956746|10070354|FG003|STARTED|Overall Study||42
9007294|NCT02956746|10070351|FG000|COMPLETED|Overall Study||38
9007295|NCT02956746|10070352|FG001|COMPLETED|Overall Study||37
9007296|NCT02956746|10070353|FG002|COMPLETED|Overall Study||36
9007297|NCT02956746|10070354|FG003|COMPLETED|Overall Study||38
9007298|NCT02956746|10070351|FG000|NOT COMPLETED|Overall Study||2
9007299|NCT02956746|10070352|FG001|NOT COMPLETED|Overall Study||3
9007300|NCT02956746|10070353|FG002|NOT COMPLETED|Overall Study||6
9007301|NCT02956746|10070354|FG003|NOT COMPLETED|Overall Study||4
9007302|NCT02956837|10070369|FG000|STARTED|Overall Study||100
9007303|NCT02956837|10070370|FG001|STARTED|Overall Study||99
8893077|NCT02018887|9950845|FG009|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
8893078|NCT02018887|9950846|FG010|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
8893079|NCT02018887|9950836|FG000|STARTED|Part C: Cohort 8 Overall||0
8893080|NCT02018887|9950837|FG001|STARTED|Part C: Cohort 8 Overall||0
8893081|NCT02018887|9950838|FG002|STARTED|Part C: Cohort 8 Overall|Placebo was not administered in this period.|0
8893082|NCT02018887|9950839|FG003|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0
8893083|NCT02018887|9950840|FG004|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0
8893084|NCT02018887|9950841|FG005|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0
8893085|NCT02018887|9950842|FG006|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0
8893086|NCT02018887|9950843|FG007|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0
8893087|NCT02018887|9950844|FG008|STARTED|Part C: Cohort 8 Overall||10
8893088|NCT02018887|9950845|FG009|STARTED|Part C: Cohort 8 Overall||4
8893089|NCT02018887|9950846|FG010|STARTED|Part C: Cohort 8 Overall||7
8893090|NCT02018887|9950836|FG000|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
8893091|NCT02018887|9950837|FG001|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
8893092|NCT02018887|9950838|FG002|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
8893093|NCT02018887|9950839|FG003|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
8893094|NCT02018887|9950840|FG004|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
8893095|NCT02018887|9950841|FG005|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
8893096|NCT02018887|9950842|FG006|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
8893097|NCT02018887|9950843|FG007|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
8893098|NCT02018887|9950844|FG008|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||10
8893099|NCT02018887|9950845|FG009|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||4
8893100|NCT02018887|9950846|FG010|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||7
8893101|NCT02018887|9950836|FG000|COMPLETED|Part C: Cohort 8 Overall||0
8893102|NCT02018887|9950837|FG001|COMPLETED|Part C: Cohort 8 Overall||0
8893103|NCT02018887|9950838|FG002|COMPLETED|Part C: Cohort 8 Overall||0
8893104|NCT02018887|9950839|FG003|COMPLETED|Part C: Cohort 8 Overall||0
8893105|NCT02018887|9950840|FG004|COMPLETED|Part C: Cohort 8 Overall||0
8893106|NCT02018887|9950841|FG005|COMPLETED|Part C: Cohort 8 Overall||0
8893107|NCT02018887|9950842|FG006|COMPLETED|Part C: Cohort 8 Overall||0
8893108|NCT02018887|9950843|FG007|COMPLETED|Part C: Cohort 8 Overall||0
8893109|NCT02018887|9950844|FG008|COMPLETED|Part C: Cohort 8 Overall||7
8893110|NCT02018887|9950845|FG009|COMPLETED|Part C: Cohort 8 Overall||1
8893111|NCT02018887|9950846|FG010|COMPLETED|Part C: Cohort 8 Overall||6
8893112|NCT02018887|9950836|FG000|NOT COMPLETED|Part C: Cohort 8 Overall||0
8893113|NCT02018887|9950837|FG001|NOT COMPLETED|Part C: Cohort 8 Overall||0
8893114|NCT02018887|9950838|FG002|NOT COMPLETED|Part C: Cohort 8 Overall||0
8893115|NCT02018887|9950839|FG003|NOT COMPLETED|Part C: Cohort 8 Overall||0
8893116|NCT02018887|9950840|FG004|NOT COMPLETED|Part C: Cohort 8 Overall||0
9007304|NCT02956837|10070371|FG002|STARTED|Overall Study||99
9007305|NCT02956837|10070372|FG003|STARTED|Overall Study||102
9007306|NCT02956837|10070369|FG000|COMPLETED|Overall Study||100
9007307|NCT02956837|10070370|FG001|COMPLETED|Overall Study||96
9007308|NCT02956837|10070371|FG002|COMPLETED|Overall Study||97
9007309|NCT02956837|10070372|FG003|COMPLETED|Overall Study||99
9007310|NCT02956837|10070369|FG000|NOT COMPLETED|Overall Study||0
9007311|NCT02956837|10070370|FG001|NOT COMPLETED|Overall Study||3
9007312|NCT02956837|10070371|FG002|NOT COMPLETED|Overall Study||2
9007313|NCT02956837|10070372|FG003|NOT COMPLETED|Overall Study||3
9007314|NCT02956967|10070385|FG000|STARTED|Overall Study||171
9007315|NCT02956967|10070385|FG000|COMPLETED|Overall Study||123
9007316|NCT02956967|10070385|FG000|NOT COMPLETED|Overall Study||48
9007317|NCT02957123|10070389|FG000|STARTED|Overall Study||30
9007318|NCT02957123|10070389|FG000|COMPLETED|Overall Study||30
9007319|NCT02957123|10070389|FG000|NOT COMPLETED|Overall Study||0
9007320|NCT02957136|10070395|FG000|STARTED|Overall Study||95
9007321|NCT02957136|10070396|FG001|STARTED|Overall Study||99
9007322|NCT02957136|10070395|FG000|COMPLETED|Overall Study||93
9007323|NCT02957136|10070396|FG001|COMPLETED|Overall Study||98
9007324|NCT02957136|10070395|FG000|NOT COMPLETED|Overall Study||2
9007325|NCT02957136|10070396|FG001|NOT COMPLETED|Overall Study||1
9007326|NCT02957305|10070404|FG000|STARTED|Overall Study||106
9007327|NCT02957305|10070405|FG001|STARTED|Overall Study||105
9007328|NCT02957305|10070404|FG000|COMPLETED|Overall Study||106
9007329|NCT02957305|10070405|FG001|COMPLETED|Overall Study||105
9007330|NCT02957305|10070404|FG000|NOT COMPLETED|Overall Study||0
8893117|NCT02018887|9950841|FG005|NOT COMPLETED|Part C: Cohort 8 Overall||0
8893118|NCT02018887|9950842|FG006|NOT COMPLETED|Part C: Cohort 8 Overall||0
9007331|NCT02957305|10070405|FG001|NOT COMPLETED|Overall Study||0
9007332|NCT02957331|10070413|FG000|STARTED|Overall Study||14
9007333|NCT02957331|10070414|FG001|STARTED|Overall Study||12
9007334|NCT02957331|10070413|FG000|COMPLETED|Overall Study||13
9007335|NCT02957331|10070414|FG001|COMPLETED|Overall Study||12
9007336|NCT02957331|10070413|FG000|NOT COMPLETED|Overall Study||1
8893119|NCT02018887|9950843|FG007|NOT COMPLETED|Part C: Cohort 8 Overall||0
8893120|NCT02018887|9950844|FG008|NOT COMPLETED|Part C: Cohort 8 Overall||3
8893121|NCT02018887|9950845|FG009|NOT COMPLETED|Part C: Cohort 8 Overall||3
8893122|NCT02018887|9950846|FG010|NOT COMPLETED|Part C: Cohort 8 Overall||1
8893123|NCT02019069|9950912|FG000|STARTED|Overall Study||11
8893124|NCT02019069|9950912|FG000|COMPLETED|Overall Study||11
8893125|NCT02019069|9950912|FG000|NOT COMPLETED|Overall Study||0
8635093|NCT00560391|9675533|FG002|COMPLETED|Overall Study|Completed=off treatment; Disease progression-1;Maximum clinical benefit-1; Unrelated AE-1|3
8635094|NCT00560391|9675534|FG003|COMPLETED|Overall Study|Completed=off treatment; Disease progression-2; Unrelated AE 1 and Subject request 2|5
8635095|NCT00560391|9675535|FG004|COMPLETED|Overall Study|Completed=offtreatment;Disease progression-6;Study drug toxicity-7; Unrelated AE-1,Subject request-1|15
8635096|NCT00560391|9675531|FG000|NOT COMPLETED|Overall Study||0
8635097|NCT00560391|9675532|FG001|NOT COMPLETED|Overall Study||0
8635098|NCT00560391|9675533|FG002|NOT COMPLETED|Overall Study||0
8635099|NCT00560391|9675534|FG003|NOT COMPLETED|Overall Study||1
8635100|NCT00560391|9675535|FG004|NOT COMPLETED|Overall Study||2
8635101|NCT00560404|9675550|FG000|STARTED|Overall Study||112
8635102|NCT00560404|9675551|FG001|STARTED|Overall Study||121
8635103|NCT00560404|9675550|FG000|COMPLETED|Overall Study||76
8635104|NCT00560404|9675551|FG001|COMPLETED|Overall Study||100
8635105|NCT00560404|9675550|FG000|NOT COMPLETED|Overall Study||36
8635106|NCT00560404|9675551|FG001|NOT COMPLETED|Overall Study||21
8635107|NCT00560417|9675559|FG000|STARTED|Overall Study||171
8635108|NCT00560417|9675560|FG001|STARTED|Overall Study||168
8635109|NCT00560417|9675559|FG000|Intention to Treat (ITT) Population|Overall Study||170
8635110|NCT00560417|9675560|FG001|Intention to Treat (ITT) Population|Overall Study||167
8635111|NCT00560417|9675559|FG000|COMPLETED|Overall Study||154
8635112|NCT00560417|9675560|FG001|COMPLETED|Overall Study||151
8635113|NCT00560417|9675559|FG000|NOT COMPLETED|Overall Study||17
8635114|NCT00560417|9675560|FG001|NOT COMPLETED|Overall Study||17
8635115|NCT00560508|9675568|FG000|STARTED|12 Week Double-blind Period||56
8635116|NCT00560508|9675569|FG001|STARTED|12 Week Double-blind Period||56
8635117|NCT00560508|9675568|FG000|COMPLETED|12 Week Double-blind Period||51
8635118|NCT00560508|9675569|FG001|COMPLETED|12 Week Double-blind Period||53
8635119|NCT00560508|9675568|FG000|NOT COMPLETED|12 Week Double-blind Period||5
8635120|NCT00560508|9675569|FG001|NOT COMPLETED|12 Week Double-blind Period||3
8635121|NCT00560508|9675568|FG000|STARTED|52-week Open-label Period Pramipexole ER|all patients received Pramipexole ER for the 52-week open-label period|51
8635122|NCT00560508|9675569|FG001|STARTED|52-week Open-label Period Pramipexole ER|all patients received Pramipexole ER for the 52-week open-label period|53
8635123|NCT00560508|9675568|FG000|COMPLETED|52-week Open-label Period Pramipexole ER||43
8635124|NCT00560508|9675569|FG001|COMPLETED|52-week Open-label Period Pramipexole ER||42
8635125|NCT00560508|9675568|FG000|NOT COMPLETED|52-week Open-label Period Pramipexole ER||8
8635126|NCT00560508|9675569|FG001|NOT COMPLETED|52-week Open-label Period Pramipexole ER||11
8635127|NCT00560560|9675582|FG000|STARTED|Overall Study||85
8635128|NCT00560560|9675583|FG001|STARTED|Overall Study||83
8635129|NCT00560560|9675582|FG000|COMPLETED|Overall Study||0
8635130|NCT00560560|9675583|FG001|COMPLETED|Overall Study||0
8635131|NCT00560560|9675582|FG000|NOT COMPLETED|Overall Study||85
8635132|NCT00560560|9675583|FG001|NOT COMPLETED|Overall Study||83
8635133|NCT00560573|9675589|FG000|STARTED|Overall Study||6
8635134|NCT00560573|9675590|FG001|STARTED|Overall Study||3
8635135|NCT00560573|9675591|FG002|STARTED|Overall Study||6
8635136|NCT00560573|9675592|FG003|STARTED|Overall Study||10
8635137|NCT00560573|9675593|FG004|STARTED|Overall Study||8
8635138|NCT00560573|9675594|FG005|STARTED|Overall Study||13
8635139|NCT00560573|9675589|FG000|Treated|Overall Study||6
8635140|NCT00560573|9675590|FG001|Treated|Overall Study||3
8635141|NCT00560573|9675591|FG002|Treated|Overall Study||6
8635142|NCT00560573|9675592|FG003|Treated|Overall Study||10
8635143|NCT00560573|9675593|FG004|Treated|Overall Study||7
8635144|NCT00560573|9675594|FG005|Treated|Overall Study||13
8635145|NCT00560573|9675589|FG000|COMPLETED|Overall Study||0
8635146|NCT00560573|9675590|FG001|COMPLETED|Overall Study||0
8635147|NCT00560573|9675591|FG002|COMPLETED|Overall Study||0
8635148|NCT00560573|9675592|FG003|COMPLETED|Overall Study||0
8635149|NCT00560573|9675593|FG004|COMPLETED|Overall Study||1
8635150|NCT00560573|9675594|FG005|COMPLETED|Overall Study||0
8635151|NCT00560573|9675589|FG000|NOT COMPLETED|Overall Study||6
8635152|NCT00560573|9675590|FG001|NOT COMPLETED|Overall Study||3
8635153|NCT00560573|9675591|FG002|NOT COMPLETED|Overall Study||6
8635154|NCT00560573|9675592|FG003|NOT COMPLETED|Overall Study||10
8635155|NCT00560573|9675593|FG004|NOT COMPLETED|Overall Study||7
8635156|NCT00560573|9675594|FG005|NOT COMPLETED|Overall Study||13
8635157|NCT00560612|9675626|FG000|STARTED|Overall Study||5
8635158|NCT00560612|9675627|FG001|STARTED|Overall Study||7
8893126|NCT02019108|9950918|FG000|STARTED|Overall Study||40
8893127|NCT02019108|9950919|FG001|STARTED|Overall Study||39
8635159|NCT00560612|9675626|FG000|COMPLETED|Overall Study||5
8635160|NCT00560612|9675627|FG001|COMPLETED|Overall Study||7
8635161|NCT00560612|9675626|FG000|NOT COMPLETED|Overall Study||0
8635162|NCT00560612|9675627|FG001|NOT COMPLETED|Overall Study||0
8635163|NCT00560703|9675635|FG000|STARTED|Overall Study||46
8635164|NCT00560703|9675636|FG001|STARTED|Overall Study||24
8635165|NCT00560703|9675635|FG000|COMPLETED|Overall Study||46
8893128|NCT02019108|9950918|FG000|Baseline (Week 0)|Overall Study||40
8893129|NCT02019108|9950919|FG001|Baseline (Week 0)|Overall Study||39
8893130|NCT02019108|9950918|FG000|Follow-up (Week 17)|Overall Study||38
8893131|NCT02019108|9950919|FG001|Follow-up (Week 17)|Overall Study||36
8893132|NCT02019108|9950918|FG000|Retention (Week 21)|Overall Study||35
8893133|NCT02019108|9950919|FG001|Retention (Week 21)|Overall Study||32
8893134|NCT02019108|9950918|FG000|COMPLETED|Overall Study||35
8893135|NCT02019108|9950919|FG001|COMPLETED|Overall Study||32
8893136|NCT02019108|9950918|FG000|NOT COMPLETED|Overall Study||5
8893137|NCT02019108|9950919|FG001|NOT COMPLETED|Overall Study||7
8893138|NCT02019264|9950927|FG000|STARTED|Overall Study||6000
8893139|NCT02019264|9950928|FG001|STARTED|Overall Study||6000
8893140|NCT02019264|9950927|FG000|Safety Analysis Set|Overall Study||5992
8893141|NCT02019264|9950928|FG001|Safety Analysis Set|Overall Study||5995
8893142|NCT02019264|9950927|FG000|COMPLETED|Overall Study||5752
8893143|NCT02019264|9950928|FG001|COMPLETED|Overall Study||5793
8893144|NCT02019264|9950927|FG000|NOT COMPLETED|Overall Study||248
8635166|NCT00560703|9675636|FG001|COMPLETED|Overall Study||18
8635167|NCT00560703|9675635|FG000|NOT COMPLETED|Overall Study||0
8635168|NCT00560703|9675636|FG001|NOT COMPLETED|Overall Study||6
8635169|NCT00560755|9675642|FG000|STARTED|Overall Study|Vaccinated (at least one ProQuad® dose)|3388
8635170|NCT00560755|9675642|FG000|ProQuad® Dose 1 and Dose 2|Overall Study||3346
8635171|NCT00560755|9675642|FG000|COMPLETED|Overall Study||3328
8893145|NCT02019264|9950928|FG001|NOT COMPLETED|Overall Study||207
8893146|NCT02019277|9950934|FG000|STARTED|Overall Study||50
8893147|NCT02019277|9950934|FG000|COMPLETED|Overall Study||38
8893148|NCT02019277|9950934|FG000|NOT COMPLETED|Overall Study||12
8893149|NCT02019420|9950940|FG000|STARTED|Overall Study||366
8893150|NCT02019420|9950941|FG001|STARTED|Overall Study||360
8893151|NCT02019420|9950940|FG000|Treated|Overall Study||361
8893152|NCT02019420|9950941|FG001|Treated|Overall Study||357
8893153|NCT02019420|9950940|FG000|COMPLETED|Overall Study||258
8893154|NCT02019420|9950941|FG001|COMPLETED|Overall Study||254
8893155|NCT02019420|9950940|FG000|NOT COMPLETED|Overall Study||108
8893156|NCT02019420|9950941|FG001|NOT COMPLETED|Overall Study||106
8893157|NCT02019472|9950950|FG000|STARTED|Overall Study||186
8893158|NCT02019472|9950951|FG001|STARTED|Overall Study||186
8893159|NCT02019472|9950952|FG002|STARTED|Overall Study||187
8893160|NCT02019472|9950950|FG000|COMPLETED|Overall Study||149
8893161|NCT02019472|9950951|FG001|COMPLETED|Overall Study||134
8893162|NCT02019472|9950952|FG002|COMPLETED|Overall Study||145
8893163|NCT02019472|9950950|FG000|NOT COMPLETED|Overall Study||37
8893164|NCT02019472|9950951|FG001|NOT COMPLETED|Overall Study||52
8893165|NCT02019472|9950952|FG002|NOT COMPLETED|Overall Study||42
8893166|NCT02019550|9950966|FG000|STARTED|Treatment Period 1 (4 Weeks)||46
8893167|NCT02019550|9950967|FG001|STARTED|Treatment Period 1 (4 Weeks)||51
8893168|NCT02019550|9950966|FG000|COMPLETED|Treatment Period 1 (4 Weeks)||46
8893169|NCT02019550|9950967|FG001|COMPLETED|Treatment Period 1 (4 Weeks)||50
8893170|NCT02019550|9950966|FG000|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
8893171|NCT02019550|9950967|FG001|NOT COMPLETED|Treatment Period 1 (4 Weeks)||1
8893172|NCT02019550|9950966|FG000|STARTED|Treatment Period 2 (4 Weeks)||46
8893173|NCT02019550|9950967|FG001|STARTED|Treatment Period 2 (4 Weeks)||50
8893174|NCT02019550|9950966|FG000|COMPLETED|Treatment Period 2 (4 Weeks)||46
8893175|NCT02019550|9950967|FG001|COMPLETED|Treatment Period 2 (4 Weeks)||50
8893176|NCT02019550|9950966|FG000|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
8893177|NCT02019550|9950967|FG001|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
8893178|NCT02019563|9950977|FG000|STARTED|Overall Study|100 incisors were treated in the MTA/FS pulpotomy group|40
8893179|NCT02019563|9950978|FG001|STARTED|Overall Study|72 incisors were treated in the RCT group|30
8893180|NCT02019563|9950977|FG000|COMPLETED|Overall Study|100 incisors were treated in the MTA/FS pulpotomy group|40
8635172|NCT00560755|9675642|FG000|NOT COMPLETED|Overall Study||60
8635173|NCT00560794|9675647|FG000|STARTED|Overall Study||21
8635174|NCT00560794|9675647|FG000|Completed 1 Treatment Cycle|Overall Study||20
8635175|NCT00560794|9675647|FG000|COMPLETED|Overall Study||10
8726167|NCT01034163|9773318|FG000|NOT COMPLETED|Overall Study||27
8726168|NCT01034163|9773319|FG001|NOT COMPLETED|Overall Study||14
8893181|NCT02019563|9950978|FG001|COMPLETED|Overall Study|72 incisors were treated in the RCT group|30
8893182|NCT02019563|9950977|FG000|NOT COMPLETED|Overall Study||0
8893183|NCT02019563|9950978|FG001|NOT COMPLETED|Overall Study||0
8726169|NCT01034176|9773327|FG000|STARTED|Overall Study||22
8893184|NCT02019602|9950988|FG000|STARTED|Screening Period||21
8893185|NCT02019602|9950989|FG001|STARTED|Screening Period||16
8893186|NCT02019602|9950988|FG000|COMPLETED|Screening Period||16
8893187|NCT02019602|9950989|FG001|COMPLETED|Screening Period||16
8726170|NCT01034176|9773328|FG001|STARTED|Overall Study||21
8726171|NCT01034176|9773327|FG000|COMPLETED|Overall Study||20
8893188|NCT02019602|9950988|FG000|NOT COMPLETED|Screening Period||5
8893189|NCT02019602|9950989|FG001|NOT COMPLETED|Screening Period||0
8893190|NCT02019602|9950988|FG000|STARTED|Sampling Period||16
8893191|NCT02019602|9950989|FG001|STARTED|Sampling Period||16
8893192|NCT02019602|9950988|FG000|COMPLETED|Sampling Period||16
8635176|NCT00560794|9675647|FG000|NOT COMPLETED|Overall Study||11
8893193|NCT02019602|9950989|FG001|COMPLETED|Sampling Period||16
8893194|NCT02019602|9950988|FG000|NOT COMPLETED|Sampling Period||0
8893195|NCT02019602|9950989|FG001|NOT COMPLETED|Sampling Period||0
8893196|NCT02019667|9950996|FG000|STARTED|First Intervention (6 Months)||10
8635177|NCT00560833|9675658|FG000|STARTED|Overall Study||317
8635178|NCT00560833|9675659|FG001|STARTED|Overall Study||155
8893197|NCT02019667|9950997|FG001|STARTED|First Intervention (6 Months)||9
8893198|NCT02019667|9950996|FG000|COMPLETED|First Intervention (6 Months)||10
8893199|NCT02019667|9950997|FG001|COMPLETED|First Intervention (6 Months)||8
8893200|NCT02019667|9950996|FG000|NOT COMPLETED|First Intervention (6 Months)||0
8893201|NCT02019667|9950997|FG001|NOT COMPLETED|First Intervention (6 Months)||1
8893202|NCT02019667|9950996|FG000|STARTED|Washout Period (9 Weeks)||10
8893203|NCT02019667|9950997|FG001|STARTED|Washout Period (9 Weeks)||8
8893204|NCT02019667|9950996|FG000|COMPLETED|Washout Period (9 Weeks)||10
8893205|NCT02019667|9950997|FG001|COMPLETED|Washout Period (9 Weeks)||8
8893206|NCT02019667|9950996|FG000|NOT COMPLETED|Washout Period (9 Weeks)||0
8893207|NCT02019667|9950997|FG001|NOT COMPLETED|Washout Period (9 Weeks)||0
8893208|NCT02019667|9950996|FG000|STARTED|2nd Intervention (6 Months)||10
8893209|NCT02019667|9950997|FG001|STARTED|2nd Intervention (6 Months)||8
8893210|NCT02019667|9950996|FG000|COMPLETED|2nd Intervention (6 Months)||10
8893211|NCT02019667|9950997|FG001|COMPLETED|2nd Intervention (6 Months)||6
8893212|NCT02019667|9950996|FG000|NOT COMPLETED|2nd Intervention (6 Months)||0
8893213|NCT02019667|9950997|FG001|NOT COMPLETED|2nd Intervention (6 Months)||2
8893214|NCT02019667|9950996|FG000|STARTED|Washout Period (9 Weeks)||10
8893215|NCT02019667|9950997|FG001|STARTED|Washout Period (9 Weeks)||6
8893216|NCT02019667|9950996|FG000|COMPLETED|Washout Period (9 Weeks)||10
8893217|NCT02019667|9950997|FG001|COMPLETED|Washout Period (9 Weeks)||6
8893218|NCT02019667|9950996|FG000|NOT COMPLETED|Washout Period (9 Weeks)||0
8893219|NCT02019667|9950997|FG001|NOT COMPLETED|Washout Period (9 Weeks)||0
8893220|NCT02019719|9951010|FG000|STARTED|Overall Study||19
8635179|NCT00560833|9675660|FG002|STARTED|Overall Study||160
8635180|NCT00560833|9675661|FG003|STARTED|Overall Study||155
8635181|NCT00560833|9675662|FG004|STARTED|Overall Study||156
8635182|NCT00560833|9675658|FG000|Treated|Overall Study|One participant was not randomized but was treated with placebo|317
8635183|NCT00560833|9675659|FG001|Treated|Overall Study|One participant was randomized but not treated|154
8635184|NCT00560833|9675660|FG002|Treated|Overall Study||160
8635185|NCT00560833|9675661|FG003|Treated|Overall Study||155
8635186|NCT00560833|9675662|FG004|Treated|Overall Study|One participant was randomized but not treated|155
8635187|NCT00560833|9675658|FG000|COMPLETED|Overall Study||273
8635188|NCT00560833|9675659|FG001|COMPLETED|Overall Study||129
8635189|NCT00560833|9675660|FG002|COMPLETED|Overall Study||121
8635190|NCT00560833|9675661|FG003|COMPLETED|Overall Study||124
8635191|NCT00560833|9675662|FG004|COMPLETED|Overall Study||114
8635192|NCT00560833|9675658|FG000|NOT COMPLETED|Overall Study||44
8635193|NCT00560833|9675659|FG001|NOT COMPLETED|Overall Study||26
8635194|NCT00560833|9675660|FG002|NOT COMPLETED|Overall Study||39
8635195|NCT00560833|9675661|FG003|NOT COMPLETED|Overall Study||31
8635196|NCT00560833|9675662|FG004|NOT COMPLETED|Overall Study||42
8635197|NCT00560859|9675676|FG000|STARTED|Overall Study||226
8635198|NCT00560859|9675677|FG001|STARTED|Overall Study||227
8635199|NCT00560859|9675676|FG000|COMPLETED|Overall Study||194
8635200|NCT00560859|9675677|FG001|COMPLETED|Overall Study||203
8635201|NCT00560859|9675676|FG000|NOT COMPLETED|Overall Study||32
8635202|NCT00560859|9675677|FG001|NOT COMPLETED|Overall Study||24
8635203|NCT00560885|9675684|FG000|STARTED|Overall Study||55
8726172|NCT01034176|9773328|FG001|COMPLETED|Overall Study||19
8893221|NCT02019719|9951011|FG001|STARTED|Overall Study||19
8893222|NCT02019719|9951012|FG002|STARTED|Overall Study||20
8893223|NCT02019719|9951013|FG003|STARTED|Overall Study||19
8893224|NCT02019719|9951014|FG004|STARTED|Overall Study||20
8893225|NCT02019719|9951010|FG000|COMPLETED|Overall Study||13
8893226|NCT02019719|9951011|FG001|COMPLETED|Overall Study||18
8893227|NCT02019719|9951012|FG002|COMPLETED|Overall Study||20
8893228|NCT02019719|9951013|FG003|COMPLETED|Overall Study||17
8893229|NCT02019719|9951014|FG004|COMPLETED|Overall Study||18
8893230|NCT02019719|9951010|FG000|NOT COMPLETED|Overall Study||6
8893231|NCT02019719|9951011|FG001|NOT COMPLETED|Overall Study||1
8893232|NCT02019719|9951012|FG002|NOT COMPLETED|Overall Study||0
8893233|NCT02019719|9951013|FG003|NOT COMPLETED|Overall Study||2
8893234|NCT02019719|9951014|FG004|NOT COMPLETED|Overall Study||2
8893235|NCT02019758|9951035|FG000|STARTED|Overall Study|64 received intervention; 1 did not receive intervention|65
8893236|NCT02019758|9951036|FG001|STARTED|Overall Study|63 received intervention; 1 did not receive intervention|64
8893237|NCT02019758|9951035|FG000|Received Intervention|Overall Study||64
8893238|NCT02019758|9951036|FG001|Received Intervention|Overall Study||63
8893239|NCT02019758|9951035|FG000|Did Not Receive Intervention|Overall Study||1
8893240|NCT02019758|9951036|FG001|Did Not Receive Intervention|Overall Study||1
8893241|NCT02019758|9951035|FG000|Lost to Follow-up|Overall Study|8 were lost to follow-up and did not undergo week 8 endoscopy or other outcome assessments|8
8893242|NCT02019758|9951036|FG001|Lost to Follow-up|Overall Study|8 were lost to follow-up and did not undergo week 8 endoscopy or other outcome assessments|8
8893243|NCT02019758|9951035|FG000|COMPLETED|Overall Study||56
8893244|NCT02019758|9951036|FG001|COMPLETED|Overall Study|8 were lost to follow-up and did not undergo week 8 endoscopy or other outcome assessments|55
8893245|NCT02019758|9951035|FG000|NOT COMPLETED|Overall Study||9
8893246|NCT02019758|9951036|FG001|NOT COMPLETED|Overall Study||9
8893247|NCT02019888|9951045|FG000|STARTED|Overall Study||148
8893248|NCT02019888|9951046|FG001|STARTED|Overall Study||113
8635204|NCT00560885|9675684|FG000|30 Day Follow-up|Overall Study|53 pts available for 30 day follow-up, 52 pts assessed|53
8635205|NCT00560885|9675684|FG000|3 Month Follow-up|Overall Study|51 pts available for 3 month follow-up, 48 pts assessed.|51
8635206|NCT00560885|9675684|FG000|6 Month Follow-up|Overall Study|50 pts available for 6 month follow-up, 50 pts assessed|50
8893249|NCT02019888|9951047|FG002|STARTED|Overall Study||59
8893250|NCT02019888|9951045|FG000|COMPLETED|Overall Study||108
8893251|NCT02019888|9951046|FG001|COMPLETED|Overall Study||83
8893252|NCT02019888|9951047|FG002|COMPLETED|Overall Study||54
8893253|NCT02019888|9951045|FG000|NOT COMPLETED|Overall Study||40
8893254|NCT02019888|9951046|FG001|NOT COMPLETED|Overall Study||30
8893255|NCT02019888|9951047|FG002|NOT COMPLETED|Overall Study||5
8893256|NCT02019927|9951061|FG000|STARTED|Overall Study||46
8893257|NCT02019927|9951062|FG001|STARTED|Overall Study||23
8893258|NCT02019927|9951063|FG002|STARTED|Overall Study||9
8893259|NCT02019927|9951064|FG003|STARTED|Overall Study||5
8893260|NCT02019927|9951065|FG004|STARTED|Overall Study||10
8893261|NCT02019927|9951066|FG005|STARTED|Overall Study||4
8893262|NCT02019927|9951061|FG000|COMPLETED|Overall Study||44
8893263|NCT02019927|9951062|FG001|COMPLETED|Overall Study||19
8893264|NCT02019927|9951063|FG002|COMPLETED|Overall Study||8
8893265|NCT02019927|9951064|FG003|COMPLETED|Overall Study||3
8893266|NCT02019927|9951065|FG004|COMPLETED|Overall Study||7
8893267|NCT02019927|9951066|FG005|COMPLETED|Overall Study||3
8893268|NCT02019927|9951061|FG000|NOT COMPLETED|Overall Study||2
8893269|NCT02019927|9951062|FG001|NOT COMPLETED|Overall Study||4
8893270|NCT02019927|9951063|FG002|NOT COMPLETED|Overall Study||1
8893271|NCT02019927|9951064|FG003|NOT COMPLETED|Overall Study||2
8893272|NCT02019927|9951065|FG004|NOT COMPLETED|Overall Study||3
8893273|NCT02019927|9951066|FG005|NOT COMPLETED|Overall Study||1
8893274|NCT02019940|9951084|FG000|STARTED|Overall Study||18
8893275|NCT02019940|9951084|FG000|COMPLETED|Overall Study||8
8893276|NCT02019940|9951084|FG000|NOT COMPLETED|Overall Study||10
8893277|NCT02019979|9951088|FG000|STARTED|Overall Study||14
8893278|NCT02019979|9951088|FG000|COMPLETED|Overall Study||0
8893279|NCT02019979|9951088|FG000|NOT COMPLETED|Overall Study||14
8893280|NCT02020018|9951094|FG000|STARTED|Overall Study||272
8893281|NCT02020018|9951095|FG001|STARTED|Overall Study||1597
8893282|NCT02020018|9951094|FG000|COMPLETED|Overall Study||272
8893283|NCT02020018|9951095|FG001|COMPLETED|Overall Study||1597
8893284|NCT02020018|9951094|FG000|NOT COMPLETED|Overall Study||0
8893285|NCT02020018|9951095|FG001|NOT COMPLETED|Overall Study||0
8893286|NCT02020031|9951103|FG000|STARTED|Overall Study||11
8893287|NCT02020031|9951104|FG001|STARTED|Overall Study||11
8893288|NCT02020031|9951103|FG000|COMPLETED|Overall Study||10
8893289|NCT02020031|9951104|FG001|COMPLETED|Overall Study||10
8893290|NCT02020031|9951103|FG000|NOT COMPLETED|Overall Study||1
8893291|NCT02020031|9951104|FG001|NOT COMPLETED|Overall Study||1
8893292|NCT02020135|9951112|FG000|STARTED|Overall Study||9
8893293|NCT02020135|9951112|FG000|COMPLETED|Overall Study||0
8893294|NCT02020135|9951112|FG000|NOT COMPLETED|Overall Study||9
8893295|NCT02020252|9951118|FG000|STARTED|Overall Study||120
8893296|NCT02020252|9951118|FG000|COMPLETED|Overall Study||120
8893297|NCT02020252|9951118|FG000|NOT COMPLETED|Overall Study||0
8893298|NCT02020278|9951122|FG000|STARTED|Core Safety Follow-up Component||3
8893299|NCT02020278|9951122|FG000|COMPLETED|Core Safety Follow-up Component||3
8893300|NCT02020278|9951122|FG000|NOT COMPLETED|Core Safety Follow-up Component||0
8893301|NCT02020278|9951122|FG000|STARTED|Optional Tolvaptan Treatment Component||0
8893302|NCT02020278|9951122|FG000|COMPLETED|Optional Tolvaptan Treatment Component||0
8893303|NCT02020278|9951122|FG000|NOT COMPLETED|Optional Tolvaptan Treatment Component||0
8893304|NCT02020304|9951130|FG000|STARTED|Overall Study||30
8893305|NCT02020304|9951131|FG001|STARTED|Overall Study||28
8893306|NCT02020304|9951130|FG000|COMPLETED|Overall Study||27
8893307|NCT02020304|9951131|FG001|COMPLETED|Overall Study||26
8893308|NCT02020304|9951130|FG000|NOT COMPLETED|Overall Study||3
8893309|NCT02020304|9951131|FG001|NOT COMPLETED|Overall Study||2
8893310|NCT02020369|9951139|FG000|STARTED|Overall Study||14
8893311|NCT02020369|9951140|FG001|STARTED|Overall Study||13
8893312|NCT02020369|9951139|FG000|COMPLETED|Overall Study||11
8893313|NCT02020369|9951140|FG001|COMPLETED|Overall Study||11
8893314|NCT02020369|9951139|FG000|NOT COMPLETED|Overall Study||3
8893315|NCT02020369|9951140|FG001|NOT COMPLETED|Overall Study||2
8893316|NCT02020408|9951149|FG000|STARTED|Overall Study||88
8893317|NCT02020408|9951149|FG000|COMPLETED|Overall Study||85
8893318|NCT02020408|9951149|FG000|NOT COMPLETED|Overall Study||3
8893319|NCT02020512|9951159|FG000|STARTED|Overall Study||87
8893320|NCT02020512|9951159|FG000|COMPLETED|Overall Study||79
8893321|NCT02020512|9951159|FG000|NOT COMPLETED|Overall Study||8
8893322|NCT02020577|9951165|FG000|STARTED|Overall Study||3
8893323|NCT02020577|9951166|FG001|STARTED|Overall Study||55
8893324|NCT02020577|9951165|FG000|COMPLETED|Overall Study||0
8893325|NCT02020577|9951166|FG001|COMPLETED|Overall Study||0
8893326|NCT02020577|9951165|FG000|NOT COMPLETED|Overall Study||3
8893327|NCT02020577|9951166|FG001|NOT COMPLETED|Overall Study||55
8893328|NCT02020590|9951174|FG000|STARTED|Overall Study||22
8893329|NCT02020590|9951174|FG000|COMPLETED|Overall Study||22
8893330|NCT02020590|9951174|FG000|NOT COMPLETED|Overall Study||0
8893331|NCT02020616|9951185|FG000|STARTED|Overall Study||10
8893332|NCT02020616|9951186|FG001|STARTED|Overall Study||8
8893333|NCT02020616|9951187|FG002|STARTED|Overall Study||8
8893334|NCT02020616|9951188|FG003|STARTED|Overall Study||8
8893335|NCT02020616|9951189|FG004|STARTED|Overall Study||8
8893336|NCT02020616|9951190|FG005|STARTED|Overall Study||8
8893337|NCT02020616|9951191|FG006|STARTED|Overall Study||10
8893338|NCT02020616|9951185|FG000|Received at Least One Dose of Study Drug|Overall Study||10
8893339|NCT02020616|9951186|FG001|Received at Least One Dose of Study Drug|Overall Study||8
8893340|NCT02020616|9951187|FG002|Received at Least One Dose of Study Drug|Overall Study||8
8893341|NCT02020616|9951188|FG003|Received at Least One Dose of Study Drug|Overall Study||7
8893342|NCT02020616|9951189|FG004|Received at Least One Dose of Study Drug|Overall Study||8
8893343|NCT02020616|9951190|FG005|Received at Least One Dose of Study Drug|Overall Study||8
8893344|NCT02020616|9951191|FG006|Received at Least One Dose of Study Drug|Overall Study||10
8893345|NCT02020616|9951185|FG000|COMPLETED|Overall Study||10
8893346|NCT02020616|9951186|FG001|COMPLETED|Overall Study||7
8893347|NCT02020616|9951187|FG002|COMPLETED|Overall Study||6
8893348|NCT02020616|9951188|FG003|COMPLETED|Overall Study||6
8893349|NCT02020616|9951189|FG004|COMPLETED|Overall Study||6
8893350|NCT02020616|9951190|FG005|COMPLETED|Overall Study||3
8893351|NCT02020616|9951191|FG006|COMPLETED|Overall Study||6
8893352|NCT02020616|9951185|FG000|NOT COMPLETED|Overall Study||0
8893353|NCT02020616|9951186|FG001|NOT COMPLETED|Overall Study||1
8893354|NCT02020616|9951187|FG002|NOT COMPLETED|Overall Study||2
8893355|NCT02020616|9951188|FG003|NOT COMPLETED|Overall Study||2
8893356|NCT02020616|9951189|FG004|NOT COMPLETED|Overall Study||2
8893357|NCT02020616|9951190|FG005|NOT COMPLETED|Overall Study||5
8893358|NCT02020616|9951191|FG006|NOT COMPLETED|Overall Study||4
8893359|NCT02020785|9951223|FG000|STARTED|First Intervention (3 Weeks)||15
8893360|NCT02020785|9951224|FG001|STARTED|First Intervention (3 Weeks)||16
8893361|NCT02020785|9951223|FG000|COMPLETED|First Intervention (3 Weeks)||15
8893362|NCT02020785|9951224|FG001|COMPLETED|First Intervention (3 Weeks)||16
8893363|NCT02020785|9951223|FG000|NOT COMPLETED|First Intervention (3 Weeks)||0
8893364|NCT02020785|9951224|FG001|NOT COMPLETED|First Intervention (3 Weeks)||0
8893365|NCT02020785|9951223|FG000|STARTED|Second Intervention (3 Weeks)||15
8893366|NCT02020785|9951224|FG001|STARTED|Second Intervention (3 Weeks)||16
8893367|NCT02020785|9951223|FG000|COMPLETED|Second Intervention (3 Weeks)||15
8893368|NCT02020785|9951224|FG001|COMPLETED|Second Intervention (3 Weeks)||16
8893369|NCT02020785|9951223|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0
8893370|NCT02020785|9951224|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
8893371|NCT02020863|9951230|FG000|STARTED|Overall Study||40
8893372|NCT02020863|9951230|FG000|COMPLETED|Overall Study||35
8893373|NCT02020863|9951230|FG000|NOT COMPLETED|Overall Study||5
8893374|NCT02020889|9951236|FG000|STARTED|Overall Study||68
9007337|NCT02957331|10070414|FG001|NOT COMPLETED|Overall Study||0
9007338|NCT02957357|10070422|FG000|STARTED|Overall Study||10479
8893375|NCT02020889|9951237|FG001|STARTED|Overall Study||68
8893376|NCT02020889|9951236|FG000|COMPLETED|Overall Study||61
8893377|NCT02020889|9951237|FG001|COMPLETED|Overall Study||65
8893378|NCT02020889|9951236|FG000|NOT COMPLETED|Overall Study||7
8893379|NCT02020889|9951237|FG001|NOT COMPLETED|Overall Study||3
8893380|NCT02020941|9951243|FG000|STARTED|Overall Study||10
8893381|NCT02020941|9951243|FG000|COMPLETED|Overall Study||2
8893382|NCT02020941|9951243|FG000|NOT COMPLETED|Overall Study||8
8893383|NCT02020967|9951249|FG000|STARTED|Overall Study||367
8893384|NCT02020967|9951249|FG000|Examined Participants|Overall Study||329
8893385|NCT02020967|9951249|FG000|COMPLETED|Overall Study||316
8893386|NCT02020967|9951249|FG000|NOT COMPLETED|Overall Study||51
8893387|NCT02021292|9951257|FG000|STARTED|Overall Study||40
8893388|NCT02021292|9951258|FG001|STARTED|Overall Study||40
8893389|NCT02021292|9951257|FG000|COMPLETED|Overall Study||40
8893390|NCT02021292|9951258|FG001|COMPLETED|Overall Study||37
8893391|NCT02021292|9951257|FG000|NOT COMPLETED|Overall Study||0
8893392|NCT02021292|9951258|FG001|NOT COMPLETED|Overall Study||3
8893393|NCT02021318|9951268|FG000|STARTED|Overall Study||323
8893394|NCT02021318|9951269|FG001|STARTED|Overall Study||293
8893395|NCT02021318|9951268|FG000|COMPLETED|Overall Study||250
8893396|NCT02021318|9951269|FG001|COMPLETED|Overall Study||230
8893397|NCT02021318|9951268|FG000|NOT COMPLETED|Overall Study||73
8893398|NCT02021318|9951269|FG001|NOT COMPLETED|Overall Study||63
8893399|NCT02021331|9951278|FG000|STARTED|Overall Study||2
8893400|NCT02021331|9951279|FG001|STARTED|Overall Study||3
8893401|NCT02021331|9951278|FG000|COMPLETED|Overall Study||2
8893402|NCT02021331|9951279|FG001|COMPLETED|Overall Study||1
8893403|NCT02021331|9951278|FG000|NOT COMPLETED|Overall Study||0
8893404|NCT02021331|9951279|FG001|NOT COMPLETED|Overall Study||2
8893405|NCT02021461|9951285|FG000|STARTED|Overall Study||38
8893406|NCT02021461|9951285|FG000|COMPLETED|Overall Study||38
8893407|NCT02021461|9951285|FG000|NOT COMPLETED|Overall Study||0
8893408|NCT02021565|9951293|FG000|STARTED|Baseline Through Intervention||72
8893409|NCT02021565|9951294|FG001|STARTED|Baseline Through Intervention||54
8893410|NCT02021565|9951293|FG000|Caregivers|Baseline Through Intervention||36
8893411|NCT02021565|9951294|FG001|Caregivers|Baseline Through Intervention||27
8893412|NCT02021565|9951293|FG000|Care Recipients|Baseline Through Intervention||36
8893413|NCT02021565|9951294|FG001|Care Recipients|Baseline Through Intervention||27
8893414|NCT02021565|9951293|FG000|COMPLETED|Baseline Through Intervention||60
8893415|NCT02021565|9951294|FG001|COMPLETED|Baseline Through Intervention||36
8893416|NCT02021565|9951293|FG000|NOT COMPLETED|Baseline Through Intervention||12
8893417|NCT02021565|9951294|FG001|NOT COMPLETED|Baseline Through Intervention||18
8893418|NCT02021565|9951293|FG000|STARTED|3-month Follow-up||60
8893419|NCT02021565|9951294|FG001|STARTED|3-month Follow-up||36
8893420|NCT02021565|9951293|FG000|Caregivers|3-month Follow-up||30
8893421|NCT02021565|9951294|FG001|Caregivers|3-month Follow-up||18
8893422|NCT02021565|9951293|FG000|Care Recipients|3-month Follow-up||30
8893423|NCT02021565|9951294|FG001|Care Recipients|3-month Follow-up||18
8893424|NCT02021565|9951293|FG000|COMPLETED|3-month Follow-up||50
8893425|NCT02021565|9951294|FG001|COMPLETED|3-month Follow-up||34
8893426|NCT02021565|9951293|FG000|NOT COMPLETED|3-month Follow-up||10
8893427|NCT02021565|9951294|FG001|NOT COMPLETED|3-month Follow-up||2
8893428|NCT02021643|9951308|FG000|STARTED|Overall Study||156
8893429|NCT02021643|9951309|FG001|STARTED|Overall Study||290
8893430|NCT02021643|9951310|FG002|STARTED|Overall Study||11
8893431|NCT02021643|9951311|FG003|STARTED|Overall Study||230
8893432|NCT02021643|9951308|FG000|COMPLETED|Overall Study||147
8893433|NCT02021643|9951309|FG001|COMPLETED|Overall Study||280
8893434|NCT02021643|9951310|FG002|COMPLETED|Overall Study||11
8893435|NCT02021643|9951311|FG003|COMPLETED|Overall Study||218
8893436|NCT02021643|9951308|FG000|NOT COMPLETED|Overall Study||9
8893437|NCT02021643|9951309|FG001|NOT COMPLETED|Overall Study||10
8893438|NCT02021643|9951310|FG002|NOT COMPLETED|Overall Study||0
8893439|NCT02021643|9951311|FG003|NOT COMPLETED|Overall Study||12
8893440|NCT02021656|9951327|FG000|STARTED|Overall Study||384
8893441|NCT02021656|9951327|FG000|COMPLETED|Overall Study||378
8893442|NCT02021656|9951327|FG000|NOT COMPLETED|Overall Study||6
8893443|NCT02021669|9951337|FG000|STARTED|Overall Study||71
8893444|NCT02021669|9951338|FG001|STARTED|Overall Study||73
8893445|NCT02021669|9951337|FG000|COMPLETED|Overall Study||64
8893446|NCT02021669|9951338|FG001|COMPLETED|Overall Study||70
8893447|NCT02021669|9951337|FG000|NOT COMPLETED|Overall Study||7
8893448|NCT02021669|9951338|FG001|NOT COMPLETED|Overall Study||3
8893449|NCT02021812|9951344|FG000|STARTED|Overall Study||31
8893450|NCT02021812|9951344|FG000|COMPLETED|Overall Study||9
8893451|NCT02021812|9951344|FG000|NOT COMPLETED|Overall Study||22
8893452|NCT02021929|9951350|FG000|STARTED|Overall Study||16
8893453|NCT02021929|9951351|FG001|STARTED|Overall Study||12
8893454|NCT02021929|9951350|FG000|COMPLETED|Overall Study||14
8893455|NCT02021929|9951351|FG001|COMPLETED|Overall Study||11
8893456|NCT02021929|9951350|FG000|NOT COMPLETED|Overall Study||2
8893457|NCT02021929|9951351|FG001|NOT COMPLETED|Overall Study||1
8893458|NCT02021942|9951357|FG000|STARTED|Overall Study||16
8893459|NCT02021942|9951357|FG000|COMPLETED|Overall Study||16
8893460|NCT02021942|9951357|FG000|NOT COMPLETED|Overall Study||0
8893461|NCT02021955|9951364|FG000|STARTED|Step 0|Provider attrition=2; Provider addition=3; Patient discharges=14|210
8893462|NCT02021955|9951365|FG001|STARTED|Step 0|Provider attrition=0; Provider addition=0; Patient discharges=0|0
8893463|NCT02021955|9951364|FG000|COMPLETED|Step 0||210
8893464|NCT02021955|9951365|FG001|COMPLETED|Step 0||0
8893465|NCT02021955|9951364|FG000|NOT COMPLETED|Step 0||0
8893466|NCT02021955|9951365|FG001|NOT COMPLETED|Step 0||0
8893467|NCT02021955|9951364|FG000|STARTED|Step 1|Provider attrition=20; Provider addition=2; Patient discharges=14|193
8893468|NCT02021955|9951365|FG001|STARTED|Step 1|Provider attrition=7; Provider addition=0; Patient discharges: 0|18
8893469|NCT02021955|9951364|FG000|COMPLETED|Step 1||193
8893470|NCT02021955|9951365|FG001|COMPLETED|Step 1||18
8893471|NCT02021955|9951364|FG000|NOT COMPLETED|Step 1||0
8893472|NCT02021955|9951365|FG001|NOT COMPLETED|Step 1||0
8893473|NCT02021955|9951364|FG000|STARTED|Step 2|Provider attrition=5; Provider addition=21; Patient discharges=12|165
8893474|NCT02021955|9951365|FG001|STARTED|Step 2|Provider attrition=2; Provider addition=5; Patient discharges=2|21
8893475|NCT02021955|9951364|FG000|COMPLETED|Step 2||165
8893476|NCT02021955|9951365|FG001|COMPLETED|Step 2||21
8893477|NCT02021955|9951364|FG000|NOT COMPLETED|Step 2||0
8893478|NCT02021955|9951365|FG001|NOT COMPLETED|Step 2||0
8893479|NCT02021955|9951364|FG000|STARTED|Step 3|Provider attrition=2; Provider addition=4; Patient discharges=5|175
8893480|NCT02021955|9951365|FG001|STARTED|Step 3|Provider attrition=0; Provider addition=3; Patient discharges=3|30
8893481|NCT02021955|9951364|FG000|COMPLETED|Step 3||175
8893482|NCT02021955|9951365|FG001|COMPLETED|Step 3||30
8893483|NCT02021955|9951364|FG000|NOT COMPLETED|Step 3||0
8893484|NCT02021955|9951365|FG001|NOT COMPLETED|Step 3||0
8893485|NCT02021955|9951364|FG000|STARTED|Step 4|Provider attrition=0; Provider addition=3; Patient discharges: 13|173
8893486|NCT02021955|9951365|FG001|STARTED|Step 4|Provider attrition=0; Provider addition=1; Patient discharges=0|37
8893487|NCT02021955|9951364|FG000|COMPLETED|Step 4||173
8893488|NCT02021955|9951365|FG001|COMPLETED|Step 4||37
8893489|NCT02021955|9951364|FG000|NOT COMPLETED|Step 4||0
8893490|NCT02021955|9951365|FG001|NOT COMPLETED|Step 4||0
8893491|NCT02021955|9951364|FG000|STARTED|Step 5|Provider attrition=3; Provider addition=0; Patient discharges=11|174
8893492|NCT02021955|9951365|FG001|STARTED|Step 5|Provider attrition=0; Provider addition=0; Patient discharges=2|40
8893493|NCT02021955|9951364|FG000|COMPLETED|Step 5||174
8893494|NCT02021955|9951365|FG001|COMPLETED|Step 5||40
8893495|NCT02021955|9951364|FG000|NOT COMPLETED|Step 5||0
8893496|NCT02021955|9951365|FG001|NOT COMPLETED|Step 5||0
8893497|NCT02021955|9951364|FG000|STARTED|Step 6|Provider attrition=0; Provider addition=2; Patient discharges=6|158
8893498|NCT02021955|9951365|FG001|STARTED|Step 6|Provider attrition=0; Provider addition=1; Patient discharges=1|53
8893499|NCT02021955|9951364|FG000|COMPLETED|Step 6||158
8893500|NCT02021955|9951365|FG001|COMPLETED|Step 6||53
8893501|NCT02021955|9951364|FG000|NOT COMPLETED|Step 6||0
8893502|NCT02021955|9951365|FG001|NOT COMPLETED|Step 6||0
8893503|NCT02021955|9951364|FG000|STARTED|Step 7|Provider attrition=0; Provider addition=2; Patient discharges=13|157
8893504|NCT02021955|9951365|FG001|STARTED|Step 7|Provider attrition=0; Provider addition=1; Patient discharges=2|57
8893505|NCT02021955|9951364|FG000|COMPLETED|Step 7||157
8893506|NCT02021955|9951365|FG001|COMPLETED|Step 7||57
8893507|NCT02021955|9951364|FG000|NOT COMPLETED|Step 7||0
8893508|NCT02021955|9951365|FG001|NOT COMPLETED|Step 7||0
8893509|NCT02021955|9951364|FG000|STARTED|Step 8|Provider attrition=1; Provider addition=0; Patient discharges=9|144
8893510|NCT02021955|9951365|FG001|STARTED|Step 8|Provider attrition=0; Provider addition=0; Patient discharges=11|73
8893511|NCT02021955|9951364|FG000|COMPLETED|Step 8||144
8893512|NCT02021955|9951365|FG001|COMPLETED|Step 8||73
8893513|NCT02021955|9951364|FG000|NOT COMPLETED|Step 8||0
8893514|NCT02021955|9951365|FG001|NOT COMPLETED|Step 8||0
8893515|NCT02021955|9951364|FG000|STARTED|Step 9|Provider attrition=2; Provider addition=1; Patient discharges=9|139
8893516|NCT02021955|9951365|FG001|STARTED|Step 9|Provider attrition=1; Provider addition=0; Patient discharges=8|77
8893517|NCT02021955|9951364|FG000|COMPLETED|Step 9||139
8893518|NCT02021955|9951365|FG001|COMPLETED|Step 9||77
8893519|NCT02021955|9951364|FG000|NOT COMPLETED|Step 9||0
8893520|NCT02021955|9951365|FG001|NOT COMPLETED|Step 9||0
8893521|NCT02021955|9951364|FG000|STARTED|Step 10|Provider attrition=0; Provider addition=1; Patient discharges: 8|135
8893522|NCT02021955|9951365|FG001|STARTED|Step 10|Provider attrition=1; Provider addition=0; Patient discharges=5|79
8893523|NCT02021955|9951364|FG000|COMPLETED|Step 10||135
8893524|NCT02021955|9951365|FG001|COMPLETED|Step 10||79
8893525|NCT02021955|9951364|FG000|NOT COMPLETED|Step 10||0
8893526|NCT02021955|9951365|FG001|NOT COMPLETED|Step 10||0
8893527|NCT02021955|9951364|FG000|STARTED|Step 11|Provider attrition=1; Provider addition=0; Patient discharges=11|126
8635207|NCT00560885|9675684|FG000|12 Month Follow-up|Overall Study|48 pts available for 12 month follow-up, 46 pts assessed|48
8635208|NCT00560885|9675684|FG000|2 Year Follow-up|Overall Study||47
8635209|NCT00560885|9675684|FG000|COMPLETED|Overall Study||47
8635210|NCT00560885|9675684|FG000|NOT COMPLETED|Overall Study||8
8635211|NCT00560937|9675690|FG000|STARTED|Overall Study||10
8635212|NCT00560937|9675691|FG001|STARTED|Overall Study||11
8635213|NCT00560937|9675690|FG000|COMPLETED|Overall Study|One participant was withdrawn after 6 weeks and data were carried forward|9
8893528|NCT02021955|9951365|FG001|STARTED|Step 11|Provider attrition=2; Provider addition=2; Patient discharges=7|88
8893529|NCT02021955|9951364|FG000|COMPLETED|Step 11||126
8893530|NCT02021955|9951365|FG001|COMPLETED|Step 11||88
8893531|NCT02021955|9951364|FG000|NOT COMPLETED|Step 11||0
8893532|NCT02021955|9951365|FG001|NOT COMPLETED|Step 11||0
8893533|NCT02021955|9951364|FG000|STARTED|Step 12|Provider attrition=1; Provider addition=0; Patient discharges=3|123
8893534|NCT02021955|9951365|FG001|STARTED|Step 12|Provider attrition=0; Provider addition=2; Patient discharges=1|90
8893535|NCT02021955|9951364|FG000|COMPLETED|Step 12||123
8893536|NCT02021955|9951365|FG001|COMPLETED|Step 12||90
8893537|NCT02021955|9951364|FG000|NOT COMPLETED|Step 12||0
8893538|NCT02021955|9951365|FG001|NOT COMPLETED|Step 12||0
8893539|NCT02021955|9951364|FG000|STARTED|Step 13|Provider attrition=10; Provider addition=0; Patient discharges=4|118
8893540|NCT02021955|9951365|FG001|STARTED|Step 13|Provider attrition=4; Provider addition=0; Patient discharges=5|96
8893541|NCT02021955|9951364|FG000|COMPLETED|Step 13||118
8893542|NCT02021955|9951365|FG001|COMPLETED|Step 13||96
8893543|NCT02021955|9951364|FG000|NOT COMPLETED|Step 13||0
8893544|NCT02021955|9951365|FG001|NOT COMPLETED|Step 13||0
8893545|NCT02021955|9951364|FG000|STARTED|Step 14|Provider attrition=1; Provider addition=9; Patient discharges=7|105
8893546|NCT02021955|9951365|FG001|STARTED|Step 14|Provider attrition=7; Provider addition=11; Patient discharges=3|95
8893547|NCT02021955|9951364|FG000|COMPLETED|Step 14||105
8893548|NCT02021955|9951365|FG001|COMPLETED|Step 14||95
8893549|NCT02021955|9951364|FG000|NOT COMPLETED|Step 14||0
8893550|NCT02021955|9951365|FG001|NOT COMPLETED|Step 14||0
8893551|NCT02021955|9951364|FG000|STARTED|Step 15|Provider attrition=0; Provider addition=0; Patient discharges=4|110
8893552|NCT02021955|9951365|FG001|STARTED|Step 15|Provider attrition=0; Provider addition=5; Patient discharges=5|102
8893553|NCT02021955|9951364|FG000|COMPLETED|Step 15||110
8893554|NCT02021955|9951365|FG001|COMPLETED|Step 15||102
8893555|NCT02021955|9951364|FG000|NOT COMPLETED|Step 15||0
8893556|NCT02021955|9951365|FG001|NOT COMPLETED|Step 15||0
8893557|NCT02021955|9951364|FG000|STARTED|Step 16|Provider attrition=0; Provider addition=0; Patient discharges=2|103
8893558|NCT02021955|9951365|FG001|STARTED|Step 16|Provider attrition=0; Provider addition=3; Patient discharges=3|114
8893559|NCT02021955|9951364|FG000|COMPLETED|Step 16||103
8893560|NCT02021955|9951365|FG001|COMPLETED|Step 16||114
8893561|NCT02021955|9951364|FG000|NOT COMPLETED|Step 16||0
8893562|NCT02021955|9951365|FG001|NOT COMPLETED|Step 16||0
8893563|NCT02021955|9951364|FG000|STARTED|Step 17|Provider attrition=0; Provider addition=0; Patient discharges=8|99
8893564|NCT02021955|9951365|FG001|STARTED|Step 17|Provider attrition=0; Provider addition=0; Patient discharges=3|121
8893565|NCT02021955|9951364|FG000|COMPLETED|Step 17||99
8893566|NCT02021955|9951365|FG001|COMPLETED|Step 17||121
8893567|NCT02021955|9951364|FG000|NOT COMPLETED|Step 17||0
8893568|NCT02021955|9951365|FG001|NOT COMPLETED|Step 17||0
8893569|NCT02021955|9951364|FG000|STARTED|Step 18|Provider attrition=0; Provider addition=0; Patient discharges=6|96
8893570|NCT02021955|9951365|FG001|STARTED|Step 18|Provider attrition=0; Provider addition=0; Patient discharges=7|124
8893571|NCT02021955|9951364|FG000|COMPLETED|Step 18||96
8893572|NCT02021955|9951365|FG001|COMPLETED|Step 18||124
8893573|NCT02021955|9951364|FG000|NOT COMPLETED|Step 18||0
8893574|NCT02021955|9951365|FG001|NOT COMPLETED|Step 18||0
8893575|NCT02021955|9951364|FG000|STARTED|Step 19|Provider attrition=0; Provider addition=0; Patient discharges=5|94
8893576|NCT02021955|9951365|FG001|STARTED|Step 19|Provider attrition=0; Provider addition=0; Patient discharges=9|126
8893577|NCT02021955|9951364|FG000|COMPLETED|Step 19||94
8893578|NCT02021955|9951365|FG001|COMPLETED|Step 19||126
8893579|NCT02021955|9951364|FG000|NOT COMPLETED|Step 19||0
8893580|NCT02021955|9951365|FG001|NOT COMPLETED|Step 19||0
9007339|NCT02957357|10070423|FG001|STARTED|Overall Study||835
8635214|NCT00560937|9675691|FG001|COMPLETED|Overall Study||9
8635215|NCT00560937|9675690|FG000|NOT COMPLETED|Overall Study||1
8893581|NCT02021955|9951364|FG000|STARTED|Step 20|Provider attrition=0; Provider addition=1; Patient discharges=9|92
8893582|NCT02021955|9951365|FG001|STARTED|Step 20|Provider attrition=0; Provider addition=1; Patient discharges=9|128
8893583|NCT02021955|9951364|FG000|COMPLETED|Step 20||92
8893584|NCT02021955|9951365|FG001|COMPLETED|Step 20||128
8893585|NCT02021955|9951364|FG000|NOT COMPLETED|Step 20||0
8893586|NCT02021955|9951365|FG001|NOT COMPLETED|Step 20||0
8893587|NCT02021955|9951364|FG000|STARTED|Step 21|Provider attrition=0; Provider addition=7; Patient discharges=1|88
8893588|NCT02021955|9951365|FG001|STARTED|Step 21|Provider attrition=0; Provider addition=12; Patient discharges=9|134
8893589|NCT02021955|9951364|FG000|COMPLETED|Step 21||88
8893590|NCT02021955|9951365|FG001|COMPLETED|Step 21||134
8893591|NCT02021955|9951364|FG000|NOT COMPLETED|Step 21||0
8893592|NCT02021955|9951365|FG001|NOT COMPLETED|Step 21||0
8893593|NCT02021955|9951364|FG000|STARTED|Step 22|Provider attrition=0; Provider addition=0; Patient discharges=8|89
8893594|NCT02021955|9951365|FG001|STARTED|Step 22|Provider attrition=0; Provider addition=3; Patient discharges=8|152
8893595|NCT02021955|9951364|FG000|COMPLETED|Step 22||89
8893596|NCT02021955|9951365|FG001|COMPLETED|Step 22||152
8893597|NCT02021955|9951364|FG000|NOT COMPLETED|Step 22||0
8893598|NCT02021955|9951365|FG001|NOT COMPLETED|Step 22||0
8893599|NCT02021955|9951364|FG000|STARTED|Step 23|Provider attrition=0; Provider addition=1; Patient discharges=3|69
8893600|NCT02021955|9951365|FG001|STARTED|Step 23|Provider attrition=0; Provider addition=0; Patient discharges=7|175
8893601|NCT02021955|9951364|FG000|COMPLETED|Step 23||69
8893602|NCT02021955|9951365|FG001|COMPLETED|Step 23||175
8893603|NCT02021955|9951364|FG000|NOT COMPLETED|Step 23||0
8893604|NCT02021955|9951365|FG001|NOT COMPLETED|Step 23||0
8893605|NCT02021955|9951364|FG000|STARTED|Step 24|Provider attrition=0; Provider addition=0; Patient discharges=4|62
8893606|NCT02021955|9951365|FG001|STARTED|Step 24|Provider attrition=1; Provider addition=1; Patient discharges=8|183
8893607|NCT02021955|9951364|FG000|COMPLETED|Step 24||62
8893608|NCT02021955|9951365|FG001|COMPLETED|Step 24||183
8893609|NCT02021955|9951364|FG000|NOT COMPLETED|Step 24||0
8893610|NCT02021955|9951365|FG001|NOT COMPLETED|Step 24||0
8893611|NCT02021955|9951364|FG000|STARTED|Step 25|Provider attrition=0; Provider addition=1; Patient discharges=0|37
8893612|NCT02021955|9951365|FG001|STARTED|Step 25|Provider attrition=1; Provider addition=0; Patient discharges=5|208
8893613|NCT02021955|9951364|FG000|COMPLETED|Step 25||37
8893614|NCT02021955|9951365|FG001|COMPLETED|Step 25||208
8893615|NCT02021955|9951364|FG000|NOT COMPLETED|Step 25||0
8893616|NCT02021955|9951365|FG001|NOT COMPLETED|Step 25||0
8893617|NCT02021955|9951364|FG000|STARTED|Step 26|Provider attrition=0; Provider addition=0; Patient discharges=2|30
8893618|NCT02021955|9951365|FG001|STARTED|Step 26|Provider attrition=0; Provider addition=23; Patient discharges=9|215
8893619|NCT02021955|9951364|FG000|COMPLETED|Step 26||30
8893620|NCT02021955|9951365|FG001|COMPLETED|Step 26||215
8893621|NCT02021955|9951364|FG000|NOT COMPLETED|Step 26||0
8893622|NCT02021955|9951365|FG001|NOT COMPLETED|Step 26||0
8893623|NCT02021955|9951364|FG000|STARTED|Step 27|Provider attrition=1; Provider addition=1; Patient discharges=0|25
8893624|NCT02021955|9951365|FG001|STARTED|Step 27|Provider attrition=1; Provider addition=4; Patient discharges=4|243
8893625|NCT02021955|9951364|FG000|COMPLETED|Step 27||25
8893626|NCT02021955|9951365|FG001|COMPLETED|Step 27||243
8893627|NCT02021955|9951364|FG000|NOT COMPLETED|Step 27||0
8893628|NCT02021955|9951365|FG001|NOT COMPLETED|Step 27||0
8893629|NCT02021955|9951364|FG000|STARTED|Step 28|Provider attrition=0; Provider addition=2; Patient discharges=0|15
8893630|NCT02021955|9951365|FG001|STARTED|Step 28|Provider attrition=3; Provider addition=6; Patient discharges=6|256
8893631|NCT02021955|9951364|FG000|COMPLETED|Step 28||15
8893632|NCT02021955|9951365|FG001|COMPLETED|Step 28||256
8893633|NCT02021955|9951364|FG000|NOT COMPLETED|Step 28||0
8893634|NCT02021955|9951365|FG001|NOT COMPLETED|Step 28||0
8893635|NCT02021955|9951364|FG000|STARTED|Step 29|Provider attrition=0; Provider addition=0; Patient discharges=0|10
8893636|NCT02021955|9951365|FG001|STARTED|Step 29|Provider attrition=1; Provider addition=2; Patient discharges=8|266
8893637|NCT02021955|9951364|FG000|COMPLETED|Step 29||10
8893638|NCT02021955|9951365|FG001|COMPLETED|Step 29||266
8893639|NCT02021955|9951364|FG000|NOT COMPLETED|Step 29||0
8893640|NCT02021955|9951365|FG001|NOT COMPLETED|Step 29||0
8893641|NCT02021955|9951364|FG000|STARTED|Step 30|Provider attrition=0; Provider addition=0; Patient discharges=0|0
8893642|NCT02021955|9951365|FG001|STARTED|Step 30|Provider attrition=0; Provider addition=1; Patient discharges=11|277
8893643|NCT02021955|9951364|FG000|COMPLETED|Step 30||0
8893644|NCT02021955|9951365|FG001|COMPLETED|Step 30||277
8893645|NCT02021955|9951364|FG000|NOT COMPLETED|Step 30||0
8893646|NCT02021955|9951365|FG001|NOT COMPLETED|Step 30||0
8893647|NCT02022007|9951374|FG000|STARTED|Overall Study||13
8893648|NCT02022007|9951375|FG001|STARTED|Overall Study||12
8893649|NCT02022007|9951376|FG002|STARTED|Overall Study||13
8893650|NCT02022007|9951374|FG000|COMPLETED|Overall Study||12
8893651|NCT02022007|9951375|FG001|COMPLETED|Overall Study||11
8893652|NCT02022007|9951376|FG002|COMPLETED|Overall Study||11
8893653|NCT02022007|9951374|FG000|NOT COMPLETED|Overall Study||1
8893654|NCT02022007|9951375|FG001|NOT COMPLETED|Overall Study||1
8893655|NCT02022007|9951376|FG002|NOT COMPLETED|Overall Study||2
9007340|NCT02957357|10070422|FG000|COMPLETED|Overall Study||10479
9007341|NCT02957357|10070423|FG001|COMPLETED|Overall Study||835
9007342|NCT02957357|10070422|FG000|NOT COMPLETED|Overall Study||0
9007343|NCT02957357|10070423|FG001|NOT COMPLETED|Overall Study||0
9007344|NCT02957682|10070438|FG000|STARTED|Overall Study||1088
9007345|NCT02957682|10070439|FG001|STARTED|Overall Study||1088
8893656|NCT02022020|9951384|FG000|STARTED|Overall Study||220
8893657|NCT02022020|9951384|FG000|COMPLETED|Overall Study||220
8893658|NCT02022020|9951384|FG000|NOT COMPLETED|Overall Study||0
8893659|NCT02022033|9951388|FG000|STARTED|Overall Study||25
8893660|NCT02022033|9951388|FG000|COMPLETED|Overall Study||24
8893661|NCT02022033|9951388|FG000|NOT COMPLETED|Overall Study||1
8893662|NCT02022085|9951392|FG000|STARTED|Overall Study||54
8893663|NCT02022085|9951392|FG000|COMPLETED|Overall Study||53
8893664|NCT02022085|9951392|FG000|NOT COMPLETED|Overall Study||1
8893665|NCT02022111|9951398|FG000|STARTED|Overall Study||196
8893666|NCT02022111|9951399|FG001|STARTED|Overall Study||208
8893667|NCT02022111|9951398|FG000|COMPLETED|Overall Study||186
8893668|NCT02022111|9951399|FG001|COMPLETED|Overall Study||193
8893669|NCT02022111|9951398|FG000|NOT COMPLETED|Overall Study||10
8893670|NCT02022111|9951399|FG001|NOT COMPLETED|Overall Study||15
8893671|NCT02022657|9951407|FG000|STARTED|Overall Study||10
8893672|NCT02022657|9951408|FG001|STARTED|Overall Study||8
8893673|NCT02022657|9951409|FG002|STARTED|Overall Study||9
8893674|NCT02022657|9951410|FG003|STARTED|Overall Study||8
8893675|NCT02022657|9951411|FG004|STARTED|Overall Study||8
8893676|NCT02022657|9951412|FG005|STARTED|Overall Study||9
8893677|NCT02022657|9951407|FG000|COMPLETED|Overall Study||8
8893678|NCT02022657|9951408|FG001|COMPLETED|Overall Study||8
8893679|NCT02022657|9951409|FG002|COMPLETED|Overall Study||8
8893680|NCT02022657|9951410|FG003|COMPLETED|Overall Study||8
8893681|NCT02022657|9951411|FG004|COMPLETED|Overall Study||8
8893682|NCT02022657|9951412|FG005|COMPLETED|Overall Study||8
8893683|NCT02022657|9951407|FG000|NOT COMPLETED|Overall Study||2
8893684|NCT02022657|9951408|FG001|NOT COMPLETED|Overall Study||0
8893685|NCT02022657|9951409|FG002|NOT COMPLETED|Overall Study||1
8893686|NCT02022657|9951410|FG003|NOT COMPLETED|Overall Study||0
8893687|NCT02022657|9951411|FG004|NOT COMPLETED|Overall Study||0
8893688|NCT02022657|9951412|FG005|NOT COMPLETED|Overall Study||1
8893689|NCT02022670|9951421|FG000|STARTED|Overall Study||11
8893690|NCT02022670|9951422|FG001|STARTED|Overall Study||10
8893691|NCT02022670|9951423|FG002|STARTED|Overall Study||12
8893692|NCT02022670|9951421|FG000|COMPLETED|Overall Study||10
8893693|NCT02022670|9951422|FG001|COMPLETED|Overall Study||10
8893694|NCT02022670|9951423|FG002|COMPLETED|Overall Study||11
8893695|NCT02022670|9951421|FG000|NOT COMPLETED|Overall Study||1
8893696|NCT02022670|9951422|FG001|NOT COMPLETED|Overall Study||0
8893697|NCT02022670|9951423|FG002|NOT COMPLETED|Overall Study||1
8893698|NCT02022735|9951432|FG000|STARTED|Overall Study||22
8893699|NCT02022735|9951432|FG000|COMPLETED|Overall Study||22
8893700|NCT02022735|9951432|FG000|NOT COMPLETED|Overall Study||0
8893701|NCT02022748|9951444|FG000|STARTED|Overall Study||8
8893702|NCT02022748|9951445|FG001|STARTED|Overall Study||6
8893703|NCT02022748|9951446|FG002|STARTED|Overall Study||13
8893704|NCT02022748|9951444|FG000|Subject Who Started Treatment|Overall Study||8
8893705|NCT02022748|9951445|FG001|Subject Who Started Treatment|Overall Study||6
8893706|NCT02022748|9951446|FG002|Subject Who Started Treatment|Overall Study||13
8893707|NCT02022748|9951444|FG000|Subjects Who Completed Treatment|Overall Study||7
8893708|NCT02022748|9951445|FG001|Subjects Who Completed Treatment|Overall Study||4
8893709|NCT02022748|9951446|FG002|Subjects Who Completed Treatment|Overall Study||13
8893710|NCT02022748|9951444|FG000|COMPLETED|Overall Study||7
8893711|NCT02022748|9951445|FG001|COMPLETED|Overall Study||4
8893712|NCT02022748|9951446|FG002|COMPLETED|Overall Study||13
8893713|NCT02022748|9951444|FG000|NOT COMPLETED|Overall Study||1
8893714|NCT02022748|9951445|FG001|NOT COMPLETED|Overall Study||2
8893715|NCT02022748|9951446|FG002|NOT COMPLETED|Overall Study||0
8893716|NCT02022826|9951454|FG000|STARTED|Overall Study||167
8893717|NCT02022826|9951454|FG000|COMPLETED|Overall Study||139
8893718|NCT02022826|9951454|FG000|NOT COMPLETED|Overall Study||28
8893719|NCT02023099|9951461|FG000|STARTED|Overall Study||215
8893720|NCT02023099|9951462|FG001|STARTED|Overall Study||106
9007346|NCT02957682|10070438|FG000|Randomized and Treated|Overall Study||1085
9007347|NCT02957682|10070439|FG001|Randomized and Treated|Overall Study||1086
9007348|NCT02957682|10070438|FG000|COMPLETED|Overall Study||890
9007349|NCT02957682|10070439|FG001|COMPLETED|Overall Study||919
9007350|NCT02957682|10070438|FG000|NOT COMPLETED|Overall Study||198
9007351|NCT02957682|10070439|FG001|NOT COMPLETED|Overall Study||169
9007352|NCT02957747|10070447|FG000|STARTED|Overall Study||76
9007353|NCT02957747|10070448|FG001|STARTED|Overall Study||77
9007354|NCT02957747|10070447|FG000|COMPLETED|Overall Study||66
9007355|NCT02957747|10070448|FG001|COMPLETED|Overall Study||69
8893721|NCT02023099|9951463|FG002|STARTED|Overall Study||42
8893722|NCT02023099|9951461|FG000|COMPLETED|Overall Study||212
8893723|NCT02023099|9951462|FG001|COMPLETED|Overall Study||106
8893724|NCT02023099|9951463|FG002|COMPLETED|Overall Study||39
8893725|NCT02023099|9951461|FG000|NOT COMPLETED|Overall Study||3
8893726|NCT02023099|9951462|FG001|NOT COMPLETED|Overall Study||0
8893727|NCT02023099|9951463|FG002|NOT COMPLETED|Overall Study||3
8893728|NCT02023112|9951473|FG000|STARTED|Overall Study||85
8893729|NCT02023112|9951474|FG001|STARTED|Overall Study||86
8893730|NCT02023112|9951473|FG000|COMPLETED|Overall Study||83
8893731|NCT02023112|9951474|FG001|COMPLETED|Overall Study||85
8893732|NCT02023112|9951473|FG000|NOT COMPLETED|Overall Study||2
8893733|NCT02023112|9951474|FG001|NOT COMPLETED|Overall Study||1
8893734|NCT02023125|9951484|FG000|STARTED|Period 1||9
9007356|NCT02957747|10070447|FG000|NOT COMPLETED|Overall Study||10
9007357|NCT02957747|10070448|FG001|NOT COMPLETED|Overall Study||8
9007358|NCT02957942|10070457|FG000|STARTED|Overall Study||7
8893735|NCT02023125|9951485|FG001|STARTED|Period 1||9
8893736|NCT02023125|9951486|FG002|STARTED|Period 1||24
8893737|NCT02023125|9951484|FG000|COMPLETED|Period 1||9
8893738|NCT02023125|9951485|FG001|COMPLETED|Period 1||9
8893739|NCT02023125|9951486|FG002|COMPLETED|Period 1||24
8893740|NCT02023125|9951484|FG000|NOT COMPLETED|Period 1||0
8893741|NCT02023125|9951485|FG001|NOT COMPLETED|Period 1||0
8893742|NCT02023125|9951486|FG002|NOT COMPLETED|Period 1||0
8893743|NCT02023125|9951484|FG000|STARTED|Washout Period||9
8893744|NCT02023125|9951485|FG001|STARTED|Washout Period||9
8893745|NCT02023125|9951486|FG002|STARTED|Washout Period||24
8893746|NCT02023125|9951484|FG000|COMPLETED|Washout Period||9
8893747|NCT02023125|9951485|FG001|COMPLETED|Washout Period||9
8893748|NCT02023125|9951486|FG002|COMPLETED|Washout Period||24
8893749|NCT02023125|9951484|FG000|NOT COMPLETED|Washout Period||0
8893750|NCT02023125|9951485|FG001|NOT COMPLETED|Washout Period||0
8893751|NCT02023125|9951486|FG002|NOT COMPLETED|Washout Period||0
8893752|NCT02023125|9951484|FG000|STARTED|Period 2||9
8893753|NCT02023125|9951485|FG001|STARTED|Period 2||9
8893754|NCT02023125|9951486|FG002|STARTED|Period 2||24
8893755|NCT02023125|9951484|FG000|COMPLETED|Period 2||9
8893756|NCT02023125|9951485|FG001|COMPLETED|Period 2||9
8893757|NCT02023125|9951486|FG002|COMPLETED|Period 2||24
8893758|NCT02023125|9951484|FG000|NOT COMPLETED|Period 2||0
8893759|NCT02023125|9951485|FG001|NOT COMPLETED|Period 2||0
8893760|NCT02023125|9951486|FG002|NOT COMPLETED|Period 2||0
8893761|NCT02023151|9951498|FG000|STARTED|Overall Study||17
8893762|NCT02023151|9951498|FG000|COMPLETED|Overall Study||13
9007359|NCT02957942|10070458|FG001|STARTED|Overall Study|7 healthy individuals were recruited as control; 6 were recruited for practicing experiment details.|13
9007360|NCT02957942|10070457|FG000|COMPLETED|Overall Study||7
9007361|NCT02957942|10070458|FG001|COMPLETED|Overall Study||6
9007362|NCT02957942|10070457|FG000|NOT COMPLETED|Overall Study||0
9007363|NCT02957942|10070458|FG001|NOT COMPLETED|Overall Study||7
9007364|NCT02958267|10070466|FG000|STARTED|Enrollment||17
9007365|NCT02958267|10070467|FG001|STARTED|Enrollment||15
9007366|NCT02958267|10070466|FG000|COMPLETED|Enrollment||17
9007367|NCT02958267|10070467|FG001|COMPLETED|Enrollment||15
9007368|NCT02958267|10070466|FG000|NOT COMPLETED|Enrollment||0
9007369|NCT02958267|10070467|FG001|NOT COMPLETED|Enrollment||0
9007370|NCT02958267|10070466|FG000|STARTED|Enrollment to Actual Treatment Complete||17
9007371|NCT02958267|10070467|FG001|STARTED|Enrollment to Actual Treatment Complete||15
9007372|NCT02958267|10070466|FG000|COMPLETED|Enrollment to Actual Treatment Complete||15
9007373|NCT02958267|10070467|FG001|COMPLETED|Enrollment to Actual Treatment Complete||15
9007374|NCT02958267|10070466|FG000|NOT COMPLETED|Enrollment to Actual Treatment Complete||2
9007375|NCT02958267|10070467|FG001|NOT COMPLETED|Enrollment to Actual Treatment Complete||0
9007376|NCT02958267|10070466|FG000|STARTED|Follow-up Visits||15
9007377|NCT02958267|10070467|FG001|STARTED|Follow-up Visits||15
9007378|NCT02958267|10070466|FG000|3 Month Follow-up|Follow-up Visits||15
9007379|NCT02958267|10070467|FG001|3 Month Follow-up|Follow-up Visits||15
9007380|NCT02958267|10070466|FG000|6 Month Follow-up|Follow-up Visits||14
9007381|NCT02958267|10070467|FG001|6 Month Follow-up|Follow-up Visits||14
9007382|NCT02958267|10070466|FG000|12 Month Follow-up|Follow-up Visits||13
9007383|NCT02958267|10070467|FG001|12 Month Follow-up|Follow-up Visits||14
9007384|NCT02958267|10070466|FG000|COMPLETED|Follow-up Visits||13
9007385|NCT02958267|10070467|FG001|COMPLETED|Follow-up Visits||14
9007386|NCT02958267|10070466|FG000|NOT COMPLETED|Follow-up Visits||2
9007387|NCT02958267|10070467|FG001|NOT COMPLETED|Follow-up Visits||1
9007388|NCT02958345|10070475|FG000|STARTED|Overall Study||14
9007389|NCT02958345|10070476|FG001|STARTED|Overall Study||14
9007390|NCT02958345|10070475|FG000|COMPLETED|Overall Study||13
9007391|NCT02958345|10070476|FG001|COMPLETED|Overall Study||13
9007392|NCT02958345|10070475|FG000|NOT COMPLETED|Overall Study||1
9007393|NCT02958345|10070476|FG001|NOT COMPLETED|Overall Study||1
9007394|NCT02958527|10070482|FG000|STARTED|Overall Study||1408
9007395|NCT02958527|10070482|FG000|COMPLETED|Overall Study||1396
9007396|NCT02958527|10070482|FG000|NOT COMPLETED|Overall Study||12
9007397|NCT02958553|10070495|FG000|STARTED|Phase I, 1st Visit -Passive Prosthesis||8
9007398|NCT02958553|10070495|FG000|COMPLETED|Phase I, 1st Visit -Passive Prosthesis||8
9007399|NCT02958553|10070495|FG000|NOT COMPLETED|Phase I, 1st Visit -Passive Prosthesis||0
9007400|NCT02958553|10070495|FG000|STARTED|Phase I, 2nd Visit -Fitted With emPOWER||8
8893763|NCT02023151|9951498|FG000|NOT COMPLETED|Overall Study||4
8893764|NCT02023242|9951504|FG000|STARTED|Overall Study||75
8893765|NCT02023242|9951505|FG001|STARTED|Overall Study||77
8893766|NCT02023242|9951504|FG000|COMPLETED|Overall Study||72
8893767|NCT02023242|9951505|FG001|COMPLETED|Overall Study||75
8893768|NCT02023242|9951504|FG000|NOT COMPLETED|Overall Study||3
8893769|NCT02023242|9951505|FG001|NOT COMPLETED|Overall Study||2
8893770|NCT02023268|9951513|FG000|STARTED|Overall Study||52
8893771|NCT02023268|9951514|FG001|STARTED|Overall Study||53
8893772|NCT02023268|9951513|FG000|COMPLETED|Overall Study||52
8893773|NCT02023268|9951514|FG001|COMPLETED|Overall Study||49
8893774|NCT02023268|9951513|FG000|NOT COMPLETED|Overall Study||0
8893775|NCT02023268|9951514|FG001|NOT COMPLETED|Overall Study||4
8893776|NCT02023411|9951522|FG000|STARTED|Overall Study||10
8893777|NCT02023411|9951523|FG001|STARTED|Overall Study||10
8893778|NCT02023411|9951522|FG000|COMPLETED|Overall Study||10
8893779|NCT02023411|9951523|FG001|COMPLETED|Overall Study||10
8893780|NCT02023411|9951522|FG000|NOT COMPLETED|Overall Study||0
8893781|NCT02023411|9951523|FG001|NOT COMPLETED|Overall Study||0
8635216|NCT00560937|9675691|FG001|NOT COMPLETED|Overall Study||2
8635217|NCT00560950|9675699|FG000|STARTED|Overall Study||72
8635218|NCT00560950|9675700|FG001|STARTED|Overall Study||71
8635219|NCT00560950|9675699|FG000|COMPLETED|Overall Study||71
8635220|NCT00560950|9675700|FG001|COMPLETED|Overall Study||71
8893782|NCT02023515|9951532|FG000|STARTED|Overall Study||24
8893783|NCT02023515|9951533|FG001|STARTED|Overall Study||25
8893784|NCT02023515|9951532|FG000|COMPLETED|Overall Study||23
8893785|NCT02023515|9951533|FG001|COMPLETED|Overall Study||22
8893786|NCT02023515|9951532|FG000|NOT COMPLETED|Overall Study||1
8893787|NCT02023515|9951533|FG001|NOT COMPLETED|Overall Study||3
9007401|NCT02958553|10070495|FG000|COMPLETED|Phase I, 2nd Visit -Fitted With emPOWER||8
9007402|NCT02958553|10070495|FG000|NOT COMPLETED|Phase I, 2nd Visit -Fitted With emPOWER||0
9007403|NCT02958553|10070495|FG000|STARTED|Phase I, 3rd Visit -2 Week emPOWER FU||8
9007404|NCT02958553|10070495|FG000|COMPLETED|Phase I, 3rd Visit -2 Week emPOWER FU||7
9007405|NCT02958553|10070495|FG000|NOT COMPLETED|Phase I, 3rd Visit -2 Week emPOWER FU||1
9007406|NCT02958553|10070495|FG000|STARTED|Phase II, 4th Visit -3 Month emPOWER FU|Only 4 subjects started Phase II of the study. Phase II was optional per protocol.|7
9007407|NCT02958553|10070495|FG000|COMPLETED|Phase II, 4th Visit -3 Month emPOWER FU||4
9007408|NCT02958553|10070495|FG000|NOT COMPLETED|Phase II, 4th Visit -3 Month emPOWER FU||3
9007409|NCT02958553|10070495|FG000|STARTED|Phase II, 5th Visit -Crossover Visit||4
9007410|NCT02958553|10070495|FG000|COMPLETED|Phase II, 5th Visit -Crossover Visit||4
9007411|NCT02958553|10070495|FG000|NOT COMPLETED|Phase II, 5th Visit -Crossover Visit||0
9007412|NCT02958553|10070495|FG000|STARTED|Phase II, 6th Visit -6 Month emPOWER FU||4
9007413|NCT02958553|10070495|FG000|COMPLETED|Phase II, 6th Visit -6 Month emPOWER FU||2
9007414|NCT02958553|10070495|FG000|NOT COMPLETED|Phase II, 6th Visit -6 Month emPOWER FU||2
9007415|NCT02958553|10070495|FG000|STARTED|Phase II, 7th Visit -12 Month emPOWER FU||2
9007416|NCT02958553|10070495|FG000|COMPLETED|Phase II, 7th Visit -12 Month emPOWER FU||2
9007417|NCT02958553|10070495|FG000|NOT COMPLETED|Phase II, 7th Visit -12 Month emPOWER FU||0
9007418|NCT02958787|10070500|FG000|STARTED|Overall Study||135
8635221|NCT00560950|9675699|FG000|NOT COMPLETED|Overall Study||1
8635222|NCT00560950|9675700|FG001|NOT COMPLETED|Overall Study||0
8635223|NCT00561002|9675710|FG000|STARTED|Overall Study||23
8893788|NCT02023697|9951542|FG000|STARTED|Treatment Period||130
8893789|NCT02023697|9951543|FG001|STARTED|Treatment Period||130
8893790|NCT02023697|9951544|FG002|STARTED|Treatment Period||131
8635224|NCT00561002|9675711|FG001|STARTED|Overall Study||9
8635225|NCT00561002|9675710|FG000|COMPLETED|Overall Study||23
8635226|NCT00561002|9675711|FG001|COMPLETED|Overall Study||9
8635227|NCT00561002|9675710|FG000|NOT COMPLETED|Overall Study||0
8635228|NCT00561002|9675711|FG001|NOT COMPLETED|Overall Study||0
8893791|NCT02023697|9951542|FG000|Received Treatment|Treatment Period||125
8893792|NCT02023697|9951543|FG001|Received Treatment|Treatment Period||124
8893793|NCT02023697|9951544|FG002|Received Treatment|Treatment Period||121
8893794|NCT02023697|9951542|FG000|COMPLETED|Treatment Period||84
8893795|NCT02023697|9951543|FG001|COMPLETED|Treatment Period||67
8893796|NCT02023697|9951544|FG002|COMPLETED|Treatment Period||29
8893797|NCT02023697|9951542|FG000|NOT COMPLETED|Treatment Period||46
8893798|NCT02023697|9951543|FG001|NOT COMPLETED|Treatment Period||63
8893799|NCT02023697|9951544|FG002|NOT COMPLETED|Treatment Period||102
8893800|NCT02023697|9951542|FG000|STARTED|Active Follow-up Period|Not all participants in ITT entered active follow-up.|120
8893801|NCT02023697|9951543|FG001|STARTED|Active Follow-up Period|Not all participants in ITT entered active follow-up.|120
8893802|NCT02023697|9951544|FG002|STARTED|Active Follow-up Period|Not all participants in ITT entered active follow-up.|116
8893803|NCT02023697|9951542|FG000|COMPLETED|Active Follow-up Period||28
8893804|NCT02023697|9951543|FG001|COMPLETED|Active Follow-up Period||21
8893805|NCT02023697|9951544|FG002|COMPLETED|Active Follow-up Period||17
8893806|NCT02023697|9951542|FG000|NOT COMPLETED|Active Follow-up Period||92
8893807|NCT02023697|9951543|FG001|NOT COMPLETED|Active Follow-up Period||99
8893808|NCT02023697|9951544|FG002|NOT COMPLETED|Active Follow-up Period||99
8893809|NCT02023697|9951542|FG000|STARTED|Long-term Follow-up Period||28
8893810|NCT02023697|9951543|FG001|STARTED|Long-term Follow-up Period||21
8893811|NCT02023697|9951544|FG002|STARTED|Long-term Follow-up Period||17
8893812|NCT02023697|9951542|FG000|COMPLETED|Long-term Follow-up Period||0
8893813|NCT02023697|9951543|FG001|COMPLETED|Long-term Follow-up Period||0
8893814|NCT02023697|9951544|FG002|COMPLETED|Long-term Follow-up Period||0
8893815|NCT02023697|9951542|FG000|NOT COMPLETED|Long-term Follow-up Period||28
8893816|NCT02023697|9951543|FG001|NOT COMPLETED|Long-term Follow-up Period||21
8893817|NCT02023697|9951544|FG002|NOT COMPLETED|Long-term Follow-up Period||17
8893818|NCT02023801|9951559|FG000|STARTED|Overall Study|Treatment Attempted|24
8893819|NCT02023801|9951559|FG000|Treated|Overall Study|Treatment Completed|24
8893820|NCT02023801|9951559|FG000|COMPLETED|Overall Study|Completed 12 Month Follow-up|24
8893821|NCT02023801|9951559|FG000|NOT COMPLETED|Overall Study||0
8893822|NCT02023866|9951563|FG000|STARTED|Overall Study||36
8893823|NCT02023866|9951563|FG000|COMPLETED|Overall Study||30
8893824|NCT02023866|9951563|FG000|NOT COMPLETED|Overall Study||6
8893825|NCT02023879|9951570|FG000|STARTED|Period 1: 24-Week Double-blind Treatment||58
8893826|NCT02023879|9951571|FG001|STARTED|Period 1: 24-Week Double-blind Treatment||116
8893827|NCT02023879|9951572|FG002|STARTED|Period 1: 24-Week Double-blind Treatment||59
8893828|NCT02023879|9951570|FG000|Treated|Period 1: 24-Week Double-blind Treatment||58
8893829|NCT02023879|9951571|FG001|Treated|Period 1: 24-Week Double-blind Treatment||115
8893830|NCT02023879|9951572|FG002|Treated|Period 1: 24-Week Double-blind Treatment||58
8893831|NCT02023879|9951570|FG000|COMPLETED|Period 1: 24-Week Double-blind Treatment||54
8893832|NCT02023879|9951571|FG001|COMPLETED|Period 1: 24-Week Double-blind Treatment||107
8893833|NCT02023879|9951572|FG002|COMPLETED|Period 1: 24-Week Double-blind Treatment||50
8893834|NCT02023879|9951570|FG000|NOT COMPLETED|Period 1: 24-Week Double-blind Treatment||4
8893835|NCT02023879|9951571|FG001|NOT COMPLETED|Period 1: 24-Week Double-blind Treatment||9
8893836|NCT02023879|9951572|FG002|NOT COMPLETED|Period 1: 24-Week Double-blind Treatment||9
8893837|NCT02023879|9951570|FG000|STARTED|Extension Open Label Treatment|The open-label extension period was optional for participants who completed the double-blind period.|51
8893838|NCT02023879|9951571|FG001|STARTED|Extension Open Label Treatment|The open-label extension period was optional for participants who completed the double-blind period.|106
8893839|NCT02023879|9951572|FG002|STARTED|Extension Open Label Treatment|The open-label extension period was optional for participants who completed the double-blind period.|48
8893840|NCT02023879|9951570|FG000|COMPLETED|Extension Open Label Treatment||46
8893841|NCT02023879|9951571|FG001|COMPLETED|Extension Open Label Treatment||89
8893842|NCT02023879|9951572|FG002|COMPLETED|Extension Open Label Treatment||43
8893843|NCT02023879|9951570|FG000|NOT COMPLETED|Extension Open Label Treatment||5
8893844|NCT02023879|9951571|FG001|NOT COMPLETED|Extension Open Label Treatment||17
8893845|NCT02023879|9951572|FG002|NOT COMPLETED|Extension Open Label Treatment||5
8893846|NCT02023918|9951587|FG000|STARTED|Overall Study||6
8893847|NCT02023918|9951587|FG000|COMPLETED|Overall Study||6
8893848|NCT02023918|9951587|FG000|NOT COMPLETED|Overall Study||0
8893849|NCT02023944|9951593|FG000|STARTED|Overall Study||25
8893850|NCT02023944|9951594|FG001|STARTED|Overall Study||25
8893851|NCT02023944|9951593|FG000|COMPLETED|Overall Study||25
8893852|NCT02023944|9951594|FG001|COMPLETED|Overall Study||24
8893853|NCT02023944|9951593|FG000|NOT COMPLETED|Overall Study||0
8893854|NCT02023944|9951594|FG001|NOT COMPLETED|Overall Study||1
8893855|NCT02023983|9951603|FG000|STARTED|Overall Study||76
8893856|NCT02023983|9951604|FG001|STARTED|Overall Study||75
8893857|NCT02023983|9951603|FG000|COMPLETED|Overall Study||76
8893858|NCT02023983|9951604|FG001|COMPLETED|Overall Study||75
8893859|NCT02023983|9951603|FG000|NOT COMPLETED|Overall Study||0
8893860|NCT02023983|9951604|FG001|NOT COMPLETED|Overall Study||0
8635229|NCT00561015|9675723|FG000|STARTED|Overall Study||9
8635230|NCT00561015|9675724|FG001|STARTED|Overall Study||5
8635231|NCT00561015|9675725|FG002|STARTED|Overall Study||9
8635232|NCT00561015|9675726|FG003|STARTED|Overall Study||8
8635233|NCT00561015|9675727|FG004|STARTED|Overall Study||9
8893861|NCT02024087|9951612|FG000|STARTED|Overall Study||5
8893862|NCT02024087|9951613|FG001|STARTED|Overall Study|Dose change to 0.4 mg/kg and cohort expanded to 16 participants in total at this dose level|16
8893863|NCT02024087|9951612|FG000|COMPLETED|Overall Study||5
8893864|NCT02024087|9951613|FG001|COMPLETED|Overall Study||16
8893865|NCT02024087|9951612|FG000|NOT COMPLETED|Overall Study||0
8893866|NCT02024087|9951613|FG001|NOT COMPLETED|Overall Study||0
8893867|NCT02024165|9951620|FG000|STARTED|Overall Study||71
8893868|NCT02024165|9951620|FG000|COMPLETED|Overall Study||71
8893869|NCT02024165|9951620|FG000|NOT COMPLETED|Overall Study||0
8893870|NCT02024204|9951627|FG000|STARTED|Overall Study||49
8893871|NCT02024204|9951628|FG001|STARTED|Overall Study||11
8893872|NCT02024204|9951627|FG000|COMPLETED|Overall Study||49
8893873|NCT02024204|9951628|FG001|COMPLETED|Overall Study||11
8893874|NCT02024204|9951627|FG000|NOT COMPLETED|Overall Study||0
8893875|NCT02024204|9951628|FG001|NOT COMPLETED|Overall Study||0
8893876|NCT02024386|9951637|FG000|STARTED|Overall Study||6
8893877|NCT02024386|9951638|FG001|STARTED|Overall Study||11
8893878|NCT02024386|9951639|FG002|STARTED|Overall Study||5
8893879|NCT02024386|9951637|FG000|COMPLETED|Overall Study||6
8893880|NCT02024386|9951638|FG001|COMPLETED|Overall Study||11
8893881|NCT02024386|9951639|FG002|COMPLETED|Overall Study||5
8893882|NCT02024386|9951637|FG000|NOT COMPLETED|Overall Study||0
8893883|NCT02024386|9951638|FG001|NOT COMPLETED|Overall Study||0
8893884|NCT02024386|9951639|FG002|NOT COMPLETED|Overall Study||0
8893885|NCT02024477|9951650|FG000|STARTED|Overall Study||21
8893886|NCT02024477|9951651|FG001|STARTED|Overall Study||21
8893887|NCT02024477|9951650|FG000|COMPLETED|Overall Study||21
8893888|NCT02024477|9951651|FG001|COMPLETED|Overall Study||21
8893889|NCT02024477|9951650|FG000|NOT COMPLETED|Overall Study||0
8893890|NCT02024477|9951651|FG001|NOT COMPLETED|Overall Study||0
8893891|NCT02024646|9951660|FG000|STARTED|Overall Study||163
8893892|NCT02024646|9951661|FG001|STARTED|Overall Study||160
8893893|NCT02024646|9951662|FG002|STARTED|Overall Study||161
8893894|NCT02024646|9951660|FG000|COMPLETED|Overall Study||131
8893895|NCT02024646|9951661|FG001|COMPLETED|Overall Study||135
8893896|NCT02024646|9951662|FG002|COMPLETED|Overall Study||133
8893897|NCT02024646|9951660|FG000|NOT COMPLETED|Overall Study||32
8893898|NCT02024646|9951661|FG001|NOT COMPLETED|Overall Study||25
8893899|NCT02024646|9951662|FG002|NOT COMPLETED|Overall Study||28
8893900|NCT02024698|9951670|FG000|STARTED|First Intervention (7 Days)||16
8893901|NCT02024698|9951671|FG001|STARTED|First Intervention (7 Days)||27
8893902|NCT02024698|9951670|FG000|COMPLETED|First Intervention (7 Days)||16
8893903|NCT02024698|9951671|FG001|COMPLETED|First Intervention (7 Days)||26
8893904|NCT02024698|9951670|FG000|NOT COMPLETED|First Intervention (7 Days)||0
8893905|NCT02024698|9951671|FG001|NOT COMPLETED|First Intervention (7 Days)||1
8893906|NCT02024698|9951670|FG000|STARTED|Second Intervention (7 Days)||16
8893907|NCT02024698|9951671|FG001|STARTED|Second Intervention (7 Days)||26
8893908|NCT02024698|9951670|FG000|Received Etafilcon A Twice|Second Intervention (7 Days)||1
8893909|NCT02024698|9951671|FG001|Received Etafilcon A Twice|Second Intervention (7 Days)||0
8893910|NCT02024698|9951670|FG000|COMPLETED|Second Intervention (7 Days)||16
8893911|NCT02024698|9951671|FG001|COMPLETED|Second Intervention (7 Days)||26
8893912|NCT02024698|9951670|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
8893913|NCT02024698|9951671|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
8893914|NCT02024711|9951679|FG000|STARTED|Overall Study||130
8893915|NCT02024711|9951680|FG001|STARTED|Overall Study||132
8893916|NCT02024711|9951679|FG000|COMPLETED|Overall Study||129
8893917|NCT02024711|9951680|FG001|COMPLETED|Overall Study||128
8893918|NCT02024711|9951679|FG000|NOT COMPLETED|Overall Study||1
8893919|NCT02024711|9951680|FG001|NOT COMPLETED|Overall Study||4
8893920|NCT02024724|9951688|FG000|STARTED|Overall Study||30
8893921|NCT02024724|9951689|FG001|STARTED|Overall Study||30
8893922|NCT02024724|9951688|FG000|COMPLETED|Overall Study||29
8893923|NCT02024724|9951689|FG001|COMPLETED|Overall Study||30
8893924|NCT02024724|9951688|FG000|NOT COMPLETED|Overall Study||1
8893925|NCT02024724|9951689|FG001|NOT COMPLETED|Overall Study||0
8893926|NCT02024750|9951697|FG000|STARTED|Overall Study||106
8572756|NCT00116831|9604949|FG000|NOT COMPLETED|Overall Study||73
8572757|NCT00116831|9604950|FG001|NOT COMPLETED|Overall Study||72
8572758|NCT00116844|9604958|FG000|STARTED|Period 1: Treatment Period 1 (60 Days)||35
8572759|NCT00116844|9604959|FG001|STARTED|Period 1: Treatment Period 1 (60 Days)||36
8572760|NCT00116844|9604958|FG000|COMPLETED|Period 1: Treatment Period 1 (60 Days)||28
8572761|NCT00116844|9604959|FG001|COMPLETED|Period 1: Treatment Period 1 (60 Days)||33
8572762|NCT00116844|9604958|FG000|NOT COMPLETED|Period 1: Treatment Period 1 (60 Days)||7
8572763|NCT00116844|9604959|FG001|NOT COMPLETED|Period 1: Treatment Period 1 (60 Days)||3
8572764|NCT00116844|9604958|FG000|STARTED|Period 2: Washout Period (7 Days)||28
8572765|NCT00116844|9604959|FG001|STARTED|Period 2: Washout Period (7 Days)||33
8635234|NCT00561015|9675728|FG005|STARTED|Overall Study||9
8635235|NCT00561015|9675723|FG000|COMPLETED|Overall Study||5
8635236|NCT00561015|9675724|FG001|COMPLETED|Overall Study||5
8635237|NCT00561015|9675725|FG002|COMPLETED|Overall Study||9
8635238|NCT00561015|9675726|FG003|COMPLETED|Overall Study||7
8635239|NCT00561015|9675727|FG004|COMPLETED|Overall Study||8
8893927|NCT02024750|9951698|FG001|STARTED|Overall Study||108
8893928|NCT02024750|9951697|FG000|COMPLETED|Overall Study||104
8893929|NCT02024750|9951698|FG001|COMPLETED|Overall Study||107
8893930|NCT02024750|9951697|FG000|NOT COMPLETED|Overall Study||2
8893931|NCT02024750|9951698|FG001|NOT COMPLETED|Overall Study||1
8893932|NCT02024867|9951706|FG000|STARTED|Overall Study||134
8893933|NCT02024867|9951707|FG001|STARTED|Overall Study||131
8893934|NCT02024867|9951706|FG000|COMPLETED|Overall Study||125
8893935|NCT02024867|9951707|FG001|COMPLETED|Overall Study||124
8893936|NCT02024867|9951706|FG000|NOT COMPLETED|Overall Study||9
8893937|NCT02024867|9951707|FG001|NOT COMPLETED|Overall Study||7
8893938|NCT02024932|9951719|FG000|STARTED|Overall Study||2
8893939|NCT02024932|9951720|FG001|STARTED|Overall Study||4
8893940|NCT02024932|9951721|FG002|STARTED|Overall Study||2
8893941|NCT02024932|9951722|FG003|STARTED|Overall Study||2
8893942|NCT02024932|9951723|FG004|STARTED|Overall Study||18
8893943|NCT02024932|9951724|FG005|STARTED|Overall Study||9
8893944|NCT02024932|9951719|FG000|Safety Analysis Set|Overall Study||2
8893945|NCT02024932|9951720|FG001|Safety Analysis Set|Overall Study||4
8893946|NCT02024932|9951721|FG002|Safety Analysis Set|Overall Study||2
8893947|NCT02024932|9951722|FG003|Safety Analysis Set|Overall Study||2
8893948|NCT02024932|9951723|FG004|Safety Analysis Set|Overall Study||18
8893949|NCT02024932|9951724|FG005|Safety Analysis Set|Overall Study||9
8893950|NCT02024932|9951719|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||2
8893951|NCT02024932|9951720|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||4
8893952|NCT02024932|9951721|FG002|Pharmacokinetic (PK) Analysis Set|Overall Study||0
8893953|NCT02024932|9951722|FG003|Pharmacokinetic (PK) Analysis Set|Overall Study||2
8893954|NCT02024932|9951723|FG004|Pharmacokinetic (PK) Analysis Set|Overall Study||18
8893955|NCT02024932|9951724|FG005|Pharmacokinetic (PK) Analysis Set|Overall Study||0
8893956|NCT02024932|9951719|FG000|Pharmacodynamic (PD) Analysis Set|Overall Study||2
8893957|NCT02024932|9951720|FG001|Pharmacodynamic (PD) Analysis Set|Overall Study||4
8893958|NCT02024932|9951721|FG002|Pharmacodynamic (PD) Analysis Set|Overall Study||2
8893959|NCT02024932|9951722|FG003|Pharmacodynamic (PD) Analysis Set|Overall Study||2
8893960|NCT02024932|9951723|FG004|Pharmacodynamic (PD) Analysis Set|Overall Study||18
8893961|NCT02024932|9951724|FG005|Pharmacodynamic (PD) Analysis Set|Overall Study||9
8893962|NCT02024932|9951719|FG000|COMPLETED|Overall Study||0
8893963|NCT02024932|9951720|FG001|COMPLETED|Overall Study||1
8893964|NCT02024932|9951721|FG002|COMPLETED|Overall Study||2
8893965|NCT02024932|9951722|FG003|COMPLETED|Overall Study||0
8893966|NCT02024932|9951723|FG004|COMPLETED|Overall Study||16
8893967|NCT02024932|9951724|FG005|COMPLETED|Overall Study||9
8893968|NCT02024932|9951719|FG000|NOT COMPLETED|Overall Study||2
8893969|NCT02024932|9951720|FG001|NOT COMPLETED|Overall Study||3
8893970|NCT02024932|9951721|FG002|NOT COMPLETED|Overall Study||0
8893971|NCT02024932|9951722|FG003|NOT COMPLETED|Overall Study||2
8893972|NCT02024932|9951723|FG004|NOT COMPLETED|Overall Study||2
8893973|NCT02024932|9951724|FG005|NOT COMPLETED|Overall Study||0
8893974|NCT02024971|9951744|FG000|STARTED|Overall Study||1103
8893975|NCT02024971|9951744|FG000|Safety Analysis Set|Overall Study|All participants with available data who were enrolled prior to Day 15 of the start of treatment.|1067
8893976|NCT02024971|9951744|FG000|COMPLETED|Overall Study|Including 162 patients with missing efficacy data at two or more time points.|1067
8893977|NCT02024971|9951744|FG000|NOT COMPLETED|Overall Study||36
8893978|NCT02025075|9951750|FG000|STARTED|Overall Study||16
8893979|NCT02025075|9951751|FG001|STARTED|Overall Study||21
8893980|NCT02025075|9951750|FG000|COMPLETED|Overall Study||16
8893981|NCT02025075|9951751|FG001|COMPLETED|Overall Study||19
9007419|NCT02958787|10070500|FG000|COMPLETED|Overall Study||135
9007420|NCT02958787|10070500|FG000|NOT COMPLETED|Overall Study||0
9007421|NCT02958826|10070506|FG000|STARTED|Overall Study||80
9007422|NCT02958826|10070507|FG001|STARTED|Overall Study||80
9007423|NCT02958826|10070506|FG000|COMPLETED|Overall Study||80
9007424|NCT02958826|10070507|FG001|COMPLETED|Overall Study||80
9007425|NCT02958826|10070506|FG000|NOT COMPLETED|Overall Study||0
9007426|NCT02958826|10070507|FG001|NOT COMPLETED|Overall Study||0
9007427|NCT02958956|10070517|FG000|STARTED|Overall Study||38190
9007428|NCT02958956|10070518|FG001|STARTED|Overall Study||198317
9007429|NCT02958956|10070517|FG000|COMPLETED|Overall Study||38190
9007430|NCT02958956|10070518|FG001|COMPLETED|Overall Study||198317
9007431|NCT02958956|10070517|FG000|NOT COMPLETED|Overall Study||0
9007432|NCT02958956|10070518|FG001|NOT COMPLETED|Overall Study||0
9007433|NCT02958969|10070525|FG000|STARTED|Overall Study||50
9007434|NCT02958969|10070525|FG000|COMPLETED|Overall Study||50
9007435|NCT02958969|10070525|FG000|NOT COMPLETED|Overall Study||0
9007436|NCT02958982|10070540|FG000|STARTED|Cohort 1: 25 mg in SAD Study||1
9007437|NCT02958982|10070541|FG001|STARTED|Cohort 1: 25 mg in SAD Study||3
9007438|NCT02958982|10070542|FG002|STARTED|Cohort 1: 25 mg in SAD Study||0
9007439|NCT02958982|10070543|FG003|STARTED|Cohort 1: 25 mg in SAD Study||0
9007440|NCT02958982|10070544|FG004|STARTED|Cohort 1: 25 mg in SAD Study||0
9007441|NCT02958982|10070545|FG005|STARTED|Cohort 1: 25 mg in SAD Study||0
9007442|NCT02958982|10070546|FG006|STARTED|Cohort 1: 25 mg in SAD Study||0
9007443|NCT02958982|10070547|FG007|STARTED|Cohort 1: 25 mg in SAD Study||0
9007444|NCT02958982|10070548|FG008|STARTED|Cohort 1: 25 mg in SAD Study||0
9007445|NCT02958982|10070549|FG009|STARTED|Cohort 1: 25 mg in SAD Study||0
9007446|NCT02958982|10070550|FG010|STARTED|Cohort 1: 25 mg in SAD Study||0
9007447|NCT02958982|10070540|FG000|COMPLETED|Cohort 1: 25 mg in SAD Study||1
9007448|NCT02958982|10070541|FG001|COMPLETED|Cohort 1: 25 mg in SAD Study||3
9007449|NCT02958982|10070542|FG002|COMPLETED|Cohort 1: 25 mg in SAD Study||0
9007450|NCT02958982|10070543|FG003|COMPLETED|Cohort 1: 25 mg in SAD Study||0
9007451|NCT02958982|10070544|FG004|COMPLETED|Cohort 1: 25 mg in SAD Study||0
8893982|NCT02025075|9951750|FG000|NOT COMPLETED|Overall Study||0
8893983|NCT02025075|9951751|FG001|NOT COMPLETED|Overall Study||2
8893984|NCT02025179|9951766|FG000|STARTED|Overall Study||8
8893985|NCT02025179|9951767|FG001|STARTED|Overall Study||9
8893986|NCT02025179|9951768|FG002|STARTED|Overall Study||8
8893987|NCT02025179|9951766|FG000|COMPLETED|Overall Study||8
8893988|NCT02025179|9951767|FG001|COMPLETED|Overall Study||9
8893989|NCT02025179|9951768|FG002|COMPLETED|Overall Study||7
8893990|NCT02025179|9951766|FG000|NOT COMPLETED|Overall Study||0
8893991|NCT02025179|9951767|FG001|NOT COMPLETED|Overall Study||0
8893992|NCT02025179|9951768|FG002|NOT COMPLETED|Overall Study||1
8893993|NCT02025205|9951778|FG000|STARTED|Overall Study||43
8893994|NCT02025205|9951779|FG001|STARTED|Overall Study||50
8893995|NCT02025205|9951778|FG000|COMPLETED|Overall Study||40
8893996|NCT02025205|9951779|FG001|COMPLETED|Overall Study||47
8893997|NCT02025205|9951778|FG000|NOT COMPLETED|Overall Study||3
8893998|NCT02025205|9951779|FG001|NOT COMPLETED|Overall Study||3
8893999|NCT02025426|9951787|FG000|STARTED|Overall Study||9
8894000|NCT02025426|9951788|FG001|STARTED|Overall Study||4
8894001|NCT02025426|9951787|FG000|COMPLETED|Overall Study||9
8894002|NCT02025426|9951788|FG001|COMPLETED|Overall Study||4
8894003|NCT02025426|9951787|FG000|NOT COMPLETED|Overall Study||0
8894004|NCT02025426|9951788|FG001|NOT COMPLETED|Overall Study||0
8894005|NCT02025439|9951796|FG000|STARTED|Overall Study||2
8894006|NCT02025439|9951797|FG001|STARTED|Overall Study||2
8894007|NCT02025439|9951796|FG000|COMPLETED|Overall Study||2
8894008|NCT02025439|9951797|FG001|COMPLETED|Overall Study||2
8894009|NCT02025439|9951796|FG000|NOT COMPLETED|Overall Study||0
8894010|NCT02025439|9951797|FG001|NOT COMPLETED|Overall Study||0
8894011|NCT02025530|9951807|FG000|STARTED|Overall Study||296
8894012|NCT02025530|9951808|FG001|STARTED|Overall Study||734
8894013|NCT02025530|9951807|FG000|COMPLETED|Overall Study||291
8894014|NCT02025530|9951808|FG001|COMPLETED|Overall Study||733
8894015|NCT02025530|9951807|FG000|NOT COMPLETED|Overall Study||5
8894016|NCT02025530|9951808|FG001|NOT COMPLETED|Overall Study||1
8894017|NCT02025621|9951816|FG000|STARTED|Overall Study||442
8894018|NCT02025621|9951817|FG001|STARTED|Overall Study||440
8894019|NCT02025621|9951816|FG000|COMPLETED|Overall Study||428
8894020|NCT02025621|9951817|FG001|COMPLETED|Overall Study||421
8894021|NCT02025621|9951816|FG000|NOT COMPLETED|Overall Study||14
8894022|NCT02025621|9951817|FG001|NOT COMPLETED|Overall Study||19
8894023|NCT02025634|9951825|FG000|STARTED|Overall Study||65
8894024|NCT02025634|9951826|FG001|STARTED|Overall Study||54
8894025|NCT02025634|9951825|FG000|COMPLETED|Overall Study||65
8894026|NCT02025634|9951826|FG001|COMPLETED|Overall Study||54
8894027|NCT02025634|9951825|FG000|NOT COMPLETED|Overall Study||0
8894028|NCT02025634|9951826|FG001|NOT COMPLETED|Overall Study||0
8894029|NCT02025647|9951832|FG000|STARTED|Overall Study||139
8894030|NCT02025647|9951832|FG000|Session 1 (Narrative Module)|Overall Study||139
8894031|NCT02025647|9951832|FG000|Immediate Retest (Rating Module: 5 Min)|Overall Study|"27 did not generate IRS~15 technology issues or administered wrong session"|97
8894032|NCT02025647|9951832|FG000|Session 2 (Narrative Module: 24-48 Hrs)|Overall Study|"19 lost to follow up or technology issues~3 administered wrong session"|117
8894033|NCT02025647|9951832|FG000|Session 3 (Rating Module: 30-45 Days)|Overall Study|"27 did not generate IRS~36 lost to follow up"|76
8894034|NCT02025647|9951832|FG000|COMPLETED|Overall Study||139
8894035|NCT02025647|9951832|FG000|NOT COMPLETED|Overall Study||0
8894036|NCT02025725|9951838|FG000|STARTED|Overall Study||102
8894037|NCT02025725|9951839|FG001|STARTED|Overall Study||103
8894038|NCT02025725|9951838|FG000|COMPLETED|Overall Study||91
8894039|NCT02025725|9951839|FG001|COMPLETED|Overall Study||99
8894040|NCT02025725|9951838|FG000|NOT COMPLETED|Overall Study||11
8894041|NCT02025725|9951839|FG001|NOT COMPLETED|Overall Study||4
8894042|NCT02025751|9951849|FG000|STARTED|Overall Study||26
8894043|NCT02025751|9951850|FG001|STARTED|Overall Study||27
8894044|NCT02025751|9951849|FG000|COMPLETED|Overall Study||25
8894045|NCT02025751|9951850|FG001|COMPLETED|Overall Study||24
8894046|NCT02025751|9951849|FG000|NOT COMPLETED|Overall Study||1
8894047|NCT02025751|9951850|FG001|NOT COMPLETED|Overall Study||3
9007452|NCT02958982|10070545|FG005|COMPLETED|Cohort 1: 25 mg in SAD Study||0
9007453|NCT02958982|10070546|FG006|COMPLETED|Cohort 1: 25 mg in SAD Study||0
9007454|NCT02958982|10070547|FG007|COMPLETED|Cohort 1: 25 mg in SAD Study||0
9007455|NCT02958982|10070548|FG008|COMPLETED|Cohort 1: 25 mg in SAD Study||0
9007456|NCT02958982|10070549|FG009|COMPLETED|Cohort 1: 25 mg in SAD Study||0
9007457|NCT02958982|10070550|FG010|COMPLETED|Cohort 1: 25 mg in SAD Study||0
9007458|NCT02958982|10070540|FG000|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
9007459|NCT02958982|10070541|FG001|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
9007460|NCT02958982|10070542|FG002|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
9007461|NCT02958982|10070543|FG003|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
9007462|NCT02958982|10070544|FG004|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
9007463|NCT02958982|10070545|FG005|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
9007464|NCT02958982|10070546|FG006|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
9007465|NCT02958982|10070547|FG007|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
9007466|NCT02958982|10070548|FG008|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
9007467|NCT02958982|10070549|FG009|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
9007468|NCT02958982|10070550|FG010|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
9007469|NCT02958982|10070540|FG000|STARTED|Cohort 2: 50 mg in SAD Study||2
9007470|NCT02958982|10070541|FG001|STARTED|Cohort 2: 50 mg in SAD Study||0
9007471|NCT02958982|10070542|FG002|STARTED|Cohort 2: 50 mg in SAD Study||4
8894048|NCT02025829|9951858|FG000|STARTED|Overall Study||3
8894049|NCT02025829|9951859|FG001|STARTED|Overall Study||11
8894050|NCT02025829|9951858|FG000|COMPLETED|Overall Study||3
8894051|NCT02025829|9951859|FG001|COMPLETED|Overall Study||11
8894052|NCT02025829|9951858|FG000|NOT COMPLETED|Overall Study||0
8894053|NCT02025829|9951859|FG001|NOT COMPLETED|Overall Study||0
8894054|NCT02025907|9951868|FG000|STARTED|Overall Study|Participant flow is presented for safety population.|108
8894055|NCT02025907|9951869|FG001|STARTED|Overall Study|Participant flow is presented for safety population.|108
8894056|NCT02025907|9951868|FG000|COMPLETED|Overall Study||81
8894057|NCT02025907|9951869|FG001|COMPLETED|Overall Study||96
8894058|NCT02025907|9951868|FG000|NOT COMPLETED|Overall Study||27
8894059|NCT02025907|9951869|FG001|NOT COMPLETED|Overall Study||12
8894060|NCT02025985|9951880|FG000|STARTED|Overall Study||25
8894061|NCT02025985|9951881|FG001|STARTED|Overall Study||23
8894062|NCT02025985|9951882|FG002|STARTED|Overall Study||25
8894063|NCT02025985|9951883|FG003|STARTED|Overall Study||21
8894064|NCT02025985|9951884|FG004|STARTED|Overall Study||20
8894065|NCT02025985|9951880|FG000|Modified Intent-to-treat(mITT)Population|Overall Study||23
8894066|NCT02025985|9951881|FG001|Modified Intent-to-treat(mITT)Population|Overall Study||22
8894067|NCT02025985|9951882|FG002|Modified Intent-to-treat(mITT)Population|Overall Study||25
8894068|NCT02025985|9951883|FG003|Modified Intent-to-treat(mITT)Population|Overall Study||21
8894069|NCT02025985|9951884|FG004|Modified Intent-to-treat(mITT)Population|Overall Study||20
8894070|NCT02025985|9951880|FG000|COMPLETED|Overall Study||0
8894071|NCT02025985|9951881|FG001|COMPLETED|Overall Study||0
8894072|NCT02025985|9951882|FG002|COMPLETED|Overall Study||0
8894073|NCT02025985|9951883|FG003|COMPLETED|Overall Study||0
8894074|NCT02025985|9951884|FG004|COMPLETED|Overall Study||0
8894075|NCT02025985|9951880|FG000|NOT COMPLETED|Overall Study||25
8894076|NCT02025985|9951881|FG001|NOT COMPLETED|Overall Study||23
8894077|NCT02025985|9951882|FG002|NOT COMPLETED|Overall Study||25
8894078|NCT02025985|9951883|FG003|NOT COMPLETED|Overall Study||21
8894079|NCT02025985|9951884|FG004|NOT COMPLETED|Overall Study||20
8894080|NCT02026011|9951900|FG000|STARTED|Allocation 1 (First Set of Medication)||46
8894081|NCT02026011|9951901|FG001|STARTED|Allocation 1 (First Set of Medication)||41
8894082|NCT02026011|9951900|FG000|COMPLETED|Allocation 1 (First Set of Medication)||38
8894083|NCT02026011|9951901|FG001|COMPLETED|Allocation 1 (First Set of Medication)||39
8894084|NCT02026011|9951900|FG000|NOT COMPLETED|Allocation 1 (First Set of Medication)||8
8894085|NCT02026011|9951901|FG001|NOT COMPLETED|Allocation 1 (First Set of Medication)||2
8894086|NCT02026011|9951900|FG000|STARTED|Allocation 2 (Second Set of Medication)||38
8894087|NCT02026011|9951901|FG001|STARTED|Allocation 2 (Second Set of Medication)||37
8894088|NCT02026011|9951900|FG000|COMPLETED|Allocation 2 (Second Set of Medication)||37
8894089|NCT02026011|9951901|FG001|COMPLETED|Allocation 2 (Second Set of Medication)||35
8894090|NCT02026011|9951900|FG000|NOT COMPLETED|Allocation 2 (Second Set of Medication)||1
8894091|NCT02026011|9951901|FG001|NOT COMPLETED|Allocation 2 (Second Set of Medication)||2
8894092|NCT02026063|9951912|FG000|STARTED|Overall Study||22
8894093|NCT02026063|9951913|FG001|STARTED|Overall Study||102
8894094|NCT02026063|9951912|FG000|COMPLETED|Overall Study||13
8894095|NCT02026063|9951913|FG001|COMPLETED|Overall Study||53
8894096|NCT02026063|9951912|FG000|NOT COMPLETED|Overall Study||9
8894097|NCT02026063|9951913|FG001|NOT COMPLETED|Overall Study||49
8894098|NCT02026141|9951922|FG000|STARTED|Overall Study||20
8894099|NCT02026141|9951923|FG001|STARTED|Overall Study||20
8894100|NCT02026141|9951922|FG000|COMPLETED|Overall Study||20
8894101|NCT02026141|9951923|FG001|COMPLETED|Overall Study||19
8894102|NCT02026141|9951922|FG000|NOT COMPLETED|Overall Study||0
8894103|NCT02026141|9951923|FG001|NOT COMPLETED|Overall Study||1
8894104|NCT02026193|9951931|FG000|STARTED|Overall Study||3
8894105|NCT02026193|9951932|FG001|STARTED|Overall Study||8
8894106|NCT02026193|9951931|FG000|COMPLETED|Overall Study||3
8894107|NCT02026193|9951932|FG001|COMPLETED|Overall Study||8
8894108|NCT02026193|9951931|FG000|NOT COMPLETED|Overall Study||0
8894109|NCT02026193|9951932|FG001|NOT COMPLETED|Overall Study||0
8894110|NCT02026206|9951940|FG000|STARTED|Overall Study||44
8894111|NCT02026206|9951941|FG001|STARTED|Overall Study||44
8894112|NCT02026206|9951940|FG000|COMPLETED|Overall Study||40
8894113|NCT02026206|9951941|FG001|COMPLETED|Overall Study||36
8894114|NCT02026206|9951940|FG000|NOT COMPLETED|Overall Study||4
8894115|NCT02026206|9951941|FG001|NOT COMPLETED|Overall Study||8
8894116|NCT02026258|9951949|FG000|STARTED|Randomized||20
8894117|NCT02026258|9951950|FG001|STARTED|Randomized||21
8894118|NCT02026258|9951949|FG000|COMPLETED|Randomized||16
8894119|NCT02026258|9951950|FG001|COMPLETED|Randomized||19
8894120|NCT02026258|9951949|FG000|NOT COMPLETED|Randomized||4
8894121|NCT02026258|9951950|FG001|NOT COMPLETED|Randomized||2
8894122|NCT02026258|9951949|FG000|STARTED|Recieved Allocated Intervention||16
8894123|NCT02026258|9951950|FG001|STARTED|Recieved Allocated Intervention||19
8894124|NCT02026258|9951949|FG000|COMPLETED|Recieved Allocated Intervention||15
8894125|NCT02026258|9951950|FG001|COMPLETED|Recieved Allocated Intervention||17
8894126|NCT02026258|9951949|FG000|NOT COMPLETED|Recieved Allocated Intervention||1
8894127|NCT02026258|9951950|FG001|NOT COMPLETED|Recieved Allocated Intervention||2
8894128|NCT02026297|9951959|FG000|STARTED|Overall Study||7
8894129|NCT02026297|9951960|FG001|STARTED|Overall Study||13
8894130|NCT02026297|9951959|FG000|COMPLETED|Overall Study||7
8894131|NCT02026297|9951960|FG001|COMPLETED|Overall Study||13
8894132|NCT02026297|9951959|FG000|NOT COMPLETED|Overall Study||0
8894133|NCT02026297|9951960|FG001|NOT COMPLETED|Overall Study||0
8894134|NCT02026453|9951969|FG000|STARTED|Overall Study||101
8894135|NCT02026453|9951970|FG001|STARTED|Overall Study||103
8894136|NCT02026453|9951971|FG002|STARTED|Overall Study||102
8894137|NCT02026453|9951969|FG000|COMPLETED|Overall Study||95
8894138|NCT02026453|9951970|FG001|COMPLETED|Overall Study||94
8894139|NCT02026453|9951971|FG002|COMPLETED|Overall Study||89
8894140|NCT02026453|9951969|FG000|NOT COMPLETED|Overall Study||6
8894141|NCT02026453|9951970|FG001|NOT COMPLETED|Overall Study||9
8894142|NCT02026453|9951971|FG002|NOT COMPLETED|Overall Study||13
8894143|NCT02026687|9951981|FG000|STARTED|Overall Study||40
8894144|NCT02026687|9951982|FG001|STARTED|Overall Study||40
8894145|NCT02026687|9951981|FG000|COMPLETED|Overall Study||39
8894146|NCT02026687|9951982|FG001|COMPLETED|Overall Study||38
8894147|NCT02026687|9951981|FG000|NOT COMPLETED|Overall Study||1
8894148|NCT02026687|9951982|FG001|NOT COMPLETED|Overall Study||2
8894149|NCT02027025|9951991|FG000|STARTED|Overall Study||48
9007472|NCT02958982|10070543|FG003|STARTED|Cohort 2: 50 mg in SAD Study||0
9007473|NCT02958982|10070544|FG004|STARTED|Cohort 2: 50 mg in SAD Study||0
9007474|NCT02958982|10070545|FG005|STARTED|Cohort 2: 50 mg in SAD Study||0
9007475|NCT02958982|10070546|FG006|STARTED|Cohort 2: 50 mg in SAD Study||0
9007476|NCT02958982|10070547|FG007|STARTED|Cohort 2: 50 mg in SAD Study||0
9007477|NCT02958982|10070548|FG008|STARTED|Cohort 2: 50 mg in SAD Study||0
9007478|NCT02958982|10070549|FG009|STARTED|Cohort 2: 50 mg in SAD Study||0
9007479|NCT02958982|10070550|FG010|STARTED|Cohort 2: 50 mg in SAD Study||0
9007480|NCT02958982|10070540|FG000|COMPLETED|Cohort 2: 50 mg in SAD Study||2
9007481|NCT02958982|10070541|FG001|COMPLETED|Cohort 2: 50 mg in SAD Study||0
9007482|NCT02958982|10070542|FG002|COMPLETED|Cohort 2: 50 mg in SAD Study||4
9007483|NCT02958982|10070543|FG003|COMPLETED|Cohort 2: 50 mg in SAD Study||0
9007484|NCT02958982|10070544|FG004|COMPLETED|Cohort 2: 50 mg in SAD Study||0
9007485|NCT02958982|10070545|FG005|COMPLETED|Cohort 2: 50 mg in SAD Study||0
9007486|NCT02958982|10070546|FG006|COMPLETED|Cohort 2: 50 mg in SAD Study||0
9007487|NCT02958982|10070547|FG007|COMPLETED|Cohort 2: 50 mg in SAD Study||0
9007488|NCT02958982|10070548|FG008|COMPLETED|Cohort 2: 50 mg in SAD Study||0
9007489|NCT02958982|10070549|FG009|COMPLETED|Cohort 2: 50 mg in SAD Study||0
9007490|NCT02958982|10070550|FG010|COMPLETED|Cohort 2: 50 mg in SAD Study||0
9007491|NCT02958982|10070540|FG000|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
9007492|NCT02958982|10070541|FG001|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
9007493|NCT02958982|10070542|FG002|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
9007494|NCT02958982|10070543|FG003|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
9007495|NCT02958982|10070544|FG004|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
9007496|NCT02958982|10070545|FG005|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
9007497|NCT02958982|10070546|FG006|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
9007498|NCT02958982|10070547|FG007|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
9007499|NCT02958982|10070548|FG008|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
8894150|NCT02027025|9951992|FG001|STARTED|Overall Study||47
8894151|NCT02027025|9951993|FG002|STARTED|Overall Study||47
8894152|NCT02027025|9951991|FG000|COMPLETED|Overall Study||47
8894153|NCT02027025|9951992|FG001|COMPLETED|Overall Study||42
8894154|NCT02027025|9951993|FG002|COMPLETED|Overall Study||46
8894155|NCT02027025|9951991|FG000|NOT COMPLETED|Overall Study||1
8894156|NCT02027025|9951992|FG001|NOT COMPLETED|Overall Study||5
8894157|NCT02027025|9951993|FG002|NOT COMPLETED|Overall Study||1
8894158|NCT02027311|9952014|FG000|STARTED|Overall Study||33
8894159|NCT02027311|9952015|FG001|STARTED|Overall Study||35
8894160|NCT02027311|9952014|FG000|COMPLETED|Overall Study|1 case was dropped due to hypotension and 2 were desaturation.|30
8894161|NCT02027311|9952015|FG001|COMPLETED|Overall Study|1 cases was dropped due to tachycardia and 1 were desaturation.|33
8894162|NCT02027311|9952014|FG000|NOT COMPLETED|Overall Study||3
8894163|NCT02027311|9952015|FG001|NOT COMPLETED|Overall Study||2
8894164|NCT02027376|9952023|FG000|STARTED|Overall Study||5
8894165|NCT02027376|9952024|FG001|STARTED|Overall Study||4
8894166|NCT02027376|9952025|FG002|STARTED|Overall Study||3
8894167|NCT02027376|9952023|FG000|COMPLETED|Overall Study||4
8894168|NCT02027376|9952024|FG001|COMPLETED|Overall Study||4
8894169|NCT02027376|9952025|FG002|COMPLETED|Overall Study||3
8894170|NCT02027376|9952023|FG000|NOT COMPLETED|Overall Study||1
8894171|NCT02027376|9952024|FG001|NOT COMPLETED|Overall Study||0
8894172|NCT02027376|9952025|FG002|NOT COMPLETED|Overall Study||0
8894173|NCT02027402|9952037|FG000|STARTED|Overall Study||98
8894174|NCT02027402|9952038|FG001|STARTED|Overall Study||100
8894175|NCT02027402|9952037|FG000|COMPLETED|Overall Study||94
8894176|NCT02027402|9952038|FG001|COMPLETED|Overall Study||99
8894177|NCT02027402|9952037|FG000|NOT COMPLETED|Overall Study||4
8894178|NCT02027402|9952038|FG001|NOT COMPLETED|Overall Study||1
8894179|NCT02027428|9952048|FG000|STARTED|Induction||427
8894180|NCT02027428|9952049|FG001|STARTED|Induction||0
8894181|NCT02027428|9952050|FG002|STARTED|Induction||0
8894182|NCT02027428|9952048|FG000|Received Study Drug|Induction||420
8894183|NCT02027428|9952049|FG001|Received Study Drug|Induction||0
8894184|NCT02027428|9952050|FG002|Received Study Drug|Induction||0
8894185|NCT02027428|9952048|FG000|COMPLETED|Induction|If radiologically CR, PR or SD after 4 cycles of treatment, participants continue on to Maintenance.|202
8894186|NCT02027428|9952049|FG001|COMPLETED|Induction||0
8894187|NCT02027428|9952050|FG002|COMPLETED|Induction||0
8894188|NCT02027428|9952048|FG000|NOT COMPLETED|Induction||225
8894189|NCT02027428|9952049|FG001|NOT COMPLETED|Induction||0
8894190|NCT02027428|9952050|FG002|NOT COMPLETED|Induction||0
8894191|NCT02027428|9952048|FG000|STARTED|Maintenance||0
8894192|NCT02027428|9952049|FG001|STARTED|Maintenance||136
8894193|NCT02027428|9952050|FG002|STARTED|Maintenance||66
8894194|NCT02027428|9952048|FG000|COMPLETED|Maintenance||0
8894195|NCT02027428|9952049|FG001|COMPLETED|Maintenance||12
8894196|NCT02027428|9952050|FG002|COMPLETED|Maintenance||6
8894197|NCT02027428|9952048|FG000|NOT COMPLETED|Maintenance||0
8894198|NCT02027428|9952049|FG001|NOT COMPLETED|Maintenance||124
8894199|NCT02027428|9952050|FG002|NOT COMPLETED|Maintenance||60
8894200|NCT02027428|9952048|FG000|STARTED|Survival Follow-up||0
8894201|NCT02027428|9952049|FG001|STARTED|Survival Follow-up|Participants are not taking study intervention but are on appropriate standard of care.|117
8894202|NCT02027428|9952050|FG002|STARTED|Survival Follow-up|Participants are not taking study intervention but are on appropriate standard of care.|55
8894203|NCT02027428|9952048|FG000|COMPLETED|Survival Follow-up||0
8894204|NCT02027428|9952049|FG001|COMPLETED|Survival Follow-up||38
8894205|NCT02027428|9952050|FG002|COMPLETED|Survival Follow-up||9
8894206|NCT02027428|9952048|FG000|NOT COMPLETED|Survival Follow-up||0
8894207|NCT02027428|9952049|FG001|NOT COMPLETED|Survival Follow-up||79
8894208|NCT02027428|9952050|FG002|NOT COMPLETED|Survival Follow-up||46
8894209|NCT02027545|9952075|FG000|STARTED|Overall Study||261
8894210|NCT02027545|9952076|FG001|STARTED|Overall Study||175
8894211|NCT02027545|9952075|FG000|COMPLETED|Overall Study||259
8894212|NCT02027545|9952076|FG001|COMPLETED|Overall Study||173
8894213|NCT02027545|9952075|FG000|NOT COMPLETED|Overall Study||2
8894214|NCT02027545|9952076|FG001|NOT COMPLETED|Overall Study||2
8894215|NCT02027558|9952084|FG000|STARTED|Overall Study||62
8894216|NCT02027558|9952085|FG001|STARTED|Overall Study||63
8894217|NCT02027558|9952084|FG000|Post-treatment|Overall Study||49
8894218|NCT02027558|9952085|FG001|Post-treatment|Overall Study||60
8894219|NCT02027558|9952084|FG000|3-month Follow-up|Overall Study||53
8894220|NCT02027558|9952085|FG001|3-month Follow-up|Overall Study||58
8894221|NCT02027558|9952084|FG000|6-month Follow-up|Overall Study||53
8894222|NCT02027558|9952085|FG001|6-month Follow-up|Overall Study||61
8894223|NCT02027558|9952084|FG000|COMPLETED|Overall Study||53
8894224|NCT02027558|9952085|FG001|COMPLETED|Overall Study||61
8894225|NCT02027558|9952084|FG000|NOT COMPLETED|Overall Study||9
8894226|NCT02027558|9952085|FG001|NOT COMPLETED|Overall Study||2
8894227|NCT02027623|9952095|FG000|STARTED|Overall Study||77
8894228|NCT02027623|9952096|FG001|STARTED|Overall Study||77
8894229|NCT02027623|9952095|FG000|COMPLETED|Overall Study||68
8894230|NCT02027623|9952096|FG001|COMPLETED|Overall Study||65
8894231|NCT02027623|9952095|FG000|NOT COMPLETED|Overall Study||9
8894232|NCT02027623|9952096|FG001|NOT COMPLETED|Overall Study||12
8894233|NCT02027701|9952103|FG000|STARTED|Overall Study||82
8894234|NCT02027701|9952103|FG000|COMPLETED|Overall Study||66
8894235|NCT02027701|9952103|FG000|NOT COMPLETED|Overall Study||16
8894236|NCT02027844|9952112|FG000|STARTED|Overall Study||39
8894237|NCT02027844|9952113|FG001|STARTED|Overall Study||39
8894238|NCT02027844|9952114|FG002|STARTED|Overall Study||39
8894239|NCT02027844|9952112|FG000|COMPLETED|Overall Study||34
8894240|NCT02027844|9952113|FG001|COMPLETED|Overall Study||33
8894241|NCT02027844|9952114|FG002|COMPLETED|Overall Study||37
8894242|NCT02027844|9952112|FG000|NOT COMPLETED|Overall Study||5
8894243|NCT02027844|9952113|FG001|NOT COMPLETED|Overall Study||6
8894244|NCT02027844|9952114|FG002|NOT COMPLETED|Overall Study||2
8894245|NCT02027883|9952124|FG000|STARTED|Overall Study||50
8894246|NCT02027883|9952125|FG001|STARTED|Overall Study||50
8894247|NCT02027883|9952124|FG000|COMPLETED|Overall Study||50
8894248|NCT02027883|9952125|FG001|COMPLETED|Overall Study||50
8894249|NCT02027883|9952124|FG000|NOT COMPLETED|Overall Study||0
8894250|NCT02027883|9952125|FG001|NOT COMPLETED|Overall Study||0
8894251|NCT02028065|9952138|FG000|STARTED|Randomization Through Start Treatment|Randomized|76
8894252|NCT02028065|9952139|FG001|STARTED|Randomization Through Start Treatment|Randomized|154
8894253|NCT02028065|9952140|FG002|STARTED|Randomization Through Start Treatment|Randomized|152
8894254|NCT02028065|9952138|FG000|COMPLETED|Randomization Through Start Treatment||75
8894255|NCT02028065|9952139|FG001|COMPLETED|Randomization Through Start Treatment||151
8894256|NCT02028065|9952140|FG002|COMPLETED|Randomization Through Start Treatment||149
8894257|NCT02028065|9952138|FG000|NOT COMPLETED|Randomization Through Start Treatment||1
8894258|NCT02028065|9952139|FG001|NOT COMPLETED|Randomization Through Start Treatment||3
8894259|NCT02028065|9952140|FG002|NOT COMPLETED|Randomization Through Start Treatment||3
8894260|NCT02028065|9952138|FG000|STARTED|Treatment Through Study Completion|Includes 1 participant randomized to sugammadex 16 mg/kg who actually received placebo|76
8894261|NCT02028065|9952139|FG001|STARTED|Treatment Through Study Completion||151
8894262|NCT02028065|9952140|FG002|STARTED|Treatment Through Study Completion|Does not include the 1 participant randomized to sugammadex 16 mg/kg who actually received placebo|148
8894263|NCT02028065|9952138|FG000|Received First Dose|Treatment Through Study Completion||76
8894264|NCT02028065|9952139|FG001|Received First Dose|Treatment Through Study Completion||151
8894265|NCT02028065|9952140|FG002|Received First Dose|Treatment Through Study Completion||148
8894266|NCT02028065|9952138|FG000|Received Second Dose|Treatment Through Study Completion||69
8894267|NCT02028065|9952139|FG001|Received Second Dose|Treatment Through Study Completion||140
8894268|NCT02028065|9952140|FG002|Received Second Dose|Treatment Through Study Completion||138
8894269|NCT02028065|9952138|FG000|Received Third Dose|Treatment Through Study Completion||64
8894270|NCT02028065|9952139|FG001|Received Third Dose|Treatment Through Study Completion||136
8894271|NCT02028065|9952140|FG002|Received Third Dose|Treatment Through Study Completion||134
8894272|NCT02028065|9952138|FG000|COMPLETED|Treatment Through Study Completion||64
8894273|NCT02028065|9952139|FG001|COMPLETED|Treatment Through Study Completion||136
9007500|NCT02958982|10070549|FG009|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
9007501|NCT02958982|10070550|FG010|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
9007502|NCT02958982|10070540|FG000|STARTED|Cohort 3: 100 mg in SAD Study||2
9007503|NCT02958982|10070541|FG001|STARTED|Cohort 3: 100 mg in SAD Study||0
9007504|NCT02958982|10070542|FG002|STARTED|Cohort 3: 100 mg in SAD Study||0
9007505|NCT02958982|10070543|FG003|STARTED|Cohort 3: 100 mg in SAD Study||4
9007506|NCT02958982|10070544|FG004|STARTED|Cohort 3: 100 mg in SAD Study||0
9007507|NCT02958982|10070545|FG005|STARTED|Cohort 3: 100 mg in SAD Study||0
9007508|NCT02958982|10070546|FG006|STARTED|Cohort 3: 100 mg in SAD Study||0
9007509|NCT02958982|10070547|FG007|STARTED|Cohort 3: 100 mg in SAD Study||0
9007510|NCT02958982|10070548|FG008|STARTED|Cohort 3: 100 mg in SAD Study||0
9007511|NCT02958982|10070549|FG009|STARTED|Cohort 3: 100 mg in SAD Study||0
9007512|NCT02958982|10070550|FG010|STARTED|Cohort 3: 100 mg in SAD Study||0
9007513|NCT02958982|10070540|FG000|COMPLETED|Cohort 3: 100 mg in SAD Study||2
9007514|NCT02958982|10070541|FG001|COMPLETED|Cohort 3: 100 mg in SAD Study||0
9007515|NCT02958982|10070542|FG002|COMPLETED|Cohort 3: 100 mg in SAD Study||0
9007516|NCT02958982|10070543|FG003|COMPLETED|Cohort 3: 100 mg in SAD Study||4
9007517|NCT02958982|10070544|FG004|COMPLETED|Cohort 3: 100 mg in SAD Study||0
9007518|NCT02958982|10070545|FG005|COMPLETED|Cohort 3: 100 mg in SAD Study||0
9007519|NCT02958982|10070546|FG006|COMPLETED|Cohort 3: 100 mg in SAD Study||0
9007520|NCT02958982|10070547|FG007|COMPLETED|Cohort 3: 100 mg in SAD Study||0
9007521|NCT02958982|10070548|FG008|COMPLETED|Cohort 3: 100 mg in SAD Study||0
9007522|NCT02958982|10070549|FG009|COMPLETED|Cohort 3: 100 mg in SAD Study||0
9007523|NCT02958982|10070550|FG010|COMPLETED|Cohort 3: 100 mg in SAD Study||0
9007524|NCT02958982|10070540|FG000|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
9007525|NCT02958982|10070541|FG001|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
9007526|NCT02958982|10070542|FG002|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
9007527|NCT02958982|10070543|FG003|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
9007528|NCT02958982|10070544|FG004|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
9007529|NCT02958982|10070545|FG005|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
9007530|NCT02958982|10070546|FG006|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
9007531|NCT02958982|10070547|FG007|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
9007532|NCT02958982|10070548|FG008|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
9007533|NCT02958982|10070549|FG009|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
9007534|NCT02958982|10070550|FG010|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
9007535|NCT02958982|10070540|FG000|STARTED|Cohort 4: 200 mg in SAD Study||2
9007536|NCT02958982|10070541|FG001|STARTED|Cohort 4: 200 mg in SAD Study||0
9007537|NCT02958982|10070542|FG002|STARTED|Cohort 4: 200 mg in SAD Study||0
9007538|NCT02958982|10070543|FG003|STARTED|Cohort 4: 200 mg in SAD Study||0
9007539|NCT02958982|10070544|FG004|STARTED|Cohort 4: 200 mg in SAD Study||6
9007540|NCT02958982|10070545|FG005|STARTED|Cohort 4: 200 mg in SAD Study||0
9007541|NCT02958982|10070546|FG006|STARTED|Cohort 4: 200 mg in SAD Study||0
9007542|NCT02958982|10070547|FG007|STARTED|Cohort 4: 200 mg in SAD Study||0
9007543|NCT02958982|10070548|FG008|STARTED|Cohort 4: 200 mg in SAD Study||0
9007544|NCT02958982|10070549|FG009|STARTED|Cohort 4: 200 mg in SAD Study||0
9007545|NCT02958982|10070550|FG010|STARTED|Cohort 4: 200 mg in SAD Study||0
9007546|NCT02958982|10070540|FG000|COMPLETED|Cohort 4: 200 mg in SAD Study||2
9007547|NCT02958982|10070541|FG001|COMPLETED|Cohort 4: 200 mg in SAD Study||0
8894274|NCT02028065|9952140|FG002|COMPLETED|Treatment Through Study Completion||134
8894275|NCT02028065|9952138|FG000|NOT COMPLETED|Treatment Through Study Completion||12
8894276|NCT02028065|9952139|FG001|NOT COMPLETED|Treatment Through Study Completion||15
8894277|NCT02028065|9952140|FG002|NOT COMPLETED|Treatment Through Study Completion||14
8894278|NCT02028169|9952148|FG000|STARTED|Overall Study||120
8894279|NCT02028169|9952148|FG000|COMPLETED|Overall Study||92
8894280|NCT02028169|9952148|FG000|NOT COMPLETED|Overall Study||28
8894281|NCT02028182|9952152|FG000|STARTED|Overall Study||22
8894282|NCT02028182|9952152|FG000|COMPLETED|Overall Study||20
8894283|NCT02028182|9952152|FG000|NOT COMPLETED|Overall Study||2
8894284|NCT02028208|9952160|FG000|STARTED|Overall Study||21
8894285|NCT02028208|9952161|FG001|STARTED|Overall Study||13
8894286|NCT02028208|9952162|FG002|STARTED|Overall Study||22
8894287|NCT02028208|9952160|FG000|COMPLETED|Overall Study||21
8894288|NCT02028208|9952161|FG001|COMPLETED|Overall Study||13
8894289|NCT02028208|9952162|FG002|COMPLETED|Overall Study||21
8894290|NCT02028208|9952160|FG000|NOT COMPLETED|Overall Study||0
8894291|NCT02028208|9952161|FG001|NOT COMPLETED|Overall Study||0
8894292|NCT02028208|9952162|FG002|NOT COMPLETED|Overall Study||1
8894293|NCT02028221|9952172|FG000|STARTED|Overall Study||75
8894294|NCT02028221|9952173|FG001|STARTED|Overall Study||76
8894295|NCT02028221|9952172|FG000|COMPLETED|Overall Study||62
8894296|NCT02028221|9952173|FG001|COMPLETED|Overall Study||56
8894297|NCT02028221|9952172|FG000|NOT COMPLETED|Overall Study||13
8894298|NCT02028221|9952173|FG001|NOT COMPLETED|Overall Study||20
8894299|NCT02028247|9952182|FG000|STARTED|Overall Study||77
8894300|NCT02028247|9952183|FG001|STARTED|Overall Study||71
8894301|NCT02028247|9952184|FG002|STARTED|Overall Study||19
8894302|NCT02028247|9952182|FG000|COMPLETED|Overall Study||67
8894303|NCT02028247|9952183|FG001|COMPLETED|Overall Study||59
8894304|NCT02028247|9952184|FG002|COMPLETED|Overall Study||15
8894305|NCT02028247|9952182|FG000|NOT COMPLETED|Overall Study||10
8894306|NCT02028247|9952183|FG001|NOT COMPLETED|Overall Study||12
8894307|NCT02028247|9952184|FG002|NOT COMPLETED|Overall Study||4
8894308|NCT02028325|9952192|FG000|STARTED|Overall Study||136
8894309|NCT02028325|9952192|FG000|COMPLETED|Overall Study||126
8894310|NCT02028325|9952192|FG000|NOT COMPLETED|Overall Study||10
8894311|NCT02028676|9952205|FG000|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|606
8894312|NCT02028676|9952206|FG001|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|600
8894313|NCT02028676|9952207|FG002|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|0
8894314|NCT02028676|9952208|FG003|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|0
8894315|NCT02028676|9952209|FG004|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|0
8894316|NCT02028676|9952210|FG005|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
8894317|NCT02028676|9952211|FG006|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
8894318|NCT02028676|9952212|FG007|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
8894319|NCT02028676|9952213|FG008|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
8894320|NCT02028676|9952205|FG000|COMPLETED|Initial Enrolment: CDM vs LCM||606
8894321|NCT02028676|9952206|FG001|COMPLETED|Initial Enrolment: CDM vs LCM||600
8894322|NCT02028676|9952207|FG002|COMPLETED|Initial Enrolment: CDM vs LCM||0
8894323|NCT02028676|9952208|FG003|COMPLETED|Initial Enrolment: CDM vs LCM||0
8894324|NCT02028676|9952209|FG004|COMPLETED|Initial Enrolment: CDM vs LCM||0
8894325|NCT02028676|9952210|FG005|COMPLETED|Initial Enrolment: CDM vs LCM||0
8894326|NCT02028676|9952211|FG006|COMPLETED|Initial Enrolment: CDM vs LCM||0
8894327|NCT02028676|9952212|FG007|COMPLETED|Initial Enrolment: CDM vs LCM||0
8894328|NCT02028676|9952213|FG008|COMPLETED|Initial Enrolment: CDM vs LCM||0
8894329|NCT02028676|9952205|FG000|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
8894330|NCT02028676|9952206|FG001|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
8894331|NCT02028676|9952207|FG002|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
8894332|NCT02028676|9952208|FG003|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
8894333|NCT02028676|9952209|FG004|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
8894334|NCT02028676|9952210|FG005|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
8894335|NCT02028676|9952211|FG006|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
8894336|NCT02028676|9952212|FG007|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
8894337|NCT02028676|9952213|FG008|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
8894338|NCT02028676|9952205|FG000|STARTED|Initial Enrolment: Induction ART||0
8894339|NCT02028676|9952206|FG001|STARTED|Initial Enrolment: Induction ART||0
8894340|NCT02028676|9952207|FG002|STARTED|Initial Enrolment: Induction ART||397
8894341|NCT02028676|9952208|FG003|STARTED|Initial Enrolment: Induction ART||404
8894342|NCT02028676|9952209|FG004|STARTED|Initial Enrolment: Induction ART||405
8894343|NCT02028676|9952210|FG005|STARTED|Initial Enrolment: Induction ART||0
8894344|NCT02028676|9952211|FG006|STARTED|Initial Enrolment: Induction ART||0
8894345|NCT02028676|9952212|FG007|STARTED|Initial Enrolment: Induction ART||0
8894346|NCT02028676|9952213|FG008|STARTED|Initial Enrolment: Induction ART||0
8894347|NCT02028676|9952205|FG000|COMPLETED|Initial Enrolment: Induction ART||0
8894348|NCT02028676|9952206|FG001|COMPLETED|Initial Enrolment: Induction ART||0
8894349|NCT02028676|9952207|FG002|COMPLETED|Initial Enrolment: Induction ART||397
8894350|NCT02028676|9952208|FG003|COMPLETED|Initial Enrolment: Induction ART||404
8894351|NCT02028676|9952209|FG004|COMPLETED|Initial Enrolment: Induction ART||405
8894352|NCT02028676|9952210|FG005|COMPLETED|Initial Enrolment: Induction ART||0
8894353|NCT02028676|9952211|FG006|COMPLETED|Initial Enrolment: Induction ART||0
8894354|NCT02028676|9952212|FG007|COMPLETED|Initial Enrolment: Induction ART||0
8894355|NCT02028676|9952213|FG008|COMPLETED|Initial Enrolment: Induction ART||0
8894356|NCT02028676|9952205|FG000|NOT COMPLETED|Initial Enrolment: Induction ART||0
8894357|NCT02028676|9952206|FG001|NOT COMPLETED|Initial Enrolment: Induction ART||0
8894358|NCT02028676|9952207|FG002|NOT COMPLETED|Initial Enrolment: Induction ART||0
8894359|NCT02028676|9952208|FG003|NOT COMPLETED|Initial Enrolment: Induction ART||0
8894360|NCT02028676|9952209|FG004|NOT COMPLETED|Initial Enrolment: Induction ART||0
8894361|NCT02028676|9952210|FG005|NOT COMPLETED|Initial Enrolment: Induction ART||0
8894362|NCT02028676|9952211|FG006|NOT COMPLETED|Initial Enrolment: Induction ART||0
8894363|NCT02028676|9952212|FG007|NOT COMPLETED|Initial Enrolment: Induction ART||0
8894364|NCT02028676|9952213|FG008|NOT COMPLETED|Initial Enrolment: Induction ART||0
8894365|NCT02028676|9952205|FG000|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
8894366|NCT02028676|9952206|FG001|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
8894367|NCT02028676|9952207|FG002|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
8894368|NCT02028676|9952208|FG003|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
8894369|NCT02028676|9952209|FG004|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
8894370|NCT02028676|9952210|FG005|STARTED|Subsequent Once vs Twice Daily ABC+3TC||336
8894371|NCT02028676|9952211|FG006|STARTED|Subsequent Once vs Twice Daily ABC+3TC||333
8894372|NCT02028676|9952212|FG007|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
8894373|NCT02028676|9952213|FG008|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
8894374|NCT02028676|9952205|FG000|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
8894375|NCT02028676|9952206|FG001|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
8894376|NCT02028676|9952207|FG002|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
8894377|NCT02028676|9952208|FG003|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
8894378|NCT02028676|9952209|FG004|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
8894379|NCT02028676|9952210|FG005|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||336
8894380|NCT02028676|9952211|FG006|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||333
8894381|NCT02028676|9952212|FG007|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
8894382|NCT02028676|9952213|FG008|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
8894383|NCT02028676|9952205|FG000|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
8894384|NCT02028676|9952206|FG001|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
8894385|NCT02028676|9952207|FG002|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
8894386|NCT02028676|9952208|FG003|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
8894387|NCT02028676|9952209|FG004|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
8894388|NCT02028676|9952210|FG005|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
8894389|NCT02028676|9952211|FG006|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
8894390|NCT02028676|9952212|FG007|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
8894391|NCT02028676|9952213|FG008|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
8894392|NCT02028676|9952205|FG000|STARTED|Subsequent Cotrimoxazole Randomization||0
8894393|NCT02028676|9952206|FG001|STARTED|Subsequent Cotrimoxazole Randomization||0
8894394|NCT02028676|9952207|FG002|STARTED|Subsequent Cotrimoxazole Randomization||0
8894395|NCT02028676|9952208|FG003|STARTED|Subsequent Cotrimoxazole Randomization||0
8894396|NCT02028676|9952209|FG004|STARTED|Subsequent Cotrimoxazole Randomization||0
8894397|NCT02028676|9952210|FG005|STARTED|Subsequent Cotrimoxazole Randomization||0
8894398|NCT02028676|9952211|FG006|STARTED|Subsequent Cotrimoxazole Randomization||0
8894399|NCT02028676|9952212|FG007|STARTED|Subsequent Cotrimoxazole Randomization||376
8894400|NCT02028676|9952213|FG008|STARTED|Subsequent Cotrimoxazole Randomization||382
8572766|NCT00116844|9604958|FG000|COMPLETED|Period 2: Washout Period (7 Days)||28
8572767|NCT00116844|9604959|FG001|COMPLETED|Period 2: Washout Period (7 Days)||33
8635240|NCT00561015|9675728|FG005|COMPLETED|Overall Study||6
8635241|NCT00561015|9675723|FG000|NOT COMPLETED|Overall Study||4
8635242|NCT00561015|9675724|FG001|NOT COMPLETED|Overall Study||0
8635243|NCT00561015|9675725|FG002|NOT COMPLETED|Overall Study||0
8635244|NCT00561015|9675726|FG003|NOT COMPLETED|Overall Study||1
8894401|NCT02028676|9952205|FG000|COMPLETED|Subsequent Cotrimoxazole Randomization||0
8572768|NCT00116844|9604958|FG000|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
8572769|NCT00116844|9604959|FG001|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
8572770|NCT00116844|9604958|FG000|STARTED|Period 1: Treatment Period 2 (60 Days)||28
8572771|NCT00116844|9604959|FG001|STARTED|Period 1: Treatment Period 2 (60 Days)||33
8572772|NCT00116844|9604958|FG000|COMPLETED|Period 1: Treatment Period 2 (60 Days)||24
8572773|NCT00116844|9604959|FG001|COMPLETED|Period 1: Treatment Period 2 (60 Days)||28
8572774|NCT00116844|9604958|FG000|NOT COMPLETED|Period 1: Treatment Period 2 (60 Days)||4
8572775|NCT00116844|9604959|FG001|NOT COMPLETED|Period 1: Treatment Period 2 (60 Days)||5
8572776|NCT00116857|9604967|FG000|STARTED|Overall Study||62
8572777|NCT00116857|9604968|FG001|STARTED|Overall Study||60
8572778|NCT00116857|9604967|FG000|COMPLETED|Overall Study||59
8572779|NCT00116857|9604968|FG001|COMPLETED|Overall Study||56
8635245|NCT00561015|9675727|FG004|NOT COMPLETED|Overall Study||1
8635246|NCT00561015|9675728|FG005|NOT COMPLETED|Overall Study||3
8635247|NCT00561080|9675749|FG000|STARTED|Vaccination Period (up to Month 4)||253
8635248|NCT00561080|9675750|FG001|STARTED|Vaccination Period (up to Month 4)||255
8635249|NCT00561080|9675751|FG002|STARTED|Vaccination Period (up to Month 4)||251
8635250|NCT00561080|9675749|FG000|Received at Least 1 Vaccination|Vaccination Period (up to Month 4)||253
8635251|NCT00561080|9675750|FG001|Received at Least 1 Vaccination|Vaccination Period (up to Month 4)||254
8635252|NCT00561080|9675751|FG002|Received at Least 1 Vaccination|Vaccination Period (up to Month 4)||250
8635253|NCT00561080|9675749|FG000|COMPLETED|Vaccination Period (up to Month 4)||250
8635254|NCT00561080|9675750|FG001|COMPLETED|Vaccination Period (up to Month 4)||229
8635255|NCT00561080|9675751|FG002|COMPLETED|Vaccination Period (up to Month 4)||225
8635256|NCT00561080|9675749|FG000|NOT COMPLETED|Vaccination Period (up to Month 4)||3
8635257|NCT00561080|9675750|FG001|NOT COMPLETED|Vaccination Period (up to Month 4)||26
8635258|NCT00561080|9675751|FG002|NOT COMPLETED|Vaccination Period (up to Month 4)||26
8635259|NCT00561080|9675749|FG000|STARTED|12-month Post Last Dose Follow-up||250
8635260|NCT00561080|9675750|FG001|STARTED|12-month Post Last Dose Follow-up||229
8635261|NCT00561080|9675751|FG002|STARTED|12-month Post Last Dose Follow-up||225
8635262|NCT00561080|9675749|FG000|COMPLETED|12-month Post Last Dose Follow-up||243
8635263|NCT00561080|9675750|FG001|COMPLETED|12-month Post Last Dose Follow-up||220
8635264|NCT00561080|9675751|FG002|COMPLETED|12-month Post Last Dose Follow-up||215
8635265|NCT00561080|9675749|FG000|NOT COMPLETED|12-month Post Last Dose Follow-up||7
8635266|NCT00561080|9675750|FG001|NOT COMPLETED|12-month Post Last Dose Follow-up||9
8635267|NCT00561080|9675751|FG002|NOT COMPLETED|12-month Post Last Dose Follow-up||10
8635268|NCT00561080|9675749|FG000|STARTED|24-month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
8635269|NCT00561080|9675750|FG001|STARTED|24-month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
8635270|NCT00561080|9675751|FG002|STARTED|24-month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
8635271|NCT00561080|9675749|FG000|COMPLETED|24-month Post Last Dose Follow-up||0
8635272|NCT00561080|9675750|FG001|COMPLETED|24-month Post Last Dose Follow-up||0
8635273|NCT00561080|9675751|FG002|COMPLETED|24-month Post Last Dose Follow-up||0
8635274|NCT00561080|9675749|FG000|NOT COMPLETED|24-month Post Last Dose Follow-up||0
8635275|NCT00561080|9675750|FG001|NOT COMPLETED|24-month Post Last Dose Follow-up||0
8635276|NCT00561080|9675751|FG002|NOT COMPLETED|24-month Post Last Dose Follow-up||0
8635277|NCT00561080|9675749|FG000|STARTED|36 Month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
8635278|NCT00561080|9675750|FG001|STARTED|36 Month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
8635279|NCT00561080|9675751|FG002|STARTED|36 Month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
8635280|NCT00561080|9675749|FG000|COMPLETED|36 Month Post Last Dose Follow-up||0
8635281|NCT00561080|9675750|FG001|COMPLETED|36 Month Post Last Dose Follow-up||0
8635282|NCT00561080|9675751|FG002|COMPLETED|36 Month Post Last Dose Follow-up||0
8635283|NCT00561080|9675749|FG000|NOT COMPLETED|36 Month Post Last Dose Follow-up||0
8635284|NCT00561080|9675750|FG001|NOT COMPLETED|36 Month Post Last Dose Follow-up||0
8635285|NCT00561080|9675751|FG002|NOT COMPLETED|36 Month Post Last Dose Follow-up||0
8635286|NCT00561145|9675763|FG000|STARTED|Overall Study||15
8635287|NCT00561145|9675764|FG001|STARTED|Overall Study||17
8635288|NCT00561145|9675763|FG000|COMPLETED|Overall Study||15
8635289|NCT00561145|9675764|FG001|COMPLETED|Overall Study||17
8635290|NCT00561145|9675763|FG000|NOT COMPLETED|Overall Study||0
8635291|NCT00561145|9675764|FG001|NOT COMPLETED|Overall Study||0
8635292|NCT00561340|9675772|FG000|STARTED|Overall Study||13
8635293|NCT00561340|9675773|FG001|STARTED|Overall Study||16
8635294|NCT00561340|9675772|FG000|COMPLETED|Overall Study||7
8635295|NCT00561340|9675773|FG001|COMPLETED|Overall Study||16
8894402|NCT02028676|9952206|FG001|COMPLETED|Subsequent Cotrimoxazole Randomization||0
8894403|NCT02028676|9952207|FG002|COMPLETED|Subsequent Cotrimoxazole Randomization||0
8894404|NCT02028676|9952208|FG003|COMPLETED|Subsequent Cotrimoxazole Randomization||0
8894405|NCT02028676|9952209|FG004|COMPLETED|Subsequent Cotrimoxazole Randomization||0
8894406|NCT02028676|9952210|FG005|COMPLETED|Subsequent Cotrimoxazole Randomization||0
8894407|NCT02028676|9952211|FG006|COMPLETED|Subsequent Cotrimoxazole Randomization||0
8894408|NCT02028676|9952212|FG007|COMPLETED|Subsequent Cotrimoxazole Randomization||376
8894409|NCT02028676|9952213|FG008|COMPLETED|Subsequent Cotrimoxazole Randomization||382
8894410|NCT02028676|9952205|FG000|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
8894411|NCT02028676|9952206|FG001|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
8894412|NCT02028676|9952207|FG002|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
8894413|NCT02028676|9952208|FG003|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
8894414|NCT02028676|9952209|FG004|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
8894415|NCT02028676|9952210|FG005|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
8894416|NCT02028676|9952211|FG006|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
8894417|NCT02028676|9952212|FG007|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
8894418|NCT02028676|9952213|FG008|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
8894419|NCT02028715|9952239|FG000|STARTED|Overall Study||34
8894420|NCT02028715|9952240|FG001|STARTED|Overall Study||34
8894421|NCT02028715|9952239|FG000|COMPLETED|Overall Study||29
9007548|NCT02958982|10070542|FG002|COMPLETED|Cohort 4: 200 mg in SAD Study||0
9007549|NCT02958982|10070543|FG003|COMPLETED|Cohort 4: 200 mg in SAD Study||0
9007550|NCT02958982|10070544|FG004|COMPLETED|Cohort 4: 200 mg in SAD Study||6
9007551|NCT02958982|10070545|FG005|COMPLETED|Cohort 4: 200 mg in SAD Study||0
8894422|NCT02028715|9952240|FG001|COMPLETED|Overall Study||30
8894423|NCT02028715|9952239|FG000|NOT COMPLETED|Overall Study||5
8894424|NCT02028715|9952240|FG001|NOT COMPLETED|Overall Study||4
8894425|NCT02028754|9952248|FG000|STARTED|Overall Study||90
8894426|NCT02028754|9952249|FG001|STARTED|Overall Study||90
8894427|NCT02028754|9952248|FG000|COMPLETED|Overall Study||83
8894428|NCT02028754|9952249|FG001|COMPLETED|Overall Study||82
8894429|NCT02028754|9952248|FG000|NOT COMPLETED|Overall Study||7
8894430|NCT02028754|9952249|FG001|NOT COMPLETED|Overall Study||8
8894431|NCT02028767|9952255|FG000|STARTED|Treatment Period 1||16
8894432|NCT02028767|9952256|FG001|STARTED|Treatment Period 1||16
8894433|NCT02028767|9952255|FG000|COMPLETED|Treatment Period 1||16
8894434|NCT02028767|9952256|FG001|COMPLETED|Treatment Period 1||16
8894435|NCT02028767|9952255|FG000|NOT COMPLETED|Treatment Period 1||0
8894436|NCT02028767|9952256|FG001|NOT COMPLETED|Treatment Period 1||0
8894437|NCT02028767|9952255|FG000|STARTED|Treatment Period 2||16
8894438|NCT02028767|9952256|FG001|STARTED|Treatment Period 2||16
8894439|NCT02028767|9952255|FG000|COMPLETED|Treatment Period 2||14
8894440|NCT02028767|9952256|FG001|COMPLETED|Treatment Period 2||16
8894441|NCT02028767|9952255|FG000|NOT COMPLETED|Treatment Period 2||2
8894442|NCT02028767|9952256|FG001|NOT COMPLETED|Treatment Period 2||0
8894443|NCT02028780|9952274|FG000|STARTED|Observation Phase||6
8894444|NCT02028780|9952275|FG001|STARTED|Observation Phase||2
8894445|NCT02028780|9952276|FG002|STARTED|Observation Phase||6
8894446|NCT02028780|9952277|FG003|STARTED|Observation Phase||6
8894447|NCT02028780|9952278|FG004|STARTED|Observation Phase||6
8894448|NCT02028780|9952279|FG005|STARTED|Observation Phase||6
8894449|NCT02028780|9952280|FG006|STARTED|Observation Phase||9
8894450|NCT02028780|9952281|FG007|STARTED|Observation Phase||3
8894451|NCT02028780|9952282|FG008|STARTED|Observation Phase||9
8894452|NCT02028780|9952283|FG009|STARTED|Observation Phase||9
8894453|NCT02028780|9952284|FG010|STARTED|Observation Phase||9
8894454|NCT02028780|9952285|FG011|STARTED|Observation Phase||9
8894455|NCT02028780|9952274|FG000|COMPLETED|Observation Phase||6
8894456|NCT02028780|9952275|FG001|COMPLETED|Observation Phase||2
8894457|NCT02028780|9952276|FG002|COMPLETED|Observation Phase||6
8894458|NCT02028780|9952277|FG003|COMPLETED|Observation Phase||6
8894459|NCT02028780|9952278|FG004|COMPLETED|Observation Phase||6
8894460|NCT02028780|9952279|FG005|COMPLETED|Observation Phase||6
8894461|NCT02028780|9952280|FG006|COMPLETED|Observation Phase||9
8894462|NCT02028780|9952281|FG007|COMPLETED|Observation Phase||3
8894463|NCT02028780|9952282|FG008|COMPLETED|Observation Phase||9
8894464|NCT02028780|9952283|FG009|COMPLETED|Observation Phase||9
8894465|NCT02028780|9952284|FG010|COMPLETED|Observation Phase||9
8894466|NCT02028780|9952285|FG011|COMPLETED|Observation Phase||9
8894467|NCT02028780|9952274|FG000|NOT COMPLETED|Observation Phase||0
8894468|NCT02028780|9952275|FG001|NOT COMPLETED|Observation Phase||0
8894469|NCT02028780|9952276|FG002|NOT COMPLETED|Observation Phase||0
8894470|NCT02028780|9952277|FG003|NOT COMPLETED|Observation Phase||0
8894471|NCT02028780|9952278|FG004|NOT COMPLETED|Observation Phase||0
8894472|NCT02028780|9952279|FG005|NOT COMPLETED|Observation Phase||0
8894473|NCT02028780|9952280|FG006|NOT COMPLETED|Observation Phase||0
8894474|NCT02028780|9952281|FG007|NOT COMPLETED|Observation Phase||0
8894475|NCT02028780|9952282|FG008|NOT COMPLETED|Observation Phase||0
8894476|NCT02028780|9952283|FG009|NOT COMPLETED|Observation Phase||0
8894477|NCT02028780|9952284|FG010|NOT COMPLETED|Observation Phase||0
8894478|NCT02028780|9952285|FG011|NOT COMPLETED|Observation Phase||0
8894479|NCT02028780|9952274|FG000|STARTED|Follow up Phase||6
8894480|NCT02028780|9952275|FG001|STARTED|Follow up Phase||2
8894481|NCT02028780|9952276|FG002|STARTED|Follow up Phase||6
8894482|NCT02028780|9952277|FG003|STARTED|Follow up Phase||6
8894483|NCT02028780|9952278|FG004|STARTED|Follow up Phase||6
8894484|NCT02028780|9952279|FG005|STARTED|Follow up Phase||6
8894485|NCT02028780|9952280|FG006|STARTED|Follow up Phase||9
8894486|NCT02028780|9952281|FG007|STARTED|Follow up Phase||3
8894487|NCT02028780|9952282|FG008|STARTED|Follow up Phase||9
8894488|NCT02028780|9952283|FG009|STARTED|Follow up Phase||9
8894489|NCT02028780|9952284|FG010|STARTED|Follow up Phase||9
8894490|NCT02028780|9952285|FG011|STARTED|Follow up Phase||9
8894491|NCT02028780|9952274|FG000|COMPLETED|Follow up Phase||6
8894492|NCT02028780|9952275|FG001|COMPLETED|Follow up Phase||2
8894493|NCT02028780|9952276|FG002|COMPLETED|Follow up Phase||6
8894494|NCT02028780|9952277|FG003|COMPLETED|Follow up Phase||6
8894495|NCT02028780|9952278|FG004|COMPLETED|Follow up Phase||6
8894496|NCT02028780|9952279|FG005|COMPLETED|Follow up Phase||6
8894497|NCT02028780|9952280|FG006|COMPLETED|Follow up Phase||9
8894498|NCT02028780|9952281|FG007|COMPLETED|Follow up Phase||3
8894499|NCT02028780|9952282|FG008|COMPLETED|Follow up Phase||9
8894500|NCT02028780|9952283|FG009|COMPLETED|Follow up Phase||9
8894501|NCT02028780|9952284|FG010|COMPLETED|Follow up Phase||9
8894502|NCT02028780|9952285|FG011|COMPLETED|Follow up Phase||9
8894503|NCT02028780|9952274|FG000|NOT COMPLETED|Follow up Phase||0
8894504|NCT02028780|9952275|FG001|NOT COMPLETED|Follow up Phase||0
8894505|NCT02028780|9952276|FG002|NOT COMPLETED|Follow up Phase||0
8894506|NCT02028780|9952277|FG003|NOT COMPLETED|Follow up Phase||0
8894507|NCT02028780|9952278|FG004|NOT COMPLETED|Follow up Phase||0
8894508|NCT02028780|9952279|FG005|NOT COMPLETED|Follow up Phase||0
8894509|NCT02028780|9952280|FG006|NOT COMPLETED|Follow up Phase||0
8894510|NCT02028780|9952281|FG007|NOT COMPLETED|Follow up Phase||0
8894511|NCT02028780|9952282|FG008|NOT COMPLETED|Follow up Phase||0
8894512|NCT02028780|9952283|FG009|NOT COMPLETED|Follow up Phase||0
8894513|NCT02028780|9952284|FG010|NOT COMPLETED|Follow up Phase||0
8894514|NCT02028780|9952285|FG011|NOT COMPLETED|Follow up Phase||0
8894515|NCT02028871|9952331|FG000|STARTED|Overall Study||14
8894516|NCT02028871|9952332|FG001|STARTED|Overall Study||12
8894517|NCT02028871|9952331|FG000|COMPLETED|Overall Study||10
8894518|NCT02028871|9952332|FG001|COMPLETED|Overall Study||9
8894519|NCT02028871|9952331|FG000|NOT COMPLETED|Overall Study||4
8894520|NCT02028871|9952332|FG001|NOT COMPLETED|Overall Study||3
8894521|NCT02029040|9952343|FG000|STARTED|Overall Study||27
8894522|NCT02029040|9952344|FG001|STARTED|Overall Study||25
8894523|NCT02029040|9952343|FG000|COMPLETED|Overall Study||27
8894524|NCT02029040|9952344|FG001|COMPLETED|Overall Study||25
8894525|NCT02029040|9952343|FG000|NOT COMPLETED|Overall Study||0
8894526|NCT02029040|9952344|FG001|NOT COMPLETED|Overall Study||0
9007552|NCT02958982|10070546|FG006|COMPLETED|Cohort 4: 200 mg in SAD Study||0
9007553|NCT02958982|10070547|FG007|COMPLETED|Cohort 4: 200 mg in SAD Study||0
9007554|NCT02958982|10070548|FG008|COMPLETED|Cohort 4: 200 mg in SAD Study||0
9007555|NCT02958982|10070549|FG009|COMPLETED|Cohort 4: 200 mg in SAD Study||0
9007556|NCT02958982|10070550|FG010|COMPLETED|Cohort 4: 200 mg in SAD Study||0
9007557|NCT02958982|10070540|FG000|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
9007558|NCT02958982|10070541|FG001|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
9007559|NCT02958982|10070542|FG002|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
9007560|NCT02958982|10070543|FG003|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
9007561|NCT02958982|10070544|FG004|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
9007562|NCT02958982|10070545|FG005|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
9007563|NCT02958982|10070546|FG006|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
9007564|NCT02958982|10070547|FG007|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
9007565|NCT02958982|10070548|FG008|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
9007566|NCT02958982|10070549|FG009|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
9007567|NCT02958982|10070550|FG010|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
9007568|NCT02958982|10070540|FG000|STARTED|Cohort 5: 400 mg in SAD Study||2
9007569|NCT02958982|10070541|FG001|STARTED|Cohort 5: 400 mg in SAD Study||0
9007570|NCT02958982|10070542|FG002|STARTED|Cohort 5: 400 mg in SAD Study||0
9007571|NCT02958982|10070543|FG003|STARTED|Cohort 5: 400 mg in SAD Study||0
9007572|NCT02958982|10070544|FG004|STARTED|Cohort 5: 400 mg in SAD Study||0
9007573|NCT02958982|10070545|FG005|STARTED|Cohort 5: 400 mg in SAD Study||6
9007574|NCT02958982|10070546|FG006|STARTED|Cohort 5: 400 mg in SAD Study||0
9007575|NCT02958982|10070547|FG007|STARTED|Cohort 5: 400 mg in SAD Study||0
9007576|NCT02958982|10070548|FG008|STARTED|Cohort 5: 400 mg in SAD Study||0
9007577|NCT02958982|10070549|FG009|STARTED|Cohort 5: 400 mg in SAD Study||0
9007578|NCT02958982|10070550|FG010|STARTED|Cohort 5: 400 mg in SAD Study||0
9007579|NCT02958982|10070540|FG000|COMPLETED|Cohort 5: 400 mg in SAD Study||2
9007580|NCT02958982|10070541|FG001|COMPLETED|Cohort 5: 400 mg in SAD Study||0
9007581|NCT02958982|10070542|FG002|COMPLETED|Cohort 5: 400 mg in SAD Study||0
9007582|NCT02958982|10070543|FG003|COMPLETED|Cohort 5: 400 mg in SAD Study||0
9007583|NCT02958982|10070544|FG004|COMPLETED|Cohort 5: 400 mg in SAD Study||0
9007584|NCT02958982|10070545|FG005|COMPLETED|Cohort 5: 400 mg in SAD Study||6
9007585|NCT02958982|10070546|FG006|COMPLETED|Cohort 5: 400 mg in SAD Study||0
9007586|NCT02958982|10070547|FG007|COMPLETED|Cohort 5: 400 mg in SAD Study||0
9007587|NCT02958982|10070548|FG008|COMPLETED|Cohort 5: 400 mg in SAD Study||0
9007588|NCT02958982|10070549|FG009|COMPLETED|Cohort 5: 400 mg in SAD Study||0
9007589|NCT02958982|10070550|FG010|COMPLETED|Cohort 5: 400 mg in SAD Study||0
9007590|NCT02958982|10070540|FG000|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
9007591|NCT02958982|10070541|FG001|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
9007592|NCT02958982|10070542|FG002|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
9007593|NCT02958982|10070543|FG003|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
9007594|NCT02958982|10070544|FG004|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
9007595|NCT02958982|10070545|FG005|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
9007596|NCT02958982|10070546|FG006|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
9007597|NCT02958982|10070547|FG007|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
9007598|NCT02958982|10070548|FG008|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
9007599|NCT02958982|10070549|FG009|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
9007600|NCT02958982|10070550|FG010|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
9007601|NCT02958982|10070540|FG000|STARTED|Cohort 1 : 25 mg in MAD Study||0
9007602|NCT02958982|10070541|FG001|STARTED|Cohort 1 : 25 mg in MAD Study||0
9007603|NCT02958982|10070542|FG002|STARTED|Cohort 1 : 25 mg in MAD Study||0
9007604|NCT02958982|10070543|FG003|STARTED|Cohort 1 : 25 mg in MAD Study||0
9007605|NCT02958982|10070544|FG004|STARTED|Cohort 1 : 25 mg in MAD Study||0
9007606|NCT02958982|10070545|FG005|STARTED|Cohort 1 : 25 mg in MAD Study||0
9007607|NCT02958982|10070546|FG006|STARTED|Cohort 1 : 25 mg in MAD Study||2
9007608|NCT02958982|10070547|FG007|STARTED|Cohort 1 : 25 mg in MAD Study||6
9007609|NCT02958982|10070548|FG008|STARTED|Cohort 1 : 25 mg in MAD Study||0
9007610|NCT02958982|10070549|FG009|STARTED|Cohort 1 : 25 mg in MAD Study||0
9007611|NCT02958982|10070550|FG010|STARTED|Cohort 1 : 25 mg in MAD Study||0
9007612|NCT02958982|10070540|FG000|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
9007613|NCT02958982|10070541|FG001|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
9007614|NCT02958982|10070542|FG002|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
9007615|NCT02958982|10070543|FG003|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
8894527|NCT02029196|9952352|FG000|STARTED|Overall Study||306
8894528|NCT02029196|9952353|FG001|STARTED|Overall Study||102
8894529|NCT02029196|9952352|FG000|COMPLETED|Overall Study||286
8894530|NCT02029196|9952353|FG001|COMPLETED|Overall Study||101
8894531|NCT02029196|9952352|FG000|NOT COMPLETED|Overall Study||20
8894532|NCT02029196|9952353|FG001|NOT COMPLETED|Overall Study||1
8894533|NCT02029235|9952361|FG000|STARTED|Overall Study||34
8894534|NCT02029235|9952362|FG001|STARTED|Overall Study||31
8894535|NCT02029235|9952361|FG000|COMPLETED|Overall Study||30
8894536|NCT02029235|9952362|FG001|COMPLETED|Overall Study||30
8894537|NCT02029235|9952361|FG000|NOT COMPLETED|Overall Study||4
8894538|NCT02029235|9952362|FG001|NOT COMPLETED|Overall Study||1
8894539|NCT02029274|9952372|FG000|STARTED|Overall Study||5
8894540|NCT02029274|9952373|FG001|STARTED|Overall Study||4
8894541|NCT02029274|9952374|FG002|STARTED|Overall Study||4
8894542|NCT02029274|9952375|FG003|STARTED|Overall Study||4
8894543|NCT02029274|9952372|FG000|Fixed Dose Period 2|Overall Study||5
8894544|NCT02029274|9952373|FG001|Fixed Dose Period 2|Overall Study||4
8894545|NCT02029274|9952374|FG002|Fixed Dose Period 2|Overall Study||4
8726173|NCT01034176|9773327|FG000|NOT COMPLETED|Overall Study||2
8726174|NCT01034176|9773328|FG001|NOT COMPLETED|Overall Study||2
8894546|NCT02029274|9952375|FG003|Fixed Dose Period 2|Overall Study||4
8894547|NCT02029274|9952372|FG000|COMPLETED|Overall Study||4
8894548|NCT02029274|9952373|FG001|COMPLETED|Overall Study||4
8894549|NCT02029274|9952374|FG002|COMPLETED|Overall Study||2
8894550|NCT02029274|9952375|FG003|COMPLETED|Overall Study||2
8894551|NCT02029274|9952372|FG000|NOT COMPLETED|Overall Study||1
8894552|NCT02029274|9952373|FG001|NOT COMPLETED|Overall Study||0
8894553|NCT02029274|9952374|FG002|NOT COMPLETED|Overall Study||2
8894554|NCT02029274|9952375|FG003|NOT COMPLETED|Overall Study||2
8894555|NCT02029417|9952389|FG000|STARTED|Overall Study||2
8894556|NCT02029417|9952389|FG000|COMPLETED|Overall Study||0
8894557|NCT02029417|9952389|FG000|NOT COMPLETED|Overall Study||2
8894558|NCT02029495|9952396|FG000|STARTED|Overall Study||159
8894559|NCT02029495|9952397|FG001|STARTED|Overall Study||158
8894560|NCT02029495|9952398|FG002|STARTED|Overall Study||161
8894561|NCT02029495|9952396|FG000|COMPLETED|Overall Study||158
8894562|NCT02029495|9952397|FG001|COMPLETED|Overall Study||158
8894563|NCT02029495|9952398|FG002|COMPLETED|Overall Study||159
8894564|NCT02029495|9952396|FG000|NOT COMPLETED|Overall Study||1
8894565|NCT02029495|9952397|FG001|NOT COMPLETED|Overall Study||0
8894566|NCT02029495|9952398|FG002|NOT COMPLETED|Overall Study||2
8894567|NCT02029521|9952408|FG000|STARTED|Overall Study||24
8894568|NCT02029521|9952409|FG001|STARTED|Overall Study||23
8894569|NCT02029521|9952408|FG000|COMPLETED|Overall Study||22
8726175|NCT01034358|9773334|FG000|STARTED|Overall Study||15
8726176|NCT01034358|9773334|FG000|COMPLETED|Overall Study|One patient was found after enrollment to have already received one prior dose of the HPV vaccine.|13
8726177|NCT01034358|9773334|FG000|NOT COMPLETED|Overall Study||2
8726178|NCT01034397|9773340|FG000|STARTED|Overall Study||35
8726179|NCT01034397|9773341|FG001|STARTED|Overall Study||19
8726180|NCT01034397|9773340|FG000|COMPLETED|Overall Study||28
8726181|NCT01034397|9773341|FG001|COMPLETED|Overall Study||17
8894570|NCT02029521|9952409|FG001|COMPLETED|Overall Study||22
8894571|NCT02029521|9952408|FG000|NOT COMPLETED|Overall Study||2
8894572|NCT02029521|9952409|FG001|NOT COMPLETED|Overall Study||1
8894573|NCT02029638|9952421|FG000|STARTED|Overall Study||2
8894574|NCT02029638|9952422|FG001|STARTED|Overall Study||1
8894575|NCT02029638|9952423|FG002|STARTED|Overall Study||1
8894576|NCT02029638|9952421|FG000|COMPLETED|Overall Study||0
8894577|NCT02029638|9952422|FG001|COMPLETED|Overall Study||1
8894578|NCT02029638|9952423|FG002|COMPLETED|Overall Study||0
8894579|NCT02029638|9952421|FG000|NOT COMPLETED|Overall Study||2
8894580|NCT02029638|9952422|FG001|NOT COMPLETED|Overall Study||0
8894581|NCT02029638|9952423|FG002|NOT COMPLETED|Overall Study||1
8894582|NCT02029703|9952433|FG000|STARTED|Overall Study||20
8894583|NCT02029703|9952434|FG001|STARTED|Overall Study||22
8894584|NCT02029703|9952433|FG000|COMPLETED|Overall Study||20
8894585|NCT02029703|9952434|FG001|COMPLETED|Overall Study||22
8894586|NCT02029703|9952433|FG000|NOT COMPLETED|Overall Study||0
8894587|NCT02029703|9952434|FG001|NOT COMPLETED|Overall Study||0
8894588|NCT02029755|9952443|FG000|STARTED|Overall Study||36
8894589|NCT02029755|9952444|FG001|STARTED|Overall Study||36
8894590|NCT02029755|9952445|FG002|STARTED|Overall Study||36
8894591|NCT02029755|9952443|FG000|COMPLETED|Overall Study||36
8894592|NCT02029755|9952444|FG001|COMPLETED|Overall Study||36
8894593|NCT02029755|9952445|FG002|COMPLETED|Overall Study||36
8894594|NCT02029755|9952443|FG000|NOT COMPLETED|Overall Study||0
8894595|NCT02029755|9952444|FG001|NOT COMPLETED|Overall Study||0
8894596|NCT02029755|9952445|FG002|NOT COMPLETED|Overall Study||0
8894597|NCT02029872|9952455|FG000|STARTED|Overall Study||9
8894598|NCT02029872|9952456|FG001|STARTED|Overall Study||9
8894599|NCT02029872|9952455|FG000|COMPLETED|Overall Study||7
8894600|NCT02029872|9952456|FG001|COMPLETED|Overall Study||6
8894601|NCT02029872|9952455|FG000|NOT COMPLETED|Overall Study||2
8894602|NCT02029872|9952456|FG001|NOT COMPLETED|Overall Study||3
8894603|NCT02029911|9952462|FG000|STARTED|Overall Study|Treatment Attempted|60
8894604|NCT02029911|9952462|FG000|Treated|Overall Study|Treatment Completed|60
8894605|NCT02029911|9952462|FG000|COMPLETED|Overall Study|Completed 12 Month Follow-up|60
8894606|NCT02029911|9952462|FG000|NOT COMPLETED|Overall Study||0
8894607|NCT02029976|9952468|FG000|STARTED|YR-1 Post Intervention vs Baseline||132
8894608|NCT02029976|9952469|FG001|STARTED|YR-1 Post Intervention vs Baseline||132
8894609|NCT02029976|9952468|FG000|COMPLETED|YR-1 Post Intervention vs Baseline||120
8894610|NCT02029976|9952469|FG001|COMPLETED|YR-1 Post Intervention vs Baseline||124
8894611|NCT02029976|9952468|FG000|NOT COMPLETED|YR-1 Post Intervention vs Baseline||12
8894612|NCT02029976|9952469|FG001|NOT COMPLETED|YR-1 Post Intervention vs Baseline||8
8894613|NCT02029976|9952468|FG000|STARTED|YR-2 Follow Up vs Baseline|Attrition at end of year 2 was calculated based on baseline enrollment|132
8894614|NCT02029976|9952469|FG001|STARTED|YR-2 Follow Up vs Baseline|Attrition at end of year 2 was calculated based on baseline enrollment|132
8894615|NCT02029976|9952468|FG000|COMPLETED|YR-2 Follow Up vs Baseline||122
8894616|NCT02029976|9952469|FG001|COMPLETED|YR-2 Follow Up vs Baseline||124
8894617|NCT02029976|9952468|FG000|NOT COMPLETED|YR-2 Follow Up vs Baseline||10
8894618|NCT02029976|9952469|FG001|NOT COMPLETED|YR-2 Follow Up vs Baseline||8
9007616|NCT02958982|10070544|FG004|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
9007617|NCT02958982|10070545|FG005|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
9007618|NCT02958982|10070546|FG006|COMPLETED|Cohort 1 : 25 mg in MAD Study||2
9007619|NCT02958982|10070547|FG007|COMPLETED|Cohort 1 : 25 mg in MAD Study||6
9007620|NCT02958982|10070548|FG008|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
9007621|NCT02958982|10070549|FG009|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
9007622|NCT02958982|10070550|FG010|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
9007623|NCT02958982|10070540|FG000|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
9007624|NCT02958982|10070541|FG001|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
9007625|NCT02958982|10070542|FG002|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
9007626|NCT02958982|10070543|FG003|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
9007627|NCT02958982|10070544|FG004|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
9007628|NCT02958982|10070545|FG005|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
9007629|NCT02958982|10070546|FG006|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
9007630|NCT02958982|10070547|FG007|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
9007631|NCT02958982|10070548|FG008|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
9007632|NCT02958982|10070549|FG009|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
9007633|NCT02958982|10070550|FG010|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
9007634|NCT02958982|10070540|FG000|STARTED|Cohort 2: 100 mg in MAD Study||0
9007635|NCT02958982|10070541|FG001|STARTED|Cohort 2: 100 mg in MAD Study||0
9007636|NCT02958982|10070542|FG002|STARTED|Cohort 2: 100 mg in MAD Study||0
9007637|NCT02958982|10070543|FG003|STARTED|Cohort 2: 100 mg in MAD Study||0
9007638|NCT02958982|10070544|FG004|STARTED|Cohort 2: 100 mg in MAD Study||0
9007639|NCT02958982|10070545|FG005|STARTED|Cohort 2: 100 mg in MAD Study||0
9007640|NCT02958982|10070546|FG006|STARTED|Cohort 2: 100 mg in MAD Study||2
9007641|NCT02958982|10070547|FG007|STARTED|Cohort 2: 100 mg in MAD Study||0
9007642|NCT02958982|10070548|FG008|STARTED|Cohort 2: 100 mg in MAD Study||6
9007643|NCT02958982|10070549|FG009|STARTED|Cohort 2: 100 mg in MAD Study||0
9007644|NCT02958982|10070550|FG010|STARTED|Cohort 2: 100 mg in MAD Study||0
9007645|NCT02958982|10070540|FG000|COMPLETED|Cohort 2: 100 mg in MAD Study||0
9007646|NCT02958982|10070541|FG001|COMPLETED|Cohort 2: 100 mg in MAD Study||0
9007647|NCT02958982|10070542|FG002|COMPLETED|Cohort 2: 100 mg in MAD Study||0
9007648|NCT02958982|10070543|FG003|COMPLETED|Cohort 2: 100 mg in MAD Study||0
9007649|NCT02958982|10070544|FG004|COMPLETED|Cohort 2: 100 mg in MAD Study||0
9007650|NCT02958982|10070545|FG005|COMPLETED|Cohort 2: 100 mg in MAD Study||0
9007651|NCT02958982|10070546|FG006|COMPLETED|Cohort 2: 100 mg in MAD Study||2
8894619|NCT02029989|9952477|FG000|STARTED|Overall Study|A subject was given the same ID# as withdrawn subject (ID # counted twice) causing N=61 discrepancy.|61
8894620|NCT02029989|9952478|FG001|STARTED|Overall Study||60
8894621|NCT02029989|9952477|FG000|COMPLETED|Overall Study||45
8894622|NCT02029989|9952478|FG001|COMPLETED|Overall Study||49
8894623|NCT02029989|9952477|FG000|NOT COMPLETED|Overall Study||16
8894624|NCT02029989|9952478|FG001|NOT COMPLETED|Overall Study||11
8894625|NCT02030002|9952484|FG000|STARTED|Enrollment||49
8894626|NCT02030002|9952484|FG000|COMPLETED|Enrollment||44
8894627|NCT02030002|9952484|FG000|NOT COMPLETED|Enrollment||5
8894628|NCT02030002|9952484|FG000|STARTED|APC Flash-Free Adhesive Coated Appliance||44
8894629|NCT02030002|9952484|FG000|COMPLETED|APC Flash-Free Adhesive Coated Appliance||44
8894630|NCT02030002|9952484|FG000|NOT COMPLETED|APC Flash-Free Adhesive Coated Appliance||0
8894631|NCT02030002|9952484|FG000|STARTED|APC II Adhesive Coated Appliance System||44
8894632|NCT02030002|9952484|FG000|COMPLETED|APC II Adhesive Coated Appliance System||44
8894633|NCT02030002|9952484|FG000|NOT COMPLETED|APC II Adhesive Coated Appliance System||0
8894634|NCT02030002|9952484|FG000|STARTED|Follow-up||44
8894635|NCT02030002|9952484|FG000|COMPLETED|Follow-up||42
8894636|NCT02030002|9952484|FG000|NOT COMPLETED|Follow-up||2
8894637|NCT02030041|9952493|FG000|STARTED|Overall Study||11
8894638|NCT02030041|9952494|FG001|STARTED|Overall Study||11
8894639|NCT02030041|9952495|FG002|STARTED|Overall Study||11
8894640|NCT02030041|9952493|FG000|COMPLETED|Overall Study||9
8894641|NCT02030041|9952494|FG001|COMPLETED|Overall Study||9
8894642|NCT02030041|9952495|FG002|COMPLETED|Overall Study||10
8894643|NCT02030041|9952493|FG000|NOT COMPLETED|Overall Study||2
8894644|NCT02030041|9952494|FG001|NOT COMPLETED|Overall Study||2
8894645|NCT02030041|9952495|FG002|NOT COMPLETED|Overall Study||1
8894646|NCT02030080|9952507|FG000|STARTED|Overall Study|25 teams|100
8894647|NCT02030080|9952508|FG001|STARTED|Overall Study|16 teams|64
8894648|NCT02030080|9952509|FG002|STARTED|Overall Study|20 teams|80
8894649|NCT02030080|9952510|FG003|STARTED|Overall Study|11 teams|44
8894650|NCT02030080|9952507|FG000|COMPLETED|Overall Study||100
8894651|NCT02030080|9952508|FG001|COMPLETED|Overall Study||64
8894652|NCT02030080|9952509|FG002|COMPLETED|Overall Study||80
8894653|NCT02030080|9952510|FG003|COMPLETED|Overall Study||42
8894654|NCT02030080|9952507|FG000|NOT COMPLETED|Overall Study||0
8894655|NCT02030080|9952508|FG001|NOT COMPLETED|Overall Study||0
8894656|NCT02030080|9952509|FG002|NOT COMPLETED|Overall Study||0
8894657|NCT02030080|9952510|FG003|NOT COMPLETED|Overall Study||2
8894658|NCT02030119|9952524|FG000|STARTED|Overall Study||70
8894659|NCT02030119|9952525|FG001|STARTED|Overall Study||70
8894660|NCT02030119|9952526|FG002|STARTED|Overall Study||71
8894661|NCT02030119|9952527|FG003|STARTED|Overall Study||70
8894662|NCT02030119|9952524|FG000|COMPLETED|Overall Study||67
8894663|NCT02030119|9952525|FG001|COMPLETED|Overall Study||68
8894664|NCT02030119|9952526|FG002|COMPLETED|Overall Study||65
8894665|NCT02030119|9952527|FG003|COMPLETED|Overall Study||67
8894666|NCT02030119|9952524|FG000|NOT COMPLETED|Overall Study||3
8894667|NCT02030119|9952525|FG001|NOT COMPLETED|Overall Study||2
8894668|NCT02030119|9952526|FG002|NOT COMPLETED|Overall Study||6
8894669|NCT02030119|9952527|FG003|NOT COMPLETED|Overall Study||3
8894670|NCT02030288|9952539|FG000|STARTED|Overall Study||89
8894671|NCT02030288|9952540|FG001|STARTED|Overall Study||89
8894672|NCT02030288|9952539|FG000|COMPLETED|Overall Study||89
8894673|NCT02030288|9952540|FG001|COMPLETED|Overall Study||89
8894674|NCT02030288|9952539|FG000|NOT COMPLETED|Overall Study||0
8894675|NCT02030288|9952540|FG001|NOT COMPLETED|Overall Study||0
8894676|NCT02030405|9952550|FG000|STARTED|Overall Study||4
8894677|NCT02030405|9952550|FG000|COMPLETED|Overall Study||2
8894678|NCT02030405|9952550|FG000|NOT COMPLETED|Overall Study||2
8894679|NCT02030535|9952555|FG000|STARTED|Treatment Period 1 (1 Day)||53
8894680|NCT02030535|9952555|FG000|COMPLETED|Treatment Period 1 (1 Day)||53
8894681|NCT02030535|9952555|FG000|NOT COMPLETED|Treatment Period 1 (1 Day)||0
8894682|NCT02030535|9952555|FG000|STARTED|Washout Period 1 (21 Days)||53
8894683|NCT02030535|9952555|FG000|COMPLETED|Washout Period 1 (21 Days)||52
8894684|NCT02030535|9952555|FG000|NOT COMPLETED|Washout Period 1 (21 Days)||1
8894685|NCT02030535|9952555|FG000|STARTED|Treatment Period 2 (1 Day)||52
8894686|NCT02030535|9952555|FG000|COMPLETED|Treatment Period 2 (1 Day)||52
8894687|NCT02030535|9952555|FG000|NOT COMPLETED|Treatment Period 2 (1 Day)||0
8894688|NCT02030535|9952555|FG000|STARTED|Washout Period 2 (21 Days)||52
8894689|NCT02030535|9952555|FG000|COMPLETED|Washout Period 2 (21 Days)||52
8894690|NCT02030535|9952555|FG000|NOT COMPLETED|Washout Period 2 (21 Days)||0
8894691|NCT02030535|9952555|FG000|STARTED|Treatment Period 3 (1 Day)||52
8894692|NCT02030535|9952555|FG000|COMPLETED|Treatment Period 3 (1 Day)||52
8894693|NCT02030535|9952555|FG000|NOT COMPLETED|Treatment Period 3 (1 Day)||0
8894694|NCT02030574|9952569|FG000|STARTED|Overall Study||2
8894695|NCT02030574|9952569|FG000|COMPLETED|Overall Study||2
8894696|NCT02030574|9952569|FG000|NOT COMPLETED|Overall Study||0
8894697|NCT02030600|9952575|FG000|STARTED|Treatment Period 1||361
8894698|NCT02030600|9952576|FG001|STARTED|Treatment Period 1||360
8894699|NCT02030600|9952575|FG000|Exposed|Treatment Period 1||356
8894700|NCT02030600|9952576|FG001|Exposed|Treatment Period 1||357
8894701|NCT02030600|9952575|FG000|COMPLETED|Treatment Period 1||308
8894702|NCT02030600|9952576|FG001|COMPLETED|Treatment Period 1||315
8894703|NCT02030600|9952575|FG000|NOT COMPLETED|Treatment Period 1||53
8894704|NCT02030600|9952576|FG001|NOT COMPLETED|Treatment Period 1||45
8894705|NCT02030600|9952575|FG000|STARTED|Treatment Period 2||308
8894706|NCT02030600|9952576|FG001|STARTED|Treatment Period 2||315
8894707|NCT02030600|9952575|FG000|COMPLETED|Treatment Period 2||283
8894708|NCT02030600|9952576|FG001|COMPLETED|Treatment Period 2||297
8894709|NCT02030600|9952575|FG000|NOT COMPLETED|Treatment Period 2||25
8894710|NCT02030600|9952576|FG001|NOT COMPLETED|Treatment Period 2||18
8894711|NCT02030821|9952588|FG000|STARTED|Overall Study||48
8894712|NCT02030821|9952589|FG001|STARTED|Overall Study||46
8894713|NCT02030821|9952590|FG002|STARTED|Overall Study||78
8894714|NCT02030821|9952591|FG003|STARTED|Overall Study||74
8894715|NCT02030821|9952588|FG000|COMPLETED|Overall Study||46
8894716|NCT02030821|9952589|FG001|COMPLETED|Overall Study||44
8894717|NCT02030821|9952590|FG002|COMPLETED|Overall Study||73
8894718|NCT02030821|9952591|FG003|COMPLETED|Overall Study||72
8894719|NCT02030821|9952588|FG000|NOT COMPLETED|Overall Study||2
8894720|NCT02030821|9952589|FG001|NOT COMPLETED|Overall Study||2
8894721|NCT02030821|9952590|FG002|NOT COMPLETED|Overall Study||5
8894722|NCT02030821|9952591|FG003|NOT COMPLETED|Overall Study||2
8894723|NCT02030834|9952604|FG000|STARTED|Overall Study||50
8894724|NCT02030834|9952605|FG001|STARTED|Overall Study||3
8894725|NCT02030834|9952606|FG002|STARTED|Overall Study||10
8894726|NCT02030834|9952604|FG000|COMPLETED|Overall Study||39
8894727|NCT02030834|9952605|FG001|COMPLETED|Overall Study||3
8894728|NCT02030834|9952606|FG002|COMPLETED|Overall Study||7
8894729|NCT02030834|9952604|FG000|NOT COMPLETED|Overall Study||11
8894730|NCT02030834|9952605|FG001|NOT COMPLETED|Overall Study||0
8894731|NCT02030834|9952606|FG002|NOT COMPLETED|Overall Study||3
8894732|NCT02030847|9952614|FG000|STARTED|Overall Study||42
8894733|NCT02030847|9952614|FG000|COMPLETED|Overall Study||5
8894734|NCT02030847|9952614|FG000|NOT COMPLETED|Overall Study||37
8894735|NCT02030886|9952621|FG000|STARTED|Overall Study||14
8894736|NCT02030886|9952622|FG001|STARTED|Overall Study||6
8894737|NCT02030886|9952621|FG000|COMPLETED|Overall Study||14
8894738|NCT02030886|9952622|FG001|COMPLETED|Overall Study||6
8894739|NCT02030886|9952621|FG000|NOT COMPLETED|Overall Study||0
8894740|NCT02030886|9952622|FG001|NOT COMPLETED|Overall Study||0
8894741|NCT02031146|9952632|FG000|STARTED|Overall Study||11
8894742|NCT02031146|9952633|FG001|STARTED|Overall Study||3
8894743|NCT02031146|9952634|FG002|STARTED|Overall Study||18
8894744|NCT02031146|9952635|FG003|STARTED|Overall Study||148
8894745|NCT02031146|9952636|FG004|STARTED|Overall Study||42
8894746|NCT02031146|9952637|FG005|STARTED|Overall Study||4
8894747|NCT02031146|9952638|FG006|STARTED|Overall Study||5
8894748|NCT02031146|9952632|FG000|Considered in Analysis|Overall Study||11
8894749|NCT02031146|9952633|FG001|Considered in Analysis|Overall Study||3
8894750|NCT02031146|9952634|FG002|Considered in Analysis|Overall Study||18
8894751|NCT02031146|9952635|FG003|Considered in Analysis|Overall Study||48
8894752|NCT02031146|9952636|FG004|Considered in Analysis|Overall Study||16
8894753|NCT02031146|9952637|FG005|Considered in Analysis|Overall Study||0
8894754|NCT02031146|9952638|FG006|Considered in Analysis|Overall Study||0
8894755|NCT02031146|9952632|FG000|COMPLETED|Overall Study||11
8894756|NCT02031146|9952633|FG001|COMPLETED|Overall Study||3
8894757|NCT02031146|9952634|FG002|COMPLETED|Overall Study||18
8894758|NCT02031146|9952635|FG003|COMPLETED|Overall Study||48
8894759|NCT02031146|9952636|FG004|COMPLETED|Overall Study||16
8894760|NCT02031146|9952637|FG005|COMPLETED|Overall Study||0
8894761|NCT02031146|9952638|FG006|COMPLETED|Overall Study||0
8894762|NCT02031146|9952632|FG000|NOT COMPLETED|Overall Study||0
8894763|NCT02031146|9952633|FG001|NOT COMPLETED|Overall Study||0
8894764|NCT02031146|9952634|FG002|NOT COMPLETED|Overall Study||0
8894765|NCT02031146|9952635|FG003|NOT COMPLETED|Overall Study||100
8894766|NCT02031146|9952636|FG004|NOT COMPLETED|Overall Study||26
9007652|NCT02958982|10070547|FG007|COMPLETED|Cohort 2: 100 mg in MAD Study||0
9007653|NCT02958982|10070548|FG008|COMPLETED|Cohort 2: 100 mg in MAD Study||6
9007654|NCT02958982|10070549|FG009|COMPLETED|Cohort 2: 100 mg in MAD Study||0
9007655|NCT02958982|10070550|FG010|COMPLETED|Cohort 2: 100 mg in MAD Study||0
9007656|NCT02958982|10070540|FG000|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
9007657|NCT02958982|10070541|FG001|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
9007658|NCT02958982|10070542|FG002|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
9007659|NCT02958982|10070543|FG003|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
9007660|NCT02958982|10070544|FG004|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
9007661|NCT02958982|10070545|FG005|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
9007662|NCT02958982|10070546|FG006|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
9007663|NCT02958982|10070547|FG007|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
9007664|NCT02958982|10070548|FG008|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
9007665|NCT02958982|10070549|FG009|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
9007666|NCT02958982|10070550|FG010|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
9007667|NCT02958982|10070540|FG000|STARTED|Cohort 3: 400 mg in MAD Study||0
9007668|NCT02958982|10070541|FG001|STARTED|Cohort 3: 400 mg in MAD Study||0
9007669|NCT02958982|10070542|FG002|STARTED|Cohort 3: 400 mg in MAD Study||0
9007670|NCT02958982|10070543|FG003|STARTED|Cohort 3: 400 mg in MAD Study||0
9007671|NCT02958982|10070544|FG004|STARTED|Cohort 3: 400 mg in MAD Study||0
9007672|NCT02958982|10070545|FG005|STARTED|Cohort 3: 400 mg in MAD Study||0
8894767|NCT02031146|9952637|FG005|NOT COMPLETED|Overall Study||4
8894768|NCT02031146|9952638|FG006|NOT COMPLETED|Overall Study||5
8894769|NCT02031237|9952650|FG000|STARTED|Overall Study||14
8894770|NCT02031237|9952651|FG001|STARTED|Overall Study||35
8894771|NCT02031237|9952652|FG002|STARTED|Overall Study||3
8894772|NCT02031237|9952650|FG000|COMPLETED|Overall Study||9
8894773|NCT02031237|9952651|FG001|COMPLETED|Overall Study||21
8894774|NCT02031237|9952652|FG002|COMPLETED|Overall Study||0
8894775|NCT02031237|9952650|FG000|NOT COMPLETED|Overall Study||5
8894776|NCT02031237|9952651|FG001|NOT COMPLETED|Overall Study||14
8894777|NCT02031237|9952652|FG002|NOT COMPLETED|Overall Study||3
8894778|NCT02031276|9952662|FG000|STARTED|Period 1 Double-blind IV||39
8894779|NCT02031276|9952663|FG001|STARTED|Period 1 Double-blind IV||41
8894780|NCT02031276|9952664|FG002|STARTED|Period 1 Double-blind IV||41
8894781|NCT02031276|9952662|FG000|COMPLETED|Period 1 Double-blind IV||33
8894782|NCT02031276|9952663|FG001|COMPLETED|Period 1 Double-blind IV||35
8894783|NCT02031276|9952664|FG002|COMPLETED|Period 1 Double-blind IV||40
8894784|NCT02031276|9952662|FG000|NOT COMPLETED|Period 1 Double-blind IV||6
8894785|NCT02031276|9952663|FG001|NOT COMPLETED|Period 1 Double-blind IV||6
8894786|NCT02031276|9952664|FG002|NOT COMPLETED|Period 1 Double-blind IV||1
8894787|NCT02031276|9952662|FG000|STARTED|Period 2 Open-label Risankizumab IV||33
8894788|NCT02031276|9952663|FG001|STARTED|Period 2 Open-label Risankizumab IV||35
8894789|NCT02031276|9952664|FG002|STARTED|Period 2 Open-label Risankizumab IV|1 participant did not enter Period 2 (declined open-label treatment in Period 2)|39
8894790|NCT02031276|9952662|FG000|COMPLETED|Period 2 Open-label Risankizumab IV||29
8894791|NCT02031276|9952663|FG001|COMPLETED|Period 2 Open-label Risankizumab IV||33
8894792|NCT02031276|9952664|FG002|COMPLETED|Period 2 Open-label Risankizumab IV||38
8894793|NCT02031276|9952662|FG000|NOT COMPLETED|Period 2 Open-label Risankizumab IV||4
8894794|NCT02031276|9952663|FG001|NOT COMPLETED|Period 2 Open-label Risankizumab IV||2
8894795|NCT02031276|9952664|FG002|NOT COMPLETED|Period 2 Open-label Risankizumab IV||1
8894796|NCT02031276|9952662|FG000|STARTED|Period 3 Open-label Risankizumab SC|10 participants did not enter period 3 (not in clinical remission)|19
8894797|NCT02031276|9952663|FG001|STARTED|Period 3 Open-label Risankizumab SC|11 participants did not enter period 3 (not in clinical remission)|22
8894798|NCT02031276|9952664|FG002|STARTED|Period 3 Open-label Risankizumab SC|17 participants did not enter period 3 (not in clinical remission)|21
8894799|NCT02031276|9952662|FG000|COMPLETED|Period 3 Open-label Risankizumab SC||16
8894800|NCT02031276|9952663|FG001|COMPLETED|Period 3 Open-label Risankizumab SC||19
8894801|NCT02031276|9952664|FG002|COMPLETED|Period 3 Open-label Risankizumab SC||19
8894802|NCT02031276|9952662|FG000|NOT COMPLETED|Period 3 Open-label Risankizumab SC||3
8894803|NCT02031276|9952663|FG001|NOT COMPLETED|Period 3 Open-label Risankizumab SC||3
8894804|NCT02031276|9952664|FG002|NOT COMPLETED|Period 3 Open-label Risankizumab SC||2
8894805|NCT02031302|9952678|FG000|STARTED|Overall Study||1014
8894806|NCT02031302|9952679|FG001|STARTED|Overall Study||50
8894807|NCT02031302|9952678|FG000|COMPLETED|Overall Study||850
8894808|NCT02031302|9952679|FG001|COMPLETED|Overall Study||50
8894809|NCT02031302|9952678|FG000|NOT COMPLETED|Overall Study||164
8894810|NCT02031302|9952679|FG001|NOT COMPLETED|Overall Study||0
8894811|NCT02031432|9952686|FG000|STARTED|Overall Study||76
8894812|NCT02031432|9952686|FG000|Completing the Titration Phase|Overall Study||67
8894813|NCT02031432|9952686|FG000|Completing the Treatment|Overall Study||39
8894814|NCT02031432|9952686|FG000|COMPLETED|Overall Study||38
8894815|NCT02031432|9952686|FG000|NOT COMPLETED|Overall Study||38
8894816|NCT02031458|9952693|FG000|STARTED|May 8, 2015 to January 11, 2019||138
8894817|NCT02031458|9952694|FG001|STARTED|May 8, 2015 to January 11, 2019||269
8894818|NCT02031458|9952695|FG002|STARTED|May 8, 2015 to January 11, 2019||252
8894819|NCT02031458|9952693|FG000|COMPLETED|May 8, 2015 to January 11, 2019||0
8894820|NCT02031458|9952694|FG001|COMPLETED|May 8, 2015 to January 11, 2019||0
8894821|NCT02031458|9952695|FG002|COMPLETED|May 8, 2015 to January 11, 2019||0
8894822|NCT02031458|9952693|FG000|NOT COMPLETED|May 8, 2015 to January 11, 2019||138
8894823|NCT02031458|9952694|FG001|NOT COMPLETED|May 8, 2015 to January 11, 2019||269
8894824|NCT02031458|9952695|FG002|NOT COMPLETED|May 8, 2015 to January 11, 2019||252
8894825|NCT02031458|9952693|FG000|STARTED|Baseline to May 8, 2015||139
8894826|NCT02031458|9952694|FG001|STARTED|Baseline to May 8, 2015||267
8894827|NCT02031458|9952695|FG002|STARTED|Baseline to May 8, 2015||253
8894828|NCT02031458|9952693|FG000|COMPLETED|Baseline to May 8, 2015||0
8894829|NCT02031458|9952694|FG001|COMPLETED|Baseline to May 8, 2015||0
8894830|NCT02031458|9952695|FG002|COMPLETED|Baseline to May 8, 2015||0
8894831|NCT02031458|9952693|FG000|NOT COMPLETED|Baseline to May 8, 2015||139
8894832|NCT02031458|9952694|FG001|NOT COMPLETED|Baseline to May 8, 2015||267
8894833|NCT02031458|9952695|FG002|NOT COMPLETED|Baseline to May 8, 2015||253
8894834|NCT02031471|9952705|FG000|STARTED|24 Week Treatment Period||57
8894835|NCT02031471|9952705|FG000|COMPLETED|24 Week Treatment Period||46
8894836|NCT02031471|9952705|FG000|NOT COMPLETED|24 Week Treatment Period||11
8894837|NCT02031471|9952705|FG000|STARTED|Long Term Extension (LTE) Period|Only participants who achieved at least a moderate EULAR response at Week 24 entered the LTE Period.|39
8894838|NCT02031471|9952705|FG000|COMPLETED|Long Term Extension (LTE) Period||37
8894839|NCT02031471|9952705|FG000|NOT COMPLETED|Long Term Extension (LTE) Period||2
8894840|NCT02031536|9952711|FG000|STARTED|Overall Study||2
8894841|NCT02031536|9952712|FG001|STARTED|Overall Study||0
8894842|NCT02031536|9952711|FG000|COMPLETED|Overall Study||1
8894843|NCT02031536|9952712|FG001|COMPLETED|Overall Study||0
8894844|NCT02031536|9952711|FG000|NOT COMPLETED|Overall Study||1
8894845|NCT02031536|9952712|FG001|NOT COMPLETED|Overall Study||0
8894846|NCT02031627|9952721|FG000|STARTED|Overall Study||7
8894847|NCT02031627|9952722|FG001|STARTED|Overall Study||7
8894848|NCT02031627|9952723|FG002|STARTED|Overall Study||7
8894849|NCT02031627|9952721|FG000|COMPLETED|Overall Study||7
9007673|NCT02958982|10070546|FG006|STARTED|Cohort 3: 400 mg in MAD Study||2
8894850|NCT02031627|9952722|FG001|COMPLETED|Overall Study||7
8894851|NCT02031627|9952723|FG002|COMPLETED|Overall Study||7
8894852|NCT02031627|9952721|FG000|NOT COMPLETED|Overall Study||0
8894853|NCT02031627|9952722|FG001|NOT COMPLETED|Overall Study||0
8894854|NCT02031627|9952723|FG002|NOT COMPLETED|Overall Study||0
8894855|NCT02031640|9952736|FG000|STARTED|Screening Period|Consented|1113
8894856|NCT02031640|9952737|FG001|STARTED|Screening Period||0
8894857|NCT02031640|9952738|FG002|STARTED|Screening Period||0
8894858|NCT02031640|9952739|FG003|STARTED|Screening Period||0
8894859|NCT02031640|9952740|FG004|STARTED|Screening Period||0
8894860|NCT02031640|9952741|FG005|STARTED|Screening Period||0
8894861|NCT02031640|9952736|FG000|COMPLETED|Screening Period||701
8894862|NCT02031640|9952737|FG001|COMPLETED|Screening Period||0
8894863|NCT02031640|9952738|FG002|COMPLETED|Screening Period||0
8894864|NCT02031640|9952739|FG003|COMPLETED|Screening Period||0
8894865|NCT02031640|9952740|FG004|COMPLETED|Screening Period||0
8894866|NCT02031640|9952741|FG005|COMPLETED|Screening Period||0
8894867|NCT02031640|9952736|FG000|NOT COMPLETED|Screening Period||412
8894868|NCT02031640|9952737|FG001|NOT COMPLETED|Screening Period||0
8894869|NCT02031640|9952738|FG002|NOT COMPLETED|Screening Period||0
8894870|NCT02031640|9952739|FG003|NOT COMPLETED|Screening Period||0
8894871|NCT02031640|9952740|FG004|NOT COMPLETED|Screening Period||0
8894872|NCT02031640|9952741|FG005|NOT COMPLETED|Screening Period||0
8894873|NCT02031640|9952736|FG000|STARTED|Run-In Period||701
8894874|NCT02031640|9952737|FG001|STARTED|Run-In Period||0
8894875|NCT02031640|9952738|FG002|STARTED|Run-In Period||0
8894876|NCT02031640|9952739|FG003|STARTED|Run-In Period||0
8894877|NCT02031640|9952740|FG004|STARTED|Run-In Period||0
8894878|NCT02031640|9952741|FG005|STARTED|Run-In Period||0
8894879|NCT02031640|9952736|FG000|COMPLETED|Run-In Period||532
8894880|NCT02031640|9952737|FG001|COMPLETED|Run-In Period||0
8894881|NCT02031640|9952738|FG002|COMPLETED|Run-In Period||0
8894882|NCT02031640|9952739|FG003|COMPLETED|Run-In Period||0
8894883|NCT02031640|9952740|FG004|COMPLETED|Run-In Period||0
8894884|NCT02031640|9952741|FG005|COMPLETED|Run-In Period||0
8894885|NCT02031640|9952736|FG000|NOT COMPLETED|Run-In Period||169
8894886|NCT02031640|9952737|FG001|NOT COMPLETED|Run-In Period||0
8894887|NCT02031640|9952738|FG002|NOT COMPLETED|Run-In Period||0
8894888|NCT02031640|9952739|FG003|NOT COMPLETED|Run-In Period||0
8894889|NCT02031640|9952740|FG004|NOT COMPLETED|Run-In Period||0
8894890|NCT02031640|9952741|FG005|NOT COMPLETED|Run-In Period||0
8894891|NCT02031640|9952736|FG000|STARTED|Double-blind Treatment Period||0
8894892|NCT02031640|9952737|FG001|STARTED|Double-blind Treatment Period||106
8894893|NCT02031640|9952738|FG002|STARTED|Double-blind Treatment Period||106
8894894|NCT02031640|9952739|FG003|STARTED|Double-blind Treatment Period||106
8894895|NCT02031640|9952740|FG004|STARTED|Double-blind Treatment Period||107
8894896|NCT02031640|9952741|FG005|STARTED|Double-blind Treatment Period||107
8894897|NCT02031640|9952736|FG000|Full Analysis Set|Double-blind Treatment Period||0
8894898|NCT02031640|9952737|FG001|Full Analysis Set|Double-blind Treatment Period||106
8894899|NCT02031640|9952738|FG002|Full Analysis Set|Double-blind Treatment Period||104
8894900|NCT02031640|9952739|FG003|Full Analysis Set|Double-blind Treatment Period||106
8894901|NCT02031640|9952740|FG004|Full Analysis Set|Double-blind Treatment Period||106
8894902|NCT02031640|9952741|FG005|Full Analysis Set|Double-blind Treatment Period||107
8894903|NCT02031640|9952736|FG000|COMPLETED|Double-blind Treatment Period||0
8894904|NCT02031640|9952737|FG001|COMPLETED|Double-blind Treatment Period||84
8894905|NCT02031640|9952738|FG002|COMPLETED|Double-blind Treatment Period||100
8894906|NCT02031640|9952739|FG003|COMPLETED|Double-blind Treatment Period||99
8894907|NCT02031640|9952740|FG004|COMPLETED|Double-blind Treatment Period||96
8894908|NCT02031640|9952741|FG005|COMPLETED|Double-blind Treatment Period||104
8894909|NCT02031640|9952736|FG000|NOT COMPLETED|Double-blind Treatment Period||0
8894910|NCT02031640|9952737|FG001|NOT COMPLETED|Double-blind Treatment Period||22
8894911|NCT02031640|9952738|FG002|NOT COMPLETED|Double-blind Treatment Period||6
8894912|NCT02031640|9952739|FG003|NOT COMPLETED|Double-blind Treatment Period||7
8894913|NCT02031640|9952740|FG004|NOT COMPLETED|Double-blind Treatment Period||11
8894914|NCT02031640|9952741|FG005|NOT COMPLETED|Double-blind Treatment Period||3
8894915|NCT02031679|9952762|FG000|STARTED|Overall Study||14
8894916|NCT02031679|9952763|FG001|STARTED|Overall Study||14
8894917|NCT02031679|9952762|FG000|COMPLETED|Overall Study||14
8894918|NCT02031679|9952763|FG001|COMPLETED|Overall Study||12
8894919|NCT02031679|9952762|FG000|NOT COMPLETED|Overall Study||0
8894920|NCT02031679|9952763|FG001|NOT COMPLETED|Overall Study||2
9007674|NCT02958982|10070547|FG007|STARTED|Cohort 3: 400 mg in MAD Study||0
9007675|NCT02958982|10070548|FG008|STARTED|Cohort 3: 400 mg in MAD Study||0
9007676|NCT02958982|10070549|FG009|STARTED|Cohort 3: 400 mg in MAD Study||6
9007677|NCT02958982|10070550|FG010|STARTED|Cohort 3: 400 mg in MAD Study||0
9007678|NCT02958982|10070540|FG000|COMPLETED|Cohort 3: 400 mg in MAD Study||0
9007679|NCT02958982|10070541|FG001|COMPLETED|Cohort 3: 400 mg in MAD Study||0
8894921|NCT02031770|9952769|FG000|STARTED|Overall Study||10
8894922|NCT02031770|9952770|FG001|STARTED|Overall Study||10
8894923|NCT02031770|9952769|FG000|COMPLETED|Overall Study||9
8894924|NCT02031770|9952770|FG001|COMPLETED|Overall Study||9
8894925|NCT02031770|9952769|FG000|NOT COMPLETED|Overall Study||1
8894926|NCT02031770|9952770|FG001|NOT COMPLETED|Overall Study||1
8894927|NCT02031978|9952776|FG000|STARTED|Overall Study||4367
8894928|NCT02031978|9952776|FG000|COMPLETED|Overall Study||4367
8894929|NCT02031978|9952776|FG000|NOT COMPLETED|Overall Study||0
8894930|NCT02032173|9952780|FG000|STARTED|Overall Study||31
8894931|NCT02032173|9952780|FG000|Included Population - Main Group|Overall Study||31
8894932|NCT02032173|9952780|FG000|Rescue Group|Overall Study|1 participant moved to Rescue Group at M6 and trial discontinued before any data was collected.|1
8894933|NCT02032173|9952780|FG000|COMPLETED|Overall Study||0
8894934|NCT02032173|9952780|FG000|NOT COMPLETED|Overall Study||31
8894935|NCT02032212|9952788|FG000|STARTED|Overall Study||3
8894936|NCT02032212|9952789|FG001|STARTED|Overall Study||3
8894937|NCT02032212|9952790|FG002|STARTED|Overall Study||3
8894938|NCT02032212|9952791|FG003|STARTED|Overall Study||3
8894939|NCT02032212|9952788|FG000|COMPLETED|Overall Study||3
8894940|NCT02032212|9952789|FG001|COMPLETED|Overall Study||3
8894941|NCT02032212|9952790|FG002|COMPLETED|Overall Study||3
8894942|NCT02032212|9952791|FG003|COMPLETED|Overall Study||3
8894943|NCT02032212|9952788|FG000|NOT COMPLETED|Overall Study||0
8894944|NCT02032212|9952789|FG001|NOT COMPLETED|Overall Study||0
8894945|NCT02032212|9952790|FG002|NOT COMPLETED|Overall Study||0
8894946|NCT02032212|9952791|FG003|NOT COMPLETED|Overall Study||0
8894947|NCT02032238|9952803|FG000|STARTED|Overall Study||12
8894948|NCT02032238|9952804|FG001|STARTED|Overall Study|Study Terminated due to slow enrollment, no subjects enrolled in this study arm|0
8894949|NCT02032238|9952803|FG000|COMPLETED|Overall Study||10
8894950|NCT02032238|9952804|FG001|COMPLETED|Overall Study||0
8894951|NCT02032238|9952803|FG000|NOT COMPLETED|Overall Study||2
8894952|NCT02032238|9952804|FG001|NOT COMPLETED|Overall Study||0
8894953|NCT02032407|9952810|FG000|STARTED|Overall Study||68
8894954|NCT02032407|9952810|FG000|COMPLETED|Overall Study||63
8894955|NCT02032407|9952810|FG000|NOT COMPLETED|Overall Study||5
8894956|NCT02032420|9952816|FG000|STARTED|Overall Study||18
8894957|NCT02032420|9952817|FG001|STARTED|Overall Study||17
8894958|NCT02032420|9952816|FG000|COMPLETED|Overall Study||18
8894959|NCT02032420|9952817|FG001|COMPLETED|Overall Study||17
8894960|NCT02032420|9952816|FG000|NOT COMPLETED|Overall Study||0
8894961|NCT02032420|9952817|FG001|NOT COMPLETED|Overall Study||0
8894962|NCT02032433|9952825|FG000|STARTED|Overall Study||283
8894963|NCT02032433|9952826|FG001|STARTED|Overall Study||287
8894964|NCT02032433|9952825|FG000|COMPLETED|Overall Study||205
8894965|NCT02032433|9952826|FG001|COMPLETED|Overall Study||225
8894966|NCT02032433|9952825|FG000|NOT COMPLETED|Overall Study||78
8894967|NCT02032433|9952826|FG001|NOT COMPLETED|Overall Study||62
8894968|NCT02032550|9952834|FG000|STARTED|Overall Study||371
8894969|NCT02032550|9952835|FG001|STARTED|Overall Study||372
8894970|NCT02032550|9952834|FG000|COMPLETED|Overall Study||343
8894971|NCT02032550|9952835|FG001|COMPLETED|Overall Study||350
8894972|NCT02032550|9952834|FG000|NOT COMPLETED|Overall Study||28
8894973|NCT02032550|9952835|FG001|NOT COMPLETED|Overall Study||22
8894974|NCT02032641|9952841|FG000|STARTED|Overall Study|18 Brows enrolled for evaluation|9
8894975|NCT02032641|9952841|FG000|COMPLETED|Overall Study|16 brows completed study (half underwent treatment, half were control)|8
8894976|NCT02032641|9952841|FG000|NOT COMPLETED|Overall Study||1
8894977|NCT02032680|9952849|FG000|STARTED|Overall Study||22
8894978|NCT02032680|9952850|FG001|STARTED|Overall Study||8
8894979|NCT02032680|9952849|FG000|COMPLETED|Overall Study||16
8894980|NCT02032680|9952850|FG001|COMPLETED|Overall Study||7
8894981|NCT02032680|9952849|FG000|NOT COMPLETED|Overall Study||6
8894982|NCT02032680|9952850|FG001|NOT COMPLETED|Overall Study||1
8894983|NCT02032706|9952856|FG000|STARTED|Overall Study||36
8894984|NCT02032706|9952856|FG000|COMPLETED|Overall Study||30
8894985|NCT02032706|9952856|FG000|NOT COMPLETED|Overall Study||6
8894986|NCT02032758|9952862|FG000|STARTED|Overall Study||27
8894987|NCT02032758|9952863|FG001|STARTED|Overall Study||11
8894988|NCT02032758|9952862|FG000|COMPLETED|Overall Study||27
8894989|NCT02032758|9952863|FG001|COMPLETED|Overall Study||11
8894990|NCT02032758|9952862|FG000|NOT COMPLETED|Overall Study||0
8894991|NCT02032758|9952863|FG001|NOT COMPLETED|Overall Study||0
8894992|NCT02032875|9952871|FG000|STARTED|Treatment Period||53
8894993|NCT02032875|9952872|FG001|STARTED|Treatment Period||60
8894994|NCT02032875|9952871|FG000|COMPLETED|Treatment Period||52
8894995|NCT02032875|9952872|FG001|COMPLETED|Treatment Period||56
8894996|NCT02032875|9952871|FG000|NOT COMPLETED|Treatment Period||1
8894997|NCT02032875|9952872|FG001|NOT COMPLETED|Treatment Period||4
8894998|NCT02032875|9952871|FG000|STARTED|Follow-up Period|Out of 53 participants who entered the treatment period, all 53 continued in the follow-up period.|53
8894999|NCT02032875|9952872|FG001|STARTED|Follow-up Period|Of 60 participants in treatment period, 57 continued in follow-up, 3 entered treatment extension.|57
8895000|NCT02032875|9952871|FG000|COMPLETED|Follow-up Period||50
8895001|NCT02032875|9952872|FG001|COMPLETED|Follow-up Period||46
8895002|NCT02032875|9952871|FG000|NOT COMPLETED|Follow-up Period||3
8895003|NCT02032875|9952872|FG001|NOT COMPLETED|Follow-up Period||11
8895004|NCT02032888|9952882|FG000|STARTED|Treatment Period||101
8895005|NCT02032888|9952883|FG001|STARTED|Treatment Period||50
8895006|NCT02032888|9952884|FG002|STARTED|Treatment Period||52
8895007|NCT02032888|9952882|FG000|COMPLETED|Treatment Period||99
8895008|NCT02032888|9952883|FG001|COMPLETED|Treatment Period||48
8895009|NCT02032888|9952884|FG002|COMPLETED|Treatment Period||52
8895010|NCT02032888|9952882|FG000|NOT COMPLETED|Treatment Period||2
8895011|NCT02032888|9952883|FG001|NOT COMPLETED|Treatment Period||2
8895012|NCT02032888|9952884|FG002|NOT COMPLETED|Treatment Period||0
8895013|NCT02032888|9952882|FG000|STARTED|Follow-up Period|All patients who received study drug and not a nonstudy HCV therapy before treatment Week 4|100
8895014|NCT02032888|9952883|FG001|STARTED|Follow-up Period|All patients who received study drug and not a nonstudy HCV therapy before treatment Week 4|49
8895015|NCT02032888|9952884|FG002|STARTED|Follow-up Period||52
8895016|NCT02032888|9952882|FG000|COMPLETED|Follow-up Period||97
8895017|NCT02032888|9952883|FG001|COMPLETED|Follow-up Period||47
8895018|NCT02032888|9952884|FG002|COMPLETED|Follow-up Period||52
8895019|NCT02032888|9952882|FG000|NOT COMPLETED|Follow-up Period||3
8895020|NCT02032888|9952883|FG001|NOT COMPLETED|Follow-up Period||2
8895021|NCT02032888|9952884|FG002|NOT COMPLETED|Follow-up Period||0
8895022|NCT02032901|9952903|FG000|STARTED|Treatment Period (12 Weeks)||101
8895023|NCT02032901|9952904|FG001|STARTED|Treatment Period (12 Weeks)||51
8895024|NCT02032901|9952903|FG000|COMPLETED|Treatment Period (12 Weeks)||100
8895025|NCT02032901|9952904|FG001|COMPLETED|Treatment Period (12 Weeks)||51
8895026|NCT02032901|9952903|FG000|NOT COMPLETED|Treatment Period (12 Weeks)||1
8895027|NCT02032901|9952904|FG001|NOT COMPLETED|Treatment Period (12 Weeks)||0
8895028|NCT02032901|9952903|FG000|STARTED|Follow-Up Period (24 Weeks)|Participant could enter follow up period even if the treatment period was not completed.|101
8895029|NCT02032901|9952904|FG001|STARTED|Follow-Up Period (24 Weeks)||51
8895030|NCT02032901|9952903|FG000|COMPLETED|Follow-Up Period (24 Weeks)||101
8895031|NCT02032901|9952904|FG001|COMPLETED|Follow-Up Period (24 Weeks)||50
8895032|NCT02032901|9952903|FG000|NOT COMPLETED|Follow-Up Period (24 Weeks)||0
8895033|NCT02032901|9952904|FG001|NOT COMPLETED|Follow-Up Period (24 Weeks)||1
8895034|NCT02033005|9952915|FG000|STARTED|Overall Study||80
8895035|NCT02033005|9952916|FG001|STARTED|Overall Study||9
8895036|NCT02033005|9952917|FG002|STARTED|Overall Study||35
8895037|NCT02033005|9952915|FG000|COMPLETED|Overall Study||36
8895038|NCT02033005|9952916|FG001|COMPLETED|Overall Study||9
8895039|NCT02033005|9952917|FG002|COMPLETED|Overall Study||25
8895040|NCT02033005|9952915|FG000|NOT COMPLETED|Overall Study||44
8895041|NCT02033005|9952916|FG001|NOT COMPLETED|Overall Study||0
8895042|NCT02033005|9952917|FG002|NOT COMPLETED|Overall Study||10
8895043|NCT02033083|9952928|FG000|STARTED|Overall Study||90
8895044|NCT02033083|9952929|FG001|STARTED|Overall Study||90
8895045|NCT02033083|9952928|FG000|COMPLETED|Overall Study||89
8895046|NCT02033083|9952929|FG001|COMPLETED|Overall Study||89
8895047|NCT02033083|9952928|FG000|NOT COMPLETED|Overall Study||1
8895048|NCT02033083|9952929|FG001|NOT COMPLETED|Overall Study||1
8895049|NCT02033174|9952935|FG000|STARTED|First Intervention||8
8895050|NCT02033174|9952936|FG001|STARTED|First Intervention||8
8895051|NCT02033174|9952935|FG000|COMPLETED|First Intervention||8
8895052|NCT02033174|9952936|FG001|COMPLETED|First Intervention||8
8895053|NCT02033174|9952935|FG000|NOT COMPLETED|First Intervention||0
8895054|NCT02033174|9952936|FG001|NOT COMPLETED|First Intervention||0
8895055|NCT02033174|9952935|FG000|STARTED|Washout (1 Week)||8
8895056|NCT02033174|9952936|FG001|STARTED|Washout (1 Week)||8
8895057|NCT02033174|9952935|FG000|COMPLETED|Washout (1 Week)||8
8895058|NCT02033174|9952936|FG001|COMPLETED|Washout (1 Week)||8
8895059|NCT02033174|9952935|FG000|NOT COMPLETED|Washout (1 Week)||0
9007680|NCT02958982|10070542|FG002|COMPLETED|Cohort 3: 400 mg in MAD Study||0
9007681|NCT02958982|10070543|FG003|COMPLETED|Cohort 3: 400 mg in MAD Study||0
9007682|NCT02958982|10070544|FG004|COMPLETED|Cohort 3: 400 mg in MAD Study||0
9007683|NCT02958982|10070545|FG005|COMPLETED|Cohort 3: 400 mg in MAD Study||0
9007684|NCT02958982|10070546|FG006|COMPLETED|Cohort 3: 400 mg in MAD Study||2
9007685|NCT02958982|10070547|FG007|COMPLETED|Cohort 3: 400 mg in MAD Study||0
9007686|NCT02958982|10070548|FG008|COMPLETED|Cohort 3: 400 mg in MAD Study||0
9007687|NCT02958982|10070549|FG009|COMPLETED|Cohort 3: 400 mg in MAD Study||6
9007688|NCT02958982|10070550|FG010|COMPLETED|Cohort 3: 400 mg in MAD Study||0
9007689|NCT02958982|10070540|FG000|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
9007690|NCT02958982|10070541|FG001|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
9007691|NCT02958982|10070542|FG002|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
9007692|NCT02958982|10070543|FG003|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
9007693|NCT02958982|10070544|FG004|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
9007694|NCT02958982|10070545|FG005|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
9007695|NCT02958982|10070546|FG006|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
9007696|NCT02958982|10070547|FG007|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
9007697|NCT02958982|10070548|FG008|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
9007698|NCT02958982|10070549|FG009|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
9007699|NCT02958982|10070550|FG010|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
9007700|NCT02958982|10070540|FG000|STARTED|Proof of Concept Study||0
9007701|NCT02958982|10070541|FG001|STARTED|Proof of Concept Study||0
9007702|NCT02958982|10070542|FG002|STARTED|Proof of Concept Study||0
9007703|NCT02958982|10070543|FG003|STARTED|Proof of Concept Study||0
9007704|NCT02958982|10070544|FG004|STARTED|Proof of Concept Study||0
9007705|NCT02958982|10070545|FG005|STARTED|Proof of Concept Study||0
9007706|NCT02958982|10070546|FG006|STARTED|Proof of Concept Study||0
9007707|NCT02958982|10070547|FG007|STARTED|Proof of Concept Study||0
9007708|NCT02958982|10070548|FG008|STARTED|Proof of Concept Study||0
9007709|NCT02958982|10070549|FG009|STARTED|Proof of Concept Study||0
9007710|NCT02958982|10070550|FG010|STARTED|Proof of Concept Study||1
9007711|NCT02958982|10070540|FG000|COMPLETED|Proof of Concept Study||0
9007712|NCT02958982|10070541|FG001|COMPLETED|Proof of Concept Study||0
9007713|NCT02958982|10070542|FG002|COMPLETED|Proof of Concept Study||0
9007714|NCT02958982|10070543|FG003|COMPLETED|Proof of Concept Study||0
9007715|NCT02958982|10070544|FG004|COMPLETED|Proof of Concept Study||0
9007716|NCT02958982|10070545|FG005|COMPLETED|Proof of Concept Study||0
8895060|NCT02033174|9952936|FG001|NOT COMPLETED|Washout (1 Week)||0
8895061|NCT02033174|9952935|FG000|STARTED|Second Intervention||8
9007717|NCT02958982|10070546|FG006|COMPLETED|Proof of Concept Study||0
9007718|NCT02958982|10070547|FG007|COMPLETED|Proof of Concept Study||0
8895062|NCT02033174|9952936|FG001|STARTED|Second Intervention||8
8895063|NCT02033174|9952935|FG000|COMPLETED|Second Intervention||8
8895064|NCT02033174|9952936|FG001|COMPLETED|Second Intervention||8
8895065|NCT02033174|9952935|FG000|NOT COMPLETED|Second Intervention||0
8895066|NCT02033174|9952936|FG001|NOT COMPLETED|Second Intervention||0
8895067|NCT02033200|9952944|FG000|STARTED|Overall Study||40
8895068|NCT02033200|9952945|FG001|STARTED|Overall Study||40
8895069|NCT02033200|9952944|FG000|COMPLETED|Overall Study||40
8895070|NCT02033200|9952945|FG001|COMPLETED|Overall Study||40
9007719|NCT02958982|10070548|FG008|COMPLETED|Proof of Concept Study||0
9007720|NCT02958982|10070549|FG009|COMPLETED|Proof of Concept Study||0
9007721|NCT02958982|10070550|FG010|COMPLETED|Proof of Concept Study||1
9007722|NCT02958982|10070540|FG000|NOT COMPLETED|Proof of Concept Study||0
9007723|NCT02958982|10070541|FG001|NOT COMPLETED|Proof of Concept Study||0
9007724|NCT02958982|10070542|FG002|NOT COMPLETED|Proof of Concept Study||0
9007725|NCT02958982|10070543|FG003|NOT COMPLETED|Proof of Concept Study||0
9007726|NCT02958982|10070544|FG004|NOT COMPLETED|Proof of Concept Study||0
9007727|NCT02958982|10070545|FG005|NOT COMPLETED|Proof of Concept Study||0
9007728|NCT02958982|10070546|FG006|NOT COMPLETED|Proof of Concept Study||0
9007729|NCT02958982|10070547|FG007|NOT COMPLETED|Proof of Concept Study||0
9007730|NCT02958982|10070548|FG008|NOT COMPLETED|Proof of Concept Study||0
9007731|NCT02958982|10070549|FG009|NOT COMPLETED|Proof of Concept Study||0
9007732|NCT02958982|10070550|FG010|NOT COMPLETED|Proof of Concept Study||0
9007733|NCT02958995|10070585|FG000|STARTED|Overall Study||2630666
9007734|NCT02958995|10070586|FG001|STARTED|Overall Study||107495
9007735|NCT02958995|10070585|FG000|COMPLETED|Overall Study||2630666
9007736|NCT02958995|10070586|FG001|COMPLETED|Overall Study||107495
9007737|NCT02958995|10070585|FG000|NOT COMPLETED|Overall Study||0
9007738|NCT02958995|10070586|FG001|NOT COMPLETED|Overall Study||0
9007739|NCT02959138|10070595|FG000|STARTED|Overall Study||10
9007740|NCT02959138|10070596|FG001|STARTED|Overall Study||10
9007741|NCT02959138|10070597|FG002|STARTED|Overall Study||16
9007742|NCT02959138|10070595|FG000|COMPLETED|Overall Study||10
9007743|NCT02959138|10070596|FG001|COMPLETED|Overall Study||9
9007744|NCT02959138|10070597|FG002|COMPLETED|Overall Study||16
9007745|NCT02959138|10070595|FG000|NOT COMPLETED|Overall Study||0
9007746|NCT02959138|10070596|FG001|NOT COMPLETED|Overall Study||1
9007747|NCT02959138|10070597|FG002|NOT COMPLETED|Overall Study||0
9007748|NCT02959177|10070612|FG000|STARTED|Double-Blind Treatment Phase||115
9007749|NCT02959177|10070613|FG001|STARTED|Double-Blind Treatment Phase||114
9007750|NCT02959177|10070614|FG002|STARTED|Double-Blind Treatment Phase||230
9007751|NCT02959177|10070612|FG000|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||115
9007752|NCT02959177|10070613|FG001|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||114
9007753|NCT02959177|10070614|FG002|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||230
9007754|NCT02959177|10070612|FG000|COMPLETED|Double-Blind Treatment Phase||104
9007755|NCT02959177|10070613|FG001|COMPLETED|Double-Blind Treatment Phase||111
9007756|NCT02959177|10070614|FG002|COMPLETED|Double-Blind Treatment Phase||225
9007757|NCT02959177|10070612|FG000|NOT COMPLETED|Double-Blind Treatment Phase||11
9007758|NCT02959177|10070613|FG001|NOT COMPLETED|Double-Blind Treatment Phase||3
9007759|NCT02959177|10070614|FG002|NOT COMPLETED|Double-Blind Treatment Phase||5
9007760|NCT02959177|10070612|FG000|STARTED|Follow-up Post Treatment Phase|Not all participants entered Post Treatment Follow-up Phase|52
9007761|NCT02959177|10070613|FG001|STARTED|Follow-up Post Treatment Phase|Not all participants entered Post Treatment Follow-up Phase|52
9007762|NCT02959177|10070614|FG002|STARTED|Follow-up Post Treatment Phase|Not all participants entered Post Treatment Follow-up Phase|100
9007763|NCT02959177|10070612|FG000|COMPLETED|Follow-up Post Treatment Phase||51
9007764|NCT02959177|10070613|FG001|COMPLETED|Follow-up Post Treatment Phase||51
9007765|NCT02959177|10070614|FG002|COMPLETED|Follow-up Post Treatment Phase||98
9007766|NCT02959177|10070612|FG000|NOT COMPLETED|Follow-up Post Treatment Phase||1
9007767|NCT02959177|10070613|FG001|NOT COMPLETED|Follow-up Post Treatment Phase||1
9007768|NCT02959177|10070614|FG002|NOT COMPLETED|Follow-up Post Treatment Phase||2
9007769|NCT02959190|10070632|FG000|STARTED|Open Label||120
9007770|NCT02959190|10070633|FG001|STARTED|Open Label||126
9007771|NCT02959190|10070634|FG002|STARTED|Open Label||32
9007772|NCT02959190|10070635|FG003|STARTED|Open Label||33
9007773|NCT02959190|10070632|FG000|Received at Least 1 Dose of Study Drug|Open Label||120
9007774|NCT02959190|10070633|FG001|Received at Least 1 Dose of Study Drug|Open Label||126
9007775|NCT02959190|10070634|FG002|Received at Least 1 Dose of Study Drug|Open Label||32
9007776|NCT02959190|10070635|FG003|Received at Least 1 Dose of Study Drug|Open Label||33
9007777|NCT02959190|10070632|FG000|120mg/120mg Galcanezumab - EM|Open Label||58
9007778|NCT02959190|10070633|FG001|120mg/120mg Galcanezumab - EM|Open Label||0
9007779|NCT02959190|10070634|FG002|120mg/120mg Galcanezumab - EM|Open Label||0
9007780|NCT02959190|10070635|FG003|120mg/120mg Galcanezumab - EM|Open Label||0
9007781|NCT02959190|10070632|FG000|240mg/240mg Galcanezumab - EM|Open Label||0
9007782|NCT02959190|10070633|FG001|240mg/240mg Galcanezumab - EM|Open Label||62
9007783|NCT02959190|10070634|FG002|240mg/240mg Galcanezumab - EM|Open Label||0
8895071|NCT02033200|9952944|FG000|NOT COMPLETED|Overall Study||0
8895072|NCT02033200|9952945|FG001|NOT COMPLETED|Overall Study||0
8895073|NCT02033213|9952953|FG000|STARTED|Overall Study||8
8895074|NCT02033213|9952954|FG001|STARTED|Overall Study||8
8895075|NCT02033213|9952953|FG000|COMPLETED|Overall Study||8
8895076|NCT02033213|9952954|FG001|COMPLETED|Overall Study||8
8895077|NCT02033213|9952953|FG000|NOT COMPLETED|Overall Study||0
8895078|NCT02033213|9952954|FG001|NOT COMPLETED|Overall Study||0
8895079|NCT02033317|9952962|FG000|STARTED|Overall Study||6
8895080|NCT02033317|9952962|FG000|COMPLETED|Overall Study||6
8895081|NCT02033317|9952962|FG000|NOT COMPLETED|Overall Study||0
8895082|NCT02033369|9952968|FG000|STARTED|Overall Study||26
8895083|NCT02033369|9952969|FG001|STARTED|Overall Study||26
8895084|NCT02033369|9952968|FG000|COMPLETED|Overall Study||21
8895085|NCT02033369|9952969|FG001|COMPLETED|Overall Study||21
8895086|NCT02033369|9952968|FG000|NOT COMPLETED|Overall Study||5
8895087|NCT02033369|9952969|FG001|NOT COMPLETED|Overall Study||5
8895088|NCT02033382|9952975|FG000|STARTED|Overall Study||83
8895089|NCT02033382|9952976|FG001|STARTED|Overall Study||82
8895090|NCT02033382|9952975|FG000|COMPLETED|Overall Study||32
8895091|NCT02033382|9952976|FG001|COMPLETED|Overall Study||36
8895092|NCT02033382|9952975|FG000|NOT COMPLETED|Overall Study||51
8895093|NCT02033382|9952976|FG001|NOT COMPLETED|Overall Study||46
8895094|NCT02033499|9952989|FG000|STARTED|Overall Study||152
8895095|NCT02033499|9952990|FG001|STARTED|Overall Study||150
8895096|NCT02033499|9952991|FG002|STARTED|Overall Study||148
8895097|NCT02033499|9952989|FG000|COMPLETED|Overall Study||147
8895098|NCT02033499|9952990|FG001|COMPLETED|Overall Study||142
8895099|NCT02033499|9952991|FG002|COMPLETED|Overall Study||139
8895100|NCT02033499|9952989|FG000|NOT COMPLETED|Overall Study||5
8895101|NCT02033499|9952990|FG001|NOT COMPLETED|Overall Study||8
8895102|NCT02033499|9952991|FG002|NOT COMPLETED|Overall Study||9
8895103|NCT02033694|9953000|FG000|STARTED|Overall Study||1271
8895104|NCT02033694|9953000|FG000|COMPLETED|Overall Study||1271
8895105|NCT02033694|9953000|FG000|NOT COMPLETED|Overall Study||0
9007784|NCT02959190|10070635|FG003|240mg/240mg Galcanezumab - EM|Open Label||0
9007785|NCT02959190|10070632|FG000|Placebo/ 120mg Galcanezumab - EM|Open Label||62
9007786|NCT02959190|10070633|FG001|Placebo/ 120mg Galcanezumab - EM|Open Label||0
9007787|NCT02959190|10070634|FG002|Placebo/ 120mg Galcanezumab - EM|Open Label||0
9007788|NCT02959190|10070635|FG003|Placebo/ 120mg Galcanezumab - EM|Open Label||0
9007789|NCT02959190|10070632|FG000|Placebo/ 240mg Galcanezumab - EM|Open Label||0
9007790|NCT02959190|10070633|FG001|Placebo/ 240mg Galcanezumab - EM|Open Label||64
9007791|NCT02959190|10070634|FG002|Placebo/ 240mg Galcanezumab - EM|Open Label||0
9007792|NCT02959190|10070635|FG003|Placebo/ 240mg Galcanezumab - EM|Open Label||0
9007793|NCT02959190|10070632|FG000|COMPLETED|Open Label||113
9007794|NCT02959190|10070633|FG001|COMPLETED|Open Label||110
9007795|NCT02959190|10070634|FG002|COMPLETED|Open Label||28
9007796|NCT02959190|10070635|FG003|COMPLETED|Open Label||27
9007797|NCT02959190|10070632|FG000|NOT COMPLETED|Open Label||7
9007798|NCT02959190|10070633|FG001|NOT COMPLETED|Open Label||16
9007799|NCT02959190|10070634|FG002|NOT COMPLETED|Open Label||4
9007800|NCT02959190|10070635|FG003|NOT COMPLETED|Open Label||6
9007801|NCT02959190|10070632|FG000|STARTED|Post Treatment Follow Up|Participants who discontinued open-label treatment phase had an option to enter post treatment phase|117
9007802|NCT02959190|10070633|FG001|STARTED|Post Treatment Follow Up|Participants who discontinued open-label treatment phase had an option to enter post treatment phase|120
9007803|NCT02959190|10070634|FG002|STARTED|Post Treatment Follow Up|Participants who discontinued open-label treatment phase had an option to enter post treatment phase|32
9007804|NCT02959190|10070635|FG003|STARTED|Post Treatment Follow Up|Participants who discontinued open-label treatment phase had an option to enter post treatment phase|32
9007805|NCT02959190|10070632|FG000|COMPLETED|Post Treatment Follow Up||114
9007806|NCT02959190|10070633|FG001|COMPLETED|Post Treatment Follow Up||119
9007807|NCT02959190|10070634|FG002|COMPLETED|Post Treatment Follow Up||31
9007808|NCT02959190|10070635|FG003|COMPLETED|Post Treatment Follow Up||32
9007809|NCT02959190|10070632|FG000|NOT COMPLETED|Post Treatment Follow Up||3
9007810|NCT02959190|10070633|FG001|NOT COMPLETED|Post Treatment Follow Up||1
9007811|NCT02959190|10070634|FG002|NOT COMPLETED|Post Treatment Follow Up||1
9007812|NCT02959190|10070635|FG003|NOT COMPLETED|Post Treatment Follow Up||0
9007813|NCT02959307|10070656|FG000|STARTED|Phase 1||18
9007814|NCT02959307|10070657|FG001|STARTED|Phase 1||31
9007815|NCT02959307|10070656|FG000|COMPLETED|Phase 1||15
9007816|NCT02959307|10070657|FG001|COMPLETED|Phase 1||23
8635296|NCT00561340|9675772|FG000|NOT COMPLETED|Overall Study||6
8635297|NCT00561340|9675773|FG001|NOT COMPLETED|Overall Study||0
8635298|NCT00561353|9675789|FG000|STARTED|Overall Study||18
8635299|NCT00561353|9675790|FG001|STARTED|Overall Study||19
8635300|NCT00561353|9675791|FG002|STARTED|Overall Study||13
8635301|NCT00561353|9675792|FG003|STARTED|Overall Study||18
8635302|NCT00561353|9675793|FG004|STARTED|Overall Study||6
9007817|NCT02959307|10070656|FG000|NOT COMPLETED|Phase 1||3
9007818|NCT02959307|10070657|FG001|NOT COMPLETED|Phase 1||8
9007819|NCT02959307|10070656|FG000|STARTED|Phase 2|This group is increased as those in sham were re-randomized to sham or NIR.|28
9007820|NCT02959307|10070657|FG001|STARTED|Phase 2|This group is decreased as those in sham were re-randomized to sham or NIR.|10
9007821|NCT02959307|10070656|FG000|COMPLETED|Phase 2||26
9007822|NCT02959307|10070657|FG001|COMPLETED|Phase 2||10
9007823|NCT02959307|10070656|FG000|NOT COMPLETED|Phase 2||2
8635303|NCT00561353|9675794|FG005|STARTED|Overall Study||9
8635304|NCT00561353|9675795|FG006|STARTED|Overall Study||9
8635305|NCT00561353|9675796|FG007|STARTED|Overall Study||10
8895106|NCT02033759|9953007|FG000|STARTED|Overall Study||22
8895107|NCT02033759|9953008|FG001|STARTED|Overall Study||21
8895108|NCT02033759|9953007|FG000|COMPLETED|Overall Study||19
8895109|NCT02033759|9953008|FG001|COMPLETED|Overall Study||19
8895110|NCT02033759|9953007|FG000|NOT COMPLETED|Overall Study||3
8895111|NCT02033759|9953008|FG001|NOT COMPLETED|Overall Study||2
8895112|NCT02033850|9953016|FG000|STARTED|Overall Study||23
8895113|NCT02033850|9953017|FG001|STARTED|Overall Study||23
8895114|NCT02033850|9953016|FG000|COMPLETED|Overall Study||21
8895115|NCT02033850|9953017|FG001|COMPLETED|Overall Study||22
8895116|NCT02033850|9953016|FG000|NOT COMPLETED|Overall Study||2
8895117|NCT02033850|9953017|FG001|NOT COMPLETED|Overall Study||1
8895118|NCT02033876|9953025|FG000|STARTED|Overall Study||12
8895119|NCT02033876|9953026|FG001|STARTED|Overall Study||12
8895120|NCT02033876|9953025|FG000|COMPLETED|Overall Study||12
8895121|NCT02033876|9953026|FG001|COMPLETED|Overall Study||12
8895122|NCT02033876|9953025|FG000|NOT COMPLETED|Overall Study||0
8895123|NCT02033876|9953026|FG001|NOT COMPLETED|Overall Study||0
8895124|NCT02033889|9953035|FG000|STARTED|Overall Study||209
8895125|NCT02033889|9953036|FG001|STARTED|Overall Study||207
8895126|NCT02033889|9953037|FG002|STARTED|Overall Study||205
8895127|NCT02033889|9953035|FG000|COMPLETED|Overall Study||175
8895128|NCT02033889|9953036|FG001|COMPLETED|Overall Study||187
8895129|NCT02033889|9953037|FG002|COMPLETED|Overall Study||180
8895130|NCT02033889|9953035|FG000|NOT COMPLETED|Overall Study||34
8895131|NCT02033889|9953036|FG001|NOT COMPLETED|Overall Study||20
8895132|NCT02033889|9953037|FG002|NOT COMPLETED|Overall Study||25
8895133|NCT02033993|9953047|FG000|STARTED|Overall Study||99
8895134|NCT02033993|9953048|FG001|STARTED|Overall Study||100
8895135|NCT02033993|9953047|FG000|COMPLETED|Overall Study||96
8895136|NCT02033993|9953048|FG001|COMPLETED|Overall Study||91
8895137|NCT02033993|9953047|FG000|NOT COMPLETED|Overall Study||3
8895138|NCT02033993|9953048|FG001|NOT COMPLETED|Overall Study||9
8895139|NCT02034006|9953056|FG000|STARTED|Overall Study||200
8895140|NCT02034006|9953056|FG000|Once Treated Patients|Overall Study||70
8895141|NCT02034006|9953056|FG000|Re-treated Patients|Overall Study||130
8895142|NCT02034006|9953056|FG000|COMPLETED|Overall Study||186
8895143|NCT02034006|9953056|FG000|NOT COMPLETED|Overall Study||14
8895144|NCT02034019|9953065|FG000|STARTED|Overall Study||164
8895145|NCT02034019|9953066|FG001|STARTED|Overall Study||83
8895146|NCT02034019|9953065|FG000|COMPLETED|Overall Study||163
8895147|NCT02034019|9953066|FG001|COMPLETED|Overall Study||81
8895148|NCT02034019|9953065|FG000|NOT COMPLETED|Overall Study||1
8895149|NCT02034019|9953066|FG001|NOT COMPLETED|Overall Study||2
8895150|NCT02034058|9953072|FG000|STARTED|Overall Study|Study stopped early per pre-defined criteria for interim analysis.|152
8895151|NCT02034058|9953072|FG000|COMPLETED|Overall Study||149
8895152|NCT02034058|9953072|FG000|NOT COMPLETED|Overall Study||3
8895153|NCT02034162|9953078|FG000|STARTED|Double-blind||146
8895154|NCT02034162|9953079|FG001|STARTED|Double-blind||149
8895155|NCT02034162|9953080|FG002|STARTED|Double-blind||0
8895156|NCT02034162|9953078|FG000|COMPLETED|Double-blind||137
8895157|NCT02034162|9953079|FG001|COMPLETED|Double-blind||141
8895158|NCT02034162|9953080|FG002|COMPLETED|Double-blind||0
8895159|NCT02034162|9953078|FG000|NOT COMPLETED|Double-blind||9
8895160|NCT02034162|9953079|FG001|NOT COMPLETED|Double-blind||8
8895161|NCT02034162|9953080|FG002|NOT COMPLETED|Double-blind||0
8895162|NCT02034162|9953078|FG000|STARTED|Open-label||0
8895163|NCT02034162|9953079|FG001|STARTED|Open-label||0
8895164|NCT02034162|9953080|FG002|STARTED|Open-label||278
8895165|NCT02034162|9953078|FG000|COMPLETED|Open-label||0
8895166|NCT02034162|9953079|FG001|COMPLETED|Open-label||0
8895167|NCT02034162|9953080|FG002|COMPLETED|Open-label||278
8895168|NCT02034162|9953078|FG000|NOT COMPLETED|Open-label||0
8895169|NCT02034162|9953079|FG001|NOT COMPLETED|Open-label||0
8895170|NCT02034162|9953080|FG002|NOT COMPLETED|Open-label||0
8895171|NCT02034175|9953091|FG000|STARTED|Overall Study||190
8895172|NCT02034175|9953091|FG000|COMPLETED|Overall Study||190
8895173|NCT02034175|9953091|FG000|NOT COMPLETED|Overall Study||0
8895174|NCT02034409|9953097|FG000|STARTED|Sham Run-in Period||140
8895175|NCT02034409|9953098|FG001|STARTED|Sham Run-in Period|Number started is zero because there is no PLIUS arm in Sham Run-in Period|0
8635306|NCT00561353|9675797|FG008|STARTED|Overall Study||9
8635307|NCT00561353|9675798|FG009|STARTED|Overall Study||5
8895176|NCT02034409|9953097|FG000|COMPLETED|Sham Run-in Period||136
8895177|NCT02034409|9953098|FG001|COMPLETED|Sham Run-in Period|Number started is zero because there is no PLIUS arm in Sham Run-in Period|0
8895178|NCT02034409|9953097|FG000|NOT COMPLETED|Sham Run-in Period||4
8895179|NCT02034409|9953098|FG001|NOT COMPLETED|Sham Run-in Period||0
8895180|NCT02034409|9953097|FG000|STARTED|Sham-Controlled Treatment Period|Number started in Sham Arm of Sham-Controlled Treatment Period Milestone not equal to Sham Run-in Period Milestone because participants in this Milestone are randomly assigned to either Sham or PLIUS treatment arm.|67
8895181|NCT02034409|9953098|FG001|STARTED|Sham-Controlled Treatment Period|Number started in PLIUS Arm of Sham-Controlled Treatment Period Milestone not equal to Sham Run-in Period Milestone because participants in this Milestone are randomly assigned to either Sham or PLIUS treatment arm.|69
8895182|NCT02034409|9953097|FG000|COMPLETED|Sham-Controlled Treatment Period||55
8895183|NCT02034409|9953098|FG001|COMPLETED|Sham-Controlled Treatment Period||54
8635308|NCT00561353|9675789|FG000|COMPLETED|Overall Study||13
8635309|NCT00561353|9675790|FG001|COMPLETED|Overall Study||16
8635310|NCT00561353|9675791|FG002|COMPLETED|Overall Study||10
8895184|NCT02034409|9953097|FG000|NOT COMPLETED|Sham-Controlled Treatment Period||12
8895185|NCT02034409|9953098|FG001|NOT COMPLETED|Sham-Controlled Treatment Period||15
8895186|NCT02034435|9953106|FG000|STARTED|Overall Study||13
8895187|NCT02034435|9953107|FG001|STARTED|Overall Study||15
8895188|NCT02034435|9953108|FG002|STARTED|Overall Study||7
8895189|NCT02034435|9953109|FG003|STARTED|Overall Study||9
8895190|NCT02034435|9953106|FG000|Aim 1|Overall Study||13
8895191|NCT02034435|9953107|FG001|Aim 1|Overall Study||15
8895192|NCT02034435|9953108|FG002|Aim 1|Overall Study||0
8895193|NCT02034435|9953109|FG003|Aim 1|Overall Study||0
8895194|NCT02034435|9953106|FG000|Aim 2|Overall Study||0
8895195|NCT02034435|9953107|FG001|Aim 2|Overall Study||0
8895196|NCT02034435|9953108|FG002|Aim 2|Overall Study||7
8895197|NCT02034435|9953109|FG003|Aim 2|Overall Study||9
8895198|NCT02034435|9953106|FG000|COMPLETED|Overall Study||11
8895199|NCT02034435|9953107|FG001|COMPLETED|Overall Study||13
8895200|NCT02034435|9953108|FG002|COMPLETED|Overall Study||7
8895201|NCT02034435|9953109|FG003|COMPLETED|Overall Study||8
8895202|NCT02034435|9953106|FG000|NOT COMPLETED|Overall Study||2
8895203|NCT02034435|9953107|FG001|NOT COMPLETED|Overall Study||2
8895204|NCT02034435|9953108|FG002|NOT COMPLETED|Overall Study||0
8895205|NCT02034435|9953109|FG003|NOT COMPLETED|Overall Study||1
8895206|NCT02034474|9953121|FG000|STARTED|Overall Study||19
8895207|NCT02034474|9953122|FG001|STARTED|Overall Study||17
8895208|NCT02034474|9953121|FG000|1 Dose|Overall Study||2
8895209|NCT02034474|9953122|FG001|1 Dose|Overall Study||4
8895210|NCT02034474|9953121|FG000|2 Doses|Overall Study||2
8895211|NCT02034474|9953122|FG001|2 Doses|Overall Study||0
8895212|NCT02034474|9953121|FG000|3 Doses|Overall Study||15
8635311|NCT00561353|9675792|FG003|COMPLETED|Overall Study||12
8635312|NCT00561353|9675793|FG004|COMPLETED|Overall Study||5
8635313|NCT00561353|9675794|FG005|COMPLETED|Overall Study||3
8635314|NCT00561353|9675795|FG006|COMPLETED|Overall Study||3
8895213|NCT02034474|9953122|FG001|3 Doses|Overall Study||13
8895214|NCT02034474|9953121|FG000|COMPLETED|Overall Study||15
8895215|NCT02034474|9953122|FG001|COMPLETED|Overall Study||13
8895216|NCT02034474|9953121|FG000|NOT COMPLETED|Overall Study||4
8895217|NCT02034474|9953122|FG001|NOT COMPLETED|Overall Study||4
8895218|NCT02034513|9953132|FG000|STARTED|Overall Study||249
8895219|NCT02034513|9953133|FG001|STARTED|Overall Study||252
8895220|NCT02034513|9953132|FG000|Exposed|Overall Study||249
8895221|NCT02034513|9953133|FG001|Exposed|Overall Study||251
8895222|NCT02034513|9953132|FG000|COMPLETED|Overall Study||200
8895223|NCT02034513|9953133|FG001|COMPLETED|Overall Study||195
8895224|NCT02034513|9953132|FG000|NOT COMPLETED|Overall Study||49
8895225|NCT02034513|9953133|FG001|NOT COMPLETED|Overall Study||57
8895226|NCT02034552|9953144|FG000|STARTED|Overall Study||22
8895227|NCT02034552|9953145|FG001|STARTED|Overall Study||24
8895228|NCT02034552|9953146|FG002|STARTED|Overall Study||22
8895229|NCT02034552|9953144|FG000|Received Treatment|Overall Study||19
8895230|NCT02034552|9953145|FG001|Received Treatment|Overall Study||22
8895231|NCT02034552|9953146|FG002|Received Treatment|Overall Study||22
8895232|NCT02034552|9953144|FG000|COMPLETED|Overall Study||8
8895233|NCT02034552|9953145|FG001|COMPLETED|Overall Study||4
8895234|NCT02034552|9953146|FG002|COMPLETED|Overall Study||5
8895235|NCT02034552|9953144|FG000|NOT COMPLETED|Overall Study||14
8895236|NCT02034552|9953145|FG001|NOT COMPLETED|Overall Study||20
8895237|NCT02034552|9953146|FG002|NOT COMPLETED|Overall Study||17
8895238|NCT02034565|9953154|FG000|STARTED|Overall Study||7
8895239|NCT02034565|9953155|FG001|STARTED|Overall Study||7
8895240|NCT02034565|9953154|FG000|COMPLETED|Overall Study||6
8895241|NCT02034565|9953155|FG001|COMPLETED|Overall Study||7
8895242|NCT02034565|9953154|FG000|NOT COMPLETED|Overall Study||1
8895243|NCT02034565|9953155|FG001|NOT COMPLETED|Overall Study||0
8895244|NCT02034578|9953163|FG000|STARTED|Overall Study||4
8895245|NCT02034578|9953164|FG001|STARTED|Overall Study||3
8895246|NCT02034578|9953165|FG002|STARTED|Overall Study||4
8895247|NCT02034578|9953166|FG003|STARTED|Overall Study||3
8895248|NCT02034578|9953167|FG004|STARTED|Overall Study||4
8895249|NCT02034578|9953168|FG005|STARTED|Overall Study||3
8895250|NCT02034578|9953163|FG000|COMPLETED|Overall Study||4
8895251|NCT02034578|9953164|FG001|COMPLETED|Overall Study||3
8895252|NCT02034578|9953165|FG002|COMPLETED|Overall Study||4
8895253|NCT02034578|9953166|FG003|COMPLETED|Overall Study||3
8895254|NCT02034578|9953167|FG004|COMPLETED|Overall Study||4
8895255|NCT02034578|9953168|FG005|COMPLETED|Overall Study||3
8895256|NCT02034578|9953163|FG000|NOT COMPLETED|Overall Study||0
8895257|NCT02034578|9953164|FG001|NOT COMPLETED|Overall Study||0
8895258|NCT02034578|9953165|FG002|NOT COMPLETED|Overall Study||0
8895259|NCT02034578|9953166|FG003|NOT COMPLETED|Overall Study||0
8895260|NCT02034578|9953167|FG004|NOT COMPLETED|Overall Study||0
8895261|NCT02034578|9953168|FG005|NOT COMPLETED|Overall Study||0
8895262|NCT02034591|9953177|FG000|STARTED|Overall Study||4
8895263|NCT02034591|9953178|FG001|STARTED|Overall Study||3
8895264|NCT02034591|9953179|FG002|STARTED|Overall Study||4
8895265|NCT02034591|9953180|FG003|STARTED|Overall Study||3
8895266|NCT02034591|9953181|FG004|STARTED|Overall Study||4
8895267|NCT02034591|9953182|FG005|STARTED|Overall Study||3
8895268|NCT02034591|9953177|FG000|COMPLETED|Overall Study||4
8635315|NCT00561353|9675796|FG007|COMPLETED|Overall Study||6
8895269|NCT02034591|9953178|FG001|COMPLETED|Overall Study||3
8895270|NCT02034591|9953179|FG002|COMPLETED|Overall Study||4
8895271|NCT02034591|9953180|FG003|COMPLETED|Overall Study||3
8895272|NCT02034591|9953181|FG004|COMPLETED|Overall Study||3
8895273|NCT02034591|9953182|FG005|COMPLETED|Overall Study||3
8895274|NCT02034591|9953177|FG000|NOT COMPLETED|Overall Study||0
8895275|NCT02034591|9953178|FG001|NOT COMPLETED|Overall Study||0
8895276|NCT02034591|9953179|FG002|NOT COMPLETED|Overall Study||0
8895277|NCT02034591|9953180|FG003|NOT COMPLETED|Overall Study||0
8895278|NCT02034591|9953181|FG004|NOT COMPLETED|Overall Study||1
8895279|NCT02034591|9953182|FG005|NOT COMPLETED|Overall Study||0
8895280|NCT02034708|9953193|FG000|STARTED|First Contrast Agent Injection (1 Day)||138
8895281|NCT02034708|9953194|FG001|STARTED|First Contrast Agent Injection (1 Day)||130
8895282|NCT02034708|9953193|FG000|COMPLETED|First Contrast Agent Injection (1 Day)||138
8895283|NCT02034708|9953194|FG001|COMPLETED|First Contrast Agent Injection (1 Day)||130
8895284|NCT02034708|9953193|FG000|NOT COMPLETED|First Contrast Agent Injection (1 Day)||0
8895285|NCT02034708|9953194|FG001|NOT COMPLETED|First Contrast Agent Injection (1 Day)||0
8895286|NCT02034708|9953193|FG000|STARTED|Wash-out (From 2 Days up to 14 Days)||138
8895287|NCT02034708|9953194|FG001|STARTED|Wash-out (From 2 Days up to 14 Days)||130
8895288|NCT02034708|9953193|FG000|COMPLETED|Wash-out (From 2 Days up to 14 Days)||129
8895289|NCT02034708|9953194|FG001|COMPLETED|Wash-out (From 2 Days up to 14 Days)||120
8895290|NCT02034708|9953193|FG000|NOT COMPLETED|Wash-out (From 2 Days up to 14 Days)||9
8635316|NCT00561353|9675797|FG008|COMPLETED|Overall Study||2
8635317|NCT00561353|9675798|FG009|COMPLETED|Overall Study||3
8635318|NCT00561353|9675789|FG000|NOT COMPLETED|Overall Study||5
8635319|NCT00561353|9675790|FG001|NOT COMPLETED|Overall Study||3
8635320|NCT00561353|9675791|FG002|NOT COMPLETED|Overall Study||3
8635321|NCT00561353|9675792|FG003|NOT COMPLETED|Overall Study||6
8726182|NCT01034397|9773340|FG000|NOT COMPLETED|Overall Study||7
8726183|NCT01034397|9773341|FG001|NOT COMPLETED|Overall Study||2
8726184|NCT01034462|9773358|FG000|STARTED|Overall Study||217
8726185|NCT01034462|9773359|FG001|STARTED|Overall Study||217
8726186|NCT01034462|9773358|FG000|COMPLETED|Overall Study||172
8726187|NCT01034462|9773359|FG001|COMPLETED|Overall Study||163
8726188|NCT01034462|9773358|FG000|NOT COMPLETED|Overall Study||45
8726189|NCT01034462|9773359|FG001|NOT COMPLETED|Overall Study||54
8726190|NCT01034527|9773369|FG000|STARTED|Overall Study||307
8726191|NCT01034527|9773370|FG001|STARTED|Overall Study||216
8726192|NCT01034527|9773369|FG000|COMPLETED|Overall Study||307
8726193|NCT01034527|9773370|FG001|COMPLETED|Overall Study||216
8726194|NCT01034527|9773369|FG000|NOT COMPLETED|Overall Study||0
8726195|NCT01034527|9773370|FG001|NOT COMPLETED|Overall Study||0
8726196|NCT01034540|9773378|FG000|STARTED|Overall Study||11
8726197|NCT01034540|9773379|FG001|STARTED|Overall Study||12
8726198|NCT01034540|9773378|FG000|Completed 1st Treatment Intervention|Overall Study||11
8726199|NCT01034540|9773379|FG001|Completed 1st Treatment Intervention|Overall Study||11
8726200|NCT01034540|9773378|FG000|COMPLETED|Overall Study||11
8726201|NCT01034540|9773379|FG001|COMPLETED|Overall Study||11
8726202|NCT01034540|9773378|FG000|NOT COMPLETED|Overall Study||0
8726203|NCT01034540|9773379|FG001|NOT COMPLETED|Overall Study||1
8726204|NCT01034553|9773387|FG000|STARTED|Overall Study||3
8726205|NCT01034553|9773388|FG001|STARTED|Overall Study||4
8726206|NCT01034553|9773389|FG002|STARTED|Overall Study||3
8895291|NCT02034708|9953194|FG001|NOT COMPLETED|Wash-out (From 2 Days up to 14 Days)||10
8895292|NCT02034708|9953193|FG000|STARTED|Second Contrast Agent Injection (1 Day)||129
8895293|NCT02034708|9953194|FG001|STARTED|Second Contrast Agent Injection (1 Day)||120
8895294|NCT02034708|9953193|FG000|COMPLETED|Second Contrast Agent Injection (1 Day)||129
8895295|NCT02034708|9953194|FG001|COMPLETED|Second Contrast Agent Injection (1 Day)||120
8895296|NCT02034708|9953193|FG000|NOT COMPLETED|Second Contrast Agent Injection (1 Day)||0
8895297|NCT02034708|9953194|FG001|NOT COMPLETED|Second Contrast Agent Injection (1 Day)||0
8895298|NCT02034799|9953207|FG000|STARTED|Overall Study||129
8895299|NCT02034799|9953208|FG001|STARTED|Overall Study||127
8895300|NCT02034799|9953207|FG000|COMPLETED|Overall Study||127
8895301|NCT02034799|9953208|FG001|COMPLETED|Overall Study||123
8895302|NCT02034799|9953207|FG000|NOT COMPLETED|Overall Study||2
8895303|NCT02034799|9953208|FG001|NOT COMPLETED|Overall Study||4
8895304|NCT02034877|9953216|FG000|STARTED|Overall Study||200
8895305|NCT02034877|9953217|FG001|STARTED|Overall Study||999
8895306|NCT02034877|9953216|FG000|COMPLETED|Overall Study||200
8895307|NCT02034877|9953217|FG001|COMPLETED|Overall Study||993
8895308|NCT02034877|9953216|FG000|NOT COMPLETED|Overall Study||0
8895309|NCT02034877|9953217|FG001|NOT COMPLETED|Overall Study||6
8895310|NCT02034916|9953225|FG000|STARTED|Overall Study||49
8895311|NCT02034916|9953226|FG001|STARTED|Overall Study||35
8895312|NCT02034916|9953225|FG000|Treated|Overall Study||48
8895313|NCT02034916|9953226|FG001|Treated|Overall Study||35
8895314|NCT02034916|9953225|FG000|COMPLETED|Overall Study||0
8895315|NCT02034916|9953226|FG001|COMPLETED|Overall Study||0
8895316|NCT02034916|9953225|FG000|NOT COMPLETED|Overall Study||49
8895317|NCT02034916|9953226|FG001|NOT COMPLETED|Overall Study||35
8895318|NCT02035202|9953236|FG000|STARTED|Overall Study||85
8895319|NCT02035202|9953237|FG001|STARTED|Overall Study||85
8635322|NCT00561353|9675793|FG004|NOT COMPLETED|Overall Study||1
8635323|NCT00561353|9675794|FG005|NOT COMPLETED|Overall Study||6
8635324|NCT00561353|9675795|FG006|NOT COMPLETED|Overall Study||6
8635325|NCT00561353|9675796|FG007|NOT COMPLETED|Overall Study||4
8635326|NCT00561353|9675797|FG008|NOT COMPLETED|Overall Study||7
8635327|NCT00561353|9675798|FG009|NOT COMPLETED|Overall Study||2
8726207|NCT01034553|9773390|FG003|STARTED|Overall Study||3
8726208|NCT01034553|9773391|FG004|STARTED|Overall Study||6
8726209|NCT01034553|9773392|FG005|STARTED|Overall Study||7
8895320|NCT02035202|9953238|FG002|STARTED|Overall Study||85
8895321|NCT02035202|9953236|FG000|COMPLETED|Overall Study||77
8895322|NCT02035202|9953237|FG001|COMPLETED|Overall Study||69
8895323|NCT02035202|9953238|FG002|COMPLETED|Overall Study||83
8895324|NCT02035202|9953236|FG000|NOT COMPLETED|Overall Study||8
8895325|NCT02035202|9953237|FG001|NOT COMPLETED|Overall Study||16
9007824|NCT02959307|10070657|FG001|NOT COMPLETED|Phase 2||0
9007825|NCT02959437|10070667|FG000|STARTED|Overall Study||62
9007826|NCT02959437|10070668|FG001|STARTED|Overall Study||8
9007827|NCT02959437|10070669|FG002|STARTED|Overall Study|Due to early termination of the trial Treatment groups B and C were not dosed.|0
9007828|NCT02959437|10070670|FG003|STARTED|Overall Study|Due to early termination of the trial Treatment groups B and C were not dosed.|0
9007829|NCT02959437|10070667|FG000|COMPLETED|Overall Study||0
9007830|NCT02959437|10070668|FG001|COMPLETED|Overall Study||0
9007831|NCT02959437|10070669|FG002|COMPLETED|Overall Study||0
9007832|NCT02959437|10070670|FG003|COMPLETED|Overall Study||0
9007833|NCT02959437|10070667|FG000|NOT COMPLETED|Overall Study||62
9007834|NCT02959437|10070668|FG001|NOT COMPLETED|Overall Study||8
9007835|NCT02959437|10070669|FG002|NOT COMPLETED|Overall Study||0
9007836|NCT02959437|10070670|FG003|NOT COMPLETED|Overall Study||0
9007837|NCT02959671|10070681|FG000|STARTED|Overall Study||34
9007838|NCT02959671|10070681|FG000|COMPLETED|Overall Study||29
9007839|NCT02959671|10070681|FG000|NOT COMPLETED|Overall Study||5
9007840|NCT02959814|10070685|FG000|STARTED|Overall Study|22-02-2017|329
9007841|NCT02959814|10070685|FG000|COMPLETED|Overall Study|17-10-2017|272
9007842|NCT02959814|10070685|FG000|NOT COMPLETED|Overall Study||57
9007843|NCT02959827|10070690|FG000|STARTED|Overall Study||2320
9007844|NCT02959827|10070690|FG000|COMPLETED|Overall Study||2320
9007845|NCT02959827|10070690|FG000|NOT COMPLETED|Overall Study||0
9039548|NCT03339999|10100528|FG001|Modified Intent-to-Treat Population|Overall Study||6
9039549|NCT03339999|10100529|FG002|Modified Intent-to-Treat Population|Overall Study||5
9039550|NCT03339999|10100530|FG003|Modified Intent-to-Treat Population|Overall Study||4
9039551|NCT03339999|10100527|FG000|Safety Population: Received Treatment|Overall Study||7
9039552|NCT03339999|10100528|FG001|Safety Population: Received Treatment|Overall Study||6
9039553|NCT03339999|10100529|FG002|Safety Population: Received Treatment|Overall Study||6
9039554|NCT03339999|10100530|FG003|Safety Population: Received Treatment|Overall Study||4
9039555|NCT03339999|10100527|FG000|COMPLETED|Overall Study||0
9039556|NCT03339999|10100528|FG001|COMPLETED|Overall Study||0
9039557|NCT03339999|10100529|FG002|COMPLETED|Overall Study||0
9039558|NCT03339999|10100530|FG003|COMPLETED|Overall Study||0
9039559|NCT03339999|10100527|FG000|NOT COMPLETED|Overall Study||7
9039560|NCT03339999|10100528|FG001|NOT COMPLETED|Overall Study||6
9039561|NCT03339999|10100529|FG002|NOT COMPLETED|Overall Study||6
9039562|NCT03339999|10100530|FG003|NOT COMPLETED|Overall Study||5
9039563|NCT03340025|10100545|FG000|STARTED|Overall Study||11
9039564|NCT03340025|10100546|FG001|STARTED|Overall Study||9
9039565|NCT03340025|10100545|FG000|COMPLETED|Overall Study||9
9039566|NCT03340025|10100546|FG001|COMPLETED|Overall Study||7
9039567|NCT03340025|10100545|FG000|NOT COMPLETED|Overall Study||2
9039568|NCT03340025|10100546|FG001|NOT COMPLETED|Overall Study||2
8635328|NCT00561392|9675860|FG000|STARTED|Overall Study||208
8635329|NCT00561392|9675860|FG000|COMPLETED|Overall Study||155
8635330|NCT00561392|9675860|FG000|NOT COMPLETED|Overall Study||53
8635331|NCT00561418|9675864|FG000|STARTED|Overall Study||23
8635332|NCT00561418|9675864|FG000|COMPLETED|Overall Study||23
8635333|NCT00561418|9675864|FG000|NOT COMPLETED|Overall Study||0
8635334|NCT00561431|9675870|FG000|STARTED|Overall Study||100
8635335|NCT00561431|9675871|FG001|STARTED|Overall Study||100
8635336|NCT00561431|9675870|FG000|COMPLETED|Overall Study||100
8635337|NCT00561431|9675871|FG001|COMPLETED|Overall Study||100
8635338|NCT00561431|9675870|FG000|NOT COMPLETED|Overall Study||0
8635339|NCT00561431|9675871|FG001|NOT COMPLETED|Overall Study||0
8726210|NCT01034553|9773387|FG000|COMPLETED|Overall Study||3
8726211|NCT01034553|9773388|FG001|COMPLETED|Overall Study||4
8895326|NCT02035202|9953238|FG002|NOT COMPLETED|Overall Study||2
8895327|NCT02035267|9953250|FG000|STARTED|Overall Study||31
8895328|NCT02035267|9953251|FG001|STARTED|Overall Study||16
8895329|NCT02035267|9953252|FG002|STARTED|Overall Study||30
8895330|NCT02035267|9953253|FG003|STARTED|Overall Study||16
8895331|NCT02035267|9953250|FG000|COMPLETED|Overall Study||31
8895332|NCT02035267|9953251|FG001|COMPLETED|Overall Study||15
8895333|NCT02035267|9953252|FG002|COMPLETED|Overall Study||28
8895334|NCT02035267|9953253|FG003|COMPLETED|Overall Study||15
8895335|NCT02035267|9953250|FG000|NOT COMPLETED|Overall Study||0
8635340|NCT00561457|9675877|FG000|STARTED|Overall Study||134
8635341|NCT00561457|9675877|FG000|COMPLETED|Overall Study||110
8895336|NCT02035267|9953251|FG001|NOT COMPLETED|Overall Study||1
8635342|NCT00561457|9675877|FG000|NOT COMPLETED|Overall Study||24
8635343|NCT00561470|9675883|FG000|STARTED|Overall Study||614
8635344|NCT00561470|9675884|FG001|STARTED|Overall Study||612
8635345|NCT00561470|9675883|FG000|TREATED|Overall Study||609
8635346|NCT00561470|9675884|FG001|TREATED|Overall Study||607
8635347|NCT00561470|9675883|FG000|SAFETY POPULATION|Overall Study|Treated participants excluding 4 who received at least 1 dose of Aflibercept|605
8635348|NCT00561470|9675884|FG001|SAFETY POPULATION|Overall Study|Treated participants including 4 from Placebo/FOLFIRI who received at least 1 dose of Aflibercept|611
8635349|NCT00561470|9675883|FG000|ONGOING TREATMENT|Overall Study|Participants continuing treatment on the cutoff date of the final analysis|11
8635350|NCT00561470|9675884|FG001|ONGOING TREATMENT|Overall Study|Participants continuing treatment on the cutoff date of the final analysis|14
8635351|NCT00561470|9675883|FG000|COMPLETED|Overall Study|Participants met treatment discontinuation criteria or were ongoing treatment on the cutoff date|0
8635352|NCT00561470|9675884|FG001|COMPLETED|Overall Study|Participants met treatment discontinuation criteria or were ongoing treatment on the cutoff date|0
8895337|NCT02035267|9953252|FG002|NOT COMPLETED|Overall Study||2
8895338|NCT02035267|9953253|FG003|NOT COMPLETED|Overall Study||1
8895339|NCT02035332|9953265|FG000|STARTED|Overall Study|Treatment Attempted|21
8895340|NCT02035332|9953265|FG000|Treated|Overall Study|Treatment Completed|20
8895341|NCT02035332|9953265|FG000|COMPLETED|Overall Study|Completed 12 Month Follow-up|20
8895342|NCT02035332|9953265|FG000|NOT COMPLETED|Overall Study||1
8895343|NCT02035345|9953269|FG000|STARTED|Overall Study||15
8895344|NCT02035345|9953269|FG000|COMPLETED|Overall Study||15
8895345|NCT02035345|9953269|FG000|NOT COMPLETED|Overall Study||0
8895346|NCT02035475|9953274|FG000|STARTED|Overall Study|120 subjects were consented for participation in the study.|120
8895347|NCT02035475|9953274|FG000|COMPLETED|Overall Study|Six subjects did not complete the study due to withdrawal of consent.|114
8895348|NCT02035475|9953274|FG000|NOT COMPLETED|Overall Study||6
8895349|NCT02035553|9953282|FG000|STARTED|Overall Study||91
8895350|NCT02035553|9953283|FG001|STARTED|Overall Study||90
8895351|NCT02035553|9953282|FG000|COMPLETED|Overall Study||73
8895352|NCT02035553|9953283|FG001|COMPLETED|Overall Study||67
8895353|NCT02035553|9953282|FG000|NOT COMPLETED|Overall Study||18
8895354|NCT02035553|9953283|FG001|NOT COMPLETED|Overall Study||23
8895355|NCT02035696|9953293|FG000|STARTED|Overall Study||174
8895356|NCT02035696|9953294|FG001|STARTED|Overall Study||166
8895357|NCT02035696|9953295|FG002|STARTED|Overall Study||167
8895358|NCT02035696|9953296|FG003|STARTED|Overall Study||164
8895359|NCT02035696|9953293|FG000|COMPLETED|Overall Study||171
8895360|NCT02035696|9953294|FG001|COMPLETED|Overall Study||163
8895361|NCT02035696|9953295|FG002|COMPLETED|Overall Study||164
8895362|NCT02035696|9953296|FG003|COMPLETED|Overall Study||161
8895363|NCT02035696|9953293|FG000|NOT COMPLETED|Overall Study||3
8895364|NCT02035696|9953294|FG001|NOT COMPLETED|Overall Study||3
8895365|NCT02035696|9953295|FG002|NOT COMPLETED|Overall Study||3
8895366|NCT02035696|9953296|FG003|NOT COMPLETED|Overall Study||3
8895367|NCT02035748|9953310|FG000|STARTED|Overall Study||468
8895368|NCT02035748|9953310|FG000|COMPLETED|Overall Study||448
8895369|NCT02035748|9953310|FG000|NOT COMPLETED|Overall Study||20
8895370|NCT02036294|9953317|FG000|STARTED|Overall Study||120
8635353|NCT00561470|9675883|FG000|NOT COMPLETED|Overall Study||614
8895371|NCT02036294|9953318|FG001|STARTED|Overall Study||120
8895372|NCT02036294|9953317|FG000|COMPLETED|Overall Study||111
8895373|NCT02036294|9953318|FG001|COMPLETED|Overall Study||109
8895374|NCT02036294|9953317|FG000|NOT COMPLETED|Overall Study||9
8895375|NCT02036294|9953318|FG001|NOT COMPLETED|Overall Study||11
8895376|NCT02036320|9953324|FG000|STARTED|Period 1||95
8895377|NCT02036320|9953325|FG001|STARTED|Period 1||95
8895378|NCT02036320|9953324|FG000|COMPLETED|Period 1||95
8895379|NCT02036320|9953325|FG001|COMPLETED|Period 1||95
8895380|NCT02036320|9953324|FG000|NOT COMPLETED|Period 1||0
8895381|NCT02036320|9953325|FG001|NOT COMPLETED|Period 1||0
8895382|NCT02036320|9953324|FG000|STARTED|Period 2||95
8895383|NCT02036320|9953325|FG001|STARTED|Period 2||95
8895384|NCT02036320|9953324|FG000|COMPLETED|Period 2||95
8895385|NCT02036320|9953325|FG001|COMPLETED|Period 2||95
8895386|NCT02036320|9953324|FG000|NOT COMPLETED|Period 2||0
8895387|NCT02036320|9953325|FG001|NOT COMPLETED|Period 2||0
8895388|NCT02036424|9953333|FG000|STARTED|Overall Study|23 study eyes, not number of subjects|23
8895389|NCT02036424|9953334|FG001|STARTED|Overall Study|27 study eyes, not number of subjects|27
8895390|NCT02036424|9953333|FG000|COMPLETED|Overall Study|23 study eyes, not number of subjects|23
8895391|NCT02036424|9953334|FG001|COMPLETED|Overall Study|27 study eyes, not number of subjects|27
8895392|NCT02036424|9953333|FG000|NOT COMPLETED|Overall Study||0
8895393|NCT02036424|9953334|FG001|NOT COMPLETED|Overall Study||0
8895394|NCT02036502|9953348|FG000|STARTED|Part 1:Dose Determination/Escalation||6
8895395|NCT02036502|9953349|FG001|STARTED|Part 1:Dose Determination/Escalation||4
8895396|NCT02036502|9953350|FG002|STARTED|Part 1:Dose Determination/Escalation||0
8895397|NCT02036502|9953351|FG003|STARTED|Part 1:Dose Determination/Escalation||0
8895398|NCT02036502|9953352|FG004|STARTED|Part 1:Dose Determination/Escalation||0
8895399|NCT02036502|9953353|FG005|STARTED|Part 1:Dose Determination/Escalation||0
8895400|NCT02036502|9953354|FG006|STARTED|Part 1:Dose Determination/Escalation||0
8895401|NCT02036502|9953355|FG007|STARTED|Part 1:Dose Determination/Escalation||0
8895402|NCT02036502|9953348|FG000|Treated|Part 1:Dose Determination/Escalation||6
8895403|NCT02036502|9953349|FG001|Treated|Part 1:Dose Determination/Escalation||3
8895404|NCT02036502|9953350|FG002|Treated|Part 1:Dose Determination/Escalation||0
8895405|NCT02036502|9953351|FG003|Treated|Part 1:Dose Determination/Escalation||0
8895406|NCT02036502|9953352|FG004|Treated|Part 1:Dose Determination/Escalation||0
8895407|NCT02036502|9953353|FG005|Treated|Part 1:Dose Determination/Escalation||0
8895408|NCT02036502|9953354|FG006|Treated|Part 1:Dose Determination/Escalation||0
8895409|NCT02036502|9953355|FG007|Treated|Part 1:Dose Determination/Escalation||0
8895410|NCT02036502|9953348|FG000|COMPLETED|Part 1:Dose Determination/Escalation||0
8895411|NCT02036502|9953349|FG001|COMPLETED|Part 1:Dose Determination/Escalation||0
8895412|NCT02036502|9953350|FG002|COMPLETED|Part 1:Dose Determination/Escalation||0
8895413|NCT02036502|9953351|FG003|COMPLETED|Part 1:Dose Determination/Escalation||0
8895414|NCT02036502|9953352|FG004|COMPLETED|Part 1:Dose Determination/Escalation||0
8895415|NCT02036502|9953353|FG005|COMPLETED|Part 1:Dose Determination/Escalation||0
8895416|NCT02036502|9953354|FG006|COMPLETED|Part 1:Dose Determination/Escalation||0
8895417|NCT02036502|9953355|FG007|COMPLETED|Part 1:Dose Determination/Escalation||0
8895418|NCT02036502|9953348|FG000|NOT COMPLETED|Part 1:Dose Determination/Escalation||6
8895419|NCT02036502|9953349|FG001|NOT COMPLETED|Part 1:Dose Determination/Escalation||4
8895420|NCT02036502|9953350|FG002|NOT COMPLETED|Part 1:Dose Determination/Escalation||0
8895421|NCT02036502|9953351|FG003|NOT COMPLETED|Part 1:Dose Determination/Escalation||0
8895422|NCT02036502|9953352|FG004|NOT COMPLETED|Part 1:Dose Determination/Escalation||0
8895423|NCT02036502|9953353|FG005|NOT COMPLETED|Part 1:Dose Determination/Escalation||0
8895424|NCT02036502|9953354|FG006|NOT COMPLETED|Part 1:Dose Determination/Escalation||0
8895425|NCT02036502|9953355|FG007|NOT COMPLETED|Part 1:Dose Determination/Escalation||0
8895426|NCT02036502|9953348|FG000|STARTED|Part 2:Dose Confirmation||0
8895427|NCT02036502|9953349|FG001|STARTED|Part 2:Dose Confirmation||0
8895428|NCT02036502|9953350|FG002|STARTED|Part 2:Dose Confirmation|Participants added to study for dose confirmation.|6
8895429|NCT02036502|9953351|FG003|STARTED|Part 2:Dose Confirmation|Participants added to study for dose confirmation.|2
8895430|NCT02036502|9953352|FG004|STARTED|Part 2:Dose Confirmation|Participants added to study for dose confirmation.|1
8895431|NCT02036502|9953353|FG005|STARTED|Part 2:Dose Confirmation||0
8895432|NCT02036502|9953354|FG006|STARTED|Part 2:Dose Confirmation||0
8895433|NCT02036502|9953355|FG007|STARTED|Part 2:Dose Confirmation||0
8895434|NCT02036502|9953348|FG000|Treated|Part 2:Dose Confirmation||0
8895435|NCT02036502|9953349|FG001|Treated|Part 2:Dose Confirmation||0
8895436|NCT02036502|9953350|FG002|Treated|Part 2:Dose Confirmation||6
8895437|NCT02036502|9953351|FG003|Treated|Part 2:Dose Confirmation||1
8895438|NCT02036502|9953352|FG004|Treated|Part 2:Dose Confirmation||1
8895439|NCT02036502|9953353|FG005|Treated|Part 2:Dose Confirmation||0
8895440|NCT02036502|9953354|FG006|Treated|Part 2:Dose Confirmation||0
8895441|NCT02036502|9953355|FG007|Treated|Part 2:Dose Confirmation||0
8895442|NCT02036502|9953348|FG000|COMPLETED|Part 2:Dose Confirmation||0
8895443|NCT02036502|9953349|FG001|COMPLETED|Part 2:Dose Confirmation||0
8895444|NCT02036502|9953350|FG002|COMPLETED|Part 2:Dose Confirmation||0
8895445|NCT02036502|9953351|FG003|COMPLETED|Part 2:Dose Confirmation||0
8895446|NCT02036502|9953352|FG004|COMPLETED|Part 2:Dose Confirmation||0
8895447|NCT02036502|9953353|FG005|COMPLETED|Part 2:Dose Confirmation||0
8895448|NCT02036502|9953354|FG006|COMPLETED|Part 2:Dose Confirmation||0
8895449|NCT02036502|9953355|FG007|COMPLETED|Part 2:Dose Confirmation||0
8895450|NCT02036502|9953348|FG000|NOT COMPLETED|Part 2:Dose Confirmation||0
8895451|NCT02036502|9953349|FG001|NOT COMPLETED|Part 2:Dose Confirmation||0
8895452|NCT02036502|9953350|FG002|NOT COMPLETED|Part 2:Dose Confirmation||6
8895453|NCT02036502|9953351|FG003|NOT COMPLETED|Part 2:Dose Confirmation||2
8895454|NCT02036502|9953352|FG004|NOT COMPLETED|Part 2:Dose Confirmation||1
8895455|NCT02036502|9953353|FG005|NOT COMPLETED|Part 2:Dose Confirmation||0
8895456|NCT02036502|9953354|FG006|NOT COMPLETED|Part 2:Dose Confirmation||0
8895457|NCT02036502|9953355|FG007|NOT COMPLETED|Part 2:Dose Confirmation||0
8895458|NCT02036502|9953348|FG000|STARTED|Part 3:Dose Expansion||0
8895459|NCT02036502|9953349|FG001|STARTED|Part 3:Dose Expansion||0
8895460|NCT02036502|9953350|FG002|STARTED|Part 3:Dose Expansion||0
8895461|NCT02036502|9953351|FG003|STARTED|Part 3:Dose Expansion||0
8895462|NCT02036502|9953352|FG004|STARTED|Part 3:Dose Expansion||0
8895463|NCT02036502|9953353|FG005|STARTED|Part 3:Dose Expansion|Participants added to study for dose expansion|47
8895464|NCT02036502|9953354|FG006|STARTED|Part 3:Dose Expansion|Participants added to study for dose expansion|1
8895465|NCT02036502|9953355|FG007|STARTED|Part 3:Dose Expansion|Participants added to study for dose expansion|10
8895466|NCT02036502|9953348|FG000|Treated|Part 3:Dose Expansion||0
8895467|NCT02036502|9953349|FG001|Treated|Part 3:Dose Expansion||0
8895468|NCT02036502|9953350|FG002|Treated|Part 3:Dose Expansion||0
8895469|NCT02036502|9953351|FG003|Treated|Part 3:Dose Expansion||0
8895470|NCT02036502|9953352|FG004|Treated|Part 3:Dose Expansion||0
8895471|NCT02036502|9953353|FG005|Treated|Part 3:Dose Expansion||45
8895472|NCT02036502|9953354|FG006|Treated|Part 3:Dose Expansion||1
8895473|NCT02036502|9953355|FG007|Treated|Part 3:Dose Expansion||10
8895474|NCT02036502|9953348|FG000|COMPLETED|Part 3:Dose Expansion||0
8895475|NCT02036502|9953349|FG001|COMPLETED|Part 3:Dose Expansion||0
8895476|NCT02036502|9953350|FG002|COMPLETED|Part 3:Dose Expansion||0
8895477|NCT02036502|9953351|FG003|COMPLETED|Part 3:Dose Expansion||0
8895478|NCT02036502|9953352|FG004|COMPLETED|Part 3:Dose Expansion||0
8895479|NCT02036502|9953353|FG005|COMPLETED|Part 3:Dose Expansion||0
8895480|NCT02036502|9953354|FG006|COMPLETED|Part 3:Dose Expansion||0
8895481|NCT02036502|9953355|FG007|COMPLETED|Part 3:Dose Expansion||0
8895482|NCT02036502|9953348|FG000|NOT COMPLETED|Part 3:Dose Expansion||0
8895483|NCT02036502|9953349|FG001|NOT COMPLETED|Part 3:Dose Expansion||0
8895484|NCT02036502|9953350|FG002|NOT COMPLETED|Part 3:Dose Expansion||0
8895485|NCT02036502|9953351|FG003|NOT COMPLETED|Part 3:Dose Expansion||0
8895486|NCT02036502|9953352|FG004|NOT COMPLETED|Part 3:Dose Expansion||0
8895487|NCT02036502|9953353|FG005|NOT COMPLETED|Part 3:Dose Expansion||47
8895488|NCT02036502|9953354|FG006|NOT COMPLETED|Part 3:Dose Expansion||1
8895489|NCT02036502|9953355|FG007|NOT COMPLETED|Part 3:Dose Expansion||10
8895490|NCT02036515|9953378|FG000|STARTED|Overall Study||156
8895491|NCT02036515|9953379|FG001|STARTED|Overall Study||155
8895492|NCT02036515|9953380|FG002|STARTED|Overall Study||153
8895493|NCT02036515|9953378|FG000|Treated|Overall Study||156
8895494|NCT02036515|9953379|FG001|Treated|Overall Study||153
8895495|NCT02036515|9953380|FG002|Treated|Overall Study||153
8895496|NCT02036515|9953378|FG000|COMPLETED|Overall Study||151
8895497|NCT02036515|9953379|FG001|COMPLETED|Overall Study||143
8895498|NCT02036515|9953380|FG002|COMPLETED|Overall Study||139
8895499|NCT02036515|9953378|FG000|NOT COMPLETED|Overall Study||5
8895500|NCT02036515|9953379|FG001|NOT COMPLETED|Overall Study||12
8895501|NCT02036515|9953380|FG002|NOT COMPLETED|Overall Study||14
8895502|NCT02036541|9953388|FG000|STARTED|Overall Study||65
8895503|NCT02036541|9953388|FG000|Completed Endpoint Visit|Overall Study||54
8895504|NCT02036541|9953388|FG000|COMPLETED|Overall Study||49
8895505|NCT02036541|9953388|FG000|NOT COMPLETED|Overall Study||16
8895506|NCT02036580|9953395|FG000|STARTED|Overall Study||8
8895507|NCT02036580|9953396|FG001|STARTED|Overall Study||8
8895508|NCT02036580|9953397|FG002|STARTED|Overall Study||4
8895509|NCT02036580|9953395|FG000|COMPLETED|Overall Study||7
8895510|NCT02036580|9953396|FG001|COMPLETED|Overall Study||7
8895511|NCT02036580|9953397|FG002|COMPLETED|Overall Study||4
8895512|NCT02036580|9953395|FG000|NOT COMPLETED|Overall Study||1
8895513|NCT02036580|9953396|FG001|NOT COMPLETED|Overall Study||1
8895514|NCT02036580|9953397|FG002|NOT COMPLETED|Overall Study||0
8895515|NCT02036645|9953417|FG000|STARTED|SAD Cohorts : Study Part 1|Pooled across cohorts 1-5 (2 per cohort)|12
8895516|NCT02036645|9953418|FG001|STARTED|SAD Cohorts : Study Part 1||3
8895517|NCT02036645|9953419|FG002|STARTED|SAD Cohorts : Study Part 1||6
8895518|NCT02036645|9953420|FG003|STARTED|SAD Cohorts : Study Part 1||6
8895519|NCT02036645|9953421|FG004|STARTED|SAD Cohorts : Study Part 1||6
8895520|NCT02036645|9953422|FG005|STARTED|SAD Cohorts : Study Part 1||6
8895521|NCT02036645|9953423|FG006|STARTED|SAD Cohorts : Study Part 1||6
8895522|NCT02036645|9953424|FG007|STARTED|SAD Cohorts : Study Part 1||0
8895523|NCT02036645|9953425|FG008|STARTED|SAD Cohorts : Study Part 1||0
8895524|NCT02036645|9953426|FG009|STARTED|SAD Cohorts : Study Part 1||0
8895525|NCT02036645|9953427|FG010|STARTED|SAD Cohorts : Study Part 1||0
8895526|NCT02036645|9953428|FG011|STARTED|SAD Cohorts : Study Part 1||0
8895527|NCT02036645|9953417|FG000|COMPLETED|SAD Cohorts : Study Part 1||12
8895528|NCT02036645|9953418|FG001|COMPLETED|SAD Cohorts : Study Part 1||3
8895529|NCT02036645|9953419|FG002|COMPLETED|SAD Cohorts : Study Part 1||6
8895530|NCT02036645|9953420|FG003|COMPLETED|SAD Cohorts : Study Part 1||5
8895531|NCT02036645|9953421|FG004|COMPLETED|SAD Cohorts : Study Part 1||6
8895532|NCT02036645|9953422|FG005|COMPLETED|SAD Cohorts : Study Part 1||6
8895533|NCT02036645|9953423|FG006|COMPLETED|SAD Cohorts : Study Part 1||5
8895534|NCT02036645|9953424|FG007|COMPLETED|SAD Cohorts : Study Part 1||0
9007846|NCT02959840|10070701|FG000|STARTED|Overall Study||60
9007847|NCT02959840|10070702|FG001|STARTED|Overall Study||60
9007848|NCT02959840|10070703|FG002|STARTED|Overall Study||60
9007849|NCT02959840|10070701|FG000|COMPLETED|Overall Study||60
9007850|NCT02959840|10070702|FG001|COMPLETED|Overall Study||60
9007851|NCT02959840|10070703|FG002|COMPLETED|Overall Study||60
9007852|NCT02959840|10070701|FG000|NOT COMPLETED|Overall Study||0
9007853|NCT02959840|10070702|FG001|NOT COMPLETED|Overall Study||0
8635354|NCT00561470|9675884|FG001|NOT COMPLETED|Overall Study||612
8635355|NCT00561574|9675894|FG000|STARTED|Overall Study||128
8635356|NCT00561574|9675895|FG001|STARTED|Overall Study||131
8635357|NCT00561574|9675894|FG000|COMPLETED|Overall Study||80
8635358|NCT00561574|9675895|FG001|COMPLETED|Overall Study||73
8635359|NCT00561574|9675894|FG000|NOT COMPLETED|Overall Study||48
8635360|NCT00561574|9675895|FG001|NOT COMPLETED|Overall Study||58
8635361|NCT00561600|9675903|FG000|STARTED|Overall Study||130
9007854|NCT02959840|10070703|FG002|NOT COMPLETED|Overall Study||0
9007855|NCT02959853|10070713|FG000|STARTED|Overall Study||11
9007856|NCT02959853|10070714|FG001|STARTED|Overall Study||12
9007857|NCT02959853|10070713|FG000|COMPLETED|Overall Study||7
9007858|NCT02959853|10070714|FG001|COMPLETED|Overall Study||10
9007859|NCT02959853|10070713|FG000|NOT COMPLETED|Overall Study||4
9007860|NCT02959853|10070714|FG001|NOT COMPLETED|Overall Study||2
9007861|NCT02959866|10070721|FG000|STARTED|Overall Study||59
9007862|NCT02959866|10070721|FG000|Telephone Interview at 1 Month Follow-up|Overall Study||59
9007863|NCT02959866|10070721|FG000|COMPLETED|Overall Study||58
9007864|NCT02959866|10070721|FG000|NOT COMPLETED|Overall Study||1
9007865|NCT02959892|10070728|FG000|STARTED|Overall Study||6
9007866|NCT02959892|10070729|FG001|STARTED|Overall Study||6
9007867|NCT02959892|10070728|FG000|COMPLETED|Overall Study||5
9007868|NCT02959892|10070729|FG001|COMPLETED|Overall Study||5
9007869|NCT02959892|10070728|FG000|NOT COMPLETED|Overall Study||1
8635362|NCT00561600|9675904|FG001|STARTED|Overall Study||135
9007870|NCT02959892|10070729|FG001|NOT COMPLETED|Overall Study||1
9007871|NCT02959970|10070737|FG000|STARTED|Overall Study||17
9007872|NCT02959970|10070738|FG001|STARTED|Overall Study||83
8635363|NCT00561600|9675903|FG000|COMPLETED|Overall Study||112
8635364|NCT00561600|9675904|FG001|COMPLETED|Overall Study||119
8635365|NCT00561600|9675903|FG000|NOT COMPLETED|Overall Study||18
8635366|NCT00561600|9675904|FG001|NOT COMPLETED|Overall Study||16
8635367|NCT00561652|9675914|FG000|STARTED|Overall Study||10
8635368|NCT00561652|9675915|FG001|STARTED|Overall Study||20
8635369|NCT00561652|9675914|FG000|COMPLETED|Overall Study||10
8895535|NCT02036645|9953425|FG008|COMPLETED|SAD Cohorts : Study Part 1||0
8895536|NCT02036645|9953426|FG009|COMPLETED|SAD Cohorts : Study Part 1||0
8895537|NCT02036645|9953427|FG010|COMPLETED|SAD Cohorts : Study Part 1||0
8895538|NCT02036645|9953428|FG011|COMPLETED|SAD Cohorts : Study Part 1||0
8895539|NCT02036645|9953417|FG000|NOT COMPLETED|SAD Cohorts : Study Part 1||0
8895540|NCT02036645|9953418|FG001|NOT COMPLETED|SAD Cohorts : Study Part 1||0
8895541|NCT02036645|9953419|FG002|NOT COMPLETED|SAD Cohorts : Study Part 1||0
8895542|NCT02036645|9953420|FG003|NOT COMPLETED|SAD Cohorts : Study Part 1||1
8895543|NCT02036645|9953421|FG004|NOT COMPLETED|SAD Cohorts : Study Part 1||0
8895544|NCT02036645|9953422|FG005|NOT COMPLETED|SAD Cohorts : Study Part 1||0
8895545|NCT02036645|9953423|FG006|NOT COMPLETED|SAD Cohorts : Study Part 1||1
8895546|NCT02036645|9953424|FG007|NOT COMPLETED|SAD Cohorts : Study Part 1||0
8895547|NCT02036645|9953425|FG008|NOT COMPLETED|SAD Cohorts : Study Part 1||0
8895548|NCT02036645|9953426|FG009|NOT COMPLETED|SAD Cohorts : Study Part 1||0
8895549|NCT02036645|9953427|FG010|NOT COMPLETED|SAD Cohorts : Study Part 1||0
8895550|NCT02036645|9953428|FG011|NOT COMPLETED|SAD Cohorts : Study Part 1||0
8895551|NCT02036645|9953417|FG000|STARTED|MAD Cohorts: Study Part 2|Pooled across Cohorts 7 to 9 (2 per cohort)|0
8895552|NCT02036645|9953418|FG001|STARTED|MAD Cohorts: Study Part 2||0
8895553|NCT02036645|9953419|FG002|STARTED|MAD Cohorts: Study Part 2||0
8895554|NCT02036645|9953420|FG003|STARTED|MAD Cohorts: Study Part 2||0
8895555|NCT02036645|9953421|FG004|STARTED|MAD Cohorts: Study Part 2||0
8895556|NCT02036645|9953422|FG005|STARTED|MAD Cohorts: Study Part 2||0
8895557|NCT02036645|9953423|FG006|STARTED|MAD Cohorts: Study Part 2||0
8895558|NCT02036645|9953424|FG007|STARTED|MAD Cohorts: Study Part 2||8
8635370|NCT00561652|9675915|FG001|COMPLETED|Overall Study||19
8635371|NCT00561652|9675914|FG000|NOT COMPLETED|Overall Study||0
8635372|NCT00561652|9675915|FG001|NOT COMPLETED|Overall Study||1
8635373|NCT00561678|9675923|FG000|STARTED|Overall Study||197
8635374|NCT00561678|9675924|FG001|STARTED|Overall Study||207
8635375|NCT00561678|9675923|FG000|COMPLETED|Overall Study||189
8635376|NCT00561678|9675924|FG001|COMPLETED|Overall Study||201
8895559|NCT02036645|9953425|FG008|STARTED|MAD Cohorts: Study Part 2||6
8895560|NCT02036645|9953426|FG009|STARTED|MAD Cohorts: Study Part 2||6
8895561|NCT02036645|9953427|FG010|STARTED|MAD Cohorts: Study Part 2||6
8895562|NCT02036645|9953428|FG011|STARTED|MAD Cohorts: Study Part 2||6
8895563|NCT02036645|9953417|FG000|COMPLETED|MAD Cohorts: Study Part 2||0
8895564|NCT02036645|9953418|FG001|COMPLETED|MAD Cohorts: Study Part 2||0
8895565|NCT02036645|9953419|FG002|COMPLETED|MAD Cohorts: Study Part 2||0
8895566|NCT02036645|9953420|FG003|COMPLETED|MAD Cohorts: Study Part 2||0
8895567|NCT02036645|9953421|FG004|COMPLETED|MAD Cohorts: Study Part 2||0
8895568|NCT02036645|9953422|FG005|COMPLETED|MAD Cohorts: Study Part 2||0
8895569|NCT02036645|9953423|FG006|COMPLETED|MAD Cohorts: Study Part 2||0
8895570|NCT02036645|9953424|FG007|COMPLETED|MAD Cohorts: Study Part 2||8
8895571|NCT02036645|9953425|FG008|COMPLETED|MAD Cohorts: Study Part 2||6
8895572|NCT02036645|9953426|FG009|COMPLETED|MAD Cohorts: Study Part 2||6
8895573|NCT02036645|9953427|FG010|COMPLETED|MAD Cohorts: Study Part 2||6
8895574|NCT02036645|9953428|FG011|COMPLETED|MAD Cohorts: Study Part 2||6
8895575|NCT02036645|9953417|FG000|NOT COMPLETED|MAD Cohorts: Study Part 2||0
8895576|NCT02036645|9953418|FG001|NOT COMPLETED|MAD Cohorts: Study Part 2||0
8895577|NCT02036645|9953419|FG002|NOT COMPLETED|MAD Cohorts: Study Part 2||0
8895578|NCT02036645|9953420|FG003|NOT COMPLETED|MAD Cohorts: Study Part 2||0
8895579|NCT02036645|9953421|FG004|NOT COMPLETED|MAD Cohorts: Study Part 2||0
8895580|NCT02036645|9953422|FG005|NOT COMPLETED|MAD Cohorts: Study Part 2||0
8895581|NCT02036645|9953423|FG006|NOT COMPLETED|MAD Cohorts: Study Part 2||0
8895582|NCT02036645|9953424|FG007|NOT COMPLETED|MAD Cohorts: Study Part 2||0
8895583|NCT02036645|9953425|FG008|NOT COMPLETED|MAD Cohorts: Study Part 2||0
8895584|NCT02036645|9953426|FG009|NOT COMPLETED|MAD Cohorts: Study Part 2||0
8895585|NCT02036645|9953427|FG010|NOT COMPLETED|MAD Cohorts: Study Part 2||0
8895586|NCT02036645|9953428|FG011|NOT COMPLETED|MAD Cohorts: Study Part 2||0
8895587|NCT02036775|9953466|FG000|STARTED|Treatment Period 1 (6 Days)||4
8895588|NCT02036775|9953467|FG001|STARTED|Treatment Period 1 (6 Days)||4
8895589|NCT02036775|9953468|FG002|STARTED|Treatment Period 1 (6 Days)||4
8895590|NCT02036775|9953469|FG003|STARTED|Treatment Period 1 (6 Days)||4
8895591|NCT02036775|9953470|FG004|STARTED|Treatment Period 1 (6 Days)||4
8895592|NCT02036775|9953471|FG005|STARTED|Treatment Period 1 (6 Days)||4
8895593|NCT02036775|9953466|FG000|COMPLETED|Treatment Period 1 (6 Days)||4
8895594|NCT02036775|9953467|FG001|COMPLETED|Treatment Period 1 (6 Days)||4
8895595|NCT02036775|9953468|FG002|COMPLETED|Treatment Period 1 (6 Days)||4
8895596|NCT02036775|9953469|FG003|COMPLETED|Treatment Period 1 (6 Days)||4
8895597|NCT02036775|9953470|FG004|COMPLETED|Treatment Period 1 (6 Days)||4
8895598|NCT02036775|9953471|FG005|COMPLETED|Treatment Period 1 (6 Days)||4
8895599|NCT02036775|9953466|FG000|NOT COMPLETED|Treatment Period 1 (6 Days)||0
8635377|NCT00561678|9675923|FG000|NOT COMPLETED|Overall Study||8
8635378|NCT00561678|9675924|FG001|NOT COMPLETED|Overall Study||6
8635379|NCT00561730|9675930|FG000|STARTED|Overall Study||1995
8635380|NCT00561730|9675930|FG000|COMPLETED|Overall Study||1986
8635381|NCT00561730|9675930|FG000|NOT COMPLETED|Overall Study||9
8635382|NCT00561821|9675940|FG000|STARTED|Overall Study||132
8895600|NCT02036775|9953467|FG001|NOT COMPLETED|Treatment Period 1 (6 Days)||0
8895601|NCT02036775|9953468|FG002|NOT COMPLETED|Treatment Period 1 (6 Days)||0
8895602|NCT02036775|9953469|FG003|NOT COMPLETED|Treatment Period 1 (6 Days)||0
8895603|NCT02036775|9953470|FG004|NOT COMPLETED|Treatment Period 1 (6 Days)||0
8895604|NCT02036775|9953471|FG005|NOT COMPLETED|Treatment Period 1 (6 Days)||0
8895605|NCT02036775|9953466|FG000|STARTED|Treatment Period 2 (6 Days)||4
8895606|NCT02036775|9953467|FG001|STARTED|Treatment Period 2 (6 Days)||4
8895607|NCT02036775|9953468|FG002|STARTED|Treatment Period 2 (6 Days)||4
8895608|NCT02036775|9953469|FG003|STARTED|Treatment Period 2 (6 Days)||4
8895609|NCT02036775|9953470|FG004|STARTED|Treatment Period 2 (6 Days)||4
8895610|NCT02036775|9953471|FG005|STARTED|Treatment Period 2 (6 Days)||4
8895611|NCT02036775|9953466|FG000|COMPLETED|Treatment Period 2 (6 Days)||4
8895612|NCT02036775|9953467|FG001|COMPLETED|Treatment Period 2 (6 Days)||4
8895613|NCT02036775|9953468|FG002|COMPLETED|Treatment Period 2 (6 Days)||4
8895614|NCT02036775|9953469|FG003|COMPLETED|Treatment Period 2 (6 Days)||4
8895615|NCT02036775|9953470|FG004|COMPLETED|Treatment Period 2 (6 Days)||4
8895616|NCT02036775|9953471|FG005|COMPLETED|Treatment Period 2 (6 Days)||3
8895617|NCT02036775|9953466|FG000|NOT COMPLETED|Treatment Period 2 (6 Days)||0
8895618|NCT02036775|9953467|FG001|NOT COMPLETED|Treatment Period 2 (6 Days)||0
8895619|NCT02036775|9953468|FG002|NOT COMPLETED|Treatment Period 2 (6 Days)||0
8895620|NCT02036775|9953469|FG003|NOT COMPLETED|Treatment Period 2 (6 Days)||0
8895621|NCT02036775|9953470|FG004|NOT COMPLETED|Treatment Period 2 (6 Days)||0
8895622|NCT02036775|9953471|FG005|NOT COMPLETED|Treatment Period 2 (6 Days)||1
8895623|NCT02036775|9953466|FG000|STARTED|Treatment Period 3 (6 Days)||4
8895624|NCT02036775|9953467|FG001|STARTED|Treatment Period 3 (6 Days)||4
8895625|NCT02036775|9953468|FG002|STARTED|Treatment Period 3 (6 Days)||4
8895626|NCT02036775|9953469|FG003|STARTED|Treatment Period 3 (6 Days)||4
8895627|NCT02036775|9953470|FG004|STARTED|Treatment Period 3 (6 Days)||4
8895628|NCT02036775|9953471|FG005|STARTED|Treatment Period 3 (6 Days)||3
8895629|NCT02036775|9953466|FG000|COMPLETED|Treatment Period 3 (6 Days)||4
8895630|NCT02036775|9953467|FG001|COMPLETED|Treatment Period 3 (6 Days)||4
8895631|NCT02036775|9953468|FG002|COMPLETED|Treatment Period 3 (6 Days)||4
8895632|NCT02036775|9953469|FG003|COMPLETED|Treatment Period 3 (6 Days)||4
8895633|NCT02036775|9953470|FG004|COMPLETED|Treatment Period 3 (6 Days)||4
8895634|NCT02036775|9953471|FG005|COMPLETED|Treatment Period 3 (6 Days)||3
8895635|NCT02036775|9953466|FG000|NOT COMPLETED|Treatment Period 3 (6 Days)||0
8895636|NCT02036775|9953467|FG001|NOT COMPLETED|Treatment Period 3 (6 Days)||0
8895637|NCT02036775|9953468|FG002|NOT COMPLETED|Treatment Period 3 (6 Days)||0
8895638|NCT02036775|9953469|FG003|NOT COMPLETED|Treatment Period 3 (6 Days)||0
8895639|NCT02036775|9953470|FG004|NOT COMPLETED|Treatment Period 3 (6 Days)||0
8895640|NCT02036775|9953471|FG005|NOT COMPLETED|Treatment Period 3 (6 Days)||0
8895641|NCT02036840|9953479|FG000|STARTED|Overall Study||513
8895642|NCT02036840|9953479|FG000|COMPLETED|Overall Study||513
8895643|NCT02036840|9953479|FG000|NOT COMPLETED|Overall Study||0
8895644|NCT02036853|9953485|FG000|STARTED|Overall Study||6
8895645|NCT02036853|9953486|FG001|STARTED|Overall Study||14
8895646|NCT02036853|9953485|FG000|COMPLETED|Overall Study||6
8895647|NCT02036853|9953486|FG001|COMPLETED|Overall Study||8
8895648|NCT02036853|9953485|FG000|NOT COMPLETED|Overall Study||0
8895649|NCT02036853|9953486|FG001|NOT COMPLETED|Overall Study||6
8895650|NCT02037061|9953494|FG000|STARTED|Overall Study||22
8895651|NCT02037061|9953495|FG001|STARTED|Overall Study||24
8895652|NCT02037061|9953494|FG000|COMPLETED|Overall Study||22
8895653|NCT02037061|9953495|FG001|COMPLETED|Overall Study||24
8895654|NCT02037061|9953494|FG000|NOT COMPLETED|Overall Study||0
8895655|NCT02037061|9953495|FG001|NOT COMPLETED|Overall Study||0
8895656|NCT02037165|9953508|FG000|STARTED|Period 1 (2 Days)|randomized subjects|5
8895657|NCT02037165|9953509|FG001|STARTED|Period 1 (2 Days)|randomized subjects|5
8895658|NCT02037165|9953510|FG002|STARTED|Period 1 (2 Days)|randomized subjects|5
8895659|NCT02037165|9953511|FG003|STARTED|Period 1 (2 Days)|randomized subjects|5
8895660|NCT02037165|9953512|FG004|STARTED|Period 1 (2 Days)|randomized subjects|5
8895661|NCT02037165|9953508|FG000|COMPLETED|Period 1 (2 Days)||5
8895662|NCT02037165|9953509|FG001|COMPLETED|Period 1 (2 Days)||5
8895663|NCT02037165|9953510|FG002|COMPLETED|Period 1 (2 Days)||5
8895664|NCT02037165|9953511|FG003|COMPLETED|Period 1 (2 Days)||5
8895665|NCT02037165|9953512|FG004|COMPLETED|Period 1 (2 Days)||5
8895666|NCT02037165|9953508|FG000|NOT COMPLETED|Period 1 (2 Days)||0
8895667|NCT02037165|9953509|FG001|NOT COMPLETED|Period 1 (2 Days)||0
8895668|NCT02037165|9953510|FG002|NOT COMPLETED|Period 1 (2 Days)||0
8895669|NCT02037165|9953511|FG003|NOT COMPLETED|Period 1 (2 Days)||0
8895670|NCT02037165|9953512|FG004|NOT COMPLETED|Period 1 (2 Days)||0
8895671|NCT02037165|9953508|FG000|STARTED|Washout Period 1 (6 Days)||5
8895672|NCT02037165|9953509|FG001|STARTED|Washout Period 1 (6 Days)||5
8895673|NCT02037165|9953510|FG002|STARTED|Washout Period 1 (6 Days)||5
8895674|NCT02037165|9953511|FG003|STARTED|Washout Period 1 (6 Days)||5
8895675|NCT02037165|9953512|FG004|STARTED|Washout Period 1 (6 Days)||5
8895676|NCT02037165|9953508|FG000|COMPLETED|Washout Period 1 (6 Days)||5
8895677|NCT02037165|9953509|FG001|COMPLETED|Washout Period 1 (6 Days)||5
8895678|NCT02037165|9953510|FG002|COMPLETED|Washout Period 1 (6 Days)||5
8895679|NCT02037165|9953511|FG003|COMPLETED|Washout Period 1 (6 Days)||5
8895680|NCT02037165|9953512|FG004|COMPLETED|Washout Period 1 (6 Days)||5
8895681|NCT02037165|9953508|FG000|NOT COMPLETED|Washout Period 1 (6 Days)||0
8895682|NCT02037165|9953509|FG001|NOT COMPLETED|Washout Period 1 (6 Days)||0
8895683|NCT02037165|9953510|FG002|NOT COMPLETED|Washout Period 1 (6 Days)||0
8895684|NCT02037165|9953511|FG003|NOT COMPLETED|Washout Period 1 (6 Days)||0
8895685|NCT02037165|9953512|FG004|NOT COMPLETED|Washout Period 1 (6 Days)||0
8895686|NCT02037165|9953508|FG000|STARTED|Period 2 (2 Days)||5
8895687|NCT02037165|9953509|FG001|STARTED|Period 2 (2 Days)||5
8895688|NCT02037165|9953510|FG002|STARTED|Period 2 (2 Days)||5
8895689|NCT02037165|9953511|FG003|STARTED|Period 2 (2 Days)||5
8895690|NCT02037165|9953512|FG004|STARTED|Period 2 (2 Days)||5
8895691|NCT02037165|9953508|FG000|COMPLETED|Period 2 (2 Days)||5
8895692|NCT02037165|9953509|FG001|COMPLETED|Period 2 (2 Days)||5
8895693|NCT02037165|9953510|FG002|COMPLETED|Period 2 (2 Days)||5
8895694|NCT02037165|9953511|FG003|COMPLETED|Period 2 (2 Days)||5
8895695|NCT02037165|9953512|FG004|COMPLETED|Period 2 (2 Days)||5
9007873|NCT02959970|10070737|FG000|COMPLETED|Overall Study||15
9007874|NCT02959970|10070738|FG001|COMPLETED|Overall Study||76
9007875|NCT02959970|10070737|FG000|NOT COMPLETED|Overall Study||2
9007876|NCT02959970|10070738|FG001|NOT COMPLETED|Overall Study||7
9007877|NCT02959983|10070748|FG000|STARTED|Overall Study||172
9007878|NCT02959983|10070749|FG001|STARTED|Overall Study||174
9007879|NCT02959983|10070748|FG000|COMPLETED|Overall Study||146
9007880|NCT02959983|10070749|FG001|COMPLETED|Overall Study||149
9007881|NCT02959983|10070748|FG000|NOT COMPLETED|Overall Study||26
9007882|NCT02959983|10070749|FG001|NOT COMPLETED|Overall Study||25
9007883|NCT02959996|10070757|FG000|STARTED|Overall Study||40
9007884|NCT02959996|10070758|FG001|STARTED|Overall Study||39
9007885|NCT02959996|10070757|FG000|COMPLETED|Overall Study||40
9007886|NCT02959996|10070758|FG001|COMPLETED|Overall Study||39
9007887|NCT02959996|10070757|FG000|NOT COMPLETED|Overall Study||0
9007888|NCT02959996|10070758|FG001|NOT COMPLETED|Overall Study||0
9007889|NCT02960217|10070766|FG000|STARTED|Maintenance Phase: Treatment Period 1||22
9007890|NCT02960217|10070767|FG001|STARTED|Maintenance Phase: Treatment Period 1||21
9007891|NCT02960217|10070766|FG000|COMPLETED|Maintenance Phase: Treatment Period 1||21
9007892|NCT02960217|10070767|FG001|COMPLETED|Maintenance Phase: Treatment Period 1||21
9007893|NCT02960217|10070766|FG000|NOT COMPLETED|Maintenance Phase: Treatment Period 1||1
9007894|NCT02960217|10070767|FG001|NOT COMPLETED|Maintenance Phase: Treatment Period 1||0
9007895|NCT02960217|10070766|FG000|STARTED|Maintenance Phase: Crossover Washout||21
9007896|NCT02960217|10070767|FG001|STARTED|Maintenance Phase: Crossover Washout||21
9007897|NCT02960217|10070766|FG000|COMPLETED|Maintenance Phase: Crossover Washout||21
9007898|NCT02960217|10070767|FG001|COMPLETED|Maintenance Phase: Crossover Washout||21
9007899|NCT02960217|10070766|FG000|NOT COMPLETED|Maintenance Phase: Crossover Washout||0
9007900|NCT02960217|10070767|FG001|NOT COMPLETED|Maintenance Phase: Crossover Washout||0
9007901|NCT02960217|10070766|FG000|STARTED|Maintenance Phase: Treatment Period 2||21
9007902|NCT02960217|10070767|FG001|STARTED|Maintenance Phase: Treatment Period 2||21
9007903|NCT02960217|10070766|FG000|COMPLETED|Maintenance Phase: Treatment Period 2||20
9007904|NCT02960217|10070767|FG001|COMPLETED|Maintenance Phase: Treatment Period 2||18
9007905|NCT02960217|10070766|FG000|NOT COMPLETED|Maintenance Phase: Treatment Period 2||1
9007906|NCT02960217|10070767|FG001|NOT COMPLETED|Maintenance Phase: Treatment Period 2||3
9007907|NCT02960217|10070766|FG000|STARTED|Open-Label Extension Phase||20
9007908|NCT02960217|10070767|FG001|STARTED|Open-Label Extension Phase|5 participants completed the double blind period but did not continue in the open label period.|13
9007909|NCT02960217|10070766|FG000|COMPLETED|Open-Label Extension Phase||0
9007910|NCT02960217|10070767|FG001|COMPLETED|Open-Label Extension Phase||0
9007911|NCT02960217|10070766|FG000|NOT COMPLETED|Open-Label Extension Phase||20
9007912|NCT02960217|10070767|FG001|NOT COMPLETED|Open-Label Extension Phase||13
9007913|NCT02960295|10070777|FG000|STARTED|Overall Study||10
9007914|NCT02960295|10070777|FG000|COMPLETED|Overall Study||10
9007915|NCT02960295|10070777|FG000|NOT COMPLETED|Overall Study||0
9007916|NCT02960438|10070786|FG000|STARTED|Treatment Phase (Double-blind): 24 Weeks||56
9007917|NCT02960438|10070787|FG001|STARTED|Treatment Phase (Double-blind): 24 Weeks||29
9007918|NCT02960438|10070788|FG002|STARTED|Treatment Phase (Double-blind): 24 Weeks||54
9007919|NCT02960438|10070789|FG003|STARTED|Treatment Phase (Double-blind): 24 Weeks||55
9007920|NCT02960438|10070786|FG000|Treated Participants|Treatment Phase (Double-blind): 24 Weeks||54
9007921|NCT02960438|10070787|FG001|Treated Participants|Treatment Phase (Double-blind): 24 Weeks||28
9007922|NCT02960438|10070788|FG002|Treated Participants|Treatment Phase (Double-blind): 24 Weeks||54
9007923|NCT02960438|10070789|FG003|Treated Participants|Treatment Phase (Double-blind): 24 Weeks||54
9007924|NCT02960438|10070786|FG000|COMPLETED|Treatment Phase (Double-blind): 24 Weeks||47
9007925|NCT02960438|10070787|FG001|COMPLETED|Treatment Phase (Double-blind): 24 Weeks||26
9007926|NCT02960438|10070788|FG002|COMPLETED|Treatment Phase (Double-blind): 24 Weeks||50
8895696|NCT02037165|9953508|FG000|NOT COMPLETED|Period 2 (2 Days)||0
9007927|NCT02960438|10070789|FG003|COMPLETED|Treatment Phase (Double-blind): 24 Weeks||46
9007928|NCT02960438|10070786|FG000|NOT COMPLETED|Treatment Phase (Double-blind): 24 Weeks||9
9007929|NCT02960438|10070787|FG001|NOT COMPLETED|Treatment Phase (Double-blind): 24 Weeks||3
9007930|NCT02960438|10070788|FG002|NOT COMPLETED|Treatment Phase (Double-blind): 24 Weeks||4
9007931|NCT02960438|10070789|FG003|NOT COMPLETED|Treatment Phase (Double-blind): 24 Weeks||9
9007932|NCT02960438|10070786|FG000|STARTED|Extension Phase (Open-label): 80 Weeks||47
9007933|NCT02960438|10070787|FG001|STARTED|Extension Phase (Open-label): 80 Weeks||26
9007934|NCT02960438|10070788|FG002|STARTED|Extension Phase (Open-label): 80 Weeks||50
9007935|NCT02960438|10070789|FG003|STARTED|Extension Phase (Open-label): 80 Weeks||46
9007936|NCT02960438|10070786|FG000|COMPLETED|Extension Phase (Open-label): 80 Weeks||36
8895697|NCT02037165|9953509|FG001|NOT COMPLETED|Period 2 (2 Days)||0
8895698|NCT02037165|9953510|FG002|NOT COMPLETED|Period 2 (2 Days)||0
8895699|NCT02037165|9953511|FG003|NOT COMPLETED|Period 2 (2 Days)||0
8895700|NCT02037165|9953512|FG004|NOT COMPLETED|Period 2 (2 Days)||0
8895701|NCT02037165|9953508|FG000|STARTED|Washout Period 2 (6 Days)||5
8895702|NCT02037165|9953509|FG001|STARTED|Washout Period 2 (6 Days)||5
8895703|NCT02037165|9953510|FG002|STARTED|Washout Period 2 (6 Days)||5
8895704|NCT02037165|9953511|FG003|STARTED|Washout Period 2 (6 Days)||5
8895705|NCT02037165|9953512|FG004|STARTED|Washout Period 2 (6 Days)||5
8895706|NCT02037165|9953508|FG000|COMPLETED|Washout Period 2 (6 Days)||5
8895707|NCT02037165|9953509|FG001|COMPLETED|Washout Period 2 (6 Days)||5
8895708|NCT02037165|9953510|FG002|COMPLETED|Washout Period 2 (6 Days)||5
8895709|NCT02037165|9953511|FG003|COMPLETED|Washout Period 2 (6 Days)||5
8895710|NCT02037165|9953512|FG004|COMPLETED|Washout Period 2 (6 Days)||5
8895711|NCT02037165|9953508|FG000|NOT COMPLETED|Washout Period 2 (6 Days)||0
8895712|NCT02037165|9953509|FG001|NOT COMPLETED|Washout Period 2 (6 Days)||0
8895713|NCT02037165|9953510|FG002|NOT COMPLETED|Washout Period 2 (6 Days)||0
8895714|NCT02037165|9953511|FG003|NOT COMPLETED|Washout Period 2 (6 Days)||0
8895715|NCT02037165|9953512|FG004|NOT COMPLETED|Washout Period 2 (6 Days)||0
8895716|NCT02037165|9953508|FG000|STARTED|Period 3 (2 Days)||5
8895717|NCT02037165|9953509|FG001|STARTED|Period 3 (2 Days)||5
8895718|NCT02037165|9953510|FG002|STARTED|Period 3 (2 Days)||5
8895719|NCT02037165|9953511|FG003|STARTED|Period 3 (2 Days)||5
8895720|NCT02037165|9953512|FG004|STARTED|Period 3 (2 Days)||5
8895721|NCT02037165|9953508|FG000|COMPLETED|Period 3 (2 Days)||5
8895722|NCT02037165|9953509|FG001|COMPLETED|Period 3 (2 Days)||5
8895723|NCT02037165|9953510|FG002|COMPLETED|Period 3 (2 Days)||5
8895724|NCT02037165|9953511|FG003|COMPLETED|Period 3 (2 Days)||5
8895725|NCT02037165|9953512|FG004|COMPLETED|Period 3 (2 Days)||5
8895726|NCT02037165|9953508|FG000|NOT COMPLETED|Period 3 (2 Days)||0
8895727|NCT02037165|9953509|FG001|NOT COMPLETED|Period 3 (2 Days)||0
8895728|NCT02037165|9953510|FG002|NOT COMPLETED|Period 3 (2 Days)||0
8895729|NCT02037165|9953511|FG003|NOT COMPLETED|Period 3 (2 Days)||0
8895730|NCT02037165|9953512|FG004|NOT COMPLETED|Period 3 (2 Days)||0
8895731|NCT02037165|9953508|FG000|STARTED|Washout Period 3 (6 Days)||5
8895732|NCT02037165|9953509|FG001|STARTED|Washout Period 3 (6 Days)||5
8895733|NCT02037165|9953510|FG002|STARTED|Washout Period 3 (6 Days)||5
8895734|NCT02037165|9953511|FG003|STARTED|Washout Period 3 (6 Days)||5
8895735|NCT02037165|9953512|FG004|STARTED|Washout Period 3 (6 Days)||5
8895736|NCT02037165|9953508|FG000|COMPLETED|Washout Period 3 (6 Days)||5
8895737|NCT02037165|9953509|FG001|COMPLETED|Washout Period 3 (6 Days)||5
8895738|NCT02037165|9953510|FG002|COMPLETED|Washout Period 3 (6 Days)||5
8895739|NCT02037165|9953511|FG003|COMPLETED|Washout Period 3 (6 Days)||5
8895740|NCT02037165|9953512|FG004|COMPLETED|Washout Period 3 (6 Days)||5
8895741|NCT02037165|9953508|FG000|NOT COMPLETED|Washout Period 3 (6 Days)||0
8895742|NCT02037165|9953509|FG001|NOT COMPLETED|Washout Period 3 (6 Days)||0
8895743|NCT02037165|9953510|FG002|NOT COMPLETED|Washout Period 3 (6 Days)||0
8895744|NCT02037165|9953511|FG003|NOT COMPLETED|Washout Period 3 (6 Days)||0
8895745|NCT02037165|9953512|FG004|NOT COMPLETED|Washout Period 3 (6 Days)||0
8895746|NCT02037165|9953508|FG000|STARTED|Period 4 (2 Days)||5
8895747|NCT02037165|9953509|FG001|STARTED|Period 4 (2 Days)||5
8895748|NCT02037165|9953510|FG002|STARTED|Period 4 (2 Days)||5
8895749|NCT02037165|9953511|FG003|STARTED|Period 4 (2 Days)||5
8895750|NCT02037165|9953512|FG004|STARTED|Period 4 (2 Days)||5
8895751|NCT02037165|9953508|FG000|COMPLETED|Period 4 (2 Days)||5
8895752|NCT02037165|9953509|FG001|COMPLETED|Period 4 (2 Days)||5
8895753|NCT02037165|9953510|FG002|COMPLETED|Period 4 (2 Days)||5
8895754|NCT02037165|9953511|FG003|COMPLETED|Period 4 (2 Days)||5
8895755|NCT02037165|9953512|FG004|COMPLETED|Period 4 (2 Days)||5
8895756|NCT02037165|9953508|FG000|NOT COMPLETED|Period 4 (2 Days)||0
8895757|NCT02037165|9953509|FG001|NOT COMPLETED|Period 4 (2 Days)||0
8895758|NCT02037165|9953510|FG002|NOT COMPLETED|Period 4 (2 Days)||0
8895759|NCT02037165|9953511|FG003|NOT COMPLETED|Period 4 (2 Days)||0
8895760|NCT02037165|9953512|FG004|NOT COMPLETED|Period 4 (2 Days)||0
8895761|NCT02037165|9953508|FG000|STARTED|Washout Period 4 (6 Days)||5
8895762|NCT02037165|9953509|FG001|STARTED|Washout Period 4 (6 Days)||5
8895763|NCT02037165|9953510|FG002|STARTED|Washout Period 4 (6 Days)||5
8895764|NCT02037165|9953511|FG003|STARTED|Washout Period 4 (6 Days)||5
8895765|NCT02037165|9953512|FG004|STARTED|Washout Period 4 (6 Days)||5
8895766|NCT02037165|9953508|FG000|COMPLETED|Washout Period 4 (6 Days)||5
9007937|NCT02960438|10070787|FG001|COMPLETED|Extension Phase (Open-label): 80 Weeks||17
9007938|NCT02960438|10070788|FG002|COMPLETED|Extension Phase (Open-label): 80 Weeks||36
9007939|NCT02960438|10070789|FG003|COMPLETED|Extension Phase (Open-label): 80 Weeks||35
9007940|NCT02960438|10070786|FG000|NOT COMPLETED|Extension Phase (Open-label): 80 Weeks||11
9007941|NCT02960438|10070787|FG001|NOT COMPLETED|Extension Phase (Open-label): 80 Weeks||9
9007942|NCT02960438|10070788|FG002|NOT COMPLETED|Extension Phase (Open-label): 80 Weeks||14
9007943|NCT02960438|10070789|FG003|NOT COMPLETED|Extension Phase (Open-label): 80 Weeks||11
8895767|NCT02037165|9953509|FG001|COMPLETED|Washout Period 4 (6 Days)||5
8895768|NCT02037165|9953510|FG002|COMPLETED|Washout Period 4 (6 Days)||5
8895769|NCT02037165|9953511|FG003|COMPLETED|Washout Period 4 (6 Days)||5
8895770|NCT02037165|9953512|FG004|COMPLETED|Washout Period 4 (6 Days)||4
8895771|NCT02037165|9953508|FG000|NOT COMPLETED|Washout Period 4 (6 Days)||0
8895772|NCT02037165|9953509|FG001|NOT COMPLETED|Washout Period 4 (6 Days)||0
8895773|NCT02037165|9953510|FG002|NOT COMPLETED|Washout Period 4 (6 Days)||0
8895774|NCT02037165|9953511|FG003|NOT COMPLETED|Washout Period 4 (6 Days)||0
8895775|NCT02037165|9953512|FG004|NOT COMPLETED|Washout Period 4 (6 Days)||1
8895776|NCT02037165|9953508|FG000|STARTED|Period 5 (2 Days)||5
8895777|NCT02037165|9953509|FG001|STARTED|Period 5 (2 Days)||5
8895778|NCT02037165|9953510|FG002|STARTED|Period 5 (2 Days)||5
8895779|NCT02037165|9953511|FG003|STARTED|Period 5 (2 Days)||5
8895780|NCT02037165|9953512|FG004|STARTED|Period 5 (2 Days)||4
8895781|NCT02037165|9953508|FG000|COMPLETED|Period 5 (2 Days)||5
8895782|NCT02037165|9953509|FG001|COMPLETED|Period 5 (2 Days)||5
8895783|NCT02037165|9953510|FG002|COMPLETED|Period 5 (2 Days)||5
8895784|NCT02037165|9953511|FG003|COMPLETED|Period 5 (2 Days)||5
8895785|NCT02037165|9953512|FG004|COMPLETED|Period 5 (2 Days)||4
8895786|NCT02037165|9953508|FG000|NOT COMPLETED|Period 5 (2 Days)||0
8895787|NCT02037165|9953509|FG001|NOT COMPLETED|Period 5 (2 Days)||0
8895788|NCT02037165|9953510|FG002|NOT COMPLETED|Period 5 (2 Days)||0
8895789|NCT02037165|9953511|FG003|NOT COMPLETED|Period 5 (2 Days)||0
8895790|NCT02037165|9953512|FG004|NOT COMPLETED|Period 5 (2 Days)||0
8895791|NCT02037204|9953528|FG000|STARTED|Overall Study||35
8895792|NCT02037204|9953528|FG000|COMPLETED|Overall Study||35
8895793|NCT02037204|9953528|FG000|NOT COMPLETED|Overall Study||0
8895794|NCT02037230|9953537|FG000|STARTED|Overall Study||1
8895795|NCT02037230|9953538|FG001|STARTED|Overall Study||13
8895796|NCT02037230|9953539|FG002|STARTED|Overall Study||9
8895797|NCT02037230|9953540|FG003|STARTED|Overall Study||11
8895798|NCT02037230|9953537|FG000|Completed 4 Cycles of Treatment|Overall Study||1
8895799|NCT02037230|9953538|FG001|Completed 4 Cycles of Treatment|Overall Study||9
8895800|NCT02037230|9953539|FG002|Completed 4 Cycles of Treatment|Overall Study||7
8895801|NCT02037230|9953540|FG003|Completed 4 Cycles of Treatment|Overall Study||9
8895802|NCT02037230|9953537|FG000|COMPLETED|Overall Study||0
8895803|NCT02037230|9953538|FG001|COMPLETED|Overall Study||7
8895804|NCT02037230|9953539|FG002|COMPLETED|Overall Study||3
8895805|NCT02037230|9953540|FG003|COMPLETED|Overall Study||5
8895806|NCT02037230|9953537|FG000|NOT COMPLETED|Overall Study||1
9007944|NCT02960490|10070809|FG000|STARTED|Treatment Phase(Double-blind): 12 Weeks||34
9007945|NCT02960490|10070810|FG001|STARTED|Treatment Phase(Double-blind): 12 Weeks||32
9007946|NCT02960490|10070811|FG002|STARTED|Treatment Phase(Double-blind): 12 Weeks||0
9007947|NCT02960490|10070812|FG003|STARTED|Treatment Phase(Double-blind): 12 Weeks||0
9007948|NCT02960490|10070813|FG004|STARTED|Treatment Phase(Double-blind): 12 Weeks||0
9007949|NCT02960490|10070814|FG005|STARTED|Treatment Phase(Double-blind): 12 Weeks||0
9007950|NCT02960490|10070815|FG006|STARTED|Treatment Phase(Double-blind): 12 Weeks||0
9007951|NCT02960490|10070816|FG007|STARTED|Treatment Phase(Double-blind): 12 Weeks||0
9007952|NCT02960490|10070817|FG008|STARTED|Treatment Phase(Double-blind): 12 Weeks||0
9007953|NCT02960490|10070818|FG009|STARTED|Treatment Phase(Double-blind): 12 Weeks||0
9007954|NCT02960490|10070809|FG000|Treated|Treatment Phase(Double-blind): 12 Weeks||33
9007955|NCT02960490|10070810|FG001|Treated|Treatment Phase(Double-blind): 12 Weeks||31
9007956|NCT02960490|10070811|FG002|Treated|Treatment Phase(Double-blind): 12 Weeks||0
9007957|NCT02960490|10070812|FG003|Treated|Treatment Phase(Double-blind): 12 Weeks||0
9007958|NCT02960490|10070813|FG004|Treated|Treatment Phase(Double-blind): 12 Weeks||0
9007959|NCT02960490|10070814|FG005|Treated|Treatment Phase(Double-blind): 12 Weeks||0
9007960|NCT02960490|10070815|FG006|Treated|Treatment Phase(Double-blind): 12 Weeks||0
9007961|NCT02960490|10070816|FG007|Treated|Treatment Phase(Double-blind): 12 Weeks||0
9007962|NCT02960490|10070817|FG008|Treated|Treatment Phase(Double-blind): 12 Weeks||0
9007963|NCT02960490|10070818|FG009|Treated|Treatment Phase(Double-blind): 12 Weeks||0
9007964|NCT02960490|10070809|FG000|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||33
9007965|NCT02960490|10070810|FG001|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||31
9007966|NCT02960490|10070811|FG002|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0
9007967|NCT02960490|10070812|FG003|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0
9007968|NCT02960490|10070813|FG004|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0
9007969|NCT02960490|10070814|FG005|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0
9007970|NCT02960490|10070815|FG006|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0
9007971|NCT02960490|10070816|FG007|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0
9007972|NCT02960490|10070817|FG008|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0
9007973|NCT02960490|10070818|FG009|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0
9007974|NCT02960490|10070809|FG000|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||33
9007975|NCT02960490|10070810|FG001|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||31
9007976|NCT02960490|10070811|FG002|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0
9007977|NCT02960490|10070812|FG003|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0
9007978|NCT02960490|10070813|FG004|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0
9007979|NCT02960490|10070814|FG005|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0
8895807|NCT02037230|9953538|FG001|NOT COMPLETED|Overall Study||6
8895808|NCT02037230|9953539|FG002|NOT COMPLETED|Overall Study||6
8895809|NCT02037230|9953540|FG003|NOT COMPLETED|Overall Study||6
8895810|NCT02037256|9953553|FG000|STARTED|Overall Study||3
8895811|NCT02037256|9953554|FG001|STARTED|Overall Study||20
8895812|NCT02037256|9953553|FG000|COMPLETED|Overall Study||3
8895813|NCT02037256|9953554|FG001|COMPLETED|Overall Study||17
8895814|NCT02037256|9953553|FG000|NOT COMPLETED|Overall Study||0
8895815|NCT02037256|9953554|FG001|NOT COMPLETED|Overall Study||3
8895816|NCT02037295|9953566|FG000|STARTED|Phase 1: Crossover UF and OF||9
8895817|NCT02037295|9953567|FG001|STARTED|Phase 1: Crossover UF and OF||7
8895818|NCT02037295|9953568|FG002|STARTED|Phase 1: Crossover UF and OF||4
8895819|NCT02037295|9953569|FG003|STARTED|Phase 1: Crossover UF and OF||7
8895820|NCT02037295|9953566|FG000|COMPLETED|Phase 1: Crossover UF and OF||9
8895821|NCT02037295|9953567|FG001|COMPLETED|Phase 1: Crossover UF and OF||7
8895822|NCT02037295|9953568|FG002|COMPLETED|Phase 1: Crossover UF and OF||4
8895823|NCT02037295|9953569|FG003|COMPLETED|Phase 1: Crossover UF and OF||7
8895824|NCT02037295|9953566|FG000|NOT COMPLETED|Phase 1: Crossover UF and OF||0
8895825|NCT02037295|9953567|FG001|NOT COMPLETED|Phase 1: Crossover UF and OF||0
8895826|NCT02037295|9953568|FG002|NOT COMPLETED|Phase 1: Crossover UF and OF||0
8895827|NCT02037295|9953569|FG003|NOT COMPLETED|Phase 1: Crossover UF and OF||0
8895828|NCT02037295|9953566|FG000|STARTED|Phase 2: Vancomycin and Placebo||9
8895829|NCT02037295|9953567|FG001|STARTED|Phase 2: Vancomycin and Placebo||7
8895830|NCT02037295|9953568|FG002|STARTED|Phase 2: Vancomycin and Placebo||4
8895831|NCT02037295|9953569|FG003|STARTED|Phase 2: Vancomycin and Placebo||7
8895832|NCT02037295|9953566|FG000|COMPLETED|Phase 2: Vancomycin and Placebo||8
8895833|NCT02037295|9953567|FG001|COMPLETED|Phase 2: Vancomycin and Placebo||7
8895834|NCT02037295|9953568|FG002|COMPLETED|Phase 2: Vancomycin and Placebo||4
8895835|NCT02037295|9953569|FG003|COMPLETED|Phase 2: Vancomycin and Placebo||6
8895836|NCT02037295|9953566|FG000|NOT COMPLETED|Phase 2: Vancomycin and Placebo||1
8895837|NCT02037295|9953567|FG001|NOT COMPLETED|Phase 2: Vancomycin and Placebo||0
8895838|NCT02037295|9953568|FG002|NOT COMPLETED|Phase 2: Vancomycin and Placebo||0
8895839|NCT02037295|9953569|FG003|NOT COMPLETED|Phase 2: Vancomycin and Placebo||1
8895840|NCT02037347|9953581|FG000|STARTED|Overall Study||1
8895841|NCT02037347|9953581|FG000|COMPLETED|Overall Study||1
8895842|NCT02037347|9953581|FG000|NOT COMPLETED|Overall Study||0
8895843|NCT02037425|9953585|FG000|STARTED|Overall Study||44
8895844|NCT02037425|9953585|FG000|Randomized to Treatment|Overall Study||32
8895845|NCT02037425|9953585|FG000|COMPLETED|Overall Study||18
8895846|NCT02037425|9953585|FG000|NOT COMPLETED|Overall Study||26
8895847|NCT02037438|9953593|FG000|STARTED|Overall Study||920
8895848|NCT02037438|9953594|FG001|STARTED|Overall Study||916
8895849|NCT02037438|9953593|FG000|COMPLETED|Overall Study||574
9007980|NCT02960490|10070815|FG006|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0
9007981|NCT02960490|10070816|FG007|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0
9007982|NCT02960490|10070817|FG008|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0
9007983|NCT02960490|10070818|FG009|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0
9007984|NCT02960490|10070809|FG000|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||29
9007985|NCT02960490|10070810|FG001|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||26
9007986|NCT02960490|10070811|FG002|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
9007987|NCT02960490|10070812|FG003|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
9007988|NCT02960490|10070813|FG004|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
9007989|NCT02960490|10070814|FG005|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
9007990|NCT02960490|10070815|FG006|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
9007991|NCT02960490|10070816|FG007|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
9007992|NCT02960490|10070817|FG008|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
9007993|NCT02960490|10070818|FG009|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
9007994|NCT02960490|10070809|FG000|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||5
9007995|NCT02960490|10070810|FG001|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||6
9007996|NCT02960490|10070811|FG002|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
9007997|NCT02960490|10070812|FG003|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
9007998|NCT02960490|10070813|FG004|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
9007999|NCT02960490|10070814|FG005|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
9008000|NCT02960490|10070815|FG006|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
9008001|NCT02960490|10070816|FG007|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
9008002|NCT02960490|10070817|FG008|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
9008003|NCT02960490|10070818|FG009|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
9008004|NCT02960490|10070809|FG000|STARTED|Re-randomized Participants: 12 Weeks||0
9008005|NCT02960490|10070810|FG001|STARTED|Re-randomized Participants: 12 Weeks||0
9008006|NCT02960490|10070811|FG002|STARTED|Re-randomized Participants: 12 Weeks||15
9039569|NCT03340337|10100552|FG000|STARTED|Overall Study||30
8895850|NCT02037438|9953594|FG001|COMPLETED|Overall Study||561
8895851|NCT02037438|9953593|FG000|NOT COMPLETED|Overall Study||346
8895852|NCT02037438|9953594|FG001|NOT COMPLETED|Overall Study||355
8895853|NCT02037477|9953604|FG000|STARTED|Treatment Period 1||5
8895854|NCT02037477|9953605|FG001|STARTED|Treatment Period 1||5
8895855|NCT02037477|9953606|FG002|STARTED|Treatment Period 1||5
8895856|NCT02037477|9953607|FG003|STARTED|Treatment Period 1||5
8895857|NCT02037477|9953604|FG000|COMPLETED|Treatment Period 1||5
8895858|NCT02037477|9953605|FG001|COMPLETED|Treatment Period 1||5
8895859|NCT02037477|9953606|FG002|COMPLETED|Treatment Period 1||4
8895860|NCT02037477|9953607|FG003|COMPLETED|Treatment Period 1||5
8895861|NCT02037477|9953604|FG000|NOT COMPLETED|Treatment Period 1||0
8895862|NCT02037477|9953605|FG001|NOT COMPLETED|Treatment Period 1||0
8895863|NCT02037477|9953606|FG002|NOT COMPLETED|Treatment Period 1||1
8895864|NCT02037477|9953607|FG003|NOT COMPLETED|Treatment Period 1||0
8895865|NCT02037477|9953604|FG000|STARTED|Treatment Period 2||5
8895866|NCT02037477|9953605|FG001|STARTED|Treatment Period 2||5
8895867|NCT02037477|9953606|FG002|STARTED|Treatment Period 2||4
8895868|NCT02037477|9953607|FG003|STARTED|Treatment Period 2||5
8895869|NCT02037477|9953604|FG000|COMPLETED|Treatment Period 2||5
8895870|NCT02037477|9953605|FG001|COMPLETED|Treatment Period 2||5
8895871|NCT02037477|9953606|FG002|COMPLETED|Treatment Period 2||4
8895872|NCT02037477|9953607|FG003|COMPLETED|Treatment Period 2||5
8895873|NCT02037477|9953604|FG000|NOT COMPLETED|Treatment Period 2||0
8895874|NCT02037477|9953605|FG001|NOT COMPLETED|Treatment Period 2||0
8895875|NCT02037477|9953606|FG002|NOT COMPLETED|Treatment Period 2||0
9008007|NCT02960490|10070812|FG003|STARTED|Re-randomized Participants: 12 Weeks||14
9008008|NCT02960490|10070813|FG004|STARTED|Re-randomized Participants: 12 Weeks||14
9008009|NCT02960490|10070814|FG005|STARTED|Re-randomized Participants: 12 Weeks||12
9008010|NCT02960490|10070815|FG006|STARTED|Re-randomized Participants: 12 Weeks||0
9008011|NCT02960490|10070816|FG007|STARTED|Re-randomized Participants: 12 Weeks||0
9008012|NCT02960490|10070817|FG008|STARTED|Re-randomized Participants: 12 Weeks||0
9008013|NCT02960490|10070818|FG009|STARTED|Re-randomized Participants: 12 Weeks||0
9008014|NCT02960490|10070809|FG000|Treated|Re-randomized Participants: 12 Weeks||0
9008015|NCT02960490|10070810|FG001|Treated|Re-randomized Participants: 12 Weeks||0
9008016|NCT02960490|10070811|FG002|Treated|Re-randomized Participants: 12 Weeks||15
9008017|NCT02960490|10070812|FG003|Treated|Re-randomized Participants: 12 Weeks||14
9008018|NCT02960490|10070813|FG004|Treated|Re-randomized Participants: 12 Weeks||14
9008019|NCT02960490|10070814|FG005|Treated|Re-randomized Participants: 12 Weeks||12
9008020|NCT02960490|10070815|FG006|Treated|Re-randomized Participants: 12 Weeks||0
9008021|NCT02960490|10070816|FG007|Treated|Re-randomized Participants: 12 Weeks||0
9008022|NCT02960490|10070817|FG008|Treated|Re-randomized Participants: 12 Weeks||0
9008023|NCT02960490|10070818|FG009|Treated|Re-randomized Participants: 12 Weeks||0
9008024|NCT02960490|10070809|FG000|FAS|Re-randomized Participants: 12 Weeks||0
9008025|NCT02960490|10070810|FG001|FAS|Re-randomized Participants: 12 Weeks||0
9008026|NCT02960490|10070811|FG002|FAS|Re-randomized Participants: 12 Weeks||15
9008027|NCT02960490|10070812|FG003|FAS|Re-randomized Participants: 12 Weeks||14
9008028|NCT02960490|10070813|FG004|FAS|Re-randomized Participants: 12 Weeks||14
9008029|NCT02960490|10070814|FG005|FAS|Re-randomized Participants: 12 Weeks||12
9008030|NCT02960490|10070815|FG006|FAS|Re-randomized Participants: 12 Weeks||0
9008031|NCT02960490|10070816|FG007|FAS|Re-randomized Participants: 12 Weeks||0
9008032|NCT02960490|10070817|FG008|FAS|Re-randomized Participants: 12 Weeks||0
9008033|NCT02960490|10070818|FG009|FAS|Re-randomized Participants: 12 Weeks||0
8572780|NCT00116857|9604967|FG000|NOT COMPLETED|Overall Study||3
8572781|NCT00116857|9604968|FG001|NOT COMPLETED|Overall Study||4
8572782|NCT00117143|9604978|FG000|STARTED|Overall Study||4
8635383|NCT00561821|9675941|FG001|STARTED|Overall Study||136
8635384|NCT00561821|9675942|FG002|STARTED|Overall Study||134
8635385|NCT00561821|9675943|FG003|STARTED|Overall Study||136
9008034|NCT02960490|10070809|FG000|SAS|Re-randomized Participants: 12 Weeks||0
9008035|NCT02960490|10070810|FG001|SAS|Re-randomized Participants: 12 Weeks||0
9008036|NCT02960490|10070811|FG002|SAS|Re-randomized Participants: 12 Weeks||15
9008037|NCT02960490|10070812|FG003|SAS|Re-randomized Participants: 12 Weeks||14
9008038|NCT02960490|10070813|FG004|SAS|Re-randomized Participants: 12 Weeks||14
9008039|NCT02960490|10070814|FG005|SAS|Re-randomized Participants: 12 Weeks||12
8635386|NCT00561821|9675940|FG000|Treated|Overall Study||132
8635387|NCT00561821|9675941|FG001|Treated|Overall Study||136
8635388|NCT00561821|9675942|FG002|Treated|Overall Study||133
8635389|NCT00561821|9675943|FG003|Treated|Overall Study||136
8635390|NCT00561821|9675940|FG000|COMPLETED|Overall Study||127
8635391|NCT00561821|9675941|FG001|COMPLETED|Overall Study||130
8635392|NCT00561821|9675942|FG002|COMPLETED|Overall Study||132
8635393|NCT00561821|9675943|FG003|COMPLETED|Overall Study||133
9008040|NCT02960490|10070815|FG006|SAS|Re-randomized Participants: 12 Weeks||0
9008041|NCT02960490|10070816|FG007|SAS|Re-randomized Participants: 12 Weeks||0
9008042|NCT02960490|10070817|FG008|SAS|Re-randomized Participants: 12 Weeks||0
9008043|NCT02960490|10070818|FG009|SAS|Re-randomized Participants: 12 Weeks||0
9008044|NCT02960490|10070809|FG000|COMPLETED|Re-randomized Participants: 12 Weeks||0
8572783|NCT00117143|9604979|FG001|STARTED|Overall Study||4
8572784|NCT00117143|9604980|FG002|STARTED|Overall Study||7
8572785|NCT00117143|9604981|FG003|STARTED|Overall Study||1
8572786|NCT00117143|9604978|FG000|Received First Dose|Overall Study||4
8572787|NCT00117143|9604979|FG001|Received First Dose|Overall Study||4
8572788|NCT00117143|9604980|FG002|Received First Dose|Overall Study||7
8572789|NCT00117143|9604981|FG003|Received First Dose|Overall Study||1
8572790|NCT00117143|9604978|FG000|Received Second Dose|Overall Study||4
8635394|NCT00561821|9675940|FG000|NOT COMPLETED|Overall Study||5
8635395|NCT00561821|9675941|FG001|NOT COMPLETED|Overall Study||6
8895876|NCT02037477|9953607|FG003|NOT COMPLETED|Treatment Period 2||0
8895877|NCT02037555|9953619|FG000|STARTED|Overall Study||213
8895878|NCT02037555|9953620|FG001|STARTED|Overall Study||212
8895879|NCT02037555|9953619|FG000|Dosed|Overall Study||201
8895880|NCT02037555|9953620|FG001|Dosed|Overall Study||198
8895881|NCT02037555|9953619|FG000|Dosed and Operated On|Overall Study||200
8895882|NCT02037555|9953620|FG001|Dosed and Operated On|Overall Study||196
8895883|NCT02037555|9953619|FG000|COMPLETED|Overall Study||190
8895884|NCT02037555|9953620|FG001|COMPLETED|Overall Study||191
8895885|NCT02037555|9953619|FG000|NOT COMPLETED|Overall Study||23
8895886|NCT02037555|9953620|FG001|NOT COMPLETED|Overall Study||21
8895887|NCT02037568|9953628|FG000|STARTED|Overall Study||83
8895888|NCT02037568|9953629|FG001|STARTED|Overall Study||76
8895889|NCT02037568|9953628|FG000|Month 1.5 (Post Transplantation)|Overall Study||79
8895890|NCT02037568|9953629|FG001|Month 1.5 (Post Transplantation)|Overall Study||76
8895891|NCT02037568|9953628|FG000|Month 3 (Post Transplantation)|Overall Study||66
8895892|NCT02037568|9953629|FG001|Month 3 (Post Transplantation)|Overall Study||62
8895893|NCT02037568|9953628|FG000|Month 6 (Post Transplantation)|Overall Study||63
8895894|NCT02037568|9953629|FG001|Month 6 (Post Transplantation)|Overall Study||52
8895895|NCT02037568|9953628|FG000|COMPLETED|Overall Study||47
8895896|NCT02037568|9953629|FG001|COMPLETED|Overall Study||37
8895897|NCT02037568|9953628|FG000|NOT COMPLETED|Overall Study||36
8895898|NCT02037568|9953629|FG001|NOT COMPLETED|Overall Study||39
8895899|NCT02037607|9953635|FG000|STARTED|Overall Study||100
8895900|NCT02037607|9953635|FG000|COMPLETED|Overall Study||91
8895901|NCT02037607|9953635|FG000|NOT COMPLETED|Overall Study||9
8895902|NCT02037776|9953641|FG000|STARTED|Overall Study||61
8895903|NCT02037776|9953642|FG001|STARTED|Overall Study||64
8895904|NCT02037776|9953641|FG000|COMPLETED|Overall Study||56
8895905|NCT02037776|9953642|FG001|COMPLETED|Overall Study||60
8895906|NCT02037776|9953641|FG000|NOT COMPLETED|Overall Study||5
8895907|NCT02037776|9953642|FG001|NOT COMPLETED|Overall Study||4
8895908|NCT02037893|9953652|FG000|STARTED|Overall Study||32
8895909|NCT02037893|9953653|FG001|STARTED|Overall Study||25
8895910|NCT02037893|9953654|FG002|STARTED|Overall Study||27
8895911|NCT02037893|9953655|FG003|STARTED|Overall Study||28
8895912|NCT02037893|9953652|FG000|COMPLETED|Overall Study||32
8895913|NCT02037893|9953653|FG001|COMPLETED|Overall Study||25
8895914|NCT02037893|9953654|FG002|COMPLETED|Overall Study||26
8895915|NCT02037893|9953655|FG003|COMPLETED|Overall Study||28
8895916|NCT02037893|9953652|FG000|NOT COMPLETED|Overall Study||0
8895917|NCT02037893|9953653|FG001|NOT COMPLETED|Overall Study||0
8895918|NCT02037893|9953654|FG002|NOT COMPLETED|Overall Study||1
8895919|NCT02037893|9953655|FG003|NOT COMPLETED|Overall Study||0
8895920|NCT02037984|9953673|FG000|STARTED|Overall Study||20
8895921|NCT02037984|9953674|FG001|STARTED|Overall Study||20
8895922|NCT02037984|9953675|FG002|STARTED|Overall Study||50
8895923|NCT02037984|9953676|FG003|STARTED|Overall Study||51
8895924|NCT02037984|9953677|FG004|STARTED|Overall Study||50
8895925|NCT02037984|9953678|FG005|STARTED|Overall Study||49
8895926|NCT02037984|9953679|FG006|STARTED|Overall Study||50
8895927|NCT02037984|9953680|FG007|STARTED|Overall Study||51
8895928|NCT02037984|9953673|FG000|COMPLETED|Overall Study||19
8895929|NCT02037984|9953674|FG001|COMPLETED|Overall Study||20
8895930|NCT02037984|9953675|FG002|COMPLETED|Overall Study||38
8895931|NCT02037984|9953676|FG003|COMPLETED|Overall Study||30
8895932|NCT02037984|9953677|FG004|COMPLETED|Overall Study||38
8895933|NCT02037984|9953678|FG005|COMPLETED|Overall Study||37
8895934|NCT02037984|9953679|FG006|COMPLETED|Overall Study||33
8895935|NCT02037984|9953680|FG007|COMPLETED|Overall Study||39
8895936|NCT02037984|9953673|FG000|NOT COMPLETED|Overall Study||1
8895937|NCT02037984|9953674|FG001|NOT COMPLETED|Overall Study||0
8895938|NCT02037984|9953675|FG002|NOT COMPLETED|Overall Study||12
8895939|NCT02037984|9953676|FG003|NOT COMPLETED|Overall Study||21
8895940|NCT02037984|9953677|FG004|NOT COMPLETED|Overall Study||12
8895941|NCT02037984|9953678|FG005|NOT COMPLETED|Overall Study||12
8895942|NCT02037984|9953679|FG006|NOT COMPLETED|Overall Study||17
8895943|NCT02037984|9953680|FG007|NOT COMPLETED|Overall Study||12
8895944|NCT02038010|9953708|FG000|STARTED|Completed 1st Cycle and Started Cycle 2||11
8895945|NCT02038010|9953709|FG001|STARTED|Completed 1st Cycle and Started Cycle 2||6
8895946|NCT02038010|9953710|FG002|STARTED|Completed 1st Cycle and Started Cycle 2|Due to safety data, dose was de-escalated and no patients enrolled at this dose.|0
8895947|NCT02038010|9953711|FG003|STARTED|Completed 1st Cycle and Started Cycle 2|Due to safety data, dose was de-escalated and no patients enrolled at this dose.|0
8895948|NCT02038010|9953708|FG000|Completed 1st Cycle|Completed 1st Cycle and Started Cycle 2||11
8895949|NCT02038010|9953709|FG001|Completed 1st Cycle|Completed 1st Cycle and Started Cycle 2||5
8895950|NCT02038010|9953710|FG002|Completed 1st Cycle|Completed 1st Cycle and Started Cycle 2||0
8895951|NCT02038010|9953711|FG003|Completed 1st Cycle|Completed 1st Cycle and Started Cycle 2||0
8895952|NCT02038010|9953708|FG000|Continued on to Cycle 2|Completed 1st Cycle and Started Cycle 2||10
8895953|NCT02038010|9953709|FG001|Continued on to Cycle 2|Completed 1st Cycle and Started Cycle 2||4
8895954|NCT02038010|9953710|FG002|Continued on to Cycle 2|Completed 1st Cycle and Started Cycle 2||0
8895955|NCT02038010|9953711|FG003|Continued on to Cycle 2|Completed 1st Cycle and Started Cycle 2||0
8895956|NCT02038010|9953708|FG000|COMPLETED|Completed 1st Cycle and Started Cycle 2||10
8895957|NCT02038010|9953709|FG001|COMPLETED|Completed 1st Cycle and Started Cycle 2||4
8895958|NCT02038010|9953710|FG002|COMPLETED|Completed 1st Cycle and Started Cycle 2||0
8895959|NCT02038010|9953711|FG003|COMPLETED|Completed 1st Cycle and Started Cycle 2||0
8895960|NCT02038010|9953708|FG000|NOT COMPLETED|Completed 1st Cycle and Started Cycle 2||1
8895961|NCT02038010|9953709|FG001|NOT COMPLETED|Completed 1st Cycle and Started Cycle 2||2
8895962|NCT02038010|9953710|FG002|NOT COMPLETED|Completed 1st Cycle and Started Cycle 2||0
8895963|NCT02038010|9953711|FG003|NOT COMPLETED|Completed 1st Cycle and Started Cycle 2||0
8895964|NCT02038010|9953708|FG000|STARTED|Completed 3 Cycles/Reached 1st Response||10
8895965|NCT02038010|9953709|FG001|STARTED|Completed 3 Cycles/Reached 1st Response||4
8895966|NCT02038010|9953710|FG002|STARTED|Completed 3 Cycles/Reached 1st Response||0
8895967|NCT02038010|9953711|FG003|STARTED|Completed 3 Cycles/Reached 1st Response||0
8895968|NCT02038010|9953708|FG000|Completed 3 Cycles|Completed 3 Cycles/Reached 1st Response||10
8895969|NCT02038010|9953709|FG001|Completed 3 Cycles|Completed 3 Cycles/Reached 1st Response||4
8895970|NCT02038010|9953710|FG002|Completed 3 Cycles|Completed 3 Cycles/Reached 1st Response||0
8895971|NCT02038010|9953711|FG003|Completed 3 Cycles|Completed 3 Cycles/Reached 1st Response||0
8895972|NCT02038010|9953708|FG000|Continued to Cycle 4|Completed 3 Cycles/Reached 1st Response||9
8895973|NCT02038010|9953709|FG001|Continued to Cycle 4|Completed 3 Cycles/Reached 1st Response||3
8895974|NCT02038010|9953710|FG002|Continued to Cycle 4|Completed 3 Cycles/Reached 1st Response||0
8895975|NCT02038010|9953711|FG003|Continued to Cycle 4|Completed 3 Cycles/Reached 1st Response||0
8895976|NCT02038010|9953708|FG000|COMPLETED|Completed 3 Cycles/Reached 1st Response||9
8895977|NCT02038010|9953709|FG001|COMPLETED|Completed 3 Cycles/Reached 1st Response||3
8895978|NCT02038010|9953710|FG002|COMPLETED|Completed 3 Cycles/Reached 1st Response||0
8895979|NCT02038010|9953711|FG003|COMPLETED|Completed 3 Cycles/Reached 1st Response||0
8895980|NCT02038010|9953708|FG000|NOT COMPLETED|Completed 3 Cycles/Reached 1st Response||1
8895981|NCT02038010|9953709|FG001|NOT COMPLETED|Completed 3 Cycles/Reached 1st Response||1
8895982|NCT02038010|9953710|FG002|NOT COMPLETED|Completed 3 Cycles/Reached 1st Response||0
8895983|NCT02038010|9953711|FG003|NOT COMPLETED|Completed 3 Cycles/Reached 1st Response||0
8895984|NCT02038010|9953708|FG000|STARTED|Follow Up||11
8895985|NCT02038010|9953709|FG001|STARTED|Follow Up||6
8895986|NCT02038010|9953710|FG002|STARTED|Follow Up||0
8895987|NCT02038010|9953711|FG003|STARTED|Follow Up||0
8895988|NCT02038010|9953708|FG000|COMPLETED|Follow Up||4
8895989|NCT02038010|9953709|FG001|COMPLETED|Follow Up||3
8895990|NCT02038010|9953710|FG002|COMPLETED|Follow Up||0
8895991|NCT02038010|9953711|FG003|COMPLETED|Follow Up||0
8895992|NCT02038010|9953708|FG000|NOT COMPLETED|Follow Up||7
8895993|NCT02038010|9953709|FG001|NOT COMPLETED|Follow Up||3
8895994|NCT02038010|9953710|FG002|NOT COMPLETED|Follow Up||0
8895995|NCT02038010|9953711|FG003|NOT COMPLETED|Follow Up||0
8895996|NCT02038023|9953719|FG000|STARTED|Overall Study||74
8895997|NCT02038023|9953719|FG000|COMPLETED|Overall Study||73
8895998|NCT02038023|9953719|FG000|NOT COMPLETED|Overall Study||1
8895999|NCT02038036|9953727|FG000|STARTED|Core Study||74
8896000|NCT02038036|9953728|FG001|STARTED|Core Study||75
8896001|NCT02038036|9953727|FG000|Full Analysis Set|Core Study||74
8896002|NCT02038036|9953728|FG001|Full Analysis Set|Core Study||75
8896003|NCT02038036|9953727|FG000|Crossover Set|Core Study||0
8896004|NCT02038036|9953728|FG001|Crossover Set|Core Study||58
8896005|NCT02038036|9953727|FG000|COMPLETED|Core Study||59
8896006|NCT02038036|9953728|FG001|COMPLETED|Core Study||61
8896007|NCT02038036|9953727|FG000|NOT COMPLETED|Core Study||15
8896008|NCT02038036|9953728|FG001|NOT COMPLETED|Core Study||14
8896009|NCT02038036|9953727|FG000|STARTED|Crossover Period||0
8896010|NCT02038036|9953728|FG001|STARTED|Crossover Period|58 participants were eligible to crossover to the ruxolitinib arm|58
8896011|NCT02038036|9953727|FG000|COMPLETED|Crossover Period||0
8896012|NCT02038036|9953728|FG001|COMPLETED|Crossover Period||38
8896013|NCT02038036|9953727|FG000|NOT COMPLETED|Crossover Period||0
8896014|NCT02038036|9953728|FG001|NOT COMPLETED|Crossover Period||20
8896015|NCT02038049|9953739|FG000|STARTED|Overall Study||4
8896016|NCT02038049|9953740|FG001|STARTED|Overall Study||4
8896017|NCT02038049|9953739|FG000|Pharmacodynamic (PD) Analysis Set|Overall Study||4
8896018|NCT02038049|9953740|FG001|Pharmacodynamic (PD) Analysis Set|Overall Study||4
8896019|NCT02038049|9953739|FG000|COMPLETED|Overall Study||3
8896020|NCT02038049|9953740|FG001|COMPLETED|Overall Study||4
8896021|NCT02038049|9953739|FG000|NOT COMPLETED|Overall Study||1
8896022|NCT02038049|9953740|FG001|NOT COMPLETED|Overall Study||0
8896023|NCT02038075|9953752|FG000|STARTED|Overall Study||76
8896024|NCT02038075|9953753|FG001|STARTED|Overall Study||76
8896025|NCT02038075|9953752|FG000|COMPLETED|Overall Study||73
8896026|NCT02038075|9953753|FG001|COMPLETED|Overall Study||76
8896027|NCT02038075|9953752|FG000|NOT COMPLETED|Overall Study||3
8896028|NCT02038075|9953753|FG001|NOT COMPLETED|Overall Study||0
8896029|NCT02038179|9953759|FG000|STARTED|Phase 1 (4 Weeks)||52
8896030|NCT02038179|9953760|FG001|STARTED|Phase 1 (4 Weeks)||47
9008045|NCT02960490|10070810|FG001|COMPLETED|Re-randomized Participants: 12 Weeks||0
9008046|NCT02960490|10070811|FG002|COMPLETED|Re-randomized Participants: 12 Weeks||13
8896031|NCT02038179|9953759|FG000|COMPLETED|Phase 1 (4 Weeks)||48
8896032|NCT02038179|9953760|FG001|COMPLETED|Phase 1 (4 Weeks)||42
8896033|NCT02038179|9953759|FG000|NOT COMPLETED|Phase 1 (4 Weeks)||4
8896034|NCT02038179|9953760|FG001|NOT COMPLETED|Phase 1 (4 Weeks)||5
8896035|NCT02038179|9953759|FG000|STARTED|Washout (2-4 Weeks)||48
8896036|NCT02038179|9953760|FG001|STARTED|Washout (2-4 Weeks)||42
8896037|NCT02038179|9953759|FG000|COMPLETED|Washout (2-4 Weeks)||46
8896038|NCT02038179|9953760|FG001|COMPLETED|Washout (2-4 Weeks)||40
8896039|NCT02038179|9953759|FG000|NOT COMPLETED|Washout (2-4 Weeks)||2
8896040|NCT02038179|9953760|FG001|NOT COMPLETED|Washout (2-4 Weeks)||2
8896041|NCT02038179|9953759|FG000|STARTED|Phase 2 (4 Weeks)||46
8896042|NCT02038179|9953760|FG001|STARTED|Phase 2 (4 Weeks)||40
8896043|NCT02038179|9953759|FG000|COMPLETED|Phase 2 (4 Weeks)||44
8896044|NCT02038179|9953760|FG001|COMPLETED|Phase 2 (4 Weeks)||38
8896045|NCT02038179|9953759|FG000|NOT COMPLETED|Phase 2 (4 Weeks)||2
8896046|NCT02038179|9953760|FG001|NOT COMPLETED|Phase 2 (4 Weeks)||2
9008047|NCT02960490|10070812|FG003|COMPLETED|Re-randomized Participants: 12 Weeks||12
8896047|NCT02038218|9953768|FG000|STARTED|Overall Study|Drug tolerated - Arm 1: No liver disease - 98.7 mg/m2. No alterations of liver functions.|22
8896048|NCT02038218|9953769|FG001|STARTED|Overall Study|Drug tolerated - Arm 2: liver involvement - 85.5 mg/m2. No alterations of liver functions.|7
8896049|NCT02038218|9953768|FG000|COMPLETED|Overall Study|22 patients are included in a publication in progress|22
8896050|NCT02038218|9953769|FG001|COMPLETED|Overall Study|5 patients are included in a publication in progress|7
8896051|NCT02038218|9953768|FG000|NOT COMPLETED|Overall Study||0
8896052|NCT02038218|9953769|FG001|NOT COMPLETED|Overall Study||0
8896053|NCT02038543|9953779|FG000|STARTED|Overall Study||7
8896054|NCT02038543|9953780|FG001|STARTED|Overall Study||4
8896055|NCT02038543|9953781|FG002|STARTED|Overall Study||8
8896056|NCT02038543|9953782|FG003|STARTED|Overall Study||3
8896057|NCT02038543|9953779|FG000|COMPLETED|Overall Study||7
8896058|NCT02038543|9953780|FG001|COMPLETED|Overall Study||4
8896059|NCT02038543|9953781|FG002|COMPLETED|Overall Study||8
8896060|NCT02038543|9953782|FG003|COMPLETED|Overall Study||1
8896061|NCT02038543|9953779|FG000|NOT COMPLETED|Overall Study||0
8896062|NCT02038543|9953780|FG001|NOT COMPLETED|Overall Study||0
8896063|NCT02038543|9953781|FG002|NOT COMPLETED|Overall Study||0
8896064|NCT02038543|9953782|FG003|NOT COMPLETED|Overall Study||2
8896065|NCT02038569|9953792|FG000|STARTED|Overall Study||107
8896066|NCT02038569|9953792|FG000|COMPLETED|Overall Study||102
8896067|NCT02038569|9953792|FG000|NOT COMPLETED|Overall Study||5
8896068|NCT02038647|9953799|FG000|STARTED|Overall Study||89
8896069|NCT02038647|9953800|FG001|STARTED|Overall Study||89
8896070|NCT02038647|9953799|FG000|COMPLETED|Overall Study||0
8896071|NCT02038647|9953800|FG001|COMPLETED|Overall Study||0
8896072|NCT02038647|9953799|FG000|NOT COMPLETED|Overall Study||89
8896073|NCT02038647|9953800|FG001|NOT COMPLETED|Overall Study||89
8896074|NCT02038764|9953811|FG000|STARTED|Overall Study||7
8896075|NCT02038764|9953812|FG001|STARTED|Overall Study||8
8896076|NCT02038764|9953813|FG002|STARTED|Overall Study||9
8896077|NCT02038764|9953814|FG003|STARTED|Overall Study||5
8896078|NCT02038764|9953815|FG004|STARTED|Overall Study||8
8896079|NCT02038764|9953811|FG000|COMPLETED|Overall Study||6
8896080|NCT02038764|9953812|FG001|COMPLETED|Overall Study||7
8896081|NCT02038764|9953813|FG002|COMPLETED|Overall Study||7
8896082|NCT02038764|9953814|FG003|COMPLETED|Overall Study||5
8896083|NCT02038764|9953815|FG004|COMPLETED|Overall Study||7
8896084|NCT02038764|9953811|FG000|NOT COMPLETED|Overall Study||1
8896085|NCT02038764|9953812|FG001|NOT COMPLETED|Overall Study||1
8896086|NCT02038764|9953813|FG002|NOT COMPLETED|Overall Study||2
9008048|NCT02960490|10070813|FG004|COMPLETED|Re-randomized Participants: 12 Weeks||13
9008049|NCT02960490|10070814|FG005|COMPLETED|Re-randomized Participants: 12 Weeks||10
9008050|NCT02960490|10070815|FG006|COMPLETED|Re-randomized Participants: 12 Weeks||0
9008051|NCT02960490|10070816|FG007|COMPLETED|Re-randomized Participants: 12 Weeks||0
9008052|NCT02960490|10070817|FG008|COMPLETED|Re-randomized Participants: 12 Weeks||0
9008053|NCT02960490|10070818|FG009|COMPLETED|Re-randomized Participants: 12 Weeks||0
9008054|NCT02960490|10070809|FG000|NOT COMPLETED|Re-randomized Participants: 12 Weeks||0
9008055|NCT02960490|10070810|FG001|NOT COMPLETED|Re-randomized Participants: 12 Weeks||0
9008056|NCT02960490|10070811|FG002|NOT COMPLETED|Re-randomized Participants: 12 Weeks||2
9008057|NCT02960490|10070812|FG003|NOT COMPLETED|Re-randomized Participants: 12 Weeks||2
9008058|NCT02960490|10070813|FG004|NOT COMPLETED|Re-randomized Participants: 12 Weeks||1
9008059|NCT02960490|10070814|FG005|NOT COMPLETED|Re-randomized Participants: 12 Weeks||2
9008060|NCT02960490|10070815|FG006|NOT COMPLETED|Re-randomized Participants: 12 Weeks||0
9008061|NCT02960490|10070816|FG007|NOT COMPLETED|Re-randomized Participants: 12 Weeks||0
9008062|NCT02960490|10070817|FG008|NOT COMPLETED|Re-randomized Participants: 12 Weeks||0
9008063|NCT02960490|10070818|FG009|NOT COMPLETED|Re-randomized Participants: 12 Weeks||0
9008064|NCT02960490|10070809|FG000|STARTED|Extension Phase(Open-label): 80 Weeks||0
9008065|NCT02960490|10070810|FG001|STARTED|Extension Phase(Open-label): 80 Weeks||0
9008066|NCT02960490|10070811|FG002|STARTED|Extension Phase(Open-label): 80 Weeks||0
8896087|NCT02038764|9953814|FG003|NOT COMPLETED|Overall Study||0
8896088|NCT02038764|9953815|FG004|NOT COMPLETED|Overall Study||1
8896089|NCT02038790|9953831|FG000|STARTED|Day 0 - First Treatment||16
8896090|NCT02038790|9953832|FG001|STARTED|Day 0 - First Treatment||17
8896091|NCT02038790|9953831|FG000|COMPLETED|Day 0 - First Treatment||15
8896092|NCT02038790|9953832|FG001|COMPLETED|Day 0 - First Treatment||16
8896093|NCT02038790|9953831|FG000|NOT COMPLETED|Day 0 - First Treatment||1
8896094|NCT02038790|9953832|FG001|NOT COMPLETED|Day 0 - First Treatment||1
8896095|NCT02038790|9953831|FG000|STARTED|Day 1 - Second Treatment||15
8896096|NCT02038790|9953832|FG001|STARTED|Day 1 - Second Treatment||16
8896097|NCT02038790|9953831|FG000|COMPLETED|Day 1 - Second Treatment||15
8896098|NCT02038790|9953832|FG001|COMPLETED|Day 1 - Second Treatment||16
8896099|NCT02038790|9953831|FG000|NOT COMPLETED|Day 1 - Second Treatment||0
8896100|NCT02038790|9953832|FG001|NOT COMPLETED|Day 1 - Second Treatment||0
8896101|NCT02038829|9953839|FG000|STARTED|Treatment Period 1||8
8896102|NCT02038829|9953840|FG001|STARTED|Treatment Period 1||8
8896103|NCT02038829|9953841|FG002|STARTED|Treatment Period 1||8
8896104|NCT02038829|9953842|FG003|STARTED|Treatment Period 1||8
8896105|NCT02038829|9953843|FG004|STARTED|Treatment Period 1||8
8896106|NCT02038829|9953844|FG005|STARTED|Treatment Period 1||8
8896107|NCT02038829|9953845|FG006|STARTED|Treatment Period 1||8
8896108|NCT02038829|9953846|FG007|STARTED|Treatment Period 1||8
8896109|NCT02038829|9953847|FG008|STARTED|Treatment Period 1||8
8896110|NCT02038829|9953848|FG009|STARTED|Treatment Period 1||8
8896111|NCT02038829|9953849|FG010|STARTED|Treatment Period 1||8
8896112|NCT02038829|9953850|FG011|STARTED|Treatment Period 1||8
8896113|NCT02038829|9953839|FG000|COMPLETED|Treatment Period 1||8
8896114|NCT02038829|9953840|FG001|COMPLETED|Treatment Period 1||8
8896115|NCT02038829|9953841|FG002|COMPLETED|Treatment Period 1||8
8896116|NCT02038829|9953842|FG003|COMPLETED|Treatment Period 1||8
8896117|NCT02038829|9953843|FG004|COMPLETED|Treatment Period 1||8
8896118|NCT02038829|9953844|FG005|COMPLETED|Treatment Period 1||8
8896119|NCT02038829|9953845|FG006|COMPLETED|Treatment Period 1||8
8896120|NCT02038829|9953846|FG007|COMPLETED|Treatment Period 1||8
8896121|NCT02038829|9953847|FG008|COMPLETED|Treatment Period 1||8
8896122|NCT02038829|9953848|FG009|COMPLETED|Treatment Period 1||8
8896123|NCT02038829|9953849|FG010|COMPLETED|Treatment Period 1||8
8896124|NCT02038829|9953850|FG011|COMPLETED|Treatment Period 1||8
8896125|NCT02038829|9953839|FG000|NOT COMPLETED|Treatment Period 1||0
8896126|NCT02038829|9953840|FG001|NOT COMPLETED|Treatment Period 1||0
8896127|NCT02038829|9953841|FG002|NOT COMPLETED|Treatment Period 1||0
8896128|NCT02038829|9953842|FG003|NOT COMPLETED|Treatment Period 1||0
8896129|NCT02038829|9953843|FG004|NOT COMPLETED|Treatment Period 1||0
9008067|NCT02960490|10070812|FG003|STARTED|Extension Phase(Open-label): 80 Weeks||0
9008068|NCT02960490|10070813|FG004|STARTED|Extension Phase(Open-label): 80 Weeks||0
9008069|NCT02960490|10070814|FG005|STARTED|Extension Phase(Open-label): 80 Weeks||0
9008070|NCT02960490|10070815|FG006|STARTED|Extension Phase(Open-label): 80 Weeks||13
9008071|NCT02960490|10070816|FG007|STARTED|Extension Phase(Open-label): 80 Weeks|One Participant who completed Core Treatment Phase (Placebo Then E6011 400 mg arm) had inadequate therapeutic effect at Week 24, hence did not started Extension phase.|11
9008072|NCT02960490|10070817|FG008|STARTED|Extension Phase(Open-label): 80 Weeks||13
9008073|NCT02960490|10070818|FG009|STARTED|Extension Phase(Open-label): 80 Weeks||10
9008074|NCT02960490|10070809|FG000|Treated|Extension Phase(Open-label): 80 Weeks||0
9008075|NCT02960490|10070810|FG001|Treated|Extension Phase(Open-label): 80 Weeks||0
9008076|NCT02960490|10070811|FG002|Treated|Extension Phase(Open-label): 80 Weeks||0
9008077|NCT02960490|10070812|FG003|Treated|Extension Phase(Open-label): 80 Weeks||0
9008078|NCT02960490|10070813|FG004|Treated|Extension Phase(Open-label): 80 Weeks||0
9008079|NCT02960490|10070814|FG005|Treated|Extension Phase(Open-label): 80 Weeks||0
9008080|NCT02960490|10070815|FG006|Treated|Extension Phase(Open-label): 80 Weeks||13
9008081|NCT02960490|10070816|FG007|Treated|Extension Phase(Open-label): 80 Weeks||11
9008082|NCT02960490|10070817|FG008|Treated|Extension Phase(Open-label): 80 Weeks||13
9008083|NCT02960490|10070818|FG009|Treated|Extension Phase(Open-label): 80 Weeks||10
9008084|NCT02960490|10070809|FG000|FAS|Extension Phase(Open-label): 80 Weeks||0
9008085|NCT02960490|10070810|FG001|FAS|Extension Phase(Open-label): 80 Weeks||0
9008086|NCT02960490|10070811|FG002|FAS|Extension Phase(Open-label): 80 Weeks||0
9008087|NCT02960490|10070812|FG003|FAS|Extension Phase(Open-label): 80 Weeks||0
9008088|NCT02960490|10070813|FG004|FAS|Extension Phase(Open-label): 80 Weeks||0
9008089|NCT02960490|10070814|FG005|FAS|Extension Phase(Open-label): 80 Weeks||0
9008090|NCT02960490|10070815|FG006|FAS|Extension Phase(Open-label): 80 Weeks||13
9008091|NCT02960490|10070816|FG007|FAS|Extension Phase(Open-label): 80 Weeks||11
9008092|NCT02960490|10070817|FG008|FAS|Extension Phase(Open-label): 80 Weeks||13
9008093|NCT02960490|10070818|FG009|FAS|Extension Phase(Open-label): 80 Weeks||10
9008094|NCT02960490|10070809|FG000|SAS|Extension Phase(Open-label): 80 Weeks||0
9008095|NCT02960490|10070810|FG001|SAS|Extension Phase(Open-label): 80 Weeks||0
9008096|NCT02960490|10070811|FG002|SAS|Extension Phase(Open-label): 80 Weeks||0
9008097|NCT02960490|10070812|FG003|SAS|Extension Phase(Open-label): 80 Weeks||0
9008098|NCT02960490|10070813|FG004|SAS|Extension Phase(Open-label): 80 Weeks||0
9008099|NCT02960490|10070814|FG005|SAS|Extension Phase(Open-label): 80 Weeks||0
9008100|NCT02960490|10070815|FG006|SAS|Extension Phase(Open-label): 80 Weeks||13
9008101|NCT02960490|10070816|FG007|SAS|Extension Phase(Open-label): 80 Weeks||11
9008102|NCT02960490|10070817|FG008|SAS|Extension Phase(Open-label): 80 Weeks||13
9008103|NCT02960490|10070818|FG009|SAS|Extension Phase(Open-label): 80 Weeks||10
9008104|NCT02960490|10070809|FG000|COMPLETED|Extension Phase(Open-label): 80 Weeks||0
9008105|NCT02960490|10070810|FG001|COMPLETED|Extension Phase(Open-label): 80 Weeks||0
9008106|NCT02960490|10070811|FG002|COMPLETED|Extension Phase(Open-label): 80 Weeks||0
9008107|NCT02960490|10070812|FG003|COMPLETED|Extension Phase(Open-label): 80 Weeks||0
9008108|NCT02960490|10070813|FG004|COMPLETED|Extension Phase(Open-label): 80 Weeks||0
9008109|NCT02960490|10070814|FG005|COMPLETED|Extension Phase(Open-label): 80 Weeks||0
9008110|NCT02960490|10070815|FG006|COMPLETED|Extension Phase(Open-label): 80 Weeks||4
9008111|NCT02960490|10070816|FG007|COMPLETED|Extension Phase(Open-label): 80 Weeks||5
9008112|NCT02960490|10070817|FG008|COMPLETED|Extension Phase(Open-label): 80 Weeks||9
9008113|NCT02960490|10070818|FG009|COMPLETED|Extension Phase(Open-label): 80 Weeks||3
9008114|NCT02960490|10070809|FG000|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||0
8635396|NCT00561821|9675942|FG002|NOT COMPLETED|Overall Study||2
9008115|NCT02960490|10070810|FG001|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||0
9008116|NCT02960490|10070811|FG002|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||0
9008117|NCT02960490|10070812|FG003|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||0
9008118|NCT02960490|10070813|FG004|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||0
9008119|NCT02960490|10070814|FG005|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||0
8635397|NCT00561821|9675943|FG003|NOT COMPLETED|Overall Study||3
8635398|NCT00561834|9675953|FG000|STARTED|Overall Study||2
8896130|NCT02038829|9953844|FG005|NOT COMPLETED|Treatment Period 1||0
8896131|NCT02038829|9953845|FG006|NOT COMPLETED|Treatment Period 1||0
8896132|NCT02038829|9953846|FG007|NOT COMPLETED|Treatment Period 1||0
8896133|NCT02038829|9953847|FG008|NOT COMPLETED|Treatment Period 1||0
8896134|NCT02038829|9953848|FG009|NOT COMPLETED|Treatment Period 1||0
8896135|NCT02038829|9953849|FG010|NOT COMPLETED|Treatment Period 1||0
8896136|NCT02038829|9953850|FG011|NOT COMPLETED|Treatment Period 1||0
8896137|NCT02038829|9953839|FG000|STARTED|Washout Period 1||8
8896138|NCT02038829|9953840|FG001|STARTED|Washout Period 1||8
8896139|NCT02038829|9953841|FG002|STARTED|Washout Period 1||8
8896140|NCT02038829|9953842|FG003|STARTED|Washout Period 1||8
8896141|NCT02038829|9953843|FG004|STARTED|Washout Period 1||8
8896142|NCT02038829|9953844|FG005|STARTED|Washout Period 1||8
8896143|NCT02038829|9953845|FG006|STARTED|Washout Period 1||8
8896144|NCT02038829|9953846|FG007|STARTED|Washout Period 1||8
8896145|NCT02038829|9953847|FG008|STARTED|Washout Period 1||8
8896146|NCT02038829|9953848|FG009|STARTED|Washout Period 1||8
8896147|NCT02038829|9953849|FG010|STARTED|Washout Period 1||8
8896148|NCT02038829|9953850|FG011|STARTED|Washout Period 1||8
8896149|NCT02038829|9953839|FG000|COMPLETED|Washout Period 1||8
8896150|NCT02038829|9953840|FG001|COMPLETED|Washout Period 1||8
8896151|NCT02038829|9953841|FG002|COMPLETED|Washout Period 1||8
8896152|NCT02038829|9953842|FG003|COMPLETED|Washout Period 1||8
8896153|NCT02038829|9953843|FG004|COMPLETED|Washout Period 1||7
8896154|NCT02038829|9953844|FG005|COMPLETED|Washout Period 1||8
8896155|NCT02038829|9953845|FG006|COMPLETED|Washout Period 1||8
8896156|NCT02038829|9953846|FG007|COMPLETED|Washout Period 1||8
8896157|NCT02038829|9953847|FG008|COMPLETED|Washout Period 1||8
8896158|NCT02038829|9953848|FG009|COMPLETED|Washout Period 1||8
8896159|NCT02038829|9953849|FG010|COMPLETED|Washout Period 1||8
8896160|NCT02038829|9953850|FG011|COMPLETED|Washout Period 1||8
8896161|NCT02038829|9953839|FG000|NOT COMPLETED|Washout Period 1||0
8896162|NCT02038829|9953840|FG001|NOT COMPLETED|Washout Period 1||0
8896163|NCT02038829|9953841|FG002|NOT COMPLETED|Washout Period 1||0
8896164|NCT02038829|9953842|FG003|NOT COMPLETED|Washout Period 1||0
8896165|NCT02038829|9953843|FG004|NOT COMPLETED|Washout Period 1||1
8896166|NCT02038829|9953844|FG005|NOT COMPLETED|Washout Period 1||0
8896167|NCT02038829|9953845|FG006|NOT COMPLETED|Washout Period 1||0
8896168|NCT02038829|9953846|FG007|NOT COMPLETED|Washout Period 1||0
8896169|NCT02038829|9953847|FG008|NOT COMPLETED|Washout Period 1||0
8896170|NCT02038829|9953848|FG009|NOT COMPLETED|Washout Period 1||0
8896171|NCT02038829|9953849|FG010|NOT COMPLETED|Washout Period 1||0
8896172|NCT02038829|9953850|FG011|NOT COMPLETED|Washout Period 1||0
8896173|NCT02038829|9953839|FG000|STARTED|Treatment Period 2||8
8896174|NCT02038829|9953840|FG001|STARTED|Treatment Period 2||8
8896175|NCT02038829|9953841|FG002|STARTED|Treatment Period 2||8
8896176|NCT02038829|9953842|FG003|STARTED|Treatment Period 2||8
8896177|NCT02038829|9953843|FG004|STARTED|Treatment Period 2||7
8896178|NCT02038829|9953844|FG005|STARTED|Treatment Period 2||8
8896179|NCT02038829|9953845|FG006|STARTED|Treatment Period 2||8
8896180|NCT02038829|9953846|FG007|STARTED|Treatment Period 2||8
8896181|NCT02038829|9953847|FG008|STARTED|Treatment Period 2||8
8896182|NCT02038829|9953848|FG009|STARTED|Treatment Period 2||8
8896183|NCT02038829|9953849|FG010|STARTED|Treatment Period 2||8
8896184|NCT02038829|9953850|FG011|STARTED|Treatment Period 2||8
8896185|NCT02038829|9953839|FG000|COMPLETED|Treatment Period 2||7
8896186|NCT02038829|9953840|FG001|COMPLETED|Treatment Period 2||8
8896187|NCT02038829|9953841|FG002|COMPLETED|Treatment Period 2||8
8896188|NCT02038829|9953842|FG003|COMPLETED|Treatment Period 2||8
8896189|NCT02038829|9953843|FG004|COMPLETED|Treatment Period 2||7
8896190|NCT02038829|9953844|FG005|COMPLETED|Treatment Period 2||8
8896191|NCT02038829|9953845|FG006|COMPLETED|Treatment Period 2||8
8896192|NCT02038829|9953846|FG007|COMPLETED|Treatment Period 2||8
8635399|NCT00561834|9675953|FG000|COMPLETED|Overall Study||2
8635400|NCT00561834|9675953|FG000|NOT COMPLETED|Overall Study||0
8635401|NCT00561925|9675960|FG000|STARTED|14 Day Lead-In Period||1068
8635402|NCT00561925|9675961|FG001|STARTED|14 Day Lead-In Period||0
8635403|NCT00561925|9675962|FG002|STARTED|14 Day Lead-In Period||0
8635404|NCT00561925|9675963|FG003|STARTED|14 Day Lead-In Period||0
8635405|NCT00561925|9675964|FG004|STARTED|14 Day Lead-In Period||0
8635406|NCT00561925|9675960|FG000|COMPLETED|14 Day Lead-In Period||1013
8635407|NCT00561925|9675961|FG001|COMPLETED|14 Day Lead-In Period||0
8635408|NCT00561925|9675962|FG002|COMPLETED|14 Day Lead-In Period||0
8635409|NCT00561925|9675963|FG003|COMPLETED|14 Day Lead-In Period||0
8635410|NCT00561925|9675964|FG004|COMPLETED|14 Day Lead-In Period||0
8635411|NCT00561925|9675960|FG000|NOT COMPLETED|14 Day Lead-In Period||55
8896193|NCT02038829|9953847|FG008|COMPLETED|Treatment Period 2||8
8896194|NCT02038829|9953848|FG009|COMPLETED|Treatment Period 2||8
8896195|NCT02038829|9953849|FG010|COMPLETED|Treatment Period 2||7
8896196|NCT02038829|9953850|FG011|COMPLETED|Treatment Period 2||8
8896197|NCT02038829|9953839|FG000|NOT COMPLETED|Treatment Period 2||1
8896198|NCT02038829|9953840|FG001|NOT COMPLETED|Treatment Period 2||0
8896199|NCT02038829|9953841|FG002|NOT COMPLETED|Treatment Period 2||0
8896200|NCT02038829|9953842|FG003|NOT COMPLETED|Treatment Period 2||0
8896201|NCT02038829|9953843|FG004|NOT COMPLETED|Treatment Period 2||0
8896202|NCT02038829|9953844|FG005|NOT COMPLETED|Treatment Period 2||0
8896203|NCT02038829|9953845|FG006|NOT COMPLETED|Treatment Period 2||0
8896204|NCT02038829|9953846|FG007|NOT COMPLETED|Treatment Period 2||0
8896205|NCT02038829|9953847|FG008|NOT COMPLETED|Treatment Period 2||0
8635412|NCT00561925|9675961|FG001|NOT COMPLETED|14 Day Lead-In Period||0
8896206|NCT02038829|9953848|FG009|NOT COMPLETED|Treatment Period 2||0
8635413|NCT00561925|9675962|FG002|NOT COMPLETED|14 Day Lead-In Period||0
8635414|NCT00561925|9675963|FG003|NOT COMPLETED|14 Day Lead-In Period||0
8635415|NCT00561925|9675964|FG004|NOT COMPLETED|14 Day Lead-In Period||0
8635416|NCT00561925|9675960|FG000|STARTED|144-week Double-blind, Double-dummy||0
8635417|NCT00561925|9675961|FG001|STARTED|144-week Double-blind, Double-dummy||508
8635418|NCT00561925|9675962|FG002|STARTED|144-week Double-blind, Double-dummy||505
8635419|NCT00561925|9675963|FG003|STARTED|144-week Double-blind, Double-dummy||0
8635420|NCT00561925|9675964|FG004|STARTED|144-week Double-blind, Double-dummy||0
8635421|NCT00561925|9675960|FG000|COMPLETED|144-week Double-blind, Double-dummy||0
8635422|NCT00561925|9675961|FG001|COMPLETED|144-week Double-blind, Double-dummy||358
8635423|NCT00561925|9675962|FG002|COMPLETED|144-week Double-blind, Double-dummy||378
8635424|NCT00561925|9675963|FG003|COMPLETED|144-week Double-blind, Double-dummy||0
8635425|NCT00561925|9675964|FG004|COMPLETED|144-week Double-blind, Double-dummy||0
8635426|NCT00561925|9675960|FG000|NOT COMPLETED|144-week Double-blind, Double-dummy||0
8635427|NCT00561925|9675961|FG001|NOT COMPLETED|144-week Double-blind, Double-dummy||150
8635428|NCT00561925|9675962|FG002|NOT COMPLETED|144-week Double-blind, Double-dummy||127
8635429|NCT00561925|9675963|FG003|NOT COMPLETED|144-week Double-blind, Double-dummy||0
8635430|NCT00561925|9675964|FG004|NOT COMPLETED|144-week Double-blind, Double-dummy||0
8635431|NCT00561925|9675960|FG000|STARTED|Open-Label Extension Period||0
8635432|NCT00561925|9675961|FG001|STARTED|Open-Label Extension Period||1
8635433|NCT00561925|9675962|FG002|STARTED|Open-Label Extension Period||0
8635434|NCT00561925|9675963|FG003|STARTED|Open-Label Extension Period||358
8635435|NCT00561925|9675964|FG004|STARTED|Open-Label Extension Period||378
8635436|NCT00561925|9675960|FG000|COMPLETED|Open-Label Extension Period||0
8635437|NCT00561925|9675961|FG001|COMPLETED|Open-Label Extension Period||1
8635438|NCT00561925|9675962|FG002|COMPLETED|Open-Label Extension Period||0
8635439|NCT00561925|9675963|FG003|COMPLETED|Open-Label Extension Period||315
8635440|NCT00561925|9675964|FG004|COMPLETED|Open-Label Extension Period||328
8635441|NCT00561925|9675960|FG000|NOT COMPLETED|Open-Label Extension Period||0
8635442|NCT00561925|9675961|FG001|NOT COMPLETED|Open-Label Extension Period||0
8635443|NCT00561925|9675962|FG002|NOT COMPLETED|Open-Label Extension Period||0
8635444|NCT00561925|9675963|FG003|NOT COMPLETED|Open-Label Extension Period||43
8635445|NCT00561925|9675964|FG004|NOT COMPLETED|Open-Label Extension Period||50
8635446|NCT00561951|9675985|FG000|STARTED|Overall Study||318
8635447|NCT00561951|9675986|FG001|STARTED|Overall Study||320
8635448|NCT00561951|9675987|FG002|STARTED|Overall Study||313
8635449|NCT00561951|9675985|FG000|COMPLETED|Overall Study||285
8635450|NCT00561951|9675986|FG001|COMPLETED|Overall Study||286
8635451|NCT00561951|9675987|FG002|COMPLETED|Overall Study||281
8635452|NCT00561951|9675985|FG000|NOT COMPLETED|Overall Study||33
8635453|NCT00561951|9675986|FG001|NOT COMPLETED|Overall Study||34
8635454|NCT00561951|9675987|FG002|NOT COMPLETED|Overall Study||32
8635455|NCT00561977|9675998|FG000|STARTED|Overall Study||12
8635456|NCT00561977|9675999|FG001|STARTED|Overall Study||12
8635457|NCT00561977|9676000|FG002|STARTED|Overall Study||12
8635458|NCT00561977|9675998|FG000|COMPLETED|Overall Study||12
8635459|NCT00561977|9675999|FG001|COMPLETED|Overall Study||9
8635460|NCT00561977|9676000|FG002|COMPLETED|Overall Study||10
8635461|NCT00561977|9675998|FG000|NOT COMPLETED|Overall Study||0
8635462|NCT00561977|9675999|FG001|NOT COMPLETED|Overall Study||3
8635463|NCT00561977|9676000|FG002|NOT COMPLETED|Overall Study||2
8635464|NCT00562094|9676008|FG000|STARTED|Overall Study||8616
8635465|NCT00562094|9676008|FG000|COMPLETED|Overall Study||8554
8635466|NCT00562094|9676008|FG000|NOT COMPLETED|Overall Study||62
8635467|NCT00562120|9676016|FG000|STARTED|First Intervention Period||6
8635468|NCT00562120|9676017|FG001|STARTED|First Intervention Period||5
8635469|NCT00562120|9676018|FG002|STARTED|First Intervention Period||5
8635470|NCT00562120|9676019|FG003|STARTED|First Intervention Period||5
8635471|NCT00562120|9676016|FG000|Treated|First Intervention Period||5
8635472|NCT00562120|9676017|FG001|Treated|First Intervention Period||5
8635473|NCT00562120|9676018|FG002|Treated|First Intervention Period||5
8635474|NCT00562120|9676019|FG003|Treated|First Intervention Period||5
8635475|NCT00562120|9676016|FG000|COMPLETED|First Intervention Period||4
8635476|NCT00562120|9676017|FG001|COMPLETED|First Intervention Period||5
8635477|NCT00562120|9676018|FG002|COMPLETED|First Intervention Period||5
8635478|NCT00562120|9676019|FG003|COMPLETED|First Intervention Period||5
8726212|NCT01034553|9773389|FG002|COMPLETED|Overall Study||3
8726213|NCT01034553|9773390|FG003|COMPLETED|Overall Study||3
8726214|NCT01034553|9773391|FG004|COMPLETED|Overall Study||6
8726215|NCT01034553|9773392|FG005|COMPLETED|Overall Study||7
8726216|NCT01034553|9773387|FG000|NOT COMPLETED|Overall Study||0
8726217|NCT01034553|9773388|FG001|NOT COMPLETED|Overall Study||0
8726218|NCT01034553|9773389|FG002|NOT COMPLETED|Overall Study||0
9008120|NCT02960490|10070815|FG006|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||9
9008121|NCT02960490|10070816|FG007|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||6
9008122|NCT02960490|10070817|FG008|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||4
8726219|NCT01034553|9773390|FG003|NOT COMPLETED|Overall Study||0
8726220|NCT01034553|9773391|FG004|NOT COMPLETED|Overall Study||0
8726221|NCT01034553|9773392|FG005|NOT COMPLETED|Overall Study||0
8635479|NCT00562120|9676016|FG000|NOT COMPLETED|First Intervention Period||2
8635480|NCT00562120|9676017|FG001|NOT COMPLETED|First Intervention Period||0
8635481|NCT00562120|9676018|FG002|NOT COMPLETED|First Intervention Period||0
8635482|NCT00562120|9676019|FG003|NOT COMPLETED|First Intervention Period||0
8635483|NCT00562120|9676016|FG000|STARTED|Washout Period 1 (At Least 14 Days)||4
8726222|NCT01034579|9773408|FG000|STARTED|Overall Study||158
8726223|NCT01034579|9773409|FG001|STARTED|Overall Study||166
8726224|NCT01034579|9773408|FG000|COMPLETED|Overall Study||158
8726225|NCT01034579|9773409|FG001|COMPLETED|Overall Study||166
8726226|NCT01034579|9773408|FG000|NOT COMPLETED|Overall Study||0
8726227|NCT01034579|9773409|FG001|NOT COMPLETED|Overall Study||0
8726228|NCT01034592|9773415|FG000|STARTED|Overall Study||2
8726229|NCT01034592|9773415|FG000|COMPLETED|Overall Study||2
8896207|NCT02038829|9953849|FG010|NOT COMPLETED|Treatment Period 2||1
8896208|NCT02038829|9953850|FG011|NOT COMPLETED|Treatment Period 2||0
8726230|NCT01034592|9773415|FG000|NOT COMPLETED|Overall Study||0
8896209|NCT02038829|9953839|FG000|STARTED|Washout Period 2||7
8896210|NCT02038829|9953840|FG001|STARTED|Washout Period 2||8
8896211|NCT02038829|9953841|FG002|STARTED|Washout Period 2||8
8635484|NCT00562120|9676017|FG001|STARTED|Washout Period 1 (At Least 14 Days)||5
8635485|NCT00562120|9676018|FG002|STARTED|Washout Period 1 (At Least 14 Days)||5
8635486|NCT00562120|9676019|FG003|STARTED|Washout Period 1 (At Least 14 Days)||5
8635487|NCT00562120|9676016|FG000|COMPLETED|Washout Period 1 (At Least 14 Days)||4
8635488|NCT00562120|9676017|FG001|COMPLETED|Washout Period 1 (At Least 14 Days)||5
8635489|NCT00562120|9676018|FG002|COMPLETED|Washout Period 1 (At Least 14 Days)||5
8635490|NCT00562120|9676019|FG003|COMPLETED|Washout Period 1 (At Least 14 Days)||5
8635491|NCT00562120|9676016|FG000|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
8635492|NCT00562120|9676017|FG001|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
8635493|NCT00562120|9676018|FG002|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
8635494|NCT00562120|9676019|FG003|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
8635495|NCT00562120|9676016|FG000|STARTED|Second Intervention Period||4
8635496|NCT00562120|9676017|FG001|STARTED|Second Intervention Period||5
8635497|NCT00562120|9676018|FG002|STARTED|Second Intervention Period||5
8635498|NCT00562120|9676019|FG003|STARTED|Second Intervention Period||5
8635499|NCT00562120|9676016|FG000|COMPLETED|Second Intervention Period||4
8635500|NCT00562120|9676017|FG001|COMPLETED|Second Intervention Period||5
8635501|NCT00562120|9676018|FG002|COMPLETED|Second Intervention Period||5
8635502|NCT00562120|9676019|FG003|COMPLETED|Second Intervention Period||5
8635503|NCT00562120|9676016|FG000|NOT COMPLETED|Second Intervention Period||0
8635504|NCT00562120|9676017|FG001|NOT COMPLETED|Second Intervention Period||0
8635505|NCT00562120|9676018|FG002|NOT COMPLETED|Second Intervention Period||0
8635506|NCT00562120|9676019|FG003|NOT COMPLETED|Second Intervention Period||0
8635507|NCT00562120|9676016|FG000|STARTED|Washout Period 2 (At Least 14 Days)||4
8635508|NCT00562120|9676017|FG001|STARTED|Washout Period 2 (At Least 14 Days)||5
8635509|NCT00562120|9676018|FG002|STARTED|Washout Period 2 (At Least 14 Days)||5
8635510|NCT00562120|9676019|FG003|STARTED|Washout Period 2 (At Least 14 Days)||5
8635511|NCT00562120|9676016|FG000|COMPLETED|Washout Period 2 (At Least 14 Days)||4
8635512|NCT00562120|9676017|FG001|COMPLETED|Washout Period 2 (At Least 14 Days)||5
8635513|NCT00562120|9676018|FG002|COMPLETED|Washout Period 2 (At Least 14 Days)||5
8635514|NCT00562120|9676019|FG003|COMPLETED|Washout Period 2 (At Least 14 Days)||5
8635515|NCT00562120|9676016|FG000|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
8635516|NCT00562120|9676017|FG001|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
8635517|NCT00562120|9676018|FG002|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
8635518|NCT00562120|9676019|FG003|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
8635519|NCT00562120|9676016|FG000|STARTED|Third Intervention Period||4
8635520|NCT00562120|9676017|FG001|STARTED|Third Intervention Period||5
8635521|NCT00562120|9676018|FG002|STARTED|Third Intervention Period||5
8635522|NCT00562120|9676019|FG003|STARTED|Third Intervention Period||5
8635523|NCT00562120|9676016|FG000|COMPLETED|Third Intervention Period||4
8635524|NCT00562120|9676017|FG001|COMPLETED|Third Intervention Period||5
8635525|NCT00562120|9676018|FG002|COMPLETED|Third Intervention Period||5
8635526|NCT00562120|9676019|FG003|COMPLETED|Third Intervention Period||5
8635527|NCT00562120|9676016|FG000|NOT COMPLETED|Third Intervention Period||0
8635528|NCT00562120|9676017|FG001|NOT COMPLETED|Third Intervention Period||0
8635529|NCT00562120|9676018|FG002|NOT COMPLETED|Third Intervention Period||0
8635530|NCT00562120|9676019|FG003|NOT COMPLETED|Third Intervention Period||0
8635531|NCT00562120|9676016|FG000|STARTED|Washout Period 3 (At Least 14 Days)||4
8635532|NCT00562120|9676017|FG001|STARTED|Washout Period 3 (At Least 14 Days)||5
8635533|NCT00562120|9676018|FG002|STARTED|Washout Period 3 (At Least 14 Days)||5
8635534|NCT00562120|9676019|FG003|STARTED|Washout Period 3 (At Least 14 Days)||5
8635535|NCT00562120|9676016|FG000|COMPLETED|Washout Period 3 (At Least 14 Days)||4
8635536|NCT00562120|9676017|FG001|COMPLETED|Washout Period 3 (At Least 14 Days)||5
8635537|NCT00562120|9676018|FG002|COMPLETED|Washout Period 3 (At Least 14 Days)||5
8635538|NCT00562120|9676019|FG003|COMPLETED|Washout Period 3 (At Least 14 Days)||5
8635539|NCT00562120|9676016|FG000|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
8635540|NCT00562120|9676017|FG001|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
8635541|NCT00562120|9676018|FG002|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
8635542|NCT00562120|9676019|FG003|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
8726231|NCT01034631|9773423|FG000|STARTED|Phase I||15
8726232|NCT01034631|9773424|FG001|STARTED|Phase I|No Phase II Participants were enrolled during this time period|0
8726233|NCT01034631|9773425|FG002|STARTED|Phase I|No Phase II Participants were enrolled during this time period|0
8726234|NCT01034631|9773423|FG000|COMPLETED|Phase I||12
8635543|NCT00562120|9676016|FG000|STARTED|Fourth Intervention Period||4
8635544|NCT00562120|9676017|FG001|STARTED|Fourth Intervention Period||5
8726235|NCT01034631|9773424|FG001|COMPLETED|Phase I||0
8635545|NCT00562120|9676018|FG002|STARTED|Fourth Intervention Period||5
8635546|NCT00562120|9676019|FG003|STARTED|Fourth Intervention Period||5
8635547|NCT00562120|9676016|FG000|COMPLETED|Fourth Intervention Period||4
8635548|NCT00562120|9676017|FG001|COMPLETED|Fourth Intervention Period||5
8635549|NCT00562120|9676018|FG002|COMPLETED|Fourth Intervention Period||5
8726236|NCT01034631|9773425|FG002|COMPLETED|Phase I||0
8726237|NCT01034631|9773423|FG000|NOT COMPLETED|Phase I||3
8726238|NCT01034631|9773424|FG001|NOT COMPLETED|Phase I||0
8726239|NCT01034631|9773425|FG002|NOT COMPLETED|Phase I||0
8726240|NCT01034631|9773423|FG000|STARTED|Phase II|No Phase I Participants were enrolled during this time period.|0
8896212|NCT02038829|9953842|FG003|STARTED|Washout Period 2||8
8635550|NCT00562120|9676019|FG003|COMPLETED|Fourth Intervention Period||5
8635551|NCT00562120|9676016|FG000|NOT COMPLETED|Fourth Intervention Period||0
8635552|NCT00562120|9676017|FG001|NOT COMPLETED|Fourth Intervention Period||0
8635553|NCT00562120|9676018|FG002|NOT COMPLETED|Fourth Intervention Period||0
8635554|NCT00562120|9676019|FG003|NOT COMPLETED|Fourth Intervention Period||0
8635555|NCT00562159|9676031|FG000|STARTED|Overall Study||213
8635556|NCT00562159|9676032|FG001|STARTED|Overall Study||225
8635557|NCT00562159|9676031|FG000|COMPLETED|Overall Study||175
8635558|NCT00562159|9676032|FG001|COMPLETED|Overall Study||192
8635559|NCT00562159|9676031|FG000|NOT COMPLETED|Overall Study||38
8635560|NCT00562159|9676032|FG001|NOT COMPLETED|Overall Study||33
8635561|NCT00562302|9676041|FG000|STARTED|Overall Study||170
8726241|NCT01034631|9773424|FG001|STARTED|Phase II||70
8726242|NCT01034631|9773425|FG002|STARTED|Phase II||69
8726243|NCT01034631|9773423|FG000|COMPLETED|Phase II||0
8726244|NCT01034631|9773424|FG001|COMPLETED|Phase II||69
8726245|NCT01034631|9773425|FG002|COMPLETED|Phase II||67
8726246|NCT01034631|9773423|FG000|NOT COMPLETED|Phase II||0
8726247|NCT01034631|9773424|FG001|NOT COMPLETED|Phase II||1
8726248|NCT01034631|9773425|FG002|NOT COMPLETED|Phase II||2
8726249|NCT01034657|9773435|FG000|STARTED|Core Phase||34
8726250|NCT01034657|9773436|FG001|STARTED|Core Phase||0
8726251|NCT01034657|9773437|FG002|STARTED|Core Phase||0
8726252|NCT01034657|9773435|FG000|COMPLETED|Core Phase||20
8726253|NCT01034657|9773436|FG001|COMPLETED|Core Phase||0
8726254|NCT01034657|9773437|FG002|COMPLETED|Core Phase||0
8726255|NCT01034657|9773435|FG000|NOT COMPLETED|Core Phase||14
8726256|NCT01034657|9773436|FG001|NOT COMPLETED|Core Phase||0
8726257|NCT01034657|9773437|FG002|NOT COMPLETED|Core Phase||0
8896213|NCT02038829|9953843|FG004|STARTED|Washout Period 2||7
8896214|NCT02038829|9953844|FG005|STARTED|Washout Period 2||8
8896215|NCT02038829|9953845|FG006|STARTED|Washout Period 2||8
8896216|NCT02038829|9953846|FG007|STARTED|Washout Period 2||8
8896217|NCT02038829|9953847|FG008|STARTED|Washout Period 2||8
8896218|NCT02038829|9953848|FG009|STARTED|Washout Period 2||8
8896219|NCT02038829|9953849|FG010|STARTED|Washout Period 2||7
8896220|NCT02038829|9953850|FG011|STARTED|Washout Period 2||8
8896221|NCT02038829|9953839|FG000|COMPLETED|Washout Period 2||7
8896222|NCT02038829|9953840|FG001|COMPLETED|Washout Period 2||8
8896223|NCT02038829|9953841|FG002|COMPLETED|Washout Period 2||8
8896224|NCT02038829|9953842|FG003|COMPLETED|Washout Period 2||8
8896225|NCT02038829|9953843|FG004|COMPLETED|Washout Period 2||7
8896226|NCT02038829|9953844|FG005|COMPLETED|Washout Period 2||7
8896227|NCT02038829|9953845|FG006|COMPLETED|Washout Period 2||8
8896228|NCT02038829|9953846|FG007|COMPLETED|Washout Period 2||8
8896229|NCT02038829|9953847|FG008|COMPLETED|Washout Period 2||7
8896230|NCT02038829|9953848|FG009|COMPLETED|Washout Period 2||8
8896231|NCT02038829|9953849|FG010|COMPLETED|Washout Period 2||7
8896232|NCT02038829|9953850|FG011|COMPLETED|Washout Period 2||8
8896233|NCT02038829|9953839|FG000|NOT COMPLETED|Washout Period 2||0
8896234|NCT02038829|9953840|FG001|NOT COMPLETED|Washout Period 2||0
8896235|NCT02038829|9953841|FG002|NOT COMPLETED|Washout Period 2||0
8896236|NCT02038829|9953842|FG003|NOT COMPLETED|Washout Period 2||0
8896237|NCT02038829|9953843|FG004|NOT COMPLETED|Washout Period 2||0
8896238|NCT02038829|9953844|FG005|NOT COMPLETED|Washout Period 2||1
8896239|NCT02038829|9953845|FG006|NOT COMPLETED|Washout Period 2||0
8896240|NCT02038829|9953846|FG007|NOT COMPLETED|Washout Period 2||0
8896241|NCT02038829|9953847|FG008|NOT COMPLETED|Washout Period 2||1
8896242|NCT02038829|9953848|FG009|NOT COMPLETED|Washout Period 2||0
8896243|NCT02038829|9953849|FG010|NOT COMPLETED|Washout Period 2||0
8896244|NCT02038829|9953850|FG011|NOT COMPLETED|Washout Period 2||0
8896245|NCT02038829|9953839|FG000|STARTED|Treatment Period 3||7
8896246|NCT02038829|9953840|FG001|STARTED|Treatment Period 3||8
8896247|NCT02038829|9953841|FG002|STARTED|Treatment Period 3||8
9008123|NCT02960490|10070818|FG009|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||7
9008124|NCT02960854|10070842|FG000|STARTED|Overall Study||15
9008125|NCT02960854|10070843|FG001|STARTED|Overall Study||16
9008126|NCT02960854|10070842|FG000|COMPLETED|Overall Study||8
8635562|NCT00562302|9676042|FG001|STARTED|Overall Study||169
8635563|NCT00562302|9676041|FG000|COMPLETED|Overall Study||150
8726258|NCT01034657|9773435|FG000|STARTED|Randomized Phase||6
8726259|NCT01034657|9773436|FG001|STARTED|Randomized Phase||6
8726260|NCT01034657|9773437|FG002|STARTED|Randomized Phase||1
8726261|NCT01034657|9773435|FG000|COMPLETED|Randomized Phase||1
8896248|NCT02038829|9953842|FG003|STARTED|Treatment Period 3||8
8896249|NCT02038829|9953843|FG004|STARTED|Treatment Period 3||7
8896250|NCT02038829|9953844|FG005|STARTED|Treatment Period 3||7
8896251|NCT02038829|9953845|FG006|STARTED|Treatment Period 3||8
8896252|NCT02038829|9953846|FG007|STARTED|Treatment Period 3||8
8896253|NCT02038829|9953847|FG008|STARTED|Treatment Period 3||7
8896254|NCT02038829|9953848|FG009|STARTED|Treatment Period 3||8
8896255|NCT02038829|9953849|FG010|STARTED|Treatment Period 3||7
8896256|NCT02038829|9953850|FG011|STARTED|Treatment Period 3||8
8896257|NCT02038829|9953839|FG000|COMPLETED|Treatment Period 3||7
8896258|NCT02038829|9953840|FG001|COMPLETED|Treatment Period 3||8
8896259|NCT02038829|9953841|FG002|COMPLETED|Treatment Period 3||8
8896260|NCT02038829|9953842|FG003|COMPLETED|Treatment Period 3||8
8896261|NCT02038829|9953843|FG004|COMPLETED|Treatment Period 3||7
8896262|NCT02038829|9953844|FG005|COMPLETED|Treatment Period 3||7
8896263|NCT02038829|9953845|FG006|COMPLETED|Treatment Period 3||8
8896264|NCT02038829|9953846|FG007|COMPLETED|Treatment Period 3||8
8896265|NCT02038829|9953847|FG008|COMPLETED|Treatment Period 3||7
8896266|NCT02038829|9953848|FG009|COMPLETED|Treatment Period 3||8
8896267|NCT02038829|9953849|FG010|COMPLETED|Treatment Period 3||7
8896268|NCT02038829|9953850|FG011|COMPLETED|Treatment Period 3||8
8896269|NCT02038829|9953839|FG000|NOT COMPLETED|Treatment Period 3||0
8896270|NCT02038829|9953840|FG001|NOT COMPLETED|Treatment Period 3||0
8896271|NCT02038829|9953841|FG002|NOT COMPLETED|Treatment Period 3||0
8896272|NCT02038829|9953842|FG003|NOT COMPLETED|Treatment Period 3||0
8896273|NCT02038829|9953843|FG004|NOT COMPLETED|Treatment Period 3||0
8896274|NCT02038829|9953844|FG005|NOT COMPLETED|Treatment Period 3||0
8896275|NCT02038829|9953845|FG006|NOT COMPLETED|Treatment Period 3||0
8896276|NCT02038829|9953846|FG007|NOT COMPLETED|Treatment Period 3||0
8896277|NCT02038829|9953847|FG008|NOT COMPLETED|Treatment Period 3||0
8896278|NCT02038829|9953848|FG009|NOT COMPLETED|Treatment Period 3||0
8896279|NCT02038829|9953849|FG010|NOT COMPLETED|Treatment Period 3||0
8896280|NCT02038829|9953850|FG011|NOT COMPLETED|Treatment Period 3||0
8896281|NCT02038829|9953839|FG000|STARTED|Washout Period 3||7
8896282|NCT02038829|9953840|FG001|STARTED|Washout Period 3||8
8896283|NCT02038829|9953841|FG002|STARTED|Washout Period 3||8
8896284|NCT02038829|9953842|FG003|STARTED|Washout Period 3||8
8896285|NCT02038829|9953843|FG004|STARTED|Washout Period 3||7
8896286|NCT02038829|9953844|FG005|STARTED|Washout Period 3||7
8896287|NCT02038829|9953845|FG006|STARTED|Washout Period 3||8
8896288|NCT02038829|9953846|FG007|STARTED|Washout Period 3||8
8896289|NCT02038829|9953847|FG008|STARTED|Washout Period 3||7
8896290|NCT02038829|9953848|FG009|STARTED|Washout Period 3||8
8896291|NCT02038829|9953849|FG010|STARTED|Washout Period 3||7
8896292|NCT02038829|9953850|FG011|STARTED|Washout Period 3||8
8896293|NCT02038829|9953839|FG000|COMPLETED|Washout Period 3||7
8896294|NCT02038829|9953840|FG001|COMPLETED|Washout Period 3||8
8896295|NCT02038829|9953841|FG002|COMPLETED|Washout Period 3||8
8896296|NCT02038829|9953842|FG003|COMPLETED|Washout Period 3||8
8896297|NCT02038829|9953843|FG004|COMPLETED|Washout Period 3||7
8896298|NCT02038829|9953844|FG005|COMPLETED|Washout Period 3||7
8896299|NCT02038829|9953845|FG006|COMPLETED|Washout Period 3||8
8896300|NCT02038829|9953846|FG007|COMPLETED|Washout Period 3||8
8896301|NCT02038829|9953847|FG008|COMPLETED|Washout Period 3||7
8896302|NCT02038829|9953848|FG009|COMPLETED|Washout Period 3||8
8896303|NCT02038829|9953849|FG010|COMPLETED|Washout Period 3||7
8896304|NCT02038829|9953850|FG011|COMPLETED|Washout Period 3||8
8896305|NCT02038829|9953839|FG000|NOT COMPLETED|Washout Period 3||0
8896306|NCT02038829|9953840|FG001|NOT COMPLETED|Washout Period 3||0
8896307|NCT02038829|9953841|FG002|NOT COMPLETED|Washout Period 3||0
8896308|NCT02038829|9953842|FG003|NOT COMPLETED|Washout Period 3||0
8896309|NCT02038829|9953843|FG004|NOT COMPLETED|Washout Period 3||0
8896310|NCT02038829|9953844|FG005|NOT COMPLETED|Washout Period 3||0
8896311|NCT02038829|9953845|FG006|NOT COMPLETED|Washout Period 3||0
8896312|NCT02038829|9953846|FG007|NOT COMPLETED|Washout Period 3||0
8896313|NCT02038829|9953847|FG008|NOT COMPLETED|Washout Period 3||0
8896314|NCT02038829|9953848|FG009|NOT COMPLETED|Washout Period 3||0
8896315|NCT02038829|9953849|FG010|NOT COMPLETED|Washout Period 3||0
8896316|NCT02038829|9953850|FG011|NOT COMPLETED|Washout Period 3||0
8896317|NCT02038829|9953839|FG000|STARTED|Treatment Period 4||7
9008127|NCT02960854|10070843|FG001|COMPLETED|Overall Study||7
9008128|NCT02960854|10070842|FG000|NOT COMPLETED|Overall Study||7
9008129|NCT02960854|10070843|FG001|NOT COMPLETED|Overall Study||9
9008130|NCT02961062|10070851|FG000|STARTED|Overall Study||20
9008131|NCT02961062|10070852|FG001|STARTED|Overall Study||20
9008132|NCT02961062|10070851|FG000|COMPLETED|Overall Study||20
9008133|NCT02961062|10070852|FG001|COMPLETED|Overall Study||20
9008134|NCT02961062|10070851|FG000|NOT COMPLETED|Overall Study||0
9008135|NCT02961062|10070852|FG001|NOT COMPLETED|Overall Study||0
9008136|NCT02961218|10070860|FG000|STARTED|Overall Study||25
9008137|NCT02961218|10070861|FG001|STARTED|Overall Study||24
9008138|NCT02961218|10070860|FG000|Safety Analysis Set|Overall Study||25
9008139|NCT02961218|10070861|FG001|Safety Analysis Set|Overall Study||24
8896318|NCT02038829|9953840|FG001|STARTED|Treatment Period 4||8
9008140|NCT02961218|10070860|FG000|Pharmacokinetics (PK) Analysis Set|Overall Study||25
9008141|NCT02961218|10070861|FG001|Pharmacokinetics (PK) Analysis Set|Overall Study|Placebo patients were excluded from the PK analyses|0
9008142|NCT02961218|10070860|FG000|Primary PD Analysis Set|Overall Study||25
9008143|NCT02961218|10070861|FG001|Primary PD Analysis Set|Overall Study||24
8896319|NCT02038829|9953841|FG002|STARTED|Treatment Period 4||8
8896320|NCT02038829|9953842|FG003|STARTED|Treatment Period 4||8
8896321|NCT02038829|9953843|FG004|STARTED|Treatment Period 4||7
8896322|NCT02038829|9953844|FG005|STARTED|Treatment Period 4||7
8896323|NCT02038829|9953845|FG006|STARTED|Treatment Period 4||8
8896324|NCT02038829|9953846|FG007|STARTED|Treatment Period 4||8
8896325|NCT02038829|9953847|FG008|STARTED|Treatment Period 4||7
8896326|NCT02038829|9953848|FG009|STARTED|Treatment Period 4||8
8896327|NCT02038829|9953849|FG010|STARTED|Treatment Period 4||7
8896328|NCT02038829|9953850|FG011|STARTED|Treatment Period 4||8
8896329|NCT02038829|9953839|FG000|COMPLETED|Treatment Period 4||7
8896330|NCT02038829|9953840|FG001|COMPLETED|Treatment Period 4||7
8896331|NCT02038829|9953841|FG002|COMPLETED|Treatment Period 4||8
8896332|NCT02038829|9953842|FG003|COMPLETED|Treatment Period 4||8
8896333|NCT02038829|9953843|FG004|COMPLETED|Treatment Period 4||7
8896334|NCT02038829|9953844|FG005|COMPLETED|Treatment Period 4||7
8896335|NCT02038829|9953845|FG006|COMPLETED|Treatment Period 4||8
8896336|NCT02038829|9953846|FG007|COMPLETED|Treatment Period 4||8
8896337|NCT02038829|9953847|FG008|COMPLETED|Treatment Period 4||7
8896338|NCT02038829|9953848|FG009|COMPLETED|Treatment Period 4||8
8896339|NCT02038829|9953849|FG010|COMPLETED|Treatment Period 4||7
8896340|NCT02038829|9953850|FG011|COMPLETED|Treatment Period 4||8
8896341|NCT02038829|9953839|FG000|NOT COMPLETED|Treatment Period 4||0
8896342|NCT02038829|9953840|FG001|NOT COMPLETED|Treatment Period 4||1
8896343|NCT02038829|9953841|FG002|NOT COMPLETED|Treatment Period 4||0
8896344|NCT02038829|9953842|FG003|NOT COMPLETED|Treatment Period 4||0
8896345|NCT02038829|9953843|FG004|NOT COMPLETED|Treatment Period 4||0
8896346|NCT02038829|9953844|FG005|NOT COMPLETED|Treatment Period 4||0
8896347|NCT02038829|9953845|FG006|NOT COMPLETED|Treatment Period 4||0
8896348|NCT02038829|9953846|FG007|NOT COMPLETED|Treatment Period 4||0
8896349|NCT02038829|9953847|FG008|NOT COMPLETED|Treatment Period 4||0
8896350|NCT02038829|9953848|FG009|NOT COMPLETED|Treatment Period 4||0
8896351|NCT02038829|9953849|FG010|NOT COMPLETED|Treatment Period 4||0
8896352|NCT02038829|9953850|FG011|NOT COMPLETED|Treatment Period 4||0
8896353|NCT02038829|9953839|FG000|STARTED|Washout Period 4||7
8896354|NCT02038829|9953840|FG001|STARTED|Washout Period 4||7
8896355|NCT02038829|9953841|FG002|STARTED|Washout Period 4||8
8896356|NCT02038829|9953842|FG003|STARTED|Washout Period 4||8
8896357|NCT02038829|9953843|FG004|STARTED|Washout Period 4||7
8896358|NCT02038829|9953844|FG005|STARTED|Washout Period 4||7
8896359|NCT02038829|9953845|FG006|STARTED|Washout Period 4||8
8896360|NCT02038829|9953846|FG007|STARTED|Washout Period 4||8
8896361|NCT02038829|9953847|FG008|STARTED|Washout Period 4||7
8896362|NCT02038829|9953848|FG009|STARTED|Washout Period 4||8
8896363|NCT02038829|9953849|FG010|STARTED|Washout Period 4||7
8896364|NCT02038829|9953850|FG011|STARTED|Washout Period 4||8
8896365|NCT02038829|9953839|FG000|COMPLETED|Washout Period 4||7
8896366|NCT02038829|9953840|FG001|COMPLETED|Washout Period 4||7
8896367|NCT02038829|9953841|FG002|COMPLETED|Washout Period 4||8
8896368|NCT02038829|9953842|FG003|COMPLETED|Washout Period 4||8
8896369|NCT02038829|9953843|FG004|COMPLETED|Washout Period 4||7
8896370|NCT02038829|9953844|FG005|COMPLETED|Washout Period 4||7
8896371|NCT02038829|9953845|FG006|COMPLETED|Washout Period 4||7
8896372|NCT02038829|9953846|FG007|COMPLETED|Washout Period 4||8
8896373|NCT02038829|9953847|FG008|COMPLETED|Washout Period 4||7
8896374|NCT02038829|9953848|FG009|COMPLETED|Washout Period 4||8
8896375|NCT02038829|9953849|FG010|COMPLETED|Washout Period 4||7
8896376|NCT02038829|9953850|FG011|COMPLETED|Washout Period 4||8
8896377|NCT02038829|9953839|FG000|NOT COMPLETED|Washout Period 4||0
8896378|NCT02038829|9953840|FG001|NOT COMPLETED|Washout Period 4||0
8896379|NCT02038829|9953841|FG002|NOT COMPLETED|Washout Period 4||0
8896380|NCT02038829|9953842|FG003|NOT COMPLETED|Washout Period 4||0
8896381|NCT02038829|9953843|FG004|NOT COMPLETED|Washout Period 4||0
8896382|NCT02038829|9953844|FG005|NOT COMPLETED|Washout Period 4||0
8896383|NCT02038829|9953845|FG006|NOT COMPLETED|Washout Period 4||1
8896384|NCT02038829|9953846|FG007|NOT COMPLETED|Washout Period 4||0
8896385|NCT02038829|9953847|FG008|NOT COMPLETED|Washout Period 4||0
8896386|NCT02038829|9953848|FG009|NOT COMPLETED|Washout Period 4||0
8896387|NCT02038829|9953849|FG010|NOT COMPLETED|Washout Period 4||0
8896388|NCT02038829|9953850|FG011|NOT COMPLETED|Washout Period 4||0
8896389|NCT02038829|9953839|FG000|STARTED|Treatment Period 5||7
8896390|NCT02038829|9953840|FG001|STARTED|Treatment Period 5||7
8896391|NCT02038829|9953841|FG002|STARTED|Treatment Period 5||8
8896392|NCT02038829|9953842|FG003|STARTED|Treatment Period 5||8
8896393|NCT02038829|9953843|FG004|STARTED|Treatment Period 5||7
8896394|NCT02038829|9953844|FG005|STARTED|Treatment Period 5||7
8896395|NCT02038829|9953845|FG006|STARTED|Treatment Period 5||7
8896396|NCT02038829|9953846|FG007|STARTED|Treatment Period 5||8
8896397|NCT02038829|9953847|FG008|STARTED|Treatment Period 5||7
8896398|NCT02038829|9953848|FG009|STARTED|Treatment Period 5||8
8896399|NCT02038829|9953849|FG010|STARTED|Treatment Period 5||7
8896400|NCT02038829|9953850|FG011|STARTED|Treatment Period 5||8
8896401|NCT02038829|9953839|FG000|COMPLETED|Treatment Period 5||7
8896402|NCT02038829|9953840|FG001|COMPLETED|Treatment Period 5||7
8896403|NCT02038829|9953841|FG002|COMPLETED|Treatment Period 5||8
8896404|NCT02038829|9953842|FG003|COMPLETED|Treatment Period 5||8
8896405|NCT02038829|9953843|FG004|COMPLETED|Treatment Period 5||7
8896406|NCT02038829|9953844|FG005|COMPLETED|Treatment Period 5||7
8896407|NCT02038829|9953845|FG006|COMPLETED|Treatment Period 5||7
8896408|NCT02038829|9953846|FG007|COMPLETED|Treatment Period 5||8
8896409|NCT02038829|9953847|FG008|COMPLETED|Treatment Period 5||7
8896410|NCT02038829|9953848|FG009|COMPLETED|Treatment Period 5||8
8896411|NCT02038829|9953849|FG010|COMPLETED|Treatment Period 5||7
8896412|NCT02038829|9953850|FG011|COMPLETED|Treatment Period 5||8
8896413|NCT02038829|9953839|FG000|NOT COMPLETED|Treatment Period 5||0
8896414|NCT02038829|9953840|FG001|NOT COMPLETED|Treatment Period 5||0
8896415|NCT02038829|9953841|FG002|NOT COMPLETED|Treatment Period 5||0
8896416|NCT02038829|9953842|FG003|NOT COMPLETED|Treatment Period 5||0
8896417|NCT02038829|9953843|FG004|NOT COMPLETED|Treatment Period 5||0
8896418|NCT02038829|9953844|FG005|NOT COMPLETED|Treatment Period 5||0
8896419|NCT02038829|9953845|FG006|NOT COMPLETED|Treatment Period 5||0
8896420|NCT02038829|9953846|FG007|NOT COMPLETED|Treatment Period 5||0
8896421|NCT02038829|9953847|FG008|NOT COMPLETED|Treatment Period 5||0
8896422|NCT02038829|9953848|FG009|NOT COMPLETED|Treatment Period 5||0
8896423|NCT02038829|9953849|FG010|NOT COMPLETED|Treatment Period 5||0
8896424|NCT02038829|9953850|FG011|NOT COMPLETED|Treatment Period 5||0
8896425|NCT02038829|9953839|FG000|STARTED|Washout Period 5||7
8896426|NCT02038829|9953840|FG001|STARTED|Washout Period 5||7
8896427|NCT02038829|9953841|FG002|STARTED|Washout Period 5||8
8896428|NCT02038829|9953842|FG003|STARTED|Washout Period 5||8
8896429|NCT02038829|9953843|FG004|STARTED|Washout Period 5||7
8896430|NCT02038829|9953844|FG005|STARTED|Washout Period 5||7
8896431|NCT02038829|9953845|FG006|STARTED|Washout Period 5||7
8896432|NCT02038829|9953846|FG007|STARTED|Washout Period 5||8
8896433|NCT02038829|9953847|FG008|STARTED|Washout Period 5||7
8896434|NCT02038829|9953848|FG009|STARTED|Washout Period 5||8
8896435|NCT02038829|9953849|FG010|STARTED|Washout Period 5||7
8896436|NCT02038829|9953850|FG011|STARTED|Washout Period 5||8
8896437|NCT02038829|9953839|FG000|COMPLETED|Washout Period 5||7
8896438|NCT02038829|9953840|FG001|COMPLETED|Washout Period 5||7
8896439|NCT02038829|9953841|FG002|COMPLETED|Washout Period 5||8
8896440|NCT02038829|9953842|FG003|COMPLETED|Washout Period 5||8
8896441|NCT02038829|9953843|FG004|COMPLETED|Washout Period 5||7
8896442|NCT02038829|9953844|FG005|COMPLETED|Washout Period 5||7
8896443|NCT02038829|9953845|FG006|COMPLETED|Washout Period 5||7
8896444|NCT02038829|9953846|FG007|COMPLETED|Washout Period 5||8
8896445|NCT02038829|9953847|FG008|COMPLETED|Washout Period 5||7
8896446|NCT02038829|9953848|FG009|COMPLETED|Washout Period 5||8
8896447|NCT02038829|9953849|FG010|COMPLETED|Washout Period 5||7
8896448|NCT02038829|9953850|FG011|COMPLETED|Washout Period 5||8
8896449|NCT02038829|9953839|FG000|NOT COMPLETED|Washout Period 5||0
8896450|NCT02038829|9953840|FG001|NOT COMPLETED|Washout Period 5||0
8896451|NCT02038829|9953841|FG002|NOT COMPLETED|Washout Period 5||0
8896452|NCT02038829|9953842|FG003|NOT COMPLETED|Washout Period 5||0
8896453|NCT02038829|9953843|FG004|NOT COMPLETED|Washout Period 5||0
8896454|NCT02038829|9953844|FG005|NOT COMPLETED|Washout Period 5||0
8896455|NCT02038829|9953845|FG006|NOT COMPLETED|Washout Period 5||0
8896456|NCT02038829|9953846|FG007|NOT COMPLETED|Washout Period 5||0
8896457|NCT02038829|9953847|FG008|NOT COMPLETED|Washout Period 5||0
8896458|NCT02038829|9953848|FG009|NOT COMPLETED|Washout Period 5||0
8896459|NCT02038829|9953849|FG010|NOT COMPLETED|Washout Period 5||0
8896460|NCT02038829|9953850|FG011|NOT COMPLETED|Washout Period 5||0
8896461|NCT02038829|9953839|FG000|STARTED|Treatment Period 6||7
8896462|NCT02038829|9953840|FG001|STARTED|Treatment Period 6||7
8896463|NCT02038829|9953841|FG002|STARTED|Treatment Period 6||8
8896464|NCT02038829|9953842|FG003|STARTED|Treatment Period 6||8
8896465|NCT02038829|9953843|FG004|STARTED|Treatment Period 6||7
8896466|NCT02038829|9953844|FG005|STARTED|Treatment Period 6||7
8896467|NCT02038829|9953845|FG006|STARTED|Treatment Period 6||7
8896468|NCT02038829|9953846|FG007|STARTED|Treatment Period 6||8
8896469|NCT02038829|9953847|FG008|STARTED|Treatment Period 6||7
8896470|NCT02038829|9953848|FG009|STARTED|Treatment Period 6||8
8896471|NCT02038829|9953849|FG010|STARTED|Treatment Period 6||7
8896472|NCT02038829|9953850|FG011|STARTED|Treatment Period 6||8
8896473|NCT02038829|9953839|FG000|COMPLETED|Treatment Period 6||7
9008144|NCT02961218|10070860|FG000|COMPLETED|Overall Study||22
9008145|NCT02961218|10070861|FG001|COMPLETED|Overall Study||19
9008146|NCT02961218|10070860|FG000|NOT COMPLETED|Overall Study||3
9008147|NCT02961218|10070861|FG001|NOT COMPLETED|Overall Study||5
9008148|NCT02961244|10070871|FG000|STARTED|Overall Study||64
9008149|NCT02961244|10070872|FG001|STARTED|Overall Study||64
9008150|NCT02961244|10070871|FG000|Patients Excluded During Randomization|Overall Study||0
9008151|NCT02961244|10070872|FG001|Patients Excluded During Randomization|Overall Study||1
9008152|NCT02961244|10070871|FG000|COMPLETED|Overall Study||63
9008153|NCT02961244|10070872|FG001|COMPLETED|Overall Study||55
8896474|NCT02038829|9953840|FG001|COMPLETED|Treatment Period 6||7
8896475|NCT02038829|9953841|FG002|COMPLETED|Treatment Period 6||7
8896476|NCT02038829|9953842|FG003|COMPLETED|Treatment Period 6||8
8896477|NCT02038829|9953843|FG004|COMPLETED|Treatment Period 6||7
8896478|NCT02038829|9953844|FG005|COMPLETED|Treatment Period 6||7
8896479|NCT02038829|9953845|FG006|COMPLETED|Treatment Period 6||7
8896480|NCT02038829|9953846|FG007|COMPLETED|Treatment Period 6||8
8896481|NCT02038829|9953847|FG008|COMPLETED|Treatment Period 6||7
9008154|NCT02961244|10070871|FG000|NOT COMPLETED|Overall Study||1
9008155|NCT02961244|10070872|FG001|NOT COMPLETED|Overall Study||9
9008156|NCT02961751|10070878|FG000|STARTED|Overall Study||211
9008157|NCT02961751|10070878|FG000|COMPLETED|Overall Study||196
9008158|NCT02961751|10070878|FG000|NOT COMPLETED|Overall Study||15
9008159|NCT02961764|10070884|FG000|STARTED|Overall Study||160
9008160|NCT02961764|10070885|FG001|STARTED|Overall Study||153
9008161|NCT02961764|10070884|FG000|COMPLETED|Overall Study||121
9008162|NCT02961764|10070885|FG001|COMPLETED|Overall Study||128
8896482|NCT02038829|9953848|FG009|COMPLETED|Treatment Period 6||8
8896483|NCT02038829|9953849|FG010|COMPLETED|Treatment Period 6||7
8896484|NCT02038829|9953850|FG011|COMPLETED|Treatment Period 6||8
8896485|NCT02038829|9953839|FG000|NOT COMPLETED|Treatment Period 6||0
8896486|NCT02038829|9953840|FG001|NOT COMPLETED|Treatment Period 6||0
8896487|NCT02038829|9953841|FG002|NOT COMPLETED|Treatment Period 6||1
8896488|NCT02038829|9953842|FG003|NOT COMPLETED|Treatment Period 6||0
8896489|NCT02038829|9953843|FG004|NOT COMPLETED|Treatment Period 6||0
8896490|NCT02038829|9953844|FG005|NOT COMPLETED|Treatment Period 6||0
8896491|NCT02038829|9953845|FG006|NOT COMPLETED|Treatment Period 6||0
8896492|NCT02038829|9953846|FG007|NOT COMPLETED|Treatment Period 6||0
8896493|NCT02038829|9953847|FG008|NOT COMPLETED|Treatment Period 6||0
8896494|NCT02038829|9953848|FG009|NOT COMPLETED|Treatment Period 6||0
8896495|NCT02038829|9953849|FG010|NOT COMPLETED|Treatment Period 6||0
8896496|NCT02038829|9953850|FG011|NOT COMPLETED|Treatment Period 6||0
8896497|NCT02038881|9953868|FG000|STARTED|Overall Study||27
8896498|NCT02038881|9953869|FG001|STARTED|Overall Study||29
8896499|NCT02038881|9953870|FG002|STARTED|Overall Study||31
8896500|NCT02038881|9953868|FG000|COMPLETED|Overall Study||24
8896501|NCT02038881|9953869|FG001|COMPLETED|Overall Study||29
8896502|NCT02038881|9953870|FG002|COMPLETED|Overall Study||30
8896503|NCT02038881|9953868|FG000|NOT COMPLETED|Overall Study||3
8896504|NCT02038881|9953869|FG001|NOT COMPLETED|Overall Study||0
8896505|NCT02038881|9953870|FG002|NOT COMPLETED|Overall Study||1
8896506|NCT02038894|9953883|FG000|STARTED|Overall Study||60
8896507|NCT02038894|9953884|FG001|STARTED|Overall Study||58
8896508|NCT02038894|9953885|FG002|STARTED|Overall Study||61
8896509|NCT02038894|9953883|FG000|COMPLETED|Overall Study||60
8896510|NCT02038894|9953884|FG001|COMPLETED|Overall Study||58
8896511|NCT02038894|9953885|FG002|COMPLETED|Overall Study||61
8896512|NCT02038894|9953883|FG000|NOT COMPLETED|Overall Study||0
8896513|NCT02038894|9953884|FG001|NOT COMPLETED|Overall Study||0
8896514|NCT02038894|9953885|FG002|NOT COMPLETED|Overall Study||0
8896515|NCT02038907|9953911|FG000|STARTED|Overall Study||30
8896516|NCT02038907|9953912|FG001|STARTED|Overall Study||30
8896517|NCT02038907|9953913|FG002|STARTED|Overall Study||30
8896518|NCT02038907|9953914|FG003|STARTED|Overall Study||31
8896519|NCT02038907|9953915|FG004|STARTED|Overall Study||30
8896520|NCT02038907|9953916|FG005|STARTED|Overall Study||31
8896521|NCT02038907|9953917|FG006|STARTED|Overall Study||30
8896522|NCT02038907|9953918|FG007|STARTED|Overall Study||32
8896523|NCT02038907|9953919|FG008|STARTED|Overall Study||29
8896524|NCT02038907|9953920|FG009|STARTED|Overall Study||30
8896525|NCT02038907|9953921|FG010|STARTED|Overall Study||29
8896526|NCT02038907|9953922|FG011|STARTED|Overall Study||28
8896527|NCT02038907|9953923|FG012|STARTED|Overall Study||29
8896528|NCT02038907|9953924|FG013|STARTED|Overall Study||31
8896529|NCT02038907|9953911|FG000|COMPLETED|Overall Study||30
8896530|NCT02038907|9953912|FG001|COMPLETED|Overall Study||30
8896531|NCT02038907|9953913|FG002|COMPLETED|Overall Study||30
8896532|NCT02038907|9953914|FG003|COMPLETED|Overall Study||31
8896533|NCT02038907|9953915|FG004|COMPLETED|Overall Study||30
8896534|NCT02038907|9953916|FG005|COMPLETED|Overall Study||31
8896535|NCT02038907|9953917|FG006|COMPLETED|Overall Study||30
8896536|NCT02038907|9953918|FG007|COMPLETED|Overall Study||32
8896537|NCT02038907|9953919|FG008|COMPLETED|Overall Study||29
8896538|NCT02038907|9953920|FG009|COMPLETED|Overall Study||30
8896539|NCT02038907|9953921|FG010|COMPLETED|Overall Study||27
8896540|NCT02038907|9953922|FG011|COMPLETED|Overall Study||28
8896541|NCT02038907|9953923|FG012|COMPLETED|Overall Study||29
8896542|NCT02038907|9953924|FG013|COMPLETED|Overall Study||31
8896543|NCT02038907|9953911|FG000|NOT COMPLETED|Overall Study||0
8896544|NCT02038907|9953912|FG001|NOT COMPLETED|Overall Study||0
8896545|NCT02038907|9953913|FG002|NOT COMPLETED|Overall Study||0
8896546|NCT02038907|9953914|FG003|NOT COMPLETED|Overall Study||0
8896547|NCT02038907|9953915|FG004|NOT COMPLETED|Overall Study||0
8896548|NCT02038907|9953916|FG005|NOT COMPLETED|Overall Study||0
8896549|NCT02038907|9953917|FG006|NOT COMPLETED|Overall Study||0
8896550|NCT02038907|9953918|FG007|NOT COMPLETED|Overall Study||0
8896551|NCT02038907|9953919|FG008|NOT COMPLETED|Overall Study||0
8896552|NCT02038907|9953920|FG009|NOT COMPLETED|Overall Study||0
8896553|NCT02038907|9953921|FG010|NOT COMPLETED|Overall Study||2
8896554|NCT02038907|9953922|FG011|NOT COMPLETED|Overall Study||0
8896555|NCT02038907|9953923|FG012|NOT COMPLETED|Overall Study||0
8635564|NCT00562302|9676042|FG001|COMPLETED|Overall Study||137
8635565|NCT00562302|9676041|FG000|NOT COMPLETED|Overall Study||20
8635566|NCT00562302|9676042|FG001|NOT COMPLETED|Overall Study||32
8635567|NCT00562315|9676048|FG000|STARTED|Overall Study||93
8635568|NCT00562315|9676048|FG000|COMPLETED|Overall Study||93
8635569|NCT00562315|9676048|FG000|NOT COMPLETED|Overall Study||0
8691308|NCT00854100|9736551|FG002|STARTED|Overall Study||74
8691309|NCT00854100|9736549|FG000|COMPLETED|Overall Study||72
8896556|NCT02038907|9953924|FG013|NOT COMPLETED|Overall Study||0
8691310|NCT00854100|9736550|FG001|COMPLETED|Overall Study||70
8691311|NCT00854100|9736551|FG002|COMPLETED|Overall Study||63
8896557|NCT02038920|9953958|FG000|STARTED|Induction Phase (Week 0 to 14)||79
8896558|NCT02038920|9953959|FG001|STARTED|Induction Phase (Week 0 to 14)||78
8896559|NCT02038920|9953960|FG002|STARTED|Induction Phase (Week 0 to 14)||0
8896560|NCT02038920|9953961|FG003|STARTED|Induction Phase (Week 0 to 14)||0
8896561|NCT02038920|9953962|FG004|STARTED|Induction Phase (Week 0 to 14)||0
8896562|NCT02038920|9953963|FG005|STARTED|Induction Phase (Week 0 to 14)||0
8896563|NCT02038920|9953958|FG000|COMPLETED|Induction Phase (Week 0 to 14)||73
8896564|NCT02038920|9953959|FG001|COMPLETED|Induction Phase (Week 0 to 14)||66
8896565|NCT02038920|9953960|FG002|COMPLETED|Induction Phase (Week 0 to 14)||0
8896566|NCT02038920|9953961|FG003|COMPLETED|Induction Phase (Week 0 to 14)||0
8896567|NCT02038920|9953962|FG004|COMPLETED|Induction Phase (Week 0 to 14)||0
8896568|NCT02038920|9953963|FG005|COMPLETED|Induction Phase (Week 0 to 14)||0
8896569|NCT02038920|9953958|FG000|NOT COMPLETED|Induction Phase (Week 0 to 14)||6
8896570|NCT02038920|9953959|FG001|NOT COMPLETED|Induction Phase (Week 0 to 14)||12
8896571|NCT02038920|9953960|FG002|NOT COMPLETED|Induction Phase (Week 0 to 14)||0
8896572|NCT02038920|9953961|FG003|NOT COMPLETED|Induction Phase (Week 0 to 14)||0
8896573|NCT02038920|9953962|FG004|NOT COMPLETED|Induction Phase (Week 0 to 14)||0
8896574|NCT02038920|9953963|FG005|NOT COMPLETED|Induction Phase (Week 0 to 14)||0
8896575|NCT02038920|9953958|FG000|STARTED|Maintenance Phase (Week 14 to 60)||0
8896576|NCT02038920|9953959|FG001|STARTED|Maintenance Phase (Week 14 to 60)||0
8896577|NCT02038920|9953960|FG002|STARTED|Maintenance Phase (Week 14 to 60)||12
8896578|NCT02038920|9953961|FG003|STARTED|Maintenance Phase (Week 14 to 60)||12
9008163|NCT02961764|10070884|FG000|NOT COMPLETED|Overall Study||39
9008164|NCT02961764|10070885|FG001|NOT COMPLETED|Overall Study||25
9008165|NCT02961790|10070895|FG000|STARTED|Overall Study||50
9008166|NCT02961790|10070896|FG001|STARTED|Overall Study||51
9008167|NCT02961790|10070897|FG002|STARTED|Overall Study||24
9008168|NCT02961790|10070898|FG003|STARTED|Overall Study||25
9008169|NCT02961790|10070895|FG000|COMPLETED|Overall Study||35
9008170|NCT02961790|10070896|FG001|COMPLETED|Overall Study||40
9008171|NCT02961790|10070897|FG002|COMPLETED|Overall Study||18
9008172|NCT02961790|10070898|FG003|COMPLETED|Overall Study||20
9008173|NCT02961790|10070895|FG000|NOT COMPLETED|Overall Study||15
9008174|NCT02961790|10070896|FG001|NOT COMPLETED|Overall Study||11
9008175|NCT02961790|10070897|FG002|NOT COMPLETED|Overall Study||6
9008176|NCT02961790|10070898|FG003|NOT COMPLETED|Overall Study||5
9008177|NCT02961894|10070909|FG000|STARTED|Overall Study||121
9008178|NCT02961894|10070909|FG000|COMPLETED|Overall Study||121
9008179|NCT02961894|10070909|FG000|NOT COMPLETED|Overall Study||0
9008180|NCT02961920|10070915|FG000|STARTED|Overall Study||25
9008181|NCT02961920|10070916|FG001|STARTED|Overall Study||25
9008182|NCT02961920|10070915|FG000|COMPLETED|Overall Study||24
9008183|NCT02961920|10070916|FG001|COMPLETED|Overall Study||24
9008184|NCT02961920|10070915|FG000|NOT COMPLETED|Overall Study||1
9008185|NCT02961920|10070916|FG001|NOT COMPLETED|Overall Study||1
9008186|NCT02961946|10070925|FG000|STARTED|Overall Study||66
9008187|NCT02961946|10070926|FG001|STARTED|Overall Study||66
9008188|NCT02961946|10070927|FG002|STARTED|Overall Study||66
9008189|NCT02961946|10070925|FG000|COMPLETED|Overall Study||66
9008190|NCT02961946|10070926|FG001|COMPLETED|Overall Study||66
9008191|NCT02961946|10070927|FG002|COMPLETED|Overall Study||66
9008192|NCT02961946|10070925|FG000|NOT COMPLETED|Overall Study||0
9008193|NCT02961946|10070926|FG001|NOT COMPLETED|Overall Study||0
9008194|NCT02961946|10070927|FG002|NOT COMPLETED|Overall Study||0
9008195|NCT02962284|10070937|FG000|STARTED|Overall Study||9
9008196|NCT02962284|10070938|FG001|STARTED|Overall Study||11
9008197|NCT02962284|10070937|FG000|COMPLETED|Overall Study||4
9008198|NCT02962284|10070938|FG001|COMPLETED|Overall Study||8
9008199|NCT02962284|10070937|FG000|NOT COMPLETED|Overall Study||5
9008200|NCT02962284|10070938|FG001|NOT COMPLETED|Overall Study||3
9008201|NCT02962427|10070948|FG000|STARTED|Overall Study||3
9008202|NCT02962427|10070949|FG001|STARTED|Overall Study||1
9008203|NCT02962427|10070948|FG000|COMPLETED|Overall Study||3
9008204|NCT02962427|10070949|FG001|COMPLETED|Overall Study||1
9008205|NCT02962427|10070948|FG000|NOT COMPLETED|Overall Study||0
9008206|NCT02962427|10070949|FG001|NOT COMPLETED|Overall Study||0
9008207|NCT02962609|10070959|FG000|STARTED|Overall Study||38
9008208|NCT02962609|10070960|FG001|STARTED|Overall Study||42
9008209|NCT02962609|10070959|FG000|COMPLETED|Overall Study||38
9008210|NCT02962609|10070960|FG001|COMPLETED|Overall Study||42
9008211|NCT02962609|10070959|FG000|NOT COMPLETED|Overall Study||0
9008212|NCT02962609|10070960|FG001|NOT COMPLETED|Overall Study||0
9008213|NCT02962648|10070966|FG000|STARTED|Overall Study||103
9008214|NCT02962648|10070966|FG000|COMPLETED|Overall Study||94
9008215|NCT02962648|10070966|FG000|NOT COMPLETED|Overall Study||9
9008216|NCT02962674|10070970|FG000|STARTED|Overall Study|"Although a total of 49 subjects were consented to participate in the study, three (3) of those subjects are not included in the study analysis as they did not actually receive treatment. These 3 subjects could not be treated because of their anatomy and therefore are considered treatment attempts. The final enrollment number (treated subjects only)is 46 subjects."|49
9008217|NCT02962674|10070970|FG000|3 Month Endpoint|Overall Study|All treated subjects that completed the 3-month endpoint visit per protocol.|46
9008218|NCT02962674|10070970|FG000|12 Month Durability|Overall Study|All subjects that completed the 12-month follow-up visit per protocol.|46
9008219|NCT02962674|10070970|FG000|24 Month Durability|Overall Study|All subjects that completed the 24-month follow-up visit. Note that at the time of study termination, all subjects would have reached this milestone.|32
9008220|NCT02962674|10070970|FG000|36 Month Durability|Overall Study|All subjects that completed the 36-month follow-up visit. Note that at the time of study termination, not all subjects would have reached this milestone depending on time of enrollment.|18
9039570|NCT03340337|10100552|FG000|Received Neo-Russian|Overall Study||30
8896579|NCT02038920|9953962|FG004|STARTED|Maintenance Phase (Week 14 to 60)||17
8896580|NCT02038920|9953963|FG005|STARTED|Maintenance Phase (Week 14 to 60)||0
8896581|NCT02038920|9953958|FG000|COMPLETED|Maintenance Phase (Week 14 to 60)||0
8896582|NCT02038920|9953959|FG001|COMPLETED|Maintenance Phase (Week 14 to 60)||0
8896583|NCT02038920|9953960|FG002|COMPLETED|Maintenance Phase (Week 14 to 60)||7
8896584|NCT02038920|9953961|FG003|COMPLETED|Maintenance Phase (Week 14 to 60)||4
8896585|NCT02038920|9953962|FG004|COMPLETED|Maintenance Phase (Week 14 to 60)||5
8896586|NCT02038920|9953963|FG005|COMPLETED|Maintenance Phase (Week 14 to 60)||0
8896587|NCT02038920|9953958|FG000|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||0
8896588|NCT02038920|9953959|FG001|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||0
8896589|NCT02038920|9953960|FG002|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||5
8896590|NCT02038920|9953961|FG003|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||8
8896591|NCT02038920|9953962|FG004|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||12
8896592|NCT02038920|9953963|FG005|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||0
8896593|NCT02038920|9953958|FG000|STARTED|Open Label Cohort (Week 10 to 154)||0
8896594|NCT02038920|9953959|FG001|STARTED|Open Label Cohort (Week 10 to 154)||0
8896595|NCT02038920|9953960|FG002|STARTED|Open Label Cohort (Week 10 to 154)||0
8896596|NCT02038920|9953961|FG003|STARTED|Open Label Cohort (Week 10 to 154)||0
8896597|NCT02038920|9953962|FG004|STARTED|Open Label Cohort (Week 10 to 154)||0
8896598|NCT02038920|9953963|FG005|STARTED|Open Label Cohort (Week 10 to 154)||134
8896599|NCT02038920|9953958|FG000|COMPLETED|Open Label Cohort (Week 10 to 154)||0
8896600|NCT02038920|9953959|FG001|COMPLETED|Open Label Cohort (Week 10 to 154)||0
8896601|NCT02038920|9953960|FG002|COMPLETED|Open Label Cohort (Week 10 to 154)||0
8896602|NCT02038920|9953961|FG003|COMPLETED|Open Label Cohort (Week 10 to 154)||0
8896603|NCT02038920|9953962|FG004|COMPLETED|Open Label Cohort (Week 10 to 154)||0
8896604|NCT02038920|9953963|FG005|COMPLETED|Open Label Cohort (Week 10 to 154)||57
8896605|NCT02038920|9953958|FG000|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0
9008221|NCT02962674|10070970|FG000|48 Month Durability|Overall Study|All subjects that completed the 48-month follow-up visit. Note that at the time of study termination, not all subjects would have reached this milestone depending on time of enrollment.|4
9008222|NCT02962674|10070970|FG000|COMPLETED|Overall Study|Study was terminated by sponsor prior to reaching 60 Month study completion mainly due to COVID-19 effects on subject follow-up.|0
9008223|NCT02962674|10070970|FG000|NOT COMPLETED|Overall Study||49
9008224|NCT02962687|10070978|FG000|STARTED|Overall Study|This number represents 20 dyads (1 Veteran and 1 caregiver in each dyad)|40
9008225|NCT02962687|10070979|FG001|STARTED|Overall Study|This number represents 20 dyads (1 Veteran and 1 caregiver in each dyad)|40
9008226|NCT02962687|10070978|FG000|COMPLETED|Overall Study|This number represents 15 dyads (1 Veteran and 1 caregiver in each dyad)|30
9008227|NCT02962687|10070979|FG001|COMPLETED|Overall Study|This number represents 16 dyads (1 Veteran and 1 caregiver in each dyad)|32
9008228|NCT02962687|10070978|FG000|NOT COMPLETED|Overall Study||10
9008229|NCT02962687|10070979|FG001|NOT COMPLETED|Overall Study||8
9008230|NCT02962739|10070987|FG000|STARTED|Overall Study||6
9008231|NCT02962739|10070988|FG001|STARTED|Overall Study||7
9008232|NCT02962739|10070989|FG002|STARTED|Overall Study||7
9008233|NCT02962739|10070990|FG003|STARTED|Overall Study||6
9008234|NCT02962739|10070991|FG004|STARTED|Overall Study||6
9008235|NCT02962739|10070992|FG005|STARTED|Overall Study||6
9008236|NCT02962739|10070987|FG000|COMPLETED|Overall Study||6
9008237|NCT02962739|10070988|FG001|COMPLETED|Overall Study||6
9008238|NCT02962739|10070989|FG002|COMPLETED|Overall Study||6
9008239|NCT02962739|10070990|FG003|COMPLETED|Overall Study||6
9008240|NCT02962739|10070991|FG004|COMPLETED|Overall Study||5
9008241|NCT02962739|10070992|FG005|COMPLETED|Overall Study||6
9008242|NCT02962739|10070987|FG000|NOT COMPLETED|Overall Study||0
9008243|NCT02962739|10070988|FG001|NOT COMPLETED|Overall Study||1
9008244|NCT02962739|10070989|FG002|NOT COMPLETED|Overall Study||1
9008245|NCT02962739|10070990|FG003|NOT COMPLETED|Overall Study||0
9008246|NCT02962739|10070991|FG004|NOT COMPLETED|Overall Study||1
9008247|NCT02962739|10070992|FG005|NOT COMPLETED|Overall Study||0
9008248|NCT02962765|10070998|FG000|STARTED|Overall Study||78
9008249|NCT02962765|10070998|FG000|FAS Population|Overall Study||78
9008250|NCT02962765|10070998|FG000|SAF Population|Overall Study||78
9008251|NCT02962765|10070998|FG000|Prophylactic Treatment Group|Overall Study||77
9008252|NCT02962765|10070998|FG000|On Demand Treatment Group|Overall Study||2
9008253|NCT02962765|10070998|FG000|SURG Population|Overall Study||4
9008254|NCT02962765|10070998|FG000|COMPLETED|Overall Study||61
9008255|NCT02962765|10070998|FG000|NOT COMPLETED|Overall Study||17
9008256|NCT02962882|10071009|FG000|STARTED|Overall Study||50
9008257|NCT02962882|10071009|FG000|COMPLETED|Overall Study||14
9008258|NCT02962882|10071009|FG000|NOT COMPLETED|Overall Study||36
9008259|NCT02962908|10071018|FG000|STARTED|Overall Study||58
9008260|NCT02962908|10071019|FG001|STARTED|Overall Study||58
9008261|NCT02962908|10071020|FG002|STARTED|Overall Study||32
9008262|NCT02962908|10071021|FG003|STARTED|Overall Study||27
9008263|NCT02962908|10071018|FG000|COMPLETED|Overall Study||58
9008264|NCT02962908|10071019|FG001|COMPLETED|Overall Study||50
9008265|NCT02962908|10071020|FG002|COMPLETED|Overall Study||32
9008266|NCT02962908|10071021|FG003|COMPLETED|Overall Study||24
9008267|NCT02962908|10071018|FG000|NOT COMPLETED|Overall Study||0
9008268|NCT02962908|10071019|FG001|NOT COMPLETED|Overall Study||8
9008269|NCT02962908|10071020|FG002|NOT COMPLETED|Overall Study||0
9008270|NCT02962908|10071021|FG003|NOT COMPLETED|Overall Study||3
9008271|NCT02962934|10071039|FG000|STARTED|Overall Study||12
9008272|NCT02962934|10071040|FG001|STARTED|Overall Study||6
9008273|NCT02962934|10071039|FG000|COMPLETED|Overall Study||12
9008274|NCT02962934|10071040|FG001|COMPLETED|Overall Study||6
9008275|NCT02962934|10071039|FG000|NOT COMPLETED|Overall Study||0
9008276|NCT02962934|10071040|FG001|NOT COMPLETED|Overall Study||0
9008277|NCT02962960|10071049|FG000|STARTED|Overall Study||14
8896606|NCT02038920|9953959|FG001|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0
8896607|NCT02038920|9953960|FG002|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0
8896608|NCT02038920|9953961|FG003|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0
8896609|NCT02038920|9953962|FG004|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0
8896610|NCT02038920|9953963|FG005|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||77
8896611|NCT02038933|9953982|FG000|STARTED|Overall Study||121
8896612|NCT02038933|9953982|FG000|COMPLETED|Overall Study||0
8896613|NCT02038933|9953982|FG000|NOT COMPLETED|Overall Study||121
8896614|NCT02038959|9953989|FG000|STARTED|Overall Study||98
8896615|NCT02038959|9953990|FG001|STARTED|Overall Study||97
8896616|NCT02038959|9953989|FG000|COMPLETED|Overall Study||92
8896617|NCT02038959|9953990|FG001|COMPLETED|Overall Study||89
8896618|NCT02038959|9953989|FG000|NOT COMPLETED|Overall Study||6
8896619|NCT02038959|9953990|FG001|NOT COMPLETED|Overall Study||8
8896620|NCT02039115|9953998|FG000|STARTED|Overall Study||1
8896621|NCT02039115|9953999|FG001|STARTED|Overall Study||0
8896622|NCT02039115|9953998|FG000|COMPLETED|Overall Study||1
8896623|NCT02039115|9953999|FG001|COMPLETED|Overall Study||0
8896624|NCT02039115|9953998|FG000|NOT COMPLETED|Overall Study||0
8896625|NCT02039115|9953999|FG001|NOT COMPLETED|Overall Study||0
8896626|NCT02039219|9954007|FG000|STARTED|Treatment||11
8896627|NCT02039219|9954008|FG001|STARTED|Treatment||8
8896628|NCT02039219|9954007|FG000|COMPLETED|Treatment||7
8896629|NCT02039219|9954008|FG001|COMPLETED|Treatment||6
8896630|NCT02039219|9954007|FG000|NOT COMPLETED|Treatment||4
8896631|NCT02039219|9954008|FG001|NOT COMPLETED|Treatment||2
8896632|NCT02039219|9954007|FG000|STARTED|Follow up||7
8896633|NCT02039219|9954008|FG001|STARTED|Follow up||6
8896634|NCT02039219|9954007|FG000|COMPLETED|Follow up||7
8896635|NCT02039219|9954008|FG001|COMPLETED|Follow up||5
8896636|NCT02039219|9954007|FG000|NOT COMPLETED|Follow up||0
8896637|NCT02039219|9954008|FG001|NOT COMPLETED|Follow up||1
8896638|NCT02039375|9954014|FG000|STARTED|Overall Study||35
8896639|NCT02039375|9954014|FG000|COMPLETED|Overall Study||33
8896640|NCT02039375|9954014|FG000|NOT COMPLETED|Overall Study||2
8896641|NCT02039414|9954020|FG000|STARTED|Overall Study||22
8896642|NCT02039414|9954021|FG001|STARTED|Overall Study||18
8896643|NCT02039414|9954020|FG000|COMPLETED|Overall Study||16
8896644|NCT02039414|9954021|FG001|COMPLETED|Overall Study||16
8896645|NCT02039414|9954020|FG000|NOT COMPLETED|Overall Study||6
8896646|NCT02039414|9954021|FG001|NOT COMPLETED|Overall Study||2
8896647|NCT02039427|9954031|FG000|STARTED|Overall Study||48
8896648|NCT02039427|9954032|FG001|STARTED|Overall Study||48
8896649|NCT02039427|9954033|FG002|STARTED|Overall Study||48
8896650|NCT02039427|9954034|FG003|STARTED|Overall Study||48
8896651|NCT02039427|9954031|FG000|COMPLETED|Overall Study||45
8896652|NCT02039427|9954032|FG001|COMPLETED|Overall Study||47
8896653|NCT02039427|9954033|FG002|COMPLETED|Overall Study||45
8896654|NCT02039427|9954034|FG003|COMPLETED|Overall Study||43
8896655|NCT02039427|9954031|FG000|NOT COMPLETED|Overall Study||3
8896656|NCT02039427|9954032|FG001|NOT COMPLETED|Overall Study||1
8896657|NCT02039427|9954033|FG002|NOT COMPLETED|Overall Study||3
8896658|NCT02039427|9954034|FG003|NOT COMPLETED|Overall Study||5
8896659|NCT02039505|9954051|FG000|STARTED|Induction Phase (Week 0 to Week 14)||82
8896660|NCT02039505|9954052|FG001|STARTED|Induction Phase (Week 0 to Week 14)||164
8896661|NCT02039505|9954053|FG002|STARTED|Induction Phase (Week 0 to Week 14)||46
8896662|NCT02039505|9954054|FG003|STARTED|Induction Phase (Week 0 to Week 14)||0
8896663|NCT02039505|9954055|FG004|STARTED|Induction Phase (Week 0 to Week 14)||0
8896664|NCT02039505|9954056|FG005|STARTED|Induction Phase (Week 0 to Week 14)||0
8896665|NCT02039505|9954057|FG006|STARTED|Induction Phase (Week 0 to Week 14)||0
8896666|NCT02039505|9954051|FG000|COMPLETED|Induction Phase (Week 0 to Week 14)||78
8896667|NCT02039505|9954052|FG001|COMPLETED|Induction Phase (Week 0 to Week 14)||155
8896668|NCT02039505|9954053|FG002|COMPLETED|Induction Phase (Week 0 to Week 14)||36
8896669|NCT02039505|9954054|FG003|COMPLETED|Induction Phase (Week 0 to Week 14)||0
8896670|NCT02039505|9954055|FG004|COMPLETED|Induction Phase (Week 0 to Week 14)||0
8896671|NCT02039505|9954056|FG005|COMPLETED|Induction Phase (Week 0 to Week 14)||0
8896672|NCT02039505|9954057|FG006|COMPLETED|Induction Phase (Week 0 to Week 14)||0
8896673|NCT02039505|9954051|FG000|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||4
8896674|NCT02039505|9954052|FG001|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||9
8896675|NCT02039505|9954053|FG002|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||10
8896676|NCT02039505|9954054|FG003|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||0
8896677|NCT02039505|9954055|FG004|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||0
8896678|NCT02039505|9954056|FG005|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||0
8896679|NCT02039505|9954057|FG006|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||0
8896680|NCT02039505|9954051|FG000|STARTED|Maintenance Phase (Week 14 to Week 60)||0
8896681|NCT02039505|9954052|FG001|STARTED|Maintenance Phase (Week 14 to Week 60)||0
8896682|NCT02039505|9954053|FG002|STARTED|Maintenance Phase (Week 14 to Week 60)||0
8896683|NCT02039505|9954054|FG003|STARTED|Maintenance Phase (Week 14 to Week 60)||42
8896684|NCT02039505|9954055|FG004|STARTED|Maintenance Phase (Week 14 to Week 60)||41
8896685|NCT02039505|9954056|FG005|STARTED|Maintenance Phase (Week 14 to Week 60)||26
8896686|NCT02039505|9954057|FG006|STARTED|Maintenance Phase (Week 14 to Week 60)||0
8896687|NCT02039505|9954051|FG000|COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
8896688|NCT02039505|9954052|FG001|COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
8896689|NCT02039505|9954053|FG002|COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
8896690|NCT02039505|9954054|FG003|COMPLETED|Maintenance Phase (Week 14 to Week 60)||18
8896691|NCT02039505|9954055|FG004|COMPLETED|Maintenance Phase (Week 14 to Week 60)||30
8896692|NCT02039505|9954056|FG005|COMPLETED|Maintenance Phase (Week 14 to Week 60)||12
8896693|NCT02039505|9954057|FG006|COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
8896694|NCT02039505|9954051|FG000|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
8896695|NCT02039505|9954052|FG001|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
8896696|NCT02039505|9954053|FG002|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
8896697|NCT02039505|9954054|FG003|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||24
8896698|NCT02039505|9954055|FG004|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||11
8896699|NCT02039505|9954056|FG005|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||14
8896700|NCT02039505|9954057|FG006|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
8896701|NCT02039505|9954051|FG000|STARTED|Open-Label (Week 10 up to Week 154)||0
8896702|NCT02039505|9954052|FG001|STARTED|Open-Label (Week 10 up to Week 154)||0
8896703|NCT02039505|9954053|FG002|STARTED|Open-Label (Week 10 up to Week 154)||0
8896704|NCT02039505|9954054|FG003|STARTED|Open-Label (Week 10 up to Week 154)||0
8896705|NCT02039505|9954055|FG004|STARTED|Open-Label (Week 10 up to Week 154)||0
8896706|NCT02039505|9954056|FG005|STARTED|Open-Label (Week 10 up to Week 154)||0
8896707|NCT02039505|9954057|FG006|STARTED|Open-Label (Week 10 up to Week 154)||259
8896708|NCT02039505|9954051|FG000|COMPLETED|Open-Label (Week 10 up to Week 154)||0
8896709|NCT02039505|9954052|FG001|COMPLETED|Open-Label (Week 10 up to Week 154)||0
8896710|NCT02039505|9954053|FG002|COMPLETED|Open-Label (Week 10 up to Week 154)||0
8896711|NCT02039505|9954054|FG003|COMPLETED|Open-Label (Week 10 up to Week 154)||0
8896712|NCT02039505|9954055|FG004|COMPLETED|Open-Label (Week 10 up to Week 154)||0
8896713|NCT02039505|9954056|FG005|COMPLETED|Open-Label (Week 10 up to Week 154)||0
8896714|NCT02039505|9954057|FG006|COMPLETED|Open-Label (Week 10 up to Week 154)||188
8896715|NCT02039505|9954051|FG000|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
8896716|NCT02039505|9954052|FG001|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
8896717|NCT02039505|9954053|FG002|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
8896718|NCT02039505|9954054|FG003|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
8896719|NCT02039505|9954055|FG004|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
8896720|NCT02039505|9954056|FG005|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
8896721|NCT02039505|9954057|FG006|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||71
8896722|NCT02039674|9954091|FG000|STARTED|Overall Study||13
8896723|NCT02039674|9954092|FG001|STARTED|Overall Study||12
8896724|NCT02039674|9954093|FG002|STARTED|Overall Study||12
9008278|NCT02962960|10071050|FG001|STARTED|Overall Study||13
9008279|NCT02962960|10071051|FG002|STARTED|Overall Study||9
9008280|NCT02962960|10071049|FG000|COMPLETED|Overall Study||11
9008281|NCT02962960|10071050|FG001|COMPLETED|Overall Study||11
9008282|NCT02962960|10071051|FG002|COMPLETED|Overall Study||9
9008283|NCT02962960|10071049|FG000|NOT COMPLETED|Overall Study||3
9008284|NCT02962960|10071050|FG001|NOT COMPLETED|Overall Study||2
9008285|NCT02962960|10071051|FG002|NOT COMPLETED|Overall Study||0
9008286|NCT02963311|10071061|FG000|STARTED|Overall Study||9
9008287|NCT02963311|10071061|FG000|COMPLETED|Overall Study||4
9008288|NCT02963311|10071061|FG000|NOT COMPLETED|Overall Study||5
9008289|NCT02963376|10071069|FG000|STARTED|Overall Study||6
9008290|NCT02963376|10071070|FG001|STARTED|Overall Study||2
9008291|NCT02963376|10071071|FG002|STARTED|Overall Study||6
9008292|NCT02963376|10071072|FG003|STARTED|Overall Study||2
9008293|NCT02963376|10071073|FG004|STARTED|Overall Study||6
9008294|NCT02963376|10071074|FG005|STARTED|Overall Study||2
9008295|NCT02963376|10071069|FG000|COMPLETED|Overall Study||6
9008296|NCT02963376|10071070|FG001|COMPLETED|Overall Study||2
9008297|NCT02963376|10071071|FG002|COMPLETED|Overall Study||6
9008298|NCT02963376|10071072|FG003|COMPLETED|Overall Study||2
9008299|NCT02963376|10071073|FG004|COMPLETED|Overall Study||6
9008300|NCT02963376|10071074|FG005|COMPLETED|Overall Study||2
9008301|NCT02963376|10071069|FG000|NOT COMPLETED|Overall Study||0
9008302|NCT02963376|10071070|FG001|NOT COMPLETED|Overall Study||0
9008303|NCT02963376|10071071|FG002|NOT COMPLETED|Overall Study||0
9008304|NCT02963376|10071072|FG003|NOT COMPLETED|Overall Study||0
9008305|NCT02963376|10071073|FG004|NOT COMPLETED|Overall Study||0
9008306|NCT02963376|10071074|FG005|NOT COMPLETED|Overall Study||0
9008307|NCT02963441|10071096|FG000|STARTED|Overall Study||900
9008308|NCT02963441|10071096|FG000|COMPLETED|Overall Study||819
9008309|NCT02963441|10071096|FG000|NOT COMPLETED|Overall Study||81
9008310|NCT02963506|10071106|FG000|STARTED|Double-Blind Period||60
9008311|NCT02963506|10071107|FG001|STARTED|Double-Blind Period||61
9008312|NCT02963506|10071108|FG002|STARTED|Double-Blind Period||61
9008313|NCT02963506|10071109|FG003|STARTED|Double-Blind Period||60
9008314|NCT02963506|10071110|FG004|STARTED|Double-Blind Period||61
9008315|NCT02963506|10071111|FG005|STARTED|Double-Blind Period||0
9008316|NCT02963506|10071112|FG006|STARTED|Double-Blind Period||0
9008317|NCT02963506|10071113|FG007|STARTED|Double-Blind Period||0
9008318|NCT02963506|10071114|FG008|STARTED|Double-Blind Period||0
9008319|NCT02963506|10071115|FG009|STARTED|Double-Blind Period||0
9008320|NCT02963506|10071116|FG010|STARTED|Double-Blind Period||0
9008321|NCT02963506|10071117|FG011|STARTED|Double-Blind Period||0
9008322|NCT02963506|10071118|FG012|STARTED|Double-Blind Period||0
9008323|NCT02963506|10071106|FG000|Completed Double-Blind Period|Double-Blind Period||60
9008324|NCT02963506|10071107|FG001|Completed Double-Blind Period|Double-Blind Period||59
9008325|NCT02963506|10071108|FG002|Completed Double-Blind Period|Double-Blind Period||59
8896725|NCT02039674|9954094|FG003|STARTED|Overall Study||13
8896726|NCT02039674|9954095|FG004|STARTED|Overall Study||12
8896727|NCT02039674|9954096|FG005|STARTED|Overall Study||12
8896728|NCT02039674|9954097|FG006|STARTED|Overall Study||3
8896729|NCT02039674|9954098|FG007|STARTED|Overall Study||3
8896730|NCT02039674|9954099|FG008|STARTED|Overall Study||12
8896731|NCT02039674|9954100|FG009|STARTED|Overall Study||12
8896732|NCT02039674|9954101|FG010|STARTED|Overall Study||7
8896733|NCT02039674|9954102|FG011|STARTED|Overall Study||60
8896734|NCT02039674|9954103|FG012|STARTED|Overall Study||63
8896735|NCT02039674|9954104|FG013|STARTED|Overall Study||33
8896736|NCT02039674|9954091|FG000|Treated|Overall Study||13
8896737|NCT02039674|9954092|FG001|Treated|Overall Study||12
8896738|NCT02039674|9954093|FG002|Treated|Overall Study||11
8896739|NCT02039674|9954094|FG003|Treated|Overall Study||13
8896740|NCT02039674|9954095|FG004|Treated|Overall Study||12
8896741|NCT02039674|9954096|FG005|Treated|Overall Study||12
8896742|NCT02039674|9954097|FG006|Treated|Overall Study||3
8896743|NCT02039674|9954098|FG007|Treated|Overall Study||3
8896744|NCT02039674|9954099|FG008|Treated|Overall Study||12
8896745|NCT02039674|9954100|FG009|Treated|Overall Study||12
8896746|NCT02039674|9954101|FG010|Treated|Overall Study||7
8896747|NCT02039674|9954102|FG011|Treated|Overall Study||59
8896748|NCT02039674|9954103|FG012|Treated|Overall Study||62
8896749|NCT02039674|9954104|FG013|Treated|Overall Study||33
8896750|NCT02039674|9954091|FG000|COMPLETED|Overall Study||1
8896751|NCT02039674|9954092|FG001|COMPLETED|Overall Study||0
8896752|NCT02039674|9954093|FG002|COMPLETED|Overall Study||0
8896753|NCT02039674|9954094|FG003|COMPLETED|Overall Study||0
8896754|NCT02039674|9954095|FG004|COMPLETED|Overall Study||0
8896755|NCT02039674|9954096|FG005|COMPLETED|Overall Study||0
8896756|NCT02039674|9954097|FG006|COMPLETED|Overall Study||0
8896757|NCT02039674|9954098|FG007|COMPLETED|Overall Study||0
8896758|NCT02039674|9954099|FG008|COMPLETED|Overall Study||0
8896759|NCT02039674|9954100|FG009|COMPLETED|Overall Study||0
8896760|NCT02039674|9954101|FG010|COMPLETED|Overall Study||0
8896761|NCT02039674|9954102|FG011|COMPLETED|Overall Study||0
8896762|NCT02039674|9954103|FG012|COMPLETED|Overall Study||0
8896763|NCT02039674|9954104|FG013|COMPLETED|Overall Study||0
8896764|NCT02039674|9954091|FG000|NOT COMPLETED|Overall Study||12
8896765|NCT02039674|9954092|FG001|NOT COMPLETED|Overall Study||12
8896766|NCT02039674|9954093|FG002|NOT COMPLETED|Overall Study||12
8896767|NCT02039674|9954094|FG003|NOT COMPLETED|Overall Study||13
8896768|NCT02039674|9954095|FG004|NOT COMPLETED|Overall Study||12
8896769|NCT02039674|9954096|FG005|NOT COMPLETED|Overall Study||12
8896770|NCT02039674|9954097|FG006|NOT COMPLETED|Overall Study||3
8896771|NCT02039674|9954098|FG007|NOT COMPLETED|Overall Study||3
8896772|NCT02039674|9954099|FG008|NOT COMPLETED|Overall Study||12
8896773|NCT02039674|9954100|FG009|NOT COMPLETED|Overall Study||12
8896774|NCT02039674|9954101|FG010|NOT COMPLETED|Overall Study||7
8896775|NCT02039674|9954102|FG011|NOT COMPLETED|Overall Study||60
8896776|NCT02039674|9954103|FG012|NOT COMPLETED|Overall Study||63
8896777|NCT02039674|9954104|FG013|NOT COMPLETED|Overall Study||33
8896778|NCT02039687|9954141|FG000|STARTED|Overall Study||16
8896779|NCT02039687|9954142|FG001|STARTED|Overall Study||16
8896780|NCT02039687|9954143|FG002|STARTED|Overall Study||16
8896781|NCT02039687|9954144|FG003|STARTED|Overall Study||16
8896782|NCT02039687|9954141|FG000|COMPLETED|Overall Study||16
8896783|NCT02039687|9954142|FG001|COMPLETED|Overall Study||15
8896784|NCT02039687|9954143|FG002|COMPLETED|Overall Study||13
8896785|NCT02039687|9954144|FG003|COMPLETED|Overall Study||16
8896786|NCT02039687|9954141|FG000|NOT COMPLETED|Overall Study||0
8896787|NCT02039687|9954142|FG001|NOT COMPLETED|Overall Study||1
8635570|NCT00562328|9676054|FG000|STARTED|Overall Study||33
8896788|NCT02039687|9954143|FG002|NOT COMPLETED|Overall Study||3
8896789|NCT02039687|9954144|FG003|NOT COMPLETED|Overall Study||0
8896790|NCT02039726|9954156|FG000|STARTED|Overall Study||245
8896791|NCT02039726|9954157|FG001|STARTED|Overall Study||122
8896792|NCT02039726|9954156|FG000|Ongoing (as of Data Cutoff)|Overall Study||45
8896793|NCT02039726|9954157|FG001|Ongoing (as of Data Cutoff)|Overall Study||16
8896794|NCT02039726|9954156|FG000|Did Not Receive Treatment|Overall Study||4
8896795|NCT02039726|9954157|FG001|Did Not Receive Treatment|Overall Study||28
8896796|NCT02039726|9954156|FG000|COMPLETED|Overall Study||200
8896797|NCT02039726|9954157|FG001|COMPLETED|Overall Study||106
8896798|NCT02039726|9954156|FG000|NOT COMPLETED|Overall Study||45
8896799|NCT02039726|9954157|FG001|NOT COMPLETED|Overall Study||16
8896800|NCT02039778|9954163|FG000|STARTED|Overall Study||4
8896801|NCT02039778|9954163|FG000|COMPLETED|Overall Study||0
8896802|NCT02039778|9954163|FG000|NOT COMPLETED|Overall Study||4
8896803|NCT02039817|9954169|FG000|STARTED|Overall Study||8
8896804|NCT02039817|9954170|FG001|STARTED|Overall Study||8
8896805|NCT02039817|9954169|FG000|COMPLETED|Overall Study||8
8896806|NCT02039817|9954170|FG001|COMPLETED|Overall Study||8
8896807|NCT02039817|9954169|FG000|NOT COMPLETED|Overall Study||0
8896808|NCT02039817|9954170|FG001|NOT COMPLETED|Overall Study||0
8896809|NCT02039856|9954177|FG000|STARTED|Overall Study||2720
8896810|NCT02039856|9954178|FG001|STARTED|Overall Study||1180
8896811|NCT02039856|9954177|FG000|Baseline Started - Patients|Overall Study||2183
8896812|NCT02039856|9954178|FG001|Baseline Started - Patients|Overall Study||919
8896813|NCT02039856|9954177|FG000|Baseline Completed - Patients|Overall Study||953
8896814|NCT02039856|9954178|FG001|Baseline Completed - Patients|Overall Study||442
8896815|NCT02039856|9954177|FG000|Baseline Started - Providers/Staff|Overall Study||537
8635571|NCT00562328|9676054|FG000|COMPLETED|Overall Study||33
8635572|NCT00562328|9676054|FG000|NOT COMPLETED|Overall Study||0
8635573|NCT00562354|9676060|FG000|STARTED|Overall Study||134
8896816|NCT02039856|9954178|FG001|Baseline Started - Providers/Staff|Overall Study||261
8896817|NCT02039856|9954177|FG000|Baseline Completed -Providers/Staff|Overall Study||194
8896818|NCT02039856|9954178|FG001|Baseline Completed -Providers/Staff|Overall Study||94
8896819|NCT02039856|9954177|FG000|Total Baseline Completed|Overall Study||1147
8896820|NCT02039856|9954178|FG001|Total Baseline Completed|Overall Study||536
8896821|NCT02039856|9954177|FG000|12-month Started-patients|Overall Study||953
8896822|NCT02039856|9954178|FG001|12-month Started-patients|Overall Study||442
8896823|NCT02039856|9954177|FG000|12-month Completed- Patients|Overall Study||580
8896824|NCT02039856|9954178|FG001|12-month Completed- Patients|Overall Study||241
8896825|NCT02039856|9954177|FG000|12-month Providers/Staff|Overall Study||0
8896826|NCT02039856|9954178|FG001|12-month Providers/Staff|Overall Study||0
8896827|NCT02039856|9954177|FG000|24-month Started|Overall Study||1518
8896828|NCT02039856|9954178|FG001|24-month Started|Overall Study||746
8896829|NCT02039856|9954177|FG000|24-month Started - Patients|Overall Study||953
8896830|NCT02039856|9954178|FG001|24-month Started - Patients|Overall Study||442
8896831|NCT02039856|9954177|FG000|24-month Completed - Patients|Overall Study||519
8896832|NCT02039856|9954178|FG001|24-month Completed - Patients|Overall Study||222
8896833|NCT02039856|9954177|FG000|24-month Started Providers/Staff|Overall Study||565
8896834|NCT02039856|9954178|FG001|24-month Started Providers/Staff|Overall Study||304
8896835|NCT02039856|9954177|FG000|24-month Completed Providers/Staff|Overall Study||174
8896836|NCT02039856|9954178|FG001|24-month Completed Providers/Staff|Overall Study||105
8896837|NCT02039856|9954177|FG000|Total 24-month Completed|Overall Study||693
8896838|NCT02039856|9954178|FG001|Total 24-month Completed|Overall Study||327
8896839|NCT02039856|9954177|FG000|COMPLETED|Overall Study||693
8896840|NCT02039856|9954178|FG001|COMPLETED|Overall Study||327
8896841|NCT02039856|9954177|FG000|NOT COMPLETED|Overall Study||2027
8896842|NCT02039856|9954178|FG001|NOT COMPLETED|Overall Study||853
8896843|NCT02039908|9954186|FG000|STARTED|Phase 1-Summer||129
8896844|NCT02039908|9954187|FG001|STARTED|Phase 1-Summer||138
8896845|NCT02039908|9954188|FG002|STARTED|Phase 1-Summer||0
8896846|NCT02039908|9954189|FG003|STARTED|Phase 1-Summer||0
8896847|NCT02039908|9954186|FG000|COMPLETED|Phase 1-Summer||116
8896848|NCT02039908|9954187|FG001|COMPLETED|Phase 1-Summer||132
8896849|NCT02039908|9954188|FG002|COMPLETED|Phase 1-Summer||0
8896850|NCT02039908|9954189|FG003|COMPLETED|Phase 1-Summer||0
8896851|NCT02039908|9954186|FG000|NOT COMPLETED|Phase 1-Summer||13
8896852|NCT02039908|9954187|FG001|NOT COMPLETED|Phase 1-Summer||6
8896853|NCT02039908|9954188|FG002|NOT COMPLETED|Phase 1-Summer||0
8896854|NCT02039908|9954189|FG003|NOT COMPLETED|Phase 1-Summer||0
8896855|NCT02039908|9954186|FG000|STARTED|Phase 2-School Year||0
8896856|NCT02039908|9954187|FG001|STARTED|Phase 2-School Year||0
8896857|NCT02039908|9954188|FG002|STARTED|Phase 2-School Year||121
8635574|NCT00562354|9676061|FG001|STARTED|Overall Study||137
8635575|NCT00562354|9676060|FG000|Received Study Treatment|Overall Study||134
8635576|NCT00562354|9676061|FG001|Received Study Treatment|Overall Study||136
8635577|NCT00562354|9676060|FG000|Evaluable Immunogenicity Population|Overall Study||134
8635578|NCT00562354|9676061|FG001|Evaluable Immunogenicity Population|Overall Study||134
8896858|NCT02039908|9954189|FG003|STARTED|Phase 2-School Year||124
8896859|NCT02039908|9954186|FG000|COMPLETED|Phase 2-School Year||0
8896860|NCT02039908|9954187|FG001|COMPLETED|Phase 2-School Year||0
8896861|NCT02039908|9954188|FG002|COMPLETED|Phase 2-School Year||109
8896862|NCT02039908|9954189|FG003|COMPLETED|Phase 2-School Year||116
8896863|NCT02039908|9954186|FG000|NOT COMPLETED|Phase 2-School Year||0
8896864|NCT02039908|9954187|FG001|NOT COMPLETED|Phase 2-School Year||0
8896865|NCT02039908|9954188|FG002|NOT COMPLETED|Phase 2-School Year||12
8896866|NCT02039908|9954189|FG003|NOT COMPLETED|Phase 2-School Year||8
9008326|NCT02963506|10071109|FG003|Completed Double-Blind Period|Double-Blind Period||58
9008327|NCT02963506|10071110|FG004|Completed Double-Blind Period|Double-Blind Period||61
9008328|NCT02963506|10071111|FG005|Completed Double-Blind Period|Double-Blind Period||0
9008329|NCT02963506|10071112|FG006|Completed Double-Blind Period|Double-Blind Period||0
8635579|NCT00562354|9676060|FG000|COMPLETED|Overall Study||134
8635580|NCT00562354|9676061|FG001|COMPLETED|Overall Study||135
8635581|NCT00562354|9676060|FG000|NOT COMPLETED|Overall Study||0
8635582|NCT00562354|9676061|FG001|NOT COMPLETED|Overall Study||2
8635583|NCT00562484|9676071|FG000|STARTED|Overall Study||10033
8635584|NCT00562484|9676072|FG001|STARTED|Overall Study||5011
8635585|NCT00562484|9676071|FG000|COMPLETED|Overall Study||9827
8635586|NCT00562484|9676072|FG001|COMPLETED|Overall Study||4907
8635587|NCT00562484|9676071|FG000|NOT COMPLETED|Overall Study||206
9008330|NCT02963506|10071113|FG007|Completed Double-Blind Period|Double-Blind Period||0
9008331|NCT02963506|10071114|FG008|Completed Double-Blind Period|Double-Blind Period||0
9008332|NCT02963506|10071115|FG009|Completed Double-Blind Period|Double-Blind Period||0
9008333|NCT02963506|10071116|FG010|Completed Double-Blind Period|Double-Blind Period||0
9008334|NCT02963506|10071117|FG011|Completed Double-Blind Period|Double-Blind Period||0
9008335|NCT02963506|10071118|FG012|Completed Double-Blind Period|Double-Blind Period||0
9008336|NCT02963506|10071106|FG000|Completed Week 12 - Started Dose-Blind|Double-Blind Period||60
9008337|NCT02963506|10071107|FG001|Completed Week 12 - Started Dose-Blind|Double-Blind Period||58
9008338|NCT02963506|10071108|FG002|Completed Week 12 - Started Dose-Blind|Double-Blind Period||59
9008339|NCT02963506|10071109|FG003|Completed Week 12 - Started Dose-Blind|Double-Blind Period||58
9039571|NCT03340337|10100552|FG000|Received Aussie|Overall Study||30
8896867|NCT02039947|9954201|FG000|STARTED|Overall Study||76
8896868|NCT02039947|9954202|FG001|STARTED|Overall Study||16
8896869|NCT02039947|9954203|FG002|STARTED|Overall Study||16
8896870|NCT02039947|9954204|FG003|STARTED|Overall Study||17
8896871|NCT02039947|9954201|FG000|COMPLETED|Overall Study||76
8896872|NCT02039947|9954202|FG001|COMPLETED|Overall Study||16
8896873|NCT02039947|9954203|FG002|COMPLETED|Overall Study||16
8896874|NCT02039947|9954204|FG003|COMPLETED|Overall Study||17
8896875|NCT02039947|9954201|FG000|NOT COMPLETED|Overall Study||0
8896876|NCT02039947|9954202|FG001|NOT COMPLETED|Overall Study||0
8896877|NCT02039947|9954203|FG002|NOT COMPLETED|Overall Study||0
8896878|NCT02039947|9954204|FG003|NOT COMPLETED|Overall Study||0
8896879|NCT02040077|9954221|FG000|STARTED|Overall Study||27
8896880|NCT02040077|9954222|FG001|STARTED|Overall Study||24
8896881|NCT02040077|9954223|FG002|STARTED|Overall Study||25
8896882|NCT02040077|9954221|FG000|COMPLETED|Overall Study||27
8896883|NCT02040077|9954222|FG001|COMPLETED|Overall Study||24
8896884|NCT02040077|9954223|FG002|COMPLETED|Overall Study||25
8896885|NCT02040077|9954221|FG000|NOT COMPLETED|Overall Study||0
8896886|NCT02040077|9954222|FG001|NOT COMPLETED|Overall Study||0
8896887|NCT02040077|9954223|FG002|NOT COMPLETED|Overall Study||0
8896888|NCT02040090|9954234|FG000|STARTED|Overall Study||59
8896889|NCT02040090|9954235|FG001|STARTED|Overall Study||59
8896890|NCT02040090|9954234|FG000|COMPLETED|Overall Study||56
8896891|NCT02040090|9954235|FG001|COMPLETED|Overall Study||57
8896892|NCT02040090|9954234|FG000|NOT COMPLETED|Overall Study||3
8896893|NCT02040090|9954235|FG001|NOT COMPLETED|Overall Study||2
8896894|NCT02040116|9954241|FG000|STARTED|Overall Study||19
8896895|NCT02040116|9954241|FG000|COMPLETED|Overall Study||19
8896896|NCT02040116|9954241|FG000|NOT COMPLETED|Overall Study||0
8896897|NCT02040259|9954249|FG000|STARTED|Overall Study||2008
8896898|NCT02040259|9954249|FG000|COMPLETED|Overall Study||1645
8896899|NCT02040259|9954249|FG000|NOT COMPLETED|Overall Study||363
8896900|NCT02040298|9954257|FG000|STARTED|First Intervention (3 Months)||25
8896901|NCT02040298|9954258|FG001|STARTED|First Intervention (3 Months)||25
8896902|NCT02040298|9954257|FG000|COMPLETED|First Intervention (3 Months)||25
8896903|NCT02040298|9954258|FG001|COMPLETED|First Intervention (3 Months)||25
8896904|NCT02040298|9954257|FG000|NOT COMPLETED|First Intervention (3 Months)||0
8896905|NCT02040298|9954258|FG001|NOT COMPLETED|First Intervention (3 Months)||0
8896906|NCT02040298|9954257|FG000|STARTED|Second Intervention (2 Months)||25
8896907|NCT02040298|9954258|FG001|STARTED|Second Intervention (2 Months)||25
8896908|NCT02040298|9954257|FG000|COMPLETED|Second Intervention (2 Months)||25
8896909|NCT02040298|9954258|FG001|COMPLETED|Second Intervention (2 Months)||25
8896910|NCT02040298|9954257|FG000|NOT COMPLETED|Second Intervention (2 Months)||0
8896911|NCT02040298|9954258|FG001|NOT COMPLETED|Second Intervention (2 Months)||0
8896912|NCT02040428|9954272|FG000|STARTED|Overall Study||75
8896913|NCT02040428|9954273|FG001|STARTED|Overall Study||81
8896914|NCT02040428|9954272|FG000|Intent to Treat (Randomized Subjects)|Overall Study||76
8896915|NCT02040428|9954273|FG001|Intent to Treat (Randomized Subjects)|Overall Study||80
8896916|NCT02040428|9954272|FG000|COMPLETED|Overall Study||70
8896917|NCT02040428|9954273|FG001|COMPLETED|Overall Study||77
8896918|NCT02040428|9954272|FG000|NOT COMPLETED|Overall Study||5
8896919|NCT02040428|9954273|FG001|NOT COMPLETED|Overall Study||4
8896920|NCT02040532|9954279|FG000|STARTED|Overall Study||32
8896921|NCT02040532|9954279|FG000|Received at Least One Dose of Medication|Overall Study||26
8896922|NCT02040532|9954279|FG000|COMPLETED|Overall Study||20
8896923|NCT02040532|9954279|FG000|NOT COMPLETED|Overall Study||12
8896924|NCT02040623|9954286|FG000|STARTED|Overall Study||11
8896925|NCT02040623|9954287|FG001|STARTED|Overall Study||12
8896926|NCT02040623|9954288|FG002|STARTED|Overall Study||12
8896927|NCT02040623|9954286|FG000|COMPLETED|Overall Study||7
8896928|NCT02040623|9954287|FG001|COMPLETED|Overall Study||6
8896929|NCT02040623|9954288|FG002|COMPLETED|Overall Study||10
8896930|NCT02040623|9954286|FG000|NOT COMPLETED|Overall Study||4
8896931|NCT02040623|9954287|FG001|NOT COMPLETED|Overall Study||6
8896932|NCT02040623|9954288|FG002|NOT COMPLETED|Overall Study||2
8896933|NCT02040766|9954301|FG000|STARTED|Overall Study||127
8896934|NCT02040766|9954302|FG001|STARTED|Overall Study||126
8896935|NCT02040766|9954303|FG002|STARTED|Overall Study||125
8896936|NCT02040766|9954304|FG003|STARTED|Overall Study||125
8896937|NCT02040766|9954305|FG004|STARTED|Overall Study||125
8896938|NCT02040766|9954301|FG000|COMPLETED|Overall Study||109
9008340|NCT02963506|10071110|FG004|Completed Week 12 - Started Dose-Blind|Double-Blind Period||61
9008341|NCT02963506|10071111|FG005|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
8896939|NCT02040766|9954302|FG001|COMPLETED|Overall Study||116
8896940|NCT02040766|9954303|FG002|COMPLETED|Overall Study||113
8896941|NCT02040766|9954304|FG003|COMPLETED|Overall Study||112
8896942|NCT02040766|9954305|FG004|COMPLETED|Overall Study||112
8896943|NCT02040766|9954301|FG000|NOT COMPLETED|Overall Study||18
8896944|NCT02040766|9954302|FG001|NOT COMPLETED|Overall Study||10
8896945|NCT02040766|9954303|FG002|NOT COMPLETED|Overall Study||12
8896946|NCT02040766|9954304|FG003|NOT COMPLETED|Overall Study||13
8896947|NCT02040766|9954305|FG004|NOT COMPLETED|Overall Study||13
8896948|NCT02040779|9954321|FG000|STARTED|Overall Study||91
8896949|NCT02040779|9954322|FG001|STARTED|Overall Study||90
8896950|NCT02040779|9954323|FG002|STARTED|Overall Study||92
8896951|NCT02040779|9954321|FG000|Full Analysis Set (FAS)|Overall Study||90
8896952|NCT02040779|9954322|FG001|Full Analysis Set (FAS)|Overall Study||88
9008342|NCT02963506|10071112|FG006|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
8896953|NCT02040779|9954323|FG002|Full Analysis Set (FAS)|Overall Study||92
8896954|NCT02040779|9954321|FG000|COMPLETED|Overall Study||79
8896955|NCT02040779|9954322|FG001|COMPLETED|Overall Study||83
8896956|NCT02040779|9954323|FG002|COMPLETED|Overall Study||88
8896957|NCT02040779|9954321|FG000|NOT COMPLETED|Overall Study||12
8896958|NCT02040779|9954322|FG001|NOT COMPLETED|Overall Study||7
8896959|NCT02040779|9954323|FG002|NOT COMPLETED|Overall Study||4
9008343|NCT02963506|10071113|FG007|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
9008344|NCT02963506|10071114|FG008|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
9008345|NCT02963506|10071115|FG009|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
9008346|NCT02963506|10071116|FG010|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
9008347|NCT02963506|10071117|FG011|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
9008348|NCT02963506|10071118|FG012|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
9008349|NCT02963506|10071106|FG000|COMPLETED|Double-Blind Period||60
9008350|NCT02963506|10071107|FG001|COMPLETED|Double-Blind Period||58
9008351|NCT02963506|10071108|FG002|COMPLETED|Double-Blind Period||59
9008352|NCT02963506|10071109|FG003|COMPLETED|Double-Blind Period||58
9008353|NCT02963506|10071110|FG004|COMPLETED|Double-Blind Period||61
9008354|NCT02963506|10071111|FG005|COMPLETED|Double-Blind Period||0
9008355|NCT02963506|10071112|FG006|COMPLETED|Double-Blind Period||0
9008356|NCT02963506|10071113|FG007|COMPLETED|Double-Blind Period||0
9008357|NCT02963506|10071114|FG008|COMPLETED|Double-Blind Period||0
9008358|NCT02963506|10071115|FG009|COMPLETED|Double-Blind Period||0
9008359|NCT02963506|10071116|FG010|COMPLETED|Double-Blind Period||0
9008360|NCT02963506|10071117|FG011|COMPLETED|Double-Blind Period||0
9008361|NCT02963506|10071118|FG012|COMPLETED|Double-Blind Period||0
9008362|NCT02963506|10071106|FG000|NOT COMPLETED|Double-Blind Period||0
9008363|NCT02963506|10071107|FG001|NOT COMPLETED|Double-Blind Period||3
9008364|NCT02963506|10071108|FG002|NOT COMPLETED|Double-Blind Period||2
9008365|NCT02963506|10071109|FG003|NOT COMPLETED|Double-Blind Period||2
9008366|NCT02963506|10071110|FG004|NOT COMPLETED|Double-Blind Period||0
9008367|NCT02963506|10071111|FG005|NOT COMPLETED|Double-Blind Period||0
9008368|NCT02963506|10071112|FG006|NOT COMPLETED|Double-Blind Period||0
9008369|NCT02963506|10071113|FG007|NOT COMPLETED|Double-Blind Period||0
9008370|NCT02963506|10071114|FG008|NOT COMPLETED|Double-Blind Period||0
9008371|NCT02963506|10071115|FG009|NOT COMPLETED|Double-Blind Period||0
9008372|NCT02963506|10071116|FG010|NOT COMPLETED|Double-Blind Period||0
9008373|NCT02963506|10071117|FG011|NOT COMPLETED|Double-Blind Period||0
9008374|NCT02963506|10071118|FG012|NOT COMPLETED|Double-Blind Period||0
9008375|NCT02963506|10071106|FG000|STARTED|Dose-Blind Period||0
9008376|NCT02963506|10071107|FG001|STARTED|Dose-Blind Period||0
9008377|NCT02963506|10071108|FG002|STARTED|Dose-Blind Period||0
9008378|NCT02963506|10071109|FG003|STARTED|Dose-Blind Period||0
9008379|NCT02963506|10071110|FG004|STARTED|Dose-Blind Period||0
9008380|NCT02963506|10071111|FG005|STARTED|Dose-Blind Period||24
9008381|NCT02963506|10071112|FG006|STARTED|Dose-Blind Period||36
9008382|NCT02963506|10071113|FG007|STARTED|Dose-Blind Period||31
9008383|NCT02963506|10071114|FG008|STARTED|Dose-Blind Period||27
9008384|NCT02963506|10071115|FG009|STARTED|Dose-Blind Period||34
9008385|NCT02963506|10071116|FG010|STARTED|Dose-Blind Period||25
9008386|NCT02963506|10071117|FG011|STARTED|Dose-Blind Period||58
9008387|NCT02963506|10071118|FG012|STARTED|Dose-Blind Period||61
9008388|NCT02963506|10071106|FG000|COMPLETED|Dose-Blind Period||0
9008389|NCT02963506|10071107|FG001|COMPLETED|Dose-Blind Period||0
9008390|NCT02963506|10071108|FG002|COMPLETED|Dose-Blind Period||0
9008391|NCT02963506|10071109|FG003|COMPLETED|Dose-Blind Period||0
9008392|NCT02963506|10071110|FG004|COMPLETED|Dose-Blind Period||0
9008393|NCT02963506|10071111|FG005|COMPLETED|Dose-Blind Period||20
9008394|NCT02963506|10071112|FG006|COMPLETED|Dose-Blind Period||31
9008395|NCT02963506|10071113|FG007|COMPLETED|Dose-Blind Period||26
9008396|NCT02963506|10071114|FG008|COMPLETED|Dose-Blind Period||24
9008397|NCT02963506|10071115|FG009|COMPLETED|Dose-Blind Period||30
9008398|NCT02963506|10071116|FG010|COMPLETED|Dose-Blind Period||24
9008399|NCT02963506|10071117|FG011|COMPLETED|Dose-Blind Period||56
9008400|NCT02963506|10071118|FG012|COMPLETED|Dose-Blind Period||54
9008401|NCT02963506|10071106|FG000|NOT COMPLETED|Dose-Blind Period||0
9008402|NCT02963506|10071107|FG001|NOT COMPLETED|Dose-Blind Period||0
9008403|NCT02963506|10071108|FG002|NOT COMPLETED|Dose-Blind Period||0
9008404|NCT02963506|10071109|FG003|NOT COMPLETED|Dose-Blind Period||0
9008405|NCT02963506|10071110|FG004|NOT COMPLETED|Dose-Blind Period||0
9008406|NCT02963506|10071111|FG005|NOT COMPLETED|Dose-Blind Period||4
9008407|NCT02963506|10071112|FG006|NOT COMPLETED|Dose-Blind Period||5
9008408|NCT02963506|10071113|FG007|NOT COMPLETED|Dose-Blind Period||5
9008409|NCT02963506|10071114|FG008|NOT COMPLETED|Dose-Blind Period||3
9008410|NCT02963506|10071115|FG009|NOT COMPLETED|Dose-Blind Period||4
9008411|NCT02963506|10071116|FG010|NOT COMPLETED|Dose-Blind Period||1
9008412|NCT02963506|10071117|FG011|NOT COMPLETED|Dose-Blind Period||2
9008413|NCT02963506|10071118|FG012|NOT COMPLETED|Dose-Blind Period||7
9008414|NCT02963597|10071137|FG000|STARTED|Overall Study||10
9008415|NCT02963597|10071138|FG001|STARTED|Overall Study||11
9008416|NCT02963597|10071137|FG000|COMPLETED|Overall Study||10
9008417|NCT02963597|10071138|FG001|COMPLETED|Overall Study||11
9008418|NCT02963597|10071137|FG000|NOT COMPLETED|Overall Study||0
9008419|NCT02963597|10071138|FG001|NOT COMPLETED|Overall Study||0
9008420|NCT02963701|10071146|FG000|STARTED|Period 1 (Including Washout) (2 Days)||28
9008421|NCT02963701|10071147|FG001|STARTED|Period 1 (Including Washout) (2 Days)||28
9039572|NCT03340337|10100552|FG000|Received RBS|Overall Study||30
8635588|NCT00562484|9676072|FG001|NOT COMPLETED|Overall Study||104
8635589|NCT00562588|9676080|FG000|STARTED|Overall Study||260
8635590|NCT00562588|9676081|FG001|STARTED|Overall Study||283
8896960|NCT02040805|9954333|FG000|STARTED|Overall Study||160
8896961|NCT02040805|9954334|FG001|STARTED|Overall Study||163
8896962|NCT02040805|9954333|FG000|COMPLETED|Overall Study||118
8896963|NCT02040805|9954334|FG001|COMPLETED|Overall Study||113
8896964|NCT02040805|9954333|FG000|NOT COMPLETED|Overall Study||42
8896965|NCT02040805|9954334|FG001|NOT COMPLETED|Overall Study||50
8896966|NCT02040844|9954343|FG000|STARTED|Overall Study||138
8896967|NCT02040844|9954344|FG001|STARTED|Overall Study||148
8896968|NCT02040844|9954345|FG002|STARTED|Overall Study||144
8896969|NCT02040844|9954343|FG000|COMPLETED|Overall Study||88
8896970|NCT02040844|9954344|FG001|COMPLETED|Overall Study||109
8896971|NCT02040844|9954345|FG002|COMPLETED|Overall Study||97
8896972|NCT02040844|9954343|FG000|NOT COMPLETED|Overall Study||50
8896973|NCT02040844|9954344|FG001|NOT COMPLETED|Overall Study||39
8896974|NCT02040844|9954345|FG002|NOT COMPLETED|Overall Study||47
8896975|NCT02040870|9954353|FG000|STARTED|Overall Study||103
8896976|NCT02040870|9954353|FG000|Entered Post-treatment Follow-up|Overall Study||2
8896977|NCT02040870|9954353|FG000|Entered Survival Follow-up|Overall Study||75
8896978|NCT02040870|9954353|FG000|Discontinue From Study|Overall Study||26
8896979|NCT02040870|9954353|FG000|COMPLETED|Overall Study||0
8896980|NCT02040870|9954353|FG000|NOT COMPLETED|Overall Study||103
8896981|NCT02041091|9954359|FG000|STARTED|Treatment||112
8896982|NCT02041091|9954360|FG001|STARTED|Treatment||114
8896983|NCT02041091|9954359|FG000|Received At Least One Dose of Study Drug|Treatment||112
8896984|NCT02041091|9954360|FG001|Received At Least One Dose of Study Drug|Treatment||114
8896985|NCT02041091|9954359|FG000|Participated in Follow Up|Treatment||106
8896986|NCT02041091|9954360|FG001|Participated in Follow Up|Treatment||96
8896987|NCT02041091|9954359|FG000|COMPLETED|Treatment||90
8896988|NCT02041091|9954360|FG001|COMPLETED|Treatment||91
8896989|NCT02041091|9954359|FG000|NOT COMPLETED|Treatment||22
8896990|NCT02041091|9954360|FG001|NOT COMPLETED|Treatment||23
8896991|NCT02041091|9954359|FG000|STARTED|Optional Safety Extension Period|Participation was optional for the Safety Extension Period.|85
8896992|NCT02041091|9954360|FG001|STARTED|Optional Safety Extension Period|Participation was optional for the Safety Extension Period.|82
8896993|NCT02041091|9954359|FG000|COMPLETED|Optional Safety Extension Period||0
8896994|NCT02041091|9954360|FG001|COMPLETED|Optional Safety Extension Period||0
8896995|NCT02041091|9954359|FG000|NOT COMPLETED|Optional Safety Extension Period||85
8896996|NCT02041091|9954360|FG001|NOT COMPLETED|Optional Safety Extension Period||82
8896997|NCT02041104|9954374|FG000|STARTED|Overall Study||28
8896998|NCT02041104|9954375|FG001|STARTED|Overall Study||23
8896999|NCT02041104|9954374|FG000|COMPLETED|Overall Study||27
8897000|NCT02041104|9954375|FG001|COMPLETED|Overall Study||16
8897001|NCT02041104|9954374|FG000|NOT COMPLETED|Overall Study||1
8897002|NCT02041104|9954375|FG001|NOT COMPLETED|Overall Study||7
8897003|NCT02041221|9954389|FG000|STARTED|Part 1||6
8897004|NCT02041221|9954390|FG001|STARTED|Part 1||6
8897005|NCT02041221|9954391|FG002|STARTED|Part 1||6
8897006|NCT02041221|9954392|FG003|STARTED|Part 1||6
8897007|NCT02041221|9954393|FG004|STARTED|Part 1||6
8897008|NCT02041221|9954394|FG005|STARTED|Part 1||10
8897009|NCT02041221|9954389|FG000|COMPLETED|Part 1||6
8897010|NCT02041221|9954390|FG001|COMPLETED|Part 1||6
8897011|NCT02041221|9954391|FG002|COMPLETED|Part 1||6
8897012|NCT02041221|9954392|FG003|COMPLETED|Part 1||6
8897013|NCT02041221|9954393|FG004|COMPLETED|Part 1||6
8897014|NCT02041221|9954394|FG005|COMPLETED|Part 1||10
8635591|NCT00562588|9676080|FG000|COMPLETED|Overall Study||168
8635592|NCT00562588|9676081|FG001|COMPLETED|Overall Study||184
8635593|NCT00562588|9676080|FG000|NOT COMPLETED|Overall Study||92
8635594|NCT00562588|9676081|FG001|NOT COMPLETED|Overall Study||99
8635595|NCT00562627|9676090|FG000|STARTED|Overall Study||34
8726262|NCT01034657|9773436|FG001|COMPLETED|Randomized Phase||0
8897015|NCT02041221|9954389|FG000|NOT COMPLETED|Part 1||0
8897016|NCT02041221|9954390|FG001|NOT COMPLETED|Part 1||0
8897017|NCT02041221|9954391|FG002|NOT COMPLETED|Part 1||0
8897018|NCT02041221|9954392|FG003|NOT COMPLETED|Part 1||0
8897019|NCT02041221|9954393|FG004|NOT COMPLETED|Part 1||0
8897020|NCT02041221|9954394|FG005|NOT COMPLETED|Part 1||0
8897021|NCT02041221|9954389|FG000|STARTED|Part 2||6
8897022|NCT02041221|9954390|FG001|STARTED|Part 2||6
8897023|NCT02041221|9954391|FG002|STARTED|Part 2||6
8897024|NCT02041221|9954392|FG003|STARTED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually.|0
8897025|NCT02041221|9954393|FG004|STARTED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually|0
8897026|NCT02041221|9954394|FG005|STARTED|Part 2||6
8897027|NCT02041221|9954389|FG000|COMPLETED|Part 2||6
8897028|NCT02041221|9954390|FG001|COMPLETED|Part 2||6
8897029|NCT02041221|9954391|FG002|COMPLETED|Part 2||5
8897030|NCT02041221|9954392|FG003|COMPLETED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually|0
8635596|NCT00562627|9676091|FG001|STARTED|Overall Study||34
8635597|NCT00562627|9676092|FG002|STARTED|Overall Study||34
8897031|NCT02041221|9954393|FG004|COMPLETED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually|0
8897032|NCT02041221|9954394|FG005|COMPLETED|Part 2||6
8897033|NCT02041221|9954389|FG000|NOT COMPLETED|Part 2||0
8897034|NCT02041221|9954390|FG001|NOT COMPLETED|Part 2||0
8897035|NCT02041221|9954391|FG002|NOT COMPLETED|Part 2||1
8897036|NCT02041221|9954392|FG003|NOT COMPLETED|Part 2||0
8897037|NCT02041221|9954393|FG004|NOT COMPLETED|Part 2||0
8897038|NCT02041221|9954394|FG005|NOT COMPLETED|Part 2||0
8897039|NCT02041286|9954408|FG000|STARTED|Overall Study||136
8897040|NCT02041286|9954408|FG000|COMPLETED|Overall Study|One subject discontinued from testing after low BG fingerstick result (hypoglycemia AE).|135
8897041|NCT02041286|9954408|FG000|NOT COMPLETED|Overall Study||1
8897042|NCT02041299|9954416|FG000|STARTED|Overall Study||152
8897043|NCT02041299|9954417|FG001|STARTED|Overall Study|Two participants double-enrolled under different subject numbers so were each counted twice.|78
8897044|NCT02041299|9954416|FG000|COMPLETED|Overall Study||106
8897045|NCT02041299|9954417|FG001|COMPLETED|Overall Study||58
8897046|NCT02041299|9954416|FG000|NOT COMPLETED|Overall Study||46
8897047|NCT02041299|9954417|FG001|NOT COMPLETED|Overall Study||20
8897048|NCT02041325|9954429|FG000|STARTED|Overall Study||22
8897049|NCT02041325|9954430|FG001|STARTED|Overall Study||16
8897050|NCT02041325|9954429|FG000|COMPLETED|Overall Study||19
8897051|NCT02041325|9954430|FG001|COMPLETED|Overall Study||13
8635598|NCT00562627|9676090|FG000|COMPLETED|Overall Study||33
8635599|NCT00562627|9676091|FG001|COMPLETED|Overall Study||33
8635600|NCT00562627|9676092|FG002|COMPLETED|Overall Study||33
8635601|NCT00562627|9676090|FG000|NOT COMPLETED|Overall Study||1
8635602|NCT00562627|9676091|FG001|NOT COMPLETED|Overall Study||1
8635603|NCT00562627|9676092|FG002|NOT COMPLETED|Overall Study||1
8635604|NCT00562718|9676100|FG000|STARTED|Overall Study||50
8635605|NCT00562718|9676100|FG000|COMPLETED|Overall Study||39
8635606|NCT00562718|9676100|FG000|NOT COMPLETED|Overall Study||11
8635607|NCT00562861|9676106|FG000|STARTED|Overall Study||60
8635608|NCT00562861|9676107|FG001|STARTED|Overall Study||59
8897052|NCT02041325|9954429|FG000|NOT COMPLETED|Overall Study||3
8897053|NCT02041325|9954430|FG001|NOT COMPLETED|Overall Study||3
8897054|NCT02041377|9954440|FG000|STARTED|Overall Study||134
8897055|NCT02041377|9954440|FG000|COMPLETED|Overall Study||134
8897056|NCT02041377|9954440|FG000|NOT COMPLETED|Overall Study||0
8897057|NCT02041429|9954448|FG000|STARTED|Overall Study||3
8897058|NCT02041429|9954449|FG001|STARTED|Overall Study||4
8897059|NCT02041429|9954450|FG002|STARTED|Overall Study||7
8897060|NCT02041429|9954451|FG003|STARTED|Overall Study||6
8897061|NCT02041429|9954448|FG000|Treated|Overall Study||3
8897062|NCT02041429|9954449|FG001|Treated|Overall Study||3
8897063|NCT02041429|9954450|FG002|Treated|Overall Study||7
8897064|NCT02041429|9954451|FG003|Treated|Overall Study||6
8897065|NCT02041429|9954448|FG000|Evaluable for Dose Limiting Toxicity|Overall Study||3
8897066|NCT02041429|9954449|FG001|Evaluable for Dose Limiting Toxicity|Overall Study||3
8635609|NCT00562861|9676106|FG000|COMPLETED|Overall Study||40
8897067|NCT02041429|9954450|FG002|Evaluable for Dose Limiting Toxicity|Overall Study||6
8897068|NCT02041429|9954451|FG003|Evaluable for Dose Limiting Toxicity|Overall Study||6
8897069|NCT02041429|9954448|FG000|COMPLETED|Overall Study||0
8897070|NCT02041429|9954449|FG001|COMPLETED|Overall Study||0
8897071|NCT02041429|9954450|FG002|COMPLETED|Overall Study||0
8897072|NCT02041429|9954451|FG003|COMPLETED|Overall Study||0
8897073|NCT02041429|9954448|FG000|NOT COMPLETED|Overall Study||3
8897074|NCT02041429|9954449|FG001|NOT COMPLETED|Overall Study||4
8897075|NCT02041429|9954450|FG002|NOT COMPLETED|Overall Study||7
8897076|NCT02041429|9954451|FG003|NOT COMPLETED|Overall Study||6
8897077|NCT02041494|9954468|FG000|STARTED|Overall Study||82
8897078|NCT02041494|9954469|FG001|STARTED|Overall Study||83
8897079|NCT02041494|9954468|FG000|COMPLETED|Overall Study||63
8897080|NCT02041494|9954469|FG001|COMPLETED|Overall Study||63
8897081|NCT02041494|9954468|FG000|NOT COMPLETED|Overall Study||19
8897082|NCT02041494|9954469|FG001|NOT COMPLETED|Overall Study||20
8897083|NCT02041520|9954478|FG000|STARTED|Overall Study|35 patients randomly assigned to omega 3 fatty acids|35
8897084|NCT02041520|9954479|FG001|STARTED|Overall Study|35 patients randomly assigned to placebo|35
8897085|NCT02041520|9954478|FG000|COMPLETED|Overall Study||29
8897086|NCT02041520|9954479|FG001|COMPLETED|Overall Study||28
8897087|NCT02041520|9954478|FG000|NOT COMPLETED|Overall Study||6
8635610|NCT00562861|9676107|FG001|COMPLETED|Overall Study||48
8897088|NCT02041520|9954479|FG001|NOT COMPLETED|Overall Study||7
8897089|NCT02041702|9954489|FG000|STARTED|Overall Study||140
8897090|NCT02041702|9954490|FG001|STARTED|Overall Study||143
8897091|NCT02041702|9954489|FG000|Pre MRI Scan/ Pre Waitng|Overall Study||129
8897092|NCT02041702|9954490|FG001|Pre MRI Scan/ Pre Waitng|Overall Study||140
8897093|NCT02041702|9954489|FG000|Post MRI Scan/ Post Waiting|Overall Study||129
8897094|NCT02041702|9954490|FG001|Post MRI Scan/ Post Waiting|Overall Study||140
8897095|NCT02041702|9954489|FG000|COMPLETED|Overall Study||129
8897096|NCT02041702|9954490|FG001|COMPLETED|Overall Study||134
8897097|NCT02041702|9954489|FG000|NOT COMPLETED|Overall Study||11
8897098|NCT02041702|9954490|FG001|NOT COMPLETED|Overall Study||9
8897099|NCT02041923|9954498|FG000|STARTED|Overall Study||102
8897100|NCT02041923|9954499|FG001|STARTED|Overall Study||96
8897101|NCT02041923|9954498|FG000|COMPLETED|Overall Study||76
8897102|NCT02041923|9954499|FG001|COMPLETED|Overall Study||66
8635611|NCT00562861|9676106|FG000|NOT COMPLETED|Overall Study||20
8897103|NCT02041923|9954498|FG000|NOT COMPLETED|Overall Study||26
8897104|NCT02041923|9954499|FG001|NOT COMPLETED|Overall Study||30
8897105|NCT02041962|9954509|FG000|STARTED|Overall Study||123
8897106|NCT02041962|9954510|FG001|STARTED|Overall Study||115
8897107|NCT02041962|9954509|FG000|Participants Completing 6 mo. f/up|Overall Study||69
8897108|NCT02041962|9954510|FG001|Participants Completing 6 mo. f/up|Overall Study||44
8897109|NCT02041962|9954509|FG000|Participants Completing 12 mo. f/up|Overall Study||42
8897110|NCT02041962|9954510|FG001|Participants Completing 12 mo. f/up|Overall Study||31
8897111|NCT02041962|9954509|FG000|COMPLETED|Overall Study||42
8897112|NCT02041962|9954510|FG001|COMPLETED|Overall Study||31
8897113|NCT02041962|9954509|FG000|NOT COMPLETED|Overall Study||81
8897114|NCT02041962|9954510|FG001|NOT COMPLETED|Overall Study||84
8897115|NCT02042014|9954516|FG000|STARTED|Overall Study||8
8897116|NCT02042014|9954516|FG000|COMPLETED|Overall Study||0
8897117|NCT02042014|9954516|FG000|NOT COMPLETED|Overall Study||8
8897118|NCT02042131|9954523|FG000|STARTED|Overall Study||32
8897119|NCT02042131|9954524|FG001|STARTED|Overall Study||32
8897120|NCT02042131|9954525|FG002|STARTED|Overall Study||33
8897121|NCT02042131|9954523|FG000|COMPLETED|Overall Study||32
8897122|NCT02042131|9954524|FG001|COMPLETED|Overall Study||32
8897123|NCT02042131|9954525|FG002|COMPLETED|Overall Study||33
8897124|NCT02042131|9954523|FG000|NOT COMPLETED|Overall Study||0
8897125|NCT02042131|9954524|FG001|NOT COMPLETED|Overall Study||0
8897126|NCT02042131|9954525|FG002|NOT COMPLETED|Overall Study||0
8897127|NCT02042183|9954537|FG000|STARTED|Overall Study||404
8897128|NCT02042183|9954538|FG001|STARTED|Overall Study||202
8897129|NCT02042183|9954537|FG000|Safety Population|Overall Study||400
8897130|NCT02042183|9954538|FG001|Safety Population|Overall Study||195
8897131|NCT02042183|9954537|FG000|Modified Intent-to-treat (mITT)|Overall Study||399
8897132|NCT02042183|9954538|FG001|Modified Intent-to-treat (mITT)|Overall Study||195
8897133|NCT02042183|9954537|FG000|COMPLETED|Overall Study||339
8897134|NCT02042183|9954538|FG001|COMPLETED|Overall Study||166
8897135|NCT02042183|9954537|FG000|NOT COMPLETED|Overall Study||65
8897136|NCT02042183|9954538|FG001|NOT COMPLETED|Overall Study||36
8897137|NCT02042274|9954546|FG000|STARTED|Overall Study||12
8897138|NCT02042274|9954546|FG000|COMPLETED|Overall Study||12
8897139|NCT02042274|9954546|FG000|NOT COMPLETED|Overall Study||0
8897140|NCT02042404|9954550|FG000|STARTED|Overall Study|Enrollment was stopped after 43 were enrolled, had approval to enroll 45 primary cohort subjects|43
8897141|NCT02042404|9954551|FG001|STARTED|Overall Study||5
8897142|NCT02042404|9954550|FG000|COMPLETED|Overall Study|39 subjects completed 30 days evaluation. 38 subjects completed 120 days evaluation.|38
9008422|NCT02963701|10071146|FG000|COMPLETED|Period 1 (Including Washout) (2 Days)|One subject withdrawn from the study after period 1|27
9008423|NCT02963701|10071147|FG001|COMPLETED|Period 1 (Including Washout) (2 Days)||28
9008424|NCT02963701|10071146|FG000|NOT COMPLETED|Period 1 (Including Washout) (2 Days)||1
9008425|NCT02963701|10071147|FG001|NOT COMPLETED|Period 1 (Including Washout) (2 Days)||0
9008426|NCT02963701|10071146|FG000|STARTED|Period 2 (2 Days)||27
9008427|NCT02963701|10071147|FG001|STARTED|Period 2 (2 Days)||28
9008428|NCT02963701|10071146|FG000|COMPLETED|Period 2 (2 Days)||27
9008429|NCT02963701|10071147|FG001|COMPLETED|Period 2 (2 Days)||28
8635612|NCT00562861|9676107|FG001|NOT COMPLETED|Overall Study||11
8635613|NCT00562965|9676115|FG000|STARTED|Overall Study||15
8635614|NCT00562965|9676116|FG001|STARTED|Overall Study||14
8635615|NCT00562965|9676115|FG000|Treated|Overall Study||15
8635616|NCT00562965|9676116|FG001|Treated|Overall Study||13
8635617|NCT00562965|9676115|FG000|COMPLETED|Overall Study||12
8635618|NCT00562965|9676116|FG001|COMPLETED|Overall Study||8
8635619|NCT00562965|9676115|FG000|NOT COMPLETED|Overall Study||3
8635620|NCT00562965|9676116|FG001|NOT COMPLETED|Overall Study||6
8635621|NCT00562978|9676124|FG000|STARTED|Overall Study||6
8635622|NCT00562978|9676125|FG001|STARTED|Overall Study||48
8635623|NCT00562978|9676124|FG000|COMPLETED|Overall Study||5
8726263|NCT01034657|9773437|FG002|COMPLETED|Randomized Phase||0
8726264|NCT01034657|9773435|FG000|NOT COMPLETED|Randomized Phase||5
8726265|NCT01034657|9773436|FG001|NOT COMPLETED|Randomized Phase||6
8726266|NCT01034657|9773437|FG002|NOT COMPLETED|Randomized Phase||1
8726267|NCT01034709|9773449|FG000|STARTED|Overall Study||53
8726268|NCT01034709|9773450|FG001|STARTED|Overall Study||58
8726269|NCT01034709|9773449|FG000|COMPLETED|Overall Study||44
8726270|NCT01034709|9773450|FG001|COMPLETED|Overall Study||42
8726271|NCT01034709|9773449|FG000|NOT COMPLETED|Overall Study||9
8726272|NCT01034709|9773450|FG001|NOT COMPLETED|Overall Study||16
8726273|NCT01035047|9773458|FG000|STARTED|Overall Study||52
8726274|NCT01035047|9773459|FG001|STARTED|Overall Study||53
8897143|NCT02042404|9954551|FG001|COMPLETED|Overall Study||5
8726275|NCT01035047|9773458|FG000|COMPLETED|Overall Study||52
8897144|NCT02042404|9954550|FG000|NOT COMPLETED|Overall Study||5
8897145|NCT02042404|9954551|FG001|NOT COMPLETED|Overall Study||0
8897146|NCT02042443|9954560|FG000|STARTED|Overall Study||27
8897147|NCT02042443|9954561|FG001|STARTED|Overall Study||26
8897148|NCT02042443|9954560|FG000|Eligible and Analyzable|Overall Study||24
8897149|NCT02042443|9954561|FG001|Eligible and Analyzable|Overall Study||20
8635624|NCT00562978|9676125|FG001|COMPLETED|Overall Study||37
8726276|NCT01035047|9773459|FG001|COMPLETED|Overall Study||53
8897150|NCT02042443|9954560|FG000|COMPLETED|Overall Study||0
8897151|NCT02042443|9954561|FG001|COMPLETED|Overall Study||0
8897152|NCT02042443|9954560|FG000|NOT COMPLETED|Overall Study||27
8897153|NCT02042443|9954561|FG001|NOT COMPLETED|Overall Study||26
8897154|NCT02042534|9954570|FG000|STARTED|Overall Study||101
8897155|NCT02042534|9954571|FG001|STARTED|Overall Study||94
8897156|NCT02042534|9954570|FG000|COMPLETED|Overall Study||101
8897157|NCT02042534|9954571|FG001|COMPLETED|Overall Study||94
8897158|NCT02042534|9954570|FG000|NOT COMPLETED|Overall Study||0
8897159|NCT02042534|9954571|FG001|NOT COMPLETED|Overall Study||0
8897160|NCT02042872|9954579|FG000|STARTED|Overall Study||8
8897161|NCT02042872|9954580|FG001|STARTED|Overall Study||13
8897162|NCT02042872|9954579|FG000|COMPLETED|Overall Study||8
8897163|NCT02042872|9954580|FG001|COMPLETED|Overall Study||8
8897164|NCT02042872|9954579|FG000|NOT COMPLETED|Overall Study||0
8897165|NCT02042872|9954580|FG001|NOT COMPLETED|Overall Study||5
8897166|NCT02042911|9954586|FG000|STARTED|Overall Study||10
8897167|NCT02042911|9954586|FG000|COMPLETED|Overall Study||9
8897168|NCT02042911|9954586|FG000|NOT COMPLETED|Overall Study||1
8897169|NCT02043015|9954590|FG000|STARTED|Overall Study||115
8897170|NCT02043015|9954590|FG000|COMPLETED|Overall Study||87
8897171|NCT02043015|9954590|FG000|NOT COMPLETED|Overall Study||28
8897172|NCT02043132|9954598|FG000|STARTED|Overall Study||58
8897173|NCT02043132|9954599|FG001|STARTED|Overall Study||58
8897174|NCT02043132|9954598|FG000|COMPLETED|Overall Study||53
8897175|NCT02043132|9954599|FG001|COMPLETED|Overall Study||49
8726277|NCT01035047|9773458|FG000|NOT COMPLETED|Overall Study||0
8726278|NCT01035047|9773459|FG001|NOT COMPLETED|Overall Study||0
8726279|NCT01035060|9773467|FG000|STARTED|Overall Study||39
8726280|NCT01035060|9773468|FG001|STARTED|Overall Study||29
8726281|NCT01035060|9773467|FG000|COMPLETED|Overall Study||15
8726282|NCT01035060|9773468|FG001|COMPLETED|Overall Study||15
8726283|NCT01035060|9773467|FG000|NOT COMPLETED|Overall Study||24
8726284|NCT01035060|9773468|FG001|NOT COMPLETED|Overall Study||14
8897176|NCT02043132|9954598|FG000|NOT COMPLETED|Overall Study||5
8897177|NCT02043132|9954599|FG001|NOT COMPLETED|Overall Study||9
8897178|NCT02043145|9954608|FG000|STARTED|Overall Study||55
8897179|NCT02043145|9954609|FG001|STARTED|Overall Study||247
8897180|NCT02043145|9954610|FG002|STARTED|Overall Study||425
8897181|NCT02043145|9954608|FG000|COMPLETED|Overall Study||55
8897182|NCT02043145|9954609|FG001|COMPLETED|Overall Study||247
8897183|NCT02043145|9954610|FG002|COMPLETED|Overall Study||425
8897184|NCT02043145|9954608|FG000|NOT COMPLETED|Overall Study||0
8897185|NCT02043145|9954609|FG001|NOT COMPLETED|Overall Study||0
8897186|NCT02043145|9954610|FG002|NOT COMPLETED|Overall Study||0
8897187|NCT02043197|9954620|FG000|STARTED|Overall Study||300
8897188|NCT02043197|9954620|FG000|COMPLETED|Overall Study||292
8897189|NCT02043197|9954620|FG000|NOT COMPLETED|Overall Study||8
8897190|NCT02043301|9954627|FG000|STARTED|Overall Study||25
8897191|NCT02043301|9954628|FG001|STARTED|Overall Study||25
8897192|NCT02043301|9954629|FG002|STARTED|Overall Study||25
8897193|NCT02043301|9954627|FG000|COMPLETED|Overall Study||25
8897194|NCT02043301|9954628|FG001|COMPLETED|Overall Study||24
8897195|NCT02043301|9954629|FG002|COMPLETED|Overall Study||25
8897196|NCT02043301|9954627|FG000|NOT COMPLETED|Overall Study||0
8897197|NCT02043301|9954628|FG001|NOT COMPLETED|Overall Study||1
8897198|NCT02043301|9954629|FG002|NOT COMPLETED|Overall Study||0
8897199|NCT02043366|9954643|FG000|STARTED|Overall Study||30
8897200|NCT02043366|9954644|FG001|STARTED|Overall Study||30
8897201|NCT02043366|9954645|FG002|STARTED|Overall Study||30
8897202|NCT02043366|9954646|FG003|STARTED|Overall Study||30
8897203|NCT02043366|9954647|FG004|STARTED|Overall Study||30
8897204|NCT02043366|9954648|FG005|STARTED|Overall Study||30
9008430|NCT02963701|10071146|FG000|NOT COMPLETED|Period 2 (2 Days)||0
9008431|NCT02963701|10071147|FG001|NOT COMPLETED|Period 2 (2 Days)||0
9008432|NCT02963922|10071155|FG000|STARTED|Overall Study||198
9008433|NCT02963922|10071156|FG001|STARTED|Overall Study||198
9008434|NCT02963922|10071155|FG000|COMPLETED|Overall Study||166
9008435|NCT02963922|10071156|FG001|COMPLETED|Overall Study||168
9008436|NCT02963922|10071155|FG000|NOT COMPLETED|Overall Study||32
9008437|NCT02963922|10071156|FG001|NOT COMPLETED|Overall Study||30
9008438|NCT02963935|10071164|FG000|STARTED|Overall Study||142
9008439|NCT02963935|10071165|FG001|STARTED|Overall Study||140
9008440|NCT02963935|10071164|FG000|COMPLETED|Overall Study||114
8897205|NCT02043366|9954643|FG000|COMPLETED|Overall Study||28
8897206|NCT02043366|9954644|FG001|COMPLETED|Overall Study||28
8897207|NCT02043366|9954645|FG002|COMPLETED|Overall Study||28
8897208|NCT02043366|9954646|FG003|COMPLETED|Overall Study||28
9008441|NCT02963935|10071165|FG001|COMPLETED|Overall Study||103
9008442|NCT02963935|10071164|FG000|NOT COMPLETED|Overall Study||28
9008443|NCT02963935|10071165|FG001|NOT COMPLETED|Overall Study||37
8726285|NCT01035099|9773476|FG000|STARTED|Overall Study||18
8897209|NCT02043366|9954647|FG004|COMPLETED|Overall Study||28
8897210|NCT02043366|9954648|FG005|COMPLETED|Overall Study||28
8897211|NCT02043366|9954643|FG000|NOT COMPLETED|Overall Study||2
8897212|NCT02043366|9954644|FG001|NOT COMPLETED|Overall Study||2
8897213|NCT02043366|9954645|FG002|NOT COMPLETED|Overall Study||2
8897214|NCT02043366|9954646|FG003|NOT COMPLETED|Overall Study||2
8897215|NCT02043366|9954647|FG004|NOT COMPLETED|Overall Study||2
8897216|NCT02043366|9954648|FG005|NOT COMPLETED|Overall Study||2
8897217|NCT02043379|9954666|FG000|STARTED|Overall Study||30
8897218|NCT02043379|9954667|FG001|STARTED|Overall Study||20
8897219|NCT02043379|9954666|FG000|COMPLETED|Overall Study||30
8897220|NCT02043379|9954667|FG001|COMPLETED|Overall Study||20
8897221|NCT02043379|9954666|FG000|NOT COMPLETED|Overall Study||0
8897222|NCT02043379|9954667|FG001|NOT COMPLETED|Overall Study||0
8897223|NCT02043509|9954675|FG000|STARTED|Baseline to 1st Follow-up||203
8897224|NCT02043509|9954676|FG001|STARTED|Baseline to 1st Follow-up||204
8897225|NCT02043509|9954675|FG000|COMPLETED|Baseline to 1st Follow-up||138
8897226|NCT02043509|9954676|FG001|COMPLETED|Baseline to 1st Follow-up||157
8897227|NCT02043509|9954675|FG000|NOT COMPLETED|Baseline to 1st Follow-up||65
8897228|NCT02043509|9954676|FG001|NOT COMPLETED|Baseline to 1st Follow-up||47
8897229|NCT02043509|9954675|FG000|STARTED|Baseline to 2nd Follow-up||203
8897230|NCT02043509|9954676|FG001|STARTED|Baseline to 2nd Follow-up||204
8897231|NCT02043509|9954675|FG000|COMPLETED|Baseline to 2nd Follow-up||129
8897232|NCT02043509|9954676|FG001|COMPLETED|Baseline to 2nd Follow-up||132
8897233|NCT02043509|9954675|FG000|NOT COMPLETED|Baseline to 2nd Follow-up||74
8897234|NCT02043509|9954676|FG001|NOT COMPLETED|Baseline to 2nd Follow-up||72
8897235|NCT02043548|9954684|FG000|STARTED|Overall Study||18
8897236|NCT02043548|9954685|FG001|STARTED|Overall Study||18
8897237|NCT02043548|9954684|FG000|COMPLETED|Overall Study||17
8897238|NCT02043548|9954685|FG001|COMPLETED|Overall Study||17
8897239|NCT02043548|9954684|FG000|NOT COMPLETED|Overall Study||1
8897240|NCT02043548|9954685|FG001|NOT COMPLETED|Overall Study||1
8897241|NCT02043574|9954693|FG000|STARTED|Overall Study||25
8897242|NCT02043574|9954694|FG001|STARTED|Overall Study||26
9008444|NCT02963974|10071171|FG000|STARTED|Overall Study||20
9008445|NCT02963974|10071171|FG000|COMPLETED|Overall Study||19
9008446|NCT02963974|10071171|FG000|NOT COMPLETED|Overall Study||1
9008447|NCT02963987|10071175|FG000|STARTED|First Intervention Period||31
9008448|NCT02963987|10071176|FG001|STARTED|First Intervention Period||19
9008449|NCT02963987|10071175|FG000|COMPLETED|First Intervention Period||31
9008450|NCT02963987|10071176|FG001|COMPLETED|First Intervention Period||19
9008451|NCT02963987|10071175|FG000|NOT COMPLETED|First Intervention Period||0
9008452|NCT02963987|10071176|FG001|NOT COMPLETED|First Intervention Period||0
9008453|NCT02963987|10071175|FG000|STARTED|Second Intervention Period||31
9008454|NCT02963987|10071176|FG001|STARTED|Second Intervention Period||19
9008455|NCT02963987|10071175|FG000|COMPLETED|Second Intervention Period||31
9008456|NCT02963987|10071176|FG001|COMPLETED|Second Intervention Period||19
9008457|NCT02963987|10071175|FG000|NOT COMPLETED|Second Intervention Period||0
9008458|NCT02963987|10071176|FG001|NOT COMPLETED|Second Intervention Period||0
9008459|NCT02964234|10071186|FG000|STARTED|Overall Study||76
9008460|NCT02964234|10071187|FG001|STARTED|Overall Study||69
9008461|NCT02964234|10071186|FG000|COMPLETED|Overall Study||54
9008462|NCT02964234|10071187|FG001|COMPLETED|Overall Study||56
9008463|NCT02964234|10071186|FG000|NOT COMPLETED|Overall Study||22
9008464|NCT02964234|10071187|FG001|NOT COMPLETED|Overall Study||13
9008465|NCT02964247|10071195|FG000|STARTED|Overall Study||203
9008466|NCT02964247|10071196|FG001|STARTED|Overall Study||100
9008467|NCT02964247|10071195|FG000|Exposed to Trial Product|Overall Study||202
9008468|NCT02964247|10071196|FG001|Exposed to Trial Product|Overall Study||100
9008469|NCT02964247|10071195|FG000|COMPLETED|Overall Study||200
9008470|NCT02964247|10071196|FG001|COMPLETED|Overall Study||98
9008471|NCT02964247|10071195|FG000|NOT COMPLETED|Overall Study||3
9008472|NCT02964247|10071196|FG001|NOT COMPLETED|Overall Study||2
9008473|NCT02964312|10071202|FG000|STARTED|Overall Study||166
9008474|NCT02964312|10071202|FG000|1-Month Follow-up|Overall Study||164
9008475|NCT02964312|10071202|FG000|3-Month Follow-up|Overall Study||159
9008476|NCT02964312|10071202|FG000|6-Month Follow-up|Overall Study||152
9008477|NCT02964312|10071202|FG000|12-Month Follow-up|Overall Study||139
9008478|NCT02964312|10071202|FG000|18-Month Follow-up|Overall Study||112
9008479|NCT02964312|10071202|FG000|24-Month Follow-up|Overall Study||102
9008480|NCT02964312|10071202|FG000|COMPLETED|Overall Study||102
9008481|NCT02964312|10071202|FG000|NOT COMPLETED|Overall Study||64
9008482|NCT02964325|10071211|FG000|STARTED|Overall Study||164
8635625|NCT00562978|9676124|FG000|NOT COMPLETED|Overall Study||1
8635626|NCT00562978|9676125|FG001|NOT COMPLETED|Overall Study||11
8635627|NCT00563186|9676133|FG000|STARTED|Overall Study|Patients allocated to the Novel Hospital Ward|1008
8635628|NCT00563186|9676134|FG001|STARTED|Overall Study|Patients allocated to the Traditional Hospital Ward|679
8635629|NCT00563186|9676133|FG000|COMPLETED|Overall Study||910
8635630|NCT00563186|9676134|FG001|COMPLETED|Overall Study||604
9008483|NCT02964325|10071212|FG001|STARTED|Overall Study||166
9008484|NCT02964325|10071211|FG000|Full Analysis Set|Overall Study||164
9008485|NCT02964325|10071212|FG001|Full Analysis Set|Overall Study||166
9008486|NCT02964325|10071211|FG000|Modified Intent-to-Treat|Overall Study||145
8635631|NCT00563186|9676133|FG000|NOT COMPLETED|Overall Study||98
8635632|NCT00563186|9676134|FG001|NOT COMPLETED|Overall Study||75
8897243|NCT02043574|9954693|FG000|COMPLETED|Overall Study||19
8897244|NCT02043574|9954694|FG001|COMPLETED|Overall Study||20
9008487|NCT02964325|10071212|FG001|Modified Intent-to-Treat|Overall Study||152
8897245|NCT02043574|9954693|FG000|NOT COMPLETED|Overall Study||6
8897246|NCT02043574|9954694|FG001|NOT COMPLETED|Overall Study||6
8897247|NCT02043652|9954701|FG000|STARTED|Overall Study||119
8897248|NCT02043652|9954701|FG000|COMPLETED|Overall Study||93
9008488|NCT02964325|10071211|FG000|Safety Set|Overall Study||141
9008489|NCT02964325|10071212|FG001|Safety Set|Overall Study||161
9008490|NCT02964325|10071211|FG000|COMPLETED|Overall Study||143
9008491|NCT02964325|10071212|FG001|COMPLETED|Overall Study||143
9008492|NCT02964325|10071211|FG000|NOT COMPLETED|Overall Study||21
9008493|NCT02964325|10071212|FG001|NOT COMPLETED|Overall Study||23
9008494|NCT02964338|10071221|FG000|STARTED|Overall Study||84
9008495|NCT02964338|10071222|FG001|STARTED|Overall Study||88
9008496|NCT02964338|10071223|FG002|STARTED|Overall Study||87
9008497|NCT02964338|10071221|FG000|Safety Analysis Set|Overall Study||83
9008498|NCT02964338|10071222|FG001|Safety Analysis Set|Overall Study||88
8635633|NCT00563290|9676145|FG000|STARTED|Overall Study||3
8897249|NCT02043652|9954701|FG000|NOT COMPLETED|Overall Study||26
8897250|NCT02043704|9954707|FG000|STARTED|Overall Study||50
8897251|NCT02043704|9954708|FG001|STARTED|Overall Study||50
8897252|NCT02043704|9954707|FG000|COMPLETED|Overall Study||47
8897253|NCT02043704|9954708|FG001|COMPLETED|Overall Study||43
8897254|NCT02043704|9954707|FG000|NOT COMPLETED|Overall Study||3
8897255|NCT02043704|9954708|FG001|NOT COMPLETED|Overall Study||7
8897256|NCT02043782|9954714|FG000|STARTED|Period 1||7
8897257|NCT02043782|9954715|FG001|STARTED|Period 1||6
8897258|NCT02043782|9954716|FG002|STARTED|Period 1||7
8897259|NCT02043782|9954717|FG003|STARTED|Period 1||6
8897260|NCT02043782|9954718|FG004|STARTED|Period 1||6
8897261|NCT02043782|9954719|FG005|STARTED|Period 1||6
8897262|NCT02043782|9954714|FG000|COMPLETED|Period 1||7
8897263|NCT02043782|9954715|FG001|COMPLETED|Period 1||6
8897264|NCT02043782|9954716|FG002|COMPLETED|Period 1|One subject discontinued due to an adverse event while testing own product|6
8897265|NCT02043782|9954717|FG003|COMPLETED|Period 1||6
8897266|NCT02043782|9954718|FG004|COMPLETED|Period 1||6
8897267|NCT02043782|9954719|FG005|COMPLETED|Period 1||6
8897268|NCT02043782|9954714|FG000|NOT COMPLETED|Period 1||0
8897269|NCT02043782|9954715|FG001|NOT COMPLETED|Period 1||0
8897270|NCT02043782|9954716|FG002|NOT COMPLETED|Period 1||1
8897271|NCT02043782|9954717|FG003|NOT COMPLETED|Period 1||0
8897272|NCT02043782|9954718|FG004|NOT COMPLETED|Period 1||0
8897273|NCT02043782|9954719|FG005|NOT COMPLETED|Period 1||0
8897274|NCT02043782|9954714|FG000|STARTED|Period 2||7
8897275|NCT02043782|9954715|FG001|STARTED|Period 2||6
8897276|NCT02043782|9954716|FG002|STARTED|Period 2||6
8897277|NCT02043782|9954717|FG003|STARTED|Period 2||6
8897278|NCT02043782|9954718|FG004|STARTED|Period 2||6
8897279|NCT02043782|9954719|FG005|STARTED|Period 2||6
8897280|NCT02043782|9954714|FG000|COMPLETED|Period 2||7
8897281|NCT02043782|9954715|FG001|COMPLETED|Period 2||6
8897282|NCT02043782|9954716|FG002|COMPLETED|Period 2||6
9008499|NCT02964338|10071223|FG002|Safety Analysis Set|Overall Study||87
9008500|NCT02964338|10071221|FG000|Full Analysis Set|Overall Study||81
9008501|NCT02964338|10071222|FG001|Full Analysis Set|Overall Study||86
9008502|NCT02964338|10071223|FG002|Full Analysis Set|Overall Study||87
9008503|NCT02964338|10071221|FG000|COMPLETED|Overall Study||67
9008504|NCT02964338|10071222|FG001|COMPLETED|Overall Study||64
9008505|NCT02964338|10071223|FG002|COMPLETED|Overall Study||68
9008506|NCT02964338|10071221|FG000|NOT COMPLETED|Overall Study||17
9008507|NCT02964338|10071222|FG001|NOT COMPLETED|Overall Study||24
9008508|NCT02964338|10071223|FG002|NOT COMPLETED|Overall Study||19
9008509|NCT02964416|10071233|FG000|STARTED|Overall Study||39
9008510|NCT02964416|10071234|FG001|STARTED|Overall Study||41
9008511|NCT02964416|10071233|FG000|COMPLETED|Overall Study||38
9008512|NCT02964416|10071234|FG001|COMPLETED|Overall Study||41
9008513|NCT02964416|10071233|FG000|NOT COMPLETED|Overall Study||1
9008514|NCT02964416|10071234|FG001|NOT COMPLETED|Overall Study||0
9008515|NCT02964767|10071243|FG000|STARTED|Overall Study||171
9008516|NCT02964767|10071244|FG001|STARTED|Overall Study||48
9008517|NCT02964767|10071243|FG000|COMPLETED|Overall Study||171
9008518|NCT02964767|10071244|FG001|COMPLETED|Overall Study||48
9008519|NCT02964767|10071243|FG000|NOT COMPLETED|Overall Study||0
9008520|NCT02964767|10071244|FG001|NOT COMPLETED|Overall Study||0
9008521|NCT02964910|10071253|FG000|STARTED|Overall Study||235
9008522|NCT02964910|10071254|FG001|STARTED|Overall Study||240
9008523|NCT02964910|10071253|FG000|COMPLETED|Overall Study||192
9008524|NCT02964910|10071254|FG001|COMPLETED|Overall Study||196
9008525|NCT02964910|10071253|FG000|NOT COMPLETED|Overall Study||43
9008526|NCT02964910|10071254|FG001|NOT COMPLETED|Overall Study||44
9008527|NCT02965144|10071262|FG000|STARTED|Overall Study||13
9008528|NCT02965144|10071262|FG000|COMPLETED|Overall Study||13
9008529|NCT02965144|10071262|FG000|NOT COMPLETED|Overall Study||0
9008530|NCT02965378|10071271|FG000|STARTED|Overall Study||25
9008531|NCT02965378|10071272|FG001|STARTED|Overall Study||9
9008532|NCT02965378|10071271|FG000|Participants on Docetaxel Re-registered to AZD4547 After Progression.|Overall Study||0
9008533|NCT02965378|10071272|FG001|Participants on Docetaxel Re-registered to AZD4547 After Progression.|Overall Study||2
9008534|NCT02965378|10071271|FG000|COMPLETED|Overall Study||0
9008535|NCT02965378|10071272|FG001|COMPLETED|Overall Study||0
9008536|NCT02965378|10071271|FG000|NOT COMPLETED|Overall Study||25
9008537|NCT02965378|10071272|FG001|NOT COMPLETED|Overall Study||9
9008538|NCT02965456|10071280|FG000|STARTED|Overall Study||413
9008539|NCT02965456|10071281|FG001|STARTED|Overall Study||407
9008540|NCT02965456|10071280|FG000|Intent-to-treat (ITT) Population|Overall Study||413
9008541|NCT02965456|10071281|FG001|Intent-to-treat (ITT) Population|Overall Study||407
9008542|NCT02965456|10071280|FG000|Safety Population|Overall Study||389
9008543|NCT02965456|10071281|FG001|Safety Population|Overall Study||398
8897283|NCT02043782|9954717|FG003|COMPLETED|Period 2||6
8897284|NCT02043782|9954718|FG004|COMPLETED|Period 2||6
8897285|NCT02043782|9954719|FG005|COMPLETED|Period 2||6
8897286|NCT02043782|9954714|FG000|NOT COMPLETED|Period 2||0
8897287|NCT02043782|9954715|FG001|NOT COMPLETED|Period 2||0
8897288|NCT02043782|9954716|FG002|NOT COMPLETED|Period 2||0
8897289|NCT02043782|9954717|FG003|NOT COMPLETED|Period 2||0
8897290|NCT02043782|9954718|FG004|NOT COMPLETED|Period 2||0
8897291|NCT02043782|9954719|FG005|NOT COMPLETED|Period 2||0
8897292|NCT02043782|9954714|FG000|STARTED|Period 3||7
9008544|NCT02965456|10071280|FG000|COMPLETED|Overall Study||342
9008545|NCT02965456|10071281|FG001|COMPLETED|Overall Study||364
9008546|NCT02965456|10071280|FG000|NOT COMPLETED|Overall Study||71
8897293|NCT02043782|9954715|FG001|STARTED|Period 3||6
8897294|NCT02043782|9954716|FG002|STARTED|Period 3||6
8897295|NCT02043782|9954717|FG003|STARTED|Period 3||6
8897296|NCT02043782|9954718|FG004|STARTED|Period 3||6
8897297|NCT02043782|9954719|FG005|STARTED|Period 3||6
8897298|NCT02043782|9954714|FG000|COMPLETED|Period 3||7
8897299|NCT02043782|9954715|FG001|COMPLETED|Period 3||6
8897300|NCT02043782|9954716|FG002|COMPLETED|Period 3||6
8897301|NCT02043782|9954717|FG003|COMPLETED|Period 3||6
8897302|NCT02043782|9954718|FG004|COMPLETED|Period 3||6
8897303|NCT02043782|9954719|FG005|COMPLETED|Period 3||6
8897304|NCT02043782|9954714|FG000|NOT COMPLETED|Period 3||0
8897305|NCT02043782|9954715|FG001|NOT COMPLETED|Period 3||0
8897306|NCT02043782|9954716|FG002|NOT COMPLETED|Period 3||0
8897307|NCT02043782|9954717|FG003|NOT COMPLETED|Period 3||0
8897308|NCT02043782|9954718|FG004|NOT COMPLETED|Period 3||0
8897309|NCT02043782|9954719|FG005|NOT COMPLETED|Period 3||0
8897310|NCT02043808|9954729|FG000|STARTED|Overall Study||12793
8897311|NCT02043808|9954730|FG001|STARTED|Overall Study||12793
8897312|NCT02043808|9954729|FG000|COMPLETED|Overall Study||12793
8897313|NCT02043808|9954730|FG001|COMPLETED|Overall Study||12793
8897314|NCT02043808|9954729|FG000|NOT COMPLETED|Overall Study||0
8897315|NCT02043808|9954730|FG001|NOT COMPLETED|Overall Study||0
8897316|NCT02043899|9954736|FG000|STARTED|Overall Study||36
8897317|NCT02043899|9954736|FG000|Underwent Routine [123I]mIBG Planar and SPECT/CT Imaging|Overall Study||32
8897318|NCT02043899|9954736|FG000|Underwent [124I]mIBG PET/CT Imaging|Overall Study||9
8897319|NCT02043899|9954736|FG000|COMPLETED|Overall Study||9
8897320|NCT02043899|9954736|FG000|NOT COMPLETED|Overall Study||27
8897321|NCT02043938|9954740|FG000|STARTED|Overall Study||46
8897322|NCT02043938|9954740|FG000|COMPLETED|Overall Study||36
8897323|NCT02043938|9954740|FG000|NOT COMPLETED|Overall Study||10
8897324|NCT02044094|9954747|FG000|STARTED|RBP-6000 Injection 1 (Day 1 to Day 28)||39
8897325|NCT02044094|9954747|FG000|Intent to Treat Population|RBP-6000 Injection 1 (Day 1 to Day 28)|Subjects who receive >=1 dose of RBP-6000 and have >=1 complete sequence of hydromorphone challenges|38
8897326|NCT02044094|9954747|FG000|Completers Population|RBP-6000 Injection 1 (Day 1 to Day 28)|Subjects that reached Day 28 + completed all challenges at Week 4 were considered study completers.|30
8897327|NCT02044094|9954747|FG000|COMPLETED|RBP-6000 Injection 1 (Day 1 to Day 28)||30
8897328|NCT02044094|9954747|FG000|NOT COMPLETED|RBP-6000 Injection 1 (Day 1 to Day 28)||9
8897329|NCT02044094|9954747|FG000|STARTED|RBP-6000 Injection 2 (Day 29 to Week 12)||30
8897330|NCT02044094|9954747|FG000|COMPLETED|RBP-6000 Injection 2 (Day 29 to Week 12)||17
8897331|NCT02044094|9954747|FG000|NOT COMPLETED|RBP-6000 Injection 2 (Day 29 to Week 12)||13
8897332|NCT02044159|9954764|FG000|STARTED|Overall Study||27
8897333|NCT02044159|9954765|FG001|STARTED|Overall Study||30
8897334|NCT02044159|9954764|FG000|COMPLETED|Overall Study||23
8897335|NCT02044159|9954765|FG001|COMPLETED|Overall Study||26
8897336|NCT02044159|9954764|FG000|NOT COMPLETED|Overall Study||4
8897337|NCT02044159|9954765|FG001|NOT COMPLETED|Overall Study||4
8897338|NCT02044367|9954774|FG000|STARTED|Overall Study||9
8897339|NCT02044367|9954775|FG001|STARTED|Overall Study||9
8897340|NCT02044367|9954776|FG002|STARTED|Overall Study||9
8897341|NCT02044367|9954777|FG003|STARTED|Overall Study||9
8897342|NCT02044367|9954778|FG004|STARTED|Overall Study||9
8897343|NCT02044367|9954779|FG005|STARTED|Overall Study||9
8897344|NCT02044367|9954774|FG000|COMPLETED|Overall Study||9
8897345|NCT02044367|9954775|FG001|COMPLETED|Overall Study||9
8897346|NCT02044367|9954776|FG002|COMPLETED|Overall Study||9
8897347|NCT02044367|9954777|FG003|COMPLETED|Overall Study||9
8897348|NCT02044367|9954778|FG004|COMPLETED|Overall Study||9
8897349|NCT02044367|9954779|FG005|COMPLETED|Overall Study||9
8897350|NCT02044367|9954774|FG000|NOT COMPLETED|Overall Study||0
8897351|NCT02044367|9954775|FG001|NOT COMPLETED|Overall Study||0
8897352|NCT02044367|9954776|FG002|NOT COMPLETED|Overall Study||0
8897353|NCT02044367|9954777|FG003|NOT COMPLETED|Overall Study||0
8897354|NCT02044367|9954778|FG004|NOT COMPLETED|Overall Study||0
8897355|NCT02044367|9954779|FG005|NOT COMPLETED|Overall Study||0
8897356|NCT02044380|9954791|FG000|STARTED|Overall Study|Started are the treated patients|14
8897357|NCT02044380|9954791|FG000|COMPLETED|Overall Study||14
8897358|NCT02044380|9954791|FG000|NOT COMPLETED|Overall Study||0
8897359|NCT02044393|9954797|FG000|STARTED|Period 1||10
8897360|NCT02044393|9954798|FG001|STARTED|Period 1||10
8897361|NCT02044393|9954797|FG000|COMPLETED|Period 1||10
8897362|NCT02044393|9954798|FG001|COMPLETED|Period 1||10
8635634|NCT00563290|9676146|FG001|STARTED|Overall Study||4
8635635|NCT00563290|9676145|FG000|COMPLETED|Overall Study||3
8635636|NCT00563290|9676146|FG001|COMPLETED|Overall Study||4
8635637|NCT00563290|9676145|FG000|NOT COMPLETED|Overall Study||0
8635638|NCT00563290|9676146|FG001|NOT COMPLETED|Overall Study||0
8726286|NCT01035099|9773477|FG001|STARTED|Overall Study||22
8897363|NCT02044393|9954797|FG000|NOT COMPLETED|Period 1||0
8897364|NCT02044393|9954798|FG001|NOT COMPLETED|Period 1||0
8897365|NCT02044393|9954797|FG000|STARTED|Period 2||10
8897366|NCT02044393|9954798|FG001|STARTED|Period 2||10
9008547|NCT02965456|10071281|FG001|NOT COMPLETED|Overall Study||43
8897367|NCT02044393|9954797|FG000|COMPLETED|Period 2||10
8897368|NCT02044393|9954798|FG001|COMPLETED|Period 2||10
8897369|NCT02044393|9954797|FG000|NOT COMPLETED|Period 2||0
8897370|NCT02044393|9954798|FG001|NOT COMPLETED|Period 2||0
8897371|NCT02044419|9954811|FG000|STARTED|First Intervention||11
8897372|NCT02044419|9954812|FG001|STARTED|First Intervention||10
8635639|NCT00563316|9676154|FG000|STARTED|Overall Study||28
8726287|NCT01035099|9773476|FG000|COMPLETED|Overall Study||18
8897373|NCT02044419|9954813|FG002|STARTED|First Intervention||11
8897374|NCT02044419|9954811|FG000|COMPLETED|First Intervention||11
8897375|NCT02044419|9954812|FG001|COMPLETED|First Intervention||9
8897376|NCT02044419|9954813|FG002|COMPLETED|First Intervention||10
8897377|NCT02044419|9954811|FG000|NOT COMPLETED|First Intervention||0
8897378|NCT02044419|9954812|FG001|NOT COMPLETED|First Intervention||1
8897379|NCT02044419|9954813|FG002|NOT COMPLETED|First Intervention||1
8897380|NCT02044419|9954811|FG000|STARTED|Second Intervention||11
8897381|NCT02044419|9954812|FG001|STARTED|Second Intervention||9
8897382|NCT02044419|9954813|FG002|STARTED|Second Intervention||10
8897383|NCT02044419|9954811|FG000|COMPLETED|Second Intervention||11
8897384|NCT02044419|9954812|FG001|COMPLETED|Second Intervention||9
8897385|NCT02044419|9954813|FG002|COMPLETED|Second Intervention||10
8897386|NCT02044419|9954811|FG000|NOT COMPLETED|Second Intervention||0
8897387|NCT02044419|9954812|FG001|NOT COMPLETED|Second Intervention||0
8897388|NCT02044419|9954813|FG002|NOT COMPLETED|Second Intervention||0
8897389|NCT02044419|9954811|FG000|STARTED|Third Intervention||11
8897390|NCT02044419|9954812|FG001|STARTED|Third Intervention||9
8897391|NCT02044419|9954813|FG002|STARTED|Third Intervention||10
8897392|NCT02044419|9954811|FG000|COMPLETED|Third Intervention||11
8897393|NCT02044419|9954812|FG001|COMPLETED|Third Intervention||9
8897394|NCT02044419|9954813|FG002|COMPLETED|Third Intervention||10
8897395|NCT02044419|9954811|FG000|NOT COMPLETED|Third Intervention||0
8897396|NCT02044419|9954812|FG001|NOT COMPLETED|Third Intervention||0
8897397|NCT02044419|9954813|FG002|NOT COMPLETED|Third Intervention||0
8897398|NCT02044458|9954823|FG000|STARTED|Overall Study||65
8897399|NCT02044458|9954824|FG001|STARTED|Overall Study||69
8897400|NCT02044458|9954823|FG000|COMPLETED|Overall Study||62
8897401|NCT02044458|9954824|FG001|COMPLETED|Overall Study||61
8897402|NCT02044458|9954823|FG000|NOT COMPLETED|Overall Study||3
8897403|NCT02044458|9954824|FG001|NOT COMPLETED|Overall Study||8
8897404|NCT02044510|9954832|FG000|STARTED|Overall Study||16
8897405|NCT02044510|9954833|FG001|STARTED|Overall Study||16
8897406|NCT02044510|9954832|FG000|COMPLETED|Overall Study||15
8897407|NCT02044510|9954833|FG001|COMPLETED|Overall Study||14
8897408|NCT02044510|9954832|FG000|NOT COMPLETED|Overall Study||1
8897409|NCT02044510|9954833|FG001|NOT COMPLETED|Overall Study||2
8897410|NCT02044796|9954841|FG000|STARTED|Overall Study||9
8897411|NCT02044796|9954842|FG001|STARTED|Overall Study||9
8897412|NCT02044796|9954843|FG002|STARTED|Overall Study||9
8897413|NCT02044796|9954844|FG003|STARTED|Overall Study||6
8897414|NCT02044796|9954845|FG004|STARTED|Overall Study||10
8897415|NCT02044796|9954846|FG005|STARTED|Overall Study||6
8897416|NCT02044796|9954847|FG006|STARTED|Overall Study||6
8897417|NCT02044796|9954848|FG007|STARTED|Overall Study||4
8897418|NCT02044796|9954849|FG008|STARTED|Overall Study||106
8897419|NCT02044796|9954850|FG009|STARTED|Overall Study||34
8897420|NCT02044796|9954841|FG000|COMPLETED|Overall Study||9
8897421|NCT02044796|9954842|FG001|COMPLETED|Overall Study||9
8897422|NCT02044796|9954843|FG002|COMPLETED|Overall Study||9
8897423|NCT02044796|9954844|FG003|COMPLETED|Overall Study||6
8897424|NCT02044796|9954845|FG004|COMPLETED|Overall Study||10
8897425|NCT02044796|9954846|FG005|COMPLETED|Overall Study||6
8897426|NCT02044796|9954847|FG006|COMPLETED|Overall Study||6
8897427|NCT02044796|9954848|FG007|COMPLETED|Overall Study||4
8897428|NCT02044796|9954849|FG008|COMPLETED|Overall Study||106
8897429|NCT02044796|9954850|FG009|COMPLETED|Overall Study||34
8897430|NCT02044796|9954841|FG000|NOT COMPLETED|Overall Study||0
8897431|NCT02044796|9954842|FG001|NOT COMPLETED|Overall Study||0
8897432|NCT02044796|9954843|FG002|NOT COMPLETED|Overall Study||0
8897433|NCT02044796|9954844|FG003|NOT COMPLETED|Overall Study||0
8897434|NCT02044796|9954845|FG004|NOT COMPLETED|Overall Study||0
8897435|NCT02044796|9954846|FG005|NOT COMPLETED|Overall Study||0
8897436|NCT02044796|9954847|FG006|NOT COMPLETED|Overall Study||0
8897437|NCT02044796|9954848|FG007|NOT COMPLETED|Overall Study||0
8897438|NCT02044796|9954849|FG008|NOT COMPLETED|Overall Study||0
8897439|NCT02044796|9954850|FG009|NOT COMPLETED|Overall Study||0
8897440|NCT02044874|9954871|FG000|STARTED|Overall Study||201
8897441|NCT02044874|9954872|FG001|STARTED|Overall Study||202
8897442|NCT02044874|9954873|FG002|STARTED|Overall Study||200
8897443|NCT02044874|9954871|FG000|COMPLETED|Overall Study||171
8897444|NCT02044874|9954872|FG001|COMPLETED|Overall Study||147
8897445|NCT02044874|9954873|FG002|COMPLETED|Overall Study||140
8897446|NCT02044874|9954871|FG000|NOT COMPLETED|Overall Study||30
8897447|NCT02044874|9954872|FG001|NOT COMPLETED|Overall Study||55
8897448|NCT02044874|9954873|FG002|NOT COMPLETED|Overall Study||60
8897449|NCT02044991|9954885|FG000|STARTED|Overall Study||2
8897450|NCT02044991|9954886|FG001|STARTED|Overall Study||0
8897451|NCT02044991|9954885|FG000|COMPLETED|Overall Study||2
8897452|NCT02044991|9954886|FG001|COMPLETED|Overall Study||0
8897453|NCT02044991|9954885|FG000|NOT COMPLETED|Overall Study||0
8897454|NCT02044991|9954886|FG001|NOT COMPLETED|Overall Study||0
8897455|NCT02045095|9954892|FG000|STARTED|Overall Study||3
8897456|NCT02045095|9954893|FG001|STARTED|Overall Study||4
8897457|NCT02045095|9954894|FG002|STARTED|Overall Study||4
8897458|NCT02045095|9954895|FG003|STARTED|Overall Study||4
8897459|NCT02045095|9954896|FG004|STARTED|Overall Study||5
8897460|NCT02045095|9954897|FG005|STARTED|Overall Study||8
8897461|NCT02045095|9954898|FG006|STARTED|Overall Study||1
8897462|NCT02045095|9954892|FG000|COMPLETED|Overall Study||0
8897463|NCT02045095|9954893|FG001|COMPLETED|Overall Study||0
8897464|NCT02045095|9954894|FG002|COMPLETED|Overall Study||0
8897465|NCT02045095|9954895|FG003|COMPLETED|Overall Study||0
8897466|NCT02045095|9954896|FG004|COMPLETED|Overall Study||0
8897467|NCT02045095|9954897|FG005|COMPLETED|Overall Study||0
8897468|NCT02045095|9954898|FG006|COMPLETED|Overall Study||0
8897469|NCT02045095|9954892|FG000|NOT COMPLETED|Overall Study||3
8897470|NCT02045095|9954893|FG001|NOT COMPLETED|Overall Study||4
8897471|NCT02045095|9954894|FG002|NOT COMPLETED|Overall Study||4
8897472|NCT02045095|9954895|FG003|NOT COMPLETED|Overall Study||4
8897473|NCT02045095|9954896|FG004|NOT COMPLETED|Overall Study||5
8897474|NCT02045095|9954897|FG005|NOT COMPLETED|Overall Study||8
8897475|NCT02045095|9954898|FG006|NOT COMPLETED|Overall Study||1
8897476|NCT02045108|9954918|FG000|STARTED|Overall Study||22
8897477|NCT02045108|9954919|FG001|STARTED|Overall Study||15
8897478|NCT02045108|9954920|FG002|STARTED|Overall Study||20
8897479|NCT02045108|9954921|FG003|STARTED|Overall Study||20
8897480|NCT02045108|9954918|FG000|COMPLETED|Overall Study||21
8897481|NCT02045108|9954919|FG001|COMPLETED|Overall Study||12
8897482|NCT02045108|9954920|FG002|COMPLETED|Overall Study||18
8897483|NCT02045108|9954921|FG003|COMPLETED|Overall Study||19
8897484|NCT02045108|9954918|FG000|NOT COMPLETED|Overall Study||1
8897485|NCT02045108|9954919|FG001|NOT COMPLETED|Overall Study||3
8897486|NCT02045108|9954920|FG002|NOT COMPLETED|Overall Study||2
8897487|NCT02045108|9954921|FG003|NOT COMPLETED|Overall Study||1
8897488|NCT02045212|9954933|FG000|STARTED|Overall Study||13
8897489|NCT02045212|9954934|FG001|STARTED|Overall Study||9
8897490|NCT02045212|9954933|FG000|COMPLETED|Overall Study||11
8897491|NCT02045212|9954934|FG001|COMPLETED|Overall Study||8
8897492|NCT02045212|9954933|FG000|NOT COMPLETED|Overall Study||2
8897493|NCT02045212|9954934|FG001|NOT COMPLETED|Overall Study||1
8897494|NCT02045238|9954946|FG000|STARTED|Overall Study||16
8897495|NCT02045238|9954947|FG001|STARTED|Overall Study||15
8897496|NCT02045238|9954946|FG000|COMPLETED|Overall Study||9
8897497|NCT02045238|9954947|FG001|COMPLETED|Overall Study||14
8897498|NCT02045238|9954946|FG000|NOT COMPLETED|Overall Study||7
8897499|NCT02045238|9954947|FG001|NOT COMPLETED|Overall Study||1
8897500|NCT02045264|9954953|FG000|STARTED|Overall Study||12
8897501|NCT02045264|9954953|FG000|COMPLETED|Overall Study||12
8897502|NCT02045264|9954953|FG000|NOT COMPLETED|Overall Study||0
8897503|NCT02045277|9954961|FG000|STARTED|Overall Study||59
8897504|NCT02045277|9954962|FG001|STARTED|Overall Study||63
8897505|NCT02045277|9954963|FG002|STARTED|Overall Study||59
8897506|NCT02045277|9954964|FG003|STARTED|Overall Study||31
8897507|NCT02045277|9954961|FG000|COMPLETED|Overall Study||55
8897508|NCT02045277|9954962|FG001|COMPLETED|Overall Study||62
8897509|NCT02045277|9954963|FG002|COMPLETED|Overall Study||47
8897510|NCT02045277|9954964|FG003|COMPLETED|Overall Study||29
8897511|NCT02045277|9954961|FG000|NOT COMPLETED|Overall Study||4
8897512|NCT02045277|9954962|FG001|NOT COMPLETED|Overall Study||1
8897513|NCT02045277|9954963|FG002|NOT COMPLETED|Overall Study||12
8897514|NCT02045277|9954964|FG003|NOT COMPLETED|Overall Study||2
8897515|NCT02045433|9954974|FG000|STARTED|Overall Study||16
8897516|NCT02045433|9954974|FG000|COMPLETED|Overall Study|Study was Prematurely ended due to toxicity|15
8897517|NCT02045433|9954974|FG000|NOT COMPLETED|Overall Study||1
8897518|NCT02045511|9954980|FG000|STARTED|Overall Study||8
8897519|NCT02045511|9954981|FG001|STARTED|Overall Study||7
8897520|NCT02045511|9954980|FG000|COMPLETED|Overall Study||8
8897521|NCT02045511|9954981|FG001|COMPLETED|Overall Study||7
8897522|NCT02045511|9954980|FG000|NOT COMPLETED|Overall Study||0
8897523|NCT02045511|9954981|FG001|NOT COMPLETED|Overall Study||0
8897524|NCT02045732|9954989|FG000|STARTED|Overall Study||1
8897525|NCT02045732|9954990|FG001|STARTED|Overall Study||3
8897526|NCT02045732|9954989|FG000|COMPLETED|Overall Study||0
8897527|NCT02045732|9954990|FG001|COMPLETED|Overall Study||2
8897528|NCT02045732|9954989|FG000|NOT COMPLETED|Overall Study||1
8897529|NCT02045732|9954990|FG001|NOT COMPLETED|Overall Study||1
8897530|NCT02045836|9954998|FG000|STARTED|Overall Study||432
8897531|NCT02045836|9954999|FG001|STARTED|Overall Study||433
8897532|NCT02045836|9954998|FG000|COMPLETED|Overall Study||423
8897533|NCT02045836|9954999|FG001|COMPLETED|Overall Study||419
8897534|NCT02045836|9954998|FG000|NOT COMPLETED|Overall Study||9
8897535|NCT02045836|9954999|FG001|NOT COMPLETED|Overall Study||14
8897536|NCT02045862|9955009|FG000|STARTED|Overall Study||306
8897537|NCT02045862|9955010|FG001|STARTED|Overall Study||305
8897538|NCT02045862|9955011|FG002|STARTED|Overall Study||1218
8897539|NCT02045862|9955009|FG000|Treated|Overall Study||306
8897540|NCT02045862|9955010|FG001|Treated|Overall Study||303
8897541|NCT02045862|9955011|FG002|Treated|Overall Study||1210
8897542|NCT02045862|9955009|FG000|COMPLETED|Overall Study||267
8897543|NCT02045862|9955010|FG001|COMPLETED|Overall Study||265
8897544|NCT02045862|9955011|FG002|COMPLETED|Overall Study||1092
8897545|NCT02045862|9955009|FG000|NOT COMPLETED|Overall Study||39
8897546|NCT02045862|9955010|FG001|NOT COMPLETED|Overall Study||40
8897547|NCT02045862|9955011|FG002|NOT COMPLETED|Overall Study||126
8897548|NCT02045875|9955021|FG000|STARTED|Overall Study||27
8897549|NCT02045875|9955022|FG001|STARTED|Overall Study||23
8897550|NCT02045875|9955021|FG000|COMPLETED|Overall Study||20
8897551|NCT02045875|9955022|FG001|COMPLETED|Overall Study||20
8897552|NCT02045875|9955021|FG000|NOT COMPLETED|Overall Study||7
8897553|NCT02045875|9955022|FG001|NOT COMPLETED|Overall Study||3
8897554|NCT02045979|9955031|FG000|STARTED|Overall Study|1 subject (not included to the 108) was randomized but did never take any study medication.|108
8897555|NCT02045979|9955032|FG001|STARTED|Overall Study|1 subject (not included to the 108) was randomized but did never take any study medication..|108
8897556|NCT02045979|9955033|FG002|STARTED|Overall Study|1 subject (not included to the 108) was randomized but did never take any study medication.|108
8897557|NCT02045979|9955031|FG000|COMPLETED|Overall Study||106
8897558|NCT02045979|9955032|FG001|COMPLETED|Overall Study||107
8897559|NCT02045979|9955033|FG002|COMPLETED|Overall Study||107
8897560|NCT02045979|9955031|FG000|NOT COMPLETED|Overall Study||2
8897561|NCT02045979|9955032|FG001|NOT COMPLETED|Overall Study||1
8897562|NCT02045979|9955033|FG002|NOT COMPLETED|Overall Study||1
8897563|NCT02046005|9955044|FG000|STARTED|Overall Study||80
8897564|NCT02046005|9955045|FG001|STARTED|Overall Study||78
8897565|NCT02046005|9955046|FG002|STARTED|Overall Study||80
8897566|NCT02046005|9955044|FG000|COMPLETED|Overall Study||72
8897567|NCT02046005|9955045|FG001|COMPLETED|Overall Study||71
8897568|NCT02046005|9955046|FG002|COMPLETED|Overall Study||70
8897569|NCT02046005|9955044|FG000|NOT COMPLETED|Overall Study||8
8897570|NCT02046005|9955045|FG001|NOT COMPLETED|Overall Study||7
8897571|NCT02046005|9955046|FG002|NOT COMPLETED|Overall Study||10
8897572|NCT02046070|9955057|FG000|STARTED|Overall Study||36
8897573|NCT02046070|9955058|FG001|STARTED|Overall Study||34
8897574|NCT02046070|9955059|FG002|STARTED|Overall Study||78
8897575|NCT02046070|9955057|FG000|COMPLETED|Overall Study||4
8572791|NCT00117143|9604979|FG001|Received Second Dose|Overall Study||4
8572792|NCT00117143|9604980|FG002|Received Second Dose|Overall Study||6
8572793|NCT00117143|9604981|FG003|Received Second Dose|Overall Study||0
8572794|NCT00117143|9604978|FG000|COMPLETED|Overall Study||4
8572795|NCT00117143|9604979|FG001|COMPLETED|Overall Study||4
8572796|NCT00117143|9604980|FG002|COMPLETED|Overall Study||7
8572797|NCT00117143|9604981|FG003|COMPLETED|Overall Study||1
8572798|NCT00117143|9604978|FG000|NOT COMPLETED|Overall Study||0
8572799|NCT00117143|9604979|FG001|NOT COMPLETED|Overall Study||0
8572800|NCT00117143|9604980|FG002|NOT COMPLETED|Overall Study||0
8572801|NCT00117143|9604981|FG003|NOT COMPLETED|Overall Study||0
8572802|NCT00117156|9604991|FG000|STARTED|Overall Study||26
8572803|NCT00117156|9604991|FG000|COMPLETED|Overall Study||15
8572804|NCT00117156|9604991|FG000|NOT COMPLETED|Overall Study||11
8572805|NCT00117286|9604997|FG000|STARTED|Overall Study|Safety analysis set|30
8572806|NCT00117286|9604998|FG001|STARTED|Overall Study||27
8572807|NCT00117286|9604997|FG000|Switched to Higher Dose|Overall Study|A protocol amendment changed the dosage to 160 mg (40 mg/mL)|17
8572808|NCT00117286|9604998|FG001|Switched to Higher Dose|Overall Study||17
8572809|NCT00117286|9604997|FG000|COMPLETED|Overall Study|Participants ongoing at the time of study closure were considered to have completed the study|2
8572810|NCT00117286|9604998|FG001|COMPLETED|Overall Study||6
8572811|NCT00117286|9604997|FG000|NOT COMPLETED|Overall Study||28
8572812|NCT00117286|9604998|FG001|NOT COMPLETED|Overall Study||21
8572813|NCT00117312|9605008|FG000|STARTED|Overall Study||10
8572814|NCT00117312|9605009|FG001|STARTED|Overall Study||24
8572815|NCT00117312|9605010|FG002|STARTED|Overall Study||24
8572816|NCT00117312|9605011|FG003|STARTED|Overall Study||24
8572817|NCT00117312|9605008|FG000|Started FE200486 CS06A|Overall Study||1
8572818|NCT00117312|9605009|FG001|Started FE200486 CS06A|Overall Study||11
8572819|NCT00117312|9605010|FG002|Started FE200486 CS06A|Overall Study||16
8572820|NCT00117312|9605011|FG003|Started FE200486 CS06A|Overall Study||9
8572821|NCT00117312|9605008|FG000|COMPLETED|Overall Study||0
8572822|NCT00117312|9605009|FG001|COMPLETED|Overall Study|Defined as those patients ongoing when the extension study was terminated|4
8897576|NCT02046070|9955058|FG001|COMPLETED|Overall Study||6
8897577|NCT02046070|9955059|FG002|COMPLETED|Overall Study||8
8897578|NCT02046070|9955057|FG000|NOT COMPLETED|Overall Study||32
8897579|NCT02046070|9955058|FG001|NOT COMPLETED|Overall Study||28
8897580|NCT02046070|9955059|FG002|NOT COMPLETED|Overall Study||70
8897581|NCT02046122|9955067|FG000|STARTED|Overall Study||17
8897582|NCT02046122|9955067|FG000|COMPLETED|Overall Study||8
8897583|NCT02046122|9955067|FG000|NOT COMPLETED|Overall Study||9
8897584|NCT02046135|9955073|FG000|STARTED|Overall Study||26
8897585|NCT02046135|9955074|FG001|STARTED|Overall Study||25
8897586|NCT02046135|9955073|FG000|COMPLETED|Overall Study||26
9008548|NCT02965534|10071287|FG000|STARTED|Overall Study|test period: 14 days with each test glasses|45
9008549|NCT02965534|10071288|FG001|STARTED|Overall Study|test period: 14 days with each test glasses|55
9008550|NCT02965534|10071287|FG000|COMPLETED|Overall Study||45
9008551|NCT02965534|10071288|FG001|COMPLETED|Overall Study||55
9008552|NCT02965534|10071287|FG000|NOT COMPLETED|Overall Study||0
9008553|NCT02965534|10071288|FG001|NOT COMPLETED|Overall Study||0
9008554|NCT02965573|10071297|FG000|STARTED|Overall Study||12
9008555|NCT02965573|10071298|FG001|STARTED|Overall Study||12
9008556|NCT02965573|10071297|FG000|COMPLETED|Overall Study||11
9008557|NCT02965573|10071298|FG001|COMPLETED|Overall Study||12
9008558|NCT02965573|10071297|FG000|NOT COMPLETED|Overall Study||1
9008559|NCT02965573|10071298|FG001|NOT COMPLETED|Overall Study||0
9008560|NCT02965599|10071306|FG000|STARTED|Overall Study||2
9008561|NCT02965599|10071307|FG001|STARTED|Overall Study||1
9008562|NCT02965599|10071306|FG000|COMPLETED|Overall Study||1
9008563|NCT02965599|10071307|FG001|COMPLETED|Overall Study||1
8635640|NCT00563316|9676154|FG000|Received Investigational Product|Overall Study||27
8635641|NCT00563316|9676154|FG000|COMPLETED|Overall Study||16
8635642|NCT00563316|9676154|FG000|NOT COMPLETED|Overall Study||12
8635643|NCT00563368|9676169|FG000|STARTED|Overall Study||109
8635644|NCT00563368|9676170|FG001|STARTED|Overall Study||109
8635645|NCT00563368|9676171|FG002|STARTED|Overall Study||108
8635646|NCT00563368|9676172|FG003|STARTED|Overall Study||107
8897587|NCT02046135|9955074|FG001|COMPLETED|Overall Study||25
8897588|NCT02046135|9955073|FG000|NOT COMPLETED|Overall Study||0
8897589|NCT02046135|9955074|FG001|NOT COMPLETED|Overall Study||0
8897590|NCT02046148|9955082|FG000|STARTED|Overall Study||49
8897591|NCT02046148|9955083|FG001|STARTED|Overall Study||26
8897592|NCT02046148|9955082|FG000|COMPLETED|Overall Study||48
8897593|NCT02046148|9955083|FG001|COMPLETED|Overall Study||23
8897594|NCT02046148|9955082|FG000|NOT COMPLETED|Overall Study||1
8897595|NCT02046148|9955083|FG001|NOT COMPLETED|Overall Study||3
8897596|NCT02046174|9955089|FG000|STARTED|Overall Study||42
8897597|NCT02046174|9955090|FG001|STARTED|Overall Study||3
8897598|NCT02046174|9955089|FG000|COMPLETED|Overall Study||41
8897599|NCT02046174|9955090|FG001|COMPLETED|Overall Study||3
8897600|NCT02046174|9955089|FG000|NOT COMPLETED|Overall Study||1
8897601|NCT02046174|9955090|FG001|NOT COMPLETED|Overall Study||0
8897602|NCT02046200|9955175|FG000|STARTED|First Intervention (1 Day)||5
8897603|NCT02046200|9955176|FG001|STARTED|First Intervention (1 Day)||6
8897604|NCT02046200|9955175|FG000|COMPLETED|First Intervention (1 Day)||5
8897605|NCT02046200|9955176|FG001|COMPLETED|First Intervention (1 Day)||6
8897606|NCT02046200|9955175|FG000|NOT COMPLETED|First Intervention (1 Day)||0
8897607|NCT02046200|9955176|FG001|NOT COMPLETED|First Intervention (1 Day)||0
8897608|NCT02046200|9955175|FG000|STARTED|Second Intervention (1 Day)||5
8897609|NCT02046200|9955176|FG001|STARTED|Second Intervention (1 Day)||6
8897610|NCT02046200|9955175|FG000|COMPLETED|Second Intervention (1 Day)||5
8897611|NCT02046200|9955176|FG001|COMPLETED|Second Intervention (1 Day)||6
8897612|NCT02046200|9955175|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
8897613|NCT02046200|9955176|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
8897614|NCT02046265|9955194|FG000|STARTED|Overall Study||17
8897615|NCT02046265|9955195|FG001|STARTED|Overall Study||17
8897616|NCT02046265|9955196|FG002|STARTED|Overall Study||12
8897617|NCT02046265|9955197|FG003|STARTED|Overall Study||14
8897618|NCT02046265|9955194|FG000|COMPLETED|Overall Study||16
8897619|NCT02046265|9955195|FG001|COMPLETED|Overall Study||15
8897620|NCT02046265|9955196|FG002|COMPLETED|Overall Study||10
8897621|NCT02046265|9955197|FG003|COMPLETED|Overall Study||12
8897622|NCT02046265|9955194|FG000|NOT COMPLETED|Overall Study||1
8897623|NCT02046265|9955195|FG001|NOT COMPLETED|Overall Study||2
8897624|NCT02046265|9955196|FG002|NOT COMPLETED|Overall Study||2
8897625|NCT02046265|9955197|FG003|NOT COMPLETED|Overall Study||2
8897626|NCT02046317|9955209|FG000|STARTED|Overall Study||4
8897627|NCT02046317|9955210|FG001|STARTED|Overall Study||8
8897628|NCT02046317|9955209|FG000|COMPLETED|Overall Study||4
8897629|NCT02046317|9955210|FG001|COMPLETED|Overall Study||8
8897630|NCT02046317|9955209|FG000|NOT COMPLETED|Overall Study||0
8897631|NCT02046317|9955210|FG001|NOT COMPLETED|Overall Study||0
8897632|NCT02046369|9955218|FG000|STARTED|Overall Study||176
8897633|NCT02046369|9955219|FG001|STARTED|Overall Study||174
8897634|NCT02046369|9955218|FG000|COMPLETED|Overall Study||162
8897635|NCT02046369|9955219|FG001|COMPLETED|Overall Study||156
8897636|NCT02046369|9955218|FG000|NOT COMPLETED|Overall Study||14
9008564|NCT02965599|10071306|FG000|NOT COMPLETED|Overall Study||1
8897637|NCT02046369|9955219|FG001|NOT COMPLETED|Overall Study||18
8897638|NCT02046382|9955227|FG000|STARTED|Overall Study||65
8897639|NCT02046382|9955228|FG001|STARTED|Overall Study||67
8897640|NCT02046382|9955227|FG000|COMPLETED|Overall Study||57
8897641|NCT02046382|9955228|FG001|COMPLETED|Overall Study||47
8897642|NCT02046382|9955227|FG000|NOT COMPLETED|Overall Study||8
8897643|NCT02046382|9955228|FG001|NOT COMPLETED|Overall Study||20
8897644|NCT02046525|9955236|FG000|STARTED|Overall Study||5
8897645|NCT02046525|9955237|FG001|STARTED|Overall Study||5
8897646|NCT02046525|9955236|FG000|COMPLETED|Overall Study||5
8897647|NCT02046525|9955237|FG001|COMPLETED|Overall Study||5
8897648|NCT02046525|9955236|FG000|NOT COMPLETED|Overall Study||0
8897649|NCT02046525|9955237|FG001|NOT COMPLETED|Overall Study||0
8897650|NCT02046564|9955245|FG000|STARTED|Overall Study||209
8897651|NCT02046564|9955246|FG001|STARTED|Overall Study||203
8897652|NCT02046564|9955245|FG000|COMPLETED|Overall Study||194
8897653|NCT02046564|9955246|FG001|COMPLETED|Overall Study||183
8897654|NCT02046564|9955245|FG000|NOT COMPLETED|Overall Study||15
8897655|NCT02046564|9955246|FG001|NOT COMPLETED|Overall Study||20
8897656|NCT02046603|9955254|FG000|STARTED|Overall Study||22
8897657|NCT02046603|9955255|FG001|STARTED|Overall Study||140
8897658|NCT02046603|9955254|FG000|Received at Least 1 Dose of Tocilizumab|Overall Study||21
8897659|NCT02046603|9955255|FG001|Received at Least 1 Dose of Tocilizumab|Overall Study||140
8897660|NCT02046603|9955254|FG000|COMPLETED|Overall Study||7
8897661|NCT02046603|9955255|FG001|COMPLETED|Overall Study||65
8897662|NCT02046603|9955254|FG000|NOT COMPLETED|Overall Study||15
8897663|NCT02046603|9955255|FG001|NOT COMPLETED|Overall Study||75
8897664|NCT02046616|9955262|FG000|STARTED|24-Week Treatment Period||133
8897665|NCT02046616|9955262|FG000|COMPLETED|24-Week Treatment Period||114
9008565|NCT02965599|10071307|FG001|NOT COMPLETED|Overall Study||0
9008566|NCT02965781|10071317|FG000|STARTED|Overall Study||46
9008567|NCT02965781|10071318|FG001|STARTED|Overall Study||46
9008568|NCT02965781|10071319|FG002|STARTED|Overall Study||47
9008569|NCT02965781|10071317|FG000|COMPLETED|Overall Study||46
9008570|NCT02965781|10071318|FG001|COMPLETED|Overall Study||46
9008571|NCT02965781|10071319|FG002|COMPLETED|Overall Study||47
9008572|NCT02965781|10071317|FG000|NOT COMPLETED|Overall Study||0
9008573|NCT02965781|10071318|FG001|NOT COMPLETED|Overall Study||0
9008574|NCT02965781|10071319|FG002|NOT COMPLETED|Overall Study||0
9008575|NCT02965820|10071327|FG000|STARTED|Period 1, First 30 Days||59
9008576|NCT02965820|10071328|FG001|STARTED|Period 1, First 30 Days||62
9008577|NCT02965820|10071327|FG000|COMPLETED|Period 1, First 30 Days||59
9008578|NCT02965820|10071328|FG001|COMPLETED|Period 1, First 30 Days||62
9008579|NCT02965820|10071327|FG000|NOT COMPLETED|Period 1, First 30 Days||0
9008580|NCT02965820|10071328|FG001|NOT COMPLETED|Period 1, First 30 Days||0
9008581|NCT02965820|10071327|FG000|STARTED|Period 2, Second 30 Days|One subject discontinued due to an AE after completion of Period 1 but before beginning Period 2.|58
9008582|NCT02965820|10071328|FG001|STARTED|Period 2, Second 30 Days||62
9008583|NCT02965820|10071327|FG000|COMPLETED|Period 2, Second 30 Days||57
9008584|NCT02965820|10071328|FG001|COMPLETED|Period 2, Second 30 Days||61
9008585|NCT02965820|10071327|FG000|NOT COMPLETED|Period 2, Second 30 Days||1
9008586|NCT02965820|10071328|FG001|NOT COMPLETED|Period 2, Second 30 Days||1
9008587|NCT02965833|10071334|FG000|STARTED|Period 1, First 30 Days of Wear||67
9008588|NCT02965833|10071335|FG001|STARTED|Period 1, First 30 Days of Wear||54
9008589|NCT02965833|10071334|FG000|COMPLETED|Period 1, First 30 Days of Wear||64
9008590|NCT02965833|10071335|FG001|COMPLETED|Period 1, First 30 Days of Wear||52
9008591|NCT02965833|10071334|FG000|NOT COMPLETED|Period 1, First 30 Days of Wear||3
9008592|NCT02965833|10071335|FG001|NOT COMPLETED|Period 1, First 30 Days of Wear||2
9008593|NCT02965833|10071334|FG000|STARTED|Period 2, Second 30 Days of Wear||64
9008594|NCT02965833|10071335|FG001|STARTED|Period 2, Second 30 Days of Wear||52
9008595|NCT02965833|10071334|FG000|COMPLETED|Period 2, Second 30 Days of Wear||62
9008596|NCT02965833|10071335|FG001|COMPLETED|Period 2, Second 30 Days of Wear||52
9008597|NCT02965833|10071334|FG000|NOT COMPLETED|Period 2, Second 30 Days of Wear||2
9008598|NCT02965833|10071335|FG001|NOT COMPLETED|Period 2, Second 30 Days of Wear||0
9008599|NCT02965924|10071341|FG000|STARTED|Overall Study||20
9008600|NCT02965924|10071341|FG000|COMPLETED|Overall Study||20
9008601|NCT02965924|10071341|FG000|NOT COMPLETED|Overall Study||0
9008602|NCT02965989|10071347|FG000|STARTED|Overall Study||26
8635647|NCT00563368|9676173|FG004|STARTED|Overall Study||108
8635648|NCT00563368|9676174|FG005|STARTED|Overall Study||107
8635649|NCT00563368|9676175|FG006|STARTED|Overall Study||108
8635650|NCT00563368|9676169|FG000|COMPLETED|Overall Study||74
8635651|NCT00563368|9676170|FG001|COMPLETED|Overall Study||79
8635652|NCT00563368|9676171|FG002|COMPLETED|Overall Study||78
8897666|NCT02046616|9955262|FG000|NOT COMPLETED|24-Week Treatment Period||19
8897667|NCT02046616|9955262|FG000|STARTED|8-Week FU Period||114
8897668|NCT02046616|9955262|FG000|COMPLETED|8-Week FU Period||113
8897669|NCT02046616|9955262|FG000|NOT COMPLETED|8-Week FU Period||1
8897670|NCT02046772|9955268|FG000|STARTED|Overall Study||30
8897671|NCT02046772|9955269|FG001|STARTED|Overall Study||33
8897672|NCT02046772|9955268|FG000|COMPLETED|Overall Study||30
9008603|NCT02965989|10071348|FG001|STARTED|Overall Study||22
9008604|NCT02965989|10071347|FG000|COMPLETED|Overall Study||26
9008605|NCT02965989|10071348|FG001|COMPLETED|Overall Study||22
9008606|NCT02965989|10071347|FG000|NOT COMPLETED|Overall Study||0
9008607|NCT02965989|10071348|FG001|NOT COMPLETED|Overall Study||0
9008608|NCT02966002|10071360|FG000|STARTED|Overall Study||9
9008609|NCT02966002|10071360|FG000|COMPLETED|Overall Study||5
9008610|NCT02966002|10071360|FG000|NOT COMPLETED|Overall Study||4
8897673|NCT02046772|9955269|FG001|COMPLETED|Overall Study||33
8897674|NCT02046772|9955268|FG000|NOT COMPLETED|Overall Study||0
8897675|NCT02046772|9955269|FG001|NOT COMPLETED|Overall Study||0
8897676|NCT02046863|9955275|FG000|STARTED|Overall Study||7
8897677|NCT02046863|9955275|FG000|COMPLETED|Overall Study||7
8897678|NCT02046863|9955275|FG000|NOT COMPLETED|Overall Study||0
8897679|NCT02046902|9955282|FG000|STARTED|Overall Study||336
8897680|NCT02046902|9955283|FG001|STARTED|Overall Study||113
8897681|NCT02046902|9955284|FG002|STARTED|Overall Study||137
8897682|NCT02046902|9955282|FG000|COMPLETED|Overall Study||336
8897683|NCT02046902|9955283|FG001|COMPLETED|Overall Study||113
8897684|NCT02046902|9955284|FG002|COMPLETED|Overall Study||137
8897685|NCT02046902|9955282|FG000|NOT COMPLETED|Overall Study||0
8897686|NCT02046902|9955283|FG001|NOT COMPLETED|Overall Study||0
8897687|NCT02046902|9955284|FG002|NOT COMPLETED|Overall Study||0
9008611|NCT02966015|10071366|FG000|STARTED|Inclusion Visit||95
9008612|NCT02966015|10071367|FG001|STARTED|Inclusion Visit||58
9008613|NCT02966015|10071366|FG000|COMPLETED|Inclusion Visit||87
9008614|NCT02966015|10071367|FG001|COMPLETED|Inclusion Visit||55
9008615|NCT02966015|10071366|FG000|NOT COMPLETED|Inclusion Visit||8
9008616|NCT02966015|10071367|FG001|NOT COMPLETED|Inclusion Visit||3
9008617|NCT02966015|10071366|FG000|STARTED|Test Period||87
9008618|NCT02966015|10071367|FG001|STARTED|Test Period||55
9008619|NCT02966015|10071366|FG000|COMPLETED|Test Period||87
9008620|NCT02966015|10071367|FG001|COMPLETED|Test Period||55
9008621|NCT02966015|10071366|FG000|NOT COMPLETED|Test Period||0
9008622|NCT02966015|10071367|FG001|NOT COMPLETED|Test Period||0
9008623|NCT02966028|10071376|FG000|STARTED|Overall Study||92
9008624|NCT02966028|10071377|FG001|STARTED|Overall Study||91
9008625|NCT02966028|10071378|FG002|STARTED|Overall Study||91
9008626|NCT02966028|10071376|FG000|COMPLETED|Overall Study||68
9008627|NCT02966028|10071377|FG001|COMPLETED|Overall Study||57
9008628|NCT02966028|10071378|FG002|COMPLETED|Overall Study||60
9008629|NCT02966028|10071376|FG000|NOT COMPLETED|Overall Study||24
9008630|NCT02966028|10071377|FG001|NOT COMPLETED|Overall Study||34
9008631|NCT02966028|10071378|FG002|NOT COMPLETED|Overall Study||31
9008632|NCT02966275|10071390|FG000|STARTED|Overall Study||10
9008633|NCT02966275|10071390|FG000|COMPLETED|Overall Study||10
9008634|NCT02966275|10071390|FG000|NOT COMPLETED|Overall Study||0
9008635|NCT02966314|10071399|FG000|STARTED|Overall Study||5
9008636|NCT02966314|10071400|FG001|STARTED|Overall Study||5
9008637|NCT02966314|10071399|FG000|COMPLETED|Overall Study||4
9008638|NCT02966314|10071400|FG001|COMPLETED|Overall Study||5
9008639|NCT02966314|10071399|FG000|NOT COMPLETED|Overall Study||1
9008640|NCT02966314|10071400|FG001|NOT COMPLETED|Overall Study||0
9008641|NCT02966340|10071406|FG000|STARTED|Overall Study||37
9008642|NCT02966340|10071407|FG001|STARTED|Overall Study||33
9008643|NCT02966340|10071406|FG000|COMPLETED|Overall Study||34
9008644|NCT02966340|10071407|FG001|COMPLETED|Overall Study||30
9008645|NCT02966340|10071406|FG000|NOT COMPLETED|Overall Study||3
9008646|NCT02966340|10071407|FG001|NOT COMPLETED|Overall Study||3
9008647|NCT02966353|10071413|FG000|STARTED|Overall Study||51
9008648|NCT02966353|10071413|FG000|Completed After Data Cutoff|Overall Study||1
9008649|NCT02966353|10071413|FG000|COMPLETED|Overall Study||29
9008650|NCT02966353|10071413|FG000|NOT COMPLETED|Overall Study||22
9008651|NCT02966509|10071419|FG000|STARTED|Baseline Satisfaction Survey||105
9008652|NCT02966509|10071420|FG001|STARTED|Baseline Satisfaction Survey||108
9008653|NCT02966509|10071419|FG000|COMPLETED|Baseline Satisfaction Survey||101
8572823|NCT00117312|9605010|FG002|COMPLETED|Overall Study||0
8572824|NCT00117312|9605011|FG003|COMPLETED|Overall Study||3
8572825|NCT00117312|9605008|FG000|NOT COMPLETED|Overall Study||10
8572826|NCT00117312|9605009|FG001|NOT COMPLETED|Overall Study||20
8572827|NCT00117312|9605010|FG002|NOT COMPLETED|Overall Study||24
8572828|NCT00117312|9605011|FG003|NOT COMPLETED|Overall Study||21
8572829|NCT00117325|9605023|FG000|STARTED|Overall Study||173
8572830|NCT00117325|9605024|FG001|STARTED|Overall Study||179
8572831|NCT00117325|9605023|FG000|COMPLETED|Overall Study||160
8572832|NCT00117325|9605024|FG001|COMPLETED|Overall Study||167
8897688|NCT02046941|9955292|FG000|STARTED|Overall Study||17
8897689|NCT02046941|9955292|FG000|COMPLETED|Overall Study||10
8897690|NCT02046941|9955292|FG000|NOT COMPLETED|Overall Study||7
8897691|NCT02046980|9955299|FG000|STARTED|Overall Study||72
8897692|NCT02046980|9955300|FG001|STARTED|Overall Study||72
8897693|NCT02046980|9955301|FG002|STARTED|Overall Study||73
8897694|NCT02046980|9955299|FG000|COMPLETED|Overall Study||70
8897695|NCT02046980|9955300|FG001|COMPLETED|Overall Study||67
8897696|NCT02046980|9955301|FG002|COMPLETED|Overall Study||72
8897697|NCT02046980|9955299|FG000|NOT COMPLETED|Overall Study||2
8897698|NCT02046980|9955300|FG001|NOT COMPLETED|Overall Study||5
8897699|NCT02046980|9955301|FG002|NOT COMPLETED|Overall Study||1
9008654|NCT02966509|10071420|FG001|COMPLETED|Baseline Satisfaction Survey||101
9008655|NCT02966509|10071419|FG000|NOT COMPLETED|Baseline Satisfaction Survey||4
9008656|NCT02966509|10071420|FG001|NOT COMPLETED|Baseline Satisfaction Survey||7
9008657|NCT02966509|10071419|FG000|STARTED|6 Month Satisfaction Decision Survey||105
9008658|NCT02966509|10071420|FG001|STARTED|6 Month Satisfaction Decision Survey||108
9008659|NCT02966509|10071419|FG000|COMPLETED|6 Month Satisfaction Decision Survey||80
9008660|NCT02966509|10071420|FG001|COMPLETED|6 Month Satisfaction Decision Survey||77
9008661|NCT02966509|10071419|FG000|NOT COMPLETED|6 Month Satisfaction Decision Survey||25
9008662|NCT02966509|10071420|FG001|NOT COMPLETED|6 Month Satisfaction Decision Survey||31
9008663|NCT02966509|10071419|FG000|STARTED|6 Month Satisfaction Survey||105
8897700|NCT02046993|9955311|FG000|STARTED|Overall Study||105
8897701|NCT02046993|9955312|FG001|STARTED|Overall Study||105
8897702|NCT02046993|9955311|FG000|3rd Month|Overall Study||104
8897703|NCT02046993|9955312|FG001|3rd Month|Overall Study||97
8897704|NCT02046993|9955311|FG000|6th Month|Overall Study||102
8897705|NCT02046993|9955312|FG001|6th Month|Overall Study||94
8897706|NCT02046993|9955311|FG000|COMPLETED|Overall Study||102
8897707|NCT02046993|9955312|FG001|COMPLETED|Overall Study||94
8897708|NCT02046993|9955311|FG000|NOT COMPLETED|Overall Study||3
8897709|NCT02046993|9955312|FG001|NOT COMPLETED|Overall Study||11
8897710|NCT02047032|9955322|FG000|STARTED|Overall Study||250
8897711|NCT02047032|9955323|FG001|STARTED|Overall Study||250
8897712|NCT02047032|9955322|FG000|COMPLETED|Overall Study||245
8897713|NCT02047032|9955323|FG001|COMPLETED|Overall Study||235
8897714|NCT02047032|9955322|FG000|NOT COMPLETED|Overall Study||5
8897715|NCT02047032|9955323|FG001|NOT COMPLETED|Overall Study||15
8897716|NCT02047045|9955333|FG000|STARTED|Baseline||280
8897717|NCT02047045|9955334|FG001|STARTED|Baseline||280
8897718|NCT02047045|9955333|FG000|COMPLETED|Baseline||277
8897719|NCT02047045|9955334|FG001|COMPLETED|Baseline||278
8897720|NCT02047045|9955333|FG000|NOT COMPLETED|Baseline||3
8897721|NCT02047045|9955334|FG001|NOT COMPLETED|Baseline||2
8897722|NCT02047045|9955333|FG000|STARTED|Treatment Period (8 Weeks )||277
8897723|NCT02047045|9955334|FG001|STARTED|Treatment Period (8 Weeks )||278
8897724|NCT02047045|9955333|FG000|COMPLETED|Treatment Period (8 Weeks )||266
8897725|NCT02047045|9955334|FG001|COMPLETED|Treatment Period (8 Weeks )||263
8897726|NCT02047045|9955333|FG000|NOT COMPLETED|Treatment Period (8 Weeks )||11
8897727|NCT02047045|9955334|FG001|NOT COMPLETED|Treatment Period (8 Weeks )||15
8897728|NCT02047045|9955333|FG000|STARTED|Follow-up Period (24 Weeks)||266
8897729|NCT02047045|9955334|FG001|STARTED|Follow-up Period (24 Weeks)||263
8897730|NCT02047045|9955333|FG000|COMPLETED|Follow-up Period (24 Weeks)||265
8897731|NCT02047045|9955334|FG001|COMPLETED|Follow-up Period (24 Weeks)||262
8897732|NCT02047045|9955333|FG000|NOT COMPLETED|Follow-up Period (24 Weeks)||1
8897733|NCT02047045|9955334|FG001|NOT COMPLETED|Follow-up Period (24 Weeks)||1
8897734|NCT02047110|9955344|FG000|STARTED|DB Treatment Period up to Week 24|Started are the treated patients|40
8897735|NCT02047110|9955345|FG001|STARTED|DB Treatment Period up to Week 24|Started are the treated patients|40
8897736|NCT02047110|9955346|FG002|STARTED|DB Treatment Period up to Week 24|Started are the treated patients|39
8897737|NCT02047110|9955347|FG003|STARTED|DB Treatment Period up to Week 24|Started are the treated patients|40
8897738|NCT02047110|9955344|FG000|COMPLETED|DB Treatment Period up to Week 24||35
8897739|NCT02047110|9955345|FG001|COMPLETED|DB Treatment Period up to Week 24||38
8897740|NCT02047110|9955346|FG002|COMPLETED|DB Treatment Period up to Week 24||36
8897741|NCT02047110|9955347|FG003|COMPLETED|DB Treatment Period up to Week 24||38
8897742|NCT02047110|9955344|FG000|NOT COMPLETED|DB Treatment Period up to Week 24||5
8897743|NCT02047110|9955345|FG001|NOT COMPLETED|DB Treatment Period up to Week 24||2
8897744|NCT02047110|9955346|FG002|NOT COMPLETED|DB Treatment Period up to Week 24||3
8897745|NCT02047110|9955347|FG003|NOT COMPLETED|DB Treatment Period up to Week 24||2
8897746|NCT02047110|9955344|FG000|STARTED|DB (Week 12 up to Week 24)|Patients who continued treatment in the DB treatment period up to Week 24|9
8897747|NCT02047110|9955345|FG001|STARTED|DB (Week 12 up to Week 24)|Patients who continued treatment in the DB treatment period up to Week 24|17
8897748|NCT02047110|9955346|FG002|STARTED|DB (Week 12 up to Week 24)|Patients who continued treatment in the DB treatment period up to Week 24|13
8897749|NCT02047110|9955347|FG003|STARTED|DB (Week 12 up to Week 24)|Patients who continued treatment in the DB treatment period up to Week 24|12
8897750|NCT02047110|9955344|FG000|COMPLETED|DB (Week 12 up to Week 24)||9
8897751|NCT02047110|9955345|FG001|COMPLETED|DB (Week 12 up to Week 24)||15
8897752|NCT02047110|9955346|FG002|COMPLETED|DB (Week 12 up to Week 24)||12
8897753|NCT02047110|9955347|FG003|COMPLETED|DB (Week 12 up to Week 24)||12
8897754|NCT02047110|9955344|FG000|NOT COMPLETED|DB (Week 12 up to Week 24)||0
8897755|NCT02047110|9955345|FG001|NOT COMPLETED|DB (Week 12 up to Week 24)||2
8897756|NCT02047110|9955346|FG002|NOT COMPLETED|DB (Week 12 up to Week 24)||1
8897757|NCT02047110|9955347|FG003|NOT COMPLETED|DB (Week 12 up to Week 24)||0
8897758|NCT02047110|9955344|FG000|STARTED|Escape Treatment Period|Assessment in SpondyloArthritis international Society (ASAS) 20 nonresponders|26
8897759|NCT02047110|9955345|FG001|STARTED|Escape Treatment Period|ASAS 20 nonresponders|21
8897760|NCT02047110|9955346|FG002|STARTED|Escape Treatment Period|ASAS 20 nonresponders|23
8897761|NCT02047110|9955347|FG003|STARTED|Escape Treatment Period|ASAS 20 nonresponders|26
8897762|NCT02047110|9955344|FG000|COMPLETED|Escape Treatment Period||23
8897763|NCT02047110|9955345|FG001|COMPLETED|Escape Treatment Period||15
8897764|NCT02047110|9955346|FG002|COMPLETED|Escape Treatment Period||20
8897765|NCT02047110|9955347|FG003|COMPLETED|Escape Treatment Period||24
8897766|NCT02047110|9955344|FG000|NOT COMPLETED|Escape Treatment Period||3
8897767|NCT02047110|9955345|FG001|NOT COMPLETED|Escape Treatment Period||6
8897768|NCT02047110|9955346|FG002|NOT COMPLETED|Escape Treatment Period||3
8897769|NCT02047110|9955347|FG003|NOT COMPLETED|Escape Treatment Period||2
9008664|NCT02966509|10071420|FG001|STARTED|6 Month Satisfaction Survey||108
9008665|NCT02966509|10071419|FG000|COMPLETED|6 Month Satisfaction Survey||58
9008666|NCT02966509|10071420|FG001|COMPLETED|6 Month Satisfaction Survey||60
9008667|NCT02966509|10071419|FG000|NOT COMPLETED|6 Month Satisfaction Survey||47
9008668|NCT02966509|10071420|FG001|NOT COMPLETED|6 Month Satisfaction Survey||48
9008669|NCT02966509|10071419|FG000|STARTED|6-Month Utilization and Cost||105
9008670|NCT02966509|10071420|FG001|STARTED|6-Month Utilization and Cost||108
9008671|NCT02966509|10071419|FG000|COMPLETED|6-Month Utilization and Cost||105
8897770|NCT02047110|9955344|FG000|STARTED|OLE Treatment Period|Patients with loss of ASAS 20 response compared with baseline|4
8897771|NCT02047110|9955345|FG001|STARTED|OLE Treatment Period|Patients with loss of ASAS 20 response compared with baseline|8
8897772|NCT02047110|9955346|FG002|STARTED|OLE Treatment Period|Patients with loss of ASAS 20 response compared with baseline|5
8897773|NCT02047110|9955347|FG003|STARTED|OLE Treatment Period|Patients with loss of ASAS 20 response compared with baseline|9
8897774|NCT02047110|9955344|FG000|COMPLETED|OLE Treatment Period||4
8897775|NCT02047110|9955345|FG001|COMPLETED|OLE Treatment Period||8
8897776|NCT02047110|9955346|FG002|COMPLETED|OLE Treatment Period||4
8897777|NCT02047110|9955347|FG003|COMPLETED|OLE Treatment Period||9
8897778|NCT02047110|9955344|FG000|NOT COMPLETED|OLE Treatment Period||0
8897779|NCT02047110|9955345|FG001|NOT COMPLETED|OLE Treatment Period||0
8897780|NCT02047110|9955346|FG002|NOT COMPLETED|OLE Treatment Period||1
8897781|NCT02047110|9955347|FG003|NOT COMPLETED|OLE Treatment Period||0
8897782|NCT02047227|9955366|FG000|STARTED|Overall Study||462
8897783|NCT02047227|9955367|FG001|STARTED|Overall Study||477
8897784|NCT02047227|9955366|FG000|Completed Ovarian Stimulation Phase|Overall Study||424
8897785|NCT02047227|9955367|FG001|Completed Ovarian Stimulation Phase|Overall Study||440
8897786|NCT02047227|9955366|FG000|COMPLETED|Overall Study||318
8897787|NCT02047227|9955367|FG001|COMPLETED|Overall Study||347
8897788|NCT02047227|9955366|FG000|NOT COMPLETED|Overall Study||144
8897789|NCT02047227|9955367|FG001|NOT COMPLETED|Overall Study||130
8897790|NCT02047253|9955373|FG000|STARTED|Overall Study||28
8897791|NCT02047253|9955373|FG000|COMPLETED|Overall Study||20
8897792|NCT02047253|9955373|FG000|NOT COMPLETED|Overall Study||8
8897793|NCT02047305|9955377|FG000|STARTED|Overall Study||96
8897794|NCT02047305|9955377|FG000|COMPLETED|Overall Study||96
8897795|NCT02047305|9955377|FG000|NOT COMPLETED|Overall Study||0
8897796|NCT02047318|9955381|FG000|STARTED|Core Study Period||19
8897797|NCT02047318|9955381|FG000|Received MRX 14 ug/kg/Day|Core Study Period||6
8897798|NCT02047318|9955381|FG000|Received MRX 35 ug/kg/Day|Core Study Period||6
8897799|NCT02047318|9955381|FG000|Received MRX 70 ug/kg/Day|Core Study Period||6
8897800|NCT02047318|9955381|FG000|Received MRX 140 ug/kg/Day|Core Study Period||11
8897801|NCT02047318|9955381|FG000|Received MRX 280 ug/kg/Day|Core Study Period||19
8897802|NCT02047318|9955381|FG000|COMPLETED|Core Study Period||7
8897803|NCT02047318|9955381|FG000|NOT COMPLETED|Core Study Period||12
8897804|NCT02047318|9955381|FG000|STARTED|52-week Follow-up Treatment Period||6
8897805|NCT02047318|9955381|FG000|COMPLETED|52-week Follow-up Treatment Period||6
8897806|NCT02047318|9955381|FG000|NOT COMPLETED|52-week Follow-up Treatment Period||0
8897807|NCT02047318|9955381|FG000|STARTED|Long-term Follow-up Treatment Period||7
8897808|NCT02047318|9955381|FG000|Received MRX 280 ug/kg/Day|Long-term Follow-up Treatment Period||7
8897809|NCT02047318|9955381|FG000|Received 420 ug/kg/Day|Long-term Follow-up Treatment Period||5
8897810|NCT02047318|9955381|FG000|Received 560 ug/kg/Day|Long-term Follow-up Treatment Period||5
8897811|NCT02047318|9955381|FG000|COMPLETED|Long-term Follow-up Treatment Period||6
8897812|NCT02047318|9955381|FG000|NOT COMPLETED|Long-term Follow-up Treatment Period||1
8897813|NCT02047344|9955398|FG000|STARTED|Overall Study|one patient is not evaluable in process. however, evaluable to safety report.|16
8897814|NCT02047344|9955399|FG001|STARTED|Overall Study||15
8897815|NCT02047344|9955398|FG000|COMPLETED|Overall Study||16
8897816|NCT02047344|9955399|FG001|COMPLETED|Overall Study||15
8897817|NCT02047344|9955398|FG000|NOT COMPLETED|Overall Study||0
8897818|NCT02047344|9955399|FG001|NOT COMPLETED|Overall Study||0
8897819|NCT02047500|9955411|FG000|STARTED|Overall Study||19
8897820|NCT02047500|9955411|FG000|COMPLETED|Overall Study||0
8897821|NCT02047500|9955411|FG000|NOT COMPLETED|Overall Study||19
8897822|NCT02047604|9955421|FG000|STARTED|Overall Study||6
8897823|NCT02047604|9955422|FG001|STARTED|Overall Study||7
8897824|NCT02047604|9955423|FG002|STARTED|Overall Study||6
8897825|NCT02047604|9955424|FG003|STARTED|Overall Study||6
8897826|NCT02047604|9955425|FG004|STARTED|Overall Study||6
8897827|NCT02047604|9955426|FG005|STARTED|Overall Study||10
8897828|NCT02047604|9955421|FG000|COMPLETED|Overall Study||6
8897829|NCT02047604|9955422|FG001|COMPLETED|Overall Study||7
8897830|NCT02047604|9955423|FG002|COMPLETED|Overall Study||6
8897831|NCT02047604|9955424|FG003|COMPLETED|Overall Study||6
8897832|NCT02047604|9955425|FG004|COMPLETED|Overall Study||5
8897833|NCT02047604|9955426|FG005|COMPLETED|Overall Study||9
8897834|NCT02047604|9955421|FG000|NOT COMPLETED|Overall Study||0
8897835|NCT02047604|9955422|FG001|NOT COMPLETED|Overall Study||0
8897836|NCT02047604|9955423|FG002|NOT COMPLETED|Overall Study||0
8897837|NCT02047604|9955424|FG003|NOT COMPLETED|Overall Study||0
8897838|NCT02047604|9955425|FG004|NOT COMPLETED|Overall Study||1
8897839|NCT02047604|9955426|FG005|NOT COMPLETED|Overall Study||1
8897840|NCT02047643|9955440|FG000|STARTED|Overall Study||9
8897841|NCT02047643|9955441|FG001|STARTED|Overall Study||9
8897842|NCT02047643|9955440|FG000|COMPLETED|Overall Study||9
8897843|NCT02047643|9955441|FG001|COMPLETED|Overall Study||9
8897844|NCT02047643|9955440|FG000|NOT COMPLETED|Overall Study||0
8897845|NCT02047643|9955441|FG001|NOT COMPLETED|Overall Study||0
8897846|NCT02047734|9955450|FG000|STARTED|Overall Study||443
8897847|NCT02047734|9955451|FG001|STARTED|Overall Study||443
8897848|NCT02047734|9955452|FG002|STARTED|Overall Study||434
8897849|NCT02047734|9955450|FG000|Received Treatment|Overall Study|One participant received ozanimod 0.5 mg in error|441
8897850|NCT02047734|9955451|FG001|Received Treatment|Overall Study|One participant received ozanimod 1.0 mg in error|439
9008672|NCT02966509|10071420|FG001|COMPLETED|6-Month Utilization and Cost||108
8897851|NCT02047734|9955452|FG002|Received Treatment|Overall Study||433
8897852|NCT02047734|9955450|FG000|COMPLETED|Overall Study||376
8897853|NCT02047734|9955451|FG001|COMPLETED|Overall Study||374
8897854|NCT02047734|9955452|FG002|COMPLETED|Overall Study||388
8897855|NCT02047734|9955450|FG000|NOT COMPLETED|Overall Study||67
8897856|NCT02047734|9955451|FG001|NOT COMPLETED|Overall Study||69
8897857|NCT02047734|9955452|FG002|NOT COMPLETED|Overall Study||46
8897858|NCT02047903|9955460|FG000|STARTED|Overall Study||161
8897859|NCT02047903|9955460|FG000|Treated|Overall Study||152
8897860|NCT02047903|9955460|FG000|COMPLETED|Overall Study||102
8897861|NCT02047903|9955460|FG000|NOT COMPLETED|Overall Study||59
8897862|NCT02047981|9955466|FG000|STARTED|MORDOR Stage I Year 1-2||97047
8897863|NCT02047981|9955467|FG001|STARTED|MORDOR Stage I Year 1-2||93191
8897864|NCT02047981|9955466|FG000|COMPLETED|MORDOR Stage I Year 1-2||87650
8897865|NCT02047981|9955467|FG001|COMPLETED|MORDOR Stage I Year 1-2||84474
8897866|NCT02047981|9955466|FG000|NOT COMPLETED|MORDOR Stage I Year 1-2||9397
8897867|NCT02047981|9955467|FG001|NOT COMPLETED|MORDOR Stage I Year 1-2||8717
8897868|NCT02047981|9955466|FG000|STARTED|MORDOR Stage II Year 3||37497
8897869|NCT02047981|9955467|FG001|STARTED|MORDOR Stage II Year 3||33294
8897870|NCT02047981|9955466|FG000|COMPLETED|MORDOR Stage II Year 3||34611
8897871|NCT02047981|9955467|FG001|COMPLETED|MORDOR Stage II Year 3||30931
8897872|NCT02047981|9955466|FG000|NOT COMPLETED|MORDOR Stage II Year 3||2886
8897873|NCT02047981|9955467|FG001|NOT COMPLETED|MORDOR Stage II Year 3||2363
9008673|NCT02966509|10071419|FG000|NOT COMPLETED|6-Month Utilization and Cost||0
9008674|NCT02966509|10071420|FG001|NOT COMPLETED|6-Month Utilization and Cost||0
9008675|NCT02966509|10071419|FG000|STARTED|15-Month Utilization and Cost||105
9008676|NCT02966509|10071420|FG001|STARTED|15-Month Utilization and Cost||108
9008677|NCT02966509|10071419|FG000|COMPLETED|15-Month Utilization and Cost||105
9008678|NCT02966509|10071420|FG001|COMPLETED|15-Month Utilization and Cost||108
9008679|NCT02966509|10071419|FG000|NOT COMPLETED|15-Month Utilization and Cost||0
9008680|NCT02966509|10071420|FG001|NOT COMPLETED|15-Month Utilization and Cost||0
9008681|NCT02966509|10071419|FG000|STARTED|End of Life Utilization and Cost 6 Month||105
9008682|NCT02966509|10071420|FG001|STARTED|End of Life Utilization and Cost 6 Month||108
9008683|NCT02966509|10071419|FG000|COMPLETED|End of Life Utilization and Cost 6 Month||36
9008684|NCT02966509|10071420|FG001|COMPLETED|End of Life Utilization and Cost 6 Month||33
9008685|NCT02966509|10071419|FG000|NOT COMPLETED|End of Life Utilization and Cost 6 Month||69
9008686|NCT02966509|10071420|FG001|NOT COMPLETED|End of Life Utilization and Cost 6 Month||75
9008687|NCT02966509|10071419|FG000|STARTED|End of Life Utilization and Cost 15month||105
9008688|NCT02966509|10071420|FG001|STARTED|End of Life Utilization and Cost 15month||108
9008689|NCT02966509|10071419|FG000|COMPLETED|End of Life Utilization and Cost 15month||60
9008690|NCT02966509|10071420|FG001|COMPLETED|End of Life Utilization and Cost 15month||60
9008691|NCT02966509|10071419|FG000|NOT COMPLETED|End of Life Utilization and Cost 15month||45
9008692|NCT02966509|10071420|FG001|NOT COMPLETED|End of Life Utilization and Cost 15month||48
9008693|NCT02966795|10071428|FG000|STARTED|Overall Study||23
9008694|NCT02966795|10071429|FG001|STARTED|Overall Study||61
9008695|NCT02966795|10071428|FG000|COMPLETED|Overall Study||23
9008696|NCT02966795|10071429|FG001|COMPLETED|Overall Study||60
9008697|NCT02966795|10071428|FG000|NOT COMPLETED|Overall Study||0
9008698|NCT02966795|10071429|FG001|NOT COMPLETED|Overall Study||1
9008699|NCT02966834|10071440|FG000|STARTED|Main Study Period (Up to 12 Weeks)||36
9008700|NCT02966834|10071441|FG001|STARTED|Main Study Period (Up to 12 Weeks)||16
9008701|NCT02966834|10071442|FG002|STARTED|Main Study Period (Up to 12 Weeks)||23
9008702|NCT02966834|10071443|FG003|STARTED|Main Study Period (Up to 12 Weeks)||27
9008703|NCT02966834|10071444|FG004|STARTED|Main Study Period (Up to 12 Weeks)||23
9008704|NCT02966834|10071445|FG005|STARTED|Main Study Period (Up to 12 Weeks)||22
9008705|NCT02966834|10071440|FG000|COMPLETED|Main Study Period (Up to 12 Weeks)||35
9008706|NCT02966834|10071441|FG001|COMPLETED|Main Study Period (Up to 12 Weeks)||16
9008707|NCT02966834|10071442|FG002|COMPLETED|Main Study Period (Up to 12 Weeks)||19
9008708|NCT02966834|10071443|FG003|COMPLETED|Main Study Period (Up to 12 Weeks)||19
9008709|NCT02966834|10071444|FG004|COMPLETED|Main Study Period (Up to 12 Weeks)||22
9008710|NCT02966834|10071445|FG005|COMPLETED|Main Study Period (Up to 12 Weeks)||17
9008711|NCT02966834|10071440|FG000|NOT COMPLETED|Main Study Period (Up to 12 Weeks)||1
9008712|NCT02966834|10071441|FG001|NOT COMPLETED|Main Study Period (Up to 12 Weeks)||0
9008713|NCT02966834|10071442|FG002|NOT COMPLETED|Main Study Period (Up to 12 Weeks)||4
9008714|NCT02966834|10071443|FG003|NOT COMPLETED|Main Study Period (Up to 12 Weeks)||8
9008715|NCT02966834|10071444|FG004|NOT COMPLETED|Main Study Period (Up to 12 Weeks)||1
9008716|NCT02966834|10071445|FG005|NOT COMPLETED|Main Study Period (Up to 12 Weeks)||5
9008717|NCT02966834|10071440|FG000|STARTED|Final Study Period (Up to 4 Weeks)||35
9008718|NCT02966834|10071441|FG001|STARTED|Final Study Period (Up to 4 Weeks)||16
9008719|NCT02966834|10071442|FG002|STARTED|Final Study Period (Up to 4 Weeks)||19
9008720|NCT02966834|10071443|FG003|STARTED|Final Study Period (Up to 4 Weeks)||19
9008721|NCT02966834|10071444|FG004|STARTED|Final Study Period (Up to 4 Weeks)|One participant did not enter Final Study Period.|21
9008722|NCT02966834|10071445|FG005|STARTED|Final Study Period (Up to 4 Weeks)||17
9008723|NCT02966834|10071440|FG000|COMPLETED|Final Study Period (Up to 4 Weeks)||35
9008724|NCT02966834|10071441|FG001|COMPLETED|Final Study Period (Up to 4 Weeks)||16
9008725|NCT02966834|10071442|FG002|COMPLETED|Final Study Period (Up to 4 Weeks)||19
9008726|NCT02966834|10071443|FG003|COMPLETED|Final Study Period (Up to 4 Weeks)||19
9008727|NCT02966834|10071444|FG004|COMPLETED|Final Study Period (Up to 4 Weeks)||21
9008728|NCT02966834|10071445|FG005|COMPLETED|Final Study Period (Up to 4 Weeks)||17
8897874|NCT02048072|9955473|FG000|STARTED|Overall Study||33
8897875|NCT02048072|9955473|FG000|COMPLETED|Overall Study||29
8897876|NCT02048072|9955473|FG000|NOT COMPLETED|Overall Study||4
8897877|NCT02048241|9955479|FG000|STARTED|Overall Study||5
8897878|NCT02048241|9955480|FG001|STARTED|Overall Study||6
8897879|NCT02048241|9955479|FG000|COMPLETED|Overall Study||5
8897880|NCT02048241|9955480|FG001|COMPLETED|Overall Study||5
8897881|NCT02048241|9955479|FG000|NOT COMPLETED|Overall Study||0
8897882|NCT02048241|9955480|FG001|NOT COMPLETED|Overall Study||1
8897883|NCT02048670|9955488|FG000|STARTED|Overall Study||6
8897884|NCT02048670|9955489|FG001|STARTED|Overall Study||6
8897885|NCT02048670|9955488|FG000|COMPLETED|Overall Study||6
9008729|NCT02966834|10071440|FG000|NOT COMPLETED|Final Study Period (Up to 4 Weeks)||0
8897886|NCT02048670|9955489|FG001|COMPLETED|Overall Study||6
8897887|NCT02048670|9955488|FG000|NOT COMPLETED|Overall Study||0
8897888|NCT02048670|9955489|FG001|NOT COMPLETED|Overall Study||0
8897889|NCT02048826|9955497|FG000|STARTED|Overall Study||16
8897890|NCT02048826|9955498|FG001|STARTED|Overall Study||15
8897891|NCT02048826|9955497|FG000|COMPLETED|Overall Study||15
8897892|NCT02048826|9955498|FG001|COMPLETED|Overall Study||15
8897893|NCT02048826|9955497|FG000|NOT COMPLETED|Overall Study||1
8897894|NCT02048826|9955498|FG001|NOT COMPLETED|Overall Study||0
8897895|NCT02048878|9955506|FG000|STARTED|Overall Study||13
8897896|NCT02048878|9955507|FG001|STARTED|Overall Study||15
8897897|NCT02048878|9955506|FG000|COMPLETED|Overall Study||12
8897898|NCT02048878|9955507|FG001|COMPLETED|Overall Study||12
8897899|NCT02048878|9955506|FG000|NOT COMPLETED|Overall Study||1
8897900|NCT02048878|9955507|FG001|NOT COMPLETED|Overall Study||3
8897901|NCT02048891|9955515|FG000|STARTED|Overall Study||2
8897902|NCT02048891|9955516|FG001|STARTED|Overall Study||1
8897903|NCT02048891|9955515|FG000|COMPLETED|Overall Study||2
8897904|NCT02048891|9955516|FG001|COMPLETED|Overall Study||1
8897905|NCT02048891|9955515|FG000|NOT COMPLETED|Overall Study||0
8897906|NCT02048891|9955516|FG001|NOT COMPLETED|Overall Study||0
8897907|NCT02049151|9955524|FG000|STARTED|Overall Study|2 subjects did not receive treatment|15
8897908|NCT02049151|9955525|FG001|STARTED|Overall Study|1 subject did not receive treatment|17
8897909|NCT02049151|9955524|FG000|COMPLETED|Overall Study||15
8897910|NCT02049151|9955525|FG001|COMPLETED|Overall Study||17
8897911|NCT02049151|9955524|FG000|NOT COMPLETED|Overall Study||0
8897912|NCT02049151|9955525|FG001|NOT COMPLETED|Overall Study||0
8897913|NCT02049307|9955533|FG000|STARTED|Overall Study||52
8897914|NCT02049307|9955534|FG001|STARTED|Overall Study||56
8897915|NCT02049307|9955533|FG000|COMPLETED|Overall Study||50
8897916|NCT02049307|9955534|FG001|COMPLETED|Overall Study||55
8897917|NCT02049307|9955533|FG000|NOT COMPLETED|Overall Study||2
8897918|NCT02049307|9955534|FG001|NOT COMPLETED|Overall Study||1
8897919|NCT02049385|9955542|FG000|STARTED|First Intervention||4
8897920|NCT02049385|9955543|FG001|STARTED|First Intervention||2
8897921|NCT02049385|9955542|FG000|COMPLETED|First Intervention||1
8897922|NCT02049385|9955543|FG001|COMPLETED|First Intervention||2
8897923|NCT02049385|9955542|FG000|NOT COMPLETED|First Intervention||3
8897924|NCT02049385|9955543|FG001|NOT COMPLETED|First Intervention||0
8897925|NCT02049385|9955542|FG000|STARTED|Second Intervention||1
8897926|NCT02049385|9955543|FG001|STARTED|Second Intervention||2
8897927|NCT02049385|9955542|FG000|COMPLETED|Second Intervention||1
8897928|NCT02049385|9955543|FG001|COMPLETED|Second Intervention||0
8897929|NCT02049385|9955542|FG000|NOT COMPLETED|Second Intervention||0
8897930|NCT02049385|9955543|FG001|NOT COMPLETED|Second Intervention||2
8897931|NCT02049437|9955551|FG000|STARTED|Period 1||17
8897932|NCT02049437|9955552|FG001|STARTED|Period 1||17
8897933|NCT02049437|9955551|FG000|COMPLETED|Period 1||15
8897934|NCT02049437|9955552|FG001|COMPLETED|Period 1|Dropout due to low trough levels|16
8897935|NCT02049437|9955551|FG000|NOT COMPLETED|Period 1||2
8897936|NCT02049437|9955552|FG001|NOT COMPLETED|Period 1||1
8897937|NCT02049437|9955551|FG000|STARTED|Washout 1||15
8897938|NCT02049437|9955552|FG001|STARTED|Washout 1||16
8897939|NCT02049437|9955551|FG000|COMPLETED|Washout 1||15
8897940|NCT02049437|9955552|FG001|COMPLETED|Washout 1||16
8897941|NCT02049437|9955551|FG000|NOT COMPLETED|Washout 1||0
8897942|NCT02049437|9955552|FG001|NOT COMPLETED|Washout 1||0
8897943|NCT02049437|9955551|FG000|STARTED|Period 2||15
8897944|NCT02049437|9955552|FG001|STARTED|Period 2||16
8897945|NCT02049437|9955551|FG000|COMPLETED|Period 2||15
8897946|NCT02049437|9955552|FG001|COMPLETED|Period 2||16
8897947|NCT02049437|9955551|FG000|NOT COMPLETED|Period 2||0
8897948|NCT02049437|9955552|FG001|NOT COMPLETED|Period 2||0
9008730|NCT02966834|10071441|FG001|NOT COMPLETED|Final Study Period (Up to 4 Weeks)||0
9008731|NCT02966834|10071442|FG002|NOT COMPLETED|Final Study Period (Up to 4 Weeks)||0
8897949|NCT02049437|9955551|FG000|STARTED|Washout 2||15
8897950|NCT02049437|9955552|FG001|STARTED|Washout 2||16
8897951|NCT02049437|9955551|FG000|COMPLETED|Washout 2||15
8897952|NCT02049437|9955552|FG001|COMPLETED|Washout 2||16
8897953|NCT02049437|9955551|FG000|NOT COMPLETED|Washout 2||0
8897954|NCT02049437|9955552|FG001|NOT COMPLETED|Washout 2||0
8897955|NCT02049450|9955558|FG000|STARTED|Overall Study||30
8897956|NCT02049450|9955558|FG000|Discontinued Treatment Prior to Week 30|Overall Study||4
8897957|NCT02049450|9955558|FG000|Entered Extension Phase|Overall Study|Of 26 who completed Core phase 18 moved into Ext. phase; All 18 eventually discontinued Ext. phase|18
8897958|NCT02049450|9955558|FG000|COMPLETED|Overall Study|Completed = Completed Core phase of study|26
8897959|NCT02049450|9955558|FG000|NOT COMPLETED|Overall Study||4
8897960|NCT02049476|9955569|FG000|STARTED|Overall Study|First patient enrolled on 1/31/2014|20
8897961|NCT02049476|9955569|FG000|COMPLETED|Overall Study|20th patient completed the study|20
8897962|NCT02049476|9955569|FG000|NOT COMPLETED|Overall Study||0
8897963|NCT02049502|9955573|FG000|STARTED|Overall Study||8
8897964|NCT02049502|9955573|FG000|COMPLETED|Overall Study||8
8897965|NCT02049502|9955573|FG000|NOT COMPLETED|Overall Study||0
8897966|NCT02049749|9955579|FG000|STARTED|Overall Study|40 children plus 40 caregivers|80
8897967|NCT02049749|9955580|FG001|STARTED|Overall Study|80 children plus 80 caregivers|160
8897968|NCT02049749|9955579|FG000|COMPLETED|Overall Study||80
8897969|NCT02049749|9955580|FG001|COMPLETED|Overall Study|80 children plus 80 caregivers|160
8897970|NCT02049749|9955579|FG000|NOT COMPLETED|Overall Study||0
8897971|NCT02049749|9955580|FG001|NOT COMPLETED|Overall Study||0
8897972|NCT02049814|9955589|FG000|STARTED|Overall Study||248
8897973|NCT02049814|9955590|FG001|STARTED|Overall Study||246
8897974|NCT02049814|9955589|FG000|Safety Set|Overall Study||248
8897975|NCT02049814|9955590|FG001|Safety Set|Overall Study||245
8897976|NCT02049814|9955589|FG000|COMPLETED|Overall Study||219
8897977|NCT02049814|9955590|FG001|COMPLETED|Overall Study||219
8897978|NCT02049814|9955589|FG000|NOT COMPLETED|Overall Study||29
8897979|NCT02049814|9955590|FG001|NOT COMPLETED|Overall Study||27
8897980|NCT02049866|9955596|FG000|STARTED|Overall Study||33
8897981|NCT02049866|9955596|FG000|COMPLETED|Overall Study||32
8897982|NCT02049866|9955596|FG000|NOT COMPLETED|Overall Study||1
8897983|NCT02049931|9955603|FG000|STARTED|Overall Study||20
8897984|NCT02049931|9955604|FG001|STARTED|Overall Study||20
9008732|NCT02966834|10071443|FG003|NOT COMPLETED|Final Study Period (Up to 4 Weeks)||0
9008733|NCT02966834|10071444|FG004|NOT COMPLETED|Final Study Period (Up to 4 Weeks)||0
9008734|NCT02966834|10071445|FG005|NOT COMPLETED|Final Study Period (Up to 4 Weeks)||0
9008735|NCT02966834|10071440|FG000|STARTED|Follow-up (Up to 4 Weeks)||35
9008736|NCT02966834|10071441|FG001|STARTED|Follow-up (Up to 4 Weeks)||16
9008737|NCT02966834|10071442|FG002|STARTED|Follow-up (Up to 4 Weeks)|4 participants discontinued study treatment in Main study period and directly entered follow-up.|23
9008738|NCT02966834|10071443|FG003|STARTED|Follow-up (Up to 4 Weeks)|8 participants discontinued study treatment in Main Study period and directly entered follow-up.|27
9008739|NCT02966834|10071444|FG004|STARTED|Follow-up (Up to 4 Weeks)|1 participant who completed main study period directly entered follow-up in this arm|22
9008740|NCT02966834|10071445|FG005|STARTED|Follow-up (Up to 4 Weeks)|5 participants discontinued study treatment in Main study period and directly entered follow-up|22
9008741|NCT02966834|10071440|FG000|COMPLETED|Follow-up (Up to 4 Weeks)||35
9008742|NCT02966834|10071441|FG001|COMPLETED|Follow-up (Up to 4 Weeks)||16
9008743|NCT02966834|10071442|FG002|COMPLETED|Follow-up (Up to 4 Weeks)||22
9008744|NCT02966834|10071443|FG003|COMPLETED|Follow-up (Up to 4 Weeks)||22
9008745|NCT02966834|10071444|FG004|COMPLETED|Follow-up (Up to 4 Weeks)||22
9008746|NCT02966834|10071445|FG005|COMPLETED|Follow-up (Up to 4 Weeks)||21
9008747|NCT02966834|10071440|FG000|NOT COMPLETED|Follow-up (Up to 4 Weeks)||0
8897985|NCT02049931|9955605|FG002|STARTED|Overall Study||20
8897986|NCT02049931|9955603|FG000|COMPLETED|Overall Study||17
8897987|NCT02049931|9955604|FG001|COMPLETED|Overall Study||15
9008748|NCT02966834|10071441|FG001|NOT COMPLETED|Follow-up (Up to 4 Weeks)||0
8897988|NCT02049931|9955605|FG002|COMPLETED|Overall Study||17
8897989|NCT02049931|9955603|FG000|NOT COMPLETED|Overall Study||3
8897990|NCT02049931|9955604|FG001|NOT COMPLETED|Overall Study||5
8897991|NCT02049931|9955605|FG002|NOT COMPLETED|Overall Study||3
8897992|NCT02049944|9955613|FG000|STARTED|Overall Study||30
8897993|NCT02049944|9955613|FG000|Obese (BMI 30-40kg/m^2)|Overall Study||14
8897994|NCT02049944|9955613|FG000|Extremely Obese (BMI >40kg/m^2)|Overall Study||14
8897995|NCT02049944|9955613|FG000|COMPLETED|Overall Study||28
8897996|NCT02049944|9955613|FG000|NOT COMPLETED|Overall Study||2
8897997|NCT02049957|9955626|FG000|STARTED|Overall Study||6
8897998|NCT02049957|9955627|FG001|STARTED|Overall Study||6
8897999|NCT02049957|9955628|FG002|STARTED|Overall Study||3
8898000|NCT02049957|9955629|FG003|STARTED|Overall Study||3
8898001|NCT02049957|9955630|FG004|STARTED|Overall Study||6
8898002|NCT02049957|9955631|FG005|STARTED|Overall Study||43
8898003|NCT02049957|9955632|FG006|STARTED|Overall Study||8
8898004|NCT02049957|9955633|FG007|STARTED|Overall Study||35
8898005|NCT02049957|9955634|FG008|STARTED|Overall Study||8
8898006|NCT02049957|9955626|FG000|COMPLETED|Overall Study||0
8898007|NCT02049957|9955627|FG001|COMPLETED|Overall Study||0
8898008|NCT02049957|9955628|FG002|COMPLETED|Overall Study||0
8898009|NCT02049957|9955629|FG003|COMPLETED|Overall Study||0
8898010|NCT02049957|9955630|FG004|COMPLETED|Overall Study||0
8898011|NCT02049957|9955631|FG005|COMPLETED|Overall Study||0
8898012|NCT02049957|9955632|FG006|COMPLETED|Overall Study||0
8898013|NCT02049957|9955633|FG007|COMPLETED|Overall Study||0
8898014|NCT02049957|9955634|FG008|COMPLETED|Overall Study||0
8898015|NCT02049957|9955626|FG000|NOT COMPLETED|Overall Study||6
8898016|NCT02049957|9955627|FG001|NOT COMPLETED|Overall Study||6
8898017|NCT02049957|9955628|FG002|NOT COMPLETED|Overall Study||3
8898018|NCT02049957|9955629|FG003|NOT COMPLETED|Overall Study||3
8898019|NCT02049957|9955630|FG004|NOT COMPLETED|Overall Study||6
8898020|NCT02049957|9955631|FG005|NOT COMPLETED|Overall Study||43
8898021|NCT02049957|9955632|FG006|NOT COMPLETED|Overall Study||8
8898022|NCT02049957|9955633|FG007|NOT COMPLETED|Overall Study||35
8898023|NCT02049957|9955634|FG008|NOT COMPLETED|Overall Study||8
8898024|NCT02050048|9955656|FG000|STARTED|Overall Study||14
8898025|NCT02050048|9955657|FG001|STARTED|Overall Study||12
8898026|NCT02050048|9955656|FG000|COMPLETED|Overall Study||9
8898027|NCT02050048|9955657|FG001|COMPLETED|Overall Study||10
8898028|NCT02050048|9955656|FG000|NOT COMPLETED|Overall Study||5
8898029|NCT02050048|9955657|FG001|NOT COMPLETED|Overall Study||2
8898030|NCT02050321|9955663|FG000|STARTED|Overall Study||2
8898031|NCT02050321|9955663|FG000|COMPLETED|Overall Study||0
8898032|NCT02050321|9955663|FG000|NOT COMPLETED|Overall Study||2
8898033|NCT02050334|9955669|FG000|STARTED|Overall Study||9
8898034|NCT02050334|9955670|FG001|STARTED|Overall Study||9
8898035|NCT02050334|9955669|FG000|COMPLETED|Overall Study||9
8898036|NCT02050334|9955670|FG001|COMPLETED|Overall Study||9
8898037|NCT02050334|9955669|FG000|NOT COMPLETED|Overall Study||0
8898038|NCT02050334|9955670|FG001|NOT COMPLETED|Overall Study||0
8898039|NCT02050373|9955679|FG000|STARTED|Overall Study||34
8898040|NCT02050373|9955680|FG001|STARTED|Overall Study||34
8898041|NCT02050373|9955679|FG000|COMPLETED|Overall Study||27
8898042|NCT02050373|9955680|FG001|COMPLETED|Overall Study||24
8898043|NCT02050373|9955679|FG000|NOT COMPLETED|Overall Study||7
8898044|NCT02050373|9955680|FG001|NOT COMPLETED|Overall Study||10
8898045|NCT02050841|9955687|FG000|STARTED|Overall Study||50
8898046|NCT02050841|9955687|FG000|COMPLETED|Overall Study||49
8898047|NCT02050841|9955687|FG000|NOT COMPLETED|Overall Study||1
8898048|NCT02051296|9955699|FG000|STARTED|Overall Study||66
8898049|NCT02051296|9955700|FG001|STARTED|Overall Study||65
8898050|NCT02051296|9955699|FG000|Received Allocated Intervention|Overall Study||59
8898051|NCT02051296|9955700|FG001|Received Allocated Intervention|Overall Study||58
8898052|NCT02051296|9955699|FG000|COMPLETED|Overall Study||58
8898053|NCT02051296|9955700|FG001|COMPLETED|Overall Study||56
8898054|NCT02051296|9955699|FG000|NOT COMPLETED|Overall Study||8
8898055|NCT02051296|9955700|FG001|NOT COMPLETED|Overall Study||9
8898056|NCT02051335|9955710|FG000|STARTED|Period 1||7
8898057|NCT02051335|9955711|FG001|STARTED|Period 1||7
8898058|NCT02051335|9955712|FG002|STARTED|Period 1||7
8898059|NCT02051335|9955713|FG003|STARTED|Period 1||6
8898060|NCT02051335|9955710|FG000|COMPLETED|Period 1||7
8898061|NCT02051335|9955711|FG001|COMPLETED|Period 1||7
8898062|NCT02051335|9955712|FG002|COMPLETED|Period 1||7
8898063|NCT02051335|9955713|FG003|COMPLETED|Period 1||6
8898064|NCT02051335|9955710|FG000|NOT COMPLETED|Period 1||0
8898065|NCT02051335|9955711|FG001|NOT COMPLETED|Period 1||0
8898066|NCT02051335|9955712|FG002|NOT COMPLETED|Period 1||0
8898067|NCT02051335|9955713|FG003|NOT COMPLETED|Period 1||0
8898068|NCT02051335|9955710|FG000|STARTED|Period 2||7
8898069|NCT02051335|9955711|FG001|STARTED|Period 2||7
8898070|NCT02051335|9955712|FG002|STARTED|Period 2||7
8898071|NCT02051335|9955713|FG003|STARTED|Period 2|2 Participants received treatment in Period 1 but discontinued prior to Period 2.|4
8898072|NCT02051335|9955710|FG000|COMPLETED|Period 2||7
8898073|NCT02051335|9955711|FG001|COMPLETED|Period 2||7
8898074|NCT02051335|9955712|FG002|COMPLETED|Period 2||7
8898075|NCT02051335|9955713|FG003|COMPLETED|Period 2||4
8898076|NCT02051335|9955710|FG000|NOT COMPLETED|Period 2||0
8898077|NCT02051335|9955711|FG001|NOT COMPLETED|Period 2||0
8898078|NCT02051335|9955712|FG002|NOT COMPLETED|Period 2||0
8898079|NCT02051335|9955713|FG003|NOT COMPLETED|Period 2||0
8898080|NCT02051335|9955710|FG000|STARTED|Period 3||7
8898081|NCT02051335|9955711|FG001|STARTED|Period 3||7
8898082|NCT02051335|9955712|FG002|STARTED|Period 3|2 Participants received treatment in Period 2 but discontinued prior to Period 3.|5
8898083|NCT02051335|9955713|FG003|STARTED|Period 3||4
8898084|NCT02051335|9955710|FG000|COMPLETED|Period 3||7
8898085|NCT02051335|9955711|FG001|COMPLETED|Period 3||7
8898086|NCT02051335|9955712|FG002|COMPLETED|Period 3||5
8898087|NCT02051335|9955713|FG003|COMPLETED|Period 3||4
8898088|NCT02051335|9955710|FG000|NOT COMPLETED|Period 3||0
8898089|NCT02051335|9955711|FG001|NOT COMPLETED|Period 3||0
8898090|NCT02051335|9955712|FG002|NOT COMPLETED|Period 3||0
8898091|NCT02051335|9955713|FG003|NOT COMPLETED|Period 3||0
8898092|NCT02051335|9955710|FG000|STARTED|Period 4||7
8898093|NCT02051335|9955711|FG001|STARTED|Period 4||7
8898094|NCT02051335|9955712|FG002|STARTED|Period 4||5
8898095|NCT02051335|9955713|FG003|STARTED|Period 4||4
8898096|NCT02051335|9955710|FG000|COMPLETED|Period 4||7
8898097|NCT02051335|9955711|FG001|COMPLETED|Period 4||7
8898098|NCT02051335|9955712|FG002|COMPLETED|Period 4||5
8898099|NCT02051335|9955713|FG003|COMPLETED|Period 4||4
8898100|NCT02051335|9955710|FG000|NOT COMPLETED|Period 4||0
8898101|NCT02051335|9955711|FG001|NOT COMPLETED|Period 4||0
8898102|NCT02051335|9955712|FG002|NOT COMPLETED|Period 4||0
8898103|NCT02051335|9955713|FG003|NOT COMPLETED|Period 4||0
8898104|NCT02051426|9955725|FG000|STARTED|First Intervention||16
8898105|NCT02051426|9955726|FG001|STARTED|First Intervention||19
8898106|NCT02051426|9955725|FG000|COMPLETED|First Intervention||16
8898107|NCT02051426|9955726|FG001|COMPLETED|First Intervention||19
8898108|NCT02051426|9955725|FG000|NOT COMPLETED|First Intervention||0
8898109|NCT02051426|9955726|FG001|NOT COMPLETED|First Intervention||0
8898110|NCT02051426|9955725|FG000|STARTED|Washout Period of 1 Month||16
8898111|NCT02051426|9955726|FG001|STARTED|Washout Period of 1 Month||19
8898112|NCT02051426|9955725|FG000|COMPLETED|Washout Period of 1 Month||16
8898113|NCT02051426|9955726|FG001|COMPLETED|Washout Period of 1 Month||19
8898114|NCT02051426|9955725|FG000|NOT COMPLETED|Washout Period of 1 Month||0
8898115|NCT02051426|9955726|FG001|NOT COMPLETED|Washout Period of 1 Month||0
8898116|NCT02051426|9955725|FG000|STARTED|Second Intervention||16
8898117|NCT02051426|9955726|FG001|STARTED|Second Intervention||19
8898118|NCT02051426|9955725|FG000|COMPLETED|Second Intervention||16
8898119|NCT02051426|9955726|FG001|COMPLETED|Second Intervention||19
8898120|NCT02051426|9955725|FG000|NOT COMPLETED|Second Intervention||0
8635653|NCT00563368|9676172|FG003|COMPLETED|Overall Study||78
8635654|NCT00563368|9676173|FG004|COMPLETED|Overall Study||80
8635655|NCT00563368|9676174|FG005|COMPLETED|Overall Study||77
8635656|NCT00563368|9676175|FG006|COMPLETED|Overall Study||75
8635657|NCT00563368|9676169|FG000|NOT COMPLETED|Overall Study||35
8635658|NCT00563368|9676170|FG001|NOT COMPLETED|Overall Study||30
8635659|NCT00563368|9676171|FG002|NOT COMPLETED|Overall Study||30
8635660|NCT00563368|9676172|FG003|NOT COMPLETED|Overall Study||29
8635661|NCT00563368|9676173|FG004|NOT COMPLETED|Overall Study||28
8635662|NCT00563368|9676174|FG005|NOT COMPLETED|Overall Study||30
8635663|NCT00563368|9676175|FG006|NOT COMPLETED|Overall Study||33
8635664|NCT00563381|9676193|FG000|STARTED|Overall Study|Started treatment|3707
8635665|NCT00563381|9676194|FG001|STARTED|Overall Study|Started treatment|3669
8635666|NCT00563381|9676193|FG000|COMPLETED|Overall Study|Completed treatment|3122
8898121|NCT02051426|9955726|FG001|NOT COMPLETED|Second Intervention||0
8898122|NCT02051452|9955734|FG000|STARTED|Overall Study||16
8898123|NCT02051452|9955735|FG001|STARTED|Overall Study||16
8898124|NCT02051452|9955734|FG000|COMPLETED|Overall Study||16
8898125|NCT02051452|9955735|FG001|COMPLETED|Overall Study||16
8898126|NCT02051452|9955734|FG000|NOT COMPLETED|Overall Study||0
8898127|NCT02051452|9955735|FG001|NOT COMPLETED|Overall Study||0
8898128|NCT02051595|9955741|FG000|STARTED|Overall Study||25
8898129|NCT02051595|9955741|FG000|COMPLETED|Overall Study||25
8898130|NCT02051595|9955741|FG000|NOT COMPLETED|Overall Study||0
8898131|NCT02051686|9955747|FG000|STARTED|Overall Study||42
8898132|NCT02051686|9955748|FG001|STARTED|Overall Study||46
8898133|NCT02051686|9955747|FG000|COMPLETED|Overall Study||42
8898134|NCT02051686|9955748|FG001|COMPLETED|Overall Study||46
8898135|NCT02051686|9955747|FG000|NOT COMPLETED|Overall Study||0
8898136|NCT02051686|9955748|FG001|NOT COMPLETED|Overall Study||0
8898137|NCT02051764|9955756|FG000|STARTED|Overall Study||16
8898138|NCT02051764|9955757|FG001|STARTED|Overall Study||28
8898139|NCT02051764|9955756|FG000|COMPLETED|Overall Study||16
8898140|NCT02051764|9955757|FG001|COMPLETED|Overall Study||21
8898141|NCT02051764|9955756|FG000|NOT COMPLETED|Overall Study||0
8898142|NCT02051764|9955757|FG001|NOT COMPLETED|Overall Study||7
8898143|NCT02051790|9955763|FG000|STARTED|Overall Study||241
8898144|NCT02051790|9955763|FG000|COMPLETED|Overall Study||241
8898145|NCT02051790|9955763|FG000|NOT COMPLETED|Overall Study||0
8691312|NCT00854100|9736549|FG000|NOT COMPLETED|Overall Study||9
8898146|NCT02051816|9955771|FG000|STARTED|Overall Study||37
8898147|NCT02051816|9955772|FG001|STARTED|Overall Study||40
8898148|NCT02051816|9955773|FG002|STARTED|Overall Study||37
8898149|NCT02051816|9955774|FG003|STARTED|Overall Study||36
8898150|NCT02051816|9955771|FG000|COMPLETED|Overall Study||37
8898151|NCT02051816|9955772|FG001|COMPLETED|Overall Study||40
8898152|NCT02051816|9955773|FG002|COMPLETED|Overall Study||37
8898153|NCT02051816|9955774|FG003|COMPLETED|Overall Study||36
8898154|NCT02051816|9955771|FG000|NOT COMPLETED|Overall Study||0
8898155|NCT02051816|9955772|FG001|NOT COMPLETED|Overall Study||0
8898156|NCT02051816|9955773|FG002|NOT COMPLETED|Overall Study||0
8898157|NCT02051816|9955774|FG003|NOT COMPLETED|Overall Study||0
8898158|NCT02052011|9955790|FG000|STARTED|Overall Study||21
8898159|NCT02052011|9955791|FG001|STARTED|Overall Study||10
8898160|NCT02052011|9955790|FG000|COMPLETED|Overall Study||17
8898161|NCT02052011|9955791|FG001|COMPLETED|Overall Study||8
8898162|NCT02052011|9955790|FG000|NOT COMPLETED|Overall Study||4
8898163|NCT02052011|9955791|FG001|NOT COMPLETED|Overall Study||2
9008749|NCT02966834|10071442|FG002|NOT COMPLETED|Follow-up (Up to 4 Weeks)||1
9008750|NCT02966834|10071443|FG003|NOT COMPLETED|Follow-up (Up to 4 Weeks)||5
9008751|NCT02966834|10071444|FG004|NOT COMPLETED|Follow-up (Up to 4 Weeks)||0
9008752|NCT02966834|10071445|FG005|NOT COMPLETED|Follow-up (Up to 4 Weeks)||1
9008753|NCT02967016|10071496|FG000|STARTED|Overall Study||25
9008754|NCT02967016|10071497|FG001|STARTED|Overall Study||25
9008755|NCT02967016|10071496|FG000|COMPLETED|Overall Study||25
9008756|NCT02967016|10071497|FG001|COMPLETED|Overall Study||25
9008757|NCT02967016|10071496|FG000|NOT COMPLETED|Overall Study||0
9008758|NCT02967016|10071497|FG001|NOT COMPLETED|Overall Study||0
9008759|NCT02967055|10071503|FG000|STARTED|Overall Study|Assessed for eligibility|54
9008760|NCT02967055|10071503|FG000|In-person Screening|Overall Study||14
9008761|NCT02967055|10071503|FG000|Enrolled|Overall Study|Enrolled|9
9008762|NCT02967055|10071503|FG000|Completed 4 Week Follow-up Visit|Overall Study||8
9008763|NCT02967055|10071503|FG000|COMPLETED|Overall Study||5
9008764|NCT02967055|10071503|FG000|NOT COMPLETED|Overall Study||49
9008765|NCT02967354|10071512|FG000|STARTED|Overall Study||8
9008766|NCT02967354|10071513|FG001|STARTED|Overall Study||7
9008767|NCT02967354|10071514|FG002|STARTED|Overall Study||9
9008768|NCT02967354|10071515|FG003|STARTED|Overall Study||7
9008769|NCT02967354|10071516|FG004|STARTED|Overall Study||8
9008770|NCT02967354|10071512|FG000|COMPLETED|Overall Study||8
9008771|NCT02967354|10071513|FG001|COMPLETED|Overall Study||7
9008772|NCT02967354|10071514|FG002|COMPLETED|Overall Study||9
9008773|NCT02967354|10071515|FG003|COMPLETED|Overall Study||7
9008774|NCT02967354|10071516|FG004|COMPLETED|Overall Study||8
9008775|NCT02967354|10071512|FG000|NOT COMPLETED|Overall Study||0
9008776|NCT02967354|10071513|FG001|NOT COMPLETED|Overall Study||0
8898164|NCT02052141|9955799|FG000|STARTED|Intervention Period 1||5
8898165|NCT02052141|9955800|FG001|STARTED|Intervention Period 1||7
8898166|NCT02052141|9955799|FG000|COMPLETED|Intervention Period 1||5
8898167|NCT02052141|9955800|FG001|COMPLETED|Intervention Period 1||7
8898168|NCT02052141|9955799|FG000|NOT COMPLETED|Intervention Period 1||0
8898169|NCT02052141|9955800|FG001|NOT COMPLETED|Intervention Period 1||0
8898170|NCT02052141|9955799|FG000|STARTED|Intervention Period 2||5
8898171|NCT02052141|9955800|FG001|STARTED|Intervention Period 2||7
8898172|NCT02052141|9955799|FG000|COMPLETED|Intervention Period 2||5
8898173|NCT02052141|9955800|FG001|COMPLETED|Intervention Period 2||7
8898174|NCT02052141|9955799|FG000|NOT COMPLETED|Intervention Period 2||0
8898175|NCT02052141|9955800|FG001|NOT COMPLETED|Intervention Period 2||0
8898176|NCT02052310|9955808|FG000|STARTED|Overall Study||522
8898177|NCT02052310|9955809|FG001|STARTED|Overall Study||521
8898178|NCT02052310|9955808|FG000|Received at Least 1 Dose of Study Drug|Overall Study||522
8898179|NCT02052310|9955809|FG001|Received at Least 1 Dose of Study Drug|Overall Study||517
8898180|NCT02052310|9955808|FG000|COMPLETED|Overall Study||307
8898181|NCT02052310|9955809|FG001|COMPLETED|Overall Study||309
8898182|NCT02052310|9955808|FG000|NOT COMPLETED|Overall Study||215
8898183|NCT02052310|9955809|FG001|NOT COMPLETED|Overall Study||212
8898184|NCT02052414|9955815|FG000|STARTED|Overall Study||34
8898185|NCT02052414|9955815|FG000|COMPLETED|Overall Study||17
8898186|NCT02052414|9955815|FG000|NOT COMPLETED|Overall Study||17
8898187|NCT02052440|9955822|FG000|STARTED|Overall Study||50
8898188|NCT02052440|9955823|FG001|STARTED|Overall Study||52
8898189|NCT02052440|9955822|FG000|COMPLETED|Overall Study||50
8898190|NCT02052440|9955823|FG001|COMPLETED|Overall Study||51
8898191|NCT02052440|9955822|FG000|NOT COMPLETED|Overall Study||0
8898192|NCT02052440|9955823|FG001|NOT COMPLETED|Overall Study||1
8898193|NCT02052466|9955829|FG000|STARTED|Overall Study||32
8898194|NCT02052466|9955829|FG000|COMPLETED|Overall Study||30
8898195|NCT02052466|9955829|FG000|NOT COMPLETED|Overall Study||2
8898196|NCT02052544|9955833|FG000|STARTED|Overall Study|First Subject In|123
8898197|NCT02052544|9955833|FG000|COMPLETED|Overall Study|Last Subject Out|123
8898198|NCT02052544|9955833|FG000|NOT COMPLETED|Overall Study||0
8898199|NCT02052557|9955840|FG000|STARTED|Overall Study||26
8898200|NCT02052557|9955841|FG001|STARTED|Overall Study||25
8898201|NCT02052557|9955840|FG000|COMPLETED|Overall Study||26
8898202|NCT02052557|9955841|FG001|COMPLETED|Overall Study||25
8898203|NCT02052557|9955840|FG000|NOT COMPLETED|Overall Study||0
8898204|NCT02052557|9955841|FG001|NOT COMPLETED|Overall Study||0
8898205|NCT02052596|9955851|FG000|STARTED|Active Phase||412
8898206|NCT02052596|9955852|FG001|STARTED|Active Phase||418
8898207|NCT02052596|9955851|FG000|COMPLETED|Active Phase||396
8898208|NCT02052596|9955852|FG001|COMPLETED|Active Phase||398
8898209|NCT02052596|9955851|FG000|NOT COMPLETED|Active Phase||16
8898210|NCT02052596|9955852|FG001|NOT COMPLETED|Active Phase||20
8898211|NCT02052596|9955851|FG000|STARTED|Safety Phase||412
8898212|NCT02052596|9955852|FG001|STARTED|Safety Phase||418
8898213|NCT02052596|9955851|FG000|COMPLETED|Safety Phase||385
8898214|NCT02052596|9955852|FG001|COMPLETED|Safety Phase||383
8898215|NCT02052596|9955851|FG000|NOT COMPLETED|Safety Phase||27
8898216|NCT02052596|9955852|FG001|NOT COMPLETED|Safety Phase||35
8898217|NCT02052635|9955860|FG000|STARTED|Overall Study||7
8898218|NCT02052635|9955861|FG001|STARTED|Overall Study||6
8898219|NCT02052635|9955860|FG000|COMPLETED|Overall Study||7
8898220|NCT02052635|9955861|FG001|COMPLETED|Overall Study||6
8898221|NCT02052635|9955860|FG000|NOT COMPLETED|Overall Study||0
8898222|NCT02052635|9955861|FG001|NOT COMPLETED|Overall Study||0
8898223|NCT02052661|9955867|FG000|STARTED|Overall Study||300
8898224|NCT02052661|9955867|FG000|COMPLETED|Overall Study||300
8898225|NCT02052661|9955867|FG000|NOT COMPLETED|Overall Study||0
8898226|NCT02052752|9955874|FG000|STARTED|Overall Study||30
8898227|NCT02052752|9955875|FG001|STARTED|Overall Study||30
8898228|NCT02052752|9955876|FG002|STARTED|Overall Study||30
8898229|NCT02052752|9955874|FG000|COMPLETED|Overall Study||30
8898230|NCT02052752|9955875|FG001|COMPLETED|Overall Study||30
8898231|NCT02052752|9955876|FG002|COMPLETED|Overall Study||30
8898232|NCT02052752|9955874|FG000|NOT COMPLETED|Overall Study||0
8898233|NCT02052752|9955875|FG001|NOT COMPLETED|Overall Study||0
8898234|NCT02052752|9955876|FG002|NOT COMPLETED|Overall Study||0
8898235|NCT02052895|9955888|FG000|STARTED|Overall Study||196
8898236|NCT02052895|9955889|FG001|STARTED|Overall Study||15
8898237|NCT02052895|9955890|FG002|STARTED|Overall Study||15
8898238|NCT02052895|9955888|FG000|COMPLETED|Overall Study||196
8898239|NCT02052895|9955889|FG001|COMPLETED|Overall Study||15
8898240|NCT02052895|9955890|FG002|COMPLETED|Overall Study||15
8898241|NCT02052895|9955888|FG000|NOT COMPLETED|Overall Study||0
8898242|NCT02052895|9955889|FG001|NOT COMPLETED|Overall Study||0
8898243|NCT02052895|9955890|FG002|NOT COMPLETED|Overall Study||0
8898244|NCT02052960|9955899|FG000|STARTED|Overall Study||117
8898245|NCT02052960|9955900|FG001|STARTED|Overall Study||123
8898246|NCT02052960|9955899|FG000|Treated Patients|Overall Study||115
8898247|NCT02052960|9955900|FG001|Treated Patients|Overall Study||122
8898248|NCT02052960|9955899|FG000|COMPLETED|Overall Study||63
8898249|NCT02052960|9955900|FG001|COMPLETED|Overall Study||77
8898250|NCT02052960|9955899|FG000|NOT COMPLETED|Overall Study||54
8898251|NCT02052960|9955900|FG001|NOT COMPLETED|Overall Study||46
8898252|NCT02053077|9955909|FG000|STARTED|Overall Study||150
8898253|NCT02053077|9955909|FG000|COMPLETED|Overall Study||150
8898254|NCT02053077|9955909|FG000|NOT COMPLETED|Overall Study||0
8898255|NCT02053168|9955913|FG000|STARTED|Overall Study||25
8898256|NCT02053168|9955913|FG000|COMPLETED|Overall Study||22
8898257|NCT02053168|9955913|FG000|NOT COMPLETED|Overall Study||3
8635667|NCT00563381|9676194|FG001|COMPLETED|Overall Study|Completed treatment|3021
8635668|NCT00563381|9676193|FG000|NOT COMPLETED|Overall Study||585
8635669|NCT00563381|9676194|FG001|NOT COMPLETED|Overall Study||648
8898258|NCT02053259|9955921|FG000|STARTED|Overall Study||25
8898259|NCT02053259|9955922|FG001|STARTED|Overall Study||24
8898260|NCT02053259|9955923|FG002|STARTED|Overall Study||24
8898261|NCT02053259|9955924|FG003|STARTED|Overall Study||23
8898262|NCT02053259|9955921|FG000|COMPLETED|Overall Study||25
8898263|NCT02053259|9955922|FG001|COMPLETED|Overall Study||24
8898264|NCT02053259|9955923|FG002|COMPLETED|Overall Study||24
9008777|NCT02967354|10071514|FG002|NOT COMPLETED|Overall Study||0
9008778|NCT02967354|10071515|FG003|NOT COMPLETED|Overall Study||0
9008779|NCT02967354|10071516|FG004|NOT COMPLETED|Overall Study||0
9008780|NCT02967367|10071533|FG000|STARTED|Overall Study||36
9008781|NCT02967367|10071533|FG000|COMPLETED|Overall Study||22
9008782|NCT02967367|10071533|FG000|NOT COMPLETED|Overall Study||14
9008783|NCT02967393|10071539|FG000|STARTED|Overall Study||20
9008784|NCT02967393|10071540|FG001|STARTED|Overall Study||20
9008785|NCT02967393|10071539|FG000|COMPLETED|Overall Study||20
9008786|NCT02967393|10071540|FG001|COMPLETED|Overall Study||20
9008787|NCT02967393|10071539|FG000|NOT COMPLETED|Overall Study||0
9008788|NCT02967393|10071540|FG001|NOT COMPLETED|Overall Study||0
9008789|NCT02967458|10071548|FG000|STARTED|Overall Study||55
9008790|NCT02967458|10071548|FG000|COMPLETED|Overall Study||55
9008791|NCT02967458|10071548|FG000|NOT COMPLETED|Overall Study||0
9008792|NCT02967510|10071557|FG000|STARTED|Overall Study||70
9008793|NCT02967510|10071558|FG001|STARTED|Overall Study||70
9008794|NCT02967510|10071559|FG002|STARTED|Overall Study||72
9008795|NCT02967510|10071560|FG003|STARTED|Overall Study||71
9008796|NCT02967510|10071557|FG000|COMPLETED|Overall Study||66
9008797|NCT02967510|10071558|FG001|COMPLETED|Overall Study||67
9008798|NCT02967510|10071559|FG002|COMPLETED|Overall Study||65
9008799|NCT02967510|10071560|FG003|COMPLETED|Overall Study||63
9008800|NCT02967510|10071557|FG000|NOT COMPLETED|Overall Study||4
9008801|NCT02967510|10071558|FG001|NOT COMPLETED|Overall Study||3
9008802|NCT02967510|10071559|FG002|NOT COMPLETED|Overall Study||7
9008803|NCT02967510|10071560|FG003|NOT COMPLETED|Overall Study||8
9008804|NCT02967562|10071572|FG000|STARTED|Overall Study||32
9008805|NCT02967562|10071573|FG001|STARTED|Overall Study||31
9008806|NCT02967562|10071572|FG000|COMPLETED|Overall Study||30
9008807|NCT02967562|10071573|FG001|COMPLETED|Overall Study||30
9008808|NCT02967562|10071572|FG000|NOT COMPLETED|Overall Study||2
9008809|NCT02967562|10071573|FG001|NOT COMPLETED|Overall Study||1
9008810|NCT02967679|10071579|FG000|STARTED|Overall Study||15
9008811|NCT02967679|10071579|FG000|COMPLETED|Overall Study||14
9008812|NCT02967679|10071579|FG000|NOT COMPLETED|Overall Study||1
9008813|NCT02967991|10071583|FG000|STARTED|Overall Study|First Intervention: 10 minutes Washout: 1 minute Second Intervention: 10 minutes|10
9008814|NCT02967991|10071584|FG001|STARTED|Overall Study|First Intervention: 10 minutes Washout: 1 minute Second Intervention: 10 minutes|10
9008815|NCT02967991|10071583|FG000|COMPLETED|Overall Study||10
9008816|NCT02967991|10071584|FG001|COMPLETED|Overall Study||10
9008817|NCT02967991|10071583|FG000|NOT COMPLETED|Overall Study||0
9008818|NCT02967991|10071584|FG001|NOT COMPLETED|Overall Study||0
9008819|NCT02968004|10071596|FG000|STARTED|Overall Study||109
9008820|NCT02968004|10071597|FG001|STARTED|Overall Study||115
9008821|NCT02968004|10071596|FG000|COMPLETED|Overall Study||108
9008822|NCT02968004|10071597|FG001|COMPLETED|Overall Study||114
9008823|NCT02968004|10071596|FG000|NOT COMPLETED|Overall Study||1
9008824|NCT02968004|10071597|FG001|NOT COMPLETED|Overall Study||1
9008825|NCT02968134|10071603|FG000|STARTED|Overall Study||8
9008826|NCT02968134|10071603|FG000|COMPLETED|Overall Study||8
9008827|NCT02968134|10071603|FG000|NOT COMPLETED|Overall Study||0
9008828|NCT02968173|10071607|FG000|STARTED|Overall Study||50
9008829|NCT02968173|10071607|FG000|COMPLETED|Overall Study||49
9008830|NCT02968173|10071607|FG000|NOT COMPLETED|Overall Study||1
9008831|NCT02968277|10071615|FG000|STARTED|Overall Study||10
9008832|NCT02968277|10071616|FG001|STARTED|Overall Study||7
9008833|NCT02968277|10071617|FG002|STARTED|Overall Study||13
9008834|NCT02968277|10071615|FG000|COMPLETED|Overall Study||10
9008835|NCT02968277|10071616|FG001|COMPLETED|Overall Study||7
9008836|NCT02968277|10071617|FG002|COMPLETED|Overall Study||13
9008837|NCT02968277|10071615|FG000|NOT COMPLETED|Overall Study||0
9008838|NCT02968277|10071616|FG001|NOT COMPLETED|Overall Study||0
9008839|NCT02968277|10071617|FG002|NOT COMPLETED|Overall Study||0
9008840|NCT02968368|10071631|FG000|STARTED|Double Blind Phase||111
9008841|NCT02968368|10071632|FG001|STARTED|Double Blind Phase||56
9008842|NCT02968368|10071631|FG000|COMPLETED|Double Blind Phase||90
9008843|NCT02968368|10071632|FG001|COMPLETED|Double Blind Phase||39
9008844|NCT02968368|10071631|FG000|NOT COMPLETED|Double Blind Phase||21
8635670|NCT00563706|9676209|FG000|STARTED|DB Treatment Period (Day 1 up to Day 28)||37
8635671|NCT00563706|9676210|FG001|STARTED|DB Treatment Period (Day 1 up to Day 28)||18
8635672|NCT00563706|9676211|FG002|STARTED|DB Treatment Period (Day 1 up to Day 28)||8
8635673|NCT00563706|9676212|FG003|STARTED|DB Treatment Period (Day 1 up to Day 28)||19
8635674|NCT00563706|9676213|FG004|STARTED|DB Treatment Period (Day 1 up to Day 28)||16
8691313|NCT00854100|9736550|FG001|NOT COMPLETED|Overall Study||6
9008845|NCT02968368|10071632|FG001|NOT COMPLETED|Double Blind Phase||17
8898265|NCT02053259|9955924|FG003|COMPLETED|Overall Study||23
8898266|NCT02053259|9955921|FG000|NOT COMPLETED|Overall Study||0
8898267|NCT02053259|9955922|FG001|NOT COMPLETED|Overall Study||0
8898268|NCT02053259|9955923|FG002|NOT COMPLETED|Overall Study||0
8898269|NCT02053259|9955924|FG003|NOT COMPLETED|Overall Study||0
8898270|NCT02053376|9955934|FG000|STARTED|Overall Study||43
8898271|NCT02053376|9955934|FG000|COMPLETED|Overall Study||43
8898272|NCT02053376|9955934|FG000|NOT COMPLETED|Overall Study||0
8898273|NCT02053493|9955940|FG000|STARTED|Overall Study||51
8898274|NCT02053493|9955941|FG001|STARTED|Overall Study||59
8898275|NCT02053493|9955940|FG000|COMPLETED|Overall Study||50
8898276|NCT02053493|9955941|FG001|COMPLETED|Overall Study||58
8898277|NCT02053493|9955940|FG000|NOT COMPLETED|Overall Study||1
8898278|NCT02053493|9955941|FG001|NOT COMPLETED|Overall Study||1
8898279|NCT02053610|9955949|FG000|STARTED|Overall Study||330
8898280|NCT02053610|9955950|FG001|STARTED|Overall Study||333
8898281|NCT02053610|9955949|FG000|Received Study Drug|Overall Study||326
8898282|NCT02053610|9955950|FG001|Received Study Drug|Overall Study||331
8898283|NCT02053610|9955949|FG000|COMPLETED|Overall Study|Completed=Completed Treatment|288
8898284|NCT02053610|9955950|FG001|COMPLETED|Overall Study|Completed=Completed Treatment|266
8898285|NCT02053610|9955949|FG000|NOT COMPLETED|Overall Study||42
8898286|NCT02053610|9955950|FG001|NOT COMPLETED|Overall Study||67
8898287|NCT02053753|9955958|FG000|STARTED|Overall Study||72
8898288|NCT02053753|9955959|FG001|STARTED|Overall Study||74
8898289|NCT02053753|9955958|FG000|Received Treatment|Overall Study||71
8898290|NCT02053753|9955959|FG001|Received Treatment|Overall Study||71
8898291|NCT02053753|9955958|FG000|COMPLETED|Overall Study||65
8898292|NCT02053753|9955959|FG001|COMPLETED|Overall Study||66
8898293|NCT02053753|9955958|FG000|NOT COMPLETED|Overall Study||7
8898294|NCT02053753|9955959|FG001|NOT COMPLETED|Overall Study||8
8898295|NCT02054130|9955969|FG000|STARTED|Overall Study||138
8898296|NCT02054130|9955970|FG001|STARTED|Overall Study||138
8898297|NCT02054130|9955971|FG002|STARTED|Overall Study||137
8898298|NCT02054130|9955972|FG003|STARTED|Overall Study||137
8898299|NCT02054130|9955969|FG000|COMPLETED|Overall Study||130
8898300|NCT02054130|9955970|FG001|COMPLETED|Overall Study||127
8898301|NCT02054130|9955971|FG002|COMPLETED|Overall Study||122
8898302|NCT02054130|9955972|FG003|COMPLETED|Overall Study||115
8898303|NCT02054130|9955969|FG000|NOT COMPLETED|Overall Study||8
8898304|NCT02054130|9955970|FG001|NOT COMPLETED|Overall Study||11
8898305|NCT02054130|9955971|FG002|NOT COMPLETED|Overall Study||15
8898306|NCT02054130|9955972|FG003|NOT COMPLETED|Overall Study||22
8898307|NCT02054156|9955987|FG000|STARTED|Overall Study||110
8898308|NCT02054156|9955988|FG001|STARTED|Overall Study||111
8898309|NCT02054156|9955987|FG000|COMPLETED|Overall Study||35
8898310|NCT02054156|9955988|FG001|COMPLETED|Overall Study||30
8898311|NCT02054156|9955987|FG000|NOT COMPLETED|Overall Study||75
8898312|NCT02054156|9955988|FG001|NOT COMPLETED|Overall Study||81
8898313|NCT02054325|9955996|FG000|STARTED|Overall Study||51
8898314|NCT02054325|9955997|FG001|STARTED|Overall Study||55
8898315|NCT02054325|9955996|FG000|COMPLETED|Overall Study||43
8898316|NCT02054325|9955997|FG001|COMPLETED|Overall Study||50
8898317|NCT02054325|9955996|FG000|NOT COMPLETED|Overall Study||8
8898318|NCT02054325|9955997|FG001|NOT COMPLETED|Overall Study||5
8898319|NCT02054338|9956005|FG000|STARTED|Overall Study||503
8898320|NCT02054338|9956006|FG001|STARTED|Overall Study||501
8898321|NCT02054338|9956005|FG000|COMPLETED|Overall Study||0
8898322|NCT02054338|9956006|FG001|COMPLETED|Overall Study||0
8898323|NCT02054338|9956005|FG000|NOT COMPLETED|Overall Study||503
8898324|NCT02054338|9956006|FG001|NOT COMPLETED|Overall Study||501
8898325|NCT02054481|9956016|FG000|STARTED|Overall Study||43
8898326|NCT02054481|9956017|FG001|STARTED|Overall Study||41
8898327|NCT02054481|9956018|FG002|STARTED|Overall Study||42
8898328|NCT02054481|9956019|FG003|STARTED|Overall Study||40
8898329|NCT02054481|9956016|FG000|COMPLETED|Overall Study||39
8898330|NCT02054481|9956017|FG001|COMPLETED|Overall Study||39
8898331|NCT02054481|9956018|FG002|COMPLETED|Overall Study||40
8898332|NCT02054481|9956019|FG003|COMPLETED|Overall Study||39
8898333|NCT02054481|9956016|FG000|NOT COMPLETED|Overall Study||4
8898334|NCT02054481|9956017|FG001|NOT COMPLETED|Overall Study||2
8898335|NCT02054481|9956018|FG002|NOT COMPLETED|Overall Study||2
8898336|NCT02054481|9956019|FG003|NOT COMPLETED|Overall Study||1
8898337|NCT02054520|9956036|FG000|STARTED|Overall Study||11
8898338|NCT02054520|9956037|FG001|STARTED|Overall Study||16
8898339|NCT02054520|9956038|FG002|STARTED|Overall Study||6
8898340|NCT02054520|9956039|FG003|STARTED|Overall Study||6
8898341|NCT02054520|9956040|FG004|STARTED|Overall Study||5
8898342|NCT02054520|9956041|FG005|STARTED|Overall Study||3
8898343|NCT02054520|9956036|FG000|COMPLETED|Overall Study||2
8898344|NCT02054520|9956037|FG001|COMPLETED|Overall Study||11
8898345|NCT02054520|9956038|FG002|COMPLETED|Overall Study||0
8898346|NCT02054520|9956039|FG003|COMPLETED|Overall Study||0
8898347|NCT02054520|9956040|FG004|COMPLETED|Overall Study||0
8898348|NCT02054520|9956041|FG005|COMPLETED|Overall Study||0
8898349|NCT02054520|9956036|FG000|NOT COMPLETED|Overall Study||9
8898350|NCT02054520|9956037|FG001|NOT COMPLETED|Overall Study||5
8898351|NCT02054520|9956038|FG002|NOT COMPLETED|Overall Study||6
8898352|NCT02054520|9956039|FG003|NOT COMPLETED|Overall Study||6
8898353|NCT02054520|9956040|FG004|NOT COMPLETED|Overall Study||5
8898354|NCT02054520|9956041|FG005|NOT COMPLETED|Overall Study||3
8898355|NCT02054572|9956055|FG000|STARTED|Overall Study||6
8898356|NCT02054572|9956055|FG000|COMPLETED|Overall Study||6
8898357|NCT02054572|9956055|FG000|NOT COMPLETED|Overall Study||0
8898358|NCT02054702|9956061|FG000|STARTED|Overall Study||64
8898359|NCT02054702|9956062|FG001|STARTED|Overall Study||33
8898360|NCT02054702|9956061|FG000|COMPLETED|Overall Study||40
8898361|NCT02054702|9956062|FG001|COMPLETED|Overall Study||21
8898362|NCT02054702|9956061|FG000|NOT COMPLETED|Overall Study||24
8898363|NCT02054702|9956062|FG001|NOT COMPLETED|Overall Study||12
8898364|NCT02054715|9956070|FG000|STARTED|Baseline/Follow-up 1||219
8898365|NCT02054715|9956071|FG001|STARTED|Baseline/Follow-up 1||199
8898366|NCT02054715|9956070|FG000|COMPLETED|Baseline/Follow-up 1||211
8898367|NCT02054715|9956071|FG001|COMPLETED|Baseline/Follow-up 1||192
8898368|NCT02054715|9956070|FG000|NOT COMPLETED|Baseline/Follow-up 1||8
8898369|NCT02054715|9956071|FG001|NOT COMPLETED|Baseline/Follow-up 1||7
8898370|NCT02054715|9956070|FG000|STARTED|Follow-up 2||211
8898371|NCT02054715|9956071|FG001|STARTED|Follow-up 2||192
8898372|NCT02054715|9956070|FG000|COMPLETED|Follow-up 2||192
8898373|NCT02054715|9956071|FG001|COMPLETED|Follow-up 2||173
8898374|NCT02054715|9956070|FG000|NOT COMPLETED|Follow-up 2||19
8898375|NCT02054715|9956071|FG001|NOT COMPLETED|Follow-up 2||19
8898376|NCT02054754|9956079|FG000|STARTED|Overall Study||6
8898377|NCT02054754|9956080|FG001|STARTED|Overall Study||6
8898378|NCT02054754|9956081|FG002|STARTED|Overall Study||6
8898379|NCT02054754|9956082|FG003|STARTED|Overall Study||6
8898380|NCT02054754|9956083|FG004|STARTED|Overall Study||6
8898381|NCT02054754|9956084|FG005|STARTED|Overall Study||10
8898382|NCT02054754|9956079|FG000|COMPLETED|Overall Study||6
8898383|NCT02054754|9956080|FG001|COMPLETED|Overall Study||6
8898384|NCT02054754|9956081|FG002|COMPLETED|Overall Study||6
8898385|NCT02054754|9956082|FG003|COMPLETED|Overall Study||6
8898386|NCT02054754|9956083|FG004|COMPLETED|Overall Study||6
8898387|NCT02054754|9956084|FG005|COMPLETED|Overall Study||10
8898388|NCT02054754|9956079|FG000|NOT COMPLETED|Overall Study||0
8898389|NCT02054754|9956080|FG001|NOT COMPLETED|Overall Study||0
8898390|NCT02054754|9956081|FG002|NOT COMPLETED|Overall Study||0
8898391|NCT02054754|9956082|FG003|NOT COMPLETED|Overall Study||0
8898392|NCT02054754|9956083|FG004|NOT COMPLETED|Overall Study||0
8898393|NCT02054754|9956084|FG005|NOT COMPLETED|Overall Study||0
8898394|NCT02054897|9956102|FG000|STARTED|Overall Study||129
8898395|NCT02054897|9956103|FG001|STARTED|Overall Study||130
8898396|NCT02054897|9956104|FG002|STARTED|Overall Study||129
8898397|NCT02054897|9956102|FG000|Exposed|Overall Study||128
8898398|NCT02054897|9956103|FG001|Exposed|Overall Study||130
8898399|NCT02054897|9956104|FG002|Exposed|Overall Study||129
8898400|NCT02054897|9956102|FG000|COMPLETED|Overall Study||119
8898401|NCT02054897|9956103|FG001|COMPLETED|Overall Study||123
8898402|NCT02054897|9956104|FG002|COMPLETED|Overall Study||117
8898403|NCT02054897|9956102|FG000|NOT COMPLETED|Overall Study||10
8898404|NCT02054897|9956103|FG001|NOT COMPLETED|Overall Study||7
8898405|NCT02054897|9956104|FG002|NOT COMPLETED|Overall Study||12
8898406|NCT02055118|9956115|FG000|STARTED|Overall Study||15
8898407|NCT02055118|9956116|FG001|STARTED|Overall Study||34
8898408|NCT02055118|9956117|FG002|STARTED|Overall Study||9
8898409|NCT02055118|9956115|FG000|COMPLETED|Overall Study||15
8898410|NCT02055118|9956116|FG001|COMPLETED|Overall Study||32
8898411|NCT02055118|9956117|FG002|COMPLETED|Overall Study||9
8898412|NCT02055118|9956115|FG000|NOT COMPLETED|Overall Study||0
8898413|NCT02055118|9956116|FG001|NOT COMPLETED|Overall Study||2
8898414|NCT02055118|9956117|FG002|NOT COMPLETED|Overall Study||0
8898415|NCT02055157|9956130|FG000|STARTED|Initial 6 Months||8
8898416|NCT02055157|9956131|FG001|STARTED|Initial 6 Months||8
8898417|NCT02055157|9956132|FG002|STARTED|Initial 6 Months||10
8898418|NCT02055157|9956133|FG003|STARTED|Initial 6 Months||9
8898419|NCT02055157|9956130|FG000|COMPLETED|Initial 6 Months||7
8898420|NCT02055157|9956131|FG001|COMPLETED|Initial 6 Months||7
8898421|NCT02055157|9956132|FG002|COMPLETED|Initial 6 Months||10
8898422|NCT02055157|9956133|FG003|COMPLETED|Initial 6 Months||8
8898423|NCT02055157|9956130|FG000|NOT COMPLETED|Initial 6 Months||1
8898424|NCT02055157|9956131|FG001|NOT COMPLETED|Initial 6 Months||1
8898425|NCT02055157|9956132|FG002|NOT COMPLETED|Initial 6 Months||0
8898426|NCT02055157|9956133|FG003|NOT COMPLETED|Initial 6 Months||1
8898427|NCT02055157|9956130|FG000|STARTED|18-month Extension||7
8898428|NCT02055157|9956131|FG001|STARTED|18-month Extension||7
8898429|NCT02055157|9956132|FG002|STARTED|18-month Extension||10
8898430|NCT02055157|9956133|FG003|STARTED|18-month Extension||8
8898431|NCT02055157|9956130|FG000|COMPLETED|18-month Extension||6
8898432|NCT02055157|9956131|FG001|COMPLETED|18-month Extension||6
8898433|NCT02055157|9956132|FG002|COMPLETED|18-month Extension||10
8898434|NCT02055157|9956133|FG003|COMPLETED|18-month Extension||8
8898435|NCT02055157|9956130|FG000|NOT COMPLETED|18-month Extension||1
8898436|NCT02055157|9956131|FG001|NOT COMPLETED|18-month Extension||1
8898437|NCT02055157|9956132|FG002|NOT COMPLETED|18-month Extension||0
8898438|NCT02055157|9956133|FG003|NOT COMPLETED|18-month Extension||0
8898439|NCT02055352|9956156|FG000|STARTED|Overall Study||109
8898440|NCT02055352|9956157|FG001|STARTED|Overall Study||113
8898441|NCT02055352|9956156|FG000|Per-Protocol Set (PPS)|Overall Study||108
8898442|NCT02055352|9956157|FG001|Per-Protocol Set (PPS)|Overall Study||111
8898443|NCT02055352|9956156|FG000|COMPLETED|Overall Study||103
8898444|NCT02055352|9956157|FG001|COMPLETED|Overall Study||96
8898445|NCT02055352|9956156|FG000|NOT COMPLETED|Overall Study||6
8898446|NCT02055352|9956157|FG001|NOT COMPLETED|Overall Study||17
8898447|NCT02055365|9956163|FG000|STARTED|Overall Study||10
8898448|NCT02055365|9956163|FG000|COMPLETED|Overall Study||9
8898449|NCT02055365|9956163|FG000|NOT COMPLETED|Overall Study||1
8898450|NCT02055404|9956174|FG000|STARTED|Overall Study||3
8898451|NCT02055404|9956174|FG000|COMPLETED|Overall Study||3
8898452|NCT02055404|9956174|FG000|NOT COMPLETED|Overall Study||0
8898453|NCT02055430|9956189|FG000|STARTED|Overall Study||45
8898454|NCT02055430|9956190|FG001|STARTED|Overall Study||45
8898455|NCT02055430|9956189|FG000|COMPLETED|Overall Study||45
8898456|NCT02055430|9956190|FG001|COMPLETED|Overall Study||45
8898457|NCT02055430|9956189|FG000|NOT COMPLETED|Overall Study||0
8898458|NCT02055430|9956190|FG001|NOT COMPLETED|Overall Study||0
8898459|NCT02055638|9956198|FG000|STARTED|Overall Study||49
8898460|NCT02055638|9956199|FG001|STARTED|Overall Study||48
8898461|NCT02055638|9956198|FG000|COMPLETED|Overall Study||39
8898462|NCT02055638|9956199|FG001|COMPLETED|Overall Study||40
8898463|NCT02055638|9956198|FG000|NOT COMPLETED|Overall Study||10
8898464|NCT02055638|9956199|FG001|NOT COMPLETED|Overall Study||8
8898465|NCT02055781|9956208|FG000|STARTED|Overall Study||104
8898466|NCT02055781|9956209|FG001|STARTED|Overall Study||107
8898467|NCT02055781|9956210|FG002|STARTED|Overall Study||100
8898468|NCT02055781|9956208|FG000|COMPLETED|Overall Study||62
8898469|NCT02055781|9956209|FG001|COMPLETED|Overall Study||79
8898470|NCT02055781|9956210|FG002|COMPLETED|Overall Study||63
8898471|NCT02055781|9956208|FG000|NOT COMPLETED|Overall Study||42
8898472|NCT02055781|9956209|FG001|NOT COMPLETED|Overall Study||28
8898473|NCT02055781|9956210|FG002|NOT COMPLETED|Overall Study||37
8898474|NCT02055820|9956228|FG000|STARTED|Phase I: Dose-Finding||7
8898475|NCT02055820|9956229|FG001|STARTED|Phase I: Dose-Finding||3
8635675|NCT00563706|9676214|FG005|STARTED|DB Treatment Period (Day 1 up to Day 28)||19
8635676|NCT00563706|9676215|FG006|STARTED|DB Treatment Period (Day 1 up to Day 28)||12
8635677|NCT00563706|9676216|FG007|STARTED|DB Treatment Period (Day 1 up to Day 28)||30
8635678|NCT00563706|9676217|FG008|STARTED|DB Treatment Period (Day 1 up to Day 28)||43
8635679|NCT00563706|9676209|FG000|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||20
8898476|NCT02055820|9956230|FG002|STARTED|Phase I: Dose-Finding||8
8898477|NCT02055820|9956231|FG003|STARTED|Phase I: Dose-Finding||6
8898478|NCT02055820|9956232|FG004|STARTED|Phase I: Dose-Finding||0
8898479|NCT02055820|9956233|FG005|STARTED|Phase I: Dose-Finding||7
8898480|NCT02055820|9956234|FG006|STARTED|Phase I: Dose-Finding||7
8898481|NCT02055820|9956235|FG007|STARTED|Phase I: Dose-Finding||6
8898482|NCT02055820|9956236|FG008|STARTED|Phase I: Dose-Finding||6
8898483|NCT02055820|9956237|FG009|STARTED|Phase I: Dose-Finding||6
8898484|NCT02055820|9956228|FG000|COMPLETED|Phase I: Dose-Finding||6
8898485|NCT02055820|9956229|FG001|COMPLETED|Phase I: Dose-Finding||3
8898486|NCT02055820|9956230|FG002|COMPLETED|Phase I: Dose-Finding||7
8898487|NCT02055820|9956231|FG003|COMPLETED|Phase I: Dose-Finding||3
8898488|NCT02055820|9956232|FG004|COMPLETED|Phase I: Dose-Finding||0
8898489|NCT02055820|9956233|FG005|COMPLETED|Phase I: Dose-Finding||5
8898490|NCT02055820|9956234|FG006|COMPLETED|Phase I: Dose-Finding||5
8898491|NCT02055820|9956235|FG007|COMPLETED|Phase I: Dose-Finding||6
8898492|NCT02055820|9956236|FG008|COMPLETED|Phase I: Dose-Finding||6
8898493|NCT02055820|9956237|FG009|COMPLETED|Phase I: Dose-Finding||6
8898494|NCT02055820|9956228|FG000|NOT COMPLETED|Phase I: Dose-Finding||1
8898495|NCT02055820|9956229|FG001|NOT COMPLETED|Phase I: Dose-Finding||0
8898496|NCT02055820|9956230|FG002|NOT COMPLETED|Phase I: Dose-Finding||1
8898497|NCT02055820|9956231|FG003|NOT COMPLETED|Phase I: Dose-Finding||3
8898498|NCT02055820|9956232|FG004|NOT COMPLETED|Phase I: Dose-Finding||0
8898499|NCT02055820|9956233|FG005|NOT COMPLETED|Phase I: Dose-Finding||2
8898500|NCT02055820|9956234|FG006|NOT COMPLETED|Phase I: Dose-Finding||2
8898501|NCT02055820|9956235|FG007|NOT COMPLETED|Phase I: Dose-Finding||0
8898502|NCT02055820|9956236|FG008|NOT COMPLETED|Phase I: Dose-Finding||0
8898503|NCT02055820|9956237|FG009|NOT COMPLETED|Phase I: Dose-Finding||0
8898504|NCT02055820|9956228|FG000|STARTED|Phase II: Expansion||0
8898505|NCT02055820|9956229|FG001|STARTED|Phase II: Expansion||0
8898506|NCT02055820|9956230|FG002|STARTED|Phase II: Expansion||0
8898507|NCT02055820|9956231|FG003|STARTED|Phase II: Expansion||0
8898508|NCT02055820|9956232|FG004|STARTED|Phase II: Expansion||208
8898509|NCT02055820|9956233|FG005|STARTED|Phase II: Expansion||0
8898510|NCT02055820|9956234|FG006|STARTED|Phase II: Expansion||0
8898511|NCT02055820|9956235|FG007|STARTED|Phase II: Expansion||0
8898512|NCT02055820|9956236|FG008|STARTED|Phase II: Expansion||0
8898513|NCT02055820|9956237|FG009|STARTED|Phase II: Expansion||0
8898514|NCT02055820|9956228|FG000|COMPLETED|Phase II: Expansion||0
8898515|NCT02055820|9956229|FG001|COMPLETED|Phase II: Expansion||0
8898516|NCT02055820|9956230|FG002|COMPLETED|Phase II: Expansion||0
8898517|NCT02055820|9956231|FG003|COMPLETED|Phase II: Expansion||0
8898518|NCT02055820|9956232|FG004|COMPLETED|Phase II: Expansion||159
8898519|NCT02055820|9956233|FG005|COMPLETED|Phase II: Expansion||0
8898520|NCT02055820|9956234|FG006|COMPLETED|Phase II: Expansion||0
8898521|NCT02055820|9956235|FG007|COMPLETED|Phase II: Expansion||0
8898522|NCT02055820|9956236|FG008|COMPLETED|Phase II: Expansion||0
8898523|NCT02055820|9956237|FG009|COMPLETED|Phase II: Expansion||0
8635680|NCT00563706|9676210|FG001|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||13
8898524|NCT02055820|9956228|FG000|NOT COMPLETED|Phase II: Expansion||0
8898525|NCT02055820|9956229|FG001|NOT COMPLETED|Phase II: Expansion||0
8898526|NCT02055820|9956230|FG002|NOT COMPLETED|Phase II: Expansion||0
8898527|NCT02055820|9956231|FG003|NOT COMPLETED|Phase II: Expansion||0
8898528|NCT02055820|9956232|FG004|NOT COMPLETED|Phase II: Expansion||49
8898529|NCT02055820|9956233|FG005|NOT COMPLETED|Phase II: Expansion||0
8898530|NCT02055820|9956234|FG006|NOT COMPLETED|Phase II: Expansion||0
8898531|NCT02055820|9956235|FG007|NOT COMPLETED|Phase II: Expansion||0
8898532|NCT02055820|9956236|FG008|NOT COMPLETED|Phase II: Expansion||0
8898533|NCT02055820|9956237|FG009|NOT COMPLETED|Phase II: Expansion||0
8898534|NCT02055898|9956281|FG000|STARTED|First Intervention (5 Days)||7
8898535|NCT02055898|9956282|FG001|STARTED|First Intervention (5 Days)||6
8898536|NCT02055898|9956281|FG000|COMPLETED|First Intervention (5 Days)||5
8898537|NCT02055898|9956282|FG001|COMPLETED|First Intervention (5 Days)||5
8898538|NCT02055898|9956281|FG000|NOT COMPLETED|First Intervention (5 Days)||2
8898539|NCT02055898|9956282|FG001|NOT COMPLETED|First Intervention (5 Days)||1
8898540|NCT02055898|9956281|FG000|STARTED|Washout (at Least 14 Days)||5
8898541|NCT02055898|9956282|FG001|STARTED|Washout (at Least 14 Days)||5
8898542|NCT02055898|9956281|FG000|COMPLETED|Washout (at Least 14 Days)||5
8898543|NCT02055898|9956282|FG001|COMPLETED|Washout (at Least 14 Days)||5
8898544|NCT02055898|9956281|FG000|NOT COMPLETED|Washout (at Least 14 Days)||0
8898545|NCT02055898|9956282|FG001|NOT COMPLETED|Washout (at Least 14 Days)||0
8898546|NCT02055898|9956281|FG000|STARTED|Second Intervention (5 Days)||5
8898547|NCT02055898|9956282|FG001|STARTED|Second Intervention (5 Days)||5
8898548|NCT02055898|9956281|FG000|COMPLETED|Second Intervention (5 Days)||5
8898549|NCT02055898|9956282|FG001|COMPLETED|Second Intervention (5 Days)||5
8898550|NCT02055898|9956281|FG000|NOT COMPLETED|Second Intervention (5 Days)||0
8898551|NCT02055898|9956282|FG001|NOT COMPLETED|Second Intervention (5 Days)||0
8898552|NCT02055976|9956297|FG000|STARTED|Overall Study||25
8898553|NCT02055976|9956298|FG001|STARTED|Overall Study||24
8898554|NCT02055976|9956299|FG002|STARTED|Overall Study||24
8898555|NCT02055976|9956300|FG003|STARTED|Overall Study||26
8898556|NCT02055976|9956301|FG004|STARTED|Overall Study||22
8898557|NCT02055976|9956302|FG005|STARTED|Overall Study||25
8898558|NCT02055976|9956303|FG006|STARTED|Overall Study||25
8898559|NCT02055976|9956304|FG007|STARTED|Overall Study||24
8898560|NCT02055976|9956305|FG008|STARTED|Overall Study||23
8898561|NCT02055976|9956297|FG000|COMPLETED|Overall Study||25
8898562|NCT02055976|9956298|FG001|COMPLETED|Overall Study||24
8898563|NCT02055976|9956299|FG002|COMPLETED|Overall Study||23
8898564|NCT02055976|9956300|FG003|COMPLETED|Overall Study||25
8898565|NCT02055976|9956301|FG004|COMPLETED|Overall Study||22
8898566|NCT02055976|9956302|FG005|COMPLETED|Overall Study||24
8635681|NCT00563706|9676211|FG002|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||3
8635682|NCT00563706|9676212|FG003|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||9
8635683|NCT00563706|9676213|FG004|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||11
8635684|NCT00563706|9676214|FG005|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||14
8635685|NCT00563706|9676215|FG006|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||9
8635686|NCT00563706|9676216|FG007|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||16
8898567|NCT02055976|9956303|FG006|COMPLETED|Overall Study||23
8898568|NCT02055976|9956304|FG007|COMPLETED|Overall Study||24
8898569|NCT02055976|9956305|FG008|COMPLETED|Overall Study||23
8898570|NCT02055976|9956297|FG000|NOT COMPLETED|Overall Study||0
8898571|NCT02055976|9956298|FG001|NOT COMPLETED|Overall Study||0
8898572|NCT02055976|9956299|FG002|NOT COMPLETED|Overall Study||1
8898573|NCT02055976|9956300|FG003|NOT COMPLETED|Overall Study||1
8898574|NCT02055976|9956301|FG004|NOT COMPLETED|Overall Study||0
8898575|NCT02055976|9956302|FG005|NOT COMPLETED|Overall Study||1
8898576|NCT02055976|9956303|FG006|NOT COMPLETED|Overall Study||2
8898577|NCT02055976|9956304|FG007|NOT COMPLETED|Overall Study||0
8898578|NCT02055976|9956305|FG008|NOT COMPLETED|Overall Study||0
8898579|NCT02056171|9956334|FG000|STARTED|Overall Study||3
8898580|NCT02056171|9956335|FG001|STARTED|Overall Study||3
8898581|NCT02056171|9956334|FG000|COMPLETED|Overall Study||3
8898582|NCT02056171|9956335|FG001|COMPLETED|Overall Study||3
8898583|NCT02056171|9956334|FG000|NOT COMPLETED|Overall Study||0
8898584|NCT02056171|9956335|FG001|NOT COMPLETED|Overall Study||0
8898585|NCT02056288|9956343|FG000|STARTED|In-Hospital Data||40
8898586|NCT02056288|9956344|FG001|STARTED|In-Hospital Data||38
8898587|NCT02056288|9956343|FG000|COMPLETED|In-Hospital Data||35
8898588|NCT02056288|9956344|FG001|COMPLETED|In-Hospital Data||38
8898589|NCT02056288|9956343|FG000|NOT COMPLETED|In-Hospital Data||5
8898590|NCT02056288|9956344|FG001|NOT COMPLETED|In-Hospital Data||0
8898591|NCT02056288|9956343|FG000|STARTED|48-Hour Post-Discharge Data||35
8898592|NCT02056288|9956344|FG001|STARTED|48-Hour Post-Discharge Data||38
8898593|NCT02056288|9956343|FG000|COMPLETED|48-Hour Post-Discharge Data||21
8898594|NCT02056288|9956344|FG001|COMPLETED|48-Hour Post-Discharge Data||18
8898595|NCT02056288|9956343|FG000|NOT COMPLETED|48-Hour Post-Discharge Data||14
8898596|NCT02056288|9956344|FG001|NOT COMPLETED|48-Hour Post-Discharge Data||20
8898597|NCT02056301|9956352|FG000|STARTED|Overall Study||33
8898598|NCT02056301|9956353|FG001|STARTED|Overall Study||29
8898599|NCT02056301|9956352|FG000|COMPLETED|Overall Study||31
8898600|NCT02056301|9956353|FG001|COMPLETED|Overall Study||23
8898601|NCT02056301|9956352|FG000|NOT COMPLETED|Overall Study||2
8898602|NCT02056301|9956353|FG001|NOT COMPLETED|Overall Study||6
8898603|NCT02056340|9956361|FG000|STARTED|Overall Study||59
8898604|NCT02056340|9956362|FG001|STARTED|Overall Study||57
8898605|NCT02056340|9956361|FG000|COMPLETED|Overall Study||52
8898606|NCT02056340|9956362|FG001|COMPLETED|Overall Study||46
8898607|NCT02056340|9956361|FG000|NOT COMPLETED|Overall Study||7
8898608|NCT02056340|9956362|FG001|NOT COMPLETED|Overall Study||11
8898609|NCT02056392|9956374|FG000|STARTED|Overall Study||10
8898610|NCT02056392|9956375|FG001|STARTED|Overall Study||9
8898611|NCT02056392|9956376|FG002|STARTED|Overall Study||9
8898612|NCT02056392|9956377|FG003|STARTED|Overall Study||9
8898613|NCT02056392|9956378|FG004|STARTED|Overall Study||8
8898614|NCT02056392|9956379|FG005|STARTED|Overall Study||9
8898615|NCT02056392|9956374|FG000|COMPLETED|Overall Study||8
8898616|NCT02056392|9956375|FG001|COMPLETED|Overall Study||8
8898617|NCT02056392|9956376|FG002|COMPLETED|Overall Study||6
8898618|NCT02056392|9956377|FG003|COMPLETED|Overall Study||9
8898619|NCT02056392|9956378|FG004|COMPLETED|Overall Study||7
8898620|NCT02056392|9956379|FG005|COMPLETED|Overall Study||9
8898621|NCT02056392|9956374|FG000|NOT COMPLETED|Overall Study||2
8898622|NCT02056392|9956375|FG001|NOT COMPLETED|Overall Study||1
8898623|NCT02056392|9956376|FG002|NOT COMPLETED|Overall Study||3
8898624|NCT02056392|9956377|FG003|NOT COMPLETED|Overall Study||0
8898625|NCT02056392|9956378|FG004|NOT COMPLETED|Overall Study||1
8898626|NCT02056392|9956379|FG005|NOT COMPLETED|Overall Study||0
8898627|NCT02056431|9956389|FG000|STARTED|Overall Study||604
8898628|NCT02056431|9956390|FG001|STARTED|Overall Study||666
8898629|NCT02056431|9956389|FG000|COMPLETED|Overall Study||560
8898630|NCT02056431|9956390|FG001|COMPLETED|Overall Study||619
8898631|NCT02056431|9956389|FG000|NOT COMPLETED|Overall Study||44
8898632|NCT02056431|9956390|FG001|NOT COMPLETED|Overall Study||47
8898633|NCT02056626|9956402|FG000|STARTED|Overall Study||13
8898634|NCT02056626|9956403|FG001|STARTED|Overall Study||13
8898635|NCT02056626|9956404|FG002|STARTED|Overall Study||4
8898636|NCT02056626|9956405|FG003|STARTED|Overall Study||14
8898637|NCT02056626|9956402|FG000|COMPLETED|Overall Study||10
8898638|NCT02056626|9956403|FG001|COMPLETED|Overall Study||12
8898639|NCT02056626|9956404|FG002|COMPLETED|Overall Study||4
8898640|NCT02056626|9956405|FG003|COMPLETED|Overall Study||14
8898641|NCT02056626|9956402|FG000|NOT COMPLETED|Overall Study||3
8898642|NCT02056626|9956403|FG001|NOT COMPLETED|Overall Study||1
8898643|NCT02056626|9956404|FG002|NOT COMPLETED|Overall Study||0
8898644|NCT02056626|9956405|FG003|NOT COMPLETED|Overall Study||0
8898645|NCT02056639|9956417|FG000|STARTED|Overall Study||23
8898646|NCT02056639|9956418|FG001|STARTED|Overall Study||23
8898647|NCT02056639|9956417|FG000|COMPLETED|Overall Study||23
8898648|NCT02056639|9956418|FG001|COMPLETED|Overall Study||23
8898649|NCT02056639|9956417|FG000|NOT COMPLETED|Overall Study||0
8898650|NCT02056639|9956418|FG001|NOT COMPLETED|Overall Study||0
8898651|NCT02056652|9956428|FG000|STARTED|Overall Study||61
8898652|NCT02056652|9956429|FG001|STARTED|Overall Study||61
8898653|NCT02056652|9956428|FG000|COMPLETED|Overall Study||60
8898654|NCT02056652|9956429|FG001|COMPLETED|Overall Study||58
8898655|NCT02056652|9956428|FG000|NOT COMPLETED|Overall Study||1
8898656|NCT02056652|9956429|FG001|NOT COMPLETED|Overall Study||3
8898657|NCT02056834|9956435|FG000|STARTED|Overall Study||36
8898658|NCT02056834|9956435|FG000|6 Weeks|Overall Study||34
8898659|NCT02056834|9956435|FG000|6 Months|Overall Study||31
8898660|NCT02056834|9956435|FG000|COMPLETED|Overall Study||29
8898661|NCT02056834|9956435|FG000|NOT COMPLETED|Overall Study||7
8898662|NCT02057042|9956442|FG000|STARTED|Overall Study||163
8898663|NCT02057042|9956443|FG001|STARTED|Overall Study||167
8898664|NCT02057042|9956442|FG000|COMPLETED|Overall Study||118
8898665|NCT02057042|9956443|FG001|COMPLETED|Overall Study||101
8898666|NCT02057042|9956442|FG000|NOT COMPLETED|Overall Study||45
8898667|NCT02057042|9956443|FG001|NOT COMPLETED|Overall Study||66
8898668|NCT02057068|9956451|FG000|STARTED|Overall Study||60
8898669|NCT02057068|9956452|FG001|STARTED|Overall Study||36
8898670|NCT02057068|9956451|FG000|COMPLETED|Overall Study||52
8898671|NCT02057068|9956452|FG001|COMPLETED|Overall Study||28
8898672|NCT02057068|9956451|FG000|NOT COMPLETED|Overall Study||8
8898673|NCT02057068|9956452|FG001|NOT COMPLETED|Overall Study||8
8898674|NCT02057081|9956462|FG000|STARTED|Overall Study||136
8898675|NCT02057081|9956463|FG001|STARTED|Overall Study||112
8898676|NCT02057081|9956462|FG000|Completed Baseline|Overall Study||88
8898677|NCT02057081|9956463|FG001|Completed Baseline|Overall Study||80
8898678|NCT02057081|9956462|FG000|Post-Treatment Assessment|Overall Study||58
8898679|NCT02057081|9956463|FG001|Post-Treatment Assessment|Overall Study||52
8898680|NCT02057081|9956462|FG000|COMPLETED|Overall Study||46
8898681|NCT02057081|9956463|FG001|COMPLETED|Overall Study||44
8898682|NCT02057081|9956462|FG000|NOT COMPLETED|Overall Study||90
8898683|NCT02057081|9956463|FG001|NOT COMPLETED|Overall Study||68
8898684|NCT02057198|9956472|FG000|STARTED|Overall Study||11
8898685|NCT02057198|9956473|FG001|STARTED|Overall Study||11
8898686|NCT02057198|9956474|FG002|STARTED|Overall Study||11
8898687|NCT02057198|9956472|FG000|COMPLETED|Overall Study||11
8898688|NCT02057198|9956473|FG001|COMPLETED|Overall Study||10
8898689|NCT02057198|9956474|FG002|COMPLETED|Overall Study||10
8898690|NCT02057198|9956472|FG000|NOT COMPLETED|Overall Study||0
8898691|NCT02057198|9956473|FG001|NOT COMPLETED|Overall Study||1
8898692|NCT02057198|9956474|FG002|NOT COMPLETED|Overall Study||1
8898693|NCT02057250|9956486|FG000|STARTED|AID Assessment Phase||56
8898694|NCT02057250|9956487|FG001|STARTED|AID Assessment Phase||53
8898695|NCT02057250|9956488|FG002|STARTED|AID Assessment Phase||52
8898696|NCT02057250|9956489|FG003|STARTED|AID Assessment Phase||56
8898697|NCT02057250|9956490|FG004|STARTED|AID Assessment Phase||0
8898698|NCT02057250|9956486|FG000|COMPLETED|AID Assessment Phase||52
8898699|NCT02057250|9956487|FG001|COMPLETED|AID Assessment Phase||50
8898700|NCT02057250|9956488|FG002|COMPLETED|AID Assessment Phase||45
8898701|NCT02057250|9956489|FG003|COMPLETED|AID Assessment Phase||54
8898702|NCT02057250|9956490|FG004|COMPLETED|AID Assessment Phase||0
8898703|NCT02057250|9956486|FG000|NOT COMPLETED|AID Assessment Phase||4
8898704|NCT02057250|9956487|FG001|NOT COMPLETED|AID Assessment Phase||3
8898705|NCT02057250|9956488|FG002|NOT COMPLETED|AID Assessment Phase||7
8898706|NCT02057250|9956489|FG003|NOT COMPLETED|AID Assessment Phase||2
8898707|NCT02057250|9956490|FG004|NOT COMPLETED|AID Assessment Phase||0
8898708|NCT02057250|9956486|FG000|STARTED|Extension Phase||0
9008846|NCT02968368|10071631|FG000|STARTED|Open Label Phase||86
9008847|NCT02968368|10071632|FG001|STARTED|Open Label Phase||39
9008848|NCT02968368|10071631|FG000|COMPLETED|Open Label Phase||67
9008849|NCT02968368|10071632|FG001|COMPLETED|Open Label Phase||25
9008850|NCT02968368|10071631|FG000|NOT COMPLETED|Open Label Phase||19
9008851|NCT02968368|10071632|FG001|NOT COMPLETED|Open Label Phase||14
9008852|NCT02968420|10071643|FG000|STARTED|Overall Study||6
9008853|NCT02968420|10071644|FG001|STARTED|Overall Study||6
9008854|NCT02968420|10071645|FG002|STARTED|Overall Study||6
9008855|NCT02968420|10071643|FG000|COMPLETED|Overall Study||6
9008856|NCT02968420|10071644|FG001|COMPLETED|Overall Study||6
9008857|NCT02968420|10071645|FG002|COMPLETED|Overall Study||6
9008858|NCT02968420|10071643|FG000|NOT COMPLETED|Overall Study||0
9008859|NCT02968420|10071644|FG001|NOT COMPLETED|Overall Study||0
9008860|NCT02968420|10071645|FG002|NOT COMPLETED|Overall Study||0
9008861|NCT02968433|10071653|FG000|STARTED|Overall Study||16
9008862|NCT02968433|10071653|FG000|COMPLETED|Overall Study||15
9008863|NCT02968433|10071653|FG000|NOT COMPLETED|Overall Study||1
9008864|NCT02968576|10071663|FG000|STARTED|Overall Study||11
9008865|NCT02968576|10071664|FG001|STARTED|Overall Study||14
9008866|NCT02968576|10071663|FG000|COMPLETED|Overall Study||11
9008867|NCT02968576|10071664|FG001|COMPLETED|Overall Study||13
9008868|NCT02968576|10071663|FG000|NOT COMPLETED|Overall Study||0
9008869|NCT02968576|10071664|FG001|NOT COMPLETED|Overall Study||1
9008870|NCT02968758|10071670|FG000|STARTED|Overall Study||797
9008871|NCT02968758|10071671|FG001|STARTED|Overall Study||1664
9008872|NCT02968758|10071670|FG000|COMPLETED|Overall Study||797
9008873|NCT02968758|10071671|FG001|COMPLETED|Overall Study||1664
9008874|NCT02968758|10071670|FG000|NOT COMPLETED|Overall Study||0
9008875|NCT02968758|10071671|FG001|NOT COMPLETED|Overall Study||0
9008876|NCT02968914|10071678|FG000|STARTED|Overall Study||90
9008877|NCT02968914|10071679|FG001|STARTED|Overall Study||90
9008878|NCT02968914|10071678|FG000|COMPLETED|Overall Study||90
9008879|NCT02968914|10071679|FG001|COMPLETED|Overall Study||90
9008880|NCT02968914|10071678|FG000|NOT COMPLETED|Overall Study||0
9008881|NCT02968914|10071679|FG001|NOT COMPLETED|Overall Study||0
9008882|NCT02968979|10071685|FG000|STARTED|Overall Study||539
9008883|NCT02968979|10071685|FG000|COMPLETED|Overall Study|This cross-sectional study had only 1 visit.|531
9008884|NCT02968979|10071685|FG000|NOT COMPLETED|Overall Study||8
9008885|NCT02968992|10071737|FG000|STARTED|Overall Study||18
9008886|NCT02968992|10071738|FG001|STARTED|Overall Study||18
9008887|NCT02968992|10071737|FG000|COMPLETED|Overall Study||18
9008888|NCT02968992|10071738|FG001|COMPLETED|Overall Study||17
9008889|NCT02968992|10071737|FG000|NOT COMPLETED|Overall Study||0
9008890|NCT02968992|10071738|FG001|NOT COMPLETED|Overall Study||1
9008891|NCT02969018|10071752|FG000|STARTED|Overall Study||25
9008892|NCT02969018|10071753|FG001|STARTED|Overall Study||29
9008893|NCT02969018|10071754|FG002|STARTED|Overall Study||26
9008894|NCT02969018|10071755|FG003|STARTED|Overall Study||25
9008895|NCT02969018|10071756|FG004|STARTED|Overall Study||29
9008896|NCT02969018|10071757|FG005|STARTED|Overall Study||25
9008897|NCT02969018|10071758|FG006|STARTED|Overall Study||30
9008898|NCT02969018|10071759|FG007|STARTED|Overall Study||23
9008899|NCT02969018|10071752|FG000|COMPLETED|Overall Study||21
9008900|NCT02969018|10071753|FG001|COMPLETED|Overall Study||21
8572833|NCT00117325|9605023|FG000|NOT COMPLETED|Overall Study||13
8572834|NCT00117325|9605024|FG001|NOT COMPLETED|Overall Study||12
8572835|NCT00117507|9605031|FG000|STARTED|Overall Study||24
8572836|NCT00117507|9605031|FG000|COMPLETED|Overall Study||9
8572837|NCT00117507|9605031|FG000|NOT COMPLETED|Overall Study||15
8572838|NCT00117559|9605038|FG000|STARTED|Overall Study||9
8572839|NCT00117559|9605039|FG001|STARTED|Overall Study||10
8898709|NCT02057250|9956487|FG001|STARTED|Extension Phase||0
8898710|NCT02057250|9956488|FG002|STARTED|Extension Phase||0
8898711|NCT02057250|9956489|FG003|STARTED|Extension Phase||0
8898712|NCT02057250|9956490|FG004|STARTED|Extension Phase|9 participants who completed AID Assessment phase did not enter extension phase.|192
8898713|NCT02057250|9956486|FG000|Treated|Extension Phase||0
8898714|NCT02057250|9956487|FG001|Treated|Extension Phase||0
8898715|NCT02057250|9956488|FG002|Treated|Extension Phase||0
8898716|NCT02057250|9956489|FG003|Treated|Extension Phase||0
8898717|NCT02057250|9956490|FG004|Treated|Extension Phase||188
9008901|NCT02969018|10071754|FG002|COMPLETED|Overall Study||20
9008902|NCT02969018|10071755|FG003|COMPLETED|Overall Study||20
9008903|NCT02969018|10071756|FG004|COMPLETED|Overall Study||27
9008904|NCT02969018|10071757|FG005|COMPLETED|Overall Study||17
8898718|NCT02057250|9956486|FG000|COMPLETED|Extension Phase||0
8898719|NCT02057250|9956487|FG001|COMPLETED|Extension Phase||0
8898720|NCT02057250|9956488|FG002|COMPLETED|Extension Phase||0
8898721|NCT02057250|9956489|FG003|COMPLETED|Extension Phase||0
8898722|NCT02057250|9956490|FG004|COMPLETED|Extension Phase||156
8898723|NCT02057250|9956486|FG000|NOT COMPLETED|Extension Phase||0
8898724|NCT02057250|9956487|FG001|NOT COMPLETED|Extension Phase||0
8898725|NCT02057250|9956488|FG002|NOT COMPLETED|Extension Phase||0
8898726|NCT02057250|9956489|FG003|NOT COMPLETED|Extension Phase||0
8898727|NCT02057250|9956490|FG004|NOT COMPLETED|Extension Phase||36
8898728|NCT02057393|9956502|FG000|STARTED|Overall Study||89
8898729|NCT02057393|9956502|FG000|COMPLETED|Overall Study||87
8898730|NCT02057393|9956502|FG000|NOT COMPLETED|Overall Study||2
8898731|NCT02057406|9956509|FG000|STARTED|Overall Study||36
8898732|NCT02057406|9956510|FG001|STARTED|Overall Study||36
8898733|NCT02057406|9956511|FG002|STARTED|Overall Study||36
8898734|NCT02057406|9956509|FG000|COMPLETED|Overall Study||35
8898735|NCT02057406|9956510|FG001|COMPLETED|Overall Study||33
8898736|NCT02057406|9956511|FG002|COMPLETED|Overall Study||32
8898737|NCT02057406|9956509|FG000|NOT COMPLETED|Overall Study||1
8898738|NCT02057406|9956510|FG001|NOT COMPLETED|Overall Study||3
8898739|NCT02057406|9956511|FG002|NOT COMPLETED|Overall Study||4
8898740|NCT02057458|9956519|FG000|STARTED|Recruited for Participation||8
8898741|NCT02057458|9956520|FG001|STARTED|Recruited for Participation||8
8898742|NCT02057458|9956521|FG002|STARTED|Recruited for Participation||3
8898743|NCT02057458|9956519|FG000|COMPLETED|Recruited for Participation||8
8898744|NCT02057458|9956520|FG001|COMPLETED|Recruited for Participation||8
8898745|NCT02057458|9956521|FG002|COMPLETED|Recruited for Participation||3
8898746|NCT02057458|9956519|FG000|NOT COMPLETED|Recruited for Participation||0
8898747|NCT02057458|9956520|FG001|NOT COMPLETED|Recruited for Participation||0
8898748|NCT02057458|9956521|FG002|NOT COMPLETED|Recruited for Participation||0
8898749|NCT02057458|9956519|FG000|STARTED|Met Inclusion Criteria||8
8898750|NCT02057458|9956520|FG001|STARTED|Met Inclusion Criteria||8
8898751|NCT02057458|9956521|FG002|STARTED|Met Inclusion Criteria||3
8898752|NCT02057458|9956519|FG000|COMPLETED|Met Inclusion Criteria||8
8898753|NCT02057458|9956520|FG001|COMPLETED|Met Inclusion Criteria||7
8898754|NCT02057458|9956521|FG002|COMPLETED|Met Inclusion Criteria||3
8898755|NCT02057458|9956519|FG000|NOT COMPLETED|Met Inclusion Criteria||0
8898756|NCT02057458|9956520|FG001|NOT COMPLETED|Met Inclusion Criteria||1
8898757|NCT02057458|9956521|FG002|NOT COMPLETED|Met Inclusion Criteria||0
8898758|NCT02057458|9956519|FG000|STARTED|Acute Study (1 Hour): First Intervention||8
8898759|NCT02057458|9956520|FG001|STARTED|Acute Study (1 Hour): First Intervention||7
8898760|NCT02057458|9956521|FG002|STARTED|Acute Study (1 Hour): First Intervention||0
8898761|NCT02057458|9956519|FG000|COMPLETED|Acute Study (1 Hour): First Intervention||6
8898762|NCT02057458|9956520|FG001|COMPLETED|Acute Study (1 Hour): First Intervention||7
8635687|NCT00563706|9676217|FG008|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||32
8635688|NCT00563706|9676209|FG000|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||17
8635689|NCT00563706|9676210|FG001|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
8635690|NCT00563706|9676211|FG002|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
8635691|NCT00563706|9676212|FG003|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||10
8898763|NCT02057458|9956521|FG002|COMPLETED|Acute Study (1 Hour): First Intervention||0
8898764|NCT02057458|9956519|FG000|NOT COMPLETED|Acute Study (1 Hour): First Intervention||2
8898765|NCT02057458|9956520|FG001|NOT COMPLETED|Acute Study (1 Hour): First Intervention||0
8898766|NCT02057458|9956521|FG002|NOT COMPLETED|Acute Study (1 Hour): First Intervention||0
8898767|NCT02057458|9956519|FG000|STARTED|Acute Study (1 Hour): Second Int.||6
8898768|NCT02057458|9956520|FG001|STARTED|Acute Study (1 Hour): Second Int.||7
8898769|NCT02057458|9956521|FG002|STARTED|Acute Study (1 Hour): Second Int.||0
8898770|NCT02057458|9956519|FG000|COMPLETED|Acute Study (1 Hour): Second Int.||6
8898771|NCT02057458|9956520|FG001|COMPLETED|Acute Study (1 Hour): Second Int.||7
8898772|NCT02057458|9956521|FG002|COMPLETED|Acute Study (1 Hour): Second Int.||0
8898773|NCT02057458|9956519|FG000|NOT COMPLETED|Acute Study (1 Hour): Second Int.||0
8898774|NCT02057458|9956520|FG001|NOT COMPLETED|Acute Study (1 Hour): Second Int.||0
8898775|NCT02057458|9956521|FG002|NOT COMPLETED|Acute Study (1 Hour): Second Int.||0
8898776|NCT02057458|9956519|FG000|STARTED|Sub-Chronic Study (4 Weeks)||6
8898777|NCT02057458|9956520|FG001|STARTED|Sub-Chronic Study (4 Weeks)||7
8898778|NCT02057458|9956521|FG002|STARTED|Sub-Chronic Study (4 Weeks)||3
8898779|NCT02057458|9956519|FG000|COMPLETED|Sub-Chronic Study (4 Weeks)||5
8898780|NCT02057458|9956520|FG001|COMPLETED|Sub-Chronic Study (4 Weeks)||7
8898781|NCT02057458|9956521|FG002|COMPLETED|Sub-Chronic Study (4 Weeks)||3
8898782|NCT02057458|9956519|FG000|NOT COMPLETED|Sub-Chronic Study (4 Weeks)||1
8898783|NCT02057458|9956520|FG001|NOT COMPLETED|Sub-Chronic Study (4 Weeks)||0
8898784|NCT02057458|9956521|FG002|NOT COMPLETED|Sub-Chronic Study (4 Weeks)||0
8898785|NCT02057523|9956551|FG000|STARTED|Overall Study||2
8898786|NCT02057523|9956551|FG000|COMPLETED|Overall Study||0
8898787|NCT02057523|9956551|FG000|NOT COMPLETED|Overall Study||2
8898788|NCT02057549|9956557|FG000|STARTED|Overall Study||18
8898789|NCT02057549|9956558|FG001|STARTED|Overall Study||18
8898790|NCT02057549|9956557|FG000|COMPLETED|Overall Study||15
8898791|NCT02057549|9956558|FG001|COMPLETED|Overall Study||18
8898792|NCT02057549|9956557|FG000|NOT COMPLETED|Overall Study||3
8898793|NCT02057549|9956558|FG001|NOT COMPLETED|Overall Study||0
8898794|NCT02057575|9956568|FG000|STARTED|Overall Study||74
8898795|NCT02057575|9956569|FG001|STARTED|Overall Study||73
8898796|NCT02057575|9956570|FG002|STARTED|Overall Study||78
8898797|NCT02057575|9956571|FG003|STARTED|Overall Study||73
8898798|NCT02057575|9956568|FG000|COMPLETED|Overall Study||73
8898799|NCT02057575|9956569|FG001|COMPLETED|Overall Study||69
8898800|NCT02057575|9956570|FG002|COMPLETED|Overall Study||78
8898801|NCT02057575|9956571|FG003|COMPLETED|Overall Study||72
8898802|NCT02057575|9956568|FG000|NOT COMPLETED|Overall Study||1
8898803|NCT02057575|9956569|FG001|NOT COMPLETED|Overall Study||4
8898804|NCT02057575|9956570|FG002|NOT COMPLETED|Overall Study||0
8898805|NCT02057575|9956571|FG003|NOT COMPLETED|Overall Study||1
8898806|NCT02057640|9956583|FG000|STARTED|Weeks 1-4|1 extra participant accidentally treated at DL1 (in addition to initial 3).|4
8898807|NCT02057640|9956584|FG001|STARTED|Weeks 1-4||3
8898808|NCT02057640|9956583|FG000|COMPLETED|Weeks 1-4||4
8898809|NCT02057640|9956584|FG001|COMPLETED|Weeks 1-4||3
8898810|NCT02057640|9956583|FG000|NOT COMPLETED|Weeks 1-4||0
8898811|NCT02057640|9956584|FG001|NOT COMPLETED|Weeks 1-4||0
8898812|NCT02057640|9956583|FG000|STARTED|Phase II Portion of Study at DL2||0
8898813|NCT02057640|9956584|FG001|STARTED|Phase II Portion of Study at DL2||9
8898814|NCT02057640|9956583|FG000|COMPLETED|Phase II Portion of Study at DL2||0
8898815|NCT02057640|9956584|FG001|COMPLETED|Phase II Portion of Study at DL2||9
8898816|NCT02057640|9956583|FG000|NOT COMPLETED|Phase II Portion of Study at DL2||0
8898817|NCT02057640|9956584|FG001|NOT COMPLETED|Phase II Portion of Study at DL2||0
8898818|NCT02057666|9956593|FG000|STARTED|Double Blind Treatment Period||96
8898819|NCT02057666|9956594|FG001|STARTED|Double Blind Treatment Period||50
8898820|NCT02057666|9956593|FG000|COMPLETED|Double Blind Treatment Period|Number of patients who continued into the open-label treatment period.|0
8898821|NCT02057666|9956594|FG001|COMPLETED|Double Blind Treatment Period|Number of patients who continued into the open-label treatment period.|6
8898822|NCT02057666|9956593|FG000|NOT COMPLETED|Double Blind Treatment Period||96
8898823|NCT02057666|9956594|FG001|NOT COMPLETED|Double Blind Treatment Period||44
8898824|NCT02057666|9956593|FG000|STARTED|Open-Label Treatment Period||0
8898825|NCT02057666|9956594|FG001|STARTED|Open-Label Treatment Period||6
8898826|NCT02057666|9956593|FG000|COMPLETED|Open-Label Treatment Period||0
8898827|NCT02057666|9956594|FG001|COMPLETED|Open-Label Treatment Period||0
8898828|NCT02057666|9956593|FG000|NOT COMPLETED|Open-Label Treatment Period||0
8898829|NCT02057666|9956594|FG001|NOT COMPLETED|Open-Label Treatment Period||6
8898830|NCT02057692|9956604|FG000|STARTED|Overall Study||8
8898831|NCT02057692|9956605|FG001|STARTED|Overall Study||11
8898832|NCT02057692|9956606|FG002|STARTED|Overall Study||6
8898833|NCT02057692|9956607|FG003|STARTED|Overall Study||12
8898834|NCT02057692|9956604|FG000|COMPLETED|Overall Study||7
8898835|NCT02057692|9956605|FG001|COMPLETED|Overall Study||11
8898836|NCT02057692|9956606|FG002|COMPLETED|Overall Study||6
8898837|NCT02057692|9956607|FG003|COMPLETED|Overall Study||11
8898838|NCT02057692|9956604|FG000|NOT COMPLETED|Overall Study||1
8898839|NCT02057692|9956605|FG001|NOT COMPLETED|Overall Study||0
8898840|NCT02057692|9956606|FG002|NOT COMPLETED|Overall Study||0
8898841|NCT02057692|9956607|FG003|NOT COMPLETED|Overall Study||1
9008905|NCT02969018|10071758|FG006|COMPLETED|Overall Study||22
9008906|NCT02969018|10071759|FG007|COMPLETED|Overall Study||16
9008907|NCT02969018|10071752|FG000|NOT COMPLETED|Overall Study||4
9008908|NCT02969018|10071753|FG001|NOT COMPLETED|Overall Study||8
9008909|NCT02969018|10071754|FG002|NOT COMPLETED|Overall Study||6
9008910|NCT02969018|10071755|FG003|NOT COMPLETED|Overall Study||5
9008911|NCT02969018|10071756|FG004|NOT COMPLETED|Overall Study||2
9008912|NCT02969018|10071757|FG005|NOT COMPLETED|Overall Study||8
9008913|NCT02969018|10071758|FG006|NOT COMPLETED|Overall Study||8
9008914|NCT02969018|10071759|FG007|NOT COMPLETED|Overall Study||7
9008915|NCT02969031|10071782|FG000|STARTED|Enrolled and Randomized||73
9008916|NCT02969031|10071783|FG001|STARTED|Enrolled and Randomized||75
9008917|NCT02969031|10071782|FG000|COMPLETED|Enrolled and Randomized||73
9008918|NCT02969031|10071783|FG001|COMPLETED|Enrolled and Randomized||75
9008919|NCT02969031|10071782|FG000|NOT COMPLETED|Enrolled and Randomized||0
9008920|NCT02969031|10071783|FG001|NOT COMPLETED|Enrolled and Randomized||0
9008921|NCT02969031|10071782|FG000|STARTED|Collection of Baseline Surveys||73
9008922|NCT02969031|10071783|FG001|STARTED|Collection of Baseline Surveys||75
9008923|NCT02969031|10071782|FG000|COMPLETED|Collection of Baseline Surveys||34
9008924|NCT02969031|10071783|FG001|COMPLETED|Collection of Baseline Surveys||23
9008925|NCT02969031|10071782|FG000|NOT COMPLETED|Collection of Baseline Surveys||39
9008926|NCT02969031|10071783|FG001|NOT COMPLETED|Collection of Baseline Surveys||52
9008927|NCT02969031|10071782|FG000|STARTED|Collection of Baseline Recordings||34
9008928|NCT02969031|10071783|FG001|STARTED|Collection of Baseline Recordings||23
9008929|NCT02969031|10071782|FG000|COMPLETED|Collection of Baseline Recordings||22
9008930|NCT02969031|10071783|FG001|COMPLETED|Collection of Baseline Recordings||18
9008931|NCT02969031|10071782|FG000|NOT COMPLETED|Collection of Baseline Recordings||12
9008932|NCT02969031|10071783|FG001|NOT COMPLETED|Collection of Baseline Recordings||5
9008933|NCT02969031|10071782|FG000|STARTED|Completed Intervention||22
9008934|NCT02969031|10071783|FG001|STARTED|Completed Intervention||18
9008935|NCT02969031|10071782|FG000|COMPLETED|Completed Intervention||15
9008936|NCT02969031|10071783|FG001|COMPLETED|Completed Intervention||14
9008937|NCT02969031|10071782|FG000|NOT COMPLETED|Completed Intervention||7
9008938|NCT02969031|10071783|FG001|NOT COMPLETED|Completed Intervention||4
9008939|NCT02969031|10071782|FG000|STARTED|Collection of Follow-Up Surveys||15
9008940|NCT02969031|10071783|FG001|STARTED|Collection of Follow-Up Surveys||14
9008941|NCT02969031|10071782|FG000|COMPLETED|Collection of Follow-Up Surveys||15
8898842|NCT02057718|9956625|FG000|STARTED|Completed Study Treatment Through Wk. 72||8
8898843|NCT02057718|9956626|FG001|STARTED|Completed Study Treatment Through Wk. 72||25
8898844|NCT02057718|9956625|FG000|Completed Study Treatment Through Week 72|Completed Study Treatment Through Wk. 72||6
8898845|NCT02057718|9956626|FG001|Completed Study Treatment Through Week 72|Completed Study Treatment Through Wk. 72||16
8898846|NCT02057718|9956625|FG000|COMPLETED|Completed Study Treatment Through Wk. 72||6
8898847|NCT02057718|9956626|FG001|COMPLETED|Completed Study Treatment Through Wk. 72||16
8898848|NCT02057718|9956625|FG000|NOT COMPLETED|Completed Study Treatment Through Wk. 72||2
8898849|NCT02057718|9956626|FG001|NOT COMPLETED|Completed Study Treatment Through Wk. 72||9
8898850|NCT02057718|9956625|FG000|STARTED|Optional Follow-up Treatment Period||6
8898851|NCT02057718|9956626|FG001|STARTED|Optional Follow-up Treatment Period||16
8898852|NCT02057718|9956625|FG000|COMPLETED|Optional Follow-up Treatment Period||4
8898853|NCT02057718|9956626|FG001|COMPLETED|Optional Follow-up Treatment Period||8
8898854|NCT02057718|9956625|FG000|NOT COMPLETED|Optional Follow-up Treatment Period||2
8898855|NCT02057718|9956626|FG001|NOT COMPLETED|Optional Follow-up Treatment Period||8
8898856|NCT02057757|9956634|FG000|STARTED|Overall Study||131
8635692|NCT00563706|9676213|FG004|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
8635693|NCT00563706|9676214|FG005|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
8635694|NCT00563706|9676215|FG006|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||3
8635695|NCT00563706|9676216|FG007|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||14
9008942|NCT02969031|10071783|FG001|COMPLETED|Collection of Follow-Up Surveys||12
9008943|NCT02969031|10071782|FG000|NOT COMPLETED|Collection of Follow-Up Surveys||0
9008944|NCT02969031|10071783|FG001|NOT COMPLETED|Collection of Follow-Up Surveys||2
9008945|NCT02969031|10071782|FG000|STARTED|Collection of Follow-Up Recordings||15
9008946|NCT02969031|10071783|FG001|STARTED|Collection of Follow-Up Recordings||12
9008947|NCT02969031|10071782|FG000|COMPLETED|Collection of Follow-Up Recordings||15
9008948|NCT02969031|10071783|FG001|COMPLETED|Collection of Follow-Up Recordings||12
9008949|NCT02969031|10071782|FG000|NOT COMPLETED|Collection of Follow-Up Recordings||0
9008950|NCT02969031|10071783|FG001|NOT COMPLETED|Collection of Follow-Up Recordings||0
9008951|NCT02969031|10071782|FG000|STARTED|Completed and Analyzed||15
9008952|NCT02969031|10071783|FG001|STARTED|Completed and Analyzed||12
9008953|NCT02969031|10071782|FG000|COMPLETED|Completed and Analyzed||15
9008954|NCT02969031|10071783|FG001|COMPLETED|Completed and Analyzed||12
9008955|NCT02969031|10071782|FG000|NOT COMPLETED|Completed and Analyzed||0
9008956|NCT02969031|10071783|FG001|NOT COMPLETED|Completed and Analyzed||0
9008957|NCT02969044|10071791|FG000|STARTED|Overall Study||42
9008958|NCT02969044|10071792|FG001|STARTED|Overall Study||28
9008959|NCT02969044|10071791|FG000|COMPLETED|Overall Study||37
9008960|NCT02969044|10071792|FG001|COMPLETED|Overall Study||22
9008961|NCT02969044|10071791|FG000|NOT COMPLETED|Overall Study||5
9008962|NCT02969044|10071792|FG001|NOT COMPLETED|Overall Study||6
9008963|NCT02969187|10071800|FG000|STARTED|Overall Study||63
9008964|NCT02969187|10071801|FG001|STARTED|Overall Study||63
9008965|NCT02969187|10071800|FG000|COMPLETED|Overall Study||51
9008966|NCT02969187|10071801|FG001|COMPLETED|Overall Study||50
9008967|NCT02969187|10071800|FG000|NOT COMPLETED|Overall Study||12
9008968|NCT02969187|10071801|FG001|NOT COMPLETED|Overall Study||13
9008969|NCT02969317|10071809|FG000|STARTED|Overall Study||12
9008970|NCT02969317|10071809|FG000|COMPLETED|Overall Study||12
9008971|NCT02969317|10071809|FG000|NOT COMPLETED|Overall Study||0
9008972|NCT02969356|10071814|FG000|STARTED|Overall Study||157
9008973|NCT02969356|10071814|FG000|Intent-to-Treat (ITT) Population|Overall Study||153
9008974|NCT02969356|10071814|FG000|COMPLETED|Overall Study||134
9008975|NCT02969356|10071814|FG000|NOT COMPLETED|Overall Study||23
9039573|NCT03340337|10100552|FG000|COMPLETED|Overall Study||30
9039574|NCT03340337|10100552|FG000|NOT COMPLETED|Overall Study||0
9039575|NCT03340350|10100567|FG000|STARTED|Overall Study||10
9039576|NCT03340350|10100567|FG000|COMPLETED|Overall Study||4
9039577|NCT03340350|10100567|FG000|NOT COMPLETED|Overall Study||6
9039578|NCT03340415|10100574|FG000|STARTED|Overall Study||29
9039579|NCT03340415|10100575|FG001|STARTED|Overall Study||24
9039580|NCT03340415|10100574|FG000|COMPLETED|Overall Study||29
9039581|NCT03340415|10100575|FG001|COMPLETED|Overall Study||21
8635696|NCT00563706|9676217|FG008|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||11
8635697|NCT00563706|9676209|FG000|STARTED|Taper Phase (Day 29 up to Day 35)||20
8635698|NCT00563706|9676210|FG001|STARTED|Taper Phase (Day 29 up to Day 35)||13
9039582|NCT03340415|10100574|FG000|NOT COMPLETED|Overall Study||0
9039583|NCT03340415|10100575|FG001|NOT COMPLETED|Overall Study||3
9039584|NCT03340428|10100585|FG000|STARTED|Overall Study||117
9039585|NCT03340428|10100586|FG001|STARTED|Overall Study||59
9039586|NCT03340428|10100585|FG000|COMPLETED|Overall Study||116
9039587|NCT03340428|10100586|FG001|COMPLETED|Overall Study||59
8898857|NCT02057757|9956635|FG001|STARTED|Overall Study||129
8898858|NCT02057757|9956634|FG000|Intent to Treat|Overall Study||130
8898859|NCT02057757|9956635|FG001|Intent to Treat|Overall Study||127
8898860|NCT02057757|9956634|FG000|COMPLETED|Overall Study||117
8898861|NCT02057757|9956635|FG001|COMPLETED|Overall Study||121
8898862|NCT02057757|9956634|FG000|NOT COMPLETED|Overall Study||14
8898863|NCT02057757|9956635|FG001|NOT COMPLETED|Overall Study||8
8898864|NCT02057835|9956655|FG000|STARTED|Overall Study||8
8898865|NCT02057835|9956656|FG001|STARTED|Overall Study||6
8898866|NCT02057835|9956657|FG002|STARTED|Overall Study||6
8898867|NCT02057835|9956658|FG003|STARTED|Overall Study||6
8898868|NCT02057835|9956659|FG004|STARTED|Overall Study||6
8898869|NCT02057835|9956660|FG005|STARTED|Overall Study||8
8898870|NCT02057835|9956661|FG006|STARTED|Overall Study||6
8898871|NCT02057835|9956662|FG007|STARTED|Overall Study||6
8898872|NCT02057835|9956663|FG008|STARTED|Overall Study||6
8898873|NCT02057835|9956664|FG009|STARTED|Overall Study||6
8898874|NCT02057835|9956655|FG000|COMPLETED|Overall Study||8
8898875|NCT02057835|9956656|FG001|COMPLETED|Overall Study||4
8898876|NCT02057835|9956657|FG002|COMPLETED|Overall Study||6
8898877|NCT02057835|9956658|FG003|COMPLETED|Overall Study||6
8898878|NCT02057835|9956659|FG004|COMPLETED|Overall Study||6
8898879|NCT02057835|9956660|FG005|COMPLETED|Overall Study||8
8898880|NCT02057835|9956661|FG006|COMPLETED|Overall Study||6
8898881|NCT02057835|9956662|FG007|COMPLETED|Overall Study||6
8898882|NCT02057835|9956663|FG008|COMPLETED|Overall Study||6
8898883|NCT02057835|9956664|FG009|COMPLETED|Overall Study||6
8898884|NCT02057835|9956655|FG000|NOT COMPLETED|Overall Study||0
8898885|NCT02057835|9956656|FG001|NOT COMPLETED|Overall Study||2
8898886|NCT02057835|9956657|FG002|NOT COMPLETED|Overall Study||0
8898887|NCT02057835|9956658|FG003|NOT COMPLETED|Overall Study||0
8898888|NCT02057835|9956659|FG004|NOT COMPLETED|Overall Study||0
8898889|NCT02057835|9956660|FG005|NOT COMPLETED|Overall Study||0
8898890|NCT02057835|9956661|FG006|NOT COMPLETED|Overall Study||0
8898891|NCT02057835|9956662|FG007|NOT COMPLETED|Overall Study||0
8898892|NCT02057835|9956663|FG008|NOT COMPLETED|Overall Study||0
8898893|NCT02057835|9956664|FG009|NOT COMPLETED|Overall Study||0
8898894|NCT02057939|9956693|FG000|STARTED|Overall Study||38
8898895|NCT02057939|9956693|FG000|COMPLETED|Overall Study||37
8898896|NCT02057939|9956693|FG000|NOT COMPLETED|Overall Study||1
8898897|NCT02057952|9956700|FG000|STARTED|Overall Study||51
8898898|NCT02057952|9956701|FG001|STARTED|Overall Study||49
8898899|NCT02057952|9956702|FG002|STARTED|Overall Study||50
8898900|NCT02057952|9956700|FG000|COMPLETED|Overall Study||43
8898901|NCT02057952|9956701|FG001|COMPLETED|Overall Study||39
8898902|NCT02057952|9956702|FG002|COMPLETED|Overall Study||28
8898903|NCT02057952|9956700|FG000|NOT COMPLETED|Overall Study||8
8898904|NCT02057952|9956701|FG001|NOT COMPLETED|Overall Study||10
8898905|NCT02057952|9956702|FG002|NOT COMPLETED|Overall Study||22
8898906|NCT02058069|9956710|FG000|STARTED|Overall Study||100
8898907|NCT02058069|9956710|FG000|COMPLETED|Overall Study||89
8898908|NCT02058069|9956710|FG000|NOT COMPLETED|Overall Study||11
8898909|NCT02058095|9956716|FG000|STARTED|Overall Study||15
8898910|NCT02058095|9956717|FG001|STARTED|Overall Study||7
9008976|NCT02969382|10071820|FG000|STARTED|Overall Study||125
9008977|NCT02969382|10071821|FG001|STARTED|Overall Study||120
9008978|NCT02969382|10071820|FG000|Subjects Continued Into Extension Study|Overall Study||79
9008979|NCT02969382|10071821|FG001|Subjects Continued Into Extension Study|Overall Study||78
9008980|NCT02969382|10071820|FG000|COMPLETED|Overall Study||99
9008981|NCT02969382|10071821|FG001|COMPLETED|Overall Study||94
9008982|NCT02969382|10071820|FG000|NOT COMPLETED|Overall Study||26
9008983|NCT02969382|10071821|FG001|NOT COMPLETED|Overall Study||26
9008984|NCT02969408|10071827|FG000|STARTED|Overall Study||397
9008985|NCT02969408|10071827|FG000|Used ABS eMDPI at Least Once|Overall Study||370
9008986|NCT02969408|10071827|FG000|COMPLETED|Overall Study||381
9008987|NCT02969408|10071827|FG000|NOT COMPLETED|Overall Study||16
9008988|NCT02969421|10071833|FG000|STARTED|Overall Study||33
9008989|NCT02969421|10071834|FG001|STARTED|Overall Study||33
9008990|NCT02969421|10071833|FG000|COMPLETED|Overall Study||33
9008991|NCT02969421|10071834|FG001|COMPLETED|Overall Study||33
9008992|NCT02969421|10071833|FG000|NOT COMPLETED|Overall Study||0
9008993|NCT02969421|10071834|FG001|NOT COMPLETED|Overall Study||0
9008994|NCT02969499|10071840|FG000|STARTED|Overall Study||33
9008995|NCT02969499|10071840|FG000|COMPLETED|Overall Study||33
9008996|NCT02969499|10071840|FG000|NOT COMPLETED|Overall Study||0
9008997|NCT02969525|10071849|FG000|STARTED|Double-Blind Period||42
9008998|NCT02969525|10071850|FG001|STARTED|Double-Blind Period||41
9008999|NCT02969525|10071851|FG002|STARTED|Double-Blind Period||41
9009000|NCT02969525|10071852|FG003|STARTED|Double-Blind Period||41
9009001|NCT02969525|10071853|FG004|STARTED|Double-Blind Period||41
9009002|NCT02969525|10071854|FG005|STARTED|Double-Blind Period||0
8898911|NCT02058095|9956716|FG000|COMPLETED|Overall Study||14
8898912|NCT02058095|9956717|FG001|COMPLETED|Overall Study||7
8898913|NCT02058095|9956716|FG000|NOT COMPLETED|Overall Study||1
8898914|NCT02058095|9956717|FG001|NOT COMPLETED|Overall Study||0
9009003|NCT02969525|10071855|FG006|STARTED|Double-Blind Period||0
9009004|NCT02969525|10071856|FG007|STARTED|Double-Blind Period||0
9009005|NCT02969525|10071857|FG008|STARTED|Double-Blind Period||0
9009006|NCT02969525|10071858|FG009|STARTED|Double-Blind Period||0
8898915|NCT02058108|9956725|FG000|STARTED|Overall Study||43
8898916|NCT02058108|9956726|FG001|STARTED|Overall Study||10
8898917|NCT02058108|9956725|FG000|Switched to Telbivudine After Week 24|Overall Study||0
8898918|NCT02058108|9956726|FG001|Switched to Telbivudine After Week 24|Overall Study||5
8898919|NCT02058108|9956725|FG000|COMPLETED|Overall Study||2
8898920|NCT02058108|9956726|FG001|COMPLETED|Overall Study||0
8898921|NCT02058108|9956725|FG000|NOT COMPLETED|Overall Study||41
8898922|NCT02058108|9956726|FG001|NOT COMPLETED|Overall Study||10
8898923|NCT02058147|9956737|FG000|STARTED|Overall Study||469
8898924|NCT02058147|9956738|FG001|STARTED|Overall Study||467
8898925|NCT02058147|9956739|FG002|STARTED|Overall Study||234
8898926|NCT02058147|9956737|FG000|Treated|Overall Study||469
8898927|NCT02058147|9956738|FG001|Treated|Overall Study||467
8898928|NCT02058147|9956739|FG002|Treated|Overall Study||233
8898929|NCT02058147|9956737|FG000|COMPLETED|Overall Study||440
8898930|NCT02058147|9956738|FG001|COMPLETED|Overall Study||440
8898931|NCT02058147|9956739|FG002|COMPLETED|Overall Study||205
8898932|NCT02058147|9956737|FG000|NOT COMPLETED|Overall Study||29
8898933|NCT02058147|9956738|FG001|NOT COMPLETED|Overall Study||27
8898934|NCT02058147|9956739|FG002|NOT COMPLETED|Overall Study||29
8898935|NCT02058160|9956749|FG000|STARTED|Overall Study||367
8898936|NCT02058160|9956750|FG001|STARTED|Overall Study||369
8898937|NCT02058160|9956749|FG000|Treated|Overall Study||365
8898938|NCT02058160|9956750|FG001|Treated|Overall Study||365
8898939|NCT02058160|9956749|FG000|COMPLETED|Overall Study||336
8898940|NCT02058160|9956750|FG001|COMPLETED|Overall Study||355
8898941|NCT02058160|9956749|FG000|NOT COMPLETED|Overall Study||31
8898942|NCT02058160|9956750|FG001|NOT COMPLETED|Overall Study||14
8898943|NCT02058251|9956758|FG000|STARTED|Overall Study||35
8898944|NCT02058251|9956759|FG001|STARTED|Overall Study||38
8898945|NCT02058251|9956758|FG000|COMPLETED|Overall Study||35
8898946|NCT02058251|9956759|FG001|COMPLETED|Overall Study||38
8898947|NCT02058251|9956758|FG000|NOT COMPLETED|Overall Study||0
8898948|NCT02058251|9956759|FG001|NOT COMPLETED|Overall Study||0
8898949|NCT02058290|9956767|FG000|STARTED|Overall Study||77
8898950|NCT02058290|9956768|FG001|STARTED|Overall Study||45
8898951|NCT02058290|9956767|FG000|COMPLETED|Overall Study||66
8898952|NCT02058290|9956768|FG001|COMPLETED|Overall Study||36
8898953|NCT02058290|9956767|FG000|NOT COMPLETED|Overall Study||11
8898954|NCT02058290|9956768|FG001|NOT COMPLETED|Overall Study||9
8898955|NCT02058368|9956776|FG000|STARTED|Overall Study||302
8898956|NCT02058368|9956777|FG001|STARTED|Overall Study||305
8898957|NCT02058368|9956776|FG000|COMPLETED|Overall Study||261
8898958|NCT02058368|9956777|FG001|COMPLETED|Overall Study||251
8898959|NCT02058368|9956776|FG000|NOT COMPLETED|Overall Study||41
8898960|NCT02058368|9956777|FG001|NOT COMPLETED|Overall Study||54
8898961|NCT02058498|9956783|FG000|STARTED|Overall Study||12
8898962|NCT02058498|9956783|FG000|6 Weeks|Overall Study||8
8898963|NCT02058498|9956783|FG000|COMPLETED|Overall Study||8
8898964|NCT02058498|9956783|FG000|NOT COMPLETED|Overall Study||4
8898965|NCT02058511|9956787|FG000|STARTED|Overall Study||24
8898966|NCT02058511|9956787|FG000|COMPLETED|Overall Study||24
8898967|NCT02058511|9956787|FG000|NOT COMPLETED|Overall Study||0
8898968|NCT02058563|9956793|FG000|STARTED|Overall Study||454
8898969|NCT02058563|9956794|FG001|STARTED|Overall Study||457
8898970|NCT02058563|9956793|FG000|COMPLETED|Overall Study||426
8898971|NCT02058563|9956794|FG001|COMPLETED|Overall Study||433
8898972|NCT02058563|9956793|FG000|NOT COMPLETED|Overall Study||28
8898973|NCT02058563|9956794|FG001|NOT COMPLETED|Overall Study||24
8898974|NCT02058589|9956802|FG000|STARTED|Overall Study||132
8898975|NCT02058589|9956803|FG001|STARTED|Overall Study||132
8898976|NCT02058589|9956802|FG000|COMPLETED|Overall Study||130
8898977|NCT02058589|9956803|FG001|COMPLETED|Overall Study||130
8898978|NCT02058589|9956802|FG000|NOT COMPLETED|Overall Study||2
8898979|NCT02058589|9956803|FG001|NOT COMPLETED|Overall Study||2
8898980|NCT02058628|9956813|FG000|STARTED|Overall Study||111
8898981|NCT02058628|9956814|FG001|STARTED|Overall Study||110
8898982|NCT02058628|9956813|FG000|COMPLETED|Overall Study||104
8898983|NCT02058628|9956814|FG001|COMPLETED|Overall Study||102
8898984|NCT02058628|9956813|FG000|NOT COMPLETED|Overall Study||7
8898985|NCT02058628|9956814|FG001|NOT COMPLETED|Overall Study||8
8898986|NCT02058836|9956825|FG000|STARTED|Overall Study||4
8898987|NCT02058836|9956826|FG001|STARTED|Overall Study||4
8898988|NCT02058836|9956825|FG000|COMPLETED|Overall Study||3
8898989|NCT02058836|9956826|FG001|COMPLETED|Overall Study||3
8898990|NCT02058836|9956825|FG000|NOT COMPLETED|Overall Study||1
8898991|NCT02058836|9956826|FG001|NOT COMPLETED|Overall Study||1
8898992|NCT02058849|9956834|FG000|STARTED|Overall Study||11
8898993|NCT02058849|9956835|FG001|STARTED|Overall Study||2
8898994|NCT02058849|9956834|FG000|COMPLETED|Overall Study||4
8898995|NCT02058849|9956835|FG001|COMPLETED|Overall Study||1
8898996|NCT02058849|9956834|FG000|NOT COMPLETED|Overall Study||7
8898997|NCT02058849|9956835|FG001|NOT COMPLETED|Overall Study||1
8898998|NCT02058940|9956841|FG000|STARTED|Overall Study||8
8898999|NCT02058940|9956841|FG000|COMPLETED|Overall Study||7
8899000|NCT02058940|9956841|FG000|NOT COMPLETED|Overall Study||1
8899001|NCT02058966|9956845|FG000|STARTED|Open-Label Methamphetamine||19
8899002|NCT02058966|9956845|FG000|Received Methamphetamine|Open-Label Methamphetamine||18
8899003|NCT02058966|9956845|FG000|COMPLETED|Open-Label Methamphetamine||18
8899004|NCT02058966|9956845|FG000|NOT COMPLETED|Open-Label Methamphetamine||1
8899005|NCT02058966|9956845|FG000|STARTED|First Intervention||15
8899006|NCT02058966|9956845|FG000|Received Placebo-Placebo|First Intervention||3
8899007|NCT02058966|9956845|FG000|Received Placebo-Meth|First Intervention||4
8899008|NCT02058966|9956845|FG000|Received Entacapone-Placebo|First Intervention||2
8899009|NCT02058966|9956845|FG000|Received Entacapone-Meth|First Intervention||5
8899010|NCT02058966|9956845|FG000|COMPLETED|First Intervention||14
8899011|NCT02058966|9956845|FG000|NOT COMPLETED|First Intervention||1
8899012|NCT02058966|9956845|FG000|STARTED|Second Intervention||13
8899013|NCT02058966|9956845|FG000|Received Placebo-Placebo|Second Intervention||2
8899014|NCT02058966|9956845|FG000|Received Placebo-Meth|Second Intervention||2
8899015|NCT02058966|9956845|FG000|Received Entacapone-Placebo|Second Intervention||6
8899016|NCT02058966|9956845|FG000|Received Entacapone-Meth|Second Intervention||3
8899017|NCT02058966|9956845|FG000|COMPLETED|Second Intervention||13
8899018|NCT02058966|9956845|FG000|NOT COMPLETED|Second Intervention||0
8899019|NCT02058966|9956845|FG000|STARTED|Third Intervention||12
8899020|NCT02058966|9956845|FG000|Received Placebo-Placebo|Third Intervention||4
8899021|NCT02058966|9956845|FG000|Received Placebo-Meth|Third Intervention||4
8899022|NCT02058966|9956845|FG000|Received Entacapone-Placebo|Third Intervention||1
8899023|NCT02058966|9956845|FG000|Received Entacapone-Meth|Third Intervention||3
8899024|NCT02058966|9956845|FG000|COMPLETED|Third Intervention||12
8899025|NCT02058966|9956845|FG000|NOT COMPLETED|Third Intervention||0
8899026|NCT02058966|9956845|FG000|STARTED|Fourth Intervention||12
8899027|NCT02058966|9956845|FG000|Received Placebo-Placebo|Fourth Intervention||4
8899028|NCT02058966|9956845|FG000|Received Placebo-Meth|Fourth Intervention||3
8899029|NCT02058966|9956845|FG000|Received Entacapone-Placebo|Fourth Intervention||3
8899030|NCT02058966|9956845|FG000|Received Entacapone-Meth|Fourth Intervention||2
8899031|NCT02058966|9956845|FG000|COMPLETED|Fourth Intervention||12
8899032|NCT02058966|9956845|FG000|NOT COMPLETED|Fourth Intervention||0
8899033|NCT02058992|9956857|FG000|STARTED|Overall Study||3339
8899034|NCT02058992|9956857|FG000|COMPLETED|Overall Study||3223
9009007|NCT02969525|10071859|FG010|STARTED|Double-Blind Period||0
9009008|NCT02969525|10071860|FG011|STARTED|Double-Blind Period||0
9009009|NCT02969525|10071849|FG000|Completed Double-Blind Period|Double-Blind Period||42
9009010|NCT02969525|10071850|FG001|Completed Double-Blind Period|Double-Blind Period||41
9009011|NCT02969525|10071851|FG002|Completed Double-Blind Period|Double-Blind Period||40
9009012|NCT02969525|10071852|FG003|Completed Double-Blind Period|Double-Blind Period||39
9009013|NCT02969525|10071853|FG004|Completed Double-Blind Period|Double-Blind Period||41
9009014|NCT02969525|10071854|FG005|Completed Double-Blind Period|Double-Blind Period||0
9009015|NCT02969525|10071855|FG006|Completed Double-Blind Period|Double-Blind Period||0
9009016|NCT02969525|10071856|FG007|Completed Double-Blind Period|Double-Blind Period||0
9009017|NCT02969525|10071857|FG008|Completed Double-Blind Period|Double-Blind Period||0
9009018|NCT02969525|10071858|FG009|Completed Double-Blind Period|Double-Blind Period||0
9009019|NCT02969525|10071859|FG010|Completed Double-Blind Period|Double-Blind Period||0
9009020|NCT02969525|10071860|FG011|Completed Double-Blind Period|Double-Blind Period||0
9009021|NCT02969525|10071849|FG000|Completed Wk12 and Started Dose-Blind|Double-Blind Period||40
9009022|NCT02969525|10071850|FG001|Completed Wk12 and Started Dose-Blind|Double-Blind Period||41
9009023|NCT02969525|10071851|FG002|Completed Wk12 and Started Dose-Blind|Double-Blind Period||40
9009024|NCT02969525|10071852|FG003|Completed Wk12 and Started Dose-Blind|Double-Blind Period||37
9009025|NCT02969525|10071853|FG004|Completed Wk12 and Started Dose-Blind|Double-Blind Period||41
9009026|NCT02969525|10071854|FG005|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0
9009027|NCT02969525|10071855|FG006|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0
9009028|NCT02969525|10071856|FG007|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0
9009029|NCT02969525|10071857|FG008|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0
9009030|NCT02969525|10071858|FG009|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0
9009031|NCT02969525|10071859|FG010|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0
9009032|NCT02969525|10071860|FG011|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0
9009033|NCT02969525|10071849|FG000|COMPLETED|Double-Blind Period||40
9009034|NCT02969525|10071850|FG001|COMPLETED|Double-Blind Period||41
9009035|NCT02969525|10071851|FG002|COMPLETED|Double-Blind Period||40
9009036|NCT02969525|10071852|FG003|COMPLETED|Double-Blind Period||37
9009037|NCT02969525|10071853|FG004|COMPLETED|Double-Blind Period||41
9009038|NCT02969525|10071854|FG005|COMPLETED|Double-Blind Period||0
9009039|NCT02969525|10071855|FG006|COMPLETED|Double-Blind Period||0
9009040|NCT02969525|10071856|FG007|COMPLETED|Double-Blind Period||0
9009041|NCT02969525|10071857|FG008|COMPLETED|Double-Blind Period||0
9009042|NCT02969525|10071858|FG009|COMPLETED|Double-Blind Period||0
9009043|NCT02969525|10071859|FG010|COMPLETED|Double-Blind Period||0
9009044|NCT02969525|10071860|FG011|COMPLETED|Double-Blind Period||0
9009045|NCT02969525|10071849|FG000|NOT COMPLETED|Double-Blind Period||2
9009046|NCT02969525|10071850|FG001|NOT COMPLETED|Double-Blind Period||0
9009047|NCT02969525|10071851|FG002|NOT COMPLETED|Double-Blind Period||1
9009048|NCT02969525|10071852|FG003|NOT COMPLETED|Double-Blind Period||4
9009049|NCT02969525|10071853|FG004|NOT COMPLETED|Double-Blind Period||0
9009050|NCT02969525|10071854|FG005|NOT COMPLETED|Double-Blind Period||0
8899035|NCT02058992|9956857|FG000|NOT COMPLETED|Overall Study||116
8899036|NCT02059005|9956863|FG000|STARTED|Overall Study||49
8899037|NCT02059005|9956864|FG001|STARTED|Overall Study||48
8899038|NCT02059005|9956863|FG000|3 Month Assessment|Overall Study||37
8899039|NCT02059005|9956864|FG001|3 Month Assessment|Overall Study||33
8899040|NCT02059005|9956863|FG000|6 Month Assessment|Overall Study||29
8899041|NCT02059005|9956864|FG001|6 Month Assessment|Overall Study||24
8899042|NCT02059005|9956863|FG000|COMPLETED|Overall Study||29
8899043|NCT02059005|9956864|FG001|COMPLETED|Overall Study||24
8899044|NCT02059005|9956863|FG000|NOT COMPLETED|Overall Study||20
8635699|NCT00563706|9676211|FG002|STARTED|Taper Phase (Day 29 up to Day 35)||3
8635700|NCT00563706|9676212|FG003|STARTED|Taper Phase (Day 29 up to Day 35)||9
8635701|NCT00563706|9676213|FG004|STARTED|Taper Phase (Day 29 up to Day 35)||11
8635702|NCT00563706|9676214|FG005|STARTED|Taper Phase (Day 29 up to Day 35)||14
8899045|NCT02059005|9956864|FG001|NOT COMPLETED|Overall Study||24
8899046|NCT02059057|9956872|FG000|STARTED|Overall Study||102
8899047|NCT02059057|9956872|FG000|COMPLETED|Overall Study||87
8899048|NCT02059057|9956872|FG000|NOT COMPLETED|Overall Study||15
8899049|NCT02059070|9956879|FG000|STARTED|Overall Study||19
8899050|NCT02059070|9956880|FG001|STARTED|Overall Study||20
8899051|NCT02059070|9956879|FG000|COMPLETED|Overall Study||14
8899052|NCT02059070|9956880|FG001|COMPLETED|Overall Study||16
8899053|NCT02059070|9956879|FG000|NOT COMPLETED|Overall Study||5
8899054|NCT02059070|9956880|FG001|NOT COMPLETED|Overall Study||4
8899055|NCT02059135|9956888|FG000|STARTED|Maternal Follow-up (ITT Population)||62
8899056|NCT02059135|9956889|FG001|STARTED|Maternal Follow-up (ITT Population)||58
8899057|NCT02059135|9956888|FG000|COMPLETED|Maternal Follow-up (ITT Population)||59
8899058|NCT02059135|9956889|FG001|COMPLETED|Maternal Follow-up (ITT Population)||51
8899059|NCT02059135|9956888|FG000|NOT COMPLETED|Maternal Follow-up (ITT Population)||3
8899060|NCT02059135|9956889|FG001|NOT COMPLETED|Maternal Follow-up (ITT Population)||7
8899061|NCT02059135|9956888|FG000|STARTED|Neonatal Follow-up (Safety Population)||60
8899062|NCT02059135|9956889|FG001|STARTED|Neonatal Follow-up (Safety Population)||54
8899063|NCT02059135|9956888|FG000|COMPLETED|Neonatal Follow-up (Safety Population)||56
8899064|NCT02059135|9956889|FG001|COMPLETED|Neonatal Follow-up (Safety Population)||50
8899065|NCT02059135|9956888|FG000|NOT COMPLETED|Neonatal Follow-up (Safety Population)||4
8899066|NCT02059135|9956889|FG001|NOT COMPLETED|Neonatal Follow-up (Safety Population)||4
8899067|NCT02059148|9956897|FG000|STARTED|Treatment 1||4
8899068|NCT02059148|9956898|FG001|STARTED|Treatment 1||4
8899069|NCT02059148|9956899|FG002|STARTED|Treatment 1||4
8899070|NCT02059148|9956900|FG003|STARTED|Treatment 1||4
8899071|NCT02059148|9956901|FG004|STARTED|Treatment 1||4
8899072|NCT02059148|9956902|FG005|STARTED|Treatment 1||4
8899073|NCT02059148|9956897|FG000|COMPLETED|Treatment 1||4
8899074|NCT02059148|9956898|FG001|COMPLETED|Treatment 1||4
8899075|NCT02059148|9956899|FG002|COMPLETED|Treatment 1||4
8899076|NCT02059148|9956900|FG003|COMPLETED|Treatment 1||4
8899077|NCT02059148|9956901|FG004|COMPLETED|Treatment 1||4
8899078|NCT02059148|9956902|FG005|COMPLETED|Treatment 1||3
8899079|NCT02059148|9956897|FG000|NOT COMPLETED|Treatment 1||0
8899080|NCT02059148|9956898|FG001|NOT COMPLETED|Treatment 1||0
8899081|NCT02059148|9956899|FG002|NOT COMPLETED|Treatment 1||0
8899082|NCT02059148|9956900|FG003|NOT COMPLETED|Treatment 1||0
8899083|NCT02059148|9956901|FG004|NOT COMPLETED|Treatment 1||0
8899084|NCT02059148|9956902|FG005|NOT COMPLETED|Treatment 1||1
8899085|NCT02059148|9956897|FG000|STARTED|Treatment 2||4
8899086|NCT02059148|9956898|FG001|STARTED|Treatment 2||4
8899087|NCT02059148|9956899|FG002|STARTED|Treatment 2||4
8899088|NCT02059148|9956900|FG003|STARTED|Treatment 2||4
8899089|NCT02059148|9956901|FG004|STARTED|Treatment 2||4
8899090|NCT02059148|9956902|FG005|STARTED|Treatment 2||3
8899091|NCT02059148|9956897|FG000|COMPLETED|Treatment 2||4
8899092|NCT02059148|9956898|FG001|COMPLETED|Treatment 2||4
8899093|NCT02059148|9956899|FG002|COMPLETED|Treatment 2||4
8899094|NCT02059148|9956900|FG003|COMPLETED|Treatment 2||4
8899095|NCT02059148|9956901|FG004|COMPLETED|Treatment 2||4
8899096|NCT02059148|9956902|FG005|COMPLETED|Treatment 2||3
8899097|NCT02059148|9956897|FG000|NOT COMPLETED|Treatment 2||0
8899098|NCT02059148|9956898|FG001|NOT COMPLETED|Treatment 2||0
8899099|NCT02059148|9956899|FG002|NOT COMPLETED|Treatment 2||0
8899100|NCT02059148|9956900|FG003|NOT COMPLETED|Treatment 2||0
8899101|NCT02059148|9956901|FG004|NOT COMPLETED|Treatment 2||0
8899102|NCT02059148|9956902|FG005|NOT COMPLETED|Treatment 2||0
8899103|NCT02059148|9956897|FG000|STARTED|Treatment 3||4
8899104|NCT02059148|9956898|FG001|STARTED|Treatment 3||4
8899105|NCT02059148|9956899|FG002|STARTED|Treatment 3||4
8899106|NCT02059148|9956900|FG003|STARTED|Treatment 3||4
8899107|NCT02059148|9956901|FG004|STARTED|Treatment 3||4
8899108|NCT02059148|9956902|FG005|STARTED|Treatment 3||3
8899109|NCT02059148|9956897|FG000|COMPLETED|Treatment 3||4
8899110|NCT02059148|9956898|FG001|COMPLETED|Treatment 3||4
8899111|NCT02059148|9956899|FG002|COMPLETED|Treatment 3||4
8899112|NCT02059148|9956900|FG003|COMPLETED|Treatment 3||4
8899113|NCT02059148|9956901|FG004|COMPLETED|Treatment 3||4
8899114|NCT02059148|9956902|FG005|COMPLETED|Treatment 3||3
8899115|NCT02059148|9956897|FG000|NOT COMPLETED|Treatment 3||0
8899116|NCT02059148|9956898|FG001|NOT COMPLETED|Treatment 3||0
8899117|NCT02059148|9956899|FG002|NOT COMPLETED|Treatment 3||0
8899118|NCT02059148|9956900|FG003|NOT COMPLETED|Treatment 3||0
8899119|NCT02059148|9956901|FG004|NOT COMPLETED|Treatment 3||0
8899120|NCT02059148|9956902|FG005|NOT COMPLETED|Treatment 3||0
8899121|NCT02059161|9956915|FG000|STARTED|Overall Study||245
8899122|NCT02059161|9956916|FG001|STARTED|Overall Study||263
8899123|NCT02059161|9956915|FG000|Treated|Overall Study||241
8899124|NCT02059161|9956916|FG001|Treated|Overall Study||258
8899125|NCT02059161|9956915|FG000|COMPLETED|Overall Study||196
8899126|NCT02059161|9956916|FG001|COMPLETED|Overall Study||222
8899127|NCT02059161|9956915|FG000|NOT COMPLETED|Overall Study||49
8899128|NCT02059161|9956916|FG001|NOT COMPLETED|Overall Study||41
8899129|NCT02059174|9956922|FG000|STARTED|Period 1||37
8899130|NCT02059174|9956923|FG001|STARTED|Period 1||39
8899131|NCT02059174|9956922|FG000|COMPLETED|Period 1||37
8899132|NCT02059174|9956923|FG001|COMPLETED|Period 1||37
8899133|NCT02059174|9956922|FG000|NOT COMPLETED|Period 1||0
8899134|NCT02059174|9956923|FG001|NOT COMPLETED|Period 1||2
8899135|NCT02059174|9956922|FG000|STARTED|Period 2||37
8899136|NCT02059174|9956923|FG001|STARTED|Period 2||37
8899137|NCT02059174|9956922|FG000|COMPLETED|Period 2||36
8899138|NCT02059174|9956923|FG001|COMPLETED|Period 2||35
8899139|NCT02059174|9956922|FG000|NOT COMPLETED|Period 2||1
8899140|NCT02059174|9956923|FG001|NOT COMPLETED|Period 2||2
8899141|NCT02059174|9956922|FG000|STARTED|Period 3||36
8899142|NCT02059174|9956923|FG001|STARTED|Period 3||35
8899143|NCT02059174|9956922|FG000|COMPLETED|Period 3||35
8899144|NCT02059174|9956923|FG001|COMPLETED|Period 3||35
8899145|NCT02059174|9956922|FG000|NOT COMPLETED|Period 3||1
8635703|NCT00563706|9676215|FG006|STARTED|Taper Phase (Day 29 up to Day 35)||9
8635704|NCT00563706|9676216|FG007|STARTED|Taper Phase (Day 29 up to Day 35)||16
8635705|NCT00563706|9676217|FG008|STARTED|Taper Phase (Day 29 up to Day 35)||32
8899146|NCT02059174|9956923|FG001|NOT COMPLETED|Period 3||0
8899147|NCT02059174|9956922|FG000|STARTED|Period 4||35
8899148|NCT02059174|9956923|FG001|STARTED|Period 4||35
8899149|NCT02059174|9956922|FG000|COMPLETED|Period 4||35
8899150|NCT02059174|9956923|FG001|COMPLETED|Period 4||35
8899151|NCT02059174|9956922|FG000|NOT COMPLETED|Period 4||0
8899152|NCT02059174|9956923|FG001|NOT COMPLETED|Period 4||0
8899153|NCT02059187|9956931|FG000|STARTED|Overall Study||265
8899154|NCT02059187|9956932|FG001|STARTED|Overall Study||266
8899155|NCT02059187|9956931|FG000|COMPLETED|Overall Study||240
8899156|NCT02059187|9956932|FG001|COMPLETED|Overall Study||244
8899157|NCT02059187|9956931|FG000|NOT COMPLETED|Overall Study||25
8899158|NCT02059187|9956932|FG001|NOT COMPLETED|Overall Study||22
8899159|NCT02059213|9956940|FG000|STARTED|Overall Study||20
8899160|NCT02059213|9956941|FG001|STARTED|Overall Study||42
8899161|NCT02059213|9956940|FG000|Initiated Treatment|Overall Study||20
8899162|NCT02059213|9956941|FG001|Initiated Treatment|Overall Study||40
8899163|NCT02059213|9956940|FG000|COMPLETED|Overall Study||20
8899164|NCT02059213|9956941|FG001|COMPLETED|Overall Study||40
8899165|NCT02059213|9956940|FG000|NOT COMPLETED|Overall Study||0
8899166|NCT02059213|9956941|FG001|NOT COMPLETED|Overall Study||2
8899167|NCT02059239|9956952|FG000|STARTED|Overall Study||18
8899168|NCT02059239|9956953|FG001|STARTED|Overall Study||16
8899169|NCT02059239|9956952|FG000|COMPLETED|Overall Study||16
8899170|NCT02059239|9956953|FG001|COMPLETED|Overall Study||13
8899171|NCT02059239|9956952|FG000|NOT COMPLETED|Overall Study||2
8899172|NCT02059239|9956953|FG001|NOT COMPLETED|Overall Study||3
8899173|NCT02059278|9956962|FG000|STARTED|Overall Study||165
8899174|NCT02059278|9956963|FG001|STARTED|Overall Study||170
8635706|NCT00563706|9676209|FG000|COMPLETED|Taper Phase (Day 29 up to Day 35)||20
8635707|NCT00563706|9676210|FG001|COMPLETED|Taper Phase (Day 29 up to Day 35)||13
8899175|NCT02059278|9956962|FG000|COMPLETED|Overall Study||162
9009051|NCT02969525|10071855|FG006|NOT COMPLETED|Double-Blind Period||0
9009052|NCT02969525|10071856|FG007|NOT COMPLETED|Double-Blind Period||0
9009053|NCT02969525|10071857|FG008|NOT COMPLETED|Double-Blind Period||0
9009054|NCT02969525|10071858|FG009|NOT COMPLETED|Double-Blind Period||0
9009055|NCT02969525|10071859|FG010|NOT COMPLETED|Double-Blind Period||0
9009056|NCT02969525|10071860|FG011|NOT COMPLETED|Double-Blind Period||0
9009057|NCT02969525|10071849|FG000|STARTED|Dose-Blind Period||0
9009058|NCT02969525|10071850|FG001|STARTED|Dose-Blind Period||0
9009059|NCT02969525|10071851|FG002|STARTED|Dose-Blind Period||0
9009060|NCT02969525|10071852|FG003|STARTED|Dose-Blind Period||0
9009061|NCT02969525|10071853|FG004|STARTED|Dose-Blind Period||0
9009062|NCT02969525|10071854|FG005|STARTED|Dose-Blind Period||20
9009063|NCT02969525|10071855|FG006|STARTED|Dose-Blind Period||20
9009064|NCT02969525|10071856|FG007|STARTED|Dose-Blind Period||22
9009065|NCT02969525|10071857|FG008|STARTED|Dose-Blind Period||19
9009066|NCT02969525|10071858|FG009|STARTED|Dose-Blind Period||37
9009067|NCT02969525|10071859|FG010|STARTED|Dose-Blind Period||40
9009068|NCT02969525|10071860|FG011|STARTED|Dose-Blind Period||41
9009069|NCT02969525|10071849|FG000|COMPLETED|Dose-Blind Period||0
9009070|NCT02969525|10071850|FG001|COMPLETED|Dose-Blind Period||0
9009071|NCT02969525|10071851|FG002|COMPLETED|Dose-Blind Period||0
9009072|NCT02969525|10071852|FG003|COMPLETED|Dose-Blind Period||0
9009073|NCT02969525|10071853|FG004|COMPLETED|Dose-Blind Period||0
9009074|NCT02969525|10071854|FG005|COMPLETED|Dose-Blind Period||20
9009075|NCT02969525|10071855|FG006|COMPLETED|Dose-Blind Period||18
9009076|NCT02969525|10071856|FG007|COMPLETED|Dose-Blind Period||22
9009077|NCT02969525|10071857|FG008|COMPLETED|Dose-Blind Period||18
8635708|NCT00563706|9676211|FG002|COMPLETED|Taper Phase (Day 29 up to Day 35)||3
8635709|NCT00563706|9676212|FG003|COMPLETED|Taper Phase (Day 29 up to Day 35)||9
8899176|NCT02059278|9956963|FG001|COMPLETED|Overall Study||166
9009078|NCT02969525|10071858|FG009|COMPLETED|Dose-Blind Period||34
9009079|NCT02969525|10071859|FG010|COMPLETED|Dose-Blind Period||38
8899177|NCT02059278|9956962|FG000|NOT COMPLETED|Overall Study||3
8899178|NCT02059278|9956963|FG001|NOT COMPLETED|Overall Study||4
9009080|NCT02969525|10071860|FG011|COMPLETED|Dose-Blind Period||39
9009081|NCT02969525|10071849|FG000|NOT COMPLETED|Dose-Blind Period||0
9009082|NCT02969525|10071850|FG001|NOT COMPLETED|Dose-Blind Period||0
9009083|NCT02969525|10071851|FG002|NOT COMPLETED|Dose-Blind Period||0
9009084|NCT02969525|10071852|FG003|NOT COMPLETED|Dose-Blind Period||0
9009085|NCT02969525|10071853|FG004|NOT COMPLETED|Dose-Blind Period||0
8899179|NCT02059291|9956978|FG000|STARTED|Epoch 2||31
8899180|NCT02059291|9956979|FG001|STARTED|Epoch 2||32
8899181|NCT02059291|9956980|FG002|STARTED|Epoch 2||37
8899182|NCT02059291|9956981|FG003|STARTED|Epoch 2||35
8899183|NCT02059291|9956982|FG004|STARTED|Epoch 2||22
8899184|NCT02059291|9956983|FG005|STARTED|Epoch 2||24
8899185|NCT02059291|9956984|FG006|STARTED|Epoch 2||2
8899186|NCT02059291|9956985|FG007|STARTED|Epoch 2||2
8899187|NCT02059291|9956986|FG008|STARTED|Epoch 2|This Epoch 3 group is shown in Epoch 2 to account for the 203 patients enrolled in the study.|18
8899188|NCT02059291|9956987|FG009|STARTED|Epoch 2||0
8899189|NCT02059291|9956988|FG010|STARTED|Epoch 2||0
8899190|NCT02059291|9956989|FG011|STARTED|Epoch 2||0
8899191|NCT02059291|9956990|FG012|STARTED|Epoch 2||0
8899192|NCT02059291|9956991|FG013|STARTED|Epoch 2||0
8899193|NCT02059291|9956992|FG014|STARTED|Epoch 2||0
8899194|NCT02059291|9956993|FG015|STARTED|Epoch 2||0
8899195|NCT02059291|9956994|FG016|STARTED|Epoch 2||0
8899196|NCT02059291|9956995|FG017|STARTED|Epoch 2||0
8899197|NCT02059291|9956996|FG018|STARTED|Epoch 2||0
8899198|NCT02059291|9956997|FG019|STARTED|Epoch 2||0
8899199|NCT02059291|9956998|FG020|STARTED|Epoch 2||0
8899200|NCT02059291|9956999|FG021|STARTED|Epoch 2||0
8899201|NCT02059291|9957000|FG022|STARTED|Epoch 2||0
8899202|NCT02059291|9957001|FG023|STARTED|Epoch 2||0
8899203|NCT02059291|9957002|FG024|STARTED|Epoch 2||0
8899204|NCT02059291|9956978|FG000|COMPLETED|Epoch 2||31
8899205|NCT02059291|9956979|FG001|COMPLETED|Epoch 2||31
8899206|NCT02059291|9956980|FG002|COMPLETED|Epoch 2||36
8899207|NCT02059291|9956981|FG003|COMPLETED|Epoch 2||33
8899208|NCT02059291|9956982|FG004|COMPLETED|Epoch 2||22
8899209|NCT02059291|9956983|FG005|COMPLETED|Epoch 2||22
8899210|NCT02059291|9956984|FG006|COMPLETED|Epoch 2||2
8899211|NCT02059291|9956985|FG007|COMPLETED|Epoch 2||1
8899212|NCT02059291|9956986|FG008|COMPLETED|Epoch 2||16
8899213|NCT02059291|9956987|FG009|COMPLETED|Epoch 2||0
8899214|NCT02059291|9956988|FG010|COMPLETED|Epoch 2||0
8899215|NCT02059291|9956989|FG011|COMPLETED|Epoch 2||0
8899216|NCT02059291|9956990|FG012|COMPLETED|Epoch 2||0
8899217|NCT02059291|9956991|FG013|COMPLETED|Epoch 2||0
9009086|NCT02969525|10071854|FG005|NOT COMPLETED|Dose-Blind Period||0
9009087|NCT02969525|10071855|FG006|NOT COMPLETED|Dose-Blind Period||2
9009088|NCT02969525|10071856|FG007|NOT COMPLETED|Dose-Blind Period||0
9009089|NCT02969525|10071857|FG008|NOT COMPLETED|Dose-Blind Period||1
8899218|NCT02059291|9956992|FG014|COMPLETED|Epoch 2||0
8899219|NCT02059291|9956993|FG015|COMPLETED|Epoch 2||0
8899220|NCT02059291|9956994|FG016|COMPLETED|Epoch 2||0
8899221|NCT02059291|9956995|FG017|COMPLETED|Epoch 2||0
8899222|NCT02059291|9956996|FG018|COMPLETED|Epoch 2||0
8899223|NCT02059291|9956997|FG019|COMPLETED|Epoch 2||0
8899224|NCT02059291|9956998|FG020|COMPLETED|Epoch 2||0
8899225|NCT02059291|9956999|FG021|COMPLETED|Epoch 2||0
8899226|NCT02059291|9957000|FG022|COMPLETED|Epoch 2||0
8899227|NCT02059291|9957001|FG023|COMPLETED|Epoch 2||0
8899228|NCT02059291|9957002|FG024|COMPLETED|Epoch 2||0
8899229|NCT02059291|9956978|FG000|NOT COMPLETED|Epoch 2||0
8899230|NCT02059291|9956979|FG001|NOT COMPLETED|Epoch 2||1
8899231|NCT02059291|9956980|FG002|NOT COMPLETED|Epoch 2||1
8899232|NCT02059291|9956981|FG003|NOT COMPLETED|Epoch 2||2
8899233|NCT02059291|9956982|FG004|NOT COMPLETED|Epoch 2||0
8899234|NCT02059291|9956983|FG005|NOT COMPLETED|Epoch 2||2
8899235|NCT02059291|9956984|FG006|NOT COMPLETED|Epoch 2||0
8899236|NCT02059291|9956985|FG007|NOT COMPLETED|Epoch 2||1
8899237|NCT02059291|9956986|FG008|NOT COMPLETED|Epoch 2||2
8899238|NCT02059291|9956987|FG009|NOT COMPLETED|Epoch 2||0
8899239|NCT02059291|9956988|FG010|NOT COMPLETED|Epoch 2||0
8899240|NCT02059291|9956989|FG011|NOT COMPLETED|Epoch 2||0
8899241|NCT02059291|9956990|FG012|NOT COMPLETED|Epoch 2||0
8899242|NCT02059291|9956991|FG013|NOT COMPLETED|Epoch 2||0
8899243|NCT02059291|9956992|FG014|NOT COMPLETED|Epoch 2||0
8899244|NCT02059291|9956993|FG015|NOT COMPLETED|Epoch 2||0
8899245|NCT02059291|9956994|FG016|NOT COMPLETED|Epoch 2||0
8899246|NCT02059291|9956995|FG017|NOT COMPLETED|Epoch 2||0
8899247|NCT02059291|9956996|FG018|NOT COMPLETED|Epoch 2||0
8899248|NCT02059291|9956997|FG019|NOT COMPLETED|Epoch 2||0
8899249|NCT02059291|9956998|FG020|NOT COMPLETED|Epoch 2||0
8899250|NCT02059291|9956999|FG021|NOT COMPLETED|Epoch 2||0
8899251|NCT02059291|9957000|FG022|NOT COMPLETED|Epoch 2||0
8899252|NCT02059291|9957001|FG023|NOT COMPLETED|Epoch 2||0
8899253|NCT02059291|9957002|FG024|NOT COMPLETED|Epoch 2||0
8899254|NCT02059291|9956978|FG000|STARTED|Epoch 3||0
8899255|NCT02059291|9956979|FG001|STARTED|Epoch 3||0
8899256|NCT02059291|9956980|FG002|STARTED|Epoch 3||0
8899257|NCT02059291|9956981|FG003|STARTED|Epoch 3||0
8899258|NCT02059291|9956982|FG004|STARTED|Epoch 3||0
8899259|NCT02059291|9956983|FG005|STARTED|Epoch 3||0
8899260|NCT02059291|9956984|FG006|STARTED|Epoch 3||2
8899261|NCT02059291|9956985|FG007|STARTED|Epoch 3||1
8899262|NCT02059291|9956986|FG008|STARTED|Epoch 3|Presented in Epoch 2.|0
8899263|NCT02059291|9956987|FG009|STARTED|Epoch 3||9
8899264|NCT02059291|9956988|FG010|STARTED|Epoch 3||10
8899265|NCT02059291|9956989|FG011|STARTED|Epoch 3||6
8899266|NCT02059291|9956990|FG012|STARTED|Epoch 3||7
8899267|NCT02059291|9956991|FG013|STARTED|Epoch 3||4
8899268|NCT02059291|9956992|FG014|STARTED|Epoch 3||5
8899269|NCT02059291|9956993|FG015|STARTED|Epoch 3||126
9009090|NCT02969525|10071858|FG009|NOT COMPLETED|Dose-Blind Period||3
9009091|NCT02969525|10071859|FG010|NOT COMPLETED|Dose-Blind Period||2
8899270|NCT02059291|9956994|FG016|STARTED|Epoch 3||0
8899271|NCT02059291|9956995|FG017|STARTED|Epoch 3||0
8899272|NCT02059291|9956996|FG018|STARTED|Epoch 3||0
8572840|NCT00117559|9605038|FG000|COMPLETED|Overall Study||8
8572841|NCT00117559|9605039|FG001|COMPLETED|Overall Study||9
8572842|NCT00117559|9605038|FG000|NOT COMPLETED|Overall Study||1
8572843|NCT00117559|9605039|FG001|NOT COMPLETED|Overall Study||1
8572844|NCT00117572|9605047|FG000|STARTED|Overall Study||144
8572845|NCT00117572|9605048|FG001|STARTED|Overall Study||141
8572846|NCT00117572|9605047|FG000|COMPLETED|Overall Study||138
8572847|NCT00117572|9605048|FG001|COMPLETED|Overall Study||135
8572848|NCT00117572|9605047|FG000|NOT COMPLETED|Overall Study||6
8572849|NCT00117572|9605048|FG001|NOT COMPLETED|Overall Study||6
8572850|NCT00117585|9605054|FG000|STARTED|Overall Study||341
8899273|NCT02059291|9956997|FG019|STARTED|Epoch 3||0
8572851|NCT00117585|9605054|FG000|COMPLETED|Overall Study||341
8572852|NCT00117585|9605054|FG000|NOT COMPLETED|Overall Study||0
8572853|NCT00117598|9605061|FG000|STARTED|Prior to Treatment Cross Over||57
8572854|NCT00117598|9605062|FG001|STARTED|Prior to Treatment Cross Over||56
8572855|NCT00117598|9605063|FG002|STARTED|Prior to Treatment Cross Over||56
8572856|NCT00117598|9605064|FG003|STARTED|Prior to Treatment Cross Over||0
8572857|NCT00117598|9605065|FG004|STARTED|Prior to Treatment Cross Over||0
8572858|NCT00117598|9605061|FG000|COMPLETED|Prior to Treatment Cross Over||0
8572859|NCT00117598|9605062|FG001|COMPLETED|Prior to Treatment Cross Over||3
8572860|NCT00117598|9605063|FG002|COMPLETED|Prior to Treatment Cross Over||4
8572861|NCT00117598|9605064|FG003|COMPLETED|Prior to Treatment Cross Over||0
8572862|NCT00117598|9605065|FG004|COMPLETED|Prior to Treatment Cross Over||0
8572863|NCT00117598|9605061|FG000|NOT COMPLETED|Prior to Treatment Cross Over||57
8572864|NCT00117598|9605062|FG001|NOT COMPLETED|Prior to Treatment Cross Over||53
8572865|NCT00117598|9605063|FG002|NOT COMPLETED|Prior to Treatment Cross Over||52
8572866|NCT00117598|9605064|FG003|NOT COMPLETED|Prior to Treatment Cross Over||0
8572867|NCT00117598|9605065|FG004|NOT COMPLETED|Prior to Treatment Cross Over||0
8572868|NCT00117598|9605061|FG000|STARTED|After Treament Cross Over||0
8572869|NCT00117598|9605062|FG001|STARTED|After Treament Cross Over||0
8572870|NCT00117598|9605063|FG002|STARTED|After Treament Cross Over||0
8572871|NCT00117598|9605064|FG003|STARTED|After Treament Cross Over||3
8572872|NCT00117598|9605065|FG004|STARTED|After Treament Cross Over||4
8572873|NCT00117598|9605061|FG000|COMPLETED|After Treament Cross Over||0
8572874|NCT00117598|9605062|FG001|COMPLETED|After Treament Cross Over||0
8572875|NCT00117598|9605063|FG002|COMPLETED|After Treament Cross Over||0
8899274|NCT02059291|9956998|FG020|STARTED|Epoch 3||0
8899275|NCT02059291|9956999|FG021|STARTED|Epoch 3||0
8899276|NCT02059291|9957000|FG022|STARTED|Epoch 3||0
8572876|NCT00117598|9605064|FG003|COMPLETED|After Treament Cross Over||0
8572877|NCT00117598|9605065|FG004|COMPLETED|After Treament Cross Over||0
8572878|NCT00117598|9605061|FG000|NOT COMPLETED|After Treament Cross Over||0
8572879|NCT00117598|9605062|FG001|NOT COMPLETED|After Treament Cross Over||0
8572880|NCT00117598|9605063|FG002|NOT COMPLETED|After Treament Cross Over||0
8572881|NCT00117598|9605064|FG003|NOT COMPLETED|After Treament Cross Over||3
8572882|NCT00117598|9605065|FG004|NOT COMPLETED|After Treament Cross Over||4
8572883|NCT00117637|9605077|FG000|STARTED|First Intervention (Period 1)||97
8572884|NCT00117637|9605078|FG001|STARTED|First Intervention (Period 1)||92
8899277|NCT02059291|9957001|FG023|STARTED|Epoch 3||0
8899278|NCT02059291|9957002|FG024|STARTED|Epoch 3||0
8899279|NCT02059291|9956978|FG000|COMPLETED|Epoch 3||0
8899280|NCT02059291|9956979|FG001|COMPLETED|Epoch 3||0
8899281|NCT02059291|9956980|FG002|COMPLETED|Epoch 3||0
8899282|NCT02059291|9956981|FG003|COMPLETED|Epoch 3||0
8899283|NCT02059291|9956982|FG004|COMPLETED|Epoch 3||0
8899284|NCT02059291|9956983|FG005|COMPLETED|Epoch 3||0
8899285|NCT02059291|9956984|FG006|COMPLETED|Epoch 3||2
8899286|NCT02059291|9956985|FG007|COMPLETED|Epoch 3||1
8899287|NCT02059291|9956986|FG008|COMPLETED|Epoch 3||0
8899288|NCT02059291|9956987|FG009|COMPLETED|Epoch 3||9
8899289|NCT02059291|9956988|FG010|COMPLETED|Epoch 3||10
8899290|NCT02059291|9956989|FG011|COMPLETED|Epoch 3||6
8899291|NCT02059291|9956990|FG012|COMPLETED|Epoch 3||7
8899292|NCT02059291|9956991|FG013|COMPLETED|Epoch 3||3
8899293|NCT02059291|9956992|FG014|COMPLETED|Epoch 3||5
8899294|NCT02059291|9956993|FG015|COMPLETED|Epoch 3||120
8899295|NCT02059291|9956994|FG016|COMPLETED|Epoch 3||0
8899296|NCT02059291|9956995|FG017|COMPLETED|Epoch 3||0
8899297|NCT02059291|9956996|FG018|COMPLETED|Epoch 3||0
8899298|NCT02059291|9956997|FG019|COMPLETED|Epoch 3||0
8899299|NCT02059291|9956998|FG020|COMPLETED|Epoch 3||0
8899300|NCT02059291|9956999|FG021|COMPLETED|Epoch 3||0
8899301|NCT02059291|9957000|FG022|COMPLETED|Epoch 3||0
8899302|NCT02059291|9957001|FG023|COMPLETED|Epoch 3||0
8899303|NCT02059291|9957002|FG024|COMPLETED|Epoch 3||0
8899304|NCT02059291|9956978|FG000|NOT COMPLETED|Epoch 3||0
8899305|NCT02059291|9956979|FG001|NOT COMPLETED|Epoch 3||0
8899306|NCT02059291|9956980|FG002|NOT COMPLETED|Epoch 3||0
8899307|NCT02059291|9956981|FG003|NOT COMPLETED|Epoch 3||0
8899308|NCT02059291|9956982|FG004|NOT COMPLETED|Epoch 3||0
8899309|NCT02059291|9956983|FG005|NOT COMPLETED|Epoch 3||0
8899310|NCT02059291|9956984|FG006|NOT COMPLETED|Epoch 3||0
8899311|NCT02059291|9956985|FG007|NOT COMPLETED|Epoch 3||0
8899312|NCT02059291|9956986|FG008|NOT COMPLETED|Epoch 3||0
8899313|NCT02059291|9956987|FG009|NOT COMPLETED|Epoch 3||0
8899314|NCT02059291|9956988|FG010|NOT COMPLETED|Epoch 3||0
8899315|NCT02059291|9956989|FG011|NOT COMPLETED|Epoch 3||0
8899316|NCT02059291|9956990|FG012|NOT COMPLETED|Epoch 3||0
8899317|NCT02059291|9956991|FG013|NOT COMPLETED|Epoch 3||1
8899318|NCT02059291|9956992|FG014|NOT COMPLETED|Epoch 3||0
8899319|NCT02059291|9956993|FG015|NOT COMPLETED|Epoch 3||6
8899320|NCT02059291|9956994|FG016|NOT COMPLETED|Epoch 3||0
8899321|NCT02059291|9956995|FG017|NOT COMPLETED|Epoch 3||0
8899322|NCT02059291|9956996|FG018|NOT COMPLETED|Epoch 3||0
8899323|NCT02059291|9956997|FG019|NOT COMPLETED|Epoch 3||0
8899324|NCT02059291|9956998|FG020|NOT COMPLETED|Epoch 3||0
8899325|NCT02059291|9956999|FG021|NOT COMPLETED|Epoch 3||0
8899326|NCT02059291|9957000|FG022|NOT COMPLETED|Epoch 3||0
8899327|NCT02059291|9957001|FG023|NOT COMPLETED|Epoch 3||0
8899328|NCT02059291|9957002|FG024|NOT COMPLETED|Epoch 3||0
8899329|NCT02059291|9956978|FG000|STARTED|Epoch 4||0
8899330|NCT02059291|9956979|FG001|STARTED|Epoch 4||0
8899331|NCT02059291|9956980|FG002|STARTED|Epoch 4||0
8899332|NCT02059291|9956981|FG003|STARTED|Epoch 4||0
8899333|NCT02059291|9956982|FG004|STARTED|Epoch 4||0
8899334|NCT02059291|9956983|FG005|STARTED|Epoch 4||0
8899335|NCT02059291|9956984|FG006|STARTED|Epoch 4||0
8899336|NCT02059291|9956985|FG007|STARTED|Epoch 4||0
8899337|NCT02059291|9956986|FG008|STARTED|Epoch 4||0
8899338|NCT02059291|9956987|FG009|STARTED|Epoch 4||0
8899339|NCT02059291|9956988|FG010|STARTED|Epoch 4||0
8899340|NCT02059291|9956989|FG011|STARTED|Epoch 4||0
8899341|NCT02059291|9956990|FG012|STARTED|Epoch 4||0
8899342|NCT02059291|9956991|FG013|STARTED|Epoch 4||0
8899343|NCT02059291|9956992|FG014|STARTED|Epoch 4||0
8899344|NCT02059291|9956993|FG015|STARTED|Epoch 4||0
8899345|NCT02059291|9956994|FG016|STARTED|Epoch 4||43
8899346|NCT02059291|9956995|FG017|STARTED|Epoch 4||14
8899347|NCT02059291|9956996|FG018|STARTED|Epoch 4||2
8899348|NCT02059291|9956997|FG019|STARTED|Epoch 4||18
8899349|NCT02059291|9956998|FG020|STARTED|Epoch 4||34
8899350|NCT02059291|9956999|FG021|STARTED|Epoch 4||14
8899351|NCT02059291|9957000|FG022|STARTED|Epoch 4||31
8899352|NCT02059291|9957001|FG023|STARTED|Epoch 4||22
8899353|NCT02059291|9957002|FG024|STARTED|Epoch 4||0
8899354|NCT02059291|9956978|FG000|COMPLETED|Epoch 4||0
8899355|NCT02059291|9956979|FG001|COMPLETED|Epoch 4||0
8899356|NCT02059291|9956980|FG002|COMPLETED|Epoch 4||0
8899357|NCT02059291|9956981|FG003|COMPLETED|Epoch 4||0
8899358|NCT02059291|9956982|FG004|COMPLETED|Epoch 4||0
8899359|NCT02059291|9956983|FG005|COMPLETED|Epoch 4||0
8899360|NCT02059291|9956984|FG006|COMPLETED|Epoch 4||0
8899361|NCT02059291|9956985|FG007|COMPLETED|Epoch 4||0
8899362|NCT02059291|9956986|FG008|COMPLETED|Epoch 4||0
8899363|NCT02059291|9956987|FG009|COMPLETED|Epoch 4||0
8899364|NCT02059291|9956988|FG010|COMPLETED|Epoch 4||0
8899365|NCT02059291|9956989|FG011|COMPLETED|Epoch 4||0
8899366|NCT02059291|9956990|FG012|COMPLETED|Epoch 4||0
8899367|NCT02059291|9956991|FG013|COMPLETED|Epoch 4||0
8899368|NCT02059291|9956992|FG014|COMPLETED|Epoch 4||0
8899369|NCT02059291|9956993|FG015|COMPLETED|Epoch 4||0
8899370|NCT02059291|9956994|FG016|COMPLETED|Epoch 4||41
8899371|NCT02059291|9956995|FG017|COMPLETED|Epoch 4||14
8899372|NCT02059291|9956996|FG018|COMPLETED|Epoch 4||2
8899373|NCT02059291|9956997|FG019|COMPLETED|Epoch 4||18
8899374|NCT02059291|9956998|FG020|COMPLETED|Epoch 4||33
8899375|NCT02059291|9956999|FG021|COMPLETED|Epoch 4||14
8899376|NCT02059291|9957000|FG022|COMPLETED|Epoch 4||30
8899377|NCT02059291|9957001|FG023|COMPLETED|Epoch 4||21
8899378|NCT02059291|9957002|FG024|COMPLETED|Epoch 4||0
8899379|NCT02059291|9956978|FG000|NOT COMPLETED|Epoch 4||0
8899380|NCT02059291|9956979|FG001|NOT COMPLETED|Epoch 4||0
8899381|NCT02059291|9956980|FG002|NOT COMPLETED|Epoch 4||0
8899382|NCT02059291|9956981|FG003|NOT COMPLETED|Epoch 4||0
8899383|NCT02059291|9956982|FG004|NOT COMPLETED|Epoch 4||0
8899384|NCT02059291|9956983|FG005|NOT COMPLETED|Epoch 4||0
8899385|NCT02059291|9956984|FG006|NOT COMPLETED|Epoch 4||0
8899386|NCT02059291|9956985|FG007|NOT COMPLETED|Epoch 4||0
8899387|NCT02059291|9956986|FG008|NOT COMPLETED|Epoch 4||0
8899388|NCT02059291|9956987|FG009|NOT COMPLETED|Epoch 4||0
8899389|NCT02059291|9956988|FG010|NOT COMPLETED|Epoch 4||0
8899390|NCT02059291|9956989|FG011|NOT COMPLETED|Epoch 4||0
8899391|NCT02059291|9956990|FG012|NOT COMPLETED|Epoch 4||0
8899392|NCT02059291|9956991|FG013|NOT COMPLETED|Epoch 4||0
8899393|NCT02059291|9956992|FG014|NOT COMPLETED|Epoch 4||0
8899394|NCT02059291|9956993|FG015|NOT COMPLETED|Epoch 4||0
8899395|NCT02059291|9956994|FG016|NOT COMPLETED|Epoch 4||2
8899396|NCT02059291|9956995|FG017|NOT COMPLETED|Epoch 4||0
8899397|NCT02059291|9956996|FG018|NOT COMPLETED|Epoch 4||0
8899398|NCT02059291|9956997|FG019|NOT COMPLETED|Epoch 4||0
8899399|NCT02059291|9956998|FG020|NOT COMPLETED|Epoch 4||1
8899400|NCT02059291|9956999|FG021|NOT COMPLETED|Epoch 4||0
8899401|NCT02059291|9957000|FG022|NOT COMPLETED|Epoch 4||1
8899402|NCT02059291|9957001|FG023|NOT COMPLETED|Epoch 4||1
8899403|NCT02059291|9957002|FG024|NOT COMPLETED|Epoch 4||0
8899404|NCT02059395|9957032|FG000|STARTED|Overall Study||22
8899405|NCT02059395|9957033|FG001|STARTED|Overall Study||27
8899406|NCT02059395|9957032|FG000|COMPLETED|Overall Study||20
8899407|NCT02059395|9957033|FG001|COMPLETED|Overall Study||23
8899408|NCT02059395|9957032|FG000|NOT COMPLETED|Overall Study||2
8899409|NCT02059395|9957033|FG001|NOT COMPLETED|Overall Study||4
8899410|NCT02059408|9957042|FG000|STARTED|Overall Study||604
8899411|NCT02059408|9957043|FG001|STARTED|Overall Study||599
8899412|NCT02059408|9957044|FG002|STARTED|Overall Study||616
8899413|NCT02059408|9957042|FG000|COMPLETED|Overall Study||604
8899414|NCT02059408|9957043|FG001|COMPLETED|Overall Study||269
8899415|NCT02059408|9957044|FG002|COMPLETED|Overall Study||258
8899416|NCT02059408|9957042|FG000|NOT COMPLETED|Overall Study||0
8899417|NCT02059408|9957043|FG001|NOT COMPLETED|Overall Study||330
9009092|NCT02969525|10071860|FG011|NOT COMPLETED|Dose-Blind Period||2
9009093|NCT02969590|10071882|FG000|STARTED|Screening Period||5
9009094|NCT02969590|10071883|FG001|STARTED|Screening Period||0
9009095|NCT02969590|10071884|FG002|STARTED|Screening Period||0
9009096|NCT02969590|10071882|FG000|COMPLETED|Screening Period||4
9009097|NCT02969590|10071883|FG001|COMPLETED|Screening Period||0
9009098|NCT02969590|10071884|FG002|COMPLETED|Screening Period||0
9009099|NCT02969590|10071882|FG000|NOT COMPLETED|Screening Period||1
9009100|NCT02969590|10071883|FG001|NOT COMPLETED|Screening Period||0
8635710|NCT00563706|9676213|FG004|COMPLETED|Taper Phase (Day 29 up to Day 35)||11
8899418|NCT02059408|9957044|FG002|NOT COMPLETED|Overall Study||358
8899419|NCT02059434|9957063|FG000|STARTED|Period 1 (After Screening/run-in Period)||2
8899420|NCT02059434|9957064|FG001|STARTED|Period 1 (After Screening/run-in Period)||2
8899421|NCT02059434|9957065|FG002|STARTED|Period 1 (After Screening/run-in Period)||2
8899422|NCT02059434|9957066|FG003|STARTED|Period 1 (After Screening/run-in Period)||2
8899423|NCT02059434|9957067|FG004|STARTED|Period 1 (After Screening/run-in Period)||2
8899424|NCT02059434|9957068|FG005|STARTED|Period 1 (After Screening/run-in Period)||2
8899425|NCT02059434|9957069|FG006|STARTED|Period 1 (After Screening/run-in Period)||2
8899426|NCT02059434|9957070|FG007|STARTED|Period 1 (After Screening/run-in Period)||3
8899427|NCT02059434|9957071|FG008|STARTED|Period 1 (After Screening/run-in Period)|Part 2 followed Part 1, and comprised 5 treatment periods|0
8899428|NCT02059434|9957063|FG000|COMPLETED|Period 1 (After Screening/run-in Period)||2
8899429|NCT02059434|9957064|FG001|COMPLETED|Period 1 (After Screening/run-in Period)||2
8899430|NCT02059434|9957065|FG002|COMPLETED|Period 1 (After Screening/run-in Period)||2
9009101|NCT02969590|10071884|FG002|NOT COMPLETED|Screening Period||0
9009102|NCT02969590|10071882|FG000|STARTED|Treatment Period 1||0
9009103|NCT02969590|10071883|FG001|STARTED|Treatment Period 1||2
8899431|NCT02059434|9957066|FG003|COMPLETED|Period 1 (After Screening/run-in Period)||2
8899432|NCT02059434|9957067|FG004|COMPLETED|Period 1 (After Screening/run-in Period)||2
8899433|NCT02059434|9957068|FG005|COMPLETED|Period 1 (After Screening/run-in Period)||2
8899434|NCT02059434|9957069|FG006|COMPLETED|Period 1 (After Screening/run-in Period)||2
8899435|NCT02059434|9957070|FG007|COMPLETED|Period 1 (After Screening/run-in Period)||3
8899436|NCT02059434|9957071|FG008|COMPLETED|Period 1 (After Screening/run-in Period)|Part 2 followed Part 1, and comprised 5 treatment periods|0
8899437|NCT02059434|9957063|FG000|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
8899438|NCT02059434|9957064|FG001|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
8899439|NCT02059434|9957065|FG002|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
8899440|NCT02059434|9957066|FG003|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
8899441|NCT02059434|9957067|FG004|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
8899442|NCT02059434|9957068|FG005|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
8899443|NCT02059434|9957069|FG006|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
8899444|NCT02059434|9957070|FG007|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
8899445|NCT02059434|9957071|FG008|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
8899446|NCT02059434|9957063|FG000|STARTED|Washout Between Periods 1 and 2||2
8899447|NCT02059434|9957064|FG001|STARTED|Washout Between Periods 1 and 2||2
8899448|NCT02059434|9957065|FG002|STARTED|Washout Between Periods 1 and 2||2
8899449|NCT02059434|9957066|FG003|STARTED|Washout Between Periods 1 and 2||2
8899450|NCT02059434|9957067|FG004|STARTED|Washout Between Periods 1 and 2||2
8899451|NCT02059434|9957068|FG005|STARTED|Washout Between Periods 1 and 2||2
8899452|NCT02059434|9957069|FG006|STARTED|Washout Between Periods 1 and 2||2
8899453|NCT02059434|9957070|FG007|STARTED|Washout Between Periods 1 and 2||3
8899454|NCT02059434|9957071|FG008|STARTED|Washout Between Periods 1 and 2|Part 2 followed Part 1, and comprised 5 treatment periods|0
8899455|NCT02059434|9957063|FG000|COMPLETED|Washout Between Periods 1 and 2||2
8899456|NCT02059434|9957064|FG001|COMPLETED|Washout Between Periods 1 and 2||2
8899457|NCT02059434|9957065|FG002|COMPLETED|Washout Between Periods 1 and 2||2
8899458|NCT02059434|9957066|FG003|COMPLETED|Washout Between Periods 1 and 2||2
8899459|NCT02059434|9957067|FG004|COMPLETED|Washout Between Periods 1 and 2||2
8899460|NCT02059434|9957068|FG005|COMPLETED|Washout Between Periods 1 and 2||2
8899461|NCT02059434|9957069|FG006|COMPLETED|Washout Between Periods 1 and 2||2
8899462|NCT02059434|9957070|FG007|COMPLETED|Washout Between Periods 1 and 2||2
8899463|NCT02059434|9957071|FG008|COMPLETED|Washout Between Periods 1 and 2|Part 2 followed Part 1, and comprised 5 treatment periods|0
8899464|NCT02059434|9957063|FG000|NOT COMPLETED|Washout Between Periods 1 and 2||0
8899465|NCT02059434|9957064|FG001|NOT COMPLETED|Washout Between Periods 1 and 2||0
8899466|NCT02059434|9957065|FG002|NOT COMPLETED|Washout Between Periods 1 and 2||0
8899467|NCT02059434|9957066|FG003|NOT COMPLETED|Washout Between Periods 1 and 2||0
8899468|NCT02059434|9957067|FG004|NOT COMPLETED|Washout Between Periods 1 and 2||0
8899469|NCT02059434|9957068|FG005|NOT COMPLETED|Washout Between Periods 1 and 2||0
8899470|NCT02059434|9957069|FG006|NOT COMPLETED|Washout Between Periods 1 and 2||0
8899471|NCT02059434|9957070|FG007|NOT COMPLETED|Washout Between Periods 1 and 2||1
8899472|NCT02059434|9957071|FG008|NOT COMPLETED|Washout Between Periods 1 and 2||0
8899473|NCT02059434|9957063|FG000|STARTED|Period 2||2
8899474|NCT02059434|9957064|FG001|STARTED|Period 2||2
8899475|NCT02059434|9957065|FG002|STARTED|Period 2||2
8899476|NCT02059434|9957066|FG003|STARTED|Period 2||2
8899477|NCT02059434|9957067|FG004|STARTED|Period 2||2
8899478|NCT02059434|9957068|FG005|STARTED|Period 2||2
8899479|NCT02059434|9957069|FG006|STARTED|Period 2||2
8899480|NCT02059434|9957070|FG007|STARTED|Period 2||2
8899481|NCT02059434|9957071|FG008|STARTED|Period 2|Part 2 followed Part 1, and comprised 5 treatment periods|0
8899482|NCT02059434|9957063|FG000|COMPLETED|Period 2||2
8899483|NCT02059434|9957064|FG001|COMPLETED|Period 2||2
8899484|NCT02059434|9957065|FG002|COMPLETED|Period 2||2
8899485|NCT02059434|9957066|FG003|COMPLETED|Period 2||2
8899486|NCT02059434|9957067|FG004|COMPLETED|Period 2||2
8899487|NCT02059434|9957068|FG005|COMPLETED|Period 2||2
8899488|NCT02059434|9957069|FG006|COMPLETED|Period 2||2
8899489|NCT02059434|9957070|FG007|COMPLETED|Period 2||2
8899490|NCT02059434|9957071|FG008|COMPLETED|Period 2|Part 2 followed Part 1, and comprised 5 treatment periods|0
8899491|NCT02059434|9957063|FG000|NOT COMPLETED|Period 2||0
8899492|NCT02059434|9957064|FG001|NOT COMPLETED|Period 2||0
8899493|NCT02059434|9957065|FG002|NOT COMPLETED|Period 2||0
8635711|NCT00563706|9676214|FG005|COMPLETED|Taper Phase (Day 29 up to Day 35)||14
8635712|NCT00563706|9676215|FG006|COMPLETED|Taper Phase (Day 29 up to Day 35)||9
8899494|NCT02059434|9957066|FG003|NOT COMPLETED|Period 2||0
8899495|NCT02059434|9957067|FG004|NOT COMPLETED|Period 2||0
8899496|NCT02059434|9957068|FG005|NOT COMPLETED|Period 2||0
8899497|NCT02059434|9957069|FG006|NOT COMPLETED|Period 2||0
8899498|NCT02059434|9957070|FG007|NOT COMPLETED|Period 2||0
8899499|NCT02059434|9957071|FG008|NOT COMPLETED|Period 2||0
8899500|NCT02059434|9957063|FG000|STARTED|Washout Between Periods 2 and 3||2
8899501|NCT02059434|9957064|FG001|STARTED|Washout Between Periods 2 and 3||2
8899502|NCT02059434|9957065|FG002|STARTED|Washout Between Periods 2 and 3||2
8899503|NCT02059434|9957066|FG003|STARTED|Washout Between Periods 2 and 3||2
8899504|NCT02059434|9957067|FG004|STARTED|Washout Between Periods 2 and 3||2
8899505|NCT02059434|9957068|FG005|STARTED|Washout Between Periods 2 and 3||2
8899506|NCT02059434|9957069|FG006|STARTED|Washout Between Periods 2 and 3||2
8635713|NCT00563706|9676216|FG007|COMPLETED|Taper Phase (Day 29 up to Day 35)||16
8899507|NCT02059434|9957070|FG007|STARTED|Washout Between Periods 2 and 3||2
8899508|NCT02059434|9957071|FG008|STARTED|Washout Between Periods 2 and 3|Part 2 followed Part 1, and comprised 5 treatment periods|0
8899509|NCT02059434|9957063|FG000|COMPLETED|Washout Between Periods 2 and 3||2
8899510|NCT02059434|9957064|FG001|COMPLETED|Washout Between Periods 2 and 3||2
8899511|NCT02059434|9957065|FG002|COMPLETED|Washout Between Periods 2 and 3||2
8899512|NCT02059434|9957066|FG003|COMPLETED|Washout Between Periods 2 and 3||2
8899513|NCT02059434|9957067|FG004|COMPLETED|Washout Between Periods 2 and 3||2
8899514|NCT02059434|9957068|FG005|COMPLETED|Washout Between Periods 2 and 3||2
8899515|NCT02059434|9957069|FG006|COMPLETED|Washout Between Periods 2 and 3||2
8899516|NCT02059434|9957070|FG007|COMPLETED|Washout Between Periods 2 and 3||2
8899517|NCT02059434|9957071|FG008|COMPLETED|Washout Between Periods 2 and 3|Part 2 followed Part 1, and comprised 5 treatment periods|0
8899518|NCT02059434|9957063|FG000|NOT COMPLETED|Washout Between Periods 2 and 3||0
8899519|NCT02059434|9957064|FG001|NOT COMPLETED|Washout Between Periods 2 and 3||0
8899520|NCT02059434|9957065|FG002|NOT COMPLETED|Washout Between Periods 2 and 3||0
8899521|NCT02059434|9957066|FG003|NOT COMPLETED|Washout Between Periods 2 and 3||0
8899522|NCT02059434|9957067|FG004|NOT COMPLETED|Washout Between Periods 2 and 3||0
8899523|NCT02059434|9957068|FG005|NOT COMPLETED|Washout Between Periods 2 and 3||0
8899524|NCT02059434|9957069|FG006|NOT COMPLETED|Washout Between Periods 2 and 3||0
8899525|NCT02059434|9957070|FG007|NOT COMPLETED|Washout Between Periods 2 and 3||0
8899526|NCT02059434|9957071|FG008|NOT COMPLETED|Washout Between Periods 2 and 3||0
8899527|NCT02059434|9957063|FG000|STARTED|Period 3||2
8899528|NCT02059434|9957064|FG001|STARTED|Period 3||2
9009104|NCT02969590|10071884|FG002|STARTED|Treatment Period 1||2
9009105|NCT02969590|10071882|FG000|COMPLETED|Treatment Period 1||0
9009106|NCT02969590|10071883|FG001|COMPLETED|Treatment Period 1||2
9009107|NCT02969590|10071884|FG002|COMPLETED|Treatment Period 1||2
9009108|NCT02969590|10071882|FG000|NOT COMPLETED|Treatment Period 1||0
9009109|NCT02969590|10071883|FG001|NOT COMPLETED|Treatment Period 1||0
9009110|NCT02969590|10071884|FG002|NOT COMPLETED|Treatment Period 1||0
9009111|NCT02969590|10071882|FG000|STARTED|Treatment Period 2||0
9009112|NCT02969590|10071883|FG001|STARTED|Treatment Period 2||2
9009113|NCT02969590|10071884|FG002|STARTED|Treatment Period 2||2
8899529|NCT02059434|9957065|FG002|STARTED|Period 3||2
8899530|NCT02059434|9957066|FG003|STARTED|Period 3||2
8899531|NCT02059434|9957067|FG004|STARTED|Period 3||2
8899532|NCT02059434|9957068|FG005|STARTED|Period 3||2
8899533|NCT02059434|9957069|FG006|STARTED|Period 3||2
8899534|NCT02059434|9957070|FG007|STARTED|Period 3||2
8899535|NCT02059434|9957071|FG008|STARTED|Period 3|Part 2 followed Part 1, and comprised 5 treatment periods|0
8899536|NCT02059434|9957063|FG000|COMPLETED|Period 3||2
8899537|NCT02059434|9957064|FG001|COMPLETED|Period 3||2
8899538|NCT02059434|9957065|FG002|COMPLETED|Period 3||2
8899539|NCT02059434|9957066|FG003|COMPLETED|Period 3||2
9009114|NCT02969590|10071882|FG000|COMPLETED|Treatment Period 2||0
8899540|NCT02059434|9957067|FG004|COMPLETED|Period 3||2
8899541|NCT02059434|9957068|FG005|COMPLETED|Period 3||2
8899542|NCT02059434|9957069|FG006|COMPLETED|Period 3||2
8899543|NCT02059434|9957070|FG007|COMPLETED|Period 3||2
8899544|NCT02059434|9957071|FG008|COMPLETED|Period 3|Part 2 followed Part 1, and comprised 5 treatment periods|0
8899545|NCT02059434|9957063|FG000|NOT COMPLETED|Period 3||0
8899546|NCT02059434|9957064|FG001|NOT COMPLETED|Period 3||0
8899547|NCT02059434|9957065|FG002|NOT COMPLETED|Period 3||0
8899548|NCT02059434|9957066|FG003|NOT COMPLETED|Period 3||0
8899549|NCT02059434|9957067|FG004|NOT COMPLETED|Period 3||0
8899550|NCT02059434|9957068|FG005|NOT COMPLETED|Period 3||0
8899551|NCT02059434|9957069|FG006|NOT COMPLETED|Period 3||0
8899552|NCT02059434|9957070|FG007|NOT COMPLETED|Period 3||0
8899553|NCT02059434|9957071|FG008|NOT COMPLETED|Period 3||0
8899554|NCT02059434|9957063|FG000|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
8899555|NCT02059434|9957064|FG001|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
8899556|NCT02059434|9957065|FG002|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
8899557|NCT02059434|9957066|FG003|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
8899558|NCT02059434|9957067|FG004|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
8899559|NCT02059434|9957068|FG005|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
8899560|NCT02059434|9957069|FG006|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
8899561|NCT02059434|9957070|FG007|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
8899562|NCT02059434|9957071|FG008|STARTED|Period 4 (After Screening/run-in Period)||38
8899563|NCT02059434|9957063|FG000|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
8899564|NCT02059434|9957064|FG001|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
8899565|NCT02059434|9957065|FG002|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
8899566|NCT02059434|9957066|FG003|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
8899567|NCT02059434|9957067|FG004|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
8899568|NCT02059434|9957068|FG005|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
8899569|NCT02059434|9957069|FG006|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
8899570|NCT02059434|9957070|FG007|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
8899571|NCT02059434|9957071|FG008|COMPLETED|Period 4 (After Screening/run-in Period)||38
8899572|NCT02059434|9957063|FG000|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
8899573|NCT02059434|9957064|FG001|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
8899574|NCT02059434|9957065|FG002|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
8899575|NCT02059434|9957066|FG003|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
8899576|NCT02059434|9957067|FG004|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
8899577|NCT02059434|9957068|FG005|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
8899578|NCT02059434|9957069|FG006|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
8899579|NCT02059434|9957070|FG007|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
8899580|NCT02059434|9957071|FG008|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
8899581|NCT02059434|9957063|FG000|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
8899582|NCT02059434|9957064|FG001|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
8899583|NCT02059434|9957065|FG002|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
8899584|NCT02059434|9957066|FG003|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
8899585|NCT02059434|9957067|FG004|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
8899586|NCT02059434|9957068|FG005|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
8899587|NCT02059434|9957069|FG006|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
8899588|NCT02059434|9957070|FG007|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
8899589|NCT02059434|9957071|FG008|STARTED|Washout Between Periods 4 and 5||38
8899590|NCT02059434|9957063|FG000|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
8899591|NCT02059434|9957064|FG001|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
8899592|NCT02059434|9957065|FG002|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
8899593|NCT02059434|9957066|FG003|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
8899594|NCT02059434|9957067|FG004|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
8899595|NCT02059434|9957068|FG005|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
8899596|NCT02059434|9957069|FG006|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
8899597|NCT02059434|9957070|FG007|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
8899598|NCT02059434|9957071|FG008|COMPLETED|Washout Between Periods 4 and 5||37
8899599|NCT02059434|9957063|FG000|NOT COMPLETED|Washout Between Periods 4 and 5||0
8899600|NCT02059434|9957064|FG001|NOT COMPLETED|Washout Between Periods 4 and 5||0
8899601|NCT02059434|9957065|FG002|NOT COMPLETED|Washout Between Periods 4 and 5||0
8899602|NCT02059434|9957066|FG003|NOT COMPLETED|Washout Between Periods 4 and 5||0
9009115|NCT02969590|10071883|FG001|COMPLETED|Treatment Period 2||2
8899603|NCT02059434|9957067|FG004|NOT COMPLETED|Washout Between Periods 4 and 5||0
8899604|NCT02059434|9957068|FG005|NOT COMPLETED|Washout Between Periods 4 and 5||0
8899605|NCT02059434|9957069|FG006|NOT COMPLETED|Washout Between Periods 4 and 5||0
8899606|NCT02059434|9957070|FG007|NOT COMPLETED|Washout Between Periods 4 and 5||0
8899607|NCT02059434|9957071|FG008|NOT COMPLETED|Washout Between Periods 4 and 5||1
8899608|NCT02059434|9957063|FG000|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
8899609|NCT02059434|9957064|FG001|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
8899610|NCT02059434|9957065|FG002|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
8899611|NCT02059434|9957066|FG003|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
8899612|NCT02059434|9957067|FG004|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
8899613|NCT02059434|9957068|FG005|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
8899614|NCT02059434|9957069|FG006|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
8899615|NCT02059434|9957070|FG007|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
8899616|NCT02059434|9957071|FG008|STARTED|Period 5||37
8899617|NCT02059434|9957063|FG000|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
8899618|NCT02059434|9957064|FG001|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
8899619|NCT02059434|9957065|FG002|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
8899620|NCT02059434|9957066|FG003|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
8899621|NCT02059434|9957067|FG004|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
8899622|NCT02059434|9957068|FG005|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
8899623|NCT02059434|9957069|FG006|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
8899624|NCT02059434|9957070|FG007|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
8899625|NCT02059434|9957071|FG008|COMPLETED|Period 5||37
8899626|NCT02059434|9957063|FG000|NOT COMPLETED|Period 5||0
8899627|NCT02059434|9957064|FG001|NOT COMPLETED|Period 5||0
8899628|NCT02059434|9957065|FG002|NOT COMPLETED|Period 5||0
8899629|NCT02059434|9957066|FG003|NOT COMPLETED|Period 5||0
8899630|NCT02059434|9957067|FG004|NOT COMPLETED|Period 5||0
8899631|NCT02059434|9957068|FG005|NOT COMPLETED|Period 5||0
8899632|NCT02059434|9957069|FG006|NOT COMPLETED|Period 5||0
8899633|NCT02059434|9957070|FG007|NOT COMPLETED|Period 5||0
8899634|NCT02059434|9957071|FG008|NOT COMPLETED|Period 5||0
8899635|NCT02059434|9957063|FG000|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
8899636|NCT02059434|9957064|FG001|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
8899637|NCT02059434|9957065|FG002|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
9009116|NCT02969590|10071884|FG002|COMPLETED|Treatment Period 2||2
9009117|NCT02969590|10071882|FG000|NOT COMPLETED|Treatment Period 2||0
9009118|NCT02969590|10071883|FG001|NOT COMPLETED|Treatment Period 2||0
9009119|NCT02969590|10071884|FG002|NOT COMPLETED|Treatment Period 2||0
9009120|NCT02969655|10071896|FG000|STARTED|Overall Study||136
8635714|NCT00563706|9676217|FG008|COMPLETED|Taper Phase (Day 29 up to Day 35)||32
8635715|NCT00563706|9676209|FG000|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
8635716|NCT00563706|9676210|FG001|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
8635717|NCT00563706|9676211|FG002|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
8635718|NCT00563706|9676212|FG003|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
9009121|NCT02969655|10071897|FG001|STARTED|Overall Study||135
9009122|NCT02969655|10071896|FG000|COMPLETED|Overall Study||115
9009123|NCT02969655|10071897|FG001|COMPLETED|Overall Study||120
9009124|NCT02969655|10071896|FG000|NOT COMPLETED|Overall Study||21
9009125|NCT02969655|10071897|FG001|NOT COMPLETED|Overall Study||15
9009126|NCT02969707|10071906|FG000|STARTED|Overall Study||49
9009127|NCT02969707|10071907|FG001|STARTED|Overall Study||52
9009128|NCT02969707|10071906|FG000|COMPLETED|Overall Study||41
9009129|NCT02969707|10071907|FG001|COMPLETED|Overall Study||44
9009130|NCT02969707|10071906|FG000|NOT COMPLETED|Overall Study||8
9009131|NCT02969707|10071907|FG001|NOT COMPLETED|Overall Study||8
9009132|NCT02969863|10071918|FG000|STARTED|Overall Study||4
9009133|NCT02969863|10071919|FG001|STARTED|Overall Study||4
9009134|NCT02969863|10071920|FG002|STARTED|Overall Study||4
9009135|NCT02969863|10071921|FG003|STARTED|Overall Study||4
9009136|NCT02969863|10071922|FG004|STARTED|Overall Study||4
9009137|NCT02969863|10071923|FG005|STARTED|Overall Study||4
9009138|NCT02969863|10071918|FG000|COMPLETED|Overall Study||3
9009139|NCT02969863|10071919|FG001|COMPLETED|Overall Study||4
9009140|NCT02969863|10071920|FG002|COMPLETED|Overall Study||4
9009141|NCT02969863|10071921|FG003|COMPLETED|Overall Study||4
9009142|NCT02969863|10071922|FG004|COMPLETED|Overall Study||4
9009143|NCT02969863|10071923|FG005|COMPLETED|Overall Study||4
9009144|NCT02969863|10071918|FG000|NOT COMPLETED|Overall Study||1
9009145|NCT02969863|10071919|FG001|NOT COMPLETED|Overall Study||0
9009146|NCT02969863|10071920|FG002|NOT COMPLETED|Overall Study||0
9009147|NCT02969863|10071921|FG003|NOT COMPLETED|Overall Study||0
9009148|NCT02969863|10071922|FG004|NOT COMPLETED|Overall Study||0
9009149|NCT02969863|10071923|FG005|NOT COMPLETED|Overall Study||0
9009150|NCT02969876|10071937|FG000|STARTED|Overall Study||2
9009151|NCT02969876|10071937|FG000|COMPLETED|Overall Study||2
9009152|NCT02969876|10071937|FG000|NOT COMPLETED|Overall Study||0
9009153|NCT02970006|10071942|FG000|STARTED|Overall Study||15
9009154|NCT02970006|10071942|FG000|COMPLETED|Overall Study||14
9009155|NCT02970006|10071942|FG000|NOT COMPLETED|Overall Study||1
9009156|NCT02970032|10071946|FG000|STARTED|Standard Heparin Dose||20
9009157|NCT02970032|10071946|FG000|COMPLETED|Standard Heparin Dose||20
8899638|NCT02059434|9957066|FG003|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
8899639|NCT02059434|9957067|FG004|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
8899640|NCT02059434|9957068|FG005|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
8899641|NCT02059434|9957069|FG006|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
8899642|NCT02059434|9957070|FG007|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
8899643|NCT02059434|9957071|FG008|STARTED|Washout Between Periods 5 and 6||37
8899644|NCT02059434|9957063|FG000|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
8899645|NCT02059434|9957064|FG001|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
8899646|NCT02059434|9957065|FG002|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
8899647|NCT02059434|9957066|FG003|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
8899648|NCT02059434|9957067|FG004|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
8899649|NCT02059434|9957068|FG005|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
8899650|NCT02059434|9957069|FG006|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
8899651|NCT02059434|9957070|FG007|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
8899652|NCT02059434|9957071|FG008|COMPLETED|Washout Between Periods 5 and 6||37
8899653|NCT02059434|9957063|FG000|NOT COMPLETED|Washout Between Periods 5 and 6||0
8635719|NCT00563706|9676213|FG004|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
8635720|NCT00563706|9676214|FG005|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
8635721|NCT00563706|9676215|FG006|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
8635722|NCT00563706|9676216|FG007|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
8635723|NCT00563706|9676217|FG008|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
8635724|NCT00563784|9676237|FG000|STARTED|Overall Study||68
8899654|NCT02059434|9957064|FG001|NOT COMPLETED|Washout Between Periods 5 and 6||0
8899655|NCT02059434|9957065|FG002|NOT COMPLETED|Washout Between Periods 5 and 6||0
8899656|NCT02059434|9957066|FG003|NOT COMPLETED|Washout Between Periods 5 and 6||0
8899657|NCT02059434|9957067|FG004|NOT COMPLETED|Washout Between Periods 5 and 6||0
8899658|NCT02059434|9957068|FG005|NOT COMPLETED|Washout Between Periods 5 and 6||0
8899659|NCT02059434|9957069|FG006|NOT COMPLETED|Washout Between Periods 5 and 6||0
8899660|NCT02059434|9957070|FG007|NOT COMPLETED|Washout Between Periods 5 and 6||0
8899661|NCT02059434|9957071|FG008|NOT COMPLETED|Washout Between Periods 5 and 6||0
8899662|NCT02059434|9957063|FG000|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
8899663|NCT02059434|9957064|FG001|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
8899664|NCT02059434|9957065|FG002|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
8899665|NCT02059434|9957066|FG003|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
8899666|NCT02059434|9957067|FG004|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
8899667|NCT02059434|9957068|FG005|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
8899668|NCT02059434|9957069|FG006|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
8899669|NCT02059434|9957070|FG007|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
8899670|NCT02059434|9957071|FG008|STARTED|Period 6||37
8899671|NCT02059434|9957063|FG000|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
8899672|NCT02059434|9957064|FG001|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
8899673|NCT02059434|9957065|FG002|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
8899674|NCT02059434|9957066|FG003|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
8899675|NCT02059434|9957067|FG004|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
8899676|NCT02059434|9957068|FG005|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
8899677|NCT02059434|9957069|FG006|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
8899678|NCT02059434|9957070|FG007|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
8899679|NCT02059434|9957071|FG008|COMPLETED|Period 6||37
8899680|NCT02059434|9957063|FG000|NOT COMPLETED|Period 6||0
8899681|NCT02059434|9957064|FG001|NOT COMPLETED|Period 6||0
8899682|NCT02059434|9957065|FG002|NOT COMPLETED|Period 6||0
8899683|NCT02059434|9957066|FG003|NOT COMPLETED|Period 6||0
8899684|NCT02059434|9957067|FG004|NOT COMPLETED|Period 6||0
8899685|NCT02059434|9957068|FG005|NOT COMPLETED|Period 6||0
8899686|NCT02059434|9957069|FG006|NOT COMPLETED|Period 6||0
8899687|NCT02059434|9957070|FG007|NOT COMPLETED|Period 6||0
8899688|NCT02059434|9957071|FG008|NOT COMPLETED|Period 6||0
8899689|NCT02059434|9957063|FG000|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
8899690|NCT02059434|9957064|FG001|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
8899691|NCT02059434|9957065|FG002|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
8899692|NCT02059434|9957066|FG003|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
8899693|NCT02059434|9957067|FG004|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
8899694|NCT02059434|9957068|FG005|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
8899695|NCT02059434|9957069|FG006|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
8899696|NCT02059434|9957070|FG007|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
8899697|NCT02059434|9957071|FG008|STARTED|Washout Between Periods 6 and 7||37
8899698|NCT02059434|9957063|FG000|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
8635725|NCT00563784|9676237|FG000|COMPLETED|Overall Study||46
8899699|NCT02059434|9957064|FG001|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
8899700|NCT02059434|9957065|FG002|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
8899701|NCT02059434|9957066|FG003|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
8899702|NCT02059434|9957067|FG004|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
8899703|NCT02059434|9957068|FG005|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
8899704|NCT02059434|9957069|FG006|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
9009158|NCT02970032|10071946|FG000|NOT COMPLETED|Standard Heparin Dose||0
9009159|NCT02970032|10071946|FG000|STARTED|Real Time Heparin Dose Adjustment||20
9009160|NCT02970032|10071946|FG000|COMPLETED|Real Time Heparin Dose Adjustment||20
9009161|NCT02970032|10071946|FG000|NOT COMPLETED|Real Time Heparin Dose Adjustment||0
9009162|NCT02970162|10071953|FG000|STARTED|Overall Study||13
9009163|NCT02970162|10071954|FG001|STARTED|Overall Study||13
9009164|NCT02970162|10071953|FG000|COMPLETED|Overall Study||13
9009165|NCT02970162|10071954|FG001|COMPLETED|Overall Study||13
9009166|NCT02970162|10071953|FG000|NOT COMPLETED|Overall Study||0
9009167|NCT02970162|10071954|FG001|NOT COMPLETED|Overall Study||0
9009168|NCT02970292|10071962|FG000|STARTED|Overall Study||198
9009169|NCT02970292|10071963|FG001|STARTED|Overall Study||198
9009170|NCT02970292|10071962|FG000|COMPLETED|Overall Study||174
9009171|NCT02970292|10071963|FG001|COMPLETED|Overall Study||190
9009172|NCT02970292|10071962|FG000|NOT COMPLETED|Overall Study||24
9009173|NCT02970292|10071963|FG001|NOT COMPLETED|Overall Study||8
9009174|NCT02970305|10071971|FG000|STARTED|Overall Study||201
9009175|NCT02970305|10071972|FG001|STARTED|Overall Study||202
9009176|NCT02970305|10071971|FG000|COMPLETED|Overall Study||172
9009177|NCT02970305|10071972|FG001|COMPLETED|Overall Study||174
9009178|NCT02970305|10071971|FG000|NOT COMPLETED|Overall Study||29
9009179|NCT02970305|10071972|FG001|NOT COMPLETED|Overall Study||28
9009180|NCT02970422|10071978|FG000|STARTED|Overall Study||200
9009181|NCT02970422|10071978|FG000|COMPLETED|Overall Study||200
9009182|NCT02970422|10071978|FG000|NOT COMPLETED|Overall Study||0
9009183|NCT02970552|10072003|FG000|STARTED|Overall Study||70
9009184|NCT02970552|10072004|FG001|STARTED|Overall Study||70
9009185|NCT02970552|10072003|FG000|COMPLETED|Overall Study||67
9009186|NCT02970552|10072004|FG001|COMPLETED|Overall Study||67
8572885|NCT00117637|9605077|FG000|Subjects Received Treatment|First Intervention (Period 1)||97
8572886|NCT00117637|9605078|FG001|Subjects Received Treatment|First Intervention (Period 1)||90
8572887|NCT00117637|9605077|FG000|COMPLETED|First Intervention (Period 1)||79
8572888|NCT00117637|9605078|FG001|COMPLETED|First Intervention (Period 1)||67
8899705|NCT02059434|9957070|FG007|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
8899706|NCT02059434|9957071|FG008|COMPLETED|Washout Between Periods 6 and 7||36
8899707|NCT02059434|9957063|FG000|NOT COMPLETED|Washout Between Periods 6 and 7||0
8899708|NCT02059434|9957064|FG001|NOT COMPLETED|Washout Between Periods 6 and 7||0
8899709|NCT02059434|9957065|FG002|NOT COMPLETED|Washout Between Periods 6 and 7||0
9009187|NCT02970552|10072003|FG000|NOT COMPLETED|Overall Study||3
9009188|NCT02970552|10072004|FG001|NOT COMPLETED|Overall Study||3
9009189|NCT02970669|10072016|FG000|STARTED|Double-blind Period||70
9009190|NCT02970669|10072017|FG001|STARTED|Double-blind Period||70
9009191|NCT02970669|10072016|FG000|COMPLETED|Double-blind Period||62
9009192|NCT02970669|10072017|FG001|COMPLETED|Double-blind Period||64
9009193|NCT02970669|10072016|FG000|NOT COMPLETED|Double-blind Period||8
9009194|NCT02970669|10072017|FG001|NOT COMPLETED|Double-blind Period||6
9009195|NCT02970669|10072016|FG000|STARTED|Open-label Period||62
9009196|NCT02970669|10072017|FG001|STARTED|Open-label Period||64
9009197|NCT02970669|10072016|FG000|COMPLETED|Open-label Period||58
9009198|NCT02970669|10072017|FG001|COMPLETED|Open-label Period||62
9009199|NCT02970669|10072016|FG000|NOT COMPLETED|Open-label Period||4
9009200|NCT02970669|10072017|FG001|NOT COMPLETED|Open-label Period||2
9009201|NCT02970812|10072027|FG000|STARTED|Overall Study||30
9009202|NCT02970812|10072028|FG001|STARTED|Overall Study||30
9009203|NCT02970812|10072027|FG000|COMPLETED|Overall Study||22
9009204|NCT02970812|10072028|FG001|COMPLETED|Overall Study||28
9009205|NCT02970812|10072027|FG000|NOT COMPLETED|Overall Study||8
8899710|NCT02059434|9957066|FG003|NOT COMPLETED|Washout Between Periods 6 and 7||0
9009206|NCT02970812|10072028|FG001|NOT COMPLETED|Overall Study||2
9009207|NCT02970942|10072038|FG000|STARTED|Overall Study||80
9009208|NCT02970942|10072039|FG001|STARTED|Overall Study||78
9009209|NCT02970942|10072040|FG002|STARTED|Overall Study||82
9009210|NCT02970942|10072041|FG003|STARTED|Overall Study||80
9009211|NCT02970942|10072038|FG000|Full Analysis Set|Overall Study||80
9009212|NCT02970942|10072039|FG001|Full Analysis Set|Overall Study||78
9009213|NCT02970942|10072040|FG002|Full Analysis Set|Overall Study||82
9009214|NCT02970942|10072041|FG003|Full Analysis Set|Overall Study||80
9009215|NCT02970942|10072038|FG000|Safety Analysis Set|Overall Study||80
9009216|NCT02970942|10072039|FG001|Safety Analysis Set|Overall Study||78
9009217|NCT02970942|10072040|FG002|Safety Analysis Set|Overall Study||81
9009218|NCT02970942|10072041|FG003|Safety Analysis Set|Overall Study||80
9009219|NCT02970942|10072038|FG000|Exposed|Overall Study||80
9009220|NCT02970942|10072039|FG001|Exposed|Overall Study||78
9009221|NCT02970942|10072040|FG002|Exposed|Overall Study||81
9009222|NCT02970942|10072041|FG003|Exposed|Overall Study||80
9009223|NCT02970942|10072038|FG000|COMPLETED|Overall Study||76
9009224|NCT02970942|10072039|FG001|COMPLETED|Overall Study||72
9009225|NCT02970942|10072040|FG002|COMPLETED|Overall Study||77
9009226|NCT02970942|10072041|FG003|COMPLETED|Overall Study||77
9009227|NCT02970942|10072038|FG000|NOT COMPLETED|Overall Study||4
9009228|NCT02970942|10072039|FG001|NOT COMPLETED|Overall Study||6
9009229|NCT02970942|10072040|FG002|NOT COMPLETED|Overall Study||5
9009230|NCT02970942|10072041|FG003|NOT COMPLETED|Overall Study||3
9009231|NCT02971007|10072054|FG000|STARTED|Overall Study||46
9009232|NCT02971007|10072055|FG001|STARTED|Overall Study||45
9009233|NCT02971007|10072056|FG002|STARTED|Overall Study||46
9009234|NCT02971007|10072054|FG000|COMPLETED|Overall Study||44
9009235|NCT02971007|10072055|FG001|COMPLETED|Overall Study||42
9009236|NCT02971007|10072056|FG002|COMPLETED|Overall Study||45
9009237|NCT02971007|10072054|FG000|NOT COMPLETED|Overall Study||2
9009238|NCT02971007|10072055|FG001|NOT COMPLETED|Overall Study||3
9009239|NCT02971007|10072056|FG002|NOT COMPLETED|Overall Study||1
9009240|NCT02971163|10072066|FG000|STARTED|Overall Study||24
9009241|NCT02971163|10072067|FG001|STARTED|Overall Study||26
9009242|NCT02971163|10072066|FG000|COMPLETED|Overall Study||20
9009243|NCT02971163|10072067|FG001|COMPLETED|Overall Study||24
9009244|NCT02971163|10072066|FG000|NOT COMPLETED|Overall Study||4
9009245|NCT02971163|10072067|FG001|NOT COMPLETED|Overall Study||2
9009246|NCT02971202|10072076|FG000|STARTED|Overall Study||12
9009247|NCT02971202|10072077|FG001|STARTED|Overall Study||10
9009248|NCT02971202|10072078|FG002|STARTED|Overall Study||11
9009249|NCT02971202|10072076|FG000|Started Study|Overall Study||11
9009250|NCT02971202|10072077|FG001|Started Study|Overall Study||10
9009251|NCT02971202|10072078|FG002|Started Study|Overall Study||10
9009252|NCT02971202|10072076|FG000|COMPLETED|Overall Study||10
9009253|NCT02971202|10072077|FG001|COMPLETED|Overall Study||10
9009254|NCT02971202|10072078|FG002|COMPLETED|Overall Study||10
9009255|NCT02971202|10072076|FG000|NOT COMPLETED|Overall Study||2
9009256|NCT02971202|10072077|FG001|NOT COMPLETED|Overall Study||0
9009257|NCT02971202|10072078|FG002|NOT COMPLETED|Overall Study||1
9009258|NCT02971228|10072086|FG000|STARTED|Overall Study||1
9009259|NCT02971228|10072087|FG001|STARTED|Overall Study||7
9009260|NCT02971228|10072088|FG002|STARTED|Overall Study||5
9009261|NCT02971228|10072089|FG003|STARTED|Overall Study|Due to iLet unavailability, trial was stopped upon completion of Part 1. Part 2 was not conducted.|0
9009262|NCT02971228|10072090|FG004|STARTED|Overall Study|Due to iLet unavailability, trial was stopped upon completion of Part 1. Part 2 was not conducted.|0
9009263|NCT02971228|10072086|FG000|Randomized and Treated|Overall Study||0
9009264|NCT02971228|10072087|FG001|Randomized and Treated|Overall Study||7
9009265|NCT02971228|10072088|FG002|Randomized and Treated|Overall Study||5
9009266|NCT02971228|10072089|FG003|Randomized and Treated|Overall Study||0
9009267|NCT02971228|10072090|FG004|Randomized and Treated|Overall Study||0
9009268|NCT02971228|10072086|FG000|COMPLETED|Overall Study||0
9009269|NCT02971228|10072087|FG001|COMPLETED|Overall Study||5
9009270|NCT02971228|10072088|FG002|COMPLETED|Overall Study||5
9009271|NCT02971228|10072089|FG003|COMPLETED|Overall Study|Due to iLet unavailability, trial was stopped upon completion of Part 1. Part 2 was not conducted.|0
9009272|NCT02971228|10072090|FG004|COMPLETED|Overall Study|Due to iLet unavailability, trial was stopped upon completion of Part 1. Part 2 was not conducted.|0
9009273|NCT02971228|10072086|FG000|NOT COMPLETED|Overall Study||1
9009274|NCT02971228|10072087|FG001|NOT COMPLETED|Overall Study||2
9009275|NCT02971228|10072088|FG002|NOT COMPLETED|Overall Study||0
9009276|NCT02971228|10072089|FG003|NOT COMPLETED|Overall Study||0
9009277|NCT02971228|10072090|FG004|NOT COMPLETED|Overall Study||0
8899711|NCT02059434|9957067|FG004|NOT COMPLETED|Washout Between Periods 6 and 7||0
8899712|NCT02059434|9957068|FG005|NOT COMPLETED|Washout Between Periods 6 and 7||0
8899713|NCT02059434|9957069|FG006|NOT COMPLETED|Washout Between Periods 6 and 7||0
8899714|NCT02059434|9957070|FG007|NOT COMPLETED|Washout Between Periods 6 and 7||0
8899715|NCT02059434|9957071|FG008|NOT COMPLETED|Washout Between Periods 6 and 7||1
8899716|NCT02059434|9957063|FG000|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
8899717|NCT02059434|9957064|FG001|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
9009278|NCT02971293|10072101|FG000|STARTED|Overall Study||42
9009279|NCT02971293|10072101|FG000|COMPLETED|Overall Study||31
9009280|NCT02971293|10072101|FG000|NOT COMPLETED|Overall Study||11
9009281|NCT02971488|10072109|FG000|STARTED|Overall Study||529
9009282|NCT02971488|10072109|FG000|COMPLETED|Overall Study||529
8899718|NCT02059434|9957065|FG002|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
8899719|NCT02059434|9957066|FG003|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
8899720|NCT02059434|9957067|FG004|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
8899721|NCT02059434|9957068|FG005|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
8899722|NCT02059434|9957069|FG006|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
8899723|NCT02059434|9957070|FG007|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
8899724|NCT02059434|9957071|FG008|STARTED|Period 7||36
8899725|NCT02059434|9957063|FG000|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
8899726|NCT02059434|9957064|FG001|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
8899727|NCT02059434|9957065|FG002|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
8899728|NCT02059434|9957066|FG003|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
8899729|NCT02059434|9957067|FG004|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
8899730|NCT02059434|9957068|FG005|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
8899731|NCT02059434|9957069|FG006|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
8899732|NCT02059434|9957070|FG007|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
8899733|NCT02059434|9957071|FG008|COMPLETED|Period 7||36
8899734|NCT02059434|9957063|FG000|NOT COMPLETED|Period 7||0
8899735|NCT02059434|9957064|FG001|NOT COMPLETED|Period 7||0
8899736|NCT02059434|9957065|FG002|NOT COMPLETED|Period 7||0
8899737|NCT02059434|9957066|FG003|NOT COMPLETED|Period 7||0
8899738|NCT02059434|9957067|FG004|NOT COMPLETED|Period 7||0
8899739|NCT02059434|9957068|FG005|NOT COMPLETED|Period 7||0
8899740|NCT02059434|9957069|FG006|NOT COMPLETED|Period 7||0
8899741|NCT02059434|9957070|FG007|NOT COMPLETED|Period 7||0
8899742|NCT02059434|9957071|FG008|NOT COMPLETED|Period 7||0
8899743|NCT02059434|9957063|FG000|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
8899744|NCT02059434|9957064|FG001|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
8899745|NCT02059434|9957065|FG002|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
8899746|NCT02059434|9957066|FG003|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
8899747|NCT02059434|9957067|FG004|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
8899748|NCT02059434|9957068|FG005|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
8899749|NCT02059434|9957069|FG006|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
8899750|NCT02059434|9957070|FG007|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
8899751|NCT02059434|9957071|FG008|STARTED|Washout Between Periods 7 and 8||36
9009283|NCT02971488|10072109|FG000|NOT COMPLETED|Overall Study||0
9009284|NCT02971605|10072116|FG000|STARTED|Overall Study||13
9009285|NCT02971605|10072116|FG000|COMPLETED|Overall Study||12
9009286|NCT02971605|10072116|FG000|NOT COMPLETED|Overall Study||1
9009287|NCT02971631|10072122|FG000|STARTED|First Intervention - One Day||3
9009288|NCT02971631|10072123|FG001|STARTED|First Intervention - One Day||2
9009289|NCT02971631|10072122|FG000|COMPLETED|First Intervention - One Day||3
9009290|NCT02971631|10072123|FG001|COMPLETED|First Intervention - One Day||2
9009291|NCT02971631|10072122|FG000|NOT COMPLETED|First Intervention - One Day||0
9009292|NCT02971631|10072123|FG001|NOT COMPLETED|First Intervention - One Day||0
9009293|NCT02971631|10072122|FG000|STARTED|Second Intervention - One Day||3
9009294|NCT02971631|10072123|FG001|STARTED|Second Intervention - One Day||2
9009295|NCT02971631|10072122|FG000|COMPLETED|Second Intervention - One Day||3
9009296|NCT02971631|10072123|FG001|COMPLETED|Second Intervention - One Day||2
9009297|NCT02971631|10072122|FG000|NOT COMPLETED|Second Intervention - One Day||0
9009298|NCT02971631|10072123|FG001|NOT COMPLETED|Second Intervention - One Day||0
9009299|NCT02971670|10072134|FG000|STARTED|Overall Study||13
9009300|NCT02971670|10072135|FG001|STARTED|Overall Study||2
9009301|NCT02971670|10072136|FG002|STARTED|Overall Study||5
9009302|NCT02971670|10072137|FG003|STARTED|Overall Study||3
9009303|NCT02971670|10072134|FG000|COMPLETED|Overall Study||9
9009304|NCT02971670|10072135|FG001|COMPLETED|Overall Study||1
9009305|NCT02971670|10072136|FG002|COMPLETED|Overall Study||4
9009306|NCT02971670|10072137|FG003|COMPLETED|Overall Study||1
9009307|NCT02971670|10072134|FG000|NOT COMPLETED|Overall Study||4
9009308|NCT02971670|10072135|FG001|NOT COMPLETED|Overall Study||1
9009309|NCT02971670|10072136|FG002|NOT COMPLETED|Overall Study||1
9009310|NCT02971670|10072137|FG003|NOT COMPLETED|Overall Study||2
9009311|NCT02971735|10072149|FG000|STARTED|Overall Study||30
9009312|NCT02971735|10072150|FG001|STARTED|Overall Study||30
9009313|NCT02971735|10072149|FG000|COMPLETED|Overall Study||30
9009314|NCT02971735|10072150|FG001|COMPLETED|Overall Study||30
9009315|NCT02971735|10072149|FG000|NOT COMPLETED|Overall Study||0
9009316|NCT02971735|10072150|FG001|NOT COMPLETED|Overall Study||0
9009317|NCT02971800|10072156|FG000|STARTED|Overall Study||37
9009318|NCT02971800|10072156|FG000|COMPLETED|Overall Study||30
9009319|NCT02971800|10072156|FG000|NOT COMPLETED|Overall Study||7
9009320|NCT02972242|10072162|FG000|STARTED|Overall Study||82
9009321|NCT02972242|10072163|FG001|STARTED|Overall Study||93
9009322|NCT02972242|10072162|FG000|COMPLETED|Overall Study||81
9009323|NCT02972242|10072163|FG001|COMPLETED|Overall Study||93
9009324|NCT02972242|10072162|FG000|NOT COMPLETED|Overall Study||1
9009325|NCT02972242|10072163|FG001|NOT COMPLETED|Overall Study||0
9009326|NCT02972359|10072169|FG000|STARTED|Overall Study||318
9009327|NCT02972359|10072169|FG000|COMPLETED|Overall Study||247
9009328|NCT02972359|10072169|FG000|NOT COMPLETED|Overall Study||71
8899752|NCT02059434|9957063|FG000|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
8899753|NCT02059434|9957064|FG001|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
8899754|NCT02059434|9957065|FG002|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
8899755|NCT02059434|9957066|FG003|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
8899756|NCT02059434|9957067|FG004|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
8899757|NCT02059434|9957068|FG005|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
8899758|NCT02059434|9957069|FG006|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
8899759|NCT02059434|9957070|FG007|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
8899760|NCT02059434|9957071|FG008|COMPLETED|Washout Between Periods 7 and 8||34
8899761|NCT02059434|9957063|FG000|NOT COMPLETED|Washout Between Periods 7 and 8||0
8899762|NCT02059434|9957064|FG001|NOT COMPLETED|Washout Between Periods 7 and 8||0
8899763|NCT02059434|9957065|FG002|NOT COMPLETED|Washout Between Periods 7 and 8||0
8899764|NCT02059434|9957066|FG003|NOT COMPLETED|Washout Between Periods 7 and 8||0
8899765|NCT02059434|9957067|FG004|NOT COMPLETED|Washout Between Periods 7 and 8||0
8899766|NCT02059434|9957068|FG005|NOT COMPLETED|Washout Between Periods 7 and 8||0
8899767|NCT02059434|9957069|FG006|NOT COMPLETED|Washout Between Periods 7 and 8||0
8899768|NCT02059434|9957070|FG007|NOT COMPLETED|Washout Between Periods 7 and 8||0
8899769|NCT02059434|9957071|FG008|NOT COMPLETED|Washout Between Periods 7 and 8||2
8899770|NCT02059434|9957063|FG000|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
8899771|NCT02059434|9957064|FG001|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
8899772|NCT02059434|9957065|FG002|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
8899773|NCT02059434|9957066|FG003|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
8899774|NCT02059434|9957067|FG004|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
8899775|NCT02059434|9957068|FG005|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
8899776|NCT02059434|9957069|FG006|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
8899777|NCT02059434|9957070|FG007|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
8899778|NCT02059434|9957071|FG008|STARTED|Period 8||34
8899779|NCT02059434|9957063|FG000|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
8899780|NCT02059434|9957064|FG001|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
8899781|NCT02059434|9957065|FG002|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
8899782|NCT02059434|9957066|FG003|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
8899783|NCT02059434|9957067|FG004|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
8899784|NCT02059434|9957068|FG005|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
8899785|NCT02059434|9957069|FG006|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
8899786|NCT02059434|9957070|FG007|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
8899787|NCT02059434|9957071|FG008|COMPLETED|Period 8||34
8899788|NCT02059434|9957063|FG000|NOT COMPLETED|Period 8||0
9009329|NCT02972502|10072175|FG000|STARTED|Overall Study||35
9009330|NCT02972502|10072176|FG001|STARTED|Overall Study||31
8572889|NCT00117637|9605077|FG000|NOT COMPLETED|First Intervention (Period 1)||18
8572890|NCT00117637|9605078|FG001|NOT COMPLETED|First Intervention (Period 1)||25
8572891|NCT00117637|9605077|FG000|STARTED|Second Intervention (Period 2)|Not all patients who completed Period 1 (first progression) enter into Period 2|49
8572892|NCT00117637|9605078|FG001|STARTED|Second Intervention (Period 2)|Not all patients who completed Period 1 (first progression) enter into Period 2|61
8572893|NCT00117637|9605077|FG000|Subjects Received Treatment|Second Intervention (Period 2)||49
8635726|NCT00563784|9676237|FG000|NOT COMPLETED|Overall Study||22
9009331|NCT02972502|10072175|FG000|COMPLETED|Overall Study||31
9009332|NCT02972502|10072176|FG001|COMPLETED|Overall Study||29
9009333|NCT02972502|10072175|FG000|NOT COMPLETED|Overall Study||4
8635727|NCT00563797|9676243|FG000|STARTED|Overall Study||11
8635728|NCT00563797|9676244|FG001|STARTED|Overall Study||10
8635729|NCT00563797|9676243|FG000|Received Allocated Intervention|Overall Study||11
8635730|NCT00563797|9676244|FG001|Received Allocated Intervention|Overall Study||10
8635731|NCT00563797|9676243|FG000|Follow-Up|Overall Study||11
8635732|NCT00563797|9676244|FG001|Follow-Up|Overall Study||10
8635733|NCT00563797|9676243|FG000|COMPLETED|Overall Study||4
8635734|NCT00563797|9676244|FG001|COMPLETED|Overall Study||8
8635735|NCT00563797|9676243|FG000|NOT COMPLETED|Overall Study||7
8635736|NCT00563797|9676244|FG001|NOT COMPLETED|Overall Study||2
8635737|NCT00564018|9676255|FG000|STARTED|Overall Study||11
8635738|NCT00564018|9676256|FG001|STARTED|Overall Study||10
8635739|NCT00564018|9676257|FG002|STARTED|Overall Study||12
8635740|NCT00564018|9676255|FG000|COMPLETED|Overall Study||9
8635741|NCT00564018|9676256|FG001|COMPLETED|Overall Study||7
8635742|NCT00564018|9676257|FG002|COMPLETED|Overall Study||11
8635743|NCT00564018|9676255|FG000|NOT COMPLETED|Overall Study||2
8635744|NCT00564018|9676256|FG001|NOT COMPLETED|Overall Study||3
8572894|NCT00117637|9605078|FG001|Subjects Received Treatment|Second Intervention (Period 2)||61
8572895|NCT00117637|9605077|FG000|COMPLETED|Second Intervention (Period 2)||39
8635745|NCT00564018|9676257|FG002|NOT COMPLETED|Overall Study||1
8635746|NCT00564070|9676267|FG000|STARTED|Overall Study||42
8635747|NCT00564070|9676268|FG001|STARTED|Overall Study||45
8635748|NCT00564070|9676267|FG000|COMPLETED|Overall Study||30
8635749|NCT00564070|9676268|FG001|COMPLETED|Overall Study||38
8635750|NCT00564070|9676267|FG000|NOT COMPLETED|Overall Study||12
8635751|NCT00564070|9676268|FG001|NOT COMPLETED|Overall Study||7
8635752|NCT00564265|9676274|FG000|STARTED|Overall Study||24
8635753|NCT00564265|9676274|FG000|COMPLETED|Overall Study||24
8899789|NCT02059434|9957064|FG001|NOT COMPLETED|Period 8||0
8899790|NCT02059434|9957065|FG002|NOT COMPLETED|Period 8||0
8899791|NCT02059434|9957066|FG003|NOT COMPLETED|Period 8||0
8899792|NCT02059434|9957067|FG004|NOT COMPLETED|Period 8||0
8899793|NCT02059434|9957068|FG005|NOT COMPLETED|Period 8||0
8899794|NCT02059434|9957069|FG006|NOT COMPLETED|Period 8||0
8899795|NCT02059434|9957070|FG007|NOT COMPLETED|Period 8||0
8899796|NCT02059434|9957071|FG008|NOT COMPLETED|Period 8||0
8899797|NCT02059512|9957102|FG000|STARTED|Overall Study||46
8899798|NCT02059512|9957103|FG001|STARTED|Overall Study||34
8899799|NCT02059512|9957104|FG002|STARTED|Overall Study||37
8899800|NCT02059512|9957102|FG000|COMPLETED|Overall Study||37
8899801|NCT02059512|9957103|FG001|COMPLETED|Overall Study||25
9009334|NCT02972502|10072176|FG001|NOT COMPLETED|Overall Study||2
9009335|NCT02972515|10072182|FG000|STARTED|Overall Study||166
9009336|NCT02972515|10072182|FG000|COMPLETED|Overall Study||88
9009337|NCT02972515|10072182|FG000|NOT COMPLETED|Overall Study||78
9009338|NCT02972554|10072188|FG000|STARTED|Overall Study||44
9009339|NCT02972554|10072189|FG001|STARTED|Overall Study||48
9009340|NCT02972554|10072188|FG000|COMPLETED|Overall Study||44
9009341|NCT02972554|10072189|FG001|COMPLETED|Overall Study||48
9009342|NCT02972554|10072188|FG000|NOT COMPLETED|Overall Study||0
9009343|NCT02972554|10072189|FG001|NOT COMPLETED|Overall Study||0
9009344|NCT02972632|10072195|FG000|STARTED|Overall Study||123
9009345|NCT02972632|10072195|FG000|Safety Analysis Set|Overall Study||122
9009346|NCT02972632|10072195|FG000|COMPLETED|Overall Study||106
9009347|NCT02972632|10072195|FG000|NOT COMPLETED|Overall Study||17
9009348|NCT02972658|10072203|FG000|STARTED|Overall Study||76
9009349|NCT02972658|10072204|FG001|STARTED|Overall Study||139
9009350|NCT02972658|10072205|FG002|STARTED|Overall Study||75
9009351|NCT02972658|10072206|FG003|STARTED|Overall Study||131
9009352|NCT02972658|10072203|FG000|Received at Least 1 Dose of Study Drug|Overall Study||76
9009353|NCT02972658|10072204|FG001|Received at Least 1 Dose of Study Drug|Overall Study||139
9009354|NCT02972658|10072205|FG002|Received at Least 1 Dose of Study Drug|Overall Study||74
9009355|NCT02972658|10072206|FG003|Received at Least 1 Dose of Study Drug|Overall Study||131
9009356|NCT02972658|10072203|FG000|COMPLETED|Overall Study||0
9009357|NCT02972658|10072204|FG001|COMPLETED|Overall Study|"1 participant was incorrectly marked as Completed rather than study terminated by Sponsor."|1
9009358|NCT02972658|10072205|FG002|COMPLETED|Overall Study||0
9009359|NCT02972658|10072206|FG003|COMPLETED|Overall Study||0
9009360|NCT02972658|10072203|FG000|NOT COMPLETED|Overall Study||76
9009361|NCT02972658|10072204|FG001|NOT COMPLETED|Overall Study||138
9009362|NCT02972658|10072205|FG002|NOT COMPLETED|Overall Study||75
9009363|NCT02972658|10072206|FG003|NOT COMPLETED|Overall Study||131
9009364|NCT02973048|10072218|FG000|STARTED|Overall Study||20
9009365|NCT02973048|10072219|FG001|STARTED|Overall Study||20
9009366|NCT02973048|10072218|FG000|COMPLETED|Overall Study||19
9009367|NCT02973048|10072219|FG001|COMPLETED|Overall Study||17
9009368|NCT02973048|10072218|FG000|NOT COMPLETED|Overall Study||1
9009369|NCT02973048|10072219|FG001|NOT COMPLETED|Overall Study||3
9009370|NCT02973087|10072227|FG000|STARTED|Overall Study||13
9009371|NCT02973087|10072228|FG001|STARTED|Overall Study||10
9009372|NCT02973087|10072227|FG000|COMPLETED|Overall Study||9
9009373|NCT02973087|10072228|FG001|COMPLETED|Overall Study||8
9009374|NCT02973087|10072227|FG000|NOT COMPLETED|Overall Study||4
9009375|NCT02973087|10072228|FG001|NOT COMPLETED|Overall Study||2
9009376|NCT02973100|10072239|FG000|STARTED|Overall Study||82
9009377|NCT02973100|10072240|FG001|STARTED|Overall Study||81
9009378|NCT02973100|10072241|FG002|STARTED|Overall Study||79
9009379|NCT02973100|10072242|FG003|STARTED|Overall Study||76
9009380|NCT02973100|10072239|FG000|Received at Least 1 Dose of Study Drug|Overall Study||81
9009381|NCT02973100|10072240|FG001|Received at Least 1 Dose of Study Drug|Overall Study||81
9009382|NCT02973100|10072241|FG002|Received at Least 1 Dose of Study Drug|Overall Study||79
9009383|NCT02973100|10072242|FG003|Received at Least 1 Dose of Study Drug|Overall Study||76
9009384|NCT02973100|10072239|FG000|COMPLETED|Overall Study||75
9009385|NCT02973100|10072240|FG001|COMPLETED|Overall Study||73
9009386|NCT02973100|10072241|FG002|COMPLETED|Overall Study||75
9009387|NCT02973100|10072242|FG003|COMPLETED|Overall Study||69
9009388|NCT02973100|10072239|FG000|NOT COMPLETED|Overall Study||7
9009389|NCT02973100|10072240|FG001|NOT COMPLETED|Overall Study||8
9009390|NCT02973100|10072241|FG002|NOT COMPLETED|Overall Study||4
9009391|NCT02973100|10072242|FG003|NOT COMPLETED|Overall Study||7
9009392|NCT02973438|10072259|FG000|STARTED|First Treatment Session (4 Days)||2
9009393|NCT02973438|10072260|FG001|STARTED|First Treatment Session (4 Days)||1
9009394|NCT02973438|10072261|FG002|STARTED|First Treatment Session (4 Days)||2
9009395|NCT02973438|10072262|FG003|STARTED|First Treatment Session (4 Days)||1
9009396|NCT02973438|10072259|FG000|COMPLETED|First Treatment Session (4 Days)||2
9009397|NCT02973438|10072260|FG001|COMPLETED|First Treatment Session (4 Days)||1
9009398|NCT02973438|10072261|FG002|COMPLETED|First Treatment Session (4 Days)||2
9009399|NCT02973438|10072262|FG003|COMPLETED|First Treatment Session (4 Days)||1
8635754|NCT00564265|9676274|FG000|NOT COMPLETED|Overall Study||0
8899802|NCT02059512|9957104|FG002|COMPLETED|Overall Study||23
8899803|NCT02059512|9957102|FG000|NOT COMPLETED|Overall Study||9
8899804|NCT02059512|9957103|FG001|NOT COMPLETED|Overall Study||9
8899805|NCT02059512|9957104|FG002|NOT COMPLETED|Overall Study||14
8899806|NCT02059642|9957130|FG000|STARTED|Overall Study||148
8899807|NCT02059642|9957131|FG001|STARTED|Overall Study||152
8899808|NCT02059642|9957130|FG000|COMPLETED|Overall Study||121
8899809|NCT02059642|9957131|FG001|COMPLETED|Overall Study||128
8899810|NCT02059642|9957130|FG000|NOT COMPLETED|Overall Study||27
8899811|NCT02059642|9957131|FG001|NOT COMPLETED|Overall Study||24
8899812|NCT02059902|9957139|FG000|STARTED|Overall Study||18
8899813|NCT02059902|9957140|FG001|STARTED|Overall Study||18
8899814|NCT02059902|9957139|FG000|COMPLETED|Overall Study||14
8899815|NCT02059902|9957140|FG001|COMPLETED|Overall Study||14
8899816|NCT02059902|9957139|FG000|NOT COMPLETED|Overall Study||4
8899817|NCT02059902|9957140|FG001|NOT COMPLETED|Overall Study||4
8899818|NCT02059928|9957146|FG000|STARTED|Overall Study||20
8899819|NCT02059928|9957146|FG000|COMPLETED|Overall Study||20
8899820|NCT02059928|9957146|FG000|NOT COMPLETED|Overall Study||0
8899821|NCT02059980|9957152|FG000|STARTED|Overall Study||18
8899822|NCT02059980|9957153|FG001|STARTED|Overall Study||15
8899823|NCT02059980|9957152|FG000|COMPLETED|Overall Study||16
8899824|NCT02059980|9957153|FG001|COMPLETED|Overall Study||14
8899825|NCT02059980|9957152|FG000|NOT COMPLETED|Overall Study||2
8899826|NCT02059980|9957153|FG001|NOT COMPLETED|Overall Study||1
8899827|NCT02059993|9957161|FG000|STARTED|Overall Study||42
8899828|NCT02059993|9957162|FG001|STARTED|Overall Study||41
8899829|NCT02059993|9957161|FG000|COMPLETED|Overall Study||40
8899830|NCT02059993|9957162|FG001|COMPLETED|Overall Study||37
8899831|NCT02059993|9957161|FG000|NOT COMPLETED|Overall Study||2
8899832|NCT02059993|9957162|FG001|NOT COMPLETED|Overall Study||4
8899833|NCT02060058|9957171|FG000|STARTED|Overall Study||4
8899834|NCT02060058|9957172|FG001|STARTED|Overall Study||0
8899835|NCT02060058|9957173|FG002|STARTED|Overall Study||8
8899836|NCT02060058|9957171|FG000|COMPLETED|Overall Study||4
8899837|NCT02060058|9957172|FG001|COMPLETED|Overall Study||0
8899838|NCT02060058|9957173|FG002|COMPLETED|Overall Study||8
8899839|NCT02060058|9957171|FG000|NOT COMPLETED|Overall Study||0
8899840|NCT02060058|9957172|FG001|NOT COMPLETED|Overall Study||0
8899841|NCT02060058|9957173|FG002|NOT COMPLETED|Overall Study||0
8899842|NCT02060370|9957182|FG000|STARTED|Overall Study||60
8899843|NCT02060370|9957182|FG000|COMPLETED|Overall Study||59
8899844|NCT02060370|9957182|FG000|NOT COMPLETED|Overall Study||1
8899845|NCT02060383|9957191|FG000|STARTED|Core Phase||38
8899846|NCT02060383|9957192|FG001|STARTED|Core Phase||43
8899847|NCT02060383|9957193|FG002|STARTED|Core Phase||19
8899848|NCT02060383|9957194|FG003|STARTED|Core Phase||46
8899849|NCT02060383|9957195|FG004|STARTED|Core Phase||103
8899850|NCT02060383|9957191|FG000|Completed Core/Entered Extension|Core Phase||17
8899851|NCT02060383|9957192|FG001|Completed Core/Entered Extension|Core Phase||17
8899852|NCT02060383|9957193|FG002|Completed Core/Entered Extension|Core Phase||10
8899853|NCT02060383|9957194|FG003|Completed Core/Entered Extension|Core Phase||21
8899854|NCT02060383|9957195|FG004|Completed Core/Entered Extension|Core Phase||53
8899855|NCT02060383|9957191|FG000|Completed Core/Did Not Enter Extension|Core Phase||18
8899856|NCT02060383|9957192|FG001|Completed Core/Did Not Enter Extension|Core Phase||20
8899857|NCT02060383|9957193|FG002|Completed Core/Did Not Enter Extension|Core Phase||9
8899858|NCT02060383|9957194|FG003|Completed Core/Did Not Enter Extension|Core Phase||18
8899859|NCT02060383|9957195|FG004|Completed Core/Did Not Enter Extension|Core Phase||42
8899860|NCT02060383|9957191|FG000|COMPLETED|Core Phase||35
8899861|NCT02060383|9957192|FG001|COMPLETED|Core Phase||37
8899862|NCT02060383|9957193|FG002|COMPLETED|Core Phase||19
8899863|NCT02060383|9957194|FG003|COMPLETED|Core Phase||39
8899864|NCT02060383|9957195|FG004|COMPLETED|Core Phase||95
8899865|NCT02060383|9957191|FG000|NOT COMPLETED|Core Phase||3
8899866|NCT02060383|9957192|FG001|NOT COMPLETED|Core Phase||6
8899867|NCT02060383|9957193|FG002|NOT COMPLETED|Core Phase||0
8899868|NCT02060383|9957194|FG003|NOT COMPLETED|Core Phase||7
8899869|NCT02060383|9957195|FG004|NOT COMPLETED|Core Phase||8
8899870|NCT02060383|9957191|FG000|STARTED|Extension Phase||17
8899871|NCT02060383|9957192|FG001|STARTED|Extension Phase||17
8899872|NCT02060383|9957193|FG002|STARTED|Extension Phase||10
8899873|NCT02060383|9957194|FG003|STARTED|Extension Phase||21
8899874|NCT02060383|9957195|FG004|STARTED|Extension Phase||53
8635755|NCT00564278|9676280|FG000|STARTED|Overall Study||97
8899875|NCT02060383|9957191|FG000|COMPLETED|Extension Phase||14
8899876|NCT02060383|9957192|FG001|COMPLETED|Extension Phase||14
8899877|NCT02060383|9957193|FG002|COMPLETED|Extension Phase||7
8899878|NCT02060383|9957194|FG003|COMPLETED|Extension Phase||19
8899879|NCT02060383|9957195|FG004|COMPLETED|Extension Phase||46
8899880|NCT02060383|9957191|FG000|NOT COMPLETED|Extension Phase||3
8899881|NCT02060383|9957192|FG001|NOT COMPLETED|Extension Phase||3
8899882|NCT02060383|9957193|FG002|NOT COMPLETED|Extension Phase||3
8899883|NCT02060383|9957194|FG003|NOT COMPLETED|Extension Phase||2
8899884|NCT02060383|9957195|FG004|NOT COMPLETED|Extension Phase||7
8899885|NCT02060461|9957207|FG000|STARTED|Overall Study||33
8899886|NCT02060461|9957207|FG000|COMPLETED|Overall Study||33
8899887|NCT02060461|9957207|FG000|NOT COMPLETED|Overall Study||0
8899888|NCT02060526|9957216|FG000|STARTED|Overall Study||7
8899889|NCT02060526|9957217|FG001|STARTED|Overall Study||7
8635756|NCT00564278|9676281|FG001|STARTED|Overall Study||98
8635757|NCT00564278|9676280|FG000|COMPLETED|Overall Study||50
8899890|NCT02060526|9957218|FG002|STARTED|Overall Study||7
8899891|NCT02060526|9957216|FG000|COMPLETED|Overall Study||7
8899892|NCT02060526|9957217|FG001|COMPLETED|Overall Study||7
8899893|NCT02060526|9957218|FG002|COMPLETED|Overall Study||7
8899894|NCT02060526|9957216|FG000|NOT COMPLETED|Overall Study||0
8899895|NCT02060526|9957217|FG001|NOT COMPLETED|Overall Study||0
8899896|NCT02060526|9957218|FG002|NOT COMPLETED|Overall Study||0
8899897|NCT02060539|9957228|FG000|STARTED|Overall Study||19
8899898|NCT02060539|9957228|FG000|COMPLETED|Overall Study||19
8899899|NCT02060539|9957228|FG000|NOT COMPLETED|Overall Study||0
8899900|NCT02060838|9957234|FG000|STARTED|Overall Study||28
8899901|NCT02060838|9957235|FG001|STARTED|Overall Study||22
8899902|NCT02060838|9957234|FG000|COMPLETED|Overall Study||28
8899903|NCT02060838|9957235|FG001|COMPLETED|Overall Study||22
8899904|NCT02060838|9957234|FG000|NOT COMPLETED|Overall Study||0
8899905|NCT02060838|9957235|FG001|NOT COMPLETED|Overall Study||0
8899906|NCT02060890|9957241|FG000|STARTED|Overall Study||20
8899907|NCT02060890|9957241|FG000|COMPLETED|Overall Study||16
8899908|NCT02060890|9957241|FG000|NOT COMPLETED|Overall Study||4
8899909|NCT02060903|9957248|FG000|STARTED|Overall Study||187
8899910|NCT02060903|9957249|FG001|STARTED|Overall Study||192
8899911|NCT02060903|9957248|FG000|COMPLETED|Overall Study||183
8899912|NCT02060903|9957249|FG001|COMPLETED|Overall Study||185
8899913|NCT02060903|9957248|FG000|NOT COMPLETED|Overall Study||4
8899914|NCT02060903|9957249|FG001|NOT COMPLETED|Overall Study||7
8899915|NCT02061202|9957257|FG000|STARTED|Overall Study||36
8899916|NCT02061202|9957258|FG001|STARTED|Overall Study||18
8899917|NCT02061202|9957257|FG000|COMPLETED|Overall Study||35
8899918|NCT02061202|9957258|FG001|COMPLETED|Overall Study||17
8899919|NCT02061202|9957257|FG000|NOT COMPLETED|Overall Study||1
8899920|NCT02061202|9957258|FG001|NOT COMPLETED|Overall Study||1
8899921|NCT02061280|9957266|FG000|STARTED|Overall Study||71
8899922|NCT02061280|9957267|FG001|STARTED|Overall Study||37
8899923|NCT02061280|9957266|FG000|Randomized to Treatment|Overall Study||54
8899924|NCT02061280|9957267|FG001|Randomized to Treatment|Overall Study||25
8899925|NCT02061280|9957266|FG000|COMPLETED|Overall Study||53
8899926|NCT02061280|9957267|FG001|COMPLETED|Overall Study||25
8899927|NCT02061280|9957266|FG000|NOT COMPLETED|Overall Study||18
8899928|NCT02061280|9957267|FG001|NOT COMPLETED|Overall Study||12
8899929|NCT02061358|9957285|FG000|STARTED|Overall Study||6
8899930|NCT02061358|9957286|FG001|STARTED|Overall Study||6
8899931|NCT02061358|9957287|FG002|STARTED|Overall Study||6
8899932|NCT02061358|9957288|FG003|STARTED|Overall Study||6
8899933|NCT02061358|9957289|FG004|STARTED|Overall Study||6
8899934|NCT02061358|9957290|FG005|STARTED|Overall Study||6
8899935|NCT02061358|9957291|FG006|STARTED|Overall Study||6
9009400|NCT02973438|10072259|FG000|NOT COMPLETED|First Treatment Session (4 Days)||0
9009401|NCT02973438|10072260|FG001|NOT COMPLETED|First Treatment Session (4 Days)||0
9009402|NCT02973438|10072261|FG002|NOT COMPLETED|First Treatment Session (4 Days)||0
9009403|NCT02973438|10072262|FG003|NOT COMPLETED|First Treatment Session (4 Days)||0
9009404|NCT02973438|10072259|FG000|STARTED|Washout (Three Weeks)||2
9009405|NCT02973438|10072260|FG001|STARTED|Washout (Three Weeks)||1
8635758|NCT00564278|9676281|FG001|COMPLETED|Overall Study||56
8635759|NCT00564278|9676280|FG000|NOT COMPLETED|Overall Study||47
8635760|NCT00564278|9676281|FG001|NOT COMPLETED|Overall Study||42
8635761|NCT00564395|9676287|FG000|STARTED|First Intervention (10 Days)||9
9009406|NCT02973438|10072261|FG002|STARTED|Washout (Three Weeks)||2
9009407|NCT02973438|10072262|FG003|STARTED|Washout (Three Weeks)||1
9009408|NCT02973438|10072259|FG000|COMPLETED|Washout (Three Weeks)||2
9009409|NCT02973438|10072260|FG001|COMPLETED|Washout (Three Weeks)||1
9009410|NCT02973438|10072261|FG002|COMPLETED|Washout (Three Weeks)||2
9009411|NCT02973438|10072262|FG003|COMPLETED|Washout (Three Weeks)||1
9009412|NCT02973438|10072259|FG000|NOT COMPLETED|Washout (Three Weeks)||0
9009413|NCT02973438|10072260|FG001|NOT COMPLETED|Washout (Three Weeks)||0
9009414|NCT02973438|10072261|FG002|NOT COMPLETED|Washout (Three Weeks)||0
9009415|NCT02973438|10072262|FG003|NOT COMPLETED|Washout (Three Weeks)||0
9009416|NCT02973438|10072259|FG000|STARTED|Second Treatment Session (4 Days)||2
9009417|NCT02973438|10072260|FG001|STARTED|Second Treatment Session (4 Days)||1
9009418|NCT02973438|10072261|FG002|STARTED|Second Treatment Session (4 Days)||2
9009419|NCT02973438|10072262|FG003|STARTED|Second Treatment Session (4 Days)||1
9009420|NCT02973438|10072259|FG000|COMPLETED|Second Treatment Session (4 Days)||2
9009421|NCT02973438|10072260|FG001|COMPLETED|Second Treatment Session (4 Days)||1
9009422|NCT02973438|10072261|FG002|COMPLETED|Second Treatment Session (4 Days)||2
9009423|NCT02973438|10072262|FG003|COMPLETED|Second Treatment Session (4 Days)||1
9009424|NCT02973438|10072259|FG000|NOT COMPLETED|Second Treatment Session (4 Days)||0
9009425|NCT02973438|10072260|FG001|NOT COMPLETED|Second Treatment Session (4 Days)||0
9009426|NCT02973438|10072261|FG002|NOT COMPLETED|Second Treatment Session (4 Days)||0
9009427|NCT02973438|10072262|FG003|NOT COMPLETED|Second Treatment Session (4 Days)||0
8899936|NCT02061358|9957292|FG007|STARTED|Overall Study||6
8899937|NCT02061358|9957293|FG008|STARTED|Overall Study||16
8899938|NCT02061358|9957285|FG000|COMPLETED|Overall Study||6
8899939|NCT02061358|9957286|FG001|COMPLETED|Overall Study||6
8899940|NCT02061358|9957287|FG002|COMPLETED|Overall Study||6
8899941|NCT02061358|9957288|FG003|COMPLETED|Overall Study||6
8899942|NCT02061358|9957289|FG004|COMPLETED|Overall Study||6
8899943|NCT02061358|9957290|FG005|COMPLETED|Overall Study||6
8899944|NCT02061358|9957291|FG006|COMPLETED|Overall Study||6
8899945|NCT02061358|9957292|FG007|COMPLETED|Overall Study||6
8899946|NCT02061358|9957293|FG008|COMPLETED|Overall Study||16
8899947|NCT02061358|9957285|FG000|NOT COMPLETED|Overall Study||0
8899948|NCT02061358|9957286|FG001|NOT COMPLETED|Overall Study||0
8899949|NCT02061358|9957287|FG002|NOT COMPLETED|Overall Study||0
9009428|NCT02973477|10072275|FG000|STARTED|First Intervention||19
8899950|NCT02061358|9957288|FG003|NOT COMPLETED|Overall Study||0
8899951|NCT02061358|9957289|FG004|NOT COMPLETED|Overall Study||0
8899952|NCT02061358|9957290|FG005|NOT COMPLETED|Overall Study||0
8899953|NCT02061358|9957291|FG006|NOT COMPLETED|Overall Study||0
8899954|NCT02061358|9957292|FG007|NOT COMPLETED|Overall Study||0
8899955|NCT02061358|9957293|FG008|NOT COMPLETED|Overall Study||0
8899956|NCT02061384|9957315|FG000|STARTED|Overall Study||10
8899957|NCT02061384|9957316|FG001|STARTED|Overall Study||10
8899958|NCT02061384|9957315|FG000|COMPLETED|Overall Study||10
8899959|NCT02061384|9957316|FG001|COMPLETED|Overall Study||10
8899960|NCT02061384|9957315|FG000|NOT COMPLETED|Overall Study||0
8899961|NCT02061384|9957316|FG001|NOT COMPLETED|Overall Study||0
8899962|NCT02061397|9957322|FG000|STARTED|Simvastatin 20 mg Oral Daily for 2 Month||10
8899963|NCT02061397|9957322|FG000|COMPLETED|Simvastatin 20 mg Oral Daily for 2 Month||10
8899964|NCT02061397|9957322|FG000|NOT COMPLETED|Simvastatin 20 mg Oral Daily for 2 Month||0
8899965|NCT02061397|9957322|FG000|STARTED|Simvastatin 40 mg Oral Daily for 2 Month||10
8899966|NCT02061397|9957322|FG000|COMPLETED|Simvastatin 40 mg Oral Daily for 2 Month||10
8899967|NCT02061397|9957322|FG000|NOT COMPLETED|Simvastatin 40 mg Oral Daily for 2 Month||0
8899968|NCT02061540|9957326|FG000|STARTED|Overall Study||27
8899969|NCT02061540|9957326|FG000|Down-Titrated on LUM001 During the Study|Overall Study||5
8899970|NCT02061540|9957326|FG000|COMPLETED|Overall Study||23
8899971|NCT02061540|9957326|FG000|NOT COMPLETED|Overall Study||4
8899972|NCT02061592|9957337|FG000|STARTED|Period 1||66
8899973|NCT02061592|9957338|FG001|STARTED|Period 1||62
8899974|NCT02061592|9957337|FG000|COMPLETED|Period 1||64
8899975|NCT02061592|9957338|FG001|COMPLETED|Period 1||62
8899976|NCT02061592|9957337|FG000|NOT COMPLETED|Period 1||2
8899977|NCT02061592|9957338|FG001|NOT COMPLETED|Period 1||0
8899978|NCT02061592|9957337|FG000|STARTED|Period 2||64
8899979|NCT02061592|9957338|FG001|STARTED|Period 2||62
8899980|NCT02061592|9957337|FG000|COMPLETED|Period 2||64
8899981|NCT02061592|9957338|FG001|COMPLETED|Period 2||61
8899982|NCT02061592|9957337|FG000|NOT COMPLETED|Period 2||0
8899983|NCT02061592|9957338|FG001|NOT COMPLETED|Period 2||1
9009429|NCT02973477|10072276|FG001|STARTED|First Intervention||26
9009430|NCT02973477|10072275|FG000|COMPLETED|First Intervention||19
9009431|NCT02973477|10072276|FG001|COMPLETED|First Intervention||24
9009432|NCT02973477|10072275|FG000|NOT COMPLETED|First Intervention||0
9009433|NCT02973477|10072276|FG001|NOT COMPLETED|First Intervention||2
9009434|NCT02973477|10072275|FG000|STARTED|Washout||19
9009435|NCT02973477|10072276|FG001|STARTED|Washout||24
9009436|NCT02973477|10072275|FG000|COMPLETED|Washout||18
9009437|NCT02973477|10072276|FG001|COMPLETED|Washout||24
9009438|NCT02973477|10072275|FG000|NOT COMPLETED|Washout||1
9009439|NCT02973477|10072276|FG001|NOT COMPLETED|Washout||0
9009440|NCT02973477|10072275|FG000|STARTED|Second Intervention||18
9009441|NCT02973477|10072276|FG001|STARTED|Second Intervention||24
9009442|NCT02973477|10072275|FG000|COMPLETED|Second Intervention||17
9009443|NCT02973477|10072276|FG001|COMPLETED|Second Intervention||24
9009444|NCT02973477|10072275|FG000|NOT COMPLETED|Second Intervention||1
9009445|NCT02973477|10072276|FG001|NOT COMPLETED|Second Intervention||0
9009446|NCT02973503|10072288|FG000|STARTED|Overall Study||117
9009447|NCT02973503|10072288|FG000|COMPLETED|Overall Study||117
9009448|NCT02973503|10072288|FG000|NOT COMPLETED|Overall Study||0
9009449|NCT02973516|10072299|FG000|STARTED|Overall Study||30
9009450|NCT02973516|10072300|FG001|STARTED|Overall Study||10
9009451|NCT02973516|10072299|FG000|COMPLETED|Overall Study||30
9009452|NCT02973516|10072300|FG001|COMPLETED|Overall Study||10
9009453|NCT02973516|10072299|FG000|NOT COMPLETED|Overall Study||0
9009454|NCT02973516|10072300|FG001|NOT COMPLETED|Overall Study||0
9009455|NCT02973802|10072306|FG000|STARTED|Overall Study||12
9009456|NCT02973802|10072306|FG000|COMPLETED|Overall Study||10
9009457|NCT02973802|10072306|FG000|NOT COMPLETED|Overall Study||2
9009458|NCT02974010|10072315|FG000|STARTED|Overall Study||12
9009459|NCT02974010|10072316|FG001|STARTED|Overall Study||5
9009460|NCT02974010|10072317|FG002|STARTED|Overall Study||4
9009461|NCT02974010|10072318|FG003|STARTED|Overall Study||1
9009462|NCT02974010|10072315|FG000|COMPLETED|Overall Study||6
9009463|NCT02974010|10072316|FG001|COMPLETED|Overall Study||2
9009464|NCT02974010|10072317|FG002|COMPLETED|Overall Study||2
9009465|NCT02974010|10072318|FG003|COMPLETED|Overall Study||1
9009466|NCT02974010|10072315|FG000|NOT COMPLETED|Overall Study||6
9009467|NCT02974010|10072316|FG001|NOT COMPLETED|Overall Study||3
9009468|NCT02974010|10072317|FG002|NOT COMPLETED|Overall Study||2
9009469|NCT02974010|10072318|FG003|NOT COMPLETED|Overall Study||0
9009470|NCT02974088|10072330|FG000|STARTED|Overall Study||23
8899984|NCT02061683|9957346|FG000|STARTED|Overall Study||263
8899985|NCT02061683|9957346|FG000|COMPLETED|Overall Study||203
8899986|NCT02061683|9957346|FG000|NOT COMPLETED|Overall Study||60
8899987|NCT02061696|9957352|FG000|STARTED|Overall Study||17
8899988|NCT02061696|9957353|FG001|STARTED|Overall Study||22
8899989|NCT02061696|9957352|FG000|COMPLETED|Overall Study||17
8899990|NCT02061696|9957353|FG001|COMPLETED|Overall Study||22
9009471|NCT02974088|10072331|FG001|STARTED|Overall Study||24
9009472|NCT02974088|10072330|FG000|COMPLETED|Overall Study||23
9009473|NCT02974088|10072331|FG001|COMPLETED|Overall Study|Nurse left without notice and took CRFs and data for 2 subjects.|21
9009474|NCT02974088|10072330|FG000|NOT COMPLETED|Overall Study||0
9009475|NCT02974088|10072331|FG001|NOT COMPLETED|Overall Study||3
9009476|NCT02974114|10072340|FG000|STARTED|Overall Study||6
9009477|NCT02974114|10072341|FG001|STARTED|Overall Study||7
9009478|NCT02974114|10072342|FG002|STARTED|Overall Study||8
8899991|NCT02061696|9957352|FG000|NOT COMPLETED|Overall Study||0
8899992|NCT02061696|9957353|FG001|NOT COMPLETED|Overall Study||0
8899993|NCT02061748|9957361|FG000|STARTED|Overall Study||7646
8899994|NCT02061748|9957362|FG001|STARTED|Overall Study||30853
8899995|NCT02061748|9957361|FG000|COMPLETED|Overall Study||7646
8899996|NCT02061748|9957362|FG001|COMPLETED|Overall Study||30853
8899997|NCT02061748|9957361|FG000|NOT COMPLETED|Overall Study||0
8899998|NCT02061748|9957362|FG001|NOT COMPLETED|Overall Study||0
8899999|NCT02061774|9957370|FG000|STARTED|Overall Study||10
8900000|NCT02061774|9957371|FG001|STARTED|Overall Study||11
8900001|NCT02061774|9957370|FG000|COMPLETED|Overall Study||10
8900002|NCT02061774|9957371|FG001|COMPLETED|Overall Study||11
8900003|NCT02061774|9957370|FG000|NOT COMPLETED|Overall Study||0
8900004|NCT02061774|9957371|FG001|NOT COMPLETED|Overall Study||0
8900005|NCT02061813|9957377|FG000|STARTED|Overall Study||40
8900006|NCT02061813|9957377|FG000|Abametapir Lotion|Overall Study||40
8900007|NCT02061813|9957377|FG000|Vehicle Lotion|Overall Study||40
8900008|NCT02061813|9957377|FG000|Saline 0.9%|Overall Study||40
8900009|NCT02061813|9957377|FG000|SLS 0.2%|Overall Study||40
8900010|NCT02061813|9957377|FG000|COMPLETED|Overall Study||37
8900011|NCT02061813|9957377|FG000|NOT COMPLETED|Overall Study||3
8900012|NCT02061969|9957386|FG000|STARTED|Overall Study||73
8900013|NCT02061969|9957387|FG001|STARTED|Overall Study||67
8900014|NCT02061969|9957386|FG000|COMPLETED|Overall Study||73
8900015|NCT02061969|9957387|FG001|COMPLETED|Overall Study||67
8900016|NCT02061969|9957386|FG000|NOT COMPLETED|Overall Study||0
8900017|NCT02061969|9957387|FG001|NOT COMPLETED|Overall Study||0
8900018|NCT02062008|9957393|FG000|STARTED|Overall Study||2
8900019|NCT02062008|9957393|FG000|COMPLETED|Overall Study||2
8900020|NCT02062008|9957393|FG000|NOT COMPLETED|Overall Study||0
8900021|NCT02062151|9957397|FG000|STARTED|Overall Study||21
8900022|NCT02062151|9957397|FG000|COMPLETED|Overall Study||20
8900023|NCT02062151|9957397|FG000|NOT COMPLETED|Overall Study||1
8900024|NCT02062177|9957403|FG000|STARTED|Overall Study||70
8900025|NCT02062177|9957404|FG001|STARTED|Overall Study||70
8900026|NCT02062177|9957403|FG000|COMPLETED|Overall Study||70
8900027|NCT02062177|9957404|FG001|COMPLETED|Overall Study||70
8900028|NCT02062177|9957403|FG000|NOT COMPLETED|Overall Study||0
8900029|NCT02062177|9957404|FG001|NOT COMPLETED|Overall Study||0
8900030|NCT02062294|9957410|FG000|STARTED|Overall Study||14
8900031|NCT02062294|9957410|FG000|COMPLETED|Overall Study||14
8900032|NCT02062294|9957410|FG000|NOT COMPLETED|Overall Study||0
9009479|NCT02974114|10072340|FG000|COMPLETED|Overall Study||6
9009480|NCT02974114|10072341|FG001|COMPLETED|Overall Study||6
9009481|NCT02974114|10072342|FG002|COMPLETED|Overall Study||6
9009482|NCT02974114|10072340|FG000|NOT COMPLETED|Overall Study||0
9009483|NCT02974114|10072341|FG001|NOT COMPLETED|Overall Study||1
9009484|NCT02974114|10072342|FG002|NOT COMPLETED|Overall Study||2
9009485|NCT02974140|10072352|FG000|STARTED|Overall Study||39
9009486|NCT02974140|10072352|FG000|CRS (Left or Right Eye)|Overall Study||38
9009487|NCT02974140|10072352|FG000|Manual (Fellow Eye)|Overall Study||38
9009488|NCT02974140|10072352|FG000|COMPLETED|Overall Study||0
9009489|NCT02974140|10072352|FG000|NOT COMPLETED|Overall Study||39
9009490|NCT02974153|10072362|FG000|STARTED|Overall Study||374
9009491|NCT02974153|10072363|FG001|STARTED|Overall Study||372
9009492|NCT02974153|10072364|FG002|STARTED|Overall Study||375
9009493|NCT02974153|10072362|FG000|Participants Treated|Overall Study||350
9009494|NCT02974153|10072363|FG001|Participants Treated|Overall Study||356
9009495|NCT02974153|10072364|FG002|Participants Treated|Overall Study||366
9009496|NCT02974153|10072362|FG000|COMPLETED|Overall Study||322
9009497|NCT02974153|10072363|FG001|COMPLETED|Overall Study||324
9009498|NCT02974153|10072364|FG002|COMPLETED|Overall Study||325
9009499|NCT02974153|10072362|FG000|NOT COMPLETED|Overall Study||52
9009500|NCT02974153|10072363|FG001|NOT COMPLETED|Overall Study||48
9009501|NCT02974153|10072364|FG002|NOT COMPLETED|Overall Study||50
9009502|NCT02974296|10072374|FG000|STARTED|Overall Study||10
9009503|NCT02974296|10072375|FG001|STARTED|Overall Study||23
9009504|NCT02974296|10072374|FG000|COMPLETED|Overall Study||10
9009505|NCT02974296|10072375|FG001|COMPLETED|Overall Study||22
9009506|NCT02974296|10072374|FG000|NOT COMPLETED|Overall Study||0
9009507|NCT02974296|10072375|FG001|NOT COMPLETED|Overall Study||1
9009508|NCT02974543|10072383|FG000|STARTED|Overall Study||11
9009509|NCT02974543|10072384|FG001|STARTED|Overall Study||10
9009510|NCT02974543|10072383|FG000|Began Washout Period|Overall Study||10
9009511|NCT02974543|10072384|FG001|Began Washout Period|Overall Study||10
9009512|NCT02974543|10072383|FG000|Began Crossover Assignment|Overall Study||10
8900033|NCT02062359|9957414|FG000|STARTED|Overall Study||2
8900034|NCT02062359|9957414|FG000|COMPLETED|Overall Study||2
8900035|NCT02062359|9957414|FG000|NOT COMPLETED|Overall Study||0
8900036|NCT02062385|9957422|FG000|STARTED|Overall Study||1620
8900037|NCT02062385|9957423|FG001|STARTED|Overall Study||1620
8900038|NCT02062385|9957424|FG002|STARTED|Overall Study||400
8900039|NCT02062385|9957425|FG003|STARTED|Overall Study||400
8900040|NCT02062385|9957422|FG000|Received Vaccination 1|Overall Study||1618
8900041|NCT02062385|9957423|FG001|Received Vaccination 1|Overall Study||1619
8900042|NCT02062385|9957424|FG002|Received Vaccination 1|Overall Study||400
8900043|NCT02062385|9957425|FG003|Received Vaccination 1|Overall Study||400
9009513|NCT02974543|10072384|FG001|Began Crossover Assignment|Overall Study||10
9009514|NCT02974543|10072383|FG000|COMPLETED|Overall Study||10
9009515|NCT02974543|10072384|FG001|COMPLETED|Overall Study||10
9009516|NCT02974543|10072383|FG000|NOT COMPLETED|Overall Study||1
8900044|NCT02062385|9957422|FG000|Received Vaccination 2|Overall Study||1554
8900045|NCT02062385|9957423|FG001|Received Vaccination 2|Overall Study||1566
8900046|NCT02062385|9957424|FG002|Received Vaccination 2|Overall Study||392
8900047|NCT02062385|9957425|FG003|Received Vaccination 2|Overall Study||393
8900048|NCT02062385|9957422|FG000|Received Vaccination 3|Overall Study||1543
8900049|NCT02062385|9957423|FG001|Received Vaccination 3|Overall Study||1554
8900050|NCT02062385|9957424|FG002|Received Vaccination 3|Overall Study||389
8900051|NCT02062385|9957425|FG003|Received Vaccination 3|Overall Study||392
8900052|NCT02062385|9957422|FG000|COMPLETED|Overall Study||1542
8900053|NCT02062385|9957423|FG001|COMPLETED|Overall Study||1555
8900054|NCT02062385|9957424|FG002|COMPLETED|Overall Study||388
8900055|NCT02062385|9957425|FG003|COMPLETED|Overall Study||391
8900056|NCT02062385|9957422|FG000|NOT COMPLETED|Overall Study||78
8900057|NCT02062385|9957423|FG001|NOT COMPLETED|Overall Study||65
8900058|NCT02062385|9957424|FG002|NOT COMPLETED|Overall Study||12
8900059|NCT02062385|9957425|FG003|NOT COMPLETED|Overall Study||9
8900060|NCT02062398|9957433|FG000|STARTED|Overall Study||13
8900061|NCT02062398|9957433|FG000|COMPLETED|Overall Study||12
8900062|NCT02062398|9957433|FG000|NOT COMPLETED|Overall Study||1
8900063|NCT02062437|9957437|FG000|STARTED|Overall Study|132 patients who undergone THR (July-Oct 2010), complying with in/exclusion criteria were identified|132
8900064|NCT02062437|9957437|FG000|COMPLETED|Overall Study|80 patients were effectively enrolled, when coming back for their 2-year follow-up visit.|80
8900065|NCT02062437|9957437|FG000|NOT COMPLETED|Overall Study||52
8900066|NCT02062450|9957443|FG000|STARTED|Overall Study|379 patients were successfully reached by phone and convoked for the 2-year follow-up visit.|379
8900067|NCT02062450|9957443|FG000|Per Protocol Cohort|Overall Study|255 patients attended their 2-year follow-up visit.|255
8900068|NCT02062450|9957443|FG000|COMPLETED|Overall Study||255
8900069|NCT02062450|9957443|FG000|NOT COMPLETED|Overall Study||124
8900070|NCT02062502|9957453|FG000|STARTED|Overall Study||306
8900071|NCT02062502|9957454|FG001|STARTED|Overall Study||305
8900072|NCT02062502|9957453|FG000|Vaccinated Dose 1|Overall Study||306
8900073|NCT02062502|9957454|FG001|Vaccinated Dose 1|Overall Study||305
8900074|NCT02062502|9957453|FG000|COMPLETED|Overall Study||263
8900075|NCT02062502|9957454|FG001|COMPLETED|Overall Study||270
8900076|NCT02062502|9957453|FG000|NOT COMPLETED|Overall Study||43
8900077|NCT02062502|9957454|FG001|NOT COMPLETED|Overall Study||35
8900078|NCT02062580|9957462|FG000|STARTED|Overall Study||71
8900079|NCT02062580|9957463|FG001|STARTED|Overall Study||78
8900080|NCT02062580|9957462|FG000|COMPLETED|Overall Study||59
8900081|NCT02062580|9957463|FG001|COMPLETED|Overall Study||65
8900082|NCT02062580|9957462|FG000|NOT COMPLETED|Overall Study||12
8900083|NCT02062580|9957463|FG001|NOT COMPLETED|Overall Study||13
8900084|NCT02062593|9957471|FG000|STARTED|Overall Study||105
8900085|NCT02062593|9957472|FG001|STARTED|Overall Study||95
8900086|NCT02062593|9957471|FG000|COMPLETED|Overall Study||105
8900087|NCT02062593|9957472|FG001|COMPLETED|Overall Study||91
8900088|NCT02062593|9957471|FG000|NOT COMPLETED|Overall Study||0
8900089|NCT02062593|9957472|FG001|NOT COMPLETED|Overall Study||4
8900090|NCT02062606|9957478|FG000|STARTED|Overall Study||188
8900091|NCT02062606|9957478|FG000|COMPLETED|Overall Study||99
8900092|NCT02062606|9957478|FG000|NOT COMPLETED|Overall Study||89
8900093|NCT02062632|9957511|FG000|STARTED|Overall Study||3
8900094|NCT02062632|9957511|FG000|COMPLETED|Overall Study||2
8900095|NCT02062632|9957511|FG000|NOT COMPLETED|Overall Study||1
8900096|NCT02062645|9957515|FG000|STARTED|Overall Study||115
8900097|NCT02062645|9957515|FG000|COMPLETED|Overall Study||100
8900098|NCT02062645|9957515|FG000|NOT COMPLETED|Overall Study||15
8900099|NCT02062658|9957519|FG000|STARTED|Overall Study||10
8900100|NCT02062658|9957519|FG000|COMPLETED|Overall Study||8
8900101|NCT02062658|9957519|FG000|NOT COMPLETED|Overall Study||2
8635762|NCT00564395|9676288|FG001|STARTED|First Intervention (10 Days)||9
8635763|NCT00564395|9676287|FG000|Received Intervention|First Intervention (10 Days)||7
8691314|NCT00854100|9736551|FG002|NOT COMPLETED|Overall Study||11
8900102|NCT02062710|9957523|FG000|STARTED|Overall Study|3 of total 22 subjects randomized to receive the 3 study drugs in this particular sequence|3
8900103|NCT02062710|9957524|FG001|STARTED|Overall Study|4 of the total 22 subjects randomized to receive the 3 study drugs in this particular sequence|4
8900104|NCT02062710|9957525|FG002|STARTED|Overall Study|5 of total of 22 subjects randomized to receive the 3 study drugs in this particular sequence|5
8900105|NCT02062710|9957526|FG003|STARTED|Overall Study|3 of 22 subjects randomized to receive the 3 study drugs in this particular sequence|3
8900106|NCT02062710|9957527|FG004|STARTED|Overall Study|3 of 22 subjects randomized to receive the 3 study drugs in this aprticular sequence|3
8900107|NCT02062710|9957528|FG005|STARTED|Overall Study|4 of 22 subjects randomized to receive the 3 study drugs in this particular sequence|4
8900108|NCT02062710|9957523|FG000|COMPLETED|Overall Study||3
8900109|NCT02062710|9957524|FG001|COMPLETED|Overall Study||4
8900110|NCT02062710|9957525|FG002|COMPLETED|Overall Study||5
8900111|NCT02062710|9957526|FG003|COMPLETED|Overall Study||3
8900112|NCT02062710|9957527|FG004|COMPLETED|Overall Study||3
8900113|NCT02062710|9957528|FG005|COMPLETED|Overall Study||4
8900114|NCT02062710|9957523|FG000|NOT COMPLETED|Overall Study||0
8900115|NCT02062710|9957524|FG001|NOT COMPLETED|Overall Study||0
8900116|NCT02062710|9957525|FG002|NOT COMPLETED|Overall Study||0
8900117|NCT02062710|9957526|FG003|NOT COMPLETED|Overall Study||0
8900118|NCT02062710|9957527|FG004|NOT COMPLETED|Overall Study||0
8900119|NCT02062710|9957528|FG005|NOT COMPLETED|Overall Study||0
8900120|NCT02062801|9957538|FG000|STARTED|Overall Study||301
8900121|NCT02062801|9957539|FG001|STARTED|Overall Study||301
8900122|NCT02062801|9957538|FG000|COMPLETED|Overall Study||299
8900123|NCT02062801|9957539|FG001|COMPLETED|Overall Study||297
8900124|NCT02062801|9957538|FG000|NOT COMPLETED|Overall Study||2
8900125|NCT02062801|9957539|FG001|NOT COMPLETED|Overall Study||4
8900126|NCT02062879|9957547|FG000|STARTED|Overall Study||10
8900127|NCT02062879|9957548|FG001|STARTED|Overall Study||10
8900128|NCT02062879|9957547|FG000|COMPLETED|Overall Study||6
8900129|NCT02062879|9957548|FG001|COMPLETED|Overall Study||9
8900130|NCT02062879|9957547|FG000|NOT COMPLETED|Overall Study||4
8900131|NCT02062879|9957548|FG001|NOT COMPLETED|Overall Study||1
8900132|NCT02062905|9957556|FG000|STARTED|Overall Study||35
8900133|NCT02062905|9957557|FG001|STARTED|Overall Study||33
8900134|NCT02062905|9957556|FG000|COMPLETED|Overall Study||28
8900135|NCT02062905|9957557|FG001|COMPLETED|Overall Study||31
8900136|NCT02062905|9957556|FG000|NOT COMPLETED|Overall Study||7
8900137|NCT02062905|9957557|FG001|NOT COMPLETED|Overall Study||2
8900138|NCT02063035|9957565|FG000|STARTED|Overall Study||12
8900139|NCT02063035|9957566|FG001|STARTED|Overall Study||17
8900140|NCT02063035|9957565|FG000|COMPLETED|Overall Study||12
8900141|NCT02063035|9957566|FG001|COMPLETED|Overall Study||17
8900142|NCT02063035|9957565|FG000|NOT COMPLETED|Overall Study||0
8900143|NCT02063035|9957566|FG001|NOT COMPLETED|Overall Study||0
8900144|NCT02063087|9957574|FG000|STARTED|Emergency Department Intervention||493
8900145|NCT02063087|9957575|FG001|STARTED|Emergency Department Intervention||478
8900146|NCT02063087|9957574|FG000|COMPLETED|Emergency Department Intervention||493
8900147|NCT02063087|9957575|FG001|COMPLETED|Emergency Department Intervention||478
8900148|NCT02063087|9957574|FG000|NOT COMPLETED|Emergency Department Intervention||0
8900149|NCT02063087|9957575|FG001|NOT COMPLETED|Emergency Department Intervention||0
8900150|NCT02063087|9957574|FG000|STARTED|7 Day Follow-up||493
8900151|NCT02063087|9957575|FG001|STARTED|7 Day Follow-up||478
8900152|NCT02063087|9957574|FG000|COMPLETED|7 Day Follow-up||493
8900153|NCT02063087|9957575|FG001|COMPLETED|7 Day Follow-up||478
8900154|NCT02063087|9957574|FG000|NOT COMPLETED|7 Day Follow-up||0
8900155|NCT02063087|9957575|FG001|NOT COMPLETED|7 Day Follow-up||0
8900156|NCT02063178|9957583|FG000|STARTED|Overall Study||124
8900157|NCT02063178|9957584|FG001|STARTED|Overall Study||124
8900158|NCT02063178|9957583|FG000|COMPLETED|Overall Study||95
8900159|NCT02063178|9957584|FG001|COMPLETED|Overall Study||77
8900160|NCT02063178|9957583|FG000|NOT COMPLETED|Overall Study||29
8900161|NCT02063178|9957584|FG001|NOT COMPLETED|Overall Study||47
8900162|NCT02063217|9957597|FG000|STARTED|Overall Study||12
8900163|NCT02063217|9957598|FG001|STARTED|Overall Study||12
8900164|NCT02063217|9957599|FG002|STARTED|Overall Study||12
8900165|NCT02063217|9957597|FG000|COMPLETED|Overall Study||11
8900166|NCT02063217|9957598|FG001|COMPLETED|Overall Study||12
8900167|NCT02063217|9957599|FG002|COMPLETED|Overall Study||12
8900168|NCT02063217|9957597|FG000|NOT COMPLETED|Overall Study||1
8900169|NCT02063217|9957598|FG001|NOT COMPLETED|Overall Study||0
8900170|NCT02063217|9957599|FG002|NOT COMPLETED|Overall Study||0
8900171|NCT02063230|9957611|FG000|STARTED|Overall Study||8
8900172|NCT02063230|9957612|FG001|STARTED|Overall Study||8
8900173|NCT02063230|9957613|FG002|STARTED|Overall Study||8
8900174|NCT02063230|9957614|FG003|STARTED|Overall Study||8
8900175|NCT02063230|9957611|FG000|Received Treatment|Overall Study||8
8900176|NCT02063230|9957612|FG001|Received Treatment|Overall Study||8
8900177|NCT02063230|9957613|FG002|Received Treatment|Overall Study||8
8900178|NCT02063230|9957614|FG003|Received Treatment|Overall Study||8
8900179|NCT02063230|9957611|FG000|COMPLETED|Overall Study||8
8900180|NCT02063230|9957612|FG001|COMPLETED|Overall Study||8
8900181|NCT02063230|9957613|FG002|COMPLETED|Overall Study||8
8900182|NCT02063230|9957614|FG003|COMPLETED|Overall Study||8
8900183|NCT02063230|9957611|FG000|NOT COMPLETED|Overall Study||0
8900184|NCT02063230|9957612|FG001|NOT COMPLETED|Overall Study||0
8900185|NCT02063230|9957613|FG002|NOT COMPLETED|Overall Study||0
8900186|NCT02063230|9957614|FG003|NOT COMPLETED|Overall Study||0
8900187|NCT02063516|9957626|FG000|STARTED|Overall Study||40
8900188|NCT02063516|9957627|FG001|STARTED|Overall Study||40
8900189|NCT02063516|9957626|FG000|COMPLETED|Overall Study||40
8900190|NCT02063516|9957627|FG001|COMPLETED|Overall Study||40
8900191|NCT02063516|9957626|FG000|NOT COMPLETED|Overall Study||0
8900192|NCT02063516|9957627|FG001|NOT COMPLETED|Overall Study||0
8900193|NCT02063659|9957636|FG000|STARTED|Double-Blind Treatment Period||26
8900194|NCT02063659|9957637|FG001|STARTED|Double-Blind Treatment Period||25
8900195|NCT02063659|9957638|FG002|STARTED|Double-Blind Treatment Period||25
8900196|NCT02063659|9957639|FG003|STARTED|Double-Blind Treatment Period||0
8900197|NCT02063659|9957636|FG000|COMPLETED|Double-Blind Treatment Period||24
8900198|NCT02063659|9957637|FG001|COMPLETED|Double-Blind Treatment Period||22
8900199|NCT02063659|9957638|FG002|COMPLETED|Double-Blind Treatment Period||22
8900200|NCT02063659|9957639|FG003|COMPLETED|Double-Blind Treatment Period||0
8900201|NCT02063659|9957636|FG000|NOT COMPLETED|Double-Blind Treatment Period||2
8900202|NCT02063659|9957637|FG001|NOT COMPLETED|Double-Blind Treatment Period||3
8900203|NCT02063659|9957638|FG002|NOT COMPLETED|Double-Blind Treatment Period||3
8900204|NCT02063659|9957639|FG003|NOT COMPLETED|Double-Blind Treatment Period||0
8900205|NCT02063659|9957636|FG000|STARTED|Open-Label Extension Period (OLE)||0
8900206|NCT02063659|9957637|FG001|STARTED|Open-Label Extension Period (OLE)||0
8900207|NCT02063659|9957638|FG002|STARTED|Open-Label Extension Period (OLE)||0
8900208|NCT02063659|9957639|FG003|STARTED|Open-Label Extension Period (OLE)||67
8900209|NCT02063659|9957636|FG000|COMPLETED|Open-Label Extension Period (OLE)||0
9009517|NCT02974543|10072384|FG001|NOT COMPLETED|Overall Study||0
8900210|NCT02063659|9957637|FG001|COMPLETED|Open-Label Extension Period (OLE)||0
8900211|NCT02063659|9957638|FG002|COMPLETED|Open-Label Extension Period (OLE)||0
8900212|NCT02063659|9957639|FG003|COMPLETED|Open-Label Extension Period (OLE)||47
8900213|NCT02063659|9957636|FG000|NOT COMPLETED|Open-Label Extension Period (OLE)||0
8900214|NCT02063659|9957637|FG001|NOT COMPLETED|Open-Label Extension Period (OLE)||0
8900215|NCT02063659|9957638|FG002|NOT COMPLETED|Open-Label Extension Period (OLE)||0
8900216|NCT02063659|9957639|FG003|NOT COMPLETED|Open-Label Extension Period (OLE)||20
8900217|NCT02063672|9957655|FG000|STARTED|Overall Study||53
8900218|NCT02063672|9957656|FG001|STARTED|Overall Study||29
8900219|NCT02063672|9957655|FG000|COMPLETED|Overall Study||18
8900220|NCT02063672|9957656|FG001|COMPLETED|Overall Study||7
8635764|NCT00564395|9676288|FG001|Received Intervention|First Intervention (10 Days)||7
8635765|NCT00564395|9676287|FG000|COMPLETED|First Intervention (10 Days)||7
8635766|NCT00564395|9676288|FG001|COMPLETED|First Intervention (10 Days)||7
8635767|NCT00564395|9676287|FG000|NOT COMPLETED|First Intervention (10 Days)||2
8635768|NCT00564395|9676288|FG001|NOT COMPLETED|First Intervention (10 Days)||2
8635769|NCT00564395|9676287|FG000|STARTED|Second Intervention (10 Days)||7
8635770|NCT00564395|9676288|FG001|STARTED|Second Intervention (10 Days)||7
8635771|NCT00564395|9676287|FG000|COMPLETED|Second Intervention (10 Days)||7
8900221|NCT02063672|9957655|FG000|NOT COMPLETED|Overall Study||35
8900222|NCT02063672|9957656|FG001|NOT COMPLETED|Overall Study||22
8900223|NCT02063698|9957664|FG000|STARTED|Overall Study||15
8900224|NCT02063698|9957665|FG001|STARTED|Overall Study||15
8900225|NCT02063698|9957664|FG000|COMPLETED|Overall Study||14
8900226|NCT02063698|9957665|FG001|COMPLETED|Overall Study||13
8900227|NCT02063698|9957664|FG000|NOT COMPLETED|Overall Study||1
8900228|NCT02063698|9957665|FG001|NOT COMPLETED|Overall Study||2
8900229|NCT02063737|9957673|FG000|STARTED|Overall Study||52
8900230|NCT02063737|9957674|FG001|STARTED|Overall Study||48
8900231|NCT02063737|9957673|FG000|COMPLETED|Overall Study||41
8900232|NCT02063737|9957674|FG001|COMPLETED|Overall Study||44
8900233|NCT02063737|9957673|FG000|NOT COMPLETED|Overall Study||11
8900234|NCT02063737|9957674|FG001|NOT COMPLETED|Overall Study||4
8900235|NCT02063828|9957683|FG000|STARTED|Overall Study||14
8900236|NCT02063828|9957684|FG001|STARTED|Overall Study||14
8900237|NCT02063828|9957685|FG002|STARTED|Overall Study||18
8900238|NCT02063828|9957683|FG000|Week 6|Overall Study||11
8900239|NCT02063828|9957684|FG001|Week 6|Overall Study||9
8900240|NCT02063828|9957685|FG002|Week 6|Overall Study||14
8900241|NCT02063828|9957683|FG000|COMPLETED|Overall Study||10
8900242|NCT02063828|9957684|FG001|COMPLETED|Overall Study||8
8900243|NCT02063828|9957685|FG002|COMPLETED|Overall Study||14
8900244|NCT02063828|9957683|FG000|NOT COMPLETED|Overall Study||4
8900245|NCT02063828|9957684|FG001|NOT COMPLETED|Overall Study||6
8900246|NCT02063828|9957685|FG002|NOT COMPLETED|Overall Study||4
8900247|NCT02063854|9957700|FG000|STARTED|Overall Study||199
8900248|NCT02063854|9957701|FG001|STARTED|Overall Study||66
8900249|NCT02063854|9957702|FG002|STARTED|Overall Study||206
8900250|NCT02063854|9957703|FG003|STARTED|Overall Study||68
8900251|NCT02063854|9957704|FG004|STARTED|Overall Study||65
8900252|NCT02063854|9957705|FG005|STARTED|Overall Study||201
8900253|NCT02063854|9957706|FG006|STARTED|Overall Study||66
8900254|NCT02063854|9957700|FG000|Full Analysis Set: Received Study Drug|Overall Study||199
8900255|NCT02063854|9957701|FG001|Full Analysis Set: Received Study Drug|Overall Study||66
8900256|NCT02063854|9957702|FG002|Full Analysis Set: Received Study Drug|Overall Study||206
8900257|NCT02063854|9957703|FG003|Full Analysis Set: Received Study Drug|Overall Study||68
8900258|NCT02063854|9957704|FG004|Full Analysis Set: Received Study Drug|Overall Study||65
8900259|NCT02063854|9957705|FG005|Full Analysis Set: Received Study Drug|Overall Study||200
8900260|NCT02063854|9957706|FG006|Full Analysis Set: Received Study Drug|Overall Study||66
8900261|NCT02063854|9957700|FG000|COMPLETED|Overall Study||178
8900262|NCT02063854|9957701|FG001|COMPLETED|Overall Study||54
8900263|NCT02063854|9957702|FG002|COMPLETED|Overall Study||176
8900264|NCT02063854|9957703|FG003|COMPLETED|Overall Study||58
8900265|NCT02063854|9957704|FG004|COMPLETED|Overall Study||54
8900266|NCT02063854|9957705|FG005|COMPLETED|Overall Study||170
8900267|NCT02063854|9957706|FG006|COMPLETED|Overall Study||60
8900268|NCT02063854|9957700|FG000|NOT COMPLETED|Overall Study||21
8900269|NCT02063854|9957701|FG001|NOT COMPLETED|Overall Study||12
8900270|NCT02063854|9957702|FG002|NOT COMPLETED|Overall Study||30
8900271|NCT02063854|9957703|FG003|NOT COMPLETED|Overall Study||10
8900272|NCT02063854|9957704|FG004|NOT COMPLETED|Overall Study||11
8900273|NCT02063854|9957705|FG005|NOT COMPLETED|Overall Study||31
8900274|NCT02063854|9957706|FG006|NOT COMPLETED|Overall Study||6
8900275|NCT02063867|9957726|FG000|STARTED|Overall Study||156889
8900276|NCT02063867|9957727|FG001|STARTED|Overall Study||183013
8900277|NCT02063867|9957726|FG000|COMPLETED|Overall Study||152598
8900278|NCT02063867|9957727|FG001|COMPLETED|Overall Study||180048
8900279|NCT02063867|9957726|FG000|NOT COMPLETED|Overall Study||4291
8900280|NCT02063867|9957727|FG001|NOT COMPLETED|Overall Study||2965
8900281|NCT02063880|9957735|FG000|STARTED|Overall Study||90
8900282|NCT02063880|9957736|FG001|STARTED|Overall Study||93
8900283|NCT02063880|9957735|FG000|COMPLETED|Overall Study||62
8900284|NCT02063880|9957736|FG001|COMPLETED|Overall Study||66
8635772|NCT00564395|9676288|FG001|COMPLETED|Second Intervention (10 Days)||7
8635773|NCT00564395|9676287|FG000|NOT COMPLETED|Second Intervention (10 Days)||0
8900285|NCT02063880|9957735|FG000|NOT COMPLETED|Overall Study||28
8900286|NCT02063880|9957736|FG001|NOT COMPLETED|Overall Study||27
8900287|NCT02063984|9957744|FG000|STARTED|Overall Study||29
8900288|NCT02063984|9957745|FG001|STARTED|Overall Study||30
8900289|NCT02063984|9957744|FG000|COMPLETED|Overall Study||23
8635774|NCT00564395|9676288|FG001|NOT COMPLETED|Second Intervention (10 Days)||0
8635775|NCT00564447|9676302|FG000|STARTED|Overall Study||6
8635776|NCT00564447|9676303|FG001|STARTED|Overall Study||6
8900290|NCT02063984|9957745|FG001|COMPLETED|Overall Study||25
8900291|NCT02063984|9957744|FG000|NOT COMPLETED|Overall Study||6
8900292|NCT02063984|9957745|FG001|NOT COMPLETED|Overall Study||5
8900293|NCT02064166|9957757|FG000|STARTED|Overall Study||9
8900294|NCT02064166|9957758|FG001|STARTED|Overall Study||6
8900295|NCT02064166|9957757|FG000|COMPLETED|Overall Study||8
8900296|NCT02064166|9957758|FG001|COMPLETED|Overall Study||6
8900297|NCT02064166|9957757|FG000|NOT COMPLETED|Overall Study||1
8900298|NCT02064166|9957758|FG001|NOT COMPLETED|Overall Study||0
8900299|NCT02064205|9957786|FG000|STARTED|Overall Study||32
8900300|NCT02064205|9957786|FG000|Condition A|Overall Study||32
8900301|NCT02064205|9957786|FG000|Condition B|Overall Study||32
8900302|NCT02064205|9957786|FG000|Condition C|Overall Study||31
8900303|NCT02064205|9957786|FG000|Condition D|Overall Study||32
8900304|NCT02064205|9957786|FG000|COMPLETED|Overall Study||31
8900305|NCT02064205|9957786|FG000|NOT COMPLETED|Overall Study||1
8900306|NCT02064231|9957802|FG000|STARTED|First Test Period (Test A or Test C)||14
8900307|NCT02064231|9957803|FG001|STARTED|First Test Period (Test A or Test C)||12
8900308|NCT02064231|9957804|FG002|STARTED|First Test Period (Test A or Test C)||1
8900309|NCT02064231|9957805|FG003|STARTED|First Test Period (Test A or Test C)||1
8900310|NCT02064231|9957802|FG000|COMPLETED|First Test Period (Test A or Test C)||7
8900311|NCT02064231|9957803|FG001|COMPLETED|First Test Period (Test A or Test C)||8
8900312|NCT02064231|9957804|FG002|COMPLETED|First Test Period (Test A or Test C)||0
8900313|NCT02064231|9957805|FG003|COMPLETED|First Test Period (Test A or Test C)||1
8900314|NCT02064231|9957802|FG000|NOT COMPLETED|First Test Period (Test A or Test C)||7
8900315|NCT02064231|9957803|FG001|NOT COMPLETED|First Test Period (Test A or Test C)||4
8900316|NCT02064231|9957804|FG002|NOT COMPLETED|First Test Period (Test A or Test C)||1
8900317|NCT02064231|9957805|FG003|NOT COMPLETED|First Test Period (Test A or Test C)||0
8900318|NCT02064231|9957802|FG000|STARTED|Second Test Period (Test B or Test D)||7
8900319|NCT02064231|9957803|FG001|STARTED|Second Test Period (Test B or Test D)||8
8900320|NCT02064231|9957804|FG002|STARTED|Second Test Period (Test B or Test D)||0
8900321|NCT02064231|9957805|FG003|STARTED|Second Test Period (Test B or Test D)||1
8900322|NCT02064231|9957802|FG000|COMPLETED|Second Test Period (Test B or Test D)||6
8900323|NCT02064231|9957803|FG001|COMPLETED|Second Test Period (Test B or Test D)||7
8900324|NCT02064231|9957804|FG002|COMPLETED|Second Test Period (Test B or Test D)||0
8900325|NCT02064231|9957805|FG003|COMPLETED|Second Test Period (Test B or Test D)||1
8900326|NCT02064231|9957802|FG000|NOT COMPLETED|Second Test Period (Test B or Test D)||1
8900327|NCT02064231|9957803|FG001|NOT COMPLETED|Second Test Period (Test B or Test D)||1
8900328|NCT02064231|9957804|FG002|NOT COMPLETED|Second Test Period (Test B or Test D)||0
8900329|NCT02064231|9957805|FG003|NOT COMPLETED|Second Test Period (Test B or Test D)||0
8900330|NCT02064231|9957802|FG000|STARTED|Third Test Period (Own Product)|One subject who discontinued testing Test A proceeded to test Own product afterwards.|8
8900331|NCT02064231|9957803|FG001|STARTED|Third Test Period (Own Product)|One subject who discontinued testing Test C proceeded to test Own product afterwards|8
8900332|NCT02064231|9957804|FG002|STARTED|Third Test Period (Own Product)||0
8900333|NCT02064231|9957805|FG003|STARTED|Third Test Period (Own Product)||1
8900334|NCT02064231|9957802|FG000|COMPLETED|Third Test Period (Own Product)||8
8900335|NCT02064231|9957803|FG001|COMPLETED|Third Test Period (Own Product)||8
8900336|NCT02064231|9957804|FG002|COMPLETED|Third Test Period (Own Product)||0
8900337|NCT02064231|9957805|FG003|COMPLETED|Third Test Period (Own Product)||1
8900338|NCT02064231|9957802|FG000|NOT COMPLETED|Third Test Period (Own Product)||0
8900339|NCT02064231|9957803|FG001|NOT COMPLETED|Third Test Period (Own Product)||0
8900340|NCT02064231|9957804|FG002|NOT COMPLETED|Third Test Period (Own Product)||0
8900341|NCT02064231|9957805|FG003|NOT COMPLETED|Third Test Period (Own Product)||0
8900342|NCT02064270|9957819|FG000|STARTED|Overall Study||263
8900343|NCT02064270|9957820|FG001|STARTED|Overall Study||263
8900344|NCT02064270|9957819|FG000|COMPLETED|Overall Study||201
8900345|NCT02064270|9957820|FG001|COMPLETED|Overall Study||231
8900346|NCT02064270|9957819|FG000|NOT COMPLETED|Overall Study||62
8900347|NCT02064270|9957820|FG001|NOT COMPLETED|Overall Study||32
8900348|NCT02064439|9957829|FG000|STARTED|Overall Study|Full Analysis Set (FAS), randomized and received study medication|1127
8900349|NCT02064439|9957830|FG001|STARTED|Overall Study|FAS, randomized and received study medication|1107
8900350|NCT02064439|9957831|FG002|STARTED|Overall Study|FAS, randomized and received study medication|1131
8900351|NCT02064439|9957829|FG000|COMPLETED|Overall Study||984
8900352|NCT02064439|9957830|FG001|COMPLETED|Overall Study||969
8900353|NCT02064439|9957831|FG002|COMPLETED|Overall Study||949
9009518|NCT02974634|10072400|FG000|STARTED|Overall Study||106
9009519|NCT02974634|10072401|FG001|STARTED|Overall Study||110
9009520|NCT02974634|10072400|FG000|COMPLETED|Overall Study||78
8900354|NCT02064439|9957829|FG000|NOT COMPLETED|Overall Study||143
8900355|NCT02064439|9957830|FG001|NOT COMPLETED|Overall Study||138
8900356|NCT02064439|9957831|FG002|NOT COMPLETED|Overall Study||182
8900357|NCT02064582|9957839|FG000|STARTED|Overall Study||7
8900358|NCT02064582|9957839|FG000|COMPLETED|Overall Study||7
8635777|NCT00564447|9676304|FG002|STARTED|Overall Study||6
8635778|NCT00564447|9676305|FG003|STARTED|Overall Study||6
8900359|NCT02064582|9957839|FG000|NOT COMPLETED|Overall Study||0
8900360|NCT02064816|9957845|FG000|STARTED|Overall Study||104
8900361|NCT02064816|9957846|FG001|STARTED|Overall Study||96
8900362|NCT02064816|9957845|FG000|COMPLETED|Overall Study||96
8900363|NCT02064816|9957846|FG001|COMPLETED|Overall Study||88
8900364|NCT02064816|9957845|FG000|NOT COMPLETED|Overall Study||8
8900365|NCT02064816|9957846|FG001|NOT COMPLETED|Overall Study||8
8900366|NCT02064855|9957852|FG000|STARTED|Overall Study||108
8900367|NCT02064855|9957852|FG000|COMPLETED|Overall Study||53
8900368|NCT02064855|9957852|FG000|NOT COMPLETED|Overall Study||55
8900369|NCT02064868|9957901|FG000|STARTED|Overall Study||1756
8900370|NCT02064868|9957902|FG001|STARTED|Overall Study||894
8900371|NCT02064868|9957901|FG000|Full Analysis Set|Overall Study||1756
8900372|NCT02064868|9957902|FG001|Full Analysis Set|Overall Study||894
8900373|NCT02064868|9957901|FG000|Safety Set|Overall Study|The Safety Set includes one patient not randomized but treated with serelaxin|1729
8900374|NCT02064868|9957902|FG001|Safety Set|Overall Study||894
8900375|NCT02064868|9957901|FG000|Per Protocol Set|Overall Study||1155
8900376|NCT02064868|9957902|FG001|Per Protocol Set|Overall Study||627
8900377|NCT02064868|9957901|FG000|COMPLETED|Overall Study||1722
8900378|NCT02064868|9957902|FG001|COMPLETED|Overall Study||881
8900379|NCT02064868|9957901|FG000|NOT COMPLETED|Overall Study||34
8900380|NCT02064868|9957902|FG001|NOT COMPLETED|Overall Study||13
8900381|NCT02064894|9957911|FG000|STARTED|Overall Study|"Received allocated intervention (n=98)~Did not receive intervention (n=1)"|99
8900382|NCT02064894|9957912|FG001|STARTED|Overall Study|"Received allocated intervention (n=198)~Did not receive allocated intervention (n=3)"|201
8900383|NCT02064894|9957913|FG002|STARTED|Overall Study|"Received allocated intervention (n=199)~Did not receive allocated intervention (n=2)"|201
8900384|NCT02064894|9957911|FG000|Available at T-60|Overall Study||91
8900385|NCT02064894|9957912|FG001|Available at T-60|Overall Study||188
8900386|NCT02064894|9957913|FG002|Available at T-60|Overall Study||177
8900387|NCT02064894|9957911|FG000|Avalaible at T-90|Overall Study||74
8900388|NCT02064894|9957912|FG001|Avalaible at T-90|Overall Study||134
8900389|NCT02064894|9957913|FG002|Avalaible at T-90|Overall Study||129
8900390|NCT02064894|9957911|FG000|COMPLETED|Overall Study||56
8900391|NCT02064894|9957912|FG001|COMPLETED|Overall Study||99
8900392|NCT02064894|9957913|FG002|COMPLETED|Overall Study||86
8900393|NCT02064894|9957911|FG000|NOT COMPLETED|Overall Study||43
8900394|NCT02064894|9957912|FG001|NOT COMPLETED|Overall Study||102
9009521|NCT02974634|10072401|FG001|COMPLETED|Overall Study||89
9009522|NCT02974634|10072400|FG000|NOT COMPLETED|Overall Study||28
9009523|NCT02974634|10072401|FG001|NOT COMPLETED|Overall Study||21
9009524|NCT02974842|10072408|FG000|STARTED|Overall Study|Participants|50
9009525|NCT02974842|10072408|FG000|COMPLETED|Overall Study||42
9009526|NCT02974842|10072408|FG000|NOT COMPLETED|Overall Study||8
9009527|NCT02974855|10072416|FG000|STARTED|Overall Study||7
9009528|NCT02974855|10072417|FG001|STARTED|Overall Study||6
9009529|NCT02974855|10072418|FG002|STARTED|Overall Study||6
9009530|NCT02974855|10072419|FG003|STARTED|Overall Study||7
9009531|NCT02974855|10072416|FG000|COMPLETED|Overall Study||7
9009532|NCT02974855|10072417|FG001|COMPLETED|Overall Study||5
9009533|NCT02974855|10072418|FG002|COMPLETED|Overall Study||6
9009534|NCT02974855|10072419|FG003|COMPLETED|Overall Study||6
9009535|NCT02974855|10072416|FG000|NOT COMPLETED|Overall Study||0
9009536|NCT02974855|10072417|FG001|NOT COMPLETED|Overall Study||1
9009537|NCT02974855|10072418|FG002|NOT COMPLETED|Overall Study||0
9009538|NCT02974855|10072419|FG003|NOT COMPLETED|Overall Study||1
9009539|NCT02974868|10072436|FG000|STARTED|Initial 24-Week Treatment Period (TP)||24
9009540|NCT02974868|10072437|FG001|STARTED|Initial 24-Week Treatment Period (TP)||23
9009541|NCT02974868|10072438|FG002|STARTED|Initial 24-Week Treatment Period (TP)||48
9009542|NCT02974868|10072439|FG003|STARTED|Initial 24-Week Treatment Period (TP)||47
9009543|NCT02974868|10072436|FG000|COMPLETED|Initial 24-Week Treatment Period (TP)||20
9009544|NCT02974868|10072437|FG001|COMPLETED|Initial 24-Week Treatment Period (TP)||14
9009545|NCT02974868|10072438|FG002|COMPLETED|Initial 24-Week Treatment Period (TP)||45
9009546|NCT02974868|10072439|FG003|COMPLETED|Initial 24-Week Treatment Period (TP)||35
9009547|NCT02974868|10072436|FG000|NOT COMPLETED|Initial 24-Week Treatment Period (TP)||4
9009548|NCT02974868|10072437|FG001|NOT COMPLETED|Initial 24-Week Treatment Period (TP)||9
9009549|NCT02974868|10072438|FG002|NOT COMPLETED|Initial 24-Week Treatment Period (TP)||3
9009550|NCT02974868|10072439|FG003|NOT COMPLETED|Initial 24-Week Treatment Period (TP)||12
9009551|NCT02974868|10072436|FG000|STARTED|Single-Blind Extension (SBE) Period||17
9009552|NCT02974868|10072437|FG001|STARTED|Single-Blind Extension (SBE) Period||12
9009553|NCT02974868|10072438|FG002|STARTED|Single-Blind Extension (SBE) Period||38
9009554|NCT02974868|10072439|FG003|STARTED|Single-Blind Extension (SBE) Period||29
9009555|NCT02974868|10072436|FG000|COMPLETED|Single-Blind Extension (SBE) Period||15
9009556|NCT02974868|10072437|FG001|COMPLETED|Single-Blind Extension (SBE) Period||11
9009557|NCT02974868|10072438|FG002|COMPLETED|Single-Blind Extension (SBE) Period||27
8572896|NCT00117637|9605078|FG001|COMPLETED|Second Intervention (Period 2)||39
8900395|NCT02064894|9957913|FG002|NOT COMPLETED|Overall Study||115
8900396|NCT02064907|9957923|FG000|STARTED|Period 1||26
8900397|NCT02064907|9957924|FG001|STARTED|Period 1||26
8900398|NCT02064907|9957923|FG000|COMPLETED|Period 1||26
8900399|NCT02064907|9957924|FG001|COMPLETED|Period 1||26
8900400|NCT02064907|9957923|FG000|NOT COMPLETED|Period 1||0
9009558|NCT02974868|10072439|FG003|COMPLETED|Single-Blind Extension (SBE) Period||23
9009559|NCT02974868|10072436|FG000|NOT COMPLETED|Single-Blind Extension (SBE) Period||2
9009560|NCT02974868|10072437|FG001|NOT COMPLETED|Single-Blind Extension (SBE) Period||1
8900401|NCT02064907|9957924|FG001|NOT COMPLETED|Period 1||0
8900402|NCT02064907|9957923|FG000|STARTED|Period 2||26
8900403|NCT02064907|9957924|FG001|STARTED|Period 2||26
8900404|NCT02064907|9957923|FG000|COMPLETED|Period 2||26
8900405|NCT02064907|9957924|FG001|COMPLETED|Period 2||26
8900406|NCT02064907|9957923|FG000|NOT COMPLETED|Period 2||0
8900407|NCT02064907|9957924|FG001|NOT COMPLETED|Period 2||0
8900408|NCT02064920|9957932|FG000|STARTED|Overall Study||6
8900409|NCT02064920|9957933|FG001|STARTED|Overall Study||30
8900410|NCT02064920|9957932|FG000|Treated|Overall Study||6
8900411|NCT02064920|9957933|FG001|Treated|Overall Study|Two participants discontinued from study prior to treatment|28
8900412|NCT02064920|9957932|FG000|COMPLETED|Overall Study||5
8900413|NCT02064920|9957933|FG001|COMPLETED|Overall Study||21
8900414|NCT02064920|9957932|FG000|NOT COMPLETED|Overall Study||1
8900415|NCT02064920|9957933|FG001|NOT COMPLETED|Overall Study||9
8900416|NCT02064959|9957941|FG000|STARTED|Overall Study||16
8900417|NCT02064959|9957942|FG001|STARTED|Overall Study||16
8900418|NCT02064959|9957941|FG000|COMPLETED|Overall Study||16
8900419|NCT02064959|9957942|FG001|COMPLETED|Overall Study||16
8900420|NCT02064959|9957941|FG000|NOT COMPLETED|Overall Study||0
8900421|NCT02064959|9957942|FG001|NOT COMPLETED|Overall Study||0
8900422|NCT02064985|9957951|FG000|STARTED|Overall Study||12
8900423|NCT02064985|9957952|FG001|STARTED|Overall Study||12
8900424|NCT02064985|9957953|FG002|STARTED|Overall Study||12
8900425|NCT02064985|9957951|FG000|COMPLETED|Overall Study||12
8900426|NCT02064985|9957952|FG001|COMPLETED|Overall Study||12
8900427|NCT02064985|9957953|FG002|COMPLETED|Overall Study||12
8900428|NCT02064985|9957951|FG000|NOT COMPLETED|Overall Study||0
8900429|NCT02064985|9957952|FG001|NOT COMPLETED|Overall Study||0
8900430|NCT02064985|9957953|FG002|NOT COMPLETED|Overall Study||0
8900431|NCT02065245|9957968|FG000|STARTED|Infusion 1||5
8900432|NCT02065245|9957969|FG001|STARTED|Infusion 1||5
8900433|NCT02065245|9957970|FG002|STARTED|Infusion 1||5
8900434|NCT02065245|9957971|FG003|STARTED|Infusion 1||10
8900435|NCT02065245|9957972|FG004|STARTED|Infusion 1||10
8900436|NCT02065245|9957973|FG005|STARTED|Infusion 1||10
8900437|NCT02065245|9957974|FG006|STARTED|Infusion 1||20
8900438|NCT02065245|9957968|FG000|COMPLETED|Infusion 1||5
8900439|NCT02065245|9957969|FG001|COMPLETED|Infusion 1||5
8900440|NCT02065245|9957970|FG002|COMPLETED|Infusion 1||4
8900441|NCT02065245|9957971|FG003|COMPLETED|Infusion 1||10
8900442|NCT02065245|9957972|FG004|COMPLETED|Infusion 1||9
8900443|NCT02065245|9957973|FG005|COMPLETED|Infusion 1||10
8900444|NCT02065245|9957974|FG006|COMPLETED|Infusion 1||19
8900445|NCT02065245|9957968|FG000|NOT COMPLETED|Infusion 1||0
8900446|NCT02065245|9957969|FG001|NOT COMPLETED|Infusion 1||0
8900447|NCT02065245|9957970|FG002|NOT COMPLETED|Infusion 1||1
8900448|NCT02065245|9957971|FG003|NOT COMPLETED|Infusion 1||0
8900449|NCT02065245|9957972|FG004|NOT COMPLETED|Infusion 1||1
8900450|NCT02065245|9957973|FG005|NOT COMPLETED|Infusion 1||0
8900451|NCT02065245|9957974|FG006|NOT COMPLETED|Infusion 1||1
8900452|NCT02065245|9957968|FG000|STARTED|Infusion 2||5
8900453|NCT02065245|9957969|FG001|STARTED|Infusion 2||5
8900454|NCT02065245|9957970|FG002|STARTED|Infusion 2||2
8900455|NCT02065245|9957971|FG003|STARTED|Infusion 2||0
8900456|NCT02065245|9957972|FG004|STARTED|Infusion 2||0
8900457|NCT02065245|9957973|FG005|STARTED|Infusion 2||6
8900458|NCT02065245|9957974|FG006|STARTED|Infusion 2||12
8900459|NCT02065245|9957968|FG000|COMPLETED|Infusion 2||5
8900460|NCT02065245|9957969|FG001|COMPLETED|Infusion 2||5
8900461|NCT02065245|9957970|FG002|COMPLETED|Infusion 2||2
8900462|NCT02065245|9957971|FG003|COMPLETED|Infusion 2||0
8900463|NCT02065245|9957972|FG004|COMPLETED|Infusion 2||0
8900464|NCT02065245|9957973|FG005|COMPLETED|Infusion 2||6
8900465|NCT02065245|9957974|FG006|COMPLETED|Infusion 2||11
8900466|NCT02065245|9957968|FG000|NOT COMPLETED|Infusion 2||0
8900467|NCT02065245|9957969|FG001|NOT COMPLETED|Infusion 2||0
8900468|NCT02065245|9957970|FG002|NOT COMPLETED|Infusion 2||0
8900469|NCT02065245|9957971|FG003|NOT COMPLETED|Infusion 2||0
8900470|NCT02065245|9957972|FG004|NOT COMPLETED|Infusion 2||0
8900471|NCT02065245|9957973|FG005|NOT COMPLETED|Infusion 2||0
8900472|NCT02065245|9957974|FG006|NOT COMPLETED|Infusion 2||1
8900473|NCT02065245|9957968|FG000|STARTED|Infusion 3||3
8900474|NCT02065245|9957969|FG001|STARTED|Infusion 3||5
8900475|NCT02065245|9957970|FG002|STARTED|Infusion 3||1
8900476|NCT02065245|9957971|FG003|STARTED|Infusion 3||0
8900477|NCT02065245|9957972|FG004|STARTED|Infusion 3||0
8900478|NCT02065245|9957973|FG005|STARTED|Infusion 3||0
8900479|NCT02065245|9957974|FG006|STARTED|Infusion 3||0
8900480|NCT02065245|9957968|FG000|COMPLETED|Infusion 3||2
8900481|NCT02065245|9957969|FG001|COMPLETED|Infusion 3||4
8900482|NCT02065245|9957970|FG002|COMPLETED|Infusion 3||1
8900483|NCT02065245|9957971|FG003|COMPLETED|Infusion 3||0
8900484|NCT02065245|9957972|FG004|COMPLETED|Infusion 3||0
8900485|NCT02065245|9957973|FG005|COMPLETED|Infusion 3||0
8900486|NCT02065245|9957974|FG006|COMPLETED|Infusion 3||0
8900487|NCT02065245|9957968|FG000|NOT COMPLETED|Infusion 3||1
8900488|NCT02065245|9957969|FG001|NOT COMPLETED|Infusion 3||1
8900489|NCT02065245|9957970|FG002|NOT COMPLETED|Infusion 3||0
8900490|NCT02065245|9957971|FG003|NOT COMPLETED|Infusion 3||0
8900491|NCT02065245|9957972|FG004|NOT COMPLETED|Infusion 3||0
8900492|NCT02065245|9957973|FG005|NOT COMPLETED|Infusion 3||0
8900493|NCT02065245|9957974|FG006|NOT COMPLETED|Infusion 3||0
8900494|NCT02065245|9957968|FG000|STARTED|Infusion 4||1
8900495|NCT02065245|9957969|FG001|STARTED|Infusion 4||2
8900496|NCT02065245|9957970|FG002|STARTED|Infusion 4||1
8900497|NCT02065245|9957971|FG003|STARTED|Infusion 4||0
8900498|NCT02065245|9957972|FG004|STARTED|Infusion 4||0
8900499|NCT02065245|9957973|FG005|STARTED|Infusion 4||0
8900500|NCT02065245|9957974|FG006|STARTED|Infusion 4||0
8900501|NCT02065245|9957968|FG000|COMPLETED|Infusion 4||1
8900502|NCT02065245|9957969|FG001|COMPLETED|Infusion 4||2
8900503|NCT02065245|9957970|FG002|COMPLETED|Infusion 4||1
8900504|NCT02065245|9957971|FG003|COMPLETED|Infusion 4||0
8900505|NCT02065245|9957972|FG004|COMPLETED|Infusion 4||0
8900506|NCT02065245|9957973|FG005|COMPLETED|Infusion 4||0
8900507|NCT02065245|9957974|FG006|COMPLETED|Infusion 4||0
8900508|NCT02065245|9957968|FG000|NOT COMPLETED|Infusion 4||0
8900509|NCT02065245|9957969|FG001|NOT COMPLETED|Infusion 4||0
8900510|NCT02065245|9957970|FG002|NOT COMPLETED|Infusion 4||0
8900511|NCT02065245|9957971|FG003|NOT COMPLETED|Infusion 4||0
8900512|NCT02065245|9957972|FG004|NOT COMPLETED|Infusion 4||0
8900513|NCT02065245|9957973|FG005|NOT COMPLETED|Infusion 4||0
8900514|NCT02065245|9957974|FG006|NOT COMPLETED|Infusion 4||0
8900515|NCT02065336|9957998|FG000|STARTED|Main Study||6
8900516|NCT02065336|9957999|FG001|STARTED|Main Study||6
8900517|NCT02065336|9958000|FG002|STARTED|Main Study||6
8900518|NCT02065336|9958001|FG003|STARTED|Main Study||6
8900519|NCT02065336|9958002|FG004|STARTED|Main Study||6
8900520|NCT02065336|9958003|FG005|STARTED|Main Study||6
8900521|NCT02065336|9958004|FG006|STARTED|Main Study||12
8900522|NCT02065336|9958005|FG007|STARTED|Main Study||10
8900523|NCT02065336|9958006|FG008|STARTED|Main Study||0
8900524|NCT02065336|9958007|FG009|STARTED|Main Study||0
8900525|NCT02065336|9957998|FG000|COMPLETED|Main Study||6
8900526|NCT02065336|9957999|FG001|COMPLETED|Main Study||6
8900527|NCT02065336|9958000|FG002|COMPLETED|Main Study||6
8900528|NCT02065336|9958001|FG003|COMPLETED|Main Study||6
8900529|NCT02065336|9958002|FG004|COMPLETED|Main Study||6
8900530|NCT02065336|9958003|FG005|COMPLETED|Main Study||6
8900531|NCT02065336|9958004|FG006|COMPLETED|Main Study||12
8900532|NCT02065336|9958005|FG007|COMPLETED|Main Study||10
8900533|NCT02065336|9958006|FG008|COMPLETED|Main Study||0
8900534|NCT02065336|9958007|FG009|COMPLETED|Main Study||0
8900535|NCT02065336|9957998|FG000|NOT COMPLETED|Main Study||0
8900536|NCT02065336|9957999|FG001|NOT COMPLETED|Main Study||0
8900537|NCT02065336|9958000|FG002|NOT COMPLETED|Main Study||0
8900538|NCT02065336|9958001|FG003|NOT COMPLETED|Main Study||0
8900539|NCT02065336|9958002|FG004|NOT COMPLETED|Main Study||0
8900540|NCT02065336|9958003|FG005|NOT COMPLETED|Main Study||0
8900541|NCT02065336|9958004|FG006|NOT COMPLETED|Main Study||0
8900542|NCT02065336|9958005|FG007|NOT COMPLETED|Main Study||0
8900543|NCT02065336|9958006|FG008|NOT COMPLETED|Main Study||0
8900544|NCT02065336|9958007|FG009|NOT COMPLETED|Main Study||0
8900545|NCT02065336|9957998|FG000|STARTED|Extension Phase||0
8900546|NCT02065336|9957999|FG001|STARTED|Extension Phase||0
8900547|NCT02065336|9958000|FG002|STARTED|Extension Phase||0
8900548|NCT02065336|9958001|FG003|STARTED|Extension Phase||0
8900549|NCT02065336|9958002|FG004|STARTED|Extension Phase||0
8900550|NCT02065336|9958003|FG005|STARTED|Extension Phase||0
8900551|NCT02065336|9958004|FG006|STARTED|Extension Phase||0
8900552|NCT02065336|9958005|FG007|STARTED|Extension Phase||0
8900553|NCT02065336|9958006|FG008|STARTED|Extension Phase||2
8900554|NCT02065336|9958007|FG009|STARTED|Extension Phase||8
8900555|NCT02065336|9957998|FG000|COMPLETED|Extension Phase||0
8900556|NCT02065336|9957999|FG001|COMPLETED|Extension Phase||0
8900557|NCT02065336|9958000|FG002|COMPLETED|Extension Phase||0
8900558|NCT02065336|9958001|FG003|COMPLETED|Extension Phase||0
8900559|NCT02065336|9958002|FG004|COMPLETED|Extension Phase||0
8900560|NCT02065336|9958003|FG005|COMPLETED|Extension Phase||0
8900561|NCT02065336|9958004|FG006|COMPLETED|Extension Phase||0
8900562|NCT02065336|9958005|FG007|COMPLETED|Extension Phase||0
8900563|NCT02065336|9958006|FG008|COMPLETED|Extension Phase||0
8900564|NCT02065336|9958007|FG009|COMPLETED|Extension Phase||0
8900565|NCT02065336|9957998|FG000|NOT COMPLETED|Extension Phase||0
8900566|NCT02065336|9957999|FG001|NOT COMPLETED|Extension Phase||0
8900567|NCT02065336|9958000|FG002|NOT COMPLETED|Extension Phase||0
8900568|NCT02065336|9958001|FG003|NOT COMPLETED|Extension Phase||0
8900569|NCT02065336|9958002|FG004|NOT COMPLETED|Extension Phase||0
8900570|NCT02065336|9958003|FG005|NOT COMPLETED|Extension Phase||0
8900571|NCT02065336|9958004|FG006|NOT COMPLETED|Extension Phase||0
8900572|NCT02065336|9958005|FG007|NOT COMPLETED|Extension Phase||0
8900573|NCT02065336|9958006|FG008|NOT COMPLETED|Extension Phase||2
8900574|NCT02065336|9958007|FG009|NOT COMPLETED|Extension Phase||8
8900575|NCT02065453|9958040|FG000|STARTED|Overall Study||27
8900576|NCT02065453|9958041|FG001|STARTED|Overall Study||25
8900577|NCT02065453|9958040|FG000|COMPLETED|Overall Study||24
8900578|NCT02065453|9958041|FG001|COMPLETED|Overall Study||21
8900579|NCT02065453|9958040|FG000|NOT COMPLETED|Overall Study||3
8900580|NCT02065453|9958041|FG001|NOT COMPLETED|Overall Study||4
8900581|NCT02065479|9958048|FG000|STARTED|Overall Study||33
8900582|NCT02065479|9958049|FG001|STARTED|Overall Study||32
8900583|NCT02065479|9958048|FG000|COMPLETED|Overall Study||33
8900584|NCT02065479|9958049|FG001|COMPLETED|Overall Study||32
8900585|NCT02065479|9958048|FG000|NOT COMPLETED|Overall Study||0
8900586|NCT02065479|9958049|FG001|NOT COMPLETED|Overall Study||0
8900587|NCT02065518|9958059|FG000|STARTED|Overall Study||19
8900588|NCT02065518|9958060|FG001|STARTED|Overall Study||19
8900589|NCT02065518|9958061|FG002|STARTED|Overall Study||20
8900590|NCT02065518|9958062|FG003|STARTED|Overall Study||20
8900591|NCT02065518|9958059|FG000|COMPLETED|Overall Study||13
8900592|NCT02065518|9958060|FG001|COMPLETED|Overall Study||11
8900593|NCT02065518|9958061|FG002|COMPLETED|Overall Study||11
8900594|NCT02065518|9958062|FG003|COMPLETED|Overall Study||15
8900595|NCT02065518|9958059|FG000|NOT COMPLETED|Overall Study||6
8900596|NCT02065518|9958060|FG001|NOT COMPLETED|Overall Study||8
8900597|NCT02065518|9958061|FG002|NOT COMPLETED|Overall Study||9
8635779|NCT00564447|9676306|FG004|STARTED|Overall Study||6
8635780|NCT00564447|9676307|FG005|STARTED|Overall Study||6
8635781|NCT00564447|9676308|FG006|STARTED|Overall Study||6
8900598|NCT02065518|9958062|FG003|NOT COMPLETED|Overall Study||5
8900599|NCT02065557|9958075|FG000|STARTED|Induction Period||32
8900600|NCT02065557|9958076|FG001|STARTED|Induction Period||51
8900601|NCT02065557|9958077|FG002|STARTED|Induction Period||18
8900602|NCT02065557|9958078|FG003|STARTED|Induction Period||0
8900603|NCT02065557|9958079|FG004|STARTED|Induction Period||0
8900604|NCT02065557|9958080|FG005|STARTED|Induction Period||0
8900605|NCT02065557|9958075|FG000|Enrolled in Main Study|Induction Period||30
8900606|NCT02065557|9958076|FG001|Enrolled in Main Study|Induction Period||47
8900607|NCT02065557|9958077|FG002|Enrolled in Main Study|Induction Period||16
8900608|NCT02065557|9958078|FG003|Enrolled in Main Study|Induction Period||0
8726288|NCT01035099|9773477|FG001|COMPLETED|Overall Study||22
8726289|NCT01035099|9773476|FG000|NOT COMPLETED|Overall Study||0
8726290|NCT01035099|9773477|FG001|NOT COMPLETED|Overall Study||0
8726291|NCT01035138|9773487|FG000|STARTED|Overall Study||73
8635782|NCT00564447|9676309|FG007|STARTED|Overall Study||6
8635783|NCT00564447|9676302|FG000|COMPLETED|Overall Study||6
8635784|NCT00564447|9676303|FG001|COMPLETED|Overall Study||6
8635785|NCT00564447|9676304|FG002|COMPLETED|Overall Study||6
8726292|NCT01035138|9773488|FG001|STARTED|Overall Study||60
8726293|NCT01035138|9773489|FG002|STARTED|Overall Study||47
8726294|NCT01035138|9773487|FG000|COMPLETED|Overall Study||0
8726295|NCT01035138|9773488|FG001|COMPLETED|Overall Study||0
8726296|NCT01035138|9773489|FG002|COMPLETED|Overall Study||0
8726297|NCT01035138|9773487|FG000|NOT COMPLETED|Overall Study||73
8726298|NCT01035138|9773488|FG001|NOT COMPLETED|Overall Study||60
8726299|NCT01035138|9773489|FG002|NOT COMPLETED|Overall Study||47
8726300|NCT01035151|9773501|FG000|STARTED|Overall Study||209
8726301|NCT01035151|9773502|FG001|STARTED|Overall Study||200
8726302|NCT01035151|9773501|FG000|COMPLETED|Overall Study||188
8726303|NCT01035151|9773502|FG001|COMPLETED|Overall Study||185
8726304|NCT01035151|9773501|FG000|NOT COMPLETED|Overall Study||21
8726305|NCT01035151|9773502|FG001|NOT COMPLETED|Overall Study||15
8726306|NCT01035229|9773510|FG000|STARTED|Overall Study||362
8726307|NCT01035229|9773511|FG001|STARTED|Overall Study||184
8900609|NCT02065557|9958079|FG004|Enrolled in Main Study|Induction Period||0
8900610|NCT02065557|9958080|FG005|Enrolled in Main Study|Induction Period||0
8900611|NCT02065557|9958075|FG000|Enrolled in Japan Sub-study|Induction Period||2
8900612|NCT02065557|9958076|FG001|Enrolled in Japan Sub-study|Induction Period||4
9009561|NCT02974868|10072438|FG002|NOT COMPLETED|Single-Blind Extension (SBE) Period||11
9009562|NCT02974868|10072439|FG003|NOT COMPLETED|Single-Blind Extension (SBE) Period||6
9009563|NCT02974868|10072436|FG000|STARTED|Cross-Over Extension (COE) Period||7
9009564|NCT02974868|10072437|FG001|STARTED|Cross-Over Extension (COE) Period||2
9009565|NCT02974868|10072438|FG002|STARTED|Cross-Over Extension (COE) Period||11
9009566|NCT02974868|10072439|FG003|STARTED|Cross-Over Extension (COE) Period||3
9009567|NCT02974868|10072436|FG000|COMPLETED|Cross-Over Extension (COE) Period||5
9009568|NCT02974868|10072437|FG001|COMPLETED|Cross-Over Extension (COE) Period||1
9009569|NCT02974868|10072438|FG002|COMPLETED|Cross-Over Extension (COE) Period||8
9009570|NCT02974868|10072439|FG003|COMPLETED|Cross-Over Extension (COE) Period||3
9009571|NCT02974868|10072436|FG000|NOT COMPLETED|Cross-Over Extension (COE) Period||2
9009572|NCT02974868|10072437|FG001|NOT COMPLETED|Cross-Over Extension (COE) Period||1
9009573|NCT02974868|10072438|FG002|NOT COMPLETED|Cross-Over Extension (COE) Period||3
9009574|NCT02974868|10072439|FG003|NOT COMPLETED|Cross-Over Extension (COE) Period||0
9009575|NCT02975206|10072483|FG000|STARTED|Overall Study||161
9009576|NCT02975206|10072484|FG001|STARTED|Overall Study||161
9009577|NCT02975206|10072485|FG002|STARTED|Overall Study||162
8635786|NCT00564447|9676305|FG003|COMPLETED|Overall Study||6
8635787|NCT00564447|9676306|FG004|COMPLETED|Overall Study||6
8635788|NCT00564447|9676307|FG005|COMPLETED|Overall Study||6
9009578|NCT02975206|10072483|FG000|COMPLETED|Overall Study||134
9009579|NCT02975206|10072484|FG001|COMPLETED|Overall Study||144
9009580|NCT02975206|10072485|FG002|COMPLETED|Overall Study||145
9009581|NCT02975206|10072483|FG000|NOT COMPLETED|Overall Study||27
9009582|NCT02975206|10072484|FG001|NOT COMPLETED|Overall Study||17
8635789|NCT00564447|9676308|FG006|COMPLETED|Overall Study||6
8726308|NCT01035229|9773510|FG000|COMPLETED|Overall Study||0
8726309|NCT01035229|9773511|FG001|COMPLETED|Overall Study||0
8726310|NCT01035229|9773510|FG000|NOT COMPLETED|Overall Study||362
9009583|NCT02975206|10072485|FG002|NOT COMPLETED|Overall Study||17
8726311|NCT01035229|9773511|FG001|NOT COMPLETED|Overall Study||184
8900613|NCT02065557|9958077|FG002|Enrolled in Japan Sub-study|Induction Period||2
8900614|NCT02065557|9958078|FG003|Enrolled in Japan Sub-study|Induction Period||0
8900615|NCT02065557|9958079|FG004|Enrolled in Japan Sub-study|Induction Period||0
8635790|NCT00564447|9676309|FG007|COMPLETED|Overall Study||6
8900616|NCT02065557|9958080|FG005|Enrolled in Japan Sub-study|Induction Period||0
8900617|NCT02065557|9958075|FG000|COMPLETED|Induction Period||22
8900618|NCT02065557|9958076|FG001|COMPLETED|Induction Period||43
8900619|NCT02065557|9958077|FG002|COMPLETED|Induction Period||16
8900620|NCT02065557|9958078|FG003|COMPLETED|Induction Period||0
8900621|NCT02065557|9958079|FG004|COMPLETED|Induction Period||0
8900622|NCT02065557|9958080|FG005|COMPLETED|Induction Period||0
8900623|NCT02065557|9958075|FG000|NOT COMPLETED|Induction Period||10
8900624|NCT02065557|9958076|FG001|NOT COMPLETED|Induction Period||8
8900625|NCT02065557|9958077|FG002|NOT COMPLETED|Induction Period||2
8900626|NCT02065557|9958078|FG003|NOT COMPLETED|Induction Period||0
8900627|NCT02065557|9958079|FG004|NOT COMPLETED|Induction Period||0
8900628|NCT02065557|9958080|FG005|NOT COMPLETED|Induction Period||0
8900629|NCT02065557|9958075|FG000|STARTED|Maintenance Period||0
8900630|NCT02065557|9958076|FG001|STARTED|Maintenance Period||0
8900631|NCT02065557|9958077|FG002|STARTED|Maintenance Period||0
8900632|NCT02065557|9958078|FG003|STARTED|Maintenance Period||12
8900633|NCT02065557|9958079|FG004|STARTED|Maintenance Period||33
8900634|NCT02065557|9958080|FG005|STARTED|Maintenance Period||36
8900635|NCT02065557|9958075|FG000|COMPLETED|Maintenance Period||0
8900636|NCT02065557|9958076|FG001|COMPLETED|Maintenance Period||0
8900637|NCT02065557|9958077|FG002|COMPLETED|Maintenance Period||0
8900638|NCT02065557|9958078|FG003|COMPLETED|Maintenance Period||11
8900639|NCT02065557|9958079|FG004|COMPLETED|Maintenance Period||25
8900640|NCT02065557|9958080|FG005|COMPLETED|Maintenance Period||32
8900641|NCT02065557|9958075|FG000|NOT COMPLETED|Maintenance Period||0
8900642|NCT02065557|9958076|FG001|NOT COMPLETED|Maintenance Period||0
8900643|NCT02065557|9958077|FG002|NOT COMPLETED|Maintenance Period||0
8900644|NCT02065557|9958078|FG003|NOT COMPLETED|Maintenance Period||1
8900645|NCT02065557|9958079|FG004|NOT COMPLETED|Maintenance Period||8
8900646|NCT02065557|9958080|FG005|NOT COMPLETED|Maintenance Period||4
8900647|NCT02065570|9958107|FG000|STARTED|Induction Study||206
8900648|NCT02065570|9958108|FG001|STARTED|Induction Study||308
8900649|NCT02065570|9958109|FG002|STARTED|Induction Study||0
8900650|NCT02065570|9958110|FG003|STARTED|Induction Study||0
8900651|NCT02065570|9958107|FG000|COMPLETED|Induction Study||192
8900652|NCT02065570|9958108|FG001|COMPLETED|Induction Study||287
8900653|NCT02065570|9958109|FG002|COMPLETED|Induction Study||0
8900654|NCT02065570|9958110|FG003|COMPLETED|Induction Study||0
8900655|NCT02065570|9958107|FG000|NOT COMPLETED|Induction Study||14
8900656|NCT02065570|9958108|FG001|NOT COMPLETED|Induction Study||21
8900657|NCT02065570|9958109|FG002|NOT COMPLETED|Induction Study||0
8900658|NCT02065570|9958110|FG003|NOT COMPLETED|Induction Study||0
8900659|NCT02065570|9958107|FG000|STARTED|Maintenance Study||0
8900660|NCT02065570|9958108|FG001|STARTED|Maintenance Study||0
8900661|NCT02065570|9958109|FG002|STARTED|Maintenance Study||109
8900662|NCT02065570|9958110|FG003|STARTED|Maintenance Study||109
8900663|NCT02065570|9958107|FG000|COMPLETED|Maintenance Study||0
8900664|NCT02065570|9958108|FG001|COMPLETED|Maintenance Study||0
8900665|NCT02065570|9958109|FG002|COMPLETED|Maintenance Study||87
8900666|NCT02065570|9958110|FG003|COMPLETED|Maintenance Study||90
8900667|NCT02065570|9958107|FG000|NOT COMPLETED|Maintenance Study||0
8900668|NCT02065570|9958108|FG001|NOT COMPLETED|Maintenance Study||0
8900669|NCT02065570|9958109|FG002|NOT COMPLETED|Maintenance Study||22
8900670|NCT02065570|9958110|FG003|NOT COMPLETED|Maintenance Study||19
8900671|NCT02065622|9958123|FG000|STARTED|Induction Study||379
8900672|NCT02065622|9958124|FG001|STARTED|Induction Study||573
8900673|NCT02065622|9958125|FG002|STARTED|Induction Study||0
8900674|NCT02065622|9958126|FG003|STARTED|Induction Study||0
8900675|NCT02065622|9958127|FG004|STARTED|Induction Study||0
8900676|NCT02065622|9958123|FG000|Enrolled in Main Study|Induction Study||340
8900677|NCT02065622|9958124|FG001|Enrolled in Main Study|Induction Study||512
8900678|NCT02065622|9958125|FG002|Enrolled in Main Study|Induction Study||0
8900679|NCT02065622|9958126|FG003|Enrolled in Main Study|Induction Study||0
8900680|NCT02065622|9958127|FG004|Enrolled in Main Study|Induction Study||0
8900681|NCT02065622|9958123|FG000|Enrolled in Japan Sub-Study|Induction Study||39
8900682|NCT02065622|9958124|FG001|Enrolled in Japan Sub-Study|Induction Study||61
8900683|NCT02065622|9958125|FG002|Enrolled in Japan Sub-Study|Induction Study||0
8900684|NCT02065622|9958126|FG003|Enrolled in Japan Sub-Study|Induction Study||0
8900685|NCT02065622|9958127|FG004|Enrolled in Japan Sub-Study|Induction Study||0
8900686|NCT02065622|9958123|FG000|COMPLETED|Induction Study||332
8900687|NCT02065622|9958124|FG001|COMPLETED|Induction Study||514
8900688|NCT02065622|9958125|FG002|COMPLETED|Induction Study||0
8900689|NCT02065622|9958126|FG003|COMPLETED|Induction Study||0
8900690|NCT02065622|9958127|FG004|COMPLETED|Induction Study||0
8900691|NCT02065622|9958123|FG000|NOT COMPLETED|Induction Study||47
8900692|NCT02065622|9958124|FG001|NOT COMPLETED|Induction Study||59
8900693|NCT02065622|9958125|FG002|NOT COMPLETED|Induction Study||0
8900694|NCT02065622|9958126|FG003|NOT COMPLETED|Induction Study||0
8900695|NCT02065622|9958127|FG004|NOT COMPLETED|Induction Study||0
8900696|NCT02065622|9958123|FG000|STARTED|Maintenance Study||0
8900697|NCT02065622|9958124|FG001|STARTED|Maintenance Study||0
8900698|NCT02065622|9958125|FG002|STARTED|Maintenance Study||345
8900699|NCT02065622|9958126|FG003|STARTED|Maintenance Study||350
8900700|NCT02065622|9958127|FG004|STARTED|Maintenance Study||151
8900701|NCT02065622|9958123|FG000|COMPLETED|Maintenance Study||0
8900702|NCT02065622|9958124|FG001|COMPLETED|Maintenance Study||0
8900703|NCT02065622|9958125|FG002|COMPLETED|Maintenance Study||221
8900704|NCT02065622|9958126|FG003|COMPLETED|Maintenance Study||246
8900705|NCT02065622|9958127|FG004|COMPLETED|Maintenance Study||105
8900706|NCT02065622|9958123|FG000|NOT COMPLETED|Maintenance Study||0
8900707|NCT02065622|9958124|FG001|NOT COMPLETED|Maintenance Study||0
8900708|NCT02065622|9958125|FG002|NOT COMPLETED|Maintenance Study||124
8900709|NCT02065622|9958126|FG003|NOT COMPLETED|Maintenance Study||104
8900710|NCT02065622|9958127|FG004|NOT COMPLETED|Maintenance Study||46
8900711|NCT02065687|9958144|FG000|STARTED|Overall Study||234
8900712|NCT02065687|9958145|FG001|STARTED|Overall Study||235
8900713|NCT02065687|9958144|FG000|COMPLETED|Overall Study||234
8900714|NCT02065687|9958145|FG001|COMPLETED|Overall Study||235
8900715|NCT02065687|9958144|FG000|NOT COMPLETED|Overall Study||0
8900716|NCT02065687|9958145|FG001|NOT COMPLETED|Overall Study||0
8900717|NCT02065713|9958153|FG000|STARTED|Overall Study||23
8900718|NCT02065713|9958154|FG001|STARTED|Overall Study||21
8900719|NCT02065713|9958153|FG000|COMPLETED|Overall Study||22
8900720|NCT02065713|9958154|FG001|COMPLETED|Overall Study||20
8900721|NCT02065713|9958153|FG000|NOT COMPLETED|Overall Study||1
8900722|NCT02065713|9958154|FG001|NOT COMPLETED|Overall Study||1
8900723|NCT02065791|9958162|FG000|STARTED|Overall Study||2199
8900724|NCT02065791|9958163|FG001|STARTED|Overall Study||2202
8900725|NCT02065791|9958162|FG000|Treated|Overall Study||2197
8900726|NCT02065791|9958163|FG001|Treated|Overall Study||2200
8900727|NCT02065791|9958162|FG000|COMPLETED|Overall Study||2174
8900728|NCT02065791|9958163|FG001|COMPLETED|Overall Study||2187
8900729|NCT02065791|9958162|FG000|NOT COMPLETED|Overall Study||25
8900730|NCT02065791|9958163|FG001|NOT COMPLETED|Overall Study||15
8900731|NCT02065895|9958169|FG000|STARTED|Overall Study||1
8900732|NCT02065895|9958170|FG001|STARTED|Overall Study||3
8900733|NCT02065895|9958171|FG002|STARTED|Overall Study||1
8900734|NCT02065895|9958172|FG003|STARTED|Overall Study||1
8900735|NCT02065895|9958173|FG004|STARTED|Overall Study||1
8900736|NCT02065895|9958174|FG005|STARTED|Overall Study||1
8900737|NCT02065895|9958169|FG000|COMPLETED|Overall Study||0
8900738|NCT02065895|9958170|FG001|COMPLETED|Overall Study||2
8900739|NCT02065895|9958171|FG002|COMPLETED|Overall Study||1
8900740|NCT02065895|9958172|FG003|COMPLETED|Overall Study||0
8900741|NCT02065895|9958173|FG004|COMPLETED|Overall Study||1
8900742|NCT02065895|9958174|FG005|COMPLETED|Overall Study||1
8900743|NCT02065895|9958169|FG000|NOT COMPLETED|Overall Study||1
8900744|NCT02065895|9958170|FG001|NOT COMPLETED|Overall Study||1
8900745|NCT02065895|9958171|FG002|NOT COMPLETED|Overall Study||0
8900746|NCT02065895|9958172|FG003|NOT COMPLETED|Overall Study||1
8900747|NCT02065895|9958173|FG004|NOT COMPLETED|Overall Study||0
8900748|NCT02065895|9958174|FG005|NOT COMPLETED|Overall Study||0
8900749|NCT02066051|9958191|FG000|STARTED|Overall Study||8
8900750|NCT02066051|9958191|FG000|COMPLETED|Overall Study||7
8900751|NCT02066051|9958191|FG000|NOT COMPLETED|Overall Study||1
8900752|NCT02066129|9958197|FG000|STARTED|Overall Study||127
8900753|NCT02066129|9958198|FG001|STARTED|Overall Study||127
8900754|NCT02066129|9958197|FG000|COMPLETED|Overall Study||98
8900755|NCT02066129|9958198|FG001|COMPLETED|Overall Study||94
8900756|NCT02066129|9958197|FG000|NOT COMPLETED|Overall Study||29
8900757|NCT02066129|9958198|FG001|NOT COMPLETED|Overall Study||33
8900758|NCT02066233|9958206|FG000|STARTED|EG Scan II (Day 1)||50
8900759|NCT02066233|9958207|FG001|STARTED|EG Scan II (Day 1)||50
8900760|NCT02066233|9958206|FG000|COMPLETED|EG Scan II (Day 1)||44
8900761|NCT02066233|9958207|FG001|COMPLETED|EG Scan II (Day 1)||44
8900762|NCT02066233|9958206|FG000|NOT COMPLETED|EG Scan II (Day 1)||6
8900763|NCT02066233|9958207|FG001|NOT COMPLETED|EG Scan II (Day 1)||6
8900764|NCT02066233|9958206|FG000|STARTED|Standard Endoscopy (Day 2)||44
8900765|NCT02066233|9958207|FG001|STARTED|Standard Endoscopy (Day 2)||44
8900766|NCT02066233|9958206|FG000|COMPLETED|Standard Endoscopy (Day 2)||44
8900767|NCT02066233|9958207|FG001|COMPLETED|Standard Endoscopy (Day 2)||44
8900768|NCT02066233|9958206|FG000|NOT COMPLETED|Standard Endoscopy (Day 2)||0
8900769|NCT02066233|9958207|FG001|NOT COMPLETED|Standard Endoscopy (Day 2)||0
8900770|NCT02066298|9958219|FG000|STARTED|Overall Study||49
8900771|NCT02066298|9958220|FG001|STARTED|Overall Study||48
8900772|NCT02066298|9958221|FG002|STARTED|Overall Study||50
8900773|NCT02066298|9958222|FG003|STARTED|Overall Study||51
8900774|NCT02066298|9958223|FG004|STARTED|Overall Study||47
8900775|NCT02066298|9958224|FG005|STARTED|Overall Study||50
8900776|NCT02066298|9958219|FG000|Completed 1st Period|Overall Study||44
8900777|NCT02066298|9958220|FG001|Completed 1st Period|Overall Study||47
8900778|NCT02066298|9958221|FG002|Completed 1st Period|Overall Study||45
8900779|NCT02066298|9958222|FG003|Completed 1st Period|Overall Study||48
8900780|NCT02066298|9958223|FG004|Completed 1st Period|Overall Study||46
8900781|NCT02066298|9958224|FG005|Completed 1st Period|Overall Study||45
8900782|NCT02066298|9958219|FG000|Completed 2nd Period|Overall Study||41
8900783|NCT02066298|9958220|FG001|Completed 2nd Period|Overall Study||41
8900784|NCT02066298|9958221|FG002|Completed 2nd Period|Overall Study||41
8900785|NCT02066298|9958222|FG003|Completed 2nd Period|Overall Study||46
8900786|NCT02066298|9958223|FG004|Completed 2nd Period|Overall Study||42
8900787|NCT02066298|9958224|FG005|Completed 2nd Period|Overall Study||41
8900788|NCT02066298|9958219|FG000|Completed 3rd Period|Overall Study||40
8900789|NCT02066298|9958220|FG001|Completed 3rd Period|Overall Study||40
8900790|NCT02066298|9958221|FG002|Completed 3rd Period|Overall Study||40
8900791|NCT02066298|9958222|FG003|Completed 3rd Period|Overall Study||45
8900792|NCT02066298|9958223|FG004|Completed 3rd Period|Overall Study||38
8900793|NCT02066298|9958224|FG005|Completed 3rd Period|Overall Study||38
8900794|NCT02066298|9958219|FG000|COMPLETED|Overall Study||40
8900795|NCT02066298|9958220|FG001|COMPLETED|Overall Study||40
8900796|NCT02066298|9958221|FG002|COMPLETED|Overall Study||40
8900797|NCT02066298|9958222|FG003|COMPLETED|Overall Study||45
8900798|NCT02066298|9958223|FG004|COMPLETED|Overall Study||38
8900799|NCT02066298|9958224|FG005|COMPLETED|Overall Study||38
8900800|NCT02066298|9958219|FG000|NOT COMPLETED|Overall Study||9
8900801|NCT02066298|9958220|FG001|NOT COMPLETED|Overall Study||8
8900802|NCT02066298|9958221|FG002|NOT COMPLETED|Overall Study||10
8900803|NCT02066298|9958222|FG003|NOT COMPLETED|Overall Study||6
8900804|NCT02066298|9958223|FG004|NOT COMPLETED|Overall Study||9
8900805|NCT02066298|9958224|FG005|NOT COMPLETED|Overall Study||12
8900806|NCT02066311|9958236|FG000|STARTED|Overall Study||15
8900807|NCT02066311|9958236|FG000|COMPLETED|Overall Study|Stage 1 terminated 6/1/18 prior to completion of Stage 1 due to low enrollment and efficacy.|10
9009584|NCT02975297|10072495|FG000|STARTED|Overall Study||41
9009585|NCT02975297|10072496|FG001|STARTED|Overall Study||41
9009586|NCT02975297|10072495|FG000|COMPLETED|Overall Study||34
9009587|NCT02975297|10072496|FG001|COMPLETED|Overall Study||35
9009588|NCT02975297|10072495|FG000|NOT COMPLETED|Overall Study||7
9009589|NCT02975297|10072496|FG001|NOT COMPLETED|Overall Study||6
9009590|NCT02975336|10072506|FG000|STARTED|DBPC (52 Weeks)||117
9009591|NCT02975336|10072507|FG001|STARTED|DBPC (52 Weeks)||118
9009592|NCT02975336|10072508|FG002|STARTED|DBPC (52 Weeks)||117
9009593|NCT02975336|10072509|FG003|STARTED|DBPC (52 Weeks)||117
8572897|NCT00117637|9605077|FG000|NOT COMPLETED|Second Intervention (Period 2)||10
8572898|NCT00117637|9605078|FG001|NOT COMPLETED|Second Intervention (Period 2)||22
8572899|NCT00117676|9605093|FG000|STARTED|Double-blind Period Through Week 48||254
8572900|NCT00117676|9605094|FG001|STARTED|Double-blind Period Through Week 48||128
8572901|NCT00117676|9605093|FG000|COMPLETED|Double-blind Period Through Week 48||244
8572902|NCT00117676|9605094|FG001|COMPLETED|Double-blind Period Through Week 48||121
8572903|NCT00117676|9605093|FG000|NOT COMPLETED|Double-blind Period Through Week 48||10
8572904|NCT00117676|9605094|FG001|NOT COMPLETED|Double-blind Period Through Week 48||7
8572905|NCT00117676|9605093|FG000|STARTED|Open-label Period: Weeks 49 - 96|9 participants completed 48 weeks but did not continue on study.|235
8572906|NCT00117676|9605094|FG001|STARTED|Open-label Period: Weeks 49 - 96|9 participants completed 48 weeks but did not continue on study.|112
8572907|NCT00117676|9605093|FG000|COMPLETED|Open-label Period: Weeks 49 - 96||225
8572908|NCT00117676|9605094|FG001|COMPLETED|Open-label Period: Weeks 49 - 96||110
8572909|NCT00117676|9605093|FG000|NOT COMPLETED|Open-label Period: Weeks 49 - 96||10
8572910|NCT00117676|9605094|FG001|NOT COMPLETED|Open-label Period: Weeks 49 - 96||2
8572911|NCT00117676|9605093|FG000|STARTED|Open-label Period: Weeks 97 - 144||225
8572912|NCT00117676|9605094|FG001|STARTED|Open-label Period: Weeks 97 - 144||110
8572913|NCT00117676|9605093|FG000|COMPLETED|Open-label Period: Weeks 97 - 144||219
8572914|NCT00117676|9605094|FG001|COMPLETED|Open-label Period: Weeks 97 - 144||109
8572915|NCT00117676|9605093|FG000|NOT COMPLETED|Open-label Period: Weeks 97 - 144||6
8572916|NCT00117676|9605094|FG001|NOT COMPLETED|Open-label Period: Weeks 97 - 144||1
8572917|NCT00117676|9605093|FG000|STARTED|Open-label Period: Weeks 145 - 192||219
8572918|NCT00117676|9605094|FG001|STARTED|Open-label Period: Weeks 145 - 192||109
8572919|NCT00117676|9605093|FG000|COMPLETED|Open-label Period: Weeks 145 - 192||209
8572920|NCT00117676|9605094|FG001|COMPLETED|Open-label Period: Weeks 145 - 192||106
8572921|NCT00117676|9605093|FG000|NOT COMPLETED|Open-label Period: Weeks 145 - 192||10
8572922|NCT00117676|9605094|FG001|NOT COMPLETED|Open-label Period: Weeks 145 - 192||3
8572923|NCT00117676|9605093|FG000|STARTED|Open-label Period: Weeks 193 - 240||209
8572924|NCT00117676|9605094|FG001|STARTED|Open-label Period: Weeks 193 - 240||106
8572925|NCT00117676|9605093|FG000|COMPLETED|Open-label Period: Weeks 193 - 240||202
8572926|NCT00117676|9605094|FG001|COMPLETED|Open-label Period: Weeks 193 - 240||103
8572927|NCT00117676|9605093|FG000|NOT COMPLETED|Open-label Period: Weeks 193 - 240||7
8572928|NCT00117676|9605094|FG001|NOT COMPLETED|Open-label Period: Weeks 193 - 240||3
8572929|NCT00117676|9605093|FG000|STARTED|Open-label Period: Weeks 241 - 288||202
8572930|NCT00117676|9605094|FG001|STARTED|Open-label Period: Weeks 241 - 288||103
8572931|NCT00117676|9605093|FG000|COMPLETED|Open-label Period: Weeks 241 - 288||192
8572932|NCT00117676|9605094|FG001|COMPLETED|Open-label Period: Weeks 241 - 288||100
8572933|NCT00117676|9605093|FG000|NOT COMPLETED|Open-label Period: Weeks 241 - 288||10
8572934|NCT00117676|9605094|FG001|NOT COMPLETED|Open-label Period: Weeks 241 - 288||3
8577920|NCT00165841|9610862|FG001|COMPLETED|Overall Study||35
8635791|NCT00564447|9676302|FG000|NOT COMPLETED|Overall Study||0
9009594|NCT02975336|10072510|FG004|STARTED|DBPC (52 Weeks)||0
9009595|NCT02975336|10072511|FG005|STARTED|DBPC (52 Weeks)||0
9009596|NCT02975336|10072512|FG006|STARTED|DBPC (52 Weeks)||0
9009597|NCT02975336|10072513|FG007|STARTED|DBPC (52 Weeks)||0
8900808|NCT02066311|9958236|FG000|NOT COMPLETED|Overall Study||5
8900809|NCT02066389|9958246|FG000|STARTED|Overall Study||50
8900810|NCT02066389|9958247|FG001|STARTED|Overall Study||50
8900811|NCT02066389|9958248|FG002|STARTED|Overall Study||50
8900812|NCT02066389|9958249|FG003|STARTED|Overall Study||50
8900813|NCT02066389|9958250|FG004|STARTED|Overall Study||50
8900814|NCT02066389|9958251|FG005|STARTED|Overall Study||50
8900815|NCT02066389|9958246|FG000|Received Study Drug|Overall Study||50
8900816|NCT02066389|9958247|FG001|Received Study Drug|Overall Study||50
8900817|NCT02066389|9958248|FG002|Received Study Drug|Overall Study||50
8900818|NCT02066389|9958249|FG003|Received Study Drug|Overall Study||50
8900819|NCT02066389|9958250|FG004|Received Study Drug|Overall Study||50
8900820|NCT02066389|9958251|FG005|Received Study Drug|Overall Study||49
8900821|NCT02066389|9958246|FG000|COMPLETED|Overall Study||45
8900822|NCT02066389|9958247|FG001|COMPLETED|Overall Study||49
8900823|NCT02066389|9958248|FG002|COMPLETED|Overall Study||44
8900824|NCT02066389|9958249|FG003|COMPLETED|Overall Study||47
8900825|NCT02066389|9958250|FG004|COMPLETED|Overall Study||43
8900826|NCT02066389|9958251|FG005|COMPLETED|Overall Study||45
8900827|NCT02066389|9958246|FG000|NOT COMPLETED|Overall Study||5
8900828|NCT02066389|9958247|FG001|NOT COMPLETED|Overall Study||1
8900829|NCT02066389|9958248|FG002|NOT COMPLETED|Overall Study||6
8900830|NCT02066389|9958249|FG003|NOT COMPLETED|Overall Study||3
8900831|NCT02066389|9958250|FG004|NOT COMPLETED|Overall Study||7
8900832|NCT02066389|9958251|FG005|NOT COMPLETED|Overall Study||5
8900833|NCT02066402|9958267|FG000|STARTED|Overall Study||300
8900834|NCT02066402|9958268|FG001|STARTED|Overall Study||298
8900835|NCT02066402|9958267|FG000|Participants Received Treatment|Overall Study||292
8900836|NCT02066402|9958268|FG001|Participants Received Treatment|Overall Study||297
8900837|NCT02066402|9958267|FG000|Completed Study Treatment Period|Overall Study||261
8900838|NCT02066402|9958268|FG001|Completed Study Treatment Period|Overall Study||256
8900839|NCT02066402|9958267|FG000|COMPLETED|Overall Study||274
8900840|NCT02066402|9958268|FG001|COMPLETED|Overall Study||275
8900841|NCT02066402|9958267|FG000|NOT COMPLETED|Overall Study||26
8900842|NCT02066402|9958268|FG001|NOT COMPLETED|Overall Study||23
8900843|NCT02066467|9958274|FG000|STARTED|Overall Study||863
8900844|NCT02066467|9958274|FG000|COMPLETED|Overall Study||648
8900845|NCT02066467|9958274|FG000|NOT COMPLETED|Overall Study||215
8900846|NCT02066727|9958280|FG000|STARTED|Overall Study||30
8900847|NCT02066727|9958281|FG001|STARTED|Overall Study||30
8900848|NCT02066727|9958280|FG000|COMPLETED|Overall Study||30
8900849|NCT02066727|9958281|FG001|COMPLETED|Overall Study||30
8900850|NCT02066727|9958280|FG000|NOT COMPLETED|Overall Study||0
8900851|NCT02066727|9958281|FG001|NOT COMPLETED|Overall Study||0
8900852|NCT02066740|9958287|FG000|STARTED|Overall Study||34
8900853|NCT02066740|9958287|FG000|COMPLETED|Overall Study||32
8900854|NCT02066740|9958287|FG000|NOT COMPLETED|Overall Study||2
8900855|NCT02066792|9958295|FG000|STARTED|Overall Study||40
8900856|NCT02066792|9958296|FG001|STARTED|Overall Study||38
8900857|NCT02066792|9958297|FG002|STARTED|Overall Study||38
8900858|NCT02066792|9958298|FG003|STARTED|Overall Study||36
8900859|NCT02066792|9958295|FG000|COMPLETED|Overall Study||33
8900860|NCT02066792|9958296|FG001|COMPLETED|Overall Study||33
8900861|NCT02066792|9958297|FG002|COMPLETED|Overall Study||30
8900862|NCT02066792|9958298|FG003|COMPLETED|Overall Study||27
8900863|NCT02066792|9958295|FG000|NOT COMPLETED|Overall Study||7
8900864|NCT02066792|9958296|FG001|NOT COMPLETED|Overall Study||5
8900865|NCT02066792|9958297|FG002|NOT COMPLETED|Overall Study||8
8900866|NCT02066792|9958298|FG003|NOT COMPLETED|Overall Study||9
8900867|NCT02066857|9958310|FG000|STARTED|Overall Study||1
8900868|NCT02066857|9958311|FG001|STARTED|Overall Study||4
8900869|NCT02066857|9958310|FG000|COMPLETED|Overall Study||0
8900870|NCT02066857|9958311|FG001|COMPLETED|Overall Study||3
8900871|NCT02066857|9958310|FG000|NOT COMPLETED|Overall Study||1
8900872|NCT02066857|9958311|FG001|NOT COMPLETED|Overall Study||1
8900873|NCT02066896|9958320|FG000|STARTED|Overall Study||33
8900874|NCT02066896|9958321|FG001|STARTED|Overall Study||33
8900875|NCT02066896|9958320|FG000|COMPLETED|Overall Study||33
8900876|NCT02066896|9958321|FG001|COMPLETED|Overall Study||33
8900877|NCT02066896|9958320|FG000|NOT COMPLETED|Overall Study||0
8900878|NCT02066896|9958321|FG001|NOT COMPLETED|Overall Study||0
8900879|NCT02066922|9958327|FG000|STARTED|Overall Study||15
8900880|NCT02066922|9958327|FG000|COMPLETED|Overall Study||14
8900881|NCT02066922|9958327|FG000|NOT COMPLETED|Overall Study||1
8900882|NCT02067000|9958334|FG000|STARTED|Overall Study||217
8900883|NCT02067000|9958334|FG000|COMPLETED|Overall Study||167
9009598|NCT02975336|10072506|FG000|COMPLETED|DBPC (52 Weeks)||85
8900884|NCT02067000|9958334|FG000|NOT COMPLETED|Overall Study||50
8900885|NCT02067039|9958340|FG000|STARTED|Overall Study||1325
8900886|NCT02067039|9958341|FG001|STARTED|Overall Study||1340
8900887|NCT02067039|9958340|FG000|3 Month Survey|Overall Study||824
8900888|NCT02067039|9958341|FG001|3 Month Survey|Overall Study||766
8900889|NCT02067039|9958340|FG000|6 Month Survey|Overall Study||735
8900890|NCT02067039|9958341|FG001|6 Month Survey|Overall Study||756
9009599|NCT02975336|10072507|FG001|COMPLETED|DBPC (52 Weeks)||89
8900891|NCT02067039|9958340|FG000|9 Month Survey|Overall Study||748
8900892|NCT02067039|9958341|FG001|9 Month Survey|Overall Study||838
8900893|NCT02067039|9958340|FG000|COMPLETED|Overall Study||752
8900894|NCT02067039|9958341|FG001|COMPLETED|Overall Study||832
8900895|NCT02067039|9958340|FG000|NOT COMPLETED|Overall Study||573
8900896|NCT02067039|9958341|FG001|NOT COMPLETED|Overall Study||508
8900897|NCT02067273|9958351|FG000|STARTED|Overall Study||5
8900898|NCT02067273|9958352|FG001|STARTED|Overall Study||15
8900899|NCT02067273|9958351|FG000|COMPLETED|Overall Study||5
8900900|NCT02067273|9958352|FG001|COMPLETED|Overall Study||12
8900901|NCT02067273|9958351|FG000|NOT COMPLETED|Overall Study||0
8900902|NCT02067273|9958352|FG001|NOT COMPLETED|Overall Study||3
8900903|NCT02067468|9958361|FG000|STARTED|Overall Study||882
8900904|NCT02067468|9958362|FG001|STARTED|Overall Study||890
8900905|NCT02067468|9958363|FG002|STARTED|Overall Study||889
8900906|NCT02067468|9958361|FG000|Followed-up Through Medical Records|Overall Study||882
8900907|NCT02067468|9958362|FG001|Followed-up Through Medical Records|Overall Study||890
8900908|NCT02067468|9958363|FG002|Followed-up Through Medical Records|Overall Study||889
8900909|NCT02067468|9958361|FG000|Had at Least One Routine Colposcopy|Overall Study||772
8635792|NCT00564447|9676303|FG001|NOT COMPLETED|Overall Study||0
8635793|NCT00564447|9676304|FG002|NOT COMPLETED|Overall Study||0
8635794|NCT00564447|9676305|FG003|NOT COMPLETED|Overall Study||0
8635795|NCT00564447|9676306|FG004|NOT COMPLETED|Overall Study||0
8635796|NCT00564447|9676307|FG005|NOT COMPLETED|Overall Study||0
8635797|NCT00564447|9676308|FG006|NOT COMPLETED|Overall Study||0
8900910|NCT02067468|9958362|FG001|Had at Least One Routine Colposcopy|Overall Study||372
8900911|NCT02067468|9958363|FG002|Had at Least One Routine Colposcopy|Overall Study||462
8900912|NCT02067468|9958361|FG000|COMPLETED|Overall Study||882
8900913|NCT02067468|9958362|FG001|COMPLETED|Overall Study||890
8900914|NCT02067468|9958363|FG002|COMPLETED|Overall Study||889
8900915|NCT02067468|9958361|FG000|NOT COMPLETED|Overall Study||0
8900916|NCT02067468|9958362|FG001|NOT COMPLETED|Overall Study||0
8900917|NCT02067468|9958363|FG002|NOT COMPLETED|Overall Study||0
8900918|NCT02067533|9958373|FG000|STARTED|Overall Study||45
8900919|NCT02067533|9958374|FG001|STARTED|Overall Study||46
8900920|NCT02067533|9958373|FG000|COMPLETED|Overall Study||41
8900921|NCT02067533|9958374|FG001|COMPLETED|Overall Study||44
8900922|NCT02067533|9958373|FG000|NOT COMPLETED|Overall Study||4
8900923|NCT02067533|9958374|FG001|NOT COMPLETED|Overall Study||2
8900924|NCT02067585|9958383|FG000|STARTED|Overall Study||16
8900925|NCT02067585|9958384|FG001|STARTED|Overall Study||16
8900926|NCT02067585|9958385|FG002|STARTED|Overall Study||16
8900927|NCT02067585|9958383|FG000|COMPLETED|Overall Study||16
8900928|NCT02067585|9958384|FG001|COMPLETED|Overall Study||16
8900929|NCT02067585|9958385|FG002|COMPLETED|Overall Study||16
8900930|NCT02067585|9958383|FG000|NOT COMPLETED|Overall Study||0
8900931|NCT02067585|9958384|FG001|NOT COMPLETED|Overall Study||0
8900932|NCT02067585|9958385|FG002|NOT COMPLETED|Overall Study||0
8900933|NCT02067663|9958395|FG000|STARTED|Overall Study||68
8900934|NCT02067663|9958396|FG001|STARTED|Overall Study||55
8900935|NCT02067663|9958395|FG000|COMPLETED|Overall Study||55
8900936|NCT02067663|9958396|FG001|COMPLETED|Overall Study||41
8900937|NCT02067663|9958395|FG000|NOT COMPLETED|Overall Study||13
8900938|NCT02067663|9958396|FG001|NOT COMPLETED|Overall Study||14
8900939|NCT02067676|9958408|FG000|STARTED|Overall Study||8
8900940|NCT02067676|9958409|FG001|STARTED|Overall Study||8
8900941|NCT02067676|9958410|FG002|STARTED|Overall Study||8
8900942|NCT02067676|9958411|FG003|STARTED|Overall Study||8
8635798|NCT00564447|9676309|FG007|NOT COMPLETED|Overall Study||0
8635799|NCT00564486|9676330|FG000|STARTED|Overall Study||43
8635800|NCT00564486|9676331|FG001|STARTED|Overall Study|One subject was randomized to receive 1 g IVAPAP but was administered 650 mg IV in error|92
8635801|NCT00564486|9676332|FG002|STARTED|Overall Study|One subject randomized to receive 1 g IVAPAP but was administered 650 mg IV in error|42
8635802|NCT00564486|9676333|FG003|STARTED|Overall Study||67
8635803|NCT00564486|9676330|FG000|COMPLETED|Overall Study|Includes all subjects who returned to clinic for Day 7 visit.|36
8635804|NCT00564486|9676331|FG001|COMPLETED|Overall Study|Includes all subjects who returned to clinic for Day 7 visit.|91
8635805|NCT00564486|9676332|FG002|COMPLETED|Overall Study|Includes all subjects who returned to clinic for Day 7 visit.|39
8635806|NCT00564486|9676333|FG003|COMPLETED|Overall Study||60
8900943|NCT02067676|9958412|FG004|STARTED|Overall Study||8
8900944|NCT02067676|9958413|FG005|STARTED|Overall Study||8
8900945|NCT02067676|9958408|FG000|COMPLETED|Overall Study||7
9009600|NCT02975336|10072508|FG002|COMPLETED|DBPC (52 Weeks)||90
9009601|NCT02975336|10072509|FG003|COMPLETED|DBPC (52 Weeks)||84
9009602|NCT02975336|10072510|FG004|COMPLETED|DBPC (52 Weeks)||0
9009603|NCT02975336|10072511|FG005|COMPLETED|DBPC (52 Weeks)||0
9009604|NCT02975336|10072512|FG006|COMPLETED|DBPC (52 Weeks)||0
9009605|NCT02975336|10072513|FG007|COMPLETED|DBPC (52 Weeks)||0
9009606|NCT02975336|10072506|FG000|NOT COMPLETED|DBPC (52 Weeks)||32
9009607|NCT02975336|10072507|FG001|NOT COMPLETED|DBPC (52 Weeks)||29
9009608|NCT02975336|10072508|FG002|NOT COMPLETED|DBPC (52 Weeks)||27
9009609|NCT02975336|10072509|FG003|NOT COMPLETED|DBPC (52 Weeks)||33
9009610|NCT02975336|10072510|FG004|NOT COMPLETED|DBPC (52 Weeks)||0
9009611|NCT02975336|10072511|FG005|NOT COMPLETED|DBPC (52 Weeks)||0
9009612|NCT02975336|10072512|FG006|NOT COMPLETED|DBPC (52 Weeks)||0
9009613|NCT02975336|10072513|FG007|NOT COMPLETED|DBPC (52 Weeks)||0
9009614|NCT02975336|10072506|FG000|STARTED|LTE (104 Weeks)||0
8635807|NCT00564486|9676330|FG000|NOT COMPLETED|Overall Study||7
8900946|NCT02067676|9958409|FG001|COMPLETED|Overall Study||8
8900947|NCT02067676|9958410|FG002|COMPLETED|Overall Study||8
8900948|NCT02067676|9958411|FG003|COMPLETED|Overall Study||8
8900949|NCT02067676|9958412|FG004|COMPLETED|Overall Study||8
8900950|NCT02067676|9958413|FG005|COMPLETED|Overall Study||8
9009615|NCT02975336|10072507|FG001|STARTED|LTE (104 Weeks)||0
9009616|NCT02975336|10072508|FG002|STARTED|LTE (104 Weeks)||0
8900951|NCT02067676|9958408|FG000|NOT COMPLETED|Overall Study||1
8900952|NCT02067676|9958409|FG001|NOT COMPLETED|Overall Study||0
8900953|NCT02067676|9958410|FG002|NOT COMPLETED|Overall Study||0
8900954|NCT02067676|9958411|FG003|NOT COMPLETED|Overall Study||0
8900955|NCT02067676|9958412|FG004|NOT COMPLETED|Overall Study||0
8900956|NCT02067676|9958413|FG005|NOT COMPLETED|Overall Study||0
8900957|NCT02067728|9958434|FG000|STARTED|Baseline - 1 Month Follow up Survey||220
8900958|NCT02067728|9958435|FG001|STARTED|Baseline - 1 Month Follow up Survey||210
8900959|NCT02067728|9958434|FG000|COMPLETED|Baseline - 1 Month Follow up Survey|213 parents/guardians completed the surveys, along with 82 teens.|213
8900960|NCT02067728|9958435|FG001|COMPLETED|Baseline - 1 Month Follow up Survey|182 parent/guardians completed the surveys, along with 75 teens.|182
8900961|NCT02067728|9958434|FG000|NOT COMPLETED|Baseline - 1 Month Follow up Survey||7
8900962|NCT02067728|9958435|FG001|NOT COMPLETED|Baseline - 1 Month Follow up Survey||28
8900963|NCT02067728|9958434|FG000|STARTED|6 Month Follow up Survey|Participants completed the 6 month follow up even if 1 month data wasn't able to be collected.|220
8900964|NCT02067728|9958435|FG001|STARTED|6 Month Follow up Survey|Participants completed the 6 month follow up even if 1 month data wasn't able to be collected.|210
9009617|NCT02975336|10072509|FG003|STARTED|LTE (104 Weeks)||0
9009618|NCT02975336|10072510|FG004|STARTED|LTE (104 Weeks)||62
9009619|NCT02975336|10072511|FG005|STARTED|LTE (104 Weeks)||69
9009620|NCT02975336|10072512|FG006|STARTED|LTE (104 Weeks)||80
9009621|NCT02975336|10072513|FG007|STARTED|LTE (104 Weeks)||72
9009622|NCT02975336|10072506|FG000|COMPLETED|LTE (104 Weeks)||0
9009623|NCT02975336|10072507|FG001|COMPLETED|LTE (104 Weeks)||0
9009624|NCT02975336|10072508|FG002|COMPLETED|LTE (104 Weeks)||0
9009625|NCT02975336|10072509|FG003|COMPLETED|LTE (104 Weeks)||0
9009626|NCT02975336|10072510|FG004|COMPLETED|LTE (104 Weeks)||0
9009627|NCT02975336|10072511|FG005|COMPLETED|LTE (104 Weeks)||0
8635808|NCT00564486|9676331|FG001|NOT COMPLETED|Overall Study||1
8635809|NCT00564486|9676332|FG002|NOT COMPLETED|Overall Study||3
8635810|NCT00564486|9676333|FG003|NOT COMPLETED|Overall Study||7
8635811|NCT00564629|9676349|FG000|STARTED|Overall Study||51
8635812|NCT00564629|9676350|FG001|STARTED|Overall Study||54
8635813|NCT00564629|9676349|FG000|COMPLETED|Overall Study||36
8635814|NCT00564629|9676350|FG001|COMPLETED|Overall Study||45
8635815|NCT00564629|9676349|FG000|NOT COMPLETED|Overall Study||15
8635816|NCT00564629|9676350|FG001|NOT COMPLETED|Overall Study||9
8635817|NCT00564681|9676360|FG000|STARTED|Overall Study||117
8635818|NCT00564681|9676361|FG001|STARTED|Overall Study||61
8635819|NCT00564681|9676362|FG002|STARTED|Overall Study||43
9009628|NCT02975336|10072512|FG006|COMPLETED|LTE (104 Weeks)||0
9009629|NCT02975336|10072513|FG007|COMPLETED|LTE (104 Weeks)||0
9009630|NCT02975336|10072506|FG000|NOT COMPLETED|LTE (104 Weeks)||0
9009631|NCT02975336|10072507|FG001|NOT COMPLETED|LTE (104 Weeks)||0
9009632|NCT02975336|10072508|FG002|NOT COMPLETED|LTE (104 Weeks)||0
9009633|NCT02975336|10072509|FG003|NOT COMPLETED|LTE (104 Weeks)||0
9009634|NCT02975336|10072510|FG004|NOT COMPLETED|LTE (104 Weeks)||62
9009635|NCT02975336|10072511|FG005|NOT COMPLETED|LTE (104 Weeks)||69
9009636|NCT02975336|10072512|FG006|NOT COMPLETED|LTE (104 Weeks)||80
9009637|NCT02975336|10072513|FG007|NOT COMPLETED|LTE (104 Weeks)||72
9009638|NCT02975349|10072532|FG000|STARTED|Active Treatment Period (24 Weeks)||54
9009639|NCT02975349|10072533|FG001|STARTED|Active Treatment Period (24 Weeks)||0
9009640|NCT02975349|10072534|FG002|STARTED|Active Treatment Period (24 Weeks)||52
9009641|NCT02975349|10072535|FG003|STARTED|Active Treatment Period (24 Weeks)||53
9009642|NCT02975349|10072536|FG004|STARTED|Active Treatment Period (24 Weeks)||54
9009643|NCT02975349|10072537|FG005|STARTED|Active Treatment Period (24 Weeks)||54
9009644|NCT02975349|10072532|FG000|COMPLETED|Active Treatment Period (24 Weeks)||49
9009645|NCT02975349|10072533|FG001|COMPLETED|Active Treatment Period (24 Weeks)||0
9009646|NCT02975349|10072534|FG002|COMPLETED|Active Treatment Period (24 Weeks)||47
9009647|NCT02975349|10072535|FG003|COMPLETED|Active Treatment Period (24 Weeks)||48
9009648|NCT02975349|10072536|FG004|COMPLETED|Active Treatment Period (24 Weeks)||48
9009649|NCT02975349|10072537|FG005|COMPLETED|Active Treatment Period (24 Weeks)||52
9009650|NCT02975349|10072532|FG000|NOT COMPLETED|Active Treatment Period (24 Weeks)||5
9009651|NCT02975349|10072533|FG001|NOT COMPLETED|Active Treatment Period (24 Weeks)||0
9009652|NCT02975349|10072534|FG002|NOT COMPLETED|Active Treatment Period (24 Weeks)||5
9009653|NCT02975349|10072535|FG003|NOT COMPLETED|Active Treatment Period (24 Weeks)||5
9009654|NCT02975349|10072536|FG004|NOT COMPLETED|Active Treatment Period (24 Weeks)||6
9009655|NCT02975349|10072537|FG005|NOT COMPLETED|Active Treatment Period (24 Weeks)||2
9009656|NCT02975349|10072532|FG000|STARTED|Blinded Extension Period (24 Weeks)||0
9009657|NCT02975349|10072533|FG001|STARTED|Blinded Extension Period (24 Weeks)||49
9009658|NCT02975349|10072534|FG002|STARTED|Blinded Extension Period (24 Weeks)||47
9009659|NCT02975349|10072535|FG003|STARTED|Blinded Extension Period (24 Weeks)||48
9009660|NCT02975349|10072536|FG004|STARTED|Blinded Extension Period (24 Weeks)||48
9009661|NCT02975349|10072537|FG005|STARTED|Blinded Extension Period (24 Weeks)||52
9009662|NCT02975349|10072532|FG000|COMPLETED|Blinded Extension Period (24 Weeks)||0
9009663|NCT02975349|10072533|FG001|COMPLETED|Blinded Extension Period (24 Weeks)||42
9009664|NCT02975349|10072534|FG002|COMPLETED|Blinded Extension Period (24 Weeks)||43
9009665|NCT02975349|10072535|FG003|COMPLETED|Blinded Extension Period (24 Weeks)||44
9009666|NCT02975349|10072536|FG004|COMPLETED|Blinded Extension Period (24 Weeks)||46
9009667|NCT02975349|10072537|FG005|COMPLETED|Blinded Extension Period (24 Weeks)||52
8635820|NCT00564681|9676363|FG003|STARTED|Overall Study||21
8635821|NCT00564681|9676360|FG000|COMPLETED|Overall Study||106
8635822|NCT00564681|9676361|FG001|COMPLETED|Overall Study||58
8635823|NCT00564681|9676362|FG002|COMPLETED|Overall Study||40
8635824|NCT00564681|9676363|FG003|COMPLETED|Overall Study||19
8900965|NCT02067728|9958434|FG000|COMPLETED|6 Month Follow up Survey|172 parent/guardians completed surveys at this time point, along with 71 teens.|172
8900966|NCT02067728|9958435|FG001|COMPLETED|6 Month Follow up Survey|150 parent/guardians completed surveys at this time point, along with 69 teens.|150
8900967|NCT02067728|9958434|FG000|NOT COMPLETED|6 Month Follow up Survey||48
8900968|NCT02067728|9958435|FG001|NOT COMPLETED|6 Month Follow up Survey||60
8900969|NCT02067728|9958434|FG000|STARTED|6 Month Measurements||220
8900970|NCT02067728|9958435|FG001|STARTED|6 Month Measurements||210
8900971|NCT02067728|9958434|FG000|COMPLETED|6 Month Measurements|Number includes 6 month measurements & chart review for visits at 6 months +/- 2 months from initial|106
8900972|NCT02067728|9958435|FG001|COMPLETED|6 Month Measurements|Number includes 6 month measurements & chart review for visits at 6 months +/- 2 months from initial|113
8900973|NCT02067728|9958434|FG000|NOT COMPLETED|6 Month Measurements||114
8900974|NCT02067728|9958435|FG001|NOT COMPLETED|6 Month Measurements||97
8900975|NCT02067806|9958441|FG000|STARTED|Overall Study||394
8900976|NCT02067806|9958441|FG000|COMPLETED|Overall Study||387
8900977|NCT02067806|9958441|FG000|NOT COMPLETED|Overall Study||7
8900978|NCT02067858|9958446|FG000|STARTED|Overall Study||6
8900979|NCT02067858|9958446|FG000|COMPLETED|Overall Study||6
8900980|NCT02067858|9958446|FG000|NOT COMPLETED|Overall Study||0
8900981|NCT02068027|9958452|FG000|STARTED|Overall Study||130
8900982|NCT02068027|9958453|FG001|STARTED|Overall Study||130
8900983|NCT02068027|9958452|FG000|COMPLETED|Overall Study||117
8900984|NCT02068027|9958453|FG001|COMPLETED|Overall Study||114
8900985|NCT02068027|9958452|FG000|NOT COMPLETED|Overall Study||13
8900986|NCT02068027|9958453|FG001|NOT COMPLETED|Overall Study||16
8900987|NCT02068118|9958461|FG000|STARTED|18-month Comparative Study Period||455
8900988|NCT02068118|9958462|FG001|STARTED|18-month Comparative Study Period||482
8900989|NCT02068118|9958461|FG000|COMPLETED|18-month Comparative Study Period||327
8900990|NCT02068118|9958462|FG001|COMPLETED|18-month Comparative Study Period||305
8900991|NCT02068118|9958461|FG000|NOT COMPLETED|18-month Comparative Study Period||128
8900992|NCT02068118|9958462|FG001|NOT COMPLETED|18-month Comparative Study Period||177
8900993|NCT02068118|9958461|FG000|STARTED|Extension Period|Standard Care/Tele-cardiology : Patients entered Period 2 if they wished and consented|7
8900994|NCT02068118|9958462|FG001|STARTED|Extension Period|Tele-cardiology/Tele-cardiology : Patients entered Period 2 if they wished and consented|13
8900995|NCT02068118|9958461|FG000|COMPLETED|Extension Period||5
8900996|NCT02068118|9958462|FG001|COMPLETED|Extension Period||10
8900997|NCT02068118|9958461|FG000|NOT COMPLETED|Extension Period||2
8900998|NCT02068118|9958462|FG001|NOT COMPLETED|Extension Period||3
8900999|NCT02068157|9958470|FG000|STARTED|Overall Study||3
8901000|NCT02068157|9958470|FG000|COMPLETED|Overall Study||3
8901001|NCT02068157|9958470|FG000|NOT COMPLETED|Overall Study||0
8901002|NCT02068222|9958474|FG000|STARTED|Overall Study||10
8901003|NCT02068222|9958474|FG000|COMPLETED|Overall Study||9
8901004|NCT02068222|9958474|FG000|NOT COMPLETED|Overall Study||1
8901005|NCT02068352|9958481|FG000|STARTED|Overall Study||41
8901006|NCT02068352|9958482|FG001|STARTED|Overall Study||43
8901007|NCT02068352|9958483|FG002|STARTED|Overall Study||37
8901008|NCT02068352|9958481|FG000|COMPLETED|Overall Study||31
8901009|NCT02068352|9958482|FG001|COMPLETED|Overall Study||35
8901010|NCT02068352|9958483|FG002|COMPLETED|Overall Study||28
8901011|NCT02068352|9958481|FG000|NOT COMPLETED|Overall Study||10
8901012|NCT02068352|9958482|FG001|NOT COMPLETED|Overall Study||8
8901013|NCT02068352|9958483|FG002|NOT COMPLETED|Overall Study||9
8901014|NCT02068443|9958494|FG000|STARTED|Overall Study||71
8901015|NCT02068443|9958495|FG001|STARTED|Overall Study||152
8901016|NCT02068443|9958496|FG002|STARTED|Overall Study||151
8901017|NCT02068443|9958494|FG000|COMPLETED|Overall Study||64
8901018|NCT02068443|9958495|FG001|COMPLETED|Overall Study||146
8901019|NCT02068443|9958496|FG002|COMPLETED|Overall Study||148
8901020|NCT02068443|9958494|FG000|NOT COMPLETED|Overall Study||7
8901021|NCT02068443|9958495|FG001|NOT COMPLETED|Overall Study||6
8901022|NCT02068443|9958496|FG002|NOT COMPLETED|Overall Study||3
8901023|NCT02068495|9958504|FG000|STARTED|Overall Study||3409
8901024|NCT02068495|9958504|FG000|COMPLETED|Overall Study||3300
8901025|NCT02068495|9958504|FG000|NOT COMPLETED|Overall Study||109
8901026|NCT02068508|9958508|FG000|STARTED|Overall Study||1067
8901027|NCT02068508|9958508|FG000|COMPLETED|Overall Study||1035
8901028|NCT02068508|9958508|FG000|NOT COMPLETED|Overall Study||32
8901029|NCT02068599|9958515|FG000|STARTED|Overall Study||130
8901030|NCT02068599|9958516|FG001|STARTED|Overall Study||129
8901031|NCT02068599|9958517|FG002|STARTED|Overall Study||130
8901032|NCT02068599|9958515|FG000|Safety Analysis Set|Overall Study|One participant withdrew before taking any study drug.|129
8901033|NCT02068599|9958516|FG001|Safety Analysis Set|Overall Study|One participant withdrew before taking any study drug.|128
8901034|NCT02068599|9958517|FG002|Safety Analysis Set|Overall Study||130
8901035|NCT02068599|9958515|FG000|Full Analysis Set|Overall Study||129
8901036|NCT02068599|9958516|FG001|Full Analysis Set|Overall Study||128
8901037|NCT02068599|9958517|FG002|Full Analysis Set|Overall Study||130
8901038|NCT02068599|9958515|FG000|COMPLETED|Overall Study||119
8901039|NCT02068599|9958516|FG001|COMPLETED|Overall Study||119
8901040|NCT02068599|9958517|FG002|COMPLETED|Overall Study||117
8901041|NCT02068599|9958515|FG000|NOT COMPLETED|Overall Study||11
8901042|NCT02068599|9958516|FG001|NOT COMPLETED|Overall Study||10
8901043|NCT02068599|9958517|FG002|NOT COMPLETED|Overall Study||13
8901044|NCT02068729|9958525|FG000|STARTED|Overall Study||131
8901045|NCT02068729|9958525|FG000|COMPLETED|Overall Study||56
8901046|NCT02068729|9958525|FG000|NOT COMPLETED|Overall Study||75
8901047|NCT02068768|9958584|FG000|STARTED|Overall Study||13
8635825|NCT00564681|9676360|FG000|NOT COMPLETED|Overall Study||11
8635826|NCT00564681|9676361|FG001|NOT COMPLETED|Overall Study||3
8635827|NCT00564681|9676362|FG002|NOT COMPLETED|Overall Study||3
8901048|NCT02068768|9958584|FG000|COMPLETED|Overall Study||6
8901049|NCT02068768|9958584|FG000|NOT COMPLETED|Overall Study||7
8901050|NCT02068820|9958590|FG000|STARTED|Overall Study||20
8901051|NCT02068820|9958591|FG001|STARTED|Overall Study||180
8901052|NCT02068820|9958590|FG000|COMPLETED|Overall Study||20
8901053|NCT02068820|9958591|FG001|COMPLETED|Overall Study||180
8901054|NCT02068820|9958590|FG000|NOT COMPLETED|Overall Study||0
8901055|NCT02068820|9958591|FG001|NOT COMPLETED|Overall Study||0
8901056|NCT02068846|9958604|FG000|STARTED|Overall Study||9
8901057|NCT02068846|9958605|FG001|STARTED|Overall Study||8
9009668|NCT02975349|10072532|FG000|NOT COMPLETED|Blinded Extension Period (24 Weeks)||0
9009669|NCT02975349|10072533|FG001|NOT COMPLETED|Blinded Extension Period (24 Weeks)||7
9009670|NCT02975349|10072534|FG002|NOT COMPLETED|Blinded Extension Period (24 Weeks)||4
9009671|NCT02975349|10072535|FG003|NOT COMPLETED|Blinded Extension Period (24 Weeks)||4
9009672|NCT02975349|10072536|FG004|NOT COMPLETED|Blinded Extension Period (24 Weeks)||2
9009673|NCT02975349|10072537|FG005|NOT COMPLETED|Blinded Extension Period (24 Weeks)||0
9009674|NCT02975557|10072559|FG000|STARTED|Overall Study||4
9009675|NCT02975557|10072560|FG001|STARTED|Overall Study||5
9009676|NCT02975557|10072561|FG002|STARTED|Overall Study||6
9009677|NCT02975557|10072559|FG000|COMPLETED|Overall Study||3
9009678|NCT02975557|10072560|FG001|COMPLETED|Overall Study||2
9009679|NCT02975557|10072561|FG002|COMPLETED|Overall Study||5
9009680|NCT02975557|10072559|FG000|NOT COMPLETED|Overall Study||1
9009681|NCT02975557|10072560|FG001|NOT COMPLETED|Overall Study||3
9009682|NCT02975557|10072561|FG002|NOT COMPLETED|Overall Study||1
9009683|NCT02975804|10072571|FG000|STARTED|Overall Study||9
9009684|NCT02975804|10072572|FG001|STARTED|Overall Study||9
9009685|NCT02975804|10072571|FG000|COMPLETED|Overall Study||9
9009686|NCT02975804|10072572|FG001|COMPLETED|Overall Study||9
9009687|NCT02975804|10072571|FG000|NOT COMPLETED|Overall Study||0
9009688|NCT02975804|10072572|FG001|NOT COMPLETED|Overall Study||0
9009689|NCT02975973|10072582|FG000|STARTED|Overall Study||1
9009690|NCT02975973|10072583|FG001|STARTED|Overall Study||2
9009691|NCT02975973|10072584|FG002|STARTED|Overall Study||1
9009692|NCT02975973|10072585|FG003|STARTED|Overall Study||4
9009693|NCT02975973|10072582|FG000|COMPLETED|Overall Study||0
9009694|NCT02975973|10072583|FG001|COMPLETED|Overall Study||1
9009695|NCT02975973|10072584|FG002|COMPLETED|Overall Study||0
9009696|NCT02975973|10072585|FG003|COMPLETED|Overall Study||4
9009697|NCT02975973|10072582|FG000|NOT COMPLETED|Overall Study||1
9009698|NCT02975973|10072583|FG001|NOT COMPLETED|Overall Study||1
9009699|NCT02975973|10072584|FG002|NOT COMPLETED|Overall Study||1
9009700|NCT02975973|10072585|FG003|NOT COMPLETED|Overall Study||0
9009701|NCT02976103|10072597|FG000|STARTED|Overall Study||67
9009702|NCT02976103|10072598|FG001|STARTED|Overall Study||72
9009703|NCT02976103|10072597|FG000|COMPLETED|Overall Study|54 participants answered final (T3) questionnaire|54
9009704|NCT02976103|10072598|FG001|COMPLETED|Overall Study|64 participants answered final (T3 questionnaire)|64
9009705|NCT02976103|10072597|FG000|NOT COMPLETED|Overall Study||13
9009706|NCT02976103|10072598|FG001|NOT COMPLETED|Overall Study||8
9009707|NCT02976181|10072605|FG000|STARTED|Overall Study||113
9009708|NCT02976181|10072605|FG000|COMPLETED|Overall Study||112
9009709|NCT02976181|10072605|FG000|NOT COMPLETED|Overall Study||1
9009710|NCT02976519|10072617|FG000|STARTED|Treatment Period 1 (Part 1 and Part 2)||8
9009711|NCT02976519|10072618|FG001|STARTED|Treatment Period 1 (Part 1 and Part 2)||8
9009712|NCT02976519|10072619|FG002|STARTED|Treatment Period 1 (Part 1 and Part 2)||8
9009713|NCT02976519|10072620|FG003|STARTED|Treatment Period 1 (Part 1 and Part 2)||8
9009714|NCT02976519|10072621|FG004|STARTED|Treatment Period 1 (Part 1 and Part 2)||8
9009715|NCT02976519|10072622|FG005|STARTED|Treatment Period 1 (Part 1 and Part 2)||12
9009716|NCT02976519|10072623|FG006|STARTED|Treatment Period 1 (Part 1 and Part 2)||12
9009717|NCT02976519|10072617|FG000|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||8
9009718|NCT02976519|10072618|FG001|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||7
9009719|NCT02976519|10072619|FG002|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||8
9009720|NCT02976519|10072620|FG003|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||7
9009721|NCT02976519|10072621|FG004|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||8
8635828|NCT00564681|9676363|FG003|NOT COMPLETED|Overall Study||2
8901058|NCT02068846|9958604|FG000|COMPLETED|Overall Study||8
8901059|NCT02068846|9958605|FG001|COMPLETED|Overall Study||7
8901060|NCT02068846|9958604|FG000|NOT COMPLETED|Overall Study||1
8901061|NCT02068846|9958605|FG001|NOT COMPLETED|Overall Study||1
9009722|NCT02976519|10072622|FG005|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||12
9009723|NCT02976519|10072623|FG006|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||12
9009724|NCT02976519|10072617|FG000|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0
9009725|NCT02976519|10072618|FG001|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||1
9009726|NCT02976519|10072619|FG002|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0
9009727|NCT02976519|10072620|FG003|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||1
9009728|NCT02976519|10072621|FG004|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0
9009729|NCT02976519|10072622|FG005|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0
9009730|NCT02976519|10072623|FG006|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0
9009731|NCT02976519|10072617|FG000|STARTED|Wash-out Period (Part 2 Only)||0
8635829|NCT00564733|9676372|FG000|STARTED|Overall Study||55
8635830|NCT00564733|9676372|FG000|COMPLETED|Overall Study||46
8901062|NCT02068885|9958614|FG000|STARTED|Overall Study||57
8901063|NCT02068885|9958615|FG001|STARTED|Overall Study||53
8901064|NCT02068885|9958616|FG002|STARTED|Overall Study||54
8901065|NCT02068885|9958614|FG000|Provided Data at Midpoint Test Phase|Overall Study||56
8901066|NCT02068885|9958615|FG001|Provided Data at Midpoint Test Phase|Overall Study||50
8901067|NCT02068885|9958616|FG002|Provided Data at Midpoint Test Phase|Overall Study||48
8901068|NCT02068885|9958614|FG000|Provided Data at End of Test Phase|Overall Study||54
8901069|NCT02068885|9958615|FG001|Provided Data at End of Test Phase|Overall Study||48
8901070|NCT02068885|9958616|FG002|Provided Data at End of Test Phase|Overall Study||46
8901071|NCT02068885|9958614|FG000|Included in Intention-to-treat Analysis|Overall Study||56
8901072|NCT02068885|9958615|FG001|Included in Intention-to-treat Analysis|Overall Study||52
8901073|NCT02068885|9958616|FG002|Included in Intention-to-treat Analysis|Overall Study||54
8901074|NCT02068885|9958614|FG000|COMPLETED|Overall Study||54
8901075|NCT02068885|9958615|FG001|COMPLETED|Overall Study||48
8901076|NCT02068885|9958616|FG002|COMPLETED|Overall Study||46
8901077|NCT02068885|9958614|FG000|NOT COMPLETED|Overall Study||3
8901078|NCT02068885|9958615|FG001|NOT COMPLETED|Overall Study||5
8901079|NCT02068885|9958616|FG002|NOT COMPLETED|Overall Study||8
8901080|NCT02069015|9958627|FG000|STARTED|Overall Study|Baseline and enrollment at Emergency Department (ED)|71
8901081|NCT02069015|9958628|FG001|STARTED|Overall Study||68
8901082|NCT02069015|9958627|FG000|7 Day|Overall Study|7 day post ED discharge at Clinical Research Center (CRC)|44
8901083|NCT02069015|9958628|FG001|7 Day|Overall Study|7 day post ED discharge at CRC|45
8901084|NCT02069015|9958627|FG000|30 Day|Overall Study|30 day post-discharge at CRC|38
8901085|NCT02069015|9958628|FG001|30 Day|Overall Study|30 day post-discharge at CRC|43
8901086|NCT02069015|9958627|FG000|90 Day|Overall Study|90 day post ED discharge at CRC|32
8901087|NCT02069015|9958628|FG001|90 Day|Overall Study|90 day post ED discharge|35
8901088|NCT02069015|9958627|FG000|COMPLETED|Overall Study|180 post ED discharge at CRC|31
8901089|NCT02069015|9958628|FG001|COMPLETED|Overall Study|180 day post ED discharge at CRC|35
8901090|NCT02069015|9958627|FG000|NOT COMPLETED|Overall Study||40
8901091|NCT02069015|9958628|FG001|NOT COMPLETED|Overall Study||33
8901092|NCT02069041|9958635|FG000|STARTED|Overall Study||8
8901093|NCT02069041|9958635|FG000|Received at Least One Dose of Study Drug|Overall Study||8
8901094|NCT02069041|9958635|FG000|COMPLETED|Overall Study||8
8901095|NCT02069041|9958635|FG000|NOT COMPLETED|Overall Study||0
8901096|NCT02069093|9958639|FG000|STARTED|Overall Study||86
8901097|NCT02069093|9958639|FG000|Pharmacokinetic Analysis Set|Overall Study||50
8901098|NCT02069093|9958639|FG000|COMPLETED|Overall Study||56
8901099|NCT02069093|9958639|FG000|NOT COMPLETED|Overall Study||30
8901100|NCT02069119|9958647|FG000|STARTED|Overall Study||20
8901101|NCT02069119|9958648|FG001|STARTED|Overall Study||4
8901102|NCT02069119|9958649|FG002|STARTED|Overall Study||20
8901103|NCT02069119|9958650|FG003|STARTED|Overall Study||4
8901104|NCT02069119|9958647|FG000|COMPLETED|Overall Study||20
8901105|NCT02069119|9958648|FG001|COMPLETED|Overall Study||4
8901106|NCT02069119|9958649|FG002|COMPLETED|Overall Study||20
8901107|NCT02069119|9958650|FG003|COMPLETED|Overall Study||4
8901108|NCT02069119|9958647|FG000|NOT COMPLETED|Overall Study||0
8901109|NCT02069119|9958648|FG001|NOT COMPLETED|Overall Study||0
8901110|NCT02069119|9958649|FG002|NOT COMPLETED|Overall Study||0
8901111|NCT02069119|9958650|FG003|NOT COMPLETED|Overall Study||0
8901112|NCT02069184|9958664|FG000|STARTED|Overall Study||33
8901113|NCT02069184|9958665|FG001|STARTED|Overall Study||33
8901114|NCT02069184|9958664|FG000|COMPLETED|Overall Study||27
8901115|NCT02069184|9958665|FG001|COMPLETED|Overall Study||31
8901116|NCT02069184|9958664|FG000|NOT COMPLETED|Overall Study||6
8901117|NCT02069184|9958665|FG001|NOT COMPLETED|Overall Study||2
8901118|NCT02069353|9958671|FG000|STARTED|Overall Study||4
8901119|NCT02069353|9958671|FG000|COMPLETED|Overall Study||4
8901120|NCT02069353|9958671|FG000|NOT COMPLETED|Overall Study||0
8901121|NCT02069379|9958677|FG000|STARTED|Baseline Measurements||30
8901122|NCT02069379|9958678|FG001|STARTED|Baseline Measurements||4
8901123|NCT02069379|9958679|FG002|STARTED|Baseline Measurements||2
8901124|NCT02069379|9958680|FG003|STARTED|Baseline Measurements||6
8901125|NCT02069379|9958677|FG000|Baseline Measurements Taken|Baseline Measurements||30
8901126|NCT02069379|9958678|FG001|Baseline Measurements Taken|Baseline Measurements||4
8901127|NCT02069379|9958679|FG002|Baseline Measurements Taken|Baseline Measurements||2
8901128|NCT02069379|9958680|FG003|Baseline Measurements Taken|Baseline Measurements||6
8901129|NCT02069379|9958677|FG000|COMPLETED|Baseline Measurements||27
8901130|NCT02069379|9958678|FG001|COMPLETED|Baseline Measurements||4
8901131|NCT02069379|9958679|FG002|COMPLETED|Baseline Measurements||2
8901132|NCT02069379|9958680|FG003|COMPLETED|Baseline Measurements||4
8901133|NCT02069379|9958677|FG000|NOT COMPLETED|Baseline Measurements||3
8901134|NCT02069379|9958678|FG001|NOT COMPLETED|Baseline Measurements||0
8901135|NCT02069379|9958679|FG002|NOT COMPLETED|Baseline Measurements||0
8901136|NCT02069379|9958680|FG003|NOT COMPLETED|Baseline Measurements||2
8901137|NCT02069379|9958677|FG000|STARTED|First Treatment Arm|Controls are not involved after initial baseline collection|0
8901138|NCT02069379|9958678|FG001|STARTED|First Treatment Arm||4
8901139|NCT02069379|9958679|FG002|STARTED|First Treatment Arm||2
8901140|NCT02069379|9958680|FG003|STARTED|First Treatment Arm|Insulin resistant woman not randomized are not involved after initial baseline collection|0
8901141|NCT02069379|9958677|FG000|COMPLETED|First Treatment Arm||0
8901142|NCT02069379|9958678|FG001|COMPLETED|First Treatment Arm||3
8901143|NCT02069379|9958679|FG002|COMPLETED|First Treatment Arm||1
8901144|NCT02069379|9958680|FG003|COMPLETED|First Treatment Arm||0
8901145|NCT02069379|9958677|FG000|NOT COMPLETED|First Treatment Arm||0
8901146|NCT02069379|9958678|FG001|NOT COMPLETED|First Treatment Arm||1
8901147|NCT02069379|9958679|FG002|NOT COMPLETED|First Treatment Arm||1
8901148|NCT02069379|9958680|FG003|NOT COMPLETED|First Treatment Arm||0
9009732|NCT02976519|10072618|FG001|STARTED|Wash-out Period (Part 2 Only)||0
9009733|NCT02976519|10072619|FG002|STARTED|Wash-out Period (Part 2 Only)||0
9009734|NCT02976519|10072620|FG003|STARTED|Wash-out Period (Part 2 Only)||0
9009735|NCT02976519|10072621|FG004|STARTED|Wash-out Period (Part 2 Only)||0
9009736|NCT02976519|10072622|FG005|STARTED|Wash-out Period (Part 2 Only)||12
9009737|NCT02976519|10072623|FG006|STARTED|Wash-out Period (Part 2 Only)||12
9009738|NCT02976519|10072617|FG000|COMPLETED|Wash-out Period (Part 2 Only)||0
9009739|NCT02976519|10072618|FG001|COMPLETED|Wash-out Period (Part 2 Only)||0
9009740|NCT02976519|10072619|FG002|COMPLETED|Wash-out Period (Part 2 Only)||0
9009741|NCT02976519|10072620|FG003|COMPLETED|Wash-out Period (Part 2 Only)||0
9009742|NCT02976519|10072621|FG004|COMPLETED|Wash-out Period (Part 2 Only)||0
9009743|NCT02976519|10072622|FG005|COMPLETED|Wash-out Period (Part 2 Only)||12
9009744|NCT02976519|10072623|FG006|COMPLETED|Wash-out Period (Part 2 Only)||10
9009745|NCT02976519|10072617|FG000|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
9009746|NCT02976519|10072618|FG001|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
9009747|NCT02976519|10072619|FG002|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
9009748|NCT02976519|10072620|FG003|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
9009749|NCT02976519|10072621|FG004|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
9009750|NCT02976519|10072622|FG005|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
9009751|NCT02976519|10072623|FG006|NOT COMPLETED|Wash-out Period (Part 2 Only)||2
9009752|NCT02976519|10072617|FG000|STARTED|Treatment Period 2 (Part 2 Only)||0
9009753|NCT02976519|10072618|FG001|STARTED|Treatment Period 2 (Part 2 Only)||0
9009754|NCT02976519|10072619|FG002|STARTED|Treatment Period 2 (Part 2 Only)||0
9009755|NCT02976519|10072620|FG003|STARTED|Treatment Period 2 (Part 2 Only)||0
9009756|NCT02976519|10072621|FG004|STARTED|Treatment Period 2 (Part 2 Only)||0
9009757|NCT02976519|10072622|FG005|STARTED|Treatment Period 2 (Part 2 Only)||12
8635831|NCT00564733|9676372|FG000|NOT COMPLETED|Overall Study||9
8635832|NCT00564850|9676376|FG000|STARTED|Overall Study||37
8635833|NCT00564850|9676376|FG000|COMPLETED|Overall Study||35
8635834|NCT00564850|9676376|FG000|NOT COMPLETED|Overall Study||2
9009758|NCT02976519|10072623|FG006|STARTED|Treatment Period 2 (Part 2 Only)||10
9009759|NCT02976519|10072617|FG000|COMPLETED|Treatment Period 2 (Part 2 Only)||0
9009760|NCT02976519|10072618|FG001|COMPLETED|Treatment Period 2 (Part 2 Only)||0
9009761|NCT02976519|10072619|FG002|COMPLETED|Treatment Period 2 (Part 2 Only)||0
9009762|NCT02976519|10072620|FG003|COMPLETED|Treatment Period 2 (Part 2 Only)||0
9009763|NCT02976519|10072621|FG004|COMPLETED|Treatment Period 2 (Part 2 Only)||0
9009764|NCT02976519|10072622|FG005|COMPLETED|Treatment Period 2 (Part 2 Only)||12
9009765|NCT02976519|10072623|FG006|COMPLETED|Treatment Period 2 (Part 2 Only)||9
9009766|NCT02976519|10072617|FG000|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
9009767|NCT02976519|10072618|FG001|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
9009768|NCT02976519|10072619|FG002|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
9009769|NCT02976519|10072620|FG003|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
9009770|NCT02976519|10072621|FG004|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
9009771|NCT02976519|10072622|FG005|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
9009772|NCT02976519|10072623|FG006|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||1
9009773|NCT02977507|10072643|FG000|STARTED|Overall Study||8
9009774|NCT02977507|10072644|FG001|STARTED|Overall Study||10
9009775|NCT02977507|10072643|FG000|COMPLETED|Overall Study||6
9009776|NCT02977507|10072644|FG001|COMPLETED|Overall Study||10
9009777|NCT02977507|10072643|FG000|NOT COMPLETED|Overall Study||2
9009778|NCT02977507|10072644|FG001|NOT COMPLETED|Overall Study||0
9009779|NCT02977572|10072653|FG000|STARTED|Overall Study||58
9009780|NCT02977572|10072654|FG001|STARTED|Overall Study||56
9009781|NCT02977572|10072653|FG000|COMPLETED|Overall Study||56
9009782|NCT02977572|10072654|FG001|COMPLETED|Overall Study||54
9009783|NCT02977572|10072653|FG000|NOT COMPLETED|Overall Study||2
9009784|NCT02977572|10072654|FG001|NOT COMPLETED|Overall Study||2
9009785|NCT02978157|10072666|FG000|STARTED|Overall Study||52
9009786|NCT02978157|10072667|FG001|STARTED|Overall Study||50
9009787|NCT02978157|10072666|FG000|COMPLETED|Overall Study||52
9009788|NCT02978157|10072667|FG001|COMPLETED|Overall Study||50
8635835|NCT00564889|9676380|FG000|STARTED|Overall Study||35
8635836|NCT00564889|9676380|FG000|COMPLETED|Overall Study||6
8635837|NCT00564889|9676380|FG000|NOT COMPLETED|Overall Study||29
8901149|NCT02069379|9958677|FG000|STARTED|Washout Period (4 Weeks)|Controls are not involved after initial baseline collection|0
8901150|NCT02069379|9958678|FG001|STARTED|Washout Period (4 Weeks)||3
8901151|NCT02069379|9958679|FG002|STARTED|Washout Period (4 Weeks)||1
8901152|NCT02069379|9958680|FG003|STARTED|Washout Period (4 Weeks)|Insulin resistant woman who were not randomized are not involved after initial baseline collection|0
8901153|NCT02069379|9958677|FG000|COMPLETED|Washout Period (4 Weeks)||0
8901154|NCT02069379|9958678|FG001|COMPLETED|Washout Period (4 Weeks)||1
9009789|NCT02978157|10072666|FG000|NOT COMPLETED|Overall Study||0
9009790|NCT02978157|10072667|FG001|NOT COMPLETED|Overall Study||0
8901155|NCT02069379|9958679|FG002|COMPLETED|Washout Period (4 Weeks)||1
8901156|NCT02069379|9958680|FG003|COMPLETED|Washout Period (4 Weeks)||0
8901157|NCT02069379|9958677|FG000|NOT COMPLETED|Washout Period (4 Weeks)||0
8901158|NCT02069379|9958678|FG001|NOT COMPLETED|Washout Period (4 Weeks)||2
8901159|NCT02069379|9958679|FG002|NOT COMPLETED|Washout Period (4 Weeks)||0
8901160|NCT02069379|9958680|FG003|NOT COMPLETED|Washout Period (4 Weeks)||0
8901161|NCT02069379|9958677|FG000|STARTED|Second Treatment Arm|Controls are not involved after initial baseline collection|0
8901162|NCT02069379|9958678|FG001|STARTED|Second Treatment Arm||1
8901163|NCT02069379|9958679|FG002|STARTED|Second Treatment Arm||1
8901164|NCT02069379|9958680|FG003|STARTED|Second Treatment Arm|Insulin resistant women who are not randomized are not involved after initial baseline collection|0
8901165|NCT02069379|9958677|FG000|COMPLETED|Second Treatment Arm||0
8901166|NCT02069379|9958678|FG001|COMPLETED|Second Treatment Arm||1
8901167|NCT02069379|9958679|FG002|COMPLETED|Second Treatment Arm||0
8901168|NCT02069379|9958680|FG003|COMPLETED|Second Treatment Arm||0
8901169|NCT02069379|9958677|FG000|NOT COMPLETED|Second Treatment Arm||0
8901170|NCT02069379|9958678|FG001|NOT COMPLETED|Second Treatment Arm||0
8901171|NCT02069379|9958679|FG002|NOT COMPLETED|Second Treatment Arm||1
8901172|NCT02069379|9958680|FG003|NOT COMPLETED|Second Treatment Arm||0
8901173|NCT02069392|9958692|FG000|STARTED|Overall Study||14
8901174|NCT02069392|9958693|FG001|STARTED|Overall Study||17
8901175|NCT02069392|9958692|FG000|COMPLETED|Overall Study||10
8901176|NCT02069392|9958693|FG001|COMPLETED|Overall Study||15
8901177|NCT02069392|9958692|FG000|NOT COMPLETED|Overall Study||4
8901178|NCT02069392|9958693|FG001|NOT COMPLETED|Overall Study||2
8901179|NCT02069704|9958703|FG000|STARTED|Overall Study|Two patients were randomized but they did not received study treatment|69
8901180|NCT02069704|9958704|FG001|STARTED|Overall Study||71
8901181|NCT02069704|9958703|FG000|COMPLETED|Overall Study||69
8901182|NCT02069704|9958704|FG001|COMPLETED|Overall Study||71
8901183|NCT02069704|9958703|FG000|NOT COMPLETED|Overall Study||0
8901184|NCT02069704|9958704|FG001|NOT COMPLETED|Overall Study||0
8901185|NCT02069847|9958719|FG000|STARTED|Overall Study||22
8901186|NCT02069847|9958720|FG001|STARTED|Overall Study||68
8901187|NCT02069847|9958719|FG000|COMPLETED|Overall Study||22
8901188|NCT02069847|9958720|FG001|COMPLETED|Overall Study||68
8901189|NCT02069847|9958719|FG000|NOT COMPLETED|Overall Study||0
8901190|NCT02069847|9958720|FG001|NOT COMPLETED|Overall Study||0
8901191|NCT02070237|9958727|FG000|STARTED|Overall Study||45
8901192|NCT02070237|9958728|FG001|STARTED|Overall Study||45
8901193|NCT02070237|9958727|FG000|COMPLETED|Overall Study||42
8901194|NCT02070237|9958728|FG001|COMPLETED|Overall Study||42
8901195|NCT02070237|9958727|FG000|NOT COMPLETED|Overall Study||3
8901196|NCT02070237|9958728|FG001|NOT COMPLETED|Overall Study||3
8901197|NCT02070276|9958737|FG000|STARTED|Overall Study||149
8901198|NCT02070276|9958738|FG001|STARTED|Overall Study||132
8901199|NCT02070276|9958739|FG002|STARTED|Overall Study||148
8901200|NCT02070276|9958737|FG000|COMPLETED|Overall Study||149
8901201|NCT02070276|9958738|FG001|COMPLETED|Overall Study||132
8901202|NCT02070276|9958739|FG002|COMPLETED|Overall Study||148
8901203|NCT02070276|9958737|FG000|NOT COMPLETED|Overall Study||0
8901204|NCT02070276|9958738|FG001|NOT COMPLETED|Overall Study||0
8901205|NCT02070276|9958739|FG002|NOT COMPLETED|Overall Study||0
8901206|NCT02070302|9958749|FG000|STARTED|Overall Study||5
8901207|NCT02070302|9958750|FG001|STARTED|Overall Study||5
8901208|NCT02070302|9958749|FG000|COMPLETED|Overall Study||5
8901209|NCT02070302|9958750|FG001|COMPLETED|Overall Study||5
8901210|NCT02070302|9958749|FG000|NOT COMPLETED|Overall Study||0
8901211|NCT02070302|9958750|FG001|NOT COMPLETED|Overall Study||0
8635838|NCT00564902|9676387|FG000|STARTED|Overall Study||10
8635839|NCT00564902|9676388|FG001|STARTED|Overall Study||25
8635840|NCT00564902|9676389|FG002|STARTED|Overall Study||25
8726312|NCT01035255|9773521|FG000|STARTED|Overall Study||4209
8726313|NCT01035255|9773522|FG001|STARTED|Overall Study||4233
8726314|NCT01035255|9773521|FG000|GCP Violations|Overall Study||18
8726315|NCT01035255|9773522|FG001|GCP Violations|Overall Study||19
8726316|NCT01035255|9773521|FG000|Mis-randomized|Overall Study||4
8726317|NCT01035255|9773522|FG001|Mis-randomized|Overall Study||2
8901212|NCT02070380|9958760|FG000|STARTED|First Injection||31
8901213|NCT02070380|9958761|FG001|STARTED|First Injection||39
8901214|NCT02070380|9958762|FG002|STARTED|First Injection||53
8635841|NCT00564902|9676387|FG000|4 Months|Overall Study||9
8635842|NCT00564902|9676388|FG001|4 Months|Overall Study||24
8635843|NCT00564902|9676389|FG002|4 Months|Overall Study||23
8635844|NCT00564902|9676387|FG000|8 Months|Overall Study||9
8635845|NCT00564902|9676388|FG001|8 Months|Overall Study||22
8635846|NCT00564902|9676389|FG002|8 Months|Overall Study||21
8635847|NCT00564902|9676387|FG000|12 Months|Overall Study||9
8635848|NCT00564902|9676388|FG001|12 Months|Overall Study||21
8806559|NCT01478321|9858785|FG000|Went on to Cycle 2 +|Adjuvant Therapy Until PD or Toxicity||27
8806560|NCT01478321|9858785|FG000|COMPLETED|Adjuvant Therapy Until PD or Toxicity||27
8806561|NCT01478321|9858785|FG000|NOT COMPLETED|Adjuvant Therapy Until PD or Toxicity||10
8806562|NCT01478321|9858785|FG000|STARTED|Follow-up Until Death or 12.31.18 Occurs||54
8806563|NCT01478321|9858785|FG000|COMPLETED|Follow-up Until Death or 12.31.18 Occurs||54
8806564|NCT01478321|9858785|FG000|NOT COMPLETED|Follow-up Until Death or 12.31.18 Occurs||0
8806565|NCT01478347|9858789|FG000|STARTED|Visit 1-Visit 3 (Day 0-91) - Part I||18
8806566|NCT01478347|9858789|FG000|COMPLETED|Visit 1-Visit 3 (Day 0-91) - Part I||17
8806567|NCT01478347|9858789|FG000|NOT COMPLETED|Visit 1-Visit 3 (Day 0-91) - Part I||1
8901215|NCT02070380|9958763|FG003|STARTED|First Injection||54
8901216|NCT02070380|9958760|FG000|COMPLETED|First Injection||31
8901217|NCT02070380|9958761|FG001|COMPLETED|First Injection||39
8901218|NCT02070380|9958762|FG002|COMPLETED|First Injection||53
8901219|NCT02070380|9958763|FG003|COMPLETED|First Injection||54
8901220|NCT02070380|9958760|FG000|NOT COMPLETED|First Injection||0
8901221|NCT02070380|9958761|FG001|NOT COMPLETED|First Injection||0
8901222|NCT02070380|9958762|FG002|NOT COMPLETED|First Injection||0
8901223|NCT02070380|9958763|FG003|NOT COMPLETED|First Injection||0
8901224|NCT02070380|9958760|FG000|STARTED|Washout (no Second Injection/MRI)||31
8901225|NCT02070380|9958761|FG001|STARTED|Washout (no Second Injection/MRI)||39
8901226|NCT02070380|9958762|FG002|STARTED|Washout (no Second Injection/MRI)||53
9009791|NCT02978183|10072675|FG000|STARTED|Overall Study||34
9009792|NCT02978183|10072676|FG001|STARTED|Overall Study||36
9009793|NCT02978183|10072675|FG000|COMPLETED|Overall Study||34
9009794|NCT02978183|10072676|FG001|COMPLETED|Overall Study||36
9009795|NCT02978183|10072675|FG000|NOT COMPLETED|Overall Study||0
9009796|NCT02978183|10072676|FG001|NOT COMPLETED|Overall Study||0
9009797|NCT02978339|10072682|FG000|STARTED|Overall Study||15
9009798|NCT02978339|10072682|FG000|COMPLETED|Overall Study||15
9009799|NCT02978339|10072682|FG000|NOT COMPLETED|Overall Study||0
9009800|NCT02978417|10072688|FG000|STARTED|Overall Study||5
9009801|NCT02978417|10072689|FG001|STARTED|Overall Study||5
9009802|NCT02978417|10072688|FG000|COMPLETED|Overall Study||3
9009803|NCT02978417|10072689|FG001|COMPLETED|Overall Study||3
9009804|NCT02978417|10072688|FG000|NOT COMPLETED|Overall Study||2
9009805|NCT02978417|10072689|FG001|NOT COMPLETED|Overall Study||2
9009806|NCT02978508|10072697|FG000|STARTED|Overall Study||70
9009807|NCT02978508|10072698|FG001|STARTED|Overall Study||70
9009808|NCT02978508|10072697|FG000|COMPLETED|Overall Study||70
9009809|NCT02978508|10072698|FG001|COMPLETED|Overall Study||70
9009810|NCT02978508|10072697|FG000|NOT COMPLETED|Overall Study||0
9009811|NCT02978508|10072698|FG001|NOT COMPLETED|Overall Study||0
9009812|NCT02979054|10072706|FG000|STARTED|Overall Study||71
9009813|NCT02979054|10072707|FG001|STARTED|Overall Study||64
9009814|NCT02979054|10072706|FG000|COMPLETED|Overall Study||71
9009815|NCT02979054|10072707|FG001|COMPLETED|Overall Study||64
9009816|NCT02979054|10072706|FG000|NOT COMPLETED|Overall Study||0
9009817|NCT02979054|10072707|FG001|NOT COMPLETED|Overall Study||0
9009818|NCT02979197|10072716|FG000|STARTED|Overall Study||48
9009819|NCT02979197|10072717|FG001|STARTED|Overall Study||49
9009820|NCT02979197|10072718|FG002|STARTED|Overall Study||8
9009821|NCT02979197|10072716|FG000|COMPLETED|Overall Study||44
9009822|NCT02979197|10072717|FG001|COMPLETED|Overall Study||45
9009823|NCT02979197|10072718|FG002|COMPLETED|Overall Study||8
9009824|NCT02979197|10072716|FG000|NOT COMPLETED|Overall Study||4
9009825|NCT02979197|10072717|FG001|NOT COMPLETED|Overall Study||4
9009826|NCT02979197|10072718|FG002|NOT COMPLETED|Overall Study||0
9009827|NCT02979249|10072726|FG000|STARTED|Overall Study||16
9009828|NCT02979249|10072726|FG000|COMPLETED|Overall Study||10
9009829|NCT02979249|10072726|FG000|NOT COMPLETED|Overall Study||6
9009830|NCT02979262|10072732|FG000|STARTED|Overall Study||33
9009831|NCT02979262|10072733|FG001|STARTED|Overall Study||29
9009832|NCT02979262|10072732|FG000|Received Allocated Intervention|Overall Study||30
9009833|NCT02979262|10072733|FG001|Received Allocated Intervention|Overall Study||27
9009834|NCT02979262|10072732|FG000|COMPLETED|Overall Study||21
9009835|NCT02979262|10072733|FG001|COMPLETED|Overall Study||20
9009836|NCT02979262|10072732|FG000|NOT COMPLETED|Overall Study||12
9009837|NCT02979262|10072733|FG001|NOT COMPLETED|Overall Study||9
9009838|NCT02979301|10072741|FG000|STARTED|Overall Study||11
9009839|NCT02979301|10072742|FG001|STARTED|Overall Study||11
9009840|NCT02979301|10072741|FG000|COMPLETED|Overall Study||10
9009841|NCT02979301|10072742|FG001|COMPLETED|Overall Study||11
9009842|NCT02979301|10072741|FG000|NOT COMPLETED|Overall Study||1
9009843|NCT02979301|10072742|FG001|NOT COMPLETED|Overall Study||0
9009844|NCT02979431|10072752|FG000|STARTED|Overall Study||44
9009845|NCT02979431|10072753|FG001|STARTED|Overall Study||46
9009846|NCT02979431|10072754|FG002|STARTED|Overall Study||45
9009847|NCT02979431|10072755|FG003|STARTED|Overall Study||45
9009848|NCT02979431|10072752|FG000|Included in the mITT Population|Overall Study||42
9009849|NCT02979431|10072753|FG001|Included in the mITT Population|Overall Study||45
9009850|NCT02979431|10072754|FG002|Included in the mITT Population|Overall Study||43
9009851|NCT02979431|10072755|FG003|Included in the mITT Population|Overall Study||45
9009852|NCT02979431|10072752|FG000|Included in the Safety Population|Overall Study||40
9009853|NCT02979431|10072753|FG001|Included in the Safety Population|Overall Study||45
9009854|NCT02979431|10072754|FG002|Included in the Safety Population|Overall Study|Includes a subject that was randomized to placebo but received a dose of ALX-0171 6.0 mg/kg|44
9009855|NCT02979431|10072755|FG003|Included in the Safety Population|Overall Study|Includes a subject that was randomized to placebo but received a dose of ALX-0171 9.0 mg/kg|46
9009856|NCT02979431|10072752|FG000|COMPLETED|Overall Study||40
9009857|NCT02979431|10072753|FG001|COMPLETED|Overall Study||44
9009858|NCT02979431|10072754|FG002|COMPLETED|Overall Study||43
9009859|NCT02979431|10072755|FG003|COMPLETED|Overall Study||44
9009860|NCT02979431|10072752|FG000|NOT COMPLETED|Overall Study||4
9009861|NCT02979431|10072753|FG001|NOT COMPLETED|Overall Study||2
9009862|NCT02979431|10072754|FG002|NOT COMPLETED|Overall Study||2
9009863|NCT02979431|10072755|FG003|NOT COMPLETED|Overall Study||1
9009864|NCT02979444|10072768|FG000|STARTED|Overall Study||405
9009865|NCT02979444|10072769|FG001|STARTED|Overall Study||310
8901227|NCT02070380|9958763|FG003|STARTED|Washout (no Second Injection/MRI)||54
8901228|NCT02070380|9958760|FG000|COMPLETED|Washout (no Second Injection/MRI)||31
8901229|NCT02070380|9958761|FG001|COMPLETED|Washout (no Second Injection/MRI)||34
8901230|NCT02070380|9958762|FG002|COMPLETED|Washout (no Second Injection/MRI)||51
8901231|NCT02070380|9958763|FG003|COMPLETED|Washout (no Second Injection/MRI)||51
8901232|NCT02070380|9958760|FG000|NOT COMPLETED|Washout (no Second Injection/MRI)||0
8901233|NCT02070380|9958761|FG001|NOT COMPLETED|Washout (no Second Injection/MRI)||5
8901234|NCT02070380|9958762|FG002|NOT COMPLETED|Washout (no Second Injection/MRI)||2
8901235|NCT02070380|9958763|FG003|NOT COMPLETED|Washout (no Second Injection/MRI)||3
8635849|NCT00564902|9676389|FG002|12 Months|Overall Study||21
8901236|NCT02070380|9958760|FG000|STARTED|Second Injection||31
8901237|NCT02070380|9958761|FG001|STARTED|Second Injection||34
8901238|NCT02070380|9958762|FG002|STARTED|Second Injection||51
8901239|NCT02070380|9958763|FG003|STARTED|Second Injection||51
8901240|NCT02070380|9958760|FG000|COMPLETED|Second Injection||31
8901241|NCT02070380|9958761|FG001|COMPLETED|Second Injection||32
8901242|NCT02070380|9958762|FG002|COMPLETED|Second Injection||50
9009866|NCT02979444|10072770|FG002|STARTED|Overall Study||159
9009867|NCT02979444|10072768|FG000|COMPLETED|Overall Study||382
9009868|NCT02979444|10072769|FG001|COMPLETED|Overall Study||293
9009869|NCT02979444|10072770|FG002|COMPLETED|Overall Study||149
9009870|NCT02979444|10072768|FG000|NOT COMPLETED|Overall Study||23
9009871|NCT02979444|10072769|FG001|NOT COMPLETED|Overall Study||17
9009872|NCT02979444|10072770|FG002|NOT COMPLETED|Overall Study||10
9009873|NCT02979522|10072780|FG000|STARTED|Period 1: Phase 1||8
9009874|NCT02979522|10072781|FG001|STARTED|Period 1: Phase 1||0
9009875|NCT02979522|10072780|FG000|COMPLETED|Period 1: Phase 1||8
9009876|NCT02979522|10072781|FG001|COMPLETED|Period 1: Phase 1||0
9009877|NCT02979522|10072780|FG000|NOT COMPLETED|Period 1: Phase 1||0
9009878|NCT02979522|10072781|FG001|NOT COMPLETED|Period 1: Phase 1||0
9009879|NCT02979522|10072780|FG000|STARTED|Period 2: Phase 2||0
9009880|NCT02979522|10072781|FG001|STARTED|Period 2: Phase 2|Participants treated in Phase 1 entered Phase 2 along with additional participants enrolled in Phase 2.|59
9009881|NCT02979522|10072780|FG000|COMPLETED|Period 2: Phase 2||0
9009882|NCT02979522|10072781|FG001|COMPLETED|Period 2: Phase 2||59
9009883|NCT02979522|10072780|FG000|NOT COMPLETED|Period 2: Phase 2||0
9009884|NCT02979522|10072781|FG001|NOT COMPLETED|Period 2: Phase 2||0
9009885|NCT02979613|10072789|FG000|STARTED|Double-Blind Phase||245
9009886|NCT02979613|10072790|FG001|STARTED|Double-Blind Phase||245
9009887|NCT02979613|10072789|FG000|COMPLETED|Double-Blind Phase||235
9009888|NCT02979613|10072790|FG001|COMPLETED|Double-Blind Phase||237
9009889|NCT02979613|10072789|FG000|NOT COMPLETED|Double-Blind Phase||10
9009890|NCT02979613|10072790|FG001|NOT COMPLETED|Double-Blind Phase||8
9009891|NCT02979613|10072789|FG000|STARTED|Open-Label Extension (OLE) Phase||235
9009892|NCT02979613|10072790|FG001|STARTED|Open-Label Extension (OLE) Phase||237
9009893|NCT02979613|10072789|FG000|COMPLETED|Open-Label Extension (OLE) Phase||232
9009894|NCT02979613|10072790|FG001|COMPLETED|Open-Label Extension (OLE) Phase||231
9009895|NCT02979613|10072789|FG000|NOT COMPLETED|Open-Label Extension (OLE) Phase||3
9009896|NCT02979613|10072790|FG001|NOT COMPLETED|Open-Label Extension (OLE) Phase||6
9009897|NCT02979626|10072800|FG000|STARTED|Overall Study||313
9009898|NCT02979626|10072801|FG001|STARTED|Overall Study||98
9009899|NCT02979626|10072800|FG000|COMPLETED|Overall Study||313
9009900|NCT02979626|10072801|FG001|COMPLETED|Overall Study||98
9009901|NCT02979626|10072800|FG000|NOT COMPLETED|Overall Study||0
9009902|NCT02979626|10072801|FG001|NOT COMPLETED|Overall Study||0
9009903|NCT02979639|10072807|FG000|STARTED|Overall Study||401
9009904|NCT02979639|10072807|FG000|COMPLETED|Overall Study||387
8635850|NCT00564902|9676387|FG000|COMPLETED|Overall Study||9
8635851|NCT00564902|9676388|FG001|COMPLETED|Overall Study||21
8901243|NCT02070380|9958763|FG003|COMPLETED|Second Injection||46
8901244|NCT02070380|9958760|FG000|NOT COMPLETED|Second Injection||0
8901245|NCT02070380|9958761|FG001|NOT COMPLETED|Second Injection||2
8901246|NCT02070380|9958762|FG002|NOT COMPLETED|Second Injection||1
8901247|NCT02070380|9958763|FG003|NOT COMPLETED|Second Injection||5
8901248|NCT02070484|9958777|FG000|STARTED|Overall Study||3
8901249|NCT02070484|9958778|FG001|STARTED|Overall Study||3
8901250|NCT02070484|9958777|FG000|COMPLETED|Overall Study||2
8901251|NCT02070484|9958778|FG001|COMPLETED|Overall Study||3
8901252|NCT02070484|9958777|FG000|NOT COMPLETED|Overall Study||1
8901253|NCT02070484|9958778|FG001|NOT COMPLETED|Overall Study||0
8901254|NCT02070588|9958787|FG000|STARTED|Overall Study||86
8901255|NCT02070588|9958788|FG001|STARTED|Overall Study||26
8901256|NCT02070588|9958789|FG002|STARTED|Overall Study||0
8901257|NCT02070588|9958787|FG000|COMPLETED|Overall Study||47
8901258|NCT02070588|9958788|FG001|COMPLETED|Overall Study||25
8901259|NCT02070588|9958789|FG002|COMPLETED|Overall Study||0
8901260|NCT02070588|9958787|FG000|NOT COMPLETED|Overall Study||39
8901261|NCT02070588|9958788|FG001|NOT COMPLETED|Overall Study||1
8901262|NCT02070588|9958789|FG002|NOT COMPLETED|Overall Study||0
8901263|NCT02070640|9958799|FG000|STARTED|Overall Study||93
8901264|NCT02070640|9958800|FG001|STARTED|Overall Study||6
8901265|NCT02070640|9958799|FG000|COMPLETED|Overall Study||82
8901266|NCT02070640|9958800|FG001|COMPLETED|Overall Study||6
8901267|NCT02070640|9958799|FG000|NOT COMPLETED|Overall Study||11
8901268|NCT02070640|9958800|FG001|NOT COMPLETED|Overall Study||0
8901269|NCT02070692|9958809|FG000|STARTED|Overall Study||28
8901270|NCT02070692|9958810|FG001|STARTED|Overall Study||28
8901271|NCT02070692|9958809|FG000|COMPLETED|Overall Study||18
8901272|NCT02070692|9958810|FG001|COMPLETED|Overall Study||16
8901273|NCT02070692|9958809|FG000|NOT COMPLETED|Overall Study||10
8901274|NCT02070692|9958810|FG001|NOT COMPLETED|Overall Study||12
8901275|NCT02070744|9958820|FG000|STARTED|PC Phase (12 Weeks)||6
8901276|NCT02070744|9958821|FG001|STARTED|PC Phase (12 Weeks)||5
8901277|NCT02070744|9958822|FG002|STARTED|PC Phase (12 Weeks)||15
8901278|NCT02070744|9958823|FG003|STARTED|PC Phase (12 Weeks)||14
8901279|NCT02070744|9958824|FG004|STARTED|PC Phase (12 Weeks)||0
8901280|NCT02070744|9958820|FG000|Treated|PC Phase (12 Weeks)||6
8901281|NCT02070744|9958821|FG001|Treated|PC Phase (12 Weeks)||5
8901282|NCT02070744|9958822|FG002|Treated|PC Phase (12 Weeks)||15
8901283|NCT02070744|9958823|FG003|Treated|PC Phase (12 Weeks)||13
8901284|NCT02070744|9958824|FG004|Treated|PC Phase (12 Weeks)||0
8901285|NCT02070744|9958820|FG000|COMPLETED|PC Phase (12 Weeks)||6
8901286|NCT02070744|9958821|FG001|COMPLETED|PC Phase (12 Weeks)||5
8901287|NCT02070744|9958822|FG002|COMPLETED|PC Phase (12 Weeks)||15
8901288|NCT02070744|9958823|FG003|COMPLETED|PC Phase (12 Weeks)||13
8901289|NCT02070744|9958824|FG004|COMPLETED|PC Phase (12 Weeks)||0
8901290|NCT02070744|9958820|FG000|NOT COMPLETED|PC Phase (12 Weeks)||0
8901291|NCT02070744|9958821|FG001|NOT COMPLETED|PC Phase (12 Weeks)||0
8901292|NCT02070744|9958822|FG002|NOT COMPLETED|PC Phase (12 Weeks)||0
8901293|NCT02070744|9958823|FG003|NOT COMPLETED|PC Phase (12 Weeks)||1
8901294|NCT02070744|9958824|FG004|NOT COMPLETED|PC Phase (12 Weeks)||0
8901295|NCT02070744|9958820|FG000|STARTED|OLE Phase (48 Weeks)||0
8901296|NCT02070744|9958821|FG001|STARTED|OLE Phase (48 Weeks)||0
8901297|NCT02070744|9958822|FG002|STARTED|OLE Phase (48 Weeks)||0
8901298|NCT02070744|9958823|FG003|STARTED|OLE Phase (48 Weeks)||0
8901299|NCT02070744|9958824|FG004|STARTED|OLE Phase (48 Weeks)|12 participants completed PC phase, but did not enter OLE phase.|27
8901300|NCT02070744|9958820|FG000|COMPLETED|OLE Phase (48 Weeks)||0
8901301|NCT02070744|9958821|FG001|COMPLETED|OLE Phase (48 Weeks)||0
8901302|NCT02070744|9958822|FG002|COMPLETED|OLE Phase (48 Weeks)||0
8901303|NCT02070744|9958823|FG003|COMPLETED|OLE Phase (48 Weeks)||0
8901304|NCT02070744|9958824|FG004|COMPLETED|OLE Phase (48 Weeks)||24
8901305|NCT02070744|9958820|FG000|NOT COMPLETED|OLE Phase (48 Weeks)||0
8901306|NCT02070744|9958821|FG001|NOT COMPLETED|OLE Phase (48 Weeks)||0
8901307|NCT02070744|9958822|FG002|NOT COMPLETED|OLE Phase (48 Weeks)||0
8901308|NCT02070744|9958823|FG003|NOT COMPLETED|OLE Phase (48 Weeks)||0
8901309|NCT02070744|9958824|FG004|NOT COMPLETED|OLE Phase (48 Weeks)||3
8901310|NCT02070757|9958841|FG000|STARTED|Overall Study||362
8901311|NCT02070757|9958842|FG001|STARTED|Overall Study||364
8901312|NCT02070757|9958841|FG000|Treated Participants|Overall Study||361
8901313|NCT02070757|9958842|FG001|Treated Participants|Overall Study||359
8901314|NCT02070757|9958841|FG000|COMPLETED|Overall Study||245
8901315|NCT02070757|9958842|FG001|COMPLETED|Overall Study||250
8901316|NCT02070757|9958841|FG000|NOT COMPLETED|Overall Study||117
8901317|NCT02070757|9958842|FG001|NOT COMPLETED|Overall Study||114
8901318|NCT02070965|9958851|FG000|STARTED|Overall Study||27
8901319|NCT02070965|9958852|FG001|STARTED|Overall Study||23
8901320|NCT02070965|9958853|FG002|STARTED|Overall Study||25
8901321|NCT02070965|9958851|FG000|COMPLETED|Overall Study||25
8901322|NCT02070965|9958852|FG001|COMPLETED|Overall Study||21
8901323|NCT02070965|9958853|FG002|COMPLETED|Overall Study||24
8901324|NCT02070965|9958851|FG000|NOT COMPLETED|Overall Study||2
8901325|NCT02070965|9958852|FG001|NOT COMPLETED|Overall Study||2
8901326|NCT02070965|9958853|FG002|NOT COMPLETED|Overall Study||1
8901327|NCT02070978|9958864|FG000|STARTED|Overall Study||83
8901328|NCT02070978|9958865|FG001|STARTED|Overall Study||82
8901329|NCT02070978|9958866|FG002|STARTED|Overall Study||88
8901330|NCT02070978|9958864|FG000|COMPLETED|Overall Study||36
8901331|NCT02070978|9958865|FG001|COMPLETED|Overall Study||29
8901332|NCT02070978|9958866|FG002|COMPLETED|Overall Study||35
8901333|NCT02070978|9958864|FG000|NOT COMPLETED|Overall Study||47
8901334|NCT02070978|9958865|FG001|NOT COMPLETED|Overall Study||53
8901335|NCT02070978|9958866|FG002|NOT COMPLETED|Overall Study||53
8901336|NCT02070991|9958876|FG000|STARTED|Overall Study||31
8901337|NCT02070991|9958877|FG001|STARTED|Overall Study||32
8635852|NCT00564902|9676389|FG002|COMPLETED|Overall Study||21
8635853|NCT00564902|9676387|FG000|NOT COMPLETED|Overall Study||1
8635854|NCT00564902|9676388|FG001|NOT COMPLETED|Overall Study||4
8635855|NCT00564902|9676389|FG002|NOT COMPLETED|Overall Study||4
8635856|NCT00564954|9676399|FG000|STARTED|Period 1- 1 Week||44
8635857|NCT00564954|9676400|FG001|STARTED|Period 1- 1 Week||42
8635858|NCT00564954|9676399|FG000|COMPLETED|Period 1- 1 Week||44
8635859|NCT00564954|9676400|FG001|COMPLETED|Period 1- 1 Week||42
8635860|NCT00564954|9676399|FG000|NOT COMPLETED|Period 1- 1 Week||0
8901338|NCT02070991|9958876|FG000|COMPLETED|Overall Study||28
8901339|NCT02070991|9958877|FG001|COMPLETED|Overall Study||32
8901340|NCT02070991|9958876|FG000|NOT COMPLETED|Overall Study||3
8901341|NCT02070991|9958877|FG001|NOT COMPLETED|Overall Study||0
8901342|NCT02071082|9958885|FG000|STARTED|Overall Study||4
8901343|NCT02071082|9958886|FG001|STARTED|Overall Study||75
8901344|NCT02071082|9958885|FG000|COMPLETED|Overall Study||2
8901345|NCT02071082|9958886|FG001|COMPLETED|Overall Study||68
9009905|NCT02979639|10072807|FG000|NOT COMPLETED|Overall Study||14
9009906|NCT02979899|10072813|FG000|STARTED|Overall Study||64
9009907|NCT02979899|10072814|FG001|STARTED|Overall Study||64
9009908|NCT02979899|10072813|FG000|COMPLETED|Overall Study||64
9009909|NCT02979899|10072814|FG001|COMPLETED|Overall Study||64
9009910|NCT02979899|10072813|FG000|NOT COMPLETED|Overall Study||0
9009911|NCT02979899|10072814|FG001|NOT COMPLETED|Overall Study||0
9009912|NCT02979925|10072822|FG000|STARTED|Overall Study||28
9009913|NCT02979925|10072823|FG001|STARTED|Overall Study||29
9009914|NCT02979925|10072822|FG000|COMPLETED|Overall Study||28
9009915|NCT02979925|10072823|FG001|COMPLETED|Overall Study||23
9009916|NCT02979925|10072822|FG000|NOT COMPLETED|Overall Study||0
9009917|NCT02979925|10072823|FG001|NOT COMPLETED|Overall Study||6
9009918|NCT02980042|10072831|FG000|STARTED|Overall Study||100
9009919|NCT02980042|10072832|FG001|STARTED|Overall Study||100
9009920|NCT02980042|10072831|FG000|COMPLETED|Overall Study|All 100 subjects completed their Week 24 infusion. 7 subjects did not complete the 12 month visit.|93
9009921|NCT02980042|10072832|FG001|COMPLETED|Overall Study||100
9009922|NCT02980042|10072831|FG000|NOT COMPLETED|Overall Study||7
9009923|NCT02980042|10072832|FG001|NOT COMPLETED|Overall Study||0
9009924|NCT02980107|10072852|FG000|STARTED|Overall Study||105
9009925|NCT02980107|10072853|FG001|STARTED|Overall Study||107
9009926|NCT02980107|10072852|FG000|COMPLETED|Overall Study||54
9009927|NCT02980107|10072853|FG001|COMPLETED|Overall Study||45
9009928|NCT02980107|10072852|FG000|NOT COMPLETED|Overall Study||51
9009929|NCT02980107|10072853|FG001|NOT COMPLETED|Overall Study||62
9009930|NCT02980133|10072863|FG000|STARTED|Overall Study||209
9009931|NCT02980133|10072864|FG001|STARTED|Overall Study||211
9009932|NCT02980133|10072865|FG002|STARTED|Overall Study||210
9009933|NCT02980133|10072866|FG003|STARTED|Overall Study||211
9009934|NCT02980133|10072863|FG000|Received at Least 1 Dose of Study Drug|Overall Study||209
9009935|NCT02980133|10072864|FG001|Received at Least 1 Dose of Study Drug|Overall Study||211
9009936|NCT02980133|10072865|FG002|Received at Least 1 Dose of Study Drug|Overall Study||208
9009937|NCT02980133|10072866|FG003|Received at Least 1 Dose of Study Drug|Overall Study||211
9009938|NCT02980133|10072863|FG000|COMPLETED|Overall Study||202
9009939|NCT02980133|10072864|FG001|COMPLETED|Overall Study||206
9009940|NCT02980133|10072865|FG002|COMPLETED|Overall Study||203
9009941|NCT02980133|10072866|FG003|COMPLETED|Overall Study||205
9009942|NCT02980133|10072863|FG000|NOT COMPLETED|Overall Study||7
9009943|NCT02980133|10072864|FG001|NOT COMPLETED|Overall Study||5
9009944|NCT02980133|10072865|FG002|NOT COMPLETED|Overall Study||7
9009945|NCT02980133|10072866|FG003|NOT COMPLETED|Overall Study||6
9009946|NCT02980211|10072879|FG000|STARTED|Overall Study||17
9009947|NCT02980211|10072879|FG000|COMPLETED|Overall Study||17
9009948|NCT02980211|10072879|FG000|NOT COMPLETED|Overall Study||0
9009949|NCT02980224|10072885|FG000|STARTED|Overall Study||89
8635861|NCT00564954|9676400|FG001|NOT COMPLETED|Period 1- 1 Week||0
9009950|NCT02980224|10072886|FG001|STARTED|Overall Study||91
9009951|NCT02980224|10072885|FG000|COMPLETED|Overall Study||85
9009952|NCT02980224|10072886|FG001|COMPLETED|Overall Study||88
9009953|NCT02980224|10072885|FG000|NOT COMPLETED|Overall Study||4
9009954|NCT02980224|10072886|FG001|NOT COMPLETED|Overall Study||3
8901346|NCT02071082|9958885|FG000|NOT COMPLETED|Overall Study||2
8901347|NCT02071082|9958886|FG001|NOT COMPLETED|Overall Study||7
8901348|NCT02071095|9958894|FG000|STARTED|Overall Study||12
9009955|NCT02980523|10072897|FG000|STARTED|Overall Study||30
9009956|NCT02980523|10072898|FG001|STARTED|Overall Study||30
9009957|NCT02980523|10072899|FG002|STARTED|Overall Study||30
9009958|NCT02980523|10072900|FG003|STARTED|Overall Study||30
9009959|NCT02980523|10072901|FG004|STARTED|Overall Study||30
9009960|NCT02980523|10072897|FG000|COMPLETED|Overall Study||27
9009961|NCT02980523|10072898|FG001|COMPLETED|Overall Study||19
9009962|NCT02980523|10072899|FG002|COMPLETED|Overall Study||24
9009963|NCT02980523|10072900|FG003|COMPLETED|Overall Study||21
9009964|NCT02980523|10072901|FG004|COMPLETED|Overall Study||20
9009965|NCT02980523|10072897|FG000|NOT COMPLETED|Overall Study||3
9009966|NCT02980523|10072898|FG001|NOT COMPLETED|Overall Study||11
9009967|NCT02980523|10072899|FG002|NOT COMPLETED|Overall Study||6
9009968|NCT02980523|10072900|FG003|NOT COMPLETED|Overall Study||9
9009969|NCT02980523|10072901|FG004|NOT COMPLETED|Overall Study||10
9009970|NCT02980601|10072918|FG000|STARTED|Overall Study||6
9009971|NCT02980601|10072919|FG001|STARTED|Overall Study||4
9009972|NCT02980601|10072918|FG000|COMPLETED|Overall Study||1
8901349|NCT02071095|9958895|FG001|STARTED|Overall Study||3
8901350|NCT02071095|9958894|FG000|COMPLETED|Overall Study||12
8901351|NCT02071095|9958895|FG001|COMPLETED|Overall Study||3
8901352|NCT02071095|9958894|FG000|NOT COMPLETED|Overall Study||0
8901353|NCT02071095|9958895|FG001|NOT COMPLETED|Overall Study||0
8901354|NCT02071108|9958901|FG000|STARTED|Overall Study||35
8901355|NCT02071108|9958901|FG000|COMPLETED|Overall Study||35
8901356|NCT02071108|9958901|FG000|NOT COMPLETED|Overall Study||0
8901357|NCT02071173|9958905|FG000|STARTED|Overall Study||2244
8901358|NCT02071173|9958905|FG000|Implanted/Attempted With a Study Device|Overall Study||2200
8901359|NCT02071173|9958905|FG000|RELIANCE 4-FRONT Endpoint Population|Overall Study|1507 with active fixation 4-FRONT lead, 37 with passive fixation 4-FRONT lead|1544
8901360|NCT02071173|9958905|FG000|ACUITY X4 Endpoint Population|Overall Study|536 with ACUITY X4 Spiral lead, 228 with ACUITY X4 Straight lead|764
8901361|NCT02071173|9958905|FG000|COMPLETED|Overall Study|Follow-up is ongoing. Data as of 5-Feb-2020.|409
8901362|NCT02071173|9958905|FG000|NOT COMPLETED|Overall Study||1835
8901363|NCT02071225|9958910|FG000|STARTED|Overall Study||72
8901364|NCT02071225|9958910|FG000|COMPLETED|Overall Study||42
8901365|NCT02071225|9958910|FG000|NOT COMPLETED|Overall Study||30
8901366|NCT02071290|9958916|FG000|STARTED|Overall Study||25
8901367|NCT02071290|9958917|FG001|STARTED|Overall Study||25
8901368|NCT02071290|9958916|FG000|COMPLETED|Overall Study||21
8901369|NCT02071290|9958917|FG001|COMPLETED|Overall Study||18
8901370|NCT02071290|9958916|FG000|NOT COMPLETED|Overall Study||4
8901371|NCT02071290|9958917|FG001|NOT COMPLETED|Overall Study||7
8901372|NCT02071420|9958925|FG000|STARTED|Overall Study||30
8901373|NCT02071420|9958926|FG001|STARTED|Overall Study||30
8901374|NCT02071420|9958925|FG000|COMPLETED|Overall Study||27
8901375|NCT02071420|9958926|FG001|COMPLETED|Overall Study||27
8901376|NCT02071420|9958925|FG000|NOT COMPLETED|Overall Study||3
8901377|NCT02071420|9958926|FG001|NOT COMPLETED|Overall Study||3
8901378|NCT02071706|9958932|FG000|STARTED|Overall Study||62
8901379|NCT02071706|9958932|FG000|COMPLETED|Overall Study||59
8901380|NCT02071706|9958932|FG000|NOT COMPLETED|Overall Study||3
8901381|NCT02071771|9958936|FG000|STARTED|Period 1: First 10 Days||41
8901382|NCT02071771|9958937|FG001|STARTED|Period 1: First 10 Days||39
8901383|NCT02071771|9958936|FG000|Dispensed|Period 1: First 10 Days||39
8901384|NCT02071771|9958937|FG001|Dispensed|Period 1: First 10 Days||39
8901385|NCT02071771|9958936|FG000|COMPLETED|Period 1: First 10 Days||39
8901386|NCT02071771|9958937|FG001|COMPLETED|Period 1: First 10 Days||39
8635862|NCT00564954|9676399|FG000|STARTED|Period 2- 1 Week||44
8635863|NCT00564954|9676400|FG001|STARTED|Period 2- 1 Week||42
8635864|NCT00564954|9676399|FG000|COMPLETED|Period 2- 1 Week||44
8635865|NCT00564954|9676400|FG001|COMPLETED|Period 2- 1 Week||42
8901387|NCT02071771|9958936|FG000|NOT COMPLETED|Period 1: First 10 Days||2
8901388|NCT02071771|9958937|FG001|NOT COMPLETED|Period 1: First 10 Days||0
8901389|NCT02071771|9958936|FG000|STARTED|Period 2: Second 10 Days||39
8901390|NCT02071771|9958937|FG001|STARTED|Period 2: Second 10 Days|One participant completed Period 1 but did not start Period 2 due to unacceptable fit with DACP T.|38
8901391|NCT02071771|9958936|FG000|COMPLETED|Period 2: Second 10 Days||39
8901392|NCT02071771|9958937|FG001|COMPLETED|Period 2: Second 10 Days||38
8901393|NCT02071771|9958936|FG000|NOT COMPLETED|Period 2: Second 10 Days||0
8901394|NCT02071771|9958937|FG001|NOT COMPLETED|Period 2: Second 10 Days||0
8901395|NCT02071810|9958948|FG000|STARTED|Overall Study||6
8901396|NCT02071810|9958949|FG001|STARTED|Overall Study||6
8901397|NCT02071810|9958950|FG002|STARTED|Overall Study||6
8901398|NCT02071810|9958951|FG003|STARTED|Overall Study||7
8901399|NCT02071810|9958952|FG004|STARTED|Overall Study||9
8901400|NCT02071810|9958948|FG000|COMPLETED|Overall Study||6
8901401|NCT02071810|9958949|FG001|COMPLETED|Overall Study||6
8901402|NCT02071810|9958950|FG002|COMPLETED|Overall Study||6
8901403|NCT02071810|9958951|FG003|COMPLETED|Overall Study||6
8901404|NCT02071810|9958952|FG004|COMPLETED|Overall Study||8
8901405|NCT02071810|9958948|FG000|NOT COMPLETED|Overall Study||0
8901406|NCT02071810|9958949|FG001|NOT COMPLETED|Overall Study||0
8901407|NCT02071810|9958950|FG002|NOT COMPLETED|Overall Study||0
8901408|NCT02071810|9958951|FG003|NOT COMPLETED|Overall Study||1
8901409|NCT02071810|9958952|FG004|NOT COMPLETED|Overall Study||1
8901410|NCT02071823|9958966|FG000|STARTED|Overall Study||6
8901411|NCT02071823|9958967|FG001|STARTED|Overall Study||6
8901412|NCT02071823|9958966|FG000|COMPLETED|Overall Study||5
8901413|NCT02071823|9958967|FG001|COMPLETED|Overall Study||6
8901414|NCT02071823|9958966|FG000|NOT COMPLETED|Overall Study||1
8901415|NCT02071823|9958967|FG001|NOT COMPLETED|Overall Study||0
9009973|NCT02980601|10072919|FG001|COMPLETED|Overall Study||1
9009974|NCT02980601|10072918|FG000|NOT COMPLETED|Overall Study||5
9009975|NCT02980601|10072919|FG001|NOT COMPLETED|Overall Study||3
9009976|NCT02980692|10072930|FG000|STARTED|Overall Study||78
9009977|NCT02980692|10072931|FG001|STARTED|Overall Study||79
9009978|NCT02980692|10072932|FG002|STARTED|Overall Study||77
9009979|NCT02980692|10072933|FG003|STARTED|Overall Study||78
9009980|NCT02980692|10072934|FG004|STARTED|Overall Study||79
9009981|NCT02980692|10072930|FG000|COMPLETED|Overall Study||69
9009982|NCT02980692|10072931|FG001|COMPLETED|Overall Study||73
9009983|NCT02980692|10072932|FG002|COMPLETED|Overall Study||65
9009984|NCT02980692|10072933|FG003|COMPLETED|Overall Study||69
9009985|NCT02980692|10072934|FG004|COMPLETED|Overall Study||68
9009986|NCT02980692|10072930|FG000|NOT COMPLETED|Overall Study||9
9009987|NCT02980692|10072931|FG001|NOT COMPLETED|Overall Study||6
9009988|NCT02980692|10072932|FG002|NOT COMPLETED|Overall Study||12
9009989|NCT02980692|10072933|FG003|NOT COMPLETED|Overall Study||9
8901416|NCT02071849|9958975|FG000|STARTED|6-month Primary Endpoint||20
8901417|NCT02071849|9958975|FG000|COMPLETED|6-month Primary Endpoint||15
8901418|NCT02071849|9958975|FG000|NOT COMPLETED|6-month Primary Endpoint||5
8901419|NCT02071849|9958975|FG000|STARTED|2-year Extended Follow-up||15
8901420|NCT02071849|9958975|FG000|COMPLETED|2-year Extended Follow-up||14
8901421|NCT02071849|9958975|FG000|NOT COMPLETED|2-year Extended Follow-up||1
8901422|NCT02071914|9958982|FG000|STARTED|Overall Study||27
8901423|NCT02071914|9958983|FG001|STARTED|Overall Study||27
8901424|NCT02071914|9958984|FG002|STARTED|Overall Study||27
8901425|NCT02071914|9958982|FG000|COMPLETED|Overall Study||27
8901426|NCT02071914|9958983|FG001|COMPLETED|Overall Study||27
8901427|NCT02071914|9958984|FG002|COMPLETED|Overall Study||27
8901428|NCT02071914|9958982|FG000|NOT COMPLETED|Overall Study||0
8901429|NCT02071914|9958983|FG001|NOT COMPLETED|Overall Study||0
8901430|NCT02071914|9958984|FG002|NOT COMPLETED|Overall Study||0
8901431|NCT02072096|9958994|FG000|STARTED|Overall Study||99
9009990|NCT02980692|10072934|FG004|NOT COMPLETED|Overall Study||11
9009991|NCT02980705|10072949|FG000|STARTED|Overall Study||50
9009992|NCT02980705|10072950|FG001|STARTED|Overall Study||51
9009993|NCT02980705|10072949|FG000|COMPLETED|Overall Study||42
9009994|NCT02980705|10072950|FG001|COMPLETED|Overall Study||40
9009995|NCT02980705|10072949|FG000|NOT COMPLETED|Overall Study||8
8901432|NCT02072096|9958995|FG001|STARTED|Overall Study||93
8901433|NCT02072096|9958994|FG000|Received at Least One Dose of Study Drug|Overall Study||98
9009996|NCT02980705|10072950|FG001|NOT COMPLETED|Overall Study||11
9009997|NCT02980783|10072957|FG000|STARTED|Overall Study||53
9009998|NCT02980783|10072957|FG000|COMPLETED|Overall Study||52
8572935|NCT00117676|9605093|FG000|STARTED|Open-label Period: Weeks 289 - 336||192
8572936|NCT00117676|9605094|FG001|STARTED|Open-label Period: Weeks 289 - 336||100
8572937|NCT00117676|9605093|FG000|COMPLETED|Open-label Period: Weeks 289 - 336||183
8572938|NCT00117676|9605094|FG001|COMPLETED|Open-label Period: Weeks 289 - 336||93
8572939|NCT00117676|9605093|FG000|NOT COMPLETED|Open-label Period: Weeks 289 - 336||9
8901434|NCT02072096|9958995|FG001|Received at Least One Dose of Study Drug|Overall Study||93
9009999|NCT02980783|10072957|FG000|NOT COMPLETED|Overall Study||1
9010000|NCT02980874|10072963|FG000|STARTED|Overall Study||231
9010001|NCT02980874|10072964|FG001|STARTED|Overall Study||229
9010002|NCT02980874|10072963|FG000|COMPLETED|Overall Study||128
9010003|NCT02980874|10072964|FG001|COMPLETED|Overall Study||127
9010004|NCT02980874|10072963|FG000|NOT COMPLETED|Overall Study||103
9010005|NCT02980874|10072964|FG001|NOT COMPLETED|Overall Study||102
9010006|NCT02980978|10072972|FG000|STARTED|Overall Study||60
9010007|NCT02980978|10072973|FG001|STARTED|Overall Study||58
9010008|NCT02980978|10072972|FG000|COMPLETED|Overall Study||54
9010009|NCT02980978|10072973|FG001|COMPLETED|Overall Study||50
9010010|NCT02980978|10072972|FG000|NOT COMPLETED|Overall Study||6
9010011|NCT02980978|10072973|FG001|NOT COMPLETED|Overall Study||8
9010012|NCT02981342|10072983|FG000|STARTED|Overall Study||7
9010013|NCT02981342|10072984|FG001|STARTED|Overall Study||33
9010014|NCT02981342|10072985|FG002|STARTED|Overall Study||33
9010015|NCT02981342|10072986|FG003|STARTED|Overall Study||33
9010016|NCT02981342|10072983|FG000|Received at Least One Dose of Study Drug|Overall Study||7
9010017|NCT02981342|10072984|FG001|Received at Least One Dose of Study Drug|Overall Study||32
9010018|NCT02981342|10072985|FG002|Received at Least One Dose of Study Drug|Overall Study||33
9010019|NCT02981342|10072986|FG003|Received at Least One Dose of Study Drug|Overall Study||26
9010020|NCT02981342|10072983|FG000|COMPLETED|Overall Study||7
9010021|NCT02981342|10072984|FG001|COMPLETED|Overall Study||22
9010022|NCT02981342|10072985|FG002|COMPLETED|Overall Study||20
9010023|NCT02981342|10072986|FG003|COMPLETED|Overall Study||19
9010024|NCT02981342|10072983|FG000|NOT COMPLETED|Overall Study||0
9010025|NCT02981342|10072984|FG001|NOT COMPLETED|Overall Study||11
9010026|NCT02981342|10072985|FG002|NOT COMPLETED|Overall Study||13
9010027|NCT02981342|10072986|FG003|NOT COMPLETED|Overall Study||14
9039588|NCT03340428|10100585|FG000|NOT COMPLETED|Overall Study||1
9039589|NCT03340428|10100586|FG001|NOT COMPLETED|Overall Study||0
9039590|NCT03340610|10100592|FG000|STARTED|Overall Study||30
9039591|NCT03340610|10100592|FG000|COMPLETED|Overall Study||27
9039592|NCT03340610|10100592|FG000|NOT COMPLETED|Overall Study||3
9039593|NCT03340805|10100598|FG000|STARTED|Overall Study||24
9039594|NCT03340805|10100599|FG001|STARTED|Overall Study||26
9039595|NCT03340805|10100598|FG000|COMPLETED|Overall Study|1 subject withdrew early from study fluid administration but stayed in trial for outcome assessment|24
9039596|NCT03340805|10100599|FG001|COMPLETED|Overall Study||26
9039597|NCT03340805|10100598|FG000|NOT COMPLETED|Overall Study||0
9039598|NCT03340805|10100599|FG001|NOT COMPLETED|Overall Study||0
9039599|NCT03340883|10100607|FG000|STARTED|Overall Study||4
8901435|NCT02072096|9958994|FG000|COMPLETED|Overall Study||14
9039600|NCT03340883|10100608|FG001|STARTED|Overall Study||3
9039601|NCT03340883|10100609|FG002|STARTED|Overall Study||4
9039602|NCT03340883|10100610|FG003|STARTED|Overall Study||4
9039603|NCT03340883|10100611|FG004|STARTED|Overall Study||3
9039604|NCT03340883|10100612|FG005|STARTED|Overall Study||3
9039605|NCT03340883|10100607|FG000|COMPLETED|Overall Study||4
9039606|NCT03340883|10100608|FG001|COMPLETED|Overall Study||3
9039607|NCT03340883|10100609|FG002|COMPLETED|Overall Study||4
9039608|NCT03340883|10100610|FG003|COMPLETED|Overall Study||4
9039609|NCT03340883|10100611|FG004|COMPLETED|Overall Study||3
9039610|NCT03340883|10100612|FG005|COMPLETED|Overall Study||3
9039611|NCT03340883|10100607|FG000|NOT COMPLETED|Overall Study||0
8572940|NCT00117676|9605094|FG001|NOT COMPLETED|Open-label Period: Weeks 289 - 336||7
8901436|NCT02072096|9958995|FG001|COMPLETED|Overall Study||15
8901437|NCT02072096|9958994|FG000|NOT COMPLETED|Overall Study||85
8901438|NCT02072096|9958995|FG001|NOT COMPLETED|Overall Study||78
8901439|NCT02072174|9959004|FG000|STARTED|Overall Study||290
8901440|NCT02072174|9959005|FG001|STARTED|Overall Study||279
8901441|NCT02072174|9959004|FG000|COMPLETED|Overall Study||258
8901442|NCT02072174|9959005|FG001|COMPLETED|Overall Study||240
8901443|NCT02072174|9959004|FG000|NOT COMPLETED|Overall Study||32
8901444|NCT02072174|9959005|FG001|NOT COMPLETED|Overall Study||39
8901445|NCT02072200|9959013|FG000|STARTED|Overall Study||147
8901446|NCT02072200|9959013|FG000|COMPLETED|Overall Study||145
8901447|NCT02072200|9959013|FG000|NOT COMPLETED|Overall Study||2
8901448|NCT02072226|9959019|FG000|STARTED|Overall Study||156
8901449|NCT02072226|9959020|FG001|STARTED|Overall Study||157
8901450|NCT02072226|9959019|FG000|COMPLETED|Overall Study||141
8901451|NCT02072226|9959020|FG001|COMPLETED|Overall Study||147
8901452|NCT02072226|9959019|FG000|NOT COMPLETED|Overall Study||15
8901453|NCT02072226|9959020|FG001|NOT COMPLETED|Overall Study||10
8901454|NCT02072421|9959026|FG000|STARTED|Overall Study||2879
8901455|NCT02072421|9959026|FG000|COMPLETED|Overall Study||2489
8901456|NCT02072421|9959026|FG000|NOT COMPLETED|Overall Study||390
8901457|NCT02072434|9959033|FG000|STARTED|Overall Study||1095
8901458|NCT02072434|9959034|FG001|STARTED|Overall Study||1104
8901459|NCT02072434|9959033|FG000|Intent to Treat Analysis Set|Overall Study||1095
8901460|NCT02072434|9959034|FG001|Intent to Treat Analysis Set|Overall Study||1104
8901461|NCT02072434|9959033|FG000|Received Study Drug|Overall Study||1067
8901462|NCT02072434|9959034|FG001|Received Study Drug|Overall Study||1082
8901463|NCT02072434|9959033|FG000|Safety Analysis Set|Overall Study||1067
8901464|NCT02072434|9959034|FG001|Safety Analysis Set|Overall Study||1082
8901465|NCT02072434|9959033|FG000|COMPLETED|Overall Study||1041
8901466|NCT02072434|9959034|FG001|COMPLETED|Overall Study||1014
8901467|NCT02072434|9959033|FG000|NOT COMPLETED|Overall Study||54
8901468|NCT02072434|9959034|FG001|NOT COMPLETED|Overall Study||90
8901469|NCT02072668|9959040|FG000|STARTED|First Intervention||7
8901470|NCT02072668|9959041|FG001|STARTED|First Intervention||7
8901471|NCT02072668|9959040|FG000|COMPLETED|First Intervention||7
8901472|NCT02072668|9959041|FG001|COMPLETED|First Intervention||7
8901473|NCT02072668|9959040|FG000|NOT COMPLETED|First Intervention||0
8901474|NCT02072668|9959041|FG001|NOT COMPLETED|First Intervention||0
8901475|NCT02072668|9959040|FG000|STARTED|Washout (2 Weeks)||7
8901476|NCT02072668|9959041|FG001|STARTED|Washout (2 Weeks)||7
8901477|NCT02072668|9959040|FG000|COMPLETED|Washout (2 Weeks)||7
8901478|NCT02072668|9959041|FG001|COMPLETED|Washout (2 Weeks)||7
8901479|NCT02072668|9959040|FG000|NOT COMPLETED|Washout (2 Weeks)||0
8901480|NCT02072668|9959041|FG001|NOT COMPLETED|Washout (2 Weeks)||0
8901481|NCT02072668|9959040|FG000|STARTED|Second Intervention||7
8901482|NCT02072668|9959041|FG001|STARTED|Second Intervention||7
8901483|NCT02072668|9959040|FG000|COMPLETED|Second Intervention||6
8901484|NCT02072668|9959041|FG001|COMPLETED|Second Intervention||7
8901485|NCT02072668|9959040|FG000|NOT COMPLETED|Second Intervention||1
8901486|NCT02072668|9959041|FG001|NOT COMPLETED|Second Intervention||0
8901487|NCT02072824|9959052|FG000|STARTED|Overall Study||71
8901488|NCT02072824|9959053|FG001|STARTED|Overall Study||34
8901489|NCT02072824|9959054|FG002|STARTED|Overall Study||70
8901490|NCT02072824|9959052|FG000|COMPLETED|Overall Study||69
8901491|NCT02072824|9959053|FG001|COMPLETED|Overall Study||33
8901492|NCT02072824|9959054|FG002|COMPLETED|Overall Study||67
8901493|NCT02072824|9959052|FG000|NOT COMPLETED|Overall Study||2
8901494|NCT02072824|9959053|FG001|NOT COMPLETED|Overall Study||1
8901495|NCT02072824|9959054|FG002|NOT COMPLETED|Overall Study||3
8901496|NCT02072928|9959062|FG000|STARTED|Overall Study||55
8901497|NCT02072928|9959062|FG000|COMPLETED|Overall Study||55
8901498|NCT02072928|9959062|FG000|NOT COMPLETED|Overall Study||0
8901499|NCT02072941|9959068|FG000|STARTED|Overall Study||219
8901500|NCT02072941|9959069|FG001|STARTED|Overall Study||226
8901501|NCT02072941|9959068|FG000|COMPLETED|Overall Study||181
8901502|NCT02072941|9959069|FG001|COMPLETED|Overall Study||197
8901503|NCT02072941|9959068|FG000|NOT COMPLETED|Overall Study||38
8901504|NCT02072941|9959069|FG001|NOT COMPLETED|Overall Study||29
8901505|NCT02072980|9959075|FG000|STARTED|Period 1, First Wear||7
8901506|NCT02072980|9959076|FG001|STARTED|Period 1, First Wear||8
8901507|NCT02072980|9959075|FG000|COMPLETED|Period 1, First Wear||7
8901508|NCT02072980|9959076|FG001|COMPLETED|Period 1, First Wear||8
8901509|NCT02072980|9959075|FG000|NOT COMPLETED|Period 1, First Wear||0
8901510|NCT02072980|9959076|FG001|NOT COMPLETED|Period 1, First Wear||0
8901511|NCT02072980|9959075|FG000|STARTED|Period 2, Second Wear||7
8901512|NCT02072980|9959076|FG001|STARTED|Period 2, Second Wear||8
8901513|NCT02072980|9959075|FG000|COMPLETED|Period 2, Second Wear||7
8901514|NCT02072980|9959076|FG001|COMPLETED|Period 2, Second Wear||7
8901515|NCT02072980|9959075|FG000|NOT COMPLETED|Period 2, Second Wear||0
8901516|NCT02072980|9959076|FG001|NOT COMPLETED|Period 2, Second Wear||1
8901517|NCT02073162|9959084|FG000|STARTED|Overall Study||1499
8901518|NCT02073162|9959085|FG001|STARTED|Overall Study||1501
8901519|NCT02073162|9959084|FG000|COMPLETED|Overall Study||1493
8901520|NCT02073162|9959085|FG001|COMPLETED|Overall Study||1490
8901521|NCT02073162|9959084|FG000|NOT COMPLETED|Overall Study||6
8901522|NCT02073162|9959085|FG001|NOT COMPLETED|Overall Study||11
8901523|NCT02073331|9959091|FG000|STARTED|Overall Study||1420
8901524|NCT02073331|9959091|FG000|COMPLETED|Overall Study||1420
8901525|NCT02073331|9959091|FG000|NOT COMPLETED|Overall Study||0
8901526|NCT02073435|9959097|FG000|STARTED|Overall Study||81
8901527|NCT02073435|9959098|FG001|STARTED|Overall Study||96
8901528|NCT02073435|9959097|FG000|COMPLETED|Overall Study||81
8901529|NCT02073435|9959098|FG001|COMPLETED|Overall Study||96
8901530|NCT02073435|9959097|FG000|NOT COMPLETED|Overall Study||0
8901531|NCT02073435|9959098|FG001|NOT COMPLETED|Overall Study||0
8901532|NCT02073448|9959107|FG000|STARTED|Overall Study||101
8901533|NCT02073448|9959108|FG001|STARTED|Overall Study||212
8901534|NCT02073448|9959109|FG002|STARTED|Overall Study||104
8901535|NCT02073448|9959107|FG000|COMPLETED|Overall Study||99
8901536|NCT02073448|9959108|FG001|COMPLETED|Overall Study||200
8901537|NCT02073448|9959109|FG002|COMPLETED|Overall Study||99
8901538|NCT02073448|9959107|FG000|NOT COMPLETED|Overall Study||2
8901539|NCT02073448|9959108|FG001|NOT COMPLETED|Overall Study||12
8901540|NCT02073448|9959109|FG002|NOT COMPLETED|Overall Study||5
8901541|NCT02073461|9959122|FG000|STARTED|Overall Study||79
8901542|NCT02073461|9959123|FG001|STARTED|Overall Study||78
8901543|NCT02073461|9959124|FG002|STARTED|Overall Study||79
8901544|NCT02073461|9959122|FG000|COMPLETED|Overall Study||75
8901545|NCT02073461|9959123|FG001|COMPLETED|Overall Study||77
8901546|NCT02073461|9959124|FG002|COMPLETED|Overall Study||78
8901547|NCT02073461|9959122|FG000|NOT COMPLETED|Overall Study||4
8901548|NCT02073461|9959123|FG001|NOT COMPLETED|Overall Study||1
8901549|NCT02073461|9959124|FG002|NOT COMPLETED|Overall Study||1
8901550|NCT02073487|9959134|FG000|STARTED|Overall Study||16
8901551|NCT02073487|9959135|FG001|STARTED|Overall Study||16
8901552|NCT02073487|9959134|FG000|COMPLETED|Overall Study||14
8901553|NCT02073487|9959135|FG001|COMPLETED|Overall Study||16
8901554|NCT02073487|9959134|FG000|NOT COMPLETED|Overall Study||2
8901555|NCT02073487|9959135|FG001|NOT COMPLETED|Overall Study||0
8901556|NCT02073643|9959142|FG000|STARTED|Overall Study||204
8901557|NCT02073643|9959142|FG000|COMPLETED|Overall Study||180
8901558|NCT02073643|9959142|FG000|NOT COMPLETED|Overall Study||24
8901559|NCT02073656|9959146|FG000|STARTED|Primary Study||335
8901560|NCT02073656|9959146|FG000|COMPLETED|Primary Study||327
8901561|NCT02073656|9959146|FG000|NOT COMPLETED|Primary Study||8
8901562|NCT02073656|9959146|FG000|STARTED|Retreatment Substudy|Only participants experiencing virologic relapse in the Primary Study were eligible for retreatment.|9
8901563|NCT02073656|9959146|FG000|COMPLETED|Retreatment Substudy||9
8901564|NCT02073656|9959146|FG000|NOT COMPLETED|Retreatment Substudy||0
8901565|NCT02073682|9959154|FG000|STARTED|Overall Study||522
8901566|NCT02073682|9959155|FG001|STARTED|Overall Study||524
8901567|NCT02073682|9959154|FG000|COMPLETED|Overall Study||200
8901568|NCT02073682|9959155|FG001|COMPLETED|Overall Study||154
8901569|NCT02073682|9959154|FG000|NOT COMPLETED|Overall Study||322
8901570|NCT02073682|9959155|FG001|NOT COMPLETED|Overall Study||370
8901571|NCT02073747|9959163|FG000|STARTED|Overall Study||15
8901572|NCT02073747|9959164|FG001|STARTED|Overall Study||15
8901573|NCT02073747|9959163|FG000|COMPLETED|Overall Study||14
8901574|NCT02073747|9959164|FG001|COMPLETED|Overall Study||14
8901575|NCT02073747|9959163|FG000|NOT COMPLETED|Overall Study||1
8901576|NCT02073747|9959164|FG001|NOT COMPLETED|Overall Study||1
8901577|NCT02073929|9959172|FG000|STARTED|Overall Study||48
8901578|NCT02073929|9959173|FG001|STARTED|Overall Study||24
8901579|NCT02073929|9959172|FG000|COMPLETED|Overall Study||44
8901580|NCT02073929|9959173|FG001|COMPLETED|Overall Study||21
8901581|NCT02073929|9959172|FG000|NOT COMPLETED|Overall Study||4
8901582|NCT02073929|9959173|FG001|NOT COMPLETED|Overall Study||3
8901583|NCT02074059|9959185|FG000|STARTED|Overall Study||8
9010028|NCT02981368|10073000|FG000|STARTED|Overall Study||268
9010029|NCT02981368|10073001|FG001|STARTED|Overall Study||117
9010030|NCT02981368|10073000|FG000|COMPLETED|Overall Study||248
9010031|NCT02981368|10073001|FG001|COMPLETED|Overall Study||102
9010032|NCT02981368|10073000|FG000|NOT COMPLETED|Overall Study||20
9010033|NCT02981368|10073001|FG001|NOT COMPLETED|Overall Study||15
9010034|NCT02981524|10073034|FG000|STARTED|Overall Study||17
9010035|NCT02981524|10073034|FG000|COMPLETED|Overall Study||0
9010036|NCT02981524|10073034|FG000|NOT COMPLETED|Overall Study||17
9010037|NCT02981602|10073043|FG000|STARTED|Overall Study||6
9010038|NCT02981602|10073044|FG001|STARTED|Overall Study||12
9010039|NCT02981602|10073045|FG002|STARTED|Overall Study||6
9010040|NCT02981602|10073046|FG003|STARTED|Overall Study||5
9010041|NCT02981602|10073047|FG004|STARTED|Overall Study||2
9010042|NCT02981602|10073043|FG000|COMPLETED|Overall Study||6
8901584|NCT02074059|9959186|FG001|STARTED|Overall Study||8
8901585|NCT02074059|9959187|FG002|STARTED|Overall Study||8
8901586|NCT02074059|9959188|FG003|STARTED|Overall Study||8
8901587|NCT02074059|9959189|FG004|STARTED|Overall Study||8
8901588|NCT02074059|9959190|FG005|STARTED|Overall Study||40
8901589|NCT02074059|9959185|FG000|COMPLETED|Overall Study||8
8901590|NCT02074059|9959186|FG001|COMPLETED|Overall Study||8
8901591|NCT02074059|9959187|FG002|COMPLETED|Overall Study||8
8901592|NCT02074059|9959188|FG003|COMPLETED|Overall Study||8
8901593|NCT02074059|9959189|FG004|COMPLETED|Overall Study||7
8901594|NCT02074059|9959190|FG005|COMPLETED|Overall Study||39
9010043|NCT02981602|10073044|FG001|COMPLETED|Overall Study||12
9010044|NCT02981602|10073045|FG002|COMPLETED|Overall Study||6
9010045|NCT02981602|10073046|FG003|COMPLETED|Overall Study||4
9010046|NCT02981602|10073047|FG004|COMPLETED|Overall Study||2
9010047|NCT02981602|10073043|FG000|NOT COMPLETED|Overall Study||0
8901595|NCT02074059|9959185|FG000|NOT COMPLETED|Overall Study||0
8901596|NCT02074059|9959186|FG001|NOT COMPLETED|Overall Study||0
8901597|NCT02074059|9959187|FG002|NOT COMPLETED|Overall Study||0
8901598|NCT02074059|9959188|FG003|NOT COMPLETED|Overall Study||0
8901599|NCT02074059|9959189|FG004|NOT COMPLETED|Overall Study||1
8901600|NCT02074059|9959190|FG005|NOT COMPLETED|Overall Study||1
8901601|NCT02074345|9959205|FG000|STARTED|Overall Study||31
8901602|NCT02074345|9959205|FG000|COMPLETED|Overall Study||31
8901603|NCT02074345|9959205|FG000|NOT COMPLETED|Overall Study||0
8901604|NCT02074358|9959209|FG000|STARTED|Overall Study||3
8901605|NCT02074358|9959210|FG001|STARTED|Overall Study||3
8901606|NCT02074358|9959211|FG002|STARTED|Overall Study||2
8901607|NCT02074358|9959212|FG003|STARTED|Overall Study||2
8901608|NCT02074358|9959213|FG004|STARTED|Overall Study||3
8901609|NCT02074358|9959214|FG005|STARTED|Overall Study||2
8901610|NCT02074358|9959209|FG000|COMPLETED|Overall Study||3
8901611|NCT02074358|9959210|FG001|COMPLETED|Overall Study||3
8901612|NCT02074358|9959211|FG002|COMPLETED|Overall Study||2
8901613|NCT02074358|9959212|FG003|COMPLETED|Overall Study||2
8901614|NCT02074358|9959213|FG004|COMPLETED|Overall Study||3
8901615|NCT02074358|9959214|FG005|COMPLETED|Overall Study||2
8901616|NCT02074358|9959209|FG000|NOT COMPLETED|Overall Study||0
8901617|NCT02074358|9959210|FG001|NOT COMPLETED|Overall Study||0
8901618|NCT02074358|9959211|FG002|NOT COMPLETED|Overall Study||0
8901619|NCT02074358|9959212|FG003|NOT COMPLETED|Overall Study||0
8901620|NCT02074358|9959213|FG004|NOT COMPLETED|Overall Study||0
8901621|NCT02074358|9959214|FG005|NOT COMPLETED|Overall Study||0
8901622|NCT02074384|9959225|FG000|STARTED|Overall Study||74
8901623|NCT02074384|9959226|FG001|STARTED|Overall Study||70
8901624|NCT02074384|9959227|FG002|STARTED|Overall Study||17
8901625|NCT02074384|9959225|FG000|COMPLETED|Overall Study||74
8901626|NCT02074384|9959226|FG001|COMPLETED|Overall Study||70
8901627|NCT02074384|9959227|FG002|COMPLETED|Overall Study||17
8901628|NCT02074384|9959225|FG000|NOT COMPLETED|Overall Study||0
8901629|NCT02074384|9959226|FG001|NOT COMPLETED|Overall Study||0
8901630|NCT02074384|9959227|FG002|NOT COMPLETED|Overall Study||0
8901631|NCT02074514|9959239|FG000|STARTED|Overall Study||59
8901632|NCT02074514|9959240|FG001|STARTED|Overall Study||58
8901633|NCT02074514|9959239|FG000|COMPLETED|Overall Study||56
8901634|NCT02074514|9959240|FG001|COMPLETED|Overall Study||54
8901635|NCT02074514|9959239|FG000|NOT COMPLETED|Overall Study||3
8901636|NCT02074514|9959240|FG001|NOT COMPLETED|Overall Study||4
8901637|NCT02074553|9959252|FG000|STARTED|Intervention Period 1||12
8901638|NCT02074553|9959253|FG001|STARTED|Intervention Period 1||12
8901639|NCT02074553|9959254|FG002|STARTED|Intervention Period 1||12
8901640|NCT02074553|9959255|FG003|STARTED|Intervention Period 1||13
8901641|NCT02074553|9959256|FG004|STARTED|Intervention Period 1||12
8901642|NCT02074553|9959257|FG005|STARTED|Intervention Period 1||12
8901643|NCT02074553|9959258|FG006|STARTED|Intervention Period 1||12
8901644|NCT02074553|9959259|FG007|STARTED|Intervention Period 1||12
8901645|NCT02074553|9959252|FG000|COMPLETED|Intervention Period 1||12
8901646|NCT02074553|9959253|FG001|COMPLETED|Intervention Period 1||12
8901647|NCT02074553|9959254|FG002|COMPLETED|Intervention Period 1||12
8901648|NCT02074553|9959255|FG003|COMPLETED|Intervention Period 1||12
8901649|NCT02074553|9959256|FG004|COMPLETED|Intervention Period 1||12
8901650|NCT02074553|9959257|FG005|COMPLETED|Intervention Period 1||12
8901651|NCT02074553|9959258|FG006|COMPLETED|Intervention Period 1||12
8901652|NCT02074553|9959259|FG007|COMPLETED|Intervention Period 1||12
8901653|NCT02074553|9959252|FG000|NOT COMPLETED|Intervention Period 1||0
8901654|NCT02074553|9959253|FG001|NOT COMPLETED|Intervention Period 1||0
8901655|NCT02074553|9959254|FG002|NOT COMPLETED|Intervention Period 1||0
8901656|NCT02074553|9959255|FG003|NOT COMPLETED|Intervention Period 1||1
8901657|NCT02074553|9959256|FG004|NOT COMPLETED|Intervention Period 1||0
8901658|NCT02074553|9959257|FG005|NOT COMPLETED|Intervention Period 1||0
8901659|NCT02074553|9959258|FG006|NOT COMPLETED|Intervention Period 1||0
8901660|NCT02074553|9959259|FG007|NOT COMPLETED|Intervention Period 1||0
8901661|NCT02074553|9959252|FG000|STARTED|Washout Period 1||12
8901662|NCT02074553|9959253|FG001|STARTED|Washout Period 1||12
8901663|NCT02074553|9959254|FG002|STARTED|Washout Period 1||12
8901664|NCT02074553|9959255|FG003|STARTED|Washout Period 1||12
8901665|NCT02074553|9959256|FG004|STARTED|Washout Period 1||12
8901666|NCT02074553|9959257|FG005|STARTED|Washout Period 1||12
8901667|NCT02074553|9959258|FG006|STARTED|Washout Period 1||12
8901668|NCT02074553|9959259|FG007|STARTED|Washout Period 1||12
8901669|NCT02074553|9959252|FG000|COMPLETED|Washout Period 1||11
8901670|NCT02074553|9959253|FG001|COMPLETED|Washout Period 1||12
8901671|NCT02074553|9959254|FG002|COMPLETED|Washout Period 1||12
8901672|NCT02074553|9959255|FG003|COMPLETED|Washout Period 1||11
8901673|NCT02074553|9959256|FG004|COMPLETED|Washout Period 1||12
8901674|NCT02074553|9959257|FG005|COMPLETED|Washout Period 1||11
8901675|NCT02074553|9959258|FG006|COMPLETED|Washout Period 1||12
8901676|NCT02074553|9959259|FG007|COMPLETED|Washout Period 1||12
8901677|NCT02074553|9959252|FG000|NOT COMPLETED|Washout Period 1||1
8901678|NCT02074553|9959253|FG001|NOT COMPLETED|Washout Period 1||0
8901679|NCT02074553|9959254|FG002|NOT COMPLETED|Washout Period 1||0
8901680|NCT02074553|9959255|FG003|NOT COMPLETED|Washout Period 1||1
8901681|NCT02074553|9959256|FG004|NOT COMPLETED|Washout Period 1||0
8901682|NCT02074553|9959257|FG005|NOT COMPLETED|Washout Period 1||1
8901683|NCT02074553|9959258|FG006|NOT COMPLETED|Washout Period 1||0
8901684|NCT02074553|9959259|FG007|NOT COMPLETED|Washout Period 1||0
8901685|NCT02074553|9959252|FG000|STARTED|Intervention Period 2||11
8901686|NCT02074553|9959253|FG001|STARTED|Intervention Period 2||12
8901687|NCT02074553|9959254|FG002|STARTED|Intervention Period 2||12
8901688|NCT02074553|9959255|FG003|STARTED|Intervention Period 2||11
8901689|NCT02074553|9959256|FG004|STARTED|Intervention Period 2||12
8901690|NCT02074553|9959257|FG005|STARTED|Intervention Period 2||11
8901691|NCT02074553|9959258|FG006|STARTED|Intervention Period 2||12
8901692|NCT02074553|9959259|FG007|STARTED|Intervention Period 2||12
8901693|NCT02074553|9959252|FG000|COMPLETED|Intervention Period 2||11
8901694|NCT02074553|9959253|FG001|COMPLETED|Intervention Period 2||12
8901695|NCT02074553|9959254|FG002|COMPLETED|Intervention Period 2||12
8901696|NCT02074553|9959255|FG003|COMPLETED|Intervention Period 2||11
8901697|NCT02074553|9959256|FG004|COMPLETED|Intervention Period 2||12
8901698|NCT02074553|9959257|FG005|COMPLETED|Intervention Period 2||11
8901699|NCT02074553|9959258|FG006|COMPLETED|Intervention Period 2||12
9010048|NCT02981602|10073044|FG001|NOT COMPLETED|Overall Study||0
9010049|NCT02981602|10073045|FG002|NOT COMPLETED|Overall Study||0
9010050|NCT02981602|10073046|FG003|NOT COMPLETED|Overall Study||1
9010051|NCT02981602|10073047|FG004|NOT COMPLETED|Overall Study||0
9010052|NCT02981953|10073060|FG000|STARTED|Overall Study||40
9010053|NCT02981953|10073060|FG000|COMPLETED|Overall Study||29
9010054|NCT02981953|10073060|FG000|NOT COMPLETED|Overall Study||11
9010055|NCT02982018|10073066|FG000|STARTED|Overall Study||67
9010056|NCT02982018|10073067|FG001|STARTED|Overall Study||64
9010057|NCT02982018|10073066|FG000|COMPLETED|Overall Study||62
9010058|NCT02982018|10073067|FG001|COMPLETED|Overall Study||61
9010059|NCT02982018|10073066|FG000|NOT COMPLETED|Overall Study||5
9010060|NCT02982018|10073067|FG001|NOT COMPLETED|Overall Study||3
9010061|NCT02982187|10073075|FG000|STARTED|Overall Study||20
9010062|NCT02982187|10073076|FG001|STARTED|Overall Study||20
9010063|NCT02982187|10073077|FG002|STARTED|Overall Study||20
9010064|NCT02982187|10073078|FG003|STARTED|Overall Study||20
9010065|NCT02982187|10073079|FG004|STARTED|Overall Study||20
9010066|NCT02982187|10073080|FG005|STARTED|Overall Study||20
9010067|NCT02982187|10073081|FG006|STARTED|Overall Study||20
9010068|NCT02982187|10073082|FG007|STARTED|Overall Study||20
9010069|NCT02982187|10073075|FG000|COMPLETED|Overall Study||20
9010070|NCT02982187|10073076|FG001|COMPLETED|Overall Study||20
9010071|NCT02982187|10073077|FG002|COMPLETED|Overall Study||20
9010072|NCT02982187|10073078|FG003|COMPLETED|Overall Study||20
9010073|NCT02982187|10073079|FG004|COMPLETED|Overall Study||20
9010074|NCT02982187|10073080|FG005|COMPLETED|Overall Study||20
9010075|NCT02982187|10073081|FG006|COMPLETED|Overall Study||19
9010076|NCT02982187|10073082|FG007|COMPLETED|Overall Study||20
9010077|NCT02982187|10073075|FG000|NOT COMPLETED|Overall Study||0
9010078|NCT02982187|10073076|FG001|NOT COMPLETED|Overall Study||0
9010079|NCT02982187|10073077|FG002|NOT COMPLETED|Overall Study||0
9010080|NCT02982187|10073078|FG003|NOT COMPLETED|Overall Study||0
9010081|NCT02982187|10073079|FG004|NOT COMPLETED|Overall Study||0
9010082|NCT02982187|10073080|FG005|NOT COMPLETED|Overall Study||0
9010083|NCT02982187|10073081|FG006|NOT COMPLETED|Overall Study||1
9010084|NCT02982187|10073082|FG007|NOT COMPLETED|Overall Study||0
9010085|NCT02982213|10073094|FG000|STARTED|Overall Study||75
9010086|NCT02982213|10073095|FG001|STARTED|Overall Study||75
9010087|NCT02982213|10073094|FG000|COMPLETED|Overall Study||70
9010088|NCT02982213|10073095|FG001|COMPLETED|Overall Study||74
9010089|NCT02982213|10073094|FG000|NOT COMPLETED|Overall Study||5
9010090|NCT02982213|10073095|FG001|NOT COMPLETED|Overall Study||1
9010091|NCT02982239|10073103|FG000|STARTED|Overall Study||20
9010092|NCT02982239|10073104|FG001|STARTED|Overall Study||20
9010093|NCT02982239|10073103|FG000|COMPLETED|Overall Study||17
9010094|NCT02982239|10073104|FG001|COMPLETED|Overall Study||18
9010095|NCT02982239|10073103|FG000|NOT COMPLETED|Overall Study||3
9010096|NCT02982239|10073104|FG001|NOT COMPLETED|Overall Study||2
9010097|NCT02982590|10073113|FG000|STARTED|Overall Study||13
8901700|NCT02074553|9959259|FG007|COMPLETED|Intervention Period 2||12
8901701|NCT02074553|9959252|FG000|NOT COMPLETED|Intervention Period 2||0
8901702|NCT02074553|9959253|FG001|NOT COMPLETED|Intervention Period 2||0
9010098|NCT02982590|10073114|FG001|STARTED|Overall Study||14
9010099|NCT02982590|10073113|FG000|COMPLETED|Overall Study||9
9010100|NCT02982590|10073114|FG001|COMPLETED|Overall Study||13
9010101|NCT02982590|10073113|FG000|NOT COMPLETED|Overall Study||4
9010102|NCT02982590|10073114|FG001|NOT COMPLETED|Overall Study||1
9010103|NCT02982772|10073122|FG000|STARTED|Enrollment||245
9010104|NCT02982772|10073123|FG001|STARTED|Enrollment||243
9010105|NCT02982772|10073122|FG000|COMPLETED|Enrollment||245
9010106|NCT02982772|10073123|FG001|COMPLETED|Enrollment||243
9010107|NCT02982772|10073122|FG000|NOT COMPLETED|Enrollment||0
9010108|NCT02982772|10073123|FG001|NOT COMPLETED|Enrollment||0
9010109|NCT02982772|10073122|FG000|STARTED|Intervention||245
9010110|NCT02982772|10073123|FG001|STARTED|Intervention||243
9010111|NCT02982772|10073122|FG000|COMPLETED|Intervention||226
9010112|NCT02982772|10073123|FG001|COMPLETED|Intervention||230
9010113|NCT02982772|10073122|FG000|NOT COMPLETED|Intervention||19
9010114|NCT02982772|10073123|FG001|NOT COMPLETED|Intervention||13
9010115|NCT02982772|10073122|FG000|STARTED|1M Follow-Up||226
9010116|NCT02982772|10073123|FG001|STARTED|1M Follow-Up||230
9010117|NCT02982772|10073122|FG000|COMPLETED|1M Follow-Up||205
9010118|NCT02982772|10073123|FG001|COMPLETED|1M Follow-Up||212
9010119|NCT02982772|10073122|FG000|NOT COMPLETED|1M Follow-Up||21
9010120|NCT02982772|10073123|FG001|NOT COMPLETED|1M Follow-Up||18
9010121|NCT02982772|10073122|FG000|STARTED|3M Follow-Up||205
8635866|NCT00564954|9676399|FG000|NOT COMPLETED|Period 2- 1 Week||0
8901703|NCT02074553|9959254|FG002|NOT COMPLETED|Intervention Period 2||0
8901704|NCT02074553|9959255|FG003|NOT COMPLETED|Intervention Period 2||0
8901705|NCT02074553|9959256|FG004|NOT COMPLETED|Intervention Period 2||0
8901706|NCT02074553|9959257|FG005|NOT COMPLETED|Intervention Period 2||0
8901707|NCT02074553|9959258|FG006|NOT COMPLETED|Intervention Period 2||0
8901708|NCT02074553|9959259|FG007|NOT COMPLETED|Intervention Period 2||0
8901709|NCT02074553|9959252|FG000|STARTED|Washout Period 2||11
8901710|NCT02074553|9959253|FG001|STARTED|Washout Period 2||12
8901711|NCT02074553|9959254|FG002|STARTED|Washout Period 2||12
9010122|NCT02982772|10073123|FG001|STARTED|3M Follow-Up||212
9010123|NCT02982772|10073122|FG000|COMPLETED|3M Follow-Up||188
9010124|NCT02982772|10073123|FG001|COMPLETED|3M Follow-Up||201
9010125|NCT02982772|10073122|FG000|NOT COMPLETED|3M Follow-Up||17
9010126|NCT02982772|10073123|FG001|NOT COMPLETED|3M Follow-Up||11
9010127|NCT02982772|10073122|FG000|STARTED|6M Follow-Up||188
9010128|NCT02982772|10073123|FG001|STARTED|6M Follow-Up||201
9010129|NCT02982772|10073122|FG000|COMPLETED|6M Follow-Up||177
9010130|NCT02982772|10073123|FG001|COMPLETED|6M Follow-Up||192
9010131|NCT02982772|10073122|FG000|NOT COMPLETED|6M Follow-Up||11
9010132|NCT02982772|10073123|FG001|NOT COMPLETED|6M Follow-Up||9
9010133|NCT02982772|10073122|FG000|STARTED|12M Follow-Up||177
9010134|NCT02982772|10073123|FG001|STARTED|12M Follow-Up||192
9010135|NCT02982772|10073122|FG000|COMPLETED|12M Follow-Up||166
9010136|NCT02982772|10073123|FG001|COMPLETED|12M Follow-Up||187
9010137|NCT02982772|10073122|FG000|NOT COMPLETED|12M Follow-Up||11
9010138|NCT02982772|10073123|FG001|NOT COMPLETED|12M Follow-Up||5
9010139|NCT02982863|10073136|FG000|STARTED|Overall Study||5745
9010140|NCT02982863|10073137|FG001|STARTED|Overall Study||16745
9010141|NCT02982863|10073138|FG002|STARTED|Overall Study||13238
9010142|NCT02982863|10073139|FG003|STARTED|Overall Study||10158
8635867|NCT00564954|9676400|FG001|NOT COMPLETED|Period 2- 1 Week||0
8635868|NCT00565045|9676408|FG000|STARTED|Overall Study||10
8635869|NCT00565045|9676409|FG001|STARTED|Overall Study||11
8901712|NCT02074553|9959255|FG003|STARTED|Washout Period 2||11
9010143|NCT02982863|10073140|FG004|STARTED|Overall Study||2760
9010144|NCT02982863|10073136|FG000|COMPLETED|Overall Study||4936
9010145|NCT02982863|10073137|FG001|COMPLETED|Overall Study||12484
9010146|NCT02982863|10073138|FG002|COMPLETED|Overall Study||11386
9010147|NCT02982863|10073139|FG003|COMPLETED|Overall Study||8758
9010148|NCT02982863|10073140|FG004|COMPLETED|Overall Study||2268
9010149|NCT02982863|10073136|FG000|NOT COMPLETED|Overall Study||809
9010150|NCT02982863|10073137|FG001|NOT COMPLETED|Overall Study||4261
9010151|NCT02982863|10073138|FG002|NOT COMPLETED|Overall Study||1852
9010152|NCT02982863|10073139|FG003|NOT COMPLETED|Overall Study||1400
9010153|NCT02982863|10073140|FG004|NOT COMPLETED|Overall Study||492
9010154|NCT02982928|10073156|FG000|STARTED|Overall Study||11
9010155|NCT02982928|10073156|FG000|COMPLETED|Overall Study||11
9010156|NCT02982928|10073156|FG000|NOT COMPLETED|Overall Study||0
9010157|NCT02983058|10073162|FG000|STARTED|Overall Study||7
9010158|NCT02983058|10073163|FG001|STARTED|Overall Study||5
9010159|NCT02983058|10073162|FG000|COMPLETED|Overall Study||2
9010160|NCT02983058|10073163|FG001|COMPLETED|Overall Study||2
9010161|NCT02983058|10073162|FG000|NOT COMPLETED|Overall Study||5
9010162|NCT02983058|10073163|FG001|NOT COMPLETED|Overall Study||3
9010163|NCT02983227|10073171|FG000|STARTED|Overall Study||410
9010164|NCT02983227|10073172|FG001|STARTED|Overall Study||86
9010165|NCT02983227|10073171|FG000|COMPLETED|Overall Study||351
9010166|NCT02983227|10073172|FG001|COMPLETED|Overall Study||72
9010167|NCT02983227|10073171|FG000|NOT COMPLETED|Overall Study||59
9010168|NCT02983227|10073172|FG001|NOT COMPLETED|Overall Study||14
9010169|NCT02983305|10073180|FG000|STARTED|Overall Study||12
8635870|NCT00565045|9676408|FG000|COMPLETED|Overall Study||9
8901713|NCT02074553|9959256|FG004|STARTED|Washout Period 2||12
8901714|NCT02074553|9959257|FG005|STARTED|Washout Period 2||11
8901715|NCT02074553|9959258|FG006|STARTED|Washout Period 2||12
8901716|NCT02074553|9959259|FG007|STARTED|Washout Period 2||12
8901717|NCT02074553|9959252|FG000|COMPLETED|Washout Period 2||11
8901718|NCT02074553|9959253|FG001|COMPLETED|Washout Period 2||12
8901719|NCT02074553|9959254|FG002|COMPLETED|Washout Period 2||11
8901720|NCT02074553|9959255|FG003|COMPLETED|Washout Period 2||11
8901721|NCT02074553|9959256|FG004|COMPLETED|Washout Period 2||12
8901722|NCT02074553|9959257|FG005|COMPLETED|Washout Period 2||10
9010170|NCT02983305|10073181|FG001|STARTED|Overall Study||10
9010171|NCT02983305|10073180|FG000|COMPLETED|Overall Study||10
9010172|NCT02983305|10073181|FG001|COMPLETED|Overall Study||10
9010173|NCT02983305|10073180|FG000|NOT COMPLETED|Overall Study||2
9010174|NCT02983305|10073181|FG001|NOT COMPLETED|Overall Study||0
9010175|NCT02983448|10073187|FG000|STARTED|Overall Study||12
9010176|NCT02983448|10073188|FG001|STARTED|Overall Study||12
9010177|NCT02983448|10073187|FG000|COMPLETED|Overall Study||12
9010178|NCT02983448|10073188|FG001|COMPLETED|Overall Study||12
9010179|NCT02983448|10073187|FG000|NOT COMPLETED|Overall Study||0
9010180|NCT02983448|10073188|FG001|NOT COMPLETED|Overall Study||0
9010181|NCT02983552|10073200|FG000|STARTED|Overall Study||69
9010182|NCT02983552|10073201|FG001|STARTED|Overall Study||69
9010183|NCT02983552|10073202|FG002|STARTED|Overall Study||92
9010184|NCT02983552|10073203|FG003|STARTED|Overall Study||90
9010185|NCT02983552|10073200|FG000|4 Week Visit|Overall Study||69
9010186|NCT02983552|10073201|FG001|4 Week Visit|Overall Study||67
9010187|NCT02983552|10073202|FG002|4 Week Visit|Overall Study||85
8901723|NCT02074553|9959258|FG006|COMPLETED|Washout Period 2||11
8901724|NCT02074553|9959259|FG007|COMPLETED|Washout Period 2||12
8901725|NCT02074553|9959252|FG000|NOT COMPLETED|Washout Period 2||0
8901726|NCT02074553|9959253|FG001|NOT COMPLETED|Washout Period 2||0
8901727|NCT02074553|9959254|FG002|NOT COMPLETED|Washout Period 2||1
8901728|NCT02074553|9959255|FG003|NOT COMPLETED|Washout Period 2||0
8901729|NCT02074553|9959256|FG004|NOT COMPLETED|Washout Period 2||0
8901730|NCT02074553|9959257|FG005|NOT COMPLETED|Washout Period 2||1
8901731|NCT02074553|9959258|FG006|NOT COMPLETED|Washout Period 2||1
8901732|NCT02074553|9959259|FG007|NOT COMPLETED|Washout Period 2||0
8901733|NCT02074553|9959252|FG000|STARTED|Intervention Period 3||11
8901734|NCT02074553|9959253|FG001|STARTED|Intervention Period 3||12
8901735|NCT02074553|9959254|FG002|STARTED|Intervention Period 3||11
8901736|NCT02074553|9959255|FG003|STARTED|Intervention Period 3||11
8901737|NCT02074553|9959256|FG004|STARTED|Intervention Period 3||12
8901738|NCT02074553|9959257|FG005|STARTED|Intervention Period 3||10
8901739|NCT02074553|9959258|FG006|STARTED|Intervention Period 3||11
8901740|NCT02074553|9959259|FG007|STARTED|Intervention Period 3||12
8901741|NCT02074553|9959252|FG000|COMPLETED|Intervention Period 3||11
8901742|NCT02074553|9959253|FG001|COMPLETED|Intervention Period 3||12
8901743|NCT02074553|9959254|FG002|COMPLETED|Intervention Period 3||11
8901744|NCT02074553|9959255|FG003|COMPLETED|Intervention Period 3||11
8901745|NCT02074553|9959256|FG004|COMPLETED|Intervention Period 3||12
8901746|NCT02074553|9959257|FG005|COMPLETED|Intervention Period 3||10
8901747|NCT02074553|9959258|FG006|COMPLETED|Intervention Period 3||11
8901748|NCT02074553|9959259|FG007|COMPLETED|Intervention Period 3||12
8901749|NCT02074553|9959252|FG000|NOT COMPLETED|Intervention Period 3||0
8901750|NCT02074553|9959253|FG001|NOT COMPLETED|Intervention Period 3||0
8901751|NCT02074553|9959254|FG002|NOT COMPLETED|Intervention Period 3||0
8901752|NCT02074553|9959255|FG003|NOT COMPLETED|Intervention Period 3||0
8901753|NCT02074553|9959256|FG004|NOT COMPLETED|Intervention Period 3||0
8901754|NCT02074553|9959257|FG005|NOT COMPLETED|Intervention Period 3||0
8901755|NCT02074553|9959258|FG006|NOT COMPLETED|Intervention Period 3||0
8901756|NCT02074553|9959259|FG007|NOT COMPLETED|Intervention Period 3||0
8901757|NCT02074553|9959252|FG000|STARTED|Washout Period 3||11
8901758|NCT02074553|9959253|FG001|STARTED|Washout Period 3||12
8901759|NCT02074553|9959254|FG002|STARTED|Washout Period 3||11
8901760|NCT02074553|9959255|FG003|STARTED|Washout Period 3||11
8901761|NCT02074553|9959256|FG004|STARTED|Washout Period 3||12
8901762|NCT02074553|9959257|FG005|STARTED|Washout Period 3||10
8901763|NCT02074553|9959258|FG006|STARTED|Washout Period 3||11
8901764|NCT02074553|9959259|FG007|STARTED|Washout Period 3||12
8901765|NCT02074553|9959252|FG000|COMPLETED|Washout Period 3||11
8901766|NCT02074553|9959253|FG001|COMPLETED|Washout Period 3||12
8901767|NCT02074553|9959254|FG002|COMPLETED|Washout Period 3||11
8901768|NCT02074553|9959255|FG003|COMPLETED|Washout Period 3||11
8901769|NCT02074553|9959256|FG004|COMPLETED|Washout Period 3||12
8901770|NCT02074553|9959257|FG005|COMPLETED|Washout Period 3||10
8901771|NCT02074553|9959258|FG006|COMPLETED|Washout Period 3||11
8901772|NCT02074553|9959259|FG007|COMPLETED|Washout Period 3||11
8901773|NCT02074553|9959252|FG000|NOT COMPLETED|Washout Period 3||0
8901774|NCT02074553|9959253|FG001|NOT COMPLETED|Washout Period 3||0
8901775|NCT02074553|9959254|FG002|NOT COMPLETED|Washout Period 3||0
8901776|NCT02074553|9959255|FG003|NOT COMPLETED|Washout Period 3||0
8901777|NCT02074553|9959256|FG004|NOT COMPLETED|Washout Period 3||0
8901778|NCT02074553|9959257|FG005|NOT COMPLETED|Washout Period 3||0
8901779|NCT02074553|9959258|FG006|NOT COMPLETED|Washout Period 3||0
8901780|NCT02074553|9959259|FG007|NOT COMPLETED|Washout Period 3||1
8901781|NCT02074553|9959252|FG000|STARTED|Intervention Period 4||11
8901782|NCT02074553|9959253|FG001|STARTED|Intervention Period 4||12
8901783|NCT02074553|9959254|FG002|STARTED|Intervention Period 4||11
9010188|NCT02983552|10073203|FG003|4 Week Visit|Overall Study||84
9010189|NCT02983552|10073200|FG000|8 Week Visit|Overall Study||67
9010190|NCT02983552|10073201|FG001|8 Week Visit|Overall Study||68
9010191|NCT02983552|10073202|FG002|8 Week Visit|Overall Study||85
9010192|NCT02983552|10073203|FG003|8 Week Visit|Overall Study||84
9010193|NCT02983552|10073200|FG000|16 Week Visit|Overall Study|The 16 week visit was elective for those who were originally assigned to continued spectacle correction. After completing 8 weeks of continued spectacle correction, participants were able to complete 8 weeks of binocular therapy. Values are not provided for the binocular computer game treatment cohorts as this visit was not applicable.|0
9010194|NCT02983552|10073201|FG001|16 Week Visit|Overall Study||66
9010195|NCT02983552|10073202|FG002|16 Week Visit|Overall Study|The 16 week visit was elective for those who were originally assigned to continued spectacle correction. After completing 8 weeks of continued spectacle correction, participants were able to complete 8 weeks of binocular therapy. Values are not provided for the binocular computer game treatment cohorts as this visit was not applicable.|0
9010196|NCT02983552|10073203|FG003|16 Week Visit|Overall Study||72
8901784|NCT02074553|9959255|FG003|STARTED|Intervention Period 4||11
8901785|NCT02074553|9959256|FG004|STARTED|Intervention Period 4||12
8901786|NCT02074553|9959257|FG005|STARTED|Intervention Period 4||10
8901787|NCT02074553|9959258|FG006|STARTED|Intervention Period 4||11
8901788|NCT02074553|9959259|FG007|STARTED|Intervention Period 4||11
8901789|NCT02074553|9959252|FG000|COMPLETED|Intervention Period 4||11
8901790|NCT02074553|9959253|FG001|COMPLETED|Intervention Period 4||12
8901791|NCT02074553|9959254|FG002|COMPLETED|Intervention Period 4||11
8901792|NCT02074553|9959255|FG003|COMPLETED|Intervention Period 4||11
8901793|NCT02074553|9959256|FG004|COMPLETED|Intervention Period 4||12
8901794|NCT02074553|9959257|FG005|COMPLETED|Intervention Period 4||10
8901795|NCT02074553|9959258|FG006|COMPLETED|Intervention Period 4||11
8901796|NCT02074553|9959259|FG007|COMPLETED|Intervention Period 4||11
8901797|NCT02074553|9959252|FG000|NOT COMPLETED|Intervention Period 4||0
8901798|NCT02074553|9959253|FG001|NOT COMPLETED|Intervention Period 4||0
8901799|NCT02074553|9959254|FG002|NOT COMPLETED|Intervention Period 4||0
8901800|NCT02074553|9959255|FG003|NOT COMPLETED|Intervention Period 4||0
8901801|NCT02074553|9959256|FG004|NOT COMPLETED|Intervention Period 4||0
8901802|NCT02074553|9959257|FG005|NOT COMPLETED|Intervention Period 4||0
8901803|NCT02074553|9959258|FG006|NOT COMPLETED|Intervention Period 4||0
8901804|NCT02074553|9959259|FG007|NOT COMPLETED|Intervention Period 4||0
8901805|NCT02074709|9959279|FG000|STARTED|Overall Study||30
8901806|NCT02074709|9959280|FG001|STARTED|Overall Study||30
8901807|NCT02074709|9959279|FG000|COMPLETED|Overall Study||29
8901808|NCT02074709|9959280|FG001|COMPLETED|Overall Study||29
8901809|NCT02074709|9959279|FG000|NOT COMPLETED|Overall Study||1
8901810|NCT02074709|9959280|FG001|NOT COMPLETED|Overall Study||1
8901811|NCT02074735|9959288|FG000|STARTED|Overall Study||29
8901812|NCT02074735|9959289|FG001|STARTED|Overall Study||33
8901813|NCT02074735|9959288|FG000|COMPLETED|Overall Study||26
8901814|NCT02074735|9959289|FG001|COMPLETED|Overall Study||29
8901815|NCT02074735|9959288|FG000|NOT COMPLETED|Overall Study||3
8901816|NCT02074735|9959289|FG001|NOT COMPLETED|Overall Study||4
8901817|NCT02074982|9959297|FG000|STARTED|Overall Study||337
8901818|NCT02074982|9959298|FG001|STARTED|Overall Study||339
8901819|NCT02074982|9959297|FG000|Full Analysis Set (FAS)|Overall Study||336
8901820|NCT02074982|9959298|FG001|Full Analysis Set (FAS)|Overall Study||339
8901821|NCT02074982|9959297|FG000|Safety Set (SF)|Overall Study||335
8901822|NCT02074982|9959298|FG001|Safety Set (SF)|Overall Study||336
8901823|NCT02074982|9959297|FG000|COMPLETED|Overall Study||286
8901824|NCT02074982|9959298|FG001|COMPLETED|Overall Study||285
8901825|NCT02074982|9959297|FG000|NOT COMPLETED|Overall Study||51
8901826|NCT02074982|9959298|FG001|NOT COMPLETED|Overall Study||54
8901827|NCT02074995|9959304|FG000|STARTED|Overall Study||1
8901828|NCT02074995|9959305|FG001|STARTED|Overall Study||0
8901829|NCT02074995|9959306|FG002|STARTED|Overall Study||0
8901830|NCT02074995|9959304|FG000|COMPLETED|Overall Study||1
8901831|NCT02074995|9959305|FG001|COMPLETED|Overall Study||0
8901832|NCT02074995|9959306|FG002|COMPLETED|Overall Study||0
9010197|NCT02983552|10073200|FG000|COMPLETED|Overall Study||69
9010198|NCT02983552|10073201|FG001|COMPLETED|Overall Study||67
9010199|NCT02983552|10073202|FG002|COMPLETED|Overall Study||92
9010200|NCT02983552|10073203|FG003|COMPLETED|Overall Study||90
9010201|NCT02983552|10073200|FG000|NOT COMPLETED|Overall Study||0
9010202|NCT02983552|10073201|FG001|NOT COMPLETED|Overall Study||2
9010203|NCT02983552|10073202|FG002|NOT COMPLETED|Overall Study||0
9010204|NCT02983552|10073203|FG003|NOT COMPLETED|Overall Study||0
9010205|NCT02983604|10073221|FG000|STARTED|Overall Study||4
8635871|NCT00565045|9676409|FG001|COMPLETED|Overall Study||8
8635872|NCT00565045|9676408|FG000|NOT COMPLETED|Overall Study||1
8635873|NCT00565045|9676409|FG001|NOT COMPLETED|Overall Study||3
8635874|NCT00565058|9676417|FG000|STARTED|Overall Study||10
8635875|NCT00565058|9676418|FG001|STARTED|Overall Study||15
8901833|NCT02074995|9959304|FG000|NOT COMPLETED|Overall Study||0
8901834|NCT02074995|9959305|FG001|NOT COMPLETED|Overall Study||0
8901835|NCT02074995|9959306|FG002|NOT COMPLETED|Overall Study||0
8901836|NCT02075008|9959310|FG000|STARTED|Overall Study||270
8901837|NCT02075008|9959310|FG000|COMPLETED|Overall Study||94
8901838|NCT02075008|9959310|FG000|NOT COMPLETED|Overall Study||176
8901839|NCT02075047|9959316|FG000|STARTED|Treatment Phase (4 Weeks)||86
8901840|NCT02075047|9959317|FG001|STARTED|Treatment Phase (4 Weeks)||85
9010206|NCT02983604|10073222|FG001|STARTED|Overall Study||3
9010207|NCT02983604|10073223|FG002|STARTED|Overall Study||4
9010208|NCT02983604|10073224|FG003|STARTED|Overall Study||3
8901841|NCT02075047|9959316|FG000|COMPLETED|Treatment Phase (4 Weeks)||63
8901842|NCT02075047|9959317|FG001|COMPLETED|Treatment Phase (4 Weeks)||75
8901843|NCT02075047|9959316|FG000|NOT COMPLETED|Treatment Phase (4 Weeks)||23
8901844|NCT02075047|9959317|FG001|NOT COMPLETED|Treatment Phase (4 Weeks)||10
8901845|NCT02075047|9959316|FG000|STARTED|Follow up Phase (5 Weeks)|Participants were followed up after completion or discontinuation of treatment.|86
8901846|NCT02075047|9959317|FG001|STARTED|Follow up Phase (5 Weeks)|Participants were followed up after completion or discontinuation of treatment.|85
8901847|NCT02075047|9959316|FG000|COMPLETED|Follow up Phase (5 Weeks)||60
8901848|NCT02075047|9959317|FG001|COMPLETED|Follow up Phase (5 Weeks)||72
8901849|NCT02075047|9959316|FG000|NOT COMPLETED|Follow up Phase (5 Weeks)||26
8901850|NCT02075047|9959317|FG001|NOT COMPLETED|Follow up Phase (5 Weeks)||13
8901851|NCT02075073|9959326|FG000|STARTED|Overall Study||36
8901852|NCT02075073|9959327|FG001|STARTED|Overall Study||37
8901853|NCT02075073|9959328|FG002|STARTED|Overall Study||36
8901854|NCT02075073|9959326|FG000|COMPLETED|Overall Study||36
8901855|NCT02075073|9959327|FG001|COMPLETED|Overall Study||36
8901856|NCT02075073|9959328|FG002|COMPLETED|Overall Study||36
8901857|NCT02075073|9959326|FG000|NOT COMPLETED|Overall Study||0
8901858|NCT02075073|9959327|FG001|NOT COMPLETED|Overall Study||1
8901859|NCT02075073|9959328|FG002|NOT COMPLETED|Overall Study||0
8901860|NCT02075125|9959338|FG000|STARTED|Overall Study||19
8901861|NCT02075125|9959339|FG001|STARTED|Overall Study||20
8901862|NCT02075125|9959338|FG000|COMPLETED|Overall Study||19
8901863|NCT02075125|9959339|FG001|COMPLETED|Overall Study|One patient switched to clopidogrel treatment after 18 days of ticagrelor treatment.|19
8901864|NCT02075125|9959338|FG000|NOT COMPLETED|Overall Study||0
8901865|NCT02075125|9959339|FG001|NOT COMPLETED|Overall Study||1
8635876|NCT00565058|9676417|FG000|COMPLETED|Overall Study||9
8635877|NCT00565058|9676418|FG001|COMPLETED|Overall Study||15
8635878|NCT00565058|9676417|FG000|NOT COMPLETED|Overall Study||1
8635879|NCT00565058|9676418|FG001|NOT COMPLETED|Overall Study||0
8635880|NCT00565084|9676424|FG000|STARTED|First Treatment Period||11
8635881|NCT00565084|9676425|FG001|STARTED|First Treatment Period||11
8635882|NCT00565084|9676426|FG002|STARTED|First Treatment Period||11
8635883|NCT00565084|9676424|FG000|COMPLETED|First Treatment Period||11
8635884|NCT00565084|9676425|FG001|COMPLETED|First Treatment Period||11
8635885|NCT00565084|9676426|FG002|COMPLETED|First Treatment Period||11
8635886|NCT00565084|9676424|FG000|NOT COMPLETED|First Treatment Period||0
8635887|NCT00565084|9676425|FG001|NOT COMPLETED|First Treatment Period||0
8635888|NCT00565084|9676426|FG002|NOT COMPLETED|First Treatment Period||0
8635889|NCT00565084|9676424|FG000|STARTED|Second Treatment Period||11
8635890|NCT00565084|9676425|FG001|STARTED|Second Treatment Period||11
8635891|NCT00565084|9676426|FG002|STARTED|Second Treatment Period||11
8635892|NCT00565084|9676424|FG000|COMPLETED|Second Treatment Period||11
8635893|NCT00565084|9676425|FG001|COMPLETED|Second Treatment Period||11
8635894|NCT00565084|9676426|FG002|COMPLETED|Second Treatment Period||11
8635895|NCT00565084|9676424|FG000|NOT COMPLETED|Second Treatment Period||0
8635896|NCT00565084|9676425|FG001|NOT COMPLETED|Second Treatment Period||0
8635897|NCT00565084|9676426|FG002|NOT COMPLETED|Second Treatment Period||0
8635898|NCT00565084|9676424|FG000|STARTED|Third Treatment Period||11
8635899|NCT00565084|9676425|FG001|STARTED|Third Treatment Period||11
8635900|NCT00565084|9676426|FG002|STARTED|Third Treatment Period||11
8635901|NCT00565084|9676424|FG000|COMPLETED|Third Treatment Period||11
8635902|NCT00565084|9676425|FG001|COMPLETED|Third Treatment Period||11
8635903|NCT00565084|9676426|FG002|COMPLETED|Third Treatment Period||11
8635904|NCT00565084|9676424|FG000|NOT COMPLETED|Third Treatment Period||0
8635905|NCT00565084|9676425|FG001|NOT COMPLETED|Third Treatment Period||0
8635906|NCT00565084|9676426|FG002|NOT COMPLETED|Third Treatment Period||0
8635907|NCT00565110|9676436|FG000|STARTED|Overall Study||230
8635908|NCT00565110|9676437|FG001|STARTED|Overall Study||242
8635909|NCT00565110|9676436|FG000|12-Month|Overall Study||114
8635910|NCT00565110|9676437|FG001|12-Month|Overall Study||144
8635911|NCT00565110|9676436|FG000|COMPLETED|Overall Study||99
8635912|NCT00565110|9676437|FG001|COMPLETED|Overall Study||111
8635913|NCT00565110|9676436|FG000|NOT COMPLETED|Overall Study||131
8635914|NCT00565110|9676437|FG001|NOT COMPLETED|Overall Study||131
8635915|NCT00565136|9676443|FG000|STARTED|Overall Study||29
8635916|NCT00565136|9676443|FG000|COMPLETED|Overall Study||26
8635917|NCT00565136|9676443|FG000|NOT COMPLETED|Overall Study||3
8635918|NCT00565266|9676447|FG000|STARTED|Overall Study||210
8635919|NCT00565266|9676447|FG000|COMPLETED|Overall Study||174
8635920|NCT00565266|9676447|FG000|NOT COMPLETED|Overall Study||36
8635921|NCT00565370|9676455|FG000|STARTED|Overall Study||21
8635922|NCT00565370|9676455|FG000|COMPLETED|Overall Study||21
8635923|NCT00565370|9676455|FG000|NOT COMPLETED|Overall Study||0
8635924|NCT00565409|9676459|FG000|STARTED|Period 1 Open Label||834
8635925|NCT00565409|9676460|FG001|STARTED|Period 1 Open Label||0
8635926|NCT00565409|9676461|FG002|STARTED|Period 1 Open Label||0
8635927|NCT00565409|9676462|FG003|STARTED|Period 1 Open Label||0
8635928|NCT00565409|9676459|FG000|COMPLETED|Period 1 Open Label||756
8635929|NCT00565409|9676460|FG001|COMPLETED|Period 1 Open Label||0
8901866|NCT02075203|9959348|FG000|STARTED|Overall Study||330
8901867|NCT02075203|9959349|FG001|STARTED|Overall Study||330
8635930|NCT00565409|9676461|FG002|COMPLETED|Period 1 Open Label||0
8635931|NCT00565409|9676462|FG003|COMPLETED|Period 1 Open Label||0
8635932|NCT00565409|9676459|FG000|NOT COMPLETED|Period 1 Open Label||78
8635933|NCT00565409|9676460|FG001|NOT COMPLETED|Period 1 Open Label||0
8635934|NCT00565409|9676461|FG002|NOT COMPLETED|Period 1 Open Label||0
8635935|NCT00565409|9676462|FG003|NOT COMPLETED|Period 1 Open Label||0
8635936|NCT00565409|9676459|FG000|STARTED|After Period 1, Prior to Period 2||756
8635937|NCT00565409|9676460|FG001|STARTED|After Period 1, Prior to Period 2||0
8635938|NCT00565409|9676461|FG002|STARTED|After Period 1, Prior to Period 2||0
8635939|NCT00565409|9676462|FG003|STARTED|After Period 1, Prior to Period 2||0
8635940|NCT00565409|9676459|FG000|COMPLETED|After Period 1, Prior to Period 2||604
8635941|NCT00565409|9676460|FG001|COMPLETED|After Period 1, Prior to Period 2||0
8635942|NCT00565409|9676461|FG002|COMPLETED|After Period 1, Prior to Period 2||0
8635943|NCT00565409|9676462|FG003|COMPLETED|After Period 1, Prior to Period 2||0
8635944|NCT00565409|9676459|FG000|NOT COMPLETED|After Period 1, Prior to Period 2||152
8635945|NCT00565409|9676460|FG001|NOT COMPLETED|After Period 1, Prior to Period 2||0
8635946|NCT00565409|9676461|FG002|NOT COMPLETED|After Period 1, Prior to Period 2||0
8635947|NCT00565409|9676462|FG003|NOT COMPLETED|After Period 1, Prior to Period 2||0
8635948|NCT00565409|9676459|FG000|STARTED|Period 2 Double-Blind||0
8635949|NCT00565409|9676460|FG001|STARTED|Period 2 Double-Blind||202
8635950|NCT00565409|9676461|FG002|STARTED|Period 2 Double-Blind||202
8635951|NCT00565409|9676462|FG003|STARTED|Period 2 Double-Blind||200
8635952|NCT00565409|9676459|FG000|COMPLETED|Period 2 Double-Blind||0
8635953|NCT00565409|9676460|FG001|COMPLETED|Period 2 Double-Blind||181
8635954|NCT00565409|9676461|FG002|COMPLETED|Period 2 Double-Blind||175
8635955|NCT00565409|9676462|FG003|COMPLETED|Period 2 Double-Blind||141
8635956|NCT00565409|9676459|FG000|NOT COMPLETED|Period 2 Double-Blind||0
8635957|NCT00565409|9676460|FG001|NOT COMPLETED|Period 2 Double-Blind||21
8635958|NCT00565409|9676461|FG002|NOT COMPLETED|Period 2 Double-Blind||27
8635959|NCT00565409|9676462|FG003|NOT COMPLETED|Period 2 Double-Blind||59
8635960|NCT00565448|9676474|FG000|STARTED|Overall Study|Intent to treat (ITT) population: all randomized participants. All were treated.|50
8635961|NCT00565448|9676475|FG001|STARTED|Overall Study|ITT population: all randomized participants. All were treated.|25
8635962|NCT00565448|9676474|FG000|COMPLETED|Overall Study|Completed induction period as per protocol.|47
8635963|NCT00565448|9676475|FG001|COMPLETED|Overall Study|Completed induction period as per protocol.|23
8635964|NCT00565448|9676474|FG000|NOT COMPLETED|Overall Study||3
8635965|NCT00565448|9676475|FG001|NOT COMPLETED|Overall Study||2
8635966|NCT00565604|9676484|FG000|STARTED|Overall Study||43
8635967|NCT00565604|9676484|FG000|7 Day|Overall Study||41
8635968|NCT00565604|9676484|FG000|2 Week|Overall Study||41
8635969|NCT00565604|9676484|FG000|6 Week|Overall Study||39
8635970|NCT00565604|9676484|FG000|6 Month|Overall Study||39
8635971|NCT00565604|9676484|FG000|COMPLETED|Overall Study||39
8635972|NCT00565604|9676484|FG000|NOT COMPLETED|Overall Study||4
8635973|NCT00565643|9676490|FG000|STARTED|Overall Study||380
8635974|NCT00565643|9676491|FG001|STARTED|Overall Study||373
8635975|NCT00565643|9676490|FG000|Safety Data|Overall Study||380
8635976|NCT00565643|9676491|FG001|Safety Data|Overall Study||373
8635977|NCT00565643|9676490|FG000|Primary Outcome (Subsequent Cesarean)|Overall Study||80
8635978|NCT00565643|9676491|FG001|Primary Outcome (Subsequent Cesarean)|Overall Study||92
8635979|NCT00565643|9676490|FG000|COMPLETED|Overall Study||380
8635980|NCT00565643|9676491|FG001|COMPLETED|Overall Study||373
8635981|NCT00565643|9676490|FG000|NOT COMPLETED|Overall Study||0
8635982|NCT00565643|9676491|FG001|NOT COMPLETED|Overall Study||0
8635983|NCT00565669|9676500|FG000|STARTED|Overall Study||11
8635984|NCT00565669|9676501|FG001|STARTED|Overall Study||9
8635985|NCT00565669|9676500|FG000|COMPLETED|Overall Study||11
8635986|NCT00565669|9676501|FG001|COMPLETED|Overall Study||9
8635987|NCT00565669|9676500|FG000|NOT COMPLETED|Overall Study||0
8635988|NCT00565669|9676501|FG001|NOT COMPLETED|Overall Study||0
8635989|NCT00565721|9676507|FG000|STARTED|Overall Study||33
8635990|NCT00565721|9676507|FG000|COMPLETED|Overall Study||16
8635991|NCT00565721|9676507|FG000|NOT COMPLETED|Overall Study||17
8635992|NCT00565747|9676528|FG000|STARTED|Overall Study||654
8635993|NCT00565747|9676529|FG001|STARTED|Overall Study||678
8635994|NCT00565747|9676528|FG000|COMPLETED|Overall Study|Completed with an embryo transfer|587
8635995|NCT00565747|9676529|FG001|COMPLETED|Overall Study|Completed with an embryo transfer|605
8635996|NCT00565747|9676528|FG000|NOT COMPLETED|Overall Study||67
8635997|NCT00565747|9676529|FG001|NOT COMPLETED|Overall Study||73
8635998|NCT00565773|9676535|FG000|STARTED|Overall Study||40
8635999|NCT00565773|9676535|FG000|COMPLETED|Overall Study||38
8636000|NCT00565773|9676535|FG000|NOT COMPLETED|Overall Study||2
8636001|NCT00565812|9676542|FG000|STARTED|Overall Study||485
8636002|NCT00565812|9676543|FG001|STARTED|Overall Study||486
8636003|NCT00565812|9676544|FG002|STARTED|Overall Study||486
8636004|NCT00565812|9676542|FG000|COMPLETED|Overall Study||341
8636005|NCT00565812|9676543|FG001|COMPLETED|Overall Study||351
8636006|NCT00565812|9676544|FG002|COMPLETED|Overall Study||356
8636007|NCT00565812|9676542|FG000|NOT COMPLETED|Overall Study||144
8636008|NCT00565812|9676543|FG001|NOT COMPLETED|Overall Study||135
8636009|NCT00565812|9676544|FG002|NOT COMPLETED|Overall Study||130
8636010|NCT00565864|9676555|FG000|STARTED|Overall Study||58
8636011|NCT00565864|9676556|FG001|STARTED|Overall Study||59
8636012|NCT00565864|9676557|FG002|STARTED|Overall Study||56
8636013|NCT00565864|9676555|FG000|COMPLETED|Overall Study||46
8636014|NCT00565864|9676556|FG001|COMPLETED|Overall Study||47
8636015|NCT00565864|9676557|FG002|COMPLETED|Overall Study||45
8636016|NCT00565864|9676555|FG000|NOT COMPLETED|Overall Study||12
8636017|NCT00565864|9676556|FG001|NOT COMPLETED|Overall Study||12
8636018|NCT00565864|9676557|FG002|NOT COMPLETED|Overall Study||11
8636019|NCT00565916|9676569|FG000|STARTED|Overall Study||11
8636020|NCT00565916|9676570|FG001|STARTED|Overall Study||11
8636021|NCT00565916|9676569|FG000|COMPLETED|Overall Study||11
8636022|NCT00565916|9676570|FG001|COMPLETED|Overall Study||11
8636023|NCT00565916|9676569|FG000|NOT COMPLETED|Overall Study||0
8636024|NCT00565916|9676570|FG001|NOT COMPLETED|Overall Study||0
8636025|NCT00566020|9676576|FG000|STARTED|6-week Dosage Adjustment Phase||92
8636026|NCT00566020|9676577|FG001|STARTED|6-week Dosage Adjustment Phase||0
8636027|NCT00566020|9676576|FG000|COMPLETED|6-week Dosage Adjustment Phase||85
8636028|NCT00566020|9676577|FG001|COMPLETED|6-week Dosage Adjustment Phase||0
8636029|NCT00566020|9676576|FG000|NOT COMPLETED|6-week Dosage Adjustment Phase||7
8636030|NCT00566020|9676577|FG001|NOT COMPLETED|6-week Dosage Adjustment Phase||0
8636031|NCT00566020|9676576|FG000|STARTED|46-week Long-term Administration Phase||0
8636032|NCT00566020|9676577|FG001|STARTED|46-week Long-term Administration Phase||85
8636033|NCT00566020|9676576|FG000|COMPLETED|46-week Long-term Administration Phase||0
8636034|NCT00566020|9676577|FG001|COMPLETED|46-week Long-term Administration Phase||68
8636035|NCT00566020|9676576|FG000|NOT COMPLETED|46-week Long-term Administration Phase||0
8636036|NCT00566020|9676577|FG001|NOT COMPLETED|46-week Long-term Administration Phase||17
8636037|NCT00566098|9676582|FG000|STARTED|Collection of MILs||25
8726318|NCT01035255|9773521|FG000|Full Analysis Set (FAS)|Overall Study|patents with GCP violation and mis-randomized are not included in FAS|4187
8726319|NCT01035255|9773522|FG001|Full Analysis Set (FAS)|Overall Study|patents with GCP violation and mis-randomized are not included in FAS|4212
8726320|NCT01035255|9773521|FG000|COMPLETED|Overall Study||3468
8726321|NCT01035255|9773522|FG001|COMPLETED|Overall Study||3371
8726322|NCT01035255|9773521|FG000|NOT COMPLETED|Overall Study||741
8726323|NCT01035255|9773522|FG001|NOT COMPLETED|Overall Study||862
8726324|NCT01035333|9773528|FG000|STARTED|Overall Study||19
8726325|NCT01035333|9773528|FG000|COMPLETED|Overall Study||9
8726326|NCT01035333|9773528|FG000|NOT COMPLETED|Overall Study||10
8726327|NCT01035346|9773534|FG000|STARTED|Overall Study||7
8726328|NCT01035346|9773535|FG001|STARTED|Overall Study||9
8726329|NCT01035346|9773534|FG000|COMPLETED|Overall Study||7
8726330|NCT01035346|9773535|FG001|COMPLETED|Overall Study||9
8726331|NCT01035346|9773534|FG000|NOT COMPLETED|Overall Study||0
8726332|NCT01035346|9773535|FG001|NOT COMPLETED|Overall Study||0
8726333|NCT01035463|9773543|FG000|STARTED|Overall Study||6
8726334|NCT01035463|9773544|FG001|STARTED|Overall Study||3
8726335|NCT01035463|9773545|FG002|STARTED|Overall Study||6
8726336|NCT01035463|9773546|FG003|STARTED|Overall Study||4
8726337|NCT01035463|9773547|FG004|STARTED|Overall Study||7
8726338|NCT01035463|9773548|FG005|STARTED|Overall Study||33
8726339|NCT01035463|9773543|FG000|COMPLETED|Overall Study||6
8726340|NCT01035463|9773544|FG001|COMPLETED|Overall Study||1
8726341|NCT01035463|9773545|FG002|COMPLETED|Overall Study||1
8726342|NCT01035463|9773546|FG003|COMPLETED|Overall Study||2
8726343|NCT01035463|9773547|FG004|COMPLETED|Overall Study||1
8726344|NCT01035463|9773548|FG005|COMPLETED|Overall Study||15
8636038|NCT00566098|9676582|FG000|COMPLETED|Collection of MILs||23
8636039|NCT00566098|9676582|FG000|NOT COMPLETED|Collection of MILs||2
8636040|NCT00566098|9676582|FG000|STARTED|Generation of MILs Product||23
8636041|NCT00566098|9676582|FG000|COMPLETED|Generation of MILs Product||22
8636042|NCT00566098|9676582|FG000|NOT COMPLETED|Generation of MILs Product||1
8636043|NCT00566098|9676582|FG000|STARTED|Administration of ASCT+MILs||22
8636044|NCT00566098|9676582|FG000|COMPLETED|Administration of ASCT+MILs||4
8636045|NCT00566098|9676582|FG000|NOT COMPLETED|Administration of ASCT+MILs||18
8636046|NCT00566111|9676589|FG000|STARTED|Overall Study||2
8636047|NCT00566111|9676590|FG001|STARTED|Overall Study||3
8636048|NCT00566111|9676589|FG000|COMPLETED|Overall Study||2
8636049|NCT00566111|9676590|FG001|COMPLETED|Overall Study||1
8636050|NCT00566111|9676589|FG000|NOT COMPLETED|Overall Study||0
8636051|NCT00566111|9676590|FG001|NOT COMPLETED|Overall Study||2
8636052|NCT00566150|9676598|FG000|STARTED|Overall Study||19
8636053|NCT00566150|9676599|FG001|STARTED|Overall Study||16
8636054|NCT00566150|9676598|FG000|COMPLETED|Overall Study||10
8636055|NCT00566150|9676599|FG001|COMPLETED|Overall Study||11
8636056|NCT00566150|9676598|FG000|NOT COMPLETED|Overall Study||9
8636057|NCT00566150|9676599|FG001|NOT COMPLETED|Overall Study||5
8636058|NCT00566228|9676607|FG000|STARTED|Overall Study||62
8636059|NCT00566228|9676608|FG001|STARTED|Overall Study||60
8636060|NCT00566228|9676607|FG000|COMPLETED|Overall Study||56
8636061|NCT00566228|9676608|FG001|COMPLETED|Overall Study||55
8636062|NCT00566228|9676607|FG000|NOT COMPLETED|Overall Study||6
8636063|NCT00566228|9676608|FG001|NOT COMPLETED|Overall Study||5
8636064|NCT00566254|9676616|FG000|STARTED|Overall Study||100
8636065|NCT00566254|9676617|FG001|STARTED|Overall Study||107
8636066|NCT00566254|9676616|FG000|COMPLETED|Overall Study||90
8636067|NCT00566254|9676617|FG001|COMPLETED|Overall Study||93
8636068|NCT00566254|9676616|FG000|NOT COMPLETED|Overall Study||10
8636069|NCT00566254|9676617|FG001|NOT COMPLETED|Overall Study||14
8636070|NCT00566501|9676625|FG000|STARTED|Overall Study||570
8636071|NCT00566501|9676626|FG001|STARTED|Overall Study||332
8636072|NCT00566501|9676625|FG000|COMPLETED|Overall Study||423
8636073|NCT00566501|9676626|FG001|COMPLETED|Overall Study||210
8636074|NCT00566501|9676625|FG000|NOT COMPLETED|Overall Study||147
8636075|NCT00566501|9676626|FG001|NOT COMPLETED|Overall Study||122
8636076|NCT00566527|9676635|FG000|STARTED|Overall Study|Number randomized.|541
8726345|NCT01035463|9773543|FG000|NOT COMPLETED|Overall Study||0
8726346|NCT01035463|9773544|FG001|NOT COMPLETED|Overall Study||2
8726347|NCT01035463|9773545|FG002|NOT COMPLETED|Overall Study||5
8636077|NCT00566527|9676636|FG001|STARTED|Overall Study|Number randomized.|540
8636078|NCT00566527|9676637|FG002|STARTED|Overall Study|Number randomized.|539
8636079|NCT00566527|9676635|FG000|Received ProQuad® Dose 1|Overall Study||529
8636080|NCT00566527|9676636|FG001|Received ProQuad® Dose 1|Overall Study||484
8636081|NCT00566527|9676637|FG002|Received ProQuad® Dose 1|Overall Study||470
8636082|NCT00566527|9676635|FG000|Received ProQuad® Dose 2|Overall Study||525
8636083|NCT00566527|9676636|FG001|Received ProQuad® Dose 2|Overall Study||478
8636084|NCT00566527|9676637|FG002|Received ProQuad® Dose 2|Overall Study||462
8636085|NCT00566527|9676635|FG000|COMPLETED|Overall Study||524
8636086|NCT00566527|9676636|FG001|COMPLETED|Overall Study||474
8636087|NCT00566527|9676637|FG002|COMPLETED|Overall Study||461
8636088|NCT00566527|9676635|FG000|NOT COMPLETED|Overall Study||17
8636089|NCT00566527|9676636|FG001|NOT COMPLETED|Overall Study||66
8636090|NCT00566527|9676637|FG002|NOT COMPLETED|Overall Study||78
8636091|NCT00566540|9676647|FG000|STARTED|Overall Study||11
8636092|NCT00566540|9676647|FG000|COMPLETED|Overall Study||11
8636093|NCT00566540|9676647|FG000|NOT COMPLETED|Overall Study||0
8636094|NCT00566579|9676653|FG000|STARTED|Overall Study||29
8636095|NCT00566579|9676654|FG001|STARTED|Overall Study||31
8636096|NCT00566579|9676653|FG000|COMPLETED|Overall Study||29
8636097|NCT00566579|9676654|FG001|COMPLETED|Overall Study||31
8636098|NCT00566579|9676653|FG000|NOT COMPLETED|Overall Study||0
8636099|NCT00566579|9676654|FG001|NOT COMPLETED|Overall Study||0
8636100|NCT00566631|9676660|FG000|STARTED|Part 1: Core Treatment Phase||294
8636101|NCT00566631|9676660|FG000|COMPLETED|Part 1: Core Treatment Phase||234
8636102|NCT00566631|9676660|FG000|NOT COMPLETED|Part 1: Core Treatment Phase||60
8636103|NCT00566631|9676660|FG000|STARTED|Between Treatment and Extension Phase||234
8636104|NCT00566631|9676660|FG000|COMPLETED|Between Treatment and Extension Phase||139
8636105|NCT00566631|9676660|FG000|NOT COMPLETED|Between Treatment and Extension Phase||95
8726348|NCT01035463|9773546|FG003|NOT COMPLETED|Overall Study||2
8726349|NCT01035463|9773547|FG004|NOT COMPLETED|Overall Study||6
8726350|NCT01035463|9773548|FG005|NOT COMPLETED|Overall Study||18
8726351|NCT01035606|9773558|FG000|STARTED|Overall Study||19
8726352|NCT01035606|9773559|FG001|STARTED|Overall Study||19
8726353|NCT01035606|9773560|FG002|STARTED|Overall Study||11
8726354|NCT01035606|9773558|FG000|COMPLETED|Overall Study||16
8726355|NCT01035606|9773559|FG001|COMPLETED|Overall Study||16
8726356|NCT01035606|9773560|FG002|COMPLETED|Overall Study||7
8726357|NCT01035606|9773558|FG000|NOT COMPLETED|Overall Study||3
8726358|NCT01035606|9773559|FG001|NOT COMPLETED|Overall Study||3
8726359|NCT01035606|9773560|FG002|NOT COMPLETED|Overall Study||4
8726360|NCT01035658|9773572|FG000|STARTED|Overall Study||5
8726361|NCT01035658|9773573|FG001|STARTED|Overall Study||8
8726362|NCT01035658|9773574|FG002|STARTED|Overall Study||3
8726363|NCT01035658|9773575|FG003|STARTED|Overall Study||6
8726364|NCT01035658|9773572|FG000|COMPLETED|Overall Study||5
8726365|NCT01035658|9773573|FG001|COMPLETED|Overall Study||8
8726366|NCT01035658|9773574|FG002|COMPLETED|Overall Study||3
8726367|NCT01035658|9773575|FG003|COMPLETED|Overall Study||6
8726368|NCT01035658|9773572|FG000|NOT COMPLETED|Overall Study||0
8726369|NCT01035658|9773573|FG001|NOT COMPLETED|Overall Study||0
8726370|NCT01035658|9773574|FG002|NOT COMPLETED|Overall Study||0
8726371|NCT01035658|9773575|FG003|NOT COMPLETED|Overall Study||0
8726372|NCT01035749|9773592|FG000|STARTED|Overall Study||66
8726373|NCT01035749|9773593|FG001|STARTED|Overall Study||66
8726374|NCT01035749|9773594|FG002|STARTED|Overall Study||68
8726375|NCT01035749|9773595|FG003|STARTED|Overall Study||110
8726376|NCT01035749|9773592|FG000|COMPLETED|Overall Study||66
8726377|NCT01035749|9773593|FG001|COMPLETED|Overall Study||66
8726378|NCT01035749|9773594|FG002|COMPLETED|Overall Study||68
8726379|NCT01035749|9773595|FG003|COMPLETED|Overall Study||110
8726380|NCT01035749|9773592|FG000|NOT COMPLETED|Overall Study||0
8726381|NCT01035749|9773593|FG001|NOT COMPLETED|Overall Study||0
8726382|NCT01035749|9773594|FG002|NOT COMPLETED|Overall Study||0
8726383|NCT01035749|9773595|FG003|NOT COMPLETED|Overall Study||0
8726384|NCT01035788|9773607|FG000|STARTED|Overall Study|23 couples = 23 Veterans + 23 partners; only data for Veterans will be included for primary outcome.|23
8726385|NCT01035788|9773608|FG001|STARTED|Overall Study|23 couples = 23 Veterans + 23 partners; only data for Veterans will be included for primary outcome.|23
8726386|NCT01035788|9773607|FG000|COMPLETED|Overall Study||17
8726387|NCT01035788|9773608|FG001|COMPLETED|Overall Study||9
8726388|NCT01035788|9773607|FG000|NOT COMPLETED|Overall Study||6
8726389|NCT01035788|9773608|FG001|NOT COMPLETED|Overall Study||14
8726390|NCT01035905|9773616|FG000|STARTED|Overall Study||32
8726391|NCT01035905|9773617|FG001|STARTED|Overall Study||31
8726392|NCT01035905|9773616|FG000|COMPLETED|Overall Study||31
8726393|NCT01035905|9773617|FG001|COMPLETED|Overall Study||30
8726394|NCT01035905|9773616|FG000|NOT COMPLETED|Overall Study||1
8726395|NCT01035905|9773617|FG001|NOT COMPLETED|Overall Study||1
8726396|NCT01036009|9773625|FG000|STARTED|Overall Study||17
8726397|NCT01036009|9773626|FG001|STARTED|Overall Study||26
8636106|NCT00566631|9676660|FG000|STARTED|Part 2: Extension Phase||139
8636107|NCT00566631|9676660|FG000|COMPLETED|Part 2: Extension Phase||57
8636108|NCT00566631|9676660|FG000|NOT COMPLETED|Part 2: Extension Phase||82
8636109|NCT00566696|9676664|FG000|STARTED|Overall Study||73
8636110|NCT00566696|9676664|FG000|COMPLETED|Overall Study||31
8636111|NCT00566696|9676664|FG000|NOT COMPLETED|Overall Study||42
8636112|NCT00566709|9676670|FG000|STARTED|Overall Study||51
8636113|NCT00566709|9676671|FG001|STARTED|Overall Study||51
8636114|NCT00566709|9676670|FG000|COMPLETED|Overall Study||46
8636115|NCT00566709|9676671|FG001|COMPLETED|Overall Study||51
8636116|NCT00566709|9676670|FG000|NOT COMPLETED|Overall Study||5
8636117|NCT00566709|9676671|FG001|NOT COMPLETED|Overall Study||0
8636118|NCT00566722|9676680|FG000|STARTED|Overall Study||41
8636119|NCT00566722|9676681|FG001|STARTED|Overall Study||29
8636120|NCT00566722|9676682|FG002|STARTED|Overall Study||82
8636121|NCT00566722|9676680|FG000|COMPLETED|Overall Study||39
8636122|NCT00566722|9676681|FG001|COMPLETED|Overall Study||24
8636123|NCT00566722|9676682|FG002|COMPLETED|Overall Study||73
8636124|NCT00566722|9676680|FG000|NOT COMPLETED|Overall Study||2
8636125|NCT00566722|9676681|FG001|NOT COMPLETED|Overall Study||5
8636126|NCT00566722|9676682|FG002|NOT COMPLETED|Overall Study||9
8636127|NCT00566735|9676695|FG000|STARTED|Overall Study||20
8636128|NCT00566735|9676696|FG001|STARTED|Overall Study||19
8636129|NCT00566735|9676695|FG000|Withdrew Before Baseline Measures|Overall Study||2
8636130|NCT00566735|9676696|FG001|Withdrew Before Baseline Measures|Overall Study||7
8636131|NCT00566735|9676695|FG000|COMPLETED|Overall Study|2 participants withdrew before baselines. Therefore, 18 participants will be included in baselines.|18
8636132|NCT00566735|9676696|FG001|COMPLETED|Overall Study|7 participants withdrew before baselines. Therefore, 12 participants will be included in baselines.|12
8636133|NCT00566735|9676695|FG000|NOT COMPLETED|Overall Study||2
8726398|NCT01036009|9773625|FG000|COMPLETED|Overall Study||17
8726399|NCT01036009|9773626|FG001|COMPLETED|Overall Study||26
8726400|NCT01036009|9773625|FG000|NOT COMPLETED|Overall Study||0
8726401|NCT01036009|9773626|FG001|NOT COMPLETED|Overall Study||0
8726402|NCT01036022|9773639|FG000|STARTED|Overall Study||15
8726403|NCT01036022|9773640|FG001|STARTED|Overall Study||11
8726404|NCT01036022|9773641|FG002|STARTED|Overall Study||12
8726405|NCT01036022|9773642|FG003|STARTED|Overall Study||12
8726406|NCT01036022|9773643|FG004|STARTED|Overall Study||12
8726407|NCT01036022|9773644|FG005|STARTED|Overall Study||16
8726408|NCT01036022|9773639|FG000|COMPLETED|Overall Study||13
8726409|NCT01036022|9773640|FG001|COMPLETED|Overall Study||7
8726410|NCT01036022|9773641|FG002|COMPLETED|Overall Study||8
8726411|NCT01036022|9773642|FG003|COMPLETED|Overall Study||10
8726412|NCT01036022|9773643|FG004|COMPLETED|Overall Study||9
8726413|NCT01036022|9773644|FG005|COMPLETED|Overall Study||13
8726414|NCT01036022|9773639|FG000|NOT COMPLETED|Overall Study||2
8726415|NCT01036022|9773640|FG001|NOT COMPLETED|Overall Study||4
8726416|NCT01036022|9773641|FG002|NOT COMPLETED|Overall Study||4
8726417|NCT01036022|9773642|FG003|NOT COMPLETED|Overall Study||2
8726418|NCT01036022|9773643|FG004|NOT COMPLETED|Overall Study||3
8726419|NCT01036022|9773644|FG005|NOT COMPLETED|Overall Study||3
8726420|NCT01036165|9773666|FG000|STARTED|Overall Study||103
8726421|NCT01036165|9773666|FG000|COMPLETED|Overall Study||88
8726422|NCT01036165|9773666|FG000|NOT COMPLETED|Overall Study||15
8726423|NCT01036321|9773672|FG000|STARTED|Overall Study||36
8726424|NCT01036321|9773673|FG001|STARTED|Overall Study||35
8726425|NCT01036321|9773672|FG000|COMPLETED|Overall Study||31
8726426|NCT01036321|9773673|FG001|COMPLETED|Overall Study||31
8726427|NCT01036321|9773672|FG000|NOT COMPLETED|Overall Study||5
8726428|NCT01036321|9773673|FG001|NOT COMPLETED|Overall Study||4
8726429|NCT01036438|9773681|FG000|STARTED|Overall Study||101
8726430|NCT01036438|9773682|FG001|STARTED|Overall Study||100
8901868|NCT02075203|9959350|FG002|STARTED|Overall Study||329
8901869|NCT02075203|9959348|FG000|COMPLETED|Overall Study||327
8901870|NCT02075203|9959349|FG001|COMPLETED|Overall Study||330
8901871|NCT02075203|9959350|FG002|COMPLETED|Overall Study||328
8901872|NCT02075203|9959348|FG000|NOT COMPLETED|Overall Study||3
8901873|NCT02075203|9959349|FG001|NOT COMPLETED|Overall Study||0
8901874|NCT02075203|9959350|FG002|NOT COMPLETED|Overall Study||1
8901875|NCT02075255|9959361|FG000|STARTED|Overall Study||72
8901876|NCT02075255|9959362|FG001|STARTED|Overall Study||73
8901877|NCT02075255|9959363|FG002|STARTED|Overall Study||75
8901878|NCT02075255|9959361|FG000|COMPLETED|Overall Study||68
8901879|NCT02075255|9959362|FG001|COMPLETED|Overall Study||69
8901880|NCT02075255|9959363|FG002|COMPLETED|Overall Study||72
8901881|NCT02075255|9959361|FG000|NOT COMPLETED|Overall Study||4
8901882|NCT02075255|9959362|FG001|NOT COMPLETED|Overall Study||4
8901883|NCT02075255|9959363|FG002|NOT COMPLETED|Overall Study||3
8901884|NCT02075463|9959371|FG000|STARTED|Overall Study||15
9010209|NCT02983604|10073221|FG000|COMPLETED|Overall Study||4
8636134|NCT00566735|9676696|FG001|NOT COMPLETED|Overall Study||7
8636135|NCT00566813|9676704|FG000|STARTED|Overall Study||4
8636136|NCT00566813|9676705|FG001|STARTED|Overall Study||6
8636137|NCT00566813|9676704|FG000|COMPLETED|Overall Study||4
8636138|NCT00566813|9676705|FG001|COMPLETED|Overall Study||6
8726431|NCT01036438|9773681|FG000|COMPLETED|Overall Study||91
8726432|NCT01036438|9773682|FG001|COMPLETED|Overall Study||90
8726433|NCT01036438|9773681|FG000|NOT COMPLETED|Overall Study||10
8726434|NCT01036438|9773682|FG001|NOT COMPLETED|Overall Study||10
8726435|NCT01036490|9773690|FG000|STARTED|Overall Study||18
8726436|NCT01036490|9773691|FG001|STARTED|Overall Study||18
8901885|NCT02075463|9959371|FG000|COMPLETED|Overall Study||7
8901886|NCT02075463|9959371|FG000|NOT COMPLETED|Overall Study||8
8901887|NCT02075476|9959378|FG000|STARTED|Overall Study||20
8901888|NCT02075476|9959379|FG001|STARTED|Overall Study||20
8901889|NCT02075476|9959378|FG000|COMPLETED|Overall Study||17
8901890|NCT02075476|9959379|FG001|COMPLETED|Overall Study||15
8901891|NCT02075476|9959378|FG000|NOT COMPLETED|Overall Study||3
8901892|NCT02075476|9959379|FG001|NOT COMPLETED|Overall Study||5
8901893|NCT02075515|9959388|FG000|STARTED|Overall Study||218
9010210|NCT02983604|10073222|FG001|COMPLETED|Overall Study||3
8636139|NCT00566813|9676704|FG000|NOT COMPLETED|Overall Study||0
8636140|NCT00566813|9676705|FG001|NOT COMPLETED|Overall Study||0
8636141|NCT00566852|9676713|FG000|STARTED|Overall Study||278
8636142|NCT00566852|9676714|FG001|STARTED|Overall Study||276
8636143|NCT00566852|9676713|FG000|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|71
8636144|NCT00566852|9676714|FG001|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|78
8636145|NCT00566852|9676713|FG000|NOT COMPLETED|Overall Study||207
8636146|NCT00566852|9676714|FG001|NOT COMPLETED|Overall Study||198
8636147|NCT00566930|9676723|FG000|STARTED|Overall Study||29
8636148|NCT00566930|9676724|FG001|STARTED|Overall Study||36
8636149|NCT00566930|9676725|FG002|STARTED|Overall Study||33
8636150|NCT00566930|9676723|FG000|COMPLETED|Overall Study||27
8636151|NCT00566930|9676724|FG001|COMPLETED|Overall Study||32
8636152|NCT00566930|9676725|FG002|COMPLETED|Overall Study||32
8636153|NCT00566930|9676723|FG000|NOT COMPLETED|Overall Study||2
8636154|NCT00566930|9676724|FG001|NOT COMPLETED|Overall Study||4
8636155|NCT00566930|9676725|FG002|NOT COMPLETED|Overall Study||1
8636156|NCT00566943|9676735|FG000|STARTED|Overall Study||52
8636157|NCT00566943|9676736|FG001|STARTED|Overall Study||49
8636158|NCT00566943|9676735|FG000|COMPLETED|Overall Study||52
8636159|NCT00566943|9676736|FG001|COMPLETED|Overall Study||49
8636160|NCT00566943|9676735|FG000|NOT COMPLETED|Overall Study||0
8636161|NCT00566943|9676736|FG001|NOT COMPLETED|Overall Study||0
8636162|NCT00566969|9676751|FG000|STARTED|Overall Study||34
8636163|NCT00566969|9676752|FG001|STARTED|Overall Study||37
8636164|NCT00566969|9676753|FG002|STARTED|Overall Study||35
8636165|NCT00566969|9676751|FG000|COMPLETED|Overall Study||19
8636166|NCT00566969|9676752|FG001|COMPLETED|Overall Study||28
8636167|NCT00566969|9676753|FG002|COMPLETED|Overall Study||23
8636168|NCT00566969|9676751|FG000|NOT COMPLETED|Overall Study||15
8636169|NCT00566969|9676752|FG001|NOT COMPLETED|Overall Study||9
8636170|NCT00566969|9676753|FG002|NOT COMPLETED|Overall Study||12
8636171|NCT00566982|9676763|FG000|STARTED|Overall Study||63
8636172|NCT00566982|9676764|FG001|STARTED|Overall Study||363
8636173|NCT00566982|9676763|FG000|COMPLETED|Overall Study||55
8636174|NCT00566982|9676764|FG001|COMPLETED|Overall Study||294
8636175|NCT00566982|9676763|FG000|NOT COMPLETED|Overall Study||8
8636176|NCT00566982|9676764|FG001|NOT COMPLETED|Overall Study||69
8636177|NCT00567008|9676775|FG000|STARTED|Overall Study||18
8636178|NCT00567008|9676776|FG001|STARTED|Overall Study||19
8636179|NCT00567008|9676775|FG000|COMPLETED|Overall Study||17
8636180|NCT00567008|9676776|FG001|COMPLETED|Overall Study||18
8636181|NCT00567008|9676775|FG000|NOT COMPLETED|Overall Study||1
8636182|NCT00567008|9676776|FG001|NOT COMPLETED|Overall Study||1
8636183|NCT00567112|9676782|FG000|STARTED|Treatment Period 1 (3 Days)||7
8636184|NCT00567112|9676783|FG001|STARTED|Treatment Period 1 (3 Days)||8
8636185|NCT00567112|9676784|FG002|STARTED|Treatment Period 1 (3 Days)||0
8636186|NCT00567112|9676782|FG000|COMPLETED|Treatment Period 1 (3 Days)||7
8636187|NCT00567112|9676783|FG001|COMPLETED|Treatment Period 1 (3 Days)||8
8636188|NCT00567112|9676784|FG002|COMPLETED|Treatment Period 1 (3 Days)||0
8636189|NCT00567112|9676782|FG000|NOT COMPLETED|Treatment Period 1 (3 Days)||0
8636190|NCT00567112|9676783|FG001|NOT COMPLETED|Treatment Period 1 (3 Days)||0
8636191|NCT00567112|9676784|FG002|NOT COMPLETED|Treatment Period 1 (3 Days)||0
8636192|NCT00567112|9676782|FG000|STARTED|Washout Period 1 (3 Days)||7
8636193|NCT00567112|9676783|FG001|STARTED|Washout Period 1 (3 Days)||8
8636194|NCT00567112|9676784|FG002|STARTED|Washout Period 1 (3 Days)||0
8636195|NCT00567112|9676782|FG000|COMPLETED|Washout Period 1 (3 Days)||7
8636196|NCT00567112|9676783|FG001|COMPLETED|Washout Period 1 (3 Days)||8
8636197|NCT00567112|9676784|FG002|COMPLETED|Washout Period 1 (3 Days)||0
8636198|NCT00567112|9676782|FG000|NOT COMPLETED|Washout Period 1 (3 Days)||0
8636199|NCT00567112|9676783|FG001|NOT COMPLETED|Washout Period 1 (3 Days)||0
8636200|NCT00567112|9676784|FG002|NOT COMPLETED|Washout Period 1 (3 Days)||0
8636201|NCT00567112|9676782|FG000|STARTED|Treatment Period 2 (3 Days)||7
8636202|NCT00567112|9676783|FG001|STARTED|Treatment Period 2 (3 Days)||8
8636203|NCT00567112|9676784|FG002|STARTED|Treatment Period 2 (3 Days)|3 new participants added to Treatment Group ABCD & received treatment sequence BCD for Periods 2-4|3
8636204|NCT00567112|9676782|FG000|COMPLETED|Treatment Period 2 (3 Days)||7
8636205|NCT00567112|9676783|FG001|COMPLETED|Treatment Period 2 (3 Days)||7
8636206|NCT00567112|9676784|FG002|COMPLETED|Treatment Period 2 (3 Days)||3
8636207|NCT00567112|9676782|FG000|NOT COMPLETED|Treatment Period 2 (3 Days)||0
8636208|NCT00567112|9676783|FG001|NOT COMPLETED|Treatment Period 2 (3 Days)||1
8636209|NCT00567112|9676784|FG002|NOT COMPLETED|Treatment Period 2 (3 Days)||0
8636210|NCT00567112|9676782|FG000|STARTED|Washout Period 2 (3 Days)||7
8636211|NCT00567112|9676783|FG001|STARTED|Washout Period 2 (3 Days)||7
8636212|NCT00567112|9676784|FG002|STARTED|Washout Period 2 (3 Days)||3
8636213|NCT00567112|9676782|FG000|COMPLETED|Washout Period 2 (3 Days)||7
8636214|NCT00567112|9676783|FG001|COMPLETED|Washout Period 2 (3 Days)||7
8636215|NCT00567112|9676784|FG002|COMPLETED|Washout Period 2 (3 Days)||3
8636216|NCT00567112|9676782|FG000|NOT COMPLETED|Washout Period 2 (3 Days)||0
8636217|NCT00567112|9676783|FG001|NOT COMPLETED|Washout Period 2 (3 Days)||0
8636218|NCT00567112|9676784|FG002|NOT COMPLETED|Washout Period 2 (3 Days)||0
8636219|NCT00567112|9676782|FG000|STARTED|Treatment Period 3 (3 Days)||7
8636220|NCT00567112|9676783|FG001|STARTED|Treatment Period 3 (3 Days)||7
8636221|NCT00567112|9676784|FG002|STARTED|Treatment Period 3 (3 Days)||3
8636222|NCT00567112|9676782|FG000|COMPLETED|Treatment Period 3 (3 Days)||7
8636223|NCT00567112|9676783|FG001|COMPLETED|Treatment Period 3 (3 Days)||7
8636224|NCT00567112|9676784|FG002|COMPLETED|Treatment Period 3 (3 Days)||3
8636225|NCT00567112|9676782|FG000|NOT COMPLETED|Treatment Period 3 (3 Days)||0
8636226|NCT00567112|9676783|FG001|NOT COMPLETED|Treatment Period 3 (3 Days)||0
8636227|NCT00567112|9676784|FG002|NOT COMPLETED|Treatment Period 3 (3 Days)||0
8636228|NCT00567112|9676782|FG000|STARTED|Washout Period 3 (3 Days)||7
8636229|NCT00567112|9676783|FG001|STARTED|Washout Period 3 (3 Days)||7
8636230|NCT00567112|9676784|FG002|STARTED|Washout Period 3 (3 Days)||3
8636231|NCT00567112|9676782|FG000|COMPLETED|Washout Period 3 (3 Days)||4
8636232|NCT00567112|9676783|FG001|COMPLETED|Washout Period 3 (3 Days)||7
8636233|NCT00567112|9676784|FG002|COMPLETED|Washout Period 3 (3 Days)||3
8636234|NCT00567112|9676782|FG000|NOT COMPLETED|Washout Period 3 (3 Days)||3
8636235|NCT00567112|9676783|FG001|NOT COMPLETED|Washout Period 3 (3 Days)||0
8636236|NCT00567112|9676784|FG002|NOT COMPLETED|Washout Period 3 (3 Days)||0
8636237|NCT00567112|9676782|FG000|STARTED|Treatment Period 4 (3 Days)||4
8636238|NCT00567112|9676783|FG001|STARTED|Treatment Period 4 (3 Days)||7
8636239|NCT00567112|9676784|FG002|STARTED|Treatment Period 4 (3 Days)||3
8636240|NCT00567112|9676782|FG000|COMPLETED|Treatment Period 4 (3 Days)||4
8636241|NCT00567112|9676783|FG001|COMPLETED|Treatment Period 4 (3 Days)||7
8636242|NCT00567112|9676784|FG002|COMPLETED|Treatment Period 4 (3 Days)||3
8901894|NCT02075515|9959389|FG001|STARTED|Overall Study||217
8901895|NCT02075515|9959390|FG002|STARTED|Overall Study||216
8901896|NCT02075515|9959388|FG000|COMPLETED|Overall Study||214
8901897|NCT02075515|9959389|FG001|COMPLETED|Overall Study||212
8901898|NCT02075515|9959390|FG002|COMPLETED|Overall Study||208
8901899|NCT02075515|9959388|FG000|NOT COMPLETED|Overall Study||4
8901900|NCT02075515|9959389|FG001|NOT COMPLETED|Overall Study||5
8901901|NCT02075515|9959390|FG002|NOT COMPLETED|Overall Study||8
8901902|NCT02075541|9959401|FG000|STARTED|Overall Study||73
8901903|NCT02075541|9959402|FG001|STARTED|Overall Study||72
8901904|NCT02075541|9959401|FG000|COMPLETED|Overall Study||69
8901905|NCT02075541|9959402|FG001|COMPLETED|Overall Study||64
8901906|NCT02075541|9959401|FG000|NOT COMPLETED|Overall Study||4
8901907|NCT02075541|9959402|FG001|NOT COMPLETED|Overall Study||8
8901908|NCT02075554|9959408|FG000|STARTED|Overall Study||58
8901909|NCT02075554|9959408|FG000|COMPLETED|Overall Study||43
8901910|NCT02075554|9959408|FG000|NOT COMPLETED|Overall Study||15
8901911|NCT02075606|9959412|FG000|STARTED|Overall Study||50
8901912|NCT02075606|9959412|FG000|COMPLETED|Overall Study||40
8901913|NCT02075606|9959412|FG000|NOT COMPLETED|Overall Study||10
8901914|NCT02075632|9959423|FG000|STARTED|Overall Study||162
8901915|NCT02075632|9959424|FG001|STARTED|Overall Study||148
8901916|NCT02075632|9959423|FG000|COMPLETED|Overall Study||161
8901917|NCT02075632|9959424|FG001|COMPLETED|Overall Study||143
8901918|NCT02075632|9959423|FG000|NOT COMPLETED|Overall Study||1
8901919|NCT02075632|9959424|FG001|NOT COMPLETED|Overall Study||5
8901920|NCT02075658|9959432|FG000|STARTED|Overall Study||30
8901921|NCT02075658|9959433|FG001|STARTED|Overall Study||30
8901922|NCT02075658|9959432|FG000|COMPLETED|Overall Study||28
8901923|NCT02075658|9959433|FG001|COMPLETED|Overall Study||28
8901924|NCT02075658|9959432|FG000|NOT COMPLETED|Overall Study||2
8901925|NCT02075658|9959433|FG001|NOT COMPLETED|Overall Study||2
8901926|NCT02076022|9959441|FG000|STARTED|Overall Study||7
8901927|NCT02076022|9959442|FG001|STARTED|Overall Study||3
8901928|NCT02076022|9959441|FG000|COMPLETED|Overall Study||5
8901929|NCT02076022|9959442|FG001|COMPLETED|Overall Study||3
8901930|NCT02076022|9959441|FG000|NOT COMPLETED|Overall Study||2
8901931|NCT02076022|9959442|FG001|NOT COMPLETED|Overall Study||0
8901932|NCT02076100|9959455|FG000|STARTED|Overall Study||3
9010211|NCT02983604|10073223|FG002|COMPLETED|Overall Study||3
9010212|NCT02983604|10073224|FG003|COMPLETED|Overall Study||3
9010213|NCT02983604|10073221|FG000|NOT COMPLETED|Overall Study||0
9010214|NCT02983604|10073222|FG001|NOT COMPLETED|Overall Study||0
9010215|NCT02983604|10073223|FG002|NOT COMPLETED|Overall Study||1
9010216|NCT02983604|10073224|FG003|NOT COMPLETED|Overall Study||0
9010217|NCT02983825|10073234|FG000|STARTED|Overall Study|Of 21 enrolled subjects, 9 became ineligible for between consent and intervention|12
9010218|NCT02983825|10073234|FG000|COMPLETED|Overall Study|Of 12 subjects starting intervention, 3 met specified stopping critieria|9
8636243|NCT00567112|9676782|FG000|NOT COMPLETED|Treatment Period 4 (3 Days)||0
8636244|NCT00567112|9676783|FG001|NOT COMPLETED|Treatment Period 4 (3 Days)||0
8901933|NCT02076100|9959456|FG001|STARTED|Overall Study||3
8901934|NCT02076100|9959457|FG002|STARTED|Overall Study||3
8901935|NCT02076100|9959458|FG003|STARTED|Overall Study||3
8901936|NCT02076100|9959459|FG004|STARTED|Overall Study||3
8901937|NCT02076100|9959460|FG005|STARTED|Overall Study||3
8901938|NCT02076100|9959461|FG006|STARTED|Overall Study||4
8901939|NCT02076100|9959455|FG000|COMPLETED|Overall Study||3
8901940|NCT02076100|9959456|FG001|COMPLETED|Overall Study||3
8901941|NCT02076100|9959457|FG002|COMPLETED|Overall Study||3
8901942|NCT02076100|9959458|FG003|COMPLETED|Overall Study||3
8901943|NCT02076100|9959459|FG004|COMPLETED|Overall Study||3
8901944|NCT02076100|9959460|FG005|COMPLETED|Overall Study||3
8901945|NCT02076100|9959461|FG006|COMPLETED|Overall Study||4
8901946|NCT02076100|9959455|FG000|NOT COMPLETED|Overall Study||0
8901947|NCT02076100|9959456|FG001|NOT COMPLETED|Overall Study||0
8901948|NCT02076100|9959457|FG002|NOT COMPLETED|Overall Study||0
8901949|NCT02076100|9959458|FG003|NOT COMPLETED|Overall Study||0
8901950|NCT02076100|9959459|FG004|NOT COMPLETED|Overall Study||0
8636245|NCT00567112|9676784|FG002|NOT COMPLETED|Treatment Period 4 (3 Days)||0
8636246|NCT00567164|9676796|FG000|STARTED|Overall Study||1421
8636247|NCT00567164|9676797|FG001|STARTED|Overall Study||234
8636248|NCT00567164|9676798|FG002|STARTED|Overall Study||232
8636249|NCT00567164|9676796|FG000|Subjects Received Treatment|Overall Study|Full Analysis Set|1406
8636250|NCT00567164|9676797|FG001|Subjects Received Treatment|Overall Study|Full Analysis Set|232
8636251|NCT00567164|9676798|FG002|Subjects Received Treatment|Overall Study|Full Analysis Set|226
8636252|NCT00567164|9676796|FG000|COMPLETED|Overall Study||875
8636253|NCT00567164|9676797|FG001|COMPLETED|Overall Study||161
8636254|NCT00567164|9676798|FG002|COMPLETED|Overall Study||160
8636255|NCT00567164|9676796|FG000|NOT COMPLETED|Overall Study||546
8636256|NCT00567164|9676797|FG001|NOT COMPLETED|Overall Study||73
8636257|NCT00567164|9676798|FG002|NOT COMPLETED|Overall Study||72
8636258|NCT00567190|9676812|FG000|STARTED|Overall Study||402
8636259|NCT00567190|9676813|FG001|STARTED|Overall Study||406
8636260|NCT00567190|9676812|FG000|Did Not Receive Any Study Treatment|Overall Study||2
8636261|NCT00567190|9676813|FG001|Did Not Receive Any Study Treatment|Overall Study||2
8636262|NCT00567190|9676812|FG000|Received at Least One Dose of Pertuzumab|Overall Study||399
8636263|NCT00567190|9676813|FG001|Received at Least One Dose of Pertuzumab|Overall Study|9 participants randomized to the Placebo arm actually received at least one dose of pertuzumab.|9
8636264|NCT00567190|9676812|FG000|Received at Least One Dose of Placebo|Overall Study|1 participant randomized to the Pertuzumab arm actually received placebo at every treatment cycle.|1
8636265|NCT00567190|9676813|FG001|Received at Least One Dose of Placebo|Overall Study||395
8636266|NCT00567190|9676812|FG000|Crossover From Placebo to Pertuzumab|Overall Study||0
8636267|NCT00567190|9676813|FG001|Crossover From Placebo to Pertuzumab|Overall Study|From July 2012, 50 participants randomized to Placebo arm crossed over to open-label pertuzumab.|50
8636268|NCT00567190|9676812|FG000|COMPLETED|Overall Study||119
8636269|NCT00567190|9676813|FG001|COMPLETED|Overall Study||73
8636270|NCT00567190|9676812|FG000|NOT COMPLETED|Overall Study||283
8636271|NCT00567190|9676813|FG001|NOT COMPLETED|Overall Study||333
8636272|NCT00567229|9676824|FG000|STARTED|Overall Study||3
8636273|NCT00567229|9676824|FG000|COMPLETED|Overall Study||3
8636274|NCT00567229|9676824|FG000|NOT COMPLETED|Overall Study||0
8636275|NCT00567242|9676830|FG000|STARTED|Overall Study||7
8636276|NCT00567242|9676831|FG001|STARTED|Overall Study||7
8636277|NCT00567242|9676830|FG000|COMPLETED|Overall Study||7
8636278|NCT00567242|9676831|FG001|COMPLETED|Overall Study||7
8636279|NCT00567242|9676830|FG000|NOT COMPLETED|Overall Study||0
8636280|NCT00567242|9676831|FG001|NOT COMPLETED|Overall Study||0
8636281|NCT00567255|9676839|FG000|STARTED|Overall Study||1001
8636282|NCT00567255|9676840|FG001|STARTED|Overall Study||495
8636283|NCT00567255|9676839|FG000|COMPLETED|Overall Study||538
8636284|NCT00567255|9676840|FG001|COMPLETED|Overall Study||267
8636285|NCT00567255|9676839|FG000|NOT COMPLETED|Overall Study||463
8636286|NCT00567255|9676840|FG001|NOT COMPLETED|Overall Study||228
8636287|NCT00567268|9676846|FG000|STARTED|Overall Study||1194
8636288|NCT00567268|9676846|FG000|COMPLETED|Overall Study||1144
8636289|NCT00567268|9676846|FG000|NOT COMPLETED|Overall Study||50
8636290|NCT00567307|9676887|FG000|STARTED|Overall Study||111
8636291|NCT00567307|9676888|FG001|STARTED|Overall Study||105
8636292|NCT00567307|9676887|FG000|COMPLETED|Overall Study||99
8636293|NCT00567307|9676888|FG001|COMPLETED|Overall Study||104
8636294|NCT00567307|9676887|FG000|NOT COMPLETED|Overall Study||12
8636295|NCT00567307|9676888|FG001|NOT COMPLETED|Overall Study||1
8636296|NCT00567320|9676896|FG000|STARTED|Overall Study||13
8636297|NCT00567320|9676897|FG001|STARTED|Overall Study||18
8636298|NCT00567320|9676896|FG000|COMPLETED|Overall Study||13
8636299|NCT00567320|9676897|FG001|COMPLETED|Overall Study||18
8636300|NCT00567320|9676896|FG000|NOT COMPLETED|Overall Study||0
8636301|NCT00567320|9676897|FG001|NOT COMPLETED|Overall Study||0
8636302|NCT00567359|9676903|FG000|STARTED|Overall Study||100
8636303|NCT00567359|9676903|FG000|COMPLETED|Overall Study||99
8636304|NCT00567359|9676903|FG000|NOT COMPLETED|Overall Study||1
8636305|NCT00567398|9676909|FG000|STARTED|Overall Study||127
8636306|NCT00567398|9676910|FG001|STARTED|Overall Study||124
8636307|NCT00567398|9676909|FG000|COMPLETED|Overall Study||120
8636308|NCT00567398|9676910|FG001|COMPLETED|Overall Study||101
8636309|NCT00567398|9676909|FG000|NOT COMPLETED|Overall Study||7
8636310|NCT00567398|9676910|FG001|NOT COMPLETED|Overall Study||23
8636311|NCT00567476|9676918|FG000|STARTED|Overall Study||78
8636312|NCT00567476|9676919|FG001|STARTED|Overall Study||38
8636313|NCT00567476|9676918|FG000|COMPLETED|Overall Study||70
8636314|NCT00567476|9676919|FG001|COMPLETED|Overall Study||34
8636315|NCT00567476|9676918|FG000|NOT COMPLETED|Overall Study||8
8726437|NCT01036490|9773690|FG000|COMPLETED|Overall Study||14
8726438|NCT01036490|9773691|FG001|COMPLETED|Overall Study||18
8726439|NCT01036490|9773690|FG000|NOT COMPLETED|Overall Study||4
8726440|NCT01036490|9773691|FG001|NOT COMPLETED|Overall Study||0
8726441|NCT01036529|9773699|FG000|STARTED|Overall Study||13
8726442|NCT01036529|9773700|FG001|STARTED|Overall Study||15
8726443|NCT01036529|9773699|FG000|Baseline Visit|Overall Study||10
8726444|NCT01036529|9773700|FG001|Baseline Visit|Overall Study||13
8726445|NCT01036529|9773699|FG000|Index Procedure|Overall Study|Index Procedure: Trial Stimulation|10
8726446|NCT01036529|9773700|FG001|Index Procedure|Overall Study|Index Procedure: Surgery|11
8726447|NCT01036529|9773699|FG000|3 Month Follow-up|Overall Study||7
8726448|NCT01036529|9773700|FG001|3 Month Follow-up|Overall Study||9
8636316|NCT00567476|9676919|FG001|NOT COMPLETED|Overall Study||4
8636317|NCT00567489|9676927|FG000|STARTED|Overall Study||127
8901951|NCT02076100|9959460|FG005|NOT COMPLETED|Overall Study||0
8901952|NCT02076100|9959461|FG006|NOT COMPLETED|Overall Study||0
8901953|NCT02076113|9959483|FG000|STARTED|Overall Study||63
8901954|NCT02076113|9959484|FG001|STARTED|Overall Study||100
8901955|NCT02076113|9959483|FG000|Surgery as Randomized|Overall Study|1 patient underwent dorsal fusion surgery|62
8901956|NCT02076113|9959484|FG001|Surgery as Randomized|Overall Study|4 patients underwent ventral fusion surgery|96
8901957|NCT02076113|9959483|FG000|3-Month Follow-up|Overall Study|5 missed follow-up visit; 2 lost to follow-up|56
8901958|NCT02076113|9959484|FG001|3-Month Follow-up|Overall Study|9 missed follow-up appointment; 1 lost to follow-up|90
8901959|NCT02076113|9959483|FG000|6-Month Follow-up|Overall Study|7 missed follow-up visit; 3 lost to follow-up|53
8901960|NCT02076113|9959484|FG001|6-Month Follow-up|Overall Study|7 missed follow-up visit; 1 lost to follow-up; 1 deceased|91
8901961|NCT02076113|9959483|FG000|1-Year Follow-up|Overall Study|3 lost to follow-up|60
8901962|NCT02076113|9959484|FG001|1-Year Follow-up|Overall Study|2 missed follow-up visit; 1 lost to follow-up; 2 deceased|95
8901963|NCT02076113|9959483|FG000|2-Year Follow-up|Overall Study|5 missed follow-up visit; 4 lost to follow-up; 2 withdrew consent; 1 deceased|51
8901964|NCT02076113|9959484|FG001|2-Year Follow-up|Overall Study|14 missed follow-up visit; 1 lost to follow-up; 3 withdrew consent; 3 deceased|79
8901965|NCT02076113|9959483|FG000|COMPLETED|Overall Study||56
8901966|NCT02076113|9959484|FG001|COMPLETED|Overall Study||93
8901967|NCT02076113|9959483|FG000|NOT COMPLETED|Overall Study||7
8901968|NCT02076113|9959484|FG001|NOT COMPLETED|Overall Study||7
8901969|NCT02076152|9959495|FG000|STARTED|Overall Study||2
8901970|NCT02076152|9959496|FG001|STARTED|Overall Study||9
8901971|NCT02076152|9959495|FG000|COMPLETED|Overall Study||2
8901972|NCT02076152|9959496|FG001|COMPLETED|Overall Study||9
8901973|NCT02076152|9959495|FG000|NOT COMPLETED|Overall Study||0
8901974|NCT02076152|9959496|FG001|NOT COMPLETED|Overall Study||0
8901975|NCT02076165|9959503|FG000|STARTED|Overall Study||74
8901976|NCT02076165|9959504|FG001|STARTED|Overall Study||75
8901977|NCT02076165|9959503|FG000|COMPLETED|Overall Study||66
8901978|NCT02076165|9959504|FG001|COMPLETED|Overall Study||69
8901979|NCT02076165|9959503|FG000|NOT COMPLETED|Overall Study||8
8901980|NCT02076165|9959504|FG001|NOT COMPLETED|Overall Study||6
8901981|NCT02076243|9959510|FG000|STARTED|Overall Study||2
8901982|NCT02076243|9959510|FG000|COMPLETED|Overall Study||0
8901983|NCT02076243|9959510|FG000|NOT COMPLETED|Overall Study||2
8901984|NCT02076321|9959516|FG000|STARTED|Overall Study||51
8901985|NCT02076321|9959517|FG001|STARTED|Overall Study||51
8901986|NCT02076321|9959516|FG000|COMPLETED|Overall Study||46
8901987|NCT02076321|9959517|FG001|COMPLETED|Overall Study||49
8901988|NCT02076321|9959516|FG000|NOT COMPLETED|Overall Study||5
8901989|NCT02076321|9959517|FG001|NOT COMPLETED|Overall Study||2
8901990|NCT02076334|9959527|FG000|STARTED|Overall Study||21
8901991|NCT02076334|9959528|FG001|STARTED|Overall Study||21
8901992|NCT02076334|9959529|FG002|STARTED|Overall Study||21
8901993|NCT02076334|9959530|FG003|STARTED|Overall Study||21
8901994|NCT02076334|9959527|FG000|COMPLETED|Overall Study||20
8901995|NCT02076334|9959528|FG001|COMPLETED|Overall Study||20
8901996|NCT02076334|9959529|FG002|COMPLETED|Overall Study||20
8901997|NCT02076334|9959530|FG003|COMPLETED|Overall Study||20
8901998|NCT02076334|9959527|FG000|NOT COMPLETED|Overall Study||1
8901999|NCT02076334|9959528|FG001|NOT COMPLETED|Overall Study||1
8902000|NCT02076334|9959529|FG002|NOT COMPLETED|Overall Study||1
8902001|NCT02076334|9959530|FG003|NOT COMPLETED|Overall Study||1
8902002|NCT02076399|9959542|FG000|STARTED|Overall Study||51
8902003|NCT02076399|9959543|FG001|STARTED|Overall Study||25
8902004|NCT02076399|9959542|FG000|COMPLETED|Overall Study||12
8902005|NCT02076399|9959543|FG001|COMPLETED|Overall Study||1
8902006|NCT02076399|9959542|FG000|NOT COMPLETED|Overall Study||39
8902007|NCT02076399|9959543|FG001|NOT COMPLETED|Overall Study||24
8902008|NCT02076412|9959551|FG000|STARTED|Overall Study||50
8902009|NCT02076412|9959552|FG001|STARTED|Overall Study||24
8902010|NCT02076412|9959551|FG000|COMPLETED|Overall Study||13
8902011|NCT02076412|9959552|FG001|COMPLETED|Overall Study||2
8902012|NCT02076412|9959551|FG000|NOT COMPLETED|Overall Study||37
8902013|NCT02076412|9959552|FG001|NOT COMPLETED|Overall Study||22
8902014|NCT02076425|9959560|FG000|STARTED|Overall Study||114
8902015|NCT02076425|9959561|FG001|STARTED|Overall Study||115
8902016|NCT02076425|9959560|FG000|COMPLETED|Overall Study||100
8902017|NCT02076425|9959561|FG001|COMPLETED|Overall Study||91
8902018|NCT02076425|9959560|FG000|NOT COMPLETED|Overall Study||14
8902019|NCT02076425|9959561|FG001|NOT COMPLETED|Overall Study||24
8902020|NCT02076776|9959570|FG000|STARTED|Overall Study||6
8902021|NCT02076776|9959571|FG001|STARTED|Overall Study||8
8902022|NCT02076776|9959572|FG002|STARTED|Overall Study||6
8902023|NCT02076776|9959570|FG000|COMPLETED|Overall Study||5
8902024|NCT02076776|9959571|FG001|COMPLETED|Overall Study||6
8902025|NCT02076776|9959572|FG002|COMPLETED|Overall Study||6
8902026|NCT02076776|9959570|FG000|NOT COMPLETED|Overall Study||1
8902027|NCT02076776|9959571|FG001|NOT COMPLETED|Overall Study||2
8902028|NCT02076776|9959572|FG002|NOT COMPLETED|Overall Study||0
8902029|NCT02076919|9959592|FG000|STARTED|Overall Study||24
8902030|NCT02076919|9959593|FG001|STARTED|Overall Study||8
8902031|NCT02076919|9959594|FG002|STARTED|Overall Study||36
8902032|NCT02076919|9959595|FG003|STARTED|Overall Study||12
8902033|NCT02076919|9959592|FG000|COMPLETED|Overall Study||24
8902034|NCT02076919|9959593|FG001|COMPLETED|Overall Study||8
8902035|NCT02076919|9959594|FG002|COMPLETED|Overall Study||36
8902036|NCT02076919|9959595|FG003|COMPLETED|Overall Study||12
8902037|NCT02076919|9959592|FG000|NOT COMPLETED|Overall Study||0
8902038|NCT02076919|9959593|FG001|NOT COMPLETED|Overall Study||0
8902039|NCT02076919|9959594|FG002|NOT COMPLETED|Overall Study||0
8902040|NCT02076919|9959595|FG003|NOT COMPLETED|Overall Study||0
8902041|NCT02076997|9959622|FG000|STARTED|Overall Study||23
8902042|NCT02076997|9959622|FG000|COMPLETED|Overall Study||22
8902043|NCT02076997|9959622|FG000|NOT COMPLETED|Overall Study||1
8902044|NCT02077140|9959631|FG000|STARTED|Overall Study||36
8902045|NCT02077140|9959632|FG001|STARTED|Overall Study||36
8902046|NCT02077140|9959633|FG002|STARTED|Overall Study||36
8902047|NCT02077140|9959634|FG003|STARTED|Overall Study||36
8902048|NCT02077140|9959635|FG004|STARTED|Overall Study||48
8902049|NCT02077140|9959631|FG000|COMPLETED|Overall Study||32
8902050|NCT02077140|9959632|FG001|COMPLETED|Overall Study||34
8902051|NCT02077140|9959633|FG002|COMPLETED|Overall Study||34
8902052|NCT02077140|9959634|FG003|COMPLETED|Overall Study||32
9010219|NCT02983825|10073234|FG000|NOT COMPLETED|Overall Study||3
9010220|NCT02983877|10073238|FG000|STARTED|Overall Study||38
9010221|NCT02983877|10073238|FG000|COMPLETED|Overall Study||38
9010222|NCT02983877|10073238|FG000|NOT COMPLETED|Overall Study||0
9010223|NCT02983981|10073243|FG000|STARTED|Overall Study||20
9010224|NCT02983981|10073243|FG000|COMPLETED|Overall Study||20
9010225|NCT02983981|10073243|FG000|NOT COMPLETED|Overall Study||0
9010226|NCT02984267|10073249|FG000|STARTED|Overall Study||8
9010227|NCT02984267|10073250|FG001|STARTED|Overall Study||10
9010228|NCT02984267|10073249|FG000|COMPLETED|Overall Study||7
9010229|NCT02984267|10073250|FG001|COMPLETED|Overall Study||9
9010230|NCT02984267|10073249|FG000|NOT COMPLETED|Overall Study||1
9010231|NCT02984267|10073250|FG001|NOT COMPLETED|Overall Study||1
9010232|NCT02984644|10073258|FG000|STARTED|Overall Study||20
9010233|NCT02984644|10073259|FG001|STARTED|Overall Study||10
9010234|NCT02984644|10073258|FG000|COMPLETED|Overall Study||20
9010235|NCT02984644|10073259|FG001|COMPLETED|Overall Study||10
9010236|NCT02984644|10073258|FG000|NOT COMPLETED|Overall Study||0
9010237|NCT02984644|10073259|FG001|NOT COMPLETED|Overall Study||0
9010238|NCT02984683|10073288|FG000|STARTED|Overall Study||11
9010239|NCT02984683|10073289|FG001|STARTED|Overall Study||12
9010240|NCT02984683|10073288|FG000|COMPLETED|Overall Study||0
9010241|NCT02984683|10073289|FG001|COMPLETED|Overall Study||0
9010242|NCT02984683|10073288|FG000|NOT COMPLETED|Overall Study||11
9010243|NCT02984683|10073289|FG001|NOT COMPLETED|Overall Study||12
9010244|NCT02984709|10073297|FG000|STARTED|Overall Study|We enrolled 24 adolescent-parent dyads.|24
9010245|NCT02984709|10073298|FG001|STARTED|Overall Study|We enrolled 24 adolescent-parent dyads.|24
9010246|NCT02984709|10073297|FG000|COMPLETED|Overall Study||24
9010247|NCT02984709|10073298|FG001|COMPLETED|Overall Study||24
9010248|NCT02984709|10073297|FG000|NOT COMPLETED|Overall Study||0
9010249|NCT02984709|10073298|FG001|NOT COMPLETED|Overall Study||0
9010250|NCT02984878|10073308|FG000|STARTED|Overall Study||30
9010251|NCT02984878|10073309|FG001|STARTED|Overall Study||41
9010252|NCT02984878|10073308|FG000|COMPLETED|Overall Study||30
9010253|NCT02984878|10073309|FG001|COMPLETED|Overall Study||41
9010254|NCT02984878|10073308|FG000|NOT COMPLETED|Overall Study||0
9010255|NCT02984878|10073309|FG001|NOT COMPLETED|Overall Study||0
9010256|NCT02984943|10073318|FG000|STARTED|Overall Study||14
9010257|NCT02984943|10073318|FG000|COMPLETED|Overall Study||10
9010258|NCT02984943|10073318|FG000|NOT COMPLETED|Overall Study||4
9010259|NCT02984982|10073324|FG000|STARTED|Overall Study||102
9010260|NCT02984982|10073325|FG001|STARTED|Overall Study||104
9010261|NCT02984982|10073324|FG000|Treated|Overall Study||102
9010262|NCT02984982|10073325|FG001|Treated|Overall Study||103
9010263|NCT02984982|10073324|FG000|COMPLETED|Overall Study||94
9010264|NCT02984982|10073325|FG001|COMPLETED|Overall Study||94
9010265|NCT02984982|10073324|FG000|NOT COMPLETED|Overall Study||8
9010266|NCT02984982|10073325|FG001|NOT COMPLETED|Overall Study||10
9010267|NCT02984995|10073334|FG000|STARTED|Overall Study||34
9010268|NCT02984995|10073335|FG001|STARTED|Overall Study||3
9010269|NCT02984995|10073334|FG000|COMPLETED|Overall Study||9
9010270|NCT02984995|10073335|FG001|COMPLETED|Overall Study||0
9010271|NCT02984995|10073334|FG000|NOT COMPLETED|Overall Study||25
9010272|NCT02984995|10073335|FG001|NOT COMPLETED|Overall Study||3
9010273|NCT02985021|10073347|FG000|STARTED|Overall Study||2
8902053|NCT02077140|9959635|FG004|COMPLETED|Overall Study||43
8902054|NCT02077140|9959631|FG000|NOT COMPLETED|Overall Study||4
8902055|NCT02077140|9959632|FG001|NOT COMPLETED|Overall Study||2
9010274|NCT02985021|10073347|FG000|COMPLETED|Overall Study||1
9010275|NCT02985021|10073347|FG000|NOT COMPLETED|Overall Study||1
9010276|NCT02985398|10073351|FG000|STARTED|Overall Study||128
9010277|NCT02985398|10073351|FG000|Participants Treated|Overall Study||128
9010278|NCT02985398|10073351|FG000|COMPLETED|Overall Study||106
9010279|NCT02985398|10073351|FG000|NOT COMPLETED|Overall Study||22
9010280|NCT02985450|10073355|FG000|STARTED|Overall Study||82
9010281|NCT02985450|10073355|FG000|COMPLETED|Overall Study||75
9010282|NCT02985450|10073355|FG000|NOT COMPLETED|Overall Study||7
9010283|NCT02985710|10073364|FG000|STARTED|Overall Study||69
9010284|NCT02985710|10073365|FG001|STARTED|Overall Study||33
9010285|NCT02985710|10073364|FG000|COMPLETED|Overall Study||65
9010286|NCT02985710|10073365|FG001|COMPLETED|Overall Study||33
9010287|NCT02985710|10073364|FG000|NOT COMPLETED|Overall Study||4
9010288|NCT02985710|10073365|FG001|NOT COMPLETED|Overall Study||0
9010289|NCT02985827|10073373|FG000|STARTED|Overall Study||33
9010290|NCT02985827|10073374|FG001|STARTED|Overall Study||15
9010291|NCT02985827|10073373|FG000|COMPLETED|Overall Study||33
8902056|NCT02077140|9959633|FG002|NOT COMPLETED|Overall Study||2
8902057|NCT02077140|9959634|FG003|NOT COMPLETED|Overall Study||4
8902058|NCT02077140|9959635|FG004|NOT COMPLETED|Overall Study||5
8902059|NCT02077374|9959652|FG000|STARTED|Overall Study||19
8902060|NCT02077374|9959653|FG001|STARTED|Overall Study||19
8902061|NCT02077374|9959652|FG000|COMPLETED|Overall Study||19
8902062|NCT02077374|9959653|FG001|COMPLETED|Overall Study||17
8902063|NCT02077374|9959652|FG000|NOT COMPLETED|Overall Study||0
8902064|NCT02077374|9959653|FG001|NOT COMPLETED|Overall Study||2
8902065|NCT02077465|9959664|FG000|STARTED|Overall Study||8
8902066|NCT02077465|9959665|FG001|STARTED|Overall Study||3
8902067|NCT02077465|9959664|FG000|COMPLETED|Overall Study||7
8902068|NCT02077465|9959665|FG001|COMPLETED|Overall Study||2
8902069|NCT02077465|9959664|FG000|NOT COMPLETED|Overall Study||1
8902070|NCT02077465|9959665|FG001|NOT COMPLETED|Overall Study||1
8902071|NCT02078102|9959673|FG000|STARTED|Overall Study||25
8902072|NCT02078102|9959674|FG001|STARTED|Overall Study||13
9010292|NCT02985827|10073374|FG001|COMPLETED|Overall Study||15
9010293|NCT02985827|10073373|FG000|NOT COMPLETED|Overall Study||0
9010294|NCT02985827|10073374|FG001|NOT COMPLETED|Overall Study||0
9010295|NCT02985879|10073383|FG000|STARTED|Overall Study||126
9010296|NCT02985879|10073384|FG001|STARTED|Overall Study||127
9010297|NCT02985879|10073385|FG002|STARTED|Overall Study||125
9010298|NCT02985879|10073383|FG000|COMPLETED|Overall Study||50
9010299|NCT02985879|10073384|FG001|COMPLETED|Overall Study||52
9010300|NCT02985879|10073385|FG002|COMPLETED|Overall Study||48
9010301|NCT02985879|10073383|FG000|NOT COMPLETED|Overall Study||76
9010302|NCT02985879|10073384|FG001|NOT COMPLETED|Overall Study||75
9010303|NCT02985879|10073385|FG002|NOT COMPLETED|Overall Study||77
9010304|NCT02985996|10073404|FG000|STARTED|Overall Study||5
9010305|NCT02985996|10073405|FG001|STARTED|Overall Study||8
9010306|NCT02985996|10073406|FG002|STARTED|Overall Study||10
9010307|NCT02985996|10073407|FG003|STARTED|Overall Study||7
9010308|NCT02985996|10073408|FG004|STARTED|Overall Study||9
9010309|NCT02985996|10073404|FG000|COMPLETED|Overall Study||5
9010310|NCT02985996|10073405|FG001|COMPLETED|Overall Study||7
9010311|NCT02985996|10073406|FG002|COMPLETED|Overall Study||9
9010312|NCT02985996|10073407|FG003|COMPLETED|Overall Study||7
9010313|NCT02985996|10073408|FG004|COMPLETED|Overall Study||9
9010314|NCT02985996|10073404|FG000|NOT COMPLETED|Overall Study||0
9010315|NCT02985996|10073405|FG001|NOT COMPLETED|Overall Study||1
9010316|NCT02985996|10073406|FG002|NOT COMPLETED|Overall Study||1
9010317|NCT02985996|10073407|FG003|NOT COMPLETED|Overall Study||0
9010318|NCT02985996|10073408|FG004|NOT COMPLETED|Overall Study||0
9010319|NCT02986074|10073424|FG000|STARTED|First Trial Period||26
9010320|NCT02986074|10073425|FG001|STARTED|First Trial Period||29
9010321|NCT02986074|10073426|FG002|STARTED|First Trial Period||0
9010322|NCT02986074|10073427|FG003|STARTED|First Trial Period||0
9010323|NCT02986074|10073424|FG000|COMPLETED|First Trial Period||25
9010324|NCT02986074|10073425|FG001|COMPLETED|First Trial Period||29
9010325|NCT02986074|10073426|FG002|COMPLETED|First Trial Period||0
9010326|NCT02986074|10073427|FG003|COMPLETED|First Trial Period||0
9010327|NCT02986074|10073424|FG000|NOT COMPLETED|First Trial Period||1
9010328|NCT02986074|10073425|FG001|NOT COMPLETED|First Trial Period||0
9010329|NCT02986074|10073426|FG002|NOT COMPLETED|First Trial Period||0
9010330|NCT02986074|10073427|FG003|NOT COMPLETED|First Trial Period||0
9010331|NCT02986074|10073424|FG000|STARTED|Second Trial Period||25
9010332|NCT02986074|10073425|FG001|STARTED|Second Trial Period||29
9010333|NCT02986074|10073426|FG002|STARTED|Second Trial Period||0
9010334|NCT02986074|10073427|FG003|STARTED|Second Trial Period||0
9010335|NCT02986074|10073424|FG000|COMPLETED|Second Trial Period||25
9010336|NCT02986074|10073425|FG001|COMPLETED|Second Trial Period||29
9010337|NCT02986074|10073426|FG002|COMPLETED|Second Trial Period||0
9010338|NCT02986074|10073427|FG003|COMPLETED|Second Trial Period||0
9010339|NCT02986074|10073424|FG000|NOT COMPLETED|Second Trial Period||0
9010340|NCT02986074|10073425|FG001|NOT COMPLETED|Second Trial Period||0
9010341|NCT02986074|10073426|FG002|NOT COMPLETED|Second Trial Period||0
8902073|NCT02078102|9959673|FG000|COMPLETED|Overall Study||23
9010342|NCT02986074|10073427|FG003|NOT COMPLETED|Second Trial Period||0
9010343|NCT02986074|10073424|FG000|STARTED|Follow up Period||0
9010344|NCT02986074|10073425|FG001|STARTED|Follow up Period||0
9010345|NCT02986074|10073426|FG002|STARTED|Follow up Period||21
9010346|NCT02986074|10073427|FG003|STARTED|Follow up Period||22
9010347|NCT02986074|10073424|FG000|3 Month Follow up|Follow up Period||0
8902074|NCT02078102|9959674|FG001|COMPLETED|Overall Study||12
8902075|NCT02078102|9959673|FG000|NOT COMPLETED|Overall Study||2
9010348|NCT02986074|10073425|FG001|3 Month Follow up|Follow up Period||0
9010349|NCT02986074|10073426|FG002|3 Month Follow up|Follow up Period||21
9010350|NCT02986074|10073427|FG003|3 Month Follow up|Follow up Period||21
9010351|NCT02986074|10073424|FG000|6 Month Follow up|Follow up Period||0
9010352|NCT02986074|10073425|FG001|6 Month Follow up|Follow up Period||0
9010353|NCT02986074|10073426|FG002|6 Month Follow up|Follow up Period||21
9010354|NCT02986074|10073427|FG003|6 Month Follow up|Follow up Period||20
9010355|NCT02986074|10073424|FG000|COMPLETED|Follow up Period||0
9010356|NCT02986074|10073425|FG001|COMPLETED|Follow up Period||0
9010357|NCT02986074|10073426|FG002|COMPLETED|Follow up Period||20
9010358|NCT02986074|10073427|FG003|COMPLETED|Follow up Period||19
9010359|NCT02986074|10073424|FG000|NOT COMPLETED|Follow up Period||0
8902076|NCT02078102|9959674|FG001|NOT COMPLETED|Overall Study||1
9010360|NCT02986074|10073425|FG001|NOT COMPLETED|Follow up Period||0
8902077|NCT02078180|9959681|FG000|STARTED|Overall Study||34
8902078|NCT02078180|9959681|FG000|IR75|Overall Study||30
8572941|NCT00117676|9605093|FG000|STARTED|Open-label Period: Weeks 337 - 384||183
8572942|NCT00117676|9605094|FG001|STARTED|Open-label Period: Weeks 337 - 384||93
8572943|NCT00117676|9605093|FG000|COMPLETED|Open-label Period: Weeks 337 - 384||176
8572944|NCT00117676|9605094|FG001|COMPLETED|Open-label Period: Weeks 337 - 384||90
8572945|NCT00117676|9605093|FG000|NOT COMPLETED|Open-label Period: Weeks 337 - 384||7
8572946|NCT00117676|9605094|FG001|NOT COMPLETED|Open-label Period: Weeks 337 - 384||3
8572947|NCT00117676|9605093|FG000|STARTED|Open-label Period: Weeks 385 - 432|94 participants completed 384 weeks but did not continue on study.|82
8902079|NCT02078180|9959681|FG000|IR100|Overall Study||31
8902080|NCT02078180|9959681|FG000|SR100|Overall Study||31
8902081|NCT02078180|9959681|FG000|SR150|Overall Study||32
8902082|NCT02078180|9959681|FG000|XL 150|Overall Study||31
8902083|NCT02078180|9959681|FG000|XL 300|Overall Study||32
8902084|NCT02078180|9959681|FG000|COMPLETED|Overall Study||29
8902085|NCT02078180|9959681|FG000|NOT COMPLETED|Overall Study||5
8902086|NCT02078193|9959690|FG000|STARTED|Overall Study||3
8902087|NCT02078193|9959690|FG000|COMPLETED|Overall Study||3
8902088|NCT02078193|9959690|FG000|NOT COMPLETED|Overall Study||0
8902089|NCT02078219|9959700|FG000|STARTED|Overall Study||41
8902090|NCT02078219|9959701|FG001|STARTED|Overall Study||40
8902091|NCT02078219|9959702|FG002|STARTED|Overall Study||41
8902092|NCT02078219|9959703|FG003|STARTED|Overall Study||41
8902093|NCT02078219|9959704|FG004|STARTED|Overall Study||41
9010361|NCT02986074|10073426|FG002|NOT COMPLETED|Follow up Period||1
9010362|NCT02986074|10073427|FG003|NOT COMPLETED|Follow up Period||3
9010363|NCT02986139|10073434|FG000|STARTED|Overall Study||56
9010364|NCT02986139|10073435|FG001|STARTED|Overall Study||55
9010365|NCT02986139|10073434|FG000|Received Etanercept|Overall Study||56
9010366|NCT02986139|10073435|FG001|Received Etanercept|Overall Study||53
9010367|NCT02986139|10073434|FG000|COMPLETED|Overall Study||55
9010368|NCT02986139|10073435|FG001|COMPLETED|Overall Study||51
9010369|NCT02986139|10073434|FG000|NOT COMPLETED|Overall Study||1
9010370|NCT02986139|10073435|FG001|NOT COMPLETED|Overall Study||4
9010371|NCT02986282|10073445|FG000|STARTED|Overall Study||115
9010372|NCT02986282|10073445|FG000|COMPLETED|Overall Study||99
9010373|NCT02986282|10073445|FG000|NOT COMPLETED|Overall Study||16
9010374|NCT02986373|10073449|FG000|STARTED|Overall Study||145
9010375|NCT02986373|10073449|FG000|COMPLETED|Overall Study||106
9010376|NCT02986373|10073449|FG000|NOT COMPLETED|Overall Study||39
9010377|NCT02986711|10073455|FG000|STARTED|Overall Study||78
9010378|NCT02986711|10073456|FG001|STARTED|Overall Study||80
9010379|NCT02986711|10073455|FG000|COMPLETED|Overall Study||70
9010380|NCT02986711|10073456|FG001|COMPLETED|Overall Study||70
9010381|NCT02986711|10073455|FG000|NOT COMPLETED|Overall Study||8
9010382|NCT02986711|10073456|FG001|NOT COMPLETED|Overall Study||10
9010383|NCT02986802|10073466|FG000|STARTED|Overall Study||1360
9010384|NCT02986802|10073467|FG001|STARTED|Overall Study||2839
9010385|NCT02986802|10073468|FG002|STARTED|Overall Study||1873
9010386|NCT02986802|10073469|FG003|STARTED|Overall Study||83060
9010387|NCT02986802|10073466|FG000|COMPLETED|Overall Study||1360
9010388|NCT02986802|10073467|FG001|COMPLETED|Overall Study||2839
9010389|NCT02986802|10073468|FG002|COMPLETED|Overall Study||1873
8572948|NCT00117676|9605094|FG001|STARTED|Open-label Period: Weeks 385 - 432|44 participants completed 384 weeks but did not continue on study.|46
8577921|NCT00165841|9610861|FG000|NOT COMPLETED|Overall Study||30
8902094|NCT02078219|9959700|FG000|COMPLETED|Overall Study||38
9010390|NCT02986802|10073469|FG003|COMPLETED|Overall Study||83060
9010391|NCT02986802|10073466|FG000|NOT COMPLETED|Overall Study||0
9010392|NCT02986802|10073467|FG001|NOT COMPLETED|Overall Study||0
9010393|NCT02986802|10073468|FG002|NOT COMPLETED|Overall Study||0
8902095|NCT02078219|9959701|FG001|COMPLETED|Overall Study||36
8902096|NCT02078219|9959702|FG002|COMPLETED|Overall Study||35
8902097|NCT02078219|9959703|FG003|COMPLETED|Overall Study||37
8902098|NCT02078219|9959704|FG004|COMPLETED|Overall Study||39
8902099|NCT02078219|9959700|FG000|NOT COMPLETED|Overall Study||3
8902100|NCT02078219|9959701|FG001|NOT COMPLETED|Overall Study||4
9010394|NCT02986802|10073469|FG003|NOT COMPLETED|Overall Study||0
9010395|NCT02986854|10073482|FG000|STARTED|Overall Study||301
9010396|NCT02986854|10073483|FG001|STARTED|Overall Study||300
9010397|NCT02986854|10073484|FG002|STARTED|Overall Study||100
9010398|NCT02986854|10073482|FG000|COMPLETED|Overall Study||298
9010399|NCT02986854|10073483|FG001|COMPLETED|Overall Study||288
9010400|NCT02986854|10073484|FG002|COMPLETED|Overall Study||97
9010401|NCT02986854|10073482|FG000|NOT COMPLETED|Overall Study||3
9010402|NCT02986854|10073483|FG001|NOT COMPLETED|Overall Study||12
9010403|NCT02986854|10073484|FG002|NOT COMPLETED|Overall Study||3
8636318|NCT00567489|9676928|FG001|STARTED|Overall Study||124
8636319|NCT00567489|9676927|FG000|COMPLETED|Overall Study||120
9010404|NCT02986958|10073496|FG000|STARTED|Overall Study||49
9010405|NCT02986958|10073497|FG001|STARTED|Overall Study||44
9010406|NCT02986958|10073496|FG000|COMPLETED|Overall Study||49
9010407|NCT02986958|10073497|FG001|COMPLETED|Overall Study||44
9010408|NCT02986958|10073496|FG000|NOT COMPLETED|Overall Study||0
9010409|NCT02986958|10073497|FG001|NOT COMPLETED|Overall Study||0
9010410|NCT02987205|10073503|FG000|STARTED|Overall Study||163
9010411|NCT02987205|10073503|FG000|Treated - Bilateral NLF Injection|Overall Study||163
9010412|NCT02987205|10073503|FG000|COMPLETED|Overall Study|Treatment is bilateral, subject lost to Restylane AE was lost to further Revanesse Ultra treatment|159
9010413|NCT02987205|10073503|FG000|NOT COMPLETED|Overall Study||4
9010414|NCT02987231|10073511|FG000|STARTED|Overall Study||30
9010415|NCT02987231|10073512|FG001|STARTED|Overall Study||30
9010416|NCT02987231|10073511|FG000|COMPLETED|Overall Study||30
9010417|NCT02987231|10073512|FG001|COMPLETED|Overall Study||30
9010418|NCT02987231|10073511|FG000|NOT COMPLETED|Overall Study||0
9010419|NCT02987231|10073512|FG001|NOT COMPLETED|Overall Study||0
9010420|NCT02987374|10073518|FG000|STARTED|Overall Study||10
9010421|NCT02987374|10073518|FG000|COMPLETED|Overall Study||10
9010422|NCT02987374|10073518|FG000|NOT COMPLETED|Overall Study||0
9010423|NCT02987621|10073522|FG000|STARTED|Overall Study||7
9010424|NCT02987621|10073523|FG001|STARTED|Overall Study||7
9010425|NCT02987621|10073522|FG000|COMPLETED|Overall Study||7
9010426|NCT02987621|10073523|FG001|COMPLETED|Overall Study||7
9010427|NCT02987621|10073522|FG000|NOT COMPLETED|Overall Study||0
9010428|NCT02987621|10073523|FG001|NOT COMPLETED|Overall Study||0
9010429|NCT02987660|10073533|FG000|STARTED|Overall Study||10
9010430|NCT02987660|10073534|FG001|STARTED|Overall Study||10
9010431|NCT02987660|10073533|FG000|COMPLETED|Overall Study||0
9010432|NCT02987660|10073534|FG001|COMPLETED|Overall Study||0
9010433|NCT02987660|10073533|FG000|NOT COMPLETED|Overall Study||10
9010434|NCT02987660|10073534|FG001|NOT COMPLETED|Overall Study||10
9010435|NCT02987829|10073546|FG000|STARTED|Overall Study||1
9010436|NCT02987829|10073547|FG001|STARTED|Overall Study||1
9010437|NCT02987829|10073548|FG002|STARTED|Overall Study||2
9010438|NCT02987829|10073549|FG003|STARTED|Overall Study||7
9010439|NCT02987829|10073550|FG004|STARTED|Overall Study||51
8572949|NCT00117676|9605093|FG000|COMPLETED|Open-label Period: Weeks 385 - 432||82
8572950|NCT00117676|9605094|FG001|COMPLETED|Open-label Period: Weeks 385 - 432||44
8572951|NCT00117676|9605093|FG000|NOT COMPLETED|Open-label Period: Weeks 385 - 432||0
8572952|NCT00117676|9605094|FG001|NOT COMPLETED|Open-label Period: Weeks 385 - 432||2
8572953|NCT00117676|9605093|FG000|STARTED|Open-label Period: Weeks 433 - 480||82
8572954|NCT00117676|9605094|FG001|STARTED|Open-label Period: Weeks 433 - 480|1 participant completed 432 weeks but did not continue on study.|43
8902101|NCT02078219|9959702|FG002|NOT COMPLETED|Overall Study||6
8902102|NCT02078219|9959703|FG003|NOT COMPLETED|Overall Study||4
8902103|NCT02078219|9959704|FG004|NOT COMPLETED|Overall Study||2
8902104|NCT02078284|9959721|FG000|STARTED|Overall Study||5
8902105|NCT02078284|9959722|FG001|STARTED|Overall Study||7
8902106|NCT02078284|9959723|FG002|STARTED|Overall Study||6
8902107|NCT02078284|9959724|FG003|STARTED|Overall Study||6
8902108|NCT02078284|9959725|FG004|STARTED|Overall Study||4
8902109|NCT02078284|9959721|FG000|COMPLETED|Overall Study||5
9010440|NCT02987829|10073551|FG005|STARTED|Overall Study||10
8572955|NCT00117676|9605093|FG000|COMPLETED|Open-label Period: Weeks 433 - 480||80
8636320|NCT00567489|9676928|FG001|COMPLETED|Overall Study||101
8636321|NCT00567489|9676927|FG000|NOT COMPLETED|Overall Study||7
9010441|NCT02987829|10073546|FG000|COMPLETED|Overall Study||1
9010442|NCT02987829|10073547|FG001|COMPLETED|Overall Study||1
9010443|NCT02987829|10073548|FG002|COMPLETED|Overall Study||2
9010444|NCT02987829|10073549|FG003|COMPLETED|Overall Study||7
9010445|NCT02987829|10073550|FG004|COMPLETED|Overall Study||51
9010446|NCT02987829|10073551|FG005|COMPLETED|Overall Study||10
9010447|NCT02987829|10073546|FG000|NOT COMPLETED|Overall Study||0
8902110|NCT02078284|9959722|FG001|COMPLETED|Overall Study||7
8902111|NCT02078284|9959723|FG002|COMPLETED|Overall Study||6
8902112|NCT02078284|9959724|FG003|COMPLETED|Overall Study||6
8902113|NCT02078284|9959725|FG004|COMPLETED|Overall Study||4
8902114|NCT02078284|9959721|FG000|NOT COMPLETED|Overall Study||0
8902115|NCT02078284|9959722|FG001|NOT COMPLETED|Overall Study||0
8902116|NCT02078284|9959723|FG002|NOT COMPLETED|Overall Study||0
8902117|NCT02078284|9959724|FG003|NOT COMPLETED|Overall Study||0
8902118|NCT02078284|9959725|FG004|NOT COMPLETED|Overall Study||0
8902119|NCT02078492|9959740|FG000|STARTED|Overall Study||80
8636322|NCT00567489|9676928|FG001|NOT COMPLETED|Overall Study||23
8636323|NCT00567502|9676938|FG000|STARTED|Overall Study||804
8726449|NCT01036529|9773699|FG000|6 Month Follow-up|Overall Study||6
8726450|NCT01036529|9773700|FG001|6 Month Follow-up|Overall Study||7
8726451|NCT01036529|9773699|FG000|12 Month Follow-up|Overall Study||4
8726452|NCT01036529|9773700|FG001|12 Month Follow-up|Overall Study||3
8726453|NCT01036529|9773699|FG000|Requested Crossover|Overall Study||1
8726454|NCT01036529|9773700|FG001|Requested Crossover|Overall Study||2
8726455|NCT01036529|9773699|FG000|Crossover to Other Group|Overall Study||1
8726456|NCT01036529|9773700|FG001|Crossover to Other Group|Overall Study||1
8726457|NCT01036529|9773699|FG000|COMPLETED|Overall Study||0
8726458|NCT01036529|9773700|FG001|COMPLETED|Overall Study||0
8726459|NCT01036529|9773699|FG000|NOT COMPLETED|Overall Study||13
8726460|NCT01036529|9773700|FG001|NOT COMPLETED|Overall Study||15
8726461|NCT01036594|9773706|FG000|STARTED|Run-In: Ketoconazole Only (200 mg)||32
8726462|NCT01036594|9773707|FG001|STARTED|Run-In: Ketoconazole Only (200 mg)|Dexamethasone not introduced as treatment option until after Week 12 evaluation|0
8726463|NCT01036594|9773706|FG000|COMPLETED|Run-In: Ketoconazole Only (200 mg)||31
8726464|NCT01036594|9773707|FG001|COMPLETED|Run-In: Ketoconazole Only (200 mg)||0
8636324|NCT00567502|9676939|FG001|STARTED|Overall Study||141
8636325|NCT00567502|9676940|FG002|STARTED|Overall Study||2666
8636326|NCT00567502|9676941|FG003|STARTED|Overall Study||110
8636327|NCT00567502|9676938|FG000|Initiated Treatment|Overall Study||804
8636328|NCT00567502|9676939|FG001|Initiated Treatment|Overall Study||141
8636329|NCT00567502|9676940|FG002|Initiated Treatment|Overall Study||2666
8636330|NCT00567502|9676941|FG003|Initiated Treatment|Overall Study||38
8636331|NCT00567502|9676938|FG000|COMPLETED|Overall Study||563
8636332|NCT00567502|9676939|FG001|COMPLETED|Overall Study||108
8636333|NCT00567502|9676940|FG002|COMPLETED|Overall Study||1758
8636334|NCT00567502|9676941|FG003|COMPLETED|Overall Study||23
8636335|NCT00567502|9676938|FG000|NOT COMPLETED|Overall Study||241
8636336|NCT00567502|9676939|FG001|NOT COMPLETED|Overall Study||33
8636337|NCT00567502|9676940|FG002|NOT COMPLETED|Overall Study||908
8636338|NCT00567502|9676941|FG003|NOT COMPLETED|Overall Study||87
8636339|NCT00567541|9676964|FG000|STARTED|Overall Study||7
8636340|NCT00567541|9676965|FG001|STARTED|Overall Study||9
8636341|NCT00567541|9676964|FG000|COMPLETED|Overall Study||7
8636342|NCT00567541|9676965|FG001|COMPLETED|Overall Study||8
8636343|NCT00567541|9676964|FG000|NOT COMPLETED|Overall Study||0
8636344|NCT00567541|9676965|FG001|NOT COMPLETED|Overall Study||1
8636345|NCT00567593|9676971|FG000|STARTED|Overall Study||12
8636346|NCT00567593|9676971|FG000|COMPLETED|Overall Study||10
8726465|NCT01036594|9773706|FG000|NOT COMPLETED|Run-In: Ketoconazole Only (200 mg)||1
8726466|NCT01036594|9773707|FG001|NOT COMPLETED|Run-In: Ketoconazole Only (200 mg)||0
8726467|NCT01036594|9773706|FG000|STARTED|First Treatment Regimen||31
8726468|NCT01036594|9773707|FG001|STARTED|First Treatment Regimen|Dexamethasone not introduced as treatment option until after Week 12 evaluation|0
8726469|NCT01036594|9773706|FG000|COMPLETED|First Treatment Regimen||30
8726470|NCT01036594|9773707|FG001|COMPLETED|First Treatment Regimen||0
8726471|NCT01036594|9773706|FG000|NOT COMPLETED|First Treatment Regimen||1
8726472|NCT01036594|9773707|FG001|NOT COMPLETED|First Treatment Regimen||0
8726473|NCT01036594|9773706|FG000|STARTED|Week 12 Evaluation||30
8726474|NCT01036594|9773707|FG001|STARTED|Week 12 Evaluation|Dexamethasone not introduced as treatment option until after Week 12 evaluation|0
8726475|NCT01036594|9773706|FG000|COMPLETED|Week 12 Evaluation||24
8726476|NCT01036594|9773707|FG001|COMPLETED|Week 12 Evaluation||0
8726477|NCT01036594|9773706|FG000|NOT COMPLETED|Week 12 Evaluation||6
8726478|NCT01036594|9773707|FG001|NOT COMPLETED|Week 12 Evaluation||0
8726479|NCT01036594|9773706|FG000|STARTED|Treatment Regiments Post Week 12||15
8726480|NCT01036594|9773707|FG001|STARTED|Treatment Regiments Post Week 12||9
8726481|NCT01036594|9773706|FG000|COMPLETED|Treatment Regiments Post Week 12||13
8726482|NCT01036594|9773707|FG001|COMPLETED|Treatment Regiments Post Week 12||5
8726483|NCT01036594|9773706|FG000|NOT COMPLETED|Treatment Regiments Post Week 12||2
8726484|NCT01036594|9773707|FG001|NOT COMPLETED|Treatment Regiments Post Week 12||4
8726485|NCT01036724|9773715|FG000|STARTED|Overall Study||52
8726486|NCT01036724|9773716|FG001|STARTED|Overall Study||55
8726487|NCT01036724|9773715|FG000|COMPLETED|Overall Study||46
8726488|NCT01036724|9773716|FG001|COMPLETED|Overall Study||47
8726489|NCT01036724|9773715|FG000|NOT COMPLETED|Overall Study||6
8726490|NCT01036724|9773716|FG001|NOT COMPLETED|Overall Study||8
8726491|NCT01036763|9773722|FG000|STARTED|Overall Study||1264
8726492|NCT01036763|9773722|FG000|COMPLETED|Overall Study||1171
8726493|NCT01036763|9773722|FG000|NOT COMPLETED|Overall Study||93
8726494|NCT01036802|9773728|FG000|STARTED|Overall Study||2
8726495|NCT01036802|9773729|FG001|STARTED|Overall Study||1
8726496|NCT01036802|9773728|FG000|COMPLETED|Overall Study||2
8902120|NCT02078492|9959741|FG001|STARTED|Overall Study||80
8902121|NCT02078492|9959742|FG002|STARTED|Overall Study||80
8902122|NCT02078492|9959740|FG000|COMPLETED|Overall Study||80
8902123|NCT02078492|9959741|FG001|COMPLETED|Overall Study||80
8902124|NCT02078492|9959742|FG002|COMPLETED|Overall Study||80
8902125|NCT02078492|9959740|FG000|NOT COMPLETED|Overall Study||0
8902126|NCT02078492|9959741|FG001|NOT COMPLETED|Overall Study||0
8902127|NCT02078492|9959742|FG002|NOT COMPLETED|Overall Study||0
8902128|NCT02078557|9959750|FG000|STARTED|Overall Study||4
8902129|NCT02078557|9959750|FG000|COMPLETED|Overall Study||4
8902130|NCT02078557|9959750|FG000|NOT COMPLETED|Overall Study||0
8902131|NCT02078713|9959758|FG000|STARTED|Overall Study||407
8902132|NCT02078713|9959759|FG001|STARTED|Overall Study||351
8902133|NCT02078713|9959760|FG002|STARTED|Overall Study||15
8902134|NCT02078713|9959761|FG003|STARTED|Overall Study||13
8902135|NCT02078713|9959758|FG000|COMPLETED|Overall Study||355
8902136|NCT02078713|9959759|FG001|COMPLETED|Overall Study||290
8902137|NCT02078713|9959760|FG002|COMPLETED|Overall Study||15
8902138|NCT02078713|9959761|FG003|COMPLETED|Overall Study||13
8902139|NCT02078713|9959758|FG000|NOT COMPLETED|Overall Study||52
8902140|NCT02078713|9959759|FG001|NOT COMPLETED|Overall Study||61
8902141|NCT02078713|9959760|FG002|NOT COMPLETED|Overall Study||0
8902142|NCT02078713|9959761|FG003|NOT COMPLETED|Overall Study||0
8902143|NCT02078726|9959775|FG000|STARTED|Overall Study||64
8902144|NCT02078726|9959776|FG001|STARTED|Overall Study||36
8902145|NCT02078726|9959775|FG000|COMPLETED|Overall Study||64
8902146|NCT02078726|9959776|FG001|COMPLETED|Overall Study||36
8902147|NCT02078726|9959775|FG000|NOT COMPLETED|Overall Study||0
8902148|NCT02078726|9959776|FG001|NOT COMPLETED|Overall Study||0
8902149|NCT02078752|9959792|FG000|STARTED|Overall Study||3
8902150|NCT02078752|9959793|FG001|STARTED|Overall Study||13
8902151|NCT02078752|9959794|FG002|STARTED|Overall Study||2
8902152|NCT02078752|9959795|FG003|STARTED|Overall Study||7
9010448|NCT02987829|10073547|FG001|NOT COMPLETED|Overall Study||0
9010449|NCT02987829|10073548|FG002|NOT COMPLETED|Overall Study||0
9010450|NCT02987829|10073549|FG003|NOT COMPLETED|Overall Study||0
9010451|NCT02987829|10073550|FG004|NOT COMPLETED|Overall Study||0
9010452|NCT02987829|10073551|FG005|NOT COMPLETED|Overall Study||0
9010453|NCT02987868|10073568|FG000|STARTED|First Intervention||8
9010454|NCT02987868|10073569|FG001|STARTED|First Intervention||8
9010455|NCT02987868|10073568|FG000|COMPLETED|First Intervention||8
9010456|NCT02987868|10073569|FG001|COMPLETED|First Intervention||8
9010457|NCT02987868|10073568|FG000|NOT COMPLETED|First Intervention||0
9010458|NCT02987868|10073569|FG001|NOT COMPLETED|First Intervention||0
9010459|NCT02987868|10073568|FG000|STARTED|Wash Out Period 1 Week||8
9010460|NCT02987868|10073569|FG001|STARTED|Wash Out Period 1 Week||8
9010461|NCT02987868|10073568|FG000|COMPLETED|Wash Out Period 1 Week||8
9010462|NCT02987868|10073569|FG001|COMPLETED|Wash Out Period 1 Week||8
9010463|NCT02987868|10073568|FG000|NOT COMPLETED|Wash Out Period 1 Week||0
9010464|NCT02987868|10073569|FG001|NOT COMPLETED|Wash Out Period 1 Week||0
9010465|NCT02987868|10073568|FG000|STARTED|Second Intervention||8
9010466|NCT02987868|10073569|FG001|STARTED|Second Intervention||8
9010467|NCT02987868|10073568|FG000|COMPLETED|Second Intervention||8
9010468|NCT02987868|10073569|FG001|COMPLETED|Second Intervention||8
9010469|NCT02987868|10073568|FG000|NOT COMPLETED|Second Intervention||0
9010470|NCT02987868|10073569|FG001|NOT COMPLETED|Second Intervention||0
9010471|NCT02987972|10073578|FG000|STARTED|Overall Study||351
9010472|NCT02987972|10073579|FG001|STARTED|Overall Study||350
9010473|NCT02987972|10073580|FG002|STARTED|Overall Study||350
9010474|NCT02987972|10073578|FG000|Vaccination 1|Overall Study||350
9010475|NCT02987972|10073579|FG001|Vaccination 1|Overall Study||347
9010476|NCT02987972|10073580|FG002|Vaccination 1|Overall Study||347
9010477|NCT02987972|10073578|FG000|Vaccination 2|Overall Study||333
9010478|NCT02987972|10073579|FG001|Vaccination 2|Overall Study||335
9010479|NCT02987972|10073580|FG002|Vaccination 2|Overall Study||335
9010480|NCT02987972|10073578|FG000|Vaccination 3|Overall Study||330
9010481|NCT02987972|10073579|FG001|Vaccination 3|Overall Study||331
9010482|NCT02987972|10073580|FG002|Vaccination 3|Overall Study||332
9010483|NCT02987972|10073578|FG000|Vaccination 4|Overall Study||310
9010484|NCT02987972|10073579|FG001|Vaccination 4|Overall Study||306
9010485|NCT02987972|10073580|FG002|Vaccination 4|Overall Study||311
9010486|NCT02987972|10073578|FG000|COMPLETED|Overall Study||308
9010487|NCT02987972|10073579|FG001|COMPLETED|Overall Study||305
9010488|NCT02987972|10073580|FG002|COMPLETED|Overall Study||308
9010489|NCT02987972|10073578|FG000|NOT COMPLETED|Overall Study||43
9010490|NCT02987972|10073579|FG001|NOT COMPLETED|Overall Study||45
9010491|NCT02987972|10073580|FG002|NOT COMPLETED|Overall Study||42
9010492|NCT02988050|10073590|FG000|STARTED|Overall Study||30
9010493|NCT02988050|10073591|FG001|STARTED|Overall Study||30
9010494|NCT02988050|10073590|FG000|COMPLETED|Overall Study||30
9010495|NCT02988050|10073591|FG001|COMPLETED|Overall Study||30
9010496|NCT02988050|10073590|FG000|NOT COMPLETED|Overall Study||0
9010497|NCT02988050|10073591|FG001|NOT COMPLETED|Overall Study||0
9010498|NCT02988115|10073599|FG000|STARTED|Overall Study||234
9010499|NCT02988115|10073600|FG001|STARTED|Overall Study||111
8902153|NCT02078752|9959796|FG004|STARTED|Overall Study||3
8902154|NCT02078752|9959797|FG005|STARTED|Overall Study||9
8902155|NCT02078752|9959798|FG006|STARTED|Overall Study||3
8902156|NCT02078752|9959799|FG007|STARTED|Overall Study||6
8902157|NCT02078752|9959800|FG008|STARTED|Overall Study||2
8902158|NCT02078752|9959801|FG009|STARTED|Overall Study||12
8902159|NCT02078752|9959792|FG000|COMPLETED|Overall Study||1
8902160|NCT02078752|9959793|FG001|COMPLETED|Overall Study||6
8902161|NCT02078752|9959794|FG002|COMPLETED|Overall Study||1
8902162|NCT02078752|9959795|FG003|COMPLETED|Overall Study||5
8902163|NCT02078752|9959796|FG004|COMPLETED|Overall Study||2
8902164|NCT02078752|9959797|FG005|COMPLETED|Overall Study||5
8902165|NCT02078752|9959798|FG006|COMPLETED|Overall Study||1
8902166|NCT02078752|9959799|FG007|COMPLETED|Overall Study||3
8902167|NCT02078752|9959800|FG008|COMPLETED|Overall Study||2
8902168|NCT02078752|9959801|FG009|COMPLETED|Overall Study||2
8902169|NCT02078752|9959792|FG000|NOT COMPLETED|Overall Study||2
8902170|NCT02078752|9959793|FG001|NOT COMPLETED|Overall Study||7
8902171|NCT02078752|9959794|FG002|NOT COMPLETED|Overall Study||1
8902172|NCT02078752|9959795|FG003|NOT COMPLETED|Overall Study||2
8902173|NCT02078752|9959796|FG004|NOT COMPLETED|Overall Study||1
8902174|NCT02078752|9959797|FG005|NOT COMPLETED|Overall Study||4
8902175|NCT02078752|9959798|FG006|NOT COMPLETED|Overall Study||2
8902176|NCT02078752|9959799|FG007|NOT COMPLETED|Overall Study||3
8902177|NCT02078752|9959800|FG008|NOT COMPLETED|Overall Study||0
8902178|NCT02078752|9959801|FG009|NOT COMPLETED|Overall Study||10
8902179|NCT02078817|9959832|FG000|STARTED|Overall Study||14
8902180|NCT02078817|9959832|FG000|COMPLETED|Overall Study||13
8902181|NCT02078817|9959832|FG000|NOT COMPLETED|Overall Study||1
8902182|NCT02078882|9959836|FG000|STARTED|Overall Study||16
8902183|NCT02078882|9959836|FG000|COMPLETED|Overall Study||16
8902184|NCT02078882|9959836|FG000|NOT COMPLETED|Overall Study||0
8902185|NCT02078960|9959843|FG000|STARTED|Treatment Period||2
8902186|NCT02078960|9959844|FG001|STARTED|Treatment Period||4
8902187|NCT02078960|9959845|FG002|STARTED|Treatment Period||4
8902188|NCT02078960|9959843|FG000|COMPLETED|Treatment Period||0
8902189|NCT02078960|9959844|FG001|COMPLETED|Treatment Period||1
8902190|NCT02078960|9959845|FG002|COMPLETED|Treatment Period||1
8902191|NCT02078960|9959843|FG000|NOT COMPLETED|Treatment Period||2
8902192|NCT02078960|9959844|FG001|NOT COMPLETED|Treatment Period||3
8902193|NCT02078960|9959845|FG002|NOT COMPLETED|Treatment Period||3
8902194|NCT02078960|9959843|FG000|STARTED|Follow-up Period||2
8902195|NCT02078960|9959844|FG001|STARTED|Follow-up Period||2
8902196|NCT02078960|9959845|FG002|STARTED|Follow-up Period||1
8902197|NCT02078960|9959843|FG000|COMPLETED|Follow-up Period||0
8572956|NCT00117676|9605094|FG001|COMPLETED|Open-label Period: Weeks 433 - 480||41
8572957|NCT00117676|9605093|FG000|NOT COMPLETED|Open-label Period: Weeks 433 - 480||2
8572958|NCT00117676|9605094|FG001|NOT COMPLETED|Open-label Period: Weeks 433 - 480||2
8572959|NCT00117715|9605105|FG000|STARTED|Overall Study||121
8902198|NCT02078960|9959844|FG001|COMPLETED|Follow-up Period||1
8902199|NCT02078960|9959845|FG002|COMPLETED|Follow-up Period||1
8902200|NCT02078960|9959843|FG000|NOT COMPLETED|Follow-up Period||2
8902201|NCT02078960|9959844|FG001|NOT COMPLETED|Follow-up Period||1
8902202|NCT02078960|9959845|FG002|NOT COMPLETED|Follow-up Period||0
8902203|NCT02079025|9959857|FG000|STARTED|Overall Study||839
8902204|NCT02079025|9959858|FG001|STARTED|Overall Study||837
8902205|NCT02079025|9959857|FG000|COMPLETED|Overall Study||839
8902206|NCT02079025|9959858|FG001|COMPLETED|Overall Study||837
8902207|NCT02079025|9959857|FG000|NOT COMPLETED|Overall Study||0
8902208|NCT02079025|9959858|FG001|NOT COMPLETED|Overall Study||0
8902209|NCT02079038|9959867|FG000|STARTED|Modified Intent to Treat Population||112
8902210|NCT02079038|9959868|FG001|STARTED|Modified Intent to Treat Population||56
8902211|NCT02079038|9959867|FG000|COMPLETED|Modified Intent to Treat Population||105
8902212|NCT02079038|9959868|FG001|COMPLETED|Modified Intent to Treat Population||51
8902213|NCT02079038|9959867|FG000|NOT COMPLETED|Modified Intent to Treat Population||7
8902214|NCT02079038|9959868|FG001|NOT COMPLETED|Modified Intent to Treat Population||5
8902215|NCT02079038|9959867|FG000|STARTED|Completed 6 Months||105
8902216|NCT02079038|9959868|FG001|STARTED|Completed 6 Months||51
8902217|NCT02079038|9959867|FG000|COMPLETED|Completed 6 Months||103
8902218|NCT02079038|9959868|FG001|COMPLETED|Completed 6 Months||50
8902219|NCT02079038|9959867|FG000|NOT COMPLETED|Completed 6 Months||2
8902220|NCT02079038|9959868|FG001|NOT COMPLETED|Completed 6 Months||1
8902221|NCT02079077|9959876|FG000|STARTED|Overall Study||43
8902222|NCT02079077|9959877|FG001|STARTED|Overall Study||48
8902223|NCT02079077|9959876|FG000|COMPLETED|Overall Study||37
8902224|NCT02079077|9959877|FG001|COMPLETED|Overall Study||39
8902225|NCT02079077|9959876|FG000|NOT COMPLETED|Overall Study||6
8902226|NCT02079077|9959877|FG001|NOT COMPLETED|Overall Study||9
8902227|NCT02079246|9959883|FG000|STARTED|OLEX||1463
8902228|NCT02079246|9959884|FG001|STARTED|OLEX||0
8902229|NCT02079246|9959883|FG000|COMPLETED|OLEX||1235
8902230|NCT02079246|9959884|FG001|COMPLETED|OLEX||0
8902231|NCT02079246|9959883|FG000|NOT COMPLETED|OLEX||228
8902232|NCT02079246|9959884|FG001|NOT COMPLETED|OLEX||0
8902233|NCT02079246|9959883|FG000|STARTED|OLEX-MEM||0
8902234|NCT02079246|9959884|FG001|STARTED|OLEX-MEM||101
8572960|NCT00117715|9605105|FG000|1 Year|Overall Study||88
8572961|NCT00117715|9605105|FG000|1.5 Year|Overall Study||85
8902235|NCT02079246|9959883|FG000|COMPLETED|OLEX-MEM||0
8572962|NCT00117715|9605105|FG000|2 Year|Overall Study||76
8572963|NCT00117715|9605105|FG000|2.5 Year|Overall Study||70
8572964|NCT00117715|9605105|FG000|3 Year|Overall Study||61
8572965|NCT00117715|9605105|FG000|3.5 Year|Overall Study||60
8902236|NCT02079246|9959884|FG001|COMPLETED|OLEX-MEM||82
8902237|NCT02079246|9959883|FG000|NOT COMPLETED|OLEX-MEM||0
8902238|NCT02079246|9959884|FG001|NOT COMPLETED|OLEX-MEM||19
8902239|NCT02079311|9959895|FG000|STARTED|Overall Study||28
8902240|NCT02079311|9959896|FG001|STARTED|Overall Study||27
8902241|NCT02079311|9959895|FG000|COMPLETED|Overall Study||28
8902242|NCT02079311|9959896|FG001|COMPLETED|Overall Study||26
8902243|NCT02079311|9959895|FG000|NOT COMPLETED|Overall Study||0
8902244|NCT02079311|9959896|FG001|NOT COMPLETED|Overall Study||1
8902245|NCT02079519|9959902|FG000|STARTED|Overall Study||10
8902246|NCT02079519|9959902|FG000|COMPLETED|Overall Study||0
8902247|NCT02079519|9959902|FG000|NOT COMPLETED|Overall Study||10
8902248|NCT02079532|9959906|FG000|STARTED|Overall Study||302
8902249|NCT02079532|9959906|FG000|COMPLETED|Overall Study||273
8902250|NCT02079532|9959906|FG000|NOT COMPLETED|Overall Study||29
8902251|NCT02079610|9959912|FG000|STARTED|Overall Study||19
8902252|NCT02079610|9959913|FG001|STARTED|Overall Study||17
8902253|NCT02079610|9959912|FG000|COMPLETED|Overall Study||18
8902254|NCT02079610|9959913|FG001|COMPLETED|Overall Study||16
8902255|NCT02079610|9959912|FG000|NOT COMPLETED|Overall Study||1
8902256|NCT02079610|9959913|FG001|NOT COMPLETED|Overall Study||1
8902257|NCT02079636|9959934|FG000|STARTED|Overall Study||8
8902258|NCT02079636|9959935|FG001|STARTED|Overall Study||15
8902259|NCT02079636|9959936|FG002|STARTED|Overall Study||3
8902260|NCT02079636|9959937|FG003|STARTED|Overall Study||21
9010500|NCT02988115|10073599|FG000|COMPLETED|Overall Study||220
9010501|NCT02988115|10073600|FG001|COMPLETED|Overall Study||107
9010502|NCT02988115|10073599|FG000|NOT COMPLETED|Overall Study||14
9010503|NCT02988115|10073600|FG001|NOT COMPLETED|Overall Study||4
9010504|NCT02988193|10073608|FG000|STARTED|Overall Study||12
9010505|NCT02988193|10073609|FG001|STARTED|Overall Study||16
9010506|NCT02988193|10073608|FG000|COMPLETED|Overall Study||12
9010507|NCT02988193|10073609|FG001|COMPLETED|Overall Study||16
9010508|NCT02988193|10073608|FG000|NOT COMPLETED|Overall Study||0
9010509|NCT02988193|10073609|FG001|NOT COMPLETED|Overall Study||0
9010510|NCT02988219|10073617|FG000|STARTED|Overall Study||25
9010511|NCT02988219|10073618|FG001|STARTED|Overall Study||25
9010512|NCT02988219|10073617|FG000|COMPLETED|Overall Study||24
9010513|NCT02988219|10073618|FG001|COMPLETED|Overall Study||22
9010514|NCT02988219|10073617|FG000|NOT COMPLETED|Overall Study||1
9010515|NCT02988219|10073618|FG001|NOT COMPLETED|Overall Study||3
9010516|NCT02988349|10073626|FG000|STARTED|Overall Study||21
9010517|NCT02988349|10073627|FG001|STARTED|Overall Study||21
9010518|NCT02988349|10073626|FG000|COMPLETED|Overall Study||21
9010519|NCT02988349|10073627|FG001|COMPLETED|Overall Study||21
9010520|NCT02988349|10073626|FG000|NOT COMPLETED|Overall Study||0
9010521|NCT02988349|10073627|FG001|NOT COMPLETED|Overall Study||0
9010522|NCT02988622|10073633|FG000|STARTED|Overall Study||100
9010523|NCT02988622|10073633|FG000|COMPLETED|Overall Study||83
9010524|NCT02988622|10073633|FG000|NOT COMPLETED|Overall Study||17
9010525|NCT02988843|10073639|FG000|STARTED|Overall Study||1
9010526|NCT02988843|10073639|FG000|COMPLETED|Overall Study||1
9010527|NCT02988843|10073639|FG000|NOT COMPLETED|Overall Study||0
9010528|NCT02988856|10073643|FG000|STARTED|Overall Study||11
8636347|NCT00567593|9676971|FG000|NOT COMPLETED|Overall Study||2
8636348|NCT00567840|9676980|FG000|STARTED|Overall Study||15
8902261|NCT02079636|9959938|FG004|STARTED|Overall Study||4
8902262|NCT02079636|9959939|FG005|STARTED|Overall Study||19
9010529|NCT02988856|10073643|FG000|COMPLETED|Overall Study||8
9010530|NCT02988856|10073643|FG000|NOT COMPLETED|Overall Study||3
9010531|NCT02988882|10073649|FG000|STARTED|Overall Study||44
9010532|NCT02988882|10073650|FG001|STARTED|Overall Study||42
9010533|NCT02988882|10073649|FG000|COMPLETED|Overall Study||41
9010534|NCT02988882|10073650|FG001|COMPLETED|Overall Study||40
9010535|NCT02988882|10073649|FG000|NOT COMPLETED|Overall Study||3
9010536|NCT02988882|10073650|FG001|NOT COMPLETED|Overall Study||2
9010537|NCT02988986|10073656|FG000|STARTED|Overall Study||28
9010538|NCT02988986|10073656|FG000|COMPLETED|Overall Study||25
9010539|NCT02988986|10073656|FG000|NOT COMPLETED|Overall Study||3
9010540|NCT02989168|10073663|FG000|STARTED|Overall Study||11
9010541|NCT02989168|10073664|FG001|STARTED|Overall Study||3
9010542|NCT02989168|10073663|FG000|COMPLETED|Overall Study||7
9010543|NCT02989168|10073664|FG001|COMPLETED|Overall Study||0
9010544|NCT02989168|10073663|FG000|NOT COMPLETED|Overall Study||4
9010545|NCT02989168|10073664|FG001|NOT COMPLETED|Overall Study||3
9010546|NCT02989246|10073672|FG000|STARTED|Overall Study||32
8636349|NCT00567840|9676981|FG001|STARTED|Overall Study||15
9010547|NCT02989246|10073672|FG000|COMPLETED|Overall Study||32
9010548|NCT02989246|10073672|FG000|NOT COMPLETED|Overall Study||0
9010549|NCT02989389|10073686|FG000|STARTED|Period 1||3
9010550|NCT02989389|10073687|FG001|STARTED|Period 1||4
9010551|NCT02989389|10073688|FG002|STARTED|Period 1||3
9010552|NCT02989389|10073689|FG003|STARTED|Period 1||3
8636350|NCT00567840|9676982|FG002|STARTED|Overall Study||16
8902263|NCT02079636|9959940|FG006|STARTED|Overall Study||12
8902264|NCT02079636|9959941|FG007|STARTED|Overall Study||4
9010553|NCT02989389|10073690|FG004|STARTED|Period 1||3
8902265|NCT02079636|9959942|FG008|STARTED|Overall Study||3
8902266|NCT02079636|9959943|FG009|STARTED|Overall Study||9
8902267|NCT02079636|9959944|FG010|STARTED|Overall Study||10
8902268|NCT02079636|9959945|FG011|STARTED|Overall Study||6
9010554|NCT02989389|10073691|FG005|STARTED|Period 1||3
9010555|NCT02989389|10073692|FG006|STARTED|Period 1||6
9010556|NCT02989389|10073693|FG007|STARTED|Period 1||5
9010557|NCT02989389|10073694|FG008|STARTED|Period 1||6
8902269|NCT02079636|9959946|FG012|STARTED|Overall Study||8
8902270|NCT02079636|9959947|FG013|STARTED|Overall Study||3
8902271|NCT02079636|9959948|FG014|STARTED|Overall Study||17
8902272|NCT02079636|9959934|FG000|Received at Least One Dose of Study Drug|Overall Study||8
8902273|NCT02079636|9959935|FG001|Received at Least One Dose of Study Drug|Overall Study||15
8902274|NCT02079636|9959936|FG002|Received at Least One Dose of Study Drug|Overall Study||3
8902275|NCT02079636|9959937|FG003|Received at Least One Dose of Study Drug|Overall Study||21
8902276|NCT02079636|9959938|FG004|Received at Least One Dose of Study Drug|Overall Study||4
8902277|NCT02079636|9959939|FG005|Received at Least One Dose of Study Drug|Overall Study||19
9010558|NCT02989389|10073695|FG009|STARTED|Period 1||6
9010559|NCT02989389|10073686|FG000|Received at Least 1 Dose of Study Drug|Period 1||3
9010560|NCT02989389|10073687|FG001|Received at Least 1 Dose of Study Drug|Period 1||4
9010561|NCT02989389|10073688|FG002|Received at Least 1 Dose of Study Drug|Period 1||3
9010562|NCT02989389|10073689|FG003|Received at Least 1 Dose of Study Drug|Period 1||3
9010563|NCT02989389|10073690|FG004|Received at Least 1 Dose of Study Drug|Period 1||3
9010564|NCT02989389|10073691|FG005|Received at Least 1 Dose of Study Drug|Period 1||3
9010565|NCT02989389|10073692|FG006|Received at Least 1 Dose of Study Drug|Period 1||6
9010566|NCT02989389|10073693|FG007|Received at Least 1 Dose of Study Drug|Period 1||5
9010567|NCT02989389|10073694|FG008|Received at Least 1 Dose of Study Drug|Period 1||6
9010568|NCT02989389|10073695|FG009|Received at Least 1 Dose of Study Drug|Period 1||6
9010569|NCT02989389|10073686|FG000|COMPLETED|Period 1||3
9010570|NCT02989389|10073687|FG001|COMPLETED|Period 1||3
9010571|NCT02989389|10073688|FG002|COMPLETED|Period 1||3
9010572|NCT02989389|10073689|FG003|COMPLETED|Period 1||3
9010573|NCT02989389|10073690|FG004|COMPLETED|Period 1||3
9010574|NCT02989389|10073691|FG005|COMPLETED|Period 1||3
9010575|NCT02989389|10073692|FG006|COMPLETED|Period 1||6
9010576|NCT02989389|10073693|FG007|COMPLETED|Period 1||5
9010577|NCT02989389|10073694|FG008|COMPLETED|Period 1||5
9010578|NCT02989389|10073695|FG009|COMPLETED|Period 1||6
9010579|NCT02989389|10073686|FG000|NOT COMPLETED|Period 1||0
9010580|NCT02989389|10073687|FG001|NOT COMPLETED|Period 1||1
9010581|NCT02989389|10073688|FG002|NOT COMPLETED|Period 1||0
9010582|NCT02989389|10073689|FG003|NOT COMPLETED|Period 1||0
9010583|NCT02989389|10073690|FG004|NOT COMPLETED|Period 1||0
9010584|NCT02989389|10073691|FG005|NOT COMPLETED|Period 1||0
9010585|NCT02989389|10073692|FG006|NOT COMPLETED|Period 1||0
9010586|NCT02989389|10073693|FG007|NOT COMPLETED|Period 1||0
9010587|NCT02989389|10073694|FG008|NOT COMPLETED|Period 1||1
9010588|NCT02989389|10073695|FG009|NOT COMPLETED|Period 1||0
9010589|NCT02989389|10073686|FG000|STARTED|Period 2||3
8636351|NCT00567840|9676983|FG003|STARTED|Overall Study||15
8636352|NCT00567840|9676984|FG004|STARTED|Overall Study||8
8636353|NCT00567840|9676980|FG000|COMPLETED|Overall Study||13
9010590|NCT02989389|10073687|FG001|STARTED|Period 2||3
9010591|NCT02989389|10073688|FG002|STARTED|Period 2||3
9010592|NCT02989389|10073689|FG003|STARTED|Period 2||3
9010593|NCT02989389|10073690|FG004|STARTED|Period 2||3
9010594|NCT02989389|10073691|FG005|STARTED|Period 2||3
9010595|NCT02989389|10073692|FG006|STARTED|Period 2|Part B was planned as a single period study.|0
9010596|NCT02989389|10073693|FG007|STARTED|Period 2|Part B was planned as a single period study.|0
9010597|NCT02989389|10073694|FG008|STARTED|Period 2|Part B was planned as a single period study.|0
9010598|NCT02989389|10073695|FG009|STARTED|Period 2|Part B was planned as a single period study.|0
9010599|NCT02989389|10073686|FG000|COMPLETED|Period 2||3
9010600|NCT02989389|10073687|FG001|COMPLETED|Period 2||3
9010601|NCT02989389|10073688|FG002|COMPLETED|Period 2||3
9010602|NCT02989389|10073689|FG003|COMPLETED|Period 2||3
9010603|NCT02989389|10073690|FG004|COMPLETED|Period 2||3
9010604|NCT02989389|10073691|FG005|COMPLETED|Period 2||3
9010605|NCT02989389|10073692|FG006|COMPLETED|Period 2||0
9010606|NCT02989389|10073693|FG007|COMPLETED|Period 2||0
9010607|NCT02989389|10073694|FG008|COMPLETED|Period 2||0
9010608|NCT02989389|10073695|FG009|COMPLETED|Period 2||0
9010609|NCT02989389|10073686|FG000|NOT COMPLETED|Period 2||0
9010610|NCT02989389|10073687|FG001|NOT COMPLETED|Period 2||0
9010611|NCT02989389|10073688|FG002|NOT COMPLETED|Period 2||0
9010612|NCT02989389|10073689|FG003|NOT COMPLETED|Period 2||0
9010613|NCT02989389|10073690|FG004|NOT COMPLETED|Period 2||0
9010614|NCT02989389|10073691|FG005|NOT COMPLETED|Period 2||0
9010615|NCT02989389|10073692|FG006|NOT COMPLETED|Period 2||0
9010616|NCT02989389|10073693|FG007|NOT COMPLETED|Period 2||0
8636354|NCT00567840|9676981|FG001|COMPLETED|Overall Study||15
8636355|NCT00567840|9676982|FG002|COMPLETED|Overall Study||15
8636356|NCT00567840|9676983|FG003|COMPLETED|Overall Study||14
8636357|NCT00567840|9676984|FG004|COMPLETED|Overall Study||8
8902278|NCT02079636|9959940|FG006|Received at Least One Dose of Study Drug|Overall Study||12
8902279|NCT02079636|9959941|FG007|Received at Least One Dose of Study Drug|Overall Study||4
8902280|NCT02079636|9959942|FG008|Received at Least One Dose of Study Drug|Overall Study||3
9010617|NCT02989389|10073694|FG008|NOT COMPLETED|Period 2||0
9010618|NCT02989389|10073695|FG009|NOT COMPLETED|Period 2||0
9010619|NCT02989389|10073686|FG000|STARTED|Period 3||3
9010620|NCT02989389|10073687|FG001|STARTED|Period 3||3
9010621|NCT02989389|10073688|FG002|STARTED|Period 3||3
9010622|NCT02989389|10073689|FG003|STARTED|Period 3||3
9010623|NCT02989389|10073690|FG004|STARTED|Period 3||3
9010624|NCT02989389|10073691|FG005|STARTED|Period 3||3
9010625|NCT02989389|10073692|FG006|STARTED|Period 3||0
9010626|NCT02989389|10073693|FG007|STARTED|Period 3||0
8636358|NCT00567840|9676980|FG000|NOT COMPLETED|Overall Study||2
9010627|NCT02989389|10073694|FG008|STARTED|Period 3||0
8902281|NCT02079636|9959943|FG009|Received at Least One Dose of Study Drug|Overall Study||9
8902282|NCT02079636|9959944|FG010|Received at Least One Dose of Study Drug|Overall Study||10
8902283|NCT02079636|9959945|FG011|Received at Least One Dose of Study Drug|Overall Study||6
8902284|NCT02079636|9959946|FG012|Received at Least One Dose of Study Drug|Overall Study||8
8902285|NCT02079636|9959947|FG013|Received at Least One Dose of Study Drug|Overall Study||3
8902286|NCT02079636|9959948|FG014|Received at Least One Dose of Study Drug|Overall Study||17
8902287|NCT02079636|9959934|FG000|COMPLETED|Overall Study||5
9010628|NCT02989389|10073695|FG009|STARTED|Period 3||0
9010629|NCT02989389|10073686|FG000|COMPLETED|Period 3||3
9010630|NCT02989389|10073687|FG001|COMPLETED|Period 3||3
9010631|NCT02989389|10073688|FG002|COMPLETED|Period 3||3
9010632|NCT02989389|10073689|FG003|COMPLETED|Period 3||3
9010633|NCT02989389|10073690|FG004|COMPLETED|Period 3||3
9010634|NCT02989389|10073691|FG005|COMPLETED|Period 3||3
9010635|NCT02989389|10073692|FG006|COMPLETED|Period 3||0
9010636|NCT02989389|10073693|FG007|COMPLETED|Period 3||0
9010637|NCT02989389|10073694|FG008|COMPLETED|Period 3||0
9010638|NCT02989389|10073695|FG009|COMPLETED|Period 3||0
9010639|NCT02989389|10073686|FG000|NOT COMPLETED|Period 3||0
9010640|NCT02989389|10073687|FG001|NOT COMPLETED|Period 3||0
9010641|NCT02989389|10073688|FG002|NOT COMPLETED|Period 3||0
9010642|NCT02989389|10073689|FG003|NOT COMPLETED|Period 3||0
9010643|NCT02989389|10073690|FG004|NOT COMPLETED|Period 3||0
9010644|NCT02989389|10073691|FG005|NOT COMPLETED|Period 3||0
9010645|NCT02989389|10073692|FG006|NOT COMPLETED|Period 3||0
9010646|NCT02989389|10073693|FG007|NOT COMPLETED|Period 3||0
9010647|NCT02989389|10073694|FG008|NOT COMPLETED|Period 3||0
9010648|NCT02989389|10073695|FG009|NOT COMPLETED|Period 3||0
9010649|NCT02989493|10073737|FG000|STARTED|Overall Study||29
9010650|NCT02989493|10073738|FG001|STARTED|Overall Study||32
9010651|NCT02989493|10073737|FG000|COMPLETED|Overall Study||29
9010652|NCT02989493|10073738|FG001|COMPLETED|Overall Study||32
9010653|NCT02989493|10073737|FG000|NOT COMPLETED|Overall Study||0
9010654|NCT02989493|10073738|FG001|NOT COMPLETED|Overall Study||0
9010655|NCT02989545|10073744|FG000|STARTED|Control Period - no Intervention||20
9010656|NCT02989545|10073744|FG000|COMPLETED|Control Period - no Intervention||20
9010657|NCT02989545|10073744|FG000|NOT COMPLETED|Control Period - no Intervention||0
9010658|NCT02989545|10073744|FG000|STARTED|Treatment Period - Anal Tape Provided||20
9010659|NCT02989545|10073744|FG000|COMPLETED|Treatment Period - Anal Tape Provided||20
9010660|NCT02989545|10073744|FG000|NOT COMPLETED|Treatment Period - Anal Tape Provided||0
9010661|NCT02989610|10073752|FG000|STARTED|Overall Study||234
9010662|NCT02989610|10073752|FG000|COMPLETED|Overall Study||195
9010663|NCT02989610|10073752|FG000|NOT COMPLETED|Overall Study||39
9010664|NCT02989649|10073756|FG000|STARTED|Overall Study||593
9010665|NCT02989649|10073756|FG000|Started But Not Treated|Overall Study||84
8902288|NCT02079636|9959935|FG001|COMPLETED|Overall Study||13
8902289|NCT02079636|9959936|FG002|COMPLETED|Overall Study||3
8902290|NCT02079636|9959937|FG003|COMPLETED|Overall Study||9
8902291|NCT02079636|9959938|FG004|COMPLETED|Overall Study||2
8902292|NCT02079636|9959939|FG005|COMPLETED|Overall Study||13
8902293|NCT02079636|9959940|FG006|COMPLETED|Overall Study||11
8902294|NCT02079636|9959941|FG007|COMPLETED|Overall Study||3
8902295|NCT02079636|9959942|FG008|COMPLETED|Overall Study||3
8902296|NCT02079636|9959943|FG009|COMPLETED|Overall Study||6
8902297|NCT02079636|9959944|FG010|COMPLETED|Overall Study||8
8902298|NCT02079636|9959945|FG011|COMPLETED|Overall Study||4
8902299|NCT02079636|9959946|FG012|COMPLETED|Overall Study||5
8902300|NCT02079636|9959947|FG013|COMPLETED|Overall Study||3
8902301|NCT02079636|9959948|FG014|COMPLETED|Overall Study||12
8902302|NCT02079636|9959934|FG000|NOT COMPLETED|Overall Study||3
8902303|NCT02079636|9959935|FG001|NOT COMPLETED|Overall Study||2
8902304|NCT02079636|9959936|FG002|NOT COMPLETED|Overall Study||0
8902305|NCT02079636|9959937|FG003|NOT COMPLETED|Overall Study||12
8902306|NCT02079636|9959938|FG004|NOT COMPLETED|Overall Study||2
8902307|NCT02079636|9959939|FG005|NOT COMPLETED|Overall Study||6
8902308|NCT02079636|9959940|FG006|NOT COMPLETED|Overall Study||1
8902309|NCT02079636|9959941|FG007|NOT COMPLETED|Overall Study||1
8902310|NCT02079636|9959942|FG008|NOT COMPLETED|Overall Study||0
8902311|NCT02079636|9959943|FG009|NOT COMPLETED|Overall Study||3
8902312|NCT02079636|9959944|FG010|NOT COMPLETED|Overall Study||2
8902313|NCT02079636|9959945|FG011|NOT COMPLETED|Overall Study||2
8902314|NCT02079636|9959946|FG012|NOT COMPLETED|Overall Study||3
8902315|NCT02079636|9959947|FG013|NOT COMPLETED|Overall Study||0
8902316|NCT02079636|9959948|FG014|NOT COMPLETED|Overall Study||5
8902317|NCT02079649|9960016|FG000|STARTED|Overall Study||42
8902318|NCT02079649|9960017|FG001|STARTED|Overall Study||41
8902319|NCT02079649|9960018|FG002|STARTED|Overall Study||41
8902320|NCT02079649|9960019|FG003|STARTED|Overall Study||40
8902321|NCT02079649|9960016|FG000|Treated|Overall Study||41
8902322|NCT02079649|9960017|FG001|Treated|Overall Study||41
8902323|NCT02079649|9960018|FG002|Treated|Overall Study||40
8902324|NCT02079649|9960019|FG003|Treated|Overall Study||40
8902325|NCT02079649|9960016|FG000|COMPLETED|Overall Study||41
8902326|NCT02079649|9960017|FG001|COMPLETED|Overall Study||41
8902327|NCT02079649|9960018|FG002|COMPLETED|Overall Study||40
9010666|NCT02989649|10073756|FG000|Eligible to Enter Into Treatment Period|Overall Study||509
9010667|NCT02989649|10073756|FG000|COMPLETED|Overall Study||173
9010668|NCT02989649|10073756|FG000|NOT COMPLETED|Overall Study||420
9010669|NCT02989714|10073760|FG000|STARTED|Overall Study||13
8902328|NCT02079649|9960019|FG003|COMPLETED|Overall Study||38
8902329|NCT02079649|9960016|FG000|NOT COMPLETED|Overall Study||1
8902330|NCT02079649|9960017|FG001|NOT COMPLETED|Overall Study||0
8902331|NCT02079649|9960018|FG002|NOT COMPLETED|Overall Study||1
8902332|NCT02079649|9960019|FG003|NOT COMPLETED|Overall Study||2
8902333|NCT02079805|9960032|FG000|STARTED|Overall Study||16
8902334|NCT02079805|9960033|FG001|STARTED|Overall Study||17
8902335|NCT02079805|9960032|FG000|COMPLETED|Overall Study||16
8902336|NCT02079805|9960033|FG001|COMPLETED|Overall Study||15
8902337|NCT02079805|9960032|FG000|NOT COMPLETED|Overall Study||0
8902338|NCT02079805|9960033|FG001|NOT COMPLETED|Overall Study||2
8902339|NCT02079844|9960042|FG000|STARTED|Treatment Period 1||6
8902340|NCT02079844|9960043|FG001|STARTED|Treatment Period 1||7
8902341|NCT02079844|9960044|FG002|STARTED|Treatment Period 1||7
8902342|NCT02079844|9960042|FG000|COMPLETED|Treatment Period 1||6
8902343|NCT02079844|9960043|FG001|COMPLETED|Treatment Period 1||7
8902344|NCT02079844|9960044|FG002|COMPLETED|Treatment Period 1||5
8902345|NCT02079844|9960042|FG000|NOT COMPLETED|Treatment Period 1||0
8902346|NCT02079844|9960043|FG001|NOT COMPLETED|Treatment Period 1||0
8902347|NCT02079844|9960044|FG002|NOT COMPLETED|Treatment Period 1||2
8902348|NCT02079844|9960042|FG000|STARTED|Treatment Period 2|1 Participant was withdrawn due to an Adverse Event after completing Period 1.|5
8902349|NCT02079844|9960043|FG001|STARTED|Treatment Period 2||7
8902350|NCT02079844|9960044|FG002|STARTED|Treatment Period 2||5
8902351|NCT02079844|9960042|FG000|COMPLETED|Treatment Period 2||5
8902352|NCT02079844|9960043|FG001|COMPLETED|Treatment Period 2||6
8902353|NCT02079844|9960044|FG002|COMPLETED|Treatment Period 2||5
8902354|NCT02079844|9960042|FG000|NOT COMPLETED|Treatment Period 2||0
8902355|NCT02079844|9960043|FG001|NOT COMPLETED|Treatment Period 2||1
8902356|NCT02079844|9960044|FG002|NOT COMPLETED|Treatment Period 2||0
8902357|NCT02079844|9960042|FG000|STARTED|Treatment Period 3||5
8902358|NCT02079844|9960043|FG001|STARTED|Treatment Period 3|1 Participant Voluntarily Withdrew after completing Period 2.|5
8902359|NCT02079844|9960044|FG002|STARTED|Treatment Period 3||5
8902360|NCT02079844|9960042|FG000|COMPLETED|Treatment Period 3||5
8902361|NCT02079844|9960043|FG001|COMPLETED|Treatment Period 3||5
8902362|NCT02079844|9960044|FG002|COMPLETED|Treatment Period 3||5
8902363|NCT02079844|9960042|FG000|NOT COMPLETED|Treatment Period 3||0
8902364|NCT02079844|9960043|FG001|NOT COMPLETED|Treatment Period 3||0
8902365|NCT02079844|9960044|FG002|NOT COMPLETED|Treatment Period 3||0
8902366|NCT02079909|9960058|FG000|STARTED|Overall Study||158
8902367|NCT02079909|9960059|FG001|STARTED|Overall Study||166
8902368|NCT02079909|9960060|FG002|STARTED|Overall Study||158
9010670|NCT02989714|10073760|FG000|Started Nivolumab|Overall Study||12
9010671|NCT02989714|10073760|FG000|COMPLETED|Overall Study||12
9010672|NCT02989714|10073760|FG000|NOT COMPLETED|Overall Study||1
9010673|NCT02989727|10073769|FG000|STARTED|Overall Study||46
9010674|NCT02989727|10073770|FG001|STARTED|Overall Study||44
9010675|NCT02989727|10073771|FG002|STARTED|Overall Study||30
9010676|NCT02989727|10073772|FG003|STARTED|Overall Study||30
9010677|NCT02989727|10073769|FG000|COMPLETED|Overall Study||46
9010678|NCT02989727|10073770|FG001|COMPLETED|Overall Study||44
9010679|NCT02989727|10073771|FG002|COMPLETED|Overall Study||30
9010680|NCT02989727|10073772|FG003|COMPLETED|Overall Study||30
9010681|NCT02989727|10073769|FG000|NOT COMPLETED|Overall Study||0
9010682|NCT02989727|10073770|FG001|NOT COMPLETED|Overall Study||0
9010683|NCT02989727|10073771|FG002|NOT COMPLETED|Overall Study||0
9010684|NCT02989727|10073772|FG003|NOT COMPLETED|Overall Study||0
9010685|NCT02989805|10073782|FG000|STARTED|Overall Study||160
9010686|NCT02989805|10073783|FG001|STARTED|Overall Study||166
9010687|NCT02989805|10073782|FG000|COMPLETED|Overall Study||154
9010688|NCT02989805|10073783|FG001|COMPLETED|Overall Study||162
9010689|NCT02989805|10073782|FG000|NOT COMPLETED|Overall Study||6
9010690|NCT02989805|10073783|FG001|NOT COMPLETED|Overall Study||4
9010691|NCT02990000|10073791|FG000|STARTED|Overall Study|155 patients were randomly assigned to the Pragmatic Match condition|155
9010692|NCT02990000|10073792|FG001|STARTED|Overall Study|133 patients were randomly assigned to the Scientific Match condition|133
9010693|NCT02990000|10073791|FG000|Begin Treatment|Overall Study|119 Pragmatic Match patients actually began treatment (attended at least 1 session)|119
9010694|NCT02990000|10073792|FG001|Begin Treatment|Overall Study|99 Scientifically Matched patients actually began treatment (attended at least one session)|99
9010695|NCT02990000|10073791|FG000|COMPLETED|Overall Study|119 patients provided naturalistic treatment data and were included in analyses|119
9010696|NCT02990000|10073792|FG001|COMPLETED|Overall Study|99 patients provided naturalistic treatment data and were included in analyses|99
9010697|NCT02990000|10073791|FG000|NOT COMPLETED|Overall Study||36
9010698|NCT02990000|10073792|FG001|NOT COMPLETED|Overall Study||34
9010699|NCT02990910|10073800|FG000|STARTED|Overall Study||140
9010700|NCT02990910|10073801|FG001|STARTED|Overall Study||140
8902369|NCT02079909|9960058|FG000|COMPLETED|Overall Study||120
9010701|NCT02990910|10073800|FG000|COMPLETED|Overall Study||134
9010702|NCT02990910|10073801|FG001|COMPLETED|Overall Study||130
9010703|NCT02990910|10073800|FG000|NOT COMPLETED|Overall Study||6
8902370|NCT02079909|9960059|FG001|COMPLETED|Overall Study||117
8902371|NCT02079909|9960060|FG002|COMPLETED|Overall Study||140
8902372|NCT02079909|9960058|FG000|NOT COMPLETED|Overall Study||38
9010704|NCT02990910|10073801|FG001|NOT COMPLETED|Overall Study||10
9010705|NCT02991040|10073807|FG000|STARTED|Overall Study||100
9010706|NCT02991040|10073807|FG000|COMPLETED|Overall Study||96
9010707|NCT02991040|10073807|FG000|NOT COMPLETED|Overall Study||4
8902373|NCT02079909|9960059|FG001|NOT COMPLETED|Overall Study||49
8902374|NCT02079909|9960060|FG002|NOT COMPLETED|Overall Study||18
8902375|NCT02079987|9960070|FG000|STARTED|Overall Study||557
8902376|NCT02079987|9960071|FG001|STARTED|Overall Study||544
8902377|NCT02079987|9960070|FG000|COMPLETED|Overall Study||557
8902378|NCT02079987|9960071|FG001|COMPLETED|Overall Study||544
8902379|NCT02079987|9960070|FG000|NOT COMPLETED|Overall Study||0
8902380|NCT02079987|9960071|FG001|NOT COMPLETED|Overall Study||0
8902381|NCT02080091|9960078|FG000|STARTED|Overall Study||25
8902382|NCT02080091|9960078|FG000|COMPLETED|Overall Study||0
8902383|NCT02080091|9960078|FG000|NOT COMPLETED|Overall Study||25
8902384|NCT02080195|9960082|FG000|STARTED|Overall Study||1
8902385|NCT02080195|9960082|FG000|COMPLETED|Overall Study||1
8902386|NCT02080195|9960082|FG000|NOT COMPLETED|Overall Study||0
8902387|NCT02080221|9960086|FG000|STARTED|Overall Study||50
8902388|NCT02080221|9960086|FG000|COMPLETED|Overall Study||48
8902389|NCT02080221|9960086|FG000|NOT COMPLETED|Overall Study||2
8902390|NCT02080273|9960093|FG000|STARTED|Overall Study||45
8902391|NCT02080273|9960094|FG001|STARTED|Overall Study||45
8902392|NCT02080273|9960095|FG002|STARTED|Overall Study||45
8902393|NCT02080273|9960093|FG000|COMPLETED|Overall Study||45
8902394|NCT02080273|9960094|FG001|COMPLETED|Overall Study||45
8902395|NCT02080273|9960095|FG002|COMPLETED|Overall Study||45
8902396|NCT02080273|9960093|FG000|NOT COMPLETED|Overall Study||0
8902397|NCT02080273|9960094|FG001|NOT COMPLETED|Overall Study||0
8636359|NCT00567840|9676981|FG001|NOT COMPLETED|Overall Study||0
8636360|NCT00567840|9676982|FG002|NOT COMPLETED|Overall Study||1
8636361|NCT00567840|9676983|FG003|NOT COMPLETED|Overall Study||1
8636362|NCT00567840|9676984|FG004|NOT COMPLETED|Overall Study||0
8902398|NCT02080273|9960095|FG002|NOT COMPLETED|Overall Study||0
8902399|NCT02080312|9960103|FG000|STARTED|Overall Study||6
8902400|NCT02080312|9960103|FG000|COMPLETED|Overall Study||6
8902401|NCT02080312|9960103|FG000|NOT COMPLETED|Overall Study||0
8902402|NCT02080364|9960112|FG000|STARTED|Baseline Period||197
8902403|NCT02080364|9960113|FG001|STARTED|Baseline Period||208
8902404|NCT02080364|9960114|FG002|STARTED|Baseline Period||247
8902405|NCT02080364|9960115|FG003|STARTED|Baseline Period||228
8902406|NCT02080364|9960112|FG000|COMPLETED|Baseline Period||195
8902407|NCT02080364|9960113|FG001|COMPLETED|Baseline Period||206
8902408|NCT02080364|9960114|FG002|COMPLETED|Baseline Period||246
8902409|NCT02080364|9960115|FG003|COMPLETED|Baseline Period||228
8902410|NCT02080364|9960112|FG000|NOT COMPLETED|Baseline Period||2
8902411|NCT02080364|9960113|FG001|NOT COMPLETED|Baseline Period||2
8902412|NCT02080364|9960114|FG002|NOT COMPLETED|Baseline Period||1
8902413|NCT02080364|9960115|FG003|NOT COMPLETED|Baseline Period||0
8902414|NCT02080364|9960112|FG000|STARTED|Treatment Period||195
8902415|NCT02080364|9960113|FG001|STARTED|Treatment Period||206
8902416|NCT02080364|9960114|FG002|STARTED|Treatment Period||246
8902417|NCT02080364|9960115|FG003|STARTED|Treatment Period||228
8902418|NCT02080364|9960112|FG000|COMPLETED|Treatment Period||148
8902419|NCT02080364|9960113|FG001|COMPLETED|Treatment Period||157
8902420|NCT02080364|9960114|FG002|COMPLETED|Treatment Period||9
8902421|NCT02080364|9960115|FG003|COMPLETED|Treatment Period||4
8902422|NCT02080364|9960112|FG000|NOT COMPLETED|Treatment Period||47
8902423|NCT02080364|9960113|FG001|NOT COMPLETED|Treatment Period||49
8902424|NCT02080364|9960114|FG002|NOT COMPLETED|Treatment Period||237
8902425|NCT02080364|9960115|FG003|NOT COMPLETED|Treatment Period||224
8902426|NCT02080403|9960127|FG000|STARTED|Overall Study||146
8902427|NCT02080403|9960128|FG001|STARTED|Overall Study||144
8902428|NCT02080403|9960127|FG000|COMPLETED|Overall Study||131
8902429|NCT02080403|9960128|FG001|COMPLETED|Overall Study||132
8902430|NCT02080403|9960127|FG000|NOT COMPLETED|Overall Study||15
8902431|NCT02080403|9960128|FG001|NOT COMPLETED|Overall Study||12
8902432|NCT02080455|9960136|FG000|STARTED|Overall Study||16
8902433|NCT02080455|9960137|FG001|STARTED|Overall Study||16
9010708|NCT02991118|10073815|FG000|STARTED|Overall Study||257
9010709|NCT02991118|10073816|FG001|STARTED|Overall Study||522
9010710|NCT02991118|10073815|FG000|COMPLETED|Overall Study||250
9010711|NCT02991118|10073816|FG001|COMPLETED|Overall Study||490
9010712|NCT02991118|10073815|FG000|NOT COMPLETED|Overall Study||7
9010713|NCT02991118|10073816|FG001|NOT COMPLETED|Overall Study||32
9010714|NCT02991729|10073824|FG000|STARTED|Overall Study||105
9010715|NCT02991729|10073825|FG001|STARTED|Overall Study||92
9010716|NCT02991729|10073824|FG000|COMPLETED|Overall Study||105
9010717|NCT02991729|10073825|FG001|COMPLETED|Overall Study||92
9010718|NCT02991729|10073824|FG000|NOT COMPLETED|Overall Study||0
9010719|NCT02991729|10073825|FG001|NOT COMPLETED|Overall Study||0
9010720|NCT02991820|10073835|FG000|STARTED|Overall Study||12
9010721|NCT02991820|10073836|FG001|STARTED|Overall Study||31
9010722|NCT02991820|10073835|FG000|COMPLETED|Overall Study||12
9010723|NCT02991820|10073836|FG001|COMPLETED|Overall Study||31
8902434|NCT02080455|9960136|FG000|COMPLETED|Overall Study||16
8902435|NCT02080455|9960137|FG001|COMPLETED|Overall Study||16
8902436|NCT02080455|9960136|FG000|NOT COMPLETED|Overall Study||0
8902437|NCT02080455|9960137|FG001|NOT COMPLETED|Overall Study||0
9010724|NCT02991820|10073835|FG000|NOT COMPLETED|Overall Study||0
9010725|NCT02991820|10073836|FG001|NOT COMPLETED|Overall Study||0
8636363|NCT00567879|9677002|FG000|STARTED|Overall Study||7
9010726|NCT02991859|10073861|FG000|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
9010727|NCT02991859|10073862|FG001|STARTED|Period 1,Escalation Phase 1,Upto Day 7||3
9010728|NCT02991859|10073863|FG002|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
9010729|NCT02991859|10073864|FG003|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
8902438|NCT02080468|9960153|FG000|STARTED|Overall Study||16
8902439|NCT02080468|9960154|FG001|STARTED|Overall Study||16
8902440|NCT02080468|9960153|FG000|COMPLETED|Overall Study||14
8902441|NCT02080468|9960154|FG001|COMPLETED|Overall Study||14
8902442|NCT02080468|9960153|FG000|NOT COMPLETED|Overall Study||2
8902443|NCT02080468|9960154|FG001|NOT COMPLETED|Overall Study||2
8902444|NCT02080481|9960169|FG000|STARTED|Overall Study||68
8902445|NCT02080481|9960170|FG001|STARTED|Overall Study||67
8902446|NCT02080481|9960169|FG000|COMPLETED|Overall Study||67
8902447|NCT02080481|9960170|FG001|COMPLETED|Overall Study||67
8902448|NCT02080481|9960169|FG000|NOT COMPLETED|Overall Study||1
8902449|NCT02080481|9960170|FG001|NOT COMPLETED|Overall Study||0
8902450|NCT02080507|9960178|FG000|STARTED|Overall Study||5
8902451|NCT02080507|9960179|FG001|STARTED|Overall Study||7
9010730|NCT02991859|10073865|FG004|STARTED|Period 1,Escalation Phase 1,Upto Day 7||3
9010731|NCT02991859|10073866|FG005|STARTED|Period 1,Escalation Phase 1,Upto Day 7||3
9010732|NCT02991859|10073867|FG006|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
9010733|NCT02991859|10073868|FG007|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
9010734|NCT02991859|10073869|FG008|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
9010735|NCT02991859|10073870|FG009|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
9010736|NCT02991859|10073871|FG010|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
9010737|NCT02991859|10073872|FG011|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
9010738|NCT02991859|10073873|FG012|STARTED|Period 1,Escalation Phase 1,Upto Day 7||7
9010739|NCT02991859|10073874|FG013|STARTED|Period 1,Escalation Phase 1,Upto Day 7||7
9010740|NCT02991859|10073875|FG014|STARTED|Period 1,Escalation Phase 1,Upto Day 7||6
9010741|NCT02991859|10073876|FG015|STARTED|Period 1,Escalation Phase 1,Upto Day 7||3
9010742|NCT02991859|10073877|FG016|STARTED|Period 1,Escalation Phase 1,Upto Day 7||3
9010743|NCT02991859|10073861|FG000|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
9010744|NCT02991859|10073862|FG001|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
9010745|NCT02991859|10073863|FG002|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
9010746|NCT02991859|10073864|FG003|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
9010747|NCT02991859|10073865|FG004|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
9010748|NCT02991859|10073866|FG005|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||3
9010749|NCT02991859|10073867|FG006|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
9010750|NCT02991859|10073868|FG007|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
9010751|NCT02991859|10073869|FG008|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
9010752|NCT02991859|10073870|FG009|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
9010753|NCT02991859|10073871|FG010|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
9010754|NCT02991859|10073872|FG011|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
9010755|NCT02991859|10073873|FG012|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||7
9010756|NCT02991859|10073874|FG013|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||7
9010757|NCT02991859|10073875|FG014|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||6
9010758|NCT02991859|10073876|FG015|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||3
9010759|NCT02991859|10073877|FG016|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||3
9010760|NCT02991859|10073861|FG000|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
9010761|NCT02991859|10073862|FG001|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||1
9010762|NCT02991859|10073863|FG002|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
9010763|NCT02991859|10073864|FG003|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
9010764|NCT02991859|10073865|FG004|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||1
9010765|NCT02991859|10073866|FG005|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
8636364|NCT00567879|9677003|FG001|STARTED|Overall Study||7
8636365|NCT00567879|9677004|FG002|STARTED|Overall Study|7 participants belonged to the dose expansion group at 20mg/m2 i.v.|21
9010766|NCT02991859|10073867|FG006|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
9010767|NCT02991859|10073868|FG007|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
9010768|NCT02991859|10073869|FG008|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
9010769|NCT02991859|10073870|FG009|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
9010770|NCT02991859|10073871|FG010|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
9010771|NCT02991859|10073872|FG011|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
9010772|NCT02991859|10073873|FG012|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
9010773|NCT02991859|10073874|FG013|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
9010774|NCT02991859|10073875|FG014|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
9010775|NCT02991859|10073876|FG015|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
9010776|NCT02991859|10073877|FG016|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
9010777|NCT02991859|10073861|FG000|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
9010778|NCT02991859|10073862|FG001|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
9010779|NCT02991859|10073863|FG002|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
9010780|NCT02991859|10073864|FG003|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
9010781|NCT02991859|10073865|FG004|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
9010782|NCT02991859|10073866|FG005|STARTED|Period 1,Escalation Phase2,Upto Day 14||3
9010783|NCT02991859|10073867|FG006|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
8902452|NCT02080507|9960178|FG000|COMPLETED|Overall Study||5
9010784|NCT02991859|10073868|FG007|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
9010785|NCT02991859|10073869|FG008|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
9010786|NCT02991859|10073870|FG009|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
9010787|NCT02991859|10073871|FG010|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
8902453|NCT02080507|9960179|FG001|COMPLETED|Overall Study||7
8902454|NCT02080507|9960178|FG000|NOT COMPLETED|Overall Study||0
8902455|NCT02080507|9960179|FG001|NOT COMPLETED|Overall Study||0
8902456|NCT02080546|9960187|FG000|STARTED|Overall Study||57
8902457|NCT02080546|9960188|FG001|STARTED|Overall Study||63
8902458|NCT02080546|9960187|FG000|COMPLETED|Overall Study||49
8902459|NCT02080546|9960188|FG001|COMPLETED|Overall Study||52
8902460|NCT02080546|9960187|FG000|NOT COMPLETED|Overall Study||8
8902461|NCT02080546|9960188|FG001|NOT COMPLETED|Overall Study||11
8902462|NCT02080637|9960196|FG000|STARTED|Overall Study||13
8902463|NCT02080637|9960197|FG001|STARTED|Overall Study||3
8902464|NCT02080637|9960196|FG000|COMPLETED|Overall Study||13
8902465|NCT02080637|9960197|FG001|COMPLETED|Overall Study||3
8902466|NCT02080637|9960196|FG000|NOT COMPLETED|Overall Study||0
8902467|NCT02080637|9960197|FG001|NOT COMPLETED|Overall Study||0
8902468|NCT02080780|9960203|FG000|STARTED|Overall Study||24
8902469|NCT02080780|9960203|FG000|COMPLETED|Overall Study||24
8902470|NCT02080780|9960203|FG000|NOT COMPLETED|Overall Study||0
8902471|NCT02080819|9960213|FG000|STARTED|Overall Study||63
8902472|NCT02080819|9960214|FG001|STARTED|Overall Study||35
8902473|NCT02080819|9960215|FG002|STARTED|Overall Study||33
8902474|NCT02080819|9960213|FG000|COMPLETED|Overall Study||38
8902475|NCT02080819|9960214|FG001|COMPLETED|Overall Study||9
8902476|NCT02080819|9960215|FG002|COMPLETED|Overall Study||11
8636366|NCT00567879|9677005|FG003|STARTED|Overall Study||6
8636367|NCT00567879|9677006|FG004|STARTED|Overall Study||12
8636368|NCT00567879|9677007|FG005|STARTED|Overall Study||3
8636369|NCT00567879|9677002|FG000|Maximum Tolerated Dose Determining Set|Overall Study||5
8636370|NCT00567879|9677003|FG001|Maximum Tolerated Dose Determining Set|Overall Study||7
8902477|NCT02080819|9960213|FG000|NOT COMPLETED|Overall Study||25
8902478|NCT02080819|9960214|FG001|NOT COMPLETED|Overall Study||26
8902479|NCT02080819|9960215|FG002|NOT COMPLETED|Overall Study||22
8902480|NCT02080832|9960226|FG000|STARTED|Overall Study||15
8902481|NCT02080832|9960227|FG001|STARTED|Overall Study||17
8902482|NCT02080832|9960228|FG002|STARTED|Overall Study||22
8902483|NCT02080832|9960226|FG000|COMPLETED|Overall Study||6
8902484|NCT02080832|9960227|FG001|COMPLETED|Overall Study||5
8902485|NCT02080832|9960228|FG002|COMPLETED|Overall Study||6
8902486|NCT02080832|9960226|FG000|NOT COMPLETED|Overall Study||9
8902487|NCT02080832|9960227|FG001|NOT COMPLETED|Overall Study||12
8902488|NCT02080832|9960228|FG002|NOT COMPLETED|Overall Study||16
8902489|NCT02080871|9960238|FG000|STARTED|Overall Study||134
8902490|NCT02080871|9960238|FG000|COMPLETED|Overall Study||132
8902491|NCT02080871|9960238|FG000|NOT COMPLETED|Overall Study||2
8902492|NCT02081001|9960244|FG000|STARTED|Overall Study||2
8902493|NCT02081001|9960245|FG001|STARTED|Overall Study||1
8902494|NCT02081001|9960246|FG002|STARTED|Overall Study||2
8902495|NCT02081001|9960247|FG003|STARTED|Overall Study||1
8902496|NCT02081001|9960248|FG004|STARTED|Overall Study||3
8902497|NCT02081001|9960249|FG005|STARTED|Overall Study||1
8902498|NCT02081001|9960250|FG006|STARTED|Overall Study||2
8902499|NCT02081001|9960251|FG007|STARTED|Overall Study||1
8902500|NCT02081001|9960252|FG008|STARTED|Overall Study||2
8902501|NCT02081001|9960253|FG009|STARTED|Overall Study||1
8902502|NCT02081001|9960254|FG010|STARTED|Overall Study||2
8902503|NCT02081001|9960255|FG011|STARTED|Overall Study||1
8902504|NCT02081001|9960244|FG000|COMPLETED|Overall Study||2
8902505|NCT02081001|9960245|FG001|COMPLETED|Overall Study||1
8902506|NCT02081001|9960246|FG002|COMPLETED|Overall Study||2
8902507|NCT02081001|9960247|FG003|COMPLETED|Overall Study||1
8902508|NCT02081001|9960248|FG004|COMPLETED|Overall Study||2
8902509|NCT02081001|9960249|FG005|COMPLETED|Overall Study||1
8902510|NCT02081001|9960250|FG006|COMPLETED|Overall Study||2
8902511|NCT02081001|9960251|FG007|COMPLETED|Overall Study||1
8902512|NCT02081001|9960252|FG008|COMPLETED|Overall Study||2
8902513|NCT02081001|9960253|FG009|COMPLETED|Overall Study||1
8902514|NCT02081001|9960254|FG010|COMPLETED|Overall Study||2
8902515|NCT02081001|9960255|FG011|COMPLETED|Overall Study||1
8902516|NCT02081001|9960244|FG000|NOT COMPLETED|Overall Study||0
8902517|NCT02081001|9960245|FG001|NOT COMPLETED|Overall Study||0
8902518|NCT02081001|9960246|FG002|NOT COMPLETED|Overall Study||0
8902519|NCT02081001|9960247|FG003|NOT COMPLETED|Overall Study||0
8902520|NCT02081001|9960248|FG004|NOT COMPLETED|Overall Study||1
8902521|NCT02081001|9960249|FG005|NOT COMPLETED|Overall Study||0
8902522|NCT02081001|9960250|FG006|NOT COMPLETED|Overall Study||0
8902523|NCT02081001|9960251|FG007|NOT COMPLETED|Overall Study||0
8902524|NCT02081001|9960252|FG008|NOT COMPLETED|Overall Study||0
8902525|NCT02081001|9960253|FG009|NOT COMPLETED|Overall Study||0
8902526|NCT02081001|9960254|FG010|NOT COMPLETED|Overall Study||0
8902527|NCT02081001|9960255|FG011|NOT COMPLETED|Overall Study||0
8902528|NCT02081014|9960266|FG000|STARTED|Overall Study||2
8902529|NCT02081014|9960267|FG001|STARTED|Overall Study||2
8691315|NCT00854113|9736571|FG000|STARTED|Overall Study||6
8902530|NCT02081014|9960268|FG002|STARTED|Overall Study||2
8902531|NCT02081014|9960269|FG003|STARTED|Overall Study||2
8902532|NCT02081014|9960270|FG004|STARTED|Overall Study||2
8902533|NCT02081014|9960271|FG005|STARTED|Overall Study||2
8902534|NCT02081014|9960266|FG000|COMPLETED|Overall Study||2
8902535|NCT02081014|9960267|FG001|COMPLETED|Overall Study||2
8902536|NCT02081014|9960268|FG002|COMPLETED|Overall Study||2
8902537|NCT02081014|9960269|FG003|COMPLETED|Overall Study||2
8902538|NCT02081014|9960270|FG004|COMPLETED|Overall Study||2
8902539|NCT02081014|9960271|FG005|COMPLETED|Overall Study||2
8902540|NCT02081014|9960266|FG000|NOT COMPLETED|Overall Study||0
8902541|NCT02081014|9960267|FG001|NOT COMPLETED|Overall Study||0
8902542|NCT02081014|9960268|FG002|NOT COMPLETED|Overall Study||0
8902543|NCT02081014|9960269|FG003|NOT COMPLETED|Overall Study||0
8902544|NCT02081014|9960270|FG004|NOT COMPLETED|Overall Study||0
8902545|NCT02081014|9960271|FG005|NOT COMPLETED|Overall Study||0
8902546|NCT02081079|9960292|FG000|STARTED|Overall Study||44
8902547|NCT02081079|9960293|FG001|STARTED|Overall Study||41
8902548|NCT02081079|9960292|FG000|COMPLETED|Overall Study||40
8902549|NCT02081079|9960293|FG001|COMPLETED|Overall Study||39
8902550|NCT02081079|9960292|FG000|NOT COMPLETED|Overall Study||4
8902551|NCT02081079|9960293|FG001|NOT COMPLETED|Overall Study||2
8902552|NCT02081196|9960303|FG000|STARTED|Overall Study|Treatment on one flank. Contralateral flank was untreated control.|45
8902553|NCT02081196|9960303|FG000|Untreated Control Flank|Overall Study||45
8902554|NCT02081196|9960303|FG000|COMPLETED|Overall Study|One (1) subject was lost to FU.|44
8902555|NCT02081196|9960303|FG000|NOT COMPLETED|Overall Study||1
8902556|NCT02081248|9960311|FG000|STARTED|Overall Study||98
8902557|NCT02081248|9960312|FG001|STARTED|Overall Study||100
8902558|NCT02081248|9960311|FG000|COMPLETED|Overall Study||76
8902559|NCT02081248|9960312|FG001|COMPLETED|Overall Study||87
8902560|NCT02081248|9960311|FG000|NOT COMPLETED|Overall Study||22
8902561|NCT02081248|9960312|FG001|NOT COMPLETED|Overall Study||13
8902562|NCT02081365|9960320|FG000|STARTED|Overall Study||74
8902563|NCT02081365|9960321|FG001|STARTED|Overall Study||77
8902564|NCT02081365|9960320|FG000|Received Allocated Intervention|Overall Study||46
8902565|NCT02081365|9960321|FG001|Received Allocated Intervention|Overall Study||59
8902566|NCT02081365|9960320|FG000|COMPLETED|Overall Study||44
8902567|NCT02081365|9960321|FG001|COMPLETED|Overall Study||54
8902568|NCT02081365|9960320|FG000|NOT COMPLETED|Overall Study||30
8902569|NCT02081365|9960321|FG001|NOT COMPLETED|Overall Study||23
8902570|NCT02081417|9960329|FG000|STARTED|Overall Study|Randomized to intervention|163
8902571|NCT02081417|9960330|FG001|STARTED|Overall Study||166
8902572|NCT02081417|9960329|FG000|1st Interview Completed|Overall Study||146
8902573|NCT02081417|9960330|FG001|1st Interview Completed|Overall Study||145
8902574|NCT02081417|9960329|FG000|3-Month Follow-Up|Overall Study||94
8902575|NCT02081417|9960330|FG001|3-Month Follow-Up|Overall Study||95
8902576|NCT02081417|9960329|FG000|6-Month Follow-Up|Overall Study||82
8902577|NCT02081417|9960330|FG001|6-Month Follow-Up|Overall Study||92
8902578|NCT02081417|9960329|FG000|COMPLETED|Overall Study||107
8902579|NCT02081417|9960330|FG001|COMPLETED|Overall Study||115
8902580|NCT02081417|9960329|FG000|NOT COMPLETED|Overall Study||56
8902581|NCT02081417|9960330|FG001|NOT COMPLETED|Overall Study||51
8902582|NCT02081443|9960338|FG000|STARTED|Overall Study||30
8902583|NCT02081443|9960339|FG001|STARTED|Overall Study||30
8902584|NCT02081443|9960338|FG000|COMPLETED|Overall Study||30
8902585|NCT02081443|9960339|FG001|COMPLETED|Overall Study||30
8902586|NCT02081443|9960338|FG000|NOT COMPLETED|Overall Study||0
8902587|NCT02081443|9960339|FG001|NOT COMPLETED|Overall Study||0
8902588|NCT02081456|9960347|FG000|STARTED|Overall Study||11
8902589|NCT02081456|9960348|FG001|STARTED|Overall Study||12
8902590|NCT02081456|9960347|FG000|COMPLETED|Overall Study||11
8902591|NCT02081456|9960348|FG001|COMPLETED|Overall Study||12
8902592|NCT02081456|9960347|FG000|NOT COMPLETED|Overall Study||0
8902593|NCT02081456|9960348|FG001|NOT COMPLETED|Overall Study||0
8902594|NCT02081534|9960361|FG000|STARTED|Overall Study||23
8902595|NCT02081534|9960362|FG001|STARTED|Overall Study||21
8902596|NCT02081534|9960363|FG002|STARTED|Overall Study||23
8902597|NCT02081534|9960364|FG003|STARTED|Overall Study||26
8902598|NCT02081534|9960365|FG004|STARTED|Overall Study||22
8902599|NCT02081534|9960366|FG005|STARTED|Overall Study||21
8902600|NCT02081534|9960367|FG006|STARTED|Overall Study||26
8902601|NCT02081534|9960361|FG000|COMPLETED|Overall Study||18
8902602|NCT02081534|9960362|FG001|COMPLETED|Overall Study||13
8636371|NCT00567879|9677004|FG002|Maximum Tolerated Dose Determining Set|Overall Study|6 participants belonged to the dose expansion group at 20mg/m2 i.v.|18
8636372|NCT00567879|9677005|FG003|Maximum Tolerated Dose Determining Set|Overall Study||6
8636373|NCT00567879|9677006|FG004|Maximum Tolerated Dose Determining Set|Overall Study||12
8902603|NCT02081534|9960363|FG002|COMPLETED|Overall Study||19
8902604|NCT02081534|9960364|FG003|COMPLETED|Overall Study||13
9010788|NCT02991859|10073872|FG011|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
8902605|NCT02081534|9960365|FG004|COMPLETED|Overall Study||18
8902606|NCT02081534|9960366|FG005|COMPLETED|Overall Study||12
8902607|NCT02081534|9960367|FG006|COMPLETED|Overall Study||22
8902608|NCT02081534|9960361|FG000|NOT COMPLETED|Overall Study||5
8902609|NCT02081534|9960362|FG001|NOT COMPLETED|Overall Study||8
8902610|NCT02081534|9960363|FG002|NOT COMPLETED|Overall Study||4
8902611|NCT02081534|9960364|FG003|NOT COMPLETED|Overall Study||13
8902612|NCT02081534|9960365|FG004|NOT COMPLETED|Overall Study||4
8902613|NCT02081534|9960366|FG005|NOT COMPLETED|Overall Study||9
8902614|NCT02081534|9960367|FG006|NOT COMPLETED|Overall Study||4
8902615|NCT02081573|9960383|FG000|STARTED|Overall Study||10
8902616|NCT02081573|9960383|FG000|COMPLETED|Overall Study||10
8902617|NCT02081573|9960383|FG000|NOT COMPLETED|Overall Study||0
8902618|NCT02081586|9960391|FG000|STARTED|Overall Study||3
8902619|NCT02081586|9960392|FG001|STARTED|Overall Study||3
8902620|NCT02081586|9960393|FG002|STARTED|Overall Study||4
8902621|NCT02081586|9960394|FG003|STARTED|Overall Study||3
8902622|NCT02081586|9960391|FG000|COMPLETED|Overall Study||3
8902623|NCT02081586|9960392|FG001|COMPLETED|Overall Study||2
8902624|NCT02081586|9960393|FG002|COMPLETED|Overall Study||3
8902625|NCT02081586|9960394|FG003|COMPLETED|Overall Study||2
8902626|NCT02081586|9960391|FG000|NOT COMPLETED|Overall Study||0
8902627|NCT02081586|9960392|FG001|NOT COMPLETED|Overall Study||1
8902628|NCT02081586|9960393|FG002|NOT COMPLETED|Overall Study||1
8902629|NCT02081586|9960394|FG003|NOT COMPLETED|Overall Study||1
8902630|NCT02081599|9960408|FG000|STARTED|Period 1：Double-blind Period||71
8902631|NCT02081599|9960409|FG001|STARTED|Period 1：Double-blind Period||77
8902632|NCT02081599|9960408|FG000|COMPLETED|Period 1：Double-blind Period||63
8902633|NCT02081599|9960409|FG001|COMPLETED|Period 1：Double-blind Period||75
8902634|NCT02081599|9960408|FG000|NOT COMPLETED|Period 1：Double-blind Period||8
8902635|NCT02081599|9960409|FG001|NOT COMPLETED|Period 1：Double-blind Period||2
8902636|NCT02081599|9960408|FG000|STARTED|Period 2：Open-label Period||63
8902637|NCT02081599|9960409|FG001|STARTED|Period 2：Open-label Period||75
8902638|NCT02081599|9960408|FG000|COMPLETED|Period 2：Open-label Period||57
8902639|NCT02081599|9960409|FG001|COMPLETED|Period 2：Open-label Period||71
8902640|NCT02081599|9960408|FG000|NOT COMPLETED|Period 2：Open-label Period||6
8902641|NCT02081599|9960409|FG001|NOT COMPLETED|Period 2：Open-label Period||4
8902642|NCT02081638|9960419|FG000|STARTED|Overall Study||26
8902643|NCT02081638|9960420|FG001|STARTED|Overall Study||27
8902644|NCT02081638|9960419|FG000|COMPLETED|Overall Study||24
8902645|NCT02081638|9960420|FG001|COMPLETED|Overall Study||20
8902646|NCT02081638|9960419|FG000|NOT COMPLETED|Overall Study||2
8902647|NCT02081638|9960420|FG001|NOT COMPLETED|Overall Study||7
8902648|NCT02081677|9960434|FG000|STARTED|Overall Study||19
8902649|NCT02081677|9960435|FG001|STARTED|Overall Study||19
8902650|NCT02081677|9960436|FG002|STARTED|Overall Study||19
8902651|NCT02081677|9960437|FG003|STARTED|Overall Study||19
8902652|NCT02081677|9960434|FG000|COMPLETED|Overall Study||18
8902653|NCT02081677|9960435|FG001|COMPLETED|Overall Study||18
8902654|NCT02081677|9960436|FG002|COMPLETED|Overall Study||17
8902655|NCT02081677|9960437|FG003|COMPLETED|Overall Study||19
8902656|NCT02081677|9960434|FG000|NOT COMPLETED|Overall Study||1
8902657|NCT02081677|9960435|FG001|NOT COMPLETED|Overall Study||1
8902658|NCT02081677|9960436|FG002|NOT COMPLETED|Overall Study||2
8902659|NCT02081677|9960437|FG003|NOT COMPLETED|Overall Study||0
8902660|NCT02081690|9960447|FG000|STARTED|Overall Study||88
8902661|NCT02081690|9960447|FG000|COMPLETED|Overall Study||81
8902662|NCT02081690|9960447|FG000|NOT COMPLETED|Overall Study||7
8902663|NCT02081807|9960459|FG000|STARTED|Overall Study||7668
8902664|NCT02081807|9960460|FG001|STARTED|Overall Study||26149
8902665|NCT02081807|9960461|FG002|STARTED|Overall Study||14852
8902666|NCT02081807|9960462|FG003|STARTED|Overall Study||9112
8902667|NCT02081807|9960463|FG004|STARTED|Overall Study||27456
8902668|NCT02081807|9960464|FG005|STARTED|Overall Study||76055
8902669|NCT02081807|9960465|FG006|STARTED|Overall Study||40207
8902670|NCT02081807|9960466|FG007|STARTED|Overall Study||19729
8902671|NCT02081807|9960459|FG000|COMPLETED|Overall Study||7668
8902672|NCT02081807|9960460|FG001|COMPLETED|Overall Study||26149
9010789|NCT02991859|10073873|FG012|STARTED|Period 1,Escalation Phase2,Upto Day 14||7
9010790|NCT02991859|10073874|FG013|STARTED|Period 1,Escalation Phase2,Upto Day 14||7
9010791|NCT02991859|10073875|FG014|STARTED|Period 1,Escalation Phase2,Upto Day 14||6
9010792|NCT02991859|10073876|FG015|STARTED|Period 1,Escalation Phase2,Upto Day 14||3
9010793|NCT02991859|10073877|FG016|STARTED|Period 1,Escalation Phase2,Upto Day 14||3
9010794|NCT02991859|10073861|FG000|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
9010795|NCT02991859|10073862|FG001|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
9010796|NCT02991859|10073863|FG002|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
9010797|NCT02991859|10073864|FG003|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
9010798|NCT02991859|10073865|FG004|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
9010799|NCT02991859|10073866|FG005|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||3
9010800|NCT02991859|10073867|FG006|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
9010801|NCT02991859|10073868|FG007|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
9010802|NCT02991859|10073869|FG008|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
9010803|NCT02991859|10073870|FG009|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
9010804|NCT02991859|10073871|FG010|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
9010805|NCT02991859|10073872|FG011|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
9010806|NCT02991859|10073873|FG012|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||7
9010807|NCT02991859|10073874|FG013|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||7
9010808|NCT02991859|10073875|FG014|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||6
9010809|NCT02991859|10073876|FG015|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||3
9010810|NCT02991859|10073877|FG016|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||3
9010811|NCT02991859|10073861|FG000|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
9010812|NCT02991859|10073862|FG001|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
9010813|NCT02991859|10073863|FG002|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
9010814|NCT02991859|10073864|FG003|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
9010815|NCT02991859|10073865|FG004|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
9010816|NCT02991859|10073866|FG005|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
9010817|NCT02991859|10073867|FG006|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
9010818|NCT02991859|10073868|FG007|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
9010819|NCT02991859|10073869|FG008|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
9010820|NCT02991859|10073870|FG009|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
8902673|NCT02081807|9960461|FG002|COMPLETED|Overall Study||14852
8902674|NCT02081807|9960462|FG003|COMPLETED|Overall Study||9112
8902675|NCT02081807|9960463|FG004|COMPLETED|Overall Study||27456
8902676|NCT02081807|9960464|FG005|COMPLETED|Overall Study||76055
8902677|NCT02081807|9960465|FG006|COMPLETED|Overall Study||40207
8902678|NCT02081807|9960466|FG007|COMPLETED|Overall Study||19729
8902679|NCT02081807|9960459|FG000|NOT COMPLETED|Overall Study||0
8902680|NCT02081807|9960460|FG001|NOT COMPLETED|Overall Study||0
8902681|NCT02081807|9960461|FG002|NOT COMPLETED|Overall Study||0
8902682|NCT02081807|9960462|FG003|NOT COMPLETED|Overall Study||0
8902683|NCT02081807|9960463|FG004|NOT COMPLETED|Overall Study||0
8902684|NCT02081807|9960464|FG005|NOT COMPLETED|Overall Study||0
8902685|NCT02081807|9960465|FG006|NOT COMPLETED|Overall Study||0
8902686|NCT02081807|9960466|FG007|NOT COMPLETED|Overall Study||0
8902687|NCT02081846|9960496|FG000|STARTED|Overall Study||751
8902688|NCT02081846|9960497|FG001|STARTED|Overall Study||749
8902689|NCT02081846|9960496|FG000|COMPLETED|Overall Study||749
8902690|NCT02081846|9960497|FG001|COMPLETED|Overall Study||749
8902691|NCT02081846|9960496|FG000|NOT COMPLETED|Overall Study||2
8902692|NCT02081846|9960497|FG001|NOT COMPLETED|Overall Study||0
8902693|NCT02081859|9960505|FG000|STARTED|Overall Study||150
8902694|NCT02081859|9960506|FG001|STARTED|Overall Study||150
9010821|NCT02991859|10073871|FG010|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
9010822|NCT02991859|10073872|FG011|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
9010823|NCT02991859|10073873|FG012|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
9010824|NCT02991859|10073874|FG013|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
9010825|NCT02991859|10073875|FG014|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
9010826|NCT02991859|10073876|FG015|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
9010827|NCT02991859|10073877|FG016|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
9010828|NCT02991859|10073861|FG000|STARTED|Period1, Escalation Phase3, Upto Day21||2
9010829|NCT02991859|10073862|FG001|STARTED|Period1, Escalation Phase3, Upto Day21||2
9010830|NCT02991859|10073863|FG002|STARTED|Period1, Escalation Phase3, Upto Day21||2
9010831|NCT02991859|10073864|FG003|STARTED|Period1, Escalation Phase3, Upto Day21||2
9010832|NCT02991859|10073865|FG004|STARTED|Period1, Escalation Phase3, Upto Day21||2
9010833|NCT02991859|10073866|FG005|STARTED|Period1, Escalation Phase3, Upto Day21||3
9010834|NCT02991859|10073867|FG006|STARTED|Period1, Escalation Phase3, Upto Day21||2
9010835|NCT02991859|10073868|FG007|STARTED|Period1, Escalation Phase3, Upto Day21||2
9010836|NCT02991859|10073869|FG008|STARTED|Period1, Escalation Phase3, Upto Day21||2
9010837|NCT02991859|10073870|FG009|STARTED|Period1, Escalation Phase3, Upto Day21||2
9010838|NCT02991859|10073871|FG010|STARTED|Period1, Escalation Phase3, Upto Day21||2
9010839|NCT02991859|10073872|FG011|STARTED|Period1, Escalation Phase3, Upto Day21||2
9010840|NCT02991859|10073873|FG012|STARTED|Period1, Escalation Phase3, Upto Day21||7
9010841|NCT02991859|10073874|FG013|STARTED|Period1, Escalation Phase3, Upto Day21||7
9010842|NCT02991859|10073875|FG014|STARTED|Period1, Escalation Phase3, Upto Day21||6
9010843|NCT02991859|10073876|FG015|STARTED|Period1, Escalation Phase3, Upto Day21||3
9010844|NCT02991859|10073877|FG016|STARTED|Period1, Escalation Phase3, Upto Day21||3
9010845|NCT02991859|10073861|FG000|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
9010846|NCT02991859|10073862|FG001|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
9010847|NCT02991859|10073863|FG002|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
9010848|NCT02991859|10073864|FG003|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
9010849|NCT02991859|10073865|FG004|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
9010850|NCT02991859|10073866|FG005|COMPLETED|Period1, Escalation Phase3, Upto Day21||3
9010851|NCT02991859|10073867|FG006|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
9010852|NCT02991859|10073868|FG007|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
9010853|NCT02991859|10073869|FG008|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
9010854|NCT02991859|10073870|FG009|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
9010855|NCT02991859|10073871|FG010|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
9010856|NCT02991859|10073872|FG011|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
9010857|NCT02991859|10073873|FG012|COMPLETED|Period1, Escalation Phase3, Upto Day21||6
9010858|NCT02991859|10073874|FG013|COMPLETED|Period1, Escalation Phase3, Upto Day21||6
9010859|NCT02991859|10073875|FG014|COMPLETED|Period1, Escalation Phase3, Upto Day21||6
9010860|NCT02991859|10073876|FG015|COMPLETED|Period1, Escalation Phase3, Upto Day21||3
9010861|NCT02991859|10073877|FG016|COMPLETED|Period1, Escalation Phase3, Upto Day21||3
9010862|NCT02991859|10073861|FG000|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
9010863|NCT02991859|10073862|FG001|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
9010864|NCT02991859|10073863|FG002|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
9010865|NCT02991859|10073864|FG003|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
9010866|NCT02991859|10073865|FG004|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
9010867|NCT02991859|10073866|FG005|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
8572966|NCT00117715|9605105|FG000|4 Year|Overall Study||58
8572967|NCT00117715|9605105|FG000|4.5 Year|Overall Study||55
8572968|NCT00117715|9605105|FG000|5 Year|Overall Study||49
8572969|NCT00117715|9605105|FG000|COMPLETED|Overall Study||49
8902695|NCT02081859|9960505|FG000|COMPLETED|Overall Study||116
8902696|NCT02081859|9960506|FG001|COMPLETED|Overall Study||119
8902697|NCT02081859|9960505|FG000|NOT COMPLETED|Overall Study||34
8902698|NCT02081859|9960506|FG001|NOT COMPLETED|Overall Study||31
8636374|NCT00567879|9677007|FG005|Maximum Tolerated Dose Determining Set|Overall Study||3
8636375|NCT00567879|9677002|FG000|COMPLETED|Overall Study||0
8636376|NCT00567879|9677003|FG001|COMPLETED|Overall Study||0
8636377|NCT00567879|9677004|FG002|COMPLETED|Overall Study||0
8636378|NCT00567879|9677005|FG003|COMPLETED|Overall Study||0
8902699|NCT02081950|9960512|FG000|STARTED|Treatment Period 1||14
8902700|NCT02081950|9960512|FG000|COMPLETED|Treatment Period 1||14
8902701|NCT02081950|9960512|FG000|NOT COMPLETED|Treatment Period 1||0
8902702|NCT02081950|9960512|FG000|STARTED|Treatment Period 2||14
8902703|NCT02081950|9960512|FG000|COMPLETED|Treatment Period 2||14
8902704|NCT02081950|9960512|FG000|NOT COMPLETED|Treatment Period 2||0
8902705|NCT02081963|9960520|FG000|STARTED|Overall Study||79
8902706|NCT02081963|9960521|FG001|STARTED|Overall Study||73
8902707|NCT02081963|9960520|FG000|COMPLETED|Overall Study||74
8902708|NCT02081963|9960521|FG001|COMPLETED|Overall Study||69
8902709|NCT02081963|9960520|FG000|NOT COMPLETED|Overall Study||5
8902710|NCT02081963|9960521|FG001|NOT COMPLETED|Overall Study||4
8902711|NCT02082119|9960527|FG000|STARTED|Overall Study||82
8902712|NCT02082119|9960527|FG000|COMPLETED|Overall Study||82
8902713|NCT02082119|9960527|FG000|NOT COMPLETED|Overall Study||0
8902714|NCT02082145|9960533|FG000|STARTED|Overall Study||5
8902715|NCT02082145|9960534|FG001|STARTED|Overall Study||9
8902716|NCT02082145|9960533|FG000|COMPLETED|Overall Study||5
8902717|NCT02082145|9960534|FG001|COMPLETED|Overall Study||9
8902718|NCT02082145|9960533|FG000|NOT COMPLETED|Overall Study||0
8902719|NCT02082145|9960534|FG001|NOT COMPLETED|Overall Study||0
8902720|NCT02082158|9960548|FG000|STARTED|Overall Study||66
8902721|NCT02082158|9960549|FG001|STARTED|Overall Study||61
8902722|NCT02082158|9960550|FG002|STARTED|Overall Study||52
8902723|NCT02082158|9960551|FG003|STARTED|Overall Study||72
8902724|NCT02082158|9960552|FG004|STARTED|Overall Study||68
8902725|NCT02082158|9960553|FG005|STARTED|Overall Study||63
8902726|NCT02082158|9960548|FG000|COMPLETED|Overall Study||58
8902727|NCT02082158|9960549|FG001|COMPLETED|Overall Study||53
8902728|NCT02082158|9960550|FG002|COMPLETED|Overall Study||38
8902729|NCT02082158|9960551|FG003|COMPLETED|Overall Study|Includes completion with respirator from secondary randomization after fit-test failure of 1st model|68
8902730|NCT02082158|9960552|FG004|COMPLETED|Overall Study||64
8902731|NCT02082158|9960553|FG005|COMPLETED|Overall Study||56
8902732|NCT02082158|9960548|FG000|NOT COMPLETED|Overall Study||8
8902733|NCT02082158|9960549|FG001|NOT COMPLETED|Overall Study||8
8902734|NCT02082158|9960550|FG002|NOT COMPLETED|Overall Study||14
8902735|NCT02082158|9960551|FG003|NOT COMPLETED|Overall Study||4
8902736|NCT02082158|9960552|FG004|NOT COMPLETED|Overall Study||4
8902737|NCT02082158|9960553|FG005|NOT COMPLETED|Overall Study||7
8902738|NCT02082184|9960575|FG000|STARTED|Overall Study||149
8902739|NCT02082184|9960576|FG001|STARTED|Overall Study||75
8902740|NCT02082184|9960575|FG000|COMPLETED|Overall Study||139
8902741|NCT02082184|9960576|FG001|COMPLETED|Overall Study||62
8902742|NCT02082184|9960575|FG000|NOT COMPLETED|Overall Study||10
8902743|NCT02082184|9960576|FG001|NOT COMPLETED|Overall Study||13
8902744|NCT02082210|9960588|FG000|STARTED|Overall Study||3
8902745|NCT02082210|9960589|FG001|STARTED|Overall Study||3
8902746|NCT02082210|9960590|FG002|STARTED|Overall Study||16
9010868|NCT02991859|10073867|FG006|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
9010869|NCT02991859|10073868|FG007|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
9010870|NCT02991859|10073869|FG008|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
9010871|NCT02991859|10073870|FG009|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
9010872|NCT02991859|10073871|FG010|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
9010873|NCT02991859|10073872|FG011|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
8572970|NCT00117715|9605105|FG000|NOT COMPLETED|Overall Study||72
8572971|NCT00117793|9605109|FG000|STARTED|Overall Study||17
8572972|NCT00117793|9605109|FG000|COMPLETED|Overall Study||5
8572973|NCT00117793|9605109|FG000|NOT COMPLETED|Overall Study||12
8572974|NCT00117806|9605116|FG000|STARTED|Overall Study||81
8572975|NCT00117806|9605117|FG001|STARTED|Overall Study||76
8572976|NCT00117806|9605116|FG000|COMPLETED|Overall Study||43
8572977|NCT00117806|9605117|FG001|COMPLETED|Overall Study||60
8572978|NCT00117806|9605116|FG000|NOT COMPLETED|Overall Study||38
8572979|NCT00117806|9605117|FG001|NOT COMPLETED|Overall Study||16
8572980|NCT00117845|9605126|FG000|STARTED|Overall Study||17
8572981|NCT00117845|9605126|FG000|COMPLETED|Overall Study||16
8572982|NCT00117845|9605126|FG000|NOT COMPLETED|Overall Study||1
8572983|NCT00117949|9605134|FG000|STARTED|Overall Study|Dose level terminated prematurely due to inadequate testosterone response|10
8572984|NCT00117949|9605135|FG001|STARTED|Overall Study||24
8572985|NCT00117949|9605136|FG002|STARTED|Overall Study||24
8572986|NCT00117949|9605137|FG003|STARTED|Overall Study||24
8572987|NCT00117949|9605134|FG000|COMPLETED|Overall Study||0
8636379|NCT00567879|9677006|FG004|COMPLETED|Overall Study||0
8902747|NCT02082210|9960591|FG003|STARTED|Overall Study||45
8902748|NCT02082210|9960592|FG004|STARTED|Overall Study||15
8902749|NCT02082210|9960593|FG005|STARTED|Overall Study||15
8902750|NCT02082210|9960588|FG000|Received at Least One Dose of Study Drug|Overall Study||3
8902751|NCT02082210|9960589|FG001|Received at Least One Dose of Study Drug|Overall Study||3
8902752|NCT02082210|9960590|FG002|Received at Least One Dose of Study Drug|Overall Study||16
8902753|NCT02082210|9960591|FG003|Received at Least One Dose of Study Drug|Overall Study||45
8902754|NCT02082210|9960592|FG004|Received at Least One Dose of Study Drug|Overall Study||15
8902755|NCT02082210|9960593|FG005|Received at Least One Dose of Study Drug|Overall Study||15
8636380|NCT00567879|9677007|FG005|COMPLETED|Overall Study||0
8636381|NCT00567879|9677002|FG000|NOT COMPLETED|Overall Study||7
8636382|NCT00567879|9677003|FG001|NOT COMPLETED|Overall Study||7
8636383|NCT00567879|9677004|FG002|NOT COMPLETED|Overall Study||21
8636384|NCT00567879|9677005|FG003|NOT COMPLETED|Overall Study||6
8636385|NCT00567879|9677006|FG004|NOT COMPLETED|Overall Study||12
8636386|NCT00567879|9677007|FG005|NOT COMPLETED|Overall Study||3
8636387|NCT00567892|9677027|FG000|STARTED|First Treatment (2 or 4 Weeks)||7
8902756|NCT02082210|9960588|FG000|COMPLETED|Overall Study||3
8902757|NCT02082210|9960589|FG001|COMPLETED|Overall Study||3
8902758|NCT02082210|9960590|FG002|COMPLETED|Overall Study||13
8902759|NCT02082210|9960591|FG003|COMPLETED|Overall Study||39
8902760|NCT02082210|9960592|FG004|COMPLETED|Overall Study||12
8902761|NCT02082210|9960593|FG005|COMPLETED|Overall Study||13
8902762|NCT02082210|9960588|FG000|NOT COMPLETED|Overall Study||0
8902763|NCT02082210|9960589|FG001|NOT COMPLETED|Overall Study||0
8902764|NCT02082210|9960590|FG002|NOT COMPLETED|Overall Study||3
8902765|NCT02082210|9960591|FG003|NOT COMPLETED|Overall Study||6
8902766|NCT02082210|9960592|FG004|NOT COMPLETED|Overall Study||3
8902767|NCT02082210|9960593|FG005|NOT COMPLETED|Overall Study||2
8902768|NCT02082262|9960619|FG000|STARTED|Overall Study||140
8902769|NCT02082262|9960619|FG000|COMPLETED|Overall Study||89
8902770|NCT02082262|9960619|FG000|NOT COMPLETED|Overall Study||51
8902771|NCT02082288|9960623|FG000|STARTED|Overall Study||243
8902772|NCT02082288|9960623|FG000|COMPLETED|Overall Study||243
8902773|NCT02082288|9960623|FG000|NOT COMPLETED|Overall Study||0
8902774|NCT02082340|9960629|FG000|STARTED|Overall Study||194
8902775|NCT02082340|9960630|FG001|STARTED|Overall Study||198
8902776|NCT02082340|9960629|FG000|COMPLETED|Overall Study||193
8902777|NCT02082340|9960630|FG001|COMPLETED|Overall Study||197
8902778|NCT02082340|9960629|FG000|NOT COMPLETED|Overall Study||1
8902779|NCT02082340|9960630|FG001|NOT COMPLETED|Overall Study||1
8902780|NCT02082392|9960638|FG000|STARTED|Overall Study||2
8902781|NCT02082392|9960639|FG001|STARTED|Overall Study||1
8902782|NCT02082392|9960638|FG000|COMPLETED|Overall Study||2
8726497|NCT01036802|9773729|FG001|COMPLETED|Overall Study|Patient was taken off study after 7 months as she required hip replacement surgery.|1
8726498|NCT01036802|9773728|FG000|NOT COMPLETED|Overall Study||0
8726499|NCT01036802|9773729|FG001|NOT COMPLETED|Overall Study||0
8726500|NCT01037088|9773736|FG000|STARTED|Overall Study||39
8726501|NCT01037088|9773736|FG000|Received 3.53% THC|Overall Study||36
8726502|NCT01037088|9773736|FG000|Received 1.29% THC|Overall Study||37
8726503|NCT01037088|9773736|FG000|Received Placebo|Overall Study||38
8726504|NCT01037088|9773736|FG000|COMPLETED|Overall Study||36
8902783|NCT02082392|9960639|FG001|COMPLETED|Overall Study||1
8636388|NCT00567892|9677028|FG001|STARTED|First Treatment (2 or 4 Weeks)||7
8636389|NCT00567892|9677029|FG002|STARTED|First Treatment (2 or 4 Weeks)||10
8636390|NCT00567892|9677030|FG003|STARTED|First Treatment (2 or 4 Weeks)||10
8902784|NCT02082392|9960638|FG000|NOT COMPLETED|Overall Study||0
8902785|NCT02082392|9960639|FG001|NOT COMPLETED|Overall Study||0
8902786|NCT02082483|9960647|FG000|STARTED|Overall Study||71
8902787|NCT02082483|9960648|FG001|STARTED|Overall Study||73
8902788|NCT02082483|9960647|FG000|COMPLETED|Overall Study||65
8902789|NCT02082483|9960648|FG001|COMPLETED|Overall Study||67
8902790|NCT02082483|9960647|FG000|NOT COMPLETED|Overall Study||6
8902791|NCT02082483|9960648|FG001|NOT COMPLETED|Overall Study||6
8902792|NCT02082522|9960657|FG000|STARTED|Overall Study||15
8902793|NCT02082522|9960658|FG001|STARTED|Overall Study||13
8636391|NCT00567892|9677027|FG000|COMPLETED|First Treatment (2 or 4 Weeks)||7
8636392|NCT00567892|9677028|FG001|COMPLETED|First Treatment (2 or 4 Weeks)||7
8636393|NCT00567892|9677029|FG002|COMPLETED|First Treatment (2 or 4 Weeks)||9
8636394|NCT00567892|9677030|FG003|COMPLETED|First Treatment (2 or 4 Weeks)||6
8636395|NCT00567892|9677027|FG000|NOT COMPLETED|First Treatment (2 or 4 Weeks)||0
8636396|NCT00567892|9677028|FG001|NOT COMPLETED|First Treatment (2 or 4 Weeks)||0
8636397|NCT00567892|9677029|FG002|NOT COMPLETED|First Treatment (2 or 4 Weeks)||1
8636398|NCT00567892|9677030|FG003|NOT COMPLETED|First Treatment (2 or 4 Weeks)||4
8636399|NCT00567892|9677027|FG000|STARTED|Washout (2 Weeks)||7
8636400|NCT00567892|9677028|FG001|STARTED|Washout (2 Weeks)||7
8636401|NCT00567892|9677029|FG002|STARTED|Washout (2 Weeks)||9
8726505|NCT01037088|9773736|FG000|NOT COMPLETED|Overall Study||3
8726506|NCT01037114|9773745|FG000|STARTED|Year 16||49
8902794|NCT02082522|9960657|FG000|COMPLETED|Overall Study||0
8636402|NCT00567892|9677030|FG003|STARTED|Washout (2 Weeks)||6
8636403|NCT00567892|9677027|FG000|COMPLETED|Washout (2 Weeks)||7
8902795|NCT02082522|9960658|FG001|COMPLETED|Overall Study||0
8902796|NCT02082522|9960657|FG000|NOT COMPLETED|Overall Study||15
8902797|NCT02082522|9960658|FG001|NOT COMPLETED|Overall Study||13
8902798|NCT02082678|9960666|FG000|STARTED|Overall Study||35
8902799|NCT02082678|9960667|FG001|STARTED|Overall Study||35
8902800|NCT02082678|9960666|FG000|COMPLETED|Overall Study||23
8902801|NCT02082678|9960667|FG001|COMPLETED|Overall Study||21
8902802|NCT02082678|9960666|FG000|NOT COMPLETED|Overall Study||12
8902803|NCT02082678|9960667|FG001|NOT COMPLETED|Overall Study||14
8902804|NCT02082717|9960675|FG000|STARTED|Overall Study||8
8902805|NCT02082717|9960676|FG001|STARTED|Overall Study||9
8902806|NCT02082717|9960675|FG000|COMPLETED|Overall Study||8
8902807|NCT02082717|9960676|FG001|COMPLETED|Overall Study||9
8902808|NCT02082717|9960675|FG000|NOT COMPLETED|Overall Study||0
8902809|NCT02082717|9960676|FG001|NOT COMPLETED|Overall Study||0
8902810|NCT02082769|9960689|FG000|STARTED|Overall Study||168
8902811|NCT02082769|9960690|FG001|STARTED|Overall Study||168
8902812|NCT02082769|9960691|FG002|STARTED|Overall Study||168
8902813|NCT02082769|9960689|FG000|COMPLETED|Overall Study||144
8902814|NCT02082769|9960690|FG001|COMPLETED|Overall Study||141
8902815|NCT02082769|9960691|FG002|COMPLETED|Overall Study||132
8902816|NCT02082769|9960689|FG000|NOT COMPLETED|Overall Study||24
8902817|NCT02082769|9960690|FG001|NOT COMPLETED|Overall Study||27
8902818|NCT02082769|9960691|FG002|NOT COMPLETED|Overall Study||36
8902819|NCT02082912|9960701|FG000|STARTED|Overall Study||7
8902820|NCT02082912|9960702|FG001|STARTED|Overall Study||7
8902821|NCT02082912|9960701|FG000|COMPLETED|Overall Study||7
8902822|NCT02082912|9960702|FG001|COMPLETED|Overall Study||6
8902823|NCT02082912|9960701|FG000|NOT COMPLETED|Overall Study||0
8902824|NCT02082912|9960702|FG001|NOT COMPLETED|Overall Study||1
8902825|NCT02082977|9960718|FG000|STARTED|Part 1 (Up to 3.2 Years)||2
8902826|NCT02082977|9960719|FG001|STARTED|Part 1 (Up to 3.2 Years)||1
8902827|NCT02082977|9960720|FG002|STARTED|Part 1 (Up to 3.2 Years)||1
8902828|NCT02082977|9960721|FG003|STARTED|Part 1 (Up to 3.2 Years)||1
8902829|NCT02082977|9960722|FG004|STARTED|Part 1 (Up to 3.2 Years)||3
8902830|NCT02082977|9960723|FG005|STARTED|Part 1 (Up to 3.2 Years)||4
8902831|NCT02082977|9960724|FG006|STARTED|Part 1 (Up to 3.2 Years)||10
8902832|NCT02082977|9960725|FG007|STARTED|Part 1 (Up to 3.2 Years)||12
8902833|NCT02082977|9960726|FG008|STARTED|Part 1 (Up to 3.2 Years)||7
8902834|NCT02082977|9960727|FG009|STARTED|Part 1 (Up to 3.2 Years)||0
8902835|NCT02082977|9960718|FG000|COMPLETED|Part 1 (Up to 3.2 Years)||1
8902836|NCT02082977|9960719|FG001|COMPLETED|Part 1 (Up to 3.2 Years)||1
8902837|NCT02082977|9960720|FG002|COMPLETED|Part 1 (Up to 3.2 Years)||1
8902838|NCT02082977|9960721|FG003|COMPLETED|Part 1 (Up to 3.2 Years)||1
8902839|NCT02082977|9960722|FG004|COMPLETED|Part 1 (Up to 3.2 Years)||2
8902840|NCT02082977|9960723|FG005|COMPLETED|Part 1 (Up to 3.2 Years)||1
8902841|NCT02082977|9960724|FG006|COMPLETED|Part 1 (Up to 3.2 Years)||4
8902842|NCT02082977|9960725|FG007|COMPLETED|Part 1 (Up to 3.2 Years)||7
8902843|NCT02082977|9960726|FG008|COMPLETED|Part 1 (Up to 3.2 Years)||4
8902844|NCT02082977|9960727|FG009|COMPLETED|Part 1 (Up to 3.2 Years)||0
8902845|NCT02082977|9960718|FG000|NOT COMPLETED|Part 1 (Up to 3.2 Years)||1
8902846|NCT02082977|9960719|FG001|NOT COMPLETED|Part 1 (Up to 3.2 Years)||0
8902847|NCT02082977|9960720|FG002|NOT COMPLETED|Part 1 (Up to 3.2 Years)||0
8902848|NCT02082977|9960721|FG003|NOT COMPLETED|Part 1 (Up to 3.2 Years)||0
8902849|NCT02082977|9960722|FG004|NOT COMPLETED|Part 1 (Up to 3.2 Years)||1
8902850|NCT02082977|9960723|FG005|NOT COMPLETED|Part 1 (Up to 3.2 Years)||3
8902851|NCT02082977|9960724|FG006|NOT COMPLETED|Part 1 (Up to 3.2 Years)||6
8902852|NCT02082977|9960725|FG007|NOT COMPLETED|Part 1 (Up to 3.2 Years)||5
8902853|NCT02082977|9960726|FG008|NOT COMPLETED|Part 1 (Up to 3.2 Years)||3
8902854|NCT02082977|9960727|FG009|NOT COMPLETED|Part 1 (Up to 3.2 Years)||0
8902855|NCT02082977|9960718|FG000|STARTED|Part 2 (Up to 3.2 Years)||0
8902856|NCT02082977|9960719|FG001|STARTED|Part 2 (Up to 3.2 Years)||0
8902857|NCT02082977|9960720|FG002|STARTED|Part 2 (Up to 3.2 Years)||0
8902858|NCT02082977|9960721|FG003|STARTED|Part 2 (Up to 3.2 Years)||0
8902859|NCT02082977|9960722|FG004|STARTED|Part 2 (Up to 3.2 Years)||0
8902860|NCT02082977|9960723|FG005|STARTED|Part 2 (Up to 3.2 Years)||0
8902861|NCT02082977|9960724|FG006|STARTED|Part 2 (Up to 3.2 Years)||0
8902862|NCT02082977|9960725|FG007|STARTED|Part 2 (Up to 3.2 Years)||0
8902863|NCT02082977|9960726|FG008|STARTED|Part 2 (Up to 3.2 Years)||0
8902864|NCT02082977|9960727|FG009|STARTED|Part 2 (Up to 3.2 Years)||0
8902865|NCT02082977|9960718|FG000|COMPLETED|Part 2 (Up to 3.2 Years)||0
8902866|NCT02082977|9960719|FG001|COMPLETED|Part 2 (Up to 3.2 Years)||0
8902867|NCT02082977|9960720|FG002|COMPLETED|Part 2 (Up to 3.2 Years)||0
9010874|NCT02991859|10073873|FG012|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||1
9010875|NCT02991859|10073874|FG013|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||1
9010876|NCT02991859|10073875|FG014|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
9010877|NCT02991859|10073876|FG015|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
9010878|NCT02991859|10073877|FG016|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
9010879|NCT02991859|10073861|FG000|STARTED|Period1, Escalation Phase4, Upto Day28||2
9010880|NCT02991859|10073862|FG001|STARTED|Period1, Escalation Phase4, Upto Day28||2
9010881|NCT02991859|10073863|FG002|STARTED|Period1, Escalation Phase4, Upto Day28||2
9010882|NCT02991859|10073864|FG003|STARTED|Period1, Escalation Phase4, Upto Day28||2
8572988|NCT00117949|9605135|FG001|COMPLETED|Overall Study||0
8572989|NCT00117949|9605136|FG002|COMPLETED|Overall Study||0
8572990|NCT00117949|9605137|FG003|COMPLETED|Overall Study||0
8572991|NCT00117949|9605134|FG000|NOT COMPLETED|Overall Study||10
8572992|NCT00117949|9605135|FG001|NOT COMPLETED|Overall Study||24
8572993|NCT00117949|9605136|FG002|NOT COMPLETED|Overall Study||24
8572994|NCT00117949|9605137|FG003|NOT COMPLETED|Overall Study||24
8572995|NCT00117962|9605149|FG000|STARTED|Overall Study||48
8572996|NCT00117962|9605150|FG001|STARTED|Overall Study||53
8902868|NCT02082977|9960721|FG003|COMPLETED|Part 2 (Up to 3.2 Years)||0
8902869|NCT02082977|9960722|FG004|COMPLETED|Part 2 (Up to 3.2 Years)||0
8902870|NCT02082977|9960723|FG005|COMPLETED|Part 2 (Up to 3.2 Years)||0
8902871|NCT02082977|9960724|FG006|COMPLETED|Part 2 (Up to 3.2 Years)||0
8902872|NCT02082977|9960725|FG007|COMPLETED|Part 2 (Up to 3.2 Years)||0
8902873|NCT02082977|9960726|FG008|COMPLETED|Part 2 (Up to 3.2 Years)||0
9010883|NCT02991859|10073865|FG004|STARTED|Period1, Escalation Phase4, Upto Day28||2
8902874|NCT02082977|9960727|FG009|COMPLETED|Part 2 (Up to 3.2 Years)||0
8902875|NCT02082977|9960718|FG000|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
8902876|NCT02082977|9960719|FG001|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
8902877|NCT02082977|9960720|FG002|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
8902878|NCT02082977|9960721|FG003|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
8902879|NCT02082977|9960722|FG004|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
8902880|NCT02082977|9960723|FG005|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
8902881|NCT02082977|9960724|FG006|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
8902882|NCT02082977|9960725|FG007|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
8902883|NCT02082977|9960726|FG008|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
8902884|NCT02082977|9960727|FG009|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
8902885|NCT02083107|9960762|FG000|STARTED|Overall Study|212 women received 2 tablets of Misotac® sublingually and 2 placebo tablets rectally.|212
8902886|NCT02083107|9960763|FG001|STARTED|Overall Study|212 women received 2 tablets of placebo sublingually and 2 placebo tablets rectally.|212
8902887|NCT02083107|9960764|FG002|STARTED|Overall Study|212 women received 2 tablets of Misotac® rectally and 2 placebo tablets sublingually.|212
8902888|NCT02083107|9960762|FG000|COMPLETED|Overall Study|212 women received 2 tablets of Misotac® sublingually and 2 placebo tablets rectally.|212
8902889|NCT02083107|9960763|FG001|COMPLETED|Overall Study|212 women received 2 tablets of placebo sublingually and 2 placebo tablets rectally.|212
8902890|NCT02083107|9960764|FG002|COMPLETED|Overall Study|212 women received 2 tablets of Misotac® rectally and 2 placebo tablets sublingually.|212
8902891|NCT02083107|9960762|FG000|NOT COMPLETED|Overall Study||0
8902892|NCT02083107|9960763|FG001|NOT COMPLETED|Overall Study||0
8902893|NCT02083107|9960764|FG002|NOT COMPLETED|Overall Study||0
8902894|NCT02083185|9960775|FG000|STARTED|Overall Study||56
8902895|NCT02083185|9960776|FG001|STARTED|Overall Study||56
8902896|NCT02083185|9960777|FG002|STARTED|Overall Study||24
8902897|NCT02083185|9960775|FG000|Safety Population|Overall Study||56
8902898|NCT02083185|9960776|FG001|Safety Population|Overall Study||54
8902899|NCT02083185|9960777|FG002|Safety Population|Overall Study||24
8902900|NCT02083185|9960775|FG000|COMPLETED|Overall Study||36
8902901|NCT02083185|9960776|FG001|COMPLETED|Overall Study||27
8902902|NCT02083185|9960777|FG002|COMPLETED|Overall Study||17
8902903|NCT02083185|9960775|FG000|NOT COMPLETED|Overall Study||20
8902904|NCT02083185|9960776|FG001|NOT COMPLETED|Overall Study||29
8902905|NCT02083185|9960777|FG002|NOT COMPLETED|Overall Study||7
8902906|NCT02083263|9960787|FG000|STARTED|Overall Study||16
8902907|NCT02083263|9960788|FG001|STARTED|Overall Study||16
8902908|NCT02083263|9960787|FG000|COMPLETED|Overall Study||16
8902909|NCT02083263|9960788|FG001|COMPLETED|Overall Study||16
8902910|NCT02083263|9960787|FG000|NOT COMPLETED|Overall Study||0
8902911|NCT02083263|9960788|FG001|NOT COMPLETED|Overall Study||0
8902912|NCT02083380|9960797|FG000|STARTED|Overall Study|5 subjects excluded from safety / ITT population - no drug administered|148
8902913|NCT02083380|9960798|FG001|STARTED|Overall Study|3 subjects excluded from safety / ITT population - no drug administered|151
8902914|NCT02083380|9960799|FG002|STARTED|Overall Study|3 subjects excluded from safety / ITT population - no drug administered|149
8902915|NCT02083380|9960797|FG000|COMPLETED|Overall Study||57
8902916|NCT02083380|9960798|FG001|COMPLETED|Overall Study||56
8902917|NCT02083380|9960799|FG002|COMPLETED|Overall Study||65
8902918|NCT02083380|9960797|FG000|NOT COMPLETED|Overall Study||91
8902919|NCT02083380|9960798|FG001|NOT COMPLETED|Overall Study||95
8902920|NCT02083380|9960799|FG002|NOT COMPLETED|Overall Study||84
8902921|NCT02083406|9960815|FG000|STARTED|Overall Study||7
8636404|NCT00567892|9677028|FG001|COMPLETED|Washout (2 Weeks)||7
8636405|NCT00567892|9677029|FG002|COMPLETED|Washout (2 Weeks)||9
8636406|NCT00567892|9677030|FG003|COMPLETED|Washout (2 Weeks)||6
8636407|NCT00567892|9677027|FG000|NOT COMPLETED|Washout (2 Weeks)||0
8636408|NCT00567892|9677028|FG001|NOT COMPLETED|Washout (2 Weeks)||0
8636409|NCT00567892|9677029|FG002|NOT COMPLETED|Washout (2 Weeks)||0
8636410|NCT00567892|9677030|FG003|NOT COMPLETED|Washout (2 Weeks)||0
8636411|NCT00567892|9677027|FG000|STARTED|Second Treatment (2 or 4 Weeks)||7
8636412|NCT00567892|9677028|FG001|STARTED|Second Treatment (2 or 4 Weeks)||7
8902922|NCT02083406|9960816|FG001|STARTED|Overall Study||8
8902923|NCT02083406|9960817|FG002|STARTED|Overall Study||7
8636413|NCT00567892|9677029|FG002|STARTED|Second Treatment (2 or 4 Weeks)||9
8636414|NCT00567892|9677030|FG003|STARTED|Second Treatment (2 or 4 Weeks)||6
8636415|NCT00567892|9677027|FG000|COMPLETED|Second Treatment (2 or 4 Weeks)||7
8636416|NCT00567892|9677028|FG001|COMPLETED|Second Treatment (2 or 4 Weeks)||7
8636417|NCT00567892|9677029|FG002|COMPLETED|Second Treatment (2 or 4 Weeks)||9
8636418|NCT00567892|9677030|FG003|COMPLETED|Second Treatment (2 or 4 Weeks)||5
8636419|NCT00567892|9677027|FG000|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||0
8636420|NCT00567892|9677028|FG001|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||0
8636421|NCT00567892|9677029|FG002|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||0
8636422|NCT00567892|9677030|FG003|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||1
8636423|NCT00567996|9677045|FG000|STARTED|Overall Study|Randomized participants|333
8636424|NCT00567996|9677046|FG001|STARTED|Overall Study||334
8636425|NCT00567996|9677047|FG002|STARTED|Overall Study||335
8636426|NCT00567996|9677045|FG000|Intent-to-treat: Received Study Drug|Overall Study||330
8726507|NCT01037114|9773745|FG000|COMPLETED|Year 16||49
8636427|NCT00567996|9677046|FG001|Intent-to-treat: Received Study Drug|Overall Study||333
8636428|NCT00567996|9677047|FG002|Intent-to-treat: Received Study Drug|Overall Study||335
8636429|NCT00567996|9677045|FG000|COMPLETED|Overall Study||289
8636430|NCT00567996|9677046|FG001|COMPLETED|Overall Study||284
8636431|NCT00567996|9677047|FG002|COMPLETED|Overall Study||265
8636432|NCT00567996|9677045|FG000|NOT COMPLETED|Overall Study||44
8636433|NCT00567996|9677046|FG001|NOT COMPLETED|Overall Study||50
8636434|NCT00567996|9677047|FG002|NOT COMPLETED|Overall Study||70
8902924|NCT02083406|9960815|FG000|COMPLETED|Overall Study||7
8902925|NCT02083406|9960816|FG001|COMPLETED|Overall Study||8
8902926|NCT02083406|9960817|FG002|COMPLETED|Overall Study||7
8902927|NCT02083406|9960815|FG000|NOT COMPLETED|Overall Study||0
8902928|NCT02083406|9960816|FG001|NOT COMPLETED|Overall Study||0
8902929|NCT02083406|9960817|FG002|NOT COMPLETED|Overall Study||0
8902930|NCT02083653|9960828|FG000|STARTED|Overall Study||83
8902931|NCT02083653|9960829|FG001|STARTED|Overall Study||86
8902932|NCT02083653|9960830|FG002|STARTED|Overall Study||85
8902933|NCT02083653|9960828|FG000|COMPLETED|Overall Study||1
8902934|NCT02083653|9960829|FG001|COMPLETED|Overall Study||1
8902935|NCT02083653|9960830|FG002|COMPLETED|Overall Study||1
8902936|NCT02083653|9960828|FG000|NOT COMPLETED|Overall Study||82
8902937|NCT02083653|9960829|FG001|NOT COMPLETED|Overall Study||85
8902938|NCT02083653|9960830|FG002|NOT COMPLETED|Overall Study||84
8902939|NCT02083679|9960842|FG000|STARTED|Overall Study||3
8902940|NCT02083679|9960843|FG001|STARTED|Overall Study||6
8902941|NCT02083679|9960844|FG002|STARTED|Overall Study||3
8902942|NCT02083679|9960845|FG003|STARTED|Overall Study||3
8902943|NCT02083679|9960842|FG000|COMPLETED|Overall Study||3
8902944|NCT02083679|9960843|FG001|COMPLETED|Overall Study||6
8902945|NCT02083679|9960844|FG002|COMPLETED|Overall Study||3
8902946|NCT02083679|9960845|FG003|COMPLETED|Overall Study||3
8902947|NCT02083679|9960842|FG000|NOT COMPLETED|Overall Study||0
9010884|NCT02991859|10073866|FG005|STARTED|Period1, Escalation Phase4, Upto Day28|1 Par completed Phase 3 did not enter Phase 4|2
9010885|NCT02991859|10073867|FG006|STARTED|Period1, Escalation Phase4, Upto Day28||2
9010886|NCT02991859|10073868|FG007|STARTED|Period1, Escalation Phase4, Upto Day28||2
9010887|NCT02991859|10073869|FG008|STARTED|Period1, Escalation Phase4, Upto Day28||2
9010888|NCT02991859|10073870|FG009|STARTED|Period1, Escalation Phase4, Upto Day28||2
9010889|NCT02991859|10073871|FG010|STARTED|Period1, Escalation Phase4, Upto Day28||2
9010890|NCT02991859|10073872|FG011|STARTED|Period1, Escalation Phase4, Upto Day28||2
9010891|NCT02991859|10073873|FG012|STARTED|Period1, Escalation Phase4, Upto Day28||6
9010892|NCT02991859|10073874|FG013|STARTED|Period1, Escalation Phase4, Upto Day28||6
9010893|NCT02991859|10073875|FG014|STARTED|Period1, Escalation Phase4, Upto Day28||6
9010894|NCT02991859|10073876|FG015|STARTED|Period1, Escalation Phase4, Upto Day28||3
9010895|NCT02991859|10073877|FG016|STARTED|Period1, Escalation Phase4, Upto Day28||3
9010896|NCT02991859|10073861|FG000|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
9010897|NCT02991859|10073862|FG001|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
9010898|NCT02991859|10073863|FG002|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
9010899|NCT02991859|10073864|FG003|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
9010900|NCT02991859|10073865|FG004|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
9010901|NCT02991859|10073866|FG005|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
9010902|NCT02991859|10073867|FG006|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
9010903|NCT02991859|10073868|FG007|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
9010904|NCT02991859|10073869|FG008|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
9010905|NCT02991859|10073870|FG009|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
9010906|NCT02991859|10073871|FG010|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
9010907|NCT02991859|10073872|FG011|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
9010908|NCT02991859|10073873|FG012|COMPLETED|Period1, Escalation Phase4, Upto Day28||6
9010909|NCT02991859|10073874|FG013|COMPLETED|Period1, Escalation Phase4, Upto Day28||6
9010910|NCT02991859|10073875|FG014|COMPLETED|Period1, Escalation Phase4, Upto Day28||6
9010911|NCT02991859|10073876|FG015|COMPLETED|Period1, Escalation Phase4, Upto Day28||3
9010912|NCT02991859|10073877|FG016|COMPLETED|Period1, Escalation Phase4, Upto Day28||3
9010913|NCT02991859|10073861|FG000|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
9010914|NCT02991859|10073862|FG001|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
9010915|NCT02991859|10073863|FG002|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
9010916|NCT02991859|10073864|FG003|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
9010917|NCT02991859|10073865|FG004|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
9010918|NCT02991859|10073866|FG005|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
9010919|NCT02991859|10073867|FG006|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
9010920|NCT02991859|10073868|FG007|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
9010921|NCT02991859|10073869|FG008|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
9010922|NCT02991859|10073870|FG009|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
9010923|NCT02991859|10073871|FG010|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
9010924|NCT02991859|10073872|FG011|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
9010925|NCT02991859|10073873|FG012|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
9010926|NCT02991859|10073874|FG013|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
9010927|NCT02991859|10073875|FG014|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
9010928|NCT02991859|10073876|FG015|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
9010929|NCT02991859|10073877|FG016|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
8902948|NCT02083679|9960843|FG001|NOT COMPLETED|Overall Study||0
8902949|NCT02083679|9960844|FG002|NOT COMPLETED|Overall Study||0
9010930|NCT02991859|10073861|FG000|STARTED|Period1, Escalation Phase5, Upto Day35||2
9010931|NCT02991859|10073862|FG001|STARTED|Period1, Escalation Phase5, Upto Day35||2
9010932|NCT02991859|10073863|FG002|STARTED|Period1, Escalation Phase5, Upto Day35||2
8902950|NCT02083679|9960845|FG003|NOT COMPLETED|Overall Study||0
8902951|NCT02083783|9960857|FG000|STARTED|Overall Study||52
8902952|NCT02083783|9960858|FG001|STARTED|Overall Study||48
8902953|NCT02083783|9960857|FG000|COMPLETED|Overall Study||51
8902954|NCT02083783|9960858|FG001|COMPLETED|Overall Study||48
8902955|NCT02083783|9960857|FG000|NOT COMPLETED|Overall Study||1
8902956|NCT02083783|9960858|FG001|NOT COMPLETED|Overall Study||0
8902957|NCT02083809|9960868|FG000|STARTED|Overall Study||82
8902958|NCT02083809|9960869|FG001|STARTED|Overall Study||84
8902959|NCT02083809|9960868|FG000|COMPLETED|Overall Study||78
8902960|NCT02083809|9960869|FG001|COMPLETED|Overall Study||82
8902961|NCT02083809|9960868|FG000|NOT COMPLETED|Overall Study||4
8636435|NCT00568022|9677058|FG000|STARTED|Overall Study||3
8636436|NCT00568022|9677059|FG001|STARTED|Overall Study||3
8636437|NCT00568022|9677060|FG002|STARTED|Overall Study||3
8902962|NCT02083809|9960869|FG001|NOT COMPLETED|Overall Study||2
8902963|NCT02083861|9960877|FG000|STARTED|Overall Study||57
8902964|NCT02083861|9960878|FG001|STARTED|Overall Study||36
8902965|NCT02083861|9960877|FG000|Treated|Overall Study||55
8902966|NCT02083861|9960878|FG001|Treated|Overall Study||35
8902967|NCT02083861|9960877|FG000|COMPLETED|Overall Study||51
8902968|NCT02083861|9960878|FG001|COMPLETED|Overall Study||33
8902969|NCT02083861|9960877|FG000|NOT COMPLETED|Overall Study||6
8902970|NCT02083861|9960878|FG001|NOT COMPLETED|Overall Study||3
8902971|NCT02083926|9960888|FG000|STARTED|Overall Study||9
8902972|NCT02083926|9960889|FG001|STARTED|Overall Study||9
8902973|NCT02083926|9960888|FG000|COMPLETED|Overall Study||8
8902974|NCT02083926|9960889|FG001|COMPLETED|Overall Study||9
8902975|NCT02083926|9960888|FG000|NOT COMPLETED|Overall Study||1
8902976|NCT02083926|9960889|FG001|NOT COMPLETED|Overall Study||0
8902977|NCT02083965|9960898|FG000|STARTED|PK Period 1||10
8902978|NCT02083965|9960899|FG001|STARTED|PK Period 1||9
8902979|NCT02083965|9960898|FG000|COMPLETED|PK Period 1||10
8902980|NCT02083965|9960899|FG001|COMPLETED|PK Period 1||9
8902981|NCT02083965|9960898|FG000|NOT COMPLETED|PK Period 1||0
8902982|NCT02083965|9960899|FG001|NOT COMPLETED|PK Period 1||0
8902983|NCT02083965|9960898|FG000|STARTED|Washout Period||10
8902984|NCT02083965|9960899|FG001|STARTED|Washout Period||9
8902985|NCT02083965|9960898|FG000|COMPLETED|Washout Period||10
8902986|NCT02083965|9960899|FG001|COMPLETED|Washout Period||9
8902987|NCT02083965|9960898|FG000|NOT COMPLETED|Washout Period||0
8902988|NCT02083965|9960899|FG001|NOT COMPLETED|Washout Period||0
8902989|NCT02083965|9960898|FG000|STARTED|PK Period 2||10
8902990|NCT02083965|9960899|FG001|STARTED|PK Period 2||9
8902991|NCT02083965|9960898|FG000|COMPLETED|PK Period 2||10
8902992|NCT02083965|9960899|FG001|COMPLETED|PK Period 2||9
8902993|NCT02083965|9960898|FG000|NOT COMPLETED|PK Period 2||0
8902994|NCT02083965|9960899|FG001|NOT COMPLETED|PK Period 2||0
8902995|NCT02083965|9960898|FG000|STARTED|Treatment Period||10
8902996|NCT02083965|9960899|FG001|STARTED|Treatment Period|1 participant completed PK period 1 and 2, then chose to withdraw and did not enter treatment period|8
8902997|NCT02083965|9960898|FG000|COMPLETED|Treatment Period||9
8902998|NCT02083965|9960899|FG001|COMPLETED|Treatment Period||8
8902999|NCT02083965|9960898|FG000|NOT COMPLETED|Treatment Period||1
8903000|NCT02083965|9960899|FG001|NOT COMPLETED|Treatment Period||0
8903001|NCT02084056|9960909|FG000|STARTED|Treatment Period 1 (4 Days)||28
8903002|NCT02084056|9960910|FG001|STARTED|Treatment Period 1 (4 Days)||30
8903003|NCT02084056|9960911|FG002|STARTED|Treatment Period 1 (4 Days)||8
8903004|NCT02084056|9960912|FG003|STARTED|Treatment Period 1 (4 Days)||8
8903005|NCT02084056|9960909|FG000|COMPLETED|Treatment Period 1 (4 Days)||27
8903006|NCT02084056|9960910|FG001|COMPLETED|Treatment Period 1 (4 Days)||30
8903007|NCT02084056|9960911|FG002|COMPLETED|Treatment Period 1 (4 Days)||8
8903008|NCT02084056|9960912|FG003|COMPLETED|Treatment Period 1 (4 Days)||8
8903009|NCT02084056|9960909|FG000|NOT COMPLETED|Treatment Period 1 (4 Days)||1
8903010|NCT02084056|9960910|FG001|NOT COMPLETED|Treatment Period 1 (4 Days)||0
8903011|NCT02084056|9960911|FG002|NOT COMPLETED|Treatment Period 1 (4 Days)||0
8903012|NCT02084056|9960912|FG003|NOT COMPLETED|Treatment Period 1 (4 Days)||0
8903013|NCT02084056|9960909|FG000|STARTED|Washout Period 1 (35 Days)||27
8903014|NCT02084056|9960910|FG001|STARTED|Washout Period 1 (35 Days)||30
8903015|NCT02084056|9960911|FG002|STARTED|Washout Period 1 (35 Days)||8
8903016|NCT02084056|9960912|FG003|STARTED|Washout Period 1 (35 Days)||8
8903017|NCT02084056|9960909|FG000|COMPLETED|Washout Period 1 (35 Days)||26
8903018|NCT02084056|9960910|FG001|COMPLETED|Washout Period 1 (35 Days)||30
8903019|NCT02084056|9960911|FG002|COMPLETED|Washout Period 1 (35 Days)||8
8903020|NCT02084056|9960912|FG003|COMPLETED|Washout Period 1 (35 Days)||8
8903021|NCT02084056|9960909|FG000|NOT COMPLETED|Washout Period 1 (35 Days)||1
8903022|NCT02084056|9960910|FG001|NOT COMPLETED|Washout Period 1 (35 Days)||0
8903023|NCT02084056|9960911|FG002|NOT COMPLETED|Washout Period 1 (35 Days)||0
8636438|NCT00568022|9677058|FG000|COMPLETED|Overall Study||3
8636439|NCT00568022|9677059|FG001|COMPLETED|Overall Study||3
8636440|NCT00568022|9677060|FG002|COMPLETED|Overall Study||3
8636441|NCT00568022|9677058|FG000|NOT COMPLETED|Overall Study||0
8903024|NCT02084056|9960912|FG003|NOT COMPLETED|Washout Period 1 (35 Days)||0
8903025|NCT02084056|9960909|FG000|STARTED|Treatment Period 2 (4 Days)||26
8903026|NCT02084056|9960910|FG001|STARTED|Treatment Period 2 (4 Days)||30
8903027|NCT02084056|9960911|FG002|STARTED|Treatment Period 2 (4 Days)||8
8903028|NCT02084056|9960912|FG003|STARTED|Treatment Period 2 (4 Days)||8
8903029|NCT02084056|9960909|FG000|COMPLETED|Treatment Period 2 (4 Days)||26
8903030|NCT02084056|9960910|FG001|COMPLETED|Treatment Period 2 (4 Days)||30
8903031|NCT02084056|9960911|FG002|COMPLETED|Treatment Period 2 (4 Days)||8
8903032|NCT02084056|9960912|FG003|COMPLETED|Treatment Period 2 (4 Days)||8
8903033|NCT02084056|9960909|FG000|NOT COMPLETED|Treatment Period 2 (4 Days)||0
8903034|NCT02084056|9960910|FG001|NOT COMPLETED|Treatment Period 2 (4 Days)||0
8903035|NCT02084056|9960911|FG002|NOT COMPLETED|Treatment Period 2 (4 Days)||0
8903036|NCT02084056|9960912|FG003|NOT COMPLETED|Treatment Period 2 (4 Days)||0
8903037|NCT02084069|9960924|FG000|STARTED|Overall Study||29
8903038|NCT02084069|9960925|FG001|STARTED|Overall Study||29
8903039|NCT02084069|9960924|FG000|COMPLETED|Overall Study||29
8903040|NCT02084069|9960925|FG001|COMPLETED|Overall Study||29
8903041|NCT02084069|9960924|FG000|NOT COMPLETED|Overall Study||0
8903042|NCT02084069|9960925|FG001|NOT COMPLETED|Overall Study||0
8903043|NCT02084082|9960933|FG000|STARTED|Treatment Period 1 (4 Days)||26
8903044|NCT02084082|9960934|FG001|STARTED|Treatment Period 1 (4 Days)||26
8903045|NCT02084082|9960935|FG002|STARTED|Treatment Period 1 (4 Days)||8
8903046|NCT02084082|9960936|FG003|STARTED|Treatment Period 1 (4 Days)||8
8903047|NCT02084082|9960933|FG000|COMPLETED|Treatment Period 1 (4 Days)||26
8903048|NCT02084082|9960934|FG001|COMPLETED|Treatment Period 1 (4 Days)||26
8903049|NCT02084082|9960935|FG002|COMPLETED|Treatment Period 1 (4 Days)||8
8903050|NCT02084082|9960936|FG003|COMPLETED|Treatment Period 1 (4 Days)||8
8903051|NCT02084082|9960933|FG000|NOT COMPLETED|Treatment Period 1 (4 Days)||0
8903052|NCT02084082|9960934|FG001|NOT COMPLETED|Treatment Period 1 (4 Days)||0
8903053|NCT02084082|9960935|FG002|NOT COMPLETED|Treatment Period 1 (4 Days)||0
8903054|NCT02084082|9960936|FG003|NOT COMPLETED|Treatment Period 1 (4 Days)||0
8903055|NCT02084082|9960933|FG000|STARTED|Washout Period 1 (35 Days)||26
8903056|NCT02084082|9960934|FG001|STARTED|Washout Period 1 (35 Days)||26
8903057|NCT02084082|9960935|FG002|STARTED|Washout Period 1 (35 Days)||8
8903058|NCT02084082|9960936|FG003|STARTED|Washout Period 1 (35 Days)||8
8903059|NCT02084082|9960933|FG000|COMPLETED|Washout Period 1 (35 Days)||26
8903060|NCT02084082|9960934|FG001|COMPLETED|Washout Period 1 (35 Days)||26
8903061|NCT02084082|9960935|FG002|COMPLETED|Washout Period 1 (35 Days)||7
8903062|NCT02084082|9960936|FG003|COMPLETED|Washout Period 1 (35 Days)||6
8903063|NCT02084082|9960933|FG000|NOT COMPLETED|Washout Period 1 (35 Days)||0
8903064|NCT02084082|9960934|FG001|NOT COMPLETED|Washout Period 1 (35 Days)||0
8903065|NCT02084082|9960935|FG002|NOT COMPLETED|Washout Period 1 (35 Days)||1
8903066|NCT02084082|9960936|FG003|NOT COMPLETED|Washout Period 1 (35 Days)||2
8903067|NCT02084082|9960933|FG000|STARTED|Treatment Period 2 (4 Days)||26
8903068|NCT02084082|9960934|FG001|STARTED|Treatment Period 2 (4 Days)||26
8903069|NCT02084082|9960935|FG002|STARTED|Treatment Period 2 (4 Days)||7
8903070|NCT02084082|9960936|FG003|STARTED|Treatment Period 2 (4 Days)||6
8903071|NCT02084082|9960933|FG000|COMPLETED|Treatment Period 2 (4 Days)||26
8903072|NCT02084082|9960934|FG001|COMPLETED|Treatment Period 2 (4 Days)||26
8903073|NCT02084082|9960935|FG002|COMPLETED|Treatment Period 2 (4 Days)||7
8903074|NCT02084082|9960936|FG003|COMPLETED|Treatment Period 2 (4 Days)||6
8903075|NCT02084082|9960933|FG000|NOT COMPLETED|Treatment Period 2 (4 Days)||0
8903076|NCT02084082|9960934|FG001|NOT COMPLETED|Treatment Period 2 (4 Days)||0
8903077|NCT02084082|9960935|FG002|NOT COMPLETED|Treatment Period 2 (4 Days)||0
8903078|NCT02084082|9960936|FG003|NOT COMPLETED|Treatment Period 2 (4 Days)||0
8903079|NCT02084134|9960948|FG000|STARTED|Overall Study||23
8903080|NCT02084134|9960949|FG001|STARTED|Overall Study||20
8903081|NCT02084134|9960948|FG000|COMPLETED|Overall Study||19
8903082|NCT02084134|9960949|FG001|COMPLETED|Overall Study||17
8903083|NCT02084134|9960948|FG000|NOT COMPLETED|Overall Study||4
8903084|NCT02084134|9960949|FG001|NOT COMPLETED|Overall Study||3
8903085|NCT02084160|9960955|FG000|STARTED|Overall Study||579
8903086|NCT02084160|9960955|FG000|COMPLETED|Overall Study||579
8903087|NCT02084160|9960955|FG000|NOT COMPLETED|Overall Study||0
8903088|NCT02084238|9960959|FG000|STARTED|Overall Study||40
8903089|NCT02084238|9960959|FG000|COMPLETED|Overall Study||38
8903090|NCT02084238|9960959|FG000|NOT COMPLETED|Overall Study||2
8903091|NCT02084511|9960974|FG000|STARTED|Overall Study||20
8903092|NCT02084511|9960975|FG001|STARTED|Overall Study||20
8903093|NCT02084511|9960976|FG002|STARTED|Overall Study||20
8903094|NCT02084511|9960977|FG003|STARTED|Overall Study||20
8903095|NCT02084511|9960974|FG000|COMPLETED|Overall Study||20
8903096|NCT02084511|9960975|FG001|COMPLETED|Overall Study||20
8903097|NCT02084511|9960976|FG002|COMPLETED|Overall Study||20
8903098|NCT02084511|9960977|FG003|COMPLETED|Overall Study||20
8903099|NCT02084511|9960974|FG000|NOT COMPLETED|Overall Study||0
8903100|NCT02084511|9960975|FG001|NOT COMPLETED|Overall Study||0
8903101|NCT02084511|9960976|FG002|NOT COMPLETED|Overall Study||0
8903102|NCT02084511|9960977|FG003|NOT COMPLETED|Overall Study||0
8903103|NCT02084628|9960987|FG000|STARTED|Overall Study||1
8903104|NCT02084628|9960987|FG000|COMPLETED|Overall Study||1
8903105|NCT02084628|9960987|FG000|NOT COMPLETED|Overall Study||0
8903106|NCT02084706|9960993|FG000|STARTED|Overall Study||29
8903107|NCT02084706|9960994|FG001|STARTED|Overall Study||31
8903108|NCT02084706|9960993|FG000|COMPLETED|Overall Study||29
8903109|NCT02084706|9960994|FG001|COMPLETED|Overall Study||31
8903110|NCT02084706|9960993|FG000|NOT COMPLETED|Overall Study||0
8903111|NCT02084706|9960994|FG001|NOT COMPLETED|Overall Study||0
8903112|NCT02084797|9961000|FG000|STARTED|Overall Study||10
8903113|NCT02084797|9961000|FG000|COMPLETED|Overall Study||10
8903114|NCT02084797|9961000|FG000|NOT COMPLETED|Overall Study||0
8903115|NCT02085070|9961006|FG000|STARTED|Overall Study||23
8903116|NCT02085070|9961007|FG001|STARTED|Overall Study||42
8903117|NCT02085070|9961006|FG000|COMPLETED|Overall Study||23
8903118|NCT02085070|9961007|FG001|COMPLETED|Overall Study||42
8903119|NCT02085070|9961006|FG000|NOT COMPLETED|Overall Study||0
8903120|NCT02085070|9961007|FG001|NOT COMPLETED|Overall Study||0
8903121|NCT02085135|9961015|FG000|STARTED|Overall Study||34
9010933|NCT02991859|10073864|FG003|STARTED|Period1, Escalation Phase5, Upto Day35||2
9010934|NCT02991859|10073865|FG004|STARTED|Period1, Escalation Phase5, Upto Day35||2
9010935|NCT02991859|10073866|FG005|STARTED|Period1, Escalation Phase5, Upto Day35||2
9010936|NCT02991859|10073867|FG006|STARTED|Period1, Escalation Phase5, Upto Day35||2
9010937|NCT02991859|10073868|FG007|STARTED|Period1, Escalation Phase5, Upto Day35||2
9010938|NCT02991859|10073869|FG008|STARTED|Period1, Escalation Phase5, Upto Day35||2
9010939|NCT02991859|10073870|FG009|STARTED|Period1, Escalation Phase5, Upto Day35||2
9010940|NCT02991859|10073871|FG010|STARTED|Period1, Escalation Phase5, Upto Day35|1 participant did not enter Esc Phase 5, and was not withdrawn|1
9010941|NCT02991859|10073872|FG011|STARTED|Period1, Escalation Phase5, Upto Day35||2
9010942|NCT02991859|10073873|FG012|STARTED|Period1, Escalation Phase5, Upto Day35||6
9010943|NCT02991859|10073874|FG013|STARTED|Period1, Escalation Phase5, Upto Day35||6
9010944|NCT02991859|10073875|FG014|STARTED|Period1, Escalation Phase5, Upto Day35||6
9010945|NCT02991859|10073876|FG015|STARTED|Period1, Escalation Phase5, Upto Day35||3
9010946|NCT02991859|10073877|FG016|STARTED|Period1, Escalation Phase5, Upto Day35||3
9010947|NCT02991859|10073861|FG000|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
9010948|NCT02991859|10073862|FG001|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
9010949|NCT02991859|10073863|FG002|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
9010950|NCT02991859|10073864|FG003|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
9010951|NCT02991859|10073865|FG004|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
9010952|NCT02991859|10073866|FG005|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
9010953|NCT02991859|10073867|FG006|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
9010954|NCT02991859|10073868|FG007|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
9010955|NCT02991859|10073869|FG008|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
9010956|NCT02991859|10073870|FG009|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
9010957|NCT02991859|10073871|FG010|COMPLETED|Period1, Escalation Phase5, Upto Day35||1
9010958|NCT02991859|10073872|FG011|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
9010959|NCT02991859|10073873|FG012|COMPLETED|Period1, Escalation Phase5, Upto Day35||6
9010960|NCT02991859|10073874|FG013|COMPLETED|Period1, Escalation Phase5, Upto Day35||6
9010961|NCT02991859|10073875|FG014|COMPLETED|Period1, Escalation Phase5, Upto Day35||6
9010962|NCT02991859|10073876|FG015|COMPLETED|Period1, Escalation Phase5, Upto Day35||3
9010963|NCT02991859|10073877|FG016|COMPLETED|Period1, Escalation Phase5, Upto Day35||3
9010964|NCT02991859|10073861|FG000|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
9010965|NCT02991859|10073862|FG001|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
9010966|NCT02991859|10073863|FG002|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
9010967|NCT02991859|10073864|FG003|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
9010968|NCT02991859|10073865|FG004|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
9010969|NCT02991859|10073866|FG005|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
9010970|NCT02991859|10073867|FG006|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
9010971|NCT02991859|10073868|FG007|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
9010972|NCT02991859|10073869|FG008|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
9010973|NCT02991859|10073870|FG009|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
9010974|NCT02991859|10073871|FG010|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
9010975|NCT02991859|10073872|FG011|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
9010976|NCT02991859|10073873|FG012|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
9010977|NCT02991859|10073874|FG013|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
9010978|NCT02991859|10073875|FG014|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
9010979|NCT02991859|10073876|FG015|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
9010980|NCT02991859|10073877|FG016|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
9010981|NCT02991859|10073861|FG000|STARTED|Wash Out, Up to Day 77||2
9010982|NCT02991859|10073862|FG001|STARTED|Wash Out, Up to Day 77||2
9010983|NCT02991859|10073863|FG002|STARTED|Wash Out, Up to Day 77||2
9010984|NCT02991859|10073864|FG003|STARTED|Wash Out, Up to Day 77||2
9010985|NCT02991859|10073865|FG004|STARTED|Wash Out, Up to Day 77||2
9010986|NCT02991859|10073866|FG005|STARTED|Wash Out, Up to Day 77||2
9010987|NCT02991859|10073867|FG006|STARTED|Wash Out, Up to Day 77||2
9010988|NCT02991859|10073868|FG007|STARTED|Wash Out, Up to Day 77||2
9010989|NCT02991859|10073869|FG008|STARTED|Wash Out, Up to Day 77||2
9010990|NCT02991859|10073870|FG009|STARTED|Wash Out, Up to Day 77||2
9010991|NCT02991859|10073871|FG010|STARTED|Wash Out, Up to Day 77||1
9010992|NCT02991859|10073872|FG011|STARTED|Wash Out, Up to Day 77||2
9010993|NCT02991859|10073873|FG012|STARTED|Wash Out, Up to Day 77|Participants did not enter washout and Period 2|0
9010994|NCT02991859|10073874|FG013|STARTED|Wash Out, Up to Day 77|Participants did not enter washout and Period 2|0
9010995|NCT02991859|10073875|FG014|STARTED|Wash Out, Up to Day 77|Participants did not enter washout and Period 2|0
9039612|NCT03340883|10100608|FG001|NOT COMPLETED|Overall Study||0
8903122|NCT02085135|9961016|FG001|STARTED|Overall Study||32
8903123|NCT02085135|9961015|FG000|COMPLETED|Overall Study||23
8903124|NCT02085135|9961016|FG001|COMPLETED|Overall Study||23
8903125|NCT02085135|9961015|FG000|NOT COMPLETED|Overall Study||11
8903126|NCT02085135|9961016|FG001|NOT COMPLETED|Overall Study||9
8903127|NCT02085161|9961026|FG000|STARTED|Overall Study||76
8903128|NCT02085161|9961027|FG001|STARTED|Overall Study||76
8903129|NCT02085161|9961028|FG002|STARTED|Overall Study||76
8903130|NCT02085161|9961029|FG003|STARTED|Overall Study||76
8903131|NCT02085161|9961026|FG000|COMPLETED|Overall Study||64
8903132|NCT02085161|9961027|FG001|COMPLETED|Overall Study||66
8903133|NCT02085161|9961028|FG002|COMPLETED|Overall Study||71
8903134|NCT02085161|9961029|FG003|COMPLETED|Overall Study||66
8903135|NCT02085161|9961026|FG000|NOT COMPLETED|Overall Study||12
8903136|NCT02085161|9961027|FG001|NOT COMPLETED|Overall Study||10
8903137|NCT02085161|9961028|FG002|NOT COMPLETED|Overall Study||5
8903138|NCT02085161|9961029|FG003|NOT COMPLETED|Overall Study||10
8903139|NCT02085252|9961042|FG000|STARTED|Overall Study||58
8903140|NCT02085252|9961043|FG001|STARTED|Overall Study||57
8903141|NCT02085252|9961042|FG000|COMPLETED|Overall Study||57
8903142|NCT02085252|9961043|FG001|COMPLETED|Overall Study||53
8903143|NCT02085252|9961042|FG000|NOT COMPLETED|Overall Study||1
8903144|NCT02085252|9961043|FG001|NOT COMPLETED|Overall Study||4
8903145|NCT02085356|9961053|FG000|STARTED|Overall Study||577
8903146|NCT02085356|9961054|FG001|STARTED|Overall Study||348
8903147|NCT02085356|9961055|FG002|STARTED|Overall Study||681
8903148|NCT02085356|9961056|FG003|STARTED|Overall Study||361
8903149|NCT02085356|9961053|FG000|COMPLETED|Overall Study||577
8903150|NCT02085356|9961054|FG001|COMPLETED|Overall Study||348
8903151|NCT02085356|9961055|FG002|COMPLETED|Overall Study||681
8903152|NCT02085356|9961056|FG003|COMPLETED|Overall Study||361
8903153|NCT02085356|9961053|FG000|NOT COMPLETED|Overall Study||0
8903154|NCT02085356|9961054|FG001|NOT COMPLETED|Overall Study||0
8903155|NCT02085356|9961055|FG002|NOT COMPLETED|Overall Study||0
8903156|NCT02085356|9961056|FG003|NOT COMPLETED|Overall Study||0
8903157|NCT02085447|9961066|FG000|STARTED|Overall Study||30
8903158|NCT02085447|9961066|FG000|COMPLETED|Overall Study||26
8903159|NCT02085447|9961066|FG000|NOT COMPLETED|Overall Study||4
8903160|NCT02085460|9961074|FG000|STARTED|Overall Study||31
8903161|NCT02085460|9961075|FG001|STARTED|Overall Study||32
8903162|NCT02085460|9961076|FG002|STARTED|Overall Study||31
8903163|NCT02085460|9961074|FG000|COMPLETED|Overall Study||17
8903164|NCT02085460|9961075|FG001|COMPLETED|Overall Study||24
8903165|NCT02085460|9961076|FG002|COMPLETED|Overall Study||21
8903166|NCT02085460|9961074|FG000|NOT COMPLETED|Overall Study||14
8903167|NCT02085460|9961075|FG001|NOT COMPLETED|Overall Study||8
8903168|NCT02085460|9961076|FG002|NOT COMPLETED|Overall Study||10
8903169|NCT02085473|9961088|FG000|STARTED|Overall Study||15
8903170|NCT02085473|9961089|FG001|STARTED|Overall Study||15
8903171|NCT02085473|9961090|FG002|STARTED|Overall Study||15
8903172|NCT02085473|9961091|FG003|STARTED|Overall Study||15
8903173|NCT02085473|9961088|FG000|COMPLETED|Overall Study||15
8903174|NCT02085473|9961089|FG001|COMPLETED|Overall Study||15
8903175|NCT02085473|9961090|FG002|COMPLETED|Overall Study||15
8903176|NCT02085473|9961091|FG003|COMPLETED|Overall Study||15
8903177|NCT02085473|9961088|FG000|NOT COMPLETED|Overall Study||0
8903178|NCT02085473|9961089|FG001|NOT COMPLETED|Overall Study||0
8903179|NCT02085473|9961090|FG002|NOT COMPLETED|Overall Study||0
8903180|NCT02085473|9961091|FG003|NOT COMPLETED|Overall Study||0
8903181|NCT02085551|9961101|FG000|STARTED|Overall Study||85
8903182|NCT02085551|9961101|FG000|COMPLETED|Overall Study||85
8903183|NCT02085551|9961101|FG000|NOT COMPLETED|Overall Study||0
8903184|NCT02085720|9961105|FG000|STARTED|Overall Study||819
8903185|NCT02085720|9961105|FG000|COMPLETED|Overall Study||819
8903186|NCT02085720|9961105|FG000|NOT COMPLETED|Overall Study||0
8903187|NCT02085785|9961115|FG000|STARTED|Overall Study||7
8903188|NCT02085785|9961116|FG001|STARTED|Overall Study||8
8903189|NCT02085785|9961115|FG000|COMPLETED|Overall Study||5
8903190|NCT02085785|9961116|FG001|COMPLETED|Overall Study||6
8903191|NCT02085785|9961115|FG000|NOT COMPLETED|Overall Study||2
8903192|NCT02085785|9961116|FG001|NOT COMPLETED|Overall Study||2
8903193|NCT02085980|9961124|FG000|STARTED|Overall Study||30
9010996|NCT02991859|10073876|FG015|STARTED|Wash Out, Up to Day 77|Participants did not enter washout and Period 2|0
9010997|NCT02991859|10073877|FG016|STARTED|Wash Out, Up to Day 77|Participants did not enter washout and Period 2|0
9010998|NCT02991859|10073861|FG000|COMPLETED|Wash Out, Up to Day 77||2
9010999|NCT02991859|10073862|FG001|COMPLETED|Wash Out, Up to Day 77||2
8903194|NCT02085980|9961124|FG000|COMPLETED|Overall Study||27
8903195|NCT02085980|9961124|FG000|NOT COMPLETED|Overall Study||3
8903196|NCT02086110|9961130|FG000|STARTED|Overall Study||5
8903197|NCT02086110|9961131|FG001|STARTED|Overall Study||6
8903198|NCT02086110|9961130|FG000|COMPLETED|Overall Study||4
8903199|NCT02086110|9961131|FG001|COMPLETED|Overall Study||5
8903200|NCT02086110|9961130|FG000|NOT COMPLETED|Overall Study||1
8903201|NCT02086110|9961131|FG001|NOT COMPLETED|Overall Study||1
8903202|NCT02086162|9961140|FG000|STARTED|Overall Study||78
8903203|NCT02086162|9961141|FG001|STARTED|Overall Study||84
8903204|NCT02086162|9961140|FG000|COMPLETED|Overall Study||68
8903205|NCT02086162|9961141|FG001|COMPLETED|Overall Study||77
8903206|NCT02086162|9961140|FG000|NOT COMPLETED|Overall Study||10
8903207|NCT02086162|9961141|FG001|NOT COMPLETED|Overall Study||7
8903208|NCT02086331|9961151|FG000|STARTED|Overall Study||5
8903209|NCT02086331|9961151|FG000|COMPLETED|Overall Study||5
8903210|NCT02086331|9961151|FG000|NOT COMPLETED|Overall Study||0
8903211|NCT02086500|9961166|FG000|STARTED|Overall Study||447
8903212|NCT02086500|9961167|FG001|STARTED|Overall Study||456
8903213|NCT02086500|9961166|FG000|COMPLETED|Overall Study||447
8903214|NCT02086500|9961167|FG001|COMPLETED|Overall Study||456
8903215|NCT02086500|9961166|FG000|NOT COMPLETED|Overall Study||0
8903216|NCT02086500|9961167|FG001|NOT COMPLETED|Overall Study||0
8903217|NCT02086565|9961175|FG000|STARTED|Overall Study||151
8903218|NCT02086565|9961176|FG001|STARTED|Overall Study||150
8903219|NCT02086565|9961175|FG000|COMPLETED|Overall Study||135
8903220|NCT02086565|9961176|FG001|COMPLETED|Overall Study||138
8636442|NCT00568022|9677059|FG001|NOT COMPLETED|Overall Study||0
8636443|NCT00568022|9677060|FG002|NOT COMPLETED|Overall Study||0
8636444|NCT00568061|9677071|FG000|STARTED|Overall Study||13
8636445|NCT00568061|9677072|FG001|STARTED|Overall Study||16
8636446|NCT00568061|9677071|FG000|COMPLETED|Overall Study||8
8903221|NCT02086565|9961175|FG000|NOT COMPLETED|Overall Study||16
8903222|NCT02086565|9961176|FG001|NOT COMPLETED|Overall Study||12
8903223|NCT02086591|9961182|FG000|STARTED|Overall Study||7
8903224|NCT02086591|9961182|FG000|COMPLETED|Overall Study||2
8903225|NCT02086591|9961182|FG000|NOT COMPLETED|Overall Study||5
8903226|NCT02086682|9961188|FG000|STARTED|Overall Study||156
8903227|NCT02086682|9961189|FG001|STARTED|Overall Study||182
8903228|NCT02086682|9961188|FG000|COMPLETED|Overall Study||156
8903229|NCT02086682|9961189|FG001|COMPLETED|Overall Study||182
8903230|NCT02086682|9961188|FG000|NOT COMPLETED|Overall Study||0
8903231|NCT02086682|9961189|FG001|NOT COMPLETED|Overall Study||0
8903232|NCT02086708|9961195|FG000|STARTED|Overall Study||24
8903233|NCT02086708|9961195|FG000|COMPLETED|Overall Study||24
8903234|NCT02086708|9961195|FG000|NOT COMPLETED|Overall Study||0
8903235|NCT02086786|9961209|FG000|STARTED|Overall Study||35
8903236|NCT02086786|9961210|FG001|STARTED|Overall Study||35
8903237|NCT02086786|9961209|FG000|COMPLETED|Overall Study||17
8903238|NCT02086786|9961210|FG001|COMPLETED|Overall Study||19
8903239|NCT02086786|9961209|FG000|NOT COMPLETED|Overall Study||18
8903240|NCT02086786|9961210|FG001|NOT COMPLETED|Overall Study||16
8903241|NCT02086968|9961220|FG000|STARTED|Overall Study||100
8903242|NCT02086968|9961221|FG001|STARTED|Overall Study||98
8903243|NCT02086968|9961220|FG000|COMPLETED|Overall Study||92
8903244|NCT02086968|9961221|FG001|COMPLETED|Overall Study||85
8903245|NCT02086968|9961220|FG000|NOT COMPLETED|Overall Study||8
8903246|NCT02086968|9961221|FG001|NOT COMPLETED|Overall Study||13
8903247|NCT02087046|9961227|FG000|STARTED|Overall Study||127
8903248|NCT02087046|9961227|FG000|Primary Endpoint|Overall Study||121
8903249|NCT02087046|9961227|FG000|COMPLETED|Overall Study||116
8903250|NCT02087046|9961227|FG000|NOT COMPLETED|Overall Study||11
8903251|NCT02087059|9961232|FG000|STARTED|Overall Study||51
8903252|NCT02087059|9961232|FG000|COMPLETED|Overall Study||44
8903253|NCT02087059|9961232|FG000|NOT COMPLETED|Overall Study||7
8903254|NCT02087085|9961238|FG000|STARTED|Overall Study||154
8903255|NCT02087085|9961239|FG001|STARTED|Overall Study||156
8903256|NCT02087085|9961238|FG000|COMPLETED|Overall Study||34
8903257|NCT02087085|9961239|FG001|COMPLETED|Overall Study||40
8903258|NCT02087085|9961238|FG000|NOT COMPLETED|Overall Study||120
8903259|NCT02087085|9961239|FG001|NOT COMPLETED|Overall Study||116
8903260|NCT02087150|9961248|FG000|STARTED|Overall Study||81
8903261|NCT02087150|9961249|FG001|STARTED|Overall Study||162
8903262|NCT02087150|9961250|FG002|STARTED|Overall Study||80
8903263|NCT02087150|9961248|FG000|Had a Lead-in or Randomized ETBC Proc|Overall Study||80
8903264|NCT02087150|9961249|FG001|Had a Lead-in or Randomized ETBC Proc|Overall Study||149
8903265|NCT02087150|9961250|FG002|Had a Lead-in or Randomized ETBC Proc|Overall Study||0
8903266|NCT02087150|9961248|FG000|Received a Crossover MM ETBC Procedure|Overall Study||0
8903267|NCT02087150|9961249|FG001|Received a Crossover MM ETBC Procedure|Overall Study||0
8903268|NCT02087150|9961250|FG002|Received a Crossover MM ETBC Procedure|Overall Study||70
8903269|NCT02087150|9961248|FG000|COMPLETED|Overall Study||71
8903270|NCT02087150|9961249|FG001|COMPLETED|Overall Study||128
8903271|NCT02087150|9961250|FG002|COMPLETED|Overall Study||69
8903272|NCT02087150|9961248|FG000|NOT COMPLETED|Overall Study||10
8903273|NCT02087150|9961249|FG001|NOT COMPLETED|Overall Study||34
8903274|NCT02087150|9961250|FG002|NOT COMPLETED|Overall Study||11
8903275|NCT02087163|9961259|FG000|STARTED|Overall Study||90
8903276|NCT02087163|9961259|FG000|COMPLETED|Overall Study||73
8903277|NCT02087163|9961259|FG000|NOT COMPLETED|Overall Study||17
8903278|NCT02087176|9961263|FG000|STARTED|Overall Study||32
8903279|NCT02087176|9961263|FG000|COMPLETED|Overall Study|The sponsor terminated the study early.|0
8903280|NCT02087176|9961263|FG000|NOT COMPLETED|Overall Study||32
8903281|NCT02087241|9961271|FG000|STARTED|Overall Study||3
8903282|NCT02087241|9961272|FG001|STARTED|Overall Study||3
8903283|NCT02087241|9961273|FG002|STARTED|Overall Study||1
8903284|NCT02087241|9961274|FG003|STARTED|Overall Study||7
8903285|NCT02087241|9961271|FG000|COMPLETED|Overall Study||0
8903286|NCT02087241|9961272|FG001|COMPLETED|Overall Study||0
8903287|NCT02087241|9961273|FG002|COMPLETED|Overall Study||0
8903288|NCT02087241|9961274|FG003|COMPLETED|Overall Study||0
8903289|NCT02087241|9961271|FG000|NOT COMPLETED|Overall Study||3
8903290|NCT02087241|9961272|FG001|NOT COMPLETED|Overall Study||3
8903291|NCT02087241|9961273|FG002|NOT COMPLETED|Overall Study||1
8903292|NCT02087241|9961274|FG003|NOT COMPLETED|Overall Study||7
8903293|NCT02087306|9961291|FG000|STARTED|Overall Study||65
8903294|NCT02087306|9961292|FG001|STARTED|Overall Study||93
8903295|NCT02087306|9961293|FG002|STARTED|Overall Study||43
8903296|NCT02087306|9961291|FG000|COMPLETED|Overall Study||29
8636447|NCT00568061|9677072|FG001|COMPLETED|Overall Study||14
8903297|NCT02087306|9961292|FG001|COMPLETED|Overall Study||29
8903298|NCT02087306|9961293|FG002|COMPLETED|Overall Study||16
8903299|NCT02087306|9961291|FG000|NOT COMPLETED|Overall Study||36
8903300|NCT02087306|9961292|FG001|NOT COMPLETED|Overall Study||64
8903301|NCT02087306|9961293|FG002|NOT COMPLETED|Overall Study||27
8903302|NCT02087514|9961306|FG000|STARTED|Overall Study||10
8903303|NCT02087514|9961307|FG001|STARTED|Overall Study||10
8903304|NCT02087514|9961308|FG002|STARTED|Overall Study||10
8903305|NCT02087514|9961309|FG003|STARTED|Overall Study||10
8903306|NCT02087514|9961310|FG004|STARTED|Overall Study||10
8903307|NCT02087514|9961311|FG005|STARTED|Overall Study||10
8903308|NCT02087514|9961306|FG000|COMPLETED|Overall Study||8
9011000|NCT02991859|10073863|FG002|COMPLETED|Wash Out, Up to Day 77||2
9011001|NCT02991859|10073864|FG003|COMPLETED|Wash Out, Up to Day 77||2
9011002|NCT02991859|10073865|FG004|COMPLETED|Wash Out, Up to Day 77||2
9011003|NCT02991859|10073866|FG005|COMPLETED|Wash Out, Up to Day 77||1
9011004|NCT02991859|10073867|FG006|COMPLETED|Wash Out, Up to Day 77||2
9011005|NCT02991859|10073868|FG007|COMPLETED|Wash Out, Up to Day 77||2
9011006|NCT02991859|10073869|FG008|COMPLETED|Wash Out, Up to Day 77||2
9011007|NCT02991859|10073870|FG009|COMPLETED|Wash Out, Up to Day 77||1
9011008|NCT02991859|10073871|FG010|COMPLETED|Wash Out, Up to Day 77||1
9011009|NCT02991859|10073872|FG011|COMPLETED|Wash Out, Up to Day 77||2
9011010|NCT02991859|10073873|FG012|COMPLETED|Wash Out, Up to Day 77||0
9011011|NCT02991859|10073874|FG013|COMPLETED|Wash Out, Up to Day 77||0
9011012|NCT02991859|10073875|FG014|COMPLETED|Wash Out, Up to Day 77||0
9011013|NCT02991859|10073876|FG015|COMPLETED|Wash Out, Up to Day 77||0
9011014|NCT02991859|10073877|FG016|COMPLETED|Wash Out, Up to Day 77||0
9011015|NCT02991859|10073861|FG000|NOT COMPLETED|Wash Out, Up to Day 77||0
9011016|NCT02991859|10073862|FG001|NOT COMPLETED|Wash Out, Up to Day 77||0
9011017|NCT02991859|10073863|FG002|NOT COMPLETED|Wash Out, Up to Day 77||0
9011018|NCT02991859|10073864|FG003|NOT COMPLETED|Wash Out, Up to Day 77||0
9011019|NCT02991859|10073865|FG004|NOT COMPLETED|Wash Out, Up to Day 77||0
9011020|NCT02991859|10073866|FG005|NOT COMPLETED|Wash Out, Up to Day 77||1
9011021|NCT02991859|10073867|FG006|NOT COMPLETED|Wash Out, Up to Day 77||0
9011022|NCT02991859|10073868|FG007|NOT COMPLETED|Wash Out, Up to Day 77||0
9011023|NCT02991859|10073869|FG008|NOT COMPLETED|Wash Out, Up to Day 77||0
8636448|NCT00568061|9677071|FG000|NOT COMPLETED|Overall Study||5
8636449|NCT00568061|9677072|FG001|NOT COMPLETED|Overall Study||2
8636450|NCT00568087|9677081|FG000|STARTED|Overall Study||22
9011024|NCT02991859|10073870|FG009|NOT COMPLETED|Wash Out, Up to Day 77||1
9011025|NCT02991859|10073871|FG010|NOT COMPLETED|Wash Out, Up to Day 77||0
9011026|NCT02991859|10073872|FG011|NOT COMPLETED|Wash Out, Up to Day 77||0
9011027|NCT02991859|10073873|FG012|NOT COMPLETED|Wash Out, Up to Day 77||0
9011028|NCT02991859|10073874|FG013|NOT COMPLETED|Wash Out, Up to Day 77||0
9011029|NCT02991859|10073875|FG014|NOT COMPLETED|Wash Out, Up to Day 77||0
8636451|NCT00568087|9677082|FG001|STARTED|Overall Study||24
8636452|NCT00568087|9677081|FG000|Received Intervention|Overall Study||21
8636453|NCT00568087|9677082|FG001|Received Intervention|Overall Study||23
9011030|NCT02991859|10073876|FG015|NOT COMPLETED|Wash Out, Up to Day 77||0
9011031|NCT02991859|10073877|FG016|NOT COMPLETED|Wash Out, Up to Day 77||0
9011032|NCT02991859|10073861|FG000|STARTED|Period2, Escalation Phase1, Upto Day 84||2
9011033|NCT02991859|10073862|FG001|STARTED|Period2, Escalation Phase1, Upto Day 84||2
9011034|NCT02991859|10073863|FG002|STARTED|Period2, Escalation Phase1, Upto Day 84||2
9011035|NCT02991859|10073864|FG003|STARTED|Period2, Escalation Phase1, Upto Day 84||2
9011036|NCT02991859|10073865|FG004|STARTED|Period2, Escalation Phase1, Upto Day 84||2
9011037|NCT02991859|10073866|FG005|STARTED|Period2, Escalation Phase1, Upto Day 84||1
9011038|NCT02991859|10073867|FG006|STARTED|Period2, Escalation Phase1, Upto Day 84||2
9011039|NCT02991859|10073868|FG007|STARTED|Period2, Escalation Phase1, Upto Day 84||2
9011040|NCT02991859|10073869|FG008|STARTED|Period2, Escalation Phase1, Upto Day 84||2
9011041|NCT02991859|10073870|FG009|STARTED|Period2, Escalation Phase1, Upto Day 84|1 Par directly entered into Period 2, Esc 1|2
9011042|NCT02991859|10073871|FG010|STARTED|Period2, Escalation Phase1, Upto Day 84|1 Par cont in P2 Esc 1 insteadP1 Esc 5, was not withdrawn|2
9011043|NCT02991859|10073872|FG011|STARTED|Period2, Escalation Phase1, Upto Day 84||2
9011044|NCT02991859|10073873|FG012|STARTED|Period2, Escalation Phase1, Upto Day 84||0
9011045|NCT02991859|10073874|FG013|STARTED|Period2, Escalation Phase1, Upto Day 84||0
9011046|NCT02991859|10073875|FG014|STARTED|Period2, Escalation Phase1, Upto Day 84||0
9011047|NCT02991859|10073876|FG015|STARTED|Period2, Escalation Phase1, Upto Day 84||0
9011048|NCT02991859|10073877|FG016|STARTED|Period2, Escalation Phase1, Upto Day 84||0
9011049|NCT02991859|10073861|FG000|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
9011050|NCT02991859|10073862|FG001|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
9011051|NCT02991859|10073863|FG002|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
9011052|NCT02991859|10073864|FG003|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
9011053|NCT02991859|10073865|FG004|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
9011054|NCT02991859|10073866|FG005|COMPLETED|Period2, Escalation Phase1, Upto Day 84||1
9011055|NCT02991859|10073867|FG006|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
9011056|NCT02991859|10073868|FG007|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
9011057|NCT02991859|10073869|FG008|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
9011058|NCT02991859|10073870|FG009|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
8636454|NCT00568087|9677081|FG000|COMPLETED|Overall Study||15
8903309|NCT02087514|9961307|FG001|COMPLETED|Overall Study||10
8903310|NCT02087514|9961308|FG002|COMPLETED|Overall Study||7
8903311|NCT02087514|9961309|FG003|COMPLETED|Overall Study||8
8903312|NCT02087514|9961310|FG004|COMPLETED|Overall Study||10
8903313|NCT02087514|9961311|FG005|COMPLETED|Overall Study||9
8903314|NCT02087514|9961306|FG000|NOT COMPLETED|Overall Study||2
8903315|NCT02087514|9961307|FG001|NOT COMPLETED|Overall Study||0
8903316|NCT02087514|9961308|FG002|NOT COMPLETED|Overall Study||3
8903317|NCT02087514|9961309|FG003|NOT COMPLETED|Overall Study||2
8903318|NCT02087514|9961310|FG004|NOT COMPLETED|Overall Study||0
8903319|NCT02087514|9961311|FG005|NOT COMPLETED|Overall Study||1
8903320|NCT02087670|9961327|FG000|STARTED|Overall Study||20
8903321|NCT02087670|9961328|FG001|STARTED|Overall Study||22
8903322|NCT02087670|9961327|FG000|COMPLETED|Overall Study||17
8903323|NCT02087670|9961328|FG001|COMPLETED|Overall Study||20
8903324|NCT02087670|9961327|FG000|NOT COMPLETED|Overall Study||3
8903325|NCT02087670|9961328|FG001|NOT COMPLETED|Overall Study||2
9011059|NCT02991859|10073871|FG010|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
9011060|NCT02991859|10073872|FG011|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
9011061|NCT02991859|10073873|FG012|COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
9011062|NCT02991859|10073874|FG013|COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
9011063|NCT02991859|10073875|FG014|COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
9011064|NCT02991859|10073876|FG015|COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
9011065|NCT02991859|10073877|FG016|COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
9011066|NCT02991859|10073861|FG000|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
9011067|NCT02991859|10073862|FG001|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
9011068|NCT02991859|10073863|FG002|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
9011069|NCT02991859|10073864|FG003|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
9011070|NCT02991859|10073865|FG004|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
9011071|NCT02991859|10073866|FG005|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
9011072|NCT02991859|10073867|FG006|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
9011073|NCT02991859|10073868|FG007|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
9011074|NCT02991859|10073869|FG008|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
9011075|NCT02991859|10073870|FG009|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
9011076|NCT02991859|10073871|FG010|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
9011077|NCT02991859|10073872|FG011|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
9011078|NCT02991859|10073873|FG012|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
9011079|NCT02991859|10073874|FG013|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
9011080|NCT02991859|10073875|FG014|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
9011081|NCT02991859|10073876|FG015|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
9011082|NCT02991859|10073877|FG016|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
9011083|NCT02991859|10073861|FG000|STARTED|Period2, Escalation Phase2, Upto Day 91||2
9011084|NCT02991859|10073862|FG001|STARTED|Period2, Escalation Phase2, Upto Day 91||2
9011085|NCT02991859|10073863|FG002|STARTED|Period2, Escalation Phase2, Upto Day 91||2
9011086|NCT02991859|10073864|FG003|STARTED|Period2, Escalation Phase2, Upto Day 91||2
9011087|NCT02991859|10073865|FG004|STARTED|Period2, Escalation Phase2, Upto Day 91||2
9011088|NCT02991859|10073866|FG005|STARTED|Period2, Escalation Phase2, Upto Day 91||1
9011089|NCT02991859|10073867|FG006|STARTED|Period2, Escalation Phase2, Upto Day 91||2
9011090|NCT02991859|10073868|FG007|STARTED|Period2, Escalation Phase2, Upto Day 91||2
9011091|NCT02991859|10073869|FG008|STARTED|Period2, Escalation Phase2, Upto Day 91||2
9011092|NCT02991859|10073870|FG009|STARTED|Period2, Escalation Phase2, Upto Day 91||2
9011093|NCT02991859|10073871|FG010|STARTED|Period2, Escalation Phase2, Upto Day 91||2
9011094|NCT02991859|10073872|FG011|STARTED|Period2, Escalation Phase2, Upto Day 91||2
9011095|NCT02991859|10073873|FG012|STARTED|Period2, Escalation Phase2, Upto Day 91||0
9011096|NCT02991859|10073874|FG013|STARTED|Period2, Escalation Phase2, Upto Day 91||0
9011097|NCT02991859|10073875|FG014|STARTED|Period2, Escalation Phase2, Upto Day 91||0
9011098|NCT02991859|10073876|FG015|STARTED|Period2, Escalation Phase2, Upto Day 91||0
9011099|NCT02991859|10073877|FG016|STARTED|Period2, Escalation Phase2, Upto Day 91||0
9011100|NCT02991859|10073861|FG000|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
9011101|NCT02991859|10073862|FG001|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
9011102|NCT02991859|10073863|FG002|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
9011103|NCT02991859|10073864|FG003|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
9011104|NCT02991859|10073865|FG004|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
9011105|NCT02991859|10073866|FG005|COMPLETED|Period2, Escalation Phase2, Upto Day 91||1
9011106|NCT02991859|10073867|FG006|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
9011107|NCT02991859|10073868|FG007|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
9011108|NCT02991859|10073869|FG008|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
9011109|NCT02991859|10073870|FG009|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
9011110|NCT02991859|10073871|FG010|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
9011111|NCT02991859|10073872|FG011|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
9011112|NCT02991859|10073873|FG012|COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
9011113|NCT02991859|10073874|FG013|COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
9011114|NCT02991859|10073875|FG014|COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
9011115|NCT02991859|10073876|FG015|COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
9011116|NCT02991859|10073877|FG016|COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
9011117|NCT02991859|10073861|FG000|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
8903326|NCT02087748|9961334|FG000|STARTED|Overall Study||24
8903327|NCT02087748|9961334|FG000|COMPLETED|Overall Study||24
8903328|NCT02087748|9961334|FG000|NOT COMPLETED|Overall Study||0
8903329|NCT02087774|9961344|FG000|STARTED|Overall Study||150
8903330|NCT02087774|9961345|FG001|STARTED|Overall Study||150
8903331|NCT02087774|9961344|FG000|COMPLETED|Overall Study||142
8903332|NCT02087774|9961345|FG001|COMPLETED|Overall Study||130
8903333|NCT02087774|9961344|FG000|NOT COMPLETED|Overall Study||8
8903334|NCT02087774|9961345|FG001|NOT COMPLETED|Overall Study||20
8903335|NCT02087904|9961355|FG000|STARTED|Overall Study||85
8903336|NCT02087904|9961356|FG001|STARTED|Overall Study||89
8903337|NCT02087904|9961357|FG002|STARTED|Overall Study||87
8903338|NCT02087904|9961358|FG003|STARTED|Overall Study||89
8903339|NCT02087904|9961355|FG000|COMPLETED|Overall Study||60
8903340|NCT02087904|9961356|FG001|COMPLETED|Overall Study||70
8903341|NCT02087904|9961357|FG002|COMPLETED|Overall Study||65
8903342|NCT02087904|9961358|FG003|COMPLETED|Overall Study||64
8903343|NCT02087904|9961355|FG000|NOT COMPLETED|Overall Study||25
8903344|NCT02087904|9961356|FG001|NOT COMPLETED|Overall Study||19
8903345|NCT02087904|9961357|FG002|NOT COMPLETED|Overall Study||22
8903346|NCT02087904|9961358|FG003|NOT COMPLETED|Overall Study||25
8903347|NCT02087943|9961371|FG000|STARTED|Placebo-Controlled Phase Week 0-12||64
8903348|NCT02087943|9961372|FG001|STARTED|Placebo-Controlled Phase Week 0-12||58
8903349|NCT02087943|9961373|FG002|STARTED|Placebo-Controlled Phase Week 0-12||63
8903350|NCT02087943|9961374|FG003|STARTED|Placebo-Controlled Phase Week 0-12||0
8903351|NCT02087943|9961375|FG004|STARTED|Placebo-Controlled Phase Week 0-12||0
8903352|NCT02087943|9961371|FG000|Safety Population|Placebo-Controlled Phase Week 0-12|Includes all participants who received at least one dose of study drug.|64
8903353|NCT02087943|9961372|FG001|Safety Population|Placebo-Controlled Phase Week 0-12|Includes all participants who received at least one dose of study drug.|58
8903354|NCT02087943|9961373|FG002|Safety Population|Placebo-Controlled Phase Week 0-12|Includes all participants who received at least one dose of study drug.|63
8903355|NCT02087943|9961374|FG003|Safety Population|Placebo-Controlled Phase Week 0-12||0
8903356|NCT02087943|9961375|FG004|Safety Population|Placebo-Controlled Phase Week 0-12||0
9011118|NCT02991859|10073862|FG001|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
9011119|NCT02991859|10073863|FG002|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
9011120|NCT02991859|10073864|FG003|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
9011121|NCT02991859|10073865|FG004|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
9011122|NCT02991859|10073866|FG005|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
9011123|NCT02991859|10073867|FG006|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
9011124|NCT02991859|10073868|FG007|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
9011125|NCT02991859|10073869|FG008|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
9011126|NCT02991859|10073870|FG009|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
9011127|NCT02991859|10073871|FG010|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
9011128|NCT02991859|10073872|FG011|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
9011129|NCT02991859|10073873|FG012|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
9011130|NCT02991859|10073874|FG013|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
9011131|NCT02991859|10073875|FG014|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
9011132|NCT02991859|10073876|FG015|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
9011133|NCT02991859|10073877|FG016|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
9011134|NCT02991859|10073861|FG000|STARTED|Period2, Escalation Phase3, Upto Day 98||2
9011135|NCT02991859|10073862|FG001|STARTED|Period2, Escalation Phase3, Upto Day 98||2
9011136|NCT02991859|10073863|FG002|STARTED|Period2, Escalation Phase3, Upto Day 98||2
9011137|NCT02991859|10073864|FG003|STARTED|Period2, Escalation Phase3, Upto Day 98||2
9011138|NCT02991859|10073865|FG004|STARTED|Period2, Escalation Phase3, Upto Day 98||2
9011139|NCT02991859|10073866|FG005|STARTED|Period2, Escalation Phase3, Upto Day 98||1
9011140|NCT02991859|10073867|FG006|STARTED|Period2, Escalation Phase3, Upto Day 98||2
9011141|NCT02991859|10073868|FG007|STARTED|Period2, Escalation Phase3, Upto Day 98||2
9011142|NCT02991859|10073869|FG008|STARTED|Period2, Escalation Phase3, Upto Day 98||2
9011143|NCT02991859|10073870|FG009|STARTED|Period2, Escalation Phase3, Upto Day 98||2
9011144|NCT02991859|10073871|FG010|STARTED|Period2, Escalation Phase3, Upto Day 98||2
9011145|NCT02991859|10073872|FG011|STARTED|Period2, Escalation Phase3, Upto Day 98||2
9011146|NCT02991859|10073873|FG012|STARTED|Period2, Escalation Phase3, Upto Day 98||0
9011147|NCT02991859|10073874|FG013|STARTED|Period2, Escalation Phase3, Upto Day 98||0
9011148|NCT02991859|10073875|FG014|STARTED|Period2, Escalation Phase3, Upto Day 98||0
9011149|NCT02991859|10073876|FG015|STARTED|Period2, Escalation Phase3, Upto Day 98||0
9011150|NCT02991859|10073877|FG016|STARTED|Period2, Escalation Phase3, Upto Day 98||0
9011151|NCT02991859|10073861|FG000|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
9011152|NCT02991859|10073862|FG001|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
9011153|NCT02991859|10073863|FG002|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
9011154|NCT02991859|10073864|FG003|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
9011155|NCT02991859|10073865|FG004|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
9011156|NCT02991859|10073866|FG005|COMPLETED|Period2, Escalation Phase3, Upto Day 98||1
9011157|NCT02991859|10073867|FG006|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
9011158|NCT02991859|10073868|FG007|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
9011159|NCT02991859|10073869|FG008|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
9011160|NCT02991859|10073870|FG009|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
9011161|NCT02991859|10073871|FG010|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
8903357|NCT02087943|9961371|FG000|COMPLETED|Placebo-Controlled Phase Week 0-12|3 participants who completed week 12 did not enter the active treatment phase.|50
8903358|NCT02087943|9961372|FG001|COMPLETED|Placebo-Controlled Phase Week 0-12||46
8903359|NCT02087943|9961373|FG002|COMPLETED|Placebo-Controlled Phase Week 0-12|1 participant who completed week 12 did not enter the active treatment phase.|50
8903360|NCT02087943|9961374|FG003|COMPLETED|Placebo-Controlled Phase Week 0-12||0
8903361|NCT02087943|9961375|FG004|COMPLETED|Placebo-Controlled Phase Week 0-12||0
8903362|NCT02087943|9961371|FG000|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||14
8903363|NCT02087943|9961372|FG001|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||12
8903364|NCT02087943|9961373|FG002|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||13
8903365|NCT02087943|9961374|FG003|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||0
8903366|NCT02087943|9961375|FG004|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||0
8903367|NCT02087943|9961371|FG000|STARTED|Active Treatment Phase Week 12-24||0
8903368|NCT02087943|9961372|FG001|STARTED|Active Treatment Phase Week 12-24||46
8903369|NCT02087943|9961373|FG002|STARTED|Active Treatment Phase Week 12-24||49
8903370|NCT02087943|9961374|FG003|STARTED|Active Treatment Phase Week 12-24||24
8903371|NCT02087943|9961375|FG004|STARTED|Active Treatment Phase Week 12-24||23
8903372|NCT02087943|9961371|FG000|COMPLETED|Active Treatment Phase Week 12-24||0
8903373|NCT02087943|9961372|FG001|COMPLETED|Active Treatment Phase Week 12-24||42
8903374|NCT02087943|9961373|FG002|COMPLETED|Active Treatment Phase Week 12-24||44
8903375|NCT02087943|9961374|FG003|COMPLETED|Active Treatment Phase Week 12-24||22
8903376|NCT02087943|9961375|FG004|COMPLETED|Active Treatment Phase Week 12-24||21
8903377|NCT02087943|9961371|FG000|NOT COMPLETED|Active Treatment Phase Week 12-24||0
8903378|NCT02087943|9961372|FG001|NOT COMPLETED|Active Treatment Phase Week 12-24||4
8903379|NCT02087943|9961373|FG002|NOT COMPLETED|Active Treatment Phase Week 12-24||5
8903380|NCT02087943|9961374|FG003|NOT COMPLETED|Active Treatment Phase Week 12-24||2
8903381|NCT02087943|9961375|FG004|NOT COMPLETED|Active Treatment Phase Week 12-24||2
8903382|NCT02087943|9961371|FG000|STARTED|Observational Follow-up Phase Week 24-30||0
8903383|NCT02087943|9961372|FG001|STARTED|Observational Follow-up Phase Week 24-30||46
8903384|NCT02087943|9961373|FG002|STARTED|Observational Follow-up Phase Week 24-30||48
9011162|NCT02991859|10073872|FG011|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
9011163|NCT02991859|10073873|FG012|COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
9011164|NCT02991859|10073874|FG013|COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
9011165|NCT02991859|10073875|FG014|COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
9011166|NCT02991859|10073876|FG015|COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
9011167|NCT02991859|10073877|FG016|COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
8903385|NCT02087943|9961374|FG003|STARTED|Observational Follow-up Phase Week 24-30||24
8903386|NCT02087943|9961375|FG004|STARTED|Observational Follow-up Phase Week 24-30||23
8903387|NCT02087943|9961371|FG000|COMPLETED|Observational Follow-up Phase Week 24-30||0
8903388|NCT02087943|9961372|FG001|COMPLETED|Observational Follow-up Phase Week 24-30||46
8903389|NCT02087943|9961373|FG002|COMPLETED|Observational Follow-up Phase Week 24-30||45
9011168|NCT02991859|10073861|FG000|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
9011169|NCT02991859|10073862|FG001|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
9011170|NCT02991859|10073863|FG002|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
9011171|NCT02991859|10073864|FG003|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
9011172|NCT02991859|10073865|FG004|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
9011173|NCT02991859|10073866|FG005|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
9011174|NCT02991859|10073867|FG006|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
9011175|NCT02991859|10073868|FG007|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
9011176|NCT02991859|10073869|FG008|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
8903390|NCT02087943|9961374|FG003|COMPLETED|Observational Follow-up Phase Week 24-30||23
8903391|NCT02087943|9961375|FG004|COMPLETED|Observational Follow-up Phase Week 24-30||22
8903392|NCT02087943|9961371|FG000|NOT COMPLETED|Observational Follow-up Phase Week 24-30||0
8903393|NCT02087943|9961372|FG001|NOT COMPLETED|Observational Follow-up Phase Week 24-30||0
8903394|NCT02087943|9961373|FG002|NOT COMPLETED|Observational Follow-up Phase Week 24-30||3
8903395|NCT02087943|9961374|FG003|NOT COMPLETED|Observational Follow-up Phase Week 24-30||1
8903396|NCT02087943|9961375|FG004|NOT COMPLETED|Observational Follow-up Phase Week 24-30||1
8903397|NCT02087956|9961389|FG000|STARTED|Overall Study||111
8903398|NCT02087956|9961390|FG001|STARTED|Overall Study||112
8903399|NCT02087956|9961389|FG000|COMPLETED|Overall Study||105
8903400|NCT02087956|9961390|FG001|COMPLETED|Overall Study||107
8903401|NCT02087956|9961389|FG000|NOT COMPLETED|Overall Study||6
8903402|NCT02087956|9961390|FG001|NOT COMPLETED|Overall Study||5
8903403|NCT02087995|9961398|FG000|STARTED|Overall Study||51
8903404|NCT02087995|9961398|FG000|COMPLETED|Overall Study||51
8903405|NCT02087995|9961398|FG000|NOT COMPLETED|Overall Study||0
8903406|NCT02088034|9961405|FG000|STARTED|Overall Study||33
8903407|NCT02088034|9961406|FG001|STARTED|Overall Study||30
8903408|NCT02088034|9961407|FG002|STARTED|Overall Study||29
8903409|NCT02088034|9961405|FG000|COMPLETED|Overall Study||30
8903410|NCT02088034|9961406|FG001|COMPLETED|Overall Study||28
8903411|NCT02088034|9961407|FG002|COMPLETED|Overall Study||27
8903412|NCT02088034|9961405|FG000|NOT COMPLETED|Overall Study||3
8903413|NCT02088034|9961406|FG001|NOT COMPLETED|Overall Study||2
8903414|NCT02088034|9961407|FG002|NOT COMPLETED|Overall Study||2
8903415|NCT02088047|9961417|FG000|STARTED|Overall Study||3
8903416|NCT02088047|9961418|FG001|STARTED|Overall Study||1
8903417|NCT02088047|9961417|FG000|COMPLETED|Overall Study||2
8903418|NCT02088047|9961418|FG001|COMPLETED|Overall Study||1
9011177|NCT02991859|10073870|FG009|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
9011178|NCT02991859|10073871|FG010|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
9011179|NCT02991859|10073872|FG011|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
9011180|NCT02991859|10073873|FG012|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
9011181|NCT02991859|10073874|FG013|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
9011182|NCT02991859|10073875|FG014|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
9011183|NCT02991859|10073876|FG015|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
9011184|NCT02991859|10073877|FG016|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
9011185|NCT02991859|10073861|FG000|STARTED|Period2, Escalation Phase4, Upto Day 105||2
9011186|NCT02991859|10073862|FG001|STARTED|Period2, Escalation Phase4, Upto Day 105||2
9011187|NCT02991859|10073863|FG002|STARTED|Period2, Escalation Phase4, Upto Day 105||2
9011188|NCT02991859|10073864|FG003|STARTED|Period2, Escalation Phase4, Upto Day 105||2
9011189|NCT02991859|10073865|FG004|STARTED|Period2, Escalation Phase4, Upto Day 105||2
9011190|NCT02991859|10073866|FG005|STARTED|Period2, Escalation Phase4, Upto Day 105||1
9011191|NCT02991859|10073867|FG006|STARTED|Period2, Escalation Phase4, Upto Day 105||2
9011192|NCT02991859|10073868|FG007|STARTED|Period2, Escalation Phase4, Upto Day 105||2
9011193|NCT02991859|10073869|FG008|STARTED|Period2, Escalation Phase4, Upto Day 105||2
9011194|NCT02991859|10073870|FG009|STARTED|Period2, Escalation Phase4, Upto Day 105||2
9011195|NCT02991859|10073871|FG010|STARTED|Period2, Escalation Phase4, Upto Day 105||2
9011196|NCT02991859|10073872|FG011|STARTED|Period2, Escalation Phase4, Upto Day 105||2
9011197|NCT02991859|10073873|FG012|STARTED|Period2, Escalation Phase4, Upto Day 105||0
9011198|NCT02991859|10073874|FG013|STARTED|Period2, Escalation Phase4, Upto Day 105||0
9011199|NCT02991859|10073875|FG014|STARTED|Period2, Escalation Phase4, Upto Day 105||0
9011200|NCT02991859|10073876|FG015|STARTED|Period2, Escalation Phase4, Upto Day 105||0
9011201|NCT02991859|10073877|FG016|STARTED|Period2, Escalation Phase4, Upto Day 105||0
9011202|NCT02991859|10073861|FG000|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
9011203|NCT02991859|10073862|FG001|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
9011204|NCT02991859|10073863|FG002|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
9011205|NCT02991859|10073864|FG003|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
9011206|NCT02991859|10073865|FG004|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
9011207|NCT02991859|10073866|FG005|COMPLETED|Period2, Escalation Phase4, Upto Day 105||1
9011208|NCT02991859|10073867|FG006|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
9011209|NCT02991859|10073868|FG007|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
9011210|NCT02991859|10073869|FG008|COMPLETED|Period2, Escalation Phase4, Upto Day 105||1
8903419|NCT02088047|9961417|FG000|NOT COMPLETED|Overall Study||1
8903420|NCT02088047|9961418|FG001|NOT COMPLETED|Overall Study||0
8903421|NCT02088073|9961429|FG000|STARTED|Acute Phase||258
8903422|NCT02088073|9961430|FG001|STARTED|Acute Phase||0
8903423|NCT02088073|9961431|FG002|STARTED|Acute Phase||0
8903424|NCT02088073|9961432|FG003|STARTED|Acute Phase||0
8903425|NCT02088073|9961433|FG004|STARTED|Acute Phase||0
8903426|NCT02088073|9961429|FG000|COMPLETED|Acute Phase||251
8903427|NCT02088073|9961430|FG001|COMPLETED|Acute Phase||0
8903428|NCT02088073|9961431|FG002|COMPLETED|Acute Phase||0
8903429|NCT02088073|9961432|FG003|COMPLETED|Acute Phase||0
8903430|NCT02088073|9961433|FG004|COMPLETED|Acute Phase||0
8903431|NCT02088073|9961429|FG000|NOT COMPLETED|Acute Phase||7
8903432|NCT02088073|9961430|FG001|NOT COMPLETED|Acute Phase||0
8903433|NCT02088073|9961431|FG002|NOT COMPLETED|Acute Phase||0
8903434|NCT02088073|9961432|FG003|NOT COMPLETED|Acute Phase||0
8903435|NCT02088073|9961433|FG004|NOT COMPLETED|Acute Phase||0
8903436|NCT02088073|9961429|FG000|STARTED|Maintanance Phase||0
8903437|NCT02088073|9961430|FG001|STARTED|Maintanance Phase||85
8903438|NCT02088073|9961431|FG002|STARTED|Maintanance Phase||45
8903439|NCT02088073|9961432|FG003|STARTED|Maintanance Phase||51
8903440|NCT02088073|9961433|FG004|STARTED|Maintanance Phase||56
8903441|NCT02088073|9961429|FG000|COMPLETED|Maintanance Phase|251 subjects completed the AP; 240 were eligible to enter the MP. 237 entered the MP.|0
8903442|NCT02088073|9961430|FG001|COMPLETED|Maintanance Phase||75
8903443|NCT02088073|9961431|FG002|COMPLETED|Maintanance Phase||40
8903444|NCT02088073|9961432|FG003|COMPLETED|Maintanance Phase||44
8903445|NCT02088073|9961433|FG004|COMPLETED|Maintanance Phase||49
8903446|NCT02088073|9961429|FG000|NOT COMPLETED|Maintanance Phase||0
8903447|NCT02088073|9961430|FG001|NOT COMPLETED|Maintanance Phase||10
8903448|NCT02088073|9961431|FG002|NOT COMPLETED|Maintanance Phase||5
8903449|NCT02088073|9961432|FG003|NOT COMPLETED|Maintanance Phase||7
8903450|NCT02088073|9961433|FG004|NOT COMPLETED|Maintanance Phase||7
8903451|NCT02088177|9961446|FG000|STARTED|Overall Study||12
8903452|NCT02088177|9961446|FG000|COMPLETED|Overall Study||9
8903453|NCT02088177|9961446|FG000|NOT COMPLETED|Overall Study||3
8903454|NCT02088216|9961452|FG000|STARTED|Overall Study||81
8903455|NCT02088216|9961453|FG001|STARTED|Overall Study||80
8903456|NCT02088216|9961452|FG000|COMPLETED|Overall Study||69
8903457|NCT02088216|9961453|FG001|COMPLETED|Overall Study||70
8903458|NCT02088216|9961452|FG000|NOT COMPLETED|Overall Study||12
8903459|NCT02088216|9961453|FG001|NOT COMPLETED|Overall Study||10
8903460|NCT02088385|9961461|FG000|STARTED|Overall Study||10
8903461|NCT02088385|9961462|FG001|STARTED|Overall Study||10
8903462|NCT02088385|9961461|FG000|COMPLETED|Overall Study||10
8903463|NCT02088385|9961462|FG001|COMPLETED|Overall Study||10
8903464|NCT02088385|9961461|FG000|NOT COMPLETED|Overall Study||0
8903465|NCT02088385|9961462|FG001|NOT COMPLETED|Overall Study||0
8903466|NCT02088541|9961473|FG000|STARTED|Overall Study||71
8903467|NCT02088541|9961474|FG001|STARTED|Overall Study||27
8903468|NCT02088541|9961475|FG002|STARTED|Overall Study||117
8903469|NCT02088541|9961476|FG003|STARTED|Overall Study||44
8903470|NCT02088541|9961477|FG004|STARTED|Overall Study||58
8903471|NCT02088541|9961473|FG000|Safety Population|Overall Study||71
8903472|NCT02088541|9961474|FG001|Safety Population|Overall Study||27
8903473|NCT02088541|9961475|FG002|Safety Population|Overall Study||115
8903474|NCT02088541|9961476|FG003|Safety Population|Overall Study||39
8903475|NCT02088541|9961477|FG004|Safety Population|Overall Study||45
8903476|NCT02088541|9961473|FG000|Intent-to-treat (ITT) Population|Overall Study||0
8903477|NCT02088541|9961474|FG001|Intent-to-treat (ITT) Population|Overall Study||0
8903478|NCT02088541|9961475|FG002|Intent-to-treat (ITT) Population|Overall Study|1 randomized to Selinexor 60mg (PV>=5) but treated with physician choice 2, counted under this arm.|118
8903479|NCT02088541|9961476|FG003|Intent-to-treat (ITT) Population|Overall Study||0
8903480|NCT02088541|9961477|FG004|Intent-to-treat (ITT) Population|Overall Study||57
8903481|NCT02088541|9961473|FG000|COMPLETED|Overall Study||0
8903482|NCT02088541|9961474|FG001|COMPLETED|Overall Study||0
8903483|NCT02088541|9961475|FG002|COMPLETED|Overall Study||0
8903484|NCT02088541|9961476|FG003|COMPLETED|Overall Study||0
8903485|NCT02088541|9961477|FG004|COMPLETED|Overall Study||0
8903486|NCT02088541|9961473|FG000|NOT COMPLETED|Overall Study||71
8903487|NCT02088541|9961474|FG001|NOT COMPLETED|Overall Study||27
8903488|NCT02088541|9961475|FG002|NOT COMPLETED|Overall Study||117
8903489|NCT02088541|9961476|FG003|NOT COMPLETED|Overall Study||44
8903490|NCT02088541|9961477|FG004|NOT COMPLETED|Overall Study||58
8903491|NCT02088697|9961489|FG000|STARTED|Period I||25
8903492|NCT02088697|9961490|FG001|STARTED|Period I||25
8903493|NCT02088697|9961489|FG000|COMPLETED|Period I||24
8903494|NCT02088697|9961490|FG001|COMPLETED|Period I||21
8903495|NCT02088697|9961489|FG000|NOT COMPLETED|Period I||1
8903496|NCT02088697|9961490|FG001|NOT COMPLETED|Period I||4
8903497|NCT02088697|9961489|FG000|STARTED|Wash-out Period (at Least 10 Days)||24
8903498|NCT02088697|9961490|FG001|STARTED|Wash-out Period (at Least 10 Days)||21
8903499|NCT02088697|9961489|FG000|COMPLETED|Wash-out Period (at Least 10 Days)||23
8903500|NCT02088697|9961490|FG001|COMPLETED|Wash-out Period (at Least 10 Days)||21
8903501|NCT02088697|9961489|FG000|NOT COMPLETED|Wash-out Period (at Least 10 Days)||1
9011211|NCT02991859|10073870|FG009|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
9011212|NCT02991859|10073871|FG010|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
9011213|NCT02991859|10073872|FG011|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
9011214|NCT02991859|10073873|FG012|COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
9011215|NCT02991859|10073874|FG013|COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
9011216|NCT02991859|10073875|FG014|COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
9011217|NCT02991859|10073876|FG015|COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
9011218|NCT02991859|10073877|FG016|COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
9011219|NCT02991859|10073861|FG000|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
9011220|NCT02991859|10073862|FG001|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
9011221|NCT02991859|10073863|FG002|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
9011222|NCT02991859|10073864|FG003|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
8903502|NCT02088697|9961490|FG001|NOT COMPLETED|Wash-out Period (at Least 10 Days)||0
8903503|NCT02088697|9961489|FG000|STARTED|Period II||23
8903504|NCT02088697|9961490|FG001|STARTED|Period II||21
8903505|NCT02088697|9961489|FG000|COMPLETED|Period II||23
8903506|NCT02088697|9961490|FG001|COMPLETED|Period II||21
8903507|NCT02088697|9961489|FG000|NOT COMPLETED|Period II||0
8903508|NCT02088697|9961490|FG001|NOT COMPLETED|Period II||0
8903509|NCT02088788|9961498|FG000|STARTED|Overall Study||135
8903510|NCT02088788|9961499|FG001|STARTED|Overall Study||130
8903511|NCT02088788|9961498|FG000|COMPLETED|Overall Study||105
8903512|NCT02088788|9961499|FG001|COMPLETED|Overall Study||89
8903513|NCT02088788|9961498|FG000|NOT COMPLETED|Overall Study||30
8903514|NCT02088788|9961499|FG001|NOT COMPLETED|Overall Study||41
8903515|NCT02088905|9961507|FG000|STARTED|Overall Study||13
8903516|NCT02088905|9961508|FG001|STARTED|Overall Study||10
8903517|NCT02088905|9961507|FG000|Week 9|Overall Study||10
8903518|NCT02088905|9961508|FG001|Week 9|Overall Study||9
8903519|NCT02088905|9961507|FG000|COMPLETED|Overall Study||8
8903520|NCT02088905|9961508|FG001|COMPLETED|Overall Study||9
8903521|NCT02088905|9961507|FG000|NOT COMPLETED|Overall Study||5
8903522|NCT02088905|9961508|FG001|NOT COMPLETED|Overall Study||1
8903523|NCT02089113|9961516|FG000|STARTED|Overall Study||161
8903524|NCT02089113|9961517|FG001|STARTED|Overall Study||80
8903525|NCT02089113|9961516|FG000|COMPLETED|Overall Study||160
8903526|NCT02089113|9961517|FG001|COMPLETED|Overall Study||80
8903527|NCT02089113|9961516|FG000|NOT COMPLETED|Overall Study||1
8903528|NCT02089113|9961517|FG001|NOT COMPLETED|Overall Study||0
8903529|NCT02089191|9961523|FG000|STARTED|Period 1, First 12 Hours||16
8903530|NCT02089191|9961524|FG001|STARTED|Period 1, First 12 Hours||15
8903531|NCT02089191|9961523|FG000|COMPLETED|Period 1, First 12 Hours||16
8903532|NCT02089191|9961524|FG001|COMPLETED|Period 1, First 12 Hours||15
8903533|NCT02089191|9961523|FG000|NOT COMPLETED|Period 1, First 12 Hours||0
8903534|NCT02089191|9961524|FG001|NOT COMPLETED|Period 1, First 12 Hours||0
8903535|NCT02089191|9961523|FG000|STARTED|Period 2, Second 12 Hours|One participant discontinued between Period 1 and Period 2 due to availability|15
8903536|NCT02089191|9961524|FG001|STARTED|Period 2, Second 12 Hours||15
8903537|NCT02089191|9961523|FG000|COMPLETED|Period 2, Second 12 Hours||15
8903538|NCT02089191|9961524|FG001|COMPLETED|Period 2, Second 12 Hours||15
8903539|NCT02089191|9961523|FG000|NOT COMPLETED|Period 2, Second 12 Hours||0
8903540|NCT02089191|9961524|FG001|NOT COMPLETED|Period 2, Second 12 Hours||0
8903541|NCT02089230|9961533|FG000|STARTED|Overall Study||3
8903542|NCT02089230|9961534|FG001|STARTED|Overall Study||4
8903543|NCT02089230|9961535|FG002|STARTED|Overall Study||12
8903544|NCT02089230|9961533|FG000|COMPLETED|Overall Study||3
8903545|NCT02089230|9961534|FG001|COMPLETED|Overall Study||4
8903546|NCT02089230|9961535|FG002|COMPLETED|Overall Study||6
8903547|NCT02089230|9961533|FG000|NOT COMPLETED|Overall Study||0
8903548|NCT02089230|9961534|FG001|NOT COMPLETED|Overall Study||0
8903549|NCT02089230|9961535|FG002|NOT COMPLETED|Overall Study||6
8903550|NCT02089334|9961547|FG000|STARTED|Overall Study||3
8903551|NCT02089334|9961548|FG001|STARTED|Overall Study||4
8903552|NCT02089334|9961549|FG002|STARTED|Overall Study||4
8903553|NCT02089334|9961550|FG003|STARTED|Overall Study||13
8903554|NCT02089334|9961547|FG000|Received Study Drug|Overall Study||3
8903555|NCT02089334|9961548|FG001|Received Study Drug|Overall Study||4
8903556|NCT02089334|9961549|FG002|Received Study Drug|Overall Study||3
8903557|NCT02089334|9961550|FG003|Received Study Drug|Overall Study||11
8903558|NCT02089334|9961547|FG000|COMPLETED|Overall Study||3
8903559|NCT02089334|9961548|FG001|COMPLETED|Overall Study||4
8903560|NCT02089334|9961549|FG002|COMPLETED|Overall Study||3
8903561|NCT02089334|9961550|FG003|COMPLETED|Overall Study||6
8903562|NCT02089334|9961547|FG000|NOT COMPLETED|Overall Study||0
8903563|NCT02089334|9961548|FG001|NOT COMPLETED|Overall Study||0
8903564|NCT02089334|9961549|FG002|NOT COMPLETED|Overall Study||1
8903565|NCT02089334|9961550|FG003|NOT COMPLETED|Overall Study||7
8903566|NCT02089347|9961565|FG000|STARTED|Overall Study||356
8903567|NCT02089347|9961566|FG001|STARTED|Overall Study||178
8903568|NCT02089347|9961565|FG000|COMPLETED|Overall Study||355
8903569|NCT02089347|9961566|FG001|COMPLETED|Overall Study||178
8903570|NCT02089347|9961565|FG000|NOT COMPLETED|Overall Study||1
8903571|NCT02089347|9961566|FG001|NOT COMPLETED|Overall Study||0
8903572|NCT02089464|9961574|FG000|STARTED|Overall Study||132
8903573|NCT02089464|9961575|FG001|STARTED|Overall Study||67
8903574|NCT02089464|9961574|FG000|COMPLETED|Overall Study||104
8903575|NCT02089464|9961575|FG001|COMPLETED|Overall Study||51
8903576|NCT02089464|9961574|FG000|NOT COMPLETED|Overall Study||28
8903577|NCT02089464|9961575|FG001|NOT COMPLETED|Overall Study||16
8903578|NCT02089659|9961583|FG000|STARTED|Overall Study||8
8903579|NCT02089659|9961584|FG001|STARTED|Overall Study||8
8903580|NCT02089659|9961585|FG002|STARTED|Overall Study||0
8903581|NCT02089659|9961583|FG000|COMPLETED|Overall Study||8
8903582|NCT02089659|9961584|FG001|COMPLETED|Overall Study||8
8903583|NCT02089659|9961585|FG002|COMPLETED|Overall Study||0
8903584|NCT02089659|9961583|FG000|NOT COMPLETED|Overall Study||0
8903585|NCT02089659|9961584|FG001|NOT COMPLETED|Overall Study||0
8636455|NCT00568087|9677082|FG001|COMPLETED|Overall Study||17
8903586|NCT02089659|9961585|FG002|NOT COMPLETED|Overall Study||0
8903587|NCT02089737|9961591|FG000|STARTED|Overall Study||3091
8636456|NCT00568087|9677081|FG000|NOT COMPLETED|Overall Study||7
8903588|NCT02089737|9961591|FG000|COMPLETED|Overall Study||3085
8903589|NCT02089737|9961591|FG000|NOT COMPLETED|Overall Study||6
8903590|NCT02089997|9961596|FG000|STARTED|Overall Study||3304
8903591|NCT02089997|9961596|FG000|COMPLETED|Overall Study||3058
8903592|NCT02089997|9961596|FG000|NOT COMPLETED|Overall Study||246
8903593|NCT02090075|9961602|FG000|STARTED|Overall Study||33
8903594|NCT02090075|9961603|FG001|STARTED|Overall Study||33
8903595|NCT02090075|9961602|FG000|COMPLETED|Overall Study||26
8903596|NCT02090075|9961603|FG001|COMPLETED|Overall Study||30
8903597|NCT02090075|9961602|FG000|NOT COMPLETED|Overall Study||7
8903598|NCT02090075|9961603|FG001|NOT COMPLETED|Overall Study||3
8903599|NCT02090088|9961609|FG000|STARTED|Overall Study||4
8903600|NCT02090088|9961609|FG000|Gave Birth|Overall Study||4
8903601|NCT02090088|9961609|FG000|COMPLETED|Overall Study||4
8903602|NCT02090088|9961609|FG000|NOT COMPLETED|Overall Study||0
8903603|NCT02090283|9961617|FG000|STARTED|Overall Study||17
8903604|NCT02090283|9961618|FG001|STARTED|Overall Study||15
8903605|NCT02090283|9961619|FG002|STARTED|Overall Study||10
8903606|NCT02090283|9961617|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||17
8903607|NCT02090283|9961618|FG001|Received At Least 1 Dose Of Study Drug|Overall Study||15
8903608|NCT02090283|9961619|FG002|Received At Least 1 Dose Of Study Drug|Overall Study||10
8903609|NCT02090283|9961617|FG000|COMPLETED|Overall Study||0
8903610|NCT02090283|9961618|FG001|COMPLETED|Overall Study||0
8903611|NCT02090283|9961619|FG002|COMPLETED|Overall Study||0
8903612|NCT02090283|9961617|FG000|NOT COMPLETED|Overall Study||17
8903613|NCT02090283|9961618|FG001|NOT COMPLETED|Overall Study||15
8903614|NCT02090283|9961619|FG002|NOT COMPLETED|Overall Study||10
8903615|NCT02090374|9961635|FG000|STARTED|Overall Study||8
8903616|NCT02090374|9961636|FG001|STARTED|Overall Study||4
8903617|NCT02090374|9961637|FG002|STARTED|Overall Study||4
8903618|NCT02090374|9961638|FG003|STARTED|Overall Study||9
8903619|NCT02090374|9961639|FG004|STARTED|Overall Study||35
8903620|NCT02090374|9961640|FG005|STARTED|Overall Study||15
8903621|NCT02090374|9961641|FG006|STARTED|Overall Study||16
8903622|NCT02090374|9961642|FG007|STARTED|Overall Study||2
9011223|NCT02991859|10073865|FG004|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
9011224|NCT02991859|10073866|FG005|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
9011225|NCT02991859|10073867|FG006|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
9011226|NCT02991859|10073868|FG007|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
9011227|NCT02991859|10073869|FG008|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||1
9011228|NCT02991859|10073870|FG009|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
9011229|NCT02991859|10073871|FG010|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
9011230|NCT02991859|10073872|FG011|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
9011231|NCT02991859|10073873|FG012|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
9011232|NCT02991859|10073874|FG013|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
9011233|NCT02991859|10073875|FG014|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
9011234|NCT02991859|10073876|FG015|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
9011235|NCT02991859|10073877|FG016|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
9011236|NCT02991859|10073861|FG000|STARTED|Period2,Escalation Phase5,Upto Day 112||2
9011237|NCT02991859|10073862|FG001|STARTED|Period2,Escalation Phase5,Upto Day 112||2
9011238|NCT02991859|10073863|FG002|STARTED|Period2,Escalation Phase5,Upto Day 112||2
9011239|NCT02991859|10073864|FG003|STARTED|Period2,Escalation Phase5,Upto Day 112||2
9011240|NCT02991859|10073865|FG004|STARTED|Period2,Escalation Phase5,Upto Day 112||2
9011241|NCT02991859|10073866|FG005|STARTED|Period2,Escalation Phase5,Upto Day 112||1
8572997|NCT00117962|9605149|FG000|COMPLETED|Overall Study||26
8572998|NCT00117962|9605150|FG001|COMPLETED|Overall Study||28
8572999|NCT00117962|9605149|FG000|NOT COMPLETED|Overall Study||22
8573000|NCT00117962|9605150|FG001|NOT COMPLETED|Overall Study||25
8573001|NCT00117988|9605156|FG000|STARTED|Overall Study||22
8573002|NCT00117988|9605156|FG000|COMPLETED|Overall Study||18
8573003|NCT00117988|9605156|FG000|NOT COMPLETED|Overall Study||4
8573004|NCT00118040|9605163|FG000|STARTED|Overall Study||20
8573005|NCT00118040|9605164|FG001|STARTED|Overall Study||20
8573006|NCT00118040|9605165|FG002|STARTED|Overall Study||20
8573007|NCT00118040|9605163|FG000|COMPLETED|Overall Study||19
8573008|NCT00118040|9605164|FG001|COMPLETED|Overall Study||18
8573009|NCT00118040|9605165|FG002|COMPLETED|Overall Study||14
8573010|NCT00118040|9605163|FG000|NOT COMPLETED|Overall Study||1
8573011|NCT00118040|9605164|FG001|NOT COMPLETED|Overall Study||2
8573012|NCT00118040|9605165|FG002|NOT COMPLETED|Overall Study||6
8573013|NCT00118092|9605178|FG000|STARTED|Overall Study||17
8573014|NCT00118092|9605178|FG000|COMPLETED|Overall Study||15
8573015|NCT00118092|9605178|FG000|NOT COMPLETED|Overall Study||2
8573016|NCT00118131|9605183|FG000|STARTED|Overall Study||49
8573017|NCT00118131|9605183|FG000|COMPLETED|Overall Study||49
8573018|NCT00118131|9605183|FG000|NOT COMPLETED|Overall Study||0
8573019|NCT00118144|9605187|FG000|STARTED|Overall Study||42
8573020|NCT00118144|9605187|FG000|COMPLETED|Overall Study||41
8573021|NCT00118144|9605187|FG000|NOT COMPLETED|Overall Study||1
8573022|NCT00118157|9605192|FG000|STARTED|Overall Study||19
8573023|NCT00118157|9605192|FG000|COMPLETED|Overall Study||7
8573024|NCT00118157|9605192|FG000|NOT COMPLETED|Overall Study||12
8573025|NCT00118209|9605199|FG000|STARTED|Overall Study||262
8573026|NCT00118209|9605200|FG001|STARTED|Overall Study||262
8573027|NCT00118209|9605199|FG000|Evaluable for Primary Endpoint|Overall Study||250
8573028|NCT00118209|9605200|FG001|Evaluable for Primary Endpoint|Overall Study||241
8573029|NCT00118209|9605199|FG000|Evaluable for Safety Analysis|Overall Study||243
8573030|NCT00118209|9605200|FG001|Evaluable for Safety Analysis|Overall Study||237
8573031|NCT00118209|9605199|FG000|COMPLETED|Overall Study||250
8573032|NCT00118209|9605200|FG001|COMPLETED|Overall Study||241
8573033|NCT00118209|9605199|FG000|NOT COMPLETED|Overall Study||12
8573034|NCT00118209|9605200|FG001|NOT COMPLETED|Overall Study||21
8903623|NCT02090374|9961635|FG000|COMPLETED|Overall Study||8
8903624|NCT02090374|9961636|FG001|COMPLETED|Overall Study||4
8903625|NCT02090374|9961637|FG002|COMPLETED|Overall Study||4
8903626|NCT02090374|9961638|FG003|COMPLETED|Overall Study||9
8903627|NCT02090374|9961639|FG004|COMPLETED|Overall Study||35
8903628|NCT02090374|9961640|FG005|COMPLETED|Overall Study||15
8903629|NCT02090374|9961641|FG006|COMPLETED|Overall Study||16
8903630|NCT02090374|9961642|FG007|COMPLETED|Overall Study||2
8903631|NCT02090374|9961635|FG000|NOT COMPLETED|Overall Study||0
8903632|NCT02090374|9961636|FG001|NOT COMPLETED|Overall Study||0
8903633|NCT02090374|9961637|FG002|NOT COMPLETED|Overall Study||0
8903634|NCT02090374|9961638|FG003|NOT COMPLETED|Overall Study||0
8903635|NCT02090374|9961639|FG004|NOT COMPLETED|Overall Study||0
8903636|NCT02090374|9961640|FG005|NOT COMPLETED|Overall Study||0
8903637|NCT02090374|9961641|FG006|NOT COMPLETED|Overall Study||0
8903638|NCT02090374|9961642|FG007|NOT COMPLETED|Overall Study||0
8903639|NCT02090413|9961663|FG000|STARTED|Overall Study||81
8903640|NCT02090413|9961664|FG001|STARTED|Overall Study||80
8903641|NCT02090413|9961665|FG002|STARTED|Overall Study||80
8903642|NCT02090413|9961663|FG000|COMPLETED|Overall Study||62
8903643|NCT02090413|9961664|FG001|COMPLETED|Overall Study||60
8903644|NCT02090413|9961665|FG002|COMPLETED|Overall Study||57
8903645|NCT02090413|9961663|FG000|NOT COMPLETED|Overall Study||19
8903646|NCT02090413|9961664|FG001|NOT COMPLETED|Overall Study||20
8903647|NCT02090413|9961665|FG002|NOT COMPLETED|Overall Study||23
8903648|NCT02090426|9961676|FG000|STARTED|Overall Study||401
8903649|NCT02090426|9961677|FG001|STARTED|Overall Study||399
8903650|NCT02090426|9961676|FG000|Analysis Population|Overall Study||389
8903651|NCT02090426|9961677|FG001|Analysis Population|Overall Study||393
8903652|NCT02090426|9961676|FG000|COMPLETED|Overall Study||389
8903653|NCT02090426|9961677|FG001|COMPLETED|Overall Study||393
8903654|NCT02090426|9961676|FG000|NOT COMPLETED|Overall Study||12
8903655|NCT02090426|9961677|FG001|NOT COMPLETED|Overall Study||6
8903656|NCT02090634|9961685|FG000|STARTED|Overall Study||30
8903657|NCT02090634|9961686|FG001|STARTED|Overall Study||28
8903658|NCT02090634|9961685|FG000|COMPLETED|Overall Study||25
8903659|NCT02090634|9961686|FG001|COMPLETED|Overall Study||25
8903660|NCT02090634|9961685|FG000|NOT COMPLETED|Overall Study||5
8903661|NCT02090634|9961686|FG001|NOT COMPLETED|Overall Study||3
8903662|NCT02090725|9961692|FG000|STARTED|Overall Study||4
8903663|NCT02090725|9961692|FG000|COMPLETED|Overall Study||0
8903664|NCT02090725|9961692|FG000|NOT COMPLETED|Overall Study||4
8903665|NCT02090764|9961698|FG000|STARTED|Overall Study||206
8903666|NCT02090764|9961699|FG001|STARTED|Overall Study||206
8903667|NCT02090764|9961698|FG000|COMPLETED|Overall Study||200
8903668|NCT02090764|9961699|FG001|COMPLETED|Overall Study||186
8903669|NCT02090764|9961698|FG000|NOT COMPLETED|Overall Study||6
8903670|NCT02090764|9961699|FG001|NOT COMPLETED|Overall Study||20
8903671|NCT02090777|9961705|FG000|STARTED|Overall Study||4
8903672|NCT02090777|9961705|FG000|COMPLETED|Overall Study||4
8903673|NCT02090777|9961705|FG000|NOT COMPLETED|Overall Study||0
8903674|NCT02090855|9961709|FG000|STARTED|Overall Study||108
8903675|NCT02090855|9961709|FG000|COMPLETED|Overall Study||106
8903676|NCT02090855|9961709|FG000|NOT COMPLETED|Overall Study||2
8903677|NCT02090894|9961716|FG000|STARTED|Overall Study||11
8903678|NCT02090894|9961716|FG000|COMPLETED|Overall Study||11
8903679|NCT02090894|9961716|FG000|NOT COMPLETED|Overall Study||0
8903680|NCT02090959|9961720|FG000|STARTED|Overall Study||219
8903681|NCT02090959|9961720|FG000|As-treated Population|Overall Study||218
8903682|NCT02090959|9961720|FG000|COMPLETED|Overall Study||68
8903683|NCT02090959|9961720|FG000|NOT COMPLETED|Overall Study||151
8903684|NCT02091089|9961724|FG000|STARTED|Overall Study||20
8903685|NCT02091089|9961724|FG000|COMPLETED|Overall Study||18
8903686|NCT02091089|9961724|FG000|NOT COMPLETED|Overall Study||2
8903687|NCT02091102|9961728|FG000|STARTED|Overall Study||20
8903688|NCT02091102|9961728|FG000|COMPLETED|Overall Study||20
8903689|NCT02091102|9961728|FG000|NOT COMPLETED|Overall Study||0
8903690|NCT02091167|9961734|FG000|STARTED|Overall Study||19
8903691|NCT02091167|9961735|FG001|STARTED|Overall Study||16
8903692|NCT02091167|9961734|FG000|COMPLETED|Overall Study||19
8903693|NCT02091167|9961735|FG001|COMPLETED|Overall Study||14
8903694|NCT02091167|9961734|FG000|NOT COMPLETED|Overall Study||0
8903695|NCT02091167|9961735|FG001|NOT COMPLETED|Overall Study||2
8903696|NCT02091206|9961745|FG000|STARTED|Treatment Period||10
8903697|NCT02091206|9961746|FG001|STARTED|Treatment Period||8
8903698|NCT02091206|9961747|FG002|STARTED|Treatment Period||9
8903699|NCT02091206|9961748|FG003|STARTED|Treatment Period||7
8903700|NCT02091206|9961745|FG000|Safety Analysis Set|Treatment Period||10
8903701|NCT02091206|9961746|FG001|Safety Analysis Set|Treatment Period||8
8903702|NCT02091206|9961747|FG002|Safety Analysis Set|Treatment Period||9
8903703|NCT02091206|9961748|FG003|Safety Analysis Set|Treatment Period||7
8903704|NCT02091206|9961745|FG000|COMPLETED|Treatment Period||10
8903705|NCT02091206|9961746|FG001|COMPLETED|Treatment Period||7
8903706|NCT02091206|9961747|FG002|COMPLETED|Treatment Period||8
8903707|NCT02091206|9961748|FG003|COMPLETED|Treatment Period||7
8903708|NCT02091206|9961745|FG000|NOT COMPLETED|Treatment Period||0
8903709|NCT02091206|9961746|FG001|NOT COMPLETED|Treatment Period||1
8903710|NCT02091206|9961747|FG002|NOT COMPLETED|Treatment Period||1
8903711|NCT02091206|9961748|FG003|NOT COMPLETED|Treatment Period||0
8903712|NCT02091206|9961745|FG000|STARTED|Taper Period||10
8903713|NCT02091206|9961746|FG001|STARTED|Taper Period||7
8903714|NCT02091206|9961747|FG002|STARTED|Taper Period||8
8903715|NCT02091206|9961748|FG003|STARTED|Taper Period||7
8903716|NCT02091206|9961745|FG000|COMPLETED|Taper Period||9
8903717|NCT02091206|9961746|FG001|COMPLETED|Taper Period||7
8903718|NCT02091206|9961747|FG002|COMPLETED|Taper Period||8
8903719|NCT02091206|9961748|FG003|COMPLETED|Taper Period||5
9011242|NCT02991859|10073867|FG006|STARTED|Period2,Escalation Phase5,Upto Day 112||2
9011243|NCT02991859|10073868|FG007|STARTED|Period2,Escalation Phase5,Upto Day 112||2
9011244|NCT02991859|10073869|FG008|STARTED|Period2,Escalation Phase5,Upto Day 112||1
8573035|NCT00118248|9605208|FG000|STARTED|Overall Study||17
8573036|NCT00118248|9605209|FG001|STARTED|Overall Study||24
8573037|NCT00118248|9605208|FG000|COMPLETED|Overall Study||17
8573038|NCT00118248|9605209|FG001|COMPLETED|Overall Study||24
8573039|NCT00118248|9605208|FG000|NOT COMPLETED|Overall Study||0
8573040|NCT00118248|9605209|FG001|NOT COMPLETED|Overall Study||0
8573041|NCT00118274|9605218|FG000|STARTED|Overall Study||41
8573042|NCT00118274|9605219|FG001|STARTED|Overall Study||43
8573043|NCT00118274|9605220|FG002|STARTED|Overall Study||42
8573044|NCT00118274|9605221|FG003|STARTED|Overall Study||44
8573045|NCT00118274|9605218|FG000|COMPLETED|Overall Study||21
8573046|NCT00118274|9605219|FG001|COMPLETED|Overall Study||21
8573047|NCT00118274|9605220|FG002|COMPLETED|Overall Study||25
8573048|NCT00118274|9605221|FG003|COMPLETED|Overall Study||29
8573049|NCT00118274|9605218|FG000|NOT COMPLETED|Overall Study||20
8573050|NCT00118274|9605219|FG001|NOT COMPLETED|Overall Study||22
8573051|NCT00118274|9605220|FG002|NOT COMPLETED|Overall Study||17
8573052|NCT00118274|9605221|FG003|NOT COMPLETED|Overall Study||15
8573053|NCT00118287|9605231|FG000|STARTED|Overall Study||32
8573054|NCT00118287|9605231|FG000|COMPLETED|Overall Study||30
8573055|NCT00118287|9605231|FG000|NOT COMPLETED|Overall Study||2
8573056|NCT00118352|9605238|FG000|STARTED|Overall Study||12
8573057|NCT00118352|9605239|FG001|STARTED|Overall Study||0
8573058|NCT00118352|9605240|FG002|STARTED|Overall Study||0
8573059|NCT00118352|9605238|FG000|COMPLETED|Overall Study||12
8573060|NCT00118352|9605239|FG001|COMPLETED|Overall Study||0
8573061|NCT00118352|9605240|FG002|COMPLETED|Overall Study||0
8573062|NCT00118352|9605238|FG000|NOT COMPLETED|Overall Study||0
8573063|NCT00118352|9605239|FG001|NOT COMPLETED|Overall Study||0
8573064|NCT00118352|9605240|FG002|NOT COMPLETED|Overall Study||0
8573065|NCT00118365|9605250|FG000|STARTED|Overall Study||191
8573066|NCT00118365|9605251|FG001|STARTED|Overall Study||184
8573067|NCT00118365|9605250|FG000|COMPLETED|Overall Study||132
8573068|NCT00118365|9605251|FG001|COMPLETED|Overall Study||124
8573069|NCT00118365|9605250|FG000|NOT COMPLETED|Overall Study||59
8573070|NCT00118365|9605251|FG001|NOT COMPLETED|Overall Study||60
8573071|NCT00118378|9605289|FG000|STARTED|Overall Study||62
8573072|NCT00118378|9605290|FG001|STARTED|Overall Study||53
8573073|NCT00118378|9605289|FG000|COMPLETED|Overall Study||60
8573074|NCT00118378|9605290|FG001|COMPLETED|Overall Study||45
8573075|NCT00118378|9605289|FG000|NOT COMPLETED|Overall Study||2
8573076|NCT00118378|9605290|FG001|NOT COMPLETED|Overall Study||8
8573077|NCT00118404|9605301|FG000|STARTED|Overall Study||86
8573078|NCT00118404|9605302|FG001|STARTED|Overall Study||86
8573079|NCT00118404|9605303|FG002|STARTED|Overall Study||69
8573080|NCT00118404|9605301|FG000|COMPLETED|Overall Study||62
8573081|NCT00118404|9605302|FG001|COMPLETED|Overall Study||70
8573082|NCT00118404|9605303|FG002|COMPLETED|Overall Study||49
8573083|NCT00118404|9605301|FG000|NOT COMPLETED|Overall Study||24
8573084|NCT00118404|9605302|FG001|NOT COMPLETED|Overall Study||16
8573085|NCT00118404|9605303|FG002|NOT COMPLETED|Overall Study||20
8573086|NCT00118417|9605311|FG000|STARTED|Phase I (Weeks 0 to 6)||39
8573087|NCT00118417|9605312|FG001|STARTED|Phase I (Weeks 0 to 6)|In Phase 1, all participants received open label SSRI - no second treatment arm.|0
8573088|NCT00118417|9605311|FG000|COMPLETED|Phase I (Weeks 0 to 6)||21
8573089|NCT00118417|9605312|FG001|COMPLETED|Phase I (Weeks 0 to 6)||0
8573090|NCT00118417|9605311|FG000|NOT COMPLETED|Phase I (Weeks 0 to 6)||18
8573091|NCT00118417|9605312|FG001|NOT COMPLETED|Phase I (Weeks 0 to 6)||0
8573092|NCT00118417|9605311|FG000|STARTED|Phase II (Weeks 6 to 12)|Three new participants on Phase 1 endpoint doses of SSRIs entered at Phase 2.|11
8573093|NCT00118417|9605312|FG001|STARTED|Phase II (Weeks 6 to 12)||13
8573094|NCT00118417|9605311|FG000|COMPLETED|Phase II (Weeks 6 to 12)||9
8573095|NCT00118417|9605312|FG001|COMPLETED|Phase II (Weeks 6 to 12)||10
8573096|NCT00118417|9605311|FG000|NOT COMPLETED|Phase II (Weeks 6 to 12)||2
8573097|NCT00118417|9605312|FG001|NOT COMPLETED|Phase II (Weeks 6 to 12)||3
8573098|NCT00118417|9605311|FG000|STARTED|Phase III (Weeks 12 to 24)||9
8573099|NCT00118417|9605312|FG001|STARTED|Phase III (Weeks 12 to 24)||10
8573100|NCT00118417|9605311|FG000|COMPLETED|Phase III (Weeks 12 to 24)||8
8903720|NCT02091206|9961745|FG000|NOT COMPLETED|Taper Period||1
8903721|NCT02091206|9961746|FG001|NOT COMPLETED|Taper Period||0
8903722|NCT02091206|9961747|FG002|NOT COMPLETED|Taper Period||0
8903723|NCT02091206|9961748|FG003|NOT COMPLETED|Taper Period||2
8903724|NCT02091284|9961760|FG000|STARTED|Overall Study|Two subjects from this group discontinued the protocol, data from one subject could not be included.|26
8903725|NCT02091284|9961761|FG001|STARTED|Overall Study|One subject from this group discontinued the protocol|23
8903726|NCT02091284|9961760|FG000|COMPLETED|Overall Study||23
8903727|NCT02091284|9961761|FG001|COMPLETED|Overall Study||22
8903728|NCT02091284|9961760|FG000|NOT COMPLETED|Overall Study||3
8903729|NCT02091284|9961761|FG001|NOT COMPLETED|Overall Study||1
8573101|NCT00118417|9605312|FG001|COMPLETED|Phase III (Weeks 12 to 24)||9
8573102|NCT00118417|9605311|FG000|NOT COMPLETED|Phase III (Weeks 12 to 24)||1
8573103|NCT00118417|9605312|FG001|NOT COMPLETED|Phase III (Weeks 12 to 24)||1
8573104|NCT00118430|9605325|FG000|STARTED|Overall Study||123
8573105|NCT00118430|9605326|FG001|STARTED|Overall Study||127
8573106|NCT00118430|9605327|FG002|STARTED|Overall Study||250
8903730|NCT02091362|9961771|FG000|STARTED|Period 1||133
8903731|NCT02091362|9961772|FG001|STARTED|Period 1||137
8903732|NCT02091362|9961771|FG000|COMPLETED|Period 1||128
8903733|NCT02091362|9961772|FG001|COMPLETED|Period 1||133
8903734|NCT02091362|9961771|FG000|NOT COMPLETED|Period 1||5
8726508|NCT01037114|9773745|FG000|NOT COMPLETED|Year 16||0
8903735|NCT02091362|9961772|FG001|NOT COMPLETED|Period 1||4
8903736|NCT02091362|9961771|FG000|STARTED|Wash-out||128
8903737|NCT02091362|9961772|FG001|STARTED|Wash-out||133
8903738|NCT02091362|9961771|FG000|COMPLETED|Wash-out||127
8903739|NCT02091362|9961772|FG001|COMPLETED|Wash-out||130
8903740|NCT02091362|9961771|FG000|NOT COMPLETED|Wash-out||1
8903741|NCT02091362|9961772|FG001|NOT COMPLETED|Wash-out||3
8903742|NCT02091362|9961771|FG000|STARTED|Period 2||127
8903743|NCT02091362|9961772|FG001|STARTED|Period 2||130
8903744|NCT02091362|9961771|FG000|COMPLETED|Period 2||125
8903745|NCT02091362|9961772|FG001|COMPLETED|Period 2||128
8903746|NCT02091362|9961771|FG000|NOT COMPLETED|Period 2||2
8903747|NCT02091362|9961772|FG001|NOT COMPLETED|Period 2||2
8903748|NCT02091375|9961784|FG000|STARTED|Overall Study||61
8903749|NCT02091375|9961785|FG001|STARTED|Overall Study||59
8903750|NCT02091375|9961784|FG000|Safety Analysis Set|Overall Study||61
8903751|NCT02091375|9961785|FG001|Safety Analysis Set|Overall Study||59
8903752|NCT02091375|9961784|FG000|Intention to Treat (ITT) Analysis Set|Overall Study||61
8903753|NCT02091375|9961785|FG001|Intention to Treat (ITT) Analysis Set|Overall Study||59
8903754|NCT02091375|9961784|FG000|COMPLETED|Overall Study||52
8903755|NCT02091375|9961785|FG001|COMPLETED|Overall Study||56
8903756|NCT02091375|9961784|FG000|NOT COMPLETED|Overall Study||9
8903757|NCT02091375|9961785|FG001|NOT COMPLETED|Overall Study||3
8903758|NCT02091414|9961791|FG000|STARTED|Overall Study||36
8903759|NCT02091414|9961791|FG000|COMPLETED|Overall Study||32
8903760|NCT02091414|9961791|FG000|NOT COMPLETED|Overall Study||4
8903761|NCT02091440|9961795|FG000|STARTED|Overall Study||6
8903762|NCT02091440|9961795|FG000|Primary Endpoint (Success at 180 Days)|Overall Study||6
8903763|NCT02091440|9961795|FG000|Overall Survival at 180 Days|Overall Study||6
8903764|NCT02091440|9961795|FG000|COMPLETED|Overall Study||4
8903765|NCT02091440|9961795|FG000|NOT COMPLETED|Overall Study||2
8903766|NCT02091466|9961801|FG000|STARTED|Overall Study||20
8903767|NCT02091466|9961802|FG001|STARTED|Overall Study||20
8903768|NCT02091466|9961801|FG000|COMPLETED|Overall Study||20
8903769|NCT02091466|9961802|FG001|COMPLETED|Overall Study||20
8903770|NCT02091466|9961801|FG000|NOT COMPLETED|Overall Study||0
8903771|NCT02091466|9961802|FG001|NOT COMPLETED|Overall Study||0
8903772|NCT02091531|9961808|FG000|STARTED|Overall Study||9
8903773|NCT02091531|9961808|FG000|COMPLETED|Overall Study||9
8903774|NCT02091531|9961808|FG000|NOT COMPLETED|Overall Study||0
8903775|NCT02091726|9961812|FG000|STARTED|Overall Study||110
8903776|NCT02091726|9961812|FG000|1 Week Followup|Overall Study||110
8903777|NCT02091726|9961812|FG000|4 Week Followup|Overall Study||104
8903778|NCT02091726|9961812|FG000|COMPLETED|Overall Study||104
8903779|NCT02091726|9961812|FG000|NOT COMPLETED|Overall Study||6
8903780|NCT02091739|9961819|FG000|STARTED|MP: 16 Weeks||36
8903781|NCT02091739|9961820|FG001|STARTED|MP: 16 Weeks||74
8903782|NCT02091739|9961821|FG002|STARTED|MP: 16 Weeks||74
8903783|NCT02091739|9961822|FG003|STARTED|MP: 16 Weeks||0
9011245|NCT02991859|10073870|FG009|STARTED|Period2,Escalation Phase5,Upto Day 112||2
9011246|NCT02991859|10073871|FG010|STARTED|Period2,Escalation Phase5,Upto Day 112||2
9011247|NCT02991859|10073872|FG011|STARTED|Period2,Escalation Phase5,Upto Day 112||2
9011248|NCT02991859|10073873|FG012|STARTED|Period2,Escalation Phase5,Upto Day 112||0
9011249|NCT02991859|10073874|FG013|STARTED|Period2,Escalation Phase5,Upto Day 112||0
9011250|NCT02991859|10073875|FG014|STARTED|Period2,Escalation Phase5,Upto Day 112||0
9011251|NCT02991859|10073876|FG015|STARTED|Period2,Escalation Phase5,Upto Day 112||0
9011252|NCT02991859|10073877|FG016|STARTED|Period2,Escalation Phase5,Upto Day 112||0
9011253|NCT02991859|10073861|FG000|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
9011254|NCT02991859|10073862|FG001|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
9011255|NCT02991859|10073863|FG002|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
9011256|NCT02991859|10073864|FG003|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
9011257|NCT02991859|10073865|FG004|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
9011258|NCT02991859|10073866|FG005|COMPLETED|Period2,Escalation Phase5,Upto Day 112||1
9011259|NCT02991859|10073867|FG006|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
9011260|NCT02991859|10073868|FG007|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
9011261|NCT02991859|10073869|FG008|COMPLETED|Period2,Escalation Phase5,Upto Day 112||1
8903784|NCT02091739|9961823|FG004|STARTED|MP: 16 Weeks||0
8903785|NCT02091739|9961819|FG000|COMPLETED|MP: 16 Weeks||32
8903786|NCT02091739|9961820|FG001|COMPLETED|MP: 16 Weeks||69
8903787|NCT02091739|9961821|FG002|COMPLETED|MP: 16 Weeks||72
8903788|NCT02091739|9961822|FG003|COMPLETED|MP: 16 Weeks||0
8903789|NCT02091739|9961823|FG004|COMPLETED|MP: 16 Weeks||0
8903790|NCT02091739|9961819|FG000|NOT COMPLETED|MP: 16 Weeks||4
8903791|NCT02091739|9961820|FG001|NOT COMPLETED|MP: 16 Weeks||5
8903792|NCT02091739|9961821|FG002|NOT COMPLETED|MP: 16 Weeks||2
8903793|NCT02091739|9961822|FG003|NOT COMPLETED|MP: 16 Weeks||0
8903794|NCT02091739|9961823|FG004|NOT COMPLETED|MP: 16 Weeks||0
8903795|NCT02091739|9961819|FG000|STARTED|EP: 48 Weeks||0
8903796|NCT02091739|9961820|FG001|STARTED|EP: 48 Weeks||0
8903797|NCT02091739|9961821|FG002|STARTED|EP: 48 Weeks||0
8903798|NCT02091739|9961822|FG003|STARTED|EP: 48 Weeks||84
8903799|NCT02091739|9961823|FG004|STARTED|EP: 48 Weeks||89
8903800|NCT02091739|9961819|FG000|COMPLETED|EP: 48 Weeks||0
8903801|NCT02091739|9961820|FG001|COMPLETED|EP: 48 Weeks||0
8903802|NCT02091739|9961821|FG002|COMPLETED|EP: 48 Weeks||0
8903803|NCT02091739|9961822|FG003|COMPLETED|EP: 48 Weeks||76
8903804|NCT02091739|9961823|FG004|COMPLETED|EP: 48 Weeks||75
8903805|NCT02091739|9961819|FG000|NOT COMPLETED|EP: 48 Weeks||0
8903806|NCT02091739|9961820|FG001|NOT COMPLETED|EP: 48 Weeks||0
8903807|NCT02091739|9961821|FG002|NOT COMPLETED|EP: 48 Weeks||0
8903808|NCT02091739|9961822|FG003|NOT COMPLETED|EP: 48 Weeks||8
8903809|NCT02091739|9961823|FG004|NOT COMPLETED|EP: 48 Weeks||14
8903810|NCT02091778|9961833|FG000|STARTED|Overall Study||21
8903811|NCT02091778|9961833|FG000|COMPLETED|Overall Study||20
8903812|NCT02091778|9961833|FG000|NOT COMPLETED|Overall Study||1
8903813|NCT02091856|9961840|FG000|STARTED|Active Intervention Interval||34
8903814|NCT02091856|9961841|FG001|STARTED|Active Intervention Interval||19
8903815|NCT02091856|9961842|FG002|STARTED|Active Intervention Interval||26
8903816|NCT02091856|9961840|FG000|COMPLETED|Active Intervention Interval||15
8903817|NCT02091856|9961841|FG001|COMPLETED|Active Intervention Interval||12
8903818|NCT02091856|9961842|FG002|COMPLETED|Active Intervention Interval||19
8903819|NCT02091856|9961840|FG000|NOT COMPLETED|Active Intervention Interval||19
8903820|NCT02091856|9961841|FG001|NOT COMPLETED|Active Intervention Interval||7
8903821|NCT02091856|9961842|FG002|NOT COMPLETED|Active Intervention Interval||7
8903822|NCT02091856|9961840|FG000|STARTED|Follow-up Assessment|Only a subset of C-CBT participants responded to our request to complete the follow-up assessment.|15
8903823|NCT02091856|9961841|FG001|STARTED|Follow-up Assessment|Only a subset of R-CBT participants responded to our request to complete the follow-up assessment.|12
8903824|NCT02091856|9961842|FG002|STARTED|Follow-up Assessment|WLCG participants were lost at follow-up.|0
8903825|NCT02091856|9961840|FG000|COMPLETED|Follow-up Assessment||10
8903826|NCT02091856|9961841|FG001|COMPLETED|Follow-up Assessment||9
8903827|NCT02091856|9961842|FG002|COMPLETED|Follow-up Assessment||0
8903828|NCT02091856|9961840|FG000|NOT COMPLETED|Follow-up Assessment||5
8903829|NCT02091856|9961841|FG001|NOT COMPLETED|Follow-up Assessment||3
8903830|NCT02091856|9961842|FG002|NOT COMPLETED|Follow-up Assessment||0
8903831|NCT02091869|9961852|FG000|STARTED|Overall Study||17
8903832|NCT02091869|9961853|FG001|STARTED|Overall Study||17
8903833|NCT02091869|9961852|FG000|COMPLETED|Overall Study||17
8903834|NCT02091869|9961853|FG001|COMPLETED|Overall Study||14
8903835|NCT02091869|9961852|FG000|NOT COMPLETED|Overall Study||0
8903836|NCT02091869|9961853|FG001|NOT COMPLETED|Overall Study||3
8903837|NCT02091882|9961859|FG000|STARTED|Overall Study||30
8903838|NCT02091882|9961859|FG000|COMPLETED|Overall Study||30
8903839|NCT02091882|9961859|FG000|NOT COMPLETED|Overall Study||0
8903840|NCT02091921|9961863|FG000|STARTED|Overall Study||53
8903841|NCT02091921|9961863|FG000|COMPLETED|Overall Study||50
8903842|NCT02091921|9961863|FG000|NOT COMPLETED|Overall Study||3
8903843|NCT02091986|9961873|FG000|STARTED|Overall Study||92
8903844|NCT02091986|9961874|FG001|STARTED|Overall Study||95
8903845|NCT02091986|9961875|FG002|STARTED|Overall Study||92
8903846|NCT02091986|9961873|FG000|COMPLETED|Overall Study||85
8903847|NCT02091986|9961874|FG001|COMPLETED|Overall Study||84
8903848|NCT02091986|9961875|FG002|COMPLETED|Overall Study||84
8903849|NCT02091986|9961873|FG000|NOT COMPLETED|Overall Study||7
8903850|NCT02091986|9961874|FG001|NOT COMPLETED|Overall Study||11
8903851|NCT02091986|9961875|FG002|NOT COMPLETED|Overall Study||8
8903852|NCT02092025|9961883|FG000|STARTED|Overall Study||3437
8903853|NCT02092025|9961883|FG000|COMPLETED|Overall Study||3369
9011262|NCT02991859|10073870|FG009|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
9011263|NCT02991859|10073871|FG010|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
9011264|NCT02991859|10073872|FG011|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
9011265|NCT02991859|10073873|FG012|COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
9011266|NCT02991859|10073874|FG013|COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
9011267|NCT02991859|10073875|FG014|COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
9011268|NCT02991859|10073876|FG015|COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
9011269|NCT02991859|10073877|FG016|COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
9011270|NCT02991859|10073861|FG000|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
9011271|NCT02991859|10073862|FG001|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
9011272|NCT02991859|10073863|FG002|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
9011273|NCT02991859|10073864|FG003|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
9011274|NCT02991859|10073865|FG004|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
9011275|NCT02991859|10073866|FG005|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
8903854|NCT02092025|9961883|FG000|NOT COMPLETED|Overall Study||68
8903855|NCT02092116|9961889|FG000|STARTED|Overall Study||6
8903856|NCT02092116|9961890|FG001|STARTED|Overall Study||20
8903857|NCT02092116|9961889|FG000|COMPLETED|Overall Study||6
8903858|NCT02092116|9961890|FG001|COMPLETED|Overall Study||16
8903859|NCT02092116|9961889|FG000|NOT COMPLETED|Overall Study||0
8903860|NCT02092116|9961890|FG001|NOT COMPLETED|Overall Study||4
8903861|NCT02092168|9961898|FG000|STARTED|Overall Study||12
8903862|NCT02092168|9961899|FG001|STARTED|Overall Study||12
8903863|NCT02092168|9961898|FG000|COMPLETED|Overall Study||12
8903864|NCT02092168|9961899|FG001|COMPLETED|Overall Study||12
8903865|NCT02092168|9961898|FG000|NOT COMPLETED|Overall Study||0
8903866|NCT02092168|9961899|FG001|NOT COMPLETED|Overall Study||0
8903867|NCT02092181|9961907|FG000|STARTED|Overall Study||15
8903868|NCT02092181|9961908|FG001|STARTED|Overall Study||15
8903869|NCT02092181|9961907|FG000|COMPLETED|Overall Study||12
8903870|NCT02092181|9961908|FG001|COMPLETED|Overall Study||14
8903871|NCT02092181|9961907|FG000|NOT COMPLETED|Overall Study||3
8903872|NCT02092181|9961908|FG001|NOT COMPLETED|Overall Study||1
8903873|NCT02092220|9961914|FG000|STARTED|Period 1||21
8903874|NCT02092220|9961915|FG001|STARTED|Period 1||22
8903875|NCT02092220|9961914|FG000|COMPLETED|Period 1||21
8903876|NCT02092220|9961915|FG001|COMPLETED|Period 1||20
8903877|NCT02092220|9961914|FG000|NOT COMPLETED|Period 1||0
8903878|NCT02092220|9961915|FG001|NOT COMPLETED|Period 1||2
8903879|NCT02092220|9961914|FG000|STARTED|Period 2||21
8903880|NCT02092220|9961915|FG001|STARTED|Period 2||20
8903881|NCT02092220|9961914|FG000|COMPLETED|Period 2||20
8903882|NCT02092220|9961915|FG001|COMPLETED|Period 2||19
8903883|NCT02092220|9961914|FG000|NOT COMPLETED|Period 2||1
8903884|NCT02092220|9961915|FG001|NOT COMPLETED|Period 2||1
8903885|NCT02092285|9961923|FG000|STARTED|Induction Phase||205
8903886|NCT02092285|9961923|FG000|COMPLETED|Induction Phase||170
8903887|NCT02092285|9961923|FG000|NOT COMPLETED|Induction Phase||35
8903888|NCT02092285|9961923|FG000|STARTED|Maintenance Phase & Follow-up||170
8903889|NCT02092285|9961923|FG000|COMPLETED|Maintenance Phase & Follow-up||60
8903890|NCT02092285|9961923|FG000|NOT COMPLETED|Maintenance Phase & Follow-up||110
8903891|NCT02092298|9961927|FG000|STARTED|Overall Study||19
8903892|NCT02092298|9961927|FG000|COMPLETED|Overall Study||19
8903893|NCT02092298|9961927|FG000|NOT COMPLETED|Overall Study||0
8903894|NCT02092311|9961933|FG000|STARTED|Overall Study||285
8903895|NCT02092311|9961934|FG001|STARTED|Overall Study||285
8903896|NCT02092311|9961933|FG000|COMPLETED|Overall Study||285
8903897|NCT02092311|9961934|FG001|COMPLETED|Overall Study||285
8903898|NCT02092311|9961933|FG000|NOT COMPLETED|Overall Study||0
8903899|NCT02092311|9961934|FG001|NOT COMPLETED|Overall Study||0
8903900|NCT02092324|9961942|FG000|STARTED|Overall Study||51
8903901|NCT02092324|9961942|FG000|End of Cycle 6|Overall Study|This study has an accrual goal of 25 evaluable subjects who reach cycle 7, week 1.|25
8903902|NCT02092324|9961942|FG000|Wildtype CSF3R|Overall Study||23
8903903|NCT02092324|9961942|FG000|Mutant CSF3R|Overall Study||26
8903904|NCT02092324|9961942|FG000|COMPLETED|Overall Study||32
8903905|NCT02092324|9961942|FG000|NOT COMPLETED|Overall Study||19
8903906|NCT02092350|9961951|FG000|STARTED|Overall Study||123
8903907|NCT02092350|9961952|FG001|STARTED|Overall Study||114
8903908|NCT02092350|9961951|FG000|COMPLETED|Overall Study||113
8903909|NCT02092350|9961952|FG001|COMPLETED|Overall Study||102
8903910|NCT02092350|9961951|FG000|NOT COMPLETED|Overall Study||10
8903911|NCT02092350|9961952|FG001|NOT COMPLETED|Overall Study||12
8903912|NCT02092389|9961960|FG000|STARTED|Overall Study||10
8903913|NCT02092389|9961960|FG000|COMPLETED|Overall Study||4
8903914|NCT02092389|9961960|FG000|NOT COMPLETED|Overall Study||6
8903915|NCT02092415|9961964|FG000|STARTED|Overall Study||10
8903916|NCT02092415|9961964|FG000|COMPLETED|Overall Study||10
8903917|NCT02092415|9961964|FG000|NOT COMPLETED|Overall Study||0
8903918|NCT02092441|9961971|FG000|STARTED|Overall Study||37
8903919|NCT02092441|9961972|FG001|STARTED|Overall Study||43
8903920|NCT02092441|9961971|FG000|COMPLETED|Overall Study||37
8903921|NCT02092441|9961972|FG001|COMPLETED|Overall Study||43
8903922|NCT02092441|9961971|FG000|NOT COMPLETED|Overall Study||0
8903923|NCT02092441|9961972|FG001|NOT COMPLETED|Overall Study||0
8903924|NCT02092467|9961981|FG000|STARTED|Overall Study||1457
8903925|NCT02092467|9961982|FG001|STARTED|Overall Study||1457
8903926|NCT02092467|9961983|FG002|STARTED|Overall Study||1458
8903927|NCT02092467|9961981|FG000|Treated|Overall Study||1455
8903928|NCT02092467|9961982|FG001|Treated|Overall Study||1456
8903929|NCT02092467|9961983|FG002|Treated|Overall Study||1451
8903930|NCT02092467|9961981|FG000|COMPLETED|Overall Study||1053
8903931|NCT02092467|9961982|FG001|COMPLETED|Overall Study||998
8903932|NCT02092467|9961983|FG002|COMPLETED|Overall Study||1060
8903933|NCT02092467|9961981|FG000|NOT COMPLETED|Overall Study||404
8903934|NCT02092467|9961982|FG001|NOT COMPLETED|Overall Study||459
8903935|NCT02092467|9961983|FG002|NOT COMPLETED|Overall Study||398
8903936|NCT02092610|9961995|FG000|STARTED|Overall Study||25
8903937|NCT02092610|9961996|FG001|STARTED|Overall Study||52
8903938|NCT02092610|9961995|FG000|COMPLETED|Overall Study||17
8903939|NCT02092610|9961996|FG001|COMPLETED|Overall Study||40
8903940|NCT02092610|9961995|FG000|NOT COMPLETED|Overall Study||8
8903941|NCT02092610|9961996|FG001|NOT COMPLETED|Overall Study||12
8903942|NCT02092649|9962004|FG000|STARTED|Overall Study|13 participants recruited|13
8903943|NCT02092649|9962005|FG001|STARTED|Overall Study|13 participants recruited|13
8903944|NCT02092649|9962004|FG000|COMPLETED|Overall Study|13 participants finished study|13
8903945|NCT02092649|9962005|FG001|COMPLETED|Overall Study|13 participants finished study|13
8903946|NCT02092649|9962004|FG000|NOT COMPLETED|Overall Study||0
8903947|NCT02092649|9962005|FG001|NOT COMPLETED|Overall Study||0
8903948|NCT02092662|9962013|FG000|STARTED|Overall Study||38
8903949|NCT02092662|9962014|FG001|STARTED|Overall Study||19
8903950|NCT02092662|9962013|FG000|Recruited|Overall Study||38
8903951|NCT02092662|9962014|FG001|Recruited|Overall Study||19
8903952|NCT02092662|9962013|FG000|COMPLETED|Overall Study||25
8903953|NCT02092662|9962014|FG001|COMPLETED|Overall Study||19
8903954|NCT02092662|9962013|FG000|NOT COMPLETED|Overall Study||13
8903955|NCT02092662|9962014|FG001|NOT COMPLETED|Overall Study||0
8903956|NCT02092857|9962024|FG000|STARTED|Overall Study||30
8903957|NCT02092857|9962025|FG001|STARTED|Overall Study||30
8903958|NCT02092857|9962026|FG002|STARTED|Overall Study||29
8903959|NCT02092857|9962024|FG000|COMPLETED|Overall Study||20
8903960|NCT02092857|9962025|FG001|COMPLETED|Overall Study||18
8903961|NCT02092857|9962026|FG002|COMPLETED|Overall Study||16
8903962|NCT02092857|9962024|FG000|NOT COMPLETED|Overall Study||10
8903963|NCT02092857|9962025|FG001|NOT COMPLETED|Overall Study||12
8903964|NCT02092857|9962026|FG002|NOT COMPLETED|Overall Study||13
8903965|NCT02092909|9962038|FG000|STARTED|Overall Study||6
8903966|NCT02092909|9962039|FG001|STARTED|Overall Study||5
8903967|NCT02092909|9962040|FG002|STARTED|Overall Study||14
8903968|NCT02092909|9962041|FG003|STARTED|Overall Study||6
8903969|NCT02092909|9962038|FG000|COMPLETED|Overall Study||5
8903970|NCT02092909|9962039|FG001|COMPLETED|Overall Study||2
8903971|NCT02092909|9962040|FG002|COMPLETED|Overall Study||5
8903972|NCT02092909|9962041|FG003|COMPLETED|Overall Study||0
8903973|NCT02092909|9962038|FG000|NOT COMPLETED|Overall Study||1
8903974|NCT02092909|9962039|FG001|NOT COMPLETED|Overall Study||3
8903975|NCT02092909|9962040|FG002|NOT COMPLETED|Overall Study||9
8903976|NCT02092909|9962041|FG003|NOT COMPLETED|Overall Study||6
8903977|NCT02092961|9962054|FG000|STARTED|Overall Study|Patients who received treatment|33
8903978|NCT02092961|9962055|FG001|STARTED|Overall Study|Patients who received treatment|28
8903979|NCT02092961|9962056|FG002|STARTED|Overall Study|Patients who received treatment|29
8903980|NCT02092961|9962054|FG000|Randomised But Did Not Receive Treatment|Overall Study|Study stopped|1
8903981|NCT02092961|9962055|FG001|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/study stopped|5
8903982|NCT02092961|9962056|FG002|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled|1
8903983|NCT02092961|9962054|FG000|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|12
8903984|NCT02092961|9962055|FG001|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|14
8903985|NCT02092961|9962056|FG002|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|13
8903986|NCT02092961|9962054|FG000|NOT COMPLETED|Overall Study||21
8903987|NCT02092961|9962055|FG001|NOT COMPLETED|Overall Study||14
8903988|NCT02092961|9962056|FG002|NOT COMPLETED|Overall Study||16
8903989|NCT02092987|9962067|FG000|STARTED|Overall Study||110
8903990|NCT02092987|9962068|FG001|STARTED|Overall Study||111
8903991|NCT02092987|9962067|FG000|COMPLETED|Overall Study||106
8903992|NCT02092987|9962068|FG001|COMPLETED|Overall Study||103
8903993|NCT02092987|9962067|FG000|NOT COMPLETED|Overall Study||4
8903994|NCT02092987|9962068|FG001|NOT COMPLETED|Overall Study||8
8903995|NCT02093026|9962077|FG000|STARTED|Overall Study||465
8903996|NCT02093026|9962077|FG000|COMPLETED|Overall Study|At predefined end-of-treatment date, 272 ongoing participants were designated as completed study.|272
8903997|NCT02093026|9962077|FG000|NOT COMPLETED|Overall Study||193
8903998|NCT02093221|9962087|FG000|STARTED|Overall Study||15
8903999|NCT02093221|9962088|FG001|STARTED|Overall Study||16
8904000|NCT02093221|9962089|FG002|STARTED|Overall Study||15
8904001|NCT02093221|9962090|FG003|STARTED|Overall Study||15
8904002|NCT02093221|9962091|FG004|STARTED|Overall Study||15
8904003|NCT02093221|9962087|FG000|COMPLETED|Overall Study||5
8904004|NCT02093221|9962088|FG001|COMPLETED|Overall Study||8
8904005|NCT02093221|9962089|FG002|COMPLETED|Overall Study||6
8904006|NCT02093221|9962090|FG003|COMPLETED|Overall Study||7
8904007|NCT02093221|9962091|FG004|COMPLETED|Overall Study||7
8904008|NCT02093221|9962087|FG000|NOT COMPLETED|Overall Study||10
8904009|NCT02093221|9962088|FG001|NOT COMPLETED|Overall Study||8
8904010|NCT02093221|9962089|FG002|NOT COMPLETED|Overall Study||9
8904011|NCT02093221|9962090|FG003|NOT COMPLETED|Overall Study||8
8904012|NCT02093221|9962091|FG004|NOT COMPLETED|Overall Study||8
8904013|NCT02093234|9962106|FG000|STARTED|Overall Study||56
8904014|NCT02093234|9962107|FG001|STARTED|Overall Study||56
8904015|NCT02093234|9962108|FG002|STARTED|Overall Study||54
8904016|NCT02093234|9962106|FG000|COMPLETED|Overall Study||53
8904017|NCT02093234|9962107|FG001|COMPLETED|Overall Study||52
8904018|NCT02093234|9962108|FG002|COMPLETED|Overall Study||50
8904019|NCT02093234|9962106|FG000|NOT COMPLETED|Overall Study||3
8904020|NCT02093234|9962107|FG001|NOT COMPLETED|Overall Study||4
8904021|NCT02093234|9962108|FG002|NOT COMPLETED|Overall Study||4
8904022|NCT02093351|9962119|FG000|STARTED|Part A||30
8904023|NCT02093351|9962120|FG001|STARTED|Part A||23
8904024|NCT02093351|9962121|FG002|STARTED|Part A||26
8904025|NCT02093351|9962122|FG003|STARTED|Part A||0
8904026|NCT02093351|9962119|FG000|Completing Treatment Period 1|Part A||29
8904027|NCT02093351|9962120|FG001|Completing Treatment Period 1|Part A||22
8904028|NCT02093351|9962121|FG002|Completing Treatment Period 1|Part A||23
8904029|NCT02093351|9962122|FG003|Completing Treatment Period 1|Part A||0
8904030|NCT02093351|9962119|FG000|Completing Treatment Period 2|Part A||29
8904031|NCT02093351|9962120|FG001|Completing Treatment Period 2|Part A||21
8904032|NCT02093351|9962121|FG002|Completing Treatment Period 2|Part A||23
8904033|NCT02093351|9962122|FG003|Completing Treatment Period 2|Part A||0
8904034|NCT02093351|9962119|FG000|Completing Treatment Period 3|Part A||28
8904035|NCT02093351|9962120|FG001|Completing Treatment Period 3|Part A||21
8904036|NCT02093351|9962121|FG002|Completing Treatment Period 3|Part A||23
8904037|NCT02093351|9962122|FG003|Completing Treatment Period 3|Part A||0
8904038|NCT02093351|9962119|FG000|COMPLETED|Part A||28
8904039|NCT02093351|9962120|FG001|COMPLETED|Part A||21
8904040|NCT02093351|9962121|FG002|COMPLETED|Part A||23
8904041|NCT02093351|9962122|FG003|COMPLETED|Part A||0
8904042|NCT02093351|9962119|FG000|NOT COMPLETED|Part A||2
8904043|NCT02093351|9962120|FG001|NOT COMPLETED|Part A||2
8904044|NCT02093351|9962121|FG002|NOT COMPLETED|Part A||3
8904045|NCT02093351|9962122|FG003|NOT COMPLETED|Part A||0
8904046|NCT02093351|9962119|FG000|STARTED|Part B|Only the Olaparib (Part B) arm is applicable for this period.|0
8904047|NCT02093351|9962120|FG001|STARTED|Part B|Only the Olaparib (Part B) arm is applicable for this period.|0
8904048|NCT02093351|9962121|FG002|STARTED|Part B|Only the Olaparib (Part B) arm is applicable for this period.|0
8904049|NCT02093351|9962122|FG003|STARTED|Part B|Eligible patients completing Part A entered Part B for continued access to olaparib.|69
8904050|NCT02093351|9962119|FG000|COMPLETED|Part B||0
8636457|NCT00568087|9677082|FG001|NOT COMPLETED|Overall Study||7
8636458|NCT00568126|9677090|FG000|STARTED|Overall Study||24
8636459|NCT00568126|9677091|FG001|STARTED|Overall Study||21
8636460|NCT00568126|9677090|FG000|COMPLETED|Overall Study||13
8636461|NCT00568126|9677091|FG001|COMPLETED|Overall Study||12
8636462|NCT00568126|9677090|FG000|NOT COMPLETED|Overall Study||11
8636463|NCT00568126|9677091|FG001|NOT COMPLETED|Overall Study||9
8636464|NCT00568321|9677100|FG000|STARTED|Overall Study||33
8636465|NCT00568321|9677101|FG001|STARTED|Overall Study||33
8636466|NCT00568321|9677102|FG002|STARTED|Overall Study||33
8636467|NCT00568321|9677100|FG000|Treated|Overall Study||31
8636468|NCT00568321|9677101|FG001|Treated|Overall Study||33
8636469|NCT00568321|9677102|FG002|Treated|Overall Study||32
8636470|NCT00568321|9677100|FG000|COMPLETED|Overall Study||20
8636471|NCT00568321|9677101|FG001|COMPLETED|Overall Study||28
8904051|NCT02093351|9962120|FG001|COMPLETED|Part B||0
8904052|NCT02093351|9962121|FG002|COMPLETED|Part B||0
8904053|NCT02093351|9962122|FG003|COMPLETED|Part B||6
8904054|NCT02093351|9962119|FG000|NOT COMPLETED|Part B||0
8904055|NCT02093351|9962120|FG001|NOT COMPLETED|Part B||0
8904056|NCT02093351|9962121|FG002|NOT COMPLETED|Part B||0
8904057|NCT02093351|9962122|FG003|NOT COMPLETED|Part B||63
8904058|NCT02093390|9962139|FG000|STARTED|Overall Study||20
8904059|NCT02093390|9962140|FG001|STARTED|Overall Study||20
8904060|NCT02093390|9962139|FG000|COMPLETED|Overall Study||20
8904061|NCT02093390|9962140|FG001|COMPLETED|Overall Study||19
8904062|NCT02093390|9962139|FG000|NOT COMPLETED|Overall Study||0
8904063|NCT02093390|9962140|FG001|NOT COMPLETED|Overall Study||1
8904064|NCT02093520|9962149|FG000|STARTED|Overall Study||149
8904065|NCT02093520|9962150|FG001|STARTED|Overall Study||153
8904066|NCT02093520|9962149|FG000|COMPLETED|Overall Study||143
8904067|NCT02093520|9962150|FG001|COMPLETED|Overall Study||131
8904068|NCT02093520|9962149|FG000|NOT COMPLETED|Overall Study||6
8904069|NCT02093520|9962150|FG001|NOT COMPLETED|Overall Study||22
8904070|NCT02093663|9962156|FG000|STARTED|Double Blind Acute Phase (8 Weeks)||27
8904071|NCT02093663|9962157|FG001|STARTED|Double Blind Acute Phase (8 Weeks)||26
8904072|NCT02093663|9962158|FG002|STARTED|Double Blind Acute Phase (8 Weeks)||0
8904073|NCT02093663|9962159|FG003|STARTED|Double Blind Acute Phase (8 Weeks)||0
8904074|NCT02093663|9962160|FG004|STARTED|Double Blind Acute Phase (8 Weeks)||0
8904075|NCT02093663|9962156|FG000|COMPLETED|Double Blind Acute Phase (8 Weeks)||19
8904076|NCT02093663|9962157|FG001|COMPLETED|Double Blind Acute Phase (8 Weeks)||22
8904077|NCT02093663|9962158|FG002|COMPLETED|Double Blind Acute Phase (8 Weeks)||0
8904078|NCT02093663|9962159|FG003|COMPLETED|Double Blind Acute Phase (8 Weeks)||0
8904079|NCT02093663|9962160|FG004|COMPLETED|Double Blind Acute Phase (8 Weeks)||0
8904080|NCT02093663|9962156|FG000|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||8
8904081|NCT02093663|9962157|FG001|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||4
8904082|NCT02093663|9962158|FG002|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||0
8904083|NCT02093663|9962159|FG003|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||0
8904084|NCT02093663|9962160|FG004|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||0
8904085|NCT02093663|9962156|FG000|STARTED|Open Label Acute Phase (8 Weeks)||0
8904086|NCT02093663|9962157|FG001|STARTED|Open Label Acute Phase (8 Weeks)||0
8904087|NCT02093663|9962158|FG002|STARTED|Open Label Acute Phase (8 Weeks)||18
8904088|NCT02093663|9962159|FG003|STARTED|Open Label Acute Phase (8 Weeks)||0
8904089|NCT02093663|9962160|FG004|STARTED|Open Label Acute Phase (8 Weeks)||0
8904090|NCT02093663|9962156|FG000|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||0
8904091|NCT02093663|9962157|FG001|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||0
8904092|NCT02093663|9962158|FG002|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||18
8904093|NCT02093663|9962159|FG003|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||0
8904094|NCT02093663|9962160|FG004|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||0
8904095|NCT02093663|9962156|FG000|COMPLETED|Open Label Acute Phase (8 Weeks)||0
8904096|NCT02093663|9962157|FG001|COMPLETED|Open Label Acute Phase (8 Weeks)||0
8904097|NCT02093663|9962158|FG002|COMPLETED|Open Label Acute Phase (8 Weeks)||12
8904098|NCT02093663|9962159|FG003|COMPLETED|Open Label Acute Phase (8 Weeks)||0
8904099|NCT02093663|9962160|FG004|COMPLETED|Open Label Acute Phase (8 Weeks)||0
8904100|NCT02093663|9962156|FG000|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||0
8904101|NCT02093663|9962157|FG001|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||0
8904102|NCT02093663|9962158|FG002|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||6
8636472|NCT00568321|9677102|FG002|COMPLETED|Overall Study||24
8636473|NCT00568321|9677100|FG000|NOT COMPLETED|Overall Study||13
8636474|NCT00568321|9677101|FG001|NOT COMPLETED|Overall Study||5
8636475|NCT00568321|9677102|FG002|NOT COMPLETED|Overall Study||9
8636476|NCT00568334|9677114|FG000|STARTED|Overall Study||122
8636477|NCT00568334|9677115|FG001|STARTED|Overall Study||122
8904103|NCT02093663|9962159|FG003|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||0
8904104|NCT02093663|9962160|FG004|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||0
8904105|NCT02093663|9962156|FG000|STARTED|Double Blind Maintenance Phase(26 Weeks)||0
8904106|NCT02093663|9962157|FG001|STARTED|Double Blind Maintenance Phase(26 Weeks)||0
8904107|NCT02093663|9962158|FG002|STARTED|Double Blind Maintenance Phase(26 Weeks)||0
8904108|NCT02093663|9962159|FG003|STARTED|Double Blind Maintenance Phase(26 Weeks)||42
8904109|NCT02093663|9962160|FG004|STARTED|Double Blind Maintenance Phase(26 Weeks)||45
8904110|NCT02093663|9962156|FG000|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||0
8904111|NCT02093663|9962157|FG001|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||0
8904112|NCT02093663|9962158|FG002|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||0
8904113|NCT02093663|9962159|FG003|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||26
8904114|NCT02093663|9962160|FG004|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||26
8904115|NCT02093663|9962156|FG000|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||0
8904116|NCT02093663|9962157|FG001|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||0
8904117|NCT02093663|9962158|FG002|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||0
8904118|NCT02093663|9962159|FG003|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||12
8904119|NCT02093663|9962160|FG004|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||15
8904120|NCT02093663|9962156|FG000|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||0
8904121|NCT02093663|9962157|FG001|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||0
8904122|NCT02093663|9962158|FG002|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||0
8904123|NCT02093663|9962159|FG003|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||4
8904124|NCT02093663|9962160|FG004|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||4
8904125|NCT02093663|9962156|FG000|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
8904126|NCT02093663|9962157|FG001|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
8904127|NCT02093663|9962158|FG002|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
8904128|NCT02093663|9962159|FG003|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||32
8904129|NCT02093663|9962160|FG004|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||34
8904130|NCT02093663|9962156|FG000|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
8904131|NCT02093663|9962157|FG001|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
8904132|NCT02093663|9962158|FG002|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
8904133|NCT02093663|9962159|FG003|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||10
8904134|NCT02093663|9962160|FG004|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||11
8904135|NCT02093702|9962179|FG000|STARTED|Overall Study||2
8904136|NCT02093702|9962180|FG001|STARTED|Overall Study||3
8904137|NCT02093702|9962179|FG000|COMPLETED|Overall Study||2
8904138|NCT02093702|9962180|FG001|COMPLETED|Overall Study||3
8904139|NCT02093702|9962179|FG000|NOT COMPLETED|Overall Study||0
8904140|NCT02093702|9962180|FG001|NOT COMPLETED|Overall Study||0
8904141|NCT02093793|9962190|FG000|STARTED|Overall Study||98
8904142|NCT02093793|9962191|FG001|STARTED|Overall Study||90
8904143|NCT02093793|9962192|FG002|STARTED|Overall Study||68
8904144|NCT02093793|9962190|FG000|COMPLETED|Overall Study||91
8904145|NCT02093793|9962191|FG001|COMPLETED|Overall Study||80
8904146|NCT02093793|9962192|FG002|COMPLETED|Overall Study||65
8904147|NCT02093793|9962190|FG000|NOT COMPLETED|Overall Study||7
8904148|NCT02093793|9962191|FG001|NOT COMPLETED|Overall Study||10
8904149|NCT02093793|9962192|FG002|NOT COMPLETED|Overall Study||3
8904150|NCT02093819|9962208|FG000|STARTED|Overall Study||15
8904151|NCT02093819|9962209|FG001|STARTED|Overall Study||6
8904152|NCT02093819|9962210|FG002|STARTED|Overall Study||10
8904153|NCT02093819|9962211|FG003|STARTED|Overall Study||6
8904154|NCT02093819|9962212|FG004|STARTED|Overall Study||6
8904155|NCT02093819|9962213|FG005|STARTED|Overall Study||6
8904156|NCT02093819|9962214|FG006|STARTED|Overall Study||5
8904157|NCT02093819|9962215|FG007|STARTED|Overall Study||6
8904158|NCT02093819|9962208|FG000|COMPLETED|Overall Study||15
8904159|NCT02093819|9962209|FG001|COMPLETED|Overall Study||6
8904160|NCT02093819|9962210|FG002|COMPLETED|Overall Study||10
8904161|NCT02093819|9962211|FG003|COMPLETED|Overall Study||6
8904162|NCT02093819|9962212|FG004|COMPLETED|Overall Study||6
8904163|NCT02093819|9962213|FG005|COMPLETED|Overall Study||6
8904164|NCT02093819|9962214|FG006|COMPLETED|Overall Study||5
8904165|NCT02093819|9962215|FG007|COMPLETED|Overall Study||6
8904166|NCT02093819|9962208|FG000|NOT COMPLETED|Overall Study||0
8904167|NCT02093819|9962209|FG001|NOT COMPLETED|Overall Study||0
8904168|NCT02093819|9962210|FG002|NOT COMPLETED|Overall Study||0
8904169|NCT02093819|9962211|FG003|NOT COMPLETED|Overall Study||0
8904170|NCT02093819|9962212|FG004|NOT COMPLETED|Overall Study||0
8904171|NCT02093819|9962213|FG005|NOT COMPLETED|Overall Study||0
8904172|NCT02093819|9962214|FG006|NOT COMPLETED|Overall Study||0
8904173|NCT02093819|9962215|FG007|NOT COMPLETED|Overall Study||0
8904174|NCT02093897|9962242|FG000|STARTED|Overall Study||84
8904175|NCT02093897|9962242|FG000|COMPLETED|Overall Study||65
8904176|NCT02093897|9962242|FG000|NOT COMPLETED|Overall Study||19
8904177|NCT02093923|9962258|FG000|STARTED|Overall Study||4
8904178|NCT02093923|9962259|FG001|STARTED|Overall Study||4
8904179|NCT02093923|9962260|FG002|STARTED|Overall Study||5
8904180|NCT02093923|9962261|FG003|STARTED|Overall Study||12
8904181|NCT02093923|9962262|FG004|STARTED|Overall Study||13
8904182|NCT02093923|9962258|FG000|Total Treated|Overall Study||4
8904183|NCT02093923|9962259|FG001|Total Treated|Overall Study||4
8904184|NCT02093923|9962260|FG002|Total Treated|Overall Study||5
8904185|NCT02093923|9962261|FG003|Total Treated|Overall Study||11
8904186|NCT02093923|9962262|FG004|Total Treated|Overall Study||13
8904187|NCT02093923|9962258|FG000|Treated - 1 Dose Only:|Overall Study||0
8904188|NCT02093923|9962259|FG001|Treated - 1 Dose Only:|Overall Study||0
8904189|NCT02093923|9962260|FG002|Treated - 1 Dose Only:|Overall Study||0
9011276|NCT02991859|10073867|FG006|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
9011277|NCT02991859|10073868|FG007|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
9011278|NCT02991859|10073869|FG008|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
9011279|NCT02991859|10073870|FG009|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
9011280|NCT02991859|10073871|FG010|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
9011281|NCT02991859|10073872|FG011|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
9011282|NCT02991859|10073873|FG012|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
9011283|NCT02991859|10073874|FG013|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
9011284|NCT02991859|10073875|FG014|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
9011285|NCT02991859|10073876|FG015|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
9011286|NCT02991859|10073877|FG016|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
9011287|NCT02991898|10073952|FG000|STARTED|Overall Study||3
9011288|NCT02991898|10073952|FG000|COMPLETED|Overall Study||3
9011289|NCT02991898|10073952|FG000|NOT COMPLETED|Overall Study||0
9011290|NCT02992067|10073956|FG000|STARTED|Overall Study||359
9011291|NCT02992067|10073956|FG000|COMPLETED|Overall Study||359
9011292|NCT02992067|10073956|FG000|NOT COMPLETED|Overall Study||0
9011293|NCT02992132|10073963|FG000|STARTED|Overall Study||40
9011294|NCT02992132|10073964|FG001|STARTED|Overall Study||35
9011295|NCT02992132|10073965|FG002|STARTED|Overall Study||36
9011296|NCT02992132|10073963|FG000|COMPLETED|Overall Study||27
9011297|NCT02992132|10073964|FG001|COMPLETED|Overall Study||27
9011298|NCT02992132|10073965|FG002|COMPLETED|Overall Study||29
9011299|NCT02992132|10073963|FG000|NOT COMPLETED|Overall Study||13
9011300|NCT02992132|10073964|FG001|NOT COMPLETED|Overall Study||8
9011301|NCT02992132|10073965|FG002|NOT COMPLETED|Overall Study||7
9011302|NCT02992197|10073975|FG000|STARTED|Overall Study||110
9011303|NCT02992197|10073976|FG001|STARTED|Overall Study||110
9011304|NCT02992197|10073975|FG000|COMPLETED|Overall Study||99
9011305|NCT02992197|10073976|FG001|COMPLETED|Overall Study||103
9011306|NCT02992197|10073975|FG000|NOT COMPLETED|Overall Study||11
9011307|NCT02992197|10073976|FG001|NOT COMPLETED|Overall Study||7
9011308|NCT02992236|10073984|FG000|STARTED|Overall Study||8
9011309|NCT02992236|10073985|FG001|STARTED|Overall Study||8
9011310|NCT02992236|10073984|FG000|COMPLETED|Overall Study||8
9011311|NCT02992236|10073985|FG001|COMPLETED|Overall Study||8
9011312|NCT02992236|10073984|FG000|NOT COMPLETED|Overall Study||0
9011313|NCT02992236|10073985|FG001|NOT COMPLETED|Overall Study||0
9011314|NCT02992288|10073999|FG000|STARTED|Overall Study||106
9011315|NCT02992288|10074000|FG001|STARTED|Overall Study||37
9011316|NCT02992288|10074001|FG002|STARTED|Overall Study||70
9011317|NCT02992288|10074002|FG003|STARTED|Overall Study||73
9011318|NCT02992288|10074003|FG004|STARTED|Overall Study||69
9011319|NCT02992288|10074004|FG005|STARTED|Overall Study||72
9011320|NCT02992288|10073999|FG000|Treated|Overall Study||106
9011321|NCT02992288|10074000|FG001|Treated|Overall Study||37
9011322|NCT02992288|10074001|FG002|Treated|Overall Study||70
9011323|NCT02992288|10074002|FG003|Treated|Overall Study||72
9011324|NCT02992288|10074003|FG004|Treated|Overall Study||69
9011325|NCT02992288|10074004|FG005|Treated|Overall Study||72
8573107|NCT00118430|9605325|FG000|COMPLETED|Overall Study|123 included in primary analysis due to repeated measures and interim 1,3 and 6 month assessments|102
8573108|NCT00118430|9605326|FG001|COMPLETED|Overall Study|127 included in primary analysis due to repeated measures and interim 1,3 and 6 month assessments|103
8573109|NCT00118430|9605327|FG002|COMPLETED|Overall Study||222
8573110|NCT00118430|9605325|FG000|NOT COMPLETED|Overall Study||21
8573111|NCT00118430|9605326|FG001|NOT COMPLETED|Overall Study||24
8573112|NCT00118430|9605327|FG002|NOT COMPLETED|Overall Study||28
8577581|NCT00159822|9610342|FG000|NOT COMPLETED|Post-treatment Follow-up Period||3
8904190|NCT02093923|9962261|FG003|Treated - 1 Dose Only:|Overall Study||1
8904191|NCT02093923|9962262|FG004|Treated - 1 Dose Only:|Overall Study||0
8904192|NCT02093923|9962258|FG000|Treated - 2 Doses:|Overall Study||4
8904193|NCT02093923|9962259|FG001|Treated - 2 Doses:|Overall Study||4
8904194|NCT02093923|9962260|FG002|Treated - 2 Doses:|Overall Study||5
8904195|NCT02093923|9962261|FG003|Treated - 2 Doses:|Overall Study||10
8904196|NCT02093923|9962262|FG004|Treated - 2 Doses:|Overall Study||13
8904197|NCT02093923|9962258|FG000|COMPLETED|Overall Study||4
8904198|NCT02093923|9962259|FG001|COMPLETED|Overall Study||4
8904199|NCT02093923|9962260|FG002|COMPLETED|Overall Study||5
8904200|NCT02093923|9962261|FG003|COMPLETED|Overall Study||10
8904201|NCT02093923|9962262|FG004|COMPLETED|Overall Study||13
8904202|NCT02093923|9962258|FG000|NOT COMPLETED|Overall Study||0
9011326|NCT02992288|10073999|FG000|COMPLETED|Overall Study||89
9011327|NCT02992288|10074000|FG001|COMPLETED|Overall Study||32
9011328|NCT02992288|10074001|FG002|COMPLETED|Overall Study||63
9011329|NCT02992288|10074002|FG003|COMPLETED|Overall Study||64
9011330|NCT02992288|10074003|FG004|COMPLETED|Overall Study||61
9011331|NCT02992288|10074004|FG005|COMPLETED|Overall Study||59
9011332|NCT02992288|10073999|FG000|NOT COMPLETED|Overall Study||17
9011333|NCT02992288|10074000|FG001|NOT COMPLETED|Overall Study||5
9011334|NCT02992288|10074001|FG002|NOT COMPLETED|Overall Study||7
8904203|NCT02093923|9962259|FG001|NOT COMPLETED|Overall Study||0
8904204|NCT02093923|9962260|FG002|NOT COMPLETED|Overall Study||0
8904205|NCT02093923|9962261|FG003|NOT COMPLETED|Overall Study||2
8904206|NCT02093923|9962262|FG004|NOT COMPLETED|Overall Study||0
8904207|NCT02093949|9962280|FG000|STARTED|Overall Study||105
8904208|NCT02093949|9962281|FG001|STARTED|Overall Study||47
8904209|NCT02093949|9962280|FG000|COMPLETED|Overall Study||105
8904210|NCT02093949|9962281|FG001|COMPLETED|Overall Study||47
8904211|NCT02093949|9962280|FG000|NOT COMPLETED|Overall Study||0
8904212|NCT02093949|9962281|FG001|NOT COMPLETED|Overall Study||0
8904213|NCT02093962|9962297|FG000|STARTED|Overall Study||134
8904214|NCT02093962|9962298|FG001|STARTED|Overall Study||131
8904215|NCT02093962|9962297|FG000|Received Treatment|Overall Study||130
8904216|NCT02093962|9962298|FG001|Received Treatment|Overall Study||130
8904217|NCT02093962|9962297|FG000|COMPLETED|Overall Study||0
8904218|NCT02093962|9962298|FG001|COMPLETED|Overall Study||0
8904219|NCT02093962|9962297|FG000|NOT COMPLETED|Overall Study||134
8904220|NCT02093962|9962298|FG001|NOT COMPLETED|Overall Study||131
8904221|NCT02094118|9962306|FG000|STARTED|Overall Study||85
8904222|NCT02094118|9962307|FG001|STARTED|Overall Study||86
8904223|NCT02094118|9962306|FG000|COMPLETED|Overall Study||73
8904224|NCT02094118|9962307|FG001|COMPLETED|Overall Study||81
8904225|NCT02094118|9962306|FG000|NOT COMPLETED|Overall Study||12
8904226|NCT02094118|9962307|FG001|NOT COMPLETED|Overall Study||5
8904227|NCT02094300|9962317|FG000|STARTED|Overall Study||26
8904228|NCT02094300|9962317|FG000|30 Days|Overall Study||24
8904229|NCT02094300|9962317|FG000|COMPLETED|Overall Study||6
8904230|NCT02094300|9962317|FG000|NOT COMPLETED|Overall Study||20
8904231|NCT02094326|9962321|FG000|STARTED|Overall Study||301
8904232|NCT02094326|9962321|FG000|COMPLETED|Overall Study||301
8904233|NCT02094326|9962321|FG000|NOT COMPLETED|Overall Study||0
8904234|NCT02094417|9962330|FG000|STARTED|Overall Study||7
8904235|NCT02094417|9962331|FG001|STARTED|Overall Study||9
8904236|NCT02094417|9962332|FG002|STARTED|Overall Study||9
8904237|NCT02094417|9962333|FG003|STARTED|Overall Study||10
8904238|NCT02094417|9962330|FG000|COMPLETED|Overall Study||2
8904239|NCT02094417|9962331|FG001|COMPLETED|Overall Study||1
8904240|NCT02094417|9962332|FG002|COMPLETED|Overall Study||4
8904241|NCT02094417|9962333|FG003|COMPLETED|Overall Study||3
8904242|NCT02094417|9962330|FG000|NOT COMPLETED|Overall Study||5
8904243|NCT02094417|9962331|FG001|NOT COMPLETED|Overall Study||8
8904244|NCT02094417|9962332|FG002|NOT COMPLETED|Overall Study||5
8904245|NCT02094417|9962333|FG003|NOT COMPLETED|Overall Study||7
8904246|NCT02094443|9962345|FG000|STARTED|Overall Study||26
8904247|NCT02094443|9962346|FG001|STARTED|Overall Study||26
8904248|NCT02094443|9962345|FG000|Completed at Week 12|Overall Study||0
8904249|NCT02094443|9962346|FG001|Completed at Week 12|Overall Study||1
8904250|NCT02094443|9962345|FG000|Completed at Week 24|Overall Study||11
8904251|NCT02094443|9962346|FG001|Completed at Week 24|Overall Study||8
8904252|NCT02094443|9962345|FG000|COMPLETED|Overall Study||11
8904253|NCT02094443|9962346|FG001|COMPLETED|Overall Study||9
8904254|NCT02094443|9962345|FG000|NOT COMPLETED|Overall Study||15
8904255|NCT02094443|9962346|FG001|NOT COMPLETED|Overall Study||17
8904256|NCT02094534|9962354|FG000|STARTED|Overall Study||15
8904257|NCT02094534|9962355|FG001|STARTED|Overall Study||10
9011335|NCT02992288|10074002|FG003|NOT COMPLETED|Overall Study||9
9011336|NCT02992288|10074003|FG004|NOT COMPLETED|Overall Study||8
9011337|NCT02992288|10074004|FG005|NOT COMPLETED|Overall Study||13
9011338|NCT02992691|10074018|FG000|STARTED|Overall Study||56
9011339|NCT02992691|10074018|FG000|Received Test Product 1|Overall Study||55
9011340|NCT02992691|10074018|FG000|Received Test Product 2|Overall Study||55
9011341|NCT02992691|10074018|FG000|Received Test Product 3|Overall Study||52
9011342|NCT02992691|10074018|FG000|Received Positive Control|Overall Study||55
9011343|NCT02992691|10074018|FG000|Received Negative Control|Overall Study||55
9011344|NCT02992691|10074018|FG000|COMPLETED|Overall Study||53
9011345|NCT02992691|10074018|FG000|NOT COMPLETED|Overall Study||3
9011346|NCT02992899|10074035|FG000|STARTED|Overall Study||27
9011347|NCT02992899|10074036|FG001|STARTED|Overall Study||29
9011348|NCT02992899|10074035|FG000|COMPLETED|Overall Study||25
9011349|NCT02992899|10074036|FG001|COMPLETED|Overall Study||26
8904258|NCT02094534|9962354|FG000|COMPLETED|Overall Study||15
8904259|NCT02094534|9962355|FG001|COMPLETED|Overall Study||10
8904260|NCT02094534|9962354|FG000|NOT COMPLETED|Overall Study||0
8904261|NCT02094534|9962355|FG001|NOT COMPLETED|Overall Study||0
8904262|NCT02094573|9962363|FG000|STARTED|Overall Study||112
8904263|NCT02094573|9962364|FG001|STARTED|Overall Study||110
8904264|NCT02094573|9962363|FG000|Treated|Overall Study||109
8904265|NCT02094573|9962364|FG001|Treated|Overall Study||110
8904266|NCT02094573|9962363|FG000|COMPLETED|Overall Study||0
9011350|NCT02992899|10074035|FG000|NOT COMPLETED|Overall Study||2
9011351|NCT02992899|10074036|FG001|NOT COMPLETED|Overall Study||3
9011352|NCT02993224|10074042|FG000|STARTED|Core Phase - Period 1||148
8904267|NCT02094573|9962364|FG001|COMPLETED|Overall Study||0
8904268|NCT02094573|9962363|FG000|NOT COMPLETED|Overall Study||112
8904269|NCT02094573|9962364|FG001|NOT COMPLETED|Overall Study||110
8904270|NCT02094586|9962374|FG000|STARTED|Overall Study||927
8904271|NCT02094586|9962375|FG001|STARTED|Overall Study||933
8904272|NCT02094586|9962376|FG002|STARTED|Overall Study||935
8904273|NCT02094586|9962377|FG003|STARTED|Overall Study||351
8904274|NCT02094586|9962374|FG000|COMPLETED|Overall Study||848
8904275|NCT02094586|9962375|FG001|COMPLETED|Overall Study||866
9011353|NCT02993224|10074042|FG000|COMPLETED|Core Phase - Period 1||140
8904276|NCT02094586|9962376|FG002|COMPLETED|Overall Study||876
8904277|NCT02094586|9962377|FG003|COMPLETED|Overall Study||331
8904278|NCT02094586|9962374|FG000|NOT COMPLETED|Overall Study||79
8904279|NCT02094586|9962375|FG001|NOT COMPLETED|Overall Study||67
8904280|NCT02094586|9962376|FG002|NOT COMPLETED|Overall Study||59
8904281|NCT02094586|9962377|FG003|NOT COMPLETED|Overall Study||20
9011354|NCT02993224|10074042|FG000|NOT COMPLETED|Core Phase - Period 1||8
9011355|NCT02993224|10074042|FG000|STARTED|Core Phase- Period 2||140
9011356|NCT02993224|10074042|FG000|COMPLETED|Core Phase- Period 2||136
9011357|NCT02993224|10074042|FG000|NOT COMPLETED|Core Phase- Period 2||4
9011358|NCT02993224|10074042|FG000|STARTED|Extension Phase||116
9011359|NCT02993224|10074042|FG000|COMPLETED|Extension Phase||80
9011360|NCT02993224|10074042|FG000|NOT COMPLETED|Extension Phase||36
9011361|NCT02993250|10074050|FG000|STARTED|Overall Study||22
9011362|NCT02993250|10074051|FG001|STARTED|Overall Study||11
9011363|NCT02993250|10074050|FG000|COMPLETED|Overall Study||22
9011364|NCT02993250|10074051|FG001|COMPLETED|Overall Study||10
9011365|NCT02993250|10074050|FG000|NOT COMPLETED|Overall Study||0
9011366|NCT02993250|10074051|FG001|NOT COMPLETED|Overall Study||1
9011367|NCT02993302|10074059|FG000|STARTED|Overall Study||13
9011368|NCT02993302|10074060|FG001|STARTED|Overall Study||12
9011369|NCT02993302|10074059|FG000|COMPLETED|Overall Study||13
9011370|NCT02993302|10074060|FG001|COMPLETED|Overall Study||12
9011371|NCT02993302|10074059|FG000|NOT COMPLETED|Overall Study||0
9011372|NCT02993302|10074060|FG001|NOT COMPLETED|Overall Study||0
9011373|NCT02993445|10074068|FG000|STARTED|First Intervention (5 Minutes)||6
9011374|NCT02993445|10074069|FG001|STARTED|First Intervention (5 Minutes)||5
9011375|NCT02993445|10074068|FG000|COMPLETED|First Intervention (5 Minutes)||6
9011376|NCT02993445|10074069|FG001|COMPLETED|First Intervention (5 Minutes)||5
9011377|NCT02993445|10074068|FG000|NOT COMPLETED|First Intervention (5 Minutes)||0
9011378|NCT02993445|10074069|FG001|NOT COMPLETED|First Intervention (5 Minutes)||0
9011379|NCT02993445|10074068|FG000|STARTED|Washout (2 Weeks)||6
9011380|NCT02993445|10074069|FG001|STARTED|Washout (2 Weeks)||5
9011381|NCT02993445|10074068|FG000|COMPLETED|Washout (2 Weeks)||6
9011382|NCT02993445|10074069|FG001|COMPLETED|Washout (2 Weeks)||5
9011383|NCT02993445|10074068|FG000|NOT COMPLETED|Washout (2 Weeks)||0
9011384|NCT02993445|10074069|FG001|NOT COMPLETED|Washout (2 Weeks)||0
9011385|NCT02993445|10074068|FG000|STARTED|Second Intervention (5 Mins)||6
9011386|NCT02993445|10074069|FG001|STARTED|Second Intervention (5 Mins)||5
9011387|NCT02993445|10074068|FG000|COMPLETED|Second Intervention (5 Mins)||6
9011388|NCT02993445|10074069|FG001|COMPLETED|Second Intervention (5 Mins)||5
9011389|NCT02993445|10074068|FG000|NOT COMPLETED|Second Intervention (5 Mins)||0
9011390|NCT02993445|10074069|FG001|NOT COMPLETED|Second Intervention (5 Mins)||0
9011391|NCT02993471|10074075|FG000|STARTED|Period 1 (Drug Cocktail)||28
9011392|NCT02993471|10074075|FG000|Received at Least 1 Dose of Study Drug|Period 1 (Drug Cocktail)||28
9011393|NCT02993471|10074075|FG000|COMPLETED|Period 1 (Drug Cocktail)||28
9011394|NCT02993471|10074075|FG000|NOT COMPLETED|Period 1 (Drug Cocktail)||0
9011395|NCT02993471|10074075|FG000|STARTED|Period 2 (Drug Cocktail + Ixekizumab)||28
9011396|NCT02993471|10074075|FG000|Received at Least 1 Dose of Study Drug|Period 2 (Drug Cocktail + Ixekizumab)||27
9011397|NCT02993471|10074075|FG000|COMPLETED|Period 2 (Drug Cocktail + Ixekizumab)||26
9011398|NCT02993471|10074075|FG000|NOT COMPLETED|Period 2 (Drug Cocktail + Ixekizumab)||2
9011399|NCT02993783|10074099|FG000|STARTED|Overall Study||8
9011400|NCT02993783|10074100|FG001|STARTED|Overall Study||9
9011401|NCT02993783|10074099|FG000|COMPLETED|Overall Study||2
9011402|NCT02993783|10074100|FG001|COMPLETED|Overall Study||0
9011403|NCT02993783|10074099|FG000|NOT COMPLETED|Overall Study||6
9011404|NCT02993783|10074100|FG001|NOT COMPLETED|Overall Study||9
9011405|NCT02994056|10074106|FG000|STARTED|Overall Study||32
9011406|NCT02994056|10074106|FG000|COMPLETED|Overall Study||23
9011407|NCT02994056|10074106|FG000|NOT COMPLETED|Overall Study||9
9011408|NCT02994108|10074121|FG000|STARTED|Intervention Messages||74
9011409|NCT02994108|10074122|FG001|STARTED|Intervention Messages||76
9011410|NCT02994108|10074121|FG000|COMPLETED|Intervention Messages||72
9011411|NCT02994108|10074122|FG001|COMPLETED|Intervention Messages||76
9011412|NCT02994108|10074121|FG000|NOT COMPLETED|Intervention Messages||2
9011413|NCT02994108|10074122|FG001|NOT COMPLETED|Intervention Messages||0
9011414|NCT02994108|10074121|FG000|STARTED|Phase 1 Assessment||72
9011415|NCT02994108|10074122|FG001|STARTED|Phase 1 Assessment||76
9011416|NCT02994108|10074121|FG000|COMPLETED|Phase 1 Assessment||67
9011417|NCT02994108|10074122|FG001|COMPLETED|Phase 1 Assessment||73
9011418|NCT02994108|10074121|FG000|NOT COMPLETED|Phase 1 Assessment||5
9011419|NCT02994108|10074122|FG001|NOT COMPLETED|Phase 1 Assessment||3
9011420|NCT02994108|10074121|FG000|STARTED|Phase 2 Assessment||72
9011421|NCT02994108|10074122|FG001|STARTED|Phase 2 Assessment||76
9011422|NCT02994108|10074121|FG000|COMPLETED|Phase 2 Assessment||63
9011423|NCT02994108|10074122|FG001|COMPLETED|Phase 2 Assessment||69
9011424|NCT02994108|10074121|FG000|NOT COMPLETED|Phase 2 Assessment||9
9011425|NCT02994108|10074122|FG001|NOT COMPLETED|Phase 2 Assessment||7
9011426|NCT02994238|10074131|FG000|STARTED|Overall Study||125
9011427|NCT02994238|10074132|FG001|STARTED|Overall Study||127
9011428|NCT02994238|10074131|FG000|COMPLETED|Overall Study||125
9011429|NCT02994238|10074132|FG001|COMPLETED|Overall Study||127
9011430|NCT02994238|10074131|FG000|NOT COMPLETED|Overall Study||0
9011431|NCT02994238|10074132|FG001|NOT COMPLETED|Overall Study||0
9011432|NCT02994394|10074140|FG000|STARTED|Period 1 (Days 1 to 3)||14
9011433|NCT02994394|10074141|FG001|STARTED|Period 1 (Days 1 to 3)||14
9011434|NCT02994394|10074142|FG002|STARTED|Period 1 (Days 1 to 3)||14
8636478|NCT00568334|9677114|FG000|COMPLETED|Overall Study||121
8636479|NCT00568334|9677115|FG001|COMPLETED|Overall Study||121
8636480|NCT00568334|9677114|FG000|NOT COMPLETED|Overall Study||1
8904282|NCT02094612|9962401|FG000|STARTED|Overall Study||112
8904283|NCT02094612|9962402|FG001|STARTED|Overall Study||95
8904284|NCT02094612|9962401|FG000|1 Month Follow up|Overall Study||67
8904285|NCT02094612|9962402|FG001|1 Month Follow up|Overall Study||50
8904286|NCT02094612|9962401|FG000|3 Month Follow up|Overall Study||50
8904287|NCT02094612|9962402|FG001|3 Month Follow up|Overall Study||43
8904288|NCT02094612|9962401|FG000|6 Month Follow up|Overall Study||33
8904289|NCT02094612|9962402|FG001|6 Month Follow up|Overall Study||25
8904290|NCT02094612|9962401|FG000|COMPLETED|Overall Study||33
9011435|NCT02994394|10074143|FG003|STARTED|Period 1 (Days 1 to 3)||14
9011436|NCT02994394|10074144|FG004|STARTED|Period 1 (Days 1 to 3)||14
9011437|NCT02994394|10074145|FG005|STARTED|Period 1 (Days 1 to 3)||14
9011438|NCT02994394|10074140|FG000|COMPLETED|Period 1 (Days 1 to 3)||14
9011439|NCT02994394|10074141|FG001|COMPLETED|Period 1 (Days 1 to 3)||14
9011440|NCT02994394|10074142|FG002|COMPLETED|Period 1 (Days 1 to 3)||13
9011441|NCT02994394|10074143|FG003|COMPLETED|Period 1 (Days 1 to 3)||14
9011442|NCT02994394|10074144|FG004|COMPLETED|Period 1 (Days 1 to 3)||14
9011443|NCT02994394|10074145|FG005|COMPLETED|Period 1 (Days 1 to 3)||14
9011444|NCT02994394|10074140|FG000|NOT COMPLETED|Period 1 (Days 1 to 3)||0
9011445|NCT02994394|10074141|FG001|NOT COMPLETED|Period 1 (Days 1 to 3)||0
9011446|NCT02994394|10074142|FG002|NOT COMPLETED|Period 1 (Days 1 to 3)||1
9011447|NCT02994394|10074143|FG003|NOT COMPLETED|Period 1 (Days 1 to 3)||0
9011448|NCT02994394|10074144|FG004|NOT COMPLETED|Period 1 (Days 1 to 3)||0
9011449|NCT02994394|10074145|FG005|NOT COMPLETED|Period 1 (Days 1 to 3)||0
9011450|NCT02994394|10074140|FG000|STARTED|Period 2 (Days 4 to 6)||14
9011451|NCT02994394|10074141|FG001|STARTED|Period 2 (Days 4 to 6)||14
9011452|NCT02994394|10074142|FG002|STARTED|Period 2 (Days 4 to 6)||13
9011453|NCT02994394|10074143|FG003|STARTED|Period 2 (Days 4 to 6)||14
9011454|NCT02994394|10074144|FG004|STARTED|Period 2 (Days 4 to 6)||14
9011455|NCT02994394|10074145|FG005|STARTED|Period 2 (Days 4 to 6)||14
9011456|NCT02994394|10074140|FG000|COMPLETED|Period 2 (Days 4 to 6)||14
9011457|NCT02994394|10074141|FG001|COMPLETED|Period 2 (Days 4 to 6)||13
9011458|NCT02994394|10074142|FG002|COMPLETED|Period 2 (Days 4 to 6)||13
9011459|NCT02994394|10074143|FG003|COMPLETED|Period 2 (Days 4 to 6)||14
9011460|NCT02994394|10074144|FG004|COMPLETED|Period 2 (Days 4 to 6)||13
9011461|NCT02994394|10074145|FG005|COMPLETED|Period 2 (Days 4 to 6)||14
9011462|NCT02994394|10074140|FG000|NOT COMPLETED|Period 2 (Days 4 to 6)||0
9011463|NCT02994394|10074141|FG001|NOT COMPLETED|Period 2 (Days 4 to 6)||1
9011464|NCT02994394|10074142|FG002|NOT COMPLETED|Period 2 (Days 4 to 6)||0
9011465|NCT02994394|10074143|FG003|NOT COMPLETED|Period 2 (Days 4 to 6)||0
9011466|NCT02994394|10074144|FG004|NOT COMPLETED|Period 2 (Days 4 to 6)||1
9011467|NCT02994394|10074145|FG005|NOT COMPLETED|Period 2 (Days 4 to 6)||0
9011468|NCT02994394|10074140|FG000|STARTED|Period 3 (Days 7 and 8)||14
9011469|NCT02994394|10074141|FG001|STARTED|Period 3 (Days 7 and 8)||13
9011470|NCT02994394|10074142|FG002|STARTED|Period 3 (Days 7 and 8)||13
9011471|NCT02994394|10074143|FG003|STARTED|Period 3 (Days 7 and 8)||14
9011472|NCT02994394|10074144|FG004|STARTED|Period 3 (Days 7 and 8)||13
9011473|NCT02994394|10074145|FG005|STARTED|Period 3 (Days 7 and 8)||14
9011474|NCT02994394|10074140|FG000|COMPLETED|Period 3 (Days 7 and 8)||14
9011475|NCT02994394|10074141|FG001|COMPLETED|Period 3 (Days 7 and 8)||13
9011476|NCT02994394|10074142|FG002|COMPLETED|Period 3 (Days 7 and 8)||13
9011477|NCT02994394|10074143|FG003|COMPLETED|Period 3 (Days 7 and 8)||14
9011478|NCT02994394|10074144|FG004|COMPLETED|Period 3 (Days 7 and 8)||13
9011479|NCT02994394|10074145|FG005|COMPLETED|Period 3 (Days 7 and 8)||14
9011480|NCT02994394|10074140|FG000|NOT COMPLETED|Period 3 (Days 7 and 8)||0
9011481|NCT02994394|10074141|FG001|NOT COMPLETED|Period 3 (Days 7 and 8)||0
9011482|NCT02994394|10074142|FG002|NOT COMPLETED|Period 3 (Days 7 and 8)||0
9011483|NCT02994394|10074143|FG003|NOT COMPLETED|Period 3 (Days 7 and 8)||0
9011484|NCT02994394|10074144|FG004|NOT COMPLETED|Period 3 (Days 7 and 8)||0
9011485|NCT02994394|10074145|FG005|NOT COMPLETED|Period 3 (Days 7 and 8)||0
9011486|NCT02994654|10074159|FG000|STARTED|Overall Study||12
9011487|NCT02994654|10074159|FG000|COMPLETED|Overall Study||11
9011488|NCT02994654|10074159|FG000|NOT COMPLETED|Overall Study||1
9011489|NCT02994732|10074164|FG000|STARTED|Overall Study|All subjects entered clinic on January 11, 2017|6
9011490|NCT02994732|10074164|FG000|COMPLETED|Overall Study|All subjects were discharged from the clinic by Jan 24, 2017|6
9011491|NCT02994732|10074164|FG000|NOT COMPLETED|Overall Study||0
9011492|NCT02994940|10074171|FG000|STARTED|Overall Study||37
9011493|NCT02994940|10074172|FG001|STARTED|Overall Study||37
9011494|NCT02994940|10074171|FG000|COMPLETED|Overall Study||30
9011495|NCT02994940|10074172|FG001|COMPLETED|Overall Study||36
9011496|NCT02994940|10074171|FG000|NOT COMPLETED|Overall Study||7
9011497|NCT02994940|10074172|FG001|NOT COMPLETED|Overall Study||1
9039613|NCT03340883|10100609|FG002|NOT COMPLETED|Overall Study||0
9039614|NCT03340883|10100610|FG003|NOT COMPLETED|Overall Study||0
9039615|NCT03340883|10100611|FG004|NOT COMPLETED|Overall Study||0
9039616|NCT03340883|10100612|FG005|NOT COMPLETED|Overall Study||0
9039617|NCT03340961|10100630|FG000|STARTED|Overall Study||53
9039618|NCT03340961|10100631|FG001|STARTED|Overall Study||50
8636481|NCT00568334|9677115|FG001|NOT COMPLETED|Overall Study||1
8904291|NCT02094612|9962402|FG001|COMPLETED|Overall Study||25
9039619|NCT03340961|10100632|FG002|STARTED|Overall Study||49
9039620|NCT03340961|10100633|FG003|STARTED|Overall Study||53
9039621|NCT03340961|10100630|FG000|COMPLETED|Overall Study||47
9039622|NCT03340961|10100631|FG001|COMPLETED|Overall Study||38
8904292|NCT02094612|9962401|FG000|NOT COMPLETED|Overall Study||79
8904293|NCT02094612|9962402|FG001|NOT COMPLETED|Overall Study||70
8904294|NCT02094664|9962410|FG000|STARTED|Overall Study||16
8904295|NCT02094664|9962411|FG001|STARTED|Overall Study||16
8904296|NCT02094664|9962410|FG000|COMPLETED|Overall Study||16
8904297|NCT02094664|9962411|FG001|COMPLETED|Overall Study||16
8904298|NCT02094664|9962410|FG000|NOT COMPLETED|Overall Study||0
8904299|NCT02094664|9962411|FG001|NOT COMPLETED|Overall Study||0
8904300|NCT02094677|9962419|FG000|STARTED|Overall Study||43
8904301|NCT02094677|9962420|FG001|STARTED|Overall Study||31
8904302|NCT02094677|9962419|FG000|COMPLETED|Overall Study||40
8904303|NCT02094677|9962420|FG001|COMPLETED|Overall Study||30
8904304|NCT02094677|9962419|FG000|NOT COMPLETED|Overall Study||3
8904305|NCT02094677|9962420|FG001|NOT COMPLETED|Overall Study||1
8904306|NCT02094755|9962433|FG000|STARTED|Overall Study||100
8904307|NCT02094755|9962433|FG000|COMPLETED|Overall Study||100
8904308|NCT02094755|9962433|FG000|NOT COMPLETED|Overall Study||0
8904309|NCT02094872|9962437|FG000|STARTED|Overall Study||49
8904310|NCT02094872|9962437|FG000|Received Biopsy|Overall Study||37
8904311|NCT02094872|9962437|FG000|Received Tumor-board Recommendation|Overall Study|1 individual withdrew consent after biopsy.|36
8904312|NCT02094872|9962437|FG000|Received Targeted Therapy|Overall Study||20
8904313|NCT02094872|9962437|FG000|Received Standard of Care|Overall Study|7 standard-of-care patients crossed-over and received targeted therapy.|9
8904314|NCT02094872|9962437|FG000|Patients Treated With MEK162|Overall Study||20
8904315|NCT02094872|9962437|FG000|COMPLETED|Overall Study||20
8904316|NCT02094872|9962437|FG000|NOT COMPLETED|Overall Study||29
8904317|NCT02094885|9962443|FG000|STARTED|Overall Study||125
8904318|NCT02094885|9962444|FG001|STARTED|Overall Study||127
8904319|NCT02094885|9962443|FG000|COMPLETED|Overall Study||123
8904320|NCT02094885|9962444|FG001|COMPLETED|Overall Study||122
8904321|NCT02094885|9962443|FG000|NOT COMPLETED|Overall Study||2
8904322|NCT02094885|9962444|FG001|NOT COMPLETED|Overall Study||5
8904323|NCT02094898|9962450|FG000|STARTED|Overall Study||12
8904324|NCT02094898|9962450|FG000|COMPLETED|Overall Study||7
8904325|NCT02094898|9962450|FG000|NOT COMPLETED|Overall Study||5
8904326|NCT02094937|9962456|FG000|STARTED|8 Weeks in Period 1||430
8904327|NCT02094937|9962457|FG001|STARTED|8 Weeks in Period 1||0
8904328|NCT02094937|9962458|FG002|STARTED|8 Weeks in Period 1||0
8904329|NCT02094937|9962459|FG003|STARTED|8 Weeks in Period 1||0
8904330|NCT02094937|9962456|FG000|COMPLETED|8 Weeks in Period 1||370
8904331|NCT02094937|9962457|FG001|COMPLETED|8 Weeks in Period 1||0
8904332|NCT02094937|9962458|FG002|COMPLETED|8 Weeks in Period 1||0
8904333|NCT02094937|9962459|FG003|COMPLETED|8 Weeks in Period 1||0
8904334|NCT02094937|9962456|FG000|NOT COMPLETED|8 Weeks in Period 1||60
8904335|NCT02094937|9962457|FG001|NOT COMPLETED|8 Weeks in Period 1||0
8904336|NCT02094937|9962458|FG002|NOT COMPLETED|8 Weeks in Period 1||0
8904337|NCT02094937|9962459|FG003|NOT COMPLETED|8 Weeks in Period 1||0
8904338|NCT02094937|9962456|FG000|STARTED|12 Weeks in Period 2||0
8904339|NCT02094937|9962457|FG001|STARTED|12 Weeks in Period 2||123
8904340|NCT02094937|9962458|FG002|STARTED|12 Weeks in Period 2||124
8904341|NCT02094937|9962459|FG003|STARTED|12 Weeks in Period 2||124
8904342|NCT02094937|9962456|FG000|COMPLETED|12 Weeks in Period 2||0
8904343|NCT02094937|9962457|FG001|COMPLETED|12 Weeks in Period 2||112
8904344|NCT02094937|9962458|FG002|COMPLETED|12 Weeks in Period 2||112
8904345|NCT02094937|9962459|FG003|COMPLETED|12 Weeks in Period 2||112
8904346|NCT02094937|9962456|FG000|NOT COMPLETED|12 Weeks in Period 2||0
8904347|NCT02094937|9962457|FG001|NOT COMPLETED|12 Weeks in Period 2||11
8904348|NCT02094937|9962458|FG002|NOT COMPLETED|12 Weeks in Period 2||12
8904349|NCT02094937|9962459|FG003|NOT COMPLETED|12 Weeks in Period 2||12
8904350|NCT02095106|9962470|FG000|STARTED|First Intervention (14 Days)||14
8904351|NCT02095106|9962471|FG001|STARTED|First Intervention (14 Days)||13
8904352|NCT02095106|9962470|FG000|COMPLETED|First Intervention (14 Days)||14
8904353|NCT02095106|9962471|FG001|COMPLETED|First Intervention (14 Days)||13
8904354|NCT02095106|9962470|FG000|NOT COMPLETED|First Intervention (14 Days)||0
8904355|NCT02095106|9962471|FG001|NOT COMPLETED|First Intervention (14 Days)||0
8904356|NCT02095106|9962470|FG000|STARTED|Second Intervention (14 Days)||14
8904357|NCT02095106|9962471|FG001|STARTED|Second Intervention (14 Days)||13
8904358|NCT02095106|9962470|FG000|COMPLETED|Second Intervention (14 Days)||14
8904359|NCT02095106|9962471|FG001|COMPLETED|Second Intervention (14 Days)||12
8904360|NCT02095106|9962470|FG000|NOT COMPLETED|Second Intervention (14 Days)||0
8904361|NCT02095106|9962471|FG001|NOT COMPLETED|Second Intervention (14 Days)||1
8904362|NCT02095145|9962483|FG000|STARTED|Overall Study||15
8904363|NCT02095145|9962484|FG001|STARTED|Overall Study||15
8904364|NCT02095145|9962483|FG000|COMPLETED|Overall Study||14
8904365|NCT02095145|9962484|FG001|COMPLETED|Overall Study||15
8904366|NCT02095145|9962483|FG000|NOT COMPLETED|Overall Study||1
8904367|NCT02095145|9962484|FG001|NOT COMPLETED|Overall Study||0
8904368|NCT02095158|9962492|FG000|STARTED|Overall Study||440
8904369|NCT02095158|9962492|FG000|COMPLETED|Overall Study||365
8904370|NCT02095158|9962492|FG000|NOT COMPLETED|Overall Study||75
8904371|NCT02095197|9962498|FG000|STARTED|Overall Study||40
8904372|NCT02095197|9962499|FG001|STARTED|Overall Study||39
8904373|NCT02095197|9962498|FG000|COMPLETED|Overall Study||40
8904374|NCT02095197|9962499|FG001|COMPLETED|Overall Study||36
8904375|NCT02095197|9962498|FG000|NOT COMPLETED|Overall Study||0
8904376|NCT02095197|9962499|FG001|NOT COMPLETED|Overall Study||3
8904377|NCT02095223|9962507|FG000|STARTED|Overall Study||2
8904378|NCT02095223|9962508|FG001|STARTED|Overall Study||2
8904379|NCT02095223|9962507|FG000|COMPLETED|Overall Study|1 participant dropped out of this study due to the time commitment associated with participation.|1
8904380|NCT02095223|9962508|FG001|COMPLETED|Overall Study||2
8904381|NCT02095223|9962507|FG000|NOT COMPLETED|Overall Study||1
8904382|NCT02095223|9962508|FG001|NOT COMPLETED|Overall Study||0
8904383|NCT02095340|9962517|FG000|STARTED|Overall Study|Mother (not the child) received the training.|51
8904384|NCT02095340|9962518|FG001|STARTED|Overall Study|Mother (not the child) received the training.|54
8904385|NCT02095340|9962519|FG002|STARTED|Overall Study||105
8904386|NCT02095340|9962517|FG000|COMPLETED|Overall Study||51
8904387|NCT02095340|9962518|FG001|COMPLETED|Overall Study||54
8904388|NCT02095340|9962519|FG002|COMPLETED|Overall Study||105
8904389|NCT02095340|9962517|FG000|NOT COMPLETED|Overall Study||0
8904390|NCT02095340|9962518|FG001|NOT COMPLETED|Overall Study||0
8904391|NCT02095340|9962519|FG002|NOT COMPLETED|Overall Study||0
8904392|NCT02095535|9962528|FG000|STARTED|Recruitment||20
8904393|NCT02095535|9962528|FG000|COMPLETED|Recruitment||18
8904394|NCT02095535|9962528|FG000|NOT COMPLETED|Recruitment||2
8904395|NCT02095535|9962528|FG000|STARTED|Analysis||18
8904396|NCT02095535|9962528|FG000|COMPLETED|Analysis||18
8904397|NCT02095535|9962528|FG000|NOT COMPLETED|Analysis||0
8904398|NCT02095561|9962534|FG000|STARTED|Overall Study||3049
8904399|NCT02095561|9962535|FG001|STARTED|Overall Study||2964
8904400|NCT02095561|9962534|FG000|Self-testing Acceptability|Overall Study||2616
8904401|NCT02095561|9962535|FG001|Self-testing Acceptability|Overall Study|Acceptablity only applies to the group of women being offered self-testing.|0
8904402|NCT02095561|9962534|FG000|HPV Self-tested Women|Overall Study||2519
9011498|NCT02994979|10074180|FG000|STARTED|Overall Study||114
9011499|NCT02994979|10074181|FG001|STARTED|Overall Study||105
9011500|NCT02994979|10074180|FG000|COMPLETED|Overall Study||114
9011501|NCT02994979|10074181|FG001|COMPLETED|Overall Study||105
9011502|NCT02994979|10074180|FG000|NOT COMPLETED|Overall Study||0
9011503|NCT02994979|10074181|FG001|NOT COMPLETED|Overall Study||0
9011504|NCT02995915|10074189|FG000|STARTED|Overall Study||30
9011505|NCT02995915|10074190|FG001|STARTED|Overall Study||15
9011506|NCT02995915|10074189|FG000|COMPLETED|Overall Study||30
9011507|NCT02995915|10074190|FG001|COMPLETED|Overall Study||15
9011508|NCT02995915|10074189|FG000|NOT COMPLETED|Overall Study||0
9011509|NCT02995915|10074190|FG001|NOT COMPLETED|Overall Study||0
8636482|NCT00568386|9677123|FG000|STARTED|Overall Study||20
8636483|NCT00568386|9677124|FG001|STARTED|Overall Study||20
8636484|NCT00568386|9677123|FG000|COMPLETED|Overall Study||20
8636485|NCT00568386|9677124|FG001|COMPLETED|Overall Study||20
8636486|NCT00568386|9677123|FG000|NOT COMPLETED|Overall Study||0
8636487|NCT00568386|9677124|FG001|NOT COMPLETED|Overall Study||0
8636488|NCT00568399|9677130|FG000|STARTED|Overall Study||37
8691316|NCT00854113|9736572|FG001|STARTED|Overall Study||6
8904403|NCT02095561|9962535|FG001|HPV Self-tested Women|Overall Study|HPV self-testing only applies to the HPV self-testing arm|0
9011510|NCT02995980|10074196|FG000|STARTED|Overall Study||128
9011511|NCT02995980|10074196|FG000|COMPLETED|Overall Study||114
9011512|NCT02995980|10074196|FG000|NOT COMPLETED|Overall Study||14
9011513|NCT02996097|10074201|FG000|STARTED|Overall Study||30
9011514|NCT02996097|10074202|FG001|STARTED|Overall Study||30
9011515|NCT02996097|10074201|FG000|Per Protocol Population|Overall Study||22
9011516|NCT02996097|10074202|FG001|Per Protocol Population|Overall Study||22
9011517|NCT02996097|10074201|FG000|COMPLETED|Overall Study||19
9011518|NCT02996097|10074202|FG001|COMPLETED|Overall Study||19
9011519|NCT02996097|10074201|FG000|NOT COMPLETED|Overall Study||11
9011520|NCT02996097|10074202|FG001|NOT COMPLETED|Overall Study||11
9011521|NCT02996448|10074207|FG000|STARTED|Overall Study||3
9011522|NCT02996448|10074207|FG000|COMPLETED|Overall Study||0
9011523|NCT02996448|10074207|FG000|NOT COMPLETED|Overall Study||3
9011524|NCT02996474|10074212|FG000|STARTED|Overall Study||10
9011525|NCT02996474|10074212|FG000|COMPLETED|Overall Study||5
9011526|NCT02996474|10074212|FG000|NOT COMPLETED|Overall Study||5
9011527|NCT02996500|10074222|FG000|STARTED|Overall Study||39
9011528|NCT02996500|10074223|FG001|STARTED|Overall Study||43
9011529|NCT02996500|10074224|FG002|STARTED|Overall Study||39
9011530|NCT02996500|10074225|FG003|STARTED|Overall Study||50
9011531|NCT02996500|10074226|FG004|STARTED|Overall Study||50
9011532|NCT02996500|10074227|FG005|STARTED|Overall Study||48
9011533|NCT02996500|10074222|FG000|COMPLETED|Overall Study||31
8573113|NCT00118482|9605336|FG000|STARTED|Overall Study|3 patients signed the consent but did not take the study medication.|105
8573114|NCT00118482|9605337|FG001|STARTED|Overall Study||105
8573115|NCT00118482|9605336|FG000|COMPLETED|Overall Study|210 in the Intention To Treat analysis|75
8573116|NCT00118482|9605337|FG001|COMPLETED|Overall Study||76
8573117|NCT00118482|9605336|FG000|NOT COMPLETED|Overall Study||30
8573118|NCT00118482|9605337|FG001|NOT COMPLETED|Overall Study||29
8573119|NCT00118534|9605345|FG000|STARTED|Overall Study||472
8573120|NCT00118534|9605346|FG001|STARTED|Overall Study||471
8573121|NCT00118534|9605345|FG000|COMPLETED|Overall Study||472
8573122|NCT00118534|9605346|FG001|COMPLETED|Overall Study||471
8573123|NCT00118534|9605345|FG000|NOT COMPLETED|Overall Study||0
9011534|NCT02996500|10074223|FG001|COMPLETED|Overall Study||42
9011535|NCT02996500|10074224|FG002|COMPLETED|Overall Study||29
9011536|NCT02996500|10074225|FG003|COMPLETED|Overall Study||46
9011537|NCT02996500|10074226|FG004|COMPLETED|Overall Study||45
9011538|NCT02996500|10074227|FG005|COMPLETED|Overall Study||44
9011539|NCT02996500|10074222|FG000|NOT COMPLETED|Overall Study||8
8904404|NCT02095561|9962534|FG000|HPV Tested at Health Centers|Overall Study||99
8904405|NCT02095561|9962535|FG001|HPV Tested at Health Centers|Overall Study||599
8904406|NCT02095561|9962534|FG000|COMPLETED|Overall Study|All women are part of the study, independently of whether they were tested or not.|3049
8904407|NCT02095561|9962535|FG001|COMPLETED|Overall Study|All women are part of the study, independently of whether they were tested or not.|2964
8904408|NCT02095561|9962534|FG000|NOT COMPLETED|Overall Study||0
8904409|NCT02095561|9962535|FG001|NOT COMPLETED|Overall Study||0
8904410|NCT02095678|9962543|FG000|STARTED|Overall Study||34
8904411|NCT02095678|9962544|FG001|STARTED|Overall Study||18
8904412|NCT02095678|9962543|FG000|COMPLETED|Overall Study||17
8904413|NCT02095678|9962544|FG001|COMPLETED|Overall Study||0
8904414|NCT02095678|9962543|FG000|NOT COMPLETED|Overall Study||17
8904415|NCT02095678|9962544|FG001|NOT COMPLETED|Overall Study||18
8904416|NCT02095691|9962553|FG000|STARTED|Overall Study|Subjects who were consented and treated with study ablation catheter.|19
8904417|NCT02095691|9962553|FG000|COMPLETED|Overall Study|Subjects with follow up available at 12 months.|18
8904418|NCT02095691|9962553|FG000|NOT COMPLETED|Overall Study||1
8904419|NCT02095873|9962571|FG000|STARTED|First Intervention (8 Weeks)||16
8904420|NCT02095873|9962572|FG001|STARTED|First Intervention (8 Weeks)||16
8904421|NCT02095873|9962571|FG000|COMPLETED|First Intervention (8 Weeks)||15
8904422|NCT02095873|9962572|FG001|COMPLETED|First Intervention (8 Weeks)||16
8904423|NCT02095873|9962571|FG000|NOT COMPLETED|First Intervention (8 Weeks)||1
8904424|NCT02095873|9962572|FG001|NOT COMPLETED|First Intervention (8 Weeks)||0
8904425|NCT02095873|9962571|FG000|STARTED|Second Intervention (8 Weeks)||15
8904426|NCT02095873|9962572|FG001|STARTED|Second Intervention (8 Weeks)||16
8904427|NCT02095873|9962571|FG000|COMPLETED|Second Intervention (8 Weeks)||13
8904428|NCT02095873|9962572|FG001|COMPLETED|Second Intervention (8 Weeks)||16
8904429|NCT02095873|9962571|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||2
8904430|NCT02095873|9962572|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||0
8904431|NCT02095951|9962582|FG000|STARTED|Overall Study|2 participants with 4 episodes of catheter infection was enrolled twice in this group.|13
8904432|NCT02095951|9962583|FG001|STARTED|Overall Study|1 participant with 2 episodes of catheter infection was enrolled twice in this group.|14
8904433|NCT02095951|9962582|FG000|COMPLETED|Overall Study||4
8904434|NCT02095951|9962583|FG001|COMPLETED|Overall Study||8
8904435|NCT02095951|9962582|FG000|NOT COMPLETED|Overall Study||9
8904436|NCT02095951|9962583|FG001|NOT COMPLETED|Overall Study||6
8904437|NCT02096003|9962595|FG000|STARTED|Overall Study||40
8904438|NCT02096003|9962596|FG001|STARTED|Overall Study||40
8904439|NCT02096003|9962595|FG000|COMPLETED|Overall Study||38
8904440|NCT02096003|9962596|FG001|COMPLETED|Overall Study||37
8904441|NCT02096003|9962595|FG000|NOT COMPLETED|Overall Study||2
8904442|NCT02096003|9962596|FG001|NOT COMPLETED|Overall Study||3
8904443|NCT02096029|9962604|FG000|STARTED|Overall Study||652
8904444|NCT02096029|9962605|FG001|STARTED|Overall Study||593
8904445|NCT02096029|9962604|FG000|COMPLETED|Overall Study||652
8904446|NCT02096029|9962605|FG001|COMPLETED|Overall Study||593
8904447|NCT02096029|9962604|FG000|NOT COMPLETED|Overall Study||0
8904448|NCT02096029|9962605|FG001|NOT COMPLETED|Overall Study||0
8904449|NCT02096081|9962613|FG000|STARTED|Overall Study||122
8904450|NCT02096081|9962614|FG001|STARTED|Overall Study||128
8904451|NCT02096081|9962613|FG000|COMPLETED|Overall Study||119
8904452|NCT02096081|9962614|FG001|COMPLETED|Overall Study||124
8904453|NCT02096081|9962613|FG000|NOT COMPLETED|Overall Study||3
8904454|NCT02096081|9962614|FG001|NOT COMPLETED|Overall Study||4
8904455|NCT02096107|9962622|FG000|STARTED|Overall Study||30
8904456|NCT02096107|9962623|FG001|STARTED|Overall Study||30
8904457|NCT02096107|9962622|FG000|COMPLETED|Overall Study||30
8904458|NCT02096107|9962623|FG001|COMPLETED|Overall Study||30
8904459|NCT02096107|9962622|FG000|NOT COMPLETED|Overall Study||0
8904460|NCT02096107|9962623|FG001|NOT COMPLETED|Overall Study||0
8904461|NCT02096263|9962632|FG000|STARTED|Overall Study||195
8904462|NCT02096263|9962633|FG001|STARTED|Overall Study||194
8904463|NCT02096263|9962634|FG002|STARTED|Overall Study||196
8904464|NCT02096263|9962632|FG000|COMPLETED|Overall Study||161
8904465|NCT02096263|9962633|FG001|COMPLETED|Overall Study||158
8904466|NCT02096263|9962634|FG002|COMPLETED|Overall Study||157
8904467|NCT02096263|9962632|FG000|NOT COMPLETED|Overall Study||34
8904468|NCT02096263|9962633|FG001|NOT COMPLETED|Overall Study||36
8904469|NCT02096263|9962634|FG002|NOT COMPLETED|Overall Study||39
8904470|NCT02096276|9962644|FG000|STARTED|Overall Study||250
9011540|NCT02996500|10074223|FG001|NOT COMPLETED|Overall Study||1
9011541|NCT02996500|10074224|FG002|NOT COMPLETED|Overall Study||10
9011542|NCT02996500|10074225|FG003|NOT COMPLETED|Overall Study||4
9011543|NCT02996500|10074226|FG004|NOT COMPLETED|Overall Study||5
9011544|NCT02996500|10074227|FG005|NOT COMPLETED|Overall Study||4
9011545|NCT02996591|10074247|FG000|STARTED|Overall Study||18
9011546|NCT02996591|10074248|FG001|STARTED|Overall Study||18
9011547|NCT02996591|10074247|FG000|COMPLETED|Overall Study||18
9011548|NCT02996591|10074248|FG001|COMPLETED|Overall Study||18
9011549|NCT02996591|10074247|FG000|NOT COMPLETED|Overall Study||0
9011550|NCT02996591|10074248|FG001|NOT COMPLETED|Overall Study||0
9011551|NCT02996682|10074256|FG000|STARTED|Overall Study||51
9011552|NCT02996682|10074257|FG001|STARTED|Overall Study||51
9011553|NCT02996682|10074256|FG000|COMPLETED|Overall Study||51
9011554|NCT02996682|10074257|FG001|COMPLETED|Overall Study||48
9011555|NCT02996682|10074256|FG000|NOT COMPLETED|Overall Study||0
9011556|NCT02996682|10074257|FG001|NOT COMPLETED|Overall Study||3
9011557|NCT02996864|10074265|FG000|STARTED|Overall Study||150
8904471|NCT02096276|9962645|FG001|STARTED|Overall Study||55
8904472|NCT02096276|9962644|FG000|COMPLETED|Overall Study||250
8904473|NCT02096276|9962645|FG001|COMPLETED|Overall Study||55
8904474|NCT02096276|9962644|FG000|NOT COMPLETED|Overall Study||0
8904475|NCT02096276|9962645|FG001|NOT COMPLETED|Overall Study||0
8904476|NCT02096458|9962651|FG000|STARTED|Overall Study||8
8904477|NCT02096458|9962651|FG000|COMPLETED|Overall Study||8
8904478|NCT02096458|9962651|FG000|NOT COMPLETED|Overall Study||0
8904479|NCT02096471|9962655|FG000|STARTED|Overall Study||19
8904480|NCT02096471|9962655|FG000|COMPLETED|Overall Study|Participants terminated the study if a partial response was not achieved and/or maintained.|6
8904481|NCT02096471|9962655|FG000|NOT COMPLETED|Overall Study||13
8904482|NCT02096575|9962661|FG000|STARTED|Overall Study||68
8904483|NCT02096575|9962662|FG001|STARTED|Overall Study||67
8904484|NCT02096575|9962663|FG002|STARTED|Overall Study||5
8904485|NCT02096575|9962661|FG000|COMPLETED|Overall Study||68
8904486|NCT02096575|9962662|FG001|COMPLETED|Overall Study||67
8904487|NCT02096575|9962663|FG002|COMPLETED|Overall Study||0
8904488|NCT02096575|9962661|FG000|NOT COMPLETED|Overall Study||0
8904489|NCT02096575|9962662|FG001|NOT COMPLETED|Overall Study||0
8904490|NCT02096575|9962663|FG002|NOT COMPLETED|Overall Study||5
8904491|NCT02096588|9962672|FG000|STARTED|Overall Study||15
8904492|NCT02096588|9962673|FG001|STARTED|Overall Study||16
8904493|NCT02096588|9962672|FG000|COMPLETED|Overall Study||13
8904494|NCT02096588|9962673|FG001|COMPLETED|Overall Study||15
8904495|NCT02096588|9962672|FG000|NOT COMPLETED|Overall Study||2
8904496|NCT02096588|9962673|FG001|NOT COMPLETED|Overall Study||1
8904497|NCT02096679|9962679|FG000|STARTED|Overall Study||8
8904498|NCT02096679|9962679|FG000|COMPLETED|Overall Study||8
8904499|NCT02096679|9962679|FG000|NOT COMPLETED|Overall Study||0
8904500|NCT02096692|9962683|FG000|STARTED|Overall Study||154
8904501|NCT02096692|9962683|FG000|COMPLETED|Overall Study||150
8904502|NCT02096692|9962683|FG000|NOT COMPLETED|Overall Study||4
9011558|NCT02996864|10074266|FG001|STARTED|Overall Study||150
9011559|NCT02996864|10074265|FG000|COMPLETED|Overall Study||142
9011560|NCT02996864|10074266|FG001|COMPLETED|Overall Study||136
9011561|NCT02996864|10074265|FG000|NOT COMPLETED|Overall Study||8
9011562|NCT02996864|10074266|FG001|NOT COMPLETED|Overall Study||14
9011563|NCT02996968|10074274|FG000|STARTED|Overall Study||79
9011564|NCT02996968|10074275|FG001|STARTED|Overall Study||79
9011565|NCT02996968|10074274|FG000|COMPLETED|Overall Study||78
9011566|NCT02996968|10074275|FG001|COMPLETED|Overall Study||79
9011567|NCT02996968|10074274|FG000|NOT COMPLETED|Overall Study||1
9011568|NCT02996968|10074275|FG001|NOT COMPLETED|Overall Study||0
9011569|NCT02997085|10074284|FG000|STARTED|Overall Study||34
9011570|NCT02997085|10074285|FG001|STARTED|Overall Study||35
9011571|NCT02997085|10074286|FG002|STARTED|Overall Study||34
9011572|NCT02997085|10074284|FG000|COMPLETED|Overall Study||34
9011573|NCT02997085|10074285|FG001|COMPLETED|Overall Study||35
9011574|NCT02997085|10074286|FG002|COMPLETED|Overall Study||34
9011575|NCT02997085|10074284|FG000|NOT COMPLETED|Overall Study||0
9011576|NCT02997085|10074285|FG001|NOT COMPLETED|Overall Study||0
9011577|NCT02997085|10074286|FG002|NOT COMPLETED|Overall Study||0
9011578|NCT02997163|10074297|FG000|STARTED|Overall Study||9
9011579|NCT02997163|10074298|FG001|STARTED|Overall Study||9
9011580|NCT02997163|10074299|FG002|STARTED|Overall Study||8
9011581|NCT02997163|10074300|FG003|STARTED|Overall Study||8
9011582|NCT02997163|10074297|FG000|COMPLETED|Overall Study||8
9011583|NCT02997163|10074298|FG001|COMPLETED|Overall Study||9
9011584|NCT02997163|10074299|FG002|COMPLETED|Overall Study||8
9011585|NCT02997163|10074300|FG003|COMPLETED|Overall Study||7
9011586|NCT02997163|10074297|FG000|NOT COMPLETED|Overall Study||1
9011587|NCT02997163|10074298|FG001|NOT COMPLETED|Overall Study||0
9011588|NCT02997163|10074299|FG002|NOT COMPLETED|Overall Study||0
9011589|NCT02997163|10074300|FG003|NOT COMPLETED|Overall Study||1
9011590|NCT02997176|10074314|FG000|STARTED|Overall Study||7
9011591|NCT02997176|10074315|FG001|STARTED|Overall Study||10
9011592|NCT02997176|10074316|FG002|STARTED|Overall Study||5
9011593|NCT02997176|10074317|FG003|STARTED|Overall Study||16
9011594|NCT02997176|10074314|FG000|COMPLETED|Overall Study||6
9011595|NCT02997176|10074315|FG001|COMPLETED|Overall Study||8
9011596|NCT02997176|10074316|FG002|COMPLETED|Overall Study||3
9011597|NCT02997176|10074317|FG003|COMPLETED|Overall Study||5
9011598|NCT02997176|10074314|FG000|NOT COMPLETED|Overall Study||1
8904503|NCT02096705|9962689|FG000|STARTED|Treatment||133
8904504|NCT02096705|9962690|FG001|STARTED|Treatment||139
8904505|NCT02096705|9962689|FG000|COMPLETED|Treatment||124
8904506|NCT02096705|9962690|FG001|COMPLETED|Treatment||134
8904507|NCT02096705|9962689|FG000|NOT COMPLETED|Treatment||9
8904508|NCT02096705|9962690|FG001|NOT COMPLETED|Treatment||5
8904509|NCT02096705|9962689|FG000|STARTED|Follow-up|5 participants in this arm did not complete the treatment period and rejoined for follow-up|129
8904510|NCT02096705|9962690|FG001|STARTED|Follow-up|5 participants in this arm did not complete the treatment period and rejoined for follow-up|139
8904511|NCT02096705|9962689|FG000|COMPLETED|Follow-up||125
9011599|NCT02997176|10074315|FG001|NOT COMPLETED|Overall Study||2
9011600|NCT02997176|10074316|FG002|NOT COMPLETED|Overall Study||2
9011601|NCT02997176|10074317|FG003|NOT COMPLETED|Overall Study||11
9011602|NCT02997722|10074329|FG000|STARTED|Overall Study||3
9011603|NCT02997722|10074330|FG001|STARTED|Overall Study||1
9011604|NCT02997722|10074329|FG000|COMPLETED|Overall Study||3
9011605|NCT02997722|10074330|FG001|COMPLETED|Overall Study||1
9011606|NCT02997722|10074329|FG000|NOT COMPLETED|Overall Study||0
9011607|NCT02997722|10074330|FG001|NOT COMPLETED|Overall Study||0
8904512|NCT02096705|9962690|FG001|COMPLETED|Follow-up||135
8904513|NCT02096705|9962689|FG000|NOT COMPLETED|Follow-up||4
8904514|NCT02096705|9962690|FG001|NOT COMPLETED|Follow-up||4
8904515|NCT02096718|9962699|FG000|STARTED|Overall Study||8
8904516|NCT02096718|9962700|FG001|STARTED|Overall Study||8
8904517|NCT02096718|9962701|FG002|STARTED|Overall Study||14
8904518|NCT02096718|9962699|FG000|COMPLETED|Overall Study||8
8904519|NCT02096718|9962700|FG001|COMPLETED|Overall Study||8
8904520|NCT02096718|9962701|FG002|COMPLETED|Overall Study||14
8904521|NCT02096718|9962699|FG000|NOT COMPLETED|Overall Study||0
8904522|NCT02096718|9962700|FG001|NOT COMPLETED|Overall Study||0
8904523|NCT02096718|9962701|FG002|NOT COMPLETED|Overall Study||0
8904524|NCT02096731|9962712|FG000|STARTED|Overall Study||26442
8904525|NCT02096731|9962713|FG001|STARTED|Overall Study||88955
8904526|NCT02096731|9962712|FG000|COMPLETED|Overall Study||26442
8904527|NCT02096731|9962713|FG001|COMPLETED|Overall Study||88955
8904528|NCT02096731|9962712|FG000|NOT COMPLETED|Overall Study||0
8904529|NCT02096731|9962713|FG001|NOT COMPLETED|Overall Study||0
8904530|NCT02096744|9962722|FG000|STARTED|Treatment Period 1(7 Days)||29
8904531|NCT02096744|9962723|FG001|STARTED|Treatment Period 1(7 Days)||29
8904532|NCT02096744|9962722|FG000|COMPLETED|Treatment Period 1(7 Days)||28
8904533|NCT02096744|9962723|FG001|COMPLETED|Treatment Period 1(7 Days)||28
8904534|NCT02096744|9962722|FG000|NOT COMPLETED|Treatment Period 1(7 Days)||1
8904535|NCT02096744|9962723|FG001|NOT COMPLETED|Treatment Period 1(7 Days)||1
8904536|NCT02096744|9962722|FG000|STARTED|Washout Period 1(7 Days)||28
8904537|NCT02096744|9962723|FG001|STARTED|Washout Period 1(7 Days)||28
8904538|NCT02096744|9962722|FG000|COMPLETED|Washout Period 1(7 Days)||28
8904539|NCT02096744|9962723|FG001|COMPLETED|Washout Period 1(7 Days)||28
8904540|NCT02096744|9962722|FG000|NOT COMPLETED|Washout Period 1(7 Days)||0
8904541|NCT02096744|9962723|FG001|NOT COMPLETED|Washout Period 1(7 Days)||0
8904542|NCT02096744|9962722|FG000|STARTED|Treatment Period 2 (7 Days)||28
8904543|NCT02096744|9962723|FG001|STARTED|Treatment Period 2 (7 Days)||28
8904544|NCT02096744|9962722|FG000|COMPLETED|Treatment Period 2 (7 Days)||28
8904545|NCT02096744|9962723|FG001|COMPLETED|Treatment Period 2 (7 Days)||28
8904546|NCT02096744|9962722|FG000|NOT COMPLETED|Treatment Period 2 (7 Days)||0
8904547|NCT02096744|9962723|FG001|NOT COMPLETED|Treatment Period 2 (7 Days)||0
8904548|NCT02096744|9962722|FG000|STARTED|Washout Period 2 (3 Days)||28
8904549|NCT02096744|9962723|FG001|STARTED|Washout Period 2 (3 Days)||28
8904550|NCT02096744|9962722|FG000|COMPLETED|Washout Period 2 (3 Days)||28
8904551|NCT02096744|9962723|FG001|COMPLETED|Washout Period 2 (3 Days)||28
8904552|NCT02096744|9962722|FG000|NOT COMPLETED|Washout Period 2 (3 Days)||0
8904553|NCT02096744|9962723|FG001|NOT COMPLETED|Washout Period 2 (3 Days)||0
8904554|NCT02096744|9962722|FG000|STARTED|Treatment Period 3 (7 Days)||28
8904555|NCT02096744|9962723|FG001|STARTED|Treatment Period 3 (7 Days)||28
8904556|NCT02096744|9962722|FG000|COMPLETED|Treatment Period 3 (7 Days)||28
8573124|NCT00118534|9605346|FG001|NOT COMPLETED|Overall Study||0
8573125|NCT00118703|9605355|FG000|STARTED|Overall Study||173
8573126|NCT00118703|9605356|FG001|STARTED|Overall Study||174
8573127|NCT00118703|9605355|FG000|COMPLETED|Overall Study||168
8573128|NCT00118703|9605356|FG001|COMPLETED|Overall Study||165
8573129|NCT00118703|9605355|FG000|NOT COMPLETED|Overall Study||5
8573130|NCT00118703|9605356|FG001|NOT COMPLETED|Overall Study||9
8573131|NCT00118716|9605364|FG000|STARTED|Overall Study||124
8573132|NCT00118716|9605365|FG001|STARTED|Overall Study||124
8573133|NCT00118716|9605364|FG000|COMPLETED|Overall Study||111
8573134|NCT00118716|9605365|FG001|COMPLETED|Overall Study||102
8573135|NCT00118716|9605364|FG000|NOT COMPLETED|Overall Study||13
8573136|NCT00118716|9605365|FG001|NOT COMPLETED|Overall Study||22
8573137|NCT00118742|9605373|FG000|STARTED|Overall Study||145
8573138|NCT00118742|9605374|FG001|STARTED|Overall Study||148
8573139|NCT00118742|9605373|FG000|COMPLETED|Overall Study||96
8573140|NCT00118742|9605374|FG001|COMPLETED|Overall Study||82
8573141|NCT00118742|9605373|FG000|NOT COMPLETED|Overall Study||49
8573142|NCT00118742|9605374|FG001|NOT COMPLETED|Overall Study||66
8577582|NCT00159861|9610348|FG000|STARTED|Core Study - 16 Weeks||133
8577583|NCT00159861|9610349|FG001|STARTED|Core Study - 16 Weeks||134
8577584|NCT00159861|9610348|FG000|Treated|Core Study - 16 Weeks||131
8577585|NCT00159861|9610349|FG001|Treated|Core Study - 16 Weeks||134
8577586|NCT00159861|9610348|FG000|COMPLETED|Core Study - 16 Weeks|Entered A1481153: 115; Did not enter A1481153: 16|108
8577587|NCT00159861|9610349|FG001|COMPLETED|Core Study - 16 Weeks|Entered A1481153: 127; Did not enter A1481153: 7|122
8577588|NCT00159861|9610348|FG000|NOT COMPLETED|Core Study - 16 Weeks||25
8577589|NCT00159861|9610349|FG001|NOT COMPLETED|Core Study - 16 Weeks||12
8904557|NCT02096744|9962723|FG001|COMPLETED|Treatment Period 3 (7 Days)||27
8904558|NCT02096744|9962722|FG000|NOT COMPLETED|Treatment Period 3 (7 Days)||0
8904559|NCT02096744|9962723|FG001|NOT COMPLETED|Treatment Period 3 (7 Days)||1
8904560|NCT02096835|9962734|FG000|STARTED|Overall Study||53
8904561|NCT02096835|9962735|FG001|STARTED|Overall Study||53
8904562|NCT02096835|9962736|FG002|STARTED|Overall Study||51
8577590|NCT00159861|9610348|FG000|STARTED|Extension Study - up to 3 Years|Subjects may have entered extension study after 4 weeks in core study (prior to completion).|115
8577591|NCT00159861|9610349|FG001|STARTED|Extension Study - up to 3 Years|Subjects may have entered extension study after 4 weeks in core study (prior to completion).|127
8904563|NCT02096835|9962734|FG000|COMPLETED|Overall Study||50
8904564|NCT02096835|9962735|FG001|COMPLETED|Overall Study||53
8904565|NCT02096835|9962736|FG002|COMPLETED|Overall Study||50
8904566|NCT02096835|9962734|FG000|NOT COMPLETED|Overall Study||3
8904567|NCT02096835|9962735|FG001|NOT COMPLETED|Overall Study||0
8904568|NCT02096835|9962736|FG002|NOT COMPLETED|Overall Study||1
8904569|NCT02096861|9962748|FG000|STARTED|Overall Study|CT-P13 followed by CT-P13 from Week 30|56
8904570|NCT02096861|9962749|FG001|STARTED|Overall Study|CT-P13 followed by Remicade from Week 30|55
8904571|NCT02096861|9962750|FG002|STARTED|Overall Study|Remicade followed by Remicade from Week 30|54
8904572|NCT02096861|9962751|FG003|STARTED|Overall Study|Remicade followed by CT-P13 from Week 30|55
8904573|NCT02096861|9962748|FG000|Drug Switching at Week 30|Overall Study||48
8904574|NCT02096861|9962749|FG001|Drug Switching at Week 30|Overall Study||44
8904575|NCT02096861|9962750|FG002|Drug Switching at Week 30|Overall Study||41
8904576|NCT02096861|9962751|FG003|Drug Switching at Week 30|Overall Study||47
9011608|NCT02997735|10074338|FG000|STARTED|Overall Study||233
9011609|NCT02997735|10074339|FG001|STARTED|Overall Study||251
9011610|NCT02997735|10074338|FG000|COMPLETED|Overall Study||233
9011611|NCT02997735|10074339|FG001|COMPLETED|Overall Study||251
9011612|NCT02997735|10074338|FG000|NOT COMPLETED|Overall Study||0
9011613|NCT02997735|10074339|FG001|NOT COMPLETED|Overall Study||0
9011614|NCT02997904|10074347|FG000|STARTED|Overall Study||51
9011615|NCT02997904|10074348|FG001|STARTED|Overall Study||49
9011616|NCT02997904|10074347|FG000|COMPLETED|Overall Study||51
9011617|NCT02997904|10074348|FG001|COMPLETED|Overall Study||49
9011618|NCT02997904|10074347|FG000|NOT COMPLETED|Overall Study||0
9011619|NCT02997904|10074348|FG001|NOT COMPLETED|Overall Study||0
9011620|NCT02998021|10074360|FG000|STARTED|Overall Study||8
9011621|NCT02998021|10074361|FG001|STARTED|Overall Study||2
9011622|NCT02998021|10074360|FG000|COMPLETED|Overall Study||5
9011623|NCT02998021|10074361|FG001|COMPLETED|Overall Study||0
9011624|NCT02998021|10074360|FG000|NOT COMPLETED|Overall Study||3
9011625|NCT02998021|10074361|FG001|NOT COMPLETED|Overall Study||2
9011626|NCT02998151|10074367|FG000|STARTED|Overall Study||29
9011627|NCT02998151|10074367|FG000|Placebo|Overall Study|Two participants withdrew from the study before receiving placebo.|27
9011628|NCT02998151|10074367|FG000|Acamprosate|Overall Study|Every participant received acamprosate prior to acamprosate's discontinuance.|16
9011629|NCT02998151|10074367|FG000|Lovastatin|Overall Study|All participants received lovastatin.|29
9011630|NCT02998151|10074367|FG000|Minocycline|Overall Study|Two participants withdrew from the study before receiving minocycline.|27
8636489|NCT00568399|9677130|FG000|COMPLETED|Overall Study|Of 48 subject enrolled, 37 initiated sodium thiosulfate treatment. 22 completed the entire protocol|22
8636490|NCT00568399|9677130|FG000|NOT COMPLETED|Overall Study||15
8636491|NCT00568451|9677138|FG000|STARTED|Overall Study||0
8636492|NCT00568451|9677139|FG001|STARTED|Overall Study||0
8636493|NCT00568451|9677140|FG002|STARTED|Overall Study||2
8636494|NCT00568451|9677141|FG003|STARTED|Overall Study||9
8636495|NCT00568451|9677138|FG000|COMPLETED|Overall Study||0
8636496|NCT00568451|9677139|FG001|COMPLETED|Overall Study||0
8636497|NCT00568451|9677140|FG002|COMPLETED|Overall Study||0
8636498|NCT00568451|9677141|FG003|COMPLETED|Overall Study||2
9011631|NCT02998151|10074367|FG000|Baclofen|Overall Study|All 13 remaining participants received baclofen after acamprosate was discontinued. Five participants were re-enrolled to receive baclofen.|18
9011632|NCT02998151|10074367|FG000|COMPLETED|Overall Study|Acamprosate was discontinued mid-study due to undetectable serum levels and replaced with baclofen. Participants who already completed acamprosate were given the option to re-enroll and receive baclofen. Five participants received all 5 interventions; 26 received 4+ interventions.|5
9011633|NCT02998151|10074367|FG000|NOT COMPLETED|Overall Study||24
9011634|NCT02998541|10074382|FG000|STARTED|Overall Study||86
9011635|NCT02998541|10074383|FG001|STARTED|Overall Study||90
9011636|NCT02998541|10074384|FG002|STARTED|Overall Study||43
9011637|NCT02998541|10074382|FG000|COMPLETED|Overall Study||78
9011638|NCT02998541|10074383|FG001|COMPLETED|Overall Study||81
9011639|NCT02998541|10074384|FG002|COMPLETED|Overall Study||37
9011640|NCT02998541|10074382|FG000|NOT COMPLETED|Overall Study||8
9011641|NCT02998541|10074383|FG001|NOT COMPLETED|Overall Study||9
9011642|NCT02998541|10074384|FG002|NOT COMPLETED|Overall Study||6
9011643|NCT02998554|10074394|FG000|STARTED|Overall Study||79
9011644|NCT02998554|10074395|FG001|STARTED|Overall Study||77
9011645|NCT02998554|10074394|FG000|COMPLETED|Overall Study||68
9011646|NCT02998554|10074395|FG001|COMPLETED|Overall Study||66
9011647|NCT02998554|10074394|FG000|NOT COMPLETED|Overall Study||11
9011648|NCT02998554|10074395|FG001|NOT COMPLETED|Overall Study||11
9011649|NCT02998671|10074408|FG000|STARTED|Period 1||21
9011650|NCT02998671|10074409|FG001|STARTED|Period 1||13
9011651|NCT02998671|10074410|FG002|STARTED|Period 1||6
9011652|NCT02998671|10074411|FG003|STARTED|Period 1||8
9011653|NCT02998671|10074412|FG004|STARTED|Period 1||4
9011654|NCT02998671|10074408|FG000|COMPLETED|Period 1||17
9011655|NCT02998671|10074409|FG001|COMPLETED|Period 1||10
9011656|NCT02998671|10074410|FG002|COMPLETED|Period 1||6
9011657|NCT02998671|10074411|FG003|COMPLETED|Period 1||8
9011658|NCT02998671|10074412|FG004|COMPLETED|Period 1||0
9011659|NCT02998671|10074408|FG000|NOT COMPLETED|Period 1||4
8636499|NCT00568451|9677138|FG000|NOT COMPLETED|Overall Study||0
8636500|NCT00568451|9677139|FG001|NOT COMPLETED|Overall Study||0
8636501|NCT00568451|9677140|FG002|NOT COMPLETED|Overall Study||2
9011660|NCT02998671|10074409|FG001|NOT COMPLETED|Period 1||3
9011661|NCT02998671|10074410|FG002|NOT COMPLETED|Period 1||0
9011662|NCT02998671|10074411|FG003|NOT COMPLETED|Period 1||0
9011663|NCT02998671|10074412|FG004|NOT COMPLETED|Period 1||4
9011664|NCT02998671|10074408|FG000|STARTED|Period 2||17
9011665|NCT02998671|10074409|FG001|STARTED|Period 2||10
9011666|NCT02998671|10074410|FG002|STARTED|Period 2||6
9011667|NCT02998671|10074411|FG003|STARTED|Period 2||8
8904577|NCT02096861|9962748|FG000|COMPLETED|Overall Study||44
8904578|NCT02096861|9962749|FG001|COMPLETED|Overall Study||40
8904579|NCT02096861|9962750|FG002|COMPLETED|Overall Study||37
8904580|NCT02096861|9962751|FG003|COMPLETED|Overall Study||45
8904581|NCT02096861|9962748|FG000|NOT COMPLETED|Overall Study||12
8904582|NCT02096861|9962749|FG001|NOT COMPLETED|Overall Study||15
8904583|NCT02096861|9962750|FG002|NOT COMPLETED|Overall Study||17
8904584|NCT02096861|9962751|FG003|NOT COMPLETED|Overall Study||10
8904585|NCT02096900|9962765|FG000|STARTED|Overall Study|Allocated to Midazolam|42
8904586|NCT02096900|9962766|FG001|STARTED|Overall Study|Allocated to Zolpidem|44
8904587|NCT02096900|9962765|FG000|COMPLETED|Overall Study||38
8904588|NCT02096900|9962766|FG001|COMPLETED|Overall Study||42
8904589|NCT02096900|9962765|FG000|NOT COMPLETED|Overall Study||4
8904590|NCT02096900|9962766|FG001|NOT COMPLETED|Overall Study||2
8904591|NCT02096952|9962772|FG000|STARTED|Overall Study||15
8904592|NCT02096952|9962772|FG000|COMPLETED|Overall Study||14
8904593|NCT02096952|9962772|FG000|NOT COMPLETED|Overall Study||1
8904594|NCT02097030|9962778|FG000|STARTED|First Intervention (3 Days)||15
8636502|NCT00568451|9677141|FG003|NOT COMPLETED|Overall Study||7
8691317|NCT00854113|9736573|FG002|STARTED|Overall Study||6
8691318|NCT00854113|9736574|FG003|STARTED|Overall Study||6
8691319|NCT00854113|9736575|FG004|STARTED|Overall Study||6
8691320|NCT00854113|9736576|FG005|STARTED|Overall Study||6
8691321|NCT00854113|9736577|FG006|STARTED|Overall Study||12
8904595|NCT02097030|9962779|FG001|STARTED|First Intervention (3 Days)||17
8904596|NCT02097030|9962778|FG000|COMPLETED|First Intervention (3 Days)||14
8904597|NCT02097030|9962779|FG001|COMPLETED|First Intervention (3 Days)||16
8904598|NCT02097030|9962778|FG000|NOT COMPLETED|First Intervention (3 Days)||1
8904599|NCT02097030|9962779|FG001|NOT COMPLETED|First Intervention (3 Days)||1
8904600|NCT02097030|9962778|FG000|STARTED|Second Intervention (3 Days)||14
8904601|NCT02097030|9962779|FG001|STARTED|Second Intervention (3 Days)||16
8904602|NCT02097030|9962778|FG000|COMPLETED|Second Intervention (3 Days)||14
8904603|NCT02097030|9962779|FG001|COMPLETED|Second Intervention (3 Days)||16
8904604|NCT02097030|9962778|FG000|NOT COMPLETED|Second Intervention (3 Days)||0
8904605|NCT02097030|9962779|FG001|NOT COMPLETED|Second Intervention (3 Days)||0
8904606|NCT02097056|9962789|FG000|STARTED|Overall Study||171
8904607|NCT02097056|9962789|FG000|ParticipantsTreated|Overall Study||170
8904608|NCT02097056|9962789|FG000|COMPLETED|Overall Study||113
8904609|NCT02097056|9962789|FG000|NOT COMPLETED|Overall Study||58
8904610|NCT02097108|9962793|FG000|STARTED|Overall Study||11
8904611|NCT02097108|9962793|FG000|COMPLETED|Overall Study||9
8904612|NCT02097108|9962793|FG000|NOT COMPLETED|Overall Study||2
8904613|NCT02097238|9962797|FG000|STARTED|Overall Study||19
8904614|NCT02097238|9962797|FG000|COMPLETED|Overall Study||0
9011668|NCT02998671|10074412|FG004|STARTED|Period 2||0
9011669|NCT02998671|10074408|FG000|COMPLETED|Period 2||14
9011670|NCT02998671|10074409|FG001|COMPLETED|Period 2||3
9011671|NCT02998671|10074410|FG002|COMPLETED|Period 2||5
9011672|NCT02998671|10074411|FG003|COMPLETED|Period 2||4
9011673|NCT02998671|10074412|FG004|COMPLETED|Period 2||0
9011674|NCT02998671|10074408|FG000|NOT COMPLETED|Period 2||3
9011675|NCT02998671|10074409|FG001|NOT COMPLETED|Period 2||7
9011676|NCT02998671|10074410|FG002|NOT COMPLETED|Period 2||1
9011677|NCT02998671|10074411|FG003|NOT COMPLETED|Period 2||4
9011678|NCT02998671|10074412|FG004|NOT COMPLETED|Period 2||0
9011679|NCT02998684|10074434|FG000|STARTED|Overall Study||7
9011680|NCT02998684|10074435|FG001|STARTED|Overall Study||7
9011681|NCT02998684|10074434|FG000|COMPLETED|Overall Study||4
9011682|NCT02998684|10074435|FG001|COMPLETED|Overall Study||6
9011683|NCT02998684|10074434|FG000|NOT COMPLETED|Overall Study||3
9011684|NCT02998684|10074435|FG001|NOT COMPLETED|Overall Study||1
9011685|NCT02998996|10074447|FG000|STARTED|Overall Study||36
9011686|NCT02998996|10074448|FG001|STARTED|Overall Study||35
9011687|NCT02998996|10074449|FG002|STARTED|Overall Study||36
9011688|NCT02998996|10074450|FG003|STARTED|Overall Study||18
9011689|NCT02998996|10074451|FG004|STARTED|Overall Study||18
9011690|NCT02998996|10074452|FG005|STARTED|Overall Study||19
9011691|NCT02998996|10074447|FG000|COMPLETED|Overall Study||36
9011692|NCT02998996|10074448|FG001|COMPLETED|Overall Study||34
9011693|NCT02998996|10074449|FG002|COMPLETED|Overall Study||35
9011694|NCT02998996|10074450|FG003|COMPLETED|Overall Study||18
9011695|NCT02998996|10074451|FG004|COMPLETED|Overall Study||17
9011696|NCT02998996|10074452|FG005|COMPLETED|Overall Study||19
8691322|NCT00854113|9736578|FG007|STARTED|Overall Study||8
8691323|NCT00854113|9736579|FG008|STARTED|Overall Study||8
8691324|NCT00854113|9736580|FG009|STARTED|Overall Study||8
8904615|NCT02097238|9962797|FG000|NOT COMPLETED|Overall Study||19
8904616|NCT02097277|9962807|FG000|STARTED|Overall Study||24
9011697|NCT02998996|10074447|FG000|NOT COMPLETED|Overall Study||0
9011698|NCT02998996|10074448|FG001|NOT COMPLETED|Overall Study||1
9011699|NCT02998996|10074449|FG002|NOT COMPLETED|Overall Study||1
9011700|NCT02998996|10074450|FG003|NOT COMPLETED|Overall Study||0
9011701|NCT02998996|10074451|FG004|NOT COMPLETED|Overall Study||1
8904617|NCT02097277|9962808|FG001|STARTED|Overall Study||24
8904618|NCT02097277|9962809|FG002|STARTED|Overall Study||24
8904619|NCT02097277|9962810|FG003|STARTED|Overall Study||24
9011702|NCT02998996|10074452|FG005|NOT COMPLETED|Overall Study||0
8691325|NCT00854113|9736581|FG010|STARTED|Overall Study||6
8691326|NCT00854113|9736571|FG000|COMPLETED|Overall Study||6
9011703|NCT02999100|10074472|FG000|STARTED|Part 1 (up to 15 Days)||9
9011704|NCT02999100|10074473|FG001|STARTED|Part 1 (up to 15 Days)||8
8904620|NCT02097277|9962811|FG004|STARTED|Overall Study||24
8904621|NCT02097277|9962807|FG000|COMPLETED|Overall Study||22
8904622|NCT02097277|9962808|FG001|COMPLETED|Overall Study||21
8904623|NCT02097277|9962809|FG002|COMPLETED|Overall Study||22
8904624|NCT02097277|9962810|FG003|COMPLETED|Overall Study||20
8904625|NCT02097277|9962811|FG004|COMPLETED|Overall Study||23
8904626|NCT02097277|9962807|FG000|NOT COMPLETED|Overall Study||2
8904627|NCT02097277|9962808|FG001|NOT COMPLETED|Overall Study||3
8904628|NCT02097277|9962809|FG002|NOT COMPLETED|Overall Study||2
8904629|NCT02097277|9962810|FG003|NOT COMPLETED|Overall Study||4
8904630|NCT02097277|9962811|FG004|NOT COMPLETED|Overall Study||1
8904631|NCT02097290|9962827|FG000|STARTED|Overall Study||210
8904632|NCT02097290|9962827|FG000|COMPLETED|Overall Study|Active subjects at the end of 3 month follow up visit for primary end point data collection|193
8904633|NCT02097290|9962827|FG000|NOT COMPLETED|Overall Study||17
8904634|NCT02097303|9962831|FG000|STARTED|Overall Study||36
8636503|NCT00568555|9677154|FG000|STARTED|Overall Study||16
8636504|NCT00568555|9677155|FG001|STARTED|Overall Study||15
8636505|NCT00568555|9677154|FG000|COMPLETED|Overall Study||15
8636506|NCT00568555|9677155|FG001|COMPLETED|Overall Study||14
8636507|NCT00568555|9677154|FG000|NOT COMPLETED|Overall Study||1
8636508|NCT00568555|9677155|FG001|NOT COMPLETED|Overall Study||1
8904635|NCT02097303|9962831|FG000|COMPLETED|Overall Study||31
8904636|NCT02097303|9962831|FG000|NOT COMPLETED|Overall Study||5
8904637|NCT02097472|9962843|FG000|STARTED|Received Vaccination 1||18
8904638|NCT02097472|9962844|FG001|STARTED|Received Vaccination 1||18
8904639|NCT02097472|9962845|FG002|STARTED|Received Vaccination 1||18
8904640|NCT02097472|9962846|FG003|STARTED|Received Vaccination 1||50
8904641|NCT02097472|9962847|FG004|STARTED|Received Vaccination 1||50
8904642|NCT02097472|9962848|FG005|STARTED|Received Vaccination 1||50
8904643|NCT02097472|9962849|FG006|STARTED|Received Vaccination 1||50
8904644|NCT02097472|9962850|FG007|STARTED|Received Vaccination 1||50
8904645|NCT02097472|9962843|FG000|COMPLETED|Received Vaccination 1||18
8904646|NCT02097472|9962844|FG001|COMPLETED|Received Vaccination 1||18
8904647|NCT02097472|9962845|FG002|COMPLETED|Received Vaccination 1||18
8904648|NCT02097472|9962846|FG003|COMPLETED|Received Vaccination 1||50
8904649|NCT02097472|9962847|FG004|COMPLETED|Received Vaccination 1||50
8904650|NCT02097472|9962848|FG005|COMPLETED|Received Vaccination 1||50
8904651|NCT02097472|9962849|FG006|COMPLETED|Received Vaccination 1||50
8904652|NCT02097472|9962850|FG007|COMPLETED|Received Vaccination 1||50
8904653|NCT02097472|9962843|FG000|NOT COMPLETED|Received Vaccination 1||0
8904654|NCT02097472|9962844|FG001|NOT COMPLETED|Received Vaccination 1||0
8904655|NCT02097472|9962845|FG002|NOT COMPLETED|Received Vaccination 1||0
8904656|NCT02097472|9962846|FG003|NOT COMPLETED|Received Vaccination 1||0
8904657|NCT02097472|9962847|FG004|NOT COMPLETED|Received Vaccination 1||0
8904658|NCT02097472|9962848|FG005|NOT COMPLETED|Received Vaccination 1||0
8904659|NCT02097472|9962849|FG006|NOT COMPLETED|Received Vaccination 1||0
8904660|NCT02097472|9962850|FG007|NOT COMPLETED|Received Vaccination 1||0
8904661|NCT02097472|9962843|FG000|STARTED|Received Vaccination 2||18
8904662|NCT02097472|9962844|FG001|STARTED|Received Vaccination 2||18
8904663|NCT02097472|9962845|FG002|STARTED|Received Vaccination 2||18
8904664|NCT02097472|9962846|FG003|STARTED|Received Vaccination 2||50
8636509|NCT00568633|9677165|FG000|STARTED|Overall Study||25
8636510|NCT00568633|9677166|FG001|STARTED|Overall Study||33
8636511|NCT00568633|9677165|FG000|COMPLETED|Overall Study||25
8636512|NCT00568633|9677166|FG001|COMPLETED|Overall Study||33
8904665|NCT02097472|9962847|FG004|STARTED|Received Vaccination 2||50
8904666|NCT02097472|9962848|FG005|STARTED|Received Vaccination 2||50
8904667|NCT02097472|9962849|FG006|STARTED|Received Vaccination 2||50
8904668|NCT02097472|9962850|FG007|STARTED|Received Vaccination 2||50
8904669|NCT02097472|9962843|FG000|COMPLETED|Received Vaccination 2||18
8904670|NCT02097472|9962844|FG001|COMPLETED|Received Vaccination 2||18
8904671|NCT02097472|9962845|FG002|COMPLETED|Received Vaccination 2||18
8904672|NCT02097472|9962846|FG003|COMPLETED|Received Vaccination 2||50
8904673|NCT02097472|9962847|FG004|COMPLETED|Received Vaccination 2||50
8904674|NCT02097472|9962848|FG005|COMPLETED|Received Vaccination 2||50
8904675|NCT02097472|9962849|FG006|COMPLETED|Received Vaccination 2||49
8904676|NCT02097472|9962850|FG007|COMPLETED|Received Vaccination 2||50
8904677|NCT02097472|9962843|FG000|NOT COMPLETED|Received Vaccination 2||0
8904678|NCT02097472|9962844|FG001|NOT COMPLETED|Received Vaccination 2||0
8904679|NCT02097472|9962845|FG002|NOT COMPLETED|Received Vaccination 2||0
8904680|NCT02097472|9962846|FG003|NOT COMPLETED|Received Vaccination 2||0
8904681|NCT02097472|9962847|FG004|NOT COMPLETED|Received Vaccination 2||0
8904682|NCT02097472|9962848|FG005|NOT COMPLETED|Received Vaccination 2||0
8904683|NCT02097472|9962849|FG006|NOT COMPLETED|Received Vaccination 2||1
8904684|NCT02097472|9962850|FG007|NOT COMPLETED|Received Vaccination 2||0
8904685|NCT02097472|9962843|FG000|STARTED|Assessed for Immunogenicity||18
8904686|NCT02097472|9962844|FG001|STARTED|Assessed for Immunogenicity||18
8904687|NCT02097472|9962845|FG002|STARTED|Assessed for Immunogenicity||18
8904688|NCT02097472|9962846|FG003|STARTED|Assessed for Immunogenicity||50
8636513|NCT00568633|9677165|FG000|NOT COMPLETED|Overall Study||0
8636514|NCT00568633|9677166|FG001|NOT COMPLETED|Overall Study||0
8904689|NCT02097472|9962847|FG004|STARTED|Assessed for Immunogenicity||50
8904690|NCT02097472|9962848|FG005|STARTED|Assessed for Immunogenicity||50
8904691|NCT02097472|9962849|FG006|STARTED|Assessed for Immunogenicity||49
8904692|NCT02097472|9962850|FG007|STARTED|Assessed for Immunogenicity||50
8904693|NCT02097472|9962843|FG000|COMPLETED|Assessed for Immunogenicity||18
8904694|NCT02097472|9962844|FG001|COMPLETED|Assessed for Immunogenicity||18
8904695|NCT02097472|9962845|FG002|COMPLETED|Assessed for Immunogenicity||17
8904696|NCT02097472|9962846|FG003|COMPLETED|Assessed for Immunogenicity||48
8904697|NCT02097472|9962847|FG004|COMPLETED|Assessed for Immunogenicity||50
8904698|NCT02097472|9962848|FG005|COMPLETED|Assessed for Immunogenicity||48
8904699|NCT02097472|9962849|FG006|COMPLETED|Assessed for Immunogenicity||47
8904700|NCT02097472|9962850|FG007|COMPLETED|Assessed for Immunogenicity||49
9011705|NCT02999100|10074474|FG002|STARTED|Part 1 (up to 15 Days)||0
9011706|NCT02999100|10074475|FG003|STARTED|Part 1 (up to 15 Days)||0
9011707|NCT02999100|10074476|FG004|STARTED|Part 1 (up to 15 Days)||0
9011708|NCT02999100|10074477|FG005|STARTED|Part 1 (up to 15 Days)||0
9011709|NCT02999100|10074472|FG000|COMPLETED|Part 1 (up to 15 Days)||9
9011710|NCT02999100|10074473|FG001|COMPLETED|Part 1 (up to 15 Days)||7
9011711|NCT02999100|10074474|FG002|COMPLETED|Part 1 (up to 15 Days)||0
9011712|NCT02999100|10074475|FG003|COMPLETED|Part 1 (up to 15 Days)||0
9011713|NCT02999100|10074476|FG004|COMPLETED|Part 1 (up to 15 Days)||0
9011714|NCT02999100|10074477|FG005|COMPLETED|Part 1 (up to 15 Days)||0
9011715|NCT02999100|10074472|FG000|NOT COMPLETED|Part 1 (up to 15 Days)||0
9011716|NCT02999100|10074473|FG001|NOT COMPLETED|Part 1 (up to 15 Days)||1
9011717|NCT02999100|10074474|FG002|NOT COMPLETED|Part 1 (up to 15 Days)||0
9011718|NCT02999100|10074475|FG003|NOT COMPLETED|Part 1 (up to 15 Days)||0
9011719|NCT02999100|10074476|FG004|NOT COMPLETED|Part 1 (up to 15 Days)||0
9011720|NCT02999100|10074477|FG005|NOT COMPLETED|Part 1 (up to 15 Days)||0
9011721|NCT02999100|10074472|FG000|STARTED|Part 2 (Day 1): Dosing Session 1|Participants from Part 1 did not enter Part 2|0
9011722|NCT02999100|10074473|FG001|STARTED|Part 2 (Day 1): Dosing Session 1|Participants from Part 1 did not enter Part 2|0
9011723|NCT02999100|10074474|FG002|STARTED|Part 2 (Day 1): Dosing Session 1|New participants were enrolled in Part 2 of study|5
9011724|NCT02999100|10074475|FG003|STARTED|Part 2 (Day 1): Dosing Session 1|New participants were enrolled in Part 2 of study|3
9011725|NCT02999100|10074476|FG004|STARTED|Part 2 (Day 1): Dosing Session 1|New participants were enrolled in Part 2 of study|3
9011726|NCT02999100|10074477|FG005|STARTED|Part 2 (Day 1): Dosing Session 1|New participants were enrolled in Part 2 of study|3
9011727|NCT02999100|10074472|FG000|COMPLETED|Part 2 (Day 1): Dosing Session 1||0
9011728|NCT02999100|10074473|FG001|COMPLETED|Part 2 (Day 1): Dosing Session 1||0
9011729|NCT02999100|10074474|FG002|COMPLETED|Part 2 (Day 1): Dosing Session 1||4
9011730|NCT02999100|10074475|FG003|COMPLETED|Part 2 (Day 1): Dosing Session 1||3
9011731|NCT02999100|10074476|FG004|COMPLETED|Part 2 (Day 1): Dosing Session 1||3
9011732|NCT02999100|10074477|FG005|COMPLETED|Part 2 (Day 1): Dosing Session 1||2
9011733|NCT02999100|10074472|FG000|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||0
9011734|NCT02999100|10074473|FG001|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||0
9011735|NCT02999100|10074474|FG002|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||1
9011736|NCT02999100|10074475|FG003|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||0
9011737|NCT02999100|10074476|FG004|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||0
9011738|NCT02999100|10074477|FG005|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||1
9011739|NCT02999100|10074472|FG000|STARTED|Part 2 (Day 14): Dosing Session 2||0
9011740|NCT02999100|10074473|FG001|STARTED|Part 2 (Day 14): Dosing Session 2||0
9011741|NCT02999100|10074474|FG002|STARTED|Part 2 (Day 14): Dosing Session 2||4
9011742|NCT02999100|10074475|FG003|STARTED|Part 2 (Day 14): Dosing Session 2||3
9011743|NCT02999100|10074476|FG004|STARTED|Part 2 (Day 14): Dosing Session 2||3
9011744|NCT02999100|10074477|FG005|STARTED|Part 2 (Day 14): Dosing Session 2||2
9011745|NCT02999100|10074472|FG000|COMPLETED|Part 2 (Day 14): Dosing Session 2||0
9011746|NCT02999100|10074473|FG001|COMPLETED|Part 2 (Day 14): Dosing Session 2||0
9011747|NCT02999100|10074474|FG002|COMPLETED|Part 2 (Day 14): Dosing Session 2||4
9011748|NCT02999100|10074475|FG003|COMPLETED|Part 2 (Day 14): Dosing Session 2||3
9011749|NCT02999100|10074476|FG004|COMPLETED|Part 2 (Day 14): Dosing Session 2||3
9011750|NCT02999100|10074477|FG005|COMPLETED|Part 2 (Day 14): Dosing Session 2||2
9011751|NCT02999100|10074472|FG000|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0
9011752|NCT02999100|10074473|FG001|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0
9011753|NCT02999100|10074474|FG002|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0
9011754|NCT02999100|10074475|FG003|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0
9011755|NCT02999100|10074476|FG004|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0
9011756|NCT02999100|10074477|FG005|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0
9011757|NCT02999178|10074501|FG000|STARTED|Overall Study||332
9011758|NCT02999178|10074502|FG001|STARTED|Overall Study||331
9011759|NCT02999178|10074501|FG000|COMPLETED|Overall Study|On treatment at analysis cut-off date, 12-August-2019|218
9011760|NCT02999178|10074502|FG001|COMPLETED|Overall Study|On treatment at analysis cut-off date, 12-August-2019|231
9011761|NCT02999178|10074501|FG000|NOT COMPLETED|Overall Study||114
9011762|NCT02999178|10074502|FG001|NOT COMPLETED|Overall Study||100
9011763|NCT02999191|10074511|FG000|STARTED|Treatment Period 1 [1 Day]||6
9011764|NCT02999191|10074512|FG001|STARTED|Treatment Period 1 [1 Day]||6
9011765|NCT02999191|10074513|FG002|STARTED|Treatment Period 1 [1 Day]||6
9011766|NCT02999191|10074511|FG000|COMPLETED|Treatment Period 1 [1 Day]||6
8904701|NCT02097472|9962843|FG000|NOT COMPLETED|Assessed for Immunogenicity||0
8904702|NCT02097472|9962844|FG001|NOT COMPLETED|Assessed for Immunogenicity||0
8904703|NCT02097472|9962845|FG002|NOT COMPLETED|Assessed for Immunogenicity||1
9011767|NCT02999191|10074512|FG001|COMPLETED|Treatment Period 1 [1 Day]||6
9011768|NCT02999191|10074513|FG002|COMPLETED|Treatment Period 1 [1 Day]||6
9011769|NCT02999191|10074511|FG000|NOT COMPLETED|Treatment Period 1 [1 Day]||0
9011770|NCT02999191|10074512|FG001|NOT COMPLETED|Treatment Period 1 [1 Day]||0
8904704|NCT02097472|9962846|FG003|NOT COMPLETED|Assessed for Immunogenicity||2
8904705|NCT02097472|9962847|FG004|NOT COMPLETED|Assessed for Immunogenicity||0
8904706|NCT02097472|9962848|FG005|NOT COMPLETED|Assessed for Immunogenicity||2
8904707|NCT02097472|9962849|FG006|NOT COMPLETED|Assessed for Immunogenicity||2
8904708|NCT02097472|9962850|FG007|NOT COMPLETED|Assessed for Immunogenicity||1
8904709|NCT02097485|9962936|FG000|STARTED|Overall Study||25
8904710|NCT02097485|9962937|FG001|STARTED|Overall Study||25
8904711|NCT02097485|9962936|FG000|COMPLETED|Overall Study||25
8904712|NCT02097485|9962937|FG001|COMPLETED|Overall Study||25
8904713|NCT02097485|9962936|FG000|NOT COMPLETED|Overall Study||0
8904714|NCT02097485|9962937|FG001|NOT COMPLETED|Overall Study||0
8904715|NCT02097537|9962943|FG000|STARTED|Overall Study||10
8904716|NCT02097537|9962943|FG000|Enrollment|Overall Study|Inhalation of Methacholine Chloride|10
8904717|NCT02097537|9962943|FG000|Follow-Up|Overall Study||10
8904718|NCT02097537|9962943|FG000|COMPLETED|Overall Study||10
8904719|NCT02097537|9962943|FG000|NOT COMPLETED|Overall Study||0
8904720|NCT02097641|9962949|FG000|STARTED|Overall Study||40
8904721|NCT02097641|9962950|FG001|STARTED|Overall Study||20
8904722|NCT02097641|9962949|FG000|COMPLETED|Overall Study||40
8904723|NCT02097641|9962950|FG001|COMPLETED|Overall Study||20
8904724|NCT02097641|9962949|FG000|NOT COMPLETED|Overall Study||0
8904725|NCT02097641|9962950|FG001|NOT COMPLETED|Overall Study||0
8904726|NCT02097719|9962960|FG000|STARTED|Overall Study||49
9011771|NCT02999191|10074513|FG002|NOT COMPLETED|Treatment Period 1 [1 Day]||0
9011772|NCT02999191|10074511|FG000|STARTED|Wash-out Period 1 [21 Days]||6
9011773|NCT02999191|10074512|FG001|STARTED|Wash-out Period 1 [21 Days]||6
9011774|NCT02999191|10074513|FG002|STARTED|Wash-out Period 1 [21 Days]||6
9011775|NCT02999191|10074511|FG000|COMPLETED|Wash-out Period 1 [21 Days]||6
9011776|NCT02999191|10074512|FG001|COMPLETED|Wash-out Period 1 [21 Days]||5
9011777|NCT02999191|10074513|FG002|COMPLETED|Wash-out Period 1 [21 Days]||6
9011778|NCT02999191|10074511|FG000|NOT COMPLETED|Wash-out Period 1 [21 Days]||0
9011779|NCT02999191|10074512|FG001|NOT COMPLETED|Wash-out Period 1 [21 Days]||1
9011780|NCT02999191|10074513|FG002|NOT COMPLETED|Wash-out Period 1 [21 Days]||0
9011781|NCT02999191|10074511|FG000|STARTED|Treatment Period 2 [1 Day]||6
9011782|NCT02999191|10074512|FG001|STARTED|Treatment Period 2 [1 Day]||5
9011783|NCT02999191|10074513|FG002|STARTED|Treatment Period 2 [1 Day]||6
9011784|NCT02999191|10074511|FG000|COMPLETED|Treatment Period 2 [1 Day]||6
9011785|NCT02999191|10074512|FG001|COMPLETED|Treatment Period 2 [1 Day]||5
9011786|NCT02999191|10074513|FG002|COMPLETED|Treatment Period 2 [1 Day]||6
9011787|NCT02999191|10074511|FG000|NOT COMPLETED|Treatment Period 2 [1 Day]||0
9011788|NCT02999191|10074512|FG001|NOT COMPLETED|Treatment Period 2 [1 Day]||0
9011789|NCT02999191|10074513|FG002|NOT COMPLETED|Treatment Period 2 [1 Day]||0
9011790|NCT02999191|10074511|FG000|STARTED|Wash-out Period 2 [21 Days]||6
9011791|NCT02999191|10074512|FG001|STARTED|Wash-out Period 2 [21 Days]||5
9011792|NCT02999191|10074513|FG002|STARTED|Wash-out Period 2 [21 Days]||6
9011793|NCT02999191|10074511|FG000|COMPLETED|Wash-out Period 2 [21 Days]||6
9011794|NCT02999191|10074512|FG001|COMPLETED|Wash-out Period 2 [21 Days]||5
9011795|NCT02999191|10074513|FG002|COMPLETED|Wash-out Period 2 [21 Days]||6
9011796|NCT02999191|10074511|FG000|NOT COMPLETED|Wash-out Period 2 [21 Days]||0
9011797|NCT02999191|10074512|FG001|NOT COMPLETED|Wash-out Period 2 [21 Days]||0
9011798|NCT02999191|10074513|FG002|NOT COMPLETED|Wash-out Period 2 [21 Days]||0
9011799|NCT02999191|10074511|FG000|STARTED|Treatment Period 3 [1 Day]||6
9011800|NCT02999191|10074512|FG001|STARTED|Treatment Period 3 [1 Day]||6
9011801|NCT02999191|10074513|FG002|STARTED|Treatment Period 3 [1 Day]||6
9011802|NCT02999191|10074511|FG000|COMPLETED|Treatment Period 3 [1 Day]||6
9011803|NCT02999191|10074512|FG001|COMPLETED|Treatment Period 3 [1 Day]||6
9011804|NCT02999191|10074513|FG002|COMPLETED|Treatment Period 3 [1 Day]||6
9011805|NCT02999191|10074511|FG000|NOT COMPLETED|Treatment Period 3 [1 Day]||0
9011806|NCT02999191|10074512|FG001|NOT COMPLETED|Treatment Period 3 [1 Day]||0
9011807|NCT02999191|10074513|FG002|NOT COMPLETED|Treatment Period 3 [1 Day]||0
9011808|NCT02999672|10074523|FG000|STARTED|Overall Study||13
9011809|NCT02999672|10074524|FG001|STARTED|Overall Study||7
9011810|NCT02999672|10074523|FG000|COMPLETED|Overall Study||0
9011811|NCT02999672|10074524|FG001|COMPLETED|Overall Study||0
9011812|NCT02999672|10074523|FG000|NOT COMPLETED|Overall Study||13
9011813|NCT02999672|10074524|FG001|NOT COMPLETED|Overall Study||7
8636515|NCT00568685|9677175|FG000|STARTED|Overall Study||51
8636516|NCT00568685|9677176|FG001|STARTED|Overall Study||51
8636517|NCT00568685|9677177|FG002|STARTED|Overall Study||51
8636518|NCT00568685|9677175|FG000|COMPLETED|Overall Study||41
8636519|NCT00568685|9677176|FG001|COMPLETED|Overall Study||46
8636520|NCT00568685|9677177|FG002|COMPLETED|Overall Study||46
8636521|NCT00568685|9677175|FG000|NOT COMPLETED|Overall Study||10
8636522|NCT00568685|9677176|FG001|NOT COMPLETED|Overall Study||5
9011814|NCT02999763|10074530|FG000|STARTED|Overall Study||70
9011815|NCT02999763|10074530|FG000|COMPLETED|Overall Study||58
9011816|NCT02999763|10074530|FG000|NOT COMPLETED|Overall Study||12
9011817|NCT03000010|10074536|FG000|STARTED|Overall Study||21
9011818|NCT03000010|10074537|FG001|STARTED|Overall Study||20
8636523|NCT00568685|9677177|FG002|NOT COMPLETED|Overall Study||5
8636524|NCT00568776|9677193|FG000|STARTED|Overall Study|One randomized patient withdrew consent and did not receive placebo|83
8636525|NCT00568776|9677194|FG001|STARTED|Overall Study|One randomized patient withdrew consent and did not receive ELND005 250 mg BID|88
8904727|NCT02097719|9962961|FG001|STARTED|Overall Study||51
8904728|NCT02097719|9962960|FG000|COMPLETED|Overall Study||46
8904729|NCT02097719|9962961|FG001|COMPLETED|Overall Study||50
8904730|NCT02097719|9962960|FG000|NOT COMPLETED|Overall Study||3
8904731|NCT02097719|9962961|FG001|NOT COMPLETED|Overall Study||1
8904732|NCT02097732|9962969|FG000|STARTED|Overall Study||1
8904733|NCT02097732|9962970|FG001|STARTED|Overall Study||3
8904734|NCT02097732|9962969|FG000|COMPLETED|Overall Study||1
8904735|NCT02097732|9962970|FG001|COMPLETED|Overall Study||3
8904736|NCT02097732|9962969|FG000|NOT COMPLETED|Overall Study||0
8904737|NCT02097732|9962970|FG001|NOT COMPLETED|Overall Study||0
8904738|NCT02097745|9962977|FG000|STARTED|Overall Study|Six participants did not receive any treatment and were not included in any analyses.|335
8904739|NCT02097745|9962977|FG000|COMPLETED|Overall Study||157
8904740|NCT02097745|9962977|FG000|NOT COMPLETED|Overall Study||178
8904741|NCT02097823|9962986|FG000|STARTED|Overall Study||11
8904742|NCT02097823|9962987|FG001|STARTED|Overall Study||4
8904743|NCT02097823|9962986|FG000|COMPLETED|Overall Study||10
8904744|NCT02097823|9962987|FG001|COMPLETED|Overall Study||3
8904745|NCT02097823|9962986|FG000|NOT COMPLETED|Overall Study||1
8904746|NCT02097823|9962987|FG001|NOT COMPLETED|Overall Study||1
8904747|NCT02097849|9962996|FG000|STARTED|Overall Study||33
8904748|NCT02097849|9962997|FG001|STARTED|Overall Study||38
8904749|NCT02097849|9962996|FG000|COMPLETED|Overall Study||33
8904750|NCT02097849|9962997|FG001|COMPLETED|Overall Study||38
8904751|NCT02097849|9962996|FG000|NOT COMPLETED|Overall Study||0
8904752|NCT02097849|9962997|FG001|NOT COMPLETED|Overall Study||0
8904753|NCT02097992|9963007|FG000|STARTED|Treatment 1 (1 Day)||2
8904754|NCT02097992|9963008|FG001|STARTED|Treatment 1 (1 Day)||3
8904755|NCT02097992|9963009|FG002|STARTED|Treatment 1 (1 Day)||4
8904756|NCT02097992|9963010|FG003|STARTED|Treatment 1 (1 Day)||2
8904757|NCT02097992|9963007|FG000|COMPLETED|Treatment 1 (1 Day)||2
8904758|NCT02097992|9963008|FG001|COMPLETED|Treatment 1 (1 Day)||3
8904759|NCT02097992|9963009|FG002|COMPLETED|Treatment 1 (1 Day)||4
8904760|NCT02097992|9963010|FG003|COMPLETED|Treatment 1 (1 Day)||2
8904761|NCT02097992|9963007|FG000|NOT COMPLETED|Treatment 1 (1 Day)||0
8904762|NCT02097992|9963008|FG001|NOT COMPLETED|Treatment 1 (1 Day)||0
8904763|NCT02097992|9963009|FG002|NOT COMPLETED|Treatment 1 (1 Day)||0
8904764|NCT02097992|9963010|FG003|NOT COMPLETED|Treatment 1 (1 Day)||0
8904765|NCT02097992|9963007|FG000|STARTED|Treatment 2 (4 Weeks)||2
8904766|NCT02097992|9963008|FG001|STARTED|Treatment 2 (4 Weeks)||3
8904767|NCT02097992|9963009|FG002|STARTED|Treatment 2 (4 Weeks)||4
8904768|NCT02097992|9963010|FG003|STARTED|Treatment 2 (4 Weeks)||2
8904769|NCT02097992|9963007|FG000|COMPLETED|Treatment 2 (4 Weeks)||2
8904770|NCT02097992|9963008|FG001|COMPLETED|Treatment 2 (4 Weeks)||3
8904771|NCT02097992|9963009|FG002|COMPLETED|Treatment 2 (4 Weeks)||4
8904772|NCT02097992|9963010|FG003|COMPLETED|Treatment 2 (4 Weeks)||2
8904773|NCT02097992|9963007|FG000|NOT COMPLETED|Treatment 2 (4 Weeks)||0
8904774|NCT02097992|9963008|FG001|NOT COMPLETED|Treatment 2 (4 Weeks)||0
8904775|NCT02097992|9963009|FG002|NOT COMPLETED|Treatment 2 (4 Weeks)||0
8904776|NCT02097992|9963010|FG003|NOT COMPLETED|Treatment 2 (4 Weeks)||0
8904777|NCT02097992|9963007|FG000|STARTED|Washout (4 Weeks)||2
8904778|NCT02097992|9963008|FG001|STARTED|Washout (4 Weeks)||3
8904779|NCT02097992|9963009|FG002|STARTED|Washout (4 Weeks)||4
8904780|NCT02097992|9963010|FG003|STARTED|Washout (4 Weeks)||2
8904781|NCT02097992|9963007|FG000|COMPLETED|Washout (4 Weeks)||2
8904782|NCT02097992|9963008|FG001|COMPLETED|Washout (4 Weeks)||3
8904783|NCT02097992|9963009|FG002|COMPLETED|Washout (4 Weeks)||4
8904784|NCT02097992|9963010|FG003|COMPLETED|Washout (4 Weeks)||2
8904785|NCT02097992|9963007|FG000|NOT COMPLETED|Washout (4 Weeks)||0
8904786|NCT02097992|9963008|FG001|NOT COMPLETED|Washout (4 Weeks)||0
8904787|NCT02097992|9963009|FG002|NOT COMPLETED|Washout (4 Weeks)||0
8904788|NCT02097992|9963010|FG003|NOT COMPLETED|Washout (4 Weeks)||0
8904789|NCT02097992|9963007|FG000|STARTED|Treatment 3 (4 Weeks)||2
8904790|NCT02097992|9963008|FG001|STARTED|Treatment 3 (4 Weeks)||3
8904791|NCT02097992|9963009|FG002|STARTED|Treatment 3 (4 Weeks)||4
8904792|NCT02097992|9963010|FG003|STARTED|Treatment 3 (4 Weeks)||2
8904793|NCT02097992|9963007|FG000|COMPLETED|Treatment 3 (4 Weeks)||2
8904794|NCT02097992|9963008|FG001|COMPLETED|Treatment 3 (4 Weeks)||3
8904795|NCT02097992|9963009|FG002|COMPLETED|Treatment 3 (4 Weeks)||4
8904796|NCT02097992|9963010|FG003|COMPLETED|Treatment 3 (4 Weeks)||2
8904797|NCT02097992|9963007|FG000|NOT COMPLETED|Treatment 3 (4 Weeks)||0
8904798|NCT02097992|9963008|FG001|NOT COMPLETED|Treatment 3 (4 Weeks)||0
8904799|NCT02097992|9963009|FG002|NOT COMPLETED|Treatment 3 (4 Weeks)||0
8904800|NCT02097992|9963010|FG003|NOT COMPLETED|Treatment 3 (4 Weeks)||0
8904801|NCT02098109|9963020|FG000|STARTED|Overall Study||49
8904802|NCT02098109|9963021|FG001|STARTED|Overall Study||51
8904803|NCT02098109|9963020|FG000|COMPLETED|Overall Study||46
8904804|NCT02098109|9963021|FG001|COMPLETED|Overall Study||51
8904805|NCT02098109|9963020|FG000|NOT COMPLETED|Overall Study||3
8904806|NCT02098109|9963021|FG001|NOT COMPLETED|Overall Study||0
8904807|NCT02098304|9963027|FG000|STARTED|Overall Study||42
8904808|NCT02098304|9963027|FG000|COMPLETED|Overall Study||42
8904809|NCT02098304|9963027|FG000|NOT COMPLETED|Overall Study||0
8904810|NCT02098369|9963036|FG000|STARTED|Overall Study||142
8904811|NCT02098369|9963037|FG001|STARTED|Overall Study||154
9011819|NCT03000010|10074536|FG000|COMPLETED|Overall Study||21
9011820|NCT03000010|10074537|FG001|COMPLETED|Overall Study||20
8904812|NCT02098369|9963038|FG002|STARTED|Overall Study||148
8904813|NCT02098369|9963036|FG000|COMPLETED|Overall Study||135
8904814|NCT02098369|9963037|FG001|COMPLETED|Overall Study||145
8904815|NCT02098369|9963038|FG002|COMPLETED|Overall Study||143
9011821|NCT03000010|10074536|FG000|NOT COMPLETED|Overall Study||0
8904816|NCT02098369|9963036|FG000|NOT COMPLETED|Overall Study||7
8904817|NCT02098369|9963037|FG001|NOT COMPLETED|Overall Study||9
8904818|NCT02098369|9963038|FG002|NOT COMPLETED|Overall Study||5
8904819|NCT02098395|9963050|FG000|STARTED|Overall Study||212
8904820|NCT02098395|9963051|FG001|STARTED|Overall Study||209
8636526|NCT00568776|9677195|FG002|STARTED|Overall Study|41 patients withdrawn per interim safety review (sponsors decision); excluded in efficacy analysis.|89
8636527|NCT00568776|9677196|FG003|STARTED|Overall Study|42 patients withdrawn per interim safety review (sponsors decision); excluded in efficacy analysis.|91
8636528|NCT00568776|9677193|FG000|COMPLETED|Overall Study||53
8636529|NCT00568776|9677194|FG001|COMPLETED|Overall Study||52
8904821|NCT02098395|9963052|FG002|STARTED|Overall Study||207
8904822|NCT02098395|9963053|FG003|STARTED|Overall Study||207
8904823|NCT02098395|9963050|FG000|Exposed|Overall Study||211
8904824|NCT02098395|9963051|FG001|Exposed|Overall Study||209
8904825|NCT02098395|9963052|FG002|Exposed|Overall Study||206
8904826|NCT02098395|9963053|FG003|Exposed|Overall Study||206
8904827|NCT02098395|9963050|FG000|COMPLETED|Overall Study||186
8904828|NCT02098395|9963051|FG001|COMPLETED|Overall Study||177
8904829|NCT02098395|9963052|FG002|COMPLETED|Overall Study||165
8904830|NCT02098395|9963053|FG003|COMPLETED|Overall Study||180
8904831|NCT02098395|9963050|FG000|NOT COMPLETED|Overall Study||26
8904832|NCT02098395|9963051|FG001|NOT COMPLETED|Overall Study||32
8904833|NCT02098395|9963052|FG002|NOT COMPLETED|Overall Study||42
8904834|NCT02098395|9963053|FG003|NOT COMPLETED|Overall Study||27
8904835|NCT02098733|9963063|FG000|STARTED|Overall Study||1168
8904836|NCT02098733|9963063|FG000|COMPLETED|Overall Study||1158
8904837|NCT02098733|9963063|FG000|NOT COMPLETED|Overall Study||10
8904838|NCT02098746|9963067|FG000|STARTED|Overall Study||294
8904839|NCT02098746|9963067|FG000|COMPLETED|Overall Study||289
8904840|NCT02098746|9963067|FG000|NOT COMPLETED|Overall Study||5
8904841|NCT02098993|9963073|FG000|STARTED|Overall Study||4
8904842|NCT02098993|9963074|FG001|STARTED|Overall Study||3
8904843|NCT02098993|9963073|FG000|COMPLETED|Overall Study||4
8904844|NCT02098993|9963074|FG001|COMPLETED|Overall Study||3
8904845|NCT02098993|9963073|FG000|NOT COMPLETED|Overall Study||0
8904846|NCT02098993|9963074|FG001|NOT COMPLETED|Overall Study||0
8904847|NCT02099006|9963080|FG000|STARTED|Overall Study||9
9011822|NCT03000010|10074537|FG001|NOT COMPLETED|Overall Study||0
9011823|NCT03000075|10074546|FG000|STARTED|Part A||58
9011824|NCT03000075|10074547|FG001|STARTED|Part A||58
9011825|NCT03000075|10074548|FG002|STARTED|Part A||55
9011826|NCT03000075|10074549|FG003|STARTED|Part A||0
9011827|NCT03000075|10074550|FG004|STARTED|Part A||0
9011828|NCT03000075|10074551|FG005|STARTED|Part A||0
9011829|NCT03000075|10074552|FG006|STARTED|Part A||0
9011830|NCT03000075|10074546|FG000|COMPLETED|Part A||54
9011831|NCT03000075|10074547|FG001|COMPLETED|Part A||58
9011832|NCT03000075|10074548|FG002|COMPLETED|Part A||55
9011833|NCT03000075|10074549|FG003|COMPLETED|Part A||0
9011834|NCT03000075|10074550|FG004|COMPLETED|Part A||0
9011835|NCT03000075|10074551|FG005|COMPLETED|Part A||0
9011836|NCT03000075|10074552|FG006|COMPLETED|Part A||0
9011837|NCT03000075|10074546|FG000|NOT COMPLETED|Part A||4
9011838|NCT03000075|10074547|FG001|NOT COMPLETED|Part A||0
9011839|NCT03000075|10074548|FG002|NOT COMPLETED|Part A||0
9011840|NCT03000075|10074549|FG003|NOT COMPLETED|Part A||0
9011841|NCT03000075|10074550|FG004|NOT COMPLETED|Part A||0
9011842|NCT03000075|10074551|FG005|NOT COMPLETED|Part A||0
9011843|NCT03000075|10074552|FG006|NOT COMPLETED|Part A||0
9011844|NCT03000075|10074546|FG000|STARTED|Part B||0
9011845|NCT03000075|10074547|FG001|STARTED|Part B||0
9011846|NCT03000075|10074548|FG002|STARTED|Part B||0
9011847|NCT03000075|10074549|FG003|STARTED|Part B|Participants who received placebo in Part A received risankizumab 75 mg in Part B|27
9011848|NCT03000075|10074550|FG004|STARTED|Part B|Participants who received placebo in Part A received risankizumab 150 mg in Part B|27
9011849|NCT03000075|10074551|FG005|STARTED|Part B|Participants who received risankizumab 75 mg in Part A received risankizumab 75 mg in Part B|58
8636530|NCT00568776|9677195|FG002|COMPLETED|Overall Study||15
8636531|NCT00568776|9677196|FG003|COMPLETED|Overall Study||19
8636532|NCT00568776|9677193|FG000|NOT COMPLETED|Overall Study||30
8636533|NCT00568776|9677194|FG001|NOT COMPLETED|Overall Study||36
8636534|NCT00568776|9677195|FG002|NOT COMPLETED|Overall Study||74
8636535|NCT00568776|9677196|FG003|NOT COMPLETED|Overall Study||72
8691327|NCT00854113|9736572|FG001|COMPLETED|Overall Study||6
8904848|NCT02099006|9963080|FG000|Received Placebo|Overall Study||9
8904849|NCT02099006|9963080|FG000|Received Amitriptyline/ Baclofen|Overall Study||7
8904850|NCT02099006|9963080|FG000|Received Ketoprofen|Overall Study||3
8904851|NCT02099006|9963080|FG000|Received Loperamide|Overall Study||7
8904852|NCT02099006|9963080|FG000|Received Ketamine|Overall Study||6
8904853|NCT02099006|9963080|FG000|Received Gabapentin|Overall Study||8
8904854|NCT02099006|9963080|FG000|COMPLETED|Overall Study||8
8904855|NCT02099006|9963080|FG000|NOT COMPLETED|Overall Study||1
9011850|NCT03000075|10074552|FG006|STARTED|Part B|Participants who received risankizumab 150 mg in Part A received risankizumab 150 mg in Part B|55
9011851|NCT03000075|10074546|FG000|COMPLETED|Part B||0
9011852|NCT03000075|10074547|FG001|COMPLETED|Part B||0
9011853|NCT03000075|10074548|FG002|COMPLETED|Part B||0
9011854|NCT03000075|10074549|FG003|COMPLETED|Part B||27
9011855|NCT03000075|10074550|FG004|COMPLETED|Part B||26
8904856|NCT02099084|9963086|FG000|STARTED|First Intervention||4
9011856|NCT03000075|10074551|FG005|COMPLETED|Part B||56
9011857|NCT03000075|10074552|FG006|COMPLETED|Part B||54
9011858|NCT03000075|10074546|FG000|NOT COMPLETED|Part B||0
9011859|NCT03000075|10074547|FG001|NOT COMPLETED|Part B||0
8904857|NCT02099084|9963087|FG001|STARTED|First Intervention||4
8904858|NCT02099084|9963086|FG000|COMPLETED|First Intervention||4
8904859|NCT02099084|9963087|FG001|COMPLETED|First Intervention||4
8904860|NCT02099084|9963086|FG000|NOT COMPLETED|First Intervention||0
8904861|NCT02099084|9963087|FG001|NOT COMPLETED|First Intervention||0
8904862|NCT02099084|9963086|FG000|STARTED|Washout Period of 14 Days||4
8904863|NCT02099084|9963087|FG001|STARTED|Washout Period of 14 Days||4
8904864|NCT02099084|9963086|FG000|COMPLETED|Washout Period of 14 Days||4
8904865|NCT02099084|9963087|FG001|COMPLETED|Washout Period of 14 Days||4
8904866|NCT02099084|9963086|FG000|NOT COMPLETED|Washout Period of 14 Days||0
8904867|NCT02099084|9963087|FG001|NOT COMPLETED|Washout Period of 14 Days||0
8904868|NCT02099084|9963086|FG000|STARTED|Second Intervention||4
8904869|NCT02099084|9963087|FG001|STARTED|Second Intervention||4
8904870|NCT02099084|9963086|FG000|COMPLETED|Second Intervention||4
8904871|NCT02099084|9963087|FG001|COMPLETED|Second Intervention||4
8904872|NCT02099084|9963086|FG000|NOT COMPLETED|Second Intervention||0
8904873|NCT02099084|9963087|FG001|NOT COMPLETED|Second Intervention||0
8904874|NCT02099110|9963098|FG000|STARTED|Overall Study||250
8904875|NCT02099110|9963099|FG001|STARTED|Overall Study||248
8904876|NCT02099110|9963100|FG002|STARTED|Overall Study||247
8904877|NCT02099110|9963101|FG003|STARTED|Overall Study||243
8904878|NCT02099110|9963102|FG004|STARTED|Overall Study||245
8904879|NCT02099110|9963098|FG000|Treated|Overall Study||250
8904880|NCT02099110|9963099|FG001|Treated|Overall Study||248
8904881|NCT02099110|9963100|FG002|Treated|Overall Study||247
8904882|NCT02099110|9963101|FG003|Treated|Overall Study||243
8904883|NCT02099110|9963102|FG004|Treated|Overall Study||244
8904884|NCT02099110|9963098|FG000|COMPLETED|Overall Study||226
8904885|NCT02099110|9963099|FG001|COMPLETED|Overall Study||217
8904886|NCT02099110|9963100|FG002|COMPLETED|Overall Study||219
8904887|NCT02099110|9963101|FG003|COMPLETED|Overall Study||221
8904888|NCT02099110|9963102|FG004|COMPLETED|Overall Study||218
8904889|NCT02099110|9963098|FG000|NOT COMPLETED|Overall Study||24
8904890|NCT02099110|9963099|FG001|NOT COMPLETED|Overall Study||31
8904891|NCT02099110|9963100|FG002|NOT COMPLETED|Overall Study||28
8904892|NCT02099110|9963101|FG003|NOT COMPLETED|Overall Study||22
8904893|NCT02099110|9963102|FG004|NOT COMPLETED|Overall Study||27
8904894|NCT02099266|9963114|FG000|STARTED|Overall Study||15
8904895|NCT02099266|9963114|FG000|COMPLETED|Overall Study||15
8904896|NCT02099266|9963114|FG000|NOT COMPLETED|Overall Study||0
8904897|NCT02099461|9963124|FG000|STARTED|Overall Study||27
8904898|NCT02099461|9963125|FG001|STARTED|Overall Study||27
8904899|NCT02099461|9963126|FG002|STARTED|Overall Study||28
8904900|NCT02099461|9963124|FG000|COMPLETED|Overall Study||27
8904901|NCT02099461|9963125|FG001|COMPLETED|Overall Study||27
8904902|NCT02099461|9963126|FG002|COMPLETED|Overall Study||28
8904903|NCT02099461|9963124|FG000|NOT COMPLETED|Overall Study||0
8904904|NCT02099461|9963125|FG001|NOT COMPLETED|Overall Study||0
8904905|NCT02099461|9963126|FG002|NOT COMPLETED|Overall Study||0
8904906|NCT02099682|9963134|FG000|STARTED|Overall Study|Number of cases.|3366
8904907|NCT02099682|9963134|FG000|Safety Analysis Set (SAS)|Overall Study|All participants who took the study drug at least once.|3255
8904908|NCT02099682|9963134|FG000|COMPLETED|Overall Study||3255
8904909|NCT02099682|9963134|FG000|NOT COMPLETED|Overall Study||111
8904910|NCT02099708|9963138|FG000|STARTED|Overall Study|Number of cases.|3502
8904911|NCT02099708|9963138|FG000|Safety Analysis Set (SAS)|Overall Study|All participants who took the study drug at least once.|3302
8904912|NCT02099708|9963138|FG000|COMPLETED|Overall Study||3302
8904913|NCT02099708|9963138|FG000|NOT COMPLETED|Overall Study||200
8904914|NCT02099721|9963148|FG000|STARTED|Overall Study||1066
8636536|NCT04274192|9677208|FG000|STARTED|Overall Study||1
8636537|NCT04274192|9677209|FG001|STARTED|Overall Study||0
8636538|NCT04274192|9677208|FG000|COMPLETED|Overall Study||0
8636539|NCT04274192|9677209|FG001|COMPLETED|Overall Study||0
8904915|NCT02099721|9963149|FG001|STARTED|Overall Study||127
8904916|NCT02099721|9963150|FG002|STARTED|Overall Study||1068
8904917|NCT02099721|9963151|FG003|STARTED|Overall Study||845
8904918|NCT02099721|9963152|FG004|STARTED|Overall Study||331
8904919|NCT02099721|9963153|FG005|STARTED|Overall Study||452
8904920|NCT02099721|9963148|FG000|COMPLETED|Overall Study||990
8904921|NCT02099721|9963149|FG001|COMPLETED|Overall Study|Not implanted secondary patients were automatically exited.|0
8904922|NCT02099721|9963150|FG002|COMPLETED|Overall Study||983
8904923|NCT02099721|9963151|FG003|COMPLETED|Overall Study||774
8904924|NCT02099721|9963152|FG004|COMPLETED|Overall Study||304
8904925|NCT02099721|9963153|FG005|COMPLETED|Overall Study||432
8904926|NCT02099721|9963148|FG000|NOT COMPLETED|Overall Study||76
8904927|NCT02099721|9963149|FG001|NOT COMPLETED|Overall Study||127
8904928|NCT02099721|9963150|FG002|NOT COMPLETED|Overall Study||85
8904929|NCT02099721|9963151|FG003|NOT COMPLETED|Overall Study||71
8904930|NCT02099721|9963152|FG004|NOT COMPLETED|Overall Study||27
8904931|NCT02099721|9963153|FG005|NOT COMPLETED|Overall Study||20
8904932|NCT02099786|9963167|FG000|STARTED|Overall Study||24
8904933|NCT02099786|9963168|FG001|STARTED|Overall Study||23
8636540|NCT04274192|9677208|FG000|NOT COMPLETED|Overall Study||1
8904934|NCT02099786|9963167|FG000|Program Eval 1|Overall Study|Baseline (prior to randomization and first cisplatin dose)|24
8904935|NCT02099786|9963168|FG001|Program Eval 1|Overall Study|Baseline (prior to randomization and first cisplatin dose)|23
8904936|NCT02099786|9963167|FG000|Program Eval 2|Overall Study|One month post randomization|23
8904937|NCT02099786|9963168|FG001|Program Eval 2|Overall Study|One month post randomization|19
8904938|NCT02099786|9963167|FG000|Program Eval 3|Overall Study|One year post randomization|21
8904939|NCT02099786|9963168|FG001|Program Eval 3|Overall Study|One year post randomization|15
8904940|NCT02099786|9963167|FG000|COMPLETED|Overall Study||21
8904941|NCT02099786|9963168|FG001|COMPLETED|Overall Study||15
8904942|NCT02099786|9963167|FG000|NOT COMPLETED|Overall Study||3
8904943|NCT02099786|9963168|FG001|NOT COMPLETED|Overall Study||8
8904944|NCT02099799|9963177|FG000|STARTED|Overall Study||75
8904945|NCT02099799|9963178|FG001|STARTED|Overall Study||78
8904946|NCT02099799|9963177|FG000|COMPLETED|Overall Study||60
8904947|NCT02099799|9963178|FG001|COMPLETED|Overall Study||54
8904948|NCT02099799|9963177|FG000|NOT COMPLETED|Overall Study||15
8904949|NCT02099799|9963178|FG001|NOT COMPLETED|Overall Study||24
8904950|NCT02099838|9963188|FG000|STARTED|Overall Study||47
8904951|NCT02099838|9963189|FG001|STARTED|Overall Study||51
8904952|NCT02099838|9963188|FG000|COMPLETED|Overall Study||43
8904953|NCT02099838|9963189|FG001|COMPLETED|Overall Study||49
8904954|NCT02099838|9963188|FG000|NOT COMPLETED|Overall Study||4
9011860|NCT03000075|10074548|FG002|NOT COMPLETED|Part B||0
9011861|NCT03000075|10074549|FG003|NOT COMPLETED|Part B||0
9011862|NCT03000075|10074550|FG004|NOT COMPLETED|Part B||1
9011863|NCT03000075|10074551|FG005|NOT COMPLETED|Part B||2
9011864|NCT03000075|10074552|FG006|NOT COMPLETED|Part B||1
9011865|NCT03000088|10074570|FG000|STARTED|Overall Study||70
9011866|NCT03000088|10074571|FG001|STARTED|Overall Study||70
9011867|NCT03000088|10074570|FG000|COMPLETED|Overall Study||70
9011868|NCT03000088|10074571|FG001|COMPLETED|Overall Study||70
9011869|NCT03000088|10074570|FG000|NOT COMPLETED|Overall Study||0
9011870|NCT03000088|10074571|FG001|NOT COMPLETED|Overall Study||0
9011871|NCT03000166|10074579|FG000|STARTED|Overall Study||25
9011872|NCT03000166|10074580|FG001|STARTED|Overall Study||22
9011873|NCT03000166|10074579|FG000|COMPLETED|Overall Study||25
9011874|NCT03000166|10074580|FG001|COMPLETED|Overall Study||19
9011875|NCT03000166|10074579|FG000|NOT COMPLETED|Overall Study||0
9011876|NCT03000166|10074580|FG001|NOT COMPLETED|Overall Study||3
9011877|NCT03000283|10074587|FG000|STARTED|Overall Study||7
9011878|NCT03000283|10074587|FG000|COMPLETED|Overall Study||7
9011879|NCT03000283|10074587|FG000|NOT COMPLETED|Overall Study||0
9011880|NCT03000309|10074591|FG000|STARTED|Overall Study||20
9011881|NCT03000309|10074591|FG000|COMPLETED|Overall Study||19
9011882|NCT03000309|10074591|FG000|NOT COMPLETED|Overall Study||1
9011883|NCT03000348|10074601|FG000|STARTED|Overall Study||17
9011884|NCT03000348|10074602|FG001|STARTED|Overall Study||11
9011885|NCT03000348|10074603|FG002|STARTED|Overall Study||15
9011886|NCT03000348|10074604|FG003|STARTED|Overall Study||15
9011887|NCT03000348|10074605|FG004|STARTED|Overall Study||16
9011888|NCT03000348|10074606|FG005|STARTED|Overall Study||15
9011889|NCT03000348|10074601|FG000|Day 14 Treatment Period|Overall Study||17
9011890|NCT03000348|10074602|FG001|Day 14 Treatment Period|Overall Study||10
9011891|NCT03000348|10074603|FG002|Day 14 Treatment Period|Overall Study||13
9011892|NCT03000348|10074604|FG003|Day 14 Treatment Period|Overall Study||14
9011893|NCT03000348|10074605|FG004|Day 14 Treatment Period|Overall Study||13
9011894|NCT03000348|10074606|FG005|Day 14 Treatment Period|Overall Study||14
9011895|NCT03000348|10074601|FG000|COMPLETED|Overall Study||14
9011896|NCT03000348|10074602|FG001|COMPLETED|Overall Study||7
9011897|NCT03000348|10074603|FG002|COMPLETED|Overall Study||11
9011898|NCT03000348|10074604|FG003|COMPLETED|Overall Study||12
8573143|NCT00118755|9605382|FG000|STARTED|Overall Study||217
8573144|NCT00118755|9605383|FG001|STARTED|Overall Study||218
8573145|NCT00118755|9605382|FG000|Safety Population|Overall Study||208
8573146|NCT00118755|9605383|FG001|Safety Population|Overall Study||211
8573147|NCT00118755|9605382|FG000|COMPLETED|Overall Study||7
8573148|NCT00118755|9605383|FG001|COMPLETED|Overall Study||3
8573149|NCT00118755|9605382|FG000|NOT COMPLETED|Overall Study||210
8573150|NCT00118755|9605383|FG001|NOT COMPLETED|Overall Study||215
8573151|NCT00118898|9605393|FG000|STARTED|Overall Study||464
8573152|NCT00118898|9605394|FG001|STARTED|Overall Study||465
8573153|NCT00118898|9605395|FG002|STARTED|Overall Study||465
8573154|NCT00118898|9605396|FG003|STARTED|Overall Study||463
8573155|NCT00118898|9605393|FG000|Initiated Treatment|Overall Study||461
8573156|NCT00118898|9605394|FG001|Initiated Treatment|Overall Study||461
8573157|NCT00118898|9605395|FG002|Initiated Treatment|Overall Study||464
8573158|NCT00118898|9605396|FG003|Initiated Treatment|Overall Study||462
8573159|NCT00118898|9605393|FG000|COMPLETED|Overall Study||343
8636541|NCT04274192|9677209|FG001|NOT COMPLETED|Overall Study||0
8636542|NCT04200833|9677217|FG000|STARTED|Overall Study||10
8636543|NCT04200833|9677217|FG000|COMPLETED|Overall Study||10
8904955|NCT02099838|9963189|FG001|NOT COMPLETED|Overall Study||2
8904956|NCT02099864|9963195|FG000|STARTED|Overall Study||36
8904957|NCT02099864|9963195|FG000|COMPLETED|Overall Study||36
9011899|NCT03000348|10074605|FG004|COMPLETED|Overall Study||11
9011900|NCT03000348|10074606|FG005|COMPLETED|Overall Study||13
9011901|NCT03000348|10074601|FG000|NOT COMPLETED|Overall Study||3
9011902|NCT03000348|10074602|FG001|NOT COMPLETED|Overall Study||4
9011903|NCT03000348|10074603|FG002|NOT COMPLETED|Overall Study||4
9011904|NCT03000348|10074604|FG003|NOT COMPLETED|Overall Study||3
9011905|NCT03000348|10074605|FG004|NOT COMPLETED|Overall Study||5
9011906|NCT03000348|10074606|FG005|NOT COMPLETED|Overall Study||2
8573160|NCT00118898|9605394|FG001|COMPLETED|Overall Study||324
8573161|NCT00118898|9605395|FG002|COMPLETED|Overall Study||342
8573162|NCT00118898|9605396|FG003|COMPLETED|Overall Study||322
9011907|NCT03000452|10074623|FG000|STARTED|Treatment Period||18
9011908|NCT03000452|10074623|FG000|COMPLETED|Treatment Period||0
9011909|NCT03000452|10074623|FG000|NOT COMPLETED|Treatment Period||18
8636544|NCT04200833|9677217|FG000|NOT COMPLETED|Overall Study||0
8636545|NCT04110314|9677227|FG000|STARTED|Overall Study||71781
8636546|NCT04110314|9677228|FG001|STARTED|Overall Study||71492
8904958|NCT02099864|9963195|FG000|NOT COMPLETED|Overall Study||0
8904959|NCT02100007|9963203|FG000|STARTED|Overall Study||46
8904960|NCT02100007|9963203|FG000|COMPLETED|Overall Study||46
8904961|NCT02100007|9963203|FG000|NOT COMPLETED|Overall Study||0
8904962|NCT02100072|9963208|FG000|STARTED|Overall Study||5
8904963|NCT02100072|9963208|FG000|COMPLETED|Overall Study||5
8904964|NCT02100072|9963208|FG000|NOT COMPLETED|Overall Study||0
8904965|NCT02100124|9963215|FG000|STARTED|Overall Study||329
8904966|NCT02100124|9963216|FG001|STARTED|Overall Study||329
8904967|NCT02100124|9963217|FG002|STARTED|Overall Study||326
8904968|NCT02100124|9963215|FG000|COMPLETED|Overall Study||323
8904969|NCT02100124|9963216|FG001|COMPLETED|Overall Study||318
8904970|NCT02100124|9963217|FG002|COMPLETED|Overall Study||323
8904971|NCT02100124|9963215|FG000|NOT COMPLETED|Overall Study||6
8904972|NCT02100124|9963216|FG001|NOT COMPLETED|Overall Study||11
8904973|NCT02100124|9963217|FG002|NOT COMPLETED|Overall Study||3
8904974|NCT02100189|9963225|FG000|STARTED|Overall Study||50
8904975|NCT02100189|9963225|FG000|COMPLETED|Overall Study||50
8904976|NCT02100189|9963225|FG000|NOT COMPLETED|Overall Study||0
8904977|NCT02100228|9963231|FG000|STARTED|Overall Study|735 treated with Apixaban|753
8904978|NCT02100228|9963232|FG001|STARTED|Overall Study|721 treated with Usual Care|747
8904979|NCT02100228|9963231|FG000|COMPLETED|Overall Study||678
8904980|NCT02100228|9963232|FG001|COMPLETED|Overall Study||657
8904981|NCT02100228|9963231|FG000|NOT COMPLETED|Overall Study||75
8904982|NCT02100228|9963232|FG001|NOT COMPLETED|Overall Study||90
8904983|NCT02100280|9963240|FG000|STARTED|Overall Study||48
8904984|NCT02100280|9963241|FG001|STARTED|Overall Study||48
8904985|NCT02100280|9963240|FG000|COMPLETED|Overall Study||44
8904986|NCT02100280|9963241|FG001|COMPLETED|Overall Study||44
8904987|NCT02100280|9963240|FG000|NOT COMPLETED|Overall Study||4
8904988|NCT02100280|9963241|FG001|NOT COMPLETED|Overall Study||4
8904989|NCT02100319|9963249|FG000|STARTED|Overall Study||387
8904990|NCT02100319|9963249|FG000|COMPLETED|Overall Study||371
8904991|NCT02100319|9963249|FG000|NOT COMPLETED|Overall Study||16
8904992|NCT02100410|9963253|FG000|STARTED|Exposure Pair 1, 30 Minutes||8
8904993|NCT02100410|9963254|FG001|STARTED|Exposure Pair 1, 30 Minutes||8
8904994|NCT02100410|9963255|FG002|STARTED|Exposure Pair 1, 30 Minutes||8
8904995|NCT02100410|9963256|FG003|STARTED|Exposure Pair 1, 30 Minutes||8
8904996|NCT02100410|9963257|FG004|STARTED|Exposure Pair 1, 30 Minutes||8
8904997|NCT02100410|9963258|FG005|STARTED|Exposure Pair 1, 30 Minutes||9
8904998|NCT02100410|9963253|FG000|COMPLETED|Exposure Pair 1, 30 Minutes||8
8904999|NCT02100410|9963254|FG001|COMPLETED|Exposure Pair 1, 30 Minutes||8
8905000|NCT02100410|9963255|FG002|COMPLETED|Exposure Pair 1, 30 Minutes||8
8905001|NCT02100410|9963256|FG003|COMPLETED|Exposure Pair 1, 30 Minutes||8
8905002|NCT02100410|9963257|FG004|COMPLETED|Exposure Pair 1, 30 Minutes||8
8905003|NCT02100410|9963258|FG005|COMPLETED|Exposure Pair 1, 30 Minutes||9
8905004|NCT02100410|9963253|FG000|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
8905005|NCT02100410|9963254|FG001|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
8905006|NCT02100410|9963255|FG002|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
8905007|NCT02100410|9963256|FG003|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
8905008|NCT02100410|9963257|FG004|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
8905009|NCT02100410|9963258|FG005|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
8905010|NCT02100410|9963253|FG000|STARTED|Exposure Pair 2, 30 Minutes||8
8905011|NCT02100410|9963254|FG001|STARTED|Exposure Pair 2, 30 Minutes||8
8905012|NCT02100410|9963255|FG002|STARTED|Exposure Pair 2, 30 Minutes||8
8905013|NCT02100410|9963256|FG003|STARTED|Exposure Pair 2, 30 Minutes||8
8905014|NCT02100410|9963257|FG004|STARTED|Exposure Pair 2, 30 Minutes||8
8905015|NCT02100410|9963258|FG005|STARTED|Exposure Pair 2, 30 Minutes||9
8905016|NCT02100410|9963253|FG000|COMPLETED|Exposure Pair 2, 30 Minutes||8
8905017|NCT02100410|9963254|FG001|COMPLETED|Exposure Pair 2, 30 Minutes||8
8905018|NCT02100410|9963255|FG002|COMPLETED|Exposure Pair 2, 30 Minutes||8
8573163|NCT00118898|9605393|FG000|NOT COMPLETED|Overall Study||121
8573164|NCT00118898|9605394|FG001|NOT COMPLETED|Overall Study||141
8573165|NCT00118898|9605395|FG002|NOT COMPLETED|Overall Study||123
8573166|NCT00118898|9605396|FG003|NOT COMPLETED|Overall Study||141
8573167|NCT00118911|9605408|FG000|STARTED|Overall Study||43
8573168|NCT00118911|9605409|FG001|STARTED|Overall Study||43
8573169|NCT00118911|9605408|FG000|Received Intervention as Assigned|Overall Study||41
8573170|NCT00118911|9605409|FG001|Received Intervention as Assigned|Overall Study||38
8573171|NCT00118911|9605408|FG000|Completed Post-Treatment Assessment|Overall Study||41
8573172|NCT00118911|9605409|FG001|Completed Post-Treatment Assessment|Overall Study||37
8573173|NCT00118911|9605408|FG000|6 Month Follow-up|Overall Study||37
8636547|NCT04110314|9677229|FG002|STARTED|Overall Study||72177
8636548|NCT04110314|9677230|FG003|STARTED|Overall Study||71512
8636549|NCT04110314|9677231|FG004|STARTED|Overall Study||71536
8636550|NCT04110314|9677232|FG005|STARTED|Overall Study||72138
8636551|NCT04110314|9677227|FG000|Patients Who Met Inclusion|Overall Study||36526
8905019|NCT02100410|9963256|FG003|COMPLETED|Exposure Pair 2, 30 Minutes||8
8905020|NCT02100410|9963257|FG004|COMPLETED|Exposure Pair 2, 30 Minutes||8
8905021|NCT02100410|9963258|FG005|COMPLETED|Exposure Pair 2, 30 Minutes||9
8905022|NCT02100410|9963253|FG000|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
8905023|NCT02100410|9963254|FG001|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
8905024|NCT02100410|9963255|FG002|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
8905025|NCT02100410|9963256|FG003|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
8905026|NCT02100410|9963257|FG004|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
8905027|NCT02100410|9963258|FG005|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
8905028|NCT02100410|9963253|FG000|STARTED|Exposure Pair 3, 30 Minutes||8
8636552|NCT04110314|9677228|FG001|Patients Who Met Inclusion|Overall Study||36388
8636553|NCT04110314|9677229|FG002|Patients Who Met Inclusion|Overall Study||36541
8636554|NCT04110314|9677230|FG003|Patients Who Met Inclusion|Overall Study||36377
8636555|NCT04110314|9677231|FG004|Patients Who Met Inclusion|Overall Study||36289
8636556|NCT04110314|9677232|FG005|Patients Who Met Inclusion|Overall Study||36411
8905029|NCT02100410|9963254|FG001|STARTED|Exposure Pair 3, 30 Minutes||8
8905030|NCT02100410|9963255|FG002|STARTED|Exposure Pair 3, 30 Minutes||8
8905031|NCT02100410|9963256|FG003|STARTED|Exposure Pair 3, 30 Minutes||8
8905032|NCT02100410|9963257|FG004|STARTED|Exposure Pair 3, 30 Minutes||8
8905033|NCT02100410|9963258|FG005|STARTED|Exposure Pair 3, 30 Minutes||9
8905034|NCT02100410|9963253|FG000|COMPLETED|Exposure Pair 3, 30 Minutes||8
8905035|NCT02100410|9963254|FG001|COMPLETED|Exposure Pair 3, 30 Minutes||8
8905036|NCT02100410|9963255|FG002|COMPLETED|Exposure Pair 3, 30 Minutes||8
8905037|NCT02100410|9963256|FG003|COMPLETED|Exposure Pair 3, 30 Minutes||8
8905038|NCT02100410|9963257|FG004|COMPLETED|Exposure Pair 3, 30 Minutes||8
8905039|NCT02100410|9963258|FG005|COMPLETED|Exposure Pair 3, 30 Minutes||9
8905040|NCT02100410|9963253|FG000|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
8905041|NCT02100410|9963254|FG001|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
8905042|NCT02100410|9963255|FG002|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
8905043|NCT02100410|9963256|FG003|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
8905044|NCT02100410|9963257|FG004|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
8905045|NCT02100410|9963258|FG005|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
8905046|NCT02100475|9963272|FG000|STARTED|Overall Study||16
8905047|NCT02100475|9963273|FG001|STARTED|Overall Study||15
8905048|NCT02100475|9963272|FG000|COMPLETED|Overall Study||14
8905049|NCT02100475|9963273|FG001|COMPLETED|Overall Study||13
8905050|NCT02100475|9963272|FG000|NOT COMPLETED|Overall Study||2
8905051|NCT02100475|9963273|FG001|NOT COMPLETED|Overall Study||2
8905052|NCT02100514|9963281|FG000|STARTED|Treatment Period||247
8905053|NCT02100514|9963282|FG001|STARTED|Treatment Period||499
8905054|NCT02100514|9963283|FG002|STARTED|Treatment Period||0
8905055|NCT02100514|9963284|FG003|STARTED|Treatment Period||0
8905056|NCT02100514|9963285|FG004|STARTED|Treatment Period||0
8905057|NCT02100514|9963281|FG000|COMPLETED|Treatment Period||218
8905058|NCT02100514|9963282|FG001|COMPLETED|Treatment Period||425
8905059|NCT02100514|9963283|FG002|COMPLETED|Treatment Period||0
8905060|NCT02100514|9963284|FG003|COMPLETED|Treatment Period||0
8905061|NCT02100514|9963285|FG004|COMPLETED|Treatment Period||0
8905062|NCT02100514|9963281|FG000|NOT COMPLETED|Treatment Period||29
8905063|NCT02100514|9963282|FG001|NOT COMPLETED|Treatment Period||74
8905064|NCT02100514|9963283|FG002|NOT COMPLETED|Treatment Period||0
8905065|NCT02100514|9963284|FG003|NOT COMPLETED|Treatment Period||0
8905066|NCT02100514|9963285|FG004|NOT COMPLETED|Treatment Period||0
8905067|NCT02100514|9963281|FG000|STARTED|Extension Period||0
8905068|NCT02100514|9963282|FG001|STARTED|Extension Period||0
8905069|NCT02100514|9963283|FG002|STARTED|Extension Period||44
8905070|NCT02100514|9963284|FG003|STARTED|Extension Period||33
8905071|NCT02100514|9963285|FG004|STARTED|Extension Period||56
8905072|NCT02100514|9963281|FG000|COMPLETED|Extension Period||0
8905073|NCT02100514|9963282|FG001|COMPLETED|Extension Period||0
8905074|NCT02100514|9963283|FG002|COMPLETED|Extension Period||42
8905075|NCT02100514|9963284|FG003|COMPLETED|Extension Period||33
8905076|NCT02100514|9963285|FG004|COMPLETED|Extension Period||56
8905077|NCT02100514|9963281|FG000|NOT COMPLETED|Extension Period||0
8905078|NCT02100514|9963282|FG001|NOT COMPLETED|Extension Period||0
8905079|NCT02100514|9963283|FG002|NOT COMPLETED|Extension Period||2
8905080|NCT02100514|9963284|FG003|NOT COMPLETED|Extension Period||0
8905081|NCT02100514|9963285|FG004|NOT COMPLETED|Extension Period||0
8905082|NCT02100579|9963301|FG000|STARTED|Overall Study||20
8905083|NCT02100579|9963302|FG001|STARTED|Overall Study||20
8905084|NCT02100579|9963301|FG000|COMPLETED|Overall Study||20
8905085|NCT02100579|9963302|FG001|COMPLETED|Overall Study||20
8905086|NCT02100579|9963301|FG000|NOT COMPLETED|Overall Study||0
8905087|NCT02100579|9963302|FG001|NOT COMPLETED|Overall Study||0
8905088|NCT02100631|9963311|FG000|STARTED|Overall Study||299
8905089|NCT02100631|9963312|FG001|STARTED|Overall Study||99
8905090|NCT02100631|9963313|FG002|STARTED|Overall Study||2688
8905091|NCT02100631|9963311|FG000|COMPLETED|Overall Study||292
8905092|NCT02100631|9963312|FG001|COMPLETED|Overall Study||95
8905093|NCT02100631|9963313|FG002|COMPLETED|Overall Study||2688
8905094|NCT02100631|9963311|FG000|NOT COMPLETED|Overall Study||7
8905095|NCT02100631|9963312|FG001|NOT COMPLETED|Overall Study||4
8905096|NCT02100631|9963313|FG002|NOT COMPLETED|Overall Study||0
8905097|NCT02100644|9963321|FG000|STARTED|LTG Escalation Phase||33
8905098|NCT02100644|9963322|FG001|STARTED|LTG Escalation Phase||0
8905099|NCT02100644|9963323|FG002|STARTED|LTG Escalation Phase||0
8905100|NCT02100644|9963321|FG000|COMPLETED|LTG Escalation Phase||20
8905101|NCT02100644|9963322|FG001|COMPLETED|LTG Escalation Phase||0
8905102|NCT02100644|9963323|FG002|COMPLETED|LTG Escalation Phase||0
8905103|NCT02100644|9963321|FG000|NOT COMPLETED|LTG Escalation Phase||13
8905104|NCT02100644|9963322|FG001|NOT COMPLETED|LTG Escalation Phase||0
8905105|NCT02100644|9963323|FG002|NOT COMPLETED|LTG Escalation Phase||0
8905106|NCT02100644|9963321|FG000|STARTED|VPA Reduction Phase||0
8905107|NCT02100644|9963322|FG001|STARTED|VPA Reduction Phase||20
8905108|NCT02100644|9963323|FG002|STARTED|VPA Reduction Phase||0
8905109|NCT02100644|9963321|FG000|COMPLETED|VPA Reduction Phase||0
8905110|NCT02100644|9963322|FG001|COMPLETED|VPA Reduction Phase||20
8905111|NCT02100644|9963323|FG002|COMPLETED|VPA Reduction Phase||0
8905112|NCT02100644|9963321|FG000|NOT COMPLETED|VPA Reduction Phase||0
8905113|NCT02100644|9963322|FG001|NOT COMPLETED|VPA Reduction Phase||0
8905114|NCT02100644|9963323|FG002|NOT COMPLETED|VPA Reduction Phase||0
8905115|NCT02100644|9963321|FG000|STARTED|LTG and VPA Maintenance Phase||0
8905116|NCT02100644|9963322|FG001|STARTED|LTG and VPA Maintenance Phase||0
8905117|NCT02100644|9963323|FG002|STARTED|LTG and VPA Maintenance Phase||20
8905118|NCT02100644|9963321|FG000|COMPLETED|LTG and VPA Maintenance Phase||0
8905119|NCT02100644|9963322|FG001|COMPLETED|LTG and VPA Maintenance Phase||0
8905120|NCT02100644|9963323|FG002|COMPLETED|LTG and VPA Maintenance Phase||20
8905121|NCT02100644|9963321|FG000|NOT COMPLETED|LTG and VPA Maintenance Phase||0
8905122|NCT02100644|9963322|FG001|NOT COMPLETED|LTG and VPA Maintenance Phase||0
8905123|NCT02100644|9963323|FG002|NOT COMPLETED|LTG and VPA Maintenance Phase||0
8905124|NCT02100657|9963330|FG000|STARTED|Cohort 1: Dose Level 1||8
8905125|NCT02100657|9963331|FG001|STARTED|Cohort 1: Dose Level 1||0
8905126|NCT02100657|9963332|FG002|STARTED|Cohort 1: Dose Level 1||0
8905127|NCT02100657|9963330|FG000|COMPLETED|Cohort 1: Dose Level 1||0
8905128|NCT02100657|9963331|FG001|COMPLETED|Cohort 1: Dose Level 1||0
8905129|NCT02100657|9963332|FG002|COMPLETED|Cohort 1: Dose Level 1||0
8905130|NCT02100657|9963330|FG000|NOT COMPLETED|Cohort 1: Dose Level 1||8
8905131|NCT02100657|9963331|FG001|NOT COMPLETED|Cohort 1: Dose Level 1||0
8905132|NCT02100657|9963332|FG002|NOT COMPLETED|Cohort 1: Dose Level 1||0
8905133|NCT02100657|9963330|FG000|STARTED|Cohort 2: Dose Level 2||0
8905134|NCT02100657|9963331|FG001|STARTED|Cohort 2: Dose Level 2||4
8905135|NCT02100657|9963332|FG002|STARTED|Cohort 2: Dose Level 2||0
9011910|NCT03000452|10074623|FG000|STARTED|Follow-Up Period|1 participant died in Cycle 1 due to PD prior to evaluation.|17
9011911|NCT03000452|10074623|FG000|COMPLETED|Follow-Up Period||10
9011912|NCT03000452|10074623|FG000|NOT COMPLETED|Follow-Up Period||7
9011913|NCT03000608|10074629|FG000|STARTED|Overall Study||46
9011914|NCT03000608|10074630|FG001|STARTED|Overall Study||23
9011915|NCT03000608|10074629|FG000|COMPLETED|Overall Study||40
9011916|NCT03000608|10074630|FG001|COMPLETED|Overall Study||19
9011917|NCT03000608|10074629|FG000|NOT COMPLETED|Overall Study||6
9011918|NCT03000608|10074630|FG001|NOT COMPLETED|Overall Study||4
9011919|NCT03000673|10074640|FG000|STARTED|Overall Study||7
9011920|NCT03000673|10074641|FG001|STARTED|Overall Study||9
9011921|NCT03000673|10074642|FG002|STARTED|Overall Study||7
9011922|NCT03000673|10074643|FG003|STARTED|Overall Study||9
9011923|NCT03000673|10074640|FG000|COMPLETED|Overall Study||6
9011924|NCT03000673|10074641|FG001|COMPLETED|Overall Study||9
9011925|NCT03000673|10074642|FG002|COMPLETED|Overall Study||7
9011926|NCT03000673|10074643|FG003|COMPLETED|Overall Study||9
9011927|NCT03000673|10074640|FG000|NOT COMPLETED|Overall Study||1
9011928|NCT03000673|10074641|FG001|NOT COMPLETED|Overall Study||0
9011929|NCT03000673|10074642|FG002|NOT COMPLETED|Overall Study||0
9011930|NCT03000673|10074643|FG003|NOT COMPLETED|Overall Study||0
9011931|NCT03000686|10074656|FG000|STARTED|Part 1, Period 1 (1 Day)||5
9011932|NCT03000686|10074657|FG001|STARTED|Part 1, Period 1 (1 Day)||6
9011933|NCT03000686|10074658|FG002|STARTED|Part 1, Period 1 (1 Day)||0
9011934|NCT03000686|10074659|FG003|STARTED|Part 1, Period 1 (1 Day)||0
9011935|NCT03000686|10074656|FG000|COMPLETED|Part 1, Period 1 (1 Day)||5
9011936|NCT03000686|10074657|FG001|COMPLETED|Part 1, Period 1 (1 Day)||5
9011937|NCT03000686|10074658|FG002|COMPLETED|Part 1, Period 1 (1 Day)||0
9011938|NCT03000686|10074659|FG003|COMPLETED|Part 1, Period 1 (1 Day)||0
9011939|NCT03000686|10074656|FG000|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
9011940|NCT03000686|10074657|FG001|NOT COMPLETED|Part 1, Period 1 (1 Day)||1
9011941|NCT03000686|10074658|FG002|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
9011942|NCT03000686|10074659|FG003|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
9011943|NCT03000686|10074656|FG000|STARTED|Part 1, Wash-out (Up to 14 Days)||5
9011944|NCT03000686|10074657|FG001|STARTED|Part 1, Wash-out (Up to 14 Days)||5
9011945|NCT03000686|10074658|FG002|STARTED|Part 1, Wash-out (Up to 14 Days)||0
9011946|NCT03000686|10074659|FG003|STARTED|Part 1, Wash-out (Up to 14 Days)||0
9011947|NCT03000686|10074656|FG000|COMPLETED|Part 1, Wash-out (Up to 14 Days)||5
9011948|NCT03000686|10074657|FG001|COMPLETED|Part 1, Wash-out (Up to 14 Days)||5
9011949|NCT03000686|10074658|FG002|COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
9011950|NCT03000686|10074659|FG003|COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
9011951|NCT03000686|10074656|FG000|NOT COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
9011952|NCT03000686|10074657|FG001|NOT COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
9011953|NCT03000686|10074658|FG002|NOT COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
9011954|NCT03000686|10074659|FG003|NOT COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
9011955|NCT03000686|10074656|FG000|STARTED|Part 1, Period 2 (1 Day)||5
9011956|NCT03000686|10074657|FG001|STARTED|Part 1, Period 2 (1 Day)||5
9011957|NCT03000686|10074658|FG002|STARTED|Part 1, Period 2 (1 Day)||0
9011958|NCT03000686|10074659|FG003|STARTED|Part 1, Period 2 (1 Day)||0
9011959|NCT03000686|10074656|FG000|COMPLETED|Part 1, Period 2 (1 Day)||5
9011960|NCT03000686|10074657|FG001|COMPLETED|Part 1, Period 2 (1 Day)||5
9011961|NCT03000686|10074658|FG002|COMPLETED|Part 1, Period 2 (1 Day)||0
9011962|NCT03000686|10074659|FG003|COMPLETED|Part 1, Period 2 (1 Day)||0
9011963|NCT03000686|10074656|FG000|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
8905136|NCT02100657|9963330|FG000|COMPLETED|Cohort 2: Dose Level 2||0
8905137|NCT02100657|9963331|FG001|COMPLETED|Cohort 2: Dose Level 2||0
8905138|NCT02100657|9963332|FG002|COMPLETED|Cohort 2: Dose Level 2||0
8905139|NCT02100657|9963330|FG000|NOT COMPLETED|Cohort 2: Dose Level 2||0
8905140|NCT02100657|9963331|FG001|NOT COMPLETED|Cohort 2: Dose Level 2||4
8905141|NCT02100657|9963332|FG002|NOT COMPLETED|Cohort 2: Dose Level 2||0
8905142|NCT02100657|9963330|FG000|STARTED|Cohort 3: Dose Level 3||0
8905143|NCT02100657|9963331|FG001|STARTED|Cohort 3: Dose Level 3||0
8905144|NCT02100657|9963332|FG002|STARTED|Cohort 3: Dose Level 3||27
8905145|NCT02100657|9963330|FG000|COMPLETED|Cohort 3: Dose Level 3||0
8905146|NCT02100657|9963331|FG001|COMPLETED|Cohort 3: Dose Level 3||0
8905147|NCT02100657|9963332|FG002|COMPLETED|Cohort 3: Dose Level 3||0
8905148|NCT02100657|9963330|FG000|NOT COMPLETED|Cohort 3: Dose Level 3||0
8905149|NCT02100657|9963331|FG001|NOT COMPLETED|Cohort 3: Dose Level 3||0
8905150|NCT02100657|9963332|FG002|NOT COMPLETED|Cohort 3: Dose Level 3||27
9011964|NCT03000686|10074657|FG001|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
9011965|NCT03000686|10074658|FG002|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
9011966|NCT03000686|10074659|FG003|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
8636557|NCT04110314|9677227|FG000|COMPLETED|Overall Study||36526
8636558|NCT04110314|9677228|FG001|COMPLETED|Overall Study||36388
8636559|NCT04110314|9677229|FG002|COMPLETED|Overall Study||36541
9011967|NCT03000686|10074656|FG000|STARTED|Part 2, Period 1 (1 Day)||0
9011968|NCT03000686|10074657|FG001|STARTED|Part 2, Period 1 (1 Day)||0
9011969|NCT03000686|10074658|FG002|STARTED|Part 2, Period 1 (1 Day)||3
9011970|NCT03000686|10074659|FG003|STARTED|Part 2, Period 1 (1 Day)||3
8636560|NCT04110314|9677230|FG003|COMPLETED|Overall Study||36377
8636561|NCT04110314|9677231|FG004|COMPLETED|Overall Study||36289
8636562|NCT04110314|9677232|FG005|COMPLETED|Overall Study||36411
8905151|NCT02100670|9963345|FG000|STARTED|Overall Study||118
9011971|NCT03000686|10074656|FG000|COMPLETED|Part 2, Period 1 (1 Day)||0
9011972|NCT03000686|10074657|FG001|COMPLETED|Part 2, Period 1 (1 Day)||0
9011973|NCT03000686|10074658|FG002|COMPLETED|Part 2, Period 1 (1 Day)||3
9011974|NCT03000686|10074659|FG003|COMPLETED|Part 2, Period 1 (1 Day)||3
9011975|NCT03000686|10074656|FG000|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
9011976|NCT03000686|10074657|FG001|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
9011977|NCT03000686|10074658|FG002|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
9011978|NCT03000686|10074659|FG003|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
9011979|NCT03000686|10074656|FG000|STARTED|Part 2, Wash-out (Up to 14 Days)||0
9011980|NCT03000686|10074657|FG001|STARTED|Part 2, Wash-out (Up to 14 Days)||0
9011981|NCT03000686|10074658|FG002|STARTED|Part 2, Wash-out (Up to 14 Days)||3
9011982|NCT03000686|10074659|FG003|STARTED|Part 2, Wash-out (Up to 14 Days)||3
9011983|NCT03000686|10074656|FG000|COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
9011984|NCT03000686|10074657|FG001|COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
9011985|NCT03000686|10074658|FG002|COMPLETED|Part 2, Wash-out (Up to 14 Days)||3
9011986|NCT03000686|10074659|FG003|COMPLETED|Part 2, Wash-out (Up to 14 Days)||3
9011987|NCT03000686|10074656|FG000|NOT COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
9011988|NCT03000686|10074657|FG001|NOT COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
9011989|NCT03000686|10074658|FG002|NOT COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
9011990|NCT03000686|10074659|FG003|NOT COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
9011991|NCT03000686|10074656|FG000|STARTED|Part 2, Period 2 (1 Day)||0
9011992|NCT03000686|10074657|FG001|STARTED|Part 2, Period 2 (1 Day)||0
9011993|NCT03000686|10074658|FG002|STARTED|Part 2, Period 2 (1 Day)||3
9011994|NCT03000686|10074659|FG003|STARTED|Part 2, Period 2 (1 Day)||3
9011995|NCT03000686|10074656|FG000|COMPLETED|Part 2, Period 2 (1 Day)||0
9011996|NCT03000686|10074657|FG001|COMPLETED|Part 2, Period 2 (1 Day)||0
9011997|NCT03000686|10074658|FG002|COMPLETED|Part 2, Period 2 (1 Day)||3
9011998|NCT03000686|10074659|FG003|COMPLETED|Part 2, Period 2 (1 Day)||3
9011999|NCT03000686|10074656|FG000|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
9012000|NCT03000686|10074657|FG001|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
9012001|NCT03000686|10074658|FG002|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
9012002|NCT03000686|10074659|FG003|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
9012003|NCT03001076|10074673|FG000|STARTED|Overall Study||88
9012004|NCT03001076|10074674|FG001|STARTED|Overall Study||181
9012005|NCT03001076|10074673|FG000|COMPLETED|Overall Study||81
9012006|NCT03001076|10074674|FG001|COMPLETED|Overall Study||176
9012007|NCT03001076|10074673|FG000|NOT COMPLETED|Overall Study||7
9012008|NCT03001076|10074674|FG001|NOT COMPLETED|Overall Study||5
9012009|NCT03001219|10074682|FG000|STARTED|Proof of Concept||37
9012010|NCT03001219|10074683|FG001|STARTED|Proof of Concept||72
9012011|NCT03001219|10074682|FG000|COMPLETED|Proof of Concept||35
9012012|NCT03001219|10074683|FG001|COMPLETED|Proof of Concept||65
9012013|NCT03001219|10074682|FG000|NOT COMPLETED|Proof of Concept||2
9012014|NCT03001219|10074683|FG001|NOT COMPLETED|Proof of Concept||7
9012015|NCT03001219|10074682|FG000|STARTED|Extension Period Analysis||9
9012016|NCT03001219|10074683|FG001|STARTED|Extension Period Analysis||97
9012017|NCT03001219|10074682|FG000|COMPLETED|Extension Period Analysis||4
9012018|NCT03001219|10074683|FG001|COMPLETED|Extension Period Analysis||52
9012019|NCT03001219|10074682|FG000|NOT COMPLETED|Extension Period Analysis||5
9012020|NCT03001219|10074683|FG001|NOT COMPLETED|Extension Period Analysis||45
9012021|NCT03001258|10074697|FG000|STARTED|Overall Study||765
9012022|NCT03001258|10074698|FG001|STARTED|Overall Study||751
8905152|NCT02100670|9963346|FG001|STARTED|Overall Study||113
8636563|NCT04110314|9677227|FG000|NOT COMPLETED|Overall Study||35255
8636564|NCT04110314|9677228|FG001|NOT COMPLETED|Overall Study||35104
8636565|NCT04110314|9677229|FG002|NOT COMPLETED|Overall Study||35636
8905153|NCT02100670|9963347|FG002|STARTED|Overall Study||78
8905154|NCT02100670|9963348|FG003|STARTED|Overall Study||76
8905155|NCT02100670|9963345|FG000|COMPLETED|Overall Study||105
8905156|NCT02100670|9963346|FG001|COMPLETED|Overall Study||106
8905157|NCT02100670|9963347|FG002|COMPLETED|Overall Study||74
8905158|NCT02100670|9963348|FG003|COMPLETED|Overall Study||75
9012023|NCT03001258|10074699|FG002|STARTED|Overall Study||485
9012024|NCT03001258|10074697|FG000|COMPLETED|Overall Study||765
9012025|NCT03001258|10074698|FG001|COMPLETED|Overall Study||751
9012026|NCT03001258|10074699|FG002|COMPLETED|Overall Study||485
9012027|NCT03001258|10074697|FG000|NOT COMPLETED|Overall Study||0
9012028|NCT03001258|10074698|FG001|NOT COMPLETED|Overall Study||0
9012029|NCT03001258|10074699|FG002|NOT COMPLETED|Overall Study||0
9012030|NCT03001453|10074709|FG000|STARTED|Overall Study||50
9012031|NCT03001453|10074710|FG001|STARTED|Overall Study||57
9012032|NCT03001453|10074709|FG000|COMPLETED|Overall Study||50
9012033|NCT03001453|10074710|FG001|COMPLETED|Overall Study||57
9012034|NCT03001453|10074709|FG000|NOT COMPLETED|Overall Study||0
9012035|NCT03001453|10074710|FG001|NOT COMPLETED|Overall Study||0
9012036|NCT03001557|10074721|FG000|STARTED|Core Phase||12
9012037|NCT03001557|10074722|FG001|STARTED|Core Phase||12
9012038|NCT03001557|10074723|FG002|STARTED|Core Phase||14
8573174|NCT00118911|9605409|FG001|6 Month Follow-up|Overall Study||30
8573175|NCT00118911|9605408|FG000|12 Month Follow-up|Overall Study|1 participant did not complete the 6 month follow-up but did complete the 12 month follow-up|38
8573176|NCT00118911|9605409|FG001|12 Month Follow-up|Overall Study|2 participants did not complete the 6 month follow-up but did complete the 12 month follow-up|32
8573177|NCT00118911|9605408|FG000|COMPLETED|Overall Study||41
8573178|NCT00118911|9605409|FG001|COMPLETED|Overall Study||38
8573179|NCT00118911|9605408|FG000|NOT COMPLETED|Overall Study||2
8573180|NCT00118911|9605409|FG001|NOT COMPLETED|Overall Study||5
8573181|NCT00119015|9605417|FG000|STARTED|Open-Label Phase (2 Weeks)||102
8573182|NCT00119015|9605418|FG001|STARTED|Open-Label Phase (2 Weeks)||0
8573183|NCT00119015|9605419|FG002|STARTED|Open-Label Phase (2 Weeks)||0
8573184|NCT00119015|9605417|FG000|COMPLETED|Open-Label Phase (2 Weeks)||54
8636566|NCT04110314|9677230|FG003|NOT COMPLETED|Overall Study||35135
8636567|NCT04110314|9677231|FG004|NOT COMPLETED|Overall Study||35247
8636568|NCT04110314|9677232|FG005|NOT COMPLETED|Overall Study||35727
8636569|NCT04086472|9677249|FG000|STARTED|Overall Study||16
8636570|NCT04086472|9677250|FG001|STARTED|Overall Study||16
8636571|NCT04086472|9677251|FG002|STARTED|Overall Study||16
8636572|NCT04086472|9677252|FG003|STARTED|Overall Study||16
8636573|NCT04086472|9677253|FG004|STARTED|Overall Study||16
8636574|NCT04086472|9677249|FG000|Received MK-1654 or Placebo|Overall Study||16
8636575|NCT04086472|9677250|FG001|Received MK-1654 or Placebo|Overall Study||16
8636576|NCT04086472|9677251|FG002|Received MK-1654 or Placebo|Overall Study||16
8636577|NCT04086472|9677252|FG003|Received MK-1654 or Placebo|Overall Study||16
8636578|NCT04086472|9677253|FG004|Received MK-1654 or Placebo|Overall Study||16
8636579|NCT04086472|9677249|FG000|Inoculated With Respiratory Syncytial Virus (RSV) A Memphis 37b|Overall Study||14
8636580|NCT04086472|9677250|FG001|Inoculated With Respiratory Syncytial Virus (RSV) A Memphis 37b|Overall Study||14
8636581|NCT04086472|9677251|FG002|Inoculated With Respiratory Syncytial Virus (RSV) A Memphis 37b|Overall Study||14
8636582|NCT04086472|9677252|FG003|Inoculated With Respiratory Syncytial Virus (RSV) A Memphis 37b|Overall Study||13
8636583|NCT04086472|9677253|FG004|Inoculated With Respiratory Syncytial Virus (RSV) A Memphis 37b|Overall Study||15
8636584|NCT04086472|9677249|FG000|Not Inoculated|Overall Study||2
8636585|NCT04086472|9677250|FG001|Not Inoculated|Overall Study||2
8636586|NCT04086472|9677251|FG002|Not Inoculated|Overall Study||2
8905159|NCT02100670|9963345|FG000|NOT COMPLETED|Overall Study||13
8905160|NCT02100670|9963346|FG001|NOT COMPLETED|Overall Study||7
8905161|NCT02100670|9963347|FG002|NOT COMPLETED|Overall Study||4
8905162|NCT02100670|9963348|FG003|NOT COMPLETED|Overall Study||1
8905163|NCT02100696|9963371|FG000|STARTED|Induction Phase||130
8905164|NCT02100696|9963372|FG001|STARTED|Induction Phase||95
8905165|NCT02100696|9963373|FG002|STARTED|Induction Phase||384
8905166|NCT02100696|9963374|FG003|STARTED|Induction Phase||0
8905167|NCT02100696|9963375|FG004|STARTED|Induction Phase||0
8905168|NCT02100696|9963376|FG005|STARTED|Induction Phase||0
8905169|NCT02100696|9963371|FG000|COMPLETED|Induction Phase||115
8905170|NCT02100696|9963372|FG001|COMPLETED|Induction Phase||90
8905171|NCT02100696|9963373|FG002|COMPLETED|Induction Phase||358
8905172|NCT02100696|9963374|FG003|COMPLETED|Induction Phase||0
8905173|NCT02100696|9963375|FG004|COMPLETED|Induction Phase||0
8905174|NCT02100696|9963376|FG005|COMPLETED|Induction Phase||0
8905175|NCT02100696|9963371|FG000|NOT COMPLETED|Induction Phase||15
8905176|NCT02100696|9963372|FG001|NOT COMPLETED|Induction Phase||5
8905177|NCT02100696|9963373|FG002|NOT COMPLETED|Induction Phase||26
8905178|NCT02100696|9963374|FG003|NOT COMPLETED|Induction Phase||0
8905179|NCT02100696|9963375|FG004|NOT COMPLETED|Induction Phase||0
8636587|NCT04086472|9677252|FG003|Not Inoculated|Overall Study||3
8636588|NCT04086472|9677253|FG004|Not Inoculated|Overall Study||1
8636589|NCT04086472|9677249|FG000|COMPLETED|Overall Study||12
9012039|NCT03001557|10074724|FG003|STARTED|Core Phase||13
9012040|NCT03001557|10074725|FG004|STARTED|Core Phase||12
9012041|NCT03001557|10074726|FG005|STARTED|Core Phase||0
9012042|NCT03001557|10074727|FG006|STARTED|Core Phase||0
9012043|NCT03001557|10074728|FG007|STARTED|Core Phase||0
9012044|NCT03001557|10074721|FG000|Treated|Core Phase||12
9012045|NCT03001557|10074722|FG001|Treated|Core Phase||12
9012046|NCT03001557|10074723|FG002|Treated|Core Phase||13
8905180|NCT02100696|9963376|FG005|NOT COMPLETED|Induction Phase||0
8905181|NCT02100696|9963371|FG000|STARTED|Maintenance Phase||0
8905182|NCT02100696|9963372|FG001|STARTED|Maintenance Phase||0
8905183|NCT02100696|9963373|FG002|STARTED|Maintenance Phase||0
8905184|NCT02100696|9963374|FG003|STARTED|Maintenance Phase||27
8905185|NCT02100696|9963375|FG004|STARTED|Maintenance Phase||115
8905186|NCT02100696|9963376|FG005|STARTED|Maintenance Phase||117
8905187|NCT02100696|9963371|FG000|COMPLETED|Maintenance Phase||0
8905188|NCT02100696|9963372|FG001|COMPLETED|Maintenance Phase||0
8905189|NCT02100696|9963373|FG002|COMPLETED|Maintenance Phase||0
8905190|NCT02100696|9963374|FG003|COMPLETED|Maintenance Phase||26
8905191|NCT02100696|9963375|FG004|COMPLETED|Maintenance Phase||106
8905192|NCT02100696|9963376|FG005|COMPLETED|Maintenance Phase||112
8905193|NCT02100696|9963371|FG000|NOT COMPLETED|Maintenance Phase||0
8905194|NCT02100696|9963372|FG001|NOT COMPLETED|Maintenance Phase||0
8905195|NCT02100696|9963373|FG002|NOT COMPLETED|Maintenance Phase||0
8905196|NCT02100696|9963374|FG003|NOT COMPLETED|Maintenance Phase||1
8905197|NCT02100696|9963375|FG004|NOT COMPLETED|Maintenance Phase||9
8905198|NCT02100696|9963376|FG005|NOT COMPLETED|Maintenance Phase||5
8905199|NCT02100748|9963409|FG000|STARTED|Overall Study||25
8905200|NCT02100748|9963410|FG001|STARTED|Overall Study||24
8905201|NCT02100748|9963411|FG002|STARTED|Overall Study||22
8905202|NCT02100748|9963412|FG003|STARTED|Overall Study||22
8905203|NCT02100748|9963413|FG004|STARTED|Overall Study||25
8905204|NCT02100748|9963414|FG005|STARTED|Overall Study||23
8905205|NCT02100748|9963415|FG006|STARTED|Overall Study||20
8905206|NCT02100748|9963416|FG007|STARTED|Overall Study||38
8905207|NCT02100748|9963417|FG008|STARTED|Overall Study||36
8905208|NCT02100748|9963418|FG009|STARTED|Overall Study||31
8905209|NCT02100748|9963419|FG010|STARTED|Overall Study||28
8905210|NCT02100748|9963420|FG011|STARTED|Overall Study||39
8905211|NCT02100748|9963409|FG000|COMPLETED|Overall Study||23
8905212|NCT02100748|9963410|FG001|COMPLETED|Overall Study||23
8905213|NCT02100748|9963411|FG002|COMPLETED|Overall Study||21
8905214|NCT02100748|9963412|FG003|COMPLETED|Overall Study||21
8905215|NCT02100748|9963413|FG004|COMPLETED|Overall Study||23
8905216|NCT02100748|9963414|FG005|COMPLETED|Overall Study||23
8905217|NCT02100748|9963415|FG006|COMPLETED|Overall Study||18
8905218|NCT02100748|9963416|FG007|COMPLETED|Overall Study||34
8905219|NCT02100748|9963417|FG008|COMPLETED|Overall Study||33
8905220|NCT02100748|9963418|FG009|COMPLETED|Overall Study||29
8905221|NCT02100748|9963419|FG010|COMPLETED|Overall Study||26
8905222|NCT02100748|9963420|FG011|COMPLETED|Overall Study||39
8905223|NCT02100748|9963409|FG000|NOT COMPLETED|Overall Study||2
8905224|NCT02100748|9963410|FG001|NOT COMPLETED|Overall Study||1
8905225|NCT02100748|9963411|FG002|NOT COMPLETED|Overall Study||1
8905226|NCT02100748|9963412|FG003|NOT COMPLETED|Overall Study||1
8905227|NCT02100748|9963413|FG004|NOT COMPLETED|Overall Study||2
8905228|NCT02100748|9963414|FG005|NOT COMPLETED|Overall Study||0
8905229|NCT02100748|9963415|FG006|NOT COMPLETED|Overall Study||2
8573185|NCT00119015|9605418|FG001|COMPLETED|Open-Label Phase (2 Weeks)||0
8573186|NCT00119015|9605419|FG002|COMPLETED|Open-Label Phase (2 Weeks)||0
8573187|NCT00119015|9605417|FG000|NOT COMPLETED|Open-Label Phase (2 Weeks)||48
8573188|NCT00119015|9605418|FG001|NOT COMPLETED|Open-Label Phase (2 Weeks)||0
8573189|NCT00119015|9605419|FG002|NOT COMPLETED|Open-Label Phase (2 Weeks)||0
8905230|NCT02100748|9963416|FG007|NOT COMPLETED|Overall Study||4
8905231|NCT02100748|9963417|FG008|NOT COMPLETED|Overall Study||3
8905232|NCT02100748|9963418|FG009|NOT COMPLETED|Overall Study||2
8905233|NCT02100748|9963419|FG010|NOT COMPLETED|Overall Study||2
8905234|NCT02100748|9963420|FG011|NOT COMPLETED|Overall Study||0
8905235|NCT02100813|9963454|FG000|STARTED|Overall Study||10
8905236|NCT02100813|9963455|FG001|STARTED|Overall Study||11
8905237|NCT02100813|9963456|FG002|STARTED|Overall Study||12
8905238|NCT02100813|9963457|FG003|STARTED|Overall Study||12
8905239|NCT02100813|9963458|FG004|STARTED|Overall Study||12
8905240|NCT02100813|9963459|FG005|STARTED|Overall Study||32
8905241|NCT02100813|9963460|FG006|STARTED|Overall Study||64
8905242|NCT02100813|9963461|FG007|STARTED|Overall Study||67
8905243|NCT02100813|9963454|FG000|COMPLETED|Overall Study||10
8905244|NCT02100813|9963455|FG001|COMPLETED|Overall Study||11
8905245|NCT02100813|9963456|FG002|COMPLETED|Overall Study||12
8905246|NCT02100813|9963457|FG003|COMPLETED|Overall Study||12
8905247|NCT02100813|9963458|FG004|COMPLETED|Overall Study||12
8905248|NCT02100813|9963459|FG005|COMPLETED|Overall Study||32
8905249|NCT02100813|9963460|FG006|COMPLETED|Overall Study||64
8905250|NCT02100813|9963461|FG007|COMPLETED|Overall Study||66
8905251|NCT02100813|9963454|FG000|NOT COMPLETED|Overall Study||0
8905252|NCT02100813|9963455|FG001|NOT COMPLETED|Overall Study||0
8905253|NCT02100813|9963456|FG002|NOT COMPLETED|Overall Study||0
8905254|NCT02100813|9963457|FG003|NOT COMPLETED|Overall Study||0
8573190|NCT00119015|9605417|FG000|STARTED|Double-Blind, Randomized Phase (2 Weeks)||0
8905255|NCT02100813|9963458|FG004|NOT COMPLETED|Overall Study||0
8905256|NCT02100813|9963459|FG005|NOT COMPLETED|Overall Study||0
8905257|NCT02100813|9963460|FG006|NOT COMPLETED|Overall Study||0
8905258|NCT02100813|9963461|FG007|NOT COMPLETED|Overall Study||1
8905259|NCT02100826|9963479|FG000|STARTED|Period 1 (7 Days)||14
8905260|NCT02100826|9963480|FG001|STARTED|Period 1 (7 Days)||14
8905261|NCT02100826|9963479|FG000|COMPLETED|Period 1 (7 Days)||14
8905262|NCT02100826|9963480|FG001|COMPLETED|Period 1 (7 Days)||14
8905263|NCT02100826|9963479|FG000|NOT COMPLETED|Period 1 (7 Days)||0
8905264|NCT02100826|9963480|FG001|NOT COMPLETED|Period 1 (7 Days)||0
8905265|NCT02100826|9963479|FG000|STARTED|Washout Period (1 Day)||14
8905266|NCT02100826|9963480|FG001|STARTED|Washout Period (1 Day)||14
8905267|NCT02100826|9963479|FG000|COMPLETED|Washout Period (1 Day)||14
8905268|NCT02100826|9963480|FG001|COMPLETED|Washout Period (1 Day)||14
8905269|NCT02100826|9963479|FG000|NOT COMPLETED|Washout Period (1 Day)||0
8905270|NCT02100826|9963480|FG001|NOT COMPLETED|Washout Period (1 Day)||0
8905271|NCT02100826|9963479|FG000|STARTED|Period 2 (7 Days)||14
8905272|NCT02100826|9963480|FG001|STARTED|Period 2 (7 Days)||14
8905273|NCT02100826|9963479|FG000|COMPLETED|Period 2 (7 Days)||14
8905274|NCT02100826|9963480|FG001|COMPLETED|Period 2 (7 Days)||14
8905275|NCT02100826|9963479|FG000|NOT COMPLETED|Period 2 (7 Days)||0
8905276|NCT02100826|9963480|FG001|NOT COMPLETED|Period 2 (7 Days)||0
8905277|NCT02100839|9963488|FG000|STARTED|Single Ascending Dose||24
8905278|NCT02100839|9963489|FG001|STARTED|Single Ascending Dose||12
8905279|NCT02100839|9963488|FG000|COMPLETED|Single Ascending Dose||24
8905280|NCT02100839|9963489|FG001|COMPLETED|Single Ascending Dose||12
8905281|NCT02100839|9963488|FG000|NOT COMPLETED|Single Ascending Dose||0
8905282|NCT02100839|9963489|FG001|NOT COMPLETED|Single Ascending Dose||0
8905283|NCT02100839|9963488|FG000|STARTED|Multiple Ascending Dose||13
8905284|NCT02100839|9963489|FG001|STARTED|Multiple Ascending Dose||3
8905285|NCT02100839|9963488|FG000|COMPLETED|Multiple Ascending Dose||9
8905286|NCT02100839|9963489|FG001|COMPLETED|Multiple Ascending Dose||3
8905287|NCT02100839|9963488|FG000|NOT COMPLETED|Multiple Ascending Dose||4
8905288|NCT02100839|9963489|FG001|NOT COMPLETED|Multiple Ascending Dose||0
8905289|NCT02100930|9963495|FG000|STARTED|Overall Study||69
8905290|NCT02100930|9963495|FG000|COMPLETED|Overall Study||69
8905291|NCT02100930|9963495|FG000|NOT COMPLETED|Overall Study||0
8905292|NCT02100969|9963499|FG000|STARTED|Overall Study||23
8905293|NCT02100969|9963499|FG000|COMPLETED|Overall Study||22
8905294|NCT02100969|9963499|FG000|NOT COMPLETED|Overall Study||1
8905295|NCT02101008|9963504|FG000|STARTED|Overall Study||12
8905296|NCT02101008|9963504|FG000|COMPLETED|Overall Study||12
8905297|NCT02101008|9963504|FG000|NOT COMPLETED|Overall Study||0
8905298|NCT02101021|9963513|FG000|STARTED|Overall Study||7
8905299|NCT02101021|9963514|FG001|STARTED|Overall Study||4
8905300|NCT02101021|9963515|FG002|STARTED|Overall Study||7
8905301|NCT02101021|9963516|FG003|STARTED|Overall Study||3
8905302|NCT02101021|9963517|FG004|STARTED|Overall Study||4
8905303|NCT02101021|9963513|FG000|COMPLETED|Overall Study||0
8905304|NCT02101021|9963514|FG001|COMPLETED|Overall Study||0
8905305|NCT02101021|9963515|FG002|COMPLETED|Overall Study||0
9012047|NCT03001557|10074724|FG003|Treated|Core Phase||13
9012048|NCT03001557|10074725|FG004|Treated|Core Phase||12
9012049|NCT03001557|10074726|FG005|Treated|Core Phase||0
9012050|NCT03001557|10074727|FG006|Treated|Core Phase||0
9012051|NCT03001557|10074728|FG007|Treated|Core Phase||0
9012052|NCT03001557|10074721|FG000|COMPLETED|Core Phase||12
9012053|NCT03001557|10074722|FG001|COMPLETED|Core Phase||12
9012054|NCT03001557|10074723|FG002|COMPLETED|Core Phase||13
9012055|NCT03001557|10074724|FG003|COMPLETED|Core Phase||13
9012056|NCT03001557|10074725|FG004|COMPLETED|Core Phase||12
9012057|NCT03001557|10074726|FG005|COMPLETED|Core Phase||0
9012058|NCT03001557|10074727|FG006|COMPLETED|Core Phase||0
9012059|NCT03001557|10074728|FG007|COMPLETED|Core Phase||0
9012060|NCT03001557|10074721|FG000|NOT COMPLETED|Core Phase||0
9012061|NCT03001557|10074722|FG001|NOT COMPLETED|Core Phase||0
9012062|NCT03001557|10074723|FG002|NOT COMPLETED|Core Phase||1
9012063|NCT03001557|10074724|FG003|NOT COMPLETED|Core Phase||0
9012064|NCT03001557|10074725|FG004|NOT COMPLETED|Core Phase||0
9012065|NCT03001557|10074726|FG005|NOT COMPLETED|Core Phase||0
9012066|NCT03001557|10074727|FG006|NOT COMPLETED|Core Phase||0
9012067|NCT03001557|10074728|FG007|NOT COMPLETED|Core Phase||0
9012068|NCT03001557|10074721|FG000|STARTED|Extension Phase||0
9012069|NCT03001557|10074722|FG001|STARTED|Extension Phase||0
9012070|NCT03001557|10074723|FG002|STARTED|Extension Phase||0
9012071|NCT03001557|10074724|FG003|STARTED|Extension Phase||0
9012072|NCT03001557|10074725|FG004|STARTED|Extension Phase||0
9012073|NCT03001557|10074726|FG005|STARTED|Extension Phase||5
9012074|NCT03001557|10074727|FG006|STARTED|Extension Phase||14
9012075|NCT03001557|10074728|FG007|STARTED|Extension Phase||6
9012076|NCT03001557|10074721|FG000|COMPLETED|Extension Phase||0
9012077|NCT03001557|10074722|FG001|COMPLETED|Extension Phase||0
9012078|NCT03001557|10074723|FG002|COMPLETED|Extension Phase||0
9012079|NCT03001557|10074724|FG003|COMPLETED|Extension Phase||0
9012080|NCT03001557|10074725|FG004|COMPLETED|Extension Phase||0
9012081|NCT03001557|10074726|FG005|COMPLETED|Extension Phase||0
9012082|NCT03001557|10074727|FG006|COMPLETED|Extension Phase||0
9012083|NCT03001557|10074728|FG007|COMPLETED|Extension Phase||0
9012084|NCT03001557|10074721|FG000|NOT COMPLETED|Extension Phase||0
9012085|NCT03001557|10074722|FG001|NOT COMPLETED|Extension Phase||0
9012086|NCT03001557|10074723|FG002|NOT COMPLETED|Extension Phase||0
9012087|NCT03001557|10074724|FG003|NOT COMPLETED|Extension Phase||0
9012088|NCT03001557|10074725|FG004|NOT COMPLETED|Extension Phase||0
9012089|NCT03001557|10074726|FG005|NOT COMPLETED|Extension Phase||5
8905306|NCT02101021|9963516|FG003|COMPLETED|Overall Study||0
8905307|NCT02101021|9963517|FG004|COMPLETED|Overall Study||0
8905308|NCT02101021|9963513|FG000|NOT COMPLETED|Overall Study||7
9012090|NCT03001557|10074727|FG006|NOT COMPLETED|Extension Phase||14
9012091|NCT03001557|10074728|FG007|NOT COMPLETED|Extension Phase||6
9012092|NCT03001674|10074752|FG000|STARTED|Overall Study||10
9012093|NCT03001674|10074753|FG001|STARTED|Overall Study||5
9012094|NCT03001674|10074752|FG000|COMPLETED|Overall Study||10
9012095|NCT03001674|10074753|FG001|COMPLETED|Overall Study||5
9012096|NCT03001674|10074752|FG000|NOT COMPLETED|Overall Study||0
8905309|NCT02101021|9963514|FG001|NOT COMPLETED|Overall Study||4
8905310|NCT02101021|9963515|FG002|NOT COMPLETED|Overall Study||7
8905311|NCT02101021|9963516|FG003|NOT COMPLETED|Overall Study||3
8905312|NCT02101021|9963517|FG004|NOT COMPLETED|Overall Study||4
9012097|NCT03001674|10074753|FG001|NOT COMPLETED|Overall Study||0
9012098|NCT03001778|10074761|FG000|STARTED|Overall Study||21
9012099|NCT03001778|10074762|FG001|STARTED|Overall Study||46
9012100|NCT03001778|10074761|FG000|COMPLETED|Overall Study||21
9012101|NCT03001778|10074762|FG001|COMPLETED|Overall Study||46
9012102|NCT03001778|10074761|FG000|NOT COMPLETED|Overall Study||0
9012103|NCT03001778|10074762|FG001|NOT COMPLETED|Overall Study||0
9012104|NCT03001843|10074770|FG000|STARTED|Overall Study||27
9012105|NCT03001843|10074771|FG001|STARTED|Overall Study||27
9012106|NCT03001843|10074770|FG000|COMPLETED|Overall Study||27
9012107|NCT03001843|10074771|FG001|COMPLETED|Overall Study||27
9012108|NCT03001843|10074770|FG000|NOT COMPLETED|Overall Study||0
9012109|NCT03001843|10074771|FG001|NOT COMPLETED|Overall Study||0
9012110|NCT03002012|10074779|FG000|STARTED|Overall Study||11
9012111|NCT03002012|10074780|FG001|STARTED|Overall Study||11
9012112|NCT03002012|10074779|FG000|COMPLETED|Overall Study||11
9012113|NCT03002012|10074780|FG001|COMPLETED|Overall Study||11
9012114|NCT03002012|10074779|FG000|NOT COMPLETED|Overall Study||0
9012115|NCT03002012|10074780|FG001|NOT COMPLETED|Overall Study||0
9012116|NCT03002038|10074788|FG000|STARTED|Overall Study||46
9012117|NCT03002038|10074789|FG001|STARTED|Overall Study||40
9012118|NCT03002038|10074788|FG000|COMPLETED|Overall Study||35
9012119|NCT03002038|10074789|FG001|COMPLETED|Overall Study||33
9012120|NCT03002038|10074788|FG000|NOT COMPLETED|Overall Study||11
9012121|NCT03002038|10074789|FG001|NOT COMPLETED|Overall Study||7
9012122|NCT03002077|10074795|FG000|STARTED|Overall Study||617
9012123|NCT03002077|10074795|FG000|COMPLETED|Overall Study||179
9012124|NCT03002077|10074795|FG000|NOT COMPLETED|Overall Study||438
9012125|NCT03002194|10074799|FG000|STARTED|Overall Study||48
9012126|NCT03002194|10074799|FG000|COMPLETED|Overall Study||38
9012127|NCT03002194|10074799|FG000|NOT COMPLETED|Overall Study||10
9012128|NCT03002311|10074805|FG000|STARTED|Overall Study||147
9012129|NCT03002311|10074806|FG001|STARTED|Overall Study||180
9012130|NCT03002311|10074805|FG000|COMPLETED|Overall Study||128
9012131|NCT03002311|10074806|FG001|COMPLETED|Overall Study||150
9012132|NCT03002311|10074805|FG000|NOT COMPLETED|Overall Study||19
9012133|NCT03002311|10074806|FG001|NOT COMPLETED|Overall Study||30
9012134|NCT03002454|10074812|FG000|STARTED|Overall Study||4
9012135|NCT03002454|10074812|FG000|COMPLETED|Overall Study||4
9012136|NCT03002454|10074812|FG000|NOT COMPLETED|Overall Study||0
9012137|NCT03002506|10074817|FG000|STARTED|Overall Study||6
9012138|NCT03002506|10074817|FG000|COMPLETED|Overall Study||6
9012139|NCT03002506|10074817|FG000|NOT COMPLETED|Overall Study||0
9012140|NCT03002610|10074824|FG000|STARTED|Overall Study||24
9012141|NCT03002610|10074825|FG001|STARTED|Overall Study||50
9012142|NCT03002610|10074826|FG002|STARTED|Overall Study||34
9012143|NCT03002610|10074824|FG000|COMPLETED|Overall Study||18
9012144|NCT03002610|10074825|FG001|COMPLETED|Overall Study||25
9012145|NCT03002610|10074826|FG002|COMPLETED|Overall Study||21
9012146|NCT03002610|10074824|FG000|NOT COMPLETED|Overall Study||6
9012147|NCT03002610|10074825|FG001|NOT COMPLETED|Overall Study||25
9012148|NCT03002610|10074826|FG002|NOT COMPLETED|Overall Study||13
9012149|NCT03002623|10074836|FG000|STARTED|Overall Study||4
9012150|NCT03002623|10074837|FG001|STARTED|Overall Study||3
9012151|NCT03002623|10074836|FG000|COMPLETED|Overall Study||2
9012152|NCT03002623|10074837|FG001|COMPLETED|Overall Study||2
9012153|NCT03002623|10074836|FG000|NOT COMPLETED|Overall Study||2
9012154|NCT03002623|10074837|FG001|NOT COMPLETED|Overall Study||1
9012155|NCT03002753|10074847|FG000|STARTED|First Randomization||10
9012156|NCT03002753|10074848|FG001|STARTED|First Randomization||12
9012157|NCT03002753|10074849|FG002|STARTED|First Randomization||21
9012158|NCT03002753|10074847|FG000|COMPLETED|First Randomization||9
9012159|NCT03002753|10074848|FG001|COMPLETED|First Randomization||11
9012160|NCT03002753|10074849|FG002|COMPLETED|First Randomization||21
9012161|NCT03002753|10074847|FG000|NOT COMPLETED|First Randomization||1
9012162|NCT03002753|10074848|FG001|NOT COMPLETED|First Randomization||1
8573191|NCT00119015|9605418|FG001|STARTED|Double-Blind, Randomized Phase (2 Weeks)|Baseline Analysis Population|28
8573192|NCT00119015|9605419|FG002|STARTED|Double-Blind, Randomized Phase (2 Weeks)|Baseline Analysis Population|26
8573193|NCT00119015|9605417|FG000|COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
8573194|NCT00119015|9605418|FG001|COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||28
9012163|NCT03002753|10074849|FG002|NOT COMPLETED|First Randomization||0
9012164|NCT03002753|10074847|FG000|STARTED|Second Randomization (Re-randomization)||11
9012165|NCT03002753|10074848|FG001|STARTED|Second Randomization (Re-randomization)||10
9012166|NCT03002753|10074849|FG002|STARTED|Second Randomization (Re-randomization)||0
9012167|NCT03002753|10074847|FG000|COMPLETED|Second Randomization (Re-randomization)||11
8573195|NCT00119015|9605419|FG002|COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||26
8573196|NCT00119015|9605417|FG000|NOT COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
8573197|NCT00119015|9605418|FG001|NOT COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
8573198|NCT00119015|9605419|FG002|NOT COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
8573199|NCT00119041|9605428|FG000|STARTED|Overall Study||199
8573200|NCT00119041|9605429|FG001|STARTED|Overall Study||83
8573201|NCT00119041|9605430|FG002|STARTED|Overall Study||22
8573202|NCT00119041|9605428|FG000|COMPLETED|Overall Study||199
8573203|NCT00119041|9605429|FG001|COMPLETED|Overall Study||83
8905313|NCT02101060|9963531|FG000|STARTED|Overall Study||17
8905314|NCT02101060|9963532|FG001|STARTED|Overall Study||16
8905315|NCT02101060|9963531|FG000|COMPLETED|Overall Study||12
8905316|NCT02101060|9963532|FG001|COMPLETED|Overall Study||12
8905317|NCT02101060|9963531|FG000|NOT COMPLETED|Overall Study||5
8905318|NCT02101060|9963532|FG001|NOT COMPLETED|Overall Study||4
9012168|NCT03002753|10074848|FG001|COMPLETED|Second Randomization (Re-randomization)||9
9012169|NCT03002753|10074849|FG002|COMPLETED|Second Randomization (Re-randomization)||0
9012170|NCT03002753|10074847|FG000|NOT COMPLETED|Second Randomization (Re-randomization)||0
9012171|NCT03002753|10074848|FG001|NOT COMPLETED|Second Randomization (Re-randomization)||1
9012172|NCT03002753|10074849|FG002|NOT COMPLETED|Second Randomization (Re-randomization)||0
9012173|NCT03002818|10074857|FG000|STARTED|Overall Study||41
9012174|NCT03002818|10074857|FG000|COMPLETED|Overall Study||40
9012175|NCT03002818|10074857|FG000|NOT COMPLETED|Overall Study||1
9012176|NCT03002974|10074864|FG000|STARTED|Overall Study||55
9012177|NCT03002974|10074865|FG001|STARTED|Overall Study||56
9012178|NCT03002974|10074866|FG002|STARTED|Overall Study||54
8636590|NCT04086472|9677250|FG001|COMPLETED|Overall Study||14
8636591|NCT04086472|9677251|FG002|COMPLETED|Overall Study||14
9012179|NCT03002974|10074864|FG000|Intention To Treat Populatio|Overall Study||55
9012180|NCT03002974|10074865|FG001|Intention To Treat Populatio|Overall Study||56
9012181|NCT03002974|10074866|FG002|Intention To Treat Populatio|Overall Study||54
9012182|NCT03002974|10074864|FG000|Safety Population|Overall Study||54
9012183|NCT03002974|10074865|FG001|Safety Population|Overall Study||55
9012184|NCT03002974|10074866|FG002|Safety Population|Overall Study||52
9012185|NCT03002974|10074864|FG000|COMPLETED|Overall Study||35
9012186|NCT03002974|10074865|FG001|COMPLETED|Overall Study||40
9012187|NCT03002974|10074866|FG002|COMPLETED|Overall Study||36
9012188|NCT03002974|10074864|FG000|NOT COMPLETED|Overall Study||20
9012189|NCT03002974|10074865|FG001|NOT COMPLETED|Overall Study||16
9012190|NCT03002974|10074866|FG002|NOT COMPLETED|Overall Study||18
9012191|NCT03003000|10074877|FG000|STARTED|Overall Study||126
9012192|NCT03003000|10074878|FG001|STARTED|Overall Study||253
9012193|NCT03003000|10074879|FG002|STARTED|Overall Study||256
9012194|NCT03003000|10074877|FG000|COMPLETED|Overall Study||121
9012195|NCT03003000|10074878|FG001|COMPLETED|Overall Study||249
9012196|NCT03003000|10074879|FG002|COMPLETED|Overall Study||251
9012197|NCT03003000|10074877|FG000|NOT COMPLETED|Overall Study||5
9012198|NCT03003000|10074878|FG001|NOT COMPLETED|Overall Study||4
9012199|NCT03003000|10074879|FG002|NOT COMPLETED|Overall Study||5
9012200|NCT03003130|10074889|FG000|STARTED|Overall Study||88
9012201|NCT03003130|10074890|FG001|STARTED|Overall Study||87
9012202|NCT03003130|10074889|FG000|COMPLETED|Overall Study||80
9012203|NCT03003130|10074890|FG001|COMPLETED|Overall Study||80
9012204|NCT03003130|10074889|FG000|NOT COMPLETED|Overall Study||8
9012205|NCT03003130|10074890|FG001|NOT COMPLETED|Overall Study||7
9012206|NCT03003390|10074898|FG000|STARTED|Overall Study||27
9012207|NCT03003390|10074899|FG001|STARTED|Overall Study||24
9012208|NCT03003390|10074898|FG000|COMPLETED|Overall Study||23
9012209|NCT03003390|10074899|FG001|COMPLETED|Overall Study||24
9012210|NCT03003390|10074898|FG000|NOT COMPLETED|Overall Study||4
9012211|NCT03003390|10074899|FG001|NOT COMPLETED|Overall Study||0
9012212|NCT03003494|10074910|FG000|STARTED|Overall Study||306
9012213|NCT03003494|10074910|FG000|COMPLETED|Overall Study||278
9012214|NCT03003494|10074910|FG000|NOT COMPLETED|Overall Study||28
9012215|NCT03003676|10074916|FG000|STARTED|Overall Study||9
9012216|NCT03003676|10074917|FG001|STARTED|Overall Study||12
9012217|NCT03003676|10074916|FG000|COMPLETED|Overall Study||3
9012218|NCT03003676|10074917|FG001|COMPLETED|Overall Study||4
9012219|NCT03003676|10074916|FG000|NOT COMPLETED|Overall Study||6
9012220|NCT03003676|10074917|FG001|NOT COMPLETED|Overall Study||8
9012221|NCT03003793|10074927|FG000|STARTED|Overall Study||16
9012222|NCT03003793|10074928|FG001|STARTED|Overall Study||16
9012223|NCT03003793|10074927|FG000|COMPLETED|Overall Study||16
8636592|NCT04086472|9677252|FG003|COMPLETED|Overall Study||13
8636593|NCT04086472|9677253|FG004|COMPLETED|Overall Study||14
8905319|NCT02101112|9963538|FG000|STARTED|Overall Study||6
8905320|NCT02101112|9963539|FG001|STARTED|Overall Study||5
8905321|NCT02101112|9963540|FG002|STARTED|Overall Study||6
8905322|NCT02101112|9963541|FG003|STARTED|Overall Study||5
8905323|NCT02101112|9963542|FG004|STARTED|Overall Study||6
8905324|NCT02101112|9963543|FG005|STARTED|Overall Study||5
8905325|NCT02101112|9963538|FG000|COMPLETED|Overall Study||6
8905326|NCT02101112|9963539|FG001|COMPLETED|Overall Study||5
8905327|NCT02101112|9963540|FG002|COMPLETED|Overall Study||5
8905328|NCT02101112|9963541|FG003|COMPLETED|Overall Study||5
8905329|NCT02101112|9963542|FG004|COMPLETED|Overall Study||5
8905330|NCT02101112|9963543|FG005|COMPLETED|Overall Study||5
8905331|NCT02101112|9963538|FG000|NOT COMPLETED|Overall Study||0
8905332|NCT02101112|9963539|FG001|NOT COMPLETED|Overall Study||0
8905333|NCT02101112|9963540|FG002|NOT COMPLETED|Overall Study||1
8905334|NCT02101112|9963541|FG003|NOT COMPLETED|Overall Study||0
8905335|NCT02101112|9963542|FG004|NOT COMPLETED|Overall Study||1
8905336|NCT02101112|9963543|FG005|NOT COMPLETED|Overall Study||0
8905337|NCT02101190|9963555|FG000|STARTED|Overall Study||8
8905338|NCT02101190|9963556|FG001|STARTED|Overall Study||8
8905339|NCT02101190|9963555|FG000|COMPLETED|Overall Study||8
9012224|NCT03003793|10074928|FG001|COMPLETED|Overall Study||16
9012225|NCT03003793|10074927|FG000|NOT COMPLETED|Overall Study||0
9012226|NCT03003793|10074928|FG001|NOT COMPLETED|Overall Study||0
8636594|NCT04086472|9677249|FG000|NOT COMPLETED|Overall Study||4
8905340|NCT02101190|9963556|FG001|COMPLETED|Overall Study||8
8636595|NCT04086472|9677250|FG001|NOT COMPLETED|Overall Study||2
8636596|NCT04086472|9677251|FG002|NOT COMPLETED|Overall Study||2
8905341|NCT02101190|9963555|FG000|NOT COMPLETED|Overall Study||0
8905342|NCT02101190|9963556|FG001|NOT COMPLETED|Overall Study||0
8905343|NCT02101281|9963564|FG000|STARTED|Overall Study||20
8905344|NCT02101281|9963565|FG001|STARTED|Overall Study||20
8905345|NCT02101281|9963564|FG000|COMPLETED|Overall Study||20
8905346|NCT02101281|9963565|FG001|COMPLETED|Overall Study||19
8905347|NCT02101281|9963564|FG000|NOT COMPLETED|Overall Study||0
8905348|NCT02101281|9963565|FG001|NOT COMPLETED|Overall Study||1
8905349|NCT02101294|9963577|FG000|STARTED|Overall Study||31
8905350|NCT02101294|9963577|FG000|COMPLETED|Overall Study||20
8905351|NCT02101294|9963577|FG000|NOT COMPLETED|Overall Study||11
8905352|NCT02101359|9963586|FG000|STARTED|Overall Study||295
8905353|NCT02101359|9963587|FG001|STARTED|Overall Study||296
8905354|NCT02101359|9963586|FG000|COMPLETED|Overall Study||266
8905355|NCT02101359|9963587|FG001|COMPLETED|Overall Study||277
8905356|NCT02101359|9963586|FG000|NOT COMPLETED|Overall Study||29
8905357|NCT02101359|9963587|FG001|NOT COMPLETED|Overall Study||19
8905358|NCT02101411|9963596|FG000|STARTED|Overall Study||111
8905359|NCT02101411|9963597|FG001|STARTED|Overall Study||109
8905360|NCT02101411|9963598|FG002|STARTED|Overall Study||114
8905361|NCT02101411|9963596|FG000|COMPLETED|Overall Study||107
8905362|NCT02101411|9963597|FG001|COMPLETED|Overall Study||102
8905363|NCT02101411|9963598|FG002|COMPLETED|Overall Study||104
8905364|NCT02101411|9963596|FG000|NOT COMPLETED|Overall Study||4
8905365|NCT02101411|9963597|FG001|NOT COMPLETED|Overall Study||7
8905366|NCT02101411|9963598|FG002|NOT COMPLETED|Overall Study||10
9012227|NCT03003949|10074936|FG000|STARTED|Overall Study||40
9012228|NCT03003949|10074937|FG001|STARTED|Overall Study||42
9012229|NCT03003949|10074936|FG000|Week 8|Overall Study||40
9012230|NCT03003949|10074937|FG001|Week 8|Overall Study||42
9012231|NCT03003949|10074936|FG000|Week 16|Overall Study||38
9012232|NCT03003949|10074937|FG001|Week 16|Overall Study||35
9012233|NCT03003949|10074936|FG000|Week 20|Overall Study||35
9012234|NCT03003949|10074937|FG001|Week 20|Overall Study||33
9012235|NCT03003949|10074936|FG000|Week 24|Overall Study||35
9012236|NCT03003949|10074937|FG001|Week 24|Overall Study||32
9012237|NCT03003949|10074936|FG000|COMPLETED|Overall Study||35
9012238|NCT03003949|10074937|FG001|COMPLETED|Overall Study||32
9012239|NCT03003949|10074936|FG000|NOT COMPLETED|Overall Study||5
9012240|NCT03003949|10074937|FG001|NOT COMPLETED|Overall Study||10
9012241|NCT03004469|10074946|FG000|STARTED|Overall Study||189
9012242|NCT03004469|10074947|FG001|STARTED|Overall Study||184
9012243|NCT03004469|10074948|FG002|STARTED|Overall Study||85
9012244|NCT03004469|10074946|FG000|COMPLETED|Overall Study||128
9012245|NCT03004469|10074947|FG001|COMPLETED|Overall Study||135
9012246|NCT03004469|10074948|FG002|COMPLETED|Overall Study||60
9012247|NCT03004469|10074946|FG000|NOT COMPLETED|Overall Study||61
9012248|NCT03004469|10074947|FG001|NOT COMPLETED|Overall Study||49
9012249|NCT03004469|10074948|FG002|NOT COMPLETED|Overall Study||25
9012250|NCT03004534|10074957|FG000|STARTED|Overall Study||36
9012251|NCT03004534|10074957|FG000|COMPLETED|Overall Study||36
9012252|NCT03004534|10074957|FG000|NOT COMPLETED|Overall Study||0
9012253|NCT03004638|10074967|FG000|STARTED|Overall Study||6
9012254|NCT03004638|10074968|FG001|STARTED|Overall Study||6
9012255|NCT03004638|10074969|FG002|STARTED|Overall Study||6
9012256|NCT03004638|10074970|FG003|STARTED|Overall Study||6
9012257|NCT03004638|10074971|FG004|STARTED|Overall Study||1
9012258|NCT03004638|10074972|FG005|STARTED|Overall Study||7
9012259|NCT03004638|10074967|FG000|COMPLETED|Overall Study||6
9012260|NCT03004638|10074968|FG001|COMPLETED|Overall Study||6
9012261|NCT03004638|10074969|FG002|COMPLETED|Overall Study||6
9012262|NCT03004638|10074970|FG003|COMPLETED|Overall Study||6
9012263|NCT03004638|10074971|FG004|COMPLETED|Overall Study||1
9012264|NCT03004638|10074972|FG005|COMPLETED|Overall Study||7
9012265|NCT03004638|10074967|FG000|NOT COMPLETED|Overall Study||0
9012266|NCT03004638|10074968|FG001|NOT COMPLETED|Overall Study||0
9012267|NCT03004638|10074969|FG002|NOT COMPLETED|Overall Study||0
9012268|NCT03004638|10074970|FG003|NOT COMPLETED|Overall Study||0
9012269|NCT03004638|10074971|FG004|NOT COMPLETED|Overall Study||0
9012270|NCT03004638|10074972|FG005|NOT COMPLETED|Overall Study||0
9012271|NCT03004846|10074993|FG000|STARTED|Part A (Up to 14 Weeks)||8
9012272|NCT03004846|10074994|FG001|STARTED|Part A (Up to 14 Weeks)||0
9012273|NCT03004846|10074995|FG002|STARTED|Part A (Up to 14 Weeks)||0
8636597|NCT04086472|9677252|FG003|NOT COMPLETED|Overall Study||3
8905367|NCT02101437|9963610|FG000|STARTED|Overall Study||20
9012274|NCT03004846|10074993|FG000|COMPLETED|Part A (Up to 14 Weeks)||8
9012275|NCT03004846|10074994|FG001|COMPLETED|Part A (Up to 14 Weeks)||0
9012276|NCT03004846|10074995|FG002|COMPLETED|Part A (Up to 14 Weeks)||0
9012277|NCT03004846|10074993|FG000|NOT COMPLETED|Part A (Up to 14 Weeks)||0
9012278|NCT03004846|10074994|FG001|NOT COMPLETED|Part A (Up to 14 Weeks)||0
9012279|NCT03004846|10074995|FG002|NOT COMPLETED|Part A (Up to 14 Weeks)||0
9012280|NCT03004846|10074993|FG000|STARTED|Part B (Up to 14 Weeks)||0
9012281|NCT03004846|10074994|FG001|STARTED|Part B (Up to 14 Weeks)||0
9012282|NCT03004846|10074995|FG002|STARTED|Part B (Up to 14 Weeks)||0
9012283|NCT03004846|10074993|FG000|COMPLETED|Part B (Up to 14 Weeks)||0
8636598|NCT04086472|9677253|FG004|NOT COMPLETED|Overall Study||2
9012284|NCT03004846|10074994|FG001|COMPLETED|Part B (Up to 14 Weeks)||0
9012285|NCT03004846|10074995|FG002|COMPLETED|Part B (Up to 14 Weeks)||0
9012286|NCT03004846|10074993|FG000|NOT COMPLETED|Part B (Up to 14 Weeks)||0
8905368|NCT02101437|9963611|FG001|STARTED|Overall Study||54
8905369|NCT02101437|9963612|FG002|STARTED|Overall Study||52
8905370|NCT02101437|9963613|FG003|STARTED|Overall Study||49
8905371|NCT02101437|9963610|FG000|COMPLETED|Overall Study||20
8905372|NCT02101437|9963611|FG001|COMPLETED|Overall Study||54
8905373|NCT02101437|9963612|FG002|COMPLETED|Overall Study||52
8905374|NCT02101437|9963613|FG003|COMPLETED|Overall Study||49
8636599|NCT04084288|9677265|FG000|STARTED|Overall Study||41
8636600|NCT04084288|9677265|FG000|COMPLETED|Overall Study||41
8636601|NCT04084288|9677265|FG000|NOT COMPLETED|Overall Study||0
8636602|NCT03961204|9677274|FG000|STARTED|Overall Study||662
8636603|NCT03961204|9677274|FG000|COMPLETED|Overall Study||655
8636604|NCT03961204|9677274|FG000|NOT COMPLETED|Overall Study||7
8691328|NCT00854113|9736573|FG002|COMPLETED|Overall Study||6
8691329|NCT00854113|9736574|FG003|COMPLETED|Overall Study||6
8726509|NCT01037114|9773745|FG000|STARTED|Year 17||48
8726510|NCT01037114|9773745|FG000|COMPLETED|Year 17||48
8726511|NCT01037114|9773745|FG000|NOT COMPLETED|Year 17||0
8726512|NCT01037114|9773745|FG000|STARTED|Year 18||44
8726513|NCT01037114|9773745|FG000|COMPLETED|Year 18||44
8726514|NCT01037114|9773745|FG000|NOT COMPLETED|Year 18||0
8726515|NCT01037114|9773745|FG000|STARTED|Year 19||45
8726516|NCT01037114|9773745|FG000|COMPLETED|Year 19||45
8726517|NCT01037114|9773745|FG000|NOT COMPLETED|Year 19||0
8726518|NCT01037114|9773745|FG000|STARTED|Year 20||45
8726519|NCT01037114|9773745|FG000|COMPLETED|Year 20|One subject returned at Y20 but did not do lab test because subject met a study exclusion criteria.|44
8726520|NCT01037114|9773745|FG000|NOT COMPLETED|Year 20||1
8726521|NCT01037127|9773751|FG000|STARTED|Overall Study||40
8726522|NCT01037127|9773752|FG001|STARTED|Overall Study||57
8726523|NCT01037127|9773751|FG000|COMPLETED|Overall Study||35
8726524|NCT01037127|9773752|FG001|COMPLETED|Overall Study||36
8726525|NCT01037127|9773751|FG000|NOT COMPLETED|Overall Study||5
8726526|NCT01037127|9773752|FG001|NOT COMPLETED|Overall Study||21
8726527|NCT01037192|9773770|FG000|STARTED|Overall Study||3
8726528|NCT01037192|9773771|FG001|STARTED|Overall Study||1
8726529|NCT01037192|9773770|FG000|COMPLETED|Overall Study||3
8726530|NCT01037192|9773771|FG001|COMPLETED|Overall Study||1
8905375|NCT02101437|9963610|FG000|NOT COMPLETED|Overall Study||0
8905376|NCT02101437|9963611|FG001|NOT COMPLETED|Overall Study||0
8905377|NCT02101437|9963612|FG002|NOT COMPLETED|Overall Study||0
8905378|NCT02101437|9963613|FG003|NOT COMPLETED|Overall Study||0
8905379|NCT02101515|9963625|FG000|STARTED|Overall Study||37
8905380|NCT02101515|9963626|FG001|STARTED|Overall Study||41
8905381|NCT02101515|9963625|FG000|COMPLETED|Overall Study||37
8905382|NCT02101515|9963626|FG001|COMPLETED|Overall Study||41
8905383|NCT02101515|9963625|FG000|NOT COMPLETED|Overall Study||0
8905384|NCT02101515|9963626|FG001|NOT COMPLETED|Overall Study||0
8905385|NCT02101554|9963635|FG000|STARTED|Overall Study||6
8905386|NCT02101554|9963636|FG001|STARTED|Overall Study||10
8905387|NCT02101554|9963637|FG002|STARTED|Overall Study||3
9012287|NCT03004846|10074994|FG001|NOT COMPLETED|Part B (Up to 14 Weeks)||0
9012288|NCT03004846|10074995|FG002|NOT COMPLETED|Part B (Up to 14 Weeks)||0
8726531|NCT01037192|9773770|FG000|NOT COMPLETED|Overall Study||0
8726532|NCT01037192|9773771|FG001|NOT COMPLETED|Overall Study||0
8726533|NCT01037218|9773783|FG000|STARTED|Overall Study||147
8726534|NCT01037218|9773784|FG001|STARTED|Overall Study||149
8726535|NCT01037218|9773785|FG002|STARTED|Overall Study||155
8726536|NCT01037218|9773786|FG003|STARTED|Overall Study||150
8726537|NCT01037218|9773783|FG000|Safety Population|Overall Study||147
8726538|NCT01037218|9773784|FG001|Safety Population|Overall Study||148
8726539|NCT01037218|9773785|FG002|Safety Population|Overall Study||154
8726540|NCT01037218|9773786|FG003|Safety Population|Overall Study||150
8726541|NCT01037218|9773783|FG000|mITT Population|Overall Study||141
8726542|NCT01037218|9773784|FG001|mITT Population|Overall Study||140
8726543|NCT01037218|9773785|FG002|mITT Population|Overall Study||147
8726544|NCT01037218|9773786|FG003|mITT Population|Overall Study||141
8726545|NCT01037218|9773783|FG000|COMPLETED|Overall Study||131
8726546|NCT01037218|9773784|FG001|COMPLETED|Overall Study||128
8726547|NCT01037218|9773785|FG002|COMPLETED|Overall Study||134
8726548|NCT01037218|9773786|FG003|COMPLETED|Overall Study||134
8726549|NCT01037218|9773783|FG000|NOT COMPLETED|Overall Study||16
8726550|NCT01037218|9773784|FG001|NOT COMPLETED|Overall Study||21
8726551|NCT01037218|9773785|FG002|NOT COMPLETED|Overall Study||21
8726552|NCT01037218|9773786|FG003|NOT COMPLETED|Overall Study||16
8726553|NCT01037244|9773800|FG000|STARTED|Overall Study||154
8726554|NCT01037244|9773801|FG001|STARTED|Overall Study||152
8905388|NCT02101554|9963635|FG000|COMPLETED|Overall Study||3
8905389|NCT02101554|9963636|FG001|COMPLETED|Overall Study||5
8905390|NCT02101554|9963637|FG002|COMPLETED|Overall Study||2
8726555|NCT01037244|9773802|FG002|STARTED|Overall Study||158
8726556|NCT01037244|9773803|FG003|STARTED|Overall Study||154
8726557|NCT01037244|9773800|FG000|mITT (Modified Intent-to-Treat)|Overall Study||150
8726558|NCT01037244|9773801|FG001|mITT (Modified Intent-to-Treat)|Overall Study||148
8726559|NCT01037244|9773802|FG002|mITT (Modified Intent-to-Treat)|Overall Study||154
9012289|NCT03004911|10075006|FG000|STARTED|Overall Study||20
9012290|NCT03004911|10075007|FG001|STARTED|Overall Study||20
8905391|NCT02101554|9963635|FG000|NOT COMPLETED|Overall Study||3
8905392|NCT02101554|9963636|FG001|NOT COMPLETED|Overall Study||5
9012291|NCT03004911|10075006|FG000|COMPLETED|Overall Study||19
8691330|NCT00854113|9736575|FG004|COMPLETED|Overall Study||6
8691331|NCT00854113|9736576|FG005|COMPLETED|Overall Study||6
8691332|NCT00854113|9736577|FG006|COMPLETED|Overall Study||12
8636605|NCT03895840|9677278|FG000|STARTED|Overall Study||70
8636606|NCT03895840|9677278|FG000|6-Week Follow-Up|Overall Study||70
8636607|NCT03895840|9677278|FG000|12-Week Follow-Up|Overall Study||65
8636608|NCT03895840|9677278|FG000|24-Week Follow-Up|Overall Study||49
8636609|NCT03895840|9677278|FG000|COMPLETED|Overall Study||49
8636610|NCT03895840|9677278|FG000|NOT COMPLETED|Overall Study||21
8636611|NCT03818399|9677282|FG000|STARTED|Overall Study||19
8636612|NCT03818399|9677282|FG000|COMPLETED|Overall Study||5
8636613|NCT03818399|9677282|FG000|NOT COMPLETED|Overall Study||14
8636614|NCT03603496|9677288|FG000|STARTED|Overall Study||706
8636615|NCT03603496|9677289|FG001|STARTED|Overall Study||703
8636616|NCT03603496|9677288|FG000|COMPLETED|Overall Study||520
8636617|NCT03603496|9677289|FG001|COMPLETED|Overall Study||518
8636618|NCT03603496|9677288|FG000|NOT COMPLETED|Overall Study||186
8636619|NCT03603496|9677289|FG001|NOT COMPLETED|Overall Study||185
8691333|NCT00854113|9736578|FG007|COMPLETED|Overall Study||5
8691334|NCT00854113|9736579|FG008|COMPLETED|Overall Study||7
8691335|NCT00854113|9736580|FG009|COMPLETED|Overall Study||8
8691336|NCT00854113|9736581|FG010|COMPLETED|Overall Study||6
8691337|NCT00854113|9736571|FG000|NOT COMPLETED|Overall Study||0
8905393|NCT02101554|9963637|FG002|NOT COMPLETED|Overall Study||1
8905394|NCT02101918|9963645|FG000|STARTED|Overall Study||22
8905395|NCT02101918|9963645|FG000|COMPLETED|Overall Study||22
8905396|NCT02101918|9963645|FG000|NOT COMPLETED|Overall Study||0
8905397|NCT02101983|9963651|FG000|STARTED|Overall Study||5
8905398|NCT02101983|9963652|FG001|STARTED|Overall Study||6
8905399|NCT02101983|9963651|FG000|COMPLETED|Overall Study||4
8905400|NCT02101983|9963652|FG001|COMPLETED|Overall Study||6
8905401|NCT02101983|9963651|FG000|NOT COMPLETED|Overall Study||1
8905402|NCT02101983|9963652|FG001|NOT COMPLETED|Overall Study||0
8905403|NCT02102100|9963660|FG000|STARTED|Overall Study||32
8905404|NCT02102100|9963661|FG001|STARTED|Overall Study||25
8905405|NCT02102100|9963660|FG000|COMPLETED|Overall Study||23
8905406|NCT02102100|9963661|FG001|COMPLETED|Overall Study||18
8905407|NCT02102100|9963660|FG000|NOT COMPLETED|Overall Study||9
8905408|NCT02102100|9963661|FG001|NOT COMPLETED|Overall Study||7
8905409|NCT02102204|9963667|FG000|STARTED|Overall Study||902
8691338|NCT00854113|9736572|FG001|NOT COMPLETED|Overall Study||0
8691339|NCT00854113|9736573|FG002|NOT COMPLETED|Overall Study||0
8691340|NCT00854113|9736574|FG003|NOT COMPLETED|Overall Study||0
8905410|NCT02102204|9963667|FG000|Received Etelcalcetide|Overall Study||884
8905411|NCT02102204|9963667|FG000|COMPLETED|Overall Study||598
8905412|NCT02102204|9963667|FG000|NOT COMPLETED|Overall Study||304
8905413|NCT02102230|9963674|FG000|STARTED|Overall Study||42
8905414|NCT02102230|9963675|FG001|STARTED|Overall Study||28
8905415|NCT02102230|9963676|FG002|STARTED|Overall Study||41
8905416|NCT02102230|9963674|FG000|COMPLETED|Overall Study||25
8905417|NCT02102230|9963675|FG001|COMPLETED|Overall Study||11
8905418|NCT02102230|9963676|FG002|COMPLETED|Overall Study||24
8905419|NCT02102230|9963674|FG000|NOT COMPLETED|Overall Study||17
8905420|NCT02102230|9963675|FG001|NOT COMPLETED|Overall Study||17
8905421|NCT02102230|9963676|FG002|NOT COMPLETED|Overall Study||17
8905422|NCT02102399|9963687|FG000|STARTED|Overall Study||20
8905423|NCT02102399|9963688|FG001|STARTED|Overall Study||21
8905424|NCT02102399|9963687|FG000|COMPLETED|Overall Study||14
8905425|NCT02102399|9963688|FG001|COMPLETED|Overall Study||17
8905426|NCT02102399|9963687|FG000|NOT COMPLETED|Overall Study||6
8905427|NCT02102399|9963688|FG001|NOT COMPLETED|Overall Study||4
8905428|NCT02102464|9963701|FG000|STARTED|Randomized Study||29
8691341|NCT00854113|9736575|FG004|NOT COMPLETED|Overall Study||0
8691342|NCT00854113|9736576|FG005|NOT COMPLETED|Overall Study||0
8691343|NCT00854113|9736577|FG006|NOT COMPLETED|Overall Study||0
8691344|NCT00854113|9736578|FG007|NOT COMPLETED|Overall Study||3
8691345|NCT00854113|9736579|FG008|NOT COMPLETED|Overall Study||1
8691346|NCT00854113|9736580|FG009|NOT COMPLETED|Overall Study||0
8905429|NCT02102464|9963702|FG001|STARTED|Randomized Study||26
8905430|NCT02102464|9963703|FG002|STARTED|Randomized Study||0
8905431|NCT02102464|9963701|FG000|COMPLETED|Randomized Study||29
8905432|NCT02102464|9963702|FG001|COMPLETED|Randomized Study||25
8905433|NCT02102464|9963703|FG002|COMPLETED|Randomized Study||0
8905434|NCT02102464|9963701|FG000|NOT COMPLETED|Randomized Study||0
8905435|NCT02102464|9963702|FG001|NOT COMPLETED|Randomized Study||1
8905436|NCT02102464|9963703|FG002|NOT COMPLETED|Randomized Study||0
8905437|NCT02102464|9963701|FG000|STARTED|Crossover LipiFlow Treatment of Control||0
8905438|NCT02102464|9963702|FG001|STARTED|Crossover LipiFlow Treatment of Control||0
8905439|NCT02102464|9963703|FG002|STARTED|Crossover LipiFlow Treatment of Control||25
8905440|NCT02102464|9963701|FG000|COMPLETED|Crossover LipiFlow Treatment of Control||0
8905441|NCT02102464|9963702|FG001|COMPLETED|Crossover LipiFlow Treatment of Control||0
8905442|NCT02102464|9963703|FG002|COMPLETED|Crossover LipiFlow Treatment of Control||25
8905443|NCT02102464|9963701|FG000|NOT COMPLETED|Crossover LipiFlow Treatment of Control||0
8905444|NCT02102464|9963702|FG001|NOT COMPLETED|Crossover LipiFlow Treatment of Control||0
8905445|NCT02102464|9963703|FG002|NOT COMPLETED|Crossover LipiFlow Treatment of Control||0
8905446|NCT02102490|9963712|FG000|STARTED|Overall Study||132
8905447|NCT02102490|9963712|FG000|Received at Least 1 Dose of Study Drug|Overall Study||132
8905448|NCT02102490|9963712|FG000|COMPLETED|Overall Study||125
8905449|NCT02102490|9963712|FG000|NOT COMPLETED|Overall Study||7
8905450|NCT02102724|9963718|FG000|STARTED|Overall Study||18
8905451|NCT02102724|9963719|FG001|STARTED|Overall Study||19
8905452|NCT02102724|9963718|FG000|COMPLETED|Overall Study||16
8905453|NCT02102724|9963719|FG001|COMPLETED|Overall Study||18
8905454|NCT02102724|9963718|FG000|NOT COMPLETED|Overall Study||2
8905455|NCT02102724|9963719|FG001|NOT COMPLETED|Overall Study||1
8905456|NCT02102932|9963733|FG000|STARTED|Overall Study||12
8905457|NCT02102932|9963734|FG001|STARTED|Overall Study||12
8905458|NCT02102932|9963735|FG002|STARTED|Overall Study||12
8905459|NCT02102932|9963736|FG003|STARTED|Overall Study||12
8905460|NCT02102932|9963737|FG004|STARTED|Overall Study||12
8905461|NCT02102932|9963738|FG005|STARTED|Overall Study||12
8905462|NCT02102932|9963739|FG006|STARTED|Overall Study||12
8905463|NCT02102932|9963740|FG007|STARTED|Overall Study||12
8905464|NCT02102932|9963733|FG000|COMPLETED|Overall Study||12
8905465|NCT02102932|9963734|FG001|COMPLETED|Overall Study||12
8905466|NCT02102932|9963735|FG002|COMPLETED|Overall Study||12
8905467|NCT02102932|9963736|FG003|COMPLETED|Overall Study||12
9012292|NCT03004911|10075007|FG001|COMPLETED|Overall Study||17
9012293|NCT03004911|10075006|FG000|NOT COMPLETED|Overall Study||1
9012294|NCT03004911|10075007|FG001|NOT COMPLETED|Overall Study||3
8905468|NCT02102932|9963737|FG004|COMPLETED|Overall Study||12
8905469|NCT02102932|9963738|FG005|COMPLETED|Overall Study||12
8905470|NCT02102932|9963739|FG006|COMPLETED|Overall Study||12
8905471|NCT02102932|9963740|FG007|COMPLETED|Overall Study||12
8905472|NCT02102932|9963733|FG000|NOT COMPLETED|Overall Study||0
9012295|NCT03004924|10075016|FG000|STARTED|Overall Study||324
8905473|NCT02102932|9963734|FG001|NOT COMPLETED|Overall Study||0
8905474|NCT02102932|9963735|FG002|NOT COMPLETED|Overall Study||0
8905475|NCT02102932|9963736|FG003|NOT COMPLETED|Overall Study||0
8905476|NCT02102932|9963737|FG004|NOT COMPLETED|Overall Study||0
8905477|NCT02102932|9963738|FG005|NOT COMPLETED|Overall Study||0
8905478|NCT02102932|9963739|FG006|NOT COMPLETED|Overall Study||0
8905479|NCT02102932|9963740|FG007|NOT COMPLETED|Overall Study||0
8905480|NCT02103062|9963760|FG000|STARTED|Overall Study||18
8905481|NCT02103062|9963761|FG001|STARTED|Overall Study||23
8905482|NCT02103062|9963760|FG000|Safety Population|Overall Study|Includes participants who received at least one dose of study drug.|18
8905483|NCT02103062|9963761|FG001|Safety Population|Overall Study|Includes participants who received at least one dose of study drug.|23
8905484|NCT02103062|9963760|FG000|Intent to Treat Population|Overall Study|Includes participants who met all eligibility criteria and received at least one dose of study drug.|17
8905485|NCT02103062|9963761|FG001|Intent to Treat Population|Overall Study|Includes participants who met all eligibility criteria and received at least one dose of study drug.|20
8905486|NCT02103062|9963760|FG000|COMPLETED|Overall Study||0
8905487|NCT02103062|9963761|FG001|COMPLETED|Overall Study||0
8905488|NCT02103062|9963760|FG000|NOT COMPLETED|Overall Study||18
8905489|NCT02103062|9963761|FG001|NOT COMPLETED|Overall Study||23
8905490|NCT02103114|9963771|FG000|STARTED|Overall Study||20
8905491|NCT02103114|9963772|FG001|STARTED|Overall Study||20
8905492|NCT02103114|9963771|FG000|COMPLETED|Overall Study||20
8905493|NCT02103114|9963772|FG001|COMPLETED|Overall Study||19
8905494|NCT02103114|9963771|FG000|NOT COMPLETED|Overall Study||0
8905495|NCT02103114|9963772|FG001|NOT COMPLETED|Overall Study||1
8905496|NCT02103127|9963779|FG000|STARTED|Overall Study||20
8905497|NCT02103127|9963779|FG000|COMPLETED|Overall Study||17
8905498|NCT02103127|9963779|FG000|NOT COMPLETED|Overall Study||3
8905499|NCT02103153|9963783|FG000|STARTED|Overall Study||44
8905500|NCT02103153|9963783|FG000|COMPLETED|Overall Study||27
8905501|NCT02103153|9963783|FG000|NOT COMPLETED|Overall Study||17
8905502|NCT02103218|9963794|FG000|STARTED|Overall Study||51
8905503|NCT02103218|9963795|FG001|STARTED|Overall Study||59
8905504|NCT02103218|9963796|FG002|STARTED|Overall Study||48
8905505|NCT02103218|9963797|FG003|STARTED|Overall Study||54
8905506|NCT02103218|9963794|FG000|COMPLETED|Overall Study||46
8905507|NCT02103218|9963795|FG001|COMPLETED|Overall Study||51
8905508|NCT02103218|9963796|FG002|COMPLETED|Overall Study||44
8905509|NCT02103218|9963797|FG003|COMPLETED|Overall Study||47
8905510|NCT02103218|9963794|FG000|NOT COMPLETED|Overall Study||5
8905511|NCT02103218|9963795|FG001|NOT COMPLETED|Overall Study||8
8905512|NCT02103218|9963796|FG002|NOT COMPLETED|Overall Study||4
8905513|NCT02103218|9963797|FG003|NOT COMPLETED|Overall Study||7
8905514|NCT02103270|9963808|FG000|STARTED|Overall Study||60
8905515|NCT02103270|9963809|FG001|STARTED|Overall Study||35
8905516|NCT02103270|9963810|FG002|STARTED|Overall Study||25
8905517|NCT02103270|9963808|FG000|COMPLETED|Overall Study||51
8905518|NCT02103270|9963809|FG001|COMPLETED|Overall Study||29
8905519|NCT02103270|9963810|FG002|COMPLETED|Overall Study||1
8905520|NCT02103270|9963808|FG000|NOT COMPLETED|Overall Study||9
8905521|NCT02103270|9963809|FG001|NOT COMPLETED|Overall Study||6
8905522|NCT02103270|9963810|FG002|NOT COMPLETED|Overall Study||24
8905523|NCT02103309|9963821|FG000|STARTED|Overall Study||20
8905524|NCT02103309|9963822|FG001|STARTED|Overall Study||22
8905525|NCT02103309|9963821|FG000|COMPLETED|Overall Study||20
9012296|NCT03004924|10075017|FG001|STARTED|Overall Study||108
9012297|NCT03004924|10075018|FG002|STARTED|Overall Study||321
9012298|NCT03004924|10075016|FG000|COMPLETED|Overall Study||297
9012299|NCT03004924|10075017|FG001|COMPLETED|Overall Study||94
9012300|NCT03004924|10075018|FG002|COMPLETED|Overall Study||293
9012301|NCT03004924|10075016|FG000|NOT COMPLETED|Overall Study||27
9012302|NCT03004924|10075017|FG001|NOT COMPLETED|Overall Study||14
9012303|NCT03004924|10075018|FG002|NOT COMPLETED|Overall Study||28
9012304|NCT03005041|10075027|FG000|STARTED|Period 1||28
9012305|NCT03005041|10075028|FG001|STARTED|Period 1||27
9012306|NCT03005041|10075027|FG000|COMPLETED|Period 1||28
9012307|NCT03005041|10075028|FG001|COMPLETED|Period 1||27
9012308|NCT03005041|10075027|FG000|NOT COMPLETED|Period 1||0
9012309|NCT03005041|10075028|FG001|NOT COMPLETED|Period 1||0
9012310|NCT03005041|10075027|FG000|STARTED|Washout Period 1||28
9012311|NCT03005041|10075028|FG001|STARTED|Washout Period 1||27
9012312|NCT03005041|10075027|FG000|COMPLETED|Washout Period 1||28
9012313|NCT03005041|10075028|FG001|COMPLETED|Washout Period 1||27
9012314|NCT03005041|10075027|FG000|NOT COMPLETED|Washout Period 1||0
9012315|NCT03005041|10075028|FG001|NOT COMPLETED|Washout Period 1||0
9012316|NCT03005041|10075027|FG000|STARTED|Period 2||28
9012317|NCT03005041|10075028|FG001|STARTED|Period 2||27
9012318|NCT03005041|10075027|FG000|COMPLETED|Period 2||28
9012319|NCT03005041|10075028|FG001|COMPLETED|Period 2||27
9012320|NCT03005041|10075027|FG000|NOT COMPLETED|Period 2||0
9012321|NCT03005041|10075028|FG001|NOT COMPLETED|Period 2||0
9012322|NCT03005054|10075034|FG000|STARTED|Overall Study||3
9012323|NCT03005054|10075034|FG000|COMPLETED|Overall Study||3
9012324|NCT03005054|10075034|FG000|NOT COMPLETED|Overall Study||0
9012325|NCT03005067|10075040|FG000|STARTED|Overall Study||90
8905526|NCT02103309|9963822|FG001|COMPLETED|Overall Study||22
8905527|NCT02103309|9963821|FG000|NOT COMPLETED|Overall Study||0
9012326|NCT03005067|10075041|FG001|STARTED|Overall Study||81
9012327|NCT03005067|10075040|FG000|COMPLETED|Overall Study||80
9012328|NCT03005067|10075041|FG001|COMPLETED|Overall Study||74
9012329|NCT03005067|10075040|FG000|NOT COMPLETED|Overall Study||10
8905528|NCT02103309|9963822|FG001|NOT COMPLETED|Overall Study||0
8905529|NCT02103439|9963830|FG000|STARTED|Overall Study||70
8905530|NCT02103439|9963831|FG001|STARTED|Overall Study||70
8905531|NCT02103439|9963830|FG000|COMPLETED|Overall Study||67
8905532|NCT02103439|9963831|FG001|COMPLETED|Overall Study||67
8905533|NCT02103439|9963830|FG000|NOT COMPLETED|Overall Study||3
8905534|NCT02103439|9963831|FG001|NOT COMPLETED|Overall Study||3
8905535|NCT02103478|9963848|FG000|STARTED|Overall Study||7
8905536|NCT02103478|9963849|FG001|STARTED|Overall Study||6
8905537|NCT02103478|9963850|FG002|STARTED|Overall Study||6
8905538|NCT02103478|9963851|FG003|STARTED|Overall Study||6
8905539|NCT02103478|9963852|FG004|STARTED|Overall Study||19
8905540|NCT02103478|9963853|FG005|STARTED|Overall Study||25
8905541|NCT02103478|9963854|FG006|STARTED|Overall Study||25
8905542|NCT02103478|9963855|FG007|STARTED|Overall Study||16
8905543|NCT02103478|9963856|FG008|STARTED|Overall Study||14
8905544|NCT02103478|9963848|FG000|COMPLETED|Overall Study||0
8905545|NCT02103478|9963849|FG001|COMPLETED|Overall Study||0
8905546|NCT02103478|9963850|FG002|COMPLETED|Overall Study||0
8905547|NCT02103478|9963851|FG003|COMPLETED|Overall Study||0
8905548|NCT02103478|9963852|FG004|COMPLETED|Overall Study||0
8905549|NCT02103478|9963853|FG005|COMPLETED|Overall Study||0
8905550|NCT02103478|9963854|FG006|COMPLETED|Overall Study||0
8905551|NCT02103478|9963855|FG007|COMPLETED|Overall Study||0
8905552|NCT02103478|9963856|FG008|COMPLETED|Overall Study||0
8905553|NCT02103478|9963848|FG000|NOT COMPLETED|Overall Study||7
8905554|NCT02103478|9963849|FG001|NOT COMPLETED|Overall Study||6
8905555|NCT02103478|9963850|FG002|NOT COMPLETED|Overall Study||6
8905556|NCT02103478|9963851|FG003|NOT COMPLETED|Overall Study||6
8905557|NCT02103478|9963852|FG004|NOT COMPLETED|Overall Study||19
8905558|NCT02103478|9963853|FG005|NOT COMPLETED|Overall Study||25
8905559|NCT02103478|9963854|FG006|NOT COMPLETED|Overall Study||25
8905560|NCT02103478|9963855|FG007|NOT COMPLETED|Overall Study||16
9012330|NCT03005067|10075041|FG001|NOT COMPLETED|Overall Study||7
9012331|NCT03005106|10075047|FG000|STARTED|Overall Study||71
9012332|NCT03005106|10075047|FG000|Completed Month 3 Visit|Overall Study||64
9012333|NCT03005106|10075047|FG000|Completed Month 12 Visit|Overall Study||51
9012334|NCT03005106|10075047|FG000|COMPLETED|Overall Study||51
9012335|NCT03005106|10075047|FG000|NOT COMPLETED|Overall Study||20
9012336|NCT03005288|10075053|FG000|STARTED|Overall Study||39
9012337|NCT03005288|10075054|FG001|STARTED|Overall Study||39
9012338|NCT03005288|10075053|FG000|Safety Analysis Set|Overall Study||37
9012339|NCT03005288|10075054|FG001|Safety Analysis Set|Overall Study||38
9012340|NCT03005288|10075053|FG000|Pharmacokinetics (PK) Analysis Set|Overall Study|One subject was excluded due to a protocol deviation.|36
9012341|NCT03005288|10075054|FG001|Pharmacokinetics (PK) Analysis Set|Overall Study|PK samples were only obtained and evaluated for subjects treated with BYM338.|0
9012342|NCT03005288|10075053|FG000|Pharmacodynamics (PD) Analysis Set|Overall Study|One subject was excluded due to a protocol deviation.|36
9012343|NCT03005288|10075054|FG001|Pharmacodynamics (PD) Analysis Set|Overall Study|Two subjects were excluded due to protocol deviations.|36
9012344|NCT03005288|10075053|FG000|COMPLETED|Overall Study||27
9012345|NCT03005288|10075054|FG001|COMPLETED|Overall Study||31
9012346|NCT03005288|10075053|FG000|NOT COMPLETED|Overall Study||12
9012347|NCT03005288|10075054|FG001|NOT COMPLETED|Overall Study||8
9012348|NCT03006341|10075064|FG000|STARTED|Overall Study||26199
9012349|NCT03006341|10075065|FG001|STARTED|Overall Study||70071
9012350|NCT03006341|10075066|FG002|STARTED|Overall Study||32595
9012351|NCT03006341|10075067|FG003|STARTED|Overall Study||11322
8905561|NCT02103478|9963856|FG008|NOT COMPLETED|Overall Study||14
8905562|NCT02103608|9963886|FG000|STARTED|Overall Study||17
8905563|NCT02103608|9963886|FG000|COMPLETED|Overall Study||15
9012352|NCT03006341|10075064|FG000|COMPLETED|Overall Study||1130
9012353|NCT03006341|10075065|FG001|COMPLETED|Overall Study||2566
9012354|NCT03006341|10075066|FG002|COMPLETED|Overall Study||1602
8573204|NCT00119041|9605430|FG002|COMPLETED|Overall Study||22
8573205|NCT00119041|9605428|FG000|NOT COMPLETED|Overall Study||0
8573206|NCT00119041|9605429|FG001|NOT COMPLETED|Overall Study||0
8573207|NCT00119041|9605430|FG002|NOT COMPLETED|Overall Study||0
8573208|NCT00119106|9605441|FG000|STARTED|Overall Study||1204
8573209|NCT00119106|9605442|FG001|STARTED|Overall Study|2 participants later found to be HIV infected at baseline. Therefore 1207 in mITT analysis|1209
8573210|NCT00119106|9605441|FG000|COMPLETED|Overall Study||1025
8573211|NCT00119106|9605442|FG001|COMPLETED|Overall Study||1031
8573212|NCT00119106|9605441|FG000|NOT COMPLETED|Overall Study||179
8573213|NCT00119106|9605442|FG001|NOT COMPLETED|Overall Study||178
8573214|NCT00119158|9605458|FG000|STARTED|Active Treatment|patients are self controls|45
8573215|NCT00119158|9605459|FG001|STARTED|Active Treatment||45
8573216|NCT00119158|9605458|FG000|COMPLETED|Active Treatment||45
8573217|NCT00119158|9605459|FG001|COMPLETED|Active Treatment||45
8573218|NCT00119158|9605458|FG000|NOT COMPLETED|Active Treatment||0
8573219|NCT00119158|9605459|FG001|NOT COMPLETED|Active Treatment||0
8573220|NCT00119158|9605458|FG000|STARTED|Placebo Treatment||45
8573221|NCT00119158|9605459|FG001|STARTED|Placebo Treatment||45
8905564|NCT02103608|9963886|FG000|NOT COMPLETED|Overall Study||2
8905565|NCT02103816|9963890|FG000|STARTED|Overall Study||21
8905566|NCT02103816|9963890|FG000|COMPLETED|Overall Study||13
8905567|NCT02103816|9963890|FG000|NOT COMPLETED|Overall Study||8
8905568|NCT02103855|9963894|FG000|STARTED|Overall Study||6
8905569|NCT02103855|9963894|FG000|COMPLETED|Overall Study||4
8905570|NCT02103855|9963894|FG000|NOT COMPLETED|Overall Study||2
8905571|NCT02104141|9963898|FG000|STARTED|Overall Study||51
9012355|NCT03006341|10075067|FG003|COMPLETED|Overall Study||637
8905572|NCT02104141|9963898|FG000|COMPLETED|Overall Study||51
8905573|NCT02104141|9963898|FG000|NOT COMPLETED|Overall Study||0
8905574|NCT02104167|9963902|FG000|STARTED|Overall Study||110
8905575|NCT02104167|9963902|FG000|COMPLETED|Overall Study||110
8905576|NCT02104167|9963902|FG000|NOT COMPLETED|Overall Study||0
8905577|NCT02104219|9963906|FG000|STARTED|Overall Study||32
8905578|NCT02104219|9963906|FG000|COMPLETED|Overall Study||32
8905579|NCT02104219|9963906|FG000|NOT COMPLETED|Overall Study||0
8905580|NCT02104414|9963913|FG000|STARTED|Overall Study||5
8905581|NCT02104414|9963914|FG001|STARTED|Overall Study||4
8905582|NCT02104414|9963915|FG002|STARTED|Overall Study||2
8905583|NCT02104414|9963913|FG000|COMPLETED|Overall Study||5
8905584|NCT02104414|9963914|FG001|COMPLETED|Overall Study||4
8905585|NCT02104414|9963915|FG002|COMPLETED|Overall Study||2
8905586|NCT02104414|9963913|FG000|NOT COMPLETED|Overall Study||0
8905587|NCT02104414|9963914|FG001|NOT COMPLETED|Overall Study||0
8905588|NCT02104414|9963915|FG002|NOT COMPLETED|Overall Study||0
8905589|NCT02104427|9963923|FG000|STARTED|Overall Study||12
8905590|NCT02104427|9963923|FG000|COMPLETED|Overall Study||12
8905591|NCT02104427|9963923|FG000|NOT COMPLETED|Overall Study||0
8905592|NCT02104505|9963947|FG000|STARTED|First Intervention (14 Days)||12
8905593|NCT02104505|9963948|FG001|STARTED|First Intervention (14 Days)|one participant withdrew prior to receiving study drug|11
8905594|NCT02104505|9963947|FG000|COMPLETED|First Intervention (14 Days)||10
8905595|NCT02104505|9963948|FG001|COMPLETED|First Intervention (14 Days)||8
8905596|NCT02104505|9963947|FG000|NOT COMPLETED|First Intervention (14 Days)||2
8905597|NCT02104505|9963948|FG001|NOT COMPLETED|First Intervention (14 Days)||3
8905598|NCT02104505|9963947|FG000|STARTED|Washout (Minimum 3 Weeks)||10
8636620|NCT03480802|9677297|FG000|STARTED|Overall Study||152
8636621|NCT03480802|9677298|FG001|STARTED|Overall Study||150
8636622|NCT03480802|9677297|FG000|Week 8|Overall Study||150
8905599|NCT02104505|9963948|FG001|STARTED|Washout (Minimum 3 Weeks)||8
8905600|NCT02104505|9963947|FG000|COMPLETED|Washout (Minimum 3 Weeks)||10
8905601|NCT02104505|9963948|FG001|COMPLETED|Washout (Minimum 3 Weeks)||8
8905602|NCT02104505|9963947|FG000|NOT COMPLETED|Washout (Minimum 3 Weeks)||0
8905603|NCT02104505|9963948|FG001|NOT COMPLETED|Washout (Minimum 3 Weeks)||0
8905604|NCT02104505|9963947|FG000|STARTED|Second Intervention (14 Days)||10
8905605|NCT02104505|9963948|FG001|STARTED|Second Intervention (14 Days)||8
8905606|NCT02104505|9963947|FG000|COMPLETED|Second Intervention (14 Days)||8
8905607|NCT02104505|9963948|FG001|COMPLETED|Second Intervention (14 Days)||7
8905608|NCT02104505|9963947|FG000|NOT COMPLETED|Second Intervention (14 Days)||2
8905609|NCT02104505|9963948|FG001|NOT COMPLETED|Second Intervention (14 Days)||1
8905610|NCT02104557|9963955|FG000|STARTED|Overall Study||362
8905611|NCT02104557|9963955|FG000|Safety Population|Overall Study||337
8905612|NCT02104557|9963955|FG000|COMPLETED|Overall Study||185
8905613|NCT02104557|9963955|FG000|NOT COMPLETED|Overall Study||177
8905614|NCT02104583|9963964|FG000|STARTED|Overall Study||48
8905615|NCT02104583|9963965|FG001|STARTED|Overall Study||46
8905616|NCT02104583|9963966|FG002|STARTED|Overall Study||70
8905617|NCT02104583|9963967|FG003|STARTED|Overall Study||74
8905618|NCT02104583|9963968|FG004|STARTED|Overall Study||75
8905619|NCT02104583|9963964|FG000|COMPLETED|Overall Study||30
8905620|NCT02104583|9963965|FG001|COMPLETED|Overall Study||35
8636623|NCT03480802|9677298|FG001|Week 8|Overall Study||148
8636624|NCT03480802|9677297|FG000|COMPLETED|Overall Study||145
8636625|NCT03480802|9677298|FG001|COMPLETED|Overall Study||147
8636626|NCT03480802|9677297|FG000|NOT COMPLETED|Overall Study||7
8636627|NCT03480802|9677298|FG001|NOT COMPLETED|Overall Study||3
8636628|NCT03472521|9677308|FG000|STARTED|Overall Study||41
8636629|NCT03472521|9677309|FG001|STARTED|Overall Study||37
8905621|NCT02104583|9963966|FG002|COMPLETED|Overall Study||54
8905622|NCT02104583|9963967|FG003|COMPLETED|Overall Study||57
8905623|NCT02104583|9963968|FG004|COMPLETED|Overall Study||63
8905624|NCT02104583|9963964|FG000|NOT COMPLETED|Overall Study||18
8905625|NCT02104583|9963965|FG001|NOT COMPLETED|Overall Study||11
8905626|NCT02104583|9963966|FG002|NOT COMPLETED|Overall Study||16
8905627|NCT02104583|9963967|FG003|NOT COMPLETED|Overall Study||17
8905628|NCT02104583|9963968|FG004|NOT COMPLETED|Overall Study||12
8905629|NCT02104739|9963989|FG000|STARTED|First Intervention (1 Day)||2
8905630|NCT02104739|9963990|FG001|STARTED|First Intervention (1 Day)||5
8905631|NCT02104739|9963991|FG002|STARTED|First Intervention (1 Day)||2
8905632|NCT02104739|9963992|FG003|STARTED|First Intervention (1 Day)||8
8905633|NCT02104739|9963993|FG004|STARTED|First Intervention (1 Day)||0
8905634|NCT02104739|9963994|FG005|STARTED|First Intervention (1 Day)||3
8905635|NCT02104739|9963995|FG006|STARTED|First Intervention (1 Day)||0
8905636|NCT02104739|9963989|FG000|COMPLETED|First Intervention (1 Day)||2
8905637|NCT02104739|9963990|FG001|COMPLETED|First Intervention (1 Day)||4
8905638|NCT02104739|9963991|FG002|COMPLETED|First Intervention (1 Day)||2
8905639|NCT02104739|9963992|FG003|COMPLETED|First Intervention (1 Day)||7
8636630|NCT03472521|9677308|FG000|Received Allocated Intervention|Overall Study||41
8636631|NCT03472521|9677309|FG001|Received Allocated Intervention|Overall Study||37
8636632|NCT03472521|9677308|FG000|COMPLETED|Overall Study||35
8636633|NCT03472521|9677309|FG001|COMPLETED|Overall Study||34
8636634|NCT03472521|9677308|FG000|NOT COMPLETED|Overall Study||6
8905640|NCT02104739|9963993|FG004|COMPLETED|First Intervention (1 Day)||0
8905641|NCT02104739|9963994|FG005|COMPLETED|First Intervention (1 Day)||3
8905642|NCT02104739|9963995|FG006|COMPLETED|First Intervention (1 Day)||0
8905643|NCT02104739|9963989|FG000|NOT COMPLETED|First Intervention (1 Day)||0
8905644|NCT02104739|9963990|FG001|NOT COMPLETED|First Intervention (1 Day)||1
8905645|NCT02104739|9963991|FG002|NOT COMPLETED|First Intervention (1 Day)||0
8905646|NCT02104739|9963992|FG003|NOT COMPLETED|First Intervention (1 Day)||1
8905647|NCT02104739|9963993|FG004|NOT COMPLETED|First Intervention (1 Day)||0
8905648|NCT02104739|9963994|FG005|NOT COMPLETED|First Intervention (1 Day)||0
8905649|NCT02104739|9963995|FG006|NOT COMPLETED|First Intervention (1 Day)||0
8905650|NCT02104739|9963989|FG000|STARTED|Washout (Min of 10 and Max of 107 Days)||1
8905651|NCT02104739|9963990|FG001|STARTED|Washout (Min of 10 and Max of 107 Days)||4
8905652|NCT02104739|9963991|FG002|STARTED|Washout (Min of 10 and Max of 107 Days)||2
8905653|NCT02104739|9963992|FG003|STARTED|Washout (Min of 10 and Max of 107 Days)||7
8905654|NCT02104739|9963993|FG004|STARTED|Washout (Min of 10 and Max of 107 Days)||0
8905655|NCT02104739|9963994|FG005|STARTED|Washout (Min of 10 and Max of 107 Days)||2
8905656|NCT02104739|9963995|FG006|STARTED|Washout (Min of 10 and Max of 107 Days)||0
8905657|NCT02104739|9963989|FG000|COMPLETED|Washout (Min of 10 and Max of 107 Days)||1
8905658|NCT02104739|9963990|FG001|COMPLETED|Washout (Min of 10 and Max of 107 Days)||4
8905659|NCT02104739|9963991|FG002|COMPLETED|Washout (Min of 10 and Max of 107 Days)||2
9012356|NCT03006341|10075064|FG000|NOT COMPLETED|Overall Study||25069
9012357|NCT03006341|10075065|FG001|NOT COMPLETED|Overall Study||67505
9012358|NCT03006341|10075066|FG002|NOT COMPLETED|Overall Study||30993
9012359|NCT03006341|10075067|FG003|NOT COMPLETED|Overall Study||10685
9012360|NCT03006393|10075077|FG000|STARTED|Overall Study||21
9012361|NCT03006393|10075078|FG001|STARTED|Overall Study||21
9012362|NCT03006393|10075077|FG000|COMPLETED|Overall Study||20
9012363|NCT03006393|10075078|FG001|COMPLETED|Overall Study||18
9012364|NCT03006393|10075077|FG000|NOT COMPLETED|Overall Study||1
9012365|NCT03006393|10075078|FG001|NOT COMPLETED|Overall Study||3
9012366|NCT03006458|10075084|FG000|STARTED|First Intervention||14
9012367|NCT03006458|10075085|FG001|STARTED|First Intervention||10
9012368|NCT03006458|10075084|FG000|COMPLETED|First Intervention||14
9012369|NCT03006458|10075085|FG001|COMPLETED|First Intervention||7
9012370|NCT03006458|10075084|FG000|NOT COMPLETED|First Intervention||0
9012371|NCT03006458|10075085|FG001|NOT COMPLETED|First Intervention||3
9012372|NCT03006458|10075084|FG000|STARTED|Second Intervention||14
9012373|NCT03006458|10075085|FG001|STARTED|Second Intervention||10
9012374|NCT03006458|10075084|FG000|COMPLETED|Second Intervention||14
8636635|NCT03472521|9677309|FG001|NOT COMPLETED|Overall Study||3
8636636|NCT03360396|9677317|FG000|STARTED|Overall Study||80
8636637|NCT03360396|9677318|FG001|STARTED|Overall Study||40
8636638|NCT03360396|9677317|FG000|COMPLETED|Overall Study||0
8636639|NCT03360396|9677318|FG001|COMPLETED|Overall Study||0
9012375|NCT03006458|10075085|FG001|COMPLETED|Second Intervention||10
9012376|NCT03006458|10075084|FG000|NOT COMPLETED|Second Intervention||0
9012377|NCT03006458|10075085|FG001|NOT COMPLETED|Second Intervention||0
9012378|NCT03006471|10075093|FG000|STARTED|Overall Study||15
9012379|NCT03006471|10075094|FG001|STARTED|Overall Study||15
8573222|NCT00119158|9605458|FG000|COMPLETED|Placebo Treatment||45
8573223|NCT00119158|9605459|FG001|COMPLETED|Placebo Treatment||45
8573224|NCT00119158|9605458|FG000|NOT COMPLETED|Placebo Treatment||0
8573225|NCT00119158|9605459|FG001|NOT COMPLETED|Placebo Treatment||0
8573226|NCT00119262|9605467|FG000|STARTED|Overall Study||104
8573227|NCT00119262|9605468|FG001|STARTED|Overall Study||122
8573228|NCT00119262|9605467|FG000|Eligible|Overall Study||103
8573229|NCT00119262|9605468|FG001|Eligible|Overall Study||120
8573230|NCT00119262|9605467|FG000|Treated|Overall Study||103
8573231|NCT00119262|9605468|FG001|Treated|Overall Study||120
8573232|NCT00119262|9605467|FG000|Eligible and Treated|Overall Study||102
8573233|NCT00119262|9605468|FG001|Eligible and Treated|Overall Study||119
8573234|NCT00119262|9605467|FG000|COMPLETED|Overall Study||58
8573235|NCT00119262|9605468|FG001|COMPLETED|Overall Study||64
8573236|NCT00119262|9605467|FG000|NOT COMPLETED|Overall Study||46
8573237|NCT00119262|9605468|FG001|NOT COMPLETED|Overall Study||58
8573238|NCT00119379|9605476|FG000|STARTED|Overall Study||26
8573239|NCT00119379|9605477|FG001|STARTED|Overall Study||24
8573240|NCT00119379|9605476|FG000|COMPLETED|Overall Study||22
8573241|NCT00119379|9605477|FG001|COMPLETED|Overall Study||23
8573242|NCT00119379|9605476|FG000|NOT COMPLETED|Overall Study||4
8573243|NCT00119379|9605477|FG001|NOT COMPLETED|Overall Study||1
8573244|NCT00119392|9605483|FG000|STARTED|Overall Study||45
8573245|NCT00119392|9605483|FG000|COMPLETED|Overall Study||40
8573246|NCT00119392|9605483|FG000|NOT COMPLETED|Overall Study||5
8573247|NCT00119405|9605487|FG000|STARTED|Overall Study||18
8573248|NCT00119405|9605487|FG000|COMPLETED|Overall Study||17
8573249|NCT00119405|9605487|FG000|NOT COMPLETED|Overall Study||1
8573250|NCT00119678|9605493|FG000|STARTED|Double-blind Treatment Period||122
8636640|NCT03360396|9677317|FG000|NOT COMPLETED|Overall Study||80
8636641|NCT03360396|9677318|FG001|NOT COMPLETED|Overall Study||40
9012380|NCT03006471|10075093|FG000|COMPLETED|Overall Study|Two patients did not complete the study due to early withdrawal|13
9012381|NCT03006471|10075094|FG001|COMPLETED|Overall Study|Two patients did not complete the study due to early withdrawal|13
9012382|NCT03006471|10075093|FG000|NOT COMPLETED|Overall Study||2
9012383|NCT03006471|10075094|FG001|NOT COMPLETED|Overall Study||2
9012384|NCT03006562|10075102|FG000|STARTED|Overall Study||251
9012385|NCT03006562|10075103|FG001|STARTED|Overall Study||250
8573251|NCT00119678|9605494|FG001|STARTED|Double-blind Treatment Period||61
8573252|NCT00119678|9605493|FG000|RANDOMIZED AND TREATED|Double-blind Treatment Period||121
8636642|NCT03303950|9677324|FG000|STARTED|Overall Study||6
8636643|NCT03303950|9677324|FG000|COMPLETED|Overall Study||6
8905660|NCT02104739|9963992|FG003|COMPLETED|Washout (Min of 10 and Max of 107 Days)||7
8905661|NCT02104739|9963993|FG004|COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
8905662|NCT02104739|9963994|FG005|COMPLETED|Washout (Min of 10 and Max of 107 Days)||2
8905663|NCT02104739|9963995|FG006|COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
8905664|NCT02104739|9963989|FG000|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
8905665|NCT02104739|9963990|FG001|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
8905666|NCT02104739|9963991|FG002|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
8905667|NCT02104739|9963992|FG003|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
8905668|NCT02104739|9963993|FG004|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
8905669|NCT02104739|9963994|FG005|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
8905670|NCT02104739|9963995|FG006|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
8905671|NCT02104739|9963989|FG000|STARTED|Second Intervention (1 Day)||1
8905672|NCT02104739|9963990|FG001|STARTED|Second Intervention (1 Day)||4
8905673|NCT02104739|9963991|FG002|STARTED|Second Intervention (1 Day)||2
8905674|NCT02104739|9963992|FG003|STARTED|Second Intervention (1 Day)||7
8905675|NCT02104739|9963993|FG004|STARTED|Second Intervention (1 Day)||0
8905676|NCT02104739|9963994|FG005|STARTED|Second Intervention (1 Day)||2
8905677|NCT02104739|9963995|FG006|STARTED|Second Intervention (1 Day)||0
8905678|NCT02104739|9963989|FG000|COMPLETED|Second Intervention (1 Day)||1
8905679|NCT02104739|9963990|FG001|COMPLETED|Second Intervention (1 Day)||4
8905680|NCT02104739|9963991|FG002|COMPLETED|Second Intervention (1 Day)||2
8905681|NCT02104739|9963992|FG003|COMPLETED|Second Intervention (1 Day)||7
8905682|NCT02104739|9963993|FG004|COMPLETED|Second Intervention (1 Day)||0
9012386|NCT03006562|10075102|FG000|Voluntary Ultrasound at 30 Days|Overall Study||141
9012387|NCT03006562|10075103|FG001|Voluntary Ultrasound at 30 Days|Overall Study||137
9012388|NCT03006562|10075102|FG000|COMPLETED|Overall Study||251
9012389|NCT03006562|10075103|FG001|COMPLETED|Overall Study||249
9012390|NCT03006562|10075102|FG000|NOT COMPLETED|Overall Study||0
9012391|NCT03006562|10075103|FG001|NOT COMPLETED|Overall Study||1
9012392|NCT03006848|10075109|FG000|STARTED|Overall Study||18
9012393|NCT03006848|10075109|FG000|COMPLETED|Overall Study||0
9012394|NCT03006848|10075109|FG000|NOT COMPLETED|Overall Study||18
9012395|NCT03006887|10075120|FG000|STARTED|Overall Study||6
9012396|NCT03006887|10075120|FG000|COMPLETED|Overall Study||5
9012397|NCT03006887|10075120|FG000|NOT COMPLETED|Overall Study||1
9012398|NCT03007225|10075126|FG000|STARTED|Overall Study|Followed up for at least 6 months after DEB TACE|25
9012399|NCT03007225|10075127|FG001|STARTED|Overall Study|followed up for at least 6 months after TACE|25
9012400|NCT03007225|10075126|FG000|COMPLETED|Overall Study||25
9012401|NCT03007225|10075127|FG001|COMPLETED|Overall Study||25
9012402|NCT03007225|10075126|FG000|NOT COMPLETED|Overall Study||0
9012403|NCT03007225|10075127|FG001|NOT COMPLETED|Overall Study||0
9012404|NCT03007394|10075135|FG000|STARTED|Overall Study||118
9012405|NCT03007394|10075136|FG001|STARTED|Overall Study||154
9012406|NCT03007394|10075135|FG000|COMPLETED|Overall Study||91
9012407|NCT03007394|10075136|FG001|COMPLETED|Overall Study||91
9012408|NCT03007394|10075135|FG000|NOT COMPLETED|Overall Study||27
9012409|NCT03007394|10075136|FG001|NOT COMPLETED|Overall Study||63
9012410|NCT03007472|10075142|FG000|STARTED|Overall Study||96
9012411|NCT03007472|10075142|FG000|COMPLETED|Overall Study||91
9012412|NCT03007472|10075142|FG000|NOT COMPLETED|Overall Study||5
9012413|NCT03007953|10075148|FG000|STARTED|Overall Study||73
9012414|NCT03007953|10075149|FG001|STARTED|Overall Study||78
9012415|NCT03007953|10075148|FG000|COMPLETED|Overall Study||57
9012416|NCT03007953|10075149|FG001|COMPLETED|Overall Study||65
9012417|NCT03007953|10075148|FG000|NOT COMPLETED|Overall Study||16
9012418|NCT03007953|10075149|FG001|NOT COMPLETED|Overall Study||13
9012419|NCT03007966|10075157|FG000|STARTED|Overall Study||30
9012420|NCT03007966|10075158|FG001|STARTED|Overall Study||30
9012421|NCT03007966|10075157|FG000|COMPLETED|Overall Study||29
9012422|NCT03007966|10075158|FG001|COMPLETED|Overall Study||30
9012423|NCT03007966|10075157|FG000|NOT COMPLETED|Overall Study||1
9012424|NCT03007966|10075158|FG001|NOT COMPLETED|Overall Study||0
9012425|NCT03008070|10075168|FG000|STARTED|Overall Study||83
9012426|NCT03008070|10075169|FG001|STARTED|Overall Study||83
9012427|NCT03008070|10075170|FG002|STARTED|Overall Study||81
9012428|NCT03008070|10075168|FG000|COMPLETED|Overall Study||77
9012429|NCT03008070|10075169|FG001|COMPLETED|Overall Study||77
9012430|NCT03008070|10075170|FG002|COMPLETED|Overall Study||74
9012431|NCT03008070|10075168|FG000|NOT COMPLETED|Overall Study||6
9012432|NCT03008070|10075169|FG001|NOT COMPLETED|Overall Study||6
9012433|NCT03008070|10075170|FG002|NOT COMPLETED|Overall Study||7
9012434|NCT03008174|10075182|FG000|STARTED|Overall Study||10
9012435|NCT03008174|10075183|FG001|STARTED|Overall Study||10
9012436|NCT03008174|10075182|FG000|COMPLETED|Overall Study||7
9012437|NCT03008174|10075183|FG001|COMPLETED|Overall Study||6
9012438|NCT03008174|10075182|FG000|NOT COMPLETED|Overall Study||3
9012439|NCT03008174|10075183|FG001|NOT COMPLETED|Overall Study||4
9012440|NCT03008213|10075189|FG000|STARTED|Overall Study||1
9012441|NCT03008213|10075189|FG000|COMPLETED|Overall Study||1
9012442|NCT03008213|10075189|FG000|NOT COMPLETED|Overall Study||0
9012443|NCT03008460|10075195|FG000|STARTED|Overall Study||126
9012444|NCT03008460|10075196|FG001|STARTED|Overall Study||124
9012445|NCT03008460|10075195|FG000|COMPLETED|Overall Study||119
9012446|NCT03008460|10075196|FG001|COMPLETED|Overall Study||110
9012447|NCT03008460|10075195|FG000|NOT COMPLETED|Overall Study||7
9012448|NCT03008460|10075196|FG001|NOT COMPLETED|Overall Study||14
9012449|NCT03008590|10075204|FG000|STARTED|Overall Study||14
8905683|NCT02104739|9963994|FG005|COMPLETED|Second Intervention (1 Day)||2
8905684|NCT02104739|9963995|FG006|COMPLETED|Second Intervention (1 Day)||0
8905685|NCT02104739|9963989|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
8905686|NCT02104739|9963990|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
8905687|NCT02104739|9963991|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
8905688|NCT02104739|9963992|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
9012450|NCT03008590|10075205|FG001|STARTED|Overall Study||15
9012451|NCT03008590|10075204|FG000|COMPLETED|Overall Study||11
9012452|NCT03008590|10075205|FG001|COMPLETED|Overall Study||12
9012453|NCT03008590|10075204|FG000|NOT COMPLETED|Overall Study||3
9012454|NCT03008590|10075205|FG001|NOT COMPLETED|Overall Study||3
9012455|NCT03008707|10075213|FG000|STARTED|Overall Study||28
9012456|NCT03008707|10075214|FG001|STARTED|Overall Study||38
9012457|NCT03008707|10075213|FG000|COMPLETED|Overall Study||28
9012458|NCT03008707|10075214|FG001|COMPLETED|Overall Study||38
9012459|NCT03008707|10075213|FG000|NOT COMPLETED|Overall Study||0
9012460|NCT03008707|10075214|FG001|NOT COMPLETED|Overall Study||0
9012461|NCT03008837|10075222|FG000|STARTED|Overall Study||12
9012462|NCT03008837|10075223|FG001|STARTED|Overall Study||9
9012463|NCT03008837|10075222|FG000|COMPLETED|Overall Study||9
9012464|NCT03008837|10075223|FG001|COMPLETED|Overall Study||5
9012465|NCT03008837|10075222|FG000|NOT COMPLETED|Overall Study||3
9012466|NCT03008837|10075223|FG001|NOT COMPLETED|Overall Study||4
9012467|NCT03008889|10075234|FG000|STARTED|Overall Study||1
9012468|NCT03008889|10075235|FG001|STARTED|Overall Study||1
9012469|NCT03008889|10075234|FG000|COMPLETED|Overall Study||1
9012470|NCT03008889|10075235|FG001|COMPLETED|Overall Study||1
9012471|NCT03008889|10075234|FG000|NOT COMPLETED|Overall Study||0
9012472|NCT03008889|10075235|FG001|NOT COMPLETED|Overall Study||0
9012473|NCT03008915|10075242|FG000|STARTED|Treatment 1||8
9012474|NCT03008915|10075243|FG001|STARTED|Treatment 1||7
9012475|NCT03008915|10075242|FG000|COMPLETED|Treatment 1||8
9012476|NCT03008915|10075243|FG001|COMPLETED|Treatment 1||6
9012477|NCT03008915|10075242|FG000|NOT COMPLETED|Treatment 1||0
9012478|NCT03008915|10075243|FG001|NOT COMPLETED|Treatment 1||1
9012479|NCT03008915|10075242|FG000|STARTED|Treatment 2||8
9012480|NCT03008915|10075243|FG001|STARTED|Treatment 2||6
9012481|NCT03008915|10075242|FG000|COMPLETED|Treatment 2||8
9012482|NCT03008915|10075243|FG001|COMPLETED|Treatment 2||6
9012483|NCT03008915|10075242|FG000|NOT COMPLETED|Treatment 2||0
9012484|NCT03008915|10075243|FG001|NOT COMPLETED|Treatment 2||0
9012485|NCT03009162|10075252|FG000|STARTED|Overall Study||8
9012486|NCT03009162|10075253|FG001|STARTED|Overall Study||8
9012487|NCT03009162|10075252|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
9012488|NCT03009162|10075253|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8
9012489|NCT03009162|10075252|FG000|COMPLETED|Overall Study||8
9012490|NCT03009162|10075253|FG001|COMPLETED|Overall Study||8
9012491|NCT03009162|10075252|FG000|NOT COMPLETED|Overall Study||0
9012492|NCT03009162|10075253|FG001|NOT COMPLETED|Overall Study||0
9039623|NCT03340961|10100632|FG002|COMPLETED|Overall Study||40
9039624|NCT03340961|10100633|FG003|COMPLETED|Overall Study||35
9039625|NCT03340961|10100630|FG000|NOT COMPLETED|Overall Study||6
9039626|NCT03340961|10100631|FG001|NOT COMPLETED|Overall Study||12
9039627|NCT03340961|10100632|FG002|NOT COMPLETED|Overall Study||9
9039628|NCT03340961|10100633|FG003|NOT COMPLETED|Overall Study||18
9039629|NCT03341273|10100645|FG000|STARTED|Overall Study||249
9039630|NCT03341273|10100646|FG001|STARTED|Overall Study||250
9039631|NCT03341273|10100645|FG000|COMPLETED|Overall Study||229
9039632|NCT03341273|10100646|FG001|COMPLETED|Overall Study||238
9039633|NCT03341273|10100645|FG000|NOT COMPLETED|Overall Study||20
9039634|NCT03341273|10100646|FG001|NOT COMPLETED|Overall Study||12
9039635|NCT03341299|10100652|FG000|STARTED|Period 1||9
9039636|NCT03341299|10100653|FG001|STARTED|Period 1||9
9039637|NCT03341299|10100654|FG002|STARTED|Period 1||9
9039638|NCT03341299|10100655|FG003|STARTED|Period 1||9
9039639|NCT03341299|10100652|FG000|COMPLETED|Period 1||9
9039640|NCT03341299|10100653|FG001|COMPLETED|Period 1||9
9039641|NCT03341299|10100654|FG002|COMPLETED|Period 1||9
9039642|NCT03341299|10100655|FG003|COMPLETED|Period 1||9
9039643|NCT03341299|10100652|FG000|NOT COMPLETED|Period 1||0
9039644|NCT03341299|10100653|FG001|NOT COMPLETED|Period 1||0
9039645|NCT03341299|10100654|FG002|NOT COMPLETED|Period 1||0
9039646|NCT03341299|10100655|FG003|NOT COMPLETED|Period 1||0
9039647|NCT03341299|10100652|FG000|STARTED|Washout (A Minimum of 21 Hours)||9
9039648|NCT03341299|10100653|FG001|STARTED|Washout (A Minimum of 21 Hours)||9
9039649|NCT03341299|10100654|FG002|STARTED|Washout (A Minimum of 21 Hours)||9
9039650|NCT03341299|10100655|FG003|STARTED|Washout (A Minimum of 21 Hours)||9
9039651|NCT03341299|10100652|FG000|COMPLETED|Washout (A Minimum of 21 Hours)||9
8905689|NCT02104739|9963993|FG004|NOT COMPLETED|Second Intervention (1 Day)||0
8905690|NCT02104739|9963994|FG005|NOT COMPLETED|Second Intervention (1 Day)||0
8905691|NCT02104739|9963995|FG006|NOT COMPLETED|Second Intervention (1 Day)||0
8905692|NCT02104739|9963989|FG000|STARTED|Washout (Min of 10 and Max of 107 Days)||1
9039652|NCT03341299|10100653|FG001|COMPLETED|Washout (A Minimum of 21 Hours)||9
9039653|NCT03341299|10100654|FG002|COMPLETED|Washout (A Minimum of 21 Hours)||8
9039654|NCT03341299|10100655|FG003|COMPLETED|Washout (A Minimum of 21 Hours)||9
9039655|NCT03341299|10100652|FG000|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
9039656|NCT03341299|10100653|FG001|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
9039657|NCT03341299|10100654|FG002|NOT COMPLETED|Washout (A Minimum of 21 Hours)||1
9039658|NCT03341299|10100655|FG003|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
9039659|NCT03341299|10100652|FG000|STARTED|Period 2||9
8905693|NCT02104739|9963990|FG001|STARTED|Washout (Min of 10 and Max of 107 Days)||4
8905694|NCT02104739|9963991|FG002|STARTED|Washout (Min of 10 and Max of 107 Days)||2
8905695|NCT02104739|9963992|FG003|STARTED|Washout (Min of 10 and Max of 107 Days)||7
8905696|NCT02104739|9963993|FG004|STARTED|Washout (Min of 10 and Max of 107 Days)||0
8905697|NCT02104739|9963994|FG005|STARTED|Washout (Min of 10 and Max of 107 Days)||2
8905698|NCT02104739|9963995|FG006|STARTED|Washout (Min of 10 and Max of 107 Days)||0
8905699|NCT02104739|9963989|FG000|COMPLETED|Washout (Min of 10 and Max of 107 Days)||1
8905700|NCT02104739|9963990|FG001|COMPLETED|Washout (Min of 10 and Max of 107 Days)||4
8905701|NCT02104739|9963991|FG002|COMPLETED|Washout (Min of 10 and Max of 107 Days)||2
8905702|NCT02104739|9963992|FG003|COMPLETED|Washout (Min of 10 and Max of 107 Days)||7
8905703|NCT02104739|9963993|FG004|COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
8905704|NCT02104739|9963994|FG005|COMPLETED|Washout (Min of 10 and Max of 107 Days)||2
8905705|NCT02104739|9963995|FG006|COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
8905706|NCT02104739|9963989|FG000|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
8905707|NCT02104739|9963990|FG001|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
8905708|NCT02104739|9963991|FG002|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
8905709|NCT02104739|9963992|FG003|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
8905710|NCT02104739|9963993|FG004|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
8905711|NCT02104739|9963994|FG005|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
8905712|NCT02104739|9963995|FG006|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
8905713|NCT02104739|9963989|FG000|STARTED|Third Intervention (1 Day)||1
8905714|NCT02104739|9963990|FG001|STARTED|Third Intervention (1 Day)||4
8905715|NCT02104739|9963991|FG002|STARTED|Third Intervention (1 Day)||2
8905716|NCT02104739|9963992|FG003|STARTED|Third Intervention (1 Day)||7
8905717|NCT02104739|9963993|FG004|STARTED|Third Intervention (1 Day)||0
8905718|NCT02104739|9963994|FG005|STARTED|Third Intervention (1 Day)||2
8905719|NCT02104739|9963995|FG006|STARTED|Third Intervention (1 Day)||0
8905720|NCT02104739|9963989|FG000|COMPLETED|Third Intervention (1 Day)||1
8905721|NCT02104739|9963990|FG001|COMPLETED|Third Intervention (1 Day)||4
8905722|NCT02104739|9963991|FG002|COMPLETED|Third Intervention (1 Day)||2
8905723|NCT02104739|9963992|FG003|COMPLETED|Third Intervention (1 Day)||7
8905724|NCT02104739|9963993|FG004|COMPLETED|Third Intervention (1 Day)||0
8905725|NCT02104739|9963994|FG005|COMPLETED|Third Intervention (1 Day)||2
8905726|NCT02104739|9963995|FG006|COMPLETED|Third Intervention (1 Day)||0
8905727|NCT02104739|9963989|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
8905728|NCT02104739|9963990|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
8905729|NCT02104739|9963991|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
8905730|NCT02104739|9963992|FG003|NOT COMPLETED|Third Intervention (1 Day)||0
8905731|NCT02104739|9963993|FG004|NOT COMPLETED|Third Intervention (1 Day)||0
8905732|NCT02104739|9963994|FG005|NOT COMPLETED|Third Intervention (1 Day)||0
8905733|NCT02104739|9963995|FG006|NOT COMPLETED|Third Intervention (1 Day)||0
8905734|NCT02104739|9963989|FG000|STARTED|Washout (Min of 10 and Max of 323 Days)||0
8905735|NCT02104739|9963990|FG001|STARTED|Washout (Min of 10 and Max of 323 Days)||0
8905736|NCT02104739|9963991|FG002|STARTED|Washout (Min of 10 and Max of 323 Days)||0
8905737|NCT02104739|9963992|FG003|STARTED|Washout (Min of 10 and Max of 323 Days)||0
8905738|NCT02104739|9963993|FG004|STARTED|Washout (Min of 10 and Max of 323 Days)||0
8905739|NCT02104739|9963994|FG005|STARTED|Washout (Min of 10 and Max of 323 Days)||0
8905740|NCT02104739|9963995|FG006|STARTED|Washout (Min of 10 and Max of 323 Days)||8
8905741|NCT02104739|9963989|FG000|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
8905742|NCT02104739|9963990|FG001|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
8905743|NCT02104739|9963991|FG002|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
8905744|NCT02104739|9963992|FG003|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
8905745|NCT02104739|9963993|FG004|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
8905746|NCT02104739|9963994|FG005|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
8905747|NCT02104739|9963995|FG006|COMPLETED|Washout (Min of 10 and Max of 323 Days)||7
8905748|NCT02104739|9963989|FG000|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
8905749|NCT02104739|9963990|FG001|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
8905750|NCT02104739|9963991|FG002|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
8905751|NCT02104739|9963992|FG003|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
8905752|NCT02104739|9963993|FG004|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
8905753|NCT02104739|9963994|FG005|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
8905754|NCT02104739|9963995|FG006|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||1
8905755|NCT02104739|9963989|FG000|STARTED|Extension Phase (6 Weeks)||0
8905756|NCT02104739|9963990|FG001|STARTED|Extension Phase (6 Weeks)||0
8905757|NCT02104739|9963991|FG002|STARTED|Extension Phase (6 Weeks)||0
8905758|NCT02104739|9963992|FG003|STARTED|Extension Phase (6 Weeks)||0
8905759|NCT02104739|9963993|FG004|STARTED|Extension Phase (6 Weeks)||0
8905760|NCT02104739|9963994|FG005|STARTED|Extension Phase (6 Weeks)||0
8905761|NCT02104739|9963995|FG006|STARTED|Extension Phase (6 Weeks)||8
8905762|NCT02104739|9963989|FG000|COMPLETED|Extension Phase (6 Weeks)||0
8905763|NCT02104739|9963990|FG001|COMPLETED|Extension Phase (6 Weeks)||0
8905764|NCT02104739|9963991|FG002|COMPLETED|Extension Phase (6 Weeks)||0
8905765|NCT02104739|9963992|FG003|COMPLETED|Extension Phase (6 Weeks)||0
8905766|NCT02104739|9963993|FG004|COMPLETED|Extension Phase (6 Weeks)||0
8636644|NCT03303950|9677324|FG000|NOT COMPLETED|Overall Study||0
8691347|NCT00854113|9736581|FG010|NOT COMPLETED|Overall Study||0
8691348|NCT00854308|9736607|FG000|STARTED|Overall Study||69
8905767|NCT02104739|9963994|FG005|COMPLETED|Extension Phase (6 Weeks)||0
8905768|NCT02104739|9963995|FG006|COMPLETED|Extension Phase (6 Weeks)||7
8905769|NCT02104739|9963989|FG000|NOT COMPLETED|Extension Phase (6 Weeks)||0
8905770|NCT02104739|9963990|FG001|NOT COMPLETED|Extension Phase (6 Weeks)||0
8905771|NCT02104739|9963991|FG002|NOT COMPLETED|Extension Phase (6 Weeks)||0
8905772|NCT02104739|9963992|FG003|NOT COMPLETED|Extension Phase (6 Weeks)||0
8905773|NCT02104739|9963993|FG004|NOT COMPLETED|Extension Phase (6 Weeks)||0
8905774|NCT02104739|9963994|FG005|NOT COMPLETED|Extension Phase (6 Weeks)||0
8905775|NCT02104739|9963995|FG006|NOT COMPLETED|Extension Phase (6 Weeks)||1
8905776|NCT02104752|9964007|FG000|STARTED|Overall Study||18
8905777|NCT02104752|9964008|FG001|STARTED|Overall Study||21
8905778|NCT02104752|9964007|FG000|COMPLETED|Overall Study||17
8905779|NCT02104752|9964008|FG001|COMPLETED|Overall Study||19
8905780|NCT02104752|9964007|FG000|NOT COMPLETED|Overall Study||1
8905781|NCT02104752|9964008|FG001|NOT COMPLETED|Overall Study||2
8905782|NCT02104765|9964021|FG000|STARTED|Overall Study||8
8905783|NCT02104765|9964022|FG001|STARTED|Overall Study||6
8905784|NCT02104765|9964023|FG002|STARTED|Overall Study||6
8905785|NCT02104765|9964024|FG003|STARTED|Overall Study||7
8905786|NCT02104765|9964025|FG004|STARTED|Overall Study||8
8905787|NCT02104765|9964026|FG005|STARTED|Overall Study||2
8905788|NCT02104765|9964027|FG006|STARTED|Overall Study||8
8905789|NCT02104765|9964021|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
9012493|NCT03009396|10075259|FG000|STARTED|Overall Study||16
9012494|NCT03009396|10075260|FG001|STARTED|Overall Study||38
9012495|NCT03009396|10075259|FG000|COMPLETED|Overall Study||9
9012496|NCT03009396|10075260|FG001|COMPLETED|Overall Study||21
9012497|NCT03009396|10075259|FG000|NOT COMPLETED|Overall Study||7
9012498|NCT03009396|10075260|FG001|NOT COMPLETED|Overall Study||17
9012499|NCT03010137|10075269|FG000|STARTED|Overall Study||15
9012500|NCT03010137|10075270|FG001|STARTED|Overall Study||15
9012501|NCT03010137|10075269|FG000|COMPLETED|Overall Study||15
9012502|NCT03010137|10075270|FG001|COMPLETED|Overall Study||15
8636645|NCT02673203|9677331|FG000|STARTED|Overall Study||16
8636646|NCT02673203|9677332|FG001|STARTED|Overall Study||15
9012503|NCT03010137|10075269|FG000|NOT COMPLETED|Overall Study||0
9012504|NCT03010137|10075270|FG001|NOT COMPLETED|Overall Study||0
9012505|NCT03010254|10075278|FG000|STARTED|Overall Study||159
9012506|NCT03010254|10075279|FG001|STARTED|Overall Study||123
9012507|NCT03010254|10075278|FG000|Attempted Implantation|Overall Study||156
9012508|NCT03010254|10075279|FG001|Attempted Implantation|Overall Study||120
9012509|NCT03010254|10075278|FG000|Successful Implantation|Overall Study||156
9012510|NCT03010254|10075279|FG001|Successful Implantation|Overall Study||120
9012511|NCT03010254|10075278|FG000|COMPLETED|Overall Study||152
9012512|NCT03010254|10075279|FG001|COMPLETED|Overall Study||118
9012513|NCT03010254|10075278|FG000|NOT COMPLETED|Overall Study||7
9012514|NCT03010254|10075279|FG001|NOT COMPLETED|Overall Study||5
9012515|NCT03010462|10075294|FG000|STARTED|Overall Study||31
9012516|NCT03010462|10075295|FG001|STARTED|Overall Study||29
9012517|NCT03010462|10075294|FG000|COMPLETED|Overall Study|1 subject withdrew consent before baseline visit. 2 subjects completed treatment but were lost during follow-up|28
9012518|NCT03010462|10075295|FG001|COMPLETED|Overall Study|1 subject withdrew consent prior to baseline visit|28
9012519|NCT03010462|10075294|FG000|NOT COMPLETED|Overall Study||3
9012520|NCT03010462|10075295|FG001|NOT COMPLETED|Overall Study||1
9012521|NCT03010488|10075303|FG000|STARTED|Overall Study||22
9012522|NCT03010488|10075304|FG001|STARTED|Overall Study||22
9012523|NCT03010488|10075303|FG000|COMPLETED|Overall Study||17
9012524|NCT03010488|10075304|FG001|COMPLETED|Overall Study||15
9012525|NCT03010488|10075303|FG000|NOT COMPLETED|Overall Study||5
9012526|NCT03010488|10075304|FG001|NOT COMPLETED|Overall Study||7
9012527|NCT03010501|10075310|FG000|STARTED|Study Week 1||9
9012528|NCT03010501|10075311|FG001|STARTED|Study Week 1||15
9012529|NCT03010501|10075312|FG002|STARTED|Study Week 1||7
9012530|NCT03010501|10075313|FG003|STARTED|Study Week 1||7
9012531|NCT03010501|10075314|FG004|STARTED|Study Week 1||7
9012532|NCT03010501|10075315|FG005|STARTED|Study Week 1||11
9012533|NCT03010501|10075310|FG000|COMPLETED|Study Week 1||7
9012534|NCT03010501|10075311|FG001|COMPLETED|Study Week 1||14
9012535|NCT03010501|10075312|FG002|COMPLETED|Study Week 1||7
9012536|NCT03010501|10075313|FG003|COMPLETED|Study Week 1||5
9012537|NCT03010501|10075314|FG004|COMPLETED|Study Week 1||7
9012538|NCT03010501|10075315|FG005|COMPLETED|Study Week 1||11
9012539|NCT03010501|10075310|FG000|NOT COMPLETED|Study Week 1||2
9012540|NCT03010501|10075311|FG001|NOT COMPLETED|Study Week 1||1
9012541|NCT03010501|10075312|FG002|NOT COMPLETED|Study Week 1||0
9012542|NCT03010501|10075313|FG003|NOT COMPLETED|Study Week 1||2
9012543|NCT03010501|10075314|FG004|NOT COMPLETED|Study Week 1||0
9012544|NCT03010501|10075315|FG005|NOT COMPLETED|Study Week 1||0
9012545|NCT03010501|10075310|FG000|STARTED|Study Week 2||7
9012546|NCT03010501|10075311|FG001|STARTED|Study Week 2||14
9012547|NCT03010501|10075312|FG002|STARTED|Study Week 2||7
9012548|NCT03010501|10075313|FG003|STARTED|Study Week 2||5
9012549|NCT03010501|10075314|FG004|STARTED|Study Week 2||7
9012550|NCT03010501|10075315|FG005|STARTED|Study Week 2||11
9012551|NCT03010501|10075310|FG000|COMPLETED|Study Week 2||7
8636647|NCT02673203|9677331|FG000|COMPLETED|Overall Study||16
8636648|NCT02673203|9677332|FG001|COMPLETED|Overall Study||15
8905790|NCT02104765|9964022|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
8905791|NCT02104765|9964023|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
8905792|NCT02104765|9964024|FG003|Received at Least 1 Dose of Study Drug|Overall Study||7
8905793|NCT02104765|9964025|FG004|Received at Least 1 Dose of Study Drug|Overall Study||8
8905794|NCT02104765|9964026|FG005|Received at Least 1 Dose of Study Drug|Overall Study||2
8905795|NCT02104765|9964027|FG006|Received at Least 1 Dose of Study Drug|Overall Study||8
8905796|NCT02104765|9964021|FG000|COMPLETED|Overall Study||8
8905797|NCT02104765|9964022|FG001|COMPLETED|Overall Study||6
8905798|NCT02104765|9964023|FG002|COMPLETED|Overall Study||5
8905799|NCT02104765|9964024|FG003|COMPLETED|Overall Study||6
8905800|NCT02104765|9964025|FG004|COMPLETED|Overall Study||7
8905801|NCT02104765|9964026|FG005|COMPLETED|Overall Study||2
8905802|NCT02104765|9964027|FG006|COMPLETED|Overall Study||7
8905803|NCT02104765|9964021|FG000|NOT COMPLETED|Overall Study||0
8905804|NCT02104765|9964022|FG001|NOT COMPLETED|Overall Study||0
8905805|NCT02104765|9964023|FG002|NOT COMPLETED|Overall Study||1
8905806|NCT02104765|9964024|FG003|NOT COMPLETED|Overall Study||1
8905807|NCT02104765|9964025|FG004|NOT COMPLETED|Overall Study||1
8905808|NCT02104765|9964026|FG005|NOT COMPLETED|Overall Study||0
8905809|NCT02104765|9964027|FG006|NOT COMPLETED|Overall Study||1
8905810|NCT02104804|9964051|FG000|STARTED|Overall Study|Number of patients who were randomized|234
8905811|NCT02104804|9964052|FG001|STARTED|Overall Study|Number of patients who were randomized|232
8905812|NCT02104804|9964051|FG000|COMPLETED|Overall Study|Number of patients who completed 24 weeks of treatment|218
8905813|NCT02104804|9964052|FG001|COMPLETED|Overall Study|Of the 19 who did not complete, 1 did not take study medication after randomization.|213
8905814|NCT02104804|9964051|FG000|NOT COMPLETED|Overall Study||16
8905815|NCT02104804|9964052|FG001|NOT COMPLETED|Overall Study||19
8905816|NCT02104817|9964060|FG000|STARTED|Overall Study||6539
8905817|NCT02104817|9964061|FG001|STARTED|Overall Study||6539
8905818|NCT02104817|9964060|FG000|COMPLETED|Overall Study||80
8905819|NCT02104817|9964061|FG001|COMPLETED|Overall Study||92
8905820|NCT02104817|9964060|FG000|NOT COMPLETED|Overall Study||6459
8905821|NCT02104817|9964061|FG001|NOT COMPLETED|Overall Study||6447
8905822|NCT02104830|9964070|FG000|STARTED|Overall Study||42
8905823|NCT02104830|9964071|FG001|STARTED|Overall Study||43
8905824|NCT02104830|9964072|FG002|STARTED|Overall Study||43
8905825|NCT02104830|9964070|FG000|COMPLETED|Overall Study||38
8905826|NCT02104830|9964071|FG001|COMPLETED|Overall Study||36
8905827|NCT02104830|9964072|FG002|COMPLETED|Overall Study||36
8905828|NCT02104830|9964070|FG000|NOT COMPLETED|Overall Study||4
8905829|NCT02104830|9964071|FG001|NOT COMPLETED|Overall Study||7
8905830|NCT02104830|9964072|FG002|NOT COMPLETED|Overall Study||7
8905831|NCT02104895|9964082|FG000|STARTED|Overall Study||260
8905832|NCT02104895|9964083|FG001|STARTED|Overall Study||260
8905833|NCT02104895|9964082|FG000|COMPLETED|Overall Study||260
8905834|NCT02104895|9964083|FG001|COMPLETED|Overall Study||246
8905835|NCT02104895|9964082|FG000|NOT COMPLETED|Overall Study||0
8905836|NCT02104895|9964083|FG001|NOT COMPLETED|Overall Study||14
8905837|NCT02104947|9964091|FG000|STARTED|Overall Study||301
8905838|NCT02104947|9964092|FG001|STARTED|Overall Study||202
8905839|NCT02104947|9964091|FG000|COMPLETED|Overall Study||222
8905840|NCT02104947|9964092|FG001|COMPLETED|Overall Study||146
8905841|NCT02104947|9964091|FG000|NOT COMPLETED|Overall Study||79
8905842|NCT02104947|9964092|FG001|NOT COMPLETED|Overall Study||56
8905843|NCT02105012|9964102|FG000|STARTED|Overall Study||147
8905844|NCT02105012|9964102|FG000|BD MDI 320 µg|Overall Study||124
8905845|NCT02105012|9964102|FG000|BD MDI 160 µg|Overall Study||132
8905846|NCT02105012|9964102|FG000|BD MDI 80 µg|Overall Study||64
8905847|NCT02105012|9964102|FG000|BD MDI 40 µg|Overall Study||63
8905848|NCT02105012|9964102|FG000|Placebo MDI|Overall Study||127
8905849|NCT02105012|9964102|FG000|COMPLETED|Overall Study||114
8905850|NCT02105012|9964102|FG000|NOT COMPLETED|Overall Study||33
8905851|NCT02105246|9964116|FG000|STARTED|Overall Study||557
8905852|NCT02105246|9964117|FG001|STARTED|Overall Study||597
8905853|NCT02105246|9964116|FG000|COMPLETED|Overall Study||557
8905854|NCT02105246|9964117|FG001|COMPLETED|Overall Study||597
9012552|NCT03010501|10075311|FG001|COMPLETED|Study Week 2||14
9012553|NCT03010501|10075312|FG002|COMPLETED|Study Week 2||7
9012554|NCT03010501|10075313|FG003|COMPLETED|Study Week 2||5
9012555|NCT03010501|10075314|FG004|COMPLETED|Study Week 2||7
9012556|NCT03010501|10075315|FG005|COMPLETED|Study Week 2||11
9012557|NCT03010501|10075310|FG000|NOT COMPLETED|Study Week 2||0
9012558|NCT03010501|10075311|FG001|NOT COMPLETED|Study Week 2||0
9012559|NCT03010501|10075312|FG002|NOT COMPLETED|Study Week 2||0
9012560|NCT03010501|10075313|FG003|NOT COMPLETED|Study Week 2||0
9012561|NCT03010501|10075314|FG004|NOT COMPLETED|Study Week 2||0
9012562|NCT03010501|10075315|FG005|NOT COMPLETED|Study Week 2||0
9012563|NCT03010501|10075310|FG000|STARTED|Study Week 3||7
9012564|NCT03010501|10075311|FG001|STARTED|Study Week 3||14
9012565|NCT03010501|10075312|FG002|STARTED|Study Week 3||7
9012566|NCT03010501|10075313|FG003|STARTED|Study Week 3||5
9012567|NCT03010501|10075314|FG004|STARTED|Study Week 3||7
9012568|NCT03010501|10075315|FG005|STARTED|Study Week 3||11
9012569|NCT03010501|10075310|FG000|COMPLETED|Study Week 3||7
9012570|NCT03010501|10075311|FG001|COMPLETED|Study Week 3||14
9012571|NCT03010501|10075312|FG002|COMPLETED|Study Week 3||7
9012572|NCT03010501|10075313|FG003|COMPLETED|Study Week 3||4
9012573|NCT03010501|10075314|FG004|COMPLETED|Study Week 3||7
9012574|NCT03010501|10075315|FG005|COMPLETED|Study Week 3||11
8905855|NCT02105246|9964116|FG000|NOT COMPLETED|Overall Study||0
8905856|NCT02105246|9964117|FG001|NOT COMPLETED|Overall Study||0
8905857|NCT02105272|9964129|FG000|STARTED|Overall Study||118
8905858|NCT02105272|9964130|FG001|STARTED|Overall Study||119
8905859|NCT02105272|9964129|FG000|COMPLETED|Overall Study||113
8905860|NCT02105272|9964130|FG001|COMPLETED|Overall Study||116
8905861|NCT02105272|9964129|FG000|NOT COMPLETED|Overall Study||5
8905862|NCT02105272|9964130|FG001|NOT COMPLETED|Overall Study||3
8905863|NCT02105285|9964139|FG000|STARTED|Overall Study||78
8905864|NCT02105285|9964140|FG001|STARTED|Overall Study||78
8905865|NCT02105285|9964141|FG002|STARTED|Overall Study||37
8636649|NCT02673203|9677331|FG000|NOT COMPLETED|Overall Study||0
8636650|NCT02673203|9677332|FG001|NOT COMPLETED|Overall Study||0
8636651|NCT02664441|9677340|FG000|STARTED|Randomization||23
8905866|NCT02105285|9964139|FG000|COMPLETED|Overall Study||76
8905867|NCT02105285|9964140|FG001|COMPLETED|Overall Study||76
8905868|NCT02105285|9964141|FG002|COMPLETED|Overall Study||37
8905869|NCT02105285|9964139|FG000|NOT COMPLETED|Overall Study||2
8905870|NCT02105285|9964140|FG001|NOT COMPLETED|Overall Study||2
8905871|NCT02105285|9964141|FG002|NOT COMPLETED|Overall Study||0
8905872|NCT02105324|9964148|FG000|STARTED|Period 1||9
8905873|NCT02105324|9964149|FG001|STARTED|Period 1||10
8905874|NCT02105324|9964148|FG000|COMPLETED|Period 1||9
8905875|NCT02105324|9964149|FG001|COMPLETED|Period 1||10
8905876|NCT02105324|9964148|FG000|NOT COMPLETED|Period 1||0
9012575|NCT03010501|10075310|FG000|NOT COMPLETED|Study Week 3||0
9012576|NCT03010501|10075311|FG001|NOT COMPLETED|Study Week 3||0
9012577|NCT03010501|10075312|FG002|NOT COMPLETED|Study Week 3||0
9012578|NCT03010501|10075313|FG003|NOT COMPLETED|Study Week 3||1
9012579|NCT03010501|10075314|FG004|NOT COMPLETED|Study Week 3||0
9012580|NCT03010501|10075315|FG005|NOT COMPLETED|Study Week 3||0
9012581|NCT03010527|10075326|FG000|STARTED|Overall Study||15
9012582|NCT03010527|10075327|FG001|STARTED|Overall Study||111
9012583|NCT03010527|10075328|FG002|STARTED|Overall Study||91
9012584|NCT03010527|10075326|FG000|COMPLETED|Overall Study||15
9012585|NCT03010527|10075327|FG001|COMPLETED|Overall Study||92
9012586|NCT03010527|10075328|FG002|COMPLETED|Overall Study||75
9012587|NCT03010527|10075326|FG000|NOT COMPLETED|Overall Study||0
9012588|NCT03010527|10075327|FG001|NOT COMPLETED|Overall Study||19
9012589|NCT03010527|10075328|FG002|NOT COMPLETED|Overall Study||16
9012590|NCT03010631|10075349|FG000|STARTED|Cohort 1||18
9012591|NCT03010631|10075350|FG001|STARTED|Cohort 1||17
9012592|NCT03010631|10075351|FG002|STARTED|Cohort 1||0
9012593|NCT03010631|10075352|FG003|STARTED|Cohort 1||0
9012594|NCT03010631|10075349|FG000|COMPLETED|Cohort 1||14
9012595|NCT03010631|10075350|FG001|COMPLETED|Cohort 1||17
9012596|NCT03010631|10075351|FG002|COMPLETED|Cohort 1||0
9012597|NCT03010631|10075352|FG003|COMPLETED|Cohort 1||0
9012598|NCT03010631|10075349|FG000|NOT COMPLETED|Cohort 1||4
9012599|NCT03010631|10075350|FG001|NOT COMPLETED|Cohort 1||0
9012600|NCT03010631|10075351|FG002|NOT COMPLETED|Cohort 1||0
9012601|NCT03010631|10075352|FG003|NOT COMPLETED|Cohort 1||0
9012602|NCT03010631|10075349|FG000|STARTED|Cohort 2||0
9012603|NCT03010631|10075350|FG001|STARTED|Cohort 2||0
9012604|NCT03010631|10075351|FG002|STARTED|Cohort 2|New participants were enrolled for Cohort 2|7
9012605|NCT03010631|10075352|FG003|STARTED|Cohort 2||7
9012606|NCT03010631|10075349|FG000|COMPLETED|Cohort 2||0
9012607|NCT03010631|10075350|FG001|COMPLETED|Cohort 2||0
9012608|NCT03010631|10075351|FG002|COMPLETED|Cohort 2||7
9012609|NCT03010631|10075352|FG003|COMPLETED|Cohort 2||7
9012610|NCT03010631|10075349|FG000|NOT COMPLETED|Cohort 2||0
9012611|NCT03010631|10075350|FG001|NOT COMPLETED|Cohort 2||0
9012612|NCT03010631|10075351|FG002|NOT COMPLETED|Cohort 2||0
9012613|NCT03010631|10075352|FG003|NOT COMPLETED|Cohort 2||0
9012614|NCT03010683|10075368|FG000|STARTED|Overall Study||30
9012615|NCT03010683|10075369|FG001|STARTED|Overall Study||30
9012616|NCT03010683|10075368|FG000|COMPLETED|Overall Study||30
9012617|NCT03010683|10075369|FG001|COMPLETED|Overall Study||30
9012618|NCT03010683|10075368|FG000|NOT COMPLETED|Overall Study||0
9012619|NCT03010683|10075369|FG001|NOT COMPLETED|Overall Study||0
9012620|NCT03010800|10075377|FG000|STARTED|Initial Assignment||4
9012621|NCT03010800|10075378|FG001|STARTED|Initial Assignment||4
9012622|NCT03010800|10075377|FG000|COMPLETED|Initial Assignment||4
9012623|NCT03010800|10075378|FG001|COMPLETED|Initial Assignment||4
9012624|NCT03010800|10075377|FG000|NOT COMPLETED|Initial Assignment||0
9012625|NCT03010800|10075378|FG001|NOT COMPLETED|Initial Assignment||0
9012626|NCT03010800|10075377|FG000|STARTED|Cross Over||4
9012627|NCT03010800|10075378|FG001|STARTED|Cross Over||4
9012628|NCT03010800|10075377|FG000|COMPLETED|Cross Over||4
8636652|NCT02664441|9677341|FG001|STARTED|Randomization||19
8905877|NCT02105324|9964149|FG001|NOT COMPLETED|Period 1||0
8905878|NCT02105324|9964148|FG000|STARTED|Period 2||9
8905879|NCT02105324|9964149|FG001|STARTED|Period 2||10
8905880|NCT02105324|9964148|FG000|COMPLETED|Period 2||9
8905881|NCT02105324|9964149|FG001|COMPLETED|Period 2||10
8905882|NCT02105324|9964148|FG000|NOT COMPLETED|Period 2||0
8905883|NCT02105324|9964149|FG001|NOT COMPLETED|Period 2||0
8905884|NCT02105415|9964160|FG000|STARTED|Overall Study||76
8905885|NCT02105415|9964161|FG001|STARTED|Overall Study||84
8905886|NCT02105415|9964160|FG000|COMPLETED|Overall Study||73
8905887|NCT02105415|9964161|FG001|COMPLETED|Overall Study||79
8905888|NCT02105415|9964160|FG000|NOT COMPLETED|Overall Study||3
8905889|NCT02105415|9964161|FG001|NOT COMPLETED|Overall Study||5
8905890|NCT02105454|9964172|FG000|STARTED|Overall Study||79
9012629|NCT03010800|10075378|FG001|COMPLETED|Cross Over||4
9012630|NCT03010800|10075377|FG000|NOT COMPLETED|Cross Over||0
9012631|NCT03010800|10075378|FG001|NOT COMPLETED|Cross Over||0
9012632|NCT03011099|10075386|FG000|STARTED|Overall Study||6
9012633|NCT03011099|10075387|FG001|STARTED|Overall Study||5
9012634|NCT03011099|10075386|FG000|COMPLETED|Overall Study||6
8905891|NCT02105454|9964172|FG000|COMPLETED|Overall Study||78
8905892|NCT02105454|9964172|FG000|NOT COMPLETED|Overall Study||1
8905893|NCT02105467|9964178|FG000|STARTED|Period 1||316
8905894|NCT02105467|9964179|FG001|STARTED|Period 1||105
8905895|NCT02105467|9964178|FG000|COMPLETED|Period 1||314
8905896|NCT02105467|9964179|FG001|COMPLETED|Period 1||105
8905897|NCT02105467|9964178|FG000|NOT COMPLETED|Period 1||2
8905898|NCT02105467|9964179|FG001|NOT COMPLETED|Period 1||0
8905899|NCT02105467|9964178|FG000|STARTED|Period 2||314
8905900|NCT02105467|9964179|FG001|STARTED|Period 2|One participant did not receive deferred treatment (Period 2) but proceeded directly to Period 3|104
8905901|NCT02105467|9964178|FG000|COMPLETED|Period 2||312
8905902|NCT02105467|9964179|FG001|COMPLETED|Period 2||102
8905903|NCT02105467|9964178|FG000|NOT COMPLETED|Period 2||2
8905904|NCT02105467|9964179|FG001|NOT COMPLETED|Period 2||2
8905905|NCT02105467|9964178|FG000|STARTED|Period 3|The Immediate Treatment Group completed the study with Period 2|0
8905906|NCT02105467|9964179|FG001|STARTED|Period 3|One participant did not receive deferred treatment (Period 2) but proceeded directly to Period 3|103
8905907|NCT02105467|9964178|FG000|COMPLETED|Period 3||0
8905908|NCT02105467|9964179|FG001|COMPLETED|Period 3||102
8905909|NCT02105467|9964178|FG000|NOT COMPLETED|Period 3||0
8905910|NCT02105467|9964179|FG001|NOT COMPLETED|Period 3||1
8905911|NCT02105558|9964188|FG000|STARTED|Overall Study||15
8905912|NCT02105558|9964189|FG001|STARTED|Overall Study||28
8905913|NCT02105558|9964188|FG000|COMPLETED|Overall Study||15
8905914|NCT02105558|9964189|FG001|COMPLETED|Overall Study||28
8905915|NCT02105558|9964188|FG000|NOT COMPLETED|Overall Study||0
8905916|NCT02105558|9964189|FG001|NOT COMPLETED|Overall Study||0
8905917|NCT02105662|9964195|FG000|STARTED|Overall Study||218
8905918|NCT02105662|9964195|FG000|COMPLETED|Overall Study||212
8905919|NCT02105662|9964195|FG000|NOT COMPLETED|Overall Study||6
8905920|NCT02105688|9964201|FG000|STARTED|Part A: Double-Blind||201
8905921|NCT02105688|9964202|FG001|STARTED|Part A: Double-Blind||100
8905922|NCT02105688|9964201|FG000|COMPLETED|Part A: Double-Blind|Completed Part A|181
8905923|NCT02105688|9964202|FG001|COMPLETED|Part A: Double-Blind|Completed Part A|83
8905924|NCT02105688|9964201|FG000|NOT COMPLETED|Part A: Double-Blind||20
8905925|NCT02105688|9964202|FG001|NOT COMPLETED|Part A: Double-Blind||17
8905926|NCT02105688|9964201|FG000|STARTED|Part B: Observational Follow-up|Completed Part A and met Part B Extension criteria|131
8905927|NCT02105688|9964202|FG001|STARTED|Part B: Observational Follow-up|Completed Part A and met Part B Extension criteria|68
8905928|NCT02105688|9964201|FG000|COMPLETED|Part B: Observational Follow-up|Completed Part B extension|94
8905929|NCT02105688|9964202|FG001|COMPLETED|Part B: Observational Follow-up|Completed Part B extension|48
8905930|NCT02105688|9964201|FG000|NOT COMPLETED|Part B: Observational Follow-up||37
8905931|NCT02105688|9964202|FG001|NOT COMPLETED|Part B: Observational Follow-up||20
8905932|NCT02105701|9964213|FG000|STARTED|Overall Study||105
8905933|NCT02105701|9964214|FG001|STARTED|Overall Study||104
8905934|NCT02105701|9964215|FG002|STARTED|Overall Study||105
8905935|NCT02105701|9964216|FG003|STARTED|Overall Study||106
8905936|NCT02105701|9964213|FG000|COMPLETED|Overall Study||101
8905937|NCT02105701|9964214|FG001|COMPLETED|Overall Study||103
8905938|NCT02105701|9964215|FG002|COMPLETED|Overall Study||102
8905939|NCT02105701|9964216|FG003|COMPLETED|Overall Study||104
8905940|NCT02105701|9964213|FG000|NOT COMPLETED|Overall Study||4
8905941|NCT02105701|9964214|FG001|NOT COMPLETED|Overall Study||1
8905942|NCT02105701|9964215|FG002|NOT COMPLETED|Overall Study||3
8905943|NCT02105701|9964216|FG003|NOT COMPLETED|Overall Study||2
8905944|NCT02105740|9964228|FG000|STARTED|Overall Study|Application of EVA and HADS scales and after that application of hypnosis intervention|12
8905945|NCT02105740|9964229|FG001|STARTED|Overall Study|Application of EVA and HADS scales|12
8905946|NCT02105740|9964228|FG000|Second|Overall Study|Intervention with hypnosis and application of EVA scales and HADS (n = 12)|12
8905947|NCT02105740|9964229|FG001|Second|Overall Study|Application of EVA and HADS scales. One accompanying lost|11
8905948|NCT02105740|9964228|FG000|COMPLETED|Overall Study|Application of EVA and HADS scales and data analysis|12
8905949|NCT02105740|9964229|FG001|COMPLETED|Overall Study|Application of EVA and HADS scales and data analysis|11
8905950|NCT02105740|9964228|FG000|NOT COMPLETED|Overall Study||0
8905951|NCT02105740|9964229|FG001|NOT COMPLETED|Overall Study||1
8905952|NCT02105948|9964241|FG000|STARTED|Overall Study||229
8905953|NCT02105948|9964242|FG001|STARTED|Overall Study||233
8905954|NCT02105948|9964243|FG002|STARTED|Overall Study||190
8905955|NCT02105948|9964244|FG003|STARTED|Overall Study||184
8905956|NCT02105948|9964241|FG000|Completed Investigational Product (IP)|Overall Study||185
8905957|NCT02105948|9964242|FG001|Completed Investigational Product (IP)|Overall Study||203
8905958|NCT02105948|9964243|FG002|Completed Investigational Product (IP)|Overall Study||148
8905959|NCT02105948|9964244|FG003|Completed Investigational Product (IP)|Overall Study||149
8905960|NCT02105948|9964241|FG000|Not Completed IP|Overall Study||44
8905961|NCT02105948|9964242|FG001|Not Completed IP|Overall Study||30
8905962|NCT02105948|9964243|FG002|Not Completed IP|Overall Study||42
8905963|NCT02105948|9964244|FG003|Not Completed IP|Overall Study||35
8905964|NCT02105948|9964241|FG000|Withdrew IP Due to: Adverse Event|Overall Study||20
8905965|NCT02105948|9964242|FG001|Withdrew IP Due to: Adverse Event|Overall Study||16
8905966|NCT02105948|9964243|FG002|Withdrew IP Due to: Adverse Event|Overall Study||15
8905967|NCT02105948|9964244|FG003|Withdrew IP Due to: Adverse Event|Overall Study||13
8905968|NCT02105948|9964241|FG000|Withdrew IP Due to: Lack of Efficacy|Overall Study||5
8905969|NCT02105948|9964242|FG001|Withdrew IP Due to: Lack of Efficacy|Overall Study||2
8905970|NCT02105948|9964243|FG002|Withdrew IP Due to: Lack of Efficacy|Overall Study||8
8905971|NCT02105948|9964244|FG003|Withdrew IP Due to: Lack of Efficacy|Overall Study||2
8905972|NCT02105948|9964241|FG000|Withdrew IP Due to: Protocol Deviation|Overall Study||1
8905973|NCT02105948|9964242|FG001|Withdrew IP Due to: Protocol Deviation|Overall Study||3
8905974|NCT02105948|9964243|FG002|Withdrew IP Due to: Protocol Deviation|Overall Study||3
8905975|NCT02105948|9964244|FG003|Withdrew IP Due to: Protocol Deviation|Overall Study||0
8905976|NCT02105948|9964241|FG000|Withdrew IP Due to: Lost to Follow-up|Overall Study||0
8905977|NCT02105948|9964242|FG001|Withdrew IP Due to: Lost to Follow-up|Overall Study||0
8905978|NCT02105948|9964243|FG002|Withdrew IP Due to: Lost to Follow-up|Overall Study||1
8905979|NCT02105948|9964244|FG003|Withdrew IP Due to: Lost to Follow-up|Overall Study||2
8905980|NCT02105948|9964241|FG000|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||16
8905981|NCT02105948|9964242|FG001|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||8
8905982|NCT02105948|9964243|FG002|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||11
8905983|NCT02105948|9964244|FG003|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||15
8905984|NCT02105948|9964241|FG000|Withdrew IP Due to: Physician Decision|Overall Study||2
8905985|NCT02105948|9964242|FG001|Withdrew IP Due to: Physician Decision|Overall Study||1
8905986|NCT02105948|9964243|FG002|Withdrew IP Due to: Physician Decision|Overall Study||4
8905987|NCT02105948|9964244|FG003|Withdrew IP Due to: Physician Decision|Overall Study||2
8905988|NCT02105948|9964241|FG000|Withdrew IP Due to: Stopping Criteria|Overall Study||0
8905989|NCT02105948|9964242|FG001|Withdrew IP Due to: Stopping Criteria|Overall Study||0
8905990|NCT02105948|9964243|FG002|Withdrew IP Due to: Stopping Criteria|Overall Study||0
8905991|NCT02105948|9964244|FG003|Withdrew IP Due to: Stopping Criteria|Overall Study||1
8905992|NCT02105948|9964241|FG000|COMPLETED|Overall Study||202
8905993|NCT02105948|9964242|FG001|COMPLETED|Overall Study||213
8905994|NCT02105948|9964243|FG002|COMPLETED|Overall Study||162
8905995|NCT02105948|9964244|FG003|COMPLETED|Overall Study||157
8905996|NCT02105948|9964241|FG000|NOT COMPLETED|Overall Study||27
8905997|NCT02105948|9964242|FG001|NOT COMPLETED|Overall Study||20
8905998|NCT02105948|9964243|FG002|NOT COMPLETED|Overall Study||28
8905999|NCT02105948|9964244|FG003|NOT COMPLETED|Overall Study||27
8906000|NCT02105961|9964258|FG000|STARTED|Overall Study||226
8906001|NCT02105961|9964259|FG001|STARTED|Overall Study||223
8906002|NCT02105961|9964260|FG002|STARTED|Overall Study||225
8906003|NCT02105961|9964258|FG000|Completed Investigational Product (IP)|Overall Study||170
8906004|NCT02105961|9964259|FG001|Completed Investigational Product (IP)|Overall Study||196
8906005|NCT02105961|9964260|FG002|Completed Investigational Product (IP)|Overall Study||183
8906006|NCT02105961|9964258|FG000|Not Completed IP|Overall Study||56
8906007|NCT02105961|9964259|FG001|Not Completed IP|Overall Study||27
8906008|NCT02105961|9964260|FG002|Not Completed IP|Overall Study||42
8906009|NCT02105961|9964258|FG000|Withdrew IP Due to: Adverse Event|Overall Study||27
8906010|NCT02105961|9964259|FG001|Withdrew IP Due to: Adverse Event|Overall Study||9
8906011|NCT02105961|9964260|FG002|Withdrew IP Due to: Adverse Event|Overall Study||25
8906012|NCT02105961|9964258|FG000|Withdrew IP Due to: Stopping Criteria|Overall Study||1
8906013|NCT02105961|9964259|FG001|Withdrew IP Due to: Stopping Criteria|Overall Study||1
8906014|NCT02105961|9964260|FG002|Withdrew IP Due to: Stopping Criteria|Overall Study||0
8906015|NCT02105961|9964258|FG000|Withdrew IP Due to: Lack of Efficacy|Overall Study||6
8906016|NCT02105961|9964259|FG001|Withdrew IP Due to: Lack of Efficacy|Overall Study||2
8906017|NCT02105961|9964260|FG002|Withdrew IP Due to: Lack of Efficacy|Overall Study||2
8906018|NCT02105961|9964258|FG000|Withdrew IP Due to: Protocol Deviation|Overall Study||2
8906019|NCT02105961|9964259|FG001|Withdrew IP Due to: Protocol Deviation|Overall Study||0
8906020|NCT02105961|9964260|FG002|Withdrew IP Due to: Protocol Deviation|Overall Study||1
8906021|NCT02105961|9964258|FG000|Withdrew IP Due to: Lost to Follow-up|Overall Study||1
8906022|NCT02105961|9964259|FG001|Withdrew IP Due to: Lost to Follow-up|Overall Study||1
8906023|NCT02105961|9964260|FG002|Withdrew IP Due to: Lost to Follow-up|Overall Study||1
8906024|NCT02105961|9964258|FG000|Withdrew IP Due to: Physician Decision|Overall Study||2
8906025|NCT02105961|9964259|FG001|Withdrew IP Due to: Physician Decision|Overall Study||3
8906026|NCT02105961|9964260|FG002|Withdrew IP Due to: Physician Decision|Overall Study||1
8906027|NCT02105961|9964258|FG000|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||16
8906028|NCT02105961|9964259|FG001|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||11
8906029|NCT02105961|9964260|FG002|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||11
8906030|NCT02105961|9964258|FG000|Withdrew IP Due to: Site Closed|Overall Study||1
8906031|NCT02105961|9964259|FG001|Withdrew IP Due to: Site Closed|Overall Study||0
8906032|NCT02105961|9964260|FG002|Withdrew IP Due to: Site Closed|Overall Study||1
8906033|NCT02105961|9964258|FG000|COMPLETED|Overall Study||185
8906034|NCT02105961|9964259|FG001|COMPLETED|Overall Study||206
8906035|NCT02105961|9964260|FG002|COMPLETED|Overall Study||195
8906036|NCT02105961|9964258|FG000|NOT COMPLETED|Overall Study||41
8906037|NCT02105961|9964259|FG001|NOT COMPLETED|Overall Study||17
9012635|NCT03011099|10075387|FG001|COMPLETED|Overall Study||3
9012636|NCT03011099|10075386|FG000|NOT COMPLETED|Overall Study||0
9012637|NCT03011099|10075387|FG001|NOT COMPLETED|Overall Study||2
9012638|NCT03011333|10075402|FG000|STARTED|Overall Study||12
9012639|NCT03011333|10075403|FG001|STARTED|Overall Study||27
9012640|NCT03011333|10075404|FG002|STARTED|Overall Study||25
9012641|NCT03011333|10075405|FG003|STARTED|Overall Study||47
9012642|NCT03011333|10075406|FG004|STARTED|Overall Study||50
9012643|NCT03011333|10075407|FG005|STARTED|Overall Study||41
9012644|NCT03011333|10075408|FG006|STARTED|Overall Study||41
8906038|NCT02105961|9964260|FG002|NOT COMPLETED|Overall Study||30
8906039|NCT02105974|9964271|FG000|STARTED|2 Week Run-in Period||2423
8906040|NCT02105974|9964272|FG001|STARTED|2 Week Run-in Period||0
8906041|NCT02105974|9964273|FG002|STARTED|2 Week Run-in Period||0
8906042|NCT02105974|9964271|FG000|COMPLETED|2 Week Run-in Period||1622
8906043|NCT02105974|9964272|FG001|COMPLETED|2 Week Run-in Period||0
8906044|NCT02105974|9964273|FG002|COMPLETED|2 Week Run-in Period||0
8906045|NCT02105974|9964271|FG000|NOT COMPLETED|2 Week Run-in Period||801
8906046|NCT02105974|9964272|FG001|NOT COMPLETED|2 Week Run-in Period||0
8906047|NCT02105974|9964273|FG002|NOT COMPLETED|2 Week Run-in Period||0
8906048|NCT02105974|9964271|FG000|STARTED|12 Week (Wk) Treatment Period (TP)||0
8906049|NCT02105974|9964272|FG001|STARTED|12 Week (Wk) Treatment Period (TP)||806
8906050|NCT02105974|9964273|FG002|STARTED|12 Week (Wk) Treatment Period (TP)||814
8906051|NCT02105974|9964271|FG000|Completed the Treatment(Trt) Period|12 Week (Wk) Treatment Period (TP)||0
8906052|NCT02105974|9964272|FG001|Completed the Treatment(Trt) Period|12 Week (Wk) Treatment Period (TP)|Par completed TP if attended Visit (V7, Wk12), did not withdraw at V7 and did not stop trt before V7|764
8906053|NCT02105974|9964273|FG002|Completed the Treatment(Trt) Period|12 Week (Wk) Treatment Period (TP)|Par completed TP if attended Visit (V7, Wk12), did not withdraw at V7 and did not stop trt before V7|754
8906054|NCT02105974|9964271|FG000|COMPLETED|12 Week (Wk) Treatment Period (TP)||0
8906055|NCT02105974|9964272|FG001|COMPLETED|12 Week (Wk) Treatment Period (TP)|Par. completed study if attended visit 7, had follow-up contact and no early withdrawal|764
8906056|NCT02105974|9964273|FG002|COMPLETED|12 Week (Wk) Treatment Period (TP)|Par. completed study if attended visit 7, had follow-up contact and no early withdrawal|756
8906057|NCT02105974|9964271|FG000|NOT COMPLETED|12 Week (Wk) Treatment Period (TP)||0
8906058|NCT02105974|9964272|FG001|NOT COMPLETED|12 Week (Wk) Treatment Period (TP)||42
8906059|NCT02105974|9964273|FG002|NOT COMPLETED|12 Week (Wk) Treatment Period (TP)||58
8906060|NCT02105987|9964281|FG000|STARTED|Early Switch Phase (24 Weeks)|Number Started represents the number of par. in the Intent-To-Treat Exposed (ITT-E) Population.|275
8906061|NCT02105987|9964282|FG001|STARTED|Early Switch Phase (24 Weeks)|Number Started represents the number of par. in the Intent-To-Treat Exposed (ITT-E) Population.|278
8906062|NCT02105987|9964283|FG002|STARTED|Early Switch Phase (24 Weeks)||0
8906063|NCT02105987|9964284|FG003|STARTED|Early Switch Phase (24 Weeks)||0
8906064|NCT02105987|9964285|FG004|STARTED|Early Switch Phase (24 Weeks)||0
8906065|NCT02105987|9964286|FG005|STARTED|Early Switch Phase (24 Weeks)||0
8906066|NCT02105987|9964281|FG000|COMPLETED|Early Switch Phase (24 Weeks)||239
8906067|NCT02105987|9964282|FG001|COMPLETED|Early Switch Phase (24 Weeks)||244
8906068|NCT02105987|9964283|FG002|COMPLETED|Early Switch Phase (24 Weeks)||0
8906069|NCT02105987|9964284|FG003|COMPLETED|Early Switch Phase (24 Weeks)||0
9012645|NCT03011333|10075402|FG000|COMPLETED|Overall Study||12
9012646|NCT03011333|10075403|FG001|COMPLETED|Overall Study||26
9012647|NCT03011333|10075404|FG002|COMPLETED|Overall Study||25
9012648|NCT03011333|10075405|FG003|COMPLETED|Overall Study||46
9012649|NCT03011333|10075406|FG004|COMPLETED|Overall Study||46
9012650|NCT03011333|10075407|FG005|COMPLETED|Overall Study||37
9012651|NCT03011333|10075408|FG006|COMPLETED|Overall Study||36
9012652|NCT03011333|10075402|FG000|NOT COMPLETED|Overall Study||0
9012653|NCT03011333|10075403|FG001|NOT COMPLETED|Overall Study||1
9012654|NCT03011333|10075404|FG002|NOT COMPLETED|Overall Study||0
9012655|NCT03011333|10075405|FG003|NOT COMPLETED|Overall Study||1
9012656|NCT03011333|10075406|FG004|NOT COMPLETED|Overall Study||4
8573253|NCT00119678|9605494|FG001|RANDOMIZED AND TREATED|Double-blind Treatment Period||59
8573254|NCT00119678|9605493|FG000|RANDOMIZED,TREATED, AND ANALYZED|Double-blind Treatment Period||118
8573255|NCT00119678|9605494|FG001|RANDOMIZED,TREATED, AND ANALYZED|Double-blind Treatment Period||57
8573256|NCT00119678|9605493|FG000|COMPLETED|Double-blind Treatment Period||81
8573257|NCT00119678|9605494|FG001|COMPLETED|Double-blind Treatment Period||35
8573258|NCT00119678|9605493|FG000|NOT COMPLETED|Double-blind Treatment Period||41
8573259|NCT00119678|9605494|FG001|NOT COMPLETED|Double-blind Treatment Period||26
8573260|NCT00119678|9605493|FG000|STARTED|Open-label Treatment Period|Number of participants treated|110
8573261|NCT00119678|9605494|FG001|STARTED|Open-label Treatment Period||0
8573262|NCT00119678|9605493|FG000|COMPLETED|Open-label Treatment Period||0
8573263|NCT00119678|9605494|FG001|COMPLETED|Open-label Treatment Period||0
8573264|NCT00119678|9605493|FG000|NOT COMPLETED|Open-label Treatment Period||110
8573265|NCT00119678|9605494|FG001|NOT COMPLETED|Open-label Treatment Period||0
8573266|NCT00120250|9605502|FG000|STARTED|Overall Study||13
8573267|NCT00120250|9605503|FG001|STARTED|Overall Study||14
8573268|NCT00120250|9605502|FG000|COMPLETED|Overall Study||12
8573269|NCT00120250|9605503|FG001|COMPLETED|Overall Study||12
8573270|NCT00120250|9605502|FG000|NOT COMPLETED|Overall Study||1
8573271|NCT00120250|9605503|FG001|NOT COMPLETED|Overall Study||2
8573272|NCT00120289|9605512|FG000|STARTED|Overall Study||1718
8573273|NCT00120289|9605513|FG001|STARTED|Overall Study||1696
8573274|NCT00120289|9605512|FG000|COMPLETED|Overall Study||1597
8573275|NCT00120289|9605513|FG001|COMPLETED|Overall Study||1587
8573276|NCT00120289|9605512|FG000|NOT COMPLETED|Overall Study||121
8573277|NCT00120289|9605513|FG001|NOT COMPLETED|Overall Study||109
8573278|NCT00120406|9605521|FG000|STARTED|Overall Study||236
8573279|NCT00120406|9605522|FG001|STARTED|Overall Study||238
8573280|NCT00120406|9605521|FG000|COMPLETED|Overall Study||217
8573281|NCT00120406|9605522|FG001|COMPLETED|Overall Study||222
8573282|NCT00120406|9605521|FG000|NOT COMPLETED|Overall Study||19
8573283|NCT00120406|9605522|FG001|NOT COMPLETED|Overall Study||16
8573284|NCT00120523|9605530|FG000|STARTED|Treatment Period||1205
8906070|NCT02105987|9964285|FG004|COMPLETED|Early Switch Phase (24 Weeks)||0
8906071|NCT02105987|9964286|FG005|COMPLETED|Early Switch Phase (24 Weeks)||0
8906072|NCT02105987|9964281|FG000|NOT COMPLETED|Early Switch Phase (24 Weeks)||36
8906073|NCT02105987|9964282|FG001|NOT COMPLETED|Early Switch Phase (24 Weeks)||34
8906074|NCT02105987|9964283|FG002|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
8906075|NCT02105987|9964284|FG003|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
8906076|NCT02105987|9964285|FG004|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
8906077|NCT02105987|9964286|FG005|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
8906078|NCT02105987|9964281|FG000|STARTED|Late Switch Phase (24 Weeks)||0
8906079|NCT02105987|9964282|FG001|STARTED|Late Switch Phase (24 Weeks)||0
8906080|NCT02105987|9964283|FG002|STARTED|Late Switch Phase (24 Weeks)||275
8906081|NCT02105987|9964284|FG003|STARTED|Late Switch Phase (24 Weeks)||244
8906082|NCT02105987|9964285|FG004|STARTED|Late Switch Phase (24 Weeks)||0
8906083|NCT02105987|9964286|FG005|STARTED|Late Switch Phase (24 Weeks)||0
8906084|NCT02105987|9964281|FG000|COMPLETED|Late Switch Phase (24 Weeks)||0
8906085|NCT02105987|9964282|FG001|COMPLETED|Late Switch Phase (24 Weeks)||0
8906086|NCT02105987|9964283|FG002|COMPLETED|Late Switch Phase (24 Weeks)||230
8906087|NCT02105987|9964284|FG003|COMPLETED|Late Switch Phase (24 Weeks)||230
8906088|NCT02105987|9964285|FG004|COMPLETED|Late Switch Phase (24 Weeks)||0
8906089|NCT02105987|9964286|FG005|COMPLETED|Late Switch Phase (24 Weeks)||0
8906090|NCT02105987|9964281|FG000|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
8906091|NCT02105987|9964282|FG001|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
8906092|NCT02105987|9964283|FG002|NOT COMPLETED|Late Switch Phase (24 Weeks)||45
8906093|NCT02105987|9964284|FG003|NOT COMPLETED|Late Switch Phase (24 Weeks)||14
8906094|NCT02105987|9964285|FG004|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
8906095|NCT02105987|9964286|FG005|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
8906096|NCT02105987|9964281|FG000|STARTED|Continuation Phase||0
8906097|NCT02105987|9964282|FG001|STARTED|Continuation Phase||0
8906098|NCT02105987|9964283|FG002|STARTED|Continuation Phase||0
8906099|NCT02105987|9964284|FG003|STARTED|Continuation Phase||0
8906100|NCT02105987|9964285|FG004|STARTED|Continuation Phase||14
8906101|NCT02105987|9964286|FG005|STARTED|Continuation Phase||23
8906102|NCT02105987|9964281|FG000|COMPLETED|Continuation Phase||0
8906103|NCT02105987|9964282|FG001|COMPLETED|Continuation Phase||0
8906104|NCT02105987|9964283|FG002|COMPLETED|Continuation Phase||0
8906105|NCT02105987|9964284|FG003|COMPLETED|Continuation Phase||0
8906106|NCT02105987|9964285|FG004|COMPLETED|Continuation Phase||13
8906107|NCT02105987|9964286|FG005|COMPLETED|Continuation Phase||23
8906108|NCT02105987|9964281|FG000|NOT COMPLETED|Continuation Phase||0
8906109|NCT02105987|9964282|FG001|NOT COMPLETED|Continuation Phase||0
8906110|NCT02105987|9964283|FG002|NOT COMPLETED|Continuation Phase||0
8906111|NCT02105987|9964284|FG003|NOT COMPLETED|Continuation Phase||0
8906112|NCT02105987|9964285|FG004|NOT COMPLETED|Continuation Phase||1
8906113|NCT02105987|9964286|FG005|NOT COMPLETED|Continuation Phase||0
8906114|NCT02106065|9964295|FG000|STARTED|Overall Study||6
8906115|NCT02106065|9964296|FG001|STARTED|Overall Study||11
8906116|NCT02106065|9964297|FG002|STARTED|Overall Study||15
8906117|NCT02106065|9964295|FG000|6 Month Completion|Overall Study||3
8906118|NCT02106065|9964296|FG001|6 Month Completion|Overall Study||8
8906119|NCT02106065|9964297|FG002|6 Month Completion|Overall Study||5
8906120|NCT02106065|9964295|FG000|COMPLETED|Overall Study||3
8906121|NCT02106065|9964296|FG001|COMPLETED|Overall Study||8
8906122|NCT02106065|9964297|FG002|COMPLETED|Overall Study||5
8906123|NCT02106065|9964295|FG000|NOT COMPLETED|Overall Study||3
8906124|NCT02106065|9964296|FG001|NOT COMPLETED|Overall Study||3
8906125|NCT02106065|9964297|FG002|NOT COMPLETED|Overall Study||10
8906126|NCT02106156|9964308|FG000|STARTED|Overall Study||9620
8906127|NCT02106156|9964309|FG001|STARTED|Overall Study||90
8906128|NCT02106156|9964310|FG002|STARTED|Overall Study||518
8906129|NCT02106156|9964308|FG000|COMPLETED|Overall Study||7071
8906130|NCT02106156|9964309|FG001|COMPLETED|Overall Study||50
8906131|NCT02106156|9964310|FG002|COMPLETED|Overall Study||518
8906132|NCT02106156|9964308|FG000|NOT COMPLETED|Overall Study||2549
8906133|NCT02106156|9964309|FG001|NOT COMPLETED|Overall Study||40
8906134|NCT02106156|9964310|FG002|NOT COMPLETED|Overall Study||0
8906135|NCT02106325|9964319|FG000|STARTED|Phase 1||5
8906136|NCT02106325|9964320|FG001|STARTED|Phase 1||3
8906137|NCT02106325|9964319|FG000|COMPLETED|Phase 1||3
8906138|NCT02106325|9964320|FG001|COMPLETED|Phase 1||1
8906139|NCT02106325|9964319|FG000|NOT COMPLETED|Phase 1||2
8906140|NCT02106325|9964320|FG001|NOT COMPLETED|Phase 1||2
8906141|NCT02106325|9964319|FG000|STARTED|Phase 2||4
8906142|NCT02106325|9964320|FG001|STARTED|Phase 2||4
8906143|NCT02106325|9964319|FG000|COMPLETED|Phase 2||2
8906144|NCT02106325|9964320|FG001|COMPLETED|Phase 2||1
8906145|NCT02106325|9964319|FG000|NOT COMPLETED|Phase 2||2
8906146|NCT02106325|9964320|FG001|NOT COMPLETED|Phase 2||3
8906147|NCT02106325|9964319|FG000|STARTED|Phase 3||2
8906148|NCT02106325|9964320|FG001|STARTED|Phase 3||3
8906149|NCT02106325|9964319|FG000|COMPLETED|Phase 3||0
8906150|NCT02106325|9964320|FG001|COMPLETED|Phase 3||2
8906151|NCT02106325|9964319|FG000|NOT COMPLETED|Phase 3||2
8906152|NCT02106325|9964320|FG001|NOT COMPLETED|Phase 3||1
8906153|NCT02106351|9964329|FG000|STARTED|Treatment Cycle 1||71
8906154|NCT02106351|9964330|FG001|STARTED|Treatment Cycle 1||70
8906155|NCT02106351|9964331|FG002|STARTED|Treatment Cycle 1||71
8906156|NCT02106351|9964329|FG000|Received Treatment in TC 1|Treatment Cycle 1||70
8906157|NCT02106351|9964330|FG001|Received Treatment in TC 1|Treatment Cycle 1||70
8906158|NCT02106351|9964331|FG002|Received Treatment in TC 1|Treatment Cycle 1||70
8906159|NCT02106351|9964329|FG000|COMPLETED|Treatment Cycle 1||66
8906160|NCT02106351|9964330|FG001|COMPLETED|Treatment Cycle 1||67
8906161|NCT02106351|9964331|FG002|COMPLETED|Treatment Cycle 1||67
8906162|NCT02106351|9964329|FG000|NOT COMPLETED|Treatment Cycle 1||5
8906163|NCT02106351|9964330|FG001|NOT COMPLETED|Treatment Cycle 1||3
9012657|NCT03011333|10075407|FG005|NOT COMPLETED|Overall Study||4
9012658|NCT03011333|10075408|FG006|NOT COMPLETED|Overall Study||5
9012659|NCT03011840|10075426|FG000|STARTED|Overall Study||232
9012660|NCT03011840|10075427|FG001|STARTED|Overall Study||217
9012661|NCT03011840|10075426|FG000|COMPLETED|Overall Study||232
9012662|NCT03011840|10075427|FG001|COMPLETED|Overall Study||196
8636653|NCT02664441|9677340|FG000|COMPLETED|Randomization||23
8636654|NCT02664441|9677341|FG001|COMPLETED|Randomization||18
8636655|NCT02664441|9677340|FG000|NOT COMPLETED|Randomization||0
8636656|NCT02664441|9677341|FG001|NOT COMPLETED|Randomization||1
8636657|NCT02664441|9677340|FG000|STARTED|36-week Randomized Trial||23
8636658|NCT02664441|9677341|FG001|STARTED|36-week Randomized Trial||18
8636659|NCT02664441|9677340|FG000|COMPLETED|36-week Randomized Trial||20
8636660|NCT02664441|9677341|FG001|COMPLETED|36-week Randomized Trial||15
8636661|NCT02664441|9677340|FG000|NOT COMPLETED|36-week Randomized Trial||3
8636662|NCT02664441|9677341|FG001|NOT COMPLETED|36-week Randomized Trial||3
8636663|NCT02664441|9677340|FG000|STARTED|18-week Open Label Extension||20
8636664|NCT02664441|9677341|FG001|STARTED|18-week Open Label Extension||15
8636665|NCT02664441|9677340|FG000|COMPLETED|18-week Open Label Extension||17
8636666|NCT02664441|9677341|FG001|COMPLETED|18-week Open Label Extension||14
8636667|NCT02664441|9677340|FG000|NOT COMPLETED|18-week Open Label Extension||3
8636668|NCT02664441|9677341|FG001|NOT COMPLETED|18-week Open Label Extension||1
8636669|NCT02527187|9677350|FG000|STARTED|Overall Study||75
8636670|NCT02527187|9677351|FG001|STARTED|Overall Study||126
8636671|NCT02527187|9677350|FG000|COMPLETED|Overall Study||75
8636672|NCT02527187|9677351|FG001|COMPLETED|Overall Study||126
8636673|NCT02527187|9677350|FG000|NOT COMPLETED|Overall Study||0
8636674|NCT02527187|9677351|FG001|NOT COMPLETED|Overall Study||0
8906164|NCT02106351|9964331|FG002|NOT COMPLETED|Treatment Cycle 1||4
8906165|NCT02106351|9964329|FG000|STARTED|Treatment Cycle 2|Subjects who received Dysport 2 U/kg in TC 1 were randomised to receive 8 or 16 U/kg in TCs 2-4.|0
8906166|NCT02106351|9964330|FG001|STARTED|Treatment Cycle 2|Not all subjects who completed TC 1 required retreatment in TC 2.|88
8906167|NCT02106351|9964331|FG002|STARTED|Treatment Cycle 2|Not all subjects who completed TC 1 required retreatment in TC 2.|90
8906168|NCT02106351|9964329|FG000|COMPLETED|Treatment Cycle 2||0
8906169|NCT02106351|9964330|FG001|COMPLETED|Treatment Cycle 2||83
8906170|NCT02106351|9964331|FG002|COMPLETED|Treatment Cycle 2||87
8906171|NCT02106351|9964329|FG000|NOT COMPLETED|Treatment Cycle 2||0
8906172|NCT02106351|9964330|FG001|NOT COMPLETED|Treatment Cycle 2||5
8906173|NCT02106351|9964331|FG002|NOT COMPLETED|Treatment Cycle 2||3
8906174|NCT02106351|9964329|FG000|STARTED|Treatment Cycle 3||0
8906175|NCT02106351|9964330|FG001|STARTED|Treatment Cycle 3|Not all subjects who completed TC 2 required retreatment in TC 3.|49
8906176|NCT02106351|9964331|FG002|STARTED|Treatment Cycle 3|Not all subjects who completed TC 2 required retreatment in TC 3.|58
8906177|NCT02106351|9964329|FG000|COMPLETED|Treatment Cycle 3||0
8906178|NCT02106351|9964330|FG001|COMPLETED|Treatment Cycle 3||45
8906179|NCT02106351|9964331|FG002|COMPLETED|Treatment Cycle 3||53
8906180|NCT02106351|9964329|FG000|NOT COMPLETED|Treatment Cycle 3||0
8906181|NCT02106351|9964330|FG001|NOT COMPLETED|Treatment Cycle 3||4
8906182|NCT02106351|9964331|FG002|NOT COMPLETED|Treatment Cycle 3||5
8906183|NCT02106351|9964329|FG000|STARTED|Treatment Cycle 4||0
8906184|NCT02106351|9964330|FG001|STARTED|Treatment Cycle 4|Not all subjects who completed TC 3 required retreatment in TC 4.|22
8906185|NCT02106351|9964331|FG002|STARTED|Treatment Cycle 4|Not all subjects who completed TC 3 required retreatment in TC 4.|33
8906186|NCT02106351|9964329|FG000|COMPLETED|Treatment Cycle 4||0
8906187|NCT02106351|9964330|FG001|COMPLETED|Treatment Cycle 4||21
8906188|NCT02106351|9964331|FG002|COMPLETED|Treatment Cycle 4||31
8906189|NCT02106351|9964329|FG000|NOT COMPLETED|Treatment Cycle 4||0
8906190|NCT02106351|9964330|FG001|NOT COMPLETED|Treatment Cycle 4||1
8906191|NCT02106351|9964331|FG002|NOT COMPLETED|Treatment Cycle 4||2
8906192|NCT02106390|9964348|FG000|STARTED|Overall Study||252
8906193|NCT02106390|9964349|FG001|STARTED|Overall Study||250
8906194|NCT02106390|9964350|FG002|STARTED|Overall Study||248
8906195|NCT02106390|9964348|FG000|COMPLETED|Overall Study||203
8906196|NCT02106390|9964349|FG001|COMPLETED|Overall Study||202
8906197|NCT02106390|9964350|FG002|COMPLETED|Overall Study||205
9012663|NCT03011840|10075426|FG000|NOT COMPLETED|Overall Study||0
8636675|NCT02513472|9677361|FG000|STARTED|Overall Study||66
8636676|NCT02513472|9677362|FG001|STARTED|Overall Study||101
8636677|NCT02513472|9677361|FG000|Phase 1b Safety run-in|Overall Study||3
8636678|NCT02513472|9677362|FG001|Phase 1b Safety run-in|Overall Study||4
8636679|NCT02513472|9677361|FG000|Phase 2|Overall Study||63
8636680|NCT02513472|9677362|FG001|Phase 2|Overall Study||97
8906198|NCT02106390|9964348|FG000|NOT COMPLETED|Overall Study||49
8906199|NCT02106390|9964349|FG001|NOT COMPLETED|Overall Study||48
8906200|NCT02106390|9964350|FG002|NOT COMPLETED|Overall Study||43
8906201|NCT02106403|9964361|FG000|STARTED|Visit 1, Treatment Period 1||8
8906202|NCT02106403|9964362|FG001|STARTED|Visit 1, Treatment Period 1||8
8906203|NCT02106403|9964363|FG002|STARTED|Visit 1, Treatment Period 1||9
8636681|NCT02513472|9677361|FG000|COMPLETED|Overall Study||0
8636682|NCT02513472|9677362|FG001|COMPLETED|Overall Study||0
8636683|NCT02513472|9677361|FG000|NOT COMPLETED|Overall Study||66
8636684|NCT02513472|9677362|FG001|NOT COMPLETED|Overall Study||101
8636685|NCT02476409|9677372|FG000|STARTED|Overall Study||19
8636686|NCT02476409|9677373|FG001|STARTED|Overall Study||21
8636687|NCT02476409|9677372|FG000|COMPLETED|Overall Study||19
8636688|NCT02476409|9677373|FG001|COMPLETED|Overall Study||21
8636689|NCT02476409|9677372|FG000|NOT COMPLETED|Overall Study||0
8636690|NCT02476409|9677373|FG001|NOT COMPLETED|Overall Study||0
8636691|NCT02132650|9677385|FG000|STARTED|Overall Study||20
8636692|NCT02132650|9677386|FG001|STARTED|Overall Study||18
8636693|NCT02132650|9677385|FG000|Post-Intervention Assessment|Overall Study||19
8636694|NCT02132650|9677386|FG001|Post-Intervention Assessment|Overall Study||17
8636695|NCT02132650|9677385|FG000|COMPLETED|Overall Study||17
8636696|NCT02132650|9677386|FG001|COMPLETED|Overall Study||14
8636697|NCT02132650|9677385|FG000|NOT COMPLETED|Overall Study||3
8636698|NCT02132650|9677386|FG001|NOT COMPLETED|Overall Study||4
8636699|NCT01980355|9677394|FG000|STARTED|Overall Study||39
8636700|NCT01980355|9677395|FG001|STARTED|Overall Study||37
8636701|NCT01980355|9677394|FG000|COMPLETED|Overall Study||39
8636702|NCT01980355|9677395|FG001|COMPLETED|Overall Study||37
8906204|NCT02106403|9964364|FG003|STARTED|Visit 1, Treatment Period 1||8
8906205|NCT02106403|9964365|FG004|STARTED|Visit 1, Treatment Period 1||8
8906206|NCT02106403|9964366|FG005|STARTED|Visit 1, Treatment Period 1||9
8906207|NCT02106403|9964361|FG000|COMPLETED|Visit 1, Treatment Period 1||8
8906208|NCT02106403|9964362|FG001|COMPLETED|Visit 1, Treatment Period 1||8
8906209|NCT02106403|9964363|FG002|COMPLETED|Visit 1, Treatment Period 1||9
8906210|NCT02106403|9964364|FG003|COMPLETED|Visit 1, Treatment Period 1||8
8906211|NCT02106403|9964365|FG004|COMPLETED|Visit 1, Treatment Period 1||8
8906212|NCT02106403|9964366|FG005|COMPLETED|Visit 1, Treatment Period 1||9
8906213|NCT02106403|9964361|FG000|NOT COMPLETED|Visit 1, Treatment Period 1||0
8906214|NCT02106403|9964362|FG001|NOT COMPLETED|Visit 1, Treatment Period 1||0
8906215|NCT02106403|9964363|FG002|NOT COMPLETED|Visit 1, Treatment Period 1||0
8906216|NCT02106403|9964364|FG003|NOT COMPLETED|Visit 1, Treatment Period 1||0
8906217|NCT02106403|9964365|FG004|NOT COMPLETED|Visit 1, Treatment Period 1||0
8906218|NCT02106403|9964366|FG005|NOT COMPLETED|Visit 1, Treatment Period 1||0
8906219|NCT02106403|9964361|FG000|STARTED|Visit 1, Treatment Period 2||8
8906220|NCT02106403|9964362|FG001|STARTED|Visit 1, Treatment Period 2||8
8906221|NCT02106403|9964363|FG002|STARTED|Visit 1, Treatment Period 2||9
8906222|NCT02106403|9964364|FG003|STARTED|Visit 1, Treatment Period 2||8
8906223|NCT02106403|9964365|FG004|STARTED|Visit 1, Treatment Period 2||8
8906224|NCT02106403|9964366|FG005|STARTED|Visit 1, Treatment Period 2||9
8906225|NCT02106403|9964361|FG000|COMPLETED|Visit 1, Treatment Period 2||8
8906226|NCT02106403|9964362|FG001|COMPLETED|Visit 1, Treatment Period 2||8
8906227|NCT02106403|9964363|FG002|COMPLETED|Visit 1, Treatment Period 2||9
8906228|NCT02106403|9964364|FG003|COMPLETED|Visit 1, Treatment Period 2||8
8906229|NCT02106403|9964365|FG004|COMPLETED|Visit 1, Treatment Period 2||8
8906230|NCT02106403|9964366|FG005|COMPLETED|Visit 1, Treatment Period 2||9
8906231|NCT02106403|9964361|FG000|NOT COMPLETED|Visit 1, Treatment Period 2||0
8906232|NCT02106403|9964362|FG001|NOT COMPLETED|Visit 1, Treatment Period 2||0
8906233|NCT02106403|9964363|FG002|NOT COMPLETED|Visit 1, Treatment Period 2||0
8906234|NCT02106403|9964364|FG003|NOT COMPLETED|Visit 1, Treatment Period 2||0
8906235|NCT02106403|9964365|FG004|NOT COMPLETED|Visit 1, Treatment Period 2||0
8906236|NCT02106403|9964366|FG005|NOT COMPLETED|Visit 1, Treatment Period 2||0
8906237|NCT02106403|9964361|FG000|STARTED|Visit 1, Treatment Period 3||8
8906238|NCT02106403|9964362|FG001|STARTED|Visit 1, Treatment Period 3||8
8906239|NCT02106403|9964363|FG002|STARTED|Visit 1, Treatment Period 3||9
8906240|NCT02106403|9964364|FG003|STARTED|Visit 1, Treatment Period 3||8
8906241|NCT02106403|9964365|FG004|STARTED|Visit 1, Treatment Period 3||8
8906242|NCT02106403|9964366|FG005|STARTED|Visit 1, Treatment Period 3||9
8906243|NCT02106403|9964361|FG000|COMPLETED|Visit 1, Treatment Period 3||8
8906244|NCT02106403|9964362|FG001|COMPLETED|Visit 1, Treatment Period 3||8
8906245|NCT02106403|9964363|FG002|COMPLETED|Visit 1, Treatment Period 3||9
8906246|NCT02106403|9964364|FG003|COMPLETED|Visit 1, Treatment Period 3||8
8906247|NCT02106403|9964365|FG004|COMPLETED|Visit 1, Treatment Period 3||8
8906248|NCT02106403|9964366|FG005|COMPLETED|Visit 1, Treatment Period 3||9
8906249|NCT02106403|9964361|FG000|NOT COMPLETED|Visit 1, Treatment Period 3||0
8906250|NCT02106403|9964362|FG001|NOT COMPLETED|Visit 1, Treatment Period 3||0
8906251|NCT02106403|9964363|FG002|NOT COMPLETED|Visit 1, Treatment Period 3||0
8906252|NCT02106403|9964364|FG003|NOT COMPLETED|Visit 1, Treatment Period 3||0
8906253|NCT02106403|9964365|FG004|NOT COMPLETED|Visit 1, Treatment Period 3||0
8906254|NCT02106403|9964366|FG005|NOT COMPLETED|Visit 1, Treatment Period 3||0
8906255|NCT02106403|9964361|FG000|STARTED|Follow-Up Visit 2||8
8906256|NCT02106403|9964362|FG001|STARTED|Follow-Up Visit 2||8
8906257|NCT02106403|9964363|FG002|STARTED|Follow-Up Visit 2||9
8906258|NCT02106403|9964364|FG003|STARTED|Follow-Up Visit 2||8
9012664|NCT03011840|10075427|FG001|NOT COMPLETED|Overall Study||21
9012665|NCT03011892|10075439|FG000|STARTED|Double Blind (DB) Period||52
9012666|NCT03011892|10075440|FG001|STARTED|Double Blind (DB) Period||51
8636703|NCT01980355|9677394|FG000|NOT COMPLETED|Overall Study||0
8636704|NCT01980355|9677395|FG001|NOT COMPLETED|Overall Study||0
8636705|NCT01855412|9677404|FG000|STARTED|Overall Study||501
8636706|NCT01855412|9677405|FG001|STARTED|Overall Study||603
8636707|NCT01855412|9677406|FG002|STARTED|Overall Study||100
8636708|NCT01855412|9677404|FG000|COMPLETED|Overall Study||289
8906259|NCT02106403|9964365|FG004|STARTED|Follow-Up Visit 2||8
8906260|NCT02106403|9964366|FG005|STARTED|Follow-Up Visit 2||9
8906261|NCT02106403|9964361|FG000|COMPLETED|Follow-Up Visit 2||8
8906262|NCT02106403|9964362|FG001|COMPLETED|Follow-Up Visit 2||8
8906263|NCT02106403|9964363|FG002|COMPLETED|Follow-Up Visit 2||9
8906264|NCT02106403|9964364|FG003|COMPLETED|Follow-Up Visit 2||8
8906265|NCT02106403|9964365|FG004|COMPLETED|Follow-Up Visit 2||8
8906266|NCT02106403|9964366|FG005|COMPLETED|Follow-Up Visit 2||9
8906267|NCT02106403|9964361|FG000|NOT COMPLETED|Follow-Up Visit 2||0
8906268|NCT02106403|9964362|FG001|NOT COMPLETED|Follow-Up Visit 2||0
8906269|NCT02106403|9964363|FG002|NOT COMPLETED|Follow-Up Visit 2||0
8906270|NCT02106403|9964364|FG003|NOT COMPLETED|Follow-Up Visit 2||0
8906271|NCT02106403|9964365|FG004|NOT COMPLETED|Follow-Up Visit 2||0
8906272|NCT02106403|9964366|FG005|NOT COMPLETED|Follow-Up Visit 2||0
8906273|NCT02106403|9964361|FG000|STARTED|Follow-Up Visit 3||8
8906274|NCT02106403|9964362|FG001|STARTED|Follow-Up Visit 3||8
8906275|NCT02106403|9964363|FG002|STARTED|Follow-Up Visit 3||9
9012667|NCT03011892|10075441|FG002|STARTED|Double Blind (DB) Period||51
9012668|NCT03011892|10075442|FG003|STARTED|Double Blind (DB) Period||51
9012669|NCT03011892|10075443|FG004|STARTED|Double Blind (DB) Period||52
9012670|NCT03011892|10075444|FG005|STARTED|Double Blind (DB) Period||50
9012671|NCT03011892|10075445|FG006|STARTED|Double Blind (DB) Period||0
9012672|NCT03011892|10075446|FG007|STARTED|Double Blind (DB) Period||0
9012673|NCT03011892|10075447|FG008|STARTED|Double Blind (DB) Period||0
9012674|NCT03011892|10075448|FG009|STARTED|Double Blind (DB) Period||0
9012675|NCT03011892|10075449|FG010|STARTED|Double Blind (DB) Period||0
9012676|NCT03011892|10075450|FG011|STARTED|Double Blind (DB) Period||0
9012677|NCT03011892|10075439|FG000|Treated in DB Period|Double Blind (DB) Period||52
9012678|NCT03011892|10075440|FG001|Treated in DB Period|Double Blind (DB) Period||51
9012679|NCT03011892|10075441|FG002|Treated in DB Period|Double Blind (DB) Period||51
9012680|NCT03011892|10075442|FG003|Treated in DB Period|Double Blind (DB) Period||51
9012681|NCT03011892|10075443|FG004|Treated in DB Period|Double Blind (DB) Period||51
9012682|NCT03011892|10075444|FG005|Treated in DB Period|Double Blind (DB) Period||50
9012683|NCT03011892|10075445|FG006|Treated in DB Period|Double Blind (DB) Period||0
9012684|NCT03011892|10075446|FG007|Treated in DB Period|Double Blind (DB) Period||0
9012685|NCT03011892|10075447|FG008|Treated in DB Period|Double Blind (DB) Period||0
9012686|NCT03011892|10075448|FG009|Treated in DB Period|Double Blind (DB) Period||0
9012687|NCT03011892|10075449|FG010|Treated in DB Period|Double Blind (DB) Period||0
9012688|NCT03011892|10075450|FG011|Treated in DB Period|Double Blind (DB) Period||0
9012689|NCT03011892|10075439|FG000|Completed Treatment Through Week 4|Double Blind (DB) Period||44
9012690|NCT03011892|10075440|FG001|Completed Treatment Through Week 4|Double Blind (DB) Period||46
9012691|NCT03011892|10075441|FG002|Completed Treatment Through Week 4|Double Blind (DB) Period||48
9012692|NCT03011892|10075442|FG003|Completed Treatment Through Week 4|Double Blind (DB) Period||47
9012693|NCT03011892|10075443|FG004|Completed Treatment Through Week 4|Double Blind (DB) Period||49
9012694|NCT03011892|10075444|FG005|Completed Treatment Through Week 4|Double Blind (DB) Period||49
9012695|NCT03011892|10075445|FG006|Completed Treatment Through Week 4|Double Blind (DB) Period||0
9012696|NCT03011892|10075446|FG007|Completed Treatment Through Week 4|Double Blind (DB) Period||0
9012697|NCT03011892|10075447|FG008|Completed Treatment Through Week 4|Double Blind (DB) Period||0
9012698|NCT03011892|10075448|FG009|Completed Treatment Through Week 4|Double Blind (DB) Period||0
9012699|NCT03011892|10075449|FG010|Completed Treatment Through Week 4|Double Blind (DB) Period||0
9012700|NCT03011892|10075450|FG011|Completed Treatment Through Week 4|Double Blind (DB) Period||0
9012701|NCT03011892|10075439|FG000|COMPLETED|Double Blind (DB) Period||41
9012702|NCT03011892|10075440|FG001|COMPLETED|Double Blind (DB) Period||41
9012703|NCT03011892|10075441|FG002|COMPLETED|Double Blind (DB) Period||45
9012704|NCT03011892|10075442|FG003|COMPLETED|Double Blind (DB) Period||44
9012705|NCT03011892|10075443|FG004|COMPLETED|Double Blind (DB) Period||45
9012706|NCT03011892|10075444|FG005|COMPLETED|Double Blind (DB) Period||45
9012707|NCT03011892|10075445|FG006|COMPLETED|Double Blind (DB) Period||0
9012708|NCT03011892|10075446|FG007|COMPLETED|Double Blind (DB) Period||0
9012709|NCT03011892|10075447|FG008|COMPLETED|Double Blind (DB) Period||0
9012710|NCT03011892|10075448|FG009|COMPLETED|Double Blind (DB) Period||0
9012711|NCT03011892|10075449|FG010|COMPLETED|Double Blind (DB) Period||0
9012712|NCT03011892|10075450|FG011|COMPLETED|Double Blind (DB) Period||0
9012713|NCT03011892|10075439|FG000|NOT COMPLETED|Double Blind (DB) Period||11
9012714|NCT03011892|10075440|FG001|NOT COMPLETED|Double Blind (DB) Period||10
9012715|NCT03011892|10075441|FG002|NOT COMPLETED|Double Blind (DB) Period||6
9012716|NCT03011892|10075442|FG003|NOT COMPLETED|Double Blind (DB) Period||7
9012717|NCT03011892|10075443|FG004|NOT COMPLETED|Double Blind (DB) Period||7
9012718|NCT03011892|10075444|FG005|NOT COMPLETED|Double Blind (DB) Period||5
9012719|NCT03011892|10075445|FG006|NOT COMPLETED|Double Blind (DB) Period||0
9012720|NCT03011892|10075446|FG007|NOT COMPLETED|Double Blind (DB) Period||0
9012721|NCT03011892|10075447|FG008|NOT COMPLETED|Double Blind (DB) Period||0
9012722|NCT03011892|10075448|FG009|NOT COMPLETED|Double Blind (DB) Period||0
9012723|NCT03011892|10075449|FG010|NOT COMPLETED|Double Blind (DB) Period||0
9012724|NCT03011892|10075450|FG011|NOT COMPLETED|Double Blind (DB) Period||0
9012725|NCT03011892|10075439|FG000|STARTED|Open Label (OL) Period||0
8906276|NCT02106403|9964364|FG003|STARTED|Follow-Up Visit 3||8
8906277|NCT02106403|9964365|FG004|STARTED|Follow-Up Visit 3||8
8906278|NCT02106403|9964366|FG005|STARTED|Follow-Up Visit 3||9
8906279|NCT02106403|9964361|FG000|COMPLETED|Follow-Up Visit 3||8
9012726|NCT03011892|10075440|FG001|STARTED|Open Label (OL) Period||0
9012727|NCT03011892|10075441|FG002|STARTED|Open Label (OL) Period||0
9012728|NCT03011892|10075442|FG003|STARTED|Open Label (OL) Period||0
9012729|NCT03011892|10075443|FG004|STARTED|Open Label (OL) Period||0
9012730|NCT03011892|10075444|FG005|STARTED|Open Label (OL) Period||0
9012731|NCT03011892|10075445|FG006|STARTED|Open Label (OL) Period||41
9012732|NCT03011892|10075446|FG007|STARTED|Open Label (OL) Period||40
9012733|NCT03011892|10075447|FG008|STARTED|Open Label (OL) Period||45
9012734|NCT03011892|10075448|FG009|STARTED|Open Label (OL) Period||41
9012735|NCT03011892|10075449|FG010|STARTED|Open Label (OL) Period||42
9012736|NCT03011892|10075450|FG011|STARTED|Open Label (OL) Period||43
9012737|NCT03011892|10075439|FG000|COMPLETED|Open Label (OL) Period||0
9012738|NCT03011892|10075440|FG001|COMPLETED|Open Label (OL) Period||0
9012739|NCT03011892|10075441|FG002|COMPLETED|Open Label (OL) Period||0
9012740|NCT03011892|10075442|FG003|COMPLETED|Open Label (OL) Period||0
9012741|NCT03011892|10075443|FG004|COMPLETED|Open Label (OL) Period||0
9012742|NCT03011892|10075444|FG005|COMPLETED|Open Label (OL) Period||0
9012743|NCT03011892|10075445|FG006|COMPLETED|Open Label (OL) Period||34
9012744|NCT03011892|10075446|FG007|COMPLETED|Open Label (OL) Period||37
8573285|NCT00120523|9605531|FG001|STARTED|Treatment Period||1213
8573286|NCT00120523|9605530|FG000|COMPLETED|Treatment Period||836
8573287|NCT00120523|9605531|FG001|COMPLETED|Treatment Period||874
8573288|NCT00120523|9605530|FG000|NOT COMPLETED|Treatment Period||369
8573289|NCT00120523|9605531|FG001|NOT COMPLETED|Treatment Period||339
8573290|NCT00120523|9605530|FG000|STARTED|Follow-Up Period|Patients discontinued due to lost to follow-up or who withdrew consent were not part of this period.|120
9012745|NCT03011892|10075447|FG008|COMPLETED|Open Label (OL) Period||43
9012746|NCT03011892|10075448|FG009|COMPLETED|Open Label (OL) Period||41
9012747|NCT03011892|10075449|FG010|COMPLETED|Open Label (OL) Period||40
9012748|NCT03011892|10075450|FG011|COMPLETED|Open Label (OL) Period||40
9012749|NCT03011892|10075439|FG000|NOT COMPLETED|Open Label (OL) Period||0
9012750|NCT03011892|10075440|FG001|NOT COMPLETED|Open Label (OL) Period||0
9012751|NCT03011892|10075441|FG002|NOT COMPLETED|Open Label (OL) Period||0
9012752|NCT03011892|10075442|FG003|NOT COMPLETED|Open Label (OL) Period||0
9012753|NCT03011892|10075443|FG004|NOT COMPLETED|Open Label (OL) Period||0
9012754|NCT03011892|10075444|FG005|NOT COMPLETED|Open Label (OL) Period||0
9012755|NCT03011892|10075445|FG006|NOT COMPLETED|Open Label (OL) Period||7
9012756|NCT03011892|10075446|FG007|NOT COMPLETED|Open Label (OL) Period||3
9012757|NCT03011892|10075447|FG008|NOT COMPLETED|Open Label (OL) Period||2
9012758|NCT03011892|10075448|FG009|NOT COMPLETED|Open Label (OL) Period||0
9012759|NCT03011892|10075449|FG010|NOT COMPLETED|Open Label (OL) Period||2
9012760|NCT03011892|10075450|FG011|NOT COMPLETED|Open Label (OL) Period||3
9012761|NCT03012061|10075480|FG000|STARTED|Overall Study||143
9012762|NCT03012061|10075481|FG001|STARTED|Overall Study||139
9012763|NCT03012061|10075482|FG002|STARTED|Overall Study||139
9012764|NCT03012061|10075480|FG000|COMPLETED|Overall Study||137
9012765|NCT03012061|10075481|FG001|COMPLETED|Overall Study||130
9012766|NCT03012061|10075482|FG002|COMPLETED|Overall Study||131
9012767|NCT03012061|10075480|FG000|NOT COMPLETED|Overall Study||6
9012768|NCT03012061|10075481|FG001|NOT COMPLETED|Overall Study||9
9012769|NCT03012061|10075482|FG002|NOT COMPLETED|Overall Study||8
9012770|NCT03012191|10075493|FG000|STARTED|Overall Study||2
9012771|NCT03012191|10075494|FG001|STARTED|Overall Study||2
9012772|NCT03012191|10075495|FG002|STARTED|Overall Study||2
9012773|NCT03012191|10075493|FG000|COMPLETED|Overall Study||2
9012774|NCT03012191|10075494|FG001|COMPLETED|Overall Study||2
9012775|NCT03012191|10075495|FG002|COMPLETED|Overall Study||2
9012776|NCT03012191|10075493|FG000|NOT COMPLETED|Overall Study||0
9012777|NCT03012191|10075494|FG001|NOT COMPLETED|Overall Study||0
9012778|NCT03012191|10075495|FG002|NOT COMPLETED|Overall Study||0
9012779|NCT03012334|10075514|FG000|STARTED|Period 1||9
9012780|NCT03012334|10075515|FG001|STARTED|Period 1||9
9012781|NCT03012334|10075516|FG002|STARTED|Period 1||9
9012782|NCT03012334|10075517|FG003|STARTED|Period 1||9
9012783|NCT03012334|10075518|FG004|STARTED|Period 1||9
9012784|NCT03012334|10075519|FG005|STARTED|Period 1||9
8636709|NCT01855412|9677405|FG001|COMPLETED|Overall Study||260
8636710|NCT01855412|9677406|FG002|COMPLETED|Overall Study||24
8906280|NCT02106403|9964362|FG001|COMPLETED|Follow-Up Visit 3||8
8906281|NCT02106403|9964363|FG002|COMPLETED|Follow-Up Visit 3||9
8906282|NCT02106403|9964364|FG003|COMPLETED|Follow-Up Visit 3||8
8906283|NCT02106403|9964365|FG004|COMPLETED|Follow-Up Visit 3||8
8906284|NCT02106403|9964366|FG005|COMPLETED|Follow-Up Visit 3||8
8906285|NCT02106403|9964361|FG000|NOT COMPLETED|Follow-Up Visit 3||0
8906286|NCT02106403|9964362|FG001|NOT COMPLETED|Follow-Up Visit 3||0
8906287|NCT02106403|9964363|FG002|NOT COMPLETED|Follow-Up Visit 3||0
8906288|NCT02106403|9964364|FG003|NOT COMPLETED|Follow-Up Visit 3||0
8906289|NCT02106403|9964365|FG004|NOT COMPLETED|Follow-Up Visit 3||0
8906290|NCT02106403|9964366|FG005|NOT COMPLETED|Follow-Up Visit 3||1
8906291|NCT02106442|9964376|FG000|STARTED|Overall Study||579
8906292|NCT02106442|9964376|FG000|COMPLETED|Overall Study||542
9012785|NCT03012334|10075520|FG006|STARTED|Period 1||9
9012786|NCT03012334|10075521|FG007|STARTED|Period 1||9
9012787|NCT03012334|10075522|FG008|STARTED|Period 1||9
9012788|NCT03012334|10075523|FG009|STARTED|Period 1||9
9012789|NCT03012334|10075514|FG000|COMPLETED|Period 1||9
9012790|NCT03012334|10075515|FG001|COMPLETED|Period 1||9
9012791|NCT03012334|10075516|FG002|COMPLETED|Period 1||9
9012792|NCT03012334|10075517|FG003|COMPLETED|Period 1||9
8906293|NCT02106442|9964376|FG000|NOT COMPLETED|Overall Study||37
8906294|NCT02106455|9964380|FG000|STARTED|Overall Study||315
8906295|NCT02106455|9964380|FG000|COMPLETED|Overall Study||307
8906296|NCT02106455|9964380|FG000|NOT COMPLETED|Overall Study||8
8906297|NCT02106494|9964386|FG000|STARTED|Overall Study||471
8906298|NCT02106494|9964387|FG001|STARTED|Overall Study||471
8906299|NCT02106494|9964386|FG000|Safety Population|Overall Study||456
8906300|NCT02106494|9964387|FG001|Safety Population|Overall Study||459
8906301|NCT02106494|9964386|FG000|Efficacy Population|Overall Study||450
8906302|NCT02106494|9964387|FG001|Efficacy Population|Overall Study||452
8906303|NCT02106494|9964386|FG000|COMPLETED|Overall Study||445
8906304|NCT02106494|9964387|FG001|COMPLETED|Overall Study||446
8906305|NCT02106494|9964386|FG000|NOT COMPLETED|Overall Study||26
8906306|NCT02106494|9964387|FG001|NOT COMPLETED|Overall Study||25
8906307|NCT02106728|9964397|FG000|STARTED|Overall Study||70
9012793|NCT03012334|10075518|FG004|COMPLETED|Period 1||9
9012794|NCT03012334|10075519|FG005|COMPLETED|Period 1||9
9012795|NCT03012334|10075520|FG006|COMPLETED|Period 1||9
9012796|NCT03012334|10075521|FG007|COMPLETED|Period 1||9
9012797|NCT03012334|10075522|FG008|COMPLETED|Period 1||9
9012798|NCT03012334|10075523|FG009|COMPLETED|Period 1||8
9012799|NCT03012334|10075514|FG000|NOT COMPLETED|Period 1||0
9012800|NCT03012334|10075515|FG001|NOT COMPLETED|Period 1||0
9012801|NCT03012334|10075516|FG002|NOT COMPLETED|Period 1||0
9012802|NCT03012334|10075517|FG003|NOT COMPLETED|Period 1||0
9012803|NCT03012334|10075518|FG004|NOT COMPLETED|Period 1||0
9012804|NCT03012334|10075519|FG005|NOT COMPLETED|Period 1||0
9012805|NCT03012334|10075520|FG006|NOT COMPLETED|Period 1||0
9012806|NCT03012334|10075521|FG007|NOT COMPLETED|Period 1||0
9012807|NCT03012334|10075522|FG008|NOT COMPLETED|Period 1||0
9012808|NCT03012334|10075523|FG009|NOT COMPLETED|Period 1||1
9012809|NCT03012334|10075514|FG000|STARTED|Period 2||9
9012810|NCT03012334|10075515|FG001|STARTED|Period 2||9
9012811|NCT03012334|10075516|FG002|STARTED|Period 2||9
9012812|NCT03012334|10075517|FG003|STARTED|Period 2||9
9012813|NCT03012334|10075518|FG004|STARTED|Period 2||9
9012814|NCT03012334|10075519|FG005|STARTED|Period 2||9
9012815|NCT03012334|10075520|FG006|STARTED|Period 2||9
9012816|NCT03012334|10075521|FG007|STARTED|Period 2||9
9012817|NCT03012334|10075522|FG008|STARTED|Period 2||9
9012818|NCT03012334|10075523|FG009|STARTED|Period 2||8
9012819|NCT03012334|10075514|FG000|COMPLETED|Period 2||9
9012820|NCT03012334|10075515|FG001|COMPLETED|Period 2||8
9012821|NCT03012334|10075516|FG002|COMPLETED|Period 2||8
9012822|NCT03012334|10075517|FG003|COMPLETED|Period 2||9
9012823|NCT03012334|10075518|FG004|COMPLETED|Period 2||9
9012824|NCT03012334|10075519|FG005|COMPLETED|Period 2||9
9012825|NCT03012334|10075520|FG006|COMPLETED|Period 2||9
9012826|NCT03012334|10075521|FG007|COMPLETED|Period 2||8
9012827|NCT03012334|10075522|FG008|COMPLETED|Period 2||9
9012828|NCT03012334|10075523|FG009|COMPLETED|Period 2||8
9012829|NCT03012334|10075514|FG000|NOT COMPLETED|Period 2||0
9012830|NCT03012334|10075515|FG001|NOT COMPLETED|Period 2||1
9012831|NCT03012334|10075516|FG002|NOT COMPLETED|Period 2||1
9012832|NCT03012334|10075517|FG003|NOT COMPLETED|Period 2||0
9012833|NCT03012334|10075518|FG004|NOT COMPLETED|Period 2||0
9012834|NCT03012334|10075519|FG005|NOT COMPLETED|Period 2||0
9012835|NCT03012334|10075520|FG006|NOT COMPLETED|Period 2||0
9012836|NCT03012334|10075521|FG007|NOT COMPLETED|Period 2||1
9012837|NCT03012334|10075522|FG008|NOT COMPLETED|Period 2||0
9012838|NCT03012334|10075523|FG009|NOT COMPLETED|Period 2||0
9012839|NCT03012334|10075514|FG000|STARTED|Period 3||9
9012840|NCT03012334|10075515|FG001|STARTED|Period 3||8
9012841|NCT03012334|10075516|FG002|STARTED|Period 3||8
9012842|NCT03012334|10075517|FG003|STARTED|Period 3||9
8573291|NCT00120523|9605531|FG001|STARTED|Follow-Up Period|Patients discontinued due to lost to follow-up or who withdrew consent were not part of this period.|70
8573292|NCT00120523|9605530|FG000|COMPLETED|Follow-Up Period||90
8573293|NCT00120523|9605531|FG001|COMPLETED|Follow-Up Period||46
8573294|NCT00120523|9605530|FG000|NOT COMPLETED|Follow-Up Period||30
8906308|NCT02106728|9964398|FG001|STARTED|Overall Study||47
8906309|NCT02106728|9964397|FG000|COMPLETED|Overall Study||70
8906310|NCT02106728|9964398|FG001|COMPLETED|Overall Study||47
8906311|NCT02106728|9964397|FG000|NOT COMPLETED|Overall Study||0
8906312|NCT02106728|9964398|FG001|NOT COMPLETED|Overall Study||0
9012843|NCT03012334|10075518|FG004|STARTED|Period 3||9
9012844|NCT03012334|10075519|FG005|STARTED|Period 3||9
9012845|NCT03012334|10075520|FG006|STARTED|Period 3||9
9012846|NCT03012334|10075521|FG007|STARTED|Period 3||8
9012847|NCT03012334|10075522|FG008|STARTED|Period 3||9
9012848|NCT03012334|10075523|FG009|STARTED|Period 3||8
9012849|NCT03012334|10075514|FG000|COMPLETED|Period 3||9
9012850|NCT03012334|10075515|FG001|COMPLETED|Period 3||8
9012851|NCT03012334|10075516|FG002|COMPLETED|Period 3||8
9012852|NCT03012334|10075517|FG003|COMPLETED|Period 3||9
8906313|NCT02106832|9964414|FG000|STARTED|Overall Study||171
8906314|NCT02106832|9964415|FG001|STARTED|Overall Study||176
9012853|NCT03012334|10075518|FG004|COMPLETED|Period 3||9
9012854|NCT03012334|10075519|FG005|COMPLETED|Period 3||9
9012855|NCT03012334|10075520|FG006|COMPLETED|Period 3||9
9012856|NCT03012334|10075521|FG007|COMPLETED|Period 3||8
9012857|NCT03012334|10075522|FG008|COMPLETED|Period 3||9
9012858|NCT03012334|10075523|FG009|COMPLETED|Period 3||8
9012859|NCT03012334|10075514|FG000|NOT COMPLETED|Period 3||0
9012860|NCT03012334|10075515|FG001|NOT COMPLETED|Period 3||0
9012861|NCT03012334|10075516|FG002|NOT COMPLETED|Period 3||0
9012862|NCT03012334|10075517|FG003|NOT COMPLETED|Period 3||0
8906315|NCT02106832|9964416|FG002|STARTED|Overall Study||86
8906316|NCT02106832|9964417|FG003|STARTED|Overall Study||88
8906317|NCT02106832|9964414|FG000|Participants Received Treatment|Overall Study||171
8906318|NCT02106832|9964415|FG001|Participants Received Treatment|Overall Study||174
8906319|NCT02106832|9964416|FG002|Participants Received Treatment|Overall Study||86
8906320|NCT02106832|9964417|FG003|Participants Received Treatment|Overall Study||88
8906321|NCT02106832|9964414|FG000|COMPLETED|Overall Study||148
8906322|NCT02106832|9964415|FG001|COMPLETED|Overall Study||151
8906323|NCT02106832|9964416|FG002|COMPLETED|Overall Study||70
8906324|NCT02106832|9964417|FG003|COMPLETED|Overall Study||73
8906325|NCT02106832|9964414|FG000|NOT COMPLETED|Overall Study||23
8906326|NCT02106832|9964415|FG001|NOT COMPLETED|Overall Study||25
8906327|NCT02106832|9964416|FG002|NOT COMPLETED|Overall Study||16
8906328|NCT02106832|9964417|FG003|NOT COMPLETED|Overall Study||15
8906329|NCT02106884|9964431|FG000|STARTED|Overall Study||72
8906330|NCT02106884|9964432|FG001|STARTED|Overall Study||74
8906331|NCT02106884|9964431|FG000|COMPLETED|Overall Study||72
8906332|NCT02106884|9964432|FG001|COMPLETED|Overall Study|ITT analysis based on treatment assigned at baseline.|73
8906333|NCT02106884|9964431|FG000|NOT COMPLETED|Overall Study||0
8906334|NCT02106884|9964432|FG001|NOT COMPLETED|Overall Study||1
8906335|NCT02106910|9964443|FG000|STARTED|Overall Study||49
8906336|NCT02106910|9964444|FG001|STARTED|Overall Study||89
8906337|NCT02106910|9964443|FG000|COMPLETED|Overall Study||48
8906338|NCT02106910|9964444|FG001|COMPLETED|Overall Study||88
8906339|NCT02106910|9964443|FG000|NOT COMPLETED|Overall Study||1
8906340|NCT02106910|9964444|FG001|NOT COMPLETED|Overall Study||1
8906341|NCT02106923|9964454|FG000|STARTED|Overall Study||12
8906342|NCT02106923|9964455|FG001|STARTED|Overall Study||12
8906343|NCT02106923|9964456|FG002|STARTED|Overall Study||12
8906344|NCT02106923|9964457|FG003|STARTED|Overall Study||12
8906345|NCT02106923|9964458|FG004|STARTED|Overall Study||12
8906346|NCT02106923|9964459|FG005|STARTED|Overall Study||12
8906347|NCT02106923|9964454|FG000|COMPLETED|Overall Study||12
8906348|NCT02106923|9964455|FG001|COMPLETED|Overall Study||12
8906349|NCT02106923|9964456|FG002|COMPLETED|Overall Study||12
8906350|NCT02106923|9964457|FG003|COMPLETED|Overall Study||12
8906351|NCT02106923|9964458|FG004|COMPLETED|Overall Study||12
8906352|NCT02106923|9964459|FG005|COMPLETED|Overall Study||11
8906353|NCT02106923|9964454|FG000|NOT COMPLETED|Overall Study||0
8906354|NCT02106923|9964455|FG001|NOT COMPLETED|Overall Study||0
8906355|NCT02106923|9964456|FG002|NOT COMPLETED|Overall Study||0
8906356|NCT02106923|9964457|FG003|NOT COMPLETED|Overall Study||0
8906357|NCT02106923|9964458|FG004|NOT COMPLETED|Overall Study||0
8906358|NCT02106923|9964459|FG005|NOT COMPLETED|Overall Study||1
8906359|NCT02106962|9964475|FG000|STARTED|Overall Study||8
8906360|NCT02106962|9964476|FG001|STARTED|Overall Study||9
8906361|NCT02106962|9964475|FG000|COMPLETED|Overall Study||8
8906362|NCT02106962|9964476|FG001|COMPLETED|Overall Study||9
8906363|NCT02106962|9964475|FG000|NOT COMPLETED|Overall Study||0
8906364|NCT02106962|9964476|FG001|NOT COMPLETED|Overall Study||0
8906365|NCT02106975|9964486|FG000|STARTED|Overall Study||84
8906366|NCT02106975|9964487|FG001|STARTED|Overall Study||83
8906367|NCT02106975|9964486|FG000|COMPLETED|Overall Study||59
8906368|NCT02106975|9964487|FG001|COMPLETED|Overall Study||44
8906369|NCT02106975|9964486|FG000|NOT COMPLETED|Overall Study||25
9012863|NCT03012334|10075518|FG004|NOT COMPLETED|Period 3||0
9012864|NCT03012334|10075519|FG005|NOT COMPLETED|Period 3||0
9012865|NCT03012334|10075520|FG006|NOT COMPLETED|Period 3||0
9012866|NCT03012334|10075521|FG007|NOT COMPLETED|Period 3||0
9012867|NCT03012334|10075522|FG008|NOT COMPLETED|Period 3||0
9012868|NCT03012334|10075523|FG009|NOT COMPLETED|Period 3||0
9012869|NCT03012334|10075514|FG000|STARTED|Period 4||9
9012870|NCT03012334|10075515|FG001|STARTED|Period 4||8
9012871|NCT03012334|10075516|FG002|STARTED|Period 4||8
9012872|NCT03012334|10075517|FG003|STARTED|Period 4||9
9012873|NCT03012334|10075518|FG004|STARTED|Period 4||9
9012874|NCT03012334|10075519|FG005|STARTED|Period 4||9
9012875|NCT03012334|10075520|FG006|STARTED|Period 4||9
9012876|NCT03012334|10075521|FG007|STARTED|Period 4||8
9012877|NCT03012334|10075522|FG008|STARTED|Period 4||9
9012878|NCT03012334|10075523|FG009|STARTED|Period 4||8
9012879|NCT03012334|10075514|FG000|COMPLETED|Period 4||9
9012880|NCT03012334|10075515|FG001|COMPLETED|Period 4||8
9012881|NCT03012334|10075516|FG002|COMPLETED|Period 4||8
9012882|NCT03012334|10075517|FG003|COMPLETED|Period 4||9
9012883|NCT03012334|10075518|FG004|COMPLETED|Period 4||9
9012884|NCT03012334|10075519|FG005|COMPLETED|Period 4||9
9012885|NCT03012334|10075520|FG006|COMPLETED|Period 4||8
9012886|NCT03012334|10075521|FG007|COMPLETED|Period 4||8
9012887|NCT03012334|10075522|FG008|COMPLETED|Period 4||8
9012888|NCT03012334|10075523|FG009|COMPLETED|Period 4||8
8906370|NCT02106975|9964487|FG001|NOT COMPLETED|Overall Study||39
8906371|NCT02107014|9964493|FG000|STARTED|Overall Study||9
8906372|NCT02107014|9964493|FG000|COMPLETED|Overall Study||8
8906373|NCT02107014|9964493|FG000|NOT COMPLETED|Overall Study||1
8906374|NCT02107092|9964497|FG000|STARTED|Overall Study||123
8906375|NCT02107092|9964497|FG000|COMPLETED|Overall Study||79
8906376|NCT02107092|9964497|FG000|NOT COMPLETED|Overall Study||44
9012889|NCT03012334|10075514|FG000|NOT COMPLETED|Period 4||0
9012890|NCT03012334|10075515|FG001|NOT COMPLETED|Period 4||0
9012891|NCT03012334|10075516|FG002|NOT COMPLETED|Period 4||0
9012892|NCT03012334|10075517|FG003|NOT COMPLETED|Period 4||0
9012893|NCT03012334|10075518|FG004|NOT COMPLETED|Period 4||0
9012894|NCT03012334|10075519|FG005|NOT COMPLETED|Period 4||0
8906377|NCT02107131|9964503|FG000|STARTED|Overall Study||20
8906378|NCT02107131|9964504|FG001|STARTED|Overall Study||20
8906379|NCT02107131|9964503|FG000|COMPLETED|Overall Study||12
8906380|NCT02107131|9964504|FG001|COMPLETED|Overall Study||11
8906381|NCT02107131|9964503|FG000|NOT COMPLETED|Overall Study||8
8906382|NCT02107131|9964504|FG001|NOT COMPLETED|Overall Study||9
9012895|NCT03012334|10075520|FG006|NOT COMPLETED|Period 4||1
9012896|NCT03012334|10075521|FG007|NOT COMPLETED|Period 4||0
9012897|NCT03012334|10075522|FG008|NOT COMPLETED|Period 4||1
9012898|NCT03012334|10075523|FG009|NOT COMPLETED|Period 4||0
9012899|NCT03012334|10075514|FG000|STARTED|Period 5||9
9012900|NCT03012334|10075515|FG001|STARTED|Period 5||8
9012901|NCT03012334|10075516|FG002|STARTED|Period 5||8
9012902|NCT03012334|10075517|FG003|STARTED|Period 5||9
9012903|NCT03012334|10075518|FG004|STARTED|Period 5||9
9012904|NCT03012334|10075519|FG005|STARTED|Period 5||9
9012905|NCT03012334|10075520|FG006|STARTED|Period 5||8
9012906|NCT03012334|10075521|FG007|STARTED|Period 5||8
9012907|NCT03012334|10075522|FG008|STARTED|Period 5||8
9012908|NCT03012334|10075523|FG009|STARTED|Period 5||8
9012909|NCT03012334|10075514|FG000|COMPLETED|Period 5||9
9012910|NCT03012334|10075515|FG001|COMPLETED|Period 5||8
9012911|NCT03012334|10075516|FG002|COMPLETED|Period 5||8
9012912|NCT03012334|10075517|FG003|COMPLETED|Period 5||9
9012913|NCT03012334|10075518|FG004|COMPLETED|Period 5||9
9012914|NCT03012334|10075519|FG005|COMPLETED|Period 5||9
9012915|NCT03012334|10075520|FG006|COMPLETED|Period 5||8
9012916|NCT03012334|10075521|FG007|COMPLETED|Period 5||8
9012917|NCT03012334|10075522|FG008|COMPLETED|Period 5||8
9012918|NCT03012334|10075523|FG009|COMPLETED|Period 5||8
9012919|NCT03012334|10075514|FG000|NOT COMPLETED|Period 5||0
9012920|NCT03012334|10075515|FG001|NOT COMPLETED|Period 5||0
9012921|NCT03012334|10075516|FG002|NOT COMPLETED|Period 5||0
9012922|NCT03012334|10075517|FG003|NOT COMPLETED|Period 5||0
9012923|NCT03012334|10075518|FG004|NOT COMPLETED|Period 5||0
9012924|NCT03012334|10075519|FG005|NOT COMPLETED|Period 5||0
9012925|NCT03012334|10075520|FG006|NOT COMPLETED|Period 5||0
9012926|NCT03012334|10075521|FG007|NOT COMPLETED|Period 5||0
9012927|NCT03012334|10075522|FG008|NOT COMPLETED|Period 5||0
9012928|NCT03012334|10075523|FG009|NOT COMPLETED|Period 5||0
9012929|NCT03012477|10075536|FG000|STARTED|Overall Study||34
9012930|NCT03012477|10075536|FG000|COMPLETED|Overall Study||34
9012931|NCT03012477|10075536|FG000|NOT COMPLETED|Overall Study||0
9012932|NCT03012594|10075540|FG000|STARTED|Overall Study||12
9012933|NCT03012594|10075540|FG000|COMPLETED|Overall Study||9
9012934|NCT03012594|10075540|FG000|NOT COMPLETED|Overall Study||3
9012935|NCT03012828|10075550|FG000|STARTED|Overall Study||10
9012936|NCT03012828|10075551|FG001|STARTED|Overall Study||10
9012937|NCT03012828|10075552|FG002|STARTED|Overall Study||10
9012938|NCT03012828|10075553|FG003|STARTED|Overall Study||10
9012939|NCT03012828|10075554|FG004|STARTED|Overall Study||10
9012940|NCT03012828|10075555|FG005|STARTED|Overall Study||10
9012941|NCT03012828|10075550|FG000|COMPLETED|Overall Study||9
9012942|NCT03012828|10075551|FG001|COMPLETED|Overall Study||10
9012943|NCT03012828|10075552|FG002|COMPLETED|Overall Study||8
9012944|NCT03012828|10075553|FG003|COMPLETED|Overall Study||10
9012945|NCT03012828|10075554|FG004|COMPLETED|Overall Study||8
9012946|NCT03012828|10075555|FG005|COMPLETED|Overall Study||8
9012947|NCT03012828|10075550|FG000|NOT COMPLETED|Overall Study||1
9012948|NCT03012828|10075551|FG001|NOT COMPLETED|Overall Study||0
9012949|NCT03012828|10075552|FG002|NOT COMPLETED|Overall Study||2
9012950|NCT03012828|10075553|FG003|NOT COMPLETED|Overall Study||0
9012951|NCT03012828|10075554|FG004|NOT COMPLETED|Overall Study||2
9012952|NCT03012828|10075555|FG005|NOT COMPLETED|Overall Study||2
9012953|NCT03012841|10075571|FG000|STARTED|Overall Study||165
9012954|NCT03012841|10075572|FG001|STARTED|Overall Study||21
9012955|NCT03012841|10075571|FG000|COMPLETED|Overall Study||145
9012956|NCT03012841|10075572|FG001|COMPLETED|Overall Study||0
9012957|NCT03012841|10075571|FG000|NOT COMPLETED|Overall Study||20
9012958|NCT03012841|10075572|FG001|NOT COMPLETED|Overall Study||21
9012959|NCT03013985|10075579|FG000|STARTED|Overall Study||108
9012960|NCT03013985|10075580|FG001|STARTED|Overall Study||103
9012961|NCT03013985|10075579|FG000|COMPLETED|Overall Study||92
8906383|NCT02107157|9964515|FG000|STARTED|Overall Study||11
8906384|NCT02107157|9964516|FG001|STARTED|Overall Study||12
8906385|NCT02107157|9964517|FG002|STARTED|Overall Study||4
8906386|NCT02107157|9964515|FG000|COMPLETED|Overall Study||6
8906387|NCT02107157|9964516|FG001|COMPLETED|Overall Study||11
8906388|NCT02107157|9964517|FG002|COMPLETED|Overall Study||4
8906389|NCT02107157|9964515|FG000|NOT COMPLETED|Overall Study||5
8906390|NCT02107157|9964516|FG001|NOT COMPLETED|Overall Study||1
8906391|NCT02107157|9964517|FG002|NOT COMPLETED|Overall Study||0
8906392|NCT02107196|9964527|FG000|STARTED|12-week Treatment Period|Safety population, all enrolled patients who received at least one dose of study drug|271
8906393|NCT02107196|9964528|FG001|STARTED|12-week Treatment Period|Safety population, all enrolled patients who received at least one dose of study drug|264
8906394|NCT02107196|9964527|FG000|Intention To Treat (ITT)|12-week Treatment Period|All randomised patients who took at least one dose of study drug during 12-week treatment period|271
8906395|NCT02107196|9964528|FG001|Intention To Treat (ITT)|12-week Treatment Period|All randomised patients who took at least one dose of study drug during 12-week treatment period|264
8906396|NCT02107196|9964527|FG000|Modified ITT|12-week Treatment Period|All ITT patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|221
8906397|NCT02107196|9964528|FG001|Modified ITT|12-week Treatment Period|All ITT patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|216
8906398|NCT02107196|9964527|FG000|COMPLETED|12-week Treatment Period||227
8906399|NCT02107196|9964528|FG001|COMPLETED|12-week Treatment Period||225
8906400|NCT02107196|9964527|FG000|NOT COMPLETED|12-week Treatment Period||44
8906401|NCT02107196|9964528|FG001|NOT COMPLETED|12-week Treatment Period||39
8906402|NCT02107196|9964527|FG000|STARTED|4-week Randomized Withdrawal (RW) Period|all re-randomized patients at Visit 6 [Day85]|338
8906403|NCT02107196|9964528|FG001|STARTED|4-week Randomized Withdrawal (RW) Period|all re-randomized patients at Visit 6 [Day85]|114
8906404|NCT02107196|9964527|FG000|RW Population|4-week Randomized Withdrawal (RW) Period|All re-randomized ITT patients,who received at least 1 dose of ibodutant during RW period|338
8906405|NCT02107196|9964528|FG001|RW Population|4-week Randomized Withdrawal (RW) Period|All re-randomized ITT patients,who received at least 1 dose of placebo during RW period|114
8906406|NCT02107196|9964527|FG000|Modified RW Population|4-week Randomized Withdrawal (RW) Period|all RW patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|272
8906407|NCT02107196|9964528|FG001|Modified RW Population|4-week Randomized Withdrawal (RW) Period|all RW patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|90
8906408|NCT02107196|9964527|FG000|COMPLETED|4-week Randomized Withdrawal (RW) Period||315
8906409|NCT02107196|9964528|FG001|COMPLETED|4-week Randomized Withdrawal (RW) Period||109
8906410|NCT02107196|9964527|FG000|NOT COMPLETED|4-week Randomized Withdrawal (RW) Period||23
8906411|NCT02107196|9964528|FG001|NOT COMPLETED|4-week Randomized Withdrawal (RW) Period||5
8906412|NCT02107274|9964536|FG000|STARTED|Treatment vs. Placebo||39
8906413|NCT02107274|9964537|FG001|STARTED|Treatment vs. Placebo||39
8906414|NCT02107274|9964536|FG000|COMPLETED|Treatment vs. Placebo||36
8906415|NCT02107274|9964537|FG001|COMPLETED|Treatment vs. Placebo||37
8906416|NCT02107274|9964536|FG000|NOT COMPLETED|Treatment vs. Placebo||3
8906417|NCT02107274|9964537|FG001|NOT COMPLETED|Treatment vs. Placebo||2
8906418|NCT02107274|9964536|FG000|STARTED|Control Phase||36
8906419|NCT02107274|9964537|FG001|STARTED|Control Phase||37
8906420|NCT02107274|9964536|FG000|COMPLETED|Control Phase||33
8906421|NCT02107274|9964537|FG001|COMPLETED|Control Phase||35
8906422|NCT02107274|9964536|FG000|NOT COMPLETED|Control Phase||3
8906423|NCT02107274|9964537|FG001|NOT COMPLETED|Control Phase||2
8906424|NCT02107300|9964545|FG000|STARTED|Overall Study||16
8906425|NCT02107300|9964546|FG001|STARTED|Overall Study||15
8906426|NCT02107300|9964545|FG000|COMPLETED|Overall Study||16
8636711|NCT01855412|9677404|FG000|NOT COMPLETED|Overall Study||212
8636712|NCT01855412|9677405|FG001|NOT COMPLETED|Overall Study||343
8636713|NCT01855412|9677406|FG002|NOT COMPLETED|Overall Study||76
8636714|NCT01559935|9677420|FG000|STARTED|Car Phase||72
8636715|NCT01559935|9677420|FG000|COMPLETED|Car Phase||58
8636716|NCT01559935|9677420|FG000|NOT COMPLETED|Car Phase||14
8636717|NCT01559935|9677420|FG000|STARTED|BiRD Phase||58
8636718|NCT01559935|9677420|FG000|COMPLETED|BiRD Phase||54
8636719|NCT01559935|9677420|FG000|NOT COMPLETED|BiRD Phase||4
8636720|NCT01559935|9677420|FG000|STARTED|Maintenance Phase||54
8636721|NCT01559935|9677420|FG000|COMPLETED|Maintenance Phase||0
8906427|NCT02107300|9964546|FG001|COMPLETED|Overall Study||15
8906428|NCT02107300|9964545|FG000|NOT COMPLETED|Overall Study||0
8906429|NCT02107300|9964546|FG001|NOT COMPLETED|Overall Study||0
8906430|NCT02107313|9964552|FG000|STARTED|Overall Study||9
8906431|NCT02107313|9964553|FG001|STARTED|Overall Study|One participant from the study did not cross over and participate in the FED cohort|9
8906432|NCT02107313|9964552|FG000|COMPLETED|Overall Study||9
8906433|NCT02107313|9964553|FG001|COMPLETED|Overall Study||8
8906434|NCT02107313|9964552|FG000|NOT COMPLETED|Overall Study||0
8906435|NCT02107313|9964553|FG001|NOT COMPLETED|Overall Study||1
8906436|NCT02107339|9964561|FG000|STARTED|Overall Study||63
8906437|NCT02107339|9964562|FG001|STARTED|Overall Study||57
8906438|NCT02107339|9964561|FG000|COMPLETED|Overall Study||62
8906439|NCT02107339|9964562|FG001|COMPLETED|Overall Study||53
8906440|NCT02107339|9964561|FG000|NOT COMPLETED|Overall Study||1
8906441|NCT02107339|9964562|FG001|NOT COMPLETED|Overall Study||4
8906442|NCT02107443|9964570|FG000|STARTED|Overall Study||296
8906443|NCT02107443|9964571|FG001|STARTED|Overall Study||250
8906444|NCT02107443|9964570|FG000|COMPLETED|Overall Study||198
8906445|NCT02107443|9964571|FG001|COMPLETED|Overall Study||167
8906446|NCT02107443|9964570|FG000|NOT COMPLETED|Overall Study||98
8906447|NCT02107443|9964571|FG001|NOT COMPLETED|Overall Study||83
8906448|NCT02107482|9964578|FG000|STARTED|Overall Study|21 participants enrolled. Total of 21 participants recvd both active and sham|21
8906449|NCT02107482|9964578|FG000|COMPLETED|Overall Study||17
8906450|NCT02107482|9964578|FG000|NOT COMPLETED|Overall Study||4
8906451|NCT02107599|9964582|FG000|STARTED|Overall Study||96
8906452|NCT02107599|9964582|FG000|COMPLETED|Overall Study||96
8906453|NCT02107599|9964582|FG000|NOT COMPLETED|Overall Study||0
8906454|NCT02107703|9964591|FG000|STARTED|Overall Study||446
8906455|NCT02107703|9964592|FG001|STARTED|Overall Study||223
8906456|NCT02107703|9964591|FG000|Received at Least 1 Dose of Study Drug|Overall Study||441
8906457|NCT02107703|9964592|FG001|Received at Least 1 Dose of Study Drug|Overall Study||223
8906458|NCT02107703|9964591|FG000|COMPLETED|Overall Study||85
8906459|NCT02107703|9964592|FG001|COMPLETED|Overall Study||48
8906460|NCT02107703|9964591|FG000|NOT COMPLETED|Overall Study||361
8906461|NCT02107703|9964592|FG001|NOT COMPLETED|Overall Study||175
8906462|NCT02107859|9964601|FG000|STARTED|Overall Study||61
8636722|NCT01559935|9677420|FG000|NOT COMPLETED|Maintenance Phase||54
8636723|NCT01285362|9677426|FG000|STARTED|Overall Study||4
8636724|NCT01285362|9677427|FG001|STARTED|Overall Study||4
8636725|NCT01285362|9677426|FG000|COMPLETED|Overall Study||4
9012962|NCT03013985|10075580|FG001|COMPLETED|Overall Study||84
9012963|NCT03013985|10075579|FG000|NOT COMPLETED|Overall Study||16
9012964|NCT03013985|10075580|FG001|NOT COMPLETED|Overall Study||19
9012965|NCT03014011|10075586|FG000|STARTED|First Intervention||14
9012966|NCT03014011|10075587|FG001|STARTED|First Intervention||13
9012967|NCT03014011|10075586|FG000|COMPLETED|First Intervention||13
9012968|NCT03014011|10075587|FG001|COMPLETED|First Intervention||13
9012969|NCT03014011|10075586|FG000|NOT COMPLETED|First Intervention||1
9012970|NCT03014011|10075587|FG001|NOT COMPLETED|First Intervention||0
9012971|NCT03014011|10075586|FG000|STARTED|Washout||13
9012972|NCT03014011|10075587|FG001|STARTED|Washout||13
9012973|NCT03014011|10075586|FG000|COMPLETED|Washout||12
9012974|NCT03014011|10075587|FG001|COMPLETED|Washout||13
9012975|NCT03014011|10075586|FG000|NOT COMPLETED|Washout||1
9012976|NCT03014011|10075587|FG001|NOT COMPLETED|Washout||0
9012977|NCT03014011|10075586|FG000|STARTED|Second Intervention||12
9012978|NCT03014011|10075587|FG001|STARTED|Second Intervention||13
9012979|NCT03014011|10075586|FG000|COMPLETED|Second Intervention||12
9012980|NCT03014011|10075587|FG001|COMPLETED|Second Intervention||13
9012981|NCT03014011|10075586|FG000|NOT COMPLETED|Second Intervention||0
9012982|NCT03014011|10075587|FG001|NOT COMPLETED|Second Intervention||0
9012983|NCT03014180|10075593|FG000|STARTED|Overall Study||60
9012984|NCT03014180|10075593|FG000|COMPLETED|Overall Study||58
9012985|NCT03014180|10075593|FG000|NOT COMPLETED|Overall Study||2
9012986|NCT03014206|10075601|FG000|STARTED|Overall Study||696
9012987|NCT03014206|10075601|FG000|COMPLETED|Overall Study||684
9012988|NCT03014206|10075601|FG000|NOT COMPLETED|Overall Study||12
9012989|NCT03014453|10075605|FG000|STARTED|Overall Study||187
9012990|NCT03014453|10075605|FG000|COMPLETED|Overall Study||116
9012991|NCT03014453|10075605|FG000|NOT COMPLETED|Overall Study||71
9012992|NCT03014479|10075611|FG000|STARTED|Overall Study||110
9012993|NCT03014479|10075612|FG001|STARTED|Overall Study||109
9012994|NCT03014479|10075611|FG000|COMPLETED|Overall Study||110
9012995|NCT03014479|10075612|FG001|COMPLETED|Overall Study||105
9012996|NCT03014479|10075611|FG000|NOT COMPLETED|Overall Study||0
9012997|NCT03014479|10075612|FG001|NOT COMPLETED|Overall Study||4
9012998|NCT03014492|10075620|FG000|STARTED|Overall Study||44
9012999|NCT03014492|10075621|FG001|STARTED|Overall Study||28
9013000|NCT03014492|10075620|FG000|COMPLETED|Overall Study||44
9013001|NCT03014492|10075621|FG001|COMPLETED|Overall Study||28
9013002|NCT03014492|10075620|FG000|NOT COMPLETED|Overall Study||0
9013003|NCT03014492|10075621|FG001|NOT COMPLETED|Overall Study||0
9013004|NCT03014674|10075630|FG000|STARTED|Overall Study||85
9013005|NCT03014674|10075631|FG001|STARTED|Overall Study||79
9013006|NCT03014674|10075632|FG002|STARTED|Overall Study||80
9013007|NCT03014674|10075630|FG000|COMPLETED|Overall Study||84
9013008|NCT03014674|10075631|FG001|COMPLETED|Overall Study||79
9013009|NCT03014674|10075632|FG002|COMPLETED|Overall Study||80
9013010|NCT03014674|10075630|FG000|NOT COMPLETED|Overall Study||1
9013011|NCT03014674|10075631|FG001|NOT COMPLETED|Overall Study||0
9013012|NCT03014674|10075632|FG002|NOT COMPLETED|Overall Study||0
9013013|NCT03014700|10075642|FG000|STARTED|Overall Study||30
9013014|NCT03014700|10075643|FG001|STARTED|Overall Study||30
9013015|NCT03014700|10075642|FG000|COMPLETED|Overall Study||25
9013016|NCT03014700|10075643|FG001|COMPLETED|Overall Study||29
9013017|NCT03014700|10075642|FG000|NOT COMPLETED|Overall Study||5
9013018|NCT03014700|10075643|FG001|NOT COMPLETED|Overall Study||1
8573295|NCT00120523|9605531|FG001|NOT COMPLETED|Follow-Up Period||24
8573296|NCT00120627|9605540|FG000|STARTED|Overall Study|This is the number who enrolled and was randomly assigned to receive the Mantram Repetition Program.|71
8573297|NCT00120627|9605541|FG001|STARTED|Overall Study|This was the number that enrolled and was randomly assigned to receive the control condition.|75
8573298|NCT00120627|9605540|FG000|Began Interventions|Overall Study|Two people dropped due to scheduling conflict and illness.|69
8573299|NCT00120627|9605541|FG001|Began Interventions|Overall Study|Two people dropped due to scheduling conflict and an unknown reason.|73
8573300|NCT00120627|9605540|FG000|Did Not Complete Post-tx Assessments|Overall Study|One person had a scheduling conflict and two people were incarcerated.|3
8573301|NCT00120627|9605541|FG001|Did Not Complete Post-tx Assessments|Overall Study|Three people dropped out but no reason given.|3
8573302|NCT00120627|9605540|FG000|COMPLETED|Overall Study||66
8577592|NCT00159861|9610348|FG000|Treated|Extension Study - up to 3 Years||115
8726560|NCT01037244|9773803|FG003|mITT (Modified Intent-to-Treat)|Overall Study||153
8726561|NCT01037244|9773800|FG000|Safety Population|Overall Study|Two subjects randomized to receive placebo inadvertently received udenafil (1 - 50 mg and 1- 150 mg)|155
8726562|NCT01037244|9773801|FG001|Safety Population|Overall Study||150
9013019|NCT03015116|10075652|FG000|STARTED|Overall Study||38
9013020|NCT03015116|10075653|FG001|STARTED|Overall Study||38
9013021|NCT03015116|10075654|FG002|STARTED|Overall Study||38
8726563|NCT01037244|9773802|FG002|Safety Population|Overall Study|Two subjects randomized to receive placebo inadvertently received udenafil (1 - 50 mg and 1- 150 mg)|159
8726564|NCT01037244|9773803|FG003|Safety Population|Overall Study||152
8726565|NCT01037244|9773800|FG000|COMPLETED|Overall Study||141
9013022|NCT03015116|10075652|FG000|COMPLETED|Overall Study||31
9013023|NCT03015116|10075653|FG001|COMPLETED|Overall Study||36
9013024|NCT03015116|10075654|FG002|COMPLETED|Overall Study||36
9013025|NCT03015116|10075652|FG000|NOT COMPLETED|Overall Study||7
9013026|NCT03015116|10075653|FG001|NOT COMPLETED|Overall Study||2
9013027|NCT03015116|10075654|FG002|NOT COMPLETED|Overall Study||2
9013028|NCT03015181|10075671|FG000|STARTED|Overall Study||4
9013029|NCT03015181|10075672|FG001|STARTED|Overall Study||3
9013030|NCT03015181|10075673|FG002|STARTED|Overall Study||3
8906463|NCT02107859|9964601|FG000|As-treated Population|Overall Study||61
8906464|NCT02107859|9964601|FG000|Intent-to-treat (ITT) Population|Overall Study||60
8906465|NCT02107859|9964601|FG000|COMPLETED|Overall Study||0
8906466|NCT02107859|9964601|FG000|NOT COMPLETED|Overall Study||61
8906467|NCT02107898|9964607|FG000|STARTED|Overall Study|Randomized|72
8906468|NCT02107898|9964608|FG001|STARTED|Overall Study|Randomized|144
8906469|NCT02107898|9964607|FG000|Treated|Overall Study||72
8906470|NCT02107898|9964608|FG001|Treated|Overall Study||143
8906471|NCT02107898|9964607|FG000|COMPLETED|Overall Study||66
8906472|NCT02107898|9964608|FG001|COMPLETED|Overall Study||132
8906473|NCT02107898|9964607|FG000|NOT COMPLETED|Overall Study||6
8906474|NCT02107898|9964608|FG001|NOT COMPLETED|Overall Study||12
8906475|NCT02108171|9964616|FG000|STARTED|Overall Study||40
8906476|NCT02108171|9964617|FG001|STARTED|Overall Study||41
8906477|NCT02108171|9964616|FG000|COMPLETED|Overall Study||40
8906478|NCT02108171|9964617|FG001|COMPLETED|Overall Study||41
8906479|NCT02108171|9964616|FG000|NOT COMPLETED|Overall Study||0
8906480|NCT02108171|9964617|FG001|NOT COMPLETED|Overall Study||0
8906481|NCT02108223|9964627|FG000|STARTED|Overall Study||52
8906482|NCT02108223|9964628|FG001|STARTED|Overall Study||50
8906483|NCT02108223|9964629|FG002|STARTED|Overall Study||35
8906484|NCT02108223|9964627|FG000|COMPLETED|Overall Study||52
8906485|NCT02108223|9964628|FG001|COMPLETED|Overall Study||50
8906486|NCT02108223|9964629|FG002|COMPLETED|Overall Study||35
8906487|NCT02108223|9964627|FG000|NOT COMPLETED|Overall Study||0
8906488|NCT02108223|9964628|FG001|NOT COMPLETED|Overall Study||0
8906489|NCT02108223|9964629|FG002|NOT COMPLETED|Overall Study||0
8906490|NCT02108262|9964644|FG000|STARTED|Overall Study||9
8906491|NCT02108262|9964645|FG001|STARTED|Overall Study||419
8906492|NCT02108262|9964646|FG002|STARTED|Overall Study||421
8906493|NCT02108262|9964647|FG003|STARTED|Overall Study||418
8906494|NCT02108262|9964644|FG000|COMPLETED|Overall Study||9
8906495|NCT02108262|9964645|FG001|COMPLETED|Overall Study||375
8906496|NCT02108262|9964646|FG002|COMPLETED|Overall Study||379
8906497|NCT02108262|9964647|FG003|COMPLETED|Overall Study||376
8906498|NCT02108262|9964644|FG000|NOT COMPLETED|Overall Study||0
8906499|NCT02108262|9964645|FG001|NOT COMPLETED|Overall Study||44
8906500|NCT02108262|9964646|FG002|NOT COMPLETED|Overall Study||42
8906501|NCT02108262|9964647|FG003|NOT COMPLETED|Overall Study||42
8906502|NCT02108288|9964659|FG000|STARTED|Overall Study||10
8906503|NCT02108288|9964660|FG001|STARTED|Overall Study||10
8906504|NCT02108288|9964661|FG002|STARTED|Overall Study||10
8906505|NCT02108288|9964659|FG000|COMPLETED|Overall Study||10
8906506|NCT02108288|9964660|FG001|COMPLETED|Overall Study||10
8906507|NCT02108288|9964661|FG002|COMPLETED|Overall Study||10
8906508|NCT02108288|9964659|FG000|NOT COMPLETED|Overall Study||0
8906509|NCT02108288|9964660|FG001|NOT COMPLETED|Overall Study||0
8906510|NCT02108288|9964661|FG002|NOT COMPLETED|Overall Study||0
9013031|NCT03015181|10075674|FG003|STARTED|Overall Study||3
9013032|NCT03015181|10075675|FG004|STARTED|Overall Study||3
9013033|NCT03015181|10075676|FG005|STARTED|Overall Study||5
9013034|NCT03015181|10075677|FG006|STARTED|Overall Study||5
9013035|NCT03015181|10075671|FG000|Received VRC07-523LS Per Protocol|Overall Study||3
9013036|NCT03015181|10075672|FG001|Received VRC07-523LS Per Protocol|Overall Study||3
9013037|NCT03015181|10075673|FG002|Received VRC07-523LS Per Protocol|Overall Study||3
9013038|NCT03015181|10075674|FG003|Received VRC07-523LS Per Protocol|Overall Study||3
9013039|NCT03015181|10075675|FG004|Received VRC07-523LS Per Protocol|Overall Study||3
9013040|NCT03015181|10075676|FG005|Received VRC07-523LS Per Protocol|Overall Study||4
9013041|NCT03015181|10075677|FG006|Received VRC07-523LS Per Protocol|Overall Study||4
9013042|NCT03015181|10075671|FG000|Discontinued VRC07-523LS Administrations|Overall Study|One Group 1 subject decided not to receive the VRC07-523LS infusion|1
9013043|NCT03015181|10075672|FG001|Discontinued VRC07-523LS Administrations|Overall Study||0
9013044|NCT03015181|10075673|FG002|Discontinued VRC07-523LS Administrations|Overall Study||0
9013045|NCT03015181|10075674|FG003|Discontinued VRC07-523LS Administrations|Overall Study||0
9013046|NCT03015181|10075675|FG004|Discontinued VRC07-523LS Administrations|Overall Study||0
9013047|NCT03015181|10075676|FG005|Discontinued VRC07-523LS Administrations|Overall Study|One Group 6 subject received only 1 of 3 scheduled doses prior to withdrawing from the study|1
9013048|NCT03015181|10075677|FG006|Discontinued VRC07-523LS Administrations|Overall Study|One Group 7 subject received only 1 of 3 scheduled doses due to an unrelated intercurrent illness|1
9013049|NCT03015181|10075671|FG000|COMPLETED|Overall Study||3
9013050|NCT03015181|10075672|FG001|COMPLETED|Overall Study||3
9013051|NCT03015181|10075673|FG002|COMPLETED|Overall Study||3
9013052|NCT03015181|10075674|FG003|COMPLETED|Overall Study||3
9013053|NCT03015181|10075675|FG004|COMPLETED|Overall Study||3
9013054|NCT03015181|10075676|FG005|COMPLETED|Overall Study|Group 6 subject who received only 1 dose chose to withdraw from study after the first administration|4
9013055|NCT03015181|10075677|FG006|COMPLETED|Overall Study|Group 7 subject who received only 1 dose was withdrawn after unrelated intercurrent illness resolved|4
9013056|NCT03015181|10075671|FG000|NOT COMPLETED|Overall Study||1
9013057|NCT03015181|10075672|FG001|NOT COMPLETED|Overall Study||0
9013058|NCT03015181|10075673|FG002|NOT COMPLETED|Overall Study||0
9013059|NCT03015181|10075674|FG003|NOT COMPLETED|Overall Study||0
9013060|NCT03015181|10075675|FG004|NOT COMPLETED|Overall Study||0
9013061|NCT03015181|10075676|FG005|NOT COMPLETED|Overall Study||1
9013062|NCT03015181|10075677|FG006|NOT COMPLETED|Overall Study||1
9013063|NCT03015220|10075717|FG000|STARTED|Overall Study||131
9013064|NCT03015220|10075718|FG001|STARTED|Overall Study||132
9013065|NCT03015220|10075719|FG002|STARTED|Overall Study||130
9013066|NCT03015220|10075720|FG003|STARTED|Overall Study||65
9013067|NCT03015220|10075717|FG000|Full Analysis Set (FAS)|Overall Study||131
9013068|NCT03015220|10075718|FG001|Full Analysis Set (FAS)|Overall Study||132
9013069|NCT03015220|10075719|FG002|Full Analysis Set (FAS)|Overall Study||130
9013070|NCT03015220|10075720|FG003|Full Analysis Set (FAS)|Overall Study||65
9013071|NCT03015220|10075717|FG000|Safety Analysis Set (SAS)|Overall Study||131
9013072|NCT03015220|10075718|FG001|Safety Analysis Set (SAS)|Overall Study||132
9013073|NCT03015220|10075719|FG002|Safety Analysis Set (SAS)|Overall Study||130
9013074|NCT03015220|10075720|FG003|Safety Analysis Set (SAS)|Overall Study||65
9013075|NCT03015220|10075717|FG000|COMPLETED|Overall Study||128
9013076|NCT03015220|10075718|FG001|COMPLETED|Overall Study||130
9013077|NCT03015220|10075719|FG002|COMPLETED|Overall Study||127
9013078|NCT03015220|10075720|FG003|COMPLETED|Overall Study||63
9013079|NCT03015220|10075717|FG000|NOT COMPLETED|Overall Study||3
9013080|NCT03015220|10075718|FG001|NOT COMPLETED|Overall Study||2
9013081|NCT03015220|10075719|FG002|NOT COMPLETED|Overall Study||3
9013082|NCT03015220|10075720|FG003|NOT COMPLETED|Overall Study||2
9013083|NCT03015363|10075730|FG000|STARTED|Overall Study||37
9013084|NCT03015363|10075730|FG000|COMPLETED|Overall Study||20
9013085|NCT03015363|10075730|FG000|NOT COMPLETED|Overall Study||17
9013086|NCT03015532|10075742|FG000|STARTED|Overall Study||20
9013087|NCT03015532|10075743|FG001|STARTED|Overall Study||22
9013088|NCT03015532|10075744|FG002|STARTED|Overall Study||11
9013089|NCT03015532|10075745|FG003|STARTED|Overall Study||10
9013090|NCT03015532|10075746|FG004|STARTED|Overall Study||58
9013091|NCT03015532|10075747|FG005|STARTED|Overall Study||56
9013092|NCT03015532|10075748|FG006|STARTED|Overall Study||53
9013093|NCT03015532|10075749|FG007|STARTED|Overall Study||55
9013094|NCT03015532|10075742|FG000|COMPLETED|Overall Study||20
9013095|NCT03015532|10075743|FG001|COMPLETED|Overall Study||22
9013096|NCT03015532|10075744|FG002|COMPLETED|Overall Study||11
9013097|NCT03015532|10075745|FG003|COMPLETED|Overall Study||10
9013098|NCT03015532|10075746|FG004|COMPLETED|Overall Study||58
9013099|NCT03015532|10075747|FG005|COMPLETED|Overall Study||54
9013100|NCT03015532|10075748|FG006|COMPLETED|Overall Study||51
9013101|NCT03015532|10075749|FG007|COMPLETED|Overall Study||55
9013102|NCT03015532|10075742|FG000|NOT COMPLETED|Overall Study||0
9013103|NCT03015532|10075743|FG001|NOT COMPLETED|Overall Study||0
9013104|NCT03015532|10075744|FG002|NOT COMPLETED|Overall Study||0
9013105|NCT03015532|10075745|FG003|NOT COMPLETED|Overall Study||0
9013106|NCT03015532|10075746|FG004|NOT COMPLETED|Overall Study||0
9013107|NCT03015532|10075747|FG005|NOT COMPLETED|Overall Study||2
9013108|NCT03015532|10075748|FG006|NOT COMPLETED|Overall Study||2
9013109|NCT03015532|10075749|FG007|NOT COMPLETED|Overall Study||0
9013110|NCT03015649|10075769|FG000|STARTED|Overall Study||34
9013111|NCT03015649|10075769|FG000|COMPLETED|Overall Study||34
9013112|NCT03015649|10075769|FG000|NOT COMPLETED|Overall Study||0
9013113|NCT03015961|10075775|FG000|STARTED|Overall Study||18
9013114|NCT03015961|10075776|FG001|STARTED|Overall Study||20
9013115|NCT03015961|10075775|FG000|COMPLETED|Overall Study||18
9013116|NCT03015961|10075776|FG001|COMPLETED|Overall Study||18
9013117|NCT03015961|10075775|FG000|NOT COMPLETED|Overall Study||0
9013118|NCT03015961|10075776|FG001|NOT COMPLETED|Overall Study||2
9013119|NCT03016078|10075782|FG000|STARTED|Overall Study||21
9013120|NCT03016078|10075782|FG000|COMPLETED|Overall Study||19
9013121|NCT03016078|10075782|FG000|NOT COMPLETED|Overall Study||2
9013122|NCT03016325|10075794|FG000|STARTED|Treatment Period||48
8573303|NCT00120627|9605541|FG001|COMPLETED|Overall Study|Three people refused the post-assessments CAPS interview only.|70
8573304|NCT00120627|9605540|FG000|NOT COMPLETED|Overall Study||5
8573305|NCT00120627|9605541|FG001|NOT COMPLETED|Overall Study||5
8573306|NCT00120874|9605558|FG000|STARTED|Overall Study||10
8573307|NCT00120874|9605559|FG001|STARTED|Overall Study||10
8573308|NCT00120874|9605558|FG000|Completed Study; Started Extension Study|Overall Study||10
8726566|NCT01037244|9773801|FG001|COMPLETED|Overall Study||138
8726567|NCT01037244|9773802|FG002|COMPLETED|Overall Study||144
8726568|NCT01037244|9773803|FG003|COMPLETED|Overall Study||140
8726569|NCT01037244|9773800|FG000|NOT COMPLETED|Overall Study||13
8726570|NCT01037244|9773801|FG001|NOT COMPLETED|Overall Study||14
8726571|NCT01037244|9773802|FG002|NOT COMPLETED|Overall Study||14
8726572|NCT01037244|9773803|FG003|NOT COMPLETED|Overall Study||14
8726573|NCT01037309|9773819|FG000|STARTED|Subcutaneous Cohort 1 - 6||3
8726574|NCT01037309|9773820|FG001|STARTED|Subcutaneous Cohort 1 - 6||3
8726575|NCT01037309|9773821|FG002|STARTED|Subcutaneous Cohort 1 - 6||3
8726576|NCT01037309|9773822|FG003|STARTED|Subcutaneous Cohort 1 - 6||3
8573309|NCT00120874|9605559|FG001|Completed Study; Started Extension Study|Overall Study||10
8573310|NCT00120874|9605558|FG000|COMPLETED|Overall Study||10
8573311|NCT00120874|9605559|FG001|COMPLETED|Overall Study||9
8573312|NCT00120874|9605558|FG000|NOT COMPLETED|Overall Study||0
9013123|NCT03016325|10075795|FG001|STARTED|Treatment Period||49
9013124|NCT03016325|10075796|FG002|STARTED|Treatment Period||71
9013125|NCT03016325|10075797|FG003|STARTED|Treatment Period||71
9013126|NCT03016325|10075798|FG004|STARTED|Treatment Period||72
9013127|NCT03016325|10075799|FG005|STARTED|Treatment Period||6
9013128|NCT03016325|10075800|FG006|STARTED|Treatment Period||6
9013129|NCT03016325|10075801|FG007|STARTED|Treatment Period||6
9013130|NCT03016325|10075794|FG000|COMPLETED|Treatment Period||48
9013131|NCT03016325|10075795|FG001|COMPLETED|Treatment Period||48
9013132|NCT03016325|10075796|FG002|COMPLETED|Treatment Period||70
9013133|NCT03016325|10075797|FG003|COMPLETED|Treatment Period||71
9013134|NCT03016325|10075798|FG004|COMPLETED|Treatment Period||70
8906511|NCT02108457|9964671|FG000|STARTED|Overall Study||3
8906512|NCT02108457|9964672|FG001|STARTED|Overall Study||12
8906513|NCT02108457|9964671|FG000|COMPLETED|Overall Study||3
8906514|NCT02108457|9964672|FG001|COMPLETED|Overall Study||10
8906515|NCT02108457|9964671|FG000|NOT COMPLETED|Overall Study||0
8906516|NCT02108457|9964672|FG001|NOT COMPLETED|Overall Study||2
8906517|NCT02108522|9964678|FG000|STARTED|Screening Period||82
8906518|NCT02108522|9964678|FG000|COMPLETED|Screening Period||58
8906519|NCT02108522|9964678|FG000|NOT COMPLETED|Screening Period||24
8906520|NCT02108522|9964678|FG000|STARTED|Period 1: Initial Cohort||50
8906521|NCT02108522|9964678|FG000|COMPLETED|Period 1: Initial Cohort||28
8906522|NCT02108522|9964678|FG000|NOT COMPLETED|Period 1: Initial Cohort||22
8906523|NCT02108522|9964678|FG000|STARTED|Period 2: Expansion Cohort||8
8906524|NCT02108522|9964678|FG000|COMPLETED|Period 2: Expansion Cohort||2
8906525|NCT02108522|9964678|FG000|NOT COMPLETED|Period 2: Expansion Cohort||6
8906526|NCT02108600|9964684|FG000|STARTED|Overall Study||17
8906527|NCT02108600|9964685|FG001|STARTED|Overall Study||16
8906528|NCT02108600|9964684|FG000|COMPLETED|Overall Study||14
8906529|NCT02108600|9964685|FG001|COMPLETED|Overall Study|1 patient lost to follow up after the primary endpoint biopsy|15
8906530|NCT02108600|9964684|FG000|NOT COMPLETED|Overall Study||3
8906531|NCT02108600|9964685|FG001|NOT COMPLETED|Overall Study||1
8906532|NCT02108691|9964693|FG000|STARTED|Overall Study||40
8906533|NCT02108691|9964694|FG001|STARTED|Overall Study||40
8906534|NCT02108691|9964693|FG000|COMPLETED|Overall Study||32
8906535|NCT02108691|9964694|FG001|COMPLETED|Overall Study||31
8906536|NCT02108691|9964693|FG000|NOT COMPLETED|Overall Study||8
9013135|NCT03016325|10075799|FG005|COMPLETED|Treatment Period||6
9013136|NCT03016325|10075800|FG006|COMPLETED|Treatment Period||6
9013137|NCT03016325|10075801|FG007|COMPLETED|Treatment Period||6
9013138|NCT03016325|10075794|FG000|NOT COMPLETED|Treatment Period||0
9013139|NCT03016325|10075795|FG001|NOT COMPLETED|Treatment Period||1
9013140|NCT03016325|10075796|FG002|NOT COMPLETED|Treatment Period||1
9013141|NCT03016325|10075797|FG003|NOT COMPLETED|Treatment Period||0
9013142|NCT03016325|10075798|FG004|NOT COMPLETED|Treatment Period||2
9013143|NCT03016325|10075799|FG005|NOT COMPLETED|Treatment Period||0
9013144|NCT03016325|10075800|FG006|NOT COMPLETED|Treatment Period||0
9013145|NCT03016325|10075801|FG007|NOT COMPLETED|Treatment Period||0
9013146|NCT03016325|10075794|FG000|STARTED|32-Day Follow-Up Period||48
9013147|NCT03016325|10075795|FG001|STARTED|32-Day Follow-Up Period||49
9013148|NCT03016325|10075796|FG002|STARTED|32-Day Follow-Up Period||71
9013149|NCT03016325|10075797|FG003|STARTED|32-Day Follow-Up Period||71
9013150|NCT03016325|10075798|FG004|STARTED|32-Day Follow-Up Period||72
9013151|NCT03016325|10075799|FG005|STARTED|32-Day Follow-Up Period||6
9013152|NCT03016325|10075800|FG006|STARTED|32-Day Follow-Up Period||6
9013153|NCT03016325|10075801|FG007|STARTED|32-Day Follow-Up Period||6
9013154|NCT03016325|10075794|FG000|COMPLETED|32-Day Follow-Up Period||44
9013155|NCT03016325|10075795|FG001|COMPLETED|32-Day Follow-Up Period||47
9013156|NCT03016325|10075796|FG002|COMPLETED|32-Day Follow-Up Period||62
9013157|NCT03016325|10075797|FG003|COMPLETED|32-Day Follow-Up Period||63
9013158|NCT03016325|10075798|FG004|COMPLETED|32-Day Follow-Up Period||64
9013159|NCT03016325|10075799|FG005|COMPLETED|32-Day Follow-Up Period||6
9013160|NCT03016325|10075800|FG006|COMPLETED|32-Day Follow-Up Period||5
9013161|NCT03016325|10075801|FG007|COMPLETED|32-Day Follow-Up Period||6
9013162|NCT03016325|10075794|FG000|NOT COMPLETED|32-Day Follow-Up Period||4
9013163|NCT03016325|10075795|FG001|NOT COMPLETED|32-Day Follow-Up Period||2
9013164|NCT03016325|10075796|FG002|NOT COMPLETED|32-Day Follow-Up Period||9
9013165|NCT03016325|10075797|FG003|NOT COMPLETED|32-Day Follow-Up Period||8
9013166|NCT03016325|10075798|FG004|NOT COMPLETED|32-Day Follow-Up Period||8
9013167|NCT03016325|10075799|FG005|NOT COMPLETED|32-Day Follow-Up Period||0
9013168|NCT03016325|10075800|FG006|NOT COMPLETED|32-Day Follow-Up Period||1
9013169|NCT03016325|10075801|FG007|NOT COMPLETED|32-Day Follow-Up Period||0
9013170|NCT03016325|10075794|FG000|STARTED|182-Day Follow-Up Period||48
9013171|NCT03016325|10075795|FG001|STARTED|182-Day Follow-Up Period||49
9013172|NCT03016325|10075796|FG002|STARTED|182-Day Follow-Up Period||71
9013173|NCT03016325|10075797|FG003|STARTED|182-Day Follow-Up Period||71
9013174|NCT03016325|10075798|FG004|STARTED|182-Day Follow-Up Period||72
9013175|NCT03016325|10075799|FG005|STARTED|182-Day Follow-Up Period||6
9013176|NCT03016325|10075800|FG006|STARTED|182-Day Follow-Up Period||6
9013177|NCT03016325|10075801|FG007|STARTED|182-Day Follow-Up Period||6
8906537|NCT02108691|9964694|FG001|NOT COMPLETED|Overall Study||9
8906538|NCT02108821|9964700|FG000|STARTED|Overall Study||23
9013178|NCT03016325|10075794|FG000|COMPLETED|182-Day Follow-Up Period||44
9013179|NCT03016325|10075795|FG001|COMPLETED|182-Day Follow-Up Period||45
9013180|NCT03016325|10075796|FG002|COMPLETED|182-Day Follow-Up Period||60
9013181|NCT03016325|10075797|FG003|COMPLETED|182-Day Follow-Up Period||58
9013182|NCT03016325|10075798|FG004|COMPLETED|182-Day Follow-Up Period||60
9013183|NCT03016325|10075799|FG005|COMPLETED|182-Day Follow-Up Period||1
9013184|NCT03016325|10075800|FG006|COMPLETED|182-Day Follow-Up Period||2
9013185|NCT03016325|10075801|FG007|COMPLETED|182-Day Follow-Up Period||1
9013186|NCT03016325|10075794|FG000|NOT COMPLETED|182-Day Follow-Up Period||4
9013187|NCT03016325|10075795|FG001|NOT COMPLETED|182-Day Follow-Up Period||4
9013188|NCT03016325|10075796|FG002|NOT COMPLETED|182-Day Follow-Up Period||11
9013189|NCT03016325|10075797|FG003|NOT COMPLETED|182-Day Follow-Up Period||13
9013190|NCT03016325|10075798|FG004|NOT COMPLETED|182-Day Follow-Up Period||12
9013191|NCT03016325|10075799|FG005|NOT COMPLETED|182-Day Follow-Up Period||5
9013192|NCT03016325|10075800|FG006|NOT COMPLETED|182-Day Follow-Up Period||4
9013193|NCT03016325|10075801|FG007|NOT COMPLETED|182-Day Follow-Up Period||5
9013194|NCT03016403|10075826|FG000|STARTED|Baseline||139
9013195|NCT03016403|10075827|FG001|STARTED|Baseline||147
9013196|NCT03016403|10075828|FG002|STARTED|Baseline||118
9013197|NCT03016403|10075829|FG003|STARTED|Baseline||131
9013198|NCT03016403|10075826|FG000|COMPLETED|Baseline||123
9013199|NCT03016403|10075827|FG001|COMPLETED|Baseline||120
9013200|NCT03016403|10075828|FG002|COMPLETED|Baseline||107
9013201|NCT03016403|10075829|FG003|COMPLETED|Baseline||97
9013202|NCT03016403|10075826|FG000|NOT COMPLETED|Baseline||16
9013203|NCT03016403|10075827|FG001|NOT COMPLETED|Baseline||27
9013204|NCT03016403|10075828|FG002|NOT COMPLETED|Baseline||11
9013205|NCT03016403|10075829|FG003|NOT COMPLETED|Baseline||34
9013206|NCT03016403|10075826|FG000|STARTED|6-week Follow-up|Anyone who had at least 1 follow-up after baseline.|123
9013207|NCT03016403|10075827|FG001|STARTED|6-week Follow-up||120
9013208|NCT03016403|10075828|FG002|STARTED|6-week Follow-up||107
9013209|NCT03016403|10075829|FG003|STARTED|6-week Follow-up||97
9013210|NCT03016403|10075826|FG000|COMPLETED|6-week Follow-up||120
9013211|NCT03016403|10075827|FG001|COMPLETED|6-week Follow-up||107
9013212|NCT03016403|10075828|FG002|COMPLETED|6-week Follow-up||103
9013213|NCT03016403|10075829|FG003|COMPLETED|6-week Follow-up||88
9013214|NCT03016403|10075826|FG000|NOT COMPLETED|6-week Follow-up||3
9013215|NCT03016403|10075827|FG001|NOT COMPLETED|6-week Follow-up||13
9013216|NCT03016403|10075828|FG002|NOT COMPLETED|6-week Follow-up||4
9013217|NCT03016403|10075829|FG003|NOT COMPLETED|6-week Follow-up||9
9013218|NCT03016403|10075826|FG000|STARTED|3-month Follow-up and 6-month Follow-up||120
9013219|NCT03016403|10075827|FG001|STARTED|3-month Follow-up and 6-month Follow-up||107
9013220|NCT03016403|10075828|FG002|STARTED|3-month Follow-up and 6-month Follow-up||103
9013221|NCT03016403|10075829|FG003|STARTED|3-month Follow-up and 6-month Follow-up||88
9013222|NCT03016403|10075826|FG000|COMPLETED|3-month Follow-up and 6-month Follow-up||108
9013223|NCT03016403|10075827|FG001|COMPLETED|3-month Follow-up and 6-month Follow-up||96
9013224|NCT03016403|10075828|FG002|COMPLETED|3-month Follow-up and 6-month Follow-up||95
9013225|NCT03016403|10075829|FG003|COMPLETED|3-month Follow-up and 6-month Follow-up||81
9013226|NCT03016403|10075826|FG000|NOT COMPLETED|3-month Follow-up and 6-month Follow-up||12
9013227|NCT03016403|10075827|FG001|NOT COMPLETED|3-month Follow-up and 6-month Follow-up||11
8636726|NCT01285362|9677427|FG001|COMPLETED|Overall Study||4
8636727|NCT01285362|9677426|FG000|NOT COMPLETED|Overall Study||0
8636728|NCT01285362|9677427|FG001|NOT COMPLETED|Overall Study||0
8636729|NCT01067144|9677435|FG000|STARTED|Treatment||207
8636730|NCT01067144|9677436|FG001|STARTED|Treatment||215
8636731|NCT01067144|9677435|FG000|COMPLETED|Treatment||203
8636732|NCT01067144|9677436|FG001|COMPLETED|Treatment||208
8636733|NCT01067144|9677435|FG000|NOT COMPLETED|Treatment||4
8636734|NCT01067144|9677436|FG001|NOT COMPLETED|Treatment||7
8636735|NCT01067144|9677435|FG000|STARTED|Follow-up||203
8636736|NCT01067144|9677436|FG001|STARTED|Follow-up||208
8636737|NCT01067144|9677435|FG000|Intention-to-Treat Analysis Set|Follow-up||202
8636738|NCT01067144|9677436|FG001|Intention-to-Treat Analysis Set|Follow-up||208
8636739|NCT01067144|9677435|FG000|COMPLETED|Follow-up||144
8726577|NCT01037309|9773823|FG004|STARTED|Subcutaneous Cohort 1 - 6||3
8726578|NCT01037309|9773824|FG005|STARTED|Subcutaneous Cohort 1 - 6||3
8726579|NCT01037309|9773825|FG006|STARTED|Subcutaneous Cohort 1 - 6||0
8726580|NCT01037309|9773826|FG007|STARTED|Subcutaneous Cohort 1 - 6||0
8726581|NCT01037309|9773827|FG008|STARTED|Subcutaneous Cohort 1 - 6||0
8726582|NCT01037309|9773819|FG000|COMPLETED|Subcutaneous Cohort 1 - 6||3
9013228|NCT03016403|10075828|FG002|NOT COMPLETED|3-month Follow-up and 6-month Follow-up||8
9013229|NCT03016403|10075829|FG003|NOT COMPLETED|3-month Follow-up and 6-month Follow-up||7
9013230|NCT03016598|10075843|FG000|STARTED|Overall Study||18
9013231|NCT03016598|10075844|FG001|STARTED|Overall Study||22
9013232|NCT03016598|10075843|FG000|COMPLETED|Overall Study||18
9013233|NCT03016598|10075844|FG001|COMPLETED|Overall Study||20
9013234|NCT03016598|10075843|FG000|NOT COMPLETED|Overall Study||0
9013235|NCT03016598|10075844|FG001|NOT COMPLETED|Overall Study||2
9013236|NCT03017079|10075852|FG000|STARTED|Overall Study||20
9013237|NCT03017079|10075853|FG001|STARTED|Overall Study||20
9013238|NCT03017079|10075852|FG000|COMPLETED|Overall Study||14
9013239|NCT03017079|10075853|FG001|COMPLETED|Overall Study||14
9013240|NCT03017079|10075852|FG000|NOT COMPLETED|Overall Study||6
8636740|NCT01067144|9677436|FG001|COMPLETED|Follow-up||152
8636741|NCT01067144|9677435|FG000|NOT COMPLETED|Follow-up||59
8636742|NCT01067144|9677436|FG001|NOT COMPLETED|Follow-up||56
8636743|NCT00777036|9677445|FG000|STARTED|On Treatment||29
9013241|NCT03017079|10075853|FG001|NOT COMPLETED|Overall Study||6
9013242|NCT03017235|10075868|FG000|STARTED|Overall Study||456
9013243|NCT03017235|10075869|FG001|STARTED|Overall Study||461
9013244|NCT03017235|10075868|FG000|COMPLETED|Overall Study||444
9013245|NCT03017235|10075869|FG001|COMPLETED|Overall Study||447
9013246|NCT03017235|10075868|FG000|NOT COMPLETED|Overall Study||12
9013247|NCT03017235|10075869|FG001|NOT COMPLETED|Overall Study||14
9013248|NCT03017261|10075875|FG000|STARTED|6 Week Follow up||115
9013249|NCT03017261|10075875|FG000|COMPLETED|6 Week Follow up||115
9013250|NCT03017261|10075875|FG000|NOT COMPLETED|6 Week Follow up||0
9013251|NCT03017261|10075875|FG000|STARTED|3 Month Follow up||115
9013252|NCT03017261|10075875|FG000|COMPLETED|3 Month Follow up|1 failed to compete 3M imaging so only 114 have 3M data for tibial slope and KSS Objective Score.|115
9013253|NCT03017261|10075875|FG000|NOT COMPLETED|3 Month Follow up||0
9013254|NCT03017261|10075875|FG000|STARTED|6 Month Follow up||115
9013255|NCT03017261|10075875|FG000|COMPLETED|6 Month Follow up||106
9013256|NCT03017261|10075875|FG000|NOT COMPLETED|6 Month Follow up||9
9013257|NCT03017261|10075875|FG000|STARTED|12 Month Follow up||106
9013258|NCT03017261|10075875|FG000|COMPLETED|12 Month Follow up|1 failed to compete 12M imaging so only 58 have 12M data for KSS Objective Score.|59
9013259|NCT03017261|10075875|FG000|NOT COMPLETED|12 Month Follow up||47
9013260|NCT03017508|10075881|FG000|STARTED|Overall Study||12
9013261|NCT03017508|10075882|FG001|STARTED|Overall Study||10
9013262|NCT03017508|10075881|FG000|First Intervention (1 Day)|Overall Study||12
9013263|NCT03017508|10075882|FG001|First Intervention (1 Day)|Overall Study||10
9013264|NCT03017508|10075881|FG000|Washout (2-10 Days)|Overall Study||12
9013265|NCT03017508|10075882|FG001|Washout (2-10 Days)|Overall Study||10
9013266|NCT03017508|10075881|FG000|Second Intervention (1 Day)|Overall Study||12
9013267|NCT03017508|10075882|FG001|Second Intervention (1 Day)|Overall Study||10
9013268|NCT03017508|10075881|FG000|COMPLETED|Overall Study||12
9013269|NCT03017508|10075882|FG001|COMPLETED|Overall Study||10
9013270|NCT03017508|10075881|FG000|NOT COMPLETED|Overall Study||0
9013271|NCT03017508|10075882|FG001|NOT COMPLETED|Overall Study||0
9013272|NCT03017612|10075888|FG000|STARTED|Overall Study||13
9013273|NCT03017612|10075888|FG000|COMPLETED|Overall Study||11
9013274|NCT03017612|10075888|FG000|NOT COMPLETED|Overall Study||2
9013275|NCT03017846|10075892|FG000|STARTED|Overall Study||30
9013276|NCT03017846|10075892|FG000|COMPLETED|Overall Study||25
9013277|NCT03017846|10075892|FG000|NOT COMPLETED|Overall Study||5
9013278|NCT03017924|10075900|FG000|STARTED|Overall Study||12
9013279|NCT03017924|10075901|FG001|STARTED|Overall Study||11
9013280|NCT03017924|10075900|FG000|COMPLETED|Overall Study||10
9013281|NCT03017924|10075901|FG001|COMPLETED|Overall Study||8
9013282|NCT03017924|10075900|FG000|NOT COMPLETED|Overall Study||2
9013283|NCT03017924|10075901|FG001|NOT COMPLETED|Overall Study||3
9013284|NCT03017937|10075909|FG000|STARTED|Overall Study||155
9013285|NCT03017937|10075909|FG000|COMPLETED|Overall Study||155
9013286|NCT03017937|10075909|FG000|NOT COMPLETED|Overall Study||0
9013287|NCT03018028|10075919|FG000|STARTED|Overall Study||49
9013288|NCT03018028|10075920|FG001|STARTED|Overall Study||49
9013289|NCT03018028|10075921|FG002|STARTED|Overall Study||48
9013290|NCT03018028|10075922|FG003|STARTED|Overall Study||48
9013291|NCT03018028|10075923|FG004|STARTED|Overall Study||49
9013292|NCT03018028|10075919|FG000|Full Analysis Set (FAS)|Overall Study||49
9013293|NCT03018028|10075920|FG001|Full Analysis Set (FAS)|Overall Study||49
9013294|NCT03018028|10075921|FG002|Full Analysis Set (FAS)|Overall Study||48
9013295|NCT03018028|10075922|FG003|Full Analysis Set (FAS)|Overall Study||48
9013296|NCT03018028|10075923|FG004|Full Analysis Set (FAS)|Overall Study||49
9013297|NCT03018028|10075919|FG000|Safety Analysis Set (SAS)|Overall Study||49
9013298|NCT03018028|10075920|FG001|Safety Analysis Set (SAS)|Overall Study||49
9013299|NCT03018028|10075921|FG002|Safety Analysis Set (SAS)|Overall Study||48
9013300|NCT03018028|10075922|FG003|Safety Analysis Set (SAS)|Overall Study||48
8573313|NCT00120874|9605559|FG001|NOT COMPLETED|Overall Study||1
8573314|NCT00121134|9605569|FG000|STARTED|Overall Study||40
8573315|NCT00121134|9605570|FG001|STARTED|Overall Study||41
8573316|NCT00121134|9605571|FG002|STARTED|Overall Study||41
8573317|NCT00121134|9605572|FG003|STARTED|Overall Study||40
8573318|NCT00121134|9605569|FG000|COMPLETED|Overall Study||24
8573319|NCT00121134|9605570|FG001|COMPLETED|Overall Study||26
8726583|NCT01037309|9773820|FG001|COMPLETED|Subcutaneous Cohort 1 - 6||3
9013301|NCT03018028|10075923|FG004|Safety Analysis Set (SAS)|Overall Study||49
9013302|NCT03018028|10075919|FG000|COMPLETED|Overall Study||46
9013303|NCT03018028|10075920|FG001|COMPLETED|Overall Study||49
9013304|NCT03018028|10075921|FG002|COMPLETED|Overall Study||47
9013305|NCT03018028|10075922|FG003|COMPLETED|Overall Study||46
9013306|NCT03018028|10075923|FG004|COMPLETED|Overall Study||49
9013307|NCT03018028|10075919|FG000|NOT COMPLETED|Overall Study||3
9013308|NCT03018028|10075920|FG001|NOT COMPLETED|Overall Study||0
9013309|NCT03018028|10075921|FG002|NOT COMPLETED|Overall Study||1
9013310|NCT03018028|10075922|FG003|NOT COMPLETED|Overall Study||2
9013311|NCT03018028|10075923|FG004|NOT COMPLETED|Overall Study||0
9013312|NCT03018106|10075937|FG000|STARTED|Overall Study||0
9013313|NCT03018106|10075938|FG001|STARTED|Overall Study||1
9013314|NCT03018106|10075937|FG000|COMPLETED|Overall Study||0
9013315|NCT03018106|10075938|FG001|COMPLETED|Overall Study||0
9013316|NCT03018106|10075937|FG000|NOT COMPLETED|Overall Study||0
9013317|NCT03018106|10075938|FG001|NOT COMPLETED|Overall Study||1
8573320|NCT00121134|9605571|FG002|COMPLETED|Overall Study||20
9013318|NCT03018223|10075942|FG000|STARTED|Overall Study||32
9013319|NCT03018223|10075942|FG000|COMPLETED|Overall Study||32
8906539|NCT02108821|9964700|FG000|COMPLETED|Overall Study||23
8906540|NCT02108821|9964700|FG000|NOT COMPLETED|Overall Study||0
8906541|NCT02108912|9964708|FG000|STARTED|Overall Study||9
8906542|NCT02108912|9964709|FG001|STARTED|Overall Study||7
8906543|NCT02108912|9964708|FG000|COMPLETED|Overall Study||6
8906544|NCT02108912|9964709|FG001|COMPLETED|Overall Study||6
8906545|NCT02108912|9964708|FG000|NOT COMPLETED|Overall Study||3
8906546|NCT02108912|9964709|FG001|NOT COMPLETED|Overall Study||1
8906547|NCT02108951|9964715|FG000|STARTED|Overall Study|Indicates patients in enrolled, full analysis and safety set|20
8906548|NCT02108951|9964715|FG000|COMPLETED|Overall Study||4
8906549|NCT02108951|9964715|FG000|NOT COMPLETED|Overall Study||16
8906550|NCT02108977|9964721|FG000|STARTED|Overall Study||18
8906551|NCT02108977|9964722|FG001|STARTED|Overall Study||20
8906552|NCT02108977|9964721|FG000|COMPLETED|Overall Study||8
8906553|NCT02108977|9964722|FG001|COMPLETED|Overall Study||19
8906554|NCT02108977|9964721|FG000|NOT COMPLETED|Overall Study||10
8906555|NCT02108977|9964722|FG001|NOT COMPLETED|Overall Study||1
8906556|NCT02109029|9964733|FG000|STARTED|Part A||2
8906557|NCT02109029|9964734|FG001|STARTED|Part A||2
8906558|NCT02109029|9964735|FG002|STARTED|Part A||4
8906559|NCT02109029|9964736|FG003|STARTED|Part A||4
8906560|NCT02109029|9964737|FG004|STARTED|Part A||0
8906561|NCT02109029|9964738|FG005|STARTED|Part A||0
9013320|NCT03018223|10075942|FG000|NOT COMPLETED|Overall Study||0
9013321|NCT03018249|10075948|FG000|STARTED|Overall Study||25
9013322|NCT03018249|10075949|FG001|STARTED|Overall Study||25
9013323|NCT03018249|10075948|FG000|COMPLETED|Overall Study||23
9013324|NCT03018249|10075949|FG001|COMPLETED|Overall Study||23
9013325|NCT03018249|10075948|FG000|NOT COMPLETED|Overall Study||2
9013326|NCT03018249|10075949|FG001|NOT COMPLETED|Overall Study||2
9013327|NCT03018340|10075957|FG000|STARTED|Overall Study||52
9013328|NCT03018340|10075958|FG001|STARTED|Overall Study||155
9013329|NCT03018340|10075957|FG000|COMPLETED|Overall Study||44
9013330|NCT03018340|10075958|FG001|COMPLETED|Overall Study||125
9013331|NCT03018340|10075957|FG000|NOT COMPLETED|Overall Study||8
9013332|NCT03018340|10075958|FG001|NOT COMPLETED|Overall Study||30
9013333|NCT03018691|10075971|FG000|STARTED|Overall Study||24
9013334|NCT03018691|10075972|FG001|STARTED|Overall Study||25
9013335|NCT03018691|10075973|FG002|STARTED|Overall Study||24
9013336|NCT03018691|10075971|FG000|COMPLETED|Overall Study||22
9013337|NCT03018691|10075972|FG001|COMPLETED|Overall Study||24
9013338|NCT03018691|10075973|FG002|COMPLETED|Overall Study||17
9013339|NCT03018691|10075971|FG000|NOT COMPLETED|Overall Study||2
9013340|NCT03018691|10075972|FG001|NOT COMPLETED|Overall Study||1
9013341|NCT03018691|10075973|FG002|NOT COMPLETED|Overall Study||7
9013342|NCT03018925|10075983|FG000|STARTED|Overall Study||15
9013343|NCT03018925|10075983|FG000|COMPLETED|Overall Study||15
9013344|NCT03018925|10075983|FG000|NOT COMPLETED|Overall Study||0
9013345|NCT03018938|10076010|FG000|STARTED|Overall Study||404
9013346|NCT03018938|10076011|FG001|STARTED|Overall Study||410
9013347|NCT03018938|10076010|FG000|Received at Least 1 Dose of Study Drug|Overall Study||404
9013348|NCT03018938|10076011|FG001|Received at Least 1 Dose of Study Drug|Overall Study||410
9013349|NCT03018938|10076010|FG000|COMPLETED|Overall Study||338
9013350|NCT03018938|10076011|FG001|COMPLETED|Overall Study||325
9013351|NCT03018938|10076010|FG000|NOT COMPLETED|Overall Study||66
9013352|NCT03018938|10076011|FG001|NOT COMPLETED|Overall Study||85
9013353|NCT03019055|10076021|FG000|STARTED|Overall Study||0
9013354|NCT03019055|10076022|FG001|STARTED|Overall Study||3
9013355|NCT03019055|10076023|FG002|STARTED|Overall Study||3
9013356|NCT03019055|10076024|FG003|STARTED|Overall Study||20
9013357|NCT03019055|10076021|FG000|COMPLETED|Overall Study||0
9013358|NCT03019055|10076022|FG001|COMPLETED|Overall Study||3
9013359|NCT03019055|10076023|FG002|COMPLETED|Overall Study||3
9013360|NCT03019055|10076024|FG003|COMPLETED|Overall Study||20
9013361|NCT03019055|10076021|FG000|NOT COMPLETED|Overall Study||0
9013362|NCT03019055|10076022|FG001|NOT COMPLETED|Overall Study||0
9013363|NCT03019055|10076023|FG002|NOT COMPLETED|Overall Study||0
9013364|NCT03019055|10076024|FG003|NOT COMPLETED|Overall Study||0
9013365|NCT03019107|10076036|FG000|STARTED|Overall Study||1
9013366|NCT03019107|10076037|FG001|STARTED|Overall Study||0
9013367|NCT03019107|10076036|FG000|COMPLETED|Overall Study||1
8573321|NCT00121134|9605572|FG003|COMPLETED|Overall Study||31
8573322|NCT00121134|9605569|FG000|NOT COMPLETED|Overall Study||16
8573323|NCT00121134|9605570|FG001|NOT COMPLETED|Overall Study||15
8573324|NCT00121134|9605571|FG002|NOT COMPLETED|Overall Study||21
9013368|NCT03019107|10076037|FG001|COMPLETED|Overall Study||0
9013369|NCT03019107|10076036|FG000|NOT COMPLETED|Overall Study||0
9013370|NCT03019107|10076037|FG001|NOT COMPLETED|Overall Study||0
9013371|NCT03019289|10076052|FG000|STARTED|Overall Study||5
9013372|NCT03019289|10076053|FG001|STARTED|Overall Study||1
8573325|NCT00121134|9605572|FG003|NOT COMPLETED|Overall Study||9
8906562|NCT02109029|9964733|FG000|Received One Dose of Study Drug|Part A||2
8906563|NCT02109029|9964734|FG001|Received One Dose of Study Drug|Part A||2
8906564|NCT02109029|9964735|FG002|Received One Dose of Study Drug|Part A||4
9013373|NCT03019289|10076054|FG002|STARTED|Overall Study||3
9013374|NCT03019289|10076055|FG003|STARTED|Overall Study||2
9013375|NCT03019289|10076056|FG004|STARTED|Overall Study||1
9013376|NCT03019289|10076057|FG005|STARTED|Overall Study||1
9013377|NCT03019289|10076058|FG006|STARTED|Overall Study||3
9013378|NCT03019289|10076059|FG007|STARTED|Overall Study||4
9013379|NCT03019289|10076060|FG008|STARTED|Overall Study||3
9013380|NCT03019289|10076052|FG000|COMPLETED|Overall Study||3
9013381|NCT03019289|10076053|FG001|COMPLETED|Overall Study||1
8906565|NCT02109029|9964736|FG003|Received One Dose of Study Drug|Part A||4
8906566|NCT02109029|9964737|FG004|Received One Dose of Study Drug|Part A||0
8906567|NCT02109029|9964738|FG005|Received One Dose of Study Drug|Part A||0
8906568|NCT02109029|9964733|FG000|COMPLETED|Part A|Participants from Part A did not move on to Part B.|2
8906569|NCT02109029|9964734|FG001|COMPLETED|Part A|Participants from Part A did not move on to Part B.|2
8906570|NCT02109029|9964735|FG002|COMPLETED|Part A|Participants from Part A did not move on to Part B.|4
8906571|NCT02109029|9964736|FG003|COMPLETED|Part A|Participants from Part A did not move on to Part B.|4
8906572|NCT02109029|9964737|FG004|COMPLETED|Part A||0
8906573|NCT02109029|9964738|FG005|COMPLETED|Part A||0
8906574|NCT02109029|9964733|FG000|NOT COMPLETED|Part A||0
8906575|NCT02109029|9964734|FG001|NOT COMPLETED|Part A||0
8906576|NCT02109029|9964735|FG002|NOT COMPLETED|Part A||0
8906577|NCT02109029|9964736|FG003|NOT COMPLETED|Part A||0
8906578|NCT02109029|9964737|FG004|NOT COMPLETED|Part A||0
8906579|NCT02109029|9964738|FG005|NOT COMPLETED|Part A||0
8906580|NCT02109029|9964733|FG000|STARTED|Part B||0
8906581|NCT02109029|9964734|FG001|STARTED|Part B||0
8906582|NCT02109029|9964735|FG002|STARTED|Part B||0
8906583|NCT02109029|9964736|FG003|STARTED|Part B||0
8906584|NCT02109029|9964737|FG004|STARTED|Part B|New participants entered Part B.|6
8906585|NCT02109029|9964738|FG005|STARTED|Part B|New participants entered Part B.|6
8906586|NCT02109029|9964733|FG000|Received at Least One Dose of Study Drug|Part B||0
8906587|NCT02109029|9964734|FG001|Received at Least One Dose of Study Drug|Part B||0
8906588|NCT02109029|9964735|FG002|Received at Least One Dose of Study Drug|Part B||0
8906589|NCT02109029|9964736|FG003|Received at Least One Dose of Study Drug|Part B||0
8906590|NCT02109029|9964737|FG004|Received at Least One Dose of Study Drug|Part B||6
8906591|NCT02109029|9964738|FG005|Received at Least One Dose of Study Drug|Part B||6
8906592|NCT02109029|9964733|FG000|COMPLETED|Part B||0
8906593|NCT02109029|9964734|FG001|COMPLETED|Part B||0
8906594|NCT02109029|9964735|FG002|COMPLETED|Part B||0
8906595|NCT02109029|9964736|FG003|COMPLETED|Part B||0
8906596|NCT02109029|9964737|FG004|COMPLETED|Part B||5
8906597|NCT02109029|9964738|FG005|COMPLETED|Part B||5
8906598|NCT02109029|9964733|FG000|NOT COMPLETED|Part B||0
8906599|NCT02109029|9964734|FG001|NOT COMPLETED|Part B||0
8906600|NCT02109029|9964735|FG002|NOT COMPLETED|Part B||0
8906601|NCT02109029|9964736|FG003|NOT COMPLETED|Part B||0
8906602|NCT02109029|9964737|FG004|NOT COMPLETED|Part B||1
8906603|NCT02109029|9964738|FG005|NOT COMPLETED|Part B||1
8906604|NCT02109042|9964749|FG000|STARTED|Overall Study||15
8906605|NCT02109042|9964749|FG000|Received at Least 1 Dose of Study Drug|Overall Study||15
8906606|NCT02109042|9964749|FG000|Received 180 mg Loading Dose|Overall Study||15
8906607|NCT02109042|9964749|FG000|Receive at Least 1 Subsequent 90 mg Dose|Overall Study||15
8906608|NCT02109042|9964749|FG000|COMPLETED|Overall Study||0
8906609|NCT02109042|9964749|FG000|NOT COMPLETED|Overall Study||15
8906610|NCT02109107|9964754|FG000|STARTED|Overall Study||54
8906611|NCT02109107|9964754|FG000|COMPLETED|Overall Study||52
8906612|NCT02109107|9964754|FG000|NOT COMPLETED|Overall Study||2
8906613|NCT02109133|9964760|FG000|STARTED|Overall Study||33
8906614|NCT02109133|9964761|FG001|STARTED|Overall Study||34
8906615|NCT02109133|9964760|FG000|COMPLETED|Overall Study||32
8906616|NCT02109133|9964761|FG001|COMPLETED|Overall Study||34
8906617|NCT02109133|9964760|FG000|NOT COMPLETED|Overall Study||1
8906618|NCT02109133|9964761|FG001|NOT COMPLETED|Overall Study||0
8906619|NCT02109159|9964771|FG000|STARTED|Overall Study||4178
8906620|NCT02109159|9964772|FG001|STARTED|Overall Study||4175
8906621|NCT02109159|9964771|FG000|COMPLETED|Overall Study||4178
8906622|NCT02109159|9964772|FG001|COMPLETED|Overall Study||4175
8906623|NCT02109159|9964771|FG000|NOT COMPLETED|Overall Study||0
9013382|NCT03019289|10076054|FG002|COMPLETED|Overall Study||3
9013383|NCT03019289|10076055|FG003|COMPLETED|Overall Study||2
9013384|NCT03019289|10076056|FG004|COMPLETED|Overall Study||1
9013385|NCT03019289|10076057|FG005|COMPLETED|Overall Study||1
9013386|NCT03019289|10076058|FG006|COMPLETED|Overall Study||3
9013387|NCT03019289|10076059|FG007|COMPLETED|Overall Study||4
9013388|NCT03019289|10076060|FG008|COMPLETED|Overall Study||2
9013389|NCT03019289|10076052|FG000|NOT COMPLETED|Overall Study||2
9013390|NCT03019289|10076053|FG001|NOT COMPLETED|Overall Study||0
9013391|NCT03019289|10076054|FG002|NOT COMPLETED|Overall Study||0
9013392|NCT03019289|10076055|FG003|NOT COMPLETED|Overall Study||0
9013393|NCT03019289|10076056|FG004|NOT COMPLETED|Overall Study||0
9013394|NCT03019289|10076057|FG005|NOT COMPLETED|Overall Study||0
9013395|NCT03019289|10076058|FG006|NOT COMPLETED|Overall Study||0
9013396|NCT03019289|10076059|FG007|NOT COMPLETED|Overall Study||0
9013397|NCT03019289|10076060|FG008|NOT COMPLETED|Overall Study||1
9013398|NCT03019458|10076083|FG000|STARTED|Overall Study||24
9013399|NCT03019458|10076084|FG001|STARTED|Overall Study||26
9013400|NCT03019458|10076083|FG000|COMPLETED|Overall Study||24
9013401|NCT03019458|10076084|FG001|COMPLETED|Overall Study||25
9013402|NCT03019458|10076083|FG000|NOT COMPLETED|Overall Study||0
9013403|NCT03019458|10076084|FG001|NOT COMPLETED|Overall Study||1
8906624|NCT02109159|9964772|FG001|NOT COMPLETED|Overall Study||0
8906625|NCT02109419|9964778|FG000|STARTED|Overall Study||57
8906626|NCT02109419|9964778|FG000|COMPLETED|Overall Study||57
8906627|NCT02109419|9964778|FG000|NOT COMPLETED|Overall Study||0
9013404|NCT03019549|10076092|FG000|STARTED|Period 1||42
8906628|NCT02109432|9964784|FG000|STARTED|Overall Study||7
8906629|NCT02109432|9964784|FG000|COMPLETED|Overall Study||6
9013405|NCT03019549|10076092|FG000|Received 1 Dose of Study Drug|Period 1||42
9013406|NCT03019549|10076092|FG000|COMPLETED|Period 1||42
8906630|NCT02109432|9964784|FG000|NOT COMPLETED|Overall Study||1
8906631|NCT02109445|9964788|FG000|STARTED|Overall Study||3
8636744|NCT00777036|9677446|FG001|STARTED|On Treatment||17
8906632|NCT02109445|9964788|FG000|COMPLETED|Overall Study||0
8906633|NCT02109445|9964788|FG000|NOT COMPLETED|Overall Study||3
8906634|NCT02109458|9964792|FG000|STARTED|Overall Study||24
8906635|NCT02109458|9964792|FG000|COMPLETED|Overall Study||24
8906636|NCT02109458|9964792|FG000|NOT COMPLETED|Overall Study||0
8906637|NCT02109484|9964804|FG000|STARTED|Overall Study||5
8906638|NCT02109484|9964805|FG001|STARTED|Overall Study||13
8906639|NCT02109484|9964806|FG002|STARTED|Overall Study||12
8906640|NCT02109484|9964807|FG003|STARTED|Overall Study||12
8906641|NCT02109484|9964808|FG004|STARTED|Overall Study||50
8906642|NCT02109484|9964809|FG005|STARTED|Overall Study||12
8906643|NCT02109484|9964810|FG006|STARTED|Overall Study||50
8906644|NCT02109484|9964811|FG007|STARTED|Overall Study||50
8906645|NCT02109484|9964804|FG000|COMPLETED|Overall Study||5
8906646|NCT02109484|9964805|FG001|COMPLETED|Overall Study||13
8906647|NCT02109484|9964806|FG002|COMPLETED|Overall Study||12
8906648|NCT02109484|9964807|FG003|COMPLETED|Overall Study||11
8906649|NCT02109484|9964808|FG004|COMPLETED|Overall Study||46
8906650|NCT02109484|9964809|FG005|COMPLETED|Overall Study||11
8906651|NCT02109484|9964810|FG006|COMPLETED|Overall Study||47
8906652|NCT02109484|9964811|FG007|COMPLETED|Overall Study||47
8906653|NCT02109484|9964804|FG000|NOT COMPLETED|Overall Study||0
8906654|NCT02109484|9964805|FG001|NOT COMPLETED|Overall Study||0
8906655|NCT02109484|9964806|FG002|NOT COMPLETED|Overall Study||0
8906656|NCT02109484|9964807|FG003|NOT COMPLETED|Overall Study||1
8906657|NCT02109484|9964808|FG004|NOT COMPLETED|Overall Study||4
8906658|NCT02109484|9964809|FG005|NOT COMPLETED|Overall Study||1
8906659|NCT02109484|9964810|FG006|NOT COMPLETED|Overall Study||3
8906660|NCT02109484|9964811|FG007|NOT COMPLETED|Overall Study||3
8906661|NCT02109497|9964846|FG000|STARTED|Overall Study||18
8906662|NCT02109497|9964846|FG000|COMPLETED|Overall Study|One participant completed the safety assessments but did not complete all doses of the study drugs.|17
8906663|NCT02109497|9964846|FG000|NOT COMPLETED|Overall Study||1
8906664|NCT02109562|9964853|FG000|STARTED|Overall Study||116
8906665|NCT02109562|9964854|FG001|STARTED|Overall Study||119
8906666|NCT02109562|9964855|FG002|STARTED|Overall Study||119
8906667|NCT02109562|9964853|FG000|Safety|Overall Study||115
8906668|NCT02109562|9964854|FG001|Safety|Overall Study||117
8906669|NCT02109562|9964855|FG002|Safety|Overall Study||118
8906670|NCT02109562|9964853|FG000|Intent to Treat (ITT)|Overall Study||111
8906671|NCT02109562|9964854|FG001|Intent to Treat (ITT)|Overall Study||114
8906672|NCT02109562|9964855|FG002|Intent to Treat (ITT)|Overall Study||112
8906673|NCT02109562|9964853|FG000|COMPLETED|Overall Study||90
8906674|NCT02109562|9964854|FG001|COMPLETED|Overall Study||85
8906675|NCT02109562|9964855|FG002|COMPLETED|Overall Study||84
8906676|NCT02109562|9964853|FG000|NOT COMPLETED|Overall Study||26
8906677|NCT02109562|9964854|FG001|NOT COMPLETED|Overall Study||34
8906678|NCT02109562|9964855|FG002|NOT COMPLETED|Overall Study||35
8906679|NCT02109640|9964865|FG000|STARTED|Overall Study||27
8906680|NCT02109640|9964866|FG001|STARTED|Overall Study||23
8906681|NCT02109640|9964865|FG000|COMPLETED|Overall Study||27
8906682|NCT02109640|9964866|FG001|COMPLETED|Overall Study||23
8906683|NCT02109640|9964865|FG000|NOT COMPLETED|Overall Study||0
8906684|NCT02109640|9964866|FG001|NOT COMPLETED|Overall Study||0
8906685|NCT02109731|9964872|FG000|STARTED|Overall Study||15
8906686|NCT02109731|9964872|FG000|COMPLETED|Overall Study||15
8906687|NCT02109731|9964872|FG000|NOT COMPLETED|Overall Study||0
8906688|NCT02109939|9964878|FG000|STARTED|Overall Study||681
8906689|NCT02109939|9964879|FG001|STARTED|Overall Study||717
9013407|NCT03019549|10076092|FG000|NOT COMPLETED|Period 1||0
9013408|NCT03019549|10076092|FG000|STARTED|Washout||42
9013409|NCT03019549|10076092|FG000|COMPLETED|Washout||31
9013410|NCT03019549|10076092|FG000|NOT COMPLETED|Washout||11
9013411|NCT03019549|10076092|FG000|STARTED|Period 2||31
9013412|NCT03019549|10076092|FG000|Received at Least 1 Dose of Study Drug|Period 2||29
9013413|NCT03019549|10076092|FG000|COMPLETED|Period 2||26
9013414|NCT03019549|10076092|FG000|NOT COMPLETED|Period 2||5
9013415|NCT03019627|10076103|FG000|STARTED|Overall Study||100
9013416|NCT03019627|10076104|FG001|STARTED|Overall Study||50
9013417|NCT03019627|10076103|FG000|COMPLETED|Overall Study||85
9013418|NCT03019627|10076104|FG001|COMPLETED|Overall Study||42
9013419|NCT03019627|10076103|FG000|NOT COMPLETED|Overall Study||15
9013420|NCT03019627|10076104|FG001|NOT COMPLETED|Overall Study||8
9013421|NCT03019744|10076112|FG000|STARTED|Overall Study||38
9013422|NCT03019744|10076113|FG001|STARTED|Overall Study||44
9013423|NCT03019744|10076112|FG000|COMPLETED|Overall Study||32
9013424|NCT03019744|10076113|FG001|COMPLETED|Overall Study||36
8906690|NCT02109939|9964878|FG000|COMPLETED|Overall Study||560
8906691|NCT02109939|9964879|FG001|COMPLETED|Overall Study||607
8906692|NCT02109939|9964878|FG000|NOT COMPLETED|Overall Study||121
8906693|NCT02109939|9964879|FG001|NOT COMPLETED|Overall Study||110
8906694|NCT02110095|9964889|FG000|STARTED|Overall Study||15
8906695|NCT02110095|9964889|FG000|COMPLETED|Overall Study||8
8906696|NCT02110095|9964889|FG000|NOT COMPLETED|Overall Study||7
8636745|NCT00777036|9677447|FG002|STARTED|On Treatment||84
8906697|NCT02110108|9964893|FG000|STARTED|Overall Study||10
8906698|NCT02110108|9964893|FG000|RevLite Single Wavelength|Overall Study||10
9013425|NCT03019744|10076112|FG000|NOT COMPLETED|Overall Study||6
9013426|NCT03019744|10076113|FG001|NOT COMPLETED|Overall Study||8
9013427|NCT03019783|10076121|FG000|STARTED|Overall Study||29
8906699|NCT02110108|9964893|FG000|RevLite Combo Wavelength|Overall Study||10
8906700|NCT02110108|9964893|FG000|COMPLETED|Overall Study||7
8906701|NCT02110108|9964893|FG000|NOT COMPLETED|Overall Study||3
8906702|NCT02110121|9964903|FG000|STARTED|Overall Study||58
8906703|NCT02110121|9964904|FG001|STARTED|Overall Study||5
8906704|NCT02110121|9964903|FG000|COMPLETED|Overall Study||42
8906705|NCT02110121|9964904|FG001|COMPLETED|Overall Study||5
8906706|NCT02110121|9964903|FG000|NOT COMPLETED|Overall Study||16
8906707|NCT02110121|9964904|FG001|NOT COMPLETED|Overall Study||0
8906708|NCT02110147|9964910|FG000|STARTED|Overall Study||4
8906709|NCT02110147|9964910|FG000|COMPLETED|Overall Study||4
8906710|NCT02110147|9964910|FG000|NOT COMPLETED|Overall Study||0
8906711|NCT02110225|9964917|FG000|STARTED|Overall Study||20
8906712|NCT02110225|9964918|FG001|STARTED|Overall Study||20
8906713|NCT02110225|9964919|FG002|STARTED|Overall Study||10
8906714|NCT02110225|9964917|FG000|COMPLETED|Overall Study||20
8906715|NCT02110225|9964918|FG001|COMPLETED|Overall Study||19
8906716|NCT02110225|9964919|FG002|COMPLETED|Overall Study||10
8906717|NCT02110225|9964917|FG000|NOT COMPLETED|Overall Study||0
8906718|NCT02110225|9964918|FG001|NOT COMPLETED|Overall Study||1
8906719|NCT02110225|9964919|FG002|NOT COMPLETED|Overall Study||0
8906720|NCT02110238|9964930|FG000|STARTED|12 Week Pivotal Phase|One subject was randomized but not treated. As a result there were 211 safety subjects|212
8906721|NCT02110238|9964931|FG001|STARTED|12 Week Pivotal Phase||209
8906722|NCT02110238|9964930|FG000|COMPLETED|12 Week Pivotal Phase||202
8906723|NCT02110238|9964931|FG001|COMPLETED|12 Week Pivotal Phase||200
8906724|NCT02110238|9964930|FG000|NOT COMPLETED|12 Week Pivotal Phase||10
8906725|NCT02110238|9964931|FG001|NOT COMPLETED|12 Week Pivotal Phase||9
8906726|NCT02110238|9964930|FG000|STARTED|14 Week Blinded Extension Phase||202
8906727|NCT02110238|9964931|FG001|STARTED|14 Week Blinded Extension Phase||200
8906728|NCT02110238|9964930|FG000|COMPLETED|14 Week Blinded Extension Phase||190
8906729|NCT02110238|9964931|FG001|COMPLETED|14 Week Blinded Extension Phase||188
8906730|NCT02110238|9964930|FG000|NOT COMPLETED|14 Week Blinded Extension Phase||12
8906731|NCT02110238|9964931|FG001|NOT COMPLETED|14 Week Blinded Extension Phase||12
8906732|NCT02110264|9964940|FG000|STARTED|Overall Study||53
8906733|NCT02110264|9964941|FG001|STARTED|Overall Study||50
8906734|NCT02110264|9964942|FG002|STARTED|Overall Study||48
8906735|NCT02110264|9964940|FG000|COMPLETED|Overall Study||35
8906736|NCT02110264|9964941|FG001|COMPLETED|Overall Study||38
8906737|NCT02110264|9964942|FG002|COMPLETED|Overall Study||39
8906738|NCT02110264|9964940|FG000|NOT COMPLETED|Overall Study||18
8906739|NCT02110264|9964941|FG001|NOT COMPLETED|Overall Study||12
8906740|NCT02110264|9964942|FG002|NOT COMPLETED|Overall Study||9
8906741|NCT02110381|9964952|FG000|STARTED|Single Modality||9
8906742|NCT02110381|9964953|FG001|STARTED|Single Modality||9
8906743|NCT02110381|9964952|FG000|COMPLETED|Single Modality||7
8906744|NCT02110381|9964953|FG001|COMPLETED|Single Modality||8
8906745|NCT02110381|9964952|FG000|NOT COMPLETED|Single Modality||2
8906746|NCT02110381|9964953|FG001|NOT COMPLETED|Single Modality||1
8906747|NCT02110381|9964952|FG000|STARTED|Dual Modality||7
8906748|NCT02110381|9964953|FG001|STARTED|Dual Modality||8
8906749|NCT02110381|9964952|FG000|Began Active Treatment|Dual Modality||7
8906750|NCT02110381|9964953|FG001|Began Active Treatment|Dual Modality||7
8906751|NCT02110381|9964952|FG000|COMPLETED|Dual Modality||5
8906752|NCT02110381|9964953|FG001|COMPLETED|Dual Modality||7
8906753|NCT02110381|9964952|FG000|NOT COMPLETED|Dual Modality||2
8906754|NCT02110381|9964953|FG001|NOT COMPLETED|Dual Modality||1
8906755|NCT02110485|9964962|FG000|STARTED|Overall Study||98
8906756|NCT02110485|9964963|FG001|STARTED|Overall Study||102
8906757|NCT02110485|9964962|FG000|COMPLETED|Overall Study||91
8906758|NCT02110485|9964963|FG001|COMPLETED|Overall Study||83
8906759|NCT02110485|9964962|FG000|NOT COMPLETED|Overall Study||7
8906760|NCT02110485|9964963|FG001|NOT COMPLETED|Overall Study||19
8906761|NCT02110693|9964969|FG000|STARTED|Overall Study||1026
8906762|NCT02110693|9964970|FG001|STARTED|Overall Study||1031
8906763|NCT02110693|9964969|FG000|COMPLETED|Overall Study||998
8906764|NCT02110693|9964970|FG001|COMPLETED|Overall Study||1002
8906765|NCT02110693|9964969|FG000|NOT COMPLETED|Overall Study||28
8906766|NCT02110693|9964970|FG001|NOT COMPLETED|Overall Study||29
8906767|NCT02110706|9964992|FG000|STARTED|Overall Study||25
8906768|NCT02110706|9964993|FG001|STARTED|Overall Study||27
8906769|NCT02110706|9964992|FG000|No. Completing Study Through Week 52|Overall Study||23
8906770|NCT02110706|9964993|FG001|No. Completing Study Through Week 52|Overall Study||24
8906771|NCT02110706|9964992|FG000|COMPLETED|Overall Study||20
8906772|NCT02110706|9964993|FG001|COMPLETED|Overall Study||23
8906773|NCT02110706|9964992|FG000|NOT COMPLETED|Overall Study||5
8906774|NCT02110706|9964993|FG001|NOT COMPLETED|Overall Study||4
8906775|NCT02110732|9965003|FG000|STARTED|Overall Study||20
8906776|NCT02110732|9965004|FG001|STARTED|Overall Study||20
8906777|NCT02110732|9965003|FG000|COMPLETED|Overall Study||14
8906778|NCT02110732|9965004|FG001|COMPLETED|Overall Study||17
8906779|NCT02110732|9965003|FG000|NOT COMPLETED|Overall Study||6
8906780|NCT02110732|9965004|FG001|NOT COMPLETED|Overall Study||3
8906781|NCT02110758|9965015|FG000|STARTED|Baseline: August 2011-July 2013||0
8906782|NCT02110758|9965016|FG001|STARTED|Baseline: August 2011-July 2013||0
8906783|NCT02110758|9965017|FG002|STARTED|Baseline: August 2011-July 2013||9832
8906784|NCT02110758|9965018|FG003|STARTED|Baseline: August 2011-July 2013||18994
8906785|NCT02110758|9965019|FG004|STARTED|Baseline: August 2011-July 2013||308
8906786|NCT02110758|9965015|FG000|COMPLETED|Baseline: August 2011-July 2013||0
8906787|NCT02110758|9965016|FG001|COMPLETED|Baseline: August 2011-July 2013||0
8906788|NCT02110758|9965017|FG002|COMPLETED|Baseline: August 2011-July 2013||9832
8906789|NCT02110758|9965018|FG003|COMPLETED|Baseline: August 2011-July 2013||18994
8906790|NCT02110758|9965019|FG004|COMPLETED|Baseline: August 2011-July 2013||308
8906791|NCT02110758|9965015|FG000|NOT COMPLETED|Baseline: August 2011-July 2013||0
8906792|NCT02110758|9965016|FG001|NOT COMPLETED|Baseline: August 2011-July 2013||0
8906793|NCT02110758|9965017|FG002|NOT COMPLETED|Baseline: August 2011-July 2013||0
8906794|NCT02110758|9965018|FG003|NOT COMPLETED|Baseline: August 2011-July 2013||0
8906795|NCT02110758|9965019|FG004|NOT COMPLETED|Baseline: August 2011-July 2013||0
8906796|NCT02110758|9965015|FG000|STARTED|Start-Up: August 2013-June 2014||175
8906797|NCT02110758|9965016|FG001|STARTED|Start-Up: August 2013-June 2014||431
8906798|NCT02110758|9965017|FG002|STARTED|Start-Up: August 2013-June 2014||8057
8906799|NCT02110758|9965018|FG003|STARTED|Start-Up: August 2013-June 2014||12883
8906800|NCT02110758|9965019|FG004|STARTED|Start-Up: August 2013-June 2014||0
8906801|NCT02110758|9965015|FG000|COMPLETED|Start-Up: August 2013-June 2014||175
8906802|NCT02110758|9965016|FG001|COMPLETED|Start-Up: August 2013-June 2014||431
8906803|NCT02110758|9965017|FG002|COMPLETED|Start-Up: August 2013-June 2014||8057
8906804|NCT02110758|9965018|FG003|COMPLETED|Start-Up: August 2013-June 2014||12883
8906805|NCT02110758|9965019|FG004|COMPLETED|Start-Up: August 2013-June 2014||0
8906806|NCT02110758|9965015|FG000|NOT COMPLETED|Start-Up: August 2013-June 2014||0
8906807|NCT02110758|9965016|FG001|NOT COMPLETED|Start-Up: August 2013-June 2014||0
8906808|NCT02110758|9965017|FG002|NOT COMPLETED|Start-Up: August 2013-June 2014||0
8906809|NCT02110758|9965018|FG003|NOT COMPLETED|Start-Up: August 2013-June 2014||0
8906810|NCT02110758|9965019|FG004|NOT COMPLETED|Start-Up: August 2013-June 2014||0
8906811|NCT02110758|9965015|FG000|STARTED|Intervention: July 2014-December 2015||0
8906812|NCT02110758|9965016|FG001|STARTED|Intervention: July 2014-December 2015||0
8906813|NCT02110758|9965017|FG002|STARTED|Intervention: July 2014-December 2015||10106
9013428|NCT03019783|10076122|FG001|STARTED|Overall Study||31
9013429|NCT03019783|10076121|FG000|COMPLETED|Overall Study||29
9013430|NCT03019783|10076122|FG001|COMPLETED|Overall Study||31
9013431|NCT03019783|10076121|FG000|NOT COMPLETED|Overall Study||0
9013432|NCT03019783|10076122|FG001|NOT COMPLETED|Overall Study||0
9013433|NCT03019796|10076128|FG000|STARTED|First Intervention Drug Tests||20
9013434|NCT03019796|10076129|FG001|STARTED|First Intervention Drug Tests||20
9013435|NCT03019796|10076128|FG000|COMPLETED|First Intervention Drug Tests||20
9013436|NCT03019796|10076129|FG001|COMPLETED|First Intervention Drug Tests||20
9013437|NCT03019796|10076128|FG000|NOT COMPLETED|First Intervention Drug Tests||0
9013438|NCT03019796|10076129|FG001|NOT COMPLETED|First Intervention Drug Tests||0
9013439|NCT03019796|10076128|FG000|STARTED|Second Intervention Training (4 Months)||20
9013440|NCT03019796|10076129|FG001|STARTED|Second Intervention Training (4 Months)||20
9013441|NCT03019796|10076128|FG000|COMPLETED|Second Intervention Training (4 Months)||19
9013442|NCT03019796|10076129|FG001|COMPLETED|Second Intervention Training (4 Months)||19
9013443|NCT03019796|10076128|FG000|NOT COMPLETED|Second Intervention Training (4 Months)||1
9013444|NCT03019796|10076129|FG001|NOT COMPLETED|Second Intervention Training (4 Months)||1
9013445|NCT03019796|10076128|FG000|STARTED|Third Intervention Drug Test||19
9013446|NCT03019796|10076129|FG001|STARTED|Third Intervention Drug Test||19
8573326|NCT00121173|9605585|FG000|STARTED|Overall Study||4
8573327|NCT00121173|9605586|FG001|STARTED|Overall Study||3
8573328|NCT00121173|9605587|FG002|STARTED|Overall Study||9
8573329|NCT00121173|9605585|FG000|COMPLETED|Overall Study||3
8573330|NCT00121173|9605586|FG001|COMPLETED|Overall Study||3
8573331|NCT00121173|9605587|FG002|COMPLETED|Overall Study||9
8573332|NCT00121173|9605585|FG000|NOT COMPLETED|Overall Study||1
8573333|NCT00121173|9605586|FG001|NOT COMPLETED|Overall Study||0
8573334|NCT00121173|9605587|FG002|NOT COMPLETED|Overall Study||0
8573335|NCT00121186|9605598|FG000|STARTED|Overall Study||1
8573336|NCT00121186|9605598|FG000|COMPLETED|Overall Study||1
8573337|NCT00121186|9605598|FG000|NOT COMPLETED|Overall Study||0
8573338|NCT00121199|9605602|FG000|STARTED|Overall Study||73
8573339|NCT00121199|9605602|FG000|Eligible|Overall Study||64
8573340|NCT00121199|9605602|FG000|Eligible and Began Protocol Therapy|Overall Study||64
8573341|NCT00121199|9605602|FG000|COMPLETED|Overall Study||45
8573342|NCT00121199|9605602|FG000|NOT COMPLETED|Overall Study||28
8573343|NCT00121225|9605606|FG000|STARTED|Overall Study||32
8573344|NCT00121225|9605606|FG000|COMPLETED|Overall Study||32
8573345|NCT00121225|9605606|FG000|NOT COMPLETED|Overall Study||0
8573346|NCT00121238|9605611|FG000|STARTED|Overall Study||16
8573347|NCT00121238|9605611|FG000|COMPLETED|Overall Study|2 were later deemed ineligible (PSA rise), censored from efficacy but included for toxicity analysis|13
8573348|NCT00121238|9605611|FG000|NOT COMPLETED|Overall Study||3
8573349|NCT00121251|9605615|FG000|STARTED|Overall Study||17
8573350|NCT00121251|9605615|FG000|COMPLETED|Overall Study||17
8573351|NCT00121251|9605615|FG000|NOT COMPLETED|Overall Study||0
8573352|NCT00121472|9605619|FG000|STARTED|Overall Study||194
8573353|NCT00121472|9605619|FG000|COMPLETED|Overall Study|Followed for at least 1 year after implantation of HM II LVAS.|194
8573354|NCT00121472|9605619|FG000|NOT COMPLETED|Overall Study||0
8906814|NCT02110758|9965018|FG003|STARTED|Intervention: July 2014-December 2015||33012
8906815|NCT02110758|9965019|FG004|STARTED|Intervention: July 2014-December 2015||0
8906816|NCT02110758|9965015|FG000|COMPLETED|Intervention: July 2014-December 2015||0
8906817|NCT02110758|9965016|FG001|COMPLETED|Intervention: July 2014-December 2015||0
8573355|NCT00121485|9605629|FG000|STARTED|Overall Study||134
8573356|NCT00121485|9605630|FG001|STARTED|Overall Study||66
8573357|NCT00121485|9605629|FG000|COMPLETED|Overall Study||133
8573358|NCT00121485|9605630|FG001|COMPLETED|Overall Study||59
8906818|NCT02110758|9965017|FG002|COMPLETED|Intervention: July 2014-December 2015||10106
8906819|NCT02110758|9965018|FG003|COMPLETED|Intervention: July 2014-December 2015||33012
8906820|NCT02110758|9965019|FG004|COMPLETED|Intervention: July 2014-December 2015||0
8906821|NCT02110758|9965015|FG000|NOT COMPLETED|Intervention: July 2014-December 2015||0
8906822|NCT02110758|9965016|FG001|NOT COMPLETED|Intervention: July 2014-December 2015||0
8906823|NCT02110758|9965017|FG002|NOT COMPLETED|Intervention: July 2014-December 2015||0
8906824|NCT02110758|9965018|FG003|NOT COMPLETED|Intervention: July 2014-December 2015||0
8906825|NCT02110758|9965019|FG004|NOT COMPLETED|Intervention: July 2014-December 2015||0
8906826|NCT02110758|9965015|FG000|STARTED|Follow-Up: January-July 2016||81
8906827|NCT02110758|9965016|FG001|STARTED|Follow-Up: January-July 2016||179
8906828|NCT02110758|9965017|FG002|STARTED|Follow-Up: January-July 2016||6451
8906829|NCT02110758|9965018|FG003|STARTED|Follow-Up: January-July 2016||24392
8906830|NCT02110758|9965019|FG004|STARTED|Follow-Up: January-July 2016||349
8906831|NCT02110758|9965015|FG000|COMPLETED|Follow-Up: January-July 2016||81
8906832|NCT02110758|9965016|FG001|COMPLETED|Follow-Up: January-July 2016||179
8906833|NCT02110758|9965017|FG002|COMPLETED|Follow-Up: January-July 2016||6451
8906834|NCT02110758|9965018|FG003|COMPLETED|Follow-Up: January-July 2016||24392
8906835|NCT02110758|9965019|FG004|COMPLETED|Follow-Up: January-July 2016||349
8906836|NCT02110758|9965015|FG000|NOT COMPLETED|Follow-Up: January-July 2016||0
8906837|NCT02110758|9965016|FG001|NOT COMPLETED|Follow-Up: January-July 2016||0
8906838|NCT02110758|9965017|FG002|NOT COMPLETED|Follow-Up: January-July 2016||0
8906839|NCT02110758|9965018|FG003|NOT COMPLETED|Follow-Up: January-July 2016||0
8906840|NCT02110758|9965019|FG004|NOT COMPLETED|Follow-Up: January-July 2016||0
8906841|NCT02110901|9965033|FG000|STARTED|Overall Study||209
8906842|NCT02110901|9965034|FG001|STARTED|Overall Study||102
8906843|NCT02110901|9965033|FG000|COMPLETED|Overall Study||179
8906844|NCT02110901|9965034|FG001|COMPLETED|Overall Study||88
8906845|NCT02110901|9965033|FG000|NOT COMPLETED|Overall Study||30
8906846|NCT02110901|9965034|FG001|NOT COMPLETED|Overall Study||14
8906847|NCT02111083|9965043|FG000|STARTED|First Intervention (1 Day)||19
8906848|NCT02111083|9965044|FG001|STARTED|First Intervention (1 Day)||19
8906849|NCT02111083|9965043|FG000|COMPLETED|First Intervention (1 Day)||19
8906850|NCT02111083|9965044|FG001|COMPLETED|First Intervention (1 Day)||19
8906851|NCT02111083|9965043|FG000|NOT COMPLETED|First Intervention (1 Day)||0
8906852|NCT02111083|9965044|FG001|NOT COMPLETED|First Intervention (1 Day)||0
8906853|NCT02111083|9965043|FG000|STARTED|Interval Between Dosing (7-8 Days)||19
8906854|NCT02111083|9965044|FG001|STARTED|Interval Between Dosing (7-8 Days)||19
8906855|NCT02111083|9965043|FG000|COMPLETED|Interval Between Dosing (7-8 Days)||19
8906856|NCT02111083|9965044|FG001|COMPLETED|Interval Between Dosing (7-8 Days)||19
8906857|NCT02111083|9965043|FG000|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
8906858|NCT02111083|9965044|FG001|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
8906859|NCT02111083|9965043|FG000|STARTED|Second Intervention (1 Day)||19
8906860|NCT02111083|9965044|FG001|STARTED|Second Intervention (1 Day)||19
8906861|NCT02111083|9965043|FG000|COMPLETED|Second Intervention (1 Day)||19
8906862|NCT02111083|9965044|FG001|COMPLETED|Second Intervention (1 Day)||19
8906863|NCT02111083|9965043|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
8906864|NCT02111083|9965044|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
8906865|NCT02111083|9965043|FG000|STARTED|Interval Between Dosing (7-8 Days)||19
8906866|NCT02111083|9965044|FG001|STARTED|Interval Between Dosing (7-8 Days)||19
8906867|NCT02111083|9965043|FG000|COMPLETED|Interval Between Dosing (7-8 Days)||19
8906868|NCT02111083|9965044|FG001|COMPLETED|Interval Between Dosing (7-8 Days)||19
8906869|NCT02111083|9965043|FG000|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
8906870|NCT02111083|9965044|FG001|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
8906871|NCT02111083|9965043|FG000|STARTED|Third Intervention (1 Day)||19
8906872|NCT02111083|9965044|FG001|STARTED|Third Intervention (1 Day)||19
8906873|NCT02111083|9965043|FG000|COMPLETED|Third Intervention (1 Day)||19
8906874|NCT02111083|9965044|FG001|COMPLETED|Third Intervention (1 Day)||19
8906875|NCT02111083|9965043|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
8906876|NCT02111083|9965044|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
8906877|NCT02111083|9965043|FG000|STARTED|Interval Between Dosing (7-8 Days)||19
8906878|NCT02111083|9965044|FG001|STARTED|Interval Between Dosing (7-8 Days)||19
8906879|NCT02111083|9965043|FG000|COMPLETED|Interval Between Dosing (7-8 Days)||18
8906880|NCT02111083|9965044|FG001|COMPLETED|Interval Between Dosing (7-8 Days)||18
8906881|NCT02111083|9965043|FG000|NOT COMPLETED|Interval Between Dosing (7-8 Days)||1
8906882|NCT02111083|9965044|FG001|NOT COMPLETED|Interval Between Dosing (7-8 Days)||1
8906883|NCT02111083|9965043|FG000|STARTED|Fourth Intervention (1 Day)||18
8906884|NCT02111083|9965044|FG001|STARTED|Fourth Intervention (1 Day)||18
8906885|NCT02111083|9965043|FG000|COMPLETED|Fourth Intervention (1 Day)||18
8906886|NCT02111083|9965044|FG001|COMPLETED|Fourth Intervention (1 Day)||18
8906887|NCT02111083|9965043|FG000|NOT COMPLETED|Fourth Intervention (1 Day)||0
8906888|NCT02111083|9965044|FG001|NOT COMPLETED|Fourth Intervention (1 Day)||0
8906889|NCT02111096|9965053|FG000|STARTED|Overall Study||65
8906890|NCT02111096|9965054|FG001|STARTED|Overall Study||41
8906891|NCT02111096|9965055|FG002|STARTED|Overall Study||68
8906892|NCT02111096|9965053|FG000|Received at Least 1 Dose of Study Drug|Overall Study||65
8906893|NCT02111096|9965054|FG001|Received at Least 1 Dose of Study Drug|Overall Study||41
8906894|NCT02111096|9965055|FG002|Received at Least 1 Dose of Study Drug|Overall Study||68
8906895|NCT02111096|9965053|FG000|COMPLETED|Overall Study||1
8906896|NCT02111096|9965054|FG001|COMPLETED|Overall Study||0
8906897|NCT02111096|9965055|FG002|COMPLETED|Overall Study||2
8906898|NCT02111096|9965053|FG000|NOT COMPLETED|Overall Study||64
8906899|NCT02111096|9965054|FG001|NOT COMPLETED|Overall Study||41
8906900|NCT02111096|9965055|FG002|NOT COMPLETED|Overall Study||66
8906901|NCT02111174|9965068|FG000|STARTED|Treatment and Primary Outcome||18
8906902|NCT02111174|9965069|FG001|STARTED|Treatment and Primary Outcome||18
8906903|NCT02111174|9965068|FG000|COMPLETED|Treatment and Primary Outcome||15
8906904|NCT02111174|9965069|FG001|COMPLETED|Treatment and Primary Outcome||16
8906905|NCT02111174|9965068|FG000|NOT COMPLETED|Treatment and Primary Outcome||3
8906906|NCT02111174|9965069|FG001|NOT COMPLETED|Treatment and Primary Outcome||2
8906907|NCT02111174|9965068|FG000|STARTED|Secondary Outcomes (2 and 3 Month f/u)||15
8906908|NCT02111174|9965069|FG001|STARTED|Secondary Outcomes (2 and 3 Month f/u)||16
8906909|NCT02111174|9965068|FG000|2 Month Follow up Complete|Secondary Outcomes (2 and 3 Month f/u)||8
8906910|NCT02111174|9965069|FG001|2 Month Follow up Complete|Secondary Outcomes (2 and 3 Month f/u)||11
8906911|NCT02111174|9965068|FG000|COMPLETED|Secondary Outcomes (2 and 3 Month f/u)||7
8906912|NCT02111174|9965069|FG001|COMPLETED|Secondary Outcomes (2 and 3 Month f/u)||9
8906913|NCT02111174|9965068|FG000|NOT COMPLETED|Secondary Outcomes (2 and 3 Month f/u)||8
8906914|NCT02111174|9965069|FG001|NOT COMPLETED|Secondary Outcomes (2 and 3 Month f/u)||7
8906915|NCT02111187|9965077|FG000|STARTED|Overall Study||7
8906916|NCT02111187|9965078|FG001|STARTED|Overall Study||7
8906917|NCT02111187|9965077|FG000|COMPLETED|Overall Study||7
8906918|NCT02111187|9965078|FG001|COMPLETED|Overall Study||7
8906919|NCT02111187|9965077|FG000|NOT COMPLETED|Overall Study||0
8906920|NCT02111187|9965078|FG001|NOT COMPLETED|Overall Study||0
8906921|NCT02111200|9965088|FG000|STARTED|Overall Study||3
8906922|NCT02111200|9965089|FG001|STARTED|Overall Study||2
8906923|NCT02111200|9965090|FG002|STARTED|Overall Study||1
8906924|NCT02111200|9965091|FG003|STARTED|Overall Study||1
8906925|NCT02111200|9965088|FG000|COMPLETED|Overall Study||3
8906926|NCT02111200|9965089|FG001|COMPLETED|Overall Study||2
8906927|NCT02111200|9965090|FG002|COMPLETED|Overall Study||1
8906928|NCT02111200|9965091|FG003|COMPLETED|Overall Study||1
8906929|NCT02111200|9965088|FG000|NOT COMPLETED|Overall Study||0
8906930|NCT02111200|9965089|FG001|NOT COMPLETED|Overall Study||0
8906931|NCT02111200|9965090|FG002|NOT COMPLETED|Overall Study||0
8906932|NCT02111200|9965091|FG003|NOT COMPLETED|Overall Study||0
8906933|NCT02111213|9965101|FG000|STARTED|Overall Study||122
8906934|NCT02111213|9965102|FG001|STARTED|Overall Study||123
8906935|NCT02111213|9965101|FG000|COMPLETED|Overall Study||116
8906936|NCT02111213|9965102|FG001|COMPLETED|Overall Study||117
8906937|NCT02111213|9965101|FG000|NOT COMPLETED|Overall Study||6
8906938|NCT02111213|9965102|FG001|NOT COMPLETED|Overall Study||6
8906939|NCT02111252|9965108|FG000|STARTED|Overall Study||55
8906940|NCT02111252|9965108|FG000|COMPLETED|Overall Study||55
8906941|NCT02111252|9965108|FG000|NOT COMPLETED|Overall Study||0
8906942|NCT02111369|9965112|FG000|STARTED|Overall Study||18
8906943|NCT02111369|9965112|FG000|COMPLETED|Overall Study||15
8906944|NCT02111369|9965112|FG000|NOT COMPLETED|Overall Study||3
8906945|NCT02111447|9965120|FG000|STARTED|Overall Study||0
8906946|NCT02111447|9965121|FG001|STARTED|Overall Study||5
8906947|NCT02111447|9965122|FG002|STARTED|Overall Study||1
8906948|NCT02111447|9965123|FG003|STARTED|Overall Study||0
8906949|NCT02111447|9965120|FG000|COMPLETED|Overall Study||0
8906950|NCT02111447|9965121|FG001|COMPLETED|Overall Study||5
8906951|NCT02111447|9965122|FG002|COMPLETED|Overall Study||1
8906952|NCT02111447|9965123|FG003|COMPLETED|Overall Study||0
8906953|NCT02111447|9965120|FG000|NOT COMPLETED|Overall Study||0
8906954|NCT02111447|9965121|FG001|NOT COMPLETED|Overall Study||0
8906955|NCT02111447|9965122|FG002|NOT COMPLETED|Overall Study||0
8906956|NCT02111447|9965123|FG003|NOT COMPLETED|Overall Study||0
8906957|NCT02111564|9965135|FG000|STARTED|Overall Study||6007
8906958|NCT02111564|9965136|FG001|STARTED|Overall Study||6012
8906959|NCT02111564|9965135|FG000|Treated|Overall Study||5982
8906960|NCT02111564|9965136|FG001|Treated|Overall Study||5980
8906961|NCT02111564|9965135|FG000|COMPLETED|Overall Study||5876
8906962|NCT02111564|9965136|FG001|COMPLETED|Overall Study||5869
8906963|NCT02111564|9965135|FG000|NOT COMPLETED|Overall Study||131
8906964|NCT02111564|9965136|FG001|NOT COMPLETED|Overall Study||143
8906965|NCT02111577|9965144|FG000|STARTED|Overall Study||787
8906966|NCT02111577|9965145|FG001|STARTED|Overall Study||395
8906967|NCT02111577|9965144|FG000|COMPLETED|Overall Study||188
8906968|NCT02111577|9965145|FG001|COMPLETED|Overall Study||106
8906969|NCT02111577|9965144|FG000|NOT COMPLETED|Overall Study||599
8906970|NCT02111577|9965145|FG001|NOT COMPLETED|Overall Study||289
8906971|NCT02111603|9965153|FG000|STARTED|Overall Study||13
8906972|NCT02111603|9965153|FG000|COMPLETED|Overall Study||12
8906973|NCT02111603|9965153|FG000|NOT COMPLETED|Overall Study||1
8906974|NCT02111746|9965159|FG000|STARTED|Overall Study||172
8906975|NCT02111746|9965160|FG001|STARTED|Overall Study||171
8906976|NCT02111746|9965159|FG000|COMPLETED|Overall Study||169
8906977|NCT02111746|9965160|FG001|COMPLETED|Overall Study||169
8906978|NCT02111746|9965159|FG000|NOT COMPLETED|Overall Study||3
8906979|NCT02111746|9965160|FG001|NOT COMPLETED|Overall Study||2
8906980|NCT02111772|9965168|FG000|STARTED|Overall Study||12
8906981|NCT02111772|9965169|FG001|STARTED|Overall Study||14
8906982|NCT02111772|9965168|FG000|COMPLETED|Overall Study||12
8906983|NCT02111772|9965169|FG001|COMPLETED|Overall Study||14
8906984|NCT02111772|9965168|FG000|NOT COMPLETED|Overall Study||0
8906985|NCT02111772|9965169|FG001|NOT COMPLETED|Overall Study||0
8906986|NCT02111785|9965179|FG000|STARTED|Overall Study||3
9013447|NCT03019796|10076128|FG000|COMPLETED|Third Intervention Drug Test||19
9013448|NCT03019796|10076129|FG001|COMPLETED|Third Intervention Drug Test||19
9013449|NCT03019796|10076128|FG000|NOT COMPLETED|Third Intervention Drug Test||0
9013450|NCT03019796|10076129|FG001|NOT COMPLETED|Third Intervention Drug Test||0
9013451|NCT03019887|10076136|FG000|STARTED|Overall Study||139
9013452|NCT03019887|10076136|FG000|COMPLETED|Overall Study||130
9013453|NCT03019887|10076136|FG000|NOT COMPLETED|Overall Study||9
9013454|NCT03019939|10076140|FG000|STARTED|Overall Study||65
9013455|NCT03019939|10076140|FG000|COMPLETED|Overall Study||65
8726584|NCT01037309|9773821|FG002|COMPLETED|Subcutaneous Cohort 1 - 6||3
8726585|NCT01037309|9773822|FG003|COMPLETED|Subcutaneous Cohort 1 - 6||3
8726586|NCT01037309|9773823|FG004|COMPLETED|Subcutaneous Cohort 1 - 6||3
8726587|NCT01037309|9773824|FG005|COMPLETED|Subcutaneous Cohort 1 - 6||3
8726588|NCT01037309|9773825|FG006|COMPLETED|Subcutaneous Cohort 1 - 6||0
8726589|NCT01037309|9773826|FG007|COMPLETED|Subcutaneous Cohort 1 - 6||0
8726590|NCT01037309|9773827|FG008|COMPLETED|Subcutaneous Cohort 1 - 6||0
8726591|NCT01037309|9773819|FG000|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
8726592|NCT01037309|9773820|FG001|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
8726593|NCT01037309|9773821|FG002|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
8726594|NCT01037309|9773822|FG003|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
8726595|NCT01037309|9773823|FG004|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
8726596|NCT01037309|9773824|FG005|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
8726597|NCT01037309|9773825|FG006|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
8726598|NCT01037309|9773826|FG007|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
8726599|NCT01037309|9773827|FG008|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
8726600|NCT01037309|9773819|FG000|STARTED|Intravenous Period 7 - 9||0
8726601|NCT01037309|9773820|FG001|STARTED|Intravenous Period 7 - 9||0
8726602|NCT01037309|9773821|FG002|STARTED|Intravenous Period 7 - 9||0
8726603|NCT01037309|9773822|FG003|STARTED|Intravenous Period 7 - 9||0
8726604|NCT01037309|9773823|FG004|STARTED|Intravenous Period 7 - 9||0
8726605|NCT01037309|9773824|FG005|STARTED|Intravenous Period 7 - 9||0
8726606|NCT01037309|9773825|FG006|STARTED|Intravenous Period 7 - 9||3
8726607|NCT01037309|9773826|FG007|STARTED|Intravenous Period 7 - 9||3
8726608|NCT01037309|9773827|FG008|STARTED|Intravenous Period 7 - 9||3
8726609|NCT01037309|9773819|FG000|COMPLETED|Intravenous Period 7 - 9||0
8726610|NCT01037309|9773820|FG001|COMPLETED|Intravenous Period 7 - 9||0
8726611|NCT01037309|9773821|FG002|COMPLETED|Intravenous Period 7 - 9||0
8726612|NCT01037309|9773822|FG003|COMPLETED|Intravenous Period 7 - 9||0
8726613|NCT01037309|9773823|FG004|COMPLETED|Intravenous Period 7 - 9||0
8726614|NCT01037309|9773824|FG005|COMPLETED|Intravenous Period 7 - 9||0
8726615|NCT01037309|9773825|FG006|COMPLETED|Intravenous Period 7 - 9||3
8726616|NCT01037309|9773826|FG007|COMPLETED|Intravenous Period 7 - 9||3
8726617|NCT01037309|9773827|FG008|COMPLETED|Intravenous Period 7 - 9||3
8726618|NCT01037309|9773819|FG000|NOT COMPLETED|Intravenous Period 7 - 9||0
8726619|NCT01037309|9773820|FG001|NOT COMPLETED|Intravenous Period 7 - 9||0
8726620|NCT01037309|9773821|FG002|NOT COMPLETED|Intravenous Period 7 - 9||0
8726621|NCT01037309|9773822|FG003|NOT COMPLETED|Intravenous Period 7 - 9||0
8726622|NCT01037309|9773823|FG004|NOT COMPLETED|Intravenous Period 7 - 9||0
8726623|NCT01037309|9773824|FG005|NOT COMPLETED|Intravenous Period 7 - 9||0
8726624|NCT01037309|9773825|FG006|NOT COMPLETED|Intravenous Period 7 - 9||0
8726625|NCT01037309|9773826|FG007|NOT COMPLETED|Intravenous Period 7 - 9||0
8726626|NCT01037309|9773827|FG008|NOT COMPLETED|Intravenous Period 7 - 9||0
8726627|NCT01037413|9773850|FG000|STARTED|Part A: Skin Testing||25
8726628|NCT01037413|9773851|FG001|STARTED|Part A: Skin Testing||0
8726629|NCT01037413|9773850|FG000|COMPLETED|Part A: Skin Testing||23
8726630|NCT01037413|9773851|FG001|COMPLETED|Part A: Skin Testing||0
8726631|NCT01037413|9773850|FG000|NOT COMPLETED|Part A: Skin Testing||2
8726632|NCT01037413|9773851|FG001|NOT COMPLETED|Part A: Skin Testing||0
8726633|NCT01037413|9773850|FG000|STARTED|Part B: Scar Revision|Participants who tested negative for skin sensitization proceeded to Part B of the study. .|0
8726634|NCT01037413|9773851|FG001|STARTED|Part B: Scar Revision|Participants who completed Part A of the study and were negative for skin sensitization.|23
8726635|NCT01037413|9773850|FG000|Treated|Part B: Scar Revision||0
8726636|NCT01037413|9773851|FG001|Treated|Part B: Scar Revision||22
8726637|NCT01037413|9773850|FG000|COMPLETED|Part B: Scar Revision||0
8726638|NCT01037413|9773851|FG001|COMPLETED|Part B: Scar Revision||21
8726639|NCT01037413|9773850|FG000|NOT COMPLETED|Part B: Scar Revision||0
8726640|NCT01037413|9773851|FG001|NOT COMPLETED|Part B: Scar Revision||2
8726641|NCT01037452|9773868|FG000|STARTED|Overall Study||30
8726642|NCT01037452|9773869|FG001|STARTED|Overall Study||30
8726643|NCT01037452|9773870|FG002|STARTED|Overall Study||30
8726644|NCT01037452|9773871|FG003|STARTED|Overall Study||30
8726645|NCT01037452|9773868|FG000|COMPLETED|Overall Study||30
8726646|NCT01037452|9773869|FG001|COMPLETED|Overall Study||30
8726647|NCT01037452|9773870|FG002|COMPLETED|Overall Study||30
8726648|NCT01037452|9773871|FG003|COMPLETED|Overall Study||30
8726649|NCT01037452|9773868|FG000|NOT COMPLETED|Overall Study||0
8726650|NCT01037452|9773869|FG001|NOT COMPLETED|Overall Study||0
8726651|NCT01037452|9773870|FG002|NOT COMPLETED|Overall Study||0
8726652|NCT01037452|9773871|FG003|NOT COMPLETED|Overall Study||0
8636746|NCT00777036|9677445|FG000|COMPLETED|On Treatment|Completed = Still on treatment|14
8636747|NCT00777036|9677446|FG001|COMPLETED|On Treatment|Completed = Still on treatment|1
8636748|NCT00777036|9677447|FG002|COMPLETED|On Treatment|Completed = Still on treatment|61
8906987|NCT02111785|9965180|FG001|STARTED|Overall Study||5
8906988|NCT02111785|9965181|FG002|STARTED|Overall Study||1
8906989|NCT02111785|9965182|FG003|STARTED|Overall Study||1
8906990|NCT02111785|9965179|FG000|COMPLETED|Overall Study||3
8906991|NCT02111785|9965180|FG001|COMPLETED|Overall Study||4
8906992|NCT02111785|9965181|FG002|COMPLETED|Overall Study||1
8906993|NCT02111785|9965182|FG003|COMPLETED|Overall Study||1
8906994|NCT02111785|9965179|FG000|NOT COMPLETED|Overall Study||0
8906995|NCT02111785|9965180|FG001|NOT COMPLETED|Overall Study||1
8906996|NCT02111785|9965181|FG002|NOT COMPLETED|Overall Study||0
8906997|NCT02111785|9965182|FG003|NOT COMPLETED|Overall Study||0
8906998|NCT02111798|9965200|FG000|STARTED|Overall Study||31
8906999|NCT02111798|9965201|FG001|STARTED|Overall Study||32
8907000|NCT02111798|9965202|FG002|STARTED|Overall Study||10
8907001|NCT02111798|9965203|FG003|STARTED|Overall Study||10
8907002|NCT02111798|9965200|FG000|COMPLETED|Overall Study||20
8907003|NCT02111798|9965201|FG001|COMPLETED|Overall Study||16
8907004|NCT02111798|9965202|FG002|COMPLETED|Overall Study||10
8907005|NCT02111798|9965203|FG003|COMPLETED|Overall Study||7
8907006|NCT02111798|9965200|FG000|NOT COMPLETED|Overall Study||11
8907007|NCT02111798|9965201|FG001|NOT COMPLETED|Overall Study||16
8907008|NCT02111798|9965202|FG002|NOT COMPLETED|Overall Study||0
8907009|NCT02111798|9965203|FG003|NOT COMPLETED|Overall Study||3
8907010|NCT02111811|9965216|FG000|STARTED|Treatment Phase||139
8907011|NCT02111811|9965217|FG001|STARTED|Treatment Phase||114
8907012|NCT02111811|9965216|FG000|COMPLETED|Treatment Phase||115
8907013|NCT02111811|9965217|FG001|COMPLETED|Treatment Phase||96
8907014|NCT02111811|9965216|FG000|NOT COMPLETED|Treatment Phase||24
8907015|NCT02111811|9965217|FG001|NOT COMPLETED|Treatment Phase||18
8907016|NCT02111811|9965216|FG000|STARTED|Follow up Period (Aim 2)||139
8907017|NCT02111811|9965217|FG001|STARTED|Follow up Period (Aim 2)|All subjects were approached for followup, 1 patient completed the 2nd followup and not the first.|114
8907018|NCT02111811|9965216|FG000|COMPLETED|Follow up Period (Aim 2)||111
8907019|NCT02111811|9965217|FG001|COMPLETED|Follow up Period (Aim 2)||97
8907020|NCT02111811|9965216|FG000|NOT COMPLETED|Follow up Period (Aim 2)||28
8907021|NCT02111811|9965217|FG001|NOT COMPLETED|Follow up Period (Aim 2)||17
8907022|NCT02111863|9965223|FG000|STARTED|Overall Study||6
8573359|NCT00121485|9605629|FG000|NOT COMPLETED|Overall Study||1
8573360|NCT00121485|9605630|FG001|NOT COMPLETED|Overall Study||7
8573361|NCT00121641|9605641|FG000|STARTED|24-week Short-term Treatment Period||102
8573362|NCT00121641|9605642|FG001|STARTED|24-week Short-term Treatment Period||106
8573363|NCT00121641|9605643|FG002|STARTED|24-week Short-term Treatment Period||98
8573364|NCT00121641|9605644|FG003|STARTED|24-week Short-term Treatment Period||95
8573365|NCT00121641|9605645|FG004|STARTED|24-week Short-term Treatment Period||66
8573366|NCT00121641|9605641|FG000|COMPLETED|24-week Short-term Treatment Period||73
8573367|NCT00121641|9605642|FG001|COMPLETED|24-week Short-term Treatment Period||68
8907023|NCT02111863|9965223|FG000|COMPLETED|Overall Study||6
8907024|NCT02111863|9965223|FG000|NOT COMPLETED|Overall Study||0
8907025|NCT02111980|9965227|FG000|STARTED|Overall Study||50
8907026|NCT02111980|9965227|FG000|COMPLETED|Overall Study||50
8907027|NCT02111980|9965227|FG000|NOT COMPLETED|Overall Study||0
8907028|NCT02111993|9965236|FG000|STARTED|Overall Study||30
8907029|NCT02111993|9965237|FG001|STARTED|Overall Study||30
8907030|NCT02111993|9965236|FG000|COMPLETED|Overall Study||25
8907031|NCT02111993|9965237|FG001|COMPLETED|Overall Study||26
8907032|NCT02111993|9965236|FG000|NOT COMPLETED|Overall Study||5
8907033|NCT02111993|9965237|FG001|NOT COMPLETED|Overall Study||4
8907034|NCT02112045|9965247|FG000|STARTED|Overall Study||45
8907035|NCT02112045|9965248|FG001|STARTED|Overall Study||45
8907036|NCT02112045|9965247|FG000|COMPLETED|Overall Study||44
8907037|NCT02112045|9965248|FG001|COMPLETED|Overall Study||45
8907038|NCT02112045|9965247|FG000|NOT COMPLETED|Overall Study||1
8907039|NCT02112045|9965248|FG001|NOT COMPLETED|Overall Study||0
8907040|NCT02112370|9965256|FG000|STARTED|Overall Study||74
8907041|NCT02112370|9965257|FG001|STARTED|Overall Study||74
8907042|NCT02112370|9965256|FG000|COMPLETED|Overall Study||74
8907043|NCT02112370|9965257|FG001|COMPLETED|Overall Study||74
8907044|NCT02112370|9965256|FG000|NOT COMPLETED|Overall Study||0
8907045|NCT02112370|9965257|FG001|NOT COMPLETED|Overall Study||0
8907046|NCT02112448|9965265|FG000|STARTED|Overall Study||38
8907047|NCT02112448|9965266|FG001|STARTED|Overall Study||40
8907048|NCT02112448|9965265|FG000|COMPLETED|Overall Study||30
8907049|NCT02112448|9965266|FG001|COMPLETED|Overall Study||30
8907050|NCT02112448|9965265|FG000|NOT COMPLETED|Overall Study||8
8907051|NCT02112448|9965266|FG001|NOT COMPLETED|Overall Study||10
8907052|NCT02112838|9965277|FG000|STARTED|Overall Study||25
8907053|NCT02112838|9965278|FG001|STARTED|Overall Study||26
8907054|NCT02112838|9965279|FG002|STARTED|Overall Study||25
8907055|NCT02112838|9965277|FG000|COMPLETED|Overall Study||20
8907056|NCT02112838|9965278|FG001|COMPLETED|Overall Study||24
8907057|NCT02112838|9965279|FG002|COMPLETED|Overall Study||24
8907058|NCT02112838|9965277|FG000|NOT COMPLETED|Overall Study||5
8907059|NCT02112838|9965278|FG001|NOT COMPLETED|Overall Study||2
8907060|NCT02112838|9965279|FG002|NOT COMPLETED|Overall Study||1
8907061|NCT02112877|9965289|FG000|STARTED|Overall Study||30
8907062|NCT02112877|9965290|FG001|STARTED|Overall Study||170
8907063|NCT02112877|9965289|FG000|COMPLETED|Overall Study||28
8907064|NCT02112877|9965290|FG001|COMPLETED|Overall Study||157
8907065|NCT02112877|9965289|FG000|NOT COMPLETED|Overall Study||2
8907066|NCT02112877|9965290|FG001|NOT COMPLETED|Overall Study||13
8907067|NCT02112994|9965298|FG000|STARTED|Overall Study||6
8907068|NCT02112994|9965299|FG001|STARTED|Overall Study||16
8907069|NCT02112994|9965300|FG002|STARTED|Overall Study||9
8907070|NCT02112994|9965298|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
8907071|NCT02112994|9965299|FG001|Received at Least 1 Dose of Study Drug|Overall Study||16
8907072|NCT02112994|9965300|FG002|Received at Least 1 Dose of Study Drug|Overall Study||9
8907073|NCT02112994|9965298|FG000|Received 0.35 mg/kg QOW|Overall Study||0
8907074|NCT02112994|9965299|FG001|Received 0.35 mg/kg QOW|Overall Study||0
8907075|NCT02112994|9965300|FG002|Received 0.35 mg/kg QOW|Overall Study||1
8907076|NCT02112994|9965298|FG000|Received 1 mg/kg QOW|Overall Study||6
8907077|NCT02112994|9965299|FG001|Received 1 mg/kg QOW|Overall Study||16
8907078|NCT02112994|9965300|FG002|Received 1 mg/kg QOW|Overall Study||9
8907079|NCT02112994|9965298|FG000|Received 1 mg/kg QW|Overall Study||1
8907080|NCT02112994|9965299|FG001|Received 1 mg/kg QW|Overall Study||1
8907081|NCT02112994|9965300|FG002|Received 1 mg/kg QW|Overall Study||0
8907082|NCT02112994|9965298|FG000|Received 3 mg/kg QOW|Overall Study||3
8907083|NCT02112994|9965299|FG001|Received 3 mg/kg QOW|Overall Study||5
8907084|NCT02112994|9965300|FG002|Received 3 mg/kg QOW|Overall Study||3
8907085|NCT02112994|9965298|FG000|Received 3 mg/kg QW|Overall Study||2
8907086|NCT02112994|9965299|FG001|Received 3 mg/kg QW|Overall Study||1
8907087|NCT02112994|9965300|FG002|Received 3 mg/kg QW|Overall Study||1
8907088|NCT02112994|9965298|FG000|Completed 96-week Treatment Period|Overall Study||6
8907089|NCT02112994|9965299|FG001|Completed 96-week Treatment Period|Overall Study||14
8907090|NCT02112994|9965300|FG002|Completed 96-week Treatment Period|Overall Study||8
8907091|NCT02112994|9965298|FG000|COMPLETED|Overall Study||6
8907092|NCT02112994|9965299|FG001|COMPLETED|Overall Study||14
8907093|NCT02112994|9965300|FG002|COMPLETED|Overall Study||6
8907094|NCT02112994|9965298|FG000|NOT COMPLETED|Overall Study||0
8907095|NCT02112994|9965299|FG001|NOT COMPLETED|Overall Study||2
8907096|NCT02112994|9965300|FG002|NOT COMPLETED|Overall Study||3
8907097|NCT02113007|9965312|FG000|STARTED|Overall Study||2
8907098|NCT02113007|9965312|FG000|COMPLETED|Overall Study||0
8907099|NCT02113007|9965312|FG000|NOT COMPLETED|Overall Study||2
8907100|NCT02113124|9965318|FG000|STARTED|Overall Study||18
8907101|NCT02113124|9965319|FG001|STARTED|Overall Study||25
8907102|NCT02113124|9965318|FG000|COMPLETED|Overall Study||17
8907103|NCT02113124|9965319|FG001|COMPLETED|Overall Study||24
8907104|NCT02113124|9965318|FG000|NOT COMPLETED|Overall Study||1
8907105|NCT02113124|9965319|FG001|NOT COMPLETED|Overall Study||1
8907106|NCT02113189|9965328|FG000|STARTED|Overall Study||4
8907107|NCT02113189|9965329|FG001|STARTED|Overall Study||4
8907108|NCT02113189|9965330|FG002|STARTED|Overall Study||5
8907109|NCT02113189|9965328|FG000|COMPLETED|Overall Study||2
8907110|NCT02113189|9965329|FG001|COMPLETED|Overall Study||3
8907111|NCT02113189|9965330|FG002|COMPLETED|Overall Study||2
8907112|NCT02113189|9965328|FG000|NOT COMPLETED|Overall Study||2
8907113|NCT02113189|9965329|FG001|NOT COMPLETED|Overall Study||1
8907114|NCT02113189|9965330|FG002|NOT COMPLETED|Overall Study||3
8907115|NCT02113241|9965343|FG000|STARTED|Overall Study||12
8907116|NCT02113241|9965344|FG001|STARTED|Overall Study||12
8907117|NCT02113241|9965343|FG000|COMPLETED|Overall Study||12
8907118|NCT02113241|9965344|FG001|COMPLETED|Overall Study||11
8907119|NCT02113241|9965343|FG000|NOT COMPLETED|Overall Study||0
9013456|NCT03019939|10076140|FG000|NOT COMPLETED|Overall Study||0
9013457|NCT03019965|10076146|FG000|STARTED|Overall Study||211
9013458|NCT03019965|10076147|FG001|STARTED|Overall Study||215
9013459|NCT03019965|10076146|FG000|COMPLETED|Overall Study||201
9013460|NCT03019965|10076147|FG001|COMPLETED|Overall Study||202
9013461|NCT03019965|10076146|FG000|NOT COMPLETED|Overall Study||10
9013462|NCT03019965|10076147|FG001|NOT COMPLETED|Overall Study||13
9013463|NCT03020004|10076153|FG000|STARTED|Overall Study||70
9013464|NCT03020004|10076153|FG000|COMPLETED|Overall Study||69
9013465|NCT03020004|10076153|FG000|NOT COMPLETED|Overall Study||1
9013466|NCT03020069|10076159|FG000|STARTED|Overall Study||9
9013467|NCT03020069|10076160|FG001|STARTED|Overall Study||4
9013468|NCT03020069|10076159|FG000|COMPLETED|Overall Study||9
9013469|NCT03020069|10076160|FG001|COMPLETED|Overall Study||3
9013470|NCT03020069|10076159|FG000|NOT COMPLETED|Overall Study||0
9013471|NCT03020069|10076160|FG001|NOT COMPLETED|Overall Study||1
9013472|NCT03020082|10076166|FG000|STARTED|Overall Study||141
9013473|NCT03020082|10076166|FG000|COMPLETED|Overall Study||138
9013474|NCT03020082|10076166|FG000|NOT COMPLETED|Overall Study||3
8907120|NCT02113241|9965344|FG001|NOT COMPLETED|Overall Study||1
9013475|NCT03020095|10076170|FG000|STARTED|Overall Study||38
9013476|NCT03020095|10076170|FG000|COMPLETED|Overall Study||37
9013477|NCT03020095|10076170|FG000|NOT COMPLETED|Overall Study||1
8907121|NCT02113410|9965352|FG000|STARTED|Overall Study||65
8907122|NCT02113410|9965353|FG001|STARTED|Overall Study||66
8907123|NCT02113410|9965352|FG000|COMPLETED|Overall Study||49
8907124|NCT02113410|9965353|FG001|COMPLETED|Overall Study||63
8907125|NCT02113410|9965352|FG000|NOT COMPLETED|Overall Study||16
8907126|NCT02113410|9965353|FG001|NOT COMPLETED|Overall Study||3
8907127|NCT02113436|9965363|FG000|STARTED|Period 1: 8 Weeks||150
8907128|NCT02113436|9965364|FG001|STARTED|Period 1: 8 Weeks||150
8907129|NCT02113436|9965365|FG002|STARTED|Period 1: 8 Weeks||0
9013478|NCT03020407|10076176|FG000|STARTED|Overall Study||105
9013479|NCT03020407|10076177|FG001|STARTED|Overall Study||106
8907130|NCT02113436|9965366|FG003|STARTED|Period 1: 8 Weeks||0
8907131|NCT02113436|9965363|FG000|COMPLETED|Period 1: 8 Weeks||142
8907132|NCT02113436|9965364|FG001|COMPLETED|Period 1: 8 Weeks||148
8907133|NCT02113436|9965365|FG002|COMPLETED|Period 1: 8 Weeks||0
8907134|NCT02113436|9965366|FG003|COMPLETED|Period 1: 8 Weeks||0
8907135|NCT02113436|9965363|FG000|NOT COMPLETED|Period 1: 8 Weeks||8
8907136|NCT02113436|9965364|FG001|NOT COMPLETED|Period 1: 8 Weeks||2
8907137|NCT02113436|9965365|FG002|NOT COMPLETED|Period 1: 8 Weeks||0
8907138|NCT02113436|9965366|FG003|NOT COMPLETED|Period 1: 8 Weeks||0
8907139|NCT02113436|9965363|FG000|STARTED|Period 2: 16 Weeks||0
8907140|NCT02113436|9965364|FG001|STARTED|Period 2: 16 Weeks||0
8907141|NCT02113436|9965365|FG002|STARTED|Period 2: 16 Weeks|Par. started TP2 are not equal to that completed TP1 as 1 par. in each arm didn't transfer to TP2.|141
8907142|NCT02113436|9965366|FG003|STARTED|Period 2: 16 Weeks|Par. started TP2 are not equal to that completed TP1 as 1 par. in each arm didn't transfer to TP2.|147
8907143|NCT02113436|9965363|FG000|COMPLETED|Period 2: 16 Weeks||0
8907144|NCT02113436|9965364|FG001|COMPLETED|Period 2: 16 Weeks||0
8907145|NCT02113436|9965365|FG002|COMPLETED|Period 2: 16 Weeks||132
8907146|NCT02113436|9965366|FG003|COMPLETED|Period 2: 16 Weeks||136
8907147|NCT02113436|9965363|FG000|NOT COMPLETED|Period 2: 16 Weeks||0
8907148|NCT02113436|9965364|FG001|NOT COMPLETED|Period 2: 16 Weeks||0
8907149|NCT02113436|9965365|FG002|NOT COMPLETED|Period 2: 16 Weeks||9
8907150|NCT02113436|9965366|FG003|NOT COMPLETED|Period 2: 16 Weeks||11
8907151|NCT02113449|9965375|FG000|STARTED|Overall Study||147
8907152|NCT02113449|9965375|FG000|COMPLETED|Overall Study||143
8636749|NCT00777036|9677445|FG000|NOT COMPLETED|On Treatment||15
8636750|NCT00777036|9677446|FG001|NOT COMPLETED|On Treatment||16
8636751|NCT00777036|9677447|FG002|NOT COMPLETED|On Treatment||23
8907153|NCT02113449|9965375|FG000|NOT COMPLETED|Overall Study||4
8907154|NCT02113579|9965385|FG000|STARTED|Overall Study||186
8907155|NCT02113579|9965386|FG001|STARTED|Overall Study||189
8907156|NCT02113579|9965385|FG000|COMPLETED|Overall Study||176
8907157|NCT02113579|9965386|FG001|COMPLETED|Overall Study||185
8907158|NCT02113579|9965385|FG000|NOT COMPLETED|Overall Study||10
8907159|NCT02113579|9965386|FG001|NOT COMPLETED|Overall Study||4
8907160|NCT02113956|9965394|FG000|STARTED|Intervention End (5 Weeks Post Baseline)||150
8907161|NCT02113956|9965395|FG001|STARTED|Intervention End (5 Weeks Post Baseline)||152
8907162|NCT02113956|9965394|FG000|COMPLETED|Intervention End (5 Weeks Post Baseline)||141
8907163|NCT02113956|9965395|FG001|COMPLETED|Intervention End (5 Weeks Post Baseline)||148
8907164|NCT02113956|9965394|FG000|NOT COMPLETED|Intervention End (5 Weeks Post Baseline)||9
8907165|NCT02113956|9965395|FG001|NOT COMPLETED|Intervention End (5 Weeks Post Baseline)||4
8907166|NCT02113956|9965394|FG000|STARTED|3 Month Post-intervention||141
8907167|NCT02113956|9965395|FG001|STARTED|3 Month Post-intervention||148
8907168|NCT02113956|9965394|FG000|COMPLETED|3 Month Post-intervention||137
9013480|NCT03020407|10076176|FG000|COMPLETED|Overall Study||101
9013481|NCT03020407|10076177|FG001|COMPLETED|Overall Study||101
9013482|NCT03020407|10076176|FG000|NOT COMPLETED|Overall Study||4
9013483|NCT03020407|10076177|FG001|NOT COMPLETED|Overall Study||5
9013484|NCT03020472|10076183|FG000|STARTED|Overall Study||6
9013485|NCT03020472|10076183|FG000|COMPLETED|Overall Study||6
9013486|NCT03020472|10076183|FG000|NOT COMPLETED|Overall Study||0
9013487|NCT03020498|10076190|FG000|STARTED|Overall Study||14
9013488|NCT03020498|10076191|FG001|STARTED|Overall Study||41
9013489|NCT03020498|10076192|FG002|STARTED|Overall Study||36
8636752|NCT00777036|9677445|FG000|STARTED|Follow-Up|Not all participants who discontinued treatment entered the follow-up period|14
8636753|NCT00777036|9677446|FG001|STARTED|Follow-Up|Not all participants who discontinued treatment entered the follow-up period|13
8636754|NCT00777036|9677447|FG002|STARTED|Follow-Up|Not all participants who discontinued treatment entered the follow-up period|23
8636755|NCT00777036|9677445|FG000|COMPLETED|Follow-Up|Completed = Still in Follow-up|9
8907169|NCT02113956|9965395|FG001|COMPLETED|3 Month Post-intervention||146
9013490|NCT03020498|10076190|FG000|COMPLETED|Overall Study||14
9013491|NCT03020498|10076191|FG001|COMPLETED|Overall Study||38
9013492|NCT03020498|10076192|FG002|COMPLETED|Overall Study||36
9013493|NCT03020498|10076190|FG000|NOT COMPLETED|Overall Study||0
9013494|NCT03020498|10076191|FG001|NOT COMPLETED|Overall Study||3
9013495|NCT03020498|10076192|FG002|NOT COMPLETED|Overall Study||0
9013496|NCT03020524|10076203|FG000|STARTED|Overall Study||3
9013497|NCT03020524|10076204|FG001|STARTED|Overall Study||3
9013498|NCT03020524|10076205|FG002|STARTED|Overall Study||3
9013499|NCT03020524|10076203|FG000|COMPLETED|Overall Study||3
9013500|NCT03020524|10076204|FG001|COMPLETED|Overall Study||3
9013501|NCT03020524|10076205|FG002|COMPLETED|Overall Study||3
9013502|NCT03020524|10076203|FG000|NOT COMPLETED|Overall Study||0
9013503|NCT03020524|10076204|FG001|NOT COMPLETED|Overall Study||0
9013504|NCT03020524|10076205|FG002|NOT COMPLETED|Overall Study||0
9013505|NCT03020537|10076215|FG000|STARTED|Overall Study||1
9013506|NCT03020537|10076216|FG001|STARTED|Overall Study||7
9013507|NCT03020537|10076215|FG000|COMPLETED|Overall Study||1
9013508|NCT03020537|10076216|FG001|COMPLETED|Overall Study||7
9013509|NCT03020537|10076215|FG000|NOT COMPLETED|Overall Study||0
9013510|NCT03020537|10076216|FG001|NOT COMPLETED|Overall Study||0
9013511|NCT03020550|10076224|FG000|STARTED|Overall Study||8
9013512|NCT03020550|10076225|FG001|STARTED|Overall Study||16
8907170|NCT02113956|9965394|FG000|NOT COMPLETED|3 Month Post-intervention||4
8907171|NCT02113956|9965395|FG001|NOT COMPLETED|3 Month Post-intervention||2
9013513|NCT03020550|10076224|FG000|COMPLETED|Overall Study||8
9013514|NCT03020550|10076225|FG001|COMPLETED|Overall Study||16
9013515|NCT03020550|10076224|FG000|NOT COMPLETED|Overall Study||0
9013516|NCT03020550|10076225|FG001|NOT COMPLETED|Overall Study||0
9013517|NCT03020576|10076233|FG000|STARTED|Overall Study||15
9013518|NCT03020576|10076234|FG001|STARTED|Overall Study||16
9013519|NCT03020576|10076233|FG000|COMPLETED|Overall Study||14
8636756|NCT00777036|9677446|FG001|COMPLETED|Follow-Up|Completed = Still in Follow-up|5
8636757|NCT00777036|9677447|FG002|COMPLETED|Follow-Up|Completed = Still in Follow-up|19
8636758|NCT00777036|9677445|FG000|NOT COMPLETED|Follow-Up||5
8636759|NCT00777036|9677446|FG001|NOT COMPLETED|Follow-Up||8
8636760|NCT00777036|9677447|FG002|NOT COMPLETED|Follow-Up||4
8636761|NCT00600483|9677464|FG000|STARTED|Overall Study||753
8636762|NCT00600483|9677465|FG001|STARTED|Overall Study||749
8636763|NCT00600483|9677464|FG000|COMPLETED|Overall Study||717
8636764|NCT00600483|9677465|FG001|COMPLETED|Overall Study||702
8636765|NCT00600483|9677464|FG000|NOT COMPLETED|Overall Study||36
8636766|NCT00600483|9677465|FG001|NOT COMPLETED|Overall Study||47
8636767|NCT00568854|9677473|FG000|STARTED|Overall Study||6
8636768|NCT00568854|9677474|FG001|STARTED|Overall Study||4
8636769|NCT00568854|9677473|FG000|COMPLETED|Overall Study||6
8636770|NCT00568854|9677474|FG001|COMPLETED|Overall Study||4
8726653|NCT01037790|9773886|FG000|STARTED|Overall Study||63
8726654|NCT01037790|9773887|FG001|STARTED|Overall Study||18
8726655|NCT01037790|9773888|FG002|STARTED|Overall Study||19
8726656|NCT01037790|9773889|FG003|STARTED|Overall Study||30
8726657|NCT01037790|9773890|FG004|STARTED|Overall Study||11
8726658|NCT01037790|9773886|FG000|COMPLETED|Overall Study||63
8726659|NCT01037790|9773887|FG001|COMPLETED|Overall Study||18
8726660|NCT01037790|9773888|FG002|COMPLETED|Overall Study||19
8726661|NCT01037790|9773889|FG003|COMPLETED|Overall Study||30
8726662|NCT01037790|9773890|FG004|COMPLETED|Overall Study||11
8726663|NCT01037790|9773886|FG000|NOT COMPLETED|Overall Study||0
8726664|NCT01037790|9773887|FG001|NOT COMPLETED|Overall Study||0
8726665|NCT01037790|9773888|FG002|NOT COMPLETED|Overall Study||0
8726666|NCT01037790|9773889|FG003|NOT COMPLETED|Overall Study||0
8726667|NCT01037790|9773890|FG004|NOT COMPLETED|Overall Study||0
8726668|NCT01037881|9773909|FG000|STARTED|Overall Study||25
8726669|NCT01037881|9773910|FG001|STARTED|Overall Study||24
8726670|NCT01037881|9773911|FG002|STARTED|Overall Study||25
8726671|NCT01037881|9773912|FG003|STARTED|Overall Study||25
8726672|NCT01037881|9773913|FG004|STARTED|Overall Study||29
8726673|NCT01037881|9773914|FG005|STARTED|Overall Study||30
8726674|NCT01037881|9773915|FG006|STARTED|Overall Study||25
8726675|NCT01037881|9773909|FG000|COMPLETED|Overall Study||19
8726676|NCT01037881|9773910|FG001|COMPLETED|Overall Study||22
8726677|NCT01037881|9773911|FG002|COMPLETED|Overall Study||22
8726678|NCT01037881|9773912|FG003|COMPLETED|Overall Study||24
8726679|NCT01037881|9773913|FG004|COMPLETED|Overall Study||26
8726680|NCT01037881|9773914|FG005|COMPLETED|Overall Study||27
8726681|NCT01037881|9773915|FG006|COMPLETED|Overall Study||23
8726682|NCT01037881|9773909|FG000|NOT COMPLETED|Overall Study||6
8726683|NCT01037881|9773910|FG001|NOT COMPLETED|Overall Study||2
8726684|NCT01037881|9773911|FG002|NOT COMPLETED|Overall Study||3
8726685|NCT01037881|9773912|FG003|NOT COMPLETED|Overall Study||1
8726686|NCT01037881|9773913|FG004|NOT COMPLETED|Overall Study||3
8726687|NCT01037881|9773914|FG005|NOT COMPLETED|Overall Study||3
8726688|NCT01037881|9773915|FG006|NOT COMPLETED|Overall Study||2
8726689|NCT01037985|9773940|FG000|STARTED|Part A: Skin Testing (50 Days)||41
8726690|NCT01037985|9773941|FG001|STARTED|Part A: Skin Testing (50 Days)||0
8726691|NCT01037985|9773940|FG000|COMPLETED|Part A: Skin Testing (50 Days)||37
8726692|NCT01037985|9773941|FG001|COMPLETED|Part A: Skin Testing (50 Days)||0
8726693|NCT01037985|9773940|FG000|NOT COMPLETED|Part A: Skin Testing (50 Days)||4
8726694|NCT01037985|9773941|FG001|NOT COMPLETED|Part A: Skin Testing (50 Days)||0
8726695|NCT01037985|9773940|FG000|STARTED|Part B:Abdominoplasty Surgery (24 Weeks)|Participants who tested negative for skin sensitization proceeded to Part B of the study. .|0
8726696|NCT01037985|9773941|FG001|STARTED|Part B:Abdominoplasty Surgery (24 Weeks)|Participants who completed Part A of the study and were negative for skin sensitization.|37
8726697|NCT01037985|9773940|FG000|Treated|Part B:Abdominoplasty Surgery (24 Weeks)||0
8726698|NCT01037985|9773941|FG001|Treated|Part B:Abdominoplasty Surgery (24 Weeks)||33
8726699|NCT01037985|9773940|FG000|COMPLETED|Part B:Abdominoplasty Surgery (24 Weeks)||0
8726700|NCT01037985|9773941|FG001|COMPLETED|Part B:Abdominoplasty Surgery (24 Weeks)||32
8726701|NCT01037985|9773940|FG000|NOT COMPLETED|Part B:Abdominoplasty Surgery (24 Weeks)||0
8726702|NCT01037985|9773941|FG001|NOT COMPLETED|Part B:Abdominoplasty Surgery (24 Weeks)||5
8907172|NCT02114151|9965401|FG000|STARTED|Overall Study||103
9013520|NCT03020576|10076234|FG001|COMPLETED|Overall Study||14
8636771|NCT00568854|9677473|FG000|NOT COMPLETED|Overall Study||0
8636772|NCT00568854|9677474|FG001|NOT COMPLETED|Overall Study||0
8636773|NCT00568958|9677482|FG000|STARTED|Allocation||70
8636774|NCT00568958|9677483|FG001|STARTED|Allocation||70
8636775|NCT00568958|9677482|FG000|COMPLETED|Allocation||61
8636776|NCT00568958|9677483|FG001|COMPLETED|Allocation||67
8636777|NCT00568958|9677482|FG000|NOT COMPLETED|Allocation||9
8636778|NCT00568958|9677483|FG001|NOT COMPLETED|Allocation||3
8636779|NCT00568958|9677482|FG000|STARTED|Follow-Up||61
8636780|NCT00568958|9677483|FG001|STARTED|Follow-Up||67
8636781|NCT00568958|9677482|FG000|COMPLETED|Follow-Up||52
8636782|NCT00568958|9677483|FG001|COMPLETED|Follow-Up||60
8636783|NCT00568958|9677482|FG000|NOT COMPLETED|Follow-Up||9
8907173|NCT02114151|9965401|FG000|COMPLETED|Overall Study||96
8907174|NCT02114151|9965401|FG000|NOT COMPLETED|Overall Study||7
8907175|NCT02114164|9965407|FG000|STARTED|Overall Study||50
8907176|NCT02114164|9965408|FG001|STARTED|Overall Study||50
8907177|NCT02114164|9965407|FG000|COMPLETED|Overall Study||50
8907178|NCT02114164|9965408|FG001|COMPLETED|Overall Study||50
8907179|NCT02114164|9965407|FG000|NOT COMPLETED|Overall Study||0
8907180|NCT02114164|9965408|FG001|NOT COMPLETED|Overall Study||0
8907181|NCT02114177|9965416|FG000|STARTED|Overall Study||155
8907182|NCT02114177|9965417|FG001|STARTED|Overall Study||155
8907183|NCT02114177|9965416|FG000|COMPLETED|Overall Study||146
8907184|NCT02114177|9965417|FG001|COMPLETED|Overall Study||151
8907185|NCT02114177|9965416|FG000|NOT COMPLETED|Overall Study||9
8907186|NCT02114177|9965417|FG001|NOT COMPLETED|Overall Study||4
8907187|NCT02114203|9965426|FG000|STARTED|Overall Study||7
8907188|NCT02114203|9965427|FG001|STARTED|Overall Study||16
8907189|NCT02114203|9965428|FG002|STARTED|Overall Study||7
8907190|NCT02114203|9965426|FG000|COMPLETED|Overall Study||7
8907191|NCT02114203|9965427|FG001|COMPLETED|Overall Study||14
8907192|NCT02114203|9965428|FG002|COMPLETED|Overall Study||7
8907193|NCT02114203|9965426|FG000|NOT COMPLETED|Overall Study||0
8907194|NCT02114203|9965427|FG001|NOT COMPLETED|Overall Study||2
8907195|NCT02114203|9965428|FG002|NOT COMPLETED|Overall Study||0
8907196|NCT02114216|9965439|FG000|STARTED|Overall Study||16
8907197|NCT02114216|9965440|FG001|STARTED|Overall Study||45
8907198|NCT02114216|9965441|FG002|STARTED|Overall Study||14
8907199|NCT02114216|9965439|FG000|COMPLETED|Overall Study||16
8907200|NCT02114216|9965440|FG001|COMPLETED|Overall Study||45
8907201|NCT02114216|9965441|FG002|COMPLETED|Overall Study||14
8907202|NCT02114216|9965439|FG000|NOT COMPLETED|Overall Study||0
8907203|NCT02114216|9965440|FG001|NOT COMPLETED|Overall Study||0
8907204|NCT02114216|9965441|FG002|NOT COMPLETED|Overall Study||0
8907205|NCT02114268|9965458|FG000|STARTED|Overall Study||34
8907206|NCT02114268|9965459|FG001|STARTED|Overall Study||6
8907207|NCT02114268|9965460|FG002|STARTED|Overall Study||6
8907208|NCT02114268|9965461|FG003|STARTED|Overall Study||6
8907209|NCT02114268|9965462|FG004|STARTED|Overall Study||6
8907210|NCT02114268|9965463|FG005|STARTED|Overall Study||78
8907211|NCT02114268|9965458|FG000|COMPLETED|Overall Study||28
8907212|NCT02114268|9965459|FG001|COMPLETED|Overall Study||5
8907213|NCT02114268|9965460|FG002|COMPLETED|Overall Study||5
8907214|NCT02114268|9965461|FG003|COMPLETED|Overall Study||6
8907215|NCT02114268|9965462|FG004|COMPLETED|Overall Study||6
8907216|NCT02114268|9965463|FG005|COMPLETED|Overall Study||75
8907217|NCT02114268|9965458|FG000|NOT COMPLETED|Overall Study||6
8907218|NCT02114268|9965459|FG001|NOT COMPLETED|Overall Study||1
8907219|NCT02114268|9965460|FG002|NOT COMPLETED|Overall Study||1
8907220|NCT02114268|9965461|FG003|NOT COMPLETED|Overall Study||0
8907221|NCT02114268|9965462|FG004|NOT COMPLETED|Overall Study||0
8907222|NCT02114268|9965463|FG005|NOT COMPLETED|Overall Study||3
8907223|NCT02114307|9965484|FG000|STARTED|Overall Study||11
8907224|NCT02114307|9965485|FG001|STARTED|Overall Study||11
8907225|NCT02114307|9965484|FG000|COMPLETED|Overall Study||10
8907226|NCT02114307|9965485|FG001|COMPLETED|Overall Study||11
8907227|NCT02114307|9965484|FG000|NOT COMPLETED|Overall Study||1
8907228|NCT02114307|9965485|FG001|NOT COMPLETED|Overall Study||0
8907229|NCT02114385|9965495|FG000|STARTED|Overall Study||249
8907230|NCT02114385|9965496|FG001|STARTED|Overall Study||251
8907231|NCT02114385|9965495|FG000|Vaccinated|Overall Study||249
8907232|NCT02114385|9965496|FG001|Vaccinated|Overall Study||251
8907233|NCT02114385|9965495|FG000|COMPLETED|Overall Study||246
8907234|NCT02114385|9965496|FG001|COMPLETED|Overall Study||243
8907235|NCT02114385|9965495|FG000|NOT COMPLETED|Overall Study||3
8907236|NCT02114385|9965496|FG001|NOT COMPLETED|Overall Study||8
8907237|NCT02114515|9965504|FG000|STARTED|Overall Study||511
8907238|NCT02114515|9965505|FG001|STARTED|Overall Study||518
9013521|NCT03020576|10076233|FG000|NOT COMPLETED|Overall Study||1
9013522|NCT03020576|10076234|FG001|NOT COMPLETED|Overall Study||2
9013523|NCT03020615|10076243|FG000|STARTED|Overall Study||26
9013524|NCT03020615|10076244|FG001|STARTED|Overall Study||25
9013525|NCT03020615|10076245|FG002|STARTED|Overall Study||7
9013526|NCT03020615|10076243|FG000|COMPLETED|Overall Study||19
9013527|NCT03020615|10076244|FG001|COMPLETED|Overall Study||23
9013528|NCT03020615|10076245|FG002|COMPLETED|Overall Study||0
9013529|NCT03020615|10076243|FG000|NOT COMPLETED|Overall Study||7
9013530|NCT03020615|10076244|FG001|NOT COMPLETED|Overall Study||2
9013531|NCT03020615|10076245|FG002|NOT COMPLETED|Overall Study||7
9013532|NCT03020641|10076258|FG000|STARTED|Overall Study||50
9013533|NCT03020641|10076259|FG001|STARTED|Overall Study||50
9013534|NCT03020641|10076258|FG000|COMPLETED|Overall Study||48
9013535|NCT03020641|10076259|FG001|COMPLETED|Overall Study||47
8907239|NCT02114515|9965504|FG000|COMPLETED|Overall Study||378
8907240|NCT02114515|9965505|FG001|COMPLETED|Overall Study||368
8907241|NCT02114515|9965504|FG000|NOT COMPLETED|Overall Study||133
8907242|NCT02114515|9965505|FG001|NOT COMPLETED|Overall Study||150
8907243|NCT02114606|9965511|FG000|STARTED|Overall Study||86
8907244|NCT02114606|9965511|FG000|COMPLETED|Overall Study||80
8907245|NCT02114606|9965511|FG000|NOT COMPLETED|Overall Study||6
8907246|NCT02114684|9965517|FG000|STARTED|Overall Study||98
8907247|NCT02114684|9965518|FG001|STARTED|Overall Study||98
8907248|NCT02114684|9965517|FG000|COMPLETED|Overall Study||86
8907249|NCT02114684|9965518|FG001|COMPLETED|Overall Study||88
8907250|NCT02114684|9965517|FG000|NOT COMPLETED|Overall Study||12
9013536|NCT03020641|10076258|FG000|NOT COMPLETED|Overall Study||2
9013537|NCT03020641|10076259|FG001|NOT COMPLETED|Overall Study||3
9013538|NCT03020719|10076270|FG000|STARTED|Overall Study||30
9013539|NCT03020719|10076271|FG001|STARTED|Overall Study||30
9013540|NCT03020719|10076270|FG000|COMPLETED|Overall Study||30
9013541|NCT03020719|10076271|FG001|COMPLETED|Overall Study||28
9013542|NCT03020719|10076270|FG000|NOT COMPLETED|Overall Study||0
9013543|NCT03020719|10076271|FG001|NOT COMPLETED|Overall Study||2
9013544|NCT03020745|10076285|FG000|STARTED|Part 1 (Up to 60 Days)||3
9013545|NCT03020745|10076286|FG001|STARTED|Part 1 (Up to 60 Days)||3
9013546|NCT03020745|10076287|FG002|STARTED|Part 1 (Up to 60 Days)|No participants were enrolled in this arm as per decision made by the dose escalation committee.|0
9013547|NCT03020745|10076288|FG003|STARTED|Part 1 (Up to 60 Days)||6
9013548|NCT03020745|10076289|FG004|STARTED|Part 1 (Up to 60 Days)|No participants were enrolled in this arm as per decision made by the dose escalation committee.|0
9013549|NCT03020745|10076290|FG005|STARTED|Part 1 (Up to 60 Days)||0
9013550|NCT03020745|10076291|FG006|STARTED|Part 1 (Up to 60 Days)||0
9013551|NCT03020745|10076292|FG007|STARTED|Part 1 (Up to 60 Days)||0
9013552|NCT03020745|10076293|FG008|STARTED|Part 1 (Up to 60 Days)||0
9013553|NCT03020745|10076294|FG009|STARTED|Part 1 (Up to 60 Days)||0
9013554|NCT03020745|10076285|FG000|COMPLETED|Part 1 (Up to 60 Days)||3
9013555|NCT03020745|10076286|FG001|COMPLETED|Part 1 (Up to 60 Days)||3
9013556|NCT03020745|10076287|FG002|COMPLETED|Part 1 (Up to 60 Days)||0
9013557|NCT03020745|10076288|FG003|COMPLETED|Part 1 (Up to 60 Days)||6
9013558|NCT03020745|10076289|FG004|COMPLETED|Part 1 (Up to 60 Days)||0
9013559|NCT03020745|10076290|FG005|COMPLETED|Part 1 (Up to 60 Days)||0
9013560|NCT03020745|10076291|FG006|COMPLETED|Part 1 (Up to 60 Days)||0
9013561|NCT03020745|10076292|FG007|COMPLETED|Part 1 (Up to 60 Days)||0
9013562|NCT03020745|10076293|FG008|COMPLETED|Part 1 (Up to 60 Days)||0
9013563|NCT03020745|10076294|FG009|COMPLETED|Part 1 (Up to 60 Days)||0
9013564|NCT03020745|10076285|FG000|NOT COMPLETED|Part 1 (Up to 60 Days)||0
9013565|NCT03020745|10076286|FG001|NOT COMPLETED|Part 1 (Up to 60 Days)||0
9013566|NCT03020745|10076287|FG002|NOT COMPLETED|Part 1 (Up to 60 Days)||0
9013567|NCT03020745|10076288|FG003|NOT COMPLETED|Part 1 (Up to 60 Days)||0
9013568|NCT03020745|10076289|FG004|NOT COMPLETED|Part 1 (Up to 60 Days)||0
9013569|NCT03020745|10076290|FG005|NOT COMPLETED|Part 1 (Up to 60 Days)||0
9013570|NCT03020745|10076291|FG006|NOT COMPLETED|Part 1 (Up to 60 Days)||0
9013571|NCT03020745|10076292|FG007|NOT COMPLETED|Part 1 (Up to 60 Days)||0
9013572|NCT03020745|10076293|FG008|NOT COMPLETED|Part 1 (Up to 60 Days)||0
9013573|NCT03020745|10076294|FG009|NOT COMPLETED|Part 1 (Up to 60 Days)||0
9013574|NCT03020745|10076285|FG000|STARTED|Part 2 (Up to 169 Days)||0
9013575|NCT03020745|10076286|FG001|STARTED|Part 2 (Up to 169 Days)||0
9013576|NCT03020745|10076287|FG002|STARTED|Part 2 (Up to 169 Days)||0
9013577|NCT03020745|10076288|FG003|STARTED|Part 2 (Up to 169 Days)||0
9013578|NCT03020745|10076289|FG004|STARTED|Part 2 (Up to 169 Days)||0
9013579|NCT03020745|10076290|FG005|STARTED|Part 2 (Up to 169 Days)||10
9013580|NCT03020745|10076291|FG006|STARTED|Part 2 (Up to 169 Days)||6
9013581|NCT03020745|10076292|FG007|STARTED|Part 2 (Up to 169 Days)||20
9013582|NCT03020745|10076293|FG008|STARTED|Part 2 (Up to 169 Days)||15
9013583|NCT03020745|10076294|FG009|STARTED|Part 2 (Up to 169 Days)||15
9013584|NCT03020745|10076285|FG000|COMPLETED|Part 2 (Up to 169 Days)||0
9013585|NCT03020745|10076286|FG001|COMPLETED|Part 2 (Up to 169 Days)||0
9013586|NCT03020745|10076287|FG002|COMPLETED|Part 2 (Up to 169 Days)||0
9013587|NCT03020745|10076288|FG003|COMPLETED|Part 2 (Up to 169 Days)||0
9013588|NCT03020745|10076289|FG004|COMPLETED|Part 2 (Up to 169 Days)||0
9013589|NCT03020745|10076290|FG005|COMPLETED|Part 2 (Up to 169 Days)||10
9013590|NCT03020745|10076291|FG006|COMPLETED|Part 2 (Up to 169 Days)||6
9013591|NCT03020745|10076292|FG007|COMPLETED|Part 2 (Up to 169 Days)||19
9013592|NCT03020745|10076293|FG008|COMPLETED|Part 2 (Up to 169 Days)||14
9013593|NCT03020745|10076294|FG009|COMPLETED|Part 2 (Up to 169 Days)||15
9013594|NCT03020745|10076285|FG000|NOT COMPLETED|Part 2 (Up to 169 Days)||0
9013595|NCT03020745|10076286|FG001|NOT COMPLETED|Part 2 (Up to 169 Days)||0
9013596|NCT03020745|10076287|FG002|NOT COMPLETED|Part 2 (Up to 169 Days)||0
9013597|NCT03020745|10076288|FG003|NOT COMPLETED|Part 2 (Up to 169 Days)||0
9013598|NCT03020745|10076289|FG004|NOT COMPLETED|Part 2 (Up to 169 Days)||0
9013599|NCT03020745|10076290|FG005|NOT COMPLETED|Part 2 (Up to 169 Days)||0
9013600|NCT03020745|10076291|FG006|NOT COMPLETED|Part 2 (Up to 169 Days)||0
9013601|NCT03020745|10076292|FG007|NOT COMPLETED|Part 2 (Up to 169 Days)||1
9013602|NCT03020745|10076293|FG008|NOT COMPLETED|Part 2 (Up to 169 Days)||1
9013603|NCT03020745|10076294|FG009|NOT COMPLETED|Part 2 (Up to 169 Days)||0
9013604|NCT03020745|10076285|FG000|STARTED|Part 2:Optional FU (Up to 450 Days)||0
9013605|NCT03020745|10076286|FG001|STARTED|Part 2:Optional FU (Up to 450 Days)||0
9013606|NCT03020745|10076287|FG002|STARTED|Part 2:Optional FU (Up to 450 Days)||0
8573368|NCT00121641|9605643|FG002|COMPLETED|24-week Short-term Treatment Period||69
8577593|NCT00159861|9610349|FG001|Treated|Extension Study - up to 3 Years||127
8726703|NCT01038128|9773951|FG000|STARTED|Overall Study||5
8726704|NCT01038128|9773951|FG000|Baseline Visit|Overall Study||3
8726705|NCT01038128|9773951|FG000|COMPLETED|Overall Study||1
8726706|NCT01038128|9773951|FG000|NOT COMPLETED|Overall Study||4
8726707|NCT01038297|9773960|FG000|STARTED|Part A: Skin Testing Phase (50 Days)||10
8726708|NCT01038297|9773961|FG001|STARTED|Part A: Skin Testing Phase (50 Days)||10
8726709|NCT01038297|9773962|FG002|STARTED|Part A: Skin Testing Phase (50 Days)||10
8726710|NCT01038297|9773960|FG000|COMPLETED|Part A: Skin Testing Phase (50 Days)||9
8726711|NCT01038297|9773961|FG001|COMPLETED|Part A: Skin Testing Phase (50 Days)||10
8726712|NCT01038297|9773962|FG002|COMPLETED|Part A: Skin Testing Phase (50 Days)||10
9039660|NCT03341299|10100653|FG001|STARTED|Period 2||9
8907251|NCT02114684|9965518|FG001|NOT COMPLETED|Overall Study||10
8907252|NCT02114879|9965530|FG000|STARTED|Overall Study||115
8907253|NCT02114879|9965531|FG001|STARTED|Overall Study||114
8907254|NCT02114879|9965530|FG000|COMPLETED|Overall Study||96
8907255|NCT02114879|9965531|FG001|COMPLETED|Overall Study||90
8907256|NCT02114879|9965530|FG000|NOT COMPLETED|Overall Study||19
8907257|NCT02114879|9965531|FG001|NOT COMPLETED|Overall Study||24
8907258|NCT02114892|9965539|FG000|STARTED|Overall Study||12
8907259|NCT02114892|9965540|FG001|STARTED|Overall Study||12
8907260|NCT02114892|9965539|FG000|COMPLETED|Overall Study|One patient did not complete the study due to early withdrawl|11
8907261|NCT02114892|9965540|FG001|COMPLETED|Overall Study|Two patients did not complete the study due to early withdrawl|10
8907262|NCT02114892|9965539|FG000|NOT COMPLETED|Overall Study||1
8907263|NCT02114892|9965540|FG001|NOT COMPLETED|Overall Study||2
8907264|NCT02114931|9965548|FG000|STARTED|Overall Study||230
8907265|NCT02114931|9965549|FG001|STARTED|Overall Study||237
8907266|NCT02114931|9965548|FG000|Received Treatment|Overall Study|One participant was enrolled in error and did not receive treatment in the extension study|229
8907267|NCT02114931|9965549|FG001|Received Treatment|Overall Study||237
8907268|NCT02114931|9965548|FG000|COMPLETED|Overall Study||205
8907269|NCT02114931|9965549|FG001|COMPLETED|Overall Study||207
8907270|NCT02114931|9965548|FG000|NOT COMPLETED|Overall Study||25
8907271|NCT02114931|9965549|FG001|NOT COMPLETED|Overall Study||30
8907272|NCT02115048|9965557|FG000|STARTED|Overall Study||23
8907273|NCT02115048|9965558|FG001|STARTED|Overall Study||21
8907274|NCT02115048|9965557|FG000|COMPLETED|Overall Study||23
8907275|NCT02115048|9965558|FG001|COMPLETED|Overall Study||21
8907276|NCT02115048|9965557|FG000|NOT COMPLETED|Overall Study||0
8907277|NCT02115048|9965558|FG001|NOT COMPLETED|Overall Study||0
8907278|NCT02115113|9965564|FG000|STARTED|Participants in Run-in Period||0
8907279|NCT02115113|9965565|FG001|STARTED|Participants in Run-in Period||0
8907280|NCT02115113|9965566|FG002|STARTED|Participants in Run-in Period||78
8907281|NCT02115113|9965564|FG000|COMPLETED|Participants in Run-in Period||0
8907282|NCT02115113|9965565|FG001|COMPLETED|Participants in Run-in Period||0
8907283|NCT02115113|9965566|FG002|COMPLETED|Participants in Run-in Period||68
8907284|NCT02115113|9965564|FG000|NOT COMPLETED|Participants in Run-in Period||0
8907285|NCT02115113|9965565|FG001|NOT COMPLETED|Participants in Run-in Period||0
8907286|NCT02115113|9965566|FG002|NOT COMPLETED|Participants in Run-in Period||10
8907287|NCT02115113|9965564|FG000|STARTED|Participants Randomized||24
8907288|NCT02115113|9965565|FG001|STARTED|Participants Randomized||26
8907289|NCT02115113|9965566|FG002|STARTED|Participants Randomized||0
8907290|NCT02115113|9965564|FG000|COMPLETED|Participants Randomized||22
8907291|NCT02115113|9965565|FG001|COMPLETED|Participants Randomized||26
8907292|NCT02115113|9965566|FG002|COMPLETED|Participants Randomized||0
8907293|NCT02115113|9965564|FG000|NOT COMPLETED|Participants Randomized||2
8907294|NCT02115113|9965565|FG001|NOT COMPLETED|Participants Randomized||0
8907295|NCT02115113|9965566|FG002|NOT COMPLETED|Participants Randomized||0
8907296|NCT02115139|9965575|FG000|STARTED|Overall Study||58
8907297|NCT02115139|9965575|FG000|COMPLETED|Overall Study||51
8907298|NCT02115139|9965575|FG000|NOT COMPLETED|Overall Study||7
8907299|NCT02115256|9965581|FG000|STARTED|Overall Study||3
8907300|NCT02115256|9965582|FG001|STARTED|Overall Study||3
8907301|NCT02115256|9965581|FG000|COMPLETED|Overall Study||3
8907302|NCT02115256|9965582|FG001|COMPLETED|Overall Study||2
9013607|NCT03020745|10076288|FG003|STARTED|Part 2:Optional FU (Up to 450 Days)||0
9013608|NCT03020745|10076289|FG004|STARTED|Part 2:Optional FU (Up to 450 Days)||0
9013609|NCT03020745|10076290|FG005|STARTED|Part 2:Optional FU (Up to 450 Days)||10
9013610|NCT03020745|10076291|FG006|STARTED|Part 2:Optional FU (Up to 450 Days)|1 participant didn't enter into optional follow-up period.|5
9013611|NCT03020745|10076292|FG007|STARTED|Part 2:Optional FU (Up to 450 Days)|2 participants didn't enter into optional follow-up period.|17
9013612|NCT03020745|10076293|FG008|STARTED|Part 2:Optional FU (Up to 450 Days)|1 participant did not enter into optional follow-up period|13
9013613|NCT03020745|10076294|FG009|STARTED|Part 2:Optional FU (Up to 450 Days)||15
9013614|NCT03020745|10076285|FG000|COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
9013615|NCT03020745|10076286|FG001|COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
9013616|NCT03020745|10076287|FG002|COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
9013617|NCT03020745|10076288|FG003|COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
9013618|NCT03020745|10076289|FG004|COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
9013619|NCT03020745|10076290|FG005|COMPLETED|Part 2:Optional FU (Up to 450 Days)||9
9013620|NCT03020745|10076291|FG006|COMPLETED|Part 2:Optional FU (Up to 450 Days)||5
9013621|NCT03020745|10076292|FG007|COMPLETED|Part 2:Optional FU (Up to 450 Days)||17
9013622|NCT03020745|10076293|FG008|COMPLETED|Part 2:Optional FU (Up to 450 Days)||10
9013623|NCT03020745|10076294|FG009|COMPLETED|Part 2:Optional FU (Up to 450 Days)||15
9013624|NCT03020745|10076285|FG000|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
9013625|NCT03020745|10076286|FG001|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
9013626|NCT03020745|10076287|FG002|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
9013627|NCT03020745|10076288|FG003|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
8907303|NCT02115256|9965581|FG000|NOT COMPLETED|Overall Study||0
8907304|NCT02115256|9965582|FG001|NOT COMPLETED|Overall Study||1
8907305|NCT02115269|9965588|FG000|STARTED|Overall Study||759
8907306|NCT02115269|9965588|FG000|COMPLETED|Overall Study||702
8907307|NCT02115269|9965588|FG000|NOT COMPLETED|Overall Study||57
8907308|NCT02115282|9965605|FG000|STARTED|Overall Study||305
8907309|NCT02115282|9965606|FG001|STARTED|Overall Study||303
8907310|NCT02115282|9965605|FG000|Eligible|Overall Study||265
8907311|NCT02115282|9965606|FG001|Eligible|Overall Study||257
8907312|NCT02115282|9965605|FG000|Treated|Overall Study||296
8907313|NCT02115282|9965606|FG001|Treated|Overall Study||293
8907314|NCT02115282|9965605|FG000|COMPLETED|Overall Study||0
8907315|NCT02115282|9965606|FG001|COMPLETED|Overall Study||0
8907316|NCT02115282|9965605|FG000|NOT COMPLETED|Overall Study||305
8907317|NCT02115282|9965606|FG001|NOT COMPLETED|Overall Study||303
8907318|NCT02115308|9965616|FG000|STARTED|Overall Study|Number of subjects recruited for the CONTROL group.|15
8907319|NCT02115308|9965617|FG001|STARTED|Overall Study|Number of subjects recruited for the CAD group.|25
8907320|NCT02115308|9965616|FG000|COMPLETED|Overall Study|Number of subjects recruited to the Control group meeting all inclusion criteria.|13
8907321|NCT02115308|9965617|FG001|COMPLETED|Overall Study|Number of subjects recruited to the CAD group meeting all inclusion criteria.|23
8907322|NCT02115308|9965616|FG000|NOT COMPLETED|Overall Study||2
8907323|NCT02115308|9965617|FG001|NOT COMPLETED|Overall Study||2
8907324|NCT02115321|9965629|FG000|STARTED|Overall Study||30
8907325|NCT02115321|9965630|FG001|STARTED|Overall Study||10
8907326|NCT02115321|9965629|FG000|COMPLETED|Overall Study||29
8907327|NCT02115321|9965630|FG001|COMPLETED|Overall Study||10
8907328|NCT02115321|9965629|FG000|NOT COMPLETED|Overall Study||1
8907329|NCT02115321|9965630|FG001|NOT COMPLETED|Overall Study||0
8907330|NCT02115347|9965638|FG000|STARTED|Overall Study||8
8907331|NCT02115347|9965639|FG001|STARTED|Overall Study||8
8907332|NCT02115347|9965640|FG002|STARTED|Overall Study||0
8907333|NCT02115347|9965638|FG000|COMPLETED|Overall Study||8
8907334|NCT02115347|9965639|FG001|COMPLETED|Overall Study||8
8907335|NCT02115347|9965640|FG002|COMPLETED|Overall Study||0
8907336|NCT02115347|9965638|FG000|NOT COMPLETED|Overall Study||0
8907337|NCT02115347|9965639|FG001|NOT COMPLETED|Overall Study||0
8907338|NCT02115347|9965640|FG002|NOT COMPLETED|Overall Study||0
8907339|NCT02115373|9965649|FG000|STARTED|Overall Study||4
8907340|NCT02115373|9965650|FG001|STARTED|Overall Study||13
8907341|NCT02115373|9965651|FG002|STARTED|Overall Study||49
8907342|NCT02115373|9965649|FG000|COMPLETED|Overall Study||4
8907343|NCT02115373|9965650|FG001|COMPLETED|Overall Study||13
8907344|NCT02115373|9965651|FG002|COMPLETED|Overall Study||49
8907345|NCT02115373|9965649|FG000|NOT COMPLETED|Overall Study||0
8907346|NCT02115373|9965650|FG001|NOT COMPLETED|Overall Study||0
8907347|NCT02115373|9965651|FG002|NOT COMPLETED|Overall Study||0
8907348|NCT02115386|9965666|FG000|STARTED|Overall Study||7
8907349|NCT02115386|9965666|FG000|COMPLETED|Overall Study||0
8907350|NCT02115386|9965666|FG000|NOT COMPLETED|Overall Study||7
8907351|NCT02115542|9965670|FG000|STARTED|Overall Study||39
8907352|NCT02115542|9965670|FG000|COMPLETED|Overall Study||39
8907353|NCT02115542|9965670|FG000|NOT COMPLETED|Overall Study||0
8907354|NCT02115581|9965676|FG000|STARTED|Overall Study||17
8907355|NCT02115581|9965677|FG001|STARTED|Overall Study||21
8907356|NCT02115581|9965676|FG000|COMPLETED|Overall Study||17
8907357|NCT02115581|9965677|FG001|COMPLETED|Overall Study||21
8907358|NCT02115581|9965676|FG000|NOT COMPLETED|Overall Study||0
8907359|NCT02115581|9965677|FG001|NOT COMPLETED|Overall Study||0
8907360|NCT02115607|9965683|FG000|STARTED|Overall Study||17
8907361|NCT02115607|9965683|FG000|COMPLETED|Overall Study||16
8907362|NCT02115607|9965683|FG000|NOT COMPLETED|Overall Study||1
9013628|NCT03020745|10076289|FG004|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
9013629|NCT03020745|10076290|FG005|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||1
9013630|NCT03020745|10076291|FG006|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
9013631|NCT03020745|10076292|FG007|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
9013632|NCT03020745|10076293|FG008|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||3
9013633|NCT03020745|10076294|FG009|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
9013634|NCT03020888|10076318|FG000|STARTED|Overall Study||120
9013635|NCT03020888|10076318|FG000|COMPLETED|Overall Study||107
9013636|NCT03020888|10076318|FG000|NOT COMPLETED|Overall Study||13
9013637|NCT03020966|10076324|FG000|STARTED|Overall Study||77
9013638|NCT03020966|10076325|FG001|STARTED|Overall Study||77
9013639|NCT03020966|10076324|FG000|COMPLETED|Overall Study||75
9013640|NCT03020966|10076325|FG001|COMPLETED|Overall Study||77
9013641|NCT03020966|10076324|FG000|NOT COMPLETED|Overall Study||2
9013642|NCT03020966|10076325|FG001|NOT COMPLETED|Overall Study||0
9013643|NCT03020992|10076331|FG000|STARTED|Overall Study||89
9013644|NCT03020992|10076331|FG000|COMPLETED|Overall Study||83
9013645|NCT03020992|10076331|FG000|NOT COMPLETED|Overall Study||6
9013646|NCT03021005|10076338|FG000|STARTED|Overall Study||102
9013647|NCT03021005|10076339|FG001|STARTED|Overall Study||98
9013648|NCT03021005|10076338|FG000|COMPLETED|Overall Study||63
9013649|NCT03021005|10076339|FG001|COMPLETED|Overall Study||72
9013650|NCT03021005|10076338|FG000|NOT COMPLETED|Overall Study||39
9013651|NCT03021005|10076339|FG001|NOT COMPLETED|Overall Study||26
9013652|NCT03021018|10076348|FG000|STARTED|Overall Study||16
9013653|NCT03021018|10076349|FG001|STARTED|Overall Study||15
9013654|NCT03021018|10076350|FG002|STARTED|Overall Study||15
9013655|NCT03021018|10076348|FG000|COMPLETED|Overall Study||14
9013656|NCT03021018|10076349|FG001|COMPLETED|Overall Study||15
9013657|NCT03021018|10076350|FG002|COMPLETED|Overall Study||15
9013658|NCT03021018|10076348|FG000|NOT COMPLETED|Overall Study||2
9013659|NCT03021018|10076349|FG001|NOT COMPLETED|Overall Study||0
9013660|NCT03021018|10076350|FG002|NOT COMPLETED|Overall Study||0
9013661|NCT03021187|10076362|FG000|STARTED|Overall Study||184
9013662|NCT03021187|10076363|FG001|STARTED|Overall Study||182
9013663|NCT03021187|10076364|FG002|STARTED|Overall Study||181
8907363|NCT02115633|9965689|FG000|STARTED|Overall Study||15
8907364|NCT02115633|9965690|FG001|STARTED|Overall Study||16
8907365|NCT02115633|9965689|FG000|COMPLETED|Overall Study||15
8907366|NCT02115633|9965690|FG001|COMPLETED|Overall Study||16
8907367|NCT02115633|9965689|FG000|NOT COMPLETED|Overall Study||0
8907368|NCT02115633|9965690|FG001|NOT COMPLETED|Overall Study||0
8907369|NCT02115646|9965699|FG000|STARTED|Overall Study||29
8907370|NCT02115646|9965699|FG000|COMPLETED|Overall Study||22
8907371|NCT02115646|9965699|FG000|NOT COMPLETED|Overall Study||7
8907372|NCT02115750|9965710|FG000|STARTED|Part 1||323
8907373|NCT02115750|9965711|FG001|STARTED|Part 1||324
8907374|NCT02115750|9965710|FG000|COMPLETED|Part 1||301
8907375|NCT02115750|9965711|FG001|COMPLETED|Part 1||312
8907376|NCT02115750|9965710|FG000|NOT COMPLETED|Part 1||22
8907377|NCT02115750|9965711|FG001|NOT COMPLETED|Part 1||12
8907378|NCT02115750|9965710|FG000|STARTED|Part 2: All Subjects Receive CHS-0214||280
8907379|NCT02115750|9965711|FG001|STARTED|Part 2: All Subjects Receive CHS-0214||284
8907380|NCT02115750|9965710|FG000|COMPLETED|Part 2: All Subjects Receive CHS-0214||269
8907381|NCT02115750|9965711|FG001|COMPLETED|Part 2: All Subjects Receive CHS-0214||272
8907382|NCT02115750|9965710|FG000|NOT COMPLETED|Part 2: All Subjects Receive CHS-0214||11
8907383|NCT02115750|9965711|FG001|NOT COMPLETED|Part 2: All Subjects Receive CHS-0214||12
8907384|NCT02115815|9965726|FG000|STARTED|Overall Study||24
8907385|NCT02115815|9965727|FG001|STARTED|Overall Study||20
8907386|NCT02115815|9965728|FG002|STARTED|Overall Study||20
8907387|NCT02115815|9965729|FG003|STARTED|Overall Study||20
8907388|NCT02115815|9965730|FG004|STARTED|Overall Study||20
8907389|NCT02115815|9965731|FG005|STARTED|Overall Study||22
8907390|NCT02115815|9965732|FG006|STARTED|Overall Study||20
8907391|NCT02115815|9965726|FG000|COMPLETED|Overall Study||22
8907392|NCT02115815|9965727|FG001|COMPLETED|Overall Study||20
8907393|NCT02115815|9965728|FG002|COMPLETED|Overall Study||20
8907394|NCT02115815|9965729|FG003|COMPLETED|Overall Study||20
8907395|NCT02115815|9965730|FG004|COMPLETED|Overall Study||20
8907396|NCT02115815|9965731|FG005|COMPLETED|Overall Study||20
8907397|NCT02115815|9965732|FG006|COMPLETED|Overall Study||20
8907398|NCT02115815|9965726|FG000|NOT COMPLETED|Overall Study||2
8907399|NCT02115815|9965727|FG001|NOT COMPLETED|Overall Study||0
8907400|NCT02115815|9965728|FG002|NOT COMPLETED|Overall Study||0
8907401|NCT02115815|9965729|FG003|NOT COMPLETED|Overall Study||0
9013664|NCT03021187|10076365|FG003|STARTED|Overall Study||184
9013665|NCT03021187|10076362|FG000|Exposed|Overall Study||184
9013666|NCT03021187|10076363|FG001|Exposed|Overall Study||181
9013667|NCT03021187|10076364|FG002|Exposed|Overall Study||181
9013668|NCT03021187|10076365|FG003|Exposed|Overall Study||184
9013669|NCT03021187|10076362|FG000|Full Analysis Set (FAS)|Overall Study||184
9013670|NCT03021187|10076363|FG001|Full Analysis Set (FAS)|Overall Study||182
9013671|NCT03021187|10076364|FG002|Full Analysis Set (FAS)|Overall Study||181
9013672|NCT03021187|10076365|FG003|Full Analysis Set (FAS)|Overall Study||184
9013673|NCT03021187|10076362|FG000|Safety Analysis Set (SAS)|Overall Study||184
9013674|NCT03021187|10076363|FG001|Safety Analysis Set (SAS)|Overall Study||181
9013675|NCT03021187|10076364|FG002|Safety Analysis Set (SAS)|Overall Study||181
9013676|NCT03021187|10076365|FG003|Safety Analysis Set (SAS)|Overall Study||184
9013677|NCT03021187|10076362|FG000|COMPLETED|Overall Study||174
9013678|NCT03021187|10076363|FG001|COMPLETED|Overall Study||173
9013679|NCT03021187|10076364|FG002|COMPLETED|Overall Study||175
9013680|NCT03021187|10076365|FG003|COMPLETED|Overall Study||175
9013681|NCT03021187|10076362|FG000|NOT COMPLETED|Overall Study||10
9013682|NCT03021187|10076363|FG001|NOT COMPLETED|Overall Study||9
9013683|NCT03021187|10076364|FG002|NOT COMPLETED|Overall Study||6
9013684|NCT03021187|10076365|FG003|NOT COMPLETED|Overall Study||9
9013685|NCT03021265|10076375|FG000|STARTED|Overall Study||676
9013686|NCT03021265|10076375|FG000|COMPLETED|Overall Study||554
9013687|NCT03021265|10076375|FG000|NOT COMPLETED|Overall Study||122
9013688|NCT03021304|10076379|FG000|STARTED|Overall Study||56
9013689|NCT03021304|10076379|FG000|COMPLETED|Overall Study||55
9013690|NCT03021304|10076379|FG000|NOT COMPLETED|Overall Study||1
9013691|NCT03021343|10076385|FG000|STARTED|Overall Study||179
9013692|NCT03021343|10076386|FG001|STARTED|Overall Study||181
9013693|NCT03021343|10076385|FG000|COMPLETED|Overall Study||174
9013694|NCT03021343|10076386|FG001|COMPLETED|Overall Study||174
9013695|NCT03021343|10076385|FG000|NOT COMPLETED|Overall Study||5
9013696|NCT03021343|10076386|FG001|NOT COMPLETED|Overall Study||7
9013697|NCT03021499|10076394|FG000|STARTED|Overall Study||179
9013698|NCT03021499|10076395|FG001|STARTED|Overall Study||178
9013699|NCT03021499|10076394|FG000|Week 24|Overall Study||167
9013700|NCT03021499|10076395|FG001|Week 24|Overall Study||162
9013701|NCT03021499|10076394|FG000|Week 52|Overall Study||162
9013702|NCT03021499|10076395|FG001|Week 52|Overall Study||147
8907402|NCT02115815|9965730|FG004|NOT COMPLETED|Overall Study||0
8907403|NCT02115815|9965731|FG005|NOT COMPLETED|Overall Study||2
8907404|NCT02115815|9965732|FG006|NOT COMPLETED|Overall Study||0
9013703|NCT03021499|10076394|FG000|COMPLETED|Overall Study||163
9013704|NCT03021499|10076395|FG001|COMPLETED|Overall Study||147
9013705|NCT03021499|10076394|FG000|NOT COMPLETED|Overall Study||16
9013706|NCT03021499|10076395|FG001|NOT COMPLETED|Overall Study||31
9013707|NCT03021538|10076405|FG000|STARTED|Overall Study||6
8907405|NCT02115828|9965748|FG000|STARTED|Overall Study||9
8907406|NCT02115828|9965748|FG000|COMPLETED|Overall Study||9
8907407|NCT02115828|9965748|FG000|NOT COMPLETED|Overall Study||0
8907408|NCT02115984|9965754|FG000|STARTED|Overall Study||57
8907409|NCT02115984|9965755|FG001|STARTED|Overall Study||23
9013708|NCT03021538|10076406|FG001|STARTED|Overall Study||7
8907410|NCT02115984|9965754|FG000|COMPLETED|Overall Study||51
8907411|NCT02115984|9965755|FG001|COMPLETED|Overall Study||16
8907412|NCT02115984|9965754|FG000|NOT COMPLETED|Overall Study||6
8907413|NCT02115984|9965755|FG001|NOT COMPLETED|Overall Study||7
8907414|NCT02116205|9965765|FG000|STARTED|Overall Study||31
8907415|NCT02116205|9965766|FG001|STARTED|Overall Study||33
8907416|NCT02116205|9965767|FG002|STARTED|Overall Study||33
8907417|NCT02116205|9965768|FG003|STARTED|Overall Study||33
8907418|NCT02116205|9965765|FG000|COMPLETED|Overall Study||29
8907419|NCT02116205|9965766|FG001|COMPLETED|Overall Study||26
8907420|NCT02116205|9965767|FG002|COMPLETED|Overall Study||29
8907421|NCT02116205|9965768|FG003|COMPLETED|Overall Study||27
8907422|NCT02116205|9965765|FG000|NOT COMPLETED|Overall Study||2
8907423|NCT02116205|9965766|FG001|NOT COMPLETED|Overall Study||7
8907424|NCT02116205|9965767|FG002|NOT COMPLETED|Overall Study||4
8907425|NCT02116205|9965768|FG003|NOT COMPLETED|Overall Study||6
8907426|NCT02116309|9965780|FG000|STARTED|Overall Study||482
8907427|NCT02116309|9965781|FG001|STARTED|Overall Study||478
8907428|NCT02116309|9965780|FG000|COMPLETED|Overall Study||482
8907429|NCT02116309|9965781|FG001|COMPLETED|Overall Study||477
8907430|NCT02116309|9965780|FG000|NOT COMPLETED|Overall Study||0
8907431|NCT02116309|9965781|FG001|NOT COMPLETED|Overall Study||1
8907432|NCT02116322|9965787|FG000|STARTED|Overall Study||1
8907433|NCT02116322|9965787|FG000|COMPLETED|Overall Study||1
8907434|NCT02116322|9965787|FG000|NOT COMPLETED|Overall Study||0
8907435|NCT02116361|9965795|FG000|STARTED|Overall Study||69
8907436|NCT02116361|9965796|FG001|STARTED|Overall Study||65
8907437|NCT02116361|9965797|FG002|STARTED|Overall Study||59
8907438|NCT02116361|9965798|FG003|STARTED|Overall Study||65
8907439|NCT02116361|9965795|FG000|COMPLETED|Overall Study||38
8907440|NCT02116361|9965796|FG001|COMPLETED|Overall Study||34
8907441|NCT02116361|9965797|FG002|COMPLETED|Overall Study||33
8907442|NCT02116361|9965798|FG003|COMPLETED|Overall Study||34
8907443|NCT02116361|9965795|FG000|NOT COMPLETED|Overall Study||31
8907444|NCT02116361|9965796|FG001|NOT COMPLETED|Overall Study||31
8907445|NCT02116361|9965797|FG002|NOT COMPLETED|Overall Study||26
8907446|NCT02116361|9965798|FG003|NOT COMPLETED|Overall Study||31
8907447|NCT02116530|9965810|FG000|STARTED|Overall Study||192
8907448|NCT02116530|9965811|FG001|STARTED|Overall Study||188
8907449|NCT02116530|9965810|FG000|COMPLETED|Overall Study||183
8907450|NCT02116530|9965811|FG001|COMPLETED|Overall Study||184
8907451|NCT02116530|9965810|FG000|NOT COMPLETED|Overall Study||9
8907452|NCT02116530|9965811|FG001|NOT COMPLETED|Overall Study||4
8907453|NCT02116582|9965817|FG000|STARTED|Overall Study||215
8907454|NCT02116582|9965817|FG000|Treated|Overall Study||214
8907455|NCT02116582|9965817|FG000|COMPLETED|Overall Study||0
8907456|NCT02116582|9965817|FG000|NOT COMPLETED|Overall Study||215
8636784|NCT00568958|9677483|FG001|NOT COMPLETED|Follow-Up||7
8636785|NCT00569010|9677493|FG000|STARTED|Overall Study||6
8907457|NCT02116608|9965824|FG000|STARTED|Overall Study||9
8907458|NCT02116608|9965825|FG001|STARTED|Overall Study||9
8907459|NCT02116608|9965826|FG002|STARTED|Overall Study||8
8907460|NCT02116608|9965824|FG000|COMPLETED|Overall Study||9
8907461|NCT02116608|9965825|FG001|COMPLETED|Overall Study||7
8907462|NCT02116608|9965826|FG002|COMPLETED|Overall Study||7
8907463|NCT02116608|9965824|FG000|NOT COMPLETED|Overall Study||0
8907464|NCT02116608|9965825|FG001|NOT COMPLETED|Overall Study||2
8907465|NCT02116608|9965826|FG002|NOT COMPLETED|Overall Study||1
8907466|NCT02116621|9965836|FG000|STARTED|Baseline||108
8907467|NCT02116621|9965837|FG001|STARTED|Baseline||107
8907468|NCT02116621|9965836|FG000|Completed Baseline Visit|Baseline||108
8907469|NCT02116621|9965837|FG001|Completed Baseline Visit|Baseline||103
8907470|NCT02116621|9965836|FG000|Completed Intervention Period|Baseline||95
8907471|NCT02116621|9965837|FG001|Completed Intervention Period|Baseline||103
8907472|NCT02116621|9965836|FG000|COMPLETED|Baseline||108
8907473|NCT02116621|9965837|FG001|COMPLETED|Baseline||103
8907474|NCT02116621|9965836|FG000|NOT COMPLETED|Baseline||0
8907475|NCT02116621|9965837|FG001|NOT COMPLETED|Baseline||4
8907476|NCT02116621|9965836|FG000|STARTED|Three Month Follow-up||108
8907477|NCT02116621|9965837|FG001|STARTED|Three Month Follow-up||103
9013709|NCT03021538|10076405|FG000|COMPLETED|Overall Study||6
9013710|NCT03021538|10076406|FG001|COMPLETED|Overall Study||7
9013711|NCT03021538|10076405|FG000|NOT COMPLETED|Overall Study||0
9013712|NCT03021538|10076406|FG001|NOT COMPLETED|Overall Study||0
9013713|NCT03021564|10076414|FG000|STARTED|Overall Study||120
9013714|NCT03021564|10076415|FG001|STARTED|Overall Study||557
9013715|NCT03021564|10076414|FG000|COMPLETED|Overall Study||36
9013716|NCT03021564|10076415|FG001|COMPLETED|Overall Study||89
9013717|NCT03021564|10076414|FG000|NOT COMPLETED|Overall Study||84
9013718|NCT03021564|10076415|FG001|NOT COMPLETED|Overall Study||468
9013719|NCT03021642|10076425|FG000|STARTED|Treatment Period 1 (Day 1)||12
9013720|NCT03021642|10076426|FG001|STARTED|Treatment Period 1 (Day 1)||12
9013721|NCT03021642|10076425|FG000|COMPLETED|Treatment Period 1 (Day 1)||12
9013722|NCT03021642|10076426|FG001|COMPLETED|Treatment Period 1 (Day 1)||12
9013723|NCT03021642|10076425|FG000|NOT COMPLETED|Treatment Period 1 (Day 1)||0
9013724|NCT03021642|10076426|FG001|NOT COMPLETED|Treatment Period 1 (Day 1)||0
9013725|NCT03021642|10076425|FG000|STARTED|Washout Period (21 Days)||12
8907478|NCT02116621|9965836|FG000|COMPLETED|Three Month Follow-up||89
8907479|NCT02116621|9965837|FG001|COMPLETED|Three Month Follow-up||96
8907480|NCT02116621|9965836|FG000|NOT COMPLETED|Three Month Follow-up||19
8907481|NCT02116621|9965837|FG001|NOT COMPLETED|Three Month Follow-up||7
9013726|NCT03021642|10076426|FG001|STARTED|Washout Period (21 Days)||12
8907482|NCT02116621|9965836|FG000|STARTED|Six Month Follow-up|Patients who didn't complete 3mo survey but didn't drop from study were contacted for 6mo follow-up.|103
8907483|NCT02116621|9965837|FG001|STARTED|Six Month Follow-up|Patients who didn't complete 3mo survey but didn't drop from study were contacted for 6mo follow-up|100
8907484|NCT02116621|9965836|FG000|COMPLETED|Six Month Follow-up||99
8907485|NCT02116621|9965837|FG001|COMPLETED|Six Month Follow-up||97
8907486|NCT02116621|9965836|FG000|NOT COMPLETED|Six Month Follow-up||4
8907487|NCT02116621|9965837|FG001|NOT COMPLETED|Six Month Follow-up||3
8907488|NCT02116621|9965836|FG000|STARTED|Twelve Month Follow-up|Patients who didn't complete 6mo survey but didn't drop from study were contacted for 12mo follow-up|100
8907489|NCT02116621|9965837|FG001|STARTED|Twelve Month Follow-up|Patients who didn't complete 6mo survey but didn't drop from study were contacted for 12mo follow-up|98
8907490|NCT02116621|9965836|FG000|COMPLETED|Twelve Month Follow-up||84
8907491|NCT02116621|9965837|FG001|COMPLETED|Twelve Month Follow-up||86
8907492|NCT02116621|9965836|FG000|NOT COMPLETED|Twelve Month Follow-up||16
8907493|NCT02116621|9965837|FG001|NOT COMPLETED|Twelve Month Follow-up||12
8907494|NCT02116660|9965845|FG000|STARTED|Overall Study||6
8907495|NCT02116660|9965846|FG001|STARTED|Overall Study||5
8907496|NCT02116660|9965845|FG000|COMPLETED|Overall Study||4
8907497|NCT02116660|9965846|FG001|COMPLETED|Overall Study||1
8907498|NCT02116660|9965845|FG000|NOT COMPLETED|Overall Study||2
8907499|NCT02116660|9965846|FG001|NOT COMPLETED|Overall Study||4
8907500|NCT02116777|9965861|FG000|STARTED|Overall Study||3
8907501|NCT02116777|9965862|FG001|STARTED|Overall Study||3
8907502|NCT02116777|9965863|FG002|STARTED|Overall Study||3
8907503|NCT02116777|9965864|FG003|STARTED|Overall Study||13
8907504|NCT02116777|9965865|FG004|STARTED|Overall Study||6
8907505|NCT02116777|9965866|FG005|STARTED|Overall Study||3
8907506|NCT02116777|9965867|FG006|STARTED|Overall Study||9
8907507|NCT02116777|9965861|FG000|COMPLETED|Overall Study||0
8907508|NCT02116777|9965862|FG001|COMPLETED|Overall Study||0
8907509|NCT02116777|9965863|FG002|COMPLETED|Overall Study||0
8907510|NCT02116777|9965864|FG003|COMPLETED|Overall Study||0
8907511|NCT02116777|9965865|FG004|COMPLETED|Overall Study||0
8907512|NCT02116777|9965866|FG005|COMPLETED|Overall Study||0
8907513|NCT02116777|9965867|FG006|COMPLETED|Overall Study||0
8907514|NCT02116777|9965861|FG000|NOT COMPLETED|Overall Study||3
8907515|NCT02116777|9965862|FG001|NOT COMPLETED|Overall Study||3
8907516|NCT02116777|9965863|FG002|NOT COMPLETED|Overall Study||3
8907517|NCT02116777|9965864|FG003|NOT COMPLETED|Overall Study||13
8907518|NCT02116777|9965865|FG004|NOT COMPLETED|Overall Study||6
8907519|NCT02116777|9965866|FG005|NOT COMPLETED|Overall Study||3
8907520|NCT02116777|9965867|FG006|NOT COMPLETED|Overall Study||9
8907521|NCT02116803|9965888|FG000|STARTED|Overall Study||10
8907522|NCT02116803|9965889|FG001|STARTED|Overall Study||2
8907523|NCT02116803|9965888|FG000|COMPLETED|Overall Study||0
8907524|NCT02116803|9965889|FG001|COMPLETED|Overall Study||0
8907525|NCT02116803|9965888|FG000|NOT COMPLETED|Overall Study||10
8907526|NCT02116803|9965889|FG001|NOT COMPLETED|Overall Study||2
8907527|NCT02116972|9965898|FG000|STARTED|Overall Study||102
9013727|NCT03021642|10076425|FG000|COMPLETED|Washout Period (21 Days)||11
9013728|NCT03021642|10076426|FG001|COMPLETED|Washout Period (21 Days)||11
9013729|NCT03021642|10076425|FG000|NOT COMPLETED|Washout Period (21 Days)||1
9013730|NCT03021642|10076426|FG001|NOT COMPLETED|Washout Period (21 Days)||1
9013731|NCT03021642|10076425|FG000|STARTED|Treatment Period 2 (Day 22)||11
9013732|NCT03021642|10076426|FG001|STARTED|Treatment Period 2 (Day 22)||11
9013733|NCT03021642|10076425|FG000|COMPLETED|Treatment Period 2 (Day 22)||11
9013734|NCT03021642|10076426|FG001|COMPLETED|Treatment Period 2 (Day 22)||11
8636786|NCT00569010|9677494|FG001|STARTED|Overall Study||6
9013735|NCT03021642|10076425|FG000|NOT COMPLETED|Treatment Period 2 (Day 22)||0
9013736|NCT03021642|10076426|FG001|NOT COMPLETED|Treatment Period 2 (Day 22)||0
9013737|NCT03021668|10076434|FG000|STARTED|Overall Study||62
9013738|NCT03021668|10076435|FG001|STARTED|Overall Study||62
9013739|NCT03021668|10076434|FG000|COMPLETED|Overall Study||62
9013740|NCT03021668|10076435|FG001|COMPLETED|Overall Study||61
9013741|NCT03021668|10076434|FG000|NOT COMPLETED|Overall Study||0
9013742|NCT03021668|10076435|FG001|NOT COMPLETED|Overall Study||1
9013743|NCT03021759|10076444|FG000|STARTED|Overall Study||1566
9013744|NCT03021759|10076445|FG001|STARTED|Overall Study||1743
9013745|NCT03021759|10076446|FG002|STARTED|Overall Study||1465
9013746|NCT03021759|10076444|FG000|COMPLETED|Overall Study|32 primary care physicians were randomized to this arm and analyzed.|1566
9013747|NCT03021759|10076445|FG001|COMPLETED|Overall Study|32 primary care physicians were randomized to this arm and analyzed.|1743
9013748|NCT03021759|10076446|FG002|COMPLETED|Overall Study|32 primary care physicians were randomized to this arm and analyzed.|1465
9013749|NCT03021759|10076444|FG000|NOT COMPLETED|Overall Study||0
9013750|NCT03021759|10076445|FG001|NOT COMPLETED|Overall Study||0
9013751|NCT03021759|10076446|FG002|NOT COMPLETED|Overall Study||0
9013752|NCT03022045|10076456|FG000|STARTED|Overall Study||9
9013753|NCT03022045|10076457|FG001|STARTED|Overall Study||8
9013754|NCT03022045|10076456|FG000|COMPLETED|Overall Study||8
9013755|NCT03022045|10076457|FG001|COMPLETED|Overall Study||6
9013756|NCT03022045|10076456|FG000|NOT COMPLETED|Overall Study||1
9013757|NCT03022045|10076457|FG001|NOT COMPLETED|Overall Study||2
9039661|NCT03341299|10100654|FG002|STARTED|Period 2||8
9039662|NCT03341299|10100655|FG003|STARTED|Period 2||9
9039663|NCT03341299|10100652|FG000|COMPLETED|Period 2||9
9039664|NCT03341299|10100653|FG001|COMPLETED|Period 2||9
9039665|NCT03341299|10100654|FG002|COMPLETED|Period 2||8
8636787|NCT00569010|9677495|FG002|STARTED|Overall Study||11
8907528|NCT02116972|9965899|FG001|STARTED|Overall Study||104
8907529|NCT02116972|9965900|FG002|STARTED|Overall Study||104
8907530|NCT02116972|9965898|FG000|COMPLETED|Overall Study||83
8907531|NCT02116972|9965899|FG001|COMPLETED|Overall Study||87
8907532|NCT02116972|9965900|FG002|COMPLETED|Overall Study||85
8907533|NCT02116972|9965898|FG000|NOT COMPLETED|Overall Study||19
8907534|NCT02116972|9965899|FG001|NOT COMPLETED|Overall Study||17
8907535|NCT02116972|9965900|FG002|NOT COMPLETED|Overall Study||19
8907536|NCT02117024|9965912|FG000|STARTED|Overall Study||45
8907537|NCT02117024|9965913|FG001|STARTED|Overall Study||21
8907538|NCT02117024|9965912|FG000|COMPLETED|Overall Study||1
8907539|NCT02117024|9965913|FG001|COMPLETED|Overall Study||1
8907540|NCT02117024|9965912|FG000|NOT COMPLETED|Overall Study||44
8907541|NCT02117024|9965913|FG001|NOT COMPLETED|Overall Study||20
8907542|NCT02117193|9965919|FG000|STARTED|Overall Study||10
8907543|NCT02117193|9965919|FG000|Alcohol Intake + Normal Sleep|Overall Study||10
8907544|NCT02117193|9965919|FG000|Placebo Intake + Normal Sleep|Overall Study||10
8907545|NCT02117193|9965919|FG000|Alcohol Intake + Sleep Deprivation|Overall Study||10
8907546|NCT02117193|9965919|FG000|Placebo Intake + Sleep Deprivation|Overall Study||10
8907547|NCT02117193|9965919|FG000|COMPLETED|Overall Study||10
8907548|NCT02117193|9965919|FG000|NOT COMPLETED|Overall Study||0
8907549|NCT02117310|9965938|FG000|STARTED|Overall Study||5
8907550|NCT02117310|9965938|FG000|COMPLETED|Overall Study||5
8907551|NCT02117310|9965938|FG000|NOT COMPLETED|Overall Study||0
8907552|NCT02117349|9965944|FG000|STARTED|Overall Study||37
8907553|NCT02117349|9965945|FG001|STARTED|Overall Study||18
8907554|NCT02117349|9965944|FG000|Intent-to-treat Population|Overall Study||37
9013758|NCT03022084|10076469|FG000|STARTED|Overall Study||29
9013759|NCT03022084|10076470|FG001|STARTED|Overall Study||32
9013760|NCT03022084|10076469|FG000|COMPLETED|Overall Study||27
9013761|NCT03022084|10076470|FG001|COMPLETED|Overall Study||29
9013762|NCT03022084|10076469|FG000|NOT COMPLETED|Overall Study||2
9013763|NCT03022084|10076470|FG001|NOT COMPLETED|Overall Study||3
9013764|NCT03022370|10076480|FG000|STARTED|Overall Study||677
9013765|NCT03022370|10076481|FG001|STARTED|Overall Study||674
9013766|NCT03022370|10076480|FG000|COMPLETED|Overall Study||497
9013767|NCT03022370|10076481|FG001|COMPLETED|Overall Study||553
9013768|NCT03022370|10076480|FG000|NOT COMPLETED|Overall Study||180
8573369|NCT00121641|9605644|FG003|COMPLETED|24-week Short-term Treatment Period||55
8573370|NCT00121641|9605645|FG004|COMPLETED|24-week Short-term Treatment Period||25
8573371|NCT00121641|9605641|FG000|NOT COMPLETED|24-week Short-term Treatment Period||29
8573372|NCT00121641|9605642|FG001|NOT COMPLETED|24-week Short-term Treatment Period||38
8573373|NCT00121641|9605643|FG002|NOT COMPLETED|24-week Short-term Treatment Period||29
8573374|NCT00121641|9605644|FG003|NOT COMPLETED|24-week Short-term Treatment Period||40
8573375|NCT00121641|9605645|FG004|NOT COMPLETED|24-week Short-term Treatment Period||41
8726713|NCT01038297|9773960|FG000|NOT COMPLETED|Part A: Skin Testing Phase (50 Days)||1
8726714|NCT01038297|9773961|FG001|NOT COMPLETED|Part A: Skin Testing Phase (50 Days)||0
8726715|NCT01038297|9773962|FG002|NOT COMPLETED|Part A: Skin Testing Phase (50 Days)||0
8726716|NCT01038297|9773960|FG000|STARTED|Part B: Active Dosing Phase (13 Weeks)||9
8726717|NCT01038297|9773961|FG001|STARTED|Part B: Active Dosing Phase (13 Weeks)||10
8726718|NCT01038297|9773962|FG002|STARTED|Part B: Active Dosing Phase (13 Weeks)||10
8726719|NCT01038297|9773960|FG000|COMPLETED|Part B: Active Dosing Phase (13 Weeks)||9
8726720|NCT01038297|9773961|FG001|COMPLETED|Part B: Active Dosing Phase (13 Weeks)||10
8726721|NCT01038297|9773962|FG002|COMPLETED|Part B: Active Dosing Phase (13 Weeks)||10
8726722|NCT01038297|9773960|FG000|NOT COMPLETED|Part B: Active Dosing Phase (13 Weeks)||0
8726723|NCT01038297|9773961|FG001|NOT COMPLETED|Part B: Active Dosing Phase (13 Weeks)||0
8907555|NCT02117349|9965945|FG001|Intent-to-treat Population|Overall Study||18
8573376|NCT00121641|9605641|FG000|STARTED|48-month Short Term + Long Term Period||102
8573377|NCT00121641|9605642|FG001|STARTED|48-month Short Term + Long Term Period||106
8573378|NCT00121641|9605643|FG002|STARTED|48-month Short Term + Long Term Period||98
8573379|NCT00121641|9605644|FG003|STARTED|48-month Short Term + Long Term Period||95
8573380|NCT00121641|9605645|FG004|STARTED|48-month Short Term + Long Term Period||66
8573381|NCT00121641|9605641|FG000|COMPLETED|48-month Short Term + Long Term Period||23
8573382|NCT00121641|9605642|FG001|COMPLETED|48-month Short Term + Long Term Period||24
8573383|NCT00121641|9605643|FG002|COMPLETED|48-month Short Term + Long Term Period||28
8573384|NCT00121641|9605644|FG003|COMPLETED|48-month Short Term + Long Term Period||24
8573385|NCT00121641|9605645|FG004|COMPLETED|48-month Short Term + Long Term Period||8
8573386|NCT00121641|9605641|FG000|NOT COMPLETED|48-month Short Term + Long Term Period||79
8907556|NCT02117349|9965944|FG000|Safety Population|Overall Study||36
8907557|NCT02117349|9965945|FG001|Safety Population|Overall Study||18
8907558|NCT02117349|9965944|FG000|Modified Intent-to-treat (mITT)|Overall Study||36
8907559|NCT02117349|9965945|FG001|Modified Intent-to-treat (mITT)|Overall Study||18
8907560|NCT02117349|9965944|FG000|COMPLETED|Overall Study||34
8907561|NCT02117349|9965945|FG001|COMPLETED|Overall Study||17
8907562|NCT02117349|9965944|FG000|NOT COMPLETED|Overall Study||3
8907563|NCT02117349|9965945|FG001|NOT COMPLETED|Overall Study||1
8907564|NCT02117414|9965953|FG000|STARTED|Overall Study|Subjects randomized to the MRI group.|175
8907565|NCT02117414|9965954|FG001|STARTED|Overall Study|Subjects randomized to the Control group.|88
8907566|NCT02117414|9965953|FG000|COMPLETED|Overall Study|Subject followed up at least to the one-month post MRI/Waiting period visit in the MRI group.|160
9013769|NCT03022370|10076481|FG001|NOT COMPLETED|Overall Study||121
9013770|NCT03022396|10076497|FG000|STARTED|Overall Study||16
9013771|NCT03022396|10076498|FG001|STARTED|Overall Study||14
8907567|NCT02117414|9965954|FG001|COMPLETED|Overall Study|Subject followed up at least to the one-month post MRI/Waiting period visit in the Control group.|82
8907568|NCT02117414|9965953|FG000|NOT COMPLETED|Overall Study||15
8907569|NCT02117414|9965954|FG001|NOT COMPLETED|Overall Study||6
8907570|NCT02117427|9965965|FG000|STARTED|Overall Study||6
8907571|NCT02117427|9965966|FG001|STARTED|Overall Study||5
8907572|NCT02117427|9965967|FG002|STARTED|Overall Study||0
8907573|NCT02117427|9965965|FG000|Run in Phase & Harvest|Overall Study||6
8907574|NCT02117427|9965966|FG001|Run in Phase & Harvest|Overall Study||4
8907575|NCT02117427|9965967|FG002|Run in Phase & Harvest|Overall Study||0
8907576|NCT02117427|9965965|FG000|Implantation & Efficacy|Overall Study||6
8907577|NCT02117427|9965966|FG001|Implantation & Efficacy|Overall Study||4
8907578|NCT02117427|9965967|FG002|Implantation & Efficacy|Overall Study||0
8907579|NCT02117427|9965965|FG000|Safety Follow-up|Overall Study||1
8907580|NCT02117427|9965966|FG001|Safety Follow-up|Overall Study||0
8907581|NCT02117427|9965967|FG002|Safety Follow-up|Overall Study||0
8907582|NCT02117427|9965965|FG000|Long Term Safety Follow-up|Overall Study||1
8907583|NCT02117427|9965966|FG001|Long Term Safety Follow-up|Overall Study||0
8907584|NCT02117427|9965967|FG002|Long Term Safety Follow-up|Overall Study||0
8907585|NCT02117427|9965965|FG000|COMPLETED|Overall Study||1
9013772|NCT03022396|10076499|FG002|STARTED|Overall Study||10
9013773|NCT03022396|10076500|FG003|STARTED|Overall Study||20
9013774|NCT03022396|10076501|FG004|STARTED|Overall Study||14
9013775|NCT03022396|10076502|FG005|STARTED|Overall Study||8
9013776|NCT03022396|10076497|FG000|COMPLETED|Overall Study||16
9013777|NCT03022396|10076498|FG001|COMPLETED|Overall Study||14
9013778|NCT03022396|10076499|FG002|COMPLETED|Overall Study||10
9013779|NCT03022396|10076500|FG003|COMPLETED|Overall Study||20
9013780|NCT03022396|10076501|FG004|COMPLETED|Overall Study||14
9013781|NCT03022396|10076502|FG005|COMPLETED|Overall Study||8
9013782|NCT03022396|10076497|FG000|NOT COMPLETED|Overall Study||0
9013783|NCT03022396|10076498|FG001|NOT COMPLETED|Overall Study||0
9013784|NCT03022396|10076499|FG002|NOT COMPLETED|Overall Study||0
9013785|NCT03022396|10076500|FG003|NOT COMPLETED|Overall Study||0
9013786|NCT03022396|10076501|FG004|NOT COMPLETED|Overall Study||0
9013787|NCT03022396|10076502|FG005|NOT COMPLETED|Overall Study||0
9013788|NCT03022422|10076522|FG000|STARTED|Overall Study||8
9013789|NCT03022422|10076523|FG001|STARTED|Overall Study||10
9013790|NCT03022422|10076524|FG002|STARTED|Overall Study||23
9013791|NCT03022422|10076525|FG003|STARTED|Overall Study||12
9013792|NCT03022422|10076526|FG004|STARTED|Overall Study||5
9013793|NCT03022422|10076527|FG005|STARTED|Overall Study||5
9013794|NCT03022422|10076522|FG000|COMPLETED|Overall Study||8
9013795|NCT03022422|10076523|FG001|COMPLETED|Overall Study||10
9013796|NCT03022422|10076524|FG002|COMPLETED|Overall Study||20
9013797|NCT03022422|10076525|FG003|COMPLETED|Overall Study||12
9013798|NCT03022422|10076526|FG004|COMPLETED|Overall Study||5
9013799|NCT03022422|10076527|FG005|COMPLETED|Overall Study||5
9013800|NCT03022422|10076522|FG000|NOT COMPLETED|Overall Study||0
9013801|NCT03022422|10076523|FG001|NOT COMPLETED|Overall Study||0
9013802|NCT03022422|10076524|FG002|NOT COMPLETED|Overall Study||3
9013803|NCT03022422|10076525|FG003|NOT COMPLETED|Overall Study||0
9013804|NCT03022422|10076526|FG004|NOT COMPLETED|Overall Study||0
9013805|NCT03022422|10076527|FG005|NOT COMPLETED|Overall Study||0
9013806|NCT03022435|10076548|FG000|STARTED|Overall Study||5
9013807|NCT03022435|10076549|FG001|STARTED|Overall Study||5
9013808|NCT03022435|10076550|FG002|STARTED|Overall Study||6
9013809|NCT03022435|10076551|FG003|STARTED|Overall Study||3
9013810|NCT03022435|10076552|FG004|STARTED|Overall Study||3
8636788|NCT00569010|9677496|FG003|STARTED|Overall Study||11
8636789|NCT00569010|9677493|FG000|COMPLETED|Overall Study||6
8636790|NCT00569010|9677494|FG001|COMPLETED|Overall Study||6
8636791|NCT00569010|9677495|FG002|COMPLETED|Overall Study||11
8636792|NCT00569010|9677496|FG003|COMPLETED|Overall Study||11
9013811|NCT03022435|10076548|FG000|COMPLETED|Overall Study||5
9013812|NCT03022435|10076549|FG001|COMPLETED|Overall Study||5
9013813|NCT03022435|10076550|FG002|COMPLETED|Overall Study||6
9013814|NCT03022435|10076551|FG003|COMPLETED|Overall Study||3
9013815|NCT03022435|10076552|FG004|COMPLETED|Overall Study||3
9013816|NCT03022435|10076548|FG000|NOT COMPLETED|Overall Study||0
9013817|NCT03022435|10076549|FG001|NOT COMPLETED|Overall Study||0
9013818|NCT03022435|10076550|FG002|NOT COMPLETED|Overall Study||0
9013819|NCT03022435|10076551|FG003|NOT COMPLETED|Overall Study||0
9013820|NCT03022435|10076552|FG004|NOT COMPLETED|Overall Study||0
9013821|NCT03022526|10076569|FG000|STARTED|Overall Study||31
9013822|NCT03022526|10076570|FG001|STARTED|Overall Study||30
9013823|NCT03022526|10076569|FG000|COMPLETED|Overall Study||21
9013824|NCT03022526|10076570|FG001|COMPLETED|Overall Study||25
9013825|NCT03022526|10076569|FG000|NOT COMPLETED|Overall Study||10
9013826|NCT03022526|10076570|FG001|NOT COMPLETED|Overall Study||5
9013827|NCT03022617|10076576|FG000|STARTED|Overall Study||12
9013828|NCT03022617|10076576|FG000|COMPLETED|Overall Study||6
9013829|NCT03022617|10076576|FG000|NOT COMPLETED|Overall Study||6
9013830|NCT03022630|10076582|FG000|STARTED|Overall Study||31
9013831|NCT03022630|10076583|FG001|STARTED|Overall Study||32
8636793|NCT00569010|9677493|FG000|NOT COMPLETED|Overall Study||0
8636794|NCT00569010|9677494|FG001|NOT COMPLETED|Overall Study||0
9013832|NCT03022630|10076582|FG000|COMPLETED|Overall Study||22
9013833|NCT03022630|10076583|FG001|COMPLETED|Overall Study||20
9013834|NCT03022630|10076582|FG000|NOT COMPLETED|Overall Study||9
9013835|NCT03022630|10076583|FG001|NOT COMPLETED|Overall Study||12
9013836|NCT03022799|10076607|FG000|STARTED|Overall Study||6
9013837|NCT03022799|10076608|FG001|STARTED|Overall Study||6
9013838|NCT03022799|10076609|FG002|STARTED|Overall Study||6
9013839|NCT03022799|10076610|FG003|STARTED|Overall Study||6
9013840|NCT03022799|10076611|FG004|STARTED|Overall Study||6
9013841|NCT03022799|10076612|FG005|STARTED|Overall Study||6
9013842|NCT03022799|10076613|FG006|STARTED|Overall Study||12
9013843|NCT03022799|10076614|FG007|STARTED|Overall Study||6
9013844|NCT03022799|10076615|FG008|STARTED|Overall Study||6
9013845|NCT03022799|10076616|FG009|STARTED|Overall Study||6
9013846|NCT03022799|10076617|FG010|STARTED|Overall Study||6
9013847|NCT03022799|10076618|FG011|STARTED|Overall Study||6
9013848|NCT03022799|10076619|FG012|STARTED|Overall Study||10
9013849|NCT03022799|10076607|FG000|COMPLETED|Overall Study||6
9013850|NCT03022799|10076608|FG001|COMPLETED|Overall Study||6
9013851|NCT03022799|10076609|FG002|COMPLETED|Overall Study||6
9013852|NCT03022799|10076610|FG003|COMPLETED|Overall Study||6
9013853|NCT03022799|10076611|FG004|COMPLETED|Overall Study||6
9013854|NCT03022799|10076612|FG005|COMPLETED|Overall Study||6
9013855|NCT03022799|10076613|FG006|COMPLETED|Overall Study||12
9013856|NCT03022799|10076614|FG007|COMPLETED|Overall Study||6
9013857|NCT03022799|10076615|FG008|COMPLETED|Overall Study||6
9013858|NCT03022799|10076616|FG009|COMPLETED|Overall Study||5
9013859|NCT03022799|10076617|FG010|COMPLETED|Overall Study||5
9013860|NCT03022799|10076618|FG011|COMPLETED|Overall Study||6
9013861|NCT03022799|10076619|FG012|COMPLETED|Overall Study||10
9013862|NCT03022799|10076607|FG000|NOT COMPLETED|Overall Study||0
9013863|NCT03022799|10076608|FG001|NOT COMPLETED|Overall Study||0
9013864|NCT03022799|10076609|FG002|NOT COMPLETED|Overall Study||0
9013865|NCT03022799|10076610|FG003|NOT COMPLETED|Overall Study||0
9013866|NCT03022799|10076611|FG004|NOT COMPLETED|Overall Study||0
9013867|NCT03022799|10076612|FG005|NOT COMPLETED|Overall Study||0
9013868|NCT03022799|10076613|FG006|NOT COMPLETED|Overall Study||0
9013869|NCT03022799|10076614|FG007|NOT COMPLETED|Overall Study||0
9013870|NCT03022799|10076615|FG008|NOT COMPLETED|Overall Study||0
9013871|NCT03022799|10076616|FG009|NOT COMPLETED|Overall Study||1
9013872|NCT03022799|10076617|FG010|NOT COMPLETED|Overall Study||1
9013873|NCT03022799|10076618|FG011|NOT COMPLETED|Overall Study||0
9013874|NCT03022799|10076619|FG012|NOT COMPLETED|Overall Study||0
9013875|NCT03022916|10076664|FG000|STARTED|Overall Study||5
9013876|NCT03022916|10076665|FG001|STARTED|Overall Study||5
9013877|NCT03022916|10076666|FG002|STARTED|Overall Study||5
9013878|NCT03022916|10076667|FG003|STARTED|Overall Study||5
9013879|NCT03022916|10076664|FG000|Nail Polish|Overall Study||5
9013880|NCT03022916|10076665|FG001|Nail Polish|Overall Study||5
9013881|NCT03022916|10076666|FG002|Nail Polish|Overall Study||5
9013882|NCT03022916|10076667|FG003|Nail Polish|Overall Study||5
9013883|NCT03022916|10076664|FG000|Nail Polish, Base Coat|Overall Study||5
9013884|NCT03022916|10076665|FG001|Nail Polish, Base Coat|Overall Study||5
9013885|NCT03022916|10076666|FG002|Nail Polish, Base Coat|Overall Study||5
9013886|NCT03022916|10076667|FG003|Nail Polish, Base Coat|Overall Study||5
9013887|NCT03022916|10076664|FG000|Nail Polish, Top Coat|Overall Study||5
9013888|NCT03022916|10076665|FG001|Nail Polish, Top Coat|Overall Study||5
9013889|NCT03022916|10076666|FG002|Nail Polish, Top Coat|Overall Study||5
9013890|NCT03022916|10076667|FG003|Nail Polish, Top Coat|Overall Study||5
9013891|NCT03022916|10076664|FG000|COMPLETED|Overall Study||5
8726724|NCT01038297|9773962|FG002|NOT COMPLETED|Part B: Active Dosing Phase (13 Weeks)||0
8726725|NCT01038323|9773982|FG000|STARTED|Overall Study||20
8726726|NCT01038323|9773983|FG001|STARTED|Overall Study||19
8726727|NCT01038323|9773984|FG002|STARTED|Overall Study||19
8726728|NCT01038323|9773982|FG000|COMPLETED|Overall Study||17
8726729|NCT01038323|9773983|FG001|COMPLETED|Overall Study||17
8726730|NCT01038323|9773984|FG002|COMPLETED|Overall Study||15
8726731|NCT01038323|9773982|FG000|NOT COMPLETED|Overall Study||3
8726732|NCT01038323|9773983|FG001|NOT COMPLETED|Overall Study||2
8726733|NCT01038323|9773984|FG002|NOT COMPLETED|Overall Study||4
8726734|NCT01038336|9773995|FG000|STARTED|Overall Study||43
8726735|NCT01038336|9773996|FG001|STARTED|Overall Study||42
8726736|NCT01038336|9773997|FG002|STARTED|Overall Study||44
8907586|NCT02117427|9965966|FG001|COMPLETED|Overall Study||0
8907587|NCT02117427|9965967|FG002|COMPLETED|Overall Study||0
8907588|NCT02117427|9965965|FG000|NOT COMPLETED|Overall Study||5
8907589|NCT02117427|9965966|FG001|NOT COMPLETED|Overall Study||5
8907590|NCT02117427|9965967|FG002|NOT COMPLETED|Overall Study||0
8907591|NCT02117479|9965975|FG000|STARTED|Overall Study||161
8907592|NCT02117479|9965976|FG001|STARTED|Overall Study||160
8907593|NCT02117479|9965975|FG000|COMPLETED|Overall Study|Treatment ongoing as of 20APR2016 for remaining participants in the study.|5
8907594|NCT02117479|9965976|FG001|COMPLETED|Overall Study|Treatment ongoing as of 20APR2016 for remaining participants in the study.|4
8907595|NCT02117479|9965975|FG000|NOT COMPLETED|Overall Study||156
8907596|NCT02117479|9965976|FG001|NOT COMPLETED|Overall Study||156
8907597|NCT02117544|9965982|FG000|STARTED|Period 1||54
8907598|NCT02117544|9965983|FG001|STARTED|Period 1||55
8907599|NCT02117544|9965982|FG000|Treated|Period 1||52
8907600|NCT02117544|9965983|FG001|Treated|Period 1||55
9013892|NCT03022916|10076665|FG001|COMPLETED|Overall Study||5
9013893|NCT03022916|10076666|FG002|COMPLETED|Overall Study||5
8726737|NCT01038336|9773995|FG000|COMPLETED|Overall Study||43
8726738|NCT01038336|9773996|FG001|COMPLETED|Overall Study||42
8907601|NCT02117544|9965982|FG000|COMPLETED|Period 1||52
9013894|NCT03022916|10076667|FG003|COMPLETED|Overall Study||5
9013895|NCT03022916|10076664|FG000|NOT COMPLETED|Overall Study||0
8907602|NCT02117544|9965983|FG001|COMPLETED|Period 1||55
8907603|NCT02117544|9965982|FG000|NOT COMPLETED|Period 1||2
8907604|NCT02117544|9965983|FG001|NOT COMPLETED|Period 1||0
8907605|NCT02117544|9965982|FG000|STARTED|Period 2||52
8907606|NCT02117544|9965983|FG001|STARTED|Period 2||55
8907607|NCT02117544|9965982|FG000|COMPLETED|Period 2||52
8907608|NCT02117544|9965983|FG001|COMPLETED|Period 2||55
8907609|NCT02117544|9965982|FG000|NOT COMPLETED|Period 2||0
8907610|NCT02117544|9965983|FG001|NOT COMPLETED|Period 2||0
8907611|NCT02117570|9965993|FG000|STARTED|Stage 1 Participants Aged 50 to 64 Years|Randomized|6
8907612|NCT02117570|9965994|FG001|STARTED|Stage 1 Participants Aged 50 to 64 Years|Randomized|18
8907613|NCT02117570|9965995|FG002|STARTED|Stage 1 Participants Aged 50 to 64 Years|Randomized|18
8907614|NCT02117570|9965993|FG000|Vaccine: Dose 1|Stage 1 Participants Aged 50 to 64 Years||6
8907615|NCT02117570|9965994|FG001|Vaccine: Dose 1|Stage 1 Participants Aged 50 to 64 Years||18
8907616|NCT02117570|9965995|FG002|Vaccine: Dose 1|Stage 1 Participants Aged 50 to 64 Years||18
8907617|NCT02117570|9965993|FG000|Vaccine: Dose 2|Stage 1 Participants Aged 50 to 64 Years||6
8907618|NCT02117570|9965994|FG001|Vaccine: Dose 2|Stage 1 Participants Aged 50 to 64 Years||18
8907619|NCT02117570|9965995|FG002|Vaccine: Dose 2|Stage 1 Participants Aged 50 to 64 Years||18
8907620|NCT02117570|9965993|FG000|Vaccine: Dose 3|Stage 1 Participants Aged 50 to 64 Years||6
8907621|NCT02117570|9965994|FG001|Vaccine: Dose 3|Stage 1 Participants Aged 50 to 64 Years||17
8907622|NCT02117570|9965995|FG002|Vaccine: Dose 3|Stage 1 Participants Aged 50 to 64 Years||18
8907623|NCT02117570|9965993|FG000|COMPLETED|Stage 1 Participants Aged 50 to 64 Years||5
8907624|NCT02117570|9965994|FG001|COMPLETED|Stage 1 Participants Aged 50 to 64 Years||15
8907625|NCT02117570|9965995|FG002|COMPLETED|Stage 1 Participants Aged 50 to 64 Years||17
8907626|NCT02117570|9965993|FG000|NOT COMPLETED|Stage 1 Participants Aged 50 to 64 Years||1
8907627|NCT02117570|9965994|FG001|NOT COMPLETED|Stage 1 Participants Aged 50 to 64 Years||3
8907628|NCT02117570|9965995|FG002|NOT COMPLETED|Stage 1 Participants Aged 50 to 64 Years||1
8907629|NCT02117570|9965993|FG000|STARTED|Stage 2 Participants Aged 65 to 85 Years|Randomized|21
8907630|NCT02117570|9965994|FG001|STARTED|Stage 2 Participants Aged 65 to 85 Years|Randomized|62
8907631|NCT02117570|9965995|FG002|STARTED|Stage 2 Participants Aged 65 to 85 Years|Randomized|60
8907632|NCT02117570|9965993|FG000|Vaccine: Dose 1|Stage 2 Participants Aged 65 to 85 Years||21
8907633|NCT02117570|9965994|FG001|Vaccine: Dose 1|Stage 2 Participants Aged 65 to 85 Years||61
8907634|NCT02117570|9965995|FG002|Vaccine: Dose 1|Stage 2 Participants Aged 65 to 85 Years||60
8907635|NCT02117570|9965993|FG000|Vaccine: Dose 2|Stage 2 Participants Aged 65 to 85 Years||17
8907636|NCT02117570|9965994|FG001|Vaccine: Dose 2|Stage 2 Participants Aged 65 to 85 Years||53
8907637|NCT02117570|9965995|FG002|Vaccine: Dose 2|Stage 2 Participants Aged 65 to 85 Years||50
8907638|NCT02117570|9965993|FG000|Vaccine: Dose 3|Stage 2 Participants Aged 65 to 85 Years||4
8907639|NCT02117570|9965994|FG001|Vaccine: Dose 3|Stage 2 Participants Aged 65 to 85 Years||12
8907640|NCT02117570|9965995|FG002|Vaccine: Dose 3|Stage 2 Participants Aged 65 to 85 Years||12
8907641|NCT02117570|9965993|FG000|COMPLETED|Stage 2 Participants Aged 65 to 85 Years||20
8907642|NCT02117570|9965994|FG001|COMPLETED|Stage 2 Participants Aged 65 to 85 Years||59
8907643|NCT02117570|9965995|FG002|COMPLETED|Stage 2 Participants Aged 65 to 85 Years||54
8907644|NCT02117570|9965993|FG000|NOT COMPLETED|Stage 2 Participants Aged 65 to 85 Years||1
8907645|NCT02117570|9965994|FG001|NOT COMPLETED|Stage 2 Participants Aged 65 to 85 Years||3
8907646|NCT02117570|9965995|FG002|NOT COMPLETED|Stage 2 Participants Aged 65 to 85 Years||6
8907647|NCT02117648|9966006|FG000|STARTED|Abemaciclib Alone Period 1||26
8907648|NCT02117648|9966006|FG000|Received at Least 1 Dose of Study Drug|Abemaciclib Alone Period 1||26
8907649|NCT02117648|9966006|FG000|COMPLETED|Abemaciclib Alone Period 1||24
8907650|NCT02117648|9966006|FG000|NOT COMPLETED|Abemaciclib Alone Period 1||2
8907651|NCT02117648|9966006|FG000|STARTED|Abemaciclib + Clarithromycin Period 2||24
8907652|NCT02117648|9966006|FG000|Received at Least 1 Dose of Study Drug|Abemaciclib + Clarithromycin Period 2||21
8907653|NCT02117648|9966006|FG000|COMPLETED|Abemaciclib + Clarithromycin Period 2||20
8907654|NCT02117648|9966006|FG000|NOT COMPLETED|Abemaciclib + Clarithromycin Period 2||4
8907655|NCT02117648|9966006|FG000|STARTED|Abemaciclib Safety-Extension Phase||20
8907656|NCT02117648|9966006|FG000|COMPLETED|Abemaciclib Safety-Extension Phase||0
8907657|NCT02117648|9966006|FG000|NOT COMPLETED|Abemaciclib Safety-Extension Phase||20
8907658|NCT02117687|9966016|FG000|STARTED|Overall Study||40
8907659|NCT02117687|9966017|FG001|STARTED|Overall Study||40
9013896|NCT03022916|10076665|FG001|NOT COMPLETED|Overall Study||0
9013897|NCT03022916|10076666|FG002|NOT COMPLETED|Overall Study||0
9013898|NCT03022916|10076667|FG003|NOT COMPLETED|Overall Study||0
9013899|NCT03022981|10076677|FG000|STARTED|Overall Study||102
9013900|NCT03022981|10076678|FG001|STARTED|Overall Study||73
9013901|NCT03022981|10076679|FG002|STARTED|Overall Study||41
9013902|NCT03022981|10076677|FG000|Participated in PK Lead-in (PKL) Phase|Overall Study|All 17 participants completed treatment in the PK Lead-in phase and continued into treatment phase.|17
9013903|NCT03022981|10076678|FG001|Participated in PK Lead-in (PKL) Phase|Overall Study|All 20 participants completed treatment in the PK Lead-in phase and continued into treatment phase.|20
9013904|NCT03022981|10076679|FG002|Participated in PK Lead-in (PKL) Phase|Overall Study|All 19 participants completed treatment in the PK Lead-in phase and continued into treatment phase.|19
9013905|NCT03022981|10076677|FG000|COMPLETED|Overall Study||96
9013906|NCT03022981|10076678|FG001|COMPLETED|Overall Study||69
9013907|NCT03022981|10076679|FG002|COMPLETED|Overall Study||35
9013908|NCT03022981|10076677|FG000|NOT COMPLETED|Overall Study||6
9013909|NCT03022981|10076678|FG001|NOT COMPLETED|Overall Study||4
9013910|NCT03022981|10076679|FG002|NOT COMPLETED|Overall Study||6
8907660|NCT02117687|9966016|FG000|COMPLETED|Overall Study||39
8907661|NCT02117687|9966017|FG001|COMPLETED|Overall Study||36
8907662|NCT02117687|9966016|FG000|NOT COMPLETED|Overall Study||1
8907663|NCT02117687|9966017|FG001|NOT COMPLETED|Overall Study||4
8907664|NCT02117713|9966023|FG000|STARTED|Week 48||34
8907665|NCT02117713|9966023|FG000|COMPLETED|Week 48||26
8907666|NCT02117713|9966023|FG000|NOT COMPLETED|Week 48||8
8907667|NCT02117713|9966023|FG000|STARTED|Long Term Follow-up Treatment||26
8907668|NCT02117713|9966023|FG000|COMPLETED|Long Term Follow-up Treatment||20
8907669|NCT02117713|9966023|FG000|NOT COMPLETED|Long Term Follow-up Treatment||6
8907670|NCT02117934|9966037|FG000|STARTED|Overall Study||5592
8907671|NCT02117934|9966038|FG001|STARTED|Overall Study||2782
8907672|NCT02117934|9966037|FG000|COMPLETED|Overall Study||5092
8907673|NCT02117934|9966038|FG001|COMPLETED|Overall Study||2567
8907674|NCT02117934|9966037|FG000|NOT COMPLETED|Overall Study||500
8907675|NCT02117934|9966038|FG001|NOT COMPLETED|Overall Study||215
8907676|NCT02117999|9966046|FG000|STARTED|Overall Study||20
8907677|NCT02117999|9966047|FG001|STARTED|Overall Study||10
8907678|NCT02117999|9966046|FG000|Mean Kmax Change in Corneal Topography|Overall Study||20
8907679|NCT02117999|9966047|FG001|Mean Kmax Change in Corneal Topography|Overall Study||10
8907680|NCT02117999|9966046|FG000|COMPLETED|Overall Study||20
8907681|NCT02117999|9966047|FG001|COMPLETED|Overall Study||10
8907682|NCT02117999|9966046|FG000|NOT COMPLETED|Overall Study||0
8907683|NCT02117999|9966047|FG001|NOT COMPLETED|Overall Study||0
8907684|NCT02118012|9966057|FG000|STARTED|Overall Study||12
8907685|NCT02118012|9966058|FG001|STARTED|Overall Study||12
8907686|NCT02118012|9966057|FG000|Day 5|Overall Study||12
8907687|NCT02118012|9966058|FG001|Day 5|Overall Study||11
8907688|NCT02118012|9966057|FG000|Day 14|Overall Study||12
8907689|NCT02118012|9966058|FG001|Day 14|Overall Study||10
8907690|NCT02118012|9966057|FG000|COMPLETED|Overall Study||12
8907691|NCT02118012|9966058|FG001|COMPLETED|Overall Study||10
8907692|NCT02118012|9966057|FG000|NOT COMPLETED|Overall Study||0
8907693|NCT02118012|9966058|FG001|NOT COMPLETED|Overall Study||2
8907694|NCT02118337|9966073|FG000|STARTED|Overall Study||4
8907695|NCT02118337|9966074|FG001|STARTED|Overall Study||5
8907696|NCT02118337|9966075|FG002|STARTED|Overall Study||3
8907697|NCT02118337|9966076|FG003|STARTED|Overall Study||3
8907698|NCT02118337|9966077|FG004|STARTED|Overall Study||9
8907699|NCT02118337|9966078|FG005|STARTED|Overall Study||6
8907700|NCT02118337|9966079|FG006|STARTED|Overall Study||4
8907701|NCT02118337|9966080|FG007|STARTED|Overall Study||42
8907702|NCT02118337|9966081|FG008|STARTED|Overall Study||21
8907703|NCT02118337|9966073|FG000|COMPLETED|Overall Study||0
8907704|NCT02118337|9966074|FG001|COMPLETED|Overall Study||0
8907705|NCT02118337|9966075|FG002|COMPLETED|Overall Study||0
8907706|NCT02118337|9966076|FG003|COMPLETED|Overall Study||0
8907707|NCT02118337|9966077|FG004|COMPLETED|Overall Study||0
8907708|NCT02118337|9966078|FG005|COMPLETED|Overall Study||0
8907709|NCT02118337|9966079|FG006|COMPLETED|Overall Study||0
8907710|NCT02118337|9966080|FG007|COMPLETED|Overall Study||0
8907711|NCT02118337|9966081|FG008|COMPLETED|Overall Study||0
8907712|NCT02118337|9966073|FG000|NOT COMPLETED|Overall Study||4
8636795|NCT00569010|9677495|FG002|NOT COMPLETED|Overall Study||0
8636796|NCT00569010|9677496|FG003|NOT COMPLETED|Overall Study||0
8636797|NCT00569166|9677509|FG000|STARTED|Overall Study||30
8636798|NCT00569166|9677510|FG001|STARTED|Overall Study||31
8636799|NCT00569166|9677511|FG002|STARTED|Overall Study||31
8636800|NCT00569166|9677509|FG000|COMPLETED|Overall Study||21
8636801|NCT00569166|9677510|FG001|COMPLETED|Overall Study||25
8636802|NCT00569166|9677511|FG002|COMPLETED|Overall Study||27
8636803|NCT00569166|9677509|FG000|NOT COMPLETED|Overall Study||9
8636804|NCT00569166|9677510|FG001|NOT COMPLETED|Overall Study||6
8907713|NCT02118337|9966074|FG001|NOT COMPLETED|Overall Study||5
8907714|NCT02118337|9966075|FG002|NOT COMPLETED|Overall Study||3
8907715|NCT02118337|9966076|FG003|NOT COMPLETED|Overall Study||3
8907716|NCT02118337|9966077|FG004|NOT COMPLETED|Overall Study||9
8907717|NCT02118337|9966078|FG005|NOT COMPLETED|Overall Study||6
8907718|NCT02118337|9966079|FG006|NOT COMPLETED|Overall Study||4
8907719|NCT02118337|9966080|FG007|NOT COMPLETED|Overall Study||42
8907720|NCT02118337|9966081|FG008|NOT COMPLETED|Overall Study||21
8907721|NCT02118428|9966107|FG000|STARTED|Overall Study||113
8907722|NCT02118428|9966108|FG001|STARTED|Overall Study||113
8907723|NCT02118428|9966109|FG002|STARTED|Overall Study||1
8907724|NCT02118428|9966107|FG000|Received Study Transfusion|Overall Study||111
8907725|NCT02118428|9966108|FG001|Received Study Transfusion|Overall Study||112
8907726|NCT02118428|9966109|FG002|Received Study Transfusion|Overall Study||0
9013911|NCT03023137|10076699|FG000|STARTED|Overall Study||178
9013912|NCT03023137|10076700|FG001|STARTED|Overall Study||171
8907727|NCT02118428|9966107|FG000|COMPLETED|Overall Study||100
8907728|NCT02118428|9966108|FG001|COMPLETED|Overall Study||104
8907729|NCT02118428|9966109|FG002|COMPLETED|Overall Study||0
8907730|NCT02118428|9966107|FG000|NOT COMPLETED|Overall Study||13
8636805|NCT00569166|9677511|FG002|NOT COMPLETED|Overall Study||4
9013913|NCT03023137|10076699|FG000|COMPLETED|Overall Study||174
8907731|NCT02118428|9966108|FG001|NOT COMPLETED|Overall Study||9
8907732|NCT02118428|9966109|FG002|NOT COMPLETED|Overall Study||1
8907733|NCT02118441|9966117|FG000|STARTED|Overall Study||65
8907734|NCT02118441|9966118|FG001|STARTED|Overall Study||64
8907735|NCT02118441|9966117|FG000|COMPLETED|Overall Study||62
8907736|NCT02118441|9966118|FG001|COMPLETED|Overall Study||63
8907737|NCT02118441|9966117|FG000|NOT COMPLETED|Overall Study||3
8907738|NCT02118441|9966118|FG001|NOT COMPLETED|Overall Study||1
8907739|NCT02118597|9966125|FG000|STARTED|Overall Study||19
8907740|NCT02118597|9966125|FG000|COMPLETED|Overall Study||3
8907741|NCT02118597|9966125|FG000|NOT COMPLETED|Overall Study||16
8907742|NCT02118714|9966129|FG000|STARTED|Overall Study||20
8907743|NCT02118714|9966129|FG000|COMPLETED|Overall Study||17
8907744|NCT02118714|9966129|FG000|NOT COMPLETED|Overall Study||3
8907745|NCT02118766|9966135|FG000|STARTED|Overall Study||507
8907746|NCT02118766|9966136|FG001|STARTED|Overall Study||256
8907747|NCT02118766|9966135|FG000|Treated|Overall Study||503
8907748|NCT02118766|9966136|FG001|Treated|Overall Study||256
8907749|NCT02118766|9966135|FG000|COMPLETED|Overall Study||477
8907750|NCT02118766|9966136|FG001|COMPLETED|Overall Study||225
8907751|NCT02118766|9966135|FG000|NOT COMPLETED|Overall Study||30
8907752|NCT02118766|9966136|FG001|NOT COMPLETED|Overall Study||31
8907753|NCT02118792|9966144|FG000|STARTED|Overall Study||514
8907754|NCT02118792|9966145|FG001|STARTED|Overall Study||250
8907755|NCT02118792|9966144|FG000|Treated|Overall Study||513
8907756|NCT02118792|9966145|FG001|Treated|Overall Study||250
8907757|NCT02118792|9966144|FG000|COMPLETED|Overall Study||483
8907758|NCT02118792|9966145|FG001|COMPLETED|Overall Study||213
8907759|NCT02118792|9966144|FG000|NOT COMPLETED|Overall Study||31
8907760|NCT02118792|9966145|FG001|NOT COMPLETED|Overall Study||37
8907761|NCT02118831|9966156|FG000|STARTED|Overall Study||21
8907762|NCT02118831|9966157|FG001|STARTED|Overall Study||15
8907763|NCT02118831|9966158|FG002|STARTED|Overall Study||20
8907764|NCT02118831|9966156|FG000|COMPLETED|Overall Study||21
8907765|NCT02118831|9966157|FG001|COMPLETED|Overall Study||15
8907766|NCT02118831|9966158|FG002|COMPLETED|Overall Study||20
8907767|NCT02118831|9966156|FG000|NOT COMPLETED|Overall Study||0
8907768|NCT02118831|9966157|FG001|NOT COMPLETED|Overall Study||0
8907769|NCT02118831|9966158|FG002|NOT COMPLETED|Overall Study||0
8907770|NCT02118896|9966176|FG000|STARTED|Overall Study||47
8907771|NCT02118896|9966177|FG001|STARTED|Overall Study||47
8907772|NCT02118896|9966178|FG002|STARTED|Overall Study||67
8907773|NCT02118896|9966179|FG003|STARTED|Overall Study||79
8907774|NCT02118896|9966180|FG004|STARTED|Overall Study||130
8907775|NCT02118896|9966181|FG005|STARTED|Overall Study||191
8907776|NCT02118896|9966182|FG006|STARTED|Overall Study||85
8907777|NCT02118896|9966183|FG007|STARTED|Overall Study||107
8907778|NCT02118896|9966184|FG008|STARTED|Overall Study||88
8907779|NCT02118896|9966185|FG009|STARTED|Overall Study||9
8907780|NCT02118896|9966176|FG000|COMPLETED|Overall Study||30
8907781|NCT02118896|9966177|FG001|COMPLETED|Overall Study||32
8907782|NCT02118896|9966178|FG002|COMPLETED|Overall Study||53
8907783|NCT02118896|9966179|FG003|COMPLETED|Overall Study||55
8907784|NCT02118896|9966180|FG004|COMPLETED|Overall Study||113
8907785|NCT02118896|9966181|FG005|COMPLETED|Overall Study||163
8907786|NCT02118896|9966182|FG006|COMPLETED|Overall Study||83
8907787|NCT02118896|9966183|FG007|COMPLETED|Overall Study||105
8907788|NCT02118896|9966184|FG008|COMPLETED|Overall Study||84
8907789|NCT02118896|9966185|FG009|COMPLETED|Overall Study||7
8907790|NCT02118896|9966176|FG000|NOT COMPLETED|Overall Study||17
8907791|NCT02118896|9966177|FG001|NOT COMPLETED|Overall Study||15
8907792|NCT02118896|9966178|FG002|NOT COMPLETED|Overall Study||14
8907793|NCT02118896|9966179|FG003|NOT COMPLETED|Overall Study||24
8907794|NCT02118896|9966180|FG004|NOT COMPLETED|Overall Study||17
8907795|NCT02118896|9966181|FG005|NOT COMPLETED|Overall Study||28
8907796|NCT02118896|9966182|FG006|NOT COMPLETED|Overall Study||2
8907797|NCT02118896|9966183|FG007|NOT COMPLETED|Overall Study||2
8907798|NCT02118896|9966184|FG008|NOT COMPLETED|Overall Study||4
8907799|NCT02118896|9966185|FG009|NOT COMPLETED|Overall Study||2
8907800|NCT02118961|9966210|FG000|STARTED|Overall Study||224
8907801|NCT02118961|9966211|FG001|STARTED|Overall Study||222
8907802|NCT02118961|9966210|FG000|COMPLETED|Overall Study||223
8907803|NCT02118961|9966211|FG001|COMPLETED|Overall Study||222
8907804|NCT02118961|9966210|FG000|NOT COMPLETED|Overall Study||1
8907805|NCT02118961|9966211|FG001|NOT COMPLETED|Overall Study||0
8907806|NCT02119026|9966219|FG000|STARTED|1st-line Treatment||58
8907807|NCT02119026|9966220|FG001|STARTED|1st-line Treatment||62
8907808|NCT02119026|9966219|FG000|COMPLETED|1st-line Treatment||32
8907809|NCT02119026|9966220|FG001|COMPLETED|1st-line Treatment||24
8907810|NCT02119026|9966219|FG000|NOT COMPLETED|1st-line Treatment||26
8907811|NCT02119026|9966220|FG001|NOT COMPLETED|1st-line Treatment||38
8907812|NCT02119026|9966219|FG000|STARTED|2nd-line Treatment||32
8907813|NCT02119026|9966220|FG001|STARTED|2nd-line Treatment||24
8907814|NCT02119026|9966219|FG000|COMPLETED|2nd-line Treatment||23
8907815|NCT02119026|9966220|FG001|COMPLETED|2nd-line Treatment||22
8907816|NCT02119026|9966219|FG000|NOT COMPLETED|2nd-line Treatment||9
8907817|NCT02119026|9966220|FG001|NOT COMPLETED|2nd-line Treatment||2
8907818|NCT02119104|9966226|FG000|STARTED|Overall Study||1087
8907819|NCT02119104|9966226|FG000|COMPLETED|Overall Study||1071
8907820|NCT02119104|9966226|FG000|NOT COMPLETED|Overall Study||16
8907821|NCT02119156|9966233|FG000|STARTED|Treatment Phase (Up to 52 Weeks)||39
8907822|NCT02119156|9966234|FG001|STARTED|Treatment Phase (Up to 52 Weeks)||29
8907823|NCT02119156|9966235|FG002|STARTED|Treatment Phase (Up to 52 Weeks)||12
8907824|NCT02119156|9966233|FG000|COMPLETED|Treatment Phase (Up to 52 Weeks)||33
8907825|NCT02119156|9966234|FG001|COMPLETED|Treatment Phase (Up to 52 Weeks)||27
8907826|NCT02119156|9966235|FG002|COMPLETED|Treatment Phase (Up to 52 Weeks)||11
8907827|NCT02119156|9966233|FG000|NOT COMPLETED|Treatment Phase (Up to 52 Weeks)||6
8907828|NCT02119156|9966234|FG001|NOT COMPLETED|Treatment Phase (Up to 52 Weeks)||2
8907829|NCT02119156|9966235|FG002|NOT COMPLETED|Treatment Phase (Up to 52 Weeks)||1
8907830|NCT02119156|9966233|FG000|STARTED|Maintenance (Up to 48 Weeks of Year 2-4)|Long-term discontinuation participants were not allowed in Maintenance period|0
8907831|NCT02119156|9966234|FG001|STARTED|Maintenance (Up to 48 Weeks of Year 2-4)|Eligible participants of Treatment control and holiday group on completion of 52-weeks were included|16
8907832|NCT02119156|9966235|FG002|STARTED|Maintenance (Up to 48 Weeks of Year 2-4)|Eligible participants of Treatment control and holiday group on completion of 52-weeks were included|10
8907833|NCT02119156|9966233|FG000|COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||0
8907834|NCT02119156|9966234|FG001|COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||6
8907835|NCT02119156|9966235|FG002|COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||3
8907836|NCT02119156|9966233|FG000|NOT COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||0
8907837|NCT02119156|9966234|FG001|NOT COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||10
8907838|NCT02119156|9966235|FG002|NOT COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||7
8907839|NCT02119260|9966257|FG000|STARTED|Overall Study||9
8907840|NCT02119260|9966258|FG001|STARTED|Overall Study||12
8907841|NCT02119260|9966259|FG002|STARTED|Overall Study||8
8907842|NCT02119260|9966260|FG003|STARTED|Overall Study||10
8907843|NCT02119260|9966261|FG004|STARTED|Overall Study||13
8907844|NCT02119260|9966262|FG005|STARTED|Overall Study||6
8907845|NCT02119260|9966263|FG006|STARTED|Overall Study||2
8907846|NCT02119260|9966257|FG000|COMPLETED|Overall Study||8
8907847|NCT02119260|9966258|FG001|COMPLETED|Overall Study||11
8907848|NCT02119260|9966259|FG002|COMPLETED|Overall Study||7
8907849|NCT02119260|9966260|FG003|COMPLETED|Overall Study||10
8907850|NCT02119260|9966261|FG004|COMPLETED|Overall Study||13
8907851|NCT02119260|9966262|FG005|COMPLETED|Overall Study||6
8907852|NCT02119260|9966263|FG006|COMPLETED|Overall Study||2
8907853|NCT02119260|9966257|FG000|NOT COMPLETED|Overall Study||1
8907854|NCT02119260|9966258|FG001|NOT COMPLETED|Overall Study||1
8907855|NCT02119260|9966259|FG002|NOT COMPLETED|Overall Study||1
8907856|NCT02119260|9966260|FG003|NOT COMPLETED|Overall Study||0
8907857|NCT02119260|9966261|FG004|NOT COMPLETED|Overall Study||0
8907858|NCT02119260|9966262|FG005|NOT COMPLETED|Overall Study||0
9013914|NCT03023137|10076700|FG001|COMPLETED|Overall Study||162
9013915|NCT03023137|10076699|FG000|NOT COMPLETED|Overall Study||4
9013916|NCT03023137|10076700|FG001|NOT COMPLETED|Overall Study||9
9013917|NCT03023176|10076707|FG000|STARTED|Overall Study||20
9013918|NCT03023176|10076707|FG000|COMPLETED|Overall Study||20
9013919|NCT03023176|10076707|FG000|NOT COMPLETED|Overall Study||0
9013920|NCT03023397|10076714|FG000|STARTED|Run-In||8
9013921|NCT03023397|10076715|FG001|STARTED|Run-In||3
9013922|NCT03023397|10076716|FG002|STARTED|Run-In||1
9013923|NCT03023397|10076714|FG000|COMPLETED|Run-In||6
9013924|NCT03023397|10076715|FG001|COMPLETED|Run-In||3
9013925|NCT03023397|10076716|FG002|COMPLETED|Run-In||1
9013926|NCT03023397|10076714|FG000|NOT COMPLETED|Run-In||2
9013927|NCT03023397|10076715|FG001|NOT COMPLETED|Run-In||0
9013928|NCT03023397|10076716|FG002|NOT COMPLETED|Run-In||0
9013929|NCT03023397|10076714|FG000|STARTED|Main Study||6
9013930|NCT03023397|10076715|FG001|STARTED|Main Study||3
9013931|NCT03023397|10076716|FG002|STARTED|Main Study||1
9013932|NCT03023397|10076714|FG000|COMPLETED|Main Study||6
9013933|NCT03023397|10076715|FG001|COMPLETED|Main Study||3
9013934|NCT03023397|10076716|FG002|COMPLETED|Main Study||1
9013935|NCT03023397|10076714|FG000|NOT COMPLETED|Main Study||0
9013936|NCT03023397|10076715|FG001|NOT COMPLETED|Main Study||0
9013937|NCT03023397|10076716|FG002|NOT COMPLETED|Main Study||0
9013938|NCT03023423|10076728|FG000|STARTED|Overall Study||7
9013939|NCT03023423|10076729|FG001|STARTED|Overall Study||46
9013940|NCT03023423|10076730|FG002|STARTED|Overall Study||46
9013941|NCT03023423|10076728|FG000|Treated|Overall Study||7
9013942|NCT03023423|10076729|FG001|Treated|Overall Study||44
9013943|NCT03023423|10076730|FG002|Treated|Overall Study||44
9013944|NCT03023423|10076728|FG000|Crossover From Atezo to Dara + Atezo|Overall Study||0
9013945|NCT03023423|10076729|FG001|Crossover From Atezo to Dara + Atezo|Overall Study|Participants who met crossover eligibility criteria entered to Dara + Atezo arm.|8
9013946|NCT03023423|10076730|FG002|Crossover From Atezo to Dara + Atezo|Overall Study||0
9013947|NCT03023423|10076728|FG000|COMPLETED|Overall Study||0
9013948|NCT03023423|10076729|FG001|COMPLETED|Overall Study||0
8573387|NCT00121641|9605642|FG001|NOT COMPLETED|48-month Short Term + Long Term Period||82
8573388|NCT00121641|9605643|FG002|NOT COMPLETED|48-month Short Term + Long Term Period||70
8573389|NCT00121641|9605644|FG003|NOT COMPLETED|48-month Short Term + Long Term Period||71
8573390|NCT00121641|9605645|FG004|NOT COMPLETED|48-month Short Term + Long Term Period||58
8573391|NCT00121667|9605663|FG000|STARTED|Short Term (ST) Period||192
8573392|NCT00121667|9605664|FG001|STARTED|Short Term (ST) Period||191
8573393|NCT00121667|9605665|FG002|STARTED|Short Term (ST) Period||181
8573394|NCT00121667|9605666|FG003|STARTED|Short Term (ST) Period||179
8573395|NCT00121667|9605663|FG000|COMPLETED|Short Term (ST) Period||148
8636806|NCT00569192|9677522|FG000|STARTED|Overall Study||111
8636807|NCT00569192|9677523|FG001|STARTED|Overall Study||125
8636808|NCT00569192|9677524|FG002|STARTED|Overall Study||124
8573396|NCT00121667|9605664|FG001|COMPLETED|Short Term (ST) Period||143
8636809|NCT00569192|9677522|FG000|COMPLETED|Overall Study||88
8636810|NCT00569192|9677523|FG001|COMPLETED|Overall Study||105
8907859|NCT02119260|9966263|FG006|NOT COMPLETED|Overall Study||0
8907860|NCT02119286|9966291|FG000|STARTED|Overall Study||206
8907861|NCT02119286|9966292|FG001|STARTED|Overall Study||206
9013949|NCT03023423|10076730|FG002|COMPLETED|Overall Study||0
9013950|NCT03023423|10076728|FG000|NOT COMPLETED|Overall Study||7
8907862|NCT02119286|9966293|FG002|STARTED|Overall Study||207
8907863|NCT02119286|9966291|FG000|COMPLETED|Overall Study||180
8907864|NCT02119286|9966292|FG001|COMPLETED|Overall Study||195
8907865|NCT02119286|9966293|FG002|COMPLETED|Overall Study||200
8907866|NCT02119286|9966291|FG000|NOT COMPLETED|Overall Study||26
8907867|NCT02119286|9966292|FG001|NOT COMPLETED|Overall Study||11
8907868|NCT02119286|9966293|FG002|NOT COMPLETED|Overall Study||7
8907869|NCT02119299|9966301|FG000|STARTED|Overall Study||76
8907870|NCT02119299|9966301|FG000|COMPLETED|Overall Study||67
8907871|NCT02119299|9966301|FG000|NOT COMPLETED|Overall Study||9
8907872|NCT02119325|9966305|FG000|STARTED|Period 1||48
8907873|NCT02119325|9966306|FG001|STARTED|Period 1||48
8907874|NCT02119325|9966305|FG000|COMPLETED|Period 1||48
8907875|NCT02119325|9966306|FG001|COMPLETED|Period 1||48
8907876|NCT02119325|9966305|FG000|NOT COMPLETED|Period 1||0
8907877|NCT02119325|9966306|FG001|NOT COMPLETED|Period 1||0
8907878|NCT02119325|9966305|FG000|STARTED|Washout Period 1||48
8907879|NCT02119325|9966306|FG001|STARTED|Washout Period 1||48
8907880|NCT02119325|9966305|FG000|COMPLETED|Washout Period 1||48
8907881|NCT02119325|9966306|FG001|COMPLETED|Washout Period 1||47
8907882|NCT02119325|9966305|FG000|NOT COMPLETED|Washout Period 1||0
8907883|NCT02119325|9966306|FG001|NOT COMPLETED|Washout Period 1||1
8907884|NCT02119325|9966305|FG000|STARTED|Period 2||48
8907885|NCT02119325|9966306|FG001|STARTED|Period 2||47
8907886|NCT02119325|9966305|FG000|COMPLETED|Period 2||48
8907887|NCT02119325|9966306|FG001|COMPLETED|Period 2||47
8907888|NCT02119325|9966305|FG000|NOT COMPLETED|Period 2||0
8907889|NCT02119325|9966306|FG001|NOT COMPLETED|Period 2||0
8907890|NCT02119442|9966314|FG000|STARTED|Overall Study||90
8907891|NCT02119442|9966314|FG000|COMPLETED|Overall Study||90
8907892|NCT02119442|9966314|FG000|NOT COMPLETED|Overall Study||0
8907893|NCT02119455|9966320|FG000|STARTED|Overall Study||20
8907894|NCT02119455|9966321|FG001|STARTED|Overall Study||20
8907895|NCT02119455|9966320|FG000|COMPLETED|Overall Study||20
8907896|NCT02119455|9966321|FG001|COMPLETED|Overall Study||17
8907897|NCT02119455|9966320|FG000|NOT COMPLETED|Overall Study||0
8907898|NCT02119455|9966321|FG001|NOT COMPLETED|Overall Study||3
8907899|NCT02119650|9966329|FG000|STARTED|Overall Study||39
8907900|NCT02119650|9966330|FG001|STARTED|Overall Study||37
8907901|NCT02119650|9966329|FG000|COMPLETED|Overall Study|Participants with treatment ongoing when the study was terminated.|14
8907902|NCT02119650|9966330|FG001|COMPLETED|Overall Study|Participants with treatment ongoing when the study was terminated.|11
8907903|NCT02119650|9966329|FG000|NOT COMPLETED|Overall Study||25
8907904|NCT02119650|9966330|FG001|NOT COMPLETED|Overall Study||26
8907905|NCT02119663|9966338|FG000|STARTED|Overall Study||43
8907906|NCT02119663|9966339|FG001|STARTED|Overall Study||43
8907907|NCT02119663|9966338|FG000|COMPLETED|Overall Study|Treatment ongoing as of 13APR2016 for remaining participants in the study.|3
8907908|NCT02119663|9966339|FG001|COMPLETED|Overall Study|Treatment ongoing as of 13APR2016 for remaining participants in the study.|2
8907909|NCT02119663|9966338|FG000|NOT COMPLETED|Overall Study||40
8907910|NCT02119663|9966339|FG001|NOT COMPLETED|Overall Study||41
8907911|NCT02119676|9966349|FG000|STARTED|Overall Study||87
8907912|NCT02119676|9966350|FG001|STARTED|Overall Study||88
8907913|NCT02119676|9966351|FG002|STARTED|Overall Study||110
8907914|NCT02119676|9966352|FG003|STARTED|Overall Study||111
8907915|NCT02119676|9966349|FG000|Treated Patients|Overall Study||85
8907916|NCT02119676|9966350|FG001|Treated Patients|Overall Study||86
8907917|NCT02119676|9966351|FG002|Treated Patients|Overall Study||106
8907918|NCT02119676|9966352|FG003|Treated Patients|Overall Study||106
8907919|NCT02119676|9966349|FG000|COMPLETED|Overall Study||4
8907920|NCT02119676|9966350|FG001|COMPLETED|Overall Study||2
8907921|NCT02119676|9966351|FG002|COMPLETED|Overall Study||13
8907922|NCT02119676|9966352|FG003|COMPLETED|Overall Study||10
8907923|NCT02119676|9966349|FG000|NOT COMPLETED|Overall Study||83
8907924|NCT02119676|9966350|FG001|NOT COMPLETED|Overall Study||86
8907925|NCT02119676|9966351|FG002|NOT COMPLETED|Overall Study||97
8907926|NCT02119676|9966352|FG003|NOT COMPLETED|Overall Study||101
8907927|NCT02119819|9966368|FG000|STARTED|Overall Study||66
8907928|NCT02119819|9966369|FG001|STARTED|Overall Study||71
8907929|NCT02119819|9966370|FG002|STARTED|Overall Study||73
8907930|NCT02119819|9966371|FG003|STARTED|Overall Study||70
8907931|NCT02119819|9966372|FG004|STARTED|Overall Study||69
8907932|NCT02119819|9966373|FG005|STARTED|Overall Study||71
8907933|NCT02119819|9966368|FG000|COMPLETED|Overall Study||57
8907934|NCT02119819|9966369|FG001|COMPLETED|Overall Study||66
8907935|NCT02119819|9966370|FG002|COMPLETED|Overall Study||69
8907936|NCT02119819|9966371|FG003|COMPLETED|Overall Study||63
8907937|NCT02119819|9966372|FG004|COMPLETED|Overall Study||62
8907938|NCT02119819|9966373|FG005|COMPLETED|Overall Study||56
8907939|NCT02119819|9966368|FG000|NOT COMPLETED|Overall Study||9
8907940|NCT02119819|9966369|FG001|NOT COMPLETED|Overall Study||5
8907941|NCT02119819|9966370|FG002|NOT COMPLETED|Overall Study||4
8907942|NCT02119819|9966371|FG003|NOT COMPLETED|Overall Study||7
8907943|NCT02119819|9966372|FG004|NOT COMPLETED|Overall Study||7
8907944|NCT02119819|9966373|FG005|NOT COMPLETED|Overall Study||15
8907945|NCT02119871|9966389|FG000|STARTED|Overall Study||10
8907946|NCT02119871|9966390|FG001|STARTED|Overall Study||10
8907947|NCT02119871|9966389|FG000|COMPLETED|Overall Study||10
8907948|NCT02119871|9966390|FG001|COMPLETED|Overall Study||10
8907949|NCT02119871|9966389|FG000|NOT COMPLETED|Overall Study||0
8907950|NCT02119871|9966390|FG001|NOT COMPLETED|Overall Study||0
8907951|NCT02119936|9966396|FG000|STARTED|Overall Study||10
9013951|NCT03023423|10076729|FG001|NOT COMPLETED|Overall Study||46
9013952|NCT03023423|10076730|FG002|NOT COMPLETED|Overall Study||46
9013953|NCT03023488|10076742|FG000|STARTED|Overall Study||46
9013954|NCT03023488|10076742|FG000|COMPLETED|Overall Study||46
9013955|NCT03023488|10076742|FG000|NOT COMPLETED|Overall Study||0
9013956|NCT03023553|10076754|FG000|STARTED|Overall Study||4
9013957|NCT03023553|10076755|FG001|STARTED|Overall Study||9
9013958|NCT03023553|10076754|FG000|COMPLETED|Overall Study||4
9013959|NCT03023553|10076755|FG001|COMPLETED|Overall Study||8
9013960|NCT03023553|10076754|FG000|NOT COMPLETED|Overall Study||0
9013961|NCT03023553|10076755|FG001|NOT COMPLETED|Overall Study||1
9013962|NCT03023683|10076763|FG000|STARTED|Overall Study||0
9013963|NCT03023683|10076764|FG001|STARTED|Overall Study||18
9013964|NCT03023683|10076763|FG000|COMPLETED|Overall Study||0
8573397|NCT00121667|9605665|FG002|COMPLETED|Short Term (ST) Period||140
8573398|NCT00121667|9605666|FG003|COMPLETED|Short Term (ST) Period||112
8573399|NCT00121667|9605663|FG000|NOT COMPLETED|Short Term (ST) Period||44
8573400|NCT00121667|9605664|FG001|NOT COMPLETED|Short Term (ST) Period||48
8573401|NCT00121667|9605665|FG002|NOT COMPLETED|Short Term (ST) Period||41
8726739|NCT01038336|9773997|FG002|COMPLETED|Overall Study||44
9013965|NCT03023683|10076764|FG001|COMPLETED|Overall Study||17
9013966|NCT03023683|10076763|FG000|NOT COMPLETED|Overall Study||0
9013967|NCT03023683|10076764|FG001|NOT COMPLETED|Overall Study||1
9013968|NCT03023709|10076772|FG000|STARTED|Overall Study||3
9013969|NCT03023709|10076773|FG001|STARTED|Overall Study||0
9013970|NCT03023709|10076772|FG000|COMPLETED|Overall Study||3
9013971|NCT03023709|10076773|FG001|COMPLETED|Overall Study||0
9013972|NCT03023709|10076772|FG000|NOT COMPLETED|Overall Study||0
9013973|NCT03023709|10076773|FG001|NOT COMPLETED|Overall Study||0
9013974|NCT03023722|10076781|FG000|STARTED|Overall Study||18
9013975|NCT03023722|10076781|FG000|COMPLETED|Overall Study||14
9013976|NCT03023722|10076781|FG000|NOT COMPLETED|Overall Study||4
9013977|NCT03023826|10076785|FG000|STARTED|Period 1||4
9013978|NCT03023826|10076786|FG001|STARTED|Period 1||4
9013979|NCT03023826|10076787|FG002|STARTED|Period 1||5
9013980|NCT03023826|10076788|FG003|STARTED|Period 1||4
9013981|NCT03023826|10076789|FG004|STARTED|Period 1||4
9013982|NCT03023826|10076790|FG005|STARTED|Period 1||5
9013983|NCT03023826|10076785|FG000|Received at Least One Dose of Study Drug|Period 1||4
9013984|NCT03023826|10076786|FG001|Received at Least One Dose of Study Drug|Period 1||4
9013985|NCT03023826|10076787|FG002|Received at Least One Dose of Study Drug|Period 1||5
9013986|NCT03023826|10076788|FG003|Received at Least One Dose of Study Drug|Period 1||4
9013987|NCT03023826|10076789|FG004|Received at Least One Dose of Study Drug|Period 1||4
9013988|NCT03023826|10076790|FG005|Received at Least One Dose of Study Drug|Period 1||5
9013989|NCT03023826|10076785|FG000|COMPLETED|Period 1||4
9013990|NCT03023826|10076786|FG001|COMPLETED|Period 1||4
9013991|NCT03023826|10076787|FG002|COMPLETED|Period 1||5
9013992|NCT03023826|10076788|FG003|COMPLETED|Period 1||4
9013993|NCT03023826|10076789|FG004|COMPLETED|Period 1||3
9013994|NCT03023826|10076790|FG005|COMPLETED|Period 1||5
9013995|NCT03023826|10076785|FG000|NOT COMPLETED|Period 1||0
9013996|NCT03023826|10076786|FG001|NOT COMPLETED|Period 1||0
9013997|NCT03023826|10076787|FG002|NOT COMPLETED|Period 1||0
9013998|NCT03023826|10076788|FG003|NOT COMPLETED|Period 1||0
9013999|NCT03023826|10076789|FG004|NOT COMPLETED|Period 1||1
9014000|NCT03023826|10076790|FG005|NOT COMPLETED|Period 1||0
9014001|NCT03023826|10076785|FG000|STARTED|Period 2||4
9014002|NCT03023826|10076786|FG001|STARTED|Period 2||4
9014003|NCT03023826|10076787|FG002|STARTED|Period 2||5
9014004|NCT03023826|10076788|FG003|STARTED|Period 2||4
9014005|NCT03023826|10076789|FG004|STARTED|Period 2||3
9014006|NCT03023826|10076790|FG005|STARTED|Period 2||5
9014007|NCT03023826|10076785|FG000|COMPLETED|Period 2||4
9014008|NCT03023826|10076786|FG001|COMPLETED|Period 2||4
9014009|NCT03023826|10076787|FG002|COMPLETED|Period 2||5
9014010|NCT03023826|10076788|FG003|COMPLETED|Period 2||4
9014011|NCT03023826|10076789|FG004|COMPLETED|Period 2||3
9014012|NCT03023826|10076790|FG005|COMPLETED|Period 2||5
8726740|NCT01038336|9773995|FG000|NOT COMPLETED|Overall Study||0
8726741|NCT01038336|9773996|FG001|NOT COMPLETED|Overall Study||0
8726742|NCT01038336|9773997|FG002|NOT COMPLETED|Overall Study||0
8726743|NCT01038427|9774013|FG000|STARTED|Overall Study||317
8726744|NCT01038427|9774014|FG001|STARTED|Overall Study||320
8726745|NCT01038427|9774015|FG002|STARTED|Overall Study||158
8726746|NCT01038427|9774013|FG000|Per-Protocol (PPP) Population|Overall Study||306
8726747|NCT01038427|9774014|FG001|Per-Protocol (PPP) Population|Overall Study||307
8726748|NCT01038427|9774015|FG002|Per-Protocol (PPP) Population|Overall Study||150
8726749|NCT01038427|9774013|FG000|Intent-to-Treat (ITT) Population|Overall Study||314
8726750|NCT01038427|9774014|FG001|Intent-to-Treat (ITT) Population|Overall Study||314
8726751|NCT01038427|9774015|FG002|Intent-to-Treat (ITT) Population|Overall Study||156
8726752|NCT01038427|9774013|FG000|COMPLETED|Overall Study||314
9014013|NCT03023826|10076785|FG000|NOT COMPLETED|Period 2||0
9014014|NCT03023826|10076786|FG001|NOT COMPLETED|Period 2||0
9014015|NCT03023826|10076787|FG002|NOT COMPLETED|Period 2||0
9014016|NCT03023826|10076788|FG003|NOT COMPLETED|Period 2||0
9014017|NCT03023826|10076789|FG004|NOT COMPLETED|Period 2||0
9014018|NCT03023826|10076790|FG005|NOT COMPLETED|Period 2||0
9014019|NCT03023826|10076785|FG000|STARTED|Period 3||4
9014020|NCT03023826|10076786|FG001|STARTED|Period 3||4
9014021|NCT03023826|10076787|FG002|STARTED|Period 3||5
9014022|NCT03023826|10076788|FG003|STARTED|Period 3||4
9014023|NCT03023826|10076789|FG004|STARTED|Period 3||3
9014024|NCT03023826|10076790|FG005|STARTED|Period 3||5
8907952|NCT02119936|9966396|FG000|COMPLETED|Overall Study||0
8907953|NCT02119936|9966396|FG000|NOT COMPLETED|Overall Study||10
8907954|NCT02120001|9966402|FG000|STARTED|Overall Study||17
8907955|NCT02120001|9966403|FG001|STARTED|Overall Study||19
8907956|NCT02120001|9966402|FG000|COMPLETED|Overall Study||17
8907957|NCT02120001|9966403|FG001|COMPLETED|Overall Study||19
8907958|NCT02120001|9966402|FG000|NOT COMPLETED|Overall Study||0
8907959|NCT02120001|9966403|FG001|NOT COMPLETED|Overall Study||0
8907960|NCT02120027|9966411|FG000|STARTED|Overall Study||277
8907961|NCT02120027|9966412|FG001|STARTED|Overall Study||279
8907962|NCT02120027|9966411|FG000|COMPLETED|Overall Study||161
8907963|NCT02120027|9966412|FG001|COMPLETED|Overall Study||160
8907964|NCT02120027|9966411|FG000|NOT COMPLETED|Overall Study||116
8907965|NCT02120027|9966412|FG001|NOT COMPLETED|Overall Study||119
8907966|NCT02120157|9966418|FG000|STARTED|Overall Study||32
8907967|NCT02120157|9966418|FG000|Completed 180 Days|Overall Study||30
8907968|NCT02120157|9966418|FG000|COMPLETED|Overall Study||24
8907969|NCT02120157|9966418|FG000|NOT COMPLETED|Overall Study||8
8907970|NCT02120261|9966426|FG000|STARTED|Overall Study||23
8907971|NCT02120261|9966427|FG001|STARTED|Overall Study||25
8907972|NCT02120261|9966426|FG000|COMPLETED|Overall Study||23
8907973|NCT02120261|9966427|FG001|COMPLETED|Overall Study||25
8907974|NCT02120261|9966426|FG000|NOT COMPLETED|Overall Study||0
8907975|NCT02120261|9966427|FG001|NOT COMPLETED|Overall Study||0
8907976|NCT02120287|9966433|FG000|STARTED|Overall Study||16
8907977|NCT02120287|9966433|FG000|COMPLETED|Overall Study||16
8907978|NCT02120287|9966433|FG000|NOT COMPLETED|Overall Study||0
8907979|NCT02120300|9966441|FG000|STARTED|Overall Study||101
8907980|NCT02120300|9966442|FG001|STARTED|Overall Study||5
8907981|NCT02120300|9966443|FG002|STARTED|Overall Study||10
8907982|NCT02120300|9966444|FG003|STARTED|Overall Study||6
8907983|NCT02120300|9966441|FG000|COMPLETED|Overall Study||98
8907984|NCT02120300|9966442|FG001|COMPLETED|Overall Study||5
8907985|NCT02120300|9966443|FG002|COMPLETED|Overall Study||10
8907986|NCT02120300|9966444|FG003|COMPLETED|Overall Study||5
8907987|NCT02120300|9966441|FG000|NOT COMPLETED|Overall Study||3
8907988|NCT02120300|9966442|FG001|NOT COMPLETED|Overall Study||0
8907989|NCT02120300|9966443|FG002|NOT COMPLETED|Overall Study||0
8907990|NCT02120300|9966444|FG003|NOT COMPLETED|Overall Study||1
8907991|NCT02120417|9966458|FG000|STARTED|Overall Study||76
8907992|NCT02120417|9966459|FG001|STARTED|Overall Study||73
8907993|NCT02120417|9966458|FG000|COMPLETED|Overall Study||16
8907994|NCT02120417|9966459|FG001|COMPLETED|Overall Study||5
8907995|NCT02120417|9966458|FG000|NOT COMPLETED|Overall Study||60
8907996|NCT02120417|9966459|FG001|NOT COMPLETED|Overall Study||68
8907997|NCT02120443|9966465|FG000|STARTED|Overall Study||43
8907998|NCT02120443|9966465|FG000|COMPLETED|Overall Study||43
8907999|NCT02120443|9966465|FG000|NOT COMPLETED|Overall Study||0
8908000|NCT02120456|9966478|FG000|STARTED|Part 1 Open-label, Dose-escalation Phase||12
8908001|NCT02120456|9966479|FG001|STARTED|Part 1 Open-label, Dose-escalation Phase||12
8908002|NCT02120456|9966480|FG002|STARTED|Part 1 Open-label, Dose-escalation Phase||12
8908003|NCT02120456|9966481|FG003|STARTED|Part 1 Open-label, Dose-escalation Phase||12
9014025|NCT03023826|10076785|FG000|COMPLETED|Period 3||4
8573402|NCT00121667|9605666|FG003|NOT COMPLETED|Short Term (ST) Period||67
8573403|NCT00121667|9605663|FG000|STARTED|Short Term (ST) + Long Term (LT) Period||192
8573404|NCT00121667|9605664|FG001|STARTED|Short Term (ST) + Long Term (LT) Period||191
8573405|NCT00121667|9605665|FG002|STARTED|Short Term (ST) + Long Term (LT) Period||181
8573406|NCT00121667|9605666|FG003|STARTED|Short Term (ST) + Long Term (LT) Period||179
8573407|NCT00121667|9605663|FG000|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||14
9014026|NCT03023826|10076786|FG001|COMPLETED|Period 3||4
9014027|NCT03023826|10076787|FG002|COMPLETED|Period 3||5
9014028|NCT03023826|10076788|FG003|COMPLETED|Period 3||4
9014029|NCT03023826|10076789|FG004|COMPLETED|Period 3||3
9014030|NCT03023826|10076790|FG005|COMPLETED|Period 3||5
9014031|NCT03023826|10076785|FG000|NOT COMPLETED|Period 3||0
9014032|NCT03023826|10076786|FG001|NOT COMPLETED|Period 3||0
9014033|NCT03023826|10076787|FG002|NOT COMPLETED|Period 3||0
9014034|NCT03023826|10076788|FG003|NOT COMPLETED|Period 3||0
9014035|NCT03023826|10076789|FG004|NOT COMPLETED|Period 3||0
9014036|NCT03023826|10076790|FG005|NOT COMPLETED|Period 3||0
9014037|NCT03023878|10076798|FG000|STARTED|Pre-Study Run-In Period||47
9014038|NCT03023878|10076798|FG000|COMPLETED|Pre-Study Run-In Period||30
9014039|NCT03023878|10076798|FG000|NOT COMPLETED|Pre-Study Run-In Period||17
9014040|NCT03023878|10076798|FG000|STARTED|Between Run-In and Treatment Periods||30
9014041|NCT03023878|10076798|FG000|COMPLETED|Between Run-In and Treatment Periods||28
9014042|NCT03023878|10076798|FG000|NOT COMPLETED|Between Run-In and Treatment Periods||2
9014043|NCT03023878|10076798|FG000|STARTED|Treatment Period||28
9014044|NCT03023878|10076798|FG000|Started Cycle 1|Treatment Period||28
9014045|NCT03023878|10076798|FG000|Started Cycle 2|Treatment Period||11
8573408|NCT00121667|9605664|FG001|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||18
8573409|NCT00121667|9605665|FG002|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||23
8573410|NCT00121667|9605666|FG003|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||7
8573411|NCT00121667|9605663|FG000|COMPLETED|Short Term (ST) + Long Term (LT) Period||64
8573412|NCT00121667|9605664|FG001|COMPLETED|Short Term (ST) + Long Term (LT) Period||58
8908004|NCT02120456|9966482|FG004|STARTED|Part 1 Open-label, Dose-escalation Phase||12
9014046|NCT03023878|10076798|FG000|COMPLETED|Treatment Period||25
9014047|NCT03023878|10076798|FG000|NOT COMPLETED|Treatment Period||3
8908005|NCT02120456|9966483|FG005|STARTED|Part 1 Open-label, Dose-escalation Phase||9
8908006|NCT02120456|9966484|FG006|STARTED|Part 1 Open-label, Dose-escalation Phase||0
8908007|NCT02120456|9966485|FG007|STARTED|Part 1 Open-label, Dose-escalation Phase||0
8908008|NCT02120456|9966486|FG008|STARTED|Part 1 Open-label, Dose-escalation Phase||0
8908009|NCT02120456|9966478|FG000|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
8908010|NCT02120456|9966479|FG001|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
8908011|NCT02120456|9966480|FG002|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
8908012|NCT02120456|9966481|FG003|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
8908013|NCT02120456|9966482|FG004|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
8908014|NCT02120456|9966483|FG005|COMPLETED|Part 1 Open-label, Dose-escalation Phase||9
8908015|NCT02120456|9966484|FG006|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8908016|NCT02120456|9966485|FG007|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8908017|NCT02120456|9966486|FG008|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8908018|NCT02120456|9966478|FG000|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8908019|NCT02120456|9966479|FG001|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8908020|NCT02120456|9966480|FG002|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8908021|NCT02120456|9966481|FG003|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8908022|NCT02120456|9966482|FG004|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8908023|NCT02120456|9966483|FG005|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8908024|NCT02120456|9966484|FG006|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8908025|NCT02120456|9966485|FG007|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8908026|NCT02120456|9966486|FG008|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8908027|NCT02120456|9966478|FG000|STARTED|Part 2 Double-blind Phase||0
8908028|NCT02120456|9966479|FG001|STARTED|Part 2 Double-blind Phase||0
8908029|NCT02120456|9966480|FG002|STARTED|Part 2 Double-blind Phase||0
8908030|NCT02120456|9966481|FG003|STARTED|Part 2 Double-blind Phase||0
8908031|NCT02120456|9966482|FG004|STARTED|Part 2 Double-blind Phase||0
8908032|NCT02120456|9966483|FG005|STARTED|Part 2 Double-blind Phase||0
8908033|NCT02120456|9966484|FG006|STARTED|Part 2 Double-blind Phase||32
8908034|NCT02120456|9966485|FG007|STARTED|Part 2 Double-blind Phase||60
8908035|NCT02120456|9966486|FG008|STARTED|Part 2 Double-blind Phase||63
8908036|NCT02120456|9966478|FG000|COMPLETED|Part 2 Double-blind Phase||0
8908037|NCT02120456|9966479|FG001|COMPLETED|Part 2 Double-blind Phase||0
8908038|NCT02120456|9966480|FG002|COMPLETED|Part 2 Double-blind Phase||0
8908039|NCT02120456|9966481|FG003|COMPLETED|Part 2 Double-blind Phase||0
8908040|NCT02120456|9966482|FG004|COMPLETED|Part 2 Double-blind Phase||0
8908041|NCT02120456|9966483|FG005|COMPLETED|Part 2 Double-blind Phase||0
8908042|NCT02120456|9966484|FG006|COMPLETED|Part 2 Double-blind Phase||30
8908043|NCT02120456|9966485|FG007|COMPLETED|Part 2 Double-blind Phase||60
8908044|NCT02120456|9966486|FG008|COMPLETED|Part 2 Double-blind Phase||62
8908045|NCT02120456|9966478|FG000|NOT COMPLETED|Part 2 Double-blind Phase||0
8908046|NCT02120456|9966479|FG001|NOT COMPLETED|Part 2 Double-blind Phase||0
8908047|NCT02120456|9966480|FG002|NOT COMPLETED|Part 2 Double-blind Phase||0
8908048|NCT02120456|9966481|FG003|NOT COMPLETED|Part 2 Double-blind Phase||0
8908049|NCT02120456|9966482|FG004|NOT COMPLETED|Part 2 Double-blind Phase||0
8908050|NCT02120456|9966483|FG005|NOT COMPLETED|Part 2 Double-blind Phase||0
8908051|NCT02120456|9966484|FG006|NOT COMPLETED|Part 2 Double-blind Phase||2
8908052|NCT02120456|9966485|FG007|NOT COMPLETED|Part 2 Double-blind Phase||0
8908053|NCT02120456|9966486|FG008|NOT COMPLETED|Part 2 Double-blind Phase||1
8908054|NCT02120625|9966506|FG000|STARTED|Overall Study||8
8908055|NCT02120625|9966506|FG000|COMPLETED|Overall Study||6
8908056|NCT02120625|9966506|FG000|NOT COMPLETED|Overall Study||2
8636811|NCT00569192|9677524|FG002|COMPLETED|Overall Study||99
8636812|NCT00569192|9677522|FG000|NOT COMPLETED|Overall Study||23
8636813|NCT00569192|9677523|FG001|NOT COMPLETED|Overall Study||20
8636814|NCT00569192|9677524|FG002|NOT COMPLETED|Overall Study||25
8636815|NCT00569231|9677532|FG000|STARTED|Overall Study||18
8908057|NCT02120664|9966515|FG000|STARTED|Overall Study||10
8908058|NCT02120664|9966516|FG001|STARTED|Overall Study||4
8908059|NCT02120664|9966517|FG002|STARTED|Overall Study||7
8908060|NCT02120664|9966518|FG003|STARTED|Overall Study||4
8908061|NCT02120664|9966519|FG004|STARTED|Overall Study||10
8908062|NCT02120664|9966515|FG000|COMPLETED|Overall Study||10
8908063|NCT02120664|9966516|FG001|COMPLETED|Overall Study||4
8908064|NCT02120664|9966517|FG002|COMPLETED|Overall Study||7
8908065|NCT02120664|9966518|FG003|COMPLETED|Overall Study||3
8908066|NCT02120664|9966519|FG004|COMPLETED|Overall Study||10
8908067|NCT02120664|9966515|FG000|NOT COMPLETED|Overall Study||0
8908068|NCT02120664|9966516|FG001|NOT COMPLETED|Overall Study||0
8908069|NCT02120664|9966517|FG002|NOT COMPLETED|Overall Study||0
9014048|NCT03023878|10076798|FG000|STARTED|Long Term Follow-Up Period||28
8908070|NCT02120664|9966518|FG003|NOT COMPLETED|Overall Study||1
8908071|NCT02120664|9966519|FG004|NOT COMPLETED|Overall Study||0
8908072|NCT02120716|9966534|FG000|STARTED|Overall Study||31
8908073|NCT02120716|9966535|FG001|STARTED|Overall Study||19
8908074|NCT02120716|9966534|FG000|COMPLETED|Overall Study||30
8636816|NCT00569231|9677532|FG000|COMPLETED|Overall Study||11
8908075|NCT02120716|9966535|FG001|COMPLETED|Overall Study||19
8908076|NCT02120716|9966534|FG000|NOT COMPLETED|Overall Study||1
8908077|NCT02120716|9966535|FG001|NOT COMPLETED|Overall Study||0
8908078|NCT02120781|9966543|FG000|STARTED|Overall Study||15
8908079|NCT02120781|9966544|FG001|STARTED|Overall Study||6
8908080|NCT02120781|9966543|FG000|COMPLETED|Overall Study||11
9014049|NCT03023878|10076798|FG000|COMPLETED|Long Term Follow-Up Period||26
9014050|NCT03023878|10076798|FG000|NOT COMPLETED|Long Term Follow-Up Period||2
9014051|NCT03023891|10076802|FG000|STARTED|Overall Study||18
9014052|NCT03023891|10076802|FG000|COMPLETED|Overall Study||18
9014053|NCT03023891|10076802|FG000|NOT COMPLETED|Overall Study||0
9014054|NCT03024112|10076808|FG000|STARTED|Overall Study||25
9014055|NCT03024112|10076809|FG001|STARTED|Overall Study||26
9014056|NCT03024112|10076808|FG000|COMPLETED|Overall Study||18
9014057|NCT03024112|10076809|FG001|COMPLETED|Overall Study||26
9014058|NCT03024112|10076808|FG000|NOT COMPLETED|Overall Study||7
9014059|NCT03024112|10076809|FG001|NOT COMPLETED|Overall Study||0
9014060|NCT03024606|10076817|FG000|STARTED|Overall Study||23
9014061|NCT03024606|10076818|FG001|STARTED|Overall Study||26
9014062|NCT03024606|10076817|FG000|COMPLETED|Overall Study||14
9014063|NCT03024606|10076818|FG001|COMPLETED|Overall Study||16
9014064|NCT03024606|10076817|FG000|NOT COMPLETED|Overall Study||9
9014065|NCT03024606|10076818|FG001|NOT COMPLETED|Overall Study||10
9014066|NCT03024970|10076824|FG000|STARTED|First Intervention||34
9014067|NCT03024970|10076825|FG001|STARTED|First Intervention||38
9014068|NCT03024970|10076824|FG000|COMPLETED|First Intervention||33
9014069|NCT03024970|10076825|FG001|COMPLETED|First Intervention||38
9014070|NCT03024970|10076824|FG000|NOT COMPLETED|First Intervention||1
9014071|NCT03024970|10076825|FG001|NOT COMPLETED|First Intervention||0
9014072|NCT03024970|10076824|FG000|STARTED|Second Intervention||33
9014073|NCT03024970|10076825|FG001|STARTED|Second Intervention||38
9014074|NCT03024970|10076824|FG000|COMPLETED|Second Intervention||32
9014075|NCT03024970|10076825|FG001|COMPLETED|Second Intervention||38
9014076|NCT03024970|10076824|FG000|NOT COMPLETED|Second Intervention||1
9014077|NCT03024970|10076825|FG001|NOT COMPLETED|Second Intervention||0
9014078|NCT03025217|10076831|FG000|STARTED|Overall Study||31
9014079|NCT03025217|10076831|FG000|COMPLETED|Overall Study||27
8573413|NCT00121667|9605665|FG002|COMPLETED|Short Term (ST) + Long Term (LT) Period||68
8573414|NCT00121667|9605666|FG003|COMPLETED|Short Term (ST) + Long Term (LT) Period||39
8573415|NCT00121667|9605663|FG000|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||128
8573416|NCT00121667|9605664|FG001|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||133
8573417|NCT00121667|9605665|FG002|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||113
8573418|NCT00121667|9605666|FG003|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||140
8573419|NCT00121719|9605688|FG000|STARTED|Dose Escalation (4 Weeks)||4
8573420|NCT00121719|9605689|FG001|STARTED|Dose Escalation (4 Weeks)||4
8573421|NCT00121719|9605690|FG002|STARTED|Dose Escalation (4 Weeks)||4
8573422|NCT00121719|9605691|FG003|STARTED|Dose Escalation (4 Weeks)||3
8573423|NCT00121719|9605692|FG004|STARTED|Dose Escalation (4 Weeks)||3
8573424|NCT00121719|9605693|FG005|STARTED|Dose Escalation (4 Weeks)||3
8573425|NCT00121719|9605694|FG006|STARTED|Dose Escalation (4 Weeks)||12
8573426|NCT00121719|9605695|FG007|STARTED|Dose Escalation (4 Weeks)||9
8573427|NCT00121719|9605696|FG008|STARTED|Dose Escalation (4 Weeks)||6
8573428|NCT00121719|9605697|FG009|STARTED|Dose Escalation (4 Weeks)||3
8573429|NCT00121719|9605698|FG010|STARTED|Dose Escalation (4 Weeks)||0
8573430|NCT00121719|9605699|FG011|STARTED|Dose Escalation (4 Weeks)||0
8573431|NCT00121719|9605700|FG012|STARTED|Dose Escalation (4 Weeks)||24
8573432|NCT00121719|9605701|FG013|STARTED|Dose Escalation (4 Weeks)||7
8573433|NCT00121719|9605688|FG000|COMPLETED|Dose Escalation (4 Weeks)||4
8573434|NCT00121719|9605689|FG001|COMPLETED|Dose Escalation (4 Weeks)||4
8573435|NCT00121719|9605690|FG002|COMPLETED|Dose Escalation (4 Weeks)||4
8573436|NCT00121719|9605691|FG003|COMPLETED|Dose Escalation (4 Weeks)||3
8573437|NCT00121719|9605692|FG004|COMPLETED|Dose Escalation (4 Weeks)||3
8573438|NCT00121719|9605693|FG005|COMPLETED|Dose Escalation (4 Weeks)||3
8573439|NCT00121719|9605694|FG006|COMPLETED|Dose Escalation (4 Weeks)||12
8573440|NCT00121719|9605695|FG007|COMPLETED|Dose Escalation (4 Weeks)||9
8573441|NCT00121719|9605696|FG008|COMPLETED|Dose Escalation (4 Weeks)||6
8573442|NCT00121719|9605697|FG009|COMPLETED|Dose Escalation (4 Weeks)||3
8573443|NCT00121719|9605698|FG010|COMPLETED|Dose Escalation (4 Weeks)||0
8573444|NCT00121719|9605699|FG011|COMPLETED|Dose Escalation (4 Weeks)||0
8573445|NCT00121719|9605700|FG012|COMPLETED|Dose Escalation (4 Weeks)||24
8573446|NCT00121719|9605701|FG013|COMPLETED|Dose Escalation (4 Weeks)||7
8573447|NCT00121719|9605688|FG000|NOT COMPLETED|Dose Escalation (4 Weeks)||0
8573448|NCT00121719|9605689|FG001|NOT COMPLETED|Dose Escalation (4 Weeks)||0
8573449|NCT00121719|9605690|FG002|NOT COMPLETED|Dose Escalation (4 Weeks)||0
8726753|NCT01038427|9774014|FG001|COMPLETED|Overall Study||314
8726754|NCT01038427|9774015|FG002|COMPLETED|Overall Study||154
8726755|NCT01038427|9774013|FG000|NOT COMPLETED|Overall Study||3
8726756|NCT01038427|9774014|FG001|NOT COMPLETED|Overall Study||6
8726757|NCT01038427|9774015|FG002|NOT COMPLETED|Overall Study||4
8726758|NCT01038557|9774026|FG000|STARTED|Overall Study||82
8726759|NCT01038557|9774027|FG001|STARTED|Overall Study||86
8726760|NCT01038557|9774028|FG002|STARTED|Overall Study||86
8726761|NCT01038557|9774026|FG000|COMPLETED|Overall Study||82
8726762|NCT01038557|9774027|FG001|COMPLETED|Overall Study||86
8726763|NCT01038557|9774028|FG002|COMPLETED|Overall Study||86
8726764|NCT01038557|9774026|FG000|NOT COMPLETED|Overall Study||0
8726765|NCT01038557|9774027|FG001|NOT COMPLETED|Overall Study||0
8726766|NCT01038557|9774028|FG002|NOT COMPLETED|Overall Study||0
9014080|NCT03025217|10076831|FG000|NOT COMPLETED|Overall Study||4
9039666|NCT03341299|10100655|FG003|COMPLETED|Period 2||9
9039667|NCT03341299|10100652|FG000|NOT COMPLETED|Period 2||0
9039668|NCT03341299|10100653|FG001|NOT COMPLETED|Period 2||0
9039669|NCT03341299|10100654|FG002|NOT COMPLETED|Period 2||0
8908081|NCT02120781|9966544|FG001|COMPLETED|Overall Study||5
8908082|NCT02120781|9966543|FG000|NOT COMPLETED|Overall Study||4
8908083|NCT02120781|9966544|FG001|NOT COMPLETED|Overall Study||1
8908084|NCT02120794|9966550|FG000|STARTED|Overall Study||194
8908085|NCT02120794|9966550|FG000|COMPLETED|Overall Study||136
8908086|NCT02120794|9966550|FG000|NOT COMPLETED|Overall Study||58
8908087|NCT02120833|9966556|FG000|STARTED|Overall Study||39
8908088|NCT02120833|9966557|FG001|STARTED|Overall Study||12
8908089|NCT02120833|9966556|FG000|COMPLETED|Overall Study||35
8908090|NCT02120833|9966557|FG001|COMPLETED|Overall Study||11
8908091|NCT02120833|9966556|FG000|NOT COMPLETED|Overall Study||4
8908092|NCT02120833|9966557|FG001|NOT COMPLETED|Overall Study||1
8908093|NCT02120898|9966566|FG000|STARTED|Overall Study||187
8908094|NCT02120898|9966567|FG001|STARTED|Overall Study||187
8908095|NCT02120898|9966568|FG002|STARTED|Overall Study||93
8908096|NCT02120898|9966566|FG000|Safety Population|Overall Study||187
8908097|NCT02120898|9966567|FG001|Safety Population|Overall Study||187
8908098|NCT02120898|9966568|FG002|Safety Population|Overall Study||93
8908099|NCT02120898|9966566|FG000|Intent-to-Treat (ITT) Population|Overall Study||183
8908100|NCT02120898|9966567|FG001|Intent-to-Treat (ITT) Population|Overall Study||185
8908101|NCT02120898|9966568|FG002|Intent-to-Treat (ITT) Population|Overall Study||93
8908102|NCT02120898|9966566|FG000|COMPLETED|Overall Study||178
8908103|NCT02120898|9966567|FG001|COMPLETED|Overall Study||181
8908104|NCT02120898|9966568|FG002|COMPLETED|Overall Study||89
8908105|NCT02120898|9966566|FG000|NOT COMPLETED|Overall Study||9
8908106|NCT02120898|9966567|FG001|NOT COMPLETED|Overall Study||6
8908107|NCT02120898|9966568|FG002|NOT COMPLETED|Overall Study||4
8908108|NCT02120924|9966579|FG000|STARTED|Overall Study||404
8908109|NCT02120924|9966580|FG001|STARTED|Overall Study||403
8908110|NCT02120924|9966581|FG002|STARTED|Overall Study||202
8908111|NCT02120924|9966579|FG000|COMPLETED|Overall Study||362
8908112|NCT02120924|9966580|FG001|COMPLETED|Overall Study||357
8908113|NCT02120924|9966581|FG002|COMPLETED|Overall Study||173
8908114|NCT02120924|9966579|FG000|NOT COMPLETED|Overall Study||42
8908115|NCT02120924|9966580|FG001|NOT COMPLETED|Overall Study||46
8908116|NCT02120924|9966581|FG002|NOT COMPLETED|Overall Study||29
8908117|NCT02120950|9966592|FG000|STARTED|Overall Study||157
8908118|NCT02120950|9966593|FG001|STARTED|Overall Study||161
8908119|NCT02120950|9966594|FG002|STARTED|Overall Study||15
8908120|NCT02120950|9966592|FG000|COMPLETED|Overall Study|Completed Treatment (Week 96)|137
8908121|NCT02120950|9966593|FG001|COMPLETED|Overall Study|Completed Treatment (Week 96)|147
8908122|NCT02120950|9966594|FG002|COMPLETED|Overall Study||0
8908123|NCT02120950|9966592|FG000|NOT COMPLETED|Overall Study||20
8908124|NCT02120950|9966593|FG001|NOT COMPLETED|Overall Study||14
8908125|NCT02120950|9966594|FG002|NOT COMPLETED|Overall Study||15
8908126|NCT02121002|9966604|FG000|STARTED|Overall Study||392
8908127|NCT02121002|9966605|FG001|STARTED|Overall Study||393
8908128|NCT02121002|9966606|FG002|STARTED|Overall Study||391
8908129|NCT02121002|9966604|FG000|COMPLETED|Overall Study||385
8908130|NCT02121002|9966605|FG001|COMPLETED|Overall Study||389
8908131|NCT02121002|9966606|FG002|COMPLETED|Overall Study||381
8908132|NCT02121002|9966604|FG000|NOT COMPLETED|Overall Study||7
8908133|NCT02121002|9966605|FG001|NOT COMPLETED|Overall Study||4
8908134|NCT02121002|9966606|FG002|NOT COMPLETED|Overall Study||10
8908135|NCT02121041|9966616|FG000|STARTED|Overall Study||14
8908136|NCT02121041|9966617|FG001|STARTED|Overall Study||14
8908137|NCT02121041|9966616|FG000|COMPLETED|Overall Study||13
8908138|NCT02121041|9966617|FG001|COMPLETED|Overall Study||8
8908139|NCT02121041|9966616|FG000|NOT COMPLETED|Overall Study||1
8908140|NCT02121041|9966617|FG001|NOT COMPLETED|Overall Study||6
8908141|NCT02121067|9966623|FG000|STARTED|Overall Study||50
8908142|NCT02121067|9966623|FG000|COMPLETED|Overall Study||50
8908143|NCT02121067|9966623|FG000|NOT COMPLETED|Overall Study||0
8908144|NCT02121210|9966630|FG000|STARTED|Overall Study||65
9014081|NCT03025945|10076837|FG000|STARTED|Overall Study||331
9014082|NCT03025945|10076838|FG001|STARTED|Overall Study||331
9014083|NCT03025945|10076837|FG000|COMPLETED|Overall Study||331
9014084|NCT03025945|10076838|FG001|COMPLETED|Overall Study||331
9014085|NCT03025945|10076837|FG000|NOT COMPLETED|Overall Study||0
9014086|NCT03025945|10076838|FG001|NOT COMPLETED|Overall Study||0
9014087|NCT03026075|10076844|FG000|STARTED|Overall Study||47
9014088|NCT03026075|10076844|FG000|COMPLETED|Overall Study||46
9014089|NCT03026075|10076844|FG000|NOT COMPLETED|Overall Study||1
9014090|NCT03026088|10076848|FG000|STARTED|Overall Study||20
9014091|NCT03026088|10076848|FG000|COMPLETED|Overall Study||0
9014092|NCT03026088|10076848|FG000|NOT COMPLETED|Overall Study||20
9014093|NCT03026166|10076854|FG000|STARTED|Overall Study||30
9014094|NCT03026166|10076855|FG001|STARTED|Overall Study||12
9014095|NCT03026166|10076854|FG000|COMPLETED|Overall Study||0
9014096|NCT03026166|10076855|FG001|COMPLETED|Overall Study||0
9014097|NCT03026166|10076854|FG000|NOT COMPLETED|Overall Study||30
9014098|NCT03026166|10076855|FG001|NOT COMPLETED|Overall Study||12
9014099|NCT03026257|10076867|FG000|STARTED|Overall Study||60
9014100|NCT03026257|10076868|FG001|STARTED|Overall Study||64
8908145|NCT02121210|9966631|FG001|STARTED|Overall Study||67
8908146|NCT02121210|9966630|FG000|COMPLETED|Overall Study||58
9014101|NCT03026257|10076869|FG002|STARTED|Overall Study||34
9014102|NCT03026257|10076870|FG003|STARTED|Overall Study||25
9014103|NCT03026257|10076871|FG004|STARTED|Overall Study||23
9014104|NCT03026257|10076872|FG005|STARTED|Overall Study||46
9014105|NCT03026257|10076867|FG000|Treated|Overall Study||58
9014106|NCT03026257|10076868|FG001|Treated|Overall Study||65
9014107|NCT03026257|10076869|FG002|Treated|Overall Study||35
9014108|NCT03026257|10076870|FG003|Treated|Overall Study||24
9014109|NCT03026257|10076871|FG004|Treated|Overall Study||23
9014110|NCT03026257|10076872|FG005|Treated|Overall Study||47
9014111|NCT03026257|10076867|FG000|COMPLETED|Overall Study||54
8636817|NCT00569231|9677532|FG000|NOT COMPLETED|Overall Study||7
8636818|NCT00569270|9677536|FG000|STARTED|Period: First Intervention|randomized cross over study|15
8636819|NCT00569270|9677537|FG001|STARTED|Period: First Intervention||15
8636820|NCT00569270|9677536|FG000|COMPLETED|Period: First Intervention||15
8636821|NCT00569270|9677537|FG001|COMPLETED|Period: First Intervention||14
9014112|NCT03026257|10076868|FG001|COMPLETED|Overall Study||63
9014113|NCT03026257|10076869|FG002|COMPLETED|Overall Study||34
9014114|NCT03026257|10076870|FG003|COMPLETED|Overall Study||24
9014115|NCT03026257|10076871|FG004|COMPLETED|Overall Study||22
9014116|NCT03026257|10076872|FG005|COMPLETED|Overall Study||46
9014117|NCT03026257|10076867|FG000|NOT COMPLETED|Overall Study||6
9014118|NCT03026257|10076868|FG001|NOT COMPLETED|Overall Study||1
9014119|NCT03026257|10076869|FG002|NOT COMPLETED|Overall Study||0
9014120|NCT03026257|10076870|FG003|NOT COMPLETED|Overall Study||1
9014121|NCT03026257|10076871|FG004|NOT COMPLETED|Overall Study||1
9014122|NCT03026257|10076872|FG005|NOT COMPLETED|Overall Study||0
9014123|NCT03026283|10076886|FG000|STARTED|CCTA Diagnosis||586
9014124|NCT03026283|10076887|FG001|STARTED|CCTA Diagnosis||0
9014125|NCT03026283|10076888|FG002|STARTED|CCTA Diagnosis||0
8573450|NCT00121719|9605691|FG003|NOT COMPLETED|Dose Escalation (4 Weeks)||0
8573451|NCT00121719|9605692|FG004|NOT COMPLETED|Dose Escalation (4 Weeks)||0
8573452|NCT00121719|9605693|FG005|NOT COMPLETED|Dose Escalation (4 Weeks)||0
8573453|NCT00121719|9605694|FG006|NOT COMPLETED|Dose Escalation (4 Weeks)||0
8573454|NCT00121719|9605695|FG007|NOT COMPLETED|Dose Escalation (4 Weeks)||0
8573455|NCT00121719|9605696|FG008|NOT COMPLETED|Dose Escalation (4 Weeks)||0
8573456|NCT00121719|9605697|FG009|NOT COMPLETED|Dose Escalation (4 Weeks)||0
8573457|NCT00121719|9605698|FG010|NOT COMPLETED|Dose Escalation (4 Weeks)||0
8573458|NCT00121719|9605699|FG011|NOT COMPLETED|Dose Escalation (4 Weeks)||0
8573459|NCT00121719|9605700|FG012|NOT COMPLETED|Dose Escalation (4 Weeks)||0
8573460|NCT00121719|9605701|FG013|NOT COMPLETED|Dose Escalation (4 Weeks)||0
8573461|NCT00121719|9605688|FG000|STARTED|Food-Effect Pilot Study (4 Weeks)||0
8573462|NCT00121719|9605689|FG001|STARTED|Food-Effect Pilot Study (4 Weeks)||0
8636822|NCT00569270|9677536|FG000|NOT COMPLETED|Period: First Intervention||0
8636823|NCT00569270|9677537|FG001|NOT COMPLETED|Period: First Intervention||1
8636824|NCT00569270|9677536|FG000|STARTED|Period: Second Intervention||15
8636825|NCT00569270|9677537|FG001|STARTED|Period: Second Intervention||14
8636826|NCT00569270|9677536|FG000|29 Days|Period: Second Intervention||15
8636827|NCT00569270|9677537|FG001|29 Days|Period: Second Intervention||14
8726767|NCT01038609|9774041|FG000|STARTED|Overall Study||50
8726768|NCT01038609|9774042|FG001|STARTED|Overall Study||52
8726769|NCT01038609|9774043|FG002|STARTED|Overall Study||49
8726770|NCT01038609|9774044|FG003|STARTED|Overall Study||48
8726771|NCT01038609|9774045|FG004|STARTED|Overall Study||51
8726772|NCT01038609|9774041|FG000|COMPLETED|Overall Study||49
8726773|NCT01038609|9774042|FG001|COMPLETED|Overall Study||51
8726774|NCT01038609|9774043|FG002|COMPLETED|Overall Study||48
8726775|NCT01038609|9774044|FG003|COMPLETED|Overall Study||47
8726776|NCT01038609|9774045|FG004|COMPLETED|Overall Study||50
8726777|NCT01038609|9774041|FG000|NOT COMPLETED|Overall Study||1
8573463|NCT00121719|9605690|FG002|STARTED|Food-Effect Pilot Study (4 Weeks)||0
8573464|NCT00121719|9605691|FG003|STARTED|Food-Effect Pilot Study (4 Weeks)||0
8636828|NCT00569270|9677536|FG000|COMPLETED|Period: Second Intervention||15
8726778|NCT01038609|9774042|FG001|NOT COMPLETED|Overall Study||1
8726779|NCT01038609|9774043|FG002|NOT COMPLETED|Overall Study||1
8726780|NCT01038609|9774044|FG003|NOT COMPLETED|Overall Study||1
9014126|NCT03026283|10076889|FG003|STARTED|CCTA Diagnosis||0
9014127|NCT03026283|10076890|FG004|STARTED|CCTA Diagnosis||0
9014128|NCT03026283|10076891|FG005|STARTED|CCTA Diagnosis||0
9014129|NCT03026283|10076892|FG006|STARTED|CCTA Diagnosis||0
9014130|NCT03026283|10076893|FG007|STARTED|CCTA Diagnosis||0
8908147|NCT02121210|9966631|FG001|COMPLETED|Overall Study||58
8908148|NCT02121210|9966630|FG000|NOT COMPLETED|Overall Study||7
8908149|NCT02121210|9966631|FG001|NOT COMPLETED|Overall Study||9
8908150|NCT02121262|9966639|FG000|STARTED|Overall Study||139
8908151|NCT02121262|9966640|FG001|STARTED|Overall Study||145
8908152|NCT02121262|9966639|FG000|Treated|Overall Study||129
8908153|NCT02121262|9966640|FG001|Treated|Overall Study||145
8908154|NCT02121262|9966639|FG000|Modified Intent-to-treat Population|Overall Study||127
8908155|NCT02121262|9966640|FG001|Modified Intent-to-treat Population|Overall Study||145
8908156|NCT02121262|9966639|FG000|COMPLETED|Overall Study||108
8908157|NCT02121262|9966640|FG001|COMPLETED|Overall Study||135
8908158|NCT02121262|9966639|FG000|NOT COMPLETED|Overall Study||31
8908159|NCT02121262|9966640|FG001|NOT COMPLETED|Overall Study||10
8908160|NCT02121301|9966649|FG000|STARTED|Overall Study||30
8908161|NCT02121301|9966650|FG001|STARTED|Overall Study||30
8908162|NCT02121301|9966651|FG002|STARTED|Overall Study||31
8908163|NCT02121301|9966649|FG000|COMPLETED|Overall Study||29
8908164|NCT02121301|9966650|FG001|COMPLETED|Overall Study||26
8908165|NCT02121301|9966651|FG002|COMPLETED|Overall Study||30
8908166|NCT02121301|9966649|FG000|NOT COMPLETED|Overall Study||1
8908167|NCT02121301|9966650|FG001|NOT COMPLETED|Overall Study||4
8908168|NCT02121301|9966651|FG002|NOT COMPLETED|Overall Study||1
8908169|NCT02121392|9966661|FG000|STARTED|Prior to Intervention||83
8908170|NCT02121392|9966662|FG001|STARTED|Prior to Intervention||82
8908171|NCT02121392|9966661|FG000|COMPLETED|Prior to Intervention||35
8908172|NCT02121392|9966662|FG001|COMPLETED|Prior to Intervention||41
8908173|NCT02121392|9966661|FG000|NOT COMPLETED|Prior to Intervention||48
8908174|NCT02121392|9966662|FG001|NOT COMPLETED|Prior to Intervention||41
8908175|NCT02121392|9966661|FG000|STARTED|After Placement of AC Block vs Sham||35
8908176|NCT02121392|9966662|FG001|STARTED|After Placement of AC Block vs Sham||41
8908177|NCT02121392|9966661|FG000|COMPLETED|After Placement of AC Block vs Sham||32
8908178|NCT02121392|9966662|FG001|COMPLETED|After Placement of AC Block vs Sham||38
8908179|NCT02121392|9966661|FG000|NOT COMPLETED|After Placement of AC Block vs Sham||3
8908180|NCT02121392|9966662|FG001|NOT COMPLETED|After Placement of AC Block vs Sham||3
8908181|NCT02121418|9966668|FG000|STARTED|Overall Study||12
8908182|NCT02121418|9966668|FG000|COMPLETED|Overall Study||12
8908183|NCT02121418|9966668|FG000|NOT COMPLETED|Overall Study||0
8908184|NCT02121483|9966675|FG000|STARTED|Overall Study||9
8908185|NCT02121483|9966676|FG001|STARTED|Overall Study||8
8908186|NCT02121483|9966677|FG002|STARTED|Overall Study||10
8908187|NCT02121483|9966675|FG000|COMPLETED|Overall Study||9
8908188|NCT02121483|9966676|FG001|COMPLETED|Overall Study||8
8908189|NCT02121483|9966677|FG002|COMPLETED|Overall Study||10
8908190|NCT02121483|9966675|FG000|NOT COMPLETED|Overall Study||0
8908191|NCT02121483|9966676|FG001|NOT COMPLETED|Overall Study||0
8908192|NCT02121483|9966677|FG002|NOT COMPLETED|Overall Study||0
8908193|NCT02121509|9966687|FG000|STARTED|Treatment Period-1 (4 Days)||30
8908194|NCT02121509|9966688|FG001|STARTED|Treatment Period-1 (4 Days)||28
8908195|NCT02121509|9966689|FG002|STARTED|Treatment Period-1 (4 Days)||8
8908196|NCT02121509|9966690|FG003|STARTED|Treatment Period-1 (4 Days)||8
8908197|NCT02121509|9966687|FG000|COMPLETED|Treatment Period-1 (4 Days)||30
8908198|NCT02121509|9966688|FG001|COMPLETED|Treatment Period-1 (4 Days)||28
8908199|NCT02121509|9966689|FG002|COMPLETED|Treatment Period-1 (4 Days)||8
8908200|NCT02121509|9966690|FG003|COMPLETED|Treatment Period-1 (4 Days)||8
8908201|NCT02121509|9966687|FG000|NOT COMPLETED|Treatment Period-1 (4 Days)||0
8908202|NCT02121509|9966688|FG001|NOT COMPLETED|Treatment Period-1 (4 Days)||0
8908203|NCT02121509|9966689|FG002|NOT COMPLETED|Treatment Period-1 (4 Days)||0
8908204|NCT02121509|9966690|FG003|NOT COMPLETED|Treatment Period-1 (4 Days)||0
8908205|NCT02121509|9966687|FG000|STARTED|Washout Period (35 Days)||30
8908206|NCT02121509|9966688|FG001|STARTED|Washout Period (35 Days)||28
8908207|NCT02121509|9966689|FG002|STARTED|Washout Period (35 Days)||8
8908208|NCT02121509|9966690|FG003|STARTED|Washout Period (35 Days)||8
8908209|NCT02121509|9966687|FG000|COMPLETED|Washout Period (35 Days)||28
8908210|NCT02121509|9966688|FG001|COMPLETED|Washout Period (35 Days)||24
8908211|NCT02121509|9966689|FG002|COMPLETED|Washout Period (35 Days)||8
8908212|NCT02121509|9966690|FG003|COMPLETED|Washout Period (35 Days)||8
8908213|NCT02121509|9966687|FG000|NOT COMPLETED|Washout Period (35 Days)||2
8908214|NCT02121509|9966688|FG001|NOT COMPLETED|Washout Period (35 Days)||4
8908215|NCT02121509|9966689|FG002|NOT COMPLETED|Washout Period (35 Days)||0
8908216|NCT02121509|9966690|FG003|NOT COMPLETED|Washout Period (35 Days)||0
8908217|NCT02121509|9966687|FG000|STARTED|Treatment Period-2 (4 Days)||28
8908218|NCT02121509|9966688|FG001|STARTED|Treatment Period-2 (4 Days)||24
8908219|NCT02121509|9966689|FG002|STARTED|Treatment Period-2 (4 Days)||8
8908220|NCT02121509|9966690|FG003|STARTED|Treatment Period-2 (4 Days)||8
8908221|NCT02121509|9966687|FG000|COMPLETED|Treatment Period-2 (4 Days)||28
8908222|NCT02121509|9966688|FG001|COMPLETED|Treatment Period-2 (4 Days)||24
8908223|NCT02121509|9966689|FG002|COMPLETED|Treatment Period-2 (4 Days)||8
8908224|NCT02121509|9966690|FG003|COMPLETED|Treatment Period-2 (4 Days)||8
8908225|NCT02121509|9966687|FG000|NOT COMPLETED|Treatment Period-2 (4 Days)||0
8908226|NCT02121509|9966688|FG001|NOT COMPLETED|Treatment Period-2 (4 Days)||0
8908227|NCT02121509|9966689|FG002|NOT COMPLETED|Treatment Period-2 (4 Days)||0
8908228|NCT02121509|9966690|FG003|NOT COMPLETED|Treatment Period-2 (4 Days)||0
8908229|NCT02121522|9966700|FG000|STARTED|Overall Study||14
8908230|NCT02121522|9966700|FG000|COMPLETED|Overall Study||13
8908231|NCT02121522|9966700|FG000|NOT COMPLETED|Overall Study||1
8908232|NCT02121535|9966706|FG000|STARTED|Period 1 (8 Trial Days)||36
9014131|NCT03026283|10076886|FG000|COMPLETED|CCTA Diagnosis||572
9014132|NCT03026283|10076887|FG001|COMPLETED|CCTA Diagnosis||0
9014133|NCT03026283|10076888|FG002|COMPLETED|CCTA Diagnosis||0
9014134|NCT03026283|10076889|FG003|COMPLETED|CCTA Diagnosis||0
9014135|NCT03026283|10076890|FG004|COMPLETED|CCTA Diagnosis||0
9014136|NCT03026283|10076891|FG005|COMPLETED|CCTA Diagnosis||0
9014137|NCT03026283|10076892|FG006|COMPLETED|CCTA Diagnosis||0
9014138|NCT03026283|10076893|FG007|COMPLETED|CCTA Diagnosis||0
9014139|NCT03026283|10076886|FG000|NOT COMPLETED|CCTA Diagnosis||14
9014140|NCT03026283|10076887|FG001|NOT COMPLETED|CCTA Diagnosis||0
9014141|NCT03026283|10076888|FG002|NOT COMPLETED|CCTA Diagnosis||0
9014142|NCT03026283|10076889|FG003|NOT COMPLETED|CCTA Diagnosis||0
9014143|NCT03026283|10076890|FG004|NOT COMPLETED|CCTA Diagnosis||0
9014144|NCT03026283|10076891|FG005|NOT COMPLETED|CCTA Diagnosis||0
9014145|NCT03026283|10076892|FG006|NOT COMPLETED|CCTA Diagnosis||0
9014146|NCT03026283|10076893|FG007|NOT COMPLETED|CCTA Diagnosis||0
9014147|NCT03026283|10076886|FG000|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0
9014148|NCT03026283|10076887|FG001|STARTED|Optimal Medical Care/FFR-CT Diagnosis||289
9014149|NCT03026283|10076888|FG002|STARTED|Optimal Medical Care/FFR-CT Diagnosis||280
9014150|NCT03026283|10076889|FG003|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0
9014151|NCT03026283|10076890|FG004|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0
9014152|NCT03026283|10076891|FG005|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0
9014153|NCT03026283|10076892|FG006|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0
8573465|NCT00121719|9605692|FG004|STARTED|Food-Effect Pilot Study (4 Weeks)||0
8573466|NCT00121719|9605693|FG005|STARTED|Food-Effect Pilot Study (4 Weeks)||0
8573467|NCT00121719|9605694|FG006|STARTED|Food-Effect Pilot Study (4 Weeks)||0
8573468|NCT00121719|9605695|FG007|STARTED|Food-Effect Pilot Study (4 Weeks)||0
8573469|NCT00121719|9605696|FG008|STARTED|Food-Effect Pilot Study (4 Weeks)||0
8573470|NCT00121719|9605697|FG009|STARTED|Food-Effect Pilot Study (4 Weeks)||0
8573471|NCT00121719|9605698|FG010|STARTED|Food-Effect Pilot Study (4 Weeks)||6
8573472|NCT00121719|9605699|FG011|STARTED|Food-Effect Pilot Study (4 Weeks)||5
8573473|NCT00121719|9605700|FG012|STARTED|Food-Effect Pilot Study (4 Weeks)||0
8573474|NCT00121719|9605701|FG013|STARTED|Food-Effect Pilot Study (4 Weeks)||0
8573475|NCT00121719|9605688|FG000|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8573476|NCT00121719|9605689|FG001|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8573477|NCT00121719|9605690|FG002|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8573478|NCT00121719|9605691|FG003|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8573479|NCT00121719|9605692|FG004|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8573480|NCT00121719|9605693|FG005|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8573481|NCT00121719|9605694|FG006|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8573482|NCT00121719|9605695|FG007|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8573483|NCT00121719|9605696|FG008|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8573484|NCT00121719|9605697|FG009|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8573485|NCT00121719|9605698|FG010|COMPLETED|Food-Effect Pilot Study (4 Weeks)||6
8573486|NCT00121719|9605699|FG011|COMPLETED|Food-Effect Pilot Study (4 Weeks)||5
8573487|NCT00121719|9605700|FG012|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8573488|NCT00121719|9605701|FG013|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8573489|NCT00121719|9605688|FG000|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8573490|NCT00121719|9605689|FG001|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8573491|NCT00121719|9605690|FG002|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8573492|NCT00121719|9605691|FG003|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8573493|NCT00121719|9605692|FG004|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8573494|NCT00121719|9605693|FG005|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8573495|NCT00121719|9605694|FG006|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8573496|NCT00121719|9605695|FG007|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8573497|NCT00121719|9605696|FG008|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8573498|NCT00121719|9605697|FG009|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8573499|NCT00121719|9605698|FG010|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8573500|NCT00121719|9605699|FG011|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8573501|NCT00121719|9605700|FG012|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8573502|NCT00121719|9605701|FG013|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8573503|NCT00121810|9605745|FG000|STARTED|Overall Study||151
8573504|NCT00121810|9605746|FG001|STARTED|Overall Study||154
8573505|NCT00121810|9605745|FG000|Safety Population|Overall Study||148
8573506|NCT00121810|9605746|FG001|Safety Population|Overall Study||153
8573507|NCT00121810|9605745|FG000|Intent-to-Treat (ITT) Population|Overall Study||148
8573508|NCT00121810|9605746|FG001|Intent-to-Treat (ITT) Population|Overall Study||151
8573509|NCT00121810|9605745|FG000|COMPLETED|Overall Study||121
8573510|NCT00121810|9605746|FG001|COMPLETED|Overall Study||115
8726781|NCT01038609|9774045|FG004|NOT COMPLETED|Overall Study||1
8726782|NCT01038635|9774066|FG000|STARTED|Overall Study||5
8726783|NCT01038635|9774067|FG001|STARTED|Overall Study||3
8726784|NCT01038635|9774068|FG002|STARTED|Overall Study||3
8726785|NCT01038635|9774069|FG003|STARTED|Overall Study||3
8726786|NCT01038635|9774070|FG004|STARTED|Overall Study||4
8726787|NCT01038635|9774071|FG005|STARTED|Overall Study||3
8726788|NCT01038635|9774072|FG006|STARTED|Overall Study||7
8726789|NCT01038635|9774073|FG007|STARTED|Overall Study||20
8726790|NCT01038635|9774074|FG008|STARTED|Overall Study||40
9014154|NCT03026283|10076893|FG007|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0
9014155|NCT03026283|10076886|FG000|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
9014156|NCT03026283|10076887|FG001|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||286
8908233|NCT02121535|9966707|FG001|STARTED|Period 1 (8 Trial Days)||36
8908234|NCT02121535|9966706|FG000|COMPLETED|Period 1 (8 Trial Days)||36
8908235|NCT02121535|9966707|FG001|COMPLETED|Period 1 (8 Trial Days)|1 subject withdrew his consent during the washout period between Period 1 and 2.|35
8908236|NCT02121535|9966706|FG000|NOT COMPLETED|Period 1 (8 Trial Days)||0
8908237|NCT02121535|9966707|FG001|NOT COMPLETED|Period 1 (8 Trial Days)||1
8908238|NCT02121535|9966706|FG000|STARTED|Period 2 (8 Trial Days)||36
8908239|NCT02121535|9966707|FG001|STARTED|Period 2 (8 Trial Days)||35
8908240|NCT02121535|9966706|FG000|COMPLETED|Period 2 (8 Trial Days)||36
8908241|NCT02121535|9966707|FG001|COMPLETED|Period 2 (8 Trial Days)||35
8908242|NCT02121535|9966706|FG000|NOT COMPLETED|Period 2 (8 Trial Days)||0
8908243|NCT02121535|9966707|FG001|NOT COMPLETED|Period 2 (8 Trial Days)||0
8908244|NCT02121535|9966706|FG000|STARTED|Period 3 (8 Trial Days)||36
8908245|NCT02121535|9966707|FG001|STARTED|Period 3 (8 Trial Days)||35
8908246|NCT02121535|9966706|FG000|COMPLETED|Period 3 (8 Trial Days)|1 subject withdrew consent during the washout period between Period 3 and 4.|35
8908247|NCT02121535|9966707|FG001|COMPLETED|Period 3 (8 Trial Days)||35
8908248|NCT02121535|9966706|FG000|NOT COMPLETED|Period 3 (8 Trial Days)||1
8908249|NCT02121535|9966707|FG001|NOT COMPLETED|Period 3 (8 Trial Days)||0
8908250|NCT02121535|9966706|FG000|STARTED|Period 4 (8 Trial Days)||35
8908251|NCT02121535|9966707|FG001|STARTED|Period 4 (8 Trial Days)||35
8908252|NCT02121535|9966706|FG000|COMPLETED|Period 4 (8 Trial Days)||35
8908253|NCT02121535|9966707|FG001|COMPLETED|Period 4 (8 Trial Days)||35
8908254|NCT02121535|9966706|FG000|NOT COMPLETED|Period 4 (8 Trial Days)||0
8908255|NCT02121535|9966707|FG001|NOT COMPLETED|Period 4 (8 Trial Days)||0
8908256|NCT02121756|9966716|FG000|STARTED|Overall Study||21
8908257|NCT02121756|9966717|FG001|STARTED|Overall Study||19
8908258|NCT02121756|9966716|FG000|COMPLETED|Overall Study||15
8908259|NCT02121756|9966717|FG001|COMPLETED|Overall Study||17
8908260|NCT02121756|9966716|FG000|NOT COMPLETED|Overall Study||6
8908261|NCT02121756|9966717|FG001|NOT COMPLETED|Overall Study||2
8908262|NCT02121795|9966728|FG000|STARTED|Double-Blind Phase||334
8908263|NCT02121795|9966729|FG001|STARTED|Double-Blind Phase||334
8908264|NCT02121795|9966728|FG000|Safety Analysis Set|Double-Blind Phase||333
8908265|NCT02121795|9966729|FG001|Safety Analysis Set|Double-Blind Phase||330
8908266|NCT02121795|9966728|FG000|COMPLETED|Double-Blind Phase||296
8908267|NCT02121795|9966729|FG001|COMPLETED|Double-Blind Phase||300
8908268|NCT02121795|9966728|FG000|NOT COMPLETED|Double-Blind Phase||38
8908269|NCT02121795|9966729|FG001|NOT COMPLETED|Double-Blind Phase||34
8908270|NCT02121795|9966728|FG000|STARTED|Open-Label Phase|Not all participants entered the Open-Label Phase.|33
8908271|NCT02121795|9966729|FG001|STARTED|Open-Label Phase|Not all participants entered the Open-Label Phase.|31
8908272|NCT02121795|9966728|FG000|COMPLETED|Open-Label Phase||21
8908273|NCT02121795|9966729|FG001|COMPLETED|Open-Label Phase||21
8908274|NCT02121795|9966728|FG000|NOT COMPLETED|Open-Label Phase||12
8908275|NCT02121795|9966729|FG001|NOT COMPLETED|Open-Label Phase||10
8908276|NCT02121808|9966737|FG000|STARTED|Overall Study||20
8908277|NCT02121808|9966737|FG000|COMPLETED|Overall Study||17
8908278|NCT02121808|9966737|FG000|NOT COMPLETED|Overall Study||3
8908279|NCT02121834|9966753|FG000|STARTED|Overall Study||12
8908280|NCT02121834|9966754|FG001|STARTED|Overall Study||11
8908281|NCT02121834|9966755|FG002|STARTED|Overall Study||9
8908282|NCT02121834|9966756|FG003|STARTED|Overall Study||10
8908283|NCT02121834|9966757|FG004|STARTED|Overall Study||9
8908284|NCT02121834|9966758|FG005|STARTED|Overall Study||9
8908285|NCT02121834|9966759|FG006|STARTED|Overall Study||3
8908286|NCT02121834|9966753|FG000|Received at Least One Dose of Study Drug|Overall Study||12
8908287|NCT02121834|9966754|FG001|Received at Least One Dose of Study Drug|Overall Study||11
9014157|NCT03026283|10076888|FG002|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||265
9014158|NCT03026283|10076889|FG003|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
9014159|NCT03026283|10076890|FG004|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
9014160|NCT03026283|10076891|FG005|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
9014161|NCT03026283|10076892|FG006|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
9014162|NCT03026283|10076893|FG007|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
9014163|NCT03026283|10076886|FG000|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
9014164|NCT03026283|10076887|FG001|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||3
9014165|NCT03026283|10076888|FG002|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||15
9014166|NCT03026283|10076889|FG003|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
9014167|NCT03026283|10076890|FG004|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
9014168|NCT03026283|10076891|FG005|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
9014169|NCT03026283|10076892|FG006|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
9014170|NCT03026283|10076893|FG007|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
9014171|NCT03026283|10076886|FG000|STARTED|Optimal Care/Stress Test/ICA||0
9014172|NCT03026283|10076887|FG001|STARTED|Optimal Care/Stress Test/ICA||0
9014173|NCT03026283|10076888|FG002|STARTED|Optimal Care/Stress Test/ICA||0
9014174|NCT03026283|10076889|FG003|STARTED|Optimal Care/Stress Test/ICA||128
9014175|NCT03026283|10076890|FG004|STARTED|Optimal Care/Stress Test/ICA||52
9014176|NCT03026283|10076891|FG005|STARTED|Optimal Care/Stress Test/ICA||101
9014177|NCT03026283|10076892|FG006|STARTED|Optimal Care/Stress Test/ICA||0
9014178|NCT03026283|10076893|FG007|STARTED|Optimal Care/Stress Test/ICA||0
9014179|NCT03026283|10076886|FG000|COMPLETED|Optimal Care/Stress Test/ICA||0
9014180|NCT03026283|10076887|FG001|COMPLETED|Optimal Care/Stress Test/ICA||0
9014181|NCT03026283|10076888|FG002|COMPLETED|Optimal Care/Stress Test/ICA||0
8908288|NCT02121834|9966755|FG002|Received at Least One Dose of Study Drug|Overall Study||9
8908289|NCT02121834|9966756|FG003|Received at Least One Dose of Study Drug|Overall Study||10
8908290|NCT02121834|9966757|FG004|Received at Least One Dose of Study Drug|Overall Study||9
8908291|NCT02121834|9966758|FG005|Received at Least One Dose of Study Drug|Overall Study||9
8908292|NCT02121834|9966759|FG006|Received at Least One Dose of Study Drug|Overall Study||3
8908293|NCT02121834|9966753|FG000|COMPLETED|Overall Study||12
8908294|NCT02121834|9966754|FG001|COMPLETED|Overall Study||9
8908295|NCT02121834|9966755|FG002|COMPLETED|Overall Study||7
8908296|NCT02121834|9966756|FG003|COMPLETED|Overall Study||10
8908297|NCT02121834|9966757|FG004|COMPLETED|Overall Study||9
8908298|NCT02121834|9966758|FG005|COMPLETED|Overall Study||9
8908299|NCT02121834|9966759|FG006|COMPLETED|Overall Study||3
8908300|NCT02121834|9966753|FG000|NOT COMPLETED|Overall Study||0
8908301|NCT02121834|9966754|FG001|NOT COMPLETED|Overall Study||2
8908302|NCT02121834|9966755|FG002|NOT COMPLETED|Overall Study||2
8908303|NCT02121834|9966756|FG003|NOT COMPLETED|Overall Study||0
8908304|NCT02121834|9966757|FG004|NOT COMPLETED|Overall Study||0
8908305|NCT02121834|9966758|FG005|NOT COMPLETED|Overall Study||0
8908306|NCT02121834|9966759|FG006|NOT COMPLETED|Overall Study||0
8908307|NCT02121847|9966785|FG000|STARTED|Overall Study||40
8908308|NCT02121847|9966785|FG000|COMPLETED|Overall Study||37
8908309|NCT02121847|9966785|FG000|NOT COMPLETED|Overall Study||3
8908310|NCT02121860|9966793|FG000|STARTED|Overall Study||8
8908311|NCT02121860|9966794|FG001|STARTED|Overall Study||12
8908312|NCT02121860|9966795|FG002|STARTED|Overall Study||8
8908313|NCT02121860|9966796|FG003|STARTED|Overall Study||8
8908314|NCT02121860|9966793|FG000|COMPLETED|Overall Study||8
8908315|NCT02121860|9966794|FG001|COMPLETED|Overall Study||12
8908316|NCT02121860|9966795|FG002|COMPLETED|Overall Study||8
8908317|NCT02121860|9966796|FG003|COMPLETED|Overall Study||8
8908318|NCT02121860|9966793|FG000|NOT COMPLETED|Overall Study||0
8908319|NCT02121860|9966794|FG001|NOT COMPLETED|Overall Study||0
8908320|NCT02121860|9966795|FG002|NOT COMPLETED|Overall Study||0
8908321|NCT02121860|9966796|FG003|NOT COMPLETED|Overall Study||0
8908322|NCT02121912|9966805|FG000|STARTED|Overall Study||25
8908323|NCT02121912|9966806|FG001|STARTED|Overall Study||25
8908324|NCT02121912|9966805|FG000|COMPLETED|Overall Study||21
8908325|NCT02121912|9966806|FG001|COMPLETED|Overall Study||25
8908326|NCT02121912|9966805|FG000|NOT COMPLETED|Overall Study||4
8908327|NCT02121912|9966806|FG001|NOT COMPLETED|Overall Study||0
8908328|NCT02122146|9966820|FG000|STARTED|Part 1: Dose Escalation||2
8908329|NCT02122146|9966821|FG001|STARTED|Part 1: Dose Escalation||2
8908330|NCT02122146|9966822|FG002|STARTED|Part 1: Dose Escalation||4
8908331|NCT02122146|9966823|FG003|STARTED|Part 1: Dose Escalation||4
8908332|NCT02122146|9966824|FG004|STARTED|Part 1: Dose Escalation||4
8908333|NCT02122146|9966825|FG005|STARTED|Part 1: Dose Escalation||6
8908334|NCT02122146|9966826|FG006|STARTED|Part 1: Dose Escalation||1
8908335|NCT02122146|9966827|FG007|STARTED|Part 1: Dose Escalation||8
8908336|NCT02122146|9966820|FG000|COMPLETED|Part 1: Dose Escalation||1
8908337|NCT02122146|9966821|FG001|COMPLETED|Part 1: Dose Escalation||1
8908338|NCT02122146|9966822|FG002|COMPLETED|Part 1: Dose Escalation||2
8908339|NCT02122146|9966823|FG003|COMPLETED|Part 1: Dose Escalation||3
9014182|NCT03026283|10076889|FG003|COMPLETED|Optimal Care/Stress Test/ICA||108
9014183|NCT03026283|10076890|FG004|COMPLETED|Optimal Care/Stress Test/ICA||14
9014184|NCT03026283|10076891|FG005|COMPLETED|Optimal Care/Stress Test/ICA||73
9014185|NCT03026283|10076892|FG006|COMPLETED|Optimal Care/Stress Test/ICA||0
9014186|NCT03026283|10076893|FG007|COMPLETED|Optimal Care/Stress Test/ICA||0
9014187|NCT03026283|10076886|FG000|NOT COMPLETED|Optimal Care/Stress Test/ICA||0
9014188|NCT03026283|10076887|FG001|NOT COMPLETED|Optimal Care/Stress Test/ICA||0
9014189|NCT03026283|10076888|FG002|NOT COMPLETED|Optimal Care/Stress Test/ICA||0
9014190|NCT03026283|10076889|FG003|NOT COMPLETED|Optimal Care/Stress Test/ICA||20
8573511|NCT00121810|9605745|FG000|NOT COMPLETED|Overall Study||30
8573512|NCT00121810|9605746|FG001|NOT COMPLETED|Overall Study||39
8573513|NCT00121836|9605752|FG000|STARTED|Overall Study||109
8573514|NCT00121836|9605752|FG000|COMPLETED|Overall Study||54
8573515|NCT00121836|9605752|FG000|NOT COMPLETED|Overall Study||55
8573516|NCT00121992|9605759|FG000|STARTED|Overall Study||521
8573517|NCT00121992|9605760|FG001|STARTED|Overall Study||539
8573518|NCT00121992|9605759|FG000|Hormone-receptor Positive and HER2 Positive Status Subjects|Overall Study||28
8573519|NCT00121992|9605760|FG001|Hormone-receptor Positive and HER2 Positive Status Subjects|Overall Study||30
8573520|NCT00121992|9605759|FG000|Hormone-receptor Negative and HER2 Positive Status Subjects|Overall Study||24
8573521|NCT00121992|9605760|FG001|Hormone-receptor Negative and HER2 Positive Status Subjects|Overall Study||22
8573522|NCT00121992|9605759|FG000|Hormone-receptor Positive and HER2 Negative Status Subjects|Overall Study||209
8908340|NCT02122146|9966824|FG004|COMPLETED|Part 1: Dose Escalation||3
8908341|NCT02122146|9966825|FG005|COMPLETED|Part 1: Dose Escalation||5
8908342|NCT02122146|9966826|FG006|COMPLETED|Part 1: Dose Escalation||0
8908343|NCT02122146|9966827|FG007|COMPLETED|Part 1: Dose Escalation||6
8908344|NCT02122146|9966820|FG000|NOT COMPLETED|Part 1: Dose Escalation||1
8908345|NCT02122146|9966821|FG001|NOT COMPLETED|Part 1: Dose Escalation||1
8908346|NCT02122146|9966822|FG002|NOT COMPLETED|Part 1: Dose Escalation||2
8908347|NCT02122146|9966823|FG003|NOT COMPLETED|Part 1: Dose Escalation||1
8908348|NCT02122146|9966824|FG004|NOT COMPLETED|Part 1: Dose Escalation||1
8908349|NCT02122146|9966825|FG005|NOT COMPLETED|Part 1: Dose Escalation||1
8908350|NCT02122146|9966826|FG006|NOT COMPLETED|Part 1: Dose Escalation||1
8908351|NCT02122146|9966827|FG007|NOT COMPLETED|Part 1: Dose Escalation||2
8908352|NCT02122146|9966820|FG000|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
8908353|NCT02122146|9966821|FG001|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
8908354|NCT02122146|9966822|FG002|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
8908355|NCT02122146|9966823|FG003|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
8908356|NCT02122146|9966824|FG004|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
8908357|NCT02122146|9966825|FG005|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
8908358|NCT02122146|9966826|FG006|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
8908359|NCT02122146|9966827|FG007|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
8908360|NCT02122146|9966820|FG000|COMPLETED|Part 2: Maximum Tolerated Dose||0
8908361|NCT02122146|9966821|FG001|COMPLETED|Part 2: Maximum Tolerated Dose||0
8908362|NCT02122146|9966822|FG002|COMPLETED|Part 2: Maximum Tolerated Dose||0
8908363|NCT02122146|9966823|FG003|COMPLETED|Part 2: Maximum Tolerated Dose||0
8908364|NCT02122146|9966824|FG004|COMPLETED|Part 2: Maximum Tolerated Dose||0
8908365|NCT02122146|9966825|FG005|COMPLETED|Part 2: Maximum Tolerated Dose||0
8908366|NCT02122146|9966826|FG006|COMPLETED|Part 2: Maximum Tolerated Dose||0
8908367|NCT02122146|9966827|FG007|COMPLETED|Part 2: Maximum Tolerated Dose||0
8908368|NCT02122146|9966820|FG000|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
8908369|NCT02122146|9966821|FG001|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
8908370|NCT02122146|9966822|FG002|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
8908371|NCT02122146|9966823|FG003|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
8908372|NCT02122146|9966824|FG004|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
8908373|NCT02122146|9966825|FG005|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
8908374|NCT02122146|9966826|FG006|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
8908375|NCT02122146|9966827|FG007|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
8908376|NCT02122146|9966820|FG000|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
8908377|NCT02122146|9966821|FG001|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
8908378|NCT02122146|9966822|FG002|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
8908379|NCT02122146|9966823|FG003|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
8908380|NCT02122146|9966824|FG004|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
8908381|NCT02122146|9966825|FG005|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
8908382|NCT02122146|9966826|FG006|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
8908383|NCT02122146|9966827|FG007|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
8908384|NCT02122146|9966820|FG000|COMPLETED|Part 3: Expansion||0
8908385|NCT02122146|9966821|FG001|COMPLETED|Part 3: Expansion||0
8908386|NCT02122146|9966822|FG002|COMPLETED|Part 3: Expansion||0
8908387|NCT02122146|9966823|FG003|COMPLETED|Part 3: Expansion||0
8908388|NCT02122146|9966824|FG004|COMPLETED|Part 3: Expansion||0
8908389|NCT02122146|9966825|FG005|COMPLETED|Part 3: Expansion||0
8908390|NCT02122146|9966826|FG006|COMPLETED|Part 3: Expansion||0
8908391|NCT02122146|9966827|FG007|COMPLETED|Part 3: Expansion||0
8908392|NCT02122146|9966820|FG000|NOT COMPLETED|Part 3: Expansion||0
8908393|NCT02122146|9966821|FG001|NOT COMPLETED|Part 3: Expansion||0
8908394|NCT02122146|9966822|FG002|NOT COMPLETED|Part 3: Expansion||0
8908395|NCT02122146|9966823|FG003|NOT COMPLETED|Part 3: Expansion||0
8908396|NCT02122146|9966824|FG004|NOT COMPLETED|Part 3: Expansion||0
8908397|NCT02122146|9966825|FG005|NOT COMPLETED|Part 3: Expansion||0
8908398|NCT02122146|9966826|FG006|NOT COMPLETED|Part 3: Expansion||0
8908399|NCT02122146|9966827|FG007|NOT COMPLETED|Part 3: Expansion||0
8908400|NCT02122341|9966848|FG000|STARTED|Overall Study||17
8908401|NCT02122341|9966849|FG001|STARTED|Overall Study||18
8908402|NCT02122341|9966848|FG000|COMPLETED|Overall Study||17
8908403|NCT02122341|9966849|FG001|COMPLETED|Overall Study||18
8908404|NCT02122341|9966848|FG000|NOT COMPLETED|Overall Study||0
8908405|NCT02122341|9966849|FG001|NOT COMPLETED|Overall Study||0
8908406|NCT02122380|9966857|FG000|STARTED|First Intervention (30 Days)||11
8908407|NCT02122380|9966858|FG001|STARTED|First Intervention (30 Days)||12
8908408|NCT02122380|9966857|FG000|COMPLETED|First Intervention (30 Days)||10
8908409|NCT02122380|9966858|FG001|COMPLETED|First Intervention (30 Days)||11
8908410|NCT02122380|9966857|FG000|NOT COMPLETED|First Intervention (30 Days)||1
8908411|NCT02122380|9966858|FG001|NOT COMPLETED|First Intervention (30 Days)||1
8908412|NCT02122380|9966857|FG000|STARTED|Washout (8 Weeks)||10
8908413|NCT02122380|9966858|FG001|STARTED|Washout (8 Weeks)||11
8908414|NCT02122380|9966857|FG000|COMPLETED|Washout (8 Weeks)||9
8908415|NCT02122380|9966858|FG001|COMPLETED|Washout (8 Weeks)||9
8908416|NCT02122380|9966857|FG000|NOT COMPLETED|Washout (8 Weeks)||1
8908417|NCT02122380|9966858|FG001|NOT COMPLETED|Washout (8 Weeks)||2
8908418|NCT02122380|9966857|FG000|STARTED|Second Intervention (30 Days)||9
8908419|NCT02122380|9966858|FG001|STARTED|Second Intervention (30 Days)||9
8908420|NCT02122380|9966857|FG000|COMPLETED|Second Intervention (30 Days)||9
8908421|NCT02122380|9966858|FG001|COMPLETED|Second Intervention (30 Days)||7
8908422|NCT02122380|9966857|FG000|NOT COMPLETED|Second Intervention (30 Days)||0
8908423|NCT02122380|9966858|FG001|NOT COMPLETED|Second Intervention (30 Days)||2
8908424|NCT02122406|9966865|FG000|STARTED|Overall Study||200
8908425|NCT02122406|9966865|FG000|COMPLETED|Overall Study||200
8908426|NCT02122406|9966865|FG000|NOT COMPLETED|Overall Study||0
8908427|NCT02122445|9966869|FG000|STARTED|Overall Study||20
8908428|NCT02122445|9966869|FG000|COMPLETED|Overall Study||20
8908429|NCT02122445|9966869|FG000|NOT COMPLETED|Overall Study||0
9014191|NCT03026283|10076890|FG004|NOT COMPLETED|Optimal Care/Stress Test/ICA||38
9014192|NCT03026283|10076891|FG005|NOT COMPLETED|Optimal Care/Stress Test/ICA||28
9014193|NCT03026283|10076892|FG006|NOT COMPLETED|Optimal Care/Stress Test/ICA||0
9014194|NCT03026283|10076893|FG007|NOT COMPLETED|Optimal Care/Stress Test/ICA||0
9014195|NCT03026283|10076886|FG000|STARTED|Optimal Care/ICA Diagnostic Cath||0
9014196|NCT03026283|10076887|FG001|STARTED|Optimal Care/ICA Diagnostic Cath||0
9014197|NCT03026283|10076888|FG002|STARTED|Optimal Care/ICA Diagnostic Cath||0
9014198|NCT03026283|10076889|FG003|STARTED|Optimal Care/ICA Diagnostic Cath||0
9014199|NCT03026283|10076890|FG004|STARTED|Optimal Care/ICA Diagnostic Cath||0
9014200|NCT03026283|10076891|FG005|STARTED|Optimal Care/ICA Diagnostic Cath||0
9014201|NCT03026283|10076892|FG006|STARTED|Optimal Care/ICA Diagnostic Cath||21
9014202|NCT03026283|10076893|FG007|STARTED|Optimal Care/ICA Diagnostic Cath||0
9014203|NCT03026283|10076886|FG000|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
9014204|NCT03026283|10076887|FG001|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
9014205|NCT03026283|10076888|FG002|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
9014206|NCT03026283|10076889|FG003|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
9014207|NCT03026283|10076890|FG004|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
9014208|NCT03026283|10076891|FG005|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
9014209|NCT03026283|10076892|FG006|COMPLETED|Optimal Care/ICA Diagnostic Cath||21
9014210|NCT03026283|10076893|FG007|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
9014211|NCT03026283|10076886|FG000|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
9014212|NCT03026283|10076887|FG001|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
9014213|NCT03026283|10076888|FG002|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
9014214|NCT03026283|10076889|FG003|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
9014215|NCT03026283|10076890|FG004|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
9014216|NCT03026283|10076891|FG005|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
9014217|NCT03026283|10076892|FG006|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
9014218|NCT03026283|10076893|FG007|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
9014219|NCT03026530|10076908|FG000|STARTED|Overall Study||100
9014220|NCT03026530|10076909|FG001|STARTED|Overall Study||100
9014221|NCT03026530|10076908|FG000|COMPLETED|Overall Study||79
9014222|NCT03026530|10076909|FG001|COMPLETED|Overall Study||71
9014223|NCT03026530|10076908|FG000|NOT COMPLETED|Overall Study||21
9014224|NCT03026530|10076909|FG001|NOT COMPLETED|Overall Study||29
9014225|NCT03026556|10076918|FG000|STARTED|Overall Study||12763
9014226|NCT03026556|10076919|FG001|STARTED|Overall Study||17177
9014227|NCT03026556|10076920|FG002|STARTED|Overall Study||12594
9014228|NCT03026556|10076918|FG000|COMPLETED|Overall Study||12763
9014229|NCT03026556|10076919|FG001|COMPLETED|Overall Study||17177
9014230|NCT03026556|10076920|FG002|COMPLETED|Overall Study||12594
9014231|NCT03026556|10076918|FG000|NOT COMPLETED|Overall Study||0
9014232|NCT03026556|10076919|FG001|NOT COMPLETED|Overall Study||0
9014233|NCT03026556|10076920|FG002|NOT COMPLETED|Overall Study||0
9014234|NCT03026777|10076931|FG000|STARTED|Overall Study||168
9014235|NCT03026777|10076932|FG001|STARTED|Overall Study||169
9014236|NCT03026777|10076931|FG000|COMPLETED|Overall Study||168
9014237|NCT03026777|10076932|FG001|COMPLETED|Overall Study||169
9014238|NCT03026777|10076931|FG000|NOT COMPLETED|Overall Study||0
9014239|NCT03026777|10076932|FG001|NOT COMPLETED|Overall Study||0
9014240|NCT03026803|10076938|FG000|STARTED|Overall Study||4
9014241|NCT03026803|10076938|FG000|COMPLETED|Overall Study||4
9014242|NCT03026803|10076938|FG000|NOT COMPLETED|Overall Study||0
9014243|NCT03027466|10076946|FG000|STARTED|Overall Study||2027
9014244|NCT03027466|10076947|FG001|STARTED|Overall Study||1984
9014245|NCT03027466|10076948|FG002|STARTED|Overall Study||1903
9014246|NCT03027466|10076949|FG003|STARTED|Overall Study||1985
9014247|NCT03027466|10076946|FG000|COMPLETED|Overall Study||158
9014248|NCT03027466|10076947|FG001|COMPLETED|Overall Study||165
9014249|NCT03027466|10076948|FG002|COMPLETED|Overall Study||160
9014250|NCT03027466|10076949|FG003|COMPLETED|Overall Study||164
9014251|NCT03027466|10076946|FG000|NOT COMPLETED|Overall Study||1869
9014252|NCT03027466|10076947|FG001|NOT COMPLETED|Overall Study||1819
9014253|NCT03027466|10076948|FG002|NOT COMPLETED|Overall Study||1743
9014254|NCT03027466|10076949|FG003|NOT COMPLETED|Overall Study||1821
8573523|NCT00121992|9605760|FG001|Hormone-receptor Positive and HER2 Negative Status Subjects|Overall Study||220
8573524|NCT00121992|9605759|FG000|Hormone-receptor Negative and HER2 Negative Status Subjects|Overall Study||92
8573525|NCT00121992|9605760|FG001|Hormone-receptor Negative and HER2 Negative Status Subjects|Overall Study||103
8573526|NCT00121992|9605759|FG000|COMPLETED|Overall Study||519
8573527|NCT00121992|9605760|FG001|COMPLETED|Overall Study||528
8573528|NCT00121992|9605759|FG000|NOT COMPLETED|Overall Study||2
8573529|NCT00121992|9605760|FG001|NOT COMPLETED|Overall Study||11
8573530|NCT00122109|9605768|FG000|STARTED|Overall Study|ITT|61
8573531|NCT00122109|9605769|FG001|STARTED|Overall Study|ITT|64
8573532|NCT00122109|9605768|FG000|COMPLETED|Overall Study||55
8573533|NCT00122109|9605769|FG001|COMPLETED|Overall Study||57
8573534|NCT00122109|9605768|FG000|NOT COMPLETED|Overall Study||6
8573535|NCT00122109|9605769|FG001|NOT COMPLETED|Overall Study||7
8573536|NCT00122135|9605780|FG000|STARTED|Overall Study||60
8573537|NCT00122135|9605781|FG001|STARTED|Overall Study||60
9014255|NCT03027557|10076962|FG000|STARTED|Overall Study||15
9014256|NCT03027557|10076963|FG001|STARTED|Overall Study||16
9014257|NCT03027557|10076964|FG002|STARTED|Overall Study||15
8573538|NCT00122135|9605780|FG000|COMPLETED|Overall Study||57
8908430|NCT02122471|9966876|FG000|STARTED|Overall Study||445
8908431|NCT02122471|9966877|FG001|STARTED|Overall Study||443
8908432|NCT02122471|9966878|FG002|STARTED|Overall Study||449
8908433|NCT02122471|9966876|FG000|COMPLETED|Overall Study||406
8908434|NCT02122471|9966877|FG001|COMPLETED|Overall Study||392
8908435|NCT02122471|9966878|FG002|COMPLETED|Overall Study||405
8908436|NCT02122471|9966876|FG000|NOT COMPLETED|Overall Study||39
8908437|NCT02122471|9966877|FG001|NOT COMPLETED|Overall Study||51
8908438|NCT02122471|9966878|FG002|NOT COMPLETED|Overall Study||44
8908439|NCT02122549|9966887|FG000|STARTED|Overall Study||59
8908440|NCT02122549|9966887|FG000|COMPLETED|Overall Study||59
8908441|NCT02122549|9966887|FG000|NOT COMPLETED|Overall Study||0
9014258|NCT03027557|10076962|FG000|COMPLETED|Overall Study||14
9014259|NCT03027557|10076963|FG001|COMPLETED|Overall Study||16
9014260|NCT03027557|10076964|FG002|COMPLETED|Overall Study||15
9014261|NCT03027557|10076962|FG000|NOT COMPLETED|Overall Study||1
9014262|NCT03027557|10076963|FG001|NOT COMPLETED|Overall Study||0
9014263|NCT03027557|10076964|FG002|NOT COMPLETED|Overall Study||0
9014264|NCT03027661|10076974|FG000|STARTED|Overall Study||20
9014265|NCT03027661|10076975|FG001|STARTED|Overall Study||21
9014266|NCT03027661|10076974|FG000|COMPLETED|Overall Study||20
9014267|NCT03027661|10076975|FG001|COMPLETED|Overall Study||21
9014268|NCT03027661|10076974|FG000|NOT COMPLETED|Overall Study||0
9014269|NCT03027661|10076975|FG001|NOT COMPLETED|Overall Study||0
9014270|NCT03028012|10076984|FG000|STARTED|Overall Study||4
9014271|NCT03028012|10076985|FG001|STARTED|Overall Study||3
9014272|NCT03028012|10076986|FG002|STARTED|Overall Study||3
9014273|NCT03028012|10076984|FG000|COMPLETED|Overall Study||2
9014274|NCT03028012|10076985|FG001|COMPLETED|Overall Study||0
9014275|NCT03028012|10076986|FG002|COMPLETED|Overall Study||0
9014276|NCT03028012|10076984|FG000|NOT COMPLETED|Overall Study||2
9014277|NCT03028012|10076985|FG001|NOT COMPLETED|Overall Study||3
9014278|NCT03028012|10076986|FG002|NOT COMPLETED|Overall Study||3
9014279|NCT03028025|10076997|FG000|STARTED|Overall Study||90
9014280|NCT03028025|10076998|FG001|STARTED|Overall Study||94
9014281|NCT03028025|10076997|FG000|COMPLETED|Overall Study||87
9014282|NCT03028025|10076998|FG001|COMPLETED|Overall Study||93
9014283|NCT03028025|10076997|FG000|NOT COMPLETED|Overall Study||3
9014284|NCT03028025|10076998|FG001|NOT COMPLETED|Overall Study||1
9014285|NCT03028103|10077006|FG000|STARTED|Overall Study||16
9014286|NCT03028103|10077007|FG001|STARTED|Overall Study||16
9014287|NCT03028103|10077006|FG000|COMPLETED|Overall Study||16
9014288|NCT03028103|10077007|FG001|COMPLETED|Overall Study||16
9014289|NCT03028103|10077006|FG000|NOT COMPLETED|Overall Study||0
9014290|NCT03028103|10077007|FG001|NOT COMPLETED|Overall Study||0
9014291|NCT03028129|10077019|FG000|STARTED|Overall Study||258
9014292|NCT03028129|10077020|FG001|STARTED|Overall Study||209
9014293|NCT03028129|10077019|FG000|COMPLETED|Overall Study||132
9014294|NCT03028129|10077020|FG001|COMPLETED|Overall Study||122
9014295|NCT03028129|10077019|FG000|NOT COMPLETED|Overall Study||126
9014296|NCT03028129|10077020|FG001|NOT COMPLETED|Overall Study||87
9014297|NCT03028142|10077026|FG000|STARTED|Overall Study||5
9014298|NCT03028142|10077027|FG001|STARTED|Overall Study||5
9014299|NCT03028142|10077028|FG002|STARTED|Overall Study||6
9014300|NCT03028142|10077029|FG003|STARTED|Overall Study||4
9014301|NCT03028142|10077030|FG004|STARTED|Overall Study||6
9014302|NCT03028142|10077031|FG005|STARTED|Overall Study||4
9014303|NCT03028142|10077026|FG000|COMPLETED|Overall Study||4
9014304|NCT03028142|10077027|FG001|COMPLETED|Overall Study||4
9014305|NCT03028142|10077028|FG002|COMPLETED|Overall Study||6
9014306|NCT03028142|10077029|FG003|COMPLETED|Overall Study||4
9014307|NCT03028142|10077030|FG004|COMPLETED|Overall Study||5
9014308|NCT03028142|10077031|FG005|COMPLETED|Overall Study||3
9014309|NCT03028142|10077026|FG000|NOT COMPLETED|Overall Study||1
9014310|NCT03028142|10077027|FG001|NOT COMPLETED|Overall Study||1
9014311|NCT03028142|10077028|FG002|NOT COMPLETED|Overall Study||0
9014312|NCT03028142|10077029|FG003|NOT COMPLETED|Overall Study||0
9014313|NCT03028142|10077030|FG004|NOT COMPLETED|Overall Study||1
9014314|NCT03028142|10077031|FG005|NOT COMPLETED|Overall Study||1
9014315|NCT03028220|10077042|FG000|STARTED|Overall Study||20
9014316|NCT03028220|10077043|FG001|STARTED|Overall Study||20
9014317|NCT03028220|10077042|FG000|COMPLETED|Overall Study||20
9014318|NCT03028220|10077043|FG001|COMPLETED|Overall Study||20
9014319|NCT03028220|10077042|FG000|NOT COMPLETED|Overall Study||0
9014320|NCT03028220|10077043|FG001|NOT COMPLETED|Overall Study||0
9014321|NCT03028324|10077049|FG000|STARTED|Overall Study||4
9014322|NCT03028324|10077049|FG000|COMPLETED|Overall Study||4
9014323|NCT03028324|10077049|FG000|NOT COMPLETED|Overall Study||0
9014324|NCT03028363|10077055|FG000|STARTED|Overall Study||498
9014325|NCT03028363|10077056|FG001|STARTED|Overall Study||261
9014326|NCT03028363|10077055|FG000|COMPLETED|Overall Study||420
9014327|NCT03028363|10077056|FG001|COMPLETED|Overall Study||228
9014328|NCT03028363|10077055|FG000|NOT COMPLETED|Overall Study||78
8908442|NCT02122770|9966895|FG000|STARTED|Part A: Drug-drug Interaction 2||13
8908443|NCT02122770|9966896|FG001|STARTED|Part A: Drug-drug Interaction 2||13
9014329|NCT03028363|10077056|FG001|NOT COMPLETED|Overall Study||33
9014330|NCT03028415|10077064|FG000|STARTED|Overall Study||39
8908444|NCT02122770|9966897|FG002|STARTED|Part A: Drug-drug Interaction 2||6
8908445|NCT02122770|9966898|FG003|STARTED|Part A: Drug-drug Interaction 2||19
9014331|NCT03028415|10077065|FG001|STARTED|Overall Study||17
9014332|NCT03028415|10077064|FG000|Modified Intention-to-treat (mITT) Population|Overall Study||39
9014333|NCT03028415|10077065|FG001|Modified Intention-to-treat (mITT) Population|Overall Study||17
8908446|NCT02122770|9966899|FG004|STARTED|Part A: Drug-drug Interaction 2||0
8908447|NCT02122770|9966900|FG005|STARTED|Part A: Drug-drug Interaction 2||0
8908448|NCT02122770|9966895|FG000|COMPLETED|Part A: Drug-drug Interaction 2||9
8908449|NCT02122770|9966896|FG001|COMPLETED|Part A: Drug-drug Interaction 2||7
8908450|NCT02122770|9966897|FG002|COMPLETED|Part A: Drug-drug Interaction 2||4
8908451|NCT02122770|9966898|FG003|COMPLETED|Part A: Drug-drug Interaction 2||16
8908452|NCT02122770|9966899|FG004|COMPLETED|Part A: Drug-drug Interaction 2||0
8908453|NCT02122770|9966900|FG005|COMPLETED|Part A: Drug-drug Interaction 2||0
8908454|NCT02122770|9966895|FG000|NOT COMPLETED|Part A: Drug-drug Interaction 2||4
8908455|NCT02122770|9966896|FG001|NOT COMPLETED|Part A: Drug-drug Interaction 2||6
8908456|NCT02122770|9966897|FG002|NOT COMPLETED|Part A: Drug-drug Interaction 2||2
8908457|NCT02122770|9966898|FG003|NOT COMPLETED|Part A: Drug-drug Interaction 2||3
8908458|NCT02122770|9966899|FG004|NOT COMPLETED|Part A: Drug-drug Interaction 2||0
8908459|NCT02122770|9966900|FG005|NOT COMPLETED|Part A: Drug-drug Interaction 2||0
8908460|NCT02122770|9966895|FG000|STARTED|Part B: Standard of Care||0
8908461|NCT02122770|9966896|FG001|STARTED|Part B: Standard of Care||0
8908462|NCT02122770|9966897|FG002|STARTED|Part B: Standard of Care||0
8908463|NCT02122770|9966898|FG003|STARTED|Part B: Standard of Care||0
8908464|NCT02122770|9966899|FG004|STARTED|Part B: Standard of Care||23
8908465|NCT02122770|9966900|FG005|STARTED|Part B: Standard of Care||13
8908466|NCT02122770|9966895|FG000|COMPLETED|Part B: Standard of Care||0
8908467|NCT02122770|9966896|FG001|COMPLETED|Part B: Standard of Care||0
8908468|NCT02122770|9966897|FG002|COMPLETED|Part B: Standard of Care||0
8908469|NCT02122770|9966898|FG003|COMPLETED|Part B: Standard of Care||0
8908470|NCT02122770|9966899|FG004|COMPLETED|Part B: Standard of Care||0
8908471|NCT02122770|9966900|FG005|COMPLETED|Part B: Standard of Care||0
8908472|NCT02122770|9966895|FG000|NOT COMPLETED|Part B: Standard of Care||0
8908473|NCT02122770|9966896|FG001|NOT COMPLETED|Part B: Standard of Care||0
8908474|NCT02122770|9966897|FG002|NOT COMPLETED|Part B: Standard of Care||0
8908475|NCT02122770|9966898|FG003|NOT COMPLETED|Part B: Standard of Care||0
8908476|NCT02122770|9966899|FG004|NOT COMPLETED|Part B: Standard of Care||23
8908477|NCT02122770|9966900|FG005|NOT COMPLETED|Part B: Standard of Care||13
8908478|NCT02122783|9966925|FG000|STARTED|Overall Study||2
8908479|NCT02122783|9966926|FG001|STARTED|Overall Study||3
8908480|NCT02122783|9966925|FG000|COMPLETED|Overall Study||2
8908481|NCT02122783|9966926|FG001|COMPLETED|Overall Study||2
8908482|NCT02122783|9966925|FG000|NOT COMPLETED|Overall Study||0
8908483|NCT02122783|9966926|FG001|NOT COMPLETED|Overall Study||1
8908484|NCT02122796|9966937|FG000|STARTED|Visit 1||15
8908485|NCT02122796|9966938|FG001|STARTED|Visit 1||15
8908486|NCT02122796|9966937|FG000|COMPLETED|Visit 1||15
8908487|NCT02122796|9966938|FG001|COMPLETED|Visit 1||15
8908488|NCT02122796|9966937|FG000|NOT COMPLETED|Visit 1||0
8908489|NCT02122796|9966938|FG001|NOT COMPLETED|Visit 1||0
8908490|NCT02122796|9966937|FG000|STARTED|Visit 2||15
8908491|NCT02122796|9966938|FG001|STARTED|Visit 2||15
8908492|NCT02122796|9966937|FG000|COMPLETED|Visit 2||12
8908493|NCT02122796|9966938|FG001|COMPLETED|Visit 2||14
8908494|NCT02122796|9966937|FG000|NOT COMPLETED|Visit 2||3
8908495|NCT02122796|9966938|FG001|NOT COMPLETED|Visit 2||1
8908496|NCT02122887|9966947|FG000|STARTED|Overall Study||60
8908497|NCT02122887|9966948|FG001|STARTED|Overall Study||41
8908498|NCT02122887|9966947|FG000|COMPLETED|Overall Study||40
8636829|NCT00569270|9677537|FG001|COMPLETED|Period: Second Intervention||14
8636830|NCT00569270|9677536|FG000|NOT COMPLETED|Period: Second Intervention||0
8636831|NCT00569270|9677537|FG001|NOT COMPLETED|Period: Second Intervention||0
8636832|NCT00569309|9677552|FG000|STARTED|Overall Study||30
8908499|NCT02122887|9966948|FG001|COMPLETED|Overall Study||39
8908500|NCT02122887|9966947|FG000|NOT COMPLETED|Overall Study||20
8908501|NCT02122887|9966948|FG001|NOT COMPLETED|Overall Study||2
8908502|NCT02122952|9966956|FG000|STARTED|Overall Study||3
8908503|NCT02122952|9966957|FG001|STARTED|Overall Study||12
8908504|NCT02122952|9966956|FG000|COMPLETED|Overall Study||3
8908505|NCT02122952|9966957|FG001|COMPLETED|Overall Study||12
8908506|NCT02122952|9966956|FG000|NOT COMPLETED|Overall Study||0
8908507|NCT02122952|9966957|FG001|NOT COMPLETED|Overall Study||0
8908508|NCT02123017|9966966|FG000|STARTED|Overall Study||8
8908509|NCT02123017|9966967|FG001|STARTED|Overall Study||12
8908510|NCT02123017|9966968|FG002|STARTED|Overall Study||12
8908511|NCT02123017|9966966|FG000|COMPLETED|Overall Study||8
8908512|NCT02123017|9966967|FG001|COMPLETED|Overall Study||12
8908513|NCT02123017|9966968|FG002|COMPLETED|Overall Study||12
8908514|NCT02123017|9966966|FG000|NOT COMPLETED|Overall Study||0
8908515|NCT02123017|9966967|FG001|NOT COMPLETED|Overall Study||0
8908516|NCT02123017|9966968|FG002|NOT COMPLETED|Overall Study||0
8908517|NCT02123134|9966978|FG000|STARTED|Overall Study||28
8908518|NCT02123134|9966979|FG001|STARTED|Overall Study||27
8908519|NCT02123134|9966978|FG000|COMPLETED|Overall Study||25
8908520|NCT02123134|9966979|FG001|COMPLETED|Overall Study||24
8908521|NCT02123134|9966978|FG000|NOT COMPLETED|Overall Study||3
8908522|NCT02123134|9966979|FG001|NOT COMPLETED|Overall Study||3
8908523|NCT02123251|9966987|FG000|STARTED|Overall Study||159
8908524|NCT02123251|9966988|FG001|STARTED|Overall Study||161
8636833|NCT00569309|9677552|FG000|COMPLETED|Overall Study||30
8636834|NCT00569309|9677552|FG000|NOT COMPLETED|Overall Study||0
8908525|NCT02123251|9966987|FG000|COMPLETED|Overall Study||125
8908526|NCT02123251|9966988|FG001|COMPLETED|Overall Study||131
8908527|NCT02123251|9966987|FG000|NOT COMPLETED|Overall Study||34
8908528|NCT02123251|9966988|FG001|NOT COMPLETED|Overall Study||30
8908529|NCT02123329|9966997|FG000|STARTED|3 Month Outcome Measure||147
8908530|NCT02123329|9966998|FG001|STARTED|3 Month Outcome Measure||167
8908531|NCT02123329|9966997|FG000|COMPLETED|3 Month Outcome Measure||98
9014334|NCT03028415|10077064|FG000|COMPLETED|Overall Study||31
9014335|NCT03028415|10077065|FG001|COMPLETED|Overall Study||14
9014336|NCT03028415|10077064|FG000|NOT COMPLETED|Overall Study||8
9014337|NCT03028415|10077065|FG001|NOT COMPLETED|Overall Study||3
9014338|NCT03028467|10077076|FG000|STARTED|Overall Study||4
9014339|NCT03028467|10077077|FG001|STARTED|Overall Study||3
9014340|NCT03028467|10077078|FG002|STARTED|Overall Study||4
9014341|NCT03028467|10077079|FG003|STARTED|Overall Study||4
9014342|NCT03028467|10077076|FG000|COMPLETED|Overall Study||4
9014343|NCT03028467|10077077|FG001|COMPLETED|Overall Study||3
9014344|NCT03028467|10077078|FG002|COMPLETED|Overall Study||4
9014345|NCT03028467|10077079|FG003|COMPLETED|Overall Study||4
8573539|NCT00122135|9605781|FG001|COMPLETED|Overall Study||60
8573540|NCT00122135|9605780|FG000|NOT COMPLETED|Overall Study||3
8573541|NCT00122135|9605781|FG001|NOT COMPLETED|Overall Study||0
8573542|NCT00122187|9605789|FG000|STARTED|Overall Study||4
8573543|NCT00122187|9605790|FG001|STARTED|Overall Study||4
8573544|NCT00122187|9605789|FG000|Matched by Colonoscopy Volume|Overall Study||4
8573545|NCT00122187|9605790|FG001|Matched by Colonoscopy Volume|Overall Study||4
8573546|NCT00122187|9605789|FG000|Randomized to Intervention or Usual Care|Overall Study||4
8573547|NCT00122187|9605790|FG001|Randomized to Intervention or Usual Care|Overall Study||4
8573548|NCT00122187|9605789|FG000|Intervention Implemented|Overall Study||3
8573549|NCT00122187|9605790|FG001|Intervention Implemented|Overall Study||4
8573550|NCT00122187|9605789|FG000|Post-intervention Data Collection|Overall Study||2
8573551|NCT00122187|9605790|FG001|Post-intervention Data Collection|Overall Study||2
8573552|NCT00122187|9605789|FG000|COMPLETED|Overall Study||2
8573553|NCT00122187|9605790|FG001|COMPLETED|Overall Study||2
8573554|NCT00122187|9605789|FG000|NOT COMPLETED|Overall Study||2
8573555|NCT00122187|9605790|FG001|NOT COMPLETED|Overall Study||2
8573556|NCT00122278|9605800|FG000|STARTED|Overall Study||106
8573557|NCT00122278|9605801|FG001|STARTED|Overall Study||99
8573558|NCT00122278|9605800|FG000|COMPLETED|Overall Study||104
8573559|NCT00122278|9605801|FG001|COMPLETED|Overall Study||99
8908532|NCT02123329|9966998|FG001|COMPLETED|3 Month Outcome Measure||101
8908533|NCT02123329|9966997|FG000|NOT COMPLETED|3 Month Outcome Measure||49
8908534|NCT02123329|9966998|FG001|NOT COMPLETED|3 Month Outcome Measure||66
8908535|NCT02123329|9966997|FG000|STARTED|6 Month Outcome Measure||147
8908536|NCT02123329|9966998|FG001|STARTED|6 Month Outcome Measure||167
8908537|NCT02123329|9966997|FG000|COMPLETED|6 Month Outcome Measure||99
8908538|NCT02123329|9966998|FG001|COMPLETED|6 Month Outcome Measure||100
8908539|NCT02123329|9966997|FG000|NOT COMPLETED|6 Month Outcome Measure||48
8908540|NCT02123329|9966998|FG001|NOT COMPLETED|6 Month Outcome Measure||67
8908541|NCT02123329|9966997|FG000|STARTED|12 Month Outcome Measure||147
8908542|NCT02123329|9966998|FG001|STARTED|12 Month Outcome Measure||167
8908543|NCT02123329|9966997|FG000|COMPLETED|12 Month Outcome Measure||83
8908544|NCT02123329|9966998|FG001|COMPLETED|12 Month Outcome Measure||88
8908545|NCT02123329|9966997|FG000|NOT COMPLETED|12 Month Outcome Measure||64
8908546|NCT02123329|9966998|FG001|NOT COMPLETED|12 Month Outcome Measure||79
8908547|NCT02123446|9967004|FG000|STARTED|Period 1 (7 Days)||14
8908548|NCT02123446|9967005|FG001|STARTED|Period 1 (7 Days)||14
8908549|NCT02123446|9967004|FG000|COMPLETED|Period 1 (7 Days)||14
8908550|NCT02123446|9967005|FG001|COMPLETED|Period 1 (7 Days)||14
8908551|NCT02123446|9967004|FG000|NOT COMPLETED|Period 1 (7 Days)||0
8908552|NCT02123446|9967005|FG001|NOT COMPLETED|Period 1 (7 Days)||0
8908553|NCT02123446|9967004|FG000|STARTED|Washout Period (1 Day)||14
8908554|NCT02123446|9967005|FG001|STARTED|Washout Period (1 Day)||14
8908555|NCT02123446|9967004|FG000|COMPLETED|Washout Period (1 Day)||13
8908556|NCT02123446|9967005|FG001|COMPLETED|Washout Period (1 Day)||14
8908557|NCT02123446|9967004|FG000|NOT COMPLETED|Washout Period (1 Day)||1
8908558|NCT02123446|9967005|FG001|NOT COMPLETED|Washout Period (1 Day)||0
8908559|NCT02123446|9967004|FG000|STARTED|Period 2 (7 Days)||13
8908560|NCT02123446|9967005|FG001|STARTED|Period 2 (7 Days)||14
8908561|NCT02123446|9967004|FG000|COMPLETED|Period 2 (7 Days)||13
8908562|NCT02123446|9967005|FG001|COMPLETED|Period 2 (7 Days)||14
8908563|NCT02123446|9967004|FG000|NOT COMPLETED|Period 2 (7 Days)||0
8908564|NCT02123446|9967005|FG001|NOT COMPLETED|Period 2 (7 Days)||0
8908565|NCT02123459|9967011|FG000|STARTED|Period 1 (7 Days)||14
8908566|NCT02123459|9967012|FG001|STARTED|Period 1 (7 Days)||14
8908567|NCT02123459|9967011|FG000|COMPLETED|Period 1 (7 Days)||14
8908568|NCT02123459|9967012|FG001|COMPLETED|Period 1 (7 Days)||14
8908569|NCT02123459|9967011|FG000|NOT COMPLETED|Period 1 (7 Days)||0
8908570|NCT02123459|9967012|FG001|NOT COMPLETED|Period 1 (7 Days)||0
8908571|NCT02123459|9967011|FG000|STARTED|Washout Period (1 Day)||14
8908572|NCT02123459|9967012|FG001|STARTED|Washout Period (1 Day)||14
9014346|NCT03028467|10077076|FG000|NOT COMPLETED|Overall Study||0
8573560|NCT00122278|9605800|FG000|NOT COMPLETED|Overall Study||2
8573561|NCT00122278|9605801|FG001|NOT COMPLETED|Overall Study||0
8573562|NCT00122317|9605807|FG000|STARTED|Overall Study||187
8908573|NCT02123459|9967011|FG000|COMPLETED|Washout Period (1 Day)||13
8908574|NCT02123459|9967012|FG001|COMPLETED|Washout Period (1 Day)||14
8908575|NCT02123459|9967011|FG000|NOT COMPLETED|Washout Period (1 Day)||1
8908576|NCT02123459|9967012|FG001|NOT COMPLETED|Washout Period (1 Day)||0
8908577|NCT02123459|9967011|FG000|STARTED|Period 2 (7 Days)||13
8908578|NCT02123459|9967012|FG001|STARTED|Period 2 (7 Days)||14
8908579|NCT02123459|9967011|FG000|COMPLETED|Period 2 (7 Days)||13
8908580|NCT02123459|9967012|FG001|COMPLETED|Period 2 (7 Days)||14
8908581|NCT02123459|9967011|FG000|NOT COMPLETED|Period 2 (7 Days)||0
8908582|NCT02123459|9967012|FG001|NOT COMPLETED|Period 2 (7 Days)||0
8908583|NCT02123472|9967018|FG000|STARTED|Period 1 (7 Days)||14
8908584|NCT02123472|9967019|FG001|STARTED|Period 1 (7 Days)||14
8908585|NCT02123472|9967018|FG000|COMPLETED|Period 1 (7 Days)||14
8908586|NCT02123472|9967019|FG001|COMPLETED|Period 1 (7 Days)||14
8908587|NCT02123472|9967018|FG000|NOT COMPLETED|Period 1 (7 Days)||0
8908588|NCT02123472|9967019|FG001|NOT COMPLETED|Period 1 (7 Days)||0
8908589|NCT02123472|9967018|FG000|STARTED|Washout Period (1 Day)||14
8908590|NCT02123472|9967019|FG001|STARTED|Washout Period (1 Day)||14
8908591|NCT02123472|9967018|FG000|COMPLETED|Washout Period (1 Day)||14
8908592|NCT02123472|9967019|FG001|COMPLETED|Washout Period (1 Day)||14
8908593|NCT02123472|9967018|FG000|NOT COMPLETED|Washout Period (1 Day)||0
8908594|NCT02123472|9967019|FG001|NOT COMPLETED|Washout Period (1 Day)||0
8908595|NCT02123472|9967018|FG000|STARTED|Period 2 (7 Days)||14
8908596|NCT02123472|9967019|FG001|STARTED|Period 2 (7 Days)||14
8908597|NCT02123472|9967018|FG000|COMPLETED|Period 2 (7 Days)||14
8908598|NCT02123472|9967019|FG001|COMPLETED|Period 2 (7 Days)||13
8908599|NCT02123472|9967018|FG000|NOT COMPLETED|Period 2 (7 Days)||0
8908600|NCT02123472|9967019|FG001|NOT COMPLETED|Period 2 (7 Days)||1
8908601|NCT02123485|9967027|FG000|STARTED|Overall Study||18
8908602|NCT02123485|9967028|FG001|STARTED|Overall Study||17
8908603|NCT02123485|9967027|FG000|COMPLETED|Overall Study||17
8908604|NCT02123485|9967028|FG001|COMPLETED|Overall Study||17
8908605|NCT02123485|9967027|FG000|NOT COMPLETED|Overall Study||1
8908606|NCT02123485|9967028|FG001|NOT COMPLETED|Overall Study||0
8908607|NCT02123511|9967036|FG000|STARTED|Overall Study||18
8908608|NCT02123511|9967037|FG001|STARTED|Overall Study||16
8908609|NCT02123511|9967036|FG000|Eligible Patients|Overall Study||17
8908610|NCT02123511|9967037|FG001|Eligible Patients|Overall Study||15
8908611|NCT02123511|9967036|FG000|COMPLETED|Overall Study||16
8908612|NCT02123511|9967037|FG001|COMPLETED|Overall Study||12
8908613|NCT02123511|9967036|FG000|NOT COMPLETED|Overall Study||2
8908614|NCT02123511|9967037|FG001|NOT COMPLETED|Overall Study||4
8908615|NCT02123576|9967045|FG000|STARTED|Overall Study||6
9014347|NCT03028467|10077077|FG001|NOT COMPLETED|Overall Study||0
9014348|NCT03028467|10077078|FG002|NOT COMPLETED|Overall Study||0
9014349|NCT03028467|10077079|FG003|NOT COMPLETED|Overall Study||0
9014350|NCT03028636|10077092|FG000|STARTED|Overall Study||17
9014351|NCT03028636|10077092|FG000|COMPLETED|Overall Study||11
9014352|NCT03028636|10077092|FG000|NOT COMPLETED|Overall Study||6
9014353|NCT03028870|10077105|FG000|STARTED|Overall Study||74
9014354|NCT03028870|10077106|FG001|STARTED|Overall Study||67
9014355|NCT03028870|10077107|FG002|STARTED|Overall Study||76
9014356|NCT03028870|10077108|FG003|STARTED|Overall Study||74
9014357|NCT03028870|10077105|FG000|COMPLETED|Overall Study||57
9014358|NCT03028870|10077106|FG001|COMPLETED|Overall Study||57
9014359|NCT03028870|10077107|FG002|COMPLETED|Overall Study||60
9014360|NCT03028870|10077108|FG003|COMPLETED|Overall Study||65
9014361|NCT03028870|10077105|FG000|NOT COMPLETED|Overall Study||17
9014362|NCT03028870|10077106|FG001|NOT COMPLETED|Overall Study||10
9014363|NCT03028870|10077107|FG002|NOT COMPLETED|Overall Study||16
9014364|NCT03028870|10077108|FG003|NOT COMPLETED|Overall Study||9
9014365|NCT03028974|10077123|FG000|STARTED|2014-2015||1
9014366|NCT03028974|10077124|FG001|STARTED|2014-2015||0
9014367|NCT03028974|10077125|FG002|STARTED|2014-2015||0
9014368|NCT03028974|10077126|FG003|STARTED|2014-2015||3
9014369|NCT03028974|10077127|FG004|STARTED|2014-2015||0
9014370|NCT03028974|10077128|FG005|STARTED|2014-2015||11
9014371|NCT03028974|10077129|FG006|STARTED|2014-2015||13
9014372|NCT03028974|10077123|FG000|COMPLETED|2014-2015||1
8908616|NCT02123576|9967046|FG001|STARTED|Overall Study||6
8908617|NCT02123576|9967045|FG000|COMPLETED|Overall Study||5
8908618|NCT02123576|9967046|FG001|COMPLETED|Overall Study||6
8908619|NCT02123576|9967045|FG000|NOT COMPLETED|Overall Study||1
8908620|NCT02123576|9967046|FG001|NOT COMPLETED|Overall Study||0
8908621|NCT02123745|9967052|FG000|STARTED|Overall Study||71
8908622|NCT02123745|9967052|FG000|COMPLETED|Overall Study||71
8908623|NCT02123745|9967052|FG000|NOT COMPLETED|Overall Study||0
9014373|NCT03028974|10077124|FG001|COMPLETED|2014-2015||0
9014374|NCT03028974|10077125|FG002|COMPLETED|2014-2015||0
9014375|NCT03028974|10077126|FG003|COMPLETED|2014-2015||3
9014376|NCT03028974|10077127|FG004|COMPLETED|2014-2015||0
9014377|NCT03028974|10077128|FG005|COMPLETED|2014-2015|2 participants did not continue to the next period.|11
9014378|NCT03028974|10077129|FG006|COMPLETED|2014-2015|13 participants did not continue to the next period.|13
9014379|NCT03028974|10077123|FG000|NOT COMPLETED|2014-2015||0
9014380|NCT03028974|10077124|FG001|NOT COMPLETED|2014-2015||0
9014381|NCT03028974|10077125|FG002|NOT COMPLETED|2014-2015||0
9014382|NCT03028974|10077126|FG003|NOT COMPLETED|2014-2015||0
8908624|NCT02123797|9967058|FG000|STARTED|Baseline Intervention||178
8908625|NCT02123797|9967059|FG001|STARTED|Baseline Intervention||348
9014383|NCT03028974|10077127|FG004|NOT COMPLETED|2014-2015||0
9014384|NCT03028974|10077128|FG005|NOT COMPLETED|2014-2015||0
9014385|NCT03028974|10077129|FG006|NOT COMPLETED|2014-2015||0
8908626|NCT02123797|9967060|FG002|STARTED|Baseline Intervention||100
8908627|NCT02123797|9967061|FG003|STARTED|Baseline Intervention||144
8908628|NCT02123797|9967062|FG004|STARTED|Baseline Intervention||11
8908629|NCT02123797|9967058|FG000|COMPLETED|Baseline Intervention||156
8908630|NCT02123797|9967059|FG001|COMPLETED|Baseline Intervention||306
8908631|NCT02123797|9967060|FG002|COMPLETED|Baseline Intervention||100
8908632|NCT02123797|9967061|FG003|COMPLETED|Baseline Intervention||144
8908633|NCT02123797|9967062|FG004|COMPLETED|Baseline Intervention||11
8908634|NCT02123797|9967058|FG000|NOT COMPLETED|Baseline Intervention||22
8908635|NCT02123797|9967059|FG001|NOT COMPLETED|Baseline Intervention||42
8908636|NCT02123797|9967060|FG002|NOT COMPLETED|Baseline Intervention||0
8908637|NCT02123797|9967061|FG003|NOT COMPLETED|Baseline Intervention||0
8908638|NCT02123797|9967062|FG004|NOT COMPLETED|Baseline Intervention||0
8908639|NCT02123797|9967058|FG000|STARTED|3-month Follow up (Cumulative Counts)||156
8908640|NCT02123797|9967059|FG001|STARTED|3-month Follow up (Cumulative Counts)||306
8908641|NCT02123797|9967060|FG002|STARTED|3-month Follow up (Cumulative Counts)||100
8908642|NCT02123797|9967061|FG003|STARTED|3-month Follow up (Cumulative Counts)||144
8908643|NCT02123797|9967062|FG004|STARTED|3-month Follow up (Cumulative Counts)|Clinical providers received 6 month follow-up rather than 3 month follow-up at this stage.|11
8908644|NCT02123797|9967058|FG000|COMPLETED|3-month Follow up (Cumulative Counts)||99
8908645|NCT02123797|9967059|FG001|COMPLETED|3-month Follow up (Cumulative Counts)||189
8908646|NCT02123797|9967060|FG002|COMPLETED|3-month Follow up (Cumulative Counts)||50
8908647|NCT02123797|9967061|FG003|COMPLETED|3-month Follow up (Cumulative Counts)||62
8908648|NCT02123797|9967062|FG004|COMPLETED|3-month Follow up (Cumulative Counts)||8
8908649|NCT02123797|9967058|FG000|NOT COMPLETED|3-month Follow up (Cumulative Counts)||57
8908650|NCT02123797|9967059|FG001|NOT COMPLETED|3-month Follow up (Cumulative Counts)||117
8908651|NCT02123797|9967060|FG002|NOT COMPLETED|3-month Follow up (Cumulative Counts)||50
8908652|NCT02123797|9967061|FG003|NOT COMPLETED|3-month Follow up (Cumulative Counts)||82
8908653|NCT02123797|9967062|FG004|NOT COMPLETED|3-month Follow up (Cumulative Counts)||3
8908654|NCT02123797|9967058|FG000|STARTED|6-month Follow up (Cumulative Counts)||156
8908655|NCT02123797|9967059|FG001|STARTED|6-month Follow up (Cumulative Counts)||306
8908656|NCT02123797|9967060|FG002|STARTED|6-month Follow up (Cumulative Counts)||100
8908657|NCT02123797|9967061|FG003|STARTED|6-month Follow up (Cumulative Counts)||144
8908658|NCT02123797|9967062|FG004|STARTED|6-month Follow up (Cumulative Counts)|Clinical providers received 12 month follow-up rather than 6-month follow-up at this stage.|8
8908659|NCT02123797|9967058|FG000|COMPLETED|6-month Follow up (Cumulative Counts)||101
8908660|NCT02123797|9967059|FG001|COMPLETED|6-month Follow up (Cumulative Counts)||178
8908661|NCT02123797|9967060|FG002|COMPLETED|6-month Follow up (Cumulative Counts)||34
8908662|NCT02123797|9967061|FG003|COMPLETED|6-month Follow up (Cumulative Counts)||31
8908663|NCT02123797|9967062|FG004|COMPLETED|6-month Follow up (Cumulative Counts)||5
8908664|NCT02123797|9967058|FG000|NOT COMPLETED|6-month Follow up (Cumulative Counts)||55
8908665|NCT02123797|9967059|FG001|NOT COMPLETED|6-month Follow up (Cumulative Counts)||128
8908666|NCT02123797|9967060|FG002|NOT COMPLETED|6-month Follow up (Cumulative Counts)||66
8908667|NCT02123797|9967061|FG003|NOT COMPLETED|6-month Follow up (Cumulative Counts)||113
8908668|NCT02123797|9967062|FG004|NOT COMPLETED|6-month Follow up (Cumulative Counts)||3
8908669|NCT02123849|9967084|FG000|STARTED|Overall Study||27
8908670|NCT02123849|9967085|FG001|STARTED|Overall Study||27
8908671|NCT02123849|9967084|FG000|COMPLETED|Overall Study||23
8636835|NCT00569374|9677556|FG000|STARTED|Overall Study||8
8636836|NCT00569374|9677556|FG000|COMPLETED|Overall Study||4
8636837|NCT00569374|9677556|FG000|NOT COMPLETED|Overall Study||4
8908672|NCT02123849|9967085|FG001|COMPLETED|Overall Study||18
8908673|NCT02123849|9967084|FG000|NOT COMPLETED|Overall Study||4
8908674|NCT02123849|9967085|FG001|NOT COMPLETED|Overall Study||9
8908675|NCT02123966|9967093|FG000|STARTED|Overall Study||10
8908676|NCT02123966|9967093|FG000|COMPLETED|Overall Study||9
8908677|NCT02123966|9967093|FG000|NOT COMPLETED|Overall Study||1
8908678|NCT02124018|9967100|FG000|STARTED|Overall Study||371
8908679|NCT02124018|9967101|FG001|STARTED|Overall Study||111
8908680|NCT02124018|9967102|FG002|STARTED|Overall Study||41
8908681|NCT02124018|9967100|FG000|COMPLETED|Overall Study||371
8908682|NCT02124018|9967101|FG001|COMPLETED|Overall Study||111
8908683|NCT02124018|9967102|FG002|COMPLETED|Overall Study|Numbers do not add up to 575 (enrolled) due to refusals of programmed ventricular stimulation|41
8908684|NCT02124018|9967100|FG000|NOT COMPLETED|Overall Study||0
8908685|NCT02124018|9967101|FG001|NOT COMPLETED|Overall Study||0
8908686|NCT02124018|9967102|FG002|NOT COMPLETED|Overall Study||0
8908687|NCT02124044|9967115|FG000|STARTED|Overall Study||20
8908688|NCT02124044|9967116|FG001|STARTED|Overall Study||10
8908689|NCT02124044|9967115|FG000|COMPLETED|Overall Study||20
8908690|NCT02124044|9967116|FG001|COMPLETED|Overall Study||9
8908691|NCT02124044|9967115|FG000|NOT COMPLETED|Overall Study||0
8636838|NCT00569530|9677562|FG000|STARTED|Overall Study||43
8636839|NCT00569530|9677563|FG001|STARTED|Overall Study||42
8636840|NCT00569530|9677562|FG000|COMPLETED|Overall Study||43
8636841|NCT00569530|9677563|FG001|COMPLETED|Overall Study||42
8636842|NCT00569530|9677562|FG000|NOT COMPLETED|Overall Study||0
8636843|NCT00569530|9677563|FG001|NOT COMPLETED|Overall Study||0
8636844|NCT00569582|9677569|FG000|STARTED|Overall Study||50
8636845|NCT00569582|9677569|FG000|COMPLETED|Overall Study||34
8636846|NCT00569582|9677569|FG000|NOT COMPLETED|Overall Study||16
8636847|NCT00569660|9677573|FG000|STARTED|Overall Study||34
8636848|NCT00569660|9677573|FG000|COMPLETED|Overall Study||34
8908692|NCT02124044|9967116|FG001|NOT COMPLETED|Overall Study||1
8908693|NCT02124083|9967122|FG000|STARTED|Overall Study||12
8908694|NCT02124083|9967122|FG000|COMPLETED|Overall Study||11
8908695|NCT02124083|9967122|FG000|NOT COMPLETED|Overall Study||1
8908696|NCT02124122|9967128|FG000|STARTED|Overall Study||41
8908697|NCT02124122|9967129|FG001|STARTED|Overall Study||19
8908698|NCT02124122|9967128|FG000|COMPLETED|Overall Study||41
8908699|NCT02124122|9967129|FG001|COMPLETED|Overall Study||19
8908700|NCT02124122|9967128|FG000|NOT COMPLETED|Overall Study||0
8908701|NCT02124122|9967129|FG001|NOT COMPLETED|Overall Study||0
8908702|NCT02124161|9967137|FG000|STARTED|Overall Study||441
8908703|NCT02124161|9967138|FG001|STARTED|Overall Study||441
8908704|NCT02124161|9967137|FG000|Vaccination 1|Overall Study||439
8908705|NCT02124161|9967138|FG001|Vaccination 1|Overall Study||437
8908706|NCT02124161|9967137|FG000|Vaccination 2|Overall Study||431
8908707|NCT02124161|9967138|FG001|Vaccination 2|Overall Study||432
8908708|NCT02124161|9967137|FG000|COMPLETED|Overall Study||425
8908709|NCT02124161|9967138|FG001|COMPLETED|Overall Study||426
8908710|NCT02124161|9967137|FG000|NOT COMPLETED|Overall Study||16
8908711|NCT02124161|9967138|FG001|NOT COMPLETED|Overall Study||15
8908712|NCT02124265|9967151|FG000|STARTED|Overall Study||3
8908713|NCT02124265|9967151|FG000|COMPLETED|Overall Study||2
8908714|NCT02124265|9967151|FG000|NOT COMPLETED|Overall Study||1
8908715|NCT02124304|9967157|FG000|STARTED|Overall Study||15
8908716|NCT02124304|9967158|FG001|STARTED|Overall Study||15
8908717|NCT02124304|9967157|FG000|COMPLETED|Overall Study||15
8908718|NCT02124304|9967158|FG001|COMPLETED|Overall Study||15
8908719|NCT02124304|9967157|FG000|NOT COMPLETED|Overall Study||0
8908720|NCT02124304|9967158|FG001|NOT COMPLETED|Overall Study||0
8908721|NCT02124460|9967166|FG000|STARTED|Overall Study||361
8908722|NCT02124460|9967167|FG001|STARTED|Overall Study||360
8908723|NCT02124460|9967166|FG000|COMPLETED|Overall Study||328
8908724|NCT02124460|9967167|FG001|COMPLETED|Overall Study||336
8908725|NCT02124460|9967166|FG000|NOT COMPLETED|Overall Study||33
8908726|NCT02124460|9967167|FG001|NOT COMPLETED|Overall Study||24
8908727|NCT02124512|9967176|FG000|STARTED|Overall Study||6
8908728|NCT02124512|9967177|FG001|STARTED|Overall Study||6
8908729|NCT02124512|9967176|FG000|COMPLETED|Overall Study||6
8908730|NCT02124512|9967177|FG001|COMPLETED|Overall Study||6
8908731|NCT02124512|9967176|FG000|NOT COMPLETED|Overall Study||0
8908732|NCT02124512|9967177|FG001|NOT COMPLETED|Overall Study||0
9014386|NCT03028974|10077123|FG000|STARTED|2015-2016||0
9014387|NCT03028974|10077124|FG001|STARTED|2015-2016||0
9014388|NCT03028974|10077125|FG002|STARTED|2015-2016||0
9014389|NCT03028974|10077126|FG003|STARTED|2015-2016|One participant joined from Group A, 2 new were enrolled.|6
9014390|NCT03028974|10077127|FG004|STARTED|2015-2016||0
9014391|NCT03028974|10077128|FG005|STARTED|2015-2016|10 new participants were enrolled; 4 subjects switched from Group G.|14
9014392|NCT03028974|10077129|FG006|STARTED|2015-2016|11 new participants were enrolled; 9 subjects switched from Group F.|20
9014393|NCT03028974|10077123|FG000|COMPLETED|2015-2016||0
9014394|NCT03028974|10077124|FG001|COMPLETED|2015-2016||0
9014395|NCT03028974|10077125|FG002|COMPLETED|2015-2016||0
9014396|NCT03028974|10077126|FG003|COMPLETED|2015-2016|3 participants did not continue to the next period. 1 Participant returned in period 4 (2017-2018).|6
9014397|NCT03028974|10077127|FG004|COMPLETED|2015-2016||0
9014398|NCT03028974|10077128|FG005|COMPLETED|2015-2016|14 participants did not continue to the next period.|14
9014399|NCT03028974|10077129|FG006|COMPLETED|2015-2016|20 participants did not continue to the next period.|20
9014400|NCT03028974|10077123|FG000|NOT COMPLETED|2015-2016||0
9014401|NCT03028974|10077124|FG001|NOT COMPLETED|2015-2016||0
9014402|NCT03028974|10077125|FG002|NOT COMPLETED|2015-2016||0
9014403|NCT03028974|10077126|FG003|NOT COMPLETED|2015-2016||0
9014404|NCT03028974|10077127|FG004|NOT COMPLETED|2015-2016||0
9014405|NCT03028974|10077128|FG005|NOT COMPLETED|2015-2016||0
9014406|NCT03028974|10077129|FG006|NOT COMPLETED|2015-2016||0
9014407|NCT03028974|10077123|FG000|STARTED|2016-2017||0
9014408|NCT03028974|10077124|FG001|STARTED|2016-2017||0
9014409|NCT03028974|10077125|FG002|STARTED|2016-2017||0
9014410|NCT03028974|10077126|FG003|STARTED|2016-2017|1 new participant was enrolled.|4
9014411|NCT03028974|10077127|FG004|STARTED|2016-2017|2 new participants were enrolled.|2
9014412|NCT03028974|10077128|FG005|STARTED|2016-2017||0
9014413|NCT03028974|10077129|FG006|STARTED|2016-2017|18 new participants were enrolled.|18
9014414|NCT03028974|10077123|FG000|COMPLETED|2016-2017||0
9014415|NCT03028974|10077124|FG001|COMPLETED|2016-2017||0
9014416|NCT03028974|10077125|FG002|COMPLETED|2016-2017||0
9014417|NCT03028974|10077126|FG003|COMPLETED|2016-2017||4
9014418|NCT03028974|10077127|FG004|COMPLETED|2016-2017|2 participants did not continue to the next period|2
9014419|NCT03028974|10077128|FG005|COMPLETED|2016-2017||0
8573563|NCT00122317|9605807|FG000|COMPLETED|Overall Study||176
8573564|NCT00122317|9605807|FG000|NOT COMPLETED|Overall Study||11
8573565|NCT00122369|9605814|FG000|STARTED|Overall Study||76
8636849|NCT00569660|9677573|FG000|NOT COMPLETED|Overall Study||0
8908733|NCT02124564|9967183|FG000|STARTED|Treatment Period||19
8908734|NCT02124564|9967183|FG000|Started Treatment Period|Treatment Period||19
8908735|NCT02124564|9967183|FG000|Started Titration Period|Treatment Period||19
8908736|NCT02124564|9967183|FG000|Started AED Withdrawal Period|Treatment Period||19
8908737|NCT02124564|9967183|FG000|Started Monotherapy Period|Treatment Period||17
8908738|NCT02124564|9967183|FG000|Started Evaluation Period|Treatment Period||17
8908739|NCT02124564|9967183|FG000|Started Follow-Up Period|Treatment Period||13
8908740|NCT02124564|9967183|FG000|COMPLETED|Treatment Period||12
9014420|NCT03028974|10077129|FG006|COMPLETED|2016-2017|18 participants did not continue to the next period.|18
9014421|NCT03028974|10077123|FG000|NOT COMPLETED|2016-2017||0
9014422|NCT03028974|10077124|FG001|NOT COMPLETED|2016-2017||0
9014423|NCT03028974|10077125|FG002|NOT COMPLETED|2016-2017||0
9014424|NCT03028974|10077126|FG003|NOT COMPLETED|2016-2017||0
9014425|NCT03028974|10077127|FG004|NOT COMPLETED|2016-2017||0
9014426|NCT03028974|10077128|FG005|NOT COMPLETED|2016-2017||0
9014427|NCT03028974|10077129|FG006|NOT COMPLETED|2016-2017||0
9014428|NCT03028974|10077123|FG000|STARTED|2017-2018||0
9014429|NCT03028974|10077124|FG001|STARTED|2017-2018||0
9014430|NCT03028974|10077125|FG002|STARTED|2017-2018||0
9014431|NCT03028974|10077126|FG003|STARTED|2017-2018||5
9014432|NCT03028974|10077127|FG004|STARTED|2017-2018||0
9014433|NCT03028974|10077128|FG005|STARTED|2017-2018||0
9014434|NCT03028974|10077129|FG006|STARTED|2017-2018|5 new participants were enrolled.|5
9014435|NCT03028974|10077123|FG000|COMPLETED|2017-2018||0
9014436|NCT03028974|10077124|FG001|COMPLETED|2017-2018||0
9014437|NCT03028974|10077125|FG002|COMPLETED|2017-2018||0
9014438|NCT03028974|10077126|FG003|COMPLETED|2017-2018||5
9014439|NCT03028974|10077127|FG004|COMPLETED|2017-2018||0
9014440|NCT03028974|10077128|FG005|COMPLETED|2017-2018||0
9014441|NCT03028974|10077129|FG006|COMPLETED|2017-2018||5
9014442|NCT03028974|10077123|FG000|NOT COMPLETED|2017-2018||0
9014443|NCT03028974|10077124|FG001|NOT COMPLETED|2017-2018||0
9014444|NCT03028974|10077125|FG002|NOT COMPLETED|2017-2018||0
9014445|NCT03028974|10077126|FG003|NOT COMPLETED|2017-2018||0
9014446|NCT03028974|10077127|FG004|NOT COMPLETED|2017-2018||0
9014447|NCT03028974|10077128|FG005|NOT COMPLETED|2017-2018||0
9014448|NCT03028974|10077129|FG006|NOT COMPLETED|2017-2018||0
9014449|NCT03028987|10077144|FG000|STARTED|Overall Study||5
9014450|NCT03028987|10077145|FG001|STARTED|Overall Study||5
9014451|NCT03028987|10077144|FG000|COMPLETED|Overall Study||5
9014452|NCT03028987|10077145|FG001|COMPLETED|Overall Study||5
9014453|NCT03028987|10077144|FG000|NOT COMPLETED|Overall Study||0
9014454|NCT03028987|10077145|FG001|NOT COMPLETED|Overall Study||0
9014455|NCT03029091|10077153|FG000|STARTED|Overall Study||8
9014456|NCT03029091|10077154|FG001|STARTED|Overall Study||7
9014457|NCT03029091|10077153|FG000|COMPLETED|Overall Study||8
9014458|NCT03029091|10077154|FG001|COMPLETED|Overall Study||7
9014459|NCT03029091|10077153|FG000|NOT COMPLETED|Overall Study||0
9014460|NCT03029091|10077154|FG001|NOT COMPLETED|Overall Study||0
9014461|NCT03029143|10077162|FG000|STARTED|Lead-in Period (6 Weeks)||278
9014462|NCT03029143|10077163|FG001|STARTED|Lead-in Period (6 Weeks)||0
9014463|NCT03029143|10077164|FG002|STARTED|Lead-in Period (6 Weeks)||0
9014464|NCT03029143|10077162|FG000|COMPLETED|Lead-in Period (6 Weeks)||109
9014465|NCT03029143|10077163|FG001|COMPLETED|Lead-in Period (6 Weeks)||0
9014466|NCT03029143|10077164|FG002|COMPLETED|Lead-in Period (6 Weeks)||0
9014467|NCT03029143|10077162|FG000|NOT COMPLETED|Lead-in Period (6 Weeks)||169
9014468|NCT03029143|10077163|FG001|NOT COMPLETED|Lead-in Period (6 Weeks)||0
9014469|NCT03029143|10077164|FG002|NOT COMPLETED|Lead-in Period (6 Weeks)||0
9014470|NCT03029143|10077162|FG000|STARTED|Randomized Treatment Period (24 Weeks)||0
9014471|NCT03029143|10077163|FG001|STARTED|Randomized Treatment Period (24 Weeks)||54
9014472|NCT03029143|10077164|FG002|STARTED|Randomized Treatment Period (24 Weeks)||55
9014473|NCT03029143|10077162|FG000|Not Treated Post Randomization|Randomized Treatment Period (24 Weeks)||0
9014474|NCT03029143|10077163|FG001|Not Treated Post Randomization|Randomized Treatment Period (24 Weeks)|One participant was randomized to Randomized Treatment Period: Standard Treatment Arm, but was not treated and was thus included in the Lead-in failure vedolizumab arm for the Safety Analysis Set (N=170).|1
8573566|NCT00122369|9605815|FG001|STARTED|Overall Study||82
8573567|NCT00122369|9605816|FG002|STARTED|Overall Study||78
8573568|NCT00122369|9605814|FG000|COMPLETED|Overall Study||76
8573569|NCT00122369|9605815|FG001|COMPLETED|Overall Study||82
8573570|NCT00122369|9605816|FG002|COMPLETED|Overall Study||78
8573571|NCT00122369|9605814|FG000|NOT COMPLETED|Overall Study||0
8573572|NCT00122369|9605815|FG001|NOT COMPLETED|Overall Study||0
8573573|NCT00122369|9605816|FG002|NOT COMPLETED|Overall Study||0
8573574|NCT00122382|9605829|FG000|STARTED|Double-Blind Study|participants randomized|256
8573575|NCT00122382|9605830|FG001|STARTED|Double-Blind Study|participants randomized|255
8726791|NCT01038635|9774066|FG000|COMPLETED|Overall Study||3
8726792|NCT01038635|9774067|FG001|COMPLETED|Overall Study||3
8726793|NCT01038635|9774068|FG002|COMPLETED|Overall Study||3
8726794|NCT01038635|9774069|FG003|COMPLETED|Overall Study||3
8726795|NCT01038635|9774070|FG004|COMPLETED|Overall Study||3
8726796|NCT01038635|9774071|FG005|COMPLETED|Overall Study||3
8726797|NCT01038635|9774072|FG006|COMPLETED|Overall Study||5
8726798|NCT01038635|9774073|FG007|COMPLETED|Overall Study||15
8726799|NCT01038635|9774074|FG008|COMPLETED|Overall Study||38
8726800|NCT01038635|9774066|FG000|NOT COMPLETED|Overall Study||2
8726801|NCT01038635|9774067|FG001|NOT COMPLETED|Overall Study||0
8726802|NCT01038635|9774068|FG002|NOT COMPLETED|Overall Study||0
8726803|NCT01038635|9774069|FG003|NOT COMPLETED|Overall Study||0
9014475|NCT03029143|10077164|FG002|Not Treated Post Randomization|Randomized Treatment Period (24 Weeks)||0
9014476|NCT03029143|10077162|FG000|Safety Population|Randomized Treatment Period (24 Weeks)||0
9014477|NCT03029143|10077163|FG001|Safety Population|Randomized Treatment Period (24 Weeks)||53
9014478|NCT03029143|10077164|FG002|Safety Population|Randomized Treatment Period (24 Weeks)|Regimen A = 28 Regimen B = 27|55
9014479|NCT03029143|10077162|FG000|COMPLETED|Randomized Treatment Period (24 Weeks)||0
8573576|NCT00122382|9605831|FG002|STARTED|Double-Blind Study||0
8573577|NCT00122382|9605829|FG000|Treated|Double-Blind Study||256
8908741|NCT02124564|9967183|FG000|NOT COMPLETED|Treatment Period||7
8908742|NCT02124564|9967183|FG000|STARTED|Taper Period||2
8908743|NCT02124564|9967183|FG000|COMPLETED|Taper Period||2
8908744|NCT02124564|9967183|FG000|NOT COMPLETED|Taper Period||0
8908745|NCT02124603|9967188|FG000|STARTED|Overall Study||120
8908746|NCT02124603|9967188|FG000|COMPLETED|Overall Study||120
8908747|NCT02124603|9967188|FG000|NOT COMPLETED|Overall Study||0
8908748|NCT02124707|9967193|FG000|STARTED|Overall Study||14
8908749|NCT02124707|9967193|FG000|COMPLETED|Overall Study||7
8908750|NCT02124707|9967193|FG000|NOT COMPLETED|Overall Study||7
8908751|NCT02124746|9967201|FG000|STARTED|Overall Study||30
8908752|NCT02124746|9967202|FG001|STARTED|Overall Study||22
8908753|NCT02124746|9967203|FG002|STARTED|Overall Study||22
8908754|NCT02124746|9967201|FG000|COMPLETED|Overall Study||11
8908755|NCT02124746|9967202|FG001|COMPLETED|Overall Study||4
8908756|NCT02124746|9967203|FG002|COMPLETED|Overall Study||0
8908757|NCT02124746|9967201|FG000|NOT COMPLETED|Overall Study||19
8908758|NCT02124746|9967202|FG001|NOT COMPLETED|Overall Study||18
8908759|NCT02124746|9967203|FG002|NOT COMPLETED|Overall Study||22
8908760|NCT02124759|9967214|FG000|STARTED|Overall Study||6
8908761|NCT02124759|9967215|FG001|STARTED|Overall Study||7
8908762|NCT02124759|9967216|FG002|STARTED|Overall Study||7
8908763|NCT02124759|9967214|FG000|Subjects Randomized to Intervention|Overall Study||4
8908764|NCT02124759|9967215|FG001|Subjects Randomized to Intervention|Overall Study||5
8908765|NCT02124759|9967216|FG002|Subjects Randomized to Intervention|Overall Study||4
8908766|NCT02124759|9967214|FG000|Low Fat Diet|Overall Study|2 subjects did not complete and were withdrawn|4
8908767|NCT02124759|9967215|FG001|Low Fat Diet|Overall Study||4
8908768|NCT02124759|9967216|FG002|Low Fat Diet|Overall Study||4
8908769|NCT02124759|9967214|FG000|High Fat Diet|Overall Study|1 subject did not complete|2
8908770|NCT02124759|9967215|FG001|High Fat Diet|Overall Study|One subject withdrew (low fat diet had already been completed)|5
8908771|NCT02124759|9967216|FG002|High Fat Diet|Overall Study|One subject withdrew and did not complete the low fat diet|4
8908772|NCT02124759|9967214|FG000|COMPLETED|Overall Study||1
8908773|NCT02124759|9967215|FG001|COMPLETED|Overall Study||4
8908774|NCT02124759|9967216|FG002|COMPLETED|Overall Study||3
8908775|NCT02124759|9967214|FG000|NOT COMPLETED|Overall Study||5
8908776|NCT02124759|9967215|FG001|NOT COMPLETED|Overall Study||3
8908777|NCT02124759|9967216|FG002|NOT COMPLETED|Overall Study||4
8908778|NCT02124772|9967242|FG000|STARTED|Overall Study||3
8908779|NCT02124772|9967243|FG001|STARTED|Overall Study||19
8908780|NCT02124772|9967244|FG002|STARTED|Overall Study||12
8908781|NCT02124772|9967245|FG003|STARTED|Overall Study||16
8908782|NCT02124772|9967246|FG004|STARTED|Overall Study||11
8908783|NCT02124772|9967247|FG005|STARTED|Overall Study||10
8908784|NCT02124772|9967248|FG006|STARTED|Overall Study||10
8908785|NCT02124772|9967249|FG007|STARTED|Overall Study||10
8908786|NCT02124772|9967250|FG008|STARTED|Overall Study||3
8908787|NCT02124772|9967251|FG009|STARTED|Overall Study||9
8908788|NCT02124772|9967252|FG010|STARTED|Overall Study||6
8908789|NCT02124772|9967253|FG011|STARTED|Overall Study||20
8908790|NCT02124772|9967254|FG012|STARTED|Overall Study||10
8908791|NCT02124772|9967242|FG000|COMPLETED|Overall Study||0
8908792|NCT02124772|9967243|FG001|COMPLETED|Overall Study||5
8908793|NCT02124772|9967244|FG002|COMPLETED|Overall Study||6
8908794|NCT02124772|9967245|FG003|COMPLETED|Overall Study||3
8908795|NCT02124772|9967246|FG004|COMPLETED|Overall Study||2
8908796|NCT02124772|9967247|FG005|COMPLETED|Overall Study||2
8908797|NCT02124772|9967248|FG006|COMPLETED|Overall Study||2
8908798|NCT02124772|9967249|FG007|COMPLETED|Overall Study||1
8908799|NCT02124772|9967250|FG008|COMPLETED|Overall Study||2
8908800|NCT02124772|9967251|FG009|COMPLETED|Overall Study||2
8908801|NCT02124772|9967252|FG010|COMPLETED|Overall Study||4
8908802|NCT02124772|9967253|FG011|COMPLETED|Overall Study||14
8908803|NCT02124772|9967254|FG012|COMPLETED|Overall Study||8
8908804|NCT02124772|9967242|FG000|NOT COMPLETED|Overall Study||3
8908805|NCT02124772|9967243|FG001|NOT COMPLETED|Overall Study||14
8908806|NCT02124772|9967244|FG002|NOT COMPLETED|Overall Study||6
8908807|NCT02124772|9967245|FG003|NOT COMPLETED|Overall Study||13
8908808|NCT02124772|9967246|FG004|NOT COMPLETED|Overall Study||9
8908809|NCT02124772|9967247|FG005|NOT COMPLETED|Overall Study||8
8908810|NCT02124772|9967248|FG006|NOT COMPLETED|Overall Study||8
8908811|NCT02124772|9967249|FG007|NOT COMPLETED|Overall Study||9
8908812|NCT02124772|9967250|FG008|NOT COMPLETED|Overall Study||1
8908813|NCT02124772|9967251|FG009|NOT COMPLETED|Overall Study||7
8908814|NCT02124772|9967252|FG010|NOT COMPLETED|Overall Study||2
8908815|NCT02124772|9967253|FG011|NOT COMPLETED|Overall Study||6
8908816|NCT02124772|9967254|FG012|NOT COMPLETED|Overall Study||2
8908817|NCT02124798|9967306|FG000|STARTED|Overall Study||95
8908818|NCT02124798|9967306|FG000|COMPLETED|Overall Study||91
8908819|NCT02124798|9967306|FG000|NOT COMPLETED|Overall Study||4
8908820|NCT02124811|9967312|FG000|STARTED|Overall Study||5
8908821|NCT02124811|9967313|FG001|STARTED|Overall Study||5
8908822|NCT02124811|9967312|FG000|COMPLETED|Overall Study||2
8908823|NCT02124811|9967313|FG001|COMPLETED|Overall Study||3
8908824|NCT02124811|9967312|FG000|NOT COMPLETED|Overall Study||3
8908825|NCT02124811|9967313|FG001|NOT COMPLETED|Overall Study||2
8908826|NCT02124863|9967319|FG000|STARTED|Overall Study||67
8908827|NCT02124863|9967319|FG000|COMPLETED|Overall Study||50
8908828|NCT02124863|9967319|FG000|NOT COMPLETED|Overall Study||17
8908829|NCT02124889|9967327|FG000|STARTED|Overall Study||12
8908830|NCT02124889|9967328|FG001|STARTED|Overall Study||12
9014480|NCT03029143|10077163|FG001|COMPLETED|Randomized Treatment Period (24 Weeks)||31
9014481|NCT03029143|10077164|FG002|COMPLETED|Randomized Treatment Period (24 Weeks)||31
9014482|NCT03029143|10077162|FG000|NOT COMPLETED|Randomized Treatment Period (24 Weeks)||0
9014483|NCT03029143|10077163|FG001|NOT COMPLETED|Randomized Treatment Period (24 Weeks)||23
9014484|NCT03029143|10077164|FG002|NOT COMPLETED|Randomized Treatment Period (24 Weeks)||24
9014485|NCT03029208|10077175|FG000|STARTED|Overall Study||157
9014486|NCT03029208|10077176|FG001|STARTED|Overall Study||155
9014487|NCT03029208|10077175|FG000|COMPLETED|Overall Study||155
9014488|NCT03029208|10077176|FG001|COMPLETED|Overall Study||151
9014489|NCT03029208|10077175|FG000|NOT COMPLETED|Overall Study||2
9014490|NCT03029208|10077176|FG001|NOT COMPLETED|Overall Study||4
9014491|NCT03029247|10077193|FG000|STARTED|Acute Challenge 1 (Day 1)||45
9014492|NCT03029247|10077194|FG001|STARTED|Acute Challenge 1 (Day 1)||43
9014493|NCT03029247|10077193|FG000|COMPLETED|Acute Challenge 1 (Day 1)||45
9014494|NCT03029247|10077194|FG001|COMPLETED|Acute Challenge 1 (Day 1)||43
8573578|NCT00122382|9605830|FG001|Treated|Double-Blind Study||253
8573579|NCT00122382|9605831|FG002|Treated|Double-Blind Study||0
8573580|NCT00122382|9605829|FG000|COMPLETED|Double-Blind Study||232
8573581|NCT00122382|9605830|FG001|COMPLETED|Double-Blind Study||227
8573582|NCT00122382|9605831|FG002|COMPLETED|Double-Blind Study||0
8573583|NCT00122382|9605829|FG000|NOT COMPLETED|Double-Blind Study||24
8573584|NCT00122382|9605830|FG001|NOT COMPLETED|Double-Blind Study||28
8573585|NCT00122382|9605831|FG002|NOT COMPLETED|Double-Blind Study||0
8573586|NCT00122382|9605829|FG000|STARTED|Open-Label Study||0
8573587|NCT00122382|9605830|FG001|STARTED|Open-Label Study||0
8573588|NCT00122382|9605831|FG002|STARTED|Open-Label Study||459
8573589|NCT00122382|9605829|FG000|COMPLETED|Open-Label Study||0
8573590|NCT00122382|9605830|FG001|COMPLETED|Open-Label Study||0
8573591|NCT00122382|9605831|FG002|COMPLETED|Open-Label Study||433
8573592|NCT00122382|9605829|FG000|NOT COMPLETED|Open-Label Study||0
8573593|NCT00122382|9605830|FG001|NOT COMPLETED|Open-Label Study||0
8573594|NCT00122382|9605831|FG002|NOT COMPLETED|Open-Label Study||26
8573595|NCT00122447|9605853|FG000|STARTED|Overall Study||18
8573596|NCT00122447|9605854|FG001|STARTED|Overall Study||18
8573597|NCT00122447|9605855|FG002|STARTED|Overall Study||17
8573598|NCT00122447|9605856|FG003|STARTED|Overall Study||17
8573599|NCT00122447|9605853|FG000|COMPLETED|Overall Study||17
8573600|NCT00122447|9605854|FG001|COMPLETED|Overall Study||13
8573601|NCT00122447|9605855|FG002|COMPLETED|Overall Study||16
8573602|NCT00122447|9605856|FG003|COMPLETED|Overall Study||14
8573603|NCT00122447|9605853|FG000|NOT COMPLETED|Overall Study||1
8573604|NCT00122447|9605854|FG001|NOT COMPLETED|Overall Study||5
8573605|NCT00122447|9605855|FG002|NOT COMPLETED|Overall Study||1
8573606|NCT00122447|9605856|FG003|NOT COMPLETED|Overall Study||3
8573607|NCT00122460|9605872|FG000|STARTED|Overall Study|Intention To Treat population, treatment group as randomized|222
8573608|NCT00122460|9605873|FG001|STARTED|Overall Study|Intention To Treat population, treatment group as randomized|220
8573609|NCT00122460|9605872|FG000|COMPLETED|Overall Study||215
8573610|NCT00122460|9605873|FG001|COMPLETED|Overall Study||219
8573611|NCT00122460|9605872|FG000|NOT COMPLETED|Overall Study||7
8573612|NCT00122460|9605873|FG001|NOT COMPLETED|Overall Study||1
8573613|NCT00122681|9605881|FG000|STARTED|Overall Study||9325
8573614|NCT00122681|9605882|FG001|STARTED|Overall Study||9319
8573615|NCT00122681|9605881|FG000|COMPLETED|Overall Study||7811
8726804|NCT01038635|9774070|FG004|NOT COMPLETED|Overall Study||1
8726805|NCT01038635|9774071|FG005|NOT COMPLETED|Overall Study||0
8726806|NCT01038635|9774072|FG006|NOT COMPLETED|Overall Study||2
8726807|NCT01038635|9774073|FG007|NOT COMPLETED|Overall Study||5
8726808|NCT01038635|9774074|FG008|NOT COMPLETED|Overall Study||2
8726809|NCT01038687|9774098|FG000|STARTED|Overall Study||12
8726810|NCT01038687|9774099|FG001|STARTED|Overall Study||11
8726811|NCT01038687|9774100|FG002|STARTED|Overall Study||13
8726812|NCT01038687|9774098|FG000|COMPLETED|Overall Study||12
9014495|NCT03029247|10077193|FG000|NOT COMPLETED|Acute Challenge 1 (Day 1)||0
9014496|NCT03029247|10077194|FG001|NOT COMPLETED|Acute Challenge 1 (Day 1)||0
9014497|NCT03029247|10077193|FG000|STARTED|Hgb Maintenance Phase (8 Weeks)||45
9014498|NCT03029247|10077194|FG001|STARTED|Hgb Maintenance Phase (8 Weeks)||43
9014499|NCT03029247|10077193|FG000|COMPLETED|Hgb Maintenance Phase (8 Weeks)||32
9014500|NCT03029247|10077194|FG001|COMPLETED|Hgb Maintenance Phase (8 Weeks)||36
9014501|NCT03029247|10077193|FG000|NOT COMPLETED|Hgb Maintenance Phase (8 Weeks)||13
9014502|NCT03029247|10077194|FG001|NOT COMPLETED|Hgb Maintenance Phase (8 Weeks)||7
9014503|NCT03029247|10077193|FG000|STARTED|Acute Challenge 2 (Day 57)||32
9014504|NCT03029247|10077194|FG001|STARTED|Acute Challenge 2 (Day 57)||36
9014505|NCT03029247|10077193|FG000|COMPLETED|Acute Challenge 2 (Day 57)||32
9014506|NCT03029247|10077194|FG001|COMPLETED|Acute Challenge 2 (Day 57)||36
9014507|NCT03029247|10077193|FG000|NOT COMPLETED|Acute Challenge 2 (Day 57)||0
9014508|NCT03029247|10077194|FG001|NOT COMPLETED|Acute Challenge 2 (Day 57)||0
9014509|NCT03029247|10077193|FG000|STARTED|Follow-up Period (14 Days)||32
8573616|NCT00122681|9605882|FG001|COMPLETED|Overall Study||7798
8573617|NCT00122681|9605881|FG000|NOT COMPLETED|Overall Study||1514
8573618|NCT00122681|9605882|FG001|NOT COMPLETED|Overall Study||1521
8726813|NCT01038687|9774099|FG001|COMPLETED|Overall Study||9
8726814|NCT01038687|9774100|FG002|COMPLETED|Overall Study||12
8726815|NCT01038687|9774098|FG000|NOT COMPLETED|Overall Study||0
8726816|NCT01038687|9774099|FG001|NOT COMPLETED|Overall Study||2
8726817|NCT01038687|9774100|FG002|NOT COMPLETED|Overall Study||1
8908831|NCT02124889|9967327|FG000|COMPLETED|Overall Study||12
8908832|NCT02124889|9967328|FG001|COMPLETED|Overall Study||12
8908833|NCT02124889|9967327|FG000|NOT COMPLETED|Overall Study||0
8908834|NCT02124889|9967328|FG001|NOT COMPLETED|Overall Study||0
8908835|NCT02125279|9967334|FG000|STARTED|Overall Study||54
8908836|NCT02125279|9967334|FG000|COMPLETED|Overall Study||41
8908837|NCT02125279|9967334|FG000|NOT COMPLETED|Overall Study||13
8908838|NCT02125292|9967340|FG000|STARTED|First Intervention (1 Hour)||3
8908839|NCT02125292|9967341|FG001|STARTED|First Intervention (1 Hour)||3
8908840|NCT02125292|9967342|FG002|STARTED|First Intervention (1 Hour)||3
8908841|NCT02125292|9967343|FG003|STARTED|First Intervention (1 Hour)||3
8908842|NCT02125292|9967344|FG004|STARTED|First Intervention (1 Hour)||3
8908843|NCT02125292|9967345|FG005|STARTED|First Intervention (1 Hour)||3
8908844|NCT02125292|9967340|FG000|COMPLETED|First Intervention (1 Hour)||3
8908845|NCT02125292|9967341|FG001|COMPLETED|First Intervention (1 Hour)||3
8908846|NCT02125292|9967342|FG002|COMPLETED|First Intervention (1 Hour)||3
8908847|NCT02125292|9967343|FG003|COMPLETED|First Intervention (1 Hour)||3
8908848|NCT02125292|9967344|FG004|COMPLETED|First Intervention (1 Hour)||3
8908849|NCT02125292|9967345|FG005|COMPLETED|First Intervention (1 Hour)||3
8908850|NCT02125292|9967340|FG000|NOT COMPLETED|First Intervention (1 Hour)||0
8908851|NCT02125292|9967341|FG001|NOT COMPLETED|First Intervention (1 Hour)||0
8908852|NCT02125292|9967342|FG002|NOT COMPLETED|First Intervention (1 Hour)||0
8908853|NCT02125292|9967343|FG003|NOT COMPLETED|First Intervention (1 Hour)||0
8908854|NCT02125292|9967344|FG004|NOT COMPLETED|First Intervention (1 Hour)||0
8908855|NCT02125292|9967345|FG005|NOT COMPLETED|First Intervention (1 Hour)||0
8908856|NCT02125292|9967340|FG000|STARTED|Washout (2 Hours)||3
8908857|NCT02125292|9967341|FG001|STARTED|Washout (2 Hours)||3
8908858|NCT02125292|9967342|FG002|STARTED|Washout (2 Hours)||3
8908859|NCT02125292|9967343|FG003|STARTED|Washout (2 Hours)||3
8908860|NCT02125292|9967344|FG004|STARTED|Washout (2 Hours)||3
8908861|NCT02125292|9967345|FG005|STARTED|Washout (2 Hours)||3
8908862|NCT02125292|9967340|FG000|COMPLETED|Washout (2 Hours)||3
8908863|NCT02125292|9967341|FG001|COMPLETED|Washout (2 Hours)||3
8908864|NCT02125292|9967342|FG002|COMPLETED|Washout (2 Hours)||3
8908865|NCT02125292|9967343|FG003|COMPLETED|Washout (2 Hours)||3
8908866|NCT02125292|9967344|FG004|COMPLETED|Washout (2 Hours)||3
8908867|NCT02125292|9967345|FG005|COMPLETED|Washout (2 Hours)||3
8908868|NCT02125292|9967340|FG000|NOT COMPLETED|Washout (2 Hours)||0
8908869|NCT02125292|9967341|FG001|NOT COMPLETED|Washout (2 Hours)||0
8908870|NCT02125292|9967342|FG002|NOT COMPLETED|Washout (2 Hours)||0
8908871|NCT02125292|9967343|FG003|NOT COMPLETED|Washout (2 Hours)||0
8908872|NCT02125292|9967344|FG004|NOT COMPLETED|Washout (2 Hours)||0
8908873|NCT02125292|9967345|FG005|NOT COMPLETED|Washout (2 Hours)||0
8908874|NCT02125292|9967340|FG000|STARTED|Second Intervention (1 Hour)||3
8908875|NCT02125292|9967341|FG001|STARTED|Second Intervention (1 Hour)||3
8908876|NCT02125292|9967342|FG002|STARTED|Second Intervention (1 Hour)||3
8908877|NCT02125292|9967343|FG003|STARTED|Second Intervention (1 Hour)||3
8908878|NCT02125292|9967344|FG004|STARTED|Second Intervention (1 Hour)||3
8908879|NCT02125292|9967345|FG005|STARTED|Second Intervention (1 Hour)||3
8908880|NCT02125292|9967340|FG000|COMPLETED|Second Intervention (1 Hour)||3
8908881|NCT02125292|9967341|FG001|COMPLETED|Second Intervention (1 Hour)||3
8908882|NCT02125292|9967342|FG002|COMPLETED|Second Intervention (1 Hour)||3
8908883|NCT02125292|9967343|FG003|COMPLETED|Second Intervention (1 Hour)||3
8908884|NCT02125292|9967344|FG004|COMPLETED|Second Intervention (1 Hour)||3
8908885|NCT02125292|9967345|FG005|COMPLETED|Second Intervention (1 Hour)||3
8908886|NCT02125292|9967340|FG000|NOT COMPLETED|Second Intervention (1 Hour)||0
8908887|NCT02125292|9967341|FG001|NOT COMPLETED|Second Intervention (1 Hour)||0
8908888|NCT02125292|9967342|FG002|NOT COMPLETED|Second Intervention (1 Hour)||0
9014510|NCT03029247|10077194|FG001|STARTED|Follow-up Period (14 Days)||36
9014511|NCT03029247|10077193|FG000|COMPLETED|Follow-up Period (14 Days)||32
9014512|NCT03029247|10077194|FG001|COMPLETED|Follow-up Period (14 Days)||36
9014513|NCT03029247|10077193|FG000|NOT COMPLETED|Follow-up Period (14 Days)||0
9014514|NCT03029247|10077194|FG001|NOT COMPLETED|Follow-up Period (14 Days)||0
9014515|NCT03029585|10077202|FG000|STARTED|Overall Study||7
9014516|NCT03029585|10077203|FG001|STARTED|Overall Study||3
9014517|NCT03029585|10077202|FG000|COMPLETED|Overall Study||5
9014518|NCT03029585|10077203|FG001|COMPLETED|Overall Study||2
9014519|NCT03029585|10077202|FG000|NOT COMPLETED|Overall Study||2
9014520|NCT03029585|10077203|FG001|NOT COMPLETED|Overall Study||1
9014521|NCT03029624|10077209|FG000|STARTED|Overall Study||46
9014522|NCT03029624|10077209|FG000|Primary Endpoint (3 Months)|Overall Study||44
9014523|NCT03029624|10077209|FG000|COMPLETED|Overall Study||41
9014524|NCT03029624|10077209|FG000|NOT COMPLETED|Overall Study||5
9014525|NCT03029650|10077215|FG000|STARTED|First Intervention (3 - 6 Days)|More subjects not enrolled after consent in other group leaving uneven number.|14
9014526|NCT03029650|10077216|FG001|STARTED|First Intervention (3 - 6 Days)||12
8908889|NCT02125292|9967343|FG003|NOT COMPLETED|Second Intervention (1 Hour)||0
8908890|NCT02125292|9967344|FG004|NOT COMPLETED|Second Intervention (1 Hour)||0
8908891|NCT02125292|9967345|FG005|NOT COMPLETED|Second Intervention (1 Hour)||0
8908892|NCT02125292|9967340|FG000|STARTED|Washout (2 Hours)||3
9014527|NCT03029650|10077215|FG000|COMPLETED|First Intervention (3 - 6 Days)||14
9014528|NCT03029650|10077216|FG001|COMPLETED|First Intervention (3 - 6 Days)||12
9014529|NCT03029650|10077215|FG000|NOT COMPLETED|First Intervention (3 - 6 Days)||0
9014530|NCT03029650|10077216|FG001|NOT COMPLETED|First Intervention (3 - 6 Days)||0
8908893|NCT02125292|9967341|FG001|STARTED|Washout (2 Hours)||3
8908894|NCT02125292|9967342|FG002|STARTED|Washout (2 Hours)||3
8908895|NCT02125292|9967343|FG003|STARTED|Washout (2 Hours)||3
8908896|NCT02125292|9967344|FG004|STARTED|Washout (2 Hours)||3
8908897|NCT02125292|9967345|FG005|STARTED|Washout (2 Hours)||3
8908898|NCT02125292|9967340|FG000|COMPLETED|Washout (2 Hours)||3
8908899|NCT02125292|9967341|FG001|COMPLETED|Washout (2 Hours)||3
8908900|NCT02125292|9967342|FG002|COMPLETED|Washout (2 Hours)||3
8908901|NCT02125292|9967343|FG003|COMPLETED|Washout (2 Hours)||3
8908902|NCT02125292|9967344|FG004|COMPLETED|Washout (2 Hours)||3
8908903|NCT02125292|9967345|FG005|COMPLETED|Washout (2 Hours)||3
8908904|NCT02125292|9967340|FG000|NOT COMPLETED|Washout (2 Hours)||0
8908905|NCT02125292|9967341|FG001|NOT COMPLETED|Washout (2 Hours)||0
8908906|NCT02125292|9967342|FG002|NOT COMPLETED|Washout (2 Hours)||0
8908907|NCT02125292|9967343|FG003|NOT COMPLETED|Washout (2 Hours)||0
8908908|NCT02125292|9967344|FG004|NOT COMPLETED|Washout (2 Hours)||0
8908909|NCT02125292|9967345|FG005|NOT COMPLETED|Washout (2 Hours)||0
8908910|NCT02125292|9967340|FG000|STARTED|Third Intervention (1 Hour)||3
8908911|NCT02125292|9967341|FG001|STARTED|Third Intervention (1 Hour)||3
8908912|NCT02125292|9967342|FG002|STARTED|Third Intervention (1 Hour)||3
8908913|NCT02125292|9967343|FG003|STARTED|Third Intervention (1 Hour)||3
8908914|NCT02125292|9967344|FG004|STARTED|Third Intervention (1 Hour)||3
8908915|NCT02125292|9967345|FG005|STARTED|Third Intervention (1 Hour)||3
8908916|NCT02125292|9967340|FG000|COMPLETED|Third Intervention (1 Hour)||3
8908917|NCT02125292|9967341|FG001|COMPLETED|Third Intervention (1 Hour)||3
8908918|NCT02125292|9967342|FG002|COMPLETED|Third Intervention (1 Hour)||3
8908919|NCT02125292|9967343|FG003|COMPLETED|Third Intervention (1 Hour)||3
8908920|NCT02125292|9967344|FG004|COMPLETED|Third Intervention (1 Hour)||3
8908921|NCT02125292|9967345|FG005|COMPLETED|Third Intervention (1 Hour)||3
8908922|NCT02125292|9967340|FG000|NOT COMPLETED|Third Intervention (1 Hour)||0
8908923|NCT02125292|9967341|FG001|NOT COMPLETED|Third Intervention (1 Hour)||0
8908924|NCT02125292|9967342|FG002|NOT COMPLETED|Third Intervention (1 Hour)||0
8908925|NCT02125292|9967343|FG003|NOT COMPLETED|Third Intervention (1 Hour)||0
8908926|NCT02125292|9967344|FG004|NOT COMPLETED|Third Intervention (1 Hour)||0
8908927|NCT02125292|9967345|FG005|NOT COMPLETED|Third Intervention (1 Hour)||0
8908928|NCT02125331|9967356|FG000|STARTED|Overall Study||58
8908929|NCT02125331|9967357|FG001|STARTED|Overall Study||25
8908930|NCT02125331|9967356|FG000|COMPLETED|Overall Study||53
8908931|NCT02125331|9967357|FG001|COMPLETED|Overall Study||25
8908932|NCT02125331|9967356|FG000|NOT COMPLETED|Overall Study||5
8908933|NCT02125331|9967357|FG001|NOT COMPLETED|Overall Study||0
8908934|NCT02125604|9967363|FG000|STARTED|Overall Study|enrolled and received at least 1 dose of study drug|211
8908935|NCT02125604|9967363|FG000|COMPLETED|Overall Study||180
8908936|NCT02125604|9967363|FG000|NOT COMPLETED|Overall Study||31
8908937|NCT02125721|9967367|FG000|STARTED|Overall Study||10
8908938|NCT02125721|9967367|FG000|COMPLETED|Overall Study||10
8908939|NCT02125721|9967367|FG000|NOT COMPLETED|Overall Study||0
8908940|NCT02125734|9967373|FG000|STARTED|Period 1||40
8908941|NCT02125734|9967374|FG001|STARTED|Period 1||48
8908942|NCT02125734|9967373|FG000|COMPLETED|Period 1||40
8908943|NCT02125734|9967374|FG001|COMPLETED|Period 1||48
8908944|NCT02125734|9967373|FG000|NOT COMPLETED|Period 1||0
8908945|NCT02125734|9967374|FG001|NOT COMPLETED|Period 1||0
8908946|NCT02125734|9967373|FG000|STARTED|Period 2||40
8908947|NCT02125734|9967374|FG001|STARTED|Period 2||48
8908948|NCT02125734|9967373|FG000|COMPLETED|Period 2||40
8908949|NCT02125734|9967374|FG001|COMPLETED|Period 2||47
8908950|NCT02125734|9967373|FG000|NOT COMPLETED|Period 2||0
8908951|NCT02125734|9967374|FG001|NOT COMPLETED|Period 2||1
8908952|NCT02125838|9967382|FG000|STARTED|Overall Study|Lost to follow-up (n= 4 ) Turned to laparotomy (Adhesions)(n= 2) NBA used (n= 2)|54
8908953|NCT02125838|9967383|FG001|STARTED|Overall Study|Lost to follow-up (n= 4 ) Turned to laparotomy (Adhesions) (n= 2) NBA used (n= 2)|54
8908954|NCT02125838|9967382|FG000|COMPLETED|Overall Study|Analysed (n=50 )|50
8908955|NCT02125838|9967383|FG001|COMPLETED|Overall Study|Analysed (n=50 )|50
8908956|NCT02125838|9967382|FG000|NOT COMPLETED|Overall Study||4
8908957|NCT02125838|9967383|FG001|NOT COMPLETED|Overall Study||4
8908958|NCT02125877|9967391|FG000|STARTED|Overall Study||86
8908959|NCT02125877|9967392|FG001|STARTED|Overall Study||87
8908960|NCT02125877|9967391|FG000|Pharmacokinetic Analysis Set|Overall Study||83
8908961|NCT02125877|9967392|FG001|Pharmacokinetic Analysis Set|Overall Study||83
8908962|NCT02125877|9967391|FG000|Pharmacokinetic Subset A|Overall Study||16
8908963|NCT02125877|9967392|FG001|Pharmacokinetic Subset A|Overall Study||15
8908964|NCT02125877|9967391|FG000|Safety Set|Overall Study||86
8908965|NCT02125877|9967392|FG001|Safety Set|Overall Study||87
8908966|NCT02125877|9967391|FG000|COMPLETED|Overall Study||73
8908967|NCT02125877|9967392|FG001|COMPLETED|Overall Study||77
8908968|NCT02125877|9967391|FG000|NOT COMPLETED|Overall Study||13
8908969|NCT02125877|9967392|FG001|NOT COMPLETED|Overall Study||10
8908970|NCT02126306|9967400|FG000|STARTED|Overall Study||10
8908971|NCT02126306|9967401|FG001|STARTED|Overall Study||13
8908972|NCT02126306|9967400|FG000|COMPLETED|Overall Study||10
8908973|NCT02126306|9967401|FG001|COMPLETED|Overall Study||13
8908974|NCT02126306|9967400|FG000|NOT COMPLETED|Overall Study||0
8908975|NCT02126306|9967401|FG001|NOT COMPLETED|Overall Study||0
8908976|NCT02126319|9967409|FG000|STARTED|Overall Study||61
8908977|NCT02126319|9967410|FG001|STARTED|Overall Study||67
8908978|NCT02126319|9967409|FG000|COMPLETED|Overall Study||40
8908979|NCT02126319|9967410|FG001|COMPLETED|Overall Study||43
8908980|NCT02126319|9967409|FG000|NOT COMPLETED|Overall Study||21
8908981|NCT02126319|9967410|FG001|NOT COMPLETED|Overall Study||24
8908982|NCT02126670|9967422|FG000|STARTED|Overall Study||26
8908983|NCT02126670|9967423|FG001|STARTED|Overall Study||24
8908984|NCT02126670|9967424|FG002|STARTED|Overall Study||25
8908985|NCT02126670|9967425|FG003|STARTED|Overall Study||25
8908986|NCT02126670|9967422|FG000|COMPLETED|Overall Study||25
8908987|NCT02126670|9967423|FG001|COMPLETED|Overall Study||24
8908988|NCT02126670|9967424|FG002|COMPLETED|Overall Study||25
8908989|NCT02126670|9967425|FG003|COMPLETED|Overall Study||24
8908990|NCT02126670|9967422|FG000|NOT COMPLETED|Overall Study||1
8908991|NCT02126670|9967423|FG001|NOT COMPLETED|Overall Study||0
8908992|NCT02126670|9967424|FG002|NOT COMPLETED|Overall Study||0
8908993|NCT02126670|9967425|FG003|NOT COMPLETED|Overall Study||1
8908994|NCT02126748|9967438|FG000|STARTED|Overall Study||33
8908995|NCT02126748|9967439|FG001|STARTED|Overall Study||34
8908996|NCT02126748|9967440|FG002|STARTED|Overall Study||36
8908997|NCT02126748|9967438|FG000|COMPLETED|Overall Study||31
8908998|NCT02126748|9967439|FG001|COMPLETED|Overall Study||31
8908999|NCT02126748|9967440|FG002|COMPLETED|Overall Study||31
8909000|NCT02126748|9967438|FG000|NOT COMPLETED|Overall Study||2
8909001|NCT02126748|9967439|FG001|NOT COMPLETED|Overall Study||3
8909002|NCT02126748|9967440|FG002|NOT COMPLETED|Overall Study||5
8909003|NCT02126826|9967455|FG000|STARTED|Overall Study||9
8909004|NCT02126826|9967456|FG001|STARTED|Overall Study||9
8909005|NCT02126826|9967457|FG002|STARTED|Overall Study||9
8909006|NCT02126826|9967458|FG003|STARTED|Overall Study||9
8909007|NCT02126826|9967459|FG004|STARTED|Overall Study||5
8909008|NCT02126826|9967460|FG005|STARTED|Overall Study||9
8909009|NCT02126826|9967461|FG006|STARTED|Overall Study||8
8909010|NCT02126826|9967455|FG000|COMPLETED|Overall Study||9
8909011|NCT02126826|9967456|FG001|COMPLETED|Overall Study||9
8909012|NCT02126826|9967457|FG002|COMPLETED|Overall Study||9
8909013|NCT02126826|9967458|FG003|COMPLETED|Overall Study||8
8909014|NCT02126826|9967459|FG004|COMPLETED|Overall Study||5
8909015|NCT02126826|9967460|FG005|COMPLETED|Overall Study||9
8909016|NCT02126826|9967461|FG006|COMPLETED|Overall Study||8
8909017|NCT02126826|9967455|FG000|NOT COMPLETED|Overall Study||0
8909018|NCT02126826|9967456|FG001|NOT COMPLETED|Overall Study||0
8909019|NCT02126826|9967457|FG002|NOT COMPLETED|Overall Study||0
8909020|NCT02126826|9967458|FG003|NOT COMPLETED|Overall Study||1
8909021|NCT02126826|9967459|FG004|NOT COMPLETED|Overall Study||0
8909022|NCT02126826|9967460|FG005|NOT COMPLETED|Overall Study||0
8909023|NCT02126826|9967461|FG006|NOT COMPLETED|Overall Study||0
8909024|NCT02126839|9967484|FG000|STARTED|Overall Study||92
8909025|NCT02126839|9967485|FG001|STARTED|Overall Study||94
8909026|NCT02126839|9967484|FG000|Safety Population|Overall Study||92
8909027|NCT02126839|9967485|FG001|Safety Population|Overall Study||93
8909028|NCT02126839|9967484|FG000|Full Analysis Set|Overall Study||92
8909029|NCT02126839|9967485|FG001|Full Analysis Set|Overall Study||92
8909030|NCT02126839|9967484|FG000|COMPLETED|Overall Study||82
8909031|NCT02126839|9967485|FG001|COMPLETED|Overall Study||80
8909032|NCT02126839|9967484|FG000|NOT COMPLETED|Overall Study||10
8909033|NCT02126839|9967485|FG001|NOT COMPLETED|Overall Study||14
8909034|NCT02126969|9967493|FG000|STARTED|Overall Study||23
8909035|NCT02126969|9967494|FG001|STARTED|Overall Study||22
8909036|NCT02126969|9967493|FG000|COMPLETED|Overall Study||22
8909037|NCT02126969|9967494|FG001|COMPLETED|Overall Study||20
8909038|NCT02126969|9967493|FG000|NOT COMPLETED|Overall Study||1
8909039|NCT02126969|9967494|FG001|NOT COMPLETED|Overall Study||2
8909040|NCT02127125|9967509|FG000|STARTED|Overall Study||6
8909041|NCT02127125|9967510|FG001|STARTED|Overall Study||8
8909042|NCT02127125|9967511|FG002|STARTED|Overall Study||9
8909043|NCT02127125|9967512|FG003|STARTED|Overall Study||11
8909044|NCT02127125|9967513|FG004|STARTED|Overall Study||12
8909045|NCT02127125|9967514|FG005|STARTED|Overall Study||12
8909046|NCT02127125|9967515|FG006|STARTED|Overall Study||2
8909047|NCT02127125|9967516|FG007|STARTED|Overall Study||0
8909048|NCT02127125|9967517|FG008|STARTED|Overall Study||1
8909049|NCT02127125|9967509|FG000|COMPLETED|Overall Study||6
8909050|NCT02127125|9967510|FG001|COMPLETED|Overall Study||8
8909051|NCT02127125|9967511|FG002|COMPLETED|Overall Study||8
8909052|NCT02127125|9967512|FG003|COMPLETED|Overall Study||10
8909053|NCT02127125|9967513|FG004|COMPLETED|Overall Study||9
8909054|NCT02127125|9967514|FG005|COMPLETED|Overall Study||9
8909055|NCT02127125|9967515|FG006|COMPLETED|Overall Study||2
8909056|NCT02127125|9967516|FG007|COMPLETED|Overall Study||0
8909057|NCT02127125|9967517|FG008|COMPLETED|Overall Study||1
8909058|NCT02127125|9967509|FG000|NOT COMPLETED|Overall Study||0
8909059|NCT02127125|9967510|FG001|NOT COMPLETED|Overall Study||0
8909060|NCT02127125|9967511|FG002|NOT COMPLETED|Overall Study||1
8909061|NCT02127125|9967512|FG003|NOT COMPLETED|Overall Study||1
8909062|NCT02127125|9967513|FG004|NOT COMPLETED|Overall Study||3
8909063|NCT02127125|9967514|FG005|NOT COMPLETED|Overall Study||3
8909064|NCT02127125|9967515|FG006|NOT COMPLETED|Overall Study||0
8909065|NCT02127125|9967516|FG007|NOT COMPLETED|Overall Study||0
8909066|NCT02127125|9967517|FG008|NOT COMPLETED|Overall Study||0
8909067|NCT02127281|9967539|FG000|STARTED|Overall Study||80
8909068|NCT02127281|9967540|FG001|STARTED|Overall Study||80
8909069|NCT02127281|9967539|FG000|COMPLETED|Overall Study||79
8909070|NCT02127281|9967540|FG001|COMPLETED|Overall Study||80
8909071|NCT02127281|9967539|FG000|NOT COMPLETED|Overall Study||1
8909072|NCT02127281|9967540|FG001|NOT COMPLETED|Overall Study||0
8909073|NCT02127307|9967546|FG000|STARTED|Overall Study||964
8909074|NCT02127307|9967546|FG000|COMPLETED|Overall Study||656
8909075|NCT02127307|9967546|FG000|NOT COMPLETED|Overall Study||308
8909076|NCT02127372|9967552|FG000|STARTED|Overall Study|Signed Consent|15
8909077|NCT02127372|9967553|FG001|STARTED|Overall Study|Signed Consent|28
8909078|NCT02127372|9967552|FG000|Started Study Treatment|Overall Study||15
8909079|NCT02127372|9967553|FG001|Started Study Treatment|Overall Study||28
8909080|NCT02127372|9967552|FG000|COMPLETED|Overall Study|Completed at least one cycle and were available for dose limiting toxicity (DLT) evaluation.|14
8909081|NCT02127372|9967553|FG001|COMPLETED|Overall Study||28
8909082|NCT02127372|9967552|FG000|NOT COMPLETED|Overall Study||1
8909083|NCT02127372|9967553|FG001|NOT COMPLETED|Overall Study||0
8909084|NCT02127567|9967560|FG000|STARTED|Overall Study|41 participants completed 123 domains, 3 domains were completed with the tool per participant|41
8909085|NCT02127567|9967560|FG000|COMPLETED|Overall Study||41
8909086|NCT02127567|9967560|FG000|NOT COMPLETED|Overall Study||0
8909087|NCT02127632|9967570|FG000|STARTED|Overall Study||50
8909088|NCT02127632|9967571|FG001|STARTED|Overall Study||50
8909089|NCT02127632|9967570|FG000|COMPLETED|Overall Study||50
8909090|NCT02127632|9967571|FG001|COMPLETED|Overall Study||50
8909091|NCT02127632|9967570|FG000|NOT COMPLETED|Overall Study||0
8909092|NCT02127632|9967571|FG001|NOT COMPLETED|Overall Study||0
8909093|NCT02127710|9967580|FG000|STARTED|Overall Study||46
8636850|NCT00569673|9677577|FG000|STARTED|Overall Study|Total number participants enrolled on study|71
8636851|NCT00569673|9677577|FG000|COMPLETED|Overall Study|Total number participants that are eligible and evaluable.|71
8636852|NCT00569673|9677577|FG000|NOT COMPLETED|Overall Study||0
8636853|NCT00569777|9677583|FG000|STARTED|Overall Study||206
8909094|NCT02127710|9967581|FG001|STARTED|Overall Study||47
8909095|NCT02127710|9967582|FG002|STARTED|Overall Study||16
8909096|NCT02127710|9967580|FG000|COMPLETED|Overall Study||46
8909097|NCT02127710|9967581|FG001|COMPLETED|Overall Study||47
8909098|NCT02127710|9967582|FG002|COMPLETED|Overall Study||16
8909099|NCT02127710|9967580|FG000|NOT COMPLETED|Overall Study||0
8909100|NCT02127710|9967581|FG001|NOT COMPLETED|Overall Study||0
8909101|NCT02127710|9967582|FG002|NOT COMPLETED|Overall Study||0
8909102|NCT02127723|9967593|FG000|STARTED|Overall Study||20
8909103|NCT02127723|9967593|FG000|COMPLETED|Overall Study||19
8909104|NCT02127723|9967593|FG000|NOT COMPLETED|Overall Study||1
8909105|NCT02127892|9967601|FG000|STARTED|Overall Study||7
8909106|NCT02127892|9967602|FG001|STARTED|Overall Study||2
8909107|NCT02127892|9967603|FG002|STARTED|Overall Study||0
8909108|NCT02127892|9967604|FG003|STARTED|Overall Study||0
8909109|NCT02127892|9967601|FG000|COMPLETED|Overall Study||6
8909110|NCT02127892|9967602|FG001|COMPLETED|Overall Study||1
8909111|NCT02127892|9967603|FG002|COMPLETED|Overall Study||0
8909112|NCT02127892|9967604|FG003|COMPLETED|Overall Study||0
8909113|NCT02127892|9967601|FG000|NOT COMPLETED|Overall Study||1
8909114|NCT02127892|9967602|FG001|NOT COMPLETED|Overall Study||1
8909115|NCT02127892|9967603|FG002|NOT COMPLETED|Overall Study||0
8909116|NCT02127892|9967604|FG003|NOT COMPLETED|Overall Study||0
8909117|NCT02127931|9967614|FG000|STARTED|Overall Study||18
8909118|NCT02127931|9967614|FG000|COMPLETED|Overall Study||17
8909119|NCT02127931|9967614|FG000|NOT COMPLETED|Overall Study||1
8909120|NCT02127970|9967621|FG000|STARTED|Overall Study||349
8909121|NCT02127970|9967622|FG001|STARTED|Overall Study||349
8909122|NCT02127970|9967621|FG000|COMPLETED|Overall Study||323
8909123|NCT02127970|9967622|FG001|COMPLETED|Overall Study||322
8909124|NCT02127970|9967621|FG000|NOT COMPLETED|Overall Study||26
8909125|NCT02127970|9967622|FG001|NOT COMPLETED|Overall Study||27
8909126|NCT02128074|9967628|FG000|STARTED|Overall Study||32
8909127|NCT02128074|9967628|FG000|COMPLETED|Overall Study||26
8909128|NCT02128074|9967628|FG000|NOT COMPLETED|Overall Study||6
8909129|NCT02128217|9967634|FG000|STARTED|Overall Study||17
8909130|NCT02128217|9967635|FG001|STARTED|Overall Study||27
8909131|NCT02128217|9967634|FG000|COMPLETED|Overall Study||17
8909132|NCT02128217|9967635|FG001|COMPLETED|Overall Study||26
8909133|NCT02128217|9967634|FG000|NOT COMPLETED|Overall Study||0
8909134|NCT02128217|9967635|FG001|NOT COMPLETED|Overall Study||1
8909135|NCT02128230|9967646|FG000|STARTED|Overall Study||20
8909136|NCT02128230|9967646|FG000|COMPLETED|Overall Study||1
8909137|NCT02128230|9967646|FG000|NOT COMPLETED|Overall Study||19
8909138|NCT02128269|9967650|FG000|STARTED|Treatment Period||9
8909139|NCT02128269|9967650|FG000|COMPLETED|Treatment Period||7
8909140|NCT02128269|9967650|FG000|NOT COMPLETED|Treatment Period||2
8909141|NCT02128269|9967650|FG000|STARTED|Follow-up|All enrolled patients were followed for 12 weeks after their last infusion of ALXN1007.|9
8909142|NCT02128269|9967650|FG000|COMPLETED|Follow-up||9
8909143|NCT02128269|9967650|FG000|NOT COMPLETED|Follow-up||0
8909144|NCT02128490|9967659|FG000|STARTED|Overall Study||38
8909145|NCT02128490|9967660|FG001|STARTED|Overall Study||37
9014531|NCT03029650|10077215|FG000|STARTED|Washout (1 Week)||14
9014532|NCT03029650|10077216|FG001|STARTED|Washout (1 Week)||12
8909146|NCT02128490|9967661|FG002|STARTED|Overall Study||39
8909147|NCT02128490|9967662|FG003|STARTED|Overall Study||37
8909148|NCT02128490|9967663|FG004|STARTED|Overall Study||38
8909149|NCT02128490|9967659|FG000|COMPLETED|Overall Study||33
8909150|NCT02128490|9967660|FG001|COMPLETED|Overall Study||31
8909151|NCT02128490|9967661|FG002|COMPLETED|Overall Study||34
8909152|NCT02128490|9967662|FG003|COMPLETED|Overall Study||31
8909153|NCT02128490|9967663|FG004|COMPLETED|Overall Study||31
9014533|NCT03029650|10077215|FG000|COMPLETED|Washout (1 Week)||13
9014534|NCT03029650|10077216|FG001|COMPLETED|Washout (1 Week)||10
8726818|NCT01038713|9774111|FG000|STARTED|Overall Study||26
8726819|NCT01038713|9774112|FG001|STARTED|Overall Study||20
8726820|NCT01038713|9774113|FG002|STARTED|Overall Study||17
8726821|NCT01038713|9774111|FG000|COMPLETED|Overall Study||21
8726822|NCT01038713|9774112|FG001|COMPLETED|Overall Study||17
8726823|NCT01038713|9774113|FG002|COMPLETED|Overall Study||16
8726824|NCT01038713|9774111|FG000|NOT COMPLETED|Overall Study||5
8726825|NCT01038713|9774112|FG001|NOT COMPLETED|Overall Study||3
8726826|NCT01038713|9774113|FG002|NOT COMPLETED|Overall Study||1
8726827|NCT01038856|9774121|FG000|STARTED|Overall Study||5
8726828|NCT01038856|9774121|FG000|COMPLETED|Overall Study||3
8726829|NCT01038856|9774121|FG000|NOT COMPLETED|Overall Study||2
8726830|NCT01038869|9774127|FG000|STARTED|Overall Study||20
8726831|NCT01038869|9774127|FG000|COMPLETED|Overall Study||13
8726832|NCT01038869|9774127|FG000|NOT COMPLETED|Overall Study||7
8726833|NCT01038921|9774137|FG000|STARTED|Overall Study|19 subjects received melatonin first(10 weeks), washout (6 weeks), placebo second (10 weeks)|19
8726834|NCT01038921|9774138|FG001|STARTED|Overall Study|20 subjects received placebo first (10 weeks), washout (6 weeks), melatonin second ( 10 weeks)|20
8726835|NCT01038921|9774137|FG000|COMPLETED|Overall Study|2 subjects withdrew|17
8726836|NCT01038921|9774138|FG001|COMPLETED|Overall Study||20
8726837|NCT01038921|9774137|FG000|NOT COMPLETED|Overall Study||2
8726838|NCT01038921|9774138|FG001|NOT COMPLETED|Overall Study||0
8726839|NCT01039207|9774144|FG000|STARTED|Overall Study||31
8726840|NCT01039207|9774144|FG000|COMPLETED|Overall Study||31
8726841|NCT01039207|9774144|FG000|NOT COMPLETED|Overall Study||0
8726842|NCT01039376|9774150|FG000|STARTED|Overall Study||240
8726843|NCT01039376|9774151|FG001|STARTED|Overall Study||240
8726844|NCT01039376|9774150|FG000|COMPLETED|Overall Study||110
8726845|NCT01039376|9774151|FG001|COMPLETED|Overall Study||114
8726846|NCT01039376|9774150|FG000|NOT COMPLETED|Overall Study||130
8726847|NCT01039376|9774151|FG001|NOT COMPLETED|Overall Study||126
8726848|NCT01039428|9774160|FG000|STARTED|Overall Study||35
8726849|NCT01039428|9774161|FG001|STARTED|Overall Study||28
8726850|NCT01039428|9774160|FG000|COMPLETED|Overall Study||33
8726851|NCT01039428|9774161|FG001|COMPLETED|Overall Study||28
8726852|NCT01039428|9774160|FG000|NOT COMPLETED|Overall Study||2
8726853|NCT01039428|9774161|FG001|NOT COMPLETED|Overall Study||0
8726854|NCT01039467|9774169|FG000|STARTED|Overall Study||196
8726855|NCT01039467|9774170|FG001|STARTED|Overall Study||189
8726856|NCT01039467|9774169|FG000|COMPLETED|Overall Study||156
8726857|NCT01039467|9774170|FG001|COMPLETED|Overall Study||140
8726858|NCT01039467|9774169|FG000|NOT COMPLETED|Overall Study||40
8726859|NCT01039467|9774170|FG001|NOT COMPLETED|Overall Study||49
8726860|NCT01039519|9774178|FG000|STARTED|Treatment||27
8726861|NCT01039519|9774178|FG000|COMPLETED|Treatment|Reason not completed represents reason for terminating treatment.|0
8726862|NCT01039519|9774178|FG000|NOT COMPLETED|Treatment||27
8726863|NCT01039519|9774178|FG000|STARTED|Survival Follow-up||27
8726864|NCT01039519|9774178|FG000|COMPLETED|Survival Follow-up||0
8726865|NCT01039519|9774178|FG000|NOT COMPLETED|Survival Follow-up||27
8726866|NCT01039584|9774185|FG000|STARTED|Overall Study||246
8726867|NCT01039584|9774186|FG001|STARTED|Overall Study||243
8726868|NCT01039584|9774187|FG002|STARTED|Overall Study||122
8726869|NCT01039584|9774185|FG000|COMPLETED|Overall Study||143
8726870|NCT01039584|9774186|FG001|COMPLETED|Overall Study||146
8726871|NCT01039584|9774187|FG002|COMPLETED|Overall Study||65
8726872|NCT01039584|9774185|FG000|NOT COMPLETED|Overall Study||103
8726873|NCT01039584|9774186|FG001|NOT COMPLETED|Overall Study||97
8726874|NCT01039584|9774187|FG002|NOT COMPLETED|Overall Study||57
8806568|NCT01478347|9858789|FG000|STARTED|Visit 4-Visit 7 (Day 151-331) - Part II||12
8806569|NCT01478347|9858789|FG000|COMPLETED|Visit 4-Visit 7 (Day 151-331) - Part II||4
8806570|NCT01478347|9858789|FG000|NOT COMPLETED|Visit 4-Visit 7 (Day 151-331) - Part II||8
8806571|NCT01478360|9858795|FG000|STARTED|Overall Study||31
8806572|NCT01478360|9858796|FG001|STARTED|Overall Study||15
8806573|NCT01478360|9858795|FG000|PD (Pharmacodynamic) Analysis Set|Overall Study||31
8806574|NCT01478360|9858796|FG001|PD (Pharmacodynamic) Analysis Set|Overall Study||15
8806575|NCT01478360|9858795|FG000|PK (Pharmacokinetics) Analysis Set|Overall Study|Serum samples were collected during the study and analyzed only for the AIN457 group|31
8806576|NCT01478360|9858796|FG001|PK (Pharmacokinetics) Analysis Set|Overall Study||0
8806577|NCT01478360|9858795|FG000|COMPLETED|Overall Study||29
8806578|NCT01478360|9858796|FG001|COMPLETED|Overall Study||12
8806579|NCT01478360|9858795|FG000|NOT COMPLETED|Overall Study||2
8806580|NCT01478360|9858796|FG001|NOT COMPLETED|Overall Study||3
8806581|NCT01478373|9858802|FG000|STARTED|Treatment Phase||39
8806582|NCT01478373|9858802|FG000|COMPLETED|Treatment Phase||38
8806583|NCT01478373|9858802|FG000|NOT COMPLETED|Treatment Phase||1
8806584|NCT01478373|9858802|FG000|STARTED|Survival Phase||38
8806585|NCT01478373|9858802|FG000|COMPLETED|Survival Phase||0
8806586|NCT01478373|9858802|FG000|NOT COMPLETED|Survival Phase||38
8806587|NCT01478581|9858810|FG000|STARTED|Overall Study||13
8806588|NCT01478581|9858811|FG001|STARTED|Overall Study||18
8806589|NCT01478581|9858812|FG002|STARTED|Overall Study||18
8806590|NCT01478581|9858813|FG003|STARTED|Overall Study|Simon 2-stage design - cohort 4 expansion per stage 1 data (≥3 Clinical Benefit Responders observed|43
8806591|NCT01478581|9858810|FG000|COMPLETED|Overall Study||13
8806592|NCT01478581|9858811|FG001|COMPLETED|Overall Study||18
9014535|NCT03029650|10077215|FG000|NOT COMPLETED|Washout (1 Week)||1
9014536|NCT03029650|10077216|FG001|NOT COMPLETED|Washout (1 Week)||2
9014537|NCT03029650|10077215|FG000|STARTED|2nd Intervention (3 - 6 Days)||13
9014538|NCT03029650|10077216|FG001|STARTED|2nd Intervention (3 - 6 Days)||10
9014539|NCT03029650|10077215|FG000|COMPLETED|2nd Intervention (3 - 6 Days)||13
9014540|NCT03029650|10077216|FG001|COMPLETED|2nd Intervention (3 - 6 Days)||10
9014541|NCT03029650|10077215|FG000|NOT COMPLETED|2nd Intervention (3 - 6 Days)||0
9014542|NCT03029650|10077216|FG001|NOT COMPLETED|2nd Intervention (3 - 6 Days)||0
9014543|NCT03029715|10077228|FG000|STARTED|Overall Study||50
9014544|NCT03029715|10077229|FG001|STARTED|Overall Study||50
9014545|NCT03029715|10077228|FG000|COMPLETED|Overall Study||50
9014546|NCT03029715|10077229|FG001|COMPLETED|Overall Study||50
9014547|NCT03029715|10077228|FG000|NOT COMPLETED|Overall Study||0
9014548|NCT03029715|10077229|FG001|NOT COMPLETED|Overall Study||0
9014549|NCT03029780|10077237|FG000|STARTED|Overall Study||52
8726875|NCT01039675|9774197|FG000|STARTED|Overall Study||9
8726876|NCT01039675|9774198|FG001|STARTED|Overall Study||42
8726877|NCT01039675|9774197|FG000|COMPLETED|Overall Study||9
8726878|NCT01039675|9774198|FG001|COMPLETED|Overall Study||35
8726879|NCT01039675|9774197|FG000|NOT COMPLETED|Overall Study||0
8726880|NCT01039675|9774198|FG001|NOT COMPLETED|Overall Study||7
8726881|NCT01039688|9774207|FG000|STARTED|Overall Study||373
8726882|NCT01039688|9774208|FG001|STARTED|Overall Study||397
8726883|NCT01039688|9774209|FG002|STARTED|Overall Study||186
8726884|NCT01039688|9774207|FG000|COMPLETED|Overall Study||266
8726885|NCT01039688|9774208|FG001|COMPLETED|Overall Study||286
8726886|NCT01039688|9774209|FG002|COMPLETED|Overall Study||106
8726887|NCT01039688|9774207|FG000|NOT COMPLETED|Overall Study||107
8726888|NCT01039688|9774208|FG001|NOT COMPLETED|Overall Study||111
8726889|NCT01039688|9774209|FG002|NOT COMPLETED|Overall Study||80
8726890|NCT01039792|9774222|FG000|STARTED|Overall Study||29
8726891|NCT01039792|9774223|FG001|STARTED|Overall Study||28
8726892|NCT01039792|9774222|FG000|COMPLETED|Overall Study||23
8726893|NCT01039792|9774223|FG001|COMPLETED|Overall Study||27
8726894|NCT01039792|9774222|FG000|NOT COMPLETED|Overall Study||6
8726895|NCT01039792|9774223|FG001|NOT COMPLETED|Overall Study||1
8726896|NCT01040052|9774229|FG000|STARTED|Overall Study||30
8726897|NCT01040052|9774229|FG000|COMPLETED|Overall Study||30
8726898|NCT01040052|9774229|FG000|NOT COMPLETED|Overall Study||0
8726899|NCT01040130|9774233|FG000|STARTED|Overall Study|Number of patients entered and treated|25
8726900|NCT01040130|9774234|FG001|STARTED|Overall Study||25
8726901|NCT01040130|9774235|FG002|STARTED|Overall Study||25
8726902|NCT01040130|9774236|FG003|STARTED|Overall Study||25
8726903|NCT01040130|9774237|FG004|STARTED|Overall Study||25
8726904|NCT01040130|9774238|FG005|STARTED|Overall Study||26
8726905|NCT01040130|9774233|FG000|COMPLETED|Overall Study|Number of patients who did not discontinue from the trial.|22
8726906|NCT01040130|9774234|FG001|COMPLETED|Overall Study||22
8726907|NCT01040130|9774235|FG002|COMPLETED|Overall Study||23
8726908|NCT01040130|9774236|FG003|COMPLETED|Overall Study||20
8726909|NCT01040130|9774237|FG004|COMPLETED|Overall Study||25
8726910|NCT01040130|9774238|FG005|COMPLETED|Overall Study||22
8726911|NCT01040130|9774233|FG000|NOT COMPLETED|Overall Study||3
8726912|NCT01040130|9774234|FG001|NOT COMPLETED|Overall Study||3
8726913|NCT01040130|9774235|FG002|NOT COMPLETED|Overall Study||2
8726914|NCT01040130|9774236|FG003|NOT COMPLETED|Overall Study||5
8726915|NCT01040130|9774237|FG004|NOT COMPLETED|Overall Study||0
8726916|NCT01040130|9774238|FG005|NOT COMPLETED|Overall Study||4
8726917|NCT01040169|9774250|FG000|STARTED|Overall Study||35
8726918|NCT01040169|9774251|FG001|STARTED|Overall Study||44
8726919|NCT01040169|9774250|FG000|COMPLETED|Overall Study||32
8726920|NCT01040169|9774251|FG001|COMPLETED|Overall Study||36
8726921|NCT01040169|9774250|FG000|NOT COMPLETED|Overall Study||3
8726922|NCT01040169|9774251|FG001|NOT COMPLETED|Overall Study||8
8726923|NCT01040208|9774260|FG000|STARTED|Overall Study||45
8726924|NCT01040208|9774261|FG001|STARTED|Overall Study||28
8726925|NCT01040208|9774262|FG002|STARTED|Overall Study||38
8726926|NCT01040208|9774260|FG000|COMPLETED|Overall Study||39
8726927|NCT01040208|9774261|FG001|COMPLETED|Overall Study||15
8726928|NCT01040208|9774262|FG002|COMPLETED|Overall Study||35
8726929|NCT01040208|9774260|FG000|NOT COMPLETED|Overall Study||6
8726930|NCT01040208|9774261|FG001|NOT COMPLETED|Overall Study||13
8726931|NCT01040208|9774262|FG002|NOT COMPLETED|Overall Study||3
8726932|NCT01040260|9774277|FG000|STARTED|Overall Study||53
8726933|NCT01040260|9774278|FG001|STARTED|Overall Study||50
8726934|NCT01040260|9774277|FG000|COMPLETED|Overall Study||38
8726935|NCT01040260|9774278|FG001|COMPLETED|Overall Study||39
8726936|NCT01040260|9774277|FG000|NOT COMPLETED|Overall Study||15
8726937|NCT01040260|9774278|FG001|NOT COMPLETED|Overall Study||11
8726938|NCT01040351|9774286|FG000|STARTED|Overall Study|October 2006|55
8726939|NCT01040351|9774287|FG001|STARTED|Overall Study|October 2006|55
9014550|NCT03029780|10077238|FG001|STARTED|Overall Study||52
9014551|NCT03029780|10077237|FG000|COMPLETED|Overall Study||46
8726940|NCT01040351|9774286|FG000|COMPLETED|Overall Study|May 2010|54
8726941|NCT01040351|9774287|FG001|COMPLETED|Overall Study|May 2010|53
8726942|NCT01040351|9774286|FG000|NOT COMPLETED|Overall Study||1
8726943|NCT01040351|9774287|FG001|NOT COMPLETED|Overall Study||2
8726944|NCT01040403|9774293|FG000|STARTED|Overall Study||233
9014552|NCT03029780|10077238|FG001|COMPLETED|Overall Study||41
8909154|NCT02128490|9967659|FG000|NOT COMPLETED|Overall Study||5
8909155|NCT02128490|9967660|FG001|NOT COMPLETED|Overall Study||6
8909156|NCT02128490|9967661|FG002|NOT COMPLETED|Overall Study||5
8909157|NCT02128490|9967662|FG003|NOT COMPLETED|Overall Study||6
8909158|NCT02128490|9967663|FG004|NOT COMPLETED|Overall Study||7
8909159|NCT02128542|9967677|FG000|STARTED|Overall Study||47
8909160|NCT02128542|9967678|FG001|STARTED|Overall Study||19
8909161|NCT02128542|9967677|FG000|COMPLETED|Overall Study||43
8909162|NCT02128542|9967678|FG001|COMPLETED|Overall Study||19
8909163|NCT02128542|9967677|FG000|NOT COMPLETED|Overall Study||4
8909164|NCT02128542|9967678|FG001|NOT COMPLETED|Overall Study||0
8909165|NCT02128724|9967690|FG000|STARTED|Overall Study||4
8909166|NCT02128724|9967691|FG001|STARTED|Overall Study||4
8909167|NCT02128724|9967692|FG002|STARTED|Overall Study||3
8909168|NCT02128724|9967693|FG003|STARTED|Overall Study||10
8909169|NCT02128724|9967690|FG000|COMPLETED|Overall Study||3
8909170|NCT02128724|9967691|FG001|COMPLETED|Overall Study||3
8909171|NCT02128724|9967692|FG002|COMPLETED|Overall Study||3
8909172|NCT02128724|9967693|FG003|COMPLETED|Overall Study||7
8636854|NCT00569777|9677584|FG001|STARTED|Overall Study||104
8636855|NCT00569777|9677583|FG000|COMPLETED|Overall Study||196
8909173|NCT02128724|9967690|FG000|NOT COMPLETED|Overall Study||1
8909174|NCT02128724|9967691|FG001|NOT COMPLETED|Overall Study||1
8909175|NCT02128724|9967692|FG002|NOT COMPLETED|Overall Study||0
8909176|NCT02128724|9967693|FG003|NOT COMPLETED|Overall Study||3
8909177|NCT02128763|9967704|FG000|STARTED|Overall Study||349
8909178|NCT02128763|9967705|FG001|STARTED|Overall Study||186
8909179|NCT02128763|9967704|FG000|COMPLETED|Overall Study||329
8909180|NCT02128763|9967705|FG001|COMPLETED|Overall Study||170
8909181|NCT02128763|9967704|FG000|NOT COMPLETED|Overall Study||20
8909182|NCT02128763|9967705|FG001|NOT COMPLETED|Overall Study||16
8909183|NCT02128828|9967714|FG000|STARTED|Overall Study||20
8909184|NCT02128828|9967714|FG000|COMPLETED|Overall Study||17
8909185|NCT02128828|9967714|FG000|NOT COMPLETED|Overall Study||3
8909186|NCT02128867|9967721|FG000|STARTED|Overall Study||53
8909187|NCT02128867|9967722|FG001|STARTED|Overall Study||52
8909188|NCT02128867|9967723|FG002|STARTED|Overall Study||54
8909189|NCT02128867|9967721|FG000|COMPLETED|Overall Study||50
8909190|NCT02128867|9967722|FG001|COMPLETED|Overall Study||50
8909191|NCT02128867|9967723|FG002|COMPLETED|Overall Study||50
8909192|NCT02128867|9967721|FG000|NOT COMPLETED|Overall Study||3
8909193|NCT02128867|9967722|FG001|NOT COMPLETED|Overall Study||2
8909194|NCT02128867|9967723|FG002|NOT COMPLETED|Overall Study||4
8909195|NCT02128919|9967733|FG000|STARTED|Overall Study||17
8909196|NCT02128919|9967734|FG001|STARTED|Overall Study||16
8909197|NCT02128919|9967733|FG000|COMPLETED|Overall Study||14
8909198|NCT02128919|9967734|FG001|COMPLETED|Overall Study||15
8909199|NCT02128919|9967733|FG000|NOT COMPLETED|Overall Study||3
8909200|NCT02128919|9967734|FG001|NOT COMPLETED|Overall Study||1
8909201|NCT02128932|9967744|FG000|STARTED|Overall Study||362
8909202|NCT02128932|9967745|FG001|STARTED|Overall Study||360
8909203|NCT02128932|9967746|FG002|STARTED|Overall Study||360
8909204|NCT02128932|9967744|FG000|COMPLETED|Overall Study||335
9014553|NCT03029780|10077237|FG000|NOT COMPLETED|Overall Study||6
9014554|NCT03029780|10077238|FG001|NOT COMPLETED|Overall Study||11
9014555|NCT03029819|10077246|FG000|STARTED|Overall Study||33
9014556|NCT03029819|10077247|FG001|STARTED|Overall Study||39
9014557|NCT03029819|10077246|FG000|COMPLETED|Overall Study||30
9014558|NCT03029819|10077247|FG001|COMPLETED|Overall Study||33
9014559|NCT03029819|10077246|FG000|NOT COMPLETED|Overall Study||3
9014560|NCT03029819|10077247|FG001|NOT COMPLETED|Overall Study||6
9014561|NCT03029988|10077256|FG000|STARTED|Overall Study||3
9014562|NCT03029988|10077256|FG000|COMPLETED|Overall Study||3
9014563|NCT03029988|10077256|FG000|NOT COMPLETED|Overall Study||0
9014564|NCT03030183|10077261|FG000|STARTED|Overall Study||3
9014565|NCT03030183|10077261|FG000|COMPLETED|Overall Study||3
9014566|NCT03030183|10077261|FG000|NOT COMPLETED|Overall Study||0
9014567|NCT03030599|10077265|FG000|STARTED|Open Label Treatment and Titration||201
9014568|NCT03030599|10077266|FG001|STARTED|Open Label Treatment and Titration||0
9014569|NCT03030599|10077267|FG002|STARTED|Open Label Treatment and Titration||0
9014570|NCT03030599|10077265|FG000|COMPLETED|Open Label Treatment and Titration||155
9014571|NCT03030599|10077266|FG001|COMPLETED|Open Label Treatment and Titration||0
9014572|NCT03030599|10077267|FG002|COMPLETED|Open Label Treatment and Titration||0
9014573|NCT03030599|10077265|FG000|NOT COMPLETED|Open Label Treatment and Titration||46
9014574|NCT03030599|10077266|FG001|NOT COMPLETED|Open Label Treatment and Titration||0
9014575|NCT03030599|10077267|FG002|NOT COMPLETED|Open Label Treatment and Titration||0
9014576|NCT03030599|10077265|FG000|STARTED|Stable Dose|149 subjects of the 201 entered the Stable Dose Period. Of those subjects, 136 were randomized.|149
9014577|NCT03030599|10077266|FG001|STARTED|Stable Dose||0
9014578|NCT03030599|10077267|FG002|STARTED|Stable Dose||0
9014579|NCT03030599|10077265|FG000|COMPLETED|Stable Dose||144
9014580|NCT03030599|10077266|FG001|COMPLETED|Stable Dose||0
8909205|NCT02128932|9967745|FG001|COMPLETED|Overall Study||341
8909206|NCT02128932|9967746|FG002|COMPLETED|Overall Study||342
8909207|NCT02128932|9967744|FG000|NOT COMPLETED|Overall Study||27
8909208|NCT02128932|9967745|FG001|NOT COMPLETED|Overall Study||19
8909209|NCT02128932|9967746|FG002|NOT COMPLETED|Overall Study||18
8909210|NCT02128997|9967756|FG000|STARTED|Overall Study||67
8909211|NCT02128997|9967757|FG001|STARTED|Overall Study||69
8909212|NCT02128997|9967756|FG000|COMPLETED|Overall Study||61
8909213|NCT02128997|9967757|FG001|COMPLETED|Overall Study||58
9014581|NCT03030599|10077267|FG002|COMPLETED|Stable Dose||0
9014582|NCT03030599|10077265|FG000|NOT COMPLETED|Stable Dose||5
9014583|NCT03030599|10077266|FG001|NOT COMPLETED|Stable Dose||0
9014584|NCT03030599|10077267|FG002|NOT COMPLETED|Stable Dose||0
9014585|NCT03030599|10077265|FG000|STARTED|Double Blind Randomized Withdrawal||0
9014586|NCT03030599|10077266|FG001|STARTED|Double Blind Randomized Withdrawal|134 of the 136 subjects randomized received at least 1 dose of study drug in the DB RWP.|69
9014587|NCT03030599|10077267|FG002|STARTED|Double Blind Randomized Withdrawal|134 of the 136 subjects randomized received at least 1 dose of study drug in the DB RWP.|67
9014588|NCT03030599|10077265|FG000|COMPLETED|Double Blind Randomized Withdrawal||0
9014589|NCT03030599|10077266|FG001|COMPLETED|Double Blind Randomized Withdrawal||69
9014590|NCT03030599|10077267|FG002|COMPLETED|Double Blind Randomized Withdrawal||59
9014591|NCT03030599|10077265|FG000|NOT COMPLETED|Double Blind Randomized Withdrawal||0
9014592|NCT03030599|10077266|FG001|NOT COMPLETED|Double Blind Randomized Withdrawal||0
9014593|NCT03030599|10077267|FG002|NOT COMPLETED|Double Blind Randomized Withdrawal||8
9014594|NCT03030599|10077265|FG000|STARTED|Open-label Extension||74
9014595|NCT03030599|10077266|FG001|STARTED|Open-label Extension||0
9014596|NCT03030599|10077267|FG002|STARTED|Open-label Extension||0
9014597|NCT03030599|10077265|FG000|COMPLETED|Open-label Extension||67
9014598|NCT03030599|10077266|FG001|COMPLETED|Open-label Extension||0
9014599|NCT03030599|10077267|FG002|COMPLETED|Open-label Extension||0
8573619|NCT00122954|9605898|FG000|STARTED|Overall Study||18
8573620|NCT00122954|9605899|FG001|STARTED|Overall Study||21
8573621|NCT00122954|9605898|FG000|COMPLETED|Overall Study||16
8573622|NCT00122954|9605899|FG001|COMPLETED|Overall Study||18
8573623|NCT00122954|9605898|FG000|NOT COMPLETED|Overall Study||2
8573624|NCT00122954|9605899|FG001|NOT COMPLETED|Overall Study||3
8573625|NCT00122980|9605907|FG000|STARTED|Overall Study|Randomized sample: 67; Intent-to-treat sample: 67|67
8573626|NCT00122980|9605908|FG001|STARTED|Overall Study|Randomized sample: 67; Intent-to-treat sample: 66|66
8573627|NCT00122980|9605907|FG000|COMPLETED|Overall Study|Study terminated early|24
8573628|NCT00122980|9605908|FG001|COMPLETED|Overall Study|Study terminated early|26
8573629|NCT00122980|9605907|FG000|NOT COMPLETED|Overall Study||43
8573630|NCT00122980|9605908|FG001|NOT COMPLETED|Overall Study||40
8573631|NCT00123110|9605917|FG000|STARTED|Overall Study||12
8573632|NCT00123110|9605918|FG001|STARTED|Overall Study||12
8573633|NCT00123110|9605919|FG002|STARTED|Overall Study||11
8573634|NCT00123110|9605917|FG000|COMPLETED|Overall Study||12
8573635|NCT00123110|9605918|FG001|COMPLETED|Overall Study||12
8636856|NCT00569777|9677584|FG001|COMPLETED|Overall Study||101
8636857|NCT00569777|9677583|FG000|NOT COMPLETED|Overall Study||10
8636858|NCT00569777|9677584|FG001|NOT COMPLETED|Overall Study||3
8636859|NCT00569803|9677598|FG000|STARTED|Overall Study||5
8726945|NCT01040403|9774293|FG000|Completed Olo 5|Overall Study||106
8573636|NCT00123110|9605919|FG002|COMPLETED|Overall Study||11
8573637|NCT00123110|9605917|FG000|NOT COMPLETED|Overall Study||0
8636860|NCT00569803|9677599|FG001|STARTED|Overall Study||5
8636861|NCT00569803|9677600|FG002|STARTED|Overall Study||5
8636862|NCT00569803|9677601|FG003|STARTED|Overall Study||6
8636863|NCT00569803|9677602|FG004|STARTED|Overall Study||5
8636864|NCT00569803|9677603|FG005|STARTED|Overall Study||5
8636865|NCT00569803|9677604|FG006|STARTED|Overall Study||10
8726946|NCT01040403|9774293|FG000|Completed T+O 1.25/5|Overall Study||105
8726947|NCT01040403|9774293|FG000|Completed T+O 2.5/5|Overall Study||111
8726948|NCT01040403|9774293|FG000|Completed T+O 5/5|Overall Study||106
8726949|NCT01040403|9774293|FG000|Completed Olo 10|Overall Study||109
8726950|NCT01040403|9774293|FG000|Completed T+O 1.25/10|Overall Study||106
8726951|NCT01040403|9774293|FG000|Completed T+O 2.5/10|Overall Study||110
8726952|NCT01040403|9774293|FG000|Completed T+O 5/10|Overall Study||107
8726953|NCT01040403|9774293|FG000|COMPLETED|Overall Study|All treatment periods|213
8726954|NCT01040403|9774293|FG000|NOT COMPLETED|Overall Study||20
8726955|NCT01040689|9774312|FG000|STARTED|Overall Study||27
8726956|NCT01040689|9774313|FG001|STARTED|Overall Study||27
8726957|NCT01040689|9774314|FG002|STARTED|Overall Study||27
8726958|NCT01040689|9774315|FG003|STARTED|Overall Study||27
8726959|NCT01040689|9774312|FG000|COMPLETED|Overall Study||24
8726960|NCT01040689|9774313|FG001|COMPLETED|Overall Study||25
8726961|NCT01040689|9774314|FG002|COMPLETED|Overall Study||23
8726962|NCT01040689|9774315|FG003|COMPLETED|Overall Study||23
8726963|NCT01040689|9774312|FG000|NOT COMPLETED|Overall Study||3
8726964|NCT01040689|9774313|FG001|NOT COMPLETED|Overall Study||2
8726965|NCT01040689|9774314|FG002|NOT COMPLETED|Overall Study||4
8726966|NCT01040689|9774315|FG003|NOT COMPLETED|Overall Study||4
8726967|NCT01040728|9774330|FG000|STARTED|Overall Study||31
8726968|NCT01040728|9774331|FG001|STARTED|Overall Study||30
8726969|NCT01040728|9774332|FG002|STARTED|Overall Study||31
8726970|NCT01040728|9774333|FG003|STARTED|Overall Study||30
8726971|NCT01040728|9774330|FG000|COMPLETED|Overall Study||27
8726972|NCT01040728|9774331|FG001|COMPLETED|Overall Study||19
8726973|NCT01040728|9774332|FG002|COMPLETED|Overall Study||30
8726974|NCT01040728|9774333|FG003|COMPLETED|Overall Study||24
8726975|NCT01040728|9774330|FG000|NOT COMPLETED|Overall Study||4
8726976|NCT01040728|9774331|FG001|NOT COMPLETED|Overall Study||11
8726977|NCT01040728|9774332|FG002|NOT COMPLETED|Overall Study||1
8726978|NCT01040728|9774333|FG003|NOT COMPLETED|Overall Study||6
8726979|NCT01040780|9774351|FG000|STARTED|Overall Study||200
8726980|NCT01040780|9774352|FG001|STARTED|Overall Study||199
8726981|NCT01040780|9774351|FG000|COMPLETED|Overall Study||199
8909214|NCT02128997|9967756|FG000|NOT COMPLETED|Overall Study||6
8909215|NCT02128997|9967757|FG001|NOT COMPLETED|Overall Study||11
8909216|NCT02129062|9967763|FG000|STARTED|Overall Study||3
8909217|NCT02129062|9967763|FG000|COMPLETED|Overall Study||0
8909218|NCT02129062|9967763|FG000|NOT COMPLETED|Overall Study||3
8909219|NCT02129075|9967769|FG000|STARTED|Overall Study||30
8909220|NCT02129075|9967770|FG001|STARTED|Overall Study||30
8909221|NCT02129075|9967769|FG000|COMPLETED|Overall Study||30
8909222|NCT02129075|9967770|FG001|COMPLETED|Overall Study||30
8909223|NCT02129075|9967769|FG000|NOT COMPLETED|Overall Study||0
8909224|NCT02129075|9967770|FG001|NOT COMPLETED|Overall Study||0
8909225|NCT02129192|9967780|FG000|STARTED|Period 1 Including Washout Period||36
8909226|NCT02129192|9967781|FG001|STARTED|Period 1 Including Washout Period||36
8909227|NCT02129192|9967780|FG000|COMPLETED|Period 1 Including Washout Period||36
8909228|NCT02129192|9967781|FG001|COMPLETED|Period 1 Including Washout Period|Withdrawal by one subject in washout period|35
8909229|NCT02129192|9967780|FG000|NOT COMPLETED|Period 1 Including Washout Period||0
8909230|NCT02129192|9967781|FG001|NOT COMPLETED|Period 1 Including Washout Period||1
8909231|NCT02129192|9967780|FG000|STARTED|Period 2 Including Washout Period||36
8909232|NCT02129192|9967781|FG001|STARTED|Period 2 Including Washout Period||35
8909233|NCT02129192|9967780|FG000|COMPLETED|Period 2 Including Washout Period||36
8909234|NCT02129192|9967781|FG001|COMPLETED|Period 2 Including Washout Period||35
9014600|NCT03030599|10077265|FG000|NOT COMPLETED|Open-label Extension||7
9014601|NCT03030599|10077266|FG001|NOT COMPLETED|Open-label Extension||0
9014602|NCT03030599|10077267|FG002|NOT COMPLETED|Open-label Extension||0
9014603|NCT03030638|10077281|FG000|STARTED|Overall Study||1386
9014604|NCT03030638|10077282|FG001|STARTED|Overall Study||1841
9014605|NCT03030638|10077283|FG002|STARTED|Overall Study||1712
9014606|NCT03030638|10077284|FG003|STARTED|Overall Study||6406
9014607|NCT03030638|10077285|FG004|STARTED|Overall Study||696
8636866|NCT00569803|9677605|FG007|STARTED|Overall Study||6
8636867|NCT00569803|9677598|FG000|COMPLETED|Overall Study||4
8636868|NCT00569803|9677599|FG001|COMPLETED|Overall Study||5
9014608|NCT03030638|10077286|FG005|STARTED|Overall Study||1592
9014609|NCT03030638|10077287|FG006|STARTED|Overall Study||364
9014610|NCT03030638|10077288|FG007|STARTED|Overall Study||127
9014611|NCT03030638|10077281|FG000|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||372
9014612|NCT03030638|10077282|FG001|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||636
9014613|NCT03030638|10077283|FG002|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
9014614|NCT03030638|10077284|FG003|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
9014615|NCT03030638|10077285|FG004|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
9014616|NCT03030638|10077286|FG005|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
9014617|NCT03030638|10077287|FG006|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
9014618|NCT03030638|10077288|FG007|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
9014619|NCT03030638|10077281|FG000|COMPLETED|Overall Study||1386
9014620|NCT03030638|10077282|FG001|COMPLETED|Overall Study||1841
9014621|NCT03030638|10077283|FG002|COMPLETED|Overall Study||1712
9014622|NCT03030638|10077284|FG003|COMPLETED|Overall Study||6406
9014623|NCT03030638|10077285|FG004|COMPLETED|Overall Study||696
9014624|NCT03030638|10077286|FG005|COMPLETED|Overall Study||1592
9014625|NCT03030638|10077287|FG006|COMPLETED|Overall Study||364
9014626|NCT03030638|10077288|FG007|COMPLETED|Overall Study||127
9014627|NCT03030638|10077281|FG000|NOT COMPLETED|Overall Study||0
9014628|NCT03030638|10077282|FG001|NOT COMPLETED|Overall Study||0
9014629|NCT03030638|10077283|FG002|NOT COMPLETED|Overall Study||0
9014630|NCT03030638|10077284|FG003|NOT COMPLETED|Overall Study||0
9014631|NCT03030638|10077285|FG004|NOT COMPLETED|Overall Study||0
9014632|NCT03030638|10077286|FG005|NOT COMPLETED|Overall Study||0
9014633|NCT03030638|10077287|FG006|NOT COMPLETED|Overall Study||0
9014634|NCT03030638|10077288|FG007|NOT COMPLETED|Overall Study||0
9014635|NCT03030989|10077310|FG000|STARTED|Overall Study||21
9014636|NCT03030989|10077311|FG001|STARTED|Overall Study||29
9014637|NCT03030989|10077310|FG000|COMPLETED|Overall Study||9
9014638|NCT03030989|10077311|FG001|COMPLETED|Overall Study||15
9014639|NCT03030989|10077310|FG000|NOT COMPLETED|Overall Study||12
9014640|NCT03030989|10077311|FG001|NOT COMPLETED|Overall Study||14
9014641|NCT03031431|10077317|FG000|STARTED|Overall Study||130
9014642|NCT03031431|10077317|FG000|COMPLETED|Overall Study||129
9014643|NCT03031431|10077317|FG000|NOT COMPLETED|Overall Study||1
9014644|NCT03031496|10077321|FG000|STARTED|Period 1||21
9014645|NCT03031496|10077322|FG001|STARTED|Period 1||21
9014646|NCT03031496|10077321|FG000|COMPLETED|Period 1||19
9014647|NCT03031496|10077322|FG001|COMPLETED|Period 1||19
9014648|NCT03031496|10077321|FG000|NOT COMPLETED|Period 1||2
9014649|NCT03031496|10077322|FG001|NOT COMPLETED|Period 1||2
9014650|NCT03031496|10077321|FG000|STARTED|Period 2||19
9014651|NCT03031496|10077322|FG001|STARTED|Period 2||19
9014652|NCT03031496|10077321|FG000|COMPLETED|Period 2||19
9014653|NCT03031496|10077322|FG001|COMPLETED|Period 2||19
9014654|NCT03031496|10077321|FG000|NOT COMPLETED|Period 2||0
9014655|NCT03031496|10077322|FG001|NOT COMPLETED|Period 2||0
8636869|NCT00569803|9677600|FG002|COMPLETED|Overall Study||5
8636870|NCT00569803|9677601|FG003|COMPLETED|Overall Study||5
9014656|NCT03031678|10077328|FG000|STARTED|Overall Study||50
9014657|NCT03031678|10077328|FG000|EAS Test Condition Complete|Overall Study||39
9014658|NCT03031678|10077328|FG000|CI Alone Test Condition Complete|Overall Study||10
9014659|NCT03031678|10077328|FG000|COMPLETED|Overall Study||49
9014660|NCT03031678|10077328|FG000|NOT COMPLETED|Overall Study||1
8636871|NCT00569803|9677602|FG004|COMPLETED|Overall Study||5
8909235|NCT02129192|9967780|FG000|NOT COMPLETED|Period 2 Including Washout Period||0
8909236|NCT02129192|9967781|FG001|NOT COMPLETED|Period 2 Including Washout Period||0
8909237|NCT02129192|9967780|FG000|STARTED|Period 3 Including Washout Period||36
8909238|NCT02129192|9967781|FG001|STARTED|Period 3 Including Washout Period||35
8909239|NCT02129192|9967780|FG000|COMPLETED|Period 3 Including Washout Period||36
8909240|NCT02129192|9967781|FG001|COMPLETED|Period 3 Including Washout Period||35
8909241|NCT02129192|9967780|FG000|NOT COMPLETED|Period 3 Including Washout Period||0
8909242|NCT02129192|9967781|FG001|NOT COMPLETED|Period 3 Including Washout Period||0
8909243|NCT02129192|9967780|FG000|STARTED|Period 4 Including Washout Period||36
8909244|NCT02129192|9967781|FG001|STARTED|Period 4 Including Washout Period||35
8909245|NCT02129192|9967780|FG000|COMPLETED|Period 4 Including Washout Period||36
8909246|NCT02129192|9967781|FG001|COMPLETED|Period 4 Including Washout Period||35
8909247|NCT02129192|9967780|FG000|NOT COMPLETED|Period 4 Including Washout Period||0
8909248|NCT02129192|9967781|FG001|NOT COMPLETED|Period 4 Including Washout Period||0
8909249|NCT02129192|9967780|FG000|STARTED|Period 5||36
8909250|NCT02129192|9967781|FG001|STARTED|Period 5|This sequence consists of only 4 periods.|0
8909251|NCT02129192|9967780|FG000|COMPLETED|Period 5||36
8909252|NCT02129192|9967781|FG001|COMPLETED|Period 5||0
8909253|NCT02129192|9967780|FG000|NOT COMPLETED|Period 5||0
8909254|NCT02129192|9967781|FG001|NOT COMPLETED|Period 5||0
8909255|NCT02129205|9967800|FG000|STARTED|Overall Study||2
8909256|NCT02129205|9967801|FG001|STARTED|Overall Study||2
8909257|NCT02129205|9967802|FG002|STARTED|Overall Study||2
8636872|NCT00569803|9677603|FG005|COMPLETED|Overall Study||5
8636873|NCT00569803|9677604|FG006|COMPLETED|Overall Study||10
8636874|NCT00569803|9677605|FG007|COMPLETED|Overall Study||5
8636875|NCT00569803|9677598|FG000|NOT COMPLETED|Overall Study||1
8636876|NCT00569803|9677599|FG001|NOT COMPLETED|Overall Study||0
8636877|NCT00569803|9677600|FG002|NOT COMPLETED|Overall Study||0
8636878|NCT00569803|9677601|FG003|NOT COMPLETED|Overall Study||1
8636879|NCT00569803|9677602|FG004|NOT COMPLETED|Overall Study||0
8909258|NCT02129205|9967803|FG003|STARTED|Overall Study||2
8909259|NCT02129205|9967804|FG004|STARTED|Overall Study||7
8909260|NCT02129205|9967805|FG005|STARTED|Overall Study||11
8909261|NCT02129205|9967806|FG006|STARTED|Overall Study||6
8909262|NCT02129205|9967807|FG007|STARTED|Overall Study||6
8909263|NCT02129205|9967808|FG008|STARTED|Overall Study||2
8909264|NCT02129205|9967809|FG009|STARTED|Overall Study||0
8909265|NCT02129205|9967800|FG000|COMPLETED|Overall Study||1
9014661|NCT03031795|10077338|FG000|STARTED|Overall Study||35
9014662|NCT03031795|10077339|FG001|STARTED|Overall Study||36
9014663|NCT03031795|10077338|FG000|COMPLETED|Overall Study||35
9014664|NCT03031795|10077339|FG001|COMPLETED|Overall Study||35
9014665|NCT03031795|10077338|FG000|NOT COMPLETED|Overall Study||0
9014666|NCT03031795|10077339|FG001|NOT COMPLETED|Overall Study||1
9014667|NCT03031899|10077345|FG000|STARTED|Overall Study||27
9014668|NCT03031899|10077345|FG000|COMPLETED|Overall Study||25
9014669|NCT03031899|10077345|FG000|NOT COMPLETED|Overall Study||2
9014670|NCT03031938|10077355|FG000|STARTED|Overall Study||2
9014671|NCT03031938|10077356|FG001|STARTED|Overall Study||2
9014672|NCT03031938|10077355|FG000|COMPLETED|Overall Study||1
9014673|NCT03031938|10077356|FG001|COMPLETED|Overall Study||2
9014674|NCT03031938|10077355|FG000|NOT COMPLETED|Overall Study||1
9014675|NCT03031938|10077356|FG001|NOT COMPLETED|Overall Study||0
9014676|NCT03032263|10077364|FG000|STARTED|Overall Study||6
9014677|NCT03032263|10077365|FG001|STARTED|Overall Study||6
9014678|NCT03032263|10077364|FG000|COMPLETED|Overall Study||6
9014679|NCT03032263|10077365|FG001|COMPLETED|Overall Study||6
9014680|NCT03032263|10077364|FG000|NOT COMPLETED|Overall Study||0
9014681|NCT03032263|10077365|FG001|NOT COMPLETED|Overall Study||0
9014682|NCT03032380|10077373|FG000|STARTED|Overall Study||148
9014683|NCT03032380|10077374|FG001|STARTED|Overall Study||152
9014684|NCT03032380|10077373|FG000|Received Treatment|Overall Study||148
9014685|NCT03032380|10077374|FG001|Received Treatment|Overall Study||150
9014686|NCT03032380|10077373|FG000|COMPLETED|Overall Study||106
9014687|NCT03032380|10077374|FG001|COMPLETED|Overall Study||112
9014688|NCT03032380|10077373|FG000|NOT COMPLETED|Overall Study||42
9014689|NCT03032380|10077374|FG001|NOT COMPLETED|Overall Study||40
9014690|NCT03032393|10077382|FG000|STARTED|Overall Study||15
9014691|NCT03032393|10077383|FG001|STARTED|Overall Study||15
9014692|NCT03032393|10077382|FG000|COMPLETED|Overall Study||15
9014693|NCT03032393|10077383|FG001|COMPLETED|Overall Study||15
9014694|NCT03032393|10077382|FG000|NOT COMPLETED|Overall Study||0
9014695|NCT03032393|10077383|FG001|NOT COMPLETED|Overall Study||0
9014696|NCT03032523|10077391|FG000|STARTED|Overall Study||15
9014697|NCT03032523|10077392|FG001|STARTED|Overall Study||6
9014698|NCT03032523|10077391|FG000|COMPLETED|Overall Study||12
9014699|NCT03032523|10077392|FG001|COMPLETED|Overall Study||4
9014700|NCT03032523|10077391|FG000|NOT COMPLETED|Overall Study||3
9014701|NCT03032523|10077392|FG001|NOT COMPLETED|Overall Study||2
9014702|NCT03032965|10077401|FG000|STARTED|Overall Study||61
9014703|NCT03032965|10077402|FG001|STARTED|Overall Study||68
9014704|NCT03032965|10077401|FG000|COMPLETED|Overall Study||61
8636880|NCT00569803|9677603|FG005|NOT COMPLETED|Overall Study||0
8636881|NCT00569803|9677604|FG006|NOT COMPLETED|Overall Study||0
8909266|NCT02129205|9967801|FG001|COMPLETED|Overall Study||2
9014705|NCT03032965|10077402|FG001|COMPLETED|Overall Study||68
9014706|NCT03032965|10077401|FG000|NOT COMPLETED|Overall Study||0
9014707|NCT03032965|10077402|FG001|NOT COMPLETED|Overall Study||0
9014708|NCT03033108|10077411|FG000|STARTED|Overall Study||7
8909267|NCT02129205|9967802|FG002|COMPLETED|Overall Study||2
8909268|NCT02129205|9967803|FG003|COMPLETED|Overall Study||2
8909269|NCT02129205|9967804|FG004|COMPLETED|Overall Study||4
8909270|NCT02129205|9967805|FG005|COMPLETED|Overall Study||7
8909271|NCT02129205|9967806|FG006|COMPLETED|Overall Study||2
8909272|NCT02129205|9967807|FG007|COMPLETED|Overall Study||4
8909273|NCT02129205|9967808|FG008|COMPLETED|Overall Study||0
8909274|NCT02129205|9967809|FG009|COMPLETED|Overall Study||0
8909275|NCT02129205|9967800|FG000|NOT COMPLETED|Overall Study||1
8909276|NCT02129205|9967801|FG001|NOT COMPLETED|Overall Study||0
8909277|NCT02129205|9967802|FG002|NOT COMPLETED|Overall Study||0
8909278|NCT02129205|9967803|FG003|NOT COMPLETED|Overall Study||0
8909279|NCT02129205|9967804|FG004|NOT COMPLETED|Overall Study||3
8909280|NCT02129205|9967805|FG005|NOT COMPLETED|Overall Study||4
8909281|NCT02129205|9967806|FG006|NOT COMPLETED|Overall Study||4
8909282|NCT02129205|9967807|FG007|NOT COMPLETED|Overall Study||2
8909283|NCT02129205|9967808|FG008|NOT COMPLETED|Overall Study||2
8909284|NCT02129205|9967809|FG009|NOT COMPLETED|Overall Study||0
8909285|NCT02129426|9967835|FG000|STARTED|Overall Study||7
8909286|NCT02129426|9967836|FG001|STARTED|Overall Study||13
8909287|NCT02129426|9967835|FG000|COMPLETED|Overall Study||0
8909288|NCT02129426|9967836|FG001|COMPLETED|Overall Study||0
8909289|NCT02129426|9967835|FG000|NOT COMPLETED|Overall Study||7
8909290|NCT02129426|9967836|FG001|NOT COMPLETED|Overall Study||13
8909291|NCT02129478|9967842|FG000|STARTED|Overall Study||15
8909292|NCT02129478|9967842|FG000|COMPLETED|Overall Study||15
8909293|NCT02129478|9967842|FG000|NOT COMPLETED|Overall Study||0
8909294|NCT02129556|9967849|FG000|STARTED|Overall Study||3
8909295|NCT02129556|9967850|FG001|STARTED|Overall Study||3
8909296|NCT02129556|9967851|FG002|STARTED|Overall Study||40
8909297|NCT02129556|9967852|FG003|STARTED|Overall Study||12
8909298|NCT02129556|9967849|FG000|COMPLETED|Overall Study||3
8909299|NCT02129556|9967850|FG001|COMPLETED|Overall Study||3
8909300|NCT02129556|9967851|FG002|COMPLETED|Overall Study||37
8909301|NCT02129556|9967852|FG003|COMPLETED|Overall Study||12
8909302|NCT02129556|9967849|FG000|NOT COMPLETED|Overall Study||0
8909303|NCT02129556|9967850|FG001|NOT COMPLETED|Overall Study||0
9014709|NCT03033108|10077412|FG001|STARTED|Overall Study||9
9014710|NCT03033108|10077413|FG002|STARTED|Overall Study||7
9014711|NCT03033108|10077411|FG000|COMPLETED|Overall Study||7
9014712|NCT03033108|10077412|FG001|COMPLETED|Overall Study||8
9014713|NCT03033108|10077413|FG002|COMPLETED|Overall Study||7
9014714|NCT03033108|10077411|FG000|NOT COMPLETED|Overall Study||0
9014715|NCT03033108|10077412|FG001|NOT COMPLETED|Overall Study||1
9014716|NCT03033108|10077413|FG002|NOT COMPLETED|Overall Study||0
9014717|NCT03033134|10077423|FG000|STARTED|Overall Study||42
9014718|NCT03033134|10077424|FG001|STARTED|Overall Study||12
9014719|NCT03033134|10077423|FG000|6-month Primary Endpoints|Overall Study||42
9014720|NCT03033134|10077424|FG001|6-month Primary Endpoints|Overall Study||12
9014721|NCT03033134|10077423|FG000|COMPLETED|Overall Study||0
9014722|NCT03033134|10077424|FG001|COMPLETED|Overall Study||0
9014723|NCT03033134|10077423|FG000|NOT COMPLETED|Overall Study||42
9014724|NCT03033134|10077424|FG001|NOT COMPLETED|Overall Study||12
9014725|NCT03033394|10077432|FG000|STARTED|Completed Sampling||65
8636882|NCT00569803|9677605|FG007|NOT COMPLETED|Overall Study||1
8636883|NCT00569855|9677627|FG000|STARTED|Overall Study|832 subjects enrolled; however, study records only available for analysis from 2004 =446 subjects|785
8636884|NCT00569855|9677627|FG000|COMPLETED|Overall Study|785 subjects treated with study drug|785
9014726|NCT03033394|10077432|FG000|COMPLETED|Completed Sampling||65
9014727|NCT03033394|10077432|FG000|NOT COMPLETED|Completed Sampling||0
9014728|NCT03033394|10077432|FG000|STARTED|Completed Pharmacokinetic Analysis||65
9014729|NCT03033394|10077432|FG000|COMPLETED|Completed Pharmacokinetic Analysis||59
9014730|NCT03033394|10077432|FG000|NOT COMPLETED|Completed Pharmacokinetic Analysis||6
9014731|NCT03033394|10077432|FG000|STARTED|Completed Final Analysis||59
9014732|NCT03033394|10077432|FG000|COMPLETED|Completed Final Analysis||58
9014733|NCT03033394|10077432|FG000|NOT COMPLETED|Completed Final Analysis||1
9014734|NCT03033511|10077443|FG000|STARTED|Overall Study||376
9014735|NCT03033511|10077444|FG001|STARTED|Overall Study||372
9014736|NCT03033511|10077443|FG000|COMPLETED|Overall Study||376
9014737|NCT03033511|10077444|FG001|COMPLETED|Overall Study||372
9014738|NCT03033511|10077443|FG000|NOT COMPLETED|Overall Study||0
9014739|NCT03033511|10077444|FG001|NOT COMPLETED|Overall Study||0
9014740|NCT03033745|10077453|FG000|STARTED|Overall Study||15
9014741|NCT03033745|10077454|FG001|STARTED|Overall Study||18
9014742|NCT03033745|10077455|FG002|STARTED|Overall Study||16
9014743|NCT03033745|10077453|FG000|COMPLETED|Overall Study||14
9014744|NCT03033745|10077454|FG001|COMPLETED|Overall Study||17
9014745|NCT03033745|10077455|FG002|COMPLETED|Overall Study||14
9014746|NCT03033745|10077453|FG000|NOT COMPLETED|Overall Study||1
9014747|NCT03033745|10077454|FG001|NOT COMPLETED|Overall Study||1
9014748|NCT03033745|10077455|FG002|NOT COMPLETED|Overall Study||2
9014749|NCT03033784|10077472|FG000|STARTED|Overall Study||9
9014750|NCT03033784|10077473|FG001|STARTED|Overall Study||2
9014751|NCT03033784|10077474|FG002|STARTED|Overall Study||4
8909304|NCT02129556|9967851|FG002|NOT COMPLETED|Overall Study||3
8909305|NCT02129556|9967852|FG003|NOT COMPLETED|Overall Study||0
8909306|NCT02129608|9967864|FG000|STARTED|Overall Study||15
9014752|NCT03033784|10077475|FG003|STARTED|Overall Study||4
9014753|NCT03033784|10077476|FG004|STARTED|Overall Study||3
9014754|NCT03033784|10077477|FG005|STARTED|Overall Study||2
9014755|NCT03033784|10077478|FG006|STARTED|Overall Study||2
8909307|NCT02129608|9967865|FG001|STARTED|Overall Study||14
8909308|NCT02129608|9967866|FG002|STARTED|Overall Study||15
8909309|NCT02129608|9967864|FG000|End of Treatment|Overall Study||15
8909310|NCT02129608|9967865|FG001|End of Treatment|Overall Study||13
8909311|NCT02129608|9967866|FG002|End of Treatment|Overall Study||12
8909312|NCT02129608|9967864|FG000|COMPLETED|Overall Study||15
8909313|NCT02129608|9967865|FG001|COMPLETED|Overall Study||13
8909314|NCT02129608|9967866|FG002|COMPLETED|Overall Study||12
8909315|NCT02129608|9967864|FG000|NOT COMPLETED|Overall Study||0
8909316|NCT02129608|9967865|FG001|NOT COMPLETED|Overall Study||1
8909317|NCT02129608|9967866|FG002|NOT COMPLETED|Overall Study||3
8909318|NCT02129660|9967879|FG000|STARTED|Overall Study||21
8909319|NCT02129660|9967880|FG001|STARTED|Overall Study||20
8909320|NCT02129660|9967881|FG002|STARTED|Overall Study||22
8909321|NCT02129660|9967882|FG003|STARTED|Overall Study||20
9014756|NCT03033784|10077479|FG007|STARTED|Overall Study||2
9014757|NCT03033784|10077480|FG008|STARTED|Overall Study||1
9014758|NCT03033784|10077481|FG009|STARTED|Overall Study||1
9014759|NCT03033784|10077482|FG010|STARTED|Overall Study||1
9014760|NCT03033784|10077483|FG011|STARTED|Overall Study||1
9014761|NCT03033784|10077484|FG012|STARTED|Overall Study||19
9014762|NCT03033784|10077472|FG000|Clinical Visit 2|Overall Study||9
9014763|NCT03033784|10077473|FG001|Clinical Visit 2|Overall Study||2
9014764|NCT03033784|10077474|FG002|Clinical Visit 2|Overall Study||4
9014765|NCT03033784|10077475|FG003|Clinical Visit 2|Overall Study||4
9014766|NCT03033784|10077476|FG004|Clinical Visit 2|Overall Study||3
9014767|NCT03033784|10077477|FG005|Clinical Visit 2|Overall Study||2
9014768|NCT03033784|10077478|FG006|Clinical Visit 2|Overall Study||2
9014769|NCT03033784|10077479|FG007|Clinical Visit 2|Overall Study||2
9014770|NCT03033784|10077480|FG008|Clinical Visit 2|Overall Study||1
9014771|NCT03033784|10077481|FG009|Clinical Visit 2|Overall Study||1
9014772|NCT03033784|10077482|FG010|Clinical Visit 2|Overall Study||1
9014773|NCT03033784|10077483|FG011|Clinical Visit 2|Overall Study||1
9014774|NCT03033784|10077484|FG012|Clinical Visit 2|Overall Study||17
9014775|NCT03033784|10077472|FG000|Clinical Visit 3|Overall Study||9
9014776|NCT03033784|10077473|FG001|Clinical Visit 3|Overall Study||1
9014777|NCT03033784|10077474|FG002|Clinical Visit 3|Overall Study||4
9014778|NCT03033784|10077475|FG003|Clinical Visit 3|Overall Study||4
9014779|NCT03033784|10077476|FG004|Clinical Visit 3|Overall Study||3
9014780|NCT03033784|10077477|FG005|Clinical Visit 3|Overall Study||2
9014781|NCT03033784|10077478|FG006|Clinical Visit 3|Overall Study||2
9014782|NCT03033784|10077479|FG007|Clinical Visit 3|Overall Study||2
9014783|NCT03033784|10077480|FG008|Clinical Visit 3|Overall Study||1
9014784|NCT03033784|10077481|FG009|Clinical Visit 3|Overall Study||1
9014785|NCT03033784|10077482|FG010|Clinical Visit 3|Overall Study||1
9014786|NCT03033784|10077483|FG011|Clinical Visit 3|Overall Study||1
9014787|NCT03033784|10077484|FG012|Clinical Visit 3|Overall Study||0
9014788|NCT03033784|10077472|FG000|Clinical Visit 4|Overall Study||9
9014789|NCT03033784|10077473|FG001|Clinical Visit 4|Overall Study||1
9014790|NCT03033784|10077474|FG002|Clinical Visit 4|Overall Study||4
9014791|NCT03033784|10077475|FG003|Clinical Visit 4|Overall Study||4
9014792|NCT03033784|10077476|FG004|Clinical Visit 4|Overall Study||3
9014793|NCT03033784|10077477|FG005|Clinical Visit 4|Overall Study||2
8573638|NCT00123110|9605918|FG001|NOT COMPLETED|Overall Study||0
8573639|NCT00123110|9605919|FG002|NOT COMPLETED|Overall Study||0
8573640|NCT00123123|9605930|FG000|STARTED|Overall Study||59
8573641|NCT00123123|9605931|FG001|STARTED|Overall Study||58
8573642|NCT00123123|9605932|FG002|STARTED|Overall Study||58
8573643|NCT00123123|9605930|FG000|COMPLETED|Overall Study||59
8573644|NCT00123123|9605931|FG001|COMPLETED|Overall Study||58
8573645|NCT00123123|9605932|FG002|COMPLETED|Overall Study||58
8573646|NCT00123123|9605930|FG000|NOT COMPLETED|Overall Study||0
8573647|NCT00123123|9605931|FG001|NOT COMPLETED|Overall Study||0
8573648|NCT00123123|9605932|FG002|NOT COMPLETED|Overall Study||0
8573649|NCT00123162|9605942|FG000|STARTED|Overall Study||13
8573650|NCT00123162|9605943|FG001|STARTED|Overall Study||12
8573651|NCT00123162|9605942|FG000|COMPLETED|Overall Study||13
8573652|NCT00123162|9605943|FG001|COMPLETED|Overall Study||12
8573653|NCT00123162|9605942|FG000|NOT COMPLETED|Overall Study||0
8573654|NCT00123162|9605943|FG001|NOT COMPLETED|Overall Study||0
8573655|NCT00123409|9605951|FG000|STARTED|Overall Study||72
8573656|NCT00123409|9605952|FG001|STARTED|Overall Study||74
8636885|NCT00569855|9677627|FG000|NOT COMPLETED|Overall Study||0
8636886|NCT00569946|9677631|FG000|STARTED|Overall Study||64
8636887|NCT00569946|9677631|FG000|COMPLETED|Overall Study||5
8636888|NCT00569946|9677631|FG000|NOT COMPLETED|Overall Study||59
8636889|NCT00570037|9677637|FG000|STARTED|Overall Study||238
8636890|NCT00570037|9677638|FG001|STARTED|Overall Study||306
8636891|NCT00570037|9677637|FG000|COMPLETED|Overall Study||194
8636892|NCT00570037|9677638|FG001|COMPLETED|Overall Study||237
9014794|NCT03033784|10077478|FG006|Clinical Visit 4|Overall Study||2
9014795|NCT03033784|10077479|FG007|Clinical Visit 4|Overall Study||2
9014796|NCT03033784|10077480|FG008|Clinical Visit 4|Overall Study||1
9014797|NCT03033784|10077481|FG009|Clinical Visit 4|Overall Study||1
9014798|NCT03033784|10077482|FG010|Clinical Visit 4|Overall Study||1
8909322|NCT02129660|9967883|FG004|STARTED|Overall Study||22
9014799|NCT03033784|10077483|FG011|Clinical Visit 4|Overall Study||1
9014800|NCT03033784|10077484|FG012|Clinical Visit 4|Overall Study||0
9014801|NCT03033784|10077472|FG000|COMPLETED|Overall Study||9
9014802|NCT03033784|10077473|FG001|COMPLETED|Overall Study||1
8909323|NCT02129660|9967879|FG000|COMPLETED|Overall Study||19
8909324|NCT02129660|9967880|FG001|COMPLETED|Overall Study||20
8909325|NCT02129660|9967881|FG002|COMPLETED|Overall Study||21
8909326|NCT02129660|9967882|FG003|COMPLETED|Overall Study||20
8909327|NCT02129660|9967883|FG004|COMPLETED|Overall Study||20
8909328|NCT02129660|9967879|FG000|NOT COMPLETED|Overall Study||2
8909329|NCT02129660|9967880|FG001|NOT COMPLETED|Overall Study||0
8909330|NCT02129660|9967881|FG002|NOT COMPLETED|Overall Study||1
8909331|NCT02129660|9967882|FG003|NOT COMPLETED|Overall Study||0
8909332|NCT02129660|9967883|FG004|NOT COMPLETED|Overall Study||2
8909333|NCT02129725|9967898|FG000|STARTED|Overall Study||8
8909334|NCT02129725|9967899|FG001|STARTED|Overall Study||7
8909335|NCT02129725|9967898|FG000|COMPLETED|Overall Study||6
8909336|NCT02129725|9967899|FG001|COMPLETED|Overall Study||4
8909337|NCT02129725|9967898|FG000|NOT COMPLETED|Overall Study||2
8909338|NCT02129725|9967899|FG001|NOT COMPLETED|Overall Study||3
8909339|NCT02129777|9967910|FG000|STARTED|Double-Blind Period||24
8909340|NCT02129777|9967911|FG001|STARTED|Double-Blind Period||24
8909341|NCT02129777|9967912|FG002|STARTED|Double-Blind Period||24
8909342|NCT02129777|9967913|FG003|STARTED|Double-Blind Period||25
8909343|NCT02129777|9967914|FG004|STARTED|Double-Blind Period||25
8909344|NCT02129777|9967915|FG005|STARTED|Double-Blind Period||0
8909345|NCT02129777|9967916|FG006|STARTED|Double-Blind Period||0
8909346|NCT02129777|9967910|FG000|COMPLETED|Double-Blind Period||17
8909347|NCT02129777|9967911|FG001|COMPLETED|Double-Blind Period||16
8909348|NCT02129777|9967912|FG002|COMPLETED|Double-Blind Period||20
8909349|NCT02129777|9967913|FG003|COMPLETED|Double-Blind Period||18
8909350|NCT02129777|9967914|FG004|COMPLETED|Double-Blind Period||18
8909351|NCT02129777|9967915|FG005|COMPLETED|Double-Blind Period||0
8909352|NCT02129777|9967916|FG006|COMPLETED|Double-Blind Period||0
8909353|NCT02129777|9967910|FG000|NOT COMPLETED|Double-Blind Period||7
8909354|NCT02129777|9967911|FG001|NOT COMPLETED|Double-Blind Period||8
8909355|NCT02129777|9967912|FG002|NOT COMPLETED|Double-Blind Period||4
8909356|NCT02129777|9967913|FG003|NOT COMPLETED|Double-Blind Period||7
8909357|NCT02129777|9967914|FG004|NOT COMPLETED|Double-Blind Period||7
8909358|NCT02129777|9967915|FG005|NOT COMPLETED|Double-Blind Period||0
8909359|NCT02129777|9967916|FG006|NOT COMPLETED|Double-Blind Period||0
8909360|NCT02129777|9967910|FG000|STARTED|Open-Label Period||0
8909361|NCT02129777|9967911|FG001|STARTED|Open-Label Period||0
8909362|NCT02129777|9967912|FG002|STARTED|Open-Label Period||0
8909363|NCT02129777|9967913|FG003|STARTED|Open-Label Period||0
8909364|NCT02129777|9967914|FG004|STARTED|Open-Label Period||0
8909365|NCT02129777|9967915|FG005|STARTED|Open-Label Period||12
8909366|NCT02129777|9967916|FG006|STARTED|Open-Label Period||48
8909367|NCT02129777|9967910|FG000|COMPLETED|Open-Label Period||0
8909368|NCT02129777|9967911|FG001|COMPLETED|Open-Label Period||0
8909369|NCT02129777|9967912|FG002|COMPLETED|Open-Label Period||0
8909370|NCT02129777|9967913|FG003|COMPLETED|Open-Label Period||0
8909371|NCT02129777|9967914|FG004|COMPLETED|Open-Label Period||0
8909372|NCT02129777|9967915|FG005|COMPLETED|Open-Label Period||0
8909373|NCT02129777|9967916|FG006|COMPLETED|Open-Label Period||0
8909374|NCT02129777|9967910|FG000|NOT COMPLETED|Open-Label Period||0
8909375|NCT02129777|9967911|FG001|NOT COMPLETED|Open-Label Period||0
8909376|NCT02129777|9967912|FG002|NOT COMPLETED|Open-Label Period||0
8909377|NCT02129777|9967913|FG003|NOT COMPLETED|Open-Label Period||0
8909378|NCT02129777|9967914|FG004|NOT COMPLETED|Open-Label Period||0
8909379|NCT02129777|9967915|FG005|NOT COMPLETED|Open-Label Period||12
8909380|NCT02129777|9967916|FG006|NOT COMPLETED|Open-Label Period||48
8909381|NCT02129803|9967937|FG000|STARTED|Overall Study||12
8909382|NCT02129803|9967938|FG001|STARTED|Overall Study||12
8909383|NCT02129803|9967937|FG000|COMPLETED|Overall Study||6
8909384|NCT02129803|9967938|FG001|COMPLETED|Overall Study||9
8909385|NCT02129803|9967937|FG000|NOT COMPLETED|Overall Study||6
8909386|NCT02129803|9967938|FG001|NOT COMPLETED|Overall Study||3
8909387|NCT02130024|9967946|FG000|STARTED|Overall Study||142
8909388|NCT02130024|9967947|FG001|STARTED|Overall Study||139
8909389|NCT02130024|9967946|FG000|Safety Set|Overall Study|One randomized patient did not receive treatment|141
8909390|NCT02130024|9967947|FG001|Safety Set|Overall Study||139
8909391|NCT02130024|9967946|FG000|Full Analysis Set (FAS)|Overall Study||141
8909392|NCT02130024|9967947|FG001|Full Analysis Set (FAS)|Overall Study|2 patients had no post Baseline geographic atrophy (GA) data|137
8909393|NCT02130024|9967946|FG000|COMPLETED|Overall Study||117
8909394|NCT02130024|9967947|FG001|COMPLETED|Overall Study||108
8909395|NCT02130024|9967946|FG000|NOT COMPLETED|Overall Study||25
8909396|NCT02130024|9967947|FG001|NOT COMPLETED|Overall Study||31
8909397|NCT02130063|9967955|FG000|STARTED|Overall Study||342
8909398|NCT02130063|9967956|FG001|STARTED|Overall Study||169
8909399|NCT02130063|9967955|FG000|COMPLETED|Overall Study||317
8909400|NCT02130063|9967956|FG001|COMPLETED|Overall Study||152
8909401|NCT02130063|9967955|FG000|NOT COMPLETED|Overall Study||25
8909402|NCT02130063|9967956|FG001|NOT COMPLETED|Overall Study||17
8909403|NCT02130193|9967964|FG000|STARTED|Part A: 4-week Open-label Period||9
8909404|NCT02130193|9967965|FG001|STARTED|Part A: 4-week Open-label Period||0
9014803|NCT03033784|10077474|FG002|COMPLETED|Overall Study||4
9014804|NCT03033784|10077475|FG003|COMPLETED|Overall Study||4
9014805|NCT03033784|10077476|FG004|COMPLETED|Overall Study||3
9014806|NCT03033784|10077477|FG005|COMPLETED|Overall Study||2
9014807|NCT03033784|10077478|FG006|COMPLETED|Overall Study||2
9014808|NCT03033784|10077479|FG007|COMPLETED|Overall Study||2
9014809|NCT03033784|10077480|FG008|COMPLETED|Overall Study||1
9014810|NCT03033784|10077481|FG009|COMPLETED|Overall Study||1
9014811|NCT03033784|10077482|FG010|COMPLETED|Overall Study||1
9014812|NCT03033784|10077483|FG011|COMPLETED|Overall Study||1
9014813|NCT03033784|10077484|FG012|COMPLETED|Overall Study||17
9014814|NCT03033784|10077472|FG000|NOT COMPLETED|Overall Study||0
9014815|NCT03033784|10077473|FG001|NOT COMPLETED|Overall Study||1
9014816|NCT03033784|10077474|FG002|NOT COMPLETED|Overall Study||0
9014817|NCT03033784|10077475|FG003|NOT COMPLETED|Overall Study||0
9014818|NCT03033784|10077476|FG004|NOT COMPLETED|Overall Study||0
9014819|NCT03033784|10077477|FG005|NOT COMPLETED|Overall Study||0
9014820|NCT03033784|10077478|FG006|NOT COMPLETED|Overall Study||0
9014821|NCT03033784|10077479|FG007|NOT COMPLETED|Overall Study||0
9014822|NCT03033784|10077480|FG008|NOT COMPLETED|Overall Study||0
9014823|NCT03033784|10077481|FG009|NOT COMPLETED|Overall Study||0
9014824|NCT03033784|10077482|FG010|NOT COMPLETED|Overall Study||0
9014825|NCT03033784|10077483|FG011|NOT COMPLETED|Overall Study||0
9014826|NCT03033784|10077484|FG012|NOT COMPLETED|Overall Study||2
9014827|NCT03034044|10077495|FG000|STARTED|Overall Study||106
9014828|NCT03034044|10077495|FG000|Received Xyntha|Overall Study||105
9014829|NCT03034044|10077495|FG000|COMPLETED|Overall Study||105
9014830|NCT03034044|10077495|FG000|NOT COMPLETED|Overall Study||1
9014831|NCT03034057|10077499|FG000|STARTED|Overall Study||169
9014832|NCT03034057|10077499|FG000|COMPLETED|Overall Study||114
9014833|NCT03034057|10077499|FG000|NOT COMPLETED|Overall Study||55
9014834|NCT03034135|10077503|FG000|STARTED|Overall Study||23
9014835|NCT03034135|10077503|FG000|COMPLETED|Overall Study||21
9014836|NCT03034135|10077503|FG000|NOT COMPLETED|Overall Study||2
9014837|NCT03034460|10077509|FG000|STARTED|Overall Study||48
9014838|NCT03034460|10077510|FG001|STARTED|Overall Study||22
9014839|NCT03034460|10077509|FG000|COMPLETED|Overall Study||45
9014840|NCT03034460|10077510|FG001|COMPLETED|Overall Study||19
9014841|NCT03034460|10077509|FG000|NOT COMPLETED|Overall Study||3
9014842|NCT03034460|10077510|FG001|NOT COMPLETED|Overall Study||3
9014843|NCT03034577|10077522|FG000|STARTED|Overall Study||175
9014844|NCT03034577|10077523|FG001|STARTED|Overall Study||175
9014845|NCT03034577|10077522|FG000|COMPLETED|Overall Study||144
9014846|NCT03034577|10077523|FG001|COMPLETED|Overall Study||140
9014847|NCT03034577|10077522|FG000|NOT COMPLETED|Overall Study||31
9014848|NCT03034577|10077523|FG001|NOT COMPLETED|Overall Study||35
9014849|NCT03034772|10077533|FG000|STARTED|Overall Study||27
9014850|NCT03034772|10077534|FG001|STARTED|Overall Study||25
9014851|NCT03034772|10077533|FG000|COMPLETED|Overall Study||27
9014852|NCT03034772|10077534|FG001|COMPLETED|Overall Study||23
9014853|NCT03034772|10077533|FG000|NOT COMPLETED|Overall Study||0
9014854|NCT03034772|10077534|FG001|NOT COMPLETED|Overall Study||2
9014855|NCT03034915|10077543|FG000|STARTED|Overall Study||812
9014856|NCT03034915|10077544|FG001|STARTED|Overall Study||804
9014857|NCT03034915|10077545|FG002|STARTED|Overall Study||809
9014858|NCT03034915|10077543|FG000|COMPLETED|Overall Study||717
9014859|NCT03034915|10077544|FG001|COMPLETED|Overall Study||650
9014860|NCT03034915|10077545|FG002|COMPLETED|Overall Study||683
9014861|NCT03034915|10077543|FG000|NOT COMPLETED|Overall Study||95
9014862|NCT03034915|10077544|FG001|NOT COMPLETED|Overall Study||154
9014863|NCT03034915|10077545|FG002|NOT COMPLETED|Overall Study||126
9014864|NCT03034928|10077553|FG000|STARTED|Period 1, First 2 Hours of Wear||8
9014865|NCT03034928|10077554|FG001|STARTED|Period 1, First 2 Hours of Wear||8
9014866|NCT03034928|10077555|FG002|STARTED|Period 1, First 2 Hours of Wear||9
9014867|NCT03034928|10077556|FG003|STARTED|Period 1, First 2 Hours of Wear||8
9014868|NCT03034928|10077553|FG000|COMPLETED|Period 1, First 2 Hours of Wear||8
9014869|NCT03034928|10077554|FG001|COMPLETED|Period 1, First 2 Hours of Wear||8
9014870|NCT03034928|10077555|FG002|COMPLETED|Period 1, First 2 Hours of Wear||9
9014871|NCT03034928|10077556|FG003|COMPLETED|Period 1, First 2 Hours of Wear||8
9014872|NCT03034928|10077553|FG000|NOT COMPLETED|Period 1, First 2 Hours of Wear||0
9014873|NCT03034928|10077554|FG001|NOT COMPLETED|Period 1, First 2 Hours of Wear||0
9014874|NCT03034928|10077555|FG002|NOT COMPLETED|Period 1, First 2 Hours of Wear||0
9014875|NCT03034928|10077556|FG003|NOT COMPLETED|Period 1, First 2 Hours of Wear||0
9014876|NCT03034928|10077553|FG000|STARTED|Washout Period Between Lens Wear||8
9014877|NCT03034928|10077554|FG001|STARTED|Washout Period Between Lens Wear||8
9014878|NCT03034928|10077555|FG002|STARTED|Washout Period Between Lens Wear||9
9014879|NCT03034928|10077556|FG003|STARTED|Washout Period Between Lens Wear||8
9014880|NCT03034928|10077553|FG000|COMPLETED|Washout Period Between Lens Wear||8
9014881|NCT03034928|10077554|FG001|COMPLETED|Washout Period Between Lens Wear||8
9014882|NCT03034928|10077555|FG002|COMPLETED|Washout Period Between Lens Wear||9
9014883|NCT03034928|10077556|FG003|COMPLETED|Washout Period Between Lens Wear||8
9014884|NCT03034928|10077553|FG000|NOT COMPLETED|Washout Period Between Lens Wear||0
9014885|NCT03034928|10077554|FG001|NOT COMPLETED|Washout Period Between Lens Wear||0
9014886|NCT03034928|10077555|FG002|NOT COMPLETED|Washout Period Between Lens Wear||0
9014887|NCT03034928|10077556|FG003|NOT COMPLETED|Washout Period Between Lens Wear||0
9014888|NCT03034928|10077553|FG000|STARTED|Period 2, Second 2 Hours of Wear||8
9014889|NCT03034928|10077554|FG001|STARTED|Period 2, Second 2 Hours of Wear||8
8726982|NCT01040780|9774352|FG001|COMPLETED|Overall Study||196
8726983|NCT01040780|9774351|FG000|NOT COMPLETED|Overall Study||1
8726984|NCT01040780|9774352|FG001|NOT COMPLETED|Overall Study||3
8726985|NCT01040793|9774361|FG000|STARTED|Overall Study|Entered and treated|26
8726986|NCT01040793|9774362|FG001|STARTED|Overall Study||26
9014890|NCT03034928|10077555|FG002|STARTED|Period 2, Second 2 Hours of Wear||9
8726987|NCT01040793|9774363|FG002|STARTED|Overall Study||26
8726988|NCT01040793|9774364|FG003|STARTED|Overall Study||26
9014891|NCT03034928|10077556|FG003|STARTED|Period 2, Second 2 Hours of Wear||8
8909405|NCT02130193|9967966|FG002|STARTED|Part A: 4-week Open-label Period||0
8909406|NCT02130193|9967964|FG000|COMPLETED|Part A: 4-week Open-label Period||9
8909407|NCT02130193|9967965|FG001|COMPLETED|Part A: 4-week Open-label Period||0
8909408|NCT02130193|9967966|FG002|COMPLETED|Part A: 4-week Open-label Period||0
8909409|NCT02130193|9967964|FG000|NOT COMPLETED|Part A: 4-week Open-label Period||0
8909410|NCT02130193|9967965|FG001|NOT COMPLETED|Part A: 4-week Open-label Period||0
8909411|NCT02130193|9967966|FG002|NOT COMPLETED|Part A: 4-week Open-label Period||0
8909412|NCT02130193|9967964|FG000|STARTED|Part B: 52-week Double-blind Period||0
8909413|NCT02130193|9967965|FG001|STARTED|Part B: 52-week Double-blind Period||48
8909414|NCT02130193|9967966|FG002|STARTED|Part B: 52-week Double-blind Period||45
8909415|NCT02130193|9967964|FG000|COMPLETED|Part B: 52-week Double-blind Period||0
8909416|NCT02130193|9967965|FG001|COMPLETED|Part B: 52-week Double-blind Period||38
9014892|NCT03034928|10077553|FG000|COMPLETED|Period 2, Second 2 Hours of Wear||8
9014893|NCT03034928|10077554|FG001|COMPLETED|Period 2, Second 2 Hours of Wear||8
9014894|NCT03034928|10077555|FG002|COMPLETED|Period 2, Second 2 Hours of Wear||9
9014895|NCT03034928|10077556|FG003|COMPLETED|Period 2, Second 2 Hours of Wear||8
9014896|NCT03034928|10077553|FG000|NOT COMPLETED|Period 2, Second 2 Hours of Wear||0
9014897|NCT03034928|10077554|FG001|NOT COMPLETED|Period 2, Second 2 Hours of Wear||0
9014898|NCT03034928|10077555|FG002|NOT COMPLETED|Period 2, Second 2 Hours of Wear||0
9014899|NCT03034928|10077556|FG003|NOT COMPLETED|Period 2, Second 2 Hours of Wear||0
9014900|NCT03034954|10077567|FG000|STARTED|Overall Study||21
9014901|NCT03034954|10077568|FG001|STARTED|Overall Study||21
9014902|NCT03034954|10077567|FG000|COMPLETED|Overall Study||20
9014903|NCT03034954|10077568|FG001|COMPLETED|Overall Study||21
9014904|NCT03034954|10077567|FG000|NOT COMPLETED|Overall Study||1
9014905|NCT03034954|10077568|FG001|NOT COMPLETED|Overall Study||0
9014906|NCT03034967|10077580|FG000|STARTED|Overall Study||102
9014907|NCT03034967|10077581|FG001|STARTED|Overall Study||102
9014908|NCT03034967|10077582|FG002|STARTED|Overall Study||103
9014909|NCT03034967|10077583|FG003|STARTED|Overall Study||103
9014910|NCT03034967|10077584|FG004|STARTED|Overall Study||102
9014911|NCT03034967|10077585|FG005|STARTED|Overall Study||102
9014912|NCT03034967|10077580|FG000|COMPLETED|Overall Study||88
9014913|NCT03034967|10077581|FG001|COMPLETED|Overall Study||97
9014914|NCT03034967|10077582|FG002|COMPLETED|Overall Study||90
9014915|NCT03034967|10077583|FG003|COMPLETED|Overall Study||92
9014916|NCT03034967|10077584|FG004|COMPLETED|Overall Study||88
9014917|NCT03034967|10077585|FG005|COMPLETED|Overall Study||87
9014918|NCT03034967|10077580|FG000|NOT COMPLETED|Overall Study||14
9014919|NCT03034967|10077581|FG001|NOT COMPLETED|Overall Study||5
9014920|NCT03034967|10077582|FG002|NOT COMPLETED|Overall Study||13
9014921|NCT03034967|10077583|FG003|NOT COMPLETED|Overall Study||11
9014922|NCT03034967|10077584|FG004|NOT COMPLETED|Overall Study||14
9014923|NCT03034967|10077585|FG005|NOT COMPLETED|Overall Study||15
9014924|NCT03035032|10077604|FG000|STARTED|Overall Study||107
9014925|NCT03035032|10077604|FG000|COMPLETED|Overall Study||64
9014926|NCT03035032|10077604|FG000|NOT COMPLETED|Overall Study||43
9014927|NCT03035318|10077613|FG000|STARTED|Overall Study||24
9014928|NCT03035318|10077614|FG001|STARTED|Overall Study||25
9014929|NCT03035318|10077615|FG002|STARTED|Overall Study||25
9014930|NCT03035318|10077616|FG003|STARTED|Overall Study||25
9014931|NCT03035318|10077617|FG004|STARTED|Overall Study||27
9014932|NCT03035318|10077613|FG000|COMPLETED|Overall Study||22
9014933|NCT03035318|10077614|FG001|COMPLETED|Overall Study||21
9014934|NCT03035318|10077615|FG002|COMPLETED|Overall Study||21
9014935|NCT03035318|10077616|FG003|COMPLETED|Overall Study||23
9014936|NCT03035318|10077617|FG004|COMPLETED|Overall Study||20
9014937|NCT03035318|10077613|FG000|NOT COMPLETED|Overall Study||2
9014938|NCT03035318|10077614|FG001|NOT COMPLETED|Overall Study||4
9014939|NCT03035318|10077615|FG002|NOT COMPLETED|Overall Study||4
9014940|NCT03035318|10077616|FG003|NOT COMPLETED|Overall Study||2
9014941|NCT03035318|10077617|FG004|NOT COMPLETED|Overall Study||7
9014942|NCT03035487|10077629|FG000|STARTED|Overall Study||9
9014943|NCT03035487|10077629|FG000|COMPLETED|Overall Study||9
9014944|NCT03035487|10077629|FG000|NOT COMPLETED|Overall Study||0
9014945|NCT03035708|10077635|FG000|STARTED|Overall Study||23
9014946|NCT03035708|10077636|FG001|STARTED|Overall Study||24
9014947|NCT03035708|10077635|FG000|COMPLETED|Overall Study||19
9014948|NCT03035708|10077636|FG001|COMPLETED|Overall Study||13
9014949|NCT03035708|10077635|FG000|NOT COMPLETED|Overall Study||4
9014950|NCT03035708|10077636|FG001|NOT COMPLETED|Overall Study||11
9039670|NCT03341299|10100655|FG003|NOT COMPLETED|Period 2||0
9039671|NCT03341299|10100652|FG000|STARTED|Washout (A Minimum of 21 Hours)||9
8636893|NCT00570037|9677637|FG000|NOT COMPLETED|Overall Study||44
8636894|NCT00570037|9677638|FG001|NOT COMPLETED|Overall Study||69
8909417|NCT02130193|9967966|FG002|COMPLETED|Part B: 52-week Double-blind Period||37
9039672|NCT03341299|10100653|FG001|STARTED|Washout (A Minimum of 21 Hours)||9
9039673|NCT03341299|10100654|FG002|STARTED|Washout (A Minimum of 21 Hours)||8
9039674|NCT03341299|10100655|FG003|STARTED|Washout (A Minimum of 21 Hours)||9
9039675|NCT03341299|10100652|FG000|COMPLETED|Washout (A Minimum of 21 Hours)||9
9039676|NCT03341299|10100653|FG001|COMPLETED|Washout (A Minimum of 21 Hours)||9
9039677|NCT03341299|10100654|FG002|COMPLETED|Washout (A Minimum of 21 Hours)||8
8636895|NCT00570063|9677646|FG000|STARTED|Overall Study||24
9039678|NCT03341299|10100655|FG003|COMPLETED|Washout (A Minimum of 21 Hours)||9
8636896|NCT00570063|9677647|FG001|STARTED|Overall Study||11
8636897|NCT00570063|9677646|FG000|COMPLETED|Overall Study||9
9039679|NCT03341299|10100652|FG000|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
8636898|NCT00570063|9677647|FG001|COMPLETED|Overall Study||3
8636899|NCT00570063|9677646|FG000|NOT COMPLETED|Overall Study||15
8636900|NCT00570063|9677647|FG001|NOT COMPLETED|Overall Study||8
8636901|NCT00570089|9677653|FG000|STARTED|Period 1||10
8636902|NCT00570089|9677654|FG001|STARTED|Period 1||10
8636903|NCT00570089|9677653|FG000|COMPLETED|Period 1||10
8636904|NCT00570089|9677654|FG001|COMPLETED|Period 1||10
8636905|NCT00570089|9677653|FG000|NOT COMPLETED|Period 1||0
8636906|NCT00570089|9677654|FG001|NOT COMPLETED|Period 1||0
8909418|NCT02130193|9967964|FG000|NOT COMPLETED|Part B: 52-week Double-blind Period||0
8909419|NCT02130193|9967965|FG001|NOT COMPLETED|Part B: 52-week Double-blind Period||10
8909420|NCT02130193|9967966|FG002|NOT COMPLETED|Part B: 52-week Double-blind Period||8
8909421|NCT02130258|9967977|FG000|STARTED|Overall Study||9
8909422|NCT02130258|9967978|FG001|STARTED|Overall Study||11
8909423|NCT02130258|9967977|FG000|COMPLETED|Overall Study||9
8909424|NCT02130258|9967978|FG001|COMPLETED|Overall Study||11
8909425|NCT02130258|9967977|FG000|NOT COMPLETED|Overall Study||0
8909426|NCT02130258|9967978|FG001|NOT COMPLETED|Overall Study||0
8909427|NCT02130284|9967984|FG000|STARTED|Overall Study||80
8909428|NCT02130284|9967984|FG000|COMPLETED|Overall Study||71
8909429|NCT02130284|9967984|FG000|NOT COMPLETED|Overall Study||9
8909430|NCT02130297|9967988|FG000|STARTED|Overall Study||30
8909431|NCT02130297|9967988|FG000|COMPLETED|Overall Study||26
9014951|NCT03035760|10077649|FG000|STARTED|First Intervention - 10/7 Days Follow-up||8
9014952|NCT03035760|10077650|FG001|STARTED|First Intervention - 10/7 Days Follow-up||8
9014953|NCT03035760|10077651|FG002|STARTED|First Intervention - 10/7 Days Follow-up||8
9014954|NCT03035760|10077652|FG003|STARTED|First Intervention - 10/7 Days Follow-up||6
9014955|NCT03035760|10077653|FG004|STARTED|First Intervention - 10/7 Days Follow-up||6
9014956|NCT03035760|10077649|FG000|COMPLETED|First Intervention - 10/7 Days Follow-up||8
9014957|NCT03035760|10077650|FG001|COMPLETED|First Intervention - 10/7 Days Follow-up||8
8636907|NCT00570089|9677653|FG000|STARTED|Perod 2||10
8636908|NCT00570089|9677654|FG001|STARTED|Perod 2||10
8636909|NCT00570089|9677653|FG000|COMPLETED|Perod 2||10
8636910|NCT00570089|9677654|FG001|COMPLETED|Perod 2||10
8636911|NCT00570089|9677653|FG000|NOT COMPLETED|Perod 2||0
8636912|NCT00570089|9677654|FG001|NOT COMPLETED|Perod 2||0
8636913|NCT00570128|9677664|FG000|STARTED|Overall Study||64
8636914|NCT00570128|9677665|FG001|STARTED|Overall Study||65
8636915|NCT00570128|9677664|FG000|Intent to Treat (ITT) Population|Overall Study||62
8636916|NCT00570128|9677665|FG001|Intent to Treat (ITT) Population|Overall Study||65
8636917|NCT00570128|9677664|FG000|COMPLETED|Overall Study||60
8909432|NCT02130297|9967988|FG000|NOT COMPLETED|Overall Study||4
8909433|NCT02130427|9967992|FG000|STARTED|Overall Study||74
9014958|NCT03035760|10077651|FG002|COMPLETED|First Intervention - 10/7 Days Follow-up||8
9014959|NCT03035760|10077652|FG003|COMPLETED|First Intervention - 10/7 Days Follow-up||6
9014960|NCT03035760|10077653|FG004|COMPLETED|First Intervention - 10/7 Days Follow-up||6
9014961|NCT03035760|10077649|FG000|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0
9014962|NCT03035760|10077650|FG001|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0
9014963|NCT03035760|10077651|FG002|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0
9014964|NCT03035760|10077652|FG003|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0
9014965|NCT03035760|10077653|FG004|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0
9014966|NCT03035760|10077649|FG000|STARTED|Second Intervention - 7 Days Follow-up||0
8573657|NCT00123409|9605951|FG000|COMPLETED|Overall Study||68
8573658|NCT00123409|9605952|FG001|COMPLETED|Overall Study||71
8636918|NCT00570128|9677665|FG001|COMPLETED|Overall Study||65
8636919|NCT00570128|9677664|FG000|NOT COMPLETED|Overall Study||4
8636920|NCT00570128|9677665|FG001|NOT COMPLETED|Overall Study||0
8636921|NCT00570141|9677671|FG000|STARTED|Overall Study||13
8636922|NCT00570141|9677671|FG000|COMPLETED|Overall Study||10
8636923|NCT00570141|9677671|FG000|NOT COMPLETED|Overall Study||3
8636924|NCT00570232|9677675|FG000|STARTED|Overall Study||31
8636925|NCT00570232|9677675|FG000|COMPLETED|Overall Study||8
8636926|NCT00570232|9677675|FG000|NOT COMPLETED|Overall Study||23
8691349|NCT00854308|9736608|FG001|STARTED|Overall Study||68
8691350|NCT00854308|9736607|FG000|Received Study Drug|Overall Study||69
8691351|NCT00854308|9736608|FG001|Received Study Drug|Overall Study||67
8691352|NCT00854308|9736607|FG000|COMPLETED|Overall Study|Completed participants in both arms were still receiving study drug when analyses were performed.|7
8691353|NCT00854308|9736608|FG001|COMPLETED|Overall Study||1
8909434|NCT02130427|9967992|FG000|COMPLETED|Overall Study||44
8909435|NCT02130427|9967992|FG000|NOT COMPLETED|Overall Study||30
8573659|NCT00123409|9605951|FG000|NOT COMPLETED|Overall Study||4
8573660|NCT00123409|9605952|FG001|NOT COMPLETED|Overall Study||3
8573661|NCT00123422|9605963|FG000|STARTED|Overall Study||35
8573662|NCT00123422|9605964|FG001|STARTED|Overall Study||33
8573663|NCT00123422|9605965|FG002|STARTED|Overall Study||35
8573664|NCT00123422|9605963|FG000|8-week Testing|Overall Study||32
8573665|NCT00123422|9605964|FG001|8-week Testing|Overall Study||30
8573666|NCT00123422|9605965|FG002|8-week Testing|Overall Study||27
8573667|NCT00123422|9605963|FG000|COMPLETED|Overall Study||31
8573668|NCT00123422|9605964|FG001|COMPLETED|Overall Study||27
8573669|NCT00123422|9605965|FG002|COMPLETED|Overall Study||25
8573670|NCT00123422|9605963|FG000|NOT COMPLETED|Overall Study||4
8573671|NCT00123422|9605964|FG001|NOT COMPLETED|Overall Study||6
8573672|NCT00123422|9605965|FG002|NOT COMPLETED|Overall Study||10
8573673|NCT00123474|9605977|FG000|STARTED|Randomized to Treatment||167
8573674|NCT00123474|9605978|FG001|STARTED|Randomized to Treatment||167
8909436|NCT02130557|9967998|FG000|STARTED|Overall Study||268
8909437|NCT02130557|9967999|FG001|STARTED|Overall Study||268
8909438|NCT02130557|9967998|FG000|Treated|Overall Study||268
8909439|NCT02130557|9967999|FG001|Treated|Overall Study||265
8909440|NCT02130557|9967998|FG000|mITT Population|Overall Study||246
8909441|NCT02130557|9967999|FG001|mITT Population|Overall Study||241
8909442|NCT02130557|9967998|FG000|COMPLETED|Overall Study||232
8909443|NCT02130557|9967999|FG001|COMPLETED|Overall Study||231
8909444|NCT02130557|9967998|FG000|NOT COMPLETED|Overall Study||36
8909445|NCT02130557|9967999|FG001|NOT COMPLETED|Overall Study||37
8909446|NCT02130570|9968007|FG000|STARTED|Overall Study||987
8909447|NCT02130570|9968008|FG001|STARTED|Overall Study||692
8909448|NCT02130570|9968007|FG000|COMPLETED|Overall Study|Participants enrolled, did not die during index admission, did not withdraw consent|978
8909449|NCT02130570|9968008|FG001|COMPLETED|Overall Study|Participants enrolled, did not die during index admission, did not withdraw consent|679
8909450|NCT02130570|9968007|FG000|NOT COMPLETED|Overall Study||9
8909451|NCT02130570|9968008|FG001|NOT COMPLETED|Overall Study||13
9014967|NCT03035760|10077650|FG001|STARTED|Second Intervention - 7 Days Follow-up||0
9014968|NCT03035760|10077651|FG002|STARTED|Second Intervention - 7 Days Follow-up||0
9014969|NCT03035760|10077652|FG003|STARTED|Second Intervention - 7 Days Follow-up||6
9014970|NCT03035760|10077653|FG004|STARTED|Second Intervention - 7 Days Follow-up||6
9014971|NCT03035760|10077649|FG000|COMPLETED|Second Intervention - 7 Days Follow-up||0
9014972|NCT03035760|10077650|FG001|COMPLETED|Second Intervention - 7 Days Follow-up||0
9014973|NCT03035760|10077651|FG002|COMPLETED|Second Intervention - 7 Days Follow-up||0
9014974|NCT03035760|10077652|FG003|COMPLETED|Second Intervention - 7 Days Follow-up||6
9014975|NCT03035760|10077653|FG004|COMPLETED|Second Intervention - 7 Days Follow-up||6
9014976|NCT03035760|10077649|FG000|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0
9014977|NCT03035760|10077650|FG001|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0
9014978|NCT03035760|10077651|FG002|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0
9014979|NCT03035760|10077652|FG003|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0
9014980|NCT03035760|10077653|FG004|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0
9014981|NCT03035864|10077668|FG000|STARTED|Treatment Period||120
9014982|NCT03035864|10077669|FG001|STARTED|Treatment Period||60
9014983|NCT03035864|10077668|FG000|COMPLETED|Treatment Period||116
9014984|NCT03035864|10077669|FG001|COMPLETED|Treatment Period||59
9014985|NCT03035864|10077668|FG000|NOT COMPLETED|Treatment Period||4
9014986|NCT03035864|10077669|FG001|NOT COMPLETED|Treatment Period||1
9014987|NCT03035864|10077668|FG000|STARTED|Follow-up Period||116
9014988|NCT03035864|10077669|FG001|STARTED|Follow-up Period||59
9014989|NCT03035864|10077668|FG000|COMPLETED|Follow-up Period||105
9014990|NCT03035864|10077669|FG001|COMPLETED|Follow-up Period||55
9014991|NCT03035864|10077668|FG000|NOT COMPLETED|Follow-up Period||11
9014992|NCT03035864|10077669|FG001|NOT COMPLETED|Follow-up Period||4
9014993|NCT03035916|10077678|FG000|STARTED|Overall Study||30
9014994|NCT03035916|10077679|FG001|STARTED|Overall Study||30
9014995|NCT03035916|10077680|FG002|STARTED|Overall Study||31
9014996|NCT03035916|10077678|FG000|COMPLETED|Overall Study||30
9014997|NCT03035916|10077679|FG001|COMPLETED|Overall Study||28
9014998|NCT03035916|10077680|FG002|COMPLETED|Overall Study||31
9014999|NCT03035916|10077678|FG000|NOT COMPLETED|Overall Study||0
9015000|NCT03035916|10077679|FG001|NOT COMPLETED|Overall Study||2
9015001|NCT03035916|10077680|FG002|NOT COMPLETED|Overall Study||0
9015002|NCT03035929|10077688|FG000|STARTED|Overall Study||10
9015003|NCT03035929|10077688|FG000|COMPLETED|Overall Study||10
9015004|NCT03035929|10077688|FG000|NOT COMPLETED|Overall Study||0
9015005|NCT03035942|10077696|FG000|STARTED|Overall Study||45
9015006|NCT03035942|10077697|FG001|STARTED|Overall Study||45
9015007|NCT03035942|10077698|FG002|STARTED|Overall Study||45
9015008|NCT03035942|10077696|FG000|COMPLETED|Overall Study||37
9015009|NCT03035942|10077697|FG001|COMPLETED|Overall Study||41
9015010|NCT03035942|10077698|FG002|COMPLETED|Overall Study||40
9015011|NCT03035942|10077696|FG000|NOT COMPLETED|Overall Study||8
9015012|NCT03035942|10077697|FG001|NOT COMPLETED|Overall Study||4
9015013|NCT03035942|10077698|FG002|NOT COMPLETED|Overall Study||5
9015014|NCT03035955|10077710|FG000|STARTED|Overall Study||10
9015015|NCT03035955|10077711|FG001|STARTED|Overall Study||10
9015016|NCT03035955|10077710|FG000|COMPLETED|Overall Study||9
9015017|NCT03035955|10077711|FG001|COMPLETED|Overall Study||9
9015018|NCT03035955|10077710|FG000|NOT COMPLETED|Overall Study||1
9015019|NCT03035955|10077711|FG001|NOT COMPLETED|Overall Study||1
9015020|NCT03036072|10077719|FG000|STARTED|Overall Study||12
9015021|NCT03036072|10077720|FG001|STARTED|Overall Study||13
9015022|NCT03036072|10077719|FG000|COMPLETED|Overall Study||12
9015023|NCT03036072|10077720|FG001|COMPLETED|Overall Study||10
9015024|NCT03036072|10077719|FG000|NOT COMPLETED|Overall Study||0
9015025|NCT03036072|10077720|FG001|NOT COMPLETED|Overall Study||3
9015026|NCT03036124|10077728|FG000|STARTED|Overall Study||2373
9015027|NCT03036124|10077729|FG001|STARTED|Overall Study||2371
9015028|NCT03036124|10077728|FG000|COMPLETED|Overall Study||2368
9015029|NCT03036124|10077729|FG001|COMPLETED|Overall Study||2365
9015030|NCT03036124|10077728|FG000|NOT COMPLETED|Overall Study||5
9015031|NCT03036124|10077729|FG001|NOT COMPLETED|Overall Study||6
9015032|NCT03036150|10077737|FG000|STARTED|Overall Study||2152
9015033|NCT03036150|10077738|FG001|STARTED|Overall Study||2152
9015034|NCT03036150|10077737|FG000|COMPLETED|Overall Study||2142
9015035|NCT03036150|10077738|FG001|COMPLETED|Overall Study||2147
9015036|NCT03036150|10077737|FG000|NOT COMPLETED|Overall Study||10
9015037|NCT03036150|10077738|FG001|NOT COMPLETED|Overall Study||5
8909452|NCT02130583|9968017|FG000|STARTED|Overall Study||26
8909453|NCT02130583|9968018|FG001|STARTED|Overall Study||26
8909454|NCT02130583|9968017|FG000|COMPLETED|Overall Study||17
8909455|NCT02130583|9968018|FG001|COMPLETED|Overall Study||19
8909456|NCT02130583|9968017|FG000|NOT COMPLETED|Overall Study||9
8909457|NCT02130583|9968018|FG001|NOT COMPLETED|Overall Study||7
8909458|NCT02130635|9968033|FG000|STARTED|Part A-Safety and Tolerability||7
8909459|NCT02130635|9968034|FG001|STARTED|Part A-Safety and Tolerability||21
8909460|NCT02130635|9968035|FG002|STARTED|Part A-Safety and Tolerability||0
8909461|NCT02130635|9968036|FG003|STARTED|Part A-Safety and Tolerability||0
8909462|NCT02130635|9968037|FG004|STARTED|Part A-Safety and Tolerability||0
8909463|NCT02130635|9968038|FG005|STARTED|Part A-Safety and Tolerability||0
8909464|NCT02130635|9968039|FG006|STARTED|Part A-Safety and Tolerability||0
8909465|NCT02130635|9968040|FG007|STARTED|Part A-Safety and Tolerability||0
8909466|NCT02130635|9968041|FG008|STARTED|Part A-Safety and Tolerability||0
8909467|NCT02130635|9968033|FG000|COMPLETED|Part A-Safety and Tolerability||7
8909468|NCT02130635|9968034|FG001|COMPLETED|Part A-Safety and Tolerability||21
8909469|NCT02130635|9968035|FG002|COMPLETED|Part A-Safety and Tolerability||0
8909470|NCT02130635|9968036|FG003|COMPLETED|Part A-Safety and Tolerability||0
8909471|NCT02130635|9968037|FG004|COMPLETED|Part A-Safety and Tolerability||0
8909472|NCT02130635|9968038|FG005|COMPLETED|Part A-Safety and Tolerability||0
8909473|NCT02130635|9968039|FG006|COMPLETED|Part A-Safety and Tolerability||0
8909474|NCT02130635|9968040|FG007|COMPLETED|Part A-Safety and Tolerability||0
8909475|NCT02130635|9968041|FG008|COMPLETED|Part A-Safety and Tolerability||0
8909476|NCT02130635|9968033|FG000|NOT COMPLETED|Part A-Safety and Tolerability||0
8909477|NCT02130635|9968034|FG001|NOT COMPLETED|Part A-Safety and Tolerability||0
8909478|NCT02130635|9968035|FG002|NOT COMPLETED|Part A-Safety and Tolerability||0
8909479|NCT02130635|9968036|FG003|NOT COMPLETED|Part A-Safety and Tolerability||0
8909480|NCT02130635|9968037|FG004|NOT COMPLETED|Part A-Safety and Tolerability||0
8909481|NCT02130635|9968038|FG005|NOT COMPLETED|Part A-Safety and Tolerability||0
8909482|NCT02130635|9968039|FG006|NOT COMPLETED|Part A-Safety and Tolerability||0
8909483|NCT02130635|9968040|FG007|NOT COMPLETED|Part A-Safety and Tolerability||0
8909484|NCT02130635|9968041|FG008|NOT COMPLETED|Part A-Safety and Tolerability||0
8909485|NCT02130635|9968033|FG000|STARTED|Part B-Dose-Response Relationship||0
8909486|NCT02130635|9968034|FG001|STARTED|Part B-Dose-Response Relationship||0
8909487|NCT02130635|9968035|FG002|STARTED|Part B-Dose-Response Relationship||5
8909488|NCT02130635|9968036|FG003|STARTED|Part B-Dose-Response Relationship||5
8909489|NCT02130635|9968037|FG004|STARTED|Part B-Dose-Response Relationship||5
8909490|NCT02130635|9968038|FG005|STARTED|Part B-Dose-Response Relationship||5
8909491|NCT02130635|9968039|FG006|STARTED|Part B-Dose-Response Relationship||6
8909492|NCT02130635|9968040|FG007|STARTED|Part B-Dose-Response Relationship||5
8909493|NCT02130635|9968041|FG008|STARTED|Part B-Dose-Response Relationship||5
8909494|NCT02130635|9968033|FG000|COMPLETED|Part B-Dose-Response Relationship||0
8909495|NCT02130635|9968034|FG001|COMPLETED|Part B-Dose-Response Relationship||0
8909496|NCT02130635|9968035|FG002|COMPLETED|Part B-Dose-Response Relationship||5
8909497|NCT02130635|9968036|FG003|COMPLETED|Part B-Dose-Response Relationship||5
8909498|NCT02130635|9968037|FG004|COMPLETED|Part B-Dose-Response Relationship||5
8909499|NCT02130635|9968038|FG005|COMPLETED|Part B-Dose-Response Relationship||5
8909500|NCT02130635|9968039|FG006|COMPLETED|Part B-Dose-Response Relationship||6
8909501|NCT02130635|9968040|FG007|COMPLETED|Part B-Dose-Response Relationship||5
8909502|NCT02130635|9968041|FG008|COMPLETED|Part B-Dose-Response Relationship||5
9015038|NCT03036163|10077751|FG000|STARTED|Overall Study||6
9015039|NCT03036163|10077752|FG001|STARTED|Overall Study||6
9015040|NCT03036163|10077753|FG002|STARTED|Overall Study||6
9015041|NCT03036163|10077754|FG003|STARTED|Overall Study||6
9015042|NCT03036163|10077755|FG004|STARTED|Overall Study||6
9015043|NCT03036163|10077756|FG005|STARTED|Overall Study||5
9015044|NCT03036163|10077757|FG006|STARTED|Overall Study||5
9015045|NCT03036163|10077751|FG000|COMPLETED|Overall Study||6
9015046|NCT03036163|10077752|FG001|COMPLETED|Overall Study||6
9015047|NCT03036163|10077753|FG002|COMPLETED|Overall Study||6
8909503|NCT02130635|9968033|FG000|NOT COMPLETED|Part B-Dose-Response Relationship||0
8909504|NCT02130635|9968034|FG001|NOT COMPLETED|Part B-Dose-Response Relationship||0
8909505|NCT02130635|9968035|FG002|NOT COMPLETED|Part B-Dose-Response Relationship||0
8909506|NCT02130635|9968036|FG003|NOT COMPLETED|Part B-Dose-Response Relationship||0
8909507|NCT02130635|9968037|FG004|NOT COMPLETED|Part B-Dose-Response Relationship||0
8909508|NCT02130635|9968038|FG005|NOT COMPLETED|Part B-Dose-Response Relationship||0
8909509|NCT02130635|9968039|FG006|NOT COMPLETED|Part B-Dose-Response Relationship||0
8909510|NCT02130635|9968040|FG007|NOT COMPLETED|Part B-Dose-Response Relationship||0
8909511|NCT02130635|9968041|FG008|NOT COMPLETED|Part B-Dose-Response Relationship||0
8909512|NCT02130765|9968072|FG000|STARTED|Overall Study||11
8909513|NCT02130765|9968073|FG001|STARTED|Overall Study||8
8909514|NCT02130765|9968074|FG002|STARTED|Overall Study||26
8909515|NCT02130765|9968075|FG003|STARTED|Overall Study||19
8909516|NCT02130765|9968072|FG000|COMPLETED|Overall Study||7
8909517|NCT02130765|9968073|FG001|COMPLETED|Overall Study||8
8909518|NCT02130765|9968074|FG002|COMPLETED|Overall Study||26
8909519|NCT02130765|9968075|FG003|COMPLETED|Overall Study||19
8909520|NCT02130765|9968072|FG000|NOT COMPLETED|Overall Study||4
8909521|NCT02130765|9968073|FG001|NOT COMPLETED|Overall Study||0
8909522|NCT02130765|9968074|FG002|NOT COMPLETED|Overall Study||0
8909523|NCT02130765|9968075|FG003|NOT COMPLETED|Overall Study||0
9015048|NCT03036163|10077754|FG003|COMPLETED|Overall Study||6
9015049|NCT03036163|10077755|FG004|COMPLETED|Overall Study||6
9015050|NCT03036163|10077756|FG005|COMPLETED|Overall Study||5
9015051|NCT03036163|10077757|FG006|COMPLETED|Overall Study||5
9015052|NCT03036163|10077751|FG000|NOT COMPLETED|Overall Study||0
9015053|NCT03036163|10077752|FG001|NOT COMPLETED|Overall Study||0
9015054|NCT03036163|10077753|FG002|NOT COMPLETED|Overall Study||0
9015055|NCT03036163|10077754|FG003|NOT COMPLETED|Overall Study||0
9015056|NCT03036163|10077755|FG004|NOT COMPLETED|Overall Study||0
9015057|NCT03036163|10077756|FG005|NOT COMPLETED|Overall Study||0
9015058|NCT03036163|10077757|FG006|NOT COMPLETED|Overall Study||0
9015059|NCT03036215|10077775|FG000|STARTED|Overall Study||41
9015060|NCT03036215|10077776|FG001|STARTED|Overall Study||39
8573675|NCT00123474|9605979|FG002|STARTED|Randomized to Treatment||168
8573676|NCT00123474|9605980|FG003|STARTED|Randomized to Treatment||168
8573677|NCT00123474|9605977|FG000|COMPLETED|Randomized to Treatment||166
8636927|NCT00570310|9677681|FG000|STARTED|Overall Study||53
8636928|NCT00570310|9677682|FG001|STARTED|Overall Study||51
8636929|NCT00570310|9677681|FG000|COMPLETED|Overall Study||51
8636930|NCT00570310|9677682|FG001|COMPLETED|Overall Study||45
8636931|NCT00570310|9677681|FG000|NOT COMPLETED|Overall Study||2
8726989|NCT01040793|9774365|FG004|STARTED|Overall Study||26
8726990|NCT01040793|9774366|FG005|STARTED|Overall Study||27
8726991|NCT01040793|9774361|FG000|COMPLETED|Overall Study||20
8726992|NCT01040793|9774362|FG001|COMPLETED|Overall Study||21
8726993|NCT01040793|9774363|FG002|COMPLETED|Overall Study||23
8726994|NCT01040793|9774364|FG003|COMPLETED|Overall Study||22
8726995|NCT01040793|9774365|FG004|COMPLETED|Overall Study||22
8726996|NCT01040793|9774366|FG005|COMPLETED|Overall Study||26
8726997|NCT01040793|9774361|FG000|NOT COMPLETED|Overall Study||6
8726998|NCT01040793|9774362|FG001|NOT COMPLETED|Overall Study||5
8726999|NCT01040793|9774363|FG002|NOT COMPLETED|Overall Study||3
8727000|NCT01040793|9774364|FG003|NOT COMPLETED|Overall Study||4
8727001|NCT01040793|9774365|FG004|NOT COMPLETED|Overall Study||4
8727002|NCT01040793|9774366|FG005|NOT COMPLETED|Overall Study||1
8727003|NCT01040819|9774378|FG000|STARTED|Overall Study||13
8727004|NCT01040819|9774379|FG001|STARTED|Overall Study||12
8727005|NCT01040819|9774378|FG000|COMPLETED|Overall Study||13
8727006|NCT01040819|9774379|FG001|COMPLETED|Overall Study||12
8727007|NCT01040819|9774378|FG000|NOT COMPLETED|Overall Study||0
8727008|NCT01040819|9774379|FG001|NOT COMPLETED|Overall Study||0
8727009|NCT01040832|9774387|FG000|STARTED|Overall Study|One participant was treated with study drug 'Cetuximab Plus EMD 1201081' but was not randomized|54
8727010|NCT01040832|9774388|FG001|STARTED|Overall Study||53
8727011|NCT01040832|9774387|FG000|COMPLETED|Overall Study||8
8727012|NCT01040832|9774388|FG001|COMPLETED|Overall Study||16
8727013|NCT01040832|9774387|FG000|NOT COMPLETED|Overall Study||46
8727014|NCT01040832|9774388|FG001|NOT COMPLETED|Overall Study||37
8727015|NCT01040845|9774396|FG000|STARTED|Overall Study||15
8727016|NCT01040845|9774397|FG001|STARTED|Overall Study||15
8727017|NCT01040845|9774396|FG000|COMPLETED|Overall Study|withdrew consent due to schedule conflict (1); dropped by physician due to positive drug screen (1)|13
8727018|NCT01040845|9774397|FG001|COMPLETED|Overall Study|withdrew consent due to schedule conflict (1)|14
8727019|NCT01040845|9774396|FG000|NOT COMPLETED|Overall Study||2
8727020|NCT01040845|9774397|FG001|NOT COMPLETED|Overall Study||1
8727021|NCT01040858|9774407|FG000|STARTED|Overall Study||59
8727022|NCT01040858|9774408|FG001|STARTED|Overall Study||69
8727023|NCT01040858|9774407|FG000|COMPLETED|Overall Study||50
8727024|NCT01040858|9774408|FG001|COMPLETED|Overall Study||69
8727025|NCT01040858|9774407|FG000|NOT COMPLETED|Overall Study||9
8727026|NCT01040858|9774408|FG001|NOT COMPLETED|Overall Study||0
8727027|NCT01040871|9774419|FG000|STARTED|Overall Study|Intent to Treat, Randomized|84
8727028|NCT01040871|9774420|FG001|STARTED|Overall Study|Intent to Treat, Randomized|80
8727029|NCT01040871|9774419|FG000|COMPLETED|Overall Study||71
8727030|NCT01040871|9774420|FG001|COMPLETED|Overall Study||73
8573678|NCT00123474|9605978|FG001|COMPLETED|Randomized to Treatment||163
8573679|NCT00123474|9605979|FG002|COMPLETED|Randomized to Treatment||166
8636932|NCT00570310|9677682|FG001|NOT COMPLETED|Overall Study||6
8636933|NCT00570323|9677690|FG000|STARTED|Started Treatment After Randomization||36
8636934|NCT00570323|9677691|FG001|STARTED|Started Treatment After Randomization||36
8636935|NCT00570323|9677690|FG000|COMPLETED|Started Treatment After Randomization||34
8636936|NCT00570323|9677691|FG001|COMPLETED|Started Treatment After Randomization||35
8636937|NCT00570323|9677690|FG000|NOT COMPLETED|Started Treatment After Randomization||2
8636938|NCT00570323|9677691|FG001|NOT COMPLETED|Started Treatment After Randomization||1
8636939|NCT00570323|9677690|FG000|STARTED|Complete Study After Start||34
8636940|NCT00570323|9677691|FG001|STARTED|Complete Study After Start||35
8636941|NCT00570323|9677690|FG000|COMPLETED|Complete Study After Start||31
8636942|NCT00570323|9677691|FG001|COMPLETED|Complete Study After Start||34
8636943|NCT00570323|9677690|FG000|NOT COMPLETED|Complete Study After Start||3
8573680|NCT00123474|9605980|FG003|COMPLETED|Randomized to Treatment||167
8573681|NCT00123474|9605977|FG000|NOT COMPLETED|Randomized to Treatment||1
8573682|NCT00123474|9605978|FG001|NOT COMPLETED|Randomized to Treatment||4
8573683|NCT00123474|9605979|FG002|NOT COMPLETED|Randomized to Treatment||2
8573684|NCT00123474|9605980|FG003|NOT COMPLETED|Randomized to Treatment||1
8727031|NCT01040871|9774419|FG000|NOT COMPLETED|Overall Study||13
9015061|NCT03036215|10077775|FG000|COMPLETED|Overall Study||39
9015062|NCT03036215|10077776|FG001|COMPLETED|Overall Study||36
8909524|NCT02130986|9968089|FG000|STARTED|Overall Study||830
8909525|NCT02130986|9968090|FG001|STARTED|Overall Study||834
8909526|NCT02130986|9968089|FG000|COMPLETED|Overall Study||675
8909527|NCT02130986|9968090|FG001|COMPLETED|Overall Study||670
8909528|NCT02130986|9968089|FG000|NOT COMPLETED|Overall Study||155
8909529|NCT02130986|9968090|FG001|NOT COMPLETED|Overall Study||164
8909530|NCT02130999|9968098|FG000|STARTED|Overall Study||6
8909531|NCT02130999|9968099|FG001|STARTED|Overall Study||8
8909532|NCT02130999|9968098|FG000|COMPLETED|Overall Study||6
8909533|NCT02130999|9968099|FG001|COMPLETED|Overall Study||8
8909534|NCT02130999|9968098|FG000|NOT COMPLETED|Overall Study||0
8909535|NCT02130999|9968099|FG001|NOT COMPLETED|Overall Study||0
8909536|NCT02131064|9968112|FG000|STARTED|Overall Study||221
8909537|NCT02131064|9968113|FG001|STARTED|Overall Study||223
8909538|NCT02131064|9968112|FG000|COMPLETED|Overall Study||196
8909539|NCT02131064|9968113|FG001|COMPLETED|Overall Study||189
8909540|NCT02131064|9968112|FG000|NOT COMPLETED|Overall Study||25
8909541|NCT02131064|9968113|FG001|NOT COMPLETED|Overall Study||34
8909542|NCT02131129|9968122|FG000|STARTED|Overall Study||10
8909543|NCT02131129|9968123|FG001|STARTED|Overall Study||10
8909544|NCT02131129|9968122|FG000|COMPLETED|Overall Study||9
8909545|NCT02131129|9968123|FG001|COMPLETED|Overall Study||10
8909546|NCT02131129|9968122|FG000|NOT COMPLETED|Overall Study||1
8909547|NCT02131129|9968123|FG001|NOT COMPLETED|Overall Study||0
8909548|NCT02131233|9968131|FG000|STARTED|Overall Study|Enrolled participants|533
8909549|NCT02131233|9968132|FG001|STARTED|Overall Study|Enrolled participants|269
8909550|NCT02131233|9968131|FG000|Treated|Overall Study||531
8909551|NCT02131233|9968132|FG001|Treated|Overall Study||266
8909552|NCT02131233|9968131|FG000|COMPLETED|Overall Study|Completed to Week 96|467
8909553|NCT02131233|9968132|FG001|COMPLETED|Overall Study|Completed to Week 96|227
8909554|NCT02131233|9968131|FG000|NOT COMPLETED|Overall Study||66
8909555|NCT02131233|9968132|FG001|NOT COMPLETED|Overall Study||42
8909556|NCT02131259|9968138|FG000|STARTED|Overall Study|Patients received treatment of GIOTRIF® Tablets|1602
8909557|NCT02131259|9968138|FG000|COMPLETED|Overall Study|Completed is defined as 52 weeks follow-up after starting administration of GIOTRIF® tablets.|377
8909558|NCT02131259|9968138|FG000|NOT COMPLETED|Overall Study||1225
8909559|NCT02131272|9968144|FG000|STARTED|Overall Study||20
8909560|NCT02131272|9968145|FG001|STARTED|Overall Study||22
8909561|NCT02131272|9968144|FG000|COMPLETED|Overall Study||19
8909562|NCT02131272|9968145|FG001|COMPLETED|Overall Study||20
8909563|NCT02131272|9968144|FG000|NOT COMPLETED|Overall Study||1
8909564|NCT02131272|9968145|FG001|NOT COMPLETED|Overall Study||2
8909565|NCT02131311|9968151|FG000|STARTED|Overall Study||90
8909566|NCT02131311|9968151|FG000|COMPLETED|Overall Study||86
8909567|NCT02131311|9968151|FG000|NOT COMPLETED|Overall Study||4
8909568|NCT02131324|9968158|FG000|STARTED|Overall Study|2 subjects randomized into Comp01 not included in analysis as there was no post-baseline information|24
8909569|NCT02131324|9968159|FG001|STARTED|Overall Study|2 subjects randomized into DFD-06 not included in analysis as there was no post-baseline information|26
8909570|NCT02131324|9968158|FG000|Analyzed|Overall Study||22
8909571|NCT02131324|9968159|FG001|Analyzed|Overall Study||24
8909572|NCT02131324|9968158|FG000|COMPLETED|Overall Study||22
8909573|NCT02131324|9968159|FG001|COMPLETED|Overall Study||23
8909574|NCT02131324|9968158|FG000|NOT COMPLETED|Overall Study||2
8909575|NCT02131324|9968159|FG001|NOT COMPLETED|Overall Study||3
8909576|NCT02131402|9968165|FG000|STARTED|Overall Study||60
8909577|NCT02131402|9968165|FG000|COMPLETED|Overall Study||60
8909578|NCT02131402|9968165|FG000|NOT COMPLETED|Overall Study||0
8909579|NCT02131532|9968228|FG000|STARTED|Overall Study||12
8909580|NCT02131532|9968228|FG000|COMPLETED|Overall Study||8
8909581|NCT02131532|9968228|FG000|NOT COMPLETED|Overall Study||4
8909582|NCT02131636|9968235|FG000|STARTED|Overall Study||222
8909583|NCT02131636|9968236|FG001|STARTED|Overall Study||218
8909584|NCT02131636|9968235|FG000|COMPLETED|Overall Study||210
8909585|NCT02131636|9968236|FG001|COMPLETED|Overall Study||213
8909586|NCT02131636|9968235|FG000|NOT COMPLETED|Overall Study||12
8909587|NCT02131636|9968236|FG001|NOT COMPLETED|Overall Study||5
8909588|NCT02131662|9968247|FG000|STARTED|Overall Study||62
8909589|NCT02131662|9968248|FG001|STARTED|Overall Study||61
8909590|NCT02131662|9968249|FG002|STARTED|Overall Study||63
8909591|NCT02131662|9968250|FG003|STARTED|Overall Study||62
8909592|NCT02131662|9968251|FG004|STARTED|Overall Study||61
8909593|NCT02131662|9968247|FG000|Treated|Overall Study||60
8909594|NCT02131662|9968248|FG001|Treated|Overall Study||61
8909595|NCT02131662|9968249|FG002|Treated|Overall Study||61
8909596|NCT02131662|9968250|FG003|Treated|Overall Study||60
8909597|NCT02131662|9968251|FG004|Treated|Overall Study||58
8909598|NCT02131662|9968247|FG000|Completed Treatment|Overall Study||57
8909599|NCT02131662|9968248|FG001|Completed Treatment|Overall Study||60
8909600|NCT02131662|9968249|FG002|Completed Treatment|Overall Study||61
8909601|NCT02131662|9968250|FG003|Completed Treatment|Overall Study||56
8909602|NCT02131662|9968251|FG004|Completed Treatment|Overall Study||52
8909603|NCT02131662|9968247|FG000|Completed Follow-up|Overall Study||54
8909604|NCT02131662|9968248|FG001|Completed Follow-up|Overall Study||47
8909605|NCT02131662|9968249|FG002|Completed Follow-up|Overall Study||56
8909606|NCT02131662|9968250|FG003|Completed Follow-up|Overall Study||42
8909607|NCT02131662|9968251|FG004|Completed Follow-up|Overall Study||44
8909608|NCT02131662|9968247|FG000|COMPLETED|Overall Study||54
8909609|NCT02131662|9968248|FG001|COMPLETED|Overall Study||47
8909610|NCT02131662|9968249|FG002|COMPLETED|Overall Study||56
8909611|NCT02131662|9968250|FG003|COMPLETED|Overall Study||41
8909612|NCT02131662|9968251|FG004|COMPLETED|Overall Study||43
8909613|NCT02131662|9968247|FG000|NOT COMPLETED|Overall Study||8
8909614|NCT02131662|9968248|FG001|NOT COMPLETED|Overall Study||14
8909615|NCT02131662|9968249|FG002|NOT COMPLETED|Overall Study||7
8909616|NCT02131662|9968250|FG003|NOT COMPLETED|Overall Study||21
8909617|NCT02131662|9968251|FG004|NOT COMPLETED|Overall Study||18
8909618|NCT02131766|9968267|FG000|STARTED|Overall Study||44
8909619|NCT02131766|9968267|FG000|COMPLETED|Overall Study||40
8909620|NCT02131766|9968267|FG000|NOT COMPLETED|Overall Study||4
8909621|NCT02132117|9968276|FG000|STARTED|Overall Study||224
8909622|NCT02132117|9968277|FG001|STARTED|Overall Study||221
8909623|NCT02132117|9968276|FG000|COMPLETED|Overall Study||213
8909624|NCT02132117|9968277|FG001|COMPLETED|Overall Study||216
8909625|NCT02132117|9968276|FG000|NOT COMPLETED|Overall Study||11
8909626|NCT02132117|9968277|FG001|NOT COMPLETED|Overall Study||5
8909627|NCT02132130|9968287|FG000|STARTED|Overall Study||3
8909628|NCT02132130|9968288|FG001|STARTED|Overall Study||12
8909629|NCT02132130|9968289|FG002|STARTED|Overall Study||4
8909630|NCT02132130|9968290|FG003|STARTED|Overall Study||3
8909631|NCT02132130|9968287|FG000|COMPLETED|Overall Study||3
8909632|NCT02132130|9968288|FG001|COMPLETED|Overall Study||10
8909633|NCT02132130|9968289|FG002|COMPLETED|Overall Study||4
8909634|NCT02132130|9968290|FG003|COMPLETED|Overall Study||2
8909635|NCT02132130|9968287|FG000|NOT COMPLETED|Overall Study||0
8909636|NCT02132130|9968288|FG001|NOT COMPLETED|Overall Study||2
8909637|NCT02132130|9968289|FG002|NOT COMPLETED|Overall Study||0
8909638|NCT02132130|9968290|FG003|NOT COMPLETED|Overall Study||1
8909639|NCT02132169|9968306|FG000|STARTED|Overall Study||341
8909640|NCT02132169|9968307|FG001|STARTED|Overall Study||171
8909641|NCT02132169|9968306|FG000|COMPLETED|Overall Study||326
9015063|NCT03036215|10077775|FG000|NOT COMPLETED|Overall Study||2
9015064|NCT03036215|10077776|FG001|NOT COMPLETED|Overall Study||3
9015065|NCT03036293|10077789|FG000|STARTED|Overall Study||127
9015066|NCT03036293|10077790|FG001|STARTED|Overall Study||67
9015067|NCT03036293|10077791|FG002|STARTED|Overall Study||131
9015068|NCT03036293|10077792|FG003|STARTED|Overall Study||65
9015069|NCT03036293|10077789|FG000|COMPLETED|Overall Study||126
9015070|NCT03036293|10077790|FG001|COMPLETED|Overall Study||64
9015071|NCT03036293|10077791|FG002|COMPLETED|Overall Study||130
9015072|NCT03036293|10077792|FG003|COMPLETED|Overall Study||64
9015073|NCT03036293|10077789|FG000|NOT COMPLETED|Overall Study||1
9015074|NCT03036293|10077790|FG001|NOT COMPLETED|Overall Study||3
9015075|NCT03036293|10077791|FG002|NOT COMPLETED|Overall Study||1
9015076|NCT03036293|10077792|FG003|NOT COMPLETED|Overall Study||1
9015077|NCT03036384|10077804|FG000|STARTED|Overall Study||4
9015078|NCT03036384|10077805|FG001|STARTED|Overall Study||4
9015079|NCT03036384|10077806|FG002|STARTED|Overall Study||4
9015080|NCT03036384|10077807|FG003|STARTED|Overall Study||4
9015081|NCT03036384|10077808|FG004|STARTED|Overall Study||4
9015082|NCT03036384|10077809|FG005|STARTED|Overall Study||4
9015083|NCT03036384|10077810|FG006|STARTED|Overall Study||4
9015084|NCT03036384|10077811|FG007|STARTED|Overall Study||4
9015085|NCT03036384|10077812|FG008|STARTED|Overall Study||4
9015086|NCT03036384|10077813|FG009|STARTED|Overall Study||4
9015087|NCT03036384|10077804|FG000|COMPLETED|Overall Study||4
9015088|NCT03036384|10077805|FG001|COMPLETED|Overall Study||4
9015089|NCT03036384|10077806|FG002|COMPLETED|Overall Study||4
9015090|NCT03036384|10077807|FG003|COMPLETED|Overall Study||4
9015091|NCT03036384|10077808|FG004|COMPLETED|Overall Study||4
9015092|NCT03036384|10077809|FG005|COMPLETED|Overall Study||4
9015093|NCT03036384|10077810|FG006|COMPLETED|Overall Study||4
9015094|NCT03036384|10077811|FG007|COMPLETED|Overall Study||4
9015095|NCT03036384|10077812|FG008|COMPLETED|Overall Study||4
9015096|NCT03036384|10077813|FG009|COMPLETED|Overall Study||4
9015097|NCT03036384|10077804|FG000|NOT COMPLETED|Overall Study||0
9015098|NCT03036384|10077805|FG001|NOT COMPLETED|Overall Study||0
9015099|NCT03036384|10077806|FG002|NOT COMPLETED|Overall Study||0
9015100|NCT03036384|10077807|FG003|NOT COMPLETED|Overall Study||0
9015101|NCT03036384|10077808|FG004|NOT COMPLETED|Overall Study||0
9015102|NCT03036384|10077809|FG005|NOT COMPLETED|Overall Study||0
9015103|NCT03036384|10077810|FG006|NOT COMPLETED|Overall Study||0
9015104|NCT03036384|10077811|FG007|NOT COMPLETED|Overall Study||0
9015105|NCT03036384|10077812|FG008|NOT COMPLETED|Overall Study||0
9015106|NCT03036384|10077813|FG009|NOT COMPLETED|Overall Study||0
9015107|NCT03036813|10077834|FG000|STARTED|Overall Study||92
8909642|NCT02132169|9968307|FG001|COMPLETED|Overall Study||162
8909643|NCT02132169|9968306|FG000|NOT COMPLETED|Overall Study||15
8909644|NCT02132169|9968307|FG001|NOT COMPLETED|Overall Study||9
8909645|NCT02132195|9968316|FG000|STARTED|Initial Assignment||15
8909646|NCT02132195|9968317|FG001|STARTED|Initial Assignment||16
8909647|NCT02132195|9968318|FG002|STARTED|Initial Assignment||0
8909648|NCT02132195|9968316|FG000|COMPLETED|Initial Assignment||1
8909649|NCT02132195|9968317|FG001|COMPLETED|Initial Assignment||16
8909650|NCT02132195|9968318|FG002|COMPLETED|Initial Assignment||0
8909651|NCT02132195|9968316|FG000|NOT COMPLETED|Initial Assignment||14
8909652|NCT02132195|9968317|FG001|NOT COMPLETED|Initial Assignment||0
8909653|NCT02132195|9968318|FG002|NOT COMPLETED|Initial Assignment||0
9015108|NCT03036813|10077835|FG001|STARTED|Overall Study||90
9015109|NCT03036813|10077836|FG002|STARTED|Overall Study||92
9015110|NCT03036813|10077834|FG000|COMPLETED|Overall Study||70
9015111|NCT03036813|10077835|FG001|COMPLETED|Overall Study||63
9015112|NCT03036813|10077836|FG002|COMPLETED|Overall Study||66
9015113|NCT03036813|10077834|FG000|NOT COMPLETED|Overall Study||22
8909654|NCT02132195|9968316|FG000|STARTED|Rescue Therapy||0
8909655|NCT02132195|9968317|FG001|STARTED|Rescue Therapy||0
8909656|NCT02132195|9968318|FG002|STARTED|Rescue Therapy||13
8909657|NCT02132195|9968316|FG000|COMPLETED|Rescue Therapy||0
8909658|NCT02132195|9968317|FG001|COMPLETED|Rescue Therapy||0
9015114|NCT03036813|10077835|FG001|NOT COMPLETED|Overall Study||27
9015115|NCT03036813|10077836|FG002|NOT COMPLETED|Overall Study||26
9015116|NCT03036839|10077850|FG000|STARTED|Overall Study||45
9015117|NCT03036839|10077851|FG001|STARTED|Overall Study||31
9015118|NCT03036839|10077852|FG002|STARTED|Overall Study||19
9015119|NCT03036839|10077850|FG000|COMPLETED|Overall Study||42
9015120|NCT03036839|10077851|FG001|COMPLETED|Overall Study||31
9015121|NCT03036839|10077852|FG002|COMPLETED|Overall Study||14
9015122|NCT03036839|10077850|FG000|NOT COMPLETED|Overall Study||3
9015123|NCT03036839|10077851|FG001|NOT COMPLETED|Overall Study||0
9015124|NCT03036839|10077852|FG002|NOT COMPLETED|Overall Study||5
9015125|NCT03036852|10077866|FG000|STARTED|Overall Study||59
9015126|NCT03036852|10077866|FG000|COMPLETED|Overall Study||53
9015127|NCT03036852|10077866|FG000|NOT COMPLETED|Overall Study||6
9015128|NCT03037203|10077880|FG000|STARTED|Overall Study||28
9015129|NCT03037203|10077881|FG001|STARTED|Overall Study||28
8909659|NCT02132195|9968318|FG002|COMPLETED|Rescue Therapy||2
8909660|NCT02132195|9968316|FG000|NOT COMPLETED|Rescue Therapy||0
8909661|NCT02132195|9968317|FG001|NOT COMPLETED|Rescue Therapy||0
8909662|NCT02132195|9968318|FG002|NOT COMPLETED|Rescue Therapy||11
8909663|NCT02132247|9968328|FG000|STARTED|Overall Study||52
8909664|NCT02132247|9968329|FG001|STARTED|Overall Study||52
9015130|NCT03037203|10077882|FG002|STARTED|Overall Study||10
8909665|NCT02132247|9968328|FG000|COMPLETED|Overall Study||51
8909666|NCT02132247|9968329|FG001|COMPLETED|Overall Study||52
8909667|NCT02132247|9968328|FG000|NOT COMPLETED|Overall Study||1
8909668|NCT02132247|9968329|FG001|NOT COMPLETED|Overall Study||0
8909669|NCT02132312|9968337|FG000|STARTED|Overall Study||37
8909670|NCT02132312|9968338|FG001|STARTED|Overall Study||41
8909671|NCT02132312|9968337|FG000|COMPLETED|Overall Study||31
8909672|NCT02132312|9968338|FG001|COMPLETED|Overall Study||38
8909673|NCT02132312|9968337|FG000|NOT COMPLETED|Overall Study||6
8909674|NCT02132312|9968338|FG001|NOT COMPLETED|Overall Study||3
8909675|NCT02132468|9968344|FG000|STARTED|Overall Study||18
8636944|NCT00570323|9677691|FG001|NOT COMPLETED|Complete Study After Start||1
8636945|NCT00570349|9677702|FG000|STARTED|Overall Study||6
8909676|NCT02132468|9968344|FG000|COMPLETED|Overall Study||11
8909677|NCT02132468|9968344|FG000|NOT COMPLETED|Overall Study||7
8909678|NCT02132520|9968351|FG000|STARTED|Overall Study||0
8909679|NCT02132520|9968352|FG001|STARTED|Overall Study||1
8909680|NCT02132520|9968353|FG002|STARTED|Overall Study||2
8909681|NCT02132520|9968351|FG000|COMPLETED|Overall Study||0
8909682|NCT02132520|9968352|FG001|COMPLETED|Overall Study||1
8909683|NCT02132520|9968353|FG002|COMPLETED|Overall Study||2
8909684|NCT02132520|9968351|FG000|NOT COMPLETED|Overall Study||0
8909685|NCT02132520|9968352|FG001|NOT COMPLETED|Overall Study||0
8909686|NCT02132520|9968353|FG002|NOT COMPLETED|Overall Study||0
8909687|NCT02132533|9968362|FG000|STARTED|Overall Study||46
8909688|NCT02132533|9968363|FG001|STARTED|Overall Study||42
8909689|NCT02132533|9968362|FG000|COMPLETED|Overall Study||46
8909690|NCT02132533|9968363|FG001|COMPLETED|Overall Study||42
8909691|NCT02132533|9968362|FG000|NOT COMPLETED|Overall Study||0
8909692|NCT02132533|9968363|FG001|NOT COMPLETED|Overall Study||0
8909693|NCT02132572|9968369|FG000|STARTED|Overall Study||201
8909694|NCT02132572|9968369|FG000|COMPLETED|Overall Study||201
8909695|NCT02132572|9968369|FG000|NOT COMPLETED|Overall Study||0
8909696|NCT02132598|9968373|FG000|STARTED|Overall Study||5
8909697|NCT02132598|9968373|FG000|COMPLETED|Overall Study||5
8909698|NCT02132598|9968373|FG000|NOT COMPLETED|Overall Study||0
8909699|NCT02132637|9968379|FG000|STARTED|Study Period 1||34
8909700|NCT02132637|9968380|FG001|STARTED|Study Period 1||34
8909701|NCT02132637|9968379|FG000|Received at Least One Dose of Study Drug|Study Period 1||34
8909702|NCT02132637|9968380|FG001|Received at Least One Dose of Study Drug|Study Period 1||34
8909703|NCT02132637|9968379|FG000|COMPLETED|Study Period 1||33
8909704|NCT02132637|9968380|FG001|COMPLETED|Study Period 1||30
8909705|NCT02132637|9968379|FG000|NOT COMPLETED|Study Period 1||1
8909706|NCT02132637|9968380|FG001|NOT COMPLETED|Study Period 1||4
8909707|NCT02132637|9968379|FG000|STARTED|Study Period 2 (Crossover)||33
8909708|NCT02132637|9968380|FG001|STARTED|Study Period 2 (Crossover)||30
8909709|NCT02132637|9968379|FG000|COMPLETED|Study Period 2 (Crossover)||31
8909710|NCT02132637|9968380|FG001|COMPLETED|Study Period 2 (Crossover)||29
8909711|NCT02132637|9968379|FG000|NOT COMPLETED|Study Period 2 (Crossover)||2
8909712|NCT02132637|9968380|FG001|NOT COMPLETED|Study Period 2 (Crossover)||1
8909713|NCT02132676|9968388|FG000|STARTED|Overall Study||727
8909714|NCT02132676|9968389|FG001|STARTED|Overall Study||809
8909715|NCT02132676|9968388|FG000|COMPLETED|Overall Study||727
8909716|NCT02132676|9968389|FG001|COMPLETED|Overall Study||809
8909717|NCT02132676|9968388|FG000|NOT COMPLETED|Overall Study||0
8909718|NCT02132676|9968389|FG001|NOT COMPLETED|Overall Study||0
8909719|NCT02132754|9968430|FG000|STARTED|Overall Study||1
8909720|NCT02132754|9968431|FG001|STARTED|Overall Study||1
8909721|NCT02132754|9968432|FG002|STARTED|Overall Study||1
8909722|NCT02132754|9968433|FG003|STARTED|Overall Study||1
8909723|NCT02132754|9968434|FG004|STARTED|Overall Study||1
8909724|NCT02132754|9968435|FG005|STARTED|Overall Study||1
8909725|NCT02132754|9968436|FG006|STARTED|Overall Study||1
8909726|NCT02132754|9968437|FG007|STARTED|Overall Study||1
8909727|NCT02132754|9968438|FG008|STARTED|Overall Study||1
8909728|NCT02132754|9968439|FG009|STARTED|Overall Study||6
8909729|NCT02132754|9968440|FG010|STARTED|Overall Study||3
8909730|NCT02132754|9968441|FG011|STARTED|Overall Study||3
8909731|NCT02132754|9968442|FG012|STARTED|Overall Study||4
8909732|NCT02132754|9968443|FG013|STARTED|Overall Study||3
8909733|NCT02132754|9968444|FG014|STARTED|Overall Study||3
8909734|NCT02132754|9968445|FG015|STARTED|Overall Study||5
8909735|NCT02132754|9968446|FG016|STARTED|Overall Study||4
8909736|NCT02132754|9968447|FG017|STARTED|Overall Study||3
8909737|NCT02132754|9968448|FG018|STARTED|Overall Study||3
8909738|NCT02132754|9968449|FG019|STARTED|Overall Study||4
8909739|NCT02132754|9968450|FG020|STARTED|Overall Study||3
9015131|NCT03037203|10077880|FG000|COMPLETED|Overall Study||27
9015132|NCT03037203|10077881|FG001|COMPLETED|Overall Study||26
8636946|NCT00570349|9677703|FG001|STARTED|Overall Study||6
8636947|NCT00570349|9677704|FG002|STARTED|Overall Study||6
8909740|NCT02132754|9968451|FG021|STARTED|Overall Study||5
8909741|NCT02132754|9968452|FG022|STARTED|Overall Study||3
8909742|NCT02132754|9968453|FG023|STARTED|Overall Study||3
8909743|NCT02132754|9968454|FG024|STARTED|Overall Study||3
8909744|NCT02132754|9968455|FG025|STARTED|Overall Study||3
8909745|NCT02132754|9968456|FG026|STARTED|Overall Study||4
8909746|NCT02132754|9968457|FG027|STARTED|Overall Study||3
8909747|NCT02132754|9968458|FG028|STARTED|Overall Study||3
8909748|NCT02132754|9968459|FG029|STARTED|Overall Study||3
9015133|NCT03037203|10077882|FG002|COMPLETED|Overall Study||9
8909749|NCT02132754|9968460|FG030|STARTED|Overall Study||3
9015134|NCT03037203|10077880|FG000|NOT COMPLETED|Overall Study||1
8909750|NCT02132754|9968461|FG031|STARTED|Overall Study||3
8909751|NCT02132754|9968462|FG032|STARTED|Overall Study||4
8909752|NCT02132754|9968463|FG033|STARTED|Overall Study||23
8909753|NCT02132754|9968430|FG000|Treated|Overall Study||1
8909754|NCT02132754|9968431|FG001|Treated|Overall Study||1
8909755|NCT02132754|9968432|FG002|Treated|Overall Study||1
8909756|NCT02132754|9968433|FG003|Treated|Overall Study||1
8909757|NCT02132754|9968434|FG004|Treated|Overall Study||1
8909758|NCT02132754|9968435|FG005|Treated|Overall Study||1
8909759|NCT02132754|9968436|FG006|Treated|Overall Study||1
8909760|NCT02132754|9968437|FG007|Treated|Overall Study||1
8909761|NCT02132754|9968438|FG008|Treated|Overall Study||1
8909762|NCT02132754|9968439|FG009|Treated|Overall Study||6
8909763|NCT02132754|9968440|FG010|Treated|Overall Study||3
8909764|NCT02132754|9968441|FG011|Treated|Overall Study||3
8909765|NCT02132754|9968442|FG012|Treated|Overall Study||3
8909766|NCT02132754|9968443|FG013|Treated|Overall Study||3
8909767|NCT02132754|9968444|FG014|Treated|Overall Study||3
8909768|NCT02132754|9968445|FG015|Treated|Overall Study||5
8909769|NCT02132754|9968446|FG016|Treated|Overall Study||4
8909770|NCT02132754|9968447|FG017|Treated|Overall Study||3
8909771|NCT02132754|9968448|FG018|Treated|Overall Study||3
8909772|NCT02132754|9968449|FG019|Treated|Overall Study||3
8909773|NCT02132754|9968450|FG020|Treated|Overall Study||3
8909774|NCT02132754|9968451|FG021|Treated|Overall Study||4
8909775|NCT02132754|9968452|FG022|Treated|Overall Study||3
8909776|NCT02132754|9968453|FG023|Treated|Overall Study||3
8909777|NCT02132754|9968454|FG024|Treated|Overall Study||3
8909778|NCT02132754|9968455|FG025|Treated|Overall Study||3
8909779|NCT02132754|9968456|FG026|Treated|Overall Study||4
8909780|NCT02132754|9968457|FG027|Treated|Overall Study||3
8909781|NCT02132754|9968458|FG028|Treated|Overall Study||3
8909782|NCT02132754|9968459|FG029|Treated|Overall Study||3
8909783|NCT02132754|9968460|FG030|Treated|Overall Study||3
8909784|NCT02132754|9968461|FG031|Treated|Overall Study||3
8909785|NCT02132754|9968462|FG032|Treated|Overall Study||4
8909786|NCT02132754|9968463|FG033|Treated|Overall Study||23
8909787|NCT02132754|9968430|FG000|COMPLETED|Overall Study||0
8909788|NCT02132754|9968431|FG001|COMPLETED|Overall Study||0
8909789|NCT02132754|9968432|FG002|COMPLETED|Overall Study||0
8909790|NCT02132754|9968433|FG003|COMPLETED|Overall Study||0
8909791|NCT02132754|9968434|FG004|COMPLETED|Overall Study||0
8909792|NCT02132754|9968435|FG005|COMPLETED|Overall Study||0
8909793|NCT02132754|9968436|FG006|COMPLETED|Overall Study||0
8909794|NCT02132754|9968437|FG007|COMPLETED|Overall Study||0
8909795|NCT02132754|9968438|FG008|COMPLETED|Overall Study||0
8909796|NCT02132754|9968439|FG009|COMPLETED|Overall Study||0
8909797|NCT02132754|9968440|FG010|COMPLETED|Overall Study||0
8909798|NCT02132754|9968441|FG011|COMPLETED|Overall Study||0
8909799|NCT02132754|9968442|FG012|COMPLETED|Overall Study||0
8909800|NCT02132754|9968443|FG013|COMPLETED|Overall Study||0
8909801|NCT02132754|9968444|FG014|COMPLETED|Overall Study||0
8909802|NCT02132754|9968445|FG015|COMPLETED|Overall Study||0
8909803|NCT02132754|9968446|FG016|COMPLETED|Overall Study||0
8909804|NCT02132754|9968447|FG017|COMPLETED|Overall Study||0
8909805|NCT02132754|9968448|FG018|COMPLETED|Overall Study||0
8909806|NCT02132754|9968449|FG019|COMPLETED|Overall Study||0
8909807|NCT02132754|9968450|FG020|COMPLETED|Overall Study||0
8909808|NCT02132754|9968451|FG021|COMPLETED|Overall Study||0
8909809|NCT02132754|9968452|FG022|COMPLETED|Overall Study||0
8909810|NCT02132754|9968453|FG023|COMPLETED|Overall Study||0
8909811|NCT02132754|9968454|FG024|COMPLETED|Overall Study||0
8909812|NCT02132754|9968455|FG025|COMPLETED|Overall Study||0
8909813|NCT02132754|9968456|FG026|COMPLETED|Overall Study||0
8909814|NCT02132754|9968457|FG027|COMPLETED|Overall Study||0
8909815|NCT02132754|9968458|FG028|COMPLETED|Overall Study||0
8909816|NCT02132754|9968459|FG029|COMPLETED|Overall Study||0
8909817|NCT02132754|9968460|FG030|COMPLETED|Overall Study||0
8909818|NCT02132754|9968461|FG031|COMPLETED|Overall Study||0
8909819|NCT02132754|9968462|FG032|COMPLETED|Overall Study||0
8909820|NCT02132754|9968463|FG033|COMPLETED|Overall Study||0
8909821|NCT02132754|9968430|FG000|NOT COMPLETED|Overall Study||1
8909822|NCT02132754|9968431|FG001|NOT COMPLETED|Overall Study||1
8909823|NCT02132754|9968432|FG002|NOT COMPLETED|Overall Study||1
8909824|NCT02132754|9968433|FG003|NOT COMPLETED|Overall Study||1
8909825|NCT02132754|9968434|FG004|NOT COMPLETED|Overall Study||1
8909826|NCT02132754|9968435|FG005|NOT COMPLETED|Overall Study||1
8909827|NCT02132754|9968436|FG006|NOT COMPLETED|Overall Study||1
8909828|NCT02132754|9968437|FG007|NOT COMPLETED|Overall Study||1
8577594|NCT00159861|9610348|FG000|COMPLETED|Extension Study - up to 3 Years||53
8909829|NCT02132754|9968438|FG008|NOT COMPLETED|Overall Study||1
8909830|NCT02132754|9968439|FG009|NOT COMPLETED|Overall Study||6
8909831|NCT02132754|9968440|FG010|NOT COMPLETED|Overall Study||3
8909832|NCT02132754|9968441|FG011|NOT COMPLETED|Overall Study||3
8909833|NCT02132754|9968442|FG012|NOT COMPLETED|Overall Study||4
8909834|NCT02132754|9968443|FG013|NOT COMPLETED|Overall Study||3
8909835|NCT02132754|9968444|FG014|NOT COMPLETED|Overall Study||3
8909836|NCT02132754|9968445|FG015|NOT COMPLETED|Overall Study||5
8909837|NCT02132754|9968446|FG016|NOT COMPLETED|Overall Study||4
8909838|NCT02132754|9968447|FG017|NOT COMPLETED|Overall Study||3
8909839|NCT02132754|9968448|FG018|NOT COMPLETED|Overall Study||3
8909840|NCT02132754|9968449|FG019|NOT COMPLETED|Overall Study||4
8909841|NCT02132754|9968450|FG020|NOT COMPLETED|Overall Study||3
8909842|NCT02132754|9968451|FG021|NOT COMPLETED|Overall Study||5
8909843|NCT02132754|9968452|FG022|NOT COMPLETED|Overall Study||3
8909844|NCT02132754|9968453|FG023|NOT COMPLETED|Overall Study||3
8909845|NCT02132754|9968454|FG024|NOT COMPLETED|Overall Study||3
8909846|NCT02132754|9968455|FG025|NOT COMPLETED|Overall Study||3
8909847|NCT02132754|9968456|FG026|NOT COMPLETED|Overall Study||4
8909848|NCT02132754|9968457|FG027|NOT COMPLETED|Overall Study||3
8909849|NCT02132754|9968458|FG028|NOT COMPLETED|Overall Study||3
8909850|NCT02132754|9968459|FG029|NOT COMPLETED|Overall Study||3
8909851|NCT02132754|9968460|FG030|NOT COMPLETED|Overall Study||3
8909852|NCT02132754|9968461|FG031|NOT COMPLETED|Overall Study||3
8909853|NCT02132754|9968462|FG032|NOT COMPLETED|Overall Study||4
8909854|NCT02132754|9968463|FG033|NOT COMPLETED|Overall Study||23
8909855|NCT02132767|9968575|FG000|STARTED|Overall Study||262
8909856|NCT02132767|9968576|FG001|STARTED|Overall Study||261
8909857|NCT02132767|9968575|FG000|COMPLETED|Overall Study||245
8909858|NCT02132767|9968576|FG001|COMPLETED|Overall Study||246
8909859|NCT02132767|9968575|FG000|NOT COMPLETED|Overall Study||17
8909860|NCT02132767|9968576|FG001|NOT COMPLETED|Overall Study||15
8909861|NCT02132832|9968584|FG000|STARTED|Overall Study||19
8909862|NCT02132832|9968585|FG001|STARTED|Overall Study||23
8909863|NCT02132832|9968584|FG000|COMPLETED|Overall Study||16
8909864|NCT02132832|9968585|FG001|COMPLETED|Overall Study||16
8909865|NCT02132832|9968584|FG000|NOT COMPLETED|Overall Study||3
8909866|NCT02132832|9968585|FG001|NOT COMPLETED|Overall Study||7
8909867|NCT02132910|9968593|FG000|STARTED|Overall Study||34
8909868|NCT02132910|9968594|FG001|STARTED|Overall Study||34
8909869|NCT02132910|9968593|FG000|COMPLETED|Overall Study||34
8909870|NCT02132910|9968594|FG001|COMPLETED|Overall Study||34
8909871|NCT02132910|9968593|FG000|NOT COMPLETED|Overall Study||0
8909872|NCT02132910|9968594|FG001|NOT COMPLETED|Overall Study||0
8909873|NCT02132936|9968604|FG000|STARTED|Overall Study||185
8909874|NCT02132936|9968605|FG001|STARTED|Overall Study||47
8909875|NCT02132936|9968606|FG002|STARTED|Overall Study||188
8909876|NCT02132936|9968607|FG003|STARTED|Overall Study||43
8909877|NCT02132936|9968604|FG000|COMPLETED|Overall Study||175
8909878|NCT02132936|9968605|FG001|COMPLETED|Overall Study||38
8909879|NCT02132936|9968606|FG002|COMPLETED|Overall Study||174
8909880|NCT02132936|9968607|FG003|COMPLETED|Overall Study||29
8909881|NCT02132936|9968604|FG000|NOT COMPLETED|Overall Study||10
8909882|NCT02132936|9968605|FG001|NOT COMPLETED|Overall Study||9
8909883|NCT02132936|9968606|FG002|NOT COMPLETED|Overall Study||14
8909884|NCT02132936|9968607|FG003|NOT COMPLETED|Overall Study||14
8909885|NCT02132949|9968620|FG000|STARTED|Overall Study||199
8909886|NCT02132949|9968621|FG001|STARTED|Overall Study|1 participant enrolled in Cohort B received Cohort A treatment (and was counted as part of Cohort B for efficacy).|201
8909887|NCT02132949|9968620|FG000|Received Any Cohort A Study Treatment|Overall Study|1 participant withdrew prior to receiving any study drug.|198
8909888|NCT02132949|9968621|FG001|Received Any Cohort A Study Treatment|Overall Study|1 participant enrolled in Cohort B received Cohort A treatment (and was counted as part of Cohort A for safety).|1
8909889|NCT02132949|9968620|FG000|Received Any Cohort B Study Treatment|Overall Study||0
8909890|NCT02132949|9968621|FG001|Received Any Cohort B Study Treatment|Overall Study|2 participants withdrew prior to receiving any study drug.|198
8909891|NCT02132949|9968620|FG000|Underwent Surgery|Overall Study||187
8909892|NCT02132949|9968621|FG001|Underwent Surgery|Overall Study||194
8909893|NCT02132949|9968620|FG000|Completed Neoadjuvant Treatment (25 Weeks)|Overall Study||182
8909894|NCT02132949|9968621|FG001|Completed Neoadjuvant Treatment (25 Weeks)|Overall Study||189
8909895|NCT02132949|9968620|FG000|Started Adjuvant Treatment|Overall Study||181
8909896|NCT02132949|9968621|FG001|Started Adjuvant Treatment|Overall Study|1 participant did not complete neoadjuvant treatment but started adjuvant treatment.|190
8909897|NCT02132949|9968620|FG000|Completed Adjuvant Treatment (Up to 39 Weeks)|Overall Study||163
8909898|NCT02132949|9968621|FG001|Completed Adjuvant Treatment (Up to 39 Weeks)|Overall Study||176
8909899|NCT02132949|9968620|FG000|Started Treatment-Free Follow-Up (Up to 5 Years)|Overall Study||195
8909900|NCT02132949|9968621|FG001|Started Treatment-Free Follow-Up (Up to 5 Years)|Overall Study||195
8909901|NCT02132949|9968620|FG000|COMPLETED|Overall Study||158
8909902|NCT02132949|9968621|FG001|COMPLETED|Overall Study||173
8909903|NCT02132949|9968620|FG000|NOT COMPLETED|Overall Study||41
8909904|NCT02132949|9968621|FG001|NOT COMPLETED|Overall Study||28
9015135|NCT03037203|10077881|FG001|NOT COMPLETED|Overall Study||2
9015136|NCT03037203|10077882|FG002|NOT COMPLETED|Overall Study||1
9015137|NCT03037281|10077902|FG000|STARTED|Overall Study||6
9015138|NCT03037281|10077903|FG001|STARTED|Overall Study||8
9015139|NCT03037281|10077902|FG000|COMPLETED|Overall Study||6
9015140|NCT03037281|10077903|FG001|COMPLETED|Overall Study||8
9015141|NCT03037281|10077902|FG000|NOT COMPLETED|Overall Study||0
9015142|NCT03037281|10077903|FG001|NOT COMPLETED|Overall Study||0
9015143|NCT03037307|10077914|FG000|STARTED|Period 1||7
9015144|NCT03037307|10077915|FG001|STARTED|Period 1||7
8577595|NCT00159861|9610349|FG001|COMPLETED|Extension Study - up to 3 Years||56
8909905|NCT02133001|9968629|FG000|STARTED|Double Blind (Day 1-25)||32
8909906|NCT02133001|9968630|FG001|STARTED|Double Blind (Day 1-25)||36
8909907|NCT02133001|9968629|FG000|Safety|Double Blind (Day 1-25)||31
8909908|NCT02133001|9968630|FG001|Safety|Double Blind (Day 1-25)||35
9015145|NCT03037307|10077916|FG002|STARTED|Period 1||8
9015146|NCT03037307|10077917|FG003|STARTED|Period 1||7
9015147|NCT03037307|10077918|FG004|STARTED|Period 1||7
9015148|NCT03037307|10077919|FG005|STARTED|Period 1||8
9015149|NCT03037307|10077914|FG000|COMPLETED|Period 1||7
9015150|NCT03037307|10077915|FG001|COMPLETED|Period 1||7
9015151|NCT03037307|10077916|FG002|COMPLETED|Period 1||8
8636948|NCT00570349|9677702|FG000|COMPLETED|Overall Study||6
8636949|NCT00570349|9677703|FG001|COMPLETED|Overall Study||6
8636950|NCT00570349|9677704|FG002|COMPLETED|Overall Study||6
8636951|NCT00570349|9677702|FG000|NOT COMPLETED|Overall Study||0
8636952|NCT00570349|9677703|FG001|NOT COMPLETED|Overall Study||0
8636953|NCT00570349|9677704|FG002|NOT COMPLETED|Overall Study||0
8909909|NCT02133001|9968629|FG000|COMPLETED|Double Blind (Day 1-25)|Participants who completed continued to follow-up phase.|22
8909910|NCT02133001|9968630|FG001|COMPLETED|Double Blind (Day 1-25)|Participants who completed continued to follow-up phase.|27
8909911|NCT02133001|9968629|FG000|NOT COMPLETED|Double Blind (Day 1-25)||10
8909912|NCT02133001|9968630|FG001|NOT COMPLETED|Double Blind (Day 1-25)||9
8909913|NCT02133001|9968629|FG000|STARTED|Follow-Up Phase (Day 26-81)||22
8909914|NCT02133001|9968630|FG001|STARTED|Follow-Up Phase (Day 26-81)||27
8909915|NCT02133001|9968629|FG000|COMPLETED|Follow-Up Phase (Day 26-81)||20
8909916|NCT02133001|9968630|FG001|COMPLETED|Follow-Up Phase (Day 26-81)||24
8909917|NCT02133001|9968629|FG000|NOT COMPLETED|Follow-Up Phase (Day 26-81)||2
8909918|NCT02133001|9968630|FG001|NOT COMPLETED|Follow-Up Phase (Day 26-81)||3
8909919|NCT02133066|9968640|FG000|STARTED|Overall Study||64
8909920|NCT02133066|9968641|FG001|STARTED|Overall Study||64
8909921|NCT02133066|9968640|FG000|COMPLETED|Overall Study||64
8909922|NCT02133066|9968641|FG001|COMPLETED|Overall Study||64
8909923|NCT02133066|9968640|FG000|NOT COMPLETED|Overall Study||0
8909924|NCT02133066|9968641|FG001|NOT COMPLETED|Overall Study||0
8909925|NCT02133131|9968654|FG000|STARTED|Overall Study||31
8909926|NCT02133131|9968655|FG001|STARTED|Overall Study||30
8909927|NCT02133131|9968656|FG002|STARTED|Overall Study||20
8909928|NCT02133131|9968657|FG003|STARTED|Overall Study||21
8909929|NCT02133131|9968658|FG004|STARTED|Overall Study||15
8909930|NCT02133131|9968659|FG005|STARTED|Overall Study||14
8909931|NCT02133131|9968660|FG006|STARTED|Overall Study||12
8909932|NCT02133131|9968654|FG000|COMPLETED|Overall Study||26
8909933|NCT02133131|9968655|FG001|COMPLETED|Overall Study||25
8909934|NCT02133131|9968656|FG002|COMPLETED|Overall Study||19
8909935|NCT02133131|9968657|FG003|COMPLETED|Overall Study||15
8909936|NCT02133131|9968658|FG004|COMPLETED|Overall Study||0
9015152|NCT03037307|10077917|FG003|COMPLETED|Period 1||6
9015153|NCT03037307|10077918|FG004|COMPLETED|Period 1||7
9015154|NCT03037307|10077919|FG005|COMPLETED|Period 1||8
9015155|NCT03037307|10077914|FG000|NOT COMPLETED|Period 1||0
9015156|NCT03037307|10077915|FG001|NOT COMPLETED|Period 1||0
9015157|NCT03037307|10077916|FG002|NOT COMPLETED|Period 1||0
9015158|NCT03037307|10077917|FG003|NOT COMPLETED|Period 1||1
9015159|NCT03037307|10077918|FG004|NOT COMPLETED|Period 1||0
9015160|NCT03037307|10077919|FG005|NOT COMPLETED|Period 1||0
9015161|NCT03037307|10077914|FG000|STARTED|Wash Out Period 1||7
9015162|NCT03037307|10077915|FG001|STARTED|Wash Out Period 1||7
9015163|NCT03037307|10077916|FG002|STARTED|Wash Out Period 1||8
9015164|NCT03037307|10077917|FG003|STARTED|Wash Out Period 1||6
9015165|NCT03037307|10077918|FG004|STARTED|Wash Out Period 1||7
9015166|NCT03037307|10077919|FG005|STARTED|Wash Out Period 1||8
9015167|NCT03037307|10077914|FG000|COMPLETED|Wash Out Period 1||7
9015168|NCT03037307|10077915|FG001|COMPLETED|Wash Out Period 1||7
9015169|NCT03037307|10077916|FG002|COMPLETED|Wash Out Period 1||8
9015170|NCT03037307|10077917|FG003|COMPLETED|Wash Out Period 1||6
9015171|NCT03037307|10077918|FG004|COMPLETED|Wash Out Period 1||7
9015172|NCT03037307|10077919|FG005|COMPLETED|Wash Out Period 1||8
9015173|NCT03037307|10077914|FG000|NOT COMPLETED|Wash Out Period 1||0
9015174|NCT03037307|10077915|FG001|NOT COMPLETED|Wash Out Period 1||0
9015175|NCT03037307|10077916|FG002|NOT COMPLETED|Wash Out Period 1||0
9015176|NCT03037307|10077917|FG003|NOT COMPLETED|Wash Out Period 1||0
9015177|NCT03037307|10077918|FG004|NOT COMPLETED|Wash Out Period 1||0
9015178|NCT03037307|10077919|FG005|NOT COMPLETED|Wash Out Period 1||0
9015179|NCT03037307|10077914|FG000|STARTED|Period 2||7
9015180|NCT03037307|10077915|FG001|STARTED|Period 2||7
9015181|NCT03037307|10077916|FG002|STARTED|Period 2||8
9015182|NCT03037307|10077917|FG003|STARTED|Period 2||6
9015183|NCT03037307|10077918|FG004|STARTED|Period 2||7
9015184|NCT03037307|10077919|FG005|STARTED|Period 2||8
9015185|NCT03037307|10077914|FG000|COMPLETED|Period 2||7
8636954|NCT00570362|9677714|FG000|STARTED|Overall Study||19
8636955|NCT00570362|9677715|FG001|STARTED|Overall Study||30
8636956|NCT00570362|9677714|FG000|COMPLETED|Overall Study||19
8636957|NCT00570362|9677715|FG001|COMPLETED|Overall Study||30
8636958|NCT00570362|9677714|FG000|NOT COMPLETED|Overall Study||0
9015186|NCT03037307|10077915|FG001|COMPLETED|Period 2||7
9015187|NCT03037307|10077916|FG002|COMPLETED|Period 2||8
9015188|NCT03037307|10077917|FG003|COMPLETED|Period 2||6
9015189|NCT03037307|10077918|FG004|COMPLETED|Period 2||7
9015190|NCT03037307|10077919|FG005|COMPLETED|Period 2||8
9015191|NCT03037307|10077914|FG000|NOT COMPLETED|Period 2||0
9015192|NCT03037307|10077915|FG001|NOT COMPLETED|Period 2||0
9015193|NCT03037307|10077916|FG002|NOT COMPLETED|Period 2||0
8636959|NCT00570362|9677715|FG001|NOT COMPLETED|Overall Study||0
8636960|NCT00570401|9677721|FG000|STARTED|Overall Study||21
8636961|NCT00570401|9677721|FG000|COMPLETED|Overall Study||19
8636962|NCT00570401|9677721|FG000|NOT COMPLETED|Overall Study||2
9015194|NCT03037307|10077917|FG003|NOT COMPLETED|Period 2||0
9015195|NCT03037307|10077918|FG004|NOT COMPLETED|Period 2||0
9015196|NCT03037307|10077919|FG005|NOT COMPLETED|Period 2||0
9015197|NCT03037307|10077914|FG000|STARTED|Wash Out Period 2||7
9015198|NCT03037307|10077915|FG001|STARTED|Wash Out Period 2||7
9015199|NCT03037307|10077916|FG002|STARTED|Wash Out Period 2||8
8909937|NCT02133131|9968659|FG005|COMPLETED|Overall Study||0
8909938|NCT02133131|9968660|FG006|COMPLETED|Overall Study||0
8909939|NCT02133131|9968654|FG000|NOT COMPLETED|Overall Study||5
8909940|NCT02133131|9968655|FG001|NOT COMPLETED|Overall Study||5
8909941|NCT02133131|9968656|FG002|NOT COMPLETED|Overall Study||1
8909942|NCT02133131|9968657|FG003|NOT COMPLETED|Overall Study||6
8909943|NCT02133131|9968658|FG004|NOT COMPLETED|Overall Study||15
8909944|NCT02133131|9968659|FG005|NOT COMPLETED|Overall Study||14
8909945|NCT02133131|9968660|FG006|NOT COMPLETED|Overall Study||12
8909946|NCT02133235|9968678|FG000|STARTED|Overall Study||55
8909947|NCT02133235|9968679|FG001|STARTED|Overall Study||57
8909948|NCT02133235|9968678|FG000|COMPLETED|Overall Study||55
8909949|NCT02133235|9968679|FG001|COMPLETED|Overall Study||57
8909950|NCT02133235|9968678|FG000|NOT COMPLETED|Overall Study||0
8909951|NCT02133235|9968679|FG001|NOT COMPLETED|Overall Study||0
8909952|NCT02133352|9968691|FG000|STARTED|Main Study (180 Day)||10
8909953|NCT02133352|9968691|FG000|COMPLETED|Main Study (180 Day)||10
8909954|NCT02133352|9968691|FG000|NOT COMPLETED|Main Study (180 Day)||0
8909955|NCT02133352|9968691|FG000|STARTED|Longer Term Extension||10
8909956|NCT02133352|9968691|FG000|COMPLETED|Longer Term Extension||4
8909957|NCT02133352|9968691|FG000|NOT COMPLETED|Longer Term Extension||6
8909958|NCT02133508|9968695|FG000|STARTED|Overall Study||156
8909959|NCT02133508|9968695|FG000|COMPLETED|Overall Study||141
8909960|NCT02133508|9968695|FG000|NOT COMPLETED|Overall Study||15
8909961|NCT02133664|9968701|FG000|STARTED|Overall Study||26
8909962|NCT02133664|9968702|FG001|STARTED|Overall Study||28
8909963|NCT02133664|9968701|FG000|COMPLETED|Overall Study||21
8909964|NCT02133664|9968702|FG001|COMPLETED|Overall Study||21
8909965|NCT02133664|9968701|FG000|NOT COMPLETED|Overall Study||5
8909966|NCT02133664|9968702|FG001|NOT COMPLETED|Overall Study||7
8909967|NCT02133742|9968708|FG000|STARTED|Period 1: Dose Finding Phase (6 Months)||11
8909968|NCT02133742|9968708|FG000|COMPLETED|Period 1: Dose Finding Phase (6 Months)||11
8909969|NCT02133742|9968708|FG000|NOT COMPLETED|Period 1: Dose Finding Phase (6 Months)||0
8909970|NCT02133742|9968708|FG000|STARTED|Period 2:Dose Expansion Phase (1344days)|Participants participated in dose finding phase continued treatment in dose expansion phase.|52
8909971|NCT02133742|9968708|FG000|COMPLETED|Period 2:Dose Expansion Phase (1344days)||0
8909972|NCT02133742|9968708|FG000|NOT COMPLETED|Period 2:Dose Expansion Phase (1344days)||52
8636963|NCT00570492|9677727|FG000|STARTED|16-week Single-blind Baseline Period||910
8636964|NCT00570492|9677728|FG001|STARTED|16-week Single-blind Baseline Period||0
8636965|NCT00570492|9677729|FG002|STARTED|16-week Single-blind Baseline Period||0
8636966|NCT00570492|9677727|FG000|COMPLETED|16-week Single-blind Baseline Period||474
8636967|NCT00570492|9677728|FG001|COMPLETED|16-week Single-blind Baseline Period||0
8636968|NCT00570492|9677729|FG002|COMPLETED|16-week Single-blind Baseline Period||0
8636969|NCT00570492|9677727|FG000|NOT COMPLETED|16-week Single-blind Baseline Period||436
8636970|NCT00570492|9677728|FG001|NOT COMPLETED|16-week Single-blind Baseline Period||0
8636971|NCT00570492|9677729|FG002|NOT COMPLETED|16-week Single-blind Baseline Period||0
8636972|NCT00570492|9677727|FG000|STARTED|52-week Double-blind Treatment Period||0
8636973|NCT00570492|9677728|FG001|STARTED|52-week Double-blind Treatment Period||237
8636974|NCT00570492|9677729|FG002|STARTED|52-week Double-blind Treatment Period||237
8636975|NCT00570492|9677727|FG000|COMPLETED|52-week Double-blind Treatment Period||0
8636976|NCT00570492|9677728|FG001|COMPLETED|52-week Double-blind Treatment Period||187
8636977|NCT00570492|9677729|FG002|COMPLETED|52-week Double-blind Treatment Period||186
8636978|NCT00570492|9677727|FG000|NOT COMPLETED|52-week Double-blind Treatment Period||0
8636979|NCT00570492|9677728|FG001|NOT COMPLETED|52-week Double-blind Treatment Period||50
8636980|NCT00570492|9677729|FG002|NOT COMPLETED|52-week Double-blind Treatment Period||51
8636981|NCT00570505|9677735|FG000|STARTED|Overall Study||149
8636982|NCT00570505|9677735|FG000|COMPLETED|Overall Study|The number of subjects completing the 60-month study|108
8636983|NCT00570505|9677735|FG000|NOT COMPLETED|Overall Study||41
8636984|NCT00570661|9677739|FG000|STARTED|Overall Study||17
8909973|NCT02133781|9968717|FG000|STARTED|Overall Study||6
8909974|NCT02133781|9968718|FG001|STARTED|Overall Study||24
8909975|NCT02133781|9968719|FG002|STARTED|Overall Study||21
8909976|NCT02133781|9968717|FG000|COMPLETED|Overall Study||6
8909977|NCT02133781|9968718|FG001|COMPLETED|Overall Study||24
8909978|NCT02133781|9968719|FG002|COMPLETED|Overall Study||21
8909979|NCT02133781|9968717|FG000|NOT COMPLETED|Overall Study||0
8909980|NCT02133781|9968718|FG001|NOT COMPLETED|Overall Study||0
8909981|NCT02133781|9968719|FG002|NOT COMPLETED|Overall Study||0
8909982|NCT02134015|9968729|FG000|STARTED|Overall Study||71
8909983|NCT02134015|9968730|FG001|STARTED|Overall Study||74
8909984|NCT02134015|9968729|FG000|COMPLETED|Overall Study||0
9015200|NCT03037307|10077917|FG003|STARTED|Wash Out Period 2||6
8636985|NCT00570661|9677739|FG000|COMPLETED|Overall Study||10
8636986|NCT00570661|9677739|FG000|NOT COMPLETED|Overall Study||7
8909985|NCT02134015|9968730|FG001|COMPLETED|Overall Study||0
8909986|NCT02134015|9968729|FG000|NOT COMPLETED|Overall Study||71
8909987|NCT02134015|9968730|FG001|NOT COMPLETED|Overall Study||74
8909988|NCT02134119|9968738|FG000|STARTED|Overall Study||30
8909989|NCT02134119|9968739|FG001|STARTED|Overall Study||15
8909990|NCT02134119|9968738|FG000|COMPLETED|Overall Study||30
8909991|NCT02134119|9968739|FG001|COMPLETED|Overall Study||15
8909992|NCT02134119|9968738|FG000|NOT COMPLETED|Overall Study||0
8909993|NCT02134119|9968739|FG001|NOT COMPLETED|Overall Study||0
8909994|NCT02134184|9968748|FG000|STARTED|Overall Study||33
8636987|NCT00570674|9677744|FG000|STARTED|Overall Study||6
8636988|NCT00570674|9677745|FG001|STARTED|Overall Study||3
8636989|NCT00570674|9677746|FG002|STARTED|Overall Study||4
8636990|NCT00570674|9677747|FG003|STARTED|Overall Study||3
8636991|NCT00570674|9677748|FG004|STARTED|Overall Study||3
8636992|NCT00570674|9677749|FG005|STARTED|Overall Study||10
8636993|NCT00570674|9677750|FG006|STARTED|Overall Study|The study did not continue beyond phase I.|0
8636994|NCT00570674|9677744|FG000|Treated|Overall Study||6
8636995|NCT00570674|9677745|FG001|Treated|Overall Study||3
8636996|NCT00570674|9677746|FG002|Treated|Overall Study||3
8636997|NCT00570674|9677747|FG003|Treated|Overall Study||3
8636998|NCT00570674|9677748|FG004|Treated|Overall Study||3
8636999|NCT00570674|9677749|FG005|Treated|Overall Study||10
8637000|NCT00570674|9677750|FG006|Treated|Overall Study||0
8637001|NCT00570674|9677744|FG000|PEG Evaluable|Overall Study||6
8637002|NCT00570674|9677745|FG001|PEG Evaluable|Overall Study||3
8637003|NCT00570674|9677746|FG002|PEG Evaluable|Overall Study||3
8637004|NCT00570674|9677747|FG003|PEG Evaluable|Overall Study||3
8637005|NCT00570674|9677748|FG004|PEG Evaluable|Overall Study||2
8637006|NCT00570674|9677749|FG005|PEG Evaluable|Overall Study||10
8637007|NCT00570674|9677750|FG006|PEG Evaluable|Overall Study||0
8637008|NCT00570674|9677744|FG000|COMPLETED|Overall Study||6
8637009|NCT00570674|9677745|FG001|COMPLETED|Overall Study||3
8637010|NCT00570674|9677746|FG002|COMPLETED|Overall Study||3
8637011|NCT00570674|9677747|FG003|COMPLETED|Overall Study||3
8637012|NCT00570674|9677748|FG004|COMPLETED|Overall Study||3
8637013|NCT00570674|9677749|FG005|COMPLETED|Overall Study||10
8727032|NCT01040871|9774420|FG001|NOT COMPLETED|Overall Study||7
8909995|NCT02134184|9968749|FG001|STARTED|Overall Study||37
8909996|NCT02134184|9968750|FG002|STARTED|Overall Study||8
8909997|NCT02134184|9968748|FG000|COMPLETED|Overall Study||33
8909998|NCT02134184|9968749|FG001|COMPLETED|Overall Study||37
8909999|NCT02134184|9968750|FG002|COMPLETED|Overall Study||8
8910000|NCT02134184|9968748|FG000|NOT COMPLETED|Overall Study||0
8910001|NCT02134184|9968749|FG001|NOT COMPLETED|Overall Study||0
8910002|NCT02134184|9968750|FG002|NOT COMPLETED|Overall Study||0
8910003|NCT02134210|9968760|FG000|STARTED|Part One: Weeks 0-12||260
8910004|NCT02134210|9968761|FG001|STARTED|Part One: Weeks 0-12||261
8910005|NCT02134210|9968760|FG000|COMPLETED|Part One: Weeks 0-12||241
8910006|NCT02134210|9968761|FG001|COMPLETED|Part One: Weeks 0-12||255
8910007|NCT02134210|9968760|FG000|NOT COMPLETED|Part One: Weeks 0-12||19
8910008|NCT02134210|9968761|FG001|NOT COMPLETED|Part One: Weeks 0-12||6
8910009|NCT02134210|9968760|FG000|STARTED|Part Two: Weeks 13-48||241
8910010|NCT02134210|9968761|FG001|STARTED|Part Two: Weeks 13-48||255
8910011|NCT02134210|9968760|FG000|COMPLETED|Part Two: Weeks 13-48||211
8910012|NCT02134210|9968761|FG001|COMPLETED|Part Two: Weeks 13-48||227
8910013|NCT02134210|9968760|FG000|NOT COMPLETED|Part Two: Weeks 13-48||30
8910014|NCT02134210|9968761|FG001|NOT COMPLETED|Part Two: Weeks 13-48||28
8910015|NCT02134314|9968769|FG000|STARTED|Overall Study||35
8910016|NCT02134314|9968770|FG001|STARTED|Overall Study||35
8910017|NCT02134314|9968769|FG000|COMPLETED|Overall Study||34
8910018|NCT02134314|9968770|FG001|COMPLETED|Overall Study||34
8910019|NCT02134314|9968769|FG000|NOT COMPLETED|Overall Study||1
8910020|NCT02134314|9968770|FG001|NOT COMPLETED|Overall Study||1
8910021|NCT02134353|9968779|FG000|STARTED|Overall Study||209
8910022|NCT02134353|9968780|FG001|STARTED|Overall Study||214
8910023|NCT02134353|9968779|FG000|COMPLETED|Overall Study||183
8910024|NCT02134353|9968780|FG001|COMPLETED|Overall Study||190
8910025|NCT02134353|9968779|FG000|NOT COMPLETED|Overall Study||26
8910026|NCT02134353|9968780|FG001|NOT COMPLETED|Overall Study||24
8910027|NCT02134522|9968786|FG000|STARTED|Overall Study||1
8910028|NCT02134522|9968786|FG000|COMPLETED|Overall Study||1
8910029|NCT02134522|9968786|FG000|NOT COMPLETED|Overall Study||0
8910030|NCT02134587|9968790|FG000|STARTED|Overall Study||203
8910031|NCT02134587|9968790|FG000|COMPLETED|Overall Study||173
8910032|NCT02134587|9968790|FG000|NOT COMPLETED|Overall Study||30
8910033|NCT02134756|9968801|FG000|STARTED|Overall Study||15
8910034|NCT02134756|9968802|FG001|STARTED|Overall Study||15
8910035|NCT02134756|9968801|FG000|COMPLETED|Overall Study||14
8910036|NCT02134756|9968802|FG001|COMPLETED|Overall Study||13
8910037|NCT02134756|9968801|FG000|NOT COMPLETED|Overall Study||1
8910038|NCT02134756|9968802|FG001|NOT COMPLETED|Overall Study||2
8910039|NCT02134951|9968810|FG000|STARTED|Overall Study||39
8910040|NCT02134951|9968811|FG001|STARTED|Overall Study||20
8910041|NCT02134951|9968810|FG000|COMPLETED|Overall Study|number of subjects with at least one valid scan|39
8910042|NCT02134951|9968811|FG001|COMPLETED|Overall Study|number of subjects with at least one valid scan|20
8910043|NCT02134951|9968810|FG000|NOT COMPLETED|Overall Study||0
8910044|NCT02134951|9968811|FG001|NOT COMPLETED|Overall Study||0
9015201|NCT03037307|10077918|FG004|STARTED|Wash Out Period 2||7
9015202|NCT03037307|10077919|FG005|STARTED|Wash Out Period 2||8
8910045|NCT02134977|9968817|FG000|STARTED|Overall Study||2816
8910046|NCT02134977|9968817|FG000|COMPLETED|Overall Study||2714
8910047|NCT02134977|9968817|FG000|NOT COMPLETED|Overall Study||102
9015203|NCT03037307|10077914|FG000|COMPLETED|Wash Out Period 2||7
9015204|NCT03037307|10077915|FG001|COMPLETED|Wash Out Period 2||7
8637014|NCT00570674|9677750|FG006|COMPLETED|Overall Study||0
8637015|NCT00570674|9677744|FG000|NOT COMPLETED|Overall Study||0
8637016|NCT00570674|9677745|FG001|NOT COMPLETED|Overall Study||0
8637017|NCT00570674|9677746|FG002|NOT COMPLETED|Overall Study||1
8637018|NCT00570674|9677747|FG003|NOT COMPLETED|Overall Study||0
8727033|NCT01041209|9774428|FG000|STARTED|Overall Study||60
8910048|NCT02135016|9968824|FG000|STARTED|Overall Study||15
8910049|NCT02135016|9968825|FG001|STARTED|Overall Study||15
8910050|NCT02135016|9968826|FG002|STARTED|Overall Study||15
8910051|NCT02135016|9968824|FG000|COMPLETED|Overall Study||15
8910052|NCT02135016|9968825|FG001|COMPLETED|Overall Study||15
8910053|NCT02135016|9968826|FG002|COMPLETED|Overall Study||15
8910054|NCT02135016|9968824|FG000|NOT COMPLETED|Overall Study||0
8910055|NCT02135016|9968825|FG001|NOT COMPLETED|Overall Study||0
8910056|NCT02135016|9968826|FG002|NOT COMPLETED|Overall Study||0
8910057|NCT02135094|9968836|FG000|STARTED|Overall Study||25
8910058|NCT02135094|9968837|FG001|STARTED|Overall Study||8
8910059|NCT02135094|9968836|FG000|Week 2|Overall Study||25
8910060|NCT02135094|9968837|FG001|Week 2|Overall Study||8
8910061|NCT02135094|9968836|FG000|Week 3|Overall Study||25
8910062|NCT02135094|9968837|FG001|Week 3|Overall Study||8
8910063|NCT02135094|9968836|FG000|Week 4|Overall Study||25
8910064|NCT02135094|9968837|FG001|Week 4|Overall Study||8
8910065|NCT02135094|9968836|FG000|COMPLETED|Overall Study||25
8910066|NCT02135094|9968837|FG001|COMPLETED|Overall Study||8
8910067|NCT02135094|9968836|FG000|NOT COMPLETED|Overall Study||0
8910068|NCT02135094|9968837|FG001|NOT COMPLETED|Overall Study||0
8910069|NCT02135107|9968845|FG000|STARTED|Treatment Period||437
8910070|NCT02135107|9968846|FG001|STARTED|Treatment Period||80
8910071|NCT02135107|9968847|FG002|STARTED|Treatment Period||0
8910072|NCT02135107|9968848|FG003|STARTED|Treatment Period||0
8910073|NCT02135107|9968845|FG000|COMPLETED|Treatment Period||305
8910074|NCT02135107|9968846|FG001|COMPLETED|Treatment Period||54
8910075|NCT02135107|9968847|FG002|COMPLETED|Treatment Period||0
8910076|NCT02135107|9968848|FG003|COMPLETED|Treatment Period||0
8910077|NCT02135107|9968845|FG000|NOT COMPLETED|Treatment Period||132
8910078|NCT02135107|9968846|FG001|NOT COMPLETED|Treatment Period||26
8910079|NCT02135107|9968847|FG002|NOT COMPLETED|Treatment Period||0
8910080|NCT02135107|9968848|FG003|NOT COMPLETED|Treatment Period||0
8910081|NCT02135107|9968845|FG000|STARTED|Maintenance Therapy Period|Treatment Phase only|0
9015205|NCT03037307|10077916|FG002|COMPLETED|Wash Out Period 2||8
9015206|NCT03037307|10077917|FG003|COMPLETED|Wash Out Period 2||6
9015207|NCT03037307|10077918|FG004|COMPLETED|Wash Out Period 2||7
9015208|NCT03037307|10077919|FG005|COMPLETED|Wash Out Period 2||8
9015209|NCT03037307|10077914|FG000|NOT COMPLETED|Wash Out Period 2||0
9015210|NCT03037307|10077915|FG001|NOT COMPLETED|Wash Out Period 2||0
9015211|NCT03037307|10077916|FG002|NOT COMPLETED|Wash Out Period 2||0
9015212|NCT03037307|10077917|FG003|NOT COMPLETED|Wash Out Period 2||0
9015213|NCT03037307|10077918|FG004|NOT COMPLETED|Wash Out Period 2||0
9015214|NCT03037307|10077919|FG005|NOT COMPLETED|Wash Out Period 2||0
9015215|NCT03037307|10077914|FG000|STARTED|Period 3||7
9015216|NCT03037307|10077915|FG001|STARTED|Period 3||7
9015217|NCT03037307|10077916|FG002|STARTED|Period 3||8
9015218|NCT03037307|10077917|FG003|STARTED|Period 3||6
9015219|NCT03037307|10077918|FG004|STARTED|Period 3||7
9015220|NCT03037307|10077919|FG005|STARTED|Period 3||8
9015221|NCT03037307|10077914|FG000|COMPLETED|Period 3||7
9015222|NCT03037307|10077915|FG001|COMPLETED|Period 3||7
9015223|NCT03037307|10077916|FG002|COMPLETED|Period 3||8
9015224|NCT03037307|10077917|FG003|COMPLETED|Period 3||6
9015225|NCT03037307|10077918|FG004|COMPLETED|Period 3||7
9015226|NCT03037307|10077919|FG005|COMPLETED|Period 3||8
9015227|NCT03037307|10077914|FG000|NOT COMPLETED|Period 3||0
9015228|NCT03037307|10077915|FG001|NOT COMPLETED|Period 3||0
9015229|NCT03037307|10077916|FG002|NOT COMPLETED|Period 3||0
9015230|NCT03037307|10077917|FG003|NOT COMPLETED|Period 3||0
9015231|NCT03037307|10077918|FG004|NOT COMPLETED|Period 3||0
9015232|NCT03037307|10077919|FG005|NOT COMPLETED|Period 3||0
9015233|NCT03037489|10077930|FG000|STARTED|Overall Study||46
9015234|NCT03037489|10077931|FG001|STARTED|Overall Study||4
9015235|NCT03037489|10077930|FG000|COMPLETED|Overall Study||39
9015236|NCT03037489|10077931|FG001|COMPLETED|Overall Study||4
9015237|NCT03037489|10077930|FG000|NOT COMPLETED|Overall Study||7
9015238|NCT03037489|10077931|FG001|NOT COMPLETED|Overall Study||0
9015239|NCT03037541|10077939|FG000|STARTED|Overall Study||30
9015240|NCT03037541|10077940|FG001|STARTED|Overall Study||30
9015241|NCT03037541|10077939|FG000|COMPLETED|Overall Study||30
9015242|NCT03037541|10077940|FG001|COMPLETED|Overall Study||30
9015243|NCT03037541|10077939|FG000|NOT COMPLETED|Overall Study||0
9015244|NCT03037541|10077940|FG001|NOT COMPLETED|Overall Study||0
8910082|NCT02135107|9968846|FG001|STARTED|Maintenance Therapy Period|Treatment Phase only|0
8910083|NCT02135107|9968847|FG002|STARTED|Maintenance Therapy Period|Only eligible participants entered into the Maintenance Therapy Period|178
8910084|NCT02135107|9968848|FG003|STARTED|Maintenance Therapy Period|Only eligible participants entered into the Maintenance Therapy Period|181
9015245|NCT03037580|10077948|FG000|STARTED|Overall Study||41
9015246|NCT03037580|10077949|FG001|STARTED|Overall Study||43
9015247|NCT03037580|10077948|FG000|COMPLETED|Overall Study||25
9015248|NCT03037580|10077949|FG001|COMPLETED|Overall Study||27
9015249|NCT03037580|10077948|FG000|NOT COMPLETED|Overall Study||16
9015250|NCT03037580|10077949|FG001|NOT COMPLETED|Overall Study||16
9015251|NCT03037619|10077957|FG000|STARTED|Overall Study||8
9015252|NCT03037619|10077958|FG001|STARTED|Overall Study|8 participants and 7 buddies|15
9015253|NCT03037619|10077957|FG000|COMPLETED|Overall Study||8
9015254|NCT03037619|10077958|FG001|COMPLETED|Overall Study|7 participants and 7 buddies|14
9015255|NCT03037619|10077957|FG000|NOT COMPLETED|Overall Study||0
9015256|NCT03037619|10077958|FG001|NOT COMPLETED|Overall Study||1
9015257|NCT03037905|10077966|FG000|STARTED|Overall Study||50
9015258|NCT03037905|10077967|FG001|STARTED|Overall Study||50
9015259|NCT03037905|10077966|FG000|COMPLETED|Overall Study||50
9015260|NCT03037905|10077967|FG001|COMPLETED|Overall Study||50
9015261|NCT03037905|10077966|FG000|NOT COMPLETED|Overall Study||0
9015262|NCT03037905|10077967|FG001|NOT COMPLETED|Overall Study||0
9015263|NCT03037983|10077977|FG000|STARTED|Overall Study||5
9015264|NCT03037983|10077978|FG001|STARTED|Overall Study||4
9015265|NCT03037983|10077977|FG000|COMPLETED|Overall Study||5
9015266|NCT03037983|10077978|FG001|COMPLETED|Overall Study||4
9015267|NCT03037983|10077977|FG000|NOT COMPLETED|Overall Study||0
9015268|NCT03037983|10077978|FG001|NOT COMPLETED|Overall Study||0
9015269|NCT03038113|10077998|FG000|STARTED|Overall Study||8
9015270|NCT03038113|10077999|FG001|STARTED|Overall Study||8
9015271|NCT03038113|10078000|FG002|STARTED|Overall Study||8
9015272|NCT03038113|10078001|FG003|STARTED|Overall Study||8
9015273|NCT03038113|10078002|FG004|STARTED|Overall Study||8
9015274|NCT03038113|10078003|FG005|STARTED|Overall Study||8
9015275|NCT03038113|10078004|FG006|STARTED|Overall Study||12
9015276|NCT03038113|10078005|FG007|STARTED|Overall Study||6
9015277|NCT03038113|10078006|FG008|STARTED|Overall Study||7
9015278|NCT03038113|10078007|FG009|STARTED|Overall Study||6
9015279|NCT03038113|10078008|FG010|STARTED|Overall Study||14
9015280|NCT03038113|10078009|FG011|STARTED|Overall Study||7
9015281|NCT03038113|10078010|FG012|STARTED|Overall Study||4
9015282|NCT03038113|10078011|FG013|STARTED|Overall Study||15
9015283|NCT03038113|10077998|FG000|COMPLETED|Overall Study||8
9015284|NCT03038113|10077999|FG001|COMPLETED|Overall Study||8
9015285|NCT03038113|10078000|FG002|COMPLETED|Overall Study||7
9015286|NCT03038113|10078001|FG003|COMPLETED|Overall Study||8
9015287|NCT03038113|10078002|FG004|COMPLETED|Overall Study||8
9015288|NCT03038113|10078003|FG005|COMPLETED|Overall Study||8
9015289|NCT03038113|10078004|FG006|COMPLETED|Overall Study||11
9015290|NCT03038113|10078005|FG007|COMPLETED|Overall Study||6
9015291|NCT03038113|10078006|FG008|COMPLETED|Overall Study||7
9015292|NCT03038113|10078007|FG009|COMPLETED|Overall Study||6
9015293|NCT03038113|10078008|FG010|COMPLETED|Overall Study||14
9015294|NCT03038113|10078009|FG011|COMPLETED|Overall Study||7
9015295|NCT03038113|10078010|FG012|COMPLETED|Overall Study||4
9015296|NCT03038113|10078011|FG013|COMPLETED|Overall Study||14
9015297|NCT03038113|10077998|FG000|NOT COMPLETED|Overall Study||0
9015298|NCT03038113|10077999|FG001|NOT COMPLETED|Overall Study||0
9015299|NCT03038113|10078000|FG002|NOT COMPLETED|Overall Study||1
9015300|NCT03038113|10078001|FG003|NOT COMPLETED|Overall Study||0
9015301|NCT03038113|10078002|FG004|NOT COMPLETED|Overall Study||0
9015302|NCT03038113|10078003|FG005|NOT COMPLETED|Overall Study||0
9015303|NCT03038113|10078004|FG006|NOT COMPLETED|Overall Study||1
9015304|NCT03038113|10078005|FG007|NOT COMPLETED|Overall Study||0
9015305|NCT03038113|10078006|FG008|NOT COMPLETED|Overall Study||0
9015306|NCT03038113|10078007|FG009|NOT COMPLETED|Overall Study||0
9015307|NCT03038113|10078008|FG010|NOT COMPLETED|Overall Study||0
9015308|NCT03038113|10078009|FG011|NOT COMPLETED|Overall Study||0
9015309|NCT03038113|10078010|FG012|NOT COMPLETED|Overall Study||0
9015310|NCT03038113|10078011|FG013|NOT COMPLETED|Overall Study||1
9015311|NCT03038126|10078060|FG000|STARTED|Overall Study||63
9015312|NCT03038126|10078061|FG001|STARTED|Overall Study||55
9015313|NCT03038126|10078060|FG000|COMPLETED|Overall Study||54
9015314|NCT03038126|10078061|FG001|COMPLETED|Overall Study||51
9015315|NCT03038126|10078060|FG000|NOT COMPLETED|Overall Study||9
9015316|NCT03038126|10078061|FG001|NOT COMPLETED|Overall Study||4
9015317|NCT03038308|10078067|FG000|STARTED|Overall Study||15
9015318|NCT03038308|10078067|FG000|COMPLETED|Overall Study||11
9015319|NCT03038308|10078067|FG000|NOT COMPLETED|Overall Study||4
9015320|NCT03038399|10078075|FG000|STARTED|Overall Study||11
9015321|NCT03038399|10078076|FG001|STARTED|Overall Study||12
9015322|NCT03038399|10078077|FG002|STARTED|Overall Study||12
9015323|NCT03038399|10078078|FG003|STARTED|Overall Study||11
9015324|NCT03038399|10078075|FG000|COMPLETED|Overall Study||10
9015325|NCT03038399|10078076|FG001|COMPLETED|Overall Study||11
9015326|NCT03038399|10078077|FG002|COMPLETED|Overall Study||11
9015327|NCT03038399|10078078|FG003|COMPLETED|Overall Study|Subjects escalated from lower dose groups|9
9015328|NCT03038399|10078075|FG000|NOT COMPLETED|Overall Study||1
9015329|NCT03038399|10078076|FG001|NOT COMPLETED|Overall Study||1
9015330|NCT03038399|10078077|FG002|NOT COMPLETED|Overall Study||1
9015331|NCT03038399|10078078|FG003|NOT COMPLETED|Overall Study||2
9015332|NCT03038620|10078092|FG000|STARTED|Overall Study||92
9015333|NCT03038620|10078093|FG001|STARTED|Overall Study||93
9015334|NCT03038620|10078092|FG000|COMPLETED|Overall Study||73
9015335|NCT03038620|10078093|FG001|COMPLETED|Overall Study||55
9015336|NCT03038620|10078092|FG000|NOT COMPLETED|Overall Study||19
9015337|NCT03038620|10078093|FG001|NOT COMPLETED|Overall Study||38
8727034|NCT01041209|9774429|FG001|STARTED|Overall Study||60
8727035|NCT01041209|9774428|FG000|COMPLETED|Overall Study||60
8727036|NCT01041209|9774429|FG001|COMPLETED|Overall Study||60
8727037|NCT01041209|9774428|FG000|NOT COMPLETED|Overall Study||0
8727038|NCT01041209|9774429|FG001|NOT COMPLETED|Overall Study||0
8727039|NCT01041248|9774436|FG000|STARTED|Overall Study|January 2010|1
8727040|NCT01041248|9774436|FG000|COMPLETED|Overall Study||1
9015338|NCT03038815|10078101|FG000|STARTED|Controll Condition, 1 Hour||10
9015339|NCT03038815|10078102|FG001|STARTED|Controll Condition, 1 Hour||10
9015340|NCT03038815|10078101|FG000|COMPLETED|Controll Condition, 1 Hour||10
9015341|NCT03038815|10078102|FG001|COMPLETED|Controll Condition, 1 Hour||10
9015342|NCT03038815|10078101|FG000|NOT COMPLETED|Controll Condition, 1 Hour||0
9015343|NCT03038815|10078102|FG001|NOT COMPLETED|Controll Condition, 1 Hour||0
9015344|NCT03038815|10078101|FG000|STARTED|Intervention 1, 1 Hour||10
9015345|NCT03038815|10078102|FG001|STARTED|Intervention 1, 1 Hour||10
9015346|NCT03038815|10078101|FG000|COMPLETED|Intervention 1, 1 Hour||10
9015347|NCT03038815|10078102|FG001|COMPLETED|Intervention 1, 1 Hour||10
9015348|NCT03038815|10078101|FG000|NOT COMPLETED|Intervention 1, 1 Hour||0
9015349|NCT03038815|10078102|FG001|NOT COMPLETED|Intervention 1, 1 Hour||0
9015350|NCT03038815|10078101|FG000|STARTED|Intervention 2, 1 Hour||10
9015351|NCT03038815|10078102|FG001|STARTED|Intervention 2, 1 Hour||10
9015352|NCT03038815|10078101|FG000|COMPLETED|Intervention 2, 1 Hour||10
9015353|NCT03038815|10078102|FG001|COMPLETED|Intervention 2, 1 Hour||10
9015354|NCT03038815|10078101|FG000|NOT COMPLETED|Intervention 2, 1 Hour||0
9015355|NCT03038815|10078102|FG001|NOT COMPLETED|Intervention 2, 1 Hour||0
9015356|NCT03038867|10078111|FG000|STARTED|Overall Study||37
9015357|NCT03038867|10078112|FG001|STARTED|Overall Study||32
9015358|NCT03038867|10078111|FG000|COMPLETED|Overall Study||37
9015359|NCT03038867|10078112|FG001|COMPLETED|Overall Study||32
9015360|NCT03038867|10078111|FG000|NOT COMPLETED|Overall Study||0
9015361|NCT03038867|10078112|FG001|NOT COMPLETED|Overall Study||0
9015362|NCT03038880|10078121|FG000|STARTED|Overall Study||24
9015363|NCT03038880|10078122|FG001|STARTED|Overall Study||31
9015364|NCT03038880|10078123|FG002|STARTED|Overall Study||16
9015365|NCT03038880|10078121|FG000|COMPLETED|Overall Study||21
9015366|NCT03038880|10078122|FG001|COMPLETED|Overall Study||28
9015367|NCT03038880|10078123|FG002|COMPLETED|Overall Study||16
9015368|NCT03038880|10078121|FG000|NOT COMPLETED|Overall Study||3
9015369|NCT03038880|10078122|FG001|NOT COMPLETED|Overall Study||3
9015370|NCT03038880|10078123|FG002|NOT COMPLETED|Overall Study||0
9015371|NCT03039023|10078136|FG000|STARTED|Overall Study||19
9015372|NCT03039023|10078137|FG001|STARTED|Overall Study||20
9015373|NCT03039023|10078138|FG002|STARTED|Overall Study||17
9015374|NCT03039023|10078139|FG003|STARTED|Overall Study||20
9015375|NCT03039023|10078140|FG004|STARTED|Overall Study||10
9015376|NCT03039023|10078136|FG000|COMPLETED|Overall Study||18
9015377|NCT03039023|10078137|FG001|COMPLETED|Overall Study||20
9015378|NCT03039023|10078138|FG002|COMPLETED|Overall Study||16
9015379|NCT03039023|10078139|FG003|COMPLETED|Overall Study||18
9015380|NCT03039023|10078140|FG004|COMPLETED|Overall Study||10
9015381|NCT03039023|10078136|FG000|NOT COMPLETED|Overall Study||1
8637019|NCT00570674|9677748|FG004|NOT COMPLETED|Overall Study||0
8637020|NCT00570674|9677749|FG005|NOT COMPLETED|Overall Study||0
8637021|NCT00570674|9677750|FG006|NOT COMPLETED|Overall Study||0
9015382|NCT03039023|10078137|FG001|NOT COMPLETED|Overall Study||0
9015383|NCT03039023|10078138|FG002|NOT COMPLETED|Overall Study||1
9015384|NCT03039023|10078139|FG003|NOT COMPLETED|Overall Study||2
9015385|NCT03039023|10078140|FG004|NOT COMPLETED|Overall Study||0
9015386|NCT03039088|10078154|FG000|STARTED|Overall Study||192
9015387|NCT03039088|10078155|FG001|STARTED|Overall Study||316
9015388|NCT03039088|10078154|FG000|COMPLETED|Overall Study||192
9015389|NCT03039088|10078155|FG001|COMPLETED|Overall Study||316
9015390|NCT03039088|10078154|FG000|NOT COMPLETED|Overall Study||0
9015391|NCT03039088|10078155|FG001|NOT COMPLETED|Overall Study||0
9015392|NCT03039179|10078163|FG000|STARTED|Overall Study||38
9015393|NCT03039179|10078164|FG001|STARTED|Overall Study||42
9015394|NCT03039179|10078163|FG000|COMPLETED|Overall Study||38
9015395|NCT03039179|10078164|FG001|COMPLETED|Overall Study||42
9015396|NCT03039179|10078163|FG000|NOT COMPLETED|Overall Study||0
9015397|NCT03039179|10078164|FG001|NOT COMPLETED|Overall Study||0
9015398|NCT03039192|10078172|FG000|STARTED|Overall Study||112
9015399|NCT03039192|10078173|FG001|STARTED|Overall Study||114
9015400|NCT03039192|10078172|FG000|Treated|Overall Study||112
9015401|NCT03039192|10078173|FG001|Treated|Overall Study||113
9015402|NCT03039192|10078172|FG000|COMPLETED|Overall Study||80
9015403|NCT03039192|10078173|FG001|COMPLETED|Overall Study||84
9015404|NCT03039192|10078172|FG000|NOT COMPLETED|Overall Study||32
9015405|NCT03039192|10078173|FG001|NOT COMPLETED|Overall Study||30
9015406|NCT03039283|10078179|FG000|STARTED|Overall Study||162
9015407|NCT03039283|10078179|FG000|COMPLETED|Overall Study||160
9015408|NCT03039283|10078179|FG000|NOT COMPLETED|Overall Study||2
9015409|NCT03039543|10078185|FG000|STARTED|Overall Study||54
9015410|NCT03039543|10078186|FG001|STARTED|Overall Study||54
9015411|NCT03039543|10078185|FG000|COMPLETED|Overall Study||53
9015412|NCT03039543|10078186|FG001|COMPLETED|Overall Study||51
9015413|NCT03039543|10078185|FG000|NOT COMPLETED|Overall Study||1
8637022|NCT00570687|9677763|FG000|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
9015414|NCT03039543|10078186|FG001|NOT COMPLETED|Overall Study||3
9015415|NCT03039569|10078194|FG000|STARTED|Overall Study||40
9015416|NCT03039569|10078195|FG001|STARTED|Overall Study||39
9015417|NCT03039569|10078194|FG000|COMPLETED|Overall Study||35
9015418|NCT03039569|10078195|FG001|COMPLETED|Overall Study||35
9015419|NCT03039569|10078194|FG000|NOT COMPLETED|Overall Study||5
9015420|NCT03039569|10078195|FG001|NOT COMPLETED|Overall Study||4
9015421|NCT03039621|10078204|FG000|STARTED|Overall Study||143
9015422|NCT03039621|10078205|FG001|STARTED|Overall Study||144
9015423|NCT03039621|10078204|FG000|COMPLETED|Overall Study||131
9015424|NCT03039621|10078205|FG001|COMPLETED|Overall Study||128
9015425|NCT03039621|10078204|FG000|NOT COMPLETED|Overall Study||12
9015426|NCT03039621|10078205|FG001|NOT COMPLETED|Overall Study||16
9015427|NCT03039686|10078214|FG000|STARTED|Double-blind Period||56
9015428|NCT03039686|10078215|FG001|STARTED|Double-blind Period||55
8637023|NCT00570687|9677764|FG001|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
9015429|NCT03039686|10078216|FG002|STARTED|Double-blind Period||55
8910085|NCT02135107|9968845|FG000|COMPLETED|Maintenance Therapy Period||0
8910086|NCT02135107|9968846|FG001|COMPLETED|Maintenance Therapy Period||0
8910087|NCT02135107|9968847|FG002|COMPLETED|Maintenance Therapy Period||163
8910088|NCT02135107|9968848|FG003|COMPLETED|Maintenance Therapy Period||161
8910089|NCT02135107|9968845|FG000|NOT COMPLETED|Maintenance Therapy Period||0
8910090|NCT02135107|9968846|FG001|NOT COMPLETED|Maintenance Therapy Period||0
8910091|NCT02135107|9968847|FG002|NOT COMPLETED|Maintenance Therapy Period||15
8910092|NCT02135107|9968848|FG003|NOT COMPLETED|Maintenance Therapy Period||20
8910093|NCT02135146|9968862|FG000|STARTED|Overall Study||20
8910094|NCT02135146|9968863|FG001|STARTED|Overall Study||20
8910095|NCT02135146|9968862|FG000|COMPLETED|Overall Study||20
8910096|NCT02135146|9968863|FG001|COMPLETED|Overall Study||20
8910097|NCT02135146|9968862|FG000|NOT COMPLETED|Overall Study||0
8910098|NCT02135146|9968863|FG001|NOT COMPLETED|Overall Study||0
8910099|NCT02135432|9968871|FG000|STARTED|Overall Study||8
8910100|NCT02135432|9968872|FG001|STARTED|Overall Study||4
8910101|NCT02135432|9968871|FG000|COMPLETED|Overall Study||8
8910102|NCT02135432|9968872|FG001|COMPLETED|Overall Study||4
8910103|NCT02135432|9968871|FG000|NOT COMPLETED|Overall Study||0
8910104|NCT02135432|9968872|FG001|NOT COMPLETED|Overall Study||0
8910105|NCT02135445|9968881|FG000|STARTED|Overall Study||65
8910106|NCT02135445|9968882|FG001|STARTED|Overall Study||38
8910107|NCT02135445|9968881|FG000|COMPLETED|Overall Study||63
8910108|NCT02135445|9968882|FG001|COMPLETED|Overall Study||38
8910109|NCT02135445|9968881|FG000|NOT COMPLETED|Overall Study||2
8910110|NCT02135445|9968882|FG001|NOT COMPLETED|Overall Study||0
8910111|NCT02135614|9968890|FG000|STARTED|Overall Study||94
8910112|NCT02135614|9968891|FG001|STARTED|Overall Study||95
8910113|NCT02135614|9968890|FG000|COMPLETED|Overall Study||86
8910114|NCT02135614|9968891|FG001|COMPLETED|Overall Study||90
8910115|NCT02135614|9968890|FG000|NOT COMPLETED|Overall Study||8
8910116|NCT02135614|9968891|FG001|NOT COMPLETED|Overall Study||5
8910117|NCT02135653|9968899|FG000|STARTED|Overall Study||35
9015430|NCT03039686|10078214|FG000|COMPLETED|Double-blind Period||29
9015431|NCT03039686|10078215|FG001|COMPLETED|Double-blind Period||26
9015432|NCT03039686|10078216|FG002|COMPLETED|Double-blind Period||32
9015433|NCT03039686|10078214|FG000|NOT COMPLETED|Double-blind Period||27
9015434|NCT03039686|10078215|FG001|NOT COMPLETED|Double-blind Period||29
9015435|NCT03039686|10078216|FG002|NOT COMPLETED|Double-blind Period||23
9015436|NCT03039686|10078214|FG000|STARTED|Open Label Period|Double-blind (DB) placebo participants switched to RO7239361 (RO) for the open label phase.|0
9015437|NCT03039686|10078215|FG001|STARTED|Open Label Period|14 DB placebo participants switched to the RO Low Dose for the open-label phase.|38
9015438|NCT03039686|10078216|FG002|STARTED|Open Label Period|13 DB placebo participants switched to the RO High Dose for the open-label phase.|42
9015439|NCT03039686|10078214|FG000|Completed DB, Did Not Start OL|Open Label Period||2
9015440|NCT03039686|10078215|FG001|Completed DB, Did Not Start OL|Open Label Period||2
9015441|NCT03039686|10078216|FG002|Completed DB, Did Not Start OL|Open Label Period||3
9015442|NCT03039686|10078214|FG000|COMPLETED|Open Label Period||0
9015443|NCT03039686|10078215|FG001|COMPLETED|Open Label Period||0
9015444|NCT03039686|10078216|FG002|COMPLETED|Open Label Period||0
9015445|NCT03039686|10078214|FG000|NOT COMPLETED|Open Label Period||0
9015446|NCT03039686|10078215|FG001|NOT COMPLETED|Open Label Period||38
9015447|NCT03039686|10078216|FG002|NOT COMPLETED|Open Label Period||42
9015448|NCT03039699|10078236|FG000|STARTED|Overall Study||127
9015449|NCT03039699|10078237|FG001|STARTED|Overall Study||132
9015450|NCT03039699|10078236|FG000|COMPLETED|Overall Study||105
9015451|NCT03039699|10078237|FG001|COMPLETED|Overall Study||97
9015452|NCT03039699|10078236|FG000|NOT COMPLETED|Overall Study||22
9015453|NCT03039699|10078237|FG001|NOT COMPLETED|Overall Study||35
9015454|NCT03039738|10078245|FG000|STARTED|Overall Study||206
9015455|NCT03039738|10078246|FG001|STARTED|Overall Study|This arm did not initiate. The study was terminated following the completion of the telemetry phase.|0
9015456|NCT03039738|10078245|FG000|COMPLETED|Overall Study||152
9015457|NCT03039738|10078246|FG001|COMPLETED|Overall Study||0
9015458|NCT03039738|10078245|FG000|NOT COMPLETED|Overall Study||54
9015459|NCT03039738|10078246|FG001|NOT COMPLETED|Overall Study||0
9015460|NCT03040011|10078255|FG000|STARTED|Received Randomized Study Intervention||25
9015461|NCT03040011|10078256|FG001|STARTED|Received Randomized Study Intervention||25
9015462|NCT03040011|10078257|FG002|STARTED|Received Randomized Study Intervention||25
9015463|NCT03040011|10078255|FG000|COMPLETED|Received Randomized Study Intervention||25
9015464|NCT03040011|10078256|FG001|COMPLETED|Received Randomized Study Intervention||25
9015465|NCT03040011|10078257|FG002|COMPLETED|Received Randomized Study Intervention||25
9015466|NCT03040011|10078255|FG000|NOT COMPLETED|Received Randomized Study Intervention||0
9015467|NCT03040011|10078256|FG001|NOT COMPLETED|Received Randomized Study Intervention||0
9015468|NCT03040011|10078257|FG002|NOT COMPLETED|Received Randomized Study Intervention||0
9015469|NCT03040011|10078255|FG000|STARTED|Primary Outcome Follow Up||25
9015470|NCT03040011|10078256|FG001|STARTED|Primary Outcome Follow Up||25
9015471|NCT03040011|10078257|FG002|STARTED|Primary Outcome Follow Up||25
9015472|NCT03040011|10078255|FG000|COMPLETED|Primary Outcome Follow Up|Postoperative day one pain score not available for four patients|21
9015473|NCT03040011|10078256|FG001|COMPLETED|Primary Outcome Follow Up|Postoperative day one pain score not available for one patient|24
8910118|NCT02135653|9968900|FG001|STARTED|Overall Study||33
8910119|NCT02135653|9968899|FG000|COMPLETED|Overall Study||22
8910120|NCT02135653|9968900|FG001|COMPLETED|Overall Study||28
8910121|NCT02135653|9968899|FG000|NOT COMPLETED|Overall Study||13
8910122|NCT02135653|9968900|FG001|NOT COMPLETED|Overall Study||5
8910123|NCT02135692|9968908|FG000|STARTED|Overall Study||339
8910124|NCT02135692|9968908|FG000|COMPLETED|Overall Study||0
8910125|NCT02135692|9968908|FG000|NOT COMPLETED|Overall Study||339
8910126|NCT02135848|9968914|FG000|STARTED|Overall Study||26
8910127|NCT02135848|9968915|FG001|STARTED|Overall Study||20
8910128|NCT02135848|9968914|FG000|COMPLETED|Overall Study||23
8910129|NCT02135848|9968915|FG001|COMPLETED|Overall Study||19
8910130|NCT02135848|9968914|FG000|NOT COMPLETED|Overall Study||3
8910131|NCT02135848|9968915|FG001|NOT COMPLETED|Overall Study||1
8910132|NCT02135861|9968931|FG000|STARTED|Overall Study||21
8910133|NCT02135861|9968932|FG001|STARTED|Overall Study||12
8910134|NCT02135861|9968933|FG002|STARTED|Overall Study||3
8910135|NCT02135861|9968931|FG000|COMPLETED|Overall Study||21
8910136|NCT02135861|9968932|FG001|COMPLETED|Overall Study||12
8910137|NCT02135861|9968933|FG002|COMPLETED|Overall Study||3
8910138|NCT02135861|9968931|FG000|NOT COMPLETED|Overall Study||0
8910139|NCT02135861|9968932|FG001|NOT COMPLETED|Overall Study||0
8910140|NCT02135861|9968933|FG002|NOT COMPLETED|Overall Study||0
8910141|NCT02135900|9968943|FG000|STARTED|Overall Study|32 subjects started the study. 50 subjects were screened.|32
8910142|NCT02135900|9968943|FG000|COMPLETED|Overall Study||32
8910143|NCT02135900|9968943|FG000|NOT COMPLETED|Overall Study||0
8910144|NCT02136004|9968949|FG000|STARTED|Overall Study|Enrollment commenced on May 20, 2014 and the last subject completed follow-up on February 28, 2015|220
8910145|NCT02136004|9968949|FG000|COMPLETED|Overall Study||219
8910146|NCT02136004|9968949|FG000|NOT COMPLETED|Overall Study||1
8910147|NCT02136238|9968955|FG000|STARTED|Overall Study||4
8910148|NCT02136238|9968956|FG001|STARTED|Overall Study||4
8910149|NCT02136238|9968957|FG002|STARTED|Overall Study||10
8910150|NCT02136238|9968955|FG000|COMPLETED|Overall Study||4
8910151|NCT02136238|9968956|FG001|COMPLETED|Overall Study||4
8910152|NCT02136238|9968957|FG002|COMPLETED|Overall Study||10
8910153|NCT02136238|9968955|FG000|NOT COMPLETED|Overall Study||0
8910154|NCT02136238|9968956|FG001|NOT COMPLETED|Overall Study||0
8910155|NCT02136238|9968957|FG002|NOT COMPLETED|Overall Study||0
8910156|NCT02136420|9968972|FG000|STARTED|Overall Study||10
8910157|NCT02136420|9968973|FG001|STARTED|Overall Study||0
8910158|NCT02136420|9968974|FG002|STARTED|Overall Study||0
8910159|NCT02136420|9968975|FG003|STARTED|Overall Study||0
8910160|NCT02136420|9968976|FG004|STARTED|Overall Study||10
8910161|NCT02136420|9968977|FG005|STARTED|Overall Study||0
8910162|NCT02136420|9968978|FG006|STARTED|Overall Study||0
8910163|NCT02136420|9968979|FG007|STARTED|Overall Study||0
8910164|NCT02136420|9968980|FG008|STARTED|Overall Study||5
8910165|NCT02136420|9968981|FG009|STARTED|Overall Study||5
8910166|NCT02136420|9968972|FG000|COMPLETED|Overall Study||9
8910167|NCT02136420|9968973|FG001|COMPLETED|Overall Study||0
8910168|NCT02136420|9968974|FG002|COMPLETED|Overall Study||0
8910169|NCT02136420|9968975|FG003|COMPLETED|Overall Study||0
8910170|NCT02136420|9968976|FG004|COMPLETED|Overall Study||10
8910171|NCT02136420|9968977|FG005|COMPLETED|Overall Study||0
8910172|NCT02136420|9968978|FG006|COMPLETED|Overall Study||0
8910173|NCT02136420|9968979|FG007|COMPLETED|Overall Study||0
8910174|NCT02136420|9968980|FG008|COMPLETED|Overall Study||5
8910175|NCT02136420|9968981|FG009|COMPLETED|Overall Study||5
8910176|NCT02136420|9968972|FG000|NOT COMPLETED|Overall Study||1
8910177|NCT02136420|9968973|FG001|NOT COMPLETED|Overall Study||0
8910178|NCT02136420|9968974|FG002|NOT COMPLETED|Overall Study||0
8910179|NCT02136420|9968975|FG003|NOT COMPLETED|Overall Study||0
8910180|NCT02136420|9968976|FG004|NOT COMPLETED|Overall Study||0
8910181|NCT02136420|9968977|FG005|NOT COMPLETED|Overall Study||0
8910182|NCT02136420|9968978|FG006|NOT COMPLETED|Overall Study||0
8910183|NCT02136420|9968979|FG007|NOT COMPLETED|Overall Study||0
8910184|NCT02136420|9968980|FG008|NOT COMPLETED|Overall Study||0
8573685|NCT00123474|9605977|FG000|STARTED|As Treated at Study Closure|Randomized to 50 mg BID but received 100 mg QD.|165
8573686|NCT00123474|9605978|FG001|STARTED|As Treated at Study Closure||163
8573687|NCT00123474|9605979|FG002|STARTED|As Treated at Study Closure||167
8573688|NCT00123474|9605980|FG003|STARTED|As Treated at Study Closure||167
8573689|NCT00123474|9605977|FG000|COMPLETED|As Treated at Study Closure||0
8573690|NCT00123474|9605978|FG001|COMPLETED|As Treated at Study Closure||0
8573691|NCT00123474|9605979|FG002|COMPLETED|As Treated at Study Closure|Randomized to 100 mg QD but received 50 mg BID.|0
8573692|NCT00123474|9605980|FG003|COMPLETED|As Treated at Study Closure||0
8573693|NCT00123474|9605977|FG000|NOT COMPLETED|As Treated at Study Closure||165
8573694|NCT00123474|9605978|FG001|NOT COMPLETED|As Treated at Study Closure||163
8573695|NCT00123474|9605979|FG002|NOT COMPLETED|As Treated at Study Closure||167
8573696|NCT00123474|9605980|FG003|NOT COMPLETED|As Treated at Study Closure||167
8573697|NCT00123487|9606013|FG000|STARTED|Randomized||306
8573698|NCT00123487|9606014|FG001|STARTED|Randomized||305
8573699|NCT00123487|9606013|FG000|COMPLETED|Randomized||305
8573700|NCT00123487|9606014|FG001|COMPLETED|Randomized||304
8573701|NCT00123487|9606013|FG000|NOT COMPLETED|Randomized||1
8573702|NCT00123487|9606014|FG001|NOT COMPLETED|Randomized||1
8910185|NCT02136420|9968981|FG009|NOT COMPLETED|Overall Study||0
8910186|NCT02136498|9968998|FG000|STARTED|Overall Study||33
8910187|NCT02136498|9968999|FG001|STARTED|Overall Study||33
8910188|NCT02136498|9968998|FG000|COMPLETED|Overall Study||33
8910189|NCT02136498|9968999|FG001|COMPLETED|Overall Study||33
8910190|NCT02136498|9968998|FG000|NOT COMPLETED|Overall Study||0
8910191|NCT02136498|9968999|FG001|NOT COMPLETED|Overall Study||0
8910192|NCT02136576|9969008|FG000|STARTED|Overall Study||13
8910193|NCT02136576|9969009|FG001|STARTED|Overall Study||13
8910194|NCT02136576|9969010|FG002|STARTED|Overall Study||13
8910195|NCT02136576|9969008|FG000|COMPLETED|Overall Study||11
8910196|NCT02136576|9969009|FG001|COMPLETED|Overall Study||13
8910197|NCT02136576|9969010|FG002|COMPLETED|Overall Study||13
8910198|NCT02136576|9969008|FG000|NOT COMPLETED|Overall Study||2
8910199|NCT02136576|9969009|FG001|NOT COMPLETED|Overall Study||0
8910200|NCT02136576|9969010|FG002|NOT COMPLETED|Overall Study||0
9015474|NCT03040011|10078257|FG002|COMPLETED|Primary Outcome Follow Up|Postoperative day one pain score not available for one patient|24
9015475|NCT03040011|10078255|FG000|NOT COMPLETED|Primary Outcome Follow Up||4
9015476|NCT03040011|10078256|FG001|NOT COMPLETED|Primary Outcome Follow Up||1
9015477|NCT03040011|10078257|FG002|NOT COMPLETED|Primary Outcome Follow Up||1
9015478|NCT03040024|10078268|FG000|STARTED|Overall Study||21
9015479|NCT03040024|10078269|FG001|STARTED|Overall Study||26
9015480|NCT03040024|10078270|FG002|STARTED|Overall Study||24
8910201|NCT02136680|9969020|FG000|STARTED|Overall Study||112
8910202|NCT02136680|9969021|FG001|STARTED|Overall Study||85
8910203|NCT02136680|9969020|FG000|Interview 1|Overall Study||112
8910204|NCT02136680|9969021|FG001|Interview 1|Overall Study||85
8910205|NCT02136680|9969020|FG000|Interview 2|Overall Study||97
8910206|NCT02136680|9969021|FG001|Interview 2|Overall Study||70
8910207|NCT02136680|9969020|FG000|Interview 3|Overall Study||80
8910208|NCT02136680|9969021|FG001|Interview 3|Overall Study||56
8910209|NCT02136680|9969020|FG000|COMPLETED|Overall Study||80
9015481|NCT03040024|10078268|FG000|COMPLETED|Overall Study||21
9015482|NCT03040024|10078269|FG001|COMPLETED|Overall Study||24
9015483|NCT03040024|10078270|FG002|COMPLETED|Overall Study||23
9015484|NCT03040024|10078268|FG000|NOT COMPLETED|Overall Study||0
9015485|NCT03040024|10078269|FG001|NOT COMPLETED|Overall Study||2
9015486|NCT03040024|10078270|FG002|NOT COMPLETED|Overall Study||1
8910210|NCT02136680|9969021|FG001|COMPLETED|Overall Study||56
8910211|NCT02136680|9969020|FG000|NOT COMPLETED|Overall Study||32
8910212|NCT02136680|9969021|FG001|NOT COMPLETED|Overall Study||29
8910213|NCT02136810|9969027|FG000|STARTED|Overall Study||200
8910214|NCT02136810|9969027|FG000|COMPLETED|Overall Study||200
8910215|NCT02136810|9969027|FG000|NOT COMPLETED|Overall Study||0
8910216|NCT02136914|9969033|FG000|STARTED|Overall Study||63
8910217|NCT02136914|9969034|FG001|STARTED|Overall Study||63
8910218|NCT02136914|9969033|FG000|Received Study Drug|Overall Study||60
8910219|NCT02136914|9969034|FG001|Received Study Drug|Overall Study||63
8910220|NCT02136914|9969033|FG000|COMPLETED|Overall Study||42
8910221|NCT02136914|9969034|FG001|COMPLETED|Overall Study||42
8910222|NCT02136914|9969033|FG000|NOT COMPLETED|Overall Study||21
8910223|NCT02136914|9969034|FG001|NOT COMPLETED|Overall Study||21
8910224|NCT02137226|9969042|FG000|STARTED|Period 1 (Initial Randomization)||324
8910225|NCT02137226|9969043|FG001|STARTED|Period 1 (Initial Randomization)||321
8910226|NCT02137226|9969044|FG002|STARTED|Period 1 (Initial Randomization)||0
8910227|NCT02137226|9969045|FG003|STARTED|Period 1 (Initial Randomization)||0
8910228|NCT02137226|9969046|FG004|STARTED|Period 1 (Initial Randomization)||0
8910229|NCT02137226|9969042|FG000|COMPLETED|Period 1 (Initial Randomization)|Not completed are discontinued from study|304
8910230|NCT02137226|9969043|FG001|COMPLETED|Period 1 (Initial Randomization)|Not completed are discontinued from study|305
8910231|NCT02137226|9969044|FG002|COMPLETED|Period 1 (Initial Randomization)||0
8910232|NCT02137226|9969045|FG003|COMPLETED|Period 1 (Initial Randomization)||0
8910233|NCT02137226|9969046|FG004|COMPLETED|Period 1 (Initial Randomization)||0
8910234|NCT02137226|9969042|FG000|NOT COMPLETED|Period 1 (Initial Randomization)||20
8910235|NCT02137226|9969043|FG001|NOT COMPLETED|Period 1 (Initial Randomization)||16
8910236|NCT02137226|9969044|FG002|NOT COMPLETED|Period 1 (Initial Randomization)||0
8910237|NCT02137226|9969045|FG003|NOT COMPLETED|Period 1 (Initial Randomization)||0
8910238|NCT02137226|9969046|FG004|NOT COMPLETED|Period 1 (Initial Randomization)||0
8910239|NCT02137226|9969042|FG000|STARTED|Period 2 (Re - Randomization)||0
8910240|NCT02137226|9969043|FG001|STARTED|Period 2 (Re - Randomization)||0
8910241|NCT02137226|9969044|FG002|STARTED|Period 2 (Re - Randomization)||298
8910242|NCT02137226|9969045|FG003|STARTED|Period 2 (Re - Randomization)||148
8910243|NCT02137226|9969046|FG004|STARTED|Period 2 (Re - Randomization)||147
8910244|NCT02137226|9969042|FG000|COMPLETED|Period 2 (Re - Randomization)||0
8910245|NCT02137226|9969043|FG001|COMPLETED|Period 2 (Re - Randomization)||0
8910246|NCT02137226|9969044|FG002|COMPLETED|Period 2 (Re - Randomization)|Not completed are discontinued from study|281
8910247|NCT02137226|9969045|FG003|COMPLETED|Period 2 (Re - Randomization)|Not completed are discontinued from study|140
8910248|NCT02137226|9969046|FG004|COMPLETED|Period 2 (Re - Randomization)|Not completed are discontinued from study|138
8910249|NCT02137226|9969042|FG000|NOT COMPLETED|Period 2 (Re - Randomization)||0
8910250|NCT02137226|9969043|FG001|NOT COMPLETED|Period 2 (Re - Randomization)||0
8910251|NCT02137226|9969044|FG002|NOT COMPLETED|Period 2 (Re - Randomization)||17
8910252|NCT02137226|9969045|FG003|NOT COMPLETED|Period 2 (Re - Randomization)||8
8910253|NCT02137226|9969046|FG004|NOT COMPLETED|Period 2 (Re - Randomization)||9
8910254|NCT02137369|9969056|FG000|STARTED|Overall Study||49
8910255|NCT02137369|9969057|FG001|STARTED|Overall Study||11
8910256|NCT02137369|9969056|FG000|COMPLETED|Overall Study||41
8910257|NCT02137369|9969057|FG001|COMPLETED|Overall Study||9
8910258|NCT02137369|9969056|FG000|NOT COMPLETED|Overall Study||8
8910259|NCT02137369|9969057|FG001|NOT COMPLETED|Overall Study||2
8910260|NCT02137382|9969064|FG000|STARTED|Cross-over Period 1||20
8910261|NCT02137382|9969065|FG001|STARTED|Cross-over Period 1||21
8910262|NCT02137382|9969064|FG000|COMPLETED|Cross-over Period 1||18
8910263|NCT02137382|9969065|FG001|COMPLETED|Cross-over Period 1||21
8910264|NCT02137382|9969064|FG000|NOT COMPLETED|Cross-over Period 1||2
8910265|NCT02137382|9969065|FG001|NOT COMPLETED|Cross-over Period 1||0
8910266|NCT02137382|9969064|FG000|STARTED|Wash Out||18
8910267|NCT02137382|9969065|FG001|STARTED|Wash Out||21
8910268|NCT02137382|9969064|FG000|COMPLETED|Wash Out||18
8910269|NCT02137382|9969065|FG001|COMPLETED|Wash Out||21
8910270|NCT02137382|9969064|FG000|NOT COMPLETED|Wash Out||0
8910271|NCT02137382|9969065|FG001|NOT COMPLETED|Wash Out||0
8910272|NCT02137382|9969064|FG000|STARTED|Cross-over Period 2||18
8910273|NCT02137382|9969065|FG001|STARTED|Cross-over Period 2||21
8910274|NCT02137382|9969064|FG000|COMPLETED|Cross-over Period 2||18
8910275|NCT02137382|9969065|FG001|COMPLETED|Cross-over Period 2||21
8910276|NCT02137382|9969064|FG000|NOT COMPLETED|Cross-over Period 2||0
8910277|NCT02137382|9969065|FG001|NOT COMPLETED|Cross-over Period 2||0
8910278|NCT02137447|9969072|FG000|STARTED|Overall Study||10
8910279|NCT02137447|9969072|FG000|COMPLETED|Overall Study||10
8910280|NCT02137447|9969072|FG000|NOT COMPLETED|Overall Study||0
8910281|NCT02137486|9969078|FG000|STARTED|Overall Study||112
8910282|NCT02137486|9969079|FG001|STARTED|Overall Study||102
8910283|NCT02137486|9969078|FG000|COMPLETED|Overall Study||112
9015487|NCT03040154|10078280|FG000|STARTED|Overall Study||110
8910284|NCT02137486|9969079|FG001|COMPLETED|Overall Study||102
8910285|NCT02137486|9969078|FG000|NOT COMPLETED|Overall Study||0
8910286|NCT02137486|9969079|FG001|NOT COMPLETED|Overall Study||0
8910287|NCT02137499|9969093|FG000|STARTED|Overall Study||10
8910288|NCT02137499|9969094|FG001|STARTED|Overall Study||10
8910289|NCT02137499|9969095|FG002|STARTED|Overall Study||10
8910290|NCT02137499|9969096|FG003|STARTED|Overall Study||10
8910291|NCT02137499|9969093|FG000|COMPLETED|Overall Study||10
8910292|NCT02137499|9969094|FG001|COMPLETED|Overall Study||10
8910293|NCT02137499|9969095|FG002|COMPLETED|Overall Study||10
8910294|NCT02137499|9969096|FG003|COMPLETED|Overall Study||10
8910295|NCT02137499|9969093|FG000|NOT COMPLETED|Overall Study||0
8910296|NCT02137499|9969094|FG001|NOT COMPLETED|Overall Study||0
8910297|NCT02137499|9969095|FG002|NOT COMPLETED|Overall Study||0
8910298|NCT02137499|9969096|FG003|NOT COMPLETED|Overall Study||0
8910299|NCT02137512|9969106|FG000|STARTED|2-Week Baseline Sensor-Augmented Pump||30
8910300|NCT02137512|9969106|FG000|COMPLETED|2-Week Baseline Sensor-Augmented Pump||30
8910301|NCT02137512|9969106|FG000|NOT COMPLETED|2-Week Baseline Sensor-Augmented Pump||0
8910302|NCT02137512|9969106|FG000|STARTED|2-Week Overnight-Only Closed-Loop||30
8910303|NCT02137512|9969106|FG000|COMPLETED|2-Week Overnight-Only Closed-Loop||30
8910304|NCT02137512|9969106|FG000|NOT COMPLETED|2-Week Overnight-Only Closed-Loop||0
8910305|NCT02137512|9969106|FG000|STARTED|2-Week 24/7 Closed-Loop||30
8910306|NCT02137512|9969106|FG000|COMPLETED|2-Week 24/7 Closed-Loop||30
8910307|NCT02137512|9969106|FG000|NOT COMPLETED|2-Week 24/7 Closed-Loop||0
8910308|NCT02137512|9969106|FG000|STARTED|5-Month 24/7 Closed-Loop||14
8910309|NCT02137512|9969106|FG000|COMPLETED|5-Month 24/7 Closed-Loop||14
8910310|NCT02137512|9969106|FG000|NOT COMPLETED|5-Month 24/7 Closed-Loop||0
8910311|NCT02137538|9969116|FG000|STARTED|Overall Study||39
8910312|NCT02137538|9969117|FG001|STARTED|Overall Study||40
8910313|NCT02137538|9969116|FG000|COMPLETED|Overall Study||23
8910314|NCT02137538|9969117|FG001|COMPLETED|Overall Study||26
8910315|NCT02137538|9969116|FG000|NOT COMPLETED|Overall Study||16
8910316|NCT02137538|9969117|FG001|NOT COMPLETED|Overall Study||14
8910317|NCT02137603|9969125|FG000|STARTED|Overall Study||18
8910318|NCT02137603|9969126|FG001|STARTED|Overall Study||18
8910319|NCT02137603|9969125|FG000|COMPLETED|Overall Study||16
8910320|NCT02137603|9969126|FG001|COMPLETED|Overall Study||18
8910321|NCT02137603|9969125|FG000|NOT COMPLETED|Overall Study||2
8910322|NCT02137603|9969126|FG001|NOT COMPLETED|Overall Study||0
8910323|NCT02137772|9969134|FG000|STARTED|Overall Study|Randomized participants|376
8910324|NCT02137772|9969135|FG001|STARTED|Overall Study|Randomized participants|194
8910325|NCT02137772|9969134|FG000|Treated Participants|Overall Study||373
8910326|NCT02137772|9969135|FG001|Treated Participants|Overall Study||192
8910327|NCT02137772|9969134|FG000|COMPLETED|Overall Study||244
8910328|NCT02137772|9969135|FG001|COMPLETED|Overall Study||119
8910329|NCT02137772|9969134|FG000|NOT COMPLETED|Overall Study||132
8910330|NCT02137772|9969135|FG001|NOT COMPLETED|Overall Study||75
8910331|NCT02137785|9969143|FG000|STARTED|Overall Study||135
8910332|NCT02137785|9969144|FG001|STARTED|Overall Study||134
8910333|NCT02137785|9969143|FG000|COMPLETED|Overall Study||132
8910334|NCT02137785|9969144|FG001|COMPLETED|Overall Study||130
8910335|NCT02137785|9969143|FG000|NOT COMPLETED|Overall Study||3
8910336|NCT02137785|9969144|FG001|NOT COMPLETED|Overall Study||4
8910337|NCT02137837|9969153|FG000|STARTED|Overall Study||13
8910338|NCT02137837|9969154|FG001|STARTED|Overall Study||12
8910339|NCT02137837|9969155|FG002|STARTED|Overall Study||12
8910340|NCT02137837|9969153|FG000|Received Protocol Therapy|Overall Study||13
9015488|NCT03040154|10078281|FG001|STARTED|Overall Study||105
9015489|NCT03040154|10078280|FG000|COMPLETED|Overall Study||110
9015490|NCT03040154|10078281|FG001|COMPLETED|Overall Study||105
9015491|NCT03040154|10078280|FG000|NOT COMPLETED|Overall Study||0
9015492|NCT03040154|10078281|FG001|NOT COMPLETED|Overall Study||0
9015493|NCT03040336|10078289|FG000|STARTED|Overall Study||10
9015494|NCT03040336|10078290|FG001|STARTED|Overall Study||7
9015495|NCT03040336|10078289|FG000|COMPLETED|Overall Study||7
9015496|NCT03040336|10078290|FG001|COMPLETED|Overall Study||4
9015497|NCT03040336|10078289|FG000|NOT COMPLETED|Overall Study||3
9015498|NCT03040336|10078290|FG001|NOT COMPLETED|Overall Study||3
9015499|NCT03040362|10078297|FG000|STARTED|Overall Study||8
9015500|NCT03040362|10078297|FG000|Received at Least 1dose of Study Drug|Overall Study||8
9015501|NCT03040362|10078297|FG000|COMPLETED|Overall Study||8
9015502|NCT03040362|10078297|FG000|NOT COMPLETED|Overall Study||0
9015503|NCT03040414|10078303|FG000|STARTED|Overall Study||57
9015504|NCT03040414|10078304|FG001|STARTED|Overall Study||56
9015505|NCT03040414|10078303|FG000|Completed Period 1|Overall Study||56
9015506|NCT03040414|10078304|FG001|Completed Period 1|Overall Study||55
9015507|NCT03040414|10078303|FG000|Started Period 2|Overall Study||56
9015508|NCT03040414|10078304|FG001|Started Period 2|Overall Study||55
9015509|NCT03040414|10078303|FG000|COMPLETED|Overall Study||56
9015510|NCT03040414|10078304|FG001|COMPLETED|Overall Study||55
9015511|NCT03040414|10078303|FG000|NOT COMPLETED|Overall Study||1
9015512|NCT03040414|10078304|FG001|NOT COMPLETED|Overall Study||1
9015513|NCT03040427|10078313|FG000|STARTED|Overall Study||2
9015514|NCT03040427|10078314|FG001|STARTED|Overall Study||6
9015515|NCT03040427|10078315|FG002|STARTED|Overall Study||4
9015516|NCT03040427|10078313|FG000|COMPLETED|Overall Study||2
9015517|NCT03040427|10078314|FG001|COMPLETED|Overall Study||6
9015518|NCT03040427|10078315|FG002|COMPLETED|Overall Study||4
9015519|NCT03040427|10078313|FG000|NOT COMPLETED|Overall Study||0
9015520|NCT03040427|10078314|FG001|NOT COMPLETED|Overall Study||0
9015521|NCT03040427|10078315|FG002|NOT COMPLETED|Overall Study||0
9015522|NCT03040466|10078325|FG000|STARTED|Overall Study||65
9015523|NCT03040466|10078326|FG001|STARTED|Overall Study||115
9015524|NCT03040466|10078325|FG000|COMPLETED|Overall Study||65
9015525|NCT03040466|10078326|FG001|COMPLETED|Overall Study||115
9015526|NCT03040466|10078325|FG000|NOT COMPLETED|Overall Study||0
9015527|NCT03040466|10078326|FG001|NOT COMPLETED|Overall Study||0
9015528|NCT03040479|10078335|FG000|STARTED|Overall Study||8
9015529|NCT03040479|10078336|FG001|STARTED|Overall Study||8
9015530|NCT03040479|10078337|FG002|STARTED|Overall Study||8
9015531|NCT03040479|10078335|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
8573703|NCT00123487|9606013|FG000|STARTED|Treated With Study Drug|1 participant randomized to QD but received BID in error. 304 represents actual QD treatment.|304
8573704|NCT00123487|9606014|FG001|STARTED|Treated With Study Drug|1 participant randomized to QD but received BID in error. 305 represents actual BID treatment.|305
8573705|NCT00123487|9606013|FG000|COMPLETED|Treated With Study Drug||0
8573706|NCT00123487|9606014|FG001|COMPLETED|Treated With Study Drug||0
8573707|NCT00123487|9606013|FG000|NOT COMPLETED|Treated With Study Drug||304
8573708|NCT00123487|9606014|FG001|NOT COMPLETED|Treated With Study Drug||305
8573709|NCT00123604|9606023|FG000|STARTED|Overall Study||19
8573710|NCT00123604|9606024|FG001|STARTED|Overall Study||17
8573711|NCT00123604|9606023|FG000|COMPLETED|Overall Study||18
8573712|NCT00123604|9606024|FG001|COMPLETED|Overall Study||16
8573713|NCT00123604|9606023|FG000|NOT COMPLETED|Overall Study||1
8573714|NCT00123604|9606024|FG001|NOT COMPLETED|Overall Study||1
8573715|NCT00123630|9606032|FG000|STARTED|Overall Study||15
8573716|NCT00123630|9606033|FG001|STARTED|Overall Study||15
8573717|NCT00123630|9606032|FG000|COMPLETED|Overall Study||15
8573718|NCT00123630|9606033|FG001|COMPLETED|Overall Study||15
8573719|NCT00123630|9606032|FG000|NOT COMPLETED|Overall Study||0
8573720|NCT00123630|9606033|FG001|NOT COMPLETED|Overall Study||0
8573721|NCT00123643|9606041|FG000|STARTED|Overall Study||20
8573722|NCT00123643|9606042|FG001|STARTED|Overall Study||16
8573723|NCT00123643|9606041|FG000|COMPLETED|Overall Study||20
8573724|NCT00123643|9606042|FG001|COMPLETED|Overall Study||16
8573725|NCT00123643|9606041|FG000|NOT COMPLETED|Overall Study||0
8573726|NCT00123643|9606042|FG001|NOT COMPLETED|Overall Study||0
8573727|NCT00123682|9606052|FG000|STARTED|Overall Study||1069
8573728|NCT00123682|9606053|FG001|STARTED|Overall Study||934
8573729|NCT00123682|9606054|FG002|STARTED|Overall Study||592
8573730|NCT00123682|9606055|FG003|STARTED|Overall Study||525
8573731|NCT00123682|9606052|FG000|COMPLETED|Overall Study||749
8573732|NCT00123682|9606053|FG001|COMPLETED|Overall Study||731
8573733|NCT00123682|9606054|FG002|COMPLETED|Overall Study||438
8573734|NCT00123682|9606055|FG003|COMPLETED|Overall Study||430
8573735|NCT00123682|9606052|FG000|NOT COMPLETED|Overall Study||320
8573736|NCT00123682|9606053|FG001|NOT COMPLETED|Overall Study||203
8573737|NCT00123682|9606054|FG002|NOT COMPLETED|Overall Study||154
8573738|NCT00123682|9606055|FG003|NOT COMPLETED|Overall Study||95
8573739|NCT00123734|9606069|FG000|STARTED|Overall Study||82
8573740|NCT00123734|9606069|FG000|COMPLETED|Overall Study||74
8573741|NCT00123734|9606069|FG000|NOT COMPLETED|Overall Study||8
8573742|NCT00123955|9606078|FG000|STARTED|Overall Study||42
8573743|NCT00123955|9606079|FG001|STARTED|Overall Study||38
8573744|NCT00123955|9606078|FG000|COMPLETED|Overall Study||37
8573745|NCT00123955|9606079|FG001|COMPLETED|Overall Study||34
8637024|NCT00570687|9677765|FG002|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
8637025|NCT00570687|9677766|FG003|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
8637026|NCT00570687|9677767|FG004|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
8637027|NCT00570687|9677768|FG005|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
8637028|NCT00570687|9677769|FG006|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
8637029|NCT00570687|9677770|FG007|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
8637030|NCT00570687|9677771|FG008|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
8637031|NCT00570687|9677772|FG009|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
8637032|NCT00570687|9677763|FG000|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
8637033|NCT00570687|9677764|FG001|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
8637034|NCT00570687|9677765|FG002|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
8727041|NCT01041248|9774436|FG000|NOT COMPLETED|Overall Study||0
8727042|NCT01041274|9774443|FG000|STARTED|Overall Study||49
8727043|NCT01041274|9774444|FG001|STARTED|Overall Study||46
8727044|NCT01041274|9774443|FG000|COMPLETED|Overall Study||26
8727045|NCT01041274|9774444|FG001|COMPLETED|Overall Study||25
8727046|NCT01041274|9774443|FG000|NOT COMPLETED|Overall Study||23
8727047|NCT01041274|9774444|FG001|NOT COMPLETED|Overall Study||21
8727048|NCT01041287|9774452|FG000|STARTED|Treatment Period 1 (3 Months)||19
8727049|NCT01041287|9774453|FG001|STARTED|Treatment Period 1 (3 Months)||19
8727050|NCT01041287|9774452|FG000|COMPLETED|Treatment Period 1 (3 Months)||19
8727051|NCT01041287|9774453|FG001|COMPLETED|Treatment Period 1 (3 Months)||19
8727052|NCT01041287|9774452|FG000|NOT COMPLETED|Treatment Period 1 (3 Months)||0
8727053|NCT01041287|9774453|FG001|NOT COMPLETED|Treatment Period 1 (3 Months)||0
8727054|NCT01041287|9774452|FG000|STARTED|Treatment Period 2 (3 Months)||19
8727055|NCT01041287|9774453|FG001|STARTED|Treatment Period 2 (3 Months)||19
8727056|NCT01041287|9774452|FG000|COMPLETED|Treatment Period 2 (3 Months)||16
8573746|NCT00123955|9606078|FG000|NOT COMPLETED|Overall Study||5
8573747|NCT00123955|9606079|FG001|NOT COMPLETED|Overall Study||4
8573748|NCT00124020|9606087|FG000|STARTED|Overall Study||377
8573749|NCT00124020|9606088|FG001|STARTED|Overall Study||380
8573750|NCT00124020|9606087|FG000|COMPLETED|Overall Study||289
8573751|NCT00124020|9606088|FG001|COMPLETED|Overall Study||289
8573752|NCT00124020|9606087|FG000|NOT COMPLETED|Overall Study||88
8573753|NCT00124020|9606088|FG001|NOT COMPLETED|Overall Study||91
8573754|NCT00124072|9606098|FG000|STARTED|Overall Study||3017
8573755|NCT00124072|9606099|FG001|STARTED|Overall Study||3016
8573756|NCT00124072|9606100|FG002|STARTED|Overall Study||3016
8573757|NCT00124072|9606101|FG003|STARTED|Overall Study||3015
8573758|NCT00124072|9606098|FG000|COMPLETED|Overall Study||2503
8910341|NCT02137837|9969154|FG001|Received Protocol Therapy|Overall Study||11
8910342|NCT02137837|9969155|FG002|Received Protocol Therapy|Overall Study||12
8910343|NCT02137837|9969153|FG000|COMPLETED|Overall Study||0
8910344|NCT02137837|9969154|FG001|COMPLETED|Overall Study||0
8910345|NCT02137837|9969155|FG002|COMPLETED|Overall Study||0
8910346|NCT02137837|9969153|FG000|NOT COMPLETED|Overall Study||13
8910347|NCT02137837|9969154|FG001|NOT COMPLETED|Overall Study||12
8910348|NCT02137837|9969155|FG002|NOT COMPLETED|Overall Study||12
8910349|NCT02138006|9969170|FG000|STARTED|Overall Study||48
8910350|NCT02138006|9969171|FG001|STARTED|Overall Study||54
8910351|NCT02138006|9969170|FG000|COMPLETED|Overall Study||48
8910352|NCT02138006|9969171|FG001|COMPLETED|Overall Study||54
8910353|NCT02138006|9969170|FG000|NOT COMPLETED|Overall Study||0
8910354|NCT02138006|9969171|FG001|NOT COMPLETED|Overall Study||0
8910355|NCT02138097|9969195|FG000|STARTED|Overall Study||155345
8910356|NCT02138097|9969196|FG001|STARTED|Overall Study||459722
8910357|NCT02138097|9969195|FG000|COMPLETED|Overall Study||155345
8910358|NCT02138097|9969196|FG001|COMPLETED|Overall Study||459722
8910359|NCT02138097|9969195|FG000|NOT COMPLETED|Overall Study||0
8910360|NCT02138097|9969196|FG001|NOT COMPLETED|Overall Study||0
8910361|NCT02138110|9969220|FG000|STARTED|Enrolled in Study||20
8910362|NCT02138110|9969220|FG000|COMPLETED|Enrolled in Study||20
8910363|NCT02138110|9969220|FG000|NOT COMPLETED|Enrolled in Study||0
8910364|NCT02138110|9969220|FG000|STARTED|Enrolled for Scaffold Implantation||20
8910365|NCT02138110|9969220|FG000|COMPLETED|Enrolled for Scaffold Implantation||19
8910366|NCT02138110|9969220|FG000|NOT COMPLETED|Enrolled for Scaffold Implantation||1
8910367|NCT02138110|9969220|FG000|STARTED|Overall Scaffold Implantation||19
8910368|NCT02138110|9969220|FG000|6-month Follow-Up|Overall Scaffold Implantation||16
8910369|NCT02138110|9969220|FG000|COMPLETED|Overall Scaffold Implantation||16
8910370|NCT02138110|9969220|FG000|NOT COMPLETED|Overall Scaffold Implantation||3
8910371|NCT02138136|9969224|FG000|STARTED|Overall Study||419
8910372|NCT02138136|9969224|FG000|Safety Analysis Set|Overall Study||419
8910373|NCT02138136|9969224|FG000|Modified Intent to Treat (mITT)|Overall Study||418
8910374|NCT02138136|9969224|FG000|COMPLETED|Overall Study||280
8910375|NCT02138136|9969224|FG000|NOT COMPLETED|Overall Study||139
8910376|NCT02138214|9969232|FG000|STARTED|Overall Study||30
8910377|NCT02138214|9969233|FG001|STARTED|Overall Study||30
9015532|NCT03040479|10078336|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8
9015533|NCT03040479|10078337|FG002|Received at Least 1 Dose of Study Drug|Overall Study||8
8637035|NCT00570687|9677766|FG003|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
8637036|NCT00570687|9677767|FG004|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
9015534|NCT03040479|10078335|FG000|COMPLETED|Overall Study||8
9015535|NCT03040479|10078336|FG001|COMPLETED|Overall Study||8
9015536|NCT03040479|10078337|FG002|COMPLETED|Overall Study||8
9015537|NCT03040479|10078335|FG000|NOT COMPLETED|Overall Study||0
9015538|NCT03040479|10078336|FG001|NOT COMPLETED|Overall Study||0
9015539|NCT03040479|10078337|FG002|NOT COMPLETED|Overall Study||0
9015540|NCT03040674|10078347|FG000|STARTED|Overall Study||489
9015541|NCT03040674|10078347|FG000|Participants Completing 3 Month Survey|Overall Study||351
9015542|NCT03040674|10078347|FG000|Participants Completing 6 Month Survey|Overall Study||241
9015543|NCT03040674|10078347|FG000|COMPLETED|Overall Study||241
9015544|NCT03040674|10078347|FG000|NOT COMPLETED|Overall Study||248
9015545|NCT03040687|10078355|FG000|STARTED|Overall Study||20
9015546|NCT03040687|10078356|FG001|STARTED|Overall Study||20
9015547|NCT03040687|10078357|FG002|STARTED|Overall Study||20
9015548|NCT03040687|10078355|FG000|COMPLETED|Overall Study||19
9015549|NCT03040687|10078356|FG001|COMPLETED|Overall Study||20
9015550|NCT03040687|10078357|FG002|COMPLETED|Overall Study||20
9015551|NCT03040687|10078355|FG000|NOT COMPLETED|Overall Study||1
9015552|NCT03040687|10078356|FG001|NOT COMPLETED|Overall Study||0
9015553|NCT03040687|10078357|FG002|NOT COMPLETED|Overall Study||0
9015554|NCT03040713|10078365|FG000|STARTED|Overall Study||16
9015555|NCT03040713|10078365|FG000|COMPLETED|Overall Study||13
9015556|NCT03040713|10078365|FG000|NOT COMPLETED|Overall Study||3
9015557|NCT03040804|10078369|FG000|STARTED|Overall Study||2
9015558|NCT03040804|10078369|FG000|COMPLETED|Overall Study||2
9015559|NCT03040804|10078369|FG000|NOT COMPLETED|Overall Study||0
9015560|NCT03040986|10078375|FG000|STARTED|Overall Study||6
9015561|NCT03040986|10078376|FG001|STARTED|Overall Study||2
9015562|NCT03040986|10078375|FG000|COMPLETED|Overall Study||0
9015563|NCT03040986|10078376|FG001|COMPLETED|Overall Study||0
9015564|NCT03040986|10078375|FG000|NOT COMPLETED|Overall Study||6
9015565|NCT03040986|10078376|FG001|NOT COMPLETED|Overall Study||2
9015566|NCT03041025|10078387|FG000|STARTED|Overall Study||8
9015567|NCT03041025|10078388|FG001|STARTED|Overall Study||3
9015568|NCT03041025|10078389|FG002|STARTED|Overall Study||24
9015569|NCT03041025|10078387|FG000|COMPLETED|Overall Study||7
9015570|NCT03041025|10078388|FG001|COMPLETED|Overall Study||3
9015571|NCT03041025|10078389|FG002|COMPLETED|Overall Study||22
9015572|NCT03041025|10078387|FG000|NOT COMPLETED|Overall Study||1
9015573|NCT03041025|10078388|FG001|NOT COMPLETED|Overall Study||0
9015574|NCT03041025|10078389|FG002|NOT COMPLETED|Overall Study||2
8910378|NCT02138214|9969234|FG002|STARTED|Overall Study||30
8910379|NCT02138214|9969232|FG000|Analyzed for Baseline Measures|Overall Study||30
8910380|NCT02138214|9969233|FG001|Analyzed for Baseline Measures|Overall Study||29
8910381|NCT02138214|9969234|FG002|Analyzed for Baseline Measures|Overall Study||30
8910382|NCT02138214|9969232|FG000|COMPLETED|Overall Study||30
8910383|NCT02138214|9969233|FG001|COMPLETED|Overall Study||26
8910384|NCT02138214|9969234|FG002|COMPLETED|Overall Study||26
8910385|NCT02138214|9969232|FG000|NOT COMPLETED|Overall Study||0
8910386|NCT02138214|9969233|FG001|NOT COMPLETED|Overall Study||4
8910387|NCT02138214|9969234|FG002|NOT COMPLETED|Overall Study||4
8910388|NCT02138227|9969243|FG000|STARTED|Overall Study||55
8910389|NCT02138227|9969244|FG001|STARTED|Overall Study||218
8910390|NCT02138227|9969243|FG000|COMPLETED|Overall Study||55
8910391|NCT02138227|9969244|FG001|COMPLETED|Overall Study||218
8910392|NCT02138227|9969243|FG000|NOT COMPLETED|Overall Study||0
8910393|NCT02138227|9969244|FG001|NOT COMPLETED|Overall Study||0
8910394|NCT02138240|9969275|FG000|STARTED|Overall Study||34
8910395|NCT02138240|9969275|FG000|COMPLETED|Overall Study||34
8910396|NCT02138240|9969275|FG000|NOT COMPLETED|Overall Study||0
8910397|NCT02138253|9969281|FG000|STARTED|Overall Study||41
8910398|NCT02138253|9969282|FG001|STARTED|Overall Study||23
8910399|NCT02138253|9969281|FG000|COMPLETED|Overall Study||32
8910400|NCT02138253|9969282|FG001|COMPLETED|Overall Study||19
8910401|NCT02138253|9969281|FG000|NOT COMPLETED|Overall Study||9
8910402|NCT02138253|9969282|FG001|NOT COMPLETED|Overall Study||4
8910403|NCT02138461|9969290|FG000|STARTED|Overall Study||101
8910404|NCT02138461|9969291|FG001|STARTED|Overall Study||110
8910405|NCT02138461|9969290|FG000|COMPLETED|Overall Study||101
8910406|NCT02138461|9969291|FG001|COMPLETED|Overall Study||110
8910407|NCT02138461|9969290|FG000|NOT COMPLETED|Overall Study||0
8910408|NCT02138461|9969291|FG001|NOT COMPLETED|Overall Study||0
8910409|NCT02138578|9969300|FG000|STARTED|Overall Study||1
8910410|NCT02138578|9969301|FG001|STARTED|Overall Study||0
8910411|NCT02138578|9969302|FG002|STARTED|Overall Study||3
8910412|NCT02138578|9969300|FG000|COMPLETED|Overall Study||1
8910413|NCT02138578|9969301|FG001|COMPLETED|Overall Study||0
8910414|NCT02138578|9969302|FG002|COMPLETED|Overall Study||3
8910415|NCT02138578|9969300|FG000|NOT COMPLETED|Overall Study||0
8910416|NCT02138578|9969301|FG001|NOT COMPLETED|Overall Study||0
8910417|NCT02138578|9969302|FG002|NOT COMPLETED|Overall Study||0
8910418|NCT02138747|9969314|FG000|STARTED|Treatment Period 1||156
8910419|NCT02138747|9969315|FG001|STARTED|Treatment Period 1||157
8910420|NCT02138747|9969316|FG002|STARTED|Treatment Period 1||31
8910421|NCT02138747|9969317|FG003|STARTED|Treatment Period 1||32
8910422|NCT02138747|9969314|FG000|COMPLETED|Treatment Period 1||136
8910423|NCT02138747|9969315|FG001|COMPLETED|Treatment Period 1||132
8910424|NCT02138747|9969316|FG002|COMPLETED|Treatment Period 1||27
8910425|NCT02138747|9969317|FG003|COMPLETED|Treatment Period 1||28
8910426|NCT02138747|9969314|FG000|NOT COMPLETED|Treatment Period 1||20
8910427|NCT02138747|9969315|FG001|NOT COMPLETED|Treatment Period 1||25
8910428|NCT02138747|9969316|FG002|NOT COMPLETED|Treatment Period 1||4
8910429|NCT02138747|9969317|FG003|NOT COMPLETED|Treatment Period 1||4
8910430|NCT02138747|9969314|FG000|STARTED|Treatment Period 2|Two participants who discontinued treatment in period 1 entered period 2.|138
8910431|NCT02138747|9969315|FG001|STARTED|Treatment Period 2||132
8910432|NCT02138747|9969316|FG002|STARTED|Treatment Period 2|One participant completed treatment in period 1.|26
8910433|NCT02138747|9969317|FG003|STARTED|Treatment Period 2|One participant completed treatment in period 1.|27
8910434|NCT02138747|9969314|FG000|COMPLETED|Treatment Period 2||121
8910435|NCT02138747|9969315|FG001|COMPLETED|Treatment Period 2||125
8910436|NCT02138747|9969316|FG002|COMPLETED|Treatment Period 2||24
8910437|NCT02138747|9969317|FG003|COMPLETED|Treatment Period 2||24
8910438|NCT02138747|9969314|FG000|NOT COMPLETED|Treatment Period 2||17
8910439|NCT02138747|9969315|FG001|NOT COMPLETED|Treatment Period 2||7
8910440|NCT02138747|9969316|FG002|NOT COMPLETED|Treatment Period 2||2
8910441|NCT02138747|9969317|FG003|NOT COMPLETED|Treatment Period 2||3
8910442|NCT02138786|9969330|FG000|STARTED|Overall Study||3
8910443|NCT02138786|9969331|FG001|STARTED|Overall Study||15
8910444|NCT02138786|9969332|FG002|STARTED|Overall Study||8
8910445|NCT02138786|9969330|FG000|COMPLETED|Overall Study||0
8910446|NCT02138786|9969331|FG001|COMPLETED|Overall Study||0
8910447|NCT02138786|9969332|FG002|COMPLETED|Overall Study||0
8910448|NCT02138786|9969330|FG000|NOT COMPLETED|Overall Study||3
8910449|NCT02138786|9969331|FG001|NOT COMPLETED|Overall Study||15
8910450|NCT02138786|9969332|FG002|NOT COMPLETED|Overall Study||8
9015575|NCT03041038|10078402|FG000|STARTED|Overall Study||11
9015576|NCT03041038|10078403|FG001|STARTED|Overall Study||9
9015577|NCT03041038|10078402|FG000|Week 16|Overall Study||10
9015578|NCT03041038|10078403|FG001|Week 16|Overall Study||8
9015579|NCT03041038|10078402|FG000|Week 32|Overall Study||9
9015580|NCT03041038|10078403|FG001|Week 32|Overall Study||8
9015581|NCT03041038|10078402|FG000|COMPLETED|Overall Study||5
9015582|NCT03041038|10078403|FG001|COMPLETED|Overall Study||7
9015583|NCT03041038|10078402|FG000|NOT COMPLETED|Overall Study||6
9015584|NCT03041038|10078403|FG001|NOT COMPLETED|Overall Study||2
9015585|NCT03041090|10078413|FG000|STARTED|Overall Study||109
9015586|NCT03041090|10078414|FG001|STARTED|Overall Study||24
9015587|NCT03041090|10078413|FG000|COMPLETED|Overall Study||109
9015588|NCT03041090|10078414|FG001|COMPLETED|Overall Study|3 consented subjects in the dynamic arm were not included in analysis due to technical errors.|21
9015589|NCT03041090|10078413|FG000|NOT COMPLETED|Overall Study||0
9015590|NCT03041090|10078414|FG001|NOT COMPLETED|Overall Study||3
9015591|NCT03041116|10078422|FG000|STARTED|Double-blind||41
9015592|NCT03041116|10078423|FG001|STARTED|Double-blind||43
9015593|NCT03041116|10078422|FG000|Received at Least 1 Dose of Study Drug|Double-blind||41
8910451|NCT02138825|9969340|FG000|STARTED|Main Study Treatment|safety population|73
8910452|NCT02138825|9969341|FG001|STARTED|Main Study Treatment|safety population|74
8910453|NCT02138825|9969340|FG000|COMPLETED|Main Study Treatment||33
8910454|NCT02138825|9969341|FG001|COMPLETED|Main Study Treatment||39
8910455|NCT02138825|9969340|FG000|NOT COMPLETED|Main Study Treatment||40
8910456|NCT02138825|9969341|FG001|NOT COMPLETED|Main Study Treatment||35
8910457|NCT02138825|9969340|FG000|STARTED|Long-term Extension||32
8910458|NCT02138825|9969341|FG001|STARTED|Long-term Extension||38
8910459|NCT02138825|9969340|FG000|COMPLETED|Long-term Extension|no participants were considered as completed LTE phase at time of study termination|0
8910460|NCT02138825|9969341|FG001|COMPLETED|Long-term Extension|no participants were considered as completed LTE phase at time of study termination|0
8910461|NCT02138825|9969340|FG000|NOT COMPLETED|Long-term Extension||32
8910462|NCT02138825|9969341|FG001|NOT COMPLETED|Long-term Extension||38
8910463|NCT02138825|9969340|FG000|STARTED|Safety Follow-up|Participants from main study treatment and LTE phase entered safety follow-up|72
8910464|NCT02138825|9969341|FG001|STARTED|Safety Follow-up|Participants from main study treatment and LTE phase entered safety follow-up|64
8910465|NCT02138825|9969340|FG000|COMPLETED|Safety Follow-up||50
8910466|NCT02138825|9969341|FG001|COMPLETED|Safety Follow-up||47
8910467|NCT02138825|9969340|FG000|NOT COMPLETED|Safety Follow-up||22
8910468|NCT02138825|9969341|FG001|NOT COMPLETED|Safety Follow-up||17
8910469|NCT02138838|9969354|FG000|STARTED|Overall Study||28
8910470|NCT02138838|9969355|FG001|STARTED|Overall Study||27
8910471|NCT02138838|9969354|FG000|Received Study Drug|Overall Study||28
8910472|NCT02138838|9969355|FG001|Received Study Drug|Overall Study||25
8910473|NCT02138838|9969354|FG000|COMPLETED|Overall Study||20
8910474|NCT02138838|9969355|FG001|COMPLETED|Overall Study||16
8910475|NCT02138838|9969354|FG000|NOT COMPLETED|Overall Study||8
8910476|NCT02138838|9969355|FG001|NOT COMPLETED|Overall Study||11
8910477|NCT02138890|9969363|FG000|STARTED|Overall Study||31
8910478|NCT02138890|9969364|FG001|STARTED|Overall Study||15
8910479|NCT02138890|9969363|FG000|COMPLETED|Overall Study||30
8910480|NCT02138890|9969364|FG001|COMPLETED|Overall Study||15
8910481|NCT02138890|9969363|FG000|NOT COMPLETED|Overall Study||1
8910482|NCT02138890|9969364|FG001|NOT COMPLETED|Overall Study||0
8910483|NCT02138916|9969374|FG000|STARTED|Overall Study||554
8910484|NCT02138916|9969375|FG001|STARTED|Overall Study||552
8910485|NCT02138916|9969376|FG002|STARTED|Overall Study||550
8910486|NCT02138916|9969374|FG000|COMPLETED|Overall Study||497
8910487|NCT02138916|9969375|FG001|COMPLETED|Overall Study||492
8910488|NCT02138916|9969376|FG002|COMPLETED|Overall Study||491
8910489|NCT02138916|9969374|FG000|NOT COMPLETED|Overall Study||57
8910490|NCT02138916|9969375|FG001|NOT COMPLETED|Overall Study||60
8910491|NCT02138916|9969376|FG002|NOT COMPLETED|Overall Study||59
8910492|NCT02139007|9969386|FG000|STARTED|Study Site Recruitment||4
8910493|NCT02139007|9969387|FG001|STARTED|Study Site Recruitment||5
8910494|NCT02139007|9969386|FG000|COMPLETED|Study Site Recruitment||1
8910495|NCT02139007|9969387|FG001|COMPLETED|Study Site Recruitment||1
8910496|NCT02139007|9969386|FG000|NOT COMPLETED|Study Site Recruitment||3
8910497|NCT02139007|9969387|FG001|NOT COMPLETED|Study Site Recruitment||4
8910498|NCT02139007|9969386|FG000|STARTED|Patient Participant Recruitment||13
8910499|NCT02139007|9969387|FG001|STARTED|Patient Participant Recruitment||14
8910500|NCT02139007|9969386|FG000|COMPLETED|Patient Participant Recruitment||11
8910501|NCT02139007|9969387|FG001|COMPLETED|Patient Participant Recruitment||13
8910502|NCT02139007|9969386|FG000|NOT COMPLETED|Patient Participant Recruitment||2
8910503|NCT02139007|9969387|FG001|NOT COMPLETED|Patient Participant Recruitment||1
8910504|NCT02139046|9969401|FG000|STARTED|Overall Study||358
8910505|NCT02139046|9969402|FG001|STARTED|Overall Study||359
8910506|NCT02139046|9969403|FG002|STARTED|Overall Study||357
8910507|NCT02139046|9969404|FG003|STARTED|Overall Study||358
8910508|NCT02139046|9969405|FG004|STARTED|Overall Study||358
8910509|NCT02139046|9969401|FG000|Safety Analysis Set|Overall Study||356
8910510|NCT02139046|9969402|FG001|Safety Analysis Set|Overall Study||358
8910511|NCT02139046|9969403|FG002|Safety Analysis Set|Overall Study||355
8910512|NCT02139046|9969404|FG003|Safety Analysis Set|Overall Study||357
8910513|NCT02139046|9969405|FG004|Safety Analysis Set|Overall Study||357
8910514|NCT02139046|9969401|FG000|Full Analysis Set|Overall Study||357
8910515|NCT02139046|9969402|FG001|Full Analysis Set|Overall Study||357
8910516|NCT02139046|9969403|FG002|Full Analysis Set|Overall Study||355
8910517|NCT02139046|9969404|FG003|Full Analysis Set|Overall Study||357
8910518|NCT02139046|9969405|FG004|Full Analysis Set|Overall Study||357
8910519|NCT02139046|9969401|FG000|COMPLETED|Overall Study|Completed=Completed Study Drug|296
8910520|NCT02139046|9969402|FG001|COMPLETED|Overall Study||305
8910521|NCT02139046|9969403|FG002|COMPLETED|Overall Study||298
8910522|NCT02139046|9969404|FG003|COMPLETED|Overall Study||290
8910523|NCT02139046|9969405|FG004|COMPLETED|Overall Study||301
8910524|NCT02139046|9969401|FG000|NOT COMPLETED|Overall Study||62
8910525|NCT02139046|9969402|FG001|NOT COMPLETED|Overall Study||54
8910526|NCT02139046|9969403|FG002|NOT COMPLETED|Overall Study||59
8910527|NCT02139046|9969404|FG003|NOT COMPLETED|Overall Study||68
8910528|NCT02139046|9969405|FG004|NOT COMPLETED|Overall Study||57
8910529|NCT02139124|9969422|FG000|STARTED|Overall Study||78
8910530|NCT02139124|9969423|FG001|STARTED|Overall Study||77
8910531|NCT02139124|9969424|FG002|STARTED|Overall Study||73
8910532|NCT02139124|9969425|FG003|STARTED|Overall Study||73
8910533|NCT02139124|9969426|FG004|STARTED|Overall Study||74
8910534|NCT02139124|9969422|FG000|COMPLETED|Overall Study||69
8910535|NCT02139124|9969423|FG001|COMPLETED|Overall Study||73
8910536|NCT02139124|9969424|FG002|COMPLETED|Overall Study||69
8910537|NCT02139124|9969425|FG003|COMPLETED|Overall Study||61
8910538|NCT02139124|9969426|FG004|COMPLETED|Overall Study||61
8910539|NCT02139124|9969422|FG000|NOT COMPLETED|Overall Study||9
8910540|NCT02139124|9969423|FG001|NOT COMPLETED|Overall Study||4
8910541|NCT02139124|9969424|FG002|NOT COMPLETED|Overall Study||4
8910542|NCT02139124|9969425|FG003|NOT COMPLETED|Overall Study||12
8910543|NCT02139124|9969426|FG004|NOT COMPLETED|Overall Study||13
8910544|NCT02139137|9969440|FG000|STARTED|Overall Study||22
8910545|NCT02139137|9969441|FG001|STARTED|Overall Study||20
8910546|NCT02139137|9969440|FG000|COMPLETED|Overall Study||15
8910547|NCT02139137|9969441|FG001|COMPLETED|Overall Study||10
8910548|NCT02139137|9969440|FG000|NOT COMPLETED|Overall Study||7
8910549|NCT02139137|9969441|FG001|NOT COMPLETED|Overall Study||10
8910550|NCT02139176|9969449|FG000|STARTED|Overall Study||100
8910551|NCT02139176|9969450|FG001|STARTED|Overall Study||100
8910552|NCT02139176|9969449|FG000|COMPLETED|Overall Study||100
8910553|NCT02139176|9969450|FG001|COMPLETED|Overall Study||100
8910554|NCT02139176|9969449|FG000|NOT COMPLETED|Overall Study||0
8910555|NCT02139176|9969450|FG001|NOT COMPLETED|Overall Study||0
8910556|NCT02139228|9969459|FG000|STARTED|Overall Study||215
8910557|NCT02139228|9969460|FG001|STARTED|Overall Study||211
8910558|NCT02139228|9969459|FG000|COMPLETED|Overall Study||215
8910559|NCT02139228|9969460|FG001|COMPLETED|Overall Study||211
8910560|NCT02139228|9969459|FG000|NOT COMPLETED|Overall Study||0
8910561|NCT02139228|9969460|FG001|NOT COMPLETED|Overall Study||0
8910562|NCT02139280|9969468|FG000|STARTED|Overall Study||34
8910563|NCT02139280|9969469|FG001|STARTED|Overall Study||20
8910564|NCT02139280|9969468|FG000|COMPLETED|Overall Study||32
8910565|NCT02139280|9969469|FG001|COMPLETED|Overall Study||20
8910566|NCT02139280|9969468|FG000|NOT COMPLETED|Overall Study||2
8910567|NCT02139280|9969469|FG001|NOT COMPLETED|Overall Study||0
8910568|NCT02139306|9969477|FG000|STARTED|Overall Study||140
8910569|NCT02139306|9969478|FG001|STARTED|Overall Study||139
8910570|NCT02139306|9969477|FG000|COMPLETED|Overall Study||127
8910571|NCT02139306|9969478|FG001|COMPLETED|Overall Study||125
8910572|NCT02139306|9969477|FG000|NOT COMPLETED|Overall Study||13
8910573|NCT02139306|9969478|FG001|NOT COMPLETED|Overall Study||14
8910574|NCT02139358|9969485|FG000|STARTED|Overall Study||15
8910575|NCT02139358|9969485|FG000|COMPLETED|Overall Study||15
8910576|NCT02139358|9969485|FG000|NOT COMPLETED|Overall Study||0
8910577|NCT02139592|9969489|FG000|STARTED|Overall Study||292
8910578|NCT02139592|9969489|FG000|COMPLETED|Overall Study||284
8910579|NCT02139592|9969489|FG000|NOT COMPLETED|Overall Study||8
8910580|NCT02139644|9969498|FG000|STARTED|Run-In Period (Pre-assignment)|Enrolled|787
8910581|NCT02139644|9969499|FG001|STARTED|Run-In Period (Pre-assignment)||0
8910582|NCT02139644|9969500|FG002|STARTED|Run-In Period (Pre-assignment)||0
8910583|NCT02139644|9969501|FG003|STARTED|Run-In Period (Pre-assignment)||0
8910584|NCT02139644|9969502|FG004|STARTED|Run-In Period (Pre-assignment)||0
8910585|NCT02139644|9969503|FG005|STARTED|Run-In Period (Pre-assignment)||0
8910586|NCT02139644|9969498|FG000|COMPLETED|Run-In Period (Pre-assignment)||647
8910587|NCT02139644|9969499|FG001|COMPLETED|Run-In Period (Pre-assignment)||0
8910588|NCT02139644|9969500|FG002|COMPLETED|Run-In Period (Pre-assignment)||0
8910589|NCT02139644|9969501|FG003|COMPLETED|Run-In Period (Pre-assignment)||0
8910590|NCT02139644|9969502|FG004|COMPLETED|Run-In Period (Pre-assignment)||0
8910591|NCT02139644|9969503|FG005|COMPLETED|Run-In Period (Pre-assignment)||0
8910592|NCT02139644|9969498|FG000|NOT COMPLETED|Run-In Period (Pre-assignment)||140
8910593|NCT02139644|9969499|FG001|NOT COMPLETED|Run-In Period (Pre-assignment)||0
8910594|NCT02139644|9969500|FG002|NOT COMPLETED|Run-In Period (Pre-assignment)||0
8910595|NCT02139644|9969501|FG003|NOT COMPLETED|Run-In Period (Pre-assignment)||0
8910596|NCT02139644|9969502|FG004|NOT COMPLETED|Run-In Period (Pre-assignment)||0
8910597|NCT02139644|9969503|FG005|NOT COMPLETED|Run-In Period (Pre-assignment)||0
8910598|NCT02139644|9969498|FG000|STARTED|Treatment Period||0
8910599|NCT02139644|9969499|FG001|STARTED|Treatment Period|Randomized|129
8910600|NCT02139644|9969500|FG002|STARTED|Treatment Period|Randomized|129
8910601|NCT02139644|9969501|FG003|STARTED|Treatment Period|Randomized|130
8910602|NCT02139644|9969502|FG004|STARTED|Treatment Period|Randomized|129
8910603|NCT02139644|9969503|FG005|STARTED|Treatment Period|Randomized|130
8910604|NCT02139644|9969498|FG000|COMPLETED|Treatment Period||0
8910605|NCT02139644|9969499|FG001|COMPLETED|Treatment Period||126
8910606|NCT02139644|9969500|FG002|COMPLETED|Treatment Period||121
8910607|NCT02139644|9969501|FG003|COMPLETED|Treatment Period||121
8910608|NCT02139644|9969502|FG004|COMPLETED|Treatment Period||121
8910609|NCT02139644|9969503|FG005|COMPLETED|Treatment Period||113
8910610|NCT02139644|9969498|FG000|NOT COMPLETED|Treatment Period||0
8910611|NCT02139644|9969499|FG001|NOT COMPLETED|Treatment Period||3
8910612|NCT02139644|9969500|FG002|NOT COMPLETED|Treatment Period||8
8910613|NCT02139644|9969501|FG003|NOT COMPLETED|Treatment Period||9
8910614|NCT02139644|9969502|FG004|NOT COMPLETED|Treatment Period||8
8910615|NCT02139644|9969503|FG005|NOT COMPLETED|Treatment Period||17
8910616|NCT02139800|9969517|FG000|STARTED|Overall Study||224
8910617|NCT02139800|9969518|FG001|STARTED|Overall Study||236
8910618|NCT02139800|9969517|FG000|COMPLETED|Overall Study||211
8910619|NCT02139800|9969518|FG001|COMPLETED|Overall Study||215
8910620|NCT02139800|9969517|FG000|NOT COMPLETED|Overall Study||13
8910621|NCT02139800|9969518|FG001|NOT COMPLETED|Overall Study||21
8910622|NCT02139826|9969524|FG000|STARTED|Overall Study||12
8910623|NCT02139826|9969524|FG000|COMPLETED|Overall Study||11
8910624|NCT02139826|9969524|FG000|NOT COMPLETED|Overall Study||1
8910625|NCT02139878|9969534|FG000|STARTED|First Intervention (7 Days)||10
8910626|NCT02139878|9969535|FG001|STARTED|First Intervention (7 Days)||10
8910627|NCT02139878|9969534|FG000|COMPLETED|First Intervention (7 Days)||9
8910628|NCT02139878|9969535|FG001|COMPLETED|First Intervention (7 Days)||10
8910629|NCT02139878|9969534|FG000|NOT COMPLETED|First Intervention (7 Days)||1
8910630|NCT02139878|9969535|FG001|NOT COMPLETED|First Intervention (7 Days)||0
8910631|NCT02139878|9969534|FG000|STARTED|Washout Period (8 Days)||9
8910632|NCT02139878|9969535|FG001|STARTED|Washout Period (8 Days)||10
8910633|NCT02139878|9969534|FG000|COMPLETED|Washout Period (8 Days)||9
8910634|NCT02139878|9969535|FG001|COMPLETED|Washout Period (8 Days)||10
8910635|NCT02139878|9969534|FG000|NOT COMPLETED|Washout Period (8 Days)||0
8910636|NCT02139878|9969535|FG001|NOT COMPLETED|Washout Period (8 Days)||0
8910637|NCT02139878|9969534|FG000|STARTED|Second Intervention (7 Days)||9
8910638|NCT02139878|9969535|FG001|STARTED|Second Intervention (7 Days)||10
8910639|NCT02139878|9969534|FG000|COMPLETED|Second Intervention (7 Days)||9
8910640|NCT02139878|9969535|FG001|COMPLETED|Second Intervention (7 Days)||10
8910641|NCT02139878|9969534|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
8910642|NCT02139878|9969535|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
8910643|NCT02139943|9969544|FG000|STARTED|Overall Study||117
8910644|NCT02139943|9969545|FG001|STARTED|Overall Study||117
8910645|NCT02139943|9969546|FG002|STARTED|Overall Study||117
8910646|NCT02139943|9969544|FG000|COMPLETED|Overall Study||107
8910647|NCT02139943|9969545|FG001|COMPLETED|Overall Study||111
8910648|NCT02139943|9969546|FG002|COMPLETED|Overall Study||110
8910649|NCT02139943|9969544|FG000|NOT COMPLETED|Overall Study||10
8910650|NCT02139943|9969545|FG001|NOT COMPLETED|Overall Study||6
8910651|NCT02139943|9969546|FG002|NOT COMPLETED|Overall Study||7
8910652|NCT02139969|9969554|FG000|STARTED|Overall Study||956
8910653|NCT02139969|9969554|FG000|COMPLETED|Overall Study||956
8910654|NCT02139969|9969554|FG000|NOT COMPLETED|Overall Study||0
8910655|NCT02139982|9969568|FG000|STARTED|Overall Study||8
8910656|NCT02139982|9969569|FG001|STARTED|Overall Study||8
8910657|NCT02139982|9969570|FG002|STARTED|Overall Study||8
8910658|NCT02139982|9969571|FG003|STARTED|Overall Study||8
8910659|NCT02139982|9969572|FG004|STARTED|Overall Study||13
8910660|NCT02139982|9969573|FG005|STARTED|Overall Study||13
8910661|NCT02139982|9969574|FG006|STARTED|Overall Study||13
8910662|NCT02139982|9969575|FG007|STARTED|Overall Study||13
8910663|NCT02139982|9969576|FG008|STARTED|Overall Study||13
8910664|NCT02139982|9969577|FG009|STARTED|Overall Study||13
8910665|NCT02139982|9969568|FG000|COMPLETED|Overall Study||8
8910666|NCT02139982|9969569|FG001|COMPLETED|Overall Study||7
8910667|NCT02139982|9969570|FG002|COMPLETED|Overall Study||8
8910668|NCT02139982|9969571|FG003|COMPLETED|Overall Study||7
8910669|NCT02139982|9969572|FG004|COMPLETED|Overall Study||13
8910670|NCT02139982|9969573|FG005|COMPLETED|Overall Study||13
8910671|NCT02139982|9969574|FG006|COMPLETED|Overall Study||13
8910672|NCT02139982|9969575|FG007|COMPLETED|Overall Study||13
8910673|NCT02139982|9969576|FG008|COMPLETED|Overall Study||13
8910674|NCT02139982|9969577|FG009|COMPLETED|Overall Study||13
8910675|NCT02139982|9969568|FG000|NOT COMPLETED|Overall Study||0
8910676|NCT02139982|9969569|FG001|NOT COMPLETED|Overall Study||1
8910677|NCT02139982|9969570|FG002|NOT COMPLETED|Overall Study||0
8910678|NCT02139982|9969571|FG003|NOT COMPLETED|Overall Study||1
8910679|NCT02139982|9969572|FG004|NOT COMPLETED|Overall Study||0
8910680|NCT02139982|9969573|FG005|NOT COMPLETED|Overall Study||0
8910681|NCT02139982|9969574|FG006|NOT COMPLETED|Overall Study||0
8910682|NCT02139982|9969575|FG007|NOT COMPLETED|Overall Study||0
8910683|NCT02139982|9969576|FG008|NOT COMPLETED|Overall Study||0
8910684|NCT02139982|9969577|FG009|NOT COMPLETED|Overall Study||0
8910685|NCT02140060|9969605|FG000|STARTED|Overall Study||44
8910686|NCT02140060|9969606|FG001|STARTED|Overall Study||44
8910687|NCT02140060|9969607|FG002|STARTED|Overall Study||44
8910688|NCT02140060|9969608|FG003|STARTED|Overall Study||45
8910689|NCT02140060|9969609|FG004|STARTED|Overall Study||45
8910690|NCT02140060|9969610|FG005|STARTED|Overall Study||44
8910691|NCT02140060|9969605|FG000|COMPLETED|Overall Study||44
8910692|NCT02140060|9969606|FG001|COMPLETED|Overall Study||44
8910693|NCT02140060|9969607|FG002|COMPLETED|Overall Study||44
8910694|NCT02140060|9969608|FG003|COMPLETED|Overall Study||43
8910695|NCT02140060|9969609|FG004|COMPLETED|Overall Study||44
8910696|NCT02140060|9969610|FG005|COMPLETED|Overall Study||43
8910697|NCT02140060|9969605|FG000|NOT COMPLETED|Overall Study||0
8910698|NCT02140060|9969606|FG001|NOT COMPLETED|Overall Study||0
8910699|NCT02140060|9969607|FG002|NOT COMPLETED|Overall Study||0
8910700|NCT02140060|9969608|FG003|NOT COMPLETED|Overall Study||2
8910701|NCT02140060|9969609|FG004|NOT COMPLETED|Overall Study||1
8910702|NCT02140060|9969610|FG005|NOT COMPLETED|Overall Study||1
8910703|NCT02140164|9969625|FG000|STARTED|Overall Study||7
8910704|NCT02140164|9969625|FG000|COMPLETED|Overall Study||5
8910705|NCT02140164|9969625|FG000|NOT COMPLETED|Overall Study||2
8910706|NCT02140372|9969629|FG000|STARTED|Overall Study||10
8910707|NCT02140372|9969629|FG000|COMPLETED|Overall Study||10
8910708|NCT02140372|9969629|FG000|NOT COMPLETED|Overall Study||0
8910709|NCT02140411|9969633|FG000|STARTED|Overall Study||21
8910710|NCT02140411|9969633|FG000|COMPLETED|Overall Study||20
8910711|NCT02140411|9969633|FG000|NOT COMPLETED|Overall Study||1
8910712|NCT02140567|9969637|FG000|STARTED|Overall Study||140
8910713|NCT02140567|9969637|FG000|COMPLETED|Overall Study||134
8910714|NCT02140567|9969637|FG000|NOT COMPLETED|Overall Study||6
8910715|NCT02140593|9969644|FG000|STARTED|Overall Study||63
8910716|NCT02140593|9969645|FG001|STARTED|Overall Study||65
8910717|NCT02140593|9969644|FG000|COMPLETED|Overall Study||63
8910718|NCT02140593|9969645|FG001|COMPLETED|Overall Study||65
8910719|NCT02140593|9969644|FG000|NOT COMPLETED|Overall Study||0
8910720|NCT02140593|9969645|FG001|NOT COMPLETED|Overall Study||0
8910721|NCT02140645|9969657|FG000|STARTED|Overall Study||5732
8910722|NCT02140645|9969658|FG001|STARTED|Overall Study||64695
8637037|NCT00570687|9677768|FG005|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
8637038|NCT00570687|9677769|FG006|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
8910723|NCT02140645|9969659|FG002|STARTED|Overall Study||4441
8910724|NCT02140645|9969660|FG003|STARTED|Overall Study||14363
8910725|NCT02140645|9969661|FG004|STARTED|Overall Study||3436
8910726|NCT02140645|9969662|FG005|STARTED|Overall Study||73946
8910727|NCT02140645|9969657|FG000|COMPLETED|Overall Study||243
8910728|NCT02140645|9969658|FG001|COMPLETED|Overall Study||3041
8910729|NCT02140645|9969659|FG002|COMPLETED|Overall Study||205
8910730|NCT02140645|9969660|FG003|COMPLETED|Overall Study||530
8910731|NCT02140645|9969661|FG004|COMPLETED|Overall Study||150
8910732|NCT02140645|9969662|FG005|COMPLETED|Overall Study||3050
8910733|NCT02140645|9969657|FG000|NOT COMPLETED|Overall Study||5489
8910734|NCT02140645|9969658|FG001|NOT COMPLETED|Overall Study||61654
8910735|NCT02140645|9969659|FG002|NOT COMPLETED|Overall Study||4236
8910736|NCT02140645|9969660|FG003|NOT COMPLETED|Overall Study||13833
8910737|NCT02140645|9969661|FG004|NOT COMPLETED|Overall Study||3286
8910738|NCT02140645|9969662|FG005|NOT COMPLETED|Overall Study||70896
8910739|NCT02140762|9969673|FG000|STARTED|Overall Study||154
8910740|NCT02140762|9969674|FG001|STARTED|Overall Study||151
8910741|NCT02140762|9969673|FG000|COMPLETED|Overall Study||137
8910742|NCT02140762|9969674|FG001|COMPLETED|Overall Study||139
9015594|NCT03041116|10078423|FG001|Received at Least 1 Dose of Study Drug|Double-blind||43
9015595|NCT03041116|10078422|FG000|COMPLETED|Double-blind||41
9015596|NCT03041116|10078423|FG001|COMPLETED|Double-blind||37
9015597|NCT03041116|10078422|FG000|NOT COMPLETED|Double-blind||0
9015598|NCT03041116|10078423|FG001|NOT COMPLETED|Double-blind||6
9015599|NCT03041116|10078422|FG000|STARTED|Open-label||41
9015600|NCT03041116|10078423|FG001|STARTED|Open-label||37
9015601|NCT03041116|10078422|FG000|Received At Least 1 Dose of Study Drug|Open-label||41
9015602|NCT03041116|10078423|FG001|Received At Least 1 Dose of Study Drug|Open-label||37
9015603|NCT03041116|10078422|FG000|COMPLETED|Open-label||0
9015604|NCT03041116|10078423|FG001|COMPLETED|Open-label||0
9015605|NCT03041116|10078422|FG000|NOT COMPLETED|Open-label||41
9015606|NCT03041116|10078423|FG001|NOT COMPLETED|Open-label||37
9015607|NCT03041181|10078435|FG000|STARTED|Overall Study||1
9015608|NCT03041181|10078436|FG001|STARTED|Overall Study||2
9015609|NCT03041181|10078435|FG000|COMPLETED|Overall Study||0
9015610|NCT03041181|10078436|FG001|COMPLETED|Overall Study||0
9015611|NCT03041181|10078435|FG000|NOT COMPLETED|Overall Study||1
9015612|NCT03041181|10078436|FG001|NOT COMPLETED|Overall Study||2
9015613|NCT03041298|10078442|FG000|STARTED|Overall Study||1537
9015614|NCT03041298|10078442|FG000|COMPLETED|Overall Study||1537
9015615|NCT03041298|10078442|FG000|NOT COMPLETED|Overall Study||0
9015616|NCT03041441|10078446|FG000|STARTED|Overall Study||5
9015617|NCT03041441|10078446|FG000|COMPLETED|Overall Study||3
9015618|NCT03041441|10078446|FG000|NOT COMPLETED|Overall Study||2
9015619|NCT03041467|10078453|FG000|STARTED|Overall Study||170
9015620|NCT03041467|10078454|FG001|STARTED|Overall Study||160
9015621|NCT03041467|10078453|FG000|COMPLETED|Overall Study||0
9015622|NCT03041467|10078454|FG001|COMPLETED|Overall Study||0
9015623|NCT03041467|10078453|FG000|NOT COMPLETED|Overall Study||170
9015624|NCT03041467|10078454|FG001|NOT COMPLETED|Overall Study||160
9015625|NCT03041636|10078462|FG000|STARTED|Overall Study||1
9015626|NCT03041636|10078462|FG000|COMPLETED|Overall Study||1
9015627|NCT03041636|10078462|FG000|NOT COMPLETED|Overall Study||0
9015628|NCT03041792|10078468|FG000|STARTED|Overall Study||32
9015629|NCT03041792|10078469|FG001|STARTED|Overall Study||29
9015630|NCT03041792|10078468|FG000|Received Treatment|Overall Study||32
9015631|NCT03041792|10078469|FG001|Received Treatment|Overall Study||28
9015632|NCT03041792|10078468|FG000|COMPLETED|Overall Study||28
9015633|NCT03041792|10078469|FG001|COMPLETED|Overall Study||26
9015634|NCT03041792|10078468|FG000|NOT COMPLETED|Overall Study||4
8573759|NCT00124072|9606099|FG001|COMPLETED|Overall Study||2504
8573760|NCT00124072|9606100|FG002|COMPLETED|Overall Study||2524
8573761|NCT00124072|9606101|FG003|COMPLETED|Overall Study||2515
8573762|NCT00124072|9606098|FG000|NOT COMPLETED|Overall Study||514
8573763|NCT00124072|9606099|FG001|NOT COMPLETED|Overall Study||512
8573764|NCT00124072|9606100|FG002|NOT COMPLETED|Overall Study||492
8573765|NCT00124072|9606101|FG003|NOT COMPLETED|Overall Study||500
8573766|NCT00124176|9606113|FG000|STARTED|Overall Study||40
8573767|NCT00124176|9606114|FG001|STARTED|Overall Study||41
8577596|NCT00159861|9610348|FG000|NOT COMPLETED|Extension Study - up to 3 Years||62
8910743|NCT02140762|9969673|FG000|NOT COMPLETED|Overall Study||17
8910744|NCT02140762|9969674|FG001|NOT COMPLETED|Overall Study||12
8910745|NCT02140775|9969687|FG000|STARTED|Overall Study||87
8910746|NCT02140775|9969688|FG001|STARTED|Overall Study||29
8910747|NCT02140775|9969687|FG000|COMPLETED|Overall Study||57
8910748|NCT02140775|9969688|FG001|COMPLETED|Overall Study||22
9015635|NCT03041792|10078469|FG001|NOT COMPLETED|Overall Study||3
9015636|NCT03041896|10078479|FG000|STARTED|Overall Study||1486
9015637|NCT03041896|10078480|FG001|STARTED|Overall Study||1009
9015638|NCT03041896|10078481|FG002|STARTED|Overall Study||2299
9015639|NCT03041896|10078482|FG003|STARTED|Overall Study||256
9015640|NCT03041896|10078479|FG000|COMPLETED|Overall Study||1486
8910749|NCT02140775|9969687|FG000|NOT COMPLETED|Overall Study||30
8910750|NCT02140775|9969688|FG001|NOT COMPLETED|Overall Study||7
8910751|NCT02140957|9969698|FG000|STARTED|Overall Study||129
8910752|NCT02140957|9969699|FG001|STARTED|Overall Study||122
8910753|NCT02140957|9969698|FG000|COMPLETED|Overall Study||102
8910754|NCT02140957|9969699|FG001|COMPLETED|Overall Study||99
8910755|NCT02140957|9969698|FG000|NOT COMPLETED|Overall Study||27
8910756|NCT02140957|9969699|FG001|NOT COMPLETED|Overall Study||23
8910757|NCT02140970|9969707|FG000|STARTED|Overall Study||24
8910758|NCT02140970|9969708|FG001|STARTED|Overall Study||25
8910759|NCT02140970|9969707|FG000|Received Intervention|Overall Study||23
8910760|NCT02140970|9969708|FG001|Received Intervention|Overall Study||25
8910761|NCT02140970|9969707|FG000|Analyzed|Overall Study||22
8910762|NCT02140970|9969708|FG001|Analyzed|Overall Study||22
8910763|NCT02140970|9969707|FG000|COMPLETED|Overall Study||22
8910764|NCT02140970|9969708|FG001|COMPLETED|Overall Study||22
8910765|NCT02140970|9969707|FG000|NOT COMPLETED|Overall Study||2
8910766|NCT02140970|9969708|FG001|NOT COMPLETED|Overall Study||3
8910767|NCT02141204|9969716|FG000|STARTED|Overall Study||224
8910768|NCT02141204|9969717|FG001|STARTED|Overall Study||225
8910769|NCT02141204|9969716|FG000|COMPLETED|Overall Study||209
8910770|NCT02141204|9969717|FG001|COMPLETED|Overall Study||210
8910771|NCT02141204|9969716|FG000|NOT COMPLETED|Overall Study||15
8910772|NCT02141204|9969717|FG001|NOT COMPLETED|Overall Study||15
8910773|NCT02141217|9969725|FG000|STARTED|Overall Study||234
8910774|NCT02141217|9969726|FG001|STARTED|Overall Study||237
8910775|NCT02141217|9969725|FG000|ITT Population-Randomized Treatment Arm|Overall Study||234
8910776|NCT02141217|9969726|FG001|ITT Population-Randomized Treatment Arm|Overall Study||237
8910777|NCT02141217|9969725|FG000|ITT Population-Actual Treatment Received|Overall Study||236
8910778|NCT02141217|9969726|FG001|ITT Population-Actual Treatment Received|Overall Study||235
8910779|NCT02141217|9969725|FG000|COMPLETED|Overall Study||223
8910780|NCT02141217|9969726|FG001|COMPLETED|Overall Study||229
8910781|NCT02141217|9969725|FG000|NOT COMPLETED|Overall Study||11
8910782|NCT02141217|9969726|FG001|NOT COMPLETED|Overall Study||8
8910783|NCT02141295|9969738|FG000|STARTED|Overall Study||8
8910784|NCT02141295|9969739|FG001|STARTED|Overall Study||94
8910785|NCT02141295|9969740|FG002|STARTED|Overall Study||95
8910786|NCT02141295|9969738|FG000|COMPLETED|Overall Study||2
8910787|NCT02141295|9969739|FG001|COMPLETED|Overall Study||0
8910788|NCT02141295|9969740|FG002|COMPLETED|Overall Study||0
8910789|NCT02141295|9969738|FG000|NOT COMPLETED|Overall Study||6
8910790|NCT02141295|9969739|FG001|NOT COMPLETED|Overall Study||94
8910791|NCT02141295|9969740|FG002|NOT COMPLETED|Overall Study||95
8910792|NCT02141360|9969752|FG000|STARTED|Overall Study||11
8910793|NCT02141360|9969753|FG001|STARTED|Overall Study||6
8910794|NCT02141360|9969754|FG002|STARTED|Overall Study||6
9015641|NCT03041896|10078480|FG001|COMPLETED|Overall Study||1009
9015642|NCT03041896|10078481|FG002|COMPLETED|Overall Study||2236
9015643|NCT03041896|10078482|FG003|COMPLETED|Overall Study||253
9015644|NCT03041896|10078479|FG000|NOT COMPLETED|Overall Study||0
9015645|NCT03041896|10078480|FG001|NOT COMPLETED|Overall Study||0
9015646|NCT03041896|10078481|FG002|NOT COMPLETED|Overall Study||63
9015647|NCT03041896|10078482|FG003|NOT COMPLETED|Overall Study||3
9015648|NCT03041909|10078499|FG000|STARTED|Overall Study||3
9015649|NCT03041909|10078500|FG001|STARTED|Overall Study||1
9015650|NCT03041909|10078501|FG002|STARTED|Overall Study||1
9015651|NCT03041909|10078499|FG000|COMPLETED|Overall Study||3
9015652|NCT03041909|10078500|FG001|COMPLETED|Overall Study||1
9015653|NCT03041909|10078501|FG002|COMPLETED|Overall Study||1
9015654|NCT03041909|10078499|FG000|NOT COMPLETED|Overall Study||0
9015655|NCT03041909|10078500|FG001|NOT COMPLETED|Overall Study||0
9015656|NCT03041909|10078501|FG002|NOT COMPLETED|Overall Study||0
9015657|NCT03042299|10078511|FG000|STARTED|Intervention Period 1 (6 Days)||7
9015658|NCT03042299|10078512|FG001|STARTED|Intervention Period 1 (6 Days)||7
9015659|NCT03042299|10078511|FG000|COMPLETED|Intervention Period 1 (6 Days)||7
9015660|NCT03042299|10078512|FG001|COMPLETED|Intervention Period 1 (6 Days)||7
9015661|NCT03042299|10078511|FG000|NOT COMPLETED|Intervention Period 1 (6 Days)||0
9015662|NCT03042299|10078512|FG001|NOT COMPLETED|Intervention Period 1 (6 Days)||0
9015663|NCT03042299|10078511|FG000|STARTED|Washout Period (at Least 6 Days)||7
9015664|NCT03042299|10078512|FG001|STARTED|Washout Period (at Least 6 Days)||7
9015665|NCT03042299|10078511|FG000|COMPLETED|Washout Period (at Least 6 Days)||7
9015666|NCT03042299|10078512|FG001|COMPLETED|Washout Period (at Least 6 Days)||7
9015667|NCT03042299|10078511|FG000|NOT COMPLETED|Washout Period (at Least 6 Days)||0
9015668|NCT03042299|10078512|FG001|NOT COMPLETED|Washout Period (at Least 6 Days)||0
9015669|NCT03042299|10078511|FG000|STARTED|Intervention Period 2 (6 Days)||7
9015670|NCT03042299|10078512|FG001|STARTED|Intervention Period 2 (6 Days)||7
9015671|NCT03042299|10078511|FG000|COMPLETED|Intervention Period 2 (6 Days)||7
9015672|NCT03042299|10078512|FG001|COMPLETED|Intervention Period 2 (6 Days)||7
9015673|NCT03042299|10078511|FG000|NOT COMPLETED|Intervention Period 2 (6 Days)||0
9015674|NCT03042299|10078512|FG001|NOT COMPLETED|Intervention Period 2 (6 Days)||0
8910795|NCT02141360|9969752|FG000|COMPLETED|Overall Study||4
8910796|NCT02141360|9969753|FG001|COMPLETED|Overall Study||6
8910797|NCT02141360|9969754|FG002|COMPLETED|Overall Study||6
8910798|NCT02141360|9969752|FG000|NOT COMPLETED|Overall Study||7
8910799|NCT02141360|9969753|FG001|NOT COMPLETED|Overall Study||0
8910800|NCT02141360|9969754|FG002|NOT COMPLETED|Overall Study||0
8910801|NCT02141399|9969762|FG000|STARTED|Overall Study||1485
8910802|NCT02141399|9969762|FG000|COMPLETED|Overall Study||741
8910803|NCT02141399|9969762|FG000|NOT COMPLETED|Overall Study||744
8910804|NCT02141451|9969770|FG000|STARTED|Overall Study||3
8910805|NCT02141451|9969771|FG001|STARTED|Overall Study||4
8910806|NCT02141451|9969772|FG002|STARTED|Overall Study||7
8910807|NCT02141451|9969773|FG003|STARTED|Overall Study||16
8910808|NCT02141451|9969770|FG000|COMPLETED|Overall Study||3
8910809|NCT02141451|9969771|FG001|COMPLETED|Overall Study||2
8910810|NCT02141451|9969772|FG002|COMPLETED|Overall Study||2
8727057|NCT01041287|9774453|FG001|COMPLETED|Treatment Period 2 (3 Months)||14
8727058|NCT01041287|9774452|FG000|NOT COMPLETED|Treatment Period 2 (3 Months)||3
8727059|NCT01041287|9774453|FG001|NOT COMPLETED|Treatment Period 2 (3 Months)||5
8727060|NCT01041404|9774461|FG000|STARTED|Overall Study||290
8727061|NCT01041404|9774462|FG001|STARTED|Overall Study||294
8910811|NCT02141451|9969773|FG003|COMPLETED|Overall Study||7
8910812|NCT02141451|9969770|FG000|NOT COMPLETED|Overall Study||0
8910813|NCT02141451|9969771|FG001|NOT COMPLETED|Overall Study||2
8910814|NCT02141451|9969772|FG002|NOT COMPLETED|Overall Study||5
8910815|NCT02141451|9969773|FG003|NOT COMPLETED|Overall Study||9
8910816|NCT02141490|9969789|FG000|STARTED|Overall Study||34
8910817|NCT02141490|9969790|FG001|STARTED|Overall Study||6
8910818|NCT02141490|9969791|FG002|STARTED|Overall Study||3
8910819|NCT02141490|9969789|FG000|COMPLETED|Overall Study||30
8910820|NCT02141490|9969790|FG001|COMPLETED|Overall Study||6
8910821|NCT02141490|9969791|FG002|COMPLETED|Overall Study||3
8910822|NCT02141490|9969789|FG000|NOT COMPLETED|Overall Study||4
8910823|NCT02141490|9969790|FG001|NOT COMPLETED|Overall Study||0
8910824|NCT02141490|9969791|FG002|NOT COMPLETED|Overall Study||0
8910825|NCT02141516|9969804|FG000|STARTED|Overall Study||40
8910826|NCT02141516|9969805|FG001|STARTED|Overall Study||112
8910827|NCT02141516|9969806|FG002|STARTED|Overall Study||87
8910828|NCT02141516|9969804|FG000|COMPLETED|Overall Study||40
8910829|NCT02141516|9969805|FG001|COMPLETED|Overall Study||107
8910830|NCT02141516|9969806|FG002|COMPLETED|Overall Study||87
8910831|NCT02141516|9969804|FG000|NOT COMPLETED|Overall Study||0
9015675|NCT03042312|10078520|FG000|STARTED|Overall Study||28
9015676|NCT03042312|10078521|FG001|STARTED|Overall Study||43
9015677|NCT03042312|10078520|FG000|Safety Population|Overall Study||23
9015678|NCT03042312|10078521|FG001|Safety Population|Overall Study||41
9015679|NCT03042312|10078520|FG000|COMPLETED|Overall Study||18
9015680|NCT03042312|10078521|FG001|COMPLETED|Overall Study||31
9015681|NCT03042312|10078520|FG000|NOT COMPLETED|Overall Study||10
9015682|NCT03042312|10078521|FG001|NOT COMPLETED|Overall Study||12
9015683|NCT03042559|10078529|FG000|STARTED|Overall Study||22
9015684|NCT03042559|10078530|FG001|STARTED|Overall Study||21
9015685|NCT03042559|10078529|FG000|COMPLETED|Overall Study||21
9015686|NCT03042559|10078530|FG001|COMPLETED|Overall Study||20
9015687|NCT03042559|10078529|FG000|NOT COMPLETED|Overall Study||1
9015688|NCT03042559|10078530|FG001|NOT COMPLETED|Overall Study||1
9015689|NCT03042702|10078536|FG000|STARTED|Overall Study||2
9015690|NCT03042702|10078536|FG000|COMPLETED|Overall Study||2
9015691|NCT03042702|10078536|FG000|NOT COMPLETED|Overall Study||0
9015692|NCT03042715|10078541|FG000|STARTED|Overall Study||6
9015693|NCT03042715|10078541|FG000|COMPLETED|Overall Study||5
9015694|NCT03042715|10078541|FG000|NOT COMPLETED|Overall Study||1
9015695|NCT03042767|10078547|FG000|STARTED|Overall Study||12
9015696|NCT03042767|10078548|FG001|STARTED|Overall Study||13
9015697|NCT03042767|10078547|FG000|COMPLETED|Overall Study||11
9015698|NCT03042767|10078548|FG001|COMPLETED|Overall Study||11
9015699|NCT03042767|10078547|FG000|NOT COMPLETED|Overall Study||1
9015700|NCT03042767|10078548|FG001|NOT COMPLETED|Overall Study||2
9015701|NCT03042910|10078554|FG000|STARTED|Overall Study||38
9015702|NCT03042910|10078554|FG000|Treated|Overall Study||37
9015703|NCT03042910|10078554|FG000|COMPLETED|Overall Study||31
9015704|NCT03042910|10078554|FG000|NOT COMPLETED|Overall Study||7
9015705|NCT03043079|10078561|FG000|STARTED|Overall Study||21
9015706|NCT03043079|10078562|FG001|STARTED|Overall Study||14
9015707|NCT03043079|10078563|FG002|STARTED|Overall Study||10
9015708|NCT03043079|10078561|FG000|COMPLETED|Overall Study||21
9015709|NCT03043079|10078562|FG001|COMPLETED|Overall Study||14
9015710|NCT03043079|10078563|FG002|COMPLETED|Overall Study||10
9015711|NCT03043079|10078561|FG000|NOT COMPLETED|Overall Study||0
9015712|NCT03043079|10078562|FG001|NOT COMPLETED|Overall Study||0
9015713|NCT03043079|10078563|FG002|NOT COMPLETED|Overall Study||0
9015714|NCT03043105|10078572|FG000|STARTED|Overall Study||25
9015715|NCT03043105|10078572|FG000|COMPLETED|Overall Study||25
9015716|NCT03043105|10078572|FG000|NOT COMPLETED|Overall Study||0
9015717|NCT03043274|10078578|FG000|STARTED|Overall Study||13
9015718|NCT03043274|10078579|FG001|STARTED|Overall Study||10
8727062|NCT01041404|9774461|FG000|Entered Follow-Up|Overall Study||251
8727063|NCT01041404|9774462|FG001|Entered Follow-Up|Overall Study||251
8910832|NCT02141516|9969805|FG001|NOT COMPLETED|Overall Study||5
9015719|NCT03043274|10078578|FG000|COMPLETED|Overall Study|The study was terminated because of slow recruitment.|13
9015720|NCT03043274|10078579|FG001|COMPLETED|Overall Study|The study was terminated because of slow recruitment.|9
9015721|NCT03043274|10078578|FG000|NOT COMPLETED|Overall Study||0
8910833|NCT02141516|9969806|FG002|NOT COMPLETED|Overall Study||0
8910834|NCT02141555|9969820|FG000|STARTED|Overall Study||2
8910835|NCT02141555|9969821|FG001|STARTED|Overall Study||2
8910836|NCT02141555|9969820|FG000|COMPLETED|Overall Study||2
9015722|NCT03043274|10078579|FG001|NOT COMPLETED|Overall Study||1
9015723|NCT03043365|10078587|FG000|STARTED|Weeks 0 to Week 8||20
8910837|NCT02141555|9969821|FG001|COMPLETED|Overall Study||2
8910838|NCT02141555|9969820|FG000|NOT COMPLETED|Overall Study||0
8910839|NCT02141555|9969821|FG001|NOT COMPLETED|Overall Study||0
8910840|NCT02141581|9969830|FG000|STARTED|Overall Study||42
8910841|NCT02141581|9969831|FG001|STARTED|Overall Study||19
8910842|NCT02141581|9969832|FG002|STARTED|Overall Study||25
8910843|NCT02141581|9969830|FG000|COMPLETED|Overall Study||42
8573768|NCT00124176|9606113|FG000|Received Study Drug|Overall Study|3 never started on drug due to improvement but were kept in the study by intention to treat.|37
8573769|NCT00124176|9606114|FG001|Received Study Drug|Overall Study||41
8573770|NCT00124176|9606113|FG000|COMPLETED|Overall Study||40
8573771|NCT00124176|9606114|FG001|COMPLETED|Overall Study||41
8573772|NCT00124176|9606113|FG000|NOT COMPLETED|Overall Study||0
8573773|NCT00124176|9606114|FG001|NOT COMPLETED|Overall Study||0
8573774|NCT00124449|9606122|FG000|STARTED|6-month Double-Blind Treatment Period||28
8577922|NCT00165841|9610862|FG001|NOT COMPLETED|Overall Study||62
8910844|NCT02141581|9969831|FG001|COMPLETED|Overall Study||19
8910845|NCT02141581|9969832|FG002|COMPLETED|Overall Study||25
8910846|NCT02141581|9969830|FG000|NOT COMPLETED|Overall Study||0
8910847|NCT02141581|9969831|FG001|NOT COMPLETED|Overall Study||0
8910848|NCT02141581|9969832|FG002|NOT COMPLETED|Overall Study||0
8910849|NCT02141620|9969840|FG000|STARTED|Treatment Condition 1 (7 Days)||8
8910850|NCT02141620|9969841|FG001|STARTED|Treatment Condition 1 (7 Days)||7
8910851|NCT02141620|9969840|FG000|COMPLETED|Treatment Condition 1 (7 Days)|7 completing subjects switched to n-acetylcysteine for Condition 2.|7
8910852|NCT02141620|9969841|FG001|COMPLETED|Treatment Condition 1 (7 Days)|7 completing subjects switched to placebo for Condition 2.|7
8910853|NCT02141620|9969840|FG000|NOT COMPLETED|Treatment Condition 1 (7 Days)||1
8910854|NCT02141620|9969841|FG001|NOT COMPLETED|Treatment Condition 1 (7 Days)||0
8910855|NCT02141620|9969840|FG000|STARTED|Treatment Condition 2 (7 Days)||7
8910856|NCT02141620|9969841|FG001|STARTED|Treatment Condition 2 (7 Days)||7
8910857|NCT02141620|9969840|FG000|COMPLETED|Treatment Condition 2 (7 Days)||7
8910858|NCT02141620|9969841|FG001|COMPLETED|Treatment Condition 2 (7 Days)||7
8910859|NCT02141620|9969840|FG000|NOT COMPLETED|Treatment Condition 2 (7 Days)||0
8910860|NCT02141620|9969841|FG001|NOT COMPLETED|Treatment Condition 2 (7 Days)||0
8910861|NCT02141633|9969849|FG000|STARTED|Overall Study||16
8910862|NCT02141633|9969850|FG001|STARTED|Overall Study||15
8910863|NCT02141633|9969849|FG000|COMPLETED|Overall Study||15
8910864|NCT02141633|9969850|FG001|COMPLETED|Overall Study||15
8910865|NCT02141633|9969849|FG000|NOT COMPLETED|Overall Study||1
8910866|NCT02141633|9969850|FG001|NOT COMPLETED|Overall Study||0
8910867|NCT02141659|9969862|FG000|STARTED|Overall Study||3
8910868|NCT02141659|9969863|FG001|STARTED|Overall Study||4
8910869|NCT02141659|9969864|FG002|STARTED|Overall Study||3
8910870|NCT02141659|9969865|FG003|STARTED|Overall Study||3
8910871|NCT02141659|9969866|FG004|STARTED|Overall Study||15
8910872|NCT02141659|9969867|FG005|STARTED|Overall Study||15
8910873|NCT02141659|9969862|FG000|COMPLETED|Overall Study||3
8910874|NCT02141659|9969863|FG001|COMPLETED|Overall Study||3
8910875|NCT02141659|9969864|FG002|COMPLETED|Overall Study||3
8910876|NCT02141659|9969865|FG003|COMPLETED|Overall Study||3
8910877|NCT02141659|9969866|FG004|COMPLETED|Overall Study||13
8910878|NCT02141659|9969867|FG005|COMPLETED|Overall Study||13
8910879|NCT02141659|9969862|FG000|NOT COMPLETED|Overall Study||0
8910880|NCT02141659|9969863|FG001|NOT COMPLETED|Overall Study||1
8910881|NCT02141659|9969864|FG002|NOT COMPLETED|Overall Study||0
8910882|NCT02141659|9969865|FG003|NOT COMPLETED|Overall Study||0
8910883|NCT02141659|9969866|FG004|NOT COMPLETED|Overall Study||2
8910884|NCT02141659|9969867|FG005|NOT COMPLETED|Overall Study||2
8910885|NCT02141672|9969884|FG000|STARTED|Overall Study||89
8910886|NCT02141672|9969885|FG001|STARTED|Overall Study||88
8910887|NCT02141672|9969886|FG002|STARTED|Overall Study||88
8910888|NCT02141672|9969884|FG000|COMPLETED|Overall Study||73
8910889|NCT02141672|9969885|FG001|COMPLETED|Overall Study||80
8910890|NCT02141672|9969886|FG002|COMPLETED|Overall Study||70
8910891|NCT02141672|9969884|FG000|NOT COMPLETED|Overall Study||16
8910892|NCT02141672|9969885|FG001|NOT COMPLETED|Overall Study||8
8910893|NCT02141672|9969886|FG002|NOT COMPLETED|Overall Study||18
8910894|NCT02141854|9969899|FG000|STARTED|Run-In Period (Pre-assignment)||882
8910895|NCT02141854|9969900|FG001|STARTED|Run-In Period (Pre-assignment)||0
8910896|NCT02141854|9969901|FG002|STARTED|Run-In Period (Pre-assignment)||0
8910897|NCT02141854|9969902|FG003|STARTED|Run-In Period (Pre-assignment)||0
8910898|NCT02141854|9969903|FG004|STARTED|Run-In Period (Pre-assignment)||0
8910899|NCT02141854|9969904|FG005|STARTED|Run-In Period (Pre-assignment)||0
8910900|NCT02141854|9969899|FG000|COMPLETED|Run-In Period (Pre-assignment)||728
8910901|NCT02141854|9969900|FG001|COMPLETED|Run-In Period (Pre-assignment)||0
8910902|NCT02141854|9969901|FG002|COMPLETED|Run-In Period (Pre-assignment)||0
8910903|NCT02141854|9969902|FG003|COMPLETED|Run-In Period (Pre-assignment)||0
8910904|NCT02141854|9969903|FG004|COMPLETED|Run-In Period (Pre-assignment)||0
8910905|NCT02141854|9969904|FG005|COMPLETED|Run-In Period (Pre-assignment)||0
8910906|NCT02141854|9969899|FG000|NOT COMPLETED|Run-In Period (Pre-assignment)||154
8910907|NCT02141854|9969900|FG001|NOT COMPLETED|Run-In Period (Pre-assignment)||0
8910908|NCT02141854|9969901|FG002|NOT COMPLETED|Run-In Period (Pre-assignment)||0
8910909|NCT02141854|9969902|FG003|NOT COMPLETED|Run-In Period (Pre-assignment)||0
8910910|NCT02141854|9969903|FG004|NOT COMPLETED|Run-In Period (Pre-assignment)||0
8910911|NCT02141854|9969904|FG005|NOT COMPLETED|Run-In Period (Pre-assignment)||0
8910912|NCT02141854|9969899|FG000|STARTED|Treatment Period||0
8910913|NCT02141854|9969900|FG001|STARTED|Treatment Period||146
8910914|NCT02141854|9969901|FG002|STARTED|Treatment Period||145
8910915|NCT02141854|9969902|FG003|STARTED|Treatment Period||146
8910916|NCT02141854|9969903|FG004|STARTED|Treatment Period||146
8910917|NCT02141854|9969904|FG005|STARTED|Treatment Period||145
8910918|NCT02141854|9969899|FG000|Intent to Treat Population|Treatment Period||0
8910919|NCT02141854|9969900|FG001|Intent to Treat Population|Treatment Period||146
8910920|NCT02141854|9969901|FG002|Intent to Treat Population|Treatment Period||145
8910921|NCT02141854|9969902|FG003|Intent to Treat Population|Treatment Period||146
8910922|NCT02141854|9969903|FG004|Intent to Treat Population|Treatment Period||146
8910923|NCT02141854|9969904|FG005|Intent to Treat Population|Treatment Period||145
8910924|NCT02141854|9969899|FG000|Safety Population|Treatment Period||0
8910925|NCT02141854|9969900|FG001|Safety Population|Treatment Period||145
8910926|NCT02141854|9969901|FG002|Safety Population|Treatment Period||143
8910927|NCT02141854|9969902|FG003|Safety Population|Treatment Period||146
8910928|NCT02141854|9969903|FG004|Safety Population|Treatment Period||145
8910929|NCT02141854|9969904|FG005|Safety Population|Treatment Period||144
9015724|NCT03043365|10078588|FG001|STARTED|Weeks 0 to Week 8||17
9015725|NCT03043365|10078587|FG000|COMPLETED|Weeks 0 to Week 8||17
9015726|NCT03043365|10078588|FG001|COMPLETED|Weeks 0 to Week 8||14
9015727|NCT03043365|10078587|FG000|NOT COMPLETED|Weeks 0 to Week 8||3
9015728|NCT03043365|10078588|FG001|NOT COMPLETED|Weeks 0 to Week 8||3
9015729|NCT03043365|10078587|FG000|STARTED|Week 8 to Week 16 - Washout Period||17
9015730|NCT03043365|10078588|FG001|STARTED|Week 8 to Week 16 - Washout Period||14
9015731|NCT03043365|10078587|FG000|COMPLETED|Week 8 to Week 16 - Washout Period||16
9015732|NCT03043365|10078588|FG001|COMPLETED|Week 8 to Week 16 - Washout Period||14
9015733|NCT03043365|10078587|FG000|NOT COMPLETED|Week 8 to Week 16 - Washout Period||1
9015734|NCT03043365|10078588|FG001|NOT COMPLETED|Week 8 to Week 16 - Washout Period||0
8573775|NCT00124449|9606123|FG001|STARTED|6-month Double-Blind Treatment Period||28
8573776|NCT00124449|9606122|FG000|COMPLETED|6-month Double-Blind Treatment Period||22
8573777|NCT00124449|9606123|FG001|COMPLETED|6-month Double-Blind Treatment Period||17
8573778|NCT00124449|9606122|FG000|NOT COMPLETED|6-month Double-Blind Treatment Period||6
8573779|NCT00124449|9606123|FG001|NOT COMPLETED|6-month Double-Blind Treatment Period||11
8573780|NCT00124449|9606122|FG000|STARTED|18-Month Untreated Observation Period||22
8573781|NCT00124449|9606123|FG001|STARTED|18-Month Untreated Observation Period||17
8573782|NCT00124449|9606122|FG000|Completed Year 1 of Study|18-Month Untreated Observation Period||14
8573783|NCT00124449|9606123|FG001|Completed Year 1 of Study|18-Month Untreated Observation Period||9
8573784|NCT00124449|9606122|FG000|COMPLETED|18-Month Untreated Observation Period||7
8573785|NCT00124449|9606123|FG001|COMPLETED|18-Month Untreated Observation Period||4
8573786|NCT00124449|9606122|FG000|NOT COMPLETED|18-Month Untreated Observation Period||15
8573787|NCT00124449|9606123|FG001|NOT COMPLETED|18-Month Untreated Observation Period||13
8573788|NCT00124462|9606132|FG000|STARTED|Overall Study||40
8573789|NCT00124462|9606133|FG001|STARTED|Overall Study||40
8573790|NCT00124462|9606132|FG000|COMPLETED|Overall Study||29
8573791|NCT00124462|9606133|FG001|COMPLETED|Overall Study||27
8573792|NCT00124462|9606132|FG000|NOT COMPLETED|Overall Study||11
8573793|NCT00124462|9606133|FG001|NOT COMPLETED|Overall Study||13
8573794|NCT00124514|9606144|FG000|STARTED|Overall Study||6
8573795|NCT00124514|9606145|FG001|STARTED|Overall Study||9
8573796|NCT00124514|9606146|FG002|STARTED|Overall Study||8
8573797|NCT00124514|9606147|FG003|STARTED|Overall Study||6
8573798|NCT00124514|9606148|FG004|STARTED|Overall Study||2
8573799|NCT00124514|9606144|FG000|COMPLETED|Overall Study||2
8573800|NCT00124514|9606145|FG001|COMPLETED|Overall Study||7
8573801|NCT00124514|9606146|FG002|COMPLETED|Overall Study||7
8573802|NCT00124514|9606147|FG003|COMPLETED|Overall Study||5
8573803|NCT00124514|9606148|FG004|COMPLETED|Overall Study||1
8573804|NCT00124514|9606144|FG000|NOT COMPLETED|Overall Study||4
8573805|NCT00124514|9606145|FG001|NOT COMPLETED|Overall Study||2
8573806|NCT00124514|9606146|FG002|NOT COMPLETED|Overall Study||1
8573807|NCT00124514|9606147|FG003|NOT COMPLETED|Overall Study||1
8573808|NCT00124514|9606148|FG004|NOT COMPLETED|Overall Study||1
8573809|NCT00124579|9606155|FG000|STARTED|Induction||7
8573810|NCT00124579|9606155|FG000|COMPLETED|Induction||2
8573811|NCT00124579|9606155|FG000|NOT COMPLETED|Induction||5
8573812|NCT00124579|9606155|FG000|STARTED|Maintenance||2
8573813|NCT00124579|9606155|FG000|COMPLETED|Maintenance||0
8573814|NCT00124579|9606155|FG000|NOT COMPLETED|Maintenance||2
9015735|NCT03043365|10078587|FG000|STARTED|Week 16 to Week 24||16
9015736|NCT03043365|10078588|FG001|STARTED|Week 16 to Week 24||14
9015737|NCT03043365|10078587|FG000|COMPLETED|Week 16 to Week 24||16
9015738|NCT03043365|10078588|FG001|COMPLETED|Week 16 to Week 24||14
9015739|NCT03043365|10078587|FG000|NOT COMPLETED|Week 16 to Week 24||0
8573815|NCT00124618|9606160|FG000|STARTED|Overall Study||58
8637039|NCT00570687|9677770|FG007|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
8910930|NCT02141854|9969899|FG000|Full Analysis Set|Treatment Period||0
8910931|NCT02141854|9969900|FG001|Full Analysis Set|Treatment Period||145
8910932|NCT02141854|9969901|FG002|Full Analysis Set|Treatment Period||141
8910933|NCT02141854|9969902|FG003|Full Analysis Set|Treatment Period||146
8910934|NCT02141854|9969903|FG004|Full Analysis Set|Treatment Period||145
8910935|NCT02141854|9969904|FG005|Full Analysis Set|Treatment Period||143
8573816|NCT00124618|9606160|FG000|COMPLETED|Overall Study||57
8573817|NCT00124618|9606160|FG000|NOT COMPLETED|Overall Study||1
8573818|NCT00124657|9606167|FG000|STARTED|Overall Study||18
8910936|NCT02141854|9969899|FG000|COMPLETED|Treatment Period||0
8910937|NCT02141854|9969900|FG001|COMPLETED|Treatment Period||136
8910938|NCT02141854|9969901|FG002|COMPLETED|Treatment Period||136
8910939|NCT02141854|9969902|FG003|COMPLETED|Treatment Period||135
8910940|NCT02141854|9969903|FG004|COMPLETED|Treatment Period||136
8910941|NCT02141854|9969904|FG005|COMPLETED|Treatment Period||107
8910942|NCT02141854|9969899|FG000|NOT COMPLETED|Treatment Period||0
8910943|NCT02141854|9969900|FG001|NOT COMPLETED|Treatment Period||10
8910944|NCT02141854|9969901|FG002|NOT COMPLETED|Treatment Period||9
8910945|NCT02141854|9969902|FG003|NOT COMPLETED|Treatment Period||11
8910946|NCT02141854|9969903|FG004|NOT COMPLETED|Treatment Period||10
8910947|NCT02141854|9969904|FG005|NOT COMPLETED|Treatment Period||38
8910948|NCT02141867|9969916|FG000|STARTED|Overall Study||4021
8910949|NCT02141867|9969916|FG000|COMPLETED|Overall Study||3927
8910950|NCT02141867|9969916|FG000|NOT COMPLETED|Overall Study||94
8910951|NCT02141984|9969920|FG000|STARTED|Overall Study||28
8910952|NCT02141984|9969920|FG000|COMPLETED|Overall Study||26
8910953|NCT02141984|9969920|FG000|NOT COMPLETED|Overall Study||2
8910954|NCT02141997|9969928|FG000|STARTED|Overall Study||56
8910955|NCT02141997|9969929|FG001|STARTED|Overall Study||55
8910956|NCT02141997|9969930|FG002|STARTED|Overall Study||56
8910957|NCT02141997|9969931|FG003|STARTED|Overall Study||55
8910958|NCT02141997|9969928|FG000|COMPLETED|Overall Study||53
8910959|NCT02141997|9969929|FG001|COMPLETED|Overall Study||49
8910960|NCT02141997|9969930|FG002|COMPLETED|Overall Study||53
8910961|NCT02141997|9969931|FG003|COMPLETED|Overall Study||54
8910962|NCT02141997|9969928|FG000|NOT COMPLETED|Overall Study||3
8910963|NCT02141997|9969929|FG001|NOT COMPLETED|Overall Study||6
8910964|NCT02141997|9969930|FG002|NOT COMPLETED|Overall Study||3
8910965|NCT02141997|9969931|FG003|NOT COMPLETED|Overall Study||1
8910966|NCT02142049|9969946|FG000|STARTED|Overall Study||3
8910967|NCT02142049|9969947|FG001|STARTED|Overall Study||3
8910968|NCT02142049|9969948|FG002|STARTED|Overall Study||3
8910969|NCT02142049|9969949|FG003|STARTED|Overall Study||6
8910970|NCT02142049|9969950|FG004|STARTED|Overall Study||20
8910971|NCT02142049|9969946|FG000|COMPLETED|Overall Study||3
8910972|NCT02142049|9969947|FG001|COMPLETED|Overall Study||3
8910973|NCT02142049|9969948|FG002|COMPLETED|Overall Study||3
8910974|NCT02142049|9969949|FG003|COMPLETED|Overall Study||6
8910975|NCT02142049|9969950|FG004|COMPLETED|Overall Study||20
8910976|NCT02142049|9969946|FG000|NOT COMPLETED|Overall Study||0
8910977|NCT02142049|9969947|FG001|NOT COMPLETED|Overall Study||0
8910978|NCT02142049|9969948|FG002|NOT COMPLETED|Overall Study||0
8910979|NCT02142049|9969949|FG003|NOT COMPLETED|Overall Study||0
8910980|NCT02142049|9969950|FG004|NOT COMPLETED|Overall Study||0
8910981|NCT02142153|9969977|FG000|STARTED|Overall Study||6
8910982|NCT02142153|9969978|FG001|STARTED|Overall Study||2
8910983|NCT02142153|9969979|FG002|STARTED|Overall Study||6
8910984|NCT02142153|9969980|FG003|STARTED|Overall Study||2
8910985|NCT02142153|9969981|FG004|STARTED|Overall Study||6
8910986|NCT02142153|9969982|FG005|STARTED|Overall Study||2
8910987|NCT02142153|9969983|FG006|STARTED|Overall Study||6
8910988|NCT02142153|9969984|FG007|STARTED|Overall Study||2
8910989|NCT02142153|9969985|FG008|STARTED|Overall Study||6
8910990|NCT02142153|9969986|FG009|STARTED|Overall Study||2
9015740|NCT03043365|10078588|FG001|NOT COMPLETED|Week 16 to Week 24||0
9015741|NCT03043534|10078598|FG000|STARTED|Overall Study||15
9015742|NCT03043534|10078599|FG001|STARTED|Overall Study||14
8637040|NCT00570687|9677771|FG008|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
8637041|NCT00570687|9677772|FG009|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
8637042|NCT00570687|9677763|FG000|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
8637043|NCT00570687|9677764|FG001|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
8637044|NCT00570687|9677765|FG002|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
8637045|NCT00570687|9677766|FG003|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
8637046|NCT00570687|9677767|FG004|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
8637047|NCT00570687|9677768|FG005|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
8637048|NCT00570687|9677769|FG006|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
8637049|NCT00570687|9677770|FG007|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
8637050|NCT00570687|9677771|FG008|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
8910991|NCT02142153|9969977|FG000|COMPLETED|Overall Study||6
8910992|NCT02142153|9969978|FG001|COMPLETED|Overall Study||2
8910993|NCT02142153|9969979|FG002|COMPLETED|Overall Study||6
8910994|NCT02142153|9969980|FG003|COMPLETED|Overall Study||2
8910995|NCT02142153|9969981|FG004|COMPLETED|Overall Study||6
8910996|NCT02142153|9969982|FG005|COMPLETED|Overall Study||2
8910997|NCT02142153|9969983|FG006|COMPLETED|Overall Study||6
8910998|NCT02142153|9969984|FG007|COMPLETED|Overall Study||2
8910999|NCT02142153|9969985|FG008|COMPLETED|Overall Study||6
8911000|NCT02142153|9969986|FG009|COMPLETED|Overall Study||2
8911001|NCT02142153|9969977|FG000|NOT COMPLETED|Overall Study||0
8911002|NCT02142153|9969978|FG001|NOT COMPLETED|Overall Study||0
8911003|NCT02142153|9969979|FG002|NOT COMPLETED|Overall Study||0
8911004|NCT02142153|9969980|FG003|NOT COMPLETED|Overall Study||0
8911005|NCT02142153|9969981|FG004|NOT COMPLETED|Overall Study||0
8911006|NCT02142153|9969982|FG005|NOT COMPLETED|Overall Study||0
8911007|NCT02142153|9969983|FG006|NOT COMPLETED|Overall Study||0
8911008|NCT02142153|9969984|FG007|NOT COMPLETED|Overall Study||0
8911009|NCT02142153|9969985|FG008|NOT COMPLETED|Overall Study||0
8911010|NCT02142153|9969986|FG009|NOT COMPLETED|Overall Study||0
9015743|NCT03043534|10078598|FG000|COMPLETED|Overall Study||15
9015744|NCT03043534|10078599|FG001|COMPLETED|Overall Study||14
9015745|NCT03043534|10078598|FG000|NOT COMPLETED|Overall Study||0
9015746|NCT03043534|10078599|FG001|NOT COMPLETED|Overall Study||0
9015747|NCT03043560|10078607|FG000|STARTED|Overall Study||21
9015748|NCT03043560|10078608|FG001|STARTED|Overall Study||24
9015749|NCT03043560|10078607|FG000|COMPLETED|Overall Study||20
9015750|NCT03043560|10078608|FG001|COMPLETED|Overall Study||21
9015751|NCT03043560|10078607|FG000|NOT COMPLETED|Overall Study||1
9015752|NCT03043560|10078608|FG001|NOT COMPLETED|Overall Study||3
9015753|NCT03043651|10078614|FG000|STARTED|Overall Study||48
9015754|NCT03043651|10078614|FG000|COMPLETED|Overall Study||0
9015755|NCT03043651|10078614|FG000|NOT COMPLETED|Overall Study||48
9015756|NCT03043885|10078622|FG000|STARTED|Overall Study||10
9015757|NCT03043885|10078623|FG001|STARTED|Overall Study||10
9015758|NCT03043885|10078624|FG002|STARTED|Overall Study||10
9015759|NCT03043885|10078625|FG003|STARTED|Overall Study||10
9015760|NCT03043885|10078622|FG000|COMPLETED|Overall Study||10
9015761|NCT03043885|10078623|FG001|COMPLETED|Overall Study||10
9015762|NCT03043885|10078624|FG002|COMPLETED|Overall Study||10
9015763|NCT03043885|10078625|FG003|COMPLETED|Overall Study||10
9015764|NCT03043885|10078622|FG000|NOT COMPLETED|Overall Study||0
9015765|NCT03043885|10078623|FG001|NOT COMPLETED|Overall Study||0
9015766|NCT03043885|10078624|FG002|NOT COMPLETED|Overall Study||0
9015767|NCT03043885|10078625|FG003|NOT COMPLETED|Overall Study||0
9015768|NCT03044028|10078638|FG000|STARTED|Overall Study||22
9015769|NCT03044028|10078639|FG001|STARTED|Overall Study||22
9015770|NCT03044028|10078640|FG002|STARTED|Overall Study||22
9015771|NCT03044028|10078638|FG000|COMPLETED|Overall Study||12
9015772|NCT03044028|10078639|FG001|COMPLETED|Overall Study||12
9015773|NCT03044028|10078640|FG002|COMPLETED|Overall Study||22
9015774|NCT03044028|10078638|FG000|NOT COMPLETED|Overall Study||10
9015775|NCT03044028|10078639|FG001|NOT COMPLETED|Overall Study||10
9015776|NCT03044028|10078640|FG002|NOT COMPLETED|Overall Study||0
9015777|NCT03044106|10078649|FG000|STARTED|Visit 1||22
9015778|NCT03044106|10078650|FG001|STARTED|Visit 1||22
9015779|NCT03044106|10078649|FG000|COMPLETED|Visit 1||22
8573819|NCT00124657|9606168|FG001|STARTED|Overall Study||5
8573820|NCT00124657|9606169|FG002|STARTED|Overall Study||39
8573821|NCT00124657|9606167|FG000|COMPLETED|Overall Study||2
8573822|NCT00124657|9606168|FG001|COMPLETED|Overall Study||0
8573823|NCT00124657|9606169|FG002|COMPLETED|Overall Study||7
8573824|NCT00124657|9606167|FG000|NOT COMPLETED|Overall Study||16
8573825|NCT00124657|9606168|FG001|NOT COMPLETED|Overall Study||5
8573826|NCT00124657|9606169|FG002|NOT COMPLETED|Overall Study||32
8573827|NCT00124709|9606192|FG000|STARTED|Overall Study||546
8573828|NCT00124709|9606193|FG001|STARTED|Overall Study||545
8573829|NCT00124709|9606192|FG000|Patients Who Received Study Medication|Overall Study||543
8573830|NCT00124709|9606193|FG001|Patients Who Received Study Medication|Overall Study||544
8573831|NCT00124709|9606192|FG000|COMPLETED|Overall Study|232 Participants entered the OL phase of the study.|291
8573832|NCT00124709|9606193|FG001|COMPLETED|Overall Study|232 Participants entered the OL phase of the study.|273
8573833|NCT00124709|9606192|FG000|NOT COMPLETED|Overall Study||255
8573834|NCT00124709|9606193|FG001|NOT COMPLETED|Overall Study||272
8573835|NCT00124735|9606209|FG000|STARTED|Overall Study||5
8573836|NCT00124735|9606210|FG001|STARTED|Overall Study||8
8573837|NCT00124735|9606211|FG002|STARTED|Overall Study||18
8573838|NCT00124735|9606212|FG003|STARTED|Overall Study||21
8573839|NCT00124735|9606213|FG004|STARTED|Overall Study||19
8573840|NCT00124735|9606214|FG005|STARTED|Overall Study||7
8573841|NCT00124735|9606215|FG006|STARTED|Overall Study||6
8573842|NCT00124735|9606216|FG007|STARTED|Overall Study||20
8573843|NCT00124735|9606217|FG008|STARTED|Overall Study||25
8573844|NCT00124735|9606218|FG009|STARTED|Overall Study||20
8573845|NCT00124735|9606209|FG000|COMPLETED|Overall Study||4
8573846|NCT00124735|9606210|FG001|COMPLETED|Overall Study||6
8573847|NCT00124735|9606211|FG002|COMPLETED|Overall Study||18
8573848|NCT00124735|9606212|FG003|COMPLETED|Overall Study||18
8573849|NCT00124735|9606213|FG004|COMPLETED|Overall Study||17
8573850|NCT00124735|9606214|FG005|COMPLETED|Overall Study||5
8573851|NCT00124735|9606215|FG006|COMPLETED|Overall Study||6
8573852|NCT00124735|9606216|FG007|COMPLETED|Overall Study||19
8573853|NCT00124735|9606217|FG008|COMPLETED|Overall Study||22
8573854|NCT00124735|9606218|FG009|COMPLETED|Overall Study||18
8573855|NCT00124735|9606209|FG000|NOT COMPLETED|Overall Study||1
8637051|NCT00570687|9677772|FG009|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
8637052|NCT00570687|9677763|FG000|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
9015780|NCT03044106|10078650|FG001|COMPLETED|Visit 1||22
9015781|NCT03044106|10078649|FG000|NOT COMPLETED|Visit 1||0
8573856|NCT00124735|9606210|FG001|NOT COMPLETED|Overall Study||2
8573857|NCT00124735|9606211|FG002|NOT COMPLETED|Overall Study||0
8573858|NCT00124735|9606212|FG003|NOT COMPLETED|Overall Study||3
8573859|NCT00124735|9606213|FG004|NOT COMPLETED|Overall Study||2
8573860|NCT00124735|9606214|FG005|NOT COMPLETED|Overall Study||2
8573861|NCT00124735|9606215|FG006|NOT COMPLETED|Overall Study||0
8573862|NCT00124735|9606216|FG007|NOT COMPLETED|Overall Study||1
8637053|NCT00570687|9677764|FG001|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
8637054|NCT00570687|9677765|FG002|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
8637055|NCT00570687|9677766|FG003|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
8637056|NCT00570687|9677767|FG004|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
9015782|NCT03044106|10078650|FG001|NOT COMPLETED|Visit 1||0
9015783|NCT03044106|10078649|FG000|STARTED|Washout (1 Week)||22
8911011|NCT02142283|9970020|FG000|STARTED|Overall Study||107
8911012|NCT02142283|9970021|FG001|STARTED|Overall Study||99
8911013|NCT02142283|9970020|FG000|COMPLETED|Overall Study||86
8911014|NCT02142283|9970021|FG001|COMPLETED|Overall Study||78
8911015|NCT02142283|9970020|FG000|NOT COMPLETED|Overall Study||21
8911016|NCT02142283|9970021|FG001|NOT COMPLETED|Overall Study||21
8911017|NCT02142361|9970027|FG000|STARTED|Overall Study||20
8911018|NCT02142361|9970028|FG001|STARTED|Overall Study||20
8911019|NCT02142361|9970029|FG002|STARTED|Overall Study||20
8911020|NCT02142361|9970027|FG000|COMPLETED|Overall Study||20
8911021|NCT02142361|9970028|FG001|COMPLETED|Overall Study||20
8911022|NCT02142361|9970029|FG002|COMPLETED|Overall Study||20
8911023|NCT02142361|9970027|FG000|NOT COMPLETED|Overall Study||0
8911024|NCT02142361|9970028|FG001|NOT COMPLETED|Overall Study||0
8911025|NCT02142361|9970029|FG002|NOT COMPLETED|Overall Study||0
8911026|NCT02142387|9970042|FG000|STARTED|Overall Study|Out-of-hospital cardiac arrest (OHCA) patients with presumed cardiac etiology.|2551
8911027|NCT02142387|9970043|FG001|STARTED|Overall Study||16271
8911028|NCT02142387|9970042|FG000|COMPLETED|Overall Study|Limited to the case where OHCA occurred in the private place.|1486
8911029|NCT02142387|9970043|FG001|COMPLETED|Overall Study||8641
8911030|NCT02142387|9970042|FG000|NOT COMPLETED|Overall Study||1065
8911031|NCT02142387|9970043|FG001|NOT COMPLETED|Overall Study||7630
8911032|NCT02142504|9970052|FG000|STARTED|Overall Study||153
8911033|NCT02142504|9970053|FG001|STARTED|Overall Study||147
8911034|NCT02142504|9970054|FG002|STARTED|Overall Study||154
8911035|NCT02142504|9970052|FG000|Randomized and Received Treatment|Overall Study||153
8911036|NCT02142504|9970053|FG001|Randomized and Received Treatment|Overall Study||145
8911037|NCT02142504|9970054|FG002|Randomized and Received Treatment|Overall Study||154
8911038|NCT02142504|9970052|FG000|Received Booster (Second Vaccination)|Overall Study||126
8911039|NCT02142504|9970053|FG001|Received Booster (Second Vaccination)|Overall Study||109
8911040|NCT02142504|9970054|FG002|Received Booster (Second Vaccination)|Overall Study||116
8911041|NCT02142504|9970052|FG000|COMPLETED|Overall Study||122
8911042|NCT02142504|9970053|FG001|COMPLETED|Overall Study||105
8911043|NCT02142504|9970054|FG002|COMPLETED|Overall Study||111
8911044|NCT02142504|9970052|FG000|NOT COMPLETED|Overall Study||31
8911045|NCT02142504|9970053|FG001|NOT COMPLETED|Overall Study||42
8911046|NCT02142504|9970054|FG002|NOT COMPLETED|Overall Study||43
8911047|NCT02142608|9970062|FG000|STARTED|Overall Study||18
8911048|NCT02142608|9970062|FG000|COMPLETED|Overall Study||18
9015784|NCT03044106|10078650|FG001|STARTED|Washout (1 Week)||22
9015785|NCT03044106|10078649|FG000|COMPLETED|Washout (1 Week)||22
9015786|NCT03044106|10078650|FG001|COMPLETED|Washout (1 Week)||20
9015787|NCT03044106|10078649|FG000|NOT COMPLETED|Washout (1 Week)||0
9015788|NCT03044106|10078650|FG001|NOT COMPLETED|Washout (1 Week)||2
9015789|NCT03044106|10078649|FG000|STARTED|Visit 2||22
9015790|NCT03044106|10078650|FG001|STARTED|Visit 2||20
9015791|NCT03044106|10078649|FG000|COMPLETED|Visit 2||22
9015792|NCT03044106|10078650|FG001|COMPLETED|Visit 2||20
9015793|NCT03044106|10078649|FG000|NOT COMPLETED|Visit 2||0
9015794|NCT03044106|10078650|FG001|NOT COMPLETED|Visit 2||0
9015795|NCT03044197|10078665|FG000|STARTED|Overall Study||12
9015796|NCT03044197|10078666|FG001|STARTED|Overall Study||12
9015797|NCT03044197|10078665|FG000|COMPLETED|Overall Study||9
9015798|NCT03044197|10078666|FG001|COMPLETED|Overall Study||11
9015799|NCT03044197|10078665|FG000|NOT COMPLETED|Overall Study||3
9015800|NCT03044197|10078666|FG001|NOT COMPLETED|Overall Study||1
9015801|NCT03044249|10078674|FG000|STARTED|Overall Study||42
9015802|NCT03044249|10078675|FG001|STARTED|Overall Study||39
9015803|NCT03044249|10078674|FG000|Received at Least One Dose of Study Drug|Overall Study||42
9015804|NCT03044249|10078675|FG001|Received at Least One Dose of Study Drug|Overall Study||39
9015805|NCT03044249|10078674|FG000|COMPLETED|Overall Study||32
9015806|NCT03044249|10078675|FG001|COMPLETED|Overall Study||25
9015807|NCT03044249|10078674|FG000|NOT COMPLETED|Overall Study||10
9015808|NCT03044249|10078675|FG001|NOT COMPLETED|Overall Study||14
9015809|NCT03044353|10078689|FG000|STARTED|Overall Study||6
9015810|NCT03044353|10078690|FG001|STARTED|Overall Study||1
9015811|NCT03044353|10078691|FG002|STARTED|Overall Study|No participant was enrolled in Group-3 due to early termination of the study.|0
9015812|NCT03044353|10078689|FG000|COMPLETED|Overall Study||6
9015813|NCT03044353|10078690|FG001|COMPLETED|Overall Study||0
9015814|NCT03044353|10078691|FG002|COMPLETED|Overall Study||0
9015815|NCT03044353|10078689|FG000|NOT COMPLETED|Overall Study||0
9015816|NCT03044353|10078690|FG001|NOT COMPLETED|Overall Study||1
9015817|NCT03044353|10078691|FG002|NOT COMPLETED|Overall Study||0
9015818|NCT03044418|10078698|FG000|STARTED|Overall Study||30
9015819|NCT03044418|10078698|FG000|COMPLETED|Overall Study||30
9015820|NCT03044418|10078698|FG000|NOT COMPLETED|Overall Study||0
9015821|NCT03044431|10078702|FG000|STARTED|Overall Study||207
9015822|NCT03044431|10078702|FG000|COMPLETED|Overall Study||148
9015823|NCT03044431|10078702|FG000|NOT COMPLETED|Overall Study||59
9015824|NCT03044574|10078708|FG000|STARTED|Overall Study||204
9015825|NCT03044574|10078709|FG001|STARTED|Overall Study||203
9015826|NCT03044574|10078708|FG000|Inpatient Period|Overall Study||204
9015827|NCT03044574|10078709|FG001|Inpatient Period|Overall Study||203
9015828|NCT03044574|10078708|FG000|30 Days After Surgery|Overall Study||193
9015829|NCT03044574|10078709|FG001|30 Days After Surgery|Overall Study||194
8911049|NCT02142608|9970062|FG000|NOT COMPLETED|Overall Study||0
9015830|NCT03044574|10078708|FG000|180 Days After Surgery|Overall Study||167
9015831|NCT03044574|10078709|FG001|180 Days After Surgery|Overall Study||158
9015832|NCT03044574|10078708|FG000|COMPLETED|Overall Study||167
9015833|NCT03044574|10078709|FG001|COMPLETED|Overall Study||158
9015834|NCT03044574|10078708|FG000|NOT COMPLETED|Overall Study||37
9015835|NCT03044574|10078709|FG001|NOT COMPLETED|Overall Study||45
9015836|NCT03044691|10078717|FG000|STARTED|Overall Study||0
9015837|NCT03044691|10078718|FG001|STARTED|Overall Study||84
9015838|NCT03044691|10078717|FG000|COMPLETED|Overall Study||0
9015839|NCT03044691|10078718|FG001|COMPLETED|Overall Study||84
9015840|NCT03044691|10078717|FG000|NOT COMPLETED|Overall Study||0
9015841|NCT03044691|10078718|FG001|NOT COMPLETED|Overall Study||0
9015842|NCT03044730|10078724|FG000|STARTED|3 Cycles of Pembro + Capecitab||30
9015843|NCT03044730|10078724|FG000|Attempted Cycle 1|3 Cycles of Pembro + Capecitab||30
9015844|NCT03044730|10078724|FG000|Attempted Cycle 2|3 Cycles of Pembro + Capecitab||28
9015845|NCT03044730|10078724|FG000|Attempted Cycle 3|3 Cycles of Pembro + Capecitab||26
9015846|NCT03044730|10078724|FG000|COMPLETED|3 Cycles of Pembro + Capecitab||26
9015847|NCT03044730|10078724|FG000|NOT COMPLETED|3 Cycles of Pembro + Capecitab||4
9015848|NCT03044730|10078724|FG000|STARTED|Cycles 4 and Beyond||26
9015849|NCT03044730|10078724|FG000|Assessed for Cycle 4|Cycles 4 and Beyond||26
9015850|NCT03044730|10078724|FG000|Started Cycle 4|Cycles 4 and Beyond||20
9015851|NCT03044730|10078724|FG000|Went on to Cycle 5 and Beyond|Cycles 4 and Beyond||16
9015852|NCT03044730|10078724|FG000|COMPLETED|Cycles 4 and Beyond||16
9015853|NCT03044730|10078724|FG000|NOT COMPLETED|Cycles 4 and Beyond||10
9015854|NCT03044730|10078724|FG000|STARTED|On Follow-up for 2 Years||29
9015855|NCT03044730|10078724|FG000|COMPLETED|On Follow-up for 2 Years||4
9015856|NCT03044730|10078724|FG000|NOT COMPLETED|On Follow-up for 2 Years||25
9015857|NCT03044886|10078732|FG000|STARTED|Overall Study||120
9015858|NCT03044886|10078733|FG001|STARTED|Overall Study||120
9015859|NCT03044886|10078734|FG002|STARTED|Overall Study||120
9015860|NCT03044886|10078732|FG000|COMPLETED|Overall Study||105
9015861|NCT03044886|10078733|FG001|COMPLETED|Overall Study||110
9015862|NCT03044886|10078734|FG002|COMPLETED|Overall Study||108
9015863|NCT03044886|10078732|FG000|NOT COMPLETED|Overall Study||15
9015864|NCT03044886|10078733|FG001|NOT COMPLETED|Overall Study||10
9015865|NCT03044886|10078734|FG002|NOT COMPLETED|Overall Study||12
9015866|NCT03045081|10078744|FG000|STARTED|Overall Study||51
9015867|NCT03045081|10078745|FG001|STARTED|Overall Study||48
9015868|NCT03045081|10078744|FG000|COMPLETED|Overall Study||45
9015869|NCT03045081|10078745|FG001|COMPLETED|Overall Study||37
9015870|NCT03045081|10078744|FG000|NOT COMPLETED|Overall Study||6
9015871|NCT03045081|10078745|FG001|NOT COMPLETED|Overall Study||11
9015872|NCT03045302|10078751|FG000|STARTED|Overall Study||4
9015873|NCT03045302|10078751|FG000|COMPLETED|Overall Study||3
9015874|NCT03045302|10078751|FG000|NOT COMPLETED|Overall Study||1
8573863|NCT00124735|9606217|FG008|NOT COMPLETED|Overall Study||3
8573864|NCT00124735|9606218|FG009|NOT COMPLETED|Overall Study||2
8573865|NCT00124748|9606234|FG000|STARTED|Overall Study||157
8573866|NCT00124748|9606235|FG001|STARTED|Overall Study||319
8573867|NCT00124748|9606234|FG000|Safety Population|Overall Study||157
8573868|NCT00124748|9606235|FG001|Safety Population|Overall Study||316
8573869|NCT00124748|9606234|FG000|COMPLETED|Overall Study||14
8573870|NCT00124748|9606235|FG001|COMPLETED|Overall Study||35
8573871|NCT00124748|9606234|FG000|NOT COMPLETED|Overall Study||143
8573872|NCT00124748|9606235|FG001|NOT COMPLETED|Overall Study||284
8573873|NCT00124917|9606241|FG000|STARTED|Overall Study||6
8573874|NCT00124917|9606241|FG000|COMPLETED|Overall Study||3
8573875|NCT00124917|9606241|FG000|NOT COMPLETED|Overall Study||3
8573876|NCT00124943|9606250|FG000|STARTED|Phase I||3
8573877|NCT00124943|9606251|FG001|STARTED|Phase I||3
8573878|NCT00124943|9606252|FG002|STARTED|Phase I||3
8573879|NCT00124943|9606253|FG003|STARTED|Phase I||3
8573880|NCT00124943|9606250|FG000|COMPLETED|Phase I||3
8573881|NCT00124943|9606251|FG001|COMPLETED|Phase I||3
8573882|NCT00124943|9606252|FG002|COMPLETED|Phase I||3
8573883|NCT00124943|9606253|FG003|COMPLETED|Phase I||3
8573884|NCT00124943|9606250|FG000|NOT COMPLETED|Phase I||0
8727064|NCT01041404|9774461|FG000|Died in Follow-up|Overall Study||199
8727065|NCT01041404|9774462|FG001|Died in Follow-up|Overall Study||200
8727066|NCT01041404|9774461|FG000|Lost to Follow-up|Overall Study||12
8727067|NCT01041404|9774462|FG001|Lost to Follow-up|Overall Study||10
8727068|NCT01041404|9774461|FG000|Alive in Follow-up|Overall Study||40
8727069|NCT01041404|9774462|FG001|Alive in Follow-up|Overall Study||41
8727070|NCT01041404|9774461|FG000|COMPLETED|Overall Study|Summary of withdrawals represents withdrawals from treatment, rather than withdrawals from study.|0
8727071|NCT01041404|9774462|FG001|COMPLETED|Overall Study|Summary of withdrawals represents withdrawals from treatment, rather than withdrawals from study.|0
8727072|NCT01041404|9774461|FG000|NOT COMPLETED|Overall Study||290
8727073|NCT01041404|9774462|FG001|NOT COMPLETED|Overall Study||294
8727074|NCT01041417|9774473|FG000|STARTED|Overall Study||80
8727075|NCT01041417|9774474|FG001|STARTED|Overall Study||79
8727076|NCT01041417|9774473|FG000|COMPLETED|Overall Study||73
8727077|NCT01041417|9774474|FG001|COMPLETED|Overall Study||76
8573885|NCT00124943|9606251|FG001|NOT COMPLETED|Phase I||0
8573886|NCT00124943|9606252|FG002|NOT COMPLETED|Phase I||0
8727078|NCT01041417|9774473|FG000|NOT COMPLETED|Overall Study||7
8727079|NCT01041417|9774474|FG001|NOT COMPLETED|Overall Study||3
9015875|NCT03045328|10078755|FG000|STARTED|Overall Study||22
9015876|NCT03045328|10078755|FG000|COMPLETED|Overall Study||20
9015877|NCT03045328|10078755|FG000|NOT COMPLETED|Overall Study||2
9015878|NCT03045809|10078759|FG000|STARTED|Overall Study||705
9039680|NCT03341299|10100653|FG001|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
8573887|NCT00124943|9606253|FG003|NOT COMPLETED|Phase I||0
9015879|NCT03045809|10078759|FG000|Attended an Additional Visit (if Needed)|Overall Study|(only if needed, for medical follow-up, to complete study procedures, or to report adverse events).|51
9015880|NCT03045809|10078759|FG000|COMPLETED|Overall Study||705
9015881|NCT03045809|10078759|FG000|NOT COMPLETED|Overall Study||0
9039681|NCT03341299|10100654|FG002|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
9039682|NCT03341299|10100655|FG003|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
9039683|NCT03341299|10100652|FG000|STARTED|Period 3||9
9039684|NCT03341299|10100653|FG001|STARTED|Period 3||9
9039685|NCT03341299|10100654|FG002|STARTED|Period 3||8
9039686|NCT03341299|10100655|FG003|STARTED|Period 3||9
9039687|NCT03341299|10100652|FG000|COMPLETED|Period 3||9
9039688|NCT03341299|10100653|FG001|COMPLETED|Period 3||9
9039689|NCT03341299|10100654|FG002|COMPLETED|Period 3||8
9039690|NCT03341299|10100655|FG003|COMPLETED|Period 3||9
9039691|NCT03341299|10100652|FG000|NOT COMPLETED|Period 3||0
9039692|NCT03341299|10100653|FG001|NOT COMPLETED|Period 3||0
9039693|NCT03341299|10100654|FG002|NOT COMPLETED|Period 3||0
9039694|NCT03341299|10100655|FG003|NOT COMPLETED|Period 3||0
9039695|NCT03341299|10100652|FG000|STARTED|Washout (A Minimum of 21 Hours)||9
9039696|NCT03341299|10100653|FG001|STARTED|Washout (A Minimum of 21 Hours)||9
9039697|NCT03341299|10100654|FG002|STARTED|Washout (A Minimum of 21 Hours)||8
9039698|NCT03341299|10100655|FG003|STARTED|Washout (A Minimum of 21 Hours)||9
9039699|NCT03341299|10100652|FG000|COMPLETED|Washout (A Minimum of 21 Hours)||9
9039700|NCT03341299|10100653|FG001|COMPLETED|Washout (A Minimum of 21 Hours)||9
9039701|NCT03341299|10100654|FG002|COMPLETED|Washout (A Minimum of 21 Hours)||8
9039702|NCT03341299|10100655|FG003|COMPLETED|Washout (A Minimum of 21 Hours)||9
9039703|NCT03341299|10100652|FG000|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
9039704|NCT03341299|10100653|FG001|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
9039705|NCT03341299|10100654|FG002|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
9039706|NCT03341299|10100655|FG003|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
9039707|NCT03341299|10100652|FG000|STARTED|Period 4||9
9039708|NCT03341299|10100653|FG001|STARTED|Period 4||9
9039709|NCT03341299|10100654|FG002|STARTED|Period 4||8
9039710|NCT03341299|10100655|FG003|STARTED|Period 4||9
9039711|NCT03341299|10100652|FG000|COMPLETED|Period 4||9
9039712|NCT03341299|10100653|FG001|COMPLETED|Period 4||9
9039713|NCT03341299|10100654|FG002|COMPLETED|Period 4||8
9039714|NCT03341299|10100655|FG003|COMPLETED|Period 4||9
9039715|NCT03341299|10100652|FG000|NOT COMPLETED|Period 4||0
9039716|NCT03341299|10100653|FG001|NOT COMPLETED|Period 4||0
9039717|NCT03341299|10100654|FG002|NOT COMPLETED|Period 4||0
9039718|NCT03341299|10100655|FG003|NOT COMPLETED|Period 4||0
9039719|NCT03341312|10100667|FG000|STARTED|Period 1||9
9039720|NCT03341312|10100668|FG001|STARTED|Period 1||10
9039721|NCT03341312|10100669|FG002|STARTED|Period 1||9
9039722|NCT03341312|10100670|FG003|STARTED|Period 1||8
9039723|NCT03341312|10100667|FG000|Received at Least One Dose of Study Drug|Period 1||9
9039724|NCT03341312|10100668|FG001|Received at Least One Dose of Study Drug|Period 1||10
9039725|NCT03341312|10100669|FG002|Received at Least One Dose of Study Drug|Period 1||9
9039726|NCT03341312|10100670|FG003|Received at Least One Dose of Study Drug|Period 1||8
9039727|NCT03341312|10100667|FG000|COMPLETED|Period 1||9
9039728|NCT03341312|10100668|FG001|COMPLETED|Period 1||9
9039729|NCT03341312|10100669|FG002|COMPLETED|Period 1||9
9039730|NCT03341312|10100670|FG003|COMPLETED|Period 1||8
9039731|NCT03341312|10100667|FG000|NOT COMPLETED|Period 1||0
9039732|NCT03341312|10100668|FG001|NOT COMPLETED|Period 1||1
9039733|NCT03341312|10100669|FG002|NOT COMPLETED|Period 1||0
9039734|NCT03341312|10100670|FG003|NOT COMPLETED|Period 1||0
9039735|NCT03341312|10100667|FG000|STARTED|Period 2||9
9039736|NCT03341312|10100668|FG001|STARTED|Period 2||9
9039737|NCT03341312|10100669|FG002|STARTED|Period 2||9
9039738|NCT03341312|10100670|FG003|STARTED|Period 2||8
9039739|NCT03341312|10100667|FG000|COMPLETED|Period 2||9
9039740|NCT03341312|10100668|FG001|COMPLETED|Period 2||9
9039741|NCT03341312|10100669|FG002|COMPLETED|Period 2||9
9039742|NCT03341312|10100670|FG003|COMPLETED|Period 2||8
9039743|NCT03341312|10100667|FG000|NOT COMPLETED|Period 2||0
9039744|NCT03341312|10100668|FG001|NOT COMPLETED|Period 2||0
9039745|NCT03341312|10100669|FG002|NOT COMPLETED|Period 2||0
9039746|NCT03341312|10100670|FG003|NOT COMPLETED|Period 2||0
9039747|NCT03341312|10100667|FG000|STARTED|Period 3||9
9039748|NCT03341312|10100668|FG001|STARTED|Period 3||9
9039749|NCT03341312|10100669|FG002|STARTED|Period 3||9
9039750|NCT03341312|10100670|FG003|STARTED|Period 3||8
9039751|NCT03341312|10100667|FG000|COMPLETED|Period 3||9
9039752|NCT03341312|10100668|FG001|COMPLETED|Period 3||9
9039753|NCT03341312|10100669|FG002|COMPLETED|Period 3||9
9039754|NCT03341312|10100670|FG003|COMPLETED|Period 3||8
8727080|NCT01041495|9774484|FG000|STARTED|Overall Study||16
8727081|NCT01041495|9774485|FG001|STARTED|Overall Study||12
8727082|NCT01041495|9774484|FG000|COMPLETED|Overall Study||12
9039755|NCT03341312|10100667|FG000|NOT COMPLETED|Period 3||0
9039756|NCT03341312|10100668|FG001|NOT COMPLETED|Period 3||0
9039757|NCT03341312|10100669|FG002|NOT COMPLETED|Period 3||0
9039758|NCT03341312|10100670|FG003|NOT COMPLETED|Period 3||0
8727083|NCT01041495|9774485|FG001|COMPLETED|Overall Study||5
8727084|NCT01041495|9774484|FG000|NOT COMPLETED|Overall Study||4
9039759|NCT03341312|10100667|FG000|STARTED|Period 4||9
9039760|NCT03341312|10100668|FG001|STARTED|Period 4||9
9039761|NCT03341312|10100669|FG002|STARTED|Period 4||9
9039762|NCT03341312|10100670|FG003|STARTED|Period 4||8
9039763|NCT03341312|10100667|FG000|COMPLETED|Period 4||9
9039764|NCT03341312|10100668|FG001|COMPLETED|Period 4||9
9039765|NCT03341312|10100669|FG002|COMPLETED|Period 4||9
9015882|NCT03045861|10078769|FG000|STARTED|Part A (Up to 10 Days)||0
9015883|NCT03045861|10078770|FG001|STARTED|Part A (Up to 10 Days)||0
9015884|NCT03045861|10078771|FG002|STARTED|Part A (Up to 10 Days)||10
9015885|NCT03045861|10078772|FG003|STARTED|Part A (Up to 10 Days)||0
9015886|NCT03045861|10078769|FG000|COMPLETED|Part A (Up to 10 Days)||0
9015887|NCT03045861|10078770|FG001|COMPLETED|Part A (Up to 10 Days)||0
9015888|NCT03045861|10078771|FG002|COMPLETED|Part A (Up to 10 Days)||10
9015889|NCT03045861|10078772|FG003|COMPLETED|Part A (Up to 10 Days)||0
9015890|NCT03045861|10078769|FG000|NOT COMPLETED|Part A (Up to 10 Days)||0
9015891|NCT03045861|10078770|FG001|NOT COMPLETED|Part A (Up to 10 Days)||0
9015892|NCT03045861|10078771|FG002|NOT COMPLETED|Part A (Up to 10 Days)||0
8573888|NCT00124943|9606250|FG000|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|3
8573889|NCT00124943|9606251|FG001|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|51
8573890|NCT00124943|9606252|FG002|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|3
8573891|NCT00124943|9606253|FG003|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|55
8573892|NCT00124943|9606250|FG000|COMPLETED|Phase II||3
8573893|NCT00124943|9606251|FG001|COMPLETED|Phase II||49
8573894|NCT00124943|9606252|FG002|COMPLETED|Phase II||3
8573895|NCT00124943|9606253|FG003|COMPLETED|Phase II||50
8573896|NCT00124943|9606250|FG000|NOT COMPLETED|Phase II||0
8573897|NCT00124943|9606251|FG001|NOT COMPLETED|Phase II||2
8573898|NCT00124943|9606252|FG002|NOT COMPLETED|Phase II||0
8573899|NCT00124943|9606253|FG003|NOT COMPLETED|Phase II||5
8573900|NCT00124982|9606265|FG000|STARTED|Short-term Period||449
8573901|NCT00124982|9606266|FG001|STARTED|Short-term Period||597
8573902|NCT00124982|9606267|FG002|STARTED|Short-term Period||0
8573903|NCT00124982|9606265|FG000|COMPLETED|Short-term Period||377
8573904|NCT00124982|9606266|FG001|COMPLETED|Short-term Period||483
8573905|NCT00124982|9606267|FG002|COMPLETED|Short-term Period||0
8573906|NCT00124982|9606265|FG000|NOT COMPLETED|Short-term Period||72
8573907|NCT00124982|9606266|FG001|NOT COMPLETED|Short-term Period||114
8573908|NCT00124982|9606267|FG002|NOT COMPLETED|Short-term Period||0
8573909|NCT00124982|9606265|FG000|STARTED|Long-term Period||0
8573910|NCT00124982|9606266|FG001|STARTED|Long-term Period||0
8573911|NCT00124982|9606267|FG002|STARTED|Long-term Period|A large number did not continue due to a rollover from study drug to commercially available drug.|530
8573912|NCT00124982|9606265|FG000|COMPLETED|Long-term Period||0
8573913|NCT00124982|9606266|FG001|COMPLETED|Long-term Period||0
8573914|NCT00124982|9606267|FG002|COMPLETED|Long-term Period||441
8573915|NCT00124982|9606265|FG000|NOT COMPLETED|Long-term Period||0
8573916|NCT00124982|9606266|FG001|NOT COMPLETED|Long-term Period||0
8573917|NCT00124982|9606267|FG002|NOT COMPLETED|Long-term Period||89
8573918|NCT00125034|9606278|FG000|STARTED|Overall Study|Randomized & treated. 1 subject was not randomized correctly and was excluded in the ITT population.|170
8573919|NCT00125034|9606279|FG001|STARTED|Overall Study|Randomized & treated|168
8573920|NCT00125034|9606278|FG000|COMPLETED|Overall Study||170
8573921|NCT00125034|9606279|FG001|COMPLETED|Overall Study||168
8573922|NCT00125034|9606278|FG000|NOT COMPLETED|Overall Study||0
8573923|NCT00125034|9606279|FG001|NOT COMPLETED|Overall Study||0
8573924|NCT00125138|9606289|FG000|STARTED|Overall Study||15
8573925|NCT00125138|9606290|FG001|STARTED|Overall Study|One subject requested withdrawal prior to treatment; data for the subject are excluded from results.|20
8573926|NCT00125138|9606291|FG002|STARTED|Overall Study||25
8573927|NCT00125138|9606292|FG003|STARTED|Overall Study||30
8573928|NCT00125138|9606289|FG000|COMPLETED|Overall Study||12
8573929|NCT00125138|9606290|FG001|COMPLETED|Overall Study||17
8573930|NCT00125138|9606291|FG002|COMPLETED|Overall Study||21
8573931|NCT00125138|9606292|FG003|COMPLETED|Overall Study||25
8573932|NCT00125138|9606289|FG000|NOT COMPLETED|Overall Study||3
8573933|NCT00125138|9606290|FG001|NOT COMPLETED|Overall Study||3
8573934|NCT00125138|9606291|FG002|NOT COMPLETED|Overall Study||4
8573935|NCT00125138|9606292|FG003|NOT COMPLETED|Overall Study||5
8573936|NCT00125164|9606306|FG000|STARTED|Overall Study||25
8573937|NCT00125164|9606307|FG001|STARTED|Overall Study||16
8573938|NCT00125164|9606308|FG002|STARTED|Overall Study||44
8573939|NCT00125164|9606309|FG003|STARTED|Overall Study||51
8573940|NCT00125164|9606306|FG000|COMPLETED|Overall Study||23
8573941|NCT00125164|9606307|FG001|COMPLETED|Overall Study||16
8573942|NCT00125164|9606308|FG002|COMPLETED|Overall Study||40
8573943|NCT00125164|9606309|FG003|COMPLETED|Overall Study||45
8573944|NCT00125164|9606306|FG000|NOT COMPLETED|Overall Study||2
8573945|NCT00125164|9606307|FG001|NOT COMPLETED|Overall Study||0
8573946|NCT00125164|9606308|FG002|NOT COMPLETED|Overall Study||4
8573947|NCT00125164|9606309|FG003|NOT COMPLETED|Overall Study||6
8573948|NCT00125190|9606319|FG000|STARTED|Overall Study||45
8573949|NCT00125190|9606319|FG000|Completed 34 Weeks of Study|Overall Study||43
8727085|NCT01041495|9774485|FG001|NOT COMPLETED|Overall Study||7
8727086|NCT01041521|9774493|FG000|STARTED|Overall Study||61
8727087|NCT01041521|9774494|FG001|STARTED|Overall Study||56
8727088|NCT01041521|9774493|FG000|COMPLETED|Overall Study||44
8727089|NCT01041521|9774494|FG001|COMPLETED|Overall Study||40
8727090|NCT01041521|9774493|FG000|NOT COMPLETED|Overall Study||17
8727091|NCT01041521|9774494|FG001|NOT COMPLETED|Overall Study||16
8727092|NCT01041573|9774504|FG000|STARTED|Overall Study||540
8727093|NCT01041573|9774505|FG001|STARTED|Overall Study||871
8727094|NCT01041573|9774506|FG002|STARTED|Overall Study||394
8727095|NCT01041573|9774507|FG003|STARTED|Overall Study||64
9015893|NCT03045861|10078772|FG003|NOT COMPLETED|Part A (Up to 10 Days)||0
9015894|NCT03045861|10078769|FG000|STARTED|Part B (Up to 10 Days)||7
9015895|NCT03045861|10078770|FG001|STARTED|Part B (Up to 10 Days)||8
9015896|NCT03045861|10078771|FG002|STARTED|Part B (Up to 10 Days)||0
9015897|NCT03045861|10078772|FG003|STARTED|Part B (Up to 10 Days)||8
9015898|NCT03045861|10078769|FG000|COMPLETED|Part B (Up to 10 Days)||7
9015899|NCT03045861|10078770|FG001|COMPLETED|Part B (Up to 10 Days)||8
9015900|NCT03045861|10078771|FG002|COMPLETED|Part B (Up to 10 Days)||0
9015901|NCT03045861|10078772|FG003|COMPLETED|Part B (Up to 10 Days)||8
9015902|NCT03045861|10078769|FG000|NOT COMPLETED|Part B (Up to 10 Days)||0
9015903|NCT03045861|10078770|FG001|NOT COMPLETED|Part B (Up to 10 Days)||0
9015904|NCT03045861|10078771|FG002|NOT COMPLETED|Part B (Up to 10 Days)||0
9015905|NCT03045861|10078772|FG003|NOT COMPLETED|Part B (Up to 10 Days)||0
9015906|NCT03045887|10078793|FG000|STARTED|Part A, Period (1 Day)||7
9015907|NCT03045887|10078794|FG001|STARTED|Part A, Period (1 Day)||4
9015908|NCT03045887|10078795|FG002|STARTED|Part A, Period (1 Day)||5
9015909|NCT03045887|10078796|FG003|STARTED|Part A, Period (1 Day)||5
9015910|NCT03045887|10078797|FG004|STARTED|Part A, Period (1 Day)||4
9015911|NCT03045887|10078798|FG005|STARTED|Part A, Period (1 Day)||4
9015912|NCT03045887|10078799|FG006|STARTED|Part A, Period (1 Day)||4
9015913|NCT03045887|10078800|FG007|STARTED|Part A, Period (1 Day)||4
9015914|NCT03045887|10078801|FG008|STARTED|Part A, Period (1 Day)||0
9015915|NCT03045887|10078802|FG009|STARTED|Part A, Period (1 Day)||0
9015916|NCT03045887|10078793|FG000|COMPLETED|Part A, Period (1 Day)||7
9015917|NCT03045887|10078794|FG001|COMPLETED|Part A, Period (1 Day)||4
9015918|NCT03045887|10078795|FG002|COMPLETED|Part A, Period (1 Day)||5
9015919|NCT03045887|10078796|FG003|COMPLETED|Part A, Period (1 Day)||5
9015920|NCT03045887|10078797|FG004|COMPLETED|Part A, Period (1 Day)||4
9015921|NCT03045887|10078798|FG005|COMPLETED|Part A, Period (1 Day)||4
9015922|NCT03045887|10078799|FG006|COMPLETED|Part A, Period (1 Day)||4
9015923|NCT03045887|10078800|FG007|COMPLETED|Part A, Period (1 Day)||4
9015924|NCT03045887|10078801|FG008|COMPLETED|Part A, Period (1 Day)||0
9015925|NCT03045887|10078802|FG009|COMPLETED|Part A, Period (1 Day)||0
9015926|NCT03045887|10078793|FG000|NOT COMPLETED|Part A, Period (1 Day)||0
9015927|NCT03045887|10078794|FG001|NOT COMPLETED|Part A, Period (1 Day)||0
9015928|NCT03045887|10078795|FG002|NOT COMPLETED|Part A, Period (1 Day)||0
9015929|NCT03045887|10078796|FG003|NOT COMPLETED|Part A, Period (1 Day)||0
9015930|NCT03045887|10078797|FG004|NOT COMPLETED|Part A, Period (1 Day)||0
9015931|NCT03045887|10078798|FG005|NOT COMPLETED|Part A, Period (1 Day)||0
9015932|NCT03045887|10078799|FG006|NOT COMPLETED|Part A, Period (1 Day)||0
9015933|NCT03045887|10078800|FG007|NOT COMPLETED|Part A, Period (1 Day)||0
9015934|NCT03045887|10078801|FG008|NOT COMPLETED|Part A, Period (1 Day)||0
9015935|NCT03045887|10078802|FG009|NOT COMPLETED|Part A, Period (1 Day)||0
9015936|NCT03045887|10078793|FG000|STARTED|Part A,Washout Period 1(4 Weeks)||7
8573950|NCT00125190|9606319|FG000|COMPLETED|Overall Study||30
8573951|NCT00125190|9606319|FG000|NOT COMPLETED|Overall Study||15
8573952|NCT00125242|9606326|FG000|STARTED|Overall Study||94
8573953|NCT00125242|9606327|FG001|STARTED|Overall Study||16
8573954|NCT00125242|9606326|FG000|COMPLETED|Overall Study||87
8573955|NCT00125242|9606327|FG001|COMPLETED|Overall Study||14
8573956|NCT00125242|9606326|FG000|NOT COMPLETED|Overall Study||7
8573957|NCT00125242|9606327|FG001|NOT COMPLETED|Overall Study||2
8573958|NCT00125359|9606332|FG000|STARTED|Overall Study||42
8573959|NCT00125359|9606332|FG000|COMPLETED|Overall Study||19
8573960|NCT00125359|9606332|FG000|NOT COMPLETED|Overall Study||23
8727096|NCT01041573|9774504|FG000|COMPLETED|Overall Study||535
8573961|NCT00125372|9606336|FG000|STARTED|Overall Study||12
8573962|NCT00125372|9606336|FG000|COMPLETED|Overall Study||10
8573963|NCT00125372|9606336|FG000|NOT COMPLETED|Overall Study||2
9015937|NCT03045887|10078794|FG001|STARTED|Part A,Washout Period 1(4 Weeks)||4
9015938|NCT03045887|10078795|FG002|STARTED|Part A,Washout Period 1(4 Weeks)||5
9015939|NCT03045887|10078796|FG003|STARTED|Part A,Washout Period 1(4 Weeks)||5
9015940|NCT03045887|10078797|FG004|STARTED|Part A,Washout Period 1(4 Weeks)||4
9015941|NCT03045887|10078798|FG005|STARTED|Part A,Washout Period 1(4 Weeks)||4
9015942|NCT03045887|10078799|FG006|STARTED|Part A,Washout Period 1(4 Weeks)||4
9015943|NCT03045887|10078800|FG007|STARTED|Part A,Washout Period 1(4 Weeks)||4
9015944|NCT03045887|10078801|FG008|STARTED|Part A,Washout Period 1(4 Weeks)||0
9015945|NCT03045887|10078802|FG009|STARTED|Part A,Washout Period 1(4 Weeks)||0
9015946|NCT03045887|10078793|FG000|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
9015947|NCT03045887|10078794|FG001|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
9015948|NCT03045887|10078795|FG002|COMPLETED|Part A,Washout Period 1(4 Weeks)||5
9015949|NCT03045887|10078796|FG003|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
9015950|NCT03045887|10078797|FG004|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
9015951|NCT03045887|10078798|FG005|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
9015952|NCT03045887|10078799|FG006|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
9015953|NCT03045887|10078800|FG007|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
9015954|NCT03045887|10078801|FG008|COMPLETED|Part A,Washout Period 1(4 Weeks)||0
9015955|NCT03045887|10078802|FG009|COMPLETED|Part A,Washout Period 1(4 Weeks)||0
9015956|NCT03045887|10078793|FG000|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||3
9015957|NCT03045887|10078794|FG001|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
9015958|NCT03045887|10078795|FG002|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
9015959|NCT03045887|10078796|FG003|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||1
9015960|NCT03045887|10078797|FG004|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
9015961|NCT03045887|10078798|FG005|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
9015962|NCT03045887|10078799|FG006|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
9015963|NCT03045887|10078800|FG007|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
9015964|NCT03045887|10078801|FG008|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
9015965|NCT03045887|10078802|FG009|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
9015966|NCT03045887|10078793|FG000|STARTED|Part A, Period 2 (1 Day)||4
8727097|NCT01041573|9774505|FG001|COMPLETED|Overall Study||858
8727098|NCT01041573|9774506|FG002|COMPLETED|Overall Study||387
9015967|NCT03045887|10078794|FG001|STARTED|Part A, Period 2 (1 Day)||4
9015968|NCT03045887|10078795|FG002|STARTED|Part A, Period 2 (1 Day)||5
9015969|NCT03045887|10078796|FG003|STARTED|Part A, Period 2 (1 Day)||4
9015970|NCT03045887|10078797|FG004|STARTED|Part A, Period 2 (1 Day)||4
9015971|NCT03045887|10078798|FG005|STARTED|Part A, Period 2 (1 Day)||4
9015972|NCT03045887|10078799|FG006|STARTED|Part A, Period 2 (1 Day)||4
9015973|NCT03045887|10078800|FG007|STARTED|Part A, Period 2 (1 Day)||4
9015974|NCT03045887|10078801|FG008|STARTED|Part A, Period 2 (1 Day)||0
9015975|NCT03045887|10078802|FG009|STARTED|Part A, Period 2 (1 Day)||0
9015976|NCT03045887|10078793|FG000|COMPLETED|Part A, Period 2 (1 Day)||3
9015977|NCT03045887|10078794|FG001|COMPLETED|Part A, Period 2 (1 Day)||4
9015978|NCT03045887|10078795|FG002|COMPLETED|Part A, Period 2 (1 Day)||5
9015979|NCT03045887|10078796|FG003|COMPLETED|Part A, Period 2 (1 Day)||4
9015980|NCT03045887|10078797|FG004|COMPLETED|Part A, Period 2 (1 Day)||4
9015981|NCT03045887|10078798|FG005|COMPLETED|Part A, Period 2 (1 Day)||4
9015982|NCT03045887|10078799|FG006|COMPLETED|Part A, Period 2 (1 Day)||4
9015983|NCT03045887|10078800|FG007|COMPLETED|Part A, Period 2 (1 Day)||4
9015984|NCT03045887|10078801|FG008|COMPLETED|Part A, Period 2 (1 Day)||0
9015985|NCT03045887|10078802|FG009|COMPLETED|Part A, Period 2 (1 Day)||0
9015986|NCT03045887|10078793|FG000|NOT COMPLETED|Part A, Period 2 (1 Day)||1
9015987|NCT03045887|10078794|FG001|NOT COMPLETED|Part A, Period 2 (1 Day)||0
9015988|NCT03045887|10078795|FG002|NOT COMPLETED|Part A, Period 2 (1 Day)||0
9015989|NCT03045887|10078796|FG003|NOT COMPLETED|Part A, Period 2 (1 Day)||0
9015990|NCT03045887|10078797|FG004|NOT COMPLETED|Part A, Period 2 (1 Day)||0
9015991|NCT03045887|10078798|FG005|NOT COMPLETED|Part A, Period 2 (1 Day)||0
9015992|NCT03045887|10078799|FG006|NOT COMPLETED|Part A, Period 2 (1 Day)||0
9015993|NCT03045887|10078800|FG007|NOT COMPLETED|Part A, Period 2 (1 Day)||0
9015994|NCT03045887|10078801|FG008|NOT COMPLETED|Part A, Period 2 (1 Day)||0
9015995|NCT03045887|10078802|FG009|NOT COMPLETED|Part A, Period 2 (1 Day)||0
9015996|NCT03045887|10078793|FG000|STARTED|Part A,Washout Period 2 (4 Weeks)||3
9015997|NCT03045887|10078794|FG001|STARTED|Part A,Washout Period 2 (4 Weeks)||4
9015998|NCT03045887|10078795|FG002|STARTED|Part A,Washout Period 2 (4 Weeks)||5
9015999|NCT03045887|10078796|FG003|STARTED|Part A,Washout Period 2 (4 Weeks)||4
9016000|NCT03045887|10078797|FG004|STARTED|Part A,Washout Period 2 (4 Weeks)||4
9016001|NCT03045887|10078798|FG005|STARTED|Part A,Washout Period 2 (4 Weeks)||4
9016002|NCT03045887|10078799|FG006|STARTED|Part A,Washout Period 2 (4 Weeks)||4
9016003|NCT03045887|10078800|FG007|STARTED|Part A,Washout Period 2 (4 Weeks)||4
8573964|NCT00125515|9606343|FG000|STARTED|Overall Study||27
9016004|NCT03045887|10078801|FG008|STARTED|Part A,Washout Period 2 (4 Weeks)||0
9016005|NCT03045887|10078802|FG009|STARTED|Part A,Washout Period 2 (4 Weeks)||0
9016006|NCT03045887|10078793|FG000|COMPLETED|Part A,Washout Period 2 (4 Weeks)||3
9016007|NCT03045887|10078794|FG001|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
9016008|NCT03045887|10078795|FG002|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
9016009|NCT03045887|10078796|FG003|COMPLETED|Part A,Washout Period 2 (4 Weeks)||2
9016010|NCT03045887|10078797|FG004|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
9016011|NCT03045887|10078798|FG005|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
8727099|NCT01041573|9774507|FG003|COMPLETED|Overall Study||62
9016012|NCT03045887|10078799|FG006|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
9016013|NCT03045887|10078800|FG007|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
9016014|NCT03045887|10078801|FG008|COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
8573965|NCT00125515|9606344|FG001|STARTED|Overall Study||27
8573966|NCT00125515|9606345|FG002|STARTED|Overall Study||27
8573967|NCT00125515|9606343|FG000|COMPLETED|Overall Study||7
8573968|NCT00125515|9606344|FG001|COMPLETED|Overall Study||7
8573969|NCT00125515|9606345|FG002|COMPLETED|Overall Study||6
8573970|NCT00125515|9606343|FG000|NOT COMPLETED|Overall Study||20
8573971|NCT00125515|9606344|FG001|NOT COMPLETED|Overall Study||20
8573972|NCT00125515|9606345|FG002|NOT COMPLETED|Overall Study||21
8573973|NCT00125528|9606355|FG000|STARTED|Overall Study||20
8573974|NCT00125528|9606356|FG001|STARTED|Overall Study||21
8573975|NCT00125528|9606355|FG000|COMPLETED|Overall Study||18
8573976|NCT00125528|9606356|FG001|COMPLETED|Overall Study||20
8573977|NCT00125528|9606355|FG000|NOT COMPLETED|Overall Study||2
8573978|NCT00125528|9606356|FG001|NOT COMPLETED|Overall Study||1
8573979|NCT00125593|9606364|FG000|STARTED|Overall Study||4650
8573980|NCT00125593|9606365|FG001|STARTED|Overall Study||4620
8573981|NCT00125593|9606364|FG000|COMPLETED|Overall Study||4549
9016015|NCT03045887|10078802|FG009|COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
9016016|NCT03045887|10078793|FG000|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
9016017|NCT03045887|10078794|FG001|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
9016018|NCT03045887|10078795|FG002|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||1
9016019|NCT03045887|10078796|FG003|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||2
9016020|NCT03045887|10078797|FG004|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
9016021|NCT03045887|10078798|FG005|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
9016022|NCT03045887|10078799|FG006|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
9016023|NCT03045887|10078800|FG007|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
8573982|NCT00125593|9606365|FG001|COMPLETED|Overall Study||4517
8573983|NCT00125593|9606364|FG000|NOT COMPLETED|Overall Study||101
8573984|NCT00125593|9606365|FG001|NOT COMPLETED|Overall Study||103
8573985|NCT00125619|9606373|FG000|STARTED|Overall Study||8
8573986|NCT00125619|9606374|FG001|STARTED|Overall Study||8
8573987|NCT00125619|9606373|FG000|COMPLETED|Overall Study||8
8573988|NCT00125619|9606374|FG001|COMPLETED|Overall Study||8
8573989|NCT00125619|9606373|FG000|NOT COMPLETED|Overall Study||0
8573990|NCT00125619|9606374|FG001|NOT COMPLETED|Overall Study||0
8573991|NCT00125658|9606383|FG000|STARTED|Overall Study||8
8573992|NCT00125658|9606384|FG001|STARTED|Overall Study||6
8573993|NCT00125658|9606383|FG000|COMPLETED|Overall Study||8
8573994|NCT00125658|9606384|FG001|COMPLETED|Overall Study||6
8573995|NCT00125658|9606383|FG000|NOT COMPLETED|Overall Study||0
8573996|NCT00125658|9606384|FG001|NOT COMPLETED|Overall Study||0
8573997|NCT00125762|9606392|FG000|STARTED|Overall Study||907
8573998|NCT00125762|9606392|FG000|COMPLETED|Overall Study||748
8573999|NCT00125762|9606392|FG000|NOT COMPLETED|Overall Study||159
8574000|NCT00125788|9606398|FG000|STARTED|Overall Study||37
8574001|NCT00125788|9606399|FG001|STARTED|Overall Study||33
8574002|NCT00125788|9606398|FG000|COMPLETED|Overall Study||33
8574003|NCT00125788|9606399|FG001|COMPLETED|Overall Study||29
8574004|NCT00125788|9606398|FG000|NOT COMPLETED|Overall Study||4
8574005|NCT00125788|9606399|FG001|NOT COMPLETED|Overall Study||4
8574006|NCT00125853|9606405|FG000|STARTED|Wash-out (4 Weeks)||27
8574007|NCT00125853|9606406|FG001|STARTED|Wash-out (4 Weeks)||27
8574008|NCT00125853|9606405|FG000|COMPLETED|Wash-out (4 Weeks)||27
8574009|NCT00125853|9606406|FG001|COMPLETED|Wash-out (4 Weeks)||27
8574010|NCT00125853|9606405|FG000|NOT COMPLETED|Wash-out (4 Weeks)||0
8574011|NCT00125853|9606406|FG001|NOT COMPLETED|Wash-out (4 Weeks)||0
8574012|NCT00125853|9606405|FG000|STARTED|First Intervention (8 Weeks)||27
8574013|NCT00125853|9606406|FG001|STARTED|First Intervention (8 Weeks)||27
8574014|NCT00125853|9606405|FG000|COMPLETED|First Intervention (8 Weeks)||27
8574015|NCT00125853|9606406|FG001|COMPLETED|First Intervention (8 Weeks)||27
8574016|NCT00125853|9606405|FG000|NOT COMPLETED|First Intervention (8 Weeks)||0
8574017|NCT00125853|9606406|FG001|NOT COMPLETED|First Intervention (8 Weeks)||0
8574018|NCT00125853|9606405|FG000|STARTED|Wash-out (4 Weeks)||27
8574019|NCT00125853|9606406|FG001|STARTED|Wash-out (4 Weeks)||27
8574020|NCT00125853|9606405|FG000|COMPLETED|Wash-out (4 Weeks)||24
8574021|NCT00125853|9606406|FG001|COMPLETED|Wash-out (4 Weeks)||20
8574022|NCT00125853|9606405|FG000|NOT COMPLETED|Wash-out (4 Weeks)||3
8574023|NCT00125853|9606406|FG001|NOT COMPLETED|Wash-out (4 Weeks)||7
8574024|NCT00125853|9606405|FG000|STARTED|Second Intervention (8 Weeks)||24
8574025|NCT00125853|9606406|FG001|STARTED|Second Intervention (8 Weeks)||20
8574026|NCT00125853|9606405|FG000|COMPLETED|Second Intervention (8 Weeks)||24
8574027|NCT00125853|9606406|FG001|COMPLETED|Second Intervention (8 Weeks)||20
8574028|NCT00125853|9606405|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||0
8574029|NCT00125853|9606406|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||0
8574030|NCT00125931|9606412|FG000|STARTED|Overall Study||10
8637057|NCT00570687|9677768|FG005|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
8637058|NCT00570687|9677769|FG006|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
8637059|NCT00570687|9677770|FG007|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
8637060|NCT00570687|9677771|FG008|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
8637061|NCT00570687|9677772|FG009|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
8637062|NCT00570687|9677763|FG000|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
8637063|NCT00570687|9677764|FG001|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
8637064|NCT00570687|9677765|FG002|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
8637065|NCT00570687|9677766|FG003|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
8637066|NCT00570687|9677767|FG004|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
8637067|NCT00570687|9677768|FG005|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
8637068|NCT00570687|9677769|FG006|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
8637069|NCT00570687|9677770|FG007|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
8637070|NCT00570687|9677771|FG008|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
8637071|NCT00570687|9677772|FG009|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
8637072|NCT00570687|9677763|FG000|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
8637073|NCT00570687|9677764|FG001|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
8637074|NCT00570687|9677765|FG002|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
9016024|NCT03045887|10078801|FG008|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
8574031|NCT00125931|9606412|FG000|COMPLETED|Overall Study||10
8574032|NCT00125931|9606412|FG000|NOT COMPLETED|Overall Study||0
8574033|NCT00125957|9606418|FG000|STARTED|First Intervention (3 Weeks)||15
8574034|NCT00125957|9606419|FG001|STARTED|First Intervention (3 Weeks)||17
8574035|NCT00125957|9606418|FG000|COMPLETED|First Intervention (3 Weeks)||15
9016025|NCT03045887|10078802|FG009|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
9016026|NCT03045887|10078793|FG000|STARTED|Part A, Period 3 (1 Day)||3
9016027|NCT03045887|10078794|FG001|STARTED|Part A, Period 3 (1 Day)||4
9016028|NCT03045887|10078795|FG002|STARTED|Part A, Period 3 (1 Day)||4
9016029|NCT03045887|10078796|FG003|STARTED|Part A, Period 3 (1 Day)||2
9016030|NCT03045887|10078797|FG004|STARTED|Part A, Period 3 (1 Day)||4
9016031|NCT03045887|10078798|FG005|STARTED|Part A, Period 3 (1 Day)||4
9016032|NCT03045887|10078799|FG006|STARTED|Part A, Period 3 (1 Day)||4
9016033|NCT03045887|10078800|FG007|STARTED|Part A, Period 3 (1 Day)||4
9016034|NCT03045887|10078801|FG008|STARTED|Part A, Period 3 (1 Day)||0
9016035|NCT03045887|10078802|FG009|STARTED|Part A, Period 3 (1 Day)||0
9016036|NCT03045887|10078793|FG000|COMPLETED|Part A, Period 3 (1 Day)||3
9016037|NCT03045887|10078794|FG001|COMPLETED|Part A, Period 3 (1 Day)||4
9016038|NCT03045887|10078795|FG002|COMPLETED|Part A, Period 3 (1 Day)||4
9016039|NCT03045887|10078796|FG003|COMPLETED|Part A, Period 3 (1 Day)||2
9016040|NCT03045887|10078797|FG004|COMPLETED|Part A, Period 3 (1 Day)||4
9016041|NCT03045887|10078798|FG005|COMPLETED|Part A, Period 3 (1 Day)||4
9016042|NCT03045887|10078799|FG006|COMPLETED|Part A, Period 3 (1 Day)||4
9016043|NCT03045887|10078800|FG007|COMPLETED|Part A, Period 3 (1 Day)||4
9016044|NCT03045887|10078801|FG008|COMPLETED|Part A, Period 3 (1 Day)||0
9016045|NCT03045887|10078802|FG009|COMPLETED|Part A, Period 3 (1 Day)||0
9016046|NCT03045887|10078793|FG000|NOT COMPLETED|Part A, Period 3 (1 Day)||0
9016047|NCT03045887|10078794|FG001|NOT COMPLETED|Part A, Period 3 (1 Day)||0
9016048|NCT03045887|10078795|FG002|NOT COMPLETED|Part A, Period 3 (1 Day)||0
9016049|NCT03045887|10078796|FG003|NOT COMPLETED|Part A, Period 3 (1 Day)||0
9016050|NCT03045887|10078797|FG004|NOT COMPLETED|Part A, Period 3 (1 Day)||0
9016051|NCT03045887|10078798|FG005|NOT COMPLETED|Part A, Period 3 (1 Day)||0
9016052|NCT03045887|10078799|FG006|NOT COMPLETED|Part A, Period 3 (1 Day)||0
9016053|NCT03045887|10078800|FG007|NOT COMPLETED|Part A, Period 3 (1 Day)||0
9016054|NCT03045887|10078801|FG008|NOT COMPLETED|Part A, Period 3 (1 Day)||0
9016055|NCT03045887|10078802|FG009|NOT COMPLETED|Part A, Period 3 (1 Day)||0
9016056|NCT03045887|10078793|FG000|STARTED|Part B (14 Days)||0
9016057|NCT03045887|10078794|FG001|STARTED|Part B (14 Days)||0
9016058|NCT03045887|10078795|FG002|STARTED|Part B (14 Days)||0
9016059|NCT03045887|10078796|FG003|STARTED|Part B (14 Days)||0
9016060|NCT03045887|10078797|FG004|STARTED|Part B (14 Days)||0
9016061|NCT03045887|10078798|FG005|STARTED|Part B (14 Days)||0
9016062|NCT03045887|10078799|FG006|STARTED|Part B (14 Days)||0
9016063|NCT03045887|10078800|FG007|STARTED|Part B (14 Days)||0
9016064|NCT03045887|10078801|FG008|STARTED|Part B (14 Days)||3
9016065|NCT03045887|10078802|FG009|STARTED|Part B (14 Days)||9
9016066|NCT03045887|10078793|FG000|COMPLETED|Part B (14 Days)||0
9016067|NCT03045887|10078794|FG001|COMPLETED|Part B (14 Days)||0
9016068|NCT03045887|10078795|FG002|COMPLETED|Part B (14 Days)||0
9016069|NCT03045887|10078796|FG003|COMPLETED|Part B (14 Days)||0
9016070|NCT03045887|10078797|FG004|COMPLETED|Part B (14 Days)||0
9016071|NCT03045887|10078798|FG005|COMPLETED|Part B (14 Days)||0
9016072|NCT03045887|10078799|FG006|COMPLETED|Part B (14 Days)||0
9016073|NCT03045887|10078800|FG007|COMPLETED|Part B (14 Days)||0
9016074|NCT03045887|10078801|FG008|COMPLETED|Part B (14 Days)||3
9016075|NCT03045887|10078802|FG009|COMPLETED|Part B (14 Days)||9
9016076|NCT03045887|10078793|FG000|NOT COMPLETED|Part B (14 Days)||0
9016077|NCT03045887|10078794|FG001|NOT COMPLETED|Part B (14 Days)||0
9016078|NCT03045887|10078795|FG002|NOT COMPLETED|Part B (14 Days)||0
9016079|NCT03045887|10078796|FG003|NOT COMPLETED|Part B (14 Days)||0
9016080|NCT03045887|10078797|FG004|NOT COMPLETED|Part B (14 Days)||0
9016081|NCT03045887|10078798|FG005|NOT COMPLETED|Part B (14 Days)||0
9016082|NCT03045887|10078799|FG006|NOT COMPLETED|Part B (14 Days)||0
9016083|NCT03045887|10078800|FG007|NOT COMPLETED|Part B (14 Days)||0
9016084|NCT03045887|10078801|FG008|NOT COMPLETED|Part B (14 Days)||0
9016085|NCT03045887|10078802|FG009|NOT COMPLETED|Part B (14 Days)||0
9016086|NCT03045926|10078829|FG000|STARTED|Overall Study||35
9016087|NCT03045926|10078829|FG000|COMPLETED|Overall Study||35
9016088|NCT03045926|10078829|FG000|NOT COMPLETED|Overall Study||0
9016089|NCT03046056|10078836|FG000|STARTED|Overall Study||28
9016090|NCT03046056|10078837|FG001|STARTED|Overall Study||32
9016091|NCT03046056|10078838|FG002|STARTED|Overall Study||18
9016092|NCT03046056|10078836|FG000|COMPLETED|Overall Study||16
9016093|NCT03046056|10078837|FG001|COMPLETED|Overall Study||16
9016094|NCT03046056|10078838|FG002|COMPLETED|Overall Study||11
9016095|NCT03046056|10078836|FG000|NOT COMPLETED|Overall Study||12
9016096|NCT03046056|10078837|FG001|NOT COMPLETED|Overall Study||16
9016097|NCT03046056|10078838|FG002|NOT COMPLETED|Overall Study||7
9016098|NCT03046212|10078848|FG000|STARTED|Overall Study||15
9016099|NCT03046212|10078849|FG001|STARTED|Overall Study||15
9016100|NCT03046212|10078848|FG000|COMPLETED|Overall Study||15
9016101|NCT03046212|10078849|FG001|COMPLETED|Overall Study||15
9016102|NCT03046212|10078848|FG000|NOT COMPLETED|Overall Study||0
9016103|NCT03046212|10078849|FG001|NOT COMPLETED|Overall Study||0
9016104|NCT03046225|10078857|FG000|STARTED|Overall Study||13
9016105|NCT03046225|10078858|FG001|STARTED|Overall Study||13
9016106|NCT03046225|10078857|FG000|COMPLETED|Overall Study||13
9016107|NCT03046225|10078858|FG001|COMPLETED|Overall Study||13
9016108|NCT03046225|10078857|FG000|NOT COMPLETED|Overall Study||0
9016109|NCT03046225|10078858|FG001|NOT COMPLETED|Overall Study||0
9016110|NCT03046446|10078864|FG000|STARTED|Overall Study||208
9016111|NCT03046446|10078864|FG000|Second Injection|Overall Study||179
9016112|NCT03046446|10078864|FG000|Completed at Week 12|Overall Study||10
9016113|NCT03046446|10078864|FG000|Completed at Week 24|Overall Study||6
9016114|NCT03046446|10078864|FG000|Completed at Week 52|Overall Study||133
9016115|NCT03046446|10078864|FG000|COMPLETED|Overall Study||149
9016116|NCT03046446|10078864|FG000|NOT COMPLETED|Overall Study||59
9016117|NCT03046472|10078870|FG000|STARTED|Overall Study||33
9016118|NCT03046472|10078871|FG001|STARTED|Overall Study||17
9016119|NCT03046472|10078870|FG000|COMPLETED|Overall Study||33
9016120|NCT03046472|10078871|FG001|COMPLETED|Overall Study||17
9016121|NCT03046472|10078870|FG000|NOT COMPLETED|Overall Study||0
9016122|NCT03046472|10078871|FG001|NOT COMPLETED|Overall Study||0
9016123|NCT03046966|10078879|FG000|STARTED|Overall Study||51
9016124|NCT03046966|10078880|FG001|STARTED|Overall Study||51
9016125|NCT03046966|10078879|FG000|COMPLETED|Overall Study||51
9016126|NCT03046966|10078880|FG001|COMPLETED|Overall Study||51
9016127|NCT03046966|10078879|FG000|NOT COMPLETED|Overall Study||0
9016128|NCT03046966|10078880|FG001|NOT COMPLETED|Overall Study||0
9016129|NCT03047174|10078888|FG000|STARTED|Overall Study||28
9016130|NCT03047174|10078889|FG001|STARTED|Overall Study||29
9016131|NCT03047174|10078888|FG000|COMPLETED|Overall Study||9
9016132|NCT03047174|10078889|FG001|COMPLETED|Overall Study||27
9016133|NCT03047174|10078888|FG000|NOT COMPLETED|Overall Study||19
9016134|NCT03047174|10078889|FG001|NOT COMPLETED|Overall Study||2
9016135|NCT03047447|10078912|FG000|STARTED|Overall Study||10
9016136|NCT03047447|10078913|FG001|STARTED|Overall Study||10
9016137|NCT03047447|10078914|FG002|STARTED|Overall Study||10
9016138|NCT03047447|10078912|FG000|COMPLETED|Overall Study||10
9016139|NCT03047447|10078913|FG001|COMPLETED|Overall Study||10
9016140|NCT03047447|10078914|FG002|COMPLETED|Overall Study||10
9016141|NCT03047447|10078912|FG000|NOT COMPLETED|Overall Study||0
9016142|NCT03047447|10078913|FG001|NOT COMPLETED|Overall Study||0
9016143|NCT03047447|10078914|FG002|NOT COMPLETED|Overall Study||0
9016144|NCT03047551|10078927|FG000|STARTED|Overall Study||319
9016145|NCT03047551|10078928|FG001|STARTED|Overall Study||315
9016146|NCT03047551|10078927|FG000|COMPLETED|Overall Study||317
9016147|NCT03047551|10078928|FG001|COMPLETED|Overall Study||312
9016148|NCT03047551|10078927|FG000|NOT COMPLETED|Overall Study||2
9016149|NCT03047551|10078928|FG001|NOT COMPLETED|Overall Study||3
9016150|NCT03047720|10078936|FG000|STARTED|First Intervention (6weeks)||12
9016151|NCT03047720|10078937|FG001|STARTED|First Intervention (6weeks)||0
9016152|NCT03047720|10078936|FG000|COMPLETED|First Intervention (6weeks)||5
9016153|NCT03047720|10078937|FG001|COMPLETED|First Intervention (6weeks)||0
9016154|NCT03047720|10078936|FG000|NOT COMPLETED|First Intervention (6weeks)||7
9016155|NCT03047720|10078937|FG001|NOT COMPLETED|First Intervention (6weeks)||0
9016156|NCT03047720|10078936|FG000|STARTED|Second Intervention (6weeks)||0
9016157|NCT03047720|10078937|FG001|STARTED|Second Intervention (6weeks)||0
9016158|NCT03047720|10078936|FG000|COMPLETED|Second Intervention (6weeks)||0
9016159|NCT03047720|10078937|FG001|COMPLETED|Second Intervention (6weeks)||0
9016160|NCT03047720|10078936|FG000|NOT COMPLETED|Second Intervention (6weeks)||0
9016161|NCT03047720|10078937|FG001|NOT COMPLETED|Second Intervention (6weeks)||0
9016162|NCT03047980|10078943|FG000|STARTED|Overall Study||10
9016163|NCT03047980|10078943|FG000|COMPLETED|Overall Study||9
9016164|NCT03047980|10078943|FG000|NOT COMPLETED|Overall Study||1
9016165|NCT03048006|10078947|FG000|STARTED|Overall Study||44456
9016166|NCT03048006|10078947|FG000|COMPLETED|Overall Study||44456
8637075|NCT00570687|9677766|FG003|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
8637076|NCT00570687|9677767|FG004|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
8637077|NCT00570687|9677768|FG005|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
8637078|NCT00570687|9677769|FG006|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
8637079|NCT00570687|9677770|FG007|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
8637080|NCT00570687|9677771|FG008|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
8637081|NCT00570687|9677772|FG009|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
8637082|NCT00570687|9677763|FG000|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
8637083|NCT00570687|9677764|FG001|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
8637084|NCT00570687|9677765|FG002|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
8637085|NCT00570687|9677766|FG003|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
8637086|NCT00570687|9677767|FG004|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
9016167|NCT03048006|10078947|FG000|NOT COMPLETED|Overall Study||0
9016168|NCT03048058|10078953|FG000|STARTED|Overall Study||10
9016169|NCT03048058|10078954|FG001|STARTED|Overall Study||10
9016170|NCT03048058|10078953|FG000|COMPLETED|Overall Study||6
9016171|NCT03048058|10078954|FG001|COMPLETED|Overall Study||6
9016172|NCT03048058|10078953|FG000|NOT COMPLETED|Overall Study||4
9016173|NCT03048058|10078954|FG001|NOT COMPLETED|Overall Study||4
9016174|NCT03048383|10078963|FG000|STARTED|Overall Study||28
9016175|NCT03048383|10078964|FG001|STARTED|Overall Study||21
9016176|NCT03048383|10078965|FG002|STARTED|Overall Study||22
9016177|NCT03048383|10078963|FG000|COMPLETED|Overall Study||15
9016178|NCT03048383|10078964|FG001|COMPLETED|Overall Study||13
9016179|NCT03048383|10078965|FG002|COMPLETED|Overall Study||10
9016180|NCT03048383|10078963|FG000|NOT COMPLETED|Overall Study||13
9016181|NCT03048383|10078964|FG001|NOT COMPLETED|Overall Study||8
9016182|NCT03048383|10078965|FG002|NOT COMPLETED|Overall Study||12
9016183|NCT03048500|10078973|FG000|STARTED|2 Cycles of Treatment||17
9016184|NCT03048500|10078973|FG000|Attempted 1st Cycle|2 Cycles of Treatment||17
9016185|NCT03048500|10078973|FG000|Attempted 2nd Cycle|2 Cycles of Treatment||16
9016186|NCT03048500|10078973|FG000|COMPLETED|2 Cycles of Treatment||16
9016187|NCT03048500|10078973|FG000|NOT COMPLETED|2 Cycles of Treatment||1
9016188|NCT03048500|10078973|FG000|STARTED|Reached 1st Response/Continued Treatment||16
9016189|NCT03048500|10078973|FG000|Assessed for First Response|Reached 1st Response/Continued Treatment||16
9016190|NCT03048500|10078973|FG000|Went on to Cycle 3 and Beyond|Reached 1st Response/Continued Treatment||9
9016191|NCT03048500|10078973|FG000|COMPLETED|Reached 1st Response/Continued Treatment||9
9016192|NCT03048500|10078973|FG000|NOT COMPLETED|Reached 1st Response/Continued Treatment||7
9016193|NCT03048500|10078973|FG000|STARTED|Follow up for 3 Years|1 patient died whilst on study.|16
9016194|NCT03048500|10078973|FG000|COMPLETED|Follow up for 3 Years||0
9016195|NCT03048500|10078973|FG000|NOT COMPLETED|Follow up for 3 Years||16
9016196|NCT03048747|10078977|FG000|STARTED|Overall Study||16
9016197|NCT03048747|10078977|FG000|COMPLETED|Overall Study||11
9016198|NCT03048747|10078977|FG000|NOT COMPLETED|Overall Study||5
9016199|NCT03049215|10078984|FG000|STARTED|Overall Study||1
9016200|NCT03049215|10078985|FG001|STARTED|Overall Study||0
8574036|NCT00125957|9606419|FG001|COMPLETED|First Intervention (3 Weeks)||17
8574037|NCT00125957|9606418|FG000|NOT COMPLETED|First Intervention (3 Weeks)||0
8574038|NCT00125957|9606419|FG001|NOT COMPLETED|First Intervention (3 Weeks)||0
8574039|NCT00125957|9606418|FG000|STARTED|Second Intervention (3 Weeks)||15
8574040|NCT00125957|9606419|FG001|STARTED|Second Intervention (3 Weeks)||17
8574041|NCT00125957|9606418|FG000|COMPLETED|Second Intervention (3 Weeks)||15
8574042|NCT00125957|9606419|FG001|COMPLETED|Second Intervention (3 Weeks)||17
8574043|NCT00125957|9606418|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0
8574044|NCT00125957|9606419|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
8574045|NCT00126113|9606427|FG000|STARTED|Overall Study||37
8574046|NCT00126113|9606428|FG001|STARTED|Overall Study||37
8574047|NCT00126113|9606427|FG000|COMPLETED|Overall Study||34
8574048|NCT00126113|9606428|FG001|COMPLETED|Overall Study||35
8574049|NCT00126113|9606427|FG000|NOT COMPLETED|Overall Study||3
8574050|NCT00126113|9606428|FG001|NOT COMPLETED|Overall Study||2
8574051|NCT00126126|9606436|FG000|STARTED|Overall Study||9
8574052|NCT00126126|9606437|FG001|STARTED|Overall Study||9
8574053|NCT00126126|9606436|FG000|COMPLETED|Overall Study||9
8574054|NCT00126126|9606437|FG001|COMPLETED|Overall Study||7
8574055|NCT00126126|9606436|FG000|NOT COMPLETED|Overall Study||0
8574056|NCT00126126|9606437|FG001|NOT COMPLETED|Overall Study||2
8574057|NCT00126191|9606445|FG000|STARTED|Overall Study||2
8574058|NCT00126191|9606446|FG001|STARTED|Overall Study||8
8574059|NCT00126191|9606445|FG000|COMPLETED|Overall Study||2
8574060|NCT00126191|9606446|FG001|COMPLETED|Overall Study|1 pt off study during cycle 1 due to toxicity|6
8574061|NCT00126191|9606445|FG000|NOT COMPLETED|Overall Study||0
8574062|NCT00126191|9606446|FG001|NOT COMPLETED|Overall Study||2
8574063|NCT00126425|9606454|FG000|STARTED|Overall Study||539
8574064|NCT00126425|9606455|FG001|STARTED|Overall Study||48
8574065|NCT00126425|9606454|FG000|COMPLETED|Overall Study||498
8574066|NCT00126425|9606455|FG001|COMPLETED|Overall Study||37
8574067|NCT00126425|9606454|FG000|NOT COMPLETED|Overall Study||41
8574068|NCT00126425|9606455|FG001|NOT COMPLETED|Overall Study||11
8574069|NCT00126438|9606463|FG000|STARTED|Overall Study||453
8574070|NCT00126438|9606464|FG001|STARTED|Overall Study||62
8574071|NCT00126438|9606463|FG000|COMPLETED|Overall Study||419
8574072|NCT00126438|9606464|FG001|COMPLETED|Overall Study||52
8574073|NCT00126438|9606463|FG000|NOT COMPLETED|Overall Study||34
8574074|NCT00126438|9606464|FG001|NOT COMPLETED|Overall Study||10
8574075|NCT00126490|9606470|FG000|STARTED|Overall Study||19
8574076|NCT00126490|9606470|FG000|COMPLETED|Overall Study||18
8574077|NCT00126490|9606470|FG000|NOT COMPLETED|Overall Study||1
8574078|NCT00126503|9606476|FG000|STARTED|Overall Study||48
8574079|NCT00126503|9606477|FG001|STARTED|Overall Study||21
8574080|NCT00126503|9606476|FG000|COMPLETED|Overall Study||1
8574081|NCT00126503|9606477|FG001|COMPLETED|Overall Study||0
8574082|NCT00126503|9606476|FG000|NOT COMPLETED|Overall Study||47
8574083|NCT00126503|9606477|FG001|NOT COMPLETED|Overall Study||21
8574084|NCT00126555|9606487|FG000|STARTED|Overall Study||23
8574085|NCT00126555|9606487|FG000|Stratum 1- Resectable|Overall Study|1 participant did not participate|18
8574086|NCT00126555|9606487|FG000|Stratum 2- Unresectable|Overall Study||4
8574087|NCT00126555|9606487|FG000|COMPLETED|Overall Study||17
8574088|NCT00126555|9606487|FG000|NOT COMPLETED|Overall Study||6
8574089|NCT00126568|9606503|FG000|STARTED|Overall Study||20
8574090|NCT00126568|9606503|FG000|COMPLETED|Overall Study|Disease progression at beginning of study, not evaluable|18
8574091|NCT00126568|9606503|FG000|NOT COMPLETED|Overall Study||2
8574092|NCT00126581|9606510|FG000|STARTED|Overall Study||81
8574093|NCT00126581|9606511|FG001|STARTED|Overall Study||100
8574094|NCT00126581|9606510|FG000|COMPLETED|Overall Study||68
8574095|NCT00126581|9606511|FG001|COMPLETED|Overall Study||80
8574096|NCT00126581|9606510|FG000|NOT COMPLETED|Overall Study||13
8574097|NCT00126581|9606511|FG001|NOT COMPLETED|Overall Study||20
8637087|NCT00570687|9677768|FG005|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
9016201|NCT03049215|10078984|FG000|COMPLETED|Overall Study||1
9016202|NCT03049215|10078985|FG001|COMPLETED|Overall Study||0
8577597|NCT00159861|9610349|FG001|NOT COMPLETED|Extension Study - up to 3 Years||71
8577598|NCT00159874|9610367|FG000|STARTED|Overall Study||42
8577599|NCT00159874|9610368|FG001|STARTED|Overall Study||55
8577600|NCT00159874|9610369|FG002|STARTED|Overall Study||77
8577601|NCT00159874|9610370|FG003|STARTED|Overall Study||13
8577602|NCT00159874|9610371|FG004|STARTED|Overall Study||19
8577603|NCT00159874|9610372|FG005|STARTED|Overall Study||23
8577604|NCT00159874|9610373|FG006|STARTED|Overall Study||5
9016203|NCT03049215|10078984|FG000|NOT COMPLETED|Overall Study||0
9016204|NCT03049215|10078985|FG001|NOT COMPLETED|Overall Study||0
9016205|NCT03049280|10078991|FG000|STARTED|Overall Study||33
9016206|NCT03049280|10078991|FG000|COMPLETED|Overall Study||32
9016207|NCT03049280|10078991|FG000|NOT COMPLETED|Overall Study||1
9016208|NCT03049488|10079003|FG000|STARTED|Overall Study||15
9016209|NCT03049488|10079004|FG001|STARTED|Overall Study||15
9016210|NCT03049488|10079005|FG002|STARTED|Overall Study||20
9016211|NCT03049488|10079006|FG003|STARTED|Overall Study||15
9016212|NCT03049488|10079007|FG004|STARTED|Overall Study||15
9016213|NCT03049488|10079008|FG005|STARTED|Overall Study||15
9016214|NCT03049488|10079003|FG000|Received First Product Administration|Overall Study||15
9016215|NCT03049488|10079004|FG001|Received First Product Administration|Overall Study||15
9016216|NCT03049488|10079005|FG002|Received First Product Administration|Overall Study||20
9016217|NCT03049488|10079006|FG003|Received First Product Administration|Overall Study||15
9016218|NCT03049488|10079007|FG004|Received First Product Administration|Overall Study||15
9016219|NCT03049488|10079008|FG005|Received First Product Administration|Overall Study||15
9016220|NCT03049488|10079003|FG000|Received Optional Second Dose|Overall Study||10
9016221|NCT03049488|10079004|FG001|Received Optional Second Dose|Overall Study||11
9016222|NCT03049488|10079005|FG002|Received Optional Second Dose|Overall Study||11
9016223|NCT03049488|10079006|FG003|Received Optional Second Dose|Overall Study||9
9016224|NCT03049488|10079007|FG004|Received Optional Second Dose|Overall Study||11
9016225|NCT03049488|10079008|FG005|Received Optional Second Dose|Overall Study||10
9016226|NCT03049488|10079003|FG000|COMPLETED|Overall Study||13
8574098|NCT00126594|9606521|FG000|STARTED|Overall Study||40
8574099|NCT00126594|9606522|FG001|STARTED|Overall Study||40
8574100|NCT00126594|9606521|FG000|COMPLETED|Overall Study||1
8574101|NCT00126594|9606522|FG001|COMPLETED|Overall Study||3
8574102|NCT00126594|9606521|FG000|NOT COMPLETED|Overall Study||39
8574103|NCT00126594|9606522|FG001|NOT COMPLETED|Overall Study||37
8574104|NCT00126737|9606533|FG000|STARTED|Overall Study||28
8574105|NCT00126737|9606534|FG001|STARTED|Overall Study||27
8574106|NCT00126737|9606535|FG002|STARTED|Overall Study||30
8574107|NCT00126737|9606536|FG003|STARTED|Overall Study||25
8574108|NCT00126737|9606533|FG000|COMPLETED|Overall Study||22
8574109|NCT00126737|9606534|FG001|COMPLETED|Overall Study||24
8574110|NCT00126737|9606535|FG002|COMPLETED|Overall Study||24
8637088|NCT00570687|9677769|FG006|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
8637089|NCT00570687|9677770|FG007|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
8637090|NCT00570687|9677771|FG008|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
8637091|NCT00570687|9677772|FG009|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
9016227|NCT03049488|10079004|FG001|COMPLETED|Overall Study||13
9016228|NCT03049488|10079005|FG002|COMPLETED|Overall Study||20
9016229|NCT03049488|10079006|FG003|COMPLETED|Overall Study||13
9016230|NCT03049488|10079007|FG004|COMPLETED|Overall Study||13
9016231|NCT03049488|10079008|FG005|COMPLETED|Overall Study||15
9016232|NCT03049488|10079003|FG000|NOT COMPLETED|Overall Study||2
9016233|NCT03049488|10079004|FG001|NOT COMPLETED|Overall Study||2
9016234|NCT03049488|10079005|FG002|NOT COMPLETED|Overall Study||0
9016235|NCT03049488|10079006|FG003|NOT COMPLETED|Overall Study||2
9016236|NCT03049488|10079007|FG004|NOT COMPLETED|Overall Study||2
9016237|NCT03049488|10079008|FG005|NOT COMPLETED|Overall Study||0
9016238|NCT03049501|10079025|FG000|STARTED|Overall Study||123
9016239|NCT03049501|10079026|FG001|STARTED|Overall Study||121
9016240|NCT03049501|10079025|FG000|6 Month Follow up|Overall Study||107
9016241|NCT03049501|10079026|FG001|6 Month Follow up|Overall Study||91
9016242|NCT03049501|10079025|FG000|12 Month Follow up|Overall Study||101
9016243|NCT03049501|10079026|FG001|12 Month Follow up|Overall Study||92
9016244|NCT03049501|10079025|FG000|COMPLETED|Overall Study||101
9016245|NCT03049501|10079026|FG001|COMPLETED|Overall Study||92
9016246|NCT03049501|10079025|FG000|NOT COMPLETED|Overall Study||22
9016247|NCT03049501|10079026|FG001|NOT COMPLETED|Overall Study||29
9016248|NCT03049748|10079034|FG000|STARTED|Overall Study||20
9016249|NCT03049748|10079035|FG001|STARTED|Overall Study||20
9016250|NCT03049748|10079034|FG000|COMPLETED|Overall Study||16
9016251|NCT03049748|10079035|FG001|COMPLETED|Overall Study||14
9016252|NCT03049748|10079034|FG000|NOT COMPLETED|Overall Study||4
8574111|NCT00126737|9606536|FG003|COMPLETED|Overall Study||18
8574112|NCT00126737|9606533|FG000|NOT COMPLETED|Overall Study||6
8574113|NCT00126737|9606534|FG001|NOT COMPLETED|Overall Study||3
8574114|NCT00126737|9606535|FG002|NOT COMPLETED|Overall Study||6
9016253|NCT03049748|10079035|FG001|NOT COMPLETED|Overall Study||6
9016254|NCT03049852|10079044|FG000|STARTED|Overall Study||24
9016255|NCT03049852|10079045|FG001|STARTED|Overall Study||25
9016256|NCT03049852|10079046|FG002|STARTED|Overall Study||26
9016257|NCT03049852|10079044|FG000|COMPLETED|Overall Study||24
9016258|NCT03049852|10079045|FG001|COMPLETED|Overall Study||24
9016259|NCT03049852|10079046|FG002|COMPLETED|Overall Study||26
9016260|NCT03049852|10079044|FG000|NOT COMPLETED|Overall Study||0
9016261|NCT03049852|10079045|FG001|NOT COMPLETED|Overall Study||1
9016262|NCT03049852|10079046|FG002|NOT COMPLETED|Overall Study||0
9016263|NCT03049917|10079061|FG000|STARTED|Overall Study||90
9016264|NCT03049917|10079062|FG001|STARTED|Overall Study||89
9016265|NCT03049917|10079063|FG002|STARTED|Overall Study||93
9016266|NCT03049917|10079064|FG003|STARTED|Overall Study||92
9016267|NCT03049917|10079065|FG004|STARTED|Overall Study||88
9016268|NCT03049917|10079061|FG000|COMPLETED|Overall Study||31
9016269|NCT03049917|10079062|FG001|COMPLETED|Overall Study||31
9016270|NCT03049917|10079063|FG002|COMPLETED|Overall Study||44
9016271|NCT03049917|10079064|FG003|COMPLETED|Overall Study||51
9016272|NCT03049917|10079065|FG004|COMPLETED|Overall Study||54
9016273|NCT03049917|10079061|FG000|NOT COMPLETED|Overall Study||59
9016274|NCT03049917|10079062|FG001|NOT COMPLETED|Overall Study||58
9016275|NCT03049917|10079063|FG002|NOT COMPLETED|Overall Study||49
9016276|NCT03049917|10079064|FG003|NOT COMPLETED|Overall Study||41
9016277|NCT03049917|10079065|FG004|NOT COMPLETED|Overall Study||34
9016278|NCT03050203|10079101|FG000|STARTED|Overall Study||19
9016279|NCT03050203|10079102|FG001|STARTED|Overall Study||18
9016280|NCT03050203|10079101|FG000|COMPLETED|Overall Study||19
9016281|NCT03050203|10079102|FG001|COMPLETED|Overall Study||18
9016282|NCT03050203|10079101|FG000|NOT COMPLETED|Overall Study||0
9016283|NCT03050203|10079102|FG001|NOT COMPLETED|Overall Study||0
9016284|NCT03050216|10079108|FG000|STARTED|Overall Study||8
9016285|NCT03050216|10079108|FG000|COMPLETED|Overall Study||8
9016286|NCT03050216|10079108|FG000|NOT COMPLETED|Overall Study||0
9016287|NCT03050294|10079116|FG000|STARTED|Overall Study||6
9016288|NCT03050294|10079117|FG001|STARTED|Overall Study||6
9016289|NCT03050294|10079118|FG002|STARTED|Overall Study||6
9016290|NCT03050294|10079119|FG003|STARTED|Overall Study||6
9016291|NCT03050294|10079116|FG000|COMPLETED|Overall Study||6
9016292|NCT03050294|10079117|FG001|COMPLETED|Overall Study||6
9016293|NCT03050294|10079118|FG002|COMPLETED|Overall Study||6
9016294|NCT03050294|10079119|FG003|COMPLETED|Overall Study||6
9016295|NCT03050294|10079116|FG000|NOT COMPLETED|Overall Study||0
9016296|NCT03050294|10079117|FG001|NOT COMPLETED|Overall Study||0
9016297|NCT03050294|10079118|FG002|NOT COMPLETED|Overall Study||0
9016298|NCT03050294|10079119|FG003|NOT COMPLETED|Overall Study||0
8574115|NCT00126737|9606536|FG003|NOT COMPLETED|Overall Study||7
8574116|NCT00126750|9606551|FG000|STARTED|Overall Study|Number of providers from 84 clinics|385
8574117|NCT00126750|9606552|FG001|STARTED|Overall Study|Number of providers from 84 clinics|462
8574118|NCT00126750|9606551|FG000|COMPLETED|Overall Study|Total providers at participating clinic locations were given the option to 'enroll'.|205
8574119|NCT00126750|9606552|FG001|COMPLETED|Overall Study|Total providers at clinic locations were given the option to 'enroll'.|196
8574120|NCT00126750|9606551|FG000|NOT COMPLETED|Overall Study||180
8574121|NCT00126750|9606552|FG001|NOT COMPLETED|Overall Study||266
8574122|NCT00127036|9606560|FG000|STARTED|Overall Study||34
8574123|NCT00127036|9606561|FG001|STARTED|Overall Study||31
8574124|NCT00127036|9606560|FG000|COMPLETED|Overall Study|26 Participants were evaluable.|26
8574125|NCT00127036|9606561|FG001|COMPLETED|Overall Study|20 Participants were evaluable.|20
8574126|NCT00127036|9606560|FG000|NOT COMPLETED|Overall Study||8
8574127|NCT00127036|9606561|FG001|NOT COMPLETED|Overall Study||11
8574128|NCT00127062|9606569|FG000|STARTED|First intervention_Oxford Street||31
8574129|NCT00127062|9606570|FG001|STARTED|First intervention_Oxford Street||29
8574130|NCT00127062|9606569|FG000|COMPLETED|First intervention_Oxford Street||31
8574131|NCT00127062|9606570|FG001|COMPLETED|First intervention_Oxford Street||29
9016299|NCT03050307|10079131|FG000|STARTED|Overall Study||115
9016300|NCT03050307|10079132|FG001|STARTED|Overall Study||119
9016301|NCT03050307|10079131|FG000|COMPLETED|Overall Study||107
9016302|NCT03050307|10079132|FG001|COMPLETED|Overall Study||110
9016303|NCT03050307|10079131|FG000|NOT COMPLETED|Overall Study||8
9016304|NCT03050307|10079132|FG001|NOT COMPLETED|Overall Study||9
9016305|NCT03050320|10079142|FG000|STARTED|Overall Study||21
9016306|NCT03050320|10079143|FG001|STARTED|Overall Study||22
8574132|NCT00127062|9606569|FG000|NOT COMPLETED|First intervention_Oxford Street||0
8574133|NCT00127062|9606570|FG001|NOT COMPLETED|First intervention_Oxford Street||0
8574134|NCT00127062|9606569|FG000|STARTED|Second intervention_Hyde Park||31
8574135|NCT00127062|9606570|FG001|STARTED|Second intervention_Hyde Park||29
8574136|NCT00127062|9606569|FG000|COMPLETED|Second intervention_Hyde Park||31
8574137|NCT00127062|9606570|FG001|COMPLETED|Second intervention_Hyde Park||29
8574138|NCT00127062|9606569|FG000|NOT COMPLETED|Second intervention_Hyde Park||0
8574139|NCT00127062|9606570|FG001|NOT COMPLETED|Second intervention_Hyde Park||0
8574140|NCT00127101|9606586|FG000|STARTED|Base Protocol||3
8574141|NCT00127101|9606587|FG001|STARTED|Base Protocol||5
8574142|NCT00127101|9606588|FG002|STARTED|Base Protocol||3
8574143|NCT00127101|9606589|FG003|STARTED|Base Protocol||3
8574144|NCT00127101|9606590|FG004|STARTED|Base Protocol||5
8574145|NCT00127101|9606591|FG005|STARTED|Base Protocol||4
8574146|NCT00127101|9606586|FG000|COMPLETED|Base Protocol||1
9016307|NCT03050320|10079142|FG000|COMPLETED|Overall Study||20
9016308|NCT03050320|10079143|FG001|COMPLETED|Overall Study||21
9016309|NCT03050320|10079142|FG000|NOT COMPLETED|Overall Study||1
9016310|NCT03050320|10079143|FG001|NOT COMPLETED|Overall Study||1
9016311|NCT03050359|10079151|FG000|STARTED|Overall Study||265
9016312|NCT03050359|10079152|FG001|STARTED|Overall Study||268
9016313|NCT03050359|10079151|FG000|COMPLETED|Overall Study||248
9016314|NCT03050359|10079152|FG001|COMPLETED|Overall Study||248
9016315|NCT03050359|10079151|FG000|NOT COMPLETED|Overall Study||17
9016316|NCT03050359|10079152|FG001|NOT COMPLETED|Overall Study||20
9016317|NCT03050372|10079160|FG000|STARTED|Adaptation Night (Night #1 PSG)||6
9016318|NCT03050372|10079161|FG001|STARTED|Adaptation Night (Night #1 PSG)||6
9016319|NCT03050372|10079160|FG000|COMPLETED|Adaptation Night (Night #1 PSG)|N=1 subject removed from study due to mild sleep apnea during adaptation night|5
9016320|NCT03050372|10079161|FG001|COMPLETED|Adaptation Night (Night #1 PSG)||6
8574147|NCT00127101|9606587|FG001|COMPLETED|Base Protocol||1
8637092|NCT00570687|9677763|FG000|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
8637093|NCT00570687|9677764|FG001|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
8637094|NCT00570687|9677765|FG002|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
8637095|NCT00570687|9677766|FG003|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
8637096|NCT00570687|9677767|FG004|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
8637097|NCT00570687|9677768|FG005|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
8637098|NCT00570687|9677769|FG006|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
8637099|NCT00570687|9677770|FG007|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
8637100|NCT00570687|9677771|FG008|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
8637101|NCT00570687|9677772|FG009|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
8637102|NCT00570687|9677763|FG000|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
8637103|NCT00570687|9677764|FG001|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
8637104|NCT00570687|9677765|FG002|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
8637105|NCT00570687|9677766|FG003|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
8637106|NCT00570687|9677767|FG004|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
8637107|NCT00570687|9677768|FG005|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
8637108|NCT00570687|9677769|FG006|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
8637109|NCT00570687|9677770|FG007|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
8637110|NCT00570687|9677771|FG008|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
8637111|NCT00570687|9677772|FG009|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
8637112|NCT00570687|9677763|FG000|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
8637113|NCT00570687|9677764|FG001|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
8637114|NCT00570687|9677765|FG002|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
8637115|NCT00570687|9677766|FG003|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
8637116|NCT00570687|9677767|FG004|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
8637117|NCT00570687|9677768|FG005|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
8637118|NCT00570687|9677769|FG006|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
8637119|NCT00570687|9677770|FG007|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
8637120|NCT00570687|9677771|FG008|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
8637121|NCT00570687|9677772|FG009|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
8637122|NCT00570687|9677763|FG000|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
8637123|NCT00570687|9677764|FG001|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
8637124|NCT00570687|9677765|FG002|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
8637125|NCT00570687|9677766|FG003|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
8637126|NCT00570687|9677767|FG004|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
8637127|NCT00570687|9677768|FG005|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
8637128|NCT00570687|9677769|FG006|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
8637129|NCT00570687|9677770|FG007|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
8637130|NCT00570687|9677771|FG008|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
8637131|NCT00570687|9677772|FG009|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
8637132|NCT00570687|9677763|FG000|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
8637133|NCT00570687|9677764|FG001|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
8637134|NCT00570687|9677765|FG002|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
8637135|NCT00570687|9677766|FG003|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
8637136|NCT00570687|9677767|FG004|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
8637137|NCT00570687|9677768|FG005|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
8637138|NCT00570687|9677769|FG006|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
8637139|NCT00570687|9677770|FG007|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
8637140|NCT00570687|9677771|FG008|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
8637141|NCT00570687|9677772|FG009|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
8637142|NCT00570687|9677763|FG000|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
8637143|NCT00570687|9677764|FG001|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
8637144|NCT00570687|9677765|FG002|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
8637145|NCT00570687|9677766|FG003|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
9016321|NCT03050372|10079160|FG000|NOT COMPLETED|Adaptation Night (Night #1 PSG)||1
8574148|NCT00127101|9606588|FG002|COMPLETED|Base Protocol||1
8574149|NCT00127101|9606589|FG003|COMPLETED|Base Protocol||3
8574150|NCT00127101|9606590|FG004|COMPLETED|Base Protocol||3
8574151|NCT00127101|9606591|FG005|COMPLETED|Base Protocol||3
8574152|NCT00127101|9606586|FG000|NOT COMPLETED|Base Protocol||2
8574153|NCT00127101|9606587|FG001|NOT COMPLETED|Base Protocol||4
8574154|NCT00127101|9606588|FG002|NOT COMPLETED|Base Protocol||2
8574155|NCT00127101|9606589|FG003|NOT COMPLETED|Base Protocol||0
8574156|NCT00127101|9606590|FG004|NOT COMPLETED|Base Protocol||2
8574157|NCT00127101|9606591|FG005|NOT COMPLETED|Base Protocol||1
9016322|NCT03050372|10079161|FG001|NOT COMPLETED|Adaptation Night (Night #1 PSG)||0
9016323|NCT03050372|10079160|FG000|STARTED|First Intervention (Nights #2 and #3)||5
9016324|NCT03050372|10079161|FG001|STARTED|First Intervention (Nights #2 and #3)||6
9016325|NCT03050372|10079160|FG000|COMPLETED|First Intervention (Nights #2 and #3)||5
9016326|NCT03050372|10079161|FG001|COMPLETED|First Intervention (Nights #2 and #3)||6
9016327|NCT03050372|10079160|FG000|NOT COMPLETED|First Intervention (Nights #2 and #3)||0
9016328|NCT03050372|10079161|FG001|NOT COMPLETED|First Intervention (Nights #2 and #3)||0
9016329|NCT03050372|10079160|FG000|STARTED|Second Intervention (Nights #4 and #5)||5
9016330|NCT03050372|10079161|FG001|STARTED|Second Intervention (Nights #4 and #5)||6
9016331|NCT03050372|10079160|FG000|COMPLETED|Second Intervention (Nights #4 and #5)||5
9016332|NCT03050372|10079161|FG001|COMPLETED|Second Intervention (Nights #4 and #5)|N=1 subject (blind only broken after double-blind analysis) moved out off State; lost to study|5
9016333|NCT03050372|10079160|FG000|NOT COMPLETED|Second Intervention (Nights #4 and #5)||0
9016334|NCT03050372|10079161|FG001|NOT COMPLETED|Second Intervention (Nights #4 and #5)||1
9016335|NCT03050450|10079171|FG000|STARTED|Overall Study||6
9016336|NCT03050450|10079172|FG001|STARTED|Overall Study||0
9016337|NCT03050450|10079173|FG002|STARTED|Overall Study||0
9016338|NCT03050450|10079174|FG003|STARTED|Overall Study||0
9016339|NCT03050450|10079175|FG004|STARTED|Overall Study||0
9016340|NCT03050450|10079171|FG000|COMPLETED|Overall Study||5
9016341|NCT03050450|10079172|FG001|COMPLETED|Overall Study||0
9016342|NCT03050450|10079173|FG002|COMPLETED|Overall Study||0
9016343|NCT03050450|10079174|FG003|COMPLETED|Overall Study||0
9016344|NCT03050450|10079175|FG004|COMPLETED|Overall Study||0
9016345|NCT03050450|10079171|FG000|NOT COMPLETED|Overall Study||1
9016346|NCT03050450|10079172|FG001|NOT COMPLETED|Overall Study||0
9016347|NCT03050450|10079173|FG002|NOT COMPLETED|Overall Study||0
9016348|NCT03050450|10079174|FG003|NOT COMPLETED|Overall Study||0
9016349|NCT03050450|10079175|FG004|NOT COMPLETED|Overall Study||0
9016350|NCT03050541|10079190|FG000|STARTED|Overall Study||28
9016351|NCT03050541|10079191|FG001|STARTED|Overall Study||28
9016352|NCT03050541|10079192|FG002|STARTED|Overall Study||28
9016353|NCT03050541|10079190|FG000|COMPLETED|Overall Study||20
9016354|NCT03050541|10079191|FG001|COMPLETED|Overall Study||20
9016355|NCT03050541|10079192|FG002|COMPLETED|Overall Study||20
9016356|NCT03050541|10079190|FG000|NOT COMPLETED|Overall Study||8
9016357|NCT03050541|10079191|FG001|NOT COMPLETED|Overall Study||8
9016358|NCT03050541|10079192|FG002|NOT COMPLETED|Overall Study||8
9016359|NCT03050619|10079206|FG000|STARTED|Overall Study||129
9016360|NCT03050619|10079207|FG001|STARTED|Overall Study||3926
9016361|NCT03050619|10079208|FG002|STARTED|Overall Study||6416
9016362|NCT03050619|10079209|FG003|STARTED|Overall Study||14007
9016363|NCT03050619|10079210|FG004|STARTED|Overall Study||6079
9016364|NCT03050619|10079211|FG005|STARTED|Overall Study||1351
9016365|NCT03050619|10079206|FG000|COMPLETED|Overall Study||129
9016366|NCT03050619|10079207|FG001|COMPLETED|Overall Study||3926
9016367|NCT03050619|10079208|FG002|COMPLETED|Overall Study||6416
9016368|NCT03050619|10079209|FG003|COMPLETED|Overall Study||14007
9016369|NCT03050619|10079210|FG004|COMPLETED|Overall Study||6079
9016370|NCT03050619|10079211|FG005|COMPLETED|Overall Study||1351
9016371|NCT03050619|10079206|FG000|NOT COMPLETED|Overall Study||0
9016372|NCT03050619|10079207|FG001|NOT COMPLETED|Overall Study||0
9016373|NCT03050619|10079208|FG002|NOT COMPLETED|Overall Study||0
9016374|NCT03050619|10079209|FG003|NOT COMPLETED|Overall Study||0
9016375|NCT03050619|10079210|FG004|NOT COMPLETED|Overall Study||0
9016376|NCT03050619|10079211|FG005|NOT COMPLETED|Overall Study||0
9016377|NCT03050697|10079225|FG000|STARTED|Overall Study||12
9016378|NCT03050697|10079225|FG000|COMPLETED|Overall Study||12
9016379|NCT03050697|10079225|FG000|NOT COMPLETED|Overall Study||0
9016380|NCT03050775|10079243|FG000|STARTED|Overall Study||35
9016381|NCT03050775|10079244|FG001|STARTED|Overall Study||35
9016382|NCT03050775|10079243|FG000|COMPLETED|Overall Study||35
9016383|NCT03050775|10079244|FG001|COMPLETED|Overall Study||35
9016384|NCT03050775|10079243|FG000|NOT COMPLETED|Overall Study||0
9016385|NCT03050775|10079244|FG001|NOT COMPLETED|Overall Study||0
9016386|NCT03050801|10079256|FG000|STARTED|Experiment 1||3
9016387|NCT03050801|10079257|FG001|STARTED|Experiment 1||13
9016388|NCT03050801|10079258|FG002|STARTED|Experiment 1||8
9016389|NCT03050801|10079259|FG003|STARTED|Experiment 1||0
9016390|NCT03050801|10079260|FG004|STARTED|Experiment 1||0
9016391|NCT03050801|10079261|FG005|STARTED|Experiment 1||0
9016392|NCT03050801|10079256|FG000|COMPLETED|Experiment 1||3
9016393|NCT03050801|10079257|FG001|COMPLETED|Experiment 1||6
9016394|NCT03050801|10079258|FG002|COMPLETED|Experiment 1||6
9016395|NCT03050801|10079259|FG003|COMPLETED|Experiment 1||0
9016396|NCT03050801|10079260|FG004|COMPLETED|Experiment 1||0
9016397|NCT03050801|10079261|FG005|COMPLETED|Experiment 1||0
9016398|NCT03050801|10079256|FG000|NOT COMPLETED|Experiment 1||0
9016399|NCT03050801|10079257|FG001|NOT COMPLETED|Experiment 1||7
9016400|NCT03050801|10079258|FG002|NOT COMPLETED|Experiment 1||2
9016401|NCT03050801|10079259|FG003|NOT COMPLETED|Experiment 1||0
9016402|NCT03050801|10079260|FG004|NOT COMPLETED|Experiment 1||0
9016403|NCT03050801|10079261|FG005|NOT COMPLETED|Experiment 1||0
9016404|NCT03050801|10079256|FG000|STARTED|Experiment 2||0
9016405|NCT03050801|10079257|FG001|STARTED|Experiment 2||0
9016406|NCT03050801|10079258|FG002|STARTED|Experiment 2||0
9016407|NCT03050801|10079259|FG003|STARTED|Experiment 2||21
9016408|NCT03050801|10079260|FG004|STARTED|Experiment 2||19
9039766|NCT03341312|10100670|FG003|COMPLETED|Period 4||8
9039767|NCT03341312|10100667|FG000|NOT COMPLETED|Period 4||0
9016409|NCT03050801|10079261|FG005|STARTED|Experiment 2|Experiment 2 (Prefrontal Cortex Stimulation) was terminated early due to adverse events (intolerance of stimulation) in 2 of 4 participants.|4
9016410|NCT03050801|10079256|FG000|COMPLETED|Experiment 2||0
9016411|NCT03050801|10079257|FG001|COMPLETED|Experiment 2||0
8574158|NCT00127101|9606586|FG000|STARTED|Continuation Phase||0
8574159|NCT00127101|9606587|FG001|STARTED|Continuation Phase||0
8574160|NCT00127101|9606588|FG002|STARTED|Continuation Phase||1
8574161|NCT00127101|9606589|FG003|STARTED|Continuation Phase|No patients from the 2b Cohort entered into the extension phase|0
8574162|NCT00127101|9606590|FG004|STARTED|Continuation Phase||3
8574163|NCT00127101|9606591|FG005|STARTED|Continuation Phase||3
8574164|NCT00127101|9606586|FG000|COMPLETED|Continuation Phase||0
8574165|NCT00127101|9606587|FG001|COMPLETED|Continuation Phase||0
8574166|NCT00127101|9606588|FG002|COMPLETED|Continuation Phase||0
8574167|NCT00127101|9606589|FG003|COMPLETED|Continuation Phase||0
8574168|NCT00127101|9606590|FG004|COMPLETED|Continuation Phase||0
8574169|NCT00127101|9606591|FG005|COMPLETED|Continuation Phase||0
8574170|NCT00127101|9606586|FG000|NOT COMPLETED|Continuation Phase||0
8574171|NCT00127101|9606587|FG001|NOT COMPLETED|Continuation Phase||0
8574172|NCT00127101|9606588|FG002|NOT COMPLETED|Continuation Phase||1
8574173|NCT00127101|9606589|FG003|NOT COMPLETED|Continuation Phase||0
8574174|NCT00127101|9606590|FG004|NOT COMPLETED|Continuation Phase||3
8574175|NCT00127101|9606591|FG005|NOT COMPLETED|Continuation Phase||3
8574176|NCT00127166|9606607|FG000|STARTED|Period I||78
8574177|NCT00127166|9606608|FG001|STARTED|Period I||76
8574178|NCT00127166|9606607|FG000|COMPLETED|Period I||75
8574179|NCT00127166|9606608|FG001|COMPLETED|Period I||74
8574180|NCT00127166|9606607|FG000|NOT COMPLETED|Period I||3
8574181|NCT00127166|9606608|FG001|NOT COMPLETED|Period I||2
8574182|NCT00127166|9606607|FG000|STARTED|Washout Period||75
8574183|NCT00127166|9606608|FG001|STARTED|Washout Period||74
8574184|NCT00127166|9606607|FG000|COMPLETED|Washout Period||75
8574185|NCT00127166|9606608|FG001|COMPLETED|Washout Period||73
8574186|NCT00127166|9606607|FG000|NOT COMPLETED|Washout Period||0
8574187|NCT00127166|9606608|FG001|NOT COMPLETED|Washout Period||1
8574188|NCT00127166|9606607|FG000|STARTED|Period II||75
8574189|NCT00127166|9606608|FG001|STARTED|Period II||73
8574190|NCT00127166|9606607|FG000|COMPLETED|Period II||72
8574191|NCT00127166|9606608|FG001|COMPLETED|Period II||73
8574192|NCT00127166|9606607|FG000|NOT COMPLETED|Period II||3
8574193|NCT00127166|9606608|FG001|NOT COMPLETED|Period II||0
8574194|NCT00127192|9606619|FG000|STARTED|Overall Study|Study enrolled slightly more than the target of N=70|80
8574195|NCT00127192|9606620|FG001|STARTED|Overall Study|Study enrolled slightly more than the target of N=70|72
8574196|NCT00127192|9606621|FG002|STARTED|Overall Study|Study enrolled as per the target of N=70|70
8574197|NCT00127192|9606622|FG003|STARTED|Overall Study|Study enrolled slightly less than the target of N=70|68
8574198|NCT00127192|9606623|FG004|STARTED|Overall Study|Study enrolled slightly more than the target of N=70|73
8574199|NCT00127192|9606619|FG000|COMPLETED|Overall Study||77
8574200|NCT00127192|9606620|FG001|COMPLETED|Overall Study||71
8574201|NCT00127192|9606621|FG002|COMPLETED|Overall Study||68
8574202|NCT00127192|9606622|FG003|COMPLETED|Overall Study||67
8574203|NCT00127192|9606623|FG004|COMPLETED|Overall Study||68
8574204|NCT00127192|9606619|FG000|NOT COMPLETED|Overall Study||3
8574205|NCT00127192|9606620|FG001|NOT COMPLETED|Overall Study||1
8574206|NCT00127192|9606621|FG002|NOT COMPLETED|Overall Study||2
8574207|NCT00127192|9606622|FG003|NOT COMPLETED|Overall Study||1
8574208|NCT00127192|9606623|FG004|NOT COMPLETED|Overall Study||5
8574209|NCT00127205|9606638|FG000|STARTED|Overall Study||2262
8574210|NCT00127205|9606639|FG001|STARTED|Overall Study||2268
8574211|NCT00127205|9606640|FG002|STARTED|Overall Study||1567
8574212|NCT00127205|9606638|FG000|COMPLETED|Overall Study||1433
8574213|NCT00127205|9606639|FG001|COMPLETED|Overall Study||1295
8637146|NCT00570687|9677767|FG004|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
8637147|NCT00570687|9677768|FG005|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
8637148|NCT00570687|9677769|FG006|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
8637149|NCT00570687|9677770|FG007|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
8637150|NCT00570687|9677771|FG008|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
8637151|NCT00570687|9677772|FG009|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
8637152|NCT00570687|9677763|FG000|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
9016412|NCT03050801|10079258|FG002|COMPLETED|Experiment 2||0
9016413|NCT03050801|10079259|FG003|COMPLETED|Experiment 2||15
9016414|NCT03050801|10079260|FG004|COMPLETED|Experiment 2||15
9016415|NCT03050801|10079261|FG005|COMPLETED|Experiment 2||2
9016416|NCT03050801|10079256|FG000|NOT COMPLETED|Experiment 2||0
9016417|NCT03050801|10079257|FG001|NOT COMPLETED|Experiment 2||0
9016418|NCT03050801|10079258|FG002|NOT COMPLETED|Experiment 2||0
8574214|NCT00127205|9606640|FG002|COMPLETED|Overall Study||955
8574215|NCT00127205|9606638|FG000|NOT COMPLETED|Overall Study||829
8574216|NCT00127205|9606639|FG001|NOT COMPLETED|Overall Study||973
8574217|NCT00127205|9606640|FG002|NOT COMPLETED|Overall Study||612
8574218|NCT00127218|9606652|FG000|STARTED|Overall Study||72
8574219|NCT00127218|9606653|FG001|STARTED|Overall Study||73
8574220|NCT00127218|9606652|FG000|COMPLETED|Overall Study||59
8574221|NCT00127218|9606653|FG001|COMPLETED|Overall Study||58
8574222|NCT00127218|9606652|FG000|NOT COMPLETED|Overall Study||13
8574223|NCT00127218|9606653|FG001|NOT COMPLETED|Overall Study||15
8574224|NCT00127231|9606663|FG000|STARTED|Overall Study||74
8574225|NCT00127231|9606664|FG001|STARTED|Overall Study||74
8574226|NCT00127231|9606663|FG000|COMPLETED|Overall Study||68
9016419|NCT03050801|10079259|FG003|NOT COMPLETED|Experiment 2||6
9016420|NCT03050801|10079260|FG004|NOT COMPLETED|Experiment 2||4
9016421|NCT03050801|10079261|FG005|NOT COMPLETED|Experiment 2||2
9016422|NCT03050918|10079280|FG000|STARTED|Overall Study||1534
9016423|NCT03050918|10079281|FG001|STARTED|Overall Study||1520
9016424|NCT03050918|10079280|FG000|COMPLETED|Overall Study||1534
9016425|NCT03050918|10079281|FG001|COMPLETED|Overall Study||1520
9016426|NCT03050918|10079280|FG000|NOT COMPLETED|Overall Study||0
9016427|NCT03050918|10079281|FG001|NOT COMPLETED|Overall Study||0
9016428|NCT03051100|10079289|FG000|STARTED|Overall Study||20
9016429|NCT03051100|10079290|FG001|STARTED|Overall Study||43
9016430|NCT03051100|10079289|FG000|COMPLETED|Overall Study||19
9016431|NCT03051100|10079290|FG001|COMPLETED|Overall Study||43
9016432|NCT03051100|10079289|FG000|NOT COMPLETED|Overall Study||1
8574227|NCT00127231|9606664|FG001|COMPLETED|Overall Study||68
8574228|NCT00127231|9606663|FG000|NOT COMPLETED|Overall Study||6
8574229|NCT00127231|9606664|FG001|NOT COMPLETED|Overall Study||6
8574230|NCT00127413|9606674|FG000|STARTED|Overall Study||12
8574231|NCT00127413|9606675|FG001|STARTED|Overall Study||10
8574232|NCT00127413|9606676|FG002|STARTED|Overall Study||13
8574233|NCT00127413|9606677|FG003|STARTED|Overall Study||7
8574234|NCT00127413|9606674|FG000|COMPLETED|Overall Study||6
8574235|NCT00127413|9606675|FG001|COMPLETED|Overall Study||6
8574236|NCT00127413|9606676|FG002|COMPLETED|Overall Study||5
8574237|NCT00127413|9606677|FG003|COMPLETED|Overall Study||5
8574238|NCT00127413|9606674|FG000|NOT COMPLETED|Overall Study||6
8574239|NCT00127413|9606675|FG001|NOT COMPLETED|Overall Study||4
8574240|NCT00127413|9606676|FG002|NOT COMPLETED|Overall Study||8
8574241|NCT00127413|9606677|FG003|NOT COMPLETED|Overall Study||2
8574242|NCT00127439|9606689|FG000|STARTED|Overall Study||9
8574243|NCT00127439|9606690|FG001|STARTED|Overall Study||10
8574244|NCT00127439|9606689|FG000|COMPLETED|Overall Study||9
8574245|NCT00127439|9606690|FG001|COMPLETED|Overall Study||10
8574246|NCT00127439|9606689|FG000|NOT COMPLETED|Overall Study||0
8574247|NCT00127439|9606690|FG001|NOT COMPLETED|Overall Study||0
8574248|NCT00127530|9606701|FG000|STARTED|Overall Study||72
8574249|NCT00127530|9606702|FG001|STARTED|Overall Study||228
8574250|NCT00127530|9606701|FG000|COMPLETED|Overall Study||71
8574251|NCT00127530|9606702|FG001|COMPLETED|Overall Study||207
8574252|NCT00127530|9606701|FG000|NOT COMPLETED|Overall Study||1
8574253|NCT00127530|9606702|FG001|NOT COMPLETED|Overall Study||21
8574254|NCT00127608|9606708|FG000|STARTED|Overall Study||36
8574255|NCT00127608|9606708|FG000|COMPLETED|Overall Study||35
8574256|NCT00127608|9606708|FG000|NOT COMPLETED|Overall Study||1
8574257|NCT00127660|9606716|FG000|STARTED|Overall Study||153
8574258|NCT00127660|9606717|FG001|STARTED|Overall Study||154
8574259|NCT00127660|9606718|FG002|STARTED|Overall Study||148
8574260|NCT00127660|9606719|FG003|STARTED|Overall Study||150
8574261|NCT00127660|9606716|FG000|COMPLETED|Overall Study||150
8574262|NCT00127660|9606717|FG001|COMPLETED|Overall Study||151
8574263|NCT00127660|9606718|FG002|COMPLETED|Overall Study||143
8574264|NCT00127660|9606719|FG003|COMPLETED|Overall Study||150
8574265|NCT00127660|9606716|FG000|NOT COMPLETED|Overall Study||3
8574266|NCT00127660|9606717|FG001|NOT COMPLETED|Overall Study||3
8574267|NCT00127660|9606718|FG002|NOT COMPLETED|Overall Study||5
8574268|NCT00127660|9606719|FG003|NOT COMPLETED|Overall Study||0
8574269|NCT00127712|9606731|FG000|STARTED|Overall Study||65
8574270|NCT00127712|9606732|FG001|STARTED|Overall Study||65
8574271|NCT00127712|9606731|FG000|COMPLETED|Overall Study||60
8574272|NCT00127712|9606732|FG001|COMPLETED|Overall Study||65
8574273|NCT00127712|9606731|FG000|NOT COMPLETED|Overall Study||5
8574274|NCT00127712|9606732|FG001|NOT COMPLETED|Overall Study||0
8574275|NCT00127790|9606742|FG000|STARTED|Pre-Treatment|7 enrolled subjects were withdrawn prior to randomization; 21 of 28 enrolled were randomized.|6
8574276|NCT00127790|9606743|FG001|STARTED|Pre-Treatment||5
8574277|NCT00127790|9606744|FG002|STARTED|Pre-Treatment||6
8574278|NCT00127790|9606745|FG003|STARTED|Pre-Treatment||4
8574279|NCT00127790|9606742|FG000|COMPLETED|Pre-Treatment||6
8574280|NCT00127790|9606743|FG001|COMPLETED|Pre-Treatment||5
8574281|NCT00127790|9606744|FG002|COMPLETED|Pre-Treatment||6
8574282|NCT00127790|9606745|FG003|COMPLETED|Pre-Treatment||4
8574283|NCT00127790|9606742|FG000|NOT COMPLETED|Pre-Treatment||0
8574284|NCT00127790|9606743|FG001|NOT COMPLETED|Pre-Treatment||0
8574285|NCT00127790|9606744|FG002|NOT COMPLETED|Pre-Treatment||0
8574286|NCT00127790|9606745|FG003|NOT COMPLETED|Pre-Treatment||0
8574287|NCT00127790|9606742|FG000|STARTED|Post-Treatment||6
9016433|NCT03051100|10079290|FG001|NOT COMPLETED|Overall Study||0
8574288|NCT00127790|9606743|FG001|STARTED|Post-Treatment||5
8574289|NCT00127790|9606744|FG002|STARTED|Post-Treatment||6
8574290|NCT00127790|9606745|FG003|STARTED|Post-Treatment||4
8574291|NCT00127790|9606742|FG000|COMPLETED|Post-Treatment||6
8574292|NCT00127790|9606743|FG001|COMPLETED|Post-Treatment||5
8574293|NCT00127790|9606744|FG002|COMPLETED|Post-Treatment||6
8574294|NCT00127790|9606745|FG003|COMPLETED|Post-Treatment||4
8574295|NCT00127790|9606742|FG000|NOT COMPLETED|Post-Treatment||0
8574296|NCT00127790|9606743|FG001|NOT COMPLETED|Post-Treatment||0
8574297|NCT00127790|9606744|FG002|NOT COMPLETED|Post-Treatment||0
8574298|NCT00127790|9606745|FG003|NOT COMPLETED|Post-Treatment||0
8574299|NCT00127803|9606759|FG000|STARTED|Overall Study||13
8574300|NCT00127803|9606760|FG001|STARTED|Overall Study||13
8574301|NCT00127803|9606761|FG002|STARTED|Overall Study||12
8574302|NCT00127803|9606762|FG003|STARTED|Overall Study||12
8574303|NCT00127803|9606759|FG000|COMPLETED|Overall Study||10
9016434|NCT03051165|10079296|FG000|STARTED|Overall Study||13
9016435|NCT03051165|10079296|FG000|Completed Some Baseline Assessments|Overall Study||1
9016436|NCT03051165|10079296|FG000|Completed Some Day 105 Assessments|Overall Study||1
9016437|NCT03051165|10079296|FG000|Began HGNS Treatment Withdrawal|Overall Study||0
9016438|NCT03051165|10079296|FG000|Completed Some Day 137 Assessments|Overall Study||0
8574304|NCT00127803|9606760|FG001|COMPLETED|Overall Study||13
8574305|NCT00127803|9606761|FG002|COMPLETED|Overall Study||12
8574306|NCT00127803|9606762|FG003|COMPLETED|Overall Study||11
8574307|NCT00127803|9606759|FG000|NOT COMPLETED|Overall Study||3
8574308|NCT00127803|9606760|FG001|NOT COMPLETED|Overall Study||0
8574309|NCT00127803|9606761|FG002|NOT COMPLETED|Overall Study||0
8574310|NCT00127803|9606762|FG003|NOT COMPLETED|Overall Study||1
8574311|NCT00127842|9606772|FG000|STARTED|Overall Study||110
8574312|NCT00127842|9606772|FG000|COMPLETED|Overall Study||71
8574313|NCT00127842|9606772|FG000|NOT COMPLETED|Overall Study||39
8574314|NCT00127855|9606781|FG000|STARTED|Primary Vaccination Course||82
8574315|NCT00127855|9606782|FG001|STARTED|Primary Vaccination Course||82
8574316|NCT00127855|9606783|FG002|STARTED|Primary Vaccination Course||80
8574317|NCT00127855|9606784|FG003|STARTED|Primary Vaccination Course||81
8574318|NCT00127855|9606785|FG004|STARTED|Primary Vaccination Course||82
8574319|NCT00127855|9606781|FG000|COMPLETED|Primary Vaccination Course||80
8574320|NCT00127855|9606782|FG001|COMPLETED|Primary Vaccination Course||81
8574321|NCT00127855|9606783|FG002|COMPLETED|Primary Vaccination Course||78
8574322|NCT00127855|9606784|FG003|COMPLETED|Primary Vaccination Course||81
8574323|NCT00127855|9606785|FG004|COMPLETED|Primary Vaccination Course||78
8574324|NCT00127855|9606781|FG000|NOT COMPLETED|Primary Vaccination Course||2
8574325|NCT00127855|9606782|FG001|NOT COMPLETED|Primary Vaccination Course||1
8574326|NCT00127855|9606783|FG002|NOT COMPLETED|Primary Vaccination Course||2
8574327|NCT00127855|9606784|FG003|NOT COMPLETED|Primary Vaccination Course||0
8574328|NCT00127855|9606785|FG004|NOT COMPLETED|Primary Vaccination Course||4
8574329|NCT00127855|9606781|FG000|STARTED|Polysaccharide Challenge Dose||80
8574330|NCT00127855|9606782|FG001|STARTED|Polysaccharide Challenge Dose||79
8574331|NCT00127855|9606783|FG002|STARTED|Polysaccharide Challenge Dose||77
8574332|NCT00127855|9606784|FG003|STARTED|Polysaccharide Challenge Dose||81
8637153|NCT00570687|9677764|FG001|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
8637154|NCT00570687|9677765|FG002|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
8637155|NCT00570687|9677766|FG003|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
8637156|NCT00570687|9677767|FG004|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
8637157|NCT00570687|9677768|FG005|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
8637158|NCT00570687|9677769|FG006|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
8637159|NCT00570687|9677770|FG007|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
8637160|NCT00570687|9677771|FG008|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
8637161|NCT00570687|9677772|FG009|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
8637162|NCT00570687|9677763|FG000|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
8637163|NCT00570687|9677764|FG001|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
8637164|NCT00570687|9677765|FG002|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
8637165|NCT00570687|9677766|FG003|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
8637166|NCT00570687|9677767|FG004|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
8637167|NCT00570687|9677768|FG005|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
8637168|NCT00570687|9677769|FG006|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
8637169|NCT00570687|9677770|FG007|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
8637170|NCT00570687|9677771|FG008|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
8637171|NCT00570687|9677772|FG009|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
8637172|NCT00570687|9677763|FG000|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
8637173|NCT00570687|9677764|FG001|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
8637174|NCT00570687|9677765|FG002|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
8637175|NCT00570687|9677766|FG003|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
8637176|NCT00570687|9677767|FG004|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
8637177|NCT00570687|9677768|FG005|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
9016439|NCT03051165|10079296|FG000|COMPLETED|Overall Study||0
9016440|NCT03051165|10079296|FG000|NOT COMPLETED|Overall Study||13
9016441|NCT03051256|10079303|FG000|STARTED|Overall Study||19
9016442|NCT03051256|10079304|FG001|STARTED|Overall Study||21
9016443|NCT03051256|10079305|FG002|STARTED|Overall Study||22
9016444|NCT03051256|10079303|FG000|COMPLETED|Overall Study||19
9016445|NCT03051256|10079304|FG001|COMPLETED|Overall Study||21
9016446|NCT03051256|10079305|FG002|COMPLETED|Overall Study||21
9016447|NCT03051256|10079303|FG000|NOT COMPLETED|Overall Study||0
9016448|NCT03051256|10079304|FG001|NOT COMPLETED|Overall Study||0
9016449|NCT03051256|10079305|FG002|NOT COMPLETED|Overall Study||1
9016450|NCT03051607|10079314|FG000|STARTED|Overall Study||66
9016451|NCT03051607|10079314|FG000|COMPLETED|Overall Study||0
9016452|NCT03051607|10079314|FG000|NOT COMPLETED|Overall Study||66
9016453|NCT03051620|10079318|FG000|STARTED|Overall Study||142
8574333|NCT00127855|9606785|FG004|STARTED|Polysaccharide Challenge Dose||77
8574334|NCT00127855|9606781|FG000|COMPLETED|Polysaccharide Challenge Dose||80
8574335|NCT00127855|9606782|FG001|COMPLETED|Polysaccharide Challenge Dose||79
8574336|NCT00127855|9606783|FG002|COMPLETED|Polysaccharide Challenge Dose||77
8574337|NCT00127855|9606784|FG003|COMPLETED|Polysaccharide Challenge Dose||81
8574338|NCT00127855|9606785|FG004|COMPLETED|Polysaccharide Challenge Dose||77
9016454|NCT03051620|10079318|FG000|COMPLETED|Overall Study||124
9016455|NCT03051620|10079318|FG000|NOT COMPLETED|Overall Study||18
9016456|NCT03051633|10079324|FG000|STARTED|Overall Study||342
9016457|NCT03051633|10079325|FG001|STARTED|Overall Study||186
9016458|NCT03051633|10079324|FG000|COMPLETED|Overall Study||249
9016459|NCT03051633|10079325|FG001|COMPLETED|Overall Study||179
9016460|NCT03051633|10079324|FG000|NOT COMPLETED|Overall Study||93
9016461|NCT03051633|10079325|FG001|NOT COMPLETED|Overall Study||7
9016462|NCT03051646|10079333|FG000|STARTED|Overall Study||6
9016463|NCT03051646|10079334|FG001|STARTED|Overall Study||6
9016464|NCT03051646|10079333|FG000|COMPLETED|Overall Study||6
9016465|NCT03051646|10079334|FG001|COMPLETED|Overall Study||6
9016466|NCT03051646|10079333|FG000|NOT COMPLETED|Overall Study||0
9016467|NCT03051646|10079334|FG001|NOT COMPLETED|Overall Study||0
9016468|NCT03051672|10079342|FG000|STARTED|Overall Study||8
8637178|NCT00570687|9677769|FG006|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
8637179|NCT00570687|9677770|FG007|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
8637180|NCT00570687|9677771|FG008|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
8637181|NCT00570687|9677772|FG009|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
8637182|NCT00570687|9677763|FG000|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
8637183|NCT00570687|9677764|FG001|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
8637184|NCT00570687|9677765|FG002|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
8637185|NCT00570687|9677766|FG003|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
8637186|NCT00570687|9677767|FG004|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
8574339|NCT00127855|9606781|FG000|NOT COMPLETED|Polysaccharide Challenge Dose||0
8574340|NCT00127855|9606782|FG001|NOT COMPLETED|Polysaccharide Challenge Dose||0
8574341|NCT00127855|9606783|FG002|NOT COMPLETED|Polysaccharide Challenge Dose||0
8574342|NCT00127855|9606784|FG003|NOT COMPLETED|Polysaccharide Challenge Dose||0
8574343|NCT00127855|9606785|FG004|NOT COMPLETED|Polysaccharide Challenge Dose||0
8574344|NCT00127933|9606799|FG000|STARTED|Overall Study||123
9016469|NCT03051672|10079342|FG000|Began Treatment|Overall Study||8
9016470|NCT03051672|10079342|FG000|COMPLETED|Overall Study||8
9016471|NCT03051672|10079342|FG000|NOT COMPLETED|Overall Study||0
9016472|NCT03052257|10079349|FG000|STARTED|Overall Study||100
9016473|NCT03052257|10079350|FG001|STARTED|Overall Study||100
9016474|NCT03052257|10079349|FG000|COMPLETED|Overall Study||95
9016475|NCT03052257|10079350|FG001|COMPLETED|Overall Study||97
9016476|NCT03052257|10079349|FG000|NOT COMPLETED|Overall Study||5
9016477|NCT03052257|10079350|FG001|NOT COMPLETED|Overall Study||3
9016478|NCT03052322|10079358|FG000|STARTED|Overall Study||143
9016479|NCT03052322|10079359|FG001|STARTED|Overall Study||145
9016480|NCT03052322|10079358|FG000|COMPLETED|Overall Study||122
9016481|NCT03052322|10079359|FG001|COMPLETED|Overall Study||113
9016482|NCT03052322|10079358|FG000|NOT COMPLETED|Overall Study||21
9016483|NCT03052322|10079359|FG001|NOT COMPLETED|Overall Study||32
9016484|NCT03052426|10079368|FG000|STARTED|Overall Study||6
9016485|NCT03052426|10079369|FG001|STARTED|Overall Study||6
9016486|NCT03052426|10079370|FG002|STARTED|Overall Study||6
9016487|NCT03052426|10079368|FG000|COMPLETED|Overall Study||4
9016488|NCT03052426|10079369|FG001|COMPLETED|Overall Study||5
9016489|NCT03052426|10079370|FG002|COMPLETED|Overall Study||5
9016490|NCT03052426|10079368|FG000|NOT COMPLETED|Overall Study||2
9016491|NCT03052426|10079369|FG001|NOT COMPLETED|Overall Study||1
9016492|NCT03052426|10079370|FG002|NOT COMPLETED|Overall Study||1
9016493|NCT03052517|10079386|FG000|STARTED|Overall Study||1093
9016494|NCT03052517|10079387|FG001|STARTED|Overall Study||1085
9016495|NCT03052517|10079388|FG002|STARTED|Overall Study||360
9016496|NCT03052517|10079386|FG000|Safety Set (SAF)|Overall Study|One patient received placebo. This patient was not included in QAW039 150 mg group in the SAF|1092
9016497|NCT03052517|10079387|FG001|Safety Set (SAF)|Overall Study|One patient had no treatment administered and thus was excluded from the SAF|1084
9016498|NCT03052517|10079388|FG002|Safety Set (SAF)|Overall Study|One patient in QAW039 150 mg group received placebo and was included in the placebo group in the SAF|361
9016499|NCT03052517|10079386|FG000|COMPLETED|Overall Study||76
9016500|NCT03052517|10079387|FG001|COMPLETED|Overall Study||71
9016501|NCT03052517|10079388|FG002|COMPLETED|Overall Study||32
9016502|NCT03052517|10079386|FG000|NOT COMPLETED|Overall Study||1017
9016503|NCT03052517|10079387|FG001|NOT COMPLETED|Overall Study||1014
8574345|NCT00127933|9606800|FG001|STARTED|Overall Study||34
8637187|NCT00570687|9677768|FG005|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
8637188|NCT00570687|9677769|FG006|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||1
8637189|NCT00570687|9677770|FG007|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
8637190|NCT00570687|9677771|FG008|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||1
8637191|NCT00570687|9677772|FG009|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
8637192|NCT00570687|9677763|FG000|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
8637193|NCT00570687|9677764|FG001|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
8637194|NCT00570687|9677765|FG002|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
8637195|NCT00570687|9677766|FG003|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
8637196|NCT00570687|9677767|FG004|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
8637197|NCT00570687|9677768|FG005|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
8637198|NCT00570687|9677769|FG006|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||2
8637199|NCT00570687|9677770|FG007|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
8574346|NCT00127933|9606799|FG000|Pathological Response|Overall Study||101
8574347|NCT00127933|9606800|FG001|Pathological Response|Overall Study||28
8574348|NCT00127933|9606799|FG000|Clinical Response|Overall Study||122
9016504|NCT03052517|10079388|FG002|NOT COMPLETED|Overall Study||328
9016505|NCT03052530|10079396|FG000|STARTED|Overall Study||61
9016506|NCT03052530|10079396|FG000|COMPLETED|Overall Study||61
8574349|NCT00127933|9606800|FG001|Clinical Response|Overall Study||34
8574350|NCT00127933|9606799|FG000|Safety Population|Overall Study||122
8574351|NCT00127933|9606800|FG001|Safety Population|Overall Study||34
8574352|NCT00127933|9606799|FG000|Quality of Life Population|Overall Study||118
8574353|NCT00127933|9606800|FG001|Quality of Life Population|Overall Study||33
8574354|NCT00127933|9606799|FG000|Postoperative|Overall Study||98
8574355|NCT00127933|9606800|FG001|Postoperative|Overall Study||27
8574356|NCT00127933|9606799|FG000|COMPLETED|Overall Study||122
8574357|NCT00127933|9606800|FG001|COMPLETED|Overall Study||34
8574358|NCT00127933|9606799|FG000|NOT COMPLETED|Overall Study||1
8574359|NCT00127933|9606800|FG001|NOT COMPLETED|Overall Study||0
8574360|NCT00128102|9606808|FG000|STARTED|Overall Study||329
8574361|NCT00128102|9606809|FG001|STARTED|Overall Study||332
8574362|NCT00128102|9606808|FG000|Treated|Overall Study||329
8574363|NCT00128102|9606809|FG001|Treated|Overall Study||329
8574364|NCT00128102|9606808|FG000|COMPLETED|Overall Study||1
8574365|NCT00128102|9606809|FG001|COMPLETED|Overall Study||0
8574366|NCT00128102|9606808|FG000|NOT COMPLETED|Overall Study||328
8574367|NCT00128102|9606809|FG001|NOT COMPLETED|Overall Study||332
8574368|NCT00128180|9606817|FG000|STARTED|Overall Study||32
8574369|NCT00128180|9606818|FG001|STARTED|Overall Study||34
8574370|NCT00128180|9606817|FG000|COMPLETED|Overall Study||32
8574371|NCT00128180|9606818|FG001|COMPLETED|Overall Study||34
8574372|NCT00128180|9606817|FG000|NOT COMPLETED|Overall Study||0
8574373|NCT00128180|9606818|FG001|NOT COMPLETED|Overall Study||0
8574374|NCT00128193|9606836|FG000|STARTED|Overall Study||5
8574375|NCT00128193|9606837|FG001|STARTED|Overall Study||5
8574376|NCT00128193|9606838|FG002|STARTED|Overall Study||45
8574377|NCT00128193|9606839|FG003|STARTED|Overall Study||45
8574378|NCT00128193|9606840|FG004|STARTED|Overall Study||20
8574379|NCT00128193|9606841|FG005|STARTED|Overall Study||20
8574380|NCT00128193|9606842|FG006|STARTED|Overall Study||20
8574381|NCT00128193|9606843|FG007|STARTED|Overall Study||20
8574382|NCT00128193|9606844|FG008|STARTED|Overall Study||20
8574383|NCT00128193|9606845|FG009|STARTED|Overall Study||20
8574384|NCT00128193|9606846|FG010|STARTED|Overall Study||20
8574385|NCT00128193|9606847|FG011|STARTED|Overall Study||20
8574386|NCT00128193|9606836|FG000|COMPLETED|Overall Study||5
8574387|NCT00128193|9606837|FG001|COMPLETED|Overall Study||5
8574388|NCT00128193|9606838|FG002|COMPLETED|Overall Study||42
8574389|NCT00128193|9606839|FG003|COMPLETED|Overall Study||44
8574390|NCT00128193|9606840|FG004|COMPLETED|Overall Study||18
8574391|NCT00128193|9606841|FG005|COMPLETED|Overall Study||17
8574392|NCT00128193|9606842|FG006|COMPLETED|Overall Study||16
8574393|NCT00128193|9606843|FG007|COMPLETED|Overall Study||20
8574394|NCT00128193|9606844|FG008|COMPLETED|Overall Study||18
8574395|NCT00128193|9606845|FG009|COMPLETED|Overall Study||18
8574396|NCT00128193|9606846|FG010|COMPLETED|Overall Study||17
8574397|NCT00128193|9606847|FG011|COMPLETED|Overall Study||18
8574398|NCT00128193|9606836|FG000|NOT COMPLETED|Overall Study||0
8574399|NCT00128193|9606837|FG001|NOT COMPLETED|Overall Study||0
8574400|NCT00128193|9606838|FG002|NOT COMPLETED|Overall Study||3
8574401|NCT00128193|9606839|FG003|NOT COMPLETED|Overall Study||1
8574402|NCT00128193|9606840|FG004|NOT COMPLETED|Overall Study||2
8574403|NCT00128193|9606841|FG005|NOT COMPLETED|Overall Study||3
8574404|NCT00128193|9606842|FG006|NOT COMPLETED|Overall Study||4
8574405|NCT00128193|9606843|FG007|NOT COMPLETED|Overall Study||0
8574406|NCT00128193|9606844|FG008|NOT COMPLETED|Overall Study||2
9016507|NCT03052530|10079396|FG000|NOT COMPLETED|Overall Study||0
9016508|NCT03052725|10079402|FG000|STARTED|Overall Study||194
9016509|NCT03052725|10079403|FG001|STARTED|Overall Study||197
9016510|NCT03052725|10079402|FG000|Safety Analysis Set|Overall Study||194
9016511|NCT03052725|10079403|FG001|Safety Analysis Set|Overall Study||196
9016512|NCT03052725|10079402|FG000|COMPLETED|Overall Study||46
9016513|NCT03052725|10079403|FG001|COMPLETED|Overall Study||47
9016514|NCT03052725|10079402|FG000|NOT COMPLETED|Overall Study||148
9016515|NCT03052725|10079403|FG001|NOT COMPLETED|Overall Study||150
9016516|NCT03052751|10079410|FG000|STARTED|Dosing Period 1||22
9016517|NCT03052751|10079411|FG001|STARTED|Dosing Period 1||21
9016518|NCT03052751|10079412|FG002|STARTED|Dosing Period 1||0
9016519|NCT03052751|10079413|FG003|STARTED|Dosing Period 1||0
9016520|NCT03052751|10079414|FG004|STARTED|Dosing Period 1||0
9016521|NCT03052751|10079415|FG005|STARTED|Dosing Period 1||0
9016522|NCT03052751|10079410|FG000|Completed Period 1|Dosing Period 1||22
9016523|NCT03052751|10079411|FG001|Completed Period 1|Dosing Period 1||21
9016524|NCT03052751|10079412|FG002|Completed Period 1|Dosing Period 1||0
9016525|NCT03052751|10079413|FG003|Completed Period 1|Dosing Period 1||0
9016526|NCT03052751|10079414|FG004|Completed Period 1|Dosing Period 1||0
9016527|NCT03052751|10079415|FG005|Completed Period 1|Dosing Period 1||0
9016528|NCT03052751|10079410|FG000|Completed Period 1 and Started Period 2|Dosing Period 1||22
9016529|NCT03052751|10079411|FG001|Completed Period 1 and Started Period 2|Dosing Period 1||20
9016530|NCT03052751|10079412|FG002|Completed Period 1 and Started Period 2|Dosing Period 1||0
9016531|NCT03052751|10079413|FG003|Completed Period 1 and Started Period 2|Dosing Period 1||0
9016532|NCT03052751|10079414|FG004|Completed Period 1 and Started Period 2|Dosing Period 1||0
9016533|NCT03052751|10079415|FG005|Completed Period 1 and Started Period 2|Dosing Period 1||0
9016534|NCT03052751|10079410|FG000|COMPLETED|Dosing Period 1||22
9016535|NCT03052751|10079411|FG001|COMPLETED|Dosing Period 1||20
9016536|NCT03052751|10079412|FG002|COMPLETED|Dosing Period 1||0
9016537|NCT03052751|10079413|FG003|COMPLETED|Dosing Period 1||0
9016538|NCT03052751|10079414|FG004|COMPLETED|Dosing Period 1||0
9016539|NCT03052751|10079415|FG005|COMPLETED|Dosing Period 1||0
9016540|NCT03052751|10079410|FG000|NOT COMPLETED|Dosing Period 1||0
9016541|NCT03052751|10079411|FG001|NOT COMPLETED|Dosing Period 1||1
9016542|NCT03052751|10079412|FG002|NOT COMPLETED|Dosing Period 1||0
9016543|NCT03052751|10079413|FG003|NOT COMPLETED|Dosing Period 1||0
9016544|NCT03052751|10079414|FG004|NOT COMPLETED|Dosing Period 1||0
9016545|NCT03052751|10079415|FG005|NOT COMPLETED|Dosing Period 1||0
9016546|NCT03052751|10079410|FG000|STARTED|Dosing Period 2||0
9016547|NCT03052751|10079411|FG001|STARTED|Dosing Period 2||0
9016548|NCT03052751|10079412|FG002|STARTED|Dosing Period 2||11
9016549|NCT03052751|10079413|FG003|STARTED|Dosing Period 2||11
9016550|NCT03052751|10079414|FG004|STARTED|Dosing Period 2||10
9016551|NCT03052751|10079415|FG005|STARTED|Dosing Period 2||10
9016552|NCT03052751|10079410|FG000|COMPLETED|Dosing Period 2||0
9016553|NCT03052751|10079411|FG001|COMPLETED|Dosing Period 2||0
9016554|NCT03052751|10079412|FG002|COMPLETED|Dosing Period 2||8
9016555|NCT03052751|10079413|FG003|COMPLETED|Dosing Period 2||11
9016556|NCT03052751|10079414|FG004|COMPLETED|Dosing Period 2||10
9016557|NCT03052751|10079415|FG005|COMPLETED|Dosing Period 2||10
9016558|NCT03052751|10079410|FG000|NOT COMPLETED|Dosing Period 2||0
9016559|NCT03052751|10079411|FG001|NOT COMPLETED|Dosing Period 2||0
9016560|NCT03052751|10079412|FG002|NOT COMPLETED|Dosing Period 2||3
9016561|NCT03052751|10079413|FG003|NOT COMPLETED|Dosing Period 2||0
9016562|NCT03052751|10079414|FG004|NOT COMPLETED|Dosing Period 2||0
9016563|NCT03052751|10079415|FG005|NOT COMPLETED|Dosing Period 2||0
9016564|NCT03052751|10079410|FG000|STARTED|Observation Period||22
9016565|NCT03052751|10079411|FG001|STARTED|Observation Period||21
9016566|NCT03052751|10079412|FG002|STARTED|Observation Period||11
9016567|NCT03052751|10079413|FG003|STARTED|Observation Period||11
9016568|NCT03052751|10079414|FG004|STARTED|Observation Period||10
9016569|NCT03052751|10079415|FG005|STARTED|Observation Period||10
8574407|NCT00128193|9606845|FG009|NOT COMPLETED|Overall Study||2
8574408|NCT00128193|9606846|FG010|NOT COMPLETED|Overall Study||3
8574409|NCT00128193|9606847|FG011|NOT COMPLETED|Overall Study||2
8574410|NCT00128206|9606929|FG000|STARTED|Overall Study||184
8574411|NCT00128206|9606930|FG001|STARTED|Overall Study||180
8574412|NCT00128206|9606929|FG000|COMPLETED|Overall Study||47
8574413|NCT00128206|9606930|FG001|COMPLETED|Overall Study||60
8574414|NCT00128206|9606929|FG000|NOT COMPLETED|Overall Study||137
8574415|NCT00128206|9606930|FG001|NOT COMPLETED|Overall Study||120
8574416|NCT00128219|9606938|FG000|STARTED|Overall Study||333
8574417|NCT00128219|9606939|FG001|STARTED|Overall Study||334
8574418|NCT00128219|9606938|FG000|COMPLETED|Overall Study||264
8574419|NCT00128219|9606939|FG001|COMPLETED|Overall Study||263
8574420|NCT00128219|9606938|FG000|NOT COMPLETED|Overall Study||69
8574421|NCT00128219|9606939|FG001|NOT COMPLETED|Overall Study||71
8574422|NCT00128401|9606947|FG000|STARTED|Overall Study||20
8574423|NCT00128401|9606948|FG001|STARTED|Overall Study||19
8574424|NCT00128401|9606947|FG000|COMPLETED|Overall Study||14
8574425|NCT00128401|9606948|FG001|COMPLETED|Overall Study||15
8574426|NCT00128401|9606947|FG000|NOT COMPLETED|Overall Study||6
8574427|NCT00128401|9606948|FG001|NOT COMPLETED|Overall Study||4
8574428|NCT00128492|9606957|FG000|STARTED|Overall Study||85
8574429|NCT00128492|9606958|FG001|STARTED|Overall Study||189
8574430|NCT00128492|9606957|FG000|COMPLETED|Overall Study||65
8574431|NCT00128492|9606958|FG001|COMPLETED|Overall Study||130
9016570|NCT03052751|10079410|FG000|COMPLETED|Observation Period||22
9016571|NCT03052751|10079411|FG001|COMPLETED|Observation Period||21
9016572|NCT03052751|10079412|FG002|COMPLETED|Observation Period||11
9016573|NCT03052751|10079413|FG003|COMPLETED|Observation Period||11
9016574|NCT03052751|10079414|FG004|COMPLETED|Observation Period||9
8574432|NCT00128492|9606957|FG000|NOT COMPLETED|Overall Study||20
8574433|NCT00128492|9606958|FG001|NOT COMPLETED|Overall Study||59
8574434|NCT00128661|9606966|FG000|STARTED|Overall Study||3727
8574435|NCT00128661|9606967|FG001|STARTED|Overall Study||3739
8574436|NCT00128661|9606966|FG000|COMPLETED|Overall Study||3453
9016575|NCT03052751|10079415|FG005|COMPLETED|Observation Period||10
8574437|NCT00128661|9606967|FG001|COMPLETED|Overall Study||3481
8574438|NCT00128661|9606966|FG000|NOT COMPLETED|Overall Study||274
8574439|NCT00128661|9606967|FG001|NOT COMPLETED|Overall Study||258
8574440|NCT00128713|9606976|FG000|STARTED|Overall Study||453
8574441|NCT00128713|9606977|FG001|STARTED|Overall Study||449
8574442|NCT00128713|9606978|FG002|STARTED|Overall Study||449
9016576|NCT03052751|10079410|FG000|NOT COMPLETED|Observation Period||0
9016577|NCT03052751|10079411|FG001|NOT COMPLETED|Observation Period||0
9016578|NCT03052751|10079412|FG002|NOT COMPLETED|Observation Period||0
9016579|NCT03052751|10079413|FG003|NOT COMPLETED|Observation Period||0
9016580|NCT03052751|10079414|FG004|NOT COMPLETED|Observation Period||1
9016581|NCT03052751|10079415|FG005|NOT COMPLETED|Observation Period||0
9016582|NCT03052764|10079427|FG000|STARTED|Double-Blind Treatment Period||80
9016583|NCT03052764|10079428|FG001|STARTED|Double-Blind Treatment Period||40
9016584|NCT03052764|10079427|FG000|mITT|Double-Blind Treatment Period||78
9016585|NCT03052764|10079428|FG001|mITT|Double-Blind Treatment Period||39
9016586|NCT03052764|10079427|FG000|COMPLETED|Double-Blind Treatment Period||70
9016587|NCT03052764|10079428|FG001|COMPLETED|Double-Blind Treatment Period||37
9016588|NCT03052764|10079427|FG000|NOT COMPLETED|Double-Blind Treatment Period||10
9016589|NCT03052764|10079428|FG001|NOT COMPLETED|Double-Blind Treatment Period||3
9016590|NCT03052764|10079427|FG000|STARTED|Open-Label Re-Treatment Period||58
9016591|NCT03052764|10079428|FG001|STARTED|Open-Label Re-Treatment Period||33
9016592|NCT03052764|10079427|FG000|COMPLETED|Open-Label Re-Treatment Period||58
9016593|NCT03052764|10079428|FG001|COMPLETED|Open-Label Re-Treatment Period||33
9016594|NCT03052764|10079427|FG000|NOT COMPLETED|Open-Label Re-Treatment Period||0
9016595|NCT03052764|10079428|FG001|NOT COMPLETED|Open-Label Re-Treatment Period||0
9016596|NCT03052816|10079438|FG000|STARTED|Overall Study||33
9016597|NCT03052816|10079439|FG001|STARTED|Overall Study||33
9016598|NCT03052816|10079438|FG000|COMPLETED|Overall Study||30
9016599|NCT03052816|10079439|FG001|COMPLETED|Overall Study||33
9016600|NCT03052816|10079438|FG000|NOT COMPLETED|Overall Study||3
9016601|NCT03052816|10079439|FG001|NOT COMPLETED|Overall Study||0
9016602|NCT03052959|10079449|FG000|STARTED|Overall Study||59
9016603|NCT03052959|10079450|FG001|STARTED|Overall Study||66
9016604|NCT03052959|10079449|FG000|COMPLETED|Overall Study||55
9016605|NCT03052959|10079450|FG001|COMPLETED|Overall Study||61
9016606|NCT03052959|10079449|FG000|NOT COMPLETED|Overall Study||4
9016607|NCT03052959|10079450|FG001|NOT COMPLETED|Overall Study||5
9016608|NCT03052972|10079459|FG000|STARTED|Overall Study||18
9016609|NCT03052972|10079460|FG001|STARTED|Overall Study||5
9016610|NCT03052972|10079459|FG000|COMPLETED|Overall Study||18
9016611|NCT03052972|10079460|FG001|COMPLETED|Overall Study||5
9016612|NCT03052972|10079459|FG000|NOT COMPLETED|Overall Study||0
9016613|NCT03052972|10079460|FG001|NOT COMPLETED|Overall Study||0
9016614|NCT03053050|10079470|FG000|STARTED|Randomized Phase||324
9016615|NCT03053050|10079471|FG001|STARTED|Randomized Phase||323
9016616|NCT03053050|10079472|FG002|STARTED|Randomized Phase||161
9016617|NCT03053050|10079473|FG003|STARTED|Randomized Phase||0
9016618|NCT03053050|10079470|FG000|COMPLETED|Randomized Phase||0
9016619|NCT03053050|10079471|FG001|COMPLETED|Randomized Phase||0
9016620|NCT03053050|10079472|FG002|COMPLETED|Randomized Phase||0
9016621|NCT03053050|10079473|FG003|COMPLETED|Randomized Phase||0
9016622|NCT03053050|10079470|FG000|NOT COMPLETED|Randomized Phase||324
9016623|NCT03053050|10079471|FG001|NOT COMPLETED|Randomized Phase||323
9016624|NCT03053050|10079472|FG002|NOT COMPLETED|Randomized Phase||161
9016625|NCT03053050|10079473|FG003|NOT COMPLETED|Randomized Phase||0
9016626|NCT03053050|10079470|FG000|STARTED|Open-label Phase||0
9016627|NCT03053050|10079471|FG001|STARTED|Open-label Phase||0
9016628|NCT03053050|10079472|FG002|STARTED|Open-label Phase||0
9016629|NCT03053050|10079473|FG003|STARTED|Open-label Phase|Participants with hepatic clinical event or progression to cirrhosis had option to go into OL Phase.|99
9016630|NCT03053050|10079470|FG000|COMPLETED|Open-label Phase||0
9016631|NCT03053050|10079471|FG001|COMPLETED|Open-label Phase||0
9016632|NCT03053050|10079472|FG002|COMPLETED|Open-label Phase||0
9016633|NCT03053050|10079473|FG003|COMPLETED|Open-label Phase||0
9016634|NCT03053050|10079470|FG000|NOT COMPLETED|Open-label Phase||0
9016635|NCT03053050|10079471|FG001|NOT COMPLETED|Open-label Phase||0
9016636|NCT03053050|10079472|FG002|NOT COMPLETED|Open-label Phase||0
9016637|NCT03053050|10079473|FG003|NOT COMPLETED|Open-label Phase||99
9016638|NCT03053063|10079485|FG000|STARTED|Randomized Phase||355
9016639|NCT03053063|10079486|FG001|STARTED|Randomized Phase||354
9016640|NCT03053063|10079487|FG002|STARTED|Randomized Phase||174
9016641|NCT03053063|10079488|FG003|STARTED|Randomized Phase||0
9016642|NCT03053063|10079485|FG000|COMPLETED|Randomized Phase||0
9016643|NCT03053063|10079486|FG001|COMPLETED|Randomized Phase||0
9016644|NCT03053063|10079487|FG002|COMPLETED|Randomized Phase||0
9016645|NCT03053063|10079488|FG003|COMPLETED|Randomized Phase||0
9016646|NCT03053063|10079485|FG000|NOT COMPLETED|Randomized Phase||355
9016647|NCT03053063|10079486|FG001|NOT COMPLETED|Randomized Phase||354
9016648|NCT03053063|10079487|FG002|NOT COMPLETED|Randomized Phase||174
9016649|NCT03053063|10079488|FG003|NOT COMPLETED|Randomized Phase||0
9016650|NCT03053063|10079485|FG000|STARTED|Open-Label Phase||0
9016651|NCT03053063|10079486|FG001|STARTED|Open-Label Phase||0
9016652|NCT03053063|10079487|FG002|STARTED|Open-Label Phase||0
9016653|NCT03053063|10079488|FG003|STARTED|Open-Label Phase|Participants who experienced a hepatic clinical event had the option to roll over into the OL Phase.|23
9016654|NCT03053063|10079485|FG000|COMPLETED|Open-Label Phase||0
9016655|NCT03053063|10079486|FG001|COMPLETED|Open-Label Phase||0
9016656|NCT03053063|10079487|FG002|COMPLETED|Open-Label Phase||0
9016657|NCT03053063|10079488|FG003|COMPLETED|Open-Label Phase||0
9016658|NCT03053063|10079485|FG000|NOT COMPLETED|Open-Label Phase||0
9016659|NCT03053063|10079486|FG001|NOT COMPLETED|Open-Label Phase||0
9016660|NCT03053063|10079487|FG002|NOT COMPLETED|Open-Label Phase||0
9016661|NCT03053063|10079488|FG003|NOT COMPLETED|Open-Label Phase||23
9016662|NCT03053102|10079497|FG000|STARTED|Study Part 1: 28-Day Treatment||10
9016663|NCT03053102|10079497|FG000|Received at Least 1 Dose of Study Drug|Study Part 1: 28-Day Treatment||10
9016664|NCT03053102|10079497|FG000|COMPLETED|Study Part 1: 28-Day Treatment||10
9016665|NCT03053102|10079497|FG000|NOT COMPLETED|Study Part 1: 28-Day Treatment||0
9016666|NCT03053102|10079497|FG000|STARTED|Study Part 2: 84-Day Treatment||10
9016667|NCT03053102|10079497|FG000|COMPLETED|Study Part 2: 84-Day Treatment||8
9016668|NCT03053102|10079497|FG000|NOT COMPLETED|Study Part 2: 84-Day Treatment||2
9016669|NCT03053180|10079502|FG000|STARTED|Overall Study||60
9016670|NCT03053180|10079502|FG000|COMPLETED|Overall Study||59
9016671|NCT03053180|10079502|FG000|NOT COMPLETED|Overall Study||1
9016672|NCT03053271|10079506|FG000|STARTED|Overall Study||4
9016673|NCT03053271|10079506|FG000|COMPLETED|Overall Study|All completed the open-label dose escalation, but did not meet criteria for randomization|0
9016674|NCT03053271|10079506|FG000|NOT COMPLETED|Overall Study||4
9016675|NCT03053401|10079512|FG000|STARTED|Overall Study||26
9016676|NCT03053401|10079513|FG001|STARTED|Overall Study||26
9016677|NCT03053401|10079512|FG000|COMPLETED|Overall Study||26
9016678|NCT03053401|10079513|FG001|COMPLETED|Overall Study||26
9016679|NCT03053401|10079512|FG000|NOT COMPLETED|Overall Study||0
9016680|NCT03053401|10079513|FG001|NOT COMPLETED|Overall Study||0
9016681|NCT03053427|10079522|FG000|STARTED|Overall Study||186
9016682|NCT03053427|10079523|FG001|STARTED|Overall Study||189
9016683|NCT03053427|10079522|FG000|COMPLETED|Overall Study||173
9016684|NCT03053427|10079523|FG001|COMPLETED|Overall Study||173
9016685|NCT03053427|10079522|FG000|NOT COMPLETED|Overall Study||13
9016686|NCT03053427|10079523|FG001|NOT COMPLETED|Overall Study||16
9016687|NCT03053492|10079531|FG000|STARTED|Overall Study||33
9016688|NCT03053492|10079532|FG001|STARTED|Overall Study||33
9016689|NCT03053492|10079531|FG000|COMPLETED|Overall Study||25
9016690|NCT03053492|10079532|FG001|COMPLETED|Overall Study||27
9016691|NCT03053492|10079531|FG000|NOT COMPLETED|Overall Study||8
9016692|NCT03053492|10079532|FG001|NOT COMPLETED|Overall Study||6
9016693|NCT03054051|10079540|FG000|STARTED|Overall Study||30
9016694|NCT03054051|10079541|FG001|STARTED|Overall Study||30
9016695|NCT03054051|10079540|FG000|COMPLETED|Overall Study||30
9016696|NCT03054051|10079541|FG001|COMPLETED|Overall Study||30
9016697|NCT03054051|10079540|FG000|NOT COMPLETED|Overall Study||0
9016698|NCT03054051|10079541|FG001|NOT COMPLETED|Overall Study||0
9016699|NCT03054064|10079549|FG000|STARTED|Overall Study||48
9016700|NCT03054064|10079549|FG000|Screen Failure|Overall Study||2
9016701|NCT03054064|10079549|FG000|COMPLETED|Overall Study||42
9016702|NCT03054064|10079549|FG000|NOT COMPLETED|Overall Study||6
9016703|NCT03054077|10079555|FG000|STARTED|Overall Study||12
9016704|NCT03054077|10079556|FG001|STARTED|Overall Study||12
9016705|NCT03054077|10079555|FG000|COMPLETED|Overall Study||12
9016706|NCT03054077|10079556|FG001|COMPLETED|Overall Study||12
9016707|NCT03054077|10079555|FG000|NOT COMPLETED|Overall Study||0
9016708|NCT03054077|10079556|FG001|NOT COMPLETED|Overall Study||0
9016709|NCT03054103|10079565|FG000|STARTED|Overall Study||41
9016710|NCT03054103|10079566|FG001|STARTED|Overall Study||29
9016711|NCT03054103|10079567|FG002|STARTED|Overall Study||35
9016712|NCT03054103|10079565|FG000|COMPLETED|Overall Study||41
9016713|NCT03054103|10079566|FG001|COMPLETED|Overall Study||29
9016714|NCT03054103|10079567|FG002|COMPLETED|Overall Study||35
9016715|NCT03054103|10079565|FG000|NOT COMPLETED|Overall Study||0
9016716|NCT03054103|10079566|FG001|NOT COMPLETED|Overall Study||0
9016717|NCT03054103|10079567|FG002|NOT COMPLETED|Overall Study||0
9016718|NCT03054337|10079581|FG000|STARTED|Primary Efficacy Period (6 Weeks)||12
9016719|NCT03054337|10079582|FG001|STARTED|Primary Efficacy Period (6 Weeks)||12
9016720|NCT03054337|10079583|FG002|STARTED|Primary Efficacy Period (6 Weeks)||13
9016721|NCT03054337|10079584|FG003|STARTED|Primary Efficacy Period (6 Weeks)||5
9016722|NCT03054337|10079585|FG004|STARTED|Primary Efficacy Period (6 Weeks)||4
9016723|NCT03054337|10079586|FG005|STARTED|Primary Efficacy Period (6 Weeks)||5
9016724|NCT03054337|10079581|FG000|COMPLETED|Primary Efficacy Period (6 Weeks)||12
9016725|NCT03054337|10079582|FG001|COMPLETED|Primary Efficacy Period (6 Weeks)||12
9016726|NCT03054337|10079583|FG002|COMPLETED|Primary Efficacy Period (6 Weeks)||13
9016727|NCT03054337|10079584|FG003|COMPLETED|Primary Efficacy Period (6 Weeks)||5
9016728|NCT03054337|10079585|FG004|COMPLETED|Primary Efficacy Period (6 Weeks)||4
9016729|NCT03054337|10079586|FG005|COMPLETED|Primary Efficacy Period (6 Weeks)||5
9016730|NCT03054337|10079581|FG000|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||0
9016731|NCT03054337|10079582|FG001|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||0
9016732|NCT03054337|10079583|FG002|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||0
9016733|NCT03054337|10079584|FG003|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||0
8574443|NCT00128713|9606976|FG000|COMPLETED|Overall Study||453
9016734|NCT03054337|10079585|FG004|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||0
9016735|NCT03054337|10079586|FG005|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||0
9016736|NCT03054337|10079581|FG000|STARTED|Dose Adjustment and Maintenance Period||12
9016737|NCT03054337|10079582|FG001|STARTED|Dose Adjustment and Maintenance Period||12
9016738|NCT03054337|10079583|FG002|STARTED|Dose Adjustment and Maintenance Period||13
9016739|NCT03054337|10079584|FG003|STARTED|Dose Adjustment and Maintenance Period||5
9016740|NCT03054337|10079585|FG004|STARTED|Dose Adjustment and Maintenance Period||4
9016741|NCT03054337|10079586|FG005|STARTED|Dose Adjustment and Maintenance Period||5
9016742|NCT03054337|10079581|FG000|COMPLETED|Dose Adjustment and Maintenance Period||11
9016743|NCT03054337|10079582|FG001|COMPLETED|Dose Adjustment and Maintenance Period||10
8574444|NCT00128713|9606977|FG001|COMPLETED|Overall Study||449
9016744|NCT03054337|10079583|FG002|COMPLETED|Dose Adjustment and Maintenance Period||12
9016745|NCT03054337|10079584|FG003|COMPLETED|Dose Adjustment and Maintenance Period||5
9016746|NCT03054337|10079585|FG004|COMPLETED|Dose Adjustment and Maintenance Period||4
9016747|NCT03054337|10079586|FG005|COMPLETED|Dose Adjustment and Maintenance Period||4
9016748|NCT03054337|10079581|FG000|NOT COMPLETED|Dose Adjustment and Maintenance Period||1
9016749|NCT03054337|10079582|FG001|NOT COMPLETED|Dose Adjustment and Maintenance Period||2
9016750|NCT03054337|10079583|FG002|NOT COMPLETED|Dose Adjustment and Maintenance Period||1
9016751|NCT03054337|10079584|FG003|NOT COMPLETED|Dose Adjustment and Maintenance Period||0
9016752|NCT03054337|10079585|FG004|NOT COMPLETED|Dose Adjustment and Maintenance Period||0
9016753|NCT03054337|10079586|FG005|NOT COMPLETED|Dose Adjustment and Maintenance Period||1
9016754|NCT03054350|10079619|FG000|STARTED|Primary Efficacy Period (6 Weeks)||15
9016755|NCT03054350|10079620|FG001|STARTED|Primary Efficacy Period (6 Weeks)||15
9016756|NCT03054350|10079621|FG002|STARTED|Primary Efficacy Period (6 Weeks)||15
9016757|NCT03054350|10079622|FG003|STARTED|Primary Efficacy Period (6 Weeks)||5
9016758|NCT03054350|10079623|FG004|STARTED|Primary Efficacy Period (6 Weeks)||5
9016759|NCT03054350|10079624|FG005|STARTED|Primary Efficacy Period (6 Weeks)||5
9016760|NCT03054350|10079619|FG000|COMPLETED|Primary Efficacy Period (6 Weeks)||11
9016761|NCT03054350|10079620|FG001|COMPLETED|Primary Efficacy Period (6 Weeks)||13
9016762|NCT03054350|10079621|FG002|COMPLETED|Primary Efficacy Period (6 Weeks)||13
9016763|NCT03054350|10079622|FG003|COMPLETED|Primary Efficacy Period (6 Weeks)||3
9016764|NCT03054350|10079623|FG004|COMPLETED|Primary Efficacy Period (6 Weeks)||1
9016765|NCT03054350|10079624|FG005|COMPLETED|Primary Efficacy Period (6 Weeks)||2
8574445|NCT00128713|9606978|FG002|COMPLETED|Overall Study||449
8574446|NCT00128713|9606976|FG000|NOT COMPLETED|Overall Study||0
8574447|NCT00128713|9606977|FG001|NOT COMPLETED|Overall Study||0
8574448|NCT00128713|9606978|FG002|NOT COMPLETED|Overall Study||0
8574449|NCT00128830|9606986|FG000|STARTED|Overall Study||211
8574450|NCT00128830|9606986|FG000|COMPLETED|Overall Study||139
8574451|NCT00128830|9606986|FG000|NOT COMPLETED|Overall Study||72
8574452|NCT00128921|9606995|FG000|STARTED|Overall Study||10
8574453|NCT00128921|9606996|FG001|STARTED|Overall Study||8
8574454|NCT00128921|9606997|FG002|STARTED|Overall Study||0
8574455|NCT00128921|9606995|FG000|Received Bortezomib|Overall Study||10
8574456|NCT00128921|9606996|FG001|Received Bortezomib|Overall Study||6
8574457|NCT00128921|9606997|FG002|Received Bortezomib|Overall Study||0
8574458|NCT00128921|9606995|FG000|COMPLETED|Overall Study||5
8574459|NCT00128921|9606996|FG001|COMPLETED|Overall Study||3
8574460|NCT00128921|9606997|FG002|COMPLETED|Overall Study||0
8574461|NCT00128921|9606995|FG000|NOT COMPLETED|Overall Study||5
8574462|NCT00128921|9606996|FG001|NOT COMPLETED|Overall Study||5
8574463|NCT00128921|9606997|FG002|NOT COMPLETED|Overall Study||0
8574464|NCT00129116|9607012|FG000|STARTED|Primary Phase||78
8574465|NCT00129116|9607013|FG001|STARTED|Primary Phase||77
8574466|NCT00129116|9607014|FG002|STARTED|Primary Phase||78
8574467|NCT00129116|9607015|FG003|STARTED|Primary Phase||78
8574468|NCT00129116|9607016|FG004|STARTED|Primary Phase||77
8574469|NCT00129116|9607012|FG000|COMPLETED|Primary Phase||76
8574470|NCT00129116|9607013|FG001|COMPLETED|Primary Phase||73
8574471|NCT00129116|9607014|FG002|COMPLETED|Primary Phase||77
8574472|NCT00129116|9607015|FG003|COMPLETED|Primary Phase||77
8574473|NCT00129116|9607016|FG004|COMPLETED|Primary Phase||76
8574474|NCT00129116|9607012|FG000|NOT COMPLETED|Primary Phase||2
8574475|NCT00129116|9607013|FG001|NOT COMPLETED|Primary Phase||4
8574476|NCT00129116|9607014|FG002|NOT COMPLETED|Primary Phase||1
8574477|NCT00129116|9607015|FG003|NOT COMPLETED|Primary Phase||1
8574478|NCT00129116|9607016|FG004|NOT COMPLETED|Primary Phase||1
8574479|NCT00129116|9607012|FG000|STARTED|Booster Phase||47
8574480|NCT00129116|9607013|FG001|STARTED|Booster Phase||42
8574481|NCT00129116|9607014|FG002|STARTED|Booster Phase||44
8574482|NCT00129116|9607015|FG003|STARTED|Booster Phase||44
8574483|NCT00129116|9607016|FG004|STARTED|Booster Phase||44
8574484|NCT00129116|9607012|FG000|COMPLETED|Booster Phase||45
8574485|NCT00129116|9607013|FG001|COMPLETED|Booster Phase||42
8574486|NCT00129116|9607014|FG002|COMPLETED|Booster Phase||44
8574487|NCT00129116|9607015|FG003|COMPLETED|Booster Phase||44
8574488|NCT00129116|9607016|FG004|COMPLETED|Booster Phase||43
8574489|NCT00129116|9607012|FG000|NOT COMPLETED|Booster Phase||2
8574490|NCT00129116|9607013|FG001|NOT COMPLETED|Booster Phase||0
8574491|NCT00129116|9607014|FG002|NOT COMPLETED|Booster Phase||0
8574492|NCT00129116|9607015|FG003|NOT COMPLETED|Booster Phase||0
8574493|NCT00129116|9607016|FG004|NOT COMPLETED|Booster Phase||1
8574494|NCT00129129|9607031|FG000|STARTED|Primary Phase||287
8574495|NCT00129129|9607032|FG001|STARTED|Primary Phase||319
8574496|NCT00129129|9607033|FG002|STARTED|Primary Phase||150
8574497|NCT00129129|9607034|FG003|STARTED|Primary Phase||0
8574498|NCT00129129|9607035|FG004|STARTED|Primary Phase||0
8574499|NCT00129129|9607031|FG000|COMPLETED|Primary Phase||262
8574500|NCT00129129|9607032|FG001|COMPLETED|Primary Phase||294
8574501|NCT00129129|9607033|FG002|COMPLETED|Primary Phase||150
8574502|NCT00129129|9607034|FG003|COMPLETED|Primary Phase||0
8574503|NCT00129129|9607035|FG004|COMPLETED|Primary Phase||0
8574504|NCT00129129|9607031|FG000|NOT COMPLETED|Primary Phase||25
8574505|NCT00129129|9607032|FG001|NOT COMPLETED|Primary Phase||25
8574506|NCT00129129|9607033|FG002|NOT COMPLETED|Primary Phase||0
8574507|NCT00129129|9607034|FG003|NOT COMPLETED|Primary Phase||0
8574508|NCT00129129|9607035|FG004|NOT COMPLETED|Primary Phase||0
8574509|NCT00129129|9607031|FG000|STARTED|Fourth Dose Phase||236
8574510|NCT00129129|9607032|FG001|STARTED|Fourth Dose Phase||0
9016766|NCT03054350|10079619|FG000|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||4
9016767|NCT03054350|10079620|FG001|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||2
9016768|NCT03054350|10079621|FG002|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||2
9016769|NCT03054350|10079622|FG003|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||2
9016770|NCT03054350|10079623|FG004|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||4
9016771|NCT03054350|10079624|FG005|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||3
9016772|NCT03054350|10079619|FG000|STARTED|Dose Adjustment and Maintenance Period||11
9016773|NCT03054350|10079620|FG001|STARTED|Dose Adjustment and Maintenance Period||13
9016774|NCT03054350|10079621|FG002|STARTED|Dose Adjustment and Maintenance Period||13
9016775|NCT03054350|10079622|FG003|STARTED|Dose Adjustment and Maintenance Period||3
9016776|NCT03054350|10079623|FG004|STARTED|Dose Adjustment and Maintenance Period||1
9016777|NCT03054350|10079624|FG005|STARTED|Dose Adjustment and Maintenance Period||2
9016778|NCT03054350|10079619|FG000|COMPLETED|Dose Adjustment and Maintenance Period||10
9016779|NCT03054350|10079620|FG001|COMPLETED|Dose Adjustment and Maintenance Period||13
9016780|NCT03054350|10079621|FG002|COMPLETED|Dose Adjustment and Maintenance Period||12
9016781|NCT03054350|10079622|FG003|COMPLETED|Dose Adjustment and Maintenance Period||2
9016782|NCT03054350|10079623|FG004|COMPLETED|Dose Adjustment and Maintenance Period||1
9016783|NCT03054350|10079624|FG005|COMPLETED|Dose Adjustment and Maintenance Period||2
9016784|NCT03054350|10079619|FG000|NOT COMPLETED|Dose Adjustment and Maintenance Period||1
9016785|NCT03054350|10079620|FG001|NOT COMPLETED|Dose Adjustment and Maintenance Period||0
9016786|NCT03054350|10079621|FG002|NOT COMPLETED|Dose Adjustment and Maintenance Period||1
9016787|NCT03054350|10079622|FG003|NOT COMPLETED|Dose Adjustment and Maintenance Period||1
9016788|NCT03054350|10079623|FG004|NOT COMPLETED|Dose Adjustment and Maintenance Period||0
9016789|NCT03054350|10079624|FG005|NOT COMPLETED|Dose Adjustment and Maintenance Period||0
9016790|NCT03054428|10079658|FG000|STARTED|Overall Study||85
9016791|NCT03054428|10079659|FG001|STARTED|Overall Study||84
9016792|NCT03054428|10079660|FG002|STARTED|Overall Study||82
9016793|NCT03054428|10079658|FG000|Completed Wk 16 End of Treatment (EOT)|Overall Study||80
9016794|NCT03054428|10079659|FG001|Completed Wk 16 End of Treatment (EOT)|Overall Study||81
9016795|NCT03054428|10079660|FG002|Completed Wk 16 End of Treatment (EOT)|Overall Study||79
9016796|NCT03054428|10079658|FG000|Completed Week 28 (End of Study)|Overall Study||2
9016797|NCT03054428|10079659|FG001|Completed Week 28 (End of Study)|Overall Study||4
9016798|NCT03054428|10079660|FG002|Completed Week 28 (End of Study)|Overall Study||3
9016799|NCT03054428|10079658|FG000|COMPLETED|Overall Study||2
9016800|NCT03054428|10079659|FG001|COMPLETED|Overall Study||4
9016801|NCT03054428|10079660|FG002|COMPLETED|Overall Study||3
9016802|NCT03054428|10079658|FG000|NOT COMPLETED|Overall Study||83
9016803|NCT03054428|10079659|FG001|NOT COMPLETED|Overall Study||80
9016804|NCT03054428|10079660|FG002|NOT COMPLETED|Overall Study||79
9016805|NCT03054506|10079671|FG000|STARTED|Overall Study||20
9016806|NCT03054506|10079672|FG001|STARTED|Overall Study||11
9016807|NCT03054506|10079673|FG002|STARTED|Overall Study||9
9016808|NCT03054506|10079671|FG000|COMPLETED|Overall Study||19
9016809|NCT03054506|10079672|FG001|COMPLETED|Overall Study||11
9016810|NCT03054506|10079673|FG002|COMPLETED|Overall Study||9
9016811|NCT03054506|10079671|FG000|NOT COMPLETED|Overall Study||1
9016812|NCT03054506|10079672|FG001|NOT COMPLETED|Overall Study||0
9016813|NCT03054506|10079673|FG002|NOT COMPLETED|Overall Study||0
9016814|NCT03054649|10079681|FG000|STARTED|Overall Study||27
9016815|NCT03054649|10079682|FG001|STARTED|Overall Study||27
9016816|NCT03054649|10079681|FG000|COMPLETED|Overall Study||27
9016817|NCT03054649|10079682|FG001|COMPLETED|Overall Study||27
9016818|NCT03054649|10079681|FG000|NOT COMPLETED|Overall Study||0
9016819|NCT03054649|10079682|FG001|NOT COMPLETED|Overall Study||0
9016820|NCT03054740|10079713|FG000|STARTED|Overall Study||15
9016821|NCT03054740|10079714|FG001|STARTED|Overall Study||15
9016822|NCT03054740|10079713|FG000|COMPLETED|Overall Study||15
9016823|NCT03054740|10079714|FG001|COMPLETED|Overall Study||15
9016824|NCT03054740|10079713|FG000|NOT COMPLETED|Overall Study||0
9016825|NCT03054740|10079714|FG001|NOT COMPLETED|Overall Study||0
9016826|NCT03054805|10079723|FG000|STARTED|Overall Study||58
9016827|NCT03054805|10079724|FG001|STARTED|Overall Study||51
9016828|NCT03054805|10079725|FG002|STARTED|Overall Study||44
9016829|NCT03054805|10079723|FG000|COMPLETED|Overall Study||42
9016830|NCT03054805|10079724|FG001|COMPLETED|Overall Study||41
9016831|NCT03054805|10079725|FG002|COMPLETED|Overall Study||42
9016832|NCT03054805|10079723|FG000|NOT COMPLETED|Overall Study||16
9016833|NCT03054805|10079724|FG001|NOT COMPLETED|Overall Study||10
9016834|NCT03054805|10079725|FG002|NOT COMPLETED|Overall Study||2
9016835|NCT03054844|10079735|FG000|STARTED|Overall Study||28
9016836|NCT03054844|10079736|FG001|STARTED|Overall Study||27
9016837|NCT03054844|10079735|FG000|COMPLETED|Overall Study||25
9016838|NCT03054844|10079736|FG001|COMPLETED|Overall Study||26
9016839|NCT03054844|10079735|FG000|NOT COMPLETED|Overall Study||3
9016840|NCT03054844|10079736|FG001|NOT COMPLETED|Overall Study||1
9016841|NCT03054857|10079744|FG000|STARTED|Overall Study||50
9016842|NCT03054857|10079745|FG001|STARTED|Overall Study||50
9016843|NCT03054857|10079744|FG000|COMPLETED|Overall Study||49
9016844|NCT03054857|10079745|FG001|COMPLETED|Overall Study||50
9016845|NCT03054857|10079744|FG000|NOT COMPLETED|Overall Study||1
9016846|NCT03054857|10079745|FG001|NOT COMPLETED|Overall Study||0
9016847|NCT03054870|10079755|FG000|STARTED|Day of Ventilation Imaging|16 of 226 enrolled subjects were withdrawn from the study prior to receiving Technegas and were not included in further study assessments.|210
9016848|NCT03054870|10079755|FG000|COMPLETED|Day of Ventilation Imaging||205
9016849|NCT03054870|10079755|FG000|NOT COMPLETED|Day of Ventilation Imaging||5
9016850|NCT03054870|10079755|FG000|STARTED|24-hour Follow-up|24-hour follow-up was omitted from Protocol Amendment 1, so 92 subjects enrolled under Amendment 1 not included.|118
9016851|NCT03054870|10079755|FG000|COMPLETED|24-hour Follow-up||118
9016852|NCT03054870|10079755|FG000|NOT COMPLETED|24-hour Follow-up||0
9016853|NCT03054870|10079755|FG000|STARTED|Blinded Read of Images|At time of study termination, 200 subjects had completed the blinded read assessments. The decision to terminate was based on the positive results of an unplanned interim analysis of these blind read data by a third party statistician.|200
9016854|NCT03054870|10079755|FG000|COMPLETED|Blinded Read of Images||200
9016855|NCT03054870|10079755|FG000|NOT COMPLETED|Blinded Read of Images||0
9016856|NCT03054922|10079773|FG000|STARTED|Overall Study||20
9016857|NCT03054922|10079774|FG001|STARTED|Overall Study||19
9016858|NCT03054922|10079775|FG002|STARTED|Overall Study||20
9016859|NCT03054922|10079773|FG000|COMPLETED|Overall Study||20
9016860|NCT03054922|10079774|FG001|COMPLETED|Overall Study||19
8574511|NCT00129129|9607033|FG002|STARTED|Fourth Dose Phase||0
8574512|NCT00129129|9607034|FG003|STARTED|Fourth Dose Phase||132
8574513|NCT00129129|9607035|FG004|STARTED|Fourth Dose Phase||130
8574514|NCT00129129|9607031|FG000|COMPLETED|Fourth Dose Phase||232
8574515|NCT00129129|9607032|FG001|COMPLETED|Fourth Dose Phase||0
8574516|NCT00129129|9607033|FG002|COMPLETED|Fourth Dose Phase||0
8574517|NCT00129129|9607034|FG003|COMPLETED|Fourth Dose Phase||128
8574518|NCT00129129|9607035|FG004|COMPLETED|Fourth Dose Phase||124
8574519|NCT00129129|9607031|FG000|NOT COMPLETED|Fourth Dose Phase||4
8574520|NCT00129129|9607032|FG001|NOT COMPLETED|Fourth Dose Phase||0
8574521|NCT00129129|9607033|FG002|NOT COMPLETED|Fourth Dose Phase||0
8574522|NCT00129129|9607034|FG003|NOT COMPLETED|Fourth Dose Phase||4
8574523|NCT00129129|9607035|FG004|NOT COMPLETED|Fourth Dose Phase||6
8574524|NCT00129220|9607058|FG000|STARTED|Study Period II||105
8574525|NCT00129220|9607059|FG001|STARTED|Study Period II||20
8574526|NCT00129220|9607060|FG002|STARTED|Study Period II||99
8574527|NCT00129220|9607058|FG000|Received at Least One Dose of Study Drug|Study Period II||104
8574528|NCT00129220|9607059|FG001|Received at Least One Dose of Study Drug|Study Period II||20
8574529|NCT00129220|9607060|FG002|Received at Least One Dose of Study Drug|Study Period II||97
8574530|NCT00129220|9607058|FG000|COMPLETED|Study Period II||72
8574531|NCT00129220|9607059|FG001|COMPLETED|Study Period II||8
8574532|NCT00129220|9607060|FG002|COMPLETED|Study Period II||52
8574533|NCT00129220|9607058|FG000|NOT COMPLETED|Study Period II||33
8574534|NCT00129220|9607059|FG001|NOT COMPLETED|Study Period II||12
8574535|NCT00129220|9607060|FG002|NOT COMPLETED|Study Period II||47
8574536|NCT00129220|9607058|FG000|STARTED|Study Period III||72
8574537|NCT00129220|9607059|FG001|STARTED|Study Period III||8
8574538|NCT00129220|9607060|FG002|STARTED|Study Period III||52
8574539|NCT00129220|9607058|FG000|COMPLETED|Study Period III||59
8574540|NCT00129220|9607059|FG001|COMPLETED|Study Period III||7
8574541|NCT00129220|9607060|FG002|COMPLETED|Study Period III||42
8574542|NCT00129220|9607058|FG000|NOT COMPLETED|Study Period III||13
8574543|NCT00129220|9607059|FG001|NOT COMPLETED|Study Period III||1
8574544|NCT00129220|9607060|FG002|NOT COMPLETED|Study Period III||10
8574545|NCT00129246|9607072|FG000|STARTED|Overall Study||20
8574546|NCT00129246|9607073|FG001|STARTED|Overall Study||20
8574547|NCT00129246|9607072|FG000|COMPLETED|Overall Study||20
8574548|NCT00129246|9607073|FG001|COMPLETED|Overall Study||20
8574549|NCT00129246|9607072|FG000|NOT COMPLETED|Overall Study||0
8574550|NCT00129246|9607073|FG001|NOT COMPLETED|Overall Study||0
8574551|NCT00129259|9607081|FG000|STARTED|Overall Study|Subjects not in the Intent-to-treat group did not have a baseline visit and are not included here|52
8574552|NCT00129259|9607082|FG001|STARTED|Overall Study|Subjects not in the Intent-to-treat group did not have a baseline visit and are not included here|25
8574553|NCT00129259|9607081|FG000|Received All or Part of Cycle 1|Overall Study||52
8574554|NCT00129259|9607082|FG001|Received All or Part of Cycle 1|Overall Study||0
8574555|NCT00129259|9607081|FG000|Received All or Part of Cycle 2|Overall Study||40
8574556|NCT00129259|9607082|FG001|Received All or Part of Cycle 2|Overall Study||0
8574557|NCT00129259|9607081|FG000|COMPLETED|Overall Study||49
8574558|NCT00129259|9607082|FG001|COMPLETED|Overall Study||22
8574559|NCT00129259|9607081|FG000|NOT COMPLETED|Overall Study||3
8574560|NCT00129259|9607082|FG001|NOT COMPLETED|Overall Study||3
8574561|NCT00129272|9607090|FG000|STARTED|Overall Study||71
8574562|NCT00129272|9607091|FG001|STARTED|Overall Study||73
8574563|NCT00129272|9607090|FG000|COMPLETED|Overall Study||54
8574564|NCT00129272|9607091|FG001|COMPLETED|Overall Study||51
8574565|NCT00129272|9607090|FG000|NOT COMPLETED|Overall Study||17
8574566|NCT00129272|9607091|FG001|NOT COMPLETED|Overall Study||22
8574567|NCT00129285|9607100|FG000|STARTED|Overall Study||65
8574568|NCT00129285|9607101|FG001|STARTED|Overall Study||70
8574569|NCT00129285|9607102|FG002|STARTED|Overall Study||75
8574570|NCT00129285|9607100|FG000|COMPLETED|Overall Study||40
8574571|NCT00129285|9607101|FG001|COMPLETED|Overall Study||43
8574572|NCT00129285|9607102|FG002|COMPLETED|Overall Study||37
9016861|NCT03054922|10079775|FG002|COMPLETED|Overall Study||20
8574573|NCT00129285|9607100|FG000|NOT COMPLETED|Overall Study||25
8574574|NCT00129285|9607101|FG001|NOT COMPLETED|Overall Study||27
8574575|NCT00129285|9607102|FG002|NOT COMPLETED|Overall Study||38
8574576|NCT00129311|9607116|FG000|STARTED|Overall Study||51
8574577|NCT00129311|9607117|FG001|STARTED|Overall Study||50
8574578|NCT00129311|9607116|FG000|COMPLETED|Overall Study||39
8574579|NCT00129311|9607117|FG001|COMPLETED|Overall Study||31
8574580|NCT00129311|9607116|FG000|NOT COMPLETED|Overall Study||12
8574581|NCT00129311|9607117|FG001|NOT COMPLETED|Overall Study||19
9016862|NCT03054922|10079773|FG000|NOT COMPLETED|Overall Study||0
9016863|NCT03054922|10079774|FG001|NOT COMPLETED|Overall Study||0
9016864|NCT03054922|10079775|FG002|NOT COMPLETED|Overall Study||0
9016865|NCT03055000|10079786|FG000|STARTED|Overall Study||16
9016866|NCT03055000|10079787|FG001|STARTED|Overall Study||17
9016867|NCT03055000|10079788|FG002|STARTED|Overall Study||16
9016868|NCT03055000|10079786|FG000|COMPLETED|Overall Study||16
9016869|NCT03055000|10079787|FG001|COMPLETED|Overall Study||17
9016870|NCT03055000|10079788|FG002|COMPLETED|Overall Study||16
9016871|NCT03055000|10079786|FG000|NOT COMPLETED|Overall Study||0
9016872|NCT03055000|10079787|FG001|NOT COMPLETED|Overall Study||0
9016873|NCT03055000|10079788|FG002|NOT COMPLETED|Overall Study||0
9016874|NCT03055156|10079798|FG000|STARTED|Overall Study||281
9016875|NCT03055156|10079799|FG001|STARTED|Overall Study||273
9016876|NCT03055156|10079798|FG000|COMPLETED|Overall Study||281
9016877|NCT03055156|10079799|FG001|COMPLETED|Overall Study||273
9016878|NCT03055156|10079798|FG000|NOT COMPLETED|Overall Study||0
9016879|NCT03055156|10079799|FG001|NOT COMPLETED|Overall Study||0
9016880|NCT03055195|10079807|FG000|STARTED|Overall Study||16
9016881|NCT03055195|10079808|FG001|STARTED|Overall Study||18
9016882|NCT03055195|10079807|FG000|COMPLETED|Overall Study||4
9016883|NCT03055195|10079808|FG001|COMPLETED|Overall Study||4
9016884|NCT03055195|10079807|FG000|NOT COMPLETED|Overall Study||12
9016885|NCT03055195|10079808|FG001|NOT COMPLETED|Overall Study||14
9016886|NCT03055221|10079814|FG000|STARTED|Overall Study||16
9016887|NCT03055221|10079814|FG000|COMPLETED|Overall Study||0
9016888|NCT03055221|10079814|FG000|NOT COMPLETED|Overall Study||16
9016889|NCT03055260|10079820|FG000|STARTED|Overall Study||8
9016890|NCT03055260|10079821|FG001|STARTED|Overall Study||0
9016891|NCT03055260|10079820|FG000|COMPLETED|Overall Study||7
9016892|NCT03055260|10079821|FG001|COMPLETED|Overall Study||0
9016893|NCT03055260|10079820|FG000|NOT COMPLETED|Overall Study||1
9016894|NCT03055260|10079821|FG001|NOT COMPLETED|Overall Study||0
9016895|NCT03055338|10079830|FG000|STARTED|Overall Study||90
9016896|NCT03055338|10079831|FG001|STARTED|Overall Study||45
9016897|NCT03055338|10079832|FG002|STARTED|Overall Study||89
9016898|NCT03055338|10079830|FG000|COMPLETED|Overall Study||72
9016899|NCT03055338|10079831|FG001|COMPLETED|Overall Study||34
9016900|NCT03055338|10079832|FG002|COMPLETED|Overall Study||77
9016901|NCT03055338|10079830|FG000|NOT COMPLETED|Overall Study||18
9016902|NCT03055338|10079831|FG001|NOT COMPLETED|Overall Study||11
9016903|NCT03055338|10079832|FG002|NOT COMPLETED|Overall Study||12
9016904|NCT03055494|10079842|FG000|STARTED|Overall Study||54
9016905|NCT03055494|10079843|FG001|STARTED|Overall Study||28
9016906|NCT03055494|10079842|FG000|COMPLETED|Overall Study||44
9016907|NCT03055494|10079843|FG001|COMPLETED|Overall Study||27
9016908|NCT03055494|10079842|FG000|NOT COMPLETED|Overall Study||10
9016909|NCT03055494|10079843|FG001|NOT COMPLETED|Overall Study||1
9016910|NCT03055624|10079850|FG000|STARTED|Overall Study||9
9016911|NCT03055624|10079850|FG000|COMPLETED|Overall Study||0
9016912|NCT03055624|10079850|FG000|NOT COMPLETED|Overall Study||9
9016913|NCT03055650|10079854|FG000|STARTED|Overall Study||30
9016914|NCT03055650|10079854|FG000|COMPLETED|Overall Study||30
9016915|NCT03055650|10079854|FG000|NOT COMPLETED|Overall Study||0
9016916|NCT03055806|10079862|FG000|STARTED|Overall Study||48
9016917|NCT03055806|10079863|FG001|STARTED|Overall Study||48
9016918|NCT03055806|10079864|FG002|STARTED|Overall Study||71
9016919|NCT03055806|10079865|FG003|STARTED|Overall Study||72
9016920|NCT03055806|10079862|FG000|COMPLETED|Overall Study||42
9016921|NCT03055806|10079863|FG001|COMPLETED|Overall Study||41
8637200|NCT00570687|9677771|FG008|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||2
8637201|NCT00570687|9677772|FG009|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
8637202|NCT00570687|9677763|FG000|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
9016922|NCT03055806|10079864|FG002|COMPLETED|Overall Study||58
9016923|NCT03055806|10079865|FG003|COMPLETED|Overall Study||57
9016924|NCT03055806|10079862|FG000|NOT COMPLETED|Overall Study||6
9016925|NCT03055806|10079863|FG001|NOT COMPLETED|Overall Study||7
9016926|NCT03055806|10079864|FG002|NOT COMPLETED|Overall Study||13
9016927|NCT03055806|10079865|FG003|NOT COMPLETED|Overall Study||15
9016928|NCT03055832|10079877|FG000|STARTED|Baseline||71
9016929|NCT03055832|10079878|FG001|STARTED|Baseline||71
9016930|NCT03055832|10079877|FG000|COMPLETED|Baseline||71
9016931|NCT03055832|10079878|FG001|COMPLETED|Baseline||71
9016932|NCT03055832|10079877|FG000|NOT COMPLETED|Baseline||0
9016933|NCT03055832|10079878|FG001|NOT COMPLETED|Baseline||0
9016934|NCT03055832|10079877|FG000|STARTED|Immediately Post-Procedure (Hour 1)||71
9016935|NCT03055832|10079878|FG001|STARTED|Immediately Post-Procedure (Hour 1)||71
9016936|NCT03055832|10079877|FG000|COMPLETED|Immediately Post-Procedure (Hour 1)||71
9016937|NCT03055832|10079878|FG001|COMPLETED|Immediately Post-Procedure (Hour 1)||71
9016938|NCT03055832|10079877|FG000|NOT COMPLETED|Immediately Post-Procedure (Hour 1)||0
9016939|NCT03055832|10079878|FG001|NOT COMPLETED|Immediately Post-Procedure (Hour 1)||0
9016940|NCT03055832|10079877|FG000|STARTED|Day 1||71
9016941|NCT03055832|10079878|FG001|STARTED|Day 1||71
9016942|NCT03055832|10079877|FG000|COMPLETED|Day 1||71
9016943|NCT03055832|10079878|FG001|COMPLETED|Day 1||71
9016944|NCT03055832|10079877|FG000|NOT COMPLETED|Day 1||0
9016945|NCT03055832|10079878|FG001|NOT COMPLETED|Day 1||0
9016946|NCT03055832|10079877|FG000|STARTED|Week 2||71
9016947|NCT03055832|10079878|FG001|STARTED|Week 2||71
9016948|NCT03055832|10079877|FG000|COMPLETED|Week 2||70
9016949|NCT03055832|10079878|FG001|COMPLETED|Week 2||71
9016950|NCT03055832|10079877|FG000|NOT COMPLETED|Week 2||1
9016951|NCT03055832|10079878|FG001|NOT COMPLETED|Week 2||0
9016952|NCT03055832|10079877|FG000|STARTED|Week 4||70
9016953|NCT03055832|10079878|FG001|STARTED|Week 4||71
9016954|NCT03055832|10079877|FG000|COMPLETED|Week 4||70
9016955|NCT03055832|10079878|FG001|COMPLETED|Week 4||71
9016956|NCT03055832|10079877|FG000|NOT COMPLETED|Week 4||0
9016957|NCT03055832|10079878|FG001|NOT COMPLETED|Week 4||0
9016958|NCT03055858|10079898|FG000|STARTED|Overall Study||200
9016959|NCT03055858|10079898|FG000|IDE Cohort|Overall Study||50
9016960|NCT03055858|10079898|FG000|CAP Cohort|Overall Study||150
9016961|NCT03055858|10079898|FG000|COMPLETED|Overall Study||194
9016962|NCT03055858|10079898|FG000|NOT COMPLETED|Overall Study||6
9016963|NCT03055897|10079902|FG000|STARTED|Overall Study||15
9016964|NCT03055897|10079902|FG000|COMPLETED|Overall Study||15
9016965|NCT03055897|10079902|FG000|NOT COMPLETED|Overall Study||0
9016966|NCT03055936|10079910|FG000|STARTED|Overall Study||14
9016967|NCT03055936|10079911|FG001|STARTED|Overall Study||14
9016968|NCT03055936|10079912|FG002|STARTED|Overall Study||14
9016969|NCT03055936|10079913|FG003|STARTED|Overall Study||14
9016970|NCT03055936|10079910|FG000|COMPLETED|Overall Study||12
9016971|NCT03055936|10079911|FG001|COMPLETED|Overall Study||13
9016972|NCT03055936|10079912|FG002|COMPLETED|Overall Study||12
9016973|NCT03055936|10079913|FG003|COMPLETED|Overall Study||13
9016974|NCT03055936|10079910|FG000|NOT COMPLETED|Overall Study||2
9016975|NCT03055936|10079911|FG001|NOT COMPLETED|Overall Study||1
9016976|NCT03055936|10079912|FG002|NOT COMPLETED|Overall Study||2
9016977|NCT03055936|10079913|FG003|NOT COMPLETED|Overall Study||1
9016978|NCT03055988|10079947|FG000|STARTED|Period 1||38
9016979|NCT03055988|10079948|FG001|STARTED|Period 1||38
9016980|NCT03055988|10079947|FG000|COMPLETED|Period 1||37
9016981|NCT03055988|10079948|FG001|COMPLETED|Period 1||33
9016982|NCT03055988|10079947|FG000|NOT COMPLETED|Period 1||1
9016983|NCT03055988|10079948|FG001|NOT COMPLETED|Period 1||5
9016984|NCT03055988|10079947|FG000|STARTED|Period 2||37
9016985|NCT03055988|10079948|FG001|STARTED|Period 2||33
9016986|NCT03055988|10079947|FG000|COMPLETED|Period 2||36
9016987|NCT03055988|10079948|FG001|COMPLETED|Period 2||31
9016988|NCT03055988|10079947|FG000|NOT COMPLETED|Period 2||1
9016989|NCT03055988|10079948|FG001|NOT COMPLETED|Period 2||2
9016990|NCT03056040|10079956|FG000|STARTED|Primary Evaluation Period||97
9016991|NCT03056040|10079957|FG001|STARTED|Primary Evaluation Period||98
9016992|NCT03056040|10079956|FG000|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||97
8574582|NCT00129376|9607123|FG000|STARTED|Overall Study||63
8574583|NCT00129376|9607123|FG000|COMPLETED|Overall Study||61
8574584|NCT00129376|9607123|FG000|NOT COMPLETED|Overall Study||2
8574585|NCT00129389|9607129|FG000|STARTED|Overall Study||974
8574586|NCT00129389|9607130|FG001|STARTED|Overall Study||951
8574587|NCT00129389|9607129|FG000|COMPLETED|Overall Study|1 patient was crossed from arm A to B by error. 16 patients were crossed from arm B, to A by error.|941
8574588|NCT00129389|9607130|FG001|COMPLETED|Overall Study|16 patients were crossed from arm B to A by error. 1 patient was crossed from arm A to B by error.|811
8574589|NCT00129389|9607129|FG000|NOT COMPLETED|Overall Study||33
8574590|NCT00129389|9607130|FG001|NOT COMPLETED|Overall Study||140
8574591|NCT00129441|9607138|FG000|STARTED|Overall Study||9
8574592|NCT00129441|9607139|FG001|STARTED|Overall Study||6
8574593|NCT00129441|9607138|FG000|Baseline, Visit 1|Overall Study|Baseline # only includes those who completed 4-week trial (one L-830982 subject did not complete).|9
8574594|NCT00129441|9607139|FG001|Baseline, Visit 1|Overall Study||6
8574595|NCT00129441|9607138|FG000|Week 1, Visit 2|Overall Study||9
8574596|NCT00129441|9607139|FG001|Week 1, Visit 2|Overall Study||6
8574597|NCT00129441|9607138|FG000|Week 2, Visit 3|Overall Study||9
8574598|NCT00129441|9607139|FG001|Week 2, Visit 3|Overall Study||6
8574599|NCT00129441|9607138|FG000|Week 3, Visit 4|Overall Study||9
8574600|NCT00129441|9607139|FG001|Week 3, Visit 4|Overall Study||6
8574601|NCT00129441|9607138|FG000|Week 4, Visit 5|Overall Study||9
8574602|NCT00129441|9607139|FG001|Week 4, Visit 5|Overall Study||6
8574603|NCT00129441|9607138|FG000|Week 5, Visit 6|Overall Study||9
8574604|NCT00129441|9607139|FG001|Week 5, Visit 6|Overall Study||6
8574605|NCT00129441|9607138|FG000|Week 26, Visit 7|Overall Study||9
8574606|NCT00129441|9607139|FG001|Week 26, Visit 7|Overall Study||6
8574607|NCT00129441|9607138|FG000|Year 1, Visit 8|Overall Study||9
8574608|NCT00129441|9607139|FG001|Year 1, Visit 8|Overall Study||6
8574609|NCT00129441|9607138|FG000|COMPLETED|Overall Study||9
8574610|NCT00129441|9607139|FG001|COMPLETED|Overall Study||6
8574611|NCT00129441|9607138|FG000|NOT COMPLETED|Overall Study||0
8574612|NCT00129441|9607139|FG001|NOT COMPLETED|Overall Study||0
8574613|NCT00129467|9607147|FG000|STARTED|Received Intervention||15
9016993|NCT03056040|10079957|FG001|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||98
9016994|NCT03056040|10079956|FG000|COMPLETED|Primary Evaluation Period||96
9016995|NCT03056040|10079957|FG001|COMPLETED|Primary Evaluation Period||95
9016996|NCT03056040|10079956|FG000|NOT COMPLETED|Primary Evaluation Period||1
9016997|NCT03056040|10079957|FG001|NOT COMPLETED|Primary Evaluation Period||3
9016998|NCT03056040|10079956|FG000|STARTED|Extension Period||96
9016999|NCT03056040|10079957|FG001|STARTED|Extension Period||95
9017000|NCT03056040|10079956|FG000|Received at Least 1 Dose of Ravulizumab|Extension Period||96
9017001|NCT03056040|10079957|FG001|Received at Least 1 Dose of Ravulizumab|Extension Period||95
9017002|NCT03056040|10079956|FG000|COMPLETED|Extension Period||0
9017003|NCT03056040|10079957|FG001|COMPLETED|Extension Period||0
9017004|NCT03056040|10079956|FG000|NOT COMPLETED|Extension Period||96
9017005|NCT03056040|10079957|FG001|NOT COMPLETED|Extension Period||95
9017006|NCT03056144|10079963|FG000|STARTED|Overall Study||1
9017007|NCT03056144|10079963|FG000|COMPLETED|Overall Study||1
9017008|NCT03056144|10079963|FG000|NOT COMPLETED|Overall Study||0
9017009|NCT03056300|10079967|FG000|STARTED|Overall Study||50
9017010|NCT03056300|10079967|FG000|COMPLETED|Overall Study||47
9017011|NCT03056300|10079967|FG000|NOT COMPLETED|Overall Study||3
9039768|NCT03341312|10100668|FG001|NOT COMPLETED|Period 4||0
9039769|NCT03341312|10100669|FG002|NOT COMPLETED|Period 4||0
9039770|NCT03341312|10100670|FG003|NOT COMPLETED|Period 4||0
9039771|NCT03341507|10100682|FG000|STARTED|Overall Study||64
9039772|NCT03341507|10100682|FG000|COMPLETED|Overall Study||30
9039773|NCT03341507|10100682|FG000|NOT COMPLETED|Overall Study||34
9039774|NCT03341533|10100688|FG000|STARTED|Overall Study||72
9039775|NCT03341533|10100689|FG001|STARTED|Overall Study||70
9039776|NCT03341533|10100688|FG000|COMPLETED|Overall Study||69
9039777|NCT03341533|10100689|FG001|COMPLETED|Overall Study||68
9039778|NCT03341533|10100688|FG000|NOT COMPLETED|Overall Study||3
9039779|NCT03341533|10100689|FG001|NOT COMPLETED|Overall Study||2
9039780|NCT03341546|10100695|FG000|STARTED|Overall Study||20
9039781|NCT03341546|10100695|FG000|COMPLETED|Overall Study||20
9039782|NCT03341546|10100695|FG000|NOT COMPLETED|Overall Study||0
9039783|NCT03341637|10100701|FG000|STARTED|Overall Study||100
9039784|NCT03341637|10100702|FG001|STARTED|Overall Study||300
9039785|NCT03341637|10100701|FG000|COMPLETED|Overall Study||95
9039786|NCT03341637|10100702|FG001|COMPLETED|Overall Study||296
9039787|NCT03341637|10100701|FG000|NOT COMPLETED|Overall Study||5
9039788|NCT03341637|10100702|FG001|NOT COMPLETED|Overall Study||4
9039789|NCT03341728|10100708|FG000|STARTED|Session 1||7
9039790|NCT03341728|10100709|FG001|STARTED|Session 1||7
9039791|NCT03341728|10100708|FG000|COMPLETED|Session 1||7
9039792|NCT03341728|10100709|FG001|COMPLETED|Session 1||7
9039793|NCT03341728|10100708|FG000|NOT COMPLETED|Session 1||0
9039794|NCT03341728|10100709|FG001|NOT COMPLETED|Session 1||0
9039795|NCT03341728|10100708|FG000|STARTED|Washout (1 Week)||7
9039796|NCT03341728|10100709|FG001|STARTED|Washout (1 Week)||7
9039797|NCT03341728|10100708|FG000|COMPLETED|Washout (1 Week)||7
9039798|NCT03341728|10100709|FG001|COMPLETED|Washout (1 Week)||7
9039799|NCT03341728|10100708|FG000|NOT COMPLETED|Washout (1 Week)||0
9039800|NCT03341728|10100709|FG001|NOT COMPLETED|Washout (1 Week)||0
9039801|NCT03341728|10100708|FG000|STARTED|Session 2||7
9039802|NCT03341728|10100709|FG001|STARTED|Session 2||7
9039803|NCT03341728|10100708|FG000|COMPLETED|Session 2||7
9039804|NCT03341728|10100709|FG001|COMPLETED|Session 2||7
9039805|NCT03341728|10100708|FG000|NOT COMPLETED|Session 2||0
9039806|NCT03341728|10100709|FG001|NOT COMPLETED|Session 2||0
9039807|NCT03341910|10100719|FG000|STARTED|Overall Study||54
9039808|NCT03341910|10100720|FG001|STARTED|Overall Study||49
9039809|NCT03341910|10100721|FG002|STARTED|Overall Study||26
9039810|NCT03341910|10100722|FG003|STARTED|Overall Study||26
9039811|NCT03341910|10100719|FG000|COMPLETED|Overall Study||54
9039812|NCT03341910|10100720|FG001|COMPLETED|Overall Study||49
9039813|NCT03341910|10100721|FG002|COMPLETED|Overall Study||26
9039814|NCT03341910|10100722|FG003|COMPLETED|Overall Study||26
9039815|NCT03341910|10100719|FG000|NOT COMPLETED|Overall Study||0
9039816|NCT03341910|10100720|FG001|NOT COMPLETED|Overall Study||0
9039817|NCT03341910|10100721|FG002|NOT COMPLETED|Overall Study||0
9039818|NCT03341910|10100722|FG003|NOT COMPLETED|Overall Study||0
9039819|NCT03341923|10100732|FG000|STARTED|Period 1, First 14 Days of Wear||67
9039820|NCT03341923|10100733|FG001|STARTED|Period 1, First 14 Days of Wear||67
9039821|NCT03341923|10100732|FG000|COMPLETED|Period 1, First 14 Days of Wear||67
9039822|NCT03341923|10100733|FG001|COMPLETED|Period 1, First 14 Days of Wear||67
9039823|NCT03341923|10100732|FG000|NOT COMPLETED|Period 1, First 14 Days of Wear||0
9039824|NCT03341923|10100733|FG001|NOT COMPLETED|Period 1, First 14 Days of Wear||0
9039825|NCT03341923|10100732|FG000|STARTED|Period 2, Second 14 Days of Wear||67
9039826|NCT03341923|10100733|FG001|STARTED|Period 2, Second 14 Days of Wear|Subject completed Period 1 but was discontinued before starting Period 2.|66
9039827|NCT03341923|10100732|FG000|COMPLETED|Period 2, Second 14 Days of Wear||67
9039828|NCT03341923|10100733|FG001|COMPLETED|Period 2, Second 14 Days of Wear||65
9039829|NCT03341923|10100732|FG000|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
9039830|NCT03341923|10100733|FG001|NOT COMPLETED|Period 2, Second 14 Days of Wear||1
9039831|NCT03341975|10100743|FG000|STARTED|Overall Study||44
9039832|NCT03341975|10100744|FG001|STARTED|Overall Study||47
9039833|NCT03341975|10100743|FG000|COMPLETED|Overall Study||44
9039834|NCT03341975|10100744|FG001|COMPLETED|Overall Study||47
9039835|NCT03341975|10100743|FG000|NOT COMPLETED|Overall Study||0
9039836|NCT03341975|10100744|FG001|NOT COMPLETED|Overall Study||0
9039837|NCT03342404|10100752|FG000|STARTED|Overall Study||96
9039838|NCT03342404|10100753|FG001|STARTED|Overall Study||49
9039839|NCT03342404|10100752|FG000|COMPLETED|Overall Study||81
9039840|NCT03342404|10100753|FG001|COMPLETED|Overall Study||18
9039841|NCT03342404|10100752|FG000|NOT COMPLETED|Overall Study||15
9039842|NCT03342404|10100753|FG001|NOT COMPLETED|Overall Study||31
9039843|NCT03342469|10100761|FG000|STARTED|Overall Study||9
9039844|NCT03342469|10100762|FG001|STARTED|Overall Study||9
9039845|NCT03342469|10100763|FG002|STARTED|Overall Study||3
9039846|NCT03342469|10100764|FG003|STARTED|Overall Study||8
9039847|NCT03342469|10100761|FG000|COMPLETED|Overall Study||9
9039848|NCT03342469|10100762|FG001|COMPLETED|Overall Study||8
9039849|NCT03342469|10100763|FG002|COMPLETED|Overall Study||3
9039850|NCT03342469|10100764|FG003|COMPLETED|Overall Study||8
9039851|NCT03342469|10100761|FG000|NOT COMPLETED|Overall Study||0
9039852|NCT03342469|10100762|FG001|NOT COMPLETED|Overall Study||1
9039853|NCT03342469|10100763|FG002|NOT COMPLETED|Overall Study||0
9017012|NCT03056352|10079971|FG000|STARTED|Overall Study||21
9017013|NCT03056352|10079971|FG000|COMPLETED|Overall Study||20
9017014|NCT03056352|10079971|FG000|NOT COMPLETED|Overall Study||1
9017015|NCT03056456|10079975|FG000|STARTED|Period 1||6
8574614|NCT00129467|9607148|FG001|STARTED|Received Intervention||17
8574615|NCT00129467|9607147|FG000|COMPLETED|Received Intervention||9
8574616|NCT00129467|9607148|FG001|COMPLETED|Received Intervention||13
8574617|NCT00129467|9607147|FG000|NOT COMPLETED|Received Intervention||6
8574618|NCT00129467|9607148|FG001|NOT COMPLETED|Received Intervention||4
8574619|NCT00129467|9607147|FG000|STARTED|Open Label for SSRI+Methylphenidate Arm|Eligible if in methylphenidate arm & had 50% reduction in Montgomery-Asberg Depression Rating score|4
8574620|NCT00129467|9607148|FG001|STARTED|Open Label for SSRI+Methylphenidate Arm||0
8574621|NCT00129467|9607147|FG000|COMPLETED|Open Label for SSRI+Methylphenidate Arm||2
8574622|NCT00129467|9607148|FG001|COMPLETED|Open Label for SSRI+Methylphenidate Arm||0
8574623|NCT00129467|9607147|FG000|NOT COMPLETED|Open Label for SSRI+Methylphenidate Arm||2
8574624|NCT00129467|9607148|FG001|NOT COMPLETED|Open Label for SSRI+Methylphenidate Arm||0
8574625|NCT00129480|9607156|FG000|STARTED|Overall Study||187
8574626|NCT00129480|9607157|FG001|STARTED|Overall Study||214
8574627|NCT00129480|9607156|FG000|COMPLETED|Overall Study||187
8574628|NCT00129480|9607157|FG001|COMPLETED|Overall Study||214
8574629|NCT00129480|9607156|FG000|NOT COMPLETED|Overall Study||0
8574630|NCT00129480|9607157|FG001|NOT COMPLETED|Overall Study||0
8574631|NCT00129545|9607166|FG000|STARTED|Overall Study||93
8574632|NCT00129545|9607167|FG001|STARTED|Overall Study|2:1 randomization WATCHMAN to warfarin|463
8574633|NCT00129545|9607168|FG002|STARTED|Overall Study||244
8574634|NCT00129545|9607166|FG000|COMPLETED|Overall Study||67
8574635|NCT00129545|9607167|FG001|COMPLETED|Overall Study||299
8911050|NCT02142712|9970070|FG000|STARTED|Overall Study||1
8911051|NCT02142712|9970071|FG001|STARTED|Overall Study||1
8911052|NCT02142712|9970072|FG002|STARTED|Overall Study||1
8574636|NCT00129545|9607168|FG002|COMPLETED|Overall Study||133
8574637|NCT00129545|9607166|FG000|NOT COMPLETED|Overall Study||26
8574638|NCT00129545|9607167|FG001|NOT COMPLETED|Overall Study||164
8574639|NCT00129545|9607168|FG002|NOT COMPLETED|Overall Study||111
8574640|NCT00129623|9607178|FG000|STARTED|Overall Study||83
8574641|NCT00129623|9607179|FG001|STARTED|Overall Study||77
8574642|NCT00129623|9607178|FG000|Intent-to-treat (ITT)/ Safety Population|Overall Study||83
8574643|NCT00129623|9607179|FG001|Intent-to-treat (ITT)/ Safety Population|Overall Study||77
8574644|NCT00129623|9607178|FG000|COMPLETED|Overall Study||73
8574645|NCT00129623|9607179|FG001|COMPLETED|Overall Study||65
8574646|NCT00129623|9607178|FG000|NOT COMPLETED|Overall Study||10
8574647|NCT00129623|9607179|FG001|NOT COMPLETED|Overall Study||12
8574648|NCT00129649|9607189|FG000|STARTED|Overall Study||258
8574649|NCT00129649|9607190|FG001|STARTED|Overall Study||246
8574650|NCT00129649|9607189|FG000|COMPLETED|Overall Study||182
8574651|NCT00129649|9607190|FG001|COMPLETED|Overall Study||181
8574652|NCT00129649|9607189|FG000|NOT COMPLETED|Overall Study||76
8574653|NCT00129649|9607190|FG001|NOT COMPLETED|Overall Study||65
8574654|NCT00129701|9607196|FG000|STARTED|Overall Study||104
8574655|NCT00129701|9607196|FG000|COMPLETED|Overall Study||71
8574656|NCT00129701|9607196|FG000|NOT COMPLETED|Overall Study||33
8574657|NCT00129727|9607203|FG000|STARTED|Overall Study||62
8574658|NCT00129727|9607203|FG000|COMPLETED|Overall Study||57
8574659|NCT00129727|9607203|FG000|NOT COMPLETED|Overall Study||5
8574660|NCT00129740|9607207|FG000|STARTED|Overall Study||148
8574661|NCT00129740|9607207|FG000|COMPLETED|Overall Study||148
8574662|NCT00129740|9607207|FG000|NOT COMPLETED|Overall Study||0
8911053|NCT02142712|9970073|FG003|STARTED|Overall Study||0
8911054|NCT02142712|9970070|FG000|COMPLETED|Overall Study||0
8911055|NCT02142712|9970071|FG001|COMPLETED|Overall Study||0
8911056|NCT02142712|9970072|FG002|COMPLETED|Overall Study||0
8911057|NCT02142712|9970073|FG003|COMPLETED|Overall Study||0
8911058|NCT02142712|9970070|FG000|NOT COMPLETED|Overall Study||1
8911059|NCT02142712|9970071|FG001|NOT COMPLETED|Overall Study||1
8911060|NCT02142712|9970072|FG002|NOT COMPLETED|Overall Study||1
8911061|NCT02142712|9970073|FG003|NOT COMPLETED|Overall Study||0
8911062|NCT02142738|9970084|FG000|STARTED|Overall Study||154
8911063|NCT02142738|9970085|FG001|STARTED|Overall Study||151
8911064|NCT02142738|9970084|FG000|Treated|Overall Study||154
8911065|NCT02142738|9970085|FG001|Treated|Overall Study||150
8911066|NCT02142738|9970084|FG000|COMPLETED|Overall Study||0
8911067|NCT02142738|9970085|FG001|COMPLETED|Overall Study||0
8911068|NCT02142738|9970084|FG000|NOT COMPLETED|Overall Study||154
8911069|NCT02142738|9970085|FG001|NOT COMPLETED|Overall Study||151
8911070|NCT02142894|9970091|FG000|STARTED|Overall Study||33
8911071|NCT02142894|9970091|FG000|COMPLETED|Overall Study||25
8911072|NCT02142894|9970091|FG000|NOT COMPLETED|Overall Study||8
8911073|NCT02143024|9970097|FG000|STARTED|Overall Study||15
8911074|NCT02143024|9970098|FG001|STARTED|Overall Study||8
8911075|NCT02143024|9970097|FG000|Received Treatment|Overall Study||13
8911076|NCT02143024|9970098|FG001|Received Treatment|Overall Study||7
8911077|NCT02143024|9970097|FG000|COMPLETED|Overall Study||13
8911078|NCT02143024|9970098|FG001|COMPLETED|Overall Study||7
8911079|NCT02143024|9970097|FG000|NOT COMPLETED|Overall Study||2
8911080|NCT02143024|9970098|FG001|NOT COMPLETED|Overall Study||1
9017016|NCT03056456|10079976|FG001|STARTED|Period 1||6
9017017|NCT03056456|10079977|FG002|STARTED|Period 1||6
9017018|NCT03056456|10079978|FG003|STARTED|Period 1||6
9017019|NCT03056456|10079975|FG000|Received One Dose of Study Drug|Period 1||6
9017020|NCT03056456|10079976|FG001|Received One Dose of Study Drug|Period 1||6
9017021|NCT03056456|10079977|FG002|Received One Dose of Study Drug|Period 1||6
9017022|NCT03056456|10079978|FG003|Received One Dose of Study Drug|Period 1||6
9017023|NCT03056456|10079975|FG000|COMPLETED|Period 1||6
9017024|NCT03056456|10079976|FG001|COMPLETED|Period 1||6
9017025|NCT03056456|10079977|FG002|COMPLETED|Period 1||6
9017026|NCT03056456|10079978|FG003|COMPLETED|Period 1||6
9017027|NCT03056456|10079975|FG000|NOT COMPLETED|Period 1||0
9017028|NCT03056456|10079976|FG001|NOT COMPLETED|Period 1||0
9017029|NCT03056456|10079977|FG002|NOT COMPLETED|Period 1||0
9017030|NCT03056456|10079978|FG003|NOT COMPLETED|Period 1||0
9017031|NCT03056456|10079975|FG000|STARTED|Period 2||6
9017032|NCT03056456|10079976|FG001|STARTED|Period 2||6
9017033|NCT03056456|10079977|FG002|STARTED|Period 2||6
9017034|NCT03056456|10079978|FG003|STARTED|Period 2||6
9017035|NCT03056456|10079975|FG000|COMPLETED|Period 2||6
9017036|NCT03056456|10079976|FG001|COMPLETED|Period 2||6
9017037|NCT03056456|10079977|FG002|COMPLETED|Period 2||6
9017038|NCT03056456|10079978|FG003|COMPLETED|Period 2||6
9017039|NCT03056456|10079975|FG000|NOT COMPLETED|Period 2||0
9017040|NCT03056456|10079976|FG001|NOT COMPLETED|Period 2||0
9017041|NCT03056456|10079977|FG002|NOT COMPLETED|Period 2||0
9017042|NCT03056456|10079978|FG003|NOT COMPLETED|Period 2||0
9017043|NCT03056456|10079975|FG000|STARTED|Period 3||6
9017044|NCT03056456|10079976|FG001|STARTED|Period 3||6
9017045|NCT03056456|10079977|FG002|STARTED|Period 3||6
9017046|NCT03056456|10079978|FG003|STARTED|Period 3||6
9017047|NCT03056456|10079975|FG000|COMPLETED|Period 3||6
9017048|NCT03056456|10079976|FG001|COMPLETED|Period 3||6
9017049|NCT03056456|10079977|FG002|COMPLETED|Period 3||6
9017050|NCT03056456|10079978|FG003|COMPLETED|Period 3||6
9017051|NCT03056456|10079975|FG000|NOT COMPLETED|Period 3||0
9017052|NCT03056456|10079976|FG001|NOT COMPLETED|Period 3||0
9017053|NCT03056456|10079977|FG002|NOT COMPLETED|Period 3||0
9017054|NCT03056456|10079978|FG003|NOT COMPLETED|Period 3||0
9017055|NCT03056456|10079975|FG000|STARTED|Period 4||6
9017056|NCT03056456|10079976|FG001|STARTED|Period 4||6
9017057|NCT03056456|10079977|FG002|STARTED|Period 4||6
9017058|NCT03056456|10079978|FG003|STARTED|Period 4|Participant deviated from 1 week maximum between consecutive periods and did not start Period 4.|5
9017059|NCT03056456|10079975|FG000|COMPLETED|Period 4||6
9017060|NCT03056456|10079976|FG001|COMPLETED|Period 4||6
9017061|NCT03056456|10079977|FG002|COMPLETED|Period 4||6
9017062|NCT03056456|10079978|FG003|COMPLETED|Period 4||5
9017063|NCT03056456|10079975|FG000|NOT COMPLETED|Period 4||0
8637203|NCT00570687|9677764|FG001|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
8637204|NCT00570687|9677765|FG002|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
8637205|NCT00570687|9677766|FG003|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
9017064|NCT03056456|10079976|FG001|NOT COMPLETED|Period 4||0
9017065|NCT03056456|10079977|FG002|NOT COMPLETED|Period 4||0
9017066|NCT03056456|10079978|FG003|NOT COMPLETED|Period 4||0
9017067|NCT03056573|10079993|FG000|STARTED|Overall Study||45
9017068|NCT03056573|10079994|FG001|STARTED|Overall Study||19
9017069|NCT03056573|10079993|FG000|COMPLETED|Overall Study||40
9017070|NCT03056573|10079994|FG001|COMPLETED|Overall Study||14
9017071|NCT03056573|10079993|FG000|NOT COMPLETED|Overall Study||5
9017072|NCT03056573|10079994|FG001|NOT COMPLETED|Overall Study||5
9017073|NCT03056690|10080002|FG000|STARTED|Overall Study||95
9017074|NCT03056690|10080003|FG001|STARTED|Overall Study||91
9017075|NCT03056690|10080002|FG000|Treated|Overall Study||94
9017076|NCT03056690|10080003|FG001|Treated|Overall Study||90
9017077|NCT03056690|10080002|FG000|COMPLETED|Overall Study||81
9017078|NCT03056690|10080003|FG001|COMPLETED|Overall Study||75
9017079|NCT03056690|10080002|FG000|NOT COMPLETED|Overall Study||14
9017080|NCT03056690|10080003|FG001|NOT COMPLETED|Overall Study||16
9017081|NCT03057132|10080009|FG000|STARTED|Overall Study||1
9017082|NCT03057132|10080009|FG000|COMPLETED|Overall Study||1
9017083|NCT03057132|10080009|FG000|NOT COMPLETED|Overall Study||0
9017084|NCT03057366|10080014|FG000|STARTED|Part A||8
9017085|NCT03057366|10080015|FG001|STARTED|Part A||0
9017086|NCT03057366|10080016|FG002|STARTED|Part A||0
9017087|NCT03057366|10080014|FG000|COMPLETED|Part A||8
9017088|NCT03057366|10080015|FG001|COMPLETED|Part A||0
9017089|NCT03057366|10080016|FG002|COMPLETED|Part A||0
9017090|NCT03057366|10080014|FG000|NOT COMPLETED|Part A||0
9017091|NCT03057366|10080015|FG001|NOT COMPLETED|Part A||0
9017092|NCT03057366|10080016|FG002|NOT COMPLETED|Part A||0
9017093|NCT03057366|10080014|FG000|STARTED|Part B||0
9017094|NCT03057366|10080015|FG001|STARTED|Part B|Participants completed Part A, met eligibility criteria, and provided consent for Part B.|5
9017095|NCT03057366|10080016|FG002|STARTED|Part B|Participants completed Part A, met eligibility criteria, and provided consent for Part B.|2
9017096|NCT03057366|10080014|FG000|COMPLETED|Part B||0
9017097|NCT03057366|10080015|FG001|COMPLETED|Part B||5
9017098|NCT03057366|10080016|FG002|COMPLETED|Part B||2
9017099|NCT03057366|10080014|FG000|NOT COMPLETED|Part B||0
9017100|NCT03057366|10080015|FG001|NOT COMPLETED|Part B||0
9017101|NCT03057366|10080016|FG002|NOT COMPLETED|Part B||0
9017102|NCT03057496|10080026|FG000|STARTED|Overall Study||49
9017103|NCT03057496|10080026|FG000|Started Home-use Trial|Overall Study||36
9017104|NCT03057496|10080026|FG000|COMPLETED|Overall Study||31
9017105|NCT03057496|10080026|FG000|NOT COMPLETED|Overall Study||18
9017106|NCT03057613|10080032|FG000|STARTED|Overall Study||18
9017107|NCT03057613|10080032|FG000|COMPLETED|Overall Study||18
9017108|NCT03057613|10080032|FG000|NOT COMPLETED|Overall Study||0
9017109|NCT03057704|10080038|FG000|STARTED|Overall Study||25
9017110|NCT03057704|10080039|FG001|STARTED|Overall Study||25
9017111|NCT03057704|10080038|FG000|COMPLETED|Overall Study||25
9017112|NCT03057704|10080039|FG001|COMPLETED|Overall Study||25
9017113|NCT03057704|10080038|FG000|NOT COMPLETED|Overall Study||0
9017114|NCT03057704|10080039|FG001|NOT COMPLETED|Overall Study||0
9017115|NCT03057977|10080047|FG000|STARTED|Discontinuation From Treatment||1867
9017116|NCT03057977|10080048|FG001|STARTED|Discontinuation From Treatment||1863
9017117|NCT03057977|10080047|FG000|Treated|Discontinuation From Treatment||1863
9017118|NCT03057977|10080048|FG001|Treated|Discontinuation From Treatment||1863
9017119|NCT03057977|10080047|FG000|COMPLETED|Discontinuation From Treatment||1352
9017120|NCT03057977|10080048|FG001|COMPLETED|Discontinuation From Treatment||1381
9017121|NCT03057977|10080047|FG000|NOT COMPLETED|Discontinuation From Treatment||515
9017122|NCT03057977|10080048|FG001|NOT COMPLETED|Discontinuation From Treatment||482
9017123|NCT03057977|10080047|FG000|STARTED|Discontinuation From Trial||1867
9017124|NCT03057977|10080048|FG001|STARTED|Discontinuation From Trial||1863
9017125|NCT03057977|10080047|FG000|Treated|Discontinuation From Trial||1863
8574663|NCT00129766|9607213|FG000|STARTED|Overall Study||3306
8574664|NCT00129766|9607214|FG001|STARTED|Overall Study||3329
8574665|NCT00129766|9607213|FG000|COMPLETED|Overall Study||3246
8574666|NCT00129766|9607214|FG001|COMPLETED|Overall Study||3270
8574667|NCT00129766|9607213|FG000|NOT COMPLETED|Overall Study||60
8574668|NCT00129766|9607214|FG001|NOT COMPLETED|Overall Study||59
8574669|NCT00129935|9607223|FG000|STARTED|Overall Study||669
8574670|NCT00129935|9607224|FG001|STARTED|Overall Study||715
8574671|NCT00129935|9607223|FG000|COMPLETED|Overall Study|2 patients crossed from arm A to B by error, and 1 patient received other treatment by error.|633
8574672|NCT00129935|9607224|FG001|COMPLETED|Overall Study|1 patient crossed from arm B to A by error.|623
8574673|NCT00129935|9607223|FG000|NOT COMPLETED|Overall Study||36
8574674|NCT00129935|9607224|FG001|NOT COMPLETED|Overall Study||92
8637206|NCT00570687|9677767|FG004|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
8637207|NCT00570687|9677768|FG005|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
8637208|NCT00570687|9677769|FG006|STARTED|Clamp 1 (1 Day) - Orig Protocol||1
8637209|NCT00570687|9677770|FG007|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
8637210|NCT00570687|9677771|FG008|STARTED|Clamp 1 (1 Day) - Orig Protocol||1
8637211|NCT00570687|9677772|FG009|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
9017126|NCT03057977|10080048|FG001|Treated|Discontinuation From Trial||1863
8574675|NCT00129961|9607232|FG000|STARTED|Overall Study||39
8574676|NCT00129961|9607233|FG001|STARTED|Overall Study||47
8574677|NCT00129961|9607232|FG000|COMPLETED|Overall Study||20
8574678|NCT00129961|9607233|FG001|COMPLETED|Overall Study||24
8574679|NCT00129961|9607232|FG000|NOT COMPLETED|Overall Study||19
8574680|NCT00129961|9607233|FG001|NOT COMPLETED|Overall Study||23
8574681|NCT00129987|9607241|FG000|STARTED|1st Educational Session||287
8574682|NCT00129987|9607242|FG001|STARTED|1st Educational Session||280
8574683|NCT00129987|9607241|FG000|COMPLETED|1st Educational Session||146
8574684|NCT00129987|9607242|FG001|COMPLETED|1st Educational Session||171
8574685|NCT00129987|9607241|FG000|NOT COMPLETED|1st Educational Session||141
8574686|NCT00129987|9607242|FG001|NOT COMPLETED|1st Educational Session||109
8574687|NCT00129987|9607241|FG000|STARTED|1 Year||146
8574688|NCT00129987|9607242|FG001|STARTED|1 Year||171
8574689|NCT00129987|9607241|FG000|COMPLETED|1 Year||114
8574690|NCT00129987|9607242|FG001|COMPLETED|1 Year||150
8574691|NCT00129987|9607241|FG000|NOT COMPLETED|1 Year||32
8574692|NCT00129987|9607242|FG001|NOT COMPLETED|1 Year||21
8574693|NCT00130039|9607250|FG000|STARTED|Overall Study||232
8574694|NCT00130039|9607251|FG001|STARTED|Overall Study||225
8574695|NCT00130039|9607250|FG000|COMPLETED|Overall Study|full analysis set|202
8574696|NCT00130039|9607251|FG001|COMPLETED|Overall Study|full analysis set|207
8574697|NCT00130039|9607250|FG000|NOT COMPLETED|Overall Study||30
8574698|NCT00130039|9607251|FG001|NOT COMPLETED|Overall Study||18
8574699|NCT00130117|9607259|FG000|STARTED|Overall Study||11
8574700|NCT00130117|9607260|FG001|STARTED|Overall Study||9
8574701|NCT00130117|9607259|FG000|COMPLETED|Overall Study||7
8574702|NCT00130117|9607260|FG001|COMPLETED|Overall Study||6
8574703|NCT00130117|9607259|FG000|NOT COMPLETED|Overall Study||4
8574704|NCT00130117|9607260|FG001|NOT COMPLETED|Overall Study||3
8574705|NCT00130208|9607269|FG000|STARTED|Maintenance Period (26 Weeks)||524
8574706|NCT00130208|9607270|FG001|STARTED|Maintenance Period (26 Weeks)||532
8574707|NCT00130208|9607269|FG000|Valid Albumin Creatinine Ratio|Maintenance Period (26 Weeks)||492
8574708|NCT00130208|9607270|FG001|Valid Albumin Creatinine Ratio|Maintenance Period (26 Weeks)||494
8574709|NCT00130208|9607269|FG000|COMPLETED|Maintenance Period (26 Weeks)||500
8574710|NCT00130208|9607270|FG001|COMPLETED|Maintenance Period (26 Weeks)||502
8574711|NCT00130208|9607269|FG000|NOT COMPLETED|Maintenance Period (26 Weeks)||24
8574712|NCT00130208|9607270|FG001|NOT COMPLETED|Maintenance Period (26 Weeks)||30
8574713|NCT00130208|9607269|FG000|STARTED|Washout Period (8 Weeks)||500
8574714|NCT00130208|9607270|FG001|STARTED|Washout Period (8 Weeks)||502
8574715|NCT00130208|9607269|FG000|COMPLETED|Washout Period (8 Weeks)||494
8574716|NCT00130208|9607270|FG001|COMPLETED|Washout Period (8 Weeks)||490
8574717|NCT00130208|9607269|FG000|NOT COMPLETED|Washout Period (8 Weeks)||6
8574718|NCT00130208|9607270|FG001|NOT COMPLETED|Washout Period (8 Weeks)||12
8574719|NCT00130247|9607278|FG000|STARTED|Overall Study||196
8574720|NCT00130247|9607279|FG001|STARTED|Overall Study||198
9017127|NCT03057977|10080047|FG000|COMPLETED|Discontinuation From Trial||1847
9017128|NCT03057977|10080048|FG001|COMPLETED|Discontinuation From Trial||1841
9017129|NCT03057977|10080047|FG000|NOT COMPLETED|Discontinuation From Trial||20
9017130|NCT03057977|10080048|FG001|NOT COMPLETED|Discontinuation From Trial||22
9017131|NCT03058679|10080056|FG000|STARTED|Baseline to Week 6|3 randomized to SCD withdrew before starting diet;2 randomized pts w/ baseline sCDAI<150 excluded.|99
9017132|NCT03058679|10080057|FG001|STARTED|Baseline to Week 6|Due to an error 1 participant was randomized with a baseline sCDAI<150. This pt was excluded.|92
9017133|NCT03058679|10080056|FG000|COMPLETED|Baseline to Week 6||81
9017134|NCT03058679|10080057|FG001|COMPLETED|Baseline to Week 6||77
9017135|NCT03058679|10080056|FG000|NOT COMPLETED|Baseline to Week 6||18
9017136|NCT03058679|10080057|FG001|NOT COMPLETED|Baseline to Week 6||15
9017137|NCT03058679|10080056|FG000|STARTED|Week 6 to Week 12||81
9017138|NCT03058679|10080057|FG001|STARTED|Week 6 to Week 12||77
9017139|NCT03058679|10080056|FG000|COMPLETED|Week 6 to Week 12||61
9017140|NCT03058679|10080057|FG001|COMPLETED|Week 6 to Week 12||60
9017141|NCT03058679|10080056|FG000|NOT COMPLETED|Week 6 to Week 12||20
9017142|NCT03058679|10080057|FG001|NOT COMPLETED|Week 6 to Week 12||17
9017143|NCT03058692|10080065|FG000|STARTED|Overall Study||61
9017144|NCT03058692|10080066|FG001|STARTED|Overall Study||59
9017145|NCT03058692|10080065|FG000|COMPLETED|Overall Study||58
9017146|NCT03058692|10080066|FG001|COMPLETED|Overall Study||57
9017147|NCT03058692|10080065|FG000|NOT COMPLETED|Overall Study||3
9017148|NCT03058692|10080066|FG001|NOT COMPLETED|Overall Study||2
9017149|NCT03058991|10080076|FG000|STARTED|Overall Study||39
9017150|NCT03058991|10080077|FG001|STARTED|Overall Study||32
9017151|NCT03058991|10080078|FG002|STARTED|Overall Study||37
9017152|NCT03058991|10080076|FG000|1-Week Follow Up|Overall Study||23
9017153|NCT03058991|10080077|FG001|1-Week Follow Up|Overall Study||27
9017154|NCT03058991|10080078|FG002|1-Week Follow Up|Overall Study||28
9017155|NCT03058991|10080076|FG000|COMPLETED|Overall Study||21
9017156|NCT03058991|10080077|FG001|COMPLETED|Overall Study||20
9017157|NCT03058991|10080078|FG002|COMPLETED|Overall Study||25
9017158|NCT03058991|10080076|FG000|NOT COMPLETED|Overall Study||18
9017159|NCT03058991|10080077|FG001|NOT COMPLETED|Overall Study||12
9017160|NCT03058991|10080078|FG002|NOT COMPLETED|Overall Study||12
9017161|NCT03059810|10080086|FG000|STARTED|Overall Study||63
9017162|NCT03059810|10080086|FG000|COMPLETED|Overall Study||63
9017163|NCT03059810|10080086|FG000|NOT COMPLETED|Overall Study||0
9017164|NCT03059901|10080092|FG000|STARTED|Overall Study||30
9017165|NCT03059901|10080093|FG001|STARTED|Overall Study||30
8574721|NCT00130247|9607278|FG000|COMPLETED|Overall Study||194
8574722|NCT00130247|9607279|FG001|COMPLETED|Overall Study||194
8574723|NCT00130247|9607278|FG000|NOT COMPLETED|Overall Study||2
8574724|NCT00130247|9607279|FG001|NOT COMPLETED|Overall Study||4
8574725|NCT00130286|9607289|FG000|STARTED|Overall Study||22
8574726|NCT00130286|9607290|FG001|STARTED|Overall Study||19
8574727|NCT00130286|9607291|FG002|STARTED|Overall Study||17
8574728|NCT00130286|9607292|FG003|STARTED|Overall Study||19
8574729|NCT00130286|9607289|FG000|COMPLETED|Overall Study||22
8574730|NCT00130286|9607290|FG001|COMPLETED|Overall Study||16
8574731|NCT00130286|9607291|FG002|COMPLETED|Overall Study||13
8574732|NCT00130286|9607292|FG003|COMPLETED|Overall Study||17
8574733|NCT00130286|9607289|FG000|NOT COMPLETED|Overall Study||0
8574734|NCT00130286|9607290|FG001|NOT COMPLETED|Overall Study||3
8574735|NCT00130286|9607291|FG002|NOT COMPLETED|Overall Study||4
8574736|NCT00130286|9607292|FG003|NOT COMPLETED|Overall Study||2
8574737|NCT00130442|9607304|FG000|STARTED|Overall Study||66
8574738|NCT00130442|9607305|FG001|STARTED|Overall Study||68
8574739|NCT00130442|9607304|FG000|COMPLETED|Overall Study||65
8574740|NCT00130442|9607305|FG001|COMPLETED|Overall Study||66
8574741|NCT00130442|9607304|FG000|NOT COMPLETED|Overall Study||1
8574742|NCT00130442|9607305|FG001|NOT COMPLETED|Overall Study||2
8574743|NCT00130520|9607313|FG000|STARTED|Overall Study|85 women were screened for eligibility, 56 consented, 40 treated.|40
8574744|NCT00130520|9607313|FG000|Completion of at Least One Cycle|Overall Study||39
8574745|NCT00130520|9607313|FG000|COMPLETED|Overall Study||1
8574746|NCT00130520|9607313|FG000|NOT COMPLETED|Overall Study||39
8574747|NCT00130533|9607319|FG000|STARTED|Overall Study||448
8574748|NCT00130533|9607320|FG001|STARTED|Overall Study||428
8574749|NCT00130533|9607319|FG000|COMPLETED|Overall Study||337
8574750|NCT00130533|9607320|FG001|COMPLETED|Overall Study||398
8574751|NCT00130533|9607319|FG000|NOT COMPLETED|Overall Study||111
8574752|NCT00130533|9607320|FG001|NOT COMPLETED|Overall Study||30
8574753|NCT00130637|9607326|FG000|STARTED|Overall Study||6
8574754|NCT00130637|9607326|FG000|COMPLETED|Overall Study||3
9017166|NCT03059901|10080092|FG000|COMPLETED|Overall Study||26
9017167|NCT03059901|10080093|FG001|COMPLETED|Overall Study||28
8574755|NCT00130637|9607326|FG000|NOT COMPLETED|Overall Study||3
8574756|NCT00130689|9607330|FG000|STARTED|Overall Study||43
8574757|NCT00130689|9607330|FG000|Eligible|Overall Study||37
8574758|NCT00130689|9607330|FG000|Treated|Overall Study||35
8574759|NCT00130689|9607330|FG000|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
8574760|NCT00130689|9607330|FG000|NOT COMPLETED|Overall Study||43
8574761|NCT00130728|9607336|FG000|STARTED|Overall Study||319
8574762|NCT00130728|9607337|FG001|STARTED|Overall Study||317
8574763|NCT00130728|9607336|FG000|Received Study Drug (Safety Population)|Overall Study||313
8574764|NCT00130728|9607337|FG001|Received Study Drug (Safety Population)|Overall Study||313
8574765|NCT00130728|9607336|FG000|COMPLETED|Overall Study||57
9017168|NCT03059901|10080092|FG000|NOT COMPLETED|Overall Study||4
9017169|NCT03059901|10080093|FG001|NOT COMPLETED|Overall Study||2
9017170|NCT03060447|10080101|FG000|STARTED|Overall Study||17
9017171|NCT03060447|10080102|FG001|STARTED|Overall Study||8
9017172|NCT03060447|10080101|FG000|COMPLETED|Overall Study||15
9017173|NCT03060447|10080102|FG001|COMPLETED|Overall Study||8
9017174|NCT03060447|10080101|FG000|NOT COMPLETED|Overall Study||2
9017175|NCT03060447|10080102|FG001|NOT COMPLETED|Overall Study||0
8574766|NCT00130728|9607337|FG001|COMPLETED|Overall Study||57
8574767|NCT00130728|9607336|FG000|NOT COMPLETED|Overall Study||262
8574768|NCT00130728|9607337|FG001|NOT COMPLETED|Overall Study||260
8637212|NCT00570687|9677763|FG000|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
8637213|NCT00570687|9677764|FG001|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
8637214|NCT00570687|9677765|FG002|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
8637215|NCT00570687|9677766|FG003|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
8637216|NCT00570687|9677767|FG004|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
8637217|NCT00570687|9677768|FG005|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
8637218|NCT00570687|9677769|FG006|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||1
8637219|NCT00570687|9677770|FG007|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
8637220|NCT00570687|9677771|FG008|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||1
8637221|NCT00570687|9677772|FG009|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
8637222|NCT00570687|9677763|FG000|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
8637223|NCT00570687|9677764|FG001|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
8637224|NCT00570687|9677765|FG002|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
8637225|NCT00570687|9677766|FG003|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
8637226|NCT00570687|9677767|FG004|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
8637227|NCT00570687|9677768|FG005|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
8637228|NCT00570687|9677769|FG006|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
8637229|NCT00570687|9677770|FG007|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
8637230|NCT00570687|9677771|FG008|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
8637231|NCT00570687|9677772|FG009|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
8637232|NCT00570687|9677763|FG000|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
8637233|NCT00570687|9677764|FG001|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
8637234|NCT00570687|9677765|FG002|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
8637235|NCT00570687|9677766|FG003|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
8637236|NCT00570687|9677767|FG004|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
8637237|NCT00570687|9677768|FG005|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
8637238|NCT00570687|9677769|FG006|STARTED|Washout 4 (7-21 Days) - Orig Protocol||1
8637239|NCT00570687|9677770|FG007|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
8637240|NCT00570687|9677771|FG008|STARTED|Washout 4 (7-21 Days) - Orig Protocol||1
8637241|NCT00570687|9677772|FG009|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
8637242|NCT00570687|9677763|FG000|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
8637243|NCT00570687|9677764|FG001|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
8637244|NCT00570687|9677765|FG002|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
8637245|NCT00570687|9677766|FG003|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
8637246|NCT00570687|9677767|FG004|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
8637247|NCT00570687|9677768|FG005|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
8637248|NCT00570687|9677769|FG006|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||1
8637249|NCT00570687|9677770|FG007|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
8637250|NCT00570687|9677771|FG008|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
8637251|NCT00570687|9677772|FG009|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
8637252|NCT00570687|9677763|FG000|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
8637253|NCT00570687|9677764|FG001|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
8637254|NCT00570687|9677765|FG002|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
8637255|NCT00570687|9677766|FG003|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
8637256|NCT00570687|9677767|FG004|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
8637257|NCT00570687|9677768|FG005|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
8637258|NCT00570687|9677769|FG006|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
8637259|NCT00570687|9677770|FG007|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
8637260|NCT00570687|9677771|FG008|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||1
8637261|NCT00570687|9677772|FG009|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
8637262|NCT00570687|9677763|FG000|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
8637263|NCT00570687|9677764|FG001|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
8637264|NCT00570687|9677765|FG002|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
8637265|NCT00570687|9677766|FG003|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
8637266|NCT00570687|9677767|FG004|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
8637267|NCT00570687|9677768|FG005|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
8637268|NCT00570687|9677769|FG006|STARTED|Clamp 2 (1 Day) - Orig Protocol||1
8637269|NCT00570687|9677770|FG007|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
8637270|NCT00570687|9677771|FG008|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
8637271|NCT00570687|9677772|FG009|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
8637272|NCT00570687|9677763|FG000|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
8637273|NCT00570687|9677764|FG001|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
8637274|NCT00570687|9677765|FG002|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
8637275|NCT00570687|9677766|FG003|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
8574769|NCT00130780|9607345|FG000|STARTED|Overall Study||51
8574770|NCT00130780|9607346|FG001|STARTED|Overall Study||20
8574771|NCT00130780|9607345|FG000|COMPLETED|Overall Study||51
8574772|NCT00130780|9607346|FG001|COMPLETED|Overall Study||20
8574773|NCT00130780|9607345|FG000|NOT COMPLETED|Overall Study||0
8574774|NCT00130780|9607346|FG001|NOT COMPLETED|Overall Study||0
9017176|NCT03060486|10080114|FG000|STARTED|Overall Study||15
8574775|NCT00130793|9607354|FG000|STARTED|Overall Study||183
8574776|NCT00130793|9607355|FG001|STARTED|Overall Study||185
9017177|NCT03060486|10080114|FG000|COMPLETED|Overall Study||15
9017178|NCT03060486|10080114|FG000|NOT COMPLETED|Overall Study||0
9017179|NCT03060512|10080120|FG000|STARTED|Overall Study||137
9017180|NCT03060512|10080121|FG001|STARTED|Overall Study||139
9017181|NCT03060512|10080120|FG000|Treated With Movantik|Overall Study||136
9017182|NCT03060512|10080121|FG001|Treated With Movantik|Overall Study||135
9017183|NCT03060512|10080120|FG000|Treated With PEG 3350|Overall Study||130
9017184|NCT03060512|10080121|FG001|Treated With PEG 3350|Overall Study||138
9017185|NCT03060512|10080120|FG000|COMPLETED|Overall Study||130
9017186|NCT03060512|10080121|FG001|COMPLETED|Overall Study||130
9017187|NCT03060512|10080120|FG000|NOT COMPLETED|Overall Study||7
9017188|NCT03060512|10080121|FG001|NOT COMPLETED|Overall Study||9
9017189|NCT03060551|10080132|FG000|STARTED|Overall Study||20
9017190|NCT03060551|10080132|FG000|COMPLETED|Overall Study||18
9017191|NCT03060551|10080132|FG000|NOT COMPLETED|Overall Study||2
9017192|NCT03060759|10080138|FG000|STARTED|Overall Study||20
9017193|NCT03060759|10080139|FG001|STARTED|Overall Study||15
9017194|NCT03060759|10080138|FG000|COMPLETED|Overall Study||15
9017195|NCT03060759|10080139|FG001|COMPLETED|Overall Study||12
9017196|NCT03060759|10080138|FG000|NOT COMPLETED|Overall Study||5
9017197|NCT03060759|10080139|FG001|NOT COMPLETED|Overall Study||3
9017198|NCT03061097|10080147|FG000|STARTED|Overall Study||4
9017199|NCT03061097|10080148|FG001|STARTED|Overall Study||3
9017200|NCT03061097|10080147|FG000|COMPLETED|Overall Study||4
9017201|NCT03061097|10080148|FG001|COMPLETED|Overall Study||0
9017202|NCT03061097|10080147|FG000|NOT COMPLETED|Overall Study||0
9017203|NCT03061097|10080148|FG001|NOT COMPLETED|Overall Study||3
9017204|NCT03061175|10080156|FG000|STARTED|Baseline||47
9017205|NCT03061175|10080157|FG001|STARTED|Baseline||47
9017206|NCT03061175|10080156|FG000|COMPLETED|Baseline||46
9017207|NCT03061175|10080157|FG001|COMPLETED|Baseline||47
9017208|NCT03061175|10080156|FG000|NOT COMPLETED|Baseline||1
9017209|NCT03061175|10080157|FG001|NOT COMPLETED|Baseline||0
9017210|NCT03061175|10080156|FG000|STARTED|Followup 1 at 2-4 Weeks Post-surgery|1 Participant dropped out of the study before the follow-up survey was to be sent|45
9017211|NCT03061175|10080157|FG001|STARTED|Followup 1 at 2-4 Weeks Post-surgery||47
9017212|NCT03061175|10080156|FG000|COMPLETED|Followup 1 at 2-4 Weeks Post-surgery|39 participants completed the follow-up survey out of the 45 who were sent the survey|39
9017213|NCT03061175|10080157|FG001|COMPLETED|Followup 1 at 2-4 Weeks Post-surgery|44 participants completed the follow-up survey out of the 47 who were sent the survey|44
9017214|NCT03061175|10080156|FG000|NOT COMPLETED|Followup 1 at 2-4 Weeks Post-surgery||6
9017215|NCT03061175|10080157|FG001|NOT COMPLETED|Followup 1 at 2-4 Weeks Post-surgery||3
9017216|NCT03061175|10080156|FG000|STARTED|Followup 2 at 6 Months|Participants who skipped the first follow-up survey were still sent the second FU survey|45
9017217|NCT03061175|10080157|FG001|STARTED|Followup 2 at 6 Months|1 participant withdrew from the study in between the 1st and 2nd follow-up survey so only 46 sent|46
9017218|NCT03061175|10080156|FG000|COMPLETED|Followup 2 at 6 Months|41 participants completed the 2nd follow-up survey out of the 45 who were sent the survey|41
9017219|NCT03061175|10080157|FG001|COMPLETED|Followup 2 at 6 Months|39 participants completed the follow-up survey out of the 46 who were sent the survey|39
9017220|NCT03061175|10080156|FG000|NOT COMPLETED|Followup 2 at 6 Months||4
9017221|NCT03061175|10080157|FG001|NOT COMPLETED|Followup 2 at 6 Months||7
9017222|NCT03061188|10080167|FG000|STARTED|Completed 1st Cycle||0
9017223|NCT03061188|10080168|FG001|STARTED|Completed 1st Cycle||3
9017224|NCT03061188|10080169|FG002|STARTED|Completed 1st Cycle||6
9017225|NCT03061188|10080170|FG003|STARTED|Completed 1st Cycle||6
9017226|NCT03061188|10080167|FG000|COMPLETED|Completed 1st Cycle||0
9017227|NCT03061188|10080168|FG001|COMPLETED|Completed 1st Cycle||3
9017228|NCT03061188|10080169|FG002|COMPLETED|Completed 1st Cycle||6
9017229|NCT03061188|10080170|FG003|COMPLETED|Completed 1st Cycle||6
9017230|NCT03061188|10080167|FG000|NOT COMPLETED|Completed 1st Cycle||0
9017231|NCT03061188|10080168|FG001|NOT COMPLETED|Completed 1st Cycle||0
9017232|NCT03061188|10080169|FG002|NOT COMPLETED|Completed 1st Cycle||0
9017233|NCT03061188|10080170|FG003|NOT COMPLETED|Completed 1st Cycle||0
9017234|NCT03061188|10080167|FG000|STARTED|Went on to Cycle 2 and Beyond||0
9017235|NCT03061188|10080168|FG001|STARTED|Went on to Cycle 2 and Beyond||3
9017236|NCT03061188|10080169|FG002|STARTED|Went on to Cycle 2 and Beyond||6
9017237|NCT03061188|10080170|FG003|STARTED|Went on to Cycle 2 and Beyond||6
9017238|NCT03061188|10080167|FG000|Received Dose of Study Drugs|Went on to Cycle 2 and Beyond||0
9017239|NCT03061188|10080168|FG001|Received Dose of Study Drugs|Went on to Cycle 2 and Beyond||3
9017240|NCT03061188|10080169|FG002|Received Dose of Study Drugs|Went on to Cycle 2 and Beyond||5
9017241|NCT03061188|10080170|FG003|Received Dose of Study Drugs|Went on to Cycle 2 and Beyond||5
9017242|NCT03061188|10080167|FG000|COMPLETED|Went on to Cycle 2 and Beyond||0
9017243|NCT03061188|10080168|FG001|COMPLETED|Went on to Cycle 2 and Beyond||3
9017244|NCT03061188|10080169|FG002|COMPLETED|Went on to Cycle 2 and Beyond||5
9017245|NCT03061188|10080170|FG003|COMPLETED|Went on to Cycle 2 and Beyond||5
9017246|NCT03061188|10080167|FG000|NOT COMPLETED|Went on to Cycle 2 and Beyond||0
9017247|NCT03061188|10080168|FG001|NOT COMPLETED|Went on to Cycle 2 and Beyond||0
9017248|NCT03061188|10080169|FG002|NOT COMPLETED|Went on to Cycle 2 and Beyond||1
9017249|NCT03061188|10080170|FG003|NOT COMPLETED|Went on to Cycle 2 and Beyond||1
9017250|NCT03061188|10080167|FG000|STARTED|On Follow-up for 3 Years||0
9017251|NCT03061188|10080168|FG001|STARTED|On Follow-up for 3 Years||3
9017252|NCT03061188|10080169|FG002|STARTED|On Follow-up for 3 Years|Patients who received at least one dose of study drug go into follow-up.|6
9017253|NCT03061188|10080170|FG003|STARTED|On Follow-up for 3 Years|Patients who receive at least one dose of study drug go into follow-up.|6
9017254|NCT03061188|10080167|FG000|COMPLETED|On Follow-up for 3 Years||0
9017255|NCT03061188|10080168|FG001|COMPLETED|On Follow-up for 3 Years||0
9017256|NCT03061188|10080169|FG002|COMPLETED|On Follow-up for 3 Years||1
9017257|NCT03061188|10080170|FG003|COMPLETED|On Follow-up for 3 Years||1
9017258|NCT03061188|10080167|FG000|NOT COMPLETED|On Follow-up for 3 Years||0
9017259|NCT03061188|10080168|FG001|NOT COMPLETED|On Follow-up for 3 Years||3
9017260|NCT03061188|10080169|FG002|NOT COMPLETED|On Follow-up for 3 Years||5
9017261|NCT03061188|10080170|FG003|NOT COMPLETED|On Follow-up for 3 Years||5
9017262|NCT03061214|10080188|FG000|STARTED|Overall Study||288
9017263|NCT03061214|10080189|FG001|STARTED|Overall Study||290
9017264|NCT03061214|10080190|FG002|STARTED|Overall Study||290
9017265|NCT03061214|10080188|FG000|Exposed|Overall Study||287
9017266|NCT03061214|10080189|FG001|Exposed|Overall Study||290
9017267|NCT03061214|10080190|FG002|Exposed|Overall Study||290
9017268|NCT03061214|10080188|FG000|Full Analysis Set (FAS)|Overall Study||288
9017269|NCT03061214|10080189|FG001|Full Analysis Set (FAS)|Overall Study||290
9017270|NCT03061214|10080190|FG002|Full Analysis Set (FAS)|Overall Study||290
9017271|NCT03061214|10080188|FG000|Safety Analysis Set (SAS)|Overall Study||287
9017272|NCT03061214|10080189|FG001|Safety Analysis Set (SAS)|Overall Study||290
9017273|NCT03061214|10080190|FG002|Safety Analysis Set (SAS)|Overall Study||290
9017274|NCT03061214|10080188|FG000|COMPLETED|Overall Study||263
9017275|NCT03061214|10080189|FG001|COMPLETED|Overall Study||262
8637276|NCT00570687|9677767|FG004|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
8637277|NCT00570687|9677768|FG005|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
8637278|NCT00570687|9677769|FG006|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||1
8637279|NCT00570687|9677770|FG007|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
8637280|NCT00570687|9677771|FG008|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
8637281|NCT00570687|9677772|FG009|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
8637282|NCT00570687|9677763|FG000|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
8637283|NCT00570687|9677764|FG001|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
8637284|NCT00570687|9677765|FG002|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
9017276|NCT03061214|10080190|FG002|COMPLETED|Overall Study||280
9017277|NCT03061214|10080188|FG000|NOT COMPLETED|Overall Study||25
9017278|NCT03061214|10080189|FG001|NOT COMPLETED|Overall Study||28
9017279|NCT03061214|10080190|FG002|NOT COMPLETED|Overall Study||10
9017280|NCT03061331|10080200|FG000|STARTED|Treatment Period 1 (8 Weeks)||10
9017281|NCT03061331|10080201|FG001|STARTED|Treatment Period 1 (8 Weeks)||10
9017282|NCT03061331|10080200|FG000|COMPLETED|Treatment Period 1 (8 Weeks)||10
9017283|NCT03061331|10080201|FG001|COMPLETED|Treatment Period 1 (8 Weeks)||10
9017284|NCT03061331|10080200|FG000|NOT COMPLETED|Treatment Period 1 (8 Weeks)||0
9017285|NCT03061331|10080201|FG001|NOT COMPLETED|Treatment Period 1 (8 Weeks)||0
9017286|NCT03061331|10080200|FG000|STARTED|Washout Period (8 Weeks)||10
9017287|NCT03061331|10080201|FG001|STARTED|Washout Period (8 Weeks)||10
9017288|NCT03061331|10080200|FG000|COMPLETED|Washout Period (8 Weeks)||8
9017289|NCT03061331|10080201|FG001|COMPLETED|Washout Period (8 Weeks)||9
9017290|NCT03061331|10080200|FG000|NOT COMPLETED|Washout Period (8 Weeks)||2
9017291|NCT03061331|10080201|FG001|NOT COMPLETED|Washout Period (8 Weeks)||1
9017292|NCT03061331|10080200|FG000|STARTED|Treatment Period 2 (8 Weeks)||8
9017293|NCT03061331|10080201|FG001|STARTED|Treatment Period 2 (8 Weeks)||9
9017294|NCT03061331|10080200|FG000|COMPLETED|Treatment Period 2 (8 Weeks)||8
9017295|NCT03061331|10080201|FG001|COMPLETED|Treatment Period 2 (8 Weeks)||9
9017296|NCT03061331|10080200|FG000|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
9017297|NCT03061331|10080201|FG001|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
9017298|NCT03061513|10080209|FG000|STARTED|Overall Study||6
9017299|NCT03061513|10080210|FG001|STARTED|Overall Study||5
9017300|NCT03061513|10080209|FG000|COMPLETED|Overall Study||6
9017301|NCT03061513|10080210|FG001|COMPLETED|Overall Study||4
9017302|NCT03061513|10080209|FG000|NOT COMPLETED|Overall Study||0
9017303|NCT03061513|10080210|FG001|NOT COMPLETED|Overall Study||1
9017304|NCT03061812|10080218|FG000|STARTED|Overall Study||148
9017305|NCT03061812|10080219|FG001|STARTED|Overall Study||296
9017306|NCT03061812|10080218|FG000|COMPLETED|Overall Study||148
9017307|NCT03061812|10080219|FG001|COMPLETED|Overall Study||296
9017308|NCT03061812|10080218|FG000|NOT COMPLETED|Overall Study||0
9017309|NCT03061812|10080219|FG001|NOT COMPLETED|Overall Study||0
9017310|NCT03062228|10080225|FG000|STARTED|Overall Study||162
9017311|NCT03062228|10080225|FG000|COMPLETED|Overall Study||162
9017312|NCT03062228|10080225|FG000|NOT COMPLETED|Overall Study||0
9017313|NCT03062267|10080231|FG000|STARTED|Overall Study||12
9017314|NCT03062267|10080232|FG001|STARTED|Overall Study||37
9017315|NCT03062267|10080231|FG000|COMPLETED|Overall Study||10
9017316|NCT03062267|10080232|FG001|COMPLETED|Overall Study||32
8637285|NCT00570687|9677766|FG003|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
8727100|NCT01041573|9774504|FG000|NOT COMPLETED|Overall Study||5
8727101|NCT01041573|9774505|FG001|NOT COMPLETED|Overall Study||13
8727102|NCT01041573|9774506|FG002|NOT COMPLETED|Overall Study||7
8727103|NCT01041573|9774507|FG003|NOT COMPLETED|Overall Study||2
8727104|NCT01041638|9774526|FG000|STARTED|Overall Study||105
8727105|NCT01041638|9774526|FG000|COMPLETED|Overall Study||78
9017317|NCT03062267|10080231|FG000|NOT COMPLETED|Overall Study||2
9017318|NCT03062267|10080232|FG001|NOT COMPLETED|Overall Study||5
9017319|NCT03062488|10080241|FG000|STARTED|Overall Study||51
9017320|NCT03062488|10080242|FG001|STARTED|Overall Study||51
9017321|NCT03062488|10080243|FG002|STARTED|Overall Study||41
9017322|NCT03062488|10080241|FG000|COMPLETED|Overall Study||51
9017323|NCT03062488|10080242|FG001|COMPLETED|Overall Study||51
9017324|NCT03062488|10080243|FG002|COMPLETED|Overall Study||41
9017325|NCT03062488|10080241|FG000|NOT COMPLETED|Overall Study||0
9017326|NCT03062488|10080242|FG001|NOT COMPLETED|Overall Study||0
9017327|NCT03062488|10080243|FG002|NOT COMPLETED|Overall Study||0
9017328|NCT03062605|10080253|FG000|STARTED|Overall Study||25
9017329|NCT03062605|10080254|FG001|STARTED|Overall Study||23
9017330|NCT03062605|10080253|FG000|COMPLETED|Overall Study||14
9017331|NCT03062605|10080254|FG001|COMPLETED|Overall Study||13
9017332|NCT03062605|10080253|FG000|NOT COMPLETED|Overall Study||11
9017333|NCT03062605|10080254|FG001|NOT COMPLETED|Overall Study||10
9017334|NCT03062891|10080262|FG000|STARTED|Overall Study||99
9017335|NCT03062891|10080263|FG001|STARTED|Overall Study||100
9017336|NCT03062891|10080262|FG000|Mid-intervention|Overall Study||68
8574777|NCT00130793|9607354|FG000|Vaccinated|Overall Study|One subject was allocated but not vaccinated.|182
8574778|NCT00130793|9607355|FG001|Vaccinated|Overall Study||185
8574779|NCT00130793|9607354|FG000|COMPLETED|Overall Study|Subject received vaccine, completed blood draws, returned vaccination report card (VRC) at Week 4|180
8574780|NCT00130793|9607355|FG001|COMPLETED|Overall Study|Subject received vaccine, completed blood draws, returned VRC at Week 4|181
8574781|NCT00130793|9607354|FG000|NOT COMPLETED|Overall Study||3
8574782|NCT00130793|9607355|FG001|NOT COMPLETED|Overall Study||4
8574783|NCT00130832|9607364|FG000|STARTED|Overall Study||372
8574784|NCT00130832|9607365|FG001|STARTED|Overall Study||363
8574785|NCT00130832|9607364|FG000|COMPLETED|Overall Study|Those who received all 3 doses of concomitant RotaTeq™/ OPV with blood draw ~42 days postdose 3|356
8574786|NCT00130832|9607365|FG001|COMPLETED|Overall Study|Those who received all 3 doses; last 2 blood draws ~42 days postdose 3 of RotaTeq™ and postdose OPV|346
8574787|NCT00130832|9607364|FG000|NOT COMPLETED|Overall Study||16
8574788|NCT00130832|9607365|FG001|NOT COMPLETED|Overall Study||17
8574789|NCT00130923|9607373|FG000|STARTED|Overall Study||49
8574790|NCT00130923|9607374|FG001|STARTED|Overall Study||46
8574791|NCT00130923|9607373|FG000|COMPLETED|Overall Study||36
8574792|NCT00130923|9607374|FG001|COMPLETED|Overall Study||32
8574793|NCT00130923|9607373|FG000|NOT COMPLETED|Overall Study||13
8574794|NCT00130923|9607374|FG001|NOT COMPLETED|Overall Study||14
8574795|NCT00131248|9607381|FG000|STARTED|Intervention 1 (3-day Course)||9
8574796|NCT00131248|9607382|FG001|STARTED|Intervention 1 (3-day Course)||9
8574797|NCT00131248|9607381|FG000|COMPLETED|Intervention 1 (3-day Course)||8
8574798|NCT00131248|9607382|FG001|COMPLETED|Intervention 1 (3-day Course)||9
8574799|NCT00131248|9607381|FG000|NOT COMPLETED|Intervention 1 (3-day Course)||1
8574800|NCT00131248|9607382|FG001|NOT COMPLETED|Intervention 1 (3-day Course)||0
8574801|NCT00131248|9607381|FG000|STARTED|Washout (24 Hour)||8
8574802|NCT00131248|9607382|FG001|STARTED|Washout (24 Hour)||9
8574803|NCT00131248|9607381|FG000|COMPLETED|Washout (24 Hour)||8
8574804|NCT00131248|9607382|FG001|COMPLETED|Washout (24 Hour)||9
8574805|NCT00131248|9607381|FG000|NOT COMPLETED|Washout (24 Hour)||0
8574806|NCT00131248|9607382|FG001|NOT COMPLETED|Washout (24 Hour)||0
8574807|NCT00131248|9607381|FG000|STARTED|Intervention 2 (7-day Course)||8
8574808|NCT00131248|9607382|FG001|STARTED|Intervention 2 (7-day Course)||9
8574809|NCT00131248|9607381|FG000|COMPLETED|Intervention 2 (7-day Course)||8
8574810|NCT00131248|9607382|FG001|COMPLETED|Intervention 2 (7-day Course)||9
8574811|NCT00131248|9607381|FG000|NOT COMPLETED|Intervention 2 (7-day Course)||0
8574812|NCT00131248|9607382|FG001|NOT COMPLETED|Intervention 2 (7-day Course)||0
8574813|NCT00131248|9607381|FG000|STARTED|Washout 2 (24 Hours)||8
8574814|NCT00131248|9607382|FG001|STARTED|Washout 2 (24 Hours)||9
8574815|NCT00131248|9607381|FG000|COMPLETED|Washout 2 (24 Hours)||8
8574816|NCT00131248|9607382|FG001|COMPLETED|Washout 2 (24 Hours)||9
8574817|NCT00131248|9607381|FG000|NOT COMPLETED|Washout 2 (24 Hours)||0
8574818|NCT00131248|9607382|FG001|NOT COMPLETED|Washout 2 (24 Hours)||0
8574819|NCT00131248|9607381|FG000|STARTED|Intervention 3 (4-day Course)||8
8574820|NCT00131248|9607382|FG001|STARTED|Intervention 3 (4-day Course)||9
8574821|NCT00131248|9607381|FG000|COMPLETED|Intervention 3 (4-day Course)||8
8574822|NCT00131248|9607382|FG001|COMPLETED|Intervention 3 (4-day Course)||9
8574823|NCT00131248|9607381|FG000|NOT COMPLETED|Intervention 3 (4-day Course)||0
8574824|NCT00131248|9607382|FG001|NOT COMPLETED|Intervention 3 (4-day Course)||0
8574825|NCT00131352|9607390|FG000|STARTED|Initial Treatment Period|Safety population|123
8574826|NCT00131352|9607391|FG001|STARTED|Initial Treatment Period|Safety population|130
8574827|NCT00131352|9607390|FG000|Intent to Treat Population|Initial Treatment Period||124
8574828|NCT00131352|9607391|FG001|Intent to Treat Population|Initial Treatment Period||129
8574829|NCT00131352|9607390|FG000|COMPLETED|Initial Treatment Period||114
8574830|NCT00131352|9607391|FG001|COMPLETED|Initial Treatment Period||118
8574831|NCT00131352|9607390|FG000|NOT COMPLETED|Initial Treatment Period||9
8574832|NCT00131352|9607391|FG001|NOT COMPLETED|Initial Treatment Period||12
8574833|NCT00131352|9607390|FG000|STARTED|Repeat Treatment Period|Safety population: 77 Synvisc + 83 Saline Control participants from the Initial Treatment period.|160
8574834|NCT00131352|9607391|FG001|STARTED|Repeat Treatment Period||0
8574835|NCT00131352|9607390|FG000|COMPLETED|Repeat Treatment Period||158
8574836|NCT00131352|9607391|FG001|COMPLETED|Repeat Treatment Period||0
8574837|NCT00131352|9607390|FG000|NOT COMPLETED|Repeat Treatment Period||2
8574838|NCT00131352|9607391|FG001|NOT COMPLETED|Repeat Treatment Period||0
9017337|NCT03062891|10080263|FG001|Mid-intervention|Overall Study||74
9017338|NCT03062891|10080262|FG000|End of Intervention|Overall Study||67
9017339|NCT03062891|10080263|FG001|End of Intervention|Overall Study||78
9017340|NCT03062891|10080262|FG000|Followup|Overall Study||47
9017341|NCT03062891|10080263|FG001|Followup|Overall Study||62
9017342|NCT03062891|10080262|FG000|COMPLETED|Overall Study||47
9017343|NCT03062891|10080263|FG001|COMPLETED|Overall Study||62
9017344|NCT03062891|10080262|FG000|NOT COMPLETED|Overall Study||52
9017345|NCT03062891|10080263|FG001|NOT COMPLETED|Overall Study||38
9017346|NCT03062917|10080275|FG000|STARTED|Overall Study||32
9017347|NCT03062917|10080276|FG001|STARTED|Overall Study||51
9017348|NCT03062917|10080277|FG002|STARTED|Overall Study||49
9017349|NCT03062917|10080278|FG003|STARTED|Overall Study||20
9017350|NCT03062917|10080279|FG004|STARTED|Overall Study||0
9017351|NCT03062917|10080275|FG000|COMPLETED|Overall Study||32
9017352|NCT03062917|10080276|FG001|COMPLETED|Overall Study||51
9017353|NCT03062917|10080277|FG002|COMPLETED|Overall Study||49
9017354|NCT03062917|10080278|FG003|COMPLETED|Overall Study||20
9017355|NCT03062917|10080279|FG004|COMPLETED|Overall Study||0
9017356|NCT03062917|10080275|FG000|NOT COMPLETED|Overall Study||0
9017357|NCT03062917|10080276|FG001|NOT COMPLETED|Overall Study||0
9017358|NCT03062917|10080277|FG002|NOT COMPLETED|Overall Study||0
9017359|NCT03062917|10080278|FG003|NOT COMPLETED|Overall Study||0
9017360|NCT03062917|10080279|FG004|NOT COMPLETED|Overall Study||0
9017361|NCT03063086|10080290|FG000|STARTED|Overall Study||19
9017362|NCT03063086|10080291|FG001|STARTED|Overall Study||20
9017363|NCT03063086|10080292|FG002|STARTED|Overall Study||18
9017364|NCT03063086|10080293|FG003|STARTED|Overall Study||20
9017365|NCT03063086|10080294|FG004|STARTED|Overall Study||20
9017366|NCT03063086|10080295|FG005|STARTED|Overall Study||19
9017367|NCT03063086|10080290|FG000|COMPLETED|Overall Study||16
9017368|NCT03063086|10080291|FG001|COMPLETED|Overall Study||19
9017369|NCT03063086|10080292|FG002|COMPLETED|Overall Study||17
9017370|NCT03063086|10080293|FG003|COMPLETED|Overall Study||17
9017371|NCT03063086|10080294|FG004|COMPLETED|Overall Study||20
9017372|NCT03063086|10080295|FG005|COMPLETED|Overall Study||18
9017373|NCT03063086|10080290|FG000|NOT COMPLETED|Overall Study||3
9017374|NCT03063086|10080291|FG001|NOT COMPLETED|Overall Study||1
9017375|NCT03063086|10080292|FG002|NOT COMPLETED|Overall Study||1
9017376|NCT03063086|10080293|FG003|NOT COMPLETED|Overall Study||3
9017377|NCT03063086|10080294|FG004|NOT COMPLETED|Overall Study||0
9017378|NCT03063086|10080295|FG005|NOT COMPLETED|Overall Study||1
9017379|NCT03063125|10080304|FG000|STARTED|Overall Study||25
9017380|NCT03063125|10080304|FG000|COMPLETED|Overall Study||23
9017381|NCT03063125|10080304|FG000|NOT COMPLETED|Overall Study||2
9017382|NCT03063255|10080310|FG000|STARTED|Overall Study||30
9017383|NCT03063255|10080311|FG001|STARTED|Overall Study||30
9017384|NCT03063255|10080310|FG000|COMPLETED|Overall Study||29
9017385|NCT03063255|10080311|FG001|COMPLETED|Overall Study||30
9017386|NCT03063255|10080310|FG000|NOT COMPLETED|Overall Study||1
9017387|NCT03063255|10080311|FG001|NOT COMPLETED|Overall Study||0
9017388|NCT03063294|10080319|FG000|STARTED|Overall Study|2463 equals the sum of 1241 cross-sectional survey respondents at baseline and 1222 at follow-up.|2463
9017389|NCT03063294|10080320|FG001|STARTED|Overall Study|2502 equals the sum of 1243 cross-sectional survey respondents at baseline and 1259 at follow-up.|2502
9017390|NCT03063294|10080319|FG000|COMPLETED|Overall Study|2463 equals the sum of 1241 cross-sectional survey respondents at baseline and 1222 at follow-up.|2463
9017391|NCT03063294|10080320|FG001|COMPLETED|Overall Study|2502 equals the sum of 1243 cross-sectional survey respondents at baseline and 1259 at follow-up.|2502
9017392|NCT03063294|10080319|FG000|NOT COMPLETED|Overall Study||0
9017393|NCT03063294|10080320|FG001|NOT COMPLETED|Overall Study||0
9017394|NCT03063385|10080328|FG000|STARTED|Overall Study||330
9017395|NCT03063385|10080329|FG001|STARTED|Overall Study||330
9017396|NCT03063385|10080328|FG000|3-month Follow-up|Overall Study||257
9017397|NCT03063385|10080329|FG001|3-month Follow-up|Overall Study||259
9017398|NCT03063385|10080328|FG000|6-month Follow-up|Overall Study||265
9017399|NCT03063385|10080329|FG001|6-month Follow-up|Overall Study||259
9017400|NCT03063385|10080328|FG000|12-month Follow-up|Overall Study||243
9017401|NCT03063385|10080329|FG001|12-month Follow-up|Overall Study||254
9017402|NCT03063385|10080328|FG000|COMPLETED|Overall Study||243
9017403|NCT03063385|10080329|FG001|COMPLETED|Overall Study||254
9017404|NCT03063385|10080328|FG000|NOT COMPLETED|Overall Study||87
9017405|NCT03063385|10080329|FG001|NOT COMPLETED|Overall Study||76
9017406|NCT03063437|10080337|FG000|STARTED|Overall Study||4
9017407|NCT03063437|10080338|FG001|STARTED|Overall Study||5
9017408|NCT03063437|10080337|FG000|COMPLETED|Overall Study||4
9017409|NCT03063437|10080338|FG001|COMPLETED|Overall Study||5
9017410|NCT03063437|10080337|FG000|NOT COMPLETED|Overall Study||0
9017411|NCT03063437|10080338|FG001|NOT COMPLETED|Overall Study||0
9017412|NCT03063476|10080344|FG000|STARTED|Overall Study||2
9017413|NCT03063476|10080344|FG000|COMPLETED|Overall Study||2
9017414|NCT03063476|10080344|FG000|NOT COMPLETED|Overall Study||0
9017415|NCT03064152|10080350|FG000|STARTED|Overall Study||26
9017416|NCT03064152|10080351|FG001|STARTED|Overall Study||23
8574839|NCT00131365|9607399|FG000|STARTED|Overall Study|Only safety data was reported due to early closure of the study due to device obsolescence.|9
8574840|NCT00131365|9607399|FG000|COMPLETED|Overall Study||5
8574841|NCT00131365|9607399|FG000|NOT COMPLETED|Overall Study||4
8574842|NCT00131378|9607408|FG000|STARTED|Overall Study||40
8574843|NCT00131378|9607409|FG001|STARTED|Overall Study||40
8574844|NCT00131378|9607410|FG002|STARTED|Overall Study||32
9017417|NCT03064152|10080350|FG000|COMPLETED|Overall Study||26
9017418|NCT03064152|10080351|FG001|COMPLETED|Overall Study||23
9017419|NCT03064152|10080350|FG000|NOT COMPLETED|Overall Study||0
8574845|NCT00131378|9607411|FG003|STARTED|Overall Study||30
8574846|NCT00131378|9607408|FG000|COMPLETED|Overall Study||29
9017420|NCT03064152|10080351|FG001|NOT COMPLETED|Overall Study||0
9017421|NCT03064438|10080359|FG000|STARTED|Overall Study||27
9017422|NCT03064438|10080360|FG001|STARTED|Overall Study||13
9017423|NCT03064438|10080359|FG000|COMPLETED|Overall Study||26
9017424|NCT03064438|10080360|FG001|COMPLETED|Overall Study||12
9017425|NCT03064438|10080359|FG000|NOT COMPLETED|Overall Study||1
9017426|NCT03064438|10080360|FG001|NOT COMPLETED|Overall Study||1
8574847|NCT00131378|9607409|FG001|COMPLETED|Overall Study||22
8574848|NCT00131378|9607410|FG002|COMPLETED|Overall Study||22
8574849|NCT00131378|9607411|FG003|COMPLETED|Overall Study||21
8574850|NCT00131378|9607408|FG000|NOT COMPLETED|Overall Study||11
8574851|NCT00131378|9607409|FG001|NOT COMPLETED|Overall Study||18
8574852|NCT00131378|9607410|FG002|NOT COMPLETED|Overall Study||10
8574853|NCT00131378|9607411|FG003|NOT COMPLETED|Overall Study||9
8574854|NCT00131456|9607425|FG000|STARTED|Overall Study||52
8574855|NCT00131456|9607426|FG001|STARTED|Overall Study||51
8574856|NCT00131456|9607425|FG000|COMPLETED|Overall Study||33
8574857|NCT00131456|9607426|FG001|COMPLETED|Overall Study||31
8574858|NCT00131456|9607425|FG000|NOT COMPLETED|Overall Study||19
8574859|NCT00131456|9607426|FG001|NOT COMPLETED|Overall Study||20
8574860|NCT00131469|9607434|FG000|STARTED|Overall Study||38
8574861|NCT00131469|9607435|FG001|STARTED|Overall Study||40
8574862|NCT00131469|9607434|FG000|COMPLETED|Overall Study||29
8574863|NCT00131469|9607435|FG001|COMPLETED|Overall Study||27
8574864|NCT00131469|9607434|FG000|NOT COMPLETED|Overall Study||9
8574865|NCT00131469|9607435|FG001|NOT COMPLETED|Overall Study||13
8574866|NCT00131508|9607443|FG000|STARTED|Overall Study||12
8574867|NCT00131508|9607444|FG001|STARTED|Overall Study||13
8574868|NCT00131508|9607443|FG000|COMPLETED|Overall Study||9
8574869|NCT00131508|9607444|FG001|COMPLETED|Overall Study||5
8574870|NCT00131508|9607443|FG000|NOT COMPLETED|Overall Study||3
8574871|NCT00131508|9607444|FG001|NOT COMPLETED|Overall Study||8
8574872|NCT00131573|9607452|FG000|STARTED|Overall Study||46
8574873|NCT00131573|9607453|FG001|STARTED|Overall Study||39
8574874|NCT00131573|9607452|FG000|COMPLETED|Overall Study||13
8574875|NCT00131573|9607453|FG001|COMPLETED|Overall Study||13
8574876|NCT00131573|9607452|FG000|NOT COMPLETED|Overall Study||33
8574877|NCT00131573|9607453|FG001|NOT COMPLETED|Overall Study||26
8574878|NCT00131664|9607463|FG000|STARTED|First Period (First 6 Months)||136
8574879|NCT00131664|9607464|FG001|STARTED|First Period (First 6 Months)||135
8574880|NCT00131664|9607465|FG002|STARTED|First Period (First 6 Months)||120
8574881|NCT00131664|9607466|FG003|STARTED|First Period (First 6 Months)||0
8574882|NCT00131664|9607467|FG004|STARTED|First Period (First 6 Months)||0
8574883|NCT00131664|9607468|FG005|STARTED|First Period (First 6 Months)||0
8574884|NCT00131664|9607463|FG000|COMPLETED|First Period (First 6 Months)||111
8574885|NCT00131664|9607464|FG001|COMPLETED|First Period (First 6 Months)||117
8574886|NCT00131664|9607465|FG002|COMPLETED|First Period (First 6 Months)||104
8574887|NCT00131664|9607466|FG003|COMPLETED|First Period (First 6 Months)||0
8574888|NCT00131664|9607467|FG004|COMPLETED|First Period (First 6 Months)||0
8574889|NCT00131664|9607468|FG005|COMPLETED|First Period (First 6 Months)||0
8574890|NCT00131664|9607463|FG000|NOT COMPLETED|First Period (First 6 Months)||25
8574891|NCT00131664|9607464|FG001|NOT COMPLETED|First Period (First 6 Months)||18
9017427|NCT03064451|10080366|FG000|STARTED|Overall Study||60
9017428|NCT03064451|10080366|FG000|Safety Population|Overall Study||52
9017429|NCT03064451|10080366|FG000|COMPLETED|Overall Study||46
9017430|NCT03064451|10080366|FG000|NOT COMPLETED|Overall Study||14
9017431|NCT03064841|10080370|FG000|STARTED|Overall Study||1537
9017432|NCT03064841|10080370|FG000|COMPLETED|Overall Study||1520
9017433|NCT03064841|10080370|FG000|NOT COMPLETED|Overall Study||17
9017434|NCT03065023|10080378|FG000|STARTED|Overall Study||3
8574892|NCT00131664|9607465|FG002|NOT COMPLETED|First Period (First 6 Months)||16
8574893|NCT00131664|9607466|FG003|NOT COMPLETED|First Period (First 6 Months)||0
8574894|NCT00131664|9607467|FG004|NOT COMPLETED|First Period (First 6 Months)||0
8574895|NCT00131664|9607468|FG005|NOT COMPLETED|First Period (First 6 Months)||0
8574896|NCT00131664|9607463|FG000|STARTED|Second Period (Additional Drug Added)|21 had added Metformin at Month 6|90
8574897|NCT00131664|9607464|FG001|STARTED|Second Period (Additional Drug Added)|16 had added Amaryl at Month 6|101
8574898|NCT00131664|9607465|FG002|STARTED|Second Period (Additional Drug Added)|25 had added Amaryl at Month 6|79
8574899|NCT00131664|9607466|FG003|STARTED|Second Period (Additional Drug Added)||21
8574900|NCT00131664|9607467|FG004|STARTED|Second Period (Additional Drug Added)||16
8574901|NCT00131664|9607468|FG005|STARTED|Second Period (Additional Drug Added)||25
8574902|NCT00131664|9607463|FG000|COMPLETED|Second Period (Additional Drug Added)||81
8574903|NCT00131664|9607464|FG001|COMPLETED|Second Period (Additional Drug Added)||97
8574904|NCT00131664|9607465|FG002|COMPLETED|Second Period (Additional Drug Added)||76
8574905|NCT00131664|9607466|FG003|COMPLETED|Second Period (Additional Drug Added)||19
8574906|NCT00131664|9607467|FG004|COMPLETED|Second Period (Additional Drug Added)||15
8574907|NCT00131664|9607468|FG005|COMPLETED|Second Period (Additional Drug Added)||22
8574908|NCT00131664|9607463|FG000|NOT COMPLETED|Second Period (Additional Drug Added)||9
8574909|NCT00131664|9607464|FG001|NOT COMPLETED|Second Period (Additional Drug Added)||4
8574910|NCT00131664|9607465|FG002|NOT COMPLETED|Second Period (Additional Drug Added)||3
8574911|NCT00131664|9607466|FG003|NOT COMPLETED|Second Period (Additional Drug Added)||2
8574912|NCT00131664|9607467|FG004|NOT COMPLETED|Second Period (Additional Drug Added)||1
8574913|NCT00131664|9607468|FG005|NOT COMPLETED|Second Period (Additional Drug Added)||3
8574914|NCT00131677|9607481|FG000|STARTED|Overall Study|201 randomized to active drug; 101 to start immediately and 100 after a 9 month delay.|201
8574915|NCT00131677|9607482|FG001|STARTED|Overall Study|199 randomized to placebo; 99 to start immediately and 100 after a 9 month delay.|199
8574916|NCT00131677|9607481|FG000|COMPLETED|Overall Study||171
8574917|NCT00131677|9607482|FG001|COMPLETED|Overall Study||160
8574918|NCT00131677|9607481|FG000|NOT COMPLETED|Overall Study||30
8574919|NCT00131677|9607482|FG001|NOT COMPLETED|Overall Study||39
8574920|NCT00131885|9607497|FG000|STARTED|Time 1: First Intervention||9
8574921|NCT00131885|9607498|FG001|STARTED|Time 1: First Intervention||9
8574922|NCT00131885|9607499|FG002|STARTED|Time 1: First Intervention||9
8574923|NCT00131885|9607500|FG003|STARTED|Time 1: First Intervention||9
8574924|NCT00131885|9607497|FG000|COMPLETED|Time 1: First Intervention||9
8574925|NCT00131885|9607498|FG001|COMPLETED|Time 1: First Intervention||9
8574926|NCT00131885|9607499|FG002|COMPLETED|Time 1: First Intervention||9
8574927|NCT00131885|9607500|FG003|COMPLETED|Time 1: First Intervention||9
8574928|NCT00131885|9607497|FG000|NOT COMPLETED|Time 1: First Intervention||0
8574929|NCT00131885|9607498|FG001|NOT COMPLETED|Time 1: First Intervention||0
8574930|NCT00131885|9607499|FG002|NOT COMPLETED|Time 1: First Intervention||0
8574931|NCT00131885|9607500|FG003|NOT COMPLETED|Time 1: First Intervention||0
8574932|NCT00131885|9607497|FG000|STARTED|Time 2: Second Intervention||9
8574933|NCT00131885|9607498|FG001|STARTED|Time 2: Second Intervention||9
8574934|NCT00131885|9607499|FG002|STARTED|Time 2: Second Intervention||9
8574935|NCT00131885|9607500|FG003|STARTED|Time 2: Second Intervention||9
8637286|NCT00570687|9677767|FG004|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
8637287|NCT00570687|9677768|FG005|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
8637288|NCT00570687|9677769|FG006|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
8637289|NCT00570687|9677770|FG007|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
8637290|NCT00570687|9677771|FG008|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
8637291|NCT00570687|9677772|FG009|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
8637292|NCT00570687|9677763|FG000|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
8637293|NCT00570687|9677764|FG001|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
8637294|NCT00570687|9677765|FG002|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
8637295|NCT00570687|9677766|FG003|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
8637296|NCT00570687|9677767|FG004|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
8637297|NCT00570687|9677768|FG005|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
8637298|NCT00570687|9677769|FG006|STARTED|Washout 5 (7-21 Days) - Orig Protocol||1
8637299|NCT00570687|9677770|FG007|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
8637300|NCT00570687|9677771|FG008|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
8637301|NCT00570687|9677772|FG009|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
8637302|NCT00570687|9677763|FG000|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
8637303|NCT00570687|9677764|FG001|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
8637304|NCT00570687|9677765|FG002|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
9017435|NCT03065023|10080379|FG001|STARTED|Overall Study||3
9017436|NCT03065023|10080380|FG002|STARTED|Overall Study||3
9017437|NCT03065023|10080381|FG003|STARTED|Overall Study||6
9017438|NCT03065023|10080382|FG004|STARTED|Overall Study|Group B not started for business reasons.|0
9017439|NCT03065023|10080378|FG000|COMPLETED|Overall Study||1
9017440|NCT03065023|10080379|FG001|COMPLETED|Overall Study||1
9017441|NCT03065023|10080380|FG002|COMPLETED|Overall Study||2
9017442|NCT03065023|10080381|FG003|COMPLETED|Overall Study||3
9017443|NCT03065023|10080382|FG004|COMPLETED|Overall Study||0
9017444|NCT03065023|10080378|FG000|NOT COMPLETED|Overall Study||2
9017445|NCT03065023|10080379|FG001|NOT COMPLETED|Overall Study||2
9017446|NCT03065023|10080380|FG002|NOT COMPLETED|Overall Study||1
9017447|NCT03065023|10080381|FG003|NOT COMPLETED|Overall Study||3
9017448|NCT03065023|10080382|FG004|NOT COMPLETED|Overall Study||0
9017449|NCT03065075|10080394|FG000|STARTED|Overall Study||76
9017450|NCT03065075|10080395|FG001|STARTED|Overall Study||76
9017451|NCT03065075|10080394|FG000|Intent-to-treat Analysis|Overall Study||72
9017452|NCT03065075|10080395|FG001|Intent-to-treat Analysis|Overall Study||74
9017453|NCT03065075|10080394|FG000|As-treated Analysis|Overall Study||69
9017454|NCT03065075|10080395|FG001|As-treated Analysis|Overall Study||77
9017455|NCT03065075|10080394|FG000|COMPLETED|Overall Study||76
9017456|NCT03065075|10080395|FG001|COMPLETED|Overall Study||76
9017457|NCT03065075|10080394|FG000|NOT COMPLETED|Overall Study||0
9017458|NCT03065075|10080395|FG001|NOT COMPLETED|Overall Study||0
9017459|NCT03065179|10080401|FG000|STARTED|Overall Study||25
9017460|NCT03065179|10080401|FG000|COMPLETED|Overall Study||25
9017461|NCT03065179|10080401|FG000|NOT COMPLETED|Overall Study||0
9017462|NCT03065205|10080405|FG000|STARTED|Overall Study||65
9017463|NCT03065205|10080405|FG000|COMPLETED|Overall Study||53
9017464|NCT03065205|10080405|FG000|NOT COMPLETED|Overall Study||12
9017465|NCT03065283|10080412|FG000|STARTED|Overall Study||50
9017466|NCT03065283|10080413|FG001|STARTED|Overall Study||25
9017467|NCT03065283|10080412|FG000|COMPLETED|Overall Study||50
9017468|NCT03065283|10080413|FG001|COMPLETED|Overall Study||25
9017469|NCT03065283|10080412|FG000|NOT COMPLETED|Overall Study||0
9017470|NCT03065283|10080413|FG001|NOT COMPLETED|Overall Study||0
9017471|NCT03065400|10080419|FG000|STARTED|Overall Study||10
9017472|NCT03065400|10080419|FG000|COMPLETED|Overall Study||0
9017473|NCT03065400|10080419|FG000|NOT COMPLETED|Overall Study||10
9017474|NCT03065530|10080427|FG000|STARTED|Overall Study||30
9017475|NCT03065530|10080428|FG001|STARTED|Overall Study||30
9017476|NCT03065530|10080429|FG002|STARTED|Overall Study||30
9017477|NCT03065530|10080430|FG003|STARTED|Overall Study||30
9017478|NCT03065530|10080427|FG000|COMPLETED|Overall Study||28
9017479|NCT03065530|10080428|FG001|COMPLETED|Overall Study||29
9017480|NCT03065530|10080429|FG002|COMPLETED|Overall Study||29
9017481|NCT03065530|10080430|FG003|COMPLETED|Overall Study||28
9017482|NCT03065530|10080427|FG000|NOT COMPLETED|Overall Study||2
8637305|NCT00570687|9677766|FG003|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
8637306|NCT00570687|9677767|FG004|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
8637307|NCT00570687|9677768|FG005|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
8637308|NCT00570687|9677769|FG006|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
8637309|NCT00570687|9677770|FG007|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
8637310|NCT00570687|9677771|FG008|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
8637311|NCT00570687|9677772|FG009|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
8637312|NCT00570687|9677763|FG000|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
8637313|NCT00570687|9677764|FG001|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
8637314|NCT00570687|9677765|FG002|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
8637315|NCT00570687|9677766|FG003|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
8637316|NCT00570687|9677767|FG004|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
8637317|NCT00570687|9677768|FG005|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
8637318|NCT00570687|9677769|FG006|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||1
8637319|NCT00570687|9677770|FG007|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
8637320|NCT00570687|9677771|FG008|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
8637321|NCT00570687|9677772|FG009|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
8727106|NCT01041638|9774526|FG000|NOT COMPLETED|Overall Study||27
8727107|NCT01041781|9774532|FG000|STARTED|Overall Study||154
8727108|NCT01041781|9774533|FG001|STARTED|Overall Study||158
8727109|NCT01041781|9774532|FG000|COMPLETED|Overall Study||154
8727110|NCT01041781|9774533|FG001|COMPLETED|Overall Study||158
8727111|NCT01041781|9774532|FG000|NOT COMPLETED|Overall Study||0
8727112|NCT01041781|9774533|FG001|NOT COMPLETED|Overall Study||0
8727113|NCT01041859|9774549|FG000|STARTED|Open-Label Titration|Of 460 total enrollment, one subject enrolled twice; this subject's second enrollment is excluded.|459
8727114|NCT01041859|9774550|FG001|STARTED|Open-Label Titration||0
8727115|NCT01041859|9774551|FG002|STARTED|Open-Label Titration||0
8727116|NCT01041859|9774549|FG000|COMPLETED|Open-Label Titration|Of 358 completed subjects, 320 were randomized to the Double-Blind Maintenance Period.|358
8727117|NCT01041859|9774550|FG001|COMPLETED|Open-Label Titration||0
8727118|NCT01041859|9774551|FG002|COMPLETED|Open-Label Titration||0
9017483|NCT03065530|10080428|FG001|NOT COMPLETED|Overall Study||1
9017484|NCT03065530|10080429|FG002|NOT COMPLETED|Overall Study||1
9017485|NCT03065530|10080430|FG003|NOT COMPLETED|Overall Study||2
9017486|NCT03065647|10080450|FG000|STARTED|Overall Study||3
9017487|NCT03065647|10080451|FG001|STARTED|Overall Study||12
9017488|NCT03065647|10080450|FG000|COMPLETED|Overall Study||3
9017489|NCT03065647|10080451|FG001|COMPLETED|Overall Study||12
9017490|NCT03065647|10080450|FG000|NOT COMPLETED|Overall Study||0
9017491|NCT03065647|10080451|FG001|NOT COMPLETED|Overall Study||0
9017492|NCT03066102|10080457|FG000|STARTED|Overall Study||30
9017493|NCT03066102|10080457|FG000|COMPLETED|Overall Study||30
8637322|NCT00570687|9677763|FG000|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||4
8637323|NCT00570687|9677764|FG001|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||2
9017494|NCT03066102|10080457|FG000|NOT COMPLETED|Overall Study||0
9017495|NCT03066193|10080461|FG000|STARTED|Overall Study||17
9017496|NCT03066193|10080461|FG000|COMPLETED|Overall Study||16
9017497|NCT03066193|10080461|FG000|NOT COMPLETED|Overall Study||1
9017498|NCT03066609|10080468|FG000|STARTED|INDUCTION||136
9017499|NCT03066609|10080469|FG001|STARTED|INDUCTION||272
9017500|NCT03066609|10080470|FG002|STARTED|INDUCTION||135
9017501|NCT03066609|10080471|FG003|STARTED|INDUCTION||0
9017502|NCT03066609|10080468|FG000|COMPLETED|INDUCTION||134
9017503|NCT03066609|10080469|FG001|COMPLETED|INDUCTION||270
9017504|NCT03066609|10080470|FG002|COMPLETED|INDUCTION||133
9017505|NCT03066609|10080471|FG003|COMPLETED|INDUCTION||0
9017506|NCT03066609|10080468|FG000|NOT COMPLETED|INDUCTION||2
9017507|NCT03066609|10080469|FG001|NOT COMPLETED|INDUCTION||2
9017508|NCT03066609|10080470|FG002|NOT COMPLETED|INDUCTION||2
9017509|NCT03066609|10080471|FG003|NOT COMPLETED|INDUCTION||0
9017510|NCT03066609|10080468|FG000|STARTED|MAINTENANCE||134
9017511|NCT03066609|10080469|FG001|STARTED|MAINTENANCE||270
9017512|NCT03066609|10080470|FG002|STARTED|MAINTENANCE||4
9017513|NCT03066609|10080471|FG003|STARTED|MAINTENANCE||129
9017514|NCT03066609|10080468|FG000|COMPLETED|MAINTENANCE||127
9017515|NCT03066609|10080469|FG001|COMPLETED|MAINTENANCE||266
9017516|NCT03066609|10080470|FG002|COMPLETED|MAINTENANCE||2
9017517|NCT03066609|10080471|FG003|COMPLETED|MAINTENANCE||126
9017518|NCT03066609|10080468|FG000|NOT COMPLETED|MAINTENANCE||7
9017519|NCT03066609|10080469|FG001|NOT COMPLETED|MAINTENANCE||4
9017520|NCT03066609|10080470|FG002|NOT COMPLETED|MAINTENANCE||2
9017521|NCT03066609|10080471|FG003|NOT COMPLETED|MAINTENANCE||3
9017522|NCT03066609|10080468|FG000|STARTED|OVERALL STUDY||136
9017523|NCT03066609|10080469|FG001|STARTED|OVERALL STUDY||272
9017524|NCT03066609|10080470|FG002|STARTED|OVERALL STUDY||6
9017525|NCT03066609|10080471|FG003|STARTED|OVERALL STUDY||129
9017526|NCT03066609|10080468|FG000|COMPLETED|OVERALL STUDY||126
9017527|NCT03066609|10080469|FG001|COMPLETED|OVERALL STUDY||264
9017528|NCT03066609|10080470|FG002|COMPLETED|OVERALL STUDY||2
9017529|NCT03066609|10080471|FG003|COMPLETED|OVERALL STUDY||124
9017530|NCT03066609|10080468|FG000|NOT COMPLETED|OVERALL STUDY||10
9017531|NCT03066609|10080469|FG001|NOT COMPLETED|OVERALL STUDY||8
9017532|NCT03066609|10080470|FG002|NOT COMPLETED|OVERALL STUDY||4
9017533|NCT03066609|10080471|FG003|NOT COMPLETED|OVERALL STUDY||5
9017534|NCT03066778|10080484|FG000|STARTED|Overall Study||228
9017535|NCT03066778|10080485|FG001|STARTED|Overall Study||225
9017536|NCT03066778|10080484|FG000|Treated|Overall Study|1 participant randomized to the pembrolizumab+etoposide arm was treated with placebo+etoposide.|223
9017537|NCT03066778|10080485|FG001|Treated|Overall Study|1 participant randomized to the pembrolizumab+etoposide arm was treated with placebo+etoposide.|223
9017538|NCT03066778|10080484|FG000|COMPLETED|Overall Study||0
9017539|NCT03066778|10080485|FG001|COMPLETED|Overall Study||0
9017540|NCT03066778|10080484|FG000|NOT COMPLETED|Overall Study||228
9017541|NCT03066778|10080485|FG001|NOT COMPLETED|Overall Study||225
9017542|NCT03066804|10080493|FG000|STARTED|Overall Study||1286
9017543|NCT03066804|10080494|FG001|STARTED|Overall Study||1286
9017544|NCT03066804|10080493|FG000|COMPLETED|Overall Study||1235
9017545|NCT03066804|10080494|FG001|COMPLETED|Overall Study||1236
9017546|NCT03066804|10080493|FG000|NOT COMPLETED|Overall Study||51
9017547|NCT03066804|10080494|FG001|NOT COMPLETED|Overall Study||50
9017548|NCT03066830|10080503|FG000|STARTED|Overall Study||254
9017549|NCT03066830|10080504|FG001|STARTED|Overall Study||253
9017550|NCT03066830|10080503|FG000|COMPLETED|Overall Study||221
9017551|NCT03066830|10080504|FG001|COMPLETED|Overall Study||231
9017552|NCT03066830|10080503|FG000|NOT COMPLETED|Overall Study||33
9017553|NCT03066830|10080504|FG001|NOT COMPLETED|Overall Study||22
9017554|NCT03066947|10080511|FG000|STARTED|Overall Study||24
9017555|NCT03066947|10080511|FG000|COMPLETED|Overall Study||14
9017556|NCT03066947|10080511|FG000|NOT COMPLETED|Overall Study||10
9017557|NCT03066999|10080518|FG000|STARTED|Overall Study||2
9017558|NCT03066999|10080519|FG001|STARTED|Overall Study||3
9017559|NCT03066999|10080518|FG000|COMPLETED|Overall Study||2
9017560|NCT03066999|10080519|FG001|COMPLETED|Overall Study||1
9017561|NCT03066999|10080518|FG000|NOT COMPLETED|Overall Study||0
9017562|NCT03066999|10080519|FG001|NOT COMPLETED|Overall Study||2
9017563|NCT03067129|10080530|FG000|STARTED|Overall Study||47
9017564|NCT03067129|10080531|FG001|STARTED|Overall Study||29
9017565|NCT03067129|10080532|FG002|STARTED|Overall Study||27
9017566|NCT03067129|10080533|FG003|STARTED|Overall Study||24
9017567|NCT03067129|10080530|FG000|COMPLETED|Overall Study||2
9017568|NCT03067129|10080531|FG001|COMPLETED|Overall Study||1
9017569|NCT03067129|10080532|FG002|COMPLETED|Overall Study||0
9017570|NCT03067129|10080533|FG003|COMPLETED|Overall Study||0
9017571|NCT03067129|10080530|FG000|NOT COMPLETED|Overall Study||45
9017572|NCT03067129|10080531|FG001|NOT COMPLETED|Overall Study||28
9017573|NCT03067129|10080532|FG002|NOT COMPLETED|Overall Study||27
9017574|NCT03067129|10080533|FG003|NOT COMPLETED|Overall Study||24
9017575|NCT03067311|10080553|FG000|STARTED|Overall Study||19
9017576|NCT03067311|10080554|FG001|STARTED|Overall Study||19
9017577|NCT03067311|10080553|FG000|COMPLETED|Overall Study||17
9017578|NCT03067311|10080554|FG001|COMPLETED|Overall Study||17
9017579|NCT03067311|10080553|FG000|NOT COMPLETED|Overall Study||2
9017580|NCT03067311|10080554|FG001|NOT COMPLETED|Overall Study||2
9017581|NCT03067441|10080562|FG000|STARTED|Overall Study||492
9017582|NCT03067441|10080563|FG001|STARTED|Overall Study||970
9017583|NCT03067441|10080562|FG000|COMPLETED|Overall Study||459
9017584|NCT03067441|10080563|FG001|COMPLETED|Overall Study||913
9017585|NCT03067441|10080562|FG000|NOT COMPLETED|Overall Study||33
9017586|NCT03067441|10080563|FG001|NOT COMPLETED|Overall Study||57
9017587|NCT03067506|10080572|FG000|STARTED|Overall Study||30
9017588|NCT03067506|10080572|FG000|COMPLETED|Overall Study||30
9017589|NCT03067506|10080572|FG000|NOT COMPLETED|Overall Study||0
9017590|NCT03067948|10080576|FG000|STARTED|Overall Study||32
9017591|NCT03067948|10080576|FG000|COMPLETED|Overall Study||32
8574936|NCT00131885|9607497|FG000|COMPLETED|Time 2: Second Intervention||9
8574937|NCT00131885|9607498|FG001|COMPLETED|Time 2: Second Intervention||9
8574938|NCT00131885|9607499|FG002|COMPLETED|Time 2: Second Intervention||9
8574939|NCT00131885|9607500|FG003|COMPLETED|Time 2: Second Intervention||9
8574940|NCT00131885|9607497|FG000|NOT COMPLETED|Time 2: Second Intervention||0
8574941|NCT00131885|9607498|FG001|NOT COMPLETED|Time 2: Second Intervention||0
8574942|NCT00131885|9607499|FG002|NOT COMPLETED|Time 2: Second Intervention||0
8574943|NCT00131885|9607500|FG003|NOT COMPLETED|Time 2: Second Intervention||0
8637324|NCT00570687|9677765|FG002|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||2
8637325|NCT00570687|9677766|FG003|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||4
8637326|NCT00570687|9677767|FG004|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
8637327|NCT00570687|9677768|FG005|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
8637328|NCT00570687|9677769|FG006|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
8637329|NCT00570687|9677770|FG007|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
8637330|NCT00570687|9677771|FG008|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
8637331|NCT00570687|9677772|FG009|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
8637332|NCT00570687|9677763|FG000|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||4
8637333|NCT00570687|9677764|FG001|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||2
8637334|NCT00570687|9677765|FG002|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||2
8637335|NCT00570687|9677766|FG003|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||4
8637336|NCT00570687|9677767|FG004|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
8637337|NCT00570687|9677768|FG005|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
8637338|NCT00570687|9677769|FG006|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
8637339|NCT00570687|9677770|FG007|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
8637340|NCT00570687|9677771|FG008|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
8637341|NCT00570687|9677772|FG009|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
8637342|NCT00570687|9677763|FG000|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
8637343|NCT00570687|9677764|FG001|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
8637344|NCT00570687|9677765|FG002|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
8637345|NCT00570687|9677766|FG003|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
8637346|NCT00570687|9677767|FG004|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
8637347|NCT00570687|9677768|FG005|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
8637348|NCT00570687|9677769|FG006|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
8637349|NCT00570687|9677770|FG007|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
8637350|NCT00570687|9677771|FG008|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
8637351|NCT00570687|9677772|FG009|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
8637352|NCT00570687|9677763|FG000|STARTED|Washout 1 (7-21 Days) - Amendment 1||4
8637353|NCT00570687|9677764|FG001|STARTED|Washout 1 (7-21 Days) - Amendment 1||2
8637354|NCT00570687|9677765|FG002|STARTED|Washout 1 (7-21 Days) - Amendment 1||2
8637355|NCT00570687|9677766|FG003|STARTED|Washout 1 (7-21 Days) - Amendment 1||4
8637356|NCT00570687|9677767|FG004|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
8637357|NCT00570687|9677768|FG005|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
8637358|NCT00570687|9677769|FG006|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
8637359|NCT00570687|9677770|FG007|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
8637360|NCT00570687|9677771|FG008|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
8637361|NCT00570687|9677772|FG009|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
8637362|NCT00570687|9677763|FG000|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||4
8637363|NCT00570687|9677764|FG001|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||2
8637364|NCT00570687|9677765|FG002|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||2
8637365|NCT00570687|9677766|FG003|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||4
8637366|NCT00570687|9677767|FG004|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
8637367|NCT00570687|9677768|FG005|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
8637368|NCT00570687|9677769|FG006|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
8637369|NCT00570687|9677770|FG007|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
8637370|NCT00570687|9677771|FG008|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
8637371|NCT00570687|9677772|FG009|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
8637372|NCT00570687|9677763|FG000|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
8637373|NCT00570687|9677764|FG001|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
8637374|NCT00570687|9677765|FG002|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
8637375|NCT00570687|9677766|FG003|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
8637376|NCT00570687|9677767|FG004|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
8637377|NCT00570687|9677768|FG005|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
8637378|NCT00570687|9677769|FG006|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
8637379|NCT00570687|9677770|FG007|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
9017592|NCT03067948|10080576|FG000|NOT COMPLETED|Overall Study||0
9017593|NCT03067987|10080582|FG000|STARTED|Overall Study||50
9017594|NCT03067987|10080583|FG001|STARTED|Overall Study||53
9017595|NCT03067987|10080582|FG000|COMPLETED|Overall Study||40
9017596|NCT03067987|10080583|FG001|COMPLETED|Overall Study||40
9017597|NCT03067987|10080582|FG000|NOT COMPLETED|Overall Study||10
9017598|NCT03067987|10080583|FG001|NOT COMPLETED|Overall Study||13
8574944|NCT00131911|9607512|FG000|STARTED|Overall Study||51
9017599|NCT03068091|10080589|FG000|STARTED|Overall Study||25
9017600|NCT03068091|10080589|FG000|COMPLETED|Overall Study||24
9017601|NCT03068091|10080589|FG000|NOT COMPLETED|Overall Study||1
9017602|NCT03068312|10080596|FG000|STARTED|Overall Study||19
9017603|NCT03068312|10080597|FG001|STARTED|Overall Study||19
9017604|NCT03068312|10080596|FG000|COMPLETED|Overall Study||19
9017605|NCT03068312|10080597|FG001|COMPLETED|Overall Study||19
9017606|NCT03068312|10080596|FG000|NOT COMPLETED|Overall Study||0
9017607|NCT03068312|10080597|FG001|NOT COMPLETED|Overall Study||0
9017608|NCT03068455|10080605|FG000|STARTED|Pre-treatment Period||920
9017609|NCT03068455|10080606|FG001|STARTED|Pre-treatment Period||924
9017610|NCT03068455|10080605|FG000|COMPLETED|Pre-treatment Period||916
9017611|NCT03068455|10080606|FG001|COMPLETED|Pre-treatment Period||917
9017612|NCT03068455|10080605|FG000|NOT COMPLETED|Pre-treatment Period||4
8637380|NCT00570687|9677771|FG008|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
8637381|NCT00570687|9677772|FG009|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
8727119|NCT01041859|9774549|FG000|NOT COMPLETED|Open-Label Titration||101
9017613|NCT03068455|10080606|FG001|NOT COMPLETED|Pre-treatment Period||7
9017614|NCT03068455|10080605|FG000|STARTED|Treatment Period||916
9017615|NCT03068455|10080606|FG001|STARTED|Treatment Period||917
9017616|NCT03068455|10080605|FG000|COMPLETED|Treatment Period||364
9017617|NCT03068455|10080606|FG001|COMPLETED|Treatment Period||561
9017618|NCT03068455|10080605|FG000|NOT COMPLETED|Treatment Period||552
9017619|NCT03068455|10080606|FG001|NOT COMPLETED|Treatment Period||356
9017620|NCT03068468|10080614|FG000|STARTED|Placebo-Controlled Period||166
9017621|NCT03068468|10080615|FG001|STARTED|Placebo-Controlled Period||324
9017622|NCT03068468|10080616|FG002|STARTED|Placebo-Controlled Period||0
9017623|NCT03068468|10080617|FG003|STARTED|Placebo-Controlled Period||0
8574945|NCT00131911|9607513|FG001|STARTED|Overall Study||42
8574946|NCT00131911|9607512|FG000|COMPLETED|Overall Study||50
8574947|NCT00131911|9607513|FG001|COMPLETED|Overall Study||42
8574948|NCT00131911|9607512|FG000|NOT COMPLETED|Overall Study||1
8574949|NCT00131911|9607513|FG001|NOT COMPLETED|Overall Study||0
8574950|NCT00131937|9607518|FG000|STARTED|Overall Study||14
8574951|NCT00131937|9607518|FG000|COMPLETED|Overall Study||0
8574952|NCT00131937|9607518|FG000|NOT COMPLETED|Overall Study||14
8574953|NCT00132002|9607522|FG000|STARTED|Overall Study||14
8574954|NCT00132002|9607522|FG000|COMPLETED|Overall Study||14
8574955|NCT00132002|9607522|FG000|NOT COMPLETED|Overall Study||0
8574956|NCT00132028|9607526|FG000|STARTED|Overall Study||27
8574957|NCT00132028|9607526|FG000|Eligible|Overall Study||25
8574958|NCT00132028|9607526|FG000|Eligible and Began Protocol Therapy|Overall Study||25
8574959|NCT00132028|9607526|FG000|COMPLETED|Overall Study|"Since there was no maximum number of cycles, patients could not complete treatment."|0
8574960|NCT00132028|9607526|FG000|NOT COMPLETED|Overall Study||27
8574961|NCT00132041|9607530|FG000|STARTED|Baseline||51
8574962|NCT00132041|9607530|FG000|Eligible|Baseline||45
8574963|NCT00132041|9607530|FG000|COMPLETED|Baseline||45
8574964|NCT00132041|9607530|FG000|NOT COMPLETED|Baseline||6
8574965|NCT00132041|9607530|FG000|STARTED|3 Months Post Ablation||45
8574966|NCT00132041|9607530|FG000|COMPLETED|3 Months Post Ablation||42
8574967|NCT00132041|9607530|FG000|NOT COMPLETED|3 Months Post Ablation||3
8574968|NCT00132041|9607530|FG000|STARTED|6 Months Post Ablation||42
8574969|NCT00132041|9607530|FG000|COMPLETED|6 Months Post Ablation||32
8574970|NCT00132041|9607530|FG000|NOT COMPLETED|6 Months Post Ablation||10
8574971|NCT00132041|9607530|FG000|STARTED|9 Months Post Ablation||32
8574972|NCT00132041|9607530|FG000|COMPLETED|9 Months Post Ablation||30
8574973|NCT00132041|9607530|FG000|NOT COMPLETED|9 Months Post Ablation||2
8574974|NCT00132041|9607530|FG000|STARTED|12 Months Post Ablation||30
8574975|NCT00132041|9607530|FG000|COMPLETED|12 Months Post Ablation||26
8574976|NCT00132041|9607530|FG000|NOT COMPLETED|12 Months Post Ablation||4
8574977|NCT00132041|9607530|FG000|STARTED|15 Months Post Ablation||26
8574978|NCT00132041|9607530|FG000|COMPLETED|15 Months Post Ablation||18
8574979|NCT00132041|9607530|FG000|NOT COMPLETED|15 Months Post Ablation||8
8574980|NCT00132041|9607530|FG000|STARTED|18 Months Post Ablation||18
8574981|NCT00132041|9607530|FG000|COMPLETED|18 Months Post Ablation||12
8574982|NCT00132041|9607530|FG000|NOT COMPLETED|18 Months Post Ablation||6
8574983|NCT00132132|9607542|FG000|STARTED|Overall Study||15
8574984|NCT00132132|9607543|FG001|STARTED|Overall Study||15
8574985|NCT00132132|9607542|FG000|COMPLETED|Overall Study||8
8574986|NCT00132132|9607543|FG001|COMPLETED|Overall Study||13
8574987|NCT00132132|9607542|FG000|NOT COMPLETED|Overall Study||7
8574988|NCT00132132|9607543|FG001|NOT COMPLETED|Overall Study||2
8574989|NCT00132301|9607551|FG000|STARTED|Overall Study||141
8574990|NCT00132301|9607552|FG001|STARTED|Overall Study||157
8574991|NCT00132301|9607551|FG000|COMPLETED|Overall Study||121
8574992|NCT00132301|9607552|FG001|COMPLETED|Overall Study||144
8574993|NCT00132301|9607551|FG000|NOT COMPLETED|Overall Study||20
8574994|NCT00132301|9607552|FG001|NOT COMPLETED|Overall Study||13
8574995|NCT00132314|9607560|FG000|STARTED|Overall Study||190
8574996|NCT00132314|9607561|FG001|STARTED|Overall Study||192
9017624|NCT03068468|10080614|FG000|Treated|Placebo-Controlled Period||165
9017625|NCT03068468|10080615|FG001|Treated|Placebo-Controlled Period||321
8574997|NCT00132314|9607560|FG000|Received Treatment|Overall Study||188
8574998|NCT00132314|9607561|FG001|Received Treatment|Overall Study||185
8574999|NCT00132314|9607560|FG000|Completed Baseline Visit, Provided SSN|Overall Study|This is the ITT cohort|187
8575000|NCT00132314|9607561|FG001|Completed Baseline Visit, Provided SSN|Overall Study|This is the ITT cohort.|182
8575001|NCT00132314|9607560|FG000|COMPLETED|Overall Study||117
8575002|NCT00132314|9607561|FG001|COMPLETED|Overall Study||120
9017626|NCT03068468|10080616|FG002|Treated|Placebo-Controlled Period||0
9017627|NCT03068468|10080617|FG003|Treated|Placebo-Controlled Period||0
9017628|NCT03068468|10080614|FG000|COMPLETED|Placebo-Controlled Period||144
9017629|NCT03068468|10080615|FG001|COMPLETED|Placebo-Controlled Period||279
9017630|NCT03068468|10080616|FG002|COMPLETED|Placebo-Controlled Period||0
9017631|NCT03068468|10080617|FG003|COMPLETED|Placebo-Controlled Period||0
9017632|NCT03068468|10080614|FG000|NOT COMPLETED|Placebo-Controlled Period||22
8575003|NCT00132314|9607560|FG000|NOT COMPLETED|Overall Study||73
8575004|NCT00132314|9607561|FG001|NOT COMPLETED|Overall Study||72
8575005|NCT00132496|9607569|FG000|STARTED|Overall Study||54
8575006|NCT00132496|9607570|FG001|STARTED|Overall Study||57
8575007|NCT00132496|9607569|FG000|COMPLETED|Overall Study||52
8575008|NCT00132496|9607570|FG001|COMPLETED|Overall Study||55
8575009|NCT00132496|9607569|FG000|NOT COMPLETED|Overall Study||2
8575010|NCT00132496|9607570|FG001|NOT COMPLETED|Overall Study||2
8575011|NCT00132678|9607578|FG000|STARTED|Period II (Open-Label Oral Risperidone)||0
8575012|NCT00132678|9607579|FG001|STARTED|Period II (Open-Label Oral Risperidone)||0
8575013|NCT00132678|9607580|FG002|STARTED|Period II (Open-Label Oral Risperidone)||440
8575014|NCT00132678|9607578|FG000|COMPLETED|Period II (Open-Label Oral Risperidone)||0
8575015|NCT00132678|9607579|FG001|COMPLETED|Period II (Open-Label Oral Risperidone)||0
8575016|NCT00132678|9607580|FG002|COMPLETED|Period II (Open-Label Oral Risperidone)||382
8575017|NCT00132678|9607578|FG000|NOT COMPLETED|Period II (Open-Label Oral Risperidone)||0
8575018|NCT00132678|9607579|FG001|NOT COMPLETED|Period II (Open-Label Oral Risperidone)||0
8575019|NCT00132678|9607580|FG002|NOT COMPLETED|Period II (Open-Label Oral Risperidone)||58
8575020|NCT00132678|9607578|FG000|STARTED|Period III (Open-Label Stabilization)||501
8575021|NCT00132678|9607579|FG001|STARTED|Period III (Open-Label Stabilization)||0
8575022|NCT00132678|9607580|FG002|STARTED|Period III (Open-Label Stabilization)||0
8575023|NCT00132678|9607578|FG000|COMPLETED|Period III (Open-Label Stabilization)||303
8575024|NCT00132678|9607579|FG001|COMPLETED|Period III (Open-Label Stabilization)||0
8575025|NCT00132678|9607580|FG002|COMPLETED|Period III (Open-Label Stabilization)||0
8575026|NCT00132678|9607578|FG000|NOT COMPLETED|Period III (Open-Label Stabilization)||198
8575027|NCT00132678|9607579|FG001|NOT COMPLETED|Period III (Open-Label Stabilization)||0
8575028|NCT00132678|9607580|FG002|NOT COMPLETED|Period III (Open-Label Stabilization)||0
8575029|NCT00132678|9607578|FG000|STARTED|Period IV (Double-Blind Treatment)||154
8575030|NCT00132678|9607579|FG001|STARTED|Period IV (Double-Blind Treatment)||149
8637382|NCT00570687|9677763|FG000|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||4
8637383|NCT00570687|9677764|FG001|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||2
8637384|NCT00570687|9677765|FG002|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||2
8575031|NCT00132678|9607580|FG002|STARTED|Period IV (Double-Blind Treatment)||0
8575032|NCT00132678|9607578|FG000|COMPLETED|Period IV (Double-Blind Treatment)||117
8575033|NCT00132678|9607579|FG001|COMPLETED|Period IV (Double-Blind Treatment)||109
8575034|NCT00132678|9607580|FG002|COMPLETED|Period IV (Double-Blind Treatment)||0
8575035|NCT00132678|9607578|FG000|NOT COMPLETED|Period IV (Double-Blind Treatment)||37
8575036|NCT00132678|9607579|FG001|NOT COMPLETED|Period IV (Double-Blind Treatment)||40
8575037|NCT00132678|9607580|FG002|NOT COMPLETED|Period IV (Double-Blind Treatment)||0
8575038|NCT00132691|9607590|FG000|STARTED|Overall Study|129 participants were assigned to implant; 122 received implant|129
8575039|NCT00132691|9607591|FG001|STARTED|Overall Study|126 participants were assigned to systemic treatment; 121 received systemic therapy|126
8575040|NCT00132691|9607590|FG000|COMPLETED|Overall Study|118 participants completed the 2-year anniversary visit|118
8575041|NCT00132691|9607591|FG001|COMPLETED|Overall Study|114 participants completed the 2-year anniversary visit|114
8575042|NCT00132691|9607590|FG000|NOT COMPLETED|Overall Study||11
8575043|NCT00132691|9607591|FG001|NOT COMPLETED|Overall Study||12
8575044|NCT00132730|9607606|FG000|STARTED|Period I - Placebo Run-in (Base)||150
8575045|NCT00132730|9607607|FG001|STARTED|Period I - Placebo Run-in (Base)||148
8575046|NCT00132730|9607608|FG002|STARTED|Period I - Placebo Run-in (Base)||153
8575047|NCT00132730|9607609|FG003|STARTED|Period I - Placebo Run-in (Base)||153
8575048|NCT00132730|9607610|FG004|STARTED|Period I - Placebo Run-in (Base)||0
8637385|NCT00570687|9677766|FG003|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||4
9017633|NCT03068468|10080615|FG001|NOT COMPLETED|Placebo-Controlled Period||45
9017634|NCT03068468|10080616|FG002|NOT COMPLETED|Placebo-Controlled Period||0
9017635|NCT03068468|10080617|FG003|NOT COMPLETED|Placebo-Controlled Period||0
9017636|NCT03068468|10080614|FG000|STARTED|Open-Label Extension Period||0
9017637|NCT03068468|10080615|FG001|STARTED|Open-Label Extension Period||0
9017638|NCT03068468|10080616|FG002|STARTED|Open-Label Extension Period|4 participants did not enter OLE period.|140
9017639|NCT03068468|10080617|FG003|STARTED|Open-Label Extension Period|3 participants did not enter OLE period.|276
9017640|NCT03068468|10080614|FG000|COMPLETED|Open-Label Extension Period||0
9017641|NCT03068468|10080615|FG001|COMPLETED|Open-Label Extension Period||0
9017642|NCT03068468|10080616|FG002|COMPLETED|Open-Label Extension Period||0
9017643|NCT03068468|10080617|FG003|COMPLETED|Open-Label Extension Period||0
9017644|NCT03068468|10080614|FG000|NOT COMPLETED|Open-Label Extension Period||0
9017645|NCT03068468|10080615|FG001|NOT COMPLETED|Open-Label Extension Period||0
9017646|NCT03068468|10080616|FG002|NOT COMPLETED|Open-Label Extension Period||140
9017647|NCT03068468|10080617|FG003|NOT COMPLETED|Open-Label Extension Period||276
9017648|NCT03068611|10080627|FG000|STARTED|Overall Study||61
9017649|NCT03068611|10080628|FG001|STARTED|Overall Study||58
9017650|NCT03068611|10080627|FG000|COMPLETED|Overall Study|This is the number of participants followed through 6 months from enrollment.|30
9039854|NCT03342469|10100764|FG003|NOT COMPLETED|Overall Study||0
9017651|NCT03068611|10080628|FG001|COMPLETED|Overall Study|This is the number of participants followed through 6 months from enrollment.|33
9017652|NCT03068611|10080627|FG000|NOT COMPLETED|Overall Study||31
9017653|NCT03068611|10080628|FG001|NOT COMPLETED|Overall Study||25
9017654|NCT03068754|10080636|FG000|STARTED|Randomized Treatment Period (RTP)||95
9017655|NCT03068754|10080637|FG001|STARTED|Randomized Treatment Period (RTP)||48
9017656|NCT03068754|10080638|FG002|STARTED|Randomized Treatment Period (RTP)|OLE Arms were not included during the RTP|0
9017657|NCT03068754|10080639|FG003|STARTED|Randomized Treatment Period (RTP)||0
9017658|NCT03068754|10080636|FG000|Intention to Treat (ITT) Population|Randomized Treatment Period (RTP)||95
9017659|NCT03068754|10080637|FG001|Intention to Treat (ITT) Population|Randomized Treatment Period (RTP)||48
9017660|NCT03068754|10080638|FG002|Intention to Treat (ITT) Population|Randomized Treatment Period (RTP)||0
9017661|NCT03068754|10080639|FG003|Intention to Treat (ITT) Population|Randomized Treatment Period (RTP)||0
9017662|NCT03068754|10080636|FG000|Safety Population|Randomized Treatment Period (RTP)||95
9017663|NCT03068754|10080637|FG001|Safety Population|Randomized Treatment Period (RTP)||47
9017664|NCT03068754|10080638|FG002|Safety Population|Randomized Treatment Period (RTP)||0
9017665|NCT03068754|10080639|FG003|Safety Population|Randomized Treatment Period (RTP)||0
9017666|NCT03068754|10080636|FG000|Modified ITT (mITT)|Randomized Treatment Period (RTP)||93
9017667|NCT03068754|10080637|FG001|Modified ITT (mITT)|Randomized Treatment Period (RTP)||46
9017668|NCT03068754|10080638|FG002|Modified ITT (mITT)|Randomized Treatment Period (RTP)||0
9017669|NCT03068754|10080639|FG003|Modified ITT (mITT)|Randomized Treatment Period (RTP)||0
9017670|NCT03068754|10080636|FG000|Completed Taper|Randomized Treatment Period (RTP)||58
9017671|NCT03068754|10080637|FG001|Completed Taper|Randomized Treatment Period (RTP)||28
9017672|NCT03068754|10080638|FG002|Completed Taper|Randomized Treatment Period (RTP)||0
9017673|NCT03068754|10080639|FG003|Completed Taper|Randomized Treatment Period (RTP)||0
9017674|NCT03068754|10080636|FG000|Completed 36 Weeks of Treatment|Randomized Treatment Period (RTP)||28
9017675|NCT03068754|10080637|FG001|Completed 36 Weeks of Treatment|Randomized Treatment Period (RTP)||9
9017676|NCT03068754|10080638|FG002|Completed 36 Weeks of Treatment|Randomized Treatment Period (RTP)||0
9017677|NCT03068754|10080639|FG003|Completed 36 Weeks of Treatment|Randomized Treatment Period (RTP)||0
9017678|NCT03068754|10080636|FG000|Completed RTP|Randomized Treatment Period (RTP)||27
9017679|NCT03068754|10080637|FG001|Completed RTP|Randomized Treatment Period (RTP)||9
9017680|NCT03068754|10080638|FG002|Completed RTP|Randomized Treatment Period (RTP)||0
9017681|NCT03068754|10080639|FG003|Completed RTP|Randomized Treatment Period (RTP)||0
9017682|NCT03068754|10080636|FG000|Enrolled in OLE Period|Randomized Treatment Period (RTP)||25
9017683|NCT03068754|10080637|FG001|Enrolled in OLE Period|Randomized Treatment Period (RTP)||8
9017684|NCT03068754|10080638|FG002|Enrolled in OLE Period|Randomized Treatment Period (RTP)||0
9017685|NCT03068754|10080639|FG003|Enrolled in OLE Period|Randomized Treatment Period (RTP)||0
9017686|NCT03068754|10080636|FG000|COMPLETED|Randomized Treatment Period (RTP)||28
9017687|NCT03068754|10080637|FG001|COMPLETED|Randomized Treatment Period (RTP)||9
9017688|NCT03068754|10080638|FG002|COMPLETED|Randomized Treatment Period (RTP)||0
9017689|NCT03068754|10080639|FG003|COMPLETED|Randomized Treatment Period (RTP)||0
9017690|NCT03068754|10080636|FG000|NOT COMPLETED|Randomized Treatment Period (RTP)||67
9017691|NCT03068754|10080637|FG001|NOT COMPLETED|Randomized Treatment Period (RTP)||39
9017692|NCT03068754|10080638|FG002|NOT COMPLETED|Randomized Treatment Period (RTP)||0
9017693|NCT03068754|10080639|FG003|NOT COMPLETED|Randomized Treatment Period (RTP)||0
9017694|NCT03068754|10080636|FG000|STARTED|Open Label Extension Period (OLE)|RTP arms were not included during the OLE period|0
9017695|NCT03068754|10080637|FG001|STARTED|Open Label Extension Period (OLE)||0
9017696|NCT03068754|10080638|FG002|STARTED|Open Label Extension Period (OLE)||25
9017697|NCT03068754|10080639|FG003|STARTED|Open Label Extension Period (OLE)||8
9017698|NCT03068754|10080636|FG000|Completed Taper|Open Label Extension Period (OLE)||0
9017699|NCT03068754|10080637|FG001|Completed Taper|Open Label Extension Period (OLE)||0
9017700|NCT03068754|10080638|FG002|Completed Taper|Open Label Extension Period (OLE)||19
9017701|NCT03068754|10080639|FG003|Completed Taper|Open Label Extension Period (OLE)||7
9017702|NCT03068754|10080636|FG000|Completed OLE Period|Open Label Extension Period (OLE)||0
9017703|NCT03068754|10080637|FG001|Completed OLE Period|Open Label Extension Period (OLE)||0
9017704|NCT03068754|10080638|FG002|Completed OLE Period|Open Label Extension Period (OLE)||3
9017705|NCT03068754|10080639|FG003|Completed OLE Period|Open Label Extension Period (OLE)||2
9017706|NCT03068754|10080636|FG000|Completed Treatment in OLE|Open Label Extension Period (OLE)||0
9017707|NCT03068754|10080637|FG001|Completed Treatment in OLE|Open Label Extension Period (OLE)||0
9017708|NCT03068754|10080638|FG002|Completed Treatment in OLE|Open Label Extension Period (OLE)||4
9017709|NCT03068754|10080639|FG003|Completed Treatment in OLE|Open Label Extension Period (OLE)||2
9017710|NCT03068754|10080636|FG000|COMPLETED|Open Label Extension Period (OLE)||0
9017711|NCT03068754|10080637|FG001|COMPLETED|Open Label Extension Period (OLE)||0
9017712|NCT03068754|10080638|FG002|COMPLETED|Open Label Extension Period (OLE)||4
9017713|NCT03068754|10080639|FG003|COMPLETED|Open Label Extension Period (OLE)||2
9017714|NCT03068754|10080636|FG000|NOT COMPLETED|Open Label Extension Period (OLE)||0
9017715|NCT03068754|10080637|FG001|NOT COMPLETED|Open Label Extension Period (OLE)||0
9017716|NCT03068754|10080638|FG002|NOT COMPLETED|Open Label Extension Period (OLE)||21
9017717|NCT03068754|10080639|FG003|NOT COMPLETED|Open Label Extension Period (OLE)||6
9017718|NCT03068767|10080651|FG000|STARTED|Overall Study|from August 2017 to September 2018|75
9017719|NCT03068767|10080652|FG001|STARTED|Overall Study|from August 2017 to September 2018|74
9017720|NCT03068767|10080651|FG000|COMPLETED|Overall Study|December 2018|65
9017721|NCT03068767|10080652|FG001|COMPLETED|Overall Study|December 2018|71
9017722|NCT03068767|10080651|FG000|NOT COMPLETED|Overall Study||10
9017723|NCT03068767|10080652|FG001|NOT COMPLETED|Overall Study||3
9017724|NCT03068897|10080662|FG000|STARTED|Overall Study||80
9017725|NCT03068897|10080663|FG001|STARTED|Overall Study||80
9017726|NCT03068897|10080664|FG002|STARTED|Overall Study||80
9017727|NCT03068897|10080665|FG003|STARTED|Overall Study||80
9017728|NCT03068897|10080662|FG000|COMPLETED|Overall Study||76
9017729|NCT03068897|10080663|FG001|COMPLETED|Overall Study||76
9017730|NCT03068897|10080664|FG002|COMPLETED|Overall Study||79
9017731|NCT03068897|10080665|FG003|COMPLETED|Overall Study||74
9017732|NCT03068897|10080662|FG000|NOT COMPLETED|Overall Study||4
9017733|NCT03068897|10080663|FG001|NOT COMPLETED|Overall Study||4
9017734|NCT03068897|10080664|FG002|NOT COMPLETED|Overall Study||1
9017735|NCT03068897|10080665|FG003|NOT COMPLETED|Overall Study||6
9017736|NCT03068949|10080679|FG000|STARTED|Overall Study||113
9017737|NCT03068949|10080680|FG001|STARTED|Overall Study||102
9017738|NCT03068949|10080681|FG002|STARTED|Overall Study||122
9017739|NCT03068949|10080682|FG003|STARTED|Overall Study||76
9017740|NCT03068949|10080679|FG000|COMPLETED|Overall Study||105
9017741|NCT03068949|10080680|FG001|COMPLETED|Overall Study||90
9017742|NCT03068949|10080681|FG002|COMPLETED|Overall Study||113
9017743|NCT03068949|10080682|FG003|COMPLETED|Overall Study||63
8575049|NCT00132730|9607611|FG005|STARTED|Period I - Placebo Run-in (Base)||0
8575050|NCT00132730|9607606|FG000|COMPLETED|Period I - Placebo Run-in (Base)||150
8575051|NCT00132730|9607607|FG001|COMPLETED|Period I - Placebo Run-in (Base)||148
8575052|NCT00132730|9607608|FG002|COMPLETED|Period I - Placebo Run-in (Base)||153
8575053|NCT00132730|9607609|FG003|COMPLETED|Period I - Placebo Run-in (Base)||153
8575054|NCT00132730|9607610|FG004|COMPLETED|Period I - Placebo Run-in (Base)||0
8575055|NCT00132730|9607611|FG005|COMPLETED|Period I - Placebo Run-in (Base)||0
8575056|NCT00132730|9607606|FG000|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
8575057|NCT00132730|9607607|FG001|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
8575058|NCT00132730|9607608|FG002|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
8575059|NCT00132730|9607609|FG003|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
8575060|NCT00132730|9607610|FG004|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
8575061|NCT00132730|9607611|FG005|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
8575062|NCT00132730|9607606|FG000|STARTED|Period II - 12-week Treatment (Base)||150
8575063|NCT00132730|9607607|FG001|STARTED|Period II - 12-week Treatment (Base)||148
8575064|NCT00132730|9607608|FG002|STARTED|Period II - 12-week Treatment (Base)||153
8575065|NCT00132730|9607609|FG003|STARTED|Period II - 12-week Treatment (Base)||153
8575066|NCT00132730|9607610|FG004|STARTED|Period II - 12-week Treatment (Base)||0
8575067|NCT00132730|9607611|FG005|STARTED|Period II - 12-week Treatment (Base)||0
8575068|NCT00132730|9607606|FG000|COMPLETED|Period II - 12-week Treatment (Base)||127
8575069|NCT00132730|9607607|FG001|COMPLETED|Period II - 12-week Treatment (Base)||133
8575070|NCT00132730|9607608|FG002|COMPLETED|Period II - 12-week Treatment (Base)||135
8575071|NCT00132730|9607609|FG003|COMPLETED|Period II - 12-week Treatment (Base)||131
8575072|NCT00132730|9607610|FG004|COMPLETED|Period II - 12-week Treatment (Base)||0
8575073|NCT00132730|9607611|FG005|COMPLETED|Period II - 12-week Treatment (Base)||0
8575074|NCT00132730|9607606|FG000|NOT COMPLETED|Period II - 12-week Treatment (Base)||23
8575075|NCT00132730|9607607|FG001|NOT COMPLETED|Period II - 12-week Treatment (Base)||15
8575076|NCT00132730|9607608|FG002|NOT COMPLETED|Period II - 12-week Treatment (Base)||18
8575077|NCT00132730|9607609|FG003|NOT COMPLETED|Period II - 12-week Treatment (Base)||22
8575078|NCT00132730|9607610|FG004|NOT COMPLETED|Period II - 12-week Treatment (Base)||0
8575079|NCT00132730|9607611|FG005|NOT COMPLETED|Period II - 12-week Treatment (Base)||0
8575080|NCT00132730|9607606|FG000|STARTED|Period III - Blinded Extension (EXT1)||0
8575081|NCT00132730|9607607|FG001|STARTED|Period III - Blinded Extension (EXT1)||0
8575082|NCT00132730|9607608|FG002|STARTED|Period III - Blinded Extension (EXT1)|Includes all MK-0873 participants from Period II. Not all eligible participants entered EXT1|317
8575083|NCT00132730|9607609|FG003|STARTED|Period III - Blinded Extension (EXT1)|Not all eligible participants entered EXT1|107
8575084|NCT00132730|9607610|FG004|STARTED|Period III - Blinded Extension (EXT1)||0
8575085|NCT00132730|9607611|FG005|STARTED|Period III - Blinded Extension (EXT1)||0
8575086|NCT00132730|9607606|FG000|COMPLETED|Period III - Blinded Extension (EXT1)||0
8575087|NCT00132730|9607607|FG001|COMPLETED|Period III - Blinded Extension (EXT1)||0
8575088|NCT00132730|9607608|FG002|COMPLETED|Period III - Blinded Extension (EXT1)||235
8637386|NCT00570687|9677767|FG004|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
8637387|NCT00570687|9677768|FG005|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
8637388|NCT00570687|9677769|FG006|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
8637389|NCT00570687|9677770|FG007|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
8637390|NCT00570687|9677771|FG008|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
8637391|NCT00570687|9677772|FG009|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
8637392|NCT00570687|9677763|FG000|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||4
8637393|NCT00570687|9677764|FG001|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||2
8637394|NCT00570687|9677765|FG002|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||2
8637395|NCT00570687|9677766|FG003|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||4
8637396|NCT00570687|9677767|FG004|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
9017744|NCT03068949|10080679|FG000|NOT COMPLETED|Overall Study||8
9017745|NCT03068949|10080680|FG001|NOT COMPLETED|Overall Study||12
9017746|NCT03068949|10080681|FG002|NOT COMPLETED|Overall Study||9
9017747|NCT03068949|10080682|FG003|NOT COMPLETED|Overall Study||13
9017748|NCT03069313|10080692|FG000|STARTED|Overall Study||41
9017749|NCT03069313|10080692|FG000|COMPLETED|Overall Study||36
9017750|NCT03069313|10080692|FG000|NOT COMPLETED|Overall Study||5
9017751|NCT03069352|10080698|FG000|STARTED|Overall Study||68
9017752|NCT03069352|10080699|FG001|STARTED|Overall Study||143
9017753|NCT03069352|10080698|FG000|Received Treatment|Overall Study||68
9017754|NCT03069352|10080699|FG001|Received Treatment|Overall Study||142
9017755|NCT03069352|10080698|FG000|COMPLETED|Overall Study||56
9017756|NCT03069352|10080699|FG001|COMPLETED|Overall Study||103
9017757|NCT03069352|10080698|FG000|NOT COMPLETED|Overall Study||12
9017758|NCT03069352|10080699|FG001|NOT COMPLETED|Overall Study||40
9017759|NCT03069365|10080705|FG000|STARTED|Overall Study||101
9017760|NCT03069365|10080705|FG000|COMPLETED|Overall Study||100
9017761|NCT03069365|10080705|FG000|NOT COMPLETED|Overall Study||1
9017762|NCT03069482|10080711|FG000|STARTED|Overall Study||34
9017763|NCT03069482|10080712|FG001|STARTED|Overall Study||29
9017764|NCT03069482|10080711|FG000|COMPLETED|Overall Study||33
9017765|NCT03069482|10080712|FG001|COMPLETED|Overall Study||28
9017766|NCT03069482|10080711|FG000|NOT COMPLETED|Overall Study||1
9017767|NCT03069482|10080712|FG001|NOT COMPLETED|Overall Study||1
9017768|NCT03069677|10080723|FG000|STARTED|Overall Study||80
9017769|NCT03069677|10080724|FG001|STARTED|Overall Study||80
9017770|NCT03069677|10080723|FG000|COMPLETED|Overall Study||77
9017771|NCT03069677|10080724|FG001|COMPLETED|Overall Study||77
9017772|NCT03069677|10080723|FG000|NOT COMPLETED|Overall Study||3
9017773|NCT03069677|10080724|FG001|NOT COMPLETED|Overall Study||3
9017774|NCT03069716|10080732|FG000|STARTED|Run-in Period (2 Weeks)||49
9017775|NCT03069716|10080733|FG001|STARTED|Run-in Period (2 Weeks)||0
9017776|NCT03069716|10080734|FG002|STARTED|Run-in Period (2 Weeks)||0
9017777|NCT03069716|10080732|FG000|COMPLETED|Run-in Period (2 Weeks)||42
9017778|NCT03069716|10080733|FG001|COMPLETED|Run-in Period (2 Weeks)||0
9017779|NCT03069716|10080734|FG002|COMPLETED|Run-in Period (2 Weeks)||0
9017780|NCT03069716|10080732|FG000|NOT COMPLETED|Run-in Period (2 Weeks)||7
9017781|NCT03069716|10080733|FG001|NOT COMPLETED|Run-in Period (2 Weeks)||0
9017782|NCT03069716|10080734|FG002|NOT COMPLETED|Run-in Period (2 Weeks)||0
9017783|NCT03069716|10080732|FG000|STARTED|Randomized Treatment||0
9017784|NCT03069716|10080733|FG001|STARTED|Randomized Treatment||20
9017785|NCT03069716|10080734|FG002|STARTED|Randomized Treatment||22
9017786|NCT03069716|10080732|FG000|COMPLETED|Randomized Treatment||0
9017787|NCT03069716|10080733|FG001|COMPLETED|Randomized Treatment||18
9017788|NCT03069716|10080734|FG002|COMPLETED|Randomized Treatment||22
9017789|NCT03069716|10080732|FG000|NOT COMPLETED|Randomized Treatment||0
9017790|NCT03069716|10080733|FG001|NOT COMPLETED|Randomized Treatment||2
9017791|NCT03069716|10080734|FG002|NOT COMPLETED|Randomized Treatment||0
9017792|NCT03069989|10080743|FG000|STARTED|Dosing Period 1 (Up to 2 Days)||3
9017793|NCT03069989|10080744|FG001|STARTED|Dosing Period 1 (Up to 2 Days)||5
9017794|NCT03069989|10080743|FG000|COMPLETED|Dosing Period 1 (Up to 2 Days)||3
9017795|NCT03069989|10080744|FG001|COMPLETED|Dosing Period 1 (Up to 2 Days)||5
8575089|NCT00132730|9607609|FG003|COMPLETED|Period III - Blinded Extension (EXT1)||82
8575090|NCT00132730|9607610|FG004|COMPLETED|Period III - Blinded Extension (EXT1)||0
8575091|NCT00132730|9607611|FG005|COMPLETED|Period III - Blinded Extension (EXT1)||0
8575092|NCT00132730|9607606|FG000|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
8575093|NCT00132730|9607607|FG001|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
8575094|NCT00132730|9607608|FG002|NOT COMPLETED|Period III - Blinded Extension (EXT1)||82
8575095|NCT00132730|9607609|FG003|NOT COMPLETED|Period III - Blinded Extension (EXT1)||25
8575096|NCT00132730|9607610|FG004|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
8575097|NCT00132730|9607611|FG005|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
8575098|NCT00132730|9607606|FG000|STARTED|Period IV - Open-label Extension (EXT2)||0
8575099|NCT00132730|9607607|FG001|STARTED|Period IV - Open-label Extension (EXT2)||0
8575100|NCT00132730|9607608|FG002|STARTED|Period IV - Open-label Extension (EXT2)||0
8575101|NCT00132730|9607609|FG003|STARTED|Period IV - Open-label Extension (EXT2)||0
8575102|NCT00132730|9607610|FG004|STARTED|Period IV - Open-label Extension (EXT2)|Includes participants from Period III. Not all eligible participants entered EXT2|187
8575103|NCT00132730|9607611|FG005|STARTED|Period IV - Open-label Extension (EXT2)|Includes paricipants from Period III. Not all eligible participants entered EXT2|71
8575104|NCT00132730|9607606|FG000|COMPLETED|Period IV - Open-label Extension (EXT2)||0
8637397|NCT00570687|9677768|FG005|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
8637398|NCT00570687|9677769|FG006|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
8637399|NCT00570687|9677770|FG007|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
8637400|NCT00570687|9677771|FG008|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
8637401|NCT00570687|9677772|FG009|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
8637402|NCT00570687|9677763|FG000|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
8637403|NCT00570687|9677764|FG001|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
8637404|NCT00570687|9677765|FG002|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
8637405|NCT00570687|9677766|FG003|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
8637406|NCT00570687|9677767|FG004|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
8637407|NCT00570687|9677768|FG005|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
9017796|NCT03069989|10080743|FG000|NOT COMPLETED|Dosing Period 1 (Up to 2 Days)||0
9017797|NCT03069989|10080744|FG001|NOT COMPLETED|Dosing Period 1 (Up to 2 Days)||0
9017798|NCT03069989|10080743|FG000|STARTED|Wash Out Period (Up to 28 Days))||3
9017799|NCT03069989|10080744|FG001|STARTED|Wash Out Period (Up to 28 Days))||5
9017800|NCT03069989|10080743|FG000|COMPLETED|Wash Out Period (Up to 28 Days))||3
9017801|NCT03069989|10080744|FG001|COMPLETED|Wash Out Period (Up to 28 Days))||5
9017802|NCT03069989|10080743|FG000|NOT COMPLETED|Wash Out Period (Up to 28 Days))||0
9017803|NCT03069989|10080744|FG001|NOT COMPLETED|Wash Out Period (Up to 28 Days))||0
9017804|NCT03069989|10080743|FG000|STARTED|Dosing Period 2 (Up to 16 Days)||3
9017805|NCT03069989|10080744|FG001|STARTED|Dosing Period 2 (Up to 16 Days)||5
9017806|NCT03069989|10080743|FG000|COMPLETED|Dosing Period 2 (Up to 16 Days)||2
9017807|NCT03069989|10080744|FG001|COMPLETED|Dosing Period 2 (Up to 16 Days)||5
9017808|NCT03069989|10080743|FG000|NOT COMPLETED|Dosing Period 2 (Up to 16 Days)||1
9017809|NCT03069989|10080744|FG001|NOT COMPLETED|Dosing Period 2 (Up to 16 Days)||0
9017810|NCT03070171|10080753|FG000|STARTED|Treatment Period 1 + Washout||80
9017811|NCT03070171|10080754|FG001|STARTED|Treatment Period 1 + Washout||80
9017812|NCT03070171|10080753|FG000|COMPLETED|Treatment Period 1 + Washout||80
9017813|NCT03070171|10080754|FG001|COMPLETED|Treatment Period 1 + Washout||80
9017814|NCT03070171|10080753|FG000|NOT COMPLETED|Treatment Period 1 + Washout||0
9017815|NCT03070171|10080754|FG001|NOT COMPLETED|Treatment Period 1 + Washout||0
9017816|NCT03070171|10080753|FG000|STARTED|Treatment Period 2 + Washout||80
9017817|NCT03070171|10080754|FG001|STARTED|Treatment Period 2 + Washout||80
9017818|NCT03070171|10080753|FG000|COMPLETED|Treatment Period 2 + Washout||80
9017819|NCT03070171|10080754|FG001|COMPLETED|Treatment Period 2 + Washout||79
9017820|NCT03070171|10080753|FG000|NOT COMPLETED|Treatment Period 2 + Washout||0
9017821|NCT03070171|10080754|FG001|NOT COMPLETED|Treatment Period 2 + Washout||1
9017822|NCT03070171|10080753|FG000|STARTED|Treatment Period 3 + Washout||80
9017823|NCT03070171|10080754|FG001|STARTED|Treatment Period 3 + Washout||79
9017824|NCT03070171|10080753|FG000|COMPLETED|Treatment Period 3 + Washout||80
9017825|NCT03070171|10080754|FG001|COMPLETED|Treatment Period 3 + Washout||79
9017826|NCT03070171|10080753|FG000|NOT COMPLETED|Treatment Period 3 + Washout||0
9017827|NCT03070171|10080754|FG001|NOT COMPLETED|Treatment Period 3 + Washout||0
9017828|NCT03070171|10080753|FG000|STARTED|Treatment Period 4 + Washout||80
9017829|NCT03070171|10080754|FG001|STARTED|Treatment Period 4 + Washout||79
9017830|NCT03070171|10080753|FG000|COMPLETED|Treatment Period 4 + Washout||80
9017831|NCT03070171|10080754|FG001|COMPLETED|Treatment Period 4 + Washout||78
9017832|NCT03070171|10080753|FG000|NOT COMPLETED|Treatment Period 4 + Washout||0
9017833|NCT03070171|10080754|FG001|NOT COMPLETED|Treatment Period 4 + Washout||1
9017834|NCT03070431|10080760|FG000|STARTED|Overall Study||44
9017835|NCT03070431|10080760|FG000|COMPLETED|Overall Study||40
9017836|NCT03070431|10080760|FG000|NOT COMPLETED|Overall Study||4
9017837|NCT03070470|10080775|FG000|STARTED|Overall Study||10
9017838|NCT03070470|10080776|FG001|STARTED|Overall Study||10
9017839|NCT03070470|10080777|FG002|STARTED|Overall Study||10
9017840|NCT03070470|10080778|FG003|STARTED|Overall Study||10
9017841|NCT03070470|10080779|FG004|STARTED|Overall Study||10
9017842|NCT03070470|10080780|FG005|STARTED|Overall Study||10
9017843|NCT03070470|10080775|FG000|COMPLETED|Overall Study||10
9017844|NCT03070470|10080776|FG001|COMPLETED|Overall Study||9
9017845|NCT03070470|10080777|FG002|COMPLETED|Overall Study||10
9017846|NCT03070470|10080778|FG003|COMPLETED|Overall Study||10
9017847|NCT03070470|10080779|FG004|COMPLETED|Overall Study||10
9017848|NCT03070470|10080780|FG005|COMPLETED|Overall Study||8
9017849|NCT03070470|10080775|FG000|NOT COMPLETED|Overall Study||0
9017850|NCT03070470|10080776|FG001|NOT COMPLETED|Overall Study||1
9017851|NCT03070470|10080777|FG002|NOT COMPLETED|Overall Study||0
9017852|NCT03070470|10080778|FG003|NOT COMPLETED|Overall Study||0
9017853|NCT03070470|10080779|FG004|NOT COMPLETED|Overall Study||0
9017854|NCT03070470|10080780|FG005|NOT COMPLETED|Overall Study||2
9017855|NCT03070483|10080796|FG000|STARTED|Overall Study||5
9017856|NCT03070483|10080796|FG000|COMPLETED|Overall Study||3
9017857|NCT03070483|10080796|FG000|NOT COMPLETED|Overall Study||2
9017858|NCT03070548|10080801|FG000|STARTED|Overall Study||6
9017859|NCT03070548|10080801|FG000|COMPLETED|Overall Study||6
9017860|NCT03070548|10080801|FG000|NOT COMPLETED|Overall Study||0
9017861|NCT03070730|10080808|FG000|STARTED|Overall Study||0
9017862|NCT03070730|10080809|FG001|STARTED|Overall Study||0
9017863|NCT03070730|10080810|FG002|STARTED|Overall Study||0
9017864|NCT03070730|10080808|FG000|COMPLETED|Overall Study||0
9017865|NCT03070730|10080809|FG001|COMPLETED|Overall Study||0
9017866|NCT03070730|10080810|FG002|COMPLETED|Overall Study||0
9017867|NCT03070730|10080808|FG000|NOT COMPLETED|Overall Study||0
9017868|NCT03070730|10080809|FG001|NOT COMPLETED|Overall Study||0
9017869|NCT03070730|10080810|FG002|NOT COMPLETED|Overall Study||0
9017870|NCT03070782|10080824|FG000|STARTED|Overall Study||48
9017871|NCT03070782|10080825|FG001|STARTED|Overall Study||48
9017872|NCT03070782|10080826|FG002|STARTED|Overall Study||47
9017873|NCT03070782|10080827|FG003|STARTED|Overall Study||48
9017874|NCT03070782|10080828|FG004|STARTED|Overall Study||48
9017875|NCT03070782|10080829|FG005|STARTED|Overall Study||47
9017876|NCT03070782|10080824|FG000|COMPLETED|Overall Study||41
9017877|NCT03070782|10080825|FG001|COMPLETED|Overall Study||47
9017878|NCT03070782|10080826|FG002|COMPLETED|Overall Study||43
9017879|NCT03070782|10080827|FG003|COMPLETED|Overall Study||43
9017880|NCT03070782|10080828|FG004|COMPLETED|Overall Study||36
9017881|NCT03070782|10080829|FG005|COMPLETED|Overall Study||40
9017882|NCT03070782|10080824|FG000|NOT COMPLETED|Overall Study||7
9017883|NCT03070782|10080825|FG001|NOT COMPLETED|Overall Study||1
9017884|NCT03070782|10080826|FG002|NOT COMPLETED|Overall Study||4
9017885|NCT03070782|10080827|FG003|NOT COMPLETED|Overall Study||5
9017886|NCT03070782|10080828|FG004|NOT COMPLETED|Overall Study||12
9017887|NCT03070782|10080829|FG005|NOT COMPLETED|Overall Study||7
9017888|NCT03070964|10080843|FG000|STARTED|Overall Study||14
9017889|NCT03070964|10080843|FG000|COMPLETED|Overall Study||0
9017890|NCT03070964|10080843|FG000|NOT COMPLETED|Overall Study||14
8575105|NCT00132730|9607607|FG001|COMPLETED|Period IV - Open-label Extension (EXT2)||0
8575106|NCT00132730|9607608|FG002|COMPLETED|Period IV - Open-label Extension (EXT2)||0
8575107|NCT00132730|9607609|FG003|COMPLETED|Period IV - Open-label Extension (EXT2)||0
8575108|NCT00132730|9607610|FG004|COMPLETED|Period IV - Open-label Extension (EXT2)||8
8575109|NCT00132730|9607611|FG005|COMPLETED|Period IV - Open-label Extension (EXT2)||3
8575110|NCT00132730|9607606|FG000|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
8575111|NCT00132730|9607607|FG001|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
8575112|NCT00132730|9607608|FG002|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
8577605|NCT00159874|9610367|FG000|Treated|Overall Study||42
8637408|NCT00570687|9677769|FG006|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
8637409|NCT00570687|9677770|FG007|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
8637410|NCT00570687|9677771|FG008|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
8637411|NCT00570687|9677772|FG009|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
8637412|NCT00570687|9677763|FG000|STARTED|Washout 2 (8 Weeks) - Amendment 1||4
8637413|NCT00570687|9677764|FG001|STARTED|Washout 2 (8 Weeks) - Amendment 1||2
8637414|NCT00570687|9677765|FG002|STARTED|Washout 2 (8 Weeks) - Amendment 1||2
8637415|NCT00570687|9677766|FG003|STARTED|Washout 2 (8 Weeks) - Amendment 1||4
8637416|NCT00570687|9677767|FG004|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
8637417|NCT00570687|9677768|FG005|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
8637418|NCT00570687|9677769|FG006|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
8637419|NCT00570687|9677770|FG007|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
8637420|NCT00570687|9677771|FG008|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
8637421|NCT00570687|9677772|FG009|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
8637422|NCT00570687|9677763|FG000|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||4
8637423|NCT00570687|9677764|FG001|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||2
8637424|NCT00570687|9677765|FG002|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||2
8637425|NCT00570687|9677766|FG003|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||4
8637426|NCT00570687|9677767|FG004|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
8637427|NCT00570687|9677768|FG005|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
8637428|NCT00570687|9677769|FG006|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
8637429|NCT00570687|9677770|FG007|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
8637430|NCT00570687|9677771|FG008|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
8637431|NCT00570687|9677772|FG009|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
8637432|NCT00570687|9677763|FG000|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
8637433|NCT00570687|9677764|FG001|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
8637434|NCT00570687|9677765|FG002|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
8637435|NCT00570687|9677766|FG003|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
8637436|NCT00570687|9677767|FG004|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
8637437|NCT00570687|9677768|FG005|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
8637438|NCT00570687|9677769|FG006|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
8637439|NCT00570687|9677770|FG007|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
8637440|NCT00570687|9677771|FG008|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
8637441|NCT00570687|9677772|FG009|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
8637442|NCT00570687|9677763|FG000|STARTED|Clamp 1 (1 Day) - Amendment 1||4
8637443|NCT00570687|9677764|FG001|STARTED|Clamp 1 (1 Day) - Amendment 1||2
8637444|NCT00570687|9677765|FG002|STARTED|Clamp 1 (1 Day) - Amendment 1||2
8637445|NCT00570687|9677766|FG003|STARTED|Clamp 1 (1 Day) - Amendment 1||4
8637446|NCT00570687|9677767|FG004|STARTED|Clamp 1 (1 Day) - Amendment 1||0
8637447|NCT00570687|9677768|FG005|STARTED|Clamp 1 (1 Day) - Amendment 1||0
8637448|NCT00570687|9677769|FG006|STARTED|Clamp 1 (1 Day) - Amendment 1||0
8637449|NCT00570687|9677770|FG007|STARTED|Clamp 1 (1 Day) - Amendment 1||0
8637450|NCT00570687|9677771|FG008|STARTED|Clamp 1 (1 Day) - Amendment 1||0
8637451|NCT00570687|9677772|FG009|STARTED|Clamp 1 (1 Day) - Amendment 1||0
8637452|NCT00570687|9677763|FG000|COMPLETED|Clamp 1 (1 Day) - Amendment 1||4
8637453|NCT00570687|9677764|FG001|COMPLETED|Clamp 1 (1 Day) - Amendment 1||2
8637454|NCT00570687|9677765|FG002|COMPLETED|Clamp 1 (1 Day) - Amendment 1||2
8637455|NCT00570687|9677766|FG003|COMPLETED|Clamp 1 (1 Day) - Amendment 1||4
8637456|NCT00570687|9677767|FG004|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
8637457|NCT00570687|9677768|FG005|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
8637458|NCT00570687|9677769|FG006|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
8637459|NCT00570687|9677770|FG007|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
8637460|NCT00570687|9677771|FG008|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
8637461|NCT00570687|9677772|FG009|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
8637462|NCT00570687|9677763|FG000|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
8637463|NCT00570687|9677764|FG001|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
8637464|NCT00570687|9677765|FG002|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
8637465|NCT00570687|9677766|FG003|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
8637466|NCT00570687|9677767|FG004|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
9017891|NCT03071094|10080849|FG000|STARTED|Overall Study||7
8637467|NCT00570687|9677768|FG005|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
8637468|NCT00570687|9677769|FG006|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
8637469|NCT00570687|9677770|FG007|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
8691354|NCT00854308|9736607|FG000|NOT COMPLETED|Overall Study||62
9017892|NCT03071094|10080850|FG001|STARTED|Overall Study||5
9017893|NCT03071094|10080849|FG000|COMPLETED|Overall Study||5
9017894|NCT03071094|10080850|FG001|COMPLETED|Overall Study||4
9017895|NCT03071094|10080849|FG000|NOT COMPLETED|Overall Study||2
9017896|NCT03071094|10080850|FG001|NOT COMPLETED|Overall Study||1
9017897|NCT03071263|10080858|FG000|STARTED|Overall Study||147
9017898|NCT03071263|10080859|FG001|STARTED|Overall Study||148
9017899|NCT03071263|10080858|FG000|COMPLETED|Overall Study||144
9017900|NCT03071263|10080859|FG001|COMPLETED|Overall Study||141
9017901|NCT03071263|10080858|FG000|NOT COMPLETED|Overall Study||3
9017902|NCT03071263|10080859|FG001|NOT COMPLETED|Overall Study||7
9017903|NCT03071276|10080865|FG000|STARTED|Overall Study||37
9017904|NCT03071276|10080865|FG000|COMPLETED|Overall Study||22
9017905|NCT03071276|10080865|FG000|NOT COMPLETED|Overall Study||15
9017906|NCT03071744|10080869|FG000|STARTED|Overall Study||6
9017907|NCT03071744|10080869|FG000|COMPLETED|Overall Study||4
9017908|NCT03071744|10080869|FG000|NOT COMPLETED|Overall Study||2
9017909|NCT03071887|10080873|FG000|STARTED|Overall Study||13
9017910|NCT03071887|10080873|FG000|COMPLETED|Overall Study||7
9017911|NCT03071887|10080873|FG000|NOT COMPLETED|Overall Study||6
9017912|NCT03072160|10080879|FG000|STARTED|Overall Study||13
9017913|NCT03072160|10080880|FG001|STARTED|Overall Study||4
9017914|NCT03072160|10080879|FG000|COMPLETED|Overall Study||2
9017915|NCT03072160|10080880|FG001|COMPLETED|Overall Study||0
9017916|NCT03072160|10080879|FG000|NOT COMPLETED|Overall Study||11
9017917|NCT03072160|10080880|FG001|NOT COMPLETED|Overall Study||4
9017918|NCT03072186|10080918|FG000|STARTED|Overall Study||23
9017919|NCT03072186|10080918|FG000|COMPLETED|Overall Study||17
9017920|NCT03072186|10080918|FG000|NOT COMPLETED|Overall Study||6
9017921|NCT03072550|10080922|FG000|STARTED|Overall Study||26
9017922|NCT03072550|10080922|FG000|COMPLETED|Overall Study||24
9017923|NCT03072550|10080922|FG000|NOT COMPLETED|Overall Study||2
9017924|NCT03072602|10080928|FG000|STARTED|Overall Study||39
9017925|NCT03072602|10080929|FG001|STARTED|Overall Study||42
9017926|NCT03072602|10080928|FG000|Total Participant Screened for the Purpose of Eligibilty|Overall Study||47
9017927|NCT03072602|10080929|FG001|Total Participant Screened for the Purpose of Eligibilty|Overall Study||47
9017928|NCT03072602|10080928|FG000|Ineligible Participants|Overall Study||8
9017929|NCT03072602|10080929|FG001|Ineligible Participants|Overall Study||5
9017930|NCT03072602|10080928|FG000|Participant Received Standardized Meals|Overall Study||39
9017931|NCT03072602|10080929|FG001|Participant Received Standardized Meals|Overall Study||42
9017932|NCT03072602|10080928|FG000|Study Dropouts|Overall Study||4
9017933|NCT03072602|10080929|FG001|Study Dropouts|Overall Study||3
9017934|NCT03072602|10080928|FG000|Participants Returned for Glucose Challenge Protocol|Overall Study||35
9017935|NCT03072602|10080929|FG001|Participants Returned for Glucose Challenge Protocol|Overall Study||39
9017936|NCT03072602|10080928|FG000|Unable to Complete the Protocol|Overall Study||1
9017937|NCT03072602|10080929|FG001|Unable to Complete the Protocol|Overall Study||1
9017938|NCT03072602|10080928|FG000|COMPLETED|Overall Study||34
9017939|NCT03072602|10080929|FG001|COMPLETED|Overall Study||38
9017940|NCT03072602|10080928|FG000|NOT COMPLETED|Overall Study||5
9017941|NCT03072602|10080929|FG001|NOT COMPLETED|Overall Study||4
9017942|NCT03072719|10080937|FG000|STARTED|Overall Study||60
9017943|NCT03072719|10080938|FG001|STARTED|Overall Study||60
9017944|NCT03072719|10080937|FG000|COMPLETED|Overall Study||59
9017945|NCT03072719|10080938|FG001|COMPLETED|Overall Study||59
9017946|NCT03072719|10080937|FG000|NOT COMPLETED|Overall Study||1
9017947|NCT03072719|10080938|FG001|NOT COMPLETED|Overall Study||1
9039855|NCT03342560|10100775|FG000|STARTED|Overall Study||30
9039856|NCT03342560|10100775|FG000|COMPLETED|Overall Study||28
9039857|NCT03342560|10100775|FG000|NOT COMPLETED|Overall Study||2
9039858|NCT03342690|10100783|FG000|STARTED|Overall Study||1164
9039859|NCT03342690|10100783|FG000|COMPLETED|Overall Study||1139
9039860|NCT03342690|10100783|FG000|NOT COMPLETED|Overall Study||25
9039861|NCT03342898|10100790|FG000|STARTED|Overall Study||300
9039862|NCT03342898|10100791|FG001|STARTED|Overall Study||300
9039863|NCT03342898|10100792|FG002|STARTED|Overall Study||300
9039864|NCT03342898|10100790|FG000|COMPLETED|Overall Study||246
9039865|NCT03342898|10100791|FG001|COMPLETED|Overall Study||247
9039866|NCT03342898|10100792|FG002|COMPLETED|Overall Study||246
9039867|NCT03342898|10100790|FG000|NOT COMPLETED|Overall Study||54
9039868|NCT03342898|10100791|FG001|NOT COMPLETED|Overall Study||53
9039869|NCT03342898|10100792|FG002|NOT COMPLETED|Overall Study||54
9039870|NCT03342963|10100804|FG000|STARTED|Overall Study||27
9039871|NCT03342963|10100805|FG001|STARTED|Overall Study||27
9039872|NCT03342963|10100806|FG002|STARTED|Overall Study||10
9039873|NCT03342963|10100807|FG003|STARTED|Overall Study||10
9039874|NCT03342963|10100804|FG000|COMPLETED|Overall Study||25
9039875|NCT03342963|10100805|FG001|COMPLETED|Overall Study||25
9039876|NCT03342963|10100806|FG002|COMPLETED|Overall Study||10
9039877|NCT03342963|10100807|FG003|COMPLETED|Overall Study||10
9039878|NCT03342963|10100804|FG000|NOT COMPLETED|Overall Study||2
9039879|NCT03342963|10100805|FG001|NOT COMPLETED|Overall Study||2
9039880|NCT03342963|10100806|FG002|NOT COMPLETED|Overall Study||0
9039881|NCT03342963|10100807|FG003|NOT COMPLETED|Overall Study||0
9039882|NCT03343067|10100820|FG000|STARTED|Open Label Period: Day 1 to Month 3||7
9039883|NCT03343067|10100821|FG001|STARTED|Open Label Period: Day 1 to Month 3||3
9039884|NCT03343067|10100822|FG002|STARTED|Open Label Period: Day 1 to Month 3||1
9039885|NCT03343067|10100820|FG000|COMPLETED|Open Label Period: Day 1 to Month 3||0
9039886|NCT03343067|10100821|FG001|COMPLETED|Open Label Period: Day 1 to Month 3||3
9017948|NCT03072732|10080946|FG000|STARTED|Overall Study||20
9017949|NCT03072732|10080947|FG001|STARTED|Overall Study||20
9017950|NCT03072732|10080946|FG000|COMPLETED|Overall Study||20
9017951|NCT03072732|10080947|FG001|COMPLETED|Overall Study||20
9017952|NCT03072732|10080946|FG000|NOT COMPLETED|Overall Study||0
9017953|NCT03072732|10080947|FG001|NOT COMPLETED|Overall Study||0
9017954|NCT03072875|10080953|FG000|STARTED|Overall Study||26
9017955|NCT03072875|10080953|FG000|COMPLETED|Overall Study||25
9017956|NCT03072875|10080953|FG000|NOT COMPLETED|Overall Study||1
9017957|NCT03072953|10080958|FG000|STARTED|Overall Study||2
9017958|NCT03072953|10080958|FG000|COMPLETED|Overall Study||2
9017959|NCT03072953|10080958|FG000|NOT COMPLETED|Overall Study||0
9017960|NCT03073005|10080966|FG000|STARTED|Overall Study||33
9017961|NCT03073005|10080967|FG001|STARTED|Overall Study||37
9017962|NCT03073005|10080968|FG002|STARTED|Overall Study||36
9017963|NCT03073005|10080969|FG003|STARTED|Overall Study||37
9017964|NCT03073005|10080966|FG000|Received Initial Training|Overall Study|29 pairs (29 patients plus their caregivers)|29
9017965|NCT03073005|10080967|FG001|Received Initial Training|Overall Study||29
9017966|NCT03073005|10080968|FG002|Received Initial Training|Overall Study|33 pairs (33 patients plus their caregivers)|33
9017967|NCT03073005|10080969|FG003|Received Initial Training|Overall Study||33
9017968|NCT03073005|10080966|FG000|COMPLETED|Overall Study|25 pairs (25 patients plus their caregivers)|25
9017969|NCT03073005|10080967|FG001|COMPLETED|Overall Study||25
9017970|NCT03073005|10080968|FG002|COMPLETED|Overall Study|24 pairs (24 patients plus their caregivers)|24
9017971|NCT03073005|10080969|FG003|COMPLETED|Overall Study||24
9017972|NCT03073005|10080966|FG000|NOT COMPLETED|Overall Study||8
9017973|NCT03073005|10080967|FG001|NOT COMPLETED|Overall Study||12
9017974|NCT03073005|10080968|FG002|NOT COMPLETED|Overall Study||12
9017975|NCT03073005|10080969|FG003|NOT COMPLETED|Overall Study||13
9017976|NCT03073109|10080984|FG000|STARTED|Overall Study||100
9017977|NCT03073109|10080985|FG001|STARTED|Overall Study||70
9017978|NCT03073109|10080984|FG000|COMPLETED|Overall Study||90
9017979|NCT03073109|10080985|FG001|COMPLETED|Overall Study||68
9017980|NCT03073109|10080984|FG000|NOT COMPLETED|Overall Study||10
9017981|NCT03073109|10080985|FG001|NOT COMPLETED|Overall Study||2
9017982|NCT03073148|10081007|FG000|STARTED|Overall Study||21
9017983|NCT03073148|10081008|FG001|STARTED|Overall Study||10
8637470|NCT00570687|9677771|FG008|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
8637471|NCT00570687|9677772|FG009|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
8637472|NCT00570687|9677763|FG000|STARTED|Washout 3 (7-21 Days) - Amendment 1||4
8637473|NCT00570687|9677764|FG001|STARTED|Washout 3 (7-21 Days) - Amendment 1||2
8637474|NCT00570687|9677765|FG002|STARTED|Washout 3 (7-21 Days) - Amendment 1||2
8637475|NCT00570687|9677766|FG003|STARTED|Washout 3 (7-21 Days) - Amendment 1||4
8637476|NCT00570687|9677767|FG004|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
8637477|NCT00570687|9677768|FG005|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
8637478|NCT00570687|9677769|FG006|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
8637479|NCT00570687|9677770|FG007|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
8637480|NCT00570687|9677771|FG008|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
8637481|NCT00570687|9677772|FG009|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
8637482|NCT00570687|9677763|FG000|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||4
8637483|NCT00570687|9677764|FG001|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||2
8637484|NCT00570687|9677765|FG002|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||2
8637485|NCT00570687|9677766|FG003|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||4
8637486|NCT00570687|9677767|FG004|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
8637487|NCT00570687|9677768|FG005|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
8637488|NCT00570687|9677769|FG006|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
8637489|NCT00570687|9677770|FG007|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
8637490|NCT00570687|9677771|FG008|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
8637491|NCT00570687|9677772|FG009|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
8637492|NCT00570687|9677763|FG000|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
8637493|NCT00570687|9677764|FG001|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
8637494|NCT00570687|9677765|FG002|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
8637495|NCT00570687|9677766|FG003|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
8637496|NCT00570687|9677767|FG004|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
8637497|NCT00570687|9677768|FG005|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
8637498|NCT00570687|9677769|FG006|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
8637499|NCT00570687|9677770|FG007|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
8637500|NCT00570687|9677771|FG008|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
8637501|NCT00570687|9677772|FG009|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
8637502|NCT00570687|9677763|FG000|STARTED|Clamp 2 (1 Day) - Amendment 1||4
8637503|NCT00570687|9677764|FG001|STARTED|Clamp 2 (1 Day) - Amendment 1||2
8637504|NCT00570687|9677765|FG002|STARTED|Clamp 2 (1 Day) - Amendment 1||2
8637505|NCT00570687|9677766|FG003|STARTED|Clamp 2 (1 Day) - Amendment 1||4
8637506|NCT00570687|9677767|FG004|STARTED|Clamp 2 (1 Day) - Amendment 1||0
8637507|NCT00570687|9677768|FG005|STARTED|Clamp 2 (1 Day) - Amendment 1||0
8637508|NCT00570687|9677769|FG006|STARTED|Clamp 2 (1 Day) - Amendment 1||0
8637509|NCT00570687|9677770|FG007|STARTED|Clamp 2 (1 Day) - Amendment 1||0
8637510|NCT00570687|9677771|FG008|STARTED|Clamp 2 (1 Day) - Amendment 1||0
8637511|NCT00570687|9677772|FG009|STARTED|Clamp 2 (1 Day) - Amendment 1||0
9017984|NCT03073148|10081009|FG002|STARTED|Overall Study||4
9017985|NCT03073148|10081007|FG000|COMPLETED|Overall Study||21
9017986|NCT03073148|10081008|FG001|COMPLETED|Overall Study||10
9017987|NCT03073148|10081009|FG002|COMPLETED|Overall Study||0
9017988|NCT03073148|10081007|FG000|NOT COMPLETED|Overall Study||0
8637512|NCT00570687|9677763|FG000|COMPLETED|Clamp 2 (1 Day) - Amendment 1||4
8637513|NCT00570687|9677764|FG001|COMPLETED|Clamp 2 (1 Day) - Amendment 1||2
8637514|NCT00570687|9677765|FG002|COMPLETED|Clamp 2 (1 Day) - Amendment 1||2
8637515|NCT00570687|9677766|FG003|COMPLETED|Clamp 2 (1 Day) - Amendment 1||4
8637516|NCT00570687|9677767|FG004|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
8637517|NCT00570687|9677768|FG005|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
8637518|NCT00570687|9677769|FG006|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
8637519|NCT00570687|9677770|FG007|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
8637520|NCT00570687|9677771|FG008|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
8637521|NCT00570687|9677772|FG009|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
8637522|NCT00570687|9677763|FG000|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
8637523|NCT00570687|9677764|FG001|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
8637524|NCT00570687|9677765|FG002|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
8637525|NCT00570687|9677766|FG003|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
8637526|NCT00570687|9677767|FG004|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
8637527|NCT00570687|9677768|FG005|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
8637528|NCT00570687|9677769|FG006|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
8637529|NCT00570687|9677770|FG007|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
8637530|NCT00570687|9677771|FG008|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
8637531|NCT00570687|9677772|FG009|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
8637532|NCT00570700|9677786|FG000|STARTED|Overall Study||38
8637533|NCT00570700|9677786|FG000|COMPLETED|Overall Study||27
8637534|NCT00570700|9677786|FG000|NOT COMPLETED|Overall Study||11
8637535|NCT00570713|9677792|FG000|STARTED|Overall Study||78
8637536|NCT00570713|9677793|FG001|STARTED|Overall Study||77
8637537|NCT00570713|9677792|FG000|COMPLETED|Overall Study||0
8637538|NCT00570713|9677793|FG001|COMPLETED|Overall Study||0
8637539|NCT00570713|9677792|FG000|NOT COMPLETED|Overall Study||78
8637540|NCT00570713|9677793|FG001|NOT COMPLETED|Overall Study||77
8637541|NCT00570739|9677803|FG000|STARTED|Overall Study||141
8637542|NCT00570739|9677804|FG001|STARTED|Overall Study||145
8637543|NCT00570739|9677805|FG002|STARTED|Overall Study||108
8637544|NCT00570739|9677806|FG003|STARTED|Overall Study||108
8637545|NCT00570739|9677803|FG000|COMPLETED|Overall Study||120
8637546|NCT00570739|9677804|FG001|COMPLETED|Overall Study||124
8637547|NCT00570739|9677805|FG002|COMPLETED|Overall Study||92
8637548|NCT00570739|9677806|FG003|COMPLETED|Overall Study||96
8637549|NCT00570739|9677803|FG000|NOT COMPLETED|Overall Study||21
8637550|NCT00570739|9677804|FG001|NOT COMPLETED|Overall Study||21
8637551|NCT00570739|9677805|FG002|NOT COMPLETED|Overall Study||16
8637552|NCT00570739|9677806|FG003|NOT COMPLETED|Overall Study||12
8637553|NCT00570765|9677839|FG000|STARTED|DB Phase||20
8637554|NCT00570765|9677840|FG001|STARTED|DB Phase||16
8637555|NCT00570765|9677841|FG002|STARTED|DB Phase||24
8637556|NCT00570765|9677842|FG003|STARTED|DB Phase||0
8637557|NCT00570765|9677839|FG000|Received at Least 1 Dose of Study Drug|DB Phase||20
8637558|NCT00570765|9677840|FG001|Received at Least 1 Dose of Study Drug|DB Phase||16
8637559|NCT00570765|9677841|FG002|Received at Least 1 Dose of Study Drug|DB Phase||23
8637560|NCT00570765|9677842|FG003|Received at Least 1 Dose of Study Drug|DB Phase||0
8637561|NCT00570765|9677839|FG000|Safety Population|DB Phase||20
8637562|NCT00570765|9677840|FG001|Safety Population|DB Phase||16
8637563|NCT00570765|9677841|FG002|Safety Population|DB Phase||23
8637564|NCT00570765|9677842|FG003|Safety Population|DB Phase||0
8637565|NCT00570765|9677839|FG000|COMPLETED|DB Phase||16
8637566|NCT00570765|9677840|FG001|COMPLETED|DB Phase||9
8637567|NCT00570765|9677841|FG002|COMPLETED|DB Phase||23
8637568|NCT00570765|9677842|FG003|COMPLETED|DB Phase||0
8637569|NCT00570765|9677839|FG000|NOT COMPLETED|DB Phase||4
8637570|NCT00570765|9677840|FG001|NOT COMPLETED|DB Phase||7
8637571|NCT00570765|9677841|FG002|NOT COMPLETED|DB Phase||1
8637572|NCT00570765|9677842|FG003|NOT COMPLETED|DB Phase||0
8637573|NCT00570765|9677839|FG000|STARTED|LTSE Phase|Eligible participants who completed the DB phase enrolled in the LTSE phase.|0
8637574|NCT00570765|9677840|FG001|STARTED|LTSE Phase|Eligible participants who completed the DB phase enrolled in the LTSE phase.|0
8637575|NCT00570765|9677841|FG002|STARTED|LTSE Phase|Eligible participants who completed the DB phase enrolled in the LTSE phase.|0
8637576|NCT00570765|9677842|FG003|STARTED|LTSE Phase|Eligible participants who completed the DB phase enrolled in the LTSE phase.|28
8637577|NCT00570765|9677839|FG000|Received at Least 1 Dose of Study Drug|LTSE Phase||0
8637578|NCT00570765|9677840|FG001|Received at Least 1 Dose of Study Drug|LTSE Phase||0
8637579|NCT00570765|9677841|FG002|Received at Least 1 Dose of Study Drug|LTSE Phase||0
8637580|NCT00570765|9677842|FG003|Received at Least 1 Dose of Study Drug|LTSE Phase||28
8637581|NCT00570765|9677839|FG000|Safety Population|LTSE Phase||0
8637582|NCT00570765|9677840|FG001|Safety Population|LTSE Phase||0
8637583|NCT00570765|9677841|FG002|Safety Population|LTSE Phase||0
8637584|NCT00570765|9677842|FG003|Safety Population|LTSE Phase||28
8637585|NCT00570765|9677839|FG000|COMPLETED|LTSE Phase||0
8637586|NCT00570765|9677840|FG001|COMPLETED|LTSE Phase||0
8637587|NCT00570765|9677841|FG002|COMPLETED|LTSE Phase||0
8637588|NCT00570765|9677842|FG003|COMPLETED|LTSE Phase||16
8637589|NCT00570765|9677839|FG000|NOT COMPLETED|LTSE Phase||0
8637590|NCT00570765|9677840|FG001|NOT COMPLETED|LTSE Phase||0
8637591|NCT00570765|9677841|FG002|NOT COMPLETED|LTSE Phase||0
8637592|NCT00570765|9677842|FG003|NOT COMPLETED|LTSE Phase||12
8637593|NCT00570778|9677853|FG000|STARTED|Overall Study||41
8637594|NCT00570778|9677854|FG001|STARTED|Overall Study||38
9017989|NCT03073148|10081008|FG001|NOT COMPLETED|Overall Study||0
9017990|NCT03073148|10081009|FG002|NOT COMPLETED|Overall Study||4
9017991|NCT03073200|10081020|FG000|STARTED|Double Blind Treatment Period||56
9017992|NCT03073200|10081021|FG001|STARTED|Double Blind Treatment Period||115
9017993|NCT03073200|10081022|FG002|STARTED|Double Blind Treatment Period||30
9017994|NCT03073200|10081023|FG003|STARTED|Double Blind Treatment Period||0
9017995|NCT03073200|10081024|FG004|STARTED|Double Blind Treatment Period||0
9017996|NCT03073200|10081025|FG005|STARTED|Double Blind Treatment Period||0
9017997|NCT03073200|10081026|FG006|STARTED|Double Blind Treatment Period||0
9017998|NCT03073200|10081027|FG007|STARTED|Double Blind Treatment Period||0
9017999|NCT03073200|10081028|FG008|STARTED|Double Blind Treatment Period||0
9018000|NCT03073200|10081029|FG009|STARTED|Double Blind Treatment Period||0
9018001|NCT03073200|10081030|FG010|STARTED|Double Blind Treatment Period||0
9018002|NCT03073200|10081031|FG011|STARTED|Double Blind Treatment Period||0
9018003|NCT03073200|10081032|FG012|STARTED|Double Blind Treatment Period||0
9018004|NCT03073200|10081033|FG013|STARTED|Double Blind Treatment Period||0
9018005|NCT03073200|10081034|FG014|STARTED|Double Blind Treatment Period||0
9018006|NCT03073200|10081020|FG000|Participants in Etanercept Approved Countries|Double Blind Treatment Period||19
9018007|NCT03073200|10081021|FG001|Participants in Etanercept Approved Countries|Double Blind Treatment Period||38
9018008|NCT03073200|10081022|FG002|Participants in Etanercept Approved Countries|Double Blind Treatment Period||30
9018009|NCT03073200|10081023|FG003|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
9018010|NCT03073200|10081024|FG004|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
9018011|NCT03073200|10081025|FG005|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
9018012|NCT03073200|10081026|FG006|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
9018013|NCT03073200|10081027|FG007|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
9018014|NCT03073200|10081028|FG008|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
9018015|NCT03073200|10081029|FG009|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
9018016|NCT03073200|10081030|FG010|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
9018017|NCT03073200|10081031|FG011|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
9018018|NCT03073200|10081032|FG012|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
9018019|NCT03073200|10081033|FG013|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
9018020|NCT03073200|10081034|FG014|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
9018021|NCT03073200|10081020|FG000|COMPLETED|Double Blind Treatment Period||54
9018022|NCT03073200|10081021|FG001|COMPLETED|Double Blind Treatment Period||114
9018023|NCT03073200|10081022|FG002|COMPLETED|Double Blind Treatment Period||30
9018024|NCT03073200|10081023|FG003|COMPLETED|Double Blind Treatment Period||0
9018025|NCT03073200|10081024|FG004|COMPLETED|Double Blind Treatment Period||0
9018026|NCT03073200|10081025|FG005|COMPLETED|Double Blind Treatment Period||0
9018027|NCT03073200|10081026|FG006|COMPLETED|Double Blind Treatment Period||0
9018028|NCT03073200|10081027|FG007|COMPLETED|Double Blind Treatment Period||0
9018029|NCT03073200|10081028|FG008|COMPLETED|Double Blind Treatment Period||0
8637595|NCT00570778|9677855|FG002|STARTED|Overall Study||37
8637596|NCT00570778|9677856|FG003|STARTED|Overall Study||38
8637597|NCT00570778|9677853|FG000|Safety Population: Received Study Drug|Overall Study|Safety Population included all participants who received at least 1 dose of any study drug.|41
8637598|NCT00570778|9677854|FG001|Safety Population: Received Study Drug|Overall Study||38
8637599|NCT00570778|9677855|FG002|Safety Population: Received Study Drug|Overall Study||36
8637600|NCT00570778|9677856|FG003|Safety Population: Received Study Drug|Overall Study||38
8637601|NCT00570778|9677853|FG000|Modified Intent-to-treat Population|Overall Study||40
8637602|NCT00570778|9677854|FG001|Modified Intent-to-treat Population|Overall Study||37
8637603|NCT00570778|9677855|FG002|Modified Intent-to-treat Population|Overall Study||35
8637604|NCT00570778|9677856|FG003|Modified Intent-to-treat Population|Overall Study||37
8637605|NCT00570778|9677853|FG000|COMPLETED|Overall Study||37
8637606|NCT00570778|9677854|FG001|COMPLETED|Overall Study||34
8637607|NCT00570778|9677855|FG002|COMPLETED|Overall Study||30
8637608|NCT00570778|9677856|FG003|COMPLETED|Overall Study||34
8637609|NCT00570778|9677853|FG000|NOT COMPLETED|Overall Study||4
8637610|NCT00570778|9677854|FG001|NOT COMPLETED|Overall Study||4
8911081|NCT02143102|9970106|FG000|STARTED|Overall Study||97
8911082|NCT02143102|9970107|FG001|STARTED|Overall Study||28
8911083|NCT02143102|9970106|FG000|COMPLETED|Overall Study||86
8911084|NCT02143102|9970107|FG001|COMPLETED|Overall Study||28
8911085|NCT02143102|9970106|FG000|NOT COMPLETED|Overall Study||11
8911086|NCT02143102|9970107|FG001|NOT COMPLETED|Overall Study||0
8911087|NCT02143141|9970115|FG000|STARTED|Overall Study||7
8911088|NCT02143141|9970116|FG001|STARTED|Overall Study||6
8911089|NCT02143141|9970115|FG000|COMPLETED|Overall Study||6
8911090|NCT02143141|9970116|FG001|COMPLETED|Overall Study||6
8911091|NCT02143141|9970115|FG000|NOT COMPLETED|Overall Study||1
8911092|NCT02143141|9970116|FG001|NOT COMPLETED|Overall Study||0
8911093|NCT02143310|9970122|FG000|STARTED|Overall Study||209
8911094|NCT02143310|9970122|FG000|COMPLETED|Overall Study||102
8911095|NCT02143310|9970122|FG000|NOT COMPLETED|Overall Study||107
8911096|NCT02143583|9970129|FG000|STARTED|Overall Study||62
8911097|NCT02143583|9970130|FG001|STARTED|Overall Study||66
8911098|NCT02143583|9970131|FG002|STARTED|Overall Study||68
8911099|NCT02143583|9970129|FG000|COMPLETED|Overall Study||61
8911100|NCT02143583|9970130|FG001|COMPLETED|Overall Study||66
9018030|NCT03073200|10081029|FG009|COMPLETED|Double Blind Treatment Period||0
9018031|NCT03073200|10081030|FG010|COMPLETED|Double Blind Treatment Period||0
9018032|NCT03073200|10081031|FG011|COMPLETED|Double Blind Treatment Period||0
9018033|NCT03073200|10081032|FG012|COMPLETED|Double Blind Treatment Period||0
9018034|NCT03073200|10081033|FG013|COMPLETED|Double Blind Treatment Period||0
9018035|NCT03073200|10081034|FG014|COMPLETED|Double Blind Treatment Period||0
9018036|NCT03073200|10081020|FG000|NOT COMPLETED|Double Blind Treatment Period||2
9018037|NCT03073200|10081021|FG001|NOT COMPLETED|Double Blind Treatment Period||1
9018038|NCT03073200|10081022|FG002|NOT COMPLETED|Double Blind Treatment Period||0
9018039|NCT03073200|10081023|FG003|NOT COMPLETED|Double Blind Treatment Period||0
9018040|NCT03073200|10081024|FG004|NOT COMPLETED|Double Blind Treatment Period||0
9018041|NCT03073200|10081025|FG005|NOT COMPLETED|Double Blind Treatment Period||0
9018042|NCT03073200|10081026|FG006|NOT COMPLETED|Double Blind Treatment Period||0
9018043|NCT03073200|10081027|FG007|NOT COMPLETED|Double Blind Treatment Period||0
9018044|NCT03073200|10081028|FG008|NOT COMPLETED|Double Blind Treatment Period||0
9018045|NCT03073200|10081029|FG009|NOT COMPLETED|Double Blind Treatment Period||0
9018046|NCT03073200|10081030|FG010|NOT COMPLETED|Double Blind Treatment Period||0
9018047|NCT03073200|10081031|FG011|NOT COMPLETED|Double Blind Treatment Period||0
9018048|NCT03073200|10081032|FG012|NOT COMPLETED|Double Blind Treatment Period||0
9018049|NCT03073200|10081033|FG013|NOT COMPLETED|Double Blind Treatment Period||0
9018050|NCT03073200|10081034|FG014|NOT COMPLETED|Double Blind Treatment Period||0
9018051|NCT03073200|10081020|FG000|STARTED|Open-Label Maintenance Period|This period is to report Maintenance Period participants.|0
9018052|NCT03073200|10081021|FG001|STARTED|Open-Label Maintenance Period|This period is to report Maintenance Period participants.|0
9018053|NCT03073200|10081022|FG002|STARTED|Open-Label Maintenance Period|This period is to report Maintenance Period participants.|0
9018054|NCT03073200|10081023|FG003|STARTED|Open-Label Maintenance Period|This period is to report Maintenance Period participants.|53
9018055|NCT03073200|10081024|FG004|STARTED|Open-Label Maintenance Period|This period is to report Maintenance Period participants.|113
9018056|NCT03073200|10081025|FG005|STARTED|Open-Label Maintenance Period|This period is to report Maintenance Period participants.|28
9018057|NCT03073200|10081026|FG006|STARTED|Open-Label Maintenance Period||0
9018058|NCT03073200|10081027|FG007|STARTED|Open-Label Maintenance Period||0
9018059|NCT03073200|10081028|FG008|STARTED|Open-Label Maintenance Period||0
9018060|NCT03073200|10081029|FG009|STARTED|Open-Label Maintenance Period||0
9018061|NCT03073200|10081030|FG010|STARTED|Open-Label Maintenance Period||0
9018062|NCT03073200|10081031|FG011|STARTED|Open-Label Maintenance Period||0
9018063|NCT03073200|10081032|FG012|STARTED|Open-Label Maintenance Period||0
9018064|NCT03073200|10081033|FG013|STARTED|Open-Label Maintenance Period||0
9018065|NCT03073200|10081034|FG014|STARTED|Open-Label Maintenance Period||0
9018066|NCT03073200|10081020|FG000|COMPLETED|Open-Label Maintenance Period||0
9018067|NCT03073200|10081021|FG001|COMPLETED|Open-Label Maintenance Period||0
9018068|NCT03073200|10081022|FG002|COMPLETED|Open-Label Maintenance Period||0
9018069|NCT03073200|10081023|FG003|COMPLETED|Open-Label Maintenance Period||49
9018070|NCT03073200|10081024|FG004|COMPLETED|Open-Label Maintenance Period||109
9018071|NCT03073200|10081025|FG005|COMPLETED|Open-Label Maintenance Period||28
9018072|NCT03073200|10081026|FG006|COMPLETED|Open-Label Maintenance Period||0
9018073|NCT03073200|10081027|FG007|COMPLETED|Open-Label Maintenance Period||0
9018074|NCT03073200|10081028|FG008|COMPLETED|Open-Label Maintenance Period||0
9018075|NCT03073200|10081029|FG009|COMPLETED|Open-Label Maintenance Period||0
9018076|NCT03073200|10081030|FG010|COMPLETED|Open-Label Maintenance Period||0
9018077|NCT03073200|10081031|FG011|COMPLETED|Open-Label Maintenance Period||0
9018078|NCT03073200|10081032|FG012|COMPLETED|Open-Label Maintenance Period||0
9018079|NCT03073200|10081033|FG013|COMPLETED|Open-Label Maintenance Period||0
9018080|NCT03073200|10081034|FG014|COMPLETED|Open-Label Maintenance Period||0
9018081|NCT03073200|10081020|FG000|NOT COMPLETED|Open-Label Maintenance Period||0
9018082|NCT03073200|10081021|FG001|NOT COMPLETED|Open-Label Maintenance Period||0
9018083|NCT03073200|10081022|FG002|NOT COMPLETED|Open-Label Maintenance Period||0
9018084|NCT03073200|10081023|FG003|NOT COMPLETED|Open-Label Maintenance Period||4
9018085|NCT03073200|10081024|FG004|NOT COMPLETED|Open-Label Maintenance Period||4
9018086|NCT03073200|10081025|FG005|NOT COMPLETED|Open-Label Maintenance Period||0
9018087|NCT03073200|10081026|FG006|NOT COMPLETED|Open-Label Maintenance Period||0
9018088|NCT03073200|10081027|FG007|NOT COMPLETED|Open-Label Maintenance Period||0
9018089|NCT03073200|10081028|FG008|NOT COMPLETED|Open-Label Maintenance Period||0
9018090|NCT03073200|10081029|FG009|NOT COMPLETED|Open-Label Maintenance Period||0
9018091|NCT03073200|10081030|FG010|NOT COMPLETED|Open-Label Maintenance Period||0
9018092|NCT03073200|10081031|FG011|NOT COMPLETED|Open-Label Maintenance Period||0
9018093|NCT03073200|10081032|FG012|NOT COMPLETED|Open-Label Maintenance Period||0
9018094|NCT03073200|10081033|FG013|NOT COMPLETED|Open-Label Maintenance Period||0
9018095|NCT03073200|10081034|FG014|NOT COMPLETED|Open-Label Maintenance Period||0
9018096|NCT03073200|10081020|FG000|STARTED|Extension Period||0
9018097|NCT03073200|10081021|FG001|STARTED|Extension Period||0
9018098|NCT03073200|10081022|FG002|STARTED|Extension Period||0
9018099|NCT03073200|10081023|FG003|STARTED|Extension Period|This period is to report Extension Period participants.|0
9018100|NCT03073200|10081024|FG004|STARTED|Extension Period|This period is to report Extension Period participants.|0
9018101|NCT03073200|10081025|FG005|STARTED|Extension Period|This period is to report Extension Period participants.|0
9018102|NCT03073200|10081026|FG006|STARTED|Extension Period|This period is to report Extension Period participants.|34
9018103|NCT03073200|10081027|FG007|STARTED|Extension Period|This period is to report Extension Period participants.|68
9018104|NCT03073200|10081028|FG008|STARTED|Extension Period|This period is to report Extension Period participants.|9
9018105|NCT03073200|10081029|FG009|STARTED|Extension Period||0
9018106|NCT03073200|10081030|FG010|STARTED|Extension Period||0
9018107|NCT03073200|10081031|FG011|STARTED|Extension Period||0
9018108|NCT03073200|10081032|FG012|STARTED|Extension Period||0
9018109|NCT03073200|10081033|FG013|STARTED|Extension Period||0
9018110|NCT03073200|10081034|FG014|STARTED|Extension Period||0
9018111|NCT03073200|10081020|FG000|COMPLETED|Extension Period||0
9018112|NCT03073200|10081021|FG001|COMPLETED|Extension Period||0
9018113|NCT03073200|10081022|FG002|COMPLETED|Extension Period||0
9018114|NCT03073200|10081023|FG003|COMPLETED|Extension Period||0
9018115|NCT03073200|10081024|FG004|COMPLETED|Extension Period||0
9018116|NCT03073200|10081025|FG005|COMPLETED|Extension Period||0
9018117|NCT03073200|10081026|FG006|COMPLETED|Extension Period||31
9018118|NCT03073200|10081027|FG007|COMPLETED|Extension Period||62
9018119|NCT03073200|10081028|FG008|COMPLETED|Extension Period||7
9018120|NCT03073200|10081029|FG009|COMPLETED|Extension Period||0
9018121|NCT03073200|10081030|FG010|COMPLETED|Extension Period||0
9018122|NCT03073200|10081031|FG011|COMPLETED|Extension Period||0
9018123|NCT03073200|10081032|FG012|COMPLETED|Extension Period||0
9018124|NCT03073200|10081033|FG013|COMPLETED|Extension Period||0
9018125|NCT03073200|10081034|FG014|COMPLETED|Extension Period||0
9018126|NCT03073200|10081020|FG000|NOT COMPLETED|Extension Period||0
9018127|NCT03073200|10081021|FG001|NOT COMPLETED|Extension Period||0
9018128|NCT03073200|10081022|FG002|NOT COMPLETED|Extension Period||0
9018129|NCT03073200|10081023|FG003|NOT COMPLETED|Extension Period||0
9018130|NCT03073200|10081024|FG004|NOT COMPLETED|Extension Period||0
9018131|NCT03073200|10081025|FG005|NOT COMPLETED|Extension Period||0
9018132|NCT03073200|10081026|FG006|NOT COMPLETED|Extension Period||3
9018133|NCT03073200|10081027|FG007|NOT COMPLETED|Extension Period||6
9018134|NCT03073200|10081028|FG008|NOT COMPLETED|Extension Period||2
9018135|NCT03073200|10081029|FG009|NOT COMPLETED|Extension Period||0
9018136|NCT03073200|10081030|FG010|NOT COMPLETED|Extension Period||0
9018137|NCT03073200|10081031|FG011|NOT COMPLETED|Extension Period||0
9018138|NCT03073200|10081032|FG012|NOT COMPLETED|Extension Period||0
9018139|NCT03073200|10081033|FG013|NOT COMPLETED|Extension Period||0
9018140|NCT03073200|10081034|FG014|NOT COMPLETED|Extension Period||0
9018141|NCT03073200|10081020|FG000|STARTED|Randomized Withdrawal Period||0
9018142|NCT03073200|10081021|FG001|STARTED|Randomized Withdrawal Period||0
9018143|NCT03073200|10081022|FG002|STARTED|Randomized Withdrawal Period||0
9018144|NCT03073200|10081023|FG003|STARTED|Randomized Withdrawal Period||0
9018145|NCT03073200|10081024|FG004|STARTED|Randomized Withdrawal Period||0
9018146|NCT03073200|10081025|FG005|STARTED|Randomized Withdrawal Period||0
9018147|NCT03073200|10081026|FG006|STARTED|Randomized Withdrawal Period|This period is to report randomized withdrawal period participants.|0
9018148|NCT03073200|10081027|FG007|STARTED|Randomized Withdrawal Period|This period is to report randomized withdrawal period participants.|0
9018149|NCT03073200|10081028|FG008|STARTED|Randomized Withdrawal Period|This period is to report randomized withdrawal period participants.|0
9018150|NCT03073200|10081029|FG009|STARTED|Randomized Withdrawal Period|This period is to report randomized withdrawal period participants.|33
8637611|NCT00570778|9677855|FG002|NOT COMPLETED|Overall Study||7
8637612|NCT00570778|9677856|FG003|NOT COMPLETED|Overall Study||4
8637613|NCT00570908|9677866|FG000|STARTED|Overall Study||12
8637614|NCT00570908|9677866|FG000|COMPLETED|Overall Study|5 patients progressed during the study treatment|5
8637615|NCT00570908|9677866|FG000|NOT COMPLETED|Overall Study||7
8637616|NCT00570921|9677870|FG000|STARTED|Overall Study||33
8637617|NCT00570921|9677870|FG000|COMPLETED|Overall Study||31
8637618|NCT00570921|9677870|FG000|NOT COMPLETED|Overall Study||2
8637619|NCT00570960|9677876|FG000|STARTED|Overall Study||4
8637620|NCT00570960|9677877|FG001|STARTED|Overall Study||4
8637621|NCT00570960|9677876|FG000|COMPLETED|Overall Study||4
8637622|NCT00570960|9677877|FG001|COMPLETED|Overall Study||4
8637623|NCT00570960|9677876|FG000|NOT COMPLETED|Overall Study||0
8637624|NCT00570960|9677877|FG001|NOT COMPLETED|Overall Study||0
8637625|NCT00571038|9677885|FG000|STARTED|Overall Study||219
8637626|NCT00571038|9677886|FG001|STARTED|Overall Study||185
8637627|NCT00571038|9677885|FG000|6 Month Follow up|Overall Study||208
8637628|NCT00571038|9677886|FG001|6 Month Follow up|Overall Study||176
8637629|NCT00571038|9677885|FG000|18 Month Survey Only|Overall Study||199
8637630|NCT00571038|9677886|FG001|18 Month Survey Only|Overall Study||163
8637631|NCT00571038|9677885|FG000|COMPLETED|Overall Study|"7 died 2 moved~1 asked to be withdrawn~1 unable to reach"|208
8637632|NCT00571038|9677886|FG001|COMPLETED|Overall Study|5 died 2 moved 3 asked to be withdrawn 4 unable to reach|171
8637633|NCT00571038|9677885|FG000|NOT COMPLETED|Overall Study||11
8637634|NCT00571038|9677886|FG001|NOT COMPLETED|Overall Study||14
8637635|NCT00571064|9677892|FG000|STARTED|Overall Study||97
8637636|NCT00571064|9677892|FG000|COMPLETED|Overall Study||76
8637637|NCT00571064|9677892|FG000|NOT COMPLETED|Overall Study||21
8637638|NCT00571103|9677897|FG000|STARTED|Overall Study||28
8637639|NCT00571103|9677897|FG000|COMPLETED|Overall Study|Of the 28 participants, 1 subject withdrew and 1 was lost to follow-up after their baseline visit.|26
8637640|NCT00571103|9677897|FG000|NOT COMPLETED|Overall Study||2
8637641|NCT00571259|9677903|FG000|STARTED|Overall Study||148
8637642|NCT00571259|9677904|FG001|STARTED|Overall Study||155
8637643|NCT00571259|9677903|FG000|COMPLETED|Overall Study||4
9039887|NCT03343067|10100822|FG002|COMPLETED|Open Label Period: Day 1 to Month 3||1
9018151|NCT03073200|10081030|FG010|STARTED|Randomized Withdrawal Period|This period is to report randomized withdrawal period participants.|34
9018152|NCT03073200|10081031|FG011|STARTED|Randomized Withdrawal Period|This period is to report randomized withdrawal period participants.|33
9018153|NCT03073200|10081032|FG012|STARTED|Randomized Withdrawal Period||0
9018154|NCT03073200|10081033|FG013|STARTED|Randomized Withdrawal Period||0
9018155|NCT03073200|10081034|FG014|STARTED|Randomized Withdrawal Period||0
9018156|NCT03073200|10081020|FG000|COMPLETED|Randomized Withdrawal Period||0
9018157|NCT03073200|10081021|FG001|COMPLETED|Randomized Withdrawal Period||0
9018158|NCT03073200|10081022|FG002|COMPLETED|Randomized Withdrawal Period||0
9018159|NCT03073200|10081023|FG003|COMPLETED|Randomized Withdrawal Period||0
9018160|NCT03073200|10081024|FG004|COMPLETED|Randomized Withdrawal Period||0
9018161|NCT03073200|10081025|FG005|COMPLETED|Randomized Withdrawal Period||0
9018162|NCT03073200|10081026|FG006|COMPLETED|Randomized Withdrawal Period||0
9018163|NCT03073200|10081027|FG007|COMPLETED|Randomized Withdrawal Period||0
9018164|NCT03073200|10081028|FG008|COMPLETED|Randomized Withdrawal Period||0
9018165|NCT03073200|10081029|FG009|COMPLETED|Randomized Withdrawal Period||33
9018166|NCT03073200|10081030|FG010|COMPLETED|Randomized Withdrawal Period||32
9018167|NCT03073200|10081031|FG011|COMPLETED|Randomized Withdrawal Period||30
9018168|NCT03073200|10081032|FG012|COMPLETED|Randomized Withdrawal Period||0
9018169|NCT03073200|10081033|FG013|COMPLETED|Randomized Withdrawal Period||0
9018170|NCT03073200|10081034|FG014|COMPLETED|Randomized Withdrawal Period||0
9018171|NCT03073200|10081020|FG000|NOT COMPLETED|Randomized Withdrawal Period||0
9018172|NCT03073200|10081021|FG001|NOT COMPLETED|Randomized Withdrawal Period||0
9018173|NCT03073200|10081022|FG002|NOT COMPLETED|Randomized Withdrawal Period||0
9018174|NCT03073200|10081023|FG003|NOT COMPLETED|Randomized Withdrawal Period||0
9018175|NCT03073200|10081024|FG004|NOT COMPLETED|Randomized Withdrawal Period||0
9018176|NCT03073200|10081025|FG005|NOT COMPLETED|Randomized Withdrawal Period||0
9018177|NCT03073200|10081026|FG006|NOT COMPLETED|Randomized Withdrawal Period||0
9018178|NCT03073200|10081027|FG007|NOT COMPLETED|Randomized Withdrawal Period||0
9018179|NCT03073200|10081028|FG008|NOT COMPLETED|Randomized Withdrawal Period||0
9018180|NCT03073200|10081029|FG009|NOT COMPLETED|Randomized Withdrawal Period||0
9018181|NCT03073200|10081030|FG010|NOT COMPLETED|Randomized Withdrawal Period||2
9018182|NCT03073200|10081031|FG011|NOT COMPLETED|Randomized Withdrawal Period||3
9018183|NCT03073200|10081032|FG012|NOT COMPLETED|Randomized Withdrawal Period||0
9018184|NCT03073200|10081033|FG013|NOT COMPLETED|Randomized Withdrawal Period||0
9018185|NCT03073200|10081034|FG014|NOT COMPLETED|Randomized Withdrawal Period||0
9018186|NCT03073200|10081020|FG000|STARTED|Post-Treatment Follow-Up Period||0
9018187|NCT03073200|10081021|FG001|STARTED|Post-Treatment Follow-Up Period||0
9018188|NCT03073200|10081022|FG002|STARTED|Post-Treatment Follow-Up Period||0
9018189|NCT03073200|10081023|FG003|STARTED|Post-Treatment Follow-Up Period||0
9018190|NCT03073200|10081024|FG004|STARTED|Post-Treatment Follow-Up Period||0
9018191|NCT03073200|10081025|FG005|STARTED|Post-Treatment Follow-Up Period||0
9018192|NCT03073200|10081026|FG006|STARTED|Post-Treatment Follow-Up Period||0
9018193|NCT03073200|10081027|FG007|STARTED|Post-Treatment Follow-Up Period||0
9018194|NCT03073200|10081028|FG008|STARTED|Post-Treatment Follow-Up Period||0
9018195|NCT03073200|10081029|FG009|STARTED|Post-Treatment Follow-Up Period|This period is to report Follow-Up period participants.|0
9018196|NCT03073200|10081030|FG010|STARTED|Post-Treatment Follow-Up Period|This period is to report Follow-Up period participants.|0
9018197|NCT03073200|10081031|FG011|STARTED|Post-Treatment Follow-Up Period|This period is to report Follow-Up period participants.|0
9018198|NCT03073200|10081032|FG012|STARTED|Post-Treatment Follow-Up Period|This period is to report Follow-Up period participants.|6
9018199|NCT03073200|10081033|FG013|STARTED|Post-Treatment Follow-Up Period|This period is to report Follow-Up period participants.|166
9018200|NCT03073200|10081034|FG014|STARTED|Post-Treatment Follow-Up Period|This period is to report Follow-Up period participants.|2
9018201|NCT03073200|10081020|FG000|COMPLETED|Post-Treatment Follow-Up Period||0
9018202|NCT03073200|10081021|FG001|COMPLETED|Post-Treatment Follow-Up Period||0
9018203|NCT03073200|10081022|FG002|COMPLETED|Post-Treatment Follow-Up Period||0
9018204|NCT03073200|10081023|FG003|COMPLETED|Post-Treatment Follow-Up Period||0
9018205|NCT03073200|10081024|FG004|COMPLETED|Post-Treatment Follow-Up Period||0
9018206|NCT03073200|10081025|FG005|COMPLETED|Post-Treatment Follow-Up Period||0
9018207|NCT03073200|10081026|FG006|COMPLETED|Post-Treatment Follow-Up Period||0
9018208|NCT03073200|10081027|FG007|COMPLETED|Post-Treatment Follow-Up Period||0
9018209|NCT03073200|10081028|FG008|COMPLETED|Post-Treatment Follow-Up Period||0
9018210|NCT03073200|10081029|FG009|COMPLETED|Post-Treatment Follow-Up Period||0
9018211|NCT03073200|10081030|FG010|COMPLETED|Post-Treatment Follow-Up Period||0
9018212|NCT03073200|10081031|FG011|COMPLETED|Post-Treatment Follow-Up Period||0
9018213|NCT03073200|10081032|FG012|COMPLETED|Post-Treatment Follow-Up Period||6
9018214|NCT03073200|10081033|FG013|COMPLETED|Post-Treatment Follow-Up Period||139
9018215|NCT03073200|10081034|FG014|COMPLETED|Post-Treatment Follow-Up Period||1
9018216|NCT03073200|10081020|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||0
9018217|NCT03073200|10081021|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||0
9018218|NCT03073200|10081022|FG002|NOT COMPLETED|Post-Treatment Follow-Up Period||0
9018219|NCT03073200|10081023|FG003|NOT COMPLETED|Post-Treatment Follow-Up Period||0
9018220|NCT03073200|10081024|FG004|NOT COMPLETED|Post-Treatment Follow-Up Period||0
9018221|NCT03073200|10081025|FG005|NOT COMPLETED|Post-Treatment Follow-Up Period||0
9018222|NCT03073200|10081026|FG006|NOT COMPLETED|Post-Treatment Follow-Up Period||0
9018223|NCT03073200|10081027|FG007|NOT COMPLETED|Post-Treatment Follow-Up Period||0
9018224|NCT03073200|10081028|FG008|NOT COMPLETED|Post-Treatment Follow-Up Period||0
9018225|NCT03073200|10081029|FG009|NOT COMPLETED|Post-Treatment Follow-Up Period||0
9018226|NCT03073200|10081030|FG010|NOT COMPLETED|Post-Treatment Follow-Up Period||0
9018227|NCT03073200|10081031|FG011|NOT COMPLETED|Post-Treatment Follow-Up Period||0
9018228|NCT03073200|10081032|FG012|NOT COMPLETED|Post-Treatment Follow-Up Period||0
9018229|NCT03073200|10081033|FG013|NOT COMPLETED|Post-Treatment Follow-Up Period||27
9018230|NCT03073200|10081034|FG014|NOT COMPLETED|Post-Treatment Follow-Up Period||1
9018231|NCT03073213|10081059|FG000|STARTED|Single Dose Period||12
9018232|NCT03073213|10081060|FG001|STARTED|Single Dose Period||0
9018233|NCT03073213|10081061|FG002|STARTED|Single Dose Period||0
9018234|NCT03073213|10081059|FG000|COMPLETED|Single Dose Period||12
9018235|NCT03073213|10081060|FG001|COMPLETED|Single Dose Period||0
9018236|NCT03073213|10081061|FG002|COMPLETED|Single Dose Period||0
9018237|NCT03073213|10081059|FG000|NOT COMPLETED|Single Dose Period||0
9018238|NCT03073213|10081060|FG001|NOT COMPLETED|Single Dose Period||0
9018239|NCT03073213|10081061|FG002|NOT COMPLETED|Single Dose Period||0
9018240|NCT03073213|10081059|FG000|STARTED|Multiple Dose Period||0
9018241|NCT03073213|10081060|FG001|STARTED|Multiple Dose Period|Participants who completed single dose had option to enroll into multiple dose.|14
9018242|NCT03073213|10081061|FG002|STARTED|Multiple Dose Period|Participants who completed single dose had option to enroll into multiple dose.|15
9018243|NCT03073213|10081059|FG000|Participants Enrolled From Single Dose|Multiple Dose Period||0
8637644|NCT00571259|9677904|FG001|COMPLETED|Overall Study||14
8637645|NCT00571259|9677903|FG000|NOT COMPLETED|Overall Study||144
8637646|NCT00571259|9677904|FG001|NOT COMPLETED|Overall Study||141
8637647|NCT00571324|9677912|FG000|STARTED|Intervention 1 (7 Hours)||5
8637648|NCT00571324|9677913|FG001|STARTED|Intervention 1 (7 Hours)||4
8637649|NCT00571324|9677912|FG000|COMPLETED|Intervention 1 (7 Hours)||5
8637650|NCT00571324|9677913|FG001|COMPLETED|Intervention 1 (7 Hours)||4
8637651|NCT00571324|9677912|FG000|NOT COMPLETED|Intervention 1 (7 Hours)||0
8637652|NCT00571324|9677913|FG001|NOT COMPLETED|Intervention 1 (7 Hours)||0
8637653|NCT00571324|9677912|FG000|STARTED|Intervention 2 (7 Hours)||5
8637654|NCT00571324|9677913|FG001|STARTED|Intervention 2 (7 Hours)||4
8637655|NCT00571324|9677912|FG000|COMPLETED|Intervention 2 (7 Hours)||5
8637656|NCT00571324|9677913|FG001|COMPLETED|Intervention 2 (7 Hours)||4
8637657|NCT00571324|9677912|FG000|NOT COMPLETED|Intervention 2 (7 Hours)||0
9018244|NCT03073213|10081060|FG001|Participants Enrolled From Single Dose|Multiple Dose Period||7
9018245|NCT03073213|10081061|FG002|Participants Enrolled From Single Dose|Multiple Dose Period||2
8637658|NCT00571324|9677913|FG001|NOT COMPLETED|Intervention 2 (7 Hours)||0
8637659|NCT00571428|9677921|FG000|STARTED|Overall Study||15
8637660|NCT00571428|9677922|FG001|STARTED|Overall Study||18
8637661|NCT00571428|9677921|FG000|COMPLETED|Overall Study||15
8637662|NCT00571428|9677922|FG001|COMPLETED|Overall Study||18
8637663|NCT00571428|9677921|FG000|NOT COMPLETED|Overall Study||0
8637664|NCT00571428|9677922|FG001|NOT COMPLETED|Overall Study||0
8637665|NCT00571493|9677928|FG000|STARTED|Overall Study||3
8637666|NCT00571493|9677929|FG001|STARTED|Overall Study||4
8637667|NCT00571493|9677930|FG002|STARTED|Overall Study||3
8637668|NCT00571493|9677931|FG003|STARTED|Overall Study||3
8637669|NCT00571493|9677932|FG004|STARTED|Overall Study||11
8637670|NCT00571493|9677933|FG005|STARTED|Overall Study||12
8637671|NCT00571493|9677934|FG006|STARTED|Overall Study||6
8637672|NCT00571493|9677928|FG000|COMPLETED|Overall Study||3
8637673|NCT00571493|9677929|FG001|COMPLETED|Overall Study||4
8637674|NCT00571493|9677930|FG002|COMPLETED|Overall Study||3
8637675|NCT00571493|9677931|FG003|COMPLETED|Overall Study||3
8637676|NCT00571493|9677932|FG004|COMPLETED|Overall Study||11
8637677|NCT00571493|9677933|FG005|COMPLETED|Overall Study||12
8637678|NCT00571493|9677934|FG006|COMPLETED|Overall Study||6
8637679|NCT00571493|9677928|FG000|NOT COMPLETED|Overall Study||0
8637680|NCT00571493|9677929|FG001|NOT COMPLETED|Overall Study||0
8637681|NCT00571493|9677930|FG002|NOT COMPLETED|Overall Study||0
8637682|NCT00571493|9677931|FG003|NOT COMPLETED|Overall Study||0
8637683|NCT00571493|9677932|FG004|NOT COMPLETED|Overall Study||0
8637684|NCT00571493|9677933|FG005|NOT COMPLETED|Overall Study||0
8637685|NCT00571493|9677934|FG006|NOT COMPLETED|Overall Study||0
8637686|NCT00571519|9677949|FG000|STARTED|Overall Study||3
8637687|NCT00571519|9677950|FG001|STARTED|Overall Study||9
8637688|NCT00571519|9677951|FG002|STARTED|Overall Study||12
8637689|NCT00571519|9677952|FG003|STARTED|Overall Study||27
8637690|NCT00571519|9677953|FG004|STARTED|Overall Study||9
8637691|NCT00571519|9677954|FG005|STARTED|Overall Study||10
8637692|NCT00571519|9677955|FG006|STARTED|Overall Study||24
8637693|NCT00571519|9677949|FG000|COMPLETED|Overall Study||0
8637694|NCT00571519|9677950|FG001|COMPLETED|Overall Study||0
8637695|NCT00571519|9677951|FG002|COMPLETED|Overall Study||0
9018246|NCT03073213|10081059|FG000|COMPLETED|Multiple Dose Period||0
9018247|NCT03073213|10081060|FG001|COMPLETED|Multiple Dose Period||14
8637696|NCT00571519|9677952|FG003|COMPLETED|Overall Study||0
8637697|NCT00571519|9677953|FG004|COMPLETED|Overall Study||0
8637698|NCT00571519|9677954|FG005|COMPLETED|Overall Study||0
9018248|NCT03073213|10081061|FG002|COMPLETED|Multiple Dose Period||14
8637699|NCT00571519|9677955|FG006|COMPLETED|Overall Study||0
8637700|NCT00571519|9677949|FG000|NOT COMPLETED|Overall Study||3
8637701|NCT00571519|9677950|FG001|NOT COMPLETED|Overall Study||9
8637702|NCT00571519|9677951|FG002|NOT COMPLETED|Overall Study||12
8637703|NCT00571519|9677952|FG003|NOT COMPLETED|Overall Study||27
8637704|NCT00571519|9677953|FG004|NOT COMPLETED|Overall Study||9
8637705|NCT00571519|9677954|FG005|NOT COMPLETED|Overall Study||10
9018249|NCT03073213|10081059|FG000|NOT COMPLETED|Multiple Dose Period||0
9018250|NCT03073213|10081060|FG001|NOT COMPLETED|Multiple Dose Period||0
9018251|NCT03073213|10081061|FG002|NOT COMPLETED|Multiple Dose Period||1
9018252|NCT03073486|10081072|FG000|STARTED|Overall Study||493
9018253|NCT03073486|10081073|FG001|STARTED|Overall Study||251
9018254|NCT03073486|10081072|FG000|COMPLETED|Overall Study||405
9018255|NCT03073486|10081073|FG001|COMPLETED|Overall Study||207
9018256|NCT03073486|10081072|FG000|NOT COMPLETED|Overall Study||88
9018257|NCT03073486|10081073|FG001|NOT COMPLETED|Overall Study||44
9018258|NCT03073759|10081081|FG000|STARTED|Overall Study||2
9018259|NCT03073759|10081082|FG001|STARTED|Overall Study||2
9018260|NCT03073759|10081081|FG000|COMPLETED|Overall Study||2
9018261|NCT03073759|10081082|FG001|COMPLETED|Overall Study||2
9018262|NCT03073759|10081081|FG000|NOT COMPLETED|Overall Study||0
9018263|NCT03073759|10081082|FG001|NOT COMPLETED|Overall Study||0
9018264|NCT03073798|10081089|FG000|STARTED|Overall Study||12
9018265|NCT03073798|10081089|FG000|COMPLETED|Overall Study||10
9018266|NCT03073798|10081089|FG000|NOT COMPLETED|Overall Study||2
9018267|NCT03073876|10081096|FG000|STARTED|Overall Study||12
9018268|NCT03073876|10081097|FG001|STARTED|Overall Study||11
9018269|NCT03073876|10081096|FG000|COMPLETED|Overall Study||12
9018270|NCT03073876|10081097|FG001|COMPLETED|Overall Study||11
9018271|NCT03073876|10081096|FG000|NOT COMPLETED|Overall Study||0
9018272|NCT03073876|10081097|FG001|NOT COMPLETED|Overall Study||0
9018273|NCT03074162|10081114|FG000|STARTED|Period 1 Including Washout 1||8
9018274|NCT03074162|10081115|FG001|STARTED|Period 1 Including Washout 1||8
9018275|NCT03074162|10081116|FG002|STARTED|Period 1 Including Washout 1||8
9018276|NCT03074162|10081117|FG003|STARTED|Period 1 Including Washout 1||8
9018277|NCT03074162|10081118|FG004|STARTED|Period 1 Including Washout 1||8
9018278|NCT03074162|10081119|FG005|STARTED|Period 1 Including Washout 1||8
9018279|NCT03074162|10081114|FG000|COMPLETED|Period 1 Including Washout 1||8
9018280|NCT03074162|10081115|FG001|COMPLETED|Period 1 Including Washout 1||8
9018281|NCT03074162|10081116|FG002|COMPLETED|Period 1 Including Washout 1||7
9018282|NCT03074162|10081117|FG003|COMPLETED|Period 1 Including Washout 1||8
9018283|NCT03074162|10081118|FG004|COMPLETED|Period 1 Including Washout 1||8
9018284|NCT03074162|10081119|FG005|COMPLETED|Period 1 Including Washout 1||8
9018285|NCT03074162|10081114|FG000|NOT COMPLETED|Period 1 Including Washout 1||0
9018286|NCT03074162|10081115|FG001|NOT COMPLETED|Period 1 Including Washout 1||0
9018287|NCT03074162|10081116|FG002|NOT COMPLETED|Period 1 Including Washout 1||1
9018288|NCT03074162|10081117|FG003|NOT COMPLETED|Period 1 Including Washout 1||0
9018289|NCT03074162|10081118|FG004|NOT COMPLETED|Period 1 Including Washout 1||0
9018290|NCT03074162|10081119|FG005|NOT COMPLETED|Period 1 Including Washout 1||0
9018291|NCT03074162|10081114|FG000|STARTED|Period 2 Including Washout 2||8
9018292|NCT03074162|10081115|FG001|STARTED|Period 2 Including Washout 2||8
9018293|NCT03074162|10081116|FG002|STARTED|Period 2 Including Washout 2||7
9018294|NCT03074162|10081117|FG003|STARTED|Period 2 Including Washout 2||8
9018295|NCT03074162|10081118|FG004|STARTED|Period 2 Including Washout 2||8
9018296|NCT03074162|10081119|FG005|STARTED|Period 2 Including Washout 2||8
9018297|NCT03074162|10081114|FG000|COMPLETED|Period 2 Including Washout 2||8
9018298|NCT03074162|10081115|FG001|COMPLETED|Period 2 Including Washout 2||8
9018299|NCT03074162|10081116|FG002|COMPLETED|Period 2 Including Washout 2||6
9018300|NCT03074162|10081117|FG003|COMPLETED|Period 2 Including Washout 2||8
9018301|NCT03074162|10081118|FG004|COMPLETED|Period 2 Including Washout 2||8
9018302|NCT03074162|10081119|FG005|COMPLETED|Period 2 Including Washout 2||7
9018303|NCT03074162|10081114|FG000|NOT COMPLETED|Period 2 Including Washout 2||0
9018304|NCT03074162|10081115|FG001|NOT COMPLETED|Period 2 Including Washout 2||0
9018305|NCT03074162|10081116|FG002|NOT COMPLETED|Period 2 Including Washout 2||1
9018306|NCT03074162|10081117|FG003|NOT COMPLETED|Period 2 Including Washout 2||0
9018307|NCT03074162|10081118|FG004|NOT COMPLETED|Period 2 Including Washout 2||0
9018308|NCT03074162|10081119|FG005|NOT COMPLETED|Period 2 Including Washout 2||1
9018309|NCT03074162|10081114|FG000|STARTED|Period 3||8
9018310|NCT03074162|10081115|FG001|STARTED|Period 3||8
9018311|NCT03074162|10081116|FG002|STARTED|Period 3||6
9018312|NCT03074162|10081117|FG003|STARTED|Period 3||8
9018313|NCT03074162|10081118|FG004|STARTED|Period 3||8
8637706|NCT00571519|9677955|FG006|NOT COMPLETED|Overall Study||24
8637707|NCT00571649|9677973|FG000|STARTED|Treatment Period||4050
8637708|NCT00571649|9677974|FG001|STARTED|Treatment Period||4051
8637709|NCT00571649|9677973|FG000|Participants Received Treatment|Treatment Period||3997
8637710|NCT00571649|9677974|FG001|Participants Received Treatment|Treatment Period||4001
8637711|NCT00571649|9677973|FG000|Day 10|Treatment Period||3454
8637712|NCT00571649|9677974|FG001|Day 10|Treatment Period||3499
8637713|NCT00571649|9677973|FG000|Day 35|Treatment Period||3033
8637714|NCT00571649|9677974|FG001|Day 35|Treatment Period||3115
8637715|NCT00571649|9677973|FG000|COMPLETED|Treatment Period||2958
8637716|NCT00571649|9677974|FG001|COMPLETED|Treatment Period||3047
8637717|NCT00571649|9677973|FG000|NOT COMPLETED|Treatment Period||1092
8637718|NCT00571649|9677974|FG001|NOT COMPLETED|Treatment Period||1004
8637719|NCT00571649|9677973|FG000|STARTED|Follow-up Period|Participants were required to enter follow-up even if treatment period not completed.|3583
8637720|NCT00571649|9677974|FG001|STARTED|Follow-up Period|Participants were required to enter follow-up even if treatment period not completed.|3635
8637721|NCT00571649|9677973|FG000|COMPLETED|Follow-up Period|Began day after last dose study drug; ended on Day 90 (+/- 7 days) .|3038
9018314|NCT03074162|10081119|FG005|STARTED|Period 3||7
8691355|NCT00854308|9736608|FG001|NOT COMPLETED|Overall Study||67
9018315|NCT03074162|10081114|FG000|COMPLETED|Period 3||7
9018316|NCT03074162|10081115|FG001|COMPLETED|Period 3||8
9018317|NCT03074162|10081116|FG002|COMPLETED|Period 3||6
9018318|NCT03074162|10081117|FG003|COMPLETED|Period 3||8
9018319|NCT03074162|10081118|FG004|COMPLETED|Period 3||7
9018320|NCT03074162|10081119|FG005|COMPLETED|Period 3||7
9018321|NCT03074162|10081114|FG000|NOT COMPLETED|Period 3||1
9018322|NCT03074162|10081115|FG001|NOT COMPLETED|Period 3||0
9018323|NCT03074162|10081116|FG002|NOT COMPLETED|Period 3||0
9018324|NCT03074162|10081117|FG003|NOT COMPLETED|Period 3||0
9018325|NCT03074162|10081118|FG004|NOT COMPLETED|Period 3||1
9018326|NCT03074162|10081119|FG005|NOT COMPLETED|Period 3||0
9018327|NCT03074331|10081127|FG000|STARTED|Overall Study||130
9018328|NCT03074331|10081127|FG000|COMPLETED|Overall Study||123
9018329|NCT03074331|10081127|FG000|NOT COMPLETED|Overall Study||7
9018330|NCT03074409|10081133|FG000|STARTED|Overall Study||41
9018331|NCT03074409|10081134|FG001|STARTED|Overall Study||42
9018332|NCT03074409|10081133|FG000|COMPLETED|Overall Study||37
9018333|NCT03074409|10081134|FG001|COMPLETED|Overall Study||38
9018334|NCT03074409|10081133|FG000|NOT COMPLETED|Overall Study||4
9018335|NCT03074409|10081134|FG001|NOT COMPLETED|Overall Study||4
9018336|NCT03074500|10081143|FG000|STARTED|Overall Study||11
9018337|NCT03074500|10081144|FG001|STARTED|Overall Study||11
9018338|NCT03074500|10081145|FG002|STARTED|Overall Study||11
9018339|NCT03074500|10081143|FG000|COMPLETED|Overall Study||10
9018340|NCT03074500|10081144|FG001|COMPLETED|Overall Study||10
9018341|NCT03074500|10081145|FG002|COMPLETED|Overall Study||10
9018342|NCT03074500|10081143|FG000|NOT COMPLETED|Overall Study||1
9018343|NCT03074500|10081144|FG001|NOT COMPLETED|Overall Study||1
9018344|NCT03074500|10081145|FG002|NOT COMPLETED|Overall Study||1
9018345|NCT03074630|10081155|FG000|STARTED|Overall Study||12
9018346|NCT03074630|10081155|FG000|COMPLETED|Overall Study||11
9018347|NCT03074630|10081155|FG000|NOT COMPLETED|Overall Study||1
9018348|NCT03074682|10081163|FG000|STARTED|Overall Study||18
9018349|NCT03074682|10081164|FG001|STARTED|Overall Study||18
9018350|NCT03074682|10081165|FG002|STARTED|Overall Study||18
9018351|NCT03074682|10081163|FG000|COMPLETED|Overall Study||18
9018352|NCT03074682|10081164|FG001|COMPLETED|Overall Study||18
9018353|NCT03074682|10081165|FG002|COMPLETED|Overall Study||18
9018354|NCT03074682|10081163|FG000|NOT COMPLETED|Overall Study||0
9018355|NCT03074682|10081164|FG001|NOT COMPLETED|Overall Study||0
9018356|NCT03074682|10081165|FG002|NOT COMPLETED|Overall Study||0
9018357|NCT03075085|10081175|FG000|STARTED|Overall Study||352
9018358|NCT03075085|10081176|FG001|STARTED|Overall Study||344
9018359|NCT03075085|10081175|FG000|COMPLETED|Overall Study||247
9018360|NCT03075085|10081176|FG001|COMPLETED|Overall Study||232
9018361|NCT03075085|10081175|FG000|NOT COMPLETED|Overall Study||105
9018362|NCT03075085|10081176|FG001|NOT COMPLETED|Overall Study||112
9018363|NCT03075163|10081184|FG000|STARTED|Overall Study||150
9018364|NCT03075163|10081185|FG001|STARTED|Overall Study||150
9018365|NCT03075163|10081184|FG000|COMPLETED|Overall Study||12
9018366|NCT03075163|10081185|FG001|COMPLETED|Overall Study||12
9018367|NCT03075163|10081184|FG000|NOT COMPLETED|Overall Study||138
9018368|NCT03075163|10081185|FG001|NOT COMPLETED|Overall Study||138
8637722|NCT00571649|9677974|FG001|COMPLETED|Follow-up Period|Began day after last dose study drug; ended on Day 90 (+/- 7 days) .|3107
8637723|NCT00571649|9677973|FG000|NOT COMPLETED|Follow-up Period||545
8637724|NCT00571649|9677974|FG001|NOT COMPLETED|Follow-up Period||528
8637725|NCT00571662|9677980|FG000|STARTED|Overall Study||76
8637726|NCT00571662|9677980|FG000|COMPLETED|Overall Study||68
8637727|NCT00571662|9677980|FG000|NOT COMPLETED|Overall Study||8
8637728|NCT00571688|9677988|FG000|STARTED|Overall Study||25
8637729|NCT00571688|9677989|FG001|STARTED|Overall Study||25
8637730|NCT00571688|9677988|FG000|COMPLETED|Overall Study||20
8637731|NCT00571688|9677989|FG001|COMPLETED|Overall Study||19
8637732|NCT00571688|9677988|FG000|NOT COMPLETED|Overall Study||5
8637733|NCT00571688|9677989|FG001|NOT COMPLETED|Overall Study||6
8637734|NCT00571701|9677997|FG000|STARTED|First Intervention 12 Months||19
8637735|NCT00571701|9677998|FG001|STARTED|First Intervention 12 Months||22
8637736|NCT00571701|9677997|FG000|COMPLETED|First Intervention 12 Months||16
8637737|NCT00571701|9677998|FG001|COMPLETED|First Intervention 12 Months||21
8637738|NCT00571701|9677997|FG000|NOT COMPLETED|First Intervention 12 Months||3
8637739|NCT00571701|9677998|FG001|NOT COMPLETED|First Intervention 12 Months||1
8637740|NCT00571701|9677997|FG000|STARTED|Second Intervention 12 Months||16
8637741|NCT00571701|9677998|FG001|STARTED|Second Intervention 12 Months||21
8637742|NCT00571701|9677997|FG000|COMPLETED|Second Intervention 12 Months||13
8637743|NCT00571701|9677998|FG001|COMPLETED|Second Intervention 12 Months||20
8637744|NCT00571701|9677997|FG000|NOT COMPLETED|Second Intervention 12 Months||3
9018369|NCT03075267|10081194|FG000|STARTED|Overall Study||32
9018370|NCT03075267|10081195|FG001|STARTED|Overall Study||32
9018371|NCT03075267|10081196|FG002|STARTED|Overall Study||32
9018372|NCT03075267|10081194|FG000|COMPLETED|Overall Study||31
9018373|NCT03075267|10081195|FG001|COMPLETED|Overall Study||32
9018374|NCT03075267|10081196|FG002|COMPLETED|Overall Study||32
8637745|NCT00571701|9677998|FG001|NOT COMPLETED|Second Intervention 12 Months||1
9018375|NCT03075267|10081194|FG000|NOT COMPLETED|Overall Study||1
9018376|NCT03075267|10081195|FG001|NOT COMPLETED|Overall Study||0
9018377|NCT03075267|10081196|FG002|NOT COMPLETED|Overall Study||0
9018378|NCT03075410|10081213|FG000|STARTED|Part A-Period 1 (14 Days)||2
9018379|NCT03075410|10081214|FG001|STARTED|Part A-Period 1 (14 Days)||1
9018380|NCT03075410|10081215|FG002|STARTED|Part A-Period 1 (14 Days)||2
9018381|NCT03075410|10081216|FG003|STARTED|Part A-Period 1 (14 Days)||1
9018382|NCT03075410|10081217|FG004|STARTED|Part A-Period 1 (14 Days)||2
9018383|NCT03075410|10081218|FG005|STARTED|Part A-Period 1 (14 Days)||1
9018384|NCT03075410|10081219|FG006|STARTED|Part A-Period 1 (14 Days)||0
9018385|NCT03075410|10081220|FG007|STARTED|Part A-Period 1 (14 Days)||0
9018386|NCT03075410|10081221|FG008|STARTED|Part A-Period 1 (14 Days)||0
8637746|NCT00571948|9678024|FG000|STARTED|Overall Study||66
8637747|NCT00571948|9678025|FG001|STARTED|Overall Study||66
8637748|NCT00571948|9678024|FG000|COMPLETED|Overall Study|Excluded from analysis (n = 2) Reason: diet record for less than 75 % of days (n = 2)|55
8637749|NCT00571948|9678025|FG001|COMPLETED|Overall Study|Excluded n = 3) Reasons: diet record < 75 % of days (n = 2); blood analysis failed (n= 1)|52
8637750|NCT00571948|9678024|FG000|NOT COMPLETED|Overall Study||11
8637751|NCT00571948|9678025|FG001|NOT COMPLETED|Overall Study||14
8637752|NCT00571961|9678031|FG000|STARTED|Overall Study||12
8637753|NCT00571961|9678031|FG000|COMPLETED|Overall Study||12
8637754|NCT00571961|9678031|FG000|NOT COMPLETED|Overall Study||0
8637755|NCT00571974|9678037|FG000|STARTED|Phase I||9
8637756|NCT00571974|9678038|FG001|STARTED|Phase I||0
8637757|NCT00571974|9678037|FG000|COMPLETED|Phase I||9
8637758|NCT00571974|9678038|FG001|COMPLETED|Phase I||0
8637759|NCT00571974|9678037|FG000|NOT COMPLETED|Phase I||0
8637760|NCT00571974|9678038|FG001|NOT COMPLETED|Phase I||0
8637761|NCT00571974|9678037|FG000|STARTED|Phase II||0
8637762|NCT00571974|9678038|FG001|STARTED|Phase II|3 participants are from phase I|21
8637763|NCT00571974|9678037|FG000|COMPLETED|Phase II||0
8637764|NCT00571974|9678038|FG001|COMPLETED|Phase II||17
8637765|NCT00571974|9678037|FG000|NOT COMPLETED|Phase II||0
8637766|NCT00571974|9678038|FG001|NOT COMPLETED|Phase II||4
8637767|NCT00571987|9678044|FG000|STARTED|Overall Study||107
8637768|NCT00571987|9678044|FG000|COMPLETED|Overall Study||100
8637769|NCT00571987|9678044|FG000|NOT COMPLETED|Overall Study||7
8637770|NCT00572039|9678051|FG000|STARTED|Overall Study||121
8637771|NCT00572039|9678052|FG001|STARTED|Overall Study||120
8637772|NCT00572039|9678051|FG000|COMPLETED|Overall Study||105
8637773|NCT00572039|9678052|FG001|COMPLETED|Overall Study||110
8637774|NCT00572039|9678051|FG000|NOT COMPLETED|Overall Study||16
8637775|NCT00572039|9678052|FG001|NOT COMPLETED|Overall Study||10
8637776|NCT00572117|9678062|FG000|STARTED|Overall Study||5
8637777|NCT00572117|9678063|FG001|STARTED|Overall Study||7
8637778|NCT00572117|9678062|FG000|COMPLETED|Overall Study||3
8637779|NCT00572117|9678063|FG001|COMPLETED|Overall Study||5
8637780|NCT00572117|9678062|FG000|NOT COMPLETED|Overall Study||2
8637781|NCT00572117|9678063|FG001|NOT COMPLETED|Overall Study||2
8637782|NCT00572156|9678075|FG000|STARTED|Overall Study||26
8637783|NCT00572156|9678076|FG001|STARTED|Overall Study||27
8637784|NCT00572156|9678077|FG002|STARTED|Overall Study||27
8637785|NCT00572156|9678078|FG003|STARTED|Overall Study||26
8637786|NCT00572156|9678075|FG000|COMPLETED|Overall Study||0
8637787|NCT00572156|9678076|FG001|COMPLETED|Overall Study||1
8637788|NCT00572156|9678077|FG002|COMPLETED|Overall Study||0
8637789|NCT00572156|9678078|FG003|COMPLETED|Overall Study||1
8637790|NCT00572156|9678075|FG000|NOT COMPLETED|Overall Study||26
8637791|NCT00572156|9678076|FG001|NOT COMPLETED|Overall Study||26
8637792|NCT00572156|9678077|FG002|NOT COMPLETED|Overall Study||27
8637793|NCT00572156|9678078|FG003|NOT COMPLETED|Overall Study||25
8637794|NCT00572195|9678088|FG000|STARTED|Overall Study||230
8637795|NCT00572195|9678088|FG000|COMPLETED|Overall Study||162
8637796|NCT00572195|9678088|FG000|NOT COMPLETED|Overall Study||68
8637797|NCT00572234|9678094|FG000|STARTED|Overall Study||19
8637798|NCT00572234|9678095|FG001|STARTED|Overall Study||21
8637799|NCT00572234|9678094|FG000|COMPLETED|Overall Study||18
8637800|NCT00572234|9678095|FG001|COMPLETED|Overall Study||16
8637801|NCT00572234|9678094|FG000|NOT COMPLETED|Overall Study||1
8637802|NCT00572234|9678095|FG001|NOT COMPLETED|Overall Study||5
8637803|NCT00572455|9678115|FG000|STARTED|Stage I (14 Days)||9
8637804|NCT00572455|9678116|FG001|STARTED|Stage I (14 Days)||9
8637805|NCT00572455|9678117|FG002|STARTED|Stage I (14 Days)||9
8637806|NCT00572455|9678118|FG003|STARTED|Stage I (14 Days)||10
9018387|NCT03075410|10081213|FG000|COMPLETED|Part A-Period 1 (14 Days)||2
9018388|NCT03075410|10081214|FG001|COMPLETED|Part A-Period 1 (14 Days)||1
9018389|NCT03075410|10081215|FG002|COMPLETED|Part A-Period 1 (14 Days)||2
9018390|NCT03075410|10081216|FG003|COMPLETED|Part A-Period 1 (14 Days)||1
9018391|NCT03075410|10081217|FG004|COMPLETED|Part A-Period 1 (14 Days)||2
9018392|NCT03075410|10081218|FG005|COMPLETED|Part A-Period 1 (14 Days)||1
9018393|NCT03075410|10081219|FG006|COMPLETED|Part A-Period 1 (14 Days)||0
9018394|NCT03075410|10081220|FG007|COMPLETED|Part A-Period 1 (14 Days)||0
9018395|NCT03075410|10081221|FG008|COMPLETED|Part A-Period 1 (14 Days)||0
9018396|NCT03075410|10081213|FG000|NOT COMPLETED|Part A-Period 1 (14 Days)||0
9018397|NCT03075410|10081214|FG001|NOT COMPLETED|Part A-Period 1 (14 Days)||0
9018398|NCT03075410|10081215|FG002|NOT COMPLETED|Part A-Period 1 (14 Days)||0
9018399|NCT03075410|10081216|FG003|NOT COMPLETED|Part A-Period 1 (14 Days)||0
9018400|NCT03075410|10081217|FG004|NOT COMPLETED|Part A-Period 1 (14 Days)||0
9018401|NCT03075410|10081218|FG005|NOT COMPLETED|Part A-Period 1 (14 Days)||0
8637807|NCT00572455|9678119|FG004|STARTED|Stage I (14 Days)||9
8637808|NCT00572455|9678120|FG005|STARTED|Stage I (14 Days)||9
8637809|NCT00572455|9678121|FG006|STARTED|Stage I (14 Days)||12
8637810|NCT00572455|9678122|FG007|STARTED|Stage I (14 Days)||0
8637811|NCT00572455|9678123|FG008|STARTED|Stage I (14 Days)||0
8637812|NCT00572455|9678124|FG009|STARTED|Stage I (14 Days)||0
8637813|NCT00572455|9678125|FG010|STARTED|Stage I (14 Days)||0
9018402|NCT03075410|10081219|FG006|NOT COMPLETED|Part A-Period 1 (14 Days)||0
9018403|NCT03075410|10081220|FG007|NOT COMPLETED|Part A-Period 1 (14 Days)||0
9018404|NCT03075410|10081221|FG008|NOT COMPLETED|Part A-Period 1 (14 Days)||0
9018405|NCT03075410|10081213|FG000|STARTED|Part A-Washout Period 1 (14 Days)||2
9018406|NCT03075410|10081214|FG001|STARTED|Part A-Washout Period 1 (14 Days)||1
9018407|NCT03075410|10081215|FG002|STARTED|Part A-Washout Period 1 (14 Days)||2
9018408|NCT03075410|10081216|FG003|STARTED|Part A-Washout Period 1 (14 Days)||1
9018409|NCT03075410|10081217|FG004|STARTED|Part A-Washout Period 1 (14 Days)||2
9018410|NCT03075410|10081218|FG005|STARTED|Part A-Washout Period 1 (14 Days)||1
9018411|NCT03075410|10081219|FG006|STARTED|Part A-Washout Period 1 (14 Days)||0
9018412|NCT03075410|10081220|FG007|STARTED|Part A-Washout Period 1 (14 Days)||0
9018413|NCT03075410|10081221|FG008|STARTED|Part A-Washout Period 1 (14 Days)||0
9018414|NCT03075410|10081213|FG000|COMPLETED|Part A-Washout Period 1 (14 Days)||2
9018415|NCT03075410|10081214|FG001|COMPLETED|Part A-Washout Period 1 (14 Days)||1
9018416|NCT03075410|10081215|FG002|COMPLETED|Part A-Washout Period 1 (14 Days)||2
9018417|NCT03075410|10081216|FG003|COMPLETED|Part A-Washout Period 1 (14 Days)||1
9018418|NCT03075410|10081217|FG004|COMPLETED|Part A-Washout Period 1 (14 Days)||2
9018419|NCT03075410|10081218|FG005|COMPLETED|Part A-Washout Period 1 (14 Days)||1
9018420|NCT03075410|10081219|FG006|COMPLETED|Part A-Washout Period 1 (14 Days)||0
9018421|NCT03075410|10081220|FG007|COMPLETED|Part A-Washout Period 1 (14 Days)||0
9018422|NCT03075410|10081221|FG008|COMPLETED|Part A-Washout Period 1 (14 Days)||0
9018423|NCT03075410|10081213|FG000|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
9018424|NCT03075410|10081214|FG001|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
9018425|NCT03075410|10081215|FG002|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
9018426|NCT03075410|10081216|FG003|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
9018427|NCT03075410|10081217|FG004|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
9018428|NCT03075410|10081218|FG005|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
9018429|NCT03075410|10081219|FG006|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
9018430|NCT03075410|10081220|FG007|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
9018431|NCT03075410|10081221|FG008|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
9018432|NCT03075410|10081213|FG000|STARTED|Part A-Period 2 (14 Days)||2
9018433|NCT03075410|10081214|FG001|STARTED|Part A-Period 2 (14 Days)||1
9018434|NCT03075410|10081215|FG002|STARTED|Part A-Period 2 (14 Days)||2
9018435|NCT03075410|10081216|FG003|STARTED|Part A-Period 2 (14 Days)||1
9018436|NCT03075410|10081217|FG004|STARTED|Part A-Period 2 (14 Days)||2
9018437|NCT03075410|10081218|FG005|STARTED|Part A-Period 2 (14 Days)||1
9018438|NCT03075410|10081219|FG006|STARTED|Part A-Period 2 (14 Days)||0
9018439|NCT03075410|10081220|FG007|STARTED|Part A-Period 2 (14 Days)||0
9018440|NCT03075410|10081221|FG008|STARTED|Part A-Period 2 (14 Days)||0
9018441|NCT03075410|10081213|FG000|COMPLETED|Part A-Period 2 (14 Days)||1
9018442|NCT03075410|10081214|FG001|COMPLETED|Part A-Period 2 (14 Days)||1
9018443|NCT03075410|10081215|FG002|COMPLETED|Part A-Period 2 (14 Days)||1
9018444|NCT03075410|10081216|FG003|COMPLETED|Part A-Period 2 (14 Days)||1
9018445|NCT03075410|10081217|FG004|COMPLETED|Part A-Period 2 (14 Days)||2
9018446|NCT03075410|10081218|FG005|COMPLETED|Part A-Period 2 (14 Days)||1
9018447|NCT03075410|10081219|FG006|COMPLETED|Part A-Period 2 (14 Days)||0
9018448|NCT03075410|10081220|FG007|COMPLETED|Part A-Period 2 (14 Days)||0
9018449|NCT03075410|10081221|FG008|COMPLETED|Part A-Period 2 (14 Days)||0
9018450|NCT03075410|10081213|FG000|NOT COMPLETED|Part A-Period 2 (14 Days)||1
9018451|NCT03075410|10081214|FG001|NOT COMPLETED|Part A-Period 2 (14 Days)||0
9018452|NCT03075410|10081215|FG002|NOT COMPLETED|Part A-Period 2 (14 Days)||1
9018453|NCT03075410|10081216|FG003|NOT COMPLETED|Part A-Period 2 (14 Days)||0
9018454|NCT03075410|10081217|FG004|NOT COMPLETED|Part A-Period 2 (14 Days)||0
9018455|NCT03075410|10081218|FG005|NOT COMPLETED|Part A-Period 2 (14 Days)||0
9018456|NCT03075410|10081219|FG006|NOT COMPLETED|Part A-Period 2 (14 Days)||0
9018457|NCT03075410|10081220|FG007|NOT COMPLETED|Part A-Period 2 (14 Days)||0
9018458|NCT03075410|10081221|FG008|NOT COMPLETED|Part A-Period 2 (14 Days)||0
9018459|NCT03075410|10081213|FG000|STARTED|Part A-Washout Period 2 (14 Days)||1
9018460|NCT03075410|10081214|FG001|STARTED|Part A-Washout Period 2 (14 Days)||1
9018461|NCT03075410|10081215|FG002|STARTED|Part A-Washout Period 2 (14 Days)||1
9018462|NCT03075410|10081216|FG003|STARTED|Part A-Washout Period 2 (14 Days)||1
9018463|NCT03075410|10081217|FG004|STARTED|Part A-Washout Period 2 (14 Days)||2
9018464|NCT03075410|10081218|FG005|STARTED|Part A-Washout Period 2 (14 Days)||1
9018465|NCT03075410|10081219|FG006|STARTED|Part A-Washout Period 2 (14 Days)||0
9018466|NCT03075410|10081220|FG007|STARTED|Part A-Washout Period 2 (14 Days)||0
9018467|NCT03075410|10081221|FG008|STARTED|Part A-Washout Period 2 (14 Days)||0
9018468|NCT03075410|10081213|FG000|COMPLETED|Part A-Washout Period 2 (14 Days)||1
9018469|NCT03075410|10081214|FG001|COMPLETED|Part A-Washout Period 2 (14 Days)||1
9018470|NCT03075410|10081215|FG002|COMPLETED|Part A-Washout Period 2 (14 Days)||1
9018471|NCT03075410|10081216|FG003|COMPLETED|Part A-Washout Period 2 (14 Days)||1
9018472|NCT03075410|10081217|FG004|COMPLETED|Part A-Washout Period 2 (14 Days)||2
9018473|NCT03075410|10081218|FG005|COMPLETED|Part A-Washout Period 2 (14 Days)||1
9018474|NCT03075410|10081219|FG006|COMPLETED|Part A-Washout Period 2 (14 Days)||0
9018475|NCT03075410|10081220|FG007|COMPLETED|Part A-Washout Period 2 (14 Days)||0
9018476|NCT03075410|10081221|FG008|COMPLETED|Part A-Washout Period 2 (14 Days)||0
9018477|NCT03075410|10081213|FG000|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
9018478|NCT03075410|10081214|FG001|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
9018479|NCT03075410|10081215|FG002|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
9018480|NCT03075410|10081216|FG003|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
9018481|NCT03075410|10081217|FG004|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
9018482|NCT03075410|10081218|FG005|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
9018483|NCT03075410|10081219|FG006|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
9018484|NCT03075410|10081220|FG007|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
9018485|NCT03075410|10081221|FG008|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
9018486|NCT03075410|10081213|FG000|STARTED|Part A-Period 3 (14 Days)|Participants who withdrew in Period 2 were replaced (2 new participants entered Part A period 3).|2
9018487|NCT03075410|10081214|FG001|STARTED|Part A-Period 3 (14 Days)||1
9018488|NCT03075410|10081215|FG002|STARTED|Part A-Period 3 (14 Days)|Participants who withdrew in Period 2 were replaced (2 new participants entered Part A period 3).|2
9018489|NCT03075410|10081216|FG003|STARTED|Part A-Period 3 (14 Days)||1
9018490|NCT03075410|10081217|FG004|STARTED|Part A-Period 3 (14 Days)||2
8637814|NCT00572455|9678126|FG011|STARTED|Stage I (14 Days)||0
8637815|NCT00572455|9678127|FG012|STARTED|Stage I (14 Days)||0
8637816|NCT00572455|9678128|FG013|STARTED|Stage I (14 Days)||0
8637817|NCT00572455|9678115|FG000|COMPLETED|Stage I (14 Days)||9
8637818|NCT00572455|9678116|FG001|COMPLETED|Stage I (14 Days)||9
8637819|NCT00572455|9678117|FG002|COMPLETED|Stage I (14 Days)||9
8637820|NCT00572455|9678118|FG003|COMPLETED|Stage I (14 Days)||10
8637821|NCT00572455|9678119|FG004|COMPLETED|Stage I (14 Days)||8
8637822|NCT00572455|9678120|FG005|COMPLETED|Stage I (14 Days)||6
8637823|NCT00572455|9678121|FG006|COMPLETED|Stage I (14 Days)||12
8637824|NCT00572455|9678122|FG007|COMPLETED|Stage I (14 Days)||0
8637825|NCT00572455|9678123|FG008|COMPLETED|Stage I (14 Days)||0
8637826|NCT00572455|9678124|FG009|COMPLETED|Stage I (14 Days)||0
8637827|NCT00572455|9678125|FG010|COMPLETED|Stage I (14 Days)||0
8637828|NCT00572455|9678126|FG011|COMPLETED|Stage I (14 Days)||0
8637829|NCT00572455|9678127|FG012|COMPLETED|Stage I (14 Days)||0
8637830|NCT00572455|9678128|FG013|COMPLETED|Stage I (14 Days)||0
8637831|NCT00572455|9678115|FG000|NOT COMPLETED|Stage I (14 Days)||0
8637832|NCT00572455|9678116|FG001|NOT COMPLETED|Stage I (14 Days)||0
8637833|NCT00572455|9678117|FG002|NOT COMPLETED|Stage I (14 Days)||0
8637834|NCT00572455|9678118|FG003|NOT COMPLETED|Stage I (14 Days)||0
8637835|NCT00572455|9678119|FG004|NOT COMPLETED|Stage I (14 Days)||1
8637836|NCT00572455|9678120|FG005|NOT COMPLETED|Stage I (14 Days)||3
8637837|NCT00572455|9678121|FG006|NOT COMPLETED|Stage I (14 Days)||0
8637838|NCT00572455|9678122|FG007|NOT COMPLETED|Stage I (14 Days)||0
8637839|NCT00572455|9678123|FG008|NOT COMPLETED|Stage I (14 Days)||0
8637840|NCT00572455|9678124|FG009|NOT COMPLETED|Stage I (14 Days)||0
8637841|NCT00572455|9678125|FG010|NOT COMPLETED|Stage I (14 Days)||0
8637842|NCT00572455|9678126|FG011|NOT COMPLETED|Stage I (14 Days)||0
8637843|NCT00572455|9678127|FG012|NOT COMPLETED|Stage I (14 Days)||0
8637844|NCT00572455|9678128|FG013|NOT COMPLETED|Stage I (14 Days)||0
8637845|NCT00572455|9678115|FG000|STARTED|Stage II (28 Days)||0
8637846|NCT00572455|9678116|FG001|STARTED|Stage II (28 Days)||0
8637847|NCT00572455|9678117|FG002|STARTED|Stage II (28 Days)||0
8637848|NCT00572455|9678118|FG003|STARTED|Stage II (28 Days)||0
8637849|NCT00572455|9678119|FG004|STARTED|Stage II (28 Days)||0
8637850|NCT00572455|9678120|FG005|STARTED|Stage II (28 Days)||0
8637851|NCT00572455|9678121|FG006|STARTED|Stage II (28 Days)||0
8637852|NCT00572455|9678122|FG007|STARTED|Stage II (28 Days)||35
8637853|NCT00572455|9678123|FG008|STARTED|Stage II (28 Days)||36
8637854|NCT00572455|9678124|FG009|STARTED|Stage II (28 Days)||36
8637855|NCT00572455|9678125|FG010|STARTED|Stage II (28 Days)||36
8637856|NCT00572455|9678126|FG011|STARTED|Stage II (28 Days)||36
8637857|NCT00572455|9678127|FG012|STARTED|Stage II (28 Days)||36
8637858|NCT00572455|9678128|FG013|STARTED|Stage II (28 Days)||36
8637859|NCT00572455|9678115|FG000|Treated|Stage II (28 Days)||0
8637860|NCT00572455|9678116|FG001|Treated|Stage II (28 Days)||0
8637861|NCT00572455|9678117|FG002|Treated|Stage II (28 Days)||0
8637862|NCT00572455|9678118|FG003|Treated|Stage II (28 Days)||0
8637863|NCT00572455|9678119|FG004|Treated|Stage II (28 Days)||0
8637864|NCT00572455|9678120|FG005|Treated|Stage II (28 Days)||0
8637865|NCT00572455|9678121|FG006|Treated|Stage II (28 Days)||0
8637866|NCT00572455|9678122|FG007|Treated|Stage II (28 Days)||35
8637867|NCT00572455|9678123|FG008|Treated|Stage II (28 Days)||36
8637868|NCT00572455|9678124|FG009|Treated|Stage II (28 Days)||36
8637869|NCT00572455|9678125|FG010|Treated|Stage II (28 Days)||36
8637870|NCT00572455|9678126|FG011|Treated|Stage II (28 Days)||36
8637871|NCT00572455|9678127|FG012|Treated|Stage II (28 Days)||36
8637872|NCT00572455|9678128|FG013|Treated|Stage II (28 Days)||35
8637873|NCT00572455|9678115|FG000|COMPLETED|Stage II (28 Days)||0
8637874|NCT00572455|9678116|FG001|COMPLETED|Stage II (28 Days)||0
8637875|NCT00572455|9678117|FG002|COMPLETED|Stage II (28 Days)||0
8637876|NCT00572455|9678118|FG003|COMPLETED|Stage II (28 Days)||0
9018491|NCT03075410|10081218|FG005|STARTED|Part A-Period 3 (14 Days)||1
9018492|NCT03075410|10081219|FG006|STARTED|Part A-Period 3 (14 Days)||0
9018493|NCT03075410|10081220|FG007|STARTED|Part A-Period 3 (14 Days)||0
9018494|NCT03075410|10081221|FG008|STARTED|Part A-Period 3 (14 Days)||0
9018495|NCT03075410|10081213|FG000|COMPLETED|Part A-Period 3 (14 Days)||1
9018496|NCT03075410|10081214|FG001|COMPLETED|Part A-Period 3 (14 Days)||1
9018497|NCT03075410|10081215|FG002|COMPLETED|Part A-Period 3 (14 Days)||2
9018498|NCT03075410|10081216|FG003|COMPLETED|Part A-Period 3 (14 Days)||1
9018499|NCT03075410|10081217|FG004|COMPLETED|Part A-Period 3 (14 Days)||2
9018500|NCT03075410|10081218|FG005|COMPLETED|Part A-Period 3 (14 Days)||1
9018501|NCT03075410|10081219|FG006|COMPLETED|Part A-Period 3 (14 Days)||0
8727120|NCT01041859|9774550|FG001|NOT COMPLETED|Open-Label Titration||0
8727121|NCT01041859|9774551|FG002|NOT COMPLETED|Open-Label Titration||0
8727122|NCT01041859|9774549|FG000|STARTED|Double-Blind Maintenance||0
8727123|NCT01041859|9774550|FG001|STARTED|Double-Blind Maintenance|168 were randomized, 2 were not treated (1 randomized in error, 1 withdrew consent).|166
8727124|NCT01041859|9774551|FG002|STARTED|Double-Blind Maintenance|152 randomized, all were treated.|152
8727125|NCT01041859|9774549|FG000|COMPLETED|Double-Blind Maintenance||0
8727126|NCT01041859|9774550|FG001|COMPLETED|Double-Blind Maintenance||120
8911101|NCT02143583|9970131|FG002|COMPLETED|Overall Study||66
8911102|NCT02143583|9970129|FG000|NOT COMPLETED|Overall Study||1
8911103|NCT02143583|9970130|FG001|NOT COMPLETED|Overall Study||0
9018502|NCT03075410|10081220|FG007|COMPLETED|Part A-Period 3 (14 Days)||0
9018503|NCT03075410|10081221|FG008|COMPLETED|Part A-Period 3 (14 Days)||0
9018504|NCT03075410|10081213|FG000|NOT COMPLETED|Part A-Period 3 (14 Days)||1
9018505|NCT03075410|10081214|FG001|NOT COMPLETED|Part A-Period 3 (14 Days)||0
9018506|NCT03075410|10081215|FG002|NOT COMPLETED|Part A-Period 3 (14 Days)||0
9018507|NCT03075410|10081216|FG003|NOT COMPLETED|Part A-Period 3 (14 Days)||0
9018508|NCT03075410|10081217|FG004|NOT COMPLETED|Part A-Period 3 (14 Days)||0
9018509|NCT03075410|10081218|FG005|NOT COMPLETED|Part A-Period 3 (14 Days)||0
9018510|NCT03075410|10081219|FG006|NOT COMPLETED|Part A-Period 3 (14 Days)||0
9018511|NCT03075410|10081220|FG007|NOT COMPLETED|Part A-Period 3 (14 Days)||0
9018512|NCT03075410|10081221|FG008|NOT COMPLETED|Part A-Period 3 (14 Days)||0
9018513|NCT03075410|10081213|FG000|STARTED|Part A-Washout Period 3 (14 Days)||1
9018514|NCT03075410|10081214|FG001|STARTED|Part A-Washout Period 3 (14 Days)||1
9018515|NCT03075410|10081215|FG002|STARTED|Part A-Washout Period 3 (14 Days)||2
9018516|NCT03075410|10081216|FG003|STARTED|Part A-Washout Period 3 (14 Days)||1
9018517|NCT03075410|10081217|FG004|STARTED|Part A-Washout Period 3 (14 Days)||2
9018518|NCT03075410|10081218|FG005|STARTED|Part A-Washout Period 3 (14 Days)||1
9018519|NCT03075410|10081219|FG006|STARTED|Part A-Washout Period 3 (14 Days)||0
9018520|NCT03075410|10081220|FG007|STARTED|Part A-Washout Period 3 (14 Days)||0
9018521|NCT03075410|10081221|FG008|STARTED|Part A-Washout Period 3 (14 Days)||0
9018522|NCT03075410|10081213|FG000|COMPLETED|Part A-Washout Period 3 (14 Days)||1
9018523|NCT03075410|10081214|FG001|COMPLETED|Part A-Washout Period 3 (14 Days)||1
9018524|NCT03075410|10081215|FG002|COMPLETED|Part A-Washout Period 3 (14 Days)||2
9018525|NCT03075410|10081216|FG003|COMPLETED|Part A-Washout Period 3 (14 Days)||1
9018526|NCT03075410|10081217|FG004|COMPLETED|Part A-Washout Period 3 (14 Days)||2
9018527|NCT03075410|10081218|FG005|COMPLETED|Part A-Washout Period 3 (14 Days)||1
9018528|NCT03075410|10081219|FG006|COMPLETED|Part A-Washout Period 3 (14 Days)||0
9018529|NCT03075410|10081220|FG007|COMPLETED|Part A-Washout Period 3 (14 Days)||0
9018530|NCT03075410|10081221|FG008|COMPLETED|Part A-Washout Period 3 (14 Days)||0
9018531|NCT03075410|10081213|FG000|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
9018532|NCT03075410|10081214|FG001|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
9018533|NCT03075410|10081215|FG002|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
9018534|NCT03075410|10081216|FG003|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
9018535|NCT03075410|10081217|FG004|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
9018536|NCT03075410|10081218|FG005|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
9018537|NCT03075410|10081219|FG006|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
9018538|NCT03075410|10081220|FG007|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
9018539|NCT03075410|10081221|FG008|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
9018540|NCT03075410|10081213|FG000|STARTED|Part A-Period 4 (14 Days)||1
9018541|NCT03075410|10081214|FG001|STARTED|Part A-Period 4 (14 Days)||1
9018542|NCT03075410|10081215|FG002|STARTED|Part A-Period 4 (14 Days)||2
9018543|NCT03075410|10081216|FG003|STARTED|Part A-Period 4 (14 Days)||1
9018544|NCT03075410|10081217|FG004|STARTED|Part A-Period 4 (14 Days)||2
9018545|NCT03075410|10081218|FG005|STARTED|Part A-Period 4 (14 Days)||1
9018546|NCT03075410|10081219|FG006|STARTED|Part A-Period 4 (14 Days)||0
9018547|NCT03075410|10081220|FG007|STARTED|Part A-Period 4 (14 Days)||0
9018548|NCT03075410|10081221|FG008|STARTED|Part A-Period 4 (14 Days)||0
9018549|NCT03075410|10081213|FG000|COMPLETED|Part A-Period 4 (14 Days)||1
9018550|NCT03075410|10081214|FG001|COMPLETED|Part A-Period 4 (14 Days)||1
9018551|NCT03075410|10081215|FG002|COMPLETED|Part A-Period 4 (14 Days)||2
9018552|NCT03075410|10081216|FG003|COMPLETED|Part A-Period 4 (14 Days)||1
9018553|NCT03075410|10081217|FG004|COMPLETED|Part A-Period 4 (14 Days)||2
8911104|NCT02143583|9970131|FG002|NOT COMPLETED|Overall Study||2
8911105|NCT02143648|9970142|FG000|STARTED|Overall Study||128
8911106|NCT02143648|9970143|FG001|STARTED|Overall Study||120
8911107|NCT02143648|9970144|FG002|STARTED|Overall Study||125
8911108|NCT02143648|9970142|FG000|COMPLETED|Overall Study||74
8911109|NCT02143648|9970143|FG001|COMPLETED|Overall Study||78
8911110|NCT02143648|9970144|FG002|COMPLETED|Overall Study||101
8911111|NCT02143648|9970142|FG000|NOT COMPLETED|Overall Study||54
9018554|NCT03075410|10081218|FG005|COMPLETED|Part A-Period 4 (14 Days)||1
9018555|NCT03075410|10081219|FG006|COMPLETED|Part A-Period 4 (14 Days)||0
9018556|NCT03075410|10081220|FG007|COMPLETED|Part A-Period 4 (14 Days)||0
9018557|NCT03075410|10081221|FG008|COMPLETED|Part A-Period 4 (14 Days)||0
9018558|NCT03075410|10081213|FG000|NOT COMPLETED|Part A-Period 4 (14 Days)||0
9018559|NCT03075410|10081214|FG001|NOT COMPLETED|Part A-Period 4 (14 Days)||0
9018560|NCT03075410|10081215|FG002|NOT COMPLETED|Part A-Period 4 (14 Days)||0
9018561|NCT03075410|10081216|FG003|NOT COMPLETED|Part A-Period 4 (14 Days)||0
9018562|NCT03075410|10081217|FG004|NOT COMPLETED|Part A-Period 4 (14 Days)||0
9018563|NCT03075410|10081218|FG005|NOT COMPLETED|Part A-Period 4 (14 Days)||0
9018564|NCT03075410|10081219|FG006|NOT COMPLETED|Part A-Period 4 (14 Days)||0
9018565|NCT03075410|10081220|FG007|NOT COMPLETED|Part A-Period 4 (14 Days)||0
8637877|NCT00572455|9678119|FG004|COMPLETED|Stage II (28 Days)||0
8637878|NCT00572455|9678120|FG005|COMPLETED|Stage II (28 Days)||0
8637879|NCT00572455|9678121|FG006|COMPLETED|Stage II (28 Days)||0
8637880|NCT00572455|9678122|FG007|COMPLETED|Stage II (28 Days)||34
8637881|NCT00572455|9678123|FG008|COMPLETED|Stage II (28 Days)||33
8637882|NCT00572455|9678124|FG009|COMPLETED|Stage II (28 Days)||33
8637883|NCT00572455|9678125|FG010|COMPLETED|Stage II (28 Days)||31
8637884|NCT00572455|9678126|FG011|COMPLETED|Stage II (28 Days)||32
8637885|NCT00572455|9678127|FG012|COMPLETED|Stage II (28 Days)||31
8637886|NCT00572455|9678128|FG013|COMPLETED|Stage II (28 Days)||34
8637887|NCT00572455|9678115|FG000|NOT COMPLETED|Stage II (28 Days)||0
8637888|NCT00572455|9678116|FG001|NOT COMPLETED|Stage II (28 Days)||0
8637889|NCT00572455|9678117|FG002|NOT COMPLETED|Stage II (28 Days)||0
8637890|NCT00572455|9678118|FG003|NOT COMPLETED|Stage II (28 Days)||0
8637891|NCT00572455|9678119|FG004|NOT COMPLETED|Stage II (28 Days)||0
8637892|NCT00572455|9678120|FG005|NOT COMPLETED|Stage II (28 Days)||0
8637893|NCT00572455|9678121|FG006|NOT COMPLETED|Stage II (28 Days)||0
8637894|NCT00572455|9678122|FG007|NOT COMPLETED|Stage II (28 Days)||1
8637895|NCT00572455|9678123|FG008|NOT COMPLETED|Stage II (28 Days)||3
8637896|NCT00572455|9678124|FG009|NOT COMPLETED|Stage II (28 Days)||3
8637897|NCT00572455|9678125|FG010|NOT COMPLETED|Stage II (28 Days)||5
8637898|NCT00572455|9678126|FG011|NOT COMPLETED|Stage II (28 Days)||4
8637899|NCT00572455|9678127|FG012|NOT COMPLETED|Stage II (28 Days)||5
8637900|NCT00572455|9678128|FG013|NOT COMPLETED|Stage II (28 Days)||2
8637901|NCT00572468|9678160|FG000|STARTED|Overall Study||22
8637902|NCT00572468|9678161|FG001|STARTED|Overall Study||20
8637903|NCT00572468|9678160|FG000|COMPLETED|Overall Study||20
8637904|NCT00572468|9678161|FG001|COMPLETED|Overall Study||16
8637905|NCT00572468|9678160|FG000|NOT COMPLETED|Overall Study||2
8637906|NCT00572468|9678161|FG001|NOT COMPLETED|Overall Study||4
8637907|NCT00572533|9678169|FG000|STARTED|Overall Study||31
8637908|NCT00572533|9678170|FG001|STARTED|Overall Study||31
8637909|NCT00572533|9678169|FG000|COMPLETED|Overall Study||24
8637910|NCT00572533|9678170|FG001|COMPLETED|Overall Study||28
8637911|NCT00572533|9678169|FG000|NOT COMPLETED|Overall Study||7
8637912|NCT00572533|9678170|FG001|NOT COMPLETED|Overall Study||3
8637913|NCT00572572|9678178|FG000|STARTED|Overall Study||35
8637914|NCT00572572|9678179|FG001|STARTED|Overall Study||34
8637915|NCT00572572|9678178|FG000|COMPLETED|Overall Study||32
8637916|NCT00572572|9678179|FG001|COMPLETED|Overall Study||28
8637917|NCT00572572|9678178|FG000|NOT COMPLETED|Overall Study||3
8637918|NCT00572572|9678179|FG001|NOT COMPLETED|Overall Study||6
8637919|NCT00572624|9678187|FG000|STARTED|Overall Study||37
8637920|NCT00572624|9678188|FG001|STARTED|Overall Study||14
8637921|NCT00572624|9678187|FG000|COMPLETED|Overall Study||20
8637922|NCT00572624|9678188|FG001|COMPLETED|Overall Study||10
8637923|NCT00572624|9678187|FG000|NOT COMPLETED|Overall Study||17
8637924|NCT00572624|9678188|FG001|NOT COMPLETED|Overall Study||4
8637925|NCT00572728|9678194|FG000|STARTED|Overall Study|Registered|90
8637926|NCT00572728|9678194|FG000|Eligible|Overall Study||87
8637927|NCT00572728|9678194|FG000|Enrolled Under Amendment 5 or Later|Overall Study||82
8637928|NCT00572728|9678194|FG000|Did Not Withdraw|Overall Study||72
8637929|NCT00572728|9678194|FG000|On Study|Overall Study||71
8637930|NCT00572728|9678194|FG000|Completed FLT1 Scan|Overall Study||67
8637931|NCT00572728|9678194|FG000|First Therapy Initiated|Overall Study||65
8637932|NCT00572728|9678194|FG000|Completed FLT2 Scan|Overall Study||60
8637933|NCT00572728|9678194|FG000|Second Chemotherapy Initiated|Overall Study||59
8637934|NCT00572728|9678194|FG000|Second Chemotherapy Initiated After FLT2|Overall Study||52
8637935|NCT00572728|9678194|FG000|Pathology Complete|Overall Study||51
8637936|NCT00572728|9678194|FG000|Completed FLT3 Scan|Overall Study|Secondary analysis milestone: 43 pts had FLT-3 performed.|43
8637937|NCT00572728|9678194|FG000|LN Evaluation After NAC|Overall Study|Secondary:38 patients were available for histopathological LN evaluation after NAC|38
8637938|NCT00572728|9678194|FG000|RCB Evaluation|Overall Study|Secondary: histopathology was available in 35 patients for RCB evaluation|35
8637939|NCT00572728|9678194|FG000|COMPLETED|Overall Study|51 patients eligible for primary objective analysis|51
8637940|NCT00572728|9678194|FG000|NOT COMPLETED|Overall Study||39
8637941|NCT00572832|9678202|FG000|STARTED|Overall Study||100
8637942|NCT00572832|9678203|FG001|STARTED|Overall Study||100
8637943|NCT00572832|9678202|FG000|COMPLETED|Overall Study||100
8637944|NCT00572832|9678203|FG001|COMPLETED|Overall Study||88
8637945|NCT00572832|9678202|FG000|NOT COMPLETED|Overall Study||0
8637946|NCT00572832|9678203|FG001|NOT COMPLETED|Overall Study||12
8637947|NCT00572897|9678211|FG000|STARTED|Overall Study||32
8637948|NCT00572897|9678212|FG001|STARTED|Overall Study||34
8727127|NCT01041859|9774551|FG002|COMPLETED|Double-Blind Maintenance||107
9018566|NCT03075410|10081221|FG008|NOT COMPLETED|Part A-Period 4 (14 Days)||0
9018567|NCT03075410|10081213|FG000|STARTED|Part B (up to 28 Days)||0
9018568|NCT03075410|10081214|FG001|STARTED|Part B (up to 28 Days)||0
9018569|NCT03075410|10081215|FG002|STARTED|Part B (up to 28 Days)||0
9018570|NCT03075410|10081216|FG003|STARTED|Part B (up to 28 Days)||0
9018571|NCT03075410|10081217|FG004|STARTED|Part B (up to 28 Days)||0
9018572|NCT03075410|10081218|FG005|STARTED|Part B (up to 28 Days)||0
9018573|NCT03075410|10081219|FG006|STARTED|Part B (up to 28 Days)||4
9018574|NCT03075410|10081220|FG007|STARTED|Part B (up to 28 Days)||7
9018575|NCT03075410|10081221|FG008|STARTED|Part B (up to 28 Days)||8
9018576|NCT03075410|10081213|FG000|COMPLETED|Part B (up to 28 Days)||0
9018577|NCT03075410|10081214|FG001|COMPLETED|Part B (up to 28 Days)||0
9018578|NCT03075410|10081215|FG002|COMPLETED|Part B (up to 28 Days)||0
9018579|NCT03075410|10081216|FG003|COMPLETED|Part B (up to 28 Days)||0
9018580|NCT03075410|10081217|FG004|COMPLETED|Part B (up to 28 Days)||0
9018581|NCT03075410|10081218|FG005|COMPLETED|Part B (up to 28 Days)||0
9018582|NCT03075410|10081219|FG006|COMPLETED|Part B (up to 28 Days)||4
9018583|NCT03075410|10081220|FG007|COMPLETED|Part B (up to 28 Days)||7
9018584|NCT03075410|10081221|FG008|COMPLETED|Part B (up to 28 Days)||8
9018585|NCT03075410|10081213|FG000|NOT COMPLETED|Part B (up to 28 Days)||0
9018586|NCT03075410|10081214|FG001|NOT COMPLETED|Part B (up to 28 Days)||0
9018587|NCT03075410|10081215|FG002|NOT COMPLETED|Part B (up to 28 Days)||0
9018588|NCT03075410|10081216|FG003|NOT COMPLETED|Part B (up to 28 Days)||0
9018589|NCT03075410|10081217|FG004|NOT COMPLETED|Part B (up to 28 Days)||0
9018590|NCT03075410|10081218|FG005|NOT COMPLETED|Part B (up to 28 Days)||0
8637949|NCT00572897|9678211|FG000|COMPLETED|Overall Study||32
8637950|NCT00572897|9678212|FG001|COMPLETED|Overall Study||34
8637951|NCT00572897|9678211|FG000|NOT COMPLETED|Overall Study||0
9018591|NCT03075410|10081219|FG006|NOT COMPLETED|Part B (up to 28 Days)||0
9018592|NCT03075410|10081220|FG007|NOT COMPLETED|Part B (up to 28 Days)||0
9018593|NCT03075410|10081221|FG008|NOT COMPLETED|Part B (up to 28 Days)||0
9018594|NCT03075449|10081245|FG000|STARTED|Overall Study||170
9018595|NCT03075449|10081245|FG000|COMPLETED|Overall Study||170
9018596|NCT03075449|10081245|FG000|NOT COMPLETED|Overall Study||0
9018597|NCT03075501|10081251|FG000|STARTED|Overall Study||89
9018598|NCT03075501|10081252|FG001|STARTED|Overall Study||44
9018599|NCT03075501|10081251|FG000|COMPLETED|Overall Study||74
9018600|NCT03075501|10081252|FG001|COMPLETED|Overall Study||35
9018601|NCT03075501|10081251|FG000|NOT COMPLETED|Overall Study||15
9018602|NCT03075501|10081252|FG001|NOT COMPLETED|Overall Study||9
9018603|NCT03075553|10081259|FG000|STARTED|Overall Study||12
9018604|NCT03075553|10081259|FG000|COMPLETED|Overall Study||12
9018605|NCT03075553|10081259|FG000|NOT COMPLETED|Overall Study||0
9018606|NCT03075644|10081265|FG000|STARTED|Overall Study||16
9018607|NCT03075644|10081266|FG001|STARTED|Overall Study||46
9018608|NCT03075644|10081265|FG000|Full Analysis Set (FAS)|Overall Study||16
9018609|NCT03075644|10081266|FG001|Full Analysis Set (FAS)|Overall Study||46
9018610|NCT03075644|10081265|FG000|Safety Analysis Set (SAS)|Overall Study||16
9018611|NCT03075644|10081266|FG001|Safety Analysis Set (SAS)|Overall Study||46
9018612|NCT03075644|10081265|FG000|COMPLETED|Overall Study||15
9018613|NCT03075644|10081266|FG001|COMPLETED|Overall Study||45
9018614|NCT03075644|10081265|FG000|NOT COMPLETED|Overall Study||1
9018615|NCT03075644|10081266|FG001|NOT COMPLETED|Overall Study||1
9018616|NCT03075761|10081275|FG000|STARTED|Overall Study||11
9018617|NCT03075761|10081276|FG001|STARTED|Overall Study||12
8637952|NCT00572897|9678212|FG001|NOT COMPLETED|Overall Study||0
8637953|NCT00572910|9678224|FG000|STARTED|Overall Study||19
8637954|NCT00572910|9678225|FG001|STARTED|Overall Study||18
8637955|NCT00572910|9678226|FG002|STARTED|Overall Study||19
8637956|NCT00572910|9678227|FG003|STARTED|Overall Study||18
8637957|NCT00572910|9678228|FG004|STARTED|Overall Study||19
8637958|NCT00572910|9678229|FG005|STARTED|Overall Study||19
8637959|NCT00572910|9678230|FG006|STARTED|Overall Study||19
8637960|NCT00572910|9678231|FG007|STARTED|Overall Study||19
9018618|NCT03075761|10081275|FG000|COMPLETED|Overall Study||10
9018619|NCT03075761|10081276|FG001|COMPLETED|Overall Study||6
9018620|NCT03075761|10081275|FG000|NOT COMPLETED|Overall Study||1
9018621|NCT03075761|10081276|FG001|NOT COMPLETED|Overall Study||6
9018622|NCT03075839|10081287|FG000|STARTED|Overall Study||33
9018623|NCT03075839|10081287|FG000|COMPLETED|Overall Study||29
9018624|NCT03075839|10081287|FG000|NOT COMPLETED|Overall Study||4
9018625|NCT03075878|10081291|FG000|STARTED|Overall Study||8
9018626|NCT03075878|10081291|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
9018627|NCT03075878|10081291|FG000|COMPLETED|Overall Study||7
9018628|NCT03075878|10081291|FG000|NOT COMPLETED|Overall Study||1
9018629|NCT03075891|10081297|FG000|STARTED|Overall Study||135
9018630|NCT03075891|10081298|FG001|STARTED|Overall Study||138
9018631|NCT03075891|10081297|FG000|COMPLETED|Overall Study||126
9018632|NCT03075891|10081298|FG001|COMPLETED|Overall Study||125
9018633|NCT03075891|10081297|FG000|NOT COMPLETED|Overall Study||9
9018634|NCT03075891|10081298|FG001|NOT COMPLETED|Overall Study||13
9018635|NCT03075904|10081306|FG000|STARTED|Overall Study||8
9018636|NCT03075904|10081306|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
9018637|NCT03075904|10081306|FG000|COMPLETED|Overall Study||4
9018638|NCT03075904|10081306|FG000|NOT COMPLETED|Overall Study||4
9018639|NCT03076190|10081312|FG000|STARTED|Overall Study||50
9018640|NCT03076190|10081313|FG001|STARTED|Overall Study||77
9018641|NCT03076190|10081312|FG000|COMPLETED|Overall Study||32
9018642|NCT03076190|10081313|FG001|COMPLETED|Overall Study||36
9018643|NCT03076190|10081312|FG000|NOT COMPLETED|Overall Study||18
9018644|NCT03076190|10081313|FG001|NOT COMPLETED|Overall Study||41
9018645|NCT03076333|10081322|FG000|STARTED|Overall Study||3
9018646|NCT03076333|10081322|FG000|COMPLETED|Overall Study||3
9018647|NCT03076333|10081322|FG000|NOT COMPLETED|Overall Study||0
9018648|NCT03076359|10081328|FG000|STARTED|Overall Study||170
9018649|NCT03076359|10081329|FG001|STARTED|Overall Study||150
8637961|NCT00572910|9678232|FG008|STARTED|Overall Study||19
8637962|NCT00572910|9678233|FG009|STARTED|Overall Study||19
8637963|NCT00572910|9678234|FG010|STARTED|Overall Study||18
8637964|NCT00572910|9678224|FG000|COMPLETED|Overall Study||15
8637965|NCT00572910|9678225|FG001|COMPLETED|Overall Study||15
8637966|NCT00572910|9678226|FG002|COMPLETED|Overall Study||17
8637967|NCT00572910|9678227|FG003|COMPLETED|Overall Study||14
8637968|NCT00572910|9678228|FG004|COMPLETED|Overall Study||17
8637969|NCT00572910|9678229|FG005|COMPLETED|Overall Study||16
8637970|NCT00572910|9678230|FG006|COMPLETED|Overall Study||15
8637971|NCT00572910|9678231|FG007|COMPLETED|Overall Study||15
8637972|NCT00572910|9678232|FG008|COMPLETED|Overall Study||16
8637973|NCT00572910|9678233|FG009|COMPLETED|Overall Study||13
8637974|NCT00572910|9678234|FG010|COMPLETED|Overall Study||15
8637975|NCT00572910|9678224|FG000|NOT COMPLETED|Overall Study||4
8637976|NCT00572910|9678225|FG001|NOT COMPLETED|Overall Study||3
8637977|NCT00572910|9678226|FG002|NOT COMPLETED|Overall Study||2
8637978|NCT00572910|9678227|FG003|NOT COMPLETED|Overall Study||4
8637979|NCT00572910|9678228|FG004|NOT COMPLETED|Overall Study||2
8637980|NCT00572910|9678229|FG005|NOT COMPLETED|Overall Study||3
8637981|NCT00572910|9678230|FG006|NOT COMPLETED|Overall Study||4
8637982|NCT00572910|9678231|FG007|NOT COMPLETED|Overall Study||4
8637983|NCT00572910|9678232|FG008|NOT COMPLETED|Overall Study||3
8637984|NCT00572910|9678233|FG009|NOT COMPLETED|Overall Study||6
8637985|NCT00572910|9678234|FG010|NOT COMPLETED|Overall Study||3
8637986|NCT00572936|9678269|FG000|STARTED|First Intervention||4
8637987|NCT00572936|9678270|FG001|STARTED|First Intervention||4
8637988|NCT00572936|9678271|FG002|STARTED|First Intervention||5
8637989|NCT00572936|9678272|FG003|STARTED|First Intervention||5
8637990|NCT00572936|9678273|FG004|STARTED|First Intervention||5
8637991|NCT00572936|9678274|FG005|STARTED|First Intervention||5
8637992|NCT00572936|9678269|FG000|COMPLETED|First Intervention||4
8637993|NCT00572936|9678270|FG001|COMPLETED|First Intervention||4
8637994|NCT00572936|9678271|FG002|COMPLETED|First Intervention||5
8637995|NCT00572936|9678272|FG003|COMPLETED|First Intervention||5
8637996|NCT00572936|9678273|FG004|COMPLETED|First Intervention||5
8637997|NCT00572936|9678274|FG005|COMPLETED|First Intervention||5
8637998|NCT00572936|9678269|FG000|NOT COMPLETED|First Intervention||0
8637999|NCT00572936|9678270|FG001|NOT COMPLETED|First Intervention||0
8638000|NCT00572936|9678271|FG002|NOT COMPLETED|First Intervention||0
8638001|NCT00572936|9678272|FG003|NOT COMPLETED|First Intervention||0
8638002|NCT00572936|9678273|FG004|NOT COMPLETED|First Intervention||0
8638003|NCT00572936|9678274|FG005|NOT COMPLETED|First Intervention||0
8638004|NCT00572936|9678269|FG000|STARTED|Second Intervention||4
8638005|NCT00572936|9678270|FG001|STARTED|Second Intervention|1 participant dropped out between the first and second intervention due to car accident|3
8638006|NCT00572936|9678271|FG002|STARTED|Second Intervention|1 participant dropped out between first intervention and second intervention due to increased IOP|4
8638007|NCT00572936|9678272|FG003|STARTED|Second Intervention||5
8638008|NCT00572936|9678273|FG004|STARTED|Second Intervention|1 participant dropped out between first intervention and second intervention due to increased IOP|4
8638009|NCT00572936|9678274|FG005|STARTED|Second Intervention||5
8638010|NCT00572936|9678269|FG000|COMPLETED|Second Intervention||4
8638011|NCT00572936|9678270|FG001|COMPLETED|Second Intervention||3
9018650|NCT03076359|10081328|FG000|COMPLETED|Overall Study||170
9018651|NCT03076359|10081329|FG001|COMPLETED|Overall Study||150
9018652|NCT03076359|10081328|FG000|NOT COMPLETED|Overall Study||0
9018653|NCT03076359|10081329|FG001|NOT COMPLETED|Overall Study||0
9018654|NCT03076515|10081339|FG000|STARTED|Overall Study||58
9018655|NCT03076515|10081340|FG001|STARTED|Overall Study||62
9018656|NCT03076515|10081339|FG000|COMPLETED|Overall Study||33
9018657|NCT03076515|10081340|FG001|COMPLETED|Overall Study||33
9018658|NCT03076515|10081339|FG000|NOT COMPLETED|Overall Study||25
9018659|NCT03076515|10081340|FG001|NOT COMPLETED|Overall Study||29
9018660|NCT03076970|10081346|FG000|STARTED|Period 1||7
9018661|NCT03076970|10081347|FG001|STARTED|Period 1||7
9018662|NCT03076970|10081348|FG002|STARTED|Period 1||7
9018663|NCT03076970|10081349|FG003|STARTED|Period 1||7
9018664|NCT03076970|10081350|FG004|STARTED|Period 1||7
9018665|NCT03076970|10081351|FG005|STARTED|Period 1||7
9018666|NCT03076970|10081346|FG000|Received at Least 1 Dose of Study Drug|Period 1||7
9018667|NCT03076970|10081347|FG001|Received at Least 1 Dose of Study Drug|Period 1||7
9018668|NCT03076970|10081348|FG002|Received at Least 1 Dose of Study Drug|Period 1||7
9018669|NCT03076970|10081349|FG003|Received at Least 1 Dose of Study Drug|Period 1||7
9018670|NCT03076970|10081350|FG004|Received at Least 1 Dose of Study Drug|Period 1||7
9018671|NCT03076970|10081351|FG005|Received at Least 1 Dose of Study Drug|Period 1||7
9018672|NCT03076970|10081346|FG000|COMPLETED|Period 1||7
9018673|NCT03076970|10081347|FG001|COMPLETED|Period 1||7
9018674|NCT03076970|10081348|FG002|COMPLETED|Period 1||7
9018675|NCT03076970|10081349|FG003|COMPLETED|Period 1||7
9018676|NCT03076970|10081350|FG004|COMPLETED|Period 1||7
9018677|NCT03076970|10081351|FG005|COMPLETED|Period 1||7
9018678|NCT03076970|10081346|FG000|NOT COMPLETED|Period 1||0
9018679|NCT03076970|10081347|FG001|NOT COMPLETED|Period 1||0
9018680|NCT03076970|10081348|FG002|NOT COMPLETED|Period 1||0
9018681|NCT03076970|10081349|FG003|NOT COMPLETED|Period 1||0
9018682|NCT03076970|10081350|FG004|NOT COMPLETED|Period 1||0
9018683|NCT03076970|10081351|FG005|NOT COMPLETED|Period 1||0
9018684|NCT03076970|10081346|FG000|STARTED|Washout Period 1||7
9018685|NCT03076970|10081347|FG001|STARTED|Washout Period 1||7
9018686|NCT03076970|10081348|FG002|STARTED|Washout Period 1||7
9018687|NCT03076970|10081349|FG003|STARTED|Washout Period 1||7
9018688|NCT03076970|10081350|FG004|STARTED|Washout Period 1||7
8638012|NCT00572936|9678271|FG002|COMPLETED|Second Intervention||4
8638013|NCT00572936|9678272|FG003|COMPLETED|Second Intervention||5
8638014|NCT00572936|9678273|FG004|COMPLETED|Second Intervention||4
9018689|NCT03076970|10081351|FG005|STARTED|Washout Period 1||7
9018690|NCT03076970|10081346|FG000|COMPLETED|Washout Period 1||7
9018691|NCT03076970|10081347|FG001|COMPLETED|Washout Period 1||7
9018692|NCT03076970|10081348|FG002|COMPLETED|Washout Period 1||7
9018693|NCT03076970|10081349|FG003|COMPLETED|Washout Period 1||7
9018694|NCT03076970|10081350|FG004|COMPLETED|Washout Period 1||7
9018695|NCT03076970|10081351|FG005|COMPLETED|Washout Period 1||7
9018696|NCT03076970|10081346|FG000|NOT COMPLETED|Washout Period 1||0
9018697|NCT03076970|10081347|FG001|NOT COMPLETED|Washout Period 1||0
9018698|NCT03076970|10081348|FG002|NOT COMPLETED|Washout Period 1||0
9018699|NCT03076970|10081349|FG003|NOT COMPLETED|Washout Period 1||0
9018700|NCT03076970|10081350|FG004|NOT COMPLETED|Washout Period 1||0
9018701|NCT03076970|10081351|FG005|NOT COMPLETED|Washout Period 1||0
9018702|NCT03076970|10081346|FG000|STARTED|Period 2||7
9018703|NCT03076970|10081347|FG001|STARTED|Period 2||7
9018704|NCT03076970|10081348|FG002|STARTED|Period 2||7
9018705|NCT03076970|10081349|FG003|STARTED|Period 2||7
9018706|NCT03076970|10081350|FG004|STARTED|Period 2||7
9018707|NCT03076970|10081351|FG005|STARTED|Period 2||7
9018708|NCT03076970|10081346|FG000|COMPLETED|Period 2||7
9018709|NCT03076970|10081347|FG001|COMPLETED|Period 2||7
9018710|NCT03076970|10081348|FG002|COMPLETED|Period 2||7
9018711|NCT03076970|10081349|FG003|COMPLETED|Period 2||7
9018712|NCT03076970|10081350|FG004|COMPLETED|Period 2||7
9018713|NCT03076970|10081351|FG005|COMPLETED|Period 2||7
9018714|NCT03076970|10081346|FG000|NOT COMPLETED|Period 2||0
9018715|NCT03076970|10081347|FG001|NOT COMPLETED|Period 2||0
9018716|NCT03076970|10081348|FG002|NOT COMPLETED|Period 2||0
9018717|NCT03076970|10081349|FG003|NOT COMPLETED|Period 2||0
9018718|NCT03076970|10081350|FG004|NOT COMPLETED|Period 2||0
9018719|NCT03076970|10081351|FG005|NOT COMPLETED|Period 2||0
9018720|NCT03076970|10081346|FG000|STARTED|Washout Period 2||7
9018721|NCT03076970|10081347|FG001|STARTED|Washout Period 2||7
9018722|NCT03076970|10081348|FG002|STARTED|Washout Period 2||7
9018723|NCT03076970|10081349|FG003|STARTED|Washout Period 2||7
9018724|NCT03076970|10081350|FG004|STARTED|Washout Period 2||7
9018725|NCT03076970|10081351|FG005|STARTED|Washout Period 2||7
9018726|NCT03076970|10081346|FG000|COMPLETED|Washout Period 2||7
9018727|NCT03076970|10081347|FG001|COMPLETED|Washout Period 2||7
9018728|NCT03076970|10081348|FG002|COMPLETED|Washout Period 2||7
9018729|NCT03076970|10081349|FG003|COMPLETED|Washout Period 2||7
9018730|NCT03076970|10081350|FG004|COMPLETED|Washout Period 2||6
8638015|NCT00572936|9678274|FG005|COMPLETED|Second Intervention||5
8638016|NCT00572936|9678269|FG000|NOT COMPLETED|Second Intervention||0
9018731|NCT03076970|10081351|FG005|COMPLETED|Washout Period 2||7
9018732|NCT03076970|10081346|FG000|NOT COMPLETED|Washout Period 2||0
9018733|NCT03076970|10081347|FG001|NOT COMPLETED|Washout Period 2||0
9018734|NCT03076970|10081348|FG002|NOT COMPLETED|Washout Period 2||0
9018735|NCT03076970|10081349|FG003|NOT COMPLETED|Washout Period 2||0
9018736|NCT03076970|10081350|FG004|NOT COMPLETED|Washout Period 2||1
9018737|NCT03076970|10081351|FG005|NOT COMPLETED|Washout Period 2||0
9018738|NCT03076970|10081346|FG000|STARTED|Period 3||7
9018739|NCT03076970|10081347|FG001|STARTED|Period 3||7
9018740|NCT03076970|10081348|FG002|STARTED|Period 3||7
9018741|NCT03076970|10081349|FG003|STARTED|Period 3||7
9018742|NCT03076970|10081350|FG004|STARTED|Period 3||6
9018743|NCT03076970|10081351|FG005|STARTED|Period 3||7
9018744|NCT03076970|10081346|FG000|COMPLETED|Period 3||7
9018745|NCT03076970|10081347|FG001|COMPLETED|Period 3||7
9018746|NCT03076970|10081348|FG002|COMPLETED|Period 3||7
9018747|NCT03076970|10081349|FG003|COMPLETED|Period 3||7
9018748|NCT03076970|10081350|FG004|COMPLETED|Period 3||5
9018749|NCT03076970|10081351|FG005|COMPLETED|Period 3||6
9018750|NCT03076970|10081346|FG000|NOT COMPLETED|Period 3||0
9018751|NCT03076970|10081347|FG001|NOT COMPLETED|Period 3||0
9018752|NCT03076970|10081348|FG002|NOT COMPLETED|Period 3||0
9018753|NCT03076970|10081349|FG003|NOT COMPLETED|Period 3||0
9018754|NCT03076970|10081350|FG004|NOT COMPLETED|Period 3||1
9018755|NCT03076970|10081351|FG005|NOT COMPLETED|Period 3||1
9018756|NCT03076970|10081346|FG000|STARTED|Washout Period 3||7
9018757|NCT03076970|10081347|FG001|STARTED|Washout Period 3||7
9018758|NCT03076970|10081348|FG002|STARTED|Washout Period 3||7
9018759|NCT03076970|10081349|FG003|STARTED|Washout Period 3||7
9018760|NCT03076970|10081350|FG004|STARTED|Washout Period 3||5
9018761|NCT03076970|10081351|FG005|STARTED|Washout Period 3||6
9018762|NCT03076970|10081346|FG000|COMPLETED|Washout Period 3||7
9018763|NCT03076970|10081347|FG001|COMPLETED|Washout Period 3||7
9018764|NCT03076970|10081348|FG002|COMPLETED|Washout Period 3||7
9018765|NCT03076970|10081349|FG003|COMPLETED|Washout Period 3||7
9018766|NCT03076970|10081350|FG004|COMPLETED|Washout Period 3||5
9018767|NCT03076970|10081351|FG005|COMPLETED|Washout Period 3||6
9018768|NCT03076970|10081346|FG000|NOT COMPLETED|Washout Period 3||0
8638017|NCT00572936|9678270|FG001|NOT COMPLETED|Second Intervention||0
8638018|NCT00572936|9678271|FG002|NOT COMPLETED|Second Intervention||0
8638019|NCT00572936|9678272|FG003|NOT COMPLETED|Second Intervention||0
9018769|NCT03076970|10081347|FG001|NOT COMPLETED|Washout Period 3||0
9018770|NCT03076970|10081348|FG002|NOT COMPLETED|Washout Period 3||0
9018771|NCT03076970|10081349|FG003|NOT COMPLETED|Washout Period 3||0
9018772|NCT03076970|10081350|FG004|NOT COMPLETED|Washout Period 3||0
9018773|NCT03076970|10081351|FG005|NOT COMPLETED|Washout Period 3||0
9018774|NCT03076983|10081364|FG000|STARTED|Overall Study||55
8638020|NCT00572936|9678273|FG004|NOT COMPLETED|Second Intervention||0
8638021|NCT00572936|9678274|FG005|NOT COMPLETED|Second Intervention||0
8638022|NCT00572936|9678269|FG000|STARTED|Third Intervention||4
8638023|NCT00572936|9678270|FG001|STARTED|Third Intervention||3
8638024|NCT00572936|9678271|FG002|STARTED|Third Intervention||4
8638025|NCT00572936|9678272|FG003|STARTED|Third Intervention||5
8638026|NCT00572936|9678273|FG004|STARTED|Third Intervention|1 participant dropped out between second intervention and third intervention due to increased IOP|3
8638027|NCT00572936|9678274|FG005|STARTED|Third Intervention||5
8638028|NCT00572936|9678269|FG000|COMPLETED|Third Intervention||4
8638029|NCT00572936|9678270|FG001|COMPLETED|Third Intervention||3
8638030|NCT00572936|9678271|FG002|COMPLETED|Third Intervention||4
8638031|NCT00572936|9678272|FG003|COMPLETED|Third Intervention||5
8638032|NCT00572936|9678273|FG004|COMPLETED|Third Intervention||3
8638033|NCT00572936|9678274|FG005|COMPLETED|Third Intervention||5
8638034|NCT00572936|9678269|FG000|NOT COMPLETED|Third Intervention||0
8638035|NCT00572936|9678270|FG001|NOT COMPLETED|Third Intervention||0
8638036|NCT00572936|9678271|FG002|NOT COMPLETED|Third Intervention||0
8638037|NCT00572936|9678272|FG003|NOT COMPLETED|Third Intervention||0
8638038|NCT00572936|9678273|FG004|NOT COMPLETED|Third Intervention||0
8638039|NCT00572936|9678274|FG005|NOT COMPLETED|Third Intervention||0
8638040|NCT00573066|9678282|FG000|STARTED|Overall Study||56
8638041|NCT00573066|9678282|FG000|COMPLETED|Overall Study||36
8638042|NCT00573066|9678282|FG000|NOT COMPLETED|Overall Study||20
8638043|NCT00573144|9678288|FG000|STARTED|Overall Study||30
8638044|NCT00573144|9678289|FG001|STARTED|Overall Study||28
8638045|NCT00573144|9678288|FG000|COMPLETED|Overall Study||28
8638046|NCT00573144|9678289|FG001|COMPLETED|Overall Study||25
8638047|NCT00573144|9678288|FG000|NOT COMPLETED|Overall Study||2
8638048|NCT00573144|9678289|FG001|NOT COMPLETED|Overall Study||3
8638049|NCT00573170|9678295|FG000|STARTED|First Treatment Period||64
8638050|NCT00573170|9678296|FG001|STARTED|First Treatment Period||60
8638051|NCT00573170|9678297|FG002|STARTED|First Treatment Period||60
8638052|NCT00573170|9678298|FG003|STARTED|First Treatment Period||66
8638053|NCT00573170|9678299|FG004|STARTED|First Treatment Period||63
8638054|NCT00573170|9678300|FG005|STARTED|First Treatment Period||62
8638055|NCT00573170|9678295|FG000|COMPLETED|First Treatment Period||64
8638056|NCT00573170|9678296|FG001|COMPLETED|First Treatment Period||60
8638057|NCT00573170|9678297|FG002|COMPLETED|First Treatment Period||60
8638058|NCT00573170|9678298|FG003|COMPLETED|First Treatment Period||66
8638059|NCT00573170|9678299|FG004|COMPLETED|First Treatment Period||62
8638060|NCT00573170|9678300|FG005|COMPLETED|First Treatment Period||62
8638061|NCT00573170|9678295|FG000|NOT COMPLETED|First Treatment Period||0
8638062|NCT00573170|9678296|FG001|NOT COMPLETED|First Treatment Period||0
8638063|NCT00573170|9678297|FG002|NOT COMPLETED|First Treatment Period||0
8638064|NCT00573170|9678298|FG003|NOT COMPLETED|First Treatment Period||0
8638065|NCT00573170|9678299|FG004|NOT COMPLETED|First Treatment Period||1
8638066|NCT00573170|9678300|FG005|NOT COMPLETED|First Treatment Period||0
8638067|NCT00573170|9678295|FG000|STARTED|First Washout Period||64
8638068|NCT00573170|9678296|FG001|STARTED|First Washout Period||60
8638069|NCT00573170|9678297|FG002|STARTED|First Washout Period||60
9018775|NCT03076983|10081365|FG001|STARTED|Overall Study||25
9018776|NCT03076983|10081364|FG000|COMPLETED|Overall Study||55
9018777|NCT03076983|10081365|FG001|COMPLETED|Overall Study||25
9018778|NCT03076983|10081364|FG000|NOT COMPLETED|Overall Study||0
9018779|NCT03076983|10081365|FG001|NOT COMPLETED|Overall Study||0
8638070|NCT00573170|9678298|FG003|STARTED|First Washout Period||66
9018780|NCT03076996|10081371|FG000|STARTED|Overall Study||41
9018781|NCT03076996|10081371|FG000|COMPLETED|Overall Study||35
9018782|NCT03076996|10081371|FG000|NOT COMPLETED|Overall Study||6
9018783|NCT03077165|10081381|FG000|STARTED|Overall Study||21
9018784|NCT03077165|10081382|FG001|STARTED|Overall Study||22
9018785|NCT03077165|10081383|FG002|STARTED|Overall Study||20
9018786|NCT03077165|10081384|FG003|STARTED|Overall Study||19
9018787|NCT03077165|10081385|FG004|STARTED|Overall Study||19
9018788|NCT03077165|10081386|FG005|STARTED|Overall Study||20
9018789|NCT03077165|10081381|FG000|COMPLETED|Overall Study||20
9018790|NCT03077165|10081382|FG001|COMPLETED|Overall Study||22
9018791|NCT03077165|10081383|FG002|COMPLETED|Overall Study||20
9018792|NCT03077165|10081384|FG003|COMPLETED|Overall Study||19
9018793|NCT03077165|10081385|FG004|COMPLETED|Overall Study||16
9018794|NCT03077165|10081386|FG005|COMPLETED|Overall Study||20
9018795|NCT03077165|10081381|FG000|NOT COMPLETED|Overall Study||1
9018796|NCT03077165|10081382|FG001|NOT COMPLETED|Overall Study||0
9018797|NCT03077165|10081383|FG002|NOT COMPLETED|Overall Study||0
9018798|NCT03077165|10081384|FG003|NOT COMPLETED|Overall Study||0
9018799|NCT03077165|10081385|FG004|NOT COMPLETED|Overall Study||3
9018800|NCT03077165|10081386|FG005|NOT COMPLETED|Overall Study||0
9018801|NCT03077607|10081402|FG000|STARTED|Period 1 (15 Days)||19
9018802|NCT03077607|10081403|FG001|STARTED|Period 1 (15 Days)||17
9018803|NCT03077607|10081402|FG000|Treated (With Any Study Drug)|Period 1 (15 Days)||19
9018804|NCT03077607|10081403|FG001|Treated (With Any Study Drug)|Period 1 (15 Days)||17
9018805|NCT03077607|10081402|FG000|Received Talazoparib|Period 1 (15 Days)||19
9018806|NCT03077607|10081403|FG001|Received Talazoparib|Period 1 (15 Days)||17
9018807|NCT03077607|10081402|FG000|COMPLETED|Period 1 (15 Days)||17
9018808|NCT03077607|10081403|FG001|COMPLETED|Period 1 (15 Days)||17
9018809|NCT03077607|10081402|FG000|NOT COMPLETED|Period 1 (15 Days)||2
9018810|NCT03077607|10081403|FG001|NOT COMPLETED|Period 1 (15 Days)||0
9018811|NCT03077607|10081402|FG000|STARTED|Period 2 (Arm A:21 Days; Arm B:23 Days)||17
9018812|NCT03077607|10081403|FG001|STARTED|Period 2 (Arm A:21 Days; Arm B:23 Days)||17
9018813|NCT03077607|10081402|FG000|Treated (With Any Study Drug)|Period 2 (Arm A:21 Days; Arm B:23 Days)||17
9018814|NCT03077607|10081403|FG001|Treated (With Any Study Drug)|Period 2 (Arm A:21 Days; Arm B:23 Days)||17
9018815|NCT03077607|10081402|FG000|Received Talazoparib|Period 2 (Arm A:21 Days; Arm B:23 Days)||15
9018816|NCT03077607|10081403|FG001|Received Talazoparib|Period 2 (Arm A:21 Days; Arm B:23 Days)||15
9018817|NCT03077607|10081402|FG000|COMPLETED|Period 2 (Arm A:21 Days; Arm B:23 Days)||14
9018818|NCT03077607|10081403|FG001|COMPLETED|Period 2 (Arm A:21 Days; Arm B:23 Days)||15
9018819|NCT03077607|10081402|FG000|NOT COMPLETED|Period 2 (Arm A:21 Days; Arm B:23 Days)||3
9018820|NCT03077607|10081403|FG001|NOT COMPLETED|Period 2 (Arm A:21 Days; Arm B:23 Days)||2
9018821|NCT03077646|10081423|FG000|STARTED|Overall Study||76
9018822|NCT03077646|10081424|FG001|STARTED|Overall Study||75
9018823|NCT03077646|10081425|FG002|STARTED|Overall Study||74
9018824|NCT03077646|10081423|FG000|COMPLETED|Overall Study|Of these 47, there were 25 paired samples for primary outcome|47
9018825|NCT03077646|10081424|FG001|COMPLETED|Overall Study|Of these 45, there were 27 paired samples for primary outcome|45
9018826|NCT03077646|10081425|FG002|COMPLETED|Overall Study|Of these 43, there were 20 paired samples for primary outcome|43
9018827|NCT03077646|10081423|FG000|NOT COMPLETED|Overall Study||29
9018828|NCT03077646|10081424|FG001|NOT COMPLETED|Overall Study||30
9018829|NCT03077646|10081425|FG002|NOT COMPLETED|Overall Study||31
9018830|NCT03077659|10081436|FG000|STARTED|Overall Study||3
9018831|NCT03077659|10081437|FG001|STARTED|Overall Study||3
9018832|NCT03077659|10081438|FG002|STARTED|Overall Study||10
9018833|NCT03077659|10081436|FG000|COMPLETED|Overall Study||3
9018834|NCT03077659|10081437|FG001|COMPLETED|Overall Study||3
9018835|NCT03077659|10081438|FG002|COMPLETED|Overall Study||9
9018836|NCT03077659|10081436|FG000|NOT COMPLETED|Overall Study||0
9018837|NCT03077659|10081437|FG001|NOT COMPLETED|Overall Study||0
9018838|NCT03077659|10081438|FG002|NOT COMPLETED|Overall Study||1
9018839|NCT03077711|10081451|FG000|STARTED|Overall Study||47
9018840|NCT03077711|10081452|FG001|STARTED|Overall Study||45
9018841|NCT03077711|10081451|FG000|COMPLETED|Overall Study||43
9018842|NCT03077711|10081452|FG001|COMPLETED|Overall Study||43
9018843|NCT03077711|10081451|FG000|NOT COMPLETED|Overall Study||4
9018844|NCT03077711|10081452|FG001|NOT COMPLETED|Overall Study||2
9018845|NCT03077724|10081462|FG000|STARTED|Overall Study||14
9018846|NCT03077724|10081463|FG001|STARTED|Overall Study||14
9018847|NCT03077724|10081462|FG000|COMPLETED|Overall Study||6
9018848|NCT03077724|10081463|FG001|COMPLETED|Overall Study||12
9018849|NCT03077724|10081462|FG000|NOT COMPLETED|Overall Study||8
9018850|NCT03077724|10081463|FG001|NOT COMPLETED|Overall Study||2
9018851|NCT03077893|10081471|FG000|STARTED|Overall Study||18
9018852|NCT03077893|10081472|FG001|STARTED|Overall Study||19
9018853|NCT03077893|10081471|FG000|COMPLETED|Overall Study||14
9018854|NCT03077893|10081472|FG001|COMPLETED|Overall Study||16
9018855|NCT03077893|10081471|FG000|NOT COMPLETED|Overall Study||4
9018856|NCT03077893|10081472|FG001|NOT COMPLETED|Overall Study||3
9018857|NCT03077919|10081481|FG000|STARTED|Overall Study||74
9018858|NCT03077919|10081482|FG001|STARTED|Overall Study||39
9018859|NCT03077919|10081481|FG000|Week 2 Visit|Overall Study||74
9018860|NCT03077919|10081482|FG001|Week 2 Visit|Overall Study||39
9018861|NCT03077919|10081481|FG000|Week 4 Visit|Overall Study||73
9018862|NCT03077919|10081482|FG001|Week 4 Visit|Overall Study||38
9018863|NCT03077919|10081481|FG000|Week 6 Visit|Overall Study||73
9018864|NCT03077919|10081482|FG001|Week 6 Visit|Overall Study||38
9018865|NCT03077919|10081481|FG000|Week 8 Visit|Overall Study||71
9018866|NCT03077919|10081482|FG001|Week 8 Visit|Overall Study||38
9018867|NCT03077919|10081481|FG000|Final CAPS|Overall Study||70
9018868|NCT03077919|10081482|FG001|Final CAPS|Overall Study||38
9018869|NCT03077919|10081481|FG000|COMPLETED|Overall Study||70
9018870|NCT03077919|10081482|FG001|COMPLETED|Overall Study||38
9018871|NCT03077919|10081481|FG000|NOT COMPLETED|Overall Study||4
9018872|NCT03077919|10081482|FG001|NOT COMPLETED|Overall Study||1
9018873|NCT03078075|10081490|FG000|STARTED|Overall Study||111
9018874|NCT03078075|10081491|FG001|STARTED|Overall Study||114
9018875|NCT03078075|10081492|FG002|STARTED|Overall Study||59
9018876|NCT03078075|10081493|FG003|STARTED|Overall Study||10
9018877|NCT03078075|10081494|FG004|STARTED|Overall Study||109
9018878|NCT03078075|10081490|FG000|COMPLETED|Overall Study||106
9018879|NCT03078075|10081491|FG001|COMPLETED|Overall Study||103
9018880|NCT03078075|10081492|FG002|COMPLETED|Overall Study||19
9018881|NCT03078075|10081493|FG003|COMPLETED|Overall Study||9
9018882|NCT03078075|10081494|FG004|COMPLETED|Overall Study||78
9018883|NCT03078075|10081490|FG000|NOT COMPLETED|Overall Study||5
9018884|NCT03078075|10081491|FG001|NOT COMPLETED|Overall Study||11
9018885|NCT03078075|10081492|FG002|NOT COMPLETED|Overall Study||40
9018886|NCT03078075|10081493|FG003|NOT COMPLETED|Overall Study||1
9018887|NCT03078075|10081494|FG004|NOT COMPLETED|Overall Study||31
9018888|NCT03078127|10081520|FG000|STARTED|First Intervention||4
9018889|NCT03078127|10081521|FG001|STARTED|First Intervention||3
9018890|NCT03078127|10081522|FG002|STARTED|First Intervention||3
9018891|NCT03078127|10081520|FG000|COMPLETED|First Intervention||4
9018892|NCT03078127|10081521|FG001|COMPLETED|First Intervention||3
9018893|NCT03078127|10081522|FG002|COMPLETED|First Intervention||3
9018894|NCT03078127|10081520|FG000|NOT COMPLETED|First Intervention||0
9018895|NCT03078127|10081521|FG001|NOT COMPLETED|First Intervention||0
9018896|NCT03078127|10081522|FG002|NOT COMPLETED|First Intervention||0
9018897|NCT03078127|10081520|FG000|STARTED|Washout (3-21 Days)||4
8638071|NCT00573170|9678299|FG004|STARTED|First Washout Period||62
8638072|NCT00573170|9678300|FG005|STARTED|First Washout Period||62
8638073|NCT00573170|9678295|FG000|COMPLETED|First Washout Period||56
8638074|NCT00573170|9678296|FG001|COMPLETED|First Washout Period||58
8638075|NCT00573170|9678297|FG002|COMPLETED|First Washout Period||59
8638076|NCT00573170|9678298|FG003|COMPLETED|First Washout Period||61
8638077|NCT00573170|9678299|FG004|COMPLETED|First Washout Period|Source data list 4 noncompleters; per number starting next period, there were only 3 noncompleters.|59
8638078|NCT00573170|9678300|FG005|COMPLETED|First Washout Period||55
8638079|NCT00573170|9678295|FG000|NOT COMPLETED|First Washout Period||8
8638080|NCT00573170|9678296|FG001|NOT COMPLETED|First Washout Period||2
8638081|NCT00573170|9678297|FG002|NOT COMPLETED|First Washout Period||1
8638082|NCT00573170|9678298|FG003|NOT COMPLETED|First Washout Period||5
8638083|NCT00573170|9678299|FG004|NOT COMPLETED|First Washout Period||3
8638084|NCT00573170|9678300|FG005|NOT COMPLETED|First Washout Period||7
8638085|NCT00573170|9678295|FG000|STARTED|Second Treatment Period||56
8638086|NCT00573170|9678296|FG001|STARTED|Second Treatment Period||58
8638087|NCT00573170|9678297|FG002|STARTED|Second Treatment Period||59
8638088|NCT00573170|9678298|FG003|STARTED|Second Treatment Period||61
8638089|NCT00573170|9678299|FG004|STARTED|Second Treatment Period||59
8638090|NCT00573170|9678300|FG005|STARTED|Second Treatment Period||55
8638091|NCT00573170|9678295|FG000|COMPLETED|Second Treatment Period||56
8638092|NCT00573170|9678296|FG001|COMPLETED|Second Treatment Period||58
8638093|NCT00573170|9678297|FG002|COMPLETED|Second Treatment Period||59
8638094|NCT00573170|9678298|FG003|COMPLETED|Second Treatment Period||61
8638095|NCT00573170|9678299|FG004|COMPLETED|Second Treatment Period||59
8638096|NCT00573170|9678300|FG005|COMPLETED|Second Treatment Period||55
8638097|NCT00573170|9678295|FG000|NOT COMPLETED|Second Treatment Period||0
8638098|NCT00573170|9678296|FG001|NOT COMPLETED|Second Treatment Period||0
8638099|NCT00573170|9678297|FG002|NOT COMPLETED|Second Treatment Period||0
8638100|NCT00573170|9678298|FG003|NOT COMPLETED|Second Treatment Period||0
8638101|NCT00573170|9678299|FG004|NOT COMPLETED|Second Treatment Period||0
8638102|NCT00573170|9678300|FG005|NOT COMPLETED|Second Treatment Period||0
8638103|NCT00573170|9678295|FG000|STARTED|Second Washout Period||56
8638104|NCT00573170|9678296|FG001|STARTED|Second Washout Period||58
8638105|NCT00573170|9678297|FG002|STARTED|Second Washout Period||59
8638106|NCT00573170|9678298|FG003|STARTED|Second Washout Period||61
8638107|NCT00573170|9678299|FG004|STARTED|Second Washout Period||59
8638108|NCT00573170|9678300|FG005|STARTED|Second Washout Period||55
8638109|NCT00573170|9678295|FG000|COMPLETED|Second Washout Period||51
8638110|NCT00573170|9678296|FG001|COMPLETED|Second Washout Period||54
8638111|NCT00573170|9678297|FG002|COMPLETED|Second Washout Period||55
8638112|NCT00573170|9678298|FG003|COMPLETED|Second Washout Period||56
8638113|NCT00573170|9678299|FG004|COMPLETED|Second Washout Period||51
8638114|NCT00573170|9678300|FG005|COMPLETED|Second Washout Period||53
8638115|NCT00573170|9678295|FG000|NOT COMPLETED|Second Washout Period||5
8638116|NCT00573170|9678296|FG001|NOT COMPLETED|Second Washout Period||4
8638117|NCT00573170|9678297|FG002|NOT COMPLETED|Second Washout Period||4
8638118|NCT00573170|9678298|FG003|NOT COMPLETED|Second Washout Period||5
8638119|NCT00573170|9678299|FG004|NOT COMPLETED|Second Washout Period||8
9018898|NCT03078127|10081521|FG001|STARTED|Washout (3-21 Days)||3
9018899|NCT03078127|10081522|FG002|STARTED|Washout (3-21 Days)||3
9018900|NCT03078127|10081520|FG000|COMPLETED|Washout (3-21 Days)||4
9018901|NCT03078127|10081521|FG001|COMPLETED|Washout (3-21 Days)||3
9018902|NCT03078127|10081522|FG002|COMPLETED|Washout (3-21 Days)||3
9018903|NCT03078127|10081520|FG000|NOT COMPLETED|Washout (3-21 Days)||0
9018904|NCT03078127|10081521|FG001|NOT COMPLETED|Washout (3-21 Days)||0
8638120|NCT00573170|9678300|FG005|NOT COMPLETED|Second Washout Period||2
8638121|NCT00573170|9678295|FG000|STARTED|Third Treatment Period||51
8638122|NCT00573170|9678296|FG001|STARTED|Third Treatment Period||54
8638123|NCT00573170|9678297|FG002|STARTED|Third Treatment Period||55
8638124|NCT00573170|9678298|FG003|STARTED|Third Treatment Period||56
8638125|NCT00573170|9678299|FG004|STARTED|Third Treatment Period||51
8638126|NCT00573170|9678300|FG005|STARTED|Third Treatment Period||53
8638127|NCT00573170|9678295|FG000|COMPLETED|Third Treatment Period||50
8638128|NCT00573170|9678296|FG001|COMPLETED|Third Treatment Period||54
8638129|NCT00573170|9678297|FG002|COMPLETED|Third Treatment Period||55
8638130|NCT00573170|9678298|FG003|COMPLETED|Third Treatment Period||56
8638131|NCT00573170|9678299|FG004|COMPLETED|Third Treatment Period||51
8638132|NCT00573170|9678300|FG005|COMPLETED|Third Treatment Period||51
8638133|NCT00573170|9678295|FG000|NOT COMPLETED|Third Treatment Period||1
8638134|NCT00573170|9678296|FG001|NOT COMPLETED|Third Treatment Period||0
8638135|NCT00573170|9678297|FG002|NOT COMPLETED|Third Treatment Period||0
8638136|NCT00573170|9678298|FG003|NOT COMPLETED|Third Treatment Period||0
8638137|NCT00573170|9678299|FG004|NOT COMPLETED|Third Treatment Period||0
8638138|NCT00573170|9678300|FG005|NOT COMPLETED|Third Treatment Period||2
8638139|NCT00573183|9678319|FG000|STARTED|Overall Study||234
8638140|NCT00573183|9678320|FG001|STARTED|Overall Study||237
8638141|NCT00573183|9678319|FG000|COMPLETED|Overall Study||162
8638142|NCT00573183|9678320|FG001|COMPLETED|Overall Study||174
8638143|NCT00573183|9678319|FG000|NOT COMPLETED|Overall Study||72
8638144|NCT00573183|9678320|FG001|NOT COMPLETED|Overall Study||63
8638145|NCT00573248|9678330|FG000|STARTED|Overall Study||40
8638146|NCT00573248|9678331|FG001|STARTED|Overall Study||38
8638147|NCT00573248|9678330|FG000|Nicotine Patches and Placebo Patches|Overall Study||25
8638148|NCT00573248|9678331|FG001|Nicotine Patches and Placebo Patches|Overall Study||27
8638149|NCT00573248|9678330|FG000|COMPLETED|Overall Study||25
8638150|NCT00573248|9678331|FG001|COMPLETED|Overall Study||27
8638151|NCT00573248|9678330|FG000|NOT COMPLETED|Overall Study||15
8638152|NCT00573248|9678331|FG001|NOT COMPLETED|Overall Study||11
8638153|NCT00573261|9678339|FG000|STARTED|Overall Study||20
8638154|NCT00573261|9678340|FG001|STARTED|Overall Study||20
8638155|NCT00573261|9678339|FG000|COMPLETED|Overall Study||14
8638156|NCT00573261|9678340|FG001|COMPLETED|Overall Study||15
8638157|NCT00573261|9678339|FG000|NOT COMPLETED|Overall Study||6
8638158|NCT00573261|9678340|FG001|NOT COMPLETED|Overall Study||5
8638159|NCT00573287|9678350|FG000|STARTED|Overall Study||7
8638160|NCT00573287|9678351|FG001|STARTED|Overall Study||7
8638161|NCT00573287|9678350|FG000|COMPLETED|Overall Study||3
8638162|NCT00573287|9678351|FG001|COMPLETED|Overall Study||4
8638163|NCT00573287|9678350|FG000|NOT COMPLETED|Overall Study||4
8638164|NCT00573287|9678351|FG001|NOT COMPLETED|Overall Study||3
8638165|NCT00573313|9678361|FG000|STARTED|Overall Study|Eighteen participants recruited to start.|18
8638166|NCT00573313|9678362|FG001|STARTED|Overall Study||28
8638167|NCT00573313|9678363|FG002|STARTED|Overall Study|Nineteen recruited to start.|19
8638168|NCT00573313|9678364|FG003|STARTED|Overall Study||26
8638169|NCT00573313|9678361|FG000|COMPLETED|Overall Study||13
8638170|NCT00573313|9678362|FG001|COMPLETED|Overall Study||28
8638171|NCT00573313|9678363|FG002|COMPLETED|Overall Study||13
8638172|NCT00573313|9678364|FG003|COMPLETED|Overall Study||26
8638173|NCT00573313|9678361|FG000|NOT COMPLETED|Overall Study||5
8638174|NCT00573313|9678362|FG001|NOT COMPLETED|Overall Study||0
8638175|NCT00573313|9678363|FG002|NOT COMPLETED|Overall Study||6
8638176|NCT00573313|9678364|FG003|NOT COMPLETED|Overall Study||0
8638177|NCT00573430|9678374|FG000|STARTED|Overall Study|randomized|40
8638178|NCT00573430|9678375|FG001|STARTED|Overall Study|randomized|45
8638179|NCT00573430|9678376|FG002|STARTED|Overall Study|randomized|43
8638180|NCT00573430|9678374|FG000|COMPLETED|Overall Study||39
8638181|NCT00573430|9678375|FG001|COMPLETED|Overall Study||40
8638182|NCT00573430|9678376|FG002|COMPLETED|Overall Study||33
8638183|NCT00573430|9678374|FG000|NOT COMPLETED|Overall Study||1
8638184|NCT00573430|9678375|FG001|NOT COMPLETED|Overall Study||5
8638185|NCT00573430|9678376|FG002|NOT COMPLETED|Overall Study||10
8638186|NCT00573443|9678387|FG000|STARTED|Double-Blind Phase||110
8638187|NCT00573443|9678388|FG001|STARTED|Double-Blind Phase||107
8638188|NCT00573443|9678389|FG002|STARTED|Double-Blind Phase||109
8638189|NCT00573443|9678387|FG000|Subjects With PBA Secondary to ALS|Double-Blind Phase||65
8638190|NCT00573443|9678388|FG001|Subjects With PBA Secondary to ALS|Double-Blind Phase||68
8638191|NCT00573443|9678389|FG002|Subjects With PBA Secondary to ALS|Double-Blind Phase||64
8638192|NCT00573443|9678387|FG000|Subjects With PBA Secondary to MS|Double-Blind Phase||45
8638193|NCT00573443|9678388|FG001|Subjects With PBA Secondary to MS|Double-Blind Phase||39
8638194|NCT00573443|9678389|FG002|Subjects With PBA Secondary to MS|Double-Blind Phase||45
8638195|NCT00573443|9678387|FG000|COMPLETED|Double-Blind Phase||101
8638196|NCT00573443|9678388|FG001|COMPLETED|Double-Blind Phase||88
8638197|NCT00573443|9678389|FG002|COMPLETED|Double-Blind Phase||94
8638198|NCT00573443|9678387|FG000|NOT COMPLETED|Double-Blind Phase||9
8727128|NCT01041859|9774549|FG000|NOT COMPLETED|Double-Blind Maintenance||0
8638199|NCT00573443|9678388|FG001|NOT COMPLETED|Double-Blind Phase||19
8638200|NCT00573443|9678389|FG002|NOT COMPLETED|Double-Blind Phase||15
8638201|NCT00573443|9678387|FG000|STARTED|Open-Label Extension Phase|Subjects who completed any of the arms in the DB phase had the option to enroll in this OLE phase|253
9018905|NCT03078127|10081522|FG002|NOT COMPLETED|Washout (3-21 Days)||0
9018906|NCT03078127|10081520|FG000|STARTED|Second Intervention||4
9018907|NCT03078127|10081521|FG001|STARTED|Second Intervention||3
9018908|NCT03078127|10081522|FG002|STARTED|Second Intervention||3
9018909|NCT03078127|10081520|FG000|COMPLETED|Second Intervention||4
9018910|NCT03078127|10081521|FG001|COMPLETED|Second Intervention||3
9018911|NCT03078127|10081522|FG002|COMPLETED|Second Intervention||3
9018912|NCT03078127|10081520|FG000|NOT COMPLETED|Second Intervention||0
9018913|NCT03078127|10081521|FG001|NOT COMPLETED|Second Intervention||0
9018914|NCT03078127|10081522|FG002|NOT COMPLETED|Second Intervention||0
9018915|NCT03078127|10081520|FG000|STARTED|Washout (3-21 Days)||4
9018916|NCT03078127|10081521|FG001|STARTED|Washout (3-21 Days)||3
9018917|NCT03078127|10081522|FG002|STARTED|Washout (3-21 Days)||3
9018918|NCT03078127|10081520|FG000|COMPLETED|Washout (3-21 Days)||4
8638202|NCT00573443|9678388|FG001|STARTED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
8638203|NCT00573443|9678389|FG002|STARTED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
8638204|NCT00573443|9678387|FG000|Subjects With PBA Secondary to ALS|Open-Label Extension Phase||146
8638205|NCT00573443|9678388|FG001|Subjects With PBA Secondary to ALS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
8638206|NCT00573443|9678389|FG002|Subjects With PBA Secondary to ALS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
8638207|NCT00573443|9678387|FG000|Subjects With PBA Secondary to MS|Open-Label Extension Phase||107
8638208|NCT00573443|9678388|FG001|Subjects With PBA Secondary to MS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
8638209|NCT00573443|9678389|FG002|Subjects With PBA Secondary to MS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
8638210|NCT00573443|9678387|FG000|COMPLETED|Open-Label Extension Phase||235
8638211|NCT00573443|9678388|FG001|COMPLETED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
8638212|NCT00573443|9678389|FG002|COMPLETED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
8638213|NCT00573443|9678387|FG000|NOT COMPLETED|Open-Label Extension Phase||18
8638214|NCT00573443|9678388|FG001|NOT COMPLETED|Open-Label Extension Phase||0
8638215|NCT00573443|9678389|FG002|NOT COMPLETED|Open-Label Extension Phase||0
8638216|NCT00573469|9678401|FG000|STARTED|Overall Study||26
8727129|NCT01041859|9774550|FG001|NOT COMPLETED|Double-Blind Maintenance||46
9018919|NCT03078127|10081521|FG001|COMPLETED|Washout (3-21 Days)||3
9018920|NCT03078127|10081522|FG002|COMPLETED|Washout (3-21 Days)||3
8638217|NCT00573469|9678402|FG001|STARTED|Overall Study||25
8638218|NCT00573469|9678403|FG002|STARTED|Overall Study||26
8638219|NCT00573469|9678401|FG000|COMPLETED|Overall Study||20
8638220|NCT00573469|9678402|FG001|COMPLETED|Overall Study||21
8638221|NCT00573469|9678403|FG002|COMPLETED|Overall Study||22
8638222|NCT00573469|9678401|FG000|NOT COMPLETED|Overall Study||6
8638223|NCT00573469|9678402|FG001|NOT COMPLETED|Overall Study||4
8638224|NCT00573469|9678403|FG002|NOT COMPLETED|Overall Study||4
8638225|NCT00573508|9678413|FG000|STARTED|Overall Study||382
8638226|NCT00573508|9678414|FG001|STARTED|Overall Study||386
8638227|NCT00573508|9678413|FG000|Full Analysis Set (FAS)|Overall Study|Patients who took >= 1 dose of double-blind study drug, had a baseline OAB-q & >= 1 subsequent visit|374
8638228|NCT00573508|9678414|FG001|Full Analysis Set (FAS)|Overall Study|Patients who took >= 1 dose of double-blind study drug, had a baseline OAB-q & >= 1 subsequent visit|377
8638229|NCT00573508|9678413|FG000|COMPLETED|Overall Study||318
8638230|NCT00573508|9678414|FG001|COMPLETED|Overall Study||345
8638231|NCT00573508|9678413|FG000|NOT COMPLETED|Overall Study||64
8638232|NCT00573508|9678414|FG001|NOT COMPLETED|Overall Study||41
8638233|NCT00573534|9678420|FG000|STARTED|Overall Study||8
8638234|NCT00573534|9678420|FG000|COMPLETED|Overall Study||5
8638235|NCT00573534|9678420|FG000|NOT COMPLETED|Overall Study||3
8638236|NCT00573755|9678427|FG000|STARTED|Overall Study||2
8638237|NCT00573755|9678428|FG001|STARTED|Overall Study||2
8638238|NCT00573755|9678427|FG000|COMPLETED|Overall Study||1
8638239|NCT00573755|9678428|FG001|COMPLETED|Overall Study||2
8638240|NCT00573755|9678427|FG000|NOT COMPLETED|Overall Study||1
8638241|NCT00573755|9678428|FG001|NOT COMPLETED|Overall Study||0
8638242|NCT00573768|9678437|FG000|STARTED|Overall Study||89
8638243|NCT00573768|9678438|FG001|STARTED|Overall Study||91
8638244|NCT00573768|9678439|FG002|STARTED|Overall Study||91
8638245|NCT00573768|9678437|FG000|COMPLETED|Overall Study||87
8638246|NCT00573768|9678438|FG001|COMPLETED|Overall Study||89
8638247|NCT00573768|9678439|FG002|COMPLETED|Overall Study||87
8638248|NCT00573768|9678437|FG000|NOT COMPLETED|Overall Study||2
8638249|NCT00573768|9678438|FG001|NOT COMPLETED|Overall Study||2
8638250|NCT00573768|9678439|FG002|NOT COMPLETED|Overall Study||4
8638251|NCT00573794|9678447|FG000|STARTED|Overall Study||585
8638252|NCT00573794|9678447|FG000|COMPLETED|Overall Study||255
8638253|NCT00573794|9678447|FG000|NOT COMPLETED|Overall Study||330
8638254|NCT00573833|9678451|FG000|STARTED|Overall Study||23
8638255|NCT00573833|9678451|FG000|COMPLETED|Overall Study||21
8638256|NCT00573833|9678451|FG000|NOT COMPLETED|Overall Study||2
8638257|NCT00573859|9678455|FG000|STARTED|Medication Versus Placebo||27
8638258|NCT00573859|9678455|FG000|COMPLETED|Medication Versus Placebo||15
9018921|NCT03078127|10081520|FG000|NOT COMPLETED|Washout (3-21 Days)||0
9018922|NCT03078127|10081521|FG001|NOT COMPLETED|Washout (3-21 Days)||0
9018923|NCT03078127|10081522|FG002|NOT COMPLETED|Washout (3-21 Days)||0
9018924|NCT03078127|10081520|FG000|STARTED|Third Intervention||4
9018925|NCT03078127|10081521|FG001|STARTED|Third Intervention||3
9018926|NCT03078127|10081522|FG002|STARTED|Third Intervention||3
9018927|NCT03078127|10081520|FG000|COMPLETED|Third Intervention||4
9018928|NCT03078127|10081521|FG001|COMPLETED|Third Intervention||3
9018929|NCT03078127|10081522|FG002|COMPLETED|Third Intervention||3
9018930|NCT03078127|10081520|FG000|NOT COMPLETED|Third Intervention||0
9018931|NCT03078127|10081521|FG001|NOT COMPLETED|Third Intervention||0
9018932|NCT03078127|10081522|FG002|NOT COMPLETED|Third Intervention||0
9018933|NCT03078504|10081533|FG000|STARTED|Overall Study||6
9018934|NCT03078504|10081533|FG000|COMPLETED|Overall Study||6
9018935|NCT03078504|10081533|FG000|NOT COMPLETED|Overall Study||0
9018936|NCT03078556|10081539|FG000|STARTED|Treatment Period 1 (4 Days)||39
9018937|NCT03078556|10081540|FG001|STARTED|Treatment Period 1 (4 Days)||39
9018938|NCT03078556|10081541|FG002|STARTED|Treatment Period 1 (4 Days)||38
9018939|NCT03078556|10081542|FG003|STARTED|Treatment Period 1 (4 Days)||38
9018940|NCT03078556|10081539|FG000|COMPLETED|Treatment Period 1 (4 Days)||39
9018941|NCT03078556|10081540|FG001|COMPLETED|Treatment Period 1 (4 Days)||38
9018942|NCT03078556|10081541|FG002|COMPLETED|Treatment Period 1 (4 Days)||38
9018943|NCT03078556|10081542|FG003|COMPLETED|Treatment Period 1 (4 Days)||38
9018944|NCT03078556|10081539|FG000|NOT COMPLETED|Treatment Period 1 (4 Days)||0
9018945|NCT03078556|10081540|FG001|NOT COMPLETED|Treatment Period 1 (4 Days)||1
9018946|NCT03078556|10081541|FG002|NOT COMPLETED|Treatment Period 1 (4 Days)||0
9018947|NCT03078556|10081542|FG003|NOT COMPLETED|Treatment Period 1 (4 Days)||0
9018948|NCT03078556|10081539|FG000|STARTED|Washout Period 1 (7 Days)||39
9018949|NCT03078556|10081540|FG001|STARTED|Washout Period 1 (7 Days)||38
9018950|NCT03078556|10081541|FG002|STARTED|Washout Period 1 (7 Days)||38
9018951|NCT03078556|10081542|FG003|STARTED|Washout Period 1 (7 Days)||38
9018952|NCT03078556|10081539|FG000|COMPLETED|Washout Period 1 (7 Days)||37
9018953|NCT03078556|10081540|FG001|COMPLETED|Washout Period 1 (7 Days)||36
9018954|NCT03078556|10081541|FG002|COMPLETED|Washout Period 1 (7 Days)||37
9018955|NCT03078556|10081542|FG003|COMPLETED|Washout Period 1 (7 Days)||37
9018956|NCT03078556|10081539|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||2
9018957|NCT03078556|10081540|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||2
9018958|NCT03078556|10081541|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||1
9018959|NCT03078556|10081542|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||1
9018960|NCT03078556|10081539|FG000|STARTED|Treatment Period 2 (4 Days)||37
9018961|NCT03078556|10081540|FG001|STARTED|Treatment Period 2 (4 Days)||36
9018962|NCT03078556|10081541|FG002|STARTED|Treatment Period 2 (4 Days)||37
9018963|NCT03078556|10081542|FG003|STARTED|Treatment Period 2 (4 Days)||37
9018964|NCT03078556|10081539|FG000|COMPLETED|Treatment Period 2 (4 Days)||37
9018965|NCT03078556|10081540|FG001|COMPLETED|Treatment Period 2 (4 Days)||36
9018966|NCT03078556|10081541|FG002|COMPLETED|Treatment Period 2 (4 Days)||37
9018967|NCT03078556|10081542|FG003|COMPLETED|Treatment Period 2 (4 Days)||37
9018968|NCT03078556|10081539|FG000|NOT COMPLETED|Treatment Period 2 (4 Days)||0
9018969|NCT03078556|10081540|FG001|NOT COMPLETED|Treatment Period 2 (4 Days)||0
9018970|NCT03078556|10081541|FG002|NOT COMPLETED|Treatment Period 2 (4 Days)||0
9018971|NCT03078556|10081542|FG003|NOT COMPLETED|Treatment Period 2 (4 Days)||0
9018972|NCT03078556|10081539|FG000|STARTED|Washout Period 2 (7 Days)||9
9018973|NCT03078556|10081540|FG001|STARTED|Washout Period 2 (7 Days)||7
9018974|NCT03078556|10081541|FG002|STARTED|Washout Period 2 (7 Days)||7
9018975|NCT03078556|10081542|FG003|STARTED|Washout Period 2 (7 Days)||9
9018976|NCT03078556|10081539|FG000|COMPLETED|Washout Period 2 (7 Days)||9
9018977|NCT03078556|10081540|FG001|COMPLETED|Washout Period 2 (7 Days)||7
8638259|NCT00573859|9678455|FG000|NOT COMPLETED|Medication Versus Placebo||12
8638260|NCT00573859|9678455|FG000|STARTED|Smoking Versus Abstinence||27
8638261|NCT00573859|9678455|FG000|COMPLETED|Smoking Versus Abstinence||15
8638262|NCT00573859|9678455|FG000|NOT COMPLETED|Smoking Versus Abstinence||12
8638263|NCT00573872|9678459|FG000|STARTED|Overall Study|# of patients that signed consent|43
8638264|NCT00573872|9678459|FG000|COMPLETED|Overall Study|# of patients that completed treatment|32
8638265|NCT00573872|9678459|FG000|NOT COMPLETED|Overall Study||11
8638266|NCT00573989|9678463|FG000|STARTED|Erlotinib Phase I||4
8638267|NCT00573989|9678464|FG001|STARTED|Erlotinib Phase I||6
8638268|NCT00573989|9678465|FG002|STARTED|Erlotinib Phase I||5
8638269|NCT00573989|9678466|FG003|STARTED|Erlotinib Phase I||0
8638270|NCT00573989|9678463|FG000|COMPLETED|Erlotinib Phase I||4
8638271|NCT00573989|9678464|FG001|COMPLETED|Erlotinib Phase I||6
8638272|NCT00573989|9678465|FG002|COMPLETED|Erlotinib Phase I||5
8638273|NCT00573989|9678466|FG003|COMPLETED|Erlotinib Phase I||0
8638274|NCT00573989|9678463|FG000|NOT COMPLETED|Erlotinib Phase I||0
8638275|NCT00573989|9678464|FG001|NOT COMPLETED|Erlotinib Phase I||0
8638276|NCT00573989|9678465|FG002|NOT COMPLETED|Erlotinib Phase I||0
8638277|NCT00573989|9678466|FG003|NOT COMPLETED|Erlotinib Phase I||0
8638278|NCT00573989|9678463|FG000|STARTED|Erlotinib 125mg- Phase II||0
8638279|NCT00573989|9678464|FG001|STARTED|Erlotinib 125mg- Phase II||0
8638280|NCT00573989|9678465|FG002|STARTED|Erlotinib 125mg- Phase II||0
8638281|NCT00573989|9678466|FG003|STARTED|Erlotinib 125mg- Phase II||12
9018978|NCT03078556|10081541|FG002|COMPLETED|Washout Period 2 (7 Days)||7
8638282|NCT00573989|9678463|FG000|COMPLETED|Erlotinib 125mg- Phase II||0
8638283|NCT00573989|9678464|FG001|COMPLETED|Erlotinib 125mg- Phase II||0
8638284|NCT00573989|9678465|FG002|COMPLETED|Erlotinib 125mg- Phase II||0
8638285|NCT00573989|9678466|FG003|COMPLETED|Erlotinib 125mg- Phase II||12
9018979|NCT03078556|10081542|FG003|COMPLETED|Washout Period 2 (7 Days)||9
9018980|NCT03078556|10081539|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
9018981|NCT03078556|10081540|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
9018982|NCT03078556|10081541|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
9018983|NCT03078556|10081542|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
9018984|NCT03078556|10081539|FG000|STARTED|Treatment Period 3 (4 Days)||9
9018985|NCT03078556|10081540|FG001|STARTED|Treatment Period 3 (4 Days)||7
9018986|NCT03078556|10081541|FG002|STARTED|Treatment Period 3 (4 Days)||7
9018987|NCT03078556|10081542|FG003|STARTED|Treatment Period 3 (4 Days)||9
9018988|NCT03078556|10081539|FG000|COMPLETED|Treatment Period 3 (4 Days)||9
9018989|NCT03078556|10081540|FG001|COMPLETED|Treatment Period 3 (4 Days)||7
9018990|NCT03078556|10081541|FG002|COMPLETED|Treatment Period 3 (4 Days)||7
9018991|NCT03078556|10081542|FG003|COMPLETED|Treatment Period 3 (4 Days)||9
9018992|NCT03078556|10081539|FG000|NOT COMPLETED|Treatment Period 3 (4 Days)||0
9018993|NCT03078556|10081540|FG001|NOT COMPLETED|Treatment Period 3 (4 Days)||0
9018994|NCT03078556|10081541|FG002|NOT COMPLETED|Treatment Period 3 (4 Days)||0
9018995|NCT03078556|10081542|FG003|NOT COMPLETED|Treatment Period 3 (4 Days)||0
9018996|NCT03078582|10081569|FG000|STARTED|Overall Study||10
9018997|NCT03078582|10081570|FG001|STARTED|Overall Study||16
9018998|NCT03078582|10081569|FG000|COMPLETED|Overall Study||10
9018999|NCT03078582|10081570|FG001|COMPLETED|Overall Study||8
9019000|NCT03078582|10081569|FG000|NOT COMPLETED|Overall Study||0
9019001|NCT03078582|10081570|FG001|NOT COMPLETED|Overall Study||8
9019002|NCT03078595|10081578|FG000|STARTED|Overall Study||24
9019003|NCT03078595|10081579|FG001|STARTED|Overall Study||24
9019004|NCT03078595|10081578|FG000|COMPLETED|Overall Study||24
9019005|NCT03078595|10081579|FG001|COMPLETED|Overall Study||24
9019006|NCT03078595|10081578|FG000|NOT COMPLETED|Overall Study||0
9019007|NCT03078595|10081579|FG001|NOT COMPLETED|Overall Study||0
9019008|NCT03078647|10081588|FG000|STARTED|Overall Study||17
9019009|NCT03078647|10081589|FG001|STARTED|Overall Study||11
9019010|NCT03078647|10081590|FG002|STARTED|Overall Study||3
9019011|NCT03078647|10081588|FG000|COMPLETED|Overall Study||17
9019012|NCT03078647|10081589|FG001|COMPLETED|Overall Study||10
9019013|NCT03078647|10081590|FG002|COMPLETED|Overall Study||3
9019014|NCT03078647|10081588|FG000|NOT COMPLETED|Overall Study||0
9019015|NCT03078647|10081589|FG001|NOT COMPLETED|Overall Study||1
9019016|NCT03078647|10081590|FG002|NOT COMPLETED|Overall Study||0
9019017|NCT03078751|10081600|FG000|STARTED|Overall Study||26
9019018|NCT03078751|10081601|FG001|STARTED|Overall Study||28
9019019|NCT03078751|10081600|FG000|Untreated Participants|Overall Study||0
9019020|NCT03078751|10081601|FG001|Untreated Participants|Overall Study||4
9019021|NCT03078751|10081600|FG000|Safety Set|Overall Study||26
9019022|NCT03078751|10081601|FG001|Safety Set|Overall Study||24
9019023|NCT03078751|10081600|FG000|COMPLETED|Overall Study||13
9019024|NCT03078751|10081601|FG001|COMPLETED|Overall Study||0
9019025|NCT03078751|10081600|FG000|NOT COMPLETED|Overall Study||13
9019026|NCT03078751|10081601|FG001|NOT COMPLETED|Overall Study||28
9019027|NCT03078816|10081607|FG000|STARTED|Overall Study||5
9019028|NCT03078816|10081607|FG000|COMPLETED|Overall Study||4
9019029|NCT03078816|10081607|FG000|NOT COMPLETED|Overall Study||1
9019030|NCT03078907|10081613|FG000|STARTED|Overall Study||53
9019031|NCT03078907|10081614|FG001|STARTED|Overall Study||55
9019032|NCT03078907|10081613|FG000|COMPLETED|Overall Study||50
9019033|NCT03078907|10081614|FG001|COMPLETED|Overall Study||54
9019034|NCT03078907|10081613|FG000|NOT COMPLETED|Overall Study||3
9019035|NCT03078907|10081614|FG001|NOT COMPLETED|Overall Study||1
9019036|NCT03078946|10081622|FG000|STARTED|Overall Study||30
9019037|NCT03078946|10081623|FG001|STARTED|Overall Study||30
9019038|NCT03078946|10081622|FG000|COMPLETED|Overall Study||30
9019039|NCT03078946|10081623|FG001|COMPLETED|Overall Study||30
9019040|NCT03078946|10081622|FG000|NOT COMPLETED|Overall Study||0
9019041|NCT03078946|10081623|FG001|NOT COMPLETED|Overall Study||0
9019042|NCT03079375|10081632|FG000|STARTED|Overall Study||503
9019043|NCT03079375|10081633|FG001|STARTED|Overall Study||499
9019044|NCT03079375|10081634|FG002|STARTED|Overall Study||497
9019045|NCT03079375|10081632|FG000|COMPLETED|Overall Study||498
9019046|NCT03079375|10081633|FG001|COMPLETED|Overall Study||493
9019047|NCT03079375|10081634|FG002|COMPLETED|Overall Study||476
9019048|NCT03079375|10081632|FG000|NOT COMPLETED|Overall Study||5
8638286|NCT00573989|9678463|FG000|NOT COMPLETED|Erlotinib 125mg- Phase II||0
8638287|NCT00573989|9678464|FG001|NOT COMPLETED|Erlotinib 125mg- Phase II||0
8638288|NCT00573989|9678465|FG002|NOT COMPLETED|Erlotinib 125mg- Phase II||0
8638289|NCT00573989|9678466|FG003|NOT COMPLETED|Erlotinib 125mg- Phase II||0
8638290|NCT00574067|9678477|FG000|STARTED|Overall Study||53
8638291|NCT00574067|9678478|FG001|STARTED|Overall Study||53
9019049|NCT03079375|10081633|FG001|NOT COMPLETED|Overall Study||6
9019050|NCT03079375|10081634|FG002|NOT COMPLETED|Overall Study||21
9019051|NCT03079531|10081646|FG000|STARTED|Overall Study||24
9019052|NCT03079531|10081646|FG000|Attended ≥1 Post-baseline Visit|Overall Study||23
9019053|NCT03079531|10081646|FG000|COMPLETED|Overall Study||17
9019054|NCT03079531|10081646|FG000|NOT COMPLETED|Overall Study||7
9019055|NCT03080142|10081652|FG000|STARTED|Overall Study||42
9019056|NCT03080142|10081653|FG001|STARTED|Overall Study||44
9019057|NCT03080142|10081652|FG000|COMPLETED|Overall Study||42
9019058|NCT03080142|10081653|FG001|COMPLETED|Overall Study||44
9019059|NCT03080142|10081652|FG000|NOT COMPLETED|Overall Study||0
9019060|NCT03080142|10081653|FG001|NOT COMPLETED|Overall Study||0
9019061|NCT03080454|10081659|FG000|STARTED|Baseline||26
9019062|NCT03080454|10081659|FG000|COMPLETED|Baseline|Two participants (pts) dropped out after consent due to hospitalizations unrelated to the study.|24
9019063|NCT03080454|10081659|FG000|NOT COMPLETED|Baseline||2
9019064|NCT03080454|10081659|FG000|STARTED|Sham Doublestim (5days)||24
9019065|NCT03080454|10081659|FG000|COMPLETED|Sham Doublestim (5days)||24
8727130|NCT01041859|9774551|FG002|NOT COMPLETED|Double-Blind Maintenance||45
8727131|NCT01041976|9774560|FG000|STARTED|Overall Study||42
8727132|NCT01041976|9774561|FG001|STARTED|Overall Study||42
8638292|NCT00574067|9678479|FG002|STARTED|Overall Study||54
8638293|NCT00574067|9678480|FG003|STARTED|Overall Study||53
8638294|NCT00574067|9678477|FG000|COMPLETED|Overall Study||52
8638295|NCT00574067|9678478|FG001|COMPLETED|Overall Study||52
8638296|NCT00574067|9678479|FG002|COMPLETED|Overall Study||54
8638297|NCT00574067|9678480|FG003|COMPLETED|Overall Study||53
8638298|NCT00574067|9678477|FG000|NOT COMPLETED|Overall Study||1
8638299|NCT00574067|9678478|FG001|NOT COMPLETED|Overall Study||1
8638300|NCT00574067|9678479|FG002|NOT COMPLETED|Overall Study||0
8638301|NCT00574067|9678480|FG003|NOT COMPLETED|Overall Study||0
8638302|NCT00574119|9678494|FG000|STARTED|Overall Study||16
8638303|NCT00574119|9678494|FG000|COMPLETED|Overall Study||12
8638304|NCT00574119|9678494|FG000|NOT COMPLETED|Overall Study||4
8638305|NCT00574145|9678500|FG000|STARTED|Overall Study||22
8638306|NCT00574145|9678501|FG001|STARTED|Overall Study||22
8638307|NCT00574145|9678500|FG000|COMPLETED|Overall Study||20
8638308|NCT00574145|9678501|FG001|COMPLETED|Overall Study||21
8638309|NCT00574145|9678500|FG000|NOT COMPLETED|Overall Study||2
8638310|NCT00574145|9678501|FG001|NOT COMPLETED|Overall Study||1
8638311|NCT00574171|9678507|FG000|STARTED|Overall Study||29
8638312|NCT00574171|9678507|FG000|COMPLETED|Overall Study||29
8638313|NCT00574171|9678507|FG000|NOT COMPLETED|Overall Study||0
8638314|NCT00574197|9678511|FG000|STARTED|Overall Study||11
8638315|NCT00574197|9678511|FG000|COMPLETED|Overall Study||6
8638316|NCT00574197|9678511|FG000|NOT COMPLETED|Overall Study||5
8638317|NCT00574236|9678515|FG000|STARTED|Overall Study||4
8638318|NCT00574236|9678515|FG000|COMPLETED|Overall Study||4
8638319|NCT00574236|9678515|FG000|NOT COMPLETED|Overall Study||0
8638320|NCT00574249|9678521|FG000|STARTED|Overall Study||364
8638321|NCT00574249|9678522|FG001|STARTED|Overall Study||366
8638322|NCT00574249|9678521|FG000|COMPLETED|Overall Study||338
8638323|NCT00574249|9678522|FG001|COMPLETED|Overall Study||338
8638324|NCT00574249|9678521|FG000|NOT COMPLETED|Overall Study||26
8638325|NCT00574249|9678522|FG001|NOT COMPLETED|Overall Study||28
8638326|NCT00574275|9678530|FG000|STARTED|Overall Study||275
8638327|NCT00574275|9678531|FG001|STARTED|Overall Study||271
8638328|NCT00574275|9678530|FG000|TREATED|Overall Study||273
8638329|NCT00574275|9678531|FG001|TREATED|Overall Study||268
8638330|NCT00574275|9678530|FG000|SAFETY POPULATION|Overall Study|Excludes 2 participants who received 1 dose of Aflibercept|271
8638331|NCT00574275|9678531|FG001|SAFETY POPULATION|Overall Study|Includes 2 participants from the Placebo and Gemcitabine arm who received 1 dose of Aflibercept|270
8638332|NCT00574275|9678530|FG000|COMPLETED|Overall Study|All participants stopped when they met treatment discontinuation criteria or by DMC recommendation|0
8638333|NCT00574275|9678531|FG001|COMPLETED|Overall Study|All participants stopped when they met treatment discontinuation criteria or by DMC recommendation|0
8638334|NCT00574275|9678530|FG000|NOT COMPLETED|Overall Study||275
8638335|NCT00574275|9678531|FG001|NOT COMPLETED|Overall Study||271
8638336|NCT00574288|9678544|FG000|STARTED|Overall Study||20
8638337|NCT00574288|9678545|FG001|STARTED|Overall Study||3
8638338|NCT00574288|9678546|FG002|STARTED|Overall Study||3
8638339|NCT00574288|9678547|FG003|STARTED|Overall Study||3
8638340|NCT00574288|9678548|FG004|STARTED|Overall Study||3
8638341|NCT00574288|9678549|FG005|STARTED|Overall Study||30
8638342|NCT00574288|9678550|FG006|STARTED|Overall Study||42
8638343|NCT00574288|9678544|FG000|COMPLETED|Overall Study||0
8638344|NCT00574288|9678545|FG001|COMPLETED|Overall Study||0
8638345|NCT00574288|9678546|FG002|COMPLETED|Overall Study||0
8638346|NCT00574288|9678547|FG003|COMPLETED|Overall Study||1
8638347|NCT00574288|9678548|FG004|COMPLETED|Overall Study||1
8638348|NCT00574288|9678549|FG005|COMPLETED|Overall Study||4
8638349|NCT00574288|9678550|FG006|COMPLETED|Overall Study||14
8638350|NCT00574288|9678544|FG000|NOT COMPLETED|Overall Study||20
8638351|NCT00574288|9678545|FG001|NOT COMPLETED|Overall Study||3
8727133|NCT01041976|9774560|FG000|6 Month Follow-up|Overall Study||39
8727134|NCT01041976|9774561|FG001|6 Month Follow-up|Overall Study||41
8727135|NCT01041976|9774560|FG000|12 Month Follow-up|Overall Study||37
8727136|NCT01041976|9774561|FG001|12 Month Follow-up|Overall Study||38
9019066|NCT03080454|10081659|FG000|NOT COMPLETED|Sham Doublestim (5days)||0
9019067|NCT03080454|10081659|FG000|STARTED|Sham FU (7days)||24
9019068|NCT03080454|10081659|FG000|COMPLETED|Sham FU (7days)||24
9019069|NCT03080454|10081659|FG000|NOT COMPLETED|Sham FU (7days)||0
9019070|NCT03080454|10081659|FG000|STARTED|Anodal Doublestim (5 Days)||24
8638352|NCT00574288|9678546|FG002|NOT COMPLETED|Overall Study||3
8638353|NCT00574288|9678547|FG003|NOT COMPLETED|Overall Study||2
8638354|NCT00574288|9678548|FG004|NOT COMPLETED|Overall Study||2
8638355|NCT00574288|9678549|FG005|NOT COMPLETED|Overall Study||26
8638356|NCT00574288|9678550|FG006|NOT COMPLETED|Overall Study||28
8638357|NCT00574340|9678576|FG000|STARTED|Study 1 (2 Days)||10
8638358|NCT00574340|9678577|FG001|STARTED|Study 1 (2 Days)||10
8638359|NCT00574340|9678576|FG000|COMPLETED|Study 1 (2 Days)||10
8638360|NCT00574340|9678577|FG001|COMPLETED|Study 1 (2 Days)||10
8638361|NCT00574340|9678576|FG000|NOT COMPLETED|Study 1 (2 Days)||0
8638362|NCT00574340|9678577|FG001|NOT COMPLETED|Study 1 (2 Days)||0
9019071|NCT03080454|10081659|FG000|COMPLETED|Anodal Doublestim (5 Days)||23
9019072|NCT03080454|10081659|FG000|NOT COMPLETED|Anodal Doublestim (5 Days)||1
9019073|NCT03080454|10081659|FG000|STARTED|Anodal FU (7 Days)||23
9019074|NCT03080454|10081659|FG000|COMPLETED|Anodal FU (7 Days)||19
9019075|NCT03080454|10081659|FG000|NOT COMPLETED|Anodal FU (7 Days)||4
9019076|NCT03080493|10081668|FG000|STARTED|Overall Study||61
9019077|NCT03080493|10081669|FG001|STARTED|Overall Study||60
9019078|NCT03080493|10081668|FG000|COMPLETED|Overall Study||60
9019079|NCT03080493|10081669|FG001|COMPLETED|Overall Study||58
9019080|NCT03080493|10081668|FG000|NOT COMPLETED|Overall Study||1
9019081|NCT03080493|10081669|FG001|NOT COMPLETED|Overall Study||2
9019082|NCT03080961|10081675|FG000|STARTED|Overall Study||46
9019083|NCT03080961|10081675|FG000|COMPLETED|Overall Study||43
9019084|NCT03080961|10081675|FG000|NOT COMPLETED|Overall Study||3
9019085|NCT03081117|10081686|FG000|STARTED|Overall Study||10
9019086|NCT03081117|10081687|FG001|STARTED|Overall Study||11
9019087|NCT03081117|10081686|FG000|Primary Outcome 1 (SAE)|Overall Study||10
8638363|NCT00574340|9678576|FG000|STARTED|Study 2 (2 Days)||6
8638364|NCT00574340|9678577|FG001|STARTED|Study 2 (2 Days)||6
8638365|NCT00574340|9678576|FG000|COMPLETED|Study 2 (2 Days)||6
8638366|NCT00574340|9678577|FG001|COMPLETED|Study 2 (2 Days)||6
8638367|NCT00574340|9678576|FG000|NOT COMPLETED|Study 2 (2 Days)||0
8638368|NCT00574340|9678577|FG001|NOT COMPLETED|Study 2 (2 Days)||0
8638369|NCT00574405|9678585|FG000|STARTED|Overall Study||12
8638370|NCT00574405|9678586|FG001|STARTED|Overall Study||12
8638371|NCT00574405|9678585|FG000|COMPLETED|Overall Study||9
8638372|NCT00574405|9678586|FG001|COMPLETED|Overall Study||10
8638373|NCT00574405|9678585|FG000|NOT COMPLETED|Overall Study||3
8638374|NCT00574405|9678586|FG001|NOT COMPLETED|Overall Study||2
8638375|NCT00574548|9678594|FG000|STARTED|Overall Study||482
8638376|NCT00574548|9678595|FG001|STARTED|Overall Study||238
8638377|NCT00574548|9678594|FG000|Received Vaccination 1 (Vax 1)|Overall Study||478
8638378|NCT00574548|9678595|FG001|Received Vaccination 1 (Vax 1)|Overall Study||237
8638379|NCT00574548|9678594|FG000|Completed Vax 1 (6 Month Contact)|Overall Study||468
8638380|NCT00574548|9678595|FG001|Completed Vax 1 (6 Month Contact)|Overall Study||234
8638381|NCT00574548|9678594|FG000|Withdrawn After Vax 1 (6 Month Contact)|Overall Study||7
8638382|NCT00574548|9678595|FG001|Withdrawn After Vax 1 (6 Month Contact)|Overall Study||3
8638383|NCT00574548|9678594|FG000|Withdrawn Before Vax 2|Overall Study||41
8638384|NCT00574548|9678595|FG001|Withdrawn Before Vax 2|Overall Study||11
8638385|NCT00574548|9678594|FG000|Received Vax 2|Overall Study||427
8638386|NCT00574548|9678595|FG001|Received Vax 2|Overall Study||223
8638387|NCT00574548|9678594|FG000|Completed Vax 2 (6 Month Contact)|Overall Study||421
8638388|NCT00574548|9678595|FG001|Completed Vax 2 (6 Month Contact)|Overall Study||222
8638389|NCT00574548|9678594|FG000|COMPLETED|Overall Study||421
8638390|NCT00574548|9678595|FG001|COMPLETED|Overall Study||222
8638391|NCT00574548|9678594|FG000|NOT COMPLETED|Overall Study||61
8638392|NCT00574548|9678595|FG001|NOT COMPLETED|Overall Study||16
8638393|NCT00574587|9678623|FG000|STARTED|Overall Study||3
8638394|NCT00574587|9678624|FG001|STARTED|Overall Study||23
8638395|NCT00574587|9678625|FG002|STARTED|Overall Study||16
8638396|NCT00574587|9678626|FG003|STARTED|Overall Study||13
8638397|NCT00574587|9678623|FG000|COMPLETED|Overall Study||3
8638398|NCT00574587|9678624|FG001|COMPLETED|Overall Study||23
8638399|NCT00574587|9678625|FG002|COMPLETED|Overall Study||16
8638400|NCT00574587|9678626|FG003|COMPLETED|Overall Study||13
8638401|NCT00574587|9678623|FG000|NOT COMPLETED|Overall Study||0
8638402|NCT00574587|9678624|FG001|NOT COMPLETED|Overall Study||0
8638403|NCT00574587|9678625|FG002|NOT COMPLETED|Overall Study||0
8638404|NCT00574587|9678626|FG003|NOT COMPLETED|Overall Study||0
8638405|NCT00574704|9678641|FG000|STARTED|Overall Study||10
8638406|NCT00574704|9678642|FG001|STARTED|Overall Study||10
8638407|NCT00574704|9678643|FG002|STARTED|Overall Study||10
8638408|NCT00574704|9678644|FG003|STARTED|Overall Study||10
8638409|NCT00574704|9678641|FG000|COMPLETED|Overall Study||10
8638410|NCT00574704|9678642|FG001|COMPLETED|Overall Study||10
8638411|NCT00574704|9678643|FG002|COMPLETED|Overall Study||9
8638412|NCT00574704|9678644|FG003|COMPLETED|Overall Study||10
8638413|NCT00574704|9678641|FG000|NOT COMPLETED|Overall Study||0
8638414|NCT00574704|9678642|FG001|NOT COMPLETED|Overall Study||0
8638415|NCT00574704|9678643|FG002|NOT COMPLETED|Overall Study||1
8638416|NCT00574704|9678644|FG003|NOT COMPLETED|Overall Study||0
8727137|NCT01041976|9774560|FG000|18 Month Follow-up|Overall Study||37
9019088|NCT03081117|10081687|FG001|Primary Outcome 1 (SAE)|Overall Study||11
9019089|NCT03081117|10081686|FG000|Secondary Measures Collected at Week 24|Overall Study||8
9019090|NCT03081117|10081687|FG001|Secondary Measures Collected at Week 24|Overall Study||9
9019091|NCT03081117|10081686|FG000|Completed (ITT): Primary Outcome 2 (GDS)|Overall Study||7
9019092|NCT03081117|10081687|FG001|Completed (ITT): Primary Outcome 2 (GDS)|Overall Study||9
9019093|NCT03081117|10081686|FG000|COMPLETED|Overall Study||6
8638417|NCT00574795|9678654|FG000|STARTED|Infant Series||193
8638418|NCT00574795|9678654|FG000|Vaccinated Dose 1|Infant Series||193
8638419|NCT00574795|9678654|FG000|Vaccinated Dose 2|Infant Series||190
8638420|NCT00574795|9678654|FG000|Vaccinated Dose 3|Infant Series||190
8638421|NCT00574795|9678654|FG000|COMPLETED|Infant Series||188
8638422|NCT00574795|9678654|FG000|NOT COMPLETED|Infant Series||5
8638423|NCT00574795|9678654|FG000|STARTED|After Infant Series||188
8638424|NCT00574795|9678654|FG000|COMPLETED|After Infant Series||185
8638425|NCT00574795|9678654|FG000|NOT COMPLETED|After Infant Series||3
8638426|NCT00574795|9678654|FG000|STARTED|Toddler Dose||185
8638427|NCT00574795|9678654|FG000|COMPLETED|Toddler Dose||184
8638428|NCT00574795|9678654|FG000|NOT COMPLETED|Toddler Dose||1
9019094|NCT03081117|10081687|FG001|COMPLETED|Overall Study||8
9019095|NCT03081117|10081686|FG000|NOT COMPLETED|Overall Study||4
9019096|NCT03081117|10081687|FG001|NOT COMPLETED|Overall Study||3
9019097|NCT03081884|10081693|FG000|STARTED|Overall Study||61
9019098|NCT03081884|10081693|FG000|COMPLETED|Overall Study||57
9019099|NCT03081884|10081693|FG000|NOT COMPLETED|Overall Study||4
9019100|NCT03082196|10081700|FG000|STARTED|Overall Study||142
9019101|NCT03082196|10081701|FG001|STARTED|Overall Study||142
9019102|NCT03082196|10081700|FG000|COMPLETED|Overall Study||133
9019103|NCT03082196|10081701|FG001|COMPLETED|Overall Study||129
9019104|NCT03082196|10081700|FG000|NOT COMPLETED|Overall Study||9
9019105|NCT03082196|10081701|FG001|NOT COMPLETED|Overall Study||13
9019106|NCT03082261|10081707|FG000|STARTED|Overall Study||269
9019107|NCT03082261|10081707|FG000|COMPLETED|Overall Study||149
9019108|NCT03082261|10081707|FG000|NOT COMPLETED|Overall Study||120
9019109|NCT03082586|10081717|FG000|STARTED|Overall Study|the patients received a total radiation dose of 57.2 Gy in this group|3
9019110|NCT03082586|10081718|FG001|STARTED|Overall Study|the patients received a total radiation dose of 64.4 Gy in this group|3
9019111|NCT03082586|10081719|FG002|STARTED|Overall Study|the patients received a total radiation dose of 71.6 Gy in this group|3
9019112|NCT03082586|10081720|FG003|STARTED|Overall Study|the patients received a total radiation dose of 78.8 Gy in this group|6
9019113|NCT03082586|10081721|FG004|STARTED|Overall Study|the patients received a total radiation dose of 86 Gy in this group|13
9019114|NCT03082586|10081722|FG005|STARTED|Overall Study|the patients received a total radiation dose of 93.2 Gy in this group|3
9019115|NCT03082586|10081717|FG000|COMPLETED|Overall Study|the patients received a total radiation dose of 57.2 Gy in this group|3
9019116|NCT03082586|10081718|FG001|COMPLETED|Overall Study|the patients received a total radiation dose of 64.4 Gy in this group|3
9019117|NCT03082586|10081719|FG002|COMPLETED|Overall Study|the patients received a total radiation dose of 71.6 Gy in this group|3
9019118|NCT03082586|10081720|FG003|COMPLETED|Overall Study|the patients received a total radiation dose of 78.8 Gy in this group|6
9019119|NCT03082586|10081721|FG004|COMPLETED|Overall Study|the patients received a total radiation dose of 86 Gy in this group|13
9019120|NCT03082586|10081722|FG005|COMPLETED|Overall Study|the patients received a total radiation dose of 93.2 Gy in this group|3
9019121|NCT03082586|10081717|FG000|NOT COMPLETED|Overall Study||0
9019122|NCT03082586|10081718|FG001|NOT COMPLETED|Overall Study||0
9019123|NCT03082586|10081719|FG002|NOT COMPLETED|Overall Study||0
9019124|NCT03082586|10081720|FG003|NOT COMPLETED|Overall Study||0
9019125|NCT03082586|10081721|FG004|NOT COMPLETED|Overall Study||0
9019126|NCT03082586|10081722|FG005|NOT COMPLETED|Overall Study||0
9019127|NCT03082599|10081744|FG000|STARTED|Overall Study||40
9019128|NCT03082599|10081745|FG001|STARTED|Overall Study||39
9019129|NCT03082599|10081744|FG000|COMPLETED|Overall Study||39
9019130|NCT03082599|10081745|FG001|COMPLETED|Overall Study||39
9019131|NCT03082599|10081744|FG000|NOT COMPLETED|Overall Study||1
9019132|NCT03082599|10081745|FG001|NOT COMPLETED|Overall Study||0
9019133|NCT03083093|10081753|FG000|STARTED|Overall Study||50
9019134|NCT03083093|10081754|FG001|STARTED|Overall Study||50
9019135|NCT03083093|10081753|FG000|COMPLETED|Overall Study||50
8638429|NCT00574834|9678672|FG000|STARTED|Overall Study||9
8638430|NCT00574834|9678673|FG001|STARTED|Overall Study||4
9019136|NCT03083093|10081754|FG001|COMPLETED|Overall Study||50
9019137|NCT03083093|10081753|FG000|NOT COMPLETED|Overall Study||0
9019138|NCT03083093|10081754|FG001|NOT COMPLETED|Overall Study||0
9019139|NCT03083132|10081762|FG000|STARTED|First 12 Weeks (Placebo vs Modafinil)||12
9019140|NCT03083132|10081763|FG001|STARTED|First 12 Weeks (Placebo vs Modafinil)||9
9019141|NCT03083132|10081762|FG000|COMPLETED|First 12 Weeks (Placebo vs Modafinil)||12
9019142|NCT03083132|10081763|FG001|COMPLETED|First 12 Weeks (Placebo vs Modafinil)||7
9019143|NCT03083132|10081762|FG000|NOT COMPLETED|First 12 Weeks (Placebo vs Modafinil)||0
9019144|NCT03083132|10081763|FG001|NOT COMPLETED|First 12 Weeks (Placebo vs Modafinil)||2
9019145|NCT03083132|10081762|FG000|STARTED|Last 12 Weeks (Drug for All Subjects)||12
9019146|NCT03083132|10081763|FG001|STARTED|Last 12 Weeks (Drug for All Subjects)||7
9019147|NCT03083132|10081762|FG000|COMPLETED|Last 12 Weeks (Drug for All Subjects)||11
9019148|NCT03083132|10081763|FG001|COMPLETED|Last 12 Weeks (Drug for All Subjects)||6
9019149|NCT03083132|10081762|FG000|NOT COMPLETED|Last 12 Weeks (Drug for All Subjects)||1
9019150|NCT03083132|10081763|FG001|NOT COMPLETED|Last 12 Weeks (Drug for All Subjects)||1
9019151|NCT03083379|10081771|FG000|STARTED|Overall Study||15
9019152|NCT03083379|10081772|FG001|STARTED|Overall Study||15
9019153|NCT03083379|10081771|FG000|COMPLETED|Overall Study||15
9019154|NCT03083379|10081772|FG001|COMPLETED|Overall Study||15
9019155|NCT03083379|10081771|FG000|NOT COMPLETED|Overall Study||0
9019156|NCT03083379|10081772|FG001|NOT COMPLETED|Overall Study||0
9019157|NCT03083470|10081783|FG000|STARTED|Overall Study||6
9019158|NCT03083470|10081784|FG001|STARTED|Overall Study||6
9019159|NCT03083470|10081785|FG002|STARTED|Overall Study||6
9019160|NCT03083470|10081786|FG003|STARTED|Overall Study||6
9019161|NCT03083470|10081787|FG004|STARTED|Overall Study||9
9019162|NCT03083470|10081783|FG000|COMPLETED|Overall Study||6
9019163|NCT03083470|10081784|FG001|COMPLETED|Overall Study||6
9019164|NCT03083470|10081785|FG002|COMPLETED|Overall Study||6
9019165|NCT03083470|10081786|FG003|COMPLETED|Overall Study||6
9019166|NCT03083470|10081787|FG004|COMPLETED|Overall Study||7
9019167|NCT03083470|10081783|FG000|NOT COMPLETED|Overall Study||0
9019168|NCT03083470|10081784|FG001|NOT COMPLETED|Overall Study||0
8638431|NCT00574834|9678674|FG002|STARTED|Overall Study||4
9019169|NCT03083470|10081785|FG002|NOT COMPLETED|Overall Study||0
8638432|NCT00574834|9678672|FG000|COMPLETED|Overall Study||9
9019170|NCT03083470|10081786|FG003|NOT COMPLETED|Overall Study||0
9019171|NCT03083470|10081787|FG004|NOT COMPLETED|Overall Study||2
9019172|NCT03083483|10081802|FG000|STARTED|Overall Study||24
9019173|NCT03083483|10081803|FG001|STARTED|Overall Study||22
9019174|NCT03083483|10081804|FG002|STARTED|Overall Study||23
9019175|NCT03083483|10081802|FG000|COMPLETED|Overall Study||20
9019176|NCT03083483|10081803|FG001|COMPLETED|Overall Study||20
9019177|NCT03083483|10081804|FG002|COMPLETED|Overall Study||20
9019178|NCT03083483|10081802|FG000|NOT COMPLETED|Overall Study||4
9019179|NCT03083483|10081803|FG001|NOT COMPLETED|Overall Study||2
9019180|NCT03083483|10081804|FG002|NOT COMPLETED|Overall Study||3
9019181|NCT03083639|10081814|FG000|STARTED|Intervention Period 1 (1 Day)||26
9019182|NCT03083639|10081815|FG001|STARTED|Intervention Period 1 (1 Day)||26
9019183|NCT03083639|10081814|FG000|COMPLETED|Intervention Period 1 (1 Day)||26
9019184|NCT03083639|10081815|FG001|COMPLETED|Intervention Period 1 (1 Day)||26
9019185|NCT03083639|10081814|FG000|NOT COMPLETED|Intervention Period 1 (1 Day)||0
9019186|NCT03083639|10081815|FG001|NOT COMPLETED|Intervention Period 1 (1 Day)||0
9019187|NCT03083639|10081814|FG000|STARTED|Washout Period (at Least 6 Days)||26
9019188|NCT03083639|10081815|FG001|STARTED|Washout Period (at Least 6 Days)||26
9019189|NCT03083639|10081814|FG000|COMPLETED|Washout Period (at Least 6 Days)||25
9019190|NCT03083639|10081815|FG001|COMPLETED|Washout Period (at Least 6 Days)||25
9019191|NCT03083639|10081814|FG000|NOT COMPLETED|Washout Period (at Least 6 Days)||1
9019192|NCT03083639|10081815|FG001|NOT COMPLETED|Washout Period (at Least 6 Days)||1
9019193|NCT03083639|10081814|FG000|STARTED|Intervention Period 2 (1 Day)||25
9019194|NCT03083639|10081815|FG001|STARTED|Intervention Period 2 (1 Day)||25
9019195|NCT03083639|10081814|FG000|COMPLETED|Intervention Period 2 (1 Day)||25
9019196|NCT03083639|10081815|FG001|COMPLETED|Intervention Period 2 (1 Day)||25
9019197|NCT03083639|10081814|FG000|NOT COMPLETED|Intervention Period 2 (1 Day)||0
9019198|NCT03083639|10081815|FG001|NOT COMPLETED|Intervention Period 2 (1 Day)||0
9019199|NCT03083769|10081823|FG000|STARTED|Overall Study||839
9019200|NCT03083769|10081824|FG001|STARTED|Overall Study||663
9019201|NCT03083769|10081823|FG000|COMPLETED|Overall Study||819
9019202|NCT03083769|10081824|FG001|COMPLETED|Overall Study||631
9019203|NCT03083769|10081823|FG000|NOT COMPLETED|Overall Study||20
9019204|NCT03083769|10081824|FG001|NOT COMPLETED|Overall Study||32
9019205|NCT03083847|10081840|FG000|STARTED|Pilot 1a||2
9019206|NCT03083847|10081841|FG001|STARTED|Pilot 1a||0
8638433|NCT00574834|9678673|FG001|COMPLETED|Overall Study||4
8638434|NCT00574834|9678674|FG002|COMPLETED|Overall Study||4
8638435|NCT00574834|9678672|FG000|NOT COMPLETED|Overall Study||0
8638436|NCT00574834|9678673|FG001|NOT COMPLETED|Overall Study||0
8638437|NCT00574834|9678674|FG002|NOT COMPLETED|Overall Study||0
8638438|NCT00574847|9678684|FG000|STARTED|Overall Study||64
8638439|NCT00574847|9678685|FG001|STARTED|Overall Study||63
8638440|NCT00574847|9678684|FG000|COMPLETED|Overall Study||56
8638441|NCT00574847|9678685|FG001|COMPLETED|Overall Study||56
8638442|NCT00574847|9678684|FG000|NOT COMPLETED|Overall Study||8
8638443|NCT00574847|9678685|FG001|NOT COMPLETED|Overall Study||7
8638444|NCT00574873|9678693|FG000|STARTED|Overall Study||250
8638445|NCT00574873|9678694|FG001|STARTED|Overall Study||252
8638446|NCT00574873|9678693|FG000|Treated|Overall Study||248
8638447|NCT00574873|9678694|FG001|Treated|Overall Study||251
8638448|NCT00574873|9678693|FG000|COMPLETED|Overall Study||12
8638449|NCT00574873|9678694|FG001|COMPLETED|Overall Study||1
8638450|NCT00574873|9678693|FG000|NOT COMPLETED|Overall Study||238
8638451|NCT00574873|9678694|FG001|NOT COMPLETED|Overall Study||251
8638452|NCT00574912|9678700|FG000|STARTED|Overall Study||20
8638453|NCT00574912|9678700|FG000|Completed Placebo|Overall Study|12 original participants started the trial.|12
8638454|NCT00574912|9678700|FG000|Completed 0.5|Overall Study||12
8638455|NCT00574912|9678700|FG000|Completed 1.0|Overall Study||12
8638456|NCT00574912|9678700|FG000|Completed 1.5|Overall Study||12
8638457|NCT00574912|9678700|FG000|Completed 2.0|Overall Study||12
8638458|NCT00574912|9678700|FG000|COMPLETED|Overall Study||12
8638459|NCT00574912|9678700|FG000|NOT COMPLETED|Overall Study||8
8638460|NCT00574951|9678712|FG000|STARTED|Overall Study||23
8638461|NCT00574951|9678712|FG000|COMPLETED|Overall Study||22
8638462|NCT00574951|9678712|FG000|NOT COMPLETED|Overall Study||1
8638463|NCT00574990|9678719|FG000|STARTED|Overall Study||12
8638464|NCT00574990|9678720|FG001|STARTED|Overall Study||19
8638465|NCT00574990|9678721|FG002|STARTED|Overall Study||8
8638466|NCT00574990|9678719|FG000|COMPLETED|Overall Study||12
8638467|NCT00574990|9678720|FG001|COMPLETED|Overall Study||19
8638468|NCT00574990|9678721|FG002|COMPLETED|Overall Study||8
8638469|NCT00574990|9678719|FG000|NOT COMPLETED|Overall Study||0
8638470|NCT00574990|9678720|FG001|NOT COMPLETED|Overall Study||0
9019207|NCT03083847|10081842|FG002|STARTED|Pilot 1a||0
9019208|NCT03083847|10081843|FG003|STARTED|Pilot 1a||0
9019209|NCT03083847|10081844|FG004|STARTED|Pilot 1a||0
9019210|NCT03083847|10081845|FG005|STARTED|Pilot 1a||0
9019211|NCT03083847|10081846|FG006|STARTED|Pilot 1a||0
9019212|NCT03083847|10081847|FG007|STARTED|Pilot 1a||0
9019213|NCT03083847|10081848|FG008|STARTED|Pilot 1a||0
8638471|NCT00574990|9678721|FG002|NOT COMPLETED|Overall Study||0
8638472|NCT00575016|9678736|FG000|STARTED|Treatment Cycle 1||17
8638473|NCT00575016|9678737|FG001|STARTED|Treatment Cycle 1||21
8638474|NCT00575016|9678738|FG002|STARTED|Treatment Cycle 1||19
8638475|NCT00575016|9678739|FG003|STARTED|Treatment Cycle 1|1 pt randomized to Placebo never received treatment|17
8638476|NCT00575016|9678736|FG000|COMPLETED|Treatment Cycle 1|3 pts from 200U group entered Cycle 2|8
9019214|NCT03083847|10081849|FG009|STARTED|Pilot 1a||0
9019215|NCT03083847|10081840|FG000|COMPLETED|Pilot 1a||2
9019216|NCT03083847|10081841|FG001|COMPLETED|Pilot 1a||0
9019217|NCT03083847|10081842|FG002|COMPLETED|Pilot 1a||0
9019218|NCT03083847|10081843|FG003|COMPLETED|Pilot 1a||0
9019219|NCT03083847|10081844|FG004|COMPLETED|Pilot 1a||0
9019220|NCT03083847|10081845|FG005|COMPLETED|Pilot 1a||0
9019221|NCT03083847|10081846|FG006|COMPLETED|Pilot 1a||0
9019222|NCT03083847|10081847|FG007|COMPLETED|Pilot 1a||0
9019223|NCT03083847|10081848|FG008|COMPLETED|Pilot 1a||0
9019224|NCT03083847|10081849|FG009|COMPLETED|Pilot 1a||0
9019225|NCT03083847|10081840|FG000|NOT COMPLETED|Pilot 1a||0
9019226|NCT03083847|10081841|FG001|NOT COMPLETED|Pilot 1a||0
9019227|NCT03083847|10081842|FG002|NOT COMPLETED|Pilot 1a||0
9019228|NCT03083847|10081843|FG003|NOT COMPLETED|Pilot 1a||0
9019229|NCT03083847|10081844|FG004|NOT COMPLETED|Pilot 1a||0
9019230|NCT03083847|10081845|FG005|NOT COMPLETED|Pilot 1a||0
9019231|NCT03083847|10081846|FG006|NOT COMPLETED|Pilot 1a||0
9019232|NCT03083847|10081847|FG007|NOT COMPLETED|Pilot 1a||0
9019233|NCT03083847|10081848|FG008|NOT COMPLETED|Pilot 1a||0
9019234|NCT03083847|10081849|FG009|NOT COMPLETED|Pilot 1a||0
9019235|NCT03083847|10081840|FG000|STARTED|Pilot Ib & 5a||0
9019236|NCT03083847|10081841|FG001|STARTED|Pilot Ib & 5a||2
9019237|NCT03083847|10081842|FG002|STARTED|Pilot Ib & 5a||2
9019238|NCT03083847|10081843|FG003|STARTED|Pilot Ib & 5a||0
9019239|NCT03083847|10081844|FG004|STARTED|Pilot Ib & 5a||0
9019240|NCT03083847|10081845|FG005|STARTED|Pilot Ib & 5a||0
9019241|NCT03083847|10081846|FG006|STARTED|Pilot Ib & 5a||0
9019242|NCT03083847|10081847|FG007|STARTED|Pilot Ib & 5a||0
9019243|NCT03083847|10081848|FG008|STARTED|Pilot Ib & 5a||0
9019244|NCT03083847|10081849|FG009|STARTED|Pilot Ib & 5a||0
9019245|NCT03083847|10081840|FG000|COMPLETED|Pilot Ib & 5a||0
9019246|NCT03083847|10081841|FG001|COMPLETED|Pilot Ib & 5a||2
9019247|NCT03083847|10081842|FG002|COMPLETED|Pilot Ib & 5a||2
9019248|NCT03083847|10081843|FG003|COMPLETED|Pilot Ib & 5a||0
9019249|NCT03083847|10081844|FG004|COMPLETED|Pilot Ib & 5a||0
9019250|NCT03083847|10081845|FG005|COMPLETED|Pilot Ib & 5a||0
9019251|NCT03083847|10081846|FG006|COMPLETED|Pilot Ib & 5a||0
9019252|NCT03083847|10081847|FG007|COMPLETED|Pilot Ib & 5a||0
9019253|NCT03083847|10081848|FG008|COMPLETED|Pilot Ib & 5a||0
9019254|NCT03083847|10081849|FG009|COMPLETED|Pilot Ib & 5a||0
9019255|NCT03083847|10081840|FG000|NOT COMPLETED|Pilot Ib & 5a||0
9019256|NCT03083847|10081841|FG001|NOT COMPLETED|Pilot Ib & 5a||0
9019257|NCT03083847|10081842|FG002|NOT COMPLETED|Pilot Ib & 5a||0
9019258|NCT03083847|10081843|FG003|NOT COMPLETED|Pilot Ib & 5a||0
9019259|NCT03083847|10081844|FG004|NOT COMPLETED|Pilot Ib & 5a||0
9019260|NCT03083847|10081845|FG005|NOT COMPLETED|Pilot Ib & 5a||0
9019261|NCT03083847|10081846|FG006|NOT COMPLETED|Pilot Ib & 5a||0
9019262|NCT03083847|10081847|FG007|NOT COMPLETED|Pilot Ib & 5a||0
9019263|NCT03083847|10081848|FG008|NOT COMPLETED|Pilot Ib & 5a||0
9019264|NCT03083847|10081849|FG009|NOT COMPLETED|Pilot Ib & 5a||0
9019265|NCT03083847|10081840|FG000|STARTED|Pilot 1d & 5b||0
9019266|NCT03083847|10081841|FG001|STARTED|Pilot 1d & 5b||0
9019267|NCT03083847|10081842|FG002|STARTED|Pilot 1d & 5b||0
9019268|NCT03083847|10081843|FG003|STARTED|Pilot 1d & 5b||4
9019269|NCT03083847|10081844|FG004|STARTED|Pilot 1d & 5b||4
9019270|NCT03083847|10081845|FG005|STARTED|Pilot 1d & 5b||0
9019271|NCT03083847|10081846|FG006|STARTED|Pilot 1d & 5b||0
9019272|NCT03083847|10081847|FG007|STARTED|Pilot 1d & 5b||0
9019273|NCT03083847|10081848|FG008|STARTED|Pilot 1d & 5b||0
9019274|NCT03083847|10081849|FG009|STARTED|Pilot 1d & 5b||0
9019275|NCT03083847|10081840|FG000|COMPLETED|Pilot 1d & 5b||0
9019276|NCT03083847|10081841|FG001|COMPLETED|Pilot 1d & 5b||0
9019277|NCT03083847|10081842|FG002|COMPLETED|Pilot 1d & 5b||0
9019278|NCT03083847|10081843|FG003|COMPLETED|Pilot 1d & 5b||4
9019279|NCT03083847|10081844|FG004|COMPLETED|Pilot 1d & 5b||4
9019280|NCT03083847|10081845|FG005|COMPLETED|Pilot 1d & 5b||0
9019281|NCT03083847|10081846|FG006|COMPLETED|Pilot 1d & 5b||0
9019282|NCT03083847|10081847|FG007|COMPLETED|Pilot 1d & 5b||0
9019283|NCT03083847|10081848|FG008|COMPLETED|Pilot 1d & 5b||0
9019284|NCT03083847|10081849|FG009|COMPLETED|Pilot 1d & 5b||0
9019285|NCT03083847|10081840|FG000|NOT COMPLETED|Pilot 1d & 5b||0
9019286|NCT03083847|10081841|FG001|NOT COMPLETED|Pilot 1d & 5b||0
9019287|NCT03083847|10081842|FG002|NOT COMPLETED|Pilot 1d & 5b||0
9019288|NCT03083847|10081843|FG003|NOT COMPLETED|Pilot 1d & 5b||0
9019289|NCT03083847|10081844|FG004|NOT COMPLETED|Pilot 1d & 5b||0
9019290|NCT03083847|10081845|FG005|NOT COMPLETED|Pilot 1d & 5b||0
9019291|NCT03083847|10081846|FG006|NOT COMPLETED|Pilot 1d & 5b||0
9019292|NCT03083847|10081847|FG007|NOT COMPLETED|Pilot 1d & 5b||0
9019293|NCT03083847|10081848|FG008|NOT COMPLETED|Pilot 1d & 5b||0
9019294|NCT03083847|10081849|FG009|NOT COMPLETED|Pilot 1d & 5b||0
9019295|NCT03083847|10081840|FG000|STARTED|Main||0
9019296|NCT03083847|10081841|FG001|STARTED|Main||0
9019297|NCT03083847|10081842|FG002|STARTED|Main||0
9019298|NCT03083847|10081843|FG003|STARTED|Main||0
9019299|NCT03083847|10081844|FG004|STARTED|Main||0
9019300|NCT03083847|10081845|FG005|STARTED|Main||9
9019301|NCT03083847|10081846|FG006|STARTED|Main||10
9019302|NCT03083847|10081847|FG007|STARTED|Main||10
9019303|NCT03083847|10081848|FG008|STARTED|Main||4
9019304|NCT03083847|10081849|FG009|STARTED|Main||8
9019305|NCT03083847|10081840|FG000|COMPLETED|Main||0
9019306|NCT03083847|10081841|FG001|COMPLETED|Main||0
9019307|NCT03083847|10081842|FG002|COMPLETED|Main||0
9019308|NCT03083847|10081843|FG003|COMPLETED|Main||0
9019309|NCT03083847|10081844|FG004|COMPLETED|Main||0
9019310|NCT03083847|10081845|FG005|COMPLETED|Main||8
9019311|NCT03083847|10081846|FG006|COMPLETED|Main||9
9019312|NCT03083847|10081847|FG007|COMPLETED|Main||6
9019313|NCT03083847|10081848|FG008|COMPLETED|Main||4
9019314|NCT03083847|10081849|FG009|COMPLETED|Main||8
9019315|NCT03083847|10081840|FG000|NOT COMPLETED|Main||0
9019316|NCT03083847|10081841|FG001|NOT COMPLETED|Main||0
9019317|NCT03083847|10081842|FG002|NOT COMPLETED|Main||0
9019318|NCT03083847|10081843|FG003|NOT COMPLETED|Main||0
9019319|NCT03083847|10081844|FG004|NOT COMPLETED|Main||0
9019320|NCT03083847|10081845|FG005|NOT COMPLETED|Main||1
9019321|NCT03083847|10081846|FG006|NOT COMPLETED|Main||1
9019322|NCT03083847|10081847|FG007|NOT COMPLETED|Main||4
9019323|NCT03083847|10081848|FG008|NOT COMPLETED|Main||0
9019324|NCT03083847|10081849|FG009|NOT COMPLETED|Main||0
9019325|NCT03083990|10081879|FG000|STARTED|Overall Study||50
9019326|NCT03083990|10081880|FG001|STARTED|Overall Study||50
9019327|NCT03083990|10081879|FG000|COMPLETED|Overall Study||49
9019328|NCT03083990|10081880|FG001|COMPLETED|Overall Study||50
8638477|NCT00575016|9678737|FG001|COMPLETED|Treatment Cycle 1|11 pts from 100U group entered Cycle 2|16
8638478|NCT00575016|9678738|FG002|COMPLETED|Treatment Cycle 1|8 pts from 50U group entered Cycle 2|15
8638479|NCT00575016|9678739|FG003|COMPLETED|Treatment Cycle 1|9 pts from Placebo group entered Cycle 2|12
8638480|NCT00575016|9678736|FG000|NOT COMPLETED|Treatment Cycle 1||9
8638481|NCT00575016|9678737|FG001|NOT COMPLETED|Treatment Cycle 1||5
8638482|NCT00575016|9678738|FG002|NOT COMPLETED|Treatment Cycle 1||4
8638483|NCT00575016|9678739|FG003|NOT COMPLETED|Treatment Cycle 1||5
8638484|NCT00575016|9678736|FG000|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|31
8638485|NCT00575016|9678737|FG001|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|0
8638486|NCT00575016|9678738|FG002|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|0
8638487|NCT00575016|9678739|FG003|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|0
8638488|NCT00575016|9678736|FG000|COMPLETED|Treatment Cycle 2||30
8638489|NCT00575016|9678737|FG001|COMPLETED|Treatment Cycle 2||0
8638490|NCT00575016|9678738|FG002|COMPLETED|Treatment Cycle 2||0
8638491|NCT00575016|9678739|FG003|COMPLETED|Treatment Cycle 2||0
8638492|NCT00575016|9678736|FG000|NOT COMPLETED|Treatment Cycle 2||1
8638493|NCT00575016|9678737|FG001|NOT COMPLETED|Treatment Cycle 2||0
8638494|NCT00575016|9678738|FG002|NOT COMPLETED|Treatment Cycle 2||0
8638495|NCT00575016|9678739|FG003|NOT COMPLETED|Treatment Cycle 2||0
8638496|NCT00575029|9678749|FG000|STARTED|Overall Study||7
8638497|NCT00575029|9678749|FG000|COMPLETED|Overall Study||7
8638498|NCT00575029|9678749|FG000|NOT COMPLETED|Overall Study||0
8638499|NCT00575042|9678753|FG000|STARTED|Overall Study||20
8638500|NCT00575042|9678753|FG000|COMPLETED|Overall Study|2 with side effects and 1 lost to follow-up|17
8638501|NCT00575042|9678753|FG000|NOT COMPLETED|Overall Study||3
8638502|NCT00575094|9678758|FG000|STARTED|Overall Study||9
8638503|NCT00575094|9678758|FG000|COMPLETED|Overall Study||6
8638504|NCT00575094|9678758|FG000|NOT COMPLETED|Overall Study||3
8638505|NCT00575146|9678762|FG000|STARTED|Overall Study||20
8638506|NCT00575146|9678762|FG000|COMPLETED|Overall Study||17
8638507|NCT00575146|9678762|FG000|NOT COMPLETED|Overall Study||3
8638508|NCT00575159|9678766|FG000|STARTED|Overall Study||10
8638509|NCT00575159|9678766|FG000|COMPLETED|Overall Study||10
8638510|NCT00575159|9678766|FG000|NOT COMPLETED|Overall Study||0
8638511|NCT00575185|9678784|FG000|STARTED|Overall Study||12
8638512|NCT00575185|9678785|FG001|STARTED|Overall Study||11
8638513|NCT00575185|9678784|FG000|COMPLETED|Overall Study||12
8638514|NCT00575185|9678785|FG001|COMPLETED|Overall Study||11
8638515|NCT00575185|9678784|FG000|NOT COMPLETED|Overall Study||0
8638516|NCT00575185|9678785|FG001|NOT COMPLETED|Overall Study||0
8638517|NCT00575328|9678795|FG000|STARTED|Overall Study||4
8638518|NCT00575328|9678796|FG001|STARTED|Overall Study||4
8638519|NCT00575328|9678795|FG000|COMPLETED|Overall Study||1
8638520|NCT00575328|9678796|FG001|COMPLETED|Overall Study||2
8638521|NCT00575328|9678795|FG000|NOT COMPLETED|Overall Study||3
8638522|NCT00575328|9678796|FG001|NOT COMPLETED|Overall Study||2
8638523|NCT00575367|9678804|FG000|STARTED|Overall Study||19
8638524|NCT00575367|9678805|FG001|STARTED|Overall Study||18
8638525|NCT00575367|9678804|FG000|COMPLETED|Overall Study||19
8638526|NCT00575367|9678805|FG001|COMPLETED|Overall Study||18
8638527|NCT00575367|9678804|FG000|NOT COMPLETED|Overall Study||0
8638528|NCT00575367|9678805|FG001|NOT COMPLETED|Overall Study||0
8638529|NCT00575380|9678813|FG000|STARTED|Overall Study||58
8638530|NCT00575380|9678814|FG001|STARTED|Overall Study||58
8638531|NCT00575380|9678813|FG000|COMPLETED|Overall Study||57
8638532|NCT00575380|9678814|FG001|COMPLETED|Overall Study||55
8638533|NCT00575380|9678813|FG000|NOT COMPLETED|Overall Study||1
8638534|NCT00575380|9678814|FG001|NOT COMPLETED|Overall Study||3
8691356|NCT00854360|9736618|FG000|STARTED|Overall Study||118
8691357|NCT00854360|9736619|FG001|STARTED|Overall Study||123
8691358|NCT00854360|9736620|FG002|STARTED|Overall Study||122
8691359|NCT00854360|9736621|FG003|STARTED|Overall Study||124
8691360|NCT00854360|9736618|FG000|Intent to Treat / Safety Population|Overall Study||118
8691361|NCT00854360|9736619|FG001|Intent to Treat / Safety Population|Overall Study||123
9019329|NCT03083990|10081879|FG000|NOT COMPLETED|Overall Study||1
9019330|NCT03083990|10081880|FG001|NOT COMPLETED|Overall Study||0
8691362|NCT00854360|9736620|FG002|Intent to Treat / Safety Population|Overall Study||122
9019331|NCT03084302|10081886|FG000|STARTED|Overall Study||120
8693639|NCT00867789|9739186|FG001|STARTED|Overall Study||70
9019332|NCT03084302|10081886|FG000|COMPLETED|Overall Study||105
9019333|NCT03084302|10081886|FG000|NOT COMPLETED|Overall Study||15
9019334|NCT03084315|10081893|FG000|STARTED|Overall Study||116
9019335|NCT03084315|10081894|FG001|STARTED|Overall Study||118
9019336|NCT03084315|10081893|FG000|COMPLETED|Overall Study||106
9019337|NCT03084315|10081894|FG001|COMPLETED|Overall Study||109
9019338|NCT03084315|10081893|FG000|NOT COMPLETED|Overall Study||10
9019339|NCT03084315|10081894|FG001|NOT COMPLETED|Overall Study||9
9019340|NCT03084796|10081906|FG000|STARTED|Overall Study||121
9019341|NCT03084796|10081907|FG001|STARTED|Overall Study||123
9019342|NCT03084796|10081908|FG002|STARTED|Overall Study||122
9019343|NCT03084796|10081909|FG003|STARTED|Overall Study||123
9019344|NCT03084796|10081910|FG004|STARTED|Overall Study||121
9019345|NCT03084796|10081911|FG005|STARTED|Overall Study||123
9019346|NCT03084796|10081906|FG000|COMPLETED|Overall Study||114
9019347|NCT03084796|10081907|FG001|COMPLETED|Overall Study||113
9019348|NCT03084796|10081908|FG002|COMPLETED|Overall Study||110
9019349|NCT03084796|10081909|FG003|COMPLETED|Overall Study||119
9019350|NCT03084796|10081910|FG004|COMPLETED|Overall Study||110
9019351|NCT03084796|10081911|FG005|COMPLETED|Overall Study||116
9019352|NCT03084796|10081906|FG000|NOT COMPLETED|Overall Study||7
9019353|NCT03084796|10081907|FG001|NOT COMPLETED|Overall Study||10
9019354|NCT03084796|10081908|FG002|NOT COMPLETED|Overall Study||12
9019355|NCT03084796|10081909|FG003|NOT COMPLETED|Overall Study||4
9019356|NCT03084796|10081910|FG004|NOT COMPLETED|Overall Study||11
9019357|NCT03084796|10081911|FG005|NOT COMPLETED|Overall Study||7
9019358|NCT03085017|10081927|FG000|STARTED|Overall Study||30
9019359|NCT03085017|10081928|FG001|STARTED|Overall Study||27
9019360|NCT03085017|10081927|FG000|COMPLETED|Overall Study||30
9019361|NCT03085017|10081928|FG001|COMPLETED|Overall Study||24
9019362|NCT03085017|10081927|FG000|NOT COMPLETED|Overall Study||0
9019363|NCT03085017|10081928|FG001|NOT COMPLETED|Overall Study||3
9019364|NCT03085238|10081934|FG000|STARTED|Overall Study||23
9019365|NCT03085238|10081934|FG000|1 Month|Overall Study||23
9019366|NCT03085238|10081934|FG000|3 Months|Overall Study||22
9019367|NCT03085238|10081934|FG000|6 Months|Overall Study||19
9019368|NCT03085238|10081934|FG000|9 Months|Overall Study||16
9019369|NCT03085238|10081934|FG000|12 Months|Overall Study||14
9019370|NCT03085238|10081934|FG000|15 Months|Overall Study||11
9019371|NCT03085238|10081934|FG000|18 Months|Overall Study||7
9019372|NCT03085238|10081934|FG000|COMPLETED|Overall Study||19
9019373|NCT03085238|10081934|FG000|NOT COMPLETED|Overall Study||4
9019374|NCT03085758|10081950|FG000|STARTED|Overall Study||72
9019375|NCT03085758|10081951|FG001|STARTED|Overall Study||77
9019376|NCT03085758|10081952|FG002|STARTED|Overall Study||152
9019377|NCT03085758|10081950|FG000|COMPLETED|Overall Study||43
9019378|NCT03085758|10081951|FG001|COMPLETED|Overall Study||49
9019379|NCT03085758|10081952|FG002|COMPLETED|Overall Study||96
9019380|NCT03085758|10081950|FG000|NOT COMPLETED|Overall Study||29
9019381|NCT03085758|10081951|FG001|NOT COMPLETED|Overall Study||28
9019382|NCT03085758|10081952|FG002|NOT COMPLETED|Overall Study||56
9019383|NCT03085797|10081966|FG000|STARTED|Treatment Period (TP) (52 Weeks)||201
9019384|NCT03085797|10081967|FG001|STARTED|Treatment Period (TP) (52 Weeks)||206
9019385|NCT03085797|10081966|FG000|Completed Investigational Product (IP)|Treatment Period (TP) (52 Weeks)||167
9019386|NCT03085797|10081967|FG001|Completed Investigational Product (IP)|Treatment Period (TP) (52 Weeks)||183
9019387|NCT03085797|10081966|FG000|Not Completed IP|Treatment Period (TP) (52 Weeks)||34
8638535|NCT00575510|9678823|FG000|STARTED|Overall Study||114
8638536|NCT00575510|9678824|FG001|STARTED|Overall Study||114
8638537|NCT00575510|9678825|FG002|STARTED|Overall Study||113
8638538|NCT00575510|9678823|FG000|COMPLETED|Overall Study||102
8638539|NCT00575510|9678824|FG001|COMPLETED|Overall Study||101
8638540|NCT00575510|9678825|FG002|COMPLETED|Overall Study||96
8638541|NCT00575510|9678823|FG000|NOT COMPLETED|Overall Study||12
8638542|NCT00575510|9678824|FG001|NOT COMPLETED|Overall Study||13
8638543|NCT00575510|9678825|FG002|NOT COMPLETED|Overall Study||17
8638544|NCT00575588|9678836|FG000|STARTED|Overall Study|Randomized and treated|428
8638545|NCT00575588|9678837|FG001|STARTED|Overall Study|Randomized and treated|430
8638546|NCT00575588|9678836|FG000|COMPLETED|Overall Study|Completed 104 weeks of treatment|165
8638547|NCT00575588|9678837|FG001|COMPLETED|Overall Study|Completed 104 weeks of treatment|147
8638548|NCT00575588|9678836|FG000|NOT COMPLETED|Overall Study||263
8638549|NCT00575588|9678837|FG001|NOT COMPLETED|Overall Study||283
8638550|NCT00575666|9678845|FG000|STARTED|Overall Study||21
8638551|NCT00575666|9678846|FG001|STARTED|Overall Study||24
8638552|NCT00575666|9678845|FG000|COMPLETED|Overall Study||17
8638553|NCT00575666|9678846|FG001|COMPLETED|Overall Study||21
8638554|NCT00575666|9678845|FG000|NOT COMPLETED|Overall Study||4
8638555|NCT00575666|9678846|FG001|NOT COMPLETED|Overall Study||3
8638556|NCT00575887|9678852|FG000|STARTED|Overall Study||25
8638557|NCT00575887|9678852|FG000|COMPLETED|Overall Study||25
8638558|NCT00575887|9678852|FG000|NOT COMPLETED|Overall Study||0
8638559|NCT00575965|9678856|FG000|STARTED|Overall Study||18
8638560|NCT00575965|9678856|FG000|COMPLETED|Overall Study||18
8638561|NCT00575965|9678856|FG000|NOT COMPLETED|Overall Study||0
8638562|NCT00576056|9678860|FG000|STARTED|Overall Study||19
9019388|NCT03085797|10081967|FG001|Not Completed IP|Treatment Period (TP) (52 Weeks)||23
9019389|NCT03085797|10081966|FG000|Withdrew IP Due to: Adverse Event|Treatment Period (TP) (52 Weeks)||4
9019390|NCT03085797|10081967|FG001|Withdrew IP Due to: Adverse Event|Treatment Period (TP) (52 Weeks)||4
9019391|NCT03085797|10081966|FG000|Withdrew IP Due to: Lack of Efficacy|Treatment Period (TP) (52 Weeks)||11
9019392|NCT03085797|10081967|FG001|Withdrew IP Due to: Lack of Efficacy|Treatment Period (TP) (52 Weeks)||5
9019393|NCT03085797|10081966|FG000|Withdrew IP Due to: Protocol Deviation|Treatment Period (TP) (52 Weeks)||1
9019394|NCT03085797|10081967|FG001|Withdrew IP Due to: Protocol Deviation|Treatment Period (TP) (52 Weeks)||0
9019395|NCT03085797|10081966|FG000|Withdrew IP Due to: Stopping Criteria|Treatment Period (TP) (52 Weeks)||1
9019396|NCT03085797|10081967|FG001|Withdrew IP Due to: Stopping Criteria|Treatment Period (TP) (52 Weeks)||1
9019397|NCT03085797|10081966|FG000|Withdrew IP Due to: Physician Decision|Treatment Period (TP) (52 Weeks)||2
9019398|NCT03085797|10081967|FG001|Withdrew IP Due to: Physician Decision|Treatment Period (TP) (52 Weeks)||1
9019399|NCT03085797|10081966|FG000|Withdrew IP Due to: Withdrawal by Par.|Treatment Period (TP) (52 Weeks)||15
9019400|NCT03085797|10081967|FG001|Withdrew IP Due to: Withdrawal by Par.|Treatment Period (TP) (52 Weeks)||12
9019401|NCT03085797|10081966|FG000|COMPLETED|Treatment Period (TP) (52 Weeks)||184
9019402|NCT03085797|10081967|FG001|COMPLETED|Treatment Period (TP) (52 Weeks)||189
9019403|NCT03085797|10081966|FG000|NOT COMPLETED|Treatment Period (TP) (52 Weeks)||17
9019404|NCT03085797|10081967|FG001|NOT COMPLETED|Treatment Period (TP) (52 Weeks)||17
9019405|NCT03085797|10081966|FG000|STARTED|No-treatment Follow-up Period (6 Months)|Only 65 Par. continued in FU to check maintenance of response after stopping treatment per protocol|65
9019406|NCT03085797|10081967|FG001|STARTED|No-treatment Follow-up Period (6 Months)|Only 69 Par. continued in FU to check maintenance of response after stopping treatment per protocol|69
9019407|NCT03085797|10081966|FG000|COMPLETED|No-treatment Follow-up Period (6 Months)||65
9019408|NCT03085797|10081967|FG001|COMPLETED|No-treatment Follow-up Period (6 Months)||68
9019409|NCT03085797|10081966|FG000|NOT COMPLETED|No-treatment Follow-up Period (6 Months)||0
9019410|NCT03085797|10081967|FG001|NOT COMPLETED|No-treatment Follow-up Period (6 Months)||1
9019411|NCT03085836|10081978|FG000|STARTED|Overall Study||12
9019412|NCT03085836|10081979|FG001|STARTED|Overall Study||11
9019413|NCT03085836|10081980|FG002|STARTED|Overall Study||10
9019414|NCT03085836|10081978|FG000|COMPLETED|Overall Study||12
9019415|NCT03085836|10081979|FG001|COMPLETED|Overall Study||11
9019416|NCT03085836|10081980|FG002|COMPLETED|Overall Study||10
9019417|NCT03085836|10081978|FG000|NOT COMPLETED|Overall Study||0
9019418|NCT03085836|10081979|FG001|NOT COMPLETED|Overall Study||0
9019419|NCT03085836|10081980|FG002|NOT COMPLETED|Overall Study||0
9019420|NCT03085914|10081995|FG000|STARTED|Overall Study||9
9019421|NCT03085914|10081996|FG001|STARTED|Overall Study||9
9019422|NCT03085914|10081997|FG002|STARTED|Overall Study||11
9019423|NCT03085914|10081998|FG003|STARTED|Overall Study||9
9019424|NCT03085914|10081999|FG004|STARTED|Overall Study||13
9019425|NCT03085914|10082000|FG005|STARTED|Overall Study||8
9019426|NCT03085914|10082001|FG006|STARTED|Overall Study||11
9019427|NCT03085914|10081995|FG000|COMPLETED|Overall Study||0
9019428|NCT03085914|10081996|FG001|COMPLETED|Overall Study||0
9019429|NCT03085914|10081997|FG002|COMPLETED|Overall Study||0
9019430|NCT03085914|10081998|FG003|COMPLETED|Overall Study||0
9019431|NCT03085914|10081999|FG004|COMPLETED|Overall Study||0
9019432|NCT03085914|10082000|FG005|COMPLETED|Overall Study||0
9019433|NCT03085914|10082001|FG006|COMPLETED|Overall Study||0
9019434|NCT03085914|10081995|FG000|NOT COMPLETED|Overall Study||9
9019435|NCT03085914|10081996|FG001|NOT COMPLETED|Overall Study||9
9019436|NCT03085914|10081997|FG002|NOT COMPLETED|Overall Study||11
9019437|NCT03085914|10081998|FG003|NOT COMPLETED|Overall Study||9
8638563|NCT00576056|9678860|FG000|COMPLETED|Overall Study||5
8638564|NCT00576056|9678860|FG000|NOT COMPLETED|Overall Study||14
8638565|NCT00576147|9678864|FG000|STARTED|Overall Study||431
8638566|NCT00576147|9678864|FG000|COMPLETED|Overall Study||431
8638567|NCT00576147|9678864|FG000|NOT COMPLETED|Overall Study||0
8638568|NCT00576199|9678868|FG000|STARTED|Overall Study||30
8638569|NCT00576199|9678868|FG000|COMPLETED|Overall Study||0
8638570|NCT00576199|9678868|FG000|NOT COMPLETED|Overall Study||30
8638571|NCT00576251|9678874|FG000|STARTED|Overall Study||109
8638572|NCT00576251|9678875|FG001|STARTED|Overall Study||112
8638573|NCT00576251|9678874|FG000|COMPLETED|Overall Study||108
8638574|NCT00576251|9678875|FG001|COMPLETED|Overall Study||111
8638575|NCT00576251|9678874|FG000|NOT COMPLETED|Overall Study||1
8638576|NCT00576251|9678875|FG001|NOT COMPLETED|Overall Study||1
8638577|NCT00576303|9678881|FG000|STARTED|Dose Titration Period||200
8638578|NCT00576303|9678881|FG000|COMPLETED|Dose Titration Period||183
8638579|NCT00576303|9678881|FG000|NOT COMPLETED|Dose Titration Period||17
8638580|NCT00576303|9678881|FG000|STARTED|Efficacy Evaluation Period||183
8638581|NCT00576303|9678881|FG000|COMPLETED|Efficacy Evaluation Period||178
8638582|NCT00576303|9678881|FG000|NOT COMPLETED|Efficacy Evaluation Period||5
8638583|NCT00576303|9678881|FG000|STARTED|Long Term Safety Period||178
8638584|NCT00576303|9678881|FG000|COMPLETED|Long Term Safety Period||162
8638585|NCT00576303|9678881|FG000|NOT COMPLETED|Long Term Safety Period||16
8638586|NCT00576316|9678885|FG000|STARTED|Overall Study|Number of patients recruited|201
8638587|NCT00576316|9678885|FG000|COMPLETED|Overall Study|Number of patients who completed study|181
8638588|NCT00576316|9678885|FG000|NOT COMPLETED|Overall Study||20
8638589|NCT00576381|9678889|FG000|STARTED|Overall Study||30
8638590|NCT00576381|9678889|FG000|COMPLETED|Overall Study||23
8638591|NCT00576381|9678889|FG000|NOT COMPLETED|Overall Study||7
8638592|NCT00576420|9678896|FG000|STARTED|Overall Study||26
8638593|NCT00576420|9678897|FG001|STARTED|Overall Study||24
8638594|NCT00576420|9678898|FG002|STARTED|Overall Study||23
8638595|NCT00576420|9678896|FG000|COMPLETED|Overall Study||26
8638596|NCT00576420|9678897|FG001|COMPLETED|Overall Study||24
8638597|NCT00576420|9678898|FG002|COMPLETED|Overall Study||22
8638598|NCT00576420|9678896|FG000|NOT COMPLETED|Overall Study||0
8638599|NCT00576420|9678897|FG001|NOT COMPLETED|Overall Study||0
8638600|NCT00576420|9678898|FG002|NOT COMPLETED|Overall Study||1
8638601|NCT00576472|9678962|FG000|STARTED|Initial Screening||230
9019438|NCT03085914|10081999|FG004|NOT COMPLETED|Overall Study||13
9019439|NCT03085914|10082000|FG005|NOT COMPLETED|Overall Study||8
9019440|NCT03085914|10082001|FG006|NOT COMPLETED|Overall Study||11
9019441|NCT03085927|10082022|FG000|STARTED|Overall Study||69
9019442|NCT03085927|10082023|FG001|STARTED|Overall Study||67
8638602|NCT00576472|9678963|FG001|STARTED|Initial Screening||40
8638603|NCT00576472|9678964|FG002|STARTED|Initial Screening||199
8638604|NCT00576472|9678965|FG003|STARTED|Initial Screening||0
8638605|NCT00576472|9678966|FG004|STARTED|Initial Screening||0
8638606|NCT00576472|9678967|FG005|STARTED|Initial Screening||0
8638607|NCT00576472|9678968|FG006|STARTED|Initial Screening||0
8638608|NCT00576472|9678969|FG007|STARTED|Initial Screening||0
8638609|NCT00576472|9678970|FG008|STARTED|Initial Screening||0
8638610|NCT00576472|9678971|FG009|STARTED|Initial Screening||0
8638611|NCT00576472|9678972|FG010|STARTED|Initial Screening||0
8638612|NCT00576472|9678973|FG011|STARTED|Initial Screening||0
8638613|NCT00576472|9678974|FG012|STARTED|Initial Screening||0
8638614|NCT00576472|9678975|FG013|STARTED|Initial Screening||0
8638615|NCT00576472|9678976|FG014|STARTED|Initial Screening||0
8638616|NCT00576472|9678962|FG000|COMPLETED|Initial Screening||230
8638617|NCT00576472|9678963|FG001|COMPLETED|Initial Screening||40
8638618|NCT00576472|9678964|FG002|COMPLETED|Initial Screening||199
8638619|NCT00576472|9678965|FG003|COMPLETED|Initial Screening||0
8638620|NCT00576472|9678966|FG004|COMPLETED|Initial Screening||0
8638621|NCT00576472|9678967|FG005|COMPLETED|Initial Screening||0
8638622|NCT00576472|9678968|FG006|COMPLETED|Initial Screening||0
8638623|NCT00576472|9678969|FG007|COMPLETED|Initial Screening||0
8638624|NCT00576472|9678970|FG008|COMPLETED|Initial Screening||0
8638625|NCT00576472|9678971|FG009|COMPLETED|Initial Screening||0
8638626|NCT00576472|9678972|FG010|COMPLETED|Initial Screening||0
8638627|NCT00576472|9678973|FG011|COMPLETED|Initial Screening||0
8638628|NCT00576472|9678974|FG012|COMPLETED|Initial Screening||0
8638629|NCT00576472|9678975|FG013|COMPLETED|Initial Screening||0
9019443|NCT03085927|10082022|FG000|Study Sessions|Overall Study|"Off Study reasons:~Child toxicity/side effects (n=1) Dyad withdrew (n=1) Dyad lost to follow-up (n=2)"|65
9019444|NCT03085927|10082023|FG001|Study Sessions|Overall Study|"Off Study reasons:~Dyad withdrew (n=3) Dyad became ineligible (n=1)"|63
9019445|NCT03085927|10082022|FG000|Time 2 Measures|Overall Study||65
9019446|NCT03085927|10082023|FG001|Time 2 Measures|Overall Study|"Off Study reasons:~Dyad withdrew (n=1)"|62
9019447|NCT03085927|10082022|FG000|COMPLETED|Overall Study|"Off Study reasons:~Death of child (n=1) Dyad lost to follow up (n=1)"|63
9019448|NCT03085927|10082023|FG001|COMPLETED|Overall Study|"Off Study reason:~Dyad lost to follow up (n=1)"|61
9019449|NCT03085927|10082022|FG000|NOT COMPLETED|Overall Study||6
9019450|NCT03085927|10082023|FG001|NOT COMPLETED|Overall Study||6
9019451|NCT03086018|10082031|FG000|STARTED|Field Testing||30
9019452|NCT03086018|10082031|FG000|COMPLETED|Field Testing||30
9019453|NCT03086018|10082031|FG000|NOT COMPLETED|Field Testing||0
9019454|NCT03086018|10082031|FG000|STARTED|Final Testing for End of Trial||30
9019455|NCT03086018|10082031|FG000|COMPLETED|Final Testing for End of Trial||28
9019456|NCT03086018|10082031|FG000|NOT COMPLETED|Final Testing for End of Trial||2
9019457|NCT03086057|10082041|FG000|STARTED|Stage 1: PrEP Uptake||55
9019458|NCT03086057|10082042|FG001|STARTED|Stage 1: PrEP Uptake||55
9019459|NCT03086057|10082043|FG002|STARTED|Stage 1: PrEP Uptake|This intervention was not provided until Stage 2|0
9019460|NCT03086057|10082044|FG003|STARTED|Stage 1: PrEP Uptake|This intervention was not provided until Stage 2|0
9019461|NCT03086057|10082041|FG000|COMPLETED|Stage 1: PrEP Uptake||44
9019462|NCT03086057|10082042|FG001|COMPLETED|Stage 1: PrEP Uptake||45
9019463|NCT03086057|10082043|FG002|COMPLETED|Stage 1: PrEP Uptake||0
9019464|NCT03086057|10082044|FG003|COMPLETED|Stage 1: PrEP Uptake||0
9019465|NCT03086057|10082041|FG000|NOT COMPLETED|Stage 1: PrEP Uptake||11
9019466|NCT03086057|10082042|FG001|NOT COMPLETED|Stage 1: PrEP Uptake||10
9019467|NCT03086057|10082043|FG002|NOT COMPLETED|Stage 1: PrEP Uptake||0
9019468|NCT03086057|10082044|FG003|NOT COMPLETED|Stage 1: PrEP Uptake||0
9019469|NCT03086057|10082041|FG000|STARTED|Stage 2: PrEP Adherence|This was only provided in Stage 1|0
9019470|NCT03086057|10082042|FG001|STARTED|Stage 2: PrEP Adherence|This was only provided in Stage 1|0
9019471|NCT03086057|10082043|FG002|STARTED|Stage 2: PrEP Adherence|Only individuals who completed Stage 1 AND initiated PrEP were randomized in Stage 2.|17
9019472|NCT03086057|10082044|FG003|STARTED|Stage 2: PrEP Adherence|Only individuals who completed Stage 1 AND initiated PrEP were randomized in Stage 2.|18
9019473|NCT03086057|10082041|FG000|COMPLETED|Stage 2: PrEP Adherence||0
9019474|NCT03086057|10082042|FG001|COMPLETED|Stage 2: PrEP Adherence||0
9019475|NCT03086057|10082043|FG002|COMPLETED|Stage 2: PrEP Adherence||11
9019476|NCT03086057|10082044|FG003|COMPLETED|Stage 2: PrEP Adherence||16
9019477|NCT03086057|10082041|FG000|NOT COMPLETED|Stage 2: PrEP Adherence||0
9019478|NCT03086057|10082042|FG001|NOT COMPLETED|Stage 2: PrEP Adherence||0
9019479|NCT03086057|10082043|FG002|NOT COMPLETED|Stage 2: PrEP Adherence||6
9019480|NCT03086057|10082044|FG003|NOT COMPLETED|Stage 2: PrEP Adherence||2
9019481|NCT03086135|10082054|FG000|STARTED|Overall Study||51
9019482|NCT03086135|10082054|FG000|COMPLETED|Overall Study||48
9019483|NCT03086135|10082054|FG000|NOT COMPLETED|Overall Study||3
9019484|NCT03086213|10082058|FG000|STARTED|Overall Study||24
9019485|NCT03086213|10082059|FG001|STARTED|Overall Study||24
9019486|NCT03086213|10082058|FG000|COMPLETED|Overall Study||24
9019487|NCT03086213|10082059|FG001|COMPLETED|Overall Study||24
9019488|NCT03086213|10082058|FG000|NOT COMPLETED|Overall Study||0
9019489|NCT03086213|10082059|FG001|NOT COMPLETED|Overall Study||0
9019490|NCT03086265|10082067|FG000|STARTED|Overall Study||10
9019491|NCT03086265|10082068|FG001|STARTED|Overall Study||10
8727138|NCT01041976|9774561|FG001|18 Month Follow-up|Overall Study||38
8727139|NCT01041976|9774560|FG000|COMPLETED|Overall Study||37
9019492|NCT03086265|10082067|FG000|COMPLETED|Overall Study||10
9019493|NCT03086265|10082068|FG001|COMPLETED|Overall Study||10
9019494|NCT03086265|10082067|FG000|NOT COMPLETED|Overall Study||0
9019495|NCT03086265|10082068|FG001|NOT COMPLETED|Overall Study||0
9019496|NCT03086330|10082076|FG000|STARTED|Overall Study||151
9019497|NCT03086330|10082077|FG001|STARTED|Overall Study||151
9019498|NCT03086330|10082076|FG000|Exposed|Overall Study||150
9019499|NCT03086330|10082077|FG001|Exposed|Overall Study||151
9019500|NCT03086330|10082076|FG000|COMPLETED|Overall Study||147
9019501|NCT03086330|10082077|FG001|COMPLETED|Overall Study||147
9019502|NCT03086330|10082076|FG000|NOT COMPLETED|Overall Study||4
9019503|NCT03086330|10082077|FG001|NOT COMPLETED|Overall Study||4
9019504|NCT03086343|10082085|FG000|STARTED|Overall Study||309
9019505|NCT03086343|10082086|FG001|STARTED|Overall Study||303
9019506|NCT03086343|10082085|FG000|COMPLETED|Overall Study||277
9019507|NCT03086343|10082086|FG001|COMPLETED|Overall Study||278
9019508|NCT03086343|10082085|FG000|NOT COMPLETED|Overall Study||32
9019509|NCT03086343|10082086|FG001|NOT COMPLETED|Overall Study||25
9019510|NCT03086356|10082092|FG000|STARTED|Overall Study||12
9019511|NCT03086356|10082092|FG000|COMPLETED|Overall Study||12
9019512|NCT03086356|10082092|FG000|NOT COMPLETED|Overall Study||0
9019513|NCT03086408|10082098|FG000|STARTED|Overall Study||10
9019514|NCT03086408|10082099|FG001|STARTED|Overall Study||10
9019515|NCT03086408|10082098|FG000|COMPLETED|Overall Study||10
9019516|NCT03086408|10082099|FG001|COMPLETED|Overall Study||10
9019517|NCT03086408|10082098|FG000|NOT COMPLETED|Overall Study||0
9019518|NCT03086408|10082099|FG001|NOT COMPLETED|Overall Study||0
9019519|NCT03086447|10082107|FG000|STARTED|Overall Study||132
9019520|NCT03086447|10082108|FG001|STARTED|Overall Study||130
9019521|NCT03086447|10082107|FG000|COMPLETED|Overall Study||121
9019522|NCT03086447|10082108|FG001|COMPLETED|Overall Study||110
8727140|NCT01041976|9774561|FG001|COMPLETED|Overall Study||38
9019523|NCT03086447|10082107|FG000|NOT COMPLETED|Overall Study||11
9019524|NCT03086447|10082108|FG001|NOT COMPLETED|Overall Study||20
9019525|NCT03086460|10082114|FG000|STARTED|Study Participants||67
9019526|NCT03086460|10082114|FG000|Treatment A|Study Participants||39
9019527|NCT03086460|10082114|FG000|Treatment B|Study Participants||35
9019528|NCT03086460|10082114|FG000|Treatment C|Study Participants||37
9019529|NCT03086460|10082114|FG000|Treatment D|Study Participants||40
9019530|NCT03086460|10082114|FG000|Treatment E|Study Participants||40
9019531|NCT03086460|10082114|FG000|Treatment F|Study Participants||41
9019532|NCT03086460|10082114|FG000|COMPLETED|Study Participants||58
9019533|NCT03086460|10082114|FG000|NOT COMPLETED|Study Participants||9
9019534|NCT03086460|10082114|FG000|STARTED|Treatment A||39
9019535|NCT03086460|10082114|FG000|COMPLETED|Treatment A||35
9019536|NCT03086460|10082114|FG000|NOT COMPLETED|Treatment A||4
9019537|NCT03086460|10082114|FG000|STARTED|Treatment B||35
9019538|NCT03086460|10082114|FG000|COMPLETED|Treatment B||35
9019539|NCT03086460|10082114|FG000|NOT COMPLETED|Treatment B||0
9019540|NCT03086460|10082114|FG000|STARTED|Treatment C||37
9019541|NCT03086460|10082114|FG000|COMPLETED|Treatment C||35
9019542|NCT03086460|10082114|FG000|NOT COMPLETED|Treatment C||2
9019543|NCT03086460|10082114|FG000|STARTED|Treatment D||40
9019544|NCT03086460|10082114|FG000|COMPLETED|Treatment D||40
9019545|NCT03086460|10082114|FG000|NOT COMPLETED|Treatment D||0
9019546|NCT03086460|10082114|FG000|STARTED|Treatment E||40
9019547|NCT03086460|10082114|FG000|COMPLETED|Treatment E||36
9019548|NCT03086460|10082114|FG000|NOT COMPLETED|Treatment E||4
9019549|NCT03086460|10082114|FG000|STARTED|Treatment F||41
8638630|NCT00576472|9678976|FG014|COMPLETED|Initial Screening||0
8638631|NCT00576472|9678962|FG000|NOT COMPLETED|Initial Screening||0
8638632|NCT00576472|9678963|FG001|NOT COMPLETED|Initial Screening||0
9019550|NCT03086460|10082114|FG000|COMPLETED|Treatment F||41
9019551|NCT03086460|10082114|FG000|NOT COMPLETED|Treatment F||0
9019552|NCT03086551|10082131|FG000|STARTED|First Intervention||5
9019553|NCT03086551|10082132|FG001|STARTED|First Intervention||5
8638633|NCT00576472|9678964|FG002|NOT COMPLETED|Initial Screening||0
8638634|NCT00576472|9678965|FG003|NOT COMPLETED|Initial Screening||0
8638635|NCT00576472|9678966|FG004|NOT COMPLETED|Initial Screening||0
8638636|NCT00576472|9678967|FG005|NOT COMPLETED|Initial Screening||0
8638637|NCT00576472|9678968|FG006|NOT COMPLETED|Initial Screening||0
8638638|NCT00576472|9678969|FG007|NOT COMPLETED|Initial Screening||0
8638639|NCT00576472|9678970|FG008|NOT COMPLETED|Initial Screening||0
8638640|NCT00576472|9678971|FG009|NOT COMPLETED|Initial Screening||0
8638641|NCT00576472|9678972|FG010|NOT COMPLETED|Initial Screening||0
8638642|NCT00576472|9678973|FG011|NOT COMPLETED|Initial Screening||0
8638643|NCT00576472|9678974|FG012|NOT COMPLETED|Initial Screening||0
8638644|NCT00576472|9678975|FG013|NOT COMPLETED|Initial Screening||0
8638645|NCT00576472|9678976|FG014|NOT COMPLETED|Initial Screening||0
8638646|NCT00576472|9678962|FG000|STARTED|MPH In-Lab Phase|Group only associated with Screening phase.|0
8638647|NCT00576472|9678963|FG001|STARTED|MPH In-Lab Phase|Group only associated with Screening phase.|0
8638648|NCT00576472|9678964|FG002|STARTED|MPH In-Lab Phase|Group only associated with Screening phase.|0
8638649|NCT00576472|9678965|FG003|STARTED|MPH In-Lab Phase||335
8638650|NCT00576472|9678966|FG004|STARTED|MPH In-Lab Phase||67
8638651|NCT00576472|9678967|FG005|STARTED|MPH In-Lab Phase||67
8638652|NCT00576472|9678968|FG006|STARTED|MPH In-Lab Phase||0
8638653|NCT00576472|9678969|FG007|STARTED|MPH In-Lab Phase||0
8638654|NCT00576472|9678970|FG008|STARTED|MPH In-Lab Phase||0
8638655|NCT00576472|9678971|FG009|STARTED|MPH In-Lab Phase||0
8638656|NCT00576472|9678972|FG010|STARTED|MPH In-Lab Phase||0
8638657|NCT00576472|9678973|FG011|STARTED|MPH In-Lab Phase||0
8638658|NCT00576472|9678974|FG012|STARTED|MPH In-Lab Phase||0
8638659|NCT00576472|9678975|FG013|STARTED|MPH In-Lab Phase||0
8638660|NCT00576472|9678976|FG014|STARTED|MPH In-Lab Phase||0
8638661|NCT00576472|9678962|FG000|COMPLETED|MPH In-Lab Phase||0
8638662|NCT00576472|9678963|FG001|COMPLETED|MPH In-Lab Phase||0
8638663|NCT00576472|9678964|FG002|COMPLETED|MPH In-Lab Phase||0
8638664|NCT00576472|9678965|FG003|COMPLETED|MPH In-Lab Phase||0
8638665|NCT00576472|9678966|FG004|COMPLETED|MPH In-Lab Phase||67
8638666|NCT00576472|9678967|FG005|COMPLETED|MPH In-Lab Phase||67
8638667|NCT00576472|9678968|FG006|COMPLETED|MPH In-Lab Phase||0
8638668|NCT00576472|9678969|FG007|COMPLETED|MPH In-Lab Phase||0
8638669|NCT00576472|9678970|FG008|COMPLETED|MPH In-Lab Phase||0
8638670|NCT00576472|9678971|FG009|COMPLETED|MPH In-Lab Phase||0
8638671|NCT00576472|9678972|FG010|COMPLETED|MPH In-Lab Phase||0
8638672|NCT00576472|9678973|FG011|COMPLETED|MPH In-Lab Phase||0
8638673|NCT00576472|9678974|FG012|COMPLETED|MPH In-Lab Phase||0
8638674|NCT00576472|9678975|FG013|COMPLETED|MPH In-Lab Phase||0
8638675|NCT00576472|9678976|FG014|COMPLETED|MPH In-Lab Phase||0
8638676|NCT00576472|9678962|FG000|NOT COMPLETED|MPH In-Lab Phase||0
8638677|NCT00576472|9678963|FG001|NOT COMPLETED|MPH In-Lab Phase||0
8638678|NCT00576472|9678964|FG002|NOT COMPLETED|MPH In-Lab Phase||0
8638679|NCT00576472|9678965|FG003|NOT COMPLETED|MPH In-Lab Phase||335
8638680|NCT00576472|9678966|FG004|NOT COMPLETED|MPH In-Lab Phase||0
8638681|NCT00576472|9678967|FG005|NOT COMPLETED|MPH In-Lab Phase||0
8638682|NCT00576472|9678968|FG006|NOT COMPLETED|MPH In-Lab Phase||0
8638683|NCT00576472|9678969|FG007|NOT COMPLETED|MPH In-Lab Phase||0
8638684|NCT00576472|9678970|FG008|NOT COMPLETED|MPH In-Lab Phase||0
8638685|NCT00576472|9678971|FG009|NOT COMPLETED|MPH In-Lab Phase||0
9019554|NCT03086551|10082131|FG000|COMPLETED|First Intervention||4
9019555|NCT03086551|10082132|FG001|COMPLETED|First Intervention||4
9019556|NCT03086551|10082131|FG000|NOT COMPLETED|First Intervention||1
8638686|NCT00576472|9678972|FG010|NOT COMPLETED|MPH In-Lab Phase||0
8638687|NCT00576472|9678973|FG011|NOT COMPLETED|MPH In-Lab Phase||0
8638688|NCT00576472|9678974|FG012|NOT COMPLETED|MPH In-Lab Phase||0
8638689|NCT00576472|9678975|FG013|NOT COMPLETED|MPH In-Lab Phase||0
8638690|NCT00576472|9678976|FG014|NOT COMPLETED|MPH In-Lab Phase||0
8638691|NCT00576472|9678962|FG000|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
8638692|NCT00576472|9678963|FG001|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
8638693|NCT00576472|9678964|FG002|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
8638694|NCT00576472|9678965|FG003|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
8638695|NCT00576472|9678966|FG004|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
8638696|NCT00576472|9678967|FG005|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
8638697|NCT00576472|9678968|FG006|STARTED|MPH Cross Over Phase||12
8638698|NCT00576472|9678969|FG007|STARTED|MPH Cross Over Phase||20
8638699|NCT00576472|9678970|FG008|STARTED|MPH Cross Over Phase||18
8638700|NCT00576472|9678971|FG009|STARTED|MPH Cross Over Phase||22
8638701|NCT00576472|9678972|FG010|STARTED|MPH Cross Over Phase||23
8638702|NCT00576472|9678973|FG011|STARTED|MPH Cross Over Phase||18
8638703|NCT00576472|9678974|FG012|STARTED|MPH Cross Over Phase||21
8638704|NCT00576472|9678975|FG013|STARTED|MPH Cross Over Phase||0
8638705|NCT00576472|9678976|FG014|STARTED|MPH Cross Over Phase||0
8638706|NCT00576472|9678962|FG000|COMPLETED|MPH Cross Over Phase||0
8638707|NCT00576472|9678963|FG001|COMPLETED|MPH Cross Over Phase||0
8638708|NCT00576472|9678964|FG002|COMPLETED|MPH Cross Over Phase||0
8638709|NCT00576472|9678965|FG003|COMPLETED|MPH Cross Over Phase||0
8638710|NCT00576472|9678966|FG004|COMPLETED|MPH Cross Over Phase||0
8638711|NCT00576472|9678967|FG005|COMPLETED|MPH Cross Over Phase||0
8638712|NCT00576472|9678968|FG006|COMPLETED|MPH Cross Over Phase||0
8638713|NCT00576472|9678969|FG007|COMPLETED|MPH Cross Over Phase||20
8638714|NCT00576472|9678970|FG008|COMPLETED|MPH Cross Over Phase||16
8638715|NCT00576472|9678971|FG009|COMPLETED|MPH Cross Over Phase||22
8638716|NCT00576472|9678972|FG010|COMPLETED|MPH Cross Over Phase||22
8638717|NCT00576472|9678973|FG011|COMPLETED|MPH Cross Over Phase||17
8638718|NCT00576472|9678974|FG012|COMPLETED|MPH Cross Over Phase||21
8638719|NCT00576472|9678975|FG013|COMPLETED|MPH Cross Over Phase||0
8638720|NCT00576472|9678976|FG014|COMPLETED|MPH Cross Over Phase||0
8638721|NCT00576472|9678962|FG000|NOT COMPLETED|MPH Cross Over Phase||0
8638722|NCT00576472|9678963|FG001|NOT COMPLETED|MPH Cross Over Phase||0
8638723|NCT00576472|9678964|FG002|NOT COMPLETED|MPH Cross Over Phase||0
8638724|NCT00576472|9678965|FG003|NOT COMPLETED|MPH Cross Over Phase||0
8638725|NCT00576472|9678966|FG004|NOT COMPLETED|MPH Cross Over Phase||0
8638726|NCT00576472|9678967|FG005|NOT COMPLETED|MPH Cross Over Phase||0
8638727|NCT00576472|9678968|FG006|NOT COMPLETED|MPH Cross Over Phase||12
8638728|NCT00576472|9678969|FG007|NOT COMPLETED|MPH Cross Over Phase||0
8638729|NCT00576472|9678970|FG008|NOT COMPLETED|MPH Cross Over Phase||2
8638730|NCT00576472|9678971|FG009|NOT COMPLETED|MPH Cross Over Phase||0
8638731|NCT00576472|9678972|FG010|NOT COMPLETED|MPH Cross Over Phase||1
8638732|NCT00576472|9678973|FG011|NOT COMPLETED|MPH Cross Over Phase||1
8638733|NCT00576472|9678974|FG012|NOT COMPLETED|MPH Cross Over Phase||0
8638734|NCT00576472|9678975|FG013|NOT COMPLETED|MPH Cross Over Phase||0
8638735|NCT00576472|9678976|FG014|NOT COMPLETED|MPH Cross Over Phase||0
8638736|NCT00576472|9678962|FG000|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
8638737|NCT00576472|9678963|FG001|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
8638738|NCT00576472|9678964|FG002|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
8638739|NCT00576472|9678965|FG003|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
8638740|NCT00576472|9678966|FG004|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
8638741|NCT00576472|9678967|FG005|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
8638742|NCT00576472|9678968|FG006|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
8638743|NCT00576472|9678969|FG007|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
8638744|NCT00576472|9678970|FG008|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
8638745|NCT00576472|9678971|FG009|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
8638746|NCT00576472|9678972|FG010|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
8638747|NCT00576472|9678973|FG011|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
8638748|NCT00576472|9678974|FG012|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
9019557|NCT03086551|10082132|FG001|NOT COMPLETED|First Intervention||1
9019558|NCT03086551|10082131|FG000|STARTED|Washout||4
9019559|NCT03086551|10082132|FG001|STARTED|Washout||4
9019560|NCT03086551|10082131|FG000|COMPLETED|Washout||1
9019561|NCT03086551|10082132|FG001|COMPLETED|Washout||1
9019562|NCT03086551|10082131|FG000|NOT COMPLETED|Washout||3
9019563|NCT03086551|10082132|FG001|NOT COMPLETED|Washout||3
9019564|NCT03086551|10082131|FG000|STARTED|Second Intervention||1
8638749|NCT00576472|9678975|FG013|STARTED|MPH Home Maintenance Phase||27
9019565|NCT03086551|10082132|FG001|STARTED|Second Intervention||1
9019566|NCT03086551|10082131|FG000|COMPLETED|Second Intervention||1
9019567|NCT03086551|10082132|FG001|COMPLETED|Second Intervention||1
9019568|NCT03086551|10082131|FG000|NOT COMPLETED|Second Intervention||0
9019569|NCT03086551|10082132|FG001|NOT COMPLETED|Second Intervention||0
9039888|NCT03343067|10100820|FG000|NOT COMPLETED|Open Label Period: Day 1 to Month 3||7
9039889|NCT03343067|10100821|FG001|NOT COMPLETED|Open Label Period: Day 1 to Month 3||0
9039890|NCT03343067|10100822|FG002|NOT COMPLETED|Open Label Period: Day 1 to Month 3||0
9039891|NCT03343067|10100820|FG000|STARTED|Double Blind Period: Month 3 to Month 6||0
8638750|NCT00576472|9678976|FG014|STARTED|MPH Home Maintenance Phase||91
8638751|NCT00576472|9678962|FG000|COMPLETED|MPH Home Maintenance Phase||0
8638752|NCT00576472|9678963|FG001|COMPLETED|MPH Home Maintenance Phase||0
8638753|NCT00576472|9678964|FG002|COMPLETED|MPH Home Maintenance Phase||0
8638754|NCT00576472|9678965|FG003|COMPLETED|MPH Home Maintenance Phase||0
8638755|NCT00576472|9678966|FG004|COMPLETED|MPH Home Maintenance Phase||0
8638756|NCT00576472|9678967|FG005|COMPLETED|MPH Home Maintenance Phase||0
8638757|NCT00576472|9678968|FG006|COMPLETED|MPH Home Maintenance Phase||0
8638758|NCT00576472|9678969|FG007|COMPLETED|MPH Home Maintenance Phase||0
8638759|NCT00576472|9678970|FG008|COMPLETED|MPH Home Maintenance Phase||0
8638760|NCT00576472|9678971|FG009|COMPLETED|MPH Home Maintenance Phase||0
8638761|NCT00576472|9678972|FG010|COMPLETED|MPH Home Maintenance Phase||0
8638762|NCT00576472|9678973|FG011|COMPLETED|MPH Home Maintenance Phase||0
8638763|NCT00576472|9678974|FG012|COMPLETED|MPH Home Maintenance Phase||0
8638764|NCT00576472|9678975|FG013|COMPLETED|MPH Home Maintenance Phase||0
8638765|NCT00576472|9678976|FG014|COMPLETED|MPH Home Maintenance Phase||68
8638766|NCT00576472|9678962|FG000|NOT COMPLETED|MPH Home Maintenance Phase||0
8638767|NCT00576472|9678963|FG001|NOT COMPLETED|MPH Home Maintenance Phase||0
8638768|NCT00576472|9678964|FG002|NOT COMPLETED|MPH Home Maintenance Phase||0
8638769|NCT00576472|9678965|FG003|NOT COMPLETED|MPH Home Maintenance Phase||0
8638770|NCT00576472|9678966|FG004|NOT COMPLETED|MPH Home Maintenance Phase||0
8638771|NCT00576472|9678967|FG005|NOT COMPLETED|MPH Home Maintenance Phase||0
8638772|NCT00576472|9678968|FG006|NOT COMPLETED|MPH Home Maintenance Phase||0
8638773|NCT00576472|9678969|FG007|NOT COMPLETED|MPH Home Maintenance Phase||0
8638774|NCT00576472|9678970|FG008|NOT COMPLETED|MPH Home Maintenance Phase||0
8638775|NCT00576472|9678971|FG009|NOT COMPLETED|MPH Home Maintenance Phase||0
8638776|NCT00576472|9678972|FG010|NOT COMPLETED|MPH Home Maintenance Phase||0
8638777|NCT00576472|9678973|FG011|NOT COMPLETED|MPH Home Maintenance Phase||0
8638778|NCT00576472|9678974|FG012|NOT COMPLETED|MPH Home Maintenance Phase||0
8638779|NCT00576472|9678975|FG013|NOT COMPLETED|MPH Home Maintenance Phase||27
8638780|NCT00576472|9678976|FG014|NOT COMPLETED|MPH Home Maintenance Phase||23
8638781|NCT00576576|9679007|FG000|STARTED|Overall Study||27
8638782|NCT00576576|9679007|FG000|COMPLETED|Overall Study||20
8638783|NCT00576576|9679007|FG000|NOT COMPLETED|Overall Study||7
8638784|NCT00576628|9679011|FG000|STARTED|Overall Study||125
8638785|NCT00576628|9679011|FG000|COMPLETED|Overall Study||82
8638786|NCT00576628|9679011|FG000|NOT COMPLETED|Overall Study||43
8638787|NCT00576680|9679016|FG000|STARTED|Overall Study||43
8638788|NCT00576680|9679016|FG000|COMPLETED|Overall Study||43
8638789|NCT00576680|9679016|FG000|NOT COMPLETED|Overall Study||0
8638790|NCT00576693|9679022|FG000|STARTED|Overall Study||224
8638791|NCT00576693|9679023|FG001|STARTED|Overall Study||227
8638792|NCT00576693|9679022|FG000|COMPLETED|Overall Study||214
8638793|NCT00576693|9679023|FG001|COMPLETED|Overall Study||203
8638794|NCT00576693|9679022|FG000|NOT COMPLETED|Overall Study||10
8638795|NCT00576693|9679023|FG001|NOT COMPLETED|Overall Study||24
8638796|NCT00576732|9679032|FG000|STARTED|DOUBLE BLIND||35
8638797|NCT00576732|9679033|FG001|STARTED|DOUBLE BLIND||30
8638798|NCT00576732|9679034|FG002|STARTED|DOUBLE BLIND||31
8638799|NCT00576732|9679035|FG003|STARTED|DOUBLE BLIND||0
8638800|NCT00576732|9679036|FG004|STARTED|DOUBLE BLIND||0
8638801|NCT00576732|9679037|FG005|STARTED|DOUBLE BLIND||0
8638802|NCT00576732|9679032|FG000|COMPLETED|DOUBLE BLIND||27
8638803|NCT00576732|9679033|FG001|COMPLETED|DOUBLE BLIND||25
8638804|NCT00576732|9679034|FG002|COMPLETED|DOUBLE BLIND||25
8638805|NCT00576732|9679035|FG003|COMPLETED|DOUBLE BLIND||0
8638806|NCT00576732|9679036|FG004|COMPLETED|DOUBLE BLIND||0
8638807|NCT00576732|9679037|FG005|COMPLETED|DOUBLE BLIND||0
9039892|NCT03343067|10100821|FG001|STARTED|Double Blind Period: Month 3 to Month 6||3
9039893|NCT03343067|10100822|FG002|STARTED|Double Blind Period: Month 3 to Month 6||1
9039894|NCT03343067|10100820|FG000|COMPLETED|Double Blind Period: Month 3 to Month 6||0
9039895|NCT03343067|10100821|FG001|COMPLETED|Double Blind Period: Month 3 to Month 6||0
9039896|NCT03343067|10100822|FG002|COMPLETED|Double Blind Period: Month 3 to Month 6||0
8638808|NCT00576732|9679032|FG000|NOT COMPLETED|DOUBLE BLIND||8
8638809|NCT00576732|9679033|FG001|NOT COMPLETED|DOUBLE BLIND||5
8638810|NCT00576732|9679034|FG002|NOT COMPLETED|DOUBLE BLIND||6
8638811|NCT00576732|9679035|FG003|NOT COMPLETED|DOUBLE BLIND||0
8638812|NCT00576732|9679036|FG004|NOT COMPLETED|DOUBLE BLIND||0
8638813|NCT00576732|9679037|FG005|NOT COMPLETED|DOUBLE BLIND||0
8638814|NCT00576732|9679032|FG000|STARTED|OPEN LABEL||0
8638815|NCT00576732|9679033|FG001|STARTED|OPEN LABEL||0
8638816|NCT00576732|9679034|FG002|STARTED|OPEN LABEL||0
8638817|NCT00576732|9679035|FG003|STARTED|OPEN LABEL|26 of 27 double-blind placebo completers and 4 of 8 placebo non-completers entered open-label.|30
8638818|NCT00576732|9679036|FG004|STARTED|OPEN LABEL|24 of 25 double-blind RIS low dose completers and 0 RIS low dose non-completers entered open-label.|24
8638819|NCT00576732|9679037|FG005|STARTED|OPEN LABEL|All 25 double-blind RIS high dose completers and 0 RIS high dose non-completers entered open-label.|25
9019570|NCT03086707|10082140|FG000|STARTED|Overall Study||7
9019571|NCT03086707|10082141|FG001|STARTED|Overall Study||7
9019572|NCT03086707|10082140|FG000|COMPLETED|Overall Study||7
9019573|NCT03086707|10082141|FG001|COMPLETED|Overall Study||7
9019574|NCT03086707|10082140|FG000|NOT COMPLETED|Overall Study||0
9019575|NCT03086707|10082141|FG001|NOT COMPLETED|Overall Study||0
9019576|NCT03087019|10082151|FG000|STARTED|Overall Study||11
9019577|NCT03087019|10082152|FG001|STARTED|Overall Study||10
9019578|NCT03087019|10082151|FG000|COMPLETED|Overall Study||10
9019579|NCT03087019|10082152|FG001|COMPLETED|Overall Study||10
9019580|NCT03087019|10082151|FG000|NOT COMPLETED|Overall Study||1
9019581|NCT03087019|10082152|FG001|NOT COMPLETED|Overall Study||0
9019582|NCT03087513|10082158|FG000|STARTED|First Intervention||40
9019583|NCT03087513|10082158|FG000|COMPLETED|First Intervention||40
9019584|NCT03087513|10082158|FG000|NOT COMPLETED|First Intervention||0
9019585|NCT03087513|10082158|FG000|STARTED|Second Intervention After 3 hr Washout||40
9019586|NCT03087513|10082158|FG000|COMPLETED|Second Intervention After 3 hr Washout||38
9019587|NCT03087513|10082158|FG000|NOT COMPLETED|Second Intervention After 3 hr Washout||2
9019588|NCT03087604|10082173|FG000|STARTED|Overall Study||50
9019589|NCT03087604|10082174|FG001|STARTED|Overall Study||50
9019590|NCT03087604|10082173|FG000|COMPLETED|Overall Study||50
9019591|NCT03087604|10082174|FG001|COMPLETED|Overall Study||50
9019592|NCT03087604|10082173|FG000|NOT COMPLETED|Overall Study||0
9019593|NCT03087604|10082174|FG001|NOT COMPLETED|Overall Study||0
9019594|NCT03087643|10082182|FG000|STARTED|Overall Study||26
9019595|NCT03087643|10082183|FG001|STARTED|Overall Study||25
8638820|NCT00576732|9679032|FG000|COMPLETED|OPEN LABEL||0
8638821|NCT00576732|9679033|FG001|COMPLETED|OPEN LABEL||0
8638822|NCT00576732|9679034|FG002|COMPLETED|OPEN LABEL||0
9019596|NCT03087643|10082182|FG000|COMPLETED|Overall Study||22
9019597|NCT03087643|10082183|FG001|COMPLETED|Overall Study||19
9019598|NCT03087643|10082182|FG000|NOT COMPLETED|Overall Study||4
9019599|NCT03087643|10082183|FG001|NOT COMPLETED|Overall Study||6
9019600|NCT03087786|10082191|FG000|STARTED|Overall Study||50
9019601|NCT03087786|10082192|FG001|STARTED|Overall Study||50
9019602|NCT03087786|10082191|FG000|COMPLETED|Overall Study||48
9019603|NCT03087786|10082192|FG001|COMPLETED|Overall Study||50
9019604|NCT03087786|10082191|FG000|NOT COMPLETED|Overall Study||2
9019605|NCT03087786|10082192|FG001|NOT COMPLETED|Overall Study||0
9019606|NCT03087851|10082201|FG000|STARTED|Overall Study||20
9019607|NCT03087851|10082202|FG001|STARTED|Overall Study||20
9019608|NCT03087851|10082203|FG002|STARTED|Overall Study||21
9019609|NCT03087851|10082201|FG000|COMPLETED|Overall Study||20
9019610|NCT03087851|10082202|FG001|COMPLETED|Overall Study||19
9019611|NCT03087851|10082203|FG002|COMPLETED|Overall Study||19
9019612|NCT03087851|10082201|FG000|NOT COMPLETED|Overall Study||0
9019613|NCT03087851|10082202|FG001|NOT COMPLETED|Overall Study||1
9019614|NCT03087851|10082203|FG002|NOT COMPLETED|Overall Study||2
9019615|NCT03088267|10082211|FG000|STARTED|Overall Study||9
9019616|NCT03088267|10082212|FG001|STARTED|Overall Study||9
9019617|NCT03088267|10082211|FG000|COMPLETED|Overall Study||9
9019618|NCT03088267|10082212|FG001|COMPLETED|Overall Study||9
9019619|NCT03088267|10082211|FG000|NOT COMPLETED|Overall Study||0
9019620|NCT03088267|10082212|FG001|NOT COMPLETED|Overall Study||0
9019621|NCT03088345|10082221|FG000|STARTED|Overall Study||10
9019622|NCT03088345|10082222|FG001|STARTED|Overall Study||10
9019623|NCT03088345|10082221|FG000|COMPLETED|Overall Study||10
9019624|NCT03088345|10082222|FG001|COMPLETED|Overall Study||10
8638823|NCT00576732|9679035|FG003|COMPLETED|OPEN LABEL||19
8638824|NCT00576732|9679036|FG004|COMPLETED|OPEN LABEL||20
8638825|NCT00576732|9679037|FG005|COMPLETED|OPEN LABEL||17
8638826|NCT00576732|9679032|FG000|NOT COMPLETED|OPEN LABEL||0
8638827|NCT00576732|9679033|FG001|NOT COMPLETED|OPEN LABEL||0
8638828|NCT00576732|9679034|FG002|NOT COMPLETED|OPEN LABEL||0
8638829|NCT00576732|9679035|FG003|NOT COMPLETED|OPEN LABEL||11
8638830|NCT00576732|9679036|FG004|NOT COMPLETED|OPEN LABEL||4
8638831|NCT00576732|9679037|FG005|NOT COMPLETED|OPEN LABEL||8
8638832|NCT00576758|9679051|FG000|STARTED|Induction Treatment Period||87
8638833|NCT00576758|9679052|FG001|STARTED|Induction Treatment Period||88
8638834|NCT00576758|9679051|FG000|Received Treatment|Induction Treatment Period||86
9019625|NCT03088345|10082221|FG000|NOT COMPLETED|Overall Study||0
9019626|NCT03088345|10082222|FG001|NOT COMPLETED|Overall Study||0
9019627|NCT03088748|10082230|FG000|STARTED|Overall Study||40
9019628|NCT03088748|10082231|FG001|STARTED|Overall Study||10
9019629|NCT03088748|10082230|FG000|COMPLETED|Overall Study||40
9019630|NCT03088748|10082231|FG001|COMPLETED|Overall Study||10
9019631|NCT03088748|10082230|FG000|NOT COMPLETED|Overall Study||0
9019632|NCT03088748|10082231|FG001|NOT COMPLETED|Overall Study||0
9019633|NCT03088800|10082240|FG000|STARTED|Overall Study||30
9019634|NCT03088800|10082241|FG001|STARTED|Overall Study||30
9019635|NCT03088800|10082242|FG002|STARTED|Overall Study||30
9019636|NCT03088800|10082240|FG000|COMPLETED|Overall Study||30
9019637|NCT03088800|10082241|FG001|COMPLETED|Overall Study||30
9019638|NCT03088800|10082242|FG002|COMPLETED|Overall Study||30
9019639|NCT03088800|10082240|FG000|NOT COMPLETED|Overall Study||0
9019640|NCT03088800|10082241|FG001|NOT COMPLETED|Overall Study||0
9019641|NCT03088800|10082242|FG002|NOT COMPLETED|Overall Study||0
9019642|NCT03088917|10082250|FG000|STARTED|Overall Study||106
9019643|NCT03088917|10082250|FG000|COMPLETED|Overall Study||10
8638835|NCT00576758|9679052|FG001|Received Treatment|Induction Treatment Period||87
8638836|NCT00576758|9679051|FG000|COMPLETED|Induction Treatment Period||79
8638837|NCT00576758|9679052|FG001|COMPLETED|Induction Treatment Period||83
9019644|NCT03088917|10082250|FG000|NOT COMPLETED|Overall Study||96
9019645|NCT03089047|10082258|FG000|STARTED|Overall Study||2
9019646|NCT03089047|10082259|FG001|STARTED|Overall Study||2
9019647|NCT03089047|10082258|FG000|COMPLETED|Overall Study||1
9019648|NCT03089047|10082259|FG001|COMPLETED|Overall Study||2
9019649|NCT03089047|10082258|FG000|NOT COMPLETED|Overall Study||1
9019650|NCT03089047|10082259|FG001|NOT COMPLETED|Overall Study||0
9019651|NCT03089216|10082269|FG000|STARTED|Overall Study||27
9019652|NCT03089216|10082270|FG001|STARTED|Overall Study||27
9019653|NCT03089216|10082271|FG002|STARTED|Overall Study||27
9019654|NCT03089216|10082272|FG003|STARTED|Overall Study||27
9019655|NCT03089216|10082269|FG000|COMPLETED|Overall Study||27
9019656|NCT03089216|10082270|FG001|COMPLETED|Overall Study||27
9019657|NCT03089216|10082271|FG002|COMPLETED|Overall Study||27
9019658|NCT03089216|10082272|FG003|COMPLETED|Overall Study||26
9019659|NCT03089216|10082269|FG000|NOT COMPLETED|Overall Study||0
9019660|NCT03089216|10082270|FG001|NOT COMPLETED|Overall Study||0
9019661|NCT03089216|10082271|FG002|NOT COMPLETED|Overall Study||0
9019662|NCT03089216|10082272|FG003|NOT COMPLETED|Overall Study||1
9019663|NCT03089580|10082286|FG000|STARTED|Overall Study||14
9019664|NCT03089580|10082286|FG000|COMPLETED|Overall Study||12
9019665|NCT03089580|10082286|FG000|NOT COMPLETED|Overall Study||2
9019666|NCT03089697|10082294|FG000|STARTED|Overall Study||13
9019667|NCT03089697|10082295|FG001|STARTED|Overall Study||12
9019668|NCT03089697|10082294|FG000|COMPLETED|Overall Study||11
9019669|NCT03089697|10082295|FG001|COMPLETED|Overall Study||10
9019670|NCT03089697|10082294|FG000|NOT COMPLETED|Overall Study||2
9019671|NCT03089697|10082295|FG001|NOT COMPLETED|Overall Study||2
9019672|NCT03089879|10082304|FG000|STARTED|Overall Study||7
9019673|NCT03089879|10082305|FG001|STARTED|Overall Study||2
9019674|NCT03089879|10082306|FG002|STARTED|Overall Study||26
8727141|NCT01041976|9774560|FG000|NOT COMPLETED|Overall Study||5
8727142|NCT01041976|9774561|FG001|NOT COMPLETED|Overall Study||4
8727143|NCT01042093|9774571|FG000|STARTED|Overall Study||40
8727144|NCT01042093|9774572|FG001|STARTED|Overall Study||40
9019675|NCT03089879|10082304|FG000|COMPLETED|Overall Study||7
9019676|NCT03089879|10082305|FG001|COMPLETED|Overall Study||2
9019677|NCT03089879|10082306|FG002|COMPLETED|Overall Study||26
9019678|NCT03089879|10082304|FG000|NOT COMPLETED|Overall Study||0
9019679|NCT03089879|10082305|FG001|NOT COMPLETED|Overall Study||0
9019680|NCT03089879|10082306|FG002|NOT COMPLETED|Overall Study||0
9019681|NCT03089944|10082315|FG000|STARTED|Overall Study||343
9019682|NCT03089944|10082315|FG000|COMPLETED|Overall Study||331
9019683|NCT03089944|10082315|FG000|NOT COMPLETED|Overall Study||12
9019684|NCT03090100|10082321|FG000|STARTED|Overall Study||534
9019685|NCT03090100|10082322|FG001|STARTED|Overall Study||514
9019686|NCT03090100|10082321|FG000|Treated|Overall Study||534
9019687|NCT03090100|10082322|FG001|Treated|Overall Study||511
9019688|NCT03090100|10082321|FG000|COMPLETED|Overall Study||507
9019689|NCT03090100|10082322|FG001|COMPLETED|Overall Study||466
9019690|NCT03090100|10082321|FG000|NOT COMPLETED|Overall Study||27
9019691|NCT03090100|10082322|FG001|NOT COMPLETED|Overall Study||48
9019692|NCT03090256|10082328|FG000|STARTED|Overall Study||68
9019693|NCT03090256|10082328|FG000|COMPLETED|Overall Study||68
9019694|NCT03090256|10082328|FG000|NOT COMPLETED|Overall Study||0
9019695|NCT03090620|10082335|FG000|STARTED|Overall Study||9
9019696|NCT03090620|10082336|FG001|STARTED|Overall Study||10
9019697|NCT03090620|10082335|FG000|COMPLETED|Overall Study||9
9019698|NCT03090620|10082336|FG001|COMPLETED|Overall Study||10
9019699|NCT03090620|10082335|FG000|NOT COMPLETED|Overall Study||0
9019700|NCT03090620|10082336|FG001|NOT COMPLETED|Overall Study||0
9019701|NCT03090958|10082342|FG000|STARTED|Overall Study||20
9019702|NCT03090958|10082342|FG000|COMPLETED|Overall Study||20
9019703|NCT03090958|10082342|FG000|NOT COMPLETED|Overall Study||0
9019704|NCT03091179|10082348|FG000|STARTED|Overall Study||10
9019705|NCT03091179|10082349|FG001|STARTED|Overall Study||10
9019706|NCT03091179|10082348|FG000|COMPLETED|Overall Study||10
9019707|NCT03091179|10082349|FG001|COMPLETED|Overall Study||10
9019708|NCT03091179|10082348|FG000|NOT COMPLETED|Overall Study||0
9019709|NCT03091179|10082349|FG001|NOT COMPLETED|Overall Study||0
9019710|NCT03091348|10082357|FG000|STARTED|Overall Study||2
9019711|NCT03091348|10082358|FG001|STARTED|Overall Study||2
9019712|NCT03091348|10082357|FG000|COMPLETED|Overall Study||0
9019713|NCT03091348|10082358|FG001|COMPLETED|Overall Study||1
9019714|NCT03091348|10082357|FG000|NOT COMPLETED|Overall Study||2
9019715|NCT03091348|10082358|FG001|NOT COMPLETED|Overall Study||1
9019716|NCT03091361|10082365|FG000|STARTED|Overall Study||30
8638838|NCT00576758|9679051|FG000|NOT COMPLETED|Induction Treatment Period||8
8638839|NCT00576758|9679052|FG001|NOT COMPLETED|Induction Treatment Period||5
9019717|NCT03091361|10082365|FG000|COMPLETED|Overall Study||30
9019718|NCT03091361|10082365|FG000|NOT COMPLETED|Overall Study||0
9019719|NCT03091400|10082371|FG000|STARTED|Phase 1 - 6 Weeks||5
9019720|NCT03091400|10082372|FG001|STARTED|Phase 1 - 6 Weeks||6
9019721|NCT03091400|10082371|FG000|COMPLETED|Phase 1 - 6 Weeks||5
9019722|NCT03091400|10082372|FG001|COMPLETED|Phase 1 - 6 Weeks||6
9019723|NCT03091400|10082371|FG000|NOT COMPLETED|Phase 1 - 6 Weeks||0
9019724|NCT03091400|10082372|FG001|NOT COMPLETED|Phase 1 - 6 Weeks||0
9019725|NCT03091400|10082371|FG000|STARTED|Washout - 2 Weeks||5
9019726|NCT03091400|10082372|FG001|STARTED|Washout - 2 Weeks||6
9019727|NCT03091400|10082371|FG000|COMPLETED|Washout - 2 Weeks||4
9019728|NCT03091400|10082372|FG001|COMPLETED|Washout - 2 Weeks||6
8727145|NCT01042093|9774573|FG002|STARTED|Overall Study||40
8727146|NCT01042093|9774574|FG003|STARTED|Overall Study||40
9019729|NCT03091400|10082371|FG000|NOT COMPLETED|Washout - 2 Weeks||1
9019730|NCT03091400|10082372|FG001|NOT COMPLETED|Washout - 2 Weeks||0
9019731|NCT03091400|10082371|FG000|STARTED|Phase 2 - 6 Weeks||4
9019732|NCT03091400|10082372|FG001|STARTED|Phase 2 - 6 Weeks||6
9019733|NCT03091400|10082371|FG000|COMPLETED|Phase 2 - 6 Weeks||4
9019734|NCT03091400|10082372|FG001|COMPLETED|Phase 2 - 6 Weeks||6
9019735|NCT03091400|10082371|FG000|NOT COMPLETED|Phase 2 - 6 Weeks||0
9019736|NCT03091400|10082372|FG001|NOT COMPLETED|Phase 2 - 6 Weeks||0
9019737|NCT03091439|10082380|FG000|STARTED|Overall Study||1
9019738|NCT03091439|10082381|FG001|STARTED|Overall Study||0
9019739|NCT03091439|10082380|FG000|COMPLETED|Overall Study||0
9019740|NCT03091439|10082381|FG001|COMPLETED|Overall Study||0
9019741|NCT03091439|10082380|FG000|NOT COMPLETED|Overall Study||1
9019742|NCT03091439|10082381|FG001|NOT COMPLETED|Overall Study||0
9019743|NCT03091478|10082387|FG000|STARTED|Overall Study||13
9019744|NCT03091478|10082387|FG000|COMPLETED|Overall Study||13
9019745|NCT03091478|10082387|FG000|NOT COMPLETED|Overall Study||0
9019746|NCT03091673|10082394|FG000|STARTED|First Dose||31
9019747|NCT03091673|10082395|FG001|STARTED|First Dose|All 31 subjects received the 0.5 mg dose during period 1.|0
9019748|NCT03091673|10082394|FG000|COMPLETED|First Dose||31
9019749|NCT03091673|10082395|FG001|COMPLETED|First Dose||0
9019750|NCT03091673|10082394|FG000|NOT COMPLETED|First Dose||0
9019751|NCT03091673|10082395|FG001|NOT COMPLETED|First Dose||0
9019752|NCT03091673|10082394|FG000|STARTED|Second Dose|No subjects received the 0.5 mg dose during period 2.|0
9019753|NCT03091673|10082395|FG001|STARTED|Second Dose|Only the 11 study subjects ages 12-<18 years were assigned the 1 mg dose during period 2.|11
9019754|NCT03091673|10082394|FG000|COMPLETED|Second Dose||0
9019755|NCT03091673|10082395|FG001|COMPLETED|Second Dose||11
9019756|NCT03091673|10082394|FG000|NOT COMPLETED|Second Dose||0
9019757|NCT03091673|10082395|FG001|NOT COMPLETED|Second Dose||0
9019758|NCT03091738|10082406|FG000|STARTED|Overall Study||10
9019759|NCT03091738|10082406|FG000|COMPLETED|Overall Study||8
9019760|NCT03091738|10082406|FG000|NOT COMPLETED|Overall Study||2
9019761|NCT03091751|10082410|FG000|STARTED|Overall Study||22
9019762|NCT03091751|10082410|FG000|COMPLETED|Overall Study||22
9019763|NCT03091751|10082410|FG000|NOT COMPLETED|Overall Study||0
9019764|NCT03091777|10082417|FG000|STARTED|Overall Study||289
9019765|NCT03091777|10082418|FG001|STARTED|Overall Study||288
9019766|NCT03091777|10082419|FG002|STARTED|Overall Study||294
9019767|NCT03091777|10082417|FG000|COMPLETED|Overall Study||257
9019768|NCT03091777|10082418|FG001|COMPLETED|Overall Study||255
9019769|NCT03091777|10082419|FG002|COMPLETED|Overall Study||257
9019770|NCT03091777|10082417|FG000|NOT COMPLETED|Overall Study||32
9019771|NCT03091777|10082418|FG001|NOT COMPLETED|Overall Study||33
9019772|NCT03091777|10082419|FG002|NOT COMPLETED|Overall Study||37
9019773|NCT03091920|10082430|FG000|STARTED|Overall Study||6
9019774|NCT03091920|10082431|FG001|STARTED|Overall Study||10
9019775|NCT03091920|10082432|FG002|STARTED|Overall Study||10
9019776|NCT03091920|10082430|FG000|COMPLETED|Overall Study||6
9019777|NCT03091920|10082431|FG001|COMPLETED|Overall Study||9
9019778|NCT03091920|10082432|FG002|COMPLETED|Overall Study||10
9019779|NCT03091920|10082430|FG000|NOT COMPLETED|Overall Study||0
8638840|NCT00576758|9679051|FG000|STARTED|Extension Treatment Period|6 patients did not enter extended treatment phase/follow-up + 1 patient entered follow-up.|72
8638841|NCT00576758|9679052|FG001|STARTED|Extension Treatment Period|8 patients did not enter extended treatment phase/follow-up phase + 2 patients entered follow-up.|73
8638842|NCT00576758|9679051|FG000|COMPLETED|Extension Treatment Period|+ 2 patients (pts) who withdrew prior to receiving study drug.|30
8638843|NCT00576758|9679052|FG001|COMPLETED|Extension Treatment Period||30
8638844|NCT00576758|9679051|FG000|NOT COMPLETED|Extension Treatment Period||42
8638845|NCT00576758|9679052|FG001|NOT COMPLETED|Extension Treatment Period||43
8638846|NCT00576758|9679051|FG000|STARTED|Follow-up Period|Includes 23 pts who entered follow-up after induction and didn't enter the extended treatment phase.|55
8693640|NCT00867789|9739185|FG000|COMPLETED|Overall Study||68
8693641|NCT00867789|9739186|FG001|COMPLETED|Overall Study||70
9019780|NCT03091920|10082431|FG001|NOT COMPLETED|Overall Study||1
9019781|NCT03091920|10082432|FG002|NOT COMPLETED|Overall Study||0
9019782|NCT03092024|10082448|FG000|STARTED|Overall Study||24
9019783|NCT03092024|10082449|FG001|STARTED|Overall Study||16
9019784|NCT03092024|10082448|FG000|COMPLETED|Overall Study||24
9019785|NCT03092024|10082449|FG001|COMPLETED|Overall Study||16
9019786|NCT03092024|10082448|FG000|NOT COMPLETED|Overall Study||0
9019787|NCT03092024|10082449|FG001|NOT COMPLETED|Overall Study||0
9019788|NCT03092089|10082455|FG000|STARTED|Overall Study||15
9019789|NCT03092089|10082455|FG000|COMPLETED|Overall Study||15
9019790|NCT03092089|10082455|FG000|NOT COMPLETED|Overall Study||0
9019791|NCT03092375|10082463|FG000|STARTED|Overall Study||78
9019792|NCT03092375|10082464|FG001|STARTED|Overall Study||49
9019793|NCT03092375|10082465|FG002|STARTED|Overall Study||21
9019794|NCT03092375|10082466|FG003|STARTED|Overall Study||29
9019795|NCT03092375|10082463|FG000|COMPLETED|Overall Study||78
9019796|NCT03092375|10082464|FG001|COMPLETED|Overall Study||48
9019797|NCT03092375|10082465|FG002|COMPLETED|Overall Study||20
9019798|NCT03092375|10082466|FG003|COMPLETED|Overall Study||29
9019799|NCT03092375|10082463|FG000|NOT COMPLETED|Overall Study||0
9019800|NCT03092375|10082464|FG001|NOT COMPLETED|Overall Study||1
9019801|NCT03092375|10082465|FG002|NOT COMPLETED|Overall Study||1
9019802|NCT03092375|10082466|FG003|NOT COMPLETED|Overall Study||0
9019803|NCT03092479|10082485|FG000|STARTED|Overall Study||24
9019804|NCT03092479|10082486|FG001|STARTED|Overall Study||26
9019805|NCT03092479|10082485|FG000|COMPLETED|Overall Study||17
9019806|NCT03092479|10082486|FG001|COMPLETED|Overall Study||24
9019807|NCT03092479|10082485|FG000|NOT COMPLETED|Overall Study||7
9019808|NCT03092479|10082486|FG001|NOT COMPLETED|Overall Study||2
9019809|NCT03092726|10082494|FG000|STARTED|Overall Study||88
9019810|NCT03092726|10082495|FG001|STARTED|Overall Study||95
9019811|NCT03092726|10082494|FG000|Treated|Overall Study||88
9019812|NCT03092726|10082495|FG001|Treated|Overall Study||95
9019813|NCT03092726|10082494|FG000|COMPLETED|Overall Study||79
9019814|NCT03092726|10082495|FG001|COMPLETED|Overall Study||81
9019815|NCT03092726|10082494|FG000|NOT COMPLETED|Overall Study||9
9019816|NCT03092726|10082495|FG001|NOT COMPLETED|Overall Study||14
9019817|NCT03092752|10082501|FG000|STARTED|Overall Study||523585
9019818|NCT03092752|10082501|FG000|COMPLETED|Overall Study||162116
9019819|NCT03092752|10082501|FG000|NOT COMPLETED|Overall Study||361469
9019820|NCT03092791|10082530|FG000|STARTED|Overall Study||20
9019821|NCT03092791|10082531|FG001|STARTED|Overall Study||20
9019822|NCT03092791|10082532|FG002|STARTED|Overall Study||30
9019823|NCT03092791|10082533|FG003|STARTED|Overall Study||30
9019824|NCT03092791|10082534|FG004|STARTED|Overall Study||60
9019825|NCT03092791|10082535|FG005|STARTED|Overall Study||60
9019826|NCT03092791|10082536|FG006|STARTED|Overall Study||60
9019827|NCT03092791|10082537|FG007|STARTED|Overall Study||60
9019828|NCT03092791|10082530|FG000|COMPLETED|Overall Study||20
9019829|NCT03092791|10082531|FG001|COMPLETED|Overall Study||20
9019830|NCT03092791|10082532|FG002|COMPLETED|Overall Study||30
9019831|NCT03092791|10082533|FG003|COMPLETED|Overall Study||30
9019832|NCT03092791|10082534|FG004|COMPLETED|Overall Study||0
9019833|NCT03092791|10082535|FG005|COMPLETED|Overall Study||0
9019834|NCT03092791|10082536|FG006|COMPLETED|Overall Study||0
9019835|NCT03092791|10082537|FG007|COMPLETED|Overall Study||0
9019836|NCT03092791|10082530|FG000|NOT COMPLETED|Overall Study||0
9019837|NCT03092791|10082531|FG001|NOT COMPLETED|Overall Study||0
9019838|NCT03092791|10082532|FG002|NOT COMPLETED|Overall Study||0
9019839|NCT03092791|10082533|FG003|NOT COMPLETED|Overall Study||0
9019840|NCT03092791|10082534|FG004|NOT COMPLETED|Overall Study||60
9019841|NCT03092791|10082535|FG005|NOT COMPLETED|Overall Study||60
9019842|NCT03092791|10082536|FG006|NOT COMPLETED|Overall Study||60
9019843|NCT03092791|10082537|FG007|NOT COMPLETED|Overall Study||60
9019844|NCT03092934|10082559|FG000|STARTED|Overall Study||8
9019845|NCT03092934|10082560|FG001|STARTED|Overall Study||2
9019846|NCT03092934|10082561|FG002|STARTED|Overall Study||2
9019847|NCT03092934|10082562|FG003|STARTED|Overall Study||1
9019848|NCT03092934|10082559|FG000|Received at Least One Dose of Study Drug|Overall Study||8
9019849|NCT03092934|10082560|FG001|Received at Least One Dose of Study Drug|Overall Study||2
9019850|NCT03092934|10082561|FG002|Received at Least One Dose of Study Drug|Overall Study||2
9019851|NCT03092934|10082562|FG003|Received at Least One Dose of Study Drug|Overall Study||1
9019852|NCT03092934|10082559|FG000|COMPLETED|Overall Study||8
9019853|NCT03092934|10082560|FG001|COMPLETED|Overall Study||2
9019854|NCT03092934|10082561|FG002|COMPLETED|Overall Study||2
9019855|NCT03092934|10082562|FG003|COMPLETED|Overall Study||1
9019856|NCT03092934|10082559|FG000|NOT COMPLETED|Overall Study||0
9019857|NCT03092934|10082560|FG001|NOT COMPLETED|Overall Study||0
9019858|NCT03092934|10082561|FG002|NOT COMPLETED|Overall Study||0
9019859|NCT03092934|10082562|FG003|NOT COMPLETED|Overall Study||0
9019860|NCT03092960|10082574|FG000|STARTED|Overall Study||212
9019861|NCT03092960|10082575|FG001|STARTED|Overall Study||212
9019862|NCT03092960|10082574|FG000|COMPLETED|Overall Study||180
9019863|NCT03092960|10082575|FG001|COMPLETED|Overall Study||186
9019864|NCT03092960|10082574|FG000|NOT COMPLETED|Overall Study||32
9019865|NCT03092960|10082575|FG001|NOT COMPLETED|Overall Study||26
9019866|NCT03093025|10082584|FG000|STARTED|Overall Study||16
9019867|NCT03093025|10082585|FG001|STARTED|Overall Study|One participant did not take any dose of investigational product after randomization.|17
9019868|NCT03093025|10082586|FG002|STARTED|Overall Study||18
8638847|NCT00576758|9679052|FG001|STARTED|Follow-up Period|Includes 21 pts who entered follow-up after induction and didn't enter the extended treatment phase.|51
8638848|NCT00576758|9679051|FG000|COMPLETED|Follow-up Period||28
8638849|NCT00576758|9679052|FG001|COMPLETED|Follow-up Period||34
8638850|NCT00576758|9679051|FG000|NOT COMPLETED|Follow-up Period||27
8638851|NCT00576758|9679052|FG001|NOT COMPLETED|Follow-up Period||17
8638852|NCT00576823|9679062|FG000|STARTED|12-week Efficacy Phase||12
8638853|NCT00576823|9679063|FG001|STARTED|12-week Efficacy Phase||6
8638854|NCT00576823|9679064|FG002|STARTED|12-week Efficacy Phase||7
8638855|NCT00576823|9679062|FG000|COMPLETED|12-week Efficacy Phase||11
8638856|NCT00576823|9679063|FG001|COMPLETED|12-week Efficacy Phase||6
8638857|NCT00576823|9679064|FG002|COMPLETED|12-week Efficacy Phase||7
8638858|NCT00576823|9679062|FG000|NOT COMPLETED|12-week Efficacy Phase||1
9019869|NCT03093025|10082584|FG000|COMPLETED|Overall Study||12
9019870|NCT03093025|10082585|FG001|COMPLETED|Overall Study||15
8638859|NCT00576823|9679063|FG001|NOT COMPLETED|12-week Efficacy Phase||0
8638860|NCT00576823|9679064|FG002|NOT COMPLETED|12-week Efficacy Phase||0
8638861|NCT00576823|9679062|FG000|STARTED|40-week Safety Extension Phase||11
8638862|NCT00576823|9679063|FG001|STARTED|40-week Safety Extension Phase||6
8693642|NCT00867789|9739185|FG000|NOT COMPLETED|Overall Study||2
9019871|NCT03093025|10082586|FG002|COMPLETED|Overall Study||16
9019872|NCT03093025|10082584|FG000|NOT COMPLETED|Overall Study||4
9019873|NCT03093025|10082585|FG001|NOT COMPLETED|Overall Study||2
9019874|NCT03093025|10082586|FG002|NOT COMPLETED|Overall Study||2
9019875|NCT03093181|10082597|FG000|STARTED|Overall Study||44
9019876|NCT03093181|10082598|FG001|STARTED|Overall Study||44
9019877|NCT03093181|10082599|FG002|STARTED|Overall Study||44
9019878|NCT03093181|10082597|FG000|COMPLETED|Overall Study||41
9019879|NCT03093181|10082598|FG001|COMPLETED|Overall Study||42
9019880|NCT03093181|10082599|FG002|COMPLETED|Overall Study||41
9019881|NCT03093181|10082597|FG000|NOT COMPLETED|Overall Study||3
9019882|NCT03093181|10082598|FG001|NOT COMPLETED|Overall Study||2
9019883|NCT03093181|10082599|FG002|NOT COMPLETED|Overall Study||3
9019884|NCT03093207|10082609|FG000|STARTED|Overall Study||17
9019885|NCT03093207|10082610|FG001|STARTED|Overall Study||17
9019886|NCT03093207|10082609|FG000|COMPLETED|Overall Study||17
9019887|NCT03093207|10082610|FG001|COMPLETED|Overall Study||17
9019888|NCT03093207|10082609|FG000|NOT COMPLETED|Overall Study||0
9019889|NCT03093207|10082610|FG001|NOT COMPLETED|Overall Study||0
9019890|NCT03093272|10082616|FG000|STARTED|Overall Study||9
9019891|NCT03093272|10082616|FG000|COMPLETED|Overall Study||9
9019892|NCT03093272|10082616|FG000|NOT COMPLETED|Overall Study||0
9019893|NCT03093324|10082622|FG000|STARTED|Overall Study||254
9019894|NCT03093324|10082623|FG001|STARTED|Overall Study||252
9019895|NCT03093324|10082622|FG000|Safety Population|Overall Study||253
9019896|NCT03093324|10082623|FG001|Safety Population|Overall Study||251
9019897|NCT03093324|10082622|FG000|COMPLETED|Overall Study||245
9019898|NCT03093324|10082623|FG001|COMPLETED|Overall Study||233
9019899|NCT03093324|10082622|FG000|NOT COMPLETED|Overall Study||9
9019900|NCT03093324|10082623|FG001|NOT COMPLETED|Overall Study||19
9019901|NCT03093415|10082632|FG000|STARTED|Assessed for Eligibility --> Enrollment||165
9019902|NCT03093415|10082633|FG001|STARTED|Assessed for Eligibility --> Enrollment||135
9019903|NCT03093415|10082634|FG002|STARTED|Assessed for Eligibility --> Enrollment||50
9019904|NCT03093415|10082632|FG000|COMPLETED|Assessed for Eligibility --> Enrollment||25
9019905|NCT03093415|10082633|FG001|COMPLETED|Assessed for Eligibility --> Enrollment||25
9019906|NCT03093415|10082634|FG002|COMPLETED|Assessed for Eligibility --> Enrollment||50
9019907|NCT03093415|10082632|FG000|NOT COMPLETED|Assessed for Eligibility --> Enrollment||140
9019908|NCT03093415|10082633|FG001|NOT COMPLETED|Assessed for Eligibility --> Enrollment||110
9019909|NCT03093415|10082634|FG002|NOT COMPLETED|Assessed for Eligibility --> Enrollment||0
9019910|NCT03093415|10082632|FG000|STARTED|Enrollment to SVR12 Results|Pre-specified 25 participants to were enrolled.|25
9019911|NCT03093415|10082633|FG001|STARTED|Enrollment to SVR12 Results|Pre-specified 25 participants to were enrolled.|25
9019912|NCT03093415|10082634|FG002|STARTED|Enrollment to SVR12 Results|Prespecified 50 participants enrolled.|50
9019913|NCT03093415|10082632|FG000|COMPLETED|Enrollment to SVR12 Results||24
9019914|NCT03093415|10082633|FG001|COMPLETED|Enrollment to SVR12 Results||17
9019915|NCT03093415|10082634|FG002|COMPLETED|Enrollment to SVR12 Results||47
9019916|NCT03093415|10082632|FG000|NOT COMPLETED|Enrollment to SVR12 Results||1
8638863|NCT00576823|9679064|FG002|STARTED|40-week Safety Extension Phase|One patient refused to continue in the extension phase.|6
8638864|NCT00576823|9679062|FG000|COMPLETED|40-week Safety Extension Phase||10
8638865|NCT00576823|9679063|FG001|COMPLETED|40-week Safety Extension Phase||6
8638866|NCT00576823|9679064|FG002|COMPLETED|40-week Safety Extension Phase||6
8638867|NCT00576823|9679062|FG000|NOT COMPLETED|40-week Safety Extension Phase||1
8638868|NCT00576823|9679063|FG001|NOT COMPLETED|40-week Safety Extension Phase||0
8638869|NCT00576823|9679064|FG002|NOT COMPLETED|40-week Safety Extension Phase||0
8638870|NCT00576901|9679075|FG000|STARTED|Overall Study||23
8638871|NCT00576901|9679075|FG000|COMPLETED|Overall Study||20
8638872|NCT00576901|9679075|FG000|NOT COMPLETED|Overall Study||3
8638873|NCT00576927|9679081|FG000|STARTED|Clinical Assessment||79
8638874|NCT00576927|9679081|FG000|COMPLETED|Clinical Assessment||43
8638875|NCT00576927|9679081|FG000|NOT COMPLETED|Clinical Assessment||36
8638876|NCT00576927|9679081|FG000|STARTED|Baseline||43
8638877|NCT00576927|9679081|FG000|COMPLETED|Baseline||30
8638878|NCT00576927|9679081|FG000|NOT COMPLETED|Baseline||13
8638879|NCT00576927|9679081|FG000|STARTED|Sleep Hygiene Behavioral Intervention||30
8638880|NCT00576927|9679081|FG000|COMPLETED|Sleep Hygiene Behavioral Intervention||23
8638881|NCT00576927|9679081|FG000|NOT COMPLETED|Sleep Hygiene Behavioral Intervention||7
8638882|NCT00576927|9679081|FG000|STARTED|Sleep Hygiene With the Placebo||23
8638883|NCT00576927|9679081|FG000|COMPLETED|Sleep Hygiene With the Placebo||22
8638884|NCT00576927|9679081|FG000|NOT COMPLETED|Sleep Hygiene With the Placebo||1
8638885|NCT00576927|9679081|FG000|STARTED|Sleep Hygiene With Study Drug||22
8638886|NCT00576927|9679081|FG000|COMPLETED|Sleep Hygiene With Study Drug||22
8638887|NCT00576927|9679081|FG000|NOT COMPLETED|Sleep Hygiene With Study Drug||0
8638888|NCT00576927|9679081|FG000|STARTED|Randomization 1:1 Placebo or Active Drug||22
8638889|NCT00576927|9679081|FG000|COMPLETED|Randomization 1:1 Placebo or Active Drug||22
8638890|NCT00576927|9679081|FG000|NOT COMPLETED|Randomization 1:1 Placebo or Active Drug||0
8638891|NCT00577005|9679089|FG000|STARTED|Overall Study||16
8638892|NCT00577005|9679090|FG001|STARTED|Overall Study||12
8638893|NCT00577005|9679089|FG000|COMPLETED|Overall Study||11
8638894|NCT00577005|9679090|FG001|COMPLETED|Overall Study||9
8638895|NCT00577005|9679089|FG000|NOT COMPLETED|Overall Study||5
8638896|NCT00577005|9679090|FG001|NOT COMPLETED|Overall Study||3
8638897|NCT00577031|9679099|FG000|STARTED|Overall Study||205
8638898|NCT00577031|9679099|FG000|COMPLETED|Overall Study||0
8638899|NCT00577031|9679099|FG000|NOT COMPLETED|Overall Study||205
8638900|NCT00577083|9679108|FG000|STARTED|First Intervention (14 Days)||48
9019917|NCT03093415|10082633|FG001|NOT COMPLETED|Enrollment to SVR12 Results||8
9019918|NCT03093415|10082634|FG002|NOT COMPLETED|Enrollment to SVR12 Results||3
9019919|NCT03093454|10082644|FG000|STARTED|Overall Study||28
9019920|NCT03093454|10082645|FG001|STARTED|Overall Study||30
9019921|NCT03093454|10082644|FG000|COMPLETED|Overall Study||22
9019922|NCT03093454|10082645|FG001|COMPLETED|Overall Study||27
9019923|NCT03093454|10082644|FG000|NOT COMPLETED|Overall Study||6
9019924|NCT03093454|10082645|FG001|NOT COMPLETED|Overall Study||3
9019925|NCT03093662|10082653|FG000|STARTED|First Intervention (3 Minutes)||18
9019926|NCT03093662|10082654|FG001|STARTED|First Intervention (3 Minutes)||19
9019927|NCT03093662|10082653|FG000|COMPLETED|First Intervention (3 Minutes)||18
9019928|NCT03093662|10082654|FG001|COMPLETED|First Intervention (3 Minutes)||19
9019929|NCT03093662|10082653|FG000|NOT COMPLETED|First Intervention (3 Minutes)||0
9019930|NCT03093662|10082654|FG001|NOT COMPLETED|First Intervention (3 Minutes)||0
9019931|NCT03093662|10082653|FG000|STARTED|Washout Period (5 Minutes)||18
9019932|NCT03093662|10082654|FG001|STARTED|Washout Period (5 Minutes)||19
9019933|NCT03093662|10082653|FG000|COMPLETED|Washout Period (5 Minutes)||18
9019934|NCT03093662|10082654|FG001|COMPLETED|Washout Period (5 Minutes)||19
9019935|NCT03093662|10082653|FG000|NOT COMPLETED|Washout Period (5 Minutes)||0
9019936|NCT03093662|10082654|FG001|NOT COMPLETED|Washout Period (5 Minutes)||0
9019937|NCT03093662|10082653|FG000|STARTED|Second Intervention (3 Minutes)||18
9019938|NCT03093662|10082654|FG001|STARTED|Second Intervention (3 Minutes)||19
9019939|NCT03093662|10082653|FG000|COMPLETED|Second Intervention (3 Minutes)||18
9019940|NCT03093662|10082654|FG001|COMPLETED|Second Intervention (3 Minutes)||19
9019941|NCT03093662|10082653|FG000|NOT COMPLETED|Second Intervention (3 Minutes)||0
9019942|NCT03093662|10082654|FG001|NOT COMPLETED|Second Intervention (3 Minutes)||0
9019943|NCT03093870|10082663|FG000|STARTED|Overall Study||24
8638901|NCT00577083|9679109|FG001|STARTED|First Intervention (14 Days)||52
8638902|NCT00577083|9679108|FG000|COMPLETED|First Intervention (14 Days)||48
8638903|NCT00577083|9679109|FG001|COMPLETED|First Intervention (14 Days)||52
8638904|NCT00577083|9679108|FG000|NOT COMPLETED|First Intervention (14 Days)||0
8638905|NCT00577083|9679109|FG001|NOT COMPLETED|First Intervention (14 Days)||0
8638906|NCT00577083|9679108|FG000|STARTED|Washout (14 Days)||48
8638907|NCT00577083|9679109|FG001|STARTED|Washout (14 Days)||52
8638908|NCT00577083|9679108|FG000|COMPLETED|Washout (14 Days)||48
8638909|NCT00577083|9679109|FG001|COMPLETED|Washout (14 Days)||52
8638910|NCT00577083|9679108|FG000|NOT COMPLETED|Washout (14 Days)||0
8638911|NCT00577083|9679109|FG001|NOT COMPLETED|Washout (14 Days)||0
8638912|NCT00577083|9679108|FG000|STARTED|Second Intervention (14days)||48
8638913|NCT00577083|9679109|FG001|STARTED|Second Intervention (14days)||52
8638914|NCT00577083|9679108|FG000|COMPLETED|Second Intervention (14days)||48
8638915|NCT00577083|9679109|FG001|COMPLETED|Second Intervention (14days)||52
8638916|NCT00577083|9679108|FG000|NOT COMPLETED|Second Intervention (14days)||0
8638917|NCT00577083|9679109|FG001|NOT COMPLETED|Second Intervention (14days)||0
8638918|NCT00577096|9679123|FG000|STARTED|Short Term Participation||69
9019944|NCT03093870|10082664|FG001|STARTED|Overall Study||64
9019945|NCT03093870|10082665|FG002|STARTED|Overall Study||63
9019946|NCT03093870|10082663|FG000|COMPLETED|Overall Study||0
9019947|NCT03093870|10082664|FG001|COMPLETED|Overall Study||23
8638919|NCT00577096|9679124|FG001|STARTED|Short Term Participation||66
8638920|NCT00577096|9679123|FG000|COMPLETED|Short Term Participation||62
8638921|NCT00577096|9679124|FG001|COMPLETED|Short Term Participation||58
8638922|NCT00577096|9679123|FG000|NOT COMPLETED|Short Term Participation||7
8638923|NCT00577096|9679124|FG001|NOT COMPLETED|Short Term Participation||8
8638924|NCT00577096|9679123|FG000|STARTED|Long Term Participation|Only the first 34 patients who met long-term eligibility (response to EPO) were enrolled.|34
8638925|NCT00577096|9679124|FG001|STARTED|Long Term Participation|Only 35 patients who met long-term eligibility (response to EPO) were enrolled.|35
8638926|NCT00577096|9679123|FG000|COMPLETED|Long Term Participation||34
8638927|NCT00577096|9679124|FG001|COMPLETED|Long Term Participation|Sub-set of patients (n=69) who completed short term (n=120) continued in long term participation.|35
8638928|NCT00577096|9679123|FG000|NOT COMPLETED|Long Term Participation||0
8638929|NCT00577096|9679124|FG001|NOT COMPLETED|Long Term Participation||0
8638930|NCT00577122|9679132|FG000|STARTED|Overall Study||14
8638931|NCT00577122|9679133|FG001|STARTED|Overall Study||16
8638932|NCT00577122|9679132|FG000|COMPLETED|Overall Study||0
8638933|NCT00577122|9679133|FG001|COMPLETED|Overall Study||0
8638934|NCT00577122|9679132|FG000|NOT COMPLETED|Overall Study||14
8638935|NCT00577122|9679133|FG001|NOT COMPLETED|Overall Study||16
8638936|NCT00577135|9679144|FG000|STARTED|Overall Study||74
8638937|NCT00577135|9679145|FG001|STARTED|Overall Study||82
8638938|NCT00577135|9679146|FG002|STARTED|Overall Study||77
8638939|NCT00577135|9679147|FG003|STARTED|Overall Study||75
8638940|NCT00577135|9679144|FG000|COMPLETED|Overall Study||74
8638941|NCT00577135|9679145|FG001|COMPLETED|Overall Study||82
8638942|NCT00577135|9679146|FG002|COMPLETED|Overall Study||77
8638943|NCT00577135|9679147|FG003|COMPLETED|Overall Study||75
8638944|NCT00577135|9679144|FG000|NOT COMPLETED|Overall Study||0
8638945|NCT00577135|9679145|FG001|NOT COMPLETED|Overall Study||0
8638946|NCT00577135|9679146|FG002|NOT COMPLETED|Overall Study||0
8638947|NCT00577135|9679147|FG003|NOT COMPLETED|Overall Study||0
8638948|NCT00577382|9679159|FG000|STARTED|Overall Study||21
8638949|NCT00577382|9679160|FG001|STARTED|Overall Study||31
8638950|NCT00577382|9679159|FG000|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
9019948|NCT03093870|10082665|FG002|COMPLETED|Overall Study||22
9019949|NCT03093870|10082663|FG000|NOT COMPLETED|Overall Study||24
9019950|NCT03093870|10082664|FG001|NOT COMPLETED|Overall Study||41
9019951|NCT03093870|10082665|FG002|NOT COMPLETED|Overall Study||41
9019952|NCT03094195|10082676|FG000|STARTED|Double-Blind Treatment Period (DB)||43
8638951|NCT00577382|9679160|FG001|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
8638952|NCT00577382|9679159|FG000|NOT COMPLETED|Overall Study||21
8638953|NCT00577382|9679160|FG001|NOT COMPLETED|Overall Study||31
8638954|NCT00577408|9679168|FG000|STARTED|Overall Study||28
8638955|NCT00577408|9679169|FG001|STARTED|Overall Study||32
8638956|NCT00577408|9679168|FG000|COMPLETED|Overall Study||16
8638957|NCT00577408|9679169|FG001|COMPLETED|Overall Study||9
8638958|NCT00577408|9679168|FG000|NOT COMPLETED|Overall Study||12
8638959|NCT00577408|9679169|FG001|NOT COMPLETED|Overall Study||23
8638960|NCT00577460|9679178|FG000|STARTED|Overall Study||129
8638961|NCT00577460|9679179|FG001|STARTED|Overall Study||123
8638962|NCT00577460|9679180|FG002|STARTED|Overall Study||139
8638963|NCT00577460|9679178|FG000|COMPLETED|Overall Study||113
8638964|NCT00577460|9679179|FG001|COMPLETED|Overall Study||104
8638965|NCT00577460|9679180|FG002|COMPLETED|Overall Study||112
8638966|NCT00577460|9679178|FG000|NOT COMPLETED|Overall Study||16
8638967|NCT00577460|9679179|FG001|NOT COMPLETED|Overall Study||19
8638968|NCT00577460|9679180|FG002|NOT COMPLETED|Overall Study||27
8638969|NCT00577473|9679197|FG000|STARTED|Overall Study||154
8638970|NCT00577473|9679198|FG001|STARTED|Overall Study||147
8638971|NCT00577473|9679197|FG000|ITT Population|Overall Study||150
8638972|NCT00577473|9679198|FG001|ITT Population|Overall Study||136
8638973|NCT00577473|9679197|FG000|COMPLETED|Overall Study||133
8638974|NCT00577473|9679198|FG001|COMPLETED|Overall Study||123
8638975|NCT00577473|9679197|FG000|NOT COMPLETED|Overall Study||21
8638976|NCT00577473|9679198|FG001|NOT COMPLETED|Overall Study||24
8638977|NCT00577512|9679204|FG000|STARTED|Overall Study||4
8638978|NCT00577512|9679204|FG000|COMPLETED|Overall Study||0
8638979|NCT00577512|9679204|FG000|NOT COMPLETED|Overall Study||4
8638980|NCT00577590|9679211|FG000|STARTED|Overall Study||28
8638981|NCT00577590|9679212|FG001|STARTED|Overall Study||27
8638982|NCT00577590|9679213|FG002|STARTED|Overall Study||23
8638983|NCT00577590|9679211|FG000|COMPLETED|Overall Study||28
8911112|NCT02143648|9970143|FG001|NOT COMPLETED|Overall Study||42
8911113|NCT02143648|9970144|FG002|NOT COMPLETED|Overall Study||24
8911114|NCT02143713|9970156|FG000|STARTED|Treatment Period (6 Months)||102
8911115|NCT02143713|9970157|FG001|STARTED|Treatment Period (6 Months)||111
8911116|NCT02143713|9970158|FG002|STARTED|Treatment Period (6 Months)||142
8911117|NCT02143713|9970159|FG003|STARTED|Treatment Period (6 Months)||140
8911118|NCT02143713|9970156|FG000|Received Elagolix|Treatment Period (6 Months)||102
8911119|NCT02143713|9970157|FG001|Received Elagolix|Treatment Period (6 Months)||111
8911120|NCT02143713|9970158|FG002|Received Elagolix|Treatment Period (6 Months)||142
8911121|NCT02143713|9970159|FG003|Received Elagolix|Treatment Period (6 Months)||140
8911122|NCT02143713|9970156|FG000|COMPLETED|Treatment Period (6 Months)||82
8911123|NCT02143713|9970157|FG001|COMPLETED|Treatment Period (6 Months)||99
8911124|NCT02143713|9970158|FG002|COMPLETED|Treatment Period (6 Months)||120
8911125|NCT02143713|9970159|FG003|COMPLETED|Treatment Period (6 Months)||112
8911126|NCT02143713|9970156|FG000|NOT COMPLETED|Treatment Period (6 Months)||20
8911127|NCT02143713|9970157|FG001|NOT COMPLETED|Treatment Period (6 Months)||12
8911128|NCT02143713|9970158|FG002|NOT COMPLETED|Treatment Period (6 Months)||22
8911129|NCT02143713|9970159|FG003|NOT COMPLETED|Treatment Period (6 Months)||28
8911130|NCT02143713|9970156|FG000|STARTED|Post-treatment Follow-up (12 Months)||85
8911131|NCT02143713|9970157|FG001|STARTED|Post-treatment Follow-up (12 Months)||105
8911132|NCT02143713|9970158|FG002|STARTED|Post-treatment Follow-up (12 Months)||125
8911133|NCT02143713|9970159|FG003|STARTED|Post-treatment Follow-up (12 Months)||122
8911134|NCT02143713|9970156|FG000|COMPLETED|Post-treatment Follow-up (12 Months)||73
8911135|NCT02143713|9970157|FG001|COMPLETED|Post-treatment Follow-up (12 Months)||81
8911136|NCT02143713|9970158|FG002|COMPLETED|Post-treatment Follow-up (12 Months)||96
8911137|NCT02143713|9970159|FG003|COMPLETED|Post-treatment Follow-up (12 Months)||95
8911138|NCT02143713|9970156|FG000|NOT COMPLETED|Post-treatment Follow-up (12 Months)||12
8911139|NCT02143713|9970157|FG001|NOT COMPLETED|Post-treatment Follow-up (12 Months)||24
8911140|NCT02143713|9970158|FG002|NOT COMPLETED|Post-treatment Follow-up (12 Months)||29
8911141|NCT02143713|9970159|FG003|NOT COMPLETED|Post-treatment Follow-up (12 Months)||27
8911142|NCT02143778|9970170|FG000|STARTED|Overall Study||246
8911143|NCT02143778|9970170|FG000|COMPLETED|Overall Study||243
8911144|NCT02143778|9970170|FG000|NOT COMPLETED|Overall Study||3
8911145|NCT02143843|9970175|FG000|STARTED|Overall Study||75
8911146|NCT02143843|9970175|FG000|COMPLETED|Overall Study||63
8638984|NCT00577590|9679212|FG001|COMPLETED|Overall Study||27
8638985|NCT00577590|9679213|FG002|COMPLETED|Overall Study||23
8638986|NCT00577590|9679211|FG000|NOT COMPLETED|Overall Study||0
8638987|NCT00577590|9679212|FG001|NOT COMPLETED|Overall Study||0
8638988|NCT00577590|9679213|FG002|NOT COMPLETED|Overall Study||0
8638989|NCT00577629|9679221|FG000|STARTED|Treatment Period||39
8638990|NCT00577629|9679221|FG000|COMPLETED|Treatment Period||38
8638991|NCT00577629|9679221|FG000|NOT COMPLETED|Treatment Period||1
8638992|NCT00577629|9679221|FG000|STARTED|Long Term Follow-Up||38
8638993|NCT00577629|9679221|FG000|COMPLETED|Long Term Follow-Up||13
8638994|NCT00577629|9679221|FG000|NOT COMPLETED|Long Term Follow-Up||25
8727147|NCT01042093|9774571|FG000|COMPLETED|Overall Study||38
8727148|NCT01042093|9774572|FG001|COMPLETED|Overall Study||38
8727149|NCT01042093|9774573|FG002|COMPLETED|Overall Study||38
8727150|NCT01042093|9774574|FG003|COMPLETED|Overall Study||36
8727151|NCT01042093|9774571|FG000|NOT COMPLETED|Overall Study||2
8727152|NCT01042093|9774572|FG001|NOT COMPLETED|Overall Study||2
8911147|NCT02143843|9970175|FG000|NOT COMPLETED|Overall Study||12
8911148|NCT02143947|9970181|FG000|STARTED|Overall Study||36
9019953|NCT03094195|10082677|FG001|STARTED|Double-Blind Treatment Period (DB)||43
9019954|NCT03094195|10082678|FG002|STARTED|Double-Blind Treatment Period (DB)||43
9019955|NCT03094195|10082679|FG003|STARTED|Double-Blind Treatment Period (DB)||0
9019956|NCT03094195|10082680|FG004|STARTED|Double-Blind Treatment Period (DB)||0
9019957|NCT03094195|10082681|FG005|STARTED|Double-Blind Treatment Period (DB)||0
9019958|NCT03094195|10082682|FG006|STARTED|Double-Blind Treatment Period (DB)||0
9019959|NCT03094195|10082683|FG007|STARTED|Double-Blind Treatment Period (DB)||0
9019960|NCT03094195|10082676|FG000|COMPLETED|Double-Blind Treatment Period (DB)||28
9019961|NCT03094195|10082677|FG001|COMPLETED|Double-Blind Treatment Period (DB)||30
9019962|NCT03094195|10082678|FG002|COMPLETED|Double-Blind Treatment Period (DB)||29
9019963|NCT03094195|10082679|FG003|COMPLETED|Double-Blind Treatment Period (DB)||0
9019964|NCT03094195|10082680|FG004|COMPLETED|Double-Blind Treatment Period (DB)||0
8638995|NCT00577642|9679227|FG000|STARTED|Overall Study||29
8638996|NCT00577642|9679227|FG000|COMPLETED|Overall Study||28
8638997|NCT00577642|9679227|FG000|NOT COMPLETED|Overall Study||1
8638998|NCT00577655|9679233|FG000|STARTED|Overall Study|This number represents the number of participants randomized.|52
8638999|NCT00577655|9679234|FG001|STARTED|Overall Study|This number represents the number of participants randomized.|51
8639000|NCT00577655|9679233|FG000|COMPLETED|Overall Study||51
8639001|NCT00577655|9679234|FG001|COMPLETED|Overall Study||47
8639002|NCT00577655|9679233|FG000|NOT COMPLETED|Overall Study||1
8639003|NCT00577655|9679234|FG001|NOT COMPLETED|Overall Study||4
8639004|NCT00577707|9679241|FG000|STARTED|Overall Study||9
8639005|NCT00577707|9679241|FG000|COMPLETED|Overall Study||6
8639006|NCT00577707|9679241|FG000|NOT COMPLETED|Overall Study||3
8639007|NCT00577720|9679249|FG000|STARTED|Overall Study||37
8639008|NCT00577720|9679250|FG001|STARTED|Overall Study||36
8639009|NCT00577720|9679251|FG002|STARTED|Overall Study||36
8639010|NCT00577720|9679252|FG003|STARTED|Overall Study||72
8639011|NCT00577720|9679249|FG000|ITT (Intent to Treat) Population|Overall Study||34
8639012|NCT00577720|9679250|FG001|ITT (Intent to Treat) Population|Overall Study||35
8639013|NCT00577720|9679251|FG002|ITT (Intent to Treat) Population|Overall Study||35
8639014|NCT00577720|9679252|FG003|ITT (Intent to Treat) Population|Overall Study||65
8639015|NCT00577720|9679249|FG000|COMPLETED|Overall Study||33
8639016|NCT00577720|9679250|FG001|COMPLETED|Overall Study||35
8639017|NCT00577720|9679251|FG002|COMPLETED|Overall Study||35
8639018|NCT00577720|9679252|FG003|COMPLETED|Overall Study||65
8639019|NCT00577720|9679249|FG000|NOT COMPLETED|Overall Study||4
8639020|NCT00577720|9679250|FG001|NOT COMPLETED|Overall Study||1
8639021|NCT00577720|9679251|FG002|NOT COMPLETED|Overall Study||1
8639022|NCT00577720|9679252|FG003|NOT COMPLETED|Overall Study||7
8639023|NCT00577824|9679265|FG000|STARTED|Overall Study|Started=Randomized|72
8639024|NCT00577824|9679266|FG001|STARTED|Overall Study||73
8639025|NCT00577824|9679267|FG002|STARTED|Overall Study||36
8639026|NCT00577824|9679265|FG000|Full Analysis Set|Overall Study|Full Analysis Set=subject received at least one dose of study medication (active or placebo)|72
8639027|NCT00577824|9679266|FG001|Full Analysis Set|Overall Study||72
8639028|NCT00577824|9679267|FG002|Full Analysis Set|Overall Study||35
8639029|NCT00577824|9679265|FG000|COMPLETED|Overall Study||65
8639030|NCT00577824|9679266|FG001|COMPLETED|Overall Study||53
8639031|NCT00577824|9679267|FG002|COMPLETED|Overall Study||34
8639032|NCT00577824|9679265|FG000|NOT COMPLETED|Overall Study||7
8639033|NCT00577824|9679266|FG001|NOT COMPLETED|Overall Study||20
8639034|NCT00577824|9679267|FG002|NOT COMPLETED|Overall Study||2
8639035|NCT00577863|9679277|FG000|STARTED|Overall Study||92
8639036|NCT00577863|9679278|FG001|STARTED|Overall Study||108
8639037|NCT00577863|9679277|FG000|Received at Least One Injection|Overall Study||92
8639038|NCT00577863|9679278|FG001|Received at Least One Injection|Overall Study||107
8639039|NCT00577863|9679277|FG000|COMPLETED|Overall Study||82
8639040|NCT00577863|9679278|FG001|COMPLETED|Overall Study||94
8639041|NCT00577863|9679277|FG000|NOT COMPLETED|Overall Study||10
8639042|NCT00577863|9679278|FG001|NOT COMPLETED|Overall Study||14
8639043|NCT00577889|9679287|FG000|STARTED|Overall Study||9
8639044|NCT00577889|9679288|FG001|STARTED|Overall Study||6
8639045|NCT00577889|9679289|FG002|STARTED|Overall Study||6
8639046|NCT00577889|9679287|FG000|COMPLETED|Overall Study||8
8639047|NCT00577889|9679288|FG001|COMPLETED|Overall Study||6
8639048|NCT00577889|9679289|FG002|COMPLETED|Overall Study||6
8639049|NCT00577889|9679287|FG000|NOT COMPLETED|Overall Study||1
8639050|NCT00577889|9679288|FG001|NOT COMPLETED|Overall Study||0
8639051|NCT00577889|9679289|FG002|NOT COMPLETED|Overall Study||0
8727153|NCT01042093|9774573|FG002|NOT COMPLETED|Overall Study||2
8911149|NCT02143947|9970182|FG001|STARTED|Overall Study||44
8911150|NCT02143947|9970181|FG000|COMPLETED|Overall Study||32
8911151|NCT02143947|9970182|FG001|COMPLETED|Overall Study||42
8911152|NCT02143947|9970181|FG000|NOT COMPLETED|Overall Study||4
8911153|NCT02143947|9970182|FG001|NOT COMPLETED|Overall Study||2
8911154|NCT02143973|9970190|FG000|STARTED|Overall Study||167
8911155|NCT02143973|9970190|FG000|COMPLETED|Overall Study||101
9019965|NCT03094195|10082681|FG005|COMPLETED|Double-Blind Treatment Period (DB)||0
8639052|NCT00577993|9679300|FG000|STARTED|Overall Study||85
8639053|NCT00577993|9679301|FG001|STARTED|Overall Study||90
8639054|NCT00577993|9679302|FG002|STARTED|Overall Study||35
8639055|NCT00577993|9679300|FG000|COMPLETED|Overall Study||78
8639056|NCT00577993|9679301|FG001|COMPLETED|Overall Study||80
8639057|NCT00577993|9679302|FG002|COMPLETED|Overall Study||32
8639058|NCT00577993|9679300|FG000|NOT COMPLETED|Overall Study||7
8639059|NCT00577993|9679301|FG001|NOT COMPLETED|Overall Study||10
8639060|NCT00577993|9679302|FG002|NOT COMPLETED|Overall Study||3
8639061|NCT00578071|9679308|FG000|STARTED|Overall Study||29
8639062|NCT00578071|9679308|FG000|COMPLETED|Overall Study||29
8639063|NCT00578071|9679308|FG000|NOT COMPLETED|Overall Study||0
8639064|NCT00578136|9679315|FG000|STARTED|Overall Study||27
8639065|NCT00578136|9679316|FG001|STARTED|Overall Study||27
8639066|NCT00578136|9679315|FG000|COMPLETED|Overall Study||26
8639067|NCT00578136|9679316|FG001|COMPLETED|Overall Study||26
8639068|NCT00578136|9679315|FG000|NOT COMPLETED|Overall Study||1
8639069|NCT00578136|9679316|FG001|NOT COMPLETED|Overall Study||1
8639070|NCT00578175|9679325|FG000|STARTED|Overall Study||705
8639071|NCT00578175|9679326|FG001|STARTED|Overall Study||689
8639072|NCT00578175|9679327|FG002|STARTED|Overall Study||389
8639073|NCT00578175|9679325|FG000|COMPLETED|Overall Study||635
8639074|NCT00578175|9679326|FG001|COMPLETED|Overall Study||646
8639075|NCT00578175|9679327|FG002|COMPLETED|Overall Study||365
8639076|NCT00578175|9679325|FG000|NOT COMPLETED|Overall Study||70
8639077|NCT00578175|9679326|FG001|NOT COMPLETED|Overall Study||43
8639078|NCT00578175|9679327|FG002|NOT COMPLETED|Overall Study||24
8639079|NCT00578214|9679340|FG000|STARTED|Overall Study||22
8639080|NCT00578214|9679341|FG001|STARTED|Overall Study||22
8639081|NCT00578214|9679342|FG002|STARTED|Overall Study||31
8639082|NCT00578214|9679340|FG000|COMPLETED|Overall Study||22
8639083|NCT00578214|9679341|FG001|COMPLETED|Overall Study||22
8639084|NCT00578214|9679342|FG002|COMPLETED|Overall Study||31
8639085|NCT00578214|9679340|FG000|NOT COMPLETED|Overall Study||0
8639086|NCT00578214|9679341|FG001|NOT COMPLETED|Overall Study||0
8639087|NCT00578214|9679342|FG002|NOT COMPLETED|Overall Study||0
8639088|NCT00578227|9679353|FG000|STARTED|Overall Study||272
8639089|NCT00578227|9679354|FG001|STARTED|Overall Study||270
8639090|NCT00578227|9679355|FG002|STARTED|Overall Study||271
8639091|NCT00578227|9679353|FG000|COMPLETED|Overall Study||267
8639092|NCT00578227|9679354|FG001|COMPLETED|Overall Study||268
8639093|NCT00578227|9679355|FG002|COMPLETED|Overall Study||267
8639094|NCT00578227|9679353|FG000|NOT COMPLETED|Overall Study||5
8639095|NCT00578227|9679354|FG001|NOT COMPLETED|Overall Study||2
8639096|NCT00578227|9679355|FG002|NOT COMPLETED|Overall Study||4
8639097|NCT00578279|9679367|FG000|STARTED|Overall Study||10
8639098|NCT00578279|9679368|FG001|STARTED|Overall Study||10
8639099|NCT00578279|9679367|FG000|COMPLETED|Overall Study||10
8639100|NCT00578279|9679368|FG001|COMPLETED|Overall Study||10
8639101|NCT00578279|9679367|FG000|NOT COMPLETED|Overall Study||0
8639102|NCT00578279|9679368|FG001|NOT COMPLETED|Overall Study||0
8639103|NCT00578292|9679374|FG000|STARTED|Overall Study||10
8639104|NCT00578292|9679374|FG000|COMPLETED|Overall Study||7
8639105|NCT00578292|9679374|FG000|NOT COMPLETED|Overall Study||3
8639106|NCT00578305|9679381|FG000|STARTED|Double-blind Treatment Phase||62
8639107|NCT00578305|9679382|FG001|STARTED|Double-blind Treatment Phase||60
8639108|NCT00578305|9679383|FG002|STARTED|Double-blind Treatment Phase||63
8639109|NCT00578305|9679381|FG000|Treated|Double-blind Treatment Phase||62
8639110|NCT00578305|9679382|FG001|Treated|Double-blind Treatment Phase||60
8639111|NCT00578305|9679383|FG002|Treated|Double-blind Treatment Phase||63
8639112|NCT00578305|9679381|FG000|COMPLETED|Double-blind Treatment Phase||59
8639113|NCT00578305|9679382|FG001|COMPLETED|Double-blind Treatment Phase||56
8639114|NCT00578305|9679383|FG002|COMPLETED|Double-blind Treatment Phase||49
8639115|NCT00578305|9679381|FG000|NOT COMPLETED|Double-blind Treatment Phase||3
8639116|NCT00578305|9679382|FG001|NOT COMPLETED|Double-blind Treatment Phase||4
8639117|NCT00578305|9679383|FG002|NOT COMPLETED|Double-blind Treatment Phase||14
8639118|NCT00578305|9679381|FG000|STARTED|Extension Phase||53
8639119|NCT00578305|9679382|FG001|STARTED|Extension Phase||50
8639120|NCT00578305|9679383|FG002|STARTED|Extension Phase||43
9019966|NCT03094195|10082682|FG006|COMPLETED|Double-Blind Treatment Period (DB)||0
9019967|NCT03094195|10082683|FG007|COMPLETED|Double-Blind Treatment Period (DB)||0
9019968|NCT03094195|10082676|FG000|NOT COMPLETED|Double-Blind Treatment Period (DB)||15
9019969|NCT03094195|10082677|FG001|NOT COMPLETED|Double-Blind Treatment Period (DB)||13
9019970|NCT03094195|10082678|FG002|NOT COMPLETED|Double-Blind Treatment Period (DB)||14
9019971|NCT03094195|10082679|FG003|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
9019972|NCT03094195|10082680|FG004|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
9019973|NCT03094195|10082681|FG005|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
9019974|NCT03094195|10082682|FG006|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
8639121|NCT00578305|9679381|FG000|COMPLETED|Extension Phase|Some participants completed the study in this period and did not enter the safety follow-up period.|49
8639122|NCT00578305|9679382|FG001|COMPLETED|Extension Phase|Some participants completed the study in this period and did not enter the safety follow-up period.|49
8639123|NCT00578305|9679383|FG002|COMPLETED|Extension Phase|Some participants completed the study in this period and did not enter the safety follow-up period.|40
8639124|NCT00578305|9679381|FG000|NOT COMPLETED|Extension Phase||4
8639125|NCT00578305|9679382|FG001|NOT COMPLETED|Extension Phase||1
8639126|NCT00578305|9679383|FG002|NOT COMPLETED|Extension Phase||3
9019975|NCT03094195|10082683|FG007|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
9019976|NCT03094195|10082676|FG000|STARTED|Treatment Withdrawal Period (TW)||0
8639127|NCT00578305|9679381|FG000|STARTED|Safety Follow-up Phase|Some participants entered safety follow-up directly from the double-blind treatment period.|57
8639128|NCT00578305|9679382|FG001|STARTED|Safety Follow-up Phase|Some participants entered safety follow-up directly from the double-blind treatment period.|54
8639129|NCT00578305|9679383|FG002|STARTED|Safety Follow-up Phase|Some participants entered safety follow-up directly from the double-blind treatment period.|54
8639130|NCT00578305|9679381|FG000|COMPLETED|Safety Follow-up Phase||11
8639131|NCT00578305|9679382|FG001|COMPLETED|Safety Follow-up Phase||9
8639132|NCT00578305|9679383|FG002|COMPLETED|Safety Follow-up Phase||8
8639133|NCT00578305|9679381|FG000|NOT COMPLETED|Safety Follow-up Phase||46
8639134|NCT00578305|9679382|FG001|NOT COMPLETED|Safety Follow-up Phase||45
8639135|NCT00578305|9679383|FG002|NOT COMPLETED|Safety Follow-up Phase||46
8639136|NCT00578318|9679399|FG000|STARTED|Overall Study||8
8639137|NCT00578318|9679400|FG001|STARTED|Overall Study||8
8639138|NCT00578318|9679399|FG000|COMPLETED|Overall Study||5
8639139|NCT00578318|9679400|FG001|COMPLETED|Overall Study||8
8639140|NCT00578318|9679399|FG000|NOT COMPLETED|Overall Study||3
8639141|NCT00578318|9679400|FG001|NOT COMPLETED|Overall Study||0
8639142|NCT00578331|9679408|FG000|STARTED|Overall Study||445
8639143|NCT00578331|9679409|FG001|STARTED|Overall Study||445
8639144|NCT00578331|9679408|FG000|COMPLETED|Overall Study||329
8639145|NCT00578331|9679409|FG001|COMPLETED|Overall Study||320
8639146|NCT00578331|9679408|FG000|NOT COMPLETED|Overall Study||116
8639147|NCT00578331|9679409|FG001|NOT COMPLETED|Overall Study||125
8639148|NCT00578344|9679415|FG000|STARTED|Overall Study||8
8639149|NCT00578344|9679415|FG000|COMPLETED|Overall Study||6
8639150|NCT00578344|9679415|FG000|NOT COMPLETED|Overall Study||2
8639151|NCT00578383|9679423|FG000|STARTED|Overall Study||37
8639152|NCT00578383|9679424|FG001|STARTED|Overall Study||36
8639153|NCT00578383|9679425|FG002|STARTED|Overall Study||19
8639154|NCT00578383|9679426|FG003|STARTED|Overall Study||15
8639155|NCT00578383|9679423|FG000|COMPLETED|Overall Study||21
8639156|NCT00578383|9679424|FG001|COMPLETED|Overall Study||20
8639157|NCT00578383|9679425|FG002|COMPLETED|Overall Study||13
8639158|NCT00578383|9679426|FG003|COMPLETED|Overall Study||9
8639159|NCT00578383|9679423|FG000|NOT COMPLETED|Overall Study||16
8639160|NCT00578383|9679424|FG001|NOT COMPLETED|Overall Study||16
8639161|NCT00578383|9679425|FG002|NOT COMPLETED|Overall Study||6
8639162|NCT00578383|9679426|FG003|NOT COMPLETED|Overall Study||6
8639163|NCT00578448|9679440|FG000|STARTED|Day 1 up to 3 Years of Planned Study||12
8639164|NCT00578448|9679440|FG000|COMPLETED|Day 1 up to 3 Years of Planned Study||9
8639165|NCT00578448|9679440|FG000|NOT COMPLETED|Day 1 up to 3 Years of Planned Study||3
8639166|NCT00578448|9679440|FG000|STARTED|1 Year Long Term Extension (LTE)||9
8639167|NCT00578448|9679440|FG000|COMPLETED|1 Year Long Term Extension (LTE)||8
8639168|NCT00578448|9679440|FG000|NOT COMPLETED|1 Year Long Term Extension (LTE)||1
8639169|NCT00578461|9679446|FG000|STARTED|Overall Study||26
8639170|NCT00578461|9679446|FG000|COMPLETED|Overall Study||26
8639171|NCT00578461|9679446|FG000|NOT COMPLETED|Overall Study||0
8639172|NCT00578539|9679450|FG000|STARTED|Overall Study||24
8639173|NCT00578539|9679450|FG000|COMPLETED|Overall Study||24
8639174|NCT00578539|9679450|FG000|NOT COMPLETED|Overall Study||0
8639175|NCT00578552|9679457|FG000|STARTED|Overall Study||27
8639176|NCT00578552|9679458|FG001|STARTED|Overall Study||27
8639177|NCT00578552|9679459|FG002|STARTED|Overall Study||26
8639178|NCT00578552|9679457|FG000|COMPLETED|Overall Study||12
8639179|NCT00578552|9679458|FG001|COMPLETED|Overall Study||13
8639180|NCT00578552|9679459|FG002|COMPLETED|Overall Study||11
8639181|NCT00578552|9679457|FG000|NOT COMPLETED|Overall Study||15
8639182|NCT00578552|9679458|FG001|NOT COMPLETED|Overall Study||14
8639183|NCT00578552|9679459|FG002|NOT COMPLETED|Overall Study||15
8639184|NCT00578565|9679467|FG000|STARTED|Overall Study||10
8639185|NCT00578565|9679467|FG000|COMPLETED|Overall Study||7
8639186|NCT00578565|9679467|FG000|NOT COMPLETED|Overall Study||3
8639187|NCT00578617|9679474|FG000|STARTED|Overall Study||31
8639188|NCT00578617|9679475|FG001|STARTED|Overall Study||29
8639189|NCT00578617|9679474|FG000|COMPLETED|Overall Study||31
8639190|NCT00578617|9679475|FG001|COMPLETED|Overall Study||29
8639191|NCT00578617|9679474|FG000|NOT COMPLETED|Overall Study||0
9019977|NCT03094195|10082677|FG001|STARTED|Treatment Withdrawal Period (TW)||0
9019978|NCT03094195|10082678|FG002|STARTED|Treatment Withdrawal Period (TW)||0
9019979|NCT03094195|10082679|FG003|STARTED|Treatment Withdrawal Period (TW)||13
9019980|NCT03094195|10082680|FG004|STARTED|Treatment Withdrawal Period (TW)||13
9019981|NCT03094195|10082681|FG005|STARTED|Treatment Withdrawal Period (TW)||15
9019982|NCT03094195|10082682|FG006|STARTED|Treatment Withdrawal Period (TW)||13
8639192|NCT00578617|9679475|FG001|NOT COMPLETED|Overall Study||0
8639193|NCT00578643|9679481|FG000|STARTED|Overall Study||15
8639194|NCT00578643|9679481|FG000|COMPLETED|Overall Study||13
8639195|NCT00578643|9679481|FG000|NOT COMPLETED|Overall Study||2
8639196|NCT00578669|9679487|FG000|STARTED|Overall Study||107
8639197|NCT00578669|9679488|FG001|STARTED|Overall Study||99
8639198|NCT00578669|9679487|FG000|COMPLETED|Overall Study||107
8639199|NCT00578669|9679488|FG001|COMPLETED|Overall Study||99
8639200|NCT00578669|9679487|FG000|NOT COMPLETED|Overall Study||0
8639201|NCT00578669|9679488|FG001|NOT COMPLETED|Overall Study||0
8639202|NCT00578734|9679496|FG000|STARTED|Overall Study||84
8639203|NCT00578734|9679497|FG001|STARTED|Overall Study||81
8639204|NCT00578734|9679496|FG000|COMPLETED|Overall Study||84
9019983|NCT03094195|10082683|FG007|STARTED|Treatment Withdrawal Period (TW)||26
9019984|NCT03094195|10082676|FG000|COMPLETED|Treatment Withdrawal Period (TW)||0
9019985|NCT03094195|10082677|FG001|COMPLETED|Treatment Withdrawal Period (TW)||0
9019986|NCT03094195|10082678|FG002|COMPLETED|Treatment Withdrawal Period (TW)||0
9019987|NCT03094195|10082679|FG003|COMPLETED|Treatment Withdrawal Period (TW)||13
9019988|NCT03094195|10082680|FG004|COMPLETED|Treatment Withdrawal Period (TW)||13
9019989|NCT03094195|10082681|FG005|COMPLETED|Treatment Withdrawal Period (TW)||15
9019990|NCT03094195|10082682|FG006|COMPLETED|Treatment Withdrawal Period (TW)||13
8639205|NCT00578734|9679497|FG001|COMPLETED|Overall Study||81
8639206|NCT00578734|9679496|FG000|NOT COMPLETED|Overall Study||0
8639207|NCT00578734|9679497|FG001|NOT COMPLETED|Overall Study||0
8639208|NCT00578786|9679506|FG000|STARTED|Overall Study||96
8639209|NCT00578786|9679507|FG001|STARTED|Overall Study||190
8639210|NCT00578786|9679508|FG002|STARTED|Overall Study||97
8639211|NCT00578786|9679506|FG000|COMPLETED|Overall Study||57
8639212|NCT00578786|9679507|FG001|COMPLETED|Overall Study||124
8639213|NCT00578786|9679508|FG002|COMPLETED|Overall Study||67
8639214|NCT00578786|9679506|FG000|NOT COMPLETED|Overall Study||39
8639215|NCT00578786|9679507|FG001|NOT COMPLETED|Overall Study||66
8639216|NCT00578786|9679508|FG002|NOT COMPLETED|Overall Study||30
8639217|NCT00578812|9679528|FG000|STARTED|Overall Study|Does not include investigational training patients (78 STARTED, 76 COMPLETED, 2 Not Treated).|224
8639218|NCT00578812|9679529|FG001|STARTED|Overall Study||192
8639219|NCT00578812|9679528|FG000|COMPLETED|Overall Study|Modified Intent-to-Treat (treated patients; analyzed as randomized).|218
8639220|NCT00578812|9679529|FG001|COMPLETED|Overall Study||185
8639221|NCT00578812|9679528|FG000|NOT COMPLETED|Overall Study||6
8639222|NCT00578812|9679529|FG001|NOT COMPLETED|Overall Study||7
8639223|NCT00578864|9679538|FG000|STARTED|Overall Study||7
8639224|NCT00578864|9679539|FG001|STARTED|Overall Study||6
8639225|NCT00578864|9679538|FG000|COMPLETED|Overall Study|died of complications of surgery after 2 cycles|6
8639226|NCT00578864|9679539|FG001|COMPLETED|Overall Study||6
8639227|NCT00578864|9679538|FG000|NOT COMPLETED|Overall Study||1
8639228|NCT00578864|9679539|FG001|NOT COMPLETED|Overall Study||0
8639229|NCT00578877|9679547|FG000|STARTED|Overall Study||150
8639230|NCT00578877|9679548|FG001|STARTED|Overall Study||300
8639231|NCT00578877|9679547|FG000|COMPLETED|Overall Study||69
8639232|NCT00578877|9679548|FG001|COMPLETED|Overall Study||172
8639233|NCT00578877|9679547|FG000|NOT COMPLETED|Overall Study||81
8639234|NCT00578877|9679548|FG001|NOT COMPLETED|Overall Study||128
8639235|NCT00578903|9679554|FG000|STARTED|Overall Study||22
8639236|NCT00578903|9679554|FG000|COMPLETED|Overall Study||22
8639237|NCT00578903|9679554|FG000|NOT COMPLETED|Overall Study||0
8639238|NCT00578929|9679562|FG000|STARTED|Vehicle Run-In Period||0
8639239|NCT00578929|9679563|FG001|STARTED|Vehicle Run-In Period||2388
8639240|NCT00578929|9679564|FG002|STARTED|Vehicle Run-In Period||0
8639241|NCT00578929|9679565|FG003|STARTED|Vehicle Run-In Period||0
8639242|NCT00578929|9679562|FG000|COMPLETED|Vehicle Run-In Period||0
8639243|NCT00578929|9679563|FG001|COMPLETED|Vehicle Run-In Period||2388
8639244|NCT00578929|9679564|FG002|COMPLETED|Vehicle Run-In Period||0
8639245|NCT00578929|9679565|FG003|COMPLETED|Vehicle Run-In Period||0
8639246|NCT00578929|9679562|FG000|NOT COMPLETED|Vehicle Run-In Period||0
8639247|NCT00578929|9679563|FG001|NOT COMPLETED|Vehicle Run-In Period||0
8639248|NCT00578929|9679564|FG002|NOT COMPLETED|Vehicle Run-In Period||0
8639249|NCT00578929|9679565|FG003|NOT COMPLETED|Vehicle Run-In Period||0
8639250|NCT00578929|9679562|FG000|STARTED|Randomized Period||298
8639251|NCT00578929|9679563|FG001|STARTED|Randomized Period||297
8639252|NCT00578929|9679564|FG002|STARTED|Randomized Period||296
8639253|NCT00578929|9679565|FG003|STARTED|Randomized Period||297
8639254|NCT00578929|9679562|FG000|COMPLETED|Randomized Period||281
8639255|NCT00578929|9679563|FG001|COMPLETED|Randomized Period||283
8639256|NCT00578929|9679564|FG002|COMPLETED|Randomized Period||288
8639257|NCT00578929|9679565|FG003|COMPLETED|Randomized Period||283
8639258|NCT00578929|9679562|FG000|NOT COMPLETED|Randomized Period||17
8639259|NCT00578929|9679563|FG001|NOT COMPLETED|Randomized Period||14
8639260|NCT00578929|9679564|FG002|NOT COMPLETED|Randomized Period||8
8639261|NCT00578929|9679565|FG003|NOT COMPLETED|Randomized Period||14
9019991|NCT03094195|10082683|FG007|COMPLETED|Treatment Withdrawal Period (TW)||26
9019992|NCT03094195|10082676|FG000|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
9019993|NCT03094195|10082677|FG001|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
9019994|NCT03094195|10082678|FG002|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
9019995|NCT03094195|10082679|FG003|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
9019996|NCT03094195|10082680|FG004|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
9019997|NCT03094195|10082681|FG005|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
9019998|NCT03094195|10082682|FG006|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
8639262|NCT00578942|9679576|FG000|STARTED|Overall Study||48
8639263|NCT00578942|9679576|FG000|COMPLETED|Overall Study||47
8639264|NCT00578942|9679576|FG000|NOT COMPLETED|Overall Study||1
8639265|NCT00578968|9679583|FG000|STARTED|Baseline (Prior to Intervention)||12
8639266|NCT00578968|9679584|FG001|STARTED|Baseline (Prior to Intervention)||12
8639267|NCT00578968|9679585|FG002|STARTED|Baseline (Prior to Intervention)||12
8639268|NCT00578968|9679583|FG000|COMPLETED|Baseline (Prior to Intervention)||12
8639269|NCT00578968|9679584|FG001|COMPLETED|Baseline (Prior to Intervention)||12
8639270|NCT00578968|9679585|FG002|COMPLETED|Baseline (Prior to Intervention)||12
8639271|NCT00578968|9679583|FG000|NOT COMPLETED|Baseline (Prior to Intervention)||0
9019999|NCT03094195|10082683|FG007|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
9020000|NCT03094325|10082701|FG000|STARTED|Overall Study||10
9020001|NCT03094325|10082701|FG000|TEE Before Cardiopulmonary Bypass|Overall Study||10
9020002|NCT03094325|10082701|FG000|OPIE Before Cardiopulmonary Bypass|Overall Study||10
9020003|NCT03094325|10082701|FG000|TEE After Cardiopulmonary Bypass|Overall Study||10
9020004|NCT03094325|10082701|FG000|OPIE After Cardiopulmonary Bypass|Overall Study||10
9020005|NCT03094325|10082701|FG000|COMPLETED|Overall Study||10
9020006|NCT03094325|10082701|FG000|NOT COMPLETED|Overall Study||0
9020007|NCT03094611|10082707|FG000|STARTED|Overall Study||4
9020008|NCT03094611|10082707|FG000|COMPLETED|Overall Study||2
9020009|NCT03094611|10082707|FG000|NOT COMPLETED|Overall Study||2
9020010|NCT03094637|10082713|FG000|STARTED|Overall Study||17
9020011|NCT03094637|10082714|FG001|STARTED|Overall Study||20
9020012|NCT03094637|10082713|FG000|COMPLETED|Overall Study||17
9020013|NCT03094637|10082714|FG001|COMPLETED|Overall Study||20
9020014|NCT03094637|10082713|FG000|NOT COMPLETED|Overall Study||0
9020015|NCT03094637|10082714|FG001|NOT COMPLETED|Overall Study||0
9020016|NCT03094806|10082723|FG000|STARTED|Overall Study||44
9020017|NCT03094806|10082724|FG001|STARTED|Overall Study||47
9020018|NCT03094806|10082723|FG000|COMPLETED|Overall Study||44
9020019|NCT03094806|10082724|FG001|COMPLETED|Overall Study||47
9020020|NCT03094806|10082723|FG000|NOT COMPLETED|Overall Study||0
9020021|NCT03094806|10082724|FG001|NOT COMPLETED|Overall Study||0
9020022|NCT03095027|10082730|FG000|STARTED|Period 1, First Week of Wear||27
9020023|NCT03095027|10082731|FG001|STARTED|Period 1, First Week of Wear||24
9020024|NCT03095027|10082730|FG000|COMPLETED|Period 1, First Week of Wear||27
9020025|NCT03095027|10082731|FG001|COMPLETED|Period 1, First Week of Wear||24
9020026|NCT03095027|10082730|FG000|NOT COMPLETED|Period 1, First Week of Wear||0
9020027|NCT03095027|10082731|FG001|NOT COMPLETED|Period 1, First Week of Wear||0
9020028|NCT03095027|10082730|FG000|STARTED|Period 2, Second Week of Wear||27
9020029|NCT03095027|10082731|FG001|STARTED|Period 2, Second Week of Wear||24
9020030|NCT03095027|10082730|FG000|COMPLETED|Period 2, Second Week of Wear||26
9020031|NCT03095027|10082731|FG001|COMPLETED|Period 2, Second Week of Wear||24
9020032|NCT03095027|10082730|FG000|NOT COMPLETED|Period 2, Second Week of Wear||1
9020033|NCT03095027|10082731|FG001|NOT COMPLETED|Period 2, Second Week of Wear||0
9020034|NCT03095053|10082739|FG000|STARTED|Overall Study|All blastocysts scored morphologically PGT-A of the single best blastocyst from the cohort|109
9020035|NCT03095053|10082740|FG001|STARTED|Overall Study|All blastocysts scored morphologically|111
9020036|NCT03095053|10082739|FG000|COMPLETED|Overall Study|29 excluded as blastocyst was predicted to be aneuploid|80
9020037|NCT03095053|10082740|FG001|COMPLETED|Overall Study||111
9020038|NCT03095053|10082739|FG000|NOT COMPLETED|Overall Study||29
9020039|NCT03095053|10082740|FG001|NOT COMPLETED|Overall Study||0
9020040|NCT03095118|10082746|FG000|STARTED|Overall Study||12
9020041|NCT03095118|10082746|FG000|COMPLETED|Overall Study||10
9020042|NCT03095118|10082746|FG000|NOT COMPLETED|Overall Study||2
9020043|NCT03095508|10082752|FG000|STARTED|Overall Study||114
9020044|NCT03095508|10082753|FG001|STARTED|Overall Study||115
9020045|NCT03095508|10082752|FG000|Per Protocol Population|Overall Study||112
9020046|NCT03095508|10082753|FG001|Per Protocol Population|Overall Study||111
9020047|NCT03095508|10082752|FG000|Safety Population|Overall Study||114
9020048|NCT03095508|10082753|FG001|Safety Population|Overall Study||115
9020049|NCT03095508|10082752|FG000|ITT Population|Overall Study||114
9020050|NCT03095508|10082753|FG001|ITT Population|Overall Study||115
9020051|NCT03095508|10082752|FG000|COMPLETED|Overall Study||114
9020052|NCT03095508|10082753|FG001|COMPLETED|Overall Study||114
9020053|NCT03095508|10082752|FG000|NOT COMPLETED|Overall Study||0
9020054|NCT03095508|10082753|FG001|NOT COMPLETED|Overall Study||1
9020055|NCT03095521|10082761|FG000|STARTED|Overall Study||115
9020056|NCT03095521|10082762|FG001|STARTED|Overall Study||113
9020057|NCT03095521|10082761|FG000|Intent to Treat Population ITT|Overall Study||115
9020058|NCT03095521|10082762|FG001|Intent to Treat Population ITT|Overall Study||113
9020059|NCT03095521|10082761|FG000|Per Protocol Population PP|Overall Study||113
9020060|NCT03095521|10082762|FG001|Per Protocol Population PP|Overall Study||107
9020061|NCT03095521|10082761|FG000|Safety Population|Overall Study||115
9020062|NCT03095521|10082762|FG001|Safety Population|Overall Study||113
9020063|NCT03095521|10082761|FG000|COMPLETED|Overall Study||115
9020064|NCT03095521|10082762|FG001|COMPLETED|Overall Study||111
9020065|NCT03095521|10082761|FG000|NOT COMPLETED|Overall Study||0
9020066|NCT03095521|10082762|FG001|NOT COMPLETED|Overall Study||2
9020067|NCT03095599|10082770|FG000|STARTED|Overall Study||741
9020068|NCT03095599|10082771|FG001|STARTED|Overall Study||148
9020069|NCT03095599|10082770|FG000|Withdrawal Before Vaccination|Overall Study||1
9020070|NCT03095599|10082771|FG001|Withdrawal Before Vaccination|Overall Study||0
9020071|NCT03095599|10082770|FG000|Vaccinated|Overall Study||740
9020072|NCT03095599|10082771|FG001|Vaccinated|Overall Study||148
9020073|NCT03095599|10082770|FG000|COMPLETED|Overall Study||738
9020074|NCT03095599|10082771|FG001|COMPLETED|Overall Study||148
9020075|NCT03095599|10082770|FG000|NOT COMPLETED|Overall Study||3
9020076|NCT03095599|10082771|FG001|NOT COMPLETED|Overall Study||0
9020077|NCT03095638|10082781|FG000|STARTED|P1: Period 1 (4 Days)||7
9020078|NCT03095638|10082782|FG001|STARTED|P1: Period 1 (4 Days)||7
9020079|NCT03095638|10082783|FG002|STARTED|P1: Period 1 (4 Days)||0
9020080|NCT03095638|10082784|FG003|STARTED|P1: Period 1 (4 Days)||0
9020081|NCT03095638|10082785|FG004|STARTED|P1: Period 1 (4 Days)||0
9020082|NCT03095638|10082786|FG005|STARTED|P1: Period 1 (4 Days)||0
9020083|NCT03095638|10082787|FG006|STARTED|P1: Period 1 (4 Days)||0
9020084|NCT03095638|10082788|FG007|STARTED|P1: Period 1 (4 Days)||0
8639272|NCT00578968|9679584|FG001|NOT COMPLETED|Baseline (Prior to Intervention)||0
8639273|NCT00578968|9679585|FG002|NOT COMPLETED|Baseline (Prior to Intervention)||0
8639274|NCT00578968|9679583|FG000|STARTED|Intervention||12
8639275|NCT00578968|9679584|FG001|STARTED|Intervention||12
8639276|NCT00578968|9679585|FG002|STARTED|Intervention||0
8639277|NCT00578968|9679583|FG000|COMPLETED|Intervention||12
8639278|NCT00578968|9679584|FG001|COMPLETED|Intervention||12
8639279|NCT00578968|9679585|FG002|COMPLETED|Intervention||0
8639280|NCT00578968|9679583|FG000|NOT COMPLETED|Intervention||0
8639281|NCT00578968|9679584|FG001|NOT COMPLETED|Intervention||0
8639282|NCT00578968|9679585|FG002|NOT COMPLETED|Intervention||0
8639283|NCT00579059|9679596|FG000|STARTED|Overall Study|Enrollment was incomplete due to study cancellation.|21
8639284|NCT00579059|9679597|FG001|STARTED|Overall Study|Enrollment was incomplete due to study cancellation.|10
8639285|NCT00579059|9679596|FG000|Immediate Post-Op|Overall Study|1 Patient didn't return for follow-up.|20
8639286|NCT00579059|9679597|FG001|Immediate Post-Op|Overall Study|1 Patient didn't return for follow-up.|9
8639287|NCT00579059|9679596|FG000|6 Months|Overall Study|10 Patients didn't return for follow-up.|11
8639288|NCT00579059|9679597|FG001|6 Months|Overall Study|6 patients didn't return for follow-up.|4
8639289|NCT00579059|9679596|FG000|1 Year|Overall Study|13 patients didn't return for follow-up.|8
8639290|NCT00579059|9679597|FG001|1 Year|Overall Study|7 patients didn't return for follow-up.|3
8639291|NCT00579059|9679596|FG000|3 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
8639292|NCT00579059|9679597|FG001|3 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
8639293|NCT00579059|9679596|FG000|5 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
8639294|NCT00579059|9679597|FG001|5 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
8639295|NCT00579059|9679596|FG000|COMPLETED|Overall Study|No Patients completed through 5 years due to study closure at 1-year of follow-up.|0
8639296|NCT00579059|9679597|FG001|COMPLETED|Overall Study|No Patients completed through 5 years due to study closure at 1-year of follow-up.|0
8639297|NCT00579059|9679596|FG000|NOT COMPLETED|Overall Study||21
8639298|NCT00579059|9679597|FG001|NOT COMPLETED|Overall Study||10
8639299|NCT00579098|9679605|FG000|STARTED|Overall Study||62
8639300|NCT00579098|9679606|FG001|STARTED|Overall Study||63
8639301|NCT00579098|9679605|FG000|COMPLETED|Overall Study||53
8639302|NCT00579098|9679606|FG001|COMPLETED|Overall Study||55
8639303|NCT00579098|9679605|FG000|NOT COMPLETED|Overall Study||9
8639304|NCT00579098|9679606|FG001|NOT COMPLETED|Overall Study||8
8639305|NCT00579111|9679614|FG000|STARTED|Overall Study||3
8639306|NCT00579111|9679615|FG001|STARTED|Overall Study||1
8639307|NCT00579111|9679614|FG000|COMPLETED|Overall Study||1
8639308|NCT00579111|9679615|FG001|COMPLETED|Overall Study||0
8639309|NCT00579111|9679614|FG000|NOT COMPLETED|Overall Study||2
8639310|NCT00579111|9679615|FG001|NOT COMPLETED|Overall Study||1
8639311|NCT00579137|9679621|FG000|STARTED|Overall Study||3
8639312|NCT00579137|9679621|FG000|COMPLETED|Overall Study||3
8639313|NCT00579137|9679621|FG000|NOT COMPLETED|Overall Study||0
8639314|NCT00579280|9679628|FG000|STARTED|Overall Study||49
8639315|NCT00579280|9679629|FG001|STARTED|Overall Study||49
8639316|NCT00579280|9679630|FG002|STARTED|Overall Study||51
8639317|NCT00579280|9679628|FG000|COMPLETED|Overall Study|LOCF evaluable sample|47
8639318|NCT00579280|9679629|FG001|COMPLETED|Overall Study|LOCF evaluable sample|46
8639319|NCT00579280|9679630|FG002|COMPLETED|Overall Study|LOCF evaluable sample|51
8639320|NCT00579280|9679628|FG000|NOT COMPLETED|Overall Study||2
8639321|NCT00579280|9679629|FG001|NOT COMPLETED|Overall Study||3
8639322|NCT00579280|9679630|FG002|NOT COMPLETED|Overall Study||0
8639323|NCT00579345|9679646|FG000|STARTED|Overall Study||549
8639324|NCT00579345|9679647|FG001|STARTED|Overall Study||169
8639325|NCT00579345|9679648|FG002|STARTED|Overall Study||391
8639326|NCT00579345|9679649|FG003|STARTED|Overall Study||144
8639327|NCT00579345|9679650|FG004|STARTED|Overall Study||90
8639328|NCT00579345|9679651|FG005|STARTED|Overall Study||78
8639329|NCT00579345|9679652|FG006|STARTED|Overall Study||57
8639330|NCT00579345|9679653|FG007|STARTED|Overall Study||44
8639331|NCT00579345|9679646|FG000|COMPLETED|Overall Study||544
8639332|NCT00579345|9679647|FG001|COMPLETED|Overall Study||168
8639333|NCT00579345|9679648|FG002|COMPLETED|Overall Study||389
8639334|NCT00579345|9679649|FG003|COMPLETED|Overall Study||143
8639335|NCT00579345|9679650|FG004|COMPLETED|Overall Study||90
8639336|NCT00579345|9679651|FG005|COMPLETED|Overall Study||78
9020085|NCT03095638|10082781|FG000|COMPLETED|P1: Period 1 (4 Days)||7
9020086|NCT03095638|10082782|FG001|COMPLETED|P1: Period 1 (4 Days)||7
9020087|NCT03095638|10082783|FG002|COMPLETED|P1: Period 1 (4 Days)||0
9020088|NCT03095638|10082784|FG003|COMPLETED|P1: Period 1 (4 Days)||0
9020089|NCT03095638|10082785|FG004|COMPLETED|P1: Period 1 (4 Days)||0
9020090|NCT03095638|10082786|FG005|COMPLETED|P1: Period 1 (4 Days)||0
9020091|NCT03095638|10082787|FG006|COMPLETED|P1: Period 1 (4 Days)||0
9020092|NCT03095638|10082788|FG007|COMPLETED|P1: Period 1 (4 Days)||0
9020093|NCT03095638|10082781|FG000|NOT COMPLETED|P1: Period 1 (4 Days)||0
8639337|NCT00579345|9679652|FG006|COMPLETED|Overall Study||57
8639338|NCT00579345|9679653|FG007|COMPLETED|Overall Study||42
8639339|NCT00579345|9679646|FG000|NOT COMPLETED|Overall Study||5
9020094|NCT03095638|10082782|FG001|NOT COMPLETED|P1: Period 1 (4 Days)||0
8639340|NCT00579345|9679647|FG001|NOT COMPLETED|Overall Study||1
9020095|NCT03095638|10082783|FG002|NOT COMPLETED|P1: Period 1 (4 Days)||0
9020096|NCT03095638|10082784|FG003|NOT COMPLETED|P1: Period 1 (4 Days)||0
9020097|NCT03095638|10082785|FG004|NOT COMPLETED|P1: Period 1 (4 Days)||0
9020098|NCT03095638|10082786|FG005|NOT COMPLETED|P1: Period 1 (4 Days)||0
9020099|NCT03095638|10082787|FG006|NOT COMPLETED|P1: Period 1 (4 Days)||0
9020100|NCT03095638|10082788|FG007|NOT COMPLETED|P1: Period 1 (4 Days)||0
9020101|NCT03095638|10082781|FG000|STARTED|P1: Period 1, Washout (7 [-4 Hours])||7
9020102|NCT03095638|10082782|FG001|STARTED|P1: Period 1, Washout (7 [-4 Hours])||7
9020103|NCT03095638|10082783|FG002|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
9020104|NCT03095638|10082784|FG003|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
9020105|NCT03095638|10082785|FG004|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
9020106|NCT03095638|10082786|FG005|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
9020107|NCT03095638|10082787|FG006|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
9020108|NCT03095638|10082788|FG007|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
9020109|NCT03095638|10082781|FG000|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||7
9020110|NCT03095638|10082782|FG001|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||7
9020111|NCT03095638|10082783|FG002|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
9020112|NCT03095638|10082784|FG003|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
9020113|NCT03095638|10082785|FG004|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
9020114|NCT03095638|10082786|FG005|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
9020115|NCT03095638|10082787|FG006|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
9020116|NCT03095638|10082788|FG007|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
9020117|NCT03095638|10082781|FG000|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
9020118|NCT03095638|10082782|FG001|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
9020119|NCT03095638|10082783|FG002|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
9020120|NCT03095638|10082784|FG003|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
9020121|NCT03095638|10082785|FG004|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
9020122|NCT03095638|10082786|FG005|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
9020123|NCT03095638|10082787|FG006|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
9020124|NCT03095638|10082788|FG007|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
9020125|NCT03095638|10082781|FG000|STARTED|P1: Period 2 (4 Days)||7
9020126|NCT03095638|10082782|FG001|STARTED|P1: Period 2 (4 Days)||7
9020127|NCT03095638|10082783|FG002|STARTED|P1: Period 2 (4 Days)||0
9020128|NCT03095638|10082784|FG003|STARTED|P1: Period 2 (4 Days)||0
9020129|NCT03095638|10082785|FG004|STARTED|P1: Period 2 (4 Days)||0
9020130|NCT03095638|10082786|FG005|STARTED|P1: Period 2 (4 Days)||0
9020131|NCT03095638|10082787|FG006|STARTED|P1: Period 2 (4 Days)||0
9020132|NCT03095638|10082788|FG007|STARTED|P1: Period 2 (4 Days)||0
9020133|NCT03095638|10082781|FG000|COMPLETED|P1: Period 2 (4 Days)||7
9020134|NCT03095638|10082782|FG001|COMPLETED|P1: Period 2 (4 Days)||7
9020135|NCT03095638|10082783|FG002|COMPLETED|P1: Period 2 (4 Days)||0
9020136|NCT03095638|10082784|FG003|COMPLETED|P1: Period 2 (4 Days)||0
9020137|NCT03095638|10082785|FG004|COMPLETED|P1: Period 2 (4 Days)||0
9020138|NCT03095638|10082786|FG005|COMPLETED|P1: Period 2 (4 Days)||0
9020139|NCT03095638|10082787|FG006|COMPLETED|P1: Period 2 (4 Days)||0
9020140|NCT03095638|10082788|FG007|COMPLETED|P1: Period 2 (4 Days)||0
9020141|NCT03095638|10082781|FG000|NOT COMPLETED|P1: Period 2 (4 Days)||0
9020142|NCT03095638|10082782|FG001|NOT COMPLETED|P1: Period 2 (4 Days)||0
9020143|NCT03095638|10082783|FG002|NOT COMPLETED|P1: Period 2 (4 Days)||0
9020144|NCT03095638|10082784|FG003|NOT COMPLETED|P1: Period 2 (4 Days)||0
9020145|NCT03095638|10082785|FG004|NOT COMPLETED|P1: Period 2 (4 Days)||0
9020146|NCT03095638|10082786|FG005|NOT COMPLETED|P1: Period 2 (4 Days)||0
9020147|NCT03095638|10082787|FG006|NOT COMPLETED|P1: Period 2 (4 Days)||0
9020148|NCT03095638|10082788|FG007|NOT COMPLETED|P1: Period 2 (4 Days)||0
9020149|NCT03095638|10082781|FG000|STARTED|P1: Period 2, Washout (7[-4 Hours])||7
9020150|NCT03095638|10082782|FG001|STARTED|P1: Period 2, Washout (7[-4 Hours])||7
8639341|NCT00579345|9679648|FG002|NOT COMPLETED|Overall Study||2
8639342|NCT00579345|9679649|FG003|NOT COMPLETED|Overall Study||1
8639343|NCT00579345|9679650|FG004|NOT COMPLETED|Overall Study||0
8639344|NCT00579345|9679651|FG005|NOT COMPLETED|Overall Study||0
8639345|NCT00579345|9679652|FG006|NOT COMPLETED|Overall Study||0
9020151|NCT03095638|10082783|FG002|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
9020152|NCT03095638|10082784|FG003|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
9020153|NCT03095638|10082785|FG004|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
9020154|NCT03095638|10082786|FG005|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
9020155|NCT03095638|10082787|FG006|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
9020156|NCT03095638|10082788|FG007|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
9020157|NCT03095638|10082781|FG000|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||7
9020158|NCT03095638|10082782|FG001|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||7
9020159|NCT03095638|10082783|FG002|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
9020160|NCT03095638|10082784|FG003|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
9020161|NCT03095638|10082785|FG004|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
9020162|NCT03095638|10082786|FG005|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
9020163|NCT03095638|10082787|FG006|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
9020164|NCT03095638|10082788|FG007|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
9020165|NCT03095638|10082781|FG000|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
9020166|NCT03095638|10082782|FG001|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
8639346|NCT00579345|9679653|FG007|NOT COMPLETED|Overall Study||2
8639347|NCT00579436|9679683|FG000|STARTED|Overall Study||19
9020167|NCT03095638|10082783|FG002|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
9020168|NCT03095638|10082784|FG003|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
9020169|NCT03095638|10082785|FG004|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
9020170|NCT03095638|10082786|FG005|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
9020171|NCT03095638|10082787|FG006|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
9020172|NCT03095638|10082788|FG007|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
9020173|NCT03095638|10082781|FG000|STARTED|P2: Period 1 (4 Days)||0
9020174|NCT03095638|10082782|FG001|STARTED|P2: Period 1 (4 Days)||0
9020175|NCT03095638|10082783|FG002|STARTED|P2: Period 1 (4 Days)||4
9020176|NCT03095638|10082784|FG003|STARTED|P2: Period 1 (4 Days)||4
9020177|NCT03095638|10082785|FG004|STARTED|P2: Period 1 (4 Days)||4
9020178|NCT03095638|10082786|FG005|STARTED|P2: Period 1 (4 Days)||4
9020179|NCT03095638|10082787|FG006|STARTED|P2: Period 1 (4 Days)||4
9020180|NCT03095638|10082788|FG007|STARTED|P2: Period 1 (4 Days)||4
9020181|NCT03095638|10082781|FG000|COMPLETED|P2: Period 1 (4 Days)||0
9020182|NCT03095638|10082782|FG001|COMPLETED|P2: Period 1 (4 Days)||0
9020183|NCT03095638|10082783|FG002|COMPLETED|P2: Period 1 (4 Days)||4
9020184|NCT03095638|10082784|FG003|COMPLETED|P2: Period 1 (4 Days)||4
9020185|NCT03095638|10082785|FG004|COMPLETED|P2: Period 1 (4 Days)||4
9020186|NCT03095638|10082786|FG005|COMPLETED|P2: Period 1 (4 Days)||4
9020187|NCT03095638|10082787|FG006|COMPLETED|P2: Period 1 (4 Days)||4
9020188|NCT03095638|10082788|FG007|COMPLETED|P2: Period 1 (4 Days)||4
9020189|NCT03095638|10082781|FG000|NOT COMPLETED|P2: Period 1 (4 Days)||0
9020190|NCT03095638|10082782|FG001|NOT COMPLETED|P2: Period 1 (4 Days)||0
9020191|NCT03095638|10082783|FG002|NOT COMPLETED|P2: Period 1 (4 Days)||0
9020192|NCT03095638|10082784|FG003|NOT COMPLETED|P2: Period 1 (4 Days)||0
9020193|NCT03095638|10082785|FG004|NOT COMPLETED|P2: Period 1 (4 Days)||0
9020194|NCT03095638|10082786|FG005|NOT COMPLETED|P2: Period 1 (4 Days)||0
9020195|NCT03095638|10082787|FG006|NOT COMPLETED|P2: Period 1 (4 Days)||0
9020196|NCT03095638|10082788|FG007|NOT COMPLETED|P2: Period 1 (4 Days)||0
9020197|NCT03095638|10082781|FG000|STARTED|P2: Period 1, Washout (7[-4 Hours])||0
9020198|NCT03095638|10082782|FG001|STARTED|P2: Period 1, Washout (7[-4 Hours])||0
9020199|NCT03095638|10082783|FG002|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
9020200|NCT03095638|10082784|FG003|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
9020201|NCT03095638|10082785|FG004|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
9020202|NCT03095638|10082786|FG005|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
9020203|NCT03095638|10082787|FG006|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
9020204|NCT03095638|10082788|FG007|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
9020205|NCT03095638|10082781|FG000|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
9020206|NCT03095638|10082782|FG001|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
9020207|NCT03095638|10082783|FG002|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
9020208|NCT03095638|10082784|FG003|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
9020209|NCT03095638|10082785|FG004|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
9020210|NCT03095638|10082786|FG005|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
9020211|NCT03095638|10082787|FG006|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
9020212|NCT03095638|10082788|FG007|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
9020213|NCT03095638|10082781|FG000|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
9020214|NCT03095638|10082782|FG001|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
9020215|NCT03095638|10082783|FG002|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
9020216|NCT03095638|10082784|FG003|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
9020217|NCT03095638|10082785|FG004|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
9020218|NCT03095638|10082786|FG005|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
9020219|NCT03095638|10082787|FG006|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
9020220|NCT03095638|10082788|FG007|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
9020221|NCT03095638|10082781|FG000|STARTED|P2: Period 2 (4 Days)||0
9020222|NCT03095638|10082782|FG001|STARTED|P2: Period 2 (4 Days)||0
9020223|NCT03095638|10082783|FG002|STARTED|P2: Period 2 (4 Days)||4
9020224|NCT03095638|10082784|FG003|STARTED|P2: Period 2 (4 Days)||4
9020225|NCT03095638|10082785|FG004|STARTED|P2: Period 2 (4 Days)||4
9020226|NCT03095638|10082786|FG005|STARTED|P2: Period 2 (4 Days)||4
9020227|NCT03095638|10082787|FG006|STARTED|P2: Period 2 (4 Days)||4
9020228|NCT03095638|10082788|FG007|STARTED|P2: Period 2 (4 Days)||4
9020229|NCT03095638|10082781|FG000|COMPLETED|P2: Period 2 (4 Days)||0
9020230|NCT03095638|10082782|FG001|COMPLETED|P2: Period 2 (4 Days)||0
9020231|NCT03095638|10082783|FG002|COMPLETED|P2: Period 2 (4 Days)||4
9020232|NCT03095638|10082784|FG003|COMPLETED|P2: Period 2 (4 Days)||4
9020233|NCT03095638|10082785|FG004|COMPLETED|P2: Period 2 (4 Days)||4
9020234|NCT03095638|10082786|FG005|COMPLETED|P2: Period 2 (4 Days)||4
9020235|NCT03095638|10082787|FG006|COMPLETED|P2: Period 2 (4 Days)||4
9020236|NCT03095638|10082788|FG007|COMPLETED|P2: Period 2 (4 Days)||4
9020237|NCT03095638|10082781|FG000|NOT COMPLETED|P2: Period 2 (4 Days)||0
9020238|NCT03095638|10082782|FG001|NOT COMPLETED|P2: Period 2 (4 Days)||0
9020239|NCT03095638|10082783|FG002|NOT COMPLETED|P2: Period 2 (4 Days)||0
9020240|NCT03095638|10082784|FG003|NOT COMPLETED|P2: Period 2 (4 Days)||0
9020241|NCT03095638|10082785|FG004|NOT COMPLETED|P2: Period 2 (4 Days)||0
9020242|NCT03095638|10082786|FG005|NOT COMPLETED|P2: Period 2 (4 Days)||0
9020243|NCT03095638|10082787|FG006|NOT COMPLETED|P2: Period 2 (4 Days)||0
9020244|NCT03095638|10082788|FG007|NOT COMPLETED|P2: Period 2 (4 Days)||0
9020245|NCT03095638|10082781|FG000|STARTED|P2: Period 2, Washout (7[-4 Hours])||0
9020246|NCT03095638|10082782|FG001|STARTED|P2: Period 2, Washout (7[-4 Hours])||0
9020247|NCT03095638|10082783|FG002|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
9020248|NCT03095638|10082784|FG003|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
9020249|NCT03095638|10082785|FG004|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
9020250|NCT03095638|10082786|FG005|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
9020251|NCT03095638|10082787|FG006|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
9020252|NCT03095638|10082788|FG007|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
9020253|NCT03095638|10082781|FG000|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
9020254|NCT03095638|10082782|FG001|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
9020255|NCT03095638|10082783|FG002|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
9020256|NCT03095638|10082784|FG003|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
9020257|NCT03095638|10082785|FG004|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
9020258|NCT03095638|10082786|FG005|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
9020259|NCT03095638|10082787|FG006|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
9020260|NCT03095638|10082788|FG007|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
9020261|NCT03095638|10082781|FG000|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
9020262|NCT03095638|10082782|FG001|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
9020263|NCT03095638|10082783|FG002|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
9020264|NCT03095638|10082784|FG003|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
9020265|NCT03095638|10082785|FG004|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
9020266|NCT03095638|10082786|FG005|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
9020267|NCT03095638|10082787|FG006|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
8639348|NCT00579436|9679684|FG001|STARTED|Overall Study||14
8639349|NCT00579436|9679683|FG000|COMPLETED|Overall Study||19
8639350|NCT00579436|9679684|FG001|COMPLETED|Overall Study||14
8639351|NCT00579436|9679683|FG000|NOT COMPLETED|Overall Study||0
8639352|NCT00579436|9679684|FG001|NOT COMPLETED|Overall Study||0
9020268|NCT03095638|10082788|FG007|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
9020269|NCT03095638|10082781|FG000|STARTED|P2: Period 3 (4 Days)||0
9020270|NCT03095638|10082782|FG001|STARTED|P2: Period 3 (4 Days)||0
9020271|NCT03095638|10082783|FG002|STARTED|P2: Period 3 (4 Days)||4
9020272|NCT03095638|10082784|FG003|STARTED|P2: Period 3 (4 Days)||4
9020273|NCT03095638|10082785|FG004|STARTED|P2: Period 3 (4 Days)||4
9020274|NCT03095638|10082786|FG005|STARTED|P2: Period 3 (4 Days)||4
9020275|NCT03095638|10082787|FG006|STARTED|P2: Period 3 (4 Days)||4
9020276|NCT03095638|10082788|FG007|STARTED|P2: Period 3 (4 Days)||4
9020277|NCT03095638|10082781|FG000|COMPLETED|P2: Period 3 (4 Days)||0
9020278|NCT03095638|10082782|FG001|COMPLETED|P2: Period 3 (4 Days)||0
9020279|NCT03095638|10082783|FG002|COMPLETED|P2: Period 3 (4 Days)||4
9020280|NCT03095638|10082784|FG003|COMPLETED|P2: Period 3 (4 Days)||4
9020281|NCT03095638|10082785|FG004|COMPLETED|P2: Period 3 (4 Days)||4
9020282|NCT03095638|10082786|FG005|COMPLETED|P2: Period 3 (4 Days)||4
9020283|NCT03095638|10082787|FG006|COMPLETED|P2: Period 3 (4 Days)||4
9020284|NCT03095638|10082788|FG007|COMPLETED|P2: Period 3 (4 Days)||4
9020285|NCT03095638|10082781|FG000|NOT COMPLETED|P2: Period 3 (4 Days)||0
9020286|NCT03095638|10082782|FG001|NOT COMPLETED|P2: Period 3 (4 Days)||0
9020287|NCT03095638|10082783|FG002|NOT COMPLETED|P2: Period 3 (4 Days)||0
9020288|NCT03095638|10082784|FG003|NOT COMPLETED|P2: Period 3 (4 Days)||0
9020289|NCT03095638|10082785|FG004|NOT COMPLETED|P2: Period 3 (4 Days)||0
9020290|NCT03095638|10082786|FG005|NOT COMPLETED|P2: Period 3 (4 Days)||0
9020291|NCT03095638|10082787|FG006|NOT COMPLETED|P2: Period 3 (4 Days)||0
9020292|NCT03095638|10082788|FG007|NOT COMPLETED|P2: Period 3 (4 Days)||0
9020293|NCT03095638|10082781|FG000|STARTED|P2: Period 3, Washout (7[-4 Hours])||0
9020294|NCT03095638|10082782|FG001|STARTED|P2: Period 3, Washout (7[-4 Hours])||0
9020295|NCT03095638|10082783|FG002|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
9020296|NCT03095638|10082784|FG003|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
9020297|NCT03095638|10082785|FG004|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
9020298|NCT03095638|10082786|FG005|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
9020299|NCT03095638|10082787|FG006|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
9020300|NCT03095638|10082788|FG007|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
9020301|NCT03095638|10082781|FG000|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
9020302|NCT03095638|10082782|FG001|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
9020303|NCT03095638|10082783|FG002|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
9020304|NCT03095638|10082784|FG003|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
9020305|NCT03095638|10082785|FG004|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
9020306|NCT03095638|10082786|FG005|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
9020307|NCT03095638|10082787|FG006|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
9020308|NCT03095638|10082788|FG007|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
9020309|NCT03095638|10082781|FG000|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
9020310|NCT03095638|10082782|FG001|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
8639353|NCT00579501|9679690|FG000|STARTED|Overall Study||29
8639354|NCT00579501|9679690|FG000|COMPLETED|Overall Study||0
8639355|NCT00579501|9679690|FG000|NOT COMPLETED|Overall Study||29
9020311|NCT03095638|10082783|FG002|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
9020312|NCT03095638|10082784|FG003|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
9020313|NCT03095638|10082785|FG004|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
9020314|NCT03095638|10082786|FG005|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
9020315|NCT03095638|10082787|FG006|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
9020316|NCT03095638|10082788|FG007|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
9020317|NCT03095651|10082816|FG000|STARTED|Overall Study||6
9020318|NCT03095651|10082817|FG001|STARTED|Overall Study||6
9020319|NCT03095651|10082818|FG002|STARTED|Overall Study||0
9020320|NCT03095651|10082819|FG003|STARTED|Overall Study||4
9020321|NCT03095651|10082820|FG004|STARTED|Overall Study||0
9020322|NCT03095651|10082821|FG005|STARTED|Overall Study||7
9020323|NCT03095651|10082822|FG006|STARTED|Overall Study||6
9020324|NCT03095651|10082823|FG007|STARTED|Overall Study||4
9020325|NCT03095651|10082816|FG000|COMPLETED|Overall Study||5
9020326|NCT03095651|10082817|FG001|COMPLETED|Overall Study||5
9020327|NCT03095651|10082818|FG002|COMPLETED|Overall Study||0
9020328|NCT03095651|10082819|FG003|COMPLETED|Overall Study||3
9020329|NCT03095651|10082820|FG004|COMPLETED|Overall Study||0
9020330|NCT03095651|10082821|FG005|COMPLETED|Overall Study||6
9020331|NCT03095651|10082822|FG006|COMPLETED|Overall Study||6
9020332|NCT03095651|10082823|FG007|COMPLETED|Overall Study||4
9020333|NCT03095651|10082816|FG000|NOT COMPLETED|Overall Study||1
9020334|NCT03095651|10082817|FG001|NOT COMPLETED|Overall Study||1
9020335|NCT03095651|10082818|FG002|NOT COMPLETED|Overall Study||0
9020336|NCT03095651|10082819|FG003|NOT COMPLETED|Overall Study||1
9020337|NCT03095651|10082820|FG004|NOT COMPLETED|Overall Study||0
9020338|NCT03095651|10082821|FG005|NOT COMPLETED|Overall Study||1
9020339|NCT03095651|10082822|FG006|NOT COMPLETED|Overall Study||0
9020340|NCT03095651|10082823|FG007|NOT COMPLETED|Overall Study||0
9020341|NCT03095885|10082841|FG000|STARTED|Overall Study||22
9020342|NCT03095885|10082841|FG000|COMPLETED|Overall Study||22
9020343|NCT03095885|10082841|FG000|NOT COMPLETED|Overall Study||0
9020344|NCT03095976|10082845|FG000|STARTED|Overall Study||4
8639356|NCT00579553|9679696|FG000|STARTED|Overall Study||82
8639357|NCT00579553|9679697|FG001|STARTED|Overall Study||92
8639358|NCT00579553|9679696|FG000|COMPLETED|Overall Study||66
8639359|NCT00579553|9679697|FG001|COMPLETED|Overall Study||79
8639360|NCT00579553|9679696|FG000|NOT COMPLETED|Overall Study||16
8639361|NCT00579553|9679697|FG001|NOT COMPLETED|Overall Study||13
8639362|NCT00579670|9679708|FG000|STARTED|Overall Study|Full Analysis Set (FAS): at least 1 dose study medication and at least 1 efficacy measurement|15
8639363|NCT00579670|9679709|FG001|STARTED|Overall Study||57
8639364|NCT00579670|9679710|FG002|STARTED|Overall Study||88
8639365|NCT00579670|9679711|FG003|STARTED|Overall Study||285
8639366|NCT00579670|9679712|FG004|STARTED|Overall Study||5
8639367|NCT00579670|9679708|FG000|Population: Within SmPC (Started)|Overall Study|"Within summary of product characteristics (SmPC): FAS subjects who received all doses Within SmPC"|15
8639368|NCT00579670|9679709|FG001|Population: Within SmPC (Started)|Overall Study||56
8639369|NCT00579670|9679710|FG002|Population: Within SmPC (Started)|Overall Study||83
8639370|NCT00579670|9679711|FG003|Population: Within SmPC (Started)|Overall Study||159
8639371|NCT00579670|9679712|FG004|Population: Within SmPC (Started)|Overall Study|"Ziprasidone Unknown reporting group is not applicable to the Within SmPC population"|0
9020345|NCT03095976|10082845|FG000|COMPLETED|Overall Study||4
9020346|NCT03095976|10082845|FG000|NOT COMPLETED|Overall Study||0
9020347|NCT03096314|10082851|FG000|STARTED|Screened Vitamin D Deficient||690
8639372|NCT00579670|9679708|FG000|Population: Within SmPC (Completed)|Overall Study|Not Completed (DC): Subject died N=1; Adverse Event (AE) N=1|13
8639373|NCT00579670|9679709|FG001|Population: Within SmPC (Completed)|Overall Study|DC: Lost to follow-up (LTFU) N=1|55
8639374|NCT00579670|9679710|FG002|Population: Within SmPC (Completed)|Overall Study|DC: AE N=1; Lack of efficacy N=1; Other unspecified N=1; Withdrawal by subject N=1|79
8639375|NCT00579670|9679711|FG003|Population: Within SmPC (Completed)|Overall Study|DC: AE N=2; Lack of efficacy N=5; LTFU N=3; Other unspecified N=2|147
8639376|NCT00579670|9679712|FG004|Population: Within SmPC (Completed)|Overall Study||0
8639377|NCT00579670|9679708|FG000|COMPLETED|Overall Study||13
8639378|NCT00579670|9679709|FG001|COMPLETED|Overall Study||56
8639379|NCT00579670|9679710|FG002|COMPLETED|Overall Study||84
8639380|NCT00579670|9679711|FG003|COMPLETED|Overall Study||263
8639381|NCT00579670|9679712|FG004|COMPLETED|Overall Study||5
8639382|NCT00579670|9679708|FG000|NOT COMPLETED|Overall Study||2
8639383|NCT00579670|9679709|FG001|NOT COMPLETED|Overall Study||1
8639384|NCT00579670|9679710|FG002|NOT COMPLETED|Overall Study||4
8639385|NCT00579670|9679711|FG003|NOT COMPLETED|Overall Study||22
9020348|NCT03096314|10082852|FG001|STARTED|Screened Vitamin D Deficient|2 randomized but not included in analysis; 1 treated but inadequate consent and 1 withdrew.|668
9020349|NCT03096314|10082851|FG000|COMPLETED|Screened Vitamin D Deficient||681
9020350|NCT03096314|10082852|FG001|COMPLETED|Screened Vitamin D Deficient||656
9020351|NCT03096314|10082851|FG000|NOT COMPLETED|Screened Vitamin D Deficient||9
9020352|NCT03096314|10082852|FG001|NOT COMPLETED|Screened Vitamin D Deficient||12
9020353|NCT03096314|10082851|FG000|STARTED|Confirmed Vitamin D Deficient|Confirmed deficient (a prior primary analysis subgroup) is a subgroup of the screened deficient.|538
8639386|NCT00579670|9679712|FG004|NOT COMPLETED|Overall Study||0
8639387|NCT00579813|9679738|FG000|STARTED|Overall Study||60
8639388|NCT00579813|9679739|FG001|STARTED|Overall Study||10
8639389|NCT00579813|9679738|FG000|COMPLETED|Overall Study||60
8639390|NCT00579813|9679739|FG001|COMPLETED|Overall Study||10
8639391|NCT00579813|9679738|FG000|NOT COMPLETED|Overall Study||0
8639392|NCT00579813|9679739|FG001|NOT COMPLETED|Overall Study||0
8639393|NCT00579878|9679749|FG000|STARTED|Overall Study||22
8639394|NCT00579878|9679750|FG001|STARTED|Overall Study||23
8639395|NCT00579878|9679751|FG002|STARTED|Overall Study||24
8639396|NCT00579878|9679749|FG000|COMPLETED|Overall Study||15
8639397|NCT00579878|9679750|FG001|COMPLETED|Overall Study||20
8639398|NCT00579878|9679751|FG002|COMPLETED|Overall Study||14
8639399|NCT00579878|9679749|FG000|NOT COMPLETED|Overall Study||7
8639400|NCT00579878|9679750|FG001|NOT COMPLETED|Overall Study||3
8639401|NCT00579878|9679751|FG002|NOT COMPLETED|Overall Study||10
8639402|NCT00579982|9679759|FG000|STARTED|Overall Study||97
8639403|NCT00579982|9679759|FG000|COMPLETED|Overall Study||89
8639404|NCT00579982|9679759|FG000|NOT COMPLETED|Overall Study||8
8639405|NCT00580034|9679763|FG000|STARTED|Overall Study||88
8639406|NCT00580034|9679764|FG001|STARTED|Overall Study||88
8639407|NCT00580034|9679763|FG000|COMPLETED|Overall Study||78
8639408|NCT00580034|9679764|FG001|COMPLETED|Overall Study||88
8727154|NCT01042093|9774574|FG003|NOT COMPLETED|Overall Study||4
8727155|NCT01042145|9774589|FG000|STARTED|Overall Study||41
8727156|NCT01042145|9774590|FG001|STARTED|Overall Study||46
8727157|NCT01042145|9774589|FG000|COMPLETED|Overall Study||40
8727158|NCT01042145|9774590|FG001|COMPLETED|Overall Study||45
8727159|NCT01042145|9774589|FG000|NOT COMPLETED|Overall Study||1
8727160|NCT01042145|9774590|FG001|NOT COMPLETED|Overall Study||1
8727161|NCT01042158|9774596|FG000|STARTED|Overall Study||25
8727162|NCT01042158|9774596|FG000|COMPLETED|Overall Study||24
8727163|NCT01042158|9774596|FG000|NOT COMPLETED|Overall Study||1
8727164|NCT01042236|9774600|FG000|STARTED|Treatment Period 1||3
8727165|NCT01042236|9774601|FG001|STARTED|Treatment Period 1||4
8727166|NCT01042236|9774602|FG002|STARTED|Treatment Period 1||3
8727167|NCT01042236|9774603|FG003|STARTED|Treatment Period 1||5
8727168|NCT01042236|9774604|FG004|STARTED|Treatment Period 1||4
8727169|NCT01042236|9774605|FG005|STARTED|Treatment Period 1||3
8727170|NCT01042236|9774600|FG000|COMPLETED|Treatment Period 1||3
8727171|NCT01042236|9774601|FG001|COMPLETED|Treatment Period 1||3
8727172|NCT01042236|9774602|FG002|COMPLETED|Treatment Period 1||3
8727173|NCT01042236|9774603|FG003|COMPLETED|Treatment Period 1||5
8727174|NCT01042236|9774604|FG004|COMPLETED|Treatment Period 1||3
8727175|NCT01042236|9774605|FG005|COMPLETED|Treatment Period 1||3
8727176|NCT01042236|9774600|FG000|NOT COMPLETED|Treatment Period 1||0
8727177|NCT01042236|9774601|FG001|NOT COMPLETED|Treatment Period 1||1
8727178|NCT01042236|9774602|FG002|NOT COMPLETED|Treatment Period 1||0
8727179|NCT01042236|9774603|FG003|NOT COMPLETED|Treatment Period 1||0
8727180|NCT01042236|9774604|FG004|NOT COMPLETED|Treatment Period 1||1
8727181|NCT01042236|9774605|FG005|NOT COMPLETED|Treatment Period 1||0
8727182|NCT01042236|9774600|FG000|STARTED|Treatment Period 2||3
8727183|NCT01042236|9774601|FG001|STARTED|Treatment Period 2||3
9020354|NCT03096314|10082852|FG001|STARTED|Confirmed Vitamin D Deficient|Confirmed deficient (a prior primary analysis subgroup) is a subgroup of the screened deficient.|540
9020355|NCT03096314|10082851|FG000|COMPLETED|Confirmed Vitamin D Deficient||531
9020356|NCT03096314|10082852|FG001|COMPLETED|Confirmed Vitamin D Deficient||528
9020357|NCT03096314|10082851|FG000|NOT COMPLETED|Confirmed Vitamin D Deficient||7
9020358|NCT03096314|10082852|FG001|NOT COMPLETED|Confirmed Vitamin D Deficient||12
9020359|NCT03096353|10082860|FG000|STARTED|Period 1||15
9020360|NCT03096353|10082861|FG001|STARTED|Period 1||13
9020361|NCT03096353|10082860|FG000|COMPLETED|Period 1||12
9020362|NCT03096353|10082861|FG001|COMPLETED|Period 1||12
9020363|NCT03096353|10082860|FG000|NOT COMPLETED|Period 1||3
9020364|NCT03096353|10082861|FG001|NOT COMPLETED|Period 1||1
9020365|NCT03096353|10082860|FG000|STARTED|Period 2||12
9020366|NCT03096353|10082861|FG001|STARTED|Period 2||12
9020367|NCT03096353|10082860|FG000|COMPLETED|Period 2||12
9020368|NCT03096353|10082861|FG001|COMPLETED|Period 2||12
9020369|NCT03096353|10082860|FG000|NOT COMPLETED|Period 2||0
9020370|NCT03096353|10082861|FG001|NOT COMPLETED|Period 2||0
9020371|NCT03096444|10082867|FG000|STARTED|Overall Study||13
9020372|NCT03096444|10082867|FG000|COMPLETED|Overall Study||13
9020373|NCT03096444|10082867|FG000|NOT COMPLETED|Overall Study||0
9020374|NCT03096483|10082879|FG000|STARTED|Overall Study||12
9020375|NCT03096483|10082879|FG000|COMPLETED|Overall Study||11
9020376|NCT03096483|10082879|FG000|NOT COMPLETED|Overall Study||1
9020377|NCT03096730|10082888|FG000|STARTED|Overall Study||30
9020378|NCT03096730|10082889|FG001|STARTED|Overall Study||30
9020379|NCT03096730|10082890|FG002|STARTED|Overall Study||30
9020380|NCT03096730|10082891|FG003|STARTED|Overall Study||30
9020381|NCT03096730|10082892|FG004|STARTED|Overall Study||30
9020382|NCT03096730|10082888|FG000|COMPLETED|Overall Study||27
9020383|NCT03096730|10082889|FG001|COMPLETED|Overall Study||27
9020384|NCT03096730|10082890|FG002|COMPLETED|Overall Study||27
9020385|NCT03096730|10082891|FG003|COMPLETED|Overall Study||27
9020386|NCT03096730|10082892|FG004|COMPLETED|Overall Study||27
9020387|NCT03096730|10082888|FG000|NOT COMPLETED|Overall Study||3
9020388|NCT03096730|10082889|FG001|NOT COMPLETED|Overall Study||3
9020389|NCT03096730|10082890|FG002|NOT COMPLETED|Overall Study||3
9020390|NCT03096730|10082891|FG003|NOT COMPLETED|Overall Study||3
9020391|NCT03096730|10082892|FG004|NOT COMPLETED|Overall Study||3
9020392|NCT03096847|10082907|FG000|STARTED|Overall Study||319
9020393|NCT03096847|10082908|FG001|STARTED|Overall Study||26
9020394|NCT03096847|10082909|FG002|STARTED|Overall Study||157
9020395|NCT03096847|10082907|FG000|Full Analysis Set|Overall Study||307
9020396|NCT03096847|10082908|FG001|Full Analysis Set|Overall Study||26
9020397|NCT03096847|10082909|FG002|Full Analysis Set|Overall Study||154
9020398|NCT03096847|10082907|FG000|COMPLETED|Overall Study|Only the primary reason for disc. is included in this table.|100
9020399|NCT03096847|10082908|FG001|COMPLETED|Overall Study|Only the primary reason for disc. is included in this table.|6
9020400|NCT03096847|10082909|FG002|COMPLETED|Overall Study|Only the primary reason for disc. is included in this table.|19
9020401|NCT03096847|10082907|FG000|NOT COMPLETED|Overall Study||219
9020402|NCT03096847|10082908|FG001|NOT COMPLETED|Overall Study||20
9020403|NCT03096847|10082909|FG002|NOT COMPLETED|Overall Study||138
9020404|NCT03096873|10082927|FG000|STARTED|Overall Study||20
9020405|NCT03096873|10082928|FG001|STARTED|Overall Study||20
9020406|NCT03096873|10082927|FG000|COMPLETED|Overall Study||20
9020407|NCT03096873|10082928|FG001|COMPLETED|Overall Study||20
9020408|NCT03096873|10082927|FG000|NOT COMPLETED|Overall Study||0
9020409|NCT03096873|10082928|FG001|NOT COMPLETED|Overall Study||0
9020410|NCT03097029|10082936|FG000|STARTED|Overall Study||15
9020411|NCT03097029|10082936|FG000|COMPLETED|Overall Study||14
9020412|NCT03097029|10082936|FG000|NOT COMPLETED|Overall Study||1
9020413|NCT03097133|10082942|FG000|STARTED|Overall Study||115
9020414|NCT03097133|10082943|FG001|STARTED|Overall Study||115
9020415|NCT03097133|10082942|FG000|Treated|Overall Study||113
9020416|NCT03097133|10082943|FG001|Treated|Overall Study||114
9020417|NCT03097133|10082942|FG000|COMPLETED|Overall Study||85
9020418|NCT03097133|10082943|FG001|COMPLETED|Overall Study||81
9020419|NCT03097133|10082942|FG000|NOT COMPLETED|Overall Study||30
9020420|NCT03097133|10082943|FG001|NOT COMPLETED|Overall Study||34
9020421|NCT03097289|10082949|FG000|STARTED|Overall Study||32
9020422|NCT03097289|10082949|FG000|COMPLETED|Overall Study||26
9020423|NCT03097289|10082949|FG000|NOT COMPLETED|Overall Study||6
9020424|NCT03097315|10082954|FG000|STARTED|Overall Study||38
9020425|NCT03097315|10082954|FG000|Intention-to-Treat Population|Overall Study||38
9020426|NCT03097315|10082954|FG000|Safety Population|Overall Study||38
9020427|NCT03097315|10082954|FG000|COMPLETED|Overall Study||37
9020428|NCT03097315|10082954|FG000|NOT COMPLETED|Overall Study||1
9020429|NCT03097341|10082963|FG000|STARTED|Overall Study||4
9020430|NCT03097341|10082964|FG001|STARTED|Overall Study||4
9020431|NCT03097341|10082965|FG002|STARTED|Overall Study||4
9020432|NCT03097341|10082966|FG003|STARTED|Overall Study||4
9020433|NCT03097341|10082967|FG004|STARTED|Overall Study||5
9020434|NCT03097341|10082963|FG000|COMPLETED|Overall Study||4
9020435|NCT03097341|10082964|FG001|COMPLETED|Overall Study||4
9020436|NCT03097341|10082965|FG002|COMPLETED|Overall Study||4
9020437|NCT03097341|10082966|FG003|COMPLETED|Overall Study||4
9020438|NCT03097341|10082967|FG004|COMPLETED|Overall Study||5
9020439|NCT03097341|10082963|FG000|NOT COMPLETED|Overall Study||0
9020440|NCT03097341|10082964|FG001|NOT COMPLETED|Overall Study||0
9020441|NCT03097341|10082965|FG002|NOT COMPLETED|Overall Study||0
9020442|NCT03097341|10082966|FG003|NOT COMPLETED|Overall Study||0
9020443|NCT03097341|10082967|FG004|NOT COMPLETED|Overall Study||0
9020444|NCT03097484|10082981|FG000|STARTED|Overall Study||19
9020445|NCT03097484|10082982|FG001|STARTED|Overall Study||19
9020446|NCT03097484|10082981|FG000|COMPLETED|Overall Study||19
9020447|NCT03097484|10082982|FG001|COMPLETED|Overall Study||19
9020448|NCT03097484|10082981|FG000|NOT COMPLETED|Overall Study||0
9020449|NCT03097484|10082982|FG001|NOT COMPLETED|Overall Study||0
8639409|NCT00580034|9679763|FG000|NOT COMPLETED|Overall Study||10
8639410|NCT00580034|9679764|FG001|NOT COMPLETED|Overall Study||0
8639411|NCT00580047|9679771|FG000|STARTED|Overall Study||24
8639412|NCT00580047|9679772|FG001|STARTED|Overall Study||23
8639413|NCT00580047|9679773|FG002|STARTED|Overall Study||12
8639414|NCT00580047|9679771|FG000|COMPLETED|Overall Study||21
8639415|NCT00580047|9679772|FG001|COMPLETED|Overall Study||21
8639416|NCT00580047|9679773|FG002|COMPLETED|Overall Study||10
8639417|NCT00580047|9679771|FG000|NOT COMPLETED|Overall Study||3
8639418|NCT00580047|9679772|FG001|NOT COMPLETED|Overall Study||2
8639419|NCT00580047|9679773|FG002|NOT COMPLETED|Overall Study||2
8639420|NCT00580073|9679784|FG000|STARTED|Overall Study||6
8639421|NCT00580073|9679784|FG000|COMPLETED|Overall Study||6
8639422|NCT00580073|9679784|FG000|NOT COMPLETED|Overall Study||0
8639423|NCT00580138|9679788|FG000|STARTED|Overall Study||30
8639424|NCT00580138|9679788|FG000|COMPLETED|Overall Study||30
8639425|NCT00580138|9679788|FG000|NOT COMPLETED|Overall Study||0
8639426|NCT00580151|9679794|FG000|STARTED|Overall Study||9
8639427|NCT00580151|9679795|FG001|STARTED|Overall Study||0
8639428|NCT00580151|9679794|FG000|COMPLETED|Overall Study||9
8639429|NCT00580151|9679795|FG001|COMPLETED|Overall Study||0
9020450|NCT03097588|10082988|FG000|STARTED|Overall Study||43
9020451|NCT03097588|10082988|FG000|COMPLETED|Overall Study||42
8639430|NCT00580151|9679794|FG000|NOT COMPLETED|Overall Study||0
8639431|NCT00580151|9679795|FG001|NOT COMPLETED|Overall Study||0
8639432|NCT00580229|9679801|FG000|STARTED|Overall Study||50
8639433|NCT00580229|9679801|FG000|COMPLETED|Overall Study||50
8639434|NCT00580229|9679801|FG000|NOT COMPLETED|Overall Study||0
8639435|NCT00580294|9679805|FG000|STARTED|Overall Study||12
8639436|NCT00580294|9679805|FG000|COMPLETED|Overall Study||12
8639437|NCT00580294|9679805|FG000|NOT COMPLETED|Overall Study||0
8639438|NCT00580333|9679809|FG000|STARTED|Overall Study||51
8639439|NCT00580333|9679809|FG000|COMPLETED|Overall Study||51
8639440|NCT00580333|9679809|FG000|NOT COMPLETED|Overall Study||0
8639441|NCT00580372|9679814|FG000|STARTED|Overall Study||231
8639442|NCT00580372|9679814|FG000|COMPLETED|Overall Study||231
8639443|NCT00580372|9679814|FG000|NOT COMPLETED|Overall Study||0
8639444|NCT00580398|9679820|FG000|STARTED|Overall Study||17
8639445|NCT00580398|9679821|FG001|STARTED|Overall Study||32
8639446|NCT00580398|9679820|FG000|COMPLETED|Overall Study||17
8639447|NCT00580398|9679821|FG001|COMPLETED|Overall Study||32
8639448|NCT00580398|9679820|FG000|NOT COMPLETED|Overall Study||0
8639449|NCT00580398|9679821|FG001|NOT COMPLETED|Overall Study||0
8639450|NCT00580502|9679827|FG000|STARTED|Overall Study||50
8639451|NCT00580502|9679827|FG000|COMPLETED|Overall Study||50
8639452|NCT00580502|9679827|FG000|NOT COMPLETED|Overall Study||0
8639453|NCT00580606|9679833|FG000|STARTED|Double Blind (DB)||20
8639454|NCT00580606|9679834|FG001|STARTED|Double Blind (DB)||20
8639455|NCT00580606|9679833|FG000|Had Week 44 Oral Food Challenge|Double Blind (DB)||18
8639456|NCT00580606|9679834|FG001|Had Week 44 Oral Food Challenge|Double Blind (DB)||19
8639457|NCT00580606|9679833|FG000|COMPLETED|Double Blind (DB)|Completed: Participants who were assessed for the primary outcome measure.|20
8639458|NCT00580606|9679834|FG001|COMPLETED|Double Blind (DB)|Completed: Participants who were assessed for the primary outcome measure.|20
8639459|NCT00580606|9679833|FG000|NOT COMPLETED|Double Blind (DB)||0
8639460|NCT00580606|9679834|FG001|NOT COMPLETED|Double Blind (DB)||0
8639461|NCT00580606|9679833|FG000|STARTED|Open Label (OL)|2 participants discontinued dosing before Open Label (OL) period.|18
8639462|NCT00580606|9679834|FG001|STARTED|Open Label (OL)|1 participant discontinued dosing before OL period; 2 passed Week 44 OFC & ineligible to crossover.|17
8639463|NCT00580606|9679833|FG000|Had Week 44 Oral Food Challenge|Open Label (OL)|The Week 44 OFC for Low Dose Peanut SLIT was done at the end of the DB Period, not the OL period.|0
8639464|NCT00580606|9679834|FG001|Had Week 44 Oral Food Challenge|Open Label (OL)|After 44 weeks of OL high dose SLIT; 1 additional participant declined Week 44 OFC in OL period.|12
8639465|NCT00580606|9679833|FG000|Had Week 68 Oral Food Challenge|Open Label (OL)||15
8639466|NCT00580606|9679834|FG001|Had Week 68 Oral Food Challenge|Open Label (OL)||12
8639467|NCT00580606|9679833|FG000|Had Week 116 Oral Food Challenge|Open Label (OL)||13
8639468|NCT00580606|9679834|FG001|Had Week 116 Oral Food Challenge|Open Label (OL)||6
8639469|NCT00580606|9679833|FG000|Had Week 164 Oral Food Challenge|Open Label (OL)||9
8639470|NCT00580606|9679834|FG001|Had Week 164 Oral Food Challenge|Open Label (OL)||5
8639471|NCT00580606|9679833|FG000|Had Week 172 Oral Food Challenge|Open Label (OL)||2
9020452|NCT03097588|10082988|FG000|NOT COMPLETED|Overall Study||1
9020453|NCT03097614|10082992|FG000|STARTED|Overall Study||57
9020454|NCT03097614|10082992|FG000|COMPLETED|Overall Study||54
9020455|NCT03097614|10082992|FG000|NOT COMPLETED|Overall Study||3
8639472|NCT00580606|9679834|FG001|Had Week 172 Oral Food Challenge|Open Label (OL)||2
8639473|NCT00580606|9679833|FG000|COMPLETED|Open Label (OL)|Completed dosing & final Wk 164 desensitization OFC & Wk 172 tolerance OFC (if passed Wk 164 OFC).|9
8639474|NCT00580606|9679834|FG001|COMPLETED|Open Label (OL)|Completed dosing & final Wk 164 desensitization OFC & Wk 172 tolerance OFC (if passed Wk 164 OFC).|5
8639475|NCT00580606|9679833|FG000|NOT COMPLETED|Open Label (OL)||9
8639476|NCT00580606|9679834|FG001|NOT COMPLETED|Open Label (OL)||12
8639477|NCT00580645|9679851|FG000|STARTED|Overall Study||20
9020456|NCT03097653|10082998|FG000|STARTED|Overall Study||472
9020457|NCT03097653|10082999|FG001|STARTED|Overall Study||529
9020458|NCT03097653|10082998|FG000|COMPLETED|Overall Study||472
9020459|NCT03097653|10082999|FG001|COMPLETED|Overall Study||529
9020460|NCT03097653|10082998|FG000|NOT COMPLETED|Overall Study||0
9020461|NCT03097653|10082999|FG001|NOT COMPLETED|Overall Study||0
9020462|NCT03097783|10083007|FG000|STARTED|Overall Study||132
9020463|NCT03097783|10083008|FG001|STARTED|Overall Study||37
9020464|NCT03097783|10083007|FG000|COMPLETED|Overall Study||123
9020465|NCT03097783|10083008|FG001|COMPLETED|Overall Study||31
9020466|NCT03097783|10083007|FG000|NOT COMPLETED|Overall Study||9
9020467|NCT03097783|10083008|FG001|NOT COMPLETED|Overall Study||6
9020468|NCT03097861|10083017|FG000|STARTED|Overall Study||145
9020469|NCT03097861|10083018|FG001|STARTED|Overall Study||276
9020470|NCT03097861|10083019|FG002|STARTED|Overall Study||131
9020471|NCT03097861|10083017|FG000|Safety Population|Overall Study||143
9020472|NCT03097861|10083018|FG001|Safety Population|Overall Study||275
9020473|NCT03097861|10083019|FG002|Safety Population|Overall Study||130
9020474|NCT03097861|10083017|FG000|Modified Intent to Treat|Overall Study||143
9020475|NCT03097861|10083018|FG001|Modified Intent to Treat|Overall Study||275
9020476|NCT03097861|10083019|FG002|Modified Intent to Treat|Overall Study||130
9020477|NCT03097861|10083017|FG000|Completers|Overall Study||129
9020478|NCT03097861|10083018|FG001|Completers|Overall Study||255
9020479|NCT03097861|10083019|FG002|Completers|Overall Study||121
9020480|NCT03097861|10083017|FG000|Per-protocol Population (PP)|Overall Study||126
9020481|NCT03097861|10083018|FG001|Per-protocol Population (PP)|Overall Study||234
9020482|NCT03097861|10083019|FG002|Per-protocol Population (PP)|Overall Study||113
9020483|NCT03097861|10083017|FG000|COMPLETED|Overall Study||138
9020484|NCT03097861|10083018|FG001|COMPLETED|Overall Study||254
9020485|NCT03097861|10083019|FG002|COMPLETED|Overall Study||122
9020486|NCT03097861|10083017|FG000|NOT COMPLETED|Overall Study||7
9020487|NCT03097861|10083018|FG001|NOT COMPLETED|Overall Study||22
9020488|NCT03097861|10083019|FG002|NOT COMPLETED|Overall Study||9
9020489|NCT03098030|10083033|FG000|STARTED|Overall Study||12
9020490|NCT03098030|10083034|FG001|STARTED|Overall Study||187
9020491|NCT03098030|10083035|FG002|STARTED|Overall Study||190
9020492|NCT03098030|10083036|FG003|STARTED|Overall Study||94
9020493|NCT03098030|10083033|FG000|COMPLETED|Overall Study|Represents number of subjects that had not discontinued the study at time of data lock.|2
9020494|NCT03098030|10083034|FG001|COMPLETED|Overall Study|Represents number of subjects that had not discontinued the study at time of data lock.|24
9020495|NCT03098030|10083035|FG002|COMPLETED|Overall Study|Represents number of subjects that had not discontinued the study at time of data lock.|24
9020496|NCT03098030|10083036|FG003|COMPLETED|Overall Study|Represents number of subjects that had not discontinued the study at time of data lock.|9
9020497|NCT03098030|10083033|FG000|NOT COMPLETED|Overall Study||10
9020498|NCT03098030|10083034|FG001|NOT COMPLETED|Overall Study||163
9020499|NCT03098030|10083035|FG002|NOT COMPLETED|Overall Study||166
9020500|NCT03098030|10083036|FG003|NOT COMPLETED|Overall Study||85
9020501|NCT03098173|10083047|FG000|STARTED|Overall Study||81
9020502|NCT03098173|10083048|FG001|STARTED|Overall Study||81
9020503|NCT03098173|10083047|FG000|COMPLETED|Overall Study||80
9020504|NCT03098173|10083048|FG001|COMPLETED|Overall Study||79
9020505|NCT03098173|10083047|FG000|NOT COMPLETED|Overall Study||1
8639478|NCT00580645|9679852|FG001|STARTED|Overall Study||20
8639479|NCT00580645|9679853|FG002|STARTED|Overall Study||20
8639480|NCT00580645|9679851|FG000|COMPLETED|Overall Study||20
8639481|NCT00580645|9679852|FG001|COMPLETED|Overall Study||20
8639482|NCT00580645|9679853|FG002|COMPLETED|Overall Study||20
8639483|NCT00580645|9679851|FG000|NOT COMPLETED|Overall Study||0
8639484|NCT00580645|9679852|FG001|NOT COMPLETED|Overall Study||0
8639485|NCT00580645|9679853|FG002|NOT COMPLETED|Overall Study||0
8639486|NCT00580671|9679864|FG000|STARTED|Overall Study||51
8639487|NCT00580671|9679865|FG001|STARTED|Overall Study||51
8639488|NCT00580671|9679866|FG002|STARTED|Overall Study||51
8639489|NCT00580671|9679864|FG000|COMPLETED|Overall Study||35
8639490|NCT00580671|9679865|FG001|COMPLETED|Overall Study||35
8639491|NCT00580671|9679866|FG002|COMPLETED|Overall Study||34
8639492|NCT00580671|9679864|FG000|NOT COMPLETED|Overall Study||16
8639493|NCT00580671|9679865|FG001|NOT COMPLETED|Overall Study||16
8639494|NCT00580671|9679866|FG002|NOT COMPLETED|Overall Study||17
8691363|NCT00854360|9736621|FG003|Intent to Treat / Safety Population|Overall Study|One patient did not receive any double-blind study medication.|123
8691364|NCT00854360|9736618|FG000|COMPLETED|Overall Study||116
8691365|NCT00854360|9736619|FG001|COMPLETED|Overall Study|One patient discontinued due to both an AE and study medication discontinuation.|120
9020506|NCT03098173|10083048|FG001|NOT COMPLETED|Overall Study||2
9020507|NCT03098420|10083059|FG000|STARTED|Overall Study||7
9020508|NCT03098420|10083060|FG001|STARTED|Overall Study||9
8691366|NCT00854360|9736620|FG002|COMPLETED|Overall Study||120
8691367|NCT00854360|9736621|FG003|COMPLETED|Overall Study||114
8691368|NCT00854360|9736618|FG000|NOT COMPLETED|Overall Study||2
8691369|NCT00854360|9736619|FG001|NOT COMPLETED|Overall Study||3
8691370|NCT00854360|9736620|FG002|NOT COMPLETED|Overall Study||2
9020509|NCT03098420|10083061|FG002|STARTED|Overall Study||13
9020510|NCT03098420|10083059|FG000|COMPLETED|Overall Study||7
9020511|NCT03098420|10083060|FG001|COMPLETED|Overall Study||9
9020512|NCT03098420|10083061|FG002|COMPLETED|Overall Study||13
9020513|NCT03098420|10083059|FG000|NOT COMPLETED|Overall Study||0
9020514|NCT03098420|10083060|FG001|NOT COMPLETED|Overall Study||0
9020515|NCT03098420|10083061|FG002|NOT COMPLETED|Overall Study||0
9020516|NCT03098433|10083069|FG000|STARTED|Overall Study||22
9020517|NCT03098433|10083069|FG000|COMPLETED|Overall Study||12
9020518|NCT03098433|10083069|FG000|NOT COMPLETED|Overall Study||10
9020519|NCT03098550|10083077|FG000|STARTED|Overall Study||41
9020520|NCT03098550|10083078|FG001|STARTED|Overall Study||21
9020521|NCT03098550|10083079|FG002|STARTED|Overall Study||43
9020522|NCT03098550|10083077|FG000|COMPLETED|Overall Study||0
9020523|NCT03098550|10083078|FG001|COMPLETED|Overall Study||1
9020524|NCT03098550|10083079|FG002|COMPLETED|Overall Study||0
8639495|NCT00580723|9679874|FG000|STARTED|Overall Study||24
8639496|NCT00580723|9679874|FG000|COMPLETED|Overall Study||16
8639497|NCT00580723|9679874|FG000|NOT COMPLETED|Overall Study||8
8639498|NCT00580788|9679882|FG000|STARTED|Overall Study||3
8639499|NCT00580788|9679883|FG001|STARTED|Overall Study||6
8639500|NCT00580788|9679884|FG002|STARTED|Overall Study||3
8639501|NCT00580788|9679885|FG003|STARTED|Overall Study||2
8639502|NCT00580788|9679882|FG000|COMPLETED|Overall Study||3
8639503|NCT00580788|9679883|FG001|COMPLETED|Overall Study||6
8639504|NCT00580788|9679884|FG002|COMPLETED|Overall Study||3
8639505|NCT00580788|9679885|FG003|COMPLETED|Overall Study|One subject was stopped early for hypertension. One subject completed but was not analyzed.|1
8639506|NCT00580788|9679882|FG000|NOT COMPLETED|Overall Study||0
8639507|NCT00580788|9679883|FG001|NOT COMPLETED|Overall Study||0
8639508|NCT00580788|9679884|FG002|NOT COMPLETED|Overall Study||0
8639509|NCT00580788|9679885|FG003|NOT COMPLETED|Overall Study||1
8639510|NCT00580801|9679905|FG000|STARTED|Overall Study||8
8639511|NCT00580801|9679906|FG001|STARTED|Overall Study||8
8639512|NCT00580801|9679907|FG002|STARTED|Overall Study||8
8639513|NCT00580801|9679905|FG000|COMPLETED|Overall Study||2
8639514|NCT00580801|9679906|FG001|COMPLETED|Overall Study||7
8639515|NCT00580801|9679907|FG002|COMPLETED|Overall Study||5
8639516|NCT00580801|9679905|FG000|NOT COMPLETED|Overall Study||6
8639517|NCT00580801|9679906|FG001|NOT COMPLETED|Overall Study||1
8639518|NCT00580801|9679907|FG002|NOT COMPLETED|Overall Study||3
8639519|NCT00580840|9679915|FG000|STARTED|Run-in|620 subjects were screened for the study with 333 being enrolled.|333
8639520|NCT00580840|9679916|FG001|STARTED|Run-in||0
8639521|NCT00580840|9679917|FG002|STARTED|Run-in||0
8639522|NCT00580840|9679918|FG003|STARTED|Run-in||0
8639523|NCT00580840|9679915|FG000|COMPLETED|Run-in|Of the 209 randomized participants, 208 are in the Full Analysis Set (FAS).|209
8639524|NCT00580840|9679916|FG001|COMPLETED|Run-in||0
8639525|NCT00580840|9679917|FG002|COMPLETED|Run-in||0
8639526|NCT00580840|9679918|FG003|COMPLETED|Run-in||0
8639527|NCT00580840|9679915|FG000|NOT COMPLETED|Run-in||124
8639528|NCT00580840|9679916|FG001|NOT COMPLETED|Run-in||0
8639529|NCT00580840|9679917|FG002|NOT COMPLETED|Run-in||0
8639530|NCT00580840|9679918|FG003|NOT COMPLETED|Run-in||0
8639531|NCT00580840|9679915|FG000|STARTED|Double-Blind||0
8639532|NCT00580840|9679916|FG001|STARTED|Double-Blind||70
8639533|NCT00580840|9679917|FG002|STARTED|Double-Blind||70
8639534|NCT00580840|9679918|FG003|STARTED|Double-Blind||69
9020525|NCT03098550|10083077|FG000|NOT COMPLETED|Overall Study||41
9020526|NCT03098550|10083078|FG001|NOT COMPLETED|Overall Study||20
9020527|NCT03098550|10083079|FG002|NOT COMPLETED|Overall Study||43
9020528|NCT03098615|10083091|FG000|STARTED|Overall Study||19
9020529|NCT03098615|10083091|FG000|COMPLETED|Overall Study||17
9020530|NCT03098615|10083091|FG000|NOT COMPLETED|Overall Study||2
9020531|NCT03098641|10083096|FG000|STARTED|Overall Study||272
9020532|NCT03098641|10083096|FG000|COMPLETED|Overall Study||220
9020533|NCT03098641|10083096|FG000|NOT COMPLETED|Overall Study||52
9020534|NCT03098745|10083100|FG000|STARTED|Day 1||7
9020535|NCT03098745|10083101|FG001|STARTED|Day 1||3
9020536|NCT03098745|10083102|FG002|STARTED|Day 1||8
9020537|NCT03098745|10083103|FG003|STARTED|Day 1||8
9020538|NCT03098745|10083104|FG004|STARTED|Day 1||10
9020539|NCT03098745|10083105|FG005|STARTED|Day 1||4
9020540|NCT03098745|10083100|FG000|COMPLETED|Day 1||7
9020541|NCT03098745|10083101|FG001|COMPLETED|Day 1||3
9020542|NCT03098745|10083102|FG002|COMPLETED|Day 1||8
9020543|NCT03098745|10083103|FG003|COMPLETED|Day 1||8
9020544|NCT03098745|10083104|FG004|COMPLETED|Day 1||10
9020545|NCT03098745|10083105|FG005|COMPLETED|Day 1||4
9020546|NCT03098745|10083100|FG000|NOT COMPLETED|Day 1||0
9020547|NCT03098745|10083101|FG001|NOT COMPLETED|Day 1||0
9020548|NCT03098745|10083102|FG002|NOT COMPLETED|Day 1||0
9020549|NCT03098745|10083103|FG003|NOT COMPLETED|Day 1||0
9020550|NCT03098745|10083104|FG004|NOT COMPLETED|Day 1||0
8639535|NCT00580840|9679915|FG000|COMPLETED|Double-Blind||0
8639536|NCT00580840|9679916|FG001|COMPLETED|Double-Blind||63
8639537|NCT00580840|9679917|FG002|COMPLETED|Double-Blind||61
8639538|NCT00580840|9679918|FG003|COMPLETED|Double-Blind||54
8639539|NCT00580840|9679915|FG000|NOT COMPLETED|Double-Blind||0
8639540|NCT00580840|9679916|FG001|NOT COMPLETED|Double-Blind||7
8639541|NCT00580840|9679917|FG002|NOT COMPLETED|Double-Blind||9
8639542|NCT00580840|9679918|FG003|NOT COMPLETED|Double-Blind||15
8639543|NCT00580853|9679931|FG000|STARTED|Overall Study||20
8639544|NCT00580853|9679932|FG001|STARTED|Overall Study||21
9020551|NCT03098745|10083105|FG005|NOT COMPLETED|Day 1||0
9020552|NCT03098745|10083100|FG000|STARTED|Day 2||7
9020553|NCT03098745|10083101|FG001|STARTED|Day 2||3
9020554|NCT03098745|10083102|FG002|STARTED|Day 2||8
9020555|NCT03098745|10083103|FG003|STARTED|Day 2||8
9020556|NCT03098745|10083104|FG004|STARTED|Day 2||10
9020557|NCT03098745|10083105|FG005|STARTED|Day 2||4
9020558|NCT03098745|10083100|FG000|COMPLETED|Day 2||7
9020559|NCT03098745|10083101|FG001|COMPLETED|Day 2||3
9020560|NCT03098745|10083102|FG002|COMPLETED|Day 2||8
9020561|NCT03098745|10083103|FG003|COMPLETED|Day 2||8
9020562|NCT03098745|10083104|FG004|COMPLETED|Day 2||10
9020563|NCT03098745|10083105|FG005|COMPLETED|Day 2||4
9020564|NCT03098745|10083100|FG000|NOT COMPLETED|Day 2||0
9020565|NCT03098745|10083101|FG001|NOT COMPLETED|Day 2||0
9020566|NCT03098745|10083102|FG002|NOT COMPLETED|Day 2||0
9020567|NCT03098745|10083103|FG003|NOT COMPLETED|Day 2||0
9020568|NCT03098745|10083104|FG004|NOT COMPLETED|Day 2||0
9020569|NCT03098745|10083105|FG005|NOT COMPLETED|Day 2||0
8639545|NCT00580853|9679933|FG002|STARTED|Overall Study||21
8639546|NCT00580853|9679931|FG000|COMPLETED|Overall Study||20
8639547|NCT00580853|9679932|FG001|COMPLETED|Overall Study||21
8639548|NCT00580853|9679933|FG002|COMPLETED|Overall Study||21
8639549|NCT00580853|9679931|FG000|NOT COMPLETED|Overall Study||0
8639550|NCT00580853|9679932|FG001|NOT COMPLETED|Overall Study||0
8639551|NCT00580853|9679933|FG002|NOT COMPLETED|Overall Study||0
8639552|NCT00580866|9679943|FG000|STARTED|Overall Study||10
8639553|NCT00580866|9679944|FG001|STARTED|Overall Study||7
8639554|NCT00580866|9679943|FG000|COMPLETED|Overall Study||8
8639555|NCT00580866|9679944|FG001|COMPLETED|Overall Study||5
8639556|NCT00580866|9679943|FG000|NOT COMPLETED|Overall Study||2
8639557|NCT00580866|9679944|FG001|NOT COMPLETED|Overall Study||2
8639558|NCT00580957|9679952|FG000|STARTED|Overall Study||28
8639559|NCT00580957|9679953|FG001|STARTED|Overall Study||28
8639560|NCT00580957|9679952|FG000|COMPLETED|Overall Study||21
8639561|NCT00580957|9679953|FG001|COMPLETED|Overall Study||21
8639562|NCT00580957|9679952|FG000|NOT COMPLETED|Overall Study||7
8639563|NCT00580957|9679953|FG001|NOT COMPLETED|Overall Study||7
8639564|NCT00580970|9679961|FG000|STARTED|Pre-treatment||73
8639565|NCT00580970|9679961|FG000|COMPLETED|Pre-treatment||72
8639566|NCT00580970|9679961|FG000|NOT COMPLETED|Pre-treatment||1
8639567|NCT00580970|9679961|FG000|STARTED|Treatment (Lovastatin)||72
8639568|NCT00580970|9679961|FG000|6 Months of Treatment|Treatment (Lovastatin)|Subjects evaluable for analysis|53
8639569|NCT00580970|9679961|FG000|COMPLETED|Treatment (Lovastatin)||53
8639570|NCT00580970|9679961|FG000|NOT COMPLETED|Treatment (Lovastatin)||19
8639571|NCT00580983|9679965|FG000|STARTED|Overall Study||80
8639572|NCT00580983|9679965|FG000|COMPLETED|Overall Study||73
8639573|NCT00580983|9679965|FG000|NOT COMPLETED|Overall Study||7
8639574|NCT00581048|9679969|FG000|STARTED|Overall Study||33
8639575|NCT00581048|9679969|FG000|COMPLETED|Overall Study||33
8639576|NCT00581048|9679969|FG000|NOT COMPLETED|Overall Study||0
8639577|NCT00581061|9679974|FG000|STARTED|Overall Study||13
8639578|NCT00581061|9679974|FG000|COMPLETED|Overall Study||13
8639579|NCT00581061|9679974|FG000|NOT COMPLETED|Overall Study||0
8639580|NCT00581100|9679982|FG000|STARTED|Overall Study||38
8639581|NCT00581100|9679983|FG001|STARTED|Overall Study||34
8639582|NCT00581100|9679982|FG000|Modified Intent-To-Treat Population|Overall Study|At least one dose of study medication, and had baseline and post-baseline data.|36
8639583|NCT00581100|9679983|FG001|Modified Intent-To-Treat Population|Overall Study|At least one dose of study medication, and had baseline and post-baseline data.|33
8639584|NCT00581100|9679982|FG000|COMPLETED|Overall Study||31
8639585|NCT00581100|9679983|FG001|COMPLETED|Overall Study||29
8639586|NCT00581100|9679982|FG000|NOT COMPLETED|Overall Study||7
8639587|NCT00581100|9679983|FG001|NOT COMPLETED|Overall Study||5
8639588|NCT00581230|9679989|FG000|STARTED|Overall Study||51
8639589|NCT00581230|9679989|FG000|Laryngoscopy Without RAMP|Overall Study||51
8639590|NCT00581230|9679989|FG000|Laryngoscopy With RAMP|Overall Study||51
8639591|NCT00581230|9679989|FG000|COMPLETED|Overall Study||51
8639592|NCT00581230|9679989|FG000|NOT COMPLETED|Overall Study||0
8639593|NCT00581256|9679998|FG000|STARTED|Overall Study||28
8639594|NCT00581256|9679999|FG001|STARTED|Overall Study||26
8639595|NCT00581256|9679998|FG000|COMPLETED|Overall Study||28
8639596|NCT00581256|9679999|FG001|COMPLETED|Overall Study||26
8639597|NCT00581256|9679998|FG000|NOT COMPLETED|Overall Study||0
8639598|NCT00581256|9679999|FG001|NOT COMPLETED|Overall Study||0
8639599|NCT00581308|9680005|FG000|STARTED|Pre Discharge||215
8639600|NCT00581308|9680005|FG000|COMPLETED|Pre Discharge||213
8639601|NCT00581308|9680005|FG000|NOT COMPLETED|Pre Discharge||2
8639602|NCT00581308|9680005|FG000|STARTED|Month 1||213
8639603|NCT00581308|9680005|FG000|COMPLETED|Month 1||205
8639604|NCT00581308|9680005|FG000|NOT COMPLETED|Month 1||8
8639605|NCT00581308|9680005|FG000|STARTED|Month 6||205
8639606|NCT00581308|9680005|FG000|COMPLETED|Month 6||202
8639607|NCT00581308|9680005|FG000|NOT COMPLETED|Month 6||3
8639608|NCT00581308|9680005|FG000|STARTED|Month 12||202
8639609|NCT00581308|9680005|FG000|COMPLETED|Month 12||182
8639610|NCT00581308|9680005|FG000|NOT COMPLETED|Month 12||20
8639611|NCT00581308|9680005|FG000|STARTED|24 Months||182
8639612|NCT00581308|9680005|FG000|COMPLETED|24 Months||176
8639613|NCT00581308|9680005|FG000|NOT COMPLETED|24 Months||6
8639614|NCT00581308|9680005|FG000|STARTED|36 Months||176
8639615|NCT00581308|9680005|FG000|COMPLETED|36 Months||170
8639616|NCT00581308|9680005|FG000|NOT COMPLETED|36 Months||6
8639617|NCT00581308|9680005|FG000|STARTED|48 Months||170
8639618|NCT00581308|9680005|FG000|COMPLETED|48 Months||161
8639619|NCT00581308|9680005|FG000|NOT COMPLETED|48 Months||9
8639620|NCT00581308|9680005|FG000|STARTED|60 Months||161
8639621|NCT00581308|9680005|FG000|COMPLETED|60 Months||158
8639622|NCT00581308|9680005|FG000|NOT COMPLETED|60 Months||3
8639623|NCT00581347|9680014|FG000|STARTED|Overall Study||3839
8639624|NCT00581347|9680015|FG001|STARTED|Overall Study||3707
8639625|NCT00581347|9680014|FG000|COMPLETED|Overall Study||3839
9020570|NCT03098745|10083100|FG000|STARTED|Day 3||7
9020571|NCT03098745|10083101|FG001|STARTED|Day 3||3
9020572|NCT03098745|10083102|FG002|STARTED|Day 3||8
9020573|NCT03098745|10083103|FG003|STARTED|Day 3||8
9020574|NCT03098745|10083104|FG004|STARTED|Day 3||10
9020575|NCT03098745|10083105|FG005|STARTED|Day 3||4
9020576|NCT03098745|10083100|FG000|COMPLETED|Day 3||7
9020577|NCT03098745|10083101|FG001|COMPLETED|Day 3||3
9020578|NCT03098745|10083102|FG002|COMPLETED|Day 3||8
9020579|NCT03098745|10083103|FG003|COMPLETED|Day 3||8
9020580|NCT03098745|10083104|FG004|COMPLETED|Day 3||10
9020581|NCT03098745|10083105|FG005|COMPLETED|Day 3||4
9020582|NCT03098745|10083100|FG000|NOT COMPLETED|Day 3||0
9020583|NCT03098745|10083101|FG001|NOT COMPLETED|Day 3||0
9020584|NCT03098745|10083102|FG002|NOT COMPLETED|Day 3||0
9020585|NCT03098745|10083103|FG003|NOT COMPLETED|Day 3||0
9020586|NCT03098745|10083104|FG004|NOT COMPLETED|Day 3||0
9020587|NCT03098745|10083105|FG005|NOT COMPLETED|Day 3||0
9020588|NCT03098966|10083114|FG000|STARTED|Overall Study||368
9020589|NCT03098966|10083114|FG000|COMPLETED|Overall Study||368
9020590|NCT03098966|10083114|FG000|NOT COMPLETED|Overall Study||0
9020591|NCT03098979|10083124|FG000|STARTED|Overall Study||76
9020592|NCT03098979|10083125|FG001|STARTED|Overall Study||27
9020593|NCT03098979|10083126|FG002|STARTED|Overall Study||50
9020594|NCT03098979|10083127|FG003|STARTED|Overall Study||51
9020595|NCT03098979|10083128|FG004|STARTED|Overall Study||50
9020596|NCT03098979|10083129|FG005|STARTED|Overall Study||51
9020597|NCT03098979|10083124|FG000|COMPLETED|Overall Study||70
9020598|NCT03098979|10083125|FG001|COMPLETED|Overall Study||25
9020599|NCT03098979|10083126|FG002|COMPLETED|Overall Study||46
9020600|NCT03098979|10083127|FG003|COMPLETED|Overall Study||46
9020601|NCT03098979|10083128|FG004|COMPLETED|Overall Study||41
9020602|NCT03098979|10083129|FG005|COMPLETED|Overall Study||47
9020603|NCT03098979|10083124|FG000|NOT COMPLETED|Overall Study||6
9020604|NCT03098979|10083125|FG001|NOT COMPLETED|Overall Study||2
9020605|NCT03098979|10083126|FG002|NOT COMPLETED|Overall Study||4
9020606|NCT03098979|10083127|FG003|NOT COMPLETED|Overall Study||5
9020607|NCT03098979|10083128|FG004|NOT COMPLETED|Overall Study||9
9020608|NCT03098979|10083129|FG005|NOT COMPLETED|Overall Study||4
9020609|NCT03099096|10083143|FG000|STARTED|Overall Study||159
9020610|NCT03099096|10083143|FG000|COMPLETED|Overall Study||157
9020611|NCT03099096|10083143|FG000|NOT COMPLETED|Overall Study||2
9020612|NCT03099161|10083150|FG000|STARTED|Overall Study||3
9020613|NCT03099161|10083151|FG001|STARTED|Overall Study||4
9020614|NCT03099161|10083152|FG002|STARTED|Overall Study||3
9020615|NCT03099161|10083150|FG000|COMPLETED|Overall Study||0
9020616|NCT03099161|10083151|FG001|COMPLETED|Overall Study||0
9020617|NCT03099161|10083152|FG002|COMPLETED|Overall Study||0
9020618|NCT03099161|10083150|FG000|NOT COMPLETED|Overall Study||3
9020619|NCT03099161|10083151|FG001|NOT COMPLETED|Overall Study||4
9020620|NCT03099161|10083152|FG002|NOT COMPLETED|Overall Study||3
9020621|NCT03099187|10083162|FG000|STARTED|Double-blind Treatment||127
9020622|NCT03099187|10083163|FG001|STARTED|Double-blind Treatment||126
9020623|NCT03099187|10083164|FG002|STARTED|Double-blind Treatment||0
9020624|NCT03099187|10083165|FG003|STARTED|Double-blind Treatment||0
9020625|NCT03099187|10083162|FG000|COMPLETED|Double-blind Treatment||94
9020626|NCT03099187|10083163|FG001|COMPLETED|Double-blind Treatment||110
9020627|NCT03099187|10083164|FG002|COMPLETED|Double-blind Treatment||0
9020628|NCT03099187|10083165|FG003|COMPLETED|Double-blind Treatment||0
9020629|NCT03099187|10083162|FG000|NOT COMPLETED|Double-blind Treatment||33
9020630|NCT03099187|10083163|FG001|NOT COMPLETED|Double-blind Treatment||16
9020631|NCT03099187|10083164|FG002|NOT COMPLETED|Double-blind Treatment||0
9020632|NCT03099187|10083165|FG003|NOT COMPLETED|Double-blind Treatment||0
9020633|NCT03099187|10083162|FG000|STARTED|12-month Safety Follow-up||0
9020634|NCT03099187|10083163|FG001|STARTED|12-month Safety Follow-up||0
9020635|NCT03099187|10083164|FG002|STARTED|12-month Safety Follow-up||94
9020636|NCT03099187|10083165|FG003|STARTED|12-month Safety Follow-up||110
9020637|NCT03099187|10083162|FG000|COMPLETED|12-month Safety Follow-up||0
9020638|NCT03099187|10083163|FG001|COMPLETED|12-month Safety Follow-up||0
9020639|NCT03099187|10083164|FG002|COMPLETED|12-month Safety Follow-up||75
9020640|NCT03099187|10083165|FG003|COMPLETED|12-month Safety Follow-up||84
9020641|NCT03099187|10083162|FG000|NOT COMPLETED|12-month Safety Follow-up||0
9020642|NCT03099187|10083163|FG001|NOT COMPLETED|12-month Safety Follow-up||0
9020643|NCT03099187|10083164|FG002|NOT COMPLETED|12-month Safety Follow-up||19
9020644|NCT03099187|10083165|FG003|NOT COMPLETED|12-month Safety Follow-up||26
9020645|NCT03099369|10083177|FG000|STARTED|Overall Study||11
8639626|NCT00581347|9680015|FG001|COMPLETED|Overall Study||3707
8639627|NCT00581347|9680014|FG000|NOT COMPLETED|Overall Study||0
8639628|NCT00581347|9680015|FG001|NOT COMPLETED|Overall Study||0
9020646|NCT03099369|10083178|FG001|STARTED|Overall Study||9
9020647|NCT03099369|10083177|FG000|COMPLETED|Overall Study||5
9020648|NCT03099369|10083178|FG001|COMPLETED|Overall Study||5
9020649|NCT03099369|10083177|FG000|NOT COMPLETED|Overall Study||6
9020650|NCT03099369|10083178|FG001|NOT COMPLETED|Overall Study||4
9020651|NCT03099538|10083185|FG000|STARTED|Overall Study||4
9020652|NCT03099538|10083185|FG000|COMPLETED|Overall Study||1
9020653|NCT03099538|10083185|FG000|NOT COMPLETED|Overall Study||3
9020654|NCT03099655|10083189|FG000|STARTED|Overall Study||440
9020655|NCT03099655|10083189|FG000|COMPLETED|Overall Study|6-Month visit with original 4798 lead implanted|379
9020656|NCT03099655|10083189|FG000|NOT COMPLETED|Overall Study||61
9039897|NCT03343067|10100820|FG000|NOT COMPLETED|Double Blind Period: Month 3 to Month 6||0
9039898|NCT03343067|10100821|FG001|NOT COMPLETED|Double Blind Period: Month 3 to Month 6||3
9020657|NCT03099694|10083198|FG000|STARTED|Overall Study||170
9020658|NCT03099694|10083199|FG001|STARTED|Overall Study||170
9020659|NCT03099694|10083198|FG000|COMPLETED|Overall Study||150
9020660|NCT03099694|10083199|FG001|COMPLETED|Overall Study||152
9020661|NCT03099694|10083198|FG000|NOT COMPLETED|Overall Study||20
9020662|NCT03099694|10083199|FG001|NOT COMPLETED|Overall Study||18
9020663|NCT03100058|10083215|FG000|STARTED|Epoch 3 (24 Weeks of Treatment)||38
9020664|NCT03100058|10083216|FG001|STARTED|Epoch 3 (24 Weeks of Treatment)||38
9020665|NCT03100058|10083217|FG002|STARTED|Epoch 3 (24 Weeks of Treatment)||38
9020666|NCT03100058|10083218|FG003|STARTED|Epoch 3 (24 Weeks of Treatment)||77
9020667|NCT03100058|10083219|FG004|STARTED|Epoch 3 (24 Weeks of Treatment)||38
9020668|NCT03100058|10083220|FG005|STARTED|Epoch 3 (24 Weeks of Treatment)||39
9020669|NCT03100058|10083221|FG006|STARTED|Epoch 3 (24 Weeks of Treatment)||38
9020670|NCT03100058|10083222|FG007|STARTED|Epoch 3 (24 Weeks of Treatment)||76
9020671|NCT03100058|10083223|FG008|STARTED|Epoch 3 (24 Weeks of Treatment)||78
9020672|NCT03100058|10083224|FG009|STARTED|Epoch 3 (24 Weeks of Treatment)||0
9020673|NCT03100058|10083225|FG010|STARTED|Epoch 3 (24 Weeks of Treatment)||0
9020674|NCT03100058|10083226|FG011|STARTED|Epoch 3 (24 Weeks of Treatment)||0
9020675|NCT03100058|10083227|FG012|STARTED|Epoch 3 (24 Weeks of Treatment)||0
9020676|NCT03100058|10083215|FG000|COMPLETED|Epoch 3 (24 Weeks of Treatment)||35
9020677|NCT03100058|10083216|FG001|COMPLETED|Epoch 3 (24 Weeks of Treatment)||31
9020678|NCT03100058|10083217|FG002|COMPLETED|Epoch 3 (24 Weeks of Treatment)||29
9020679|NCT03100058|10083218|FG003|COMPLETED|Epoch 3 (24 Weeks of Treatment)||63
9020680|NCT03100058|10083219|FG004|COMPLETED|Epoch 3 (24 Weeks of Treatment)||36
9020681|NCT03100058|10083220|FG005|COMPLETED|Epoch 3 (24 Weeks of Treatment)||37
9020682|NCT03100058|10083221|FG006|COMPLETED|Epoch 3 (24 Weeks of Treatment)||30
9020683|NCT03100058|10083222|FG007|COMPLETED|Epoch 3 (24 Weeks of Treatment)||60
9020684|NCT03100058|10083223|FG008|COMPLETED|Epoch 3 (24 Weeks of Treatment)||73
9020685|NCT03100058|10083224|FG009|COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
9020686|NCT03100058|10083225|FG010|COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
9020687|NCT03100058|10083226|FG011|COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
9020688|NCT03100058|10083227|FG012|COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
9020689|NCT03100058|10083215|FG000|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||3
9020690|NCT03100058|10083216|FG001|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||7
9020691|NCT03100058|10083217|FG002|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||9
9020692|NCT03100058|10083218|FG003|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||14
9020693|NCT03100058|10083219|FG004|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||2
9020694|NCT03100058|10083220|FG005|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||2
8639629|NCT00581360|9680021|FG000|STARTED|Overall Study||10
8639630|NCT00581360|9680021|FG000|COMPLETED|Overall Study||9
8639631|NCT00581360|9680021|FG000|NOT COMPLETED|Overall Study||1
8639632|NCT00581386|9680028|FG000|STARTED|Overall Study|05/30/2007|73
8639633|NCT00581386|9680029|FG001|STARTED|Overall Study|05/30/2007|73
8639634|NCT00581386|9680030|FG002|STARTED|Overall Study|05/30/2007|72
8727184|NCT01042236|9774602|FG002|STARTED|Treatment Period 2||3
8727185|NCT01042236|9774603|FG003|STARTED|Treatment Period 2||5
8727186|NCT01042236|9774604|FG004|STARTED|Treatment Period 2||3
8727187|NCT01042236|9774605|FG005|STARTED|Treatment Period 2||3
8727188|NCT01042236|9774600|FG000|COMPLETED|Treatment Period 2||3
8727189|NCT01042236|9774601|FG001|COMPLETED|Treatment Period 2||3
8727190|NCT01042236|9774602|FG002|COMPLETED|Treatment Period 2||3
8727191|NCT01042236|9774603|FG003|COMPLETED|Treatment Period 2||5
8727192|NCT01042236|9774604|FG004|COMPLETED|Treatment Period 2||3
8639635|NCT00581386|9680028|FG000|COMPLETED|Overall Study|04/15/2009|73
8639636|NCT00581386|9680029|FG001|COMPLETED|Overall Study|04/15/2009|73
8639637|NCT00581386|9680030|FG002|COMPLETED|Overall Study|04/15/2009|72
8639638|NCT00581386|9680028|FG000|NOT COMPLETED|Overall Study||0
8639639|NCT00581386|9680029|FG001|NOT COMPLETED|Overall Study||0
8639640|NCT00581386|9680030|FG002|NOT COMPLETED|Overall Study||0
8639641|NCT00581399|9680040|FG000|STARTED|Overall Study||46
8639642|NCT00581399|9680041|FG001|STARTED|Overall Study||48
8639643|NCT00581399|9680040|FG000|COMPLETED|Overall Study||46
8639644|NCT00581399|9680041|FG001|COMPLETED|Overall Study||48
8639645|NCT00581399|9680040|FG000|NOT COMPLETED|Overall Study||0
8639646|NCT00581399|9680041|FG001|NOT COMPLETED|Overall Study||0
8639647|NCT00581529|9680047|FG000|STARTED|Overall Study||34
8639648|NCT00581529|9680047|FG000|COMPLETED|Overall Study||34
8639649|NCT00581529|9680047|FG000|NOT COMPLETED|Overall Study||0
8639650|NCT00581542|9680053|FG000|STARTED|Overall Study||62
8639651|NCT00581542|9680054|FG001|STARTED|Overall Study||62
8639652|NCT00581542|9680053|FG000|COMPLETED|Overall Study||51
8639653|NCT00581542|9680054|FG001|COMPLETED|Overall Study||39
8639654|NCT00581542|9680053|FG000|NOT COMPLETED|Overall Study||11
8639655|NCT00581542|9680054|FG001|NOT COMPLETED|Overall Study||23
8727193|NCT01042236|9774605|FG005|COMPLETED|Treatment Period 2||3
8727194|NCT01042236|9774600|FG000|NOT COMPLETED|Treatment Period 2||0
8639656|NCT00581555|9680064|FG000|STARTED|Overall Study||62
8639657|NCT00581555|9680065|FG001|STARTED|Overall Study||58
8639658|NCT00581555|9680064|FG000|COMPLETED|Overall Study||19
8639659|NCT00581555|9680065|FG001|COMPLETED|Overall Study||38
8639660|NCT00581555|9680064|FG000|NOT COMPLETED|Overall Study||43
8639661|NCT00581555|9680065|FG001|NOT COMPLETED|Overall Study||20
8639662|NCT00581581|9680073|FG000|STARTED|Overall Study||32
8639663|NCT00581581|9680074|FG001|STARTED|Overall Study||30
8639664|NCT00581581|9680073|FG000|COMPLETED|Overall Study||32
8639665|NCT00581581|9680074|FG001|COMPLETED|Overall Study||30
9020695|NCT03100058|10083221|FG006|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||8
9020696|NCT03100058|10083222|FG007|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||16
9020697|NCT03100058|10083223|FG008|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||5
9020698|NCT03100058|10083224|FG009|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
9020699|NCT03100058|10083225|FG010|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
9020700|NCT03100058|10083226|FG011|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
9020701|NCT03100058|10083227|FG012|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
9020702|NCT03100058|10083215|FG000|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
9020703|NCT03100058|10083216|FG001|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
9020704|NCT03100058|10083217|FG002|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
9020705|NCT03100058|10083218|FG003|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
9020706|NCT03100058|10083219|FG004|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
9020707|NCT03100058|10083220|FG005|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
9020708|NCT03100058|10083221|FG006|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
9020709|NCT03100058|10083222|FG007|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
9020710|NCT03100058|10083223|FG008|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
9020711|NCT03100058|10083224|FG009|STARTED|Epoch 4 (Last 24 Weeks of the Study)||158
9020712|NCT03100058|10083225|FG010|STARTED|Epoch 4 (Last 24 Weeks of the Study)||163
9020713|NCT03100058|10083226|FG011|STARTED|Epoch 4 (Last 24 Weeks of the Study)||39
9020714|NCT03100058|10083227|FG012|STARTED|Epoch 4 (Last 24 Weeks of the Study)||34
9020715|NCT03100058|10083215|FG000|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
9020716|NCT03100058|10083216|FG001|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
9020717|NCT03100058|10083217|FG002|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
9020718|NCT03100058|10083218|FG003|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
9020719|NCT03100058|10083219|FG004|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
9020720|NCT03100058|10083220|FG005|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
9020721|NCT03100058|10083221|FG006|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
9020722|NCT03100058|10083222|FG007|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
9020723|NCT03100058|10083223|FG008|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
9020724|NCT03100058|10083224|FG009|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||153
9020725|NCT03100058|10083225|FG010|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||148
9020726|NCT03100058|10083226|FG011|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||36
9020727|NCT03100058|10083227|FG012|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||30
9020728|NCT03100058|10083215|FG000|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
9020729|NCT03100058|10083216|FG001|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
9020730|NCT03100058|10083217|FG002|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
9020731|NCT03100058|10083218|FG003|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
9020732|NCT03100058|10083219|FG004|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
9020733|NCT03100058|10083220|FG005|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
9020734|NCT03100058|10083221|FG006|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
9020735|NCT03100058|10083222|FG007|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
9020736|NCT03100058|10083223|FG008|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
9020737|NCT03100058|10083224|FG009|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||5
9020738|NCT03100058|10083225|FG010|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||15
9020739|NCT03100058|10083226|FG011|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||3
9020740|NCT03100058|10083227|FG012|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||4
9020741|NCT03100123|10083258|FG000|STARTED|Overall Study||0
8639666|NCT00581581|9680073|FG000|NOT COMPLETED|Overall Study||0
8639667|NCT00581581|9680074|FG001|NOT COMPLETED|Overall Study||0
8639668|NCT00581776|9680080|FG000|STARTED|Overall Study||30
8727195|NCT01042236|9774601|FG001|NOT COMPLETED|Treatment Period 2||0
8639669|NCT00581776|9680080|FG000|COMPLETED|Overall Study|3 subjects did not complete the planned induction chemotherapy.|27
8639670|NCT00581776|9680080|FG000|NOT COMPLETED|Overall Study||3
8639671|NCT00581828|9680084|FG000|STARTED|Overall Study||19
8639672|NCT00581828|9680084|FG000|COMPLETED|Overall Study||18
8639673|NCT00581828|9680084|FG000|NOT COMPLETED|Overall Study||1
8639674|NCT00581854|9680088|FG000|STARTED|Overall Study||22
8639675|NCT00581854|9680088|FG000|COMPLETED|Overall Study||22
8639676|NCT00581854|9680088|FG000|NOT COMPLETED|Overall Study||0
8639677|NCT00581867|9680092|FG000|STARTED|First Intervention||16
8639678|NCT00581867|9680093|FG001|STARTED|First Intervention||15
8639679|NCT00581867|9680092|FG000|COMPLETED|First Intervention||16
8639680|NCT00581867|9680093|FG001|COMPLETED|First Intervention||15
8639681|NCT00581867|9680092|FG000|NOT COMPLETED|First Intervention||0
8639682|NCT00581867|9680093|FG001|NOT COMPLETED|First Intervention||0
8639683|NCT00581867|9680092|FG000|STARTED|Second Intervention|n=1 completed period 1 (placebo) but not period 2 (insulin). This individuals died between periods.|15
8639684|NCT00581867|9680093|FG001|STARTED|Second Intervention|1 individual completed period 1 (Intranasal Insulin) but did not complete period 2 (Placebo).|14
8639685|NCT00581867|9680092|FG000|COMPLETED|Second Intervention||15
8639686|NCT00581867|9680093|FG001|COMPLETED|Second Intervention||14
8639687|NCT00581867|9680092|FG000|NOT COMPLETED|Second Intervention||0
8639688|NCT00581867|9680093|FG001|NOT COMPLETED|Second Intervention||0
8639689|NCT00581893|9680099|FG000|STARTED|First Intervention (1 Month)||10
8639690|NCT00581893|9680100|FG001|STARTED|First Intervention (1 Month)||10
8639691|NCT00581893|9680099|FG000|COMPLETED|First Intervention (1 Month)||10
8639692|NCT00581893|9680100|FG001|COMPLETED|First Intervention (1 Month)||10
8639693|NCT00581893|9680099|FG000|NOT COMPLETED|First Intervention (1 Month)||0
9020742|NCT03100123|10083259|FG001|STARTED|Overall Study||1
9020743|NCT03100123|10083258|FG000|COMPLETED|Overall Study||0
9020744|NCT03100123|10083259|FG001|COMPLETED|Overall Study||1
9020745|NCT03100123|10083258|FG000|NOT COMPLETED|Overall Study||0
9020746|NCT03100123|10083259|FG001|NOT COMPLETED|Overall Study||0
9020747|NCT03100344|10083274|FG000|STARTED|Overall Study||57
9020748|NCT03100344|10083275|FG001|STARTED|Overall Study||55
9020749|NCT03100344|10083276|FG002|STARTED|Overall Study||57
8639694|NCT00581893|9680100|FG001|NOT COMPLETED|First Intervention (1 Month)||0
8639695|NCT00581893|9680099|FG000|STARTED|Washout (14 Days)||10
8639696|NCT00581893|9680100|FG001|STARTED|Washout (14 Days)||10
8639697|NCT00581893|9680099|FG000|COMPLETED|Washout (14 Days)||10
8639698|NCT00581893|9680100|FG001|COMPLETED|Washout (14 Days)||10
8639699|NCT00581893|9680099|FG000|NOT COMPLETED|Washout (14 Days)||0
8639700|NCT00581893|9680100|FG001|NOT COMPLETED|Washout (14 Days)||0
8639701|NCT00581893|9680099|FG000|STARTED|Second Intervention (1 Month)||10
8639702|NCT00581893|9680100|FG001|STARTED|Second Intervention (1 Month)||10
8639703|NCT00581893|9680099|FG000|COMPLETED|Second Intervention (1 Month)||7
8639704|NCT00581893|9680100|FG001|COMPLETED|Second Intervention (1 Month)||8
8639705|NCT00581893|9680099|FG000|NOT COMPLETED|Second Intervention (1 Month)||3
8639706|NCT00581893|9680100|FG001|NOT COMPLETED|Second Intervention (1 Month)||2
8639707|NCT00581919|9680106|FG000|STARTED|Overall Study||32
8639708|NCT00581919|9680106|FG000|COMPLETED|Overall Study||8
8639709|NCT00581919|9680106|FG000|NOT COMPLETED|Overall Study||24
8639710|NCT00581945|9680113|FG000|STARTED|Overall Study||74
8639711|NCT00581945|9680114|FG001|STARTED|Overall Study||73
8639712|NCT00581945|9680113|FG000|COMPLETED|Overall Study||65
8639713|NCT00581945|9680114|FG001|COMPLETED|Overall Study||63
8639714|NCT00581945|9680113|FG000|NOT COMPLETED|Overall Study||9
8639715|NCT00581945|9680114|FG001|NOT COMPLETED|Overall Study||10
8639716|NCT00581971|9680120|FG000|STARTED|Overall Study||30
8727196|NCT01042236|9774602|FG002|NOT COMPLETED|Treatment Period 2||0
8727197|NCT01042236|9774603|FG003|NOT COMPLETED|Treatment Period 2||0
8727198|NCT01042236|9774604|FG004|NOT COMPLETED|Treatment Period 2||0
8727199|NCT01042236|9774605|FG005|NOT COMPLETED|Treatment Period 2||0
8727200|NCT01042236|9774600|FG000|STARTED|Treatment Period 3||3
8727201|NCT01042236|9774601|FG001|STARTED|Treatment Period 3||3
8727202|NCT01042236|9774602|FG002|STARTED|Treatment Period 3||3
8727203|NCT01042236|9774603|FG003|STARTED|Treatment Period 3||5
8727204|NCT01042236|9774604|FG004|STARTED|Treatment Period 3||3
8727205|NCT01042236|9774605|FG005|STARTED|Treatment Period 3||3
8727206|NCT01042236|9774600|FG000|COMPLETED|Treatment Period 3||3
8727207|NCT01042236|9774601|FG001|COMPLETED|Treatment Period 3||3
8727208|NCT01042236|9774602|FG002|COMPLETED|Treatment Period 3||3
8727209|NCT01042236|9774603|FG003|COMPLETED|Treatment Period 3||3
8727210|NCT01042236|9774604|FG004|COMPLETED|Treatment Period 3||3
8727211|NCT01042236|9774605|FG005|COMPLETED|Treatment Period 3||3
8727212|NCT01042236|9774600|FG000|NOT COMPLETED|Treatment Period 3||0
8727213|NCT01042236|9774601|FG001|NOT COMPLETED|Treatment Period 3||0
8727214|NCT01042236|9774602|FG002|NOT COMPLETED|Treatment Period 3||0
8727215|NCT01042236|9774603|FG003|NOT COMPLETED|Treatment Period 3||2
9020750|NCT03100344|10083277|FG003|STARTED|Overall Study||57
8727216|NCT01042236|9774604|FG004|NOT COMPLETED|Treatment Period 3||0
8727217|NCT01042236|9774605|FG005|NOT COMPLETED|Treatment Period 3||0
8727218|NCT01042288|9774613|FG000|STARTED|Overall Study||69
8727219|NCT01042288|9774613|FG000|Maintenance|Overall Study||27
8727220|NCT01042288|9774613|FG000|COMPLETED|Overall Study|Patients remained on maintenance until disease progression, toxicity or other reason to come off|0
8727221|NCT01042288|9774613|FG000|NOT COMPLETED|Overall Study||69
8727222|NCT01042366|9774620|FG000|STARTED|Overall Study||5
8727223|NCT01042366|9774621|FG001|STARTED|Overall Study||6
8727224|NCT01042366|9774622|FG002|STARTED|Overall Study||4
8727225|NCT01042366|9774620|FG000|COMPLETED|Overall Study||5
8727226|NCT01042366|9774621|FG001|COMPLETED|Overall Study||6
8727227|NCT01042366|9774622|FG002|COMPLETED|Overall Study||4
8727228|NCT01042366|9774620|FG000|NOT COMPLETED|Overall Study||0
8727229|NCT01042366|9774621|FG001|NOT COMPLETED|Overall Study||0
8727230|NCT01042366|9774622|FG002|NOT COMPLETED|Overall Study||0
8727231|NCT01042392|9774630|FG000|STARTED|Period II(Randomized,Double Blinded,8wk)||257
8727232|NCT01042392|9774631|FG001|STARTED|Period II(Randomized,Double Blinded,8wk)|This arm is used only in Period III.|0
8727233|NCT01042392|9774632|FG002|STARTED|Period II(Randomized,Double Blinded,8wk)||249
8727234|NCT01042392|9774633|FG003|STARTED|Period II(Randomized,Double Blinded,8wk)|This arm is used only in Period III.|0
8727235|NCT01042392|9774630|FG000|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)|ITT excluded patients from centers where 90% of BP measurements were rounded to 5 or 0|222
8727236|NCT01042392|9774631|FG001|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)||0
8727237|NCT01042392|9774632|FG002|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)||222
8806593|NCT01478581|9858812|FG002|COMPLETED|Overall Study||18
9020751|NCT03100344|10083274|FG000|COMPLETED|Overall Study||43
9020752|NCT03100344|10083275|FG001|COMPLETED|Overall Study||44
9020753|NCT03100344|10083276|FG002|COMPLETED|Overall Study||50
8639717|NCT00581971|9680120|FG000|COMPLETED|Overall Study||30
8639718|NCT00581971|9680120|FG000|NOT COMPLETED|Overall Study||0
8639719|NCT00582010|9680127|FG000|STARTED|Overall Study||40
8639720|NCT00582010|9680128|FG001|STARTED|Overall Study||40
8639721|NCT00582010|9680127|FG000|COMPLETED|Overall Study||40
8639722|NCT00582010|9680128|FG001|COMPLETED|Overall Study||39
8639723|NCT00582010|9680127|FG000|NOT COMPLETED|Overall Study||0
9020754|NCT03100344|10083277|FG003|COMPLETED|Overall Study||45
9020755|NCT03100344|10083274|FG000|NOT COMPLETED|Overall Study||14
9020756|NCT03100344|10083275|FG001|NOT COMPLETED|Overall Study||11
8639724|NCT00582010|9680128|FG001|NOT COMPLETED|Overall Study||1
8639725|NCT00582075|9680134|FG000|STARTED|Overall Study||25
8639726|NCT00582075|9680134|FG000|COMPLETED|Overall Study||25
8639727|NCT00582075|9680134|FG000|NOT COMPLETED|Overall Study||0
8639728|NCT00582114|9680140|FG000|STARTED|Overall Study||100
8639729|NCT00582114|9680141|FG001|STARTED|Overall Study||100
8639730|NCT00582114|9680140|FG000|COMPLETED|Overall Study||58
8639731|NCT00582114|9680141|FG001|COMPLETED|Overall Study||46
8639732|NCT00582114|9680140|FG000|NOT COMPLETED|Overall Study||42
8639733|NCT00582114|9680141|FG001|NOT COMPLETED|Overall Study||54
8639734|NCT00582166|9680147|FG000|STARTED|Overall Study||18
8639735|NCT00582166|9680147|FG000|COMPLETED|Overall Study||16
8639736|NCT00582166|9680147|FG000|NOT COMPLETED|Overall Study||2
8639737|NCT00582205|9680151|FG000|STARTED|Overall Study||21
8639738|NCT00582205|9680151|FG000|COMPLETED|Overall Study||11
8639739|NCT00582205|9680151|FG000|NOT COMPLETED|Overall Study||10
8639740|NCT00582309|9680158|FG000|STARTED|Overall Study||56
8639741|NCT00582309|9680159|FG001|STARTED|Overall Study||49
8639742|NCT00582309|9680160|FG002|STARTED|Overall Study||46
8639743|NCT00582309|9680158|FG000|COMPLETED|Overall Study||56
8639744|NCT00582309|9680159|FG001|COMPLETED|Overall Study||49
8639745|NCT00582309|9680160|FG002|COMPLETED|Overall Study|2 did not have enough data collected to be used|44
8639746|NCT00582309|9680158|FG000|NOT COMPLETED|Overall Study||0
8639747|NCT00582309|9680159|FG001|NOT COMPLETED|Overall Study||0
8639748|NCT00582309|9680160|FG002|NOT COMPLETED|Overall Study||2
8639749|NCT00582361|9680170|FG000|STARTED|Overall Study||25
8639750|NCT00582361|9680171|FG001|STARTED|Overall Study||38
8639751|NCT00582361|9680170|FG000|COMPLETED|Overall Study||25
8639752|NCT00582361|9680171|FG001|COMPLETED|Overall Study||38
8639753|NCT00582361|9680170|FG000|NOT COMPLETED|Overall Study||0
8639754|NCT00582361|9680171|FG001|NOT COMPLETED|Overall Study||0
8639755|NCT00582400|9680177|FG000|STARTED|Overall Study||9
8639756|NCT00582400|9680177|FG000|COMPLETED|Overall Study||6
8639757|NCT00582400|9680177|FG000|NOT COMPLETED|Overall Study||3
8639758|NCT00582426|9680183|FG000|STARTED|Overall Study|"Patient in both arms belongs to started indicates safety and intent to treat (ITT) populations."|68
8639759|NCT00582426|9680184|FG001|STARTED|Overall Study||71
8639760|NCT00582426|9680183|FG000|COMPLETED|Overall Study||48
8639761|NCT00582426|9680184|FG001|COMPLETED|Overall Study||58
8639762|NCT00582426|9680183|FG000|NOT COMPLETED|Overall Study||20
8639763|NCT00582426|9680184|FG001|NOT COMPLETED|Overall Study||13
8639764|NCT00582491|9680192|FG000|STARTED|Overall Study||11
8639765|NCT00582491|9680193|FG001|STARTED|Overall Study||10
8639766|NCT00582491|9680192|FG000|COMPLETED|Overall Study||10
8639767|NCT00582491|9680193|FG001|COMPLETED|Overall Study||10
8639768|NCT00582491|9680192|FG000|NOT COMPLETED|Overall Study||1
8639769|NCT00582491|9680193|FG001|NOT COMPLETED|Overall Study||0
8639770|NCT00582517|9680201|FG000|STARTED|Overall Study||45
8639771|NCT00582517|9680202|FG001|STARTED|Overall Study||55
8639772|NCT00582517|9680201|FG000|COMPLETED|Overall Study||45
8639773|NCT00582517|9680202|FG001|COMPLETED|Overall Study||55
8639774|NCT00582517|9680201|FG000|NOT COMPLETED|Overall Study||0
8639775|NCT00582517|9680202|FG001|NOT COMPLETED|Overall Study||0
8639776|NCT00582556|9680211|FG000|STARTED|Overall Study||14
8639777|NCT00582556|9680212|FG001|STARTED|Overall Study||15
8639778|NCT00582556|9680213|FG002|STARTED|Overall Study||14
8639779|NCT00582556|9680211|FG000|COMPLETED|Overall Study||14
8639780|NCT00582556|9680212|FG001|COMPLETED|Overall Study||14
8639781|NCT00582556|9680213|FG002|COMPLETED|Overall Study||12
8639782|NCT00582556|9680211|FG000|NOT COMPLETED|Overall Study||0
8639783|NCT00582556|9680212|FG001|NOT COMPLETED|Overall Study||1
8639784|NCT00582556|9680213|FG002|NOT COMPLETED|Overall Study||2
8639785|NCT00582608|9680222|FG000|STARTED|Overall Study||12
8639786|NCT00582608|9680222|FG000|COMPLETED|Overall Study||0
8639787|NCT00582608|9680222|FG000|NOT COMPLETED|Overall Study||12
8639788|NCT00582660|9680228|FG000|STARTED|Overall Study||20
8639789|NCT00582660|9680229|FG001|STARTED|Overall Study||20
8639790|NCT00582660|9680228|FG000|COMPLETED|Overall Study||20
8639791|NCT00582660|9680229|FG001|COMPLETED|Overall Study||20
8639792|NCT00582660|9680228|FG000|NOT COMPLETED|Overall Study||0
8639793|NCT00582660|9680229|FG001|NOT COMPLETED|Overall Study||0
8639794|NCT00582738|9680237|FG000|STARTED|Overall Study||21
8639795|NCT00582738|9680238|FG001|STARTED|Overall Study||22
8639796|NCT00582738|9680237|FG000|COMPLETED|Overall Study||12
8639797|NCT00582738|9680238|FG001|COMPLETED|Overall Study||4
8639798|NCT00582738|9680237|FG000|NOT COMPLETED|Overall Study||9
8639799|NCT00582738|9680238|FG001|NOT COMPLETED|Overall Study||18
8639800|NCT00582790|9680250|FG000|STARTED|Overall Study|only 11 of the 12 patients received study treatment.|12
8639801|NCT00582790|9680250|FG000|COMPLETED|Overall Study||11
8639802|NCT00582790|9680250|FG000|NOT COMPLETED|Overall Study||1
8639803|NCT00582816|9680255|FG000|STARTED|Overall Study||9
8639804|NCT00582816|9680255|FG000|COMPLETED|Overall Study|"Completed here means patients stably engrafted with donor cells."|6
8639805|NCT00582816|9680255|FG000|NOT COMPLETED|Overall Study||3
8639806|NCT00582894|9680259|FG000|STARTED|Overall Study||17
8639807|NCT00582894|9680259|FG000|Day 100 Post Transplant|Overall Study||17
8639808|NCT00582894|9680259|FG000|COMPLETED|Overall Study||17
8639809|NCT00582894|9680259|FG000|NOT COMPLETED|Overall Study||0
8639810|NCT00582907|9680263|FG000|STARTED|1st Course||4
9020757|NCT03100344|10083276|FG002|NOT COMPLETED|Overall Study||7
9020758|NCT03100344|10083277|FG003|NOT COMPLETED|Overall Study||12
9020759|NCT03100500|10083288|FG000|STARTED|Overall Study||51
9020760|NCT03100500|10083288|FG000|COMPLETED|Overall Study||51
9020761|NCT03100500|10083288|FG000|NOT COMPLETED|Overall Study||0
9020762|NCT03100825|10083292|FG000|STARTED|Overall Study||94
9020763|NCT03100825|10083292|FG000|COMPLETED|Overall Study||86
9020764|NCT03100825|10083292|FG000|NOT COMPLETED|Overall Study||8
9020765|NCT03100838|10083296|FG000|STARTED|Overall Study||16
9020766|NCT03100838|10083297|FG001|STARTED|Overall Study||16
9020767|NCT03100838|10083298|FG002|STARTED|Overall Study||16
9020768|NCT03100838|10083299|FG003|STARTED|Overall Study||16
9020769|NCT03100838|10083296|FG000|COMPLETED|Overall Study||14
9020770|NCT03100838|10083297|FG001|COMPLETED|Overall Study||14
8911156|NCT02143973|9970190|FG000|NOT COMPLETED|Overall Study||66
8911157|NCT02144012|9970196|FG000|STARTED|Overall Study||34
8911158|NCT02144012|9970197|FG001|STARTED|Overall Study||15
8911159|NCT02144012|9970196|FG000|COMPLETED|Overall Study||0
8911160|NCT02144012|9970197|FG001|COMPLETED|Overall Study||0
8911161|NCT02144012|9970196|FG000|NOT COMPLETED|Overall Study||34
8911162|NCT02144012|9970197|FG001|NOT COMPLETED|Overall Study||15
9020771|NCT03100838|10083298|FG002|COMPLETED|Overall Study||14
9020772|NCT03100838|10083299|FG003|COMPLETED|Overall Study||15
9020773|NCT03100838|10083296|FG000|NOT COMPLETED|Overall Study||2
8639811|NCT00582907|9680264|FG001|STARTED|1st Course||3
8639812|NCT00582907|9680265|FG002|STARTED|1st Course||3
8639813|NCT00582907|9680266|FG003|STARTED|1st Course||4
8639814|NCT00582907|9680263|FG000|COMPLETED|1st Course|1 left after 1st course (transportation issues)|3
8639815|NCT00582907|9680264|FG001|COMPLETED|1st Course||3
8639816|NCT00582907|9680265|FG002|COMPLETED|1st Course||3
8639817|NCT00582907|9680266|FG003|COMPLETED|1st Course|Patient lost to follow-up towards end of 1st course|3
8639818|NCT00582907|9680263|FG000|NOT COMPLETED|1st Course||1
8639819|NCT00582907|9680264|FG001|NOT COMPLETED|1st Course||0
8639820|NCT00582907|9680265|FG002|NOT COMPLETED|1st Course||0
8639821|NCT00582907|9680266|FG003|NOT COMPLETED|1st Course||1
8639822|NCT00582907|9680263|FG000|STARTED|2nd Course||3
8639823|NCT00582907|9680264|FG001|STARTED|2nd Course||3
8639824|NCT00582907|9680265|FG002|STARTED|2nd Course||3
8639825|NCT00582907|9680266|FG003|STARTED|2nd Course||3
8639826|NCT00582907|9680263|FG000|COMPLETED|2nd Course||2
8639827|NCT00582907|9680264|FG001|COMPLETED|2nd Course||3
8639828|NCT00582907|9680265|FG002|COMPLETED|2nd Course||3
8639829|NCT00582907|9680266|FG003|COMPLETED|2nd Course||3
8639830|NCT00582907|9680263|FG000|NOT COMPLETED|2nd Course||1
8639831|NCT00582907|9680264|FG001|NOT COMPLETED|2nd Course||0
8639832|NCT00582907|9680265|FG002|NOT COMPLETED|2nd Course||0
8639833|NCT00582907|9680266|FG003|NOT COMPLETED|2nd Course||0
8639834|NCT00582907|9680263|FG000|STARTED|3rd Course||2
8639835|NCT00582907|9680264|FG001|STARTED|3rd Course||3
8639836|NCT00582907|9680265|FG002|STARTED|3rd Course||3
8639837|NCT00582907|9680266|FG003|STARTED|3rd Course||3
8639838|NCT00582907|9680263|FG000|COMPLETED|3rd Course||2
8639839|NCT00582907|9680264|FG001|COMPLETED|3rd Course||3
8639840|NCT00582907|9680265|FG002|COMPLETED|3rd Course||3
8639841|NCT00582907|9680266|FG003|COMPLETED|3rd Course||3
8639842|NCT00582907|9680263|FG000|NOT COMPLETED|3rd Course||0
8639843|NCT00582907|9680264|FG001|NOT COMPLETED|3rd Course||0
8639844|NCT00582907|9680265|FG002|NOT COMPLETED|3rd Course||0
8639845|NCT00582907|9680266|FG003|NOT COMPLETED|3rd Course||0
8639846|NCT00582907|9680263|FG000|STARTED|4th Course||2
8639847|NCT00582907|9680264|FG001|STARTED|4th Course||3
8639848|NCT00582907|9680265|FG002|STARTED|4th Course||3
8639849|NCT00582907|9680266|FG003|STARTED|4th Course||3
8639850|NCT00582907|9680263|FG000|COMPLETED|4th Course||2
8639851|NCT00582907|9680264|FG001|COMPLETED|4th Course||3
8639852|NCT00582907|9680265|FG002|COMPLETED|4th Course||3
8639853|NCT00582907|9680266|FG003|COMPLETED|4th Course||3
8639854|NCT00582907|9680263|FG000|NOT COMPLETED|4th Course||0
8639855|NCT00582907|9680264|FG001|NOT COMPLETED|4th Course||0
8639856|NCT00582907|9680265|FG002|NOT COMPLETED|4th Course||0
8639857|NCT00582907|9680266|FG003|NOT COMPLETED|4th Course||0
8639858|NCT00582933|9680272|FG000|STARTED|Overall Study||95
8639859|NCT00582933|9680272|FG000|COMPLETED|Overall Study||92
8639860|NCT00582933|9680272|FG000|NOT COMPLETED|Overall Study||3
8639861|NCT00582946|9680276|FG000|STARTED|Overall Study||16
8639862|NCT00582946|9680276|FG000|COMPLETED|Overall Study||16
8639863|NCT00582946|9680276|FG000|NOT COMPLETED|Overall Study||0
8639864|NCT00582972|9680280|FG000|STARTED|Overall Study||23
8639865|NCT00582972|9680280|FG000|COMPLETED|Overall Study||21
8639866|NCT00582972|9680280|FG000|NOT COMPLETED|Overall Study||2
8639867|NCT00582998|9680287|FG000|STARTED|Overall Study||119
8639868|NCT00582998|9680288|FG001|STARTED|Overall Study||130
8639869|NCT00582998|9680287|FG000|COMPLETED|Overall Study||119
8639870|NCT00582998|9680288|FG001|COMPLETED|Overall Study||130
8639871|NCT00582998|9680287|FG000|NOT COMPLETED|Overall Study||0
8911163|NCT02144077|9970205|FG000|STARTED|Overall Study||138
8911164|NCT02144077|9970206|FG001|STARTED|Overall Study||143
8911165|NCT02144077|9970205|FG000|COMPLETED|Overall Study||128
8639872|NCT00582998|9680288|FG001|NOT COMPLETED|Overall Study||0
8639873|NCT00583011|9680296|FG000|STARTED|Overall Study||36
8639874|NCT00583011|9680297|FG001|STARTED|Overall Study||40
8639875|NCT00583011|9680296|FG000|COMPLETED|Overall Study||36
8639876|NCT00583011|9680297|FG001|COMPLETED|Overall Study||40
8639877|NCT00583011|9680296|FG000|NOT COMPLETED|Overall Study||0
9020774|NCT03100838|10083297|FG001|NOT COMPLETED|Overall Study||2
9020775|NCT03100838|10083298|FG002|NOT COMPLETED|Overall Study||2
9020776|NCT03100838|10083299|FG003|NOT COMPLETED|Overall Study||1
9020777|NCT03100864|10083309|FG000|STARTED|Overall Study||8
9020778|NCT03100864|10083309|FG000|COMPLETED|Overall Study||8
9020779|NCT03100864|10083309|FG000|NOT COMPLETED|Overall Study||0
9020780|NCT03100942|10083317|FG000|STARTED|Randomized Treatment Period||38
9020781|NCT03100942|10083318|FG001|STARTED|Randomized Treatment Period||38
9020782|NCT03100942|10083319|FG002|STARTED|Randomized Treatment Period||39
9020783|NCT03100942|10083320|FG003|STARTED|Randomized Treatment Period||37
9020784|NCT03100942|10083321|FG004|STARTED|Randomized Treatment Period||0
9020785|NCT03100942|10083322|FG005|STARTED|Randomized Treatment Period||0
9020786|NCT03100942|10083323|FG006|STARTED|Randomized Treatment Period||0
9020787|NCT03100942|10083317|FG000|COMPLETED|Randomized Treatment Period||26
9020788|NCT03100942|10083318|FG001|COMPLETED|Randomized Treatment Period||29
9020789|NCT03100942|10083319|FG002|COMPLETED|Randomized Treatment Period||33
9020790|NCT03100942|10083320|FG003|COMPLETED|Randomized Treatment Period||32
9020791|NCT03100942|10083321|FG004|COMPLETED|Randomized Treatment Period||0
9020792|NCT03100942|10083322|FG005|COMPLETED|Randomized Treatment Period||0
9020793|NCT03100942|10083323|FG006|COMPLETED|Randomized Treatment Period||0
9020794|NCT03100942|10083317|FG000|NOT COMPLETED|Randomized Treatment Period||12
9020795|NCT03100942|10083318|FG001|NOT COMPLETED|Randomized Treatment Period||9
9020796|NCT03100942|10083319|FG002|NOT COMPLETED|Randomized Treatment Period||6
9020797|NCT03100942|10083320|FG003|NOT COMPLETED|Randomized Treatment Period||5
9020798|NCT03100942|10083321|FG004|NOT COMPLETED|Randomized Treatment Period||0
9020799|NCT03100942|10083322|FG005|NOT COMPLETED|Randomized Treatment Period||0
9020800|NCT03100942|10083323|FG006|NOT COMPLETED|Randomized Treatment Period||0
9020801|NCT03100942|10083317|FG000|STARTED|Placebo Arm Re-Randomized||0
9020802|NCT03100942|10083318|FG001|STARTED|Placebo Arm Re-Randomized||0
9020803|NCT03100942|10083319|FG002|STARTED|Placebo Arm Re-Randomized||0
9020804|NCT03100942|10083320|FG003|STARTED|Placebo Arm Re-Randomized||0
9020805|NCT03100942|10083321|FG004|STARTED|Placebo Arm Re-Randomized||10
9020806|NCT03100942|10083322|FG005|STARTED|Placebo Arm Re-Randomized||12
9020807|NCT03100942|10083323|FG006|STARTED|Placebo Arm Re-Randomized||10
9020808|NCT03100942|10083317|FG000|COMPLETED|Placebo Arm Re-Randomized||0
9020809|NCT03100942|10083318|FG001|COMPLETED|Placebo Arm Re-Randomized||0
9020810|NCT03100942|10083319|FG002|COMPLETED|Placebo Arm Re-Randomized||0
9020811|NCT03100942|10083320|FG003|COMPLETED|Placebo Arm Re-Randomized||0
9020812|NCT03100942|10083321|FG004|COMPLETED|Placebo Arm Re-Randomized||10
9020813|NCT03100942|10083322|FG005|COMPLETED|Placebo Arm Re-Randomized||12
9020814|NCT03100942|10083323|FG006|COMPLETED|Placebo Arm Re-Randomized||9
9020815|NCT03100942|10083317|FG000|NOT COMPLETED|Placebo Arm Re-Randomized||0
9020816|NCT03100942|10083318|FG001|NOT COMPLETED|Placebo Arm Re-Randomized||0
9020817|NCT03100942|10083319|FG002|NOT COMPLETED|Placebo Arm Re-Randomized||0
9020818|NCT03100942|10083320|FG003|NOT COMPLETED|Placebo Arm Re-Randomized||0
9020819|NCT03100942|10083321|FG004|NOT COMPLETED|Placebo Arm Re-Randomized||0
9020820|NCT03100942|10083322|FG005|NOT COMPLETED|Placebo Arm Re-Randomized||0
9020821|NCT03100942|10083323|FG006|NOT COMPLETED|Placebo Arm Re-Randomized||1
9020822|NCT03100968|10083338|FG000|STARTED|Overall Study||75
9020823|NCT03100968|10083339|FG001|STARTED|Overall Study||75
9020824|NCT03100968|10083338|FG000|COMPLETED|Overall Study||75
9020825|NCT03100968|10083339|FG001|COMPLETED|Overall Study||75
9020826|NCT03100968|10083338|FG000|NOT COMPLETED|Overall Study||0
9020827|NCT03100968|10083339|FG001|NOT COMPLETED|Overall Study||0
9020828|NCT03101020|10083347|FG000|STARTED|Overall Study||10
9020829|NCT03101020|10083348|FG001|STARTED|Overall Study||10
9020830|NCT03101020|10083347|FG000|COMPLETED|Overall Study||9
9020831|NCT03101020|10083348|FG001|COMPLETED|Overall Study||7
8639878|NCT00583011|9680297|FG001|NOT COMPLETED|Overall Study||0
8639879|NCT00583050|9680304|FG000|STARTED|Overall Study||1366
8639880|NCT00583050|9680304|FG000|COMPLETED|Overall Study||1366
8639881|NCT00583050|9680304|FG000|NOT COMPLETED|Overall Study||0
8639882|NCT00583102|9680308|FG000|STARTED|Overall Study||23
9020832|NCT03101020|10083347|FG000|NOT COMPLETED|Overall Study||1
9020833|NCT03101020|10083348|FG001|NOT COMPLETED|Overall Study||3
9020834|NCT03101033|10083356|FG000|STARTED|Overall Study||32
9020835|NCT03101033|10083357|FG001|STARTED|Overall Study||60
9020836|NCT03101033|10083356|FG000|COMPLETED|Overall Study||27
9020837|NCT03101033|10083357|FG001|COMPLETED|Overall Study||51
9020838|NCT03101033|10083356|FG000|NOT COMPLETED|Overall Study||5
9020839|NCT03101033|10083357|FG001|NOT COMPLETED|Overall Study||9
8639883|NCT00583102|9680308|FG000|COMPLETED|Overall Study||20
8639884|NCT00583102|9680308|FG000|NOT COMPLETED|Overall Study||3
8639885|NCT00583219|9680312|FG000|STARTED|Phase 1|First 3 subjects in Phase 1 received 200 units Botox. The remaining subjects got 300 units Botox.|9
8639886|NCT00583219|9680312|FG000|COMPLETED|Phase 1||9
8639887|NCT00583219|9680312|FG000|NOT COMPLETED|Phase 1||0
8639888|NCT00583219|9680312|FG000|STARTED|Phase 2|6 subjects from P1 continued in P2; plus 16 new subjects. All subjects in P2 got 300 units Botox.|22
8639889|NCT00583219|9680312|FG000|COMPLETED|Phase 2||21
8639890|NCT00583219|9680312|FG000|NOT COMPLETED|Phase 2||1
9020840|NCT03101111|10083365|FG000|STARTED|Overall Study|First subject signed ICF (MV-CHIK group)|26
9020841|NCT03101111|10083366|FG001|STARTED|Overall Study|First subject signed ICF (MMR group)|8
9020842|NCT03101111|10083365|FG000|COMPLETED|Overall Study|End of Study Visit|23
9020843|NCT03101111|10083366|FG001|COMPLETED|Overall Study|End of Study Visit|7
9020844|NCT03101111|10083365|FG000|NOT COMPLETED|Overall Study||3
9020845|NCT03101111|10083366|FG001|NOT COMPLETED|Overall Study||1
9020846|NCT03101150|10083378|FG000|STARTED|Overall Study||86
9020847|NCT03101150|10083379|FG001|STARTED|Overall Study||93
9020848|NCT03101150|10083378|FG000|COMPLETED|Overall Study||81
9020849|NCT03101150|10083379|FG001|COMPLETED|Overall Study||83
9020850|NCT03101150|10083378|FG000|NOT COMPLETED|Overall Study||5
9020851|NCT03101150|10083379|FG001|NOT COMPLETED|Overall Study||10
9020852|NCT03101241|10083387|FG000|STARTED|Overall Study||48
9020853|NCT03101241|10083388|FG001|STARTED|Overall Study||47
9020854|NCT03101241|10083387|FG000|COMPLETED|Overall Study||37
9020855|NCT03101241|10083388|FG001|COMPLETED|Overall Study||42
9020856|NCT03101241|10083387|FG000|NOT COMPLETED|Overall Study||11
9020857|NCT03101241|10083388|FG001|NOT COMPLETED|Overall Study||5
9020858|NCT03101267|10083397|FG000|STARTED|Primary Study Period||50
9020859|NCT03101267|10083398|FG001|STARTED|Primary Study Period||50
9020860|NCT03101267|10083399|FG002|STARTED|Primary Study Period||50
9020861|NCT03101267|10083397|FG000|COMPLETED|Primary Study Period||47
9020862|NCT03101267|10083398|FG001|COMPLETED|Primary Study Period||48
9020863|NCT03101267|10083399|FG002|COMPLETED|Primary Study Period||47
9020864|NCT03101267|10083397|FG000|NOT COMPLETED|Primary Study Period||3
9020865|NCT03101267|10083398|FG001|NOT COMPLETED|Primary Study Period||2
9020866|NCT03101267|10083399|FG002|NOT COMPLETED|Primary Study Period||3
9020867|NCT03101267|10083397|FG000|STARTED|Pollinosis Symptoms Survey Period||47
9020868|NCT03101267|10083398|FG001|STARTED|Pollinosis Symptoms Survey Period||48
9020869|NCT03101267|10083399|FG002|STARTED|Pollinosis Symptoms Survey Period||47
9020870|NCT03101267|10083397|FG000|COMPLETED|Pollinosis Symptoms Survey Period||47
9020871|NCT03101267|10083398|FG001|COMPLETED|Pollinosis Symptoms Survey Period||48
9020872|NCT03101267|10083399|FG002|COMPLETED|Pollinosis Symptoms Survey Period||47
9020873|NCT03101267|10083397|FG000|NOT COMPLETED|Pollinosis Symptoms Survey Period||0
9020874|NCT03101267|10083398|FG001|NOT COMPLETED|Pollinosis Symptoms Survey Period||0
9020875|NCT03101267|10083399|FG002|NOT COMPLETED|Pollinosis Symptoms Survey Period||0
9020876|NCT03101293|10083409|FG000|STARTED|Intervention Period 1||7
9020877|NCT03101293|10083410|FG001|STARTED|Intervention Period 1||8
9020878|NCT03101293|10083409|FG000|COMPLETED|Intervention Period 1||7
9020879|NCT03101293|10083410|FG001|COMPLETED|Intervention Period 1||8
9020880|NCT03101293|10083409|FG000|NOT COMPLETED|Intervention Period 1||0
9020881|NCT03101293|10083410|FG001|NOT COMPLETED|Intervention Period 1||0
9020882|NCT03101293|10083409|FG000|STARTED|Washout Period (at Least 7 Days)||7
9020883|NCT03101293|10083410|FG001|STARTED|Washout Period (at Least 7 Days)||8
9020884|NCT03101293|10083409|FG000|COMPLETED|Washout Period (at Least 7 Days)||6
9020885|NCT03101293|10083410|FG001|COMPLETED|Washout Period (at Least 7 Days)||8
9020886|NCT03101293|10083409|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||1
9020887|NCT03101293|10083410|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0
9020888|NCT03101293|10083409|FG000|STARTED|Intervention Period 2||6
9020889|NCT03101293|10083410|FG001|STARTED|Intervention Period 2||8
9020890|NCT03101293|10083409|FG000|COMPLETED|Intervention Period 2||6
9020891|NCT03101293|10083410|FG001|COMPLETED|Intervention Period 2||8
9020892|NCT03101293|10083409|FG000|NOT COMPLETED|Intervention Period 2||0
9020893|NCT03101293|10083410|FG001|NOT COMPLETED|Intervention Period 2||0
9020894|NCT03101358|10083420|FG000|STARTED|Overall Study||4
9020895|NCT03101358|10083421|FG001|STARTED|Overall Study||3
9020896|NCT03101358|10083422|FG002|STARTED|Overall Study||5
9020897|NCT03101358|10083423|FG003|STARTED|Overall Study||11
9020898|NCT03101358|10083420|FG000|Completed All Dosing|Overall Study||3
9020899|NCT03101358|10083421|FG001|Completed All Dosing|Overall Study||3
9020900|NCT03101358|10083422|FG002|Completed All Dosing|Overall Study||3
9020901|NCT03101358|10083423|FG003|Completed All Dosing|Overall Study||10
9020902|NCT03101358|10083420|FG000|COMPLETED|Overall Study||1
9020903|NCT03101358|10083421|FG001|COMPLETED|Overall Study||3
9020904|NCT03101358|10083422|FG002|COMPLETED|Overall Study||3
9020905|NCT03101358|10083423|FG003|COMPLETED|Overall Study||5
9020906|NCT03101358|10083420|FG000|NOT COMPLETED|Overall Study||3
9020907|NCT03101358|10083421|FG001|NOT COMPLETED|Overall Study||0
9020908|NCT03101358|10083422|FG002|NOT COMPLETED|Overall Study||2
9020909|NCT03101358|10083423|FG003|NOT COMPLETED|Overall Study||6
8639891|NCT00583362|9680316|FG000|STARTED|Overall Study||298
9020910|NCT03101371|10083436|FG000|STARTED|Overall Study||48
9020911|NCT03101371|10083437|FG001|STARTED|Overall Study||51
9020912|NCT03101371|10083436|FG000|COMPLETED|Overall Study||45
9020913|NCT03101371|10083437|FG001|COMPLETED|Overall Study||45
9020914|NCT03101371|10083436|FG000|NOT COMPLETED|Overall Study||3
9020915|NCT03101371|10083437|FG001|NOT COMPLETED|Overall Study||6
9020916|NCT03101462|10083445|FG000|STARTED|Overall Study||19
9020917|NCT03101462|10083446|FG001|STARTED|Overall Study||19
9020918|NCT03101462|10083445|FG000|COMPLETED|Overall Study||18
9020919|NCT03101462|10083446|FG001|COMPLETED|Overall Study||18
9020920|NCT03101462|10083445|FG000|NOT COMPLETED|Overall Study||1
9020921|NCT03101462|10083446|FG001|NOT COMPLETED|Overall Study||1
9020922|NCT03101514|10083452|FG000|STARTED|Overall Study||53
9020923|NCT03101514|10083452|FG000|COMPLETED|Overall Study||46
9020924|NCT03101514|10083452|FG000|NOT COMPLETED|Overall Study||7
9020925|NCT03101592|10083459|FG000|STARTED|Overall Study||3123
9020926|NCT03101592|10083460|FG001|STARTED|Overall Study||2896
9020927|NCT03101592|10083461|FG002|STARTED|Overall Study||3099
9020928|NCT03101592|10083459|FG000|COMPLETED|Overall Study||3012
9020929|NCT03101592|10083460|FG001|COMPLETED|Overall Study||2726
9020930|NCT03101592|10083461|FG002|COMPLETED|Overall Study||2981
8639892|NCT00583362|9680316|FG000|COMPLETED|Overall Study||96
9020931|NCT03101592|10083459|FG000|NOT COMPLETED|Overall Study||111
9020932|NCT03101592|10083460|FG001|NOT COMPLETED|Overall Study||170
9020933|NCT03101592|10083461|FG002|NOT COMPLETED|Overall Study||118
9020934|NCT03102190|10083475|FG000|STARTED|Overall Study||6
9020935|NCT03102190|10083475|FG000|COMPLETED|Overall Study||6
8639893|NCT00583362|9680316|FG000|NOT COMPLETED|Overall Study||202
8639894|NCT00583375|9680322|FG000|STARTED|Overall Study||142
8639895|NCT00583375|9680323|FG001|STARTED|Overall Study||272
8639896|NCT00583375|9680322|FG000|COMPLETED|Overall Study||142
8639897|NCT00583375|9680323|FG001|COMPLETED|Overall Study||272
8639898|NCT00583375|9680322|FG000|NOT COMPLETED|Overall Study||0
8639899|NCT00583375|9680323|FG001|NOT COMPLETED|Overall Study||0
8639900|NCT00583414|9680329|FG000|STARTED|Overall Study||401
8639901|NCT00583414|9680329|FG000|COMPLETED|Overall Study||401
8639902|NCT00583414|9680329|FG000|NOT COMPLETED|Overall Study||0
8639903|NCT00583453|9680335|FG000|STARTED|Overall Study||9
8639904|NCT00583453|9680336|FG001|STARTED|Overall Study||8
8639905|NCT00583453|9680335|FG000|COMPLETED|Overall Study||9
8639906|NCT00583453|9680336|FG001|COMPLETED|Overall Study||6
8639907|NCT00583453|9680335|FG000|NOT COMPLETED|Overall Study||0
8639908|NCT00583453|9680336|FG001|NOT COMPLETED|Overall Study||2
8639909|NCT00583492|9680346|FG000|STARTED|Overall Study||21
8639910|NCT00583492|9680347|FG001|STARTED|Overall Study||23
8639911|NCT00583492|9680346|FG000|COMPLETED|Overall Study||21
8639912|NCT00583492|9680347|FG001|COMPLETED|Overall Study||23
8639913|NCT00583492|9680346|FG000|NOT COMPLETED|Overall Study||0
8639914|NCT00583492|9680347|FG001|NOT COMPLETED|Overall Study||0
8639915|NCT00583557|9680353|FG000|STARTED|Overall Study||155
8639916|NCT00583557|9680353|FG000|Received at Least 1 Dose Belimumab|Overall Study||153
8639917|NCT00583557|9680353|FG000|COMPLETED|Overall Study|Completer defined as subjects whose reason for discontinuation was sponsor discontinuation of study|85
8639918|NCT00583557|9680353|FG000|NOT COMPLETED|Overall Study||70
8639919|NCT00583596|9680357|FG000|STARTED|Overall Study|Subjects in Phase 2 clinical trial who received the AMPLATZER Duct Occluder.|436
8639920|NCT00583596|9680357|FG000|COMPLETED|Overall Study||152
8639921|NCT00583596|9680357|FG000|NOT COMPLETED|Overall Study||284
8639922|NCT00583622|9680362|FG000|STARTED|Overall Study||12
8639923|NCT00583622|9680362|FG000|COMPLETED|Overall Study||12
8639924|NCT00583622|9680362|FG000|NOT COMPLETED|Overall Study||0
8639925|NCT00583661|9680366|FG000|STARTED|Overall Study||48
8639926|NCT00583661|9680366|FG000|COMPLETED|Overall Study||48
8639927|NCT00583661|9680366|FG000|NOT COMPLETED|Overall Study||0
8639928|NCT00583700|9680373|FG000|STARTED|Overall Study||27
8639929|NCT00583700|9680374|FG001|STARTED|Overall Study||27
8639930|NCT00583700|9680373|FG000|COMPLETED|Overall Study||24
8639931|NCT00583700|9680374|FG001|COMPLETED|Overall Study||23
8639932|NCT00583700|9680373|FG000|NOT COMPLETED|Overall Study||3
8639933|NCT00583700|9680374|FG001|NOT COMPLETED|Overall Study||4
8639934|NCT00583713|9680383|FG000|STARTED|Overall Study||6
8639935|NCT00583713|9680384|FG001|STARTED|Overall Study||6
8639936|NCT00583713|9680385|FG002|STARTED|Overall Study||6
9020936|NCT03102190|10083475|FG000|NOT COMPLETED|Overall Study||0
9020937|NCT03102411|10083479|FG000|STARTED|Overall Study||1881
9020938|NCT03102411|10083479|FG000|COMPLETED|Overall Study||1718
9020939|NCT03102411|10083479|FG000|NOT COMPLETED|Overall Study||163
9020940|NCT03102437|10083486|FG000|STARTED|Overall Study||70
9020941|NCT03102437|10083487|FG001|STARTED|Overall Study||36
9020942|NCT03102437|10083486|FG000|COMPLETED|Overall Study||65
9020943|NCT03102437|10083487|FG001|COMPLETED|Overall Study||36
9020944|NCT03102437|10083486|FG000|NOT COMPLETED|Overall Study||5
9020945|NCT03102437|10083487|FG001|NOT COMPLETED|Overall Study||0
9020946|NCT03102645|10083495|FG000|STARTED|Overall Study||8
9020947|NCT03102645|10083496|FG001|STARTED|Overall Study||8
9020948|NCT03102645|10083495|FG000|COMPLETED|Overall Study||8
9020949|NCT03102645|10083496|FG001|COMPLETED|Overall Study||8
9020950|NCT03102645|10083495|FG000|NOT COMPLETED|Overall Study||0
9020951|NCT03102645|10083496|FG001|NOT COMPLETED|Overall Study||0
9020952|NCT03102710|10083506|FG000|STARTED|Overall Study||28
9020953|NCT03102710|10083507|FG001|STARTED|Overall Study||30
9020954|NCT03102710|10083508|FG002|STARTED|Overall Study||27
9020955|NCT03102710|10083506|FG000|COMPLETED|Overall Study||27
9020956|NCT03102710|10083507|FG001|COMPLETED|Overall Study||27
9020957|NCT03102710|10083508|FG002|COMPLETED|Overall Study||27
9020958|NCT03102710|10083506|FG000|NOT COMPLETED|Overall Study||1
9020959|NCT03102710|10083507|FG001|NOT COMPLETED|Overall Study||3
9020960|NCT03102710|10083508|FG002|NOT COMPLETED|Overall Study||0
9020961|NCT03102736|10083518|FG000|STARTED|Overall Study||7
9020962|NCT03102736|10083519|FG001|STARTED|Overall Study||9
9020963|NCT03102736|10083518|FG000|COMPLETED|Overall Study||7
9020964|NCT03102736|10083519|FG001|COMPLETED|Overall Study||9
9020965|NCT03102736|10083518|FG000|NOT COMPLETED|Overall Study||0
9020966|NCT03102736|10083519|FG001|NOT COMPLETED|Overall Study||0
9020967|NCT03102762|10083527|FG000|STARTED|Overall Study||35
8639937|NCT00583713|9680383|FG000|COMPLETED|Overall Study||6
8639938|NCT00583713|9680384|FG001|COMPLETED|Overall Study||6
8639939|NCT00583713|9680385|FG002|COMPLETED|Overall Study||6
9020968|NCT03102762|10083528|FG001|STARTED|Overall Study||35
9020969|NCT03102762|10083527|FG000|COMPLETED|Overall Study||34
9020970|NCT03102762|10083528|FG001|COMPLETED|Overall Study||35
9020971|NCT03102762|10083527|FG000|NOT COMPLETED|Overall Study||1
9020972|NCT03102762|10083528|FG001|NOT COMPLETED|Overall Study||0
9020973|NCT03102879|10083537|FG000|STARTED|Overall Study||18
9020974|NCT03102879|10083538|FG001|STARTED|Overall Study||18
9020975|NCT03102879|10083537|FG000|COMPLETED|Overall Study||18
9020976|NCT03102879|10083538|FG001|COMPLETED|Overall Study||18
9020977|NCT03102879|10083537|FG000|NOT COMPLETED|Overall Study||0
9020978|NCT03102879|10083538|FG001|NOT COMPLETED|Overall Study||0
9020979|NCT03102918|10083550|FG000|STARTED|Overall Study||5
9020980|NCT03102918|10083551|FG001|STARTED|Overall Study||5
9020981|NCT03102918|10083550|FG000|COMPLETED|Overall Study||4
9020982|NCT03102918|10083551|FG001|COMPLETED|Overall Study||5
9020983|NCT03102918|10083550|FG000|NOT COMPLETED|Overall Study||1
9020984|NCT03102918|10083551|FG001|NOT COMPLETED|Overall Study||0
9020985|NCT03103061|10083557|FG000|STARTED|Overall Study||24
9020986|NCT03103061|10083557|FG000|COMPLETED|Overall Study||24
8639940|NCT00583713|9680383|FG000|NOT COMPLETED|Overall Study||0
9020987|NCT03103061|10083557|FG000|NOT COMPLETED|Overall Study||0
9020988|NCT03103100|10083564|FG000|STARTED|Overall Study||25
9020989|NCT03103100|10083565|FG001|STARTED|Overall Study||25
9020990|NCT03103100|10083566|FG002|STARTED|Overall Study||25
9020991|NCT03103100|10083564|FG000|COMPLETED|Overall Study||23
9020992|NCT03103100|10083565|FG001|COMPLETED|Overall Study||25
9020993|NCT03103100|10083566|FG002|COMPLETED|Overall Study||23
9020994|NCT03103100|10083564|FG000|NOT COMPLETED|Overall Study||2
9020995|NCT03103100|10083565|FG001|NOT COMPLETED|Overall Study||0
9020996|NCT03103100|10083566|FG002|NOT COMPLETED|Overall Study||2
9020997|NCT03103282|10083574|FG000|STARTED|Overall Study||65
9020998|NCT03103282|10083574|FG000|COMPLETED|Overall Study||65
9020999|NCT03103282|10083574|FG000|NOT COMPLETED|Overall Study||0
9021000|NCT03103438|10083585|FG000|STARTED|Overall Study||1
9021001|NCT03103438|10083586|FG001|STARTED|Overall Study||3
9021002|NCT03103438|10083587|FG002|STARTED|Overall Study||3
9021003|NCT03103438|10083588|FG003|STARTED|Overall Study||3
9021004|NCT03103438|10083589|FG004|STARTED|Overall Study||3
9021005|NCT03103438|10083590|FG005|STARTED|Overall Study||3
9021006|NCT03103438|10083591|FG006|STARTED|Overall Study||3
9021007|NCT03103438|10083585|FG000|COMPLETED|Overall Study||1
9021008|NCT03103438|10083586|FG001|COMPLETED|Overall Study||3
9021009|NCT03103438|10083587|FG002|COMPLETED|Overall Study||3
9021010|NCT03103438|10083588|FG003|COMPLETED|Overall Study||3
9021011|NCT03103438|10083589|FG004|COMPLETED|Overall Study||3
9021012|NCT03103438|10083590|FG005|COMPLETED|Overall Study||3
9021013|NCT03103438|10083591|FG006|COMPLETED|Overall Study||3
9021014|NCT03103438|10083585|FG000|NOT COMPLETED|Overall Study||0
9021015|NCT03103438|10083586|FG001|NOT COMPLETED|Overall Study||0
9021016|NCT03103438|10083587|FG002|NOT COMPLETED|Overall Study||0
9021017|NCT03103438|10083588|FG003|NOT COMPLETED|Overall Study||0
9021018|NCT03103438|10083589|FG004|NOT COMPLETED|Overall Study||0
9021019|NCT03103438|10083590|FG005|NOT COMPLETED|Overall Study||0
9021020|NCT03103438|10083591|FG006|NOT COMPLETED|Overall Study||0
9021021|NCT03103503|10083607|FG000|STARTED|Overall Study||901
9021022|NCT03103503|10083607|FG000|COMPLETED|Overall Study||0
9021023|NCT03103503|10083607|FG000|NOT COMPLETED|Overall Study||901
9021024|NCT03103763|10083614|FG000|STARTED|Overall Study||44
9021025|NCT03103763|10083615|FG001|STARTED|Overall Study||44
9021026|NCT03103763|10083616|FG002|STARTED|Overall Study||44
9021027|NCT03103763|10083614|FG000|COMPLETED|Overall Study||29
9021028|NCT03103763|10083615|FG001|COMPLETED|Overall Study||36
9021029|NCT03103763|10083616|FG002|COMPLETED|Overall Study||37
9021030|NCT03103763|10083614|FG000|NOT COMPLETED|Overall Study||15
9021031|NCT03103763|10083615|FG001|NOT COMPLETED|Overall Study||8
9021032|NCT03103763|10083616|FG002|NOT COMPLETED|Overall Study||7
9021033|NCT03103906|10083626|FG000|STARTED|Overall Study||40
9021034|NCT03103906|10083627|FG001|STARTED|Overall Study||42
9021035|NCT03103906|10083626|FG000|COMPLETED|Overall Study||36
9021036|NCT03103906|10083627|FG001|COMPLETED|Overall Study||39
9021037|NCT03103906|10083626|FG000|NOT COMPLETED|Overall Study||4
9021038|NCT03103906|10083627|FG001|NOT COMPLETED|Overall Study||3
9021039|NCT03103919|10083635|FG000|STARTED|Overall Study||20
8639941|NCT00583713|9680384|FG001|NOT COMPLETED|Overall Study||0
8639942|NCT00583713|9680385|FG002|NOT COMPLETED|Overall Study||0
8639943|NCT00583791|9680393|FG000|STARTED|Overall Study||91
8639944|NCT00583791|9680393|FG000|COMPLETED|Overall Study||18
8639945|NCT00583791|9680393|FG000|NOT COMPLETED|Overall Study||73
8639946|NCT00583908|9680397|FG000|STARTED|Period 1 - First Intervention||1
8639947|NCT00583908|9680398|FG001|STARTED|Period 1 - First Intervention||2
8639948|NCT00583908|9680399|FG002|STARTED|Period 1 - First Intervention||1
9021040|NCT03103919|10083636|FG001|STARTED|Overall Study||19
9021041|NCT03103919|10083635|FG000|COMPLETED|Overall Study||18
9021042|NCT03103919|10083636|FG001|COMPLETED|Overall Study||17
9021043|NCT03103919|10083635|FG000|NOT COMPLETED|Overall Study||2
9021044|NCT03103919|10083636|FG001|NOT COMPLETED|Overall Study||2
9021045|NCT03104192|10083648|FG000|STARTED|Overall Study||9
9021046|NCT03104192|10083649|FG001|STARTED|Overall Study||27
9021047|NCT03104192|10083650|FG002|STARTED|Overall Study||16
9021048|NCT03104192|10083651|FG003|STARTED|Overall Study||17
9021049|NCT03104192|10083648|FG000|COMPLETED|Overall Study||9
9021050|NCT03104192|10083649|FG001|COMPLETED|Overall Study||23
9021051|NCT03104192|10083650|FG002|COMPLETED|Overall Study||14
9021052|NCT03104192|10083651|FG003|COMPLETED|Overall Study||14
9021053|NCT03104192|10083648|FG000|NOT COMPLETED|Overall Study||0
9021054|NCT03104192|10083649|FG001|NOT COMPLETED|Overall Study||4
8639949|NCT00583908|9680400|FG003|STARTED|Period 1 - First Intervention||1
8639950|NCT00583908|9680401|FG004|STARTED|Period 1 - First Intervention||2
9021055|NCT03104192|10083650|FG002|NOT COMPLETED|Overall Study||2
9021056|NCT03104192|10083651|FG003|NOT COMPLETED|Overall Study||3
9021057|NCT03104322|10083667|FG000|STARTED|Overall Study||7
9021058|NCT03104322|10083667|FG000|COMPLETED|Overall Study||6
9021059|NCT03104322|10083667|FG000|NOT COMPLETED|Overall Study||1
9021060|NCT03104647|10083671|FG000|STARTED|Overall Study||20
9021061|NCT03104647|10083671|FG000|COMPLETED|Overall Study||20
9021062|NCT03104647|10083671|FG000|NOT COMPLETED|Overall Study||0
9021063|NCT03104725|10083677|FG000|STARTED|Overall Study||2
9021064|NCT03104725|10083678|FG001|STARTED|Overall Study||4
9021065|NCT03104725|10083677|FG000|COMPLETED|Overall Study||2
9021066|NCT03104725|10083678|FG001|COMPLETED|Overall Study||4
9021067|NCT03104725|10083677|FG000|NOT COMPLETED|Overall Study||0
9021068|NCT03104725|10083678|FG001|NOT COMPLETED|Overall Study||0
9021069|NCT03104738|10083686|FG000|STARTED|Overall Study||20
9021070|NCT03104738|10083687|FG001|STARTED|Overall Study||20
9021071|NCT03104738|10083686|FG000|COMPLETED|Overall Study||20
9021072|NCT03104738|10083687|FG001|COMPLETED|Overall Study||20
9021073|NCT03104738|10083686|FG000|NOT COMPLETED|Overall Study||0
8727238|NCT01042392|9774633|FG003|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)||0
9021074|NCT03104738|10083687|FG001|NOT COMPLETED|Overall Study||0
9021075|NCT03104816|10083696|FG000|STARTED|Overall Study||11
9021076|NCT03104816|10083697|FG001|STARTED|Overall Study||11
9021077|NCT03104816|10083698|FG002|STARTED|Overall Study||6
9021078|NCT03104816|10083696|FG000|COMPLETED|Overall Study||9
9021079|NCT03104816|10083697|FG001|COMPLETED|Overall Study||9
9021080|NCT03104816|10083698|FG002|COMPLETED|Overall Study||4
9021081|NCT03104816|10083696|FG000|NOT COMPLETED|Overall Study||2
9021082|NCT03104816|10083697|FG001|NOT COMPLETED|Overall Study||2
9021083|NCT03104816|10083698|FG002|NOT COMPLETED|Overall Study||2
9021084|NCT03104985|10083708|FG000|STARTED|Overall Study||34
9021085|NCT03104985|10083709|FG001|STARTED|Overall Study||34
9021086|NCT03104985|10083708|FG000|COMPLETED|Overall Study||34
9021087|NCT03104985|10083709|FG001|COMPLETED|Overall Study||34
8639951|NCT00583908|9680402|FG005|STARTED|Period 1 - First Intervention||1
8639952|NCT00583908|9680403|FG006|STARTED|Period 1 - First Intervention||1
8639953|NCT00583908|9680404|FG007|STARTED|Period 1 - First Intervention||1
8639954|NCT00583908|9680405|FG008|STARTED|Period 1 - First Intervention||1
8639955|NCT00583908|9680406|FG009|STARTED|Period 1 - First Intervention||1
8639956|NCT00583908|9680407|FG010|STARTED|Period 1 - First Intervention||1
8639957|NCT00583908|9680408|FG011|STARTED|Period 1 - First Intervention||1
8639958|NCT00583908|9680397|FG000|COMPLETED|Period 1 - First Intervention||1
8639959|NCT00583908|9680398|FG001|COMPLETED|Period 1 - First Intervention||2
8639960|NCT00583908|9680399|FG002|COMPLETED|Period 1 - First Intervention||1
8639961|NCT00583908|9680400|FG003|COMPLETED|Period 1 - First Intervention||1
8639962|NCT00583908|9680401|FG004|COMPLETED|Period 1 - First Intervention||2
8639963|NCT00583908|9680402|FG005|COMPLETED|Period 1 - First Intervention||1
8639964|NCT00583908|9680403|FG006|COMPLETED|Period 1 - First Intervention||1
8639965|NCT00583908|9680404|FG007|COMPLETED|Period 1 - First Intervention||1
8639966|NCT00583908|9680405|FG008|COMPLETED|Period 1 - First Intervention||1
8639967|NCT00583908|9680406|FG009|COMPLETED|Period 1 - First Intervention||1
8639968|NCT00583908|9680407|FG010|COMPLETED|Period 1 - First Intervention||1
8639969|NCT00583908|9680408|FG011|COMPLETED|Period 1 - First Intervention||1
8639970|NCT00583908|9680397|FG000|NOT COMPLETED|Period 1 - First Intervention||0
8639971|NCT00583908|9680398|FG001|NOT COMPLETED|Period 1 - First Intervention||0
8639972|NCT00583908|9680399|FG002|NOT COMPLETED|Period 1 - First Intervention||0
8639973|NCT00583908|9680400|FG003|NOT COMPLETED|Period 1 - First Intervention||0
8639974|NCT00583908|9680401|FG004|NOT COMPLETED|Period 1 - First Intervention||0
8639975|NCT00583908|9680402|FG005|NOT COMPLETED|Period 1 - First Intervention||0
8639976|NCT00583908|9680403|FG006|NOT COMPLETED|Period 1 - First Intervention||0
8639977|NCT00583908|9680404|FG007|NOT COMPLETED|Period 1 - First Intervention||0
8639978|NCT00583908|9680405|FG008|NOT COMPLETED|Period 1 - First Intervention||0
8639979|NCT00583908|9680406|FG009|NOT COMPLETED|Period 1 - First Intervention||0
8639980|NCT00583908|9680407|FG010|NOT COMPLETED|Period 1 - First Intervention||0
8639981|NCT00583908|9680408|FG011|NOT COMPLETED|Period 1 - First Intervention||0
8639982|NCT00583908|9680397|FG000|STARTED|Period 2 - Second Intervention||1
8639983|NCT00583908|9680398|FG001|STARTED|Period 2 - Second Intervention||2
8639984|NCT00583908|9680399|FG002|STARTED|Period 2 - Second Intervention||1
8639985|NCT00583908|9680400|FG003|STARTED|Period 2 - Second Intervention||1
8639986|NCT00583908|9680401|FG004|STARTED|Period 2 - Second Intervention||2
8639987|NCT00583908|9680402|FG005|STARTED|Period 2 - Second Intervention||1
8639988|NCT00583908|9680403|FG006|STARTED|Period 2 - Second Intervention||1
8639989|NCT00583908|9680404|FG007|STARTED|Period 2 - Second Intervention||1
8639990|NCT00583908|9680405|FG008|STARTED|Period 2 - Second Intervention||1
8639991|NCT00583908|9680406|FG009|STARTED|Period 2 - Second Intervention||1
8639992|NCT00583908|9680407|FG010|STARTED|Period 2 - Second Intervention||1
8639993|NCT00583908|9680408|FG011|STARTED|Period 2 - Second Intervention||1
8639994|NCT00583908|9680397|FG000|COMPLETED|Period 2 - Second Intervention||1
8639995|NCT00583908|9680398|FG001|COMPLETED|Period 2 - Second Intervention||2
8639996|NCT00583908|9680399|FG002|COMPLETED|Period 2 - Second Intervention||1
8639997|NCT00583908|9680400|FG003|COMPLETED|Period 2 - Second Intervention||1
8639998|NCT00583908|9680401|FG004|COMPLETED|Period 2 - Second Intervention||2
8639999|NCT00583908|9680402|FG005|COMPLETED|Period 2 - Second Intervention||1
8640000|NCT00583908|9680403|FG006|COMPLETED|Period 2 - Second Intervention||1
8640001|NCT00583908|9680404|FG007|COMPLETED|Period 2 - Second Intervention||1
8640002|NCT00583908|9680405|FG008|COMPLETED|Period 2 - Second Intervention||1
8640003|NCT00583908|9680406|FG009|COMPLETED|Period 2 - Second Intervention||1
8640004|NCT00583908|9680407|FG010|COMPLETED|Period 2 - Second Intervention||1
8640005|NCT00583908|9680408|FG011|COMPLETED|Period 2 - Second Intervention||1
8640006|NCT00583908|9680397|FG000|NOT COMPLETED|Period 2 - Second Intervention||0
8640007|NCT00583908|9680398|FG001|NOT COMPLETED|Period 2 - Second Intervention||0
8640008|NCT00583908|9680399|FG002|NOT COMPLETED|Period 2 - Second Intervention||0
8640009|NCT00583908|9680400|FG003|NOT COMPLETED|Period 2 - Second Intervention||0
8640010|NCT00583908|9680401|FG004|NOT COMPLETED|Period 2 - Second Intervention||0
8640011|NCT00583908|9680402|FG005|NOT COMPLETED|Period 2 - Second Intervention||0
8640012|NCT00583908|9680403|FG006|NOT COMPLETED|Period 2 - Second Intervention||0
8640013|NCT00583908|9680404|FG007|NOT COMPLETED|Period 2 - Second Intervention||0
8640014|NCT00583908|9680405|FG008|NOT COMPLETED|Period 2 - Second Intervention||0
9021088|NCT03104985|10083708|FG000|NOT COMPLETED|Overall Study||0
9021089|NCT03104985|10083709|FG001|NOT COMPLETED|Overall Study||0
9021090|NCT03105297|10083715|FG000|STARTED|Baseline Phase (Day 1)||91
9021091|NCT03105297|10083715|FG000|COMPLETED|Baseline Phase (Day 1)||70
9021092|NCT03105297|10083715|FG000|NOT COMPLETED|Baseline Phase (Day 1)||21
9021093|NCT03105297|10083715|FG000|STARTED|Active Phase (Day 2-29)||70
9021094|NCT03105297|10083715|FG000|COMPLETED|Active Phase (Day 2-29)||70
9021095|NCT03105297|10083715|FG000|NOT COMPLETED|Active Phase (Day 2-29)||0
9021096|NCT03105297|10083715|FG000|STARTED|Nasal Resistance Phase (Day 30, 31)|14 participants withdrew from the study after the completion of active phase|56
9021097|NCT03105297|10083715|FG000|Treated|Nasal Resistance Phase (Day 30, 31)||55
9021098|NCT03105297|10083715|FG000|COMPLETED|Nasal Resistance Phase (Day 30, 31)||48
9021099|NCT03105297|10083715|FG000|NOT COMPLETED|Nasal Resistance Phase (Day 30, 31)||8
9021100|NCT03105362|10083726|FG000|STARTED|Overall Study||4
9021101|NCT03105362|10083726|FG000|Completed 1 Week of Study|Overall Study||4
9021102|NCT03105362|10083726|FG000|Completed 2 Weeks of Study|Overall Study||3
9021103|NCT03105362|10083726|FG000|Completed 2 Week Questionaire|Overall Study||2
9021104|NCT03105362|10083726|FG000|COMPLETED|Overall Study||2
9021105|NCT03105362|10083726|FG000|NOT COMPLETED|Overall Study||2
9021106|NCT03105479|10083733|FG000|STARTED|Overall Study||1
9021107|NCT03105479|10083734|FG001|STARTED|Overall Study||0
9021108|NCT03105479|10083735|FG002|STARTED|Overall Study||0
9021109|NCT03105479|10083736|FG003|STARTED|Overall Study||0
9021110|NCT03105479|10083737|FG004|STARTED|Overall Study||0
9021111|NCT03105479|10083738|FG005|STARTED|Overall Study||0
9021112|NCT03105479|10083739|FG006|STARTED|Overall Study||0
9021113|NCT03105479|10083733|FG000|COMPLETED|Overall Study||1
9021114|NCT03105479|10083734|FG001|COMPLETED|Overall Study||0
9021115|NCT03105479|10083735|FG002|COMPLETED|Overall Study||0
9021116|NCT03105479|10083736|FG003|COMPLETED|Overall Study||0
9021117|NCT03105479|10083737|FG004|COMPLETED|Overall Study||0
9021118|NCT03105479|10083738|FG005|COMPLETED|Overall Study||0
9021119|NCT03105479|10083739|FG006|COMPLETED|Overall Study||0
9021120|NCT03105479|10083733|FG000|NOT COMPLETED|Overall Study||0
9021121|NCT03105479|10083734|FG001|NOT COMPLETED|Overall Study||0
9021122|NCT03105479|10083735|FG002|NOT COMPLETED|Overall Study||0
9021123|NCT03105479|10083736|FG003|NOT COMPLETED|Overall Study||0
9021124|NCT03105479|10083737|FG004|NOT COMPLETED|Overall Study||0
9021125|NCT03105479|10083738|FG005|NOT COMPLETED|Overall Study||0
9021126|NCT03105479|10083739|FG006|NOT COMPLETED|Overall Study||0
9021127|NCT03105518|10083746|FG000|STARTED|Overall Study||100
9021128|NCT03105518|10083746|FG000|COMPLETED|Overall Study||100
9021129|NCT03105518|10083746|FG000|NOT COMPLETED|Overall Study||0
9021130|NCT03106077|10083750|FG000|STARTED|Overall Study||96
9021131|NCT03106077|10083751|FG001|STARTED|Overall Study||0
9021132|NCT03106077|10083750|FG000|COMPLETED|Overall Study||2
9021133|NCT03106077|10083751|FG001|COMPLETED|Overall Study||0
9021134|NCT03106077|10083750|FG000|NOT COMPLETED|Overall Study||94
9021135|NCT03106077|10083751|FG001|NOT COMPLETED|Overall Study||0
9021136|NCT03106337|10083756|FG000|STARTED|Overall Study||35
9021137|NCT03106337|10083756|FG000|COMPLETED|Overall Study||35
9021138|NCT03106337|10083756|FG000|NOT COMPLETED|Overall Study||0
9021139|NCT03106636|10083763|FG000|STARTED|Overall Study||226
9021140|NCT03106636|10083764|FG001|STARTED|Overall Study||190
9021141|NCT03106636|10083763|FG000|COMPLETED|Overall Study||182
9021142|NCT03106636|10083764|FG001|COMPLETED|Overall Study||164
9021143|NCT03106636|10083763|FG000|NOT COMPLETED|Overall Study||44
9021144|NCT03106636|10083764|FG001|NOT COMPLETED|Overall Study||26
9021145|NCT03106753|10083772|FG000|STARTED|Overall Study||17
9021146|NCT03106753|10083773|FG001|STARTED|Overall Study||17
9021147|NCT03106753|10083772|FG000|COMPLETED|Overall Study||17
9021148|NCT03106753|10083773|FG001|COMPLETED|Overall Study||16
9021149|NCT03106753|10083772|FG000|NOT COMPLETED|Overall Study||0
9021150|NCT03106753|10083773|FG001|NOT COMPLETED|Overall Study||1
9021151|NCT03106844|10083781|FG000|STARTED|Overall Study||50
9021152|NCT03106844|10083781|FG000|COMPLETED|Overall Study||49
9021153|NCT03106844|10083781|FG000|NOT COMPLETED|Overall Study||1
9021154|NCT03106870|10083787|FG000|STARTED|Overall Study||31
9021155|NCT03106870|10083788|FG001|STARTED|Overall Study||31
9021156|NCT03106870|10083787|FG000|COMPLETED|Overall Study||31
9021157|NCT03106870|10083788|FG001|COMPLETED|Overall Study||31
9021158|NCT03106870|10083787|FG000|NOT COMPLETED|Overall Study||0
9021159|NCT03106870|10083788|FG001|NOT COMPLETED|Overall Study||0
9021160|NCT03107026|10083797|FG000|STARTED|Overall Study||163
9021161|NCT03107026|10083798|FG001|STARTED|Overall Study||161
9021162|NCT03107026|10083799|FG002|STARTED|Overall Study||162
9021163|NCT03107026|10083797|FG000|COMPLETED|Overall Study||131
9021164|NCT03107026|10083798|FG001|COMPLETED|Overall Study||123
9021165|NCT03107026|10083799|FG002|COMPLETED|Overall Study||106
9021166|NCT03107026|10083797|FG000|NOT COMPLETED|Overall Study||32
9021167|NCT03107026|10083798|FG001|NOT COMPLETED|Overall Study||38
9021168|NCT03107026|10083799|FG002|NOT COMPLETED|Overall Study||56
9021169|NCT03107052|10083810|FG000|STARTED|Overall Study||145
9021170|NCT03107052|10083811|FG001|STARTED|Overall Study||60
9021171|NCT03107052|10083812|FG002|STARTED|Overall Study||70
9021172|NCT03107052|10083810|FG000|Safety Analysis Set|Overall Study|1 participant assigned to 225 mg monthly arm but received 675 mg quarterly after >12 weeks remission|144
9021173|NCT03107052|10083811|FG001|Safety Analysis Set|Overall Study||60
9021174|NCT03107052|10083812|FG002|Safety Analysis Set|Overall Study|1 participant assigned to 225 mg monthly arm but received 675 mg quarterly after >12 weeks remission|71
9021175|NCT03107052|10083810|FG000|COMPLETED|Overall Study||26
9021176|NCT03107052|10083811|FG001|COMPLETED|Overall Study||14
9021177|NCT03107052|10083812|FG002|COMPLETED|Overall Study||29
9021178|NCT03107052|10083810|FG000|NOT COMPLETED|Overall Study||119
9021179|NCT03107052|10083811|FG001|NOT COMPLETED|Overall Study||46
9021180|NCT03107052|10083812|FG002|NOT COMPLETED|Overall Study||41
9021181|NCT03107091|10083820|FG000|STARTED|Overall Study||6
9021182|NCT03107091|10083820|FG000|COMPLETED|Overall Study||5
9021183|NCT03107091|10083820|FG000|NOT COMPLETED|Overall Study||1
9021184|NCT03107377|10083827|FG000|STARTED|Overall Study||426
9021185|NCT03107377|10083828|FG001|STARTED|Overall Study||434
9021186|NCT03107377|10083827|FG000|COMPLETED|Overall Study||335
9021187|NCT03107377|10083828|FG001|COMPLETED|Overall Study||335
9021188|NCT03107377|10083827|FG000|NOT COMPLETED|Overall Study||91
9021189|NCT03107377|10083828|FG001|NOT COMPLETED|Overall Study||99
9021190|NCT03107715|10083836|FG000|STARTED|Overall Study||132
9021191|NCT03107715|10083837|FG001|STARTED|Overall Study||111
8640015|NCT00583908|9680406|FG009|NOT COMPLETED|Period 2 - Second Intervention||0
8640016|NCT00583908|9680407|FG010|NOT COMPLETED|Period 2 - Second Intervention||0
8640017|NCT00583908|9680408|FG011|NOT COMPLETED|Period 2 - Second Intervention||0
8640018|NCT00583908|9680397|FG000|STARTED|Period 3 - Third Intervention||1
8640019|NCT00583908|9680398|FG001|STARTED|Period 3 - Third Intervention||2
8640020|NCT00583908|9680399|FG002|STARTED|Period 3 - Third Intervention||1
8640021|NCT00583908|9680400|FG003|STARTED|Period 3 - Third Intervention||1
8640022|NCT00583908|9680401|FG004|STARTED|Period 3 - Third Intervention||2
8640023|NCT00583908|9680402|FG005|STARTED|Period 3 - Third Intervention||1
8640024|NCT00583908|9680403|FG006|STARTED|Period 3 - Third Intervention||1
8640025|NCT00583908|9680404|FG007|STARTED|Period 3 - Third Intervention||1
8640026|NCT00583908|9680405|FG008|STARTED|Period 3 - Third Intervention||1
8640027|NCT00583908|9680406|FG009|STARTED|Period 3 - Third Intervention||1
8640028|NCT00583908|9680407|FG010|STARTED|Period 3 - Third Intervention||1
8640029|NCT00583908|9680408|FG011|STARTED|Period 3 - Third Intervention||1
8640030|NCT00583908|9680397|FG000|COMPLETED|Period 3 - Third Intervention||1
8640031|NCT00583908|9680398|FG001|COMPLETED|Period 3 - Third Intervention||2
8640032|NCT00583908|9680399|FG002|COMPLETED|Period 3 - Third Intervention||1
8640033|NCT00583908|9680400|FG003|COMPLETED|Period 3 - Third Intervention||1
8640034|NCT00583908|9680401|FG004|COMPLETED|Period 3 - Third Intervention||2
8640035|NCT00583908|9680402|FG005|COMPLETED|Period 3 - Third Intervention||1
8640036|NCT00583908|9680403|FG006|COMPLETED|Period 3 - Third Intervention||1
8640037|NCT00583908|9680404|FG007|COMPLETED|Period 3 - Third Intervention||1
8640038|NCT00583908|9680405|FG008|COMPLETED|Period 3 - Third Intervention||1
8640039|NCT00583908|9680406|FG009|COMPLETED|Period 3 - Third Intervention||1
8640040|NCT00583908|9680407|FG010|COMPLETED|Period 3 - Third Intervention||1
8640041|NCT00583908|9680408|FG011|COMPLETED|Period 3 - Third Intervention||1
8640042|NCT00583908|9680397|FG000|NOT COMPLETED|Period 3 - Third Intervention||0
8640043|NCT00583908|9680398|FG001|NOT COMPLETED|Period 3 - Third Intervention||0
8640044|NCT00583908|9680399|FG002|NOT COMPLETED|Period 3 - Third Intervention||0
8640045|NCT00583908|9680400|FG003|NOT COMPLETED|Period 3 - Third Intervention||0
8640046|NCT00583908|9680401|FG004|NOT COMPLETED|Period 3 - Third Intervention||0
8640047|NCT00583908|9680402|FG005|NOT COMPLETED|Period 3 - Third Intervention||0
8640048|NCT00583908|9680403|FG006|NOT COMPLETED|Period 3 - Third Intervention||0
8640049|NCT00583908|9680404|FG007|NOT COMPLETED|Period 3 - Third Intervention||0
8640050|NCT00583908|9680405|FG008|NOT COMPLETED|Period 3 - Third Intervention||0
8640051|NCT00583908|9680406|FG009|NOT COMPLETED|Period 3 - Third Intervention||0
8640052|NCT00583908|9680407|FG010|NOT COMPLETED|Period 3 - Third Intervention||0
8640053|NCT00583908|9680408|FG011|NOT COMPLETED|Period 3 - Third Intervention||0
8640054|NCT00583908|9680397|FG000|STARTED|Period 4 - Fourth Intervention||1
8640055|NCT00583908|9680398|FG001|STARTED|Period 4 - Fourth Intervention||2
8640056|NCT00583908|9680399|FG002|STARTED|Period 4 - Fourth Intervention||1
9021192|NCT03107715|10083836|FG000|COMPLETED|Overall Study||128
9021193|NCT03107715|10083837|FG001|COMPLETED|Overall Study||104
9021194|NCT03107715|10083836|FG000|NOT COMPLETED|Overall Study||4
9021195|NCT03107715|10083837|FG001|NOT COMPLETED|Overall Study||7
9021196|NCT03107754|10083845|FG000|STARTED|Overall Study||48
9021197|NCT03107754|10083846|FG001|STARTED|Overall Study||50
9021198|NCT03107754|10083845|FG000|COMPLETED|Overall Study||48
9021199|NCT03107754|10083846|FG001|COMPLETED|Overall Study||50
9021200|NCT03107754|10083845|FG000|NOT COMPLETED|Overall Study||0
9021201|NCT03107754|10083846|FG001|NOT COMPLETED|Overall Study||0
9021202|NCT03107793|10083852|FG000|STARTED|Induction Period (16 Weeks)||500
9021203|NCT03107793|10083853|FG001|STARTED|Induction Period (16 Weeks)||0
9021204|NCT03107793|10083854|FG002|STARTED|Induction Period (16 Weeks)||0
9021205|NCT03107793|10083852|FG000|COMPLETED|Induction Period (16 Weeks)||490
9021206|NCT03107793|10083853|FG001|COMPLETED|Induction Period (16 Weeks)||0
9021207|NCT03107793|10083854|FG002|COMPLETED|Induction Period (16 Weeks)||0
9021208|NCT03107793|10083852|FG000|NOT COMPLETED|Induction Period (16 Weeks)||10
9021209|NCT03107793|10083853|FG001|NOT COMPLETED|Induction Period (16 Weeks)||0
9021210|NCT03107793|10083854|FG002|NOT COMPLETED|Induction Period (16 Weeks)||0
9021211|NCT03107793|10083852|FG000|STARTED|Maintenance Period (16-48 Week)||0
9021212|NCT03107793|10083853|FG001|STARTED|Maintenance Period (16-48 Week)||220
9021213|NCT03107793|10083854|FG002|STARTED|Maintenance Period (16-48 Week)||221
9021214|NCT03107793|10083852|FG000|COMPLETED|Maintenance Period (16-48 Week)||0
9021215|NCT03107793|10083853|FG001|COMPLETED|Maintenance Period (16-48 Week)||174
9021216|NCT03107793|10083854|FG002|COMPLETED|Maintenance Period (16-48 Week)||193
9021217|NCT03107793|10083852|FG000|NOT COMPLETED|Maintenance Period (16-48 Week)||0
9021218|NCT03107793|10083853|FG001|NOT COMPLETED|Maintenance Period (16-48 Week)||46
9021219|NCT03107793|10083854|FG002|NOT COMPLETED|Maintenance Period (16-48 Week)||28
9021220|NCT03108027|10083861|FG000|STARTED|Period 1||7
9021221|NCT03108027|10083862|FG001|STARTED|Period 1||6
9021222|NCT03108027|10083863|FG002|STARTED|Period 1||6
9021223|NCT03108027|10083864|FG003|STARTED|Period 1||6
9021224|NCT03108027|10083865|FG004|STARTED|Period 1||6
9021225|NCT03108027|10083866|FG005|STARTED|Period 1||6
9021226|NCT03108027|10083861|FG000|COMPLETED|Period 1||7
9021227|NCT03108027|10083862|FG001|COMPLETED|Period 1||6
9021228|NCT03108027|10083863|FG002|COMPLETED|Period 1||6
9021229|NCT03108027|10083864|FG003|COMPLETED|Period 1||4
9021230|NCT03108027|10083865|FG004|COMPLETED|Period 1||6
9021231|NCT03108027|10083866|FG005|COMPLETED|Period 1||6
9021232|NCT03108027|10083861|FG000|NOT COMPLETED|Period 1||0
9021233|NCT03108027|10083862|FG001|NOT COMPLETED|Period 1||0
9021234|NCT03108027|10083863|FG002|NOT COMPLETED|Period 1||0
9021235|NCT03108027|10083864|FG003|NOT COMPLETED|Period 1||2
9021236|NCT03108027|10083865|FG004|NOT COMPLETED|Period 1||0
9021237|NCT03108027|10083866|FG005|NOT COMPLETED|Period 1||0
9021238|NCT03108027|10083861|FG000|STARTED|Period 2||7
9021239|NCT03108027|10083862|FG001|STARTED|Period 2||6
9021240|NCT03108027|10083863|FG002|STARTED|Period 2||6
9021241|NCT03108027|10083864|FG003|STARTED|Period 2||4
9021242|NCT03108027|10083865|FG004|STARTED|Period 2||6
9021243|NCT03108027|10083866|FG005|STARTED|Period 2||6
9021244|NCT03108027|10083861|FG000|COMPLETED|Period 2||7
9021245|NCT03108027|10083862|FG001|COMPLETED|Period 2||6
9021246|NCT03108027|10083863|FG002|COMPLETED|Period 2||6
9021247|NCT03108027|10083864|FG003|COMPLETED|Period 2||4
9021248|NCT03108027|10083865|FG004|COMPLETED|Period 2||6
9021249|NCT03108027|10083866|FG005|COMPLETED|Period 2||6
9021250|NCT03108027|10083861|FG000|NOT COMPLETED|Period 2||0
9021251|NCT03108027|10083862|FG001|NOT COMPLETED|Period 2||0
9021252|NCT03108027|10083863|FG002|NOT COMPLETED|Period 2||0
9021253|NCT03108027|10083864|FG003|NOT COMPLETED|Period 2||0
9021254|NCT03108027|10083865|FG004|NOT COMPLETED|Period 2||0
9021255|NCT03108027|10083866|FG005|NOT COMPLETED|Period 2||0
8640057|NCT00583908|9680400|FG003|STARTED|Period 4 - Fourth Intervention||1
8640058|NCT00583908|9680401|FG004|STARTED|Period 4 - Fourth Intervention||2
8640059|NCT00583908|9680402|FG005|STARTED|Period 4 - Fourth Intervention||1
8640060|NCT00583908|9680403|FG006|STARTED|Period 4 - Fourth Intervention||1
8640061|NCT00583908|9680404|FG007|STARTED|Period 4 - Fourth Intervention||1
8640062|NCT00583908|9680405|FG008|STARTED|Period 4 - Fourth Intervention||1
8640063|NCT00583908|9680406|FG009|STARTED|Period 4 - Fourth Intervention||1
8640064|NCT00583908|9680407|FG010|STARTED|Period 4 - Fourth Intervention||1
8640065|NCT00583908|9680408|FG011|STARTED|Period 4 - Fourth Intervention||1
8640066|NCT00583908|9680397|FG000|COMPLETED|Period 4 - Fourth Intervention||1
8640067|NCT00583908|9680398|FG001|COMPLETED|Period 4 - Fourth Intervention||2
8640068|NCT00583908|9680399|FG002|COMPLETED|Period 4 - Fourth Intervention||1
8640069|NCT00583908|9680400|FG003|COMPLETED|Period 4 - Fourth Intervention||1
9021256|NCT03108027|10083861|FG000|STARTED|Period 3||7
9021257|NCT03108027|10083862|FG001|STARTED|Period 3||6
9021258|NCT03108027|10083863|FG002|STARTED|Period 3||6
9021259|NCT03108027|10083864|FG003|STARTED|Period 3||4
9021260|NCT03108027|10083865|FG004|STARTED|Period 3||6
9021261|NCT03108027|10083866|FG005|STARTED|Period 3||6
9021262|NCT03108027|10083861|FG000|COMPLETED|Period 3||7
9021263|NCT03108027|10083862|FG001|COMPLETED|Period 3||5
9021264|NCT03108027|10083863|FG002|COMPLETED|Period 3||6
9021265|NCT03108027|10083864|FG003|COMPLETED|Period 3||4
9021266|NCT03108027|10083865|FG004|COMPLETED|Period 3||6
9021267|NCT03108027|10083866|FG005|COMPLETED|Period 3||6
9021268|NCT03108027|10083861|FG000|NOT COMPLETED|Period 3||0
9021269|NCT03108027|10083862|FG001|NOT COMPLETED|Period 3||1
9021270|NCT03108027|10083863|FG002|NOT COMPLETED|Period 3||0
9021271|NCT03108027|10083864|FG003|NOT COMPLETED|Period 3||0
9021272|NCT03108027|10083865|FG004|NOT COMPLETED|Period 3||0
9021273|NCT03108027|10083866|FG005|NOT COMPLETED|Period 3||0
9021274|NCT03108157|10083876|FG000|STARTED|Overall Study||176
9021275|NCT03108157|10083877|FG001|STARTED|Overall Study||176
9021276|NCT03108157|10083876|FG000|COMPLETED|Overall Study||161
9021277|NCT03108157|10083877|FG001|COMPLETED|Overall Study||172
9021278|NCT03108157|10083876|FG000|NOT COMPLETED|Overall Study||15
9021279|NCT03108157|10083877|FG001|NOT COMPLETED|Overall Study||4
9021280|NCT03108469|10083886|FG000|STARTED|Overall Study||15
9021281|NCT03108469|10083887|FG001|STARTED|Overall Study||15
9021282|NCT03108469|10083886|FG000|COMPLETED|Overall Study||11
9021283|NCT03108469|10083887|FG001|COMPLETED|Overall Study||11
9021284|NCT03108469|10083886|FG000|NOT COMPLETED|Overall Study||4
9021285|NCT03108469|10083887|FG001|NOT COMPLETED|Overall Study||4
9021286|NCT03108482|10083897|FG000|STARTED|Overall Study||183
9021287|NCT03108482|10083898|FG001|STARTED|Overall Study||183
9021288|NCT03108482|10083899|FG002|STARTED|Overall Study||182
9021289|NCT03108482|10083900|FG003|STARTED|Overall Study||89
9021290|NCT03108482|10083897|FG000|COMPLETED|Overall Study||183
9021291|NCT03108482|10083898|FG001|COMPLETED|Overall Study||179
9021292|NCT03108482|10083899|FG002|COMPLETED|Overall Study||180
9021293|NCT03108482|10083900|FG003|COMPLETED|Overall Study||86
9021294|NCT03108482|10083897|FG000|NOT COMPLETED|Overall Study||0
9021295|NCT03108482|10083898|FG001|NOT COMPLETED|Overall Study||4
9021296|NCT03108482|10083899|FG002|NOT COMPLETED|Overall Study||2
9021297|NCT03108482|10083900|FG003|NOT COMPLETED|Overall Study||3
9021298|NCT03108521|10083912|FG000|STARTED|Overall Study||83
9021299|NCT03108521|10083913|FG001|STARTED|Overall Study||36
9021300|NCT03108521|10083912|FG000|COMPLETED|Overall Study||71
9021301|NCT03108521|10083913|FG001|COMPLETED|Overall Study||36
9021302|NCT03108521|10083912|FG000|NOT COMPLETED|Overall Study||12
9021303|NCT03108521|10083913|FG001|NOT COMPLETED|Overall Study||0
9021304|NCT03108924|10083927|FG000|STARTED|Overall Study||6
9021305|NCT03108924|10083928|FG001|STARTED|Overall Study||6
9021306|NCT03108924|10083929|FG002|STARTED|Overall Study||6
9021307|NCT03108924|10083930|FG003|STARTED|Overall Study||6
9021308|NCT03108924|10083927|FG000|COMPLETED|Overall Study||6
9021309|NCT03108924|10083928|FG001|COMPLETED|Overall Study||6
9021310|NCT03108924|10083929|FG002|COMPLETED|Overall Study||6
9021311|NCT03108924|10083930|FG003|COMPLETED|Overall Study||6
9021312|NCT03108924|10083927|FG000|NOT COMPLETED|Overall Study||0
9021313|NCT03108924|10083928|FG001|NOT COMPLETED|Overall Study||0
9021314|NCT03108924|10083929|FG002|NOT COMPLETED|Overall Study||0
9021315|NCT03108924|10083930|FG003|NOT COMPLETED|Overall Study||0
9021316|NCT03109015|10083951|FG000|STARTED|Overall Study||4
9021317|NCT03109015|10083952|FG001|STARTED|Overall Study||3
9021318|NCT03109015|10083951|FG000|COMPLETED|Overall Study||4
9021319|NCT03109015|10083952|FG001|COMPLETED|Overall Study||3
9021320|NCT03109015|10083951|FG000|NOT COMPLETED|Overall Study||0
9021321|NCT03109015|10083952|FG001|NOT COMPLETED|Overall Study||0
9021322|NCT03109184|10083960|FG000|STARTED|Overall Study||60
9021323|NCT03109184|10083961|FG001|STARTED|Overall Study||59
9021324|NCT03109184|10083960|FG000|COMPLETED|Overall Study||53
9021325|NCT03109184|10083961|FG001|COMPLETED|Overall Study||52
9021326|NCT03109184|10083960|FG000|NOT COMPLETED|Overall Study||7
9021327|NCT03109184|10083961|FG001|NOT COMPLETED|Overall Study||7
9021328|NCT03109769|10083969|FG000|STARTED|Overall Study||22
9021329|NCT03109769|10083970|FG001|STARTED|Overall Study||22
9021330|NCT03109769|10083969|FG000|COMPLETED|Overall Study||22
9021331|NCT03109769|10083970|FG001|COMPLETED|Overall Study||22
9021332|NCT03109769|10083969|FG000|NOT COMPLETED|Overall Study||0
9021333|NCT03109769|10083970|FG001|NOT COMPLETED|Overall Study||0
9021334|NCT03109951|10083976|FG000|STARTED|Overall Study||187
9021335|NCT03109951|10083976|FG000|COMPLETED|Overall Study||187
9021336|NCT03109951|10083976|FG000|NOT COMPLETED|Overall Study||0
9021337|NCT03110003|10083982|FG000|STARTED|Overall Study||21
9021338|NCT03110003|10083983|FG001|STARTED|Overall Study||24
9021339|NCT03110003|10083982|FG000|COMPLETED|Overall Study||21
9021340|NCT03110003|10083983|FG001|COMPLETED|Overall Study||24
9021341|NCT03110003|10083982|FG000|NOT COMPLETED|Overall Study||0
9021342|NCT03110003|10083983|FG001|NOT COMPLETED|Overall Study||0
9021343|NCT03110029|10083991|FG000|STARTED|Overall Study||7
9021344|NCT03110029|10083992|FG001|STARTED|Overall Study||6
9021345|NCT03110029|10083991|FG000|COMPLETED|Overall Study||6
9021346|NCT03110029|10083992|FG001|COMPLETED|Overall Study||5
9021347|NCT03110029|10083991|FG000|NOT COMPLETED|Overall Study||1
9021348|NCT03110029|10083992|FG001|NOT COMPLETED|Overall Study||1
9021349|NCT03110185|10084000|FG000|STARTED|Overall Study||27
9021350|NCT03110185|10084001|FG001|STARTED|Overall Study||64
9021351|NCT03110185|10084000|FG000|COMPLETED|Overall Study||17
9021352|NCT03110185|10084001|FG001|COMPLETED|Overall Study||33
9021353|NCT03110185|10084000|FG000|NOT COMPLETED|Overall Study||10
9021354|NCT03110185|10084001|FG001|NOT COMPLETED|Overall Study||31
9021355|NCT03110458|10084013|FG000|STARTED|Overall Study||37
9021356|NCT03110458|10084014|FG001|STARTED|Overall Study||36
9021357|NCT03110458|10084015|FG002|STARTED|Overall Study||34
9021358|NCT03110458|10084013|FG000|COMPLETED|Overall Study||31
9021359|NCT03110458|10084014|FG001|COMPLETED|Overall Study||32
9021360|NCT03110458|10084015|FG002|COMPLETED|Overall Study||31
9021361|NCT03110458|10084013|FG000|NOT COMPLETED|Overall Study||6
9021362|NCT03110458|10084014|FG001|NOT COMPLETED|Overall Study||4
9021363|NCT03110458|10084015|FG002|NOT COMPLETED|Overall Study||3
9021364|NCT03110471|10084025|FG000|STARTED|Overall Study||30
9021365|NCT03110471|10084026|FG001|STARTED|Overall Study||30
9021366|NCT03110471|10084025|FG000|COMPLETED|Overall Study||30
9021367|NCT03110471|10084026|FG001|COMPLETED|Overall Study||30
9021368|NCT03110471|10084025|FG000|NOT COMPLETED|Overall Study||0
9021369|NCT03110471|10084026|FG001|NOT COMPLETED|Overall Study||0
9021370|NCT03110562|10084032|FG000|STARTED|Overall Study||195
9021371|NCT03110562|10084033|FG001|STARTED|Overall Study||207
9021372|NCT03110562|10084032|FG000|Treated|Overall Study||195
9021373|NCT03110562|10084033|FG001|Treated|Overall Study||204
9021374|NCT03110562|10084032|FG000|COMPLETED|Overall Study||0
9021375|NCT03110562|10084033|FG001|COMPLETED|Overall Study||0
9021376|NCT03110562|10084032|FG000|NOT COMPLETED|Overall Study||195
9021377|NCT03110562|10084033|FG001|NOT COMPLETED|Overall Study||207
9021378|NCT03110601|10084039|FG000|STARTED|Conventional SCS Parameters||25
9021379|NCT03110601|10084039|FG000|COMPLETED|Conventional SCS Parameters||24
9021380|NCT03110601|10084039|FG000|NOT COMPLETED|Conventional SCS Parameters||1
9021381|NCT03110601|10084039|FG000|STARTED|Washout Period||24
9021382|NCT03110601|10084039|FG000|COMPLETED|Washout Period||23
9021383|NCT03110601|10084039|FG000|NOT COMPLETED|Washout Period||1
9021384|NCT03110601|10084039|FG000|STARTED|Stimgenics SCS Parameters||23
9021385|NCT03110601|10084039|FG000|COMPLETED|Stimgenics SCS Parameters||20
9021386|NCT03110601|10084039|FG000|NOT COMPLETED|Stimgenics SCS Parameters||3
9021387|NCT03110692|10084048|FG000|STARTED|Overall Study||679
9021388|NCT03110692|10084049|FG001|STARTED|Overall Study||509
9021389|NCT03110692|10084048|FG000|COMPLETED|Overall Study||679
9021390|NCT03110692|10084049|FG001|COMPLETED|Overall Study||509
9021391|NCT03110692|10084048|FG000|NOT COMPLETED|Overall Study||0
9021392|NCT03110692|10084049|FG001|NOT COMPLETED|Overall Study||0
9021393|NCT03110770|10084060|FG000|STARTED|Overall Study||30
9021394|NCT03110770|10084061|FG001|STARTED|Overall Study||30
9021395|NCT03110770|10084062|FG002|STARTED|Overall Study||30
9021396|NCT03110770|10084063|FG003|STARTED|Overall Study||1170
9021397|NCT03110770|10084064|FG004|STARTED|Overall Study||1168
9021398|NCT03110770|10084060|FG000|Received First Product Administration|Overall Study||30
9021399|NCT03110770|10084061|FG001|Received First Product Administration|Overall Study||30
9021400|NCT03110770|10084062|FG002|Received First Product Administration|Overall Study||30
9021401|NCT03110770|10084063|FG003|Received First Product Administration|Overall Study||1162
9021402|NCT03110770|10084064|FG004|Received First Product Administration|Overall Study||1161
9021403|NCT03110770|10084060|FG000|Received Second Product Administration|Overall Study||30
9021404|NCT03110770|10084061|FG001|Received Second Product Administration|Overall Study||29
9021405|NCT03110770|10084062|FG002|Received Second Product Administration|Overall Study||29
9021406|NCT03110770|10084063|FG003|Received Second Product Administration|Overall Study||1126
9021407|NCT03110770|10084064|FG004|Received Second Product Administration|Overall Study||1127
9021408|NCT03110770|10084060|FG000|Received Third Product Administration|Overall Study||29
9021409|NCT03110770|10084061|FG001|Received Third Product Administration|Overall Study||27
8640070|NCT00583908|9680401|FG004|COMPLETED|Period 4 - Fourth Intervention||2
8640071|NCT00583908|9680402|FG005|COMPLETED|Period 4 - Fourth Intervention||1
8640072|NCT00583908|9680403|FG006|COMPLETED|Period 4 - Fourth Intervention||1
8640073|NCT00583908|9680404|FG007|COMPLETED|Period 4 - Fourth Intervention||1
8640074|NCT00583908|9680405|FG008|COMPLETED|Period 4 - Fourth Intervention||1
8640075|NCT00583908|9680406|FG009|COMPLETED|Period 4 - Fourth Intervention||1
8640076|NCT00583908|9680407|FG010|COMPLETED|Period 4 - Fourth Intervention||1
8640077|NCT00583908|9680408|FG011|COMPLETED|Period 4 - Fourth Intervention||1
8640078|NCT00583908|9680397|FG000|NOT COMPLETED|Period 4 - Fourth Intervention||0
8640079|NCT00583908|9680398|FG001|NOT COMPLETED|Period 4 - Fourth Intervention||0
8640080|NCT00583908|9680399|FG002|NOT COMPLETED|Period 4 - Fourth Intervention||0
8640081|NCT00583908|9680400|FG003|NOT COMPLETED|Period 4 - Fourth Intervention||0
8640082|NCT00583908|9680401|FG004|NOT COMPLETED|Period 4 - Fourth Intervention||0
8640083|NCT00583908|9680402|FG005|NOT COMPLETED|Period 4 - Fourth Intervention||0
8640084|NCT00583908|9680403|FG006|NOT COMPLETED|Period 4 - Fourth Intervention||0
8640085|NCT00583908|9680404|FG007|NOT COMPLETED|Period 4 - Fourth Intervention||0
8640086|NCT00583908|9680405|FG008|NOT COMPLETED|Period 4 - Fourth Intervention||0
8640087|NCT00583908|9680406|FG009|NOT COMPLETED|Period 4 - Fourth Intervention||0
8640088|NCT00583908|9680407|FG010|NOT COMPLETED|Period 4 - Fourth Intervention||0
8640089|NCT00583908|9680408|FG011|NOT COMPLETED|Period 4 - Fourth Intervention||0
8640090|NCT00583947|9680428|FG000|STARTED|Cross-over Period|Participants were stratified by age group at randomization: ages 2-5 yrs and 6-11 years|27
8640091|NCT00583947|9680429|FG001|STARTED|Cross-over Period|Participants were stratified by age group at randomization: ages 2-5 yrs and 6-11 years|26
8640092|NCT00583947|9680428|FG000|COMPLETED|Cross-over Period||22
8640093|NCT00583947|9680429|FG001|COMPLETED|Cross-over Period||24
8640094|NCT00583947|9680428|FG000|NOT COMPLETED|Cross-over Period||5
8640095|NCT00583947|9680429|FG001|NOT COMPLETED|Cross-over Period||2
8640096|NCT00583947|9680428|FG000|STARTED|Washout||22
8640097|NCT00583947|9680429|FG001|STARTED|Washout||24
8640098|NCT00583947|9680428|FG000|COMPLETED|Washout||22
8640099|NCT00583947|9680429|FG001|COMPLETED|Washout||24
8640100|NCT00583947|9680428|FG000|NOT COMPLETED|Washout||0
8640101|NCT00583947|9680429|FG001|NOT COMPLETED|Washout||0
8640102|NCT00583947|9680428|FG000|STARTED|Open Label Period|3 subjects were dosed with arformoterol 7.5 microgram in error|22
9021410|NCT03110770|10084062|FG002|Received Third Product Administration|Overall Study||28
9021411|NCT03110770|10084063|FG003|Received Third Product Administration|Overall Study||1107
8640103|NCT00583947|9680429|FG001|STARTED|Open Label Period|3 subjects were dosed with arformoterol 7.5 microgram in error|24
8640104|NCT00583947|9680428|FG000|COMPLETED|Open Label Period||22
9021412|NCT03110770|10084064|FG004|Received Third Product Administration|Overall Study||1107
9021413|NCT03110770|10084060|FG000|COMPLETED|Overall Study||24
9021414|NCT03110770|10084061|FG001|COMPLETED|Overall Study||30
9021415|NCT03110770|10084062|FG002|COMPLETED|Overall Study||28
9021416|NCT03110770|10084063|FG003|COMPLETED|Overall Study||1037
9021417|NCT03110770|10084064|FG004|COMPLETED|Overall Study||1045
9021418|NCT03110770|10084060|FG000|NOT COMPLETED|Overall Study||6
9021419|NCT03110770|10084061|FG001|NOT COMPLETED|Overall Study||0
9021420|NCT03110770|10084062|FG002|NOT COMPLETED|Overall Study||2
9021421|NCT03110770|10084063|FG003|NOT COMPLETED|Overall Study||133
9021422|NCT03110770|10084064|FG004|NOT COMPLETED|Overall Study||123
9021423|NCT03111108|10084080|FG000|STARTED|Overall Study||53
9021424|NCT03111108|10084081|FG001|STARTED|Overall Study||64
9021425|NCT03111108|10084080|FG000|COMPLETED|Overall Study||52
8640105|NCT00583947|9680429|FG001|COMPLETED|Open Label Period||24
8640106|NCT00583947|9680428|FG000|NOT COMPLETED|Open Label Period||0
8640107|NCT00583947|9680429|FG001|NOT COMPLETED|Open Label Period||0
8640108|NCT00584077|9680437|FG000|STARTED|Overall Study||15
8640109|NCT00584077|9680437|FG000|COMPLETED|Overall Study||15
8640110|NCT00584077|9680437|FG000|NOT COMPLETED|Overall Study||0
8640111|NCT00584194|9680442|FG000|STARTED|Overall Study||278
8640112|NCT00584194|9680442|FG000|COMPLETED|Overall Study||143
8640113|NCT00584194|9680442|FG000|NOT COMPLETED|Overall Study||135
8640114|NCT00584220|9680446|FG000|STARTED|First Period||48
8640115|NCT00584220|9680447|FG001|STARTED|First Period||39
8640116|NCT00584220|9680446|FG000|COMPLETED|First Period||48
8640117|NCT00584220|9680447|FG001|COMPLETED|First Period||39
8640118|NCT00584220|9680446|FG000|NOT COMPLETED|First Period||0
8640119|NCT00584220|9680447|FG001|NOT COMPLETED|First Period||0
8640120|NCT00584220|9680446|FG000|STARTED|Second Period||48
8640121|NCT00584220|9680447|FG001|STARTED|Second Period||39
8640122|NCT00584220|9680446|FG000|COMPLETED|Second Period||48
8640123|NCT00584220|9680447|FG001|COMPLETED|Second Period||39
8640124|NCT00584220|9680446|FG000|NOT COMPLETED|Second Period||0
8640125|NCT00584220|9680447|FG001|NOT COMPLETED|Second Period||0
8640126|NCT00584285|9680453|FG000|STARTED|Overall Study||18
8640127|NCT00584285|9680453|FG000|COMPLETED|Overall Study||18
8640128|NCT00584285|9680453|FG000|NOT COMPLETED|Overall Study||0
8640129|NCT00584402|9680457|FG000|STARTED|Overall Study||8
8640130|NCT00584402|9680457|FG000|COMPLETED|Overall Study||8
8640131|NCT00584402|9680457|FG000|NOT COMPLETED|Overall Study||0
8640132|NCT00584415|9680461|FG000|STARTED|Overall Study|A total of 119 enrolled and 112 underwent the ablation procedure;|119
8640133|NCT00584415|9680461|FG000|COMPLETED|Overall Study||112
8640134|NCT00584415|9680461|FG000|NOT COMPLETED|Overall Study||7
8640135|NCT00584454|9680466|FG000|STARTED|Overall Study||10
8640136|NCT00584454|9680466|FG000|COMPLETED|Overall Study||6
8640137|NCT00584454|9680466|FG000|NOT COMPLETED|Overall Study||4
8640138|NCT00584480|9680470|FG000|STARTED|First 8 Weeks (40 Treatments)||10
8640139|NCT00584480|9680470|FG000|COMPLETED|First 8 Weeks (40 Treatments)||10
8640140|NCT00584480|9680470|FG000|NOT COMPLETED|First 8 Weeks (40 Treatments)||0
8640141|NCT00584480|9680470|FG000|STARTED|4-Week Break From Treatment||10
8640142|NCT00584480|9680470|FG000|COMPLETED|4-Week Break From Treatment||10
8640143|NCT00584480|9680470|FG000|NOT COMPLETED|4-Week Break From Treatment||0
8640144|NCT00584480|9680470|FG000|STARTED|Second 8 Weeks (40 Treatments)||10
8640145|NCT00584480|9680470|FG000|COMPLETED|Second 8 Weeks (40 Treatments)||10
8640146|NCT00584480|9680470|FG000|NOT COMPLETED|Second 8 Weeks (40 Treatments)||0
8640147|NCT00584558|9680474|FG000|STARTED|Overall Study||2420
8640148|NCT00584558|9680474|FG000|COMPLETED|Overall Study||2420
8640149|NCT00584558|9680474|FG000|NOT COMPLETED|Overall Study||0
8640150|NCT00584701|9680479|FG000|STARTED|Active Risperidone||49
8640151|NCT00584701|9680479|FG000|COMPLETED|Active Risperidone||46
8640152|NCT00584701|9680479|FG000|NOT COMPLETED|Active Risperidone||3
8640153|NCT00584701|9680479|FG000|STARTED|Follow-up||46
8640154|NCT00584701|9680479|FG000|COMPLETED|Follow-up||34
8640155|NCT00584701|9680479|FG000|NOT COMPLETED|Follow-up||12
8640156|NCT00584727|9680484|FG000|STARTED|First Intervention||17
8640157|NCT00584727|9680485|FG001|STARTED|First Intervention||17
8640158|NCT00584727|9680486|FG002|STARTED|First Intervention||16
8640159|NCT00584727|9680487|FG003|STARTED|First Intervention||14
8640160|NCT00584727|9680488|FG004|STARTED|First Intervention||16
8640161|NCT00584727|9680489|FG005|STARTED|First Intervention||16
8640162|NCT00584727|9680484|FG000|COMPLETED|First Intervention||17
8640163|NCT00584727|9680485|FG001|COMPLETED|First Intervention||17
8640164|NCT00584727|9680486|FG002|COMPLETED|First Intervention||15
8640165|NCT00584727|9680487|FG003|COMPLETED|First Intervention||14
8640166|NCT00584727|9680488|FG004|COMPLETED|First Intervention||16
8640167|NCT00584727|9680489|FG005|COMPLETED|First Intervention||16
8640168|NCT00584727|9680484|FG000|NOT COMPLETED|First Intervention||0
8640169|NCT00584727|9680485|FG001|NOT COMPLETED|First Intervention||0
8640170|NCT00584727|9680486|FG002|NOT COMPLETED|First Intervention||1
8640171|NCT00584727|9680487|FG003|NOT COMPLETED|First Intervention||0
9021426|NCT03111108|10084081|FG001|COMPLETED|Overall Study||63
8640172|NCT00584727|9680488|FG004|NOT COMPLETED|First Intervention||0
8640173|NCT00584727|9680489|FG005|NOT COMPLETED|First Intervention||0
9021427|NCT03111108|10084080|FG000|NOT COMPLETED|Overall Study||1
8640174|NCT00584727|9680484|FG000|STARTED|Second Intervention||17
8640175|NCT00584727|9680485|FG001|STARTED|Second Intervention||17
8640176|NCT00584727|9680486|FG002|STARTED|Second Intervention||15
8640177|NCT00584727|9680487|FG003|STARTED|Second Intervention||14
9021428|NCT03111108|10084081|FG001|NOT COMPLETED|Overall Study||1
9021429|NCT03111316|10084091|FG000|STARTED|Overall Study||26
9021430|NCT03111316|10084092|FG001|STARTED|Overall Study||24
9021431|NCT03111316|10084093|FG002|STARTED|Overall Study||25
9021432|NCT03111316|10084094|FG003|STARTED|Overall Study||25
9021433|NCT03111316|10084091|FG000|COMPLETED|Overall Study||26
9021434|NCT03111316|10084092|FG001|COMPLETED|Overall Study||24
9021435|NCT03111316|10084093|FG002|COMPLETED|Overall Study||25
9021436|NCT03111316|10084094|FG003|COMPLETED|Overall Study||25
9021437|NCT03111316|10084091|FG000|NOT COMPLETED|Overall Study||0
9021438|NCT03111316|10084092|FG001|NOT COMPLETED|Overall Study||0
9021439|NCT03111316|10084093|FG002|NOT COMPLETED|Overall Study||0
9021440|NCT03111316|10084094|FG003|NOT COMPLETED|Overall Study||0
9021441|NCT03111381|10084106|FG000|STARTED|Overall Study||46
9021442|NCT03111381|10084107|FG001|STARTED|Overall Study||48
9021443|NCT03111381|10084106|FG000|COMPLETED|Overall Study||46
9021444|NCT03111381|10084107|FG001|COMPLETED|Overall Study||48
9021445|NCT03111381|10084106|FG000|NOT COMPLETED|Overall Study||0
9021446|NCT03111381|10084107|FG001|NOT COMPLETED|Overall Study||0
9021447|NCT03111407|10084115|FG000|STARTED|Overall Study||45
9021448|NCT03111407|10084116|FG001|STARTED|Overall Study||27
9021449|NCT03111407|10084115|FG000|COMPLETED|Overall Study||44
9021450|NCT03111407|10084116|FG001|COMPLETED|Overall Study||26
9021451|NCT03111407|10084115|FG000|NOT COMPLETED|Overall Study||1
9021452|NCT03111407|10084116|FG001|NOT COMPLETED|Overall Study||1
9021453|NCT03111550|10084126|FG000|STARTED|Overall Study|First eye|77
9021454|NCT03111550|10084127|FG001|STARTED|Overall Study|First eye|73
9021455|NCT03111550|10084128|FG002|STARTED|Overall Study|First eye|79
9021456|NCT03111550|10084126|FG000|COMPLETED|Overall Study||73
9021457|NCT03111550|10084127|FG001|COMPLETED|Overall Study||71
9021458|NCT03111550|10084128|FG002|COMPLETED|Overall Study||76
9021459|NCT03111550|10084126|FG000|NOT COMPLETED|Overall Study||4
9021460|NCT03111550|10084127|FG001|NOT COMPLETED|Overall Study||2
9021461|NCT03111550|10084128|FG002|NOT COMPLETED|Overall Study||3
9021462|NCT03111628|10084136|FG000|STARTED|Overall Study||18
9021463|NCT03111628|10084136|FG000|COMPLETED|Overall Study||18
9021464|NCT03111628|10084136|FG000|NOT COMPLETED|Overall Study||0
9021465|NCT03111940|10084143|FG000|STARTED|Overall Study||21
9021466|NCT03111940|10084144|FG001|STARTED|Overall Study||14
9021467|NCT03111940|10084143|FG000|COMPLETED|Overall Study||21
9021468|NCT03111940|10084144|FG001|COMPLETED|Overall Study||14
9021469|NCT03111940|10084143|FG000|NOT COMPLETED|Overall Study||0
9021470|NCT03111940|10084144|FG001|NOT COMPLETED|Overall Study||0
9021471|NCT03112473|10084156|FG000|STARTED|Overall Study||30
9021472|NCT03112473|10084157|FG001|STARTED|Overall Study||30
9021473|NCT03112473|10084158|FG002|STARTED|Overall Study||30
9021474|NCT03112473|10084159|FG003|STARTED|Overall Study||30
9021475|NCT03112473|10084156|FG000|COMPLETED|Overall Study||30
9021476|NCT03112473|10084157|FG001|COMPLETED|Overall Study||30
9021477|NCT03112473|10084158|FG002|COMPLETED|Overall Study||30
9021478|NCT03112473|10084159|FG003|COMPLETED|Overall Study||30
9021479|NCT03112473|10084156|FG000|NOT COMPLETED|Overall Study||0
9021480|NCT03112473|10084157|FG001|NOT COMPLETED|Overall Study||0
9021481|NCT03112473|10084158|FG002|NOT COMPLETED|Overall Study||0
9021482|NCT03112473|10084159|FG003|NOT COMPLETED|Overall Study||0
9021483|NCT03112863|10084174|FG000|STARTED|Overall Study||21
9021484|NCT03112863|10084175|FG001|STARTED|Overall Study||23
9021485|NCT03112863|10084174|FG000|COMPLETED|Overall Study||21
9021486|NCT03112863|10084175|FG001|COMPLETED|Overall Study||23
9021487|NCT03112863|10084174|FG000|NOT COMPLETED|Overall Study||0
8577606|NCT00159874|9610368|FG001|Treated|Overall Study||55
8911166|NCT02144077|9970206|FG001|COMPLETED|Overall Study||132
8911167|NCT02144077|9970205|FG000|NOT COMPLETED|Overall Study||10
8911168|NCT02144077|9970206|FG001|NOT COMPLETED|Overall Study||11
8911169|NCT02144220|9970212|FG000|STARTED|Overall Study||277
8911170|NCT02144220|9970212|FG000|COMPLETED|Overall Study||258
8911171|NCT02144220|9970212|FG000|NOT COMPLETED|Overall Study||19
8911172|NCT02144233|9970218|FG000|STARTED|Overall Study||39
8911173|NCT02144233|9970219|FG001|STARTED|Overall Study||38
8911174|NCT02144233|9970218|FG000|COMPLETED|Overall Study|The last participant was assessed at month 3 due to early study stop|39
8911175|NCT02144233|9970219|FG001|COMPLETED|Overall Study||38
8911176|NCT02144233|9970218|FG000|NOT COMPLETED|Overall Study||0
8911177|NCT02144233|9970219|FG001|NOT COMPLETED|Overall Study||0
8911178|NCT02144259|9970228|FG000|STARTED|Overall Study||33
8911179|NCT02144259|9970229|FG001|STARTED|Overall Study||33
8911180|NCT02144259|9970230|FG002|STARTED|Overall Study||34
8911181|NCT02144259|9970228|FG000|COMPLETED|Overall Study||23
8911182|NCT02144259|9970229|FG001|COMPLETED|Overall Study||28
9021488|NCT03112863|10084175|FG001|NOT COMPLETED|Overall Study||0
9021489|NCT03113656|10084183|FG000|STARTED|Overall Study||9
9021490|NCT03113656|10084184|FG001|STARTED|Overall Study||7
9021491|NCT03113656|10084183|FG000|COMPLETED|Overall Study||9
9021492|NCT03113656|10084184|FG001|COMPLETED|Overall Study||7
9021493|NCT03113656|10084183|FG000|NOT COMPLETED|Overall Study||0
9021494|NCT03113656|10084184|FG001|NOT COMPLETED|Overall Study||0
9021495|NCT03113916|10084192|FG000|STARTED|Overall Study||99
9021496|NCT03113916|10084193|FG001|STARTED|Overall Study||96
9021497|NCT03113916|10084192|FG000|COMPLETED|Overall Study||88
9021498|NCT03113916|10084193|FG001|COMPLETED|Overall Study||84
9021499|NCT03113916|10084192|FG000|NOT COMPLETED|Overall Study||11
9021500|NCT03113916|10084193|FG001|NOT COMPLETED|Overall Study||12
9021501|NCT03114124|10084206|FG000|STARTED|Overall Study||15
9021502|NCT03114124|10084207|FG001|STARTED|Overall Study||15
8911183|NCT02144259|9970230|FG002|COMPLETED|Overall Study||16
8911184|NCT02144259|9970228|FG000|NOT COMPLETED|Overall Study||10
8911185|NCT02144259|9970229|FG001|NOT COMPLETED|Overall Study||5
8911186|NCT02144259|9970230|FG002|NOT COMPLETED|Overall Study||18
8911187|NCT02144285|9970248|FG000|STARTED|Overall Study||14
8911188|NCT02144285|9970249|FG001|STARTED|Overall Study||6
8911189|NCT02144285|9970250|FG002|STARTED|Overall Study||6
9021503|NCT03114124|10084206|FG000|COMPLETED|Overall Study||15
9021504|NCT03114124|10084207|FG001|COMPLETED|Overall Study||15
9021505|NCT03114124|10084206|FG000|NOT COMPLETED|Overall Study||0
9021506|NCT03114124|10084207|FG001|NOT COMPLETED|Overall Study||0
9021507|NCT03114488|10084213|FG000|STARTED|Time Period 1||19
9021508|NCT03114488|10084214|FG001|STARTED|Time Period 1||22
9021509|NCT03114488|10084213|FG000|COMPLETED|Time Period 1||19
9021510|NCT03114488|10084214|FG001|COMPLETED|Time Period 1||22
9021511|NCT03114488|10084213|FG000|NOT COMPLETED|Time Period 1||0
9021512|NCT03114488|10084214|FG001|NOT COMPLETED|Time Period 1||0
9021513|NCT03114488|10084213|FG000|STARTED|Time Period 2||19
9021514|NCT03114488|10084214|FG001|STARTED|Time Period 2||22
9021515|NCT03114488|10084213|FG000|COMPLETED|Time Period 2||18
9021516|NCT03114488|10084214|FG001|COMPLETED|Time Period 2||19
9021517|NCT03114488|10084213|FG000|NOT COMPLETED|Time Period 2||1
9021518|NCT03114488|10084214|FG001|NOT COMPLETED|Time Period 2||3
9021519|NCT03114657|10084226|FG000|STARTED|Overall Study||399
8911190|NCT02144285|9970251|FG003|STARTED|Overall Study||6
8911191|NCT02144285|9970252|FG004|STARTED|Overall Study||6
8911192|NCT02144285|9970253|FG005|STARTED|Overall Study||6
8911193|NCT02144285|9970254|FG006|STARTED|Overall Study||6
8911194|NCT02144285|9970255|FG007|STARTED|Overall Study||6
9021520|NCT03114657|10084227|FG001|STARTED|Overall Study||407
9021521|NCT03114657|10084226|FG000|COMPLETED|Overall Study||0
9021522|NCT03114657|10084227|FG001|COMPLETED|Overall Study||0
9021523|NCT03114657|10084226|FG000|NOT COMPLETED|Overall Study||399
9021524|NCT03114657|10084227|FG001|NOT COMPLETED|Overall Study||407
9021525|NCT03114683|10084234|FG000|STARTED|Overall Study||96
9021526|NCT03114683|10084234|FG000|COMPLETED|Overall Study||52
9021527|NCT03114683|10084234|FG000|NOT COMPLETED|Overall Study||44
9021528|NCT03114969|10084247|FG000|STARTED|Overall Study||50
9021529|NCT03114969|10084248|FG001|STARTED|Overall Study||50
9021530|NCT03114969|10084249|FG002|STARTED|Overall Study||50
9021531|NCT03114969|10084250|FG003|STARTED|Overall Study||50
9021532|NCT03114969|10084251|FG004|STARTED|Overall Study||51
9021533|NCT03114969|10084252|FG005|STARTED|Overall Study||49
9021534|NCT03114969|10084253|FG006|STARTED|Overall Study||50
8640178|NCT00584727|9680488|FG004|STARTED|Second Intervention||16
8640179|NCT00584727|9680489|FG005|STARTED|Second Intervention||16
8640180|NCT00584727|9680484|FG000|COMPLETED|Second Intervention||17
8640181|NCT00584727|9680485|FG001|COMPLETED|Second Intervention||17
8640182|NCT00584727|9680486|FG002|COMPLETED|Second Intervention||15
8640183|NCT00584727|9680487|FG003|COMPLETED|Second Intervention||14
8640184|NCT00584727|9680488|FG004|COMPLETED|Second Intervention||16
8640185|NCT00584727|9680489|FG005|COMPLETED|Second Intervention||16
8640186|NCT00584727|9680484|FG000|NOT COMPLETED|Second Intervention||0
8640187|NCT00584727|9680485|FG001|NOT COMPLETED|Second Intervention||0
8640188|NCT00584727|9680486|FG002|NOT COMPLETED|Second Intervention||0
8640189|NCT00584727|9680487|FG003|NOT COMPLETED|Second Intervention||0
8640190|NCT00584727|9680488|FG004|NOT COMPLETED|Second Intervention||0
8640191|NCT00584727|9680489|FG005|NOT COMPLETED|Second Intervention||0
8640192|NCT00584727|9680484|FG000|STARTED|Third Intervention||17
8640193|NCT00584727|9680485|FG001|STARTED|Third Intervention||17
8640194|NCT00584727|9680486|FG002|STARTED|Third Intervention||15
8640195|NCT00584727|9680487|FG003|STARTED|Third Intervention||14
8640196|NCT00584727|9680488|FG004|STARTED|Third Intervention||16
8640197|NCT00584727|9680489|FG005|STARTED|Third Intervention||16
8640198|NCT00584727|9680484|FG000|COMPLETED|Third Intervention||17
8640199|NCT00584727|9680485|FG001|COMPLETED|Third Intervention||17
8640200|NCT00584727|9680486|FG002|COMPLETED|Third Intervention||14
8640201|NCT00584727|9680487|FG003|COMPLETED|Third Intervention||14
8911195|NCT02144285|9970256|FG008|STARTED|Overall Study||2
8911196|NCT02144285|9970257|FG009|STARTED|Overall Study||6
8911197|NCT02144285|9970248|FG000|Received At Least One Dose of Study Drug|Overall Study||14
8911198|NCT02144285|9970249|FG001|Received At Least One Dose of Study Drug|Overall Study||6
8911199|NCT02144285|9970250|FG002|Received At Least One Dose of Study Drug|Overall Study||6
8911200|NCT02144285|9970251|FG003|Received At Least One Dose of Study Drug|Overall Study||6
9021535|NCT03114969|10084254|FG007|STARTED|Overall Study||50
9021536|NCT03114969|10084255|FG008|STARTED|Overall Study||50
9021537|NCT03114969|10084247|FG000|COMPLETED|Overall Study||50
9021538|NCT03114969|10084248|FG001|COMPLETED|Overall Study||50
9021539|NCT03114969|10084249|FG002|COMPLETED|Overall Study||46
9021540|NCT03114969|10084250|FG003|COMPLETED|Overall Study||48
8640202|NCT00584727|9680488|FG004|COMPLETED|Third Intervention||12
8640203|NCT00584727|9680489|FG005|COMPLETED|Third Intervention||14
8640204|NCT00584727|9680484|FG000|NOT COMPLETED|Third Intervention||0
8640205|NCT00584727|9680485|FG001|NOT COMPLETED|Third Intervention||0
8640206|NCT00584727|9680486|FG002|NOT COMPLETED|Third Intervention||1
8640207|NCT00584727|9680487|FG003|NOT COMPLETED|Third Intervention||0
8640208|NCT00584727|9680488|FG004|NOT COMPLETED|Third Intervention||4
9021541|NCT03114969|10084251|FG004|COMPLETED|Overall Study||51
9021542|NCT03114969|10084252|FG005|COMPLETED|Overall Study||48
9021543|NCT03114969|10084253|FG006|COMPLETED|Overall Study||49
9021544|NCT03114969|10084254|FG007|COMPLETED|Overall Study||50
9021545|NCT03114969|10084255|FG008|COMPLETED|Overall Study||48
9021546|NCT03114969|10084247|FG000|NOT COMPLETED|Overall Study||0
9021547|NCT03114969|10084248|FG001|NOT COMPLETED|Overall Study||0
9021548|NCT03114969|10084249|FG002|NOT COMPLETED|Overall Study||4
9021549|NCT03114969|10084250|FG003|NOT COMPLETED|Overall Study||2
9021550|NCT03114969|10084251|FG004|NOT COMPLETED|Overall Study||0
9021551|NCT03114969|10084252|FG005|NOT COMPLETED|Overall Study||1
9021552|NCT03114969|10084253|FG006|NOT COMPLETED|Overall Study||1
9021553|NCT03114969|10084254|FG007|NOT COMPLETED|Overall Study||0
9021554|NCT03114969|10084255|FG008|NOT COMPLETED|Overall Study||2
9021555|NCT03114995|10084285|FG000|STARTED|Overall Study||31
9021556|NCT03114995|10084286|FG001|STARTED|Overall Study||31
9021557|NCT03114995|10084287|FG002|STARTED|Overall Study||78
9021558|NCT03114995|10084285|FG000|COMPLETED|Overall Study||30
9021559|NCT03114995|10084286|FG001|COMPLETED|Overall Study||30
9021560|NCT03114995|10084287|FG002|COMPLETED|Overall Study||78
9021561|NCT03114995|10084285|FG000|NOT COMPLETED|Overall Study||1
9021562|NCT03114995|10084286|FG001|NOT COMPLETED|Overall Study||1
9021563|NCT03114995|10084287|FG002|NOT COMPLETED|Overall Study||0
9021564|NCT03115112|10084297|FG000|STARTED|Overall Study||192
9021565|NCT03115112|10084298|FG001|STARTED|Overall Study||194
9021566|NCT03115112|10084297|FG000|Intention-to-treat|Overall Study||191
9021567|NCT03115112|10084298|FG001|Intention-to-treat|Overall Study||193
9021568|NCT03115112|10084297|FG000|COMPLETED|Overall Study||180
9021569|NCT03115112|10084298|FG001|COMPLETED|Overall Study||189
9021570|NCT03115112|10084297|FG000|NOT COMPLETED|Overall Study||12
9021571|NCT03115112|10084298|FG001|NOT COMPLETED|Overall Study||5
9039899|NCT03343067|10100822|FG002|NOT COMPLETED|Double Blind Period: Month 3 to Month 6||1
9039900|NCT03343080|10100832|FG000|STARTED|Overall Study||14
9039901|NCT03343080|10100833|FG001|STARTED|Overall Study||18
9039902|NCT03343080|10100832|FG000|COMPLETED|Overall Study||14
9039903|NCT03343080|10100833|FG001|COMPLETED|Overall Study||18
9039904|NCT03343080|10100832|FG000|NOT COMPLETED|Overall Study||0
9039905|NCT03343080|10100833|FG001|NOT COMPLETED|Overall Study||0
9039906|NCT03343639|10100841|FG000|STARTED|Overall Study||102
9039907|NCT03343639|10100842|FG001|STARTED|Overall Study||102
9039908|NCT03343639|10100841|FG000|COMPLETED|Overall Study||88
9039909|NCT03343639|10100842|FG001|COMPLETED|Overall Study||90
9039910|NCT03343639|10100841|FG000|NOT COMPLETED|Overall Study||14
9039911|NCT03343639|10100842|FG001|NOT COMPLETED|Overall Study||12
9039912|NCT03343704|10100850|FG000|STARTED|Overall Study||13
9039913|NCT03343704|10100851|FG001|STARTED|Overall Study||6
9039914|NCT03343704|10100850|FG000|COMPLETED|Overall Study||12
9039915|NCT03343704|10100851|FG001|COMPLETED|Overall Study||4
9039916|NCT03343704|10100850|FG000|NOT COMPLETED|Overall Study||1
9039917|NCT03343704|10100851|FG001|NOT COMPLETED|Overall Study||2
9039918|NCT03344172|10100861|FG000|STARTED|Overall Study||16
9039919|NCT03344172|10100862|FG001|STARTED|Overall Study||16
9039920|NCT03344172|10100861|FG000|COMPLETED|Overall Study||15
9039921|NCT03344172|10100862|FG001|COMPLETED|Overall Study||16
9039922|NCT03344172|10100861|FG000|NOT COMPLETED|Overall Study||1
9039923|NCT03344172|10100862|FG001|NOT COMPLETED|Overall Study||0
9039924|NCT03344510|10100868|FG000|STARTED|First Injection (5 Minutes)||21
9039925|NCT03344510|10100869|FG001|STARTED|First Injection (5 Minutes)||26
9039926|NCT03344510|10100868|FG000|Received Injection|First Injection (5 Minutes)||21
9039927|NCT03344510|10100869|FG001|Received Injection|First Injection (5 Minutes)||26
9039928|NCT03344510|10100868|FG000|COMPLETED|First Injection (5 Minutes)||21
9039929|NCT03344510|10100869|FG001|COMPLETED|First Injection (5 Minutes)||26
9039930|NCT03344510|10100868|FG000|NOT COMPLETED|First Injection (5 Minutes)||0
9039931|NCT03344510|10100869|FG001|NOT COMPLETED|First Injection (5 Minutes)||0
9039932|NCT03344510|10100868|FG000|STARTED|Wash Out (10 Minutes||21
9039933|NCT03344510|10100869|FG001|STARTED|Wash Out (10 Minutes||26
9039934|NCT03344510|10100868|FG000|COMPLETED|Wash Out (10 Minutes||21
9039935|NCT03344510|10100869|FG001|COMPLETED|Wash Out (10 Minutes||26
9039936|NCT03344510|10100868|FG000|NOT COMPLETED|Wash Out (10 Minutes||0
9039937|NCT03344510|10100869|FG001|NOT COMPLETED|Wash Out (10 Minutes||0
9039938|NCT03344510|10100868|FG000|STARTED|Second Injection (5 Minutes)||21
9039939|NCT03344510|10100869|FG001|STARTED|Second Injection (5 Minutes)||26
9039940|NCT03344510|10100868|FG000|Received Injection|Second Injection (5 Minutes)||21
9039941|NCT03344510|10100869|FG001|Received Injection|Second Injection (5 Minutes)||26
9039942|NCT03344510|10100868|FG000|COMPLETED|Second Injection (5 Minutes)||21
9039943|NCT03344510|10100869|FG001|COMPLETED|Second Injection (5 Minutes)||26
9039944|NCT03344510|10100868|FG000|NOT COMPLETED|Second Injection (5 Minutes)||0
9039945|NCT03344510|10100869|FG001|NOT COMPLETED|Second Injection (5 Minutes)||0
9039946|NCT03344640|10100878|FG000|STARTED|Overall Study||49
9039947|NCT03344640|10100879|FG001|STARTED|Overall Study||47
9039948|NCT03344640|10100878|FG000|COMPLETED|Overall Study||46
9039949|NCT03344640|10100879|FG001|COMPLETED|Overall Study||44
9039950|NCT03344640|10100878|FG000|NOT COMPLETED|Overall Study||3
9039951|NCT03344640|10100879|FG001|NOT COMPLETED|Overall Study||3
9039952|NCT03344640|10100878|FG000|STARTED|Follow-up Epoch||46
9039953|NCT03344640|10100879|FG001|STARTED|Follow-up Epoch||44
9039954|NCT03344640|10100878|FG000|COMPLETED|Follow-up Epoch||46
9039955|NCT03344640|10100879|FG001|COMPLETED|Follow-up Epoch||42
9039956|NCT03344640|10100878|FG000|NOT COMPLETED|Follow-up Epoch||0
9039957|NCT03344640|10100879|FG001|NOT COMPLETED|Follow-up Epoch||2
9039958|NCT03344861|10100885|FG000|STARTED|Overall Study||10
9039959|NCT03344861|10100885|FG000|COMPLETED|Overall Study||10
9039960|NCT03344861|10100885|FG000|NOT COMPLETED|Overall Study||0
8640209|NCT00584727|9680489|FG005|NOT COMPLETED|Third Intervention||2
8640210|NCT00584740|9680502|FG000|STARTED|Overall Study||39
8640211|NCT00584740|9680503|FG001|STARTED|Overall Study||20
8640212|NCT00584740|9680502|FG000|COMPLETED|Overall Study||27
8640213|NCT00584740|9680503|FG001|COMPLETED|Overall Study||14
8640214|NCT00584740|9680502|FG000|NOT COMPLETED|Overall Study||12
8640215|NCT00584740|9680503|FG001|NOT COMPLETED|Overall Study||6
8640216|NCT00584805|9680509|FG000|STARTED|Overall Study||138
8640217|NCT00584805|9680509|FG000|COMPLETED|Overall Study||39
8640218|NCT00584805|9680509|FG000|NOT COMPLETED|Overall Study||99
8640219|NCT00584831|9680515|FG000|STARTED|Intervention 1||1
8640220|NCT00584831|9680516|FG001|STARTED|Intervention 1||3
8727239|NCT01042392|9774630|FG000|COMPLETED|Period II(Randomized,Double Blinded,8wk)||247
8727240|NCT01042392|9774631|FG001|COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
8727241|NCT01042392|9774632|FG002|COMPLETED|Period II(Randomized,Double Blinded,8wk)||241
8727242|NCT01042392|9774633|FG003|COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
8640221|NCT00584831|9680517|FG002|STARTED|Intervention 1||2
8640222|NCT00584831|9680518|FG003|STARTED|Intervention 1||1
8640223|NCT00584831|9680519|FG004|STARTED|Intervention 1||2
8640224|NCT00584831|9680520|FG005|STARTED|Intervention 1||1
8640225|NCT00584831|9680521|FG006|STARTED|Intervention 1||6
8640226|NCT00584831|9680522|FG007|STARTED|Intervention 1||2
8640227|NCT00584831|9680523|FG008|STARTED|Intervention 1||4
8640228|NCT00584831|9680524|FG009|STARTED|Intervention 1||2
8640229|NCT00584831|9680525|FG010|STARTED|Intervention 1||2
8640230|NCT00584831|9680526|FG011|STARTED|Intervention 1||1
8640231|NCT00584831|9680527|FG012|STARTED|Intervention 1||2
8640232|NCT00584831|9680528|FG013|STARTED|Intervention 1||1
8640233|NCT00584831|9680529|FG014|STARTED|Intervention 1||3
8640234|NCT00584831|9680530|FG015|STARTED|Intervention 1||1
8640235|NCT00584831|9680531|FG016|STARTED|Intervention 1||4
8640236|NCT00584831|9680532|FG017|STARTED|Intervention 1||1
8640237|NCT00584831|9680533|FG018|STARTED|Intervention 1||1
8640238|NCT00584831|9680515|FG000|COMPLETED|Intervention 1||1
8640239|NCT00584831|9680516|FG001|COMPLETED|Intervention 1||3
8640240|NCT00584831|9680517|FG002|COMPLETED|Intervention 1||2
8640241|NCT00584831|9680518|FG003|COMPLETED|Intervention 1||1
8640242|NCT00584831|9680519|FG004|COMPLETED|Intervention 1||2
8640243|NCT00584831|9680520|FG005|COMPLETED|Intervention 1||1
8640244|NCT00584831|9680521|FG006|COMPLETED|Intervention 1||6
8640245|NCT00584831|9680522|FG007|COMPLETED|Intervention 1||2
8640246|NCT00584831|9680523|FG008|COMPLETED|Intervention 1||4
8640247|NCT00584831|9680524|FG009|COMPLETED|Intervention 1||2
8640248|NCT00584831|9680525|FG010|COMPLETED|Intervention 1||2
8640249|NCT00584831|9680526|FG011|COMPLETED|Intervention 1||1
8640250|NCT00584831|9680527|FG012|COMPLETED|Intervention 1||2
8640251|NCT00584831|9680528|FG013|COMPLETED|Intervention 1||1
8640252|NCT00584831|9680529|FG014|COMPLETED|Intervention 1||3
8640253|NCT00584831|9680530|FG015|COMPLETED|Intervention 1||1
8640254|NCT00584831|9680531|FG016|COMPLETED|Intervention 1||4
8640255|NCT00584831|9680532|FG017|COMPLETED|Intervention 1||1
8640256|NCT00584831|9680533|FG018|COMPLETED|Intervention 1||1
8640257|NCT00584831|9680515|FG000|NOT COMPLETED|Intervention 1||0
8640258|NCT00584831|9680516|FG001|NOT COMPLETED|Intervention 1||0
8640259|NCT00584831|9680517|FG002|NOT COMPLETED|Intervention 1||0
8640260|NCT00584831|9680518|FG003|NOT COMPLETED|Intervention 1||0
8640261|NCT00584831|9680519|FG004|NOT COMPLETED|Intervention 1||0
8640262|NCT00584831|9680520|FG005|NOT COMPLETED|Intervention 1||0
8640263|NCT00584831|9680521|FG006|NOT COMPLETED|Intervention 1||0
8640264|NCT00584831|9680522|FG007|NOT COMPLETED|Intervention 1||0
8640265|NCT00584831|9680523|FG008|NOT COMPLETED|Intervention 1||0
8640266|NCT00584831|9680524|FG009|NOT COMPLETED|Intervention 1||0
8640267|NCT00584831|9680525|FG010|NOT COMPLETED|Intervention 1||0
8640268|NCT00584831|9680526|FG011|NOT COMPLETED|Intervention 1||0
8640269|NCT00584831|9680527|FG012|NOT COMPLETED|Intervention 1||0
8640270|NCT00584831|9680528|FG013|NOT COMPLETED|Intervention 1||0
8640271|NCT00584831|9680529|FG014|NOT COMPLETED|Intervention 1||0
8640272|NCT00584831|9680530|FG015|NOT COMPLETED|Intervention 1||0
8640273|NCT00584831|9680531|FG016|NOT COMPLETED|Intervention 1||0
8640274|NCT00584831|9680532|FG017|NOT COMPLETED|Intervention 1||0
8640275|NCT00584831|9680533|FG018|NOT COMPLETED|Intervention 1||0
8640276|NCT00584831|9680515|FG000|STARTED|Intervention 2||1
8640277|NCT00584831|9680516|FG001|STARTED|Intervention 2||3
8640278|NCT00584831|9680517|FG002|STARTED|Intervention 2||2
8640279|NCT00584831|9680518|FG003|STARTED|Intervention 2||1
8640280|NCT00584831|9680519|FG004|STARTED|Intervention 2||2
8640281|NCT00584831|9680520|FG005|STARTED|Intervention 2||1
8640282|NCT00584831|9680521|FG006|STARTED|Intervention 2||6
8640283|NCT00584831|9680522|FG007|STARTED|Intervention 2||2
8640284|NCT00584831|9680523|FG008|STARTED|Intervention 2||4
8640285|NCT00584831|9680524|FG009|STARTED|Intervention 2||2
8640286|NCT00584831|9680525|FG010|STARTED|Intervention 2||2
8640287|NCT00584831|9680526|FG011|STARTED|Intervention 2||1
8640288|NCT00584831|9680527|FG012|STARTED|Intervention 2||2
8640289|NCT00584831|9680528|FG013|STARTED|Intervention 2||1
8640290|NCT00584831|9680529|FG014|STARTED|Intervention 2||3
8640291|NCT00584831|9680530|FG015|STARTED|Intervention 2||1
8640292|NCT00584831|9680531|FG016|STARTED|Intervention 2||4
8640293|NCT00584831|9680532|FG017|STARTED|Intervention 2||1
8640294|NCT00584831|9680533|FG018|STARTED|Intervention 2||1
8640295|NCT00584831|9680515|FG000|COMPLETED|Intervention 2||1
8640296|NCT00584831|9680516|FG001|COMPLETED|Intervention 2||3
8640297|NCT00584831|9680517|FG002|COMPLETED|Intervention 2||2
9021572|NCT03115177|10084308|FG000|STARTED|Overall Study||27
9021573|NCT03115177|10084309|FG001|STARTED|Overall Study||29
9021574|NCT03115177|10084308|FG000|COMPLETED|Overall Study||27
9021575|NCT03115177|10084309|FG001|COMPLETED|Overall Study||29
9021576|NCT03115177|10084308|FG000|NOT COMPLETED|Overall Study||0
9021577|NCT03115177|10084309|FG001|NOT COMPLETED|Overall Study||0
9021578|NCT03115411|10084315|FG000|STARTED|Overall Study||23
9021579|NCT03115411|10084315|FG000|COMPLETED|Overall Study||23
9021580|NCT03115411|10084315|FG000|NOT COMPLETED|Overall Study||0
9021581|NCT03115476|10084322|FG000|STARTED|Main Trials (LP0084-119x)||407
9021582|NCT03115476|10084323|FG001|STARTED|Main Trials (LP0084-119x)||418
9021583|NCT03115476|10084324|FG002|STARTED|Main Trials (LP0084-119x)||409
9021584|NCT03115476|10084322|FG000|COMPLETED|Main Trials (LP0084-119x)||407
9021585|NCT03115476|10084323|FG001|COMPLETED|Main Trials (LP0084-119x)||418
9021586|NCT03115476|10084324|FG002|COMPLETED|Main Trials (LP0084-119x)||409
9021587|NCT03115476|10084322|FG000|NOT COMPLETED|Main Trials (LP0084-119x)||0
9021588|NCT03115476|10084323|FG001|NOT COMPLETED|Main Trials (LP0084-119x)||0
9021589|NCT03115476|10084324|FG002|NOT COMPLETED|Main Trials (LP0084-119x)||0
9021590|NCT03115476|10084322|FG000|STARTED|LP0084-1369||191
9021591|NCT03115476|10084323|FG001|STARTED|LP0084-1369||210
9021592|NCT03115476|10084324|FG002|STARTED|LP0084-1369||162
9021593|NCT03115476|10084322|FG000|COMPLETED|LP0084-1369|Trial was terminated by sponsor|0
9021594|NCT03115476|10084323|FG001|COMPLETED|LP0084-1369|Trial was terminated by sponsor|0
9021595|NCT03115476|10084324|FG002|COMPLETED|LP0084-1369|Trial was terminated by sponsor|0
9021596|NCT03115476|10084322|FG000|NOT COMPLETED|LP0084-1369||191
9021597|NCT03115476|10084323|FG001|NOT COMPLETED|LP0084-1369||210
9021598|NCT03115476|10084324|FG002|NOT COMPLETED|LP0084-1369||162
9021599|NCT03115580|10084334|FG000|STARTED|Overall Study||35
9021600|NCT03115580|10084335|FG001|STARTED|Overall Study||36
9021601|NCT03115580|10084334|FG000|COMPLETED|Overall Study||35
9021602|NCT03115580|10084335|FG001|COMPLETED|Overall Study||36
9021603|NCT03115580|10084334|FG000|NOT COMPLETED|Overall Study||0
9021604|NCT03115580|10084335|FG001|NOT COMPLETED|Overall Study||0
9021605|NCT03115801|10084343|FG000|STARTED|Overall Study||4
9021606|NCT03115801|10084344|FG001|STARTED|Overall Study||2
9021607|NCT03115801|10084343|FG000|COMPLETED|Overall Study||1
9021608|NCT03115801|10084344|FG001|COMPLETED|Overall Study||0
9021609|NCT03115801|10084343|FG000|NOT COMPLETED|Overall Study||3
9021610|NCT03115801|10084344|FG001|NOT COMPLETED|Overall Study||2
9021611|NCT03115827|10084350|FG000|STARTED|Overall Study||15
9021612|NCT03115827|10084350|FG000|COMPLETED|Overall Study||12
9021613|NCT03115827|10084350|FG000|NOT COMPLETED|Overall Study||3
9021614|NCT03116152|10084356|FG000|STARTED|Overall Study||95
8640298|NCT00584831|9680518|FG003|COMPLETED|Intervention 2||1
8640299|NCT00584831|9680519|FG004|COMPLETED|Intervention 2||2
8640300|NCT00584831|9680520|FG005|COMPLETED|Intervention 2||1
8640301|NCT00584831|9680521|FG006|COMPLETED|Intervention 2||6
8640302|NCT00584831|9680522|FG007|COMPLETED|Intervention 2||2
8640303|NCT00584831|9680523|FG008|COMPLETED|Intervention 2||4
8640304|NCT00584831|9680524|FG009|COMPLETED|Intervention 2||2
8640305|NCT00584831|9680525|FG010|COMPLETED|Intervention 2||2
8640306|NCT00584831|9680526|FG011|COMPLETED|Intervention 2||1
8640307|NCT00584831|9680527|FG012|COMPLETED|Intervention 2||2
8640308|NCT00584831|9680528|FG013|COMPLETED|Intervention 2||1
8640309|NCT00584831|9680529|FG014|COMPLETED|Intervention 2||3
8640310|NCT00584831|9680530|FG015|COMPLETED|Intervention 2||1
8640311|NCT00584831|9680531|FG016|COMPLETED|Intervention 2||4
8640312|NCT00584831|9680532|FG017|COMPLETED|Intervention 2||1
8640313|NCT00584831|9680533|FG018|COMPLETED|Intervention 2||1
8640314|NCT00584831|9680515|FG000|NOT COMPLETED|Intervention 2||0
8640315|NCT00584831|9680516|FG001|NOT COMPLETED|Intervention 2||0
8640316|NCT00584831|9680517|FG002|NOT COMPLETED|Intervention 2||0
8640317|NCT00584831|9680518|FG003|NOT COMPLETED|Intervention 2||0
8640318|NCT00584831|9680519|FG004|NOT COMPLETED|Intervention 2||0
8640319|NCT00584831|9680520|FG005|NOT COMPLETED|Intervention 2||0
8640320|NCT00584831|9680521|FG006|NOT COMPLETED|Intervention 2||0
8640321|NCT00584831|9680522|FG007|NOT COMPLETED|Intervention 2||0
8640322|NCT00584831|9680523|FG008|NOT COMPLETED|Intervention 2||0
8640323|NCT00584831|9680524|FG009|NOT COMPLETED|Intervention 2||0
8640324|NCT00584831|9680525|FG010|NOT COMPLETED|Intervention 2||0
8640325|NCT00584831|9680526|FG011|NOT COMPLETED|Intervention 2||0
8640326|NCT00584831|9680527|FG012|NOT COMPLETED|Intervention 2||0
8640327|NCT00584831|9680528|FG013|NOT COMPLETED|Intervention 2||0
8640328|NCT00584831|9680529|FG014|NOT COMPLETED|Intervention 2||0
8640329|NCT00584831|9680530|FG015|NOT COMPLETED|Intervention 2||0
9021615|NCT03116152|10084357|FG001|STARTED|Overall Study||95
9021616|NCT03116152|10084356|FG000|Treated|Overall Study||94
9021617|NCT03116152|10084357|FG001|Treated|Overall Study||87
9021618|NCT03116152|10084356|FG000|COMPLETED|Overall Study||4
9021619|NCT03116152|10084357|FG001|COMPLETED|Overall Study||0
9021620|NCT03116152|10084356|FG000|NOT COMPLETED|Overall Study||91
9021621|NCT03116152|10084357|FG001|NOT COMPLETED|Overall Study||95
9021622|NCT03116230|10084365|FG000|STARTED|Overall Study||19
9021623|NCT03116230|10084366|FG001|STARTED|Overall Study||19
9021624|NCT03116230|10084365|FG000|COMPLETED|Overall Study||15
9021625|NCT03116230|10084366|FG001|COMPLETED|Overall Study||17
8640330|NCT00584831|9680531|FG016|NOT COMPLETED|Intervention 2||0
8640331|NCT00584831|9680532|FG017|NOT COMPLETED|Intervention 2||0
8640332|NCT00584831|9680533|FG018|NOT COMPLETED|Intervention 2||0
8640333|NCT00584831|9680515|FG000|STARTED|Intervention 3||1
9021626|NCT03116230|10084365|FG000|NOT COMPLETED|Overall Study||4
9021627|NCT03116230|10084366|FG001|NOT COMPLETED|Overall Study||2
8640334|NCT00584831|9680516|FG001|STARTED|Intervention 3||3
8640335|NCT00584831|9680517|FG002|STARTED|Intervention 3||2
8640336|NCT00584831|9680518|FG003|STARTED|Intervention 3||1
8640337|NCT00584831|9680519|FG004|STARTED|Intervention 3||2
8640338|NCT00584831|9680520|FG005|STARTED|Intervention 3||1
8640339|NCT00584831|9680521|FG006|STARTED|Intervention 3||6
8640340|NCT00584831|9680522|FG007|STARTED|Intervention 3||2
8640341|NCT00584831|9680523|FG008|STARTED|Intervention 3||4
8640342|NCT00584831|9680524|FG009|STARTED|Intervention 3||2
8640343|NCT00584831|9680525|FG010|STARTED|Intervention 3||2
8640344|NCT00584831|9680526|FG011|STARTED|Intervention 3||1
8640345|NCT00584831|9680527|FG012|STARTED|Intervention 3||2
8640346|NCT00584831|9680528|FG013|STARTED|Intervention 3||1
8640347|NCT00584831|9680529|FG014|STARTED|Intervention 3||3
8640348|NCT00584831|9680530|FG015|STARTED|Intervention 3||1
8640349|NCT00584831|9680531|FG016|STARTED|Intervention 3||4
8640350|NCT00584831|9680532|FG017|STARTED|Intervention 3||1
8640351|NCT00584831|9680533|FG018|STARTED|Intervention 3||1
8640352|NCT00584831|9680515|FG000|COMPLETED|Intervention 3||1
8640353|NCT00584831|9680516|FG001|COMPLETED|Intervention 3||3
8640354|NCT00584831|9680517|FG002|COMPLETED|Intervention 3||2
8640355|NCT00584831|9680518|FG003|COMPLETED|Intervention 3||1
8640356|NCT00584831|9680519|FG004|COMPLETED|Intervention 3||2
8640357|NCT00584831|9680520|FG005|COMPLETED|Intervention 3||1
8640358|NCT00584831|9680521|FG006|COMPLETED|Intervention 3||6
8640359|NCT00584831|9680522|FG007|COMPLETED|Intervention 3||2
8640360|NCT00584831|9680523|FG008|COMPLETED|Intervention 3||4
8640361|NCT00584831|9680524|FG009|COMPLETED|Intervention 3||2
8640362|NCT00584831|9680525|FG010|COMPLETED|Intervention 3||2
8640363|NCT00584831|9680526|FG011|COMPLETED|Intervention 3||1
8640364|NCT00584831|9680527|FG012|COMPLETED|Intervention 3||2
8640365|NCT00584831|9680528|FG013|COMPLETED|Intervention 3||1
8640366|NCT00584831|9680529|FG014|COMPLETED|Intervention 3||3
8640367|NCT00584831|9680530|FG015|COMPLETED|Intervention 3||1
8640368|NCT00584831|9680531|FG016|COMPLETED|Intervention 3||4
8640369|NCT00584831|9680532|FG017|COMPLETED|Intervention 3||1
8640370|NCT00584831|9680533|FG018|COMPLETED|Intervention 3||1
8640371|NCT00584831|9680515|FG000|NOT COMPLETED|Intervention 3||0
8640372|NCT00584831|9680516|FG001|NOT COMPLETED|Intervention 3||0
8640373|NCT00584831|9680517|FG002|NOT COMPLETED|Intervention 3||0
8640374|NCT00584831|9680518|FG003|NOT COMPLETED|Intervention 3||0
8640375|NCT00584831|9680519|FG004|NOT COMPLETED|Intervention 3||0
8640376|NCT00584831|9680520|FG005|NOT COMPLETED|Intervention 3||0
8640377|NCT00584831|9680521|FG006|NOT COMPLETED|Intervention 3||0
8640378|NCT00584831|9680522|FG007|NOT COMPLETED|Intervention 3||0
8640379|NCT00584831|9680523|FG008|NOT COMPLETED|Intervention 3||0
8640380|NCT00584831|9680524|FG009|NOT COMPLETED|Intervention 3||0
8640381|NCT00584831|9680525|FG010|NOT COMPLETED|Intervention 3||0
8640382|NCT00584831|9680526|FG011|NOT COMPLETED|Intervention 3||0
8640383|NCT00584831|9680527|FG012|NOT COMPLETED|Intervention 3||0
8640384|NCT00584831|9680528|FG013|NOT COMPLETED|Intervention 3||0
8640385|NCT00584831|9680529|FG014|NOT COMPLETED|Intervention 3||0
8640386|NCT00584831|9680530|FG015|NOT COMPLETED|Intervention 3||0
8640387|NCT00584831|9680531|FG016|NOT COMPLETED|Intervention 3||0
8640388|NCT00584831|9680532|FG017|NOT COMPLETED|Intervention 3||0
8640389|NCT00584831|9680533|FG018|NOT COMPLETED|Intervention 3||0
8640390|NCT00584831|9680515|FG000|STARTED|Intervention 4||1
8640391|NCT00584831|9680516|FG001|STARTED|Intervention 4||3
8640392|NCT00584831|9680517|FG002|STARTED|Intervention 4||2
8640393|NCT00584831|9680518|FG003|STARTED|Intervention 4||1
8640394|NCT00584831|9680519|FG004|STARTED|Intervention 4||2
8640395|NCT00584831|9680520|FG005|STARTED|Intervention 4||1
8640396|NCT00584831|9680521|FG006|STARTED|Intervention 4||6
8640397|NCT00584831|9680522|FG007|STARTED|Intervention 4||2
8640398|NCT00584831|9680523|FG008|STARTED|Intervention 4||3
8640399|NCT00584831|9680524|FG009|STARTED|Intervention 4||2
8640400|NCT00584831|9680525|FG010|STARTED|Intervention 4||2
8640401|NCT00584831|9680526|FG011|STARTED|Intervention 4||1
8640402|NCT00584831|9680527|FG012|STARTED|Intervention 4||2
8640403|NCT00584831|9680528|FG013|STARTED|Intervention 4||1
8640404|NCT00584831|9680529|FG014|STARTED|Intervention 4||2
8640405|NCT00584831|9680530|FG015|STARTED|Intervention 4||1
8640406|NCT00584831|9680531|FG016|STARTED|Intervention 4||4
9021628|NCT03116698|10084376|FG000|STARTED|Overall Study||62
9021629|NCT03116698|10084377|FG001|STARTED|Overall Study||57
8640407|NCT00584831|9680532|FG017|STARTED|Intervention 4||1
8640408|NCT00584831|9680533|FG018|STARTED|Intervention 4||1
8640409|NCT00584831|9680515|FG000|COMPLETED|Intervention 4||1
8640410|NCT00584831|9680516|FG001|COMPLETED|Intervention 4||3
8640411|NCT00584831|9680517|FG002|COMPLETED|Intervention 4||2
8640412|NCT00584831|9680518|FG003|COMPLETED|Intervention 4||1
8640413|NCT00584831|9680519|FG004|COMPLETED|Intervention 4||2
8640414|NCT00584831|9680520|FG005|COMPLETED|Intervention 4||1
8640415|NCT00584831|9680521|FG006|COMPLETED|Intervention 4||6
8640416|NCT00584831|9680522|FG007|COMPLETED|Intervention 4||2
8640417|NCT00584831|9680523|FG008|COMPLETED|Intervention 4||3
8640418|NCT00584831|9680524|FG009|COMPLETED|Intervention 4||2
8640419|NCT00584831|9680525|FG010|COMPLETED|Intervention 4||2
8640420|NCT00584831|9680526|FG011|COMPLETED|Intervention 4||1
8640421|NCT00584831|9680527|FG012|COMPLETED|Intervention 4||2
8640422|NCT00584831|9680528|FG013|COMPLETED|Intervention 4||1
8640423|NCT00584831|9680529|FG014|COMPLETED|Intervention 4||2
8640424|NCT00584831|9680530|FG015|COMPLETED|Intervention 4||1
8640425|NCT00584831|9680531|FG016|COMPLETED|Intervention 4||4
9021630|NCT03116698|10084378|FG002|STARTED|Overall Study||62
9021631|NCT03116698|10084379|FG003|STARTED|Overall Study||57
9021632|NCT03116698|10084376|FG000|COMPLETED|Overall Study||56
9021633|NCT03116698|10084377|FG001|COMPLETED|Overall Study||51
9021634|NCT03116698|10084378|FG002|COMPLETED|Overall Study||54
9021635|NCT03116698|10084379|FG003|COMPLETED|Overall Study||55
9021636|NCT03116698|10084376|FG000|NOT COMPLETED|Overall Study||6
9021637|NCT03116698|10084377|FG001|NOT COMPLETED|Overall Study||6
9021638|NCT03116698|10084378|FG002|NOT COMPLETED|Overall Study||8
9021639|NCT03116698|10084379|FG003|NOT COMPLETED|Overall Study||2
9021640|NCT03116828|10084391|FG000|STARTED|Overall Study||44
9021641|NCT03116828|10084392|FG001|STARTED|Overall Study||58
9021642|NCT03116828|10084391|FG000|COMPLETED|Overall Study||36
9021643|NCT03116828|10084392|FG001|COMPLETED|Overall Study||37
9021644|NCT03116828|10084391|FG000|NOT COMPLETED|Overall Study||8
9021645|NCT03116828|10084392|FG001|NOT COMPLETED|Overall Study||21
9021646|NCT03116841|10084398|FG000|STARTED|Overall Study||3
9021647|NCT03116841|10084398|FG000|COMPLETED|Overall Study||3
9021648|NCT03116841|10084398|FG000|NOT COMPLETED|Overall Study||0
9021649|NCT03117140|10084406|FG000|STARTED|Overall Study||40
9021650|NCT03117140|10084407|FG001|STARTED|Overall Study||40
9021651|NCT03117140|10084408|FG002|STARTED|Overall Study||40
9021652|NCT03117140|10084409|FG003|STARTED|Overall Study||40
9021653|NCT03117140|10084406|FG000|COMPLETED|Overall Study||40
9021654|NCT03117140|10084407|FG001|COMPLETED|Overall Study||40
9021655|NCT03117140|10084408|FG002|COMPLETED|Overall Study||40
9021656|NCT03117140|10084409|FG003|COMPLETED|Overall Study||40
9021657|NCT03117140|10084406|FG000|NOT COMPLETED|Overall Study||0
9021658|NCT03117140|10084407|FG001|NOT COMPLETED|Overall Study||0
9021659|NCT03117140|10084408|FG002|NOT COMPLETED|Overall Study||0
9021660|NCT03117140|10084409|FG003|NOT COMPLETED|Overall Study||0
9021661|NCT03117361|10084422|FG000|STARTED|Overall Study||10
9021662|NCT03117361|10084422|FG000|COMPLETED|Overall Study||0
9021663|NCT03117361|10084422|FG000|NOT COMPLETED|Overall Study||10
9021664|NCT03117517|10084428|FG000|STARTED|Overall Study||53
9021665|NCT03117517|10084429|FG001|STARTED|Overall Study||53
9021666|NCT03117517|10084428|FG000|COMPLETED|Overall Study||48
9021667|NCT03117517|10084429|FG001|COMPLETED|Overall Study||49
9021668|NCT03117517|10084428|FG000|NOT COMPLETED|Overall Study||5
9021669|NCT03117517|10084429|FG001|NOT COMPLETED|Overall Study||4
9021670|NCT03117569|10084441|FG000|STARTED|Overall Study||127
9021671|NCT03117569|10084442|FG001|STARTED|Overall Study||253
9021672|NCT03117569|10084441|FG000|COMPLETED|Overall Study||123
9021673|NCT03117569|10084442|FG001|COMPLETED|Overall Study||241
9021674|NCT03117569|10084441|FG000|NOT COMPLETED|Overall Study||4
9021675|NCT03117569|10084442|FG001|NOT COMPLETED|Overall Study||12
9021676|NCT03117634|10084454|FG000|STARTED|Overall Study||41
9021677|NCT03117634|10084455|FG001|STARTED|Overall Study||13
9021678|NCT03117634|10084454|FG000|COMPLETED|Overall Study||39
9021679|NCT03117634|10084455|FG001|COMPLETED|Overall Study||13
9021680|NCT03117634|10084454|FG000|NOT COMPLETED|Overall Study||2
9021681|NCT03117634|10084455|FG001|NOT COMPLETED|Overall Study||0
9021682|NCT03117738|10084463|FG000|STARTED|Overall Study||11
9021683|NCT03117738|10084464|FG001|STARTED|Overall Study||10
9021684|NCT03117738|10084463|FG000|COMPLETED|Overall Study||7
8640426|NCT00584831|9680532|FG017|COMPLETED|Intervention 4||1
8640427|NCT00584831|9680533|FG018|COMPLETED|Intervention 4||1
8640428|NCT00584831|9680515|FG000|NOT COMPLETED|Intervention 4||0
8640429|NCT00584831|9680516|FG001|NOT COMPLETED|Intervention 4||0
8640430|NCT00584831|9680517|FG002|NOT COMPLETED|Intervention 4||0
9021685|NCT03117738|10084464|FG001|COMPLETED|Overall Study||5
9021686|NCT03117738|10084463|FG000|NOT COMPLETED|Overall Study||4
9021687|NCT03117738|10084464|FG001|NOT COMPLETED|Overall Study||5
9021688|NCT03118297|10084472|FG000|STARTED|Overall Study||32
9021689|NCT03118297|10084473|FG001|STARTED|Overall Study||33
9021690|NCT03118297|10084472|FG000|COMPLETED|Overall Study||32
9021691|NCT03118297|10084473|FG001|COMPLETED|Overall Study||31
9021692|NCT03118297|10084472|FG000|NOT COMPLETED|Overall Study||0
9021693|NCT03118297|10084473|FG001|NOT COMPLETED|Overall Study||2
9021694|NCT03118466|10084479|FG000|STARTED|Overall Study||40
9021695|NCT03118466|10084479|FG000|COMPLETED|Overall Study||40
9021696|NCT03118466|10084479|FG000|NOT COMPLETED|Overall Study||0
9021697|NCT03118518|10084485|FG000|STARTED|Overall Study||108
9021698|NCT03118518|10084486|FG001|STARTED|Overall Study||102
9021699|NCT03118518|10084485|FG000|Subject Treated According to Randomization Assignment|Overall Study||104
9021700|NCT03118518|10084486|FG001|Subject Treated According to Randomization Assignment|Overall Study||99
9021701|NCT03118518|10084485|FG000|COMPLETED|Overall Study||102
9021702|NCT03118518|10084486|FG001|COMPLETED|Overall Study||91
9021703|NCT03118518|10084485|FG000|NOT COMPLETED|Overall Study||6
9021704|NCT03118518|10084486|FG001|NOT COMPLETED|Overall Study||11
9021705|NCT03118596|10084494|FG000|STARTED|Overall Study||90
9021706|NCT03118596|10084495|FG001|STARTED|Overall Study||90
9021707|NCT03118596|10084494|FG000|Treated|Overall Study||2
9021708|NCT03118596|10084495|FG001|Treated|Overall Study||0
8640431|NCT00584831|9680518|FG003|NOT COMPLETED|Intervention 4||0
9021709|NCT03118596|10084494|FG000|Failed|Overall Study||0
9021710|NCT03118596|10084495|FG001|Failed|Overall Study||4
9021711|NCT03118596|10084494|FG000|COMPLETED|Overall Study||90
9021712|NCT03118596|10084495|FG001|COMPLETED|Overall Study||86
9021713|NCT03118596|10084494|FG000|NOT COMPLETED|Overall Study||0
9021714|NCT03118596|10084495|FG001|NOT COMPLETED|Overall Study||4
9021715|NCT03118739|10084503|FG000|STARTED|Overall Study||32
9021716|NCT03118739|10084504|FG001|STARTED|Overall Study||28
9021717|NCT03118739|10084503|FG000|Completed 12 Weeks of Treatment|Overall Study||26
9021718|NCT03118739|10084504|FG001|Completed 12 Weeks of Treatment|Overall Study||25
9021719|NCT03118739|10084503|FG000|Completed 24 Weeks of Treatment|Overall Study||24
9021720|NCT03118739|10084504|FG001|Completed 24 Weeks of Treatment|Overall Study||25
9021721|NCT03118739|10084503|FG000|COMPLETED|Overall Study||25
9021722|NCT03118739|10084504|FG001|COMPLETED|Overall Study||24
9021723|NCT03118739|10084503|FG000|NOT COMPLETED|Overall Study||7
9021724|NCT03118739|10084504|FG001|NOT COMPLETED|Overall Study||4
9021725|NCT03118765|10084515|FG000|STARTED|Overall Study||30
9021726|NCT03118765|10084516|FG001|STARTED|Overall Study||32
9021727|NCT03118765|10084517|FG002|STARTED|Overall Study||31
9021728|NCT03118765|10084518|FG003|STARTED|Overall Study||32
9021729|NCT03118765|10084519|FG004|STARTED|Overall Study||30
9021730|NCT03118765|10084515|FG000|COMPLETED|Overall Study||26
9021731|NCT03118765|10084516|FG001|COMPLETED|Overall Study||30
9021732|NCT03118765|10084517|FG002|COMPLETED|Overall Study||26
9021733|NCT03118765|10084518|FG003|COMPLETED|Overall Study||29
9021734|NCT03118765|10084519|FG004|COMPLETED|Overall Study||28
9021735|NCT03118765|10084515|FG000|NOT COMPLETED|Overall Study||4
9021736|NCT03118765|10084516|FG001|NOT COMPLETED|Overall Study||2
9021737|NCT03118765|10084517|FG002|NOT COMPLETED|Overall Study||5
9021738|NCT03118765|10084518|FG003|NOT COMPLETED|Overall Study||3
9021739|NCT03118765|10084519|FG004|NOT COMPLETED|Overall Study||2
9021740|NCT03118843|10084532|FG000|STARTED|Overall Study||31
9021741|NCT03118843|10084532|FG000|COMPLETED|Overall Study||31
9021742|NCT03118843|10084532|FG000|NOT COMPLETED|Overall Study||0
9021743|NCT03118934|10084539|FG000|STARTED|Overall Study||34
9021744|NCT03118934|10084540|FG001|STARTED|Overall Study||31
9021745|NCT03118934|10084541|FG002|STARTED|Overall Study||34
9021746|NCT03118934|10084542|FG003|STARTED|Overall Study||29
9021747|NCT03118934|10084543|FG004|STARTED|Overall Study||29
9021748|NCT03118934|10084544|FG005|STARTED|Overall Study||25
9021749|NCT03118934|10084539|FG000|Safety Analysis Set|Overall Study||34
9021750|NCT03118934|10084540|FG001|Safety Analysis Set|Overall Study||29
9021751|NCT03118934|10084541|FG002|Safety Analysis Set|Overall Study||34
9021752|NCT03118934|10084542|FG003|Safety Analysis Set|Overall Study||29
9021753|NCT03118934|10084543|FG004|Safety Analysis Set|Overall Study||26
9021754|NCT03118934|10084544|FG005|Safety Analysis Set|Overall Study||25
9021755|NCT03118934|10084539|FG000|COMPLETED|Overall Study||34
9021756|NCT03118934|10084540|FG001|COMPLETED|Overall Study||30
9021757|NCT03118934|10084541|FG002|COMPLETED|Overall Study||33
9021758|NCT03118934|10084542|FG003|COMPLETED|Overall Study||28
9021759|NCT03118934|10084543|FG004|COMPLETED|Overall Study||27
9021760|NCT03118934|10084544|FG005|COMPLETED|Overall Study||23
9021761|NCT03118934|10084539|FG000|NOT COMPLETED|Overall Study||0
9021762|NCT03118934|10084540|FG001|NOT COMPLETED|Overall Study||1
9021763|NCT03118934|10084541|FG002|NOT COMPLETED|Overall Study||1
9021764|NCT03118934|10084542|FG003|NOT COMPLETED|Overall Study||1
9021765|NCT03118934|10084543|FG004|NOT COMPLETED|Overall Study||2
9021766|NCT03118934|10084544|FG005|NOT COMPLETED|Overall Study||2
9021767|NCT03118947|10084554|FG000|STARTED|Overall Study||78
9021768|NCT03118947|10084554|FG000|COMPLETED|Overall Study||49
9021769|NCT03118947|10084554|FG000|NOT COMPLETED|Overall Study||29
9021770|NCT03119025|10084558|FG000|STARTED|Overall Study||10
9021771|NCT03119025|10084558|FG000|COMPLETED|Overall Study||10
9021772|NCT03119025|10084558|FG000|NOT COMPLETED|Overall Study||0
9021773|NCT03119168|10084564|FG000|STARTED|Overall Study||129
8640432|NCT00584831|9680519|FG004|NOT COMPLETED|Intervention 4||0
8640433|NCT00584831|9680520|FG005|NOT COMPLETED|Intervention 4||0
8640434|NCT00584831|9680521|FG006|NOT COMPLETED|Intervention 4||0
8640435|NCT00584831|9680522|FG007|NOT COMPLETED|Intervention 4||0
8640436|NCT00584831|9680523|FG008|NOT COMPLETED|Intervention 4||0
8640437|NCT00584831|9680524|FG009|NOT COMPLETED|Intervention 4||0
8640438|NCT00584831|9680525|FG010|NOT COMPLETED|Intervention 4||0
8640439|NCT00584831|9680526|FG011|NOT COMPLETED|Intervention 4||0
8640440|NCT00584831|9680527|FG012|NOT COMPLETED|Intervention 4||0
8640441|NCT00584831|9680528|FG013|NOT COMPLETED|Intervention 4||0
8640442|NCT00584831|9680529|FG014|NOT COMPLETED|Intervention 4||0
8640443|NCT00584831|9680530|FG015|NOT COMPLETED|Intervention 4||0
8640444|NCT00584831|9680531|FG016|NOT COMPLETED|Intervention 4||0
8640445|NCT00584831|9680532|FG017|NOT COMPLETED|Intervention 4||0
8640446|NCT00584831|9680533|FG018|NOT COMPLETED|Intervention 4||0
8640447|NCT00584844|9680543|FG000|STARTED|Overall Study||484
8640448|NCT00584844|9680543|FG000|COMPLETED|Overall Study||405
9021774|NCT03119168|10084565|FG001|STARTED|Overall Study||139
9021775|NCT03119168|10084564|FG000|COMPLETED|Overall Study||129
9021776|NCT03119168|10084565|FG001|COMPLETED|Overall Study||139
9021777|NCT03119168|10084564|FG000|NOT COMPLETED|Overall Study||0
8640449|NCT00584844|9680543|FG000|NOT COMPLETED|Overall Study||79
8640450|NCT00584857|9680551|FG000|STARTED|Overall Study||30
8640451|NCT00584857|9680551|FG000|COMPLETED|Overall Study||30
8640452|NCT00584857|9680551|FG000|NOT COMPLETED|Overall Study||0
8640453|NCT00584870|9680558|FG000|STARTED|Overall Study||88
8640454|NCT00584870|9680559|FG001|STARTED|Overall Study||89
8640455|NCT00584870|9680560|FG002|STARTED|Overall Study||43
8640456|NCT00584870|9680558|FG000|Treated|Overall Study||88
8640457|NCT00584870|9680559|FG001|Treated|Overall Study||88
9021778|NCT03119168|10084565|FG001|NOT COMPLETED|Overall Study||0
9021779|NCT03119181|10084575|FG000|STARTED|Overall Study||19
9021780|NCT03119181|10084576|FG001|STARTED|Overall Study||21
9021781|NCT03119181|10084575|FG000|COMPLETED|Overall Study||19
9021782|NCT03119181|10084576|FG001|COMPLETED|Overall Study||21
9021783|NCT03119181|10084575|FG000|NOT COMPLETED|Overall Study||0
9021784|NCT03119181|10084576|FG001|NOT COMPLETED|Overall Study||0
9021785|NCT03119389|10084584|FG000|STARTED|Overall Study||6791
9021786|NCT03119389|10084585|FG001|STARTED|Overall Study||7627
9021787|NCT03119389|10084584|FG000|COMPLETED|Overall Study||6791
9021788|NCT03119389|10084585|FG001|COMPLETED|Overall Study||7627
9021789|NCT03119389|10084584|FG000|NOT COMPLETED|Overall Study||0
9021790|NCT03119389|10084585|FG001|NOT COMPLETED|Overall Study||0
9021791|NCT03119571|10084595|FG000|STARTED|Overall Study||31
9021792|NCT03119571|10084596|FG001|STARTED|Overall Study||34
9021793|NCT03119571|10084595|FG000|COMPLETED|Overall Study||31
9021794|NCT03119571|10084596|FG001|COMPLETED|Overall Study||34
8640458|NCT00584870|9680560|FG002|Treated|Overall Study||41
8640459|NCT00584870|9680558|FG000|COMPLETED|Overall Study||59
8640460|NCT00584870|9680559|FG001|COMPLETED|Overall Study||64
8640461|NCT00584870|9680560|FG002|COMPLETED|Overall Study||25
8640462|NCT00584870|9680558|FG000|NOT COMPLETED|Overall Study||29
8640463|NCT00584870|9680559|FG001|NOT COMPLETED|Overall Study||25
8640464|NCT00584870|9680560|FG002|NOT COMPLETED|Overall Study||18
8640465|NCT00584909|9680568|FG000|STARTED|Overall Study||13
8640466|NCT00584909|9680568|FG000|COMPLETED|Overall Study||9
8640467|NCT00584909|9680568|FG000|NOT COMPLETED|Overall Study||4
8640468|NCT00584922|9680572|FG000|STARTED|Overall Study||175
8640469|NCT00584922|9680572|FG000|COMPLETED|Overall Study||175
8640470|NCT00584922|9680572|FG000|NOT COMPLETED|Overall Study||0
8640471|NCT00584948|9680578|FG000|STARTED|Overall Study||47
8640472|NCT00584948|9680579|FG001|STARTED|Overall Study||47
8640473|NCT00584948|9680578|FG000|COMPLETED|Overall Study||34
8640474|NCT00584948|9680579|FG001|COMPLETED|Overall Study||36
8640475|NCT00584948|9680578|FG000|NOT COMPLETED|Overall Study||13
8640476|NCT00584948|9680579|FG001|NOT COMPLETED|Overall Study||11
8640477|NCT00584987|9680589|FG000|STARTED|Overall Study||15
8640478|NCT00584987|9680590|FG001|STARTED|Overall Study||16
8640479|NCT00584987|9680591|FG002|STARTED|Overall Study||17
8640480|NCT00584987|9680592|FG003|STARTED|Overall Study||16
8640481|NCT00584987|9680589|FG000|COMPLETED|Overall Study||14
8640482|NCT00584987|9680590|FG001|COMPLETED|Overall Study||15
8640483|NCT00584987|9680591|FG002|COMPLETED|Overall Study||16
8640484|NCT00584987|9680592|FG003|COMPLETED|Overall Study||15
8640485|NCT00584987|9680589|FG000|NOT COMPLETED|Overall Study||1
8640486|NCT00584987|9680590|FG001|NOT COMPLETED|Overall Study||1
8640487|NCT00584987|9680591|FG002|NOT COMPLETED|Overall Study||1
8640488|NCT00584987|9680592|FG003|NOT COMPLETED|Overall Study||1
8640489|NCT00585013|9680604|FG000|STARTED|Overall Study||8
8640490|NCT00585013|9680605|FG001|STARTED|Overall Study||8
8640491|NCT00585013|9680604|FG000|COMPLETED|Overall Study||8
8640492|NCT00585013|9680605|FG001|COMPLETED|Overall Study||8
8640493|NCT00585013|9680604|FG000|NOT COMPLETED|Overall Study||0
8640494|NCT00585013|9680605|FG001|NOT COMPLETED|Overall Study||0
8640495|NCT00585039|9680615|FG000|STARTED|Overall Study||57
8640496|NCT00585039|9680616|FG001|STARTED|Overall Study||44
8640497|NCT00585039|9680615|FG000|COMPLETED|Overall Study||55
8640498|NCT00585039|9680616|FG001|COMPLETED|Overall Study||44
8640499|NCT00585039|9680615|FG000|NOT COMPLETED|Overall Study||2
8640500|NCT00585039|9680616|FG001|NOT COMPLETED|Overall Study||0
8640501|NCT00585052|9680624|FG000|STARTED|Overall Study||11
8640502|NCT00585052|9680624|FG000|COMPLETED|Overall Study||10
8640503|NCT00585052|9680624|FG000|NOT COMPLETED|Overall Study||1
8640504|NCT00585078|9680628|FG000|STARTED|Overall Study||40
8640505|NCT00585078|9680628|FG000|Treated|Overall Study||37
8640506|NCT00585078|9680628|FG000|Toxicity Evaluable|Overall Study||36
8640507|NCT00585078|9680628|FG000|Response Evaluable|Overall Study||24
8640508|NCT00585078|9680628|FG000|COMPLETED|Overall Study||0
8640509|NCT00585078|9680628|FG000|NOT COMPLETED|Overall Study||40
8640510|NCT00585104|9680632|FG000|STARTED|Overall Study||10
8640511|NCT00585104|9680632|FG000|COMPLETED|Overall Study||6
8640512|NCT00585104|9680632|FG000|NOT COMPLETED|Overall Study||4
8640513|NCT00585169|9680636|FG000|STARTED|Overall Study||29
8640514|NCT00585169|9680636|FG000|COMPLETED|Overall Study||28
8640515|NCT00585169|9680636|FG000|NOT COMPLETED|Overall Study||1
8640516|NCT00585182|9680642|FG000|STARTED|Overall Study||28
8640517|NCT00585182|9680642|FG000|COMPLETED|Overall Study||28
9021795|NCT03119571|10084595|FG000|NOT COMPLETED|Overall Study||0
9021796|NCT03119571|10084596|FG001|NOT COMPLETED|Overall Study||0
9021797|NCT03119610|10084604|FG000|STARTED|Overall Study||13
8640518|NCT00585182|9680642|FG000|NOT COMPLETED|Overall Study||0
8691371|NCT00854360|9736621|FG003|NOT COMPLETED|Overall Study||10
8691372|NCT00854373|9736633|FG000|STARTED|Overall Study||95
8691373|NCT00854373|9736634|FG001|STARTED|Overall Study||93
8691374|NCT00854373|9736633|FG000|COMPLETED|Overall Study||93
8691375|NCT00854373|9736634|FG001|COMPLETED|Overall Study||89
8691376|NCT00854373|9736633|FG000|NOT COMPLETED|Overall Study||2
8691377|NCT00854373|9736634|FG001|NOT COMPLETED|Overall Study||4
8691378|NCT00854581|9736640|FG000|STARTED|Induction (Up to Day 21)||13
8691379|NCT00854581|9736640|FG000|COMPLETED|Induction (Up to Day 21)||7
8691380|NCT00854581|9736640|FG000|NOT COMPLETED|Induction (Up to Day 21)||6
8691381|NCT00854581|9736640|FG000|STARTED|Part 1 Maintenance (Up to Day 60)||7
8691382|NCT00854581|9736640|FG000|COMPLETED|Part 1 Maintenance (Up to Day 60)||5
8691383|NCT00854581|9736640|FG000|NOT COMPLETED|Part 1 Maintenance (Up to Day 60)||2
8691384|NCT00854581|9736640|FG000|STARTED|Part 2 Maintenance (Up to 12 Months)||5
9021798|NCT03119610|10084605|FG001|STARTED|Overall Study||10
9021799|NCT03119610|10084604|FG000|COMPLETED|Overall Study||12
9021800|NCT03119610|10084605|FG001|COMPLETED|Overall Study||9
9021801|NCT03119610|10084604|FG000|NOT COMPLETED|Overall Study||1
9021802|NCT03119610|10084605|FG001|NOT COMPLETED|Overall Study||1
9021803|NCT03119649|10084616|FG000|STARTED|Overall Study||11
9021804|NCT03119649|10084617|FG001|STARTED|Overall Study||10
9021805|NCT03119649|10084618|FG002|STARTED|Overall Study||10
9021806|NCT03119649|10084619|FG003|STARTED|Overall Study||14
9021807|NCT03119649|10084620|FG004|STARTED|Overall Study||14
9021808|NCT03119649|10084616|FG000|COMPLETED|Overall Study||11
9021809|NCT03119649|10084617|FG001|COMPLETED|Overall Study||10
9021810|NCT03119649|10084618|FG002|COMPLETED|Overall Study||10
9021811|NCT03119649|10084619|FG003|COMPLETED|Overall Study||14
9021812|NCT03119649|10084620|FG004|COMPLETED|Overall Study||14
9021813|NCT03119649|10084616|FG000|NOT COMPLETED|Overall Study||0
9021814|NCT03119649|10084617|FG001|NOT COMPLETED|Overall Study||0
9021815|NCT03119649|10084618|FG002|NOT COMPLETED|Overall Study||0
9021816|NCT03119649|10084619|FG003|NOT COMPLETED|Overall Study||0
9021817|NCT03119649|10084620|FG004|NOT COMPLETED|Overall Study||0
9021818|NCT03119688|10084636|FG000|STARTED|Overall Study||48
9021819|NCT03119688|10084636|FG000|COMPLETED|Overall Study||44
9021820|NCT03119688|10084636|FG000|NOT COMPLETED|Overall Study||4
9021821|NCT03119701|10084655|FG000|STARTED|6-day Dosing||29
9021822|NCT03119701|10084656|FG001|STARTED|6-day Dosing||11
9021823|NCT03119701|10084655|FG000|COMPLETED|6-day Dosing||22
9021824|NCT03119701|10084656|FG001|COMPLETED|6-day Dosing||8
9021825|NCT03119701|10084655|FG000|NOT COMPLETED|6-day Dosing||7
9021826|NCT03119701|10084656|FG001|NOT COMPLETED|6-day Dosing||3
9021827|NCT03119701|10084655|FG000|STARTED|Mid-term (Final) Follow-up at D90|3 patients who discontinued study drug due to adverse events were also followed up.|25
9021828|NCT03119701|10084656|FG001|STARTED|Mid-term (Final) Follow-up at D90|2 patients who did not receive 6 doses were also followed up.|10
9021829|NCT03119701|10084655|FG000|COMPLETED|Mid-term (Final) Follow-up at D90||22
9021830|NCT03119701|10084656|FG001|COMPLETED|Mid-term (Final) Follow-up at D90||9
9021831|NCT03119701|10084655|FG000|NOT COMPLETED|Mid-term (Final) Follow-up at D90||3
9021832|NCT03119701|10084656|FG001|NOT COMPLETED|Mid-term (Final) Follow-up at D90||1
9021833|NCT03119831|10084665|FG000|STARTED|Overall Study||14
9021834|NCT03119831|10084666|FG001|STARTED|Overall Study||14
9021835|NCT03119831|10084667|FG002|STARTED|Overall Study||14
8640519|NCT00585247|9680648|FG000|STARTED|Overall Study||14
8640520|NCT00585247|9680649|FG001|STARTED|Overall Study||13
8640521|NCT00585247|9680648|FG000|COMPLETED|Overall Study||14
8640522|NCT00585247|9680649|FG001|COMPLETED|Overall Study||13
8640523|NCT00585247|9680648|FG000|NOT COMPLETED|Overall Study||0
8640524|NCT00585247|9680649|FG001|NOT COMPLETED|Overall Study||0
8640525|NCT00585286|9680655|FG000|STARTED|Overall Study||15
8640526|NCT00585286|9680655|FG000|COMPLETED|Overall Study||14
8640527|NCT00585286|9680655|FG000|NOT COMPLETED|Overall Study||1
8640528|NCT00585312|9680661|FG000|STARTED|Overall Study|STARTED=Randomized|55
8640529|NCT00585312|9680662|FG001|STARTED|Overall Study|STARTED=Randomized|51
8640530|NCT00585312|9680661|FG000|Treated|Overall Study||53
8640531|NCT00585312|9680662|FG001|Treated|Overall Study||48
8640532|NCT00585312|9680661|FG000|COMPLETED|Overall Study||4
8640533|NCT00585312|9680662|FG001|COMPLETED|Overall Study||7
8640534|NCT00585312|9680661|FG000|NOT COMPLETED|Overall Study||51
8640535|NCT00585312|9680662|FG001|NOT COMPLETED|Overall Study||44
8640536|NCT00585325|9680670|FG000|STARTED|Overall Study||10
8640537|NCT00585325|9680671|FG001|STARTED|Overall Study||13
8640538|NCT00585325|9680670|FG000|COMPLETED|Overall Study||9
8640539|NCT00585325|9680671|FG001|COMPLETED|Overall Study||12
8640540|NCT00585325|9680670|FG000|NOT COMPLETED|Overall Study||1
8640541|NCT00585325|9680671|FG001|NOT COMPLETED|Overall Study||1
8640542|NCT00585351|9680683|FG000|STARTED|Notification Period (Informed Consent)||50
8640543|NCT00585351|9680684|FG001|STARTED|Notification Period (Informed Consent)||50
8640544|NCT00585351|9680685|FG002|STARTED|Notification Period (Informed Consent)||0
8640545|NCT00585351|9680686|FG003|STARTED|Notification Period (Informed Consent)||0
8640546|NCT00585351|9680687|FG004|STARTED|Notification Period (Informed Consent)||0
8640547|NCT00585351|9680688|FG005|STARTED|Notification Period (Informed Consent)||0
8640548|NCT00585351|9680689|FG006|STARTED|Notification Period (Informed Consent)||0
8640549|NCT00585351|9680690|FG007|STARTED|Notification Period (Informed Consent)||0
8640550|NCT00585351|9680683|FG000|COMPLETED|Notification Period (Informed Consent)||27
8640551|NCT00585351|9680684|FG001|COMPLETED|Notification Period (Informed Consent)||25
8640552|NCT00585351|9680685|FG002|COMPLETED|Notification Period (Informed Consent)||0
8640553|NCT00585351|9680686|FG003|COMPLETED|Notification Period (Informed Consent)||0
8640554|NCT00585351|9680687|FG004|COMPLETED|Notification Period (Informed Consent)||0
8640555|NCT00585351|9680688|FG005|COMPLETED|Notification Period (Informed Consent)||0
8640556|NCT00585351|9680689|FG006|COMPLETED|Notification Period (Informed Consent)||0
8640557|NCT00585351|9680690|FG007|COMPLETED|Notification Period (Informed Consent)||0
8640558|NCT00585351|9680683|FG000|NOT COMPLETED|Notification Period (Informed Consent)||23
8640559|NCT00585351|9680684|FG001|NOT COMPLETED|Notification Period (Informed Consent)||25
8640560|NCT00585351|9680685|FG002|NOT COMPLETED|Notification Period (Informed Consent)||0
8640561|NCT00585351|9680686|FG003|NOT COMPLETED|Notification Period (Informed Consent)||0
8640562|NCT00585351|9680687|FG004|NOT COMPLETED|Notification Period (Informed Consent)||0
8640563|NCT00585351|9680688|FG005|NOT COMPLETED|Notification Period (Informed Consent)||0
9021836|NCT03119831|10084665|FG000|COMPLETED|Overall Study||14
9021837|NCT03119831|10084666|FG001|COMPLETED|Overall Study||14
9021838|NCT03119831|10084667|FG002|COMPLETED|Overall Study||14
9021839|NCT03119831|10084665|FG000|NOT COMPLETED|Overall Study||0
9021840|NCT03119831|10084666|FG001|NOT COMPLETED|Overall Study||0
9021841|NCT03119831|10084667|FG002|NOT COMPLETED|Overall Study||0
9021842|NCT03120013|10084678|FG000|STARTED|First Intervention (2 Weeks)||10
9021843|NCT03120013|10084679|FG001|STARTED|First Intervention (2 Weeks)||11
9021844|NCT03120013|10084678|FG000|Received Intervention|First Intervention (2 Weeks)||10
9021845|NCT03120013|10084679|FG001|Received Intervention|First Intervention (2 Weeks)||11
9021846|NCT03120013|10084678|FG000|COMPLETED|First Intervention (2 Weeks)||10
9021847|NCT03120013|10084679|FG001|COMPLETED|First Intervention (2 Weeks)||10
9021848|NCT03120013|10084678|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0
8640564|NCT00585351|9680689|FG006|NOT COMPLETED|Notification Period (Informed Consent)||0
8640565|NCT00585351|9680690|FG007|NOT COMPLETED|Notification Period (Informed Consent)||0
8640566|NCT00585351|9680683|FG000|STARTED|Enrollment Period (Intervention)|"Please refer to additional columns for subjects in Advanced Notification group for this period."|0
8640567|NCT00585351|9680684|FG001|STARTED|Enrollment Period (Intervention)|"Please refer to additional columns for subjects in No Advanced Notification group for this period."|0
8640568|NCT00585351|9680685|FG002|STARTED|Enrollment Period (Intervention)||15
8640569|NCT00585351|9680686|FG003|STARTED|Enrollment Period (Intervention)||15
8640570|NCT00585351|9680687|FG004|STARTED|Enrollment Period (Intervention)||5
8640571|NCT00585351|9680688|FG005|STARTED|Enrollment Period (Intervention)||7
8640572|NCT00585351|9680689|FG006|STARTED|Enrollment Period (Intervention)||7
8640573|NCT00585351|9680690|FG007|STARTED|Enrollment Period (Intervention)||3
8640574|NCT00585351|9680683|FG000|COMPLETED|Enrollment Period (Intervention)||0
8640575|NCT00585351|9680684|FG001|COMPLETED|Enrollment Period (Intervention)||0
8640576|NCT00585351|9680685|FG002|COMPLETED|Enrollment Period (Intervention)||15
8640577|NCT00585351|9680686|FG003|COMPLETED|Enrollment Period (Intervention)||15
8640578|NCT00585351|9680687|FG004|COMPLETED|Enrollment Period (Intervention)||3
8640579|NCT00585351|9680688|FG005|COMPLETED|Enrollment Period (Intervention)||5
8640580|NCT00585351|9680689|FG006|COMPLETED|Enrollment Period (Intervention)||5
8640581|NCT00585351|9680690|FG007|COMPLETED|Enrollment Period (Intervention)||2
8640582|NCT00585351|9680683|FG000|NOT COMPLETED|Enrollment Period (Intervention)||0
8640583|NCT00585351|9680684|FG001|NOT COMPLETED|Enrollment Period (Intervention)||0
8640584|NCT00585351|9680685|FG002|NOT COMPLETED|Enrollment Period (Intervention)||0
8640585|NCT00585351|9680686|FG003|NOT COMPLETED|Enrollment Period (Intervention)||0
8640586|NCT00585351|9680687|FG004|NOT COMPLETED|Enrollment Period (Intervention)||2
8640587|NCT00585351|9680688|FG005|NOT COMPLETED|Enrollment Period (Intervention)||2
8640588|NCT00585351|9680689|FG006|NOT COMPLETED|Enrollment Period (Intervention)||2
8640589|NCT00585351|9680690|FG007|NOT COMPLETED|Enrollment Period (Intervention)||1
8640590|NCT00585377|9680704|FG000|STARTED|Overall Study||50
8640591|NCT00585377|9680704|FG000|COMPLETED|Overall Study||50
8640592|NCT00585377|9680704|FG000|NOT COMPLETED|Overall Study||0
8640593|NCT00585468|9680708|FG000|STARTED|First Intervention||10
8640594|NCT00585468|9680709|FG001|STARTED|First Intervention||11
8640595|NCT00585468|9680708|FG000|COMPLETED|First Intervention||9
8640596|NCT00585468|9680709|FG001|COMPLETED|First Intervention||10
8640597|NCT00585468|9680708|FG000|NOT COMPLETED|First Intervention||1
8640598|NCT00585468|9680709|FG001|NOT COMPLETED|First Intervention||1
8640599|NCT00585468|9680708|FG000|STARTED|Second Intervention||9
8640600|NCT00585468|9680709|FG001|STARTED|Second Intervention||10
8640601|NCT00585468|9680708|FG000|COMPLETED|Second Intervention||9
8640602|NCT00585468|9680709|FG001|COMPLETED|Second Intervention||10
8640603|NCT00585468|9680708|FG000|NOT COMPLETED|Second Intervention||0
8640604|NCT00585468|9680709|FG001|NOT COMPLETED|Second Intervention||0
8640605|NCT00585494|9680717|FG000|STARTED|Overall Study||300
8640606|NCT00585494|9680717|FG000|COMPLETED|Overall Study||244
8640607|NCT00585494|9680717|FG000|NOT COMPLETED|Overall Study||56
8640608|NCT00585533|9680721|FG000|STARTED|Overall Study||40
8640609|NCT00585533|9680721|FG000|COMPLETED|Overall Study||31
8640610|NCT00585533|9680721|FG000|NOT COMPLETED|Overall Study||9
8640611|NCT00585546|9680725|FG000|STARTED|LVAD Implantation Required for 4 Months||18
8640612|NCT00585546|9680725|FG000|COMPLETED|LVAD Implantation Required for 4 Months||13
8640613|NCT00585546|9680725|FG000|NOT COMPLETED|LVAD Implantation Required for 4 Months||5
8640614|NCT00585546|9680725|FG000|STARTED|Clenbuterol Treatment - up to 12 Months||13
8640615|NCT00585546|9680725|FG000|COMPLETED|Clenbuterol Treatment - up to 12 Months||9
8640616|NCT00585546|9680725|FG000|NOT COMPLETED|Clenbuterol Treatment - up to 12 Months||4
8640617|NCT00585637|9680733|FG000|STARTED|Baseline||81
8640618|NCT00585637|9680734|FG001|STARTED|Baseline||81
9021849|NCT03120013|10084679|FG001|NOT COMPLETED|First Intervention (2 Weeks)||1
9021850|NCT03120013|10084678|FG000|STARTED|Washout (6 Months)||10
8640619|NCT00585637|9680735|FG002|STARTED|Baseline||83
8640620|NCT00585637|9680736|FG003|STARTED|Baseline||83
8640621|NCT00585637|9680733|FG000|COMPLETED|Baseline||81
8640622|NCT00585637|9680734|FG001|COMPLETED|Baseline||81
9021851|NCT03120013|10084679|FG001|STARTED|Washout (6 Months)||10
9021852|NCT03120013|10084678|FG000|COMPLETED|Washout (6 Months)||10
9021853|NCT03120013|10084679|FG001|COMPLETED|Washout (6 Months)||10
9021854|NCT03120013|10084678|FG000|NOT COMPLETED|Washout (6 Months)||0
9021855|NCT03120013|10084679|FG001|NOT COMPLETED|Washout (6 Months)||0
9021856|NCT03120013|10084678|FG000|STARTED|Second Intervention (2 Weeks)||10
9021857|NCT03120013|10084679|FG001|STARTED|Second Intervention (2 Weeks)||10
9021858|NCT03120013|10084678|FG000|COMPLETED|Second Intervention (2 Weeks)||10
9021859|NCT03120013|10084679|FG001|COMPLETED|Second Intervention (2 Weeks)||10
9021860|NCT03120013|10084678|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0
9021861|NCT03120013|10084679|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0
9021862|NCT03120351|10084687|FG000|STARTED|Overall Study||40
9021863|NCT03120351|10084688|FG001|STARTED|Overall Study||40
9021864|NCT03120351|10084687|FG000|COMPLETED|Overall Study||39
9021865|NCT03120351|10084688|FG001|COMPLETED|Overall Study||39
9021866|NCT03120351|10084687|FG000|NOT COMPLETED|Overall Study||1
9021867|NCT03120351|10084688|FG001|NOT COMPLETED|Overall Study||1
9021868|NCT03120520|10084698|FG000|STARTED|Overall Study||31
9021869|NCT03120520|10084699|FG001|STARTED|Overall Study||31
9021870|NCT03120520|10084700|FG002|STARTED|Overall Study||30
9021871|NCT03120520|10084701|FG003|STARTED|Overall Study||32
9021872|NCT03120520|10084698|FG000|COMPLETED|Overall Study||27
9021873|NCT03120520|10084699|FG001|COMPLETED|Overall Study||27
9021874|NCT03120520|10084700|FG002|COMPLETED|Overall Study||26
9021875|NCT03120520|10084701|FG003|COMPLETED|Overall Study||29
9021876|NCT03120520|10084698|FG000|NOT COMPLETED|Overall Study||4
9021877|NCT03120520|10084699|FG001|NOT COMPLETED|Overall Study||4
9021878|NCT03120520|10084700|FG002|NOT COMPLETED|Overall Study||4
9021879|NCT03120520|10084701|FG003|NOT COMPLETED|Overall Study||3
9021880|NCT03120832|10084714|FG000|STARTED|Overall Study||3
9021881|NCT03120832|10084715|FG001|STARTED|Overall Study||3
9021882|NCT03120832|10084716|FG002|STARTED|Overall Study||6
9021883|NCT03120832|10084714|FG000|COMPLETED|Overall Study||3
9021884|NCT03120832|10084715|FG001|COMPLETED|Overall Study||3
9021885|NCT03120832|10084716|FG002|COMPLETED|Overall Study||6
9021886|NCT03120832|10084714|FG000|NOT COMPLETED|Overall Study||0
8640623|NCT00585637|9680735|FG002|COMPLETED|Baseline||83
8640624|NCT00585637|9680736|FG003|COMPLETED|Baseline||83
8640625|NCT00585637|9680733|FG000|NOT COMPLETED|Baseline||0
8640626|NCT00585637|9680734|FG001|NOT COMPLETED|Baseline||0
8640627|NCT00585637|9680735|FG002|NOT COMPLETED|Baseline||0
8640628|NCT00585637|9680736|FG003|NOT COMPLETED|Baseline||0
8640629|NCT00585637|9680733|FG000|STARTED|3-month Time Point||81
8640630|NCT00585637|9680734|FG001|STARTED|3-month Time Point||81
8640631|NCT00585637|9680735|FG002|STARTED|3-month Time Point||83
8640632|NCT00585637|9680736|FG003|STARTED|3-month Time Point||83
8640633|NCT00585637|9680733|FG000|COMPLETED|3-month Time Point||71
8640634|NCT00585637|9680734|FG001|COMPLETED|3-month Time Point||67
8640635|NCT00585637|9680735|FG002|COMPLETED|3-month Time Point||76
8640636|NCT00585637|9680736|FG003|COMPLETED|3-month Time Point||78
8640637|NCT00585637|9680733|FG000|NOT COMPLETED|3-month Time Point||10
8640638|NCT00585637|9680734|FG001|NOT COMPLETED|3-month Time Point||14
8640639|NCT00585637|9680735|FG002|NOT COMPLETED|3-month Time Point||7
8640640|NCT00585637|9680736|FG003|NOT COMPLETED|3-month Time Point||5
8640641|NCT00585637|9680733|FG000|STARTED|6-month Time Point||81
8640642|NCT00585637|9680734|FG001|STARTED|6-month Time Point||81
8640643|NCT00585637|9680735|FG002|STARTED|6-month Time Point||83
8640644|NCT00585637|9680736|FG003|STARTED|6-month Time Point||83
8640645|NCT00585637|9680733|FG000|COMPLETED|6-month Time Point||75
8640646|NCT00585637|9680734|FG001|COMPLETED|6-month Time Point||68
8640647|NCT00585637|9680735|FG002|COMPLETED|6-month Time Point||72
8640648|NCT00585637|9680736|FG003|COMPLETED|6-month Time Point||77
8640649|NCT00585637|9680733|FG000|NOT COMPLETED|6-month Time Point||6
8640650|NCT00585637|9680734|FG001|NOT COMPLETED|6-month Time Point||13
8640651|NCT00585637|9680735|FG002|NOT COMPLETED|6-month Time Point||11
8640652|NCT00585637|9680736|FG003|NOT COMPLETED|6-month Time Point||6
8640653|NCT00585650|9680748|FG000|STARTED|Overall Study||8
8640654|NCT00585650|9680749|FG001|STARTED|Overall Study||12
8640655|NCT00585650|9680748|FG000|COMPLETED|Overall Study||8
8640656|NCT00585650|9680749|FG001|COMPLETED|Overall Study||12
8640657|NCT00585650|9680748|FG000|NOT COMPLETED|Overall Study||0
8640658|NCT00585650|9680749|FG001|NOT COMPLETED|Overall Study||0
8640659|NCT00585689|9680755|FG000|STARTED|Overall Study||29
8640660|NCT00585689|9680755|FG000|COMPLETED|Overall Study||22
8640661|NCT00585689|9680755|FG000|NOT COMPLETED|Overall Study||7
8640662|NCT00585715|9680761|FG000|STARTED|Overall Study||11
8640663|NCT00585715|9680762|FG001|STARTED|Overall Study||11
8640664|NCT00585715|9680761|FG000|COMPLETED|Overall Study||8
8640665|NCT00585715|9680762|FG001|COMPLETED|Overall Study||11
8640666|NCT00585715|9680761|FG000|NOT COMPLETED|Overall Study||3
8640667|NCT00585715|9680762|FG001|NOT COMPLETED|Overall Study||0
8640668|NCT00585780|9680772|FG000|STARTED|Overall Study||21
8640669|NCT00585780|9680773|FG001|STARTED|Overall Study||23
8640670|NCT00585780|9680774|FG002|STARTED|Overall Study||34
8640671|NCT00585780|9680775|FG003|STARTED|Overall Study||22
8640672|NCT00585780|9680772|FG000|COMPLETED|Overall Study||13
8640673|NCT00585780|9680773|FG001|COMPLETED|Overall Study||14
8640674|NCT00585780|9680774|FG002|COMPLETED|Overall Study||21
8640675|NCT00585780|9680775|FG003|COMPLETED|Overall Study||14
8640676|NCT00585780|9680772|FG000|NOT COMPLETED|Overall Study||8
8640677|NCT00585780|9680773|FG001|NOT COMPLETED|Overall Study||9
8640678|NCT00585780|9680774|FG002|NOT COMPLETED|Overall Study||13
8640679|NCT00585780|9680775|FG003|NOT COMPLETED|Overall Study||8
8640680|NCT00585910|9680789|FG000|STARTED|Atomoxetine (ATMX) Alone|This is the number of subjects who were exposed to ATMX in Phase I of the study.|72
8640681|NCT00585910|9680789|FG000|COMPLETED|Atomoxetine (ATMX) Alone|Number of subjects who completed Phase I. 15 completed only Phase I. 40 proceeded onto Phase II.|55
8640682|NCT00585910|9680789|FG000|NOT COMPLETED|Atomoxetine (ATMX) Alone||17
8640683|NCT00585910|9680789|FG000|STARTED|ATMX + Osmotic-Release Methylphenidate|Number of participants to add OROS MPH to their ATMX regimen|50
8640684|NCT00585910|9680789|FG000|COMPLETED|ATMX + Osmotic-Release Methylphenidate||41
8640685|NCT00585910|9680789|FG000|NOT COMPLETED|ATMX + Osmotic-Release Methylphenidate||9
8640686|NCT00585923|9680796|FG000|STARTED|Overall Study||56
8640687|NCT00585923|9680797|FG001|STARTED|Overall Study||59
8640688|NCT00585923|9680796|FG000|COMPLETED|Overall Study||25
8640689|NCT00585923|9680797|FG001|COMPLETED|Overall Study||26
8640690|NCT00585923|9680796|FG000|NOT COMPLETED|Overall Study||31
8640691|NCT00585923|9680797|FG001|NOT COMPLETED|Overall Study||33
8640692|NCT00585975|9680805|FG000|STARTED|Overall Study||277
8640693|NCT00585975|9680806|FG001|STARTED|Overall Study||291
8640694|NCT00585975|9680805|FG000|COMPLETED|Overall Study||262
8640695|NCT00585975|9680806|FG001|COMPLETED|Overall Study||278
8640696|NCT00585975|9680805|FG000|NOT COMPLETED|Overall Study||15
8640697|NCT00585975|9680806|FG001|NOT COMPLETED|Overall Study||13
8640698|NCT00586001|9680814|FG000|STARTED|Overall Study||26
8640699|NCT00586001|9680815|FG001|STARTED|Overall Study||11
8640700|NCT00586001|9680814|FG000|COMPLETED|Overall Study||22
8640701|NCT00586001|9680815|FG001|COMPLETED|Overall Study||10
8640702|NCT00586001|9680814|FG000|NOT COMPLETED|Overall Study||4
8640703|NCT00586001|9680815|FG001|NOT COMPLETED|Overall Study||1
8640704|NCT00586066|9680824|FG000|STARTED|Overall Study||48
8640705|NCT00586066|9680825|FG001|STARTED|Overall Study||24
8640706|NCT00586066|9680824|FG000|COMPLETED|Overall Study||30
8640707|NCT00586066|9680825|FG001|COMPLETED|Overall Study||14
8640708|NCT00586066|9680824|FG000|NOT COMPLETED|Overall Study||18
8640709|NCT00586066|9680825|FG001|NOT COMPLETED|Overall Study||10
8640710|NCT00586105|9680831|FG000|STARTED|Overall Study||39
8640711|NCT00586105|9680831|FG000|COMPLETED|Overall Study||0
8640712|NCT00586105|9680831|FG000|NOT COMPLETED|Overall Study||39
8640713|NCT00586157|9680835|FG000|STARTED|First Intervention||15
8640714|NCT00586157|9680836|FG001|STARTED|First Intervention||15
8640715|NCT00586157|9680835|FG000|COMPLETED|First Intervention||14
8640716|NCT00586157|9680836|FG001|COMPLETED|First Intervention||15
8640717|NCT00586157|9680835|FG000|NOT COMPLETED|First Intervention||1
8640718|NCT00586157|9680836|FG001|NOT COMPLETED|First Intervention||0
8640719|NCT00586157|9680835|FG000|STARTED|Second Intervention||14
8640720|NCT00586157|9680836|FG001|STARTED|Second Intervention||15
8640721|NCT00586157|9680835|FG000|COMPLETED|Second Intervention||12
8640722|NCT00586157|9680836|FG001|COMPLETED|Second Intervention||14
8640723|NCT00586157|9680835|FG000|NOT COMPLETED|Second Intervention||2
8640724|NCT00586157|9680836|FG001|NOT COMPLETED|Second Intervention||1
8640725|NCT00586170|9680844|FG000|STARTED|Overall Study||5
8640726|NCT00586170|9680845|FG001|STARTED|Overall Study|Initially enrollment was listed as 9. 1 placebo patient withdrew prior to surgery, so enrollment=8.|3
8640727|NCT00586170|9680844|FG000|COMPLETED|Overall Study||5
8640728|NCT00586170|9680845|FG001|COMPLETED|Overall Study||3
8640729|NCT00586170|9680844|FG000|NOT COMPLETED|Overall Study||0
8640730|NCT00586170|9680845|FG001|NOT COMPLETED|Overall Study||0
8640731|NCT00586196|9680853|FG000|STARTED|Overall Study||7
8640732|NCT00586196|9680854|FG001|STARTED|Overall Study||9
8640733|NCT00586196|9680853|FG000|COMPLETED|Overall Study||7
8640734|NCT00586196|9680854|FG001|COMPLETED|Overall Study||9
8640735|NCT00586196|9680853|FG000|NOT COMPLETED|Overall Study||0
8640736|NCT00586196|9680854|FG001|NOT COMPLETED|Overall Study||0
8640737|NCT00586261|9680862|FG000|STARTED|Overall Study||17
8640738|NCT00586261|9680863|FG001|STARTED|Overall Study||19
8640739|NCT00586261|9680862|FG000|COMPLETED|Overall Study||17
8640740|NCT00586261|9680863|FG001|COMPLETED|Overall Study||19
8640741|NCT00586261|9680862|FG000|NOT COMPLETED|Overall Study||0
8640742|NCT00586261|9680863|FG001|NOT COMPLETED|Overall Study||0
8640743|NCT00586313|9680869|FG000|STARTED|Overall Study||21
8640744|NCT00586313|9680869|FG000|COMPLETED|Overall Study||19
8640745|NCT00586313|9680869|FG000|NOT COMPLETED|Overall Study||2
8640746|NCT00586326|9680873|FG000|STARTED|Enrollment to Device Placement-Enrolled||133
8640747|NCT00586326|9680873|FG000|COMPLETED|Enrollment to Device Placement-Enrolled||118
8640748|NCT00586326|9680873|FG000|NOT COMPLETED|Enrollment to Device Placement-Enrolled||15
8640749|NCT00586326|9680873|FG000|STARTED|Device Placed toTreatment-ITT||118
8640750|NCT00586326|9680873|FG000|COMPLETED|Device Placed toTreatment-ITT||100
8640751|NCT00586326|9680873|FG000|NOT COMPLETED|Device Placed toTreatment-ITT||18
8640752|NCT00586326|9680873|FG000|STARTED|Treated Through 5-yr Follow Up-Treated||100
8693643|NCT00867789|9739186|FG001|NOT COMPLETED|Overall Study||0
8640753|NCT00586326|9680873|FG000|COMPLETED|Treated Through 5-yr Follow Up-Treated||74
8640754|NCT00586326|9680873|FG000|NOT COMPLETED|Treated Through 5-yr Follow Up-Treated||26
8640755|NCT00586339|9680884|FG000|STARTED|Overall Study||61
8640756|NCT00586339|9680885|FG001|STARTED|Overall Study||59
8640757|NCT00586339|9680886|FG002|STARTED|Overall Study||30
8640758|NCT00586339|9680884|FG000|COMPLETED|Overall Study||54
8640759|NCT00586339|9680885|FG001|COMPLETED|Overall Study||52
8640760|NCT00586339|9680886|FG002|COMPLETED|Overall Study||24
8640761|NCT00586339|9680884|FG000|NOT COMPLETED|Overall Study||7
8640762|NCT00586339|9680885|FG001|NOT COMPLETED|Overall Study||7
8640763|NCT00586339|9680886|FG002|NOT COMPLETED|Overall Study||6
8640764|NCT00586469|9680896|FG000|STARTED|Overall Study||500
8640765|NCT00586469|9680897|FG001|STARTED|Overall Study||500
8640766|NCT00586469|9680896|FG000|COMPLETED|Overall Study||500
8640767|NCT00586469|9680897|FG001|COMPLETED|Overall Study||499
8640768|NCT00586469|9680896|FG000|NOT COMPLETED|Overall Study||0
8640769|NCT00586469|9680897|FG001|NOT COMPLETED|Overall Study||1
8640770|NCT00586482|9680905|FG000|STARTED|Overall Study||22
8640771|NCT00586482|9680906|FG001|STARTED|Overall Study||24
8640772|NCT00586482|9680905|FG000|COMPLETED|Overall Study||22
8640773|NCT00586482|9680906|FG001|COMPLETED|Overall Study||24
8640774|NCT00586482|9680905|FG000|NOT COMPLETED|Overall Study||0
8640775|NCT00586482|9680906|FG001|NOT COMPLETED|Overall Study||0
8640776|NCT00586495|9680912|FG000|STARTED|Treatment Period||95
8640777|NCT00586495|9680912|FG000|COMPLETED|Treatment Period||0
8640778|NCT00586495|9680912|FG000|NOT COMPLETED|Treatment Period||95
8640779|NCT00586495|9680912|FG000|STARTED|Follow-up||92
8640780|NCT00586495|9680912|FG000|COMPLETED|Follow-up||0
8640781|NCT00586495|9680912|FG000|NOT COMPLETED|Follow-up||92
8640782|NCT00586508|9680918|FG000|STARTED|Overall Study||68
8640783|NCT00586508|9680919|FG001|STARTED|Overall Study||13
8640784|NCT00586508|9680918|FG000|Received at Least 1 Dose of Study Drug|Overall Study||68
8640785|NCT00586508|9680919|FG001|Received at Least 1 Dose of Study Drug|Overall Study||13
8640786|NCT00586508|9680918|FG000|COMPLETED|Overall Study||0
8640787|NCT00586508|9680919|FG001|COMPLETED|Overall Study||0
8640788|NCT00586508|9680918|FG000|NOT COMPLETED|Overall Study||68
8640789|NCT00586508|9680919|FG001|NOT COMPLETED|Overall Study||13
8640790|NCT00586521|9680925|FG000|STARTED|On Demand Treatment (Months 1-6)||20
8640791|NCT00586521|9680925|FG000|COMPLETED|On Demand Treatment (Months 1-6)||19
8640792|NCT00586521|9680925|FG000|NOT COMPLETED|On Demand Treatment (Months 1-6)||1
8640793|NCT00586521|9680925|FG000|STARTED|Prophylactic Treatment (Months 8-13)||19
8640794|NCT00586521|9680925|FG000|COMPLETED|Prophylactic Treatment (Months 8-13)||19
8640795|NCT00586521|9680925|FG000|NOT COMPLETED|Prophylactic Treatment (Months 8-13)||0
8640796|NCT00586573|9680929|FG000|STARTED|Overall Study||34
8640797|NCT00586573|9680929|FG000|COMPLETED|Overall Study||28
8640798|NCT00586573|9680929|FG000|NOT COMPLETED|Overall Study||6
8640799|NCT00586612|9680935|FG000|STARTED|Primary Phase||163
8640800|NCT00586612|9680936|FG001|STARTED|Primary Phase||150
8640801|NCT00586612|9680935|FG000|COMPLETED|Primary Phase||162
8640802|NCT00586612|9680936|FG001|COMPLETED|Primary Phase||147
8640803|NCT00586612|9680935|FG000|NOT COMPLETED|Primary Phase||1
8640804|NCT00586612|9680936|FG001|NOT COMPLETED|Primary Phase||3
8640805|NCT00586612|9680935|FG000|STARTED|Booster Phase||154
8640806|NCT00586612|9680936|FG001|STARTED|Booster Phase||144
8640807|NCT00586612|9680935|FG000|COMPLETED|Booster Phase||151
8640808|NCT00586612|9680936|FG001|COMPLETED|Booster Phase||143
8640809|NCT00586612|9680935|FG000|NOT COMPLETED|Booster Phase||3
8640810|NCT00586612|9680936|FG001|NOT COMPLETED|Booster Phase||1
8640811|NCT00586625|9680944|FG000|STARTED|Overall Study||575
8640812|NCT00586625|9680945|FG001|STARTED|Overall Study||286
8640813|NCT00586625|9680944|FG000|COMPLETED|Overall Study||532
8640814|NCT00586625|9680945|FG001|COMPLETED|Overall Study||269
8640815|NCT00586625|9680944|FG000|NOT COMPLETED|Overall Study||43
8640816|NCT00586625|9680945|FG001|NOT COMPLETED|Overall Study||17
8640817|NCT00586664|9680954|FG000|STARTED|Overall Study||43
8640818|NCT00586664|9680955|FG001|STARTED|Overall Study||43
8640819|NCT00586664|9680956|FG002|STARTED|Overall Study||44
8640820|NCT00586664|9680954|FG000|COMPLETED|Overall Study||38
8640821|NCT00586664|9680955|FG001|COMPLETED|Overall Study||36
8640822|NCT00586664|9680956|FG002|COMPLETED|Overall Study||43
8640823|NCT00586664|9680954|FG000|NOT COMPLETED|Overall Study||5
8640824|NCT00586664|9680955|FG001|NOT COMPLETED|Overall Study||7
8640825|NCT00586664|9680956|FG002|NOT COMPLETED|Overall Study||1
8640826|NCT00586690|9680966|FG000|STARTED|Overall Study|Four consented subjects were screen failures.|21
8640827|NCT00586690|9680967|FG001|STARTED|Overall Study||22
8640828|NCT00586690|9680966|FG000|COMPLETED|Overall Study||5
8640829|NCT00586690|9680967|FG001|COMPLETED|Overall Study||22
8640830|NCT00586690|9680966|FG000|NOT COMPLETED|Overall Study||16
8640831|NCT00586690|9680967|FG001|NOT COMPLETED|Overall Study||0
8640832|NCT00586703|9680972|FG000|STARTED|Overall Study||16
8640833|NCT00586703|9680972|FG000|COMPLETED|Overall Study||4
8640834|NCT00586703|9680972|FG000|NOT COMPLETED|Overall Study||12
8640835|NCT00586729|9680978|FG000|STARTED|Overall Study||14
8640836|NCT00586729|9680979|FG001|STARTED|Overall Study||9
8640837|NCT00586729|9680978|FG000|COMPLETED|Overall Study||11
8640838|NCT00586729|9680979|FG001|COMPLETED|Overall Study||8
8640839|NCT00586729|9680978|FG000|NOT COMPLETED|Overall Study||3
8640840|NCT00586729|9680979|FG001|NOT COMPLETED|Overall Study||1
8640841|NCT00586820|9680987|FG000|STARTED|Overall Study||12
8640842|NCT00586820|9680988|FG001|STARTED|Overall Study||11
8640843|NCT00586820|9680987|FG000|COMPLETED|Overall Study||11
8640844|NCT00586820|9680988|FG001|COMPLETED|Overall Study||11
8640845|NCT00586820|9680987|FG000|NOT COMPLETED|Overall Study||1
8640846|NCT00586820|9680988|FG001|NOT COMPLETED|Overall Study||0
8640847|NCT00586846|9680994|FG000|STARTED|Overall Study||40
8640848|NCT00586846|9680994|FG000|COMPLETED|Overall Study||34
8640849|NCT00586846|9680994|FG000|NOT COMPLETED|Overall Study||6
8640850|NCT00586898|9680998|FG000|STARTED|Overall Study||36
8640851|NCT00586898|9680998|FG000|COMPLETED|Overall Study||29
8640852|NCT00586898|9680998|FG000|NOT COMPLETED|Overall Study||7
8727243|NCT01042392|9774630|FG000|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||10
8727244|NCT01042392|9774631|FG001|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
8727245|NCT01042392|9774632|FG002|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||8
8727246|NCT01042392|9774633|FG003|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
9021887|NCT03120832|10084715|FG001|NOT COMPLETED|Overall Study||0
9021888|NCT03120832|10084716|FG002|NOT COMPLETED|Overall Study||0
8640853|NCT00587041|9681005|FG000|STARTED|Overall Study||12
8640854|NCT00587041|9681006|FG001|STARTED|Overall Study||14
8640855|NCT00587041|9681007|FG002|STARTED|Overall Study||14
8640856|NCT00587041|9681005|FG000|COMPLETED|Overall Study||12
8640857|NCT00587041|9681006|FG001|COMPLETED|Overall Study||14
8640858|NCT00587041|9681007|FG002|COMPLETED|Overall Study||14
8640859|NCT00587041|9681005|FG000|NOT COMPLETED|Overall Study||0
8640860|NCT00587041|9681006|FG001|NOT COMPLETED|Overall Study||0
8640861|NCT00587041|9681007|FG002|NOT COMPLETED|Overall Study||0
8640862|NCT00587054|9681015|FG000|STARTED|Overall Study||129
8640863|NCT00587054|9681015|FG000|COMPLETED|Overall Study||120
8640864|NCT00587054|9681015|FG000|NOT COMPLETED|Overall Study||9
8640865|NCT00587067|9681019|FG000|STARTED|Overall Study||34
8640866|NCT00587067|9681019|FG000|COMPLETED|Overall Study||34
8640867|NCT00587067|9681019|FG000|NOT COMPLETED|Overall Study||0
8640868|NCT00587132|9681027|FG000|STARTED|Overall Study||4
8640869|NCT00587132|9681028|FG001|STARTED|Overall Study||0
8640870|NCT00587132|9681029|FG002|STARTED|Overall Study||0
8640871|NCT00587132|9681030|FG003|STARTED|Overall Study||0
8640872|NCT00587132|9681027|FG000|COMPLETED|Overall Study||4
8640873|NCT00587132|9681028|FG001|COMPLETED|Overall Study||0
8640874|NCT00587132|9681029|FG002|COMPLETED|Overall Study||0
8640875|NCT00587132|9681030|FG003|COMPLETED|Overall Study||0
8640876|NCT00587132|9681027|FG000|NOT COMPLETED|Overall Study||0
8640877|NCT00587132|9681028|FG001|NOT COMPLETED|Overall Study||0
8640878|NCT00587132|9681029|FG002|NOT COMPLETED|Overall Study||0
8640879|NCT00587132|9681030|FG003|NOT COMPLETED|Overall Study||0
8640880|NCT00587158|9681042|FG000|STARTED|Overall Study||49
8640881|NCT00587158|9681043|FG001|STARTED|Overall Study||51
8640882|NCT00587158|9681042|FG000|Continued in Study|Overall Study||45
9021889|NCT03121144|10084724|FG000|STARTED|Overall Study||34
9021890|NCT03121144|10084724|FG000|COMPLETED|Overall Study||34
9021891|NCT03121144|10084724|FG000|NOT COMPLETED|Overall Study||0
9021892|NCT03121365|10084730|FG000|STARTED|Baseline||55
8640883|NCT00587158|9681043|FG001|Continued in Study|Overall Study||46
8640884|NCT00587158|9681042|FG000|COMPLETED|Overall Study||44
8640885|NCT00587158|9681043|FG001|COMPLETED|Overall Study||43
8640886|NCT00587158|9681042|FG000|NOT COMPLETED|Overall Study||5
8640887|NCT00587158|9681043|FG001|NOT COMPLETED|Overall Study||8
8640888|NCT00587171|9681051|FG000|STARTED|Overall Study||9
8640889|NCT00587171|9681052|FG001|STARTED|Overall Study||10
8640890|NCT00587171|9681051|FG000|COMPLETED|Overall Study||8
8640891|NCT00587171|9681052|FG001|COMPLETED|Overall Study||9
8640892|NCT00587171|9681051|FG000|NOT COMPLETED|Overall Study||1
8640893|NCT00587171|9681052|FG001|NOT COMPLETED|Overall Study||1
8640894|NCT00587288|9681060|FG000|STARTED|Overall Study||53
8640895|NCT00587288|9681061|FG001|STARTED|Overall Study||53
8640896|NCT00587288|9681060|FG000|COMPLETED|Overall Study||50
8640897|NCT00587288|9681061|FG001|COMPLETED|Overall Study||44
8640898|NCT00587288|9681060|FG000|NOT COMPLETED|Overall Study||3
8640899|NCT00587288|9681061|FG001|NOT COMPLETED|Overall Study||9
8640900|NCT00587431|9681071|FG000|STARTED|Overall Study||63
8640901|NCT00587431|9681072|FG001|STARTED|Overall Study||39
8640902|NCT00587431|9681071|FG000|COMPLETED|Overall Study||62
8640903|NCT00587431|9681072|FG001|COMPLETED|Overall Study||38
8640904|NCT00587431|9681071|FG000|NOT COMPLETED|Overall Study||1
8640905|NCT00587431|9681072|FG001|NOT COMPLETED|Overall Study||1
8640906|NCT00587457|9681084|FG000|STARTED|Overall Study||3
8640907|NCT00587457|9681085|FG001|STARTED|Overall Study||3
8640908|NCT00587457|9681086|FG002|STARTED|Overall Study||5
8640909|NCT00587457|9681084|FG000|COMPLETED|Overall Study||0
8640910|NCT00587457|9681085|FG001|COMPLETED|Overall Study||0
8640911|NCT00587457|9681086|FG002|COMPLETED|Overall Study||0
8640912|NCT00587457|9681084|FG000|NOT COMPLETED|Overall Study||3
8640913|NCT00587457|9681085|FG001|NOT COMPLETED|Overall Study||3
8640914|NCT00587457|9681086|FG002|NOT COMPLETED|Overall Study||5
8640915|NCT00587483|9681097|FG000|STARTED|Overall Study||115
8640916|NCT00587483|9681098|FG001|STARTED|Overall Study||115
8640917|NCT00587483|9681099|FG002|STARTED|Overall Study||112
8640918|NCT00587483|9681097|FG000|COMPLETED|Overall Study||115
8640919|NCT00587483|9681098|FG001|COMPLETED|Overall Study||115
9021893|NCT03121365|10084731|FG001|STARTED|Baseline||49
8640920|NCT00587483|9681099|FG002|COMPLETED|Overall Study||112
8640921|NCT00587483|9681097|FG000|NOT COMPLETED|Overall Study||0
8640922|NCT00587483|9681098|FG001|NOT COMPLETED|Overall Study||0
8640923|NCT00587483|9681099|FG002|NOT COMPLETED|Overall Study||0
8640924|NCT00587587|9681109|FG000|STARTED|Overall Study||17
8640925|NCT00587587|9681110|FG001|STARTED|Overall Study||13
8640926|NCT00587587|9681109|FG000|COMPLETED|Overall Study||11
8640927|NCT00587587|9681110|FG001|COMPLETED|Overall Study||12
8640928|NCT00587587|9681109|FG000|NOT COMPLETED|Overall Study||6
8640929|NCT00587587|9681110|FG001|NOT COMPLETED|Overall Study||1
8640930|NCT00587639|9681118|FG000|STARTED|Overall Study||8
8640931|NCT00587639|9681118|FG000|COMPLETED|Overall Study||7
9021894|NCT03121365|10084730|FG000|COMPLETED|Baseline||54
9021895|NCT03121365|10084731|FG001|COMPLETED|Baseline||48
9021896|NCT03121365|10084730|FG000|NOT COMPLETED|Baseline||1
8640932|NCT00587639|9681118|FG000|NOT COMPLETED|Overall Study||1
8640933|NCT00587678|9681125|FG000|STARTED|Overall Study||22
8640934|NCT00587678|9681126|FG001|STARTED|Overall Study||22
8640935|NCT00587678|9681127|FG002|STARTED|Overall Study||41
8640936|NCT00587678|9681125|FG000|COMPLETED|Overall Study||16
8640937|NCT00587678|9681126|FG001|COMPLETED|Overall Study||18
8640938|NCT00587678|9681127|FG002|COMPLETED|Overall Study||33
8640939|NCT00587678|9681125|FG000|NOT COMPLETED|Overall Study||6
8640940|NCT00587678|9681126|FG001|NOT COMPLETED|Overall Study||4
8640941|NCT00587678|9681127|FG002|NOT COMPLETED|Overall Study||8
8640942|NCT00587769|9681135|FG000|STARTED|Overall Study||38
8640943|NCT00587769|9681135|FG000|COMPLETED|Overall Study||38
8640944|NCT00587769|9681135|FG000|NOT COMPLETED|Overall Study||0
8640945|NCT00587834|9681139|FG000|STARTED|Overall Study||96
8640946|NCT00587834|9681139|FG000|COMPLETED|Overall Study||96
8640947|NCT00587834|9681139|FG000|NOT COMPLETED|Overall Study||0
8640948|NCT00587847|9681154|FG000|STARTED|Overall Study||12
8640949|NCT00587847|9681154|FG000|COMPLETED|Overall Study||5
8640950|NCT00587847|9681154|FG000|NOT COMPLETED|Overall Study||7
8691385|NCT00854581|9736640|FG000|COMPLETED|Part 2 Maintenance (Up to 12 Months)||2
8691386|NCT00854581|9736640|FG000|NOT COMPLETED|Part 2 Maintenance (Up to 12 Months)||3
8691387|NCT00854594|9736651|FG000|STARTED|Overall Study|9 sites randomized to control arm, providers completed surveys before and/or after study period|48
8691388|NCT00854594|9736652|FG001|STARTED|Overall Study|9 sites randomized to intervention, providers completed surveys before and/or after study period|69
8691389|NCT00854594|9736651|FG000|COMPLETED|Overall Study||48
8691390|NCT00854594|9736652|FG001|COMPLETED|Overall Study||69
8691391|NCT00854594|9736651|FG000|NOT COMPLETED|Overall Study||0
8691392|NCT00854594|9736652|FG001|NOT COMPLETED|Overall Study||0
8691393|NCT00854607|9736658|FG000|STARTED|Enrollment||116
8691394|NCT00854607|9736658|FG000|COMPLETED|Enrollment||116
8691395|NCT00854607|9736658|FG000|NOT COMPLETED|Enrollment||0
8691396|NCT00854607|9736658|FG000|STARTED|2 Weeks After Start Anti-fungal Therapy||116
8691397|NCT00854607|9736658|FG000|COMPLETED|2 Weeks After Start Anti-fungal Therapy||51
8691398|NCT00854607|9736658|FG000|NOT COMPLETED|2 Weeks After Start Anti-fungal Therapy||65
8691399|NCT00854620|9736669|FG000|STARTED|Overall Study||9
8691400|NCT00854620|9736669|FG000|COMPLETED|Overall Study||8
8691401|NCT00854620|9736669|FG000|NOT COMPLETED|Overall Study||1
8691402|NCT00854724|9736675|FG000|STARTED|First Intervention||8
8691403|NCT00854724|9736676|FG001|STARTED|First Intervention||8
8691404|NCT00854724|9736675|FG000|COMPLETED|First Intervention||7
8691405|NCT00854724|9736676|FG001|COMPLETED|First Intervention||7
8691406|NCT00854724|9736675|FG000|NOT COMPLETED|First Intervention||1
8691407|NCT00854724|9736676|FG001|NOT COMPLETED|First Intervention||1
8691408|NCT00854724|9736675|FG000|STARTED|Washout||7
8691409|NCT00854724|9736676|FG001|STARTED|Washout||7
8691410|NCT00854724|9736675|FG000|COMPLETED|Washout||6
8691411|NCT00854724|9736676|FG001|COMPLETED|Washout||6
8691412|NCT00854724|9736675|FG000|NOT COMPLETED|Washout||1
8691413|NCT00854724|9736676|FG001|NOT COMPLETED|Washout||1
8691414|NCT00854724|9736675|FG000|STARTED|Second Intervention||6
8691415|NCT00854724|9736676|FG001|STARTED|Second Intervention||6
8691416|NCT00854724|9736675|FG000|COMPLETED|Second Intervention||5
8691417|NCT00854724|9736676|FG001|COMPLETED|Second Intervention||5
8691418|NCT00854724|9736675|FG000|NOT COMPLETED|Second Intervention||1
8691419|NCT00854724|9736676|FG001|NOT COMPLETED|Second Intervention||1
8691420|NCT00854828|9736686|FG000|STARTED|Overall Study|6 patients crossed over to non-operative intervention.|30
8691421|NCT00854828|9736687|FG001|STARTED|Overall Study||33
8691422|NCT00854828|9736688|FG002|STARTED|Overall Study||112
8691423|NCT00854828|9736689|FG003|STARTED|Overall Study||111
8691424|NCT00854828|9736686|FG000|3 Months Post Intervention|Overall Study|6 missed visits|24
8691425|NCT00854828|9736687|FG001|3 Months Post Intervention|Overall Study|1 missed visit|32
8691426|NCT00854828|9736688|FG002|3 Months Post Intervention|Overall Study|112 (100%) of patients underwent operative treatment.|112
8691427|NCT00854828|9736689|FG003|3 Months Post Intervention|Overall Study|2 missed visits. 3 withdrew.|106
9021897|NCT03121365|10084731|FG001|NOT COMPLETED|Baseline||1
8691428|NCT00854828|9736686|FG000|12 Months Post Intervention|Overall Study|"2 missed visits.~1 withdrew.~1 deceased."|26
8691429|NCT00854828|9736687|FG001|12 Months Post Intervention|Overall Study|1 withdrew. 15 (45%) crossed over to operative treatment.|32
8691430|NCT00854828|9736688|FG002|12 Months Post Intervention|Overall Study||112
8691431|NCT00854828|9736689|FG003|12 Months Post Intervention|Overall Study|4 missed visits. 6 withdrew. 6 (5%) crossed over to operative treatment.|101
8691432|NCT00854828|9736686|FG000|24 Months Post Intervention|Overall Study|"1 missed visit.~1 withdrew.~1 deceased. 24 patients (80%) underwent surgery."|27
8691433|NCT00854828|9736687|FG001|24 Months Post Intervention|Overall Study|"1 missed visit.~1 withdrew. 21 (64%) crossed over to operative treatment."|31
9021898|NCT03121365|10084730|FG000|STARTED|1 Months||54
8640951|NCT04545008|9681159|FG000|STARTED|Overall Study||2
8640952|NCT04545008|9681159|FG000|COMPLETED|Overall Study||2
8640953|NCT04545008|9681159|FG000|NOT COMPLETED|Overall Study||0
8640954|NCT04411680|9681165|FG000|STARTED|Treatment Period||78
8640955|NCT04411680|9681166|FG001|STARTED|Treatment Period||44
8640956|NCT04411680|9681165|FG000|COMPLETED|Treatment Period||49
8640957|NCT04411680|9681166|FG001|COMPLETED|Treatment Period||36
8640958|NCT04411680|9681165|FG000|NOT COMPLETED|Treatment Period||29
8640959|NCT04411680|9681166|FG001|NOT COMPLETED|Treatment Period||8
8640960|NCT04411680|9681165|FG000|STARTED|Follow up Period||78
8640961|NCT04411680|9681166|FG001|STARTED|Follow up Period||44
8640962|NCT04411680|9681165|FG000|COMPLETED|Follow up Period||60
8640963|NCT04411680|9681166|FG001|COMPLETED|Follow up Period||30
8640964|NCT04411680|9681165|FG000|NOT COMPLETED|Follow up Period||18
8640965|NCT04411680|9681166|FG001|NOT COMPLETED|Follow up Period||14
8640966|NCT04364984|9681175|FG000|STARTED|Overall Study||37
8640967|NCT04364984|9681176|FG001|STARTED|Overall Study||44
8640968|NCT04364984|9681177|FG002|STARTED|Overall Study||31
8640969|NCT04364984|9681175|FG000|COMPLETED|Overall Study||35
8640970|NCT04364984|9681176|FG001|COMPLETED|Overall Study||42
8640971|NCT04364984|9681177|FG002|COMPLETED|Overall Study||31
8640972|NCT04364984|9681175|FG000|NOT COMPLETED|Overall Study||2
8640973|NCT04364984|9681176|FG001|NOT COMPLETED|Overall Study||2
8640974|NCT04364984|9681177|FG002|NOT COMPLETED|Overall Study||0
8640975|NCT04363437|9681187|FG000|STARTED|Overall Study||10
8640976|NCT04363437|9681188|FG001|STARTED|Overall Study||11
8640977|NCT04363437|9681187|FG000|COMPLETED|Overall Study||10
8640978|NCT04363437|9681188|FG001|COMPLETED|Overall Study||11
8640979|NCT04363437|9681187|FG000|NOT COMPLETED|Overall Study||0
8640980|NCT04363437|9681188|FG001|NOT COMPLETED|Overall Study||0
8640981|NCT04346537|9681194|FG000|STARTED|Overall Study||109
8640982|NCT04346537|9681194|FG000|Implanted With INGEVITY+ Lead|Overall Study||101
8640983|NCT04346537|9681194|FG000|COMPLETED|Overall Study||99
8640984|NCT04346537|9681194|FG000|NOT COMPLETED|Overall Study||10
8640985|NCT04033991|9681198|FG000|STARTED|Overall Study||684
8640986|NCT04033991|9681198|FG000|Participants Who Took First-line Sunitinib Therapy|Overall Study||622
8640987|NCT04033991|9681198|FG000|Participants Who Took Second-line Axitinib Therapy|Overall Study||121
8640988|NCT04033991|9681198|FG000|Participants Who Took First-line Sunitinib Therapy and Then Second-line Axitinib Therapy|Overall Study||59
8640989|NCT04033991|9681198|FG000|Participants Who Took Drugs Other Than Sunitinib as First-line and Then Second-line Axitinib Therapy|Overall Study||62
8640990|NCT04033991|9681198|FG000|COMPLETED|Overall Study||684
8640991|NCT04033991|9681198|FG000|NOT COMPLETED|Overall Study||0
8640992|NCT03930849|9681207|FG000|STARTED|Overall Study||17
8640993|NCT03930849|9681208|FG001|STARTED|Overall Study||18
8640994|NCT03930849|9681209|FG002|STARTED|Overall Study||18
8640995|NCT03930849|9681207|FG000|COMPLETED|Overall Study||13
8640996|NCT03930849|9681208|FG001|COMPLETED|Overall Study||18
8640997|NCT03930849|9681209|FG002|COMPLETED|Overall Study||14
8640998|NCT03930849|9681207|FG000|NOT COMPLETED|Overall Study||4
8640999|NCT03930849|9681208|FG001|NOT COMPLETED|Overall Study||0
8641000|NCT03930849|9681209|FG002|NOT COMPLETED|Overall Study||4
8641001|NCT03793439|9681217|FG000|STARTED|Overall Study||5
8641002|NCT03793439|9681217|FG000|COMPLETED|Overall Study||3
8641003|NCT03793439|9681217|FG000|NOT COMPLETED|Overall Study||2
8641004|NCT03711266|9681221|FG000|STARTED|Overall Study||30
8641005|NCT03711266|9681221|FG000|COMPLETED|Overall Study||20
8641006|NCT03711266|9681221|FG000|NOT COMPLETED|Overall Study||10
8641007|NCT03630393|9681227|FG000|STARTED|Overall Study||68
8641008|NCT03630393|9681228|FG001|STARTED|Overall Study||71
8641009|NCT03630393|9681227|FG000|COMPLETED|Overall Study||67
8641010|NCT03630393|9681228|FG001|COMPLETED|Overall Study||71
8641011|NCT03630393|9681227|FG000|NOT COMPLETED|Overall Study||1
8641012|NCT03630393|9681228|FG001|NOT COMPLETED|Overall Study||0
8641013|NCT03531788|9681236|FG000|STARTED|Overall Study||12
8641014|NCT03531788|9681237|FG001|STARTED|Overall Study||6
8641015|NCT03531788|9681236|FG000|COMPLETED|Overall Study||11
8641016|NCT03531788|9681237|FG001|COMPLETED|Overall Study||6
8641017|NCT03531788|9681236|FG000|NOT COMPLETED|Overall Study||1
8641018|NCT03531788|9681237|FG001|NOT COMPLETED|Overall Study||0
8641019|NCT03359811|9681245|FG000|STARTED|Overall Study||35
8641020|NCT03359811|9681246|FG001|STARTED|Overall Study||35
8641021|NCT03359811|9681245|FG000|COMPLETED|Overall Study||33
8641022|NCT03359811|9681246|FG001|COMPLETED|Overall Study||35
8641023|NCT03359811|9681245|FG000|NOT COMPLETED|Overall Study||2
8641024|NCT03359811|9681246|FG001|NOT COMPLETED|Overall Study||0
8641025|NCT03241589|9681255|FG000|STARTED|Overall Study||109
8641026|NCT03241589|9681256|FG001|STARTED|Overall Study||357
8641027|NCT03241589|9681255|FG000|COMPLETED|Overall Study||109
8641028|NCT03241589|9681256|FG001|COMPLETED|Overall Study||357
8641029|NCT03241589|9681255|FG000|NOT COMPLETED|Overall Study||0
8641030|NCT03241589|9681256|FG001|NOT COMPLETED|Overall Study||0
8641031|NCT02959775|9681267|FG000|STARTED|Overall Study||160
8641032|NCT02959775|9681268|FG001|STARTED|Overall Study||160
8641033|NCT02959775|9681269|FG002|STARTED|Overall Study||160
8641034|NCT02959775|9681267|FG000|COMPLETED|Overall Study||133
8641035|NCT02959775|9681268|FG001|COMPLETED|Overall Study||133
8641036|NCT02959775|9681269|FG002|COMPLETED|Overall Study||124
8641037|NCT02959775|9681267|FG000|NOT COMPLETED|Overall Study||27
8641038|NCT02959775|9681268|FG001|NOT COMPLETED|Overall Study||27
8641039|NCT02959775|9681269|FG002|NOT COMPLETED|Overall Study||36
8641040|NCT02954406|9681288|FG000|STARTED|Overall Study||3
8641041|NCT02954406|9681289|FG001|STARTED|Overall Study||6
8641042|NCT02954406|9681290|FG002|STARTED|Overall Study||6
8641043|NCT02954406|9681291|FG003|STARTED|Overall Study||6
8641044|NCT02954406|9681292|FG004|STARTED|Overall Study||7
8641045|NCT02954406|9681293|FG005|STARTED|Overall Study||3
8641046|NCT02954406|9681294|FG006|STARTED|Overall Study||3
8641047|NCT02954406|9681295|FG007|STARTED|Overall Study||2
8641048|NCT02954406|9681296|FG008|STARTED|Overall Study||4
8641049|NCT02954406|9681297|FG009|STARTED|Overall Study||3
8641050|NCT02954406|9681298|FG010|STARTED|Overall Study||0
8641051|NCT02954406|9681288|FG000|COMPLETED|Overall Study||0
8641052|NCT02954406|9681289|FG001|COMPLETED|Overall Study||0
8641053|NCT02954406|9681290|FG002|COMPLETED|Overall Study||0
8641054|NCT02954406|9681291|FG003|COMPLETED|Overall Study||0
8641055|NCT02954406|9681292|FG004|COMPLETED|Overall Study||0
8641056|NCT02954406|9681293|FG005|COMPLETED|Overall Study||0
8641057|NCT02954406|9681294|FG006|COMPLETED|Overall Study||0
8641058|NCT02954406|9681295|FG007|COMPLETED|Overall Study||0
8641059|NCT02954406|9681296|FG008|COMPLETED|Overall Study||0
8641060|NCT02954406|9681297|FG009|COMPLETED|Overall Study||0
8641061|NCT02954406|9681298|FG010|COMPLETED|Overall Study||0
8641062|NCT02954406|9681288|FG000|NOT COMPLETED|Overall Study||3
8641063|NCT02954406|9681289|FG001|NOT COMPLETED|Overall Study||6
8641064|NCT02954406|9681290|FG002|NOT COMPLETED|Overall Study||6
8641065|NCT02954406|9681291|FG003|NOT COMPLETED|Overall Study||6
8641066|NCT02954406|9681292|FG004|NOT COMPLETED|Overall Study||7
8641067|NCT02954406|9681293|FG005|NOT COMPLETED|Overall Study||3
8641068|NCT02954406|9681294|FG006|NOT COMPLETED|Overall Study||3
8641069|NCT02954406|9681295|FG007|NOT COMPLETED|Overall Study||2
8641070|NCT02954406|9681296|FG008|NOT COMPLETED|Overall Study||4
8641071|NCT02954406|9681297|FG009|NOT COMPLETED|Overall Study||3
8641072|NCT02954406|9681298|FG010|NOT COMPLETED|Overall Study||0
8641073|NCT02927145|9681333|FG000|STARTED|Initial Recruitment||12
8641074|NCT02927145|9681334|FG001|STARTED|Initial Recruitment||12
8641075|NCT02927145|9681335|FG002|STARTED|Initial Recruitment||12
8641076|NCT02927145|9681336|FG003|STARTED|Initial Recruitment||14
8641077|NCT02927145|9681337|FG004|STARTED|Initial Recruitment||17
8641078|NCT02927145|9681338|FG005|STARTED|Initial Recruitment||15
8641079|NCT02927145|9681339|FG006|STARTED|Initial Recruitment||0
8641080|NCT02927145|9681340|FG007|STARTED|Initial Recruitment||0
8641081|NCT02927145|9681341|FG008|STARTED|Initial Recruitment||6
8641082|NCT02927145|9681333|FG000|COMPLETED|Initial Recruitment||12
8641083|NCT02927145|9681334|FG001|COMPLETED|Initial Recruitment||11
8641084|NCT02927145|9681335|FG002|COMPLETED|Initial Recruitment||11
8641085|NCT02927145|9681336|FG003|COMPLETED|Initial Recruitment||10
8641086|NCT02927145|9681337|FG004|COMPLETED|Initial Recruitment||14
8641087|NCT02927145|9681338|FG005|COMPLETED|Initial Recruitment||14
8641088|NCT02927145|9681339|FG006|COMPLETED|Initial Recruitment||0
8641089|NCT02927145|9681340|FG007|COMPLETED|Initial Recruitment||0
8641090|NCT02927145|9681341|FG008|COMPLETED|Initial Recruitment||4
8641091|NCT02927145|9681333|FG000|NOT COMPLETED|Initial Recruitment||0
8641092|NCT02927145|9681334|FG001|NOT COMPLETED|Initial Recruitment||1
8641093|NCT02927145|9681335|FG002|NOT COMPLETED|Initial Recruitment||1
8641094|NCT02927145|9681336|FG003|NOT COMPLETED|Initial Recruitment||4
8641095|NCT02927145|9681337|FG004|NOT COMPLETED|Initial Recruitment||3
8641096|NCT02927145|9681338|FG005|NOT COMPLETED|Initial Recruitment||1
8641097|NCT02927145|9681339|FG006|NOT COMPLETED|Initial Recruitment||0
8641098|NCT02927145|9681340|FG007|NOT COMPLETED|Initial Recruitment||0
8641099|NCT02927145|9681341|FG008|NOT COMPLETED|Initial Recruitment||2
8641100|NCT02927145|9681333|FG000|STARTED|Invitation for Additional Challenge||0
8641101|NCT02927145|9681334|FG001|STARTED|Invitation for Additional Challenge||0
8641102|NCT02927145|9681335|FG002|STARTED|Invitation for Additional Challenge||0
8641103|NCT02927145|9681336|FG003|STARTED|Invitation for Additional Challenge||0
8641104|NCT02927145|9681337|FG004|STARTED|Invitation for Additional Challenge||0
8641105|NCT02927145|9681338|FG005|STARTED|Invitation for Additional Challenge||0
8641106|NCT02927145|9681339|FG006|STARTED|Invitation for Additional Challenge||9
8641107|NCT02927145|9681340|FG007|STARTED|Invitation for Additional Challenge||8
8641108|NCT02927145|9681341|FG008|STARTED|Invitation for Additional Challenge||0
8641109|NCT02927145|9681333|FG000|COMPLETED|Invitation for Additional Challenge||0
8641110|NCT02927145|9681334|FG001|COMPLETED|Invitation for Additional Challenge||0
8641111|NCT02927145|9681335|FG002|COMPLETED|Invitation for Additional Challenge||0
8641112|NCT02927145|9681336|FG003|COMPLETED|Invitation for Additional Challenge||0
8641113|NCT02927145|9681337|FG004|COMPLETED|Invitation for Additional Challenge||0
8641114|NCT02927145|9681338|FG005|COMPLETED|Invitation for Additional Challenge||0
8641115|NCT02927145|9681339|FG006|COMPLETED|Invitation for Additional Challenge||8
8641116|NCT02927145|9681340|FG007|COMPLETED|Invitation for Additional Challenge||8
8641117|NCT02927145|9681341|FG008|COMPLETED|Invitation for Additional Challenge||0
8641118|NCT02927145|9681333|FG000|NOT COMPLETED|Invitation for Additional Challenge||0
8641119|NCT02927145|9681334|FG001|NOT COMPLETED|Invitation for Additional Challenge||0
8641120|NCT02927145|9681335|FG002|NOT COMPLETED|Invitation for Additional Challenge||0
8641121|NCT02927145|9681336|FG003|NOT COMPLETED|Invitation for Additional Challenge||0
8641122|NCT02927145|9681337|FG004|NOT COMPLETED|Invitation for Additional Challenge||0
8641123|NCT02927145|9681338|FG005|NOT COMPLETED|Invitation for Additional Challenge||0
8641124|NCT02927145|9681339|FG006|NOT COMPLETED|Invitation for Additional Challenge||1
8641125|NCT02927145|9681340|FG007|NOT COMPLETED|Invitation for Additional Challenge||0
8641126|NCT02927145|9681341|FG008|NOT COMPLETED|Invitation for Additional Challenge||0
8641127|NCT02910583|9681364|FG000|STARTED|Overall Study||159
8641128|NCT02910583|9681365|FG001|STARTED|Overall Study||164
8641129|NCT02910583|9681364|FG000|MRD Cohort/ Not Randomized|Overall Study|Not applicable to this cohort.|0
8641130|NCT02910583|9681365|FG001|MRD Cohort/ Not Randomized|Overall Study||15
8641131|NCT02910583|9681364|FG000|MRD Cohort/ Confirmed uMRD: Randomized to Ibrutinib (Blinded)|Overall Study|Not applicable to this cohort.|0
8641132|NCT02910583|9681365|FG001|MRD Cohort/ Confirmed uMRD: Randomized to Ibrutinib (Blinded)|Overall Study||43
8641133|NCT02910583|9681364|FG000|MRD Cohort/ Confirmed uMRD: Randomized Placebo (Blinded)|Overall Study|Not applicable to this cohort.|0
8641134|NCT02910583|9681365|FG001|MRD Cohort/ Confirmed uMRD: Randomized Placebo (Blinded)|Overall Study||43
8641135|NCT02910583|9681364|FG000|MRD Cohort/uMRD Not Confirmed: Randomized to Ibrutinib (Open-Label)|Overall Study|Not applicable to this cohort.|0
8641136|NCT02910583|9681365|FG001|MRD Cohort/uMRD Not Confirmed: Randomized to Ibrutinib (Open-Label)|Overall Study||31
8641137|NCT02910583|9681364|FG000|MRD Cohort/uMRD Not Confirmed: Randomized Ibrutinib + Venetoclax (Open-Label)|Overall Study|Not applicable to this cohort.|0
8641138|NCT02910583|9681365|FG001|MRD Cohort/uMRD Not Confirmed: Randomized Ibrutinib + Venetoclax (Open-Label)|Overall Study||32
8641139|NCT02910583|9681364|FG000|COMPLETED|Overall Study||152
8641140|NCT02910583|9681365|FG001|COMPLETED|Overall Study||157
8641141|NCT02910583|9681364|FG000|NOT COMPLETED|Overall Study||7
8641142|NCT02910583|9681365|FG001|NOT COMPLETED|Overall Study||7
8641143|NCT02699060|9681402|FG000|STARTED|Overall Study||68
8641144|NCT02699060|9681402|FG000|COMPLETED|Overall Study||68
8641145|NCT02699060|9681402|FG000|NOT COMPLETED|Overall Study||0
8727247|NCT01042392|9774630|FG000|STARTED|Period III (Unblinded,Controlled, 1 Day)||129
8727248|NCT01042392|9774631|FG001|STARTED|Period III (Unblinded,Controlled, 1 Day)||118
8727249|NCT01042392|9774632|FG002|STARTED|Period III (Unblinded,Controlled, 1 Day)||119
8641146|NCT02598388|9681422|FG000|STARTED|Overall Study||40
8641147|NCT02598388|9681423|FG001|STARTED|Overall Study||10
8641148|NCT02598388|9681424|FG002|STARTED|Overall Study||20
8641149|NCT02598388|9681425|FG003|STARTED|Overall Study||5
8641150|NCT02598388|9681426|FG004|STARTED|Overall Study||161
8641151|NCT02598388|9681427|FG005|STARTED|Overall Study||39
8641152|NCT02598388|9681428|FG006|STARTED|Overall Study||161
8641153|NCT02598388|9681429|FG007|STARTED|Overall Study||39
8641154|NCT02598388|9681430|FG008|STARTED|Overall Study||39
8641155|NCT02598388|9681431|FG009|STARTED|Overall Study||10
8641156|NCT02598388|9681432|FG010|STARTED|Overall Study||40
8641157|NCT02598388|9681433|FG011|STARTED|Overall Study||10
8641158|NCT02598388|9681422|FG000|COMPLETED|Overall Study||39
8641159|NCT02598388|9681423|FG001|COMPLETED|Overall Study||10
8641160|NCT02598388|9681424|FG002|COMPLETED|Overall Study||18
8641161|NCT02598388|9681425|FG003|COMPLETED|Overall Study||5
8641162|NCT02598388|9681426|FG004|COMPLETED|Overall Study||151
8641163|NCT02598388|9681427|FG005|COMPLETED|Overall Study||38
8641164|NCT02598388|9681428|FG006|COMPLETED|Overall Study||156
8641165|NCT02598388|9681429|FG007|COMPLETED|Overall Study||38
8641166|NCT02598388|9681430|FG008|COMPLETED|Overall Study||39
8641167|NCT02598388|9681431|FG009|COMPLETED|Overall Study||9
8641168|NCT02598388|9681432|FG010|COMPLETED|Overall Study||39
8641169|NCT02598388|9681433|FG011|COMPLETED|Overall Study||10
8641170|NCT02598388|9681422|FG000|NOT COMPLETED|Overall Study||1
8641171|NCT02598388|9681423|FG001|NOT COMPLETED|Overall Study||0
8641172|NCT02598388|9681424|FG002|NOT COMPLETED|Overall Study||2
8641173|NCT02598388|9681425|FG003|NOT COMPLETED|Overall Study||0
8641174|NCT02598388|9681426|FG004|NOT COMPLETED|Overall Study||10
8641175|NCT02598388|9681427|FG005|NOT COMPLETED|Overall Study||1
8641176|NCT02598388|9681428|FG006|NOT COMPLETED|Overall Study||5
8641177|NCT02598388|9681429|FG007|NOT COMPLETED|Overall Study||1
8641178|NCT02598388|9681430|FG008|NOT COMPLETED|Overall Study||0
8641179|NCT02598388|9681431|FG009|NOT COMPLETED|Overall Study||1
8641180|NCT02598388|9681432|FG010|NOT COMPLETED|Overall Study||1
8641181|NCT02598388|9681433|FG011|NOT COMPLETED|Overall Study||0
8641182|NCT02493751|9681466|FG000|STARTED|Overall Study||16
8641183|NCT02493751|9681467|FG001|STARTED|Overall Study||39
8641184|NCT02493751|9681466|FG000|COMPLETED|Overall Study||0
8641185|NCT02493751|9681467|FG001|COMPLETED|Overall Study||0
8641186|NCT02493751|9681466|FG000|NOT COMPLETED|Overall Study||16
8641187|NCT02493751|9681467|FG001|NOT COMPLETED|Overall Study||39
8641188|NCT02285166|9681474|FG000|STARTED|Overall Study||15330
8641189|NCT02285166|9681474|FG000|COMPLETED|Overall Study||14364
8641190|NCT02285166|9681474|FG000|NOT COMPLETED|Overall Study||966
8641191|NCT02075593|9681480|FG000|STARTED|Overall Study||4
8641192|NCT02075593|9681480|FG000|Infants Born to Pregnant Women Who Received at Least One Dose of Study Treatment|Overall Study||4
8641193|NCT02075593|9681480|FG000|COMPLETED|Overall Study||1
8641194|NCT02075593|9681480|FG000|NOT COMPLETED|Overall Study||3
8691434|NCT00854828|9736688|FG002|24 Months Post Intervention|Overall Study|8 missed visits.|104
8691435|NCT00854828|9736689|FG003|24 Months Post Intervention|Overall Study|8 missed visits. 9 withdrew. 14 (13%) crossed over to operative treatment.|94
8691436|NCT00854828|9736686|FG000|COMPLETED|Overall Study||27
8727250|NCT01042392|9774633|FG003|STARTED|Period III (Unblinded,Controlled, 1 Day)||122
8806594|NCT01478581|9858813|FG003|COMPLETED|Overall Study||43
8806595|NCT01478581|9858810|FG000|NOT COMPLETED|Overall Study||0
8691437|NCT00854828|9736687|FG001|COMPLETED|Overall Study||31
8691438|NCT00854828|9736688|FG002|COMPLETED|Overall Study||104
8691439|NCT00854828|9736689|FG003|COMPLETED|Overall Study||94
8641195|NCT00587860|9681488|FG000|STARTED|Overall Study||35
8641196|NCT00587860|9681489|FG001|STARTED|Overall Study||35
8641197|NCT00587860|9681488|FG000|COMPLETED|Overall Study||30
8641198|NCT00587860|9681489|FG001|COMPLETED|Overall Study||30
8641199|NCT00587860|9681488|FG000|NOT COMPLETED|Overall Study||5
8641200|NCT00587860|9681489|FG001|NOT COMPLETED|Overall Study||5
8641201|NCT00587964|9681495|FG000|STARTED|Overall Study||51
8641202|NCT00587964|9681495|FG000|COMPLETED|Overall Study||39
8641203|NCT00587964|9681495|FG000|NOT COMPLETED|Overall Study||12
8641204|NCT00587990|9681502|FG000|STARTED|Overall Study||2
8641205|NCT00587990|9681503|FG001|STARTED|Overall Study||4
8641206|NCT00587990|9681504|FG002|STARTED|Overall Study||3
8641207|NCT00587990|9681502|FG000|COMPLETED|Overall Study||2
8641208|NCT00587990|9681503|FG001|COMPLETED|Overall Study||4
8641209|NCT00587990|9681504|FG002|COMPLETED|Overall Study||2
8641210|NCT00587990|9681502|FG000|NOT COMPLETED|Overall Study||0
8641211|NCT00587990|9681503|FG001|NOT COMPLETED|Overall Study||0
8641212|NCT00587990|9681504|FG002|NOT COMPLETED|Overall Study||1
8641213|NCT00588094|9681512|FG000|STARTED|Overall Study||20
8641214|NCT00588094|9681512|FG000|COMPLETED|Overall Study||15
9021899|NCT03121365|10084731|FG001|STARTED|1 Months||48
9021900|NCT03121365|10084730|FG000|COMPLETED|1 Months||52
9021901|NCT03121365|10084731|FG001|COMPLETED|1 Months||45
9021902|NCT03121365|10084730|FG000|NOT COMPLETED|1 Months||2
9021903|NCT03121365|10084731|FG001|NOT COMPLETED|1 Months||3
9021904|NCT03121365|10084730|FG000|STARTED|4 Months||54
9021905|NCT03121365|10084731|FG001|STARTED|4 Months||45
9021906|NCT03121365|10084730|FG000|COMPLETED|4 Months||51
9021907|NCT03121365|10084731|FG001|COMPLETED|4 Months||44
9021908|NCT03121365|10084730|FG000|NOT COMPLETED|4 Months||3
9021909|NCT03121365|10084731|FG001|NOT COMPLETED|4 Months||1
9021910|NCT03121365|10084730|FG000|STARTED|7 Months||54
9021911|NCT03121365|10084731|FG001|STARTED|7 Months||45
9021912|NCT03121365|10084730|FG000|COMPLETED|7 Months||44
9021913|NCT03121365|10084731|FG001|COMPLETED|7 Months||37
9021914|NCT03121365|10084730|FG000|NOT COMPLETED|7 Months||10
9021915|NCT03121365|10084731|FG001|NOT COMPLETED|7 Months||8
8641215|NCT00588094|9681512|FG000|NOT COMPLETED|Overall Study||5
8641216|NCT00588159|9681518|FG000|STARTED|Overall Study||72
8641217|NCT00588159|9681519|FG001|STARTED|Overall Study||74
8641218|NCT00588159|9681518|FG000|COMPLETED|Overall Study||57
8641219|NCT00588159|9681519|FG001|COMPLETED|Overall Study||63
8641220|NCT00588159|9681518|FG000|NOT COMPLETED|Overall Study||15
8641221|NCT00588159|9681519|FG001|NOT COMPLETED|Overall Study||11
8641222|NCT00588237|9681525|FG000|STARTED|Overall Study||42
8641223|NCT00588237|9681525|FG000|COMPLETED|Overall Study||38
8641224|NCT00588237|9681525|FG000|NOT COMPLETED|Overall Study||4
8641225|NCT00588341|9681529|FG000|STARTED|Overall Study||24
8641226|NCT00588341|9681529|FG000|COMPLETED|Overall Study||19
8641227|NCT00588341|9681529|FG000|NOT COMPLETED|Overall Study||5
8641228|NCT00588354|9681535|FG000|STARTED|Baseline to 2 Weeks||11
8641229|NCT00588354|9681536|FG001|STARTED|Baseline to 2 Weeks||15
8641230|NCT00588354|9681535|FG000|COMPLETED|Baseline to 2 Weeks||9
8641231|NCT00588354|9681536|FG001|COMPLETED|Baseline to 2 Weeks||15
8641232|NCT00588354|9681535|FG000|NOT COMPLETED|Baseline to 2 Weeks||2
8641233|NCT00588354|9681536|FG001|NOT COMPLETED|Baseline to 2 Weeks||0
8641234|NCT00588354|9681535|FG000|STARTED|Baseline to 4 Weeks||9
8641235|NCT00588354|9681536|FG001|STARTED|Baseline to 4 Weeks||15
8641236|NCT00588354|9681535|FG000|COMPLETED|Baseline to 4 Weeks||9
8641237|NCT00588354|9681536|FG001|COMPLETED|Baseline to 4 Weeks||14
8641238|NCT00588354|9681535|FG000|NOT COMPLETED|Baseline to 4 Weeks||0
8641239|NCT00588354|9681536|FG001|NOT COMPLETED|Baseline to 4 Weeks||1
8641240|NCT00588380|9681543|FG000|STARTED|Overall Study||88
8641241|NCT00588380|9681543|FG000|COMPLETED|Overall Study||88
8641242|NCT00588380|9681543|FG000|NOT COMPLETED|Overall Study||0
8641243|NCT00588406|9681550|FG000|STARTED|Overall Study||46
8641244|NCT00588406|9681551|FG001|STARTED|Overall Study||49
8641245|NCT00588406|9681550|FG000|COMPLETED|Overall Study||46
8641246|NCT00588406|9681551|FG001|COMPLETED|Overall Study||49
8641247|NCT00588406|9681550|FG000|NOT COMPLETED|Overall Study||0
8641248|NCT00588406|9681551|FG001|NOT COMPLETED|Overall Study||0
8641249|NCT00588445|9681557|FG000|STARTED|Overall Study||65
8641250|NCT00588445|9681557|FG000|COMPLETED|Overall Study||50
8641251|NCT00588445|9681557|FG000|NOT COMPLETED|Overall Study||15
8641252|NCT00588536|9681563|FG000|STARTED|Overall Study||5
8641253|NCT00588536|9681563|FG000|COMPLETED|Overall Study||5
8641254|NCT00588536|9681563|FG000|NOT COMPLETED|Overall Study||0
8641255|NCT00588640|9681567|FG000|STARTED|Overall Study||10
8641256|NCT00588640|9681567|FG000|COMPLETED|Overall Study||8
8641257|NCT00588640|9681567|FG000|NOT COMPLETED|Overall Study||2
8641258|NCT00588666|9681571|FG000|STARTED|Overall Study||51
8641259|NCT00588666|9681571|FG000|COMPLETED|Overall Study||47
8641260|NCT00588666|9681571|FG000|NOT COMPLETED|Overall Study||4
8641261|NCT00588692|9681577|FG000|STARTED|Overall Study||30
8641262|NCT00588692|9681578|FG001|STARTED|Overall Study||30
9021916|NCT03121612|10084741|FG000|STARTED|Overall Study||26
9021917|NCT03121612|10084742|FG001|STARTED|Overall Study||25
9021918|NCT03121612|10084741|FG000|COMPLETED|Overall Study||26
9021919|NCT03121612|10084742|FG001|COMPLETED|Overall Study||25
9021920|NCT03121612|10084741|FG000|NOT COMPLETED|Overall Study||0
9021921|NCT03121612|10084742|FG001|NOT COMPLETED|Overall Study||0
8641263|NCT00588692|9681577|FG000|COMPLETED|Overall Study||23
9021922|NCT03121820|10084752|FG000|STARTED|First Period||9
9021923|NCT03121820|10084753|FG001|STARTED|First Period||9
9021924|NCT03121820|10084752|FG000|COMPLETED|First Period||9
9021925|NCT03121820|10084753|FG001|COMPLETED|First Period||9
9021926|NCT03121820|10084752|FG000|NOT COMPLETED|First Period||0
9021927|NCT03121820|10084753|FG001|NOT COMPLETED|First Period||0
9021928|NCT03121820|10084752|FG000|STARTED|Second Period (After Washout)||9
9021929|NCT03121820|10084753|FG001|STARTED|Second Period (After Washout)||9
9021930|NCT03121820|10084752|FG000|COMPLETED|Second Period (After Washout)||9
9021931|NCT03121820|10084753|FG001|COMPLETED|Second Period (After Washout)||9
9021932|NCT03121820|10084752|FG000|NOT COMPLETED|Second Period (After Washout)||0
9021933|NCT03121820|10084753|FG001|NOT COMPLETED|Second Period (After Washout)||0
9021934|NCT03121950|10084761|FG000|STARTED|Overall Study||17
9021935|NCT03121950|10084762|FG001|STARTED|Overall Study||3
9021936|NCT03121950|10084761|FG000|COMPLETED|Overall Study||6
9021937|NCT03121950|10084762|FG001|COMPLETED|Overall Study||1
9021938|NCT03121950|10084761|FG000|NOT COMPLETED|Overall Study||11
9021939|NCT03121950|10084762|FG001|NOT COMPLETED|Overall Study||2
9021940|NCT03122145|10084772|FG000|STARTED|Overall Study|34 participants completed the first sub study under this IRB|37
9021941|NCT03122145|10084773|FG001|STARTED|Overall Study||12
9021942|NCT03122145|10084772|FG000|COMPLETED|Overall Study||34
9021943|NCT03122145|10084773|FG001|COMPLETED|Overall Study||12
9021944|NCT03122145|10084772|FG000|NOT COMPLETED|Overall Study||3
9021945|NCT03122145|10084773|FG001|NOT COMPLETED|Overall Study||0
9021946|NCT03122171|10084779|FG000|STARTED|Overall Study||6
9021947|NCT03122171|10084779|FG000|COMPLETED|Overall Study||5
9021948|NCT03122171|10084779|FG000|NOT COMPLETED|Overall Study||1
9021949|NCT03122184|10084785|FG000|STARTED|Overall Study||24
9021950|NCT03122184|10084786|FG001|STARTED|Overall Study||23
9021951|NCT03122184|10084785|FG000|COMPLETED|Overall Study||16
9021952|NCT03122184|10084786|FG001|COMPLETED|Overall Study||17
9021953|NCT03122184|10084785|FG000|NOT COMPLETED|Overall Study||8
9021954|NCT03122184|10084786|FG001|NOT COMPLETED|Overall Study||6
9021955|NCT03122223|10084796|FG000|STARTED|Overall Study||50
9021956|NCT03122223|10084797|FG001|STARTED|Overall Study||50
9021957|NCT03122223|10084798|FG002|STARTED|Overall Study||50
9021958|NCT03122223|10084799|FG003|STARTED|Overall Study||10
9021959|NCT03122223|10084796|FG000|Month 6.5 Immunogenicity Cohort|Overall Study||49
9021960|NCT03122223|10084797|FG001|Month 6.5 Immunogenicity Cohort|Overall Study||48
9021961|NCT03122223|10084798|FG002|Month 6.5 Immunogenicity Cohort|Overall Study||47
9021962|NCT03122223|10084799|FG003|Month 6.5 Immunogenicity Cohort|Overall Study||8
9021963|NCT03122223|10084796|FG000|Month 12 Immunogenicity Cohort|Overall Study||47
9021964|NCT03122223|10084797|FG001|Month 12 Immunogenicity Cohort|Overall Study||45
8641264|NCT00588692|9681578|FG001|COMPLETED|Overall Study||27
8641265|NCT00588692|9681577|FG000|NOT COMPLETED|Overall Study||7
8641266|NCT00588692|9681578|FG001|NOT COMPLETED|Overall Study||3
8641267|NCT00588731|9681588|FG000|STARTED|Overall Study||21
8641268|NCT00588731|9681589|FG001|STARTED|Overall Study||20
8641269|NCT00588731|9681588|FG000|COMPLETED|Overall Study||18
8641270|NCT00588731|9681589|FG001|COMPLETED|Overall Study||18
8641271|NCT00588731|9681588|FG000|NOT COMPLETED|Overall Study||3
8641272|NCT00588731|9681589|FG001|NOT COMPLETED|Overall Study||2
8641273|NCT00588809|9681595|FG000|STARTED|Overall Study||47
9021965|NCT03122223|10084798|FG002|Month 12 Immunogenicity Cohort|Overall Study||46
9021966|NCT03122223|10084799|FG003|Month 12 Immunogenicity Cohort|Overall Study||10
9021967|NCT03122223|10084796|FG000|COMPLETED|Overall Study||47
9021968|NCT03122223|10084797|FG001|COMPLETED|Overall Study||45
9021969|NCT03122223|10084798|FG002|COMPLETED|Overall Study||46
9021970|NCT03122223|10084799|FG003|COMPLETED|Overall Study||10
9021971|NCT03122223|10084796|FG000|NOT COMPLETED|Overall Study||3
9021972|NCT03122223|10084797|FG001|NOT COMPLETED|Overall Study||5
9021973|NCT03122223|10084798|FG002|NOT COMPLETED|Overall Study||4
9021974|NCT03122223|10084799|FG003|NOT COMPLETED|Overall Study||0
9021975|NCT03122457|10084809|FG000|STARTED|Overall Study||22
9021976|NCT03122457|10084809|FG000|COMPLETED|Overall Study||16
9021977|NCT03122457|10084809|FG000|NOT COMPLETED|Overall Study||6
9021978|NCT03122535|10084813|FG000|STARTED|Overall Study||115
9021979|NCT03122535|10084814|FG001|STARTED|Overall Study||115
9021980|NCT03122535|10084813|FG000|3 Months|Overall Study||92
8641274|NCT00588809|9681595|FG000|COMPLETED|Overall Study||47
9021981|NCT03122535|10084814|FG001|3 Months|Overall Study||92
9021982|NCT03122535|10084813|FG000|12 Months|Overall Study||42
9021983|NCT03122535|10084814|FG001|12 Months|Overall Study||42
9021984|NCT03122535|10084813|FG000|COMPLETED|Overall Study||42
9021985|NCT03122535|10084814|FG001|COMPLETED|Overall Study||42
9021986|NCT03122535|10084813|FG000|NOT COMPLETED|Overall Study||73
9021987|NCT03122535|10084814|FG001|NOT COMPLETED|Overall Study||73
9021988|NCT03122548|10084820|FG000|STARTED|Overall Study||5
9021989|NCT03122548|10084820|FG000|COMPLETED|Overall Study||0
9021990|NCT03122548|10084820|FG000|NOT COMPLETED|Overall Study||5
9021991|NCT03122587|10084827|FG000|STARTED|Overall Study||13
9021992|NCT03122587|10084828|FG001|STARTED|Overall Study||12
9021993|NCT03122587|10084829|FG002|STARTED|Overall Study||13
9021994|NCT03122587|10084827|FG000|COMPLETED|Overall Study||11
9021995|NCT03122587|10084828|FG001|COMPLETED|Overall Study||10
9021996|NCT03122587|10084829|FG002|COMPLETED|Overall Study||12
9021997|NCT03122587|10084827|FG000|NOT COMPLETED|Overall Study||2
9021998|NCT03122587|10084828|FG001|NOT COMPLETED|Overall Study||2
9021999|NCT03122587|10084829|FG002|NOT COMPLETED|Overall Study||1
9022000|NCT03122860|10084843|FG000|STARTED|Overall Study||117
8641275|NCT00588809|9681595|FG000|NOT COMPLETED|Overall Study||0
8641276|NCT00588822|9681599|FG000|STARTED|Overall Study||21
9022001|NCT03122860|10084844|FG001|STARTED|Overall Study||116
9022002|NCT03122860|10084845|FG002|STARTED|Overall Study||117
9022003|NCT03122860|10084846|FG003|STARTED|Overall Study||116
9022004|NCT03122860|10084847|FG004|STARTED|Overall Study||117
9022005|NCT03122860|10084848|FG005|STARTED|Overall Study||117
8641277|NCT00588822|9681599|FG000|COMPLETED|Overall Study||13
8641278|NCT00588822|9681599|FG000|NOT COMPLETED|Overall Study||8
8641279|NCT00588848|9681605|FG000|STARTED|Overall Study||3
8641280|NCT00588848|9681606|FG001|STARTED|Overall Study||8
8641281|NCT00588848|9681605|FG000|COMPLETED|Overall Study||3
8641282|NCT00588848|9681606|FG001|COMPLETED|Overall Study||5
8641283|NCT00588848|9681605|FG000|NOT COMPLETED|Overall Study||0
8641284|NCT00588848|9681606|FG001|NOT COMPLETED|Overall Study||3
8641285|NCT00588900|9681614|FG000|STARTED|Overall Study||5
8641286|NCT00588900|9681614|FG000|COMPLETED|Overall Study||5
8641287|NCT00588900|9681614|FG000|NOT COMPLETED|Overall Study||0
8641288|NCT00588952|9681620|FG000|STARTED|Overall Study||29
8641289|NCT00588952|9681621|FG001|STARTED|Overall Study||70
8641290|NCT00588952|9681620|FG000|COMPLETED|Overall Study||26
8641291|NCT00588952|9681621|FG001|COMPLETED|Overall Study||63
8641292|NCT00588952|9681620|FG000|NOT COMPLETED|Overall Study||3
8641293|NCT00588952|9681621|FG001|NOT COMPLETED|Overall Study||7
8641294|NCT00588965|9681627|FG000|STARTED|Overall Study||35
8641295|NCT00588965|9681627|FG000|COMPLETED|Overall Study||35
8641296|NCT00588965|9681627|FG000|NOT COMPLETED|Overall Study||0
8641297|NCT00589056|9681633|FG000|STARTED|Overall Study||55
8641298|NCT00589056|9681633|FG000|COMPLETED|Overall Study||52
8641299|NCT00589056|9681633|FG000|NOT COMPLETED|Overall Study||3
8641300|NCT00589108|9681640|FG000|STARTED|Overall Study||80
8641301|NCT00589108|9681641|FG001|STARTED|Overall Study||80
8641302|NCT00589108|9681642|FG002|STARTED|Overall Study||80
8641303|NCT00589108|9681640|FG000|COMPLETED|Overall Study||76
8641304|NCT00589108|9681641|FG001|COMPLETED|Overall Study||76
8641305|NCT00589108|9681642|FG002|COMPLETED|Overall Study||75
8641306|NCT00589108|9681640|FG000|NOT COMPLETED|Overall Study||4
8641307|NCT00589108|9681641|FG001|NOT COMPLETED|Overall Study||4
8641308|NCT00589108|9681642|FG002|NOT COMPLETED|Overall Study||5
8641309|NCT00589121|9681652|FG000|STARTED|Overall Study||12
8641310|NCT00589121|9681653|FG001|STARTED|Overall Study||86
8641311|NCT00589121|9681652|FG000|COMPLETED|Overall Study|Subjects with data available for the analysis are considered to have completed the study.|10
8641312|NCT00589121|9681653|FG001|COMPLETED|Overall Study|Subjects with data available for the analysis are considered to have completed the study.|79
8641313|NCT00589121|9681652|FG000|NOT COMPLETED|Overall Study||2
8641314|NCT00589121|9681653|FG001|NOT COMPLETED|Overall Study||7
8641315|NCT00589277|9681664|FG000|STARTED|Overall Study||1222
8641316|NCT00589277|9681665|FG001|STARTED|Overall Study||810
8641317|NCT00589277|9681664|FG000|Completed 2 Week Follow Up|Overall Study||603
8641318|NCT00589277|9681665|FG001|Completed 2 Week Follow Up|Overall Study||424
8641319|NCT00589277|9681664|FG000|Completed 3 Month Follow Up|Overall Study||762
8641320|NCT00589277|9681665|FG001|Completed 3 Month Follow Up|Overall Study||524
8641321|NCT00589277|9681664|FG000|COMPLETED|Overall Study||762
8641322|NCT00589277|9681665|FG001|COMPLETED|Overall Study||524
8641323|NCT00589277|9681664|FG000|NOT COMPLETED|Overall Study||460
8641324|NCT00589277|9681665|FG001|NOT COMPLETED|Overall Study||286
8641325|NCT00589290|9681671|FG000|STARTED|Overall Study||41
8641326|NCT00589290|9681671|FG000|COMPLETED|Overall Study||40
8641327|NCT00589290|9681671|FG000|NOT COMPLETED|Overall Study||1
8641328|NCT00589303|9681679|FG000|STARTED|Overall Study||14
8641329|NCT00589303|9681680|FG001|STARTED|Overall Study||13
8641330|NCT00589303|9681679|FG000|COMPLETED|Overall Study||12
8641331|NCT00589303|9681680|FG001|COMPLETED|Overall Study||12
8641332|NCT00589303|9681679|FG000|NOT COMPLETED|Overall Study||2
8641333|NCT00589303|9681680|FG001|NOT COMPLETED|Overall Study||1
8641334|NCT00589329|9681688|FG000|STARTED|Overall Study||10
8641335|NCT00589329|9681689|FG001|STARTED|Overall Study||10
8641336|NCT00589329|9681688|FG000|COMPLETED|Overall Study||10
8641337|NCT00589329|9681689|FG001|COMPLETED|Overall Study||10
8641338|NCT00589329|9681688|FG000|NOT COMPLETED|Overall Study||0
8641339|NCT00589329|9681689|FG001|NOT COMPLETED|Overall Study||0
8641340|NCT00589472|9681696|FG000|STARTED|Overall Study||19
8641341|NCT00589472|9681696|FG000|COMPLETED|Overall Study||18
8641342|NCT00589472|9681696|FG000|NOT COMPLETED|Overall Study||1
8641343|NCT00589563|9681700|FG000|STARTED|Overall Study||32
8641344|NCT00589563|9681700|FG000|COMPLETED|Overall Study||32
9022006|NCT03122860|10084843|FG000|Full Analysis Set|Overall Study||116
9022007|NCT03122860|10084844|FG001|Full Analysis Set|Overall Study||115
9022008|NCT03122860|10084845|FG002|Full Analysis Set|Overall Study||115
8641345|NCT00589563|9681700|FG000|NOT COMPLETED|Overall Study||0
8641346|NCT00589602|9681704|FG000|STARTED|Overall Study||13
8641347|NCT00589602|9681704|FG000|COMPLETED|Overall Study||12
8641348|NCT00589602|9681704|FG000|NOT COMPLETED|Overall Study||1
8641349|NCT00589628|9681712|FG000|STARTED|Overall Study||7
8641350|NCT00589628|9681713|FG001|STARTED|Overall Study||6
8641351|NCT00589628|9681712|FG000|COMPLETED|Overall Study||7
8641352|NCT00589628|9681713|FG001|COMPLETED|Overall Study||5
8641353|NCT00589628|9681712|FG000|NOT COMPLETED|Overall Study||0
8641354|NCT00589628|9681713|FG001|NOT COMPLETED|Overall Study||1
8641355|NCT00589667|9681719|FG000|STARTED|Overall Study||26
8641356|NCT00589667|9681719|FG000|COMPLETED|Overall Study||23
9022009|NCT03122860|10084846|FG003|Full Analysis Set|Overall Study||116
9022010|NCT03122860|10084847|FG004|Full Analysis Set|Overall Study||116
9022011|NCT03122860|10084848|FG005|Full Analysis Set|Overall Study||117
9022012|NCT03122860|10084843|FG000|COMPLETED|Overall Study||107
9022013|NCT03122860|10084844|FG001|COMPLETED|Overall Study||111
9022014|NCT03122860|10084845|FG002|COMPLETED|Overall Study||105
9022015|NCT03122860|10084846|FG003|COMPLETED|Overall Study||105
9022016|NCT03122860|10084847|FG004|COMPLETED|Overall Study||102
9022017|NCT03122860|10084848|FG005|COMPLETED|Overall Study||105
9022018|NCT03122860|10084843|FG000|NOT COMPLETED|Overall Study||10
9022019|NCT03122860|10084844|FG001|NOT COMPLETED|Overall Study||5
9022020|NCT03122860|10084845|FG002|NOT COMPLETED|Overall Study||12
9022021|NCT03122860|10084846|FG003|NOT COMPLETED|Overall Study||11
9022022|NCT03122860|10084847|FG004|NOT COMPLETED|Overall Study||15
9022023|NCT03122860|10084848|FG005|NOT COMPLETED|Overall Study||12
9022024|NCT03122886|10084865|FG000|STARTED|Overall Study||10
9022025|NCT03122886|10084866|FG001|STARTED|Overall Study||9
9022026|NCT03122886|10084865|FG000|COMPLETED|Overall Study||9
9022027|NCT03122886|10084866|FG001|COMPLETED|Overall Study||7
9022028|NCT03122886|10084865|FG000|NOT COMPLETED|Overall Study||1
9022029|NCT03122886|10084866|FG001|NOT COMPLETED|Overall Study||2
9022030|NCT03123055|10084872|FG000|STARTED|Overall Study||28
9022031|NCT03123055|10084872|FG000|COMPLETED|Overall Study||28
9022032|NCT03123055|10084872|FG000|NOT COMPLETED|Overall Study||0
9022033|NCT03123068|10084879|FG000|STARTED|Overall Study||22
9022034|NCT03123068|10084880|FG001|STARTED|Overall Study||20
9022035|NCT03123068|10084879|FG000|COMPLETED|Overall Study||22
9022036|NCT03123068|10084880|FG001|COMPLETED|Overall Study||20
9022037|NCT03123068|10084879|FG000|NOT COMPLETED|Overall Study||0
9022038|NCT03123068|10084880|FG001|NOT COMPLETED|Overall Study||0
9022039|NCT03123120|10084888|FG000|STARTED|Overall Study||8
9022040|NCT03123120|10084889|FG001|STARTED|Overall Study||14
9022041|NCT03123120|10084888|FG000|Safety Analysis Set (SAF)|Overall Study||7
9022042|NCT03123120|10084889|FG001|Safety Analysis Set (SAF)|Overall Study||15
9022043|NCT03123120|10084888|FG000|COMPLETED|Overall Study||8
9022044|NCT03123120|10084889|FG001|COMPLETED|Overall Study||12
9022045|NCT03123120|10084888|FG000|NOT COMPLETED|Overall Study||0
8641357|NCT00589667|9681719|FG000|NOT COMPLETED|Overall Study||3
8641358|NCT00589693|9681725|FG000|STARTED|Overall Study||115
8641359|NCT00589693|9681726|FG001|STARTED|Overall Study||112
8641360|NCT00589693|9681725|FG000|COMPLETED|Overall Study||71
8641361|NCT00589693|9681726|FG001|COMPLETED|Overall Study||83
8641362|NCT00589693|9681725|FG000|NOT COMPLETED|Overall Study||44
8641363|NCT00589693|9681726|FG001|NOT COMPLETED|Overall Study||29
8641364|NCT00589784|9681734|FG000|STARTED|Overall Study||36
8641365|NCT00589784|9681735|FG001|STARTED|Overall Study||14
8641366|NCT00589784|9681734|FG000|COMPLETED|Overall Study||35
8641367|NCT00589784|9681735|FG001|COMPLETED|Overall Study||4
8641368|NCT00589784|9681734|FG000|NOT COMPLETED|Overall Study||1
8641369|NCT00589784|9681735|FG001|NOT COMPLETED|Overall Study||10
8641370|NCT00589797|9681742|FG000|STARTED|Overall Study||264
8641371|NCT00589797|9681743|FG001|STARTED|Overall Study||112
8641372|NCT00589797|9681742|FG000|Baseline|Overall Study||218
8641373|NCT00589797|9681743|FG001|Baseline|Overall Study||106
8641374|NCT00589797|9681742|FG000|24 Months|Overall Study||191
8641375|NCT00589797|9681743|FG001|24 Months|Overall Study||89
8641376|NCT00589797|9681742|FG000|COMPLETED|Overall Study||191
8641377|NCT00589797|9681743|FG001|COMPLETED|Overall Study||89
8641378|NCT00589797|9681742|FG000|NOT COMPLETED|Overall Study||73
8641379|NCT00589797|9681743|FG001|NOT COMPLETED|Overall Study||23
8641380|NCT00589836|9681749|FG000|STARTED|Overall Study||20
9022046|NCT03123120|10084889|FG001|NOT COMPLETED|Overall Study||2
9022047|NCT03123263|10084897|FG000|STARTED|Overall Study||60
9022048|NCT03123263|10084897|FG000|COMPLETED|Overall Study||60
9022049|NCT03123263|10084897|FG000|NOT COMPLETED|Overall Study||0
9022050|NCT03123354|10084904|FG000|STARTED|Overall Study||44
9022051|NCT03123354|10084904|FG000|COMPLETED|Overall Study||38
9022052|NCT03123354|10084904|FG000|NOT COMPLETED|Overall Study||6
9022053|NCT03123471|10084910|FG000|STARTED|Placebo-controlled Phase||102
9022054|NCT03123471|10084911|FG001|STARTED|Placebo-controlled Phase||201
9022055|NCT03123471|10084910|FG000|Received at Least 1 Dose of Study Drug|Placebo-controlled Phase||102
9022056|NCT03123471|10084911|FG001|Received at Least 1 Dose of Study Drug|Placebo-controlled Phase||200
9022057|NCT03123471|10084910|FG000|COMPLETED|Placebo-controlled Phase||84
9022058|NCT03123471|10084911|FG001|COMPLETED|Placebo-controlled Phase||168
9022059|NCT03123471|10084910|FG000|NOT COMPLETED|Placebo-controlled Phase||18
9022060|NCT03123471|10084911|FG001|NOT COMPLETED|Placebo-controlled Phase||33
8641381|NCT00589836|9681749|FG000|COMPLETED|Overall Study||20
8641382|NCT00589836|9681749|FG000|NOT COMPLETED|Overall Study||0
8641383|NCT00589849|9681753|FG000|STARTED|Overall Study||32
8641384|NCT00589849|9681753|FG000|COMPLETED|Overall Study||32
8641385|NCT00589849|9681753|FG000|NOT COMPLETED|Overall Study||0
8641386|NCT00589888|9681757|FG000|STARTED|Normal Saline @ 40cc/Hour|the same 13 patients did each of the 5 arms at 5 different visits|13
8641387|NCT00589888|9681758|FG001|STARTED|Normal Saline @ 40cc/Hour||0
8641388|NCT00589888|9681759|FG002|STARTED|Normal Saline @ 40cc/Hour||0
8641389|NCT00589888|9681760|FG003|STARTED|Normal Saline @ 40cc/Hour||0
8641390|NCT00589888|9681761|FG004|STARTED|Normal Saline @ 40cc/Hour||0
8641391|NCT00589888|9681757|FG000|COMPLETED|Normal Saline @ 40cc/Hour||13
8641392|NCT00589888|9681758|FG001|COMPLETED|Normal Saline @ 40cc/Hour||0
8641393|NCT00589888|9681759|FG002|COMPLETED|Normal Saline @ 40cc/Hour||0
8641394|NCT00589888|9681760|FG003|COMPLETED|Normal Saline @ 40cc/Hour||0
9022061|NCT03123471|10084910|FG000|STARTED|Apremilast Extension Phase||84
9022062|NCT03123471|10084911|FG001|STARTED|Apremilast Extension Phase|3 participants completed the first phase; did not enter in extension phase|165
9022063|NCT03123471|10084910|FG000|Received at Least 1 Dose of Study Drug|Apremilast Extension Phase||84
9022064|NCT03123471|10084911|FG001|Received at Least 1 Dose of Study Drug|Apremilast Extension Phase||163
9022065|NCT03123471|10084910|FG000|COMPLETED|Apremilast Extension Phase||76
9022066|NCT03123471|10084911|FG001|COMPLETED|Apremilast Extension Phase||140
9022067|NCT03123471|10084910|FG000|NOT COMPLETED|Apremilast Extension Phase||8
9022068|NCT03123471|10084911|FG001|NOT COMPLETED|Apremilast Extension Phase||25
9022069|NCT03123588|10084925|FG000|STARTED|Overall Study||6
9022070|NCT03123588|10084926|FG001|STARTED|Overall Study||6
9022071|NCT03123588|10084925|FG000|COMPLETED|Overall Study||0
9022072|NCT03123588|10084926|FG001|COMPLETED|Overall Study||0
9022073|NCT03123588|10084925|FG000|NOT COMPLETED|Overall Study||6
9022074|NCT03123588|10084926|FG001|NOT COMPLETED|Overall Study||6
9022075|NCT03123614|10084935|FG000|STARTED|Overall Study||57
9022076|NCT03123614|10084936|FG001|STARTED|Overall Study||74
9022077|NCT03123614|10084935|FG000|COMPLETED|Overall Study||57
9022078|NCT03123614|10084936|FG001|COMPLETED|Overall Study||74
9022079|NCT03123614|10084935|FG000|NOT COMPLETED|Overall Study||0
9022080|NCT03123614|10084936|FG001|NOT COMPLETED|Overall Study||0
9022081|NCT03123848|10084942|FG000|STARTED|Overall Study||8
9022082|NCT03123848|10084942|FG000|COMPLETED|Overall Study||8
9022083|NCT03123848|10084942|FG000|NOT COMPLETED|Overall Study||0
9022084|NCT03123861|10084950|FG000|STARTED|Overall Study||22
9022085|NCT03123861|10084951|FG001|STARTED|Overall Study||23
9022086|NCT03123861|10084950|FG000|Received Intervention|Overall Study||21
9022087|NCT03123861|10084951|FG001|Received Intervention|Overall Study||22
9022088|NCT03123861|10084950|FG000|COMPLETED|Overall Study||19
9022089|NCT03123861|10084951|FG001|COMPLETED|Overall Study||20
9022090|NCT03123861|10084950|FG000|NOT COMPLETED|Overall Study||3
9022091|NCT03123861|10084951|FG001|NOT COMPLETED|Overall Study||3
8641395|NCT00589888|9681761|FG004|COMPLETED|Normal Saline @ 40cc/Hour||0
8641396|NCT00589888|9681757|FG000|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
8641397|NCT00589888|9681758|FG001|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
8641398|NCT00589888|9681759|FG002|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
8641399|NCT00589888|9681760|FG003|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
8641400|NCT00589888|9681761|FG004|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
8641401|NCT00589888|9681757|FG000|STARTED|Intralipid 20% @ 20cc/hr|the same 13 patients did each of the 5 arms at 5 different visits|0
8641402|NCT00589888|9681758|FG001|STARTED|Intralipid 20% @ 20cc/hr||13
8641403|NCT00589888|9681759|FG002|STARTED|Intralipid 20% @ 20cc/hr||0
8641404|NCT00589888|9681760|FG003|STARTED|Intralipid 20% @ 20cc/hr||0
8641405|NCT00589888|9681761|FG004|STARTED|Intralipid 20% @ 20cc/hr||0
8641406|NCT00589888|9681757|FG000|COMPLETED|Intralipid 20% @ 20cc/hr||0
8641407|NCT00589888|9681758|FG001|COMPLETED|Intralipid 20% @ 20cc/hr||13
8641408|NCT00589888|9681759|FG002|COMPLETED|Intralipid 20% @ 20cc/hr||0
8641409|NCT00589888|9681760|FG003|COMPLETED|Intralipid 20% @ 20cc/hr||0
8641410|NCT00589888|9681761|FG004|COMPLETED|Intralipid 20% @ 20cc/hr||0
8641411|NCT00589888|9681757|FG000|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
8641412|NCT00589888|9681758|FG001|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
8641413|NCT00589888|9681759|FG002|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
8641414|NCT00589888|9681760|FG003|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
8641415|NCT00589888|9681761|FG004|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
8641416|NCT00589888|9681757|FG000|STARTED|Intralipid 20% @ 40cc/Hour||0
8641417|NCT00589888|9681758|FG001|STARTED|Intralipid 20% @ 40cc/Hour|the same 13 patients did each of the 5 arms at 5 different visits|0
8641418|NCT00589888|9681759|FG002|STARTED|Intralipid 20% @ 40cc/Hour|the same 13 patients did each of the 5 arms at 5 different visits|13
8641419|NCT00589888|9681760|FG003|STARTED|Intralipid 20% @ 40cc/Hour||0
8641420|NCT00589888|9681761|FG004|STARTED|Intralipid 20% @ 40cc/Hour||0
8641421|NCT00589888|9681757|FG000|COMPLETED|Intralipid 20% @ 40cc/Hour||0
8641422|NCT00589888|9681758|FG001|COMPLETED|Intralipid 20% @ 40cc/Hour||0
8641423|NCT00589888|9681759|FG002|COMPLETED|Intralipid 20% @ 40cc/Hour||13
8641424|NCT00589888|9681760|FG003|COMPLETED|Intralipid 20% @ 40cc/Hour||0
8641425|NCT00589888|9681761|FG004|COMPLETED|Intralipid 20% @ 40cc/Hour||0
8641426|NCT00589888|9681757|FG000|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
9022092|NCT03123874|10084959|FG000|STARTED|Overall Study||27
9022093|NCT03123874|10084960|FG001|STARTED|Overall Study||25
9022094|NCT03123874|10084959|FG000|COMPLETED|Overall Study||27
9022095|NCT03123874|10084960|FG001|COMPLETED|Overall Study||25
9022096|NCT03123874|10084959|FG000|NOT COMPLETED|Overall Study||0
9022097|NCT03123874|10084960|FG001|NOT COMPLETED|Overall Study||0
9022098|NCT03123939|10084970|FG000|STARTED|Overall Study||74
9022099|NCT03123939|10084970|FG000|CTL019 Infused|Overall Study||69
9022100|NCT03123939|10084970|FG000|Full Analysis Set (FAS)|Overall Study||69
9022101|NCT03123939|10084970|FG000|Cellular Kinetic Analysis Set (CKAS)|Overall Study||69
9022102|NCT03123939|10084970|FG000|Safety Set (SAF)|Overall Study||69
9022103|NCT03123939|10084970|FG000|COMPLETED|Overall Study||33
9022104|NCT03123939|10084970|FG000|NOT COMPLETED|Overall Study||41
9022105|NCT03124069|10084974|FG000|STARTED|Overall Study||37
9022106|NCT03124069|10084974|FG000|COMPLETED|Overall Study||37
8641427|NCT00589888|9681758|FG001|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
9022107|NCT03124069|10084974|FG000|NOT COMPLETED|Overall Study||0
9022108|NCT03124108|10084983|FG000|STARTED|Overall Study||15
8641428|NCT00589888|9681759|FG002|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
9022109|NCT03124108|10084984|FG001|STARTED|Overall Study||15
9022110|NCT03124108|10084985|FG002|STARTED|Overall Study||15
8641429|NCT00589888|9681760|FG003|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
8641430|NCT00589888|9681761|FG004|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
8641431|NCT00589888|9681757|FG000|STARTED|32-gram Oral Fat Load||0
8641432|NCT00589888|9681758|FG001|STARTED|32-gram Oral Fat Load||0
8641433|NCT00589888|9681759|FG002|STARTED|32-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|0
8641434|NCT00589888|9681760|FG003|STARTED|32-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|13
8641435|NCT00589888|9681761|FG004|STARTED|32-gram Oral Fat Load||0
8641436|NCT00589888|9681757|FG000|COMPLETED|32-gram Oral Fat Load||0
8641437|NCT00589888|9681758|FG001|COMPLETED|32-gram Oral Fat Load||0
8641438|NCT00589888|9681759|FG002|COMPLETED|32-gram Oral Fat Load||0
8641439|NCT00589888|9681760|FG003|COMPLETED|32-gram Oral Fat Load||13
8641440|NCT00589888|9681761|FG004|COMPLETED|32-gram Oral Fat Load||0
8641441|NCT00589888|9681757|FG000|NOT COMPLETED|32-gram Oral Fat Load||0
8641442|NCT00589888|9681758|FG001|NOT COMPLETED|32-gram Oral Fat Load||0
8641443|NCT00589888|9681759|FG002|NOT COMPLETED|32-gram Oral Fat Load||0
8641444|NCT00589888|9681760|FG003|NOT COMPLETED|32-gram Oral Fat Load||0
8641445|NCT00589888|9681761|FG004|NOT COMPLETED|32-gram Oral Fat Load||0
8641446|NCT00589888|9681757|FG000|STARTED|64-gram Oral Fat Load||0
8641447|NCT00589888|9681758|FG001|STARTED|64-gram Oral Fat Load||0
8641448|NCT00589888|9681759|FG002|STARTED|64-gram Oral Fat Load||0
8641449|NCT00589888|9681760|FG003|STARTED|64-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|0
8641450|NCT00589888|9681761|FG004|STARTED|64-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|13
8641451|NCT00589888|9681757|FG000|COMPLETED|64-gram Oral Fat Load||0
8641452|NCT00589888|9681758|FG001|COMPLETED|64-gram Oral Fat Load||0
8641453|NCT00589888|9681759|FG002|COMPLETED|64-gram Oral Fat Load||0
8641454|NCT00589888|9681760|FG003|COMPLETED|64-gram Oral Fat Load||0
8641455|NCT00589888|9681761|FG004|COMPLETED|64-gram Oral Fat Load||13
8641456|NCT00589888|9681757|FG000|NOT COMPLETED|64-gram Oral Fat Load||0
8641457|NCT00589888|9681758|FG001|NOT COMPLETED|64-gram Oral Fat Load||0
8641458|NCT00589888|9681759|FG002|NOT COMPLETED|64-gram Oral Fat Load||0
8641459|NCT00589888|9681760|FG003|NOT COMPLETED|64-gram Oral Fat Load||0
8641460|NCT00589888|9681761|FG004|NOT COMPLETED|64-gram Oral Fat Load||0
8641461|NCT00589914|9681780|FG000|STARTED|Overall Study||606
8641462|NCT00589914|9681781|FG001|STARTED|Overall Study||608
8641463|NCT00589914|9681780|FG000|COMPLETED|Overall Study||456
8641464|NCT00589914|9681781|FG001|COMPLETED|Overall Study||471
8641465|NCT00589914|9681780|FG000|NOT COMPLETED|Overall Study||150
8641466|NCT00589914|9681781|FG001|NOT COMPLETED|Overall Study||137
8641467|NCT00589979|9681789|FG000|STARTED|Run-In Period||169
8641468|NCT00589979|9681790|FG001|STARTED|Run-In Period||0
8641469|NCT00589979|9681791|FG002|STARTED|Run-In Period||0
8641470|NCT00589979|9681789|FG000|COMPLETED|Run-In Period||93
8641471|NCT00589979|9681790|FG001|COMPLETED|Run-In Period||0
8641472|NCT00589979|9681791|FG002|COMPLETED|Run-In Period||0
8641473|NCT00589979|9681789|FG000|NOT COMPLETED|Run-In Period||76
8641474|NCT00589979|9681790|FG001|NOT COMPLETED|Run-In Period||0
8641475|NCT00589979|9681791|FG002|NOT COMPLETED|Run-In Period||0
8641476|NCT00589979|9681789|FG000|STARTED|Double-Blind Treatment Period 1|Participants completing the Run-in Period were then randomized to two different treatment sequences.|0
8641477|NCT00589979|9681790|FG001|STARTED|Double-Blind Treatment Period 1|N=21 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|50
8641478|NCT00589979|9681791|FG002|STARTED|Double-Blind Treatment Period 1|N=21 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|43
8641479|NCT00589979|9681789|FG000|COMPLETED|Double-Blind Treatment Period 1||0
8641480|NCT00589979|9681790|FG001|COMPLETED|Double-Blind Treatment Period 1||48
8641481|NCT00589979|9681791|FG002|COMPLETED|Double-Blind Treatment Period 1||41
8641482|NCT00589979|9681789|FG000|NOT COMPLETED|Double-Blind Treatment Period 1||0
8641483|NCT00589979|9681790|FG001|NOT COMPLETED|Double-Blind Treatment Period 1||2
8641484|NCT00589979|9681791|FG002|NOT COMPLETED|Double-Blind Treatment Period 1||2
8641485|NCT00589979|9681789|FG000|STARTED|Double-Blind Treatment Period 2||0
8641486|NCT00589979|9681790|FG001|STARTED|Double-Blind Treatment Period 2|N=19 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|48
8641487|NCT00589979|9681791|FG002|STARTED|Double-Blind Treatment Period 2|N=20 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|41
8641488|NCT00589979|9681789|FG000|COMPLETED|Double-Blind Treatment Period 2||0
8641489|NCT00589979|9681790|FG001|COMPLETED|Double-Blind Treatment Period 2||47
8641490|NCT00589979|9681791|FG002|COMPLETED|Double-Blind Treatment Period 2||39
8641491|NCT00589979|9681789|FG000|NOT COMPLETED|Double-Blind Treatment Period 2||0
8641492|NCT00589979|9681790|FG001|NOT COMPLETED|Double-Blind Treatment Period 2||1
8641493|NCT00589979|9681791|FG002|NOT COMPLETED|Double-Blind Treatment Period 2||2
8641494|NCT00589979|9681789|FG000|STARTED|Double-Blind Treatment Period 3||0
8641495|NCT00589979|9681790|FG001|STARTED|Double-Blind Treatment Period 3|N=19 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|47
8641496|NCT00589979|9681791|FG002|STARTED|Double-Blind Treatment Period 3|N=19 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|39
8641497|NCT00589979|9681789|FG000|COMPLETED|Double-Blind Treatment Period 3||0
8641498|NCT00589979|9681790|FG001|COMPLETED|Double-Blind Treatment Period 3||46
8641499|NCT00589979|9681791|FG002|COMPLETED|Double-Blind Treatment Period 3||38
8641500|NCT00589979|9681789|FG000|NOT COMPLETED|Double-Blind Treatment Period 3||0
8641501|NCT00589979|9681790|FG001|NOT COMPLETED|Double-Blind Treatment Period 3||1
8691440|NCT00854828|9736686|FG000|NOT COMPLETED|Overall Study||3
8641502|NCT00589979|9681791|FG002|NOT COMPLETED|Double-Blind Treatment Period 3||1
8641503|NCT00590005|9681803|FG000|STARTED|Overall Study||106
8641504|NCT00590005|9681804|FG001|STARTED|Overall Study||119
8641505|NCT00590005|9681803|FG000|COMPLETED|Overall Study||106
8641506|NCT00590005|9681804|FG001|COMPLETED|Overall Study||119
8641507|NCT00590005|9681803|FG000|NOT COMPLETED|Overall Study||0
8641508|NCT00590005|9681804|FG001|NOT COMPLETED|Overall Study||0
8641509|NCT00590018|9681812|FG000|STARTED|Overall Study||9
8641510|NCT00590018|9681813|FG001|STARTED|Overall Study||9
8641511|NCT00590018|9681812|FG000|COMPLETED|Overall Study||9
8641512|NCT00590018|9681813|FG001|COMPLETED|Overall Study||9
8641513|NCT00590018|9681812|FG000|NOT COMPLETED|Overall Study||0
8641514|NCT00590018|9681813|FG001|NOT COMPLETED|Overall Study||0
8641515|NCT00590031|9681819|FG000|STARTED|Overall Study||61
8641516|NCT00590031|9681819|FG000|COMPLETED|Overall Study||55
8641517|NCT00590031|9681819|FG000|NOT COMPLETED|Overall Study||6
8641518|NCT00590044|9681825|FG000|STARTED|Overall Study||38
8641519|NCT00590044|9681826|FG001|STARTED|Overall Study||36
8641520|NCT00590044|9681825|FG000|COMPLETED|Overall Study||34
8641521|NCT00590044|9681826|FG001|COMPLETED|Overall Study||34
8641522|NCT00590044|9681825|FG000|NOT COMPLETED|Overall Study||4
8641523|NCT00590044|9681826|FG001|NOT COMPLETED|Overall Study||2
8641524|NCT00590161|9681837|FG000|STARTED|Overall Study||26
8641525|NCT00590161|9681838|FG001|STARTED|Overall Study||29
8641526|NCT00590161|9681837|FG000|COMPLETED|Overall Study||23
8641527|NCT00590161|9681838|FG001|COMPLETED|Overall Study||26
8641528|NCT00590161|9681837|FG000|NOT COMPLETED|Overall Study||3
8641529|NCT00590161|9681838|FG001|NOT COMPLETED|Overall Study||3
8641530|NCT00590226|9681846|FG000|STARTED|Overall Study||67
8641531|NCT00590226|9681847|FG001|STARTED|Overall Study||63
8641532|NCT00590226|9681846|FG000|COMPLETED|Overall Study||67
8641533|NCT00590226|9681847|FG001|COMPLETED|Overall Study||63
8641534|NCT00590226|9681846|FG000|NOT COMPLETED|Overall Study||0
8641535|NCT00590226|9681847|FG001|NOT COMPLETED|Overall Study||0
8691441|NCT00854828|9736687|FG001|NOT COMPLETED|Overall Study||2
8691442|NCT00854828|9736688|FG002|NOT COMPLETED|Overall Study||8
8691443|NCT00854828|9736689|FG003|NOT COMPLETED|Overall Study||17
8691444|NCT00854906|9736699|FG000|STARTED|Overall Study|There were 26 participants whose eyes were measured in the KTBUT group.|26
8691445|NCT00854906|9736699|FG000|COMPLETED|Overall Study|There were 26 participants in this group. One person was excluded be causes of no ocular history.|25
8691446|NCT00854906|9736699|FG000|NOT COMPLETED|Overall Study||1
8691447|NCT00855010|9736708|FG000|STARTED|Overall Study||23
8691448|NCT00855010|9736709|FG001|STARTED|Overall Study||19
8691449|NCT00855010|9736708|FG000|COMPLETED|Overall Study||19
8691450|NCT00855010|9736709|FG001|COMPLETED|Overall Study||18
8691451|NCT00855010|9736708|FG000|NOT COMPLETED|Overall Study||4
8691452|NCT00855010|9736709|FG001|NOT COMPLETED|Overall Study||1
8691453|NCT00855062|9736721|FG000|STARTED|Step1||36
8691454|NCT00855062|9736722|FG001|STARTED|Step1||37
8691455|NCT00855062|9736721|FG000|COMPLETED|Step1||26
8691456|NCT00855062|9736722|FG001|COMPLETED|Step1||26
8691457|NCT00855062|9736721|FG000|NOT COMPLETED|Step1||10
8691458|NCT00855062|9736722|FG001|NOT COMPLETED|Step1||11
8691459|NCT00855062|9736721|FG000|STARTED|Step2|26 participants completed STEP1; however, only 19 out of the 26 decided to enroll in STEP2.|19
8691460|NCT00855062|9736722|FG001|STARTED|Step2|26 participants completed STEP1; however, only 21 out of the 26 decided to enroll in STEP2.|21
8691461|NCT00855062|9736721|FG000|COMPLETED|Step2||13
8691462|NCT00855062|9736722|FG001|COMPLETED|Step2||15
8691463|NCT00855062|9736721|FG000|NOT COMPLETED|Step2||6
8691464|NCT00855062|9736722|FG001|NOT COMPLETED|Step2||6
8691465|NCT00855166|9736730|FG000|STARTED|Overall Study||91
8691466|NCT00855166|9736731|FG001|STARTED|Overall Study|Of the 91 randomized participants only 89 were included in the full analysis set.|91
8691467|NCT00855166|9736730|FG000|COMPLETED|Overall Study||86
8691468|NCT00855166|9736731|FG001|COMPLETED|Overall Study||83
8691469|NCT00855166|9736730|FG000|NOT COMPLETED|Overall Study||5
8691470|NCT00855166|9736731|FG001|NOT COMPLETED|Overall Study||8
8691471|NCT00855218|9736741|FG000|STARTED|Overall Study||154
8691472|NCT00855218|9736742|FG001|STARTED|Overall Study||153
8691473|NCT00855218|9736741|FG000|Participants Received Treatment|Overall Study||153
8691474|NCT00855218|9736742|FG001|Participants Received Treatment|Overall Study||151
8691475|NCT00855218|9736741|FG000|COMPLETED|Overall Study||0
8691476|NCT00855218|9736742|FG001|COMPLETED|Overall Study||0
8691477|NCT00855218|9736741|FG000|NOT COMPLETED|Overall Study||154
8691478|NCT00855218|9736742|FG001|NOT COMPLETED|Overall Study||153
8691479|NCT00855309|9736750|FG000|STARTED|Overall Study||57
8691480|NCT00855309|9736751|FG001|STARTED|Overall Study||55
8691481|NCT00855309|9736750|FG000|COMPLETED|Overall Study||56
8691482|NCT00855309|9736751|FG001|COMPLETED|Overall Study||55
8691483|NCT00855309|9736750|FG000|NOT COMPLETED|Overall Study||1
8691484|NCT00855309|9736751|FG001|NOT COMPLETED|Overall Study||0
8691485|NCT00855335|9736762|FG000|STARTED|Overall Study||18
8691486|NCT00855335|9736763|FG001|STARTED|Overall Study||18
8691487|NCT00855335|9736764|FG002|STARTED|Overall Study||15
8691488|NCT00855335|9736765|FG003|STARTED|Overall Study||19
8691489|NCT00855335|9736766|FG004|STARTED|Overall Study||7
8691490|NCT00855335|9736762|FG000|COMPLETED|Overall Study||13
8691491|NCT00855335|9736763|FG001|COMPLETED|Overall Study||16
8691492|NCT00855335|9736764|FG002|COMPLETED|Overall Study||10
8691493|NCT00855335|9736765|FG003|COMPLETED|Overall Study||12
8691494|NCT00855335|9736766|FG004|COMPLETED|Overall Study||6
8691495|NCT00855335|9736762|FG000|NOT COMPLETED|Overall Study||5
8641536|NCT00590317|9681855|FG000|STARTED|Overall Study||32
8641537|NCT00590317|9681856|FG001|STARTED|Overall Study||32
8641538|NCT00590317|9681855|FG000|COMPLETED|Overall Study||31
8641539|NCT00590317|9681856|FG001|COMPLETED|Overall Study||27
8641540|NCT00590317|9681855|FG000|NOT COMPLETED|Overall Study||1
8641541|NCT00590317|9681856|FG001|NOT COMPLETED|Overall Study||5
8641542|NCT00590369|9681865|FG000|STARTED|Overall Study||6
8641543|NCT00590369|9681866|FG001|STARTED|Overall Study||5
8641544|NCT00590369|9681865|FG000|COMPLETED|Overall Study|Study stopped early due to difficulty recruiting subjects|6
8641545|NCT00590369|9681866|FG001|COMPLETED|Overall Study||5
8641546|NCT00590369|9681865|FG000|NOT COMPLETED|Overall Study||0
8641547|NCT00590369|9681866|FG001|NOT COMPLETED|Overall Study||0
8641548|NCT00590395|9681872|FG000|STARTED|Overall Study||19
8641549|NCT00590395|9681872|FG000|COMPLETED|Overall Study||19
8641550|NCT00590395|9681872|FG000|NOT COMPLETED|Overall Study||0
8641551|NCT00590460|9681876|FG000|STARTED|Overall Study||5
8641552|NCT00590460|9681876|FG000|COMPLETED|Overall Study||5
8641553|NCT00590460|9681876|FG000|NOT COMPLETED|Overall Study||0
8641554|NCT00590564|9681884|FG000|STARTED|Overall Study||42
8641555|NCT00590564|9681884|FG000|COMPLETED|Overall Study||24
8641556|NCT00590564|9681884|FG000|NOT COMPLETED|Overall Study||18
8641557|NCT00590577|9681892|FG000|STARTED|Overall Study||160
8641558|NCT00590577|9681893|FG001|STARTED|Overall Study||165
8641559|NCT00590577|9681894|FG002|STARTED|Overall Study||163
8641560|NCT00590577|9681895|FG003|STARTED|Overall Study||164
8641561|NCT00590577|9681892|FG000|COMPLETED|Overall Study||83
8641562|NCT00590577|9681893|FG001|COMPLETED|Overall Study||89
8641563|NCT00590577|9681894|FG002|COMPLETED|Overall Study||90
8641564|NCT00590577|9681895|FG003|COMPLETED|Overall Study||71
8641565|NCT00590577|9681892|FG000|NOT COMPLETED|Overall Study||77
8641566|NCT00590577|9681893|FG001|NOT COMPLETED|Overall Study||76
8641567|NCT00590577|9681894|FG002|NOT COMPLETED|Overall Study||73
8641568|NCT00590577|9681895|FG003|NOT COMPLETED|Overall Study||93
8641569|NCT00590590|9681908|FG000|STARTED|Overall Study||39
8641570|NCT00590590|9681909|FG001|STARTED|Overall Study||39
8641571|NCT00590590|9681910|FG002|STARTED|Overall Study||27
8641572|NCT00590590|9681908|FG000|COMPLETED|Overall Study||32
8641573|NCT00590590|9681909|FG001|COMPLETED|Overall Study||33
8641574|NCT00590590|9681910|FG002|COMPLETED|Overall Study||21
8641575|NCT00590590|9681908|FG000|NOT COMPLETED|Overall Study||7
8641576|NCT00590590|9681909|FG001|NOT COMPLETED|Overall Study||6
8641577|NCT00590590|9681910|FG002|NOT COMPLETED|Overall Study||6
8641578|NCT00590681|9681918|FG000|STARTED|Overall Study||62
8641579|NCT00590681|9681918|FG000|COMPLETED|Overall Study|The forty-two participants who did proceed to the post-RT phase|42
8641580|NCT00590681|9681918|FG000|NOT COMPLETED|Overall Study||20
8641581|NCT00590707|9681924|FG000|STARTED|Overall Study||100
8641582|NCT00590707|9681925|FG001|STARTED|Overall Study||100
8641583|NCT00590707|9681924|FG000|COMPLETED|Overall Study||100
8641584|NCT00590707|9681925|FG001|COMPLETED|Overall Study||100
8641585|NCT00590707|9681924|FG000|NOT COMPLETED|Overall Study||0
8641586|NCT00590707|9681925|FG001|NOT COMPLETED|Overall Study||0
8641587|NCT00590720|9681933|FG000|STARTED|Overall Study||4
8641588|NCT00590720|9681934|FG001|STARTED|Overall Study||7
8641589|NCT00590720|9681933|FG000|COMPLETED|Overall Study||3
8641590|NCT00590720|9681934|FG001|COMPLETED|Overall Study||6
8641591|NCT00590720|9681933|FG000|NOT COMPLETED|Overall Study||1
8641592|NCT00590720|9681934|FG001|NOT COMPLETED|Overall Study||1
8641593|NCT00590759|9681940|FG000|STARTED|Overall Study||150
8641594|NCT00590759|9681940|FG000|COMPLETED|Overall Study||70
8641595|NCT00590759|9681940|FG000|NOT COMPLETED|Overall Study||80
8641596|NCT00590772|9681944|FG000|STARTED|Overall Study||31
8641597|NCT00590772|9681944|FG000|COMPLETED|Overall Study||31
8641598|NCT00590772|9681944|FG000|NOT COMPLETED|Overall Study||0
8641599|NCT00590824|9681954|FG000|STARTED|Overall Study||11
8641600|NCT00590824|9681955|FG001|STARTED|Overall Study||9
8641601|NCT00590824|9681956|FG002|STARTED|Overall Study||2
8641602|NCT00590824|9681957|FG003|STARTED|Overall Study||1
8641603|NCT00590824|9681954|FG000|COMPLETED|Overall Study||11
8641604|NCT00590824|9681955|FG001|COMPLETED|Overall Study||7
8641605|NCT00590824|9681956|FG002|COMPLETED|Overall Study||1
8641606|NCT00590824|9681957|FG003|COMPLETED|Overall Study||0
8641607|NCT00590824|9681954|FG000|NOT COMPLETED|Overall Study||0
8641608|NCT00590824|9681955|FG001|NOT COMPLETED|Overall Study||2
8641609|NCT00590824|9681956|FG002|NOT COMPLETED|Overall Study||1
8641610|NCT00590824|9681957|FG003|NOT COMPLETED|Overall Study||1
8641611|NCT00590863|9681970|FG000|STARTED|Overall Study||221
8641612|NCT00590863|9681971|FG001|STARTED|Overall Study||220
8641613|NCT00590863|9681972|FG002|STARTED|Overall Study||224
8641614|NCT00590863|9681970|FG000|COMPLETED|Overall Study||137
8641615|NCT00590863|9681971|FG001|COMPLETED|Overall Study||138
8641616|NCT00590863|9681972|FG002|COMPLETED|Overall Study||146
8641617|NCT00590863|9681970|FG000|NOT COMPLETED|Overall Study||84
8806596|NCT01478581|9858811|FG001|NOT COMPLETED|Overall Study||0
8806597|NCT01478581|9858812|FG002|NOT COMPLETED|Overall Study||0
8641618|NCT00590863|9681971|FG001|NOT COMPLETED|Overall Study||82
8641619|NCT00590863|9681972|FG002|NOT COMPLETED|Overall Study||78
8641620|NCT00590889|9681983|FG000|STARTED|Overall Study||404
8641621|NCT00590889|9681984|FG001|STARTED|Overall Study||403
8641622|NCT00590889|9681983|FG000|COMPLETED|Overall Study||118
8641623|NCT00590889|9681984|FG001|COMPLETED|Overall Study||104
8641624|NCT00590889|9681983|FG000|NOT COMPLETED|Overall Study||286
8641625|NCT00590889|9681984|FG001|NOT COMPLETED|Overall Study||299
8641626|NCT00590902|9681990|FG000|STARTED|Overall Study||81
8641627|NCT00590902|9681990|FG000|COMPLETED|Overall Study||80
8641628|NCT00590902|9681990|FG000|NOT COMPLETED|Overall Study||1
8806598|NCT01478581|9858813|FG003|NOT COMPLETED|Overall Study||0
8641629|NCT00590954|9681994|FG000|STARTED|Overall Study||32
8641630|NCT00590954|9681994|FG000|COMPLETED|Overall Study||30
8641631|NCT00590954|9681994|FG000|NOT COMPLETED|Overall Study||2
8641632|NCT00590967|9682002|FG000|STARTED|Overall Study||44
8641633|NCT00590967|9682003|FG001|STARTED|Overall Study||25
8641634|NCT00590967|9682002|FG000|COMPLETED|Overall Study||41
8641635|NCT00590967|9682003|FG001|COMPLETED|Overall Study||20
8641636|NCT00590967|9682002|FG000|NOT COMPLETED|Overall Study||3
8641637|NCT00590967|9682003|FG001|NOT COMPLETED|Overall Study||5
8641638|NCT00590980|9682009|FG000|STARTED|Overall Study||82
8641639|NCT00590980|9682009|FG000|COMPLETED|Overall Study||72
8641640|NCT00590980|9682009|FG000|NOT COMPLETED|Overall Study||10
8641641|NCT00591006|9682013|FG000|STARTED|Overall Study||1
8641642|NCT00591006|9682014|FG001|STARTED|Overall Study||0
8641643|NCT00591006|9682015|FG002|STARTED|Overall Study||1
8641644|NCT00591006|9682016|FG003|STARTED|Overall Study||1
8641645|NCT00591006|9682017|FG004|STARTED|Overall Study||1
8641646|NCT00591006|9682018|FG005|STARTED|Overall Study||0
8641647|NCT00591006|9682019|FG006|STARTED|Overall Study||1
8641648|NCT00591006|9682020|FG007|STARTED|Overall Study||0
8641649|NCT00591006|9682021|FG008|STARTED|Overall Study||1
8641650|NCT00591006|9682022|FG009|STARTED|Overall Study||1
8641651|NCT00591006|9682023|FG010|STARTED|Overall Study||0
8641652|NCT00591006|9682024|FG011|STARTED|Overall Study||1
8641653|NCT00591006|9682025|FG012|STARTED|Overall Study||1
8641654|NCT00591006|9682026|FG013|STARTED|Overall Study||2
8641655|NCT00591006|9682027|FG014|STARTED|Overall Study||0
8641656|NCT00591006|9682028|FG015|STARTED|Overall Study||1
8641657|NCT00591006|9682029|FG016|STARTED|Overall Study||0
8641658|NCT00591006|9682030|FG017|STARTED|Overall Study||1
8641659|NCT00591006|9682031|FG018|STARTED|Overall Study||0
8641660|NCT00591006|9682032|FG019|STARTED|Overall Study||1
8641661|NCT00591006|9682033|FG020|STARTED|Overall Study||0
8641662|NCT00591006|9682034|FG021|STARTED|Overall Study||1
8641663|NCT00591006|9682035|FG022|STARTED|Overall Study||1
8641664|NCT00591006|9682036|FG023|STARTED|Overall Study||1
8641665|NCT00591006|9682013|FG000|Treatment #2|Overall Study||1
8641666|NCT00591006|9682014|FG001|Treatment #2|Overall Study||0
8641667|NCT00591006|9682015|FG002|Treatment #2|Overall Study||1
8641668|NCT00591006|9682016|FG003|Treatment #2|Overall Study||1
8641669|NCT00591006|9682017|FG004|Treatment #2|Overall Study||1
8641670|NCT00591006|9682018|FG005|Treatment #2|Overall Study||0
8641671|NCT00591006|9682019|FG006|Treatment #2|Overall Study||1
8641672|NCT00591006|9682020|FG007|Treatment #2|Overall Study||0
8641673|NCT00591006|9682021|FG008|Treatment #2|Overall Study||1
8641674|NCT00591006|9682022|FG009|Treatment #2|Overall Study||1
8641675|NCT00591006|9682023|FG010|Treatment #2|Overall Study||0
8641676|NCT00591006|9682024|FG011|Treatment #2|Overall Study||1
8641677|NCT00591006|9682025|FG012|Treatment #2|Overall Study||1
8641678|NCT00591006|9682026|FG013|Treatment #2|Overall Study||2
8641679|NCT00591006|9682027|FG014|Treatment #2|Overall Study||0
8641680|NCT00591006|9682028|FG015|Treatment #2|Overall Study||0
8641681|NCT00591006|9682029|FG016|Treatment #2|Overall Study||0
8641682|NCT00591006|9682030|FG017|Treatment #2|Overall Study||1
8641683|NCT00591006|9682031|FG018|Treatment #2|Overall Study||0
8641684|NCT00591006|9682032|FG019|Treatment #2|Overall Study||1
8641685|NCT00591006|9682033|FG020|Treatment #2|Overall Study||0
8641686|NCT00591006|9682034|FG021|Treatment #2|Overall Study||1
8641687|NCT00591006|9682035|FG022|Treatment #2|Overall Study||1
8641688|NCT00591006|9682036|FG023|Treatment #2|Overall Study||1
8641689|NCT00591006|9682013|FG000|Treatment #3|Overall Study||1
8641690|NCT00591006|9682014|FG001|Treatment #3|Overall Study||0
8641691|NCT00591006|9682015|FG002|Treatment #3|Overall Study||1
8641692|NCT00591006|9682016|FG003|Treatment #3|Overall Study||1
8641693|NCT00591006|9682017|FG004|Treatment #3|Overall Study||1
8641694|NCT00591006|9682018|FG005|Treatment #3|Overall Study||0
8641695|NCT00591006|9682019|FG006|Treatment #3|Overall Study||1
8641696|NCT00591006|9682020|FG007|Treatment #3|Overall Study||0
8641697|NCT00591006|9682021|FG008|Treatment #3|Overall Study||1
8641698|NCT00591006|9682022|FG009|Treatment #3|Overall Study||1
8641699|NCT00591006|9682023|FG010|Treatment #3|Overall Study||0
8641700|NCT00591006|9682024|FG011|Treatment #3|Overall Study||1
8641701|NCT00591006|9682025|FG012|Treatment #3|Overall Study||1
8641702|NCT00591006|9682026|FG013|Treatment #3|Overall Study||2
8641703|NCT00591006|9682027|FG014|Treatment #3|Overall Study||0
8641704|NCT00591006|9682028|FG015|Treatment #3|Overall Study||0
8641705|NCT00591006|9682029|FG016|Treatment #3|Overall Study||0
8641706|NCT00591006|9682030|FG017|Treatment #3|Overall Study||1
8641707|NCT00591006|9682031|FG018|Treatment #3|Overall Study||0
8641708|NCT00591006|9682032|FG019|Treatment #3|Overall Study||1
8641709|NCT00591006|9682033|FG020|Treatment #3|Overall Study||0
8641710|NCT00591006|9682034|FG021|Treatment #3|Overall Study||1
8641711|NCT00591006|9682035|FG022|Treatment #3|Overall Study||1
8641712|NCT00591006|9682036|FG023|Treatment #3|Overall Study||1
8641713|NCT00591006|9682013|FG000|Treatment #4|Overall Study||1
8641714|NCT00591006|9682014|FG001|Treatment #4|Overall Study||0
8641715|NCT00591006|9682015|FG002|Treatment #4|Overall Study||1
8641716|NCT00591006|9682016|FG003|Treatment #4|Overall Study||1
8641717|NCT00591006|9682017|FG004|Treatment #4|Overall Study||1
8641718|NCT00591006|9682018|FG005|Treatment #4|Overall Study||0
8641719|NCT00591006|9682019|FG006|Treatment #4|Overall Study||1
8641720|NCT00591006|9682020|FG007|Treatment #4|Overall Study||0
8641721|NCT00591006|9682021|FG008|Treatment #4|Overall Study||1
8641722|NCT00591006|9682022|FG009|Treatment #4|Overall Study||1
8641723|NCT00591006|9682023|FG010|Treatment #4|Overall Study||0
8641724|NCT00591006|9682024|FG011|Treatment #4|Overall Study||1
8641725|NCT00591006|9682025|FG012|Treatment #4|Overall Study||1
8641726|NCT00591006|9682026|FG013|Treatment #4|Overall Study||2
8641727|NCT00591006|9682027|FG014|Treatment #4|Overall Study||0
8641728|NCT00591006|9682028|FG015|Treatment #4|Overall Study||0
8641729|NCT00591006|9682029|FG016|Treatment #4|Overall Study||0
8641730|NCT00591006|9682030|FG017|Treatment #4|Overall Study||1
8641731|NCT00591006|9682031|FG018|Treatment #4|Overall Study||0
8641732|NCT00591006|9682032|FG019|Treatment #4|Overall Study||1
8641733|NCT00591006|9682033|FG020|Treatment #4|Overall Study||0
8641734|NCT00591006|9682034|FG021|Treatment #4|Overall Study||1
8641735|NCT00591006|9682035|FG022|Treatment #4|Overall Study||0
8641736|NCT00591006|9682036|FG023|Treatment #4|Overall Study||0
8641737|NCT00591006|9682013|FG000|COMPLETED|Overall Study||1
8641738|NCT00591006|9682014|FG001|COMPLETED|Overall Study||0
8641739|NCT00591006|9682015|FG002|COMPLETED|Overall Study||1
8641740|NCT00591006|9682016|FG003|COMPLETED|Overall Study||1
8641741|NCT00591006|9682017|FG004|COMPLETED|Overall Study||1
8641742|NCT00591006|9682018|FG005|COMPLETED|Overall Study||0
8641743|NCT00591006|9682019|FG006|COMPLETED|Overall Study||1
8641744|NCT00591006|9682020|FG007|COMPLETED|Overall Study||0
8641745|NCT00591006|9682021|FG008|COMPLETED|Overall Study||1
8641746|NCT00591006|9682022|FG009|COMPLETED|Overall Study||1
8641747|NCT00591006|9682023|FG010|COMPLETED|Overall Study||0
8641748|NCT00591006|9682024|FG011|COMPLETED|Overall Study||1
8641749|NCT00591006|9682025|FG012|COMPLETED|Overall Study||1
8641750|NCT00591006|9682026|FG013|COMPLETED|Overall Study||2
8641751|NCT00591006|9682027|FG014|COMPLETED|Overall Study||0
8641752|NCT00591006|9682028|FG015|COMPLETED|Overall Study||0
8641753|NCT00591006|9682029|FG016|COMPLETED|Overall Study||0
8641754|NCT00591006|9682030|FG017|COMPLETED|Overall Study||1
8641755|NCT00591006|9682031|FG018|COMPLETED|Overall Study||0
8641756|NCT00591006|9682032|FG019|COMPLETED|Overall Study||1
8641757|NCT00591006|9682033|FG020|COMPLETED|Overall Study||0
8641758|NCT00591006|9682034|FG021|COMPLETED|Overall Study||1
8641759|NCT00591006|9682035|FG022|COMPLETED|Overall Study||0
8641760|NCT00591006|9682036|FG023|COMPLETED|Overall Study||0
8641761|NCT00591006|9682013|FG000|NOT COMPLETED|Overall Study||0
8641762|NCT00591006|9682014|FG001|NOT COMPLETED|Overall Study||0
8641763|NCT00591006|9682015|FG002|NOT COMPLETED|Overall Study||0
8641764|NCT00591006|9682016|FG003|NOT COMPLETED|Overall Study||0
8641765|NCT00591006|9682017|FG004|NOT COMPLETED|Overall Study||0
8641766|NCT00591006|9682018|FG005|NOT COMPLETED|Overall Study||0
8641767|NCT00591006|9682019|FG006|NOT COMPLETED|Overall Study||0
8641768|NCT00591006|9682020|FG007|NOT COMPLETED|Overall Study||0
8641769|NCT00591006|9682021|FG008|NOT COMPLETED|Overall Study||0
8641770|NCT00591006|9682022|FG009|NOT COMPLETED|Overall Study||0
8641771|NCT00591006|9682023|FG010|NOT COMPLETED|Overall Study||0
8641772|NCT00591006|9682024|FG011|NOT COMPLETED|Overall Study||0
8641773|NCT00591006|9682025|FG012|NOT COMPLETED|Overall Study||0
8641774|NCT00591006|9682026|FG013|NOT COMPLETED|Overall Study||0
8641775|NCT00591006|9682027|FG014|NOT COMPLETED|Overall Study||0
8641776|NCT00591006|9682028|FG015|NOT COMPLETED|Overall Study||1
8641777|NCT00591006|9682029|FG016|NOT COMPLETED|Overall Study||0
8641778|NCT00591006|9682030|FG017|NOT COMPLETED|Overall Study||0
8641779|NCT00591006|9682031|FG018|NOT COMPLETED|Overall Study||0
8641780|NCT00591006|9682032|FG019|NOT COMPLETED|Overall Study||0
8641781|NCT00591006|9682033|FG020|NOT COMPLETED|Overall Study||0
8641782|NCT00591006|9682034|FG021|NOT COMPLETED|Overall Study||0
8641783|NCT00591006|9682035|FG022|NOT COMPLETED|Overall Study||1
8641784|NCT00591006|9682036|FG023|NOT COMPLETED|Overall Study||1
8641785|NCT00591019|9682053|FG000|STARTED|Baseline (1 Day)||3
8641786|NCT00591019|9682054|FG001|STARTED|Baseline (1 Day)||4
8641787|NCT00591019|9682053|FG000|COMPLETED|Baseline (1 Day)||3
8641788|NCT00591019|9682054|FG001|COMPLETED|Baseline (1 Day)||4
8641789|NCT00591019|9682053|FG000|NOT COMPLETED|Baseline (1 Day)||0
8641790|NCT00591019|9682054|FG001|NOT COMPLETED|Baseline (1 Day)||0
8641791|NCT00591019|9682053|FG000|STARTED|Intervention 1 (14 Days)|One subject dropped out after baseline|2
8641792|NCT00591019|9682054|FG001|STARTED|Intervention 1 (14 Days)|One subject dropped out after baseline|3
8641793|NCT00591019|9682053|FG000|COMPLETED|Intervention 1 (14 Days)||2
8641794|NCT00591019|9682054|FG001|COMPLETED|Intervention 1 (14 Days)||3
8641795|NCT00591019|9682053|FG000|NOT COMPLETED|Intervention 1 (14 Days)||0
8641796|NCT00591019|9682054|FG001|NOT COMPLETED|Intervention 1 (14 Days)||0
8641797|NCT00591019|9682053|FG000|STARTED|Intevention 2 (14 Days)||2
8641798|NCT00591019|9682054|FG001|STARTED|Intevention 2 (14 Days)||3
8641799|NCT00591019|9682053|FG000|COMPLETED|Intevention 2 (14 Days)||2
8641800|NCT00591019|9682054|FG001|COMPLETED|Intevention 2 (14 Days)||3
8641801|NCT00591019|9682053|FG000|NOT COMPLETED|Intevention 2 (14 Days)||0
8641802|NCT00591019|9682054|FG001|NOT COMPLETED|Intevention 2 (14 Days)||0
8641803|NCT00591123|9682062|FG000|STARTED|Overall Study||38
8691496|NCT00855335|9736763|FG001|NOT COMPLETED|Overall Study||2
8641804|NCT00591123|9682062|FG000|COMPLETED|Overall Study|38 were analyzed for safety, 33 were included for efficacy.|38
8641805|NCT00591123|9682062|FG000|NOT COMPLETED|Overall Study||0
8641806|NCT00591149|9682066|FG000|STARTED|Overall Study||16
8641807|NCT00591149|9682066|FG000|COMPLETED|Overall Study||11
8641808|NCT00591149|9682066|FG000|NOT COMPLETED|Overall Study||5
8641809|NCT00591214|9682070|FG000|STARTED|Overall Study||10
8641810|NCT00591214|9682070|FG000|COMPLETED|Overall Study||2
8641811|NCT00591214|9682070|FG000|NOT COMPLETED|Overall Study||8
8641812|NCT00591240|9682076|FG000|STARTED|Overall Study||116
8641813|NCT00591240|9682077|FG001|STARTED|Overall Study||222
8641814|NCT00591240|9682076|FG000|COMPLETED|Overall Study||116
8727251|NCT01042392|9774630|FG000|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)|PPMD excluded patients violated protocol instructions for period 3 (duration and treatment intake)|98
8727252|NCT01042392|9774631|FG001|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)||73
8727253|NCT01042392|9774632|FG002|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)||93
8727254|NCT01042392|9774633|FG003|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)||82
8727255|NCT01042392|9774630|FG000|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||127
8727256|NCT01042392|9774631|FG001|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||117
8727257|NCT01042392|9774632|FG002|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||115
8641815|NCT00591240|9682077|FG001|COMPLETED|Overall Study||222
8641816|NCT00591240|9682076|FG000|NOT COMPLETED|Overall Study||0
8641817|NCT00591240|9682077|FG001|NOT COMPLETED|Overall Study||0
8641818|NCT00591253|9682086|FG000|STARTED|Overall Study|Randomized or Treated|140
8641819|NCT00591253|9682087|FG001|STARTED|Overall Study|Randomized or Treated|137
8641820|NCT00591253|9682088|FG002|STARTED|Overall Study|Randomized or Treated|138
8641821|NCT00591253|9682086|FG000|COMPLETED|Overall Study||126
8641822|NCT00591253|9682087|FG001|COMPLETED|Overall Study||116
8641823|NCT00591253|9682088|FG002|COMPLETED|Overall Study||123
8641824|NCT00591253|9682086|FG000|NOT COMPLETED|Overall Study||14
8641825|NCT00591253|9682087|FG001|NOT COMPLETED|Overall Study||21
8641826|NCT00591253|9682088|FG002|NOT COMPLETED|Overall Study||15
8641827|NCT00591266|9682099|FG000|STARTED|Overall Study|Randomized only|189
8641828|NCT00591266|9682100|FG001|STARTED|Overall Study|Randomized only|188
8641829|NCT00591266|9682101|FG002|STARTED|Overall Study|Randomized only|189
8641830|NCT00591266|9682099|FG000|COMPLETED|Overall Study||180
8641831|NCT00591266|9682100|FG001|COMPLETED|Overall Study||177
8641832|NCT00591266|9682101|FG002|COMPLETED|Overall Study||175
8641833|NCT00591266|9682099|FG000|NOT COMPLETED|Overall Study||9
8641834|NCT00591266|9682100|FG001|NOT COMPLETED|Overall Study||11
8641835|NCT00591266|9682101|FG002|NOT COMPLETED|Overall Study||14
8641836|NCT00591305|9682111|FG000|STARTED|Overall Study||1
8641837|NCT00591305|9682112|FG001|STARTED|Overall Study||0
8641838|NCT00591305|9682111|FG000|1st Follow-up in 2 Wks After Surgery|Overall Study||1
8641839|NCT00591305|9682112|FG001|1st Follow-up in 2 Wks After Surgery|Overall Study||0
8641840|NCT00591305|9682111|FG000|COMPLETED|Overall Study||1
8641841|NCT00591305|9682112|FG001|COMPLETED|Overall Study||0
8641842|NCT00591305|9682111|FG000|NOT COMPLETED|Overall Study||0
8641843|NCT00591305|9682112|FG001|NOT COMPLETED|Overall Study||0
8641844|NCT00591344|9682121|FG000|STARTED|Overall Study|25 randomized, 1 withdrew before the 6 month test and was replaced; 24 completed the 6 month test|25
8641845|NCT00591344|9682122|FG001|STARTED|Overall Study|26 randomized, 2 withdrew before the 6 month test and were replaced, 24 completed 6 month test|26
8641846|NCT00591344|9682121|FG000|Completed the 6 Month Test|Overall Study|Number of subjects who completed the 6 month test|24
8641847|NCT00591344|9682122|FG001|Completed the 6 Month Test|Overall Study|Number of subjects who completed the 6 month test|24
8641848|NCT00591344|9682121|FG000|COMPLETED|Overall Study|Number of subjects who completed the final 24 month test|20
8641849|NCT00591344|9682122|FG001|COMPLETED|Overall Study|Number of subjects who completed the final 24 month test|18
8641850|NCT00591344|9682121|FG000|NOT COMPLETED|Overall Study||5
8641851|NCT00591344|9682122|FG001|NOT COMPLETED|Overall Study||8
8641852|NCT00591370|9682132|FG000|STARTED|Overall Study||51
8641853|NCT00591370|9682132|FG000|COMPLETED|Overall Study||49
8641854|NCT00591370|9682132|FG000|NOT COMPLETED|Overall Study||2
8641855|NCT00591409|9682146|FG000|STARTED|Overall Study||10
8641856|NCT00591409|9682147|FG001|STARTED|Overall Study||10
8641857|NCT00591409|9682148|FG002|STARTED|Overall Study||10
8641858|NCT00591409|9682149|FG003|STARTED|Overall Study||10
8641859|NCT00591409|9682150|FG004|STARTED|Overall Study||10
8641860|NCT00591409|9682151|FG005|STARTED|Overall Study||10
8641861|NCT00591409|9682152|FG006|STARTED|Overall Study||10
8641862|NCT00591409|9682153|FG007|STARTED|Overall Study||10
8641863|NCT00591409|9682154|FG008|STARTED|Overall Study||9
8641864|NCT00591409|9682155|FG009|STARTED|Overall Study||11
8641865|NCT00591409|9682146|FG000|Treated|Overall Study||10
8641866|NCT00591409|9682147|FG001|Treated|Overall Study||10
8641867|NCT00591409|9682148|FG002|Treated|Overall Study||10
8641868|NCT00591409|9682149|FG003|Treated|Overall Study||10
8641869|NCT00591409|9682150|FG004|Treated|Overall Study||9
8641870|NCT00591409|9682151|FG005|Treated|Overall Study||10
8641871|NCT00591409|9682152|FG006|Treated|Overall Study||10
8641872|NCT00591409|9682153|FG007|Treated|Overall Study||10
8641873|NCT00591409|9682154|FG008|Treated|Overall Study||9
8641874|NCT00591409|9682155|FG009|Treated|Overall Study||10
8641875|NCT00591409|9682146|FG000|COMPLETED|Overall Study||10
8641876|NCT00591409|9682147|FG001|COMPLETED|Overall Study||10
8641877|NCT00591409|9682148|FG002|COMPLETED|Overall Study||10
8641878|NCT00591409|9682149|FG003|COMPLETED|Overall Study||10
8641879|NCT00591409|9682150|FG004|COMPLETED|Overall Study||9
8641880|NCT00591409|9682151|FG005|COMPLETED|Overall Study||10
8641881|NCT00591409|9682152|FG006|COMPLETED|Overall Study||10
8641882|NCT00591409|9682153|FG007|COMPLETED|Overall Study||10
8641883|NCT00591409|9682154|FG008|COMPLETED|Overall Study||9
8641884|NCT00591409|9682155|FG009|COMPLETED|Overall Study||10
8641885|NCT00591409|9682146|FG000|NOT COMPLETED|Overall Study||0
8641886|NCT00591409|9682147|FG001|NOT COMPLETED|Overall Study||0
8641887|NCT00591409|9682148|FG002|NOT COMPLETED|Overall Study||0
8641888|NCT00591409|9682149|FG003|NOT COMPLETED|Overall Study||0
8641889|NCT00591409|9682150|FG004|NOT COMPLETED|Overall Study||1
8641890|NCT00591409|9682151|FG005|NOT COMPLETED|Overall Study||0
8641891|NCT00591409|9682152|FG006|NOT COMPLETED|Overall Study||0
8641892|NCT00591409|9682153|FG007|NOT COMPLETED|Overall Study||0
8641893|NCT00591409|9682154|FG008|NOT COMPLETED|Overall Study||0
8641894|NCT00591409|9682155|FG009|NOT COMPLETED|Overall Study||1
8641895|NCT00591565|9682177|FG000|STARTED|Overall Study||13
8641896|NCT00591565|9682177|FG000|COMPLETED|Overall Study||8
8641897|NCT00591565|9682177|FG000|NOT COMPLETED|Overall Study||5
8641898|NCT00591578|9682184|FG000|STARTED|Double-Blind Treatment Phase||327
8641899|NCT00591578|9682185|FG001|STARTED|Double-Blind Treatment Phase||329
8641900|NCT00591578|9682186|FG002|STARTED|Double-Blind Treatment Phase|Two participants randomized but not treated.|328
8641901|NCT00591578|9682184|FG000|COMPLETED|Double-Blind Treatment Phase||249
8641902|NCT00591578|9682185|FG001|COMPLETED|Double-Blind Treatment Phase||249
8641903|NCT00591578|9682186|FG002|COMPLETED|Double-Blind Treatment Phase||244
8641904|NCT00591578|9682184|FG000|NOT COMPLETED|Double-Blind Treatment Phase||78
8641905|NCT00591578|9682185|FG001|NOT COMPLETED|Double-Blind Treatment Phase||80
8641906|NCT00591578|9682186|FG002|NOT COMPLETED|Double-Blind Treatment Phase||84
8641907|NCT00591578|9682184|FG000|STARTED|Open-Label Extension Phase||55
8641908|NCT00591578|9682185|FG001|STARTED|Open-Label Extension Phase||115
8641909|NCT00591578|9682186|FG002|STARTED|Open-Label Extension Phase||0
8641910|NCT00591578|9682184|FG000|COMPLETED|Open-Label Extension Phase||49
8641911|NCT00591578|9682185|FG001|COMPLETED|Open-Label Extension Phase||105
8641912|NCT00591578|9682186|FG002|COMPLETED|Open-Label Extension Phase||0
8641913|NCT00591578|9682184|FG000|NOT COMPLETED|Open-Label Extension Phase||6
8641914|NCT00591578|9682185|FG001|NOT COMPLETED|Open-Label Extension Phase||10
8641915|NCT00591578|9682186|FG002|NOT COMPLETED|Open-Label Extension Phase||0
8641916|NCT00591591|9682197|FG000|STARTED|Overall Study||176
8641917|NCT00591591|9682198|FG001|STARTED|Overall Study||133
8641918|NCT00591591|9682197|FG000|COMPLETED|Overall Study||165
8641919|NCT00591591|9682198|FG001|COMPLETED|Overall Study||94
8641920|NCT00591591|9682197|FG000|NOT COMPLETED|Overall Study||11
8641921|NCT00591591|9682198|FG001|NOT COMPLETED|Overall Study||39
8641922|NCT00591630|9682208|FG000|STARTED|Overall Study||6
8641923|NCT00591630|9682209|FG001|STARTED|Overall Study||8
8641924|NCT00591630|9682210|FG002|STARTED|Overall Study||10
8641925|NCT00591630|9682211|FG003|STARTED|Overall Study||6
8641926|NCT00591630|9682208|FG000|COMPLETED|Overall Study||6
8641927|NCT00591630|9682209|FG001|COMPLETED|Overall Study||8
8641928|NCT00591630|9682210|FG002|COMPLETED|Overall Study||9
8641929|NCT00591630|9682211|FG003|COMPLETED|Overall Study||6
8641930|NCT00591630|9682208|FG000|NOT COMPLETED|Overall Study||0
8641931|NCT00591630|9682209|FG001|NOT COMPLETED|Overall Study||0
8641932|NCT00591630|9682210|FG002|NOT COMPLETED|Overall Study||1
8641933|NCT00591630|9682211|FG003|NOT COMPLETED|Overall Study||0
8641934|NCT00591721|9682223|FG000|STARTED|Overall Study||89
8641935|NCT00591721|9682224|FG001|STARTED|Overall Study||92
8641936|NCT00591721|9682223|FG000|COMPLETED|Overall Study||68
8641937|NCT00591721|9682224|FG001|COMPLETED|Overall Study||70
8641938|NCT00591721|9682223|FG000|NOT COMPLETED|Overall Study||21
8641939|NCT00591721|9682224|FG001|NOT COMPLETED|Overall Study||22
8641940|NCT00591734|9682230|FG000|STARTED|Overall Study||57
8641941|NCT00591734|9682230|FG000|COMPLETED|Overall Study||4
8641942|NCT00591734|9682230|FG000|NOT COMPLETED|Overall Study||53
8641943|NCT00591760|9682236|FG000|STARTED|Overall Study||28
8641944|NCT00591760|9682237|FG001|STARTED|Overall Study||28
8641945|NCT00591760|9682236|FG000|COMPLETED|Overall Study||28
8641946|NCT00591760|9682237|FG001|COMPLETED|Overall Study||28
8641947|NCT00591760|9682236|FG000|NOT COMPLETED|Overall Study||0
8641948|NCT00591760|9682237|FG001|NOT COMPLETED|Overall Study||0
8641949|NCT00591773|9682246|FG000|STARTED|Overall Study||185
8641950|NCT00591773|9682247|FG001|STARTED|Overall Study||182
8641951|NCT00591773|9682248|FG002|STARTED|Overall Study||184
8641952|NCT00591773|9682246|FG000|COMPLETED|Overall Study||169
8641953|NCT00591773|9682247|FG001|COMPLETED|Overall Study||158
8641954|NCT00591773|9682248|FG002|COMPLETED|Overall Study||168
8641955|NCT00591773|9682246|FG000|NOT COMPLETED|Overall Study||16
8641956|NCT00591773|9682247|FG001|NOT COMPLETED|Overall Study||24
8641957|NCT00591773|9682248|FG002|NOT COMPLETED|Overall Study||16
8641958|NCT00591786|9682266|FG000|STARTED|Overall Study||9
8641959|NCT00591786|9682267|FG001|STARTED|Overall Study||9
8641960|NCT00591786|9682268|FG002|STARTED|Overall Study||11
8641961|NCT00591786|9682269|FG003|STARTED|Overall Study||11
8641962|NCT00591786|9682270|FG004|STARTED|Overall Study||10
8641963|NCT00591786|9682271|FG005|STARTED|Overall Study||10
8641964|NCT00591786|9682272|FG006|STARTED|Overall Study||10
8641965|NCT00591786|9682273|FG007|STARTED|Overall Study||10
8641966|NCT00591786|9682274|FG008|STARTED|Overall Study||10
8641967|NCT00591786|9682275|FG009|STARTED|Overall Study||10
8641968|NCT00591786|9682266|FG000|Treated Participants|Overall Study||9
8641969|NCT00591786|9682267|FG001|Treated Participants|Overall Study||9
8641970|NCT00591786|9682268|FG002|Treated Participants|Overall Study||10
8641971|NCT00591786|9682269|FG003|Treated Participants|Overall Study||11
8641972|NCT00591786|9682270|FG004|Treated Participants|Overall Study||10
8641973|NCT00591786|9682271|FG005|Treated Participants|Overall Study||10
8641974|NCT00591786|9682272|FG006|Treated Participants|Overall Study||10
8641975|NCT00591786|9682273|FG007|Treated Participants|Overall Study||10
8641976|NCT00591786|9682274|FG008|Treated Participants|Overall Study||10
8641977|NCT00591786|9682275|FG009|Treated Participants|Overall Study||10
8641978|NCT00591786|9682266|FG000|COMPLETED|Overall Study||9
8641979|NCT00591786|9682267|FG001|COMPLETED|Overall Study||9
8641980|NCT00591786|9682268|FG002|COMPLETED|Overall Study||10
8641981|NCT00591786|9682269|FG003|COMPLETED|Overall Study||11
8641982|NCT00591786|9682270|FG004|COMPLETED|Overall Study||10
8641983|NCT00591786|9682271|FG005|COMPLETED|Overall Study||10
8641984|NCT00591786|9682272|FG006|COMPLETED|Overall Study||10
8641985|NCT00591786|9682273|FG007|COMPLETED|Overall Study||10
8641986|NCT00591786|9682274|FG008|COMPLETED|Overall Study||10
8641987|NCT00591786|9682275|FG009|COMPLETED|Overall Study||10
8641988|NCT00591786|9682266|FG000|NOT COMPLETED|Overall Study||0
8641989|NCT00591786|9682267|FG001|NOT COMPLETED|Overall Study||0
8641990|NCT00591786|9682268|FG002|NOT COMPLETED|Overall Study||1
8641991|NCT00591786|9682269|FG003|NOT COMPLETED|Overall Study||0
8641992|NCT00591786|9682270|FG004|NOT COMPLETED|Overall Study||0
8641993|NCT00591786|9682271|FG005|NOT COMPLETED|Overall Study||0
8641994|NCT00591786|9682272|FG006|NOT COMPLETED|Overall Study||0
8641995|NCT00591786|9682273|FG007|NOT COMPLETED|Overall Study||0
8641996|NCT00591786|9682274|FG008|NOT COMPLETED|Overall Study||0
8641997|NCT00591786|9682275|FG009|NOT COMPLETED|Overall Study||0
8641998|NCT00591825|9682301|FG000|STARTED|Overall Study||14
8641999|NCT00591825|9682302|FG001|STARTED|Overall Study||13
8642000|NCT00591825|9682303|FG002|STARTED|Overall Study||13
8642001|NCT00591825|9682304|FG003|STARTED|Overall Study||14
8642002|NCT00591825|9682301|FG000|COMPLETED|Overall Study||14
8642003|NCT00591825|9682302|FG001|COMPLETED|Overall Study||13
8642004|NCT00591825|9682303|FG002|COMPLETED|Overall Study||13
8642005|NCT00591825|9682304|FG003|COMPLETED|Overall Study||14
8642006|NCT00591825|9682301|FG000|NOT COMPLETED|Overall Study||0
8642007|NCT00591825|9682302|FG001|NOT COMPLETED|Overall Study||0
8642008|NCT00591825|9682303|FG002|NOT COMPLETED|Overall Study||0
8642009|NCT00591825|9682304|FG003|NOT COMPLETED|Overall Study||0
8642010|NCT00591838|9682329|FG000|STARTED|Overall Study||5
8642011|NCT00591838|9682330|FG001|STARTED|Overall Study||6
8642012|NCT00591838|9682331|FG002|STARTED|Overall Study||6
8642013|NCT00591838|9682332|FG003|STARTED|Overall Study||6
8642014|NCT00591838|9682333|FG004|STARTED|Overall Study||51
8642015|NCT00591838|9682329|FG000|COMPLETED|Overall Study||5
8642016|NCT00591838|9682330|FG001|COMPLETED|Overall Study||6
8642017|NCT00591838|9682331|FG002|COMPLETED|Overall Study||6
8642018|NCT00591838|9682332|FG003|COMPLETED|Overall Study||5
8642019|NCT00591838|9682333|FG004|COMPLETED|Overall Study||51
8642020|NCT00591838|9682329|FG000|NOT COMPLETED|Overall Study||0
8642021|NCT00591838|9682330|FG001|NOT COMPLETED|Overall Study||0
8642022|NCT00591838|9682331|FG002|NOT COMPLETED|Overall Study||0
8642023|NCT00591838|9682332|FG003|NOT COMPLETED|Overall Study||1
8642024|NCT00591838|9682333|FG004|NOT COMPLETED|Overall Study||0
8642025|NCT00591851|9682346|FG000|STARTED|Overall Study||70
8642026|NCT00591851|9682346|FG000|COMPLETED|Overall Study||64
8642027|NCT00591851|9682346|FG000|NOT COMPLETED|Overall Study||6
8642028|NCT00591864|9682350|FG000|STARTED|Overall Study||89
8642029|NCT00591864|9682350|FG000|COMPLETED|Overall Study||84
8642030|NCT00591864|9682350|FG000|NOT COMPLETED|Overall Study||5
8642031|NCT00591942|9682355|FG000|STARTED|Overall Study||36
8642032|NCT00591942|9682356|FG001|STARTED|Overall Study||36
8642033|NCT00591942|9682355|FG000|COMPLETED|Overall Study||36
8642034|NCT00591942|9682356|FG001|COMPLETED|Overall Study||36
8642035|NCT00591942|9682355|FG000|NOT COMPLETED|Overall Study||0
8642036|NCT00591942|9682356|FG001|NOT COMPLETED|Overall Study||0
8642037|NCT00592072|9682362|FG000|STARTED|First Sequence||6
8642038|NCT00592072|9682363|FG001|STARTED|First Sequence||6
8642039|NCT00592072|9682362|FG000|COMPLETED|First Sequence||6
8642040|NCT00592072|9682363|FG001|COMPLETED|First Sequence||6
8642041|NCT00592072|9682362|FG000|NOT COMPLETED|First Sequence||0
8642042|NCT00592072|9682363|FG001|NOT COMPLETED|First Sequence||0
8642043|NCT00592072|9682362|FG000|STARTED|Wash Out Period||6
8642044|NCT00592072|9682363|FG001|STARTED|Wash Out Period||6
8642045|NCT00592072|9682362|FG000|COMPLETED|Wash Out Period||5
8642046|NCT00592072|9682363|FG001|COMPLETED|Wash Out Period||5
8642047|NCT00592072|9682362|FG000|NOT COMPLETED|Wash Out Period||1
8642048|NCT00592072|9682363|FG001|NOT COMPLETED|Wash Out Period||1
8642049|NCT00592072|9682362|FG000|STARTED|Second Sequence||5
8642050|NCT00592072|9682363|FG001|STARTED|Second Sequence||5
8642051|NCT00592072|9682362|FG000|COMPLETED|Second Sequence||5
8642052|NCT00592072|9682363|FG001|COMPLETED|Second Sequence||5
8642053|NCT00592072|9682362|FG000|NOT COMPLETED|Second Sequence||0
8642054|NCT00592072|9682363|FG001|NOT COMPLETED|Second Sequence||0
8642055|NCT00592124|9682375|FG000|STARTED|Overall Study||28
8642056|NCT00592124|9682376|FG001|STARTED|Overall Study||29
8642057|NCT00592124|9682377|FG002|STARTED|Overall Study||30
8642058|NCT00592124|9682378|FG003|STARTED|Overall Study||27
8642059|NCT00592124|9682379|FG004|STARTED|Overall Study||27
8642060|NCT00592124|9682380|FG005|STARTED|Overall Study||27
8642061|NCT00592124|9682375|FG000|COMPLETED|Overall Study||24
8642062|NCT00592124|9682376|FG001|COMPLETED|Overall Study||24
8642063|NCT00592124|9682377|FG002|COMPLETED|Overall Study||24
8642064|NCT00592124|9682378|FG003|COMPLETED|Overall Study||24
8642065|NCT00592124|9682379|FG004|COMPLETED|Overall Study||24
8642066|NCT00592124|9682380|FG005|COMPLETED|Overall Study||24
8642067|NCT00592124|9682375|FG000|NOT COMPLETED|Overall Study||4
8642068|NCT00592124|9682376|FG001|NOT COMPLETED|Overall Study||5
8642069|NCT00592124|9682377|FG002|NOT COMPLETED|Overall Study||6
8642070|NCT00592124|9682378|FG003|NOT COMPLETED|Overall Study||3
8642071|NCT00592124|9682379|FG004|NOT COMPLETED|Overall Study||3
8642072|NCT00592124|9682380|FG005|NOT COMPLETED|Overall Study||3
8642073|NCT00592176|9682390|FG000|STARTED|Overall Study||5
8642074|NCT00592176|9682390|FG000|COMPLETED|Overall Study||5
8642075|NCT00592176|9682390|FG000|NOT COMPLETED|Overall Study||0
8642076|NCT00592319|9682396|FG000|STARTED|Overall Study||2
8642077|NCT00592319|9682397|FG001|STARTED|Overall Study||8
8642078|NCT00592319|9682396|FG000|COMPLETED|Overall Study||2
8642079|NCT00592319|9682397|FG001|COMPLETED|Overall Study||5
8642080|NCT00592319|9682396|FG000|NOT COMPLETED|Overall Study||0
8642081|NCT00592319|9682397|FG001|NOT COMPLETED|Overall Study||3
8642082|NCT00592358|9682405|FG000|STARTED|Overall Study||17
8642083|NCT00592358|9682405|FG000|COMPLETED|Overall Study||11
8642084|NCT00592358|9682405|FG000|NOT COMPLETED|Overall Study||6
8642085|NCT00592384|9682411|FG000|STARTED|Overall Study||64
8642086|NCT00592384|9682412|FG001|STARTED|Overall Study||69
8642087|NCT00592384|9682411|FG000|COMPLETED|Overall Study||59
8642088|NCT00592384|9682412|FG001|COMPLETED|Overall Study||63
8642089|NCT00592384|9682411|FG000|NOT COMPLETED|Overall Study||5
8642090|NCT00592384|9682412|FG001|NOT COMPLETED|Overall Study||6
8642091|NCT00592475|9682421|FG000|STARTED|Overall Study||6
8642092|NCT00592475|9682422|FG001|STARTED|Overall Study||9
8642093|NCT00592475|9682423|FG002|STARTED|Overall Study||5
8642094|NCT00592475|9682421|FG000|COMPLETED|Overall Study||6
8642095|NCT00592475|9682422|FG001|COMPLETED|Overall Study||9
8642096|NCT00592475|9682423|FG002|COMPLETED|Overall Study||5
8642097|NCT00592475|9682421|FG000|NOT COMPLETED|Overall Study||0
8642098|NCT00592475|9682422|FG001|NOT COMPLETED|Overall Study||0
8642099|NCT00592475|9682423|FG002|NOT COMPLETED|Overall Study||0
8642100|NCT00592488|9682433|FG000|STARTED|Overall Study||6
8642101|NCT00592488|9682434|FG001|STARTED|Overall Study||7
8642102|NCT00592488|9682433|FG000|COMPLETED|Overall Study||6
8642103|NCT00592488|9682434|FG001|COMPLETED|Overall Study||7
8642104|NCT00592488|9682433|FG000|NOT COMPLETED|Overall Study||0
8642105|NCT00592488|9682434|FG001|NOT COMPLETED|Overall Study||0
8642106|NCT00592501|9682442|FG000|STARTED|Overall Study||25
8642107|NCT00592501|9682442|FG000|COMPLETED|Overall Study||23
8642108|NCT00592501|9682442|FG000|NOT COMPLETED|Overall Study||2
8642109|NCT00592553|9682449|FG000|STARTED|Overall Study||60
8642110|NCT00592553|9682450|FG001|STARTED|Overall Study||57
8642111|NCT00592553|9682451|FG002|STARTED|Overall Study||57
8642112|NCT00592553|9682449|FG000|As-treated Population|Overall Study||60
8642113|NCT00592553|9682450|FG001|As-treated Population|Overall Study||57
8642114|NCT00592553|9682451|FG002|As-treated Population|Overall Study||57
8642115|NCT00592553|9682449|FG000|ITT Population|Overall Study||60
8642116|NCT00592553|9682450|FG001|ITT Population|Overall Study||57
8642117|NCT00592553|9682451|FG002|ITT Population|Overall Study||57
8642118|NCT00592553|9682449|FG000|COMPLETED|Overall Study||59
8642119|NCT00592553|9682450|FG001|COMPLETED|Overall Study||57
8642120|NCT00592553|9682451|FG002|COMPLETED|Overall Study||57
8642121|NCT00592553|9682449|FG000|NOT COMPLETED|Overall Study||1
8642122|NCT00592553|9682450|FG001|NOT COMPLETED|Overall Study||0
8642123|NCT00592553|9682451|FG002|NOT COMPLETED|Overall Study||0
8642124|NCT00592631|9682461|FG000|STARTED|Overall Study||16
8642125|NCT00592631|9682462|FG001|STARTED|Overall Study||11
8642126|NCT00592631|9682461|FG000|COMPLETED|Overall Study||16
8642127|NCT00592631|9682462|FG001|COMPLETED|Overall Study||9
8642128|NCT00592631|9682461|FG000|NOT COMPLETED|Overall Study||0
8642129|NCT00592631|9682462|FG001|NOT COMPLETED|Overall Study||2
8642130|NCT00592683|9682470|FG000|STARTED|Overall Study||10
8642131|NCT00592683|9682471|FG001|STARTED|Overall Study||10
8642132|NCT00592683|9682470|FG000|COMPLETED|Overall Study||6
8642133|NCT00592683|9682471|FG001|COMPLETED|Overall Study||6
8642134|NCT00592683|9682470|FG000|NOT COMPLETED|Overall Study||4
8642135|NCT00592683|9682471|FG001|NOT COMPLETED|Overall Study||4
8642136|NCT00592761|9682477|FG000|STARTED|First Intervention (2 Weeks)||9
8642137|NCT00592761|9682478|FG001|STARTED|First Intervention (2 Weeks)||9
8642138|NCT00592761|9682477|FG000|COMPLETED|First Intervention (2 Weeks)||9
8642139|NCT00592761|9682478|FG001|COMPLETED|First Intervention (2 Weeks)||9
8642140|NCT00592761|9682477|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0
8642141|NCT00592761|9682478|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0
8642142|NCT00592761|9682477|FG000|STARTED|Second Intervention (2 Weeks)||9
8642143|NCT00592761|9682478|FG001|STARTED|Second Intervention (2 Weeks)||9
8642144|NCT00592761|9682477|FG000|COMPLETED|Second Intervention (2 Weeks)||9
8642145|NCT00592761|9682478|FG001|COMPLETED|Second Intervention (2 Weeks)||9
8642146|NCT00592761|9682477|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0
8642147|NCT00592761|9682478|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0
8642148|NCT00592774|9682489|FG000|STARTED|Overall Study||26
8642149|NCT00592774|9682490|FG001|STARTED|Overall Study||53
8642150|NCT00592774|9682491|FG002|STARTED|Overall Study||22
8642151|NCT00592774|9682492|FG003|STARTED|Overall Study||22
8642152|NCT00592774|9682493|FG004|STARTED|Overall Study||23
8642153|NCT00592774|9682489|FG000|COMPLETED|Overall Study||15
8642154|NCT00592774|9682490|FG001|COMPLETED|Overall Study||21
8642155|NCT00592774|9682491|FG002|COMPLETED|Overall Study||18
8642156|NCT00592774|9682492|FG003|COMPLETED|Overall Study||8
8642157|NCT00592774|9682493|FG004|COMPLETED|Overall Study||9
8642158|NCT00592774|9682489|FG000|NOT COMPLETED|Overall Study||11
8642159|NCT00592774|9682490|FG001|NOT COMPLETED|Overall Study||32
8642160|NCT00592774|9682491|FG002|NOT COMPLETED|Overall Study||4
8642161|NCT00592774|9682492|FG003|NOT COMPLETED|Overall Study||14
8642162|NCT00592774|9682493|FG004|NOT COMPLETED|Overall Study||14
8642163|NCT00592839|9682508|FG000|STARTED|Overall Study||53
8642164|NCT00592839|9682509|FG001|STARTED|Overall Study||52
8642165|NCT00592839|9682510|FG002|STARTED|Overall Study||52
8642166|NCT00592839|9682508|FG000|COMPLETED|Overall Study||51
8642167|NCT00592839|9682509|FG001|COMPLETED|Overall Study||48
8642168|NCT00592839|9682510|FG002|COMPLETED|Overall Study||46
8642169|NCT00592839|9682508|FG000|NOT COMPLETED|Overall Study||2
8642170|NCT00592839|9682509|FG001|NOT COMPLETED|Overall Study||4
8642171|NCT00592839|9682510|FG002|NOT COMPLETED|Overall Study||6
8642172|NCT00592852|9682518|FG000|STARTED|Overall Study||13
8642173|NCT00592852|9682518|FG000|COMPLETED|Overall Study||7
8642174|NCT00592852|9682518|FG000|NOT COMPLETED|Overall Study||6
8642175|NCT00592904|9682526|FG000|STARTED|Overall Study||57
8642176|NCT00592904|9682527|FG001|STARTED|Overall Study||148
8642177|NCT00592904|9682528|FG002|STARTED|Overall Study||27
8642178|NCT00592904|9682529|FG003|STARTED|Overall Study||30
8642179|NCT00592904|9682526|FG000|COMPLETED|Overall Study||32
8642180|NCT00592904|9682527|FG001|COMPLETED|Overall Study||93
8642181|NCT00592904|9682528|FG002|COMPLETED|Overall Study||10
8642182|NCT00592904|9682529|FG003|COMPLETED|Overall Study||19
8642183|NCT00592904|9682526|FG000|NOT COMPLETED|Overall Study||25
8642184|NCT00592904|9682527|FG001|NOT COMPLETED|Overall Study||55
8642185|NCT00592904|9682528|FG002|NOT COMPLETED|Overall Study||17
8642186|NCT00592904|9682529|FG003|NOT COMPLETED|Overall Study||11
8642187|NCT00592943|9682541|FG000|STARTED|Overall Study||6
8642188|NCT00592943|9682542|FG001|STARTED|Overall Study||6
8642189|NCT00592943|9682541|FG000|COMPLETED|Overall Study||6
8642190|NCT00592943|9682542|FG001|COMPLETED|Overall Study||6
8642191|NCT00592943|9682541|FG000|NOT COMPLETED|Overall Study||0
8642192|NCT00592943|9682542|FG001|NOT COMPLETED|Overall Study||0
8642193|NCT00593112|9682550|FG000|STARTED|Overall Study||27
8642194|NCT00593112|9682551|FG001|STARTED|Overall Study||12
8642195|NCT00593112|9682550|FG000|COMPLETED|Overall Study||17
8642196|NCT00593112|9682551|FG001|COMPLETED|Overall Study||12
8642197|NCT00593112|9682550|FG000|NOT COMPLETED|Overall Study||10
8642198|NCT00593112|9682551|FG001|NOT COMPLETED|Overall Study||0
8642199|NCT00593333|9682559|FG000|STARTED|Overall Study||54
8642200|NCT00593333|9682560|FG001|STARTED|Overall Study||56
8642201|NCT00593333|9682559|FG000|COMPLETED|Overall Study||44
8642202|NCT00593333|9682560|FG001|COMPLETED|Overall Study||45
8642203|NCT00593333|9682559|FG000|NOT COMPLETED|Overall Study||10
8642204|NCT00593333|9682560|FG001|NOT COMPLETED|Overall Study||11
8642205|NCT00593346|9682566|FG000|STARTED|Overall Study||151
8642206|NCT00593346|9682566|FG000|COMPLETED|Overall Study||151
8642207|NCT00593346|9682566|FG000|NOT COMPLETED|Overall Study||0
8642208|NCT00593372|9682573|FG000|STARTED|Overall Study|Eight enrolled in behavioral treatment.|8
8642209|NCT00593372|9682574|FG001|STARTED|Overall Study|Three evaluated but only maintained medical treatment.|3
8642210|NCT00593372|9682573|FG000|COMPLETED|Overall Study|Eight completed behavioral treatment.|8
8642211|NCT00593372|9682574|FG001|COMPLETED|Overall Study|Three evaluated and completed protocol.|3
8642212|NCT00593372|9682573|FG000|NOT COMPLETED|Overall Study||0
8642213|NCT00593372|9682574|FG001|NOT COMPLETED|Overall Study||0
8642214|NCT00593385|9682580|FG000|STARTED|Overall Study||165
8642215|NCT00593385|9682580|FG000|Intention to Treat (ITT) Population|Overall Study|Excludes 13 subjects who did not meet inclusion/exclusion criteria.|152
8642216|NCT00593385|9682580|FG000|COMPLETED|Overall Study|125 of 165 enrolled patients completed the study.|125
8642217|NCT00593385|9682580|FG000|NOT COMPLETED|Overall Study||40
8642218|NCT00593450|9682590|FG000|STARTED|Overall Study||301
8642219|NCT00593450|9682591|FG001|STARTED|Overall Study||286
8642220|NCT00593450|9682592|FG002|STARTED|Overall Study||298
8642221|NCT00593450|9682593|FG003|STARTED|Overall Study||300
8642222|NCT00593450|9682590|FG000|COMPLETED|Overall Study||284
8642223|NCT00593450|9682591|FG001|COMPLETED|Overall Study||265
8642224|NCT00593450|9682592|FG002|COMPLETED|Overall Study||285
8642225|NCT00593450|9682593|FG003|COMPLETED|Overall Study||271
8642226|NCT00593450|9682590|FG000|NOT COMPLETED|Overall Study||17
8642227|NCT00593450|9682591|FG001|NOT COMPLETED|Overall Study||21
8642228|NCT00593450|9682592|FG002|NOT COMPLETED|Overall Study||13
8642229|NCT00593450|9682593|FG003|NOT COMPLETED|Overall Study||29
8642230|NCT00593489|9682605|FG000|STARTED|Allocation|allocated to intervention group to receive the intervention|75
8642231|NCT00593489|9682606|FG001|STARTED|Allocation|allocated to usual care group|79
8642232|NCT00593489|9682605|FG000|COMPLETED|Allocation||73
8642233|NCT00593489|9682606|FG001|COMPLETED|Allocation||78
8642234|NCT00593489|9682605|FG000|NOT COMPLETED|Allocation||2
8642235|NCT00593489|9682606|FG001|NOT COMPLETED|Allocation||1
8642236|NCT00593489|9682605|FG000|STARTED|Analysis|physician withdrawal (N=3) primary outcome set to 0|73
8642237|NCT00593489|9682606|FG001|STARTED|Analysis|physician withdrawal (N=3) primary outcome set to 0|78
8642238|NCT00593489|9682605|FG000|COMPLETED|Analysis||73
8642239|NCT00593489|9682606|FG001|COMPLETED|Analysis||78
8642240|NCT00593489|9682605|FG000|NOT COMPLETED|Analysis||0
8642241|NCT00593489|9682606|FG001|NOT COMPLETED|Analysis||0
8642242|NCT00593554|9682616|FG000|STARTED|Overall Study||3
8642243|NCT00593554|9682617|FG001|STARTED|Overall Study||5
8642244|NCT00593554|9682616|FG000|COMPLETED|Overall Study||0
8642245|NCT00593554|9682617|FG001|COMPLETED|Overall Study||0
8642246|NCT00593554|9682616|FG000|NOT COMPLETED|Overall Study||3
8642247|NCT00593554|9682617|FG001|NOT COMPLETED|Overall Study||5
8642248|NCT00593606|9682623|FG000|STARTED|Overall Study||124
8642249|NCT00593606|9682623|FG000|Start of Treatment - Safety Set|Overall Study||116
8642250|NCT00593606|9682623|FG000|Full Analysis Set|Overall Study||114
8642251|NCT00593606|9682623|FG000|Treatment Period Completed|Overall Study||99
8642252|NCT00593606|9682623|FG000|COMPLETED|Overall Study||97
8642253|NCT00593606|9682623|FG000|NOT COMPLETED|Overall Study||27
8642254|NCT00593645|9682627|FG000|STARTED|Overall Study||7
8642255|NCT00593645|9682627|FG000|COMPLETED|Overall Study||7
8642256|NCT00593645|9682627|FG000|NOT COMPLETED|Overall Study||0
8642257|NCT00593684|9682633|FG000|STARTED|Overall Study||25
8642258|NCT00593684|9682634|FG001|STARTED|Overall Study||25
8642259|NCT00593684|9682633|FG000|COMPLETED|Overall Study||23
8642260|NCT00593684|9682634|FG001|COMPLETED|Overall Study||24
8642261|NCT00593684|9682633|FG000|NOT COMPLETED|Overall Study||2
8642262|NCT00593684|9682634|FG001|NOT COMPLETED|Overall Study||1
8642263|NCT00593736|9682644|FG000|STARTED|Screening Period and Placebo Run-in||0
8642264|NCT00593736|9682645|FG001|STARTED|Screening Period and Placebo Run-in||0
8642265|NCT00593736|9682646|FG002|STARTED|Screening Period and Placebo Run-in||0
8642266|NCT00593736|9682647|FG003|STARTED|Screening Period and Placebo Run-in||549
8642267|NCT00593736|9682644|FG000|COMPLETED|Screening Period and Placebo Run-in||0
8642268|NCT00593736|9682645|FG001|COMPLETED|Screening Period and Placebo Run-in||0
8642269|NCT00593736|9682646|FG002|COMPLETED|Screening Period and Placebo Run-in||0
8642270|NCT00593736|9682647|FG003|COMPLETED|Screening Period and Placebo Run-in||132
8642271|NCT00593736|9682644|FG000|NOT COMPLETED|Screening Period and Placebo Run-in||0
8642272|NCT00593736|9682645|FG001|NOT COMPLETED|Screening Period and Placebo Run-in||0
8642273|NCT00593736|9682646|FG002|NOT COMPLETED|Screening Period and Placebo Run-in||0
8642274|NCT00593736|9682647|FG003|NOT COMPLETED|Screening Period and Placebo Run-in||417
8642275|NCT00593736|9682644|FG000|STARTED|Treatment Period and Placebo Run-out||32
8642276|NCT00593736|9682645|FG001|STARTED|Treatment Period and Placebo Run-out||33
8642277|NCT00593736|9682646|FG002|STARTED|Treatment Period and Placebo Run-out||35
8642278|NCT00593736|9682647|FG003|STARTED|Treatment Period and Placebo Run-out||32
8642279|NCT00593736|9682644|FG000|COMPLETED|Treatment Period and Placebo Run-out||29
8642280|NCT00593736|9682645|FG001|COMPLETED|Treatment Period and Placebo Run-out||31
8642281|NCT00593736|9682646|FG002|COMPLETED|Treatment Period and Placebo Run-out||30
8642282|NCT00593736|9682647|FG003|COMPLETED|Treatment Period and Placebo Run-out||28
8642283|NCT00593736|9682644|FG000|NOT COMPLETED|Treatment Period and Placebo Run-out||3
8642284|NCT00593736|9682645|FG001|NOT COMPLETED|Treatment Period and Placebo Run-out||2
8642285|NCT00593736|9682646|FG002|NOT COMPLETED|Treatment Period and Placebo Run-out||5
8642286|NCT00593736|9682647|FG003|NOT COMPLETED|Treatment Period and Placebo Run-out||4
8642287|NCT00593814|9682659|FG000|STARTED|Overall Study||139
8642288|NCT00593814|9682660|FG001|STARTED|Overall Study||120
8642289|NCT00593814|9682659|FG000|COMPLETED|Overall Study||115
8642290|NCT00593814|9682660|FG001|COMPLETED|Overall Study||120
8642291|NCT00593814|9682659|FG000|NOT COMPLETED|Overall Study||24
8642292|NCT00593814|9682660|FG001|NOT COMPLETED|Overall Study||0
8642293|NCT00593827|9682668|FG000|STARTED|Overall Study|Intent-to-Treat (ITT) Population: Participants who were randomized (eligible and ineligible).|85
8642294|NCT00593827|9682669|FG001|STARTED|Overall Study|ITT Population: Participants who were randomized (eligible and ineligible).|91
8642295|NCT00593827|9682668|FG000|Safety Population|Overall Study|Participants (eligible and ineligible) who received at least 1 dose of study drug.|82
8642296|NCT00593827|9682669|FG001|Safety Population|Overall Study|Participants (eligible and ineligible) who received at least 1 dose of study drug.|89
8642297|NCT00593827|9682668|FG000|Evaluable Population|Overall Study|Treated participants with CR, PR, SD, PD, or NE response. Refer outcome measure 3 and 4 for details.|79
8642298|NCT00593827|9682669|FG001|Evaluable Population|Overall Study|Treated participants with CR, PR, SD, PD, or NE response. Refer outcome measure 3 and 4 for details.|89
8642299|NCT00593827|9682668|FG000|COMPLETED|Overall Study|Completed=off-study (Major reasons: Adverse events (AE)=15; disease progression=76; not treated=3).|85
8642300|NCT00593827|9682669|FG001|COMPLETED|Overall Study|Completed=off-study (Major reasons: AEs=30; disease progression=55; not treated=2).|89
8642301|NCT00593827|9682668|FG000|NOT COMPLETED|Overall Study||0
8642302|NCT00593827|9682669|FG001|NOT COMPLETED|Overall Study||2
8642303|NCT00593840|9682675|FG000|STARTED|Overall Study||73
8642304|NCT00593840|9682675|FG000|COMPLETED|Overall Study||72
8642305|NCT00593840|9682675|FG000|NOT COMPLETED|Overall Study||1
8642306|NCT00593866|9682679|FG000|STARTED|Overall Study||50
8642307|NCT00593866|9682679|FG000|COMPLETED|Overall Study||50
8642308|NCT00593866|9682679|FG000|NOT COMPLETED|Overall Study||0
8642309|NCT00593918|9682685|FG000|STARTED|Overall Study|Number of children with Toll-like Receptor 4 (TLR4) -2026/GG Genotype|17
8642310|NCT00593918|9682686|FG001|STARTED|Overall Study|Number of children with Toll-like Receptor 4 (TLR4) -2026/AG and AA genotypes|74
8642311|NCT00593918|9682685|FG000|COMPLETED|Overall Study|Some children did not come in for the blood draw at visit 2|12
8642312|NCT00593918|9682686|FG001|COMPLETED|Overall Study|Some children did not come in for the blood draw at visit 2|50
8642313|NCT00593918|9682685|FG000|NOT COMPLETED|Overall Study||5
8642314|NCT00593918|9682686|FG001|NOT COMPLETED|Overall Study||24
8642315|NCT00593957|9682695|FG000|STARTED|Overall Study||13
8642316|NCT00593957|9682696|FG001|STARTED|Overall Study||13
8642317|NCT00593957|9682697|FG002|STARTED|Overall Study||12
8642318|NCT00593957|9682695|FG000|COMPLETED|Overall Study||13
8642319|NCT00593957|9682696|FG001|COMPLETED|Overall Study||12
8642320|NCT00593957|9682697|FG002|COMPLETED|Overall Study||10
8642321|NCT00593957|9682695|FG000|NOT COMPLETED|Overall Study||0
8642322|NCT00593957|9682696|FG001|NOT COMPLETED|Overall Study||1
8642323|NCT00593957|9682697|FG002|NOT COMPLETED|Overall Study||2
8642324|NCT00594009|9682719|FG000|STARTED|Overall Study||1
8642325|NCT00594009|9682719|FG000|COMPLETED|Overall Study||1
8642326|NCT00594009|9682719|FG000|NOT COMPLETED|Overall Study||0
8642327|NCT00594022|9682725|FG000|STARTED|Overall Study||176
8642328|NCT00594022|9682726|FG001|STARTED|Overall Study||173
8642329|NCT00594022|9682725|FG000|COMPLETED|Overall Study||176
8642330|NCT00594022|9682726|FG001|COMPLETED|Overall Study||173
8642331|NCT00594022|9682725|FG000|NOT COMPLETED|Overall Study||0
8642332|NCT00594022|9682726|FG001|NOT COMPLETED|Overall Study||0
8642333|NCT00594035|9682734|FG000|STARTED|Overall Study|102 subjects were randomized to Spinal Sealant|102
8642334|NCT00594035|9682735|FG001|STARTED|Overall Study|56 subjects were randomized to the control group (standard of care)|56
8642335|NCT00594035|9682734|FG000|COMPLETED|Overall Study|100 Spinal Sealant subjects were evaluable at the 90-day visit|100
8642336|NCT00594035|9682735|FG001|COMPLETED|Overall Study|53 control group subjects were evaluable at the 90-day visit|53
8642337|NCT00594035|9682734|FG000|NOT COMPLETED|Overall Study||2
8642338|NCT00594035|9682735|FG001|NOT COMPLETED|Overall Study||3
8642339|NCT00594061|9682741|FG000|STARTED|Overall Study||9
8642340|NCT00594061|9682741|FG000|COMPLETED|Overall Study||9
8642341|NCT00594061|9682741|FG000|NOT COMPLETED|Overall Study||0
8642342|NCT00594100|9682745|FG000|STARTED|Procedure||245
8642343|NCT00594100|9682745|FG000|COMPLETED|Procedure||236
8642344|NCT00594100|9682745|FG000|NOT COMPLETED|Procedure||9
8642345|NCT00594100|9682745|FG000|STARTED|Follow-up Through 30 Days Post Procedure||236
8642346|NCT00594100|9682745|FG000|COMPLETED|Follow-up Through 30 Days Post Procedure||224
8642347|NCT00594100|9682745|FG000|NOT COMPLETED|Follow-up Through 30 Days Post Procedure||12
8642348|NCT00594165|9682749|FG000|STARTED|Overall Study||217
8642349|NCT00594165|9682749|FG000|COMPLETED|Overall Study|Study fully recruited. Completed upon market authorization and commercial availability of Neupro.|0
8642350|NCT00594165|9682749|FG000|NOT COMPLETED|Overall Study||217
8642351|NCT00594178|9682753|FG000|STARTED|Overall Study||17
8642352|NCT00594178|9682753|FG000|COMPLETED|Overall Study||12
8642353|NCT00594178|9682753|FG000|NOT COMPLETED|Overall Study||5
8642354|NCT00594204|9682759|FG000|STARTED|Overall Study||394
8642355|NCT00594204|9682760|FG001|STARTED|Overall Study||199
8642356|NCT00594204|9682759|FG000|Received Treatment|Overall Study||390
8642357|NCT00594204|9682760|FG001|Received Treatment|Overall Study||198
8642358|NCT00594204|9682759|FG000|COMPLETED|Overall Study||336
8642359|NCT00594204|9682760|FG001|COMPLETED|Overall Study||154
8642360|NCT00594204|9682759|FG000|NOT COMPLETED|Overall Study||58
8642361|NCT00594204|9682760|FG001|NOT COMPLETED|Overall Study||45
8642362|NCT00594230|9682768|FG000|STARTED|Overall Study||16
8642363|NCT00594230|9682769|FG001|STARTED|Overall Study||10
8642364|NCT00594230|9682768|FG000|COMPLETED|Overall Study||1
8642365|NCT00594230|9682769|FG001|COMPLETED|Overall Study||1
8642366|NCT00594230|9682768|FG000|NOT COMPLETED|Overall Study||15
8642367|NCT00594230|9682769|FG001|NOT COMPLETED|Overall Study||9
8642368|NCT00594256|9682775|FG000|STARTED|Overall Study||8
8642369|NCT00594256|9682775|FG000|COMPLETED|Overall Study||8
8642370|NCT00594256|9682775|FG000|NOT COMPLETED|Overall Study||0
8642371|NCT00594308|9682780|FG000|STARTED|Overall Study||10
8642372|NCT00594308|9682780|FG000|COMPLETED|Overall Study||10
8642373|NCT00594308|9682780|FG000|NOT COMPLETED|Overall Study||0
8642374|NCT00594386|9682784|FG000|STARTED|Overall Study||258
8642375|NCT00594386|9682784|FG000|COMPLETED|Overall Study|Study fully recruited. Completed upon market authorization and commercial availability of Neupro.|0
8642376|NCT00594386|9682784|FG000|NOT COMPLETED|Overall Study||258
8642377|NCT00594399|9682790|FG000|STARTED|Initial 3 Month Counseling||180
8642378|NCT00594399|9682791|FG001|STARTED|Initial 3 Month Counseling||122
8642379|NCT00594399|9682792|FG002|STARTED|Initial 3 Month Counseling||0
8642380|NCT00594399|9682790|FG000|COMPLETED|Initial 3 Month Counseling||163
8642381|NCT00594399|9682791|FG001|COMPLETED|Initial 3 Month Counseling||118
8642382|NCT00594399|9682792|FG002|COMPLETED|Initial 3 Month Counseling||0
8642383|NCT00594399|9682790|FG000|NOT COMPLETED|Initial 3 Month Counseling||17
8642384|NCT00594399|9682791|FG001|NOT COMPLETED|Initial 3 Month Counseling||4
8642385|NCT00594399|9682792|FG002|NOT COMPLETED|Initial 3 Month Counseling||0
8642386|NCT00594399|9682790|FG000|STARTED|Rerandomization Arm 1 Only|Total sample in Arm 1 was rerandomized and allocated to remain in Arm 1 or assigned to Arm 3|81
8642387|NCT00594399|9682791|FG001|STARTED|Rerandomization Arm 1 Only||118
8642388|NCT00594399|9682792|FG002|STARTED|Rerandomization Arm 1 Only|This sample reflects newly randomized study Arm|82
8642389|NCT00594399|9682790|FG000|Rerandomization|Rerandomization Arm 1 Only|Rerandomized to continue to receive telephone calls every 2 weeks or at a reduced dose of 1/ month|81
8642390|NCT00594399|9682791|FG001|Rerandomization|Rerandomization Arm 1 Only||114
8642391|NCT00594399|9682792|FG002|Rerandomization|Rerandomization Arm 1 Only||82
8642392|NCT00594399|9682790|FG000|COMPLETED|Rerandomization Arm 1 Only||79
8642393|NCT00594399|9682791|FG001|COMPLETED|Rerandomization Arm 1 Only||114
8642394|NCT00594399|9682792|FG002|COMPLETED|Rerandomization Arm 1 Only||82
8642395|NCT00594399|9682790|FG000|NOT COMPLETED|Rerandomization Arm 1 Only||2
8642396|NCT00594399|9682791|FG001|NOT COMPLETED|Rerandomization Arm 1 Only||4
8642397|NCT00594399|9682792|FG002|NOT COMPLETED|Rerandomization Arm 1 Only||0
8642398|NCT00594425|9682801|FG000|STARTED|Overall Study||50
8642399|NCT00594425|9682802|FG001|STARTED|Overall Study||48
8642400|NCT00594425|9682803|FG002|STARTED|Overall Study||52
8642401|NCT00594425|9682801|FG000|COMPLETED|Overall Study||43
8642402|NCT00594425|9682802|FG001|COMPLETED|Overall Study||34
8642403|NCT00594425|9682803|FG002|COMPLETED|Overall Study||42
8642404|NCT00594425|9682801|FG000|NOT COMPLETED|Overall Study||7
8642405|NCT00594425|9682802|FG001|NOT COMPLETED|Overall Study||14
8642406|NCT00594425|9682803|FG002|NOT COMPLETED|Overall Study||10
8642407|NCT00594464|9682811|FG000|STARTED|Overall Study||14
8642408|NCT00594464|9682811|FG000|COMPLETED|Overall Study||11
8642409|NCT00594464|9682811|FG000|NOT COMPLETED|Overall Study||3
8642410|NCT00594516|9682821|FG000|STARTED|Open Label (OL): Tapentadol IR|one patient was enrolled but lost to follow up at the start of open label therefore was not included|116
8642411|NCT00594516|9682822|FG001|STARTED|Open Label (OL): Tapentadol IR||0
8642412|NCT00594516|9682823|FG002|STARTED|Open Label (OL): Tapentadol IR||0
8642413|NCT00594516|9682821|FG000|COMPLETED|Open Label (OL): Tapentadol IR||87
8642414|NCT00594516|9682822|FG001|COMPLETED|Open Label (OL): Tapentadol IR||0
8642415|NCT00594516|9682823|FG002|COMPLETED|Open Label (OL): Tapentadol IR||0
8642416|NCT00594516|9682821|FG000|NOT COMPLETED|Open Label (OL): Tapentadol IR||29
8642417|NCT00594516|9682822|FG001|NOT COMPLETED|Open Label (OL): Tapentadol IR||0
8642418|NCT00594516|9682823|FG002|NOT COMPLETED|Open Label (OL): Tapentadol IR||0
8642419|NCT00594516|9682821|FG000|STARTED|DB: Tapentadol IR to ER & ER to IR||0
8642420|NCT00594516|9682822|FG001|STARTED|DB: Tapentadol IR to ER & ER to IR||44
8642421|NCT00594516|9682823|FG002|STARTED|DB: Tapentadol IR to ER & ER to IR||43
8642422|NCT00594516|9682821|FG000|COMPLETED|DB: Tapentadol IR to ER & ER to IR||0
8642423|NCT00594516|9682822|FG001|COMPLETED|DB: Tapentadol IR to ER & ER to IR||37
8642424|NCT00594516|9682823|FG002|COMPLETED|DB: Tapentadol IR to ER & ER to IR||35
8642425|NCT00594516|9682821|FG000|NOT COMPLETED|DB: Tapentadol IR to ER & ER to IR||0
8642426|NCT00594516|9682822|FG001|NOT COMPLETED|DB: Tapentadol IR to ER & ER to IR||7
8642427|NCT00594516|9682823|FG002|NOT COMPLETED|DB: Tapentadol IR to ER & ER to IR||8
8642428|NCT00594568|9682830|FG000|STARTED|Initial Treatment||501
8642429|NCT00594568|9682831|FG001|STARTED|Initial Treatment||507
8642430|NCT00594568|9682832|FG002|STARTED|Initial Treatment||529
8642431|NCT00594568|9682830|FG000|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants (pts) who had at least 1 dose of study drug.|501
8642432|NCT00594568|9682831|FG001|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants who had at least 1 dose of study drug.|506
8642433|NCT00594568|9682832|FG002|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants who had at least 1 dose of study drug.|527
8642434|NCT00594568|9682830|FG000|COMPLETED|Initial Treatment||189
8642435|NCT00594568|9682831|FG001|COMPLETED|Initial Treatment||153
8642436|NCT00594568|9682832|FG002|COMPLETED|Initial Treatment||121
8642437|NCT00594568|9682830|FG000|NOT COMPLETED|Initial Treatment||312
8642438|NCT00594568|9682831|FG001|NOT COMPLETED|Initial Treatment||354
8642439|NCT00594568|9682832|FG002|NOT COMPLETED|Initial Treatment||408
8642440|NCT00594568|9682830|FG000|STARTED|Delayed Start||189
8642441|NCT00594568|9682831|FG001|STARTED|Delayed Start||153
8642442|NCT00594568|9682832|FG002|STARTED|Delayed Start||121
8642443|NCT00594568|9682830|FG000|COMPLETED|Delayed Start||91
8642444|NCT00594568|9682831|FG001|COMPLETED|Delayed Start||76
8642445|NCT00594568|9682832|FG002|COMPLETED|Delayed Start||55
8642446|NCT00594568|9682830|FG000|NOT COMPLETED|Delayed Start||98
8642447|NCT00594568|9682831|FG001|NOT COMPLETED|Delayed Start||77
8642448|NCT00594568|9682832|FG002|NOT COMPLETED|Delayed Start||66
8642449|NCT00594568|9682830|FG000|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|290
8642450|NCT00594568|9682831|FG001|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|223
8642451|NCT00594568|9682832|FG002|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional, pts entered from initial treatment and delayed start or did not enter SFU.|214
8642452|NCT00594568|9682830|FG000|COMPLETED|Safety Follow Up (SFU)-Optional||229
8642453|NCT00594568|9682831|FG001|COMPLETED|Safety Follow Up (SFU)-Optional||168
8642454|NCT00594568|9682832|FG002|COMPLETED|Safety Follow Up (SFU)-Optional||172
8642455|NCT00594568|9682830|FG000|NOT COMPLETED|Safety Follow Up (SFU)-Optional||61
8642456|NCT00594568|9682831|FG001|NOT COMPLETED|Safety Follow Up (SFU)-Optional||55
8642457|NCT00594568|9682832|FG002|NOT COMPLETED|Safety Follow Up (SFU)-Optional||42
8642458|NCT00594646|9682848|FG000|STARTED|Overall Study||100
8642459|NCT00594646|9682848|FG000|COMPLETED|Overall Study||84
8642460|NCT00594646|9682848|FG000|NOT COMPLETED|Overall Study||16
8642461|NCT00594659|9682856|FG000|STARTED|Overall Study||29
8642462|NCT00594659|9682857|FG001|STARTED|Overall Study||30
8642463|NCT00594659|9682858|FG002|STARTED|Overall Study||16
8642464|NCT00594659|9682856|FG000|COMPLETED|Overall Study||16
8642465|NCT00594659|9682857|FG001|COMPLETED|Overall Study||21
8642466|NCT00594659|9682858|FG002|COMPLETED|Overall Study||9
8642467|NCT00594659|9682856|FG000|NOT COMPLETED|Overall Study||13
8642468|NCT00594659|9682857|FG001|NOT COMPLETED|Overall Study||9
8642469|NCT00594659|9682858|FG002|NOT COMPLETED|Overall Study||7
8691497|NCT00855335|9736764|FG002|NOT COMPLETED|Overall Study||5
8691498|NCT00855335|9736765|FG003|NOT COMPLETED|Overall Study||7
8691499|NCT00855335|9736766|FG004|NOT COMPLETED|Overall Study||1
8691500|NCT00855413|9736791|FG000|STARTED|Overall Study||15
8691501|NCT00855413|9736791|FG000|COMPLETED|Overall Study||15
8691502|NCT00855413|9736791|FG000|NOT COMPLETED|Overall Study||0
8691503|NCT00855439|9736797|FG000|STARTED|Overall Study||22
8691504|NCT00855439|9736798|FG001|STARTED|Overall Study||24
8691505|NCT00855439|9736797|FG000|COMPLETED|Overall Study||19
8691506|NCT00855439|9736798|FG001|COMPLETED|Overall Study||24
8691507|NCT00855439|9736797|FG000|NOT COMPLETED|Overall Study||3
8691508|NCT00855439|9736798|FG001|NOT COMPLETED|Overall Study||0
8691509|NCT00855465|9736806|FG000|STARTED|Treatment Period||174
8691510|NCT00855465|9736807|FG001|STARTED|Treatment Period||88
8691511|NCT00855465|9736806|FG000|Participants Received Treatment|Treatment Period|1 subject randomized but not treated|173
8691512|NCT00855465|9736807|FG001|Participants Received Treatment|Treatment Period||88
8691513|NCT00855465|9736806|FG000|COMPLETED|Treatment Period||160
8691514|NCT00855465|9736807|FG001|COMPLETED|Treatment Period||83
8691515|NCT00855465|9736806|FG000|NOT COMPLETED|Treatment Period||14
8691516|NCT00855465|9736807|FG001|NOT COMPLETED|Treatment Period||5
8691517|NCT00855465|9736806|FG000|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|17
8691518|NCT00855465|9736807|FG001|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|4
8691519|NCT00855465|9736806|FG000|COMPLETED|Follow-up Period (FUP)||9
8691520|NCT00855465|9736807|FG001|COMPLETED|Follow-up Period (FUP)||2
8691521|NCT00855465|9736806|FG000|NOT COMPLETED|Follow-up Period (FUP)||8
8691522|NCT00855465|9736807|FG001|NOT COMPLETED|Follow-up Period (FUP)||2
8691523|NCT00855582|9736816|FG000|STARTED|Overall Study||198
8691524|NCT00855582|9736817|FG001|STARTED|Overall Study||208
8691525|NCT00855582|9736818|FG002|STARTED|Overall Study||200
8691526|NCT00855582|9736816|FG000|COMPLETED|Overall Study||172
8691527|NCT00855582|9736817|FG001|COMPLETED|Overall Study||184
8691528|NCT00855582|9736818|FG002|COMPLETED|Overall Study||170
8691529|NCT00855582|9736816|FG000|NOT COMPLETED|Overall Study||26
8691530|NCT00855582|9736817|FG001|NOT COMPLETED|Overall Study||24
8691531|NCT00855582|9736818|FG002|NOT COMPLETED|Overall Study||30
8691532|NCT00855595|9736831|FG000|STARTED|Overall Study||106
8691533|NCT00855595|9736832|FG001|STARTED|Overall Study||101
8691534|NCT00855595|9736831|FG000|COMPLETED|Overall Study||100
8691535|NCT00855595|9736832|FG001|COMPLETED|Overall Study||94
8691536|NCT00855595|9736831|FG000|NOT COMPLETED|Overall Study||6
8691537|NCT00855595|9736832|FG001|NOT COMPLETED|Overall Study||7
8691538|NCT00855738|9736838|FG000|STARTED|Overall Study||111
8691539|NCT00855738|9736838|FG000|At Least 1 Dose and 1 Endpoint|Overall Study|Received at least 1 dose of study drug and had data for at least 1 efficacy endpoint.|108
8691540|NCT00855738|9736838|FG000|COMPLETED|Overall Study||106
8691541|NCT00855738|9736838|FG000|NOT COMPLETED|Overall Study||5
8691542|NCT00855816|9736846|FG000|STARTED|Overall Study||47
8691543|NCT00855816|9736847|FG001|STARTED|Overall Study||33
8691544|NCT00855816|9736846|FG000|COMPLETED|Overall Study||21
8691545|NCT00855816|9736847|FG001|COMPLETED|Overall Study||12
8691546|NCT00855816|9736846|FG000|NOT COMPLETED|Overall Study||26
8691547|NCT00855816|9736847|FG001|NOT COMPLETED|Overall Study||21
8691548|NCT00855842|9736853|FG000|STARTED|Overall Study||4
8691549|NCT00855842|9736853|FG000|COMPLETED|Overall Study||4
8691550|NCT00855842|9736853|FG000|NOT COMPLETED|Overall Study||0
8691551|NCT00855868|9736859|FG000|STARTED|Overall Study||13
8691552|NCT00855868|9736860|FG001|STARTED|Overall Study||15
8691553|NCT00855868|9736859|FG000|COMPLETED|Overall Study||12
8691554|NCT00855868|9736860|FG001|COMPLETED|Overall Study||14
8691555|NCT00855868|9736859|FG000|NOT COMPLETED|Overall Study||1
8691556|NCT00855868|9736860|FG001|NOT COMPLETED|Overall Study||1
8691557|NCT00855894|9736866|FG000|STARTED|Overall Study||41
8691558|NCT00855894|9736866|FG000|COMPLETED|Overall Study||8
8691559|NCT00855894|9736866|FG000|NOT COMPLETED|Overall Study||33
8691560|NCT00855920|9736873|FG000|STARTED|Overall Study||76
8691561|NCT00855920|9736874|FG001|STARTED|Overall Study||74
8691562|NCT00855920|9736875|FG002|STARTED|Overall Study||75
8691563|NCT00855920|9736873|FG000|Safety Population|Overall Study|1 participant from Rilonacept+Indomethacin arm received Placebo (for Rilonacept)+Indomethacin|77
8691564|NCT00855920|9736874|FG001|Safety Population|Overall Study|1 participant from Rilonacept+Indomethacin arm received Placebo (for Rilonacept)+Indomethacin|73
8642470|NCT00594685|9682866|FG000|STARTED|Overall Study||10
8642471|NCT00594685|9682866|FG000|COMPLETED|Overall Study||10
8642472|NCT00594685|9682866|FG000|NOT COMPLETED|Overall Study||0
8642473|NCT00594815|9682870|FG000|STARTED|Overall Study||52
8642474|NCT00594815|9682870|FG000|COMPLETED|Overall Study||43
8642475|NCT00594815|9682870|FG000|NOT COMPLETED|Overall Study||9
8642476|NCT00594854|9682876|FG000|STARTED|Overall Study||9
8642477|NCT00594854|9682877|FG001|STARTED|Overall Study||11
8642478|NCT00594854|9682876|FG000|COMPLETED|Overall Study|POZEN reached an agreement with the FDA to terminate the study due to low and inadequate enrollment.|2
8642479|NCT00594854|9682877|FG001|COMPLETED|Overall Study|POZEN reached an agreement with the FDA to terminate the study due to low and inadequate enrollment.|1
8642480|NCT00594854|9682876|FG000|NOT COMPLETED|Overall Study||7
8642481|NCT00594854|9682877|FG001|NOT COMPLETED|Overall Study||10
8642482|NCT00594880|9682885|FG000|STARTED|Overall Study||12
8642483|NCT00594880|9682886|FG001|STARTED|Overall Study||11
8642484|NCT00594880|9682885|FG000|COMPLETED|Overall Study||10
8642485|NCT00594880|9682886|FG001|COMPLETED|Overall Study||10
8642486|NCT00594880|9682885|FG000|NOT COMPLETED|Overall Study||2
8642487|NCT00594880|9682886|FG001|NOT COMPLETED|Overall Study||1
8642488|NCT00594906|9682898|FG000|STARTED|Overall Study||7
8642489|NCT00594906|9682899|FG001|STARTED|Overall Study||3
8642490|NCT00594906|9682898|FG000|COMPLETED|Overall Study||6
8642491|NCT00594906|9682899|FG001|COMPLETED|Overall Study||1
8642492|NCT00594906|9682898|FG000|NOT COMPLETED|Overall Study||1
8642493|NCT00594906|9682899|FG001|NOT COMPLETED|Overall Study||2
8642494|NCT00594932|9682907|FG000|STARTED|First 3 Months||13
8642495|NCT00594932|9682908|FG001|STARTED|First 3 Months||14
8642496|NCT00594932|9682907|FG000|COMPLETED|First 3 Months||12
8642497|NCT00594932|9682908|FG001|COMPLETED|First 3 Months||11
8642498|NCT00594932|9682907|FG000|NOT COMPLETED|First 3 Months||1
8642499|NCT00594932|9682908|FG001|NOT COMPLETED|First 3 Months||3
8642500|NCT00594932|9682907|FG000|STARTED|Final 3 Months||12
8642501|NCT00594932|9682908|FG001|STARTED|Final 3 Months||11
8642502|NCT00594932|9682907|FG000|COMPLETED|Final 3 Months||8
8642503|NCT00594932|9682908|FG001|COMPLETED|Final 3 Months||8
8642504|NCT00594932|9682907|FG000|NOT COMPLETED|Final 3 Months||4
8642505|NCT00594932|9682908|FG001|NOT COMPLETED|Final 3 Months||3
8642506|NCT00594945|9682917|FG000|STARTED|Cohort 1 / Treatment Period 1||4
8642507|NCT00594945|9682918|FG001|STARTED|Cohort 1 / Treatment Period 1||0
8642508|NCT00594945|9682919|FG002|STARTED|Cohort 1 / Treatment Period 1||2
8642509|NCT00594945|9682917|FG000|COMPLETED|Cohort 1 / Treatment Period 1||4
8642510|NCT00594945|9682918|FG001|COMPLETED|Cohort 1 / Treatment Period 1||0
8642511|NCT00594945|9682919|FG002|COMPLETED|Cohort 1 / Treatment Period 1||2
8642512|NCT00594945|9682917|FG000|NOT COMPLETED|Cohort 1 / Treatment Period 1||0
8642513|NCT00594945|9682918|FG001|NOT COMPLETED|Cohort 1 / Treatment Period 1||0
8642514|NCT00594945|9682919|FG002|NOT COMPLETED|Cohort 1 / Treatment Period 1||0
8642515|NCT00594945|9682917|FG000|STARTED|Cohort 2 / Treatment Period 2||0
8642516|NCT00594945|9682918|FG001|STARTED|Cohort 2 / Treatment Period 2||3
8642517|NCT00594945|9682919|FG002|STARTED|Cohort 2 / Treatment Period 2||2
8642518|NCT00594945|9682917|FG000|COMPLETED|Cohort 2 / Treatment Period 2||0
8642519|NCT00594945|9682918|FG001|COMPLETED|Cohort 2 / Treatment Period 2||3
8642520|NCT00594945|9682919|FG002|COMPLETED|Cohort 2 / Treatment Period 2||2
8642521|NCT00594945|9682917|FG000|NOT COMPLETED|Cohort 2 / Treatment Period 2||0
8642522|NCT00594945|9682918|FG001|NOT COMPLETED|Cohort 2 / Treatment Period 2||0
8642523|NCT00594945|9682919|FG002|NOT COMPLETED|Cohort 2 / Treatment Period 2||0
8642524|NCT00594958|9682928|FG000|STARTED|Overall Study||214
8642525|NCT00594958|9682929|FG001|STARTED|Overall Study||213
8642526|NCT00594958|9682930|FG002|STARTED|Overall Study||212
8642527|NCT00594958|9682928|FG000|Randomized and at Least 1 Vaccination|Overall Study||212
8642528|NCT00594958|9682929|FG001|Randomized and at Least 1 Vaccination|Overall Study||213
8642529|NCT00594958|9682930|FG002|Randomized and at Least 1 Vaccination|Overall Study||211
8642530|NCT00594958|9682928|FG000|COMPLETED|Overall Study||200
8642531|NCT00594958|9682929|FG001|COMPLETED|Overall Study||210
8642532|NCT00594958|9682930|FG002|COMPLETED|Overall Study||202
8642533|NCT00594958|9682928|FG000|NOT COMPLETED|Overall Study||14
8642534|NCT00594958|9682929|FG001|NOT COMPLETED|Overall Study||3
8642535|NCT00594958|9682930|FG002|NOT COMPLETED|Overall Study||10
8642536|NCT00594997|9682940|FG000|STARTED|Overall Study||1562
8642537|NCT00594997|9682941|FG001|STARTED|Overall Study||2008
8642538|NCT00594997|9682940|FG000|COMPLETED|Overall Study||1562
8642539|NCT00594997|9682941|FG001|COMPLETED|Overall Study||2008
8642540|NCT00594997|9682940|FG000|NOT COMPLETED|Overall Study||0
8642541|NCT00594997|9682941|FG001|NOT COMPLETED|Overall Study||0
8642542|NCT00595075|9682951|FG000|STARTED|Overall Study||6
8642543|NCT00595075|9682952|FG001|STARTED|Overall Study||5
8642544|NCT00595075|9682951|FG000|COMPLETED|Overall Study||5
8642545|NCT00595075|9682952|FG001|COMPLETED|Overall Study||5
8642546|NCT00595075|9682951|FG000|NOT COMPLETED|Overall Study||1
8642547|NCT00595075|9682952|FG001|NOT COMPLETED|Overall Study||0
8642548|NCT00595088|9682958|FG000|STARTED|Overall Study||47
8642549|NCT00595088|9682958|FG000|COMPLETED|Overall Study|5 patients ongoing, 7 completed the study (week 46)and 35 withdrew prematurely|7
8642550|NCT00595088|9682958|FG000|NOT COMPLETED|Overall Study||40
8642551|NCT00595101|9682966|FG000|STARTED|Overall Study||29
8642552|NCT00595101|9682967|FG001|STARTED|Overall Study||29
8642553|NCT00595101|9682968|FG002|STARTED|Overall Study||29
8642554|NCT00595101|9682969|FG003|STARTED|Overall Study||30
8642555|NCT00595101|9682966|FG000|COMPLETED|Overall Study||29
8642556|NCT00595101|9682967|FG001|COMPLETED|Overall Study||28
8642557|NCT00595101|9682968|FG002|COMPLETED|Overall Study||29
8642558|NCT00595101|9682969|FG003|COMPLETED|Overall Study||30
8642559|NCT00595101|9682966|FG000|NOT COMPLETED|Overall Study||0
8642560|NCT00595101|9682967|FG001|NOT COMPLETED|Overall Study||1
8642561|NCT00595101|9682968|FG002|NOT COMPLETED|Overall Study||0
8642562|NCT00595101|9682969|FG003|NOT COMPLETED|Overall Study||0
8642563|NCT00595114|9682981|FG000|STARTED|Overall Study||24
8642564|NCT00595114|9682982|FG001|STARTED|Overall Study||19
8642565|NCT00595114|9682981|FG000|COMPLETED|Overall Study||24
8642566|NCT00595114|9682982|FG001|COMPLETED|Overall Study||19
8642567|NCT00595114|9682981|FG000|NOT COMPLETED|Overall Study||0
8642568|NCT00595114|9682982|FG001|NOT COMPLETED|Overall Study||0
8642569|NCT00595127|9682988|FG000|STARTED|Overall Study||21
8642570|NCT00595127|9682988|FG000|COMPLETED|Overall Study||11
8642571|NCT00595127|9682988|FG000|NOT COMPLETED|Overall Study||10
8642572|NCT00595153|9682995|FG000|STARTED|Overall Study||24
8642573|NCT00595153|9682996|FG001|STARTED|Overall Study||42
8642574|NCT00595153|9682997|FG002|STARTED|Overall Study||61
8642575|NCT00595153|9682995|FG000|COMPLETED|Overall Study||20
8642576|NCT00595153|9682996|FG001|COMPLETED|Overall Study||26
8642577|NCT00595153|9682997|FG002|COMPLETED|Overall Study||36
8642578|NCT00595153|9682995|FG000|NOT COMPLETED|Overall Study||4
8642579|NCT00595153|9682996|FG001|NOT COMPLETED|Overall Study||16
8642580|NCT00595153|9682997|FG002|NOT COMPLETED|Overall Study||25
8642581|NCT00595231|9683007|FG000|STARTED|Overall Study||120
8642582|NCT00595231|9683008|FG001|STARTED|Overall Study||119
8642583|NCT00595231|9683007|FG000|COMPLETED|Overall Study||115
8642584|NCT00595231|9683008|FG001|COMPLETED|Overall Study||114
8642585|NCT00595231|9683007|FG000|NOT COMPLETED|Overall Study||5
8642586|NCT00595231|9683008|FG001|NOT COMPLETED|Overall Study||5
8642587|NCT00595270|9683017|FG000|STARTED|Overall Study||116
8642588|NCT00595270|9683018|FG001|STARTED|Overall Study||117
8642589|NCT00595270|9683019|FG002|STARTED|Overall Study||116
8642590|NCT00595270|9683017|FG000|COMPLETED|Overall Study||110
8642591|NCT00595270|9683018|FG001|COMPLETED|Overall Study||107
8642592|NCT00595270|9683019|FG002|COMPLETED|Overall Study||108
8642593|NCT00595270|9683017|FG000|NOT COMPLETED|Overall Study||6
8642594|NCT00595270|9683018|FG001|NOT COMPLETED|Overall Study||10
8642595|NCT00595270|9683019|FG002|NOT COMPLETED|Overall Study||8
8642596|NCT00595309|9683027|FG000|STARTED|Overall Study||198
8642597|NCT00595309|9683027|FG000|COMPLETED|Overall Study||194
8642598|NCT00595309|9683027|FG000|NOT COMPLETED|Overall Study||4
8642599|NCT00595335|9683033|FG000|STARTED|Baseline to Six Months||13
8642600|NCT00595335|9683034|FG001|STARTED|Baseline to Six Months||12
8642601|NCT00595335|9683033|FG000|COMPLETED|Baseline to Six Months||11
8642602|NCT00595335|9683034|FG001|COMPLETED|Baseline to Six Months||10
8642603|NCT00595335|9683033|FG000|NOT COMPLETED|Baseline to Six Months||2
8642604|NCT00595335|9683034|FG001|NOT COMPLETED|Baseline to Six Months||2
8642605|NCT00595335|9683033|FG000|STARTED|Six Months to Twelve Months||11
8642606|NCT00595335|9683034|FG001|STARTED|Six Months to Twelve Months||10
8642607|NCT00595335|9683033|FG000|COMPLETED|Six Months to Twelve Months||10
8642608|NCT00595335|9683034|FG001|COMPLETED|Six Months to Twelve Months||9
8642609|NCT00595335|9683033|FG000|NOT COMPLETED|Six Months to Twelve Months||1
8642610|NCT00595335|9683034|FG001|NOT COMPLETED|Six Months to Twelve Months||1
8642611|NCT00595361|9683046|FG000|STARTED|Overall Study||12
8642612|NCT00595361|9683047|FG001|STARTED|Overall Study||18
8642613|NCT00595361|9683046|FG000|COMPLETED|Overall Study||12
8642614|NCT00595361|9683047|FG001|COMPLETED|Overall Study||18
8642615|NCT00595361|9683046|FG000|NOT COMPLETED|Overall Study||0
8642616|NCT00595361|9683047|FG001|NOT COMPLETED|Overall Study||0
8642617|NCT00595413|9683057|FG000|STARTED|Overall Study||76
8642618|NCT00595413|9683058|FG001|STARTED|Overall Study||78
8642619|NCT00595413|9683059|FG002|STARTED|Overall Study||78
8642620|NCT00595413|9683060|FG003|STARTED|Overall Study||79
8642621|NCT00595413|9683057|FG000|COMPLETED|Overall Study||69
8642622|NCT00595413|9683058|FG001|COMPLETED|Overall Study||73
8642623|NCT00595413|9683059|FG002|COMPLETED|Overall Study||70
8642624|NCT00595413|9683060|FG003|COMPLETED|Overall Study||75
8642625|NCT00595413|9683057|FG000|NOT COMPLETED|Overall Study||7
8642626|NCT00595413|9683058|FG001|NOT COMPLETED|Overall Study||5
8642627|NCT00595413|9683059|FG002|NOT COMPLETED|Overall Study||8
8642628|NCT00595413|9683060|FG003|NOT COMPLETED|Overall Study||4
8642629|NCT00595465|9683073|FG000|STARTED|Overall Study||130
8642630|NCT00595465|9683074|FG001|STARTED|Overall Study||129
8642631|NCT00595465|9683075|FG002|STARTED|Overall Study||128
8642632|NCT00595465|9683073|FG000|COMPLETED|Overall Study||124
8642633|NCT00595465|9683074|FG001|COMPLETED|Overall Study||125
8642634|NCT00595465|9683075|FG002|COMPLETED|Overall Study||121
8642635|NCT00595465|9683073|FG000|NOT COMPLETED|Overall Study||6
8642636|NCT00595465|9683074|FG001|NOT COMPLETED|Overall Study||4
8642637|NCT00595465|9683075|FG002|NOT COMPLETED|Overall Study||7
8642638|NCT00595478|9683085|FG000|STARTED|Treatment||37
8642639|NCT00595478|9683086|FG001|STARTED|Treatment||38
8642640|NCT00595478|9683085|FG000|COMPLETED|Treatment||37
8642641|NCT00595478|9683086|FG001|COMPLETED|Treatment||38
8642642|NCT00595478|9683085|FG000|NOT COMPLETED|Treatment||0
8642643|NCT00595478|9683086|FG001|NOT COMPLETED|Treatment||0
8642644|NCT00595478|9683085|FG000|STARTED|36-week Follow-up Period||37
8642645|NCT00595478|9683086|FG001|STARTED|36-week Follow-up Period||38
8642646|NCT00595478|9683085|FG000|COMPLETED|36-week Follow-up Period||28
8642647|NCT00595478|9683086|FG001|COMPLETED|36-week Follow-up Period||30
8642648|NCT00595478|9683085|FG000|NOT COMPLETED|36-week Follow-up Period||9
8642649|NCT00595478|9683086|FG001|NOT COMPLETED|36-week Follow-up Period||8
8642650|NCT00595504|9683094|FG000|STARTED|Overall Study||16
8642651|NCT00595504|9683095|FG001|STARTED|Overall Study||9
8642652|NCT00595504|9683094|FG000|COMPLETED|Overall Study||14
8642653|NCT00595504|9683095|FG001|COMPLETED|Overall Study||6
8642654|NCT00595504|9683094|FG000|NOT COMPLETED|Overall Study||2
8642655|NCT00595504|9683095|FG001|NOT COMPLETED|Overall Study||3
8642656|NCT00595517|9683101|FG000|STARTED|Overall Study||130
8642657|NCT00595517|9683101|FG000|COMPLETED|Overall Study||111
8642658|NCT00595517|9683101|FG000|NOT COMPLETED|Overall Study||19
8642659|NCT00595530|9683105|FG000|STARTED|Overall Study||3
8642660|NCT00595530|9683105|FG000|COMPLETED|Overall Study||3
8642661|NCT00595530|9683105|FG000|NOT COMPLETED|Overall Study||0
8642662|NCT00595556|9683112|FG000|STARTED|Overall Study||20
8642663|NCT00595556|9683113|FG001|STARTED|Overall Study||20
8642664|NCT00595556|9683112|FG000|COMPLETED|Overall Study||17
8642665|NCT00595556|9683113|FG001|COMPLETED|Overall Study||19
8642666|NCT00595556|9683112|FG000|NOT COMPLETED|Overall Study||3
8642667|NCT00595556|9683113|FG001|NOT COMPLETED|Overall Study||1
8642668|NCT00595621|9683121|FG000|STARTED|Open Label Run in||22
8642669|NCT00595621|9683122|FG001|STARTED|Open Label Run in||0
8642670|NCT00595621|9683121|FG000|COMPLETED|Open Label Run in||19
8642671|NCT00595621|9683122|FG001|COMPLETED|Open Label Run in||0
8642672|NCT00595621|9683121|FG000|NOT COMPLETED|Open Label Run in||3
8642673|NCT00595621|9683122|FG001|NOT COMPLETED|Open Label Run in||0
8642674|NCT00595621|9683121|FG000|STARTED|Randomization and Study||10
8642675|NCT00595621|9683122|FG001|STARTED|Randomization and Study||9
8642676|NCT00595621|9683121|FG000|COMPLETED|Randomization and Study||8
8642677|NCT00595621|9683122|FG001|COMPLETED|Randomization and Study||8
8642678|NCT00595621|9683121|FG000|NOT COMPLETED|Randomization and Study||2
8642679|NCT00595621|9683122|FG001|NOT COMPLETED|Randomization and Study||1
8642680|NCT00595764|9683131|FG000|STARTED|Overall Study||71
8642681|NCT00595764|9683132|FG001|STARTED|Overall Study||70
8642682|NCT00595764|9683131|FG000|COMPLETED|Overall Study||32
8642683|NCT00595764|9683132|FG001|COMPLETED|Overall Study||27
8642684|NCT00595764|9683131|FG000|NOT COMPLETED|Overall Study||39
8642685|NCT00595764|9683132|FG001|NOT COMPLETED|Overall Study||43
8642686|NCT00595790|9683141|FG000|STARTED|Overall Study||125
8642687|NCT00595790|9683142|FG001|STARTED|Overall Study|124 subjects randomized to this group, 125 subjects received 1x12 mcg.(Safety Population: N=125)|124
8642688|NCT00595790|9683143|FG002|STARTED|Overall Study|125 subjects randomized to this group, 124 subjects received 1x6 mcg.(Safety Population: N=124)|125
8642689|NCT00595790|9683141|FG000|COMPLETED|Overall Study|The Participant Flow shows all study participants randomized.Prim. Outcome is based on PP Population|123
8642690|NCT00595790|9683142|FG001|COMPLETED|Overall Study|The Participant Flow shows all study participants randomized.Prim. Outcome is based on PP Population|123
8642691|NCT00595790|9683143|FG002|COMPLETED|Overall Study|The Participant Flow shows all study participants randomized.Prim. Outcome is based on PP Population|122
8642692|NCT00595790|9683141|FG000|NOT COMPLETED|Overall Study||2
8642693|NCT00595790|9683142|FG001|NOT COMPLETED|Overall Study||1
8642694|NCT00595790|9683143|FG002|NOT COMPLETED|Overall Study||3
8642695|NCT00595868|9683153|FG000|STARTED|Overall Study||107
8642696|NCT00595868|9683154|FG001|STARTED|Overall Study||111
8642697|NCT00595868|9683153|FG000|COMPLETED|Overall Study||62
8642698|NCT00595868|9683154|FG001|COMPLETED|Overall Study||61
8642699|NCT00595868|9683153|FG000|NOT COMPLETED|Overall Study||45
8642700|NCT00595868|9683154|FG001|NOT COMPLETED|Overall Study||50
8642701|NCT00595881|9683160|FG000|STARTED|Overall Study||420
8642702|NCT00595881|9683160|FG000|COMPLETED|Overall Study||420
8642703|NCT00595881|9683160|FG000|NOT COMPLETED|Overall Study||0
8642704|NCT00595946|9683167|FG000|STARTED|Overall Study||218
8642705|NCT00595946|9683168|FG001|STARTED|Overall Study||221
8642706|NCT00595946|9683167|FG000|COMPLETED|Overall Study||154
8642707|NCT00595946|9683168|FG001|COMPLETED|Overall Study||152
8642708|NCT00595946|9683167|FG000|NOT COMPLETED|Overall Study||64
8642709|NCT00595946|9683168|FG001|NOT COMPLETED|Overall Study||69
8642710|NCT00595959|9683174|FG000|STARTED|Overall Study||65
8642711|NCT00595959|9683174|FG000|COMPLETED|Overall Study||63
8642712|NCT00595959|9683174|FG000|NOT COMPLETED|Overall Study||2
8642713|NCT00596011|9683180|FG000|STARTED|Overall Study||49
8642714|NCT00596011|9683181|FG001|STARTED|Overall Study||48
8642715|NCT00596011|9683180|FG000|COMPLETED|Overall Study||36
8642716|NCT00596011|9683181|FG001|COMPLETED|Overall Study||38
8642717|NCT00596011|9683180|FG000|NOT COMPLETED|Overall Study||13
8642718|NCT00596011|9683181|FG001|NOT COMPLETED|Overall Study||10
8642719|NCT00596102|9683190|FG000|STARTED|Up to Month 6||2283
8642720|NCT00596102|9683191|FG001|STARTED|Up to Month 6||338
8642721|NCT00596102|9683192|FG002|STARTED|Up to Month 6||637
8642722|NCT00596102|9683190|FG000|COMPLETED|Up to Month 6||2283
8642723|NCT00596102|9683191|FG001|COMPLETED|Up to Month 6||338
8642724|NCT00596102|9683192|FG002|COMPLETED|Up to Month 6||637
8642725|NCT00596102|9683190|FG000|NOT COMPLETED|Up to Month 6||0
8642726|NCT00596102|9683191|FG001|NOT COMPLETED|Up to Month 6||0
8642727|NCT00596102|9683192|FG002|NOT COMPLETED|Up to Month 6||0
8642728|NCT00596102|9683190|FG000|STARTED|Up to Month 60||2283
8642729|NCT00596102|9683191|FG001|STARTED|Up to Month 60||338
8642730|NCT00596102|9683192|FG002|STARTED|Up to Month 60||637
8642731|NCT00596102|9683190|FG000|COMPLETED|Up to Month 60|"long-term safety follow-up beyond Month 6 for a sub-set of subjects in IC51 group only"|102
8642732|NCT00596102|9683191|FG001|COMPLETED|Up to Month 60||0
8642733|NCT00596102|9683192|FG002|COMPLETED|Up to Month 60||0
8642734|NCT00596102|9683190|FG000|NOT COMPLETED|Up to Month 60||2181
8642735|NCT00596102|9683191|FG001|NOT COMPLETED|Up to Month 60||338
8642736|NCT00596102|9683192|FG002|NOT COMPLETED|Up to Month 60||637
8642737|NCT00596167|9683199|FG000|STARTED|Overall Study|All recruited subjects completed the study.|6
8642738|NCT00596167|9683199|FG000|COMPLETED|Overall Study||6
8642739|NCT00596167|9683199|FG000|NOT COMPLETED|Overall Study||0
8642740|NCT00596271|9683206|FG000|STARTED|Overall Study||65
8642741|NCT00596271|9683207|FG001|STARTED|Overall Study||65
8642742|NCT00596271|9683208|FG002|STARTED|Overall Study||62
8642743|NCT00596271|9683206|FG000|COMPLETED|Overall Study||60
8642744|NCT00596271|9683207|FG001|COMPLETED|Overall Study||59
8642745|NCT00596271|9683208|FG002|COMPLETED|Overall Study||61
8642746|NCT00596271|9683206|FG000|NOT COMPLETED|Overall Study||5
8642747|NCT00596271|9683207|FG001|NOT COMPLETED|Overall Study||6
8642748|NCT00596271|9683208|FG002|NOT COMPLETED|Overall Study||1
8642749|NCT00596362|9683217|FG000|STARTED|Overall Study||1
8642750|NCT00596362|9683217|FG000|COMPLETED|Overall Study||0
8642751|NCT00596362|9683217|FG000|NOT COMPLETED|Overall Study||1
8642752|NCT00596427|9683223|FG000|STARTED|Overall Study||30
8642753|NCT00596427|9683224|FG001|STARTED|Overall Study||30
8642754|NCT00596427|9683223|FG000|COMPLETED|Overall Study||26
8642755|NCT00596427|9683224|FG001|COMPLETED|Overall Study||28
8642756|NCT00596427|9683223|FG000|NOT COMPLETED|Overall Study||4
8642757|NCT00596427|9683224|FG001|NOT COMPLETED|Overall Study||2
8642758|NCT00596440|9683233|FG000|STARTED|Overall Study||113
8642759|NCT00596440|9683234|FG001|STARTED|Overall Study||121
8642760|NCT00596440|9683233|FG000|Showed to Eligibility Visit|Overall Study||85
8642761|NCT00596440|9683234|FG001|Showed to Eligibility Visit|Overall Study||72
8642762|NCT00596440|9683233|FG000|Showed to First Treatment Session|Overall Study||61
8642763|NCT00596440|9683234|FG001|Showed to First Treatment Session|Overall Study||52
8642764|NCT00596440|9683233|FG000|COMPLETED|Overall Study||48
8642765|NCT00596440|9683234|FG001|COMPLETED|Overall Study||41
8642766|NCT00596440|9683233|FG000|NOT COMPLETED|Overall Study||65
8642767|NCT00596440|9683234|FG001|NOT COMPLETED|Overall Study||80
8642768|NCT00596453|9683242|FG000|STARTED|Overall Study||13
8642769|NCT00596453|9683243|FG001|STARTED|Overall Study||15
8642770|NCT00596453|9683242|FG000|COMPLETED|Overall Study||12
8642771|NCT00596453|9683243|FG001|COMPLETED|Overall Study||12
8642772|NCT00596453|9683242|FG000|NOT COMPLETED|Overall Study||1
8642773|NCT00596453|9683243|FG001|NOT COMPLETED|Overall Study||3
8642774|NCT00596466|9683249|FG000|STARTED|Overall Study||75
8642775|NCT00596466|9683249|FG000|Enrolled, Treated|Overall Study||73
8642776|NCT00596466|9683249|FG000|COMPLETED|Overall Study||58
8642777|NCT00596466|9683249|FG000|NOT COMPLETED|Overall Study||17
8642778|NCT00596622|9683256|FG000|STARTED|Overall Study||46
8642779|NCT00596622|9683256|FG000|COMPLETED|Overall Study||33
8642780|NCT00596622|9683256|FG000|NOT COMPLETED|Overall Study||13
8642781|NCT00596635|9683268|FG000|STARTED|Overall Study||17
8642782|NCT00596635|9683269|FG001|STARTED|Overall Study||20
8642783|NCT00596635|9683270|FG002|STARTED|Overall Study||19
8642784|NCT00596635|9683268|FG000|COMPLETED|Overall Study||10
8642785|NCT00596635|9683269|FG001|COMPLETED|Overall Study||7
8642786|NCT00596635|9683270|FG002|COMPLETED|Overall Study||11
8642787|NCT00596635|9683268|FG000|NOT COMPLETED|Overall Study||7
8642788|NCT00596635|9683269|FG001|NOT COMPLETED|Overall Study||13
8642789|NCT00596635|9683270|FG002|NOT COMPLETED|Overall Study||8
8642790|NCT00596687|9683280|FG000|STARTED|Overall Study||118
8642791|NCT00596687|9683281|FG001|STARTED|Overall Study||116
8642792|NCT00596687|9683280|FG000|COMPLETED|Overall Study||104
8642793|NCT00596687|9683281|FG001|COMPLETED|Overall Study||107
8642794|NCT00596687|9683280|FG000|NOT COMPLETED|Overall Study||14
8642795|NCT00596687|9683281|FG001|NOT COMPLETED|Overall Study||9
8642796|NCT00596752|9683289|FG000|STARTED|Overall Study||415
8642797|NCT00596752|9683290|FG001|STARTED|Overall Study||425
8642798|NCT00596752|9683289|FG000|Randomized and Treated|Overall Study||415
8642799|NCT00596752|9683290|FG001|Randomized and Treated|Overall Study||424
8642800|NCT00596752|9683289|FG000|COMPLETED|Overall Study||289
8642801|NCT00596752|9683290|FG001|COMPLETED|Overall Study||282
8642802|NCT00596752|9683289|FG000|NOT COMPLETED|Overall Study||126
8642803|NCT00596752|9683290|FG001|NOT COMPLETED|Overall Study||143
8642804|NCT00596817|9683299|FG000|STARTED|Open-label Period||0
8642805|NCT00596817|9683300|FG001|STARTED|Open-label Period||639
8642806|NCT00596817|9683299|FG000|COMPLETED|Open-label Period||0
8642807|NCT00596817|9683300|FG001|COMPLETED|Open-label Period||492
8642808|NCT00596817|9683299|FG000|NOT COMPLETED|Open-label Period||0
8642809|NCT00596817|9683300|FG001|NOT COMPLETED|Open-label Period||147
8642810|NCT00596817|9683299|FG000|STARTED|Open-label Period to Double-blind Period||0
8642811|NCT00596817|9683300|FG001|STARTED|Open-label Period to Double-blind Period||492
8642812|NCT00596817|9683299|FG000|COMPLETED|Open-label Period to Double-blind Period||0
8642813|NCT00596817|9683300|FG001|COMPLETED|Open-label Period to Double-blind Period||400
8642814|NCT00596817|9683299|FG000|NOT COMPLETED|Open-label Period to Double-blind Period||0
8642815|NCT00596817|9683300|FG001|NOT COMPLETED|Open-label Period to Double-blind Period||92
8642816|NCT00596817|9683299|FG000|STARTED|Double-blind Period|194 patients were randomised. 2 did not receive study medication. 192 is full-analysis set (FAS).|192
8642817|NCT00596817|9683300|FG001|STARTED|Double-blind Period|206 patients were randomised. 2 did not receive study medication. 204 is FAS.|204
8642818|NCT00596817|9683299|FG000|COMPLETED|Double-blind Period||104
8642819|NCT00596817|9683300|FG001|COMPLETED|Double-blind Period||125
8642820|NCT00596817|9683299|FG000|NOT COMPLETED|Double-blind Period||88
8642821|NCT00596817|9683300|FG001|NOT COMPLETED|Double-blind Period||79
8642822|NCT00596830|9683309|FG000|STARTED|Overall Study|1 participant in this group only received paclitaxel and carboplatin (chemo).|342
8642823|NCT00596830|9683310|FG001|STARTED|Overall Study||339
8642824|NCT00596830|9683309|FG000|Treated|Overall Study|1 participant in this group only received chemo and did not complete due to death.|339
8642825|NCT00596830|9683310|FG001|Treated|Overall Study||332
8642826|NCT00596830|9683309|FG000|COMPLETED|Overall Study||0
8642827|NCT00596830|9683310|FG001|COMPLETED|Overall Study||0
8642828|NCT00596830|9683309|FG000|NOT COMPLETED|Overall Study||342
8642829|NCT00596830|9683310|FG001|NOT COMPLETED|Overall Study||339
8642830|NCT00596934|9683316|FG000|STARTED|Overall Study||9
8642831|NCT00596934|9683316|FG000|COMPLETED|Overall Study||7
8642832|NCT00596934|9683316|FG000|NOT COMPLETED|Overall Study||2
8642833|NCT00596960|9683324|FG000|STARTED|Overall Study||70
8642834|NCT00596960|9683325|FG001|STARTED|Overall Study|One subject did not have any alcohol use data and thus was excluded from the statistical analysis|69
8642835|NCT00596960|9683324|FG000|COMPLETED|Overall Study||59
8642836|NCT00596960|9683325|FG001|COMPLETED|Overall Study||60
8642837|NCT00596960|9683324|FG000|NOT COMPLETED|Overall Study||11
8642838|NCT00596960|9683325|FG001|NOT COMPLETED|Overall Study||9
8642839|NCT00597012|9683333|FG000|STARTED|Overall Study||174
8642840|NCT00597012|9683334|FG001|STARTED|Overall Study||177
8642841|NCT00597012|9683333|FG000|COMPLETED|Overall Study||161
8642842|NCT00597012|9683334|FG001|COMPLETED|Overall Study||169
8642843|NCT00597012|9683333|FG000|NOT COMPLETED|Overall Study||13
8642844|NCT00597012|9683334|FG001|NOT COMPLETED|Overall Study||8
8642845|NCT00597038|9683344|FG000|STARTED|Overall Study||16
8642846|NCT00597038|9683345|FG001|STARTED|Overall Study||34
8642847|NCT00597038|9683344|FG000|COMPLETED|Overall Study|One did not complete due to PI decision, one did not complete due to progressive disease.|14
8727258|NCT01042392|9774633|FG003|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||121
8727259|NCT01042392|9774630|FG000|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||2
8727260|NCT01042392|9774631|FG001|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||1
8727261|NCT01042392|9774632|FG002|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||4
8727262|NCT01042392|9774633|FG003|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||1
8642848|NCT00597038|9683345|FG001|COMPLETED|Overall Study|Two patients withdrew, one did not complete due to progressive disease, one patient died.|30
8642849|NCT00597038|9683344|FG000|NOT COMPLETED|Overall Study||2
8642850|NCT00597038|9683345|FG001|NOT COMPLETED|Overall Study||4
8642851|NCT00597116|9683355|FG000|STARTED|Overall Study||14
8642852|NCT00597116|9683356|FG001|STARTED|Overall Study||11
8642853|NCT00597116|9683355|FG000|COMPLETED|Overall Study|Randomised patients ongoing study treatment at data cut-off|0
8642854|NCT00597116|9683356|FG001|COMPLETED|Overall Study|Randomised patients ongoing study treatment at data cut-off|0
8642855|NCT00597116|9683355|FG000|NOT COMPLETED|Overall Study||14
8642856|NCT00597116|9683356|FG001|NOT COMPLETED|Overall Study||11
8642857|NCT00597207|9683364|FG000|STARTED|Overall Study||2099
8642858|NCT00597207|9683365|FG001|STARTED|Overall Study||2132
8642859|NCT00597207|9683364|FG000|COMPLETED|Overall Study||2094
8642860|NCT00597207|9683365|FG001|COMPLETED|Overall Study||2125
8642861|NCT00597207|9683364|FG000|NOT COMPLETED|Overall Study||5
8642862|NCT00597207|9683365|FG001|NOT COMPLETED|Overall Study||7
8642863|NCT00597246|9683371|FG000|STARTED|Overall Study||30
8642864|NCT00597246|9683371|FG000|COMPLETED|Overall Study||30
8642865|NCT00597246|9683371|FG000|NOT COMPLETED|Overall Study||0
8642866|NCT00597272|9683382|FG000|STARTED|Overall Study||1
8642867|NCT00597272|9683383|FG001|STARTED|Overall Study||1
8642868|NCT00597272|9683384|FG002|STARTED|Overall Study||10
8642869|NCT00597272|9683385|FG003|STARTED|Overall Study||1
8642870|NCT00597272|9683386|FG004|STARTED|Overall Study||1
8642871|NCT00597272|9683387|FG005|STARTED|Overall Study||10
8642872|NCT00597272|9683388|FG006|STARTED|Overall Study||10
8642873|NCT00597272|9683382|FG000|COMPLETED|Overall Study||1
8642874|NCT00597272|9683383|FG001|COMPLETED|Overall Study||1
8642875|NCT00597272|9683384|FG002|COMPLETED|Overall Study||10
8642876|NCT00597272|9683385|FG003|COMPLETED|Overall Study||1
8642877|NCT00597272|9683386|FG004|COMPLETED|Overall Study||1
8642878|NCT00597272|9683387|FG005|COMPLETED|Overall Study||10
8642879|NCT00597272|9683388|FG006|COMPLETED|Overall Study||10
8642880|NCT00597272|9683382|FG000|NOT COMPLETED|Overall Study||0
8642881|NCT00597272|9683383|FG001|NOT COMPLETED|Overall Study||0
8642882|NCT00597272|9683384|FG002|NOT COMPLETED|Overall Study||0
8642883|NCT00597272|9683385|FG003|NOT COMPLETED|Overall Study||0
8642884|NCT00597272|9683386|FG004|NOT COMPLETED|Overall Study||0
8642885|NCT00597272|9683387|FG005|NOT COMPLETED|Overall Study||0
8642886|NCT00597272|9683388|FG006|NOT COMPLETED|Overall Study||0
8642887|NCT00597376|9683406|FG000|STARTED|Overall Study||51
8642888|NCT00597376|9683407|FG001|STARTED|Overall Study||53
8642889|NCT00597376|9683406|FG000|COMPLETED|Overall Study|All participants started (51) were included in primary analyses.|43
8642890|NCT00597376|9683407|FG001|COMPLETED|Overall Study|All participants started (53) were included in primary analyses.|49
8642891|NCT00597376|9683406|FG000|NOT COMPLETED|Overall Study||8
8642892|NCT00597376|9683407|FG001|NOT COMPLETED|Overall Study||4
8642893|NCT00597402|9683413|FG000|STARTED|Overall Study||125
8642894|NCT00597402|9683413|FG000|COMPLETED|Overall Study||125
8642895|NCT00597402|9683413|FG000|NOT COMPLETED|Overall Study||0
8642896|NCT00597428|9683419|FG000|STARTED|Overall Study||214
8642897|NCT00597428|9683420|FG001|STARTED|Overall Study||223
8642898|NCT00597428|9683419|FG000|COMPLETED|Overall Study||153
8642899|NCT00597428|9683420|FG001|COMPLETED|Overall Study||152
8642900|NCT00597428|9683419|FG000|NOT COMPLETED|Overall Study||61
8642901|NCT00597428|9683420|FG001|NOT COMPLETED|Overall Study||71
8642902|NCT00597493|9683426|FG000|STARTED|Overall Study||32
8642903|NCT00597493|9683426|FG000|COMPLETED|Overall Study||32
8642904|NCT00597493|9683426|FG000|NOT COMPLETED|Overall Study||0
8642905|NCT00597506|9683434|FG000|STARTED|Overall Study||50
8642906|NCT00597506|9683434|FG000|COMPLETED|Overall Study||49
8642907|NCT00597506|9683434|FG000|NOT COMPLETED|Overall Study||1
8642908|NCT00597519|9683438|FG000|STARTED|Overall Study||28
8642909|NCT00597519|9683438|FG000|COMPLETED|Overall Study||27
8642910|NCT00597519|9683438|FG000|NOT COMPLETED|Overall Study||1
8642911|NCT00597545|9683444|FG000|STARTED|Overall Study||4
8642912|NCT00597545|9683445|FG001|STARTED|Overall Study||6
8642913|NCT00597545|9683444|FG000|COMPLETED|Overall Study||4
8642914|NCT00597545|9683445|FG001|COMPLETED|Overall Study||6
8642915|NCT00597545|9683444|FG000|NOT COMPLETED|Overall Study||0
8642916|NCT00597545|9683445|FG001|NOT COMPLETED|Overall Study||0
8642917|NCT00597558|9683451|FG000|STARTED|Overall Study||13
8642918|NCT00597558|9683451|FG000|COMPLETED|Overall Study||9
8642919|NCT00597558|9683451|FG000|NOT COMPLETED|Overall Study||4
8642920|NCT00597584|9683457|FG000|STARTED|Overall Study|Randomization was 2:1 peginesatide to epoetin|549
8642921|NCT00597584|9683458|FG001|STARTED|Overall Study||274
8642922|NCT00597584|9683457|FG000|COMPLETED|Overall Study||421
8642923|NCT00597584|9683458|FG001|COMPLETED|Overall Study||211
8642924|NCT00597584|9683457|FG000|NOT COMPLETED|Overall Study||128
8642925|NCT00597584|9683458|FG001|NOT COMPLETED|Overall Study||63
8642926|NCT00597675|9683466|FG000|STARTED|Blinded Phase||4
8642927|NCT00597675|9683467|FG001|STARTED|Blinded Phase||6
8642928|NCT00597675|9683466|FG000|COMPLETED|Blinded Phase||2
8642929|NCT00597675|9683467|FG001|COMPLETED|Blinded Phase||5
8642930|NCT00597675|9683466|FG000|NOT COMPLETED|Blinded Phase||2
8642931|NCT00597675|9683467|FG001|NOT COMPLETED|Blinded Phase||1
8642932|NCT00597675|9683466|FG000|STARTED|Open Label Phase|Patients previously on placebo were crossed over onto open label peanut OIT|2
8642933|NCT00597675|9683467|FG001|STARTED|Open Label Phase||5
8642934|NCT00597675|9683466|FG000|COMPLETED|Open Label Phase||2
8642935|NCT00597675|9683467|FG001|COMPLETED|Open Label Phase||5
8642936|NCT00597675|9683466|FG000|NOT COMPLETED|Open Label Phase||0
8642937|NCT00597675|9683467|FG001|NOT COMPLETED|Open Label Phase||0
8642938|NCT00597701|9683477|FG000|STARTED|Overall Study||25
8642939|NCT00597701|9683478|FG001|STARTED|Overall Study||21
8642940|NCT00597701|9683477|FG000|COMPLETED|Overall Study||18
8642941|NCT00597701|9683478|FG001|COMPLETED|Overall Study||13
8642942|NCT00597701|9683477|FG000|NOT COMPLETED|Overall Study||7
8642943|NCT00597701|9683478|FG001|NOT COMPLETED|Overall Study||8
8642944|NCT00597714|9683486|FG000|STARTED|Overall Study||80
8642945|NCT00597714|9683487|FG001|STARTED|Overall Study||57
8642946|NCT00597714|9683488|FG002|STARTED|Overall Study||94
8642947|NCT00597714|9683486|FG000|COMPLETED|Overall Study||24
8642948|NCT00597714|9683487|FG001|COMPLETED|Overall Study||11
8642949|NCT00597714|9683488|FG002|COMPLETED|Overall Study||84
8642950|NCT00597714|9683486|FG000|NOT COMPLETED|Overall Study||56
8642951|NCT00597714|9683487|FG001|NOT COMPLETED|Overall Study||46
8642952|NCT00597714|9683488|FG002|NOT COMPLETED|Overall Study||10
8642953|NCT00597727|9683501|FG000|STARTED|12 Month Blinded Phase||14
8642954|NCT00597727|9683502|FG001|STARTED|12 Month Blinded Phase||15
8642955|NCT00597727|9683503|FG002|STARTED|12 Month Blinded Phase||0
8642956|NCT00597727|9683504|FG003|STARTED|12 Month Blinded Phase||27
8642957|NCT00597727|9683505|FG004|STARTED|12 Month Blinded Phase||4
8642958|NCT00597727|9683501|FG000|COMPLETED|12 Month Blinded Phase||14
8642959|NCT00597727|9683502|FG001|COMPLETED|12 Month Blinded Phase||15
8642960|NCT00597727|9683503|FG002|COMPLETED|12 Month Blinded Phase||0
8642961|NCT00597727|9683504|FG003|COMPLETED|12 Month Blinded Phase||17
8642962|NCT00597727|9683505|FG004|COMPLETED|12 Month Blinded Phase||3
8642963|NCT00597727|9683501|FG000|NOT COMPLETED|12 Month Blinded Phase||0
8642964|NCT00597727|9683502|FG001|NOT COMPLETED|12 Month Blinded Phase||0
8642965|NCT00597727|9683503|FG002|NOT COMPLETED|12 Month Blinded Phase||0
8642966|NCT00597727|9683504|FG003|NOT COMPLETED|12 Month Blinded Phase||10
8642967|NCT00597727|9683505|FG004|NOT COMPLETED|12 Month Blinded Phase||1
8642968|NCT00597727|9683501|FG000|STARTED|Open-label Extended Maintenance Phase|Blinded peanut SLIT + blinded placebo SLIT continued in Ext Open Label Peanut SLIT after unblinding|0
8642969|NCT00597727|9683502|FG001|STARTED|Open-label Extended Maintenance Phase|Blinded peanut SLIT + blinded placebo SLIT continued in Ext Open Label Peanut SLIT after unblinding|0
8642970|NCT00597727|9683503|FG002|STARTED|Open-label Extended Maintenance Phase|Blinded peanut SLIT + blinded placebo SLIT continued in Ext Open Label Peanut SLIT after unblinding.|29
8642971|NCT00597727|9683504|FG003|STARTED|Open-label Extended Maintenance Phase||17
8642972|NCT00597727|9683505|FG004|STARTED|Open-label Extended Maintenance Phase||3
8642973|NCT00597727|9683501|FG000|COMPLETED|Open-label Extended Maintenance Phase||0
8642974|NCT00597727|9683502|FG001|COMPLETED|Open-label Extended Maintenance Phase||0
8642975|NCT00597727|9683503|FG002|COMPLETED|Open-label Extended Maintenance Phase||23
8642976|NCT00597727|9683504|FG003|COMPLETED|Open-label Extended Maintenance Phase||14
8642977|NCT00597727|9683505|FG004|COMPLETED|Open-label Extended Maintenance Phase||1
8642978|NCT00597727|9683501|FG000|NOT COMPLETED|Open-label Extended Maintenance Phase||0
8642979|NCT00597727|9683502|FG001|NOT COMPLETED|Open-label Extended Maintenance Phase||0
8642980|NCT00597727|9683503|FG002|NOT COMPLETED|Open-label Extended Maintenance Phase||6
8642981|NCT00597727|9683504|FG003|NOT COMPLETED|Open-label Extended Maintenance Phase||3
8642982|NCT00597727|9683505|FG004|NOT COMPLETED|Open-label Extended Maintenance Phase||2
8642983|NCT00597753|9683521|FG000|STARTED|Overall Study|Randomization was 2:1 peginesatide to epoetin alfa|532
8642984|NCT00597753|9683522|FG001|STARTED|Overall Study||271
8642985|NCT00597753|9683521|FG000|COMPLETED|Overall Study||366
8642986|NCT00597753|9683522|FG001|COMPLETED|Overall Study||202
8642987|NCT00597753|9683521|FG000|NOT COMPLETED|Overall Study||166
8642988|NCT00597753|9683522|FG001|NOT COMPLETED|Overall Study||69
8642989|NCT00597766|9683531|FG000|STARTED|Enrolled||9
8642990|NCT00597766|9683532|FG001|STARTED|Enrolled||9
8642991|NCT00597766|9683533|FG002|STARTED|Enrolled||10
8642992|NCT00597766|9683531|FG000|COMPLETED|Enrolled||9
8642993|NCT00597766|9683532|FG001|COMPLETED|Enrolled||9
8642994|NCT00597766|9683533|FG002|COMPLETED|Enrolled||10
8642995|NCT00597766|9683531|FG000|NOT COMPLETED|Enrolled||0
8642996|NCT00597766|9683532|FG001|NOT COMPLETED|Enrolled||0
8642997|NCT00597766|9683533|FG002|NOT COMPLETED|Enrolled||0
8642998|NCT00597766|9683531|FG000|STARTED|Follow-up 1, Week 4||9
8642999|NCT00597766|9683532|FG001|STARTED|Follow-up 1, Week 4||9
8643000|NCT00597766|9683533|FG002|STARTED|Follow-up 1, Week 4||10
8643001|NCT00597766|9683531|FG000|COMPLETED|Follow-up 1, Week 4||8
8643002|NCT00597766|9683532|FG001|COMPLETED|Follow-up 1, Week 4||9
8643003|NCT00597766|9683533|FG002|COMPLETED|Follow-up 1, Week 4||10
8643004|NCT00597766|9683531|FG000|NOT COMPLETED|Follow-up 1, Week 4||1
8643005|NCT00597766|9683532|FG001|NOT COMPLETED|Follow-up 1, Week 4||0
8643006|NCT00597766|9683533|FG002|NOT COMPLETED|Follow-up 1, Week 4||0
8643007|NCT00597766|9683531|FG000|STARTED|Follow-up 2, Week 8||8
8643008|NCT00597766|9683532|FG001|STARTED|Follow-up 2, Week 8||9
8643009|NCT00597766|9683533|FG002|STARTED|Follow-up 2, Week 8||10
8643010|NCT00597766|9683531|FG000|COMPLETED|Follow-up 2, Week 8||8
8643011|NCT00597766|9683532|FG001|COMPLETED|Follow-up 2, Week 8||9
8643012|NCT00597766|9683533|FG002|COMPLETED|Follow-up 2, Week 8||9
8643013|NCT00597766|9683531|FG000|NOT COMPLETED|Follow-up 2, Week 8||0
8643014|NCT00597766|9683532|FG001|NOT COMPLETED|Follow-up 2, Week 8||0
8643015|NCT00597766|9683533|FG002|NOT COMPLETED|Follow-up 2, Week 8||1
8643016|NCT00597766|9683531|FG000|STARTED|Follow-up 3, Week 12||8
8643017|NCT00597766|9683532|FG001|STARTED|Follow-up 3, Week 12||9
8643018|NCT00597766|9683533|FG002|STARTED|Follow-up 3, Week 12||9
8643019|NCT00597766|9683531|FG000|COMPLETED|Follow-up 3, Week 12||8
8643020|NCT00597766|9683532|FG001|COMPLETED|Follow-up 3, Week 12||9
8643021|NCT00597766|9683533|FG002|COMPLETED|Follow-up 3, Week 12||9
8643022|NCT00597766|9683531|FG000|NOT COMPLETED|Follow-up 3, Week 12||0
8643023|NCT00597766|9683532|FG001|NOT COMPLETED|Follow-up 3, Week 12||0
8643024|NCT00597766|9683533|FG002|NOT COMPLETED|Follow-up 3, Week 12||0
8643025|NCT00597818|9683545|FG000|STARTED|Overall Study||30
8643026|NCT00597818|9683546|FG001|STARTED|Overall Study||30
8643027|NCT00597818|9683547|FG002|STARTED|Overall Study||31
8643028|NCT00597818|9683548|FG003|STARTED|Overall Study||30
8643029|NCT00597818|9683545|FG000|COMPLETED|Overall Study||12
8643030|NCT00597818|9683546|FG001|COMPLETED|Overall Study||14
8643031|NCT00597818|9683547|FG002|COMPLETED|Overall Study||12
8643032|NCT00597818|9683548|FG003|COMPLETED|Overall Study||20
8643033|NCT00597818|9683545|FG000|NOT COMPLETED|Overall Study||18
8643034|NCT00597818|9683546|FG001|NOT COMPLETED|Overall Study||16
8643035|NCT00597818|9683547|FG002|NOT COMPLETED|Overall Study||19
8643036|NCT00597818|9683548|FG003|NOT COMPLETED|Overall Study||10
8643037|NCT00597896|9683560|FG000|STARTED|Overall Study||24
8643038|NCT00597896|9683561|FG001|STARTED|Overall Study||26
8643039|NCT00597896|9683560|FG000|COMPLETED|Overall Study||21
8643040|NCT00597896|9683561|FG001|COMPLETED|Overall Study||24
8643041|NCT00597896|9683560|FG000|NOT COMPLETED|Overall Study||3
8643042|NCT00597896|9683561|FG001|NOT COMPLETED|Overall Study||2
8643043|NCT00597935|9683572|FG000|STARTED|Randomized to Surgical and BPMT Arms||95
8643044|NCT00597935|9683573|FG001|STARTED|Randomized to Surgical and BPMT Arms||91
8643045|NCT00597935|9683574|FG002|STARTED|Randomized to Surgical and BPMT Arms||91
8643046|NCT00597935|9683575|FG003|STARTED|Randomized to Surgical and BPMT Arms||97
8643047|NCT00597935|9683572|FG000|COMPLETED|Randomized to Surgical and BPMT Arms||95
8643048|NCT00597935|9683573|FG001|COMPLETED|Randomized to Surgical and BPMT Arms||91
8643049|NCT00597935|9683574|FG002|COMPLETED|Randomized to Surgical and BPMT Arms||91
8643050|NCT00597935|9683575|FG003|COMPLETED|Randomized to Surgical and BPMT Arms||97
8643051|NCT00597935|9683572|FG000|NOT COMPLETED|Randomized to Surgical and BPMT Arms||0
8643052|NCT00597935|9683573|FG001|NOT COMPLETED|Randomized to Surgical and BPMT Arms||0
8643053|NCT00597935|9683574|FG002|NOT COMPLETED|Randomized to Surgical and BPMT Arms||0
8643054|NCT00597935|9683575|FG003|NOT COMPLETED|Randomized to Surgical and BPMT Arms||0
8643055|NCT00597935|9683572|FG000|STARTED|Baseline to 6-Months||95
8643056|NCT00597935|9683573|FG001|STARTED|Baseline to 6-Months||91
8643057|NCT00597935|9683574|FG002|STARTED|Baseline to 6-Months||91
8643058|NCT00597935|9683575|FG003|STARTED|Baseline to 6-Months||97
8643059|NCT00597935|9683572|FG000|COMPLETED|Baseline to 6-Months||93
8643060|NCT00597935|9683573|FG001|COMPLETED|Baseline to 6-Months||87
8643061|NCT00597935|9683574|FG002|COMPLETED|Baseline to 6-Months||87
8643062|NCT00597935|9683575|FG003|COMPLETED|Baseline to 6-Months||93
8643063|NCT00597935|9683572|FG000|NOT COMPLETED|Baseline to 6-Months||2
8643064|NCT00597935|9683573|FG001|NOT COMPLETED|Baseline to 6-Months||4
8643065|NCT00597935|9683574|FG002|NOT COMPLETED|Baseline to 6-Months||4
8643066|NCT00597935|9683575|FG003|NOT COMPLETED|Baseline to 6-Months||4
8643067|NCT00597935|9683572|FG000|STARTED|6-Months to 24-Months||93
8643068|NCT00597935|9683573|FG001|STARTED|6-Months to 24-Months||87
8643069|NCT00597935|9683574|FG002|STARTED|6-Months to 24-Months||87
8643070|NCT00597935|9683575|FG003|STARTED|6-Months to 24-Months||93
8643071|NCT00597935|9683572|FG000|COMPLETED|6-Months to 24-Months||76
8643072|NCT00597935|9683573|FG001|COMPLETED|6-Months to 24-Months||79
8643073|NCT00597935|9683574|FG002|COMPLETED|6-Months to 24-Months||77
8643074|NCT00597935|9683575|FG003|COMPLETED|6-Months to 24-Months||85
8643075|NCT00597935|9683572|FG000|NOT COMPLETED|6-Months to 24-Months||17
8643076|NCT00597935|9683573|FG001|NOT COMPLETED|6-Months to 24-Months||8
8643077|NCT00597935|9683574|FG002|NOT COMPLETED|6-Months to 24-Months||10
8643078|NCT00597935|9683575|FG003|NOT COMPLETED|6-Months to 24-Months||8
8643079|NCT00598078|9683585|FG000|STARTED|Period 1 (Day 1)||10
8643080|NCT00598078|9683586|FG001|STARTED|Period 1 (Day 1)||10
8643081|NCT00598078|9683585|FG000|COMPLETED|Period 1 (Day 1)||10
8643082|NCT00598078|9683586|FG001|COMPLETED|Period 1 (Day 1)||10
8643083|NCT00598078|9683585|FG000|NOT COMPLETED|Period 1 (Day 1)||0
8643084|NCT00598078|9683586|FG001|NOT COMPLETED|Period 1 (Day 1)||0
8643085|NCT00598078|9683585|FG000|STARTED|Period 2 (Day 2)||10
8643086|NCT00598078|9683586|FG001|STARTED|Period 2 (Day 2)||10
8643087|NCT00598078|9683585|FG000|COMPLETED|Period 2 (Day 2)||9
8643088|NCT00598078|9683586|FG001|COMPLETED|Period 2 (Day 2)||10
8643089|NCT00598078|9683585|FG000|NOT COMPLETED|Period 2 (Day 2)||1
8643090|NCT00598078|9683586|FG001|NOT COMPLETED|Period 2 (Day 2)||0
8643091|NCT00598078|9683585|FG000|STARTED|Period 3 (Day 3)||9
8643092|NCT00598078|9683586|FG001|STARTED|Period 3 (Day 3)||10
8643093|NCT00598078|9683585|FG000|COMPLETED|Period 3 (Day 3)||9
8643094|NCT00598078|9683586|FG001|COMPLETED|Period 3 (Day 3)||10
8643095|NCT00598078|9683585|FG000|NOT COMPLETED|Period 3 (Day 3)||0
8643096|NCT00598078|9683586|FG001|NOT COMPLETED|Period 3 (Day 3)||0
8643097|NCT00598273|9683597|FG000|STARTED|Overall Study||161
8643098|NCT00598273|9683598|FG001|STARTED|Overall Study||165
8643099|NCT00598273|9683599|FG002|STARTED|Overall Study||164
8643100|NCT00598273|9683597|FG000|COMPLETED|Overall Study||120
8643101|NCT00598273|9683598|FG001|COMPLETED|Overall Study||127
8643102|NCT00598273|9683599|FG002|COMPLETED|Overall Study||125
8643103|NCT00598273|9683597|FG000|NOT COMPLETED|Overall Study||41
8643104|NCT00598273|9683598|FG001|NOT COMPLETED|Overall Study||38
8643105|NCT00598273|9683599|FG002|NOT COMPLETED|Overall Study||39
8643106|NCT00598442|9683610|FG000|STARTED|Overall Study||167
8643107|NCT00598442|9683611|FG001|STARTED|Overall Study||163
8643108|NCT00598442|9683612|FG002|STARTED|Overall Study||163
8643109|NCT00598442|9683610|FG000|COMPLETED|Overall Study||124
8643110|NCT00598442|9683611|FG001|COMPLETED|Overall Study||124
8643111|NCT00598442|9683612|FG002|COMPLETED|Overall Study||139
8643112|NCT00598442|9683610|FG000|NOT COMPLETED|Overall Study||43
8643113|NCT00598442|9683611|FG001|NOT COMPLETED|Overall Study||39
8643114|NCT00598442|9683612|FG002|NOT COMPLETED|Overall Study||24
8643115|NCT00598481|9683620|FG000|STARTED|Baseline||12
8643116|NCT00598481|9683620|FG000|COMPLETED|Baseline||12
8643117|NCT00598481|9683620|FG000|NOT COMPLETED|Baseline||0
8643118|NCT00598481|9683620|FG000|STARTED|Treatment||12
8643119|NCT00598481|9683620|FG000|COMPLETED|Treatment||11
8643120|NCT00598481|9683620|FG000|NOT COMPLETED|Treatment||1
8643121|NCT00598507|9683627|FG000|STARTED|Overall Study||35
8643122|NCT00598507|9683627|FG000|COMPLETED|Overall Study||35
8643123|NCT00598507|9683627|FG000|NOT COMPLETED|Overall Study||0
8643124|NCT00598559|9683634|FG000|STARTED|Overall Study||92
8643125|NCT00598559|9683635|FG001|STARTED|Overall Study||91
8643126|NCT00598559|9683636|FG002|STARTED|Overall Study||30
8643127|NCT00598559|9683634|FG000|COMPLETED|Overall Study|Subjects completed 5 days of treatment|65
8643128|NCT00598559|9683635|FG001|COMPLETED|Overall Study|Subjects completed 5 days of treatment|63
8643129|NCT00598559|9683636|FG002|COMPLETED|Overall Study|Subjects completed 5 days of treatment|27
8643130|NCT00598559|9683634|FG000|NOT COMPLETED|Overall Study||27
8643131|NCT00598559|9683635|FG001|NOT COMPLETED|Overall Study||28
8643132|NCT00598559|9683636|FG002|NOT COMPLETED|Overall Study||3
8643133|NCT00598585|9683646|FG000|STARTED|Overall Study||6
8643134|NCT00598585|9683647|FG001|STARTED|Overall Study||6
8643135|NCT00598585|9683646|FG000|COMPLETED|Overall Study||5
8643136|NCT00598585|9683647|FG001|COMPLETED|Overall Study||6
8643137|NCT00598585|9683646|FG000|NOT COMPLETED|Overall Study||1
8643138|NCT00598585|9683647|FG001|NOT COMPLETED|Overall Study||0
8643139|NCT00598650|9683653|FG000|STARTED|Overall Study||108
8643140|NCT00598650|9683653|FG000|COMPLETED|Overall Study|5 subjects withdrew for multiple reasons|81
8643141|NCT00598650|9683653|FG000|NOT COMPLETED|Overall Study||27
8643142|NCT00598663|9683660|FG000|STARTED|First Intervention (6 Months)||76
8643143|NCT00598663|9683661|FG001|STARTED|First Intervention (6 Months)||77
8643144|NCT00598663|9683660|FG000|COMPLETED|First Intervention (6 Months)||73
8643145|NCT00598663|9683661|FG001|COMPLETED|First Intervention (6 Months)||71
8643146|NCT00598663|9683660|FG000|NOT COMPLETED|First Intervention (6 Months)||3
8643147|NCT00598663|9683661|FG001|NOT COMPLETED|First Intervention (6 Months)||6
8643148|NCT00598663|9683660|FG000|STARTED|Washout (4 Months)||73
8643149|NCT00598663|9683661|FG001|STARTED|Washout (4 Months)||71
8643150|NCT00598663|9683660|FG000|COMPLETED|Washout (4 Months)||73
8643151|NCT00598663|9683661|FG001|COMPLETED|Washout (4 Months)||70
8643152|NCT00598663|9683660|FG000|NOT COMPLETED|Washout (4 Months)||0
8643153|NCT00598663|9683661|FG001|NOT COMPLETED|Washout (4 Months)||1
8643154|NCT00598663|9683660|FG000|STARTED|Second Intervention (6 Months)||73
8643155|NCT00598663|9683661|FG001|STARTED|Second Intervention (6 Months)||70
8643156|NCT00598663|9683660|FG000|COMPLETED|Second Intervention (6 Months)||69
8643157|NCT00598663|9683661|FG001|COMPLETED|Second Intervention (6 Months)||69
8643158|NCT00598663|9683660|FG000|NOT COMPLETED|Second Intervention (6 Months)||4
8643159|NCT00598663|9683661|FG001|NOT COMPLETED|Second Intervention (6 Months)||1
8643160|NCT00598689|9683672|FG000|STARTED|Overall Study||40
8643161|NCT00598689|9683673|FG001|STARTED|Overall Study||40
8643162|NCT00598689|9683672|FG000|COMPLETED|Overall Study||40
8643163|NCT00598689|9683673|FG001|COMPLETED|Overall Study||40
8643164|NCT00598689|9683672|FG000|NOT COMPLETED|Overall Study||0
8643165|NCT00598689|9683673|FG001|NOT COMPLETED|Overall Study||0
8643166|NCT00598702|9683687|FG000|STARTED|Overall Study||1
8643167|NCT00598702|9683688|FG001|STARTED|Overall Study||3
8643168|NCT00598702|9683689|FG002|STARTED|Overall Study||7
8643169|NCT00598702|9683690|FG003|STARTED|Overall Study||33
8643170|NCT00598702|9683691|FG004|STARTED|Overall Study||9
8643171|NCT00598702|9683692|FG005|STARTED|Overall Study||42
8643172|NCT00598702|9683693|FG006|STARTED|Overall Study||1
8643173|NCT00598702|9683694|FG007|STARTED|Overall Study||4
8643174|NCT00598702|9683687|FG000|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|1
8643175|NCT00598702|9683688|FG001|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|1
8643176|NCT00598702|9683689|FG002|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|5
8643177|NCT00598702|9683690|FG003|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|25
8643178|NCT00598702|9683691|FG004|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|6
8643179|NCT00598702|9683692|FG005|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|30
8643180|NCT00598702|9683693|FG006|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|0
8643181|NCT00598702|9683694|FG007|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|4
8643182|NCT00598702|9683687|FG000|NOT COMPLETED|Overall Study||0
8643183|NCT00598702|9683688|FG001|NOT COMPLETED|Overall Study||2
8643184|NCT00598702|9683689|FG002|NOT COMPLETED|Overall Study||2
8643185|NCT00598702|9683690|FG003|NOT COMPLETED|Overall Study||8
8643186|NCT00598702|9683691|FG004|NOT COMPLETED|Overall Study||3
8643187|NCT00598702|9683692|FG005|NOT COMPLETED|Overall Study||12
8643188|NCT00598702|9683693|FG006|NOT COMPLETED|Overall Study||1
8643189|NCT00598702|9683694|FG007|NOT COMPLETED|Overall Study||0
8643190|NCT00598806|9683714|FG000|STARTED|Overall Study||402
8643191|NCT00598806|9683715|FG001|STARTED|Overall Study||410
8643192|NCT00598806|9683714|FG000|COMPLETED|Overall Study||329
8643193|NCT00598806|9683715|FG001|COMPLETED|Overall Study||346
8643194|NCT00598806|9683714|FG000|NOT COMPLETED|Overall Study||73
8643195|NCT00598806|9683715|FG001|NOT COMPLETED|Overall Study||64
8643196|NCT00598819|9683721|FG000|STARTED|Overall Study||14
8643197|NCT00598819|9683721|FG000|COMPLETED|Overall Study||14
8643198|NCT00598819|9683721|FG000|NOT COMPLETED|Overall Study||0
8643199|NCT00598832|9683727|FG000|STARTED|Overall Study||533
8643200|NCT00598832|9683728|FG001|STARTED|Overall Study||542
8643201|NCT00598832|9683727|FG000|COMPLETED|Overall Study||471
8643202|NCT00598832|9683728|FG001|COMPLETED|Overall Study||460
8643203|NCT00598832|9683727|FG000|NOT COMPLETED|Overall Study||62
8643204|NCT00598832|9683728|FG001|NOT COMPLETED|Overall Study||82
8643205|NCT00598871|9683736|FG000|STARTED|Overall Study||3
8643206|NCT00598871|9683737|FG001|STARTED|Overall Study||9
8643207|NCT00598871|9683736|FG000|COMPLETED|Overall Study||3
8643208|NCT00598871|9683737|FG001|COMPLETED|Overall Study||8
8643209|NCT00598871|9683736|FG000|NOT COMPLETED|Overall Study||0
8643210|NCT00598871|9683737|FG001|NOT COMPLETED|Overall Study||1
8643211|NCT00598975|9683745|FG000|STARTED|Overall Study||12
8643212|NCT00598975|9683746|FG001|STARTED|Overall Study||6
8643213|NCT00598975|9683745|FG000|Completed Cycle 1|Overall Study||12
8643214|NCT00598975|9683746|FG001|Completed Cycle 1|Overall Study||6
8643215|NCT00598975|9683745|FG000|COMPLETED|Overall Study||0
8643216|NCT00598975|9683746|FG001|COMPLETED|Overall Study||0
8643217|NCT00598975|9683745|FG000|NOT COMPLETED|Overall Study||12
8643218|NCT00598975|9683746|FG001|NOT COMPLETED|Overall Study||6
8643219|NCT00599014|9683754|FG000|STARTED|Overall Study||335
8643220|NCT00599014|9683754|FG000|COMPLETED|Overall Study||335
8643221|NCT00599014|9683754|FG000|NOT COMPLETED|Overall Study||0
8643222|NCT00599053|9683760|FG000|STARTED|Overall Study||5
8643223|NCT00599053|9683761|FG001|STARTED|Overall Study||2
8643224|NCT00599053|9683760|FG000|COMPLETED|Overall Study||5
8643225|NCT00599053|9683761|FG001|COMPLETED|Overall Study||2
8643226|NCT00599053|9683760|FG000|NOT COMPLETED|Overall Study||0
8643227|NCT00599053|9683761|FG001|NOT COMPLETED|Overall Study||0
8643228|NCT00599196|9683767|FG000|STARTED|Overall Study||381
8643229|NCT00599196|9683767|FG000|COMPLETED|Overall Study|Study fully recruited. Completed upon market authorization and commercial availability of Neupro.|0
8643230|NCT00599196|9683767|FG000|NOT COMPLETED|Overall Study||381
8643231|NCT00599248|9683773|FG000|STARTED|Overall Study||3
8643232|NCT00599248|9683774|FG001|STARTED|Overall Study||3
8643233|NCT00599248|9683775|FG002|STARTED|Overall Study||3
8643234|NCT00599248|9683776|FG003|STARTED|Overall Study||3
8643235|NCT00599248|9683773|FG000|COMPLETED|Overall Study||3
8643236|NCT00599248|9683774|FG001|COMPLETED|Overall Study||3
8643237|NCT00599248|9683775|FG002|COMPLETED|Overall Study||3
8643238|NCT00599248|9683776|FG003|COMPLETED|Overall Study||3
8643239|NCT00599248|9683773|FG000|NOT COMPLETED|Overall Study||0
8643240|NCT00599248|9683774|FG001|NOT COMPLETED|Overall Study||0
8643241|NCT00599248|9683775|FG002|NOT COMPLETED|Overall Study||0
8643242|NCT00599248|9683776|FG003|NOT COMPLETED|Overall Study||0
8643243|NCT00599313|9683785|FG000|STARTED|Overall Study||36
8643244|NCT00599313|9683785|FG000|COMPLETED|Overall Study||0
8643245|NCT00599313|9683785|FG000|NOT COMPLETED|Overall Study||36
8643246|NCT00599326|9683789|FG000|STARTED|Overall Study||10
8643247|NCT00599326|9683789|FG000|COMPLETED|Overall Study||8
8643248|NCT00599326|9683789|FG000|NOT COMPLETED|Overall Study||2
8643249|NCT00599339|9683793|FG000|STARTED|Overall Study||2195
8643250|NCT00599339|9683793|FG000|Safety Set|Overall Study||2179
8643251|NCT00599339|9683793|FG000|COMPLETED|Overall Study||1531
8643252|NCT00599339|9683793|FG000|NOT COMPLETED|Overall Study||664
8643253|NCT00599521|9683817|FG000|STARTED|Overall Study||535
8643254|NCT00599521|9683818|FG001|STARTED|Overall Study||531
8643255|NCT00599521|9683817|FG000|COMPLETED|Overall Study||475
8643256|NCT00599521|9683818|FG001|COMPLETED|Overall Study||462
8643257|NCT00599521|9683817|FG000|NOT COMPLETED|Overall Study||60
8643258|NCT00599521|9683818|FG001|NOT COMPLETED|Overall Study||69
8643259|NCT00599638|9683828|FG000|STARTED|First Intervention Period (2 Weeks)||16
8643260|NCT00599638|9683829|FG001|STARTED|First Intervention Period (2 Weeks)||14
8643261|NCT00599638|9683830|FG002|STARTED|First Intervention Period (2 Weeks)||20
8643262|NCT00599638|9683831|FG003|STARTED|First Intervention Period (2 Weeks)||22
8643263|NCT00599638|9683828|FG000|Treated|First Intervention Period (2 Weeks)||16
8643264|NCT00599638|9683829|FG001|Treated|First Intervention Period (2 Weeks)||13
8643265|NCT00599638|9683830|FG002|Treated|First Intervention Period (2 Weeks)||20
8643266|NCT00599638|9683831|FG003|Treated|First Intervention Period (2 Weeks)||21
8643267|NCT00599638|9683828|FG000|COMPLETED|First Intervention Period (2 Weeks)||14
8643268|NCT00599638|9683829|FG001|COMPLETED|First Intervention Period (2 Weeks)||12
8643269|NCT00599638|9683830|FG002|COMPLETED|First Intervention Period (2 Weeks)||17
8643270|NCT00599638|9683831|FG003|COMPLETED|First Intervention Period (2 Weeks)||17
8643271|NCT00599638|9683828|FG000|NOT COMPLETED|First Intervention Period (2 Weeks)||2
8643272|NCT00599638|9683829|FG001|NOT COMPLETED|First Intervention Period (2 Weeks)||2
8643273|NCT00599638|9683830|FG002|NOT COMPLETED|First Intervention Period (2 Weeks)||3
8643274|NCT00599638|9683831|FG003|NOT COMPLETED|First Intervention Period (2 Weeks)||5
8643275|NCT00599638|9683828|FG000|STARTED|Washout Period (2 Weeks)||14
8643276|NCT00599638|9683829|FG001|STARTED|Washout Period (2 Weeks)||12
8643277|NCT00599638|9683830|FG002|STARTED|Washout Period (2 Weeks)||17
8643278|NCT00599638|9683831|FG003|STARTED|Washout Period (2 Weeks)||17
8643279|NCT00599638|9683828|FG000|COMPLETED|Washout Period (2 Weeks)||13
8643280|NCT00599638|9683829|FG001|COMPLETED|Washout Period (2 Weeks)||11
8643281|NCT00599638|9683830|FG002|COMPLETED|Washout Period (2 Weeks)||17
8643282|NCT00599638|9683831|FG003|COMPLETED|Washout Period (2 Weeks)||14
8643283|NCT00599638|9683828|FG000|NOT COMPLETED|Washout Period (2 Weeks)||1
8643284|NCT00599638|9683829|FG001|NOT COMPLETED|Washout Period (2 Weeks)||1
8643285|NCT00599638|9683830|FG002|NOT COMPLETED|Washout Period (2 Weeks)||0
8643286|NCT00599638|9683831|FG003|NOT COMPLETED|Washout Period (2 Weeks)||3
8643287|NCT00599638|9683828|FG000|STARTED|Second Intervention Period (2 Weeks)||13
8643288|NCT00599638|9683829|FG001|STARTED|Second Intervention Period (2 Weeks)||11
8643289|NCT00599638|9683830|FG002|STARTED|Second Intervention Period (2 Weeks)||17
8643290|NCT00599638|9683831|FG003|STARTED|Second Intervention Period (2 Weeks)||14
8643291|NCT00599638|9683828|FG000|COMPLETED|Second Intervention Period (2 Weeks)||12
8643292|NCT00599638|9683829|FG001|COMPLETED|Second Intervention Period (2 Weeks)||11
8643293|NCT00599638|9683830|FG002|COMPLETED|Second Intervention Period (2 Weeks)||17
8643294|NCT00599638|9683831|FG003|COMPLETED|Second Intervention Period (2 Weeks)||14
8643295|NCT00599638|9683828|FG000|NOT COMPLETED|Second Intervention Period (2 Weeks)||1
8643296|NCT00599638|9683829|FG001|NOT COMPLETED|Second Intervention Period (2 Weeks)||0
8643297|NCT00599638|9683830|FG002|NOT COMPLETED|Second Intervention Period (2 Weeks)||0
8643298|NCT00599638|9683831|FG003|NOT COMPLETED|Second Intervention Period (2 Weeks)||0
8691565|NCT00855920|9736875|FG002|Safety Population|Overall Study||75
8691566|NCT00855920|9736873|FG000|COMPLETED|Overall Study||68
8691567|NCT00855920|9736874|FG001|COMPLETED|Overall Study||65
8691568|NCT00855920|9736875|FG002|COMPLETED|Overall Study||64
8691569|NCT00855920|9736873|FG000|NOT COMPLETED|Overall Study||8
8691570|NCT00855920|9736874|FG001|NOT COMPLETED|Overall Study||9
8691571|NCT00855920|9736875|FG002|NOT COMPLETED|Overall Study||11
8691572|NCT00855933|9736885|FG000|STARTED|Overall Study||30
8691573|NCT00855933|9736886|FG001|STARTED|Overall Study||30
8691574|NCT00855933|9736885|FG000|COMPLETED|Overall Study||30
8691575|NCT00855933|9736886|FG001|COMPLETED|Overall Study||29
8691576|NCT00855933|9736885|FG000|NOT COMPLETED|Overall Study||0
8691577|NCT00855933|9736886|FG001|NOT COMPLETED|Overall Study||1
8691578|NCT00855959|9736892|FG000|STARTED|Overall Study||108
8691579|NCT00855959|9736892|FG000|Patients Who Received Pulmicort Respules|Overall Study||105
8691580|NCT00855959|9736892|FG000|COMPLETED|Overall Study||99
8691581|NCT00855959|9736892|FG000|NOT COMPLETED|Overall Study||9
8693644|NCT00867815|9739192|FG000|STARTED|Overall Study||10
8693645|NCT00867815|9739192|FG000|COMPLETED|Overall Study||9
8693646|NCT00867815|9739192|FG000|NOT COMPLETED|Overall Study||1
8693647|NCT00867932|9739196|FG000|STARTED|Overall Study||7
8693648|NCT00867932|9739196|FG000|Induction Phase|Overall Study||7
8693649|NCT00867932|9739196|FG000|Maintenance Phase|Overall Study||7
8693783|NCT00868517|9739327|FG000|NOT COMPLETED|Overall Study||4
8643299|NCT00599755|9683839|FG000|STARTED|Overall Study||68
8643300|NCT00599755|9683839|FG000|COMPLETED|Overall Study||49
8643301|NCT00599755|9683839|FG000|NOT COMPLETED|Overall Study||19
8643302|NCT00599872|9683845|FG000|STARTED|Overall Study||216
8643303|NCT00599872|9683846|FG001|STARTED|Overall Study||214
8643304|NCT00599872|9683845|FG000|COMPLETED|Overall Study||167
8643305|NCT00599872|9683846|FG001|COMPLETED|Overall Study||181
8643306|NCT00599872|9683845|FG000|NOT COMPLETED|Overall Study||49
8643307|NCT00599872|9683846|FG001|NOT COMPLETED|Overall Study||33
8643308|NCT00599924|9683863|FG000|STARTED|Overall Study||4
8643309|NCT00599924|9683864|FG001|STARTED|Overall Study||9
8643310|NCT00599924|9683865|FG002|STARTED|Overall Study||5
8643311|NCT00599924|9683866|FG003|STARTED|Overall Study||12
8643312|NCT00599924|9683867|FG004|STARTED|Overall Study||9
8643313|NCT00599924|9683868|FG005|STARTED|Overall Study||6
8643314|NCT00599924|9683869|FG006|STARTED|Overall Study||8
8643315|NCT00599924|9683863|FG000|COMPLETED|Overall Study||1
8643316|NCT00599924|9683864|FG001|COMPLETED|Overall Study||4
8643317|NCT00599924|9683865|FG002|COMPLETED|Overall Study||3
8643318|NCT00599924|9683866|FG003|COMPLETED|Overall Study||4
8643319|NCT00599924|9683867|FG004|COMPLETED|Overall Study||3
8643320|NCT00599924|9683868|FG005|COMPLETED|Overall Study||2
8643321|NCT00599924|9683869|FG006|COMPLETED|Overall Study||3
8643322|NCT00599924|9683863|FG000|NOT COMPLETED|Overall Study||3
8643323|NCT00599924|9683864|FG001|NOT COMPLETED|Overall Study||5
8643324|NCT00599924|9683865|FG002|NOT COMPLETED|Overall Study||2
8643325|NCT00599924|9683866|FG003|NOT COMPLETED|Overall Study||8
8643326|NCT00599924|9683867|FG004|NOT COMPLETED|Overall Study||6
8643327|NCT00599924|9683868|FG005|NOT COMPLETED|Overall Study||4
8643328|NCT00599924|9683869|FG006|NOT COMPLETED|Overall Study||5
8643329|NCT00600028|9683892|FG000|STARTED|First Intervention (12 Weeks)|Number of participants starting the first intervention (prior to washout)|13
8643330|NCT00600028|9683893|FG001|STARTED|First Intervention (12 Weeks)|Number of participants starting the first intervention (prior to washout)|11
8643331|NCT00600028|9683892|FG000|COMPLETED|First Intervention (12 Weeks)||12
8643332|NCT00600028|9683893|FG001|COMPLETED|First Intervention (12 Weeks)||10
8643333|NCT00600028|9683892|FG000|NOT COMPLETED|First Intervention (12 Weeks)||1
8643334|NCT00600028|9683893|FG001|NOT COMPLETED|First Intervention (12 Weeks)||1
8643335|NCT00600028|9683892|FG000|STARTED|Second Intervention (12 Weeks)|Number of participants starting the second intervention (after a 2-week washout)|12
8643336|NCT00600028|9683893|FG001|STARTED|Second Intervention (12 Weeks)|Number of participants starting the second intervention (after a 2-week washout)|10
8643337|NCT00600028|9683892|FG000|COMPLETED|Second Intervention (12 Weeks)||12
8643338|NCT00600028|9683893|FG001|COMPLETED|Second Intervention (12 Weeks)||8
8643339|NCT00600028|9683892|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||0
8643340|NCT00600028|9683893|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||2
8643341|NCT00600067|9683904|FG000|STARTED|Overall Study||55
8643342|NCT00600067|9683905|FG001|STARTED|Overall Study||75
8643343|NCT00600067|9683904|FG000|COMPLETED|Overall Study||52
8643344|NCT00600067|9683905|FG001|COMPLETED|Overall Study||68
8643345|NCT00600067|9683904|FG000|NOT COMPLETED|Overall Study||3
8643346|NCT00600067|9683905|FG001|NOT COMPLETED|Overall Study||7
8643347|NCT00600080|9683912|FG000|STARTED|Period 1: Baseline to One-week||28
8643348|NCT00600080|9683913|FG001|STARTED|Period 1: Baseline to One-week||32
8643349|NCT00600080|9683912|FG000|COMPLETED|Period 1: Baseline to One-week||28
8643350|NCT00600080|9683913|FG001|COMPLETED|Period 1: Baseline to One-week||32
8643351|NCT00600080|9683912|FG000|NOT COMPLETED|Period 1: Baseline to One-week||0
8643352|NCT00600080|9683913|FG001|NOT COMPLETED|Period 1: Baseline to One-week||0
8643353|NCT00600080|9683912|FG000|STARTED|Period 2: One-week to Two-weeks|This is a crossover study, arms are switched at period change.|28
8643354|NCT00600080|9683913|FG001|STARTED|Period 2: One-week to Two-weeks|This is a crossover study, arms are switched at period change.|32
8643355|NCT00600080|9683912|FG000|COMPLETED|Period 2: One-week to Two-weeks||28
8643356|NCT00600080|9683913|FG001|COMPLETED|Period 2: One-week to Two-weeks||32
8643357|NCT00600080|9683912|FG000|NOT COMPLETED|Period 2: One-week to Two-weeks||0
8643358|NCT00600080|9683913|FG001|NOT COMPLETED|Period 2: One-week to Two-weeks||0
8643359|NCT00600106|9683921|FG000|STARTED|Overall Study||18
8643360|NCT00600106|9683922|FG001|STARTED|Overall Study||19
8643361|NCT00600106|9683921|FG000|COMPLETED|Overall Study||17
8643362|NCT00600106|9683922|FG001|COMPLETED|Overall Study||18
8643363|NCT00600106|9683921|FG000|NOT COMPLETED|Overall Study||1
8643364|NCT00600106|9683922|FG001|NOT COMPLETED|Overall Study||1
8643365|NCT00600119|9683934|FG000|STARTED|Single-blind Placebo run-in Period||36
8643366|NCT00600119|9683935|FG001|STARTED|Single-blind Placebo run-in Period||35
8643367|NCT00600119|9683936|FG002|STARTED|Single-blind Placebo run-in Period||29
8643368|NCT00600119|9683937|FG003|STARTED|Single-blind Placebo run-in Period||31
8643369|NCT00600119|9683938|FG004|STARTED|Single-blind Placebo run-in Period||39
8643370|NCT00600119|9683939|FG005|STARTED|Single-blind Placebo run-in Period||37
8643371|NCT00600119|9683934|FG000|COMPLETED|Single-blind Placebo run-in Period||32
8643372|NCT00600119|9683935|FG001|COMPLETED|Single-blind Placebo run-in Period||33
8643373|NCT00600119|9683936|FG002|COMPLETED|Single-blind Placebo run-in Period||27
8643374|NCT00600119|9683937|FG003|COMPLETED|Single-blind Placebo run-in Period||30
8643375|NCT00600119|9683938|FG004|COMPLETED|Single-blind Placebo run-in Period||37
8643376|NCT00600119|9683939|FG005|COMPLETED|Single-blind Placebo run-in Period||35
8643377|NCT00600119|9683934|FG000|NOT COMPLETED|Single-blind Placebo run-in Period||4
8643378|NCT00600119|9683935|FG001|NOT COMPLETED|Single-blind Placebo run-in Period||2
8643379|NCT00600119|9683936|FG002|NOT COMPLETED|Single-blind Placebo run-in Period||2
8643380|NCT00600119|9683937|FG003|NOT COMPLETED|Single-blind Placebo run-in Period||1
8643381|NCT00600119|9683938|FG004|NOT COMPLETED|Single-blind Placebo run-in Period||2
8643382|NCT00600119|9683939|FG005|NOT COMPLETED|Single-blind Placebo run-in Period||2
8643383|NCT00600119|9683934|FG000|STARTED|Double-blind Treatment Period||32
8643384|NCT00600119|9683935|FG001|STARTED|Double-blind Treatment Period||33
8643385|NCT00600119|9683936|FG002|STARTED|Double-blind Treatment Period||27
8643386|NCT00600119|9683937|FG003|STARTED|Double-blind Treatment Period||30
8643387|NCT00600119|9683938|FG004|STARTED|Double-blind Treatment Period||37
8643388|NCT00600119|9683939|FG005|STARTED|Double-blind Treatment Period||35
8643389|NCT00600119|9683934|FG000|COMPLETED|Double-blind Treatment Period||27
8643390|NCT00600119|9683935|FG001|COMPLETED|Double-blind Treatment Period||28
8643391|NCT00600119|9683936|FG002|COMPLETED|Double-blind Treatment Period||27
8643392|NCT00600119|9683937|FG003|COMPLETED|Double-blind Treatment Period||28
8643393|NCT00600119|9683938|FG004|COMPLETED|Double-blind Treatment Period||31
8643394|NCT00600119|9683939|FG005|COMPLETED|Double-blind Treatment Period||21
8643395|NCT00600119|9683934|FG000|NOT COMPLETED|Double-blind Treatment Period||5
8643396|NCT00600119|9683935|FG001|NOT COMPLETED|Double-blind Treatment Period||5
8643397|NCT00600119|9683936|FG002|NOT COMPLETED|Double-blind Treatment Period||0
8643398|NCT00600119|9683937|FG003|NOT COMPLETED|Double-blind Treatment Period||2
8643399|NCT00600119|9683938|FG004|NOT COMPLETED|Double-blind Treatment Period||6
8643400|NCT00600119|9683939|FG005|NOT COMPLETED|Double-blind Treatment Period||14
8643401|NCT00600119|9683934|FG000|STARTED|Follow-up Period||27
8643402|NCT00600119|9683935|FG001|STARTED|Follow-up Period||28
8643403|NCT00600119|9683936|FG002|STARTED|Follow-up Period||27
8643404|NCT00600119|9683937|FG003|STARTED|Follow-up Period||28
8643405|NCT00600119|9683938|FG004|STARTED|Follow-up Period||31
8643406|NCT00600119|9683939|FG005|STARTED|Follow-up Period||21
8643407|NCT00600119|9683934|FG000|COMPLETED|Follow-up Period||26
8643408|NCT00600119|9683935|FG001|COMPLETED|Follow-up Period||28
8643409|NCT00600119|9683936|FG002|COMPLETED|Follow-up Period||27
8643410|NCT00600119|9683937|FG003|COMPLETED|Follow-up Period||28
8643411|NCT00600119|9683938|FG004|COMPLETED|Follow-up Period||31
8643412|NCT00600119|9683939|FG005|COMPLETED|Follow-up Period||20
8643413|NCT00600119|9683934|FG000|NOT COMPLETED|Follow-up Period||1
8643414|NCT00600119|9683935|FG001|NOT COMPLETED|Follow-up Period||0
8643415|NCT00600119|9683936|FG002|NOT COMPLETED|Follow-up Period||0
8643416|NCT00600119|9683937|FG003|NOT COMPLETED|Follow-up Period||0
8643417|NCT00600119|9683938|FG004|NOT COMPLETED|Follow-up Period||0
8643418|NCT00600119|9683939|FG005|NOT COMPLETED|Follow-up Period||1
8643419|NCT00600171|9683959|FG000|STARTED|Overall Study||102
8643420|NCT00600171|9683960|FG001|STARTED|Overall Study||101
8643421|NCT00600171|9683961|FG002|STARTED|Overall Study||101
8643422|NCT00600171|9683962|FG003|STARTED|Overall Study||100
9022111|NCT03124108|10084983|FG000|COMPLETED|Overall Study||15
9022112|NCT03124108|10084984|FG001|COMPLETED|Overall Study||14
9022113|NCT03124108|10084985|FG002|COMPLETED|Overall Study||15
9022114|NCT03124108|10084983|FG000|NOT COMPLETED|Overall Study||0
9022115|NCT03124108|10084984|FG001|NOT COMPLETED|Overall Study||1
8643423|NCT00600171|9683963|FG004|STARTED|Overall Study||101
8643424|NCT00600171|9683964|FG005|STARTED|Overall Study||102
8643425|NCT00600171|9683959|FG000|COMPLETED|Overall Study||86
8643426|NCT00600171|9683960|FG001|COMPLETED|Overall Study||84
8643427|NCT00600171|9683961|FG002|COMPLETED|Overall Study||91
8643428|NCT00600171|9683962|FG003|COMPLETED|Overall Study||88
8643429|NCT00600171|9683963|FG004|COMPLETED|Overall Study||93
8643430|NCT00600171|9683964|FG005|COMPLETED|Overall Study||97
8643431|NCT00600171|9683959|FG000|NOT COMPLETED|Overall Study||16
8643432|NCT00600171|9683960|FG001|NOT COMPLETED|Overall Study||17
8643433|NCT00600171|9683961|FG002|NOT COMPLETED|Overall Study||10
8643434|NCT00600171|9683962|FG003|NOT COMPLETED|Overall Study||12
8643435|NCT00600171|9683963|FG004|NOT COMPLETED|Overall Study||8
8643436|NCT00600171|9683964|FG005|NOT COMPLETED|Overall Study||5
8643437|NCT00600340|9683982|FG000|STARTED|Overall Study||285
8643438|NCT00600340|9683983|FG001|STARTED|Overall Study||279
8643439|NCT00600340|9683982|FG000|COMPLETED|Overall Study||285
8643440|NCT00600340|9683983|FG001|COMPLETED|Overall Study||279
8643441|NCT00600340|9683982|FG000|NOT COMPLETED|Overall Study||0
8643442|NCT00600340|9683983|FG001|NOT COMPLETED|Overall Study||0
8643443|NCT00600353|9683991|FG000|STARTED|Overall Study||10
8643444|NCT00600353|9683992|FG001|STARTED|Overall Study||10
8643445|NCT00600353|9683991|FG000|COMPLETED|Overall Study||9
8643446|NCT00600353|9683992|FG001|COMPLETED|Overall Study||9
8643447|NCT00600353|9683991|FG000|NOT COMPLETED|Overall Study||1
8643448|NCT00600353|9683992|FG001|NOT COMPLETED|Overall Study||1
8643449|NCT00600613|9683998|FG000|STARTED|Overall Study||6
8643450|NCT00600613|9683998|FG000|COMPLETED|Overall Study||5
8643451|NCT00600613|9683998|FG000|NOT COMPLETED|Overall Study||1
8643452|NCT00600704|9684004|FG000|STARTED|Overall Study||100
8643453|NCT00600704|9684005|FG001|STARTED|Overall Study||92
8643454|NCT00600704|9684004|FG000|COMPLETED|Overall Study||100
8643455|NCT00600704|9684005|FG001|COMPLETED|Overall Study||92
8643456|NCT00600704|9684004|FG000|NOT COMPLETED|Overall Study||0
8643457|NCT00600704|9684005|FG001|NOT COMPLETED|Overall Study||0
8643458|NCT00600743|9684015|FG000|STARTED|Overall Study||4
8643459|NCT00600743|9684016|FG001|STARTED|Overall Study||4
8643460|NCT00600743|9684017|FG002|STARTED|Overall Study||8
8643461|NCT00600743|9684018|FG003|STARTED|Overall Study||7
8643462|NCT00600743|9684015|FG000|COMPLETED|Overall Study||4
8643463|NCT00600743|9684016|FG001|COMPLETED|Overall Study||4
8643464|NCT00600743|9684017|FG002|COMPLETED|Overall Study||8
8643465|NCT00600743|9684018|FG003|COMPLETED|Overall Study||7
8643466|NCT00600743|9684015|FG000|NOT COMPLETED|Overall Study||0
8643467|NCT00600743|9684016|FG001|NOT COMPLETED|Overall Study||0
8643468|NCT00600743|9684017|FG002|NOT COMPLETED|Overall Study||0
8643469|NCT00600743|9684018|FG003|NOT COMPLETED|Overall Study||0
8643470|NCT00600756|9684039|FG000|STARTED|Analysis After 6 Months||395
8643471|NCT00600756|9684040|FG001|STARTED|Analysis After 6 Months||403
8643472|NCT00600756|9684039|FG000|COMPLETED|Analysis After 6 Months|Completers are all patients who completed the study up to Visit 5 (including premature withdraw)|264
8643473|NCT00600756|9684040|FG001|COMPLETED|Analysis After 6 Months|Completers are all patients who completed the study up to Visit 5 (including premature withdraw)|283
8643474|NCT00600756|9684039|FG000|NOT COMPLETED|Analysis After 6 Months||131
8643475|NCT00600756|9684040|FG001|NOT COMPLETED|Analysis After 6 Months||120
8643476|NCT00600756|9684039|FG000|STARTED|Overall Study Analysis After 12 Months||395
8643477|NCT00600756|9684040|FG001|STARTED|Overall Study Analysis After 12 Months||403
8643478|NCT00600756|9684039|FG000|Randomized Analysis|Overall Study Analysis After 12 Months||395
8643479|NCT00600756|9684040|FG001|Randomized Analysis|Overall Study Analysis After 12 Months||403
8643480|NCT00600756|9684039|FG000|Safety Analysis|Overall Study Analysis After 12 Months||391
8643481|NCT00600756|9684040|FG001|Safety Analysis|Overall Study Analysis After 12 Months||402
8643482|NCT00600756|9684039|FG000|ITT Analysis|Overall Study Analysis After 12 Months||379
8643483|NCT00600756|9684040|FG001|ITT Analysis|Overall Study Analysis After 12 Months||392
8643484|NCT00600756|9684039|FG000|COMPLETED|Overall Study Analysis After 12 Months|Completed study to Visit 7 (includes premature withdrawals with final visit in the Visit 7 window)|212
8643485|NCT00600756|9684040|FG001|COMPLETED|Overall Study Analysis After 12 Months|Completed study to Visit 7 (includes premature withdrawals with final visit in the Visit 7 window)|227
8643486|NCT00600756|9684039|FG000|NOT COMPLETED|Overall Study Analysis After 12 Months||183
8643487|NCT00600756|9684040|FG001|NOT COMPLETED|Overall Study Analysis After 12 Months||176
8643488|NCT00600821|9684048|FG000|STARTED|Overall Study||58
8643489|NCT00600821|9684049|FG001|STARTED|Overall Study||60
8643490|NCT00600821|9684048|FG000|Treated|Overall Study||58
8643491|NCT00600821|9684049|FG001|Treated|Overall Study||59
8643492|NCT00600821|9684048|FG000|COMPLETED|Overall Study||0
8643493|NCT00600821|9684049|FG001|COMPLETED|Overall Study||0
8643494|NCT00600821|9684048|FG000|NOT COMPLETED|Overall Study||58
8643495|NCT00600821|9684049|FG001|NOT COMPLETED|Overall Study||60
8643496|NCT00600886|9684059|FG000|STARTED|Core Phase - Full Analysis Set (FAS)||176
8643497|NCT00600886|9684060|FG001|STARTED|Core Phase - Full Analysis Set (FAS)||182
8643498|NCT00600886|9684059|FG000|Did Not Enter Extension|Core Phase - Full Analysis Set (FAS)||29
8643499|NCT00600886|9684060|FG001|Did Not Enter Extension|Core Phase - Full Analysis Set (FAS)||29
8643500|NCT00600886|9684059|FG000|Entered Extension, Crossed Over|Core Phase - Full Analysis Set (FAS)||38
8643501|NCT00600886|9684060|FG001|Entered Extension, Crossed Over|Core Phase - Full Analysis Set (FAS)||81
8643502|NCT00600886|9684059|FG000|Entered Ext Continued Same Treatment|Core Phase - Full Analysis Set (FAS)||74
8643503|NCT00600886|9684060|FG001|Entered Ext Continued Same Treatment|Core Phase - Full Analysis Set (FAS)||46
8643504|NCT00600886|9684059|FG000|COMPLETED|Core Phase - Full Analysis Set (FAS)|Completed = anyone who did not discontinue prior to month 12.|141
8643505|NCT00600886|9684060|FG001|COMPLETED|Core Phase - Full Analysis Set (FAS)|Completed = anyone who did not discontinue prior to month 12.|156
8643506|NCT00600886|9684059|FG000|NOT COMPLETED|Core Phase - Full Analysis Set (FAS)||35
8643507|NCT00600886|9684060|FG001|NOT COMPLETED|Core Phase - Full Analysis Set (FAS)||26
8643508|NCT00600886|9684059|FG000|STARTED|Extension - Same Treatment (FAS)|Started = anyone who entered the extension and continued the same treatment of Pasireotide LAR|74
8643509|NCT00600886|9684060|FG001|STARTED|Extension - Same Treatment (FAS)|Started = anyone who entered the extension and continued the same treatment of Octreotide LAR|46
8643510|NCT00600886|9684059|FG000|Completed Study at Month 26|Extension - Same Treatment (FAS)|Pas. LAR pts in Ext. were not considered completers at M26 as treatment could continue after M26.|0
8643511|NCT00600886|9684060|FG001|Completed Study at Month 26|Extension - Same Treatment (FAS)|Per protocol, pts who received Octreotide LAR in ext. phase were not followed in the study after M26|31
8643512|NCT00600886|9684059|FG000|Completed Study After Month 26|Extension - Same Treatment (FAS)|Completed = Pts who transferred to a roll-over protocol or commercial supply of Pasireotide LAR|28
8643513|NCT00600886|9684060|FG001|Completed Study After Month 26|Extension - Same Treatment (FAS)|Received treatment and completed after M26: Recorded as protocol deviation|4
8643514|NCT00600886|9684059|FG000|Discontinued After Month 26|Extension - Same Treatment (FAS)||23
8643515|NCT00600886|9684060|FG001|Discontinued After Month 26|Extension - Same Treatment (FAS)|Received treatment and discontinued after M26: Recorded as protocol deviation|1
8643516|NCT00600886|9684059|FG000|Discontinued Between M12 and M26|Extension - Same Treatment (FAS)||23
8643517|NCT00600886|9684060|FG001|Discontinued Between M12 and M26|Extension - Same Treatment (FAS)||10
8643518|NCT00600886|9684059|FG000|COMPLETED|Extension - Same Treatment (FAS)|Completed= completed after M26, switched to commercial pasireotide LAR or entered roll-over protocol|28
8643519|NCT00600886|9684060|FG001|COMPLETED|Extension - Same Treatment (FAS)|Completed = completed the study|35
8643520|NCT00600886|9684059|FG000|NOT COMPLETED|Extension - Same Treatment (FAS)||46
8643521|NCT00600886|9684060|FG001|NOT COMPLETED|Extension - Same Treatment (FAS)||11
8643522|NCT00600886|9684059|FG000|STARTED|Extension - After Crossover (CAS)|Started = anyone who entered the extension and crossed over to Pasireotide LAR|81
8643523|NCT00600886|9684060|FG001|STARTED|Extension - After Crossover (CAS)|Started = anyone who entered the extension and crossed over to Octreotide LAR|38
8643524|NCT00600886|9684059|FG000|Completed Study at Month 26|Extension - After Crossover (CAS)|Pas. LAR pts in Ext. were not considered completers at M26 as treatment could continue after M26.|0
8643525|NCT00600886|9684060|FG001|Completed Study at Month 26|Extension - After Crossover (CAS)|Per protocol, Pts who received Octreotide LAR in Ext. phase were not followed in study after M26|25
8643526|NCT00600886|9684059|FG000|Completed After Month 26|Extension - After Crossover (CAS)|Completed = Pts who transferred to a roll-over protocol or commercial supply of Pasireotide LAR|19
8643527|NCT00600886|9684060|FG001|Completed After Month 26|Extension - After Crossover (CAS)|Per protocol, pts who received Octreotide LAR in ext. phase were not followed in study after M26|0
8643528|NCT00600886|9684059|FG000|Discontinued Between M12 and M26|Extension - After Crossover (CAS)||31
8643529|NCT00600886|9684060|FG001|Discontinued Between M12 and M26|Extension - After Crossover (CAS)||13
8643530|NCT00600886|9684059|FG000|Discontinued After M26|Extension - After Crossover (CAS)||31
8643531|NCT00600886|9684060|FG001|Discontinued After M26|Extension - After Crossover (CAS)|Per protocol, Pts who received Octreotide LAR in Ext. phase were not followed in study after M26|0
8643532|NCT00600886|9684059|FG000|COMPLETED|Extension - After Crossover (CAS)|Completed after month 26: transferred to a roll-over protocol or commercial supply of Pas.LAR|19
8643533|NCT00600886|9684060|FG001|COMPLETED|Extension - After Crossover (CAS)|Completed the study|25
8643534|NCT00600886|9684059|FG000|NOT COMPLETED|Extension - After Crossover (CAS)||62
8643535|NCT00600886|9684060|FG001|NOT COMPLETED|Extension - After Crossover (CAS)||13
8643536|NCT00600925|9684082|FG000|STARTED|Overall Study||300
8643537|NCT00600925|9684083|FG001|STARTED|Overall Study||302
8643538|NCT00600925|9684082|FG000|COMPLETED|Overall Study||300
8643539|NCT00600925|9684083|FG001|COMPLETED|Overall Study||302
8643540|NCT00600925|9684082|FG000|NOT COMPLETED|Overall Study||0
8643541|NCT00600925|9684083|FG001|NOT COMPLETED|Overall Study||0
8643542|NCT00600938|9684091|FG000|STARTED|Core Study||98
8643543|NCT00600938|9684092|FG001|STARTED|Core Study||99
8643544|NCT00600938|9684093|FG002|STARTED|Core Study||0
8643545|NCT00600938|9684094|FG003|STARTED|Core Study||0
8643546|NCT00600938|9684091|FG000|Core Safety Set|Core Study||96
8643547|NCT00600938|9684092|FG001|Core Safety Set|Core Study||91
8643548|NCT00600938|9684093|FG002|Core Safety Set|Core Study||0
8643549|NCT00600938|9684094|FG003|Core Safety Set|Core Study||0
8643550|NCT00600938|9684091|FG000|Per Protocol Set (PPS)|Core Study||91
8643551|NCT00600938|9684092|FG001|Per Protocol Set (PPS)|Core Study||81
8643552|NCT00600938|9684093|FG002|Per Protocol Set (PPS)|Core Study||0
8643553|NCT00600938|9684094|FG003|Per Protocol Set (PPS)|Core Study||0
8643554|NCT00600938|9684091|FG000|COMPLETED|Core Study||82
8643555|NCT00600938|9684092|FG001|COMPLETED|Core Study||78
8643556|NCT00600938|9684093|FG002|COMPLETED|Core Study||0
8643557|NCT00600938|9684094|FG003|COMPLETED|Core Study||0
8643558|NCT00600938|9684091|FG000|NOT COMPLETED|Core Study||16
8643559|NCT00600938|9684092|FG001|NOT COMPLETED|Core Study||21
8643560|NCT00600938|9684093|FG002|NOT COMPLETED|Core Study||0
8643561|NCT00600938|9684094|FG003|NOT COMPLETED|Core Study||0
8643562|NCT00600938|9684091|FG000|STARTED|Extension Study|Of the 82 patients who completed the ICL core, 74 continued on the ICL ext. phase; 1 went to ICL-DFO|74
8643563|NCT00600938|9684092|FG001|STARTED|Extension Study|Of the 78 patients who completed the DFO core, 29 went on DFO ext. phase; 42 went to the DFO-ICL|29
8643564|NCT00600938|9684093|FG002|STARTED|Extension Study|Of the 78 patients who completed the DFO core, 29 went on DFO ext. phase; 42 went to the DFO-ICL|42
8643565|NCT00600938|9684094|FG003|STARTED|Extension Study|Of the 82 patients who completed the ICL core, 74 continued on the ICL ext. phase; 1 went to ICL-DFO|1
8643566|NCT00600938|9684091|FG000|Extension Safety Set|Extension Study|1 patient did not receive drug in the ext. phase but received drug in the core phase|73
8643567|NCT00600938|9684092|FG001|Extension Safety Set|Extension Study||29
8643568|NCT00600938|9684093|FG002|Extension Safety Set|Extension Study||42
8643569|NCT00600938|9684094|FG003|Extension Safety Set|Extension Study||1
8643570|NCT00600938|9684091|FG000|COMPLETED|Extension Study||65
8643571|NCT00600938|9684092|FG001|COMPLETED|Extension Study||24
8643572|NCT00600938|9684093|FG002|COMPLETED|Extension Study||33
8643573|NCT00600938|9684094|FG003|COMPLETED|Extension Study||0
8643574|NCT00600938|9684091|FG000|NOT COMPLETED|Extension Study||9
8643575|NCT00600938|9684092|FG001|NOT COMPLETED|Extension Study||5
8643576|NCT00600938|9684093|FG002|NOT COMPLETED|Extension Study||9
8643577|NCT00600938|9684094|FG003|NOT COMPLETED|Extension Study||1
8643578|NCT00601107|9684123|FG000|STARTED|Overall Study|Randomized.|27
8643579|NCT00601107|9684124|FG001|STARTED|Overall Study||31
8643580|NCT00601107|9684125|FG002|STARTED|Overall Study||28
8643581|NCT00601107|9684126|FG003|STARTED|Overall Study||25
8643582|NCT00601107|9684123|FG000|Treated|Overall Study||27
8643583|NCT00601107|9684124|FG001|Treated|Overall Study||31
8643584|NCT00601107|9684125|FG002|Treated|Overall Study||28
8643585|NCT00601107|9684126|FG003|Treated|Overall Study||25
8643586|NCT00601107|9684123|FG000|COMPLETED|Overall Study||14
8643587|NCT00601107|9684124|FG001|COMPLETED|Overall Study||22
8643588|NCT00601107|9684125|FG002|COMPLETED|Overall Study||16
8643589|NCT00601107|9684126|FG003|COMPLETED|Overall Study||13
8643590|NCT00601107|9684123|FG000|NOT COMPLETED|Overall Study||13
8643591|NCT00601107|9684124|FG001|NOT COMPLETED|Overall Study||9
8643592|NCT00601107|9684125|FG002|NOT COMPLETED|Overall Study||12
8643593|NCT00601107|9684126|FG003|NOT COMPLETED|Overall Study||12
8643594|NCT00601146|9684136|FG000|STARTED|Overall Study||39
8643595|NCT00601146|9684136|FG000|COMPLETED|Overall Study||39
8643596|NCT00601146|9684136|FG000|NOT COMPLETED|Overall Study||0
8643597|NCT00601172|9684142|FG000|STARTED|Overall Study||355
8643598|NCT00601172|9684143|FG001|STARTED|Overall Study||355
8643599|NCT00601172|9684142|FG000|COMPLETED|Overall Study||214
8643600|NCT00601172|9684143|FG001|COMPLETED|Overall Study||228
8643601|NCT00601172|9684142|FG000|NOT COMPLETED|Overall Study||141
8643602|NCT00601172|9684143|FG001|NOT COMPLETED|Overall Study||127
8643603|NCT00601250|9684152|FG000|STARTED|Overall Study|number who started treatment|177
8643604|NCT00601250|9684153|FG001|STARTED|Overall Study|number who started treatment. One additional patient was randomised but not treated.|523
8643605|NCT00601250|9684152|FG000|COMPLETED|Overall Study|number who completed treatment|163
8643606|NCT00601250|9684153|FG001|COMPLETED|Overall Study|number who completed treatment|484
8643607|NCT00601250|9684152|FG000|NOT COMPLETED|Overall Study||14
8643608|NCT00601250|9684153|FG001|NOT COMPLETED|Overall Study||39
8643609|NCT00601354|9684161|FG000|STARTED|Overall Study||8
8643610|NCT00601354|9684162|FG001|STARTED|Overall Study||9
8643611|NCT00601354|9684161|FG000|COMPLETED|Overall Study||4
8643612|NCT00601354|9684162|FG001|COMPLETED|Overall Study||4
8643613|NCT00601354|9684161|FG000|NOT COMPLETED|Overall Study||4
8643614|NCT00601354|9684162|FG001|NOT COMPLETED|Overall Study||5
8643615|NCT00601367|9684168|FG000|STARTED|Overall Study||480
8643616|NCT00601367|9684168|FG000|COMPLETED|Overall Study||293
8643617|NCT00601367|9684168|FG000|NOT COMPLETED|Overall Study||187
8643618|NCT00601419|9684172|FG000|STARTED|Overall Study||230
8643619|NCT00601419|9684172|FG000|COMPLETED|Overall Study||226
8643620|NCT00601419|9684172|FG000|NOT COMPLETED|Overall Study||4
8643621|NCT00601458|9684195|FG000|STARTED|Overall Study||36
8643622|NCT00601458|9684196|FG001|STARTED|Overall Study||34
8643623|NCT00601458|9684197|FG002|STARTED|Overall Study||30
8643624|NCT00601458|9684195|FG000|COMPLETED|Overall Study||32
8643625|NCT00601458|9684196|FG001|COMPLETED|Overall Study||29
8643626|NCT00601458|9684197|FG002|COMPLETED|Overall Study||28
8643627|NCT00601458|9684195|FG000|NOT COMPLETED|Overall Study||4
8643628|NCT00601458|9684196|FG001|NOT COMPLETED|Overall Study||5
8643629|NCT00601458|9684197|FG002|NOT COMPLETED|Overall Study||2
8643630|NCT00601484|9684207|FG000|STARTED|Overall Study||34
8643631|NCT00601484|9684208|FG001|STARTED|Overall Study||31
8643632|NCT00601484|9684207|FG000|Treated|Overall Study||34
8643633|NCT00601484|9684208|FG001|Treated|Overall Study||30
8643634|NCT00601484|9684207|FG000|COMPLETED|Overall Study||29
8643635|NCT00601484|9684208|FG001|COMPLETED|Overall Study||23
8643636|NCT00601484|9684207|FG000|NOT COMPLETED|Overall Study||5
8643637|NCT00601484|9684208|FG001|NOT COMPLETED|Overall Study||8
8643638|NCT00601523|9684216|FG000|STARTED|Overall Study||368
8643639|NCT00601523|9684217|FG001|STARTED|Overall Study||143
8643640|NCT00601523|9684216|FG000|COMPLETED|Overall Study||291
8643641|NCT00601523|9684217|FG001|COMPLETED|Overall Study||117
8643642|NCT00601523|9684216|FG000|NOT COMPLETED|Overall Study||77
8643643|NCT00601523|9684217|FG001|NOT COMPLETED|Overall Study||26
8643644|NCT00601627|9684223|FG000|STARTED|Overall Study||51
8643645|NCT00601627|9684223|FG000|COMPLETED|Overall Study||51
8643646|NCT00601627|9684223|FG000|NOT COMPLETED|Overall Study||0
8643647|NCT00601640|9684230|FG000|STARTED|Overall Study||52
8643648|NCT00601640|9684231|FG001|STARTED|Overall Study||52
8643649|NCT00601640|9684232|FG002|STARTED|Overall Study||52
8643650|NCT00601640|9684230|FG000|COMPLETED|Overall Study||47
8643651|NCT00601640|9684231|FG001|COMPLETED|Overall Study||47
8643652|NCT00601640|9684232|FG002|COMPLETED|Overall Study||42
8643653|NCT00601640|9684230|FG000|NOT COMPLETED|Overall Study||5
8643654|NCT00601640|9684231|FG001|NOT COMPLETED|Overall Study||5
8643655|NCT00601640|9684232|FG002|NOT COMPLETED|Overall Study||10
8643656|NCT00601705|9684242|FG000|STARTED|Overall Study||61
8643657|NCT00601705|9684242|FG000|COMPLETED|Overall Study||60
8643658|NCT00601705|9684242|FG000|NOT COMPLETED|Overall Study||1
8643659|NCT00601718|9684247|FG000|STARTED|Overall Study||29
8643660|NCT00601718|9684247|FG000|COMPLETED|Overall Study||29
8643661|NCT00601718|9684247|FG000|NOT COMPLETED|Overall Study||0
8643662|NCT00601731|9684263|FG000|STARTED|Overall Study||143
8727263|NCT01042496|9774647|FG000|STARTED|Overall Study||29
8643663|NCT00601731|9684264|FG001|STARTED|Overall Study||43
8643664|NCT00601731|9684265|FG002|STARTED|Overall Study||166
8643665|NCT00601731|9684266|FG003|STARTED|Overall Study||30
8643666|NCT00601731|9684263|FG000|COMPLETED|Overall Study||120
8643667|NCT00601731|9684264|FG001|COMPLETED|Overall Study||43
8643668|NCT00601731|9684265|FG002|COMPLETED|Overall Study||151
8643669|NCT00601731|9684266|FG003|COMPLETED|Overall Study||29
8643670|NCT00601731|9684263|FG000|NOT COMPLETED|Overall Study||23
8643671|NCT00601731|9684264|FG001|NOT COMPLETED|Overall Study||0
8643672|NCT00601731|9684265|FG002|NOT COMPLETED|Overall Study||15
8643673|NCT00601731|9684266|FG003|NOT COMPLETED|Overall Study||1
8643674|NCT00601796|9684292|FG000|STARTED|Overall Study||24
8643675|NCT00601796|9684292|FG000|COMPLETED|Overall Study||24
8643676|NCT00601796|9684292|FG000|NOT COMPLETED|Overall Study||0
8643677|NCT00601835|9684298|FG000|STARTED|Overall Study||2950
8643678|NCT00601835|9684299|FG001|STARTED|Overall Study||700
8643679|NCT00601835|9684298|FG000|COMPLETED|Overall Study||2890
8643680|NCT00601835|9684299|FG001|COMPLETED|Overall Study||686
8643681|NCT00601835|9684298|FG000|NOT COMPLETED|Overall Study||60
8643682|NCT00601835|9684299|FG001|NOT COMPLETED|Overall Study||14
8643683|NCT00601926|9684305|FG000|STARTED|Overall Study||5
8643684|NCT00601926|9684305|FG000|COMPLETED|Overall Study||5
8643685|NCT00601926|9684305|FG000|NOT COMPLETED|Overall Study||0
8643686|NCT00601952|9684311|FG000|STARTED|Overall Study||14
8643687|NCT00601952|9684312|FG001|STARTED|Overall Study||17
8643688|NCT00601952|9684311|FG000|COMPLETED|Overall Study||12
8643689|NCT00601952|9684312|FG001|COMPLETED|Overall Study||17
8643690|NCT00601952|9684311|FG000|NOT COMPLETED|Overall Study||2
8643691|NCT00601952|9684312|FG001|NOT COMPLETED|Overall Study||0
8643692|NCT00601965|9684322|FG000|STARTED|Overall Study||18
8643693|NCT00601965|9684323|FG001|STARTED|Overall Study||18
8643694|NCT00601965|9684324|FG002|STARTED|Overall Study||19
8643695|NCT00601965|9684325|FG003|STARTED|Overall Study||18
8643696|NCT00601965|9684322|FG000|COMPLETED|Overall Study||18
8643697|NCT00601965|9684323|FG001|COMPLETED|Overall Study||16
8643698|NCT00601965|9684324|FG002|COMPLETED|Overall Study||19
8643699|NCT00601965|9684325|FG003|COMPLETED|Overall Study||17
8643700|NCT00601965|9684322|FG000|NOT COMPLETED|Overall Study||0
8643701|NCT00601965|9684323|FG001|NOT COMPLETED|Overall Study||2
8643702|NCT00601965|9684324|FG002|NOT COMPLETED|Overall Study||0
8643703|NCT00601965|9684325|FG003|NOT COMPLETED|Overall Study||1
8643704|NCT00602043|9684335|FG000|STARTED|Overall Study||20
8643705|NCT00602043|9684335|FG000|COMPLETED|Overall Study||15
8643706|NCT00602043|9684335|FG000|NOT COMPLETED|Overall Study||5
8643707|NCT00602225|9684342|FG000|STARTED|Overall Study||50
8643708|NCT00602225|9684342|FG000|COMPLETED|Overall Study||50
8643709|NCT00602225|9684342|FG000|NOT COMPLETED|Overall Study||0
8643710|NCT00602290|9684350|FG000|STARTED|Overall Study||48
8643711|NCT00602290|9684351|FG001|STARTED|Overall Study||48
8643712|NCT00602290|9684352|FG002|STARTED|Overall Study||47
8643713|NCT00602290|9684350|FG000|COMPLETED|Overall Study||46
8643714|NCT00602290|9684351|FG001|COMPLETED|Overall Study||46
8643715|NCT00602290|9684352|FG002|COMPLETED|Overall Study||46
8643716|NCT00602290|9684350|FG000|NOT COMPLETED|Overall Study||2
8643717|NCT00602290|9684351|FG001|NOT COMPLETED|Overall Study||2
8643718|NCT00602290|9684352|FG002|NOT COMPLETED|Overall Study||1
8643719|NCT00602355|9684363|FG000|STARTED|Overall Study||53
8643720|NCT00602355|9684364|FG001|STARTED|Overall Study||56
8643721|NCT00602355|9684365|FG002|STARTED|Overall Study||53
8643722|NCT00602355|9684363|FG000|COMPLETED|Overall Study||44
8643723|NCT00602355|9684364|FG001|COMPLETED|Overall Study||38
8643724|NCT00602355|9684365|FG002|COMPLETED|Overall Study||43
8643725|NCT00602355|9684363|FG000|NOT COMPLETED|Overall Study||9
8643726|NCT00602355|9684364|FG001|NOT COMPLETED|Overall Study||18
8643727|NCT00602355|9684365|FG002|NOT COMPLETED|Overall Study||10
8643728|NCT00602420|9684375|FG000|STARTED|Overall Study||257
8643729|NCT00602420|9684376|FG001|STARTED|Overall Study||253
8643730|NCT00602420|9684375|FG000|COMPLETED|Overall Study||232
8643731|NCT00602420|9684376|FG001|COMPLETED|Overall Study||229
8643732|NCT00602420|9684375|FG000|NOT COMPLETED|Overall Study||25
8643733|NCT00602420|9684376|FG001|NOT COMPLETED|Overall Study||24
8643734|NCT00602446|9684382|FG000|STARTED|Overall Study||3
8643735|NCT00602446|9684382|FG000|COMPLETED|Overall Study||3
8643736|NCT00602446|9684382|FG000|NOT COMPLETED|Overall Study||0
8643737|NCT00602472|9684388|FG000|STARTED|Overall Study|3 randomised patients never took medication.|263
8643738|NCT00602472|9684389|FG001|STARTED|Overall Study|3 randomised patients never took medication.|792
8643739|NCT00602472|9684388|FG000|COMPLETED|Overall Study|number who completed treatment|242
8643740|NCT00602472|9684389|FG001|COMPLETED|Overall Study|number who completed treatment|734
8643741|NCT00602472|9684388|FG000|NOT COMPLETED|Overall Study||21
8643742|NCT00602472|9684389|FG001|NOT COMPLETED|Overall Study||58
8643743|NCT00602537|9684397|FG000|STARTED|12 Week Double Blind Comparison||65
8643744|NCT00602537|9684398|FG001|STARTED|12 Week Double Blind Comparison||64
8643745|NCT00602537|9684397|FG000|Responded|12 Week Double Blind Comparison||44
8643746|NCT00602537|9684398|FG001|Responded|12 Week Double Blind Comparison||22
8643747|NCT00602537|9684397|FG000|COMPLETED|12 Week Double Blind Comparison||42
8643748|NCT00602537|9684398|FG001|COMPLETED|12 Week Double Blind Comparison||17
8643749|NCT00602537|9684397|FG000|NOT COMPLETED|12 Week Double Blind Comparison||23
8643750|NCT00602537|9684398|FG001|NOT COMPLETED|12 Week Double Blind Comparison||47
8643751|NCT00602537|9684397|FG000|STARTED|Follow Up Study Comparison||42
8643752|NCT00602537|9684398|FG001|STARTED|Follow Up Study Comparison||17
8643753|NCT00602537|9684397|FG000|COMPLETED|Follow Up Study Comparison||31
8643754|NCT00602537|9684398|FG001|COMPLETED|Follow Up Study Comparison||14
8643755|NCT00602537|9684397|FG000|NOT COMPLETED|Follow Up Study Comparison||11
8643756|NCT00602537|9684398|FG001|NOT COMPLETED|Follow Up Study Comparison||3
8643757|NCT00602771|9684406|FG000|STARTED|Overall Study||63
8643758|NCT00602771|9684407|FG001|STARTED|Overall Study||21
8643759|NCT00602771|9684406|FG000|COMPLETED|Overall Study||62
8643760|NCT00602771|9684407|FG001|COMPLETED|Overall Study||21
8643761|NCT00602771|9684406|FG000|NOT COMPLETED|Overall Study||1
8643762|NCT00602771|9684407|FG001|NOT COMPLETED|Overall Study||0
8643763|NCT00602797|9684413|FG000|STARTED|Overall Study||20
8643764|NCT00602797|9684413|FG000|COMPLETED|Overall Study||19
8643765|NCT00602797|9684413|FG000|NOT COMPLETED|Overall Study||1
8643766|NCT00602836|9684418|FG000|STARTED|Overall Study||44
8643767|NCT00602836|9684418|FG000|COMPLETED|Overall Study||39
8643768|NCT00602836|9684418|FG000|NOT COMPLETED|Overall Study||5
8643769|NCT00602927|9684424|FG000|STARTED|Period 1: 13 Days||19
8643770|NCT00602927|9684425|FG001|STARTED|Period 1: 13 Days||19
8643771|NCT00602927|9684424|FG000|COMPLETED|Period 1: 13 Days||15
8643772|NCT00602927|9684425|FG001|COMPLETED|Period 1: 13 Days||14
8643773|NCT00602927|9684424|FG000|NOT COMPLETED|Period 1: 13 Days||4
8643774|NCT00602927|9684425|FG001|NOT COMPLETED|Period 1: 13 Days||5
8643775|NCT00602927|9684424|FG000|STARTED|Period 2: 14 Days||15
8643776|NCT00602927|9684425|FG001|STARTED|Period 2: 14 Days||14
8643777|NCT00602927|9684424|FG000|COMPLETED|Period 2: 14 Days||15
8643778|NCT00602927|9684425|FG001|COMPLETED|Period 2: 14 Days||12
8643779|NCT00602927|9684424|FG000|NOT COMPLETED|Period 2: 14 Days||0
8643780|NCT00602927|9684425|FG001|NOT COMPLETED|Period 2: 14 Days||2
8643781|NCT00602927|9684424|FG000|STARTED|Period 3: 13 Days||15
8643782|NCT00602927|9684425|FG001|STARTED|Period 3: 13 Days||12
8643783|NCT00602927|9684424|FG000|COMPLETED|Period 3: 13 Days||13
8643784|NCT00602927|9684425|FG001|COMPLETED|Period 3: 13 Days||9
8643785|NCT00602927|9684424|FG000|NOT COMPLETED|Period 3: 13 Days||2
8643786|NCT00602927|9684425|FG001|NOT COMPLETED|Period 3: 13 Days||3
8643787|NCT00602953|9684436|FG000|STARTED|Overall Study||15
8643788|NCT00602953|9684437|FG001|STARTED|Overall Study||26
8643789|NCT00602953|9684438|FG002|STARTED|Overall Study||47
8643790|NCT00602953|9684439|FG003|STARTED|Overall Study||13
8643791|NCT00602953|9684440|FG004|STARTED|Overall Study||0
8643792|NCT00602953|9684436|FG000|COMPLETED|Overall Study||15
8643793|NCT00602953|9684437|FG001|COMPLETED|Overall Study||26
8643794|NCT00602953|9684438|FG002|COMPLETED|Overall Study||47
8643795|NCT00602953|9684439|FG003|COMPLETED|Overall Study||13
8643796|NCT00602953|9684440|FG004|COMPLETED|Overall Study||0
8643797|NCT00602953|9684436|FG000|NOT COMPLETED|Overall Study||0
8643798|NCT00602953|9684437|FG001|NOT COMPLETED|Overall Study||0
8643799|NCT00602953|9684438|FG002|NOT COMPLETED|Overall Study||0
8643800|NCT00602953|9684439|FG003|NOT COMPLETED|Overall Study||0
8643801|NCT00602953|9684440|FG004|NOT COMPLETED|Overall Study||0
8643802|NCT00602979|9684457|FG000|STARTED|Overall Study||48
8643803|NCT00602979|9684458|FG001|STARTED|Overall Study||48
8643804|NCT00602979|9684459|FG002|STARTED|Overall Study||48
8643805|NCT00602979|9684460|FG003|STARTED|Overall Study||48
8643806|NCT00602979|9684461|FG004|STARTED|Overall Study||48
8643807|NCT00602979|9684457|FG000|COMPLETED|Overall Study||45
8643808|NCT00602979|9684458|FG001|COMPLETED|Overall Study||45
8643809|NCT00602979|9684459|FG002|COMPLETED|Overall Study||45
8643810|NCT00602979|9684460|FG003|COMPLETED|Overall Study||45
8643811|NCT00602979|9684461|FG004|COMPLETED|Overall Study||45
8643812|NCT00602979|9684457|FG000|NOT COMPLETED|Overall Study||3
8643813|NCT00602979|9684458|FG001|NOT COMPLETED|Overall Study||3
8643814|NCT00602979|9684459|FG002|NOT COMPLETED|Overall Study||3
8643815|NCT00602979|9684460|FG003|NOT COMPLETED|Overall Study||3
8643816|NCT00602979|9684461|FG004|NOT COMPLETED|Overall Study||3
8643817|NCT00603018|9684473|FG000|STARTED|Overall Study||23
8643818|NCT00603018|9684473|FG000|COMPLETED|Overall Study||23
8643819|NCT00603018|9684473|FG000|NOT COMPLETED|Overall Study||0
8643820|NCT00603044|9684480|FG000|STARTED|Overall Study||11
8643821|NCT00603044|9684481|FG001|STARTED|Overall Study||13
8643822|NCT00603044|9684480|FG000|COMPLETED|Overall Study||11
8643823|NCT00603044|9684481|FG001|COMPLETED|Overall Study||13
8643824|NCT00603044|9684480|FG000|NOT COMPLETED|Overall Study||0
8643825|NCT00603044|9684481|FG001|NOT COMPLETED|Overall Study||0
8643826|NCT00603187|9684487|FG000|STARTED|Overall Study||4
8643827|NCT00603187|9684487|FG000|COMPLETED|Overall Study||4
8643828|NCT00603187|9684487|FG000|NOT COMPLETED|Overall Study||0
8643829|NCT00603239|9684493|FG000|STARTED|Overall Study||111
8643830|NCT00603239|9684494|FG001|STARTED|Overall Study||54
8643831|NCT00603239|9684493|FG000|COMPLETED|Overall Study||96
8643832|NCT00603239|9684494|FG001|COMPLETED|Overall Study||50
8643833|NCT00603239|9684493|FG000|NOT COMPLETED|Overall Study||15
8643834|NCT00603239|9684494|FG001|NOT COMPLETED|Overall Study||4
8643835|NCT00603265|9684503|FG000|STARTED|Overall Study|1 participant was randomized in error and did not receive study medication|76
8643836|NCT00603265|9684504|FG001|STARTED|Overall Study||78
8643837|NCT00603265|9684505|FG002|STARTED|Overall Study||72
8643838|NCT00603265|9684503|FG000|Received at Least 1 Dose of Study Drug|Overall Study||75
8643839|NCT00603265|9684504|FG001|Received at Least 1 Dose of Study Drug|Overall Study||78
8643840|NCT00603265|9684505|FG002|Received at Least 1 Dose of Study Drug|Overall Study||72
8643841|NCT00603265|9684503|FG000|COMPLETED|Overall Study||69
8643842|NCT00603265|9684504|FG001|COMPLETED|Overall Study||62
8643843|NCT00603265|9684505|FG002|COMPLETED|Overall Study||67
8643844|NCT00603265|9684503|FG000|NOT COMPLETED|Overall Study||7
8643845|NCT00603265|9684504|FG001|NOT COMPLETED|Overall Study||16
8643846|NCT00603265|9684505|FG002|NOT COMPLETED|Overall Study||5
8643847|NCT00603278|9684519|FG000|STARTED|Overall Study||107
8643848|NCT00603278|9684520|FG001|STARTED|Overall Study||105
8643849|NCT00603278|9684521|FG002|STARTED|Overall Study||101
8643850|NCT00603278|9684522|FG003|STARTED|Overall Study||103
8643851|NCT00603278|9684523|FG004|STARTED|Overall Study||99
8643852|NCT00603278|9684524|FG005|STARTED|Overall Study||100
8643853|NCT00603278|9684519|FG000|COMPLETED|Overall Study||66
8643854|NCT00603278|9684520|FG001|COMPLETED|Overall Study||88
8643855|NCT00603278|9684521|FG002|COMPLETED|Overall Study||87
8643856|NCT00603278|9684522|FG003|COMPLETED|Overall Study||92
8643857|NCT00603278|9684523|FG004|COMPLETED|Overall Study||86
8643858|NCT00603278|9684524|FG005|COMPLETED|Overall Study||81
8643859|NCT00603278|9684519|FG000|NOT COMPLETED|Overall Study||41
8643860|NCT00603278|9684520|FG001|NOT COMPLETED|Overall Study||17
8643861|NCT00603278|9684521|FG002|NOT COMPLETED|Overall Study||14
8643862|NCT00603278|9684522|FG003|NOT COMPLETED|Overall Study||11
8643863|NCT00603278|9684523|FG004|NOT COMPLETED|Overall Study||13
8643864|NCT00603278|9684524|FG005|NOT COMPLETED|Overall Study||19
8643865|NCT00603291|9684541|FG000|STARTED|Overall Study||95
8643866|NCT00603291|9684542|FG001|STARTED|Overall Study||256
8643867|NCT00603291|9684543|FG002|STARTED|Overall Study||253
8643868|NCT00603291|9684541|FG000|COMPLETED|Overall Study||75
8643869|NCT00603291|9684542|FG001|COMPLETED|Overall Study||169
8643870|NCT00603291|9684543|FG002|COMPLETED|Overall Study||157
8643871|NCT00603291|9684541|FG000|NOT COMPLETED|Overall Study||20
8643872|NCT00603291|9684542|FG001|NOT COMPLETED|Overall Study||87
8643873|NCT00603291|9684543|FG002|NOT COMPLETED|Overall Study||96
8643874|NCT00603304|9684553|FG000|STARTED|Overall Study||183
8643875|NCT00603304|9684554|FG001|STARTED|Overall Study||186
8643876|NCT00603304|9684553|FG000|COMPLETED|Overall Study||151
8643877|NCT00603304|9684554|FG001|COMPLETED|Overall Study||155
8643878|NCT00603304|9684553|FG000|NOT COMPLETED|Overall Study||32
8643879|NCT00603304|9684554|FG001|NOT COMPLETED|Overall Study||31
8643880|NCT00603382|9684568|FG000|STARTED|Overall Study||94
8643881|NCT00603382|9684569|FG001|STARTED|Overall Study||97
8643882|NCT00603382|9684570|FG002|STARTED|Overall Study||100
8643883|NCT00603382|9684571|FG003|STARTED|Overall Study||110
8643884|NCT00603382|9684572|FG004|STARTED|Overall Study||95
8643885|NCT00603382|9684573|FG005|STARTED|Overall Study||102
8643886|NCT00603382|9684568|FG000|COMPLETED|Overall Study||76
8643887|NCT00603382|9684569|FG001|COMPLETED|Overall Study||83
8643888|NCT00603382|9684570|FG002|COMPLETED|Overall Study||91
8643889|NCT00603382|9684571|FG003|COMPLETED|Overall Study||98
8643890|NCT00603382|9684572|FG004|COMPLETED|Overall Study||86
8643891|NCT00603382|9684573|FG005|COMPLETED|Overall Study||84
8643892|NCT00603382|9684568|FG000|NOT COMPLETED|Overall Study||18
8643893|NCT00603382|9684569|FG001|NOT COMPLETED|Overall Study||14
8643894|NCT00603382|9684570|FG002|NOT COMPLETED|Overall Study||9
8643895|NCT00603382|9684571|FG003|NOT COMPLETED|Overall Study||12
8643896|NCT00603382|9684572|FG004|NOT COMPLETED|Overall Study||9
8643897|NCT00603382|9684573|FG005|NOT COMPLETED|Overall Study||18
8643898|NCT00603408|9684587|FG000|STARTED|Overall Study||5
8643899|NCT00603408|9684587|FG000|COMPLETED|Overall Study||5
8643900|NCT00603408|9684587|FG000|NOT COMPLETED|Overall Study||0
8643901|NCT00603447|9684599|FG000|STARTED|Overall Study||6
8643902|NCT00603447|9684600|FG001|STARTED|Overall Study||6
8643903|NCT00603447|9684601|FG002|STARTED|Overall Study||8
8643904|NCT00603447|9684602|FG003|STARTED|Overall Study||6
8643905|NCT00603447|9684603|FG004|STARTED|Overall Study||6
8643906|NCT00603447|9684604|FG005|STARTED|Overall Study||8
8727264|NCT01042496|9774648|FG001|STARTED|Overall Study||33
8727265|NCT01042496|9774647|FG000|COMPLETED|Overall Study||29
8727266|NCT01042496|9774648|FG001|COMPLETED|Overall Study||33
8727267|NCT01042496|9774647|FG000|NOT COMPLETED|Overall Study||0
8727268|NCT01042496|9774648|FG001|NOT COMPLETED|Overall Study||0
8727269|NCT01042509|9774658|FG000|STARTED|Overall Study||15
8727270|NCT01042509|9774658|FG000|COMPLETED|Overall Study||15
8727271|NCT01042509|9774658|FG000|NOT COMPLETED|Overall Study||0
8727272|NCT01042535|9774662|FG000|STARTED|Overall Study||44
8727273|NCT01042535|9774662|FG000|COMPLETED|Overall Study||36
8727274|NCT01042535|9774662|FG000|NOT COMPLETED|Overall Study||8
8727275|NCT01042600|9774668|FG000|STARTED|Overall Study||31
8727276|NCT01042600|9774669|FG001|STARTED|Overall Study||30
8727277|NCT01042600|9774668|FG000|COMPLETED|Overall Study||30
8727278|NCT01042600|9774669|FG001|COMPLETED|Overall Study||30
8727279|NCT01042600|9774668|FG000|NOT COMPLETED|Overall Study||1
8727280|NCT01042600|9774669|FG001|NOT COMPLETED|Overall Study||0
8727281|NCT01042613|9774678|FG000|STARTED|Overall Study||72
8727282|NCT01042613|9774679|FG001|STARTED|Overall Study||74
8727283|NCT01042613|9774678|FG000|COMPLETED|Overall Study||72
8727284|NCT01042613|9774679|FG001|COMPLETED|Overall Study||74
8727285|NCT01042613|9774678|FG000|NOT COMPLETED|Overall Study||0
8727286|NCT01042613|9774679|FG001|NOT COMPLETED|Overall Study||0
8727287|NCT01042678|9774688|FG000|STARTED|Overall Study||6
8727288|NCT01042678|9774689|FG001|STARTED|Overall Study||6
8727289|NCT01042678|9774690|FG002|STARTED|Overall Study||6
8727290|NCT01042678|9774691|FG003|STARTED|Overall Study||0
8727291|NCT01042678|9774692|FG004|STARTED|Overall Study||0
8727292|NCT01042678|9774693|FG005|STARTED|Overall Study||0
8727293|NCT01042678|9774688|FG000|COMPLETED|Overall Study||5
8727294|NCT01042678|9774689|FG001|COMPLETED|Overall Study||6
8643907|NCT00603447|9684605|FG006|STARTED|Overall Study||44
8643908|NCT00603447|9684599|FG000|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|6
8727295|NCT01042678|9774690|FG002|COMPLETED|Overall Study||6
8727296|NCT01042678|9774691|FG003|COMPLETED|Overall Study||0
8727297|NCT01042678|9774692|FG004|COMPLETED|Overall Study||0
8643909|NCT00603447|9684600|FG001|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|3
8643910|NCT00603447|9684601|FG002|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|6
8643911|NCT00603447|9684602|FG003|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|4
8643912|NCT00603447|9684603|FG004|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|1
8643913|NCT00603447|9684604|FG005|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|6
8643914|NCT00603447|9684605|FG006|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|20
8643915|NCT00603447|9684599|FG000|NOT COMPLETED|Overall Study||0
8643916|NCT00603447|9684600|FG001|NOT COMPLETED|Overall Study||3
8643917|NCT00603447|9684601|FG002|NOT COMPLETED|Overall Study||2
8643918|NCT00603447|9684602|FG003|NOT COMPLETED|Overall Study||2
8643919|NCT00603447|9684603|FG004|NOT COMPLETED|Overall Study||5
8643920|NCT00603447|9684604|FG005|NOT COMPLETED|Overall Study||2
8643921|NCT00603447|9684605|FG006|NOT COMPLETED|Overall Study||24
8643922|NCT00603473|9684621|FG000|STARTED|Overall Study||89
8643923|NCT00603473|9684621|FG000|COMPLETED|Overall Study||80
8643924|NCT00603473|9684621|FG000|NOT COMPLETED|Overall Study||9
8643925|NCT00603512|9684630|FG000|STARTED|Overall Study||28
8643926|NCT00603512|9684631|FG001|STARTED|Overall Study||28
8643927|NCT00603512|9684632|FG002|STARTED|Overall Study||28
8643928|NCT00603512|9684633|FG003|STARTED|Overall Study||28
8643929|NCT00603512|9684634|FG004|STARTED|Overall Study||28
8643930|NCT00603512|9684630|FG000|Treated|Overall Study||28
8643931|NCT00603512|9684631|FG001|Treated|Overall Study||27
8643932|NCT00603512|9684632|FG002|Treated|Overall Study||27
8643933|NCT00603512|9684633|FG003|Treated|Overall Study||26
8643934|NCT00603512|9684634|FG004|Treated|Overall Study||28
8643935|NCT00603512|9684630|FG000|COMPLETED|Overall Study||26
8643936|NCT00603512|9684631|FG001|COMPLETED|Overall Study||23
8643937|NCT00603512|9684632|FG002|COMPLETED|Overall Study||23
8643938|NCT00603512|9684633|FG003|COMPLETED|Overall Study||21
8643939|NCT00603512|9684634|FG004|COMPLETED|Overall Study||23
8643940|NCT00603512|9684630|FG000|NOT COMPLETED|Overall Study||2
8643941|NCT00603512|9684631|FG001|NOT COMPLETED|Overall Study||5
8643942|NCT00603512|9684632|FG002|NOT COMPLETED|Overall Study||5
8643943|NCT00603512|9684633|FG003|NOT COMPLETED|Overall Study||7
8643944|NCT00603512|9684634|FG004|NOT COMPLETED|Overall Study||5
8643945|NCT00603525|9684648|FG000|STARTED|DB Treatment Period (24 Weeks)||84
8643946|NCT00603525|9684649|FG001|STARTED|DB Treatment Period (24 Weeks)||85
8643947|NCT00603525|9684650|FG002|STARTED|DB Treatment Period (24 Weeks)||0
8643948|NCT00603525|9684648|FG000|COMPLETED|DB Treatment Period (24 Weeks)||67
8643949|NCT00603525|9684649|FG001|COMPLETED|DB Treatment Period (24 Weeks)||63
8643950|NCT00603525|9684650|FG002|COMPLETED|DB Treatment Period (24 Weeks)||0
8643951|NCT00603525|9684648|FG000|NOT COMPLETED|DB Treatment Period (24 Weeks)||17
8643952|NCT00603525|9684649|FG001|NOT COMPLETED|DB Treatment Period (24 Weeks)||22
8643953|NCT00603525|9684650|FG002|NOT COMPLETED|DB Treatment Period (24 Weeks)||0
8643954|NCT00603525|9684648|FG000|STARTED|OL Treatment Period (120 Weeks)||0
8643955|NCT00603525|9684649|FG001|STARTED|OL Treatment Period (120 Weeks)|61 participants received OFA during the DB Period; 64 received placebo during the DB Period.|125
8643956|NCT00603525|9684650|FG002|STARTED|OL Treatment Period (120 Weeks)||0
8643957|NCT00603525|9684648|FG000|COMPLETED|OL Treatment Period (120 Weeks)||0
8643958|NCT00603525|9684649|FG001|COMPLETED|OL Treatment Period (120 Weeks)||13
8643959|NCT00603525|9684650|FG002|COMPLETED|OL Treatment Period (120 Weeks)||0
8643960|NCT00603525|9684648|FG000|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
8643961|NCT00603525|9684649|FG001|NOT COMPLETED|OL Treatment Period (120 Weeks)||112
8643962|NCT00603525|9684650|FG002|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
8643963|NCT00603525|9684648|FG000|STARTED|Follow-up Period (Approximately 2 Years)||0
8643964|NCT00603525|9684649|FG001|STARTED|Follow-up Period (Approximately 2 Years)||0
8643965|NCT00603525|9684650|FG002|STARTED|Follow-up Period (Approximately 2 Years)|124 participants (par) completing/withdrawing from the DB or OL Periods attended >=1 follow-up visit|124
8643966|NCT00603525|9684648|FG000|Unknown Reason for Withdrawal|Follow-up Period (Approximately 2 Years)||0
8643967|NCT00603525|9684649|FG001|Unknown Reason for Withdrawal|Follow-up Period (Approximately 2 Years)||0
8643968|NCT00603525|9684650|FG002|Unknown Reason for Withdrawal|Follow-up Period (Approximately 2 Years)|As par. were not on active drug during the Follow-up Period, withdrawal reasons were not collected.|111
8643969|NCT00603525|9684648|FG000|COMPLETED|Follow-up Period (Approximately 2 Years)||0
8643970|NCT00603525|9684649|FG001|COMPLETED|Follow-up Period (Approximately 2 Years)||0
8643971|NCT00603525|9684650|FG002|COMPLETED|Follow-up Period (Approximately 2 Years)||13
8643972|NCT00603525|9684648|FG000|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
8643973|NCT00603525|9684649|FG001|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
8643974|NCT00603525|9684650|FG002|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||111
8643975|NCT00603538|9684664|FG000|STARTED|Overall Study||6
8643976|NCT00603538|9684665|FG001|STARTED|Overall Study|Including one participant who discontinued from the study prior to CP-751,871 administration.|7
8643977|NCT00603538|9684666|FG002|STARTED|Overall Study||6
8643978|NCT00603538|9684664|FG000|COMPLETED|Overall Study||3
8727298|NCT01042678|9774693|FG005|COMPLETED|Overall Study||0
8643979|NCT00603538|9684665|FG001|COMPLETED|Overall Study||3
8643980|NCT00603538|9684666|FG002|COMPLETED|Overall Study||4
8643981|NCT00603538|9684664|FG000|NOT COMPLETED|Overall Study||3
8643982|NCT00603538|9684665|FG001|NOT COMPLETED|Overall Study||4
8643983|NCT00603538|9684666|FG002|NOT COMPLETED|Overall Study||2
8643984|NCT00603564|9684679|FG000|STARTED|Overall Study|January 2006|20
8643985|NCT00603564|9684680|FG001|STARTED|Overall Study|January 2006|27
8643986|NCT00603564|9684679|FG000|COMPLETED|Overall Study|February 2008|20
8643987|NCT00603564|9684680|FG001|COMPLETED|Overall Study|February 2008|27
8643988|NCT00603564|9684679|FG000|NOT COMPLETED|Overall Study||0
8643989|NCT00603564|9684680|FG001|NOT COMPLETED|Overall Study||0
8643990|NCT00603590|9684688|FG000|STARTED|Overall Study||241
8643991|NCT00603590|9684689|FG001|STARTED|Overall Study||234
8643992|NCT00603590|9684688|FG000|One Month|Overall Study||204
8643993|NCT00603590|9684689|FG001|One Month|Overall Study||212
8643994|NCT00603590|9684688|FG000|Four Months|Overall Study||187
8643995|NCT00603590|9684689|FG001|Four Months|Overall Study||200
8643996|NCT00603590|9684688|FG000|Eight Months|Overall Study||178
8643997|NCT00603590|9684689|FG001|Eight Months|Overall Study||194
8643998|NCT00603590|9684688|FG000|COMPLETED|Overall Study||165
8643999|NCT00603590|9684689|FG001|COMPLETED|Overall Study||183
8644000|NCT00603590|9684688|FG000|NOT COMPLETED|Overall Study||76
8644001|NCT00603590|9684689|FG001|NOT COMPLETED|Overall Study||51
8644002|NCT00603642|9684697|FG000|STARTED|Overall Study||12
8644003|NCT00603642|9684698|FG001|STARTED|Overall Study||22
8644004|NCT00603642|9684697|FG000|COMPLETED|Overall Study||12
8644005|NCT00603642|9684698|FG001|COMPLETED|Overall Study||22
8644006|NCT00603642|9684697|FG000|NOT COMPLETED|Overall Study||0
8644007|NCT00603642|9684698|FG001|NOT COMPLETED|Overall Study||0
8644008|NCT00603720|9684709|FG000|STARTED|Overall Study||10
8644009|NCT00603720|9684710|FG001|STARTED|Overall Study||10
8644010|NCT00603720|9684711|FG002|STARTED|Overall Study||12
8644011|NCT00603720|9684712|FG003|STARTED|Overall Study||10
8644012|NCT00603720|9684713|FG004|STARTED|Overall Study||12
8644013|NCT00603720|9684709|FG000|COMPLETED|Overall Study||10
8644014|NCT00603720|9684710|FG001|COMPLETED|Overall Study||10
8644015|NCT00603720|9684711|FG002|COMPLETED|Overall Study||12
8644016|NCT00603720|9684712|FG003|COMPLETED|Overall Study||10
8644017|NCT00603720|9684713|FG004|COMPLETED|Overall Study||12
8644018|NCT00603720|9684709|FG000|NOT COMPLETED|Overall Study||0
8644019|NCT00603720|9684710|FG001|NOT COMPLETED|Overall Study||0
8644020|NCT00603720|9684711|FG002|NOT COMPLETED|Overall Study||0
8644021|NCT00603720|9684712|FG003|NOT COMPLETED|Overall Study||0
8644022|NCT00603720|9684713|FG004|NOT COMPLETED|Overall Study||0
8644023|NCT00603733|9684727|FG000|STARTED|Active Phase ITT|Note: a total of 190 new participants were enrolled and randomized in the Active Phase|95
8644024|NCT00603733|9684728|FG001|STARTED|Active Phase ITT||95
8644025|NCT00603733|9684727|FG000|COMPLETED|Active Phase ITT||84
8644026|NCT00603733|9684728|FG001|COMPLETED|Active Phase ITT||78
8644027|NCT00603733|9684727|FG000|NOT COMPLETED|Active Phase ITT||11
8644028|NCT00603733|9684728|FG001|NOT COMPLETED|Active Phase ITT||17
8644029|NCT00603733|9684727|FG000|STARTED|Run-In Phase - 4 Weeks|Note: Of the 98 subjects randomized at Run-In, 71 progressed into the maintenance phase.|49
8644030|NCT00603733|9684728|FG001|STARTED|Run-In Phase - 4 Weeks||49
8644031|NCT00603733|9684727|FG000|COMPLETED|Run-In Phase - 4 Weeks||35
8644032|NCT00603733|9684728|FG001|COMPLETED|Run-In Phase - 4 Weeks||36
8644033|NCT00603733|9684727|FG000|NOT COMPLETED|Run-In Phase - 4 Weeks||14
9022116|NCT03124108|10084985|FG002|NOT COMPLETED|Overall Study||0
9022117|NCT03124121|10084997|FG000|STARTED|Overall Study||42
9022118|NCT03124121|10084998|FG001|STARTED|Overall Study||70
9022119|NCT03124121|10084997|FG000|COMPLETED|Overall Study||39
9022120|NCT03124121|10084998|FG001|COMPLETED|Overall Study||67
9022121|NCT03124121|10084997|FG000|NOT COMPLETED|Overall Study||3
8644034|NCT00603733|9684728|FG001|NOT COMPLETED|Run-In Phase - 4 Weeks||13
8644035|NCT00603733|9684727|FG000|STARTED|Maintenance Phase ITT|Note:82 subjects randomized at Active phase & 71 at Run-In phase progressed to the maintenance phase|71
8644036|NCT00603733|9684728|FG001|STARTED|Maintenance Phase ITT||82
8644037|NCT00603733|9684727|FG000|COMPLETED|Maintenance Phase ITT||61
8644038|NCT00603733|9684728|FG001|COMPLETED|Maintenance Phase ITT||66
8644039|NCT00603733|9684727|FG000|NOT COMPLETED|Maintenance Phase ITT||10
8644040|NCT00603733|9684728|FG001|NOT COMPLETED|Maintenance Phase ITT||16
8644041|NCT00603746|9684740|FG000|STARTED|Overall Study||103
8644042|NCT00603746|9684741|FG001|STARTED|Overall Study||99
8644043|NCT00603746|9684742|FG002|STARTED|Overall Study||101
8644044|NCT00603746|9684743|FG003|STARTED|Overall Study||107
8644045|NCT00603746|9684744|FG004|STARTED|Overall Study||102
8644046|NCT00603746|9684745|FG005|STARTED|Overall Study||110
8644047|NCT00603746|9684740|FG000|COMPLETED|Overall Study||65
8644048|NCT00603746|9684741|FG001|COMPLETED|Overall Study||81
8644049|NCT00603746|9684742|FG002|COMPLETED|Overall Study||93
8644050|NCT00603746|9684743|FG003|COMPLETED|Overall Study||94
8644051|NCT00603746|9684744|FG004|COMPLETED|Overall Study||85
8644052|NCT00603746|9684745|FG005|COMPLETED|Overall Study||97
8644053|NCT00603746|9684740|FG000|NOT COMPLETED|Overall Study||38
8644054|NCT00603746|9684741|FG001|NOT COMPLETED|Overall Study||18
9022122|NCT03124121|10084998|FG001|NOT COMPLETED|Overall Study||3
8644055|NCT00603746|9684742|FG002|NOT COMPLETED|Overall Study||8
8644056|NCT00603746|9684743|FG003|NOT COMPLETED|Overall Study||13
9022123|NCT03124199|10085006|FG000|STARTED|Overall Study||40
8644057|NCT00603746|9684744|FG004|NOT COMPLETED|Overall Study||17
8644058|NCT00603746|9684745|FG005|NOT COMPLETED|Overall Study||13
8727299|NCT01042678|9774688|FG000|NOT COMPLETED|Overall Study||1
8727300|NCT01042678|9774689|FG001|NOT COMPLETED|Overall Study||0
8727301|NCT01042678|9774690|FG002|NOT COMPLETED|Overall Study||0
8727302|NCT01042678|9774691|FG003|NOT COMPLETED|Overall Study||0
8727303|NCT01042678|9774692|FG004|NOT COMPLETED|Overall Study||0
8727304|NCT01042678|9774693|FG005|NOT COMPLETED|Overall Study||0
8727305|NCT01042795|9774701|FG000|STARTED|Dosing Period - 16 Weeks of Daily Doses||7
8727306|NCT01042795|9774701|FG000|COMPLETED|Dosing Period - 16 Weeks of Daily Doses||2
8727307|NCT01042795|9774701|FG000|NOT COMPLETED|Dosing Period - 16 Weeks of Daily Doses||5
8727308|NCT01042795|9774701|FG000|STARTED|Follow up - 22 Months After Drug Start||2
8727309|NCT01042795|9774701|FG000|COMPLETED|Follow up - 22 Months After Drug Start||0
8727310|NCT01042795|9774701|FG000|NOT COMPLETED|Follow up - 22 Months After Drug Start||2
8727311|NCT01042938|9774707|FG000|STARTED|Overall Study|1 withdrew before radiation; 1 ineligible due to other clinical trial; 1 non-compliance.|17
8727312|NCT01042938|9774708|FG001|STARTED|Overall Study|1 withdrew before radiation; 1 non-compliance.|18
8727313|NCT01042938|9774707|FG000|COMPLETED|Overall Study||14
8727314|NCT01042938|9774708|FG001|COMPLETED|Overall Study||16
8727315|NCT01042938|9774707|FG000|NOT COMPLETED|Overall Study||3
8727316|NCT01042938|9774708|FG001|NOT COMPLETED|Overall Study||2
8727317|NCT01042977|9774718|FG000|STARTED|Overall Study|Of 482 part. 480 were included in full analysis set. Thereof, 1 part. treated but not randomized.|482
8727318|NCT01042977|9774719|FG001|STARTED|Overall Study|Of the 483 participants only 482 were included in the full analysis set.|483
8727319|NCT01042977|9774718|FG000|COMPLETED|Overall Study||441
8727320|NCT01042977|9774719|FG001|COMPLETED|Overall Study||428
8727321|NCT01042977|9774718|FG000|NOT COMPLETED|Overall Study||41
8727322|NCT01042977|9774719|FG001|NOT COMPLETED|Overall Study||55
8727323|NCT01043094|9774727|FG000|STARTED|Overall Study||8
8727324|NCT01043094|9774728|FG001|STARTED|Overall Study||8
8727325|NCT01043094|9774727|FG000|COMPLETED|Overall Study||8
8727326|NCT01043094|9774728|FG001|COMPLETED|Overall Study||8
8727327|NCT01043094|9774727|FG000|NOT COMPLETED|Overall Study||0
8727328|NCT01043094|9774728|FG001|NOT COMPLETED|Overall Study||0
8727329|NCT01043133|9774736|FG000|STARTED|Overall Study||75
8727330|NCT01043133|9774737|FG001|STARTED|Overall Study||80
8727331|NCT01043133|9774736|FG000|COMPLETED|Overall Study||74
8727332|NCT01043133|9774737|FG001|COMPLETED|Overall Study||78
8727333|NCT01043133|9774736|FG000|NOT COMPLETED|Overall Study||1
8727334|NCT01043133|9774737|FG001|NOT COMPLETED|Overall Study||2
8727335|NCT01043146|9774749|FG000|STARTED|Overall Study||10
8727336|NCT01043146|9774750|FG001|STARTED|Overall Study||8
8727337|NCT01043146|9774751|FG002|STARTED|Overall Study||8
8727338|NCT01043146|9774752|FG003|STARTED|Overall Study||8
8727339|NCT01043146|9774753|FG004|STARTED|Overall Study||8
8727340|NCT01043146|9774754|FG005|STARTED|Overall Study||8
8727341|NCT01043146|9774749|FG000|COMPLETED|Overall Study||10
8727342|NCT01043146|9774750|FG001|COMPLETED|Overall Study||8
8727343|NCT01043146|9774751|FG002|COMPLETED|Overall Study||8
8727344|NCT01043146|9774752|FG003|COMPLETED|Overall Study||8
8727345|NCT01043146|9774753|FG004|COMPLETED|Overall Study||8
8727346|NCT01043146|9774754|FG005|COMPLETED|Overall Study||8
8727347|NCT01043146|9774749|FG000|NOT COMPLETED|Overall Study||0
8727348|NCT01043146|9774750|FG001|NOT COMPLETED|Overall Study||0
8727349|NCT01043146|9774751|FG002|NOT COMPLETED|Overall Study||0
8727350|NCT01043146|9774752|FG003|NOT COMPLETED|Overall Study||0
8727351|NCT01043146|9774753|FG004|NOT COMPLETED|Overall Study||0
8727352|NCT01043146|9774754|FG005|NOT COMPLETED|Overall Study||0
8727353|NCT01043185|9774768|FG000|STARTED|Period 1 - First Intervention||3
8727354|NCT01043185|9774769|FG001|STARTED|Period 1 - First Intervention||2
8727355|NCT01043185|9774770|FG002|STARTED|Period 1 - First Intervention||3
8727356|NCT01043185|9774771|FG003|STARTED|Period 1 - First Intervention||2
8727357|NCT01043185|9774772|FG004|STARTED|Period 1 - First Intervention||2
8727358|NCT01043185|9774773|FG005|STARTED|Period 1 - First Intervention||3
8727359|NCT01043185|9774774|FG006|STARTED|Period 1 - First Intervention||3
8727360|NCT01043185|9774775|FG007|STARTED|Period 1 - First Intervention||3
8644059|NCT00603798|9684762|FG000|STARTED|Overall Study||162
8644060|NCT00603798|9684763|FG001|STARTED|Overall Study||164
8644061|NCT00603798|9684764|FG002|STARTED|Overall Study||164
8644062|NCT00603798|9684762|FG000|COMPLETED|Overall Study||152
8644063|NCT00603798|9684763|FG001|COMPLETED|Overall Study||157
8644064|NCT00603798|9684764|FG002|COMPLETED|Overall Study||154
8644065|NCT00603798|9684762|FG000|NOT COMPLETED|Overall Study||10
8644066|NCT00603798|9684763|FG001|NOT COMPLETED|Overall Study||7
8644067|NCT00603798|9684764|FG002|NOT COMPLETED|Overall Study||10
8644068|NCT00603837|9684774|FG000|STARTED|Overall Study||20
8644069|NCT00603837|9684775|FG001|STARTED|Overall Study||19
8644070|NCT00603837|9684774|FG000|COMPLETED|Overall Study||17
8644071|NCT00603837|9684775|FG001|COMPLETED|Overall Study||19
8644072|NCT00603837|9684774|FG000|NOT COMPLETED|Overall Study||3
8644073|NCT00603837|9684775|FG001|NOT COMPLETED|Overall Study||0
8644074|NCT00603889|9684781|FG000|STARTED|Overall Study||12
8644075|NCT00603889|9684781|FG000|COMPLETED|Overall Study||12
8644076|NCT00603889|9684781|FG000|NOT COMPLETED|Overall Study||0
8644077|NCT00603902|9684788|FG000|STARTED|Overall Study||802
8644078|NCT00603902|9684789|FG001|STARTED|Overall Study||1603
8644079|NCT00603902|9684790|FG002|STARTED|Overall Study||1603
8644080|NCT00603902|9684788|FG000|COMPLETED|Overall Study||473
8644081|NCT00603902|9684789|FG001|COMPLETED|Overall Study||917
8644082|NCT00603902|9684790|FG002|COMPLETED|Overall Study||834
8644083|NCT00603902|9684788|FG000|NOT COMPLETED|Overall Study||329
8644084|NCT00603902|9684789|FG001|NOT COMPLETED|Overall Study||686
8644085|NCT00603902|9684790|FG002|NOT COMPLETED|Overall Study||769
8644086|NCT00603915|9684798|FG000|STARTED|Overall Study||20
8644087|NCT00603915|9684798|FG000|COMPLETED|Overall Study||19
9022124|NCT03124199|10085006|FG000|COMPLETED|Overall Study||36
9022125|NCT03124199|10085006|FG000|NOT COMPLETED|Overall Study||4
9022126|NCT03124342|10085012|FG000|STARTED|Overall Study||111
9022127|NCT03124342|10085013|FG001|STARTED|Overall Study||121
9022128|NCT03124342|10085012|FG000|COMPLETED|Overall Study||111
9022129|NCT03124342|10085013|FG001|COMPLETED|Overall Study||121
9022130|NCT03124342|10085012|FG000|NOT COMPLETED|Overall Study||0
9022131|NCT03124342|10085013|FG001|NOT COMPLETED|Overall Study||0
9022132|NCT03124368|10085022|FG000|STARTED|Overall Study||2
9022133|NCT03124368|10085023|FG001|STARTED|Overall Study||4
9022134|NCT03124368|10085022|FG000|Received at Least 1 Dose of Study Drug|Overall Study||2
9022135|NCT03124368|10085023|FG001|Received at Least 1 Dose of Study Drug|Overall Study||4
9022136|NCT03124368|10085022|FG000|COMPLETED|Overall Study||2
9022137|NCT03124368|10085023|FG001|COMPLETED|Overall Study||4
9022138|NCT03124368|10085022|FG000|NOT COMPLETED|Overall Study||0
9022139|NCT03124368|10085023|FG001|NOT COMPLETED|Overall Study||0
8644088|NCT00603915|9684798|FG000|NOT COMPLETED|Overall Study||1
8644089|NCT00603941|9684805|FG000|STARTED|Overall Study||7
8644090|NCT00603941|9684806|FG001|STARTED|Overall Study||10
8644091|NCT00603941|9684807|FG002|STARTED|Overall Study||2
8644092|NCT00603941|9684805|FG000|COMPLETED|Overall Study||0
8644093|NCT00603941|9684806|FG001|COMPLETED|Overall Study||0
8644094|NCT00603941|9684807|FG002|COMPLETED|Overall Study||0
8644095|NCT00603941|9684805|FG000|NOT COMPLETED|Overall Study||7
8644096|NCT00603941|9684806|FG001|NOT COMPLETED|Overall Study||10
8644097|NCT00603941|9684807|FG002|NOT COMPLETED|Overall Study||2
8644098|NCT00603980|9684816|FG000|STARTED|Study Qualification||31
8644099|NCT00603980|9684816|FG000|COMPLETED|Study Qualification||15
8644100|NCT00603980|9684816|FG000|NOT COMPLETED|Study Qualification||16
8644101|NCT00603980|9684816|FG000|STARTED|Main Study||15
8644102|NCT00603980|9684816|FG000|COMPLETED|Main Study||14
8644103|NCT00603980|9684816|FG000|NOT COMPLETED|Main Study||1
8644104|NCT00603993|9684836|FG000|STARTED|Overall Study||88
8644105|NCT00603993|9684836|FG000|COMPLETED|Overall Study||68
8644106|NCT00603993|9684836|FG000|NOT COMPLETED|Overall Study||20
8644107|NCT00604019|9684842|FG000|STARTED|Overall Study||134
8644108|NCT00604019|9684843|FG001|STARTED|Overall Study||118
8644109|NCT00604019|9684842|FG000|COMPLETED|Overall Study||134
8644110|NCT00604019|9684843|FG001|COMPLETED|Overall Study||118
8644111|NCT00604019|9684842|FG000|NOT COMPLETED|Overall Study||0
8644112|NCT00604019|9684843|FG001|NOT COMPLETED|Overall Study||0
8644113|NCT00604045|9684851|FG000|STARTED|Overall Study||15
8644114|NCT00604045|9684852|FG001|STARTED|Overall Study||10
8644115|NCT00604045|9684851|FG000|COMPLETED|Overall Study||14
8644116|NCT00604045|9684852|FG001|COMPLETED|Overall Study||9
8644117|NCT00604045|9684851|FG000|NOT COMPLETED|Overall Study||1
8644118|NCT00604045|9684852|FG001|NOT COMPLETED|Overall Study||1
8644119|NCT00604162|9684858|FG000|STARTED|Overall Study||332
8644120|NCT00604162|9684858|FG000|COMPLETED|Overall Study||328
8644121|NCT00604162|9684858|FG000|NOT COMPLETED|Overall Study||4
8644122|NCT00604175|9684868|FG000|STARTED|Entry Through Week 28||130
8644123|NCT00604175|9684869|FG001|STARTED|Entry Through Week 28||95
8644124|NCT00604175|9684870|FG002|STARTED|Entry Through Week 28||94
8644125|NCT00604175|9684868|FG000|COMPLETED|Entry Through Week 28|Completed 28 weeks of the study (the primary endpoint time point).|120
8644126|NCT00604175|9684869|FG001|COMPLETED|Entry Through Week 28|Completed 28 weeks of the study (the primary endpoint time point).|92
8644127|NCT00604175|9684870|FG002|COMPLETED|Entry Through Week 28|Completed 28 weeks of the study (the primary endpoint time point).|93
8644128|NCT00604175|9684868|FG000|NOT COMPLETED|Entry Through Week 28||10
8644129|NCT00604175|9684869|FG001|NOT COMPLETED|Entry Through Week 28||3
8644130|NCT00604175|9684870|FG002|NOT COMPLETED|Entry Through Week 28||1
8644131|NCT00604175|9684868|FG000|STARTED|Week 29 Through Week 72||120
8644132|NCT00604175|9684869|FG001|STARTED|Week 29 Through Week 72||92
8644133|NCT00604175|9684870|FG002|STARTED|Week 29 Through Week 72||93
8644134|NCT00604175|9684868|FG000|COMPLETED|Week 29 Through Week 72||108
8644135|NCT00604175|9684869|FG001|COMPLETED|Week 29 Through Week 72||85
8644136|NCT00604175|9684870|FG002|COMPLETED|Week 29 Through Week 72||89
8644137|NCT00604175|9684868|FG000|NOT COMPLETED|Week 29 Through Week 72||12
8644138|NCT00604175|9684869|FG001|NOT COMPLETED|Week 29 Through Week 72||7
8644139|NCT00604175|9684870|FG002|NOT COMPLETED|Week 29 Through Week 72||4
8644140|NCT00604188|9684904|FG000|STARTED|Overall Study||93
8644141|NCT00604188|9684905|FG001|STARTED|Overall Study|The ITT population for Subutex-to-Suboxone Induction is 94 participants|95
8644142|NCT00604188|9684904|FG000|COMPLETED|Overall Study||66
9022140|NCT03124381|10085036|FG000|STARTED|Overall Study||65
9022141|NCT03124381|10085037|FG001|STARTED|Overall Study||61
9022142|NCT03124381|10085036|FG000|COMPLETED|Overall Study||56
8644143|NCT00604188|9684905|FG001|COMPLETED|Overall Study||70
8644144|NCT00604188|9684904|FG000|NOT COMPLETED|Overall Study||27
8644145|NCT00604188|9684905|FG001|NOT COMPLETED|Overall Study||25
8644146|NCT00604214|9684913|FG000|STARTED|Baseline to Day 28||851
9022143|NCT03124381|10085037|FG001|COMPLETED|Overall Study||55
9022144|NCT03124381|10085036|FG000|NOT COMPLETED|Overall Study||9
9022145|NCT03124381|10085037|FG001|NOT COMPLETED|Overall Study||6
8644147|NCT00604214|9684914|FG001|STARTED|Baseline to Day 28||845
8644148|NCT00604214|9684913|FG000|Received Study Drug|Baseline to Day 28||833
8644149|NCT00604214|9684914|FG001|Received Study Drug|Baseline to Day 28||833
8644150|NCT00604214|9684913|FG000|COMPLETED|Baseline to Day 28||623
8644151|NCT00604214|9684914|FG001|COMPLETED|Baseline to Day 28||632
8644152|NCT00604214|9684913|FG000|NOT COMPLETED|Baseline to Day 28||228
8644153|NCT00604214|9684914|FG001|NOT COMPLETED|Baseline to Day 28||213
8644154|NCT00604214|9684913|FG000|STARTED|Day 29 to Day 90||623
8644155|NCT00604214|9684914|FG001|STARTED|Day 29 to Day 90||632
8644156|NCT00604214|9684913|FG000|COMPLETED|Day 29 to Day 90||555
8644157|NCT00604214|9684914|FG001|COMPLETED|Day 29 to Day 90||553
8644158|NCT00604214|9684913|FG000|NOT COMPLETED|Day 29 to Day 90||68
8644159|NCT00604214|9684914|FG001|NOT COMPLETED|Day 29 to Day 90||79
8644160|NCT00604214|9684913|FG000|STARTED|Day 91 to Day 180||555
8644161|NCT00604214|9684914|FG001|STARTED|Day 91 to Day 180||553
8644162|NCT00604214|9684913|FG000|COMPLETED|Day 91 to Day 180||529
8644163|NCT00604214|9684914|FG001|COMPLETED|Day 91 to Day 180||521
8644164|NCT00604214|9684913|FG000|NOT COMPLETED|Day 91 to Day 180||26
8644165|NCT00604214|9684914|FG001|NOT COMPLETED|Day 91 to Day 180||32
8644166|NCT00604279|9684922|FG000|STARTED|Overall Study||229
8644167|NCT00604279|9684923|FG001|STARTED|Overall Study||223
8644168|NCT00604279|9684922|FG000|COMPLETED|Overall Study||165
8644169|NCT00604279|9684923|FG001|COMPLETED|Overall Study||185
8644170|NCT00604279|9684922|FG000|NOT COMPLETED|Overall Study||64
8644171|NCT00604279|9684923|FG001|NOT COMPLETED|Overall Study||38
8644172|NCT00604383|9684931|FG000|STARTED|Overall Study||345
8644173|NCT00604383|9684932|FG001|STARTED|Overall Study||340
8644174|NCT00604383|9684931|FG000|Received at Least 1 Dose of Study Drug|Overall Study||345
8644175|NCT00604383|9684932|FG001|Received at Least 1 Dose of Study Drug|Overall Study||340
8644176|NCT00604383|9684931|FG000|Received Extended Treatment|Overall Study||136
8644177|NCT00604383|9684932|FG001|Received Extended Treatment|Overall Study||141
8644178|NCT00604383|9684931|FG000|COMPLETED|Overall Study||258
8644179|NCT00604383|9684932|FG001|COMPLETED|Overall Study||256
8644180|NCT00604383|9684931|FG000|NOT COMPLETED|Overall Study||87
8644181|NCT00604383|9684932|FG001|NOT COMPLETED|Overall Study||84
8644182|NCT00604461|9684938|FG000|STARTED|Overall Study||13
8644183|NCT00604461|9684938|FG000|COMPLETED|Overall Study|Death within 30 days of treatment occurred in 1 patient.|12
8644184|NCT00604461|9684938|FG000|NOT COMPLETED|Overall Study||1
8644185|NCT00604552|9684944|FG000|STARTED|Overall Study||189
8644186|NCT00604552|9684945|FG001|STARTED|Overall Study||160
8644187|NCT00604552|9684944|FG000|COMPLETED|Overall Study||189
8644188|NCT00604552|9684945|FG001|COMPLETED|Overall Study||160
8644189|NCT00604552|9684944|FG000|NOT COMPLETED|Overall Study||0
8644190|NCT00604552|9684945|FG001|NOT COMPLETED|Overall Study||0
8644191|NCT00604565|9684955|FG000|STARTED|Overall Study||4
8644192|NCT00604565|9684956|FG001|STARTED|Overall Study||7
8644193|NCT00604565|9684955|FG000|COMPLETED|Overall Study||4
8644194|NCT00604565|9684956|FG001|COMPLETED|Overall Study||4
8644195|NCT00604565|9684955|FG000|NOT COMPLETED|Overall Study||0
8644196|NCT00604565|9684956|FG001|NOT COMPLETED|Overall Study||3
8644197|NCT00604669|9684962|FG000|STARTED|Overall Study||170
8644198|NCT00604669|9684962|FG000|COMPLETED|Overall Study||163
8644199|NCT00604669|9684962|FG000|NOT COMPLETED|Overall Study||7
8644200|NCT00604695|9684968|FG000|STARTED|Overall Study||20
8644201|NCT00604695|9684969|FG001|STARTED|Overall Study||20
8644202|NCT00604695|9684968|FG000|COMPLETED|Overall Study||20
8644203|NCT00604695|9684969|FG001|COMPLETED|Overall Study||16
8644204|NCT00604695|9684968|FG000|NOT COMPLETED|Overall Study||0
8644205|NCT00604695|9684969|FG001|NOT COMPLETED|Overall Study||4
8644206|NCT00604708|9684977|FG000|STARTED|Overall Study||430
8644207|NCT00604708|9684978|FG001|STARTED|Overall Study||437
8644208|NCT00604708|9684977|FG000|COMPLETED|Overall Study||399
8644209|NCT00604708|9684978|FG001|COMPLETED|Overall Study||397
8644210|NCT00604708|9684977|FG000|NOT COMPLETED|Overall Study||31
8644211|NCT00604708|9684978|FG001|NOT COMPLETED|Overall Study||40
8644212|NCT00604721|9684984|FG000|STARTED|Overall Study||19
8644213|NCT00604721|9684984|FG000|COMPLETED|Overall Study|2 patients failed to complete a full cycle of therapy.|17
8644214|NCT00604721|9684984|FG000|NOT COMPLETED|Overall Study||2
8644215|NCT00604786|9684991|FG000|STARTED|Overall Study||14
8644216|NCT00604786|9684992|FG001|STARTED|Overall Study||4
8644217|NCT00604786|9684991|FG000|COMPLETED|Overall Study||12
8644218|NCT00604786|9684992|FG001|COMPLETED|Overall Study||4
8644219|NCT00604786|9684991|FG000|NOT COMPLETED|Overall Study||2
8644220|NCT00604786|9684992|FG001|NOT COMPLETED|Overall Study||0
8644221|NCT00604825|9685002|FG000|STARTED|Overall Study||90
8644222|NCT00604825|9685003|FG001|STARTED|Overall Study||87
8644223|NCT00604825|9685004|FG002|STARTED|Overall Study||89
8644224|NCT00604825|9685005|FG003|STARTED|Overall Study||90
8644225|NCT00604825|9685002|FG000|COMPLETED|Overall Study||81
8644226|NCT00604825|9685003|FG001|COMPLETED|Overall Study||72
8644227|NCT00604825|9685004|FG002|COMPLETED|Overall Study||73
8644228|NCT00604825|9685005|FG003|COMPLETED|Overall Study||79
8644229|NCT00604825|9685002|FG000|NOT COMPLETED|Overall Study||9
8644230|NCT00604825|9685003|FG001|NOT COMPLETED|Overall Study||15
8644231|NCT00604825|9685004|FG002|NOT COMPLETED|Overall Study||16
8644232|NCT00604825|9685005|FG003|NOT COMPLETED|Overall Study||11
8644233|NCT00604890|9685019|FG000|STARTED|Overall Study||47
8644234|NCT00604890|9685020|FG001|STARTED|Overall Study||45
8644235|NCT00604890|9685021|FG002|STARTED|Overall Study||48
8644236|NCT00604890|9685022|FG003|STARTED|Overall Study||46
8644237|NCT00604890|9685019|FG000|COMPLETED|Overall Study||44
8644238|NCT00604890|9685020|FG001|COMPLETED|Overall Study||45
8644239|NCT00604890|9685021|FG002|COMPLETED|Overall Study||47
8644240|NCT00604890|9685022|FG003|COMPLETED|Overall Study||42
8644241|NCT00604890|9685019|FG000|NOT COMPLETED|Overall Study||3
8644242|NCT00604890|9685020|FG001|NOT COMPLETED|Overall Study||0
8644243|NCT00604890|9685021|FG002|NOT COMPLETED|Overall Study||1
8644244|NCT00604890|9685022|FG003|NOT COMPLETED|Overall Study||4
8691582|NCT00856024|9736896|FG000|STARTED|Overall Study||902
8691583|NCT00856024|9736896|FG000|COMPLETED|Overall Study||902
8691584|NCT00856024|9736896|FG000|NOT COMPLETED|Overall Study||0
8691585|NCT00856050|9736902|FG000|STARTED|Overall Study||26
8691586|NCT00856050|9736902|FG000|COMPLETED|Overall Study||26
8691587|NCT00856050|9736902|FG000|NOT COMPLETED|Overall Study||0
8691588|NCT00856180|9736906|FG000|STARTED|Overall Study||20
8691589|NCT00856180|9736906|FG000|COMPLETED|Overall Study||0
8691590|NCT00856180|9736906|FG000|NOT COMPLETED|Overall Study||20
8691591|NCT00856193|9736912|FG000|STARTED|Period 1||16
8691592|NCT00856193|9736913|FG001|STARTED|Period 1||17
8691593|NCT00856193|9736912|FG000|COMPLETED|Period 1||16
8691594|NCT00856193|9736913|FG001|COMPLETED|Period 1||17
8691595|NCT00856193|9736912|FG000|NOT COMPLETED|Period 1||0
8691596|NCT00856193|9736913|FG001|NOT COMPLETED|Period 1||0
8691597|NCT00856193|9736912|FG000|STARTED|Period 2||16
8691598|NCT00856193|9736913|FG001|STARTED|Period 2||17
8691599|NCT00856193|9736912|FG000|COMPLETED|Period 2||16
8691600|NCT00856193|9736913|FG001|COMPLETED|Period 2||15
8691601|NCT00856193|9736912|FG000|NOT COMPLETED|Period 2||0
8691602|NCT00856193|9736913|FG001|NOT COMPLETED|Period 2||2
8691603|NCT00856206|9736921|FG000|STARTED|Overall Study||330
8691604|NCT00856206|9736922|FG001|STARTED|Overall Study||985
8691605|NCT00856206|9736921|FG000|COMPLETED|Overall Study||276
8691606|NCT00856206|9736922|FG001|COMPLETED|Overall Study||824
8691607|NCT00856206|9736921|FG000|NOT COMPLETED|Overall Study||54
8691608|NCT00856206|9736922|FG001|NOT COMPLETED|Overall Study||161
8691609|NCT00856232|9736931|FG000|STARTED|Overall Study||26
8691610|NCT00856232|9736932|FG001|STARTED|Overall Study||29
8691611|NCT00856232|9736933|FG002|STARTED|Overall Study||36
8691612|NCT00856232|9736931|FG000|COMPLETED|Overall Study||26
8691613|NCT00856232|9736932|FG001|COMPLETED|Overall Study||29
8691614|NCT00856232|9736933|FG002|COMPLETED|Overall Study||36
8691615|NCT00856232|9736931|FG000|NOT COMPLETED|Overall Study||0
8691616|NCT00856232|9736932|FG001|NOT COMPLETED|Overall Study||0
8691617|NCT00856232|9736933|FG002|NOT COMPLETED|Overall Study||0
8691618|NCT00856245|9736943|FG000|STARTED|Overall Study||19
8691619|NCT00856245|9736943|FG000|COMPLETED|Overall Study||14
8691620|NCT00856245|9736943|FG000|NOT COMPLETED|Overall Study||5
8691621|NCT00856284|9736950|FG000|STARTED|Overall Study||880
8691622|NCT00856284|9736951|FG001|STARTED|Overall Study||885
8691623|NCT00856284|9736952|FG002|STARTED|Overall Study||874
8691624|NCT00856284|9736950|FG000|Received Study Drug|Overall Study||873
8691625|NCT00856284|9736951|FG001|Received Study Drug|Overall Study||878
8691626|NCT00856284|9736952|FG002|Received Study Drug|Overall Study||869
8691627|NCT00856284|9736950|FG000|COMPLETED|Overall Study||472
8691628|NCT00856284|9736951|FG001|COMPLETED|Overall Study||493
8691629|NCT00856284|9736952|FG002|COMPLETED|Overall Study||427
8691630|NCT00856284|9736950|FG000|NOT COMPLETED|Overall Study||408
8691631|NCT00856284|9736951|FG001|NOT COMPLETED|Overall Study||392
8691632|NCT00856284|9736952|FG002|NOT COMPLETED|Overall Study||447
8691633|NCT00856297|9736965|FG000|STARTED|Overall Study||131
8691634|NCT00856297|9736966|FG001|STARTED|Overall Study||76
8691635|NCT00856297|9736967|FG002|STARTED|Overall Study||107
8691636|NCT00856297|9736968|FG003|STARTED|Overall Study||44
8691637|NCT00856297|9736969|FG004|STARTED|Overall Study||31
8691638|NCT00856297|9736965|FG000|COMPLETED|Overall Study||129
8691639|NCT00856297|9736966|FG001|COMPLETED|Overall Study||76
8691640|NCT00856297|9736967|FG002|COMPLETED|Overall Study||107
8691641|NCT00856297|9736968|FG003|COMPLETED|Overall Study||44
8691642|NCT00856297|9736969|FG004|COMPLETED|Overall Study||31
8691643|NCT00856297|9736965|FG000|NOT COMPLETED|Overall Study||2
8691644|NCT00856297|9736966|FG001|NOT COMPLETED|Overall Study||0
8691645|NCT00856297|9736967|FG002|NOT COMPLETED|Overall Study||0
8691646|NCT00856297|9736968|FG003|NOT COMPLETED|Overall Study||0
8691647|NCT00856297|9736969|FG004|NOT COMPLETED|Overall Study||0
8691648|NCT00856323|9736986|FG000|STARTED|Overall Study||53
8691649|NCT00856323|9736986|FG000|COMPLETED|Overall Study||51
8691650|NCT00856323|9736986|FG000|NOT COMPLETED|Overall Study||2
8691651|NCT00856349|9736990|FG000|STARTED|Overall Study||4132
8691652|NCT00856349|9736990|FG000|12 Month Follow-up|Overall Study||3228
8691653|NCT00856349|9736990|FG000|18 Month Follow-up|Overall Study||2467
8691654|NCT00856349|9736990|FG000|24 Month Follow-up|Overall Study||1698
8691655|NCT00856349|9736990|FG000|COMPLETED|Overall Study||3111
8691656|NCT00856349|9736990|FG000|NOT COMPLETED|Overall Study||1021
8691657|NCT00856375|9736998|FG000|STARTED|Overall Study||42
8691658|NCT00856375|9736999|FG001|STARTED|Overall Study||41
8691659|NCT00856375|9736998|FG000|COMPLETED|Overall Study||0
8691660|NCT00856375|9736999|FG001|COMPLETED|Overall Study||0
8691661|NCT00856375|9736998|FG000|NOT COMPLETED|Overall Study||42
8691662|NCT00856375|9736999|FG001|NOT COMPLETED|Overall Study||41
8691663|NCT00856388|9737005|FG000|STARTED|Overall Study||62
8691664|NCT00856388|9737005|FG000|COMPLETED|Overall Study||61
8691665|NCT00856388|9737005|FG000|NOT COMPLETED|Overall Study||1
8691666|NCT00856414|9737010|FG000|STARTED|Overall Study||45
8691667|NCT00856414|9737010|FG000|COMPLETED|Overall Study||45
8644245|NCT00604968|9685033|FG000|STARTED|Overall Study||25
8644246|NCT00604968|9685033|FG000|COMPLETED|Overall Study|Due to the nature of study, all subjects receiving drug were considered to have completed.|25
8644247|NCT00604968|9685033|FG000|NOT COMPLETED|Overall Study||0
8644248|NCT00605033|9685039|FG000|STARTED|Overall Study||143
8644249|NCT00605033|9685040|FG001|STARTED|Overall Study|One participant was randomized but withdrew before taking any study medication (treated n=97).|98
8644250|NCT00605033|9685039|FG000|COMPLETED|Overall Study||136
8644251|NCT00605033|9685040|FG001|COMPLETED|Overall Study||90
8644252|NCT00605033|9685039|FG000|NOT COMPLETED|Overall Study||7
8644253|NCT00605033|9685040|FG001|NOT COMPLETED|Overall Study||8
8644254|NCT00605072|9685049|FG000|STARTED|Overall Study||18
8644255|NCT00605072|9685050|FG001|STARTED|Overall Study||20
8644256|NCT00605072|9685051|FG002|STARTED|Overall Study||15
8644257|NCT00605072|9685049|FG000|COMPLETED|Overall Study||11
8644258|NCT00605072|9685050|FG001|COMPLETED|Overall Study||9
8644259|NCT00605072|9685051|FG002|COMPLETED|Overall Study||11
8644260|NCT00605072|9685049|FG000|NOT COMPLETED|Overall Study||7
8644261|NCT00605072|9685050|FG001|NOT COMPLETED|Overall Study||11
8644262|NCT00605072|9685051|FG002|NOT COMPLETED|Overall Study||4
8644263|NCT00605085|9685061|FG000|STARTED|Overall Study||2012
8644264|NCT00605085|9685062|FG001|STARTED|Overall Study||663
8644265|NCT00605085|9685061|FG000|COMPLETED|Overall Study||1962
8644266|NCT00605085|9685062|FG001|COMPLETED|Overall Study||638
8644267|NCT00605085|9685061|FG000|NOT COMPLETED|Overall Study||50
8644268|NCT00605085|9685062|FG001|NOT COMPLETED|Overall Study||25
8644269|NCT00605176|9685071|FG000|STARTED|Overall Study||160
8644270|NCT00605176|9685072|FG001|STARTED|Overall Study||160
8644271|NCT00605176|9685073|FG002|STARTED|Overall Study||159
8644272|NCT00605176|9685071|FG000|COMPLETED|Overall Study||149
8644273|NCT00605176|9685072|FG001|COMPLETED|Overall Study||154
8644274|NCT00605176|9685073|FG002|COMPLETED|Overall Study||150
8644275|NCT00605176|9685071|FG000|NOT COMPLETED|Overall Study||11
8644276|NCT00605176|9685072|FG001|NOT COMPLETED|Overall Study||6
8644277|NCT00605176|9685073|FG002|NOT COMPLETED|Overall Study||9
8644278|NCT00605189|9685084|FG000|STARTED|Overall Study||20
8644279|NCT00605189|9685085|FG001|STARTED|Overall Study||21
8644280|NCT00605189|9685086|FG002|STARTED|Overall Study||9
8644281|NCT00605189|9685084|FG000|COMPLETED|Overall Study||17
8644282|NCT00605189|9685085|FG001|COMPLETED|Overall Study||19
8644283|NCT00605189|9685086|FG002|COMPLETED|Overall Study||9
8644284|NCT00605189|9685084|FG000|NOT COMPLETED|Overall Study||3
8644285|NCT00605189|9685085|FG001|NOT COMPLETED|Overall Study||2
8644286|NCT00605189|9685086|FG002|NOT COMPLETED|Overall Study||0
8644287|NCT00605202|9685094|FG000|STARTED|First Intervention||5
8644288|NCT00605202|9685095|FG001|STARTED|First Intervention||5
8644289|NCT00605202|9685094|FG000|COMPLETED|First Intervention||5
8644290|NCT00605202|9685095|FG001|COMPLETED|First Intervention||5
8644291|NCT00605202|9685094|FG000|NOT COMPLETED|First Intervention||0
8644292|NCT00605202|9685095|FG001|NOT COMPLETED|First Intervention||0
8644293|NCT00605202|9685094|FG000|STARTED|Washout Period of 3 Weeks||5
8644294|NCT00605202|9685095|FG001|STARTED|Washout Period of 3 Weeks||5
8644295|NCT00605202|9685094|FG000|COMPLETED|Washout Period of 3 Weeks||5
8644296|NCT00605202|9685095|FG001|COMPLETED|Washout Period of 3 Weeks||5
8644297|NCT00605202|9685094|FG000|NOT COMPLETED|Washout Period of 3 Weeks||0
8644298|NCT00605202|9685095|FG001|NOT COMPLETED|Washout Period of 3 Weeks||0
8644299|NCT00605202|9685094|FG000|STARTED|Second Intervention||5
8644300|NCT00605202|9685095|FG001|STARTED|Second Intervention||5
8644301|NCT00605202|9685094|FG000|COMPLETED|Second Intervention||5
8644302|NCT00605202|9685095|FG001|COMPLETED|Second Intervention||5
8644303|NCT00605202|9685094|FG000|NOT COMPLETED|Second Intervention||0
8644304|NCT00605202|9685095|FG001|NOT COMPLETED|Second Intervention||0
8644305|NCT00605267|9685103|FG000|STARTED|Overall Study||98
8644306|NCT00605267|9685104|FG001|STARTED|Overall Study||99
8644307|NCT00605267|9685103|FG000|COMPLETED|Overall Study|Breast surgery performed|95
8644308|NCT00605267|9685104|FG001|COMPLETED|Overall Study|Breast surgery performed|90
8644309|NCT00605267|9685103|FG000|NOT COMPLETED|Overall Study||3
8644310|NCT00605267|9685104|FG001|NOT COMPLETED|Overall Study||9
8644311|NCT00605280|9685114|FG000|STARTED|Year 1||145
8644312|NCT00605280|9685115|FG001|STARTED|Year 1||22
8644313|NCT00605280|9685116|FG002|STARTED|Year 1||7
8644314|NCT00605280|9685117|FG003|STARTED|Year 1||143
8644315|NCT00605280|9685114|FG000|Received 0.3 mg Treatment|Year 1||144
8644316|NCT00605280|9685115|FG001|Received 0.3 mg Treatment|Year 1||13
8644317|NCT00605280|9685116|FG002|Received 0.3 mg Treatment|Year 1||3
8644318|NCT00605280|9685117|FG003|Received 0.3 mg Treatment|Year 1||0
8644319|NCT00605280|9685114|FG000|COMPLETED|Year 1||126
8644320|NCT00605280|9685115|FG001|COMPLETED|Year 1||11
8644321|NCT00605280|9685116|FG002|COMPLETED|Year 1||6
8644322|NCT00605280|9685117|FG003|COMPLETED|Year 1||124
8644323|NCT00605280|9685114|FG000|NOT COMPLETED|Year 1||19
8644324|NCT00605280|9685115|FG001|NOT COMPLETED|Year 1||11
8644325|NCT00605280|9685116|FG002|NOT COMPLETED|Year 1||1
8644326|NCT00605280|9685117|FG003|NOT COMPLETED|Year 1||19
8644327|NCT00605280|9685114|FG000|STARTED|Year 2||126
8644328|NCT00605280|9685115|FG001|STARTED|Year 2||11
8644329|NCT00605280|9685116|FG002|STARTED|Year 2||6
8644330|NCT00605280|9685117|FG003|STARTED|Year 2||124
8644331|NCT00605280|9685114|FG000|Received 0.3 mg Treatment|Year 2||126
8644332|NCT00605280|9685115|FG001|Received 0.3 mg Treatment|Year 2||3
8644333|NCT00605280|9685116|FG002|Received 0.3 mg Treatment|Year 2||2
8644334|NCT00605280|9685117|FG003|Received 0.3 mg Treatment|Year 2||0
8644335|NCT00605280|9685114|FG000|COMPLETED|Year 2||102
8644336|NCT00605280|9685115|FG001|COMPLETED|Year 2||5
8644337|NCT00605280|9685116|FG002|COMPLETED|Year 2||0
8644338|NCT00605280|9685117|FG003|COMPLETED|Year 2||102
8644339|NCT00605280|9685114|FG000|NOT COMPLETED|Year 2||24
8644340|NCT00605280|9685115|FG001|NOT COMPLETED|Year 2||6
8644341|NCT00605280|9685116|FG002|NOT COMPLETED|Year 2||6
8644342|NCT00605280|9685117|FG003|NOT COMPLETED|Year 2||22
8644343|NCT00605280|9685114|FG000|STARTED|Year 3 Extension||46
8644344|NCT00605280|9685115|FG001|STARTED|Year 3 Extension||0
8644345|NCT00605280|9685116|FG002|STARTED|Year 3 Extension||0
8644346|NCT00605280|9685117|FG003|STARTED|Year 3 Extension||54
8644347|NCT00605280|9685114|FG000|Received 0.3 mg Treatment|Year 3 Extension||46
8644348|NCT00605280|9685115|FG001|Received 0.3 mg Treatment|Year 3 Extension||0
8644349|NCT00605280|9685116|FG002|Received 0.3 mg Treatment|Year 3 Extension||0
8644350|NCT00605280|9685117|FG003|Received 0.3 mg Treatment|Year 3 Extension||54
8644351|NCT00605280|9685114|FG000|COMPLETED|Year 3 Extension||38
8644352|NCT00605280|9685115|FG001|COMPLETED|Year 3 Extension||0
8644353|NCT00605280|9685116|FG002|COMPLETED|Year 3 Extension||0
8644354|NCT00605280|9685117|FG003|COMPLETED|Year 3 Extension||45
8644355|NCT00605280|9685114|FG000|NOT COMPLETED|Year 3 Extension||8
8644356|NCT00605280|9685115|FG001|NOT COMPLETED|Year 3 Extension||0
8644357|NCT00605280|9685116|FG002|NOT COMPLETED|Year 3 Extension||0
8644358|NCT00605280|9685117|FG003|NOT COMPLETED|Year 3 Extension||9
8644359|NCT00605293|9685129|FG000|STARTED|Overall Study||65
8644360|NCT00605293|9685130|FG001|STARTED|Overall Study||36
8644361|NCT00605293|9685129|FG000|COMPLETED|Overall Study||48
8644362|NCT00605293|9685130|FG001|COMPLETED|Overall Study||31
8644363|NCT00605293|9685129|FG000|NOT COMPLETED|Overall Study||17
8644364|NCT00605293|9685130|FG001|NOT COMPLETED|Overall Study||5
8644365|NCT00605306|9685138|FG000|STARTED|Overall Study||14
8644366|NCT00605306|9685139|FG001|STARTED|Overall Study||14
8644367|NCT00605306|9685138|FG000|COMPLETED|Overall Study||14
8644368|NCT00605306|9685139|FG001|COMPLETED|Overall Study||13
8644369|NCT00605306|9685138|FG000|NOT COMPLETED|Overall Study||0
8644370|NCT00605306|9685139|FG001|NOT COMPLETED|Overall Study||1
8644371|NCT00605319|9685145|FG000|STARTED|Overall Study||17
8644372|NCT00605319|9685145|FG000|COMPLETED|Overall Study||11
8644373|NCT00605319|9685145|FG000|NOT COMPLETED|Overall Study||6
8644374|NCT00605345|9685157|FG000|STARTED|Overall Study||46
8644375|NCT00605345|9685158|FG001|STARTED|Overall Study||25
8644376|NCT00605345|9685157|FG000|COMPLETED|Overall Study||45
8644377|NCT00605345|9685158|FG001|COMPLETED|Overall Study||22
8644378|NCT00605345|9685157|FG000|NOT COMPLETED|Overall Study||1
8644379|NCT00605345|9685158|FG001|NOT COMPLETED|Overall Study||3
8644380|NCT00605358|9685166|FG000|STARTED|Overall Study||81
8644381|NCT00605358|9685167|FG001|STARTED|Overall Study||80
8644382|NCT00605358|9685166|FG000|COMPLETED|Overall Study||81
8644383|NCT00605358|9685167|FG001|COMPLETED|Overall Study||80
8644384|NCT00605358|9685166|FG000|NOT COMPLETED|Overall Study||0
8644385|NCT00605358|9685167|FG001|NOT COMPLETED|Overall Study||0
8644386|NCT00605384|9685175|FG000|STARTED|Overall Study||1
8644387|NCT00605384|9685176|FG001|STARTED|Overall Study||1
8644388|NCT00605384|9685175|FG000|COMPLETED|Overall Study|study terminated early|0
8644389|NCT00605384|9685176|FG001|COMPLETED|Overall Study|study terminated early|0
8644390|NCT00605384|9685175|FG000|NOT COMPLETED|Overall Study||1
8644391|NCT00605384|9685176|FG001|NOT COMPLETED|Overall Study||1
8644392|NCT00605423|9685184|FG000|STARTED|Overall Study||4
8644393|NCT00605423|9685185|FG001|STARTED|Overall Study||2
8644394|NCT00605423|9685184|FG000|COMPLETED|Overall Study||4
8644395|NCT00605423|9685185|FG001|COMPLETED|Overall Study||2
8644396|NCT00605423|9685184|FG000|NOT COMPLETED|Overall Study||0
8644397|NCT00605423|9685185|FG001|NOT COMPLETED|Overall Study||0
8644398|NCT00605475|9685201|FG000|STARTED|Overall Study||10
8644399|NCT00605475|9685202|FG001|STARTED|Overall Study||5
8644400|NCT00605475|9685203|FG002|STARTED|Overall Study||45
8644401|NCT00605475|9685204|FG003|STARTED|Overall Study||45
8644402|NCT00605475|9685205|FG004|STARTED|Overall Study||25
8644403|NCT00605475|9685206|FG005|STARTED|Overall Study||24
8644404|NCT00605475|9685207|FG006|STARTED|Overall Study||23
8644405|NCT00605475|9685208|FG007|STARTED|Overall Study||24
8644406|NCT00605475|9685209|FG008|STARTED|Overall Study||20
8644407|NCT00605475|9685210|FG009|STARTED|Overall Study||10
8644408|NCT00605475|9685201|FG000|COMPLETED|Overall Study||10
8644409|NCT00605475|9685202|FG001|COMPLETED|Overall Study||5
8644410|NCT00605475|9685203|FG002|COMPLETED|Overall Study||45
8644411|NCT00605475|9685204|FG003|COMPLETED|Overall Study||45
8644412|NCT00605475|9685205|FG004|COMPLETED|Overall Study||24
8644413|NCT00605475|9685206|FG005|COMPLETED|Overall Study||22
8644414|NCT00605475|9685207|FG006|COMPLETED|Overall Study||22
8644415|NCT00605475|9685208|FG007|COMPLETED|Overall Study||24
8644416|NCT00605475|9685209|FG008|COMPLETED|Overall Study||18
8644417|NCT00605475|9685210|FG009|COMPLETED|Overall Study||8
8644418|NCT00605475|9685201|FG000|NOT COMPLETED|Overall Study||0
8644419|NCT00605475|9685202|FG001|NOT COMPLETED|Overall Study||0
8644420|NCT00605475|9685203|FG002|NOT COMPLETED|Overall Study||0
8644421|NCT00605475|9685204|FG003|NOT COMPLETED|Overall Study||0
8644422|NCT00605475|9685205|FG004|NOT COMPLETED|Overall Study||1
8644423|NCT00605475|9685206|FG005|NOT COMPLETED|Overall Study||2
8644424|NCT00605475|9685207|FG006|NOT COMPLETED|Overall Study||1
8644425|NCT00605475|9685208|FG007|NOT COMPLETED|Overall Study||0
8644426|NCT00605475|9685209|FG008|NOT COMPLETED|Overall Study||2
8644427|NCT00605475|9685210|FG009|NOT COMPLETED|Overall Study||2
8644428|NCT00605540|9685253|FG000|STARTED|Overall Study||133
8644429|NCT00605540|9685253|FG000|COMPLETED|Overall Study||95
8644430|NCT00605540|9685253|FG000|NOT COMPLETED|Overall Study||38
8644431|NCT00605566|9685257|FG000|STARTED|Overall Study||22
8644432|NCT00605566|9685257|FG000|COMPLETED|Overall Study||19
8644433|NCT00605566|9685257|FG000|NOT COMPLETED|Overall Study||3
8644434|NCT00605644|9685266|FG000|STARTED|Overall Study||29
8644435|NCT00605644|9685267|FG001|STARTED|Overall Study||19
8644436|NCT00605644|9685268|FG002|STARTED|Overall Study||20
8644437|NCT00605644|9685269|FG003|STARTED|Overall Study||30
8644438|NCT00605644|9685270|FG004|STARTED|Overall Study||30
8644439|NCT00605644|9685266|FG000|COMPLETED|Overall Study||28
8644440|NCT00605644|9685267|FG001|COMPLETED|Overall Study||18
8644441|NCT00605644|9685268|FG002|COMPLETED|Overall Study||18
8644442|NCT00605644|9685269|FG003|COMPLETED|Overall Study||25
8644443|NCT00605644|9685270|FG004|COMPLETED|Overall Study||22
8644444|NCT00605644|9685266|FG000|NOT COMPLETED|Overall Study||1
8644445|NCT00605644|9685267|FG001|NOT COMPLETED|Overall Study||1
8644446|NCT00605644|9685268|FG002|NOT COMPLETED|Overall Study||2
8644447|NCT00605644|9685269|FG003|NOT COMPLETED|Overall Study||5
8644448|NCT00605644|9685270|FG004|NOT COMPLETED|Overall Study||8
8644449|NCT00605657|9685282|FG000|STARTED|Overall Study||5
8644450|NCT00605657|9685282|FG000|COMPLETED|Overall Study||3
8644451|NCT00605657|9685282|FG000|NOT COMPLETED|Overall Study||2
8644452|NCT00605696|9685288|FG000|STARTED|Overall Study||7
8644453|NCT00605696|9685289|FG001|STARTED|Overall Study||11
8644454|NCT00605696|9685288|FG000|COMPLETED|Overall Study||7
8644455|NCT00605696|9685289|FG001|COMPLETED|Overall Study||11
8644456|NCT00605696|9685288|FG000|NOT COMPLETED|Overall Study||0
8644457|NCT00605696|9685289|FG001|NOT COMPLETED|Overall Study||0
8644458|NCT00605722|9685295|FG000|STARTED|Overall Study||51
8644459|NCT00605722|9685295|FG000|COMPLETED|Overall Study|Completed=Completed Treatment.|0
8644460|NCT00605722|9685295|FG000|NOT COMPLETED|Overall Study||51
8644461|NCT00605813|9685299|FG000|STARTED|Overall Study||542
8644462|NCT00605813|9685299|FG000|COMPLETED|Overall Study||517
8644463|NCT00605813|9685299|FG000|NOT COMPLETED|Overall Study||25
8644464|NCT00605826|9685314|FG000|STARTED|Overall Study||136
8644465|NCT00605826|9685315|FG001|STARTED|Overall Study||70
8644466|NCT00605826|9685314|FG000|COMPLETED|Overall Study||129
8644467|NCT00605826|9685315|FG001|COMPLETED|Overall Study||60
8644468|NCT00605826|9685314|FG000|NOT COMPLETED|Overall Study||7
8644469|NCT00605826|9685315|FG001|NOT COMPLETED|Overall Study||10
8644470|NCT00605839|9685324|FG000|STARTED|Overall Study||40
8644471|NCT00605839|9685325|FG001|STARTED|Overall Study||37
8644472|NCT00605839|9685326|FG002|STARTED|Overall Study||28
8644473|NCT00605839|9685324|FG000|COMPLETED|Overall Study|One patient would not keep to the text messaging constraints and had to be removed.|39
8644474|NCT00605839|9685325|FG001|COMPLETED|Overall Study||37
8644475|NCT00605839|9685326|FG002|COMPLETED|Overall Study||28
8644476|NCT00605839|9685324|FG000|NOT COMPLETED|Overall Study||1
8644477|NCT00605839|9685325|FG001|NOT COMPLETED|Overall Study||0
8644478|NCT00605839|9685326|FG002|NOT COMPLETED|Overall Study||0
8644479|NCT00605865|9685334|FG000|STARTED|Overall Study||2272
8644480|NCT00605865|9685334|FG000|COMPLETED|Overall Study||2157
8644481|NCT00605865|9685334|FG000|NOT COMPLETED|Overall Study||115
8644482|NCT00605904|9685368|FG000|STARTED|Baseline Data Collection and Dosing|While 37 subjects were enrolled in the protocol, only 34 were randomized to a study arm|13
8644483|NCT00605904|9685369|FG001|STARTED|Baseline Data Collection and Dosing|While 37 subjects were enrolled in the protocol, only 34 were randomized to a study arm|21
8644484|NCT00605904|9685368|FG000|COMPLETED|Baseline Data Collection and Dosing||13
8644485|NCT00605904|9685369|FG001|COMPLETED|Baseline Data Collection and Dosing||16
8644486|NCT00605904|9685368|FG000|NOT COMPLETED|Baseline Data Collection and Dosing||0
8644487|NCT00605904|9685369|FG001|NOT COMPLETED|Baseline Data Collection and Dosing||5
8644488|NCT00605904|9685368|FG000|STARTED|Infusion Sessions||13
8644489|NCT00605904|9685369|FG001|STARTED|Infusion Sessions||16
8644490|NCT00605904|9685368|FG000|Saline Infusion|Infusion Sessions||13
8644491|NCT00605904|9685369|FG001|Saline Infusion|Infusion Sessions||14
8644492|NCT00605904|9685368|FG000|mCPP Infusion|Infusion Sessions||12
8644493|NCT00605904|9685369|FG001|mCPP Infusion|Infusion Sessions||13
8644494|NCT00605904|9685368|FG000|Yohimbine Infusion|Infusion Sessions||12
8644495|NCT00605904|9685369|FG001|Yohimbine Infusion|Infusion Sessions|Milestones (infusions) were not received in the same order for each subjects so are not consecutive.|15
8644496|NCT00605904|9685368|FG000|COMPLETED|Infusion Sessions|Subjects who completed all three types of infusion (given in a different order for each subject)|12
8644497|NCT00605904|9685369|FG001|COMPLETED|Infusion Sessions|Subjects who completed all three types of infusion (given in a different order for each subject)|13
8644498|NCT00605904|9685368|FG000|NOT COMPLETED|Infusion Sessions||1
8644499|NCT00605904|9685369|FG001|NOT COMPLETED|Infusion Sessions||3
8644500|NCT00605917|9685375|FG000|STARTED|Overall Study||987
8644501|NCT00605917|9685375|FG000|COMPLETED|Overall Study||908
8644502|NCT00605917|9685375|FG000|NOT COMPLETED|Overall Study||79
8644503|NCT00606008|9685410|FG000|STARTED|Overall Study||30
8644504|NCT00606008|9685410|FG000|COMPLETED|Overall Study||25
8644505|NCT00606008|9685410|FG000|NOT COMPLETED|Overall Study||5
8644506|NCT00606021|9685420|FG000|STARTED|Induction Phase||106
8644507|NCT00606021|9685421|FG001|STARTED|Induction Phase||0
8644508|NCT00606021|9685422|FG002|STARTED|Induction Phase||0
8644509|NCT00606021|9685420|FG000|COMPLETED|Induction Phase||19
8644510|NCT00606021|9685421|FG001|COMPLETED|Induction Phase||0
8644511|NCT00606021|9685422|FG002|COMPLETED|Induction Phase||0
8644512|NCT00606021|9685420|FG000|NOT COMPLETED|Induction Phase||87
8644513|NCT00606021|9685421|FG001|NOT COMPLETED|Induction Phase||0
8644514|NCT00606021|9685422|FG002|NOT COMPLETED|Induction Phase||0
8644515|NCT00606021|9685420|FG000|STARTED|Maintenance Phase||0
8644516|NCT00606021|9685421|FG001|STARTED|Maintenance Phase||28
8644517|NCT00606021|9685422|FG002|STARTED|Maintenance Phase||27
8644518|NCT00606021|9685420|FG000|COMPLETED|Maintenance Phase||0
8644519|NCT00606021|9685421|FG001|COMPLETED|Maintenance Phase||5
8644520|NCT00606021|9685422|FG002|COMPLETED|Maintenance Phase||10
8644521|NCT00606021|9685420|FG000|NOT COMPLETED|Maintenance Phase||0
8644522|NCT00606021|9685421|FG001|NOT COMPLETED|Maintenance Phase||23
8644523|NCT00606021|9685422|FG002|NOT COMPLETED|Maintenance Phase||17
8644524|NCT00606034|9685430|FG000|STARTED|Overall Study||21
8644525|NCT00606034|9685430|FG000|COMPLETED|Overall Study||20
8644526|NCT00606034|9685430|FG000|NOT COMPLETED|Overall Study||1
8644527|NCT00606047|9685436|FG000|STARTED|Overall Study||200
8644528|NCT00606047|9685436|FG000|COMPLETED|Overall Study||200
8644529|NCT00606047|9685436|FG000|NOT COMPLETED|Overall Study||0
8644530|NCT00606086|9685442|FG000|STARTED|Overall Study||72
8644531|NCT00606086|9685443|FG001|STARTED|Overall Study||68
8644532|NCT00606086|9685442|FG000|COMPLETED|Overall Study||60
8644533|NCT00606086|9685443|FG001|COMPLETED|Overall Study||53
8644534|NCT00606086|9685442|FG000|NOT COMPLETED|Overall Study||12
8644535|NCT00606086|9685443|FG001|NOT COMPLETED|Overall Study||15
8644536|NCT00606138|9685451|FG000|STARTED|Overall Study||6
8644537|NCT00606138|9685452|FG001|STARTED|Overall Study||2
8644538|NCT00606138|9685451|FG000|COMPLETED|Overall Study||6
8644539|NCT00606138|9685452|FG001|COMPLETED|Overall Study||2
8644540|NCT00606138|9685451|FG000|NOT COMPLETED|Overall Study||0
8644541|NCT00606138|9685452|FG001|NOT COMPLETED|Overall Study||0
8644542|NCT00606177|9685460|FG000|STARTED|Overall Study||55
8644543|NCT00606177|9685461|FG001|STARTED|Overall Study||44
8644544|NCT00606177|9685460|FG000|COMPLETED|Overall Study||28
8644545|NCT00606177|9685461|FG001|COMPLETED|Overall Study||19
8644546|NCT00606177|9685460|FG000|NOT COMPLETED|Overall Study||27
8644547|NCT00606177|9685461|FG001|NOT COMPLETED|Overall Study||25
8644548|NCT00606229|9685467|FG000|STARTED|Overall Study||41
8644549|NCT00606229|9685467|FG000|COMPLETED|Overall Study||19
8644550|NCT00606229|9685467|FG000|NOT COMPLETED|Overall Study||22
8644551|NCT00606281|9685473|FG000|STARTED|Overall Study||128
8644552|NCT00606281|9685474|FG001|STARTED|Overall Study||130
8644553|NCT00606281|9685473|FG000|COMPLETED|Overall Study||72
8644554|NCT00606281|9685474|FG001|COMPLETED|Overall Study||64
8644555|NCT00606281|9685473|FG000|NOT COMPLETED|Overall Study||56
8644556|NCT00606281|9685474|FG001|NOT COMPLETED|Overall Study||66
8644557|NCT00606294|9685482|FG000|STARTED|Overall Study||197
8644558|NCT00606294|9685483|FG001|STARTED|Overall Study||19
8644559|NCT00606294|9685482|FG000|COMPLETED|Overall Study||161
8644560|NCT00606294|9685483|FG001|COMPLETED|Overall Study||19
8644561|NCT00606294|9685482|FG000|NOT COMPLETED|Overall Study||36
8644562|NCT00606294|9685483|FG001|NOT COMPLETED|Overall Study||0
8644563|NCT00606307|9685489|FG000|STARTED|Overall Study||29
8644564|NCT00606307|9685489|FG000|COMPLETED|Overall Study||18
8644565|NCT00606307|9685489|FG000|NOT COMPLETED|Overall Study||11
8644566|NCT00606320|9685493|FG000|STARTED|Overall Study||59
8644567|NCT00606320|9685493|FG000|COMPLETED|Overall Study||22
8644568|NCT00606320|9685493|FG000|NOT COMPLETED|Overall Study||37
8644569|NCT00606489|9685499|FG000|STARTED|Overall Study||21
8644570|NCT00606489|9685500|FG001|STARTED|Overall Study||40
8644571|NCT00606489|9685499|FG000|COMPLETED|Overall Study||21
8644572|NCT00606489|9685500|FG001|COMPLETED|Overall Study||40
8644573|NCT00606489|9685499|FG000|NOT COMPLETED|Overall Study||0
8644574|NCT00606489|9685500|FG001|NOT COMPLETED|Overall Study||0
8644575|NCT00606502|9685508|FG000|STARTED|Randomization||100
8727361|NCT01043185|9774776|FG008|STARTED|Period 1 - First Intervention||3
8727362|NCT01043185|9774777|FG009|STARTED|Period 1 - First Intervention||3
8727363|NCT01043185|9774768|FG000|COMPLETED|Period 1 - First Intervention||3
8644576|NCT00606502|9685509|FG001|STARTED|Randomization||101
8644577|NCT00606502|9685508|FG000|COMPLETED|Randomization||97
8644578|NCT00606502|9685509|FG001|COMPLETED|Randomization||101
8644579|NCT00606502|9685508|FG000|NOT COMPLETED|Randomization||3
8644580|NCT00606502|9685509|FG001|NOT COMPLETED|Randomization||0
8644581|NCT00606502|9685508|FG000|STARTED|Treatment||97
8644582|NCT00606502|9685509|FG001|STARTED|Treatment||101
8644583|NCT00606502|9685508|FG000|COMPLETED|Treatment||97
8644584|NCT00606502|9685509|FG001|COMPLETED|Treatment||98
8644585|NCT00606502|9685508|FG000|NOT COMPLETED|Treatment||0
8644586|NCT00606502|9685509|FG001|NOT COMPLETED|Treatment||3
8644587|NCT00606554|9685517|FG000|STARTED|Overall Study||15
8644588|NCT00606554|9685518|FG001|STARTED|Overall Study||18
8644589|NCT00606554|9685517|FG000|COMPLETED|Overall Study||15
8644590|NCT00606554|9685518|FG001|COMPLETED|Overall Study||18
8644591|NCT00606554|9685517|FG000|NOT COMPLETED|Overall Study||0
8644592|NCT00606554|9685518|FG001|NOT COMPLETED|Overall Study||0
8644593|NCT00606580|9685531|FG000|STARTED|Overall Study||125
8644594|NCT00606580|9685532|FG001|STARTED|Overall Study||125
8644595|NCT00606580|9685533|FG002|STARTED|Overall Study||125
8644596|NCT00606580|9685531|FG000|COMPLETED|Overall Study||123
8644597|NCT00606580|9685532|FG001|COMPLETED|Overall Study||122
8644598|NCT00606580|9685533|FG002|COMPLETED|Overall Study||103
8644599|NCT00606580|9685531|FG000|NOT COMPLETED|Overall Study||2
8644600|NCT00606580|9685532|FG001|NOT COMPLETED|Overall Study||3
8644601|NCT00606580|9685533|FG002|NOT COMPLETED|Overall Study||22
8644602|NCT00606593|9685541|FG000|STARTED|Overall Study|Randomized participants|11
8644603|NCT00606593|9685542|FG001|STARTED|Overall Study|Randomized participants|11
8644604|NCT00606593|9685543|FG002|STARTED|Overall Study|Randomized participants|11
8644605|NCT00606593|9685544|FG003|STARTED|Overall Study|Randomized participants|11
8644606|NCT00606593|9685545|FG004|STARTED|Overall Study|Randomized participants|12
8644607|NCT00606593|9685546|FG005|STARTED|Overall Study|Randomized participants|11
8644608|NCT00606593|9685547|FG006|STARTED|Overall Study|Randomized participants|11
8644609|NCT00606593|9685548|FG007|STARTED|Overall Study|Randomized participants. One participant actually received the treatment sequence 200/P/100/ 50/25|11
8644610|NCT00606593|9685549|FG008|STARTED|Overall Study|Randomized participants|12
8644611|NCT00606593|9685550|FG009|STARTED|Overall Study|Randomized participants|11
8644612|NCT00606593|9685541|FG000|1st Double-blind Treatment|Overall Study||11
8644613|NCT00606593|9685542|FG001|1st Double-blind Treatment|Overall Study||11
8644614|NCT00606593|9685543|FG002|1st Double-blind Treatment|Overall Study||11
8644615|NCT00606593|9685544|FG003|1st Double-blind Treatment|Overall Study||11
8644616|NCT00606593|9685545|FG004|1st Double-blind Treatment|Overall Study||12
8644617|NCT00606593|9685546|FG005|1st Double-blind Treatment|Overall Study||11
8644618|NCT00606593|9685547|FG006|1st Double-blind Treatment|Overall Study||11
8644619|NCT00606593|9685548|FG007|1st Double-blind Treatment|Overall Study||11
8644620|NCT00606593|9685549|FG008|1st Double-blind Treatment|Overall Study||12
8644621|NCT00606593|9685550|FG009|1st Double-blind Treatment|Overall Study||11
8644622|NCT00606593|9685541|FG000|2nd Double-blind Treatment|Overall Study||11
8644623|NCT00606593|9685542|FG001|2nd Double-blind Treatment|Overall Study||11
8644624|NCT00606593|9685543|FG002|2nd Double-blind Treatment|Overall Study||11
8644625|NCT00606593|9685544|FG003|2nd Double-blind Treatment|Overall Study||10
8644626|NCT00606593|9685545|FG004|2nd Double-blind Treatment|Overall Study||12
8644627|NCT00606593|9685546|FG005|2nd Double-blind Treatment|Overall Study||11
8644628|NCT00606593|9685547|FG006|2nd Double-blind Treatment|Overall Study||10
8644629|NCT00606593|9685548|FG007|2nd Double-blind Treatment|Overall Study||9
8644630|NCT00606593|9685549|FG008|2nd Double-blind Treatment|Overall Study||12
8644631|NCT00606593|9685550|FG009|2nd Double-blind Treatment|Overall Study||11
8644632|NCT00606593|9685541|FG000|3rd Double-blind Treatment|Overall Study||11
8644633|NCT00606593|9685542|FG001|3rd Double-blind Treatment|Overall Study||11
8644634|NCT00606593|9685543|FG002|3rd Double-blind Treatment|Overall Study||10
8644635|NCT00606593|9685544|FG003|3rd Double-blind Treatment|Overall Study||10
8644636|NCT00606593|9685545|FG004|3rd Double-blind Treatment|Overall Study||11
8644637|NCT00606593|9685546|FG005|3rd Double-blind Treatment|Overall Study||11
8644638|NCT00606593|9685547|FG006|3rd Double-blind Treatment|Overall Study||10
8644639|NCT00606593|9685548|FG007|3rd Double-blind Treatment|Overall Study||9
8644640|NCT00606593|9685549|FG008|3rd Double-blind Treatment|Overall Study||12
8644641|NCT00606593|9685550|FG009|3rd Double-blind Treatment|Overall Study||11
8644642|NCT00606593|9685541|FG000|4th Double-blind Treatment|Overall Study||10
8644643|NCT00606593|9685542|FG001|4th Double-blind Treatment|Overall Study||11
8644644|NCT00606593|9685543|FG002|4th Double-blind Treatment|Overall Study||10
8644645|NCT00606593|9685544|FG003|4th Double-blind Treatment|Overall Study||10
8644646|NCT00606593|9685545|FG004|4th Double-blind Treatment|Overall Study||11
8644647|NCT00606593|9685546|FG005|4th Double-blind Treatment|Overall Study||11
8644648|NCT00606593|9685547|FG006|4th Double-blind Treatment|Overall Study||10
8644649|NCT00606593|9685548|FG007|4th Double-blind Treatment|Overall Study||9
8644650|NCT00606593|9685549|FG008|4th Double-blind Treatment|Overall Study||11
8644651|NCT00606593|9685550|FG009|4th Double-blind Treatment|Overall Study||11
8644652|NCT00606593|9685541|FG000|5th Double-blind Treatment|Overall Study||10
8644653|NCT00606593|9685542|FG001|5th Double-blind Treatment|Overall Study||11
8644654|NCT00606593|9685543|FG002|5th Double-blind Treatment|Overall Study||9
8644655|NCT00606593|9685544|FG003|5th Double-blind Treatment|Overall Study||10
8644656|NCT00606593|9685545|FG004|5th Double-blind Treatment|Overall Study||11
8644657|NCT00606593|9685546|FG005|5th Double-blind Treatment|Overall Study||11
8644658|NCT00606593|9685547|FG006|5th Double-blind Treatment|Overall Study||10
8644659|NCT00606593|9685548|FG007|5th Double-blind Treatment|Overall Study||9
8644660|NCT00606593|9685549|FG008|5th Double-blind Treatment|Overall Study||11
8644661|NCT00606593|9685550|FG009|5th Double-blind Treatment|Overall Study||11
8644662|NCT00606593|9685541|FG000|COMPLETED|Overall Study||10
8644663|NCT00606593|9685542|FG001|COMPLETED|Overall Study||11
8644664|NCT00606593|9685543|FG002|COMPLETED|Overall Study||9
8644665|NCT00606593|9685544|FG003|COMPLETED|Overall Study||10
8644666|NCT00606593|9685545|FG004|COMPLETED|Overall Study||11
8644667|NCT00606593|9685546|FG005|COMPLETED|Overall Study||11
8644668|NCT00606593|9685547|FG006|COMPLETED|Overall Study||10
8644669|NCT00606593|9685548|FG007|COMPLETED|Overall Study||9
8644670|NCT00606593|9685549|FG008|COMPLETED|Overall Study||11
8644671|NCT00606593|9685550|FG009|COMPLETED|Overall Study||11
8644672|NCT00606593|9685541|FG000|NOT COMPLETED|Overall Study||1
8644673|NCT00606593|9685542|FG001|NOT COMPLETED|Overall Study||0
8644674|NCT00606593|9685543|FG002|NOT COMPLETED|Overall Study||2
8644675|NCT00606593|9685544|FG003|NOT COMPLETED|Overall Study||1
8644676|NCT00606593|9685545|FG004|NOT COMPLETED|Overall Study||1
8644677|NCT00606593|9685546|FG005|NOT COMPLETED|Overall Study||0
8644678|NCT00606593|9685547|FG006|NOT COMPLETED|Overall Study||1
8644679|NCT00606593|9685548|FG007|NOT COMPLETED|Overall Study||2
8644680|NCT00606593|9685549|FG008|NOT COMPLETED|Overall Study||1
8644681|NCT00606593|9685550|FG009|NOT COMPLETED|Overall Study||0
8644682|NCT00606632|9685563|FG000|STARTED|Overall Study||226
8644683|NCT00606632|9685563|FG000|COMPLETED|Overall Study||204
8644684|NCT00606632|9685563|FG000|NOT COMPLETED|Overall Study||22
8644685|NCT00606684|9685578|FG000|STARTED|2-week Single-Blind Run-in Period||851
8644686|NCT00606684|9685579|FG001|STARTED|2-week Single-Blind Run-in Period||0
8727364|NCT01043185|9774769|FG001|COMPLETED|Period 1 - First Intervention||2
8727365|NCT01043185|9774770|FG002|COMPLETED|Period 1 - First Intervention||3
8727366|NCT01043185|9774771|FG003|COMPLETED|Period 1 - First Intervention||2
8644687|NCT00606684|9685580|FG002|STARTED|2-week Single-Blind Run-in Period||0
8644688|NCT00606684|9685581|FG003|STARTED|2-week Single-Blind Run-in Period||0
8644689|NCT00606684|9685582|FG004|STARTED|2-week Single-Blind Run-in Period||0
8644690|NCT00606684|9685583|FG005|STARTED|2-week Single-Blind Run-in Period||0
8644691|NCT00606684|9685584|FG006|STARTED|2-week Single-Blind Run-in Period||0
8644692|NCT00606684|9685578|FG000|COMPLETED|2-week Single-Blind Run-in Period||605
8644693|NCT00606684|9685579|FG001|COMPLETED|2-week Single-Blind Run-in Period||0
8644694|NCT00606684|9685580|FG002|COMPLETED|2-week Single-Blind Run-in Period||0
8644695|NCT00606684|9685581|FG003|COMPLETED|2-week Single-Blind Run-in Period||0
8644696|NCT00606684|9685582|FG004|COMPLETED|2-week Single-Blind Run-in Period||0
8644697|NCT00606684|9685583|FG005|COMPLETED|2-week Single-Blind Run-in Period||0
8644698|NCT00606684|9685584|FG006|COMPLETED|2-week Single-Blind Run-in Period||0
8644699|NCT00606684|9685578|FG000|NOT COMPLETED|2-week Single-Blind Run-in Period||246
8644700|NCT00606684|9685579|FG001|NOT COMPLETED|2-week Single-Blind Run-in Period||0
8644701|NCT00606684|9685580|FG002|NOT COMPLETED|2-week Single-Blind Run-in Period||0
8644702|NCT00606684|9685581|FG003|NOT COMPLETED|2-week Single-Blind Run-in Period||0
8644703|NCT00606684|9685582|FG004|NOT COMPLETED|2-week Single-Blind Run-in Period||0
8644704|NCT00606684|9685583|FG005|NOT COMPLETED|2-week Single-Blind Run-in Period||0
8644705|NCT00606684|9685584|FG006|NOT COMPLETED|2-week Single-Blind Run-in Period||0
8644706|NCT00606684|9685578|FG000|STARTED|Double-Blind Treatment Period||0
8644707|NCT00606684|9685579|FG001|STARTED|Double-Blind Treatment Period||101
8644708|NCT00606684|9685580|FG002|STARTED|Double-Blind Treatment Period||99
8644709|NCT00606684|9685581|FG003|STARTED|Double-Blind Treatment Period||101
8644710|NCT00606684|9685582|FG004|STARTED|Double-Blind Treatment Period||101
8644711|NCT00606684|9685583|FG005|STARTED|Double-Blind Treatment Period||101
8644712|NCT00606684|9685584|FG006|STARTED|Double-Blind Treatment Period||99
8644713|NCT00606684|9685578|FG000|COMPLETED|Double-Blind Treatment Period||0
8644714|NCT00606684|9685579|FG001|COMPLETED|Double-Blind Treatment Period||85
8644715|NCT00606684|9685580|FG002|COMPLETED|Double-Blind Treatment Period||88
8644716|NCT00606684|9685581|FG003|COMPLETED|Double-Blind Treatment Period||91
8644717|NCT00606684|9685582|FG004|COMPLETED|Double-Blind Treatment Period||92
8644718|NCT00606684|9685583|FG005|COMPLETED|Double-Blind Treatment Period||92
8644719|NCT00606684|9685584|FG006|COMPLETED|Double-Blind Treatment Period||91
8644720|NCT00606684|9685578|FG000|NOT COMPLETED|Double-Blind Treatment Period||0
8644721|NCT00606684|9685579|FG001|NOT COMPLETED|Double-Blind Treatment Period||16
8644722|NCT00606684|9685580|FG002|NOT COMPLETED|Double-Blind Treatment Period||11
8644723|NCT00606684|9685581|FG003|NOT COMPLETED|Double-Blind Treatment Period||10
8644724|NCT00606684|9685582|FG004|NOT COMPLETED|Double-Blind Treatment Period||9
8644725|NCT00606684|9685583|FG005|NOT COMPLETED|Double-Blind Treatment Period||9
8644726|NCT00606684|9685584|FG006|NOT COMPLETED|Double-Blind Treatment Period||8
8644727|NCT00606801|9685600|FG000|STARTED|Adaptation||17
8644728|NCT00606801|9685601|FG001|STARTED|Adaptation||17
8644729|NCT00606801|9685600|FG000|COMPLETED|Adaptation||17
8644730|NCT00606801|9685601|FG001|COMPLETED|Adaptation||17
8644731|NCT00606801|9685600|FG000|NOT COMPLETED|Adaptation||0
8644732|NCT00606801|9685601|FG001|NOT COMPLETED|Adaptation||0
8644733|NCT00606801|9685600|FG000|STARTED|Intervention||17
8644734|NCT00606801|9685601|FG001|STARTED|Intervention||17
8644735|NCT00606801|9685600|FG000|COMPLETED|Intervention||14
8644736|NCT00606801|9685601|FG001|COMPLETED|Intervention||14
8644737|NCT00606801|9685600|FG000|NOT COMPLETED|Intervention||3
8644738|NCT00606801|9685601|FG001|NOT COMPLETED|Intervention||3
8644739|NCT00606892|9685611|FG000|STARTED|Adaptation||9
8644740|NCT00606892|9685612|FG001|STARTED|Adaptation||8
8644741|NCT00606892|9685611|FG000|COMPLETED|Adaptation||9
8644742|NCT00606892|9685612|FG001|COMPLETED|Adaptation||8
8644743|NCT00606892|9685611|FG000|NOT COMPLETED|Adaptation||0
8644744|NCT00606892|9685612|FG001|NOT COMPLETED|Adaptation||0
8644745|NCT00606892|9685611|FG000|STARTED|First Intervention||9
8644746|NCT00606892|9685612|FG001|STARTED|First Intervention||8
8644747|NCT00606892|9685611|FG000|COMPLETED|First Intervention||8
8644748|NCT00606892|9685612|FG001|COMPLETED|First Intervention||4
8644749|NCT00606892|9685611|FG000|NOT COMPLETED|First Intervention||1
8644750|NCT00606892|9685612|FG001|NOT COMPLETED|First Intervention||4
8644751|NCT00606892|9685611|FG000|STARTED|Washout Period||8
8644752|NCT00606892|9685612|FG001|STARTED|Washout Period||4
8644753|NCT00606892|9685611|FG000|COMPLETED|Washout Period||8
8644754|NCT00606892|9685612|FG001|COMPLETED|Washout Period||4
8644755|NCT00606892|9685611|FG000|NOT COMPLETED|Washout Period||0
8644756|NCT00606892|9685612|FG001|NOT COMPLETED|Washout Period||0
8644757|NCT00606892|9685611|FG000|STARTED|Second Intervention||8
8644758|NCT00606892|9685612|FG001|STARTED|Second Intervention||4
8644759|NCT00606892|9685611|FG000|COMPLETED|Second Intervention||8
8644760|NCT00606892|9685612|FG001|COMPLETED|Second Intervention||4
8644761|NCT00606892|9685611|FG000|NOT COMPLETED|Second Intervention||0
8644762|NCT00606892|9685612|FG001|NOT COMPLETED|Second Intervention||0
8644763|NCT00606905|9685646|FG000|STARTED|Overall Study||38
8644764|NCT00606905|9685647|FG001|STARTED|Overall Study||39
8644765|NCT00606905|9685646|FG000|Pregnancy|Overall Study||29
8644766|NCT00606905|9685647|FG001|Pregnancy|Overall Study||33
8644767|NCT00606905|9685646|FG000|COMPLETED|Overall Study||23
8644768|NCT00606905|9685647|FG001|COMPLETED|Overall Study||24
8644769|NCT00606905|9685646|FG000|NOT COMPLETED|Overall Study||15
8644770|NCT00606905|9685647|FG001|NOT COMPLETED|Overall Study||15
8644771|NCT00606931|9685653|FG000|STARTED|Overall Study||22
8644772|NCT00606931|9685653|FG000|COMPLETED|Overall Study||19
8644773|NCT00606931|9685653|FG000|NOT COMPLETED|Overall Study||3
8644774|NCT00606944|9685659|FG000|STARTED|Overall Study||98
8727367|NCT01043185|9774772|FG004|COMPLETED|Period 1 - First Intervention||2
8727368|NCT01043185|9774773|FG005|COMPLETED|Period 1 - First Intervention||3
8727369|NCT01043185|9774774|FG006|COMPLETED|Period 1 - First Intervention||3
8727370|NCT01043185|9774775|FG007|COMPLETED|Period 1 - First Intervention||3
8727371|NCT01043185|9774776|FG008|COMPLETED|Period 1 - First Intervention||3
8727372|NCT01043185|9774777|FG009|COMPLETED|Period 1 - First Intervention||3
8727373|NCT01043185|9774768|FG000|NOT COMPLETED|Period 1 - First Intervention||0
8727374|NCT01043185|9774769|FG001|NOT COMPLETED|Period 1 - First Intervention||0
8727375|NCT01043185|9774770|FG002|NOT COMPLETED|Period 1 - First Intervention||0
8727376|NCT01043185|9774771|FG003|NOT COMPLETED|Period 1 - First Intervention||0
8727377|NCT01043185|9774772|FG004|NOT COMPLETED|Period 1 - First Intervention||0
8727378|NCT01043185|9774773|FG005|NOT COMPLETED|Period 1 - First Intervention||0
8727379|NCT01043185|9774774|FG006|NOT COMPLETED|Period 1 - First Intervention||0
8727380|NCT01043185|9774775|FG007|NOT COMPLETED|Period 1 - First Intervention||0
8727381|NCT01043185|9774776|FG008|NOT COMPLETED|Period 1 - First Intervention||0
8727382|NCT01043185|9774777|FG009|NOT COMPLETED|Period 1 - First Intervention||0
8727383|NCT01043185|9774768|FG000|STARTED|Period 2 - First Washout Period||3
8727384|NCT01043185|9774769|FG001|STARTED|Period 2 - First Washout Period||2
8727385|NCT01043185|9774770|FG002|STARTED|Period 2 - First Washout Period||3
8727386|NCT01043185|9774771|FG003|STARTED|Period 2 - First Washout Period||2
8727387|NCT01043185|9774772|FG004|STARTED|Period 2 - First Washout Period||2
8727388|NCT01043185|9774773|FG005|STARTED|Period 2 - First Washout Period||3
8727389|NCT01043185|9774774|FG006|STARTED|Period 2 - First Washout Period||3
8727390|NCT01043185|9774775|FG007|STARTED|Period 2 - First Washout Period||3
8727391|NCT01043185|9774776|FG008|STARTED|Period 2 - First Washout Period||3
8727392|NCT01043185|9774777|FG009|STARTED|Period 2 - First Washout Period||3
8727393|NCT01043185|9774768|FG000|COMPLETED|Period 2 - First Washout Period||3
8727394|NCT01043185|9774769|FG001|COMPLETED|Period 2 - First Washout Period||2
8727395|NCT01043185|9774770|FG002|COMPLETED|Period 2 - First Washout Period||3
8727396|NCT01043185|9774771|FG003|COMPLETED|Period 2 - First Washout Period||2
8727397|NCT01043185|9774772|FG004|COMPLETED|Period 2 - First Washout Period||2
8727398|NCT01043185|9774773|FG005|COMPLETED|Period 2 - First Washout Period||3
8727399|NCT01043185|9774774|FG006|COMPLETED|Period 2 - First Washout Period||3
8727400|NCT01043185|9774775|FG007|COMPLETED|Period 2 - First Washout Period||3
8727401|NCT01043185|9774776|FG008|COMPLETED|Period 2 - First Washout Period||3
8727402|NCT01043185|9774777|FG009|COMPLETED|Period 2 - First Washout Period||3
8727403|NCT01043185|9774768|FG000|NOT COMPLETED|Period 2 - First Washout Period||0
8727404|NCT01043185|9774769|FG001|NOT COMPLETED|Period 2 - First Washout Period||0
8727405|NCT01043185|9774770|FG002|NOT COMPLETED|Period 2 - First Washout Period||0
8727406|NCT01043185|9774771|FG003|NOT COMPLETED|Period 2 - First Washout Period||0
8727407|NCT01043185|9774772|FG004|NOT COMPLETED|Period 2 - First Washout Period||0
8727408|NCT01043185|9774773|FG005|NOT COMPLETED|Period 2 - First Washout Period||0
8727409|NCT01043185|9774774|FG006|NOT COMPLETED|Period 2 - First Washout Period||0
8727410|NCT01043185|9774775|FG007|NOT COMPLETED|Period 2 - First Washout Period||0
8727411|NCT01043185|9774776|FG008|NOT COMPLETED|Period 2 - First Washout Period||0
8727412|NCT01043185|9774777|FG009|NOT COMPLETED|Period 2 - First Washout Period||0
8727413|NCT01043185|9774768|FG000|STARTED|Period 3 - Second Intervention||3
8727414|NCT01043185|9774769|FG001|STARTED|Period 3 - Second Intervention||2
8727415|NCT01043185|9774770|FG002|STARTED|Period 3 - Second Intervention||3
8727416|NCT01043185|9774771|FG003|STARTED|Period 3 - Second Intervention||2
8727417|NCT01043185|9774772|FG004|STARTED|Period 3 - Second Intervention||2
8727418|NCT01043185|9774773|FG005|STARTED|Period 3 - Second Intervention||3
8727419|NCT01043185|9774774|FG006|STARTED|Period 3 - Second Intervention||3
8727420|NCT01043185|9774775|FG007|STARTED|Period 3 - Second Intervention||3
8727421|NCT01043185|9774776|FG008|STARTED|Period 3 - Second Intervention||3
8727422|NCT01043185|9774777|FG009|STARTED|Period 3 - Second Intervention||3
8727423|NCT01043185|9774768|FG000|COMPLETED|Period 3 - Second Intervention||3
8727424|NCT01043185|9774769|FG001|COMPLETED|Period 3 - Second Intervention||2
8727425|NCT01043185|9774770|FG002|COMPLETED|Period 3 - Second Intervention||3
8727426|NCT01043185|9774771|FG003|COMPLETED|Period 3 - Second Intervention||2
8727427|NCT01043185|9774772|FG004|COMPLETED|Period 3 - Second Intervention||2
8727428|NCT01043185|9774773|FG005|COMPLETED|Period 3 - Second Intervention||3
8727429|NCT01043185|9774774|FG006|COMPLETED|Period 3 - Second Intervention||3
8727430|NCT01043185|9774775|FG007|COMPLETED|Period 3 - Second Intervention||3
8727431|NCT01043185|9774776|FG008|COMPLETED|Period 3 - Second Intervention||3
8727432|NCT01043185|9774777|FG009|COMPLETED|Period 3 - Second Intervention||3
8727433|NCT01043185|9774768|FG000|NOT COMPLETED|Period 3 - Second Intervention||0
8644775|NCT00606944|9685660|FG001|STARTED|Overall Study||100
8644776|NCT00606944|9685659|FG000|COMPLETED|Overall Study||98
8644777|NCT00606944|9685660|FG001|COMPLETED|Overall Study||100
8644778|NCT00606944|9685659|FG000|NOT COMPLETED|Overall Study||0
8644779|NCT00606944|9685660|FG001|NOT COMPLETED|Overall Study||0
8644780|NCT00607022|9685669|FG000|STARTED|Overall Study||7
8644781|NCT00607022|9685670|FG001|STARTED|Overall Study||15
8644782|NCT00607022|9685671|FG002|STARTED|Overall Study||19
8644783|NCT00607022|9685669|FG000|COMPLETED|Overall Study||6
8644784|NCT00607022|9685670|FG001|COMPLETED|Overall Study||15
8644785|NCT00607022|9685671|FG002|COMPLETED|Overall Study||19
8644786|NCT00607022|9685669|FG000|NOT COMPLETED|Overall Study||1
8644787|NCT00607022|9685670|FG001|NOT COMPLETED|Overall Study||0
8644788|NCT00607022|9685671|FG002|NOT COMPLETED|Overall Study||0
8644789|NCT00607048|9685681|FG000|STARTED|Overall Study||3
8644790|NCT00607048|9685682|FG001|STARTED|Overall Study||6
8644791|NCT00607048|9685683|FG002|STARTED|Overall Study||7
8644792|NCT00607048|9685684|FG003|STARTED|Overall Study||3
8644793|NCT00607048|9685685|FG004|STARTED|Overall Study||6
8644794|NCT00607048|9685686|FG005|STARTED|Overall Study||7
8644795|NCT00607048|9685681|FG000|COMPLETED|Overall Study||0
8644796|NCT00607048|9685682|FG001|COMPLETED|Overall Study||2
8644797|NCT00607048|9685683|FG002|COMPLETED|Overall Study||3
8644798|NCT00607048|9685684|FG003|COMPLETED|Overall Study||0
8644799|NCT00607048|9685685|FG004|COMPLETED|Overall Study||0
8644800|NCT00607048|9685686|FG005|COMPLETED|Overall Study||2
8644801|NCT00607048|9685681|FG000|NOT COMPLETED|Overall Study||3
8644802|NCT00607048|9685682|FG001|NOT COMPLETED|Overall Study||4
8644803|NCT00607048|9685683|FG002|NOT COMPLETED|Overall Study||4
8644804|NCT00607048|9685684|FG003|NOT COMPLETED|Overall Study||3
8644805|NCT00607048|9685685|FG004|NOT COMPLETED|Overall Study||6
8644806|NCT00607048|9685686|FG005|NOT COMPLETED|Overall Study||5
8644807|NCT00607087|9685705|FG000|STARTED|Overall Study||99
8644808|NCT00607087|9685706|FG001|STARTED|Overall Study||95
8644809|NCT00607087|9685707|FG002|STARTED|Overall Study||94
8644810|NCT00607087|9685705|FG000|COMPLETED|Overall Study||84
8644811|NCT00607087|9685706|FG001|COMPLETED|Overall Study||84
8644812|NCT00607087|9685707|FG002|COMPLETED|Overall Study||84
8644813|NCT00607087|9685705|FG000|NOT COMPLETED|Overall Study||15
8644814|NCT00607087|9685706|FG001|NOT COMPLETED|Overall Study||11
8644815|NCT00607087|9685707|FG002|NOT COMPLETED|Overall Study||10
8644816|NCT00607087|9685705|FG000|STARTED|Period 1||99
8644817|NCT00607087|9685706|FG001|STARTED|Period 1||95
8644818|NCT00607087|9685707|FG002|STARTED|Period 1||94
8644819|NCT00607087|9685705|FG000|COMPLETED|Period 1||87
8644820|NCT00607087|9685706|FG001|COMPLETED|Period 1||89
8644821|NCT00607087|9685707|FG002|COMPLETED|Period 1||89
8644822|NCT00607087|9685705|FG000|NOT COMPLETED|Period 1||12
8644823|NCT00607087|9685706|FG001|NOT COMPLETED|Period 1||6
8644824|NCT00607087|9685707|FG002|NOT COMPLETED|Period 1||5
8644825|NCT00607087|9685705|FG000|STARTED|Period 2||87
8644826|NCT00607087|9685706|FG001|STARTED|Period 2||89
8644827|NCT00607087|9685707|FG002|STARTED|Period 2||89
8644828|NCT00607087|9685705|FG000|COMPLETED|Period 2||86
8644829|NCT00607087|9685706|FG001|COMPLETED|Period 2||86
8644830|NCT00607087|9685707|FG002|COMPLETED|Period 2||84
8644831|NCT00607087|9685705|FG000|NOT COMPLETED|Period 2||1
8644832|NCT00607087|9685706|FG001|NOT COMPLETED|Period 2||3
8644833|NCT00607087|9685707|FG002|NOT COMPLETED|Period 2||5
8644834|NCT00607087|9685705|FG000|STARTED|Period 3||86
8644835|NCT00607087|9685706|FG001|STARTED|Period 3||86
8644836|NCT00607087|9685707|FG002|STARTED|Period 3||84
8644837|NCT00607087|9685705|FG000|COMPLETED|Period 3||84
8644838|NCT00607087|9685706|FG001|COMPLETED|Period 3||84
8644839|NCT00607087|9685707|FG002|COMPLETED|Period 3||84
8644840|NCT00607087|9685705|FG000|NOT COMPLETED|Period 3||2
8644841|NCT00607087|9685706|FG001|NOT COMPLETED|Period 3||2
8644842|NCT00607087|9685707|FG002|NOT COMPLETED|Period 3||0
8644843|NCT00607113|9685717|FG000|STARTED|Overall Study||19
8644844|NCT00607113|9685718|FG001|STARTED|Overall Study||20
8644845|NCT00607113|9685717|FG000|COMPLETED|Overall Study||19
8644846|NCT00607113|9685718|FG001|COMPLETED|Overall Study||20
8644847|NCT00607113|9685717|FG000|NOT COMPLETED|Overall Study||0
8644848|NCT00607113|9685718|FG001|NOT COMPLETED|Overall Study||0
8644849|NCT00607126|9685725|FG000|STARTED|Overall Study||17
8644850|NCT00607126|9685726|FG001|STARTED|Overall Study||19
8644851|NCT00607126|9685725|FG000|COMPLETED|Overall Study||17
8644852|NCT00607126|9685726|FG001|COMPLETED|Overall Study||19
8644853|NCT00607126|9685725|FG000|NOT COMPLETED|Overall Study||0
8644854|NCT00607126|9685726|FG001|NOT COMPLETED|Overall Study||0
8644855|NCT00607243|9685734|FG000|STARTED|Initial Post-vaccination Period||82
8644856|NCT00607243|9685735|FG001|STARTED|Initial Post-vaccination Period||41
8644857|NCT00607243|9685734|FG000|COMPLETED|Initial Post-vaccination Period||82
8644858|NCT00607243|9685735|FG001|COMPLETED|Initial Post-vaccination Period||41
8644859|NCT00607243|9685734|FG000|NOT COMPLETED|Initial Post-vaccination Period||0
8644860|NCT00607243|9685735|FG001|NOT COMPLETED|Initial Post-vaccination Period||0
8644861|NCT00607243|9685734|FG000|STARTED|Telephone Safety Assessment Period||82
8644862|NCT00607243|9685735|FG001|STARTED|Telephone Safety Assessment Period||41
8911201|NCT02144285|9970252|FG004|Received At Least One Dose of Study Drug|Overall Study||6
8644863|NCT00607243|9685734|FG000|COMPLETED|Telephone Safety Assessment Period|80 Available for 3 months 77 Available for 6 months|77
8644864|NCT00607243|9685735|FG001|COMPLETED|Telephone Safety Assessment Period|40 Available for 3 months 39 Available for 6 months|39
8644865|NCT00607243|9685734|FG000|NOT COMPLETED|Telephone Safety Assessment Period||5
8644866|NCT00607243|9685735|FG001|NOT COMPLETED|Telephone Safety Assessment Period||2
8644867|NCT00607269|9685743|FG000|STARTED|Overall Study||67
8644868|NCT00607269|9685744|FG001|STARTED|Overall Study||64
8644869|NCT00607269|9685743|FG000|COMPLETED|Overall Study||67
8644870|NCT00607269|9685744|FG001|COMPLETED|Overall Study||64
8644871|NCT00607269|9685743|FG000|NOT COMPLETED|Overall Study||0
8644872|NCT00607269|9685744|FG001|NOT COMPLETED|Overall Study||0
8644873|NCT00607321|9685750|FG000|STARTED|Overall Study||60
8644874|NCT00607321|9685750|FG000|COMPLETED|Overall Study||60
8644875|NCT00607321|9685750|FG000|NOT COMPLETED|Overall Study||0
8644876|NCT00607373|9685758|FG000|STARTED|Treatment Period||17
8644877|NCT00607373|9685759|FG001|STARTED|Treatment Period||34
8644878|NCT00607373|9685758|FG000|COMPLETED|Treatment Period|16 enrolled in open-label extension study NCT00694109|17
8644879|NCT00607373|9685759|FG001|COMPLETED|Treatment Period|23 enrolled in open-label extension study NCT00694109|28
8644880|NCT00607373|9685758|FG000|NOT COMPLETED|Treatment Period||0
8644881|NCT00607373|9685759|FG001|NOT COMPLETED|Treatment Period||6
8644882|NCT00607373|9685758|FG000|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|1
8644883|NCT00607373|9685759|FG001|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|11
8644884|NCT00607373|9685758|FG000|COMPLETED|Follow-up Period||0
8644885|NCT00607373|9685759|FG001|COMPLETED|Follow-up Period||6
8644886|NCT00607373|9685758|FG000|NOT COMPLETED|Follow-up Period||1
8644887|NCT00607373|9685759|FG001|NOT COMPLETED|Follow-up Period||5
8644888|NCT00607386|9685765|FG000|STARTED|Overall Study||28
8644889|NCT00607386|9685765|FG000|COMPLETED|Overall Study||27
8644890|NCT00607386|9685765|FG000|NOT COMPLETED|Overall Study||1
8644891|NCT00607594|9685769|FG000|STARTED|Overall Study||21
8644892|NCT00607594|9685769|FG000|COMPLETED|Overall Study||21
8644893|NCT00607594|9685769|FG000|NOT COMPLETED|Overall Study||0
8644894|NCT00607620|9685777|FG000|STARTED|Overall Study||409
8644895|NCT00607620|9685778|FG001|STARTED|Overall Study||469
8644896|NCT00607620|9685777|FG000|COMPLETED|Overall Study||409
8644897|NCT00607620|9685778|FG001|COMPLETED|Overall Study||469
8644898|NCT00607620|9685777|FG000|NOT COMPLETED|Overall Study||0
8644899|NCT00607620|9685778|FG001|NOT COMPLETED|Overall Study||0
8644900|NCT00607672|9685787|FG000|STARTED|Overall Study||32
8644901|NCT00607672|9685788|FG001|STARTED|Overall Study||27
8644902|NCT00607672|9685789|FG002|STARTED|Overall Study||27
8644903|NCT00607672|9685787|FG000|COMPLETED|Overall Study||28
8644904|NCT00607672|9685788|FG001|COMPLETED|Overall Study||24
8644905|NCT00607672|9685789|FG002|COMPLETED|Overall Study||22
8644906|NCT00607672|9685787|FG000|NOT COMPLETED|Overall Study||4
8644907|NCT00607672|9685788|FG001|NOT COMPLETED|Overall Study||3
8644908|NCT00607672|9685789|FG002|NOT COMPLETED|Overall Study||5
8644909|NCT00607724|9685807|FG000|STARTED|Stage 1: Dose Escalation||7
8644910|NCT00607724|9685808|FG001|STARTED|Stage 1: Dose Escalation||9
8644911|NCT00607724|9685809|FG002|STARTED|Stage 1: Dose Escalation||4
8644912|NCT00607724|9685810|FG003|STARTED|Stage 1: Dose Escalation||0
8644913|NCT00607724|9685811|FG004|STARTED|Stage 1: Dose Escalation||0
8644914|NCT00607724|9685812|FG005|STARTED|Stage 1: Dose Escalation||0
8644915|NCT00607724|9685813|FG006|STARTED|Stage 1: Dose Escalation||0
8644916|NCT00607724|9685807|FG000|COMPLETED|Stage 1: Dose Escalation||0
8644917|NCT00607724|9685808|FG001|COMPLETED|Stage 1: Dose Escalation|Participants still on treatment at time of study closure were considered 'completers'.|1
8644918|NCT00607724|9685809|FG002|COMPLETED|Stage 1: Dose Escalation||0
8644919|NCT00607724|9685810|FG003|COMPLETED|Stage 1: Dose Escalation||0
8644920|NCT00607724|9685811|FG004|COMPLETED|Stage 1: Dose Escalation||0
8644921|NCT00607724|9685812|FG005|COMPLETED|Stage 1: Dose Escalation||0
8644922|NCT00607724|9685813|FG006|COMPLETED|Stage 1: Dose Escalation||0
8644923|NCT00607724|9685807|FG000|NOT COMPLETED|Stage 1: Dose Escalation||7
8644924|NCT00607724|9685808|FG001|NOT COMPLETED|Stage 1: Dose Escalation||8
8644925|NCT00607724|9685809|FG002|NOT COMPLETED|Stage 1: Dose Escalation||4
8644926|NCT00607724|9685810|FG003|NOT COMPLETED|Stage 1: Dose Escalation||0
8644927|NCT00607724|9685811|FG004|NOT COMPLETED|Stage 1: Dose Escalation||0
8644928|NCT00607724|9685812|FG005|NOT COMPLETED|Stage 1: Dose Escalation||0
8644929|NCT00607724|9685813|FG006|NOT COMPLETED|Stage 1: Dose Escalation||0
8644930|NCT00607724|9685807|FG000|STARTED|Stage 2: Expanded Cohort||0
8644931|NCT00607724|9685808|FG001|STARTED|Stage 2: Expanded Cohort||0
8644932|NCT00607724|9685809|FG002|STARTED|Stage 2: Expanded Cohort||0
8644933|NCT00607724|9685810|FG003|STARTED|Stage 2: Expanded Cohort||6
8644934|NCT00607724|9685811|FG004|STARTED|Stage 2: Expanded Cohort||14
8644935|NCT00607724|9685812|FG005|STARTED|Stage 2: Expanded Cohort||12
8644936|NCT00607724|9685813|FG006|STARTED|Stage 2: Expanded Cohort||16
8644937|NCT00607724|9685807|FG000|COMPLETED|Stage 2: Expanded Cohort||0
8644938|NCT00607724|9685808|FG001|COMPLETED|Stage 2: Expanded Cohort||0
8644939|NCT00607724|9685809|FG002|COMPLETED|Stage 2: Expanded Cohort||0
8644940|NCT00607724|9685810|FG003|COMPLETED|Stage 2: Expanded Cohort|Participants still on treatment at time of study closure were considered 'completers'.|1
8644941|NCT00607724|9685811|FG004|COMPLETED|Stage 2: Expanded Cohort|Participants still on treatment at time of study closure were considered 'completers'.|5
8644942|NCT00607724|9685812|FG005|COMPLETED|Stage 2: Expanded Cohort||0
8644943|NCT00607724|9685813|FG006|COMPLETED|Stage 2: Expanded Cohort|Participants still on treatment at time of study closure were considered 'completers'.|5
8644944|NCT00607724|9685807|FG000|NOT COMPLETED|Stage 2: Expanded Cohort||0
8644945|NCT00607724|9685808|FG001|NOT COMPLETED|Stage 2: Expanded Cohort||0
8644946|NCT00607724|9685809|FG002|NOT COMPLETED|Stage 2: Expanded Cohort||0
8644947|NCT00607724|9685810|FG003|NOT COMPLETED|Stage 2: Expanded Cohort||5
8644948|NCT00607724|9685811|FG004|NOT COMPLETED|Stage 2: Expanded Cohort||9
8644949|NCT00607724|9685812|FG005|NOT COMPLETED|Stage 2: Expanded Cohort||12
8644950|NCT00607724|9685813|FG006|NOT COMPLETED|Stage 2: Expanded Cohort||11
8644951|NCT00607789|9685839|FG000|STARTED|Overall Study|20 participants were randomized in each group|20
8644952|NCT00607789|9685840|FG001|STARTED|Overall Study||20
8644953|NCT00607789|9685839|FG000|COMPLETED|Overall Study||13
8644954|NCT00607789|9685840|FG001|COMPLETED|Overall Study||14
8644955|NCT00607789|9685839|FG000|NOT COMPLETED|Overall Study||7
8644956|NCT00607789|9685840|FG001|NOT COMPLETED|Overall Study||6
8644957|NCT00607815|9685848|FG000|STARTED|Overall Study||43
8644958|NCT00607815|9685849|FG001|STARTED|Overall Study||36
8644959|NCT00607815|9685848|FG000|COMPLETED|Overall Study||20
8644960|NCT00607815|9685849|FG001|COMPLETED|Overall Study||25
8644961|NCT00607815|9685848|FG000|NOT COMPLETED|Overall Study||23
8644962|NCT00607815|9685849|FG001|NOT COMPLETED|Overall Study||11
8644963|NCT00607867|9685859|FG000|STARTED|Overall Study||7
8644964|NCT00607867|9685860|FG001|STARTED|Overall Study||7
8644965|NCT00607867|9685859|FG000|COMPLETED|Overall Study||7
8644966|NCT00607867|9685860|FG001|COMPLETED|Overall Study||7
8644967|NCT00607867|9685859|FG000|NOT COMPLETED|Overall Study||0
8644968|NCT00607867|9685860|FG001|NOT COMPLETED|Overall Study||0
8644969|NCT00607880|9685868|FG000|STARTED|Overall Study||50
8644970|NCT00607880|9685869|FG001|STARTED|Overall Study||50
8644971|NCT00607880|9685868|FG000|COMPLETED|Overall Study||49
8644972|NCT00607880|9685869|FG001|COMPLETED|Overall Study||50
8644973|NCT00607880|9685868|FG000|NOT COMPLETED|Overall Study||1
8644974|NCT00607880|9685869|FG001|NOT COMPLETED|Overall Study||0
8644975|NCT00607893|9685877|FG000|STARTED|Overall Study||77
8644976|NCT00607893|9685878|FG001|STARTED|Overall Study||76
8644977|NCT00607893|9685877|FG000|Completed Baseline Visit|Overall Study||74
8644978|NCT00607893|9685878|FG001|Completed Baseline Visit|Overall Study||75
8644979|NCT00607893|9685877|FG000|Completed 8 Week Visit|Overall Study||71
8644980|NCT00607893|9685878|FG001|Completed 8 Week Visit|Overall Study||72
8644981|NCT00607893|9685877|FG000|Completed 12 Week Visit|Overall Study|12 Week Visit only offered to participants on actual CPAP Treatment|0
8644982|NCT00607893|9685878|FG001|Completed 12 Week Visit|Overall Study|12 Week Visit only offered to participants on actual CPAP Treatment|29
8644983|NCT00607893|9685877|FG000|COMPLETED|Overall Study||71
8644984|NCT00607893|9685878|FG001|COMPLETED|Overall Study||72
8644985|NCT00607893|9685877|FG000|NOT COMPLETED|Overall Study||6
8644986|NCT00607893|9685878|FG001|NOT COMPLETED|Overall Study||4
8644987|NCT00607919|9685888|FG000|STARTED|Acute Phase||120
8644988|NCT00607919|9685889|FG001|STARTED|Acute Phase||89
8644989|NCT00607919|9685888|FG000|COMPLETED|Acute Phase|2 participants completed acute phase but did not continue into open-label.|86
8644990|NCT00607919|9685889|FG001|COMPLETED|Acute Phase|2 participants completed acute phase but did not continue into open-label.|73
8644991|NCT00607919|9685888|FG000|NOT COMPLETED|Acute Phase||34
8644992|NCT00607919|9685889|FG001|NOT COMPLETED|Acute Phase||16
8644993|NCT00607919|9685888|FG000|STARTED|Open-Label Phase||84
8644994|NCT00607919|9685889|FG001|STARTED|Open-Label Phase||71
8644995|NCT00607919|9685888|FG000|COMPLETED|Open-Label Phase||74
8644996|NCT00607919|9685889|FG001|COMPLETED|Open-Label Phase||59
8644997|NCT00607919|9685888|FG000|NOT COMPLETED|Open-Label Phase||10
8644998|NCT00607919|9685889|FG001|NOT COMPLETED|Open-Label Phase||12
8644999|NCT00607997|9685901|FG000|STARTED|Overall Study||29
8645000|NCT00607997|9685902|FG001|STARTED|Overall Study||35
8645001|NCT00607997|9685903|FG002|STARTED|Overall Study||29
8645002|NCT00607997|9685904|FG003|STARTED|Overall Study||20
8645003|NCT00607997|9685901|FG000|COMPLETED|Overall Study||2
8645004|NCT00607997|9685902|FG001|COMPLETED|Overall Study||8
8645005|NCT00607997|9685903|FG002|COMPLETED|Overall Study||5
8645006|NCT00607997|9685904|FG003|COMPLETED|Overall Study||4
8645007|NCT00607997|9685901|FG000|NOT COMPLETED|Overall Study||27
8645008|NCT00607997|9685902|FG001|NOT COMPLETED|Overall Study||27
8645009|NCT00607997|9685903|FG002|NOT COMPLETED|Overall Study||24
8645010|NCT00607997|9685904|FG003|NOT COMPLETED|Overall Study||16
8645011|NCT00608062|9685925|FG000|STARTED|Overall Study|25 women completed baseline testing, 4 women withdrew prior to randomization|12
8645012|NCT00608062|9685926|FG001|STARTED|Overall Study||12
8645013|NCT00608062|9685927|FG002|STARTED|Overall Study|43 women completed baseline testing, 3 women withdrew prior to randomization|19
8645014|NCT00608062|9685928|FG003|STARTED|Overall Study||21
8645015|NCT00608062|9685929|FG004|STARTED|Overall Study||13
8645016|NCT00608062|9685930|FG005|STARTED|Overall Study||15
8645017|NCT00608062|9685925|FG000|COMPLETED|Overall Study||12
8645018|NCT00608062|9685926|FG001|COMPLETED|Overall Study||12
8645019|NCT00608062|9685927|FG002|COMPLETED|Overall Study||19
8645020|NCT00608062|9685928|FG003|COMPLETED|Overall Study||21
8727434|NCT01043185|9774769|FG001|NOT COMPLETED|Period 3 - Second Intervention||0
8727435|NCT01043185|9774770|FG002|NOT COMPLETED|Period 3 - Second Intervention||0
8727436|NCT01043185|9774771|FG003|NOT COMPLETED|Period 3 - Second Intervention||0
8727437|NCT01043185|9774772|FG004|NOT COMPLETED|Period 3 - Second Intervention||0
8727438|NCT01043185|9774773|FG005|NOT COMPLETED|Period 3 - Second Intervention||0
8727439|NCT01043185|9774774|FG006|NOT COMPLETED|Period 3 - Second Intervention||0
8727440|NCT01043185|9774775|FG007|NOT COMPLETED|Period 3 - Second Intervention||0
8727441|NCT01043185|9774776|FG008|NOT COMPLETED|Period 3 - Second Intervention||0
8727442|NCT01043185|9774777|FG009|NOT COMPLETED|Period 3 - Second Intervention||0
8727443|NCT01043185|9774768|FG000|STARTED|Period 4 - Second Washout Period||3
8727444|NCT01043185|9774769|FG001|STARTED|Period 4 - Second Washout Period||2
8727445|NCT01043185|9774770|FG002|STARTED|Period 4 - Second Washout Period||3
8645021|NCT00608062|9685929|FG004|COMPLETED|Overall Study||13
8645022|NCT00608062|9685930|FG005|COMPLETED|Overall Study||15
8645023|NCT00608062|9685925|FG000|NOT COMPLETED|Overall Study||0
8645024|NCT00608062|9685926|FG001|NOT COMPLETED|Overall Study||0
8645025|NCT00608062|9685927|FG002|NOT COMPLETED|Overall Study||0
8645026|NCT00608062|9685928|FG003|NOT COMPLETED|Overall Study||0
8645027|NCT00608062|9685929|FG004|NOT COMPLETED|Overall Study||0
8645028|NCT00608062|9685930|FG005|NOT COMPLETED|Overall Study||0
8645029|NCT00608140|9685948|FG000|STARTED|Overall Study||1
8645030|NCT00608140|9685949|FG001|STARTED|Overall Study||1
8645031|NCT00608140|9685948|FG000|COMPLETED|Overall Study|Study ended early due to low enrollment|0
8645032|NCT00608140|9685949|FG001|COMPLETED|Overall Study|Study ended early due to low enrollment|0
8645033|NCT00608140|9685948|FG000|NOT COMPLETED|Overall Study||1
8645034|NCT00608140|9685949|FG001|NOT COMPLETED|Overall Study||1
8645035|NCT00608205|9685966|FG000|STARTED|Overall Study||35
8645036|NCT00608205|9685967|FG001|STARTED|Overall Study||34
8645037|NCT00608205|9685966|FG000|COMPLETED|Overall Study||32
8645038|NCT00608205|9685967|FG001|COMPLETED|Overall Study||31
8645039|NCT00608205|9685966|FG000|NOT COMPLETED|Overall Study||3
8645040|NCT00608205|9685967|FG001|NOT COMPLETED|Overall Study||3
8645041|NCT00608244|9685975|FG000|STARTED|Overall Study||59
8645042|NCT00608244|9685975|FG000|COMPLETED|Overall Study||57
8645043|NCT00608244|9685975|FG000|NOT COMPLETED|Overall Study||2
8645044|NCT00608322|9685983|FG000|STARTED|Overall Study||26
8645045|NCT00608322|9685984|FG001|STARTED|Overall Study||23
8645046|NCT00608322|9685983|FG000|COMPLETED|Overall Study||24
8645047|NCT00608322|9685984|FG001|COMPLETED|Overall Study||22
8645048|NCT00608322|9685983|FG000|NOT COMPLETED|Overall Study||2
8645049|NCT00608322|9685984|FG001|NOT COMPLETED|Overall Study||1
8645050|NCT00608426|9685992|FG000|STARTED|Overall Study||2604
8645051|NCT00608426|9685993|FG001|STARTED|Overall Study||2519
8645052|NCT00608426|9685992|FG000|COMPLETED|Overall Study|This is total # of completed surveys. Not completed primary outcome.|1768
8645053|NCT00608426|9685993|FG001|COMPLETED|Overall Study|This is total # of completed surveys. Not completed primary outcome.|1614
8645054|NCT00608426|9685992|FG000|NOT COMPLETED|Overall Study||836
8645055|NCT00608426|9685993|FG001|NOT COMPLETED|Overall Study||905
8645056|NCT00608491|9686001|FG000|STARTED|Overall Study||94
8645057|NCT00608491|9686002|FG001|STARTED|Overall Study||94
8645058|NCT00608491|9686001|FG000|COMPLETED|Overall Study||73
8645059|NCT00608491|9686002|FG001|COMPLETED|Overall Study||72
8645060|NCT00608491|9686001|FG000|NOT COMPLETED|Overall Study||21
8645061|NCT00608491|9686002|FG001|NOT COMPLETED|Overall Study||22
8645062|NCT00608517|9686011|FG000|STARTED|Overall Study||2
8645063|NCT00608517|9686012|FG001|STARTED|Overall Study||3
8645064|NCT00608517|9686013|FG002|STARTED|Overall Study||1
8645065|NCT00608517|9686011|FG000|COMPLETED|Overall Study||1
8645066|NCT00608517|9686012|FG001|COMPLETED|Overall Study||3
8645067|NCT00608517|9686013|FG002|COMPLETED|Overall Study||1
8645068|NCT00608517|9686011|FG000|NOT COMPLETED|Overall Study||1
8645069|NCT00608517|9686012|FG001|NOT COMPLETED|Overall Study||0
8645070|NCT00608517|9686013|FG002|NOT COMPLETED|Overall Study||0
8645071|NCT00608530|9686026|FG000|STARTED|Study 1 Psychologist-delivered Treatment|Randomized|33
8645072|NCT00608530|9686027|FG001|STARTED|Study 1 Psychologist-delivered Treatment|Randomized|33
8645073|NCT00608530|9686028|FG002|STARTED|Study 1 Psychologist-delivered Treatment||0
8645074|NCT00608530|9686029|FG003|STARTED|Study 1 Psychologist-delivered Treatment||0
8645075|NCT00608530|9686026|FG000|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||28
8645076|NCT00608530|9686027|FG001|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||31
8645077|NCT00608530|9686028|FG002|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||0
8645078|NCT00608530|9686029|FG003|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||0
8645079|NCT00608530|9686026|FG000|COMPLETED|Study 1 Psychologist-delivered Treatment||22
8645080|NCT00608530|9686027|FG001|COMPLETED|Study 1 Psychologist-delivered Treatment||28
8645081|NCT00608530|9686028|FG002|COMPLETED|Study 1 Psychologist-delivered Treatment||0
8645082|NCT00608530|9686029|FG003|COMPLETED|Study 1 Psychologist-delivered Treatment||0
8645083|NCT00608530|9686026|FG000|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||11
8645084|NCT00608530|9686027|FG001|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||5
8691668|NCT00856414|9737010|FG000|NOT COMPLETED|Overall Study||0
8727446|NCT01043185|9774771|FG003|STARTED|Period 4 - Second Washout Period||2
8727447|NCT01043185|9774772|FG004|STARTED|Period 4 - Second Washout Period||2
8727448|NCT01043185|9774773|FG005|STARTED|Period 4 - Second Washout Period||3
8727449|NCT01043185|9774774|FG006|STARTED|Period 4 - Second Washout Period||3
8727450|NCT01043185|9774775|FG007|STARTED|Period 4 - Second Washout Period||3
8727451|NCT01043185|9774776|FG008|STARTED|Period 4 - Second Washout Period||3
8727452|NCT01043185|9774777|FG009|STARTED|Period 4 - Second Washout Period||3
8727453|NCT01043185|9774768|FG000|COMPLETED|Period 4 - Second Washout Period||3
8727454|NCT01043185|9774769|FG001|COMPLETED|Period 4 - Second Washout Period||2
8727455|NCT01043185|9774770|FG002|COMPLETED|Period 4 - Second Washout Period||3
8727456|NCT01043185|9774771|FG003|COMPLETED|Period 4 - Second Washout Period||2
8727457|NCT01043185|9774772|FG004|COMPLETED|Period 4 - Second Washout Period||2
8727458|NCT01043185|9774773|FG005|COMPLETED|Period 4 - Second Washout Period||3
8727459|NCT01043185|9774774|FG006|COMPLETED|Period 4 - Second Washout Period||3
8727460|NCT01043185|9774775|FG007|COMPLETED|Period 4 - Second Washout Period||3
8727461|NCT01043185|9774776|FG008|COMPLETED|Period 4 - Second Washout Period||3
8645085|NCT00608530|9686028|FG002|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||0
8645086|NCT00608530|9686029|FG003|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||0
8645087|NCT00608530|9686026|FG000|STARTED|Study 2 Nurse-delivered Treatments||0
8645088|NCT00608530|9686027|FG001|STARTED|Study 2 Nurse-delivered Treatments||0
8645089|NCT00608530|9686028|FG002|STARTED|Study 2 Nurse-delivered Treatments||33
8645090|NCT00608530|9686029|FG003|STARTED|Study 2 Nurse-delivered Treatments||34
8645091|NCT00608530|9686026|FG000|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||0
8645092|NCT00608530|9686027|FG001|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||0
8645093|NCT00608530|9686028|FG002|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||30
8645094|NCT00608530|9686029|FG003|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||31
8645095|NCT00608530|9686026|FG000|COMPLETED|Study 2 Nurse-delivered Treatments||0
8645096|NCT00608530|9686027|FG001|COMPLETED|Study 2 Nurse-delivered Treatments||0
8645097|NCT00608530|9686028|FG002|COMPLETED|Study 2 Nurse-delivered Treatments||21
8645098|NCT00608530|9686029|FG003|COMPLETED|Study 2 Nurse-delivered Treatments||27
8645099|NCT00608530|9686026|FG000|NOT COMPLETED|Study 2 Nurse-delivered Treatments||0
8645100|NCT00608530|9686027|FG001|NOT COMPLETED|Study 2 Nurse-delivered Treatments||0
8645101|NCT00608530|9686028|FG002|NOT COMPLETED|Study 2 Nurse-delivered Treatments||12
8645102|NCT00608530|9686029|FG003|NOT COMPLETED|Study 2 Nurse-delivered Treatments||7
8645103|NCT00608543|9686044|FG000|STARTED|Overall Study||17
8645104|NCT00608543|9686044|FG000|COMPLETED|Overall Study||13
8645105|NCT00608543|9686044|FG000|NOT COMPLETED|Overall Study||4
8645106|NCT00608569|9686051|FG000|STARTED|Overall Study||129
8645107|NCT00608569|9686052|FG001|STARTED|Overall Study||128
8645108|NCT00608569|9686051|FG000|COMPLETED|Overall Study||119
8645109|NCT00608569|9686052|FG001|COMPLETED|Overall Study||119
8645110|NCT00608569|9686051|FG000|NOT COMPLETED|Overall Study||10
8645111|NCT00608569|9686052|FG001|NOT COMPLETED|Overall Study||9
8645112|NCT00608582|9686060|FG000|STARTED|Overall Study||14
8645113|NCT00608582|9686061|FG001|STARTED|Overall Study||11
8645114|NCT00608582|9686060|FG000|COMPLETED|Overall Study||10
8645115|NCT00608582|9686061|FG001|COMPLETED|Overall Study||7
8645116|NCT00608582|9686060|FG000|NOT COMPLETED|Overall Study||4
8645117|NCT00608582|9686061|FG001|NOT COMPLETED|Overall Study||4
8645118|NCT00608634|9686072|FG000|STARTED|Overall Study||28
8645119|NCT00608634|9686073|FG001|STARTED|Overall Study||27
8645120|NCT00608634|9686074|FG002|STARTED|Overall Study||28
8645121|NCT00608634|9686072|FG000|COMPLETED|Overall Study||26
8645122|NCT00608634|9686073|FG001|COMPLETED|Overall Study||26
8645123|NCT00608634|9686074|FG002|COMPLETED|Overall Study||27
8645124|NCT00608634|9686072|FG000|NOT COMPLETED|Overall Study||2
8645125|NCT00608634|9686073|FG001|NOT COMPLETED|Overall Study||1
8645126|NCT00608634|9686074|FG002|NOT COMPLETED|Overall Study||1
8645127|NCT00608829|9686084|FG000|STARTED|Overall Study||23
8645128|NCT00608829|9686084|FG000|COMPLETED|Overall Study||8
8645129|NCT00608829|9686084|FG000|NOT COMPLETED|Overall Study||15
8645130|NCT00608842|9686092|FG000|STARTED|Overall Study||15
8645131|NCT00608842|9686093|FG001|STARTED|Overall Study||15
8645132|NCT00608842|9686094|FG002|STARTED|Overall Study||15
8645133|NCT00608842|9686095|FG003|STARTED|Overall Study||17
8645134|NCT00608842|9686092|FG000|COMPLETED|Overall Study||14
8645135|NCT00608842|9686093|FG001|COMPLETED|Overall Study||14
8645136|NCT00608842|9686094|FG002|COMPLETED|Overall Study||13
8645137|NCT00608842|9686095|FG003|COMPLETED|Overall Study||16
8645138|NCT00608842|9686092|FG000|NOT COMPLETED|Overall Study||1
8645139|NCT00608842|9686093|FG001|NOT COMPLETED|Overall Study||1
8645140|NCT00608842|9686094|FG002|NOT COMPLETED|Overall Study||2
8645141|NCT00608842|9686095|FG003|NOT COMPLETED|Overall Study||1
8645142|NCT00608868|9686105|FG000|STARTED|Overall Study||156
8645143|NCT00608868|9686105|FG000|Enrolled|Overall Study||156
8645144|NCT00608868|9686105|FG000|Safety Population|Overall Study|2 patients who received no study treatment were excluded|154
8645145|NCT00608868|9686105|FG000|Treatment Completed|Overall Study||141
8645146|NCT00608868|9686105|FG000|Intention to Treat (ITT) Population|Overall Study|8 patients who had no target lesion and 8 who had no tumor assessment after baseline were excluded|138
8645147|NCT00608868|9686105|FG000|Per Protocol (PP) Population|Overall Study||121
8645148|NCT00608868|9686105|FG000|COMPLETED|Overall Study||141
8645149|NCT00608868|9686105|FG000|NOT COMPLETED|Overall Study||15
8645150|NCT00608881|9686111|FG000|STARTED|Overall Study||303
8645151|NCT00608881|9686112|FG001|STARTED|Overall Study||306
8645152|NCT00608881|9686111|FG000|COMPLETED|Overall Study||224
8645153|NCT00608881|9686112|FG001|COMPLETED|Overall Study||240
8645154|NCT00608881|9686111|FG000|NOT COMPLETED|Overall Study||79
8645155|NCT00608881|9686112|FG001|NOT COMPLETED|Overall Study||66
8645156|NCT00608894|9686120|FG000|STARTED|Overall Study||7
8645157|NCT00608894|9686121|FG001|STARTED|Overall Study||6
8645158|NCT00608894|9686120|FG000|COMPLETED|Overall Study||7
8645159|NCT00608894|9686121|FG001|COMPLETED|Overall Study|One patient was granted permission to crossover to LCP-Tacro due to treatment intolerance|4
8645160|NCT00608894|9686120|FG000|NOT COMPLETED|Overall Study||0
8645161|NCT00608894|9686121|FG001|NOT COMPLETED|Overall Study||2
8645162|NCT00608907|9686132|FG000|STARTED|Overall Study||30
8645163|NCT00608907|9686133|FG001|STARTED|Overall Study||13
8645164|NCT00608907|9686134|FG002|STARTED|Overall Study||18
8645165|NCT00608907|9686132|FG000|COMPLETED|Overall Study||18
8645166|NCT00608907|9686133|FG001|COMPLETED|Overall Study||13
8645167|NCT00608907|9686134|FG002|COMPLETED|Overall Study||17
8645168|NCT00608907|9686132|FG000|NOT COMPLETED|Overall Study||12
8645169|NCT00608907|9686133|FG001|NOT COMPLETED|Overall Study||0
8645170|NCT00608907|9686134|FG002|NOT COMPLETED|Overall Study||1
8645171|NCT00608959|9686144|FG000|STARTED|Part 1|25 subjects each participated in Parts 1 and 2 .A total of 20 subjects participated in both parts.|25
8645172|NCT00608959|9686144|FG000|COMPLETED|Part 1||24
8645173|NCT00608959|9686144|FG000|NOT COMPLETED|Part 1||1
8645174|NCT00608959|9686144|FG000|STARTED|Part 2|20 Part 1 subjects also participated in Part 2.Five more subjects were enrolled for a total of 25.|25
8645175|NCT00608959|9686144|FG000|COMPLETED|Part 2||25
8645176|NCT00608959|9686144|FG000|NOT COMPLETED|Part 2||0
8645177|NCT00608985|9686158|FG000|STARTED|Overall Study|Randomized and started double-blind treatment|177
8645178|NCT00608985|9686159|FG001|STARTED|Overall Study|Randomized and started double-blind treatment|186
8645179|NCT00608985|9686160|FG002|STARTED|Overall Study|Randomized and started double-blind treatment|176
8645180|NCT00608985|9686161|FG003|STARTED|Overall Study|Randomized and started double-blind treatment|168
8645181|NCT00608985|9686158|FG000|Completed Double-blind Treatment|Overall Study||163
8645182|NCT00608985|9686159|FG001|Completed Double-blind Treatment|Overall Study||174
8645183|NCT00608985|9686160|FG002|Completed Double-blind Treatment|Overall Study||171
8645184|NCT00608985|9686161|FG003|Completed Double-blind Treatment|Overall Study||161
8645185|NCT00608985|9686158|FG000|COMPLETED|Overall Study|Completed follow-up|161
8645186|NCT00608985|9686159|FG001|COMPLETED|Overall Study|Completed follow-up|173
8645187|NCT00608985|9686160|FG002|COMPLETED|Overall Study|Completed follow-up|170
8645188|NCT00608985|9686161|FG003|COMPLETED|Overall Study|Completed follow-up|159
8645189|NCT00608985|9686158|FG000|NOT COMPLETED|Overall Study||16
8645190|NCT00608985|9686159|FG001|NOT COMPLETED|Overall Study||13
8645191|NCT00608985|9686160|FG002|NOT COMPLETED|Overall Study||6
8645192|NCT00608985|9686161|FG003|NOT COMPLETED|Overall Study||9
8645193|NCT00609128|9686171|FG000|STARTED|Overall Study||21
8645194|NCT00609128|9686171|FG000|COMPLETED|Overall Study||21
8645195|NCT00609128|9686171|FG000|NOT COMPLETED|Overall Study||0
8645196|NCT00609167|9686178|FG000|STARTED|Overall Study||33
8645197|NCT00609167|9686179|FG001|STARTED|Overall Study||30
8645198|NCT00609167|9686178|FG000|COMPLETED|Overall Study||25
8645199|NCT00609167|9686179|FG001|COMPLETED|Overall Study||23
8645200|NCT00609167|9686178|FG000|NOT COMPLETED|Overall Study||8
8645201|NCT00609167|9686179|FG001|NOT COMPLETED|Overall Study||7
8645202|NCT00609245|9686185|FG000|STARTED|Overall Study||13
8645203|NCT00609245|9686185|FG000|COMPLETED|Overall Study||12
8645204|NCT00609245|9686185|FG000|NOT COMPLETED|Overall Study||1
8645205|NCT00609271|9686193|FG000|STARTED|Overall Study||75
8645206|NCT00609271|9686194|FG001|STARTED|Overall Study||73
8645207|NCT00609271|9686193|FG000|COMPLETED|Overall Study||59
8645208|NCT00609271|9686194|FG001|COMPLETED|Overall Study||60
8645209|NCT00609271|9686193|FG000|NOT COMPLETED|Overall Study||16
8645210|NCT00609271|9686194|FG001|NOT COMPLETED|Overall Study||13
8645211|NCT00609336|9686200|FG000|STARTED|Overall Study||35
8645212|NCT00609336|9686200|FG000|Surgery|Overall Study||22
8645213|NCT00609336|9686200|FG000|COMPLETED|Overall Study||22
8645214|NCT00609336|9686200|FG000|NOT COMPLETED|Overall Study||13
8691669|NCT00856492|9737017|FG000|STARTED|Overall Study||99
8691670|NCT00856492|9737018|FG001|STARTED|Overall Study||63
8691671|NCT00856492|9737019|FG002|STARTED|Overall Study||53
8691672|NCT00856492|9737017|FG000|Toxicity Eval|Overall Study||96
8691673|NCT00856492|9737018|FG001|Toxicity Eval|Overall Study||60
8691674|NCT00856492|9737019|FG002|Toxicity Eval|Overall Study||51
8691675|NCT00856492|9737017|FG000|COMPLETED|Overall Study||98
8691676|NCT00856492|9737018|FG001|COMPLETED|Overall Study||62
8691677|NCT00856492|9737019|FG002|COMPLETED|Overall Study||51
8691678|NCT00856492|9737017|FG000|NOT COMPLETED|Overall Study||1
8691679|NCT00856492|9737018|FG001|NOT COMPLETED|Overall Study||1
8691680|NCT00856492|9737019|FG002|NOT COMPLETED|Overall Study||2
8691681|NCT00856518|9737032|FG000|STARTED|Overall Study||24
8691682|NCT00856518|9737033|FG001|STARTED|Overall Study||18
8691683|NCT00856518|9737032|FG000|COMPLETED|Overall Study||20
8691684|NCT00856518|9737033|FG001|COMPLETED|Overall Study||16
8691685|NCT00856518|9737032|FG000|NOT COMPLETED|Overall Study||4
8691686|NCT00856518|9737033|FG001|NOT COMPLETED|Overall Study||2
8691687|NCT00856544|9737045|FG000|STARTED|Overall Study||318
8691688|NCT00856544|9737046|FG001|STARTED|Overall Study||318
8691689|NCT00856544|9737047|FG002|STARTED|Overall Study||79
8691690|NCT00856544|9737048|FG003|STARTED|Overall Study||80
8691691|NCT00856544|9737045|FG000|Treated|Overall Study||315
8691692|NCT00856544|9737046|FG001|Treated|Overall Study||318
8691693|NCT00856544|9737047|FG002|Treated|Overall Study||79
8691694|NCT00856544|9737048|FG003|Treated|Overall Study||80
8691695|NCT00856544|9737045|FG000|COMPLETED|Overall Study||261
8691696|NCT00856544|9737046|FG001|COMPLETED|Overall Study||252
8691697|NCT00856544|9737047|FG002|COMPLETED|Overall Study||71
8691698|NCT00856544|9737048|FG003|COMPLETED|Overall Study||67
8691699|NCT00856544|9737045|FG000|NOT COMPLETED|Overall Study||57
8691700|NCT00856544|9737046|FG001|NOT COMPLETED|Overall Study||66
8691701|NCT00856544|9737047|FG002|NOT COMPLETED|Overall Study||8
8691702|NCT00856544|9737048|FG003|NOT COMPLETED|Overall Study||13
8691703|NCT00856557|9737072|FG000|STARTED|Overall Study||62
8691704|NCT00856557|9737073|FG001|STARTED|Overall Study||76
8691705|NCT00856557|9737072|FG000|Received Intervention/Control|Overall Study||62
8691706|NCT00856557|9737073|FG001|Received Intervention/Control|Overall Study||76
8691707|NCT00856557|9737072|FG000|Tested With Standardized Patients|Overall Study||62
8645215|NCT00609362|9686207|FG000|STARTED|Overall Study||29
8645216|NCT00609362|9686208|FG001|STARTED|Overall Study||28
8645217|NCT00609362|9686207|FG000|COMPLETED|Overall Study||26
8645218|NCT00609362|9686208|FG001|COMPLETED|Overall Study||27
8645219|NCT00609362|9686207|FG000|NOT COMPLETED|Overall Study||3
8645220|NCT00609362|9686208|FG001|NOT COMPLETED|Overall Study||1
8645221|NCT00609466|9686217|FG000|STARTED|Overall Study||96
8645222|NCT00609466|9686218|FG001|STARTED|Overall Study||96
8645223|NCT00609466|9686219|FG002|STARTED|Overall Study||99
8645224|NCT00609466|9686217|FG000|COMPLETED|Overall Study||94
8645225|NCT00609466|9686218|FG001|COMPLETED|Overall Study||90
8645226|NCT00609466|9686219|FG002|COMPLETED|Overall Study||95
8645227|NCT00609466|9686217|FG000|NOT COMPLETED|Overall Study||2
8645228|NCT00609466|9686218|FG001|NOT COMPLETED|Overall Study||6
8645229|NCT00609466|9686219|FG002|NOT COMPLETED|Overall Study||4
8645230|NCT00609492|9686230|FG000|STARTED|Overall Study||44
8645231|NCT00609492|9686231|FG001|STARTED|Overall Study||72
8645232|NCT00609492|9686232|FG002|STARTED|Overall Study||129
8645233|NCT00609492|9686230|FG000|COMPLETED|Overall Study||43
8645234|NCT00609492|9686231|FG001|COMPLETED|Overall Study||69
8645235|NCT00609492|9686232|FG002|COMPLETED|Overall Study||122
8645236|NCT00609492|9686230|FG000|NOT COMPLETED|Overall Study||1
8645237|NCT00609492|9686231|FG001|NOT COMPLETED|Overall Study||3
8645238|NCT00609492|9686232|FG002|NOT COMPLETED|Overall Study||7
8645239|NCT00609518|9686244|FG000|STARTED|Overall Study||54
8645240|NCT00609518|9686245|FG001|STARTED|Overall Study||57
8645241|NCT00609518|9686244|FG000|Completed 6 Treatment Cycles|Overall Study||19
8645242|NCT00609518|9686245|FG001|Completed 6 Treatment Cycles|Overall Study||22
8645243|NCT00609518|9686244|FG000|COMPLETED|Overall Study||11
8645244|NCT00609518|9686245|FG001|COMPLETED|Overall Study||17
8645245|NCT00609518|9686244|FG000|NOT COMPLETED|Overall Study||43
8645246|NCT00609518|9686245|FG001|NOT COMPLETED|Overall Study||40
8727462|NCT01043185|9774777|FG009|COMPLETED|Period 4 - Second Washout Period||3
8727463|NCT01043185|9774768|FG000|NOT COMPLETED|Period 4 - Second Washout Period||0
8727464|NCT01043185|9774769|FG001|NOT COMPLETED|Period 4 - Second Washout Period||0
8727465|NCT01043185|9774770|FG002|NOT COMPLETED|Period 4 - Second Washout Period||0
8727466|NCT01043185|9774771|FG003|NOT COMPLETED|Period 4 - Second Washout Period||0
8727467|NCT01043185|9774772|FG004|NOT COMPLETED|Period 4 - Second Washout Period||0
8727468|NCT01043185|9774773|FG005|NOT COMPLETED|Period 4 - Second Washout Period||0
8727469|NCT01043185|9774774|FG006|NOT COMPLETED|Period 4 - Second Washout Period||0
8727470|NCT01043185|9774775|FG007|NOT COMPLETED|Period 4 - Second Washout Period||0
8727471|NCT01043185|9774776|FG008|NOT COMPLETED|Period 4 - Second Washout Period||0
8727472|NCT01043185|9774777|FG009|NOT COMPLETED|Period 4 - Second Washout Period||0
8727473|NCT01043185|9774768|FG000|STARTED|Period 5 - Third Intervention||3
8727474|NCT01043185|9774769|FG001|STARTED|Period 5 - Third Intervention||2
8727475|NCT01043185|9774770|FG002|STARTED|Period 5 - Third Intervention||3
8727476|NCT01043185|9774771|FG003|STARTED|Period 5 - Third Intervention||2
8727477|NCT01043185|9774772|FG004|STARTED|Period 5 - Third Intervention||2
8727478|NCT01043185|9774773|FG005|STARTED|Period 5 - Third Intervention||3
8727479|NCT01043185|9774774|FG006|STARTED|Period 5 - Third Intervention||3
8727480|NCT01043185|9774775|FG007|STARTED|Period 5 - Third Intervention||3
8727481|NCT01043185|9774776|FG008|STARTED|Period 5 - Third Intervention||3
8727482|NCT01043185|9774777|FG009|STARTED|Period 5 - Third Intervention||3
8727483|NCT01043185|9774768|FG000|COMPLETED|Period 5 - Third Intervention||3
8727484|NCT01043185|9774769|FG001|COMPLETED|Period 5 - Third Intervention||2
8727485|NCT01043185|9774770|FG002|COMPLETED|Period 5 - Third Intervention||3
8727486|NCT01043185|9774771|FG003|COMPLETED|Period 5 - Third Intervention||2
8727487|NCT01043185|9774772|FG004|COMPLETED|Period 5 - Third Intervention||2
8727488|NCT01043185|9774773|FG005|COMPLETED|Period 5 - Third Intervention||3
8727489|NCT01043185|9774774|FG006|COMPLETED|Period 5 - Third Intervention||3
8727490|NCT01043185|9774775|FG007|COMPLETED|Period 5 - Third Intervention||3
8727491|NCT01043185|9774776|FG008|COMPLETED|Period 5 - Third Intervention||3
8727492|NCT01043185|9774777|FG009|COMPLETED|Period 5 - Third Intervention||3
8727493|NCT01043185|9774768|FG000|NOT COMPLETED|Period 5 - Third Intervention||0
8727494|NCT01043185|9774769|FG001|NOT COMPLETED|Period 5 - Third Intervention||0
8727495|NCT01043185|9774770|FG002|NOT COMPLETED|Period 5 - Third Intervention||0
8727496|NCT01043185|9774771|FG003|NOT COMPLETED|Period 5 - Third Intervention||0
8727497|NCT01043185|9774772|FG004|NOT COMPLETED|Period 5 - Third Intervention||0
8727498|NCT01043185|9774773|FG005|NOT COMPLETED|Period 5 - Third Intervention||0
8727499|NCT01043185|9774774|FG006|NOT COMPLETED|Period 5 - Third Intervention||0
8727500|NCT01043185|9774775|FG007|NOT COMPLETED|Period 5 - Third Intervention||0
8727501|NCT01043185|9774776|FG008|NOT COMPLETED|Period 5 - Third Intervention||0
8727502|NCT01043185|9774777|FG009|NOT COMPLETED|Period 5 - Third Intervention||0
8727503|NCT01043185|9774768|FG000|STARTED|Period 6 - Third Washout Period||3
8727504|NCT01043185|9774769|FG001|STARTED|Period 6 - Third Washout Period||2
8727505|NCT01043185|9774770|FG002|STARTED|Period 6 - Third Washout Period||3
8727506|NCT01043185|9774771|FG003|STARTED|Period 6 - Third Washout Period||2
8645247|NCT00609609|9686253|FG000|STARTED|Overall Study||30
8645248|NCT00609609|9686254|FG001|STARTED|Overall Study||51
8645249|NCT00609609|9686253|FG000|COMPLETED|Overall Study||24
8645250|NCT00609609|9686254|FG001|COMPLETED|Overall Study||49
8645251|NCT00609609|9686253|FG000|NOT COMPLETED|Overall Study||6
8645252|NCT00609609|9686254|FG001|NOT COMPLETED|Overall Study||2
8645253|NCT00609622|9686262|FG000|STARTED|Overall Study||96
8645254|NCT00609622|9686263|FG001|STARTED|Overall Study||95
8645255|NCT00609622|9686262|FG000|COMPLETED|Overall Study||0
8645256|NCT00609622|9686263|FG001|COMPLETED|Overall Study||0
8645257|NCT00609622|9686262|FG000|NOT COMPLETED|Overall Study||96
8645258|NCT00609622|9686263|FG001|NOT COMPLETED|Overall Study||95
8645259|NCT00609674|9686271|FG000|STARTED|Overall Study||155
8645260|NCT00609674|9686272|FG001|STARTED|Overall Study||160
8645261|NCT00609674|9686271|FG000|COMPLETED|Overall Study||148
8645262|NCT00609674|9686272|FG001|COMPLETED|Overall Study||153
8645263|NCT00609674|9686271|FG000|NOT COMPLETED|Overall Study||7
8645264|NCT00609674|9686272|FG001|NOT COMPLETED|Overall Study||7
8645265|NCT00609739|9686278|FG000|STARTED|Overall Study||1
8645266|NCT00609739|9686278|FG000|COMPLETED|Overall Study||1
8645267|NCT00609739|9686278|FG000|NOT COMPLETED|Overall Study||0
8645268|NCT00609804|9686284|FG000|STARTED|Overall Study||25
8645269|NCT00609804|9686285|FG001|STARTED|Overall Study||28
8645270|NCT00609804|9686284|FG000|COMPLETED|Overall Study|Pts remained on study until required to end treatment due to progression/toxicity/MD decision/etc|0
8645271|NCT00609804|9686285|FG001|COMPLETED|Overall Study|Pts remained on study until required to end treatment due to progression/toxicity/MD decision/etc|0
8645272|NCT00609804|9686284|FG000|NOT COMPLETED|Overall Study||25
8645273|NCT00609804|9686285|FG001|NOT COMPLETED|Overall Study||28
8645274|NCT00609869|9686294|FG000|STARTED|Overall Study||29
8645275|NCT00609869|9686294|FG000|COMPLETED|Overall Study||18
8645276|NCT00609869|9686294|FG000|NOT COMPLETED|Overall Study||11
8645277|NCT00609947|9686298|FG000|STARTED|Overall Study||241
8645278|NCT00609947|9686298|FG000|COMPLETED|Overall Study|One death due to automobile accident.|240
8645279|NCT00609947|9686298|FG000|NOT COMPLETED|Overall Study||1
8645280|NCT00609973|9686305|FG000|STARTED|Overall Study||17
8645281|NCT00609973|9686306|FG001|STARTED|Overall Study||16
8645282|NCT00609973|9686305|FG000|COMPLETED|Overall Study||9
8645283|NCT00609973|9686306|FG001|COMPLETED|Overall Study||10
8645284|NCT00609973|9686305|FG000|NOT COMPLETED|Overall Study||8
8645285|NCT00609973|9686306|FG001|NOT COMPLETED|Overall Study||6
8645286|NCT00609986|9686314|FG000|STARTED|Overall Study||52
8645287|NCT00609986|9686315|FG001|STARTED|Overall Study||52
8645288|NCT00609986|9686314|FG000|Received Transplant|Overall Study||44
8645289|NCT00609986|9686315|FG001|Received Transplant|Overall Study||49
8645290|NCT00609986|9686314|FG000|COMPLETED|Overall Study||44
8645291|NCT00609986|9686315|FG001|COMPLETED|Overall Study||49
8645292|NCT00609986|9686314|FG000|NOT COMPLETED|Overall Study||8
8645293|NCT00609986|9686315|FG001|NOT COMPLETED|Overall Study||3
8645294|NCT00610116|9686321|FG000|STARTED|Overall Study||305
8645295|NCT00610116|9686321|FG000|COMPLETED|Overall Study|Number of analyzable patients|292
8645296|NCT00610116|9686321|FG000|NOT COMPLETED|Overall Study||13
8645297|NCT00610129|9686325|FG000|STARTED|Overall Study||28
8645298|NCT00610129|9686325|FG000|COMPLETED|Overall Study||25
8645299|NCT00610129|9686325|FG000|NOT COMPLETED|Overall Study||3
8645300|NCT00610155|9686329|FG000|STARTED|Period 1||4
8645301|NCT00610155|9686330|FG001|STARTED|Period 1||3
8645302|NCT00610155|9686331|FG002|STARTED|Period 1||4
8645303|NCT00610155|9686332|FG003|STARTED|Period 1||3
8645304|NCT00610155|9686333|FG004|STARTED|Period 1||3
8645305|NCT00610155|9686334|FG005|STARTED|Period 1||1
8645306|NCT00610155|9686329|FG000|COMPLETED|Period 1||4
8645307|NCT00610155|9686330|FG001|COMPLETED|Period 1||3
8645308|NCT00610155|9686331|FG002|COMPLETED|Period 1||3
8645309|NCT00610155|9686332|FG003|COMPLETED|Period 1||3
8645310|NCT00610155|9686333|FG004|COMPLETED|Period 1||3
8645311|NCT00610155|9686334|FG005|COMPLETED|Period 1||1
8645312|NCT00610155|9686329|FG000|NOT COMPLETED|Period 1||0
8645313|NCT00610155|9686330|FG001|NOT COMPLETED|Period 1||0
8645314|NCT00610155|9686331|FG002|NOT COMPLETED|Period 1||1
8645315|NCT00610155|9686332|FG003|NOT COMPLETED|Period 1||0
8645316|NCT00610155|9686333|FG004|NOT COMPLETED|Period 1||0
8645317|NCT00610155|9686334|FG005|NOT COMPLETED|Period 1||0
8645318|NCT00610155|9686329|FG000|STARTED|Washout Period 1 (7 Days)||4
8645319|NCT00610155|9686330|FG001|STARTED|Washout Period 1 (7 Days)||3
8645320|NCT00610155|9686331|FG002|STARTED|Washout Period 1 (7 Days)||3
8645321|NCT00610155|9686332|FG003|STARTED|Washout Period 1 (7 Days)||3
8645322|NCT00610155|9686333|FG004|STARTED|Washout Period 1 (7 Days)||3
8645323|NCT00610155|9686334|FG005|STARTED|Washout Period 1 (7 Days)||1
8645324|NCT00610155|9686329|FG000|COMPLETED|Washout Period 1 (7 Days)||4
8645325|NCT00610155|9686330|FG001|COMPLETED|Washout Period 1 (7 Days)||3
8645326|NCT00610155|9686331|FG002|COMPLETED|Washout Period 1 (7 Days)||3
8645327|NCT00610155|9686332|FG003|COMPLETED|Washout Period 1 (7 Days)||3
8645328|NCT00610155|9686333|FG004|COMPLETED|Washout Period 1 (7 Days)||3
8645329|NCT00610155|9686334|FG005|COMPLETED|Washout Period 1 (7 Days)||1
8645330|NCT00610155|9686329|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
8645331|NCT00610155|9686330|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
8645332|NCT00610155|9686331|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
8645333|NCT00610155|9686332|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
8645334|NCT00610155|9686333|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||0
8645335|NCT00610155|9686334|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||0
8645336|NCT00610155|9686329|FG000|STARTED|Period 2||4
8645337|NCT00610155|9686330|FG001|STARTED|Period 2||3
8645338|NCT00610155|9686331|FG002|STARTED|Period 2||3
8645339|NCT00610155|9686332|FG003|STARTED|Period 2||3
8645340|NCT00610155|9686333|FG004|STARTED|Period 2||3
8645341|NCT00610155|9686334|FG005|STARTED|Period 2||1
8645342|NCT00610155|9686329|FG000|COMPLETED|Period 2||4
8645343|NCT00610155|9686330|FG001|COMPLETED|Period 2||3
8645344|NCT00610155|9686331|FG002|COMPLETED|Period 2||3
8645345|NCT00610155|9686332|FG003|COMPLETED|Period 2||3
8645346|NCT00610155|9686333|FG004|COMPLETED|Period 2||3
8645347|NCT00610155|9686334|FG005|COMPLETED|Period 2||1
8645348|NCT00610155|9686329|FG000|NOT COMPLETED|Period 2||0
8645349|NCT00610155|9686330|FG001|NOT COMPLETED|Period 2||0
8645350|NCT00610155|9686331|FG002|NOT COMPLETED|Period 2||0
8645351|NCT00610155|9686332|FG003|NOT COMPLETED|Period 2||0
8645352|NCT00610155|9686333|FG004|NOT COMPLETED|Period 2||0
8645353|NCT00610155|9686334|FG005|NOT COMPLETED|Period 2||0
8645354|NCT00610155|9686329|FG000|STARTED|Washout Period 2 (7 Days)||4
8645355|NCT00610155|9686330|FG001|STARTED|Washout Period 2 (7 Days)||3
8645356|NCT00610155|9686331|FG002|STARTED|Washout Period 2 (7 Days)||3
8727507|NCT01043185|9774772|FG004|STARTED|Period 6 - Third Washout Period||2
8727508|NCT01043185|9774773|FG005|STARTED|Period 6 - Third Washout Period||3
8727509|NCT01043185|9774774|FG006|STARTED|Period 6 - Third Washout Period||3
8727510|NCT01043185|9774775|FG007|STARTED|Period 6 - Third Washout Period||3
8727511|NCT01043185|9774776|FG008|STARTED|Period 6 - Third Washout Period||3
8727512|NCT01043185|9774777|FG009|STARTED|Period 6 - Third Washout Period||3
8727513|NCT01043185|9774768|FG000|COMPLETED|Period 6 - Third Washout Period||3
8727514|NCT01043185|9774769|FG001|COMPLETED|Period 6 - Third Washout Period||2
8727515|NCT01043185|9774770|FG002|COMPLETED|Period 6 - Third Washout Period||3
8727516|NCT01043185|9774771|FG003|COMPLETED|Period 6 - Third Washout Period||2
8727517|NCT01043185|9774772|FG004|COMPLETED|Period 6 - Third Washout Period||2
8727518|NCT01043185|9774773|FG005|COMPLETED|Period 6 - Third Washout Period||3
8727519|NCT01043185|9774774|FG006|COMPLETED|Period 6 - Third Washout Period||3
8727520|NCT01043185|9774775|FG007|COMPLETED|Period 6 - Third Washout Period||3
8645357|NCT00610155|9686332|FG003|STARTED|Washout Period 2 (7 Days)||3
8645358|NCT00610155|9686333|FG004|STARTED|Washout Period 2 (7 Days)||3
8645359|NCT00610155|9686334|FG005|STARTED|Washout Period 2 (7 Days)||1
8645360|NCT00610155|9686329|FG000|COMPLETED|Washout Period 2 (7 Days)||4
8645361|NCT00610155|9686330|FG001|COMPLETED|Washout Period 2 (7 Days)||3
8645362|NCT00610155|9686331|FG002|COMPLETED|Washout Period 2 (7 Days)||3
8645363|NCT00610155|9686332|FG003|COMPLETED|Washout Period 2 (7 Days)||3
8645364|NCT00610155|9686333|FG004|COMPLETED|Washout Period 2 (7 Days)||3
8645365|NCT00610155|9686334|FG005|COMPLETED|Washout Period 2 (7 Days)||1
8645366|NCT00610155|9686329|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
8645367|NCT00610155|9686330|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
8645368|NCT00610155|9686331|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
8645369|NCT00610155|9686332|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
8645370|NCT00610155|9686333|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0
8645371|NCT00610155|9686334|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0
8645372|NCT00610155|9686329|FG000|STARTED|Period 3||4
8645373|NCT00610155|9686330|FG001|STARTED|Period 3||3
8645374|NCT00610155|9686331|FG002|STARTED|Period 3||3
8645375|NCT00610155|9686332|FG003|STARTED|Period 3||3
8645376|NCT00610155|9686333|FG004|STARTED|Period 3||3
8645377|NCT00610155|9686334|FG005|STARTED|Period 3||1
8645378|NCT00610155|9686329|FG000|COMPLETED|Period 3||3
8645379|NCT00610155|9686330|FG001|COMPLETED|Period 3||3
8645380|NCT00610155|9686331|FG002|COMPLETED|Period 3||3
8645381|NCT00610155|9686332|FG003|COMPLETED|Period 3||3
8645382|NCT00610155|9686333|FG004|COMPLETED|Period 3||3
8645383|NCT00610155|9686334|FG005|COMPLETED|Period 3||1
8645384|NCT00610155|9686329|FG000|NOT COMPLETED|Period 3||1
8645385|NCT00610155|9686330|FG001|NOT COMPLETED|Period 3||0
8645386|NCT00610155|9686331|FG002|NOT COMPLETED|Period 3||0
8645387|NCT00610155|9686332|FG003|NOT COMPLETED|Period 3||0
8645388|NCT00610155|9686333|FG004|NOT COMPLETED|Period 3||0
8645389|NCT00610155|9686334|FG005|NOT COMPLETED|Period 3||0
8645390|NCT00610168|9686344|FG000|STARTED|Overall Study||75
8645391|NCT00610168|9686345|FG001|STARTED|Overall Study||7
8645392|NCT00610168|9686344|FG000|COMPLETED|Overall Study||73
8645393|NCT00610168|9686345|FG001|COMPLETED|Overall Study||7
8645394|NCT00610168|9686344|FG000|NOT COMPLETED|Overall Study||2
8645395|NCT00610168|9686345|FG001|NOT COMPLETED|Overall Study||0
8645396|NCT00610207|9686351|FG000|STARTED|Overall Study||21
8645397|NCT00610207|9686351|FG000|COMPLETED|Overall Study||18
8645398|NCT00610207|9686351|FG000|NOT COMPLETED|Overall Study||3
8645399|NCT00610311|9686355|FG000|STARTED|Overall Study||3
8645400|NCT00610311|9686355|FG000|COMPLETED|Overall Study||3
8645401|NCT00610311|9686355|FG000|NOT COMPLETED|Overall Study||0
8645402|NCT00610363|9686361|FG000|STARTED|Overall Study||42
8645403|NCT00610363|9686362|FG001|STARTED|Overall Study||41
8645404|NCT00610363|9686361|FG000|COMPLETED|Overall Study||31
8645405|NCT00610363|9686362|FG001|COMPLETED|Overall Study||38
8645406|NCT00610363|9686361|FG000|NOT COMPLETED|Overall Study||11
8645407|NCT00610363|9686362|FG001|NOT COMPLETED|Overall Study||3
8645408|NCT00610428|9686372|FG000|STARTED|Overall Study||24
8645409|NCT00610428|9686373|FG001|STARTED|Overall Study||24
8645410|NCT00610428|9686374|FG002|STARTED|Overall Study||27
8645411|NCT00610428|9686372|FG000|COMPLETED|Overall Study||24
8645412|NCT00610428|9686373|FG001|COMPLETED|Overall Study||23
8645413|NCT00610428|9686374|FG002|COMPLETED|Overall Study||25
8645414|NCT00610428|9686372|FG000|NOT COMPLETED|Overall Study||0
8645415|NCT00610428|9686373|FG001|NOT COMPLETED|Overall Study||1
8645416|NCT00610428|9686374|FG002|NOT COMPLETED|Overall Study||2
8645417|NCT00610441|9686386|FG000|STARTED|Treatment Period 1 - 3 Weeks||15
8645418|NCT00610441|9686387|FG001|STARTED|Treatment Period 1 - 3 Weeks||16
8645419|NCT00610441|9686388|FG002|STARTED|Treatment Period 1 - 3 Weeks||18
8645420|NCT00610441|9686389|FG003|STARTED|Treatment Period 1 - 3 Weeks||18
8645421|NCT00610441|9686386|FG000|COMPLETED|Treatment Period 1 - 3 Weeks||12
8645422|NCT00610441|9686387|FG001|COMPLETED|Treatment Period 1 - 3 Weeks||14
8645423|NCT00610441|9686388|FG002|COMPLETED|Treatment Period 1 - 3 Weeks||11
8645424|NCT00610441|9686389|FG003|COMPLETED|Treatment Period 1 - 3 Weeks||16
8645425|NCT00610441|9686386|FG000|NOT COMPLETED|Treatment Period 1 - 3 Weeks||3
8645426|NCT00610441|9686387|FG001|NOT COMPLETED|Treatment Period 1 - 3 Weeks||2
8645427|NCT00610441|9686388|FG002|NOT COMPLETED|Treatment Period 1 - 3 Weeks||7
8645428|NCT00610441|9686389|FG003|NOT COMPLETED|Treatment Period 1 - 3 Weeks||2
8645429|NCT00610441|9686386|FG000|STARTED|Placebo Washout Period - 2 Weeks||12
8645430|NCT00610441|9686387|FG001|STARTED|Placebo Washout Period - 2 Weeks||14
8645431|NCT00610441|9686388|FG002|STARTED|Placebo Washout Period - 2 Weeks||11
8645432|NCT00610441|9686389|FG003|STARTED|Placebo Washout Period - 2 Weeks||16
8645433|NCT00610441|9686386|FG000|COMPLETED|Placebo Washout Period - 2 Weeks||12
8645434|NCT00610441|9686387|FG001|COMPLETED|Placebo Washout Period - 2 Weeks||13
8645435|NCT00610441|9686388|FG002|COMPLETED|Placebo Washout Period - 2 Weeks||9
8645436|NCT00610441|9686389|FG003|COMPLETED|Placebo Washout Period - 2 Weeks||16
8645437|NCT00610441|9686386|FG000|NOT COMPLETED|Placebo Washout Period - 2 Weeks||0
8645438|NCT00610441|9686387|FG001|NOT COMPLETED|Placebo Washout Period - 2 Weeks||1
8645439|NCT00610441|9686388|FG002|NOT COMPLETED|Placebo Washout Period - 2 Weeks||2
8645440|NCT00610441|9686389|FG003|NOT COMPLETED|Placebo Washout Period - 2 Weeks||0
8645441|NCT00610441|9686386|FG000|STARTED|Treatment Period 2 - 3 Weeks||12
8645442|NCT00610441|9686387|FG001|STARTED|Treatment Period 2 - 3 Weeks||13
8645443|NCT00610441|9686388|FG002|STARTED|Treatment Period 2 - 3 Weeks||9
8645444|NCT00610441|9686389|FG003|STARTED|Treatment Period 2 - 3 Weeks||16
8645445|NCT00610441|9686386|FG000|COMPLETED|Treatment Period 2 - 3 Weeks||10
8645446|NCT00610441|9686387|FG001|COMPLETED|Treatment Period 2 - 3 Weeks||12
8645447|NCT00610441|9686388|FG002|COMPLETED|Treatment Period 2 - 3 Weeks||9
8645448|NCT00610441|9686389|FG003|COMPLETED|Treatment Period 2 - 3 Weeks||14
8645449|NCT00610441|9686386|FG000|NOT COMPLETED|Treatment Period 2 - 3 Weeks||2
8645450|NCT00610441|9686387|FG001|NOT COMPLETED|Treatment Period 2 - 3 Weeks||1
8645451|NCT00610441|9686388|FG002|NOT COMPLETED|Treatment Period 2 - 3 Weeks||0
8645452|NCT00610441|9686389|FG003|NOT COMPLETED|Treatment Period 2 - 3 Weeks||2
8645453|NCT00610480|9686403|FG000|STARTED|Overall Study|10 assigned patients x 2 interventions.|10
8645454|NCT00610480|9686404|FG001|STARTED|Overall Study|10 assigned patients x 2 interventions.|10
8645455|NCT00610480|9686403|FG000|COMPLETED|Overall Study|10 assigned patients x 2 interventions.|10
8645456|NCT00610480|9686404|FG001|COMPLETED|Overall Study|10 assigned patients x 2 interventions.|10
8645457|NCT00610480|9686403|FG000|NOT COMPLETED|Overall Study||0
8645458|NCT00610480|9686404|FG001|NOT COMPLETED|Overall Study||0
8645459|NCT00610649|9686421|FG000|STARTED|Overall Study||4
8645460|NCT00610649|9686422|FG001|STARTED|Overall Study||2
8645461|NCT00610649|9686423|FG002|STARTED|Overall Study||4
8645462|NCT00610649|9686424|FG003|STARTED|Overall Study||2
8645463|NCT00610649|9686425|FG004|STARTED|Overall Study||4
8645464|NCT00610649|9686426|FG005|STARTED|Overall Study||2
8645465|NCT00610649|9686427|FG006|STARTED|Overall Study||4
8645466|NCT00610649|9686428|FG007|STARTED|Overall Study||2
8645467|NCT00610649|9686429|FG008|STARTED|Overall Study||10
8645468|NCT00610649|9686430|FG009|STARTED|Overall Study||10
8645469|NCT00610649|9686431|FG010|STARTED|Overall Study||10
8645470|NCT00610649|9686421|FG000|COMPLETED|Overall Study||3
8645471|NCT00610649|9686422|FG001|COMPLETED|Overall Study||1
8645472|NCT00610649|9686423|FG002|COMPLETED|Overall Study||4
8645473|NCT00610649|9686424|FG003|COMPLETED|Overall Study||2
8645474|NCT00610649|9686425|FG004|COMPLETED|Overall Study||4
8645475|NCT00610649|9686426|FG005|COMPLETED|Overall Study||2
8645476|NCT00610649|9686427|FG006|COMPLETED|Overall Study||4
8645477|NCT00610649|9686428|FG007|COMPLETED|Overall Study||2
8645478|NCT00610649|9686429|FG008|COMPLETED|Overall Study||10
8645479|NCT00610649|9686430|FG009|COMPLETED|Overall Study||9
8645480|NCT00610649|9686431|FG010|COMPLETED|Overall Study||9
8645481|NCT00610649|9686421|FG000|NOT COMPLETED|Overall Study||1
8645482|NCT00610649|9686422|FG001|NOT COMPLETED|Overall Study||1
8645483|NCT00610649|9686423|FG002|NOT COMPLETED|Overall Study||0
8645484|NCT00610649|9686424|FG003|NOT COMPLETED|Overall Study||0
8645485|NCT00610649|9686425|FG004|NOT COMPLETED|Overall Study||0
8645486|NCT00610649|9686426|FG005|NOT COMPLETED|Overall Study||0
8645487|NCT00610649|9686427|FG006|NOT COMPLETED|Overall Study||0
8645488|NCT00610649|9686428|FG007|NOT COMPLETED|Overall Study||0
8645489|NCT00610649|9686429|FG008|NOT COMPLETED|Overall Study||0
8645490|NCT00610649|9686430|FG009|NOT COMPLETED|Overall Study||1
8645491|NCT00610649|9686431|FG010|NOT COMPLETED|Overall Study||1
8645492|NCT00610675|9686455|FG000|STARTED|Overall Study||346
8645493|NCT00610675|9686455|FG000|Treated|Overall Study||342
8645494|NCT00610675|9686455|FG000|COMPLETED|Overall Study||126
8645495|NCT00610675|9686455|FG000|NOT COMPLETED|Overall Study||220
8645496|NCT00610688|9686462|FG000|STARTED|Overall Study||64
8645497|NCT00610688|9686463|FG001|STARTED|Overall Study||65
8645498|NCT00610688|9686464|FG002|STARTED|Overall Study||63
8645499|NCT00610688|9686462|FG000|COMPLETED|Overall Study||55
8645500|NCT00610688|9686463|FG001|COMPLETED|Overall Study||52
8645501|NCT00610688|9686464|FG002|COMPLETED|Overall Study||55
8645502|NCT00610688|9686462|FG000|NOT COMPLETED|Overall Study||9
8645503|NCT00610688|9686463|FG001|NOT COMPLETED|Overall Study||13
8645504|NCT00610688|9686464|FG002|NOT COMPLETED|Overall Study||8
8645505|NCT00610701|9686474|FG000|STARTED|Overall Study||15
8645506|NCT00610701|9686475|FG001|STARTED|Overall Study||20
8645507|NCT00610701|9686474|FG000|COMPLETED|Overall Study||5
8645508|NCT00610701|9686475|FG001|COMPLETED|Overall Study||9
8645509|NCT00610701|9686474|FG000|NOT COMPLETED|Overall Study||10
8645510|NCT00610701|9686475|FG001|NOT COMPLETED|Overall Study||11
8645511|NCT00610714|9686483|FG000|STARTED|Overall Study||105
8645512|NCT00610714|9686484|FG001|STARTED|Overall Study||106
8645513|NCT00610714|9686483|FG000|COMPLETED|Overall Study||79
8645514|NCT00610714|9686484|FG001|COMPLETED|Overall Study||82
8645515|NCT00610714|9686483|FG000|NOT COMPLETED|Overall Study||26
8645516|NCT00610714|9686484|FG001|NOT COMPLETED|Overall Study||24
8645517|NCT00610727|9686496|FG000|STARTED|Overall Study||14
8645518|NCT00610727|9686497|FG001|STARTED|Overall Study||8
8645519|NCT00610727|9686498|FG002|STARTED|Overall Study||8
8645520|NCT00610727|9686499|FG003|STARTED|Overall Study||8
8645521|NCT00610727|9686500|FG004|STARTED|Overall Study||8
8645522|NCT00610727|9686501|FG005|STARTED|Overall Study||8
8645523|NCT00610727|9686496|FG000|COMPLETED|Overall Study||14
8645524|NCT00610727|9686497|FG001|COMPLETED|Overall Study||8
8645525|NCT00610727|9686498|FG002|COMPLETED|Overall Study||8
8645526|NCT00610727|9686499|FG003|COMPLETED|Overall Study||8
8645527|NCT00610727|9686500|FG004|COMPLETED|Overall Study||8
8645528|NCT00610727|9686501|FG005|COMPLETED|Overall Study||8
8645529|NCT00610727|9686496|FG000|NOT COMPLETED|Overall Study||0
8645530|NCT00610727|9686497|FG001|NOT COMPLETED|Overall Study||0
8645531|NCT00610727|9686498|FG002|NOT COMPLETED|Overall Study||0
8645532|NCT00610727|9686499|FG003|NOT COMPLETED|Overall Study||0
8645533|NCT00610727|9686500|FG004|NOT COMPLETED|Overall Study||0
8645534|NCT00610727|9686501|FG005|NOT COMPLETED|Overall Study||0
8645535|NCT00610740|9686519|FG000|STARTED|Overall Study||18
8645536|NCT00610740|9686519|FG000|COMPLETED|Overall Study||18
8645537|NCT00610740|9686519|FG000|NOT COMPLETED|Overall Study||0
8645538|NCT00610857|9686523|FG000|STARTED|Overall Study||37
8645539|NCT00610857|9686523|FG000|COMPLETED|Overall Study||35
8645540|NCT00610857|9686523|FG000|NOT COMPLETED|Overall Study||2
8645541|NCT00610883|9686527|FG000|STARTED|Overall Study||17
8645542|NCT00610883|9686527|FG000|COMPLETED|Overall Study||17
8645543|NCT00610883|9686527|FG000|NOT COMPLETED|Overall Study||0
8645544|NCT00610935|9686533|FG000|STARTED|Overall Study||25
8645545|NCT00610935|9686534|FG001|STARTED|Overall Study||57
8645546|NCT00610935|9686533|FG000|ITTI Population|Overall Study||25
8645547|NCT00610935|9686534|FG001|ITTI Population|Overall Study||55
8645548|NCT00610935|9686533|FG000|ITT Population|Overall Study||25
8645549|NCT00610935|9686534|FG001|ITT Population|Overall Study||57
8645550|NCT00610935|9686533|FG000|COMPLETED|Overall Study||24
8645551|NCT00610935|9686534|FG001|COMPLETED|Overall Study||54
8645552|NCT00610935|9686533|FG000|NOT COMPLETED|Overall Study||1
8645553|NCT00610935|9686534|FG001|NOT COMPLETED|Overall Study||3
8645554|NCT00610987|9686542|FG000|STARTED|Overall Study||75
8645555|NCT00610987|9686543|FG001|STARTED|Overall Study||71
8645556|NCT00610987|9686542|FG000|COMPLETED|Overall Study||75
8645557|NCT00610987|9686543|FG001|COMPLETED|Overall Study||71
8645558|NCT00610987|9686542|FG000|NOT COMPLETED|Overall Study||0
8645559|NCT00610987|9686543|FG001|NOT COMPLETED|Overall Study||0
8645560|NCT00611026|9686552|FG000|STARTED|Randomized to Double-blind Treatment||480
8645561|NCT00611026|9686553|FG001|STARTED|Randomized to Double-blind Treatment||974
8645562|NCT00611026|9686554|FG002|STARTED|Randomized to Double-blind Treatment||963
8645563|NCT00611026|9686552|FG000|COMPLETED|Randomized to Double-blind Treatment||478
8727521|NCT01043185|9774776|FG008|COMPLETED|Period 6 - Third Washout Period||2
8645564|NCT00611026|9686553|FG001|COMPLETED|Randomized to Double-blind Treatment||973
8645565|NCT00611026|9686554|FG002|COMPLETED|Randomized to Double-blind Treatment||960
8645566|NCT00611026|9686552|FG000|NOT COMPLETED|Randomized to Double-blind Treatment||2
8645567|NCT00611026|9686553|FG001|NOT COMPLETED|Randomized to Double-blind Treatment||1
8645568|NCT00611026|9686554|FG002|NOT COMPLETED|Randomized to Double-blind Treatment||3
8645569|NCT00611026|9686552|FG000|STARTED|Double-blind Treatment Period||478
8645570|NCT00611026|9686553|FG001|STARTED|Double-blind Treatment Period||973
8645571|NCT00611026|9686554|FG002|STARTED|Double-blind Treatment Period||960
8645572|NCT00611026|9686552|FG000|COMPLETED|Double-blind Treatment Period||431
8645573|NCT00611026|9686553|FG001|COMPLETED|Double-blind Treatment Period||885
8645574|NCT00611026|9686554|FG002|COMPLETED|Double-blind Treatment Period||862
8645575|NCT00611026|9686552|FG000|NOT COMPLETED|Double-blind Treatment Period||47
8645576|NCT00611026|9686553|FG001|NOT COMPLETED|Double-blind Treatment Period||88
8645577|NCT00611026|9686554|FG002|NOT COMPLETED|Double-blind Treatment Period||98
8645578|NCT00611130|9686566|FG000|STARTED|Overall Study||92
8645579|NCT00611130|9686567|FG001|STARTED|Overall Study||94
8645580|NCT00611130|9686566|FG000|Completed 12 Week Treatment Phase|Overall Study||61
8645581|NCT00611130|9686567|FG001|Completed 12 Week Treatment Phase|Overall Study||64
8645582|NCT00611130|9686566|FG000|COMPLETED|Overall Study||43
8645583|NCT00611130|9686567|FG001|COMPLETED|Overall Study||47
8645584|NCT00611130|9686566|FG000|NOT COMPLETED|Overall Study||49
8645585|NCT00611130|9686567|FG001|NOT COMPLETED|Overall Study||47
8645586|NCT00611247|9686576|FG000|STARTED|Overall Study||5
8645587|NCT00611247|9686577|FG001|STARTED|Overall Study||31
8645588|NCT00611247|9686576|FG000|COMPLETED|Overall Study||3
8645589|NCT00611247|9686577|FG001|COMPLETED|Overall Study||10
8645590|NCT00611247|9686576|FG000|NOT COMPLETED|Overall Study||2
8645591|NCT00611247|9686577|FG001|NOT COMPLETED|Overall Study||21
8645592|NCT00611325|9686586|FG000|STARTED|Overall Study||28
8645593|NCT00611325|9686587|FG001|STARTED|Overall Study||28
8645594|NCT00611325|9686586|FG000|COMPLETED|Overall Study||28
8645595|NCT00611325|9686587|FG001|COMPLETED|Overall Study||28
8645596|NCT00611325|9686586|FG000|NOT COMPLETED|Overall Study||0
8645597|NCT00611325|9686587|FG001|NOT COMPLETED|Overall Study||0
8645598|NCT00611351|9686593|FG000|STARTED|Overall Study||5
8645599|NCT00611351|9686593|FG000|COMPLETED|Overall Study||3
8645600|NCT00611351|9686593|FG000|NOT COMPLETED|Overall Study||2
8645601|NCT00611403|9686599|FG000|STARTED|Treatment Phase||68
8645602|NCT00611403|9686600|FG001|STARTED|Treatment Phase||69
8645603|NCT00611403|9686599|FG000|COMPLETED|Treatment Phase||62
8645604|NCT00611403|9686600|FG001|COMPLETED|Treatment Phase||58
8645605|NCT00611403|9686599|FG000|NOT COMPLETED|Treatment Phase||6
8645606|NCT00611403|9686600|FG001|NOT COMPLETED|Treatment Phase||11
8645607|NCT00611403|9686599|FG000|STARTED|Post Treatment Extension Phase|26 of 68 pts who received RESTASIS® in the Treatment Phase entered the Post Treatment Ext. Phase|26
8645608|NCT00611403|9686600|FG001|STARTED|Post Treatment Extension Phase|25 of 69 pts who received ENDURA® in the Treatment Phase entered the Post Treatment Extension Phase|25
8645609|NCT00611403|9686599|FG000|COMPLETED|Post Treatment Extension Phase||22
8645610|NCT00611403|9686600|FG001|COMPLETED|Post Treatment Extension Phase||24
8645611|NCT00611403|9686599|FG000|NOT COMPLETED|Post Treatment Extension Phase||4
8645612|NCT00611403|9686600|FG001|NOT COMPLETED|Post Treatment Extension Phase||1
8645613|NCT00611442|9686608|FG000|STARTED|Overall Study||95
8645614|NCT00611442|9686609|FG001|STARTED|Overall Study||96
8645615|NCT00611442|9686608|FG000|COMPLETED|Overall Study||94
8645616|NCT00611442|9686609|FG001|COMPLETED|Overall Study||94
8645617|NCT00611442|9686608|FG000|NOT COMPLETED|Overall Study||1
8645618|NCT00611442|9686609|FG001|NOT COMPLETED|Overall Study||2
8645619|NCT00611455|9686617|FG000|STARTED|DB Treatment Period (24 Weeks)||134
8645620|NCT00611455|9686618|FG001|STARTED|DB Treatment Period (24 Weeks)||131
8645621|NCT00611455|9686619|FG002|STARTED|DB Treatment Period (24 Weeks)||0
8645622|NCT00611455|9686617|FG000|COMPLETED|DB Treatment Period (24 Weeks)||121
8645623|NCT00611455|9686618|FG001|COMPLETED|DB Treatment Period (24 Weeks)||117
8645624|NCT00611455|9686619|FG002|COMPLETED|DB Treatment Period (24 Weeks)||0
8645625|NCT00611455|9686617|FG000|NOT COMPLETED|DB Treatment Period (24 Weeks)||13
8645626|NCT00611455|9686618|FG001|NOT COMPLETED|DB Treatment Period (24 Weeks)||14
8645627|NCT00611455|9686619|FG002|NOT COMPLETED|DB Treatment Period (24 Weeks)||0
8645628|NCT00611455|9686617|FG000|STARTED|OL Treatment Period (120 Weeks)||0
8645629|NCT00611455|9686618|FG001|STARTED|OL Treatment Period (120 Weeks)|118 participants received OFA during the DB Period; 113 received placebo during the DB Period.|231
8645630|NCT00611455|9686619|FG002|STARTED|OL Treatment Period (120 Weeks)||0
8645631|NCT00611455|9686617|FG000|COMPLETED|OL Treatment Period (120 Weeks)||0
8645632|NCT00611455|9686618|FG001|COMPLETED|OL Treatment Period (120 Weeks)||52
8645633|NCT00611455|9686619|FG002|COMPLETED|OL Treatment Period (120 Weeks)||0
8645634|NCT00611455|9686617|FG000|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
8645635|NCT00611455|9686618|FG001|NOT COMPLETED|OL Treatment Period (120 Weeks)||179
8645636|NCT00611455|9686619|FG002|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
8645637|NCT00611455|9686617|FG000|STARTED|Follow-up Period (Approximately 2 Years)||0
8645638|NCT00611455|9686618|FG001|STARTED|Follow-up Period (Approximately 2 Years)||0
8645639|NCT00611455|9686619|FG002|STARTED|Follow-up Period (Approximately 2 Years)|These participants received at least one infusion of placebo or ofatumumab.|260
8645640|NCT00611455|9686617|FG000|COMPLETED|Follow-up Period (Approximately 2 Years)||0
8645641|NCT00611455|9686618|FG001|COMPLETED|Follow-up Period (Approximately 2 Years)||0
8645642|NCT00611455|9686619|FG002|COMPLETED|Follow-up Period (Approximately 2 Years)||49
8645643|NCT00611455|9686617|FG000|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
8645644|NCT00611455|9686618|FG001|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
8645645|NCT00611455|9686619|FG002|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||211
8645646|NCT00611468|9686629|FG000|STARTED|Overall Study||3
8645647|NCT00611468|9686630|FG001|STARTED|Overall Study||7
8645648|NCT00611468|9686631|FG002|STARTED|Overall Study||6
8645649|NCT00611468|9686632|FG003|STARTED|Overall Study||13
8645650|NCT00611468|9686629|FG000|COMPLETED|Overall Study||3
8645651|NCT00611468|9686630|FG001|COMPLETED|Overall Study|One subject did not complete Cycle 1 of treatment and was replaced.|6
8645652|NCT00611468|9686631|FG002|COMPLETED|Overall Study||6
8645653|NCT00611468|9686632|FG003|COMPLETED|Overall Study||13
8645654|NCT00611468|9686629|FG000|NOT COMPLETED|Overall Study||0
8645655|NCT00611468|9686630|FG001|NOT COMPLETED|Overall Study||1
8645656|NCT00611468|9686631|FG002|NOT COMPLETED|Overall Study||0
8645657|NCT00611468|9686632|FG003|NOT COMPLETED|Overall Study||0
8645658|NCT00611533|9686636|FG000|STARTED|First Intervention (6 Weeks)||8
8645659|NCT00611533|9686637|FG001|STARTED|First Intervention (6 Weeks)||8
8645660|NCT00611533|9686636|FG000|COMPLETED|First Intervention (6 Weeks)||8
8645661|NCT00611533|9686637|FG001|COMPLETED|First Intervention (6 Weeks)||6
8645662|NCT00611533|9686636|FG000|NOT COMPLETED|First Intervention (6 Weeks)||0
8645663|NCT00611533|9686637|FG001|NOT COMPLETED|First Intervention (6 Weeks)||2
8645664|NCT00611533|9686636|FG000|STARTED|Second Intervention (6 Weeks)||8
8645665|NCT00611533|9686637|FG001|STARTED|Second Intervention (6 Weeks)||6
8645666|NCT00611533|9686636|FG000|COMPLETED|Second Intervention (6 Weeks)||8
8645667|NCT00611533|9686637|FG001|COMPLETED|Second Intervention (6 Weeks)||4
8645668|NCT00611533|9686636|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
8645669|NCT00611533|9686637|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||2
8645670|NCT00611559|9686647|FG000|STARTED|Overall Study||111
8645671|NCT00611559|9686648|FG001|STARTED|Overall Study||115
8645672|NCT00611559|9686649|FG002|STARTED|Overall Study||57
8645673|NCT00611559|9686647|FG000|COMPLETED|Overall Study||110
8645674|NCT00611559|9686648|FG001|COMPLETED|Overall Study||114
8645675|NCT00611559|9686649|FG002|COMPLETED|Overall Study||56
8645676|NCT00611559|9686647|FG000|NOT COMPLETED|Overall Study||1
8645677|NCT00611559|9686648|FG001|NOT COMPLETED|Overall Study||1
8645678|NCT00611559|9686649|FG002|NOT COMPLETED|Overall Study||1
8645679|NCT00611624|9686657|FG000|STARTED|Overall Study||28
8645680|NCT00611624|9686657|FG000|COMPLETED|Overall Study||28
8645681|NCT00611624|9686657|FG000|NOT COMPLETED|Overall Study||0
8645682|NCT00611715|9686664|FG000|STARTED|Overall Study||42
8645683|NCT00611715|9686665|FG001|STARTED|Overall Study||6
8645684|NCT00611715|9686664|FG000|COMPLETED|Overall Study|"2 pts in Arm 1 remain on-tx. They are not accounted for in off-tx reasonor completed data fields"|1
8645685|NCT00611715|9686665|FG001|COMPLETED|Overall Study||0
8645686|NCT00611715|9686664|FG000|NOT COMPLETED|Overall Study||41
8645687|NCT00611715|9686665|FG001|NOT COMPLETED|Overall Study||6
8645688|NCT00611767|9686679|FG000|STARTED|Overall Study||49
8645689|NCT00611767|9686680|FG001|STARTED|Overall Study||24
8645690|NCT00611767|9686679|FG000|Thiopental Test Day|Overall Study||3
8645691|NCT00611767|9686680|FG001|Thiopental Test Day|Overall Study||1
8645692|NCT00611767|9686679|FG000|Placebo Test Day|Overall Study||6
8645693|NCT00611767|9686680|FG001|Placebo Test Day|Overall Study||1
8645694|NCT00611767|9686679|FG000|COMPLETED|Overall Study||40
8645695|NCT00611767|9686680|FG001|COMPLETED|Overall Study||22
8645696|NCT00611767|9686679|FG000|NOT COMPLETED|Overall Study||9
8645697|NCT00611767|9686680|FG001|NOT COMPLETED|Overall Study||2
8645698|NCT00611806|9686688|FG000|STARTED|Overall Study||94
8645699|NCT00611806|9686689|FG001|STARTED|Overall Study||46
8645700|NCT00611806|9686688|FG000|COMPLETED|Overall Study||78
8645701|NCT00611806|9686689|FG001|COMPLETED|Overall Study||43
8645702|NCT00611806|9686688|FG000|NOT COMPLETED|Overall Study||16
8645703|NCT00611806|9686689|FG001|NOT COMPLETED|Overall Study||3
8645704|NCT00611858|9686695|FG000|STARTED|Overall Study||13
8645705|NCT00611858|9686695|FG000|COMPLETED|Overall Study||9
8645706|NCT00611858|9686695|FG000|NOT COMPLETED|Overall Study||4
8645707|NCT00611884|9686705|FG000|STARTED|Overall Study||61
8645708|NCT00611884|9686706|FG001|STARTED|Overall Study||60
8645709|NCT00611884|9686707|FG002|STARTED|Overall Study||62
8645710|NCT00611884|9686708|FG003|STARTED|Overall Study||62
8645711|NCT00611884|9686705|FG000|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial drug|58
8645712|NCT00611884|9686706|FG001|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|59
8645713|NCT00611884|9686707|FG002|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|61
8645714|NCT00611884|9686708|FG003|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|61
8645715|NCT00611884|9686705|FG000|COMPLETED|Overall Study||52
8645716|NCT00611884|9686706|FG001|COMPLETED|Overall Study||51
8645717|NCT00611884|9686707|FG002|COMPLETED|Overall Study||58
8645718|NCT00611884|9686708|FG003|COMPLETED|Overall Study||56
8645719|NCT00611884|9686705|FG000|NOT COMPLETED|Overall Study||9
8645720|NCT00611884|9686706|FG001|NOT COMPLETED|Overall Study||9
8645721|NCT00611884|9686707|FG002|NOT COMPLETED|Overall Study||4
8645722|NCT00611884|9686708|FG003|NOT COMPLETED|Overall Study||6
8645723|NCT00611897|9686718|FG000|STARTED|Day 1: Initial Treatment||8
8645724|NCT00611897|9686719|FG001|STARTED|Day 1: Initial Treatment||8
8645725|NCT00611897|9686718|FG000|COMPLETED|Day 1: Initial Treatment||8
8645726|NCT00611897|9686719|FG001|COMPLETED|Day 1: Initial Treatment||8
8645727|NCT00611897|9686718|FG000|NOT COMPLETED|Day 1: Initial Treatment||0
8645728|NCT00611897|9686719|FG001|NOT COMPLETED|Day 1: Initial Treatment||0
8645729|NCT00611897|9686718|FG000|STARTED|Day 2: Crossover Treatment||8
8645730|NCT00611897|9686719|FG001|STARTED|Day 2: Crossover Treatment||8
8645731|NCT00611897|9686718|FG000|COMPLETED|Day 2: Crossover Treatment||8
8645732|NCT00611897|9686719|FG001|COMPLETED|Day 2: Crossover Treatment||8
8645733|NCT00611897|9686718|FG000|NOT COMPLETED|Day 2: Crossover Treatment||0
8645734|NCT00611897|9686719|FG001|NOT COMPLETED|Day 2: Crossover Treatment||0
8645735|NCT00611923|9686729|FG000|STARTED|Overall Study||12
8645736|NCT00611923|9686730|FG001|STARTED|Overall Study||13
8645737|NCT00611923|9686729|FG000|COMPLETED|Overall Study||10
8645738|NCT00611923|9686730|FG001|COMPLETED|Overall Study||11
8645739|NCT00611923|9686729|FG000|NOT COMPLETED|Overall Study||2
8645740|NCT00611923|9686730|FG001|NOT COMPLETED|Overall Study||2
8645741|NCT00611975|9686740|FG000|STARTED|Overall Study||45
8645742|NCT00611975|9686741|FG001|STARTED|Overall Study||38
8645743|NCT00611975|9686740|FG000|COMPLETED|Overall Study||40
8645744|NCT00611975|9686741|FG001|COMPLETED|Overall Study||30
8645745|NCT00611975|9686740|FG000|NOT COMPLETED|Overall Study||5
8645746|NCT00611975|9686741|FG001|NOT COMPLETED|Overall Study||8
8645747|NCT00612040|9686750|FG000|STARTED|Overall Study||60
8645748|NCT00612040|9686751|FG001|STARTED|Overall Study||59
8645749|NCT00612040|9686752|FG002|STARTED|Overall Study||59
8645750|NCT00612040|9686750|FG000|Exposed|Overall Study||60
8645751|NCT00612040|9686751|FG001|Exposed|Overall Study||59
8645752|NCT00612040|9686752|FG002|Exposed|Overall Study||59
8645753|NCT00612040|9686750|FG000|COMPLETED|Overall Study||55
8645754|NCT00612040|9686751|FG001|COMPLETED|Overall Study||52
8645755|NCT00612040|9686752|FG002|COMPLETED|Overall Study||52
8645756|NCT00612040|9686750|FG000|NOT COMPLETED|Overall Study||5
8645757|NCT00612040|9686751|FG001|NOT COMPLETED|Overall Study||7
8645758|NCT00612040|9686752|FG002|NOT COMPLETED|Overall Study||7
8645759|NCT00612066|9686760|FG000|STARTED|Overall Study||2
8645760|NCT00612066|9686760|FG000|COMPLETED|Overall Study||1
8645761|NCT00612066|9686760|FG000|NOT COMPLETED|Overall Study||1
8645762|NCT00612105|9686766|FG000|STARTED|Period Title 1: 6-Week Titration Phase||125
8645763|NCT00612105|9686767|FG001|STARTED|Period Title 1: 6-Week Titration Phase||62
8645764|NCT00612105|9686766|FG000|COMPLETED|Period Title 1: 6-Week Titration Phase||89
8645765|NCT00612105|9686767|FG001|COMPLETED|Period Title 1: 6-Week Titration Phase||57
8645766|NCT00612105|9686766|FG000|NOT COMPLETED|Period Title 1: 6-Week Titration Phase||36
8645767|NCT00612105|9686767|FG001|NOT COMPLETED|Period Title 1: 6-Week Titration Phase||5
8645768|NCT00612105|9686766|FG000|STARTED|Period Title 2: 4-Week Maintenance Phase||89
8645769|NCT00612105|9686767|FG001|STARTED|Period Title 2: 4-Week Maintenance Phase||57
8645770|NCT00612105|9686766|FG000|COMPLETED|Period Title 2: 4-Week Maintenance Phase||78
8645771|NCT00612105|9686767|FG001|COMPLETED|Period Title 2: 4-Week Maintenance Phase||55
8645772|NCT00612105|9686766|FG000|NOT COMPLETED|Period Title 2: 4-Week Maintenance Phase||11
8645773|NCT00612105|9686767|FG001|NOT COMPLETED|Period Title 2: 4-Week Maintenance Phase||2
8645774|NCT00612105|9686766|FG000|STARTED|Period Title 3: 3-Week Taper Phase|Includes participants who discontinued during the titration phase and entered taper phase.|86
8645775|NCT00612105|9686767|FG001|STARTED|Period Title 3: 3-Week Taper Phase|Includes participants who discontinued during the titration phase and entered taper phase.|58
8645776|NCT00612105|9686766|FG000|COMPLETED|Period Title 3: 3-Week Taper Phase||85
8645777|NCT00612105|9686767|FG001|COMPLETED|Period Title 3: 3-Week Taper Phase||58
8645778|NCT00612105|9686766|FG000|NOT COMPLETED|Period Title 3: 3-Week Taper Phase||1
8645779|NCT00612105|9686767|FG001|NOT COMPLETED|Period Title 3: 3-Week Taper Phase||0
8645780|NCT00612222|9686773|FG000|STARTED|Overall Study||4
8645781|NCT00612222|9686773|FG000|COMPLETED|Overall Study||4
8645782|NCT00612222|9686773|FG000|NOT COMPLETED|Overall Study||0
8645783|NCT00612235|9686781|FG000|STARTED|Overall Study||20
8645784|NCT00612235|9686782|FG001|STARTED|Overall Study||20
8645785|NCT00612235|9686783|FG002|STARTED|Overall Study||20
8645786|NCT00612235|9686784|FG003|STARTED|Overall Study||20
8727522|NCT01043185|9774777|FG009|COMPLETED|Period 6 - Third Washout Period||3
8727523|NCT01043185|9774768|FG000|NOT COMPLETED|Period 6 - Third Washout Period||0
8727524|NCT01043185|9774769|FG001|NOT COMPLETED|Period 6 - Third Washout Period||0
8727525|NCT01043185|9774770|FG002|NOT COMPLETED|Period 6 - Third Washout Period||0
8727526|NCT01043185|9774771|FG003|NOT COMPLETED|Period 6 - Third Washout Period||0
8727527|NCT01043185|9774772|FG004|NOT COMPLETED|Period 6 - Third Washout Period||0
8727528|NCT01043185|9774773|FG005|NOT COMPLETED|Period 6 - Third Washout Period||0
8727529|NCT01043185|9774774|FG006|NOT COMPLETED|Period 6 - Third Washout Period||0
8727530|NCT01043185|9774775|FG007|NOT COMPLETED|Period 6 - Third Washout Period||0
8727531|NCT01043185|9774776|FG008|NOT COMPLETED|Period 6 - Third Washout Period||1
8727532|NCT01043185|9774777|FG009|NOT COMPLETED|Period 6 - Third Washout Period||0
8727533|NCT01043185|9774768|FG000|STARTED|Period 7 - Fourth Intervention||3
8727534|NCT01043185|9774769|FG001|STARTED|Period 7 - Fourth Intervention||2
8727535|NCT01043185|9774770|FG002|STARTED|Period 7 - Fourth Intervention||3
8727536|NCT01043185|9774771|FG003|STARTED|Period 7 - Fourth Intervention||2
8727537|NCT01043185|9774772|FG004|STARTED|Period 7 - Fourth Intervention||2
8727538|NCT01043185|9774773|FG005|STARTED|Period 7 - Fourth Intervention||3
8727539|NCT01043185|9774774|FG006|STARTED|Period 7 - Fourth Intervention||3
8727540|NCT01043185|9774775|FG007|STARTED|Period 7 - Fourth Intervention||3
8727541|NCT01043185|9774776|FG008|STARTED|Period 7 - Fourth Intervention||2
8727542|NCT01043185|9774777|FG009|STARTED|Period 7 - Fourth Intervention||3
8727543|NCT01043185|9774768|FG000|COMPLETED|Period 7 - Fourth Intervention||3
8727544|NCT01043185|9774769|FG001|COMPLETED|Period 7 - Fourth Intervention||2
8727545|NCT01043185|9774770|FG002|COMPLETED|Period 7 - Fourth Intervention||3
8727546|NCT01043185|9774771|FG003|COMPLETED|Period 7 - Fourth Intervention||2
8727547|NCT01043185|9774772|FG004|COMPLETED|Period 7 - Fourth Intervention||2
8727548|NCT01043185|9774773|FG005|COMPLETED|Period 7 - Fourth Intervention||3
8727549|NCT01043185|9774774|FG006|COMPLETED|Period 7 - Fourth Intervention||3
8727550|NCT01043185|9774775|FG007|COMPLETED|Period 7 - Fourth Intervention||3
8727551|NCT01043185|9774776|FG008|COMPLETED|Period 7 - Fourth Intervention||2
8727552|NCT01043185|9774777|FG009|COMPLETED|Period 7 - Fourth Intervention||3
8727553|NCT01043185|9774768|FG000|NOT COMPLETED|Period 7 - Fourth Intervention||0
8727554|NCT01043185|9774769|FG001|NOT COMPLETED|Period 7 - Fourth Intervention||0
8727555|NCT01043185|9774770|FG002|NOT COMPLETED|Period 7 - Fourth Intervention||0
8727556|NCT01043185|9774771|FG003|NOT COMPLETED|Period 7 - Fourth Intervention||0
8727557|NCT01043185|9774772|FG004|NOT COMPLETED|Period 7 - Fourth Intervention||0
8727558|NCT01043185|9774773|FG005|NOT COMPLETED|Period 7 - Fourth Intervention||0
8727559|NCT01043185|9774774|FG006|NOT COMPLETED|Period 7 - Fourth Intervention||0
8727560|NCT01043185|9774775|FG007|NOT COMPLETED|Period 7 - Fourth Intervention||0
8727561|NCT01043185|9774776|FG008|NOT COMPLETED|Period 7 - Fourth Intervention||0
8727562|NCT01043185|9774777|FG009|NOT COMPLETED|Period 7 - Fourth Intervention||0
8727563|NCT01043393|9774791|FG000|STARTED|Overall Study||12
8727564|NCT01043393|9774792|FG001|STARTED|Overall Study||12
8727565|NCT01043393|9774791|FG000|COMPLETED|Overall Study||12
8645787|NCT00612235|9686781|FG000|COMPLETED|Overall Study||20
8645788|NCT00612235|9686782|FG001|COMPLETED|Overall Study||20
8645789|NCT00612235|9686783|FG002|COMPLETED|Overall Study||20
8645790|NCT00612235|9686784|FG003|COMPLETED|Overall Study||20
8645791|NCT00612235|9686781|FG000|NOT COMPLETED|Overall Study||0
8645792|NCT00612235|9686782|FG001|NOT COMPLETED|Overall Study||0
8645793|NCT00612235|9686783|FG002|NOT COMPLETED|Overall Study||0
8645794|NCT00612235|9686784|FG003|NOT COMPLETED|Overall Study||0
8645795|NCT00612313|9686797|FG000|STARTED|Overall Study||69
8645796|NCT00612313|9686798|FG001|STARTED|Overall Study||75
8645797|NCT00612313|9686797|FG000|COMPLETED|Overall Study||52
8645798|NCT00612313|9686798|FG001|COMPLETED|Overall Study||62
8645799|NCT00612313|9686797|FG000|NOT COMPLETED|Overall Study||17
8645800|NCT00612313|9686798|FG001|NOT COMPLETED|Overall Study||13
8645801|NCT00612339|9686810|FG000|STARTED|Overall Study||41
8645802|NCT00612339|9686810|FG000|COMPLETED|Overall Study||41
8645803|NCT00612339|9686810|FG000|NOT COMPLETED|Overall Study||0
8645804|NCT00612352|9686816|FG000|STARTED|Overall Study||65
8645805|NCT00612352|9686817|FG001|STARTED|Overall Study||115
8645806|NCT00612352|9686816|FG000|40%mg & 100%mg|Overall Study||1
8645807|NCT00612352|9686817|FG001|40%mg & 100%mg|Overall Study||1
8645808|NCT00612352|9686816|FG000|Placebo & 100%mg|Overall Study||1
8645809|NCT00612352|9686817|FG001|Placebo & 100%mg|Overall Study||0
8645810|NCT00612352|9686816|FG000|100%mg|Overall Study||2
8645811|NCT00612352|9686817|FG001|100%mg|Overall Study||1
8645812|NCT00612352|9686816|FG000|40%mg|Overall Study||1
8645813|NCT00612352|9686817|FG001|40%mg|Overall Study||0
8645814|NCT00612352|9686816|FG000|Placebo|Overall Study||4
8645815|NCT00612352|9686817|FG001|Placebo|Overall Study||4
8645816|NCT00612352|9686816|FG000|COMPLETED|Overall Study||56
8645817|NCT00612352|9686817|FG001|COMPLETED|Overall Study||109
8645818|NCT00612352|9686816|FG000|NOT COMPLETED|Overall Study||9
8645819|NCT00612352|9686817|FG001|NOT COMPLETED|Overall Study||6
8645820|NCT00612430|9686825|FG000|STARTED|Overall Study||32
8645821|NCT00612430|9686826|FG001|STARTED|Overall Study||27
8645822|NCT00612430|9686825|FG000|COMPLETED|Overall Study||32
8645823|NCT00612430|9686826|FG001|COMPLETED|Overall Study||27
8645824|NCT00612430|9686825|FG000|NOT COMPLETED|Overall Study||0
8645825|NCT00612430|9686826|FG001|NOT COMPLETED|Overall Study||0
8645826|NCT00612456|9686837|FG000|STARTED|Overall Study||27
8645827|NCT00612456|9686838|FG001|STARTED|Overall Study||27
8645828|NCT00612456|9686839|FG002|STARTED|Overall Study||16
8645829|NCT00612456|9686837|FG000|COMPLETED|Overall Study||25
8645830|NCT00612456|9686838|FG001|COMPLETED|Overall Study||25
8645831|NCT00612456|9686839|FG002|COMPLETED|Overall Study||16
8645832|NCT00612456|9686837|FG000|NOT COMPLETED|Overall Study||2
8645833|NCT00612456|9686838|FG001|NOT COMPLETED|Overall Study||2
8645834|NCT00612456|9686839|FG002|NOT COMPLETED|Overall Study||0
8645835|NCT00612508|9686851|FG000|STARTED|Overall Study||7
8645836|NCT00612508|9686852|FG001|STARTED|Overall Study||7
8645837|NCT00612508|9686851|FG000|COMPLETED|Overall Study|5 desogen users returned for the 84 day biopsy|4
8645838|NCT00612508|9686852|FG001|COMPLETED|Overall Study|6 nuvaring users returned for the 84 day biopsy|3
8645839|NCT00612508|9686851|FG000|NOT COMPLETED|Overall Study||3
8645840|NCT00612508|9686852|FG001|NOT COMPLETED|Overall Study||4
8645841|NCT00612534|9686864|FG000|STARTED|Overall Study||24
8645842|NCT00612534|9686865|FG001|STARTED|Overall Study||26
8645843|NCT00612534|9686866|FG002|STARTED|Overall Study||20
8645844|NCT00612534|9686867|FG003|STARTED|Overall Study||24
8645845|NCT00612534|9686864|FG000|COMPLETED|Overall Study||11
8645846|NCT00612534|9686865|FG001|COMPLETED|Overall Study||9
8645847|NCT00612534|9686866|FG002|COMPLETED|Overall Study||13
8645848|NCT00612534|9686867|FG003|COMPLETED|Overall Study||7
8645849|NCT00612534|9686864|FG000|NOT COMPLETED|Overall Study||13
8645850|NCT00612534|9686865|FG001|NOT COMPLETED|Overall Study||17
8645851|NCT00612534|9686866|FG002|NOT COMPLETED|Overall Study||7
8645852|NCT00612534|9686867|FG003|NOT COMPLETED|Overall Study||17
8645853|NCT00612560|9686881|FG000|STARTED|Overall Study||7
8645854|NCT00612560|9686882|FG001|STARTED|Overall Study||7
8645855|NCT00612560|9686883|FG002|STARTED|Overall Study||8
8645856|NCT00612560|9686884|FG003|STARTED|Overall Study||6
8645857|NCT00612560|9686881|FG000|COMPLETED|Overall Study||7
8645858|NCT00612560|9686882|FG001|COMPLETED|Overall Study||7
8645859|NCT00612560|9686883|FG002|COMPLETED|Overall Study||8
8645860|NCT00612560|9686884|FG003|COMPLETED|Overall Study||6
8645861|NCT00612560|9686881|FG000|NOT COMPLETED|Overall Study||0
8645862|NCT00612560|9686882|FG001|NOT COMPLETED|Overall Study||0
8645863|NCT00612560|9686883|FG002|NOT COMPLETED|Overall Study||0
8645864|NCT00612560|9686884|FG003|NOT COMPLETED|Overall Study||0
8645865|NCT00612573|9686898|FG000|STARTED|Overall Study||64
8645866|NCT00612573|9686899|FG001|STARTED|Overall Study||65
8645867|NCT00612573|9686900|FG002|STARTED|Overall Study||61
8645868|NCT00612573|9686901|FG003|STARTED|Overall Study||67
8645869|NCT00612573|9686898|FG000|COMPLETED|Overall Study||52
8645870|NCT00612573|9686899|FG001|COMPLETED|Overall Study||51
8645871|NCT00612573|9686900|FG002|COMPLETED|Overall Study||52
8645872|NCT00612573|9686901|FG003|COMPLETED|Overall Study||54
8645873|NCT00612573|9686898|FG000|NOT COMPLETED|Overall Study||12
8645874|NCT00612573|9686899|FG001|NOT COMPLETED|Overall Study||14
8645875|NCT00612573|9686900|FG002|NOT COMPLETED|Overall Study||9
8645876|NCT00612573|9686901|FG003|NOT COMPLETED|Overall Study||13
8645877|NCT00612586|9686913|FG000|STARTED|Overall Study||58
8645878|NCT00612586|9686914|FG001|STARTED|Overall Study||59
8645879|NCT00612586|9686913|FG000|Received at Least 1 Dose|Overall Study||57
8645880|NCT00612586|9686914|FG001|Received at Least 1 Dose|Overall Study||58
8645881|NCT00612586|9686913|FG000|COMPLETED|Overall Study||15
8645882|NCT00612586|9686914|FG001|COMPLETED|Overall Study||18
8645883|NCT00612586|9686913|FG000|NOT COMPLETED|Overall Study||43
8645884|NCT00612586|9686914|FG001|NOT COMPLETED|Overall Study||41
8645885|NCT00612690|9686923|FG000|STARTED|Overall Study||275
8645886|NCT00612690|9686924|FG001|STARTED|Overall Study||207
8645887|NCT00612690|9686923|FG000|COMPLETED|Overall Study||160
8645888|NCT00612690|9686924|FG001|COMPLETED|Overall Study||89
8645889|NCT00612690|9686923|FG000|NOT COMPLETED|Overall Study||115
8645890|NCT00612690|9686924|FG001|NOT COMPLETED|Overall Study||118
8645891|NCT00612716|9686932|FG000|STARTED|Overall Study||6
8645892|NCT00612716|9686932|FG000|COMPLETED|Overall Study||6
8645893|NCT00612716|9686932|FG000|NOT COMPLETED|Overall Study||0
8645894|NCT00612768|9686936|FG000|STARTED|Overall Study||50
8645895|NCT00612768|9686936|FG000|COMPLETED|Overall Study||50
8645896|NCT00612768|9686936|FG000|NOT COMPLETED|Overall Study||0
8645897|NCT00612807|9686963|FG000|STARTED|Overall Study||14
8645898|NCT00612807|9686964|FG001|STARTED|Overall Study||28
8645899|NCT00612807|9686963|FG000|COMPLETED|Overall Study||12
8645900|NCT00612807|9686964|FG001|COMPLETED|Overall Study||28
8645901|NCT00612807|9686963|FG000|NOT COMPLETED|Overall Study||2
8645902|NCT00612807|9686964|FG001|NOT COMPLETED|Overall Study||0
8645903|NCT00612924|9686972|FG000|STARTED|Overall Study||101
8645904|NCT00612924|9686973|FG001|STARTED|Overall Study||94
8645905|NCT00612924|9686972|FG000|COMPLETED|Overall Study||94
8645906|NCT00612924|9686973|FG001|COMPLETED|Overall Study||85
8645907|NCT00612924|9686972|FG000|NOT COMPLETED|Overall Study||7
8645908|NCT00612924|9686973|FG001|NOT COMPLETED|Overall Study||9
8645909|NCT00613015|9686986|FG000|STARTED|Overall Study||13
8645910|NCT00613015|9686987|FG001|STARTED|Overall Study||12
8645911|NCT00613015|9686988|FG002|STARTED|Overall Study||26
8645912|NCT00613015|9686989|FG003|STARTED|Overall Study||24
8645913|NCT00613015|9686990|FG004|STARTED|Overall Study||15
8645914|NCT00613015|9686991|FG005|STARTED|Overall Study||19
8645915|NCT00613015|9686986|FG000|COMPLETED|Overall Study||13
8645916|NCT00613015|9686987|FG001|COMPLETED|Overall Study|One participant did not complete the one-week follow-up visit.|11
8645917|NCT00613015|9686988|FG002|COMPLETED|Overall Study|Three participants did not complete one-week follow-up visit.|23
8645918|NCT00613015|9686989|FG003|COMPLETED|Overall Study|Three participants did not complete one-week follow-up visit.|21
8645919|NCT00613015|9686990|FG004|COMPLETED|Overall Study|Two participants did not complete one-week follow-up visit.|13
8645920|NCT00613015|9686991|FG005|COMPLETED|Overall Study|Three participants did not complete one-week follow-up visit.|16
8645921|NCT00613015|9686986|FG000|NOT COMPLETED|Overall Study||0
8645922|NCT00613015|9686987|FG001|NOT COMPLETED|Overall Study||1
8645923|NCT00613015|9686988|FG002|NOT COMPLETED|Overall Study||3
8645924|NCT00613015|9686989|FG003|NOT COMPLETED|Overall Study||3
8645925|NCT00613015|9686990|FG004|NOT COMPLETED|Overall Study||2
8645926|NCT00613015|9686991|FG005|NOT COMPLETED|Overall Study||3
8645927|NCT00613028|9687007|FG000|STARTED|Overall Study||10
8645928|NCT00613028|9687008|FG001|STARTED|Overall Study||13
8645929|NCT00613028|9687007|FG000|COMPLETED|Overall Study||10
8645930|NCT00613028|9687008|FG001|COMPLETED|Overall Study||12
8645931|NCT00613028|9687007|FG000|NOT COMPLETED|Overall Study||0
8645932|NCT00613028|9687008|FG001|NOT COMPLETED|Overall Study||1
8645933|NCT00613080|9687014|FG000|STARTED|Overall Study||79
8645934|NCT00613080|9687014|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|68
8645935|NCT00613080|9687014|FG000|NOT COMPLETED|Overall Study||11
8645936|NCT00613106|9687020|FG000|STARTED|Overall Study||132
8645937|NCT00613106|9687021|FG001|STARTED|Overall Study||47
8645938|NCT00613106|9687020|FG000|COMPLETED|Overall Study||112
8645939|NCT00613106|9687021|FG001|COMPLETED|Overall Study||38
8645940|NCT00613106|9687020|FG000|NOT COMPLETED|Overall Study||20
8645941|NCT00613106|9687021|FG001|NOT COMPLETED|Overall Study||9
8645942|NCT00613171|9687027|FG000|STARTED|Overall Study||27
8645943|NCT00613171|9687027|FG000|COMPLETED|Overall Study||13
8645944|NCT00613171|9687027|FG000|NOT COMPLETED|Overall Study||14
8645945|NCT00613301|9687032|FG000|STARTED|Overall Study||416
8645946|NCT00613301|9687032|FG000|COMPLETED|Overall Study||188
8645947|NCT00613301|9687032|FG000|NOT COMPLETED|Overall Study||228
8645948|NCT00613314|9687037|FG000|STARTED|Overall Study||15268
8645949|NCT00613314|9687037|FG000|COMPLETED|Overall Study||15113
8645950|NCT00613314|9687037|FG000|NOT COMPLETED|Overall Study||155
8645951|NCT00613327|9687041|FG000|STARTED|Overall Study||345
8645952|NCT00613327|9687041|FG000|COMPLETED|Overall Study||244
8645953|NCT00613327|9687041|FG000|NOT COMPLETED|Overall Study||101
8645954|NCT00613366|9687047|FG000|STARTED|Overall Study||20
8645955|NCT00613366|9687048|FG001|STARTED|Overall Study||20
8645956|NCT00613366|9687047|FG000|COMPLETED|Overall Study||17
8645957|NCT00613366|9687048|FG001|COMPLETED|Overall Study||18
8645958|NCT00613366|9687047|FG000|NOT COMPLETED|Overall Study||3
8645959|NCT00613366|9687048|FG001|NOT COMPLETED|Overall Study||2
8645960|NCT00613379|9687057|FG000|STARTED|Overall Study||10
8645961|NCT00613379|9687058|FG001|STARTED|Overall Study||10
8645962|NCT00613379|9687059|FG002|STARTED|Overall Study||11
8645963|NCT00613379|9687057|FG000|COMPLETED|Overall Study||10
8645964|NCT00613379|9687058|FG001|COMPLETED|Overall Study||10
8645965|NCT00613379|9687059|FG002|COMPLETED|Overall Study||11
8645966|NCT00613379|9687057|FG000|NOT COMPLETED|Overall Study||0
8645967|NCT00613379|9687058|FG001|NOT COMPLETED|Overall Study||0
8645968|NCT00613379|9687059|FG002|NOT COMPLETED|Overall Study||0
8645969|NCT00613405|9687069|FG000|STARTED|Overall Study||45
8645970|NCT00613405|9687070|FG001|STARTED|Overall Study||42
8645971|NCT00613405|9687069|FG000|COMPLETED|Overall Study||45
8645972|NCT00613405|9687070|FG001|COMPLETED|Overall Study||42
8645973|NCT00613405|9687069|FG000|NOT COMPLETED|Overall Study||0
8645974|NCT00613405|9687070|FG001|NOT COMPLETED|Overall Study||0
8645975|NCT00613509|9687078|FG000|STARTED|Cycle 1||11
8645976|NCT00613509|9687079|FG001|STARTED|Cycle 1||12
8645977|NCT00613509|9687078|FG000|COMPLETED|Cycle 1|Completion of Cycle 1. 9 participants were deemed evaluable|6
8645978|NCT00613509|9687079|FG001|COMPLETED|Cycle 1|Completion of Cycle 1. 12 participants were deemed evaluable|4
8645979|NCT00613509|9687078|FG000|NOT COMPLETED|Cycle 1||5
8645980|NCT00613509|9687079|FG001|NOT COMPLETED|Cycle 1||8
8645981|NCT00613509|9687078|FG000|STARTED|Cycle 2 (Group 2 = Crossover)||11
8645982|NCT00613509|9687079|FG001|STARTED|Cycle 2 (Group 2 = Crossover)||4
8645983|NCT00613509|9687078|FG000|COMPLETED|Cycle 2 (Group 2 = Crossover)||11
8645984|NCT00613509|9687079|FG001|COMPLETED|Cycle 2 (Group 2 = Crossover)||4
8645985|NCT00613509|9687078|FG000|NOT COMPLETED|Cycle 2 (Group 2 = Crossover)||0
8645986|NCT00613509|9687079|FG001|NOT COMPLETED|Cycle 2 (Group 2 = Crossover)||0
8645987|NCT00613574|9687085|FG000|STARTED|Overall Study||407
8645988|NCT00613574|9687085|FG000|COMPLETED|Overall Study||401
8645989|NCT00613574|9687085|FG000|NOT COMPLETED|Overall Study||6
8645990|NCT00613626|9687092|FG000|STARTED|Overall Study||33
8645991|NCT00613626|9687093|FG001|STARTED|Overall Study||34
8645992|NCT00613626|9687094|FG002|STARTED|Overall Study|These participants provided the toxicity data to determine if ZD6474+Etopiside+Cisplatin was safe.|7
8645993|NCT00613626|9687092|FG000|1st Dose ZD6474|Overall Study||33
8645994|NCT00613626|9687093|FG001|1st Dose ZD6474|Overall Study||34
8645995|NCT00613626|9687094|FG002|1st Dose ZD6474|Overall Study||7
8645996|NCT00613626|9687092|FG000|COMPLETED|Overall Study||33
8645997|NCT00613626|9687093|FG001|COMPLETED|Overall Study||33
8645998|NCT00613626|9687094|FG002|COMPLETED|Overall Study||7
8645999|NCT00613626|9687092|FG000|NOT COMPLETED|Overall Study||0
8646000|NCT00613626|9687093|FG001|NOT COMPLETED|Overall Study||1
8646001|NCT00613626|9687094|FG002|NOT COMPLETED|Overall Study||0
8646002|NCT00613821|9687103|FG000|STARTED|Overall Study||40
8646003|NCT00613821|9687104|FG001|STARTED|Overall Study||40
8646004|NCT00613821|9687103|FG000|COMPLETED|Overall Study||38
8646005|NCT00613821|9687104|FG001|COMPLETED|Overall Study||39
8646006|NCT00613821|9687103|FG000|NOT COMPLETED|Overall Study||2
8646007|NCT00613821|9687104|FG001|NOT COMPLETED|Overall Study||1
8646008|NCT00613834|9687112|FG000|STARTED|Overall Study||29
8646009|NCT00613834|9687113|FG001|STARTED|Overall Study||29
8646010|NCT00613834|9687112|FG000|COMPLETED|Overall Study||29
8646011|NCT00613834|9687113|FG001|COMPLETED|Overall Study||26
8646012|NCT00613834|9687112|FG000|NOT COMPLETED|Overall Study||0
8646013|NCT00613834|9687113|FG001|NOT COMPLETED|Overall Study||3
8646014|NCT00613925|9687123|FG000|STARTED|Overall Study||37
8646015|NCT00613925|9687124|FG001|STARTED|Overall Study||33
8646016|NCT00613925|9687123|FG000|COMPLETED|Overall Study||37
8646017|NCT00613925|9687124|FG001|COMPLETED|Overall Study||32
8646018|NCT00613925|9687123|FG000|NOT COMPLETED|Overall Study||0
8646019|NCT00613925|9687124|FG001|NOT COMPLETED|Overall Study||1
8646020|NCT00613938|9687134|FG000|STARTED|Overall Study||69
8646021|NCT00613938|9687135|FG001|STARTED|Overall Study||275
8646022|NCT00613938|9687136|FG002|STARTED|Overall Study||278
8646023|NCT00613938|9687137|FG003|STARTED|Overall Study|one patient did not have a valid baseline score therefore excluded from above|279
8646024|NCT00613938|9687134|FG000|COMPLETED|Overall Study||49
8646025|NCT00613938|9687135|FG001|COMPLETED|Overall Study||247
8646026|NCT00613938|9687136|FG002|COMPLETED|Overall Study||255
8646027|NCT00613938|9687137|FG003|COMPLETED|Overall Study||253
8646028|NCT00613938|9687134|FG000|NOT COMPLETED|Overall Study||20
8646029|NCT00613938|9687135|FG001|NOT COMPLETED|Overall Study||28
8646030|NCT00613938|9687136|FG002|NOT COMPLETED|Overall Study||23
8646031|NCT00613938|9687137|FG003|NOT COMPLETED|Overall Study||26
8646032|NCT00613951|9687150|FG000|STARTED|Overall Study||61
8646033|NCT00613951|9687151|FG001|STARTED|Overall Study||59
8646034|NCT00613951|9687152|FG002|STARTED|Overall Study||62
8646035|NCT00613951|9687150|FG000|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|60
8646036|NCT00613951|9687151|FG001|Exposed|Overall Study||59
8646037|NCT00613951|9687152|FG002|Exposed|Overall Study||62
8646038|NCT00613951|9687150|FG000|COMPLETED|Overall Study||54
8646039|NCT00613951|9687151|FG001|COMPLETED|Overall Study||54
8646040|NCT00613951|9687152|FG002|COMPLETED|Overall Study||57
8646041|NCT00613951|9687150|FG000|NOT COMPLETED|Overall Study||7
8646042|NCT00613951|9687151|FG001|NOT COMPLETED|Overall Study||5
8646043|NCT00613951|9687152|FG002|NOT COMPLETED|Overall Study||5
8646044|NCT00614055|9687166|FG000|STARTED|Overall Study||59
8646045|NCT00614055|9687167|FG001|STARTED|Overall Study||59
8646046|NCT00614055|9687168|FG002|STARTED|Overall Study||60
8646047|NCT00614055|9687166|FG000|Exposed|Overall Study||59
8646048|NCT00614055|9687167|FG001|Exposed|Overall Study||59
8646049|NCT00614055|9687168|FG002|Exposed|Overall Study||60
8646050|NCT00614055|9687166|FG000|COMPLETED|Overall Study||55
8646051|NCT00614055|9687167|FG001|COMPLETED|Overall Study||53
8646052|NCT00614055|9687168|FG002|COMPLETED|Overall Study||55
8646053|NCT00614055|9687166|FG000|NOT COMPLETED|Overall Study||4
8646054|NCT00614055|9687167|FG001|NOT COMPLETED|Overall Study||6
8646055|NCT00614055|9687168|FG002|NOT COMPLETED|Overall Study||5
8646056|NCT00614120|9687183|FG000|STARTED|Overall Study|Randomised|231
8646057|NCT00614120|9687184|FG001|STARTED|Overall Study|Randomised|233
8646058|NCT00614120|9687185|FG002|STARTED|Overall Study|Randomised|234
8646059|NCT00614120|9687186|FG003|STARTED|Overall Study|Randomised|231
8646060|NCT00614120|9687183|FG000|Exposed to Study Drug|Overall Study||231
8646061|NCT00614120|9687184|FG001|Exposed to Study Drug|Overall Study||233
8646062|NCT00614120|9687185|FG002|Exposed to Study Drug|Overall Study|Subject withdrew before exposure to study products, and thus not included in full analysis set.|233
8646063|NCT00614120|9687186|FG003|Exposed to Study Drug|Overall Study||231
8646064|NCT00614120|9687183|FG000|COMPLETED|Overall Study||202
8646065|NCT00614120|9687184|FG001|COMPLETED|Overall Study||187
8646066|NCT00614120|9687185|FG002|COMPLETED|Overall Study||175
8646067|NCT00614120|9687186|FG003|COMPLETED|Overall Study||215
8646068|NCT00614120|9687183|FG000|NOT COMPLETED|Overall Study||29
8646069|NCT00614120|9687184|FG001|NOT COMPLETED|Overall Study||46
8646070|NCT00614120|9687185|FG002|NOT COMPLETED|Overall Study||59
8646071|NCT00614120|9687186|FG003|NOT COMPLETED|Overall Study||16
8646072|NCT00614198|9687198|FG000|STARTED|Stage 1||38
8646073|NCT00614198|9687199|FG001|STARTED|Stage 1||34
8646074|NCT00614198|9687198|FG000|COMPLETED|Stage 1||26
8646075|NCT00614198|9687199|FG001|COMPLETED|Stage 1||29
8646076|NCT00614198|9687198|FG000|NOT COMPLETED|Stage 1||12
8646077|NCT00614198|9687199|FG001|NOT COMPLETED|Stage 1||5
8646078|NCT00614198|9687198|FG000|STARTED|Stage 2||26
8646079|NCT00614198|9687199|FG001|STARTED|Stage 2|Reallocated to gluten- and casein-free dietary intervention|29
8646080|NCT00614198|9687198|FG000|COMPLETED|Stage 2||18
8646081|NCT00614198|9687199|FG001|COMPLETED|Stage 2||17
8646082|NCT00614198|9687198|FG000|NOT COMPLETED|Stage 2||8
8646083|NCT00614198|9687199|FG001|NOT COMPLETED|Stage 2||12
8646084|NCT00614315|9687205|FG000|STARTED|Overall Study||30
8646085|NCT00614315|9687205|FG000|COMPLETED|Overall Study||30
8646086|NCT00614315|9687205|FG000|NOT COMPLETED|Overall Study||0
8646087|NCT00614380|9687213|FG000|STARTED|Overall Study||564
8646088|NCT00614380|9687214|FG001|STARTED|Overall Study||206
8646089|NCT00614380|9687215|FG002|STARTED|Overall Study||25
8646090|NCT00614380|9687216|FG003|STARTED|Overall Study||181
8646091|NCT00614380|9687213|FG000|COMPLETED|Overall Study||529
8646092|NCT00614380|9687214|FG001|COMPLETED|Overall Study||198
8646093|NCT00614380|9687215|FG002|COMPLETED|Overall Study||24
8646094|NCT00614380|9687216|FG003|COMPLETED|Overall Study||179
8646095|NCT00614380|9687213|FG000|NOT COMPLETED|Overall Study||35
8646096|NCT00614380|9687214|FG001|NOT COMPLETED|Overall Study||8
8646097|NCT00614380|9687215|FG002|NOT COMPLETED|Overall Study||1
8646098|NCT00614380|9687216|FG003|NOT COMPLETED|Overall Study||2
8646099|NCT00614393|9687236|FG000|STARTED|Overall Study||180
8646100|NCT00614393|9687237|FG001|STARTED|Overall Study||8
8646101|NCT00614393|9687238|FG002|STARTED|Overall Study||10
8646102|NCT00614393|9687239|FG003|STARTED|Overall Study||180
8646103|NCT00614393|9687240|FG004|STARTED|Overall Study||180
8646104|NCT00614393|9687236|FG000|Treated|Overall Study||180
8646105|NCT00614393|9687237|FG001|Treated|Overall Study||8
8646106|NCT00614393|9687238|FG002|Treated|Overall Study||10
8646107|NCT00614393|9687239|FG003|Treated|Overall Study||180
8646108|NCT00614393|9687240|FG004|Treated|Overall Study||178
8646109|NCT00614393|9687236|FG000|COMPLETED|Overall Study||0
8646110|NCT00614393|9687237|FG001|COMPLETED|Overall Study||0
8646111|NCT00614393|9687238|FG002|COMPLETED|Overall Study||0
8646112|NCT00614393|9687239|FG003|COMPLETED|Overall Study||0
8646113|NCT00614393|9687240|FG004|COMPLETED|Overall Study||0
8646114|NCT00614393|9687236|FG000|NOT COMPLETED|Overall Study||180
8646115|NCT00614393|9687237|FG001|NOT COMPLETED|Overall Study||8
8646116|NCT00614393|9687238|FG002|NOT COMPLETED|Overall Study||10
8646117|NCT00614393|9687239|FG003|NOT COMPLETED|Overall Study||180
8646118|NCT00614393|9687240|FG004|NOT COMPLETED|Overall Study||180
8646119|NCT00614406|9687254|FG000|STARTED|Overall Study||7
8646120|NCT00614406|9687255|FG001|STARTED|Overall Study||4
8646121|NCT00614406|9687254|FG000|COMPLETED|Overall Study||7
8646122|NCT00614406|9687255|FG001|COMPLETED|Overall Study||4
8646123|NCT00614406|9687254|FG000|NOT COMPLETED|Overall Study||0
8646124|NCT00614406|9687255|FG001|NOT COMPLETED|Overall Study||0
8691708|NCT00856557|9737073|FG001|Tested With Standardized Patients|Overall Study||76
8691709|NCT00856557|9737072|FG000|With Patients With Contextual Flags|Overall Study||50
8691710|NCT00856557|9737073|FG001|With Patients With Contextual Flags|Overall Study||60
8691711|NCT00856557|9737072|FG000|COMPLETED|Overall Study||50
8691712|NCT00856557|9737073|FG001|COMPLETED|Overall Study||60
8691713|NCT00856557|9737072|FG000|NOT COMPLETED|Overall Study||12
8691714|NCT00856557|9737073|FG001|NOT COMPLETED|Overall Study||16
8691715|NCT00856583|9737081|FG000|STARTED|Overall Study|Patients treated|4905
8691716|NCT00856583|9737082|FG001|STARTED|Overall Study|Patients treated|4904
8691717|NCT00856583|9737081|FG000|COMPLETED|Overall Study|Patients who were still on study drug at the time of study closure|1768
8691718|NCT00856583|9737082|FG001|COMPLETED|Overall Study|Patients who were still on study drug at the time of study closure|2307
8691719|NCT00856583|9737081|FG000|NOT COMPLETED|Overall Study||3137
8691720|NCT00856583|9737082|FG001|NOT COMPLETED|Overall Study||2597
8691721|NCT00856609|9737090|FG000|STARTED|Overall Study||41
8691722|NCT00856609|9737091|FG001|STARTED|Overall Study||39
8646125|NCT00614432|9687263|FG000|STARTED|Overall Study||4
8646126|NCT00614432|9687264|FG001|STARTED|Overall Study||6
8646127|NCT00614432|9687263|FG000|COMPLETED|Overall Study||4
8727566|NCT01043393|9774792|FG001|COMPLETED|Overall Study||12
8727567|NCT01043393|9774791|FG000|NOT COMPLETED|Overall Study||0
8727568|NCT01043393|9774792|FG001|NOT COMPLETED|Overall Study||0
8727569|NCT01043432|9774802|FG000|STARTED|Overall Study||22
8727570|NCT01043432|9774803|FG001|STARTED|Overall Study||51
8727571|NCT01043432|9774804|FG002|STARTED|Overall Study||12
8727572|NCT01043432|9774805|FG003|STARTED|Overall Study||48
8727573|NCT01043432|9774802|FG000|COMPLETED|Overall Study||22
8727574|NCT01043432|9774803|FG001|COMPLETED|Overall Study||51
8727575|NCT01043432|9774804|FG002|COMPLETED|Overall Study||12
8727576|NCT01043432|9774805|FG003|COMPLETED|Overall Study||48
8727577|NCT01043432|9774802|FG000|NOT COMPLETED|Overall Study||0
8727578|NCT01043432|9774803|FG001|NOT COMPLETED|Overall Study||0
8727579|NCT01043432|9774804|FG002|NOT COMPLETED|Overall Study||0
8727580|NCT01043432|9774805|FG003|NOT COMPLETED|Overall Study||0
8727581|NCT01043523|9774812|FG000|STARTED|Overall Study||52
8727582|NCT01043523|9774812|FG000|Participants With Unenhanced Images|Overall Study||51
8727583|NCT01043523|9774812|FG000|COMPLETED|Overall Study||52
8727584|NCT01043523|9774812|FG000|NOT COMPLETED|Overall Study||0
8727585|NCT01043562|9774820|FG000|STARTED|Overall Study||20
8727586|NCT01043562|9774820|FG000|COMPLETED|Overall Study||20
8727587|NCT01043562|9774820|FG000|NOT COMPLETED|Overall Study||0
8727588|NCT01043640|9774827|FG000|STARTED|Overall Study||46
8727589|NCT01043640|9774827|FG000|COMPLETED|Overall Study||46
8727590|NCT01043640|9774827|FG000|NOT COMPLETED|Overall Study||0
8727591|NCT01043653|9774831|FG000|STARTED|Overall Study||250
8727592|NCT01043653|9774831|FG000|COMPLETED|Overall Study||186
8727593|NCT01043653|9774831|FG000|NOT COMPLETED|Overall Study||64
8727594|NCT01043705|9774838|FG000|STARTED|Overall Study||459
8727595|NCT01043705|9774839|FG001|STARTED|Overall Study||578
8727596|NCT01043705|9774840|FG002|STARTED|Overall Study||578
8727597|NCT01043705|9774838|FG000|COMPLETED|Overall Study||352
8727598|NCT01043705|9774839|FG001|COMPLETED|Overall Study||447
8646128|NCT00614432|9687264|FG001|COMPLETED|Overall Study||6
8646129|NCT00614432|9687263|FG000|NOT COMPLETED|Overall Study||0
8646130|NCT00614432|9687264|FG001|NOT COMPLETED|Overall Study||0
8646131|NCT00614445|9687272|FG000|STARTED|Overall Study||140
8646132|NCT00614445|9687273|FG001|STARTED|Overall Study||140
8646133|NCT00614445|9687272|FG000|COMPLETED|Overall Study||112
8646134|NCT00614445|9687273|FG001|COMPLETED|Overall Study||91
8646135|NCT00614445|9687272|FG000|NOT COMPLETED|Overall Study||28
8646136|NCT00614445|9687273|FG001|NOT COMPLETED|Overall Study||49
8646137|NCT00614458|9687279|FG000|STARTED|Overall Study||6
8646138|NCT00614458|9687279|FG000|COMPLETED|Overall Study||6
8646139|NCT00614458|9687279|FG000|NOT COMPLETED|Overall Study||0
8646140|NCT00614484|9687283|FG000|STARTED|Overall Study||28
8646141|NCT00614484|9687283|FG000|COMPLETED|Overall Study||28
8646142|NCT00614484|9687283|FG000|NOT COMPLETED|Overall Study||0
8646143|NCT00614523|9687290|FG000|STARTED|Overall Study||83
8646144|NCT00614523|9687291|FG001|STARTED|Overall Study||167
8646145|NCT00614523|9687290|FG000|COMPLETED|Overall Study||20
8646146|NCT00614523|9687291|FG001|COMPLETED|Overall Study||36
8646147|NCT00614523|9687290|FG000|NOT COMPLETED|Overall Study||63
8646148|NCT00614523|9687291|FG001|NOT COMPLETED|Overall Study||131
8646149|NCT00614575|9687297|FG000|STARTED|Overall Study|The number of patients enrolled.|1089
8646150|NCT00614575|9687297|FG000|COMPLETED|Overall Study||861
8646151|NCT00614575|9687297|FG000|NOT COMPLETED|Overall Study||228
8646152|NCT00614614|9687303|FG000|STARTED|Primary Vaccination Phase||1272
8646153|NCT00614614|9687304|FG001|STARTED|Primary Vaccination Phase||282
8646154|NCT00614614|9687305|FG002|STARTED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
8646155|NCT00614614|9687306|FG003|STARTED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
8646156|NCT00614614|9687307|FG004|STARTED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
8646157|NCT00614614|9687303|FG000|COMPLETED|Primary Vaccination Phase||1182
8646158|NCT00614614|9687304|FG001|COMPLETED|Primary Vaccination Phase||265
8646159|NCT00614614|9687305|FG002|COMPLETED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
8646160|NCT00614614|9687306|FG003|COMPLETED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
8646161|NCT00614614|9687307|FG004|COMPLETED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
8646162|NCT00614614|9687303|FG000|NOT COMPLETED|Primary Vaccination Phase||90
8646163|NCT00614614|9687304|FG001|NOT COMPLETED|Primary Vaccination Phase||17
8646164|NCT00614614|9687305|FG002|NOT COMPLETED|Primary Vaccination Phase||0
8646165|NCT00614614|9687306|FG003|NOT COMPLETED|Primary Vaccination Phase||0
8646166|NCT00614614|9687307|FG004|NOT COMPLETED|Primary Vaccination Phase||0
8646167|NCT00614614|9687303|FG000|STARTED|Booster Vaccination Phase|Menhibrix 1 Group was re-randomized to Nimenrix 1,Menhibrix 2 and Nimenrix 2 Groups in booster phase|0
8646168|NCT00614614|9687304|FG001|STARTED|Booster Vaccination Phase||233
8646169|NCT00614614|9687305|FG002|STARTED|Booster Vaccination Phase||432
8646170|NCT00614614|9687306|FG003|STARTED|Booster Vaccination Phase||229
8727599|NCT01043705|9774840|FG002|COMPLETED|Overall Study||498
8646171|NCT00614614|9687307|FG004|STARTED|Booster Vaccination Phase||409
8646172|NCT00614614|9687303|FG000|COMPLETED|Booster Vaccination Phase|Menhibrix 1 Group was re-randomized to Nimenrix 1,Menhibrix 2 and Nimenrix 2 Groups in booster phase|0
8646173|NCT00614614|9687304|FG001|COMPLETED|Booster Vaccination Phase||227
8646174|NCT00614614|9687305|FG002|COMPLETED|Booster Vaccination Phase||405
8646175|NCT00614614|9687306|FG003|COMPLETED|Booster Vaccination Phase||210
8646176|NCT00614614|9687307|FG004|COMPLETED|Booster Vaccination Phase||396
8646177|NCT00614614|9687303|FG000|NOT COMPLETED|Booster Vaccination Phase||0
8646178|NCT00614614|9687304|FG001|NOT COMPLETED|Booster Vaccination Phase||6
8646179|NCT00614614|9687305|FG002|NOT COMPLETED|Booster Vaccination Phase||27
8646180|NCT00614614|9687306|FG003|NOT COMPLETED|Booster Vaccination Phase||19
8646181|NCT00614614|9687307|FG004|NOT COMPLETED|Booster Vaccination Phase||13
8646182|NCT00614744|9687324|FG000|STARTED|Overall Study||83
8646183|NCT00614744|9687325|FG001|STARTED|Overall Study||85
8646184|NCT00614744|9687324|FG000|COMPLETED|Overall Study||78
9022146|NCT03124407|10085047|FG000|STARTED|Overall Study||40
9022147|NCT03124407|10085048|FG001|STARTED|Overall Study||20
9022148|NCT03124407|10085049|FG002|STARTED|Overall Study||40
9022149|NCT03124407|10085050|FG003|STARTED|Overall Study||20
9022150|NCT03124407|10085047|FG000|COMPLETED|Overall Study||39
9022151|NCT03124407|10085048|FG001|COMPLETED|Overall Study||20
8646185|NCT00614744|9687325|FG001|COMPLETED|Overall Study||79
8646186|NCT00614744|9687324|FG000|NOT COMPLETED|Overall Study||5
8646187|NCT00614744|9687325|FG001|NOT COMPLETED|Overall Study||6
8646188|NCT00614822|9687331|FG000|STARTED|Overall Study||50
8646189|NCT00614822|9687331|FG000|COMPLETED|Overall Study||47
8646190|NCT00614822|9687331|FG000|NOT COMPLETED|Overall Study||3
8646191|NCT00614874|9687336|FG000|STARTED|Overall Study||16
8646192|NCT00614874|9687336|FG000|COMPLETED|Overall Study||14
8646193|NCT00614874|9687336|FG000|NOT COMPLETED|Overall Study||2
8646194|NCT00614913|9687340|FG000|STARTED|Overall Study||76
8646195|NCT00614913|9687340|FG000|COMPLETED|Overall Study||76
8646196|NCT00614913|9687340|FG000|NOT COMPLETED|Overall Study||0
8646197|NCT00614926|9687346|FG000|STARTED|Overall Study||25
8646198|NCT00614926|9687347|FG001|STARTED|Overall Study||7
8646199|NCT00614926|9687346|FG000|COMPLETED|Overall Study||21
8646200|NCT00614926|9687347|FG001|COMPLETED|Overall Study||7
8646201|NCT00614926|9687346|FG000|NOT COMPLETED|Overall Study||4
8646202|NCT00614926|9687347|FG001|NOT COMPLETED|Overall Study||0
8646203|NCT00614939|9687355|FG000|STARTED|Overall Study|Randomized and treated|85
8646204|NCT00614939|9687356|FG001|STARTED|Overall Study|Randomized and treated|85
8646205|NCT00614939|9687355|FG000|COMPLETED|Overall Study|Completed 52 weeks of treatment|50
8646206|NCT00614939|9687356|FG001|COMPLETED|Overall Study|Completed 52 weeks of treatment|42
8646207|NCT00614939|9687355|FG000|NOT COMPLETED|Overall Study||35
8646208|NCT00614939|9687356|FG001|NOT COMPLETED|Overall Study||43
8646209|NCT00614991|9687368|FG000|STARTED|Overall Study||8
8646210|NCT00614991|9687369|FG001|STARTED|Overall Study||9
8646211|NCT00614991|9687370|FG002|STARTED|Overall Study||7
8646212|NCT00614991|9687371|FG003|STARTED|Overall Study||7
8646213|NCT00614991|9687372|FG004|STARTED|Overall Study||7
8646214|NCT00614991|9687373|FG005|STARTED|Overall Study||6
8646215|NCT00614991|9687368|FG000|COMPLETED|Overall Study||5
8646216|NCT00614991|9687369|FG001|COMPLETED|Overall Study||6
8646217|NCT00614991|9687370|FG002|COMPLETED|Overall Study||7
8646218|NCT00614991|9687371|FG003|COMPLETED|Overall Study||7
8646219|NCT00614991|9687372|FG004|COMPLETED|Overall Study||6
8646220|NCT00614991|9687373|FG005|COMPLETED|Overall Study||6
8646221|NCT00614991|9687368|FG000|NOT COMPLETED|Overall Study||3
8646222|NCT00614991|9687369|FG001|NOT COMPLETED|Overall Study||3
8646223|NCT00614991|9687370|FG002|NOT COMPLETED|Overall Study||0
8646224|NCT00614991|9687371|FG003|NOT COMPLETED|Overall Study||0
8646225|NCT00614991|9687372|FG004|NOT COMPLETED|Overall Study||1
8646226|NCT00614991|9687373|FG005|NOT COMPLETED|Overall Study||0
8646227|NCT00615017|9687398|FG000|STARTED|Overall Study|Patients received treatment|8
8646228|NCT00615017|9687399|FG001|STARTED|Overall Study|Patients received treatment|9
8646229|NCT00615017|9687400|FG002|STARTED|Overall Study|Patients received treatment|12
8646230|NCT00615017|9687401|FG003|STARTED|Overall Study|Patients received treatment|10
8646231|NCT00615017|9687402|FG004|STARTED|Overall Study|Patients received treatment|8
8646232|NCT00615017|9687403|FG005|STARTED|Overall Study|Patients received treatment|23
8646233|NCT00615017|9687398|FG000|COMPLETED|Overall Study|Patient completed the study drug|8
8646234|NCT00615017|9687399|FG001|COMPLETED|Overall Study|Patient completed the study drug|8
8646235|NCT00615017|9687400|FG002|COMPLETED|Overall Study|Patient completed the study drug|7
8646236|NCT00615017|9687401|FG003|COMPLETED|Overall Study|Patient completed the study drug|9
8646237|NCT00615017|9687402|FG004|COMPLETED|Overall Study|Patient completed the study drug|7
8646238|NCT00615017|9687403|FG005|COMPLETED|Overall Study|Patient completed the study drug|20
8646239|NCT00615017|9687398|FG000|NOT COMPLETED|Overall Study||0
8646240|NCT00615017|9687399|FG001|NOT COMPLETED|Overall Study||1
8646241|NCT00615017|9687400|FG002|NOT COMPLETED|Overall Study||5
8646242|NCT00615017|9687401|FG003|NOT COMPLETED|Overall Study||1
8646243|NCT00615017|9687402|FG004|NOT COMPLETED|Overall Study||1
8646244|NCT00615017|9687403|FG005|NOT COMPLETED|Overall Study||3
8646245|NCT00615030|9687417|FG000|STARTED|Period I||9
8646246|NCT00615030|9687418|FG001|STARTED|Period I||8
8646247|NCT00615030|9687419|FG002|STARTED|Period I||9
8646248|NCT00615030|9687420|FG003|STARTED|Period I||8
8646249|NCT00615030|9687421|FG004|STARTED|Period I||9
9022152|NCT03124407|10085049|FG002|COMPLETED|Overall Study||39
8646250|NCT00615030|9687422|FG005|STARTED|Period I|1 randomized patient in this sequence dropped out before exposure to study drug in Period I.|6
8646251|NCT00615030|9687423|FG006|STARTED|Period I||7
8646252|NCT00615030|9687424|FG007|STARTED|Period I||7
8646253|NCT00615030|9687425|FG008|STARTED|Period I||9
8646254|NCT00615030|9687426|FG009|STARTED|Period I||8
8646255|NCT00615030|9687427|FG010|STARTED|Period I||8
8911202|NCT02144285|9970253|FG005|Received At Least One Dose of Study Drug|Overall Study||6
8911203|NCT02144285|9970254|FG006|Received At Least One Dose of Study Drug|Overall Study||6
8911204|NCT02144285|9970255|FG007|Received At Least One Dose of Study Drug|Overall Study||6
8911205|NCT02144285|9970256|FG008|Received At Least One Dose of Study Drug|Overall Study||2
8911206|NCT02144285|9970257|FG009|Received At Least One Dose of Study Drug|Overall Study||6
8911207|NCT02144285|9970248|FG000|COMPLETED|Overall Study||14
8911208|NCT02144285|9970249|FG001|COMPLETED|Overall Study||6
8911209|NCT02144285|9970250|FG002|COMPLETED|Overall Study||6
8911210|NCT02144285|9970251|FG003|COMPLETED|Overall Study||6
8911211|NCT02144285|9970252|FG004|COMPLETED|Overall Study||5
8911212|NCT02144285|9970253|FG005|COMPLETED|Overall Study||6
8911213|NCT02144285|9970254|FG006|COMPLETED|Overall Study||6
8911214|NCT02144285|9970255|FG007|COMPLETED|Overall Study||6
8911215|NCT02144285|9970256|FG008|COMPLETED|Overall Study||2
8911216|NCT02144285|9970257|FG009|COMPLETED|Overall Study||6
8911217|NCT02144285|9970248|FG000|NOT COMPLETED|Overall Study||0
8646256|NCT00615030|9687428|FG011|STARTED|Period I||7
8646257|NCT00615030|9687417|FG000|COMPLETED|Period I||8
8646258|NCT00615030|9687418|FG001|COMPLETED|Period I||8
8646259|NCT00615030|9687419|FG002|COMPLETED|Period I||9
8646260|NCT00615030|9687420|FG003|COMPLETED|Period I||8
8646261|NCT00615030|9687421|FG004|COMPLETED|Period I||8
8646262|NCT00615030|9687422|FG005|COMPLETED|Period I||5
8646263|NCT00615030|9687423|FG006|COMPLETED|Period I||7
8646264|NCT00615030|9687424|FG007|COMPLETED|Period I||7
8646265|NCT00615030|9687425|FG008|COMPLETED|Period I||8
8646266|NCT00615030|9687426|FG009|COMPLETED|Period I||8
8646267|NCT00615030|9687427|FG010|COMPLETED|Period I||7
8646268|NCT00615030|9687428|FG011|COMPLETED|Period I||6
8646269|NCT00615030|9687417|FG000|NOT COMPLETED|Period I||1
8646270|NCT00615030|9687418|FG001|NOT COMPLETED|Period I||0
8646271|NCT00615030|9687419|FG002|NOT COMPLETED|Period I||0
8646272|NCT00615030|9687420|FG003|NOT COMPLETED|Period I||0
8646273|NCT00615030|9687421|FG004|NOT COMPLETED|Period I||1
8646274|NCT00615030|9687422|FG005|NOT COMPLETED|Period I||1
8646275|NCT00615030|9687423|FG006|NOT COMPLETED|Period I||0
8646276|NCT00615030|9687424|FG007|NOT COMPLETED|Period I||0
8646277|NCT00615030|9687425|FG008|NOT COMPLETED|Period I||1
8646278|NCT00615030|9687426|FG009|NOT COMPLETED|Period I||0
8646279|NCT00615030|9687427|FG010|NOT COMPLETED|Period I||1
8646280|NCT00615030|9687428|FG011|NOT COMPLETED|Period I||1
8646281|NCT00615030|9687417|FG000|STARTED|Period II||8
8646282|NCT00615030|9687418|FG001|STARTED|Period II||8
8727600|NCT01043705|9774838|FG000|NOT COMPLETED|Overall Study||107
8727601|NCT01043705|9774839|FG001|NOT COMPLETED|Overall Study||131
8727602|NCT01043705|9774840|FG002|NOT COMPLETED|Overall Study||80
8727603|NCT01043874|9774848|FG000|STARTED|Overall Study||45
8727604|NCT01043874|9774848|FG000|COMPLETED|Overall Study||39
8727605|NCT01043874|9774848|FG000|NOT COMPLETED|Overall Study||6
8727606|NCT01043926|9774854|FG000|STARTED|Overall Study||8
8727607|NCT01043926|9774855|FG001|STARTED|Overall Study||8
8727608|NCT01043926|9774856|FG002|STARTED|Overall Study||0
8727609|NCT01043926|9774857|FG003|STARTED|Overall Study||0
8727610|NCT01043926|9774854|FG000|COMPLETED|Overall Study||8
8727611|NCT01043926|9774855|FG001|COMPLETED|Overall Study||8
8727612|NCT01043926|9774856|FG002|COMPLETED|Overall Study||0
8727613|NCT01043926|9774857|FG003|COMPLETED|Overall Study||0
8727614|NCT01043926|9774854|FG000|NOT COMPLETED|Overall Study||0
8727615|NCT01043926|9774855|FG001|NOT COMPLETED|Overall Study||0
8727616|NCT01043926|9774856|FG002|NOT COMPLETED|Overall Study||0
8727617|NCT01043926|9774857|FG003|NOT COMPLETED|Overall Study||0
8727618|NCT01043939|9774865|FG000|STARTED|First Intervention||12
8727619|NCT01043939|9774866|FG001|STARTED|First Intervention||12
8727620|NCT01043939|9774865|FG000|COMPLETED|First Intervention||12
8727621|NCT01043939|9774866|FG001|COMPLETED|First Intervention||12
8646283|NCT00615030|9687419|FG002|STARTED|Period II||9
8646284|NCT00615030|9687420|FG003|STARTED|Period II||8
8646285|NCT00615030|9687421|FG004|STARTED|Period II||8
8646286|NCT00615030|9687422|FG005|STARTED|Period II||5
8646287|NCT00615030|9687423|FG006|STARTED|Period II||7
8646288|NCT00615030|9687424|FG007|STARTED|Period II||7
8646289|NCT00615030|9687425|FG008|STARTED|Period II||8
8646290|NCT00615030|9687426|FG009|STARTED|Period II||8
8646291|NCT00615030|9687427|FG010|STARTED|Period II||7
8646292|NCT00615030|9687428|FG011|STARTED|Period II||6
8646293|NCT00615030|9687417|FG000|COMPLETED|Period II||8
8646294|NCT00615030|9687418|FG001|COMPLETED|Period II||8
8646295|NCT00615030|9687419|FG002|COMPLETED|Period II||8
8646296|NCT00615030|9687420|FG003|COMPLETED|Period II||7
8911218|NCT02144285|9970249|FG001|NOT COMPLETED|Overall Study||0
8911219|NCT02144285|9970250|FG002|NOT COMPLETED|Overall Study||0
8911220|NCT02144285|9970251|FG003|NOT COMPLETED|Overall Study||0
8911221|NCT02144285|9970252|FG004|NOT COMPLETED|Overall Study||1
8646297|NCT00615030|9687421|FG004|COMPLETED|Period II||8
8646298|NCT00615030|9687422|FG005|COMPLETED|Period II||5
8646299|NCT00615030|9687423|FG006|COMPLETED|Period II||6
8646300|NCT00615030|9687424|FG007|COMPLETED|Period II||7
8727622|NCT01043939|9774865|FG000|NOT COMPLETED|First Intervention||0
8727623|NCT01043939|9774866|FG001|NOT COMPLETED|First Intervention||0
8727624|NCT01043939|9774865|FG000|STARTED|Washout Period||12
8727625|NCT01043939|9774866|FG001|STARTED|Washout Period||12
8727626|NCT01043939|9774865|FG000|COMPLETED|Washout Period||12
8646301|NCT00615030|9687425|FG008|COMPLETED|Period II||7
8646302|NCT00615030|9687426|FG009|COMPLETED|Period II||8
8646303|NCT00615030|9687427|FG010|COMPLETED|Period II||7
8646304|NCT00615030|9687428|FG011|COMPLETED|Period II||6
8646305|NCT00615030|9687417|FG000|NOT COMPLETED|Period II||0
8646306|NCT00615030|9687418|FG001|NOT COMPLETED|Period II||0
8646307|NCT00615030|9687419|FG002|NOT COMPLETED|Period II||1
8646308|NCT00615030|9687420|FG003|NOT COMPLETED|Period II||1
8646309|NCT00615030|9687421|FG004|NOT COMPLETED|Period II||0
8646310|NCT00615030|9687422|FG005|NOT COMPLETED|Period II||0
8646311|NCT00615030|9687423|FG006|NOT COMPLETED|Period II||1
8646312|NCT00615030|9687424|FG007|NOT COMPLETED|Period II||0
8646313|NCT00615030|9687425|FG008|NOT COMPLETED|Period II||1
8646314|NCT00615030|9687426|FG009|NOT COMPLETED|Period II||0
8646315|NCT00615030|9687427|FG010|NOT COMPLETED|Period II||0
8646316|NCT00615030|9687428|FG011|NOT COMPLETED|Period II||0
8646317|NCT00615030|9687417|FG000|STARTED|Period III||8
8646318|NCT00615030|9687418|FG001|STARTED|Period III||8
8646319|NCT00615030|9687419|FG002|STARTED|Period III||8
8646320|NCT00615030|9687420|FG003|STARTED|Period III||7
8646321|NCT00615030|9687421|FG004|STARTED|Period III||8
8646322|NCT00615030|9687422|FG005|STARTED|Period III||5
8646323|NCT00615030|9687423|FG006|STARTED|Period III||6
8646324|NCT00615030|9687424|FG007|STARTED|Period III||7
8646325|NCT00615030|9687425|FG008|STARTED|Period III||7
8646326|NCT00615030|9687426|FG009|STARTED|Period III||8
8646327|NCT00615030|9687427|FG010|STARTED|Period III||7
8646328|NCT00615030|9687428|FG011|STARTED|Period III||6
8646329|NCT00615030|9687417|FG000|COMPLETED|Period III||7
8646330|NCT00615030|9687418|FG001|COMPLETED|Period III||8
8646331|NCT00615030|9687419|FG002|COMPLETED|Period III||8
8646332|NCT00615030|9687420|FG003|COMPLETED|Period III||6
8646333|NCT00615030|9687421|FG004|COMPLETED|Period III||8
8646334|NCT00615030|9687422|FG005|COMPLETED|Period III||5
8646335|NCT00615030|9687423|FG006|COMPLETED|Period III||6
8646336|NCT00615030|9687424|FG007|COMPLETED|Period III||7
8646337|NCT00615030|9687425|FG008|COMPLETED|Period III||7
8646338|NCT00615030|9687426|FG009|COMPLETED|Period III||8
8646339|NCT00615030|9687427|FG010|COMPLETED|Period III||7
8646340|NCT00615030|9687428|FG011|COMPLETED|Period III||6
8646341|NCT00615030|9687417|FG000|NOT COMPLETED|Period III||1
8646342|NCT00615030|9687418|FG001|NOT COMPLETED|Period III||0
8646343|NCT00615030|9687419|FG002|NOT COMPLETED|Period III||0
8646344|NCT00615030|9687420|FG003|NOT COMPLETED|Period III||1
8646345|NCT00615030|9687421|FG004|NOT COMPLETED|Period III||0
8646346|NCT00615030|9687422|FG005|NOT COMPLETED|Period III||0
8646347|NCT00615030|9687423|FG006|NOT COMPLETED|Period III||0
8646348|NCT00615030|9687424|FG007|NOT COMPLETED|Period III||0
8646349|NCT00615030|9687425|FG008|NOT COMPLETED|Period III||0
8646350|NCT00615030|9687426|FG009|NOT COMPLETED|Period III||0
8646351|NCT00615030|9687427|FG010|NOT COMPLETED|Period III||0
8646352|NCT00615030|9687428|FG011|NOT COMPLETED|Period III||0
8646353|NCT00615056|9687446|FG000|STARTED|Overall Study||49
8646354|NCT00615056|9687447|FG001|STARTED|Overall Study||51
8646355|NCT00615056|9687448|FG002|STARTED|Overall Study||36
8646356|NCT00615056|9687449|FG003|STARTED|Overall Study||35
8646357|NCT00615056|9687446|FG000|Treated|Overall Study||46
8646358|NCT00615056|9687447|FG001|Treated|Overall Study||51
8646359|NCT00615056|9687448|FG002|Treated|Overall Study||36
8646360|NCT00615056|9687449|FG003|Treated|Overall Study||35
8646361|NCT00615056|9687446|FG000|COMPLETED|Overall Study||0
8646362|NCT00615056|9687447|FG001|COMPLETED|Overall Study||0
8646363|NCT00615056|9687448|FG002|COMPLETED|Overall Study||0
8646364|NCT00615056|9687449|FG003|COMPLETED|Overall Study||0
8646365|NCT00615056|9687446|FG000|NOT COMPLETED|Overall Study||49
8646366|NCT00615056|9687447|FG001|NOT COMPLETED|Overall Study||51
8646367|NCT00615056|9687448|FG002|NOT COMPLETED|Overall Study||36
8646368|NCT00615056|9687449|FG003|NOT COMPLETED|Overall Study||35
8646369|NCT00615069|9687459|FG000|STARTED|Overall Study||35
8646370|NCT00615069|9687459|FG000|COMPLETED|Overall Study||19
8646371|NCT00615069|9687459|FG000|NOT COMPLETED|Overall Study||16
8646372|NCT00615108|9687463|FG000|STARTED|Overall Study||3148
8646373|NCT00615108|9687463|FG000|COMPLETED|Overall Study||2641
8646374|NCT00615108|9687463|FG000|NOT COMPLETED|Overall Study||507
8646375|NCT00615199|9687473|FG000|STARTED|Overall Study||34
8646376|NCT00615199|9687474|FG001|STARTED|Overall Study||36
8646377|NCT00615199|9687475|FG002|STARTED|Overall Study||34
8646378|NCT00615199|9687476|FG003|STARTED|Overall Study||35
8646379|NCT00615199|9687473|FG000|COMPLETED|Overall Study||26
8646380|NCT00615199|9687474|FG001|COMPLETED|Overall Study||34
8646381|NCT00615199|9687475|FG002|COMPLETED|Overall Study||33
8646382|NCT00615199|9687476|FG003|COMPLETED|Overall Study||33
8646383|NCT00615199|9687473|FG000|NOT COMPLETED|Overall Study||8
8646384|NCT00615199|9687474|FG001|NOT COMPLETED|Overall Study||2
8646385|NCT00615199|9687475|FG002|NOT COMPLETED|Overall Study||1
8646386|NCT00615199|9687476|FG003|NOT COMPLETED|Overall Study||2
8646387|NCT00615264|9687488|FG000|STARTED|Overall Study||225
8646388|NCT00615264|9687489|FG001|STARTED|Overall Study||232
8646389|NCT00615264|9687488|FG000|Received at Least One Dose (ITT)|Overall Study||225
8646390|NCT00615264|9687489|FG001|Received at Least One Dose (ITT)|Overall Study||231
8646391|NCT00615264|9687488|FG000|ITT Patients Who Met Inc/Excl (MITT)|Overall Study||209
8646392|NCT00615264|9687489|FG001|ITT Patients Who Met Inc/Excl (MITT)|Overall Study||213
8646393|NCT00615264|9687488|FG000|COMPLETED|Overall Study||175
8646394|NCT00615264|9687489|FG001|COMPLETED|Overall Study||180
8646395|NCT00615264|9687488|FG000|NOT COMPLETED|Overall Study||50
8646396|NCT00615264|9687489|FG001|NOT COMPLETED|Overall Study||52
8646397|NCT00615290|9687495|FG000|STARTED|Overall Study||42
8646398|NCT00615290|9687495|FG000|COMPLETED|Overall Study||34
8646399|NCT00615290|9687495|FG000|NOT COMPLETED|Overall Study||8
8646400|NCT00615420|9687501|FG000|STARTED|Overall Study||54
8646401|NCT00615420|9687502|FG001|STARTED|Overall Study||52
8646402|NCT00615420|9687501|FG000|COMPLETED|Overall Study||23
8646403|NCT00615420|9687502|FG001|COMPLETED|Overall Study||25
8646404|NCT00615420|9687501|FG000|NOT COMPLETED|Overall Study||31
8646405|NCT00615420|9687502|FG001|NOT COMPLETED|Overall Study||27
8646406|NCT00615433|9687512|FG000|STARTED|Overall Study||120
8646407|NCT00615433|9687513|FG001|STARTED|Overall Study||119
8646408|NCT00615433|9687514|FG002|STARTED|Overall Study||123
8646409|NCT00615433|9687515|FG003|STARTED|Overall Study||116
8646410|NCT00615433|9687512|FG000|COMPLETED|Overall Study||77
8646411|NCT00615433|9687513|FG001|COMPLETED|Overall Study||66
8646412|NCT00615433|9687514|FG002|COMPLETED|Overall Study||84
8646413|NCT00615433|9687515|FG003|COMPLETED|Overall Study||71
8646414|NCT00615433|9687512|FG000|NOT COMPLETED|Overall Study||43
8646415|NCT00615433|9687513|FG001|NOT COMPLETED|Overall Study||53
8646416|NCT00615433|9687514|FG002|NOT COMPLETED|Overall Study||39
8646417|NCT00615433|9687515|FG003|NOT COMPLETED|Overall Study||45
8646418|NCT00615459|9687526|FG000|STARTED|Period I||41
8646419|NCT00615459|9687527|FG001|STARTED|Period I|1 randomized patient of this sequence was never exposed to drug. Hence, dropped out before Period I.|41
8646420|NCT00615459|9687528|FG002|STARTED|Period I|1 randomized patient of this sequence was never exposed to drug. Hence, dropped out before Period I.|42
8646421|NCT00615459|9687529|FG003|STARTED|Period I||43
8646422|NCT00615459|9687526|FG000|COMPLETED|Period I||37
8646423|NCT00615459|9687527|FG001|COMPLETED|Period I||40
8646424|NCT00615459|9687528|FG002|COMPLETED|Period I||40
8646425|NCT00615459|9687529|FG003|COMPLETED|Period I||42
8646426|NCT00615459|9687526|FG000|NOT COMPLETED|Period I||4
8646427|NCT00615459|9687527|FG001|NOT COMPLETED|Period I||1
8646428|NCT00615459|9687528|FG002|NOT COMPLETED|Period I||2
8646429|NCT00615459|9687529|FG003|NOT COMPLETED|Period I||1
8646430|NCT00615459|9687526|FG000|STARTED|Period II||37
8646431|NCT00615459|9687527|FG001|STARTED|Period II||40
8646432|NCT00615459|9687528|FG002|STARTED|Period II||40
8646433|NCT00615459|9687529|FG003|STARTED|Period II||42
8646434|NCT00615459|9687526|FG000|COMPLETED|Period II||36
8646435|NCT00615459|9687527|FG001|COMPLETED|Period II||40
8646436|NCT00615459|9687528|FG002|COMPLETED|Period II||40
8646437|NCT00615459|9687529|FG003|COMPLETED|Period II||41
8646438|NCT00615459|9687526|FG000|NOT COMPLETED|Period II||1
8646439|NCT00615459|9687527|FG001|NOT COMPLETED|Period II||0
8646440|NCT00615459|9687528|FG002|NOT COMPLETED|Period II||0
8646441|NCT00615459|9687529|FG003|NOT COMPLETED|Period II||1
8646442|NCT00615459|9687526|FG000|STARTED|Period III||36
8646443|NCT00615459|9687527|FG001|STARTED|Period III||40
8646444|NCT00615459|9687528|FG002|STARTED|Period III||40
8646445|NCT00615459|9687529|FG003|STARTED|Period III||41
8646446|NCT00615459|9687526|FG000|COMPLETED|Period III||36
8646447|NCT00615459|9687527|FG001|COMPLETED|Period III||37
8646448|NCT00615459|9687528|FG002|COMPLETED|Period III||39
8646449|NCT00615459|9687529|FG003|COMPLETED|Period III||41
8646450|NCT00615459|9687526|FG000|NOT COMPLETED|Period III||0
8646451|NCT00615459|9687527|FG001|NOT COMPLETED|Period III||3
8646452|NCT00615459|9687528|FG002|NOT COMPLETED|Period III||1
8646453|NCT00615459|9687529|FG003|NOT COMPLETED|Period III||0
8646454|NCT00615472|9687541|FG000|STARTED|Overall Study||30
8646455|NCT00615472|9687542|FG001|STARTED|Overall Study||28
8646456|NCT00615472|9687541|FG000|COMPLETED|Overall Study||30
8646457|NCT00615472|9687542|FG001|COMPLETED|Overall Study||28
8646458|NCT00615472|9687541|FG000|NOT COMPLETED|Overall Study||0
8646459|NCT00615472|9687542|FG001|NOT COMPLETED|Overall Study||0
8646460|NCT00615550|9687550|FG000|STARTED|Overall Study||229
8646461|NCT00615550|9687551|FG001|STARTED|Overall Study||236
8646462|NCT00615550|9687550|FG000|COMPLETED|Overall Study||223
8646463|NCT00615550|9687551|FG001|COMPLETED|Overall Study||235
8646464|NCT00615550|9687550|FG000|NOT COMPLETED|Overall Study||6
8646465|NCT00615550|9687551|FG001|NOT COMPLETED|Overall Study||1
8727627|NCT01043939|9774866|FG001|COMPLETED|Washout Period||12
8646466|NCT00615589|9687557|FG000|STARTED|Overall Study||22
8727628|NCT01043939|9774865|FG000|NOT COMPLETED|Washout Period||0
8646467|NCT00615589|9687557|FG000|COMPLETED|Overall Study||22
8646468|NCT00615589|9687557|FG000|NOT COMPLETED|Overall Study||0
8646469|NCT00615719|9687562|FG000|STARTED|Overall Study||35
8646470|NCT00615719|9687562|FG000|COMPLETED|Overall Study||30
8646471|NCT00615719|9687562|FG000|NOT COMPLETED|Overall Study||5
8646472|NCT00615784|9687566|FG000|STARTED|Overall Study||24
8646473|NCT00615784|9687566|FG000|COMPLETED|Overall Study||24
8646474|NCT00615784|9687566|FG000|NOT COMPLETED|Overall Study||0
8646475|NCT00615836|9687574|FG000|STARTED|Part I of Core Study (FE992026 CS29)||163
8646476|NCT00615836|9687575|FG001|STARTED|Part I of Core Study (FE992026 CS29)||158
8646477|NCT00615836|9687576|FG002|STARTED|Part I of Core Study (FE992026 CS29)||158
8646478|NCT00615836|9687577|FG003|STARTED|Part I of Core Study (FE992026 CS29)||160
8646479|NCT00615836|9687578|FG004|STARTED|Part I of Core Study (FE992026 CS29)||160
8691723|NCT00856609|9737090|FG000|COMPLETED|Overall Study||40
8691724|NCT00856609|9737091|FG001|COMPLETED|Overall Study||39
8646480|NCT00615836|9687574|FG000|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|155
8646481|NCT00615836|9687575|FG001|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|152
8646482|NCT00615836|9687576|FG002|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|148
8646483|NCT00615836|9687577|FG003|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|146
8646484|NCT00615836|9687578|FG004|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|156
8646485|NCT00615836|9687574|FG000|COMPLETED|Part I of Core Study (FE992026 CS29)||144
8646486|NCT00615836|9687575|FG001|COMPLETED|Part I of Core Study (FE992026 CS29)||148
8646487|NCT00615836|9687576|FG002|COMPLETED|Part I of Core Study (FE992026 CS29)||138
8646488|NCT00615836|9687577|FG003|COMPLETED|Part I of Core Study (FE992026 CS29)||135
8646489|NCT00615836|9687578|FG004|COMPLETED|Part I of Core Study (FE992026 CS29)||145
8646490|NCT00615836|9687574|FG000|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||19
8646491|NCT00615836|9687575|FG001|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||10
8646492|NCT00615836|9687576|FG002|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||20
8646493|NCT00615836|9687577|FG003|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||25
8646494|NCT00615836|9687578|FG004|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||15
8646495|NCT00615836|9687574|FG000|STARTED|Extension Study (FE992026 CS31)||141
8646496|NCT00615836|9687575|FG001|STARTED|Extension Study (FE992026 CS31)||144
8646497|NCT00615836|9687576|FG002|STARTED|Extension Study (FE992026 CS31)||132
8646498|NCT00615836|9687577|FG003|STARTED|Extension Study (FE992026 CS31)||137
8646499|NCT00615836|9687578|FG004|STARTED|Extension Study (FE992026 CS31)||0
8646500|NCT00615836|9687574|FG000|COMPLETED|Extension Study (FE992026 CS31)||0
8646501|NCT00615836|9687575|FG001|COMPLETED|Extension Study (FE992026 CS31)||58
8646502|NCT00615836|9687576|FG002|COMPLETED|Extension Study (FE992026 CS31)||59
8646503|NCT00615836|9687577|FG003|COMPLETED|Extension Study (FE992026 CS31)||53
8646504|NCT00615836|9687578|FG004|COMPLETED|Extension Study (FE992026 CS31)||0
8646505|NCT00615836|9687574|FG000|NOT COMPLETED|Extension Study (FE992026 CS31)||141
8646506|NCT00615836|9687575|FG001|NOT COMPLETED|Extension Study (FE992026 CS31)||86
8646507|NCT00615836|9687576|FG002|NOT COMPLETED|Extension Study (FE992026 CS31)||73
8646508|NCT00615836|9687577|FG003|NOT COMPLETED|Extension Study (FE992026 CS31)||84
8646509|NCT00615836|9687578|FG004|NOT COMPLETED|Extension Study (FE992026 CS31)||0
8646510|NCT00615901|9687594|FG000|STARTED|Overall Study||38
8646511|NCT00615901|9687594|FG000|COMPLETED|Overall Study||29
8646512|NCT00615901|9687594|FG000|NOT COMPLETED|Overall Study||9
8646513|NCT00615914|9687598|FG000|STARTED|Overall Study|The number of patients enrolled|1645
8646514|NCT00615914|9687598|FG000|COMPLETED|Overall Study||1008
8646515|NCT00615914|9687598|FG000|NOT COMPLETED|Overall Study||637
8646516|NCT00615927|9687605|FG000|STARTED|Overall Study||32
8646517|NCT00615927|9687606|FG001|STARTED|Overall Study||32
8646518|NCT00615927|9687605|FG000|COMPLETED|Overall Study||32
8646519|NCT00615927|9687606|FG001|COMPLETED|Overall Study||32
8646520|NCT00615927|9687605|FG000|NOT COMPLETED|Overall Study||0
8646521|NCT00615927|9687606|FG001|NOT COMPLETED|Overall Study||0
8646522|NCT00615992|9687612|FG000|STARTED|Overall Study||754
8646523|NCT00615992|9687612|FG000|COMPLETED|Overall Study||687
8646524|NCT00615992|9687612|FG000|NOT COMPLETED|Overall Study||67
8646525|NCT00616018|9687616|FG000|STARTED|Overall Study||27
8646526|NCT00616018|9687616|FG000|COMPLETED|Overall Study||24
8646527|NCT00616018|9687616|FG000|NOT COMPLETED|Overall Study||3
8646528|NCT00616109|9687621|FG000|STARTED|Overall Study||16
8646529|NCT00616109|9687621|FG000|COMPLETED|Overall Study||16
8646530|NCT00616109|9687621|FG000|NOT COMPLETED|Overall Study||0
8646531|NCT00616122|9687626|FG000|STARTED|Overall Study||4
8646532|NCT00616122|9687627|FG001|STARTED|Overall Study||7
8646533|NCT00616122|9687628|FG002|STARTED|Overall Study||10
8646534|NCT00616122|9687629|FG003|STARTED|Overall Study||11
8727629|NCT01043939|9774866|FG001|NOT COMPLETED|Washout Period||0
8646535|NCT00616122|9687626|FG000|COMPLETED|Overall Study||4
8646536|NCT00616122|9687627|FG001|COMPLETED|Overall Study||7
8646537|NCT00616122|9687628|FG002|COMPLETED|Overall Study||10
8646538|NCT00616122|9687629|FG003|COMPLETED|Overall Study||0
8646539|NCT00616122|9687626|FG000|NOT COMPLETED|Overall Study||0
8646540|NCT00616122|9687627|FG001|NOT COMPLETED|Overall Study||0
8646541|NCT00616122|9687628|FG002|NOT COMPLETED|Overall Study||0
8646542|NCT00616122|9687629|FG003|NOT COMPLETED|Overall Study||11
8646543|NCT00616200|9687636|FG000|STARTED|Two Week Standard Diet||17
8646544|NCT00616200|9687636|FG000|COMPLETED|Two Week Standard Diet||16
8646545|NCT00616200|9687636|FG000|NOT COMPLETED|Two Week Standard Diet||1
8646546|NCT00616200|9687636|FG000|STARTED|Four Week Very Low Carbohydrate Diet||16
8646547|NCT00616200|9687636|FG000|COMPLETED|Four Week Very Low Carbohydrate Diet||13
8646548|NCT00616200|9687636|FG000|NOT COMPLETED|Four Week Very Low Carbohydrate Diet||3
8646549|NCT00616239|9687640|FG000|STARTED|Overall Study||20
8646550|NCT00616239|9687640|FG000|COMPLETED|Overall Study||18
8646551|NCT00616239|9687640|FG000|NOT COMPLETED|Overall Study||2
8646552|NCT00616421|9687647|FG000|STARTED|Overall Study||359
8646553|NCT00616421|9687648|FG001|STARTED|Overall Study||1278
8646554|NCT00616421|9687649|FG002|STARTED|Overall Study||1270
8646555|NCT00616421|9687647|FG000|COMPLETED|Overall Study||333
8646556|NCT00616421|9687648|FG001|COMPLETED|Overall Study||1240
8727630|NCT01043939|9774865|FG000|STARTED|Second Intervention||12
8646557|NCT00616421|9687649|FG002|COMPLETED|Overall Study||1229
8646558|NCT00616421|9687647|FG000|NOT COMPLETED|Overall Study||26
8646559|NCT00616421|9687648|FG001|NOT COMPLETED|Overall Study||38
8646560|NCT00616421|9687649|FG002|NOT COMPLETED|Overall Study||41
8646561|NCT00616434|9687673|FG000|STARTED|Overall Study||62
8646562|NCT00616434|9687674|FG001|STARTED|Overall Study||61
8646563|NCT00616434|9687673|FG000|COMPLETED|Overall Study||56
8646564|NCT00616434|9687674|FG001|COMPLETED|Overall Study||53
8646565|NCT00616434|9687673|FG000|NOT COMPLETED|Overall Study||6
8646566|NCT00616434|9687674|FG001|NOT COMPLETED|Overall Study||8
8646567|NCT00616629|9687685|FG000|STARTED|Overall Study|Two patients never received study drug|13
8646568|NCT00616629|9687686|FG001|STARTED|Overall Study|Two patients never received study drug|14
8646569|NCT00616629|9687687|FG002|STARTED|Overall Study|One patient never received study drug|14
8646570|NCT00616629|9687688|FG003|STARTED|Overall Study||2
8646571|NCT00616629|9687689|FG004|STARTED|Overall Study||12
8646572|NCT00616629|9687685|FG000|COMPLETED|Overall Study||11
8646573|NCT00616629|9687686|FG001|COMPLETED|Overall Study||12
8646574|NCT00616629|9687687|FG002|COMPLETED|Overall Study||13
8646575|NCT00616629|9687688|FG003|COMPLETED|Overall Study||2
8646576|NCT00616629|9687689|FG004|COMPLETED|Overall Study||12
8646577|NCT00616629|9687685|FG000|NOT COMPLETED|Overall Study||2
8646578|NCT00616629|9687686|FG001|NOT COMPLETED|Overall Study||2
8646579|NCT00616629|9687687|FG002|NOT COMPLETED|Overall Study||1
8646580|NCT00616629|9687688|FG003|NOT COMPLETED|Overall Study||0
8646581|NCT00616629|9687689|FG004|NOT COMPLETED|Overall Study||0
8646582|NCT00616655|9687704|FG000|STARTED|Overall Study||152
8646583|NCT00616655|9687705|FG001|STARTED|Overall Study||153
8646584|NCT00616655|9687706|FG002|STARTED|Overall Study||151
8646585|NCT00616655|9687704|FG000|COMPLETED|Overall Study||117
8646586|NCT00616655|9687705|FG001|COMPLETED|Overall Study||112
8646587|NCT00616655|9687706|FG002|COMPLETED|Overall Study||103
8646588|NCT00616655|9687704|FG000|NOT COMPLETED|Overall Study||35
8646589|NCT00616655|9687705|FG001|NOT COMPLETED|Overall Study||41
8646590|NCT00616655|9687706|FG002|NOT COMPLETED|Overall Study||48
8646591|NCT00616772|9687716|FG000|STARTED|Overall Study||340
8646592|NCT00616772|9687717|FG001|STARTED|Overall Study||342
8646593|NCT00616772|9687716|FG000|Treated|Overall Study||337
9022153|NCT03124407|10085050|FG003|COMPLETED|Overall Study||20
9022154|NCT03124407|10085047|FG000|NOT COMPLETED|Overall Study||1
9022155|NCT03124407|10085048|FG001|NOT COMPLETED|Overall Study||0
9022156|NCT03124407|10085049|FG002|NOT COMPLETED|Overall Study||1
8646594|NCT00616772|9687717|FG001|Treated|Overall Study||339
8646595|NCT00616772|9687716|FG000|COMPLETED|Overall Study||225
8646596|NCT00616772|9687717|FG001|COMPLETED|Overall Study||240
8646597|NCT00616772|9687716|FG000|NOT COMPLETED|Overall Study||115
8646598|NCT00616772|9687717|FG001|NOT COMPLETED|Overall Study||102
8646599|NCT00616902|9687725|FG000|STARTED|Overall Study||6
8646600|NCT00616902|9687726|FG001|STARTED|Overall Study||6
8646601|NCT00616902|9687725|FG000|COMPLETED|Overall Study||0
8646602|NCT00616902|9687726|FG001|COMPLETED|Overall Study||0
8646603|NCT00616902|9687725|FG000|NOT COMPLETED|Overall Study||6
8646604|NCT00616902|9687726|FG001|NOT COMPLETED|Overall Study||6
8646605|NCT00616928|9687736|FG000|STARTED|Overall Study||2304
8646606|NCT00616928|9687737|FG001|STARTED|Overall Study||768
8646607|NCT00616928|9687738|FG002|STARTED|Overall Study||1118
8646608|NCT00616928|9687739|FG003|STARTED|Overall Study||371
8646609|NCT00616928|9687736|FG000|COMPLETED|Overall Study||2242
8646610|NCT00616928|9687737|FG001|COMPLETED|Overall Study||750
8646611|NCT00616928|9687738|FG002|COMPLETED|Overall Study||1101
8646612|NCT00616928|9687739|FG003|COMPLETED|Overall Study||364
8646613|NCT00616928|9687736|FG000|NOT COMPLETED|Overall Study||62
8646614|NCT00616928|9687737|FG001|NOT COMPLETED|Overall Study||18
8646615|NCT00616928|9687738|FG002|NOT COMPLETED|Overall Study||17
8646616|NCT00616928|9687739|FG003|NOT COMPLETED|Overall Study||7
8646617|NCT00616941|9687764|FG000|STARTED|Overall Study||4
8646618|NCT00616941|9687765|FG001|STARTED|Overall Study||13
8646619|NCT00616941|9687766|FG002|STARTED|Overall Study||11
9022157|NCT03124407|10085050|FG003|NOT COMPLETED|Overall Study||0
8646620|NCT00616941|9687764|FG000|COMPLETED|Overall Study||3
8646621|NCT00616941|9687765|FG001|COMPLETED|Overall Study||8
8646622|NCT00616941|9687766|FG002|COMPLETED|Overall Study||5
8646623|NCT00616941|9687764|FG000|NOT COMPLETED|Overall Study||1
8646624|NCT00616941|9687765|FG001|NOT COMPLETED|Overall Study||5
8646625|NCT00616941|9687766|FG002|NOT COMPLETED|Overall Study||6
8646626|NCT00617058|9687777|FG000|STARTED|Overall Study||1
8646627|NCT00617058|9687778|FG001|STARTED|Overall Study||0
8646628|NCT00617058|9687779|FG002|STARTED|Overall Study||0
8646629|NCT00617058|9687777|FG000|COMPLETED|Overall Study||1
8646630|NCT00617058|9687778|FG001|COMPLETED|Overall Study||0
8646631|NCT00617058|9687779|FG002|COMPLETED|Overall Study||0
8646632|NCT00617058|9687777|FG000|NOT COMPLETED|Overall Study||0
8646633|NCT00617058|9687778|FG001|NOT COMPLETED|Overall Study||0
8646634|NCT00617058|9687779|FG002|NOT COMPLETED|Overall Study||0
8646635|NCT00617084|9687789|FG000|STARTED|Overall Study||1140
8646636|NCT00617084|9687790|FG001|STARTED|Overall Study||1152
8646637|NCT00617084|9687789|FG000|COMPLETED|Overall Study||1119
8646638|NCT00617084|9687790|FG001|COMPLETED|Overall Study||1126
8646639|NCT00617084|9687789|FG000|NOT COMPLETED|Overall Study||21
8646640|NCT00617084|9687790|FG001|NOT COMPLETED|Overall Study||26
8646641|NCT00617097|9687798|FG000|STARTED|Overall Study||25
8646642|NCT00617097|9687799|FG001|STARTED|Overall Study||25
8646643|NCT00617097|9687798|FG000|COMPLETED|Overall Study||25
8646644|NCT00617097|9687799|FG001|COMPLETED|Overall Study||25
8646645|NCT00617097|9687798|FG000|NOT COMPLETED|Overall Study||0
8646646|NCT00617097|9687799|FG001|NOT COMPLETED|Overall Study||0
8646647|NCT00617123|9687809|FG000|STARTED|Referral Screening Period||137
8646648|NCT00617123|9687810|FG001|STARTED|Referral Screening Period||121
8646649|NCT00617123|9687809|FG000|COMPLETED|Referral Screening Period||98
8646650|NCT00617123|9687810|FG001|COMPLETED|Referral Screening Period||95
8646651|NCT00617123|9687809|FG000|NOT COMPLETED|Referral Screening Period||39
8646652|NCT00617123|9687810|FG001|NOT COMPLETED|Referral Screening Period||26
8646653|NCT00617123|9687809|FG000|STARTED|Study Treatment Period||98
8646654|NCT00617123|9687810|FG001|STARTED|Study Treatment Period||95
8646655|NCT00617123|9687809|FG000|Treated|Study Treatment Period|1 participant was not treated|97
8646656|NCT00617123|9687810|FG001|Treated|Study Treatment Period||95
8646657|NCT00617123|9687809|FG000|COMPLETED|Study Treatment Period||81
8646658|NCT00617123|9687810|FG001|COMPLETED|Study Treatment Period||79
8646659|NCT00617123|9687809|FG000|NOT COMPLETED|Study Treatment Period||17
8646660|NCT00617123|9687810|FG001|NOT COMPLETED|Study Treatment Period||16
8646661|NCT00617175|9687818|FG000|STARTED|Overall Study||954
8646662|NCT00617175|9687819|FG001|STARTED|Overall Study||948
8646663|NCT00617175|9687818|FG000|COMPLETED|Overall Study||954
8646664|NCT00617175|9687819|FG001|COMPLETED|Overall Study||948
8646665|NCT00617175|9687818|FG000|NOT COMPLETED|Overall Study||0
8646666|NCT00617175|9687819|FG001|NOT COMPLETED|Overall Study||0
8646667|NCT00617188|9687825|FG000|STARTED|Overall Study||26
8646668|NCT00617188|9687825|FG000|COMPLETED|Overall Study||26
8646669|NCT00617188|9687825|FG000|NOT COMPLETED|Overall Study||0
8646670|NCT00617201|9687831|FG000|STARTED|Overall Study||25
8646671|NCT00617201|9687832|FG001|STARTED|Overall Study||25
8646672|NCT00617201|9687831|FG000|COMPLETED|Overall Study||16
8646673|NCT00617201|9687832|FG001|COMPLETED|Overall Study||12
8646674|NCT00617201|9687831|FG000|NOT COMPLETED|Overall Study||9
8646675|NCT00617201|9687832|FG001|NOT COMPLETED|Overall Study||13
8646676|NCT00617240|9687842|FG000|STARTED|Overall Study||5
8646677|NCT00617240|9687843|FG001|STARTED|Overall Study||4
8646678|NCT00617240|9687842|FG000|COMPLETED|Overall Study||4
8646679|NCT00617240|9687843|FG001|COMPLETED|Overall Study||4
8646680|NCT00617240|9687842|FG000|NOT COMPLETED|Overall Study||1
8646681|NCT00617240|9687843|FG001|NOT COMPLETED|Overall Study||0
8646682|NCT00617279|9687851|FG000|STARTED|Overall Study||14
8646683|NCT00617279|9687852|FG001|STARTED|Overall Study||17
8646684|NCT00617279|9687851|FG000|COMPLETED|Overall Study||0
8646685|NCT00617279|9687852|FG001|COMPLETED|Overall Study||0
8646686|NCT00617279|9687851|FG000|NOT COMPLETED|Overall Study||14
8646687|NCT00617279|9687852|FG001|NOT COMPLETED|Overall Study||17
8646688|NCT00617305|9687861|FG000|STARTED|Overall Study||33
8646689|NCT00617305|9687862|FG001|STARTED|Overall Study||4
8646690|NCT00617305|9687863|FG002|STARTED|Overall Study||1
8646691|NCT00617305|9687861|FG000|Completed 24-week Primary Analysis|Overall Study||31
8646692|NCT00617305|9687862|FG001|Completed 24-week Primary Analysis|Overall Study||4
8646693|NCT00617305|9687863|FG002|Completed 24-week Primary Analysis|Overall Study||0
8646694|NCT00617305|9687861|FG000|COMPLETED|Overall Study||25
8646695|NCT00617305|9687862|FG001|COMPLETED|Overall Study||4
8646696|NCT00617305|9687863|FG002|COMPLETED|Overall Study||0
8646697|NCT00617305|9687861|FG000|NOT COMPLETED|Overall Study||8
8646698|NCT00617305|9687862|FG001|NOT COMPLETED|Overall Study||0
8646699|NCT00617305|9687863|FG002|NOT COMPLETED|Overall Study||1
8646700|NCT00617344|9687877|FG000|STARTED|Overall Study||104
8646701|NCT00617344|9687878|FG001|STARTED|Overall Study||103
8646702|NCT00617344|9687879|FG002|STARTED|Overall Study||53
8646703|NCT00617344|9687877|FG000|Received Vaccination 1|Overall Study||104
8646704|NCT00617344|9687878|FG001|Received Vaccination 1|Overall Study||103
8646705|NCT00617344|9687879|FG002|Received Vaccination 1|Overall Study||53
8646706|NCT00617344|9687877|FG000|Received Vaccination 2|Overall Study||86
8646707|NCT00617344|9687878|FG001|Received Vaccination 2|Overall Study||85
8646708|NCT00617344|9687879|FG002|Received Vaccination 2|Overall Study||46
8646709|NCT00617344|9687877|FG000|Received Vaccination 3|Overall Study||79
8646710|NCT00617344|9687878|FG001|Received Vaccination 3|Overall Study||81
8646711|NCT00617344|9687879|FG002|Received Vaccination 3|Overall Study||45
8646712|NCT00617344|9687877|FG000|COMPLETED|Overall Study||79
8646713|NCT00617344|9687878|FG001|COMPLETED|Overall Study||81
8646714|NCT00617344|9687879|FG002|COMPLETED|Overall Study||45
8646715|NCT00617344|9687877|FG000|NOT COMPLETED|Overall Study||25
8646716|NCT00617344|9687878|FG001|NOT COMPLETED|Overall Study||22
8646717|NCT00617344|9687879|FG002|NOT COMPLETED|Overall Study||8
8646718|NCT00617357|9687887|FG000|STARTED|Overall Study|83 subjects enrolled, 80 subjects received Strattice reinforcement of hernia repair|83
8646719|NCT00617357|9687887|FG000|COMPLETED|Overall Study|67 subjects completed study; 7 completed early, 60 completed 24 month visit|67
8646720|NCT00617357|9687887|FG000|NOT COMPLETED|Overall Study||16
8646721|NCT00617396|9687892|FG000|STARTED|Overall Study||25
8646722|NCT00617396|9687892|FG000|COMPLETED|Overall Study||25
8646723|NCT00617396|9687892|FG000|NOT COMPLETED|Overall Study||0
8646724|NCT00617409|9687899|FG000|STARTED|Overall Study||18
8646725|NCT00617409|9687900|FG001|STARTED|Overall Study||20
8646726|NCT00617409|9687901|FG002|STARTED|Overall Study||31
8646727|NCT00617409|9687899|FG000|COMPLETED|Overall Study||2
8646728|NCT00617409|9687900|FG001|COMPLETED|Overall Study||2
8646729|NCT00617409|9687901|FG002|COMPLETED|Overall Study||4
8646730|NCT00617409|9687899|FG000|NOT COMPLETED|Overall Study||16
8646731|NCT00617409|9687900|FG001|NOT COMPLETED|Overall Study||18
8646732|NCT00617409|9687901|FG002|NOT COMPLETED|Overall Study||27
8646733|NCT00617461|9687910|FG000|STARTED|First Treatment Intervention Period|2 par. (1 withdrawal due to inv. discretion, 1 withdrawal by subject) did not take study drug.|52
8646734|NCT00617461|9687911|FG001|STARTED|First Treatment Intervention Period||44
8646735|NCT00617461|9687910|FG000|COMPLETED|First Treatment Intervention Period||42
8646736|NCT00617461|9687911|FG001|COMPLETED|First Treatment Intervention Period||41
8646737|NCT00617461|9687910|FG000|NOT COMPLETED|First Treatment Intervention Period||10
8646738|NCT00617461|9687911|FG001|NOT COMPLETED|First Treatment Intervention Period||3
8646739|NCT00617461|9687910|FG000|STARTED|4-Day Crossover Period||42
8646740|NCT00617461|9687911|FG001|STARTED|4-Day Crossover Period|One 3600:1200 participant skipped the Crossover period, going directly to second Treatment Period.|40
8646741|NCT00617461|9687910|FG000|COMPLETED|4-Day Crossover Period||41
8646742|NCT00617461|9687911|FG001|COMPLETED|4-Day Crossover Period||40
8646743|NCT00617461|9687910|FG000|NOT COMPLETED|4-Day Crossover Period||1
8646744|NCT00617461|9687911|FG001|NOT COMPLETED|4-Day Crossover Period||0
8646745|NCT00617461|9687910|FG000|STARTED|Second Treatment Intervention Period||41
8646746|NCT00617461|9687911|FG001|STARTED|Second Treatment Intervention Period||41
8646747|NCT00617461|9687910|FG000|COMPLETED|Second Treatment Intervention Period||41
8646748|NCT00617461|9687911|FG001|COMPLETED|Second Treatment Intervention Period||37
8646749|NCT00617461|9687910|FG000|NOT COMPLETED|Second Treatment Intervention Period||0
8646750|NCT00617461|9687911|FG001|NOT COMPLETED|Second Treatment Intervention Period||4
8646751|NCT00617461|9687910|FG000|STARTED|6-Day Down-Titration Period||41
8646752|NCT00617461|9687911|FG001|STARTED|6-Day Down-Titration Period||37
8646753|NCT00617461|9687910|FG000|COMPLETED|6-Day Down-Titration Period||39
8646754|NCT00617461|9687911|FG001|COMPLETED|6-Day Down-Titration Period||35
8646755|NCT00617461|9687910|FG000|NOT COMPLETED|6-Day Down-Titration Period||2
8646756|NCT00617461|9687911|FG001|NOT COMPLETED|6-Day Down-Titration Period||2
8646757|NCT00617539|9687933|FG000|STARTED|Overall Study||30
8646758|NCT00617539|9687933|FG000|COMPLETED|Overall Study||30
8646759|NCT00617539|9687933|FG000|NOT COMPLETED|Overall Study||0
8646760|NCT00617591|9687938|FG000|STARTED|Overall Study||57
8646761|NCT00617591|9687938|FG000|COMPLETED|Overall Study||47
8646762|NCT00617591|9687938|FG000|NOT COMPLETED|Overall Study||10
8646763|NCT00617604|9687945|FG000|STARTED|Overall Study||110
8646764|NCT00617604|9687946|FG001|STARTED|Overall Study||108
8646765|NCT00617604|9687945|FG000|Received Treatment|Overall Study||107
8646766|NCT00617604|9687946|FG001|Received Treatment|Overall Study||105
8646767|NCT00617604|9687945|FG000|Completed 12 Weeks of Treatment|Overall Study||89
8646768|NCT00617604|9687946|FG001|Completed 12 Weeks of Treatment|Overall Study||83
8646769|NCT00617604|9687945|FG000|COMPLETED|Overall Study|Completed Month 6 assessment|92
8646770|NCT00617604|9687946|FG001|COMPLETED|Overall Study|Completed Month 6 assessment|88
8646771|NCT00617604|9687945|FG000|NOT COMPLETED|Overall Study||18
8646772|NCT00617604|9687946|FG001|NOT COMPLETED|Overall Study||20
8646773|NCT00617669|9687954|FG000|STARTED|Overall Study||524
8646774|NCT00617669|9687955|FG001|STARTED|Overall Study||528
8646775|NCT00617669|9687954|FG000|Patients Who Received IP|Overall Study||522
8646776|NCT00617669|9687955|FG001|Patients Who Received IP|Overall Study||525
8646777|NCT00617669|9687954|FG000|COMPLETED|Overall Study|Patients receiving ZD4054 10 mg at data cut-off|94
8646778|NCT00617669|9687955|FG001|COMPLETED|Overall Study|Patients receiving placebo at data cut-off|77
8646779|NCT00617669|9687954|FG000|NOT COMPLETED|Overall Study||430
8646780|NCT00617669|9687955|FG001|NOT COMPLETED|Overall Study||451
8646781|NCT00617734|9687963|FG000|STARTED|Overall Study||49
8646782|NCT00617734|9687964|FG001|STARTED|Overall Study||48
8646783|NCT00617734|9687963|FG000|Received at Least 1 Dose of Study Drug|Overall Study||47
8646784|NCT00617734|9687964|FG001|Received at Least 1 Dose of Study Drug|Overall Study||44
8646785|NCT00617734|9687963|FG000|COMPLETED|Overall Study||41
8646786|NCT00617734|9687964|FG001|COMPLETED|Overall Study||42
8646787|NCT00617734|9687963|FG000|NOT COMPLETED|Overall Study||8
8646788|NCT00617734|9687964|FG001|NOT COMPLETED|Overall Study||6
8646789|NCT00617773|9687970|FG000|STARTED|Overall Study||31
8646790|NCT00617773|9687970|FG000|COMPLETED|Overall Study|Patients COMPLETED were evaluated as having no disease progression at the end of cycle 3.|7
8646791|NCT00617773|9687970|FG000|NOT COMPLETED|Overall Study||24
8646792|NCT00617851|9687978|FG000|STARTED|Overall Study||430
8646793|NCT00617851|9687979|FG001|STARTED|Overall Study||431
8646794|NCT00617851|9687980|FG002|STARTED|Overall Study||429
8646795|NCT00617851|9687981|FG003|STARTED|Overall Study||217
8646796|NCT00617851|9687978|FG000|COMPLETED|Overall Study||383
8646797|NCT00617851|9687979|FG001|COMPLETED|Overall Study||391
8646798|NCT00617851|9687980|FG002|COMPLETED|Overall Study||384
8646799|NCT00617851|9687981|FG003|COMPLETED|Overall Study||192
8646800|NCT00617851|9687978|FG000|NOT COMPLETED|Overall Study||47
8646801|NCT00617851|9687979|FG001|NOT COMPLETED|Overall Study||40
8646802|NCT00617851|9687980|FG002|NOT COMPLETED|Overall Study||45
8646803|NCT00617851|9687981|FG003|NOT COMPLETED|Overall Study||25
8646804|NCT00617890|9688005|FG000|STARTED|Overall Study||35
8646805|NCT00617890|9688006|FG001|STARTED|Overall Study||33
8646806|NCT00617890|9688007|FG002|STARTED|Overall Study||35
8646807|NCT00617890|9688008|FG003|STARTED|Overall Study||116
8646808|NCT00617890|9688005|FG000|Received Treatment|Overall Study||34
8646809|NCT00617890|9688006|FG001|Received Treatment|Overall Study||33
8646810|NCT00617890|9688007|FG002|Received Treatment|Overall Study||34
8646811|NCT00617890|9688008|FG003|Received Treatment|Overall Study||115
8646812|NCT00617890|9688005|FG000|COMPLETED|Overall Study||4
8646813|NCT00617890|9688006|FG001|COMPLETED|Overall Study||5
8646814|NCT00617890|9688007|FG002|COMPLETED|Overall Study||0
8646815|NCT00617890|9688008|FG003|COMPLETED|Overall Study||1
8646816|NCT00617890|9688005|FG000|NOT COMPLETED|Overall Study||31
8646817|NCT00617890|9688006|FG001|NOT COMPLETED|Overall Study||28
8646818|NCT00617890|9688007|FG002|NOT COMPLETED|Overall Study||35
8646819|NCT00617890|9688008|FG003|NOT COMPLETED|Overall Study||115
8646820|NCT00617903|9688023|FG000|STARTED|Overall Study||41
8646821|NCT00617903|9688024|FG001|STARTED|Overall Study||42
8646822|NCT00617903|9688023|FG000|COMPLETED|Overall Study||38
8646823|NCT00617903|9688024|FG001|COMPLETED|Overall Study||35
8646824|NCT00617903|9688023|FG000|NOT COMPLETED|Overall Study||3
8646825|NCT00617903|9688024|FG001|NOT COMPLETED|Overall Study||7
8646826|NCT00617929|9688030|FG000|STARTED|Overall Study||12
8646827|NCT00617929|9688030|FG000|COMPLETED|Overall Study||11
8646828|NCT00617929|9688030|FG000|NOT COMPLETED|Overall Study||1
8646829|NCT00617942|9688036|FG000|STARTED|Overall Study||37
8646830|NCT00617942|9688037|FG001|STARTED|Overall Study||23
8646831|NCT00617942|9688036|FG000|COMPLETED|Overall Study||29
8646832|NCT00617942|9688037|FG001|COMPLETED|Overall Study||19
8646833|NCT00617942|9688036|FG000|NOT COMPLETED|Overall Study||8
8646834|NCT00617942|9688037|FG001|NOT COMPLETED|Overall Study||4
8646835|NCT00617981|9688051|FG000|STARTED|Overall Study||354
8646836|NCT00617981|9688052|FG001|STARTED|Overall Study||347
8646837|NCT00617981|9688051|FG000|COMPLETED|Overall Study||244
8646838|NCT00617981|9688052|FG001|COMPLETED|Overall Study||245
8646839|NCT00617981|9688051|FG000|NOT COMPLETED|Overall Study||110
8646840|NCT00617981|9688052|FG001|NOT COMPLETED|Overall Study||102
8646841|NCT00618072|9688061|FG000|STARTED|Overall Study||16
8646842|NCT00618072|9688062|FG001|STARTED|Overall Study||15
8646843|NCT00618072|9688063|FG002|STARTED|Overall Study||15
8646844|NCT00618072|9688061|FG000|COMPLETED|Overall Study||14
8646845|NCT00618072|9688062|FG001|COMPLETED|Overall Study||14
8646846|NCT00618072|9688063|FG002|COMPLETED|Overall Study||11
8646847|NCT00618072|9688061|FG000|NOT COMPLETED|Overall Study||2
8646848|NCT00618072|9688062|FG001|NOT COMPLETED|Overall Study||1
8646849|NCT00618072|9688063|FG002|NOT COMPLETED|Overall Study||4
8646850|NCT00618332|9688073|FG000|STARTED|Overall Study||20
8646851|NCT00618332|9688074|FG001|STARTED|Overall Study||20
8646852|NCT00618332|9688073|FG000|COMPLETED|Overall Study||20
8646853|NCT00618332|9688074|FG001|COMPLETED|Overall Study||20
8646854|NCT00618332|9688073|FG000|NOT COMPLETED|Overall Study||0
8646855|NCT00618332|9688074|FG001|NOT COMPLETED|Overall Study||0
8646856|NCT00618371|9688080|FG000|STARTED|Overall Study||12
8646857|NCT00618371|9688080|FG000|COMPLETED|Overall Study||10
8646858|NCT00618371|9688080|FG000|NOT COMPLETED|Overall Study||2
8646859|NCT00618410|9688085|FG000|STARTED|First Intervention||7
8646860|NCT00618410|9688086|FG001|STARTED|First Intervention||6
8646861|NCT00618410|9688085|FG000|COMPLETED|First Intervention||7
8646862|NCT00618410|9688086|FG001|COMPLETED|First Intervention||6
8646863|NCT00618410|9688085|FG000|NOT COMPLETED|First Intervention||0
8646864|NCT00618410|9688086|FG001|NOT COMPLETED|First Intervention||0
8646865|NCT00618410|9688085|FG000|STARTED|Washout Period (2 Weeks)||7
8646866|NCT00618410|9688086|FG001|STARTED|Washout Period (2 Weeks)||6
8646867|NCT00618410|9688085|FG000|COMPLETED|Washout Period (2 Weeks)||7
8646868|NCT00618410|9688086|FG001|COMPLETED|Washout Period (2 Weeks)||5
8646869|NCT00618410|9688085|FG000|NOT COMPLETED|Washout Period (2 Weeks)||0
8646870|NCT00618410|9688086|FG001|NOT COMPLETED|Washout Period (2 Weeks)||1
8646871|NCT00618410|9688085|FG000|STARTED|Second Intervention||7
8646872|NCT00618410|9688086|FG001|STARTED|Second Intervention||5
8646873|NCT00618410|9688085|FG000|COMPLETED|Second Intervention||7
8646874|NCT00618410|9688086|FG001|COMPLETED|Second Intervention||5
8646875|NCT00618410|9688085|FG000|NOT COMPLETED|Second Intervention||0
8646876|NCT00618410|9688086|FG001|NOT COMPLETED|Second Intervention||0
8646877|NCT00618436|9688094|FG000|STARTED|Overall Study||34
8646878|NCT00618436|9688095|FG001|STARTED|Overall Study||18
8646879|NCT00618436|9688094|FG000|COMPLETED|Overall Study||34
8646880|NCT00618436|9688095|FG001|COMPLETED|Overall Study||18
8646881|NCT00618436|9688094|FG000|NOT COMPLETED|Overall Study||0
8646882|NCT00618436|9688095|FG001|NOT COMPLETED|Overall Study||0
8646883|NCT00618449|9688103|FG000|STARTED|Overall Study||679
8646884|NCT00618449|9688104|FG001|STARTED|Overall Study||668
8646885|NCT00618449|9688103|FG000|1-month, Post-treatment|Overall Study||666
8646886|NCT00618449|9688104|FG001|1-month, Post-treatment|Overall Study||656
8646887|NCT00618449|9688103|FG000|1-year, Post-treatment|Overall Study||581
8646888|NCT00618449|9688104|FG001|1-year, Post-treatment|Overall Study||558
8646889|NCT00618449|9688103|FG000|COMPLETED|Overall Study||581
8646890|NCT00618449|9688104|FG001|COMPLETED|Overall Study||558
8646891|NCT00618449|9688103|FG000|NOT COMPLETED|Overall Study||98
8646892|NCT00618449|9688104|FG001|NOT COMPLETED|Overall Study||110
8646893|NCT00618514|9688112|FG000|STARTED|Overall Study||36
8646894|NCT00618514|9688113|FG001|STARTED|Overall Study||38
8646895|NCT00618514|9688114|FG002|STARTED|Overall Study||16
8646896|NCT00618514|9688112|FG000|COMPLETED|Overall Study||25
8646897|NCT00618514|9688113|FG001|COMPLETED|Overall Study||26
8646898|NCT00618514|9688114|FG002|COMPLETED|Overall Study||12
8646899|NCT00618514|9688112|FG000|NOT COMPLETED|Overall Study||11
8646900|NCT00618514|9688113|FG001|NOT COMPLETED|Overall Study||12
8646901|NCT00618514|9688114|FG002|NOT COMPLETED|Overall Study||4
8646902|NCT00618540|9688120|FG000|STARTED|Overall Study||1
8646903|NCT00618540|9688120|FG000|COMPLETED|Overall Study||1
8646904|NCT00618540|9688120|FG000|NOT COMPLETED|Overall Study||0
8646905|NCT00618618|9688129|FG000|STARTED|Overall Study||24
8646906|NCT00618618|9688130|FG001|STARTED|Overall Study||14
8646907|NCT00618618|9688131|FG002|STARTED|Overall Study||21
8646908|NCT00618618|9688132|FG003|STARTED|Overall Study||14
8646909|NCT00618618|9688129|FG000|Received Treatment|Overall Study||24
8646910|NCT00618618|9688130|FG001|Received Treatment|Overall Study||13
8646911|NCT00618618|9688131|FG002|Received Treatment|Overall Study||20
8646912|NCT00618618|9688132|FG003|Received Treatment|Overall Study||14
8646913|NCT00618618|9688129|FG000|COMPLETED|Overall Study||20
8646914|NCT00618618|9688130|FG001|COMPLETED|Overall Study||11
8646915|NCT00618618|9688131|FG002|COMPLETED|Overall Study||18
8646916|NCT00618618|9688132|FG003|COMPLETED|Overall Study||13
8646917|NCT00618618|9688129|FG000|NOT COMPLETED|Overall Study||4
8646918|NCT00618618|9688130|FG001|NOT COMPLETED|Overall Study||3
8646919|NCT00618618|9688131|FG002|NOT COMPLETED|Overall Study||3
8646920|NCT00618618|9688132|FG003|NOT COMPLETED|Overall Study||1
8646921|NCT00618722|9688147|FG000|STARTED|Overall Study||21
8646922|NCT00618722|9688148|FG001|STARTED|Overall Study||20
8646923|NCT00618722|9688149|FG002|STARTED|Overall Study||22
8646924|NCT00618722|9688150|FG003|STARTED|Overall Study||22
8646925|NCT00618722|9688147|FG000|Received Treatment|Overall Study||20
8646926|NCT00618722|9688148|FG001|Received Treatment|Overall Study||20
8646927|NCT00618722|9688149|FG002|Received Treatment|Overall Study||22
8646928|NCT00618722|9688150|FG003|Received Treatment|Overall Study||22
8646929|NCT00618722|9688147|FG000|COMPLETED|Overall Study||18
8646930|NCT00618722|9688148|FG001|COMPLETED|Overall Study||18
8646931|NCT00618722|9688149|FG002|COMPLETED|Overall Study||19
8646932|NCT00618722|9688150|FG003|COMPLETED|Overall Study||18
8646933|NCT00618722|9688147|FG000|NOT COMPLETED|Overall Study||3
8646934|NCT00618722|9688148|FG001|NOT COMPLETED|Overall Study||2
8646935|NCT00618722|9688149|FG002|NOT COMPLETED|Overall Study||3
8646936|NCT00618722|9688150|FG003|NOT COMPLETED|Overall Study||4
8646937|NCT00618748|9688163|FG000|STARTED|Overall Study||56
8646938|NCT00618748|9688164|FG001|STARTED|Overall Study||25
8646939|NCT00618748|9688165|FG002|STARTED|Overall Study||20
8646940|NCT00618748|9688163|FG000|COMPLETED|Overall Study||45
8646941|NCT00618748|9688164|FG001|COMPLETED|Overall Study||20
8646942|NCT00618748|9688165|FG002|COMPLETED|Overall Study||6
8646943|NCT00618748|9688163|FG000|NOT COMPLETED|Overall Study||11
8646944|NCT00618748|9688164|FG001|NOT COMPLETED|Overall Study||5
8646945|NCT00618748|9688165|FG002|NOT COMPLETED|Overall Study||14
8646946|NCT00618774|9688175|FG000|STARTED|Overall Study||211
8646947|NCT00618774|9688176|FG001|STARTED|Overall Study||48
8646948|NCT00618774|9688175|FG000|COMPLETED|Overall Study||205
8646949|NCT00618774|9688176|FG001|COMPLETED|Overall Study||45
8646950|NCT00618774|9688175|FG000|NOT COMPLETED|Overall Study||6
8646951|NCT00618774|9688176|FG001|NOT COMPLETED|Overall Study||3
8646952|NCT00618787|9688184|FG000|STARTED|Overall Study||22
8646953|NCT00618787|9688185|FG001|STARTED|Overall Study||23
8646954|NCT00618787|9688184|FG000|COMPLETED|Overall Study||19
8646955|NCT00618787|9688185|FG001|COMPLETED|Overall Study||21
8646956|NCT00618787|9688184|FG000|NOT COMPLETED|Overall Study||3
8646957|NCT00618787|9688185|FG001|NOT COMPLETED|Overall Study||2
8646958|NCT00618813|9688191|FG000|STARTED|Overall Study||35
8646959|NCT00618813|9688191|FG000|Completed Enrollment - Week 12 Treatment|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|35
8646960|NCT00618813|9688191|FG000|Completed Week 13 to Week 22 Treatment|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|34
8646961|NCT00618813|9688191|FG000|Completed Week 23 to Week 28 Therapy|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|34
8646962|NCT00618813|9688191|FG000|Completed Week 29 to Week 37 Therapy|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|33
8646963|NCT00618813|9688191|FG000|COMPLETED|Overall Study||31
8646964|NCT00618813|9688191|FG000|NOT COMPLETED|Overall Study||4
8646965|NCT00618826|9688195|FG000|STARTED|Overall Study||14
8646966|NCT00618826|9688195|FG000|COMPLETED|Overall Study||13
8646967|NCT00618826|9688195|FG000|NOT COMPLETED|Overall Study||1
8646968|NCT00618839|9688200|FG000|STARTED|Overall Study||15
8646969|NCT00618839|9688200|FG000|COMPLETED|Overall Study||15
8646970|NCT00618839|9688200|FG000|NOT COMPLETED|Overall Study||0
8646971|NCT00618917|9688210|FG000|STARTED|Overall Study||4
8646972|NCT00618917|9688211|FG001|STARTED|Overall Study||3
8646973|NCT00618917|9688212|FG002|STARTED|Overall Study||11
8646974|NCT00618917|9688210|FG000|COMPLETED|Overall Study||3
8646975|NCT00618917|9688211|FG001|COMPLETED|Overall Study||3
8646976|NCT00618917|9688212|FG002|COMPLETED|Overall Study||11
8646977|NCT00618917|9688210|FG000|NOT COMPLETED|Overall Study||1
8646978|NCT00618917|9688211|FG001|NOT COMPLETED|Overall Study||0
8646979|NCT00618917|9688212|FG002|NOT COMPLETED|Overall Study||0
8646980|NCT00618956|9688222|FG000|STARTED|Overall Study||111
8646981|NCT00618956|9688223|FG001|STARTED|Overall Study||210
8646982|NCT00618956|9688222|FG000|COMPLETED|Overall Study||86
8646983|NCT00618956|9688223|FG001|COMPLETED|Overall Study||160
8646984|NCT00618956|9688222|FG000|NOT COMPLETED|Overall Study||25
8646985|NCT00618956|9688223|FG001|NOT COMPLETED|Overall Study||50
8646986|NCT00618982|9688235|FG000|STARTED|Overall Study||83
8646987|NCT00618982|9688235|FG000|COMPLETED|Overall Study||33
8646988|NCT00618982|9688235|FG000|NOT COMPLETED|Overall Study||50
8646989|NCT00618995|9688242|FG000|STARTED|Period 1||6
8646990|NCT00618995|9688243|FG001|STARTED|Period 1||7
8646991|NCT00618995|9688244|FG002|STARTED|Period 1||7
8646992|NCT00618995|9688245|FG003|STARTED|Period 1||6
8646993|NCT00618995|9688242|FG000|COMPLETED|Period 1||6
8646994|NCT00618995|9688243|FG001|COMPLETED|Period 1||6
8646995|NCT00618995|9688244|FG002|COMPLETED|Period 1||5
8646996|NCT00618995|9688245|FG003|COMPLETED|Period 1||6
8646997|NCT00618995|9688242|FG000|NOT COMPLETED|Period 1||0
8646998|NCT00618995|9688243|FG001|NOT COMPLETED|Period 1||1
8646999|NCT00618995|9688244|FG002|NOT COMPLETED|Period 1||2
8647000|NCT00618995|9688245|FG003|NOT COMPLETED|Period 1||0
8647001|NCT00618995|9688242|FG000|STARTED|Period 2||6
8647002|NCT00618995|9688243|FG001|STARTED|Period 2||6
8647003|NCT00618995|9688244|FG002|STARTED|Period 2||5
8647004|NCT00618995|9688245|FG003|STARTED|Period 2||6
8647005|NCT00618995|9688242|FG000|COMPLETED|Period 2||6
8647006|NCT00618995|9688243|FG001|COMPLETED|Period 2||6
8647007|NCT00618995|9688244|FG002|COMPLETED|Period 2||4
8647008|NCT00618995|9688245|FG003|COMPLETED|Period 2||6
8647009|NCT00618995|9688242|FG000|NOT COMPLETED|Period 2||0
8647010|NCT00618995|9688243|FG001|NOT COMPLETED|Period 2||0
8647011|NCT00618995|9688244|FG002|NOT COMPLETED|Period 2||1
8647012|NCT00618995|9688245|FG003|NOT COMPLETED|Period 2||0
8647013|NCT00618995|9688242|FG000|STARTED|Period 3||6
8647014|NCT00618995|9688243|FG001|STARTED|Period 3||6
8647015|NCT00618995|9688244|FG002|STARTED|Period 3||4
8647016|NCT00618995|9688245|FG003|STARTED|Period 3||6
8647017|NCT00618995|9688242|FG000|COMPLETED|Period 3||6
8647018|NCT00618995|9688243|FG001|COMPLETED|Period 3||6
8647019|NCT00618995|9688244|FG002|COMPLETED|Period 3||4
8647020|NCT00618995|9688245|FG003|COMPLETED|Period 3||6
8647021|NCT00618995|9688242|FG000|NOT COMPLETED|Period 3||0
8647022|NCT00618995|9688243|FG001|NOT COMPLETED|Period 3||0
8647023|NCT00618995|9688244|FG002|NOT COMPLETED|Period 3||0
8647024|NCT00618995|9688245|FG003|NOT COMPLETED|Period 3||0
8647025|NCT00618995|9688242|FG000|STARTED|Period 4||6
8647026|NCT00618995|9688243|FG001|STARTED|Period 4||6
8647027|NCT00618995|9688244|FG002|STARTED|Period 4||4
8647028|NCT00618995|9688245|FG003|STARTED|Period 4||6
8647029|NCT00618995|9688242|FG000|COMPLETED|Period 4||5
8647030|NCT00618995|9688243|FG001|COMPLETED|Period 4||6
8647031|NCT00618995|9688244|FG002|COMPLETED|Period 4||4
8647032|NCT00618995|9688245|FG003|COMPLETED|Period 4||6
8647033|NCT00618995|9688242|FG000|NOT COMPLETED|Period 4||1
8647034|NCT00618995|9688243|FG001|NOT COMPLETED|Period 4||0
8647035|NCT00618995|9688244|FG002|NOT COMPLETED|Period 4||0
8647036|NCT00618995|9688245|FG003|NOT COMPLETED|Period 4||0
8647037|NCT00619060|9688255|FG000|STARTED|Overall Study||10
8647038|NCT00619060|9688256|FG001|STARTED|Overall Study||12
8647039|NCT00619060|9688255|FG000|COMPLETED|Overall Study||10
8647040|NCT00619060|9688256|FG001|COMPLETED|Overall Study||12
8647041|NCT00619060|9688255|FG000|NOT COMPLETED|Overall Study||0
8647042|NCT00619060|9688256|FG001|NOT COMPLETED|Overall Study||0
8647043|NCT00619073|9688264|FG000|STARTED|First Intervention - 60 Days||8
8647044|NCT00619073|9688265|FG001|STARTED|First Intervention - 60 Days||8
8647045|NCT00619073|9688264|FG000|COMPLETED|First Intervention - 60 Days||8
8647046|NCT00619073|9688265|FG001|COMPLETED|First Intervention - 60 Days||8
8647047|NCT00619073|9688264|FG000|NOT COMPLETED|First Intervention - 60 Days||0
8647048|NCT00619073|9688265|FG001|NOT COMPLETED|First Intervention - 60 Days||0
8647049|NCT00619073|9688264|FG000|STARTED|Washout Period (30 Days)||8
8647050|NCT00619073|9688265|FG001|STARTED|Washout Period (30 Days)||8
8647051|NCT00619073|9688264|FG000|COMPLETED|Washout Period (30 Days)||8
8647052|NCT00619073|9688265|FG001|COMPLETED|Washout Period (30 Days)||8
8647053|NCT00619073|9688264|FG000|NOT COMPLETED|Washout Period (30 Days)||0
8647054|NCT00619073|9688265|FG001|NOT COMPLETED|Washout Period (30 Days)||0
8647055|NCT00619073|9688264|FG000|STARTED|Second Intervention - 60 Days||8
8647056|NCT00619073|9688265|FG001|STARTED|Second Intervention - 60 Days||8
8647057|NCT00619073|9688264|FG000|COMPLETED|Second Intervention - 60 Days||8
8647058|NCT00619073|9688265|FG001|COMPLETED|Second Intervention - 60 Days||8
8647059|NCT00619073|9688264|FG000|NOT COMPLETED|Second Intervention - 60 Days||0
8647060|NCT00619073|9688265|FG001|NOT COMPLETED|Second Intervention - 60 Days||0
8647061|NCT00619099|9688273|FG000|STARTED|Overall Study|All randomized subjects|44
8647062|NCT00619099|9688274|FG001|STARTED|Overall Study|All randomized subjects|23
8647063|NCT00619099|9688273|FG000|Received at Least 2 Cycles of Treatment|Overall Study|Subjects included in the Modified Intent to Treat Population|43
8647064|NCT00619099|9688274|FG001|Received at Least 2 Cycles of Treatment|Overall Study|Subjects included in the Modified Intent to Treat Population|22
8647065|NCT00619099|9688273|FG000|COMPLETED|Overall Study||11
8647066|NCT00619099|9688274|FG001|COMPLETED|Overall Study||4
8647067|NCT00619099|9688273|FG000|NOT COMPLETED|Overall Study||33
8647068|NCT00619099|9688274|FG001|NOT COMPLETED|Overall Study||19
8647069|NCT00619112|9688282|FG000|STARTED|Overall Study||40
8647070|NCT00619112|9688283|FG001|STARTED|Overall Study||20
8647071|NCT00619112|9688282|FG000|COMPLETED|Overall Study|Data from patient who didn't complete study was still included in the final analysis.|39
8647072|NCT00619112|9688283|FG001|COMPLETED|Overall Study|Data from patients who didn't complete study was still included in the final analysis.|18
8647073|NCT00619112|9688282|FG000|NOT COMPLETED|Overall Study||1
8647074|NCT00619112|9688283|FG001|NOT COMPLETED|Overall Study||2
8647075|NCT00619177|9688292|FG000|STARTED|Overall Study|treated set = 3569 (treated with Movalis)|3569
8647076|NCT00619177|9688292|FG000|COMPLETED|Overall Study|"Due to some missing termination information, the number of completed may be larger than 3061."|3061
8647077|NCT00619177|9688292|FG000|NOT COMPLETED|Overall Study||508
8691725|NCT00856609|9737090|FG000|NOT COMPLETED|Overall Study||1
8691726|NCT00856609|9737091|FG001|NOT COMPLETED|Overall Study||0
8691727|NCT00856635|9737099|FG000|STARTED|Overall Study||22
8691728|NCT00856635|9737100|FG001|STARTED|Overall Study||22
8691729|NCT00856635|9737099|FG000|Received Study Drug|Overall Study||20
8691730|NCT00856635|9737100|FG001|Received Study Drug|Overall Study||20
8691731|NCT00856635|9737099|FG000|COMPLETED|Overall Study||12
8691732|NCT00856635|9737100|FG001|COMPLETED|Overall Study||14
8691733|NCT00856635|9737099|FG000|NOT COMPLETED|Overall Study||10
8691734|NCT00856635|9737100|FG001|NOT COMPLETED|Overall Study||8
8691735|NCT00856661|9737110|FG000|STARTED|Overall Study|Randomised|135
8691736|NCT00856661|9737111|FG001|STARTED|Overall Study|Randomised|135
8691737|NCT00856661|9737110|FG000|Treated|Overall Study||126
8691738|NCT00856661|9737111|FG001|Treated|Overall Study||131
8691739|NCT00856661|9737110|FG000|Randomized Not Treated|Overall Study||9
8691740|NCT00856661|9737111|FG001|Randomized Not Treated|Overall Study||4
8691741|NCT00856661|9737110|FG000|COMPLETED|Overall Study||108
8691742|NCT00856661|9737111|FG001|COMPLETED|Overall Study||106
8691743|NCT00856661|9737110|FG000|NOT COMPLETED|Overall Study||27
8691744|NCT00856661|9737111|FG001|NOT COMPLETED|Overall Study||29
8691745|NCT00856726|9737117|FG000|STARTED|Overall Study||26
8691746|NCT00856726|9737117|FG000|COMPLETED|Overall Study||26
8691747|NCT00856726|9737117|FG000|NOT COMPLETED|Overall Study||0
8691748|NCT00856739|9737124|FG000|STARTED|Overall Study||70
8691749|NCT00856739|9737125|FG001|STARTED|Overall Study||52
8691750|NCT00856739|9737126|FG002|STARTED|Overall Study||55
8691751|NCT00856739|9737124|FG000|COMPLETED|Overall Study||70
8691752|NCT00856739|9737125|FG001|COMPLETED|Overall Study||52
8691753|NCT00856739|9737126|FG002|COMPLETED|Overall Study||55
8691754|NCT00856739|9737124|FG000|NOT COMPLETED|Overall Study||0
8691755|NCT00856739|9737125|FG001|NOT COMPLETED|Overall Study||0
8691756|NCT00856739|9737126|FG002|NOT COMPLETED|Overall Study||0
8691757|NCT00856778|9737137|FG000|STARTED|Overall Study||98
8691758|NCT00856778|9737137|FG000|COMPLETED|Overall Study||74
8691759|NCT00856778|9737137|FG000|NOT COMPLETED|Overall Study||24
8691760|NCT00856791|9737141|FG000|STARTED|Overall Study||1
8691761|NCT00856791|9737141|FG000|COMPLETED|Overall Study||1
8691762|NCT00856791|9737141|FG000|NOT COMPLETED|Overall Study||0
8691763|NCT00856830|9737149|FG000|STARTED|Irinotecan & Bendamustine||3
8691764|NCT00856830|9737150|FG001|STARTED|Irinotecan & Bendamustine||6
8691765|NCT00856830|9737151|FG002|STARTED|Irinotecan & Bendamustine||6
8691766|NCT00856830|9737152|FG003|STARTED|Irinotecan & Bendamustine||15
8691767|NCT00856830|9737149|FG000|Maximum Tolerated Dose|Irinotecan & Bendamustine||3
8691768|NCT00856830|9737150|FG001|Maximum Tolerated Dose|Irinotecan & Bendamustine||6
8691769|NCT00856830|9737151|FG002|Maximum Tolerated Dose|Irinotecan & Bendamustine||6
8691770|NCT00856830|9737152|FG003|Maximum Tolerated Dose|Irinotecan & Bendamustine||12
8691771|NCT00856830|9737149|FG000|COMPLETED|Irinotecan & Bendamustine||3
8691772|NCT00856830|9737150|FG001|COMPLETED|Irinotecan & Bendamustine||6
8691773|NCT00856830|9737151|FG002|COMPLETED|Irinotecan & Bendamustine||6
8691774|NCT00856830|9737152|FG003|COMPLETED|Irinotecan & Bendamustine||12
8691775|NCT00856830|9737149|FG000|NOT COMPLETED|Irinotecan & Bendamustine||0
8691776|NCT00856830|9737150|FG001|NOT COMPLETED|Irinotecan & Bendamustine||0
8691777|NCT00856830|9737151|FG002|NOT COMPLETED|Irinotecan & Bendamustine||0
8691778|NCT00856830|9737152|FG003|NOT COMPLETED|Irinotecan & Bendamustine||3
8691779|NCT00856830|9737149|FG000|STARTED|Regimen - B (Carboplatin & Etoposide)||3
8691780|NCT00856830|9737150|FG001|STARTED|Regimen - B (Carboplatin & Etoposide)||6
8691781|NCT00856830|9737151|FG002|STARTED|Regimen - B (Carboplatin & Etoposide)||6
8691782|NCT00856830|9737152|FG003|STARTED|Regimen - B (Carboplatin & Etoposide)||12
8691783|NCT00856830|9737149|FG000|COMPLETED|Regimen - B (Carboplatin & Etoposide)||3
8727631|NCT01043939|9774866|FG001|STARTED|Second Intervention||12
8727632|NCT01043939|9774865|FG000|COMPLETED|Second Intervention||12
8727633|NCT01043939|9774866|FG001|COMPLETED|Second Intervention||12
8727634|NCT01043939|9774865|FG000|NOT COMPLETED|Second Intervention||0
8727635|NCT01043939|9774866|FG001|NOT COMPLETED|Second Intervention||0
8727636|NCT01044030|9774875|FG000|STARTED|Overall Study||160
8727637|NCT01044030|9774876|FG001|STARTED|Overall Study||166
8727638|NCT01044030|9774875|FG000|COMPLETED|Overall Study||141
8727639|NCT01044030|9774876|FG001|COMPLETED|Overall Study||146
8727640|NCT01044030|9774875|FG000|NOT COMPLETED|Overall Study||19
8727641|NCT01044030|9774876|FG001|NOT COMPLETED|Overall Study||20
8727642|NCT01044212|9774884|FG000|STARTED|Overall Study||35
8727643|NCT01044212|9774885|FG001|STARTED|Overall Study||37
8727644|NCT01044212|9774884|FG000|COMPLETED|Overall Study||30
8727645|NCT01044212|9774885|FG001|COMPLETED|Overall Study||30
8727646|NCT01044212|9774884|FG000|NOT COMPLETED|Overall Study||5
8727647|NCT01044212|9774885|FG001|NOT COMPLETED|Overall Study||7
8727648|NCT01044264|9774894|FG000|STARTED|Overall Study||200
8727649|NCT01044264|9774895|FG001|STARTED|Overall Study||202
8691784|NCT00856830|9737150|FG001|COMPLETED|Regimen - B (Carboplatin & Etoposide)||6
8691785|NCT00856830|9737151|FG002|COMPLETED|Regimen - B (Carboplatin & Etoposide)||6
8691786|NCT00856830|9737152|FG003|COMPLETED|Regimen - B (Carboplatin & Etoposide)||12
8691787|NCT00856830|9737149|FG000|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
8727650|NCT01044264|9774896|FG002|STARTED|Overall Study||200
8727651|NCT01044264|9774894|FG000|COMPLETED|Overall Study||110
8727652|NCT01044264|9774895|FG001|COMPLETED|Overall Study||108
8727653|NCT01044264|9774896|FG002|COMPLETED|Overall Study||108
8727654|NCT01044264|9774894|FG000|NOT COMPLETED|Overall Study||90
8647078|NCT00619190|9688298|FG000|STARTED|Overall Study||21
8647079|NCT00619190|9688299|FG001|STARTED|Overall Study||9
8647080|NCT00619190|9688298|FG000|COMPLETED|Overall Study||20
8647081|NCT00619190|9688299|FG001|COMPLETED|Overall Study||9
8647082|NCT00619190|9688298|FG000|NOT COMPLETED|Overall Study||1
8647083|NCT00619190|9688299|FG001|NOT COMPLETED|Overall Study||0
8647084|NCT00619229|9688307|FG000|STARTED|Overall Study||18
8647085|NCT00619229|9688308|FG001|STARTED|Overall Study||18
8647086|NCT00619229|9688307|FG000|Full Analysis Set (FAS)|Overall Study||16
8647087|NCT00619229|9688308|FG001|Full Analysis Set (FAS)|Overall Study||17
8647088|NCT00619229|9688307|FG000|COMPLETED|Overall Study||14
8647089|NCT00619229|9688308|FG001|COMPLETED|Overall Study||16
8647090|NCT00619229|9688307|FG000|NOT COMPLETED|Overall Study||4
8647091|NCT00619229|9688308|FG001|NOT COMPLETED|Overall Study||2
8647092|NCT00619255|9688316|FG000|STARTED|Overall Study||59
8647093|NCT00619255|9688317|FG001|STARTED|Overall Study||61
8647094|NCT00619255|9688316|FG000|COMPLETED|Overall Study||57
8647095|NCT00619255|9688317|FG001|COMPLETED|Overall Study||61
8647096|NCT00619255|9688316|FG000|NOT COMPLETED|Overall Study||2
8647097|NCT00619255|9688317|FG001|NOT COMPLETED|Overall Study||0
8647098|NCT00619307|9688325|FG000|STARTED|Overall Study||60
8647099|NCT00619307|9688326|FG001|STARTED|Overall Study||57
8647100|NCT00619307|9688325|FG000|COMPLETED|Overall Study||56
8647101|NCT00619307|9688326|FG001|COMPLETED|Overall Study||53
8647102|NCT00619307|9688325|FG000|NOT COMPLETED|Overall Study||4
8647103|NCT00619307|9688326|FG001|NOT COMPLETED|Overall Study||4
8647104|NCT00619359|9688334|FG000|STARTED|Overall Study||1147
8647105|NCT00619359|9688335|FG001|STARTED|Overall Study||1175
8647106|NCT00619359|9688334|FG000|COMPLETED|Overall Study||1080
8647107|NCT00619359|9688335|FG001|COMPLETED|Overall Study||1094
8647108|NCT00619359|9688334|FG000|NOT COMPLETED|Overall Study||67
8647109|NCT00619359|9688335|FG001|NOT COMPLETED|Overall Study||81
8647110|NCT00619385|9688344|FG000|STARTED|Overall Study||7
8647111|NCT00619385|9688345|FG001|STARTED|Overall Study||8
8647112|NCT00619385|9688346|FG002|STARTED|Overall Study||10
8647113|NCT00619385|9688344|FG000|COMPLETED|Overall Study||6
8647114|NCT00619385|9688345|FG001|COMPLETED|Overall Study||6
8647115|NCT00619385|9688346|FG002|COMPLETED|Overall Study||6
8647116|NCT00619385|9688344|FG000|NOT COMPLETED|Overall Study||1
8647117|NCT00619385|9688345|FG001|NOT COMPLETED|Overall Study||2
8647118|NCT00619385|9688346|FG002|NOT COMPLETED|Overall Study||4
8647119|NCT00619476|9688361|FG000|STARTED|Overall Study||95
8647120|NCT00619476|9688362|FG001|STARTED|Overall Study||107
8647121|NCT00619476|9688363|FG002|STARTED|Overall Study||84
8647122|NCT00619476|9688364|FG003|STARTED|Overall Study||90
8647123|NCT00619476|9688361|FG000|Intent-to-Treat Population|Overall Study||95
8647124|NCT00619476|9688362|FG001|Intent-to-Treat Population|Overall Study||107
8647125|NCT00619476|9688363|FG002|Intent-to-Treat Population|Overall Study||82
8647126|NCT00619476|9688364|FG003|Intent-to-Treat Population|Overall Study||87
8647127|NCT00619476|9688361|FG000|Safety Population|Overall Study||95
8647128|NCT00619476|9688362|FG001|Safety Population|Overall Study||107
8647129|NCT00619476|9688363|FG002|Safety Population|Overall Study||82
8647130|NCT00619476|9688364|FG003|Safety Population|Overall Study||87
8647131|NCT00619476|9688361|FG000|COMPLETED|Overall Study||64
8647132|NCT00619476|9688362|FG001|COMPLETED|Overall Study||85
8647133|NCT00619476|9688363|FG002|COMPLETED|Overall Study||60
8647134|NCT00619476|9688364|FG003|COMPLETED|Overall Study||56
8647135|NCT00619476|9688361|FG000|NOT COMPLETED|Overall Study||31
8647136|NCT00619476|9688362|FG001|NOT COMPLETED|Overall Study||22
8647137|NCT00619476|9688363|FG002|NOT COMPLETED|Overall Study||24
8647138|NCT00619476|9688364|FG003|NOT COMPLETED|Overall Study||34
8647139|NCT00619489|9688376|FG000|STARTED|Overall Study||37
8647140|NCT00619489|9688377|FG001|STARTED|Overall Study||35
8647141|NCT00619489|9688376|FG000|COMPLETED|Overall Study||14
8647142|NCT00619489|9688377|FG001|COMPLETED|Overall Study||1
8647143|NCT00619489|9688376|FG000|NOT COMPLETED|Overall Study||23
8647144|NCT00619489|9688377|FG001|NOT COMPLETED|Overall Study||34
8647145|NCT00619502|9688385|FG000|STARTED|Overall Study||130
8647146|NCT00619502|9688386|FG001|STARTED|Overall Study||124
8647147|NCT00619502|9688385|FG000|COMPLETED|Overall Study||122
8647148|NCT00619502|9688386|FG001|COMPLETED|Overall Study||114
8647149|NCT00619502|9688385|FG000|NOT COMPLETED|Overall Study||8
8647150|NCT00619502|9688386|FG001|NOT COMPLETED|Overall Study||10
8647151|NCT00619619|9688402|FG000|STARTED|Overall Study||6
8647152|NCT00619619|9688403|FG001|STARTED|Overall Study||7
8647153|NCT00619619|9688404|FG002|STARTED|Overall Study||9
8647154|NCT00619619|9688405|FG003|STARTED|Overall Study||7
8647155|NCT00619619|9688406|FG004|STARTED|Overall Study||7
8647156|NCT00619619|9688407|FG005|STARTED|Overall Study||7
8647157|NCT00619619|9688408|FG006|STARTED|Overall Study||8
8647158|NCT00619619|9688409|FG007|STARTED|Overall Study||8
8647159|NCT00619619|9688402|FG000|Entered the Extension Study|Overall Study|Extension study: 3151A6-2001 (NCT00669110)|6
8647160|NCT00619619|9688403|FG001|Entered the Extension Study|Overall Study||5
8647161|NCT00619619|9688404|FG002|Entered the Extension Study|Overall Study||8
8647162|NCT00619619|9688405|FG003|Entered the Extension Study|Overall Study||3
8647163|NCT00619619|9688406|FG004|Entered the Extension Study|Overall Study||7
8647164|NCT00619619|9688407|FG005|Entered the Extension Study|Overall Study||6
8647165|NCT00619619|9688408|FG006|Entered the Extension Study|Overall Study||6
8647166|NCT00619619|9688409|FG007|Entered the Extension Study|Overall Study||7
8647167|NCT00619619|9688402|FG000|COMPLETED|Overall Study|Completed=conclusion of Test Article (treatment) phase for all treatment groups in 3151A6-2000.|6
8647168|NCT00619619|9688403|FG001|COMPLETED|Overall Study||7
8647169|NCT00619619|9688404|FG002|COMPLETED|Overall Study||8
8647170|NCT00619619|9688405|FG003|COMPLETED|Overall Study||6
8647171|NCT00619619|9688406|FG004|COMPLETED|Overall Study||5
8647172|NCT00619619|9688407|FG005|COMPLETED|Overall Study||7
8647173|NCT00619619|9688408|FG006|COMPLETED|Overall Study||7
8647174|NCT00619619|9688409|FG007|COMPLETED|Overall Study||5
8647175|NCT00619619|9688402|FG000|NOT COMPLETED|Overall Study||0
8647176|NCT00619619|9688403|FG001|NOT COMPLETED|Overall Study||0
8647177|NCT00619619|9688404|FG002|NOT COMPLETED|Overall Study||1
8647178|NCT00619619|9688405|FG003|NOT COMPLETED|Overall Study||1
8647179|NCT00619619|9688406|FG004|NOT COMPLETED|Overall Study||2
8647180|NCT00619619|9688407|FG005|NOT COMPLETED|Overall Study||0
8647181|NCT00619619|9688408|FG006|NOT COMPLETED|Overall Study||1
8647182|NCT00619619|9688409|FG007|NOT COMPLETED|Overall Study||3
8647183|NCT00619645|9688430|FG000|STARTED|Overall Study||8
8647184|NCT00619645|9688430|FG000|COMPLETED|Overall Study||7
8647185|NCT00619645|9688430|FG000|NOT COMPLETED|Overall Study||1
8647186|NCT00619684|9688434|FG000|STARTED|Overall Study||18
8647187|NCT00619684|9688434|FG000|COMPLETED|Overall Study||18
8647188|NCT00619684|9688434|FG000|NOT COMPLETED|Overall Study||0
8647189|NCT00619723|9688440|FG000|STARTED|Overall Study||63
8647190|NCT00619723|9688441|FG001|STARTED|Overall Study||67
8647191|NCT00619723|9688440|FG000|COMPLETED|Overall Study||61
8647192|NCT00619723|9688441|FG001|COMPLETED|Overall Study||61
8647193|NCT00619723|9688440|FG000|NOT COMPLETED|Overall Study||2
8647194|NCT00619723|9688441|FG001|NOT COMPLETED|Overall Study||6
8647195|NCT00619762|9688447|FG000|STARTED|Overall Study|(29 breasts) First patient implanted 10/23/2007|17
8647196|NCT00619762|9688447|FG000|COMPLETED|Overall Study|(25 breasts) last patient visit 11/09/2009|14
8647197|NCT00619762|9688447|FG000|NOT COMPLETED|Overall Study||3
8647198|NCT00619801|9688454|FG000|STARTED|Overall Study||59
8647199|NCT00619801|9688455|FG001|STARTED|Overall Study||114
8647200|NCT00619801|9688454|FG000|Safety Population|Overall Study||59
8647201|NCT00619801|9688455|FG001|Safety Population|Overall Study||114
8647202|NCT00619801|9688454|FG000|COMPLETED|Overall Study||58
8647203|NCT00619801|9688455|FG001|COMPLETED|Overall Study||111
8647204|NCT00619801|9688454|FG000|NOT COMPLETED|Overall Study||1
8647205|NCT00619801|9688455|FG001|NOT COMPLETED|Overall Study||3
8647206|NCT00619827|9688463|FG000|STARTED|Overall Study||45
8647207|NCT00619827|9688464|FG001|STARTED|Overall Study||44
8647208|NCT00619827|9688463|FG000|COMPLETED|Overall Study||42
8647209|NCT00619827|9688464|FG001|COMPLETED|Overall Study||40
8647210|NCT00619827|9688463|FG000|NOT COMPLETED|Overall Study||3
8647211|NCT00619827|9688464|FG001|NOT COMPLETED|Overall Study||4
8647212|NCT00619866|9688473|FG000|STARTED|Weeks 1 - 12||52
8647213|NCT00619866|9688474|FG001|STARTED|Weeks 1 - 12||51
8647214|NCT00619866|9688475|FG002|STARTED|Weeks 1 - 12||52
8647215|NCT00619866|9688476|FG003|STARTED|Weeks 1 - 12||0
8647216|NCT00619866|9688477|FG004|STARTED|Weeks 1 - 12||0
8647217|NCT00619866|9688473|FG000|COMPLETED|Weeks 1 - 12||38
8647218|NCT00619866|9688474|FG001|COMPLETED|Weeks 1 - 12||45
8647219|NCT00619866|9688475|FG002|COMPLETED|Weeks 1 - 12||42
8647220|NCT00619866|9688476|FG003|COMPLETED|Weeks 1 - 12||0
8647221|NCT00619866|9688477|FG004|COMPLETED|Weeks 1 - 12||0
8647222|NCT00619866|9688473|FG000|NOT COMPLETED|Weeks 1 - 12||14
8647223|NCT00619866|9688474|FG001|NOT COMPLETED|Weeks 1 - 12||6
8647224|NCT00619866|9688475|FG002|NOT COMPLETED|Weeks 1 - 12||10
8647225|NCT00619866|9688476|FG003|NOT COMPLETED|Weeks 1 - 12||0
8647226|NCT00619866|9688477|FG004|NOT COMPLETED|Weeks 1 - 12||0
8647227|NCT00619866|9688473|FG000|STARTED|Weeks 13 - 24||0
8647228|NCT00619866|9688474|FG001|STARTED|Weeks 13 - 24||45
8647229|NCT00619866|9688475|FG002|STARTED|Weeks 13 - 24||42
8647230|NCT00619866|9688476|FG003|STARTED|Weeks 13 - 24||18
8647231|NCT00619866|9688477|FG004|STARTED|Weeks 13 - 24||20
8647232|NCT00619866|9688473|FG000|COMPLETED|Weeks 13 - 24||0
8647233|NCT00619866|9688474|FG001|COMPLETED|Weeks 13 - 24||38
8647234|NCT00619866|9688475|FG002|COMPLETED|Weeks 13 - 24||37
8647235|NCT00619866|9688476|FG003|COMPLETED|Weeks 13 - 24||14
8647236|NCT00619866|9688477|FG004|COMPLETED|Weeks 13 - 24||18
8647237|NCT00619866|9688473|FG000|NOT COMPLETED|Weeks 13 - 24||0
8647238|NCT00619866|9688474|FG001|NOT COMPLETED|Weeks 13 - 24||7
8647239|NCT00619866|9688475|FG002|NOT COMPLETED|Weeks 13 - 24||5
8647240|NCT00619866|9688476|FG003|NOT COMPLETED|Weeks 13 - 24||4
8647241|NCT00619866|9688477|FG004|NOT COMPLETED|Weeks 13 - 24||2
8727655|NCT01044264|9774895|FG001|NOT COMPLETED|Overall Study||94
8647242|NCT00619892|9688491|FG000|STARTED|Overall Study||13
8647243|NCT00619892|9688492|FG001|STARTED|Overall Study||13
8647244|NCT00619892|9688491|FG000|COMPLETED|Overall Study||10
8647245|NCT00619892|9688492|FG001|COMPLETED|Overall Study||11
8647246|NCT00619892|9688491|FG000|NOT COMPLETED|Overall Study||3
8647247|NCT00619892|9688492|FG001|NOT COMPLETED|Overall Study||2
8647248|NCT00619918|9688502|FG000|STARTED|Overall Study||230
8647249|NCT00619918|9688503|FG001|STARTED|Overall Study||217
8647250|NCT00619918|9688502|FG000|COMPLETED|Overall Study||210
8647251|NCT00619918|9688503|FG001|COMPLETED|Overall Study||195
8647252|NCT00619918|9688502|FG000|NOT COMPLETED|Overall Study||20
8647253|NCT00619918|9688503|FG001|NOT COMPLETED|Overall Study||22
8647254|NCT00619957|9688511|FG000|STARTED|Month 24 Double-Blind||93
8647255|NCT00619957|9688512|FG001|STARTED|Month 24 Double-Blind||192
8647256|NCT00619957|9688511|FG000|Intent to Treat (ITT Population)|Month 24 Double-Blind||93
8647257|NCT00619957|9688512|FG001|Intent to Treat (ITT Population)|Month 24 Double-Blind|One subject did not take any study medication.|191
8647258|NCT00619957|9688511|FG000|COMPLETED|Month 24 Double-Blind||75
8647259|NCT00619957|9688512|FG001|COMPLETED|Month 24 Double-Blind||175
8647260|NCT00619957|9688511|FG000|NOT COMPLETED|Month 24 Double-Blind||18
8647261|NCT00619957|9688512|FG001|NOT COMPLETED|Month 24 Double-Blind||17
8647262|NCT00619957|9688511|FG000|STARTED|Month 48 Open-Label||67
8647263|NCT00619957|9688512|FG001|STARTED|Month 48 Open-Label||151
8647264|NCT00619957|9688511|FG000|COMPLETED|Month 48 Open-Label||55
8647265|NCT00619957|9688512|FG001|COMPLETED|Month 48 Open-Label||134
8647266|NCT00619957|9688511|FG000|NOT COMPLETED|Month 48 Open-Label||12
8647267|NCT00619957|9688512|FG001|NOT COMPLETED|Month 48 Open-Label||17
8727656|NCT01044264|9774896|FG002|NOT COMPLETED|Overall Study||92
8727657|NCT01044290|9774907|FG000|STARTED|Randomization||75
8727658|NCT01044290|9774908|FG001|STARTED|Randomization||74
8727659|NCT01044290|9774909|FG002|STARTED|Randomization||72
8727660|NCT01044290|9774907|FG000|Randomized|Randomization||75
8727661|NCT01044290|9774908|FG001|Randomized|Randomization||74
8727662|NCT01044290|9774909|FG002|Randomized|Randomization||72
8727663|NCT01044290|9774907|FG000|COMPLETED|Randomization||75
8727664|NCT01044290|9774908|FG001|COMPLETED|Randomization||74
8727665|NCT01044290|9774909|FG002|COMPLETED|Randomization||72
8727666|NCT01044290|9774907|FG000|NOT COMPLETED|Randomization||0
8727667|NCT01044290|9774908|FG001|NOT COMPLETED|Randomization||0
8727668|NCT01044290|9774909|FG002|NOT COMPLETED|Randomization||0
8727669|NCT01044290|9774907|FG000|STARTED|Follow-up 1||75
8727670|NCT01044290|9774908|FG001|STARTED|Follow-up 1||74
8727671|NCT01044290|9774909|FG002|STARTED|Follow-up 1||72
8727672|NCT01044290|9774907|FG000|Completed F1 Interview|Follow-up 1||61
8727673|NCT01044290|9774908|FG001|Completed F1 Interview|Follow-up 1||60
8727674|NCT01044290|9774909|FG002|Completed F1 Interview|Follow-up 1||61
8727675|NCT01044290|9774907|FG000|COMPLETED|Follow-up 1||70
8727676|NCT01044290|9774908|FG001|COMPLETED|Follow-up 1||69
8727677|NCT01044290|9774909|FG002|COMPLETED|Follow-up 1||71
8727678|NCT01044290|9774907|FG000|NOT COMPLETED|Follow-up 1||5
8727679|NCT01044290|9774908|FG001|NOT COMPLETED|Follow-up 1||5
8647268|NCT00619970|9688523|FG000|STARTED|Overall Study||40
8647269|NCT00619970|9688524|FG001|STARTED|Overall Study||49
8647270|NCT00619970|9688525|FG002|STARTED|Overall Study||26
8647271|NCT00619970|9688523|FG000|COMPLETED|Overall Study||40
8647272|NCT00619970|9688524|FG001|COMPLETED|Overall Study||46
8647273|NCT00619970|9688525|FG002|COMPLETED|Overall Study||24
8647274|NCT00619970|9688523|FG000|NOT COMPLETED|Overall Study||0
8647275|NCT00619970|9688524|FG001|NOT COMPLETED|Overall Study||3
8647276|NCT00619970|9688525|FG002|NOT COMPLETED|Overall Study||2
8647277|NCT00619983|9688539|FG000|STARTED|Test Drug Alone||5
8647278|NCT00619983|9688540|FG001|STARTED|Test Drug Alone||5
8647279|NCT00619983|9688541|FG002|STARTED|Test Drug Alone||6
8647280|NCT00619983|9688542|FG003|STARTED|Test Drug Alone||6
8647281|NCT00619983|9688539|FG000|COMPLETED|Test Drug Alone||3
8647282|NCT00619983|9688540|FG001|COMPLETED|Test Drug Alone||4
8647283|NCT00619983|9688541|FG002|COMPLETED|Test Drug Alone||4
8647284|NCT00619983|9688542|FG003|COMPLETED|Test Drug Alone||3
8647285|NCT00619983|9688539|FG000|NOT COMPLETED|Test Drug Alone||2
8647286|NCT00619983|9688540|FG001|NOT COMPLETED|Test Drug Alone||1
8647287|NCT00619983|9688541|FG002|NOT COMPLETED|Test Drug Alone||2
8647288|NCT00619983|9688542|FG003|NOT COMPLETED|Test Drug Alone||3
8647289|NCT00619983|9688539|FG000|STARTED|Test Drug Plus Gabapentin||3
8647290|NCT00619983|9688540|FG001|STARTED|Test Drug Plus Gabapentin||4
8647291|NCT00619983|9688541|FG002|STARTED|Test Drug Plus Gabapentin||4
8647292|NCT00619983|9688542|FG003|STARTED|Test Drug Plus Gabapentin||3
8647293|NCT00619983|9688539|FG000|COMPLETED|Test Drug Plus Gabapentin||3
8647294|NCT00619983|9688540|FG001|COMPLETED|Test Drug Plus Gabapentin||4
8647295|NCT00619983|9688541|FG002|COMPLETED|Test Drug Plus Gabapentin||4
8647296|NCT00619983|9688542|FG003|COMPLETED|Test Drug Plus Gabapentin||3
8647297|NCT00619983|9688539|FG000|NOT COMPLETED|Test Drug Plus Gabapentin||0
8647298|NCT00619983|9688540|FG001|NOT COMPLETED|Test Drug Plus Gabapentin||0
8647299|NCT00619983|9688541|FG002|NOT COMPLETED|Test Drug Plus Gabapentin||0
8647300|NCT00619983|9688542|FG003|NOT COMPLETED|Test Drug Plus Gabapentin||0
8647301|NCT00619983|9688539|FG000|STARTED|Gabapentin Alone||3
8647302|NCT00619983|9688540|FG001|STARTED|Gabapentin Alone||4
8647303|NCT00619983|9688541|FG002|STARTED|Gabapentin Alone||4
8647304|NCT00619983|9688542|FG003|STARTED|Gabapentin Alone||3
8647305|NCT00619983|9688539|FG000|COMPLETED|Gabapentin Alone||3
8647306|NCT00619983|9688540|FG001|COMPLETED|Gabapentin Alone||4
8647307|NCT00619983|9688541|FG002|COMPLETED|Gabapentin Alone||4
8647308|NCT00619983|9688542|FG003|COMPLETED|Gabapentin Alone||3
8647309|NCT00619983|9688539|FG000|NOT COMPLETED|Gabapentin Alone||0
8647310|NCT00619983|9688540|FG001|NOT COMPLETED|Gabapentin Alone||0
8647311|NCT00619983|9688541|FG002|NOT COMPLETED|Gabapentin Alone||0
8727680|NCT01044290|9774909|FG002|NOT COMPLETED|Follow-up 1||1
8727681|NCT01044290|9774907|FG000|STARTED|Follow-Up 2||70
8727682|NCT01044290|9774908|FG001|STARTED|Follow-Up 2||69
8727683|NCT01044290|9774909|FG002|STARTED|Follow-Up 2||71
8727684|NCT01044290|9774907|FG000|Completed F2 Interview|Follow-Up 2||64
8727685|NCT01044290|9774908|FG001|Completed F2 Interview|Follow-Up 2||57
8727686|NCT01044290|9774909|FG002|Completed F2 Interview|Follow-Up 2||64
8727687|NCT01044290|9774907|FG000|COMPLETED|Follow-Up 2||70
8727688|NCT01044290|9774908|FG001|COMPLETED|Follow-Up 2||67
8647312|NCT00619983|9688542|FG003|NOT COMPLETED|Gabapentin Alone||0
8727689|NCT01044290|9774909|FG002|COMPLETED|Follow-Up 2||69
8727690|NCT01044290|9774907|FG000|NOT COMPLETED|Follow-Up 2||0
8727691|NCT01044290|9774908|FG001|NOT COMPLETED|Follow-Up 2||2
8647313|NCT00620022|9688552|FG000|STARTED|Treatment Period 1||46
8647314|NCT00620022|9688553|FG001|STARTED|Treatment Period 1|Of 44 randomized patients, 1 patient discontinued before receiving any study treatment.|43
8647315|NCT00620022|9688552|FG000|COMPLETED|Treatment Period 1||41
8647316|NCT00620022|9688553|FG001|COMPLETED|Treatment Period 1||37
8647317|NCT00620022|9688552|FG000|NOT COMPLETED|Treatment Period 1||5
8647318|NCT00620022|9688553|FG001|NOT COMPLETED|Treatment Period 1||6
8647319|NCT00620022|9688552|FG000|STARTED|Treatment Period 2||41
8647320|NCT00620022|9688553|FG001|STARTED|Treatment Period 2||37
8647321|NCT00620022|9688552|FG000|COMPLETED|Treatment Period 2||39
8647322|NCT00620022|9688553|FG001|COMPLETED|Treatment Period 2||35
8647323|NCT00620022|9688552|FG000|NOT COMPLETED|Treatment Period 2||2
8647324|NCT00620022|9688553|FG001|NOT COMPLETED|Treatment Period 2||2
8647325|NCT00620061|9688559|FG000|STARTED|Overall Study||439
8647326|NCT00620061|9688559|FG000|COMPLETED|Overall Study||286
8727692|NCT01044290|9774909|FG002|NOT COMPLETED|Follow-Up 2||2
8727693|NCT01044303|9774927|FG000|STARTED|Overall Study||32
8727694|NCT01044303|9774927|FG000|COMPLETED|Overall Study||30
8727695|NCT01044303|9774927|FG000|NOT COMPLETED|Overall Study||2
8727696|NCT01044433|9774934|FG000|STARTED|Overall Study||44
8727697|NCT01044433|9774934|FG000|COMPLETED|Overall Study||38
8727698|NCT01044433|9774934|FG000|NOT COMPLETED|Overall Study||6
8727699|NCT01044459|9774941|FG000|STARTED|Overall Study||312
8727700|NCT01044459|9774942|FG001|STARTED|Overall Study||293
8727701|NCT01044459|9774941|FG000|COMPLETED|Overall Study||179
8727702|NCT01044459|9774942|FG001|COMPLETED|Overall Study||162
8727703|NCT01044459|9774941|FG000|NOT COMPLETED|Overall Study||133
8727704|NCT01044459|9774942|FG001|NOT COMPLETED|Overall Study||131
8727705|NCT01044498|9774950|FG000|STARTED|Overall Study||23
8727706|NCT01044498|9774951|FG001|STARTED|Overall Study||23
8727707|NCT01044498|9774950|FG000|COMPLETED|Overall Study||20
8727708|NCT01044498|9774951|FG001|COMPLETED|Overall Study||21
8727709|NCT01044498|9774950|FG000|NOT COMPLETED|Overall Study||3
8727710|NCT01044498|9774951|FG001|NOT COMPLETED|Overall Study||2
8727711|NCT01044537|9774964|FG000|STARTED|Overall Study||6
8727712|NCT01044537|9774965|FG001|STARTED|Overall Study||6
8727713|NCT01044537|9774966|FG002|STARTED|Overall Study||6
8727714|NCT01044537|9774967|FG003|STARTED|Overall Study||6
8727715|NCT01044537|9774968|FG004|STARTED|Overall Study||5
8727716|NCT01044537|9774969|FG005|STARTED|Overall Study||5
8727717|NCT01044537|9774970|FG006|STARTED|Overall Study||16
8727718|NCT01044537|9774964|FG000|COMPLETED|Overall Study||6
8727719|NCT01044537|9774965|FG001|COMPLETED|Overall Study||6
8727720|NCT01044537|9774966|FG002|COMPLETED|Overall Study||6
8727721|NCT01044537|9774967|FG003|COMPLETED|Overall Study||6
8727722|NCT01044537|9774968|FG004|COMPLETED|Overall Study||5
8727723|NCT01044537|9774969|FG005|COMPLETED|Overall Study||5
8727724|NCT01044537|9774970|FG006|COMPLETED|Overall Study||16
8727725|NCT01044537|9774964|FG000|NOT COMPLETED|Overall Study||0
8727726|NCT01044537|9774965|FG001|NOT COMPLETED|Overall Study||0
8727727|NCT01044537|9774966|FG002|NOT COMPLETED|Overall Study||0
8727728|NCT01044537|9774967|FG003|NOT COMPLETED|Overall Study||0
8727729|NCT01044537|9774968|FG004|NOT COMPLETED|Overall Study||0
8727730|NCT01044537|9774969|FG005|NOT COMPLETED|Overall Study||0
8727731|NCT01044537|9774970|FG006|NOT COMPLETED|Overall Study||0
8727732|NCT01044576|9774986|FG000|STARTED|Overall Study||200
8727733|NCT01044576|9774986|FG000|COMPLETED|Overall Study||200
8727734|NCT01044576|9774986|FG000|NOT COMPLETED|Overall Study||0
8727735|NCT01044589|9774992|FG000|STARTED|Overall Study||6
8727736|NCT01044589|9774993|FG001|STARTED|Overall Study||7
8727737|NCT01044589|9774992|FG000|COMPLETED|Overall Study||3
8727738|NCT01044589|9774993|FG001|COMPLETED|Overall Study||2
8727739|NCT01044589|9774992|FG000|NOT COMPLETED|Overall Study||3
8727740|NCT01044589|9774993|FG001|NOT COMPLETED|Overall Study||5
8727741|NCT01044693|9774999|FG000|STARTED|Overall Study||3
8727742|NCT01044693|9775000|FG001|STARTED|Overall Study||1
8727743|NCT01044693|9775001|FG002|STARTED|Overall Study||1
8727744|NCT01044693|9775002|FG003|STARTED|Overall Study||1
8727745|NCT01044693|9775003|FG004|STARTED|Overall Study||1
8727746|NCT01044693|9775004|FG005|STARTED|Overall Study||2
8727747|NCT01044693|9775005|FG006|STARTED|Overall Study||1
8727748|NCT01044693|9775006|FG007|STARTED|Overall Study||1
8727749|NCT01044693|9775007|FG008|STARTED|Overall Study||1
8727750|NCT01044693|9775008|FG009|STARTED|Overall Study||1
8727751|NCT01044693|9775009|FG010|STARTED|Overall Study||1
8727752|NCT01044693|9775010|FG011|STARTED|Overall Study||1
8727753|NCT01044693|9775011|FG012|STARTED|Overall Study||2
8727754|NCT01044693|9775012|FG013|STARTED|Overall Study||1
8727755|NCT01044693|9775013|FG014|STARTED|Overall Study||1
8727756|NCT01044693|9775014|FG015|STARTED|Overall Study||1
8727757|NCT01044693|9774999|FG000|COMPLETED|Overall Study||3
8727758|NCT01044693|9775000|FG001|COMPLETED|Overall Study||1
8727759|NCT01044693|9775001|FG002|COMPLETED|Overall Study||1
8727760|NCT01044693|9775002|FG003|COMPLETED|Overall Study||1
8727761|NCT01044693|9775003|FG004|COMPLETED|Overall Study||1
8727762|NCT01044693|9775004|FG005|COMPLETED|Overall Study||2
8727763|NCT01044693|9775005|FG006|COMPLETED|Overall Study||1
8727764|NCT01044693|9775006|FG007|COMPLETED|Overall Study||1
8727765|NCT01044693|9775007|FG008|COMPLETED|Overall Study||1
8727766|NCT01044693|9775008|FG009|COMPLETED|Overall Study||1
8727767|NCT01044693|9775009|FG010|COMPLETED|Overall Study||1
8727768|NCT01044693|9775010|FG011|COMPLETED|Overall Study||1
8727769|NCT01044693|9775011|FG012|COMPLETED|Overall Study||2
8727770|NCT01044693|9775012|FG013|COMPLETED|Overall Study||1
8647327|NCT00620061|9688559|FG000|NOT COMPLETED|Overall Study||153
8647328|NCT00620074|9688564|FG000|STARTED|Overall Study||6
8647329|NCT00620074|9688564|FG000|COMPLETED|Overall Study||5
8647330|NCT00620074|9688564|FG000|NOT COMPLETED|Overall Study||1
8647331|NCT00620113|9688572|FG000|STARTED|Overall Study||73
8647332|NCT00620113|9688573|FG001|STARTED|Overall Study||74
8647333|NCT00620113|9688574|FG002|STARTED|Overall Study|Includes 1 participant who also received 50 mg dose by accident during study.|71
8647334|NCT00620113|9688575|FG003|STARTED|Overall Study||69
8727771|NCT01044693|9775013|FG014|COMPLETED|Overall Study||1
8727772|NCT01044693|9775014|FG015|COMPLETED|Overall Study||1
8727773|NCT01044693|9774999|FG000|NOT COMPLETED|Overall Study||0
8727774|NCT01044693|9775000|FG001|NOT COMPLETED|Overall Study||0
8727775|NCT01044693|9775001|FG002|NOT COMPLETED|Overall Study||0
8727776|NCT01044693|9775002|FG003|NOT COMPLETED|Overall Study||0
8727777|NCT01044693|9775003|FG004|NOT COMPLETED|Overall Study||0
8727778|NCT01044693|9775004|FG005|NOT COMPLETED|Overall Study||0
8727779|NCT01044693|9775005|FG006|NOT COMPLETED|Overall Study||0
8727780|NCT01044693|9775006|FG007|NOT COMPLETED|Overall Study||0
8727781|NCT01044693|9775007|FG008|NOT COMPLETED|Overall Study||0
8727782|NCT01044693|9775008|FG009|NOT COMPLETED|Overall Study||0
8727783|NCT01044693|9775009|FG010|NOT COMPLETED|Overall Study||0
8727784|NCT01044693|9775010|FG011|NOT COMPLETED|Overall Study||0
8727785|NCT01044693|9775011|FG012|NOT COMPLETED|Overall Study||0
8727786|NCT01044693|9775012|FG013|NOT COMPLETED|Overall Study||0
8727787|NCT01044693|9775013|FG014|NOT COMPLETED|Overall Study||0
8727788|NCT01044693|9775014|FG015|NOT COMPLETED|Overall Study||0
8727789|NCT01044706|9775026|FG000|STARTED|Overall Study||30
8727790|NCT01044706|9775027|FG001|STARTED|Overall Study||30
8727791|NCT01044706|9775026|FG000|COMPLETED|Overall Study||30
8727792|NCT01044706|9775027|FG001|COMPLETED|Overall Study||30
8727793|NCT01044706|9775026|FG000|NOT COMPLETED|Overall Study||0
8727794|NCT01044706|9775027|FG001|NOT COMPLETED|Overall Study||0
8727795|NCT01044732|9775035|FG000|STARTED|Overall Study||222
8727796|NCT01044732|9775036|FG001|STARTED|Overall Study||226
8727797|NCT01044732|9775035|FG000|COMPLETED|Overall Study||173
8727798|NCT01044732|9775036|FG001|COMPLETED|Overall Study||176
8727799|NCT01044732|9775035|FG000|NOT COMPLETED|Overall Study||49
8727800|NCT01044732|9775036|FG001|NOT COMPLETED|Overall Study||50
8647335|NCT00620113|9688572|FG000|Efficacy/Safety Population|Overall Study||73
8647336|NCT00620113|9688573|FG001|Efficacy/Safety Population|Overall Study||74
8647337|NCT00620113|9688574|FG002|Efficacy/Safety Population|Overall Study||70
8647338|NCT00620113|9688575|FG003|Efficacy/Safety Population|Overall Study||69
8647339|NCT00620113|9688572|FG000|COMPLETED|Overall Study||60
8647340|NCT00620113|9688573|FG001|COMPLETED|Overall Study||67
8647341|NCT00620113|9688574|FG002|COMPLETED|Overall Study|Includes 1 participant who also received 50 mg dose by accident during study.|66
8647342|NCT00620113|9688575|FG003|COMPLETED|Overall Study||59
8647343|NCT00620113|9688572|FG000|NOT COMPLETED|Overall Study||13
8647344|NCT00620113|9688573|FG001|NOT COMPLETED|Overall Study||7
8647345|NCT00620113|9688574|FG002|NOT COMPLETED|Overall Study||5
8647346|NCT00620113|9688575|FG003|NOT COMPLETED|Overall Study||10
8647347|NCT00620126|9688587|FG000|STARTED|Overall Study||25
8647348|NCT00620126|9688588|FG001|STARTED|Overall Study||22
8647349|NCT00620126|9688587|FG000|COMPLETED|Overall Study||14
8647350|NCT00620126|9688588|FG001|COMPLETED|Overall Study||17
8647351|NCT00620126|9688587|FG000|NOT COMPLETED|Overall Study||11
8647352|NCT00620126|9688588|FG001|NOT COMPLETED|Overall Study||5
8647353|NCT00620191|9688596|FG000|STARTED|Overall Study||40
8647354|NCT00620191|9688597|FG001|STARTED|Overall Study||40
8647355|NCT00620191|9688596|FG000|3 Month Follow-up|Overall Study||39
8647356|NCT00620191|9688597|FG001|3 Month Follow-up|Overall Study||39
8647357|NCT00620191|9688596|FG000|6 Month Follow-up|Overall Study||38
8647358|NCT00620191|9688597|FG001|6 Month Follow-up|Overall Study||36
8647359|NCT00620191|9688596|FG000|9 Month Follow-up|Overall Study||37
8647360|NCT00620191|9688597|FG001|9 Month Follow-up|Overall Study||34
8647361|NCT00620191|9688596|FG000|COMPLETED|Overall Study|12 month follow-up|33
8647362|NCT00620191|9688597|FG001|COMPLETED|Overall Study|12 month follow-up|32
8647363|NCT00620191|9688596|FG000|NOT COMPLETED|Overall Study||7
8647364|NCT00620191|9688597|FG001|NOT COMPLETED|Overall Study||8
8647365|NCT00620282|9688611|FG000|STARTED|Overall Study||16
8647366|NCT00620282|9688612|FG001|STARTED|Overall Study||16
8647367|NCT00620282|9688613|FG002|STARTED|Overall Study||17
8647368|NCT00620282|9688611|FG000|COMPLETED|Overall Study||16
8647369|NCT00620282|9688612|FG001|COMPLETED|Overall Study||14
8647370|NCT00620282|9688613|FG002|COMPLETED|Overall Study||16
8647371|NCT00620282|9688611|FG000|NOT COMPLETED|Overall Study||0
8647372|NCT00620282|9688612|FG001|NOT COMPLETED|Overall Study||2
8647373|NCT00620282|9688613|FG002|NOT COMPLETED|Overall Study||1
8647374|NCT00620321|9688623|FG000|STARTED|Overall Study||8
8647375|NCT00620321|9688624|FG001|STARTED|Overall Study||16
8647376|NCT00620321|9688623|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
8647377|NCT00620321|9688624|FG001|Received at Least 1 Dose of Study Drug|Overall Study||16
8647378|NCT00620321|9688623|FG000|COMPLETED|Overall Study||0
8647379|NCT00620321|9688624|FG001|COMPLETED|Overall Study||0
8647380|NCT00620321|9688623|FG000|NOT COMPLETED|Overall Study||8
8647381|NCT00620321|9688624|FG001|NOT COMPLETED|Overall Study||16
8647382|NCT00620373|9688630|FG000|STARTED|Overall Study||969
8647383|NCT00620373|9688630|FG000|COMPLETED|Overall Study||936
8727801|NCT01044745|9775044|FG000|STARTED|Overall Study||20
8727802|NCT01044745|9775044|FG000|COMPLETED|Overall Study||18
8647384|NCT00620373|9688630|FG000|NOT COMPLETED|Overall Study||33
8647385|NCT00620425|9688637|FG000|STARTED|Overall Study||18
8647386|NCT00620425|9688637|FG000|COMPLETED|Overall Study||18
8647387|NCT00620425|9688637|FG000|NOT COMPLETED|Overall Study||0
8647388|NCT00620503|9688648|FG000|STARTED|Screening (up to 21 Days)||2
8647389|NCT00620503|9688649|FG001|STARTED|Screening (up to 21 Days)||2
8647390|NCT00620503|9688650|FG002|STARTED|Screening (up to 21 Days)||2
8647391|NCT00620503|9688651|FG003|STARTED|Screening (up to 21 Days)||2
8647392|NCT00620503|9688652|FG004|STARTED|Screening (up to 21 Days)||2
8647393|NCT00620503|9688653|FG005|STARTED|Screening (up to 21 Days)||2
8647394|NCT00620503|9688648|FG000|COMPLETED|Screening (up to 21 Days)||2
8647395|NCT00620503|9688649|FG001|COMPLETED|Screening (up to 21 Days)||2
8647396|NCT00620503|9688650|FG002|COMPLETED|Screening (up to 21 Days)||2
8647397|NCT00620503|9688651|FG003|COMPLETED|Screening (up to 21 Days)||2
8647398|NCT00620503|9688652|FG004|COMPLETED|Screening (up to 21 Days)||2
8647399|NCT00620503|9688653|FG005|COMPLETED|Screening (up to 21 Days)||2
8647400|NCT00620503|9688648|FG000|NOT COMPLETED|Screening (up to 21 Days)||0
8647401|NCT00620503|9688649|FG001|NOT COMPLETED|Screening (up to 21 Days)||0
8647402|NCT00620503|9688650|FG002|NOT COMPLETED|Screening (up to 21 Days)||0
8647403|NCT00620503|9688651|FG003|NOT COMPLETED|Screening (up to 21 Days)||0
8647404|NCT00620503|9688652|FG004|NOT COMPLETED|Screening (up to 21 Days)||0
8647405|NCT00620503|9688653|FG005|NOT COMPLETED|Screening (up to 21 Days)||0
8647406|NCT00620503|9688648|FG000|STARTED|Treatment Period 1 (TP1) (7days)||2
8647407|NCT00620503|9688649|FG001|STARTED|Treatment Period 1 (TP1) (7days)||2
8647408|NCT00620503|9688650|FG002|STARTED|Treatment Period 1 (TP1) (7days)||2
8647409|NCT00620503|9688651|FG003|STARTED|Treatment Period 1 (TP1) (7days)||2
8647410|NCT00620503|9688652|FG004|STARTED|Treatment Period 1 (TP1) (7days)||2
8647411|NCT00620503|9688653|FG005|STARTED|Treatment Period 1 (TP1) (7days)||2
8647412|NCT00620503|9688648|FG000|COMPLETED|Treatment Period 1 (TP1) (7days)||2
8647413|NCT00620503|9688649|FG001|COMPLETED|Treatment Period 1 (TP1) (7days)||2
8647414|NCT00620503|9688650|FG002|COMPLETED|Treatment Period 1 (TP1) (7days)||2
8647415|NCT00620503|9688651|FG003|COMPLETED|Treatment Period 1 (TP1) (7days)||2
8647416|NCT00620503|9688652|FG004|COMPLETED|Treatment Period 1 (TP1) (7days)||2
8647417|NCT00620503|9688653|FG005|COMPLETED|Treatment Period 1 (TP1) (7days)||2
8647418|NCT00620503|9688648|FG000|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
8647419|NCT00620503|9688649|FG001|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
8647420|NCT00620503|9688650|FG002|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
8647421|NCT00620503|9688651|FG003|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
8647422|NCT00620503|9688652|FG004|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
8647423|NCT00620503|9688653|FG005|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
8647424|NCT00620503|9688648|FG000|STARTED|Washout (at Least 1 Day)||2
8647425|NCT00620503|9688649|FG001|STARTED|Washout (at Least 1 Day)||2
8647426|NCT00620503|9688650|FG002|STARTED|Washout (at Least 1 Day)||2
8647427|NCT00620503|9688651|FG003|STARTED|Washout (at Least 1 Day)||2
8647428|NCT00620503|9688652|FG004|STARTED|Washout (at Least 1 Day)||2
8647429|NCT00620503|9688653|FG005|STARTED|Washout (at Least 1 Day)||2
8647430|NCT00620503|9688648|FG000|COMPLETED|Washout (at Least 1 Day)||2
8647431|NCT00620503|9688649|FG001|COMPLETED|Washout (at Least 1 Day)||2
8647432|NCT00620503|9688650|FG002|COMPLETED|Washout (at Least 1 Day)||2
8647433|NCT00620503|9688651|FG003|COMPLETED|Washout (at Least 1 Day)||2
8647434|NCT00620503|9688652|FG004|COMPLETED|Washout (at Least 1 Day)||2
8647435|NCT00620503|9688653|FG005|COMPLETED|Washout (at Least 1 Day)||2
8647436|NCT00620503|9688648|FG000|NOT COMPLETED|Washout (at Least 1 Day)||0
8647437|NCT00620503|9688649|FG001|NOT COMPLETED|Washout (at Least 1 Day)||0
8647438|NCT00620503|9688650|FG002|NOT COMPLETED|Washout (at Least 1 Day)||0
8647439|NCT00620503|9688651|FG003|NOT COMPLETED|Washout (at Least 1 Day)||0
8647440|NCT00620503|9688652|FG004|NOT COMPLETED|Washout (at Least 1 Day)||0
8647441|NCT00620503|9688653|FG005|NOT COMPLETED|Washout (at Least 1 Day)||0
8647442|NCT00620503|9688648|FG000|STARTED|Treatment Period 2 (TP2) (7days)||2
8647443|NCT00620503|9688649|FG001|STARTED|Treatment Period 2 (TP2) (7days)||2
8647444|NCT00620503|9688650|FG002|STARTED|Treatment Period 2 (TP2) (7days)||2
8647445|NCT00620503|9688651|FG003|STARTED|Treatment Period 2 (TP2) (7days)||2
8647446|NCT00620503|9688652|FG004|STARTED|Treatment Period 2 (TP2) (7days)||2
8647447|NCT00620503|9688653|FG005|STARTED|Treatment Period 2 (TP2) (7days)||2
8647448|NCT00620503|9688648|FG000|COMPLETED|Treatment Period 2 (TP2) (7days)||2
8647449|NCT00620503|9688649|FG001|COMPLETED|Treatment Period 2 (TP2) (7days)||2
8647450|NCT00620503|9688650|FG002|COMPLETED|Treatment Period 2 (TP2) (7days)||2
8647451|NCT00620503|9688651|FG003|COMPLETED|Treatment Period 2 (TP2) (7days)||2
8647452|NCT00620503|9688652|FG004|COMPLETED|Treatment Period 2 (TP2) (7days)||2
8647453|NCT00620503|9688653|FG005|COMPLETED|Treatment Period 2 (TP2) (7days)||2
8647454|NCT00620503|9688648|FG000|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
8647455|NCT00620503|9688649|FG001|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
8647456|NCT00620503|9688650|FG002|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
8647457|NCT00620503|9688651|FG003|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
8647458|NCT00620503|9688652|FG004|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
8647459|NCT00620503|9688653|FG005|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
8647460|NCT00620503|9688648|FG000|STARTED|Washout (at Least 1 Day)||2
8647461|NCT00620503|9688649|FG001|STARTED|Washout (at Least 1 Day)||2
8647462|NCT00620503|9688650|FG002|STARTED|Washout (at Least 1 Day)||2
8647463|NCT00620503|9688651|FG003|STARTED|Washout (at Least 1 Day)||2
8647464|NCT00620503|9688652|FG004|STARTED|Washout (at Least 1 Day)||2
8647465|NCT00620503|9688653|FG005|STARTED|Washout (at Least 1 Day)||2
8647466|NCT00620503|9688648|FG000|COMPLETED|Washout (at Least 1 Day)||2
8647467|NCT00620503|9688649|FG001|COMPLETED|Washout (at Least 1 Day)||2
8647468|NCT00620503|9688650|FG002|COMPLETED|Washout (at Least 1 Day)||2
8647469|NCT00620503|9688651|FG003|COMPLETED|Washout (at Least 1 Day)||2
8647470|NCT00620503|9688652|FG004|COMPLETED|Washout (at Least 1 Day)||2
8647471|NCT00620503|9688653|FG005|COMPLETED|Washout (at Least 1 Day)||2
8647472|NCT00620503|9688648|FG000|NOT COMPLETED|Washout (at Least 1 Day)||0
8647473|NCT00620503|9688649|FG001|NOT COMPLETED|Washout (at Least 1 Day)||0
8647474|NCT00620503|9688650|FG002|NOT COMPLETED|Washout (at Least 1 Day)||0
8647475|NCT00620503|9688651|FG003|NOT COMPLETED|Washout (at Least 1 Day)||0
8647476|NCT00620503|9688652|FG004|NOT COMPLETED|Washout (at Least 1 Day)||0
8647477|NCT00620503|9688653|FG005|NOT COMPLETED|Washout (at Least 1 Day)||0
8647478|NCT00620503|9688648|FG000|STARTED|Treatment Period 3 (TP3) (7 Days)||2
8647479|NCT00620503|9688649|FG001|STARTED|Treatment Period 3 (TP3) (7 Days)||2
8647480|NCT00620503|9688650|FG002|STARTED|Treatment Period 3 (TP3) (7 Days)||2
8647481|NCT00620503|9688651|FG003|STARTED|Treatment Period 3 (TP3) (7 Days)||2
8647482|NCT00620503|9688652|FG004|STARTED|Treatment Period 3 (TP3) (7 Days)||2
8647483|NCT00620503|9688653|FG005|STARTED|Treatment Period 3 (TP3) (7 Days)||2
8647484|NCT00620503|9688648|FG000|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
8647485|NCT00620503|9688649|FG001|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
8647486|NCT00620503|9688650|FG002|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
8647487|NCT00620503|9688651|FG003|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
8647488|NCT00620503|9688652|FG004|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
8647489|NCT00620503|9688653|FG005|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
8647490|NCT00620503|9688648|FG000|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
8647491|NCT00620503|9688649|FG001|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
8647492|NCT00620503|9688650|FG002|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
8647493|NCT00620503|9688651|FG003|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
8647494|NCT00620503|9688652|FG004|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
8647495|NCT00620503|9688653|FG005|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
8647496|NCT00620503|9688648|FG000|STARTED|Follow-up (up to 14 Days)||2
8647497|NCT00620503|9688649|FG001|STARTED|Follow-up (up to 14 Days)||2
8647498|NCT00620503|9688650|FG002|STARTED|Follow-up (up to 14 Days)||2
8647499|NCT00620503|9688651|FG003|STARTED|Follow-up (up to 14 Days)||2
8647500|NCT00620503|9688652|FG004|STARTED|Follow-up (up to 14 Days)||2
8647501|NCT00620503|9688653|FG005|STARTED|Follow-up (up to 14 Days)||2
8647502|NCT00620503|9688648|FG000|COMPLETED|Follow-up (up to 14 Days)||2
8647503|NCT00620503|9688649|FG001|COMPLETED|Follow-up (up to 14 Days)||2
8647504|NCT00620503|9688650|FG002|COMPLETED|Follow-up (up to 14 Days)||2
8647505|NCT00620503|9688651|FG003|COMPLETED|Follow-up (up to 14 Days)||2
8647506|NCT00620503|9688652|FG004|COMPLETED|Follow-up (up to 14 Days)||2
8647507|NCT00620503|9688653|FG005|COMPLETED|Follow-up (up to 14 Days)||2
8647508|NCT00620503|9688648|FG000|NOT COMPLETED|Follow-up (up to 14 Days)||0
8647509|NCT00620503|9688649|FG001|NOT COMPLETED|Follow-up (up to 14 Days)||0
8647510|NCT00620503|9688650|FG002|NOT COMPLETED|Follow-up (up to 14 Days)||0
8647511|NCT00620503|9688651|FG003|NOT COMPLETED|Follow-up (up to 14 Days)||0
8647512|NCT00620503|9688652|FG004|NOT COMPLETED|Follow-up (up to 14 Days)||0
8647513|NCT00620503|9688653|FG005|NOT COMPLETED|Follow-up (up to 14 Days)||0
8647514|NCT00620542|9688663|FG000|STARTED|Part A (Run-in - 2 Weeks)|Of 1167 randomized, N=783 received treatment.|1167
8647515|NCT00620542|9688664|FG001|STARTED|Part A (Run-in - 2 Weeks)|Of 1166 randomized, N=795 received treatment.|1166
8647516|NCT00620542|9688665|FG002|STARTED|Part A (Run-in - 2 Weeks)||0
8647517|NCT00620542|9688666|FG003|STARTED|Part A (Run-in - 2 Weeks)||0
8647518|NCT00620542|9688663|FG000|Received Treatment|Part A (Run-in - 2 Weeks)||783
8647519|NCT00620542|9688664|FG001|Received Treatment|Part A (Run-in - 2 Weeks)||795
8647520|NCT00620542|9688665|FG002|Received Treatment|Part A (Run-in - 2 Weeks)||0
8647521|NCT00620542|9688666|FG003|Received Treatment|Part A (Run-in - 2 Weeks)||0
8647522|NCT00620542|9688663|FG000|COMPLETED|Part A (Run-in - 2 Weeks)||695
8647523|NCT00620542|9688664|FG001|COMPLETED|Part A (Run-in - 2 Weeks)||690
8647524|NCT00620542|9688665|FG002|COMPLETED|Part A (Run-in - 2 Weeks)||0
8647525|NCT00620542|9688666|FG003|COMPLETED|Part A (Run-in - 2 Weeks)||0
8647526|NCT00620542|9688663|FG000|NOT COMPLETED|Part A (Run-in - 2 Weeks)||472
8647527|NCT00620542|9688664|FG001|NOT COMPLETED|Part A (Run-in - 2 Weeks)||476
8647528|NCT00620542|9688665|FG002|NOT COMPLETED|Part A (Run-in - 2 Weeks)||0
8647529|NCT00620542|9688666|FG003|NOT COMPLETED|Part A (Run-in - 2 Weeks)||0
8647530|NCT00620542|9688663|FG000|STARTED|Part B (2 Year Core Study)||0
8647531|NCT00620542|9688664|FG001|STARTED|Part B (2 Year Core Study)||0
8647532|NCT00620542|9688665|FG002|STARTED|Part B (2 Year Core Study)|Of 694 patients randomized, N=691 received treatment.|694
8647533|NCT00620542|9688666|FG003|STARTED|Part B (2 Year Core Study)|Of 691 patients randomized, N=689 received treatment.|691
8647534|NCT00620542|9688663|FG000|Received Treatment|Part B (2 Year Core Study)||0
8647535|NCT00620542|9688664|FG001|Received Treatment|Part B (2 Year Core Study)||0
8647536|NCT00620542|9688665|FG002|Received Treatment|Part B (2 Year Core Study)||691
8647537|NCT00620542|9688666|FG003|Received Treatment|Part B (2 Year Core Study)||689
8647538|NCT00620542|9688663|FG000|Intent-to-treat Population|Part B (2 Year Core Study)||0
8647539|NCT00620542|9688664|FG001|Intent-to-treat Population|Part B (2 Year Core Study)||0
8647540|NCT00620542|9688665|FG002|Intent-to-treat Population|Part B (2 Year Core Study)|Patients who received treatment and had a baseline and end of study (Week 104) IVUS|520
8693784|NCT00868517|9739328|FG001|NOT COMPLETED|Overall Study||4
8647541|NCT00620542|9688666|FG003|Intent-to-treat Population|Part B (2 Year Core Study)|Patients who received treatment and had a baseline and end of study (Week 104) IVUS|519
8647542|NCT00620542|9688663|FG000|COMPLETED|Part B (2 Year Core Study)||0
8647543|NCT00620542|9688664|FG001|COMPLETED|Part B (2 Year Core Study)||0
8647544|NCT00620542|9688665|FG002|COMPLETED|Part B (2 Year Core Study)||546
8647545|NCT00620542|9688666|FG003|COMPLETED|Part B (2 Year Core Study)||547
8647546|NCT00620542|9688663|FG000|NOT COMPLETED|Part B (2 Year Core Study)||0
8647547|NCT00620542|9688664|FG001|NOT COMPLETED|Part B (2 Year Core Study)||0
8647548|NCT00620542|9688665|FG002|NOT COMPLETED|Part B (2 Year Core Study)||148
8647549|NCT00620542|9688666|FG003|NOT COMPLETED|Part B (2 Year Core Study)||144
8647550|NCT00620555|9688674|FG000|STARTED|Overall Study||65
8647551|NCT00620555|9688674|FG000|COMPLETED|Overall Study||44
8647552|NCT00620555|9688674|FG000|NOT COMPLETED|Overall Study||21
8647553|NCT00620659|9688678|FG000|STARTED|Treatment Period 1||21
8647554|NCT00620659|9688679|FG001|STARTED|Treatment Period 1||21
8647555|NCT00620659|9688680|FG002|STARTED|Treatment Period 1||21
8647556|NCT00620659|9688681|FG003|STARTED|Treatment Period 1||21
8647557|NCT00620659|9688682|FG004|STARTED|Treatment Period 1||21
8647558|NCT00620659|9688683|FG005|STARTED|Treatment Period 1||20
8647559|NCT00620659|9688678|FG000|COMPLETED|Treatment Period 1||18
8647560|NCT00620659|9688679|FG001|COMPLETED|Treatment Period 1||21
8647561|NCT00620659|9688680|FG002|COMPLETED|Treatment Period 1||20
8647562|NCT00620659|9688681|FG003|COMPLETED|Treatment Period 1|1 patient discontinued from MK0249, but continued in following periods, & completed the study|18
8647563|NCT00620659|9688682|FG004|COMPLETED|Treatment Period 1||20
8647564|NCT00620659|9688683|FG005|COMPLETED|Treatment Period 1||20
8647565|NCT00620659|9688678|FG000|NOT COMPLETED|Treatment Period 1||3
8647566|NCT00620659|9688679|FG001|NOT COMPLETED|Treatment Period 1||0
8647567|NCT00620659|9688680|FG002|NOT COMPLETED|Treatment Period 1||1
8647568|NCT00620659|9688681|FG003|NOT COMPLETED|Treatment Period 1||3
8647569|NCT00620659|9688682|FG004|NOT COMPLETED|Treatment Period 1||1
8647570|NCT00620659|9688683|FG005|NOT COMPLETED|Treatment Period 1||0
8647571|NCT00620659|9688678|FG000|STARTED|Placebo Washout Period 1||18
8647572|NCT00620659|9688679|FG001|STARTED|Placebo Washout Period 1||21
8647573|NCT00620659|9688680|FG002|STARTED|Placebo Washout Period 1||20
8647574|NCT00620659|9688681|FG003|STARTED|Placebo Washout Period 1||19
8647575|NCT00620659|9688682|FG004|STARTED|Placebo Washout Period 1||20
8647576|NCT00620659|9688683|FG005|STARTED|Placebo Washout Period 1||20
8647577|NCT00620659|9688678|FG000|COMPLETED|Placebo Washout Period 1||18
8647578|NCT00620659|9688679|FG001|COMPLETED|Placebo Washout Period 1||21
8647579|NCT00620659|9688680|FG002|COMPLETED|Placebo Washout Period 1||20
8647580|NCT00620659|9688681|FG003|COMPLETED|Placebo Washout Period 1||18
8647581|NCT00620659|9688682|FG004|COMPLETED|Placebo Washout Period 1||20
8647582|NCT00620659|9688683|FG005|COMPLETED|Placebo Washout Period 1||20
8647583|NCT00620659|9688678|FG000|NOT COMPLETED|Placebo Washout Period 1||0
8647584|NCT00620659|9688679|FG001|NOT COMPLETED|Placebo Washout Period 1||0
8647585|NCT00620659|9688680|FG002|NOT COMPLETED|Placebo Washout Period 1||0
8647586|NCT00620659|9688681|FG003|NOT COMPLETED|Placebo Washout Period 1||1
8647587|NCT00620659|9688682|FG004|NOT COMPLETED|Placebo Washout Period 1||0
8647588|NCT00620659|9688683|FG005|NOT COMPLETED|Placebo Washout Period 1||0
8647589|NCT00620659|9688678|FG000|STARTED|Treatment Period 2||18
8647590|NCT00620659|9688679|FG001|STARTED|Treatment Period 2||21
8647591|NCT00620659|9688680|FG002|STARTED|Treatment Period 2||20
8647592|NCT00620659|9688681|FG003|STARTED|Treatment Period 2||18
8647593|NCT00620659|9688682|FG004|STARTED|Treatment Period 2||20
8647594|NCT00620659|9688683|FG005|STARTED|Treatment Period 2||20
8647595|NCT00620659|9688678|FG000|COMPLETED|Treatment Period 2||18
8647596|NCT00620659|9688679|FG001|COMPLETED|Treatment Period 2||18
8647597|NCT00620659|9688680|FG002|COMPLETED|Treatment Period 2||19
8647598|NCT00620659|9688681|FG003|COMPLETED|Treatment Period 2||18
8647599|NCT00620659|9688682|FG004|COMPLETED|Treatment Period 2||15
8647600|NCT00620659|9688683|FG005|COMPLETED|Treatment Period 2||20
8647601|NCT00620659|9688678|FG000|NOT COMPLETED|Treatment Period 2||0
8647602|NCT00620659|9688679|FG001|NOT COMPLETED|Treatment Period 2||3
8647603|NCT00620659|9688680|FG002|NOT COMPLETED|Treatment Period 2||1
8647604|NCT00620659|9688681|FG003|NOT COMPLETED|Treatment Period 2||0
8647605|NCT00620659|9688682|FG004|NOT COMPLETED|Treatment Period 2||5
8647606|NCT00620659|9688683|FG005|NOT COMPLETED|Treatment Period 2||0
8647607|NCT00620659|9688678|FG000|STARTED|Placebo Washout Period 2||18
8647608|NCT00620659|9688679|FG001|STARTED|Placebo Washout Period 2||18
8647609|NCT00620659|9688680|FG002|STARTED|Placebo Washout Period 2||19
8647610|NCT00620659|9688681|FG003|STARTED|Placebo Washout Period 2||18
8647611|NCT00620659|9688682|FG004|STARTED|Placebo Washout Period 2||15
8647612|NCT00620659|9688683|FG005|STARTED|Placebo Washout Period 2||20
8647613|NCT00620659|9688678|FG000|COMPLETED|Placebo Washout Period 2||16
8647614|NCT00620659|9688679|FG001|COMPLETED|Placebo Washout Period 2||18
8647615|NCT00620659|9688680|FG002|COMPLETED|Placebo Washout Period 2||19
8647616|NCT00620659|9688681|FG003|COMPLETED|Placebo Washout Period 2||18
8647617|NCT00620659|9688682|FG004|COMPLETED|Placebo Washout Period 2||15
8647618|NCT00620659|9688683|FG005|COMPLETED|Placebo Washout Period 2||20
8647619|NCT00620659|9688678|FG000|NOT COMPLETED|Placebo Washout Period 2||2
8647620|NCT00620659|9688679|FG001|NOT COMPLETED|Placebo Washout Period 2||0
8647621|NCT00620659|9688680|FG002|NOT COMPLETED|Placebo Washout Period 2||0
8727803|NCT01044745|9775044|FG000|NOT COMPLETED|Overall Study||2
8727804|NCT01044758|9775056|FG000|STARTED|Overall Study||12
8727805|NCT01044758|9775057|FG001|STARTED|Overall Study||12
8647622|NCT00620659|9688681|FG003|NOT COMPLETED|Placebo Washout Period 2||0
8647623|NCT00620659|9688682|FG004|NOT COMPLETED|Placebo Washout Period 2||0
8647624|NCT00620659|9688683|FG005|NOT COMPLETED|Placebo Washout Period 2||0
8647625|NCT00620659|9688678|FG000|STARTED|Treatment Period 3||16
8647626|NCT00620659|9688679|FG001|STARTED|Treatment Period 3||18
8647627|NCT00620659|9688680|FG002|STARTED|Treatment Period 3||19
8647628|NCT00620659|9688681|FG003|STARTED|Treatment Period 3||18
8647629|NCT00620659|9688682|FG004|STARTED|Treatment Period 3||15
8647630|NCT00620659|9688683|FG005|STARTED|Treatment Period 3||20
8647631|NCT00620659|9688678|FG000|COMPLETED|Treatment Period 3||16
8647632|NCT00620659|9688679|FG001|COMPLETED|Treatment Period 3||16
8647633|NCT00620659|9688680|FG002|COMPLETED|Treatment Period 3||19
8647634|NCT00620659|9688681|FG003|COMPLETED|Treatment Period 3||17
8647635|NCT00620659|9688682|FG004|COMPLETED|Treatment Period 3||15
8647636|NCT00620659|9688683|FG005|COMPLETED|Treatment Period 3||20
8647637|NCT00620659|9688678|FG000|NOT COMPLETED|Treatment Period 3||0
8647638|NCT00620659|9688679|FG001|NOT COMPLETED|Treatment Period 3||2
8647639|NCT00620659|9688680|FG002|NOT COMPLETED|Treatment Period 3||0
8647640|NCT00620659|9688681|FG003|NOT COMPLETED|Treatment Period 3||1
8647641|NCT00620659|9688682|FG004|NOT COMPLETED|Treatment Period 3||0
8647642|NCT00620659|9688683|FG005|NOT COMPLETED|Treatment Period 3||0
8647643|NCT00620698|9688696|FG000|STARTED|Overall Study||89
8647644|NCT00620698|9688696|FG000|COMPLETED|Overall Study||60
8647645|NCT00620698|9688696|FG000|NOT COMPLETED|Overall Study||29
8647646|NCT00620711|9688700|FG000|STARTED|Overall Study||4
8647647|NCT00620711|9688700|FG000|COMPLETED|Overall Study||4
8647648|NCT00620711|9688700|FG000|NOT COMPLETED|Overall Study||0
8647649|NCT00620750|9688704|FG000|STARTED|Overall Study||65
8647650|NCT00620750|9688704|FG000|COMPLETED|Overall Study||40
8647651|NCT00620750|9688704|FG000|NOT COMPLETED|Overall Study||25
8647652|NCT00620763|9688708|FG000|STARTED|Period: First Intervention||10
8647653|NCT00620763|9688709|FG001|STARTED|Period: First Intervention||12
8647654|NCT00620763|9688708|FG000|COMPLETED|Period: First Intervention||10
8647655|NCT00620763|9688709|FG001|COMPLETED|Period: First Intervention||7
8647656|NCT00620763|9688708|FG000|NOT COMPLETED|Period: First Intervention||0
8647657|NCT00620763|9688709|FG001|NOT COMPLETED|Period: First Intervention||5
8647658|NCT00620763|9688708|FG000|STARTED|Period: Washout Period of 1 Week||10
8647659|NCT00620763|9688709|FG001|STARTED|Period: Washout Period of 1 Week||7
8647660|NCT00620763|9688708|FG000|COMPLETED|Period: Washout Period of 1 Week||10
8647661|NCT00620763|9688709|FG001|COMPLETED|Period: Washout Period of 1 Week||7
8647662|NCT00620763|9688708|FG000|NOT COMPLETED|Period: Washout Period of 1 Week||0
8647663|NCT00620763|9688709|FG001|NOT COMPLETED|Period: Washout Period of 1 Week||0
8647664|NCT00620763|9688708|FG000|STARTED|Period: Second Intervention||10
8647665|NCT00620763|9688709|FG001|STARTED|Period: Second Intervention||7
8647666|NCT00620763|9688708|FG000|COMPLETED|Period: Second Intervention||9
8647667|NCT00620763|9688709|FG001|COMPLETED|Period: Second Intervention||7
8647668|NCT00620763|9688708|FG000|NOT COMPLETED|Period: Second Intervention||1
8647669|NCT00620763|9688709|FG001|NOT COMPLETED|Period: Second Intervention||0
8647670|NCT00620776|9688717|FG000|STARTED|Overall Study|29 patients (of the 77 that were randomly assigned to add on CBT) consented to this option.|29
8647671|NCT00620776|9688718|FG001|STARTED|Overall Study|All 40 patients that were randomly assigned to not be offered CBT consented to this option.|40
8647672|NCT00620776|9688717|FG000|Received at Least One Session/Dose|Overall Study|26 out of 29 that consented to the combined treatment option received at least one session of CBT.|26
8647673|NCT00620776|9688718|FG001|Received at Least One Session/Dose|Overall Study|35 out of 40 that consented to receive medication alone received at least one dose of medication.|35
8647674|NCT00620776|9688717|FG000|COMPLETED|Overall Study|17 out of 26 attended the week 24 (last) assessment.|17
8647675|NCT00620776|9688718|FG001|COMPLETED|Overall Study|24 out of 35 attended the week 24 (last) assessment.|24
8647676|NCT00620776|9688717|FG000|NOT COMPLETED|Overall Study||12
8647677|NCT00620776|9688718|FG001|NOT COMPLETED|Overall Study||16
8647678|NCT00620815|9688727|FG000|STARTED|Overall Study||199
8647679|NCT00620815|9688728|FG001|STARTED|Overall Study||203
8647680|NCT00620815|9688729|FG002|STARTED|Overall Study||199
8647681|NCT00620815|9688727|FG000|COMPLETED|Overall Study||195
8647682|NCT00620815|9688728|FG001|COMPLETED|Overall Study||192
8647683|NCT00620815|9688729|FG002|COMPLETED|Overall Study||192
8647684|NCT00620815|9688727|FG000|NOT COMPLETED|Overall Study||4
8647685|NCT00620815|9688728|FG001|NOT COMPLETED|Overall Study||11
8647686|NCT00620815|9688729|FG002|NOT COMPLETED|Overall Study||7
8647687|NCT00620828|9688755|FG000|STARTED|Overall Study||32
8647688|NCT00620828|9688756|FG001|STARTED|Overall Study||35
8647689|NCT00620828|9688755|FG000|Number of Subjects Enrolled = 67|Overall Study||32
8647690|NCT00620828|9688756|FG001|Number of Subjects Enrolled = 67|Overall Study||35
8647691|NCT00620828|9688755|FG000|COMPLETED|Overall Study||32
8647692|NCT00620828|9688756|FG001|COMPLETED|Overall Study||35
8647693|NCT00620828|9688755|FG000|NOT COMPLETED|Overall Study||0
8647694|NCT00620828|9688756|FG001|NOT COMPLETED|Overall Study||0
8647695|NCT00620854|9688768|FG000|STARTED|Period 1||4
8647696|NCT00620854|9688769|FG001|STARTED|Period 1||4
8647697|NCT00620854|9688770|FG002|STARTED|Period 1||4
8647698|NCT00620854|9688771|FG003|STARTED|Period 1||4
8647699|NCT00620854|9688772|FG004|STARTED|Period 1||4
8647700|NCT00620854|9688773|FG005|STARTED|Period 1||4
8647701|NCT00620854|9688768|FG000|COMPLETED|Period 1||4
8647702|NCT00620854|9688769|FG001|COMPLETED|Period 1||4
8647703|NCT00620854|9688770|FG002|COMPLETED|Period 1||4
8647704|NCT00620854|9688771|FG003|COMPLETED|Period 1||4
8647705|NCT00620854|9688772|FG004|COMPLETED|Period 1||4
8647706|NCT00620854|9688773|FG005|COMPLETED|Period 1||4
8647707|NCT00620854|9688768|FG000|NOT COMPLETED|Period 1||0
8647708|NCT00620854|9688769|FG001|NOT COMPLETED|Period 1||0
8647709|NCT00620854|9688770|FG002|NOT COMPLETED|Period 1||0
8647710|NCT00620854|9688771|FG003|NOT COMPLETED|Period 1||0
8647711|NCT00620854|9688772|FG004|NOT COMPLETED|Period 1||0
8647712|NCT00620854|9688773|FG005|NOT COMPLETED|Period 1||0
8647713|NCT00620854|9688768|FG000|STARTED|Washout 1||4
8647714|NCT00620854|9688769|FG001|STARTED|Washout 1||4
8647715|NCT00620854|9688770|FG002|STARTED|Washout 1||4
8647716|NCT00620854|9688771|FG003|STARTED|Washout 1||4
8647717|NCT00620854|9688772|FG004|STARTED|Washout 1||4
8647718|NCT00620854|9688773|FG005|STARTED|Washout 1||4
8647719|NCT00620854|9688768|FG000|COMPLETED|Washout 1||4
8647720|NCT00620854|9688769|FG001|COMPLETED|Washout 1||4
8647721|NCT00620854|9688770|FG002|COMPLETED|Washout 1||3
8647722|NCT00620854|9688771|FG003|COMPLETED|Washout 1||3
8647723|NCT00620854|9688772|FG004|COMPLETED|Washout 1||4
8647724|NCT00620854|9688773|FG005|COMPLETED|Washout 1||4
8647725|NCT00620854|9688768|FG000|NOT COMPLETED|Washout 1||0
8647726|NCT00620854|9688769|FG001|NOT COMPLETED|Washout 1||0
8647727|NCT00620854|9688770|FG002|NOT COMPLETED|Washout 1||1
8647728|NCT00620854|9688771|FG003|NOT COMPLETED|Washout 1||1
8647729|NCT00620854|9688772|FG004|NOT COMPLETED|Washout 1||0
8647730|NCT00620854|9688773|FG005|NOT COMPLETED|Washout 1||0
8647731|NCT00620854|9688768|FG000|STARTED|Period 2||4
8647732|NCT00620854|9688769|FG001|STARTED|Period 2||4
8647733|NCT00620854|9688770|FG002|STARTED|Period 2||3
8647734|NCT00620854|9688771|FG003|STARTED|Period 2||3
8647735|NCT00620854|9688772|FG004|STARTED|Period 2||4
8647736|NCT00620854|9688773|FG005|STARTED|Period 2||4
8647737|NCT00620854|9688768|FG000|COMPLETED|Period 2||4
8647738|NCT00620854|9688769|FG001|COMPLETED|Period 2||4
8647739|NCT00620854|9688770|FG002|COMPLETED|Period 2||3
8647740|NCT00620854|9688771|FG003|COMPLETED|Period 2||3
8647741|NCT00620854|9688772|FG004|COMPLETED|Period 2||4
8647742|NCT00620854|9688773|FG005|COMPLETED|Period 2||4
8647743|NCT00620854|9688768|FG000|NOT COMPLETED|Period 2||0
8647744|NCT00620854|9688769|FG001|NOT COMPLETED|Period 2||0
8647745|NCT00620854|9688770|FG002|NOT COMPLETED|Period 2||0
8647746|NCT00620854|9688771|FG003|NOT COMPLETED|Period 2||0
8647747|NCT00620854|9688772|FG004|NOT COMPLETED|Period 2||0
8647748|NCT00620854|9688773|FG005|NOT COMPLETED|Period 2||0
8647749|NCT00620854|9688768|FG000|STARTED|Washout 2||4
8647750|NCT00620854|9688769|FG001|STARTED|Washout 2||4
8647751|NCT00620854|9688770|FG002|STARTED|Washout 2||3
8647752|NCT00620854|9688771|FG003|STARTED|Washout 2||3
8647753|NCT00620854|9688772|FG004|STARTED|Washout 2||4
8647754|NCT00620854|9688773|FG005|STARTED|Washout 2||4
8647755|NCT00620854|9688768|FG000|COMPLETED|Washout 2||4
8647756|NCT00620854|9688769|FG001|COMPLETED|Washout 2||4
8647757|NCT00620854|9688770|FG002|COMPLETED|Washout 2||3
8647758|NCT00620854|9688771|FG003|COMPLETED|Washout 2||3
8647759|NCT00620854|9688772|FG004|COMPLETED|Washout 2||4
8647760|NCT00620854|9688773|FG005|COMPLETED|Washout 2||4
8647761|NCT00620854|9688768|FG000|NOT COMPLETED|Washout 2||0
8647762|NCT00620854|9688769|FG001|NOT COMPLETED|Washout 2||0
8647763|NCT00620854|9688770|FG002|NOT COMPLETED|Washout 2||0
8647764|NCT00620854|9688771|FG003|NOT COMPLETED|Washout 2||0
8647765|NCT00620854|9688772|FG004|NOT COMPLETED|Washout 2||0
8647766|NCT00620854|9688773|FG005|NOT COMPLETED|Washout 2||0
8647767|NCT00620854|9688768|FG000|STARTED|Period 3||4
8647768|NCT00620854|9688769|FG001|STARTED|Period 3||4
8647769|NCT00620854|9688770|FG002|STARTED|Period 3||3
8647770|NCT00620854|9688771|FG003|STARTED|Period 3||3
8647771|NCT00620854|9688772|FG004|STARTED|Period 3||4
8727806|NCT01044758|9775058|FG002|STARTED|Overall Study||11
8727807|NCT01044758|9775059|FG003|STARTED|Overall Study||12
8727808|NCT01044758|9775060|FG004|STARTED|Overall Study||11
8727809|NCT01044758|9775061|FG005|STARTED|Overall Study||11
8727810|NCT01044758|9775062|FG006|STARTED|Overall Study||27
8727811|NCT01044758|9775056|FG000|COMPLETED|Overall Study||8
8647772|NCT00620854|9688773|FG005|STARTED|Period 3||4
8647773|NCT00620854|9688768|FG000|COMPLETED|Period 3||4
8647774|NCT00620854|9688769|FG001|COMPLETED|Period 3||4
8647775|NCT00620854|9688770|FG002|COMPLETED|Period 3||3
8647776|NCT00620854|9688771|FG003|COMPLETED|Period 3||3
8647777|NCT00620854|9688772|FG004|COMPLETED|Period 3||4
8647778|NCT00620854|9688773|FG005|COMPLETED|Period 3||4
8647779|NCT00620854|9688768|FG000|NOT COMPLETED|Period 3||0
8647780|NCT00620854|9688769|FG001|NOT COMPLETED|Period 3||0
8647781|NCT00620854|9688770|FG002|NOT COMPLETED|Period 3||0
8647782|NCT00620854|9688771|FG003|NOT COMPLETED|Period 3||0
8647783|NCT00620854|9688772|FG004|NOT COMPLETED|Period 3||0
8647784|NCT00620854|9688773|FG005|NOT COMPLETED|Period 3||0
8647785|NCT00620945|9688784|FG000|STARTED|Overall Study|Total number in the study|87
8647786|NCT00620945|9688784|FG000|COMPLETED|Overall Study||87
8647787|NCT00620945|9688784|FG000|NOT COMPLETED|Overall Study||0
8647788|NCT00621023|9688788|FG000|STARTED|Overall Study||6
8647789|NCT00621023|9688788|FG000|COMPLETED|Overall Study|Completed is defined as 5 years of follow up.|0
8647790|NCT00621023|9688788|FG000|NOT COMPLETED|Overall Study||6
8647791|NCT00621049|9688794|FG000|STARTED|Adjuvant Treatment||55
8647792|NCT00621049|9688795|FG001|STARTED|Adjuvant Treatment||57
8647793|NCT00621049|9688794|FG000|COMPLETED|Adjuvant Treatment||52
8647794|NCT00621049|9688795|FG001|COMPLETED|Adjuvant Treatment||47
8647795|NCT00621049|9688794|FG000|NOT COMPLETED|Adjuvant Treatment||3
8727812|NCT01044758|9775057|FG001|COMPLETED|Overall Study||12
8647796|NCT00621049|9688795|FG001|NOT COMPLETED|Adjuvant Treatment||10
8647797|NCT00621049|9688794|FG000|STARTED|Maintenance Treatment|3 patients came off study between the end of adjuvant therapy and the start of maintenance|49
8647798|NCT00621049|9688795|FG001|STARTED|Maintenance Treatment|Per protocol, only the Docetaxel/Carboplatin/Bevacizumab/Erlotinib arm enters maintenance therapy|0
8647799|NCT00621049|9688794|FG000|COMPLETED|Maintenance Treatment||34
8647800|NCT00621049|9688795|FG001|COMPLETED|Maintenance Treatment||0
8647801|NCT00621049|9688794|FG000|NOT COMPLETED|Maintenance Treatment||15
8647802|NCT00621049|9688795|FG001|NOT COMPLETED|Maintenance Treatment||0
8647803|NCT00621140|9688803|FG000|STARTED|Overall Study|number who started treatment|167
8647804|NCT00621140|9688804|FG001|STARTED|Overall Study|number who started treatment|336
8647805|NCT00621140|9688803|FG000|COMPLETED|Overall Study|number who completed treatment|152
8647806|NCT00621140|9688804|FG001|COMPLETED|Overall Study|number who completed treatment|318
8647807|NCT00621140|9688803|FG000|NOT COMPLETED|Overall Study||15
8647808|NCT00621140|9688804|FG001|NOT COMPLETED|Overall Study||18
8647809|NCT00621153|9688812|FG000|STARTED|Overall Study|randomised|117
8647810|NCT00621153|9688813|FG001|STARTED|Overall Study|randomised|116
8647811|NCT00621153|9688812|FG000|Discontinued|Overall Study||20
8647812|NCT00621153|9688813|FG001|Discontinued|Overall Study||15
8647813|NCT00621153|9688812|FG000|COMPLETED|Overall Study|completed|97
8647814|NCT00621153|9688813|FG001|COMPLETED|Overall Study|completed|101
8647815|NCT00621153|9688812|FG000|NOT COMPLETED|Overall Study||20
8647816|NCT00621153|9688813|FG001|NOT COMPLETED|Overall Study||15
8647817|NCT00621179|9688823|FG000|STARTED|Overall Study||12
8647818|NCT00621179|9688824|FG001|STARTED|Overall Study||8
8647819|NCT00621179|9688825|FG002|STARTED|Overall Study||7
8647820|NCT00621179|9688826|FG003|STARTED|Overall Study||10
8647821|NCT00621179|9688823|FG000|COMPLETED|Overall Study||12
8647822|NCT00621179|9688824|FG001|COMPLETED|Overall Study||8
8647823|NCT00621179|9688825|FG002|COMPLETED|Overall Study||6
8647824|NCT00621179|9688826|FG003|COMPLETED|Overall Study||9
8647825|NCT00621179|9688823|FG000|NOT COMPLETED|Overall Study||0
8647826|NCT00621179|9688824|FG001|NOT COMPLETED|Overall Study||0
8647827|NCT00621179|9688825|FG002|NOT COMPLETED|Overall Study||1
8647828|NCT00621179|9688826|FG003|NOT COMPLETED|Overall Study||1
8647829|NCT00621192|9688840|FG000|STARTED|Overall Study||39
8647830|NCT00621192|9688841|FG001|STARTED|Overall Study||103
8647831|NCT00621192|9688842|FG002|STARTED|Overall Study||31
8647832|NCT00621192|9688843|FG003|STARTED|Overall Study||27
8647833|NCT00621192|9688840|FG000|Safety Population|Overall Study||39
8647834|NCT00621192|9688841|FG001|Safety Population|Overall Study||103
8647835|NCT00621192|9688842|FG002|Safety Population|Overall Study||31
8647836|NCT00621192|9688843|FG003|Safety Population|Overall Study||27
8647837|NCT00621192|9688840|FG000|Efficacy Population|Overall Study||39
8647838|NCT00621192|9688841|FG001|Efficacy Population|Overall Study||101
8647839|NCT00621192|9688842|FG002|Efficacy Population|Overall Study||28
8647840|NCT00621192|9688843|FG003|Efficacy Population|Overall Study||27
8647841|NCT00621192|9688840|FG000|COMPLETED|Overall Study||35
8647842|NCT00621192|9688841|FG001|COMPLETED|Overall Study||94
8647843|NCT00621192|9688842|FG002|COMPLETED|Overall Study||26
8647844|NCT00621192|9688843|FG003|COMPLETED|Overall Study||24
8647845|NCT00621192|9688840|FG000|NOT COMPLETED|Overall Study||4
8647846|NCT00621192|9688841|FG001|NOT COMPLETED|Overall Study||9
8647847|NCT00621192|9688842|FG002|NOT COMPLETED|Overall Study||5
8647848|NCT00621192|9688843|FG003|NOT COMPLETED|Overall Study||3
8647849|NCT00621244|9688857|FG000|STARTED|Overall Study||86
8647850|NCT00621244|9688858|FG001|STARTED|Overall Study||34
8647851|NCT00621244|9688859|FG002|STARTED|Overall Study||33
8647852|NCT00621244|9688860|FG003|STARTED|Overall Study||23
8647853|NCT00621244|9688857|FG000|COMPLETED|Overall Study||0
8647854|NCT00621244|9688858|FG001|COMPLETED|Overall Study||0
8647855|NCT00621244|9688859|FG002|COMPLETED|Overall Study||0
8647856|NCT00621244|9688860|FG003|COMPLETED|Overall Study||0
8647857|NCT00621244|9688857|FG000|NOT COMPLETED|Overall Study||86
8647858|NCT00621244|9688858|FG001|NOT COMPLETED|Overall Study||34
8647859|NCT00621244|9688859|FG002|NOT COMPLETED|Overall Study||33
8647860|NCT00621244|9688860|FG003|NOT COMPLETED|Overall Study||23
8647861|NCT00621257|9688939|FG000|STARTED|Overall Study||24
8647862|NCT00621257|9688940|FG001|STARTED|Overall Study||24
8647863|NCT00621257|9688941|FG002|STARTED|Overall Study||23
8647864|NCT00621257|9688942|FG003|STARTED|Overall Study||32
8647865|NCT00621257|9688943|FG004|STARTED|Overall Study||31
8647866|NCT00621257|9688939|FG000|COMPLETED|Overall Study||20
8647867|NCT00621257|9688940|FG001|COMPLETED|Overall Study||21
8647868|NCT00621257|9688941|FG002|COMPLETED|Overall Study||20
8647869|NCT00621257|9688942|FG003|COMPLETED|Overall Study||26
8647870|NCT00621257|9688943|FG004|COMPLETED|Overall Study||22
8647871|NCT00621257|9688939|FG000|NOT COMPLETED|Overall Study||4
8647872|NCT00621257|9688940|FG001|NOT COMPLETED|Overall Study||3
8647873|NCT00621257|9688941|FG002|NOT COMPLETED|Overall Study||3
8647874|NCT00621257|9688942|FG003|NOT COMPLETED|Overall Study||6
8647875|NCT00621257|9688943|FG004|NOT COMPLETED|Overall Study||9
8647876|NCT00621296|9688955|FG000|STARTED|Overall Study||15
8647877|NCT00621296|9688955|FG000|COMPLETED|Overall Study||1
8647878|NCT00621296|9688955|FG000|NOT COMPLETED|Overall Study||14
8647879|NCT00621309|9688959|FG000|STARTED|Overall Study||6
8647880|NCT00621309|9688960|FG001|STARTED|Overall Study||4
8647881|NCT00621309|9688961|FG002|STARTED|Overall Study||5
8647882|NCT00621309|9688962|FG003|STARTED|Overall Study||6
8647883|NCT00621309|9688963|FG004|STARTED|Overall Study||4
8647884|NCT00621309|9688964|FG005|STARTED|Overall Study||4
8647885|NCT00621309|9688959|FG000|COMPLETED|Overall Study||4
8647886|NCT00621309|9688960|FG001|COMPLETED|Overall Study||4
8647887|NCT00621309|9688961|FG002|COMPLETED|Overall Study||4
8647888|NCT00621309|9688962|FG003|COMPLETED|Overall Study||5
8647889|NCT00621309|9688963|FG004|COMPLETED|Overall Study||3
8647890|NCT00621309|9688964|FG005|COMPLETED|Overall Study||3
8647891|NCT00621309|9688959|FG000|NOT COMPLETED|Overall Study||2
8647892|NCT00621309|9688960|FG001|NOT COMPLETED|Overall Study||0
8647893|NCT00621309|9688961|FG002|NOT COMPLETED|Overall Study||1
8647894|NCT00621309|9688962|FG003|NOT COMPLETED|Overall Study||1
8647895|NCT00621309|9688963|FG004|NOT COMPLETED|Overall Study||1
8647896|NCT00621309|9688964|FG005|NOT COMPLETED|Overall Study||1
8647897|NCT00621322|9688976|FG000|STARTED|Overall Study||10
8647898|NCT00621322|9688977|FG001|STARTED|Overall Study||10
8647899|NCT00621322|9688978|FG002|STARTED|Overall Study||40
8647900|NCT00621322|9688979|FG003|STARTED|Overall Study||40
8647901|NCT00621322|9688980|FG004|STARTED|Overall Study||40
8647902|NCT00621322|9688981|FG005|STARTED|Overall Study||40
8647903|NCT00621322|9688976|FG000|COMPLETED|Overall Study||9
8647904|NCT00621322|9688977|FG001|COMPLETED|Overall Study||10
8647905|NCT00621322|9688978|FG002|COMPLETED|Overall Study||38
8647906|NCT00621322|9688979|FG003|COMPLETED|Overall Study||37
8647907|NCT00621322|9688980|FG004|COMPLETED|Overall Study||39
8647908|NCT00621322|9688981|FG005|COMPLETED|Overall Study||36
8647909|NCT00621322|9688976|FG000|NOT COMPLETED|Overall Study||1
8647910|NCT00621322|9688977|FG001|NOT COMPLETED|Overall Study||0
8647911|NCT00621322|9688978|FG002|NOT COMPLETED|Overall Study||2
8647912|NCT00621322|9688979|FG003|NOT COMPLETED|Overall Study||3
8647913|NCT00621322|9688980|FG004|NOT COMPLETED|Overall Study||1
8647914|NCT00621322|9688981|FG005|NOT COMPLETED|Overall Study||4
8647915|NCT00621348|9688998|FG000|STARTED|Overall Study||58
8647916|NCT00621348|9688999|FG001|STARTED|Overall Study||53
8647917|NCT00621348|9689000|FG002|STARTED|Overall Study||56
8647918|NCT00621348|9688998|FG000|COMPLETED|Overall Study||58
8647919|NCT00621348|9688999|FG001|COMPLETED|Overall Study||53
8647920|NCT00621348|9689000|FG002|COMPLETED|Overall Study||56
8647921|NCT00621348|9688998|FG000|NOT COMPLETED|Overall Study||0
8647922|NCT00621348|9688999|FG001|NOT COMPLETED|Overall Study||0
8647923|NCT00621348|9689000|FG002|NOT COMPLETED|Overall Study||0
8647924|NCT00621504|9689010|FG000|STARTED|Overall Study||299
8647925|NCT00621504|9689011|FG001|STARTED|Overall Study||307
8647926|NCT00621504|9689010|FG000|COMPLETED|Overall Study||273
8647927|NCT00621504|9689011|FG001|COMPLETED|Overall Study||282
8727813|NCT01044758|9775058|FG002|COMPLETED|Overall Study||7
8727814|NCT01044758|9775059|FG003|COMPLETED|Overall Study||10
8727815|NCT01044758|9775060|FG004|COMPLETED|Overall Study||9
8727816|NCT01044758|9775061|FG005|COMPLETED|Overall Study||8
8727817|NCT01044758|9775062|FG006|COMPLETED|Overall Study||17
8727818|NCT01044758|9775056|FG000|NOT COMPLETED|Overall Study||4
8727819|NCT01044758|9775057|FG001|NOT COMPLETED|Overall Study||0
8727820|NCT01044758|9775058|FG002|NOT COMPLETED|Overall Study||4
8727821|NCT01044758|9775059|FG003|NOT COMPLETED|Overall Study||2
8727822|NCT01044758|9775060|FG004|NOT COMPLETED|Overall Study||2
8727823|NCT01044758|9775061|FG005|NOT COMPLETED|Overall Study||3
8727824|NCT01044758|9775062|FG006|NOT COMPLETED|Overall Study||10
8727825|NCT01044771|9775081|FG000|STARTED|Overall Study||20
8727826|NCT01044771|9775081|FG000|COMPLETED|Overall Study||20
8727827|NCT01044771|9775081|FG000|NOT COMPLETED|Overall Study||0
8727828|NCT01044862|9775089|FG000|STARTED|Overall Study||299
8727829|NCT01044862|9775090|FG001|STARTED|Overall Study||300
8727830|NCT01044862|9775091|FG002|STARTED|Overall Study||301
8727831|NCT01044862|9775089|FG000|COMPLETED|Overall Study||246
8727832|NCT01044862|9775090|FG001|COMPLETED|Overall Study||251
8727833|NCT01044862|9775091|FG002|COMPLETED|Overall Study||249
8727834|NCT01044862|9775089|FG000|NOT COMPLETED|Overall Study||53
8727835|NCT01044862|9775090|FG001|NOT COMPLETED|Overall Study||49
8727836|NCT01044862|9775091|FG002|NOT COMPLETED|Overall Study||52
8727837|NCT01044966|9775099|FG000|STARTED|Induction Phase||12
8727838|NCT01044966|9775099|FG000|COMPLETED|Induction Phase||12
8727839|NCT01044966|9775099|FG000|NOT COMPLETED|Induction Phase||0
8727840|NCT01044966|9775099|FG000|STARTED|Consolidation Phase||12
8727841|NCT01044966|9775099|FG000|COMPLETED|Consolidation Phase||2
8727842|NCT01044966|9775099|FG000|NOT COMPLETED|Consolidation Phase||10
8727843|NCT01045031|9775106|FG000|STARTED|Overall Study||58
8727844|NCT01045031|9775107|FG001|STARTED|Overall Study||56
8727845|NCT01045031|9775106|FG000|COMPLETED|Overall Study||49
8727846|NCT01045031|9775107|FG001|COMPLETED|Overall Study||50
8727847|NCT01045031|9775106|FG000|NOT COMPLETED|Overall Study||9
8727848|NCT01045031|9775107|FG001|NOT COMPLETED|Overall Study||6
8727849|NCT01045057|9775117|FG000|STARTED|Overall Study||27
8727850|NCT01045057|9775117|FG000|COMPLETED|Overall Study||27
8727851|NCT01045057|9775117|FG000|NOT COMPLETED|Overall Study||0
8727852|NCT01045096|9775126|FG000|STARTED|Overall Study||12
8727853|NCT01045096|9775127|FG001|STARTED|Overall Study||12
8647928|NCT00621504|9689010|FG000|NOT COMPLETED|Overall Study||26
8647929|NCT00621504|9689011|FG001|NOT COMPLETED|Overall Study||25
8647930|NCT00621517|9689019|FG000|STARTED|Overall Study||29
8647931|NCT00621517|9689020|FG001|STARTED|Overall Study||31
8647932|NCT00621517|9689019|FG000|COMPLETED|Overall Study||22
8647933|NCT00621517|9689020|FG001|COMPLETED|Overall Study||24
8647934|NCT00621517|9689019|FG000|NOT COMPLETED|Overall Study||7
8647935|NCT00621517|9689020|FG001|NOT COMPLETED|Overall Study||7
8647936|NCT00621530|9689028|FG000|STARTED|Overall Study||30
8647937|NCT00621530|9689029|FG001|STARTED|Overall Study||32
8647938|NCT00621530|9689028|FG000|COMPLETED|Overall Study||28
8647939|NCT00621530|9689029|FG001|COMPLETED|Overall Study||29
8647940|NCT00621530|9689028|FG000|NOT COMPLETED|Overall Study||2
8647941|NCT00621530|9689029|FG001|NOT COMPLETED|Overall Study||3
8647942|NCT00621543|9689038|FG000|STARTED|Overall Study||120
8647943|NCT00621543|9689038|FG000|COMPLETED|Overall Study||97
8647944|NCT00621543|9689038|FG000|NOT COMPLETED|Overall Study||23
8647945|NCT00621582|9689042|FG000|STARTED|Overall Study||4918
8647946|NCT00621582|9689042|FG000|COMPLETED|Overall Study||4812
8647947|NCT00621582|9689042|FG000|NOT COMPLETED|Overall Study||106
8647948|NCT00621621|9689049|FG000|STARTED|Overall Study|Date of Post- Approval Study protocol approval|105
8647949|NCT00621621|9689050|FG001|STARTED|Overall Study||705
8647950|NCT00621621|9689049|FG000|COMPLETED|Overall Study|Treated with the experimental catheter|75
8647951|NCT00621621|9689050|FG001|COMPLETED|Overall Study||705
8647952|NCT00621621|9689049|FG000|NOT COMPLETED|Overall Study||30
8647953|NCT00621621|9689050|FG001|NOT COMPLETED|Overall Study||0
8647954|NCT00621686|9689060|FG000|STARTED|Overall Study||19
8647955|NCT00621686|9689061|FG001|STARTED|Overall Study||35
8647956|NCT00621686|9689060|FG000|COMPLETED|Overall Study||19
8647957|NCT00621686|9689061|FG001|COMPLETED|Overall Study||35
8647958|NCT00621686|9689060|FG000|NOT COMPLETED|Overall Study||0
8647959|NCT00621686|9689061|FG001|NOT COMPLETED|Overall Study||0
8647960|NCT00621764|9689072|FG000|STARTED|Overall Study||50
8647961|NCT00621764|9689073|FG001|STARTED|Overall Study||50
8647962|NCT00621764|9689074|FG002|STARTED|Overall Study||101
8647963|NCT00621764|9689075|FG003|STARTED|Overall Study||99
8647964|NCT00621764|9689072|FG000|COMPLETED|Overall Study||50
8647965|NCT00621764|9689073|FG001|COMPLETED|Overall Study||50
8647966|NCT00621764|9689074|FG002|COMPLETED|Overall Study||101
8647967|NCT00621764|9689075|FG003|COMPLETED|Overall Study||98
8647968|NCT00621764|9689072|FG000|NOT COMPLETED|Overall Study||0
8647969|NCT00621764|9689073|FG001|NOT COMPLETED|Overall Study||0
8647970|NCT00621764|9689074|FG002|NOT COMPLETED|Overall Study||0
8647971|NCT00621764|9689075|FG003|NOT COMPLETED|Overall Study||1
8647972|NCT00621777|9689088|FG000|STARTED|Open Phase||203
8647973|NCT00621777|9689089|FG001|STARTED|Open Phase|During this open label phase, all study participants received varenicline|0
8647974|NCT00621777|9689088|FG000|COMPLETED|Open Phase||87
8647975|NCT00621777|9689089|FG001|COMPLETED|Open Phase||0
8647976|NCT00621777|9689088|FG000|NOT COMPLETED|Open Phase||116
8647977|NCT00621777|9689089|FG001|NOT COMPLETED|Open Phase||0
8647978|NCT00621777|9689088|FG000|STARTED|Randomized Phase|87 open phase participants were continuously abstinent for at least 14 days and were randomized|40
8647979|NCT00621777|9689089|FG001|STARTED|Randomized Phase||47
8647980|NCT00621777|9689088|FG000|COMPLETED|Randomized Phase||33
8647981|NCT00621777|9689089|FG001|COMPLETED|Randomized Phase||28
8647982|NCT00621777|9689088|FG000|NOT COMPLETED|Randomized Phase||7
8647983|NCT00621777|9689089|FG001|NOT COMPLETED|Randomized Phase||19
8647984|NCT00621842|9689097|FG000|STARTED|Overall Study||57
8647985|NCT00621842|9689097|FG000|COMPLETED|Overall Study||38
8647986|NCT00621842|9689097|FG000|NOT COMPLETED|Overall Study||19
8647987|NCT00621855|9689106|FG000|STARTED|Overall Study|Started means randomised to treatment|372
8647988|NCT00621855|9689107|FG001|STARTED|Overall Study|Started means randomised to treatment|371
8647989|NCT00621855|9689108|FG002|STARTED|Overall Study|Started means randomised to treatment|411
8647990|NCT00621855|9689109|FG003|STARTED|Overall Study|Started means randomised to treatment|351
8647991|NCT00621855|9689110|FG004|STARTED|Overall Study|Started means randomised to treatment|373
8647992|NCT00621855|9689106|FG000|COMPLETED|Overall Study|Completed means completed treatment|296
8647993|NCT00621855|9689107|FG001|COMPLETED|Overall Study|Completed means completed treatment|310
8647994|NCT00621855|9689108|FG002|COMPLETED|Overall Study|Completed means completed treatment|330
8647995|NCT00621855|9689109|FG003|COMPLETED|Overall Study|Completed means completed treatment|284
8647996|NCT00621855|9689110|FG004|COMPLETED|Overall Study|Completed means completed treatment|318
8647997|NCT00621855|9689106|FG000|NOT COMPLETED|Overall Study||76
8647998|NCT00621855|9689107|FG001|NOT COMPLETED|Overall Study||61
8647999|NCT00621855|9689108|FG002|NOT COMPLETED|Overall Study||81
8648000|NCT00621855|9689109|FG003|NOT COMPLETED|Overall Study||67
8648001|NCT00621855|9689110|FG004|NOT COMPLETED|Overall Study||55
8648002|NCT00621933|9689122|FG000|STARTED|Overall Study||399
8648003|NCT00621933|9689122|FG000|COMPLETED|Overall Study||399
8648004|NCT00621933|9689122|FG000|NOT COMPLETED|Overall Study||0
8648005|NCT00621946|9689128|FG000|STARTED|Overall Study||13
8648006|NCT00621946|9689129|FG001|STARTED|Overall Study||13
8648007|NCT00621946|9689128|FG000|COMPLETED|Overall Study||13
8648008|NCT00621946|9689129|FG001|COMPLETED|Overall Study||12
8648009|NCT00621946|9689128|FG000|NOT COMPLETED|Overall Study||0
8648010|NCT00621946|9689129|FG001|NOT COMPLETED|Overall Study||1
8648011|NCT00621959|9689138|FG000|STARTED|Overall Study|In all 791 subjects have been screened and 596 have been randomized|295
8648012|NCT00621959|9689139|FG001|STARTED|Overall Study||301
8648013|NCT00621959|9689138|FG000|COMPLETED|Overall Study||288
8648014|NCT00621959|9689139|FG001|COMPLETED|Overall Study||292
8648015|NCT00621959|9689138|FG000|NOT COMPLETED|Overall Study||7
8648016|NCT00621959|9689139|FG001|NOT COMPLETED|Overall Study||9
8648017|NCT00621985|9689145|FG000|STARTED|Hydrocortisone Admission||5
8648018|NCT00621985|9689145|FG000|COMPLETED|Hydrocortisone Admission||5
8648019|NCT00621985|9689145|FG000|NOT COMPLETED|Hydrocortisone Admission||0
8648020|NCT00621985|9689145|FG000|STARTED|Dexamethasone Admission||5
8648021|NCT00621985|9689145|FG000|COMPLETED|Dexamethasone Admission||4
8648022|NCT00621985|9689145|FG000|NOT COMPLETED|Dexamethasone Admission||1
8648023|NCT00622180|9689151|FG000|STARTED|Overall Study||6
8648024|NCT00622180|9689152|FG001|STARTED|Overall Study||7
8648025|NCT00622180|9689151|FG000|COMPLETED|Overall Study||5
8648026|NCT00622180|9689152|FG001|COMPLETED|Overall Study||5
8648027|NCT00622180|9689151|FG000|NOT COMPLETED|Overall Study||1
8648028|NCT00622180|9689152|FG001|NOT COMPLETED|Overall Study||2
8648029|NCT00622284|9689160|FG000|STARTED|Overall Study|Number who started treatment. One patient in the Linagliptin group was randomized but not treated.|776
8648030|NCT00622284|9689161|FG001|STARTED|Overall Study|Number who started treatment.|775
8648031|NCT00622284|9689160|FG000|COMPLETED|Overall Study|Number who completed treatment.|587
8648032|NCT00622284|9689161|FG001|COMPLETED|Overall Study|Number who completed treatment.|604
8648033|NCT00622284|9689160|FG000|NOT COMPLETED|Overall Study||189
8648034|NCT00622284|9689161|FG001|NOT COMPLETED|Overall Study||171
8648035|NCT00622336|9689167|FG000|STARTED|Treatment Phase||330
8648036|NCT00622336|9689167|FG000|Safety Population|Treatment Phase||330
8648037|NCT00622336|9689167|FG000|COMPLETED|Treatment Phase|Completed = those who completed the treatment phase and were ongoing in the extension study|21
8648038|NCT00622336|9689167|FG000|NOT COMPLETED|Treatment Phase||309
8648039|NCT00622336|9689167|FG000|STARTED|Extension Phase||21
8648040|NCT00622336|9689167|FG000|COMPLETED|Extension Phase||0
8648041|NCT00622336|9689167|FG000|NOT COMPLETED|Extension Phase||21
8648042|NCT00622388|9689173|FG000|STARTED|Overall Study||81
8648043|NCT00622388|9689173|FG000|COMPLETED|Overall Study||9
8648044|NCT00622388|9689173|FG000|NOT COMPLETED|Overall Study||72
8648045|NCT00622401|9689181|FG000|STARTED|Overall Study||6
8648046|NCT00622401|9689182|FG001|STARTED|Overall Study||2
8648047|NCT00622401|9689183|FG002|STARTED|Overall Study|Never Opened|0
8648048|NCT00622401|9689181|FG000|COMPLETED|Overall Study||3
8648049|NCT00622401|9689182|FG001|COMPLETED|Overall Study||0
8648050|NCT00622401|9689183|FG002|COMPLETED|Overall Study||0
8648051|NCT00622401|9689181|FG000|NOT COMPLETED|Overall Study||3
8648052|NCT00622401|9689182|FG001|NOT COMPLETED|Overall Study||2
8648053|NCT00622401|9689183|FG002|NOT COMPLETED|Overall Study||0
8648054|NCT00622427|9689192|FG000|STARTED|Overall Study||16
8648055|NCT00622427|9689193|FG001|STARTED|Overall Study||16
8648056|NCT00622427|9689192|FG000|COMPLETED|Overall Study|each subject received 2 weeks of Ramelteon, then 2 weeks of placebo after a two week wash out period|16
8648057|NCT00622427|9689193|FG001|COMPLETED|Overall Study|each subject received 2 weeks of placebo, then 2 weeks of Ramelteon after a two week wash out period|16
8648058|NCT00622427|9689192|FG000|NOT COMPLETED|Overall Study||0
8648059|NCT00622427|9689193|FG001|NOT COMPLETED|Overall Study||0
8648060|NCT00622440|9689203|FG000|STARTED|Baseline - Week 12 (Treatment)||35
8648061|NCT00622440|9689204|FG001|STARTED|Baseline - Week 12 (Treatment)||35
8648062|NCT00622440|9689203|FG000|COMPLETED|Baseline - Week 12 (Treatment)||31
8648063|NCT00622440|9689204|FG001|COMPLETED|Baseline - Week 12 (Treatment)||34
8648064|NCT00622440|9689203|FG000|NOT COMPLETED|Baseline - Week 12 (Treatment)||4
8648065|NCT00622440|9689204|FG001|NOT COMPLETED|Baseline - Week 12 (Treatment)||1
8648066|NCT00622440|9689203|FG000|STARTED|Week 12 - Week 48 (Treatment)||31
8648067|NCT00622440|9689204|FG001|STARTED|Week 12 - Week 48 (Treatment)||34
8648068|NCT00622440|9689203|FG000|COMPLETED|Week 12 - Week 48 (Treatment)||28
8648069|NCT00622440|9689204|FG001|COMPLETED|Week 12 - Week 48 (Treatment)||28
8648070|NCT00622440|9689203|FG000|NOT COMPLETED|Week 12 - Week 48 (Treatment)||3
8648071|NCT00622440|9689204|FG001|NOT COMPLETED|Week 12 - Week 48 (Treatment)||6
8648072|NCT00622440|9689203|FG000|STARTED|Week 60 (Post-treatment Follow-up Visit)||28
8648073|NCT00622440|9689204|FG001|STARTED|Week 60 (Post-treatment Follow-up Visit)||28
8648074|NCT00622440|9689203|FG000|COMPLETED|Week 60 (Post-treatment Follow-up Visit)||28
8648075|NCT00622440|9689204|FG001|COMPLETED|Week 60 (Post-treatment Follow-up Visit)||27
8648076|NCT00622440|9689203|FG000|NOT COMPLETED|Week 60 (Post-treatment Follow-up Visit)||0
8648077|NCT00622440|9689204|FG001|NOT COMPLETED|Week 60 (Post-treatment Follow-up Visit)||1
8648078|NCT00622466|9689210|FG000|STARTED|Overall Study||20
8648079|NCT00622466|9689210|FG000|COMPLETED|Overall Study||16
8648080|NCT00622466|9689210|FG000|NOT COMPLETED|Overall Study||4
8648081|NCT00622505|9689216|FG000|STARTED|Overall Study||79
8648082|NCT00622505|9689217|FG001|STARTED|Overall Study||42
8648083|NCT00622505|9689216|FG000|COMPLETED|Overall Study||50
8648084|NCT00622505|9689217|FG001|COMPLETED|Overall Study||19
8648085|NCT00622505|9689216|FG000|NOT COMPLETED|Overall Study||29
8648086|NCT00622505|9689217|FG001|NOT COMPLETED|Overall Study||23
8648087|NCT00622518|9689225|FG000|STARTED|Overall Study||59
8648088|NCT00622518|9689226|FG001|STARTED|Overall Study||60
8648089|NCT00622518|9689225|FG000|COMPLETED|Overall Study||59
8648090|NCT00622518|9689226|FG001|COMPLETED|Overall Study||60
8648091|NCT00622518|9689225|FG000|NOT COMPLETED|Overall Study||0
8648092|NCT00622518|9689226|FG001|NOT COMPLETED|Overall Study||0
8648093|NCT00622544|9689232|FG000|STARTED|Overall Study||44
8648094|NCT00622544|9689232|FG000|COMPLETED|Overall Study|35|35
8648095|NCT00622544|9689232|FG000|NOT COMPLETED|Overall Study||9
8648096|NCT00622635|9689236|FG000|STARTED|Treatment Period 1||13
8648097|NCT00622635|9689237|FG001|STARTED|Treatment Period 1||11
8648098|NCT00622635|9689238|FG002|STARTED|Treatment Period 1||11
8648099|NCT00622635|9689239|FG003|STARTED|Treatment Period 1||13
8648100|NCT00622635|9689240|FG004|STARTED|Treatment Period 1||10
8648101|NCT00622635|9689241|FG005|STARTED|Treatment Period 1||10
8648102|NCT00622635|9689236|FG000|COMPLETED|Treatment Period 1||13
8648103|NCT00622635|9689237|FG001|COMPLETED|Treatment Period 1||10
8648104|NCT00622635|9689238|FG002|COMPLETED|Treatment Period 1||10
8648105|NCT00622635|9689239|FG003|COMPLETED|Treatment Period 1||13
8648106|NCT00622635|9689240|FG004|COMPLETED|Treatment Period 1||9
8648107|NCT00622635|9689241|FG005|COMPLETED|Treatment Period 1||10
8648108|NCT00622635|9689236|FG000|NOT COMPLETED|Treatment Period 1||0
8648109|NCT00622635|9689237|FG001|NOT COMPLETED|Treatment Period 1||1
8648110|NCT00622635|9689238|FG002|NOT COMPLETED|Treatment Period 1||1
8648111|NCT00622635|9689239|FG003|NOT COMPLETED|Treatment Period 1||0
8648112|NCT00622635|9689240|FG004|NOT COMPLETED|Treatment Period 1||1
8648113|NCT00622635|9689241|FG005|NOT COMPLETED|Treatment Period 1||0
8648114|NCT00622635|9689236|FG000|STARTED|Treatment Period 2||13
8648115|NCT00622635|9689237|FG001|STARTED|Treatment Period 2||10
8648116|NCT00622635|9689238|FG002|STARTED|Treatment Period 2||10
8648117|NCT00622635|9689239|FG003|STARTED|Treatment Period 2||13
8648118|NCT00622635|9689240|FG004|STARTED|Treatment Period 2||9
8648119|NCT00622635|9689241|FG005|STARTED|Treatment Period 2||10
8648120|NCT00622635|9689236|FG000|COMPLETED|Treatment Period 2||12
8648121|NCT00622635|9689237|FG001|COMPLETED|Treatment Period 2||10
8648122|NCT00622635|9689238|FG002|COMPLETED|Treatment Period 2||10
8648123|NCT00622635|9689239|FG003|COMPLETED|Treatment Period 2||13
8648124|NCT00622635|9689240|FG004|COMPLETED|Treatment Period 2||9
8648125|NCT00622635|9689241|FG005|COMPLETED|Treatment Period 2||10
8648126|NCT00622635|9689236|FG000|NOT COMPLETED|Treatment Period 2||1
8648127|NCT00622635|9689237|FG001|NOT COMPLETED|Treatment Period 2||0
8648128|NCT00622635|9689238|FG002|NOT COMPLETED|Treatment Period 2||0
8648129|NCT00622635|9689239|FG003|NOT COMPLETED|Treatment Period 2||0
8648130|NCT00622635|9689240|FG004|NOT COMPLETED|Treatment Period 2||0
8648131|NCT00622635|9689241|FG005|NOT COMPLETED|Treatment Period 2||0
8648132|NCT00622635|9689236|FG000|STARTED|Treatment Period 3||12
8648133|NCT00622635|9689237|FG001|STARTED|Treatment Period 3||10
8648134|NCT00622635|9689238|FG002|STARTED|Treatment Period 3||10
8648135|NCT00622635|9689239|FG003|STARTED|Treatment Period 3||13
8648136|NCT00622635|9689240|FG004|STARTED|Treatment Period 3||9
8648137|NCT00622635|9689241|FG005|STARTED|Treatment Period 3||10
8648138|NCT00622635|9689236|FG000|COMPLETED|Treatment Period 3||12
8648139|NCT00622635|9689237|FG001|COMPLETED|Treatment Period 3||10
8648140|NCT00622635|9689238|FG002|COMPLETED|Treatment Period 3||10
8648141|NCT00622635|9689239|FG003|COMPLETED|Treatment Period 3||10
8648142|NCT00622635|9689240|FG004|COMPLETED|Treatment Period 3||9
8648143|NCT00622635|9689241|FG005|COMPLETED|Treatment Period 3||10
8648144|NCT00622635|9689236|FG000|NOT COMPLETED|Treatment Period 3||0
8648145|NCT00622635|9689237|FG001|NOT COMPLETED|Treatment Period 3||0
8648146|NCT00622635|9689238|FG002|NOT COMPLETED|Treatment Period 3||0
8648147|NCT00622635|9689239|FG003|NOT COMPLETED|Treatment Period 3||3
8648148|NCT00622635|9689240|FG004|NOT COMPLETED|Treatment Period 3||0
8648149|NCT00622635|9689241|FG005|NOT COMPLETED|Treatment Period 3||0
8648150|NCT00622700|9689252|FG000|STARTED|Core Treatment Period||197
8648151|NCT00622700|9689253|FG001|STARTED|Core Treatment Period||205
8648152|NCT00622700|9689254|FG002|STARTED|Core Treatment Period||216
8648153|NCT00622700|9689255|FG003|STARTED|Core Treatment Period||0
8648154|NCT00622700|9689256|FG004|STARTED|Core Treatment Period||0
8648155|NCT00622700|9689257|FG005|STARTED|Core Treatment Period||0
8648156|NCT00622700|9689258|FG006|STARTED|Core Treatment Period||0
8648157|NCT00622700|9689252|FG000|Treated|Core Treatment Period||197
8648158|NCT00622700|9689253|FG001|Treated|Core Treatment Period||203
8648159|NCT00622700|9689254|FG002|Treated|Core Treatment Period||214
8648160|NCT00622700|9689255|FG003|Treated|Core Treatment Period||0
8648161|NCT00622700|9689256|FG004|Treated|Core Treatment Period||0
8648162|NCT00622700|9689257|FG005|Treated|Core Treatment Period||0
8648163|NCT00622700|9689258|FG006|Treated|Core Treatment Period||0
8648164|NCT00622700|9689252|FG000|COMPLETED|Core Treatment Period||141
8648165|NCT00622700|9689253|FG001|COMPLETED|Core Treatment Period||150
8648166|NCT00622700|9689254|FG002|COMPLETED|Core Treatment Period||163
8648167|NCT00622700|9689255|FG003|COMPLETED|Core Treatment Period||0
8648168|NCT00622700|9689256|FG004|COMPLETED|Core Treatment Period||0
8648169|NCT00622700|9689257|FG005|COMPLETED|Core Treatment Period||0
8648170|NCT00622700|9689258|FG006|COMPLETED|Core Treatment Period||0
8648171|NCT00622700|9689252|FG000|NOT COMPLETED|Core Treatment Period||56
8648172|NCT00622700|9689253|FG001|NOT COMPLETED|Core Treatment Period||55
8648173|NCT00622700|9689254|FG002|NOT COMPLETED|Core Treatment Period||53
8648174|NCT00622700|9689255|FG003|NOT COMPLETED|Core Treatment Period||0
8648175|NCT00622700|9689256|FG004|NOT COMPLETED|Core Treatment Period||0
8648176|NCT00622700|9689257|FG005|NOT COMPLETED|Core Treatment Period||0
8648177|NCT00622700|9689258|FG006|NOT COMPLETED|Core Treatment Period||0
8648178|NCT00622700|9689252|FG000|STARTED|Extension Treatment Period|Participants were re-randomized in a 1:1 ratio to either teriflunomide 7 mg or 14 mg treatment arm.|0
8648179|NCT00622700|9689253|FG001|STARTED|Extension Treatment Period||0
8648180|NCT00622700|9689254|FG002|STARTED|Extension Treatment Period||0
8648181|NCT00622700|9689255|FG003|STARTED|Extension Treatment Period|10 participants completed core treatment period but did not enter in extension treatment period.|64
8648182|NCT00622700|9689256|FG004|STARTED|Extension Treatment Period|8 participants completed core treatment period but did not enter in extension treatment period.|142
8693785|NCT00868517|9739329|FG002|NOT COMPLETED|Overall Study||2
8648183|NCT00622700|9689257|FG005|STARTED|Extension Treatment Period|10 participants completed core treatment period but did not enter in extension treatment period.|67
8648184|NCT00622700|9689258|FG006|STARTED|Extension Treatment Period|13 participants completed core treatment period but did not enter in extension treatment period.|150
8648185|NCT00622700|9689252|FG000|COMPLETED|Extension Treatment Period||0
8648186|NCT00622700|9689253|FG001|COMPLETED|Extension Treatment Period||0
8648187|NCT00622700|9689254|FG002|COMPLETED|Extension Treatment Period||0
8648188|NCT00622700|9689255|FG003|COMPLETED|Extension Treatment Period||43
8648189|NCT00622700|9689256|FG004|COMPLETED|Extension Treatment Period||103
8648190|NCT00622700|9689257|FG005|COMPLETED|Extension Treatment Period||50
8648191|NCT00622700|9689258|FG006|COMPLETED|Extension Treatment Period||120
8648192|NCT00622700|9689252|FG000|NOT COMPLETED|Extension Treatment Period||0
8648193|NCT00622700|9689253|FG001|NOT COMPLETED|Extension Treatment Period||0
8648194|NCT00622700|9689254|FG002|NOT COMPLETED|Extension Treatment Period||0
8648195|NCT00622700|9689255|FG003|NOT COMPLETED|Extension Treatment Period||21
8648196|NCT00622700|9689256|FG004|NOT COMPLETED|Extension Treatment Period||39
8648197|NCT00622700|9689257|FG005|NOT COMPLETED|Extension Treatment Period||17
8648198|NCT00622700|9689258|FG006|NOT COMPLETED|Extension Treatment Period||30
8648199|NCT00622713|9689275|FG000|STARTED|Overall Study||228
8648200|NCT00622713|9689275|FG000|Exposed to Study Drug|Overall Study||226
8648201|NCT00622713|9689275|FG000|Intent to Treat (ITT) Population|Overall Study||218
8648202|NCT00622713|9689275|FG000|COMPLETED|Overall Study||169
8648203|NCT00622713|9689275|FG000|NOT COMPLETED|Overall Study||59
8648204|NCT00622726|9689281|FG000|STARTED|March, 2008 to August, 2010||75
8648205|NCT00622726|9689282|FG001|STARTED|March, 2008 to August, 2010||75
8648206|NCT00622726|9689281|FG000|COMPLETED|March, 2008 to August, 2010|All infants were extremely immature with multiple neonatal intensive care unit complications.|70
8648207|NCT00622726|9689282|FG001|COMPLETED|March, 2008 to August, 2010|All infants were extremely immature with multiple neonatal intensive care unit complications.|73
8648208|NCT00622726|9689281|FG000|NOT COMPLETED|March, 2008 to August, 2010||5
8648209|NCT00622726|9689282|FG001|NOT COMPLETED|March, 2008 to August, 2010||2
8648210|NCT00622726|9689281|FG000|STARTED|August, 2010 to April, 2013||70
8648211|NCT00622726|9689282|FG001|STARTED|August, 2010 to April, 2013||73
8648212|NCT00622726|9689281|FG000|COMPLETED|August, 2010 to April, 2013||69
8648213|NCT00622726|9689282|FG001|COMPLETED|August, 2010 to April, 2013||68
8648214|NCT00622726|9689281|FG000|NOT COMPLETED|August, 2010 to April, 2013||1
8648215|NCT00622726|9689282|FG001|NOT COMPLETED|August, 2010 to April, 2013||5
8648216|NCT00622739|9689294|FG000|STARTED|Overall Study||13
8648217|NCT00622739|9689295|FG001|STARTED|Overall Study||15
8648218|NCT00622739|9689294|FG000|COMPLETED|Overall Study||11
8648219|NCT00622739|9689295|FG001|COMPLETED|Overall Study||9
8648220|NCT00622739|9689294|FG000|NOT COMPLETED|Overall Study||2
8648221|NCT00622739|9689295|FG001|NOT COMPLETED|Overall Study||6
8648222|NCT00622869|9689306|FG000|STARTED|Overall Study||245
8648223|NCT00622869|9689307|FG001|STARTED|Overall Study||231
8648224|NCT00622869|9689308|FG002|STARTED|Overall Study||243
8648225|NCT00622869|9689306|FG000|COMPLETED|Overall Study||202
8648226|NCT00622869|9689307|FG001|COMPLETED|Overall Study||174
8648227|NCT00622869|9689308|FG002|COMPLETED|Overall Study||204
8648228|NCT00622869|9689306|FG000|NOT COMPLETED|Overall Study||43
8648229|NCT00622869|9689307|FG001|NOT COMPLETED|Overall Study||57
8648230|NCT00622869|9689308|FG002|NOT COMPLETED|Overall Study||39
8648231|NCT00622895|9689316|FG000|STARTED|Overall Study||3
8648232|NCT00622895|9689316|FG000|COMPLETED|Overall Study||3
8648233|NCT00622895|9689316|FG000|NOT COMPLETED|Overall Study||0
8648234|NCT00622908|9689325|FG000|STARTED|Overall Study|Intent to treat population|137
8648235|NCT00622908|9689326|FG001|STARTED|Overall Study|Intent to treat population|132
8648236|NCT00622908|9689325|FG000|COMPLETED|Overall Study||134
8648237|NCT00622908|9689326|FG001|COMPLETED|Overall Study||122
8648238|NCT00622908|9689325|FG000|NOT COMPLETED|Overall Study||3
8648239|NCT00622908|9689326|FG001|NOT COMPLETED|Overall Study||10
8648240|NCT00623012|9689332|FG000|STARTED|Overall Study||2
8648241|NCT00623012|9689332|FG000|COMPLETED|Overall Study||2
8648242|NCT00623012|9689332|FG000|NOT COMPLETED|Overall Study||0
8648243|NCT00623103|9689338|FG000|STARTED|Overall Study||295
8648244|NCT00623103|9689339|FG001|STARTED|Overall Study||288
8648245|NCT00623103|9689338|FG000|Safety Set: Received Study Drug|Overall Study|One randomized participant did not receive study drug and was not included in the Safety set.|294
8648246|NCT00623103|9689339|FG001|Safety Set: Received Study Drug|Overall Study||288
8648247|NCT00623103|9689338|FG000|COMPLETED|Overall Study||184
8648248|NCT00623103|9689339|FG001|COMPLETED|Overall Study||175
8648249|NCT00623103|9689338|FG000|NOT COMPLETED|Overall Study||111
8648250|NCT00623103|9689339|FG001|NOT COMPLETED|Overall Study||113
8648251|NCT00623181|9689347|FG000|STARTED|Overall Study||56
8648252|NCT00623181|9689348|FG001|STARTED|Overall Study||54
8648253|NCT00623181|9689347|FG000|COMPLETED|Overall Study||56
8648254|NCT00623181|9689348|FG001|COMPLETED|Overall Study||54
8648255|NCT00623181|9689347|FG000|NOT COMPLETED|Overall Study||0
8648256|NCT00623181|9689348|FG001|NOT COMPLETED|Overall Study||0
8648257|NCT00623194|9689358|FG000|STARTED|Overall Study||146
8648258|NCT00623194|9689358|FG000|COMPLETED|Overall Study||141
8648259|NCT00623194|9689358|FG000|NOT COMPLETED|Overall Study||5
8648260|NCT00623233|9689362|FG000|STARTED|Overall Study||52
8648261|NCT00623233|9689362|FG000|COMPLETED|Overall Study|Included those who discontinued due to PD or death and those who achieved complete response (CR).|28
8648262|NCT00623233|9689362|FG000|NOT COMPLETED|Overall Study||24
8648263|NCT00623363|9689368|FG000|STARTED|Overall Study||7
8648264|NCT00623363|9689369|FG001|STARTED|Overall Study||20
8648265|NCT00623363|9689368|FG000|COMPLETED|Overall Study||5
8648266|NCT00623363|9689369|FG001|COMPLETED|Overall Study||18
8648267|NCT00623363|9689368|FG000|NOT COMPLETED|Overall Study||2
8648268|NCT00623363|9689369|FG001|NOT COMPLETED|Overall Study||2
8648269|NCT00623428|9689378|FG000|STARTED|Treatment Period||95
8648270|NCT00623428|9689379|FG001|STARTED|Treatment Period||93
8648271|NCT00623428|9689378|FG000|COMPLETED|Treatment Period|Patients who completed 24 weeks of treatment|95
8648272|NCT00623428|9689379|FG001|COMPLETED|Treatment Period|Patients who completed 48 weeks of treatment|66
8648273|NCT00623428|9689378|FG000|NOT COMPLETED|Treatment Period||0
8648274|NCT00623428|9689379|FG001|NOT COMPLETED|Treatment Period||27
8648275|NCT00623428|9689378|FG000|STARTED|Follow-up Period||95
8648276|NCT00623428|9689379|FG001|STARTED|Follow-up Period||93
8648277|NCT00623428|9689378|FG000|COMPLETED|Follow-up Period|Patients who had an HCV RNA sample at 48 weeks of follow-up|66
8648278|NCT00623428|9689379|FG001|COMPLETED|Follow-up Period|Patients who had an HCV RNA sample at 24 weeks of follow-up|78
8648279|NCT00623428|9689378|FG000|NOT COMPLETED|Follow-up Period||29
8648280|NCT00623428|9689379|FG001|NOT COMPLETED|Follow-up Period||15
8648281|NCT00623441|9689385|FG000|STARTED|Overall Study||8314
8648282|NCT00623441|9689385|FG000|COMPLETED|Overall Study|12 months follow-up compliance was 94.2%|8314
8648283|NCT00623441|9689385|FG000|NOT COMPLETED|Overall Study||0
8648284|NCT00623467|9689389|FG000|STARTED|Overall Study||343
8648285|NCT00623467|9689389|FG000|COMPLETED|Overall Study||336
8648286|NCT00623467|9689389|FG000|NOT COMPLETED|Overall Study||7
8691788|NCT00856830|9737150|FG001|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
8691789|NCT00856830|9737151|FG002|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
8691790|NCT00856830|9737152|FG003|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
8691791|NCT00856843|9737159|FG000|STARTED|Overall Study||68
8691792|NCT00856843|9737160|FG001|STARTED|Overall Study||68
8691793|NCT00856843|9737159|FG000|COMPLETED|Overall Study||66
8691794|NCT00856843|9737160|FG001|COMPLETED|Overall Study||63
8691795|NCT00856843|9737159|FG000|NOT COMPLETED|Overall Study||2
8691796|NCT00856843|9737160|FG001|NOT COMPLETED|Overall Study||5
8691797|NCT00856856|9737166|FG000|STARTED|Baseline||101
8691798|NCT00856856|9737166|FG000|COMPLETED|Baseline||101
8691799|NCT00856856|9737166|FG000|NOT COMPLETED|Baseline||0
8691800|NCT00856856|9737166|FG000|STARTED|30-day Clinical Follow-up||101
8691801|NCT00856856|9737166|FG000|COMPLETED|30-day Clinical Follow-up||101
8691802|NCT00856856|9737166|FG000|NOT COMPLETED|30-day Clinical Follow-up||0
8691803|NCT00856856|9737166|FG000|STARTED|180-day Clinical Follow-up||101
8691804|NCT00856856|9737166|FG000|COMPLETED|180-day Clinical Follow-up||101
8691805|NCT00856856|9737166|FG000|NOT COMPLETED|180-day Clinical Follow-up||0
8691806|NCT00856856|9737166|FG000|STARTED|270-day Clinical Follow-up||101
8691807|NCT00856856|9737166|FG000|COMPLETED|270-day Clinical Follow-up||101
8691808|NCT00856856|9737166|FG000|NOT COMPLETED|270-day Clinical Follow-up||0
8691809|NCT00856856|9737166|FG000|STARTED|1-year Clinical Follow-up||101
8691810|NCT00856856|9737166|FG000|COMPLETED|1-year Clinical Follow-up||101
8691811|NCT00856856|9737166|FG000|NOT COMPLETED|1-year Clinical Follow-up||0
8691812|NCT00856856|9737166|FG000|STARTED|2-year Clinical Follow-up||101
8691813|NCT00856856|9737166|FG000|COMPLETED|2-year Clinical Follow-up||100
8691814|NCT00856856|9737166|FG000|NOT COMPLETED|2-year Clinical Follow-up||1
8691815|NCT00856856|9737166|FG000|STARTED|3-year Clinical Follow-up||100
8691816|NCT00856856|9737166|FG000|COMPLETED|3-year Clinical Follow-up||100
8691817|NCT00856856|9737166|FG000|NOT COMPLETED|3-year Clinical Follow-up||0
8691818|NCT00856856|9737166|FG000|STARTED|4-year Clinical Follow-up||100
8691819|NCT00856856|9737166|FG000|COMPLETED|4-year Clinical Follow-up||99
8691820|NCT00856856|9737166|FG000|NOT COMPLETED|4-year Clinical Follow-up||1
8691821|NCT00856856|9737166|FG000|STARTED|5-year Clinical Follow-up||100
8691822|NCT00856856|9737166|FG000|COMPLETED|5-year Clinical Follow-up|One patient missed the 4-year clinical follow-up but returned at 5 year.|100
8691823|NCT00856856|9737166|FG000|NOT COMPLETED|5-year Clinical Follow-up||0
8727854|NCT01045096|9775128|FG002|STARTED|Overall Study||12
8727855|NCT01045096|9775126|FG000|Pharmacokinetic Set|Overall Study|All patients with at least one estimable PK parameter for dexlansoprazole on Day 7.|9
8727856|NCT01045096|9775127|FG001|Pharmacokinetic Set|Overall Study||11
8727857|NCT01045096|9775128|FG002|Pharmacokinetic Set|Overall Study||11
8727858|NCT01045096|9775126|FG000|COMPLETED|Overall Study||9
8727859|NCT01045096|9775127|FG001|COMPLETED|Overall Study||12
8727860|NCT01045096|9775128|FG002|COMPLETED|Overall Study||12
8727861|NCT01045096|9775126|FG000|NOT COMPLETED|Overall Study||3
8727862|NCT01045096|9775127|FG001|NOT COMPLETED|Overall Study||0
8727863|NCT01045096|9775128|FG002|NOT COMPLETED|Overall Study||0
8727864|NCT01045122|9775136|FG000|STARTED|Dexmedetomidine Then Propofol||5
8727865|NCT01045122|9775137|FG001|STARTED|Dexmedetomidine Then Propofol||6
8727866|NCT01045122|9775136|FG000|COMPLETED|Dexmedetomidine Then Propofol||5
8727867|NCT01045122|9775137|FG001|COMPLETED|Dexmedetomidine Then Propofol||6
8727868|NCT01045122|9775136|FG000|NOT COMPLETED|Dexmedetomidine Then Propofol||0
8727869|NCT01045122|9775137|FG001|NOT COMPLETED|Dexmedetomidine Then Propofol||0
8727870|NCT01045122|9775136|FG000|STARTED|Propofol Then Dexmedetomidine||5
8727871|NCT01045122|9775137|FG001|STARTED|Propofol Then Dexmedetomidine||6
8727872|NCT01045122|9775136|FG000|COMPLETED|Propofol Then Dexmedetomidine||5
8727873|NCT01045122|9775137|FG001|COMPLETED|Propofol Then Dexmedetomidine||6
8727874|NCT01045122|9775136|FG000|NOT COMPLETED|Propofol Then Dexmedetomidine||0
8727875|NCT01045122|9775137|FG001|NOT COMPLETED|Propofol Then Dexmedetomidine||0
8727876|NCT01045135|9775143|FG000|STARTED|Overall Study||300
8648287|NCT00623480|9689397|FG000|STARTED|Overall Study||42
8648288|NCT00623480|9689398|FG001|STARTED|Overall Study||42
8648289|NCT00623480|9689397|FG000|COMPLETED|Overall Study||35
8648290|NCT00623480|9689398|FG001|COMPLETED|Overall Study||35
8648291|NCT00623480|9689397|FG000|NOT COMPLETED|Overall Study||7
8648292|NCT00623480|9689398|FG001|NOT COMPLETED|Overall Study||7
8648293|NCT00623506|9689406|FG000|STARTED|Overall Study||15
8648294|NCT00623506|9689407|FG001|STARTED|Overall Study||15
8648295|NCT00623506|9689406|FG000|Week 4|Overall Study||11
8648296|NCT00623506|9689407|FG001|Week 4|Overall Study||11
8648297|NCT00623506|9689406|FG000|COMPLETED|Overall Study||11
8648298|NCT00623506|9689407|FG001|COMPLETED|Overall Study||11
8648299|NCT00623506|9689406|FG000|NOT COMPLETED|Overall Study||4
8648300|NCT00623506|9689407|FG001|NOT COMPLETED|Overall Study||4
8648301|NCT00623545|9689413|FG000|STARTED|Overall Study||28
8648302|NCT00623545|9689413|FG000|COMPLETED|Overall Study||18
8648303|NCT00623545|9689413|FG000|NOT COMPLETED|Overall Study||10
8648304|NCT00623597|9689420|FG000|STARTED|Overall Study||5
8648305|NCT00623597|9689421|FG001|STARTED|Overall Study||13
8648306|NCT00623597|9689420|FG000|COMPLETED|Overall Study||4
8648307|NCT00623597|9689421|FG001|COMPLETED|Overall Study||13
8648308|NCT00623597|9689420|FG000|NOT COMPLETED|Overall Study||1
8648309|NCT00623597|9689421|FG001|NOT COMPLETED|Overall Study||0
8648310|NCT00623623|9689431|FG000|STARTED|Overall Study||950
8648311|NCT00623623|9689432|FG001|STARTED|Overall Study||949
8648312|NCT00623623|9689431|FG000|COMPLETED|Overall Study||949
8648313|NCT00623623|9689432|FG001|COMPLETED|Overall Study||948
8648314|NCT00623623|9689431|FG000|NOT COMPLETED|Overall Study||1
8648315|NCT00623623|9689432|FG001|NOT COMPLETED|Overall Study||1
8648316|NCT00623636|9689440|FG000|STARTED|Double Blind||452
8648317|NCT00623636|9689441|FG001|STARTED|Double Blind||450
8648318|NCT00623636|9689440|FG000|COMPLETED|Double Blind||419
8648319|NCT00623636|9689441|FG001|COMPLETED|Double Blind||422
8648320|NCT00623636|9689440|FG000|NOT COMPLETED|Double Blind||33
8648321|NCT00623636|9689441|FG001|NOT COMPLETED|Double Blind||28
8648322|NCT00623636|9689440|FG000|STARTED|Open Label|Eligible double-blind placebo patients received MAP0004 in the open-label period.|0
8648323|NCT00623636|9689441|FG001|STARTED|Open Label|Includes eligible Placebo and MAP0004 patients from the double-blind period.|675
8648324|NCT00623636|9689440|FG000|COMPLETED|Open Label||0
8648325|NCT00623636|9689441|FG001|COMPLETED|Open Label||263
8648326|NCT00623636|9689440|FG000|NOT COMPLETED|Open Label||0
8648327|NCT00623636|9689441|FG001|NOT COMPLETED|Open Label||412
8648328|NCT00623714|9689448|FG000|STARTED|Period 1||6
8648329|NCT00623714|9689449|FG001|STARTED|Period 1||7
8648330|NCT00623714|9689448|FG000|COMPLETED|Period 1||6
8648331|NCT00623714|9689449|FG001|COMPLETED|Period 1||7
8648332|NCT00623714|9689448|FG000|NOT COMPLETED|Period 1||0
8648333|NCT00623714|9689449|FG001|NOT COMPLETED|Period 1||0
8648334|NCT00623714|9689448|FG000|STARTED|Period 2||6
8648335|NCT00623714|9689449|FG001|STARTED|Period 2||7
8648336|NCT00623714|9689448|FG000|COMPLETED|Period 2||6
8648337|NCT00623714|9689449|FG001|COMPLETED|Period 2||7
8648338|NCT00623714|9689448|FG000|NOT COMPLETED|Period 2||0
8648339|NCT00623714|9689449|FG001|NOT COMPLETED|Period 2||0
8648340|NCT00623727|9689457|FG000|STARTED|Double Blind (DB)|only 67 participants are applicable for baseline characteristic evaluation|70
8648341|NCT00623727|9689458|FG001|STARTED|Double Blind (DB)|only 72 participants are applicable for baseline characteristic evaluation|73
8648342|NCT00623727|9689457|FG000|Participants Received Treatment|Double Blind (DB)||67
8648343|NCT00623727|9689458|FG001|Participants Received Treatment|Double Blind (DB)||72
8648344|NCT00623727|9689457|FG000|COMPLETED|Double Blind (DB)||34
8648345|NCT00623727|9689458|FG001|COMPLETED|Double Blind (DB)||41
8648346|NCT00623727|9689457|FG000|NOT COMPLETED|Double Blind (DB)||36
8648347|NCT00623727|9689458|FG001|NOT COMPLETED|Double Blind (DB)||32
8648348|NCT00623727|9689457|FG000|STARTED|Open Label Follow-up||0
8648349|NCT00623727|9689458|FG001|STARTED|Open Label Follow-up|13 Participants from each group after DB period terminated entered open label follow up.|26
8648350|NCT00623727|9689457|FG000|COMPLETED|Open Label Follow-up||0
8648351|NCT00623727|9689458|FG001|COMPLETED|Open Label Follow-up||18
8648352|NCT00623727|9689457|FG000|NOT COMPLETED|Open Label Follow-up||0
8648353|NCT00623727|9689458|FG001|NOT COMPLETED|Open Label Follow-up||8
8648354|NCT00623727|9689457|FG000|STARTED|Open Label Extension Period|10 participants of each group entered open-label extension period after completion of DB study|20
8648355|NCT00623727|9689458|FG001|STARTED|Open Label Extension Period||0
8648356|NCT00623727|9689457|FG000|COMPLETED|Open Label Extension Period||20
8648357|NCT00623727|9689458|FG001|COMPLETED|Open Label Extension Period||0
8648358|NCT00623727|9689457|FG000|NOT COMPLETED|Open Label Extension Period||0
8648359|NCT00623727|9689458|FG001|NOT COMPLETED|Open Label Extension Period||0
8648360|NCT00623766|9689468|FG000|STARTED|Induction Phase (Day 1 to Week 24)|Participants who received treatment|51
8648361|NCT00623766|9689469|FG001|STARTED|Induction Phase (Day 1 to Week 24)|Participants who received treatment|21
8648362|NCT00623766|9689468|FG000|COMPLETED|Induction Phase (Day 1 to Week 24)|4 patients completed Induction but did not enter Maintenance; they were only followed up with scans.|15
8648363|NCT00623766|9689469|FG001|COMPLETED|Induction Phase (Day 1 to Week 24)|3 patients completed Induction but did not enter Maintenance; they were only followed up with scans.|5
8648364|NCT00623766|9689468|FG000|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||36
8648365|NCT00623766|9689469|FG001|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||16
8648366|NCT00623766|9689468|FG000|STARTED|Maintenance Phase (Week 24 to Year 2)||11
8648367|NCT00623766|9689469|FG001|STARTED|Maintenance Phase (Week 24 to Year 2)||2
8648368|NCT00623766|9689468|FG000|COMPLETED|Maintenance Phase (Week 24 to Year 2)|Inadvertently not noted as discontinued (disease progression); data collection error at site closure|1
8648369|NCT00623766|9689469|FG001|COMPLETED|Maintenance Phase (Week 24 to Year 2)||0
8648370|NCT00623766|9689468|FG000|NOT COMPLETED|Maintenance Phase (Week 24 to Year 2)||10
8648371|NCT00623766|9689469|FG001|NOT COMPLETED|Maintenance Phase (Week 24 to Year 2)||2
8648372|NCT00623779|9689482|FG000|STARTED|Overall Study||41
8648373|NCT00623779|9689483|FG001|STARTED|Overall Study||42
8648374|NCT00623779|9689484|FG002|STARTED|Overall Study||45
8648375|NCT00623779|9689482|FG000|COMPLETED|Overall Study||38
8648376|NCT00623779|9689483|FG001|COMPLETED|Overall Study||39
8648377|NCT00623779|9689484|FG002|COMPLETED|Overall Study||44
8648378|NCT00623779|9689482|FG000|NOT COMPLETED|Overall Study||3
8648379|NCT00623779|9689483|FG001|NOT COMPLETED|Overall Study||3
8648380|NCT00623779|9689484|FG002|NOT COMPLETED|Overall Study||1
8648381|NCT00623805|9689494|FG000|STARTED|Overall Study||62
8648382|NCT00623805|9689495|FG001|STARTED|Overall Study||61
8648383|NCT00623805|9689494|FG000|COMPLETED|Overall Study||42
8648384|NCT00623805|9689495|FG001|COMPLETED|Overall Study||39
8648385|NCT00623805|9689494|FG000|NOT COMPLETED|Overall Study||20
8648386|NCT00623805|9689495|FG001|NOT COMPLETED|Overall Study||22
8648387|NCT00623831|9689503|FG000|STARTED|Overall Study||13
8648388|NCT00623831|9689504|FG001|STARTED|Overall Study||4
8648389|NCT00623831|9689503|FG000|COMPLETED|Overall Study||12
8648390|NCT00623831|9689504|FG001|COMPLETED|Overall Study||3
8648391|NCT00623831|9689503|FG000|NOT COMPLETED|Overall Study||1
8648392|NCT00623831|9689504|FG001|NOT COMPLETED|Overall Study||1
8648393|NCT00623935|9689513|FG000|STARTED|Overall Study||56
8648394|NCT00623935|9689513|FG000|COMPLETED|Overall Study||54
8648395|NCT00623935|9689513|FG000|NOT COMPLETED|Overall Study||2
8648396|NCT00624013|9689519|FG000|STARTED|Overall Study||44
8648397|NCT00624013|9689520|FG001|STARTED|Overall Study||45
8648398|NCT00624013|9689519|FG000|COMPLETED|Overall Study||36
8648399|NCT00624013|9689520|FG001|COMPLETED|Overall Study||39
8648400|NCT00624013|9689519|FG000|NOT COMPLETED|Overall Study||8
8648401|NCT00624013|9689520|FG001|NOT COMPLETED|Overall Study||6
8648402|NCT00624052|9689532|FG000|STARTED|Overall Study||219
8648403|NCT00624052|9689533|FG001|STARTED|Overall Study||436
8648404|NCT00624052|9689534|FG002|STARTED|Overall Study||91
8648405|NCT00624052|9689535|FG003|STARTED|Overall Study||92
8648406|NCT00624052|9689532|FG000|COMPLETED|Overall Study||204
8648407|NCT00624052|9689533|FG001|COMPLETED|Overall Study||422
8648408|NCT00624052|9689534|FG002|COMPLETED|Overall Study||88
8648409|NCT00624052|9689535|FG003|COMPLETED|Overall Study||88
8648410|NCT00624052|9689532|FG000|NOT COMPLETED|Overall Study||15
8648411|NCT00624052|9689533|FG001|NOT COMPLETED|Overall Study||14
8648412|NCT00624052|9689534|FG002|NOT COMPLETED|Overall Study||3
8648413|NCT00624052|9689535|FG003|NOT COMPLETED|Overall Study||4
8648414|NCT00624065|9689551|FG000|STARTED|Overall Study||216
8648415|NCT00624065|9689552|FG001|STARTED|Overall Study||216
8648416|NCT00624065|9689551|FG000|COMPLETED|Overall Study||197
8648417|NCT00624065|9689552|FG001|COMPLETED|Overall Study||192
8648418|NCT00624065|9689551|FG000|NOT COMPLETED|Overall Study||19
8648419|NCT00624065|9689552|FG001|NOT COMPLETED|Overall Study||24
8648420|NCT00624195|9689560|FG000|STARTED|Overall Study||29
8648421|NCT00624195|9689561|FG001|STARTED|Overall Study||30
8648422|NCT00624195|9689560|FG000|COMPLETED|Overall Study||26
8648423|NCT00624195|9689561|FG001|COMPLETED|Overall Study||23
8648424|NCT00624195|9689560|FG000|NOT COMPLETED|Overall Study||3
8648425|NCT00624195|9689561|FG001|NOT COMPLETED|Overall Study||7
8648426|NCT00624221|9689569|FG000|STARTED|Overall Study||20
8648427|NCT00624221|9689570|FG001|STARTED|Overall Study||20
8648428|NCT00624221|9689569|FG000|COMPLETED|Overall Study||20
8648429|NCT00624221|9689570|FG001|COMPLETED|Overall Study||20
8648430|NCT00624221|9689569|FG000|NOT COMPLETED|Overall Study||0
8648431|NCT00624221|9689570|FG001|NOT COMPLETED|Overall Study||0
8648432|NCT00624286|9689578|FG000|STARTED|Overall Study||211
8648433|NCT00624286|9689579|FG001|STARTED|Overall Study||205
8648434|NCT00624286|9689578|FG000|COMPLETED|Overall Study||186
8648435|NCT00624286|9689579|FG001|COMPLETED|Overall Study||178
8648436|NCT00624286|9689578|FG000|NOT COMPLETED|Overall Study||25
8648437|NCT00624286|9689579|FG001|NOT COMPLETED|Overall Study||27
8648438|NCT00624338|9689588|FG000|STARTED|Overall Study||159
8648439|NCT00624338|9689589|FG001|STARTED|Overall Study||145
8648440|NCT00624338|9689590|FG002|STARTED|Overall Study||157
8648441|NCT00624338|9689588|FG000|Treated|Overall Study||157
8648442|NCT00624338|9689589|FG001|Treated|Overall Study||144
8648443|NCT00624338|9689590|FG002|Treated|Overall Study||154
8648444|NCT00624338|9689588|FG000|COMPLETED|Overall Study||112
8648445|NCT00624338|9689589|FG001|COMPLETED|Overall Study||62
8648446|NCT00624338|9689590|FG002|COMPLETED|Overall Study||111
8648447|NCT00624338|9689588|FG000|NOT COMPLETED|Overall Study||47
8648448|NCT00624338|9689589|FG001|NOT COMPLETED|Overall Study||83
8648449|NCT00624338|9689590|FG002|NOT COMPLETED|Overall Study||46
8648450|NCT00624377|9689598|FG000|STARTED|Overall Study||2031
8648451|NCT00624377|9689598|FG000|COMPLETED|Overall Study||1387
8648452|NCT00624377|9689598|FG000|NOT COMPLETED|Overall Study||644
8648453|NCT00624416|9689602|FG000|STARTED|Overall Study||10
8648454|NCT00624416|9689602|FG000|COMPLETED|Overall Study||10
8648455|NCT00624416|9689602|FG000|NOT COMPLETED|Overall Study||0
8648456|NCT00624442|9689611|FG000|STARTED|Overall Study||8
8648457|NCT00624442|9689612|FG001|STARTED|Overall Study||9
8648458|NCT00624442|9689613|FG002|STARTED|Overall Study||10
8648459|NCT00624442|9689614|FG003|STARTED|Overall Study||8
8648460|NCT00624442|9689615|FG004|STARTED|Overall Study||10
8648461|NCT00624442|9689611|FG000|COMPLETED|Overall Study||8
8648462|NCT00624442|9689612|FG001|COMPLETED|Overall Study|One patient was discontinued after inadvertant overdose.|8
8648463|NCT00624442|9689613|FG002|COMPLETED|Overall Study|Two patients discontinued after meeting termination criteria during dosing.|8
8648464|NCT00624442|9689614|FG003|COMPLETED|Overall Study||8
8648465|NCT00624442|9689615|FG004|COMPLETED|Overall Study|Two patients discontinued after meeting termination criteria during dosing.|8
8648466|NCT00624442|9689611|FG000|NOT COMPLETED|Overall Study||0
8648467|NCT00624442|9689612|FG001|NOT COMPLETED|Overall Study||1
8648468|NCT00624442|9689613|FG002|NOT COMPLETED|Overall Study||2
8648469|NCT00624442|9689614|FG003|NOT COMPLETED|Overall Study||0
8648470|NCT00624442|9689615|FG004|NOT COMPLETED|Overall Study||2
8648471|NCT00624468|9689650|FG000|STARTED|Double-blind Period||17
8648472|NCT00624468|9689651|FG001|STARTED|Double-blind Period||17
8648473|NCT00624468|9689652|FG002|STARTED|Double-blind Period||0
8648474|NCT00624468|9689653|FG003|STARTED|Double-blind Period||0
8648475|NCT00624468|9689650|FG000|COMPLETED|Double-blind Period||3
8648476|NCT00624468|9689651|FG001|COMPLETED|Double-blind Period||4
8648477|NCT00624468|9689652|FG002|COMPLETED|Double-blind Period||0
8648478|NCT00624468|9689653|FG003|COMPLETED|Double-blind Period||0
8648479|NCT00624468|9689650|FG000|NOT COMPLETED|Double-blind Period||14
8727877|NCT01045135|9775143|FG000|COMPLETED|Overall Study||274
8727878|NCT01045135|9775143|FG000|NOT COMPLETED|Overall Study||26
8727879|NCT01045161|9775152|FG000|STARTED|Part A - 12 Weeks Double Blind Treatment||182
8727880|NCT01045161|9775153|FG001|STARTED|Part A - 12 Weeks Double Blind Treatment||184
8727881|NCT01045161|9775154|FG002|STARTED|Part A - 12 Weeks Double Blind Treatment||178
8727882|NCT01045161|9775152|FG000|COMPLETED|Part A - 12 Weeks Double Blind Treatment||151
8727883|NCT01045161|9775153|FG001|COMPLETED|Part A - 12 Weeks Double Blind Treatment||155
8727884|NCT01045161|9775154|FG002|COMPLETED|Part A - 12 Weeks Double Blind Treatment||148
8727885|NCT01045161|9775152|FG000|NOT COMPLETED|Part A - 12 Weeks Double Blind Treatment||31
8727886|NCT01045161|9775153|FG001|NOT COMPLETED|Part A - 12 Weeks Double Blind Treatment||29
8727887|NCT01045161|9775154|FG002|NOT COMPLETED|Part A - 12 Weeks Double Blind Treatment||30
8727888|NCT01045161|9775152|FG000|STARTED|Part B - 40 Additional Weeks Open Label||147
8727889|NCT01045161|9775153|FG001|STARTED|Part B - 40 Additional Weeks Open Label||154
8727890|NCT01045161|9775154|FG002|STARTED|Part B - 40 Additional Weeks Open Label||147
8727891|NCT01045161|9775152|FG000|COMPLETED|Part B - 40 Additional Weeks Open Label||111
8727892|NCT01045161|9775153|FG001|COMPLETED|Part B - 40 Additional Weeks Open Label||118
8727893|NCT01045161|9775154|FG002|COMPLETED|Part B - 40 Additional Weeks Open Label||115
8727894|NCT01045161|9775152|FG000|NOT COMPLETED|Part B - 40 Additional Weeks Open Label||36
8727895|NCT01045161|9775153|FG001|NOT COMPLETED|Part B - 40 Additional Weeks Open Label||36
8727896|NCT01045161|9775154|FG002|NOT COMPLETED|Part B - 40 Additional Weeks Open Label||32
8727897|NCT01045174|9775173|FG000|STARTED|Overall Study||90
8727898|NCT01045174|9775174|FG001|STARTED|Overall Study||90
8727899|NCT01045174|9775173|FG000|COMPLETED|Overall Study||90
8727900|NCT01045174|9775174|FG001|COMPLETED|Overall Study||90
8727901|NCT01045174|9775173|FG000|NOT COMPLETED|Overall Study||0
8727902|NCT01045174|9775174|FG001|NOT COMPLETED|Overall Study||0
8727903|NCT01045187|9775180|FG000|STARTED|Overall Study||15
8727904|NCT01045187|9775180|FG000|COMPLETED|Overall Study||15
8727905|NCT01045187|9775180|FG000|NOT COMPLETED|Overall Study||0
8727906|NCT01045265|9775184|FG000|STARTED|Overall Study||16
8727907|NCT01045265|9775184|FG000|COMPLETED|Overall Study||16
8727908|NCT01045265|9775184|FG000|NOT COMPLETED|Overall Study||0
8727909|NCT01045421|9775194|FG000|STARTED|Phase 1||1
8727910|NCT01045421|9775195|FG001|STARTED|Phase 1||3
8727911|NCT01045421|9775196|FG002|STARTED|Phase 1||4
8727912|NCT01045421|9775197|FG003|STARTED|Phase 1||12
8727913|NCT01045421|9775198|FG004|STARTED|Phase 1||3
8727914|NCT01045421|9775199|FG005|STARTED|Phase 1||1
8727915|NCT01045421|9775200|FG006|STARTED|Phase 1||0
8727916|NCT01045421|9775201|FG007|STARTED|Phase 1||0
8727917|NCT01045421|9775202|FG008|STARTED|Phase 1||0
8727918|NCT01045421|9775203|FG009|STARTED|Phase 1||0
8727919|NCT01045421|9775204|FG010|STARTED|Phase 1||0
8727920|NCT01045421|9775194|FG000|COMPLETED|Phase 1||1
8727921|NCT01045421|9775195|FG001|COMPLETED|Phase 1||3
8727922|NCT01045421|9775196|FG002|COMPLETED|Phase 1||4
8727923|NCT01045421|9775197|FG003|COMPLETED|Phase 1||11
8727924|NCT01045421|9775198|FG004|COMPLETED|Phase 1||2
8727925|NCT01045421|9775199|FG005|COMPLETED|Phase 1||1
8727926|NCT01045421|9775200|FG006|COMPLETED|Phase 1||0
8727927|NCT01045421|9775201|FG007|COMPLETED|Phase 1||0
8727928|NCT01045421|9775202|FG008|COMPLETED|Phase 1||0
8727929|NCT01045421|9775203|FG009|COMPLETED|Phase 1||0
8727930|NCT01045421|9775204|FG010|COMPLETED|Phase 1||0
8727931|NCT01045421|9775194|FG000|NOT COMPLETED|Phase 1||0
8727932|NCT01045421|9775195|FG001|NOT COMPLETED|Phase 1||0
8727933|NCT01045421|9775196|FG002|NOT COMPLETED|Phase 1||0
8727934|NCT01045421|9775197|FG003|NOT COMPLETED|Phase 1||1
8727935|NCT01045421|9775198|FG004|NOT COMPLETED|Phase 1||1
8727936|NCT01045421|9775199|FG005|NOT COMPLETED|Phase 1||0
8727937|NCT01045421|9775200|FG006|NOT COMPLETED|Phase 1||0
8727938|NCT01045421|9775201|FG007|NOT COMPLETED|Phase 1||0
8727939|NCT01045421|9775202|FG008|NOT COMPLETED|Phase 1||0
8727940|NCT01045421|9775203|FG009|NOT COMPLETED|Phase 1||0
8727941|NCT01045421|9775204|FG010|NOT COMPLETED|Phase 1||0
8727942|NCT01045421|9775194|FG000|STARTED|Phase 2||0
8727943|NCT01045421|9775195|FG001|STARTED|Phase 2||0
8727944|NCT01045421|9775196|FG002|STARTED|Phase 2||0
8648480|NCT00624468|9689651|FG001|NOT COMPLETED|Double-blind Period||13
8648481|NCT00624468|9689652|FG002|NOT COMPLETED|Double-blind Period||0
8648482|NCT00624468|9689653|FG003|NOT COMPLETED|Double-blind Period||0
8648483|NCT00624468|9689650|FG000|STARTED|Safety Follow-up (SFU) Period||0
8648484|NCT00624468|9689651|FG001|STARTED|Safety Follow-up (SFU) Period||0
8648485|NCT00624468|9689652|FG002|STARTED|Safety Follow-up (SFU) Period||13
8648486|NCT00624468|9689653|FG003|STARTED|Safety Follow-up (SFU) Period||14
8648487|NCT00624468|9689650|FG000|COMPLETED|Safety Follow-up (SFU) Period||0
8648488|NCT00624468|9689651|FG001|COMPLETED|Safety Follow-up (SFU) Period||0
8648489|NCT00624468|9689652|FG002|COMPLETED|Safety Follow-up (SFU) Period||11
8648490|NCT00624468|9689653|FG003|COMPLETED|Safety Follow-up (SFU) Period||11
8648491|NCT00624468|9689650|FG000|NOT COMPLETED|Safety Follow-up (SFU) Period||0
8648492|NCT00624468|9689651|FG001|NOT COMPLETED|Safety Follow-up (SFU) Period||0
8648493|NCT00624468|9689652|FG002|NOT COMPLETED|Safety Follow-up (SFU) Period||2
8648494|NCT00624468|9689653|FG003|NOT COMPLETED|Safety Follow-up (SFU) Period||3
8648495|NCT00624520|9689663|FG000|STARTED|Overall Study||56
8648496|NCT00624520|9689664|FG001|STARTED|Overall Study||47
8648497|NCT00624520|9689663|FG000|COMPLETED|Overall Study||44
8648498|NCT00624520|9689664|FG001|COMPLETED|Overall Study||39
8648499|NCT00624520|9689663|FG000|NOT COMPLETED|Overall Study||12
8648500|NCT00624520|9689664|FG001|NOT COMPLETED|Overall Study||8
8648501|NCT00624559|9689674|FG000|STARTED|Overall Study|Celebrex 1st: 3days baseline(100mmol), 7days high(350mmol) followed by 7days low(20mmol) sodium/day|3
8648502|NCT00624559|9689675|FG001|STARTED|Overall Study|Celebrex 1st: 3days baseline(100mmol), 7days low(20mmol) followed by 7days high(350mmol) sodium/day|3
8648503|NCT00624559|9689676|FG002|STARTED|Overall Study|Placebo 1st: 3days baseline(100mmol), 7days low(20mmol) followed by 7days high(350mmol) sodium/day|3
8648504|NCT00624559|9689677|FG003|STARTED|Overall Study|Placebo 1st: 3days baseline(100mmol), 7days high(350mmol) followed by 7days low(20mmol) sodium/day|3
8648505|NCT00624559|9689674|FG000|COMPLETED|Overall Study||3
8648506|NCT00624559|9689675|FG001|COMPLETED|Overall Study||3
8648507|NCT00624559|9689676|FG002|COMPLETED|Overall Study||3
8648508|NCT00624559|9689677|FG003|COMPLETED|Overall Study||3
8648509|NCT00624559|9689674|FG000|NOT COMPLETED|Overall Study||0
8648510|NCT00624559|9689675|FG001|NOT COMPLETED|Overall Study||0
8648511|NCT00624559|9689676|FG002|NOT COMPLETED|Overall Study||0
8648512|NCT00624559|9689677|FG003|NOT COMPLETED|Overall Study||0
8648513|NCT00624585|9689687|FG000|STARTED|Overall Study||18
8648514|NCT00624585|9689687|FG000|COMPLETED|Overall Study||6
8648515|NCT00624585|9689687|FG000|NOT COMPLETED|Overall Study||12
8648516|NCT00624780|9689697|FG000|STARTED|Treatment Optimization (Up to Week 12)||154
8648517|NCT00624780|9689698|FG001|STARTED|Treatment Optimization (Up to Week 12)||52
8648518|NCT00624780|9689699|FG002|STARTED|Treatment Optimization (Up to Week 12)||154
8648519|NCT00624780|9689700|FG003|STARTED|Treatment Optimization (Up to Week 12)||52
8648520|NCT00624780|9689701|FG004|STARTED|Treatment Optimization (Up to Week 12)||153
8648521|NCT00624780|9689702|FG005|STARTED|Treatment Optimization (Up to Week 12)||50
8648522|NCT00624780|9689697|FG000|COMPLETED|Treatment Optimization (Up to Week 12)||121
8648523|NCT00624780|9689698|FG001|COMPLETED|Treatment Optimization (Up to Week 12)||39
8648524|NCT00624780|9689699|FG002|COMPLETED|Treatment Optimization (Up to Week 12)||112
8648525|NCT00624780|9689700|FG003|COMPLETED|Treatment Optimization (Up to Week 12)||38
8648526|NCT00624780|9689701|FG004|COMPLETED|Treatment Optimization (Up to Week 12)||114
8648527|NCT00624780|9689702|FG005|COMPLETED|Treatment Optimization (Up to Week 12)||39
8648528|NCT00624780|9689697|FG000|NOT COMPLETED|Treatment Optimization (Up to Week 12)||33
8648529|NCT00624780|9689698|FG001|NOT COMPLETED|Treatment Optimization (Up to Week 12)||13
8648530|NCT00624780|9689699|FG002|NOT COMPLETED|Treatment Optimization (Up to Week 12)||42
8648531|NCT00624780|9689700|FG003|NOT COMPLETED|Treatment Optimization (Up to Week 12)||14
8648532|NCT00624780|9689701|FG004|NOT COMPLETED|Treatment Optimization (Up to Week 12)||39
8648533|NCT00624780|9689702|FG005|NOT COMPLETED|Treatment Optimization (Up to Week 12)||11
8648534|NCT00624780|9689697|FG000|STARTED|Fixed Dosing (Week 13 to Week 24)||121
8648535|NCT00624780|9689698|FG001|STARTED|Fixed Dosing (Week 13 to Week 24)||39
8648536|NCT00624780|9689699|FG002|STARTED|Fixed Dosing (Week 13 to Week 24)||112
8648537|NCT00624780|9689700|FG003|STARTED|Fixed Dosing (Week 13 to Week 24)||38
8648538|NCT00624780|9689701|FG004|STARTED|Fixed Dosing (Week 13 to Week 24)||114
8648539|NCT00624780|9689702|FG005|STARTED|Fixed Dosing (Week 13 to Week 24)||39
8648540|NCT00624780|9689697|FG000|COMPLETED|Fixed Dosing (Week 13 to Week 24)||106
8648541|NCT00624780|9689698|FG001|COMPLETED|Fixed Dosing (Week 13 to Week 24)||28
8648542|NCT00624780|9689699|FG002|COMPLETED|Fixed Dosing (Week 13 to Week 24)||94
8648543|NCT00624780|9689700|FG003|COMPLETED|Fixed Dosing (Week 13 to Week 24)||27
8648544|NCT00624780|9689701|FG004|COMPLETED|Fixed Dosing (Week 13 to Week 24)||95
8648545|NCT00624780|9689702|FG005|COMPLETED|Fixed Dosing (Week 13 to Week 24)||30
8648546|NCT00624780|9689697|FG000|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||15
8648547|NCT00624780|9689698|FG001|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||11
8648548|NCT00624780|9689699|FG002|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||18
8648549|NCT00624780|9689700|FG003|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||11
8648550|NCT00624780|9689701|FG004|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||19
8648551|NCT00624780|9689702|FG005|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||9
8727945|NCT01045421|9775197|FG003|STARTED|Phase 2||0
8727946|NCT01045421|9775198|FG004|STARTED|Phase 2||0
8727947|NCT01045421|9775199|FG005|STARTED|Phase 2||0
8727948|NCT01045421|9775200|FG006|STARTED|Phase 2||53
8727949|NCT01045421|9775201|FG007|STARTED|Phase 2||55
8727950|NCT01045421|9775202|FG008|STARTED|Phase 2||55
8648552|NCT00624780|9689697|FG000|STARTED|Treatment Discontinuation (Week 25)||106
8648553|NCT00624780|9689698|FG001|STARTED|Treatment Discontinuation (Week 25)||28
8648554|NCT00624780|9689699|FG002|STARTED|Treatment Discontinuation (Week 25)||94
8648555|NCT00624780|9689700|FG003|STARTED|Treatment Discontinuation (Week 25)||27
8648556|NCT00624780|9689701|FG004|STARTED|Treatment Discontinuation (Week 25)||95
8648557|NCT00624780|9689702|FG005|STARTED|Treatment Discontinuation (Week 25)||30
8648558|NCT00624780|9689697|FG000|COMPLETED|Treatment Discontinuation (Week 25)||104
8648559|NCT00624780|9689698|FG001|COMPLETED|Treatment Discontinuation (Week 25)||28
8648560|NCT00624780|9689699|FG002|COMPLETED|Treatment Discontinuation (Week 25)||91
8648561|NCT00624780|9689700|FG003|COMPLETED|Treatment Discontinuation (Week 25)||26
8648562|NCT00624780|9689701|FG004|COMPLETED|Treatment Discontinuation (Week 25)||95
8648563|NCT00624780|9689702|FG005|COMPLETED|Treatment Discontinuation (Week 25)||29
8648564|NCT00624780|9689697|FG000|NOT COMPLETED|Treatment Discontinuation (Week 25)||2
8648565|NCT00624780|9689698|FG001|NOT COMPLETED|Treatment Discontinuation (Week 25)||0
8648566|NCT00624780|9689699|FG002|NOT COMPLETED|Treatment Discontinuation (Week 25)||3
8648567|NCT00624780|9689700|FG003|NOT COMPLETED|Treatment Discontinuation (Week 25)||1
8648568|NCT00624780|9689701|FG004|NOT COMPLETED|Treatment Discontinuation (Week 25)||0
8648569|NCT00624780|9689702|FG005|NOT COMPLETED|Treatment Discontinuation (Week 25)||1
8648570|NCT00624780|9689697|FG000|STARTED|Follow-up (Week 26)||104
8648571|NCT00624780|9689698|FG001|STARTED|Follow-up (Week 26)||28
8648572|NCT00624780|9689699|FG002|STARTED|Follow-up (Week 26)||91
8648573|NCT00624780|9689700|FG003|STARTED|Follow-up (Week 26)||26
8648574|NCT00624780|9689701|FG004|STARTED|Follow-up (Week 26)||95
8648575|NCT00624780|9689702|FG005|STARTED|Follow-up (Week 26)||29
8648576|NCT00624780|9689697|FG000|COMPLETED|Follow-up (Week 26)||102
8648577|NCT00624780|9689698|FG001|COMPLETED|Follow-up (Week 26)||27
8648578|NCT00624780|9689699|FG002|COMPLETED|Follow-up (Week 26)||89
8648579|NCT00624780|9689700|FG003|COMPLETED|Follow-up (Week 26)||26
8648580|NCT00624780|9689701|FG004|COMPLETED|Follow-up (Week 26)||93
8648581|NCT00624780|9689702|FG005|COMPLETED|Follow-up (Week 26)||29
8648582|NCT00624780|9689697|FG000|NOT COMPLETED|Follow-up (Week 26)||2
8648583|NCT00624780|9689698|FG001|NOT COMPLETED|Follow-up (Week 26)||1
8648584|NCT00624780|9689699|FG002|NOT COMPLETED|Follow-up (Week 26)||2
8648585|NCT00624780|9689700|FG003|NOT COMPLETED|Follow-up (Week 26)||0
8648586|NCT00624780|9689701|FG004|NOT COMPLETED|Follow-up (Week 26)||2
8648587|NCT00624780|9689702|FG005|NOT COMPLETED|Follow-up (Week 26)||0
8648588|NCT00624806|9689721|FG000|STARTED|Overall Study||10
8648589|NCT00624806|9689722|FG001|STARTED|Overall Study||8
8648590|NCT00624806|9689721|FG000|COMPLETED|Overall Study||10
8648591|NCT00624806|9689722|FG001|COMPLETED|Overall Study||8
8648592|NCT00624806|9689721|FG000|NOT COMPLETED|Overall Study||0
8648593|NCT00624806|9689722|FG001|NOT COMPLETED|Overall Study||0
8648594|NCT00624819|9689732|FG000|STARTED|Follow-up Period: Year 1||391
8648595|NCT00624819|9689733|FG001|STARTED|Follow-up Period: Year 1||31
8648596|NCT00624819|9689734|FG002|STARTED|Follow-up Period: Year 1||102
8648597|NCT00624819|9689735|FG003|STARTED|Follow-up Period: Year 1||0
8648598|NCT00624819|9689732|FG000|COMPLETED|Follow-up Period: Year 1||391
8648599|NCT00624819|9689733|FG001|COMPLETED|Follow-up Period: Year 1||31
8648600|NCT00624819|9689734|FG002|COMPLETED|Follow-up Period: Year 1||102
8648601|NCT00624819|9689735|FG003|COMPLETED|Follow-up Period: Year 1||0
8648602|NCT00624819|9689732|FG000|NOT COMPLETED|Follow-up Period: Year 1||0
8648603|NCT00624819|9689733|FG001|NOT COMPLETED|Follow-up Period: Year 1||0
8648604|NCT00624819|9689734|FG002|NOT COMPLETED|Follow-up Period: Year 1||0
8648605|NCT00624819|9689735|FG003|NOT COMPLETED|Follow-up Period: Year 1||0
8648606|NCT00624819|9689732|FG000|STARTED|Follow-up Period: Year 2||370
8648607|NCT00624819|9689733|FG001|STARTED|Follow-up Period: Year 2||31
8648608|NCT00624819|9689734|FG002|STARTED|Follow-up Period: Year 2||96
8648609|NCT00624819|9689735|FG003|STARTED|Follow-up Period: Year 2||0
8648610|NCT00624819|9689732|FG000|COMPLETED|Follow-up Period: Year 2||370
8648611|NCT00624819|9689733|FG001|COMPLETED|Follow-up Period: Year 2||31
8648612|NCT00624819|9689734|FG002|COMPLETED|Follow-up Period: Year 2||96
8648613|NCT00624819|9689735|FG003|COMPLETED|Follow-up Period: Year 2||0
8648614|NCT00624819|9689732|FG000|NOT COMPLETED|Follow-up Period: Year 2||0
8648615|NCT00624819|9689733|FG001|NOT COMPLETED|Follow-up Period: Year 2||0
8648616|NCT00624819|9689734|FG002|NOT COMPLETED|Follow-up Period: Year 2||0
8648617|NCT00624819|9689735|FG003|NOT COMPLETED|Follow-up Period: Year 2||0
8648618|NCT00624819|9689732|FG000|STARTED|Follow-up Period: Year 4||264
8648619|NCT00624819|9689733|FG001|STARTED|Follow-up Period: Year 4||20
8648620|NCT00624819|9689734|FG002|STARTED|Follow-up Period: Year 4||65
8648621|NCT00624819|9689735|FG003|STARTED|Follow-up Period: Year 4||100
8648622|NCT00624819|9689732|FG000|COMPLETED|Follow-up Period: Year 4||263
8648623|NCT00624819|9689733|FG001|COMPLETED|Follow-up Period: Year 4||19
8648624|NCT00624819|9689734|FG002|COMPLETED|Follow-up Period: Year 4||64
8648625|NCT00624819|9689735|FG003|COMPLETED|Follow-up Period: Year 4||100
8648626|NCT00624819|9689732|FG000|NOT COMPLETED|Follow-up Period: Year 4||1
8648627|NCT00624819|9689733|FG001|NOT COMPLETED|Follow-up Period: Year 4||1
8648628|NCT00624819|9689734|FG002|NOT COMPLETED|Follow-up Period: Year 4||1
8648629|NCT00624819|9689735|FG003|NOT COMPLETED|Follow-up Period: Year 4||0
8648630|NCT00624832|9689749|FG000|STARTED|Overall Study||18
8648631|NCT00624832|9689750|FG001|STARTED|Overall Study||16
8648632|NCT00624832|9689751|FG002|STARTED|Overall Study||10
8648633|NCT00624832|9689752|FG003|STARTED|Overall Study||16
8648634|NCT00624832|9689749|FG000|COMPLETED|Overall Study||16
8648635|NCT00624832|9689750|FG001|COMPLETED|Overall Study||15
8648636|NCT00624832|9689751|FG002|COMPLETED|Overall Study||10
8648637|NCT00624832|9689752|FG003|COMPLETED|Overall Study||15
8648638|NCT00624832|9689749|FG000|NOT COMPLETED|Overall Study||2
8648639|NCT00624832|9689750|FG001|NOT COMPLETED|Overall Study||1
8648640|NCT00624832|9689751|FG002|NOT COMPLETED|Overall Study||0
8648641|NCT00624832|9689752|FG003|NOT COMPLETED|Overall Study||1
8648642|NCT00624910|9689764|FG000|STARTED|Overall Study||28
8648643|NCT00624910|9689765|FG001|STARTED|Overall Study||15
8648644|NCT00624910|9689766|FG002|STARTED|Overall Study||11
8648645|NCT00624910|9689764|FG000|COMPLETED|Overall Study||28
8648646|NCT00624910|9689765|FG001|COMPLETED|Overall Study||15
8648647|NCT00624910|9689766|FG002|COMPLETED|Overall Study||11
8648648|NCT00624910|9689764|FG000|NOT COMPLETED|Overall Study||0
8648649|NCT00624910|9689765|FG001|NOT COMPLETED|Overall Study||0
8648650|NCT00624910|9689766|FG002|NOT COMPLETED|Overall Study||0
8648651|NCT00624923|9689776|FG000|STARTED|Overall Study||127
8648652|NCT00624923|9689777|FG001|STARTED|Overall Study||124
8648653|NCT00624923|9689776|FG000|COMPLETED|Overall Study||89
8648654|NCT00624923|9689777|FG001|COMPLETED|Overall Study||101
8648655|NCT00624923|9689776|FG000|NOT COMPLETED|Overall Study||38
8648656|NCT00624923|9689777|FG001|NOT COMPLETED|Overall Study||23
8648657|NCT00625131|9689787|FG000|STARTED|Overall Study||38
8648658|NCT00625131|9689788|FG001|STARTED|Overall Study||44
8648659|NCT00625131|9689789|FG002|STARTED|Overall Study|These participants were not included in any analyses.|5
8648660|NCT00625131|9689787|FG000|COMPLETED|Overall Study||34
8648661|NCT00625131|9689788|FG001|COMPLETED|Overall Study||42
8648662|NCT00625131|9689789|FG002|COMPLETED|Overall Study||0
8648663|NCT00625131|9689787|FG000|NOT COMPLETED|Overall Study||4
8648664|NCT00625131|9689788|FG001|NOT COMPLETED|Overall Study||2
8648665|NCT00625131|9689789|FG002|NOT COMPLETED|Overall Study||5
8648666|NCT00625183|9689795|FG000|STARTED|Overall Study||5
8648667|NCT00625183|9689795|FG000|COMPLETED|Overall Study||4
8648668|NCT00625183|9689795|FG000|NOT COMPLETED|Overall Study||1
8648669|NCT00625365|9689801|FG000|STARTED|Overall Study||1060
8648670|NCT00625365|9689801|FG000|COMPLETED|Overall Study|Participants who were analyzed for safety|1053
8648671|NCT00625365|9689801|FG000|NOT COMPLETED|Overall Study||7
8648672|NCT00625391|9689809|FG000|STARTED|Overall Study||44
8648673|NCT00625391|9689810|FG001|STARTED|Overall Study||47
8648674|NCT00625391|9689811|FG002|STARTED|Overall Study||42
8648675|NCT00625391|9689812|FG003|STARTED|Overall Study||38
8648676|NCT00625391|9689809|FG000|COMPLETED|Overall Study||37
8648677|NCT00625391|9689810|FG001|COMPLETED|Overall Study||39
8648678|NCT00625391|9689811|FG002|COMPLETED|Overall Study||37
8648679|NCT00625391|9689812|FG003|COMPLETED|Overall Study||37
8648680|NCT00625391|9689809|FG000|NOT COMPLETED|Overall Study||7
8727951|NCT01045421|9775203|FG009|STARTED|Phase 2||26
8727952|NCT01045421|9775204|FG010|STARTED|Phase 2||60
8727953|NCT01045421|9775194|FG000|COMPLETED|Phase 2||0
8727954|NCT01045421|9775195|FG001|COMPLETED|Phase 2||0
8727955|NCT01045421|9775196|FG002|COMPLETED|Phase 2||0
8727956|NCT01045421|9775197|FG003|COMPLETED|Phase 2||0
8727957|NCT01045421|9775198|FG004|COMPLETED|Phase 2||0
8727958|NCT01045421|9775199|FG005|COMPLETED|Phase 2||0
8727959|NCT01045421|9775200|FG006|COMPLETED|Phase 2||53
8727960|NCT01045421|9775201|FG007|COMPLETED|Phase 2||50
8727961|NCT01045421|9775202|FG008|COMPLETED|Phase 2||53
8727962|NCT01045421|9775203|FG009|COMPLETED|Phase 2||23
8727963|NCT01045421|9775204|FG010|COMPLETED|Phase 2||58
8727964|NCT01045421|9775194|FG000|NOT COMPLETED|Phase 2||0
8727965|NCT01045421|9775195|FG001|NOT COMPLETED|Phase 2||0
8727966|NCT01045421|9775196|FG002|NOT COMPLETED|Phase 2||0
8727967|NCT01045421|9775197|FG003|NOT COMPLETED|Phase 2||0
8727968|NCT01045421|9775198|FG004|NOT COMPLETED|Phase 2||0
8727969|NCT01045421|9775199|FG005|NOT COMPLETED|Phase 2||0
8727970|NCT01045421|9775200|FG006|NOT COMPLETED|Phase 2||0
8727971|NCT01045421|9775201|FG007|NOT COMPLETED|Phase 2||5
8727972|NCT01045421|9775202|FG008|NOT COMPLETED|Phase 2||2
8727973|NCT01045421|9775203|FG009|NOT COMPLETED|Phase 2||3
8727974|NCT01045421|9775204|FG010|NOT COMPLETED|Phase 2||2
8727975|NCT01045447|9775227|FG000|STARTED|Overall Study||232
8727976|NCT01045447|9775228|FG001|STARTED|Overall Study||233
8727977|NCT01045447|9775227|FG000|Exposed|Overall Study|Two subjects withdrew prior to exposure to trial drug|230
8727978|NCT01045447|9775228|FG001|Exposed|Overall Study||233
8727979|NCT01045447|9775227|FG000|COMPLETED|Overall Study||196
8727980|NCT01045447|9775228|FG001|COMPLETED|Overall Study||205
8727981|NCT01045447|9775227|FG000|NOT COMPLETED|Overall Study||36
8727982|NCT01045447|9775228|FG001|NOT COMPLETED|Overall Study||28
8727983|NCT01045460|9775236|FG000|STARTED|Overall Study||17
8727984|NCT01045460|9775237|FG001|STARTED|Overall Study||18
8727985|NCT01045460|9775236|FG000|COMPLETED|Overall Study||11
8727986|NCT01045460|9775237|FG001|COMPLETED|Overall Study||15
8727987|NCT01045460|9775236|FG000|NOT COMPLETED|Overall Study||6
8727988|NCT01045460|9775237|FG001|NOT COMPLETED|Overall Study||3
8727989|NCT01045499|9775245|FG000|STARTED|Overall Study||137
8727990|NCT01045499|9775245|FG000|COMPLETED|Overall Study||127
8727991|NCT01045499|9775245|FG000|NOT COMPLETED|Overall Study||10
8727992|NCT01045551|9775249|FG000|STARTED|Overall Study||10
8727993|NCT01045551|9775249|FG000|COMPLETED|Overall Study||10
8727994|NCT01045551|9775249|FG000|NOT COMPLETED|Overall Study||0
8648681|NCT00625391|9689810|FG001|NOT COMPLETED|Overall Study||8
8648682|NCT00625391|9689811|FG002|NOT COMPLETED|Overall Study||5
8727995|NCT01045707|9775256|FG000|STARTED|Main: Week 0 to 26 (NN5401-3590)||266
8727996|NCT01045707|9775257|FG001|STARTED|Main: Week 0 to 26 (NN5401-3590)||264
8648683|NCT00625391|9689812|FG003|NOT COMPLETED|Overall Study||1
8648684|NCT00625404|9689824|FG000|STARTED|Overall Study||1062
8648685|NCT00625404|9689825|FG001|STARTED|Overall Study||1058
8648686|NCT00625404|9689824|FG000|COMPLETED|Overall Study||855
8648687|NCT00625404|9689825|FG001|COMPLETED|Overall Study||885
8648688|NCT00625404|9689824|FG000|NOT COMPLETED|Overall Study||207
8727997|NCT01045707|9775256|FG000|Exposed|Main: Week 0 to 26 (NN5401-3590)|One subject withdrew prior to exposure to trial drug|265
8727998|NCT01045707|9775257|FG001|Exposed|Main: Week 0 to 26 (NN5401-3590)|Three subjects withdrew prior to exposure to trial drug|261
8727999|NCT01045707|9775256|FG000|COMPLETED|Main: Week 0 to 26 (NN5401-3590)||219
8728000|NCT01045707|9775257|FG001|COMPLETED|Main: Week 0 to 26 (NN5401-3590)||232
8728001|NCT01045707|9775256|FG000|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3590)||47
8728002|NCT01045707|9775257|FG001|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3590)||32
8728003|NCT01045707|9775256|FG000|STARTED|Extension: Week 27 to 52 (NN5401-3726)|Twenty seven subjects from main trial did not continue into the extension|192
8728004|NCT01045707|9775257|FG001|STARTED|Extension: Week 27 to 52 (NN5401-3726)|Eleven subjects from main trial did not continue into the extension|221
8728005|NCT01045707|9775256|FG000|COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||179
8728006|NCT01045707|9775257|FG001|COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||209
8728007|NCT01045707|9775256|FG000|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||13
8728008|NCT01045707|9775257|FG001|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||12
8728009|NCT01045798|9775265|FG000|STARTED|Overall Study||6
8728010|NCT01045798|9775266|FG001|STARTED|Overall Study||9
8728011|NCT01045798|9775265|FG000|COMPLETED|Overall Study||4
8728012|NCT01045798|9775266|FG001|COMPLETED|Overall Study||5
8728013|NCT01045798|9775265|FG000|NOT COMPLETED|Overall Study||2
8728014|NCT01045798|9775266|FG001|NOT COMPLETED|Overall Study||4
8728015|NCT01045967|9775274|FG000|STARTED|First Intervention||28
8728016|NCT01045967|9775275|FG001|STARTED|First Intervention||28
8728017|NCT01045967|9775274|FG000|COMPLETED|First Intervention||28
8728018|NCT01045967|9775275|FG001|COMPLETED|First Intervention||28
8728019|NCT01045967|9775274|FG000|NOT COMPLETED|First Intervention||0
8728020|NCT01045967|9775275|FG001|NOT COMPLETED|First Intervention||0
8728021|NCT01045967|9775274|FG000|STARTED|Washout of 7 Days||28
8728022|NCT01045967|9775275|FG001|STARTED|Washout of 7 Days||28
8728023|NCT01045967|9775274|FG000|COMPLETED|Washout of 7 Days||28
8728024|NCT01045967|9775275|FG001|COMPLETED|Washout of 7 Days||28
8728025|NCT01045967|9775274|FG000|NOT COMPLETED|Washout of 7 Days||0
8728026|NCT01045967|9775275|FG001|NOT COMPLETED|Washout of 7 Days||0
8728027|NCT01045967|9775274|FG000|STARTED|Second Intervention||28
8728028|NCT01045967|9775275|FG001|STARTED|Second Intervention|Subject was dropped prior to dosing in Period II due to positive drug screen.|28
8728029|NCT01045967|9775274|FG000|COMPLETED|Second Intervention||28
8728030|NCT01045967|9775275|FG001|COMPLETED|Second Intervention||27
8728031|NCT01045967|9775274|FG000|NOT COMPLETED|Second Intervention||0
8728032|NCT01045967|9775275|FG001|NOT COMPLETED|Second Intervention||1
8728033|NCT01045993|9775285|FG000|STARTED|Overall Study||26
8648689|NCT00625404|9689825|FG001|NOT COMPLETED|Overall Study||173
8648690|NCT00625443|9689838|FG000|STARTED|Overall Study||12
8648691|NCT00625443|9689839|FG001|STARTED|Overall Study||26
8648692|NCT00625443|9689840|FG002|STARTED|Overall Study||15
8648693|NCT00625443|9689838|FG000|COMPLETED|Overall Study||10
8648694|NCT00625443|9689839|FG001|COMPLETED|Overall Study||15
8648695|NCT00625443|9689840|FG002|COMPLETED|Overall Study||10
8648696|NCT00625443|9689838|FG000|NOT COMPLETED|Overall Study||2
8648697|NCT00625443|9689839|FG001|NOT COMPLETED|Overall Study||11
8648698|NCT00625443|9689840|FG002|NOT COMPLETED|Overall Study||5
8648699|NCT00625729|9689851|FG000|STARTED|Overall Study||6
8648700|NCT00625729|9689851|FG000|COMPLETED|Overall Study||6
8648701|NCT00625729|9689851|FG000|NOT COMPLETED|Overall Study||0
8648702|NCT00625807|9689858|FG000|STARTED|Overall Study||22
8648703|NCT00625807|9689859|FG001|STARTED|Overall Study||28
8648704|NCT00625807|9689858|FG000|COMPLETED|Overall Study||20
8648705|NCT00625807|9689859|FG001|COMPLETED|Overall Study||20
8648706|NCT00625807|9689858|FG000|NOT COMPLETED|Overall Study||2
8648707|NCT00625807|9689859|FG001|NOT COMPLETED|Overall Study||8
8648708|NCT00625820|9689867|FG000|STARTED|Overall Study||17
8648709|NCT00625820|9689867|FG000|COMPLETED|Overall Study||16
8648710|NCT00625820|9689867|FG000|NOT COMPLETED|Overall Study||1
8648711|NCT00625846|9689876|FG000|STARTED|Overall Study||39
8648712|NCT00625846|9689877|FG001|STARTED|Overall Study||35
8648713|NCT00625846|9689878|FG002|STARTED|Overall Study||16
8648714|NCT00625846|9689879|FG003|STARTED|Overall Study||62
8648715|NCT00625846|9689876|FG000|COMPLETED|Overall Study||37
8648716|NCT00625846|9689877|FG001|COMPLETED|Overall Study||35
8648717|NCT00625846|9689878|FG002|COMPLETED|Overall Study||15
8648718|NCT00625846|9689879|FG003|COMPLETED|Overall Study||60
8648719|NCT00625846|9689876|FG000|NOT COMPLETED|Overall Study||2
8648720|NCT00625846|9689877|FG001|NOT COMPLETED|Overall Study||0
8648721|NCT00625846|9689878|FG002|NOT COMPLETED|Overall Study||1
8648722|NCT00625846|9689879|FG003|NOT COMPLETED|Overall Study||2
8648723|NCT00625872|9689895|FG000|STARTED|Overall Study||12
8648724|NCT00625872|9689896|FG001|STARTED|Overall Study||11
8648725|NCT00625872|9689895|FG000|Treated|Overall Study||12
8648726|NCT00625872|9689896|FG001|Treated|Overall Study||10
8648727|NCT00625872|9689895|FG000|COMPLETED|Overall Study||8
8648728|NCT00625872|9689896|FG001|COMPLETED|Overall Study||5
8648729|NCT00625872|9689895|FG000|NOT COMPLETED|Overall Study||4
8648730|NCT00625872|9689896|FG001|NOT COMPLETED|Overall Study||6
8648731|NCT00625989|9689902|FG000|STARTED|Overall Study||6
8648732|NCT00625989|9689903|FG001|STARTED|Overall Study||6
8648733|NCT00625989|9689902|FG000|COMPLETED|Overall Study||6
8648734|NCT00625989|9689903|FG001|COMPLETED|Overall Study||6
8648735|NCT00625989|9689902|FG000|NOT COMPLETED|Overall Study||0
8648736|NCT00625989|9689903|FG001|NOT COMPLETED|Overall Study||0
8648737|NCT00626028|9689910|FG000|STARTED|Overall Study||68
8648738|NCT00626028|9689911|FG001|STARTED|Overall Study||68
8648739|NCT00626028|9689910|FG000|COMPLETED|Overall Study||62
8648740|NCT00626028|9689911|FG001|COMPLETED|Overall Study||59
8648741|NCT00626028|9689910|FG000|NOT COMPLETED|Overall Study||6
8648742|NCT00626028|9689911|FG001|NOT COMPLETED|Overall Study||9
8648743|NCT00626093|9689917|FG000|STARTED|Overall Study||77
8648744|NCT00626093|9689917|FG000|COMPLETED|Overall Study||54
8648745|NCT00626093|9689917|FG000|NOT COMPLETED|Overall Study||23
8648746|NCT00626197|9689924|FG000|STARTED|Overall Study||127
8648747|NCT00626197|9689925|FG001|STARTED|Overall Study||128
8648748|NCT00626197|9689926|FG002|STARTED|Overall Study||126
8648749|NCT00626197|9689924|FG000|COMPLETED|Overall Study||83
8648750|NCT00626197|9689925|FG001|COMPLETED|Overall Study||74
8648751|NCT00626197|9689926|FG002|COMPLETED|Overall Study||49
8648752|NCT00626197|9689924|FG000|NOT COMPLETED|Overall Study||44
8648753|NCT00626197|9689925|FG001|NOT COMPLETED|Overall Study||54
8648754|NCT00626197|9689926|FG002|NOT COMPLETED|Overall Study||77
8648755|NCT00626210|9689940|FG000|STARTED|Overall Study||2
8648756|NCT00626210|9689940|FG000|COMPLETED|Overall Study||2
8648757|NCT00626210|9689940|FG000|NOT COMPLETED|Overall Study||0
8648758|NCT00626275|9689944|FG000|STARTED|Part A - Treatment Period 1||7
8648759|NCT00626275|9689945|FG001|STARTED|Part A - Treatment Period 1||7
8648760|NCT00626275|9689946|FG002|STARTED|Part A - Treatment Period 1||7
8648761|NCT00626275|9689947|FG003|STARTED|Part A - Treatment Period 1||8
8648762|NCT00626275|9689948|FG004|STARTED|Part A - Treatment Period 1||9
8648763|NCT00626275|9689949|FG005|STARTED|Part A - Treatment Period 1||8
8648764|NCT00626275|9689950|FG006|STARTED|Part A - Treatment Period 1||0
8648765|NCT00626275|9689951|FG007|STARTED|Part A - Treatment Period 1||0
8648766|NCT00626275|9689944|FG000|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||7
8648767|NCT00626275|9689945|FG001|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||7
8648768|NCT00626275|9689946|FG002|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||7
8648769|NCT00626275|9689947|FG003|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||8
8648770|NCT00626275|9689948|FG004|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||9
8648771|NCT00626275|9689949|FG005|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||8
8648772|NCT00626275|9689950|FG006|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||0
8648773|NCT00626275|9689951|FG007|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||0
8648774|NCT00626275|9689944|FG000|COMPLETED|Part A - Treatment Period 1||6
8648775|NCT00626275|9689945|FG001|COMPLETED|Part A - Treatment Period 1||7
8648776|NCT00626275|9689946|FG002|COMPLETED|Part A - Treatment Period 1||6
8648777|NCT00626275|9689947|FG003|COMPLETED|Part A - Treatment Period 1||8
8648778|NCT00626275|9689948|FG004|COMPLETED|Part A - Treatment Period 1||9
8648779|NCT00626275|9689949|FG005|COMPLETED|Part A - Treatment Period 1||8
8648780|NCT00626275|9689950|FG006|COMPLETED|Part A - Treatment Period 1||0
8648781|NCT00626275|9689951|FG007|COMPLETED|Part A - Treatment Period 1||0
8648782|NCT00626275|9689944|FG000|NOT COMPLETED|Part A - Treatment Period 1||1
8648783|NCT00626275|9689945|FG001|NOT COMPLETED|Part A - Treatment Period 1||0
8648784|NCT00626275|9689946|FG002|NOT COMPLETED|Part A - Treatment Period 1||1
8648785|NCT00626275|9689947|FG003|NOT COMPLETED|Part A - Treatment Period 1||0
8648786|NCT00626275|9689948|FG004|NOT COMPLETED|Part A - Treatment Period 1||0
8648787|NCT00626275|9689949|FG005|NOT COMPLETED|Part A - Treatment Period 1||0
8648788|NCT00626275|9689950|FG006|NOT COMPLETED|Part A - Treatment Period 1||0
8648789|NCT00626275|9689951|FG007|NOT COMPLETED|Part A - Treatment Period 1||0
8648790|NCT00626275|9689944|FG000|STARTED|Part A - Washout Period 1||6
8648791|NCT00626275|9689945|FG001|STARTED|Part A - Washout Period 1||7
8648792|NCT00626275|9689946|FG002|STARTED|Part A - Washout Period 1||6
8648793|NCT00626275|9689947|FG003|STARTED|Part A - Washout Period 1||8
8648794|NCT00626275|9689948|FG004|STARTED|Part A - Washout Period 1||9
8648795|NCT00626275|9689949|FG005|STARTED|Part A - Washout Period 1||8
8648796|NCT00626275|9689950|FG006|STARTED|Part A - Washout Period 1||0
8648797|NCT00626275|9689951|FG007|STARTED|Part A - Washout Period 1||0
8648798|NCT00626275|9689944|FG000|COMPLETED|Part A - Washout Period 1||6
8648799|NCT00626275|9689945|FG001|COMPLETED|Part A - Washout Period 1||7
8648800|NCT00626275|9689946|FG002|COMPLETED|Part A - Washout Period 1||6
8648801|NCT00626275|9689947|FG003|COMPLETED|Part A - Washout Period 1||8
8648802|NCT00626275|9689948|FG004|COMPLETED|Part A - Washout Period 1||9
8648803|NCT00626275|9689949|FG005|COMPLETED|Part A - Washout Period 1||8
8648804|NCT00626275|9689950|FG006|COMPLETED|Part A - Washout Period 1||0
8648805|NCT00626275|9689951|FG007|COMPLETED|Part A - Washout Period 1||0
8648806|NCT00626275|9689944|FG000|NOT COMPLETED|Part A - Washout Period 1||0
8648807|NCT00626275|9689945|FG001|NOT COMPLETED|Part A - Washout Period 1||0
8648808|NCT00626275|9689946|FG002|NOT COMPLETED|Part A - Washout Period 1||0
8648809|NCT00626275|9689947|FG003|NOT COMPLETED|Part A - Washout Period 1||0
8648810|NCT00626275|9689948|FG004|NOT COMPLETED|Part A - Washout Period 1||0
8648811|NCT00626275|9689949|FG005|NOT COMPLETED|Part A - Washout Period 1||0
8648812|NCT00626275|9689950|FG006|NOT COMPLETED|Part A - Washout Period 1||0
8648813|NCT00626275|9689951|FG007|NOT COMPLETED|Part A - Washout Period 1||0
8648814|NCT00626275|9689944|FG000|STARTED|Part A - Treatment Period 2||6
8648815|NCT00626275|9689945|FG001|STARTED|Part A - Treatment Period 2||7
8648816|NCT00626275|9689946|FG002|STARTED|Part A - Treatment Period 2||6
8648817|NCT00626275|9689947|FG003|STARTED|Part A - Treatment Period 2||8
8648818|NCT00626275|9689948|FG004|STARTED|Part A - Treatment Period 2||9
8648819|NCT00626275|9689949|FG005|STARTED|Part A - Treatment Period 2||8
8648820|NCT00626275|9689950|FG006|STARTED|Part A - Treatment Period 2||0
8648821|NCT00626275|9689951|FG007|STARTED|Part A - Treatment Period 2||0
8648822|NCT00626275|9689944|FG000|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||6
8648823|NCT00626275|9689945|FG001|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||7
8648824|NCT00626275|9689946|FG002|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||6
8648825|NCT00626275|9689947|FG003|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||8
8648826|NCT00626275|9689948|FG004|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||9
8648827|NCT00626275|9689949|FG005|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||8
8648828|NCT00626275|9689950|FG006|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||0
8648829|NCT00626275|9689951|FG007|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||0
8648830|NCT00626275|9689944|FG000|COMPLETED|Part A - Treatment Period 2||6
8648831|NCT00626275|9689945|FG001|COMPLETED|Part A - Treatment Period 2||7
8648832|NCT00626275|9689946|FG002|COMPLETED|Part A - Treatment Period 2||6
8648833|NCT00626275|9689947|FG003|COMPLETED|Part A - Treatment Period 2||8
8648834|NCT00626275|9689948|FG004|COMPLETED|Part A - Treatment Period 2||9
8648835|NCT00626275|9689949|FG005|COMPLETED|Part A - Treatment Period 2||8
8648836|NCT00626275|9689950|FG006|COMPLETED|Part A - Treatment Period 2||0
8648837|NCT00626275|9689951|FG007|COMPLETED|Part A - Treatment Period 2||0
8648838|NCT00626275|9689944|FG000|NOT COMPLETED|Part A - Treatment Period 2||0
8648839|NCT00626275|9689945|FG001|NOT COMPLETED|Part A - Treatment Period 2||0
8648840|NCT00626275|9689946|FG002|NOT COMPLETED|Part A - Treatment Period 2||0
8648841|NCT00626275|9689947|FG003|NOT COMPLETED|Part A - Treatment Period 2||0
8648842|NCT00626275|9689948|FG004|NOT COMPLETED|Part A - Treatment Period 2||0
8648843|NCT00626275|9689949|FG005|NOT COMPLETED|Part A - Treatment Period 2||0
8648844|NCT00626275|9689950|FG006|NOT COMPLETED|Part A - Treatment Period 2||0
8648845|NCT00626275|9689951|FG007|NOT COMPLETED|Part A - Treatment Period 2||0
8648846|NCT00626275|9689944|FG000|STARTED|Part A - Washout Period 2||6
8648847|NCT00626275|9689945|FG001|STARTED|Part A - Washout Period 2||7
8648848|NCT00626275|9689946|FG002|STARTED|Part A - Washout Period 2||6
8648849|NCT00626275|9689947|FG003|STARTED|Part A - Washout Period 2||8
8648850|NCT00626275|9689948|FG004|STARTED|Part A - Washout Period 2||9
8648851|NCT00626275|9689949|FG005|STARTED|Part A - Washout Period 2||8
8648852|NCT00626275|9689950|FG006|STARTED|Part A - Washout Period 2||0
8648853|NCT00626275|9689951|FG007|STARTED|Part A - Washout Period 2||0
8648854|NCT00626275|9689944|FG000|COMPLETED|Part A - Washout Period 2||6
8648855|NCT00626275|9689945|FG001|COMPLETED|Part A - Washout Period 2||7
8648856|NCT00626275|9689946|FG002|COMPLETED|Part A - Washout Period 2||6
8648857|NCT00626275|9689947|FG003|COMPLETED|Part A - Washout Period 2||8
8648858|NCT00626275|9689948|FG004|COMPLETED|Part A - Washout Period 2||9
8648859|NCT00626275|9689949|FG005|COMPLETED|Part A - Washout Period 2||8
8648860|NCT00626275|9689950|FG006|COMPLETED|Part A - Washout Period 2||0
8648861|NCT00626275|9689951|FG007|COMPLETED|Part A - Washout Period 2||0
8648862|NCT00626275|9689944|FG000|NOT COMPLETED|Part A - Washout Period 2||0
8648863|NCT00626275|9689945|FG001|NOT COMPLETED|Part A - Washout Period 2||0
8648864|NCT00626275|9689946|FG002|NOT COMPLETED|Part A - Washout Period 2||0
8648865|NCT00626275|9689947|FG003|NOT COMPLETED|Part A - Washout Period 2||0
8648866|NCT00626275|9689948|FG004|NOT COMPLETED|Part A - Washout Period 2||0
8648867|NCT00626275|9689949|FG005|NOT COMPLETED|Part A - Washout Period 2||0
8648868|NCT00626275|9689950|FG006|NOT COMPLETED|Part A - Washout Period 2||0
8648869|NCT00626275|9689951|FG007|NOT COMPLETED|Part A - Washout Period 2||0
8648870|NCT00626275|9689944|FG000|STARTED|Part A - Treatment Period 3||6
8648871|NCT00626275|9689945|FG001|STARTED|Part A - Treatment Period 3||7
8648872|NCT00626275|9689946|FG002|STARTED|Part A - Treatment Period 3||6
8648873|NCT00626275|9689947|FG003|STARTED|Part A - Treatment Period 3||8
8648874|NCT00626275|9689948|FG004|STARTED|Part A - Treatment Period 3||9
8648875|NCT00626275|9689949|FG005|STARTED|Part A - Treatment Period 3||8
8648876|NCT00626275|9689950|FG006|STARTED|Part A - Treatment Period 3||0
8648877|NCT00626275|9689951|FG007|STARTED|Part A - Treatment Period 3||0
8648878|NCT00626275|9689944|FG000|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||6
8648879|NCT00626275|9689945|FG001|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||7
8648880|NCT00626275|9689946|FG002|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||6
8648881|NCT00626275|9689947|FG003|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||8
8648882|NCT00626275|9689948|FG004|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||9
8648883|NCT00626275|9689949|FG005|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||8
8648884|NCT00626275|9689950|FG006|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||0
8648885|NCT00626275|9689951|FG007|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||0
8648886|NCT00626275|9689944|FG000|COMPLETED|Part A - Treatment Period 3||6
8648887|NCT00626275|9689945|FG001|COMPLETED|Part A - Treatment Period 3||7
8648888|NCT00626275|9689946|FG002|COMPLETED|Part A - Treatment Period 3||6
8648889|NCT00626275|9689947|FG003|COMPLETED|Part A - Treatment Period 3||8
8648890|NCT00626275|9689948|FG004|COMPLETED|Part A - Treatment Period 3||9
8648891|NCT00626275|9689949|FG005|COMPLETED|Part A - Treatment Period 3||8
8648892|NCT00626275|9689950|FG006|COMPLETED|Part A - Treatment Period 3||0
8648893|NCT00626275|9689951|FG007|COMPLETED|Part A - Treatment Period 3||0
8648894|NCT00626275|9689944|FG000|NOT COMPLETED|Part A - Treatment Period 3||0
8648895|NCT00626275|9689945|FG001|NOT COMPLETED|Part A - Treatment Period 3||0
8648896|NCT00626275|9689946|FG002|NOT COMPLETED|Part A - Treatment Period 3||0
8648897|NCT00626275|9689947|FG003|NOT COMPLETED|Part A - Treatment Period 3||0
8648898|NCT00626275|9689948|FG004|NOT COMPLETED|Part A - Treatment Period 3||0
8648899|NCT00626275|9689949|FG005|NOT COMPLETED|Part A - Treatment Period 3||0
8648900|NCT00626275|9689950|FG006|NOT COMPLETED|Part A - Treatment Period 3||0
8648901|NCT00626275|9689951|FG007|NOT COMPLETED|Part A - Treatment Period 3||0
8648902|NCT00626275|9689944|FG000|STARTED|Re-randomization Period for Part B||0
8648903|NCT00626275|9689945|FG001|STARTED|Re-randomization Period for Part B||0
8648904|NCT00626275|9689946|FG002|STARTED|Re-randomization Period for Part B||0
8648905|NCT00626275|9689947|FG003|STARTED|Re-randomization Period for Part B||0
8648906|NCT00626275|9689948|FG004|STARTED|Re-randomization Period for Part B||0
8648907|NCT00626275|9689949|FG005|STARTED|Re-randomization Period for Part B||0
8648908|NCT00626275|9689950|FG006|STARTED|Re-randomization Period for Part B||20
8648909|NCT00626275|9689951|FG007|STARTED|Re-randomization Period for Part B||24
8648910|NCT00626275|9689944|FG000|COMPLETED|Re-randomization Period for Part B||0
8648911|NCT00626275|9689945|FG001|COMPLETED|Re-randomization Period for Part B||0
8648912|NCT00626275|9689946|FG002|COMPLETED|Re-randomization Period for Part B||0
8648913|NCT00626275|9689947|FG003|COMPLETED|Re-randomization Period for Part B||0
8648914|NCT00626275|9689948|FG004|COMPLETED|Re-randomization Period for Part B||0
8648915|NCT00626275|9689949|FG005|COMPLETED|Re-randomization Period for Part B||0
8648916|NCT00626275|9689950|FG006|COMPLETED|Re-randomization Period for Part B||20
8648917|NCT00626275|9689951|FG007|COMPLETED|Re-randomization Period for Part B||24
8648918|NCT00626275|9689944|FG000|NOT COMPLETED|Re-randomization Period for Part B||0
8648919|NCT00626275|9689945|FG001|NOT COMPLETED|Re-randomization Period for Part B||0
8648920|NCT00626275|9689946|FG002|NOT COMPLETED|Re-randomization Period for Part B||0
8648921|NCT00626275|9689947|FG003|NOT COMPLETED|Re-randomization Period for Part B||0
8648922|NCT00626275|9689948|FG004|NOT COMPLETED|Re-randomization Period for Part B||0
8648923|NCT00626275|9689949|FG005|NOT COMPLETED|Re-randomization Period for Part B||0
8648924|NCT00626275|9689950|FG006|NOT COMPLETED|Re-randomization Period for Part B||0
8648925|NCT00626275|9689951|FG007|NOT COMPLETED|Re-randomization Period for Part B||0
8648926|NCT00626275|9689944|FG000|STARTED|Part B||0
8648927|NCT00626275|9689945|FG001|STARTED|Part B||0
8648928|NCT00626275|9689946|FG002|STARTED|Part B||0
8648929|NCT00626275|9689947|FG003|STARTED|Part B||0
8648930|NCT00626275|9689948|FG004|STARTED|Part B||0
8648931|NCT00626275|9689949|FG005|STARTED|Part B||0
8648932|NCT00626275|9689950|FG006|STARTED|Part B||20
8648933|NCT00626275|9689951|FG007|STARTED|Part B||24
8648934|NCT00626275|9689944|FG000|COMPLETED|Part B||0
8648935|NCT00626275|9689945|FG001|COMPLETED|Part B||0
8648936|NCT00626275|9689946|FG002|COMPLETED|Part B||0
8648937|NCT00626275|9689947|FG003|COMPLETED|Part B||0
8648938|NCT00626275|9689948|FG004|COMPLETED|Part B||0
8648939|NCT00626275|9689949|FG005|COMPLETED|Part B||0
8648940|NCT00626275|9689950|FG006|COMPLETED|Part B||19
8648941|NCT00626275|9689951|FG007|COMPLETED|Part B||23
8648942|NCT00626275|9689944|FG000|NOT COMPLETED|Part B||0
8648943|NCT00626275|9689945|FG001|NOT COMPLETED|Part B||0
8648944|NCT00626275|9689946|FG002|NOT COMPLETED|Part B||0
8648945|NCT00626275|9689947|FG003|NOT COMPLETED|Part B||0
8648946|NCT00626275|9689948|FG004|NOT COMPLETED|Part B||0
8648947|NCT00626275|9689949|FG005|NOT COMPLETED|Part B||0
8648948|NCT00626275|9689950|FG006|NOT COMPLETED|Part B||1
8648949|NCT00626275|9689951|FG007|NOT COMPLETED|Part B||1
8648950|NCT00626327|9689968|FG000|STARTED|Overall Study||504
8648951|NCT00626327|9689969|FG001|STARTED|Overall Study||616
8648952|NCT00626327|9689970|FG002|STARTED|Overall Study||510
8648953|NCT00626327|9689968|FG000|COMPLETED|Overall Study||426
8648954|NCT00626327|9689969|FG001|COMPLETED|Overall Study||557
8648955|NCT00626327|9689970|FG002|COMPLETED|Overall Study||422
8648956|NCT00626327|9689968|FG000|NOT COMPLETED|Overall Study||78
8648957|NCT00626327|9689969|FG001|NOT COMPLETED|Overall Study||59
8648958|NCT00626327|9689970|FG002|NOT COMPLETED|Overall Study||88
8648959|NCT00626340|9689986|FG000|STARTED|Overall Study||18
8648960|NCT00626340|9689986|FG000|COMPLETED|Overall Study||18
8648961|NCT00626340|9689986|FG000|NOT COMPLETED|Overall Study||0
8648962|NCT00626366|9689992|FG000|STARTED|Overall Study||9
8648963|NCT00626366|9689993|FG001|STARTED|Overall Study||9
8648964|NCT00626366|9689992|FG000|COMPLETED|Overall Study||9
8648965|NCT00626366|9689993|FG001|COMPLETED|Overall Study||9
8648966|NCT00626366|9689992|FG000|NOT COMPLETED|Overall Study||0
8648967|NCT00626366|9689993|FG001|NOT COMPLETED|Overall Study||0
8648968|NCT00626392|9690005|FG000|STARTED|Run-in Period||45
8648969|NCT00626392|9690006|FG001|STARTED|Run-in Period||44
8648970|NCT00626392|9690007|FG002|STARTED|Run-in Period||44
8648971|NCT00626392|9690008|FG003|STARTED|Run-in Period||44
8648972|NCT00626392|9690009|FG004|STARTED|Run-in Period||45
8648973|NCT00626392|9690010|FG005|STARTED|Run-in Period||45
8648974|NCT00626392|9690005|FG000|COMPLETED|Run-in Period||44
8648975|NCT00626392|9690006|FG001|COMPLETED|Run-in Period||43
8648976|NCT00626392|9690007|FG002|COMPLETED|Run-in Period||41
8648977|NCT00626392|9690008|FG003|COMPLETED|Run-in Period||43
8648978|NCT00626392|9690009|FG004|COMPLETED|Run-in Period||41
8648979|NCT00626392|9690010|FG005|COMPLETED|Run-in Period||44
8648980|NCT00626392|9690005|FG000|NOT COMPLETED|Run-in Period||1
8648981|NCT00626392|9690006|FG001|NOT COMPLETED|Run-in Period||1
8648982|NCT00626392|9690007|FG002|NOT COMPLETED|Run-in Period||3
8648983|NCT00626392|9690008|FG003|NOT COMPLETED|Run-in Period||1
8648984|NCT00626392|9690009|FG004|NOT COMPLETED|Run-in Period||4
8648985|NCT00626392|9690010|FG005|NOT COMPLETED|Run-in Period||1
8648986|NCT00626392|9690005|FG000|STARTED|Coadministration Period||44
8648987|NCT00626392|9690006|FG001|STARTED|Coadministration Period||43
8648988|NCT00626392|9690007|FG002|STARTED|Coadministration Period||41
8648989|NCT00626392|9690008|FG003|STARTED|Coadministration Period||43
8648990|NCT00626392|9690009|FG004|STARTED|Coadministration Period||41
8648991|NCT00626392|9690010|FG005|STARTED|Coadministration Period||44
8648992|NCT00626392|9690005|FG000|COMPLETED|Coadministration Period||40
8648993|NCT00626392|9690006|FG001|COMPLETED|Coadministration Period||38
8648994|NCT00626392|9690007|FG002|COMPLETED|Coadministration Period||31
8648995|NCT00626392|9690008|FG003|COMPLETED|Coadministration Period||36
8648996|NCT00626392|9690009|FG004|COMPLETED|Coadministration Period||36
8648997|NCT00626392|9690010|FG005|COMPLETED|Coadministration Period||38
8648998|NCT00626392|9690005|FG000|NOT COMPLETED|Coadministration Period||4
8648999|NCT00626392|9690006|FG001|NOT COMPLETED|Coadministration Period||5
8649000|NCT00626392|9690007|FG002|NOT COMPLETED|Coadministration Period||10
8649001|NCT00626392|9690008|FG003|NOT COMPLETED|Coadministration Period||7
8649002|NCT00626392|9690009|FG004|NOT COMPLETED|Coadministration Period||5
8649003|NCT00626392|9690010|FG005|NOT COMPLETED|Coadministration Period||6
8649004|NCT00626405|9690018|FG000|STARTED|Overall Study||43
8649005|NCT00626405|9690019|FG001|STARTED|Overall Study||52
8649006|NCT00626405|9690018|FG000|COMPLETED|Overall Study||42
8649007|NCT00626405|9690019|FG001|COMPLETED|Overall Study||51
8649008|NCT00626405|9690018|FG000|NOT COMPLETED|Overall Study||1
8649009|NCT00626405|9690019|FG001|NOT COMPLETED|Overall Study||1
8649010|NCT00626431|9690027|FG000|STARTED|Overall Study|Separate groups of subjects received Formulation A and B and data were not compared between groups.|151
8649011|NCT00626431|9690028|FG001|STARTED|Overall Study|Separate groups of subjects received Formulation A and B and data were not compared between groups.|159
8649012|NCT00626431|9690027|FG000|COMPLETED|Overall Study||134
8649013|NCT00626431|9690028|FG001|COMPLETED|Overall Study||114
8649014|NCT00626431|9690027|FG000|NOT COMPLETED|Overall Study||17
8649015|NCT00626431|9690028|FG001|NOT COMPLETED|Overall Study||45
8649016|NCT00626522|9690040|FG000|STARTED|Overall Study||121
8649017|NCT00626522|9690041|FG001|STARTED|Overall Study||120
8649018|NCT00626522|9690042|FG002|STARTED|Overall Study||125
8649019|NCT00626522|9690043|FG003|STARTED|Overall Study||76
8649020|NCT00626522|9690044|FG004|STARTED|Overall Study||65
8649021|NCT00626522|9690045|FG005|STARTED|Overall Study||59
8649022|NCT00626522|9690040|FG000|COMPLETED|Overall Study||115
8649023|NCT00626522|9690041|FG001|COMPLETED|Overall Study||113
8649024|NCT00626522|9690042|FG002|COMPLETED|Overall Study||117
8649025|NCT00626522|9690043|FG003|COMPLETED|Overall Study||74
8649026|NCT00626522|9690044|FG004|COMPLETED|Overall Study||58
8649027|NCT00626522|9690045|FG005|COMPLETED|Overall Study||57
8649028|NCT00626522|9690040|FG000|NOT COMPLETED|Overall Study||6
8649029|NCT00626522|9690041|FG001|NOT COMPLETED|Overall Study||7
8649030|NCT00626522|9690042|FG002|NOT COMPLETED|Overall Study||8
8649031|NCT00626522|9690043|FG003|NOT COMPLETED|Overall Study||2
8649032|NCT00626522|9690044|FG004|NOT COMPLETED|Overall Study||7
8649033|NCT00626522|9690045|FG005|NOT COMPLETED|Overall Study||2
8649034|NCT00626548|9690061|FG000|STARTED|Overall Study||705
8649035|NCT00626548|9690062|FG001|STARTED|Overall Study||716
8649036|NCT00626548|9690061|FG000|Patients Received Treatment|Overall Study||703
8649037|NCT00626548|9690062|FG001|Patients Received Treatment|Overall Study||712
8649038|NCT00626548|9690061|FG000|COMPLETED|Overall Study||0
8649039|NCT00626548|9690062|FG001|COMPLETED|Overall Study||0
8649040|NCT00626548|9690061|FG000|NOT COMPLETED|Overall Study||705
8649041|NCT00626548|9690062|FG001|NOT COMPLETED|Overall Study||716
8649042|NCT00626574|9690070|FG000|STARTED|Overall Study||2
8649043|NCT00626574|9690071|FG001|STARTED|Overall Study||1
8649044|NCT00626574|9690070|FG000|COMPLETED|Overall Study||2
8649045|NCT00626574|9690071|FG001|COMPLETED|Overall Study||1
8649046|NCT00626574|9690070|FG000|NOT COMPLETED|Overall Study||0
8649047|NCT00626574|9690071|FG001|NOT COMPLETED|Overall Study||0
8649048|NCT00626626|9690081|FG000|STARTED|Overall Study||5
8649049|NCT00626626|9690082|FG001|STARTED|Overall Study||3
8649050|NCT00626626|9690081|FG000|COMPLETED|Overall Study||5
8649051|NCT00626626|9690082|FG001|COMPLETED|Overall Study||3
8649052|NCT00626626|9690081|FG000|NOT COMPLETED|Overall Study||0
8649053|NCT00626626|9690082|FG001|NOT COMPLETED|Overall Study||0
8649054|NCT00626639|9690091|FG000|STARTED|Overall Study||2
8649055|NCT00626639|9690092|FG001|STARTED|Overall Study||3
8649056|NCT00626639|9690091|FG000|COMPLETED|Overall Study|Participants who received all 8 doses of investigational product.|0
8649057|NCT00626639|9690092|FG001|COMPLETED|Overall Study|Participants who received all 8 doses of investigational product.|1
8649058|NCT00626639|9690091|FG000|NOT COMPLETED|Overall Study||2
8649059|NCT00626639|9690092|FG001|NOT COMPLETED|Overall Study||2
8649060|NCT00626743|9690102|FG000|STARTED|Treatment Period 1||6
8649061|NCT00626743|9690103|FG001|STARTED|Treatment Period 1||7
8649062|NCT00626743|9690102|FG000|COMPLETED|Treatment Period 1||6
8649063|NCT00626743|9690103|FG001|COMPLETED|Treatment Period 1||6
8649064|NCT00626743|9690102|FG000|NOT COMPLETED|Treatment Period 1||0
8649065|NCT00626743|9690103|FG001|NOT COMPLETED|Treatment Period 1||1
8649066|NCT00626743|9690102|FG000|STARTED|Wash-out Period of 6 Days||6
8649067|NCT00626743|9690103|FG001|STARTED|Wash-out Period of 6 Days||6
8649068|NCT00626743|9690102|FG000|COMPLETED|Wash-out Period of 6 Days||6
8649069|NCT00626743|9690103|FG001|COMPLETED|Wash-out Period of 6 Days||6
8649070|NCT00626743|9690102|FG000|NOT COMPLETED|Wash-out Period of 6 Days||0
8649071|NCT00626743|9690103|FG001|NOT COMPLETED|Wash-out Period of 6 Days||0
8649072|NCT00626743|9690102|FG000|STARTED|Treatment Period 2||6
8649073|NCT00626743|9690103|FG001|STARTED|Treatment Period 2||6
8649074|NCT00626743|9690102|FG000|COMPLETED|Treatment Period 2||6
8649075|NCT00626743|9690103|FG001|COMPLETED|Treatment Period 2||6
8649076|NCT00626743|9690102|FG000|NOT COMPLETED|Treatment Period 2||0
8649077|NCT00626743|9690103|FG001|NOT COMPLETED|Treatment Period 2||0
8649078|NCT00626782|9690111|FG000|STARTED|Overall Study||12
8649079|NCT00626782|9690112|FG001|STARTED|Overall Study||12
8649080|NCT00626782|9690111|FG000|COMPLETED|Overall Study||12
8649081|NCT00626782|9690112|FG001|COMPLETED|Overall Study||12
8649082|NCT00626782|9690111|FG000|NOT COMPLETED|Overall Study||0
8649083|NCT00626782|9690112|FG001|NOT COMPLETED|Overall Study||0
8649084|NCT00626795|9690123|FG000|STARTED|Open-label TD1414 Cream TID Treatment||0
8649085|NCT00626795|9690124|FG001|STARTED|Open-label TD1414 Cream TID Treatment||65
8649086|NCT00626795|9690125|FG002|STARTED|Open-label TD1414 Cream TID Treatment||0
8649087|NCT00626795|9690123|FG000|COMPLETED|Open-label TD1414 Cream TID Treatment||0
8649088|NCT00626795|9690124|FG001|COMPLETED|Open-label TD1414 Cream TID Treatment||64
8649089|NCT00626795|9690125|FG002|COMPLETED|Open-label TD1414 Cream TID Treatment||0
8649090|NCT00626795|9690123|FG000|NOT COMPLETED|Open-label TD1414 Cream TID Treatment||0
8649091|NCT00626795|9690124|FG001|NOT COMPLETED|Open-label TD1414 Cream TID Treatment||1
8649092|NCT00626795|9690125|FG002|NOT COMPLETED|Open-label TD1414 Cream TID Treatment||0
8649093|NCT00626795|9690123|FG000|STARTED|Blinded Treatment||204
8649094|NCT00626795|9690124|FG001|STARTED|Blinded Treatment||205
8649095|NCT00626795|9690125|FG002|STARTED|Blinded Treatment||205
8649096|NCT00626795|9690123|FG000|COMPLETED|Blinded Treatment||194
8649097|NCT00626795|9690124|FG001|COMPLETED|Blinded Treatment||200
8649098|NCT00626795|9690125|FG002|COMPLETED|Blinded Treatment||196
8649099|NCT00626795|9690123|FG000|NOT COMPLETED|Blinded Treatment||10
8649100|NCT00626795|9690124|FG001|NOT COMPLETED|Blinded Treatment||5
8649101|NCT00626795|9690125|FG002|NOT COMPLETED|Blinded Treatment||9
8649102|NCT00626808|9690141|FG000|STARTED|Overall Study||254464
8649103|NCT00626808|9690142|FG001|STARTED|Overall Study||34316
8649104|NCT00626808|9690143|FG002|STARTED|Overall Study||30011
8649105|NCT00626808|9690144|FG003|STARTED|Overall Study||2906
8649106|NCT00626808|9690141|FG000|COMPLETED|Overall Study||254464
8649107|NCT00626808|9690142|FG001|COMPLETED|Overall Study||34316
8649108|NCT00626808|9690143|FG002|COMPLETED|Overall Study||30011
8649109|NCT00626808|9690144|FG003|COMPLETED|Overall Study||2906
8649110|NCT00626808|9690141|FG000|NOT COMPLETED|Overall Study||0
8649111|NCT00626808|9690142|FG001|NOT COMPLETED|Overall Study||0
8649112|NCT00626808|9690143|FG002|NOT COMPLETED|Overall Study||0
8649113|NCT00626808|9690144|FG003|NOT COMPLETED|Overall Study||0
8649114|NCT00626821|9690154|FG000|STARTED|Overall Study||3017
8649115|NCT00626821|9690154|FG000|Quality of Life|Overall Study|Attended both visit 1 and visit 2|2672
8649116|NCT00626821|9690154|FG000|COMPLETED|Overall Study||2796
8649117|NCT00626821|9690154|FG000|NOT COMPLETED|Overall Study||221
8649118|NCT00626886|9690160|FG000|STARTED|Overall Study||24
8649119|NCT00626886|9690161|FG001|STARTED|Overall Study||29
8649120|NCT00626886|9690160|FG000|COMPLETED|Overall Study||24
8649121|NCT00626886|9690161|FG001|COMPLETED|Overall Study||29
8649122|NCT00626886|9690160|FG000|NOT COMPLETED|Overall Study||0
8649123|NCT00626886|9690161|FG001|NOT COMPLETED|Overall Study||0
8649124|NCT00626912|9690169|FG000|STARTED|Overall Study||222
8649125|NCT00626912|9690170|FG001|STARTED|Overall Study||225
8649126|NCT00626912|9690169|FG000|COMPLETED|Overall Study||220
8649127|NCT00626912|9690170|FG001|COMPLETED|Overall Study||215
8649128|NCT00626912|9690169|FG000|NOT COMPLETED|Overall Study||2
8649129|NCT00626912|9690170|FG001|NOT COMPLETED|Overall Study||10
8649130|NCT00626925|9690178|FG000|STARTED|Overall Study||67
8649131|NCT00626925|9690179|FG001|STARTED|Overall Study||71
8649132|NCT00626925|9690178|FG000|COMPLETED|Overall Study||55
8649133|NCT00626925|9690179|FG001|COMPLETED|Overall Study||62
8649134|NCT00626925|9690178|FG000|NOT COMPLETED|Overall Study||12
8649135|NCT00626925|9690179|FG001|NOT COMPLETED|Overall Study||9
8649136|NCT00627016|9690201|FG000|STARTED|Overall Study||153
8649137|NCT00627016|9690202|FG001|STARTED|Overall Study||152
8649138|NCT00627016|9690201|FG000|COMPLETED|Overall Study||147
8649139|NCT00627016|9690202|FG001|COMPLETED|Overall Study||146
8649140|NCT00627016|9690201|FG000|NOT COMPLETED|Overall Study||6
8649141|NCT00627016|9690202|FG001|NOT COMPLETED|Overall Study||6
8649142|NCT00627042|9690208|FG000|STARTED|Overall Study||42
8649143|NCT00627042|9690208|FG000|Received at Least 1 Dose of Study Drug|Overall Study||42
8649144|NCT00627042|9690208|FG000|COMPLETED|Overall Study||40
8649145|NCT00627042|9690208|FG000|NOT COMPLETED|Overall Study||2
8649146|NCT00627094|9690214|FG000|STARTED|Overall Study||60
8649147|NCT00627094|9690215|FG001|STARTED|Overall Study||60
8649148|NCT00627094|9690214|FG000|COMPLETED|Overall Study||48
8649149|NCT00627094|9690215|FG001|COMPLETED|Overall Study||45
8649150|NCT00627094|9690214|FG000|NOT COMPLETED|Overall Study||12
8649151|NCT00627094|9690215|FG001|NOT COMPLETED|Overall Study||15
8649152|NCT00627367|9690225|FG000|STARTED|Overall Study||112
8649153|NCT00627367|9690226|FG001|STARTED|Overall Study||112
8649154|NCT00627367|9690225|FG000|COMPLETED|Overall Study||112
8649155|NCT00627367|9690226|FG001|COMPLETED|Overall Study||112
8649156|NCT00627367|9690225|FG000|NOT COMPLETED|Overall Study||0
8649157|NCT00627367|9690226|FG001|NOT COMPLETED|Overall Study||0
8649158|NCT00627393|9690235|FG000|STARTED|Intention-To-Treat Analysis||58
8649159|NCT00627393|9690236|FG001|STARTED|Intention-To-Treat Analysis||56
8649160|NCT00627393|9690235|FG000|COMPLETED|Intention-To-Treat Analysis||49
8649161|NCT00627393|9690236|FG001|COMPLETED|Intention-To-Treat Analysis||48
8649162|NCT00627393|9690235|FG000|NOT COMPLETED|Intention-To-Treat Analysis||9
8649163|NCT00627393|9690236|FG001|NOT COMPLETED|Intention-To-Treat Analysis||8
8649164|NCT00627393|9690235|FG000|STARTED|Per-Protocol Analysis||49
8649165|NCT00627393|9690236|FG001|STARTED|Per-Protocol Analysis||48
8649166|NCT00627393|9690235|FG000|COMPLETED|Per-Protocol Analysis||39
8649167|NCT00627393|9690236|FG001|COMPLETED|Per-Protocol Analysis||35
8649168|NCT00627393|9690235|FG000|NOT COMPLETED|Per-Protocol Analysis||10
8649169|NCT00627393|9690236|FG001|NOT COMPLETED|Per-Protocol Analysis||13
8649170|NCT00627406|9690248|FG000|STARTED|Overall Study||60
8649171|NCT00627406|9690249|FG001|STARTED|Overall Study||58
8649172|NCT00627406|9690250|FG002|STARTED|Overall Study||125
8649173|NCT00627406|9690251|FG003|STARTED|Overall Study||141
8649174|NCT00627406|9690248|FG000|COMPLETED|Overall Study||60
8649175|NCT00627406|9690249|FG001|COMPLETED|Overall Study||58
8649176|NCT00627406|9690250|FG002|COMPLETED|Overall Study||125
8649177|NCT00627406|9690251|FG003|COMPLETED|Overall Study||141
8649178|NCT00627406|9690248|FG000|NOT COMPLETED|Overall Study||0
8649179|NCT00627406|9690249|FG001|NOT COMPLETED|Overall Study||0
8649180|NCT00627406|9690250|FG002|NOT COMPLETED|Overall Study||0
8649181|NCT00627406|9690251|FG003|NOT COMPLETED|Overall Study||0
8649182|NCT00627445|9690263|FG000|STARTED|Overall Study||219
8649183|NCT00627445|9690264|FG001|STARTED|Overall Study||222
8649184|NCT00627445|9690263|FG000|Exposed to Study Drug|Overall Study||219
8649185|NCT00627445|9690264|FG001|Exposed to Study Drug|Overall Study||222
8649186|NCT00627445|9690263|FG000|COMPLETED|Overall Study||210
8649187|NCT00627445|9690264|FG001|COMPLETED|Overall Study||210
8649188|NCT00627445|9690263|FG000|NOT COMPLETED|Overall Study||9
8649189|NCT00627445|9690264|FG001|NOT COMPLETED|Overall Study||12
8649190|NCT00627458|9690275|FG000|STARTED|Overall Study||127
8649191|NCT00627458|9690276|FG001|STARTED|Overall Study||137
8649192|NCT00627458|9690277|FG002|STARTED|Overall Study||139
8649193|NCT00627458|9690275|FG000|COMPLETED|Overall Study||123
8649194|NCT00627458|9690276|FG001|COMPLETED|Overall Study||130
8649195|NCT00627458|9690277|FG002|COMPLETED|Overall Study||133
8649196|NCT00627458|9690275|FG000|NOT COMPLETED|Overall Study||4
8649197|NCT00627458|9690276|FG001|NOT COMPLETED|Overall Study||7
8649198|NCT00627458|9690277|FG002|NOT COMPLETED|Overall Study||6
8649199|NCT00627497|9690290|FG000|STARTED|Overall Study||14
8649200|NCT00627497|9690291|FG001|STARTED|Overall Study||12
8649201|NCT00627497|9690292|FG002|STARTED|Overall Study||4
8649202|NCT00627497|9690293|FG003|STARTED|Overall Study||2
8649203|NCT00627497|9690290|FG000|COMPLETED|Overall Study||13
8649204|NCT00627497|9690291|FG001|COMPLETED|Overall Study||11
8649205|NCT00627497|9690292|FG002|COMPLETED|Overall Study||4
8649206|NCT00627497|9690293|FG003|COMPLETED|Overall Study||2
8649207|NCT00627497|9690290|FG000|NOT COMPLETED|Overall Study||1
8649208|NCT00627497|9690291|FG001|NOT COMPLETED|Overall Study||1
8649209|NCT00627497|9690292|FG002|NOT COMPLETED|Overall Study||0
8649210|NCT00627497|9690293|FG003|NOT COMPLETED|Overall Study||0
8649211|NCT00627523|9690305|FG000|STARTED|Overall Study|22 assigned to Genotropin and 21 in Control; 1 did not take Genotropin, so considered as Control.|21
8649212|NCT00627523|9690306|FG001|STARTED|Overall Study||22
8649213|NCT00627523|9690305|FG000|COMPLETED|Overall Study||19
8649214|NCT00627523|9690306|FG001|COMPLETED|Overall Study||20
8649215|NCT00627523|9690305|FG000|NOT COMPLETED|Overall Study||2
8649216|NCT00627523|9690306|FG001|NOT COMPLETED|Overall Study||2
8649217|NCT00627679|9690312|FG000|STARTED|Overall Study||4
8649218|NCT00627679|9690313|FG001|STARTED|Overall Study||4
8649219|NCT00627679|9690314|FG002|STARTED|Overall Study||4
8649220|NCT00627679|9690315|FG003|STARTED|Overall Study||4
8649221|NCT00627679|9690312|FG000|COMPLETED|Overall Study||4
8649222|NCT00627679|9690313|FG001|COMPLETED|Overall Study||4
8649223|NCT00627679|9690314|FG002|COMPLETED|Overall Study||4
8649224|NCT00627679|9690315|FG003|COMPLETED|Overall Study||4
8649225|NCT00627679|9690312|FG000|NOT COMPLETED|Overall Study||0
8649226|NCT00627679|9690313|FG001|NOT COMPLETED|Overall Study||0
8649227|NCT00627679|9690314|FG002|NOT COMPLETED|Overall Study||0
8649228|NCT00627679|9690315|FG003|NOT COMPLETED|Overall Study||0
8649229|NCT00627705|9690327|FG000|STARTED|Overall Study||15
8649230|NCT00627705|9690328|FG001|STARTED|Overall Study||18
8649231|NCT00627705|9690327|FG000|COMPLETED|Overall Study||13
8649232|NCT00627705|9690328|FG001|COMPLETED|Overall Study||12
8649233|NCT00627705|9690327|FG000|NOT COMPLETED|Overall Study||2
8649234|NCT00627705|9690328|FG001|NOT COMPLETED|Overall Study||6
8649235|NCT00627861|9690334|FG000|STARTED|Overall Study||1
8649236|NCT00627861|9690334|FG000|COMPLETED|Overall Study||1
8649237|NCT00627861|9690334|FG000|NOT COMPLETED|Overall Study||0
8649238|NCT00627926|9690343|FG000|STARTED|Overall Study||361
8649239|NCT00627926|9690344|FG001|STARTED|Overall Study||364
8649240|NCT00627926|9690345|FG002|STARTED|Overall Study||363
8649241|NCT00627926|9690343|FG000|COMPLETED|Overall Study||202
8649242|NCT00627926|9690344|FG001|COMPLETED|Overall Study||260
8649243|NCT00627926|9690345|FG002|COMPLETED|Overall Study||268
8649244|NCT00627926|9690343|FG000|NOT COMPLETED|Overall Study||159
8649245|NCT00627926|9690344|FG001|NOT COMPLETED|Overall Study||104
8649246|NCT00627926|9690345|FG002|NOT COMPLETED|Overall Study||95
8649247|NCT00627978|9690355|FG000|STARTED|Overall Study||10
8649248|NCT00627978|9690356|FG001|STARTED|Overall Study||5
8649249|NCT00627978|9690355|FG000|COMPLETED|Overall Study||10
8649250|NCT00627978|9690356|FG001|COMPLETED|Overall Study||5
8649251|NCT00627978|9690355|FG000|NOT COMPLETED|Overall Study||0
8649252|NCT00627978|9690356|FG001|NOT COMPLETED|Overall Study||0
8649253|NCT00628030|9690364|FG000|STARTED|Baseline to Post-Assessment||92
8649254|NCT00628030|9690365|FG001|STARTED|Baseline to Post-Assessment||92
8649255|NCT00628030|9690364|FG000|COMPLETED|Baseline to Post-Assessment||59
8649256|NCT00628030|9690365|FG001|COMPLETED|Baseline to Post-Assessment||63
8649257|NCT00628030|9690364|FG000|NOT COMPLETED|Baseline to Post-Assessment||33
8649258|NCT00628030|9690365|FG001|NOT COMPLETED|Baseline to Post-Assessment||29
8649259|NCT00628030|9690364|FG000|STARTED|Post to 6 Month Follow-up||59
8649260|NCT00628030|9690365|FG001|STARTED|Post to 6 Month Follow-up||63
8649261|NCT00628030|9690364|FG000|COMPLETED|Post to 6 Month Follow-up||27
8649262|NCT00628030|9690365|FG001|COMPLETED|Post to 6 Month Follow-up||33
8649263|NCT00628030|9690364|FG000|NOT COMPLETED|Post to 6 Month Follow-up||32
8649264|NCT00628030|9690365|FG001|NOT COMPLETED|Post to 6 Month Follow-up||30
8649265|NCT00628108|9690373|FG000|STARTED|Overall Study||23
8649266|NCT00628108|9690374|FG001|STARTED|Overall Study|One subject was randomized to levocetirizine but received placebo.|46
8649267|NCT00628108|9690373|FG000|Safety Population|Overall Study||24
8649268|NCT00628108|9690374|FG001|Safety Population|Overall Study|Subjects in the Safety Population were analyzed as treated.|45
8649269|NCT00628108|9690373|FG000|COMPLETED|Overall Study||22
8649270|NCT00628108|9690374|FG001|COMPLETED|Overall Study||43
8649271|NCT00628108|9690373|FG000|NOT COMPLETED|Overall Study||1
8649272|NCT00628108|9690374|FG001|NOT COMPLETED|Overall Study||3
8649273|NCT00628134|9690380|FG000|STARTED|Overall Study||4
8649274|NCT00628134|9690381|FG001|STARTED|Overall Study||4
8649275|NCT00628134|9690380|FG000|COMPLETED|Overall Study||4
8649276|NCT00628134|9690381|FG001|COMPLETED|Overall Study||4
8649277|NCT00628134|9690380|FG000|NOT COMPLETED|Overall Study||0
8649278|NCT00628134|9690381|FG001|NOT COMPLETED|Overall Study||0
8649279|NCT00628147|9690389|FG000|STARTED|Overall Study||142
8649280|NCT00628147|9690390|FG001|STARTED|Overall Study||142
8649281|NCT00628147|9690389|FG000|COMPLETED|Overall Study||135
8649282|NCT00628147|9690390|FG001|COMPLETED|Overall Study||141
8649283|NCT00628147|9690389|FG000|NOT COMPLETED|Overall Study||7
8649284|NCT00628147|9690390|FG001|NOT COMPLETED|Overall Study||1
8649285|NCT00628212|9690400|FG000|STARTED|Overall Study||80
8649286|NCT00628212|9690401|FG001|STARTED|Overall Study||84
8649287|NCT00628212|9690402|FG002|STARTED|Overall Study||79
8649288|NCT00628212|9690403|FG003|STARTED|Overall Study||81
8649289|NCT00628212|9690400|FG000|COMPLETED|Overall Study||77
8649290|NCT00628212|9690401|FG001|COMPLETED|Overall Study||83
8649291|NCT00628212|9690402|FG002|COMPLETED|Overall Study||76
8649292|NCT00628212|9690403|FG003|COMPLETED|Overall Study||76
8649293|NCT00628212|9690400|FG000|NOT COMPLETED|Overall Study||3
8649294|NCT00628212|9690401|FG001|NOT COMPLETED|Overall Study||1
8649295|NCT00628212|9690402|FG002|NOT COMPLETED|Overall Study||3
8649296|NCT00628212|9690403|FG003|NOT COMPLETED|Overall Study||5
8649297|NCT00628251|9690416|FG000|STARTED|Randomised Part|Patients randomised|32
8649298|NCT00628251|9690417|FG001|STARTED|Randomised Part|Patients randomised|32
8649299|NCT00628251|9690418|FG002|STARTED|Randomised Part|Patients randomised|33
8649300|NCT00628251|9690416|FG000|COMPLETED|Randomised Part|Patients who received olaparib treatment|32
8649301|NCT00628251|9690417|FG001|COMPLETED|Randomised Part|Patients who received olaparib treatment|32
8649302|NCT00628251|9690418|FG002|COMPLETED|Randomised Part|1 of 33 patients did not receive Liposomal Doxorubicin. Patient voluntarily discontinued|32
8649303|NCT00628251|9690416|FG000|NOT COMPLETED|Randomised Part||0
8649304|NCT00628251|9690417|FG001|NOT COMPLETED|Randomised Part||0
8649305|NCT00628251|9690418|FG002|NOT COMPLETED|Randomised Part||1
8649306|NCT00628251|9690416|FG000|STARTED|Ongoing Initial Study Treatment at DCO|Patients who received treatment|32
8649307|NCT00628251|9690417|FG001|STARTED|Ongoing Initial Study Treatment at DCO|Patients who received treatment|32
8649308|NCT00628251|9690418|FG002|STARTED|Ongoing Initial Study Treatment at DCO|Patients who received Liposomal doxorubicin 50 mg/m2|32
8649309|NCT00628251|9690416|FG000|Discontinued Initial Study Treatment|Ongoing Initial Study Treatment at DCO||22
8649310|NCT00628251|9690417|FG001|Discontinued Initial Study Treatment|Ongoing Initial Study Treatment at DCO||20
8649311|NCT00628251|9690418|FG002|Discontinued Initial Study Treatment|Ongoing Initial Study Treatment at DCO||25
8649312|NCT00628251|9690416|FG000|Crossover to Olaparib|Ongoing Initial Study Treatment at DCO||0
8649313|NCT00628251|9690417|FG001|Crossover to Olaparib|Ongoing Initial Study Treatment at DCO||0
8649314|NCT00628251|9690418|FG002|Crossover to Olaparib|Ongoing Initial Study Treatment at DCO|Crossover dosage was 400 mg bd Olaparib|14
8649315|NCT00628251|9690416|FG000|Ongoing Crossover at DCO|Ongoing Initial Study Treatment at DCO||0
8649316|NCT00628251|9690417|FG001|Ongoing Crossover at DCO|Ongoing Initial Study Treatment at DCO||0
8649317|NCT00628251|9690418|FG002|Ongoing Crossover at DCO|Ongoing Initial Study Treatment at DCO||5
8649318|NCT00628251|9690416|FG000|Discontinued Crossover|Ongoing Initial Study Treatment at DCO||0
8649319|NCT00628251|9690417|FG001|Discontinued Crossover|Ongoing Initial Study Treatment at DCO||0
8649320|NCT00628251|9690418|FG002|Discontinued Crossover|Ongoing Initial Study Treatment at DCO||9
8649321|NCT00628251|9690416|FG000|COMPLETED|Ongoing Initial Study Treatment at DCO|Ongoing initial study treatment at primary data cut-off|10
8649322|NCT00628251|9690417|FG001|COMPLETED|Ongoing Initial Study Treatment at DCO|Ongoing initial study treatment at primary data cut-off|12
8649323|NCT00628251|9690418|FG002|COMPLETED|Ongoing Initial Study Treatment at DCO|Patients ongoing initial study treatment (Liposomal doxorubicin)|7
8649324|NCT00628251|9690416|FG000|NOT COMPLETED|Ongoing Initial Study Treatment at DCO||22
8649325|NCT00628251|9690417|FG001|NOT COMPLETED|Ongoing Initial Study Treatment at DCO||20
8649326|NCT00628251|9690418|FG002|NOT COMPLETED|Ongoing Initial Study Treatment at DCO||25
8649327|NCT00628355|9690430|FG000|STARTED|Overall Study||15
8649328|NCT00628355|9690431|FG001|STARTED|Overall Study||15
8649329|NCT00628355|9690430|FG000|COMPLETED|Overall Study||14
8649330|NCT00628355|9690431|FG001|COMPLETED|Overall Study||14
8649331|NCT00628355|9690430|FG000|NOT COMPLETED|Overall Study||1
8649332|NCT00628355|9690431|FG001|NOT COMPLETED|Overall Study||1
8728034|NCT01045993|9775286|FG001|STARTED|Overall Study||5
8728035|NCT01045993|9775287|FG002|STARTED|Overall Study||5
8728036|NCT01045993|9775288|FG003|STARTED|Overall Study||25
8728037|NCT01045993|9775285|FG000|COMPLETED|Overall Study||26
8728038|NCT01045993|9775286|FG001|COMPLETED|Overall Study||4
8728039|NCT01045993|9775287|FG002|COMPLETED|Overall Study||5
8728040|NCT01045993|9775288|FG003|COMPLETED|Overall Study||25
8728041|NCT01045993|9775285|FG000|NOT COMPLETED|Overall Study||0
8728042|NCT01045993|9775286|FG001|NOT COMPLETED|Overall Study||1
9022158|NCT03124459|10085070|FG000|STARTED|Part 1-Open Label Dose Escalation||6
9022159|NCT03124459|10085071|FG001|STARTED|Part 1-Open Label Dose Escalation||6
9022160|NCT03124459|10085072|FG002|STARTED|Part 1-Open Label Dose Escalation||6
8649333|NCT00628394|9690442|FG000|STARTED|Overall Study||14
8649334|NCT00628394|9690443|FG001|STARTED|Overall Study||13
8649335|NCT00628394|9690444|FG002|STARTED|Overall Study||13
8649336|NCT00628394|9690445|FG003|STARTED|Overall Study||13
8649337|NCT00628394|9690442|FG000|COMPLETED|Overall Study||10
8649338|NCT00628394|9690443|FG001|COMPLETED|Overall Study||9
8649339|NCT00628394|9690444|FG002|COMPLETED|Overall Study||11
8649340|NCT00628394|9690445|FG003|COMPLETED|Overall Study||10
8649341|NCT00628394|9690442|FG000|NOT COMPLETED|Overall Study||4
8649342|NCT00628394|9690443|FG001|NOT COMPLETED|Overall Study||4
8728043|NCT01045993|9775287|FG002|NOT COMPLETED|Overall Study||0
8728044|NCT01045993|9775288|FG003|NOT COMPLETED|Overall Study||0
8728045|NCT01046084|9775300|FG000|STARTED|First Intervention||25
8728046|NCT01046084|9775301|FG001|STARTED|First Intervention||25
8728047|NCT01046084|9775300|FG000|COMPLETED|First Intervention||25
8728048|NCT01046084|9775301|FG001|COMPLETED|First Intervention||25
8728049|NCT01046084|9775300|FG000|NOT COMPLETED|First Intervention||0
8728050|NCT01046084|9775301|FG001|NOT COMPLETED|First Intervention||0
8728051|NCT01046084|9775300|FG000|STARTED|First Washout of 7 Days||25
8728052|NCT01046084|9775301|FG001|STARTED|First Washout of 7 Days||25
8728053|NCT01046084|9775300|FG000|COMPLETED|First Washout of 7 Days||25
8728054|NCT01046084|9775301|FG001|COMPLETED|First Washout of 7 Days||25
8728055|NCT01046084|9775300|FG000|NOT COMPLETED|First Washout of 7 Days||0
8728056|NCT01046084|9775301|FG001|NOT COMPLETED|First Washout of 7 Days||0
8728057|NCT01046084|9775300|FG000|STARTED|Second Intervention||25
8728058|NCT01046084|9775301|FG001|STARTED|Second Intervention||25
8728059|NCT01046084|9775300|FG000|COMPLETED|Second Intervention||25
8728060|NCT01046084|9775301|FG001|COMPLETED|Second Intervention||25
8728061|NCT01046084|9775300|FG000|NOT COMPLETED|Second Intervention||0
8728062|NCT01046084|9775301|FG001|NOT COMPLETED|Second Intervention||0
8728063|NCT01046084|9775300|FG000|STARTED|Second Washout of 7 Days||25
8728064|NCT01046084|9775301|FG001|STARTED|Second Washout of 7 Days||25
8728065|NCT01046084|9775300|FG000|COMPLETED|Second Washout of 7 Days||25
8728066|NCT01046084|9775301|FG001|COMPLETED|Second Washout of 7 Days||25
8728067|NCT01046084|9775300|FG000|NOT COMPLETED|Second Washout of 7 Days||0
8728068|NCT01046084|9775301|FG001|NOT COMPLETED|Second Washout of 7 Days||0
8728069|NCT01046084|9775300|FG000|STARTED|Third Intervention||25
8728070|NCT01046084|9775301|FG001|STARTED|Third Intervention||25
8728071|NCT01046084|9775300|FG000|COMPLETED|Third Intervention||25
8728072|NCT01046084|9775301|FG001|COMPLETED|Third Intervention||25
8728073|NCT01046084|9775300|FG000|NOT COMPLETED|Third Intervention||0
8728074|NCT01046084|9775301|FG001|NOT COMPLETED|Third Intervention||0
8728075|NCT01046084|9775300|FG000|STARTED|Third Washout of 7 Days||25
8728076|NCT01046084|9775301|FG001|STARTED|Third Washout of 7 Days||25
8728077|NCT01046084|9775300|FG000|COMPLETED|Third Washout of 7 Days||23
8728078|NCT01046084|9775301|FG001|COMPLETED|Third Washout of 7 Days||25
8728079|NCT01046084|9775300|FG000|NOT COMPLETED|Third Washout of 7 Days||2
8728080|NCT01046084|9775301|FG001|NOT COMPLETED|Third Washout of 7 Days||0
8728081|NCT01046084|9775300|FG000|STARTED|Fourth Intervention||23
8728082|NCT01046084|9775301|FG001|STARTED|Fourth Intervention||25
8728083|NCT01046084|9775300|FG000|COMPLETED|Fourth Intervention||23
8728084|NCT01046084|9775301|FG001|COMPLETED|Fourth Intervention||25
9039961|NCT03345108|10100889|FG000|STARTED|Period-1||8
8649343|NCT00628394|9690444|FG002|NOT COMPLETED|Overall Study||2
8649344|NCT00628394|9690445|FG003|NOT COMPLETED|Overall Study||3
8649345|NCT00628407|9690455|FG000|STARTED|Overall Study||13
8649346|NCT00628407|9690455|FG000|COMPLETED|Overall Study||13
8728085|NCT01046084|9775300|FG000|NOT COMPLETED|Fourth Intervention||0
8728086|NCT01046084|9775301|FG001|NOT COMPLETED|Fourth Intervention||0
8806599|NCT01478594|9858829|FG000|STARTED|Overall Study||177
8806600|NCT01478594|9858830|FG001|STARTED|Overall Study||88
8806601|NCT01478594|9858829|FG000|Treated|Overall Study||177
8806602|NCT01478594|9858830|FG001|Treated|Overall Study||87
8911222|NCT02144285|9970253|FG005|NOT COMPLETED|Overall Study||0
8649347|NCT00628407|9690455|FG000|NOT COMPLETED|Overall Study||0
8649348|NCT00628498|9690459|FG000|STARTED|Overall Study||1206
8649349|NCT00628498|9690459|FG000|COMPLETED|Overall Study||1154
8649350|NCT00628498|9690459|FG000|NOT COMPLETED|Overall Study||52
8649351|NCT00628589|9690466|FG000|STARTED|Overall Study||115
8649352|NCT00628589|9690467|FG001|STARTED|Overall Study||116
8649353|NCT00628589|9690468|FG002|STARTED|Overall Study||113
8649354|NCT00628589|9690466|FG000|COMPLETED|Overall Study||114
8649355|NCT00628589|9690467|FG001|COMPLETED|Overall Study||114
8649356|NCT00628589|9690468|FG002|COMPLETED|Overall Study||110
8649357|NCT00628589|9690466|FG000|NOT COMPLETED|Overall Study||1
8649358|NCT00628589|9690467|FG001|NOT COMPLETED|Overall Study||2
8649359|NCT00628589|9690468|FG002|NOT COMPLETED|Overall Study||3
8649360|NCT00628628|9690478|FG000|STARTED|Overall Study||40
8649361|NCT00628628|9690479|FG001|STARTED|Overall Study||40
8649362|NCT00628628|9690478|FG000|COMPLETED|Overall Study||40
8649363|NCT00628628|9690479|FG001|COMPLETED|Overall Study||40
8649364|NCT00628628|9690478|FG000|NOT COMPLETED|Overall Study||0
8649365|NCT00628628|9690479|FG001|NOT COMPLETED|Overall Study||0
8649366|NCT00628758|9690487|FG000|STARTED|Overall Study||209
8649367|NCT00628758|9690488|FG001|STARTED|Overall Study||221
8649368|NCT00628758|9690487|FG000|COMPLETED|Overall Study||165
8649369|NCT00628758|9690488|FG001|COMPLETED|Overall Study||179
8649370|NCT00628758|9690487|FG000|NOT COMPLETED|Overall Study||44
8649371|NCT00628758|9690488|FG001|NOT COMPLETED|Overall Study||42
8649372|NCT00628862|9690499|FG000|STARTED|Overall Study|randomised patients|206
8649373|NCT00628862|9690500|FG001|STARTED|Overall Study|randomised patients|199
8649374|NCT00628862|9690501|FG002|STARTED|Overall Study|randomised patients|208
8649375|NCT00628862|9690499|FG000|COMPLETED|Overall Study|randomised patients|195
8649376|NCT00628862|9690500|FG001|COMPLETED|Overall Study|randomised patients|182
8649377|NCT00628862|9690501|FG002|COMPLETED|Overall Study|randomised patients|186
8649378|NCT00628862|9690499|FG000|NOT COMPLETED|Overall Study||11
8649379|NCT00628862|9690500|FG001|NOT COMPLETED|Overall Study||17
8649380|NCT00628862|9690501|FG002|NOT COMPLETED|Overall Study||22
8649381|NCT00628901|9690511|FG000|STARTED|Overall Study||30
8649382|NCT00628901|9690512|FG001|STARTED|Overall Study||30
8649383|NCT00628901|9690511|FG000|COMPLETED|Overall Study||27
8649384|NCT00628901|9690512|FG001|COMPLETED|Overall Study||29
8649385|NCT00628901|9690511|FG000|NOT COMPLETED|Overall Study||3
8649386|NCT00628901|9690512|FG001|NOT COMPLETED|Overall Study||1
8649387|NCT00628927|9690520|FG000|STARTED|Overall Study||183
8649388|NCT00628927|9690521|FG001|STARTED|Overall Study||30
8649389|NCT00628927|9690520|FG000|COMPLETED|Overall Study||175
8649390|NCT00628927|9690521|FG001|COMPLETED|Overall Study||30
8649391|NCT00628927|9690520|FG000|NOT COMPLETED|Overall Study||8
8649392|NCT00628927|9690521|FG001|NOT COMPLETED|Overall Study||0
8691824|NCT00856908|9737177|FG000|STARTED|Overall Study||15
8691825|NCT00856908|9737178|FG001|STARTED|Overall Study||5
8691826|NCT00856908|9737177|FG000|COMPLETED|Overall Study||14
8691827|NCT00856908|9737178|FG001|COMPLETED|Overall Study||5
8691828|NCT00856908|9737177|FG000|NOT COMPLETED|Overall Study||1
8691829|NCT00856908|9737178|FG001|NOT COMPLETED|Overall Study||0
8691830|NCT00856973|9737187|FG000|STARTED|Overall Study||162
8691831|NCT00856973|9737188|FG001|STARTED|Overall Study||163
8691832|NCT00856973|9737189|FG002|STARTED|Overall Study||161
8691833|NCT00856973|9737187|FG000|COMPLETED|Overall Study||126
8691834|NCT00856973|9737188|FG001|COMPLETED|Overall Study||122
8691835|NCT00856973|9737189|FG002|COMPLETED|Overall Study||123
8691836|NCT00856973|9737187|FG000|NOT COMPLETED|Overall Study||36
8691837|NCT00856973|9737188|FG001|NOT COMPLETED|Overall Study||41
8691838|NCT00856973|9737189|FG002|NOT COMPLETED|Overall Study||38
8691839|NCT00856986|9737206|FG000|STARTED|Run-in Period, Weeks -12-0||161
8691840|NCT00856986|9737207|FG001|STARTED|Run-in Period, Weeks -12-0||162
8691841|NCT00856986|9737208|FG002|STARTED|Run-in Period, Weeks -12-0||498
8691842|NCT00856986|9737209|FG003|STARTED|Run-in Period, Weeks -12-0||167
8691843|NCT00856986|9737210|FG004|STARTED|Run-in Period, Weeks -12-0||0
8691844|NCT00856986|9737206|FG000|COMPLETED|Run-in Period, Weeks -12-0||161
8691845|NCT00856986|9737207|FG001|COMPLETED|Run-in Period, Weeks -12-0||162
8691846|NCT00856986|9737208|FG002|COMPLETED|Run-in Period, Weeks -12-0||498
8691847|NCT00856986|9737209|FG003|COMPLETED|Run-in Period, Weeks -12-0|Subjects who withdrew during run-in and before randomisation were Early Withdrawals|0
8691848|NCT00856986|9737210|FG004|COMPLETED|Run-in Period, Weeks -12-0||0
8691849|NCT00856986|9737206|FG000|NOT COMPLETED|Run-in Period, Weeks -12-0||0
8691850|NCT00856986|9737207|FG001|NOT COMPLETED|Run-in Period, Weeks -12-0||0
8691851|NCT00856986|9737208|FG002|NOT COMPLETED|Run-in Period, Weeks -12-0||0
8691852|NCT00856986|9737209|FG003|NOT COMPLETED|Run-in Period, Weeks -12-0||167
8691853|NCT00856986|9737210|FG004|NOT COMPLETED|Run-in Period, Weeks -12-0||0
8691854|NCT00856986|9737206|FG000|STARTED|Main Period, Weeks 0-26||161
8691855|NCT00856986|9737207|FG001|STARTED|Main Period, Weeks 0-26||162
8691856|NCT00856986|9737208|FG002|STARTED|Main Period, Weeks 0-26||498
8691857|NCT00856986|9737209|FG003|STARTED|Main Period, Weeks 0-26||0
8691858|NCT00856986|9737210|FG004|STARTED|Main Period, Weeks 0-26||0
8691859|NCT00856986|9737206|FG000|COMPLETED|Main Period, Weeks 0-26||127
8691860|NCT00856986|9737207|FG001|COMPLETED|Main Period, Weeks 0-26||144
8691861|NCT00856986|9737208|FG002|COMPLETED|Main Period, Weeks 0-26||470
8691862|NCT00856986|9737209|FG003|COMPLETED|Main Period, Weeks 0-26||0
8691863|NCT00856986|9737210|FG004|COMPLETED|Main Period, Weeks 0-26||0
8691864|NCT00856986|9737206|FG000|NOT COMPLETED|Main Period, Weeks 0-26||34
8691865|NCT00856986|9737207|FG001|NOT COMPLETED|Main Period, Weeks 0-26||18
8649393|NCT00629018|9690534|FG000|STARTED|Overall Study||55
8649394|NCT00629018|9690535|FG001|STARTED|Overall Study||55
8649395|NCT00629018|9690534|FG000|COMPLETED|Overall Study||55
8649396|NCT00629018|9690535|FG001|COMPLETED|Overall Study||55
8649397|NCT00629018|9690534|FG000|NOT COMPLETED|Overall Study||0
8649398|NCT00629018|9690535|FG001|NOT COMPLETED|Overall Study||0
8649399|NCT00629083|9690543|FG000|STARTED|Overall Study||228
8649400|NCT00629083|9690544|FG001|STARTED|Overall Study||117
8649401|NCT00629083|9690543|FG000|COMPLETED|Overall Study||200
8649402|NCT00629083|9690544|FG001|COMPLETED|Overall Study||103
8649403|NCT00629083|9690543|FG000|NOT COMPLETED|Overall Study||28
8649404|NCT00629083|9690544|FG001|NOT COMPLETED|Overall Study||14
8649405|NCT00629122|9690554|FG000|STARTED|First Period: Day 1- 3 (Sublingual)||2
8649406|NCT00629122|9690555|FG001|STARTED|First Period: Day 1- 3 (Sublingual)||3
8649407|NCT00629122|9690554|FG000|COMPLETED|First Period: Day 1- 3 (Sublingual)||2
8649408|NCT00629122|9690555|FG001|COMPLETED|First Period: Day 1- 3 (Sublingual)||3
8649409|NCT00629122|9690554|FG000|NOT COMPLETED|First Period: Day 1- 3 (Sublingual)||0
8649410|NCT00629122|9690555|FG001|NOT COMPLETED|First Period: Day 1- 3 (Sublingual)||0
8649411|NCT00629122|9690554|FG000|STARTED|Second Period: Day 3-5 (Washout)||2
8649412|NCT00629122|9690555|FG001|STARTED|Second Period: Day 3-5 (Washout)||3
8728087|NCT01046110|9775309|FG000|STARTED|Overall Study||229
8728088|NCT01046110|9775310|FG001|STARTED|Overall Study||229
8728089|NCT01046110|9775309|FG000|Exposed|Overall Study|2 subjects were randomised in error and 1 subject did not want to take insulin|226
8728090|NCT01046110|9775310|FG001|Exposed|Overall Study|1 subject was randomised in error|228
8728091|NCT01046110|9775309|FG000|COMPLETED|Overall Study||174
8728092|NCT01046110|9775310|FG001|COMPLETED|Overall Study||174
8728093|NCT01046110|9775309|FG000|NOT COMPLETED|Overall Study||55
8728094|NCT01046110|9775310|FG001|NOT COMPLETED|Overall Study||55
8728095|NCT01046136|9775318|FG000|STARTED|Overall Study||188
8728096|NCT01046136|9775319|FG001|STARTED|Overall Study||190
8728097|NCT01046136|9775318|FG000|COMPLETED|Overall Study||184
8728098|NCT01046136|9775319|FG001|COMPLETED|Overall Study||182
8728099|NCT01046136|9775318|FG000|NOT COMPLETED|Overall Study||4
8728100|NCT01046136|9775319|FG001|NOT COMPLETED|Overall Study||8
8728101|NCT01046253|9775329|FG000|STARTED|First Intervention||25
8728102|NCT01046253|9775330|FG001|STARTED|First Intervention||25
8728103|NCT01046253|9775329|FG000|COMPLETED|First Intervention||25
8728104|NCT01046253|9775330|FG001|COMPLETED|First Intervention||25
8728105|NCT01046253|9775329|FG000|NOT COMPLETED|First Intervention||0
8728106|NCT01046253|9775330|FG001|NOT COMPLETED|First Intervention||0
8728107|NCT01046253|9775329|FG000|STARTED|First Washout of 7 Days||25
8728108|NCT01046253|9775330|FG001|STARTED|First Washout of 7 Days||25
8728109|NCT01046253|9775329|FG000|COMPLETED|First Washout of 7 Days||25
8728110|NCT01046253|9775330|FG001|COMPLETED|First Washout of 7 Days||25
8728111|NCT01046253|9775329|FG000|NOT COMPLETED|First Washout of 7 Days||0
8728112|NCT01046253|9775330|FG001|NOT COMPLETED|First Washout of 7 Days||0
8728113|NCT01046253|9775329|FG000|STARTED|Second Intervention||25
8728114|NCT01046253|9775330|FG001|STARTED|Second Intervention||25
8728115|NCT01046253|9775329|FG000|COMPLETED|Second Intervention||25
8728116|NCT01046253|9775330|FG001|COMPLETED|Second Intervention||23
8728117|NCT01046253|9775329|FG000|NOT COMPLETED|Second Intervention||0
8728118|NCT01046253|9775330|FG001|NOT COMPLETED|Second Intervention||2
8728119|NCT01046253|9775329|FG000|STARTED|Second Washout of 7 Days||25
8728120|NCT01046253|9775330|FG001|STARTED|Second Washout of 7 Days||23
8728121|NCT01046253|9775329|FG000|COMPLETED|Second Washout of 7 Days||25
8728122|NCT01046253|9775330|FG001|COMPLETED|Second Washout of 7 Days||23
8728123|NCT01046253|9775329|FG000|NOT COMPLETED|Second Washout of 7 Days||0
8728124|NCT01046253|9775330|FG001|NOT COMPLETED|Second Washout of 7 Days||0
8728125|NCT01046253|9775329|FG000|STARTED|Third Intervention||25
8728126|NCT01046253|9775330|FG001|STARTED|Third Intervention||23
8728127|NCT01046253|9775329|FG000|COMPLETED|Third Intervention||25
8728128|NCT01046253|9775330|FG001|COMPLETED|Third Intervention||23
8728129|NCT01046253|9775329|FG000|NOT COMPLETED|Third Intervention||0
8728130|NCT01046253|9775330|FG001|NOT COMPLETED|Third Intervention||0
8728131|NCT01046253|9775329|FG000|STARTED|Third Washout of 7 Days||25
8728132|NCT01046253|9775330|FG001|STARTED|Third Washout of 7 Days||23
8728133|NCT01046253|9775329|FG000|COMPLETED|Third Washout of 7 Days||25
8728134|NCT01046253|9775330|FG001|COMPLETED|Third Washout of 7 Days||23
8728135|NCT01046253|9775329|FG000|NOT COMPLETED|Third Washout of 7 Days||0
8728136|NCT01046253|9775330|FG001|NOT COMPLETED|Third Washout of 7 Days||0
8728137|NCT01046253|9775329|FG000|STARTED|Fourth Intervention||25
8728138|NCT01046253|9775330|FG001|STARTED|Fourth Intervention||23
8728139|NCT01046253|9775329|FG000|COMPLETED|Fourth Intervention||25
8728140|NCT01046253|9775330|FG001|COMPLETED|Fourth Intervention||23
8728141|NCT01046253|9775329|FG000|NOT COMPLETED|Fourth Intervention||0
8728142|NCT01046253|9775330|FG001|NOT COMPLETED|Fourth Intervention||0
8728143|NCT01046396|9775336|FG000|STARTED|Overall Study||69
8728144|NCT01046396|9775336|FG000|COMPLETED|Overall Study||64
8728145|NCT01046396|9775336|FG000|NOT COMPLETED|Overall Study||5
8728146|NCT01046565|9775343|FG000|STARTED|Overall Study||75
8728147|NCT01046565|9775343|FG000|COMPLETED|Overall Study||66
8649413|NCT00629122|9690554|FG000|COMPLETED|Second Period: Day 3-5 (Washout)||2
8649414|NCT00629122|9690555|FG001|COMPLETED|Second Period: Day 3-5 (Washout)||3
8649415|NCT00629122|9690554|FG000|NOT COMPLETED|Second Period: Day 3-5 (Washout)||0
8649416|NCT00629122|9690555|FG001|NOT COMPLETED|Second Period: Day 3-5 (Washout)||0
8649417|NCT00629122|9690554|FG000|STARTED|Third Period: Day 6-8 (Oral)||2
8649418|NCT00629122|9690555|FG001|STARTED|Third Period: Day 6-8 (Oral)||3
8649419|NCT00629122|9690554|FG000|COMPLETED|Third Period: Day 6-8 (Oral)||2
8649420|NCT00629122|9690555|FG001|COMPLETED|Third Period: Day 6-8 (Oral)||3
8649421|NCT00629122|9690554|FG000|NOT COMPLETED|Third Period: Day 6-8 (Oral)||0
8649422|NCT00629122|9690555|FG001|NOT COMPLETED|Third Period: Day 6-8 (Oral)||0
8649423|NCT00629239|9690563|FG000|STARTED|Overall Study||34
8649424|NCT00629239|9690564|FG001|STARTED|Overall Study||32
8649425|NCT00629239|9690563|FG000|COMPLETED|Overall Study||26
8649426|NCT00629239|9690564|FG001|COMPLETED|Overall Study||28
8649427|NCT00629239|9690563|FG000|NOT COMPLETED|Overall Study||8
8649428|NCT00629239|9690564|FG001|NOT COMPLETED|Overall Study||4
8649429|NCT00629265|9690572|FG000|STARTED|Overall Study||116
8649430|NCT00629265|9690573|FG001|STARTED|Overall Study||54
8649431|NCT00629265|9690572|FG000|COMPLETED|Overall Study||84
8649432|NCT00629265|9690573|FG001|COMPLETED|Overall Study||34
8649433|NCT00629265|9690572|FG000|NOT COMPLETED|Overall Study||32
8649434|NCT00629265|9690573|FG001|NOT COMPLETED|Overall Study||20
8649435|NCT00629499|9690579|FG000|STARTED|Overall Study||63
8649436|NCT00629499|9690579|FG000|COMPLETED|Overall Study||63
8649437|NCT00629499|9690579|FG000|NOT COMPLETED|Overall Study||0
8649438|NCT00629525|9690583|FG000|STARTED|Overall Study||35
8649439|NCT00629525|9690583|FG000|COMPLETED|Overall Study||32
8649440|NCT00629525|9690583|FG000|NOT COMPLETED|Overall Study||3
8649441|NCT00629707|9690589|FG000|STARTED|Overall Study||10
8649442|NCT00629707|9690590|FG001|STARTED|Overall Study||10
8649443|NCT00629707|9690589|FG000|COMPLETED|Overall Study||10
8649444|NCT00629707|9690590|FG001|COMPLETED|Overall Study||8
8649445|NCT00629707|9690589|FG000|NOT COMPLETED|Overall Study||0
8649446|NCT00629707|9690590|FG001|NOT COMPLETED|Overall Study||2
8649447|NCT00629772|9690598|FG000|STARTED|First Intervention - Day 0 - Week 14||12
8649448|NCT00629772|9690599|FG001|STARTED|First Intervention - Day 0 - Week 14||12
8649449|NCT00629772|9690598|FG000|COMPLETED|First Intervention - Day 0 - Week 14||12
8649450|NCT00629772|9690599|FG001|COMPLETED|First Intervention - Day 0 - Week 14||12
8649451|NCT00629772|9690598|FG000|NOT COMPLETED|First Intervention - Day 0 - Week 14||0
8649452|NCT00629772|9690599|FG001|NOT COMPLETED|First Intervention - Day 0 - Week 14||0
8649453|NCT00629772|9690598|FG000|STARTED|Second Intervention Week 14 - Week 26|Patient withdrew at Week 14 and therefore never received infliximab.|12
8649454|NCT00629772|9690599|FG001|STARTED|Second Intervention Week 14 - Week 26||12
8649455|NCT00629772|9690598|FG000|COMPLETED|Second Intervention Week 14 - Week 26||11
8649456|NCT00629772|9690599|FG001|COMPLETED|Second Intervention Week 14 - Week 26||10
8649457|NCT00629772|9690598|FG000|NOT COMPLETED|Second Intervention Week 14 - Week 26||1
8649458|NCT00629772|9690599|FG001|NOT COMPLETED|Second Intervention Week 14 - Week 26||2
8649459|NCT00630032|9690608|FG000|STARTED|Overall Study||398
8649460|NCT00630032|9690609|FG001|STARTED|Overall Study||364
8649461|NCT00630032|9690608|FG000|COMPLETED|Overall Study||308
8649462|NCT00630032|9690609|FG001|COMPLETED|Overall Study||269
8649463|NCT00630032|9690608|FG000|NOT COMPLETED|Overall Study||90
8649464|NCT00630032|9690609|FG001|NOT COMPLETED|Overall Study||95
8649465|NCT00630058|9690617|FG000|STARTED|Overall Study||10
8649466|NCT00630058|9690618|FG001|STARTED|Overall Study||10
8649467|NCT00630058|9690617|FG000|COMPLETED|Overall Study||6
8649468|NCT00630058|9690618|FG001|COMPLETED|Overall Study||6
8649469|NCT00630058|9690617|FG000|NOT COMPLETED|Overall Study||4
8649470|NCT00630058|9690618|FG001|NOT COMPLETED|Overall Study||4
8649471|NCT00630253|9690627|FG000|STARTED|Overall Study||16
8649472|NCT00630253|9690628|FG001|STARTED|Overall Study||9
8649473|NCT00630253|9690629|FG002|STARTED|Overall Study||6
8649474|NCT00630253|9690627|FG000|COMPLETED|Overall Study||16
8649475|NCT00630253|9690628|FG001|COMPLETED|Overall Study||9
8649476|NCT00630253|9690629|FG002|COMPLETED|Overall Study||6
8649477|NCT00630253|9690627|FG000|NOT COMPLETED|Overall Study||0
8649478|NCT00630253|9690628|FG001|NOT COMPLETED|Overall Study||0
8649479|NCT00630253|9690629|FG002|NOT COMPLETED|Overall Study||0
8649480|NCT00630305|9690637|FG000|STARTED|Overall Study||37
8649481|NCT00630305|9690637|FG000|COMPLETED|Overall Study||35
8649482|NCT00630305|9690637|FG000|NOT COMPLETED|Overall Study||2
8649483|NCT00630331|9690653|FG000|STARTED|Overall Study||3828
8649484|NCT00630331|9690654|FG001|STARTED|Overall Study||3676
8649485|NCT00630331|9690655|FG002|STARTED|Overall Study||3900
8649486|NCT00630331|9690653|FG000|COMPLETED|Overall Study||3622
8649487|NCT00630331|9690654|FG001|COMPLETED|Overall Study||3510
8649488|NCT00630331|9690655|FG002|COMPLETED|Overall Study||3712
8649489|NCT00630331|9690653|FG000|NOT COMPLETED|Overall Study||206
8649490|NCT00630331|9690654|FG001|NOT COMPLETED|Overall Study||166
8649491|NCT00630331|9690655|FG002|NOT COMPLETED|Overall Study||188
8649492|NCT00630344|9690663|FG000|STARTED|Overall Study||36
8649493|NCT00630344|9690663|FG000|COMPLETED|Overall Study||0
8649494|NCT00630344|9690663|FG000|NOT COMPLETED|Overall Study||36
8649495|NCT00630396|9690668|FG000|STARTED|Overall Study||60
8649496|NCT00630396|9690668|FG000|COMPLETED|Overall Study||53
8649497|NCT00630396|9690668|FG000|NOT COMPLETED|Overall Study||7
8649498|NCT00630409|9690672|FG000|STARTED|Overall Study||5
8649499|NCT00630409|9690672|FG000|COMPLETED|Overall Study||4
8728148|NCT01046565|9775343|FG000|NOT COMPLETED|Overall Study||9
8728149|NCT01046643|9775354|FG000|STARTED|First Period Treatment or Placebo||9
8728150|NCT01046643|9775355|FG001|STARTED|First Period Treatment or Placebo||7
8728151|NCT01046643|9775356|FG002|STARTED|First Period Treatment or Placebo||7
8728152|NCT01046643|9775357|FG003|STARTED|First Period Treatment or Placebo||7
8728153|NCT01046643|9775354|FG000|COMPLETED|First Period Treatment or Placebo||9
8728154|NCT01046643|9775355|FG001|COMPLETED|First Period Treatment or Placebo||6
8728155|NCT01046643|9775356|FG002|COMPLETED|First Period Treatment or Placebo||7
8728156|NCT01046643|9775357|FG003|COMPLETED|First Period Treatment or Placebo||7
8649500|NCT00630409|9690672|FG000|NOT COMPLETED|Overall Study||1
8649501|NCT00630539|9690681|FG000|STARTED|Overall Study||34
8649502|NCT00630539|9690682|FG001|STARTED|Overall Study||33
8649503|NCT00630539|9690683|FG002|STARTED|Overall Study||29
8649504|NCT00630539|9690684|FG003|STARTED|Overall Study||30
8649505|NCT00630539|9690681|FG000|COMPLETED|Overall Study||33
8649506|NCT00630539|9690682|FG001|COMPLETED|Overall Study||29
8649507|NCT00630539|9690683|FG002|COMPLETED|Overall Study||28
8649508|NCT00630539|9690684|FG003|COMPLETED|Overall Study||27
8649509|NCT00630539|9690681|FG000|NOT COMPLETED|Overall Study||1
8649510|NCT00630539|9690682|FG001|NOT COMPLETED|Overall Study||4
8649511|NCT00630539|9690683|FG002|NOT COMPLETED|Overall Study||1
8649512|NCT00630539|9690684|FG003|NOT COMPLETED|Overall Study||3
8649513|NCT00630734|9690704|FG000|STARTED|Overall Study||11
8649514|NCT00630734|9690705|FG001|STARTED|Overall Study||13
8649515|NCT00630734|9690706|FG002|STARTED|Overall Study||8
8649516|NCT00630734|9690704|FG000|COMPLETED|Overall Study||9
8649517|NCT00630734|9690705|FG001|COMPLETED|Overall Study||12
8649518|NCT00630734|9690706|FG002|COMPLETED|Overall Study||7
8649519|NCT00630734|9690704|FG000|NOT COMPLETED|Overall Study||2
8649520|NCT00630734|9690705|FG001|NOT COMPLETED|Overall Study||1
8649521|NCT00630734|9690706|FG002|NOT COMPLETED|Overall Study||1
8649522|NCT00630747|9690716|FG000|STARTED|Overall Study||94
8649523|NCT00630747|9690716|FG000|Participants Treated in Phase I of Study|Overall Study||94
8649524|NCT00630747|9690716|FG000|COMPLETED|Overall Study||85
8649525|NCT00630747|9690716|FG000|NOT COMPLETED|Overall Study||9
8649526|NCT00630786|9690723|FG000|STARTED|Overall Study|Includes 2 patients enrolled in Part 1 and 17 patients enrolled in Part 2.|19
8649527|NCT00630786|9690724|FG001|STARTED|Overall Study|Includes 3 patients enrolled in Part 1 and 22 patients enrolled in Part 2.|25
8649528|NCT00630786|9690725|FG002|STARTED|Overall Study|All patients were enrolled in Part 2.|9
8649529|NCT00630786|9690723|FG000|Received Study Medication|Overall Study||19
8649530|NCT00630786|9690724|FG001|Received Study Medication|Overall Study||25
8649531|NCT00630786|9690725|FG002|Received Study Medication|Overall Study||8
8649532|NCT00630786|9690723|FG000|COMPLETED|Overall Study|Completed study defined as participant death|18
8649533|NCT00630786|9690724|FG001|COMPLETED|Overall Study|Completed study defined as participant death|23
8649534|NCT00630786|9690725|FG002|COMPLETED|Overall Study|Completed study defined as participant death|7
8649535|NCT00630786|9690723|FG000|NOT COMPLETED|Overall Study||1
8649536|NCT00630786|9690724|FG001|NOT COMPLETED|Overall Study||2
8649537|NCT00630786|9690725|FG002|NOT COMPLETED|Overall Study||2
8649538|NCT00630812|9690733|FG000|STARTED|Randomisation to First Dose||192
8649539|NCT00630812|9690734|FG001|STARTED|Randomisation to First Dose||126
8649540|NCT00630812|9690733|FG000|COMPLETED|Randomisation to First Dose||184
8649541|NCT00630812|9690734|FG001|COMPLETED|Randomisation to First Dose||121
8649542|NCT00630812|9690733|FG000|NOT COMPLETED|Randomisation to First Dose||8
8649543|NCT00630812|9690734|FG001|NOT COMPLETED|Randomisation to First Dose||5
8649544|NCT00630812|9690733|FG000|STARTED|Double Blind Treatment Period||184
8649545|NCT00630812|9690734|FG001|STARTED|Double Blind Treatment Period||121
8649546|NCT00630812|9690733|FG000|COMPLETED|Double Blind Treatment Period||153
8649547|NCT00630812|9690734|FG001|COMPLETED|Double Blind Treatment Period||107
8649548|NCT00630812|9690733|FG000|NOT COMPLETED|Double Blind Treatment Period||31
8649549|NCT00630812|9690734|FG001|NOT COMPLETED|Double Blind Treatment Period||14
8649550|NCT00630825|9690744|FG000|STARTED|Overall Study||65
8649551|NCT00630825|9690745|FG001|STARTED|Overall Study||65
8649552|NCT00630825|9690746|FG002|STARTED|Overall Study||66
8649553|NCT00630825|9690747|FG003|STARTED|Overall Study||66
8649554|NCT00630825|9690744|FG000|Received at Least One Dose of Study Drug|Overall Study||65
8649555|NCT00630825|9690745|FG001|Received at Least One Dose of Study Drug|Overall Study||65
8649556|NCT00630825|9690746|FG002|Received at Least One Dose of Study Drug|Overall Study||66
8649557|NCT00630825|9690747|FG003|Received at Least One Dose of Study Drug|Overall Study||66
8649558|NCT00630825|9690744|FG000|COMPLETED|Overall Study||56
8649559|NCT00630825|9690745|FG001|COMPLETED|Overall Study||58
8649560|NCT00630825|9690746|FG002|COMPLETED|Overall Study||58
8649561|NCT00630825|9690747|FG003|COMPLETED|Overall Study||60
8649562|NCT00630825|9690744|FG000|NOT COMPLETED|Overall Study||9
8649563|NCT00630825|9690745|FG001|NOT COMPLETED|Overall Study||7
8649564|NCT00630825|9690746|FG002|NOT COMPLETED|Overall Study||8
8649565|NCT00630825|9690747|FG003|NOT COMPLETED|Overall Study||6
8649566|NCT00630838|9690759|FG000|STARTED|Overall Study||32
8649567|NCT00630838|9690760|FG001|STARTED|Overall Study||30
8649568|NCT00630838|9690759|FG000|COMPLETED|Overall Study||32
8649569|NCT00630838|9690760|FG001|COMPLETED|Overall Study||28
8649570|NCT00630838|9690759|FG000|NOT COMPLETED|Overall Study||0
8728157|NCT01046643|9775354|FG000|NOT COMPLETED|First Period Treatment or Placebo||0
8649571|NCT00630838|9690760|FG001|NOT COMPLETED|Overall Study||2
8649572|NCT00630864|9690768|FG000|STARTED|Part 1 (up to Week 6)||21
8649573|NCT00630864|9690768|FG000|COMPLETED|Part 1 (up to Week 6)||20
8649574|NCT00630864|9690768|FG000|NOT COMPLETED|Part 1 (up to Week 6)||1
8649575|NCT00630864|9690768|FG000|STARTED|Part 2 (After Week 6 up to Month 12)||20
8649576|NCT00630864|9690768|FG000|COMPLETED|Part 2 (After Week 6 up to Month 12)||18
8649577|NCT00630864|9690768|FG000|NOT COMPLETED|Part 2 (After Week 6 up to Month 12)||2
8649578|NCT00630877|9690775|FG000|STARTED|Overall Study|For all arms, started means treated.|91
8649579|NCT00630877|9690776|FG001|STARTED|Overall Study||90
8649580|NCT00630877|9690777|FG002|STARTED|Overall Study||90
8649581|NCT00630877|9690775|FG000|COMPLETED|Overall Study||72
8649582|NCT00630877|9690776|FG001|COMPLETED|Overall Study||75
8649583|NCT00630877|9690777|FG002|COMPLETED|Overall Study||80
8649584|NCT00630877|9690775|FG000|NOT COMPLETED|Overall Study||19
8649585|NCT00630877|9690776|FG001|NOT COMPLETED|Overall Study||15
8649586|NCT00630877|9690777|FG002|NOT COMPLETED|Overall Study||10
8649587|NCT00630916|9690789|FG000|STARTED|Overall Study|Total patients enrolled (i.e. consented) to participate in the study.|756
8649588|NCT00630916|9690789|FG000|Study Cohort|Overall Study|Enrolled but did not receive device via physician decision, protocol violation, or lack of efficacy.|699
8649589|NCT00630916|9690789|FG000|COMPLETED|Overall Study|The number of patients that were active (i.e. not drop out) at the end of the study.|546
8649590|NCT00630916|9690789|FG000|NOT COMPLETED|Overall Study||210
8649591|NCT00630955|9690796|FG000|STARTED|Overall Study||34
8649592|NCT00630955|9690797|FG001|STARTED|Overall Study||37
8649593|NCT00630955|9690798|FG002|STARTED|Overall Study||40
8649594|NCT00630955|9690796|FG000|COMPLETED|Overall Study||31
8649595|NCT00630955|9690797|FG001|COMPLETED|Overall Study||31
8649596|NCT00630955|9690798|FG002|COMPLETED|Overall Study||28
8649597|NCT00630955|9690796|FG000|NOT COMPLETED|Overall Study||3
8649598|NCT00630955|9690797|FG001|NOT COMPLETED|Overall Study||6
8649599|NCT00630955|9690798|FG002|NOT COMPLETED|Overall Study||12
8649600|NCT00630994|9690806|FG000|STARTED|Overall Study||4
8649601|NCT00630994|9690806|FG000|COMPLETED|Overall Study||0
8649602|NCT00630994|9690806|FG000|NOT COMPLETED|Overall Study||4
8649603|NCT00631007|9690816|FG000|STARTED|Overall Study||60
8649604|NCT00631007|9690817|FG001|STARTED|Overall Study||61
8649605|NCT00631007|9690818|FG002|STARTED|Overall Study||63
8649606|NCT00631007|9690819|FG003|STARTED|Overall Study||62
8649607|NCT00631007|9690820|FG004|STARTED|Overall Study||60
8649608|NCT00631007|9690821|FG005|STARTED|Overall Study||61
8649609|NCT00631007|9690816|FG000|COMPLETED|Overall Study||49
8649610|NCT00631007|9690817|FG001|COMPLETED|Overall Study||50
8649611|NCT00631007|9690818|FG002|COMPLETED|Overall Study||53
8649612|NCT00631007|9690819|FG003|COMPLETED|Overall Study||53
8649613|NCT00631007|9690820|FG004|COMPLETED|Overall Study||48
8649614|NCT00631007|9690821|FG005|COMPLETED|Overall Study||46
8649615|NCT00631007|9690816|FG000|NOT COMPLETED|Overall Study||11
8649616|NCT00631007|9690817|FG001|NOT COMPLETED|Overall Study||11
8649617|NCT00631007|9690818|FG002|NOT COMPLETED|Overall Study||10
8649618|NCT00631007|9690819|FG003|NOT COMPLETED|Overall Study||9
8649619|NCT00631007|9690820|FG004|NOT COMPLETED|Overall Study||12
8649620|NCT00631007|9690821|FG005|NOT COMPLETED|Overall Study||15
8649621|NCT00631020|9690835|FG000|STARTED|Overall Study||34
8649622|NCT00631020|9690835|FG000|COMPLETED|Overall Study||26
8649623|NCT00631020|9690835|FG000|NOT COMPLETED|Overall Study||8
8649624|NCT00631163|9690839|FG000|STARTED|Number of Participants in Year 1||102
8649625|NCT00631163|9690839|FG000|COMPLETED|Number of Participants in Year 1||68
8649626|NCT00631163|9690839|FG000|NOT COMPLETED|Number of Participants in Year 1||34
8649627|NCT00631163|9690839|FG000|STARTED|Number of Participants in Year 2||57
8649628|NCT00631163|9690839|FG000|COMPLETED|Number of Participants in Year 2||52
8649629|NCT00631163|9690839|FG000|NOT COMPLETED|Number of Participants in Year 2||5
8649630|NCT00631189|9690854|FG000|STARTED|Initial Phase||668
8649631|NCT00631189|9690855|FG001|STARTED|Initial Phase||0
8649632|NCT00631189|9690856|FG002|STARTED|Initial Phase||0
8649633|NCT00631189|9690857|FG003|STARTED|Initial Phase||0
8649634|NCT00631189|9690854|FG000|COMPLETED|Initial Phase||317
8649635|NCT00631189|9690855|FG001|COMPLETED|Initial Phase||0
8649636|NCT00631189|9690856|FG002|COMPLETED|Initial Phase||0
8649637|NCT00631189|9690857|FG003|COMPLETED|Initial Phase||0
8649638|NCT00631189|9690854|FG000|NOT COMPLETED|Initial Phase||351
8649639|NCT00631189|9690855|FG001|NOT COMPLETED|Initial Phase||0
8649640|NCT00631189|9690856|FG002|NOT COMPLETED|Initial Phase||0
8649641|NCT00631189|9690857|FG003|NOT COMPLETED|Initial Phase||0
8649642|NCT00631189|9690854|FG000|STARTED|Treatment Phase||0
8649643|NCT00631189|9690855|FG001|STARTED|Treatment Phase||104
8649644|NCT00631189|9690856|FG002|STARTED|Treatment Phase||103
8649645|NCT00631189|9690857|FG003|STARTED|Treatment Phase||110
8649646|NCT00631189|9690854|FG000|COMPLETED|Treatment Phase||0
8649647|NCT00631189|9690855|FG001|COMPLETED|Treatment Phase||97
8649648|NCT00631189|9690856|FG002|COMPLETED|Treatment Phase||92
8649649|NCT00631189|9690857|FG003|COMPLETED|Treatment Phase||103
8649650|NCT00631189|9690854|FG000|NOT COMPLETED|Treatment Phase||0
8649651|NCT00631189|9690855|FG001|NOT COMPLETED|Treatment Phase||7
8649652|NCT00631189|9690856|FG002|NOT COMPLETED|Treatment Phase||11
8649653|NCT00631189|9690857|FG003|NOT COMPLETED|Treatment Phase||7
8649654|NCT00631319|9690869|FG000|STARTED|Conversion and Titration Phase||343
8649655|NCT00631319|9690870|FG001|STARTED|Conversion and Titration Phase|Per the study design, no patients received placebo during this phase.|0
8649656|NCT00631319|9690869|FG000|COMPLETED|Conversion and Titration Phase||200
8649657|NCT00631319|9690870|FG001|COMPLETED|Conversion and Titration Phase||0
8649658|NCT00631319|9690869|FG000|NOT COMPLETED|Conversion and Titration Phase||143
8649659|NCT00631319|9690870|FG001|NOT COMPLETED|Conversion and Titration Phase||0
8649660|NCT00631319|9690869|FG000|STARTED|Double-blind Phase||100
8649661|NCT00631319|9690870|FG001|STARTED|Double-blind Phase||100
8649662|NCT00631319|9690869|FG000|COMPLETED|Double-blind Phase||60
8649663|NCT00631319|9690870|FG001|COMPLETED|Double-blind Phase||65
8649664|NCT00631319|9690869|FG000|NOT COMPLETED|Double-blind Phase||40
8649665|NCT00631319|9690870|FG001|NOT COMPLETED|Double-blind Phase||35
8649666|NCT00631358|9690879|FG000|STARTED|Overall Study||50
8649667|NCT00631358|9690880|FG001|STARTED|Overall Study||47
8649668|NCT00631358|9690879|FG000|COMPLETED|Overall Study||44
8649669|NCT00631358|9690880|FG001|COMPLETED|Overall Study||45
8649670|NCT00631358|9690879|FG000|NOT COMPLETED|Overall Study||6
8649671|NCT00631358|9690880|FG001|NOT COMPLETED|Overall Study||2
8649672|NCT00631371|9690888|FG000|STARTED|Overall Study||400
8649673|NCT00631371|9690889|FG001|STARTED|Overall Study||391
8649674|NCT00631371|9690888|FG000|Treated|Overall Study||393
8649675|NCT00631371|9690889|FG001|Treated|Overall Study||391
8649676|NCT00631371|9690888|FG000|COMPLETED|Overall Study||0
8649677|NCT00631371|9690889|FG001|COMPLETED|Overall Study||0
8649678|NCT00631371|9690888|FG000|NOT COMPLETED|Overall Study||400
8649679|NCT00631371|9690889|FG001|NOT COMPLETED|Overall Study||391
8649680|NCT00631410|9690897|FG000|STARTED|Overall Study||6
8649681|NCT00631410|9690898|FG001|STARTED|Overall Study||6
8649682|NCT00631410|9690897|FG000|COMPLETED|Overall Study||0
8649683|NCT00631410|9690898|FG001|COMPLETED|Overall Study||0
8649684|NCT00631410|9690897|FG000|NOT COMPLETED|Overall Study||6
8649685|NCT00631410|9690898|FG001|NOT COMPLETED|Overall Study||6
8649686|NCT00631449|9690909|FG000|STARTED|Overall Study||15
8649687|NCT00631449|9690910|FG001|STARTED|Overall Study||15
8649688|NCT00631449|9690909|FG000|COMPLETED|Overall Study||15
8649689|NCT00631449|9690910|FG001|COMPLETED|Overall Study||15
8649690|NCT00631449|9690909|FG000|NOT COMPLETED|Overall Study||0
8649691|NCT00631449|9690910|FG001|NOT COMPLETED|Overall Study||0
8649692|NCT00631475|9690918|FG000|STARTED|Overall Study||128
8649693|NCT00631475|9690918|FG000|COMPLETED|Overall Study||83
8649694|NCT00631475|9690918|FG000|NOT COMPLETED|Overall Study||45
8649695|NCT00631488|9690925|FG000|STARTED|Overall Study||48
8649696|NCT00631488|9690926|FG001|STARTED|Overall Study||49
8649697|NCT00631488|9690927|FG002|STARTED|Overall Study||49
8649698|NCT00631488|9690925|FG000|Completed Post-Treatment Period|Overall Study||44
8649699|NCT00631488|9690926|FG001|Completed Post-Treatment Period|Overall Study||47
8649700|NCT00631488|9690927|FG002|Completed Post-Treatment Period|Overall Study||47
8649701|NCT00631488|9690925|FG000|COMPLETED|Overall Study||44
8649702|NCT00631488|9690926|FG001|COMPLETED|Overall Study||47
8649703|NCT00631488|9690927|FG002|COMPLETED|Overall Study||47
8649704|NCT00631488|9690925|FG000|NOT COMPLETED|Overall Study||4
8649705|NCT00631488|9690926|FG001|NOT COMPLETED|Overall Study||2
8728158|NCT01046643|9775355|FG001|NOT COMPLETED|First Period Treatment or Placebo||1
8728159|NCT01046643|9775356|FG002|NOT COMPLETED|First Period Treatment or Placebo||0
8728160|NCT01046643|9775357|FG003|NOT COMPLETED|First Period Treatment or Placebo||0
8728161|NCT01046643|9775354|FG000|STARTED|Washout Period||9
8728162|NCT01046643|9775355|FG001|STARTED|Washout Period||6
8728163|NCT01046643|9775356|FG002|STARTED|Washout Period||7
8728164|NCT01046643|9775357|FG003|STARTED|Washout Period||7
8728165|NCT01046643|9775354|FG000|COMPLETED|Washout Period||9
8728166|NCT01046643|9775355|FG001|COMPLETED|Washout Period||6
8728167|NCT01046643|9775356|FG002|COMPLETED|Washout Period||7
8728168|NCT01046643|9775357|FG003|COMPLETED|Washout Period||7
8728169|NCT01046643|9775354|FG000|NOT COMPLETED|Washout Period||0
8728170|NCT01046643|9775355|FG001|NOT COMPLETED|Washout Period||0
8728171|NCT01046643|9775356|FG002|NOT COMPLETED|Washout Period||0
8728172|NCT01046643|9775357|FG003|NOT COMPLETED|Washout Period||0
8728173|NCT01046643|9775354|FG000|STARTED|Second Period Treatment or Placebo||9
8728174|NCT01046643|9775355|FG001|STARTED|Second Period Treatment or Placebo||6
8728175|NCT01046643|9775356|FG002|STARTED|Second Period Treatment or Placebo||7
8728176|NCT01046643|9775357|FG003|STARTED|Second Period Treatment or Placebo||7
8728177|NCT01046643|9775354|FG000|COMPLETED|Second Period Treatment or Placebo||9
8728178|NCT01046643|9775355|FG001|COMPLETED|Second Period Treatment or Placebo||6
8728179|NCT01046643|9775356|FG002|COMPLETED|Second Period Treatment or Placebo||7
8728180|NCT01046643|9775357|FG003|COMPLETED|Second Period Treatment or Placebo||7
8728181|NCT01046643|9775354|FG000|NOT COMPLETED|Second Period Treatment or Placebo||0
8728182|NCT01046643|9775355|FG001|NOT COMPLETED|Second Period Treatment or Placebo||0
8728183|NCT01046643|9775356|FG002|NOT COMPLETED|Second Period Treatment or Placebo||0
8728184|NCT01046643|9775357|FG003|NOT COMPLETED|Second Period Treatment or Placebo||0
8728185|NCT01046669|9775369|FG000|STARTED|Overall Study||226
8649706|NCT00631488|9690927|FG002|NOT COMPLETED|Overall Study||2
8649707|NCT00631540|9690935|FG000|STARTED|Overall Study||100
8649708|NCT00631540|9690935|FG000|COMPLETED|Overall Study||86
8649709|NCT00631540|9690935|FG000|NOT COMPLETED|Overall Study||14
8649710|NCT00631566|9690942|FG000|STARTED|Overall Study||21
8649711|NCT00631566|9690943|FG001|STARTED|Overall Study||28
8649712|NCT00631566|9690944|FG002|STARTED|Overall Study||501
8649713|NCT00631566|9690942|FG000|COMPLETED|Overall Study||19
8649714|NCT00631566|9690943|FG001|COMPLETED|Overall Study||24
8649715|NCT00631566|9690944|FG002|COMPLETED|Overall Study||501
8649716|NCT00631566|9690942|FG000|NOT COMPLETED|Overall Study||2
8649717|NCT00631566|9690943|FG001|NOT COMPLETED|Overall Study||4
8649718|NCT00631566|9690944|FG002|NOT COMPLETED|Overall Study||0
8649719|NCT00631657|9690954|FG000|STARTED|6-Month Treatment Period||344
8649720|NCT00631657|9690955|FG001|STARTED|6-Month Treatment Period||0
8649721|NCT00631657|9690956|FG002|STARTED|6-Month Treatment Period||116
8649722|NCT00631657|9690954|FG000|Treated|6-Month Treatment Period|Two randomized participants were not treated during the 6-month Treatment Period.|342
8649723|NCT00631657|9690955|FG001|Treated|6-Month Treatment Period||0
8649724|NCT00631657|9690956|FG002|Treated|6-Month Treatment Period|One randomized participant was not treated during the 6-month Treatment Period.|115
8649725|NCT00631657|9690954|FG000|COMPLETED|6-Month Treatment Period||203
8649726|NCT00631657|9690955|FG001|COMPLETED|6-Month Treatment Period||0
8649727|NCT00631657|9690956|FG002|COMPLETED|6-Month Treatment Period||66
8649728|NCT00631657|9690954|FG000|NOT COMPLETED|6-Month Treatment Period||141
8649729|NCT00631657|9690955|FG001|NOT COMPLETED|6-Month Treatment Period||0
8649730|NCT00631657|9690956|FG002|NOT COMPLETED|6-Month Treatment Period||50
8649731|NCT00631657|9690954|FG000|STARTED|7-Day Discontinuation Period|One participant was radomized in the Discont. Period, without completing the Treatment Period.|67
8649732|NCT00631657|9690955|FG001|STARTED|7-Day Discontinuation Period||137
8649733|NCT00631657|9690956|FG002|STARTED|7-Day Discontinuation Period||66
8649734|NCT00631657|9690954|FG000|Treated|7-Day Discontinuation Period|One participant was not treated during the Discontinuation Period.|66
8649735|NCT00631657|9690955|FG001|Treated|7-Day Discontinuation Period|One participant was not treated during the Discontinuation Period.|136
8649736|NCT00631657|9690956|FG002|Treated|7-Day Discontinuation Period|One participant was not treated during the Discontinuation Period.|65
8649737|NCT00631657|9690954|FG000|COMPLETED|7-Day Discontinuation Period||65
8649738|NCT00631657|9690955|FG001|COMPLETED|7-Day Discontinuation Period||136
8649739|NCT00631657|9690956|FG002|COMPLETED|7-Day Discontinuation Period||65
8649740|NCT00631657|9690954|FG000|NOT COMPLETED|7-Day Discontinuation Period||2
8649741|NCT00631657|9690955|FG001|NOT COMPLETED|7-Day Discontinuation Period||1
8649742|NCT00631657|9690956|FG002|NOT COMPLETED|7-Day Discontinuation Period||1
8649743|NCT00631670|9690969|FG000|STARTED|Overall Study||21
8649744|NCT00631670|9690970|FG001|STARTED|Overall Study||0
8649745|NCT00631670|9690969|FG000|COMPLETED|Overall Study||21
8649746|NCT00631670|9690970|FG001|COMPLETED|Overall Study||0
8649747|NCT00631670|9690969|FG000|NOT COMPLETED|Overall Study||0
8649748|NCT00631670|9690970|FG001|NOT COMPLETED|Overall Study||0
8649749|NCT00631696|9690982|FG000|STARTED|Overall Study||112
8649750|NCT00631696|9690983|FG001|STARTED|Overall Study||110
8649751|NCT00631696|9690982|FG000|Received Study Treatment (Tx)|Overall Study||111
8649752|NCT00631696|9690983|FG001|Received Study Treatment (Tx)|Overall Study||109
8649753|NCT00631696|9690982|FG000|Ongoing at Database Release 18Oct2011|Overall Study|Completed Tx at time of database release 18Oct2011; included in all analyses.|2
8649754|NCT00631696|9690983|FG001|Ongoing at Database Release 18Oct2011|Overall Study||0
8649755|NCT00631696|9690982|FG000|COMPLETED|Overall Study|Completed study at time of database release 18Oct2011.|75
8649756|NCT00631696|9690983|FG001|COMPLETED|Overall Study|Completed study at time of database release 18Oct2011.|70
8649757|NCT00631696|9690982|FG000|NOT COMPLETED|Overall Study||37
8649758|NCT00631696|9690983|FG001|NOT COMPLETED|Overall Study||40
8649759|NCT00631748|9690991|FG000|STARTED|Overall Study||29
8649760|NCT00631748|9690992|FG001|STARTED|Overall Study||31
8649761|NCT00631748|9690991|FG000|COMPLETED|Overall Study|11 participants completed the double-blind portion of the study; 8 participants completed follow-up.|11
8649762|NCT00631748|9690992|FG001|COMPLETED|Overall Study|9 participants completed the double-blind portion of the study; 5 participants completed follow-up.|9
8649763|NCT00631748|9690991|FG000|NOT COMPLETED|Overall Study||18
8649764|NCT00631748|9690992|FG001|NOT COMPLETED|Overall Study||22
8649765|NCT00631852|9690999|FG000|STARTED|Overall Study|Seventeen subjects were consented and 16 were considered enrolled and treated under the protocol. One was a screen fail.|16
8649766|NCT00631852|9690999|FG000|COMPLETED|Overall Study|2 patients were administratively withdrawn after treatment had been completed as they declined sharing of data after PI transfer.|16
8649767|NCT00631852|9690999|FG000|NOT COMPLETED|Overall Study||0
8649768|NCT00631917|9691005|FG000|STARTED|Overall Study||375
8649769|NCT00631917|9691006|FG001|STARTED|Overall Study||399
8649770|NCT00631917|9691005|FG000|COMPLETED|Overall Study||287
8649771|NCT00631917|9691006|FG001|COMPLETED|Overall Study||291
8649772|NCT00631917|9691005|FG000|NOT COMPLETED|Overall Study||88
8649773|NCT00631917|9691006|FG001|NOT COMPLETED|Overall Study||108
8649774|NCT00631969|9691014|FG000|STARTED|Overall Study||186
8649775|NCT00631969|9691015|FG001|STARTED|Overall Study||176
8649776|NCT00631969|9691014|FG000|Received Treatment|Overall Study|safety population|184
8649777|NCT00631969|9691015|FG001|Received Treatment|Overall Study|safety population|174
8649778|NCT00631969|9691014|FG000|COMPLETED|Overall Study||171
8649779|NCT00631969|9691015|FG001|COMPLETED|Overall Study||155
8649780|NCT00631969|9691014|FG000|NOT COMPLETED|Overall Study||15
8649781|NCT00631969|9691015|FG001|NOT COMPLETED|Overall Study||21
8649782|NCT00632021|9691025|FG000|STARTED|Overall Study||432
8649783|NCT00632021|9691026|FG001|STARTED|Overall Study||430
8649784|NCT00632021|9691025|FG000|COMPLETED|Overall Study||428
8649785|NCT00632021|9691026|FG001|COMPLETED|Overall Study||423
8649786|NCT00632021|9691025|FG000|NOT COMPLETED|Overall Study||4
8649787|NCT00632021|9691026|FG001|NOT COMPLETED|Overall Study||7
8649788|NCT00632099|9691035|FG000|STARTED|Overall Study||10
8649789|NCT00632099|9691036|FG001|STARTED|Overall Study||11
8649790|NCT00632099|9691035|FG000|COMPLETED|Overall Study||7
8649791|NCT00632099|9691036|FG001|COMPLETED|Overall Study||8
8649792|NCT00632099|9691035|FG000|NOT COMPLETED|Overall Study||3
8649793|NCT00632099|9691036|FG001|NOT COMPLETED|Overall Study||3
8691866|NCT00856986|9737208|FG002|NOT COMPLETED|Main Period, Weeks 0-26||28
8649794|NCT00632125|9691042|FG000|STARTED|Overall Study|1,698 patients were enrolled but 3 patients did not receive any study medication.|1695
8649795|NCT00632125|9691042|FG000|COMPLETED|Overall Study||1393
8649796|NCT00632125|9691042|FG000|NOT COMPLETED|Overall Study||302
8649797|NCT00632203|9691048|FG000|STARTED|Overall Study||26
8649798|NCT00632203|9691049|FG001|STARTED|Overall Study||27
8649799|NCT00632203|9691048|FG000|COMPLETED|Overall Study||25
8649800|NCT00632203|9691049|FG001|COMPLETED|Overall Study||27
8649801|NCT00632203|9691048|FG000|NOT COMPLETED|Overall Study||1
8649802|NCT00632203|9691049|FG001|NOT COMPLETED|Overall Study||0
8649803|NCT00632229|9691057|FG000|STARTED|Overall Study||17
8649804|NCT00632229|9691058|FG001|STARTED|Overall Study||17
8649805|NCT00632229|9691057|FG000|COMPLETED|Overall Study||11
8649806|NCT00632229|9691058|FG001|COMPLETED|Overall Study||11
8649807|NCT00632229|9691057|FG000|NOT COMPLETED|Overall Study||6
8649808|NCT00632229|9691058|FG001|NOT COMPLETED|Overall Study||6
8649809|NCT00632281|9691064|FG000|STARTED|Overall Study||38
8649810|NCT00632281|9691064|FG000|COMPLETED|Overall Study||38
8649811|NCT00632281|9691064|FG000|NOT COMPLETED|Overall Study||0
8649812|NCT00632359|9691068|FG000|STARTED|Overall Study||33
8649813|NCT00632359|9691068|FG000|COMPLETED|Overall Study||31
8649814|NCT00632359|9691068|FG000|NOT COMPLETED|Overall Study||2
8649815|NCT00632411|9691075|FG000|STARTED|Overall Study||649
8649816|NCT00632411|9691076|FG001|STARTED|Overall Study||649
8649817|NCT00632411|9691075|FG000|COMPLETED|Overall Study||489
8649818|NCT00632411|9691076|FG001|COMPLETED|Overall Study||473
8649819|NCT00632411|9691075|FG000|NOT COMPLETED|Overall Study||160
8649820|NCT00632411|9691076|FG001|NOT COMPLETED|Overall Study||176
8649821|NCT00632424|9691085|FG000|STARTED|Overall Study||18
8649822|NCT00632424|9691085|FG000|COMPLETED|Overall Study||0
8649823|NCT00632424|9691085|FG000|NOT COMPLETED|Overall Study||18
8649824|NCT00632463|9691102|FG000|STARTED|Overall Study||7
8649825|NCT00632463|9691103|FG001|STARTED|Overall Study||7
8649826|NCT00632463|9691104|FG002|STARTED|Overall Study||7
8649827|NCT00632463|9691102|FG000|COMPLETED|Overall Study||7
8649828|NCT00632463|9691103|FG001|COMPLETED|Overall Study||6
8649829|NCT00632463|9691104|FG002|COMPLETED|Overall Study||7
8649830|NCT00632463|9691102|FG000|NOT COMPLETED|Overall Study||0
8649831|NCT00632463|9691103|FG001|NOT COMPLETED|Overall Study||1
8649832|NCT00632463|9691104|FG002|NOT COMPLETED|Overall Study||0
8649833|NCT00632489|9691115|FG000|STARTED|Overall Study||15
8649834|NCT00632489|9691116|FG001|STARTED|Overall Study||5
8649835|NCT00632489|9691117|FG002|STARTED|Overall Study||0
8649836|NCT00632489|9691115|FG000|COMPLETED|Overall Study|Pts remained on study until disease progression, intolerable toxicity or other reason to discontinue|0
8649837|NCT00632489|9691116|FG001|COMPLETED|Overall Study|Pts remained on study until disease progression, intolerable toxicity or other reason to discontinue|0
8649838|NCT00632489|9691117|FG002|COMPLETED|Overall Study|Pts remained on study until disease progression, intolerable toxicity or other reason to discontinue|0
8649839|NCT00632489|9691115|FG000|NOT COMPLETED|Overall Study||15
8649840|NCT00632489|9691116|FG001|NOT COMPLETED|Overall Study||5
8649841|NCT00632489|9691117|FG002|NOT COMPLETED|Overall Study||0
8649842|NCT00632502|9691127|FG000|STARTED|Overall Study||25
8649843|NCT00632502|9691128|FG001|STARTED|Overall Study||12
8649844|NCT00632502|9691127|FG000|Treated|Overall Study||22
8649845|NCT00632502|9691128|FG001|Treated|Overall Study||12
8649846|NCT00632502|9691127|FG000|Completed Treatment|Overall Study||19
8649847|NCT00632502|9691128|FG001|Completed Treatment|Overall Study||9
8649848|NCT00632502|9691127|FG000|COMPLETED|Overall Study||22
8649849|NCT00632502|9691128|FG001|COMPLETED|Overall Study||11
8649850|NCT00632502|9691127|FG000|NOT COMPLETED|Overall Study||3
8649851|NCT00632502|9691128|FG001|NOT COMPLETED|Overall Study||1
8649852|NCT00632541|9691135|FG000|STARTED|Overall Study|18 subjects were accrued to the study|18
8649853|NCT00632541|9691135|FG000|COMPLETED|Overall Study||11
8649854|NCT00632541|9691135|FG000|NOT COMPLETED|Overall Study||7
8649855|NCT00632619|9691141|FG000|STARTED|Overall Study|first cohort started 9/11/09 second cohort started 12/7/11|33
8649856|NCT00632619|9691142|FG001|STARTED|Overall Study|first cohort started 9/11/09 second cohort started 12/7/11|35
8649857|NCT00632619|9691141|FG000|COMPLETED|Overall Study|"st cohort completed follow up by 5/24/10~nd cohort completed follow up 7/18/11"|25
8649858|NCT00632619|9691142|FG001|COMPLETED|Overall Study|"st cohort completed follow up by 5/24/10~nd cohort completed follow up 7/18/11"|31
8649859|NCT00632619|9691141|FG000|NOT COMPLETED|Overall Study||8
8649860|NCT00632619|9691142|FG001|NOT COMPLETED|Overall Study||4
8649861|NCT00632632|9691150|FG000|STARTED|Overall Study||13
8649862|NCT00632632|9691151|FG001|STARTED|Overall Study||12
8649863|NCT00632632|9691150|FG000|COMPLETED|Overall Study||13
8649864|NCT00632632|9691151|FG001|COMPLETED|Overall Study||9
8649865|NCT00632632|9691150|FG000|NOT COMPLETED|Overall Study||0
8649866|NCT00632632|9691151|FG001|NOT COMPLETED|Overall Study||3
8649867|NCT00632736|9691157|FG000|STARTED|Overall Study||419
8649868|NCT00632736|9691157|FG000|COMPLETED|Overall Study||151
8649869|NCT00632736|9691157|FG000|NOT COMPLETED|Overall Study||268
8649870|NCT00632749|9691175|FG000|STARTED|Overall Study||4
8649871|NCT00632749|9691176|FG001|STARTED|Overall Study||5
8649872|NCT00632749|9691177|FG002|STARTED|Overall Study||3
8649873|NCT00632749|9691178|FG003|STARTED|Overall Study||4
8649874|NCT00632749|9691179|FG004|STARTED|Overall Study||7
8649875|NCT00632749|9691180|FG005|STARTED|Overall Study||8
8649876|NCT00632749|9691181|FG006|STARTED|Overall Study||5
8649877|NCT00632749|9691182|FG007|STARTED|Overall Study||4
8649878|NCT00632749|9691183|FG008|STARTED|Overall Study||5
8649879|NCT00632749|9691184|FG009|STARTED|Overall Study||3
8649880|NCT00632749|9691185|FG010|STARTED|Overall Study||7
8649881|NCT00632749|9691186|FG011|STARTED|Overall Study||4
8649882|NCT00632749|9691187|FG012|STARTED|Overall Study||3
8649883|NCT00632749|9691188|FG013|STARTED|Overall Study||6
8649884|NCT00632749|9691175|FG000|Treated|Overall Study||4
8649885|NCT00632749|9691176|FG001|Treated|Overall Study||3
8649886|NCT00632749|9691177|FG002|Treated|Overall Study||3
8649887|NCT00632749|9691178|FG003|Treated|Overall Study||4
8649888|NCT00632749|9691179|FG004|Treated|Overall Study||7
8649889|NCT00632749|9691180|FG005|Treated|Overall Study||7
8649890|NCT00632749|9691181|FG006|Treated|Overall Study||4
8649891|NCT00632749|9691182|FG007|Treated|Overall Study||4
8649892|NCT00632749|9691183|FG008|Treated|Overall Study||5
8649893|NCT00632749|9691184|FG009|Treated|Overall Study||3
8649894|NCT00632749|9691185|FG010|Treated|Overall Study||7
8649895|NCT00632749|9691186|FG011|Treated|Overall Study||4
8649896|NCT00632749|9691187|FG012|Treated|Overall Study||3
8649897|NCT00632749|9691188|FG013|Treated|Overall Study||6
8649898|NCT00632749|9691175|FG000|Not Treated|Overall Study||0
8649899|NCT00632749|9691176|FG001|Not Treated|Overall Study||2
8649900|NCT00632749|9691177|FG002|Not Treated|Overall Study||0
8649901|NCT00632749|9691178|FG003|Not Treated|Overall Study||0
8649902|NCT00632749|9691179|FG004|Not Treated|Overall Study||0
8649903|NCT00632749|9691180|FG005|Not Treated|Overall Study||1
8649904|NCT00632749|9691181|FG006|Not Treated|Overall Study||1
8649905|NCT00632749|9691182|FG007|Not Treated|Overall Study||0
8649906|NCT00632749|9691183|FG008|Not Treated|Overall Study||0
8649907|NCT00632749|9691184|FG009|Not Treated|Overall Study||0
8649908|NCT00632749|9691185|FG010|Not Treated|Overall Study||0
8649909|NCT00632749|9691186|FG011|Not Treated|Overall Study||0
8649910|NCT00632749|9691187|FG012|Not Treated|Overall Study||0
8649911|NCT00632749|9691188|FG013|Not Treated|Overall Study||0
8649912|NCT00632749|9691175|FG000|COMPLETED|Overall Study||0
8649913|NCT00632749|9691176|FG001|COMPLETED|Overall Study||0
8649914|NCT00632749|9691177|FG002|COMPLETED|Overall Study||0
8649915|NCT00632749|9691178|FG003|COMPLETED|Overall Study||0
8649916|NCT00632749|9691179|FG004|COMPLETED|Overall Study||0
8649917|NCT00632749|9691180|FG005|COMPLETED|Overall Study||0
8649918|NCT00632749|9691181|FG006|COMPLETED|Overall Study||0
8649919|NCT00632749|9691182|FG007|COMPLETED|Overall Study||0
8649920|NCT00632749|9691183|FG008|COMPLETED|Overall Study||0
8649921|NCT00632749|9691184|FG009|COMPLETED|Overall Study||0
8649922|NCT00632749|9691185|FG010|COMPLETED|Overall Study||0
8649923|NCT00632749|9691186|FG011|COMPLETED|Overall Study||0
8649924|NCT00632749|9691187|FG012|COMPLETED|Overall Study||0
8649925|NCT00632749|9691188|FG013|COMPLETED|Overall Study||0
8649926|NCT00632749|9691175|FG000|NOT COMPLETED|Overall Study||4
8649927|NCT00632749|9691176|FG001|NOT COMPLETED|Overall Study||5
8649928|NCT00632749|9691177|FG002|NOT COMPLETED|Overall Study||3
8649929|NCT00632749|9691178|FG003|NOT COMPLETED|Overall Study||4
8649930|NCT00632749|9691179|FG004|NOT COMPLETED|Overall Study||7
8649931|NCT00632749|9691180|FG005|NOT COMPLETED|Overall Study||8
8649932|NCT00632749|9691181|FG006|NOT COMPLETED|Overall Study||5
8649933|NCT00632749|9691182|FG007|NOT COMPLETED|Overall Study||4
8649934|NCT00632749|9691183|FG008|NOT COMPLETED|Overall Study||5
8649935|NCT00632749|9691184|FG009|NOT COMPLETED|Overall Study||3
8649936|NCT00632749|9691185|FG010|NOT COMPLETED|Overall Study||7
8649937|NCT00632749|9691186|FG011|NOT COMPLETED|Overall Study||4
8649938|NCT00632749|9691187|FG012|NOT COMPLETED|Overall Study||3
8649939|NCT00632749|9691188|FG013|NOT COMPLETED|Overall Study||6
8649940|NCT00632814|9691227|FG000|STARTED|Overall Study||11
8649941|NCT00632814|9691228|FG001|STARTED|Overall Study||13
8649942|NCT00632814|9691229|FG002|STARTED|Overall Study||8
8649943|NCT00632814|9691227|FG000|COMPLETED|Overall Study||11
8649944|NCT00632814|9691228|FG001|COMPLETED|Overall Study||13
8649945|NCT00632814|9691229|FG002|COMPLETED|Overall Study||8
8649946|NCT00632814|9691227|FG000|NOT COMPLETED|Overall Study||0
8649947|NCT00632814|9691228|FG001|NOT COMPLETED|Overall Study||0
8649948|NCT00632814|9691229|FG002|NOT COMPLETED|Overall Study||0
8649949|NCT00632827|9691237|FG000|STARTED|Overall Study||21
8649950|NCT00632827|9691237|FG000|Received GVD|Overall Study||21
8649951|NCT00632827|9691237|FG000|Received M-CHOP|Overall Study||18
8649952|NCT00632827|9691237|FG000|Evaluated Post Stem Cell Transplant|Overall Study||16
8649953|NCT00632827|9691237|FG000|COMPLETED|Overall Study||11
8649954|NCT00632827|9691237|FG000|NOT COMPLETED|Overall Study||10
8649955|NCT00632931|9691242|FG000|STARTED|Part 1, Period 1||13
8649956|NCT00632931|9691243|FG001|STARTED|Part 1, Period 1||12
8649957|NCT00632931|9691244|FG002|STARTED|Part 1, Period 1||0
8649958|NCT00632931|9691242|FG000|COMPLETED|Part 1, Period 1||11
8649959|NCT00632931|9691243|FG001|COMPLETED|Part 1, Period 1||12
8649960|NCT00632931|9691244|FG002|COMPLETED|Part 1, Period 1||0
8649961|NCT00632931|9691242|FG000|NOT COMPLETED|Part 1, Period 1||2
8649962|NCT00632931|9691243|FG001|NOT COMPLETED|Part 1, Period 1||0
8649963|NCT00632931|9691244|FG002|NOT COMPLETED|Part 1, Period 1||0
8649964|NCT00632931|9691242|FG000|STARTED|Part 1, Washout||11
8649965|NCT00632931|9691243|FG001|STARTED|Part 1, Washout||12
8649966|NCT00632931|9691244|FG002|STARTED|Part 1, Washout||0
8649967|NCT00632931|9691242|FG000|COMPLETED|Part 1, Washout||11
8649968|NCT00632931|9691243|FG001|COMPLETED|Part 1, Washout||12
8649969|NCT00632931|9691244|FG002|COMPLETED|Part 1, Washout||0
8649970|NCT00632931|9691242|FG000|NOT COMPLETED|Part 1, Washout||0
8649971|NCT00632931|9691243|FG001|NOT COMPLETED|Part 1, Washout||0
8649972|NCT00632931|9691244|FG002|NOT COMPLETED|Part 1, Washout||0
8649973|NCT00632931|9691242|FG000|STARTED|Part 1, Period 2||11
8649974|NCT00632931|9691243|FG001|STARTED|Part 1, Period 2||12
8649975|NCT00632931|9691244|FG002|STARTED|Part 1, Period 2||0
8649976|NCT00632931|9691242|FG000|COMPLETED|Part 1, Period 2||11
8649977|NCT00632931|9691243|FG001|COMPLETED|Part 1, Period 2||12
8649978|NCT00632931|9691244|FG002|COMPLETED|Part 1, Period 2||0
8649979|NCT00632931|9691242|FG000|NOT COMPLETED|Part 1, Period 2||0
8649980|NCT00632931|9691243|FG001|NOT COMPLETED|Part 1, Period 2||0
8649981|NCT00632931|9691244|FG002|NOT COMPLETED|Part 1, Period 2||0
8649982|NCT00632931|9691242|FG000|STARTED|Post-Part 1 Washout|1 patient who did not complete Period 1 was subsequently enrolled into Post Part 1|12
8649983|NCT00632931|9691243|FG001|STARTED|Post-Part 1 Washout||12
8649984|NCT00632931|9691244|FG002|STARTED|Post-Part 1 Washout||0
8649985|NCT00632931|9691242|FG000|COMPLETED|Post-Part 1 Washout||12
8649986|NCT00632931|9691243|FG001|COMPLETED|Post-Part 1 Washout||12
8649987|NCT00632931|9691244|FG002|COMPLETED|Post-Part 1 Washout||0
8649988|NCT00632931|9691242|FG000|NOT COMPLETED|Post-Part 1 Washout||0
8649989|NCT00632931|9691243|FG001|NOT COMPLETED|Post-Part 1 Washout||0
8649990|NCT00632931|9691244|FG002|NOT COMPLETED|Post-Part 1 Washout||0
8649991|NCT00632931|9691242|FG000|STARTED|Part 2||0
8649992|NCT00632931|9691243|FG001|STARTED|Part 2||0
8649993|NCT00632931|9691244|FG002|STARTED|Part 2||24
8649994|NCT00632931|9691242|FG000|COMPLETED|Part 2||0
8649995|NCT00632931|9691243|FG001|COMPLETED|Part 2||0
8649996|NCT00632931|9691244|FG002|COMPLETED|Part 2||0
8649997|NCT00632931|9691242|FG000|NOT COMPLETED|Part 2||0
8649998|NCT00632931|9691243|FG001|NOT COMPLETED|Part 2||0
8649999|NCT00632931|9691244|FG002|NOT COMPLETED|Part 2||24
8650000|NCT00632970|9691251|FG000|STARTED|Overall Study||3
8650001|NCT00632970|9691252|FG001|STARTED|Overall Study||3
8650002|NCT00632970|9691251|FG000|COMPLETED|Overall Study||3
8650003|NCT00632970|9691252|FG001|COMPLETED|Overall Study||3
8650004|NCT00632970|9691251|FG000|NOT COMPLETED|Overall Study||0
8650005|NCT00632970|9691252|FG001|NOT COMPLETED|Overall Study||0
8650006|NCT00633009|9691261|FG000|STARTED|Overall Study||12
8650007|NCT00633009|9691262|FG001|STARTED|Overall Study||27
8650008|NCT00633009|9691263|FG002|STARTED|Overall Study||11
8650009|NCT00633009|9691261|FG000|COMPLETED|Overall Study||8
8650010|NCT00633009|9691262|FG001|COMPLETED|Overall Study||23
8650011|NCT00633009|9691263|FG002|COMPLETED|Overall Study||10
8650012|NCT00633009|9691261|FG000|NOT COMPLETED|Overall Study||4
8650013|NCT00633009|9691262|FG001|NOT COMPLETED|Overall Study||4
8650014|NCT00633009|9691263|FG002|NOT COMPLETED|Overall Study||1
8650015|NCT00633022|9691277|FG000|STARTED|Overall Study||34
8650016|NCT00633022|9691278|FG001|STARTED|Overall Study||33
8650017|NCT00633022|9691279|FG002|STARTED|Overall Study||32
8650018|NCT00633022|9691277|FG000|COMPLETED|Overall Study||33
8650019|NCT00633022|9691278|FG001|COMPLETED|Overall Study||32
8650020|NCT00633022|9691279|FG002|COMPLETED|Overall Study||27
8650021|NCT00633022|9691277|FG000|NOT COMPLETED|Overall Study||1
8650022|NCT00633022|9691278|FG001|NOT COMPLETED|Overall Study||1
8650023|NCT00633022|9691279|FG002|NOT COMPLETED|Overall Study||5
8650024|NCT00633074|9691289|FG000|STARTED|Overall Study||360
8650025|NCT00633074|9691290|FG001|STARTED|Overall Study||360
8650026|NCT00633074|9691289|FG000|COMPLETED|Overall Study||359
8650027|NCT00633074|9691290|FG001|COMPLETED|Overall Study||360
8650028|NCT00633074|9691289|FG000|NOT COMPLETED|Overall Study||1
8650029|NCT00633074|9691290|FG001|NOT COMPLETED|Overall Study||0
8650030|NCT00633126|9691296|FG000|STARTED|Overall Study||9
8650031|NCT00633126|9691296|FG000|COMPLETED|Overall Study||8
8650032|NCT00633126|9691296|FG000|NOT COMPLETED|Overall Study||1
8650033|NCT00633139|9691303|FG000|STARTED|Overall Study||4
8650034|NCT00633139|9691304|FG001|STARTED|Overall Study||5
8650035|NCT00633139|9691305|FG002|STARTED|Overall Study||4
8650036|NCT00633139|9691303|FG000|COMPLETED|Overall Study||4
8650037|NCT00633139|9691304|FG001|COMPLETED|Overall Study||4
8650038|NCT00633139|9691305|FG002|COMPLETED|Overall Study||3
8650039|NCT00633139|9691303|FG000|NOT COMPLETED|Overall Study||0
8650040|NCT00633139|9691304|FG001|NOT COMPLETED|Overall Study||1
8650041|NCT00633139|9691305|FG002|NOT COMPLETED|Overall Study||1
8650042|NCT00633152|9691315|FG000|STARTED|Overall Study||103
8650043|NCT00633152|9691316|FG001|STARTED|Overall Study||47
8650044|NCT00633152|9691315|FG000|MITT and Safety Population|Overall Study||98
8650045|NCT00633152|9691316|FG001|MITT and Safety Population|Overall Study||45
8650046|NCT00633152|9691315|FG000|Clinically Evaluable Population|Overall Study||86
8650047|NCT00633152|9691316|FG001|Clinically Evaluable Population|Overall Study||39
8650048|NCT00633152|9691315|FG000|COMPLETED|Overall Study||89
8650049|NCT00633152|9691316|FG001|COMPLETED|Overall Study||41
8650050|NCT00633152|9691315|FG000|NOT COMPLETED|Overall Study||14
8650051|NCT00633152|9691316|FG001|NOT COMPLETED|Overall Study||6
8650052|NCT00633217|9691326|FG000|STARTED|Overall Study||121
8650053|NCT00633217|9691327|FG001|STARTED|Overall Study||126
8650054|NCT00633217|9691326|FG000|COMPLETED|Overall Study||106
8650055|NCT00633217|9691327|FG001|COMPLETED|Overall Study||103
8650056|NCT00633217|9691326|FG000|NOT COMPLETED|Overall Study||15
8650057|NCT00633217|9691327|FG001|NOT COMPLETED|Overall Study||23
8650058|NCT00633243|9691335|FG000|STARTED|Overall Study||12
8650059|NCT00633243|9691336|FG001|STARTED|Overall Study||9
8650060|NCT00633243|9691335|FG000|COMPLETED|Overall Study||11
8650061|NCT00633243|9691336|FG001|COMPLETED|Overall Study||2
8650062|NCT00633243|9691335|FG000|NOT COMPLETED|Overall Study||1
8650063|NCT00633243|9691336|FG001|NOT COMPLETED|Overall Study||7
8650064|NCT00633256|9691344|FG000|STARTED|Overall Study||12
8650065|NCT00633256|9691345|FG001|STARTED|Overall Study||13
8650066|NCT00633256|9691344|FG000|COMPLETED|Overall Study||8
8650067|NCT00633256|9691345|FG001|COMPLETED|Overall Study||10
8650068|NCT00633256|9691344|FG000|NOT COMPLETED|Overall Study||4
8650069|NCT00633256|9691345|FG001|NOT COMPLETED|Overall Study||3
8650070|NCT00633360|9691353|FG000|STARTED|Overall Study||16
8650071|NCT00633360|9691354|FG001|STARTED|Overall Study||16
8650072|NCT00633360|9691353|FG000|COMPLETED|Overall Study||12
8650073|NCT00633360|9691354|FG001|COMPLETED|Overall Study||13
8650074|NCT00633360|9691353|FG000|NOT COMPLETED|Overall Study||4
8650075|NCT00633360|9691354|FG001|NOT COMPLETED|Overall Study||3
8650076|NCT00633399|9691364|FG000|STARTED|Overall Study||71
8650077|NCT00633399|9691365|FG001|STARTED|Overall Study||68
8650078|NCT00633399|9691364|FG000|COMPLETED|Overall Study||49
8650079|NCT00633399|9691365|FG001|COMPLETED|Overall Study||53
8650080|NCT00633399|9691364|FG000|NOT COMPLETED|Overall Study||22
8650081|NCT00633399|9691365|FG001|NOT COMPLETED|Overall Study||15
8650082|NCT00633464|9691373|FG000|STARTED|Overall Study||40
8650083|NCT00633464|9691374|FG001|STARTED|Overall Study||39
8650084|NCT00633464|9691373|FG000|Treated|Overall Study||40
8650085|NCT00633464|9691374|FG001|Treated|Overall Study||37
8650086|NCT00633464|9691373|FG000|COMPLETED|Overall Study|Completed=Offstudy;major reasons:Disease progression-27,study drug toxicity-7,max clinical benefit-3|40
8650087|NCT00633464|9691374|FG001|COMPLETED|Overall Study|Completed=Offstudy;major reasons:Disease progression-25,study drug toxicity-4,subject request-3|37
8650088|NCT00633464|9691373|FG000|NOT COMPLETED|Overall Study||0
8650089|NCT00633464|9691374|FG001|NOT COMPLETED|Overall Study||2
8650090|NCT00633477|9691382|FG000|STARTED|Overall Study|Seven subjects were randomized, however, one was not treated.|7
8650091|NCT00633477|9691383|FG001|STARTED|Overall Study||11
8650092|NCT00633477|9691382|FG000|Randomized But Not Treated|Overall Study||1
8650093|NCT00633477|9691383|FG001|Randomized But Not Treated|Overall Study||0
8650094|NCT00633477|9691382|FG000|Prematurely Discontinued Study Drug|Overall Study||1
8650095|NCT00633477|9691383|FG001|Prematurely Discontinued Study Drug|Overall Study||0
8650096|NCT00633477|9691382|FG000|Completed Study Through Day 28|Overall Study||4
8650097|NCT00633477|9691383|FG001|Completed Study Through Day 28|Overall Study||8
8650098|NCT00633477|9691382|FG000|COMPLETED|Overall Study|Include all subjects who could be evaluated for 28-d survival.|5
8650099|NCT00633477|9691383|FG001|COMPLETED|Overall Study|Include all subjects who could be evaluated for 28-d survival.|11
8650100|NCT00633477|9691382|FG000|NOT COMPLETED|Overall Study||2
8650101|NCT00633477|9691383|FG001|NOT COMPLETED|Overall Study||0
8650102|NCT00633594|9691392|FG000|STARTED|Overall Study||5
8650103|NCT00633594|9691393|FG001|STARTED|Overall Study||8
8650104|NCT00633594|9691394|FG002|STARTED|Overall Study||26
8650105|NCT00633594|9691392|FG000|COMPLETED|Overall Study||5
8650106|NCT00633594|9691393|FG001|COMPLETED|Overall Study||3
8650107|NCT00633594|9691394|FG002|COMPLETED|Overall Study||16
8728186|NCT01046669|9775370|FG001|STARTED|Overall Study||224
8728187|NCT01046669|9775369|FG000|COMPLETED|Overall Study||226
8728188|NCT01046669|9775370|FG001|COMPLETED|Overall Study||223
8728189|NCT01046669|9775369|FG000|NOT COMPLETED|Overall Study||0
8728190|NCT01046669|9775370|FG001|NOT COMPLETED|Overall Study||1
8728191|NCT01046682|9775378|FG000|STARTED|Overall Study||20
8728192|NCT01046682|9775379|FG001|STARTED|Overall Study||20
8728193|NCT01046682|9775378|FG000|COMPLETED|Overall Study||18
8728194|NCT01046682|9775379|FG001|COMPLETED|Overall Study||20
8728195|NCT01046682|9775378|FG000|NOT COMPLETED|Overall Study||2
8728196|NCT01046682|9775379|FG001|NOT COMPLETED|Overall Study||0
8728197|NCT01046695|9775387|FG000|STARTED|Overall Study||20
8728198|NCT01046695|9775388|FG001|STARTED|Overall Study||22
8728199|NCT01046695|9775387|FG000|COMPLETED|Overall Study||20
8728200|NCT01046695|9775388|FG001|COMPLETED|Overall Study||20
8728201|NCT01046695|9775387|FG000|NOT COMPLETED|Overall Study||0
8728202|NCT01046695|9775388|FG001|NOT COMPLETED|Overall Study||2
8728203|NCT01046877|9775394|FG000|STARTED|Overall Study||25
8728204|NCT01046877|9775394|FG000|Completed on Schedule|Overall Study|Final visit = the earlier of 24 months post-procedure or 12 months after extrusion.|6
8728205|NCT01046877|9775394|FG000|Completed Study Late|Overall Study|One completed (evidencing extrusions) at 23.5 mos. Missed 9 mo visit. Exam not possible at 12 mo.|1
8728206|NCT01046877|9775394|FG000|COMPLETED|Overall Study||7
8728207|NCT01046877|9775394|FG000|NOT COMPLETED|Overall Study||18
8728208|NCT01046903|9775398|FG000|STARTED|Overall Study||503
8728209|NCT01046903|9775398|FG000|COMPLETED|Overall Study||475
8728210|NCT01046903|9775398|FG000|NOT COMPLETED|Overall Study||28
8728211|NCT01047007|9775406|FG000|STARTED|Overall Study||3
8728212|NCT01047007|9775407|FG001|STARTED|Overall Study||6
8728213|NCT01047007|9775408|FG002|STARTED|Overall Study||2
8728214|NCT01047007|9775409|FG003|STARTED|Overall Study||0
8728215|NCT01047007|9775406|FG000|Treated|Overall Study||3
8728216|NCT01047007|9775407|FG001|Treated|Overall Study||6
8728217|NCT01047007|9775408|FG002|Treated|Overall Study||2
8728218|NCT01047007|9775409|FG003|Treated|Overall Study||0
8911223|NCT02144285|9970254|FG006|NOT COMPLETED|Overall Study||0
8650108|NCT00633594|9691392|FG000|NOT COMPLETED|Overall Study||0
8650109|NCT00633594|9691393|FG001|NOT COMPLETED|Overall Study||5
8728219|NCT01047007|9775406|FG000|COMPLETED|Overall Study||1
8911224|NCT02144285|9970255|FG007|NOT COMPLETED|Overall Study||0
8650110|NCT00633594|9691394|FG002|NOT COMPLETED|Overall Study||10
8650111|NCT00633750|9691405|FG000|STARTED|Overall Study||47
8650112|NCT00633750|9691405|FG000|COMPLETED|Overall Study||42
8650113|NCT00633750|9691405|FG000|NOT COMPLETED|Overall Study||5
8650114|NCT00633867|9691413|FG000|STARTED|Overall Study||60
8650115|NCT00633867|9691414|FG001|STARTED|Overall Study||60
8650116|NCT00633867|9691413|FG000|COMPLETED|Overall Study||60
8650117|NCT00633867|9691414|FG001|COMPLETED|Overall Study||60
8650118|NCT00633867|9691413|FG000|NOT COMPLETED|Overall Study||0
8650119|NCT00633867|9691414|FG001|NOT COMPLETED|Overall Study||0
8650120|NCT00633880|9691423|FG000|STARTED|Open Label Titration||181
8650121|NCT00633880|9691424|FG001|STARTED|Open Label Titration||0
8650122|NCT00633880|9691425|FG002|STARTED|Open Label Titration||0
8650123|NCT00633880|9691423|FG000|COMPLETED|Open Label Titration||101
8650124|NCT00633880|9691424|FG001|COMPLETED|Open Label Titration||0
8650125|NCT00633880|9691425|FG002|COMPLETED|Open Label Titration||0
8650126|NCT00633880|9691423|FG000|NOT COMPLETED|Open Label Titration||80
8650127|NCT00633880|9691424|FG001|NOT COMPLETED|Open Label Titration||0
8650128|NCT00633880|9691425|FG002|NOT COMPLETED|Open Label Titration||0
8650129|NCT00633880|9691423|FG000|STARTED|Randomized Double Blind||0
8650130|NCT00633880|9691424|FG001|STARTED|Randomized Double Blind||50
8650131|NCT00633880|9691425|FG002|STARTED|Randomized Double Blind||51
8650132|NCT00633880|9691423|FG000|COMPLETED|Randomized Double Blind||0
8650133|NCT00633880|9691424|FG001|COMPLETED|Randomized Double Blind||50
8650134|NCT00633880|9691425|FG002|COMPLETED|Randomized Double Blind||51
8650135|NCT00633880|9691423|FG000|NOT COMPLETED|Randomized Double Blind||0
8650136|NCT00633880|9691424|FG001|NOT COMPLETED|Randomized Double Blind||0
8650137|NCT00633880|9691425|FG002|NOT COMPLETED|Randomized Double Blind||0
8650138|NCT00633893|9691435|FG000|STARTED|Overall Study||840
8650139|NCT00633893|9691436|FG001|STARTED|Overall Study|2 participants were randomized to 5 mg study drug but not treated.|813
8650140|NCT00633893|9691437|FG002|STARTED|Overall Study|3 participants were randomized to placebo but not treated.|829
8650141|NCT00633893|9691435|FG000|COMPLETED|Overall Study||726
8650142|NCT00633893|9691436|FG001|COMPLETED|Overall Study||684
8650143|NCT00633893|9691437|FG002|COMPLETED|Overall Study||641
8650144|NCT00633893|9691435|FG000|NOT COMPLETED|Overall Study||114
8650145|NCT00633893|9691436|FG001|NOT COMPLETED|Overall Study||129
8650146|NCT00633893|9691437|FG002|NOT COMPLETED|Overall Study||188
8650147|NCT00633919|9691447|FG000|STARTED|Overall Study||63
8650148|NCT00633919|9691448|FG001|STARTED|Overall Study||61
8650149|NCT00633919|9691447|FG000|COMPLETED|Overall Study||36
8650150|NCT00633919|9691448|FG001|COMPLETED|Overall Study||39
8650151|NCT00633919|9691447|FG000|NOT COMPLETED|Overall Study||27
8650152|NCT00633919|9691448|FG001|NOT COMPLETED|Overall Study||22
8650153|NCT00633932|9691457|FG000|STARTED|Overall Study|Randomised|191
8650154|NCT00633932|9691458|FG001|STARTED|Overall Study|Randomised|190
8650155|NCT00633932|9691459|FG002|STARTED|Overall Study|Randomised|191
8650156|NCT00633932|9691457|FG000|COMPLETED|Overall Study||179
8650157|NCT00633932|9691458|FG001|COMPLETED|Overall Study||176
8650158|NCT00633932|9691459|FG002|COMPLETED|Overall Study||180
8650159|NCT00633932|9691457|FG000|NOT COMPLETED|Overall Study||12
8650160|NCT00633932|9691458|FG001|NOT COMPLETED|Overall Study||14
8650161|NCT00633932|9691459|FG002|NOT COMPLETED|Overall Study||11
8650162|NCT00633945|9691467|FG000|STARTED|Overall Study||5
8650163|NCT00633945|9691467|FG000|COMPLETED|Overall Study||3
8650164|NCT00633945|9691467|FG000|NOT COMPLETED|Overall Study||2
8650165|NCT00633984|9691475|FG000|STARTED|Overall Study||87
8650166|NCT00633984|9691476|FG001|STARTED|Overall Study||82
8650167|NCT00633984|9691475|FG000|COMPLETED|Overall Study||78
8650168|NCT00633984|9691476|FG001|COMPLETED|Overall Study||69
8650169|NCT00633984|9691475|FG000|NOT COMPLETED|Overall Study||9
8650170|NCT00633984|9691476|FG001|NOT COMPLETED|Overall Study||13
8650171|NCT00634036|9691484|FG000|STARTED|Overall Study||12
8650172|NCT00634036|9691485|FG001|STARTED|Overall Study||11
8650173|NCT00634036|9691484|FG000|COMPLETED|Overall Study||10
8650174|NCT00634036|9691485|FG001|COMPLETED|Overall Study||9
8650175|NCT00634036|9691484|FG000|NOT COMPLETED|Overall Study||2
8650176|NCT00634036|9691485|FG001|NOT COMPLETED|Overall Study||2
8650177|NCT00634049|9691491|FG000|STARTED|Overall Study||149
8650178|NCT00634049|9691491|FG000|COMPLETED|Overall Study||146
8650179|NCT00634049|9691491|FG000|NOT COMPLETED|Overall Study||3
8650180|NCT00634088|9691528|FG000|STARTED|Time Period 1: Dose Level 1||6
8650181|NCT00634088|9691529|FG001|STARTED|Time Period 1: Dose Level 1||0
8650182|NCT00634088|9691530|FG002|STARTED|Time Period 1: Dose Level 1||0
8650183|NCT00634088|9691531|FG003|STARTED|Time Period 1: Dose Level 1||0
8650184|NCT00634088|9691528|FG000|COMPLETED|Time Period 1: Dose Level 1||0
8650185|NCT00634088|9691529|FG001|COMPLETED|Time Period 1: Dose Level 1||0
8650186|NCT00634088|9691530|FG002|COMPLETED|Time Period 1: Dose Level 1||0
8650187|NCT00634088|9691531|FG003|COMPLETED|Time Period 1: Dose Level 1||0
8650188|NCT00634088|9691528|FG000|NOT COMPLETED|Time Period 1: Dose Level 1||6
8650189|NCT00634088|9691529|FG001|NOT COMPLETED|Time Period 1: Dose Level 1||0
8650190|NCT00634088|9691530|FG002|NOT COMPLETED|Time Period 1: Dose Level 1||0
8650191|NCT00634088|9691531|FG003|NOT COMPLETED|Time Period 1: Dose Level 1||0
8650192|NCT00634088|9691528|FG000|STARTED|Time Period 2: Dose Level 2||0
8650193|NCT00634088|9691529|FG001|STARTED|Time Period 2: Dose Level 2||3
8650194|NCT00634088|9691530|FG002|STARTED|Time Period 2: Dose Level 2||0
8650195|NCT00634088|9691531|FG003|STARTED|Time Period 2: Dose Level 2||0
8650196|NCT00634088|9691528|FG000|COMPLETED|Time Period 2: Dose Level 2||0
8650197|NCT00634088|9691529|FG001|COMPLETED|Time Period 2: Dose Level 2||0
8650198|NCT00634088|9691530|FG002|COMPLETED|Time Period 2: Dose Level 2||0
8650199|NCT00634088|9691531|FG003|COMPLETED|Time Period 2: Dose Level 2||0
8650200|NCT00634088|9691528|FG000|NOT COMPLETED|Time Period 2: Dose Level 2||0
8650201|NCT00634088|9691529|FG001|NOT COMPLETED|Time Period 2: Dose Level 2||3
8650202|NCT00634088|9691530|FG002|NOT COMPLETED|Time Period 2: Dose Level 2||0
8650203|NCT00634088|9691531|FG003|NOT COMPLETED|Time Period 2: Dose Level 2||0
8650204|NCT00634088|9691528|FG000|STARTED|Time Period 3: Dose Level 3||0
8650205|NCT00634088|9691529|FG001|STARTED|Time Period 3: Dose Level 3||0
8650206|NCT00634088|9691530|FG002|STARTED|Time Period 3: Dose Level 3||1
8650207|NCT00634088|9691531|FG003|STARTED|Time Period 3: Dose Level 3||0
8650208|NCT00634088|9691528|FG000|COMPLETED|Time Period 3: Dose Level 3||0
8650209|NCT00634088|9691529|FG001|COMPLETED|Time Period 3: Dose Level 3||0
8650210|NCT00634088|9691530|FG002|COMPLETED|Time Period 3: Dose Level 3||0
8650211|NCT00634088|9691531|FG003|COMPLETED|Time Period 3: Dose Level 3||0
8650212|NCT00634088|9691528|FG000|NOT COMPLETED|Time Period 3: Dose Level 3||0
8650213|NCT00634088|9691529|FG001|NOT COMPLETED|Time Period 3: Dose Level 3||0
8650214|NCT00634088|9691530|FG002|NOT COMPLETED|Time Period 3: Dose Level 3||1
8650215|NCT00634088|9691531|FG003|NOT COMPLETED|Time Period 3: Dose Level 3||0
8650216|NCT00634088|9691528|FG000|STARTED|Time Period 4: Triplet Combination||0
8650217|NCT00634088|9691529|FG001|STARTED|Time Period 4: Triplet Combination||0
8650218|NCT00634088|9691530|FG002|STARTED|Time Period 4: Triplet Combination||0
8650219|NCT00634088|9691531|FG003|STARTED|Time Period 4: Triplet Combination||0
8650220|NCT00634088|9691528|FG000|COMPLETED|Time Period 4: Triplet Combination||0
8650221|NCT00634088|9691529|FG001|COMPLETED|Time Period 4: Triplet Combination||0
8650222|NCT00634088|9691530|FG002|COMPLETED|Time Period 4: Triplet Combination||0
8650223|NCT00634088|9691531|FG003|COMPLETED|Time Period 4: Triplet Combination||0
8650224|NCT00634088|9691528|FG000|NOT COMPLETED|Time Period 4: Triplet Combination||0
8650225|NCT00634088|9691529|FG001|NOT COMPLETED|Time Period 4: Triplet Combination||0
8650226|NCT00634088|9691530|FG002|NOT COMPLETED|Time Period 4: Triplet Combination||0
8650227|NCT00634088|9691531|FG003|NOT COMPLETED|Time Period 4: Triplet Combination||0
8650228|NCT00634101|9691543|FG000|STARTED|Overall Study||66
8650229|NCT00634101|9691544|FG001|STARTED|Overall Study||59
8650230|NCT00634101|9691543|FG000|COMPLETED|Overall Study||61
8650231|NCT00634101|9691544|FG001|COMPLETED|Overall Study||56
8650232|NCT00634101|9691543|FG000|NOT COMPLETED|Overall Study||5
8650233|NCT00634101|9691544|FG001|NOT COMPLETED|Overall Study||3
8650234|NCT00634114|9691553|FG000|STARTED|Overall Study|Randomised|188
8650235|NCT00634114|9691554|FG001|STARTED|Overall Study|Randomised|189
8650236|NCT00634114|9691555|FG002|STARTED|Overall Study|Randomised|187
8650237|NCT00634114|9691553|FG000|COMPLETED|Overall Study|Completed|160
8650238|NCT00634114|9691554|FG001|COMPLETED|Overall Study|Completed|154
8650239|NCT00634114|9691555|FG002|COMPLETED|Overall Study|Completed|148
8650240|NCT00634114|9691553|FG000|NOT COMPLETED|Overall Study||28
8650241|NCT00634114|9691554|FG001|NOT COMPLETED|Overall Study||35
8650242|NCT00634114|9691555|FG002|NOT COMPLETED|Overall Study||39
8650243|NCT00634166|9691565|FG000|STARTED|Overall Study||82
8650244|NCT00634166|9691566|FG001|STARTED|Overall Study||138
8650245|NCT00634166|9691565|FG000|COMPLETED|Overall Study||22
8650246|NCT00634166|9691566|FG001|COMPLETED|Overall Study||78
8650247|NCT00634166|9691565|FG000|NOT COMPLETED|Overall Study||60
8650248|NCT00634166|9691566|FG001|NOT COMPLETED|Overall Study||60
8650249|NCT00634179|9691572|FG000|STARTED|Phase I: Induction||19
8650250|NCT00634179|9691572|FG000|COMPLETED|Phase I: Induction||19
8650251|NCT00634179|9691572|FG000|NOT COMPLETED|Phase I: Induction||0
8650252|NCT00634179|9691572|FG000|STARTED|Phase II: Maintenance||30
8650253|NCT00634179|9691572|FG000|COMPLETED|Phase II: Maintenance||29
8650254|NCT00634179|9691572|FG000|NOT COMPLETED|Phase II: Maintenance||1
8650255|NCT00634244|9691582|FG000|STARTED|Overall Study||35
8650256|NCT00634244|9691583|FG001|STARTED|Overall Study||37
8650257|NCT00634244|9691584|FG002|STARTED|Overall Study||20
8650258|NCT00634244|9691582|FG000|Eligible and Treated|Overall Study||35
8650259|NCT00634244|9691583|FG001|Eligible and Treated|Overall Study||36
8650260|NCT00634244|9691584|FG002|Eligible and Treated|Overall Study||20
8650261|NCT00634244|9691582|FG000|COMPLETED|Overall Study||34
8650262|NCT00634244|9691583|FG001|COMPLETED|Overall Study||24
8650263|NCT00634244|9691584|FG002|COMPLETED|Overall Study||20
8650264|NCT00634244|9691582|FG000|NOT COMPLETED|Overall Study||1
8650265|NCT00634244|9691583|FG001|NOT COMPLETED|Overall Study||13
8650266|NCT00634244|9691584|FG002|NOT COMPLETED|Overall Study||0
8691867|NCT00856986|9737209|FG003|NOT COMPLETED|Main Period, Weeks 0-26||0
8691868|NCT00856986|9737210|FG004|NOT COMPLETED|Main Period, Weeks 0-26||0
8691869|NCT00856986|9737206|FG000|STARTED|Extension Period, Weeks 26-52|Subjects with HbA1c ≥8.0% who accepted intensification with detemir = 17 (Intensified Group)|127
8691870|NCT00856986|9737207|FG001|STARTED|Extension Period, Weeks 26-52||144
8691871|NCT00856986|9737208|FG002|STARTED|Extension Period, Weeks 26-52|Subjects with HbA1c ≥8.0% who accepted intensification with detemir = 7 (Intensified Group)|470
8691872|NCT00856986|9737209|FG003|STARTED|Extension Period, Weeks 26-52||0
8691873|NCT00856986|9737210|FG004|STARTED|Extension Period, Weeks 26-52||0
8691874|NCT00856986|9737206|FG000|Enrolled in Extension|Extension Period, Weeks 26-52||122
8691875|NCT00856986|9737207|FG001|Enrolled in Extension|Extension Period, Weeks 26-52||140
8691876|NCT00856986|9737208|FG002|Enrolled in Extension|Extension Period, Weeks 26-52||461
8691877|NCT00856986|9737209|FG003|Enrolled in Extension|Extension Period, Weeks 26-52||0
8691878|NCT00856986|9737210|FG004|Enrolled in Extension|Extension Period, Weeks 26-52||0
8691879|NCT00856986|9737206|FG000|COMPLETED|Extension Period, Weeks 26-52||108
8650267|NCT00634270|9691594|FG000|STARTED|Overall Study|February 12, 2008|49
8650268|NCT00634270|9691595|FG001|STARTED|Overall Study||13
8650269|NCT00634270|9691594|FG000|COMPLETED|Overall Study||46
8650270|NCT00634270|9691595|FG001|COMPLETED|Overall Study||12
8650271|NCT00634270|9691594|FG000|NOT COMPLETED|Overall Study||3
8650272|NCT00634270|9691595|FG001|NOT COMPLETED|Overall Study||1
8650273|NCT00634283|9691607|FG000|STARTED|Overall Study||6
8650274|NCT00634283|9691607|FG000|COMPLETED|Overall Study||6
8650275|NCT00634283|9691607|FG000|NOT COMPLETED|Overall Study||0
8650276|NCT00634504|9691615|FG000|STARTED|Overall Study||11
8650277|NCT00634504|9691616|FG001|STARTED|Overall Study||9
8650278|NCT00634504|9691615|FG000|COMPLETED|Overall Study||10
8650279|NCT00634504|9691616|FG001|COMPLETED|Overall Study||9
8650280|NCT00634504|9691615|FG000|NOT COMPLETED|Overall Study||1
8650281|NCT00634504|9691616|FG001|NOT COMPLETED|Overall Study||0
8650282|NCT00634543|9691624|FG000|STARTED|Overall Study||78
8650283|NCT00634543|9691625|FG001|STARTED|Overall Study||84
8650284|NCT00634543|9691624|FG000|Treated|Overall Study||76
8650285|NCT00634543|9691625|FG001|Treated|Overall Study||80
8650286|NCT00634543|9691624|FG000|COMPLETED|Overall Study||59
8650287|NCT00634543|9691625|FG001|COMPLETED|Overall Study||63
8650288|NCT00634543|9691624|FG000|NOT COMPLETED|Overall Study||19
8650289|NCT00634543|9691625|FG001|NOT COMPLETED|Overall Study||21
8650290|NCT00634569|9691633|FG000|STARTED|Overall Study||14
8650291|NCT00634569|9691634|FG001|STARTED|Overall Study||10
8650292|NCT00634569|9691633|FG000|COMPLETED|Overall Study||14
8650293|NCT00634569|9691634|FG001|COMPLETED|Overall Study||5
8650294|NCT00634569|9691633|FG000|NOT COMPLETED|Overall Study||0
8650295|NCT00634569|9691634|FG001|NOT COMPLETED|Overall Study||5
8650296|NCT00634621|9691640|FG000|STARTED|Overall Study||283
8650297|NCT00634621|9691640|FG000|COMPLETED|Overall Study||283
8650298|NCT00634621|9691640|FG000|NOT COMPLETED|Overall Study||0
8650299|NCT00634647|9691648|FG000|STARTED|Overall Study||24
8650300|NCT00634647|9691648|FG000|COMPLETED|Overall Study||17
8650301|NCT00634647|9691648|FG000|NOT COMPLETED|Overall Study||7
8650302|NCT00634751|9691656|FG000|STARTED|Phase I: 200mg Sorafenib+2DOC||9
8650303|NCT00634751|9691657|FG001|STARTED|Phase I: 200mg Sorafenib+2DOC||0
8650304|NCT00634751|9691658|FG002|STARTED|Phase I: 200mg Sorafenib+2DOC||0
8650305|NCT00634751|9691659|FG003|STARTED|Phase I: 200mg Sorafenib+2DOC||0
8650306|NCT00634751|9691656|FG000|COMPLETED|Phase I: 200mg Sorafenib+2DOC||8
8650307|NCT00634751|9691657|FG001|COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
8650308|NCT00634751|9691658|FG002|COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
8650309|NCT00634751|9691659|FG003|COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
8650310|NCT00634751|9691656|FG000|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||1
8650311|NCT00634751|9691657|FG001|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
8650312|NCT00634751|9691658|FG002|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
8650313|NCT00634751|9691659|FG003|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
8650314|NCT00634751|9691656|FG000|STARTED|Phase I: 400mg Sorafenib BID+2DOC||0
8650315|NCT00634751|9691657|FG001|STARTED|Phase I: 400mg Sorafenib BID+2DOC||7
8650316|NCT00634751|9691658|FG002|STARTED|Phase I: 400mg Sorafenib BID+2DOC||0
8650317|NCT00634751|9691659|FG003|STARTED|Phase I: 400mg Sorafenib BID+2DOC||0
8650318|NCT00634751|9691656|FG000|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
8650319|NCT00634751|9691657|FG001|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||6
8650320|NCT00634751|9691658|FG002|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
8650321|NCT00634751|9691659|FG003|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
8650322|NCT00634751|9691656|FG000|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
8650323|NCT00634751|9691657|FG001|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||1
8650324|NCT00634751|9691658|FG002|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
8650325|NCT00634751|9691659|FG003|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
8650326|NCT00634751|9691656|FG000|STARTED|Pancreatic and Bilial Tract Cancer||0
8650327|NCT00634751|9691657|FG001|STARTED|Pancreatic and Bilial Tract Cancer||0
8650328|NCT00634751|9691658|FG002|STARTED|Pancreatic and Bilial Tract Cancer||24
8650329|NCT00634751|9691659|FG003|STARTED|Pancreatic and Bilial Tract Cancer||8
8650330|NCT00634751|9691656|FG000|COMPLETED|Pancreatic and Bilial Tract Cancer||0
8650331|NCT00634751|9691657|FG001|COMPLETED|Pancreatic and Bilial Tract Cancer||0
8650332|NCT00634751|9691658|FG002|COMPLETED|Pancreatic and Bilial Tract Cancer||23
8650333|NCT00634751|9691659|FG003|COMPLETED|Pancreatic and Bilial Tract Cancer||7
8650334|NCT00634751|9691656|FG000|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||0
8650335|NCT00634751|9691657|FG001|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||0
8650336|NCT00634751|9691658|FG002|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||1
8650337|NCT00634751|9691659|FG003|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||1
8650338|NCT00634803|9691672|FG000|STARTED|Overall Study||30
8650339|NCT00634803|9691673|FG001|STARTED|Overall Study||30
8650340|NCT00634803|9691674|FG002|STARTED|Overall Study||30
8650341|NCT00634803|9691672|FG000|Month 1|Overall Study||29
8650342|NCT00634803|9691673|FG001|Month 1|Overall Study||29
8650343|NCT00634803|9691674|FG002|Month 1|Overall Study||29
8650344|NCT00634803|9691672|FG000|Month 2|Overall Study||26
8650345|NCT00634803|9691673|FG001|Month 2|Overall Study||26
8650346|NCT00634803|9691674|FG002|Month 2|Overall Study||28
8650347|NCT00634803|9691672|FG000|Month 3|Overall Study||25
8650348|NCT00634803|9691673|FG001|Month 3|Overall Study||23
8650349|NCT00634803|9691674|FG002|Month 3|Overall Study||26
8650350|NCT00634803|9691672|FG000|COMPLETED|Overall Study||24
8650351|NCT00634803|9691673|FG001|COMPLETED|Overall Study||23
8650352|NCT00634803|9691674|FG002|COMPLETED|Overall Study||23
8650353|NCT00634803|9691672|FG000|NOT COMPLETED|Overall Study||6
8650354|NCT00634803|9691673|FG001|NOT COMPLETED|Overall Study||7
8650355|NCT00634803|9691674|FG002|NOT COMPLETED|Overall Study||7
8650356|NCT00634842|9691684|FG000|STARTED|Overall Study||122
8650357|NCT00634842|9691685|FG001|STARTED|Overall Study||122
8650358|NCT00634842|9691684|FG000|COMPLETED|Overall Study||107
8650359|NCT00634842|9691685|FG001|COMPLETED|Overall Study||104
8650360|NCT00634842|9691684|FG000|NOT COMPLETED|Overall Study||15
8650361|NCT00634842|9691685|FG001|NOT COMPLETED|Overall Study||18
8650362|NCT00634907|9691693|FG000|STARTED|Overall Study||131
8650363|NCT00634907|9691694|FG001|STARTED|Overall Study||132
8650364|NCT00634907|9691693|FG000|COMPLETED|Overall Study||114
8650365|NCT00634907|9691694|FG001|COMPLETED|Overall Study||115
8650366|NCT00634907|9691693|FG000|NOT COMPLETED|Overall Study||17
8650367|NCT00634907|9691694|FG001|NOT COMPLETED|Overall Study||17
8650368|NCT00634920|9691703|FG000|STARTED|Period 1 - Pre-Randomization||0
8650369|NCT00634920|9691704|FG001|STARTED|Period 1 - Pre-Randomization||0
8650370|NCT00634920|9691705|FG002|STARTED|Period 1 - Pre-Randomization|Total number of Enrolled patients|341
8650371|NCT00634920|9691703|FG000|COMPLETED|Period 1 - Pre-Randomization||0
8650372|NCT00634920|9691704|FG001|COMPLETED|Period 1 - Pre-Randomization||0
8650373|NCT00634920|9691705|FG002|COMPLETED|Period 1 - Pre-Randomization|Total number of patients who became randomized|204
8650374|NCT00634920|9691703|FG000|NOT COMPLETED|Period 1 - Pre-Randomization||0
8650375|NCT00634920|9691704|FG001|NOT COMPLETED|Period 1 - Pre-Randomization||0
8650376|NCT00634920|9691705|FG002|NOT COMPLETED|Period 1 - Pre-Randomization||137
8650377|NCT00634920|9691703|FG000|STARTED|Period 2 - Post-Randomization|2 patients randomized in this group did not receive at least one dose of study drug.|104
8650378|NCT00634920|9691704|FG001|STARTED|Period 2 - Post-Randomization||100
8650379|NCT00634920|9691705|FG002|STARTED|Period 2 - Post-Randomization|This group included patients who had renal TX but did not qualify for randomization at Visit 2.|0
8650380|NCT00634920|9691703|FG000|Full Analysis Set (FAS)|Period 2 - Post-Randomization||92
8650381|NCT00634920|9691704|FG001|Full Analysis Set (FAS)|Period 2 - Post-Randomization||90
8650382|NCT00634920|9691705|FG002|Full Analysis Set (FAS)|Period 2 - Post-Randomization||0
8650383|NCT00634920|9691703|FG000|COMPLETED|Period 2 - Post-Randomization||43
8650384|NCT00634920|9691704|FG001|COMPLETED|Period 2 - Post-Randomization||68
8650385|NCT00634920|9691705|FG002|COMPLETED|Period 2 - Post-Randomization||0
8650386|NCT00634920|9691703|FG000|NOT COMPLETED|Period 2 - Post-Randomization||61
8650387|NCT00634920|9691704|FG001|NOT COMPLETED|Period 2 - Post-Randomization||32
8650388|NCT00634920|9691705|FG002|NOT COMPLETED|Period 2 - Post-Randomization||0
8650389|NCT00634933|9691714|FG000|STARTED|Part A: Baseline to Week 24||74
8650390|NCT00634933|9691715|FG001|STARTED|Part A: Baseline to Week 24||75
8650391|NCT00634933|9691716|FG002|STARTED|Part A: Baseline to Week 24||73
8650392|NCT00634933|9691717|FG003|STARTED|Part A: Baseline to Week 24||0
8650393|NCT00634933|9691718|FG004|STARTED|Part A: Baseline to Week 24||0
8650394|NCT00634933|9691714|FG000|COMPLETED|Part A: Baseline to Week 24||63
8650395|NCT00634933|9691715|FG001|COMPLETED|Part A: Baseline to Week 24||57
8650396|NCT00634933|9691716|FG002|COMPLETED|Part A: Baseline to Week 24||55
8650397|NCT00634933|9691717|FG003|COMPLETED|Part A: Baseline to Week 24||0
8650398|NCT00634933|9691718|FG004|COMPLETED|Part A: Baseline to Week 24||0
8650399|NCT00634933|9691714|FG000|NOT COMPLETED|Part A: Baseline to Week 24||11
8650400|NCT00634933|9691715|FG001|NOT COMPLETED|Part A: Baseline to Week 24||18
8650401|NCT00634933|9691716|FG002|NOT COMPLETED|Part A: Baseline to Week 24||18
8650402|NCT00634933|9691717|FG003|NOT COMPLETED|Part A: Baseline to Week 24||0
8650403|NCT00634933|9691718|FG004|NOT COMPLETED|Part A: Baseline to Week 24||0
8650404|NCT00634933|9691714|FG000|STARTED|Between Part A and Part B||0
8650405|NCT00634933|9691715|FG001|STARTED|Between Part A and Part B||57
8650406|NCT00634933|9691716|FG002|STARTED|Between Part A and Part B||55
8650407|NCT00634933|9691717|FG003|STARTED|Between Part A and Part B||31
8650408|NCT00634933|9691718|FG004|STARTED|Between Part A and Part B||32
8650409|NCT00634933|9691714|FG000|COMPLETED|Between Part A and Part B||0
8650410|NCT00634933|9691715|FG001|COMPLETED|Between Part A and Part B||56
8650411|NCT00634933|9691716|FG002|COMPLETED|Between Part A and Part B||55
8650412|NCT00634933|9691717|FG003|COMPLETED|Between Part A and Part B||31
8650413|NCT00634933|9691718|FG004|COMPLETED|Between Part A and Part B||32
8650414|NCT00634933|9691714|FG000|NOT COMPLETED|Between Part A and Part B||0
8650415|NCT00634933|9691715|FG001|NOT COMPLETED|Between Part A and Part B||1
8650416|NCT00634933|9691716|FG002|NOT COMPLETED|Between Part A and Part B||0
8650417|NCT00634933|9691717|FG003|NOT COMPLETED|Between Part A and Part B||0
8650418|NCT00634933|9691718|FG004|NOT COMPLETED|Between Part A and Part B||0
8650419|NCT00634933|9691714|FG000|STARTED|Part B: Week 24 to Week 52||0
8650420|NCT00634933|9691715|FG001|STARTED|Part B: Week 24 to Week 52||56
8650421|NCT00634933|9691716|FG002|STARTED|Part B: Week 24 to Week 52||55
8650422|NCT00634933|9691717|FG003|STARTED|Part B: Week 24 to Week 52||31
8650423|NCT00634933|9691718|FG004|STARTED|Part B: Week 24 to Week 52||32
8650424|NCT00634933|9691714|FG000|COMPLETED|Part B: Week 24 to Week 52||0
8650425|NCT00634933|9691715|FG001|COMPLETED|Part B: Week 24 to Week 52||42
8650426|NCT00634933|9691716|FG002|COMPLETED|Part B: Week 24 to Week 52||33
8650427|NCT00634933|9691717|FG003|COMPLETED|Part B: Week 24 to Week 52||25
8650428|NCT00634933|9691718|FG004|COMPLETED|Part B: Week 24 to Week 52||22
8650429|NCT00634933|9691714|FG000|NOT COMPLETED|Part B: Week 24 to Week 52||0
8650430|NCT00634933|9691715|FG001|NOT COMPLETED|Part B: Week 24 to Week 52||14
8650431|NCT00634933|9691716|FG002|NOT COMPLETED|Part B: Week 24 to Week 52||22
8650432|NCT00634933|9691717|FG003|NOT COMPLETED|Part B: Week 24 to Week 52||6
8650433|NCT00634933|9691718|FG004|NOT COMPLETED|Part B: Week 24 to Week 52||10
8650434|NCT00635024|9691730|FG000|STARTED|Overall Study||1
8650435|NCT00635024|9691730|FG000|COMPLETED|Overall Study||0
8650436|NCT00635024|9691730|FG000|NOT COMPLETED|Overall Study||1
8650437|NCT00635050|9691734|FG000|STARTED|Overall Study|No patient received regimen B due to grade 3 toxicity in the third patient treated on regimen A.|32
8650438|NCT00635050|9691734|FG000|COMPLETED|Overall Study|Followup through 10 years planned.|31
8650439|NCT00635050|9691734|FG000|NOT COMPLETED|Overall Study||1
8650440|NCT00635089|9691741|FG000|STARTED|Overall Study||190
8650441|NCT00635089|9691741|FG000|Completed >/= 16 Weeks of Study|Overall Study||181
8650442|NCT00635089|9691741|FG000|COMPLETED|Overall Study|Participants who had not withdrawn at the time of study termination.|112
8650443|NCT00635089|9691741|FG000|NOT COMPLETED|Overall Study||78
8650444|NCT00635102|9691760|FG000|STARTED|Overall Study||27
8650445|NCT00635102|9691761|FG001|STARTED|Overall Study||30
8650446|NCT00635102|9691760|FG000|COMPLETED|Overall Study||20
8650447|NCT00635102|9691761|FG001|COMPLETED|Overall Study||22
8650448|NCT00635102|9691760|FG000|NOT COMPLETED|Overall Study||7
8650449|NCT00635102|9691761|FG001|NOT COMPLETED|Overall Study||8
8650450|NCT00635128|9691769|FG000|STARTED|Overall Study||351
8650451|NCT00635128|9691770|FG001|STARTED|Overall Study||64
8650452|NCT00635128|9691769|FG000|COMPLETED|Overall Study||351
8650453|NCT00635128|9691770|FG001|COMPLETED|Overall Study||64
8650454|NCT00635128|9691769|FG000|NOT COMPLETED|Overall Study||0
8650455|NCT00635128|9691770|FG001|NOT COMPLETED|Overall Study||0
8728220|NCT01047007|9775407|FG001|COMPLETED|Overall Study||0
8728221|NCT01047007|9775408|FG002|COMPLETED|Overall Study||0
8728222|NCT01047007|9775409|FG003|COMPLETED|Overall Study||0
8728223|NCT01047007|9775406|FG000|NOT COMPLETED|Overall Study||2
8728224|NCT01047007|9775407|FG001|NOT COMPLETED|Overall Study||6
8728225|NCT01047007|9775408|FG002|NOT COMPLETED|Overall Study||2
8728226|NCT01047007|9775409|FG003|NOT COMPLETED|Overall Study||0
8728227|NCT01047189|9775421|FG000|STARTED|Overall Study||13
8728228|NCT01047189|9775422|FG001|STARTED|Overall Study||13
8728229|NCT01047189|9775421|FG000|COMPLETED|Overall Study||9
8728230|NCT01047189|9775422|FG001|COMPLETED|Overall Study||13
8728231|NCT01047189|9775421|FG000|NOT COMPLETED|Overall Study||4
8728232|NCT01047189|9775422|FG001|NOT COMPLETED|Overall Study||0
8728233|NCT01047241|9775428|FG000|STARTED|Overall Study||50
8728234|NCT01047241|9775428|FG000|COMPLETED|Overall Study||50
8728235|NCT01047241|9775428|FG000|NOT COMPLETED|Overall Study||0
8728236|NCT01047293|9775435|FG000|STARTED|Overall Study||4
8728237|NCT01047293|9775436|FG001|STARTED|Overall Study||8
8728238|NCT01047293|9775437|FG002|STARTED|Overall Study||9
8728239|NCT01047293|9775438|FG003|STARTED|Overall Study||26
8728240|NCT01047293|9775435|FG000|COMPLETED|Overall Study||3
8728241|NCT01047293|9775436|FG001|COMPLETED|Overall Study||7
8728242|NCT01047293|9775437|FG002|COMPLETED|Overall Study||9
8728243|NCT01047293|9775438|FG003|COMPLETED|Overall Study||26
8728244|NCT01047293|9775435|FG000|NOT COMPLETED|Overall Study||1
8728245|NCT01047293|9775436|FG001|NOT COMPLETED|Overall Study||1
8728246|NCT01047293|9775437|FG002|NOT COMPLETED|Overall Study||0
8728247|NCT01047293|9775438|FG003|NOT COMPLETED|Overall Study||0
8728248|NCT01047306|9775447|FG000|STARTED|Overall Study||19
8728249|NCT01047306|9775448|FG001|STARTED|Overall Study||6
8728250|NCT01047306|9775447|FG000|Discontinued From the Study|Overall Study||3
8728251|NCT01047306|9775448|FG001|Discontinued From the Study|Overall Study||0
8728252|NCT01047306|9775447|FG000|COMPLETED|Overall Study||16
8728253|NCT01047306|9775448|FG001|COMPLETED|Overall Study||6
9022161|NCT03124459|10085073|FG003|STARTED|Part 1-Open Label Dose Escalation|Patients in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study.|0
9022162|NCT03124459|10085074|FG004|STARTED|Part 1-Open Label Dose Escalation|Patients in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study.|0
9022163|NCT03124459|10085075|FG005|STARTED|Part 1-Open Label Dose Escalation|Patients in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study. Participants that completed the double-blind portion of the study then moved into this Part 2 open-label portion of the study.|0
9022164|NCT03124459|10085070|FG000|COMPLETED|Part 1-Open Label Dose Escalation||6
9022165|NCT03124459|10085071|FG001|COMPLETED|Part 1-Open Label Dose Escalation||6
9022166|NCT03124459|10085072|FG002|COMPLETED|Part 1-Open Label Dose Escalation||6
9022167|NCT03124459|10085073|FG003|COMPLETED|Part 1-Open Label Dose Escalation|Patients in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study.|0
9039962|NCT03345108|10100890|FG001|STARTED|Period-1||8
9039963|NCT03345108|10100891|FG002|STARTED|Period-1||8
8650456|NCT00635154|9691778|FG000|STARTED|Overall Study||54
8728254|NCT01047306|9775447|FG000|NOT COMPLETED|Overall Study||3
8728255|NCT01047306|9775448|FG001|NOT COMPLETED|Overall Study||0
8728256|NCT01047332|9775458|FG000|STARTED|Overall Study||61
8728257|NCT01047332|9775459|FG001|STARTED|Overall Study||68
8728258|NCT01047332|9775458|FG000|COMPLETED|Overall Study|Alive at final follow-up|4
8728259|NCT01047332|9775459|FG001|COMPLETED|Overall Study|Alive at final follow-up|4
8728260|NCT01047332|9775458|FG000|NOT COMPLETED|Overall Study||57
8728261|NCT01047332|9775459|FG001|NOT COMPLETED|Overall Study||64
8728262|NCT01047345|9775467|FG000|STARTED|Base Study||618
8728263|NCT01047345|9775468|FG001|STARTED|Base Study||306
8728264|NCT01047345|9775469|FG002|STARTED|Base Study||0
8650457|NCT00635154|9691778|FG000|COMPLETED|Overall Study||21
8650458|NCT00635154|9691778|FG000|NOT COMPLETED|Overall Study||33
8650459|NCT00635219|9691789|FG000|STARTED|Overall Study||148
8650460|NCT00635219|9691790|FG001|STARTED|Overall Study||155
8650461|NCT00635219|9691791|FG002|STARTED|Overall Study||157
8650462|NCT00635219|9691792|FG003|STARTED|Overall Study||151
8650463|NCT00635219|9691793|FG004|STARTED|Overall Study||155
8650464|NCT00635219|9691789|FG000|COMPLETED|Overall Study||123
8650465|NCT00635219|9691790|FG001|COMPLETED|Overall Study||130
8650466|NCT00635219|9691791|FG002|COMPLETED|Overall Study||122
8650467|NCT00635219|9691792|FG003|COMPLETED|Overall Study||117
8650468|NCT00635219|9691793|FG004|COMPLETED|Overall Study||113
8650469|NCT00635219|9691789|FG000|NOT COMPLETED|Overall Study||25
8650470|NCT00635219|9691790|FG001|NOT COMPLETED|Overall Study||25
8650471|NCT00635219|9691791|FG002|NOT COMPLETED|Overall Study||35
8650472|NCT00635219|9691792|FG003|NOT COMPLETED|Overall Study||34
8650473|NCT00635219|9691793|FG004|NOT COMPLETED|Overall Study||42
8650474|NCT00635232|9691810|FG000|STARTED|Overall Study||58
8650475|NCT00635232|9691811|FG001|STARTED|Overall Study||59
8650476|NCT00635232|9691812|FG002|STARTED|Overall Study||58
8650477|NCT00635232|9691813|FG003|STARTED|Overall Study||58
8650478|NCT00635232|9691814|FG004|STARTED|Overall Study||28
8650479|NCT00635232|9691810|FG000|COMPLETED|Overall Study||44
8650480|NCT00635232|9691811|FG001|COMPLETED|Overall Study||39
8650481|NCT00635232|9691812|FG002|COMPLETED|Overall Study||55
8650482|NCT00635232|9691813|FG003|COMPLETED|Overall Study||48
8650483|NCT00635232|9691814|FG004|COMPLETED|Overall Study||20
8650484|NCT00635232|9691810|FG000|NOT COMPLETED|Overall Study||14
8650485|NCT00635232|9691811|FG001|NOT COMPLETED|Overall Study||20
8650486|NCT00635232|9691812|FG002|NOT COMPLETED|Overall Study||3
8650487|NCT00635232|9691813|FG003|NOT COMPLETED|Overall Study||10
8650488|NCT00635232|9691814|FG004|NOT COMPLETED|Overall Study||8
8650489|NCT00635349|9691828|FG000|STARTED|Overall Study||73
8650490|NCT00635349|9691829|FG001|STARTED|Overall Study||67
8650491|NCT00635349|9691828|FG000|COMPLETED|Overall Study||29
8650492|NCT00635349|9691829|FG001|COMPLETED|Overall Study||19
8650493|NCT00635349|9691828|FG000|NOT COMPLETED|Overall Study||44
8650494|NCT00635349|9691829|FG001|NOT COMPLETED|Overall Study||48
8650495|NCT00635362|9691837|FG000|STARTED|Overall Study||22
8650496|NCT00635362|9691838|FG001|STARTED|Overall Study||20
8650497|NCT00635362|9691837|FG000|COMPLETED|Overall Study||9
8650498|NCT00635362|9691838|FG001|COMPLETED|Overall Study||12
8650499|NCT00635362|9691837|FG000|NOT COMPLETED|Overall Study||13
8650500|NCT00635362|9691838|FG001|NOT COMPLETED|Overall Study||8
8650501|NCT00635427|9691849|FG000|STARTED|Overall Study|12 participants were considered ITT population as 1 participant did not have type 1 Gaucher disease|13
8650502|NCT00635427|9691850|FG001|STARTED|Overall Study|11 participants were considered ITT population as 1 participant did not have type 1 Gaucher disease|12
8650503|NCT00635427|9691851|FG002|STARTED|Overall Study||16
8650504|NCT00635427|9691852|FG003|STARTED|Overall Study||16
8650505|NCT00635427|9691853|FG004|STARTED|Overall Study||38
8650506|NCT00635427|9691849|FG000|COMPLETED|Overall Study||1
8650507|NCT00635427|9691850|FG001|COMPLETED|Overall Study||6
8650508|NCT00635427|9691851|FG002|COMPLETED|Overall Study||5
8650509|NCT00635427|9691852|FG003|COMPLETED|Overall Study||7
8650510|NCT00635427|9691853|FG004|COMPLETED|Overall Study||30
8650511|NCT00635427|9691849|FG000|NOT COMPLETED|Overall Study||12
8650512|NCT00635427|9691850|FG001|NOT COMPLETED|Overall Study||6
8650513|NCT00635427|9691851|FG002|NOT COMPLETED|Overall Study||11
8650514|NCT00635427|9691852|FG003|NOT COMPLETED|Overall Study||9
8650515|NCT00635427|9691853|FG004|NOT COMPLETED|Overall Study||8
8650516|NCT00635453|9691865|FG000|STARTED|Overall Study||360
8650517|NCT00635453|9691866|FG001|STARTED|Overall Study||355
8650518|NCT00635453|9691865|FG000|6 Months Assessment|Overall Study||322
8650519|NCT00635453|9691866|FG001|6 Months Assessment|Overall Study||311
8650520|NCT00635453|9691865|FG000|12 Months Assessment|Overall Study||285
8650521|NCT00635453|9691866|FG001|12 Months Assessment|Overall Study||260
8650522|NCT00635453|9691865|FG000|3 Years Assessment|Overall Study||246
8650523|NCT00635453|9691866|FG001|3 Years Assessment|Overall Study||204
8650524|NCT00635453|9691865|FG000|COMPLETED|Overall Study||206
8650525|NCT00635453|9691866|FG001|COMPLETED|Overall Study||181
8650526|NCT00635453|9691865|FG000|NOT COMPLETED|Overall Study||154
8650527|NCT00635453|9691866|FG001|NOT COMPLETED|Overall Study||174
8650528|NCT00635479|9691874|FG000|STARTED|Overall Study||55
8650529|NCT00635479|9691875|FG001|STARTED|Overall Study||60
8650530|NCT00635479|9691874|FG000|COMPLETED|Overall Study||49
8650531|NCT00635479|9691875|FG001|COMPLETED|Overall Study||42
8650532|NCT00635479|9691874|FG000|NOT COMPLETED|Overall Study||6
8650533|NCT00635479|9691875|FG001|NOT COMPLETED|Overall Study||18
8650534|NCT00635492|9691883|FG000|STARTED|Overall Study|This population consists of the analysis population.|1114
8650535|NCT00635492|9691884|FG001|STARTED|Overall Study|This population consists of the analysis population.|1274
8650536|NCT00635492|9691883|FG000|COMPLETED|Overall Study|This population consists of patients that completed the 24 month study.|835
8650537|NCT00635492|9691884|FG001|COMPLETED|Overall Study|This population consists of patients that completed the 24 month study.|992
8650538|NCT00635492|9691883|FG000|NOT COMPLETED|Overall Study||279
8650539|NCT00635492|9691884|FG001|NOT COMPLETED|Overall Study||282
8650540|NCT00635570|9691896|FG000|STARTED|Overall Study||136
8650541|NCT00635570|9691897|FG001|STARTED|Overall Study||137
8650542|NCT00635570|9691896|FG000|COMPLETED|Overall Study||121
8650543|NCT00635570|9691897|FG001|COMPLETED|Overall Study||126
8650544|NCT00635570|9691896|FG000|NOT COMPLETED|Overall Study||15
8650545|NCT00635570|9691897|FG001|NOT COMPLETED|Overall Study||11
8650546|NCT00635609|9691905|FG000|STARTED|Overall Study||48
8650547|NCT00635609|9691906|FG001|STARTED|Overall Study||45
8650548|NCT00635609|9691905|FG000|COMPLETED|Overall Study||41
8650549|NCT00635609|9691906|FG001|COMPLETED|Overall Study||42
8650550|NCT00635609|9691905|FG000|NOT COMPLETED|Overall Study||7
8650551|NCT00635609|9691906|FG001|NOT COMPLETED|Overall Study||3
8650552|NCT00635648|9691912|FG000|STARTED|Overall Study||63
8650553|NCT00635648|9691912|FG000|COMPLETED|Overall Study||26
8650554|NCT00635648|9691912|FG000|NOT COMPLETED|Overall Study||37
8650555|NCT00635661|9691916|FG000|STARTED|Overall Study||34
8650556|NCT00635661|9691916|FG000|COMPLETED|Overall Study||30
8650557|NCT00635661|9691916|FG000|NOT COMPLETED|Overall Study||4
8650558|NCT00635700|9691922|FG000|STARTED|Overall Study||24
8650559|NCT00635700|9691923|FG001|STARTED|Overall Study||27
8650560|NCT00635700|9691922|FG000|COMPLETED|Overall Study||9
8650561|NCT00635700|9691923|FG001|COMPLETED|Overall Study||13
8650562|NCT00635700|9691922|FG000|NOT COMPLETED|Overall Study||15
8650563|NCT00635700|9691923|FG001|NOT COMPLETED|Overall Study||14
8650564|NCT00635739|9691931|FG000|STARTED|Overall Study||42
8650565|NCT00635739|9691932|FG001|STARTED|Overall Study||38
8650566|NCT00635739|9691931|FG000|COMPLETED|Overall Study||39
8650567|NCT00635739|9691932|FG001|COMPLETED|Overall Study||36
8650568|NCT00635739|9691931|FG000|NOT COMPLETED|Overall Study||3
8650569|NCT00635739|9691932|FG001|NOT COMPLETED|Overall Study||2
8650570|NCT00635778|9691945|FG000|STARTED|Overall Study||1
8650571|NCT00635778|9691946|FG001|STARTED|Overall Study||3
8650572|NCT00635778|9691947|FG002|STARTED|Overall Study||3
8650573|NCT00635778|9691948|FG003|STARTED|Overall Study||8
8650574|NCT00635778|9691949|FG004|STARTED|Overall Study||8
8650575|NCT00635778|9691950|FG005|STARTED|Overall Study||21
8650576|NCT00635778|9691951|FG006|STARTED|Overall Study||6
8650577|NCT00635778|9691945|FG000|COMPLETED|Overall Study||0
8650578|NCT00635778|9691946|FG001|COMPLETED|Overall Study||0
8650579|NCT00635778|9691947|FG002|COMPLETED|Overall Study||0
8650580|NCT00635778|9691948|FG003|COMPLETED|Overall Study||0
8650581|NCT00635778|9691949|FG004|COMPLETED|Overall Study||0
8650582|NCT00635778|9691950|FG005|COMPLETED|Overall Study||0
8650583|NCT00635778|9691951|FG006|COMPLETED|Overall Study||0
8650584|NCT00635778|9691945|FG000|NOT COMPLETED|Overall Study||1
8650585|NCT00635778|9691946|FG001|NOT COMPLETED|Overall Study||3
8650586|NCT00635778|9691947|FG002|NOT COMPLETED|Overall Study||3
8650587|NCT00635778|9691948|FG003|NOT COMPLETED|Overall Study||8
8650588|NCT00635778|9691949|FG004|NOT COMPLETED|Overall Study||8
8650589|NCT00635778|9691950|FG005|NOT COMPLETED|Overall Study||21
8650590|NCT00635778|9691951|FG006|NOT COMPLETED|Overall Study||6
8650591|NCT00635804|9691976|FG000|STARTED|Overall Study||7
8650592|NCT00635804|9691977|FG001|STARTED|Overall Study||6
8650593|NCT00635804|9691978|FG002|STARTED|Overall Study||6
8650594|NCT00635804|9691979|FG003|STARTED|Overall Study||6
8650595|NCT00635804|9691980|FG004|STARTED|Overall Study||6
8650596|NCT00635804|9691981|FG005|STARTED|Overall Study||12
8650597|NCT00635804|9691982|FG006|STARTED|Overall Study||3
8650598|NCT00635804|9691983|FG007|STARTED|Overall Study||14
8650599|NCT00635804|9691976|FG000|COMPLETED|Overall Study||6
8650600|NCT00635804|9691977|FG001|COMPLETED|Overall Study||6
8650601|NCT00635804|9691978|FG002|COMPLETED|Overall Study||6
8650602|NCT00635804|9691979|FG003|COMPLETED|Overall Study||6
8650603|NCT00635804|9691980|FG004|COMPLETED|Overall Study||6
8650604|NCT00635804|9691981|FG005|COMPLETED|Overall Study||11
8650605|NCT00635804|9691982|FG006|COMPLETED|Overall Study||3
8650606|NCT00635804|9691983|FG007|COMPLETED|Overall Study||14
8650607|NCT00635804|9691976|FG000|NOT COMPLETED|Overall Study||1
8650608|NCT00635804|9691977|FG001|NOT COMPLETED|Overall Study||0
8650609|NCT00635804|9691978|FG002|NOT COMPLETED|Overall Study||0
8650610|NCT00635804|9691979|FG003|NOT COMPLETED|Overall Study||0
8650611|NCT00635804|9691980|FG004|NOT COMPLETED|Overall Study||0
8650612|NCT00635804|9691981|FG005|NOT COMPLETED|Overall Study||1
8650613|NCT00635804|9691982|FG006|NOT COMPLETED|Overall Study||0
8650614|NCT00635804|9691983|FG007|NOT COMPLETED|Overall Study||0
8650615|NCT00635817|9692008|FG000|STARTED|Overall Study||21
8650616|NCT00635817|9692009|FG001|STARTED|Overall Study||21
8650617|NCT00635817|9692010|FG002|STARTED|Overall Study||21
8650618|NCT00635817|9692011|FG003|STARTED|Overall Study||21
8650619|NCT00635817|9692008|FG000|COMPLETED|Overall Study||15
8650620|NCT00635817|9692009|FG001|COMPLETED|Overall Study||19
8650621|NCT00635817|9692010|FG002|COMPLETED|Overall Study||19
8650622|NCT00635817|9692011|FG003|COMPLETED|Overall Study||21
8650623|NCT00635817|9692008|FG000|NOT COMPLETED|Overall Study||6
8650624|NCT00635817|9692009|FG001|NOT COMPLETED|Overall Study||2
8650625|NCT00635817|9692010|FG002|NOT COMPLETED|Overall Study||2
8650626|NCT00635817|9692011|FG003|NOT COMPLETED|Overall Study||0
8650627|NCT00635830|9692025|FG000|STARTED|Overall Study||20
8650628|NCT00635830|9692026|FG001|STARTED|Overall Study||20
8650629|NCT00635830|9692025|FG000|COMPLETED|Overall Study||20
8650630|NCT00635830|9692026|FG001|COMPLETED|Overall Study||20
8650631|NCT00635830|9692025|FG000|NOT COMPLETED|Overall Study||0
8650632|NCT00635830|9692026|FG001|NOT COMPLETED|Overall Study||0
8650633|NCT00635999|9692035|FG000|STARTED|Overall Study||27
8650634|NCT00635999|9692036|FG001|STARTED|Overall Study||25
8650635|NCT00635999|9692037|FG002|STARTED|Overall Study||24
8650636|NCT00635999|9692035|FG000|COMPLETED|Overall Study||23
8650637|NCT00635999|9692036|FG001|COMPLETED|Overall Study||23
8650638|NCT00635999|9692037|FG002|COMPLETED|Overall Study||23
8650639|NCT00635999|9692035|FG000|NOT COMPLETED|Overall Study||4
8650640|NCT00635999|9692036|FG001|NOT COMPLETED|Overall Study||2
8650641|NCT00635999|9692037|FG002|NOT COMPLETED|Overall Study||1
8650642|NCT00636077|9692045|FG000|STARTED|Week 1||3
8650643|NCT00636077|9692046|FG001|STARTED|Week 1||3
8650644|NCT00636077|9692047|FG002|STARTED|Week 1||3
8650645|NCT00636077|9692048|FG003|STARTED|Week 1||3
8650646|NCT00636077|9692045|FG000|COMPLETED|Week 1||3
8650647|NCT00636077|9692046|FG001|COMPLETED|Week 1||3
8650648|NCT00636077|9692047|FG002|COMPLETED|Week 1||3
8650649|NCT00636077|9692048|FG003|COMPLETED|Week 1||3
8650650|NCT00636077|9692045|FG000|NOT COMPLETED|Week 1||0
8650651|NCT00636077|9692046|FG001|NOT COMPLETED|Week 1||0
8650652|NCT00636077|9692047|FG002|NOT COMPLETED|Week 1||0
8650653|NCT00636077|9692048|FG003|NOT COMPLETED|Week 1||0
8650654|NCT00636077|9692045|FG000|STARTED|Week 2||3
8650655|NCT00636077|9692046|FG001|STARTED|Week 2||3
8650656|NCT00636077|9692047|FG002|STARTED|Week 2||3
8650657|NCT00636077|9692048|FG003|STARTED|Week 2||3
8650658|NCT00636077|9692045|FG000|COMPLETED|Week 2||3
8650659|NCT00636077|9692046|FG001|COMPLETED|Week 2||3
8650660|NCT00636077|9692047|FG002|COMPLETED|Week 2||3
8650661|NCT00636077|9692048|FG003|COMPLETED|Week 2||3
8650662|NCT00636077|9692045|FG000|NOT COMPLETED|Week 2||0
8650663|NCT00636077|9692046|FG001|NOT COMPLETED|Week 2||0
8650664|NCT00636077|9692047|FG002|NOT COMPLETED|Week 2||0
8650665|NCT00636077|9692048|FG003|NOT COMPLETED|Week 2||0
8650666|NCT00636077|9692045|FG000|STARTED|Week 3||3
8650667|NCT00636077|9692046|FG001|STARTED|Week 3||3
8650668|NCT00636077|9692047|FG002|STARTED|Week 3||3
8650669|NCT00636077|9692048|FG003|STARTED|Week 3||3
8650670|NCT00636077|9692045|FG000|COMPLETED|Week 3||3
8650671|NCT00636077|9692046|FG001|COMPLETED|Week 3||3
8650672|NCT00636077|9692047|FG002|COMPLETED|Week 3||3
8650673|NCT00636077|9692048|FG003|COMPLETED|Week 3||3
8650674|NCT00636077|9692045|FG000|NOT COMPLETED|Week 3||0
8650675|NCT00636077|9692046|FG001|NOT COMPLETED|Week 3||0
8650676|NCT00636077|9692047|FG002|NOT COMPLETED|Week 3||0
8650677|NCT00636077|9692048|FG003|NOT COMPLETED|Week 3||0
8650678|NCT00636077|9692045|FG000|STARTED|Week 4||3
8650679|NCT00636077|9692046|FG001|STARTED|Week 4||3
8650680|NCT00636077|9692047|FG002|STARTED|Week 4||3
8650681|NCT00636077|9692048|FG003|STARTED|Week 4||3
8650682|NCT00636077|9692045|FG000|COMPLETED|Week 4||3
8650683|NCT00636077|9692046|FG001|COMPLETED|Week 4||3
8650684|NCT00636077|9692047|FG002|COMPLETED|Week 4||3
8650685|NCT00636077|9692048|FG003|COMPLETED|Week 4||3
8650686|NCT00636077|9692045|FG000|NOT COMPLETED|Week 4||0
8650687|NCT00636077|9692046|FG001|NOT COMPLETED|Week 4||0
8650688|NCT00636077|9692047|FG002|NOT COMPLETED|Week 4||0
8650689|NCT00636077|9692048|FG003|NOT COMPLETED|Week 4||0
8650690|NCT00636155|9692058|FG000|STARTED|Overall Study||20
8650691|NCT00636155|9692058|FG000|COMPLETED|Overall Study|Completed maximum 6 cycles of treatment|2
8650692|NCT00636155|9692058|FG000|NOT COMPLETED|Overall Study||18
8650693|NCT00636168|9692064|FG000|STARTED|Randomized to Study Drug||475
8650694|NCT00636168|9692065|FG001|STARTED|Randomized to Study Drug||476
8650695|NCT00636168|9692064|FG000|COMPLETED|Randomized to Study Drug||471
8650696|NCT00636168|9692065|FG001|COMPLETED|Randomized to Study Drug||474
8650697|NCT00636168|9692064|FG000|NOT COMPLETED|Randomized to Study Drug||4
8650698|NCT00636168|9692065|FG001|NOT COMPLETED|Randomized to Study Drug||2
8650699|NCT00636168|9692064|FG000|STARTED|Treated With Study Drug||471
8650700|NCT00636168|9692065|FG001|STARTED|Treated With Study Drug||474
8650701|NCT00636168|9692064|FG000|COMPLETED|Treated With Study Drug||63
8650702|NCT00636168|9692065|FG001|COMPLETED|Treated With Study Drug||143
8650703|NCT00636168|9692064|FG000|NOT COMPLETED|Treated With Study Drug||408
8650704|NCT00636168|9692065|FG001|NOT COMPLETED|Treated With Study Drug||331
8650705|NCT00636168|9692064|FG000|STARTED|Long Term Follow-Up||141
8650706|NCT00636168|9692065|FG001|STARTED|Long Term Follow-Up||143
8650707|NCT00636168|9692064|FG000|COMPLETED|Long Term Follow-Up||130
8650708|NCT00636168|9692065|FG001|COMPLETED|Long Term Follow-Up||129
8650709|NCT00636168|9692064|FG000|NOT COMPLETED|Long Term Follow-Up||11
8650710|NCT00636168|9692065|FG001|NOT COMPLETED|Long Term Follow-Up||14
8650711|NCT00636181|9692074|FG000|STARTED|Overall Study||54
8650712|NCT00636181|9692075|FG001|STARTED|Overall Study||53
8650713|NCT00636181|9692076|FG002|STARTED|Overall Study||57
8650714|NCT00636181|9692074|FG000|COMPLETED|Overall Study||46
8650715|NCT00636181|9692075|FG001|COMPLETED|Overall Study||47
8650716|NCT00636181|9692076|FG002|COMPLETED|Overall Study||47
8650717|NCT00636181|9692074|FG000|NOT COMPLETED|Overall Study||8
8650718|NCT00636181|9692075|FG001|NOT COMPLETED|Overall Study||6
8650719|NCT00636181|9692076|FG002|NOT COMPLETED|Overall Study||10
8650720|NCT00636194|9692086|FG000|STARTED|Overall Study||175
8650721|NCT00636194|9692087|FG001|STARTED|Overall Study||175
8650722|NCT00636194|9692086|FG000|COMPLETED|Overall Study||172
8650723|NCT00636194|9692087|FG001|COMPLETED|Overall Study||175
8650724|NCT00636194|9692086|FG000|NOT COMPLETED|Overall Study||3
8650725|NCT00636194|9692087|FG001|NOT COMPLETED|Overall Study||0
8650726|NCT00636207|9692096|FG000|STARTED|Overall Study|One participant discontinued after completing Period 2. Doses in Periods 1 and 2 were Montelukast.|1
8650727|NCT00636207|9692097|FG001|STARTED|Overall Study|One participant withdrew consent after completing all study doses.|8
8650728|NCT00636207|9692098|FG002|STARTED|Overall Study||18
8650729|NCT00636207|9692099|FG003|STARTED|Overall Study||6
8650730|NCT00636207|9692100|FG004|STARTED|Overall Study|One participant withdrew consent after completing all study doses.|9
8650731|NCT00636207|9692101|FG005|STARTED|Overall Study||1
8650732|NCT00636207|9692102|FG006|STARTED|Overall Study||3
8650733|NCT00636207|9692096|FG000|COMPLETED|Overall Study||0
8650734|NCT00636207|9692097|FG001|COMPLETED|Overall Study||7
8650735|NCT00636207|9692098|FG002|COMPLETED|Overall Study||18
8650736|NCT00636207|9692099|FG003|COMPLETED|Overall Study||6
8650737|NCT00636207|9692100|FG004|COMPLETED|Overall Study||8
8650738|NCT00636207|9692101|FG005|COMPLETED|Overall Study||1
8650739|NCT00636207|9692102|FG006|COMPLETED|Overall Study||3
8650740|NCT00636207|9692096|FG000|NOT COMPLETED|Overall Study||1
8650741|NCT00636207|9692097|FG001|NOT COMPLETED|Overall Study||1
8650742|NCT00636207|9692098|FG002|NOT COMPLETED|Overall Study||0
8728265|NCT01047345|9775467|FG000|Vaccination 1|Base Study||615
8728266|NCT01047345|9775468|FG001|Vaccination 1|Base Study||306
8728267|NCT01047345|9775469|FG002|Vaccination 1|Base Study||0
8728268|NCT01047345|9775467|FG000|Vaccination 2|Base Study||604
8728269|NCT01047345|9775468|FG001|Vaccination 2|Base Study||304
8728270|NCT01047345|9775469|FG002|Vaccination 2|Base Study||0
8728271|NCT01047345|9775467|FG000|Vaccination 3|Base Study||597
8728272|NCT01047345|9775468|FG001|Vaccination 3|Base Study||300
8728273|NCT01047345|9775469|FG002|Vaccination 3|Base Study||0
8728274|NCT01047345|9775467|FG000|COMPLETED|Base Study|Includes 1 participant for whom completion status is unknown|596
8728275|NCT01047345|9775468|FG001|COMPLETED|Base Study||300
8728276|NCT01047345|9775469|FG002|COMPLETED|Base Study||0
8728277|NCT01047345|9775467|FG000|NOT COMPLETED|Base Study||22
8728278|NCT01047345|9775468|FG001|NOT COMPLETED|Base Study||6
8728279|NCT01047345|9775469|FG002|NOT COMPLETED|Base Study||0
8728280|NCT01047345|9775467|FG000|STARTED|Extension||0
8728281|NCT01047345|9775468|FG001|STARTED|Extension||0
8728282|NCT01047345|9775469|FG002|STARTED|Extension|Not all eligible participants elected to participate in extension|102
8728283|NCT01047345|9775467|FG000|Vaccination 4|Extension||0
8728284|NCT01047345|9775468|FG001|Vaccination 4|Extension||0
8728285|NCT01047345|9775469|FG002|Vaccination 4|Extension||102
8728286|NCT01047345|9775467|FG000|Vaccination 5|Extension||0
8728287|NCT01047345|9775468|FG001|Vaccination 5|Extension||0
8728288|NCT01047345|9775469|FG002|Vaccination 5|Extension||99
8728289|NCT01047345|9775467|FG000|Vaccination 6|Extension||0
8728290|NCT01047345|9775468|FG001|Vaccination 6|Extension||0
8728291|NCT01047345|9775469|FG002|Vaccination 6|Extension|1 participant received 6th vaccination outside the context of study but completed the study.|95
8728292|NCT01047345|9775467|FG000|COMPLETED|Extension||0
8728293|NCT01047345|9775468|FG001|COMPLETED|Extension||0
8728294|NCT01047345|9775469|FG002|COMPLETED|Extension||96
8728295|NCT01047345|9775467|FG000|NOT COMPLETED|Extension||0
8728296|NCT01047345|9775468|FG001|NOT COMPLETED|Extension||0
8728297|NCT01047345|9775469|FG002|NOT COMPLETED|Extension||6
8728298|NCT01047358|9775477|FG000|STARTED|Overall Study||206
8728299|NCT01047358|9775477|FG000|COMPLETED|Overall Study|At least one safety assessment (Safety Population)|206
8728300|NCT01047358|9775477|FG000|NOT COMPLETED|Overall Study||0
8728301|NCT01047436|9775484|FG000|STARTED|Overall Study||16
8728302|NCT01047436|9775485|FG001|STARTED|Overall Study||15
8728303|NCT01047436|9775484|FG000|COMPLETED|Overall Study||15
8728304|NCT01047436|9775485|FG001|COMPLETED|Overall Study||15
8728305|NCT01047436|9775484|FG000|NOT COMPLETED|Overall Study||1
8728306|NCT01047436|9775485|FG001|NOT COMPLETED|Overall Study||0
8728307|NCT01047475|9775493|FG000|STARTED|Overall Study||34
8728308|NCT01047475|9775494|FG001|STARTED|Overall Study||38
8728309|NCT01047475|9775493|FG000|COMPLETED|Overall Study||29
8728310|NCT01047475|9775494|FG001|COMPLETED|Overall Study||31
8728311|NCT01047475|9775493|FG000|NOT COMPLETED|Overall Study||5
8728312|NCT01047475|9775494|FG001|NOT COMPLETED|Overall Study||7
8728313|NCT01047527|9775503|FG000|STARTED|Overall Study||180
8728314|NCT01047527|9775504|FG001|STARTED|Overall Study||173
8728315|NCT01047527|9775505|FG002|STARTED|Overall Study||172
8728316|NCT01047527|9775503|FG000|8 Weeks|Overall Study||148
8728317|NCT01047527|9775504|FG001|8 Weeks|Overall Study||142
8728318|NCT01047527|9775505|FG002|8 Weeks|Overall Study||138
8728319|NCT01047527|9775503|FG000|24 Weeks|Overall Study||111
8728320|NCT01047527|9775504|FG001|24 Weeks|Overall Study||123
8728321|NCT01047527|9775505|FG002|24 Weeks|Overall Study||119
8728322|NCT01047527|9775503|FG000|COMPLETED|Overall Study||95
8728323|NCT01047527|9775504|FG001|COMPLETED|Overall Study||112
8728324|NCT01047527|9775505|FG002|COMPLETED|Overall Study||107
8728325|NCT01047527|9775503|FG000|NOT COMPLETED|Overall Study||85
8728326|NCT01047527|9775504|FG001|NOT COMPLETED|Overall Study||61
8650743|NCT00636207|9692099|FG003|NOT COMPLETED|Overall Study||0
8650744|NCT00636207|9692100|FG004|NOT COMPLETED|Overall Study||1
8650745|NCT00636207|9692101|FG005|NOT COMPLETED|Overall Study||0
8650746|NCT00636207|9692102|FG006|NOT COMPLETED|Overall Study||0
8650747|NCT00636220|9692123|FG000|STARTED|Overall Study||101
8650748|NCT00636220|9692123|FG000|COMPLETED|Overall Study||101
8650749|NCT00636220|9692123|FG000|NOT COMPLETED|Overall Study||0
8650750|NCT00636363|9692130|FG000|STARTED|Overall Study||178
8650751|NCT00636363|9692131|FG001|STARTED|Overall Study||176
8650752|NCT00636363|9692132|FG002|STARTED|Overall Study||181
8650753|NCT00636363|9692130|FG000|COMPLETED|Overall Study||165
8728327|NCT01047527|9775505|FG002|NOT COMPLETED|Overall Study||65
8650754|NCT00636363|9692131|FG001|COMPLETED|Overall Study||156
8650755|NCT00636363|9692132|FG002|COMPLETED|Overall Study||163
8650756|NCT00636363|9692130|FG000|NOT COMPLETED|Overall Study||13
8728328|NCT01047553|9775516|FG000|STARTED|Overall Study||125
8728329|NCT01047553|9775517|FG001|STARTED|Overall Study||126
8728330|NCT01047553|9775516|FG000|COMPLETED|Overall Study||108
8728331|NCT01047553|9775517|FG001|COMPLETED|Overall Study||117
8650757|NCT00636363|9692131|FG001|NOT COMPLETED|Overall Study||20
8650758|NCT00636363|9692132|FG002|NOT COMPLETED|Overall Study||18
8650759|NCT00636389|9692140|FG000|STARTED|Period 1 - 1 Week||7
8650760|NCT00636389|9692141|FG001|STARTED|Period 1 - 1 Week||5
8650761|NCT00636389|9692140|FG000|COMPLETED|Period 1 - 1 Week||7
8650762|NCT00636389|9692141|FG001|COMPLETED|Period 1 - 1 Week||5
8650763|NCT00636389|9692140|FG000|NOT COMPLETED|Period 1 - 1 Week||0
8650764|NCT00636389|9692141|FG001|NOT COMPLETED|Period 1 - 1 Week||0
8650765|NCT00636389|9692140|FG000|STARTED|Period 2 - 1 Week||7
8650766|NCT00636389|9692141|FG001|STARTED|Period 2 - 1 Week||5
8650767|NCT00636389|9692140|FG000|COMPLETED|Period 2 - 1 Week||7
8650768|NCT00636389|9692141|FG001|COMPLETED|Period 2 - 1 Week||5
8650769|NCT00636389|9692140|FG000|NOT COMPLETED|Period 2 - 1 Week||0
8650770|NCT00636389|9692141|FG001|NOT COMPLETED|Period 2 - 1 Week||0
8728332|NCT01047553|9775516|FG000|NOT COMPLETED|Overall Study||17
8728333|NCT01047553|9775517|FG001|NOT COMPLETED|Overall Study||9
8728334|NCT01047709|9775523|FG000|STARTED|Positional Therapy (1 Night)||9
8728335|NCT01047709|9775524|FG001|STARTED|Positional Therapy (1 Night)||9
8728336|NCT01047709|9775523|FG000|COMPLETED|Positional Therapy (1 Night)||9
8728337|NCT01047709|9775524|FG001|COMPLETED|Positional Therapy (1 Night)||9
8728338|NCT01047709|9775523|FG000|NOT COMPLETED|Positional Therapy (1 Night)||0
8728339|NCT01047709|9775524|FG001|NOT COMPLETED|Positional Therapy (1 Night)||0
8728340|NCT01047709|9775523|FG000|STARTED|Control/Positioning ad Lib (1 Night)||9
8728341|NCT01047709|9775524|FG001|STARTED|Control/Positioning ad Lib (1 Night)||9
8728342|NCT01047709|9775523|FG000|COMPLETED|Control/Positioning ad Lib (1 Night)||9
8728343|NCT01047709|9775524|FG001|COMPLETED|Control/Positioning ad Lib (1 Night)||9
8728344|NCT01047709|9775523|FG000|NOT COMPLETED|Control/Positioning ad Lib (1 Night)||0
8728345|NCT01047709|9775524|FG001|NOT COMPLETED|Control/Positioning ad Lib (1 Night)||0
8728346|NCT01047839|9775533|FG000|STARTED|Overall Study||12
8728347|NCT01047839|9775534|FG001|STARTED|Overall Study||29
8728348|NCT01047839|9775535|FG002|STARTED|Overall Study||59
8728349|NCT01047839|9775533|FG000|COMPLETED|Overall Study||10
8728350|NCT01047839|9775534|FG001|COMPLETED|Overall Study||29
8728351|NCT01047839|9775535|FG002|COMPLETED|Overall Study||53
8728352|NCT01047839|9775533|FG000|NOT COMPLETED|Overall Study||2
8728353|NCT01047839|9775534|FG001|NOT COMPLETED|Overall Study||0
8728354|NCT01047839|9775535|FG002|NOT COMPLETED|Overall Study||6
8728355|NCT01048099|9775550|FG000|STARTED|Patients Enrolled and Blood Collected|Patients enrolled|283
8728356|NCT01048099|9775550|FG000|COMPLETED|Patients Enrolled and Blood Collected|Patients with circulating tumor cells (CTCs)|226
8728357|NCT01048099|9775550|FG000|NOT COMPLETED|Patients Enrolled and Blood Collected||57
8728358|NCT01048099|9775550|FG000|STARTED|Patients Evaluated by PRO Onc Assay|Patients with CTCs who were evaluated by PRO Onc Assay|226
8728359|NCT01048099|9775550|FG000|COMPLETED|Patients Evaluated by PRO Onc Assay|Patients evaluated by PRO Onc Assay with HER2 overexpression/activation detected|24
8728360|NCT01048099|9775550|FG000|NOT COMPLETED|Patients Evaluated by PRO Onc Assay||202
8728361|NCT01048099|9775550|FG000|STARTED|Pts w/ HER2 Overexpression/Activation|Patients with detected HER2 activation and/or overexpression|24
8728362|NCT01048099|9775550|FG000|COMPLETED|Pts w/ HER2 Overexpression/Activation|Patients who proceeded to treatment|14
8728363|NCT01048099|9775550|FG000|NOT COMPLETED|Pts w/ HER2 Overexpression/Activation||10
8728364|NCT01048099|9775550|FG000|STARTED|Treatment Per Protocol||14
8728365|NCT01048099|9775550|FG000|COMPLETED|Treatment Per Protocol|Patients continued treatment until disease progression or coming off-study for any other reason|0
8728366|NCT01048099|9775550|FG000|NOT COMPLETED|Treatment Per Protocol||14
8728367|NCT01048242|9775558|FG000|STARTED|Overall Study||12
8728368|NCT01048242|9775559|FG001|STARTED|Overall Study||15
8728369|NCT01048242|9775558|FG000|COMPLETED|Overall Study||8
8728370|NCT01048242|9775559|FG001|COMPLETED|Overall Study||13
8728371|NCT01048242|9775558|FG000|NOT COMPLETED|Overall Study||4
8728372|NCT01048242|9775559|FG001|NOT COMPLETED|Overall Study||2
8728373|NCT01048333|9775565|FG000|STARTED|Treatment Period 1||21
8728374|NCT01048333|9775566|FG001|STARTED|Treatment Period 1||19
8728375|NCT01048333|9775567|FG002|STARTED|Treatment Period 1||16
8728376|NCT01048333|9775568|FG003|STARTED|Treatment Period 1||18
8728377|NCT01048333|9775569|FG004|STARTED|Treatment Period 1||17
8728378|NCT01048333|9775570|FG005|STARTED|Treatment Period 1||18
8728379|NCT01048333|9775565|FG000|COMPLETED|Treatment Period 1||21
8728380|NCT01048333|9775566|FG001|COMPLETED|Treatment Period 1||19
8728381|NCT01048333|9775567|FG002|COMPLETED|Treatment Period 1||16
8728382|NCT01048333|9775568|FG003|COMPLETED|Treatment Period 1||18
8728383|NCT01048333|9775569|FG004|COMPLETED|Treatment Period 1||17
8728384|NCT01048333|9775570|FG005|COMPLETED|Treatment Period 1||18
8728385|NCT01048333|9775565|FG000|NOT COMPLETED|Treatment Period 1||0
8728386|NCT01048333|9775566|FG001|NOT COMPLETED|Treatment Period 1||0
8728387|NCT01048333|9775567|FG002|NOT COMPLETED|Treatment Period 1||0
8728388|NCT01048333|9775568|FG003|NOT COMPLETED|Treatment Period 1||0
8728389|NCT01048333|9775569|FG004|NOT COMPLETED|Treatment Period 1||0
8728390|NCT01048333|9775570|FG005|NOT COMPLETED|Treatment Period 1||0
8728391|NCT01048333|9775565|FG000|STARTED|Wash-Out Period 1 of 2 - 7 Days||21
8728392|NCT01048333|9775566|FG001|STARTED|Wash-Out Period 1 of 2 - 7 Days||19
8728393|NCT01048333|9775567|FG002|STARTED|Wash-Out Period 1 of 2 - 7 Days||16
8728394|NCT01048333|9775568|FG003|STARTED|Wash-Out Period 1 of 2 - 7 Days||18
8728395|NCT01048333|9775569|FG004|STARTED|Wash-Out Period 1 of 2 - 7 Days||17
8728396|NCT01048333|9775570|FG005|STARTED|Wash-Out Period 1 of 2 - 7 Days||18
8728397|NCT01048333|9775565|FG000|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||21
8650771|NCT00636441|9692154|FG000|STARTED|Overall Study||6
8650772|NCT00636441|9692155|FG001|STARTED|Overall Study||7
8650773|NCT00636441|9692156|FG002|STARTED|Overall Study||6
8650774|NCT00636441|9692157|FG003|STARTED|Overall Study||6
8650775|NCT00636441|9692158|FG004|STARTED|Overall Study||6
8650776|NCT00636441|9692159|FG005|STARTED|Overall Study||7
8650777|NCT00636441|9692160|FG006|STARTED|Overall Study||18
8650778|NCT00636441|9692154|FG000|Assigned Treatment|Overall Study||6
8650779|NCT00636441|9692155|FG001|Assigned Treatment|Overall Study||7
8650780|NCT00636441|9692156|FG002|Assigned Treatment|Overall Study||6
8650781|NCT00636441|9692157|FG003|Assigned Treatment|Overall Study||6
8650782|NCT00636441|9692158|FG004|Assigned Treatment|Overall Study||6
8650783|NCT00636441|9692159|FG005|Assigned Treatment|Overall Study||7
8650784|NCT00636441|9692160|FG006|Assigned Treatment|Overall Study|This is a late determined ineligibility.|1
8650785|NCT00636441|9692154|FG000|COMPLETED|Overall Study||6
8650786|NCT00636441|9692155|FG001|COMPLETED|Overall Study||6
8650787|NCT00636441|9692156|FG002|COMPLETED|Overall Study||5
8650788|NCT00636441|9692157|FG003|COMPLETED|Overall Study||6
8650789|NCT00636441|9692158|FG004|COMPLETED|Overall Study||6
8650790|NCT00636441|9692159|FG005|COMPLETED|Overall Study||6
8650791|NCT00636441|9692160|FG006|COMPLETED|Overall Study||0
8650792|NCT00636441|9692154|FG000|NOT COMPLETED|Overall Study||0
8650793|NCT00636441|9692155|FG001|NOT COMPLETED|Overall Study||1
8650794|NCT00636441|9692156|FG002|NOT COMPLETED|Overall Study||1
8650795|NCT00636441|9692157|FG003|NOT COMPLETED|Overall Study||0
8650796|NCT00636441|9692158|FG004|NOT COMPLETED|Overall Study||0
8650797|NCT00636441|9692159|FG005|NOT COMPLETED|Overall Study||1
8650798|NCT00636441|9692160|FG006|NOT COMPLETED|Overall Study||18
8650799|NCT00636506|9692171|FG000|STARTED|Overall Study||76
8650800|NCT00636506|9692171|FG000|COMPLETED|Overall Study||60
8650801|NCT00636506|9692171|FG000|NOT COMPLETED|Overall Study||16
8650802|NCT00636610|9692195|FG000|STARTED|Overall Study||98
8650803|NCT00636610|9692196|FG001|STARTED|Overall Study||101
8650804|NCT00636610|9692195|FG000|COMPLETED|Overall Study||6
8650805|NCT00636610|9692196|FG001|COMPLETED|Overall Study||18
8650806|NCT00636610|9692195|FG000|NOT COMPLETED|Overall Study||92
8650807|NCT00636610|9692196|FG001|NOT COMPLETED|Overall Study||83
8650808|NCT00636636|9692206|FG000|STARTED|Overall Study||221
8650809|NCT00636636|9692207|FG001|STARTED|Overall Study||231
8650810|NCT00636636|9692206|FG000|Safety & Efficacy of Gabapentin ER|Overall Study||186
8650811|NCT00636636|9692207|FG001|Safety & Efficacy of Gabapentin ER|Overall Study|1 patient randomized twice, not included in ITT, but completed medication and counted as completer|194
8650812|NCT00636636|9692206|FG000|379|Overall Study||186
8650813|NCT00636636|9692207|FG001|379|Overall Study|1 patient randomized twice, not included in ITT, but completed medication and counted as completer|194
8650814|NCT00636636|9692206|FG000|COMPLETED|Overall Study||185
8650815|NCT00636636|9692207|FG001|COMPLETED|Overall Study||192
8650816|NCT00636636|9692206|FG000|NOT COMPLETED|Overall Study||36
8650817|NCT00636636|9692207|FG001|NOT COMPLETED|Overall Study||39
8650818|NCT00636649|9692215|FG000|STARTED|Overall Study||20
8650819|NCT00636649|9692216|FG001|STARTED|Overall Study||20
8650820|NCT00636649|9692215|FG000|COMPLETED|Overall Study||20
8650821|NCT00636649|9692216|FG001|COMPLETED|Overall Study||20
8650822|NCT00636649|9692215|FG000|NOT COMPLETED|Overall Study||0
8650823|NCT00636649|9692216|FG001|NOT COMPLETED|Overall Study||0
8650824|NCT00636675|9692228|FG000|STARTED|Overall Study||951
8650825|NCT00636675|9692229|FG001|STARTED|Overall Study||775
8650826|NCT00636675|9692228|FG000|COMPLETED|Overall Study||811
8650827|NCT00636675|9692229|FG001|COMPLETED|Overall Study||734
8650828|NCT00636675|9692228|FG000|NOT COMPLETED|Overall Study||140
8650829|NCT00636675|9692229|FG001|NOT COMPLETED|Overall Study||41
8650830|NCT00636701|9692237|FG000|STARTED|Overall Study||2
8650831|NCT00636701|9692238|FG001|STARTED|Overall Study||2
8650832|NCT00636701|9692237|FG000|COMPLETED|Overall Study||2
8650833|NCT00636701|9692238|FG001|COMPLETED|Overall Study||2
8650834|NCT00636701|9692237|FG000|NOT COMPLETED|Overall Study||0
8650835|NCT00636701|9692238|FG001|NOT COMPLETED|Overall Study||0
8650836|NCT00636792|9692244|FG000|STARTED|Overall Study||73
8650837|NCT00636792|9692244|FG000|COMPLETED|Overall Study||40
8650838|NCT00636792|9692244|FG000|NOT COMPLETED|Overall Study||33
8650839|NCT00636805|9692248|FG000|STARTED|Overall Study||63
8650840|NCT00636805|9692248|FG000|COMPLETED|Overall Study||63
8650841|NCT00636805|9692248|FG000|NOT COMPLETED|Overall Study||0
8650842|NCT00636818|9692252|FG000|STARTED|Overall Study||45
8650843|NCT00636818|9692252|FG000|Received at Least One Dose of Study Drug|Overall Study|One patient was lost to follow up and did not receive any study drug.|44
8650844|NCT00636818|9692252|FG000|COMPLETED|Overall Study||34
8650845|NCT00636818|9692252|FG000|NOT COMPLETED|Overall Study||11
8650846|NCT00636961|9692258|FG000|STARTED|Period 1||14
8650847|NCT00636961|9692259|FG001|STARTED|Period 1||13
8650848|NCT00636961|9692258|FG000|COMPLETED|Period 1||13
8650849|NCT00636961|9692259|FG001|COMPLETED|Period 1||12
8650850|NCT00636961|9692258|FG000|NOT COMPLETED|Period 1||1
8650851|NCT00636961|9692259|FG001|NOT COMPLETED|Period 1||1
8650852|NCT00636961|9692258|FG000|STARTED|Period 2||13
8650853|NCT00636961|9692259|FG001|STARTED|Period 2||12
8650854|NCT00636961|9692258|FG000|COMPLETED|Period 2||12
8650855|NCT00636961|9692259|FG001|COMPLETED|Period 2||12
8650856|NCT00636961|9692258|FG000|NOT COMPLETED|Period 2||1
8650857|NCT00636961|9692259|FG001|NOT COMPLETED|Period 2||0
8650858|NCT00636987|9692265|FG000|STARTED|Overall Study||297
8650859|NCT00636987|9692265|FG000|COMPLETED|Overall Study||108
8650860|NCT00636987|9692265|FG000|NOT COMPLETED|Overall Study||189
8650861|NCT00637000|9692275|FG000|STARTED|Overall Study|Randomized and treated|20
8650862|NCT00637000|9692276|FG001|STARTED|Overall Study|Randomized and treated|18
8650863|NCT00637000|9692275|FG000|Evaluable|Overall Study||18
8650864|NCT00637000|9692276|FG001|Evaluable|Overall Study||16
8650865|NCT00637000|9692275|FG000|COMPLETED|Overall Study||16
8650866|NCT00637000|9692276|FG001|COMPLETED|Overall Study||15
8650867|NCT00637000|9692275|FG000|NOT COMPLETED|Overall Study||4
8650868|NCT00637000|9692276|FG001|NOT COMPLETED|Overall Study||3
8650869|NCT00637156|9692284|FG000|STARTED|Overall Study||209
8650870|NCT00637156|9692285|FG001|STARTED|Overall Study||188
8650871|NCT00637156|9692284|FG000|COMPLETED|Overall Study||199
8650872|NCT00637156|9692285|FG001|COMPLETED|Overall Study||164
8650873|NCT00637156|9692284|FG000|NOT COMPLETED|Overall Study||10
8650874|NCT00637156|9692285|FG001|NOT COMPLETED|Overall Study||24
8650875|NCT00637195|9692293|FG000|STARTED|Overall Study||76
8650876|NCT00637195|9692294|FG001|STARTED|Overall Study||76
8650877|NCT00637195|9692293|FG000|COMPLETED|Overall Study||73
8650878|NCT00637195|9692294|FG001|COMPLETED|Overall Study||75
8650879|NCT00637195|9692293|FG000|NOT COMPLETED|Overall Study||3
8650880|NCT00637195|9692294|FG001|NOT COMPLETED|Overall Study||1
8650881|NCT00637247|9692302|FG000|STARTED|Overall Study||72
8650882|NCT00637247|9692303|FG001|STARTED|Overall Study||70
8650883|NCT00637247|9692302|FG000|COMPLETED|Overall Study||72
8650884|NCT00637247|9692303|FG001|COMPLETED|Overall Study||70
8650885|NCT00637247|9692302|FG000|NOT COMPLETED|Overall Study||0
8650886|NCT00637247|9692303|FG001|NOT COMPLETED|Overall Study||0
8650887|NCT00637273|9692314|FG000|STARTED|Overall Study||170
8650888|NCT00637273|9692315|FG001|STARTED|Overall Study||172
8650889|NCT00637273|9692316|FG002|STARTED|Overall Study||172
8650890|NCT00637273|9692314|FG000|Intent to Treat (ITT)|Overall Study||160
8650891|NCT00637273|9692315|FG001|Intent to Treat (ITT)|Overall Study||166
8650892|NCT00637273|9692316|FG002|Intent to Treat (ITT)|Overall Study||165
8650893|NCT00637273|9692314|FG000|COMPLETED|Overall Study||127
8650894|NCT00637273|9692315|FG001|COMPLETED|Overall Study||144
8650895|NCT00637273|9692316|FG002|COMPLETED|Overall Study||131
8650896|NCT00637273|9692314|FG000|NOT COMPLETED|Overall Study||43
8650897|NCT00637273|9692315|FG001|NOT COMPLETED|Overall Study||28
8650898|NCT00637273|9692316|FG002|NOT COMPLETED|Overall Study||41
8650899|NCT00637299|9692326|FG000|STARTED|Overall Study||10
8650900|NCT00637299|9692327|FG001|STARTED|Overall Study||10
8650901|NCT00637299|9692326|FG000|COMPLETED|Overall Study||10
8650902|NCT00637299|9692327|FG001|COMPLETED|Overall Study||10
8650903|NCT00637299|9692326|FG000|NOT COMPLETED|Overall Study||0
8650904|NCT00637299|9692327|FG001|NOT COMPLETED|Overall Study||0
8650905|NCT00637377|9692337|FG000|STARTED|Overall Study||303
8650906|NCT00637377|9692338|FG001|STARTED|Overall Study||313
8650907|NCT00637377|9692339|FG002|STARTED|Overall Study||311
8650908|NCT00637377|9692340|FG003|STARTED|Overall Study||313
8650909|NCT00637377|9692337|FG000|Participants Received Treatment|Overall Study|safety population|291
8650910|NCT00637377|9692338|FG001|Participants Received Treatment|Overall Study|safety population|309
8650911|NCT00637377|9692339|FG002|Participants Received Treatment|Overall Study|safety population|297
8650912|NCT00637377|9692340|FG003|Participants Received Treatment|Overall Study|safety population|307
8650913|NCT00637377|9692337|FG000|Participants Treated (FAS)|Overall Study||291
8650914|NCT00637377|9692338|FG001|Participants Treated (FAS)|Overall Study||309
8650915|NCT00637377|9692339|FG002|Participants Treated (FAS)|Overall Study||296
8650916|NCT00637377|9692340|FG003|Participants Treated (FAS)|Overall Study||306
8650917|NCT00637377|9692337|FG000|COMPLETED|Overall Study||276
8650918|NCT00637377|9692338|FG001|COMPLETED|Overall Study||281
8650919|NCT00637377|9692339|FG002|COMPLETED|Overall Study||274
8650920|NCT00637377|9692340|FG003|COMPLETED|Overall Study||284
8650921|NCT00637377|9692337|FG000|NOT COMPLETED|Overall Study||27
8650922|NCT00637377|9692338|FG001|NOT COMPLETED|Overall Study||32
8650923|NCT00637377|9692339|FG002|NOT COMPLETED|Overall Study||37
8650924|NCT00637377|9692340|FG003|NOT COMPLETED|Overall Study||29
8650925|NCT00637494|9692352|FG000|STARTED|Overall Study||141
8650926|NCT00637494|9692353|FG001|STARTED|Overall Study||151
8650927|NCT00637494|9692352|FG000|COMPLETED|Overall Study||109
8650928|NCT00637494|9692353|FG001|COMPLETED|Overall Study||108
8650929|NCT00637494|9692352|FG000|NOT COMPLETED|Overall Study||32
8650930|NCT00637494|9692353|FG001|NOT COMPLETED|Overall Study||43
8650931|NCT00637572|9692361|FG000|STARTED|Overall Study||32
8650932|NCT00637572|9692362|FG001|STARTED|Overall Study||31
8650933|NCT00637572|9692361|FG000|COMPLETED|Overall Study||29
8650934|NCT00637572|9692362|FG001|COMPLETED|Overall Study||24
8650935|NCT00637572|9692361|FG000|NOT COMPLETED|Overall Study||3
8650936|NCT00637572|9692362|FG001|NOT COMPLETED|Overall Study||7
8650937|NCT00637780|9692368|FG000|STARTED|Overall Study||2
8650938|NCT00637780|9692368|FG000|COMPLETED|Overall Study||2
8650939|NCT00637780|9692368|FG000|NOT COMPLETED|Overall Study||0
8650940|NCT00637923|9692374|FG000|STARTED|Overall Study||75
8650941|NCT00637923|9692375|FG001|STARTED|Overall Study||37
8650942|NCT00637923|9692374|FG000|COMPLETED|Overall Study||45
8650943|NCT00637923|9692375|FG001|COMPLETED|Overall Study||18
8650944|NCT00637923|9692374|FG000|NOT COMPLETED|Overall Study||30
8650945|NCT00637923|9692375|FG001|NOT COMPLETED|Overall Study||19
8650946|NCT00638014|9692383|FG000|STARTED|Overall Study||23
8650947|NCT00638014|9692384|FG001|STARTED|Overall Study||28
8650948|NCT00638014|9692383|FG000|COMPLETED|Overall Study||23
8650949|NCT00638014|9692384|FG001|COMPLETED|Overall Study||28
8650950|NCT00638014|9692383|FG000|NOT COMPLETED|Overall Study||0
8650951|NCT00638014|9692384|FG001|NOT COMPLETED|Overall Study||0
8650952|NCT00638027|9692392|FG000|STARTED|Overall Study||11
8650953|NCT00638027|9692393|FG001|STARTED|Overall Study||10
8650954|NCT00638027|9692392|FG000|COMPLETED|Overall Study||11
8650955|NCT00638027|9692393|FG001|COMPLETED|Overall Study|all 10 included in analyses|8
8650956|NCT00638027|9692392|FG000|NOT COMPLETED|Overall Study||0
8650957|NCT00638027|9692393|FG001|NOT COMPLETED|Overall Study||2
8650958|NCT00638157|9692401|FG000|STARTED|Overall Study||12
8650959|NCT00638157|9692402|FG001|STARTED|Overall Study||12
8650960|NCT00638157|9692401|FG000|Treated|Overall Study||10
8650961|NCT00638157|9692402|FG001|Treated|Overall Study||12
8650962|NCT00638157|9692401|FG000|COMPLETED|Overall Study|4 subjects completed study drug in this arm|5
8650963|NCT00638157|9692402|FG001|COMPLETED|Overall Study|4 subjects completed study drug in this arm|8
8650964|NCT00638157|9692401|FG000|NOT COMPLETED|Overall Study||7
8650965|NCT00638157|9692402|FG001|NOT COMPLETED|Overall Study||4
8650966|NCT00638183|9692409|FG000|STARTED|Overall Study||385
8650967|NCT00638183|9692409|FG000|COMPLETED|Overall Study||266
8650968|NCT00638183|9692409|FG000|NOT COMPLETED|Overall Study||119
8650969|NCT00638235|9692422|FG000|STARTED|Overall Study||141
8650970|NCT00638235|9692423|FG001|STARTED|Overall Study||26
8650971|NCT00638235|9692424|FG002|STARTED|Overall Study||81
8650972|NCT00638235|9692425|FG003|STARTED|Overall Study||56
8650973|NCT00638235|9692426|FG004|STARTED|Overall Study||55
8650974|NCT00638235|9692427|FG005|STARTED|Overall Study||139
8650975|NCT00638235|9692428|FG006|STARTED|Overall Study||23
8650976|NCT00638235|9692429|FG007|STARTED|Overall Study||35
8650977|NCT00638235|9692430|FG008|STARTED|Overall Study||142
8650978|NCT00638235|9692422|FG000|COMPLETED|Overall Study||110
8650979|NCT00638235|9692423|FG001|COMPLETED|Overall Study||23
8650980|NCT00638235|9692424|FG002|COMPLETED|Overall Study|Ph-II ended before all subjects had 24M b/c Perigee next generation was already under trial P-III/IV|63
8650981|NCT00638235|9692425|FG003|COMPLETED|Overall Study||46
8650982|NCT00638235|9692426|FG004|COMPLETED|Overall Study||42
8650983|NCT00638235|9692427|FG005|COMPLETED|Overall Study||113
8650984|NCT00638235|9692428|FG006|COMPLETED|Overall Study||23
8650985|NCT00638235|9692429|FG007|COMPLETED|Overall Study|Ph-VI ended after 12M b/c next generation of Elevate Anterior was already under trial in Phase VII|34
8650986|NCT00638235|9692430|FG008|COMPLETED|Overall Study||124
8650987|NCT00638235|9692422|FG000|NOT COMPLETED|Overall Study||31
8650988|NCT00638235|9692423|FG001|NOT COMPLETED|Overall Study||3
8650989|NCT00638235|9692424|FG002|NOT COMPLETED|Overall Study||18
8650990|NCT00638235|9692425|FG003|NOT COMPLETED|Overall Study||10
8650991|NCT00638235|9692426|FG004|NOT COMPLETED|Overall Study||13
8650992|NCT00638235|9692427|FG005|NOT COMPLETED|Overall Study||26
8650993|NCT00638235|9692428|FG006|NOT COMPLETED|Overall Study||0
8650994|NCT00638235|9692429|FG007|NOT COMPLETED|Overall Study||1
8650995|NCT00638235|9692430|FG008|NOT COMPLETED|Overall Study||18
8650996|NCT00638274|9692459|FG000|STARTED|Overall Study||179
8650997|NCT00638274|9692460|FG001|STARTED|Overall Study||177
8650998|NCT00638274|9692459|FG000|COMPLETED|Overall Study||173
8650999|NCT00638274|9692460|FG001|COMPLETED|Overall Study||172
8651000|NCT00638274|9692459|FG000|NOT COMPLETED|Overall Study||6
8651001|NCT00638274|9692460|FG001|NOT COMPLETED|Overall Study||5
8651002|NCT00638365|9692469|FG000|STARTED|Overall Study||9
8651003|NCT00638365|9692470|FG001|STARTED|Overall Study||10
8651004|NCT00638365|9692471|FG002|STARTED|Overall Study||8
8651005|NCT00638365|9692469|FG000|COMPLETED|Overall Study||9
8651006|NCT00638365|9692470|FG001|COMPLETED|Overall Study||10
8651007|NCT00638365|9692471|FG002|COMPLETED|Overall Study||8
8651008|NCT00638365|9692469|FG000|NOT COMPLETED|Overall Study||0
8651009|NCT00638365|9692470|FG001|NOT COMPLETED|Overall Study||0
8651010|NCT00638365|9692471|FG002|NOT COMPLETED|Overall Study||0
8651011|NCT00638378|9692479|FG000|STARTED|Overall Study||22
8651012|NCT00638378|9692479|FG000|COMPLETED|Overall Study||0
8651013|NCT00638378|9692479|FG000|NOT COMPLETED|Overall Study||22
8651014|NCT00638404|9692485|FG000|STARTED|Overall Study||200
8651015|NCT00638404|9692486|FG001|STARTED|Overall Study||100
8651016|NCT00638404|9692485|FG000|COMPLETED|Overall Study||192
8651017|NCT00638404|9692486|FG001|COMPLETED|Overall Study||100
8651018|NCT00638404|9692485|FG000|NOT COMPLETED|Overall Study||8
8651019|NCT00638404|9692486|FG001|NOT COMPLETED|Overall Study||0
8651020|NCT00638443|9692496|FG000|STARTED|First Intervention||14
8651021|NCT00638443|9692497|FG001|STARTED|First Intervention||15
8651022|NCT00638443|9692496|FG000|COMPLETED|First Intervention||12
8651023|NCT00638443|9692497|FG001|COMPLETED|First Intervention||14
8651024|NCT00638443|9692496|FG000|NOT COMPLETED|First Intervention||2
8651025|NCT00638443|9692497|FG001|NOT COMPLETED|First Intervention||1
8911225|NCT02144285|9970256|FG008|NOT COMPLETED|Overall Study||0
8911226|NCT02144285|9970257|FG009|NOT COMPLETED|Overall Study||0
8911227|NCT02144337|9970295|FG000|STARTED|Baseline 0 Months||8
8911228|NCT02144337|9970296|FG001|STARTED|Baseline 0 Months||5
8911229|NCT02144337|9970295|FG000|COMPLETED|Baseline 0 Months||8
8911230|NCT02144337|9970296|FG001|COMPLETED|Baseline 0 Months||5
8911231|NCT02144337|9970295|FG000|NOT COMPLETED|Baseline 0 Months||0
8911232|NCT02144337|9970296|FG001|NOT COMPLETED|Baseline 0 Months||0
8911233|NCT02144337|9970295|FG000|STARTED|T2 Follow-up (Post-intervention)||8
8911234|NCT02144337|9970296|FG001|STARTED|T2 Follow-up (Post-intervention)||5
8911235|NCT02144337|9970295|FG000|COMPLETED|T2 Follow-up (Post-intervention)||4
8911236|NCT02144337|9970296|FG001|COMPLETED|T2 Follow-up (Post-intervention)||4
8911237|NCT02144337|9970295|FG000|NOT COMPLETED|T2 Follow-up (Post-intervention)||4
8911238|NCT02144337|9970296|FG001|NOT COMPLETED|T2 Follow-up (Post-intervention)||1
8911239|NCT02144337|9970295|FG000|STARTED|T3 Follow-up (3 Month Post-intervention)|Number not the same as number who completed previous period due to absence/loss of data at T2|8
9022168|NCT03124459|10085074|FG004|COMPLETED|Part 1-Open Label Dose Escalation|Patients in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study.|0
9039964|NCT03345108|10100892|FG003|STARTED|Period-1||8
9039965|NCT03345108|10100893|FG004|STARTED|Period-1||8
9039966|NCT03345108|10100894|FG005|STARTED|Period-1||8
9039967|NCT03345108|10100889|FG000|COMPLETED|Period-1||8
8651026|NCT00638443|9692496|FG000|STARTED|Washout||12
8651027|NCT00638443|9692497|FG001|STARTED|Washout||14
8651028|NCT00638443|9692496|FG000|COMPLETED|Washout||12
8651029|NCT00638443|9692497|FG001|COMPLETED|Washout||14
8651030|NCT00638443|9692496|FG000|NOT COMPLETED|Washout||0
8651031|NCT00638443|9692497|FG001|NOT COMPLETED|Washout||0
8651032|NCT00638443|9692496|FG000|STARTED|Second Intervention||12
8651033|NCT00638443|9692497|FG001|STARTED|Second Intervention||14
8651034|NCT00638443|9692496|FG000|COMPLETED|Second Intervention||12
8651035|NCT00638443|9692497|FG001|COMPLETED|Second Intervention||14
8651036|NCT00638443|9692496|FG000|NOT COMPLETED|Second Intervention||0
8651037|NCT00638443|9692497|FG001|NOT COMPLETED|Second Intervention||0
8651038|NCT00638456|9692507|FG000|STARTED|Overall Study||21
8651039|NCT00638456|9692508|FG001|STARTED|Overall Study||11
8651040|NCT00638456|9692507|FG000|COMPLETED|Overall Study||15
8651041|NCT00638456|9692508|FG001|COMPLETED|Overall Study||9
8651042|NCT00638456|9692507|FG000|NOT COMPLETED|Overall Study||6
8651043|NCT00638456|9692508|FG001|NOT COMPLETED|Overall Study||2
8651044|NCT00638508|9692516|FG000|STARTED|Overall Study||35
8651045|NCT00638508|9692517|FG001|STARTED|Overall Study||32
8651046|NCT00638508|9692516|FG000|COMPLETED|Overall Study||30
8651047|NCT00638508|9692517|FG001|COMPLETED|Overall Study||30
8651048|NCT00638508|9692516|FG000|NOT COMPLETED|Overall Study||5
8651049|NCT00638508|9692517|FG001|NOT COMPLETED|Overall Study||2
8651050|NCT00638651|9692527|FG000|STARTED|Overall Study||3
8651051|NCT00638651|9692527|FG000|COMPLETED|Overall Study||3
8651052|NCT00638651|9692527|FG000|NOT COMPLETED|Overall Study||0
8651053|NCT00638690|9692534|FG000|STARTED|Overall Study||797
8651054|NCT00638690|9692535|FG001|STARTED|Overall Study||398
8651055|NCT00638690|9692534|FG000|COMPLETED|Overall Study||116
8651056|NCT00638690|9692535|FG001|COMPLETED|Overall Study||56
8651057|NCT00638690|9692534|FG000|NOT COMPLETED|Overall Study||681
8651058|NCT00638690|9692535|FG001|NOT COMPLETED|Overall Study||342
8651059|NCT00638716|9692545|FG000|STARTED|Overall Study||50
8651060|NCT00638716|9692546|FG001|STARTED|Overall Study||52
8651061|NCT00638716|9692547|FG002|STARTED|Overall Study||58
8651062|NCT00638716|9692545|FG000|COMPLETED|Overall Study||43
8911240|NCT02144337|9970296|FG001|STARTED|T3 Follow-up (3 Month Post-intervention)|Number not the same as number who completed previous period due to absence/loss of data at T2|5
8911241|NCT02144337|9970295|FG000|COMPLETED|T3 Follow-up (3 Month Post-intervention)||5
8911242|NCT02144337|9970296|FG001|COMPLETED|T3 Follow-up (3 Month Post-intervention)||5
8911243|NCT02144337|9970295|FG000|NOT COMPLETED|T3 Follow-up (3 Month Post-intervention)||3
8651063|NCT00638716|9692546|FG001|COMPLETED|Overall Study||37
8651064|NCT00638716|9692547|FG002|COMPLETED|Overall Study||46
8651065|NCT00638716|9692545|FG000|NOT COMPLETED|Overall Study||7
8651066|NCT00638716|9692546|FG001|NOT COMPLETED|Overall Study||15
8651067|NCT00638716|9692547|FG002|NOT COMPLETED|Overall Study||12
8651068|NCT00638820|9692555|FG000|STARTED|Overall Study||3
8651069|NCT00638820|9692555|FG000|COMPLETED|Overall Study||3
8651070|NCT00638820|9692555|FG000|NOT COMPLETED|Overall Study||0
8651071|NCT00638846|9692561|FG000|STARTED|Overall Study||137
8651072|NCT00638846|9692562|FG001|STARTED|Overall Study||139
8651073|NCT00638846|9692561|FG000|COMPLETED|Overall Study||133
8651074|NCT00638846|9692562|FG001|COMPLETED|Overall Study||133
8651075|NCT00638846|9692561|FG000|NOT COMPLETED|Overall Study||4
8651076|NCT00638846|9692562|FG001|NOT COMPLETED|Overall Study||6
8651077|NCT00638885|9692568|FG000|STARTED|Overall Study||142
8651078|NCT00638885|9692568|FG000|COMPLETED|Overall Study||142
8651079|NCT00638885|9692568|FG000|NOT COMPLETED|Overall Study||0
8651080|NCT00638924|9692572|FG000|STARTED|Overall Study||40
8651081|NCT00638924|9692572|FG000|2 Months|Overall Study||40
8651082|NCT00638924|9692572|FG000|COMPLETED|Overall Study||40
8651083|NCT00638924|9692572|FG000|NOT COMPLETED|Overall Study||0
8651084|NCT00638937|9692576|FG000|STARTED|Overall Study||37
8651085|NCT00638937|9692576|FG000|COMPLETED|Overall Study||37
8651086|NCT00638937|9692576|FG000|NOT COMPLETED|Overall Study||0
8651087|NCT00638963|9692584|FG000|STARTED|Overall Study|Received randomized treatment assignment|3
8651088|NCT00638963|9692585|FG001|STARTED|Overall Study|Received randomized treatment assignment|3
8651089|NCT00638963|9692584|FG000|COMPLETED|Overall Study|including follow-up at Week 38 & Week 52|2
8651090|NCT00638963|9692585|FG001|COMPLETED|Overall Study|including follow-up at Week 38 & Week 52|3
8651091|NCT00638963|9692584|FG000|NOT COMPLETED|Overall Study||1
8651092|NCT00638963|9692585|FG001|NOT COMPLETED|Overall Study||0
8651093|NCT00638989|9692594|FG000|STARTED|Overall Study||10
8651094|NCT00638989|9692595|FG001|STARTED|Overall Study||10
8651095|NCT00638989|9692596|FG002|STARTED|Overall Study||10
8651096|NCT00638989|9692594|FG000|COMPLETED|Overall Study||10
8651097|NCT00638989|9692595|FG001|COMPLETED|Overall Study||10
8651098|NCT00638989|9692596|FG002|COMPLETED|Overall Study||9
8651099|NCT00638989|9692594|FG000|NOT COMPLETED|Overall Study||0
8651100|NCT00638989|9692595|FG001|NOT COMPLETED|Overall Study||0
8651101|NCT00638989|9692596|FG002|NOT COMPLETED|Overall Study||1
8651102|NCT00639002|9692606|FG000|STARTED|Overall Study||13
8651103|NCT00639002|9692606|FG000|Received Ruxolitinib|Overall Study||13
8651104|NCT00639002|9692606|FG000|Received Ruxolitinib + Dexamethasone|Overall Study||7
8651105|NCT00639002|9692606|FG000|COMPLETED|Overall Study||0
8651106|NCT00639002|9692606|FG000|NOT COMPLETED|Overall Study||13
8651107|NCT00639093|9692613|FG000|STARTED|Overall Study|45|45
8651108|NCT00639093|9692614|FG001|STARTED|Overall Study|46|46
8651109|NCT00639093|9692613|FG000|COMPLETED|Overall Study|45|45
8651110|NCT00639093|9692614|FG001|COMPLETED|Overall Study|46|46
8651111|NCT00639093|9692613|FG000|NOT COMPLETED|Overall Study||0
8651112|NCT00639093|9692614|FG001|NOT COMPLETED|Overall Study||0
8651113|NCT00639158|9692622|FG000|STARTED|Overall Study|All randomized subjects were treated.|272
8651114|NCT00639158|9692623|FG001|STARTED|Overall Study|1 subject was randomized but not treated because of an abnormal ECG that precluded treatment.|270
8651115|NCT00639158|9692622|FG000|COMPLETED|Overall Study|26 subjects prematurely discontinued treatment.|246
8651116|NCT00639158|9692623|FG001|COMPLETED|Overall Study|30 subjects prematurely discontinued treatment|240
8651117|NCT00639158|9692622|FG000|NOT COMPLETED|Overall Study||26
8651118|NCT00639158|9692623|FG001|NOT COMPLETED|Overall Study||30
8651119|NCT00639223|9692631|FG000|STARTED|Overall Study||22
8651120|NCT00639223|9692632|FG001|STARTED|Overall Study||21
8651121|NCT00639223|9692631|FG000|COMPLETED|Overall Study||22
8651122|NCT00639223|9692632|FG001|COMPLETED|Overall Study||19
8651123|NCT00639223|9692631|FG000|NOT COMPLETED|Overall Study||0
8651124|NCT00639223|9692632|FG001|NOT COMPLETED|Overall Study||2
8651125|NCT00639379|9692638|FG000|STARTED|Period 1 - 2 Weeks||44
8651126|NCT00639379|9692639|FG001|STARTED|Period 1 - 2 Weeks||45
8651127|NCT00639379|9692638|FG000|COMPLETED|Period 1 - 2 Weeks||39
8651128|NCT00639379|9692639|FG001|COMPLETED|Period 1 - 2 Weeks||45
8651129|NCT00639379|9692638|FG000|NOT COMPLETED|Period 1 - 2 Weeks||5
8651130|NCT00639379|9692639|FG001|NOT COMPLETED|Period 1 - 2 Weeks||0
8651131|NCT00639379|9692638|FG000|STARTED|Period 2 - 2 Weeks||39
8651132|NCT00639379|9692639|FG001|STARTED|Period 2 - 2 Weeks||45
8651133|NCT00639379|9692638|FG000|COMPLETED|Period 2 - 2 Weeks||39
8651134|NCT00639379|9692639|FG001|COMPLETED|Period 2 - 2 Weeks||45
8651135|NCT00639379|9692638|FG000|NOT COMPLETED|Period 2 - 2 Weeks||0
8651136|NCT00639379|9692639|FG001|NOT COMPLETED|Period 2 - 2 Weeks||0
8651137|NCT00639418|9692649|FG000|STARTED|Overall Study||28101
8651138|NCT00639418|9692650|FG001|STARTED|Overall Study||35967
8651139|NCT00639418|9692651|FG002|STARTED|Overall Study||36496
8651140|NCT00639418|9692652|FG003|STARTED|Overall Study||46930
8651141|NCT00639418|9692649|FG000|COMPLETED|Overall Study||28101
8651142|NCT00639418|9692650|FG001|COMPLETED|Overall Study||35967
8651143|NCT00639418|9692651|FG002|COMPLETED|Overall Study||36496
8651144|NCT00639418|9692652|FG003|COMPLETED|Overall Study||46930
8651145|NCT00639418|9692649|FG000|NOT COMPLETED|Overall Study||0
8651146|NCT00639418|9692650|FG001|NOT COMPLETED|Overall Study||0
8651147|NCT00639418|9692651|FG002|NOT COMPLETED|Overall Study||0
8651148|NCT00639418|9692652|FG003|NOT COMPLETED|Overall Study||0
8651149|NCT00639457|9692668|FG000|STARTED|Overall Study||22
8651150|NCT00639457|9692669|FG001|STARTED|Overall Study||22
8651151|NCT00639457|9692668|FG000|COMPLETED|Overall Study||20
8651152|NCT00639457|9692669|FG001|COMPLETED|Overall Study||19
8651153|NCT00639457|9692668|FG000|NOT COMPLETED|Overall Study||2
8651154|NCT00639457|9692669|FG001|NOT COMPLETED|Overall Study||3
8651155|NCT00639509|9692675|FG000|STARTED|Overall Study||24
8651156|NCT00639509|9692675|FG000|COMPLETED|Overall Study||23
8651157|NCT00639509|9692675|FG000|NOT COMPLETED|Overall Study||1
8651158|NCT00639678|9692683|FG000|STARTED|Overall Study||74
8651159|NCT00639678|9692684|FG001|STARTED|Overall Study||6
8651160|NCT00639678|9692685|FG002|STARTED|Overall Study||217
8651161|NCT00639678|9692686|FG003|STARTED|Overall Study||23
8651162|NCT00639678|9692683|FG000|COMPLETED|Overall Study||70
8651163|NCT00639678|9692684|FG001|COMPLETED|Overall Study||5
8651164|NCT00639678|9692685|FG002|COMPLETED|Overall Study||206
8651165|NCT00639678|9692686|FG003|COMPLETED|Overall Study||23
8651166|NCT00639678|9692683|FG000|NOT COMPLETED|Overall Study||4
8651167|NCT00639678|9692684|FG001|NOT COMPLETED|Overall Study||1
8651168|NCT00639678|9692685|FG002|NOT COMPLETED|Overall Study||11
8651169|NCT00639678|9692686|FG003|NOT COMPLETED|Overall Study||0
8651170|NCT00639717|9692698|FG000|STARTED|Overall Study||48
8651171|NCT00639717|9692698|FG000|COMPLETED|Overall Study||48
8651172|NCT00639717|9692698|FG000|NOT COMPLETED|Overall Study||0
8651173|NCT00639769|9692702|FG000|STARTED|Overall Study||40
8651174|NCT00639769|9692702|FG000|COMPLETED|Overall Study||0
8651175|NCT00639769|9692702|FG000|NOT COMPLETED|Overall Study||40
8651176|NCT00639860|9692706|FG000|STARTED|Overall Study||10
8651177|NCT00639860|9692706|FG000|COMPLETED|Overall Study||10
8651178|NCT00639860|9692706|FG000|NOT COMPLETED|Overall Study||0
8651179|NCT00640016|9692714|FG000|STARTED|Overall Study||3
8651180|NCT00640016|9692715|FG001|STARTED|Overall Study||3
8651181|NCT00640016|9692716|FG002|STARTED|Overall Study||4
8651182|NCT00640016|9692717|FG003|STARTED|Overall Study||4
8651183|NCT00640016|9692714|FG000|Treated|Overall Study||3
8651184|NCT00640016|9692715|FG001|Treated|Overall Study||2
8651185|NCT00640016|9692716|FG002|Treated|Overall Study||4
8651186|NCT00640016|9692717|FG003|Treated|Overall Study||4
8651187|NCT00640016|9692714|FG000|COMPLETED|Overall Study||1
8651188|NCT00640016|9692715|FG001|COMPLETED|Overall Study||1
8651189|NCT00640016|9692716|FG002|COMPLETED|Overall Study||1
8651190|NCT00640016|9692717|FG003|COMPLETED|Overall Study||1
8651191|NCT00640016|9692714|FG000|NOT COMPLETED|Overall Study||2
8651192|NCT00640016|9692715|FG001|NOT COMPLETED|Overall Study||2
8651193|NCT00640016|9692716|FG002|NOT COMPLETED|Overall Study||3
8651194|NCT00640016|9692717|FG003|NOT COMPLETED|Overall Study||3
8651195|NCT00640042|9692734|FG000|STARTED|Enrollment|Number of patients with evidence of prescription card receipt|1570
8651196|NCT00640042|9692734|FG000|COMPLETED|Enrollment|Number of patients with evidence of study drug receipt|1487
8651197|NCT00640042|9692734|FG000|NOT COMPLETED|Enrollment||83
8651198|NCT00640042|9692734|FG000|STARTED|Treatment||1487
8651199|NCT00640042|9692734|FG000|COMPLETED|Treatment||561
8651200|NCT00640042|9692734|FG000|NOT COMPLETED|Treatment||926
8651201|NCT00640133|9692740|FG000|STARTED|Randomization Phase (Baseline-Month 3)||15
8651202|NCT00640133|9692741|FG001|STARTED|Randomization Phase (Baseline-Month 3)||12
8651203|NCT00640133|9692740|FG000|COMPLETED|Randomization Phase (Baseline-Month 3)||15
8651204|NCT00640133|9692741|FG001|COMPLETED|Randomization Phase (Baseline-Month 3)||12
8651205|NCT00640133|9692740|FG000|NOT COMPLETED|Randomization Phase (Baseline-Month 3)||0
8651206|NCT00640133|9692741|FG001|NOT COMPLETED|Randomization Phase (Baseline-Month 3)||0
8651207|NCT00640133|9692740|FG000|STARTED|Open Label Phase (Month 4-12)||27
8651208|NCT00640133|9692741|FG001|STARTED|Open Label Phase (Month 4-12)||0
8651209|NCT00640133|9692740|FG000|COMPLETED|Open Label Phase (Month 4-12)||24
8651210|NCT00640133|9692741|FG001|COMPLETED|Open Label Phase (Month 4-12)||0
8651211|NCT00640133|9692740|FG000|NOT COMPLETED|Open Label Phase (Month 4-12)||3
8651212|NCT00640133|9692741|FG001|NOT COMPLETED|Open Label Phase (Month 4-12)||0
8651213|NCT00640146|9692751|FG000|STARTED|Overall Study||19
8651214|NCT00640146|9692752|FG001|STARTED|Overall Study||18
8651215|NCT00640146|9692751|FG000|Received at Least 1 Dose of Study Drug|Overall Study||18
8651216|NCT00640146|9692752|FG001|Received at Least 1 Dose of Study Drug|Overall Study||15
8651217|NCT00640146|9692751|FG000|COMPLETED|Overall Study||15
8651218|NCT00640146|9692752|FG001|COMPLETED|Overall Study||12
8651219|NCT00640146|9692751|FG000|NOT COMPLETED|Overall Study||4
8651220|NCT00640146|9692752|FG001|NOT COMPLETED|Overall Study||6
8651221|NCT00640224|9692762|FG000|STARTED|Overall Study||23
8651222|NCT00640224|9692763|FG001|STARTED|Overall Study||23
8651223|NCT00640224|9692764|FG002|STARTED|Overall Study||0
8651224|NCT00640224|9692765|FG003|STARTED|Overall Study||0
8651225|NCT00640224|9692762|FG000|COMPLETED|Overall Study||17
8651226|NCT00640224|9692763|FG001|COMPLETED|Overall Study||20
8651227|NCT00640224|9692764|FG002|COMPLETED|Overall Study||0
8651228|NCT00640224|9692765|FG003|COMPLETED|Overall Study||0
8651229|NCT00640224|9692762|FG000|NOT COMPLETED|Overall Study||6
8651230|NCT00640224|9692763|FG001|NOT COMPLETED|Overall Study||3
8651231|NCT00640224|9692764|FG002|NOT COMPLETED|Overall Study||0
8651232|NCT00640224|9692765|FG003|NOT COMPLETED|Overall Study||0
8651233|NCT00640250|9692775|FG000|STARTED|Overall Study||48
8651234|NCT00640250|9692775|FG000|COMPLETED|Overall Study||48
8651235|NCT00640250|9692775|FG000|NOT COMPLETED|Overall Study||0
8651236|NCT00640289|9692878|FG000|STARTED|Overall Study||72
8651237|NCT00640289|9692878|FG000|COMPLETED|Overall Study||59
8651238|NCT00640289|9692878|FG000|NOT COMPLETED|Overall Study||13
8651239|NCT00640315|9692884|FG000|STARTED|Overall Study||10
8651240|NCT00640315|9692885|FG001|STARTED|Overall Study||13
8651241|NCT00640315|9692884|FG000|Participants Received Treatment|Overall Study||10
8651242|NCT00640315|9692885|FG001|Participants Received Treatment|Overall Study||13
8651243|NCT00640315|9692884|FG000|COMPLETED|Overall Study||10
8651244|NCT00640315|9692885|FG001|COMPLETED|Overall Study||12
8651245|NCT00640315|9692884|FG000|NOT COMPLETED|Overall Study||0
8651246|NCT00640315|9692885|FG001|NOT COMPLETED|Overall Study||1
8651247|NCT00640328|9692897|FG000|STARTED|First Treatment Period (Weeks 0-24)||8
8651248|NCT00640328|9692898|FG001|STARTED|First Treatment Period (Weeks 0-24)||11
8651249|NCT00640328|9692899|FG002|STARTED|First Treatment Period (Weeks 0-24)||7
8651250|NCT00640328|9692900|FG003|STARTED|First Treatment Period (Weeks 0-24)||4
8651251|NCT00640328|9692901|FG004|STARTED|First Treatment Period (Weeks 0-24)||4
8651252|NCT00640328|9692902|FG005|STARTED|First Treatment Period (Weeks 0-24)||4
8651253|NCT00640328|9692897|FG000|COMPLETED|First Treatment Period (Weeks 0-24)||8
8651254|NCT00640328|9692898|FG001|COMPLETED|First Treatment Period (Weeks 0-24)||10
8651255|NCT00640328|9692899|FG002|COMPLETED|First Treatment Period (Weeks 0-24)||7
8651256|NCT00640328|9692900|FG003|COMPLETED|First Treatment Period (Weeks 0-24)||4
8651257|NCT00640328|9692901|FG004|COMPLETED|First Treatment Period (Weeks 0-24)||4
8651258|NCT00640328|9692902|FG005|COMPLETED|First Treatment Period (Weeks 0-24)||4
8651259|NCT00640328|9692897|FG000|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
8651260|NCT00640328|9692898|FG001|NOT COMPLETED|First Treatment Period (Weeks 0-24)||1
8651261|NCT00640328|9692899|FG002|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
8651262|NCT00640328|9692900|FG003|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
8651263|NCT00640328|9692901|FG004|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
8651264|NCT00640328|9692902|FG005|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
8651265|NCT00640328|9692897|FG000|STARTED|Second Treatment Period (Weeks 24-48)||8
8651266|NCT00640328|9692898|FG001|STARTED|Second Treatment Period (Weeks 24-48)||10
8651267|NCT00640328|9692899|FG002|STARTED|Second Treatment Period (Weeks 24-48)||7
8651268|NCT00640328|9692900|FG003|STARTED|Second Treatment Period (Weeks 24-48)||4
8651269|NCT00640328|9692901|FG004|STARTED|Second Treatment Period (Weeks 24-48)||4
8651270|NCT00640328|9692902|FG005|STARTED|Second Treatment Period (Weeks 24-48)||4
8651271|NCT00640328|9692897|FG000|COMPLETED|Second Treatment Period (Weeks 24-48)||8
8651272|NCT00640328|9692898|FG001|COMPLETED|Second Treatment Period (Weeks 24-48)||10
8651273|NCT00640328|9692899|FG002|COMPLETED|Second Treatment Period (Weeks 24-48)||7
8651274|NCT00640328|9692900|FG003|COMPLETED|Second Treatment Period (Weeks 24-48)||4
8651275|NCT00640328|9692901|FG004|COMPLETED|Second Treatment Period (Weeks 24-48)||3
8651276|NCT00640328|9692902|FG005|COMPLETED|Second Treatment Period (Weeks 24-48)||4
8651277|NCT00640328|9692897|FG000|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
8651278|NCT00640328|9692898|FG001|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
8651279|NCT00640328|9692899|FG002|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
8651280|NCT00640328|9692900|FG003|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
8728398|NCT01048333|9775566|FG001|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||19
8728399|NCT01048333|9775567|FG002|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||16
8651281|NCT00640328|9692901|FG004|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||1
8651282|NCT00640328|9692902|FG005|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
8651283|NCT00640328|9692897|FG000|STARTED|IFUP (Week 48 to Individual Termination)||8
8651284|NCT00640328|9692898|FG001|STARTED|IFUP (Week 48 to Individual Termination)||11
8651285|NCT00640328|9692899|FG002|STARTED|IFUP (Week 48 to Individual Termination)||7
8651286|NCT00640328|9692900|FG003|STARTED|IFUP (Week 48 to Individual Termination)||4
9022169|NCT03124459|10085075|FG005|COMPLETED|Part 1-Open Label Dose Escalation|Patients in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study. Participants that completed the double-blind portion of the study then moved into this Part 2 open-label portion of the study.|0
9022170|NCT03124459|10085070|FG000|NOT COMPLETED|Part 1-Open Label Dose Escalation||0
9022171|NCT03124459|10085071|FG001|NOT COMPLETED|Part 1-Open Label Dose Escalation||0
9022172|NCT03124459|10085072|FG002|NOT COMPLETED|Part 1-Open Label Dose Escalation||0
8651287|NCT00640328|9692901|FG004|STARTED|IFUP (Week 48 to Individual Termination)||4
8651288|NCT00640328|9692902|FG005|STARTED|IFUP (Week 48 to Individual Termination)||4
8651289|NCT00640328|9692897|FG000|COMPLETED|IFUP (Week 48 to Individual Termination)||8
8651290|NCT00640328|9692898|FG001|COMPLETED|IFUP (Week 48 to Individual Termination)||10
8651291|NCT00640328|9692899|FG002|COMPLETED|IFUP (Week 48 to Individual Termination)||6
8651292|NCT00640328|9692900|FG003|COMPLETED|IFUP (Week 48 to Individual Termination)||3
8651293|NCT00640328|9692901|FG004|COMPLETED|IFUP (Week 48 to Individual Termination)||4
8651294|NCT00640328|9692902|FG005|COMPLETED|IFUP (Week 48 to Individual Termination)||4
8651295|NCT00640328|9692897|FG000|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||0
8651296|NCT00640328|9692898|FG001|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||1
8651297|NCT00640328|9692899|FG002|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||1
8651298|NCT00640328|9692900|FG003|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||1
8651299|NCT00640328|9692901|FG004|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||0
8651300|NCT00640328|9692902|FG005|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||0
8651301|NCT00640341|9692926|FG000|STARTED|Overall Study|All Starting participants were dispensed lenses|170
8651302|NCT00640341|9692927|FG001|STARTED|Overall Study||170
8651303|NCT00640341|9692928|FG002|STARTED|Overall Study||170
8651304|NCT00640341|9692926|FG000|Eligible Participants at Baseline|Overall Study||165
8651305|NCT00640341|9692927|FG001|Eligible Participants at Baseline|Overall Study||167
8651306|NCT00640341|9692928|FG002|Eligible Participants at Baseline|Overall Study||168
8651307|NCT00640341|9692926|FG000|COMPLETED|Overall Study||149
8728400|NCT01048333|9775568|FG003|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||18
8728401|NCT01048333|9775569|FG004|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||17
8651308|NCT00640341|9692927|FG001|COMPLETED|Overall Study||165
8651309|NCT00640341|9692928|FG002|COMPLETED|Overall Study||163
8651310|NCT00640341|9692926|FG000|NOT COMPLETED|Overall Study||21
8651311|NCT00640341|9692927|FG001|NOT COMPLETED|Overall Study||5
8651312|NCT00640341|9692928|FG002|NOT COMPLETED|Overall Study||7
8651313|NCT00640393|9692936|FG000|STARTED|Part 1||99
8651314|NCT00640393|9692937|FG001|STARTED|Part 1||0
8651315|NCT00640393|9692938|FG002|STARTED|Part 1||0
8651316|NCT00640393|9692936|FG000|COMPLETED|Part 1||94
8651317|NCT00640393|9692937|FG001|COMPLETED|Part 1||0
8651318|NCT00640393|9692938|FG002|COMPLETED|Part 1||0
8651319|NCT00640393|9692936|FG000|NOT COMPLETED|Part 1||5
8651320|NCT00640393|9692937|FG001|NOT COMPLETED|Part 1||0
8651321|NCT00640393|9692938|FG002|NOT COMPLETED|Part 1||0
8651322|NCT00640393|9692936|FG000|STARTED|Randomization||94
8651323|NCT00640393|9692937|FG001|STARTED|Randomization||0
8651324|NCT00640393|9692938|FG002|STARTED|Randomization||0
8651325|NCT00640393|9692936|FG000|COMPLETED|Randomization||75
8651326|NCT00640393|9692937|FG001|COMPLETED|Randomization||0
8651327|NCT00640393|9692938|FG002|COMPLETED|Randomization||0
8651328|NCT00640393|9692936|FG000|NOT COMPLETED|Randomization||19
8651329|NCT00640393|9692937|FG001|NOT COMPLETED|Randomization||0
8651330|NCT00640393|9692938|FG002|NOT COMPLETED|Randomization||0
8651331|NCT00640393|9692936|FG000|STARTED|Part 2||0
8651332|NCT00640393|9692937|FG001|STARTED|Part 2||37
8651333|NCT00640393|9692938|FG002|STARTED|Part 2||38
8651334|NCT00640393|9692936|FG000|COMPLETED|Part 2||0
8651335|NCT00640393|9692937|FG001|COMPLETED|Part 2|Per Protocol analysis is of 7 participants that were compliant to protocol|27
8651336|NCT00640393|9692938|FG002|COMPLETED|Part 2|Per protocol analysis of 27 to 29 participants that were compliant depending on evaluation or visit|35
8651337|NCT00640393|9692936|FG000|NOT COMPLETED|Part 2||0
8651338|NCT00640393|9692937|FG001|NOT COMPLETED|Part 2||10
8651339|NCT00640393|9692938|FG002|NOT COMPLETED|Part 2||3
8651340|NCT00640510|9692948|FG000|STARTED|Overall Study||17
8651341|NCT00640510|9692949|FG001|STARTED|Overall Study|One patient randomized to placebo discontinued prior to receiving study drug.|17
8651342|NCT00640510|9692948|FG000|COMPLETED|Overall Study||16
8651343|NCT00640510|9692949|FG001|COMPLETED|Overall Study||15
8651344|NCT00640510|9692948|FG000|NOT COMPLETED|Overall Study||1
8651345|NCT00640510|9692949|FG001|NOT COMPLETED|Overall Study||2
8651346|NCT00640562|9692957|FG000|STARTED|Overall Study||109
8651347|NCT00640562|9692958|FG001|STARTED|Overall Study||107
8651348|NCT00640562|9692957|FG000|COMPLETED|Overall Study||91
8651349|NCT00640562|9692958|FG001|COMPLETED|Overall Study||81
8651350|NCT00640562|9692957|FG000|NOT COMPLETED|Overall Study||18
8651351|NCT00640562|9692958|FG001|NOT COMPLETED|Overall Study||26
8651352|NCT00640601|9692964|FG000|STARTED|Overall Study|331 patients enrolled and 295 patients started investigational product (IP)|295
8651353|NCT00640601|9692964|FG000|COMPLETED|Overall Study||183
8651354|NCT00640601|9692964|FG000|NOT COMPLETED|Overall Study||112
8651355|NCT00640614|9692970|FG000|STARTED|Overall Study||125
8651356|NCT00640614|9692971|FG001|STARTED|Overall Study||110
8651357|NCT00640614|9692970|FG000|COMPLETED|Overall Study||124
8651358|NCT00640614|9692971|FG001|COMPLETED|Overall Study||110
8651359|NCT00640614|9692970|FG000|NOT COMPLETED|Overall Study||1
8651360|NCT00640614|9692971|FG001|NOT COMPLETED|Overall Study||0
8651361|NCT00640653|9693005|FG000|STARTED|Overall Study||131
8651362|NCT00640653|9693006|FG001|STARTED|Overall Study||134
8651363|NCT00640653|9693007|FG002|STARTED|Overall Study||129
8651364|NCT00640653|9693008|FG003|STARTED|Overall Study||134
8651365|NCT00640653|9693009|FG004|STARTED|Overall Study||134
8651366|NCT00640653|9693005|FG000|Followed-up at 3 mo|Overall Study||126
8651367|NCT00640653|9693006|FG001|Followed-up at 3 mo|Overall Study||127
8651368|NCT00640653|9693007|FG002|Followed-up at 3 mo|Overall Study||125
8651369|NCT00640653|9693008|FG003|Followed-up at 3 mo|Overall Study||129
8651370|NCT00640653|9693009|FG004|Followed-up at 3 mo|Overall Study||126
8651371|NCT00640653|9693005|FG000|Followed-up at 6 mo|Overall Study||127
8651372|NCT00640653|9693006|FG001|Followed-up at 6 mo|Overall Study||130
8651373|NCT00640653|9693007|FG002|Followed-up at 6 mo|Overall Study||124
8651374|NCT00640653|9693008|FG003|Followed-up at 6 mo|Overall Study||130
8651375|NCT00640653|9693009|FG004|Followed-up at 6 mo|Overall Study||125
8651376|NCT00640653|9693005|FG000|Followed-up at 12 mo|Overall Study||124
8651377|NCT00640653|9693006|FG001|Followed-up at 12 mo|Overall Study||121
8651378|NCT00640653|9693007|FG002|Followed-up at 12 mo|Overall Study||115
8651379|NCT00640653|9693008|FG003|Followed-up at 12 mo|Overall Study||122
8651380|NCT00640653|9693009|FG004|Followed-up at 12 mo|Overall Study||116
8651381|NCT00640653|9693005|FG000|Followed-up at 18 mo|Overall Study||118
8651382|NCT00640653|9693006|FG001|Followed-up at 18 mo|Overall Study||112
8651383|NCT00640653|9693007|FG002|Followed-up at 18 mo|Overall Study||113
8728402|NCT01048333|9775570|FG005|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||18
8728403|NCT01048333|9775565|FG000|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
8728404|NCT01048333|9775566|FG001|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
8728405|NCT01048333|9775567|FG002|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
8728406|NCT01048333|9775568|FG003|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
8728407|NCT01048333|9775569|FG004|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
8651384|NCT00640653|9693008|FG003|Followed-up at 18 mo|Overall Study||117
8651385|NCT00640653|9693009|FG004|Followed-up at 18 mo|Overall Study||117
8651386|NCT00640653|9693005|FG000|Followed-up at 24 mo|Overall Study||114
8651387|NCT00640653|9693006|FG001|Followed-up at 24 mo|Overall Study||116
8651388|NCT00640653|9693007|FG002|Followed-up at 24 mo|Overall Study||105
8651389|NCT00640653|9693008|FG003|Followed-up at 24 mo|Overall Study||112
8651390|NCT00640653|9693009|FG004|Followed-up at 24 mo|Overall Study||112
8651391|NCT00640653|9693005|FG000|COMPLETED|Overall Study||128
8651392|NCT00640653|9693006|FG001|COMPLETED|Overall Study||131
8651393|NCT00640653|9693007|FG002|COMPLETED|Overall Study||129
8651394|NCT00640653|9693008|FG003|COMPLETED|Overall Study||132
8651395|NCT00640653|9693009|FG004|COMPLETED|Overall Study||129
8651396|NCT00640653|9693005|FG000|NOT COMPLETED|Overall Study||3
8651397|NCT00640653|9693006|FG001|NOT COMPLETED|Overall Study||3
8651398|NCT00640653|9693007|FG002|NOT COMPLETED|Overall Study||0
8651399|NCT00640653|9693008|FG003|NOT COMPLETED|Overall Study||2
8651400|NCT00640653|9693009|FG004|NOT COMPLETED|Overall Study||5
8651401|NCT00640822|9693024|FG000|STARTED|Overall Study||322
8651402|NCT00640822|9693025|FG001|STARTED|Overall Study||317
8651403|NCT00640822|9693026|FG002|STARTED|Overall Study||102
8651404|NCT00640822|9693024|FG000|COMPLETED|Overall Study||279
8651405|NCT00640822|9693025|FG001|COMPLETED|Overall Study||258
8651406|NCT00640822|9693026|FG002|COMPLETED|Overall Study||77
8651407|NCT00640822|9693024|FG000|NOT COMPLETED|Overall Study||43
8651408|NCT00640822|9693025|FG001|NOT COMPLETED|Overall Study||59
8651409|NCT00640822|9693026|FG002|NOT COMPLETED|Overall Study||25
8651410|NCT00640835|9693036|FG000|STARTED|Overall Study||194
8651411|NCT00640835|9693037|FG001|STARTED|Overall Study||188
8651412|NCT00640835|9693036|FG000|COMPLETED|Overall Study||118
8651413|NCT00640835|9693037|FG001|COMPLETED|Overall Study||131
8651414|NCT00640835|9693036|FG000|NOT COMPLETED|Overall Study||76
8651415|NCT00640835|9693037|FG001|NOT COMPLETED|Overall Study||57
8651416|NCT00640926|9693046|FG000|STARTED|Overall Study||53
8651417|NCT00640926|9693047|FG001|STARTED|Overall Study||52
8651418|NCT00640926|9693048|FG002|STARTED|Overall Study||53
8651419|NCT00640926|9693046|FG000|COMPLETED|Overall Study||45
8651420|NCT00640926|9693047|FG001|COMPLETED|Overall Study||46
8651421|NCT00640926|9693048|FG002|COMPLETED|Overall Study||45
8651422|NCT00640926|9693046|FG000|NOT COMPLETED|Overall Study||8
8651423|NCT00640926|9693047|FG001|NOT COMPLETED|Overall Study||6
8651424|NCT00640926|9693048|FG002|NOT COMPLETED|Overall Study||8
8651425|NCT00640978|9693056|FG000|STARTED|Overall Study||15
8651426|NCT00640978|9693056|FG000|COMPLETED|Overall Study||15
8651427|NCT00640978|9693056|FG000|NOT COMPLETED|Overall Study||0
8651428|NCT00641043|9693062|FG000|STARTED|Overall Study|number who started treatment|130
8651429|NCT00641043|9693063|FG001|STARTED|Overall Study|number who started treatment|259
8651430|NCT00641043|9693062|FG000|COMPLETED|Overall Study|number who completed treatment|111
8651431|NCT00641043|9693063|FG001|COMPLETED|Overall Study|number who completed treatment|244
8651432|NCT00641043|9693062|FG000|NOT COMPLETED|Overall Study||19
8651433|NCT00641043|9693063|FG001|NOT COMPLETED|Overall Study||15
8651434|NCT00641056|9693071|FG000|STARTED|Overall Study||233
8651435|NCT00641056|9693072|FG001|STARTED|Overall Study||234
8651436|NCT00641056|9693071|FG000|Intent to Treat (ITT)|Overall Study||233
8651437|NCT00641056|9693072|FG001|Intent to Treat (ITT)|Overall Study||223
8651438|NCT00641056|9693071|FG000|COMPLETED|Overall Study||204
8651439|NCT00641056|9693072|FG001|COMPLETED|Overall Study||209
8651440|NCT00641056|9693071|FG000|NOT COMPLETED|Overall Study||29
8651441|NCT00641056|9693072|FG001|NOT COMPLETED|Overall Study||25
8651442|NCT00641147|9693084|FG000|STARTED|Completed 4 Months.||21
8651443|NCT00641147|9693085|FG001|STARTED|Completed 4 Months.||23
8651444|NCT00641147|9693084|FG000|COMPLETED|Completed 4 Months.||19
8651445|NCT00641147|9693085|FG001|COMPLETED|Completed 4 Months.||23
8651446|NCT00641147|9693084|FG000|NOT COMPLETED|Completed 4 Months.||2
8651447|NCT00641147|9693085|FG001|NOT COMPLETED|Completed 4 Months.||0
8651448|NCT00641147|9693084|FG000|STARTED|Completed 8 Months.||19
8651449|NCT00641147|9693085|FG001|STARTED|Completed 8 Months.||23
8651450|NCT00641147|9693084|FG000|COMPLETED|Completed 8 Months.||16
8651451|NCT00641147|9693085|FG001|COMPLETED|Completed 8 Months.||21
8651452|NCT00641147|9693084|FG000|NOT COMPLETED|Completed 8 Months.||3
8651453|NCT00641147|9693085|FG001|NOT COMPLETED|Completed 8 Months.||2
8651454|NCT00641147|9693084|FG000|STARTED|Completed 12 Months.||16
8651455|NCT00641147|9693085|FG001|STARTED|Completed 12 Months.||21
8651456|NCT00641147|9693084|FG000|COMPLETED|Completed 12 Months.||15
8651457|NCT00641147|9693085|FG001|COMPLETED|Completed 12 Months.||19
8651458|NCT00641147|9693084|FG000|NOT COMPLETED|Completed 12 Months.||1
8651459|NCT00641147|9693085|FG001|NOT COMPLETED|Completed 12 Months.||2
8651460|NCT00641147|9693084|FG000|STARTED|Completed 16 Months.||15
8651461|NCT00641147|9693085|FG001|STARTED|Completed 16 Months.||19
8651462|NCT00641147|9693084|FG000|COMPLETED|Completed 16 Months.||13
8651463|NCT00641147|9693085|FG001|COMPLETED|Completed 16 Months.||19
8651464|NCT00641147|9693084|FG000|NOT COMPLETED|Completed 16 Months.||2
8651465|NCT00641147|9693085|FG001|NOT COMPLETED|Completed 16 Months.||0
8651466|NCT00641563|9693095|FG000|STARTED|Infusion 1||5
8651467|NCT00641563|9693096|FG001|STARTED|Infusion 1||5
8651468|NCT00641563|9693095|FG000|COMPLETED|Infusion 1||5
8651469|NCT00641563|9693096|FG001|COMPLETED|Infusion 1||5
8651470|NCT00641563|9693095|FG000|NOT COMPLETED|Infusion 1||0
8651471|NCT00641563|9693096|FG001|NOT COMPLETED|Infusion 1||0
8651472|NCT00641563|9693095|FG000|STARTED|Infusion 2||5
8651473|NCT00641563|9693096|FG001|STARTED|Infusion 2||5
8651474|NCT00641563|9693095|FG000|COMPLETED|Infusion 2||5
8651475|NCT00641563|9693096|FG001|COMPLETED|Infusion 2||5
8651476|NCT00641563|9693095|FG000|NOT COMPLETED|Infusion 2||0
8651477|NCT00641563|9693096|FG001|NOT COMPLETED|Infusion 2||0
8651478|NCT00641641|9693102|FG000|STARTED|Overall Study||16
8651479|NCT00641641|9693102|FG000|COMPLETED|Overall Study||16
8651480|NCT00641641|9693102|FG000|NOT COMPLETED|Overall Study||0
8651481|NCT00641667|9693106|FG000|STARTED|Overall Study||66
8651482|NCT00641667|9693106|FG000|COMPLETED|Overall Study||60
8651483|NCT00641667|9693106|FG000|NOT COMPLETED|Overall Study||6
8651484|NCT00641706|9693112|FG000|STARTED|Overall Study||37
8651485|NCT00641706|9693113|FG001|STARTED|Overall Study||7
8651486|NCT00641706|9693112|FG000|COMPLETED|Overall Study||28
8651487|NCT00641706|9693113|FG001|COMPLETED|Overall Study||4
8651488|NCT00641706|9693112|FG000|NOT COMPLETED|Overall Study||9
8651489|NCT00641706|9693113|FG001|NOT COMPLETED|Overall Study||3
8651490|NCT00641719|9693121|FG000|STARTED|Overall Study||129
8651491|NCT00641719|9693122|FG001|STARTED|Overall Study||129
8651492|NCT00641719|9693121|FG000|COMPLETED|Overall Study||99
8651493|NCT00641719|9693122|FG001|COMPLETED|Overall Study|1 participant discontinued during taper phase, not during treatment phase.|92
8651494|NCT00641719|9693121|FG000|NOT COMPLETED|Overall Study||30
8651495|NCT00641719|9693122|FG001|NOT COMPLETED|Overall Study||37
8651496|NCT00641745|9693130|FG000|STARTED|Overall Study||427
8651497|NCT00641745|9693131|FG001|STARTED|Overall Study||202
8651498|NCT00641745|9693130|FG000|COMPLETED|Overall Study||147
8651499|NCT00641745|9693131|FG001|COMPLETED|Overall Study||89
8728408|NCT01048333|9775570|FG005|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
8728409|NCT01048333|9775565|FG000|STARTED|Treatment Period 2||21
8728410|NCT01048333|9775566|FG001|STARTED|Treatment Period 2||19
8728411|NCT01048333|9775567|FG002|STARTED|Treatment Period 2||16
8728412|NCT01048333|9775568|FG003|STARTED|Treatment Period 2||18
8728413|NCT01048333|9775569|FG004|STARTED|Treatment Period 2||17
8728414|NCT01048333|9775570|FG005|STARTED|Treatment Period 2||18
8728415|NCT01048333|9775565|FG000|COMPLETED|Treatment Period 2||21
8728416|NCT01048333|9775566|FG001|COMPLETED|Treatment Period 2||19
8728417|NCT01048333|9775567|FG002|COMPLETED|Treatment Period 2||16
8728418|NCT01048333|9775568|FG003|COMPLETED|Treatment Period 2||18
8728419|NCT01048333|9775569|FG004|COMPLETED|Treatment Period 2||17
8728420|NCT01048333|9775570|FG005|COMPLETED|Treatment Period 2||18
8728421|NCT01048333|9775565|FG000|NOT COMPLETED|Treatment Period 2||0
8728422|NCT01048333|9775566|FG001|NOT COMPLETED|Treatment Period 2||0
8728423|NCT01048333|9775567|FG002|NOT COMPLETED|Treatment Period 2||0
8728424|NCT01048333|9775568|FG003|NOT COMPLETED|Treatment Period 2||0
8728425|NCT01048333|9775569|FG004|NOT COMPLETED|Treatment Period 2||0
8728426|NCT01048333|9775570|FG005|NOT COMPLETED|Treatment Period 2||0
8728427|NCT01048333|9775565|FG000|STARTED|Wash-Out Period 2 of 2 - 7 Days||21
8728428|NCT01048333|9775566|FG001|STARTED|Wash-Out Period 2 of 2 - 7 Days||19
8728429|NCT01048333|9775567|FG002|STARTED|Wash-Out Period 2 of 2 - 7 Days||16
8728430|NCT01048333|9775568|FG003|STARTED|Wash-Out Period 2 of 2 - 7 Days||18
8728431|NCT01048333|9775569|FG004|STARTED|Wash-Out Period 2 of 2 - 7 Days||17
8728432|NCT01048333|9775570|FG005|STARTED|Wash-Out Period 2 of 2 - 7 Days||18
8728433|NCT01048333|9775565|FG000|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||21
8728434|NCT01048333|9775566|FG001|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||18
8728435|NCT01048333|9775567|FG002|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||16
8728436|NCT01048333|9775568|FG003|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||18
8728437|NCT01048333|9775569|FG004|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||17
8728438|NCT01048333|9775570|FG005|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||18
8728439|NCT01048333|9775565|FG000|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
8728440|NCT01048333|9775566|FG001|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||1
8728441|NCT01048333|9775567|FG002|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
8728442|NCT01048333|9775568|FG003|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
8728443|NCT01048333|9775569|FG004|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
8728444|NCT01048333|9775570|FG005|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
8728445|NCT01048333|9775565|FG000|STARTED|Treatment Period 3||21
8728446|NCT01048333|9775566|FG001|STARTED|Treatment Period 3||18
8728447|NCT01048333|9775567|FG002|STARTED|Treatment Period 3||16
8728448|NCT01048333|9775568|FG003|STARTED|Treatment Period 3||18
8728449|NCT01048333|9775569|FG004|STARTED|Treatment Period 3||17
8728450|NCT01048333|9775570|FG005|STARTED|Treatment Period 3||18
8728451|NCT01048333|9775565|FG000|COMPLETED|Treatment Period 3||21
8728452|NCT01048333|9775566|FG001|COMPLETED|Treatment Period 3||18
8728453|NCT01048333|9775567|FG002|COMPLETED|Treatment Period 3||16
8728454|NCT01048333|9775568|FG003|COMPLETED|Treatment Period 3||18
8728455|NCT01048333|9775569|FG004|COMPLETED|Treatment Period 3||17
8728456|NCT01048333|9775570|FG005|COMPLETED|Treatment Period 3||18
8728457|NCT01048333|9775565|FG000|NOT COMPLETED|Treatment Period 3||0
8728458|NCT01048333|9775566|FG001|NOT COMPLETED|Treatment Period 3||0
8728459|NCT01048333|9775567|FG002|NOT COMPLETED|Treatment Period 3||0
8728460|NCT01048333|9775568|FG003|NOT COMPLETED|Treatment Period 3||0
8728461|NCT01048333|9775569|FG004|NOT COMPLETED|Treatment Period 3||0
8728462|NCT01048333|9775570|FG005|NOT COMPLETED|Treatment Period 3||0
8728463|NCT01048424|9775580|FG000|STARTED|Overall Study||10
8728464|NCT01048424|9775581|FG001|STARTED|Overall Study||10
8728465|NCT01048424|9775580|FG000|COMPLETED|Overall Study||8
8728466|NCT01048424|9775581|FG001|COMPLETED|Overall Study||10
8728467|NCT01048424|9775580|FG000|NOT COMPLETED|Overall Study||2
8728468|NCT01048424|9775581|FG001|NOT COMPLETED|Overall Study||0
8728469|NCT01048502|9775592|FG000|STARTED|Overall Study||24
8651500|NCT00641745|9693130|FG000|NOT COMPLETED|Overall Study||280
8728470|NCT01048502|9775593|FG001|STARTED|Overall Study||23
8728471|NCT01048502|9775594|FG002|STARTED|Overall Study||28
8728472|NCT01048502|9775595|FG003|STARTED|Overall Study||25
8651501|NCT00641745|9693131|FG001|NOT COMPLETED|Overall Study||113
8651502|NCT00641797|9693139|FG000|STARTED|Overall Study||11
8651503|NCT00641797|9693140|FG001|STARTED|Overall Study||15
8651504|NCT00641797|9693139|FG000|COMPLETED|Overall Study||11
8651505|NCT00641797|9693140|FG001|COMPLETED|Overall Study||15
8651506|NCT00641797|9693139|FG000|NOT COMPLETED|Overall Study||0
8651507|NCT00641797|9693140|FG001|NOT COMPLETED|Overall Study||0
8651508|NCT00641862|9693148|FG000|STARTED|Overall Study||183
8651509|NCT00641862|9693149|FG001|STARTED|Overall Study||183
8651510|NCT00641862|9693148|FG000|COMPLETED|Overall Study||139
8651511|NCT00641862|9693149|FG001|COMPLETED|Overall Study||145
8651512|NCT00641862|9693148|FG000|NOT COMPLETED|Overall Study||44
8651513|NCT00641862|9693149|FG001|NOT COMPLETED|Overall Study||38
8651514|NCT00642018|9693157|FG000|STARTED|Overall Study||52
8651515|NCT00642018|9693158|FG001|STARTED|Overall Study||102
8651516|NCT00642018|9693157|FG000|Received at Least One Dose of Study Drug|Overall Study||51
8651517|NCT00642018|9693158|FG001|Received at Least One Dose of Study Drug|Overall Study||98
8651518|NCT00642018|9693157|FG000|COMPLETED|Overall Study|Participants who completed 10 cycles of treatment.|24
8651519|NCT00642018|9693158|FG001|COMPLETED|Overall Study|Participants who completed 10 cycles of treatment.|23
8651520|NCT00642018|9693157|FG000|NOT COMPLETED|Overall Study||28
8651521|NCT00642018|9693158|FG001|NOT COMPLETED|Overall Study||79
8651522|NCT00642174|9693167|FG000|STARTED|Period 1 - Initial Drug||18
8651523|NCT00642174|9693168|FG001|STARTED|Period 1 - Initial Drug||17
8651524|NCT00642174|9693167|FG000|COMPLETED|Period 1 - Initial Drug||18
8651525|NCT00642174|9693168|FG001|COMPLETED|Period 1 - Initial Drug||16
8651526|NCT00642174|9693167|FG000|NOT COMPLETED|Period 1 - Initial Drug||0
8651527|NCT00642174|9693168|FG001|NOT COMPLETED|Period 1 - Initial Drug||1
8651528|NCT00642174|9693167|FG000|STARTED|Period 2 - Crossover Drug||18
8651529|NCT00642174|9693168|FG001|STARTED|Period 2 - Crossover Drug||16
8651530|NCT00642174|9693167|FG000|COMPLETED|Period 2 - Crossover Drug||18
8651531|NCT00642174|9693168|FG001|COMPLETED|Period 2 - Crossover Drug||16
8651532|NCT00642174|9693167|FG000|NOT COMPLETED|Period 2 - Crossover Drug||0
8651533|NCT00642174|9693168|FG001|NOT COMPLETED|Period 2 - Crossover Drug||0
8651534|NCT00642278|9693181|FG000|STARTED|Overall Study||65
8651535|NCT00642278|9693182|FG001|STARTED|Overall Study||64
8651536|NCT00642278|9693183|FG002|STARTED|Overall Study||64
8651537|NCT00642278|9693184|FG003|STARTED|Overall Study||65
8651538|NCT00642278|9693185|FG004|STARTED|Overall Study||64
8651539|NCT00642278|9693186|FG005|STARTED|Overall Study||64
8651540|NCT00642278|9693187|FG006|STARTED|Overall Study||65
8651541|NCT00642278|9693181|FG000|COMPLETED|Overall Study||55
8651542|NCT00642278|9693182|FG001|COMPLETED|Overall Study||59
8651543|NCT00642278|9693183|FG002|COMPLETED|Overall Study||59
8651544|NCT00642278|9693184|FG003|COMPLETED|Overall Study||56
8651545|NCT00642278|9693185|FG004|COMPLETED|Overall Study||56
8651546|NCT00642278|9693186|FG005|COMPLETED|Overall Study||57
8651547|NCT00642278|9693187|FG006|COMPLETED|Overall Study||60
8651548|NCT00642278|9693181|FG000|NOT COMPLETED|Overall Study||10
8651549|NCT00642278|9693182|FG001|NOT COMPLETED|Overall Study||5
8651550|NCT00642278|9693183|FG002|NOT COMPLETED|Overall Study||5
8651551|NCT00642278|9693184|FG003|NOT COMPLETED|Overall Study||9
8651552|NCT00642278|9693185|FG004|NOT COMPLETED|Overall Study||8
8651553|NCT00642278|9693186|FG005|NOT COMPLETED|Overall Study||7
8651554|NCT00642278|9693187|FG006|NOT COMPLETED|Overall Study||5
8651555|NCT00642304|9693203|FG000|STARTED|Overall Study||20
8651556|NCT00642304|9693203|FG000|COMPLETED|Overall Study||14
8651557|NCT00642304|9693203|FG000|NOT COMPLETED|Overall Study||6
8651558|NCT00642356|9693209|FG000|STARTED|Overall Study||7
8651559|NCT00642356|9693210|FG001|STARTED|Overall Study||7
8651560|NCT00642356|9693209|FG000|COMPLETED|Overall Study||5
8651561|NCT00642356|9693210|FG001|COMPLETED|Overall Study||4
8651562|NCT00642356|9693209|FG000|NOT COMPLETED|Overall Study||2
8651563|NCT00642356|9693210|FG001|NOT COMPLETED|Overall Study||3
8651564|NCT00642369|9693218|FG000|STARTED|Overall Study||30
8651565|NCT00642369|9693219|FG001|STARTED|Overall Study||30
8651566|NCT00642369|9693218|FG000|COMPLETED|Overall Study||25
8651567|NCT00642369|9693219|FG001|COMPLETED|Overall Study||24
8651568|NCT00642369|9693218|FG000|NOT COMPLETED|Overall Study||5
8651569|NCT00642369|9693219|FG001|NOT COMPLETED|Overall Study||6
8651570|NCT00642460|9693229|FG000|STARTED|Part I: 12 Week Double-Blind||37
8651571|NCT00642460|9693230|FG001|STARTED|Part I: 12 Week Double-Blind||38
8651572|NCT00642460|9693231|FG002|STARTED|Part I: 12 Week Double-Blind||37
8651573|NCT00642460|9693232|FG003|STARTED|Part I: 12 Week Double-Blind||0
8651574|NCT00642460|9693233|FG004|STARTED|Part I: 12 Week Double-Blind||0
8651575|NCT00642460|9693234|FG005|STARTED|Part I: 12 Week Double-Blind||0
8651576|NCT00642460|9693229|FG000|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||37
8651577|NCT00642460|9693230|FG001|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||38
8651578|NCT00642460|9693231|FG002|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||37
8651579|NCT00642460|9693232|FG003|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||0
8651580|NCT00642460|9693233|FG004|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||0
8651581|NCT00642460|9693234|FG005|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||0
8651582|NCT00642460|9693229|FG000|COMPLETED|Part I: 12 Week Double-Blind||36
8651583|NCT00642460|9693230|FG001|COMPLETED|Part I: 12 Week Double-Blind||37
8651584|NCT00642460|9693231|FG002|COMPLETED|Part I: 12 Week Double-Blind||36
8651585|NCT00642460|9693232|FG003|COMPLETED|Part I: 12 Week Double-Blind||0
8651586|NCT00642460|9693233|FG004|COMPLETED|Part I: 12 Week Double-Blind||0
8651587|NCT00642460|9693234|FG005|COMPLETED|Part I: 12 Week Double-Blind||0
8651588|NCT00642460|9693229|FG000|NOT COMPLETED|Part I: 12 Week Double-Blind||1
8651589|NCT00642460|9693230|FG001|NOT COMPLETED|Part I: 12 Week Double-Blind||1
8651590|NCT00642460|9693231|FG002|NOT COMPLETED|Part I: 12 Week Double-Blind||1
8651591|NCT00642460|9693232|FG003|NOT COMPLETED|Part I: 12 Week Double-Blind||0
8651592|NCT00642460|9693233|FG004|NOT COMPLETED|Part I: 12 Week Double-Blind||0
8651593|NCT00642460|9693234|FG005|NOT COMPLETED|Part I: 12 Week Double-Blind||0
8651594|NCT00642460|9693229|FG000|STARTED|Part II: Open-Label Up to Week 92|Includes Participants who received Open-Label in Part II or Open-Label escape therapy in Part I.|52
8651595|NCT00642460|9693230|FG001|STARTED|Part II: Open-Label Up to Week 92||40
8651596|NCT00642460|9693231|FG002|STARTED|Part II: Open-Label Up to Week 92|Placebo group received open-label Tocilizumab 8 mg/kg or 12 mg/kg based on body weight in Part II.|0
8651597|NCT00642460|9693232|FG003|STARTED|Part II: Open-Label Up to Week 92|19 Participants switched from 12 mg/kg to 8 mg/kg and 1 Participant switched from 8mg/kg to 12 mg/kg|20
8651598|NCT00642460|9693233|FG004|STARTED|Part II: Open-Label Up to Week 92||0
8651599|NCT00642460|9693234|FG005|STARTED|Part II: Open-Label Up to Week 92||0
8651600|NCT00642460|9693229|FG000|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||52
8651601|NCT00642460|9693230|FG001|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||40
8651602|NCT00642460|9693231|FG002|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||0
8651603|NCT00642460|9693232|FG003|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||20
8651604|NCT00642460|9693233|FG004|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||0
8651605|NCT00642460|9693234|FG005|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||0
8651606|NCT00642460|9693229|FG000|COMPLETED|Part II: Open-Label Up to Week 92||43
8651607|NCT00642460|9693230|FG001|COMPLETED|Part II: Open-Label Up to Week 92||32
8651608|NCT00642460|9693231|FG002|COMPLETED|Part II: Open-Label Up to Week 92||0
8651609|NCT00642460|9693232|FG003|COMPLETED|Part II: Open-Label Up to Week 92||17
8651610|NCT00642460|9693233|FG004|COMPLETED|Part II: Open-Label Up to Week 92||0
8651611|NCT00642460|9693234|FG005|COMPLETED|Part II: Open-Label Up to Week 92||0
8651612|NCT00642460|9693229|FG000|NOT COMPLETED|Part II: Open-Label Up to Week 92||9
8651613|NCT00642460|9693230|FG001|NOT COMPLETED|Part II: Open-Label Up to Week 92||8
8651614|NCT00642460|9693231|FG002|NOT COMPLETED|Part II: Open-Label Up to Week 92||0
8651615|NCT00642460|9693232|FG003|NOT COMPLETED|Part II: Open-Label Up to Week 92||3
8651616|NCT00642460|9693233|FG004|NOT COMPLETED|Part II: Open-Label Up to Week 92||0
8651617|NCT00642460|9693234|FG005|NOT COMPLETED|Part II: Open-Label Up to Week 92||0
8651618|NCT00642460|9693229|FG000|STARTED|Part III: Open-Label Up to Week 260||0
8651619|NCT00642460|9693230|FG001|STARTED|Part III: Open-Label Up to Week 260||0
8651620|NCT00642460|9693231|FG002|STARTED|Part III: Open-Label Up to Week 260||0
8651621|NCT00642460|9693232|FG003|STARTED|Part III: Open-Label Up to Week 260||0
8651622|NCT00642460|9693233|FG004|STARTED|Part III: Open-Label Up to Week 260||53
8651623|NCT00642460|9693234|FG005|STARTED|Part III: Open-Label Up to Week 260||59
8651624|NCT00642460|9693229|FG000|COMPLETED|Part III: Open-Label Up to Week 260||0
8651625|NCT00642460|9693230|FG001|COMPLETED|Part III: Open-Label Up to Week 260||0
8651626|NCT00642460|9693231|FG002|COMPLETED|Part III: Open-Label Up to Week 260||0
8651627|NCT00642460|9693232|FG003|COMPLETED|Part III: Open-Label Up to Week 260||0
8651628|NCT00642460|9693233|FG004|COMPLETED|Part III: Open-Label Up to Week 260||28
8651629|NCT00642460|9693234|FG005|COMPLETED|Part III: Open-Label Up to Week 260||38
8651630|NCT00642460|9693229|FG000|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
8651631|NCT00642460|9693230|FG001|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
8651632|NCT00642460|9693231|FG002|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
8651633|NCT00642460|9693232|FG003|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
8651634|NCT00642460|9693233|FG004|NOT COMPLETED|Part III: Open-Label Up to Week 260||25
8651635|NCT00642460|9693234|FG005|NOT COMPLETED|Part III: Open-Label Up to Week 260||21
8651636|NCT00642473|9693246|FG000|STARTED|Overall Study||18
8651637|NCT00642473|9693247|FG001|STARTED|Overall Study||16
8651638|NCT00642473|9693246|FG000|COMPLETED|Overall Study||14
8651639|NCT00642473|9693247|FG001|COMPLETED|Overall Study||5
8651640|NCT00642473|9693246|FG000|NOT COMPLETED|Overall Study||4
8651641|NCT00642473|9693247|FG001|NOT COMPLETED|Overall Study||11
8651642|NCT00642616|9693260|FG000|STARTED|Overall Study||9
8651643|NCT00642616|9693261|FG001|STARTED|Overall Study||8
8651644|NCT00642616|9693262|FG002|STARTED|Overall Study||9
8651645|NCT00642616|9693263|FG003|STARTED|Overall Study||8
8651646|NCT00642616|9693260|FG000|COMPLETED|Overall Study||0
8651647|NCT00642616|9693261|FG001|COMPLETED|Overall Study||1
8651648|NCT00642616|9693262|FG002|COMPLETED|Overall Study||0
8651649|NCT00642616|9693263|FG003|COMPLETED|Overall Study||1
8651650|NCT00642616|9693260|FG000|NOT COMPLETED|Overall Study||9
8651651|NCT00642616|9693261|FG001|NOT COMPLETED|Overall Study||7
8651652|NCT00642616|9693262|FG002|NOT COMPLETED|Overall Study||9
8651653|NCT00642616|9693263|FG003|NOT COMPLETED|Overall Study||7
8651654|NCT00642642|9693275|FG000|STARTED|Biopsy & Product Manufacture||122
8651655|NCT00642642|9693275|FG000|COMPLETED|Biopsy & Product Manufacture|Patients biopsied and for whom study product could be produced are considered completed|109
8651656|NCT00642642|9693275|FG000|NOT COMPLETED|Biopsy & Product Manufacture||13
8651657|NCT00642642|9693275|FG000|STARTED|Treatment & Follow Up||109
8651658|NCT00642642|9693275|FG000|COMPLETED|Treatment & Follow Up||92
8651659|NCT00642642|9693275|FG000|NOT COMPLETED|Treatment & Follow Up||17
8651660|NCT00642668|9693285|FG000|STARTED|Overall Study||35
8651661|NCT00642668|9693285|FG000|COMPLETED|Overall Study||21
8651662|NCT00642668|9693285|FG000|NOT COMPLETED|Overall Study||14
8651663|NCT00642694|9693291|FG000|STARTED|Overall Study||14
8651664|NCT00642694|9693292|FG001|STARTED|Overall Study||15
8651665|NCT00642694|9693291|FG000|COMPLETED|Overall Study||8
8651666|NCT00642694|9693292|FG001|COMPLETED|Overall Study||11
8651667|NCT00642694|9693291|FG000|NOT COMPLETED|Overall Study||6
8651668|NCT00642694|9693292|FG001|NOT COMPLETED|Overall Study||4
8651669|NCT00642707|9693302|FG000|STARTED|Overall Study||11
8651670|NCT00642707|9693303|FG001|STARTED|Overall Study||11
8651671|NCT00642707|9693304|FG002|STARTED|Overall Study||12
8651672|NCT00642707|9693305|FG003|STARTED|Overall Study||10
8651673|NCT00642707|9693302|FG000|COMPLETED|Overall Study||10
8651674|NCT00642707|9693303|FG001|COMPLETED|Overall Study||11
8651675|NCT00642707|9693304|FG002|COMPLETED|Overall Study||12
8651676|NCT00642707|9693305|FG003|COMPLETED|Overall Study||8
8651677|NCT00642707|9693302|FG000|NOT COMPLETED|Overall Study||1
8651678|NCT00642707|9693303|FG001|NOT COMPLETED|Overall Study||0
8651679|NCT00642707|9693304|FG002|NOT COMPLETED|Overall Study||0
8651680|NCT00642707|9693305|FG003|NOT COMPLETED|Overall Study||2
8651681|NCT00642746|9693317|FG000|STARTED|Overall Study||10
8651682|NCT00642746|9693318|FG001|STARTED|Overall Study||1
8651683|NCT00642746|9693317|FG000|COMPLETED|Overall Study||9
8651684|NCT00642746|9693318|FG001|COMPLETED|Overall Study||1
8651685|NCT00642746|9693317|FG000|NOT COMPLETED|Overall Study||1
8651686|NCT00642746|9693318|FG001|NOT COMPLETED|Overall Study||0
8651687|NCT00642759|9693324|FG000|STARTED|Overall Study||36
8651688|NCT00642759|9693324|FG000|COMPLETED|Overall Study||35
8651689|NCT00642759|9693324|FG000|NOT COMPLETED|Overall Study||1
8651690|NCT00642772|9693329|FG000|STARTED|Overall Study||24
8651691|NCT00642772|9693329|FG000|COMPLETED|Overall Study||14
8651692|NCT00642772|9693329|FG000|NOT COMPLETED|Overall Study||10
8651693|NCT00642811|9693339|FG000|STARTED|Overall Study||20
8651694|NCT00642811|9693340|FG001|STARTED|Overall Study||21
8651695|NCT00642811|9693341|FG002|STARTED|Overall Study||13
8651696|NCT00642811|9693342|FG003|STARTED|Overall Study||16
8728473|NCT01048502|9775592|FG000|COMPLETED|Overall Study||20
8728474|NCT01048502|9775593|FG001|COMPLETED|Overall Study||16
8728475|NCT01048502|9775594|FG002|COMPLETED|Overall Study||23
8728476|NCT01048502|9775595|FG003|COMPLETED|Overall Study||21
8728477|NCT01048502|9775592|FG000|NOT COMPLETED|Overall Study||4
8728478|NCT01048502|9775593|FG001|NOT COMPLETED|Overall Study||7
8728479|NCT01048502|9775594|FG002|NOT COMPLETED|Overall Study||5
8728480|NCT01048502|9775595|FG003|NOT COMPLETED|Overall Study||4
8728481|NCT01048541|9775606|FG000|STARTED|Overall Study||18
8728482|NCT01048541|9775607|FG001|STARTED|Overall Study||19
8728483|NCT01048541|9775606|FG000|COMPLETED|Overall Study||17
8728484|NCT01048541|9775607|FG001|COMPLETED|Overall Study||19
8728485|NCT01048541|9775606|FG000|NOT COMPLETED|Overall Study||1
8728486|NCT01048541|9775607|FG001|NOT COMPLETED|Overall Study||0
8728487|NCT01048593|9775616|FG000|STARTED|Overall Study||3
8728488|NCT01048593|9775617|FG001|STARTED|Overall Study||2
8728489|NCT01048593|9775618|FG002|STARTED|Overall Study||1
8728490|NCT01048593|9775616|FG000|COMPLETED|Overall Study||3
8728491|NCT01048593|9775617|FG001|COMPLETED|Overall Study||2
8728492|NCT01048593|9775618|FG002|COMPLETED|Overall Study||1
8728493|NCT01048593|9775616|FG000|NOT COMPLETED|Overall Study||0
8728494|NCT01048593|9775617|FG001|NOT COMPLETED|Overall Study||0
8728495|NCT01048593|9775618|FG002|NOT COMPLETED|Overall Study||0
8728496|NCT01048606|9775630|FG000|STARTED|Overall Study||28
8728497|NCT01048606|9775631|FG001|STARTED|Overall Study||15
8728498|NCT01048606|9775632|FG002|STARTED|Overall Study||26
8728499|NCT01048606|9775633|FG003|STARTED|Overall Study||10
8728500|NCT01048606|9775630|FG000|COMPLETED|Overall Study||16
8728501|NCT01048606|9775631|FG001|COMPLETED|Overall Study||8
8728502|NCT01048606|9775632|FG002|COMPLETED|Overall Study||16
8728503|NCT01048606|9775633|FG003|COMPLETED|Overall Study||5
8728504|NCT01048606|9775630|FG000|NOT COMPLETED|Overall Study||12
8728505|NCT01048606|9775631|FG001|NOT COMPLETED|Overall Study||7
8728506|NCT01048606|9775632|FG002|NOT COMPLETED|Overall Study||10
8728507|NCT01048606|9775633|FG003|NOT COMPLETED|Overall Study||5
8728508|NCT01048658|9775645|FG000|STARTED|Overall Study||80
8728509|NCT01048658|9775646|FG001|STARTED|Overall Study||80
8728510|NCT01048658|9775645|FG000|COMPLETED|Overall Study||80
8728511|NCT01048658|9775646|FG001|COMPLETED|Overall Study||80
8728512|NCT01048658|9775645|FG000|NOT COMPLETED|Overall Study||0
8728513|NCT01048658|9775646|FG001|NOT COMPLETED|Overall Study||0
8728514|NCT01048671|9775655|FG000|STARTED|Overall Study||66
8728515|NCT01048671|9775656|FG001|STARTED|Overall Study||264
8728516|NCT01048671|9775657|FG002|STARTED|Overall Study||152
8728517|NCT01048671|9775655|FG000|COMPLETED|Overall Study||66
8728518|NCT01048671|9775656|FG001|COMPLETED|Overall Study||263
8728519|NCT01048671|9775657|FG002|COMPLETED|Overall Study||151
8728520|NCT01048671|9775655|FG000|NOT COMPLETED|Overall Study||0
8728521|NCT01048671|9775656|FG001|NOT COMPLETED|Overall Study||1
8651697|NCT00642811|9693343|FG004|STARTED|Overall Study||14
8651698|NCT00642811|9693344|FG005|STARTED|Overall Study||14
8651699|NCT00642811|9693339|FG000|COMPLETED|Overall Study||17
8651700|NCT00642811|9693340|FG001|COMPLETED|Overall Study||17
8651701|NCT00642811|9693341|FG002|COMPLETED|Overall Study||13
8651702|NCT00642811|9693342|FG003|COMPLETED|Overall Study||15
8651703|NCT00642811|9693343|FG004|COMPLETED|Overall Study||13
8651704|NCT00642811|9693344|FG005|COMPLETED|Overall Study||13
8651705|NCT00642811|9693339|FG000|NOT COMPLETED|Overall Study||3
8651706|NCT00642811|9693340|FG001|NOT COMPLETED|Overall Study||4
8651707|NCT00642811|9693341|FG002|NOT COMPLETED|Overall Study||0
8728522|NCT01048671|9775657|FG002|NOT COMPLETED|Overall Study||1
8728523|NCT01048697|9775665|FG000|STARTED|Overall Study||18
8728524|NCT01048697|9775665|FG000|COMPLETED|Overall Study||18
8728525|NCT01048697|9775665|FG000|NOT COMPLETED|Overall Study||0
8728526|NCT01048788|9775672|FG000|STARTED|Overall Study||8
8728527|NCT01048788|9775673|FG001|STARTED|Overall Study||30
8728528|NCT01048788|9775674|FG002|STARTED|Overall Study||13
8651708|NCT00642811|9693342|FG003|NOT COMPLETED|Overall Study||1
8651709|NCT00642811|9693343|FG004|NOT COMPLETED|Overall Study||1
8651710|NCT00642811|9693344|FG005|NOT COMPLETED|Overall Study||1
8651711|NCT00642850|9693358|FG000|STARTED|Overall Study||188
8651712|NCT00642850|9693358|FG000|COMPLETED|Overall Study||155
8651713|NCT00642850|9693358|FG000|NOT COMPLETED|Overall Study||33
8651714|NCT00642902|9693366|FG000|STARTED|Overall Study||63
8651715|NCT00642902|9693367|FG001|STARTED|Overall Study||63
8651716|NCT00642902|9693368|FG002|STARTED|Overall Study||64
8651717|NCT00642902|9693369|FG003|STARTED|Overall Study||65
8651718|NCT00642902|9693366|FG000|Treated|Overall Study||63
8651719|NCT00642902|9693367|FG001|Treated|Overall Study||63
8651720|NCT00642902|9693368|FG002|Treated|Overall Study||63
8651721|NCT00642902|9693369|FG003|Treated|Overall Study||65
8651722|NCT00642902|9693366|FG000|COMPLETED|Overall Study||23
8651723|NCT00642902|9693367|FG001|COMPLETED|Overall Study||21
8651724|NCT00642902|9693368|FG002|COMPLETED|Overall Study||21
8651725|NCT00642902|9693369|FG003|COMPLETED|Overall Study||25
8651726|NCT00642902|9693366|FG000|NOT COMPLETED|Overall Study||40
8651727|NCT00642902|9693367|FG001|NOT COMPLETED|Overall Study||42
8651728|NCT00642902|9693368|FG002|NOT COMPLETED|Overall Study||43
8651729|NCT00642902|9693369|FG003|NOT COMPLETED|Overall Study||40
8651730|NCT00642941|9693391|FG000|STARTED|Overall Study||70
8651731|NCT00642941|9693392|FG001|STARTED|Overall Study||54
8651732|NCT00642941|9693393|FG002|STARTED|Overall Study||7
8651733|NCT00642941|9693394|FG003|STARTED|Overall Study||40
8651734|NCT00642941|9693395|FG004|STARTED|Overall Study||25
8651735|NCT00642941|9693396|FG005|STARTED|Overall Study||41
8651736|NCT00642941|9693397|FG006|STARTED|Overall Study||23
8651737|NCT00642941|9693398|FG007|STARTED|Overall Study||14
8651738|NCT00642941|9693399|FG008|STARTED|Overall Study||11
8651739|NCT00642941|9693400|FG009|STARTED|Overall Study||9
8651740|NCT00642941|9693401|FG010|STARTED|Overall Study||12
8651741|NCT00642941|9693402|FG011|STARTED|Overall Study||11
8651742|NCT00642941|9693391|FG000|COMPLETED|Overall Study||0
8651743|NCT00642941|9693392|FG001|COMPLETED|Overall Study||0
8651744|NCT00642941|9693393|FG002|COMPLETED|Overall Study||0
8651745|NCT00642941|9693394|FG003|COMPLETED|Overall Study||0
8651746|NCT00642941|9693395|FG004|COMPLETED|Overall Study||0
8651747|NCT00642941|9693396|FG005|COMPLETED|Overall Study||0
8651748|NCT00642941|9693397|FG006|COMPLETED|Overall Study||0
8651749|NCT00642941|9693398|FG007|COMPLETED|Overall Study||0
8651750|NCT00642941|9693399|FG008|COMPLETED|Overall Study||0
8651751|NCT00642941|9693400|FG009|COMPLETED|Overall Study||0
8651752|NCT00642941|9693401|FG010|COMPLETED|Overall Study||0
8651753|NCT00642941|9693402|FG011|COMPLETED|Overall Study||0
8651754|NCT00642941|9693391|FG000|NOT COMPLETED|Overall Study||70
8651755|NCT00642941|9693392|FG001|NOT COMPLETED|Overall Study||54
8651756|NCT00642941|9693393|FG002|NOT COMPLETED|Overall Study||7
8651757|NCT00642941|9693394|FG003|NOT COMPLETED|Overall Study||40
8651758|NCT00642941|9693395|FG004|NOT COMPLETED|Overall Study||25
8651759|NCT00642941|9693396|FG005|NOT COMPLETED|Overall Study||41
8651760|NCT00642941|9693397|FG006|NOT COMPLETED|Overall Study||23
8651761|NCT00642941|9693398|FG007|NOT COMPLETED|Overall Study||14
8651762|NCT00642941|9693399|FG008|NOT COMPLETED|Overall Study||11
8651763|NCT00642941|9693400|FG009|NOT COMPLETED|Overall Study||9
8651764|NCT00642941|9693401|FG010|NOT COMPLETED|Overall Study||12
8651765|NCT00642941|9693402|FG011|NOT COMPLETED|Overall Study||11
8651766|NCT00642954|9693454|FG000|STARTED|Overall Study||4
8651767|NCT00642954|9693455|FG001|STARTED|Overall Study||4
8651768|NCT00642954|9693456|FG002|STARTED|Overall Study||3
8651769|NCT00642954|9693457|FG003|STARTED|Overall Study||3
8651770|NCT00642954|9693458|FG004|STARTED|Overall Study||17
8651771|NCT00642954|9693454|FG000|COMPLETED|Overall Study||0
8651772|NCT00642954|9693455|FG001|COMPLETED|Overall Study||0
8651773|NCT00642954|9693456|FG002|COMPLETED|Overall Study||0
8651774|NCT00642954|9693457|FG003|COMPLETED|Overall Study||0
8651775|NCT00642954|9693458|FG004|COMPLETED|Overall Study||1
8651776|NCT00642954|9693454|FG000|NOT COMPLETED|Overall Study||4
8651777|NCT00642954|9693455|FG001|NOT COMPLETED|Overall Study||4
8651778|NCT00642954|9693456|FG002|NOT COMPLETED|Overall Study||3
8651779|NCT00642954|9693457|FG003|NOT COMPLETED|Overall Study||3
8651780|NCT00642954|9693458|FG004|NOT COMPLETED|Overall Study||16
8651781|NCT00642993|9693472|FG000|STARTED|Overall Study||267
8728529|NCT01048788|9775672|FG000|COMPLETED|Overall Study||3
8651782|NCT00642993|9693473|FG001|STARTED|Overall Study||134
8651783|NCT00642993|9693472|FG000|COMPLETED|Overall Study||161
8651784|NCT00642993|9693473|FG001|COMPLETED|Overall Study||118
8651785|NCT00642993|9693472|FG000|NOT COMPLETED|Overall Study||106
8651786|NCT00642993|9693473|FG001|NOT COMPLETED|Overall Study||16
8651787|NCT00643006|9693481|FG000|STARTED|Overall Study||34
8651788|NCT00643006|9693482|FG001|STARTED|Overall Study||33
8651789|NCT00643006|9693481|FG000|COMPLETED|Overall Study||29
8651790|NCT00643006|9693482|FG001|COMPLETED|Overall Study||29
8651791|NCT00643006|9693481|FG000|NOT COMPLETED|Overall Study||5
8651792|NCT00643006|9693482|FG001|NOT COMPLETED|Overall Study||4
8651793|NCT00643097|9693493|FG000|STARTED|Overall Study||18
8651794|NCT00643097|9693494|FG001|STARTED|Overall Study||12
8651795|NCT00643097|9693495|FG002|STARTED|Overall Study||10
8651796|NCT00643097|9693493|FG000|COMPLETED|Overall Study||18
8651797|NCT00643097|9693494|FG001|COMPLETED|Overall Study||12
8651798|NCT00643097|9693495|FG002|COMPLETED|Overall Study||10
8651799|NCT00643097|9693493|FG000|NOT COMPLETED|Overall Study||0
8651800|NCT00643097|9693494|FG001|NOT COMPLETED|Overall Study||0
8651801|NCT00643097|9693495|FG002|NOT COMPLETED|Overall Study||0
8651802|NCT00643123|9693505|FG000|STARTED|Overall Study||15
8651803|NCT00643123|9693506|FG001|STARTED|Overall Study||12
8651804|NCT00643123|9693505|FG000|COMPLETED|Overall Study||10
8651805|NCT00643123|9693506|FG001|COMPLETED|Overall Study||11
8651806|NCT00643123|9693505|FG000|NOT COMPLETED|Overall Study||5
8651807|NCT00643123|9693506|FG001|NOT COMPLETED|Overall Study||1
8651808|NCT00643162|9693514|FG000|STARTED|Overall Study||7
8651809|NCT00643162|9693515|FG001|STARTED|Overall Study||5
8651810|NCT00643162|9693514|FG000|COMPLETED|Overall Study||6
8651811|NCT00643162|9693515|FG001|COMPLETED|Overall Study||4
8651812|NCT00643162|9693514|FG000|NOT COMPLETED|Overall Study||1
8651813|NCT00643162|9693515|FG001|NOT COMPLETED|Overall Study||1
8651814|NCT00643201|9693523|FG000|STARTED|Randomized, Completed 6 Months of Study|15 participants were randomized to treatment but not treated.|2691
8651815|NCT00643201|9693524|FG001|STARTED|Randomized, Completed 6 Months of Study|15 participants were randomized to treatment but not treated.|2704
8651816|NCT00643201|9693523|FG000|COMPLETED|Randomized, Completed 6 Months of Study||2314
8651817|NCT00643201|9693524|FG001|COMPLETED|Randomized, Completed 6 Months of Study||2291
8651818|NCT00643201|9693523|FG000|NOT COMPLETED|Randomized, Completed 6 Months of Study||377
8651819|NCT00643201|9693524|FG001|NOT COMPLETED|Randomized, Completed 6 Months of Study||413
8651820|NCT00643201|9693523|FG000|STARTED|Completed Study Follow Up||2617
8651821|NCT00643201|9693524|FG001|STARTED|Completed Study Follow Up||2639
8651822|NCT00643201|9693523|FG000|COMPLETED|Completed Study Follow Up|Of 70 who did not complete follow up: 7 completed treatment; 63 discontinued treatment|2547
8651823|NCT00643201|9693524|FG001|COMPLETED|Completed Study Follow Up|Of 79 who did not complete follow up: 3 completed treatment, 76 discontinued treatment|2560
8651824|NCT00643201|9693523|FG000|NOT COMPLETED|Completed Study Follow Up||70
8651825|NCT00643201|9693524|FG001|NOT COMPLETED|Completed Study Follow Up||79
8651826|NCT00643279|9693534|FG000|STARTED|Overall Study||134
8651827|NCT00643279|9693535|FG001|STARTED|Overall Study||140
8651828|NCT00643279|9693534|FG000|COMPLETED|Overall Study||118
8651829|NCT00643279|9693535|FG001|COMPLETED|Overall Study||127
8651830|NCT00643279|9693534|FG000|NOT COMPLETED|Overall Study||16
8651831|NCT00643279|9693535|FG001|NOT COMPLETED|Overall Study||13
8651832|NCT00643448|9693546|FG000|STARTED|Overall Study||21
8651833|NCT00643448|9693547|FG001|STARTED|Overall Study||22
8651834|NCT00643448|9693548|FG002|STARTED|Overall Study||22
8651835|NCT00643448|9693546|FG000|COMPLETED|Overall Study||17
8651836|NCT00643448|9693547|FG001|COMPLETED|Overall Study||17
8651837|NCT00643448|9693548|FG002|COMPLETED|Overall Study||16
8651838|NCT00643448|9693546|FG000|NOT COMPLETED|Overall Study||4
8651839|NCT00643448|9693547|FG001|NOT COMPLETED|Overall Study||5
8651840|NCT00643448|9693548|FG002|NOT COMPLETED|Overall Study||6
8651841|NCT00643487|9693558|FG000|STARTED|Overall Study||8
8651842|NCT00643487|9693558|FG000|COMPLETED|Overall Study||5
8651843|NCT00643487|9693558|FG000|NOT COMPLETED|Overall Study||3
8651844|NCT00643565|9693564|FG000|STARTED|Overall Study||80
8651845|NCT00643565|9693565|FG001|STARTED|Overall Study||74
8651846|NCT00643565|9693564|FG000|COMPLETED|Overall Study||7
8651847|NCT00643565|9693565|FG001|COMPLETED|Overall Study||7
8651848|NCT00643565|9693564|FG000|NOT COMPLETED|Overall Study||73
8651849|NCT00643565|9693565|FG001|NOT COMPLETED|Overall Study||67
8651850|NCT00643578|9693572|FG000|STARTED|Overall Study||6
8651851|NCT00643578|9693573|FG001|STARTED|Overall Study||6
8651852|NCT00643578|9693572|FG000|COMPLETED|Overall Study||4
8651853|NCT00643578|9693573|FG001|COMPLETED|Overall Study||6
8651854|NCT00643578|9693572|FG000|NOT COMPLETED|Overall Study||2
8651855|NCT00643578|9693573|FG001|NOT COMPLETED|Overall Study||0
8651856|NCT00643604|9693581|FG000|STARTED|Overall Study||7
8651857|NCT00643604|9693581|FG000|COMPLETED|Overall Study||6
8651858|NCT00643604|9693581|FG000|NOT COMPLETED|Overall Study||1
8651859|NCT00643682|9693587|FG000|STARTED|Overall Study||999
8651860|NCT00643682|9693588|FG001|STARTED|Overall Study||1001
8651861|NCT00643682|9693587|FG000|COMPLETED|Overall Study||477
8651862|NCT00643682|9693588|FG001|COMPLETED|Overall Study||492
8651863|NCT00643682|9693587|FG000|NOT COMPLETED|Overall Study||522
8651864|NCT00643682|9693588|FG001|NOT COMPLETED|Overall Study||509
8651865|NCT00643760|9693599|FG000|STARTED|Overall Study||120
8651866|NCT00643760|9693600|FG001|STARTED|Overall Study||62
8651867|NCT00643760|9693601|FG002|STARTED|Overall Study||56
8651868|NCT00643760|9693602|FG003|STARTED|Overall Study||117
8651869|NCT00643760|9693603|FG004|STARTED|Overall Study||66
8651870|NCT00643760|9693599|FG000|Safety Population/Treated With Drug|Overall Study||120
8651871|NCT00643760|9693600|FG001|Safety Population/Treated With Drug|Overall Study||62
8651872|NCT00643760|9693601|FG002|Safety Population/Treated With Drug|Overall Study||56
8651873|NCT00643760|9693602|FG003|Safety Population/Treated With Drug|Overall Study||116
8651874|NCT00643760|9693603|FG004|Safety Population/Treated With Drug|Overall Study||66
8651875|NCT00643760|9693599|FG000|ITT Population|Overall Study||120
8651876|NCT00643760|9693600|FG001|ITT Population|Overall Study||62
8651877|NCT00643760|9693601|FG002|ITT Population|Overall Study||56
8651878|NCT00643760|9693602|FG003|ITT Population|Overall Study||116
8651879|NCT00643760|9693603|FG004|ITT Population|Overall Study||66
8651880|NCT00643760|9693599|FG000|COMPLETED|Overall Study||90
8651881|NCT00643760|9693600|FG001|COMPLETED|Overall Study||47
8651882|NCT00643760|9693601|FG002|COMPLETED|Overall Study||37
8651883|NCT00643760|9693602|FG003|COMPLETED|Overall Study||79
8651884|NCT00643760|9693603|FG004|COMPLETED|Overall Study||47
8651885|NCT00643760|9693599|FG000|NOT COMPLETED|Overall Study||30
8651886|NCT00643760|9693600|FG001|NOT COMPLETED|Overall Study||15
8651887|NCT00643760|9693601|FG002|NOT COMPLETED|Overall Study||19
8651888|NCT00643760|9693602|FG003|NOT COMPLETED|Overall Study||38
8651889|NCT00643760|9693603|FG004|NOT COMPLETED|Overall Study||19
8651890|NCT00643851|9693618|FG000|STARTED|Overall Study||194
8651891|NCT00643851|9693619|FG001|STARTED|Overall Study||203
8651892|NCT00643851|9693620|FG002|STARTED|Overall Study||201
8651893|NCT00643851|9693618|FG000|COMPLETED|Overall Study||177
8651894|NCT00643851|9693619|FG001|COMPLETED|Overall Study||170
8651895|NCT00643851|9693620|FG002|COMPLETED|Overall Study||171
8651896|NCT00643851|9693618|FG000|NOT COMPLETED|Overall Study||17
8651897|NCT00643851|9693619|FG001|NOT COMPLETED|Overall Study||33
8651898|NCT00643851|9693620|FG002|NOT COMPLETED|Overall Study||30
8651899|NCT00643916|9693634|FG000|STARTED|Overall Study||55
8651900|NCT00643916|9693635|FG001|STARTED|Overall Study||67
8651901|NCT00643916|9693636|FG002|STARTED|Overall Study||68
8651902|NCT00643916|9693637|FG003|STARTED|Overall Study||62
8651903|NCT00643916|9693638|FG004|STARTED|Overall Study||59
8651904|NCT00643916|9693639|FG005|STARTED|Overall Study||67
8651905|NCT00643916|9693634|FG000|COMPLETED|Overall Study||51
8651906|NCT00643916|9693635|FG001|COMPLETED|Overall Study||61
8651907|NCT00643916|9693636|FG002|COMPLETED|Overall Study||62
8651908|NCT00643916|9693637|FG003|COMPLETED|Overall Study||60
8651909|NCT00643916|9693638|FG004|COMPLETED|Overall Study||57
8651910|NCT00643916|9693639|FG005|COMPLETED|Overall Study||66
8651911|NCT00643916|9693634|FG000|NOT COMPLETED|Overall Study||4
8651912|NCT00643916|9693635|FG001|NOT COMPLETED|Overall Study||6
8651913|NCT00643916|9693636|FG002|NOT COMPLETED|Overall Study||6
8651914|NCT00643916|9693637|FG003|NOT COMPLETED|Overall Study||2
8651915|NCT00643916|9693638|FG004|NOT COMPLETED|Overall Study||2
8651916|NCT00643916|9693639|FG005|NOT COMPLETED|Overall Study||1
8651917|NCT00644059|9693656|FG000|STARTED|Overall Study||2019
8651918|NCT00644059|9693657|FG001|STARTED|Overall Study||1849
8651919|NCT00644059|9693658|FG002|STARTED|Overall Study||1034
8651920|NCT00644059|9693656|FG000|COMPLETED|Overall Study||1895
8651921|NCT00644059|9693657|FG001|COMPLETED|Overall Study||1726
8651922|NCT00644059|9693658|FG002|COMPLETED|Overall Study||969
8651923|NCT00644059|9693656|FG000|NOT COMPLETED|Overall Study||124
8651924|NCT00644059|9693657|FG001|NOT COMPLETED|Overall Study||123
8651925|NCT00644059|9693658|FG002|NOT COMPLETED|Overall Study||65
8651926|NCT00644189|9693707|FG000|STARTED|Phase I||3
8651927|NCT00644189|9693708|FG001|STARTED|Phase I||3
8651928|NCT00644189|9693709|FG002|STARTED|Phase I||6
8651929|NCT00644189|9693710|FG003|STARTED|Phase I||18
8651930|NCT00644189|9693707|FG000|COMPLETED|Phase I||3
8651931|NCT00644189|9693708|FG001|COMPLETED|Phase I||3
8651932|NCT00644189|9693709|FG002|COMPLETED|Phase I||6
8651933|NCT00644189|9693710|FG003|COMPLETED|Phase I||18
8651934|NCT00644189|9693707|FG000|NOT COMPLETED|Phase I||0
8651935|NCT00644189|9693708|FG001|NOT COMPLETED|Phase I||0
8651936|NCT00644189|9693709|FG002|NOT COMPLETED|Phase I||0
8651937|NCT00644189|9693710|FG003|NOT COMPLETED|Phase I||0
8651938|NCT00644189|9693707|FG000|STARTED|Phase II|All phase I participants were included in the 3mg Phase II dose group|0
8651939|NCT00644189|9693708|FG001|STARTED|Phase II|All phase I participants were included in the 3mg Phase II dose group|0
8651940|NCT00644189|9693709|FG002|STARTED|Phase II|All phase I participants were included in the 3mg Phase II dose group|0
8651941|NCT00644189|9693710|FG003|STARTED|Phase II|Additional participants were added to the phase I sample at the phase II 3mg dose level|50
8651942|NCT00644189|9693707|FG000|Completed All 6 Cycles of Treatment|Phase II||0
8651943|NCT00644189|9693708|FG001|Completed All 6 Cycles of Treatment|Phase II||0
8651944|NCT00644189|9693709|FG002|Completed All 6 Cycles of Treatment|Phase II||0
8651945|NCT00644189|9693710|FG003|Completed All 6 Cycles of Treatment|Phase II||19
8651946|NCT00644189|9693707|FG000|COMPLETED|Phase II||0
8651947|NCT00644189|9693708|FG001|COMPLETED|Phase II||0
8651948|NCT00644189|9693709|FG002|COMPLETED|Phase II||0
8651949|NCT00644189|9693710|FG003|COMPLETED|Phase II||50
8651950|NCT00644189|9693707|FG000|NOT COMPLETED|Phase II||0
8651951|NCT00644189|9693708|FG001|NOT COMPLETED|Phase II||0
8651952|NCT00644189|9693709|FG002|NOT COMPLETED|Phase II||0
8651953|NCT00644189|9693710|FG003|NOT COMPLETED|Phase II||0
8651954|NCT00644280|9693718|FG000|STARTED|Overall Study||6
8651955|NCT00644280|9693719|FG001|STARTED|Overall Study||5
8651956|NCT00644280|9693718|FG000|COMPLETED|Overall Study||6
8651957|NCT00644280|9693719|FG001|COMPLETED|Overall Study||5
8651958|NCT00644280|9693718|FG000|NOT COMPLETED|Overall Study||0
8651959|NCT00644280|9693719|FG001|NOT COMPLETED|Overall Study||0
8651960|NCT00644332|9693725|FG000|STARTED|Overall Study|172 patients were enrolled; one withdrew consent prior to starting treatment|171
8651961|NCT00644332|9693725|FG000|COMPLETED|Overall Study||150
8651962|NCT00644332|9693725|FG000|NOT COMPLETED|Overall Study||21
8651963|NCT00644358|9693729|FG000|STARTED|Overall Study||616
8651964|NCT00644358|9693729|FG000|COMPLETED|Overall Study||254
8651965|NCT00644358|9693729|FG000|NOT COMPLETED|Overall Study||362
8651966|NCT00644423|9693735|FG000|STARTED|Overall Study||6
8651967|NCT00644423|9693736|FG001|STARTED|Overall Study||5
8651968|NCT00644423|9693735|FG000|COMPLETED|Overall Study||5
8651969|NCT00644423|9693736|FG001|COMPLETED|Overall Study||4
8651970|NCT00644423|9693735|FG000|NOT COMPLETED|Overall Study||1
8651971|NCT00644423|9693736|FG001|NOT COMPLETED|Overall Study||1
8651972|NCT00644592|9693744|FG000|STARTED|Overall Study||5
8651973|NCT00644592|9693745|FG001|STARTED|Overall Study||6
8651974|NCT00644592|9693744|FG000|COMPLETED|Overall Study||5
8651975|NCT00644592|9693745|FG001|COMPLETED|Overall Study||6
8651976|NCT00644592|9693744|FG000|NOT COMPLETED|Overall Study||0
8651977|NCT00644592|9693745|FG001|NOT COMPLETED|Overall Study||0
8651978|NCT00644657|9693751|FG000|STARTED|Overall Study||27
8651979|NCT00644657|9693751|FG000|COMPLETED|Overall Study||27
8651980|NCT00644657|9693751|FG000|NOT COMPLETED|Overall Study||0
8651981|NCT00644787|9693755|FG000|STARTED|Period 1: Titration Phase||156
8651982|NCT00644787|9693756|FG001|STARTED|Period 1: Titration Phase||0
8651983|NCT00644787|9693757|FG002|STARTED|Period 1: Titration Phase||0
8651984|NCT00644787|9693755|FG000|COMPLETED|Period 1: Titration Phase||129
8651985|NCT00644787|9693756|FG001|COMPLETED|Period 1: Titration Phase||0
8651986|NCT00644787|9693757|FG002|COMPLETED|Period 1: Titration Phase||0
8651987|NCT00644787|9693755|FG000|NOT COMPLETED|Period 1: Titration Phase||27
8651988|NCT00644787|9693756|FG001|NOT COMPLETED|Period 1: Titration Phase||0
8651989|NCT00644787|9693757|FG002|NOT COMPLETED|Period 1: Titration Phase||0
8651990|NCT00644787|9693755|FG000|STARTED|Period 2: Double Blind Phase||0
8651991|NCT00644787|9693756|FG001|STARTED|Period 2: Double Blind Phase||58
8651992|NCT00644787|9693757|FG002|STARTED|Period 2: Double Blind Phase||62
8651993|NCT00644787|9693755|FG000|COMPLETED|Period 2: Double Blind Phase||0
8651994|NCT00644787|9693756|FG001|COMPLETED|Period 2: Double Blind Phase||49
8651995|NCT00644787|9693757|FG002|COMPLETED|Period 2: Double Blind Phase||55
8651996|NCT00644787|9693755|FG000|NOT COMPLETED|Period 2: Double Blind Phase||0
8651997|NCT00644787|9693756|FG001|NOT COMPLETED|Period 2: Double Blind Phase||9
8651998|NCT00644787|9693757|FG002|NOT COMPLETED|Period 2: Double Blind Phase||7
8651999|NCT00644878|9693765|FG000|STARTED|Overall Study||18
8652000|NCT00644878|9693765|FG000|COMPLETED|Overall Study||0
8652001|NCT00644878|9693765|FG000|NOT COMPLETED|Overall Study||18
8652002|NCT00644917|9693769|FG000|STARTED|Overall Study||38
8652003|NCT00644917|9693769|FG000|COMPLETED|Overall Study||36
8652004|NCT00644917|9693769|FG000|NOT COMPLETED|Overall Study||2
8652005|NCT00644969|9693779|FG000|STARTED|Treatment Phase||85
8652006|NCT00644969|9693780|FG001|STARTED|Treatment Phase||43
8652007|NCT00644969|9693779|FG000|COMPLETED|Treatment Phase||71
8652008|NCT00644969|9693780|FG001|COMPLETED|Treatment Phase||40
8652009|NCT00644969|9693779|FG000|NOT COMPLETED|Treatment Phase||14
8652010|NCT00644969|9693780|FG001|NOT COMPLETED|Treatment Phase||3
8652011|NCT00644969|9693779|FG000|STARTED|Post Treatment Phase||71
8652012|NCT00644969|9693780|FG001|STARTED|Post Treatment Phase||40
8652013|NCT00644969|9693779|FG000|COMPLETED|Post Treatment Phase||61
8652014|NCT00644969|9693780|FG001|COMPLETED|Post Treatment Phase||37
8652015|NCT00644969|9693779|FG000|NOT COMPLETED|Post Treatment Phase||10
8652016|NCT00644969|9693780|FG001|NOT COMPLETED|Post Treatment Phase||3
8652017|NCT00644995|9693788|FG000|STARTED|Overall Study||25
8652018|NCT00644995|9693789|FG001|STARTED|Overall Study||27
8652019|NCT00644995|9693788|FG000|Completed 4 Month Assessment|Overall Study||23
8652020|NCT00644995|9693789|FG001|Completed 4 Month Assessment|Overall Study||24
8652021|NCT00644995|9693788|FG000|COMPLETED|Overall Study|Completed 6 month assessment|23
8652022|NCT00644995|9693789|FG001|COMPLETED|Overall Study||23
8652023|NCT00644995|9693788|FG000|NOT COMPLETED|Overall Study||2
8652024|NCT00644995|9693789|FG001|NOT COMPLETED|Overall Study||4
8652025|NCT00645047|9693799|FG000|STARTED|Overall Study||103
8652026|NCT00645047|9693800|FG001|STARTED|Overall Study||104
8652027|NCT00645047|9693799|FG000|Post|Overall Study||74
8652028|NCT00645047|9693800|FG001|Post|Overall Study||80
8652029|NCT00645047|9693799|FG000|COMPLETED|Overall Study|6 month follow up|60
8652030|NCT00645047|9693800|FG001|COMPLETED|Overall Study||65
8652031|NCT00645047|9693799|FG000|NOT COMPLETED|Overall Study||43
8652032|NCT00645047|9693800|FG001|NOT COMPLETED|Overall Study||39
8652033|NCT00645099|9693808|FG000|STARTED|Overall Study||239
8652034|NCT00645099|9693809|FG001|STARTED|Overall Study||220
8652035|NCT00645099|9693808|FG000|COMPLETED|Overall Study||168
8652036|NCT00645099|9693809|FG001|COMPLETED|Overall Study||178
8652037|NCT00645099|9693808|FG000|NOT COMPLETED|Overall Study||71
8652038|NCT00645099|9693809|FG001|NOT COMPLETED|Overall Study||42
8652039|NCT00645164|9693815|FG000|STARTED|Overall Study||59
8652040|NCT00645164|9693815|FG000|COMPLETED|Overall Study||52
8652041|NCT00645164|9693815|FG000|NOT COMPLETED|Overall Study||7
8652042|NCT00645333|9693819|FG000|STARTED|Overall Study||30
8652043|NCT00645333|9693819|FG000|COMPLETED|Overall Study||30
8652044|NCT00645333|9693819|FG000|NOT COMPLETED|Overall Study||0
8652045|NCT00645411|9693827|FG000|STARTED|Overall Study||656
8652046|NCT00645411|9693828|FG001|STARTED|Overall Study||318
8652047|NCT00645411|9693829|FG002|STARTED|Overall Study||1608
8652048|NCT00645411|9693830|FG003|STARTED|Overall Study||1022
8652049|NCT00645411|9693827|FG000|COMPLETED|Overall Study||643
8652050|NCT00645411|9693828|FG001|COMPLETED|Overall Study||312
8652051|NCT00645411|9693829|FG002|COMPLETED|Overall Study||1457
8652052|NCT00645411|9693830|FG003|COMPLETED|Overall Study||919
8652053|NCT00645411|9693827|FG000|NOT COMPLETED|Overall Study||13
8652054|NCT00645411|9693828|FG001|NOT COMPLETED|Overall Study||6
8652055|NCT00645411|9693829|FG002|NOT COMPLETED|Overall Study||151
8652056|NCT00645411|9693830|FG003|NOT COMPLETED|Overall Study||103
8652057|NCT00645450|9693849|FG000|STARTED|Overall Study||5
8652058|NCT00645450|9693850|FG001|STARTED|Overall Study||4
8652059|NCT00645450|9693849|FG000|COMPLETED|Overall Study||5
8652060|NCT00645450|9693850|FG001|COMPLETED|Overall Study||4
8652061|NCT00645450|9693849|FG000|NOT COMPLETED|Overall Study||0
8652062|NCT00645450|9693850|FG001|NOT COMPLETED|Overall Study||0
8652063|NCT00645528|9693856|FG000|STARTED|Overall Study||39
8652064|NCT00645528|9693856|FG000|COMPLETED|Overall Study||32
8652065|NCT00645528|9693856|FG000|NOT COMPLETED|Overall Study||7
8652066|NCT00645593|9693862|FG000|STARTED|Overall Study||29
8652067|NCT00645593|9693863|FG001|STARTED|Overall Study||60
8652068|NCT00645593|9693862|FG000|COMPLETED|Overall Study||28
8652069|NCT00645593|9693863|FG001|COMPLETED|Overall Study||60
8652070|NCT00645593|9693862|FG000|NOT COMPLETED|Overall Study||1
8652071|NCT00645593|9693863|FG001|NOT COMPLETED|Overall Study||0
8652072|NCT00645671|9693871|FG000|STARTED|Overall Study||201
8652073|NCT00645671|9693872|FG001|STARTED|Overall Study||199
8652074|NCT00645671|9693871|FG000|COMPLETED|Overall Study||200
8652075|NCT00645671|9693872|FG001|COMPLETED|Overall Study||193
8652076|NCT00645671|9693871|FG000|NOT COMPLETED|Overall Study||1
8652077|NCT00645671|9693872|FG001|NOT COMPLETED|Overall Study||6
8652078|NCT00645710|9693881|FG000|STARTED|Overall Study||3
8652079|NCT00645710|9693882|FG001|STARTED|Overall Study||3
8652080|NCT00645710|9693883|FG002|STARTED|Overall Study||10
8652081|NCT00645710|9693881|FG000|COMPLETED|Overall Study||3
8652082|NCT00645710|9693882|FG001|COMPLETED|Overall Study||3
8652083|NCT00645710|9693883|FG002|COMPLETED|Overall Study||10
8652084|NCT00645710|9693881|FG000|NOT COMPLETED|Overall Study||0
8652085|NCT00645710|9693882|FG001|NOT COMPLETED|Overall Study||0
8652086|NCT00645710|9693883|FG002|NOT COMPLETED|Overall Study||0
8652087|NCT00645762|9693892|FG000|STARTED|Overall Study||71
8652088|NCT00645762|9693892|FG000|COMPLETED|Overall Study||67
8652089|NCT00645762|9693892|FG000|NOT COMPLETED|Overall Study||4
8652090|NCT00645788|9693902|FG000|STARTED|Overall Study||94
8652091|NCT00645788|9693903|FG001|STARTED|Overall Study||94
8652092|NCT00645788|9693904|FG002|STARTED|Overall Study||65
8652093|NCT00645788|9693905|FG003|STARTED|Overall Study||35
8652094|NCT00645788|9693902|FG000|Participants Receive Treatment|Overall Study||93
8652095|NCT00645788|9693903|FG001|Participants Receive Treatment|Overall Study||93
8652096|NCT00645788|9693904|FG002|Participants Receive Treatment|Overall Study||65
8652097|NCT00645788|9693905|FG003|Participants Receive Treatment|Overall Study||35
8652098|NCT00645788|9693902|FG000|COMPLETED|Overall Study||74
9022173|NCT03124459|10085073|FG003|NOT COMPLETED|Part 1-Open Label Dose Escalation||0
9022174|NCT03124459|10085074|FG004|NOT COMPLETED|Part 1-Open Label Dose Escalation||0
9022175|NCT03124459|10085075|FG005|NOT COMPLETED|Part 1-Open Label Dose Escalation||0
9022176|NCT03124459|10085070|FG000|STARTED|Phase 2- Randomized Doubled-blind|Participants in Part 1 Open-Label Dose escalation portion of the study were not the same participants that participated in the double-blind placebo controlled study.|0
9039968|NCT03345108|10100890|FG001|COMPLETED|Period-1||8
9039969|NCT03345108|10100891|FG002|COMPLETED|Period-1||8
8652099|NCT00645788|9693903|FG001|COMPLETED|Overall Study||67
8652100|NCT00645788|9693904|FG002|COMPLETED|Overall Study||47
8652101|NCT00645788|9693905|FG003|COMPLETED|Overall Study||21
8652102|NCT00645788|9693902|FG000|NOT COMPLETED|Overall Study||20
8652103|NCT00645788|9693903|FG001|NOT COMPLETED|Overall Study||27
8652104|NCT00645788|9693904|FG002|NOT COMPLETED|Overall Study||18
8652105|NCT00645788|9693905|FG003|NOT COMPLETED|Overall Study||14
8652106|NCT00645827|9693917|FG000|STARTED|Overall Study||14
8652107|NCT00645827|9693918|FG001|STARTED|Overall Study||17
8652108|NCT00645827|9693917|FG000|COMPLETED|Overall Study||14
8652109|NCT00645827|9693918|FG001|COMPLETED|Overall Study||17
8652110|NCT00645827|9693917|FG000|NOT COMPLETED|Overall Study||0
8652111|NCT00645827|9693918|FG001|NOT COMPLETED|Overall Study||0
8652112|NCT00645840|9693924|FG000|STARTED|Overall Study||15
8652113|NCT00645840|9693924|FG000|COMPLETED|Overall Study||12
8652114|NCT00645840|9693924|FG000|NOT COMPLETED|Overall Study||3
8652115|NCT00645853|9693930|FG000|STARTED|Overall Study||288
8652116|NCT00645853|9693931|FG001|STARTED|Overall Study||235
8652117|NCT00645853|9693930|FG000|No of Patients After Dose Switch|Overall Study|All patients in the AZD0837 arm switched from their initial doses, to a general dose of 300 mg od|209
8652118|NCT00645853|9693931|FG001|No of Patients After Dose Switch|Overall Study|No changes for VKA patients|188
8652119|NCT00645853|9693930|FG000|Discontinued Patient No Due to Closure|Overall Study|No of patients discontinued due the study termination caused tablet formulation stability problems|196
8652120|NCT00645853|9693931|FG001|Discontinued Patient No Due to Closure|Overall Study|No of patients discontinued due the study termination caused tablet formulation stability problems|178
8652121|NCT00645853|9693930|FG000|AZ Study Closure in Hungary|Overall Study||60
8652122|NCT00645853|9693931|FG001|AZ Study Closure in Hungary|Overall Study||40
8728530|NCT01048788|9775673|FG001|COMPLETED|Overall Study||28
8728531|NCT01048788|9775674|FG002|COMPLETED|Overall Study||11
8652123|NCT00645853|9693930|FG000|COMPLETED|Overall Study||196
8652124|NCT00645853|9693931|FG001|COMPLETED|Overall Study||178
8652125|NCT00645853|9693930|FG000|NOT COMPLETED|Overall Study||92
8652126|NCT00645853|9693931|FG001|NOT COMPLETED|Overall Study||57
8691880|NCT00856986|9737207|FG001|COMPLETED|Extension Period, Weeks 26-52||130
8691881|NCT00856986|9737208|FG002|COMPLETED|Extension Period, Weeks 26-52||432
8691882|NCT00856986|9737209|FG003|COMPLETED|Extension Period, Weeks 26-52||0
8691883|NCT00856986|9737210|FG004|COMPLETED|Extension Period, Weeks 26-52||0
8691884|NCT00856986|9737206|FG000|NOT COMPLETED|Extension Period, Weeks 26-52||19
8691885|NCT00856986|9737207|FG001|NOT COMPLETED|Extension Period, Weeks 26-52||14
8691886|NCT00856986|9737208|FG002|NOT COMPLETED|Extension Period, Weeks 26-52||38
8652127|NCT00645944|9693939|FG000|STARTED|Randomized||20
8652128|NCT00645944|9693940|FG001|STARTED|Randomized||19
8652129|NCT00645944|9693939|FG000|COMPLETED|Randomized||19
8652130|NCT00645944|9693940|FG001|COMPLETED|Randomized||17
8652131|NCT00645944|9693939|FG000|NOT COMPLETED|Randomized||1
8652132|NCT00645944|9693940|FG001|NOT COMPLETED|Randomized||2
8652133|NCT00645944|9693939|FG000|STARTED|Received Medication||19
8652134|NCT00645944|9693940|FG001|STARTED|Received Medication||17
8652135|NCT00645944|9693939|FG000|COMPLETED|Received Medication||13
8652136|NCT00645944|9693940|FG001|COMPLETED|Received Medication||14
8652137|NCT00645944|9693939|FG000|NOT COMPLETED|Received Medication||6
8652138|NCT00645944|9693940|FG001|NOT COMPLETED|Received Medication||3
8652139|NCT00645970|9693948|FG000|STARTED|Overall Study||141
8652140|NCT00645970|9693949|FG001|STARTED|Overall Study||218
8652141|NCT00645970|9693948|FG000|6 Months|Overall Study||58
8652142|NCT00645970|9693949|FG001|6 Months|Overall Study||97
8652143|NCT00645970|9693948|FG000|1 Year|Overall Study||37
8652144|NCT00645970|9693949|FG001|1 Year|Overall Study||42
8652145|NCT00645970|9693948|FG000|COMPLETED|Overall Study||32
8652146|NCT00645970|9693949|FG001|COMPLETED|Overall Study||32
8652147|NCT00645970|9693948|FG000|NOT COMPLETED|Overall Study||109
8652148|NCT00645970|9693949|FG001|NOT COMPLETED|Overall Study||186
8652149|NCT00646048|9693955|FG000|STARTED|Overall Study||43
8652150|NCT00646048|9693955|FG000|COMPLETED|Overall Study||27
8652151|NCT00646048|9693955|FG000|NOT COMPLETED|Overall Study||16
8652152|NCT00646113|9693959|FG000|STARTED|Overall Study|3 of the 72 enrolled participants were excluded before surgery.|69
8652153|NCT00646113|9693959|FG000|COMPLETED|Overall Study||61
8652154|NCT00646113|9693959|FG000|NOT COMPLETED|Overall Study||8
8652155|NCT00646399|9693965|FG000|STARTED|Overall Study||792
8652156|NCT00646399|9693966|FG001|STARTED|Overall Study||787
8652157|NCT00646399|9693965|FG000|COMPLETED|Overall Study||709
8652158|NCT00646399|9693966|FG001|COMPLETED|Overall Study||713
8652159|NCT00646399|9693965|FG000|NOT COMPLETED|Overall Study||83
8652160|NCT00646399|9693966|FG001|NOT COMPLETED|Overall Study||74
8652161|NCT00646451|9693972|FG000|STARTED|Overall Study||10
8652162|NCT00646451|9693973|FG001|STARTED|Overall Study||10
8652163|NCT00646451|9693972|FG000|COMPLETED|Overall Study||6
8652164|NCT00646451|9693973|FG001|COMPLETED|Overall Study||10
8652165|NCT00646451|9693972|FG000|NOT COMPLETED|Overall Study||4
8652166|NCT00646451|9693973|FG001|NOT COMPLETED|Overall Study||0
8652167|NCT00646581|9693983|FG000|STARTED|Overall Study||15
8652168|NCT00646581|9693984|FG001|STARTED|Overall Study||15
8652169|NCT00646581|9693983|FG000|COMPLETED|Overall Study||15
8652170|NCT00646581|9693984|FG001|COMPLETED|Overall Study||15
8652171|NCT00646581|9693983|FG000|NOT COMPLETED|Overall Study||0
8652172|NCT00646581|9693984|FG001|NOT COMPLETED|Overall Study||0
8652173|NCT00646646|9693994|FG000|STARTED|Overall Study||15
8652174|NCT00646646|9693995|FG001|STARTED|Overall Study||15
8652175|NCT00646646|9693996|FG002|STARTED|Overall Study||15
8652176|NCT00646646|9693997|FG003|STARTED|Overall Study||20
8652177|NCT00646646|9693994|FG000|COMPLETED|Overall Study||15
8652178|NCT00646646|9693995|FG001|COMPLETED|Overall Study||15
8652179|NCT00646646|9693996|FG002|COMPLETED|Overall Study||15
8652180|NCT00646646|9693997|FG003|COMPLETED|Overall Study||20
8652181|NCT00646646|9693994|FG000|NOT COMPLETED|Overall Study||0
8652182|NCT00646646|9693995|FG001|NOT COMPLETED|Overall Study||0
8652183|NCT00646646|9693996|FG002|NOT COMPLETED|Overall Study||0
8652184|NCT00646646|9693997|FG003|NOT COMPLETED|Overall Study||0
8652185|NCT00646763|9694009|FG000|STARTED|Overall Study||18
8652186|NCT00646763|9694010|FG001|STARTED|Overall Study||17
8652187|NCT00646763|9694009|FG000|COMPLETED|Overall Study||18
8652188|NCT00646763|9694010|FG001|COMPLETED|Overall Study||17
8652189|NCT00646763|9694009|FG000|NOT COMPLETED|Overall Study||0
8652190|NCT00646763|9694010|FG001|NOT COMPLETED|Overall Study||0
8652191|NCT00646776|9694018|FG000|STARTED|Overall Study|Treated on Day 1|15
8652192|NCT00646776|9694019|FG001|STARTED|Overall Study|Treated on Day 1|18
8652193|NCT00646776|9694018|FG000|COMPLETED|Overall Study||14
8652194|NCT00646776|9694019|FG001|COMPLETED|Overall Study||5
8652195|NCT00646776|9694018|FG000|NOT COMPLETED|Overall Study||1
8652196|NCT00646776|9694019|FG001|NOT COMPLETED|Overall Study||13
8652197|NCT00646906|9694032|FG000|STARTED|Crossover Period 1||9
8652198|NCT00646906|9694033|FG001|STARTED|Crossover Period 1||9
8652199|NCT00646906|9694034|FG002|STARTED|Crossover Period 1||10
8652200|NCT00646906|9694035|FG003|STARTED|Crossover Period 1||9
8652201|NCT00646906|9694036|FG004|STARTED|Crossover Period 1||8
8652202|NCT00646906|9694037|FG005|STARTED|Crossover Period 1||5
8652203|NCT00646906|9694038|FG006|STARTED|Crossover Period 1||5
8652204|NCT00646906|9694032|FG000|COMPLETED|Crossover Period 1||8
8652205|NCT00646906|9694033|FG001|COMPLETED|Crossover Period 1||9
8652206|NCT00646906|9694034|FG002|COMPLETED|Crossover Period 1||10
8652207|NCT00646906|9694035|FG003|COMPLETED|Crossover Period 1||9
8652208|NCT00646906|9694036|FG004|COMPLETED|Crossover Period 1|Phase 1b had only one treatment period and no crossover. Phase 1b ended here.|8
8652209|NCT00646906|9694037|FG005|COMPLETED|Crossover Period 1||4
8652210|NCT00646906|9694038|FG006|COMPLETED|Crossover Period 1||5
8652211|NCT00646906|9694032|FG000|NOT COMPLETED|Crossover Period 1||1
8652212|NCT00646906|9694033|FG001|NOT COMPLETED|Crossover Period 1||0
8652213|NCT00646906|9694034|FG002|NOT COMPLETED|Crossover Period 1||0
8652214|NCT00646906|9694035|FG003|NOT COMPLETED|Crossover Period 1||0
8652215|NCT00646906|9694036|FG004|NOT COMPLETED|Crossover Period 1||0
8652216|NCT00646906|9694037|FG005|NOT COMPLETED|Crossover Period 1||1
8652217|NCT00646906|9694038|FG006|NOT COMPLETED|Crossover Period 1||0
8652218|NCT00646906|9694032|FG000|STARTED|Washout (>/= 14 Days)||8
8652219|NCT00646906|9694033|FG001|STARTED|Washout (>/= 14 Days)||9
8652220|NCT00646906|9694034|FG002|STARTED|Washout (>/= 14 Days)||10
8652221|NCT00646906|9694035|FG003|STARTED|Washout (>/= 14 Days)||9
8652222|NCT00646906|9694036|FG004|STARTED|Washout (>/= 14 Days)|Phase 1b had only one treatment period and no crossover.|0
8652223|NCT00646906|9694037|FG005|STARTED|Washout (>/= 14 Days)||4
8652224|NCT00646906|9694038|FG006|STARTED|Washout (>/= 14 Days)||5
8652225|NCT00646906|9694032|FG000|COMPLETED|Washout (>/= 14 Days)||8
8652226|NCT00646906|9694033|FG001|COMPLETED|Washout (>/= 14 Days)||9
8652227|NCT00646906|9694034|FG002|COMPLETED|Washout (>/= 14 Days)||10
8652228|NCT00646906|9694035|FG003|COMPLETED|Washout (>/= 14 Days)||9
8652229|NCT00646906|9694036|FG004|COMPLETED|Washout (>/= 14 Days)|Phase 1b had only one treatment period and no crossover.|0
8652230|NCT00646906|9694037|FG005|COMPLETED|Washout (>/= 14 Days)||4
8652231|NCT00646906|9694038|FG006|COMPLETED|Washout (>/= 14 Days)||5
8652232|NCT00646906|9694032|FG000|NOT COMPLETED|Washout (>/= 14 Days)||0
8652233|NCT00646906|9694033|FG001|NOT COMPLETED|Washout (>/= 14 Days)||0
8652234|NCT00646906|9694034|FG002|NOT COMPLETED|Washout (>/= 14 Days)||0
8652235|NCT00646906|9694035|FG003|NOT COMPLETED|Washout (>/= 14 Days)||0
8652236|NCT00646906|9694036|FG004|NOT COMPLETED|Washout (>/= 14 Days)||0
8652237|NCT00646906|9694037|FG005|NOT COMPLETED|Washout (>/= 14 Days)||0
8652238|NCT00646906|9694038|FG006|NOT COMPLETED|Washout (>/= 14 Days)||0
8652239|NCT00646906|9694032|FG000|STARTED|Crossover Period 2||8
8652240|NCT00646906|9694033|FG001|STARTED|Crossover Period 2||9
8652241|NCT00646906|9694034|FG002|STARTED|Crossover Period 2||10
8652242|NCT00646906|9694035|FG003|STARTED|Crossover Period 2||9
8652243|NCT00646906|9694036|FG004|STARTED|Crossover Period 2|Phase 1b had only one treatment period and no crossover.|0
8652244|NCT00646906|9694037|FG005|STARTED|Crossover Period 2||4
8652245|NCT00646906|9694038|FG006|STARTED|Crossover Period 2||5
8652246|NCT00646906|9694032|FG000|COMPLETED|Crossover Period 2||8
8652247|NCT00646906|9694033|FG001|COMPLETED|Crossover Period 2||8
8652248|NCT00646906|9694034|FG002|COMPLETED|Crossover Period 2||8
8652249|NCT00646906|9694035|FG003|COMPLETED|Crossover Period 2||8
8652250|NCT00646906|9694036|FG004|COMPLETED|Crossover Period 2|Phase 1b had only one treatment period and no crossover.|0
8652251|NCT00646906|9694037|FG005|COMPLETED|Crossover Period 2||4
8652252|NCT00646906|9694038|FG006|COMPLETED|Crossover Period 2||4
8652253|NCT00646906|9694032|FG000|NOT COMPLETED|Crossover Period 2||0
8652254|NCT00646906|9694033|FG001|NOT COMPLETED|Crossover Period 2||1
8652255|NCT00646906|9694034|FG002|NOT COMPLETED|Crossover Period 2||2
8652256|NCT00646906|9694035|FG003|NOT COMPLETED|Crossover Period 2||1
8652257|NCT00646906|9694036|FG004|NOT COMPLETED|Crossover Period 2||0
8652258|NCT00646906|9694037|FG005|NOT COMPLETED|Crossover Period 2||0
8652259|NCT00646906|9694038|FG006|NOT COMPLETED|Crossover Period 2||1
8652260|NCT00646958|9694054|FG000|STARTED|Overall Study|Number (No.) Participants Randomized|51
8652261|NCT00646958|9694055|FG001|STARTED|Overall Study|No. Participants Randomized|50
8652262|NCT00646958|9694056|FG002|STARTED|Overall Study|No. Participants Randomized|49
8652263|NCT00646958|9694054|FG000|COMPLETED|Overall Study||40
8652264|NCT00646958|9694055|FG001|COMPLETED|Overall Study||41
8652265|NCT00646958|9694056|FG002|COMPLETED|Overall Study||40
8652266|NCT00646958|9694054|FG000|NOT COMPLETED|Overall Study||11
8652267|NCT00646958|9694055|FG001|NOT COMPLETED|Overall Study||9
8652268|NCT00646958|9694056|FG002|NOT COMPLETED|Overall Study||9
8652269|NCT00647270|9694067|FG000|STARTED|Period 1, Placebo-control (12 Weeks)|Placebo subjects in Period 1 received adalimumab 40 mg every other week in Period 2.|56
8652270|NCT00647270|9694068|FG001|STARTED|Period 1, Placebo-control (12 Weeks)||159
8652271|NCT00647270|9694069|FG002|STARTED|Period 1, Placebo-control (12 Weeks)||205
8652272|NCT00647270|9694067|FG000|COMPLETED|Period 1, Placebo-control (12 Weeks)||48
8652273|NCT00647270|9694068|FG001|COMPLETED|Period 1, Placebo-control (12 Weeks)||146
8652274|NCT00647270|9694069|FG002|COMPLETED|Period 1, Placebo-control (12 Weeks)||182
8652275|NCT00647270|9694067|FG000|NOT COMPLETED|Period 1, Placebo-control (12 Weeks)||8
8652276|NCT00647270|9694068|FG001|NOT COMPLETED|Period 1, Placebo-control (12 Weeks)||13
8652277|NCT00647270|9694069|FG002|NOT COMPLETED|Period 1, Placebo-control (12 Weeks)||23
8728532|NCT01048788|9775672|FG000|NOT COMPLETED|Overall Study||5
8728533|NCT01048788|9775673|FG001|NOT COMPLETED|Overall Study||2
8728534|NCT01048788|9775674|FG002|NOT COMPLETED|Overall Study||2
8728535|NCT01048866|9775684|FG000|STARTED|Overall Study||101
8728536|NCT01048866|9775685|FG001|STARTED|Overall Study||97
8728537|NCT01048866|9775684|FG000|COMPLETED|Overall Study||97
8728538|NCT01048866|9775685|FG001|COMPLETED|Overall Study||92
8728539|NCT01048866|9775684|FG000|NOT COMPLETED|Overall Study||4
8728540|NCT01048866|9775685|FG001|NOT COMPLETED|Overall Study||5
8728541|NCT01048879|9775694|FG000|STARTED|Overall Study||1
8728542|NCT01048879|9775695|FG001|STARTED|Overall Study||9
8728543|NCT01048879|9775696|FG002|STARTED|Overall Study||5
8728544|NCT01048879|9775694|FG000|COMPLETED|Overall Study||1
8728545|NCT01048879|9775695|FG001|COMPLETED|Overall Study||9
8728546|NCT01048879|9775696|FG002|COMPLETED|Overall Study||5
8652278|NCT00647270|9694067|FG000|STARTED|Period 2, Placebo Switched to Adalimumab|Placebo subjects in Period 1 received adalimumab 40 mg eow in Period 2|48
8652279|NCT00647270|9694068|FG001|STARTED|Period 2, Placebo Switched to Adalimumab||146
8652280|NCT00647270|9694069|FG002|STARTED|Period 2, Placebo Switched to Adalimumab||182
8728547|NCT01048879|9775694|FG000|NOT COMPLETED|Overall Study||0
8728548|NCT01048879|9775695|FG001|NOT COMPLETED|Overall Study||0
8652281|NCT00647270|9694067|FG000|COMPLETED|Period 2, Placebo Switched to Adalimumab||45
8652282|NCT00647270|9694068|FG001|COMPLETED|Period 2, Placebo Switched to Adalimumab||137
8652283|NCT00647270|9694069|FG002|COMPLETED|Period 2, Placebo Switched to Adalimumab||175
8652284|NCT00647270|9694067|FG000|NOT COMPLETED|Period 2, Placebo Switched to Adalimumab||3
8652285|NCT00647270|9694068|FG001|NOT COMPLETED|Period 2, Placebo Switched to Adalimumab||9
8652286|NCT00647270|9694069|FG002|NOT COMPLETED|Period 2, Placebo Switched to Adalimumab||7
8652287|NCT00647296|9694084|FG000|STARTED|Part 1: 12-week Double-Blind Treatment||27
8652288|NCT00647296|9694085|FG001|STARTED|Part 1: 12-week Double-Blind Treatment||23
8652289|NCT00647296|9694086|FG002|STARTED|Part 1: 12-week Double-Blind Treatment||26
8652290|NCT00647296|9694087|FG003|STARTED|Part 1: 12-week Double-Blind Treatment||26
8652291|NCT00647296|9694084|FG000|COMPLETED|Part 1: 12-week Double-Blind Treatment||26
8652292|NCT00647296|9694085|FG001|COMPLETED|Part 1: 12-week Double-Blind Treatment||22
8652293|NCT00647296|9694086|FG002|COMPLETED|Part 1: 12-week Double-Blind Treatment||26
8652294|NCT00647296|9694087|FG003|COMPLETED|Part 1: 12-week Double-Blind Treatment||24
8652295|NCT00647296|9694084|FG000|NOT COMPLETED|Part 1: 12-week Double-Blind Treatment||1
8652296|NCT00647296|9694085|FG001|NOT COMPLETED|Part 1: 12-week Double-Blind Treatment||1
8652297|NCT00647296|9694086|FG002|NOT COMPLETED|Part 1: 12-week Double-Blind Treatment||0
8652298|NCT00647296|9694087|FG003|NOT COMPLETED|Part 1: 12-week Double-Blind Treatment||2
8652299|NCT00647296|9694084|FG000|STARTED|Part 2: 4-week Placebo Washout||97
8652300|NCT00647296|9694085|FG001|STARTED|Part 2: 4-week Placebo Washout||0
8652301|NCT00647296|9694086|FG002|STARTED|Part 2: 4-week Placebo Washout||0
8652302|NCT00647296|9694087|FG003|STARTED|Part 2: 4-week Placebo Washout||0
8652303|NCT00647296|9694084|FG000|COMPLETED|Part 2: 4-week Placebo Washout||92
8652304|NCT00647296|9694085|FG001|COMPLETED|Part 2: 4-week Placebo Washout||0
8652305|NCT00647296|9694086|FG002|COMPLETED|Part 2: 4-week Placebo Washout||0
8652306|NCT00647296|9694087|FG003|COMPLETED|Part 2: 4-week Placebo Washout||0
8652307|NCT00647296|9694084|FG000|NOT COMPLETED|Part 2: 4-week Placebo Washout||5
8652308|NCT00647296|9694085|FG001|NOT COMPLETED|Part 2: 4-week Placebo Washout||0
8652309|NCT00647296|9694086|FG002|NOT COMPLETED|Part 2: 4-week Placebo Washout||0
8652310|NCT00647296|9694087|FG003|NOT COMPLETED|Part 2: 4-week Placebo Washout||0
8652311|NCT00647296|9694084|FG000|STARTED|Part 2: 76-week Double-Blind Treatment||0
8652312|NCT00647296|9694085|FG001|STARTED|Part 2: 76-week Double-Blind Treatment||48
8652313|NCT00647296|9694086|FG002|STARTED|Part 2: 76-week Double-Blind Treatment||0
8652314|NCT00647296|9694087|FG003|STARTED|Part 2: 76-week Double-Blind Treatment||44
8652315|NCT00647296|9694084|FG000|COMPLETED|Part 2: 76-week Double-Blind Treatment||0
8652316|NCT00647296|9694085|FG001|COMPLETED|Part 2: 76-week Double-Blind Treatment||33
8652317|NCT00647296|9694086|FG002|COMPLETED|Part 2: 76-week Double-Blind Treatment||0
8652318|NCT00647296|9694087|FG003|COMPLETED|Part 2: 76-week Double-Blind Treatment||30
8652319|NCT00647296|9694084|FG000|NOT COMPLETED|Part 2: 76-week Double-Blind Treatment||0
8652320|NCT00647296|9694085|FG001|NOT COMPLETED|Part 2: 76-week Double-Blind Treatment||15
8652321|NCT00647296|9694086|FG002|NOT COMPLETED|Part 2: 76-week Double-Blind Treatment||0
8652322|NCT00647296|9694087|FG003|NOT COMPLETED|Part 2: 76-week Double-Blind Treatment||14
8652323|NCT00647348|9694111|FG000|STARTED|Overall Study||70
8652324|NCT00647348|9694112|FG001|STARTED|Overall Study||70
8652325|NCT00647348|9694111|FG000|COMPLETED|Overall Study||67
8652326|NCT00647348|9694112|FG001|COMPLETED|Overall Study||64
8652327|NCT00647348|9694111|FG000|NOT COMPLETED|Overall Study||3
8652328|NCT00647348|9694112|FG001|NOT COMPLETED|Overall Study||6
8652329|NCT00647400|9694120|FG000|STARTED|Overall Study||89
8652330|NCT00647400|9694121|FG001|STARTED|Overall Study||58
8652331|NCT00647400|9694120|FG000|COMPLETED|Overall Study||67
8652332|NCT00647400|9694121|FG001|COMPLETED|Overall Study||45
8652333|NCT00647400|9694120|FG000|NOT COMPLETED|Overall Study||22
8652334|NCT00647400|9694121|FG001|NOT COMPLETED|Overall Study||13
8652335|NCT00647556|9694129|FG000|STARTED|Overall Study||15
8652336|NCT00647556|9694130|FG001|STARTED|Overall Study||15
8652337|NCT00647556|9694129|FG000|COMPLETED|Overall Study||12
8652338|NCT00647556|9694130|FG001|COMPLETED|Overall Study||13
8652339|NCT00647556|9694129|FG000|NOT COMPLETED|Overall Study||3
8652340|NCT00647556|9694130|FG001|NOT COMPLETED|Overall Study||2
8652341|NCT00647699|9694138|FG000|STARTED|Overall Study||73
8652342|NCT00647699|9694139|FG001|STARTED|Overall Study||74
8652343|NCT00647699|9694138|FG000|COMPLETED|Overall Study||65
8652344|NCT00647699|9694139|FG001|COMPLETED|Overall Study||62
8652345|NCT00647699|9694138|FG000|NOT COMPLETED|Overall Study||8
8652346|NCT00647699|9694139|FG001|NOT COMPLETED|Overall Study||12
8652347|NCT00647998|9694147|FG000|STARTED|Overall Study||9
8652348|NCT00647998|9694148|FG001|STARTED|Overall Study||9
8652349|NCT00647998|9694147|FG000|COMPLETED|Overall Study||9
8652350|NCT00647998|9694148|FG001|COMPLETED|Overall Study||9
8652351|NCT00647998|9694147|FG000|NOT COMPLETED|Overall Study||0
8652352|NCT00647998|9694148|FG001|NOT COMPLETED|Overall Study||0
8652353|NCT00648037|9694156|FG000|STARTED|Overall Study||26
8652354|NCT00648037|9694156|FG000|COMPLETED|Overall Study||10
8652355|NCT00648037|9694156|FG000|NOT COMPLETED|Overall Study||16
8652356|NCT00648115|9694163|FG000|STARTED|Overall Study||42
8652357|NCT00648115|9694164|FG001|STARTED|Overall Study||42
8652358|NCT00648115|9694165|FG002|STARTED|Overall Study||27
8652359|NCT00648115|9694163|FG000|COMPLETED|Overall Study||42
8652360|NCT00648115|9694164|FG001|COMPLETED|Overall Study||42
8652361|NCT00648115|9694165|FG002|COMPLETED|Overall Study||27
8652362|NCT00648115|9694163|FG000|NOT COMPLETED|Overall Study||0
8652363|NCT00648115|9694164|FG001|NOT COMPLETED|Overall Study||0
8652364|NCT00648115|9694165|FG002|NOT COMPLETED|Overall Study||0
8652365|NCT00648167|9694173|FG000|STARTED|Overall Study||55
8652366|NCT00648167|9694173|FG000|Start Dose 4.5 g/Day|Overall Study||34
8652367|NCT00648167|9694173|FG000|Start Dose 6 g/Day|Overall Study||21
8652368|NCT00648167|9694173|FG000|COMPLETED|Overall Study||48
8652369|NCT00648167|9694173|FG000|NOT COMPLETED|Overall Study||7
8652370|NCT00648375|9694179|FG000|STARTED|Overall Study||1
8652371|NCT00648375|9694180|FG001|STARTED|Overall Study||2
8652372|NCT00648375|9694179|FG000|COMPLETED|Overall Study||1
8652373|NCT00648375|9694180|FG001|COMPLETED|Overall Study||2
8652374|NCT00648375|9694179|FG000|NOT COMPLETED|Overall Study||0
8652375|NCT00648375|9694180|FG001|NOT COMPLETED|Overall Study||0
8652376|NCT00648648|9694214|FG000|STARTED|Overall Study||3
8652377|NCT00648648|9694215|FG001|STARTED|Overall Study||3
8652378|NCT00648648|9694216|FG002|STARTED|Overall Study||3
8652379|NCT00648648|9694217|FG003|STARTED|Overall Study|Does not include two Part 1 participants who were randomized to this arm.|4
8652380|NCT00648648|9694218|FG004|STARTED|Overall Study||9
8652381|NCT00648648|9694219|FG005|STARTED|Overall Study|Does not include two Part 1 participants who were randomized to this arm.|1
8652382|NCT00648648|9694220|FG006|STARTED|Overall Study|Does not include one Part 1 participant who was randomized to this arm.|10
8652383|NCT00648648|9694221|FG007|STARTED|Overall Study|Does not include two Part 1 participants who were randomized to this arm.|1
8652384|NCT00648648|9694222|FG008|STARTED|Overall Study|Does not include one Part 1 participant who was randomized to this arm.|3
8652385|NCT00648648|9694223|FG009|STARTED|Overall Study||10
8652386|NCT00648648|9694224|FG010|STARTED|Overall Study||6
8652387|NCT00648648|9694225|FG011|STARTED|Overall Study||13
8652388|NCT00648648|9694226|FG012|STARTED|Overall Study||6
8652389|NCT00648648|9694227|FG013|STARTED|Overall Study||5
8652390|NCT00648648|9694228|FG014|STARTED|Overall Study||4
8652391|NCT00648648|9694229|FG015|STARTED|Overall Study||11
8652392|NCT00648648|9694230|FG016|STARTED|Overall Study||16
8652393|NCT00648648|9694231|FG017|STARTED|Overall Study||6
8652394|NCT00648648|9694232|FG018|STARTED|Overall Study||5
8728549|NCT01048879|9775696|FG002|NOT COMPLETED|Overall Study||0
8728550|NCT01048905|9775704|FG000|STARTED|Overall Study||13
8728551|NCT01048905|9775704|FG000|COMPLETED|Overall Study||12
8728552|NCT01048905|9775704|FG000|NOT COMPLETED|Overall Study||1
8728553|NCT01048944|9775712|FG000|STARTED|Overall Study||32
8728554|NCT01048944|9775713|FG001|STARTED|Overall Study||38
8728555|NCT01048944|9775714|FG002|STARTED|Overall Study||35
8728556|NCT01048944|9775715|FG003|STARTED|Overall Study||21
8728557|NCT01048944|9775712|FG000|COMPLETED|Overall Study||24
8728558|NCT01048944|9775713|FG001|COMPLETED|Overall Study||28
8728559|NCT01048944|9775714|FG002|COMPLETED|Overall Study||25
8728560|NCT01048944|9775715|FG003|COMPLETED|Overall Study||19
8728561|NCT01048944|9775712|FG000|NOT COMPLETED|Overall Study||8
8728562|NCT01048944|9775713|FG001|NOT COMPLETED|Overall Study||10
8728563|NCT01048944|9775714|FG002|NOT COMPLETED|Overall Study||10
8728564|NCT01048944|9775715|FG003|NOT COMPLETED|Overall Study||2
8728565|NCT01049009|9775727|FG000|STARTED|Treatment Period 1 (12 Weeks)||23
8728566|NCT01049009|9775728|FG001|STARTED|Treatment Period 1 (12 Weeks)||21
8728567|NCT01049009|9775727|FG000|COMPLETED|Treatment Period 1 (12 Weeks)||21
8728568|NCT01049009|9775728|FG001|COMPLETED|Treatment Period 1 (12 Weeks)||18
8728569|NCT01049009|9775727|FG000|NOT COMPLETED|Treatment Period 1 (12 Weeks)||2
8728570|NCT01049009|9775728|FG001|NOT COMPLETED|Treatment Period 1 (12 Weeks)||3
8728571|NCT01049009|9775727|FG000|STARTED|Treatment Period 2 (12 Weeks)||21
8728572|NCT01049009|9775728|FG001|STARTED|Treatment Period 2 (12 Weeks)||18
8728573|NCT01049009|9775727|FG000|COMPLETED|Treatment Period 2 (12 Weeks)||11
8728574|NCT01049009|9775728|FG001|COMPLETED|Treatment Period 2 (12 Weeks)||8
8728575|NCT01049009|9775727|FG000|NOT COMPLETED|Treatment Period 2 (12 Weeks)||10
8728576|NCT01049009|9775728|FG001|NOT COMPLETED|Treatment Period 2 (12 Weeks)||10
8728577|NCT01049217|9775736|FG000|STARTED|Overall Study||183
8728578|NCT01049217|9775737|FG001|STARTED|Overall Study||194
8728579|NCT01049217|9775736|FG000|Treated|Overall Study||183
8728580|NCT01049217|9775737|FG001|Treated|Overall Study||192
8728581|NCT01049217|9775736|FG000|COMPLETED|Overall Study||127
8728582|NCT01049217|9775737|FG001|COMPLETED|Overall Study||131
8728583|NCT01049217|9775736|FG000|NOT COMPLETED|Overall Study||56
8728584|NCT01049217|9775737|FG001|NOT COMPLETED|Overall Study||63
8728585|NCT01049243|9775743|FG000|STARTED|Overall Study||20
8728586|NCT01049243|9775743|FG000|COMPLETED|Overall Study||18
8728587|NCT01049243|9775743|FG000|NOT COMPLETED|Overall Study||2
8728588|NCT01049308|9775748|FG000|STARTED|Evaluation of Cognitive Impairment||251
8728589|NCT01049308|9775748|FG000|COMPLETED|Evaluation of Cognitive Impairment||251
8728590|NCT01049308|9775748|FG000|NOT COMPLETED|Evaluation of Cognitive Impairment||0
8728591|NCT01049308|9775748|FG000|STARTED|Pill Counts||251
8728592|NCT01049308|9775748|FG000|COMPLETED|Pill Counts||168
8728593|NCT01049308|9775748|FG000|NOT COMPLETED|Pill Counts||83
8728594|NCT01049334|9775757|FG000|STARTED|Overall Study||102
8728595|NCT01049334|9775758|FG001|STARTED|Overall Study||102
8728596|NCT01049334|9775757|FG000|COMPLETED|Overall Study||93
8728597|NCT01049334|9775758|FG001|COMPLETED|Overall Study||95
8728598|NCT01049334|9775757|FG000|NOT COMPLETED|Overall Study||9
8728599|NCT01049334|9775758|FG001|NOT COMPLETED|Overall Study||7
8728600|NCT01049360|9775764|FG000|STARTED|Period 1||6
8728601|NCT01049360|9775765|FG001|STARTED|Period 1||6
8728602|NCT01049360|9775766|FG002|STARTED|Period 1||7
8728603|NCT01049360|9775767|FG003|STARTED|Period 1||7
8652395|NCT00648648|9694233|FG019|STARTED|Overall Study||7
8652396|NCT00648648|9694234|FG020|STARTED|Overall Study||6
8652397|NCT00648648|9694235|FG021|STARTED|Overall Study||10
8652398|NCT00648648|9694236|FG022|STARTED|Overall Study||14
8652399|NCT00648648|9694237|FG023|STARTED|Overall Study||4
8652400|NCT00648648|9694238|FG024|STARTED|Overall Study||4
8652401|NCT00648648|9694239|FG025|STARTED|Overall Study||4
8652402|NCT00648648|9694240|FG026|STARTED|Overall Study||26
8652403|NCT00648648|9694241|FG027|STARTED|Overall Study||12
8652404|NCT00648648|9694214|FG000|Treated|Overall Study||3
8652405|NCT00648648|9694215|FG001|Treated|Overall Study||3
8652406|NCT00648648|9694216|FG002|Treated|Overall Study||3
8652407|NCT00648648|9694217|FG003|Treated|Overall Study|Does not include two Part 1 participants who were treated in this arm.|4
8652408|NCT00648648|9694218|FG004|Treated|Overall Study||8
8652409|NCT00648648|9694219|FG005|Treated|Overall Study|Does not include two Part 1 participants who were treated in this arm.|1
8652410|NCT00648648|9694220|FG006|Treated|Overall Study|Does not include one treated participant who was excluded from analysis.|9
8652411|NCT00648648|9694221|FG007|Treated|Overall Study|Does not include two Part 1 participants who were treated in this arm.|1
8652412|NCT00648648|9694222|FG008|Treated|Overall Study|Does not include one Part 1 participant who was treated in this arm.|3
8652413|NCT00648648|9694223|FG009|Treated|Overall Study|Does not include one treated participant who was excluded from analysis.|9
8652414|NCT00648648|9694224|FG010|Treated|Overall Study||6
8652415|NCT00648648|9694225|FG011|Treated|Overall Study||13
8652416|NCT00648648|9694226|FG012|Treated|Overall Study||6
8652417|NCT00648648|9694227|FG013|Treated|Overall Study||5
8652418|NCT00648648|9694228|FG014|Treated|Overall Study||4
8652419|NCT00648648|9694229|FG015|Treated|Overall Study||11
8652420|NCT00648648|9694230|FG016|Treated|Overall Study||16
8652421|NCT00648648|9694231|FG017|Treated|Overall Study||6
8652422|NCT00648648|9694232|FG018|Treated|Overall Study||4
8652423|NCT00648648|9694233|FG019|Treated|Overall Study||7
8652424|NCT00648648|9694234|FG020|Treated|Overall Study||6
8652425|NCT00648648|9694235|FG021|Treated|Overall Study||10
8652426|NCT00648648|9694236|FG022|Treated|Overall Study||14
8652427|NCT00648648|9694237|FG023|Treated|Overall Study||4
8652428|NCT00648648|9694238|FG024|Treated|Overall Study||4
8652429|NCT00648648|9694239|FG025|Treated|Overall Study||4
8652430|NCT00648648|9694240|FG026|Treated|Overall Study||26
8652431|NCT00648648|9694241|FG027|Treated|Overall Study||12
8652432|NCT00648648|9694214|FG000|COMPLETED|Overall Study||3
8652433|NCT00648648|9694215|FG001|COMPLETED|Overall Study||3
8652434|NCT00648648|9694216|FG002|COMPLETED|Overall Study||3
8652435|NCT00648648|9694217|FG003|COMPLETED|Overall Study||0
8652436|NCT00648648|9694218|FG004|COMPLETED|Overall Study||0
8652437|NCT00648648|9694219|FG005|COMPLETED|Overall Study||0
8652438|NCT00648648|9694220|FG006|COMPLETED|Overall Study||0
8652439|NCT00648648|9694221|FG007|COMPLETED|Overall Study||0
8652440|NCT00648648|9694222|FG008|COMPLETED|Overall Study||0
8652441|NCT00648648|9694223|FG009|COMPLETED|Overall Study||0
8652442|NCT00648648|9694224|FG010|COMPLETED|Overall Study||0
8652443|NCT00648648|9694225|FG011|COMPLETED|Overall Study||0
8652444|NCT00648648|9694226|FG012|COMPLETED|Overall Study||0
8652445|NCT00648648|9694227|FG013|COMPLETED|Overall Study||0
8652446|NCT00648648|9694228|FG014|COMPLETED|Overall Study||0
8652447|NCT00648648|9694229|FG015|COMPLETED|Overall Study||0
8652448|NCT00648648|9694230|FG016|COMPLETED|Overall Study||2
8652449|NCT00648648|9694231|FG017|COMPLETED|Overall Study||0
8652450|NCT00648648|9694232|FG018|COMPLETED|Overall Study||0
8652451|NCT00648648|9694233|FG019|COMPLETED|Overall Study||0
8652452|NCT00648648|9694234|FG020|COMPLETED|Overall Study||0
8652453|NCT00648648|9694235|FG021|COMPLETED|Overall Study||0
8652454|NCT00648648|9694236|FG022|COMPLETED|Overall Study||0
8652455|NCT00648648|9694237|FG023|COMPLETED|Overall Study||0
8652456|NCT00648648|9694238|FG024|COMPLETED|Overall Study||0
8652457|NCT00648648|9694239|FG025|COMPLETED|Overall Study||0
8652458|NCT00648648|9694240|FG026|COMPLETED|Overall Study||0
8652459|NCT00648648|9694241|FG027|COMPLETED|Overall Study||0
8652460|NCT00648648|9694214|FG000|NOT COMPLETED|Overall Study||0
8652461|NCT00648648|9694215|FG001|NOT COMPLETED|Overall Study||0
8652462|NCT00648648|9694216|FG002|NOT COMPLETED|Overall Study||0
8652463|NCT00648648|9694217|FG003|NOT COMPLETED|Overall Study||4
8652464|NCT00648648|9694218|FG004|NOT COMPLETED|Overall Study||9
8652465|NCT00648648|9694219|FG005|NOT COMPLETED|Overall Study||1
8652466|NCT00648648|9694220|FG006|NOT COMPLETED|Overall Study||10
8652467|NCT00648648|9694221|FG007|NOT COMPLETED|Overall Study||1
8652468|NCT00648648|9694222|FG008|NOT COMPLETED|Overall Study||3
8652469|NCT00648648|9694223|FG009|NOT COMPLETED|Overall Study||10
8652470|NCT00648648|9694224|FG010|NOT COMPLETED|Overall Study||6
8652471|NCT00648648|9694225|FG011|NOT COMPLETED|Overall Study||13
8652472|NCT00648648|9694226|FG012|NOT COMPLETED|Overall Study||6
8652473|NCT00648648|9694227|FG013|NOT COMPLETED|Overall Study||5
8652474|NCT00648648|9694228|FG014|NOT COMPLETED|Overall Study||4
8652475|NCT00648648|9694229|FG015|NOT COMPLETED|Overall Study||11
8652476|NCT00648648|9694230|FG016|NOT COMPLETED|Overall Study||14
8652477|NCT00648648|9694231|FG017|NOT COMPLETED|Overall Study||6
8652478|NCT00648648|9694232|FG018|NOT COMPLETED|Overall Study||5
8652479|NCT00648648|9694233|FG019|NOT COMPLETED|Overall Study||7
8652480|NCT00648648|9694234|FG020|NOT COMPLETED|Overall Study||6
8652481|NCT00648648|9694235|FG021|NOT COMPLETED|Overall Study||10
8652482|NCT00648648|9694236|FG022|NOT COMPLETED|Overall Study||14
8652483|NCT00648648|9694237|FG023|NOT COMPLETED|Overall Study||4
8652484|NCT00648648|9694238|FG024|NOT COMPLETED|Overall Study||4
8652485|NCT00648648|9694239|FG025|NOT COMPLETED|Overall Study||4
8652486|NCT00648648|9694240|FG026|NOT COMPLETED|Overall Study||26
8652487|NCT00648648|9694241|FG027|NOT COMPLETED|Overall Study||12
8652488|NCT00648739|9694299|FG000|STARTED|Overall Study||4
8652489|NCT00648739|9694300|FG001|STARTED|Overall Study||5
8652490|NCT00648739|9694301|FG002|STARTED|Overall Study||3
8652491|NCT00648739|9694302|FG003|STARTED|Overall Study||3
8652492|NCT00648739|9694303|FG004|STARTED|Overall Study||3
8652493|NCT00648739|9694304|FG005|STARTED|Overall Study||7
8652494|NCT00648739|9694305|FG006|STARTED|Overall Study||1
8652495|NCT00648739|9694299|FG000|Received at Least 1 Dose of Study Drug|Overall Study||4
8652496|NCT00648739|9694300|FG001|Received at Least 1 Dose of Study Drug|Overall Study||5
8652497|NCT00648739|9694301|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
8652498|NCT00648739|9694302|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
8652499|NCT00648739|9694303|FG004|Received at Least 1 Dose of Study Drug|Overall Study||3
8652500|NCT00648739|9694304|FG005|Received at Least 1 Dose of Study Drug|Overall Study||7
8652501|NCT00648739|9694305|FG006|Received at Least 1 Dose of Study Drug|Overall Study||1
8652502|NCT00648739|9694299|FG000|COMPLETED|Overall Study||2
8652503|NCT00648739|9694300|FG001|COMPLETED|Overall Study||3
8652504|NCT00648739|9694301|FG002|COMPLETED|Overall Study||0
8652505|NCT00648739|9694302|FG003|COMPLETED|Overall Study||1
8652506|NCT00648739|9694303|FG004|COMPLETED|Overall Study||1
8652507|NCT00648739|9694304|FG005|COMPLETED|Overall Study||2
8652508|NCT00648739|9694305|FG006|COMPLETED|Overall Study||0
8652509|NCT00648739|9694299|FG000|NOT COMPLETED|Overall Study||2
8652510|NCT00648739|9694300|FG001|NOT COMPLETED|Overall Study||2
8652511|NCT00648739|9694301|FG002|NOT COMPLETED|Overall Study||3
8652512|NCT00648739|9694302|FG003|NOT COMPLETED|Overall Study||2
8652513|NCT00648739|9694303|FG004|NOT COMPLETED|Overall Study||2
8652514|NCT00648739|9694304|FG005|NOT COMPLETED|Overall Study||5
8652515|NCT00648739|9694305|FG006|NOT COMPLETED|Overall Study||1
8652516|NCT00648908|9694326|FG000|STARTED|Overall Study||269
8652517|NCT00648908|9694326|FG000|COMPLETED|Overall Study||154
8652518|NCT00648908|9694326|FG000|NOT COMPLETED|Overall Study||115
8652519|NCT00649220|9694331|FG000|STARTED|Overall Study||19
8652520|NCT00649220|9694331|FG000|COMPLETED|Overall Study||16
8652521|NCT00649220|9694331|FG000|NOT COMPLETED|Overall Study||3
8652522|NCT00649389|9694339|FG000|STARTED|Overall Study||628
8652523|NCT00649389|9694340|FG001|STARTED|Overall Study||637
8652524|NCT00649389|9694341|FG002|STARTED|Overall Study||600
8652525|NCT00649389|9694342|FG003|STARTED|Overall Study||627
8652526|NCT00649389|9694339|FG000|COMPLETED|Overall Study||557
8652527|NCT00649389|9694340|FG001|COMPLETED|Overall Study||531
8652528|NCT00649389|9694341|FG002|COMPLETED|Overall Study||512
8652529|NCT00649389|9694342|FG003|COMPLETED|Overall Study||516
8728604|NCT01049360|9775768|FG004|STARTED|Period 1||7
8728605|NCT01049360|9775769|FG005|STARTED|Period 1||6
8728606|NCT01049360|9775770|FG006|STARTED|Period 1||6
8728607|NCT01049360|9775771|FG007|STARTED|Period 1||6
8728608|NCT01049360|9775772|FG008|STARTED|Period 1||7
8728609|NCT01049360|9775773|FG009|STARTED|Period 1||6
8728610|NCT01049360|9775774|FG010|STARTED|Period 1||6
8728611|NCT01049360|9775775|FG011|STARTED|Period 1||6
8728612|NCT01049360|9775776|FG012|STARTED|Period 1||6
8728613|NCT01049360|9775777|FG013|STARTED|Period 1||7
8728614|NCT01049360|9775778|FG014|STARTED|Period 1||7
8728615|NCT01049360|9775779|FG015|STARTED|Period 1||7
8728616|NCT01049360|9775780|FG016|STARTED|Period 1||6
8728617|NCT01049360|9775781|FG017|STARTED|Period 1||6
8728618|NCT01049360|9775782|FG018|STARTED|Period 1||6
8728619|NCT01049360|9775783|FG019|STARTED|Period 1||7
8728620|NCT01049360|9775764|FG000|COMPLETED|Period 1||6
8728621|NCT01049360|9775765|FG001|COMPLETED|Period 1||5
8728622|NCT01049360|9775766|FG002|COMPLETED|Period 1||7
8728623|NCT01049360|9775767|FG003|COMPLETED|Period 1||6
8728624|NCT01049360|9775768|FG004|COMPLETED|Period 1||7
8728625|NCT01049360|9775769|FG005|COMPLETED|Period 1||6
8728626|NCT01049360|9775770|FG006|COMPLETED|Period 1||6
8728627|NCT01049360|9775771|FG007|COMPLETED|Period 1||4
8728628|NCT01049360|9775772|FG008|COMPLETED|Period 1||5
8728629|NCT01049360|9775773|FG009|COMPLETED|Period 1||6
8728630|NCT01049360|9775774|FG010|COMPLETED|Period 1||5
8728631|NCT01049360|9775775|FG011|COMPLETED|Period 1||6
8728632|NCT01049360|9775776|FG012|COMPLETED|Period 1||4
8728633|NCT01049360|9775777|FG013|COMPLETED|Period 1||6
8728634|NCT01049360|9775778|FG014|COMPLETED|Period 1||7
8728635|NCT01049360|9775779|FG015|COMPLETED|Period 1||7
8728636|NCT01049360|9775780|FG016|COMPLETED|Period 1||5
8728637|NCT01049360|9775781|FG017|COMPLETED|Period 1||6
8728638|NCT01049360|9775782|FG018|COMPLETED|Period 1||5
8728639|NCT01049360|9775783|FG019|COMPLETED|Period 1||7
8728640|NCT01049360|9775764|FG000|NOT COMPLETED|Period 1||0
8728641|NCT01049360|9775765|FG001|NOT COMPLETED|Period 1||1
8728642|NCT01049360|9775766|FG002|NOT COMPLETED|Period 1||0
8728643|NCT01049360|9775767|FG003|NOT COMPLETED|Period 1||1
8728644|NCT01049360|9775768|FG004|NOT COMPLETED|Period 1||0
8728645|NCT01049360|9775769|FG005|NOT COMPLETED|Period 1||0
8728646|NCT01049360|9775770|FG006|NOT COMPLETED|Period 1||0
8728647|NCT01049360|9775771|FG007|NOT COMPLETED|Period 1||2
8728648|NCT01049360|9775772|FG008|NOT COMPLETED|Period 1||2
8728649|NCT01049360|9775773|FG009|NOT COMPLETED|Period 1||0
8728650|NCT01049360|9775774|FG010|NOT COMPLETED|Period 1||1
8728651|NCT01049360|9775775|FG011|NOT COMPLETED|Period 1||0
8652530|NCT00649389|9694339|FG000|NOT COMPLETED|Overall Study||71
8652531|NCT00649389|9694340|FG001|NOT COMPLETED|Overall Study||106
8652532|NCT00649389|9694341|FG002|NOT COMPLETED|Overall Study||88
8652533|NCT00649389|9694342|FG003|NOT COMPLETED|Overall Study||111
8652534|NCT00649428|9694354|FG000|STARTED|Overall Study||100
8652535|NCT00649428|9694355|FG001|STARTED|Overall Study||103
8652536|NCT00649428|9694354|FG000|COMPLETED|Overall Study||80
8652537|NCT00649428|9694355|FG001|COMPLETED|Overall Study||88
8652538|NCT00649428|9694354|FG000|NOT COMPLETED|Overall Study||20
8652539|NCT00649428|9694355|FG001|NOT COMPLETED|Overall Study||15
8652540|NCT00649792|9694362|FG000|STARTED|Overall Study||214
8652541|NCT00649792|9694362|FG000|COMPLETED|Overall Study||146
8652542|NCT00649792|9694362|FG000|NOT COMPLETED|Overall Study||68
8652543|NCT00649961|9694366|FG000|STARTED|Overall Study||18
8652544|NCT00649961|9694366|FG000|COMPLETED|Overall Study||18
8652545|NCT00649961|9694366|FG000|NOT COMPLETED|Overall Study||0
8652546|NCT00650078|9694372|FG000|STARTED|Overall Study||231
8652547|NCT00650078|9694373|FG001|STARTED|Overall Study||119
8652548|NCT00650078|9694372|FG000|COMPLETED|Overall Study||217
8652549|NCT00650078|9694373|FG001|COMPLETED|Overall Study||106
8652550|NCT00650078|9694372|FG000|NOT COMPLETED|Overall Study||14
8652551|NCT00650078|9694373|FG001|NOT COMPLETED|Overall Study||13
8652552|NCT00650091|9694381|FG000|STARTED|Initial Study Design - Interim Analysis||81
8652553|NCT00650091|9694382|FG001|STARTED|Initial Study Design - Interim Analysis||78
8652554|NCT00650091|9694383|FG002|STARTED|Initial Study Design - Interim Analysis||77
8652555|NCT00650091|9694381|FG000|COMPLETED|Initial Study Design - Interim Analysis||81
8652556|NCT00650091|9694382|FG001|COMPLETED|Initial Study Design - Interim Analysis||78
8652557|NCT00650091|9694383|FG002|COMPLETED|Initial Study Design - Interim Analysis||77
8652558|NCT00650091|9694381|FG000|NOT COMPLETED|Initial Study Design - Interim Analysis||0
8652559|NCT00650091|9694382|FG001|NOT COMPLETED|Initial Study Design - Interim Analysis||0
8652560|NCT00650091|9694383|FG002|NOT COMPLETED|Initial Study Design - Interim Analysis||0
8652561|NCT00650091|9694381|FG000|STARTED|Amended Study Design||133
8652562|NCT00650091|9694382|FG001|STARTED|Amended Study Design||131
8652563|NCT00650091|9694383|FG002|STARTED|Amended Study Design|Study Drug was discontinued for all subjects due to safety concerns.|0
8652564|NCT00650091|9694381|FG000|COMPLETED|Amended Study Design||110
8652565|NCT00650091|9694382|FG001|COMPLETED|Amended Study Design||111
8652566|NCT00650091|9694383|FG002|COMPLETED|Amended Study Design||0
8652567|NCT00650091|9694381|FG000|NOT COMPLETED|Amended Study Design||23
8652568|NCT00650091|9694382|FG001|NOT COMPLETED|Amended Study Design||20
8652569|NCT00650091|9694383|FG002|NOT COMPLETED|Amended Study Design||0
8652570|NCT00650104|9694391|FG000|STARTED|Overall Study||83
8652571|NCT00650104|9694391|FG000|COMPLETED|Overall Study||42
8652572|NCT00650104|9694391|FG000|NOT COMPLETED|Overall Study||41
8652573|NCT00650260|9694397|FG000|STARTED|Overall Study||21
8652574|NCT00650260|9694398|FG001|STARTED|Overall Study||21
8652575|NCT00650260|9694397|FG000|COMPLETED|Overall Study||21
8652576|NCT00650260|9694398|FG001|COMPLETED|Overall Study||21
8652577|NCT00650260|9694397|FG000|NOT COMPLETED|Overall Study||0
8652578|NCT00650260|9694398|FG001|NOT COMPLETED|Overall Study||0
8652579|NCT00650546|9694404|FG000|STARTED|Overall Study||8
8652580|NCT00650546|9694404|FG000|COMPLETED|Overall Study||8
8652581|NCT00650546|9694404|FG000|NOT COMPLETED|Overall Study||0
8652582|NCT00650585|9694411|FG000|STARTED|Overall Study||4348
8652583|NCT00650585|9694412|FG001|STARTED|Overall Study||3990
8652584|NCT00650585|9694411|FG000|COMPLETED|Overall Study|Completed posttest--a self-report survey administered 30 approximately 30 days after treatment|2551
8652585|NCT00650585|9694412|FG001|COMPLETED|Overall Study|Completed posttest--a self-report survey administered 30 approximately 30 days after treatment|2513
8652586|NCT00650585|9694411|FG000|NOT COMPLETED|Overall Study||1797
8652587|NCT00650585|9694412|FG001|NOT COMPLETED|Overall Study||1477
8652588|NCT00650767|9694422|FG000|STARTED|Overall Study||51
8652589|NCT00650767|9694423|FG001|STARTED|Overall Study||50
8652590|NCT00650767|9694424|FG002|STARTED|Overall Study||50
8652591|NCT00650767|9694425|FG003|STARTED|Overall Study||50
8652592|NCT00650767|9694422|FG000|COMPLETED|Overall Study||46
8652593|NCT00650767|9694423|FG001|COMPLETED|Overall Study||41
8652594|NCT00650767|9694424|FG002|COMPLETED|Overall Study||36
8652595|NCT00650767|9694425|FG003|COMPLETED|Overall Study||39
8652596|NCT00650767|9694422|FG000|NOT COMPLETED|Overall Study||5
8652597|NCT00650767|9694423|FG001|NOT COMPLETED|Overall Study||9
8652598|NCT00650767|9694424|FG002|NOT COMPLETED|Overall Study||14
8652599|NCT00650767|9694425|FG003|NOT COMPLETED|Overall Study||11
8652600|NCT00650806|9694439|FG000|STARTED|Overall Study||89
8652601|NCT00650806|9694440|FG001|STARTED|Overall Study||98
8652602|NCT00650806|9694441|FG002|STARTED|Overall Study||93
8652603|NCT00650806|9694442|FG003|STARTED|Overall Study||96
8652604|NCT00650806|9694439|FG000|COMPLETED|Overall Study||71
8652605|NCT00650806|9694440|FG001|COMPLETED|Overall Study||77
8652606|NCT00650806|9694441|FG002|COMPLETED|Overall Study||64
8652607|NCT00650806|9694442|FG003|COMPLETED|Overall Study||70
8652608|NCT00650806|9694439|FG000|NOT COMPLETED|Overall Study||18
8652609|NCT00650806|9694440|FG001|NOT COMPLETED|Overall Study||21
8652610|NCT00650806|9694441|FG002|NOT COMPLETED|Overall Study||29
8652611|NCT00650806|9694442|FG003|NOT COMPLETED|Overall Study||26
8652612|NCT00650845|9694456|FG000|STARTED|Overall Study||75
8652613|NCT00650845|9694457|FG001|STARTED|Overall Study||57
8652614|NCT00650845|9694456|FG000|COMPLETED|Overall Study||70
8652615|NCT00650845|9694457|FG001|COMPLETED|Overall Study||44
8652616|NCT00650845|9694456|FG000|NOT COMPLETED|Overall Study||5
8652617|NCT00650845|9694457|FG001|NOT COMPLETED|Overall Study||13
8652618|NCT00650858|9694467|FG000|STARTED|Overall Study||8
8652619|NCT00650858|9694468|FG001|STARTED|Overall Study||8
8652620|NCT00650858|9694469|FG002|STARTED|Overall Study||36
8652621|NCT00650858|9694467|FG000|COMPLETED|Overall Study||8
8652622|NCT00650858|9694468|FG001|COMPLETED|Overall Study||8
8652623|NCT00650858|9694469|FG002|COMPLETED|Overall Study||36
8652624|NCT00650858|9694467|FG000|NOT COMPLETED|Overall Study||0
8652625|NCT00650858|9694468|FG001|NOT COMPLETED|Overall Study||0
8652626|NCT00650858|9694469|FG002|NOT COMPLETED|Overall Study||0
8652627|NCT00650936|9694477|FG000|STARTED|Overall Study||1000
8652628|NCT00650936|9694477|FG000|COMPLETED|Overall Study||930
8652629|NCT00650936|9694477|FG000|NOT COMPLETED|Overall Study||70
8652630|NCT00651040|9694483|FG000|STARTED|Overall Study||16
8652631|NCT00651040|9694484|FG001|STARTED|Overall Study||15
8652632|NCT00651040|9694483|FG000|COMPLETED|Overall Study||13
8652633|NCT00651040|9694484|FG001|COMPLETED|Overall Study||14
8652634|NCT00651040|9694483|FG000|NOT COMPLETED|Overall Study||3
8652635|NCT00651040|9694484|FG001|NOT COMPLETED|Overall Study||1
8652636|NCT00651118|9694494|FG000|STARTED|Overall Study||207
8652637|NCT00651118|9694495|FG001|STARTED|Overall Study||207
8652638|NCT00651118|9694496|FG002|STARTED|Overall Study||208
8652639|NCT00651118|9694497|FG003|STARTED|Overall Study||210
8652640|NCT00651118|9694494|FG000|COMPLETED|Overall Study||198
8652641|NCT00651118|9694495|FG001|COMPLETED|Overall Study||200
8652642|NCT00651118|9694496|FG002|COMPLETED|Overall Study||197
8652643|NCT00651118|9694497|FG003|COMPLETED|Overall Study||203
8652644|NCT00651118|9694494|FG000|NOT COMPLETED|Overall Study||9
8652645|NCT00651118|9694495|FG001|NOT COMPLETED|Overall Study||7
8652646|NCT00651118|9694496|FG002|NOT COMPLETED|Overall Study||11
8652647|NCT00651118|9694497|FG003|NOT COMPLETED|Overall Study||7
8652648|NCT00651157|9694510|FG000|STARTED|Overall Study||23
8652649|NCT00651157|9694510|FG000|COMPLETED|Overall Study||21
8652650|NCT00651157|9694510|FG000|NOT COMPLETED|Overall Study||2
8652651|NCT00651183|9694516|FG000|STARTED|Overall Study|"For one patient the information was not given, therefore, the patient was listed missing"|189
8652652|NCT00651183|9694517|FG001|STARTED|Overall Study||97
8652653|NCT00651183|9694516|FG000|COMPLETED|Overall Study|Case Report Form (CRF) listed reasons for early termination, of which one was|169
8652654|NCT00651183|9694517|FG001|COMPLETED|Overall Study|"other reasons. No explanation was required to be given by the physicians"|87
8652655|NCT00651183|9694516|FG000|NOT COMPLETED|Overall Study||20
8652656|NCT00651183|9694517|FG001|NOT COMPLETED|Overall Study||10
8652657|NCT00651261|9694525|FG000|STARTED|Overall Study||360
8652658|NCT00651261|9694526|FG001|STARTED|Overall Study||357
8652659|NCT00651261|9694525|FG000|COMPLETED|Overall Study||69
8652660|NCT00651261|9694526|FG001|COMPLETED|Overall Study||51
8652661|NCT00651261|9694525|FG000|NOT COMPLETED|Overall Study||291
8652662|NCT00651261|9694526|FG001|NOT COMPLETED|Overall Study||306
8652663|NCT00651313|9694534|FG000|STARTED|Overall Study||41
8652664|NCT00651313|9694535|FG001|STARTED|Overall Study||43
8652665|NCT00651313|9694534|FG000|COMPLETED|Overall Study||35
8652666|NCT00651313|9694535|FG001|COMPLETED|Overall Study||37
8652667|NCT00651313|9694534|FG000|NOT COMPLETED|Overall Study||6
8652668|NCT00651313|9694535|FG001|NOT COMPLETED|Overall Study||6
8652669|NCT00651482|9694541|FG000|STARTED|Overall Study||10
8652670|NCT00651482|9694541|FG000|COMPLETED|Overall Study||10
8652671|NCT00651482|9694541|FG000|NOT COMPLETED|Overall Study||0
8652672|NCT00651573|9694548|FG000|STARTED|Overall Study||365
8652673|NCT00651573|9694549|FG001|STARTED|Overall Study||357
8652674|NCT00651573|9694548|FG000|COMPLETED|Overall Study||363
8652675|NCT00651573|9694549|FG001|COMPLETED|Overall Study||354
8652676|NCT00651573|9694548|FG000|NOT COMPLETED|Overall Study||2
8652677|NCT00651573|9694549|FG001|NOT COMPLETED|Overall Study||3
8652678|NCT00651625|9694557|FG000|STARTED|Overall Study||219
8652679|NCT00651625|9694558|FG001|STARTED|Overall Study||218
8652680|NCT00651625|9694557|FG000|COMPLETED|Overall Study||219
8652681|NCT00651625|9694558|FG001|COMPLETED|Overall Study||218
8652682|NCT00651625|9694557|FG000|NOT COMPLETED|Overall Study||0
8652683|NCT00651625|9694558|FG001|NOT COMPLETED|Overall Study||0
8652684|NCT00651664|9694574|FG000|STARTED|Overall Study||3
8652685|NCT00651664|9694575|FG001|STARTED|Overall Study||3
8652686|NCT00651664|9694576|FG002|STARTED|Overall Study||3
8652687|NCT00651664|9694577|FG003|STARTED|Overall Study||14
8652688|NCT00651664|9694578|FG004|STARTED|Overall Study||6
8652689|NCT00651664|9694579|FG005|STARTED|Overall Study||3
8652690|NCT00651664|9694580|FG006|STARTED|Overall Study||6
8652691|NCT00651664|9694581|FG007|STARTED|Overall Study||7
8652692|NCT00651664|9694582|FG008|STARTED|Overall Study||7
8652693|NCT00651664|9694583|FG009|STARTED|Overall Study||7
8652694|NCT00651664|9694574|FG000|COMPLETED|Overall Study||0
8652695|NCT00651664|9694575|FG001|COMPLETED|Overall Study||0
8652696|NCT00651664|9694576|FG002|COMPLETED|Overall Study||0
8652697|NCT00651664|9694577|FG003|COMPLETED|Overall Study||0
8652698|NCT00651664|9694578|FG004|COMPLETED|Overall Study||0
8652699|NCT00651664|9694579|FG005|COMPLETED|Overall Study||0
8652700|NCT00651664|9694580|FG006|COMPLETED|Overall Study||0
8652701|NCT00651664|9694581|FG007|COMPLETED|Overall Study||0
8652702|NCT00651664|9694582|FG008|COMPLETED|Overall Study||0
8652703|NCT00651664|9694583|FG009|COMPLETED|Overall Study||0
8652704|NCT00651664|9694574|FG000|NOT COMPLETED|Overall Study||3
8652705|NCT00651664|9694575|FG001|NOT COMPLETED|Overall Study||3
8652706|NCT00651664|9694576|FG002|NOT COMPLETED|Overall Study||3
8652707|NCT00651664|9694577|FG003|NOT COMPLETED|Overall Study||14
8652708|NCT00651664|9694578|FG004|NOT COMPLETED|Overall Study||6
8652709|NCT00651664|9694579|FG005|NOT COMPLETED|Overall Study||3
8652710|NCT00651664|9694580|FG006|NOT COMPLETED|Overall Study||6
8652711|NCT00651664|9694581|FG007|NOT COMPLETED|Overall Study||7
8652712|NCT00651664|9694582|FG008|NOT COMPLETED|Overall Study||7
8652713|NCT00651664|9694583|FG009|NOT COMPLETED|Overall Study||7
8652714|NCT00651755|9694609|FG000|STARTED|Cycle 1 (First 21 Days)||11
8652715|NCT00651755|9694610|FG001|STARTED|Cycle 1 (First 21 Days)||9
8652716|NCT00651755|9694609|FG000|COMPLETED|Cycle 1 (First 21 Days)||10
8652717|NCT00651755|9694610|FG001|COMPLETED|Cycle 1 (First 21 Days)||9
8652718|NCT00651755|9694609|FG000|NOT COMPLETED|Cycle 1 (First 21 Days)||1
8652719|NCT00651755|9694610|FG001|NOT COMPLETED|Cycle 1 (First 21 Days)||0
8652720|NCT00651755|9694609|FG000|STARTED|Cycle 2 (Second 21 Days)||10
8652721|NCT00651755|9694610|FG001|STARTED|Cycle 2 (Second 21 Days)||9
8652722|NCT00651755|9694609|FG000|COMPLETED|Cycle 2 (Second 21 Days)||10
8652723|NCT00651755|9694610|FG001|COMPLETED|Cycle 2 (Second 21 Days)||8
8652724|NCT00651755|9694609|FG000|NOT COMPLETED|Cycle 2 (Second 21 Days)||0
8652725|NCT00651755|9694610|FG001|NOT COMPLETED|Cycle 2 (Second 21 Days)||1
8652726|NCT00651794|9694620|FG000|STARTED|Overall Study||36
8652727|NCT00651794|9694621|FG001|STARTED|Overall Study||31
8652728|NCT00651794|9694622|FG002|STARTED|Overall Study||31
8652729|NCT00651794|9694620|FG000|COMPLETED|Overall Study||15
8652730|NCT00651794|9694621|FG001|COMPLETED|Overall Study||9
8652731|NCT00651794|9694622|FG002|COMPLETED|Overall Study||10
8652732|NCT00651794|9694620|FG000|NOT COMPLETED|Overall Study||21
8652733|NCT00651794|9694621|FG001|NOT COMPLETED|Overall Study||22
8652734|NCT00651794|9694622|FG002|NOT COMPLETED|Overall Study||21
8652735|NCT00651820|9694630|FG000|STARTED|Overall Study||28
8652736|NCT00651820|9694630|FG000|COMPLETED|Overall Study||26
8652737|NCT00651820|9694630|FG000|NOT COMPLETED|Overall Study||2
8652738|NCT00651924|9694638|FG000|STARTED|Overall Study||18
8652739|NCT00651924|9694639|FG001|STARTED|Overall Study||9
8652740|NCT00651924|9694638|FG000|COMPLETED|Overall Study||18
8652741|NCT00651924|9694639|FG001|COMPLETED|Overall Study||2
8652742|NCT00651924|9694638|FG000|NOT COMPLETED|Overall Study||0
8652743|NCT00651924|9694639|FG001|NOT COMPLETED|Overall Study||7
8652744|NCT00651937|9694647|FG000|STARTED|Overall Study||39
8652745|NCT00651937|9694648|FG001|STARTED|Overall Study||41
8652746|NCT00651937|9694647|FG000|COMPLETED|Overall Study||35
8652747|NCT00651937|9694648|FG001|COMPLETED|Overall Study||40
8652748|NCT00651937|9694647|FG000|NOT COMPLETED|Overall Study||4
8652749|NCT00651937|9694648|FG001|NOT COMPLETED|Overall Study||1
8652750|NCT00652028|9694658|FG000|STARTED|Overall Study||16
8652751|NCT00652028|9694659|FG001|STARTED|Overall Study||14
8652752|NCT00652028|9694660|FG002|STARTED|Overall Study||15
8652753|NCT00652028|9694661|FG003|STARTED|Overall Study||14
8652754|NCT00652028|9694658|FG000|COMPLETED|Overall Study||15
8652755|NCT00652028|9694659|FG001|COMPLETED|Overall Study||13
8652756|NCT00652028|9694660|FG002|COMPLETED|Overall Study||14
8652757|NCT00652028|9694661|FG003|COMPLETED|Overall Study||14
8652758|NCT00652028|9694658|FG000|NOT COMPLETED|Overall Study||1
8652759|NCT00652028|9694659|FG001|NOT COMPLETED|Overall Study||1
8652760|NCT00652028|9694660|FG002|NOT COMPLETED|Overall Study||1
8652761|NCT00652028|9694661|FG003|NOT COMPLETED|Overall Study||0
8652762|NCT00652080|9694671|FG000|STARTED|Overall Study||35
8652763|NCT00652080|9694671|FG000|COMPLETED|Overall Study||31
8652764|NCT00652080|9694671|FG000|NOT COMPLETED|Overall Study||4
8652765|NCT00652093|9694683|FG000|STARTED|Overall Study||4
8652766|NCT00652093|9694684|FG001|STARTED|Overall Study||4
8652767|NCT00652093|9694685|FG002|STARTED|Overall Study||4
8652768|NCT00652093|9694686|FG003|STARTED|Overall Study||4
8652769|NCT00652093|9694687|FG004|STARTED|Overall Study||4
8652770|NCT00652093|9694688|FG005|STARTED|Overall Study||4
8652771|NCT00652093|9694683|FG000|COMPLETED|Overall Study||4
8652772|NCT00652093|9694684|FG001|COMPLETED|Overall Study||4
8652773|NCT00652093|9694685|FG002|COMPLETED|Overall Study||3
8652774|NCT00652093|9694686|FG003|COMPLETED|Overall Study||4
8652775|NCT00652093|9694687|FG004|COMPLETED|Overall Study||2
8652776|NCT00652093|9694688|FG005|COMPLETED|Overall Study||4
8652777|NCT00652093|9694683|FG000|NOT COMPLETED|Overall Study||0
8652778|NCT00652093|9694684|FG001|NOT COMPLETED|Overall Study||0
8652779|NCT00652093|9694685|FG002|NOT COMPLETED|Overall Study||1
8652780|NCT00652093|9694686|FG003|NOT COMPLETED|Overall Study||0
8652781|NCT00652093|9694687|FG004|NOT COMPLETED|Overall Study||2
8652782|NCT00652093|9694688|FG005|NOT COMPLETED|Overall Study||0
8652783|NCT00652145|9694704|FG000|STARTED|Overall Study||26
8652784|NCT00652145|9694705|FG001|STARTED|Overall Study||26
8652785|NCT00652145|9694704|FG000|COMPLETED|Overall Study||26
8652786|NCT00652145|9694705|FG001|COMPLETED|Overall Study||26
8652787|NCT00652145|9694704|FG000|NOT COMPLETED|Overall Study||0
8652788|NCT00652145|9694705|FG001|NOT COMPLETED|Overall Study||0
8652789|NCT00652314|9694715|FG000|STARTED|Overall Study||62
8652790|NCT00652314|9694716|FG001|STARTED|Overall Study||35
8652791|NCT00652314|9694715|FG000|COMPLETED|Overall Study||53
8652792|NCT00652314|9694716|FG001|COMPLETED|Overall Study||26
8652793|NCT00652314|9694715|FG000|NOT COMPLETED|Overall Study||9
8652794|NCT00652314|9694716|FG001|NOT COMPLETED|Overall Study||9
8652795|NCT00652340|9694724|FG000|STARTED|Overall Study||78
8652796|NCT00652340|9694725|FG001|STARTED|Overall Study||42
8652797|NCT00652340|9694724|FG000|COMPLETED|Overall Study|4 patients remained on study at database lock.|74
8652798|NCT00652340|9694725|FG001|COMPLETED|Overall Study|3 patients remained on study at database lock.|39
8652799|NCT00652340|9694724|FG000|NOT COMPLETED|Overall Study||4
8652800|NCT00652340|9694725|FG001|NOT COMPLETED|Overall Study||3
8652801|NCT00652366|9694736|FG000|STARTED|Overall Study||106
8652802|NCT00652366|9694737|FG001|STARTED|Overall Study||75
8652803|NCT00652366|9694738|FG002|STARTED|Overall Study||71
8652804|NCT00652366|9694739|FG003|STARTED|Overall Study||179
8652805|NCT00652366|9694740|FG004|STARTED|Overall Study||36
8652806|NCT00652366|9694736|FG000|COMPLETED|Overall Study||0
8652807|NCT00652366|9694737|FG001|COMPLETED|Overall Study||0
8652808|NCT00652366|9694738|FG002|COMPLETED|Overall Study||0
8652809|NCT00652366|9694739|FG003|COMPLETED|Overall Study||0
8652810|NCT00652366|9694740|FG004|COMPLETED|Overall Study||0
8652811|NCT00652366|9694736|FG000|NOT COMPLETED|Overall Study||106
8652812|NCT00652366|9694737|FG001|NOT COMPLETED|Overall Study||75
8652813|NCT00652366|9694738|FG002|NOT COMPLETED|Overall Study||71
8652814|NCT00652366|9694739|FG003|NOT COMPLETED|Overall Study||179
8652815|NCT00652366|9694740|FG004|NOT COMPLETED|Overall Study||36
8652816|NCT00652626|9694761|FG000|STARTED|Initial Treatment Phase||5
8652817|NCT00652626|9694762|FG001|STARTED|Initial Treatment Phase||5
8652818|NCT00652626|9694763|FG002|STARTED|Initial Treatment Phase||7
8652819|NCT00652626|9694764|FG003|STARTED|Initial Treatment Phase||6
8652820|NCT00652626|9694765|FG004|STARTED|Initial Treatment Phase||8
8652821|NCT00652626|9694766|FG005|STARTED|Initial Treatment Phase||0
8652822|NCT00652626|9694767|FG006|STARTED|Initial Treatment Phase||0
8652823|NCT00652626|9694761|FG000|Received Study Drug|Initial Treatment Phase||5
8652824|NCT00652626|9694762|FG001|Received Study Drug|Initial Treatment Phase||5
8652825|NCT00652626|9694763|FG002|Received Study Drug|Initial Treatment Phase||6
8652826|NCT00652626|9694764|FG003|Received Study Drug|Initial Treatment Phase||5
8652827|NCT00652626|9694765|FG004|Received Study Drug|Initial Treatment Phase||6
8652828|NCT00652626|9694766|FG005|Received Study Drug|Initial Treatment Phase||0
8652829|NCT00652626|9694767|FG006|Received Study Drug|Initial Treatment Phase||0
8652830|NCT00652626|9694761|FG000|COMPLETED|Initial Treatment Phase||5
8652831|NCT00652626|9694762|FG001|COMPLETED|Initial Treatment Phase||5
8652832|NCT00652626|9694763|FG002|COMPLETED|Initial Treatment Phase||6
8652833|NCT00652626|9694764|FG003|COMPLETED|Initial Treatment Phase||5
8652834|NCT00652626|9694765|FG004|COMPLETED|Initial Treatment Phase||5
8652835|NCT00652626|9694766|FG005|COMPLETED|Initial Treatment Phase||0
8652836|NCT00652626|9694767|FG006|COMPLETED|Initial Treatment Phase||0
8652837|NCT00652626|9694761|FG000|NOT COMPLETED|Initial Treatment Phase||0
8652838|NCT00652626|9694762|FG001|NOT COMPLETED|Initial Treatment Phase||0
8652839|NCT00652626|9694763|FG002|NOT COMPLETED|Initial Treatment Phase||1
8652840|NCT00652626|9694764|FG003|NOT COMPLETED|Initial Treatment Phase||1
8652841|NCT00652626|9694765|FG004|NOT COMPLETED|Initial Treatment Phase||3
8652842|NCT00652626|9694766|FG005|NOT COMPLETED|Initial Treatment Phase||0
8652843|NCT00652626|9694767|FG006|NOT COMPLETED|Initial Treatment Phase||0
8652844|NCT00652626|9694761|FG000|STARTED|Extension Phase||0
8652845|NCT00652626|9694762|FG001|STARTED|Extension Phase||0
8652846|NCT00652626|9694763|FG002|STARTED|Extension Phase||0
8652847|NCT00652626|9694764|FG003|STARTED|Extension Phase||0
8652848|NCT00652626|9694765|FG004|STARTED|Extension Phase||0
8652849|NCT00652626|9694766|FG005|STARTED|Extension Phase||14
8652850|NCT00652626|9694767|FG006|STARTED|Extension Phase||4
8652851|NCT00652626|9694761|FG000|COMPLETED|Extension Phase||0
8652852|NCT00652626|9694762|FG001|COMPLETED|Extension Phase||0
8652853|NCT00652626|9694763|FG002|COMPLETED|Extension Phase||0
8652854|NCT00652626|9694764|FG003|COMPLETED|Extension Phase||0
8652855|NCT00652626|9694765|FG004|COMPLETED|Extension Phase||0
8652856|NCT00652626|9694766|FG005|COMPLETED|Extension Phase|A participant was considered completed if they had completed 6 cycles of therapy.|2
8652857|NCT00652626|9694767|FG006|COMPLETED|Extension Phase|A participant was considered completed if they had completed 6 cycles of therapy.|1
8652858|NCT00652626|9694761|FG000|NOT COMPLETED|Extension Phase||0
8652859|NCT00652626|9694762|FG001|NOT COMPLETED|Extension Phase||0
8652860|NCT00652626|9694763|FG002|NOT COMPLETED|Extension Phase||0
8652861|NCT00652626|9694764|FG003|NOT COMPLETED|Extension Phase||0
8652862|NCT00652626|9694765|FG004|NOT COMPLETED|Extension Phase||0
8652863|NCT00652626|9694766|FG005|NOT COMPLETED|Extension Phase||12
8652864|NCT00652626|9694767|FG006|NOT COMPLETED|Extension Phase||3
8652865|NCT00652743|9694788|FG000|STARTED|Months 12-18||219
8652866|NCT00652743|9694789|FG001|STARTED|Months 12-18||188
8652867|NCT00652743|9694790|FG002|STARTED|Months 12-18||437
8652868|NCT00652743|9694788|FG000|COMPLETED|Months 12-18||218
8652869|NCT00652743|9694789|FG001|COMPLETED|Months 12-18||186
8652870|NCT00652743|9694790|FG002|COMPLETED|Months 12-18||430
8652871|NCT00652743|9694788|FG000|NOT COMPLETED|Months 12-18||1
8652872|NCT00652743|9694789|FG001|NOT COMPLETED|Months 12-18||2
8652873|NCT00652743|9694790|FG002|NOT COMPLETED|Months 12-18||7
8652874|NCT00652743|9694788|FG000|STARTED|Months 24-30||212
8652875|NCT00652743|9694789|FG001|STARTED|Months 24-30||186
8652876|NCT00652743|9694790|FG002|STARTED|Months 24-30||433
8652877|NCT00652743|9694788|FG000|COMPLETED|Months 24-30||207
8652878|NCT00652743|9694789|FG001|COMPLETED|Months 24-30||185
8652879|NCT00652743|9694790|FG002|COMPLETED|Months 24-30||422
8652880|NCT00652743|9694788|FG000|NOT COMPLETED|Months 24-30||5
8652881|NCT00652743|9694789|FG001|NOT COMPLETED|Months 24-30||1
8652882|NCT00652743|9694790|FG002|NOT COMPLETED|Months 24-30||11
8652883|NCT00652743|9694788|FG000|STARTED|Months 36-42||216
8652884|NCT00652743|9694789|FG001|STARTED|Months 36-42||185
8652885|NCT00652743|9694790|FG002|STARTED|Months 36-42||390
8652886|NCT00652743|9694788|FG000|COMPLETED|Months 36-42||210
8652887|NCT00652743|9694789|FG001|COMPLETED|Months 36-42||180
8652888|NCT00652743|9694790|FG002|COMPLETED|Months 36-42||381
8652889|NCT00652743|9694788|FG000|NOT COMPLETED|Months 36-42||6
8652890|NCT00652743|9694789|FG001|NOT COMPLETED|Months 36-42||5
8652891|NCT00652743|9694790|FG002|NOT COMPLETED|Months 36-42||9
8652892|NCT00652743|9694788|FG000|STARTED|Months 42-48||196
8652893|NCT00652743|9694789|FG001|STARTED|Months 42-48||170
8652894|NCT00652743|9694790|FG002|STARTED|Months 42-48||367
8652895|NCT00652743|9694788|FG000|COMPLETED|Months 42-48||196
8652896|NCT00652743|9694789|FG001|COMPLETED|Months 42-48||170
8652897|NCT00652743|9694790|FG002|COMPLETED|Months 42-48||367
8652898|NCT00652743|9694788|FG000|NOT COMPLETED|Months 42-48||0
8652899|NCT00652743|9694789|FG001|NOT COMPLETED|Months 42-48||0
8652900|NCT00652743|9694790|FG002|NOT COMPLETED|Months 42-48||0
8652901|NCT00652834|9694801|FG000|STARTED|Overall Study||23
8652902|NCT00652834|9694801|FG000|COMPLETED|Overall Study|3 subjects withdrew after completing baseline questionnaire. 2 did not complete 30-day visit.|18
8652903|NCT00652834|9694801|FG000|NOT COMPLETED|Overall Study||5
8652904|NCT00652899|9694805|FG000|STARTED|Overall Study||14
8652905|NCT00652899|9694805|FG000|COMPLETED|Overall Study||12
8652906|NCT00652899|9694805|FG000|NOT COMPLETED|Overall Study||2
8652907|NCT00652938|9694816|FG000|STARTED|Overall Study||247
8652908|NCT00652938|9694817|FG001|STARTED|Overall Study||247
8652909|NCT00652938|9694818|FG002|STARTED|Overall Study||247
8652910|NCT00652938|9694816|FG000|COMPLETED|Overall Study||246
8652911|NCT00652938|9694817|FG001|COMPLETED|Overall Study||240
8652912|NCT00652938|9694818|FG002|COMPLETED|Overall Study||242
8652913|NCT00652938|9694816|FG000|NOT COMPLETED|Overall Study||1
8652914|NCT00652938|9694817|FG001|NOT COMPLETED|Overall Study||7
8652915|NCT00652938|9694818|FG002|NOT COMPLETED|Overall Study||5
8652916|NCT00652951|9694829|FG000|STARTED|Primary Phase||260
8652917|NCT00652951|9694830|FG001|STARTED|Primary Phase||260
8652918|NCT00652951|9694831|FG002|STARTED|Primary Phase||260
8652919|NCT00652951|9694829|FG000|COMPLETED|Primary Phase||260
8652920|NCT00652951|9694830|FG001|COMPLETED|Primary Phase||260
8652921|NCT00652951|9694831|FG002|COMPLETED|Primary Phase||260
8652922|NCT00652951|9694829|FG000|NOT COMPLETED|Primary Phase||0
8652923|NCT00652951|9694830|FG001|NOT COMPLETED|Primary Phase||0
8652924|NCT00652951|9694831|FG002|NOT COMPLETED|Primary Phase||0
8652925|NCT00652951|9694829|FG000|STARTED|Booster Phase||257
8652926|NCT00652951|9694830|FG001|STARTED|Booster Phase||259
8652927|NCT00652951|9694831|FG002|STARTED|Booster Phase||258
8652928|NCT00652951|9694829|FG000|COMPLETED|Booster Phase||256
8652929|NCT00652951|9694830|FG001|COMPLETED|Booster Phase||258
8652930|NCT00652951|9694831|FG002|COMPLETED|Booster Phase||258
8652931|NCT00652951|9694829|FG000|NOT COMPLETED|Booster Phase||1
8652932|NCT00652951|9694830|FG001|NOT COMPLETED|Booster Phase||1
8652933|NCT00652951|9694831|FG002|NOT COMPLETED|Booster Phase||0
8652934|NCT00653133|9694841|FG000|STARTED|Overall Study||1324
8652935|NCT00653133|9694842|FG001|STARTED|Overall Study||497
8652936|NCT00653133|9694841|FG000|COMPLETED|Overall Study||1324
8652937|NCT00653133|9694842|FG001|COMPLETED|Overall Study||497
8652938|NCT00653133|9694841|FG000|NOT COMPLETED|Overall Study||0
8652939|NCT00653133|9694842|FG001|NOT COMPLETED|Overall Study||0
8652940|NCT00653159|9694850|FG000|STARTED|Overall Study||11
8652941|NCT00653159|9694851|FG001|STARTED|Overall Study||12
8652942|NCT00653159|9694850|FG000|COMPLETED|Overall Study||6
8652943|NCT00653159|9694851|FG001|COMPLETED|Overall Study||9
8652944|NCT00653159|9694850|FG000|NOT COMPLETED|Overall Study||5
8652945|NCT00653159|9694851|FG001|NOT COMPLETED|Overall Study||3
8652946|NCT00653224|9694859|FG000|STARTED|Overall Study||293
8652947|NCT00653224|9694860|FG001|STARTED|Overall Study||287
8652948|NCT00653224|9694859|FG000|COMPLETED|Overall Study||286
8652949|NCT00653224|9694860|FG001|COMPLETED|Overall Study||280
8652950|NCT00653224|9694859|FG000|NOT COMPLETED|Overall Study||7
8652951|NCT00653224|9694860|FG001|NOT COMPLETED|Overall Study||7
8652952|NCT00653263|9694866|FG000|STARTED|Overall Study|1 dropped out of treatment and the other had untreated hypertension|8
8652953|NCT00653263|9694866|FG000|COMPLETED|Overall Study||6
8652954|NCT00653263|9694866|FG000|NOT COMPLETED|Overall Study||2
8652955|NCT00653328|9694870|FG000|STARTED|Overall Study||15
8652956|NCT00653328|9694870|FG000|COMPLETED|Overall Study||0
8652957|NCT00653328|9694870|FG000|NOT COMPLETED|Overall Study||15
8652958|NCT00653432|9694876|FG000|STARTED|Overall Study||184
8652959|NCT00653432|9694877|FG001|STARTED|Overall Study||185
8652960|NCT00653432|9694876|FG000|Intend-to-treat ITT|Overall Study|3 of 184 excluded from ITT group for not having at least 1 post-injection visit. ITT=181 subjects|181
8652961|NCT00653432|9694877|FG001|Intend-to-treat ITT|Overall Study|1 of 185 excluded from ITT group for not having at least 1 post-injection visit. ITT=184 subjects|184
8652962|NCT00653432|9694876|FG000|COMPLETED|Overall Study||162
8652963|NCT00653432|9694877|FG001|COMPLETED|Overall Study||169
8652964|NCT00653432|9694876|FG000|NOT COMPLETED|Overall Study||22
8652965|NCT00653432|9694877|FG001|NOT COMPLETED|Overall Study||16
8652966|NCT00653861|9694883|FG000|STARTED|Overall Study||72
8652967|NCT00653861|9694883|FG000|COMPLETED|Overall Study||72
8652968|NCT00653861|9694883|FG000|NOT COMPLETED|Overall Study||0
8652969|NCT00653939|9694894|FG000|STARTED|Overall Study|2 patients randomized did not receive treatment due to brain metastasis or consent withdrawal.|31
8652970|NCT00653939|9694895|FG001|STARTED|Overall Study|1 patient randomized did not receive treatment due to acute renal failure.|32
8652971|NCT00653939|9694894|FG000|COMPLETED|Overall Study||19
8652972|NCT00653939|9694895|FG001|COMPLETED|Overall Study||17
8652973|NCT00653939|9694894|FG000|NOT COMPLETED|Overall Study||12
8652974|NCT00653939|9694895|FG001|NOT COMPLETED|Overall Study||15
8652975|NCT00653991|9694905|FG000|STARTED|3 Month Follow-up||444
8652976|NCT00653991|9694906|FG001|STARTED|3 Month Follow-up||491
8652977|NCT00653991|9694905|FG000|COMPLETED|3 Month Follow-up||294
8652978|NCT00653991|9694906|FG001|COMPLETED|3 Month Follow-up||334
8652979|NCT00653991|9694905|FG000|NOT COMPLETED|3 Month Follow-up||150
8652980|NCT00653991|9694906|FG001|NOT COMPLETED|3 Month Follow-up||157
8652981|NCT00653991|9694905|FG000|STARTED|6 Month Follow-up|Completion of 3 month follow-up was not required for 6-month eligibility.|444
8652982|NCT00653991|9694906|FG001|STARTED|6 Month Follow-up|Completion of 3 month follow-up was not required for 6-month eligibility.|491
8652983|NCT00653991|9694905|FG000|COMPLETED|6 Month Follow-up||311
8652984|NCT00653991|9694906|FG001|COMPLETED|6 Month Follow-up||350
8652985|NCT00653991|9694905|FG000|NOT COMPLETED|6 Month Follow-up||133
8652986|NCT00653991|9694906|FG001|NOT COMPLETED|6 Month Follow-up||141
8652987|NCT00654004|9694916|FG000|STARTED|Overall Study||14
8652988|NCT00654004|9694917|FG001|STARTED|Overall Study||12
8652989|NCT00654004|9694916|FG000|COMPLETED|Overall Study||13
8652990|NCT00654004|9694917|FG001|COMPLETED|Overall Study||12
8652991|NCT00654004|9694916|FG000|NOT COMPLETED|Overall Study||1
8652992|NCT00654004|9694917|FG001|NOT COMPLETED|Overall Study||0
8652993|NCT00654030|9694923|FG000|STARTED|Overall Study||12
8652994|NCT00654030|9694923|FG000|COMPLETED|Overall Study||11
8652995|NCT00654030|9694923|FG000|NOT COMPLETED|Overall Study||1
8652996|NCT00654069|9694930|FG000|STARTED|Overall Study||136
8652997|NCT00654069|9694931|FG001|STARTED|Overall Study||135
8652998|NCT00654069|9694932|FG002|STARTED|Overall Study||134
8652999|NCT00654069|9694930|FG000|COMPLETED|Overall Study||119
8653000|NCT00654069|9694931|FG001|COMPLETED|Overall Study||124
8653001|NCT00654069|9694932|FG002|COMPLETED|Overall Study||116
8653002|NCT00654069|9694930|FG000|NOT COMPLETED|Overall Study||17
8653003|NCT00654069|9694931|FG001|NOT COMPLETED|Overall Study||11
8653004|NCT00654069|9694932|FG002|NOT COMPLETED|Overall Study||18
8653005|NCT00654147|9694942|FG000|STARTED|Overall Study||21
8653006|NCT00654147|9694943|FG001|STARTED|Overall Study||23
8653007|NCT00654147|9694942|FG000|COMPLETED|Overall Study||19
8653008|NCT00654147|9694943|FG001|COMPLETED|Overall Study||19
8653009|NCT00654147|9694942|FG000|NOT COMPLETED|Overall Study||2
8653010|NCT00654147|9694943|FG001|NOT COMPLETED|Overall Study||4
8653011|NCT00654186|9694949|FG000|STARTED|Overall Study||32
8653012|NCT00654186|9694949|FG000|COMPLETED|Overall Study||27
8653013|NCT00654186|9694949|FG000|NOT COMPLETED|Overall Study||5
8653014|NCT00654238|9694953|FG000|STARTED|Overall Study||59
8653015|NCT00654238|9694953|FG000|COMPLETED|Overall Study||55
8653016|NCT00654238|9694953|FG000|NOT COMPLETED|Overall Study||4
8653017|NCT00654329|9694962|FG000|STARTED|Overall Study||23
8653018|NCT00654329|9694963|FG001|STARTED|Overall Study||28
8653019|NCT00654329|9694964|FG002|STARTED|Overall Study||23
8653020|NCT00654329|9694965|FG003|STARTED|Overall Study||27
8653021|NCT00654329|9694962|FG000|COMPLETED|Overall Study||23
8653022|NCT00654329|9694963|FG001|COMPLETED|Overall Study||28
8653023|NCT00654329|9694964|FG002|COMPLETED|Overall Study||23
8653024|NCT00654329|9694965|FG003|COMPLETED|Overall Study||27
8653025|NCT00654329|9694962|FG000|NOT COMPLETED|Overall Study||0
8653026|NCT00654329|9694963|FG001|NOT COMPLETED|Overall Study||0
8653027|NCT00654329|9694964|FG002|NOT COMPLETED|Overall Study||0
8653028|NCT00654329|9694965|FG003|NOT COMPLETED|Overall Study||0
8653029|NCT00654355|9694977|FG000|STARTED|Overall Study||15
8653030|NCT00654355|9694978|FG001|STARTED|Overall Study||15
8653031|NCT00654355|9694977|FG000|COMPLETED|Overall Study||13
8653032|NCT00654355|9694978|FG001|COMPLETED|Overall Study||13
8653033|NCT00654355|9694977|FG000|NOT COMPLETED|Overall Study||2
8653034|NCT00654355|9694978|FG001|NOT COMPLETED|Overall Study||2
8653035|NCT00654368|9694987|FG000|STARTED|Overall Study||53
8653036|NCT00654368|9694988|FG001|STARTED|Overall Study||98
8653037|NCT00654368|9694989|FG002|STARTED|Overall Study||107
8653038|NCT00654368|9694987|FG000|COMPLETED|Overall Study||0
8653039|NCT00654368|9694988|FG001|COMPLETED|Overall Study||50
8653040|NCT00654368|9694989|FG002|COMPLETED|Overall Study||75
8653041|NCT00654368|9694987|FG000|NOT COMPLETED|Overall Study||53
8653042|NCT00654368|9694988|FG001|NOT COMPLETED|Overall Study||48
8653043|NCT00654368|9694989|FG002|NOT COMPLETED|Overall Study||32
8653044|NCT00654381|9695000|FG000|STARTED|1st Stage||39
8653045|NCT00654381|9695001|FG001|STARTED|1st Stage||41
8653046|NCT00654381|9695002|FG002|STARTED|1st Stage||159
8653047|NCT00654381|9695003|FG003|STARTED|1st Stage||160
8653048|NCT00654381|9695004|FG004|STARTED|1st Stage||81
8653049|NCT00654381|9695005|FG005|STARTED|1st Stage||81
8653050|NCT00654381|9695000|FG000|COMPLETED|1st Stage||36
8653051|NCT00654381|9695001|FG001|COMPLETED|1st Stage||38
8653052|NCT00654381|9695002|FG002|COMPLETED|1st Stage||156
8653053|NCT00654381|9695003|FG003|COMPLETED|1st Stage||155
8653054|NCT00654381|9695004|FG004|COMPLETED|1st Stage||79
8653055|NCT00654381|9695005|FG005|COMPLETED|1st Stage||79
8653056|NCT00654381|9695000|FG000|NOT COMPLETED|1st Stage||3
8653057|NCT00654381|9695001|FG001|NOT COMPLETED|1st Stage||3
8653058|NCT00654381|9695002|FG002|NOT COMPLETED|1st Stage||3
8653059|NCT00654381|9695003|FG003|NOT COMPLETED|1st Stage||5
8653060|NCT00654381|9695004|FG004|NOT COMPLETED|1st Stage||2
8653061|NCT00654381|9695005|FG005|NOT COMPLETED|1st Stage||2
8653062|NCT00654381|9695000|FG000|STARTED|2nd Stage||36
8653063|NCT00654381|9695001|FG001|STARTED|2nd Stage||38
8653064|NCT00654381|9695002|FG002|STARTED|2nd Stage||156
8728652|NCT01049360|9775776|FG012|NOT COMPLETED|Period 1||2
8653065|NCT00654381|9695003|FG003|STARTED|2nd Stage||155
8653066|NCT00654381|9695004|FG004|STARTED|2nd Stage||79
8653067|NCT00654381|9695005|FG005|STARTED|2nd Stage||79
8653068|NCT00654381|9695000|FG000|COMPLETED|2nd Stage||34
8653069|NCT00654381|9695001|FG001|COMPLETED|2nd Stage||38
8653070|NCT00654381|9695002|FG002|COMPLETED|2nd Stage||153
8653071|NCT00654381|9695003|FG003|COMPLETED|2nd Stage||151
8653072|NCT00654381|9695004|FG004|COMPLETED|2nd Stage||71
8653073|NCT00654381|9695005|FG005|COMPLETED|2nd Stage||76
8653074|NCT00654381|9695000|FG000|NOT COMPLETED|2nd Stage||2
8653075|NCT00654381|9695001|FG001|NOT COMPLETED|2nd Stage||0
8653076|NCT00654381|9695002|FG002|NOT COMPLETED|2nd Stage||3
8653077|NCT00654381|9695003|FG003|NOT COMPLETED|2nd Stage||4
8653078|NCT00654381|9695004|FG004|NOT COMPLETED|2nd Stage||8
8653079|NCT00654381|9695005|FG005|NOT COMPLETED|2nd Stage||3
8653080|NCT00654381|9695000|FG000|STARTED|Extension Stage||34
8653081|NCT00654381|9695001|FG001|STARTED|Extension Stage||38
8653082|NCT00654381|9695002|FG002|STARTED|Extension Stage||153
8653083|NCT00654381|9695003|FG003|STARTED|Extension Stage||151
8653084|NCT00654381|9695004|FG004|STARTED|Extension Stage||71
8653085|NCT00654381|9695005|FG005|STARTED|Extension Stage||76
8653086|NCT00654381|9695000|FG000|COMPLETED|Extension Stage||33
8653087|NCT00654381|9695001|FG001|COMPLETED|Extension Stage||36
8653088|NCT00654381|9695002|FG002|COMPLETED|Extension Stage||142
8653089|NCT00654381|9695003|FG003|COMPLETED|Extension Stage||142
8653090|NCT00654381|9695004|FG004|COMPLETED|Extension Stage||68
8653091|NCT00654381|9695005|FG005|COMPLETED|Extension Stage||73
8653092|NCT00654381|9695000|FG000|NOT COMPLETED|Extension Stage||1
8653093|NCT00654381|9695001|FG001|NOT COMPLETED|Extension Stage||2
8653094|NCT00654381|9695002|FG002|NOT COMPLETED|Extension Stage||11
8653095|NCT00654381|9695003|FG003|NOT COMPLETED|Extension Stage||9
8653096|NCT00654381|9695004|FG004|NOT COMPLETED|Extension Stage||3
8653097|NCT00654381|9695005|FG005|NOT COMPLETED|Extension Stage||3
8653098|NCT00654420|9695026|FG000|STARTED|Phase I (Dose Escalation)||4
8653099|NCT00654420|9695027|FG001|STARTED|Phase I (Dose Escalation)||16
8653100|NCT00654420|9695028|FG002|STARTED|Phase I (Dose Escalation)||0
8653101|NCT00654420|9695029|FG003|STARTED|Phase I (Dose Escalation)||0
8653102|NCT00654420|9695026|FG000|COMPLETED|Phase I (Dose Escalation)||0
8653103|NCT00654420|9695027|FG001|COMPLETED|Phase I (Dose Escalation)||0
8653104|NCT00654420|9695028|FG002|COMPLETED|Phase I (Dose Escalation)||0
8653105|NCT00654420|9695029|FG003|COMPLETED|Phase I (Dose Escalation)||0
8653106|NCT00654420|9695026|FG000|NOT COMPLETED|Phase I (Dose Escalation)||4
8653107|NCT00654420|9695027|FG001|NOT COMPLETED|Phase I (Dose Escalation)||16
8653108|NCT00654420|9695028|FG002|NOT COMPLETED|Phase I (Dose Escalation)||0
8653109|NCT00654420|9695029|FG003|NOT COMPLETED|Phase I (Dose Escalation)||0
8653110|NCT00654420|9695026|FG000|STARTED|Phase II||0
8653111|NCT00654420|9695027|FG001|STARTED|Phase II||0
8653112|NCT00654420|9695028|FG002|STARTED|Phase II|New participants were enrolled in the Phase II part of the study that did not participate in Phase 1|37
8653113|NCT00654420|9695029|FG003|STARTED|Phase II|New participants were enrolled in the Phase II part of the study that did not participate in Phase 1|38
8653114|NCT00654420|9695026|FG000|COMPLETED|Phase II||0
8653115|NCT00654420|9695027|FG001|COMPLETED|Phase II||0
8653116|NCT00654420|9695028|FG002|COMPLETED|Phase II||0
8653117|NCT00654420|9695029|FG003|COMPLETED|Phase II||0
8653118|NCT00654420|9695026|FG000|NOT COMPLETED|Phase II||0
8653119|NCT00654420|9695027|FG001|NOT COMPLETED|Phase II||0
8653120|NCT00654420|9695028|FG002|NOT COMPLETED|Phase II||37
8653121|NCT00654420|9695029|FG003|NOT COMPLETED|Phase II||38
8653122|NCT00654498|9695041|FG000|STARTED|Overall Study||203
8653123|NCT00654498|9695042|FG001|STARTED|Overall Study||103
8653124|NCT00654498|9695041|FG000|COMPLETED|Overall Study||189
8653125|NCT00654498|9695042|FG001|COMPLETED|Overall Study||91
8653126|NCT00654498|9695041|FG000|NOT COMPLETED|Overall Study||14
8653127|NCT00654498|9695042|FG001|NOT COMPLETED|Overall Study||12
8653128|NCT00654511|9695052|FG000|STARTED|Overall Study||26
8653129|NCT00654511|9695053|FG001|STARTED|Overall Study||25
8653130|NCT00654511|9695054|FG002|STARTED|Overall Study||25
8653131|NCT00654511|9695055|FG003|STARTED|Overall Study||25
8653132|NCT00654511|9695052|FG000|COMPLETED|Overall Study||26
8653133|NCT00654511|9695053|FG001|COMPLETED|Overall Study||25
8653134|NCT00654511|9695054|FG002|COMPLETED|Overall Study||25
8653135|NCT00654511|9695055|FG003|COMPLETED|Overall Study||25
8653136|NCT00654511|9695052|FG000|NOT COMPLETED|Overall Study||0
8653137|NCT00654511|9695053|FG001|NOT COMPLETED|Overall Study||0
8653138|NCT00654511|9695054|FG002|NOT COMPLETED|Overall Study||0
8653139|NCT00654511|9695055|FG003|NOT COMPLETED|Overall Study||0
8653140|NCT00654615|9695071|FG000|STARTED|Overall Study||30
8653141|NCT00654615|9695072|FG001|STARTED|Overall Study||30
8653142|NCT00654615|9695071|FG000|COMPLETED|Overall Study||22
8653143|NCT00654615|9695072|FG001|COMPLETED|Overall Study||23
8653144|NCT00654615|9695071|FG000|NOT COMPLETED|Overall Study||8
8653145|NCT00654615|9695072|FG001|NOT COMPLETED|Overall Study||7
8653146|NCT00654641|9695080|FG000|STARTED|Overall Study||28
8653147|NCT00654641|9695081|FG001|STARTED|Overall Study||26
8653148|NCT00654641|9695080|FG000|COMPLETED|Overall Study||26
8653149|NCT00654641|9695081|FG001|COMPLETED|Overall Study||23
8653150|NCT00654641|9695080|FG000|NOT COMPLETED|Overall Study||2
8653151|NCT00654641|9695081|FG001|NOT COMPLETED|Overall Study||3
8653152|NCT00654654|9695087|FG000|STARTED|Overall Study||50
8653153|NCT00654654|9695087|FG000|COMPLETED|Overall Study||43
8653154|NCT00654654|9695087|FG000|NOT COMPLETED|Overall Study||7
8653155|NCT00654732|9695093|FG000|STARTED|Overall Study||26
8653156|NCT00654732|9695094|FG001|STARTED|Overall Study||32
8653157|NCT00654732|9695093|FG000|COMPLETED|Overall Study||22
8653158|NCT00654732|9695094|FG001|COMPLETED|Overall Study||26
8653159|NCT00654732|9695093|FG000|NOT COMPLETED|Overall Study||4
8653160|NCT00654732|9695094|FG001|NOT COMPLETED|Overall Study||6
8653161|NCT00654745|9695100|FG000|STARTED|Overall Study|This is single group study in which subjects were titrated to the next of 7 arms if BP goal not met.|207
8653162|NCT00654745|9695100|FG000|COMPLETED|Overall Study||164
8653163|NCT00654745|9695100|FG000|NOT COMPLETED|Overall Study||43
8653164|NCT00654784|9695112|FG000|STARTED|Overall Study||13
8653165|NCT00654784|9695113|FG001|STARTED|Overall Study||8
8653166|NCT00654784|9695112|FG000|COMPLETED|Overall Study||13
8653167|NCT00654784|9695113|FG001|COMPLETED|Overall Study||8
8653168|NCT00654784|9695112|FG000|NOT COMPLETED|Overall Study||0
8653169|NCT00654784|9695113|FG001|NOT COMPLETED|Overall Study||0
8653170|NCT00654836|9695119|FG000|STARTED|Overall Study||32
8653171|NCT00654836|9695119|FG000|COMPLETED|Overall Study||32
8653172|NCT00654836|9695119|FG000|NOT COMPLETED|Overall Study||0
8653173|NCT00654875|9695125|FG000|STARTED|Overall Study||164
8653174|NCT00654875|9695126|FG001|STARTED|Overall Study||164
8653175|NCT00654875|9695125|FG000|COMPLETED|Overall Study||147
8653176|NCT00654875|9695126|FG001|COMPLETED|Overall Study||147
8653177|NCT00654875|9695125|FG000|NOT COMPLETED|Overall Study||17
8653178|NCT00654875|9695126|FG001|NOT COMPLETED|Overall Study||17
8691887|NCT00856986|9737209|FG003|NOT COMPLETED|Extension Period, Weeks 26-52||0
8691888|NCT00856986|9737210|FG004|NOT COMPLETED|Extension Period, Weeks 26-52||0
8691889|NCT00856999|9737222|FG000|STARTED|Overall Study||50
8691890|NCT00856999|9737222|FG000|COMPLETED|Overall Study||45
8691891|NCT00856999|9737222|FG000|NOT COMPLETED|Overall Study||5
8691892|NCT00857207|9737229|FG000|STARTED|Overall Study||48
8691893|NCT00857207|9737230|FG001|STARTED|Overall Study||3
8691894|NCT00857207|9737229|FG000|COMPLETED|Overall Study||14
8691895|NCT00857207|9737230|FG001|COMPLETED|Overall Study||3
8691896|NCT00857207|9737229|FG000|NOT COMPLETED|Overall Study||34
8691897|NCT00857207|9737230|FG001|NOT COMPLETED|Overall Study||0
8691898|NCT00857220|9737237|FG000|STARTED|Overall Study||304
8691899|NCT00857220|9737237|FG000|COMPLETED|Overall Study||121
8691900|NCT00857220|9737237|FG000|NOT COMPLETED|Overall Study||183
8691901|NCT00857233|9737241|FG000|STARTED|Overall Study||297
8691902|NCT00857233|9737241|FG000|COMPLETED|Overall Study||242
8691903|NCT00857233|9737241|FG000|NOT COMPLETED|Overall Study||55
8691904|NCT00857246|9737245|FG000|STARTED|Induction Regimen||30
8691905|NCT00857246|9737245|FG000|COMPLETED|Induction Regimen||27
8691906|NCT00857246|9737245|FG000|NOT COMPLETED|Induction Regimen||3
8691907|NCT00857246|9737245|FG000|STARTED|Surgery (Curative)||27
8691908|NCT00857246|9737245|FG000|COMPLETED|Surgery (Curative)||21
8691909|NCT00857246|9737245|FG000|NOT COMPLETED|Surgery (Curative)||6
8691910|NCT00857246|9737245|FG000|STARTED|ChemoRT|6 did not start adjuvant therapy due to disease-related complications or patient withdrawal.|15
8691911|NCT00857246|9737245|FG000|COMPLETED|ChemoRT||12
8691912|NCT00857246|9737245|FG000|NOT COMPLETED|ChemoRT||3
8691913|NCT00857259|9737255|FG000|STARTED|Overall Study||8
8691914|NCT00857259|9737256|FG001|STARTED|Overall Study||1
8691915|NCT00857259|9737257|FG002|STARTED|Overall Study||7
8691916|NCT00857259|9737255|FG000|COMPLETED|Overall Study||7
8691917|NCT00857259|9737256|FG001|COMPLETED|Overall Study||1
8728653|NCT01049360|9775777|FG013|NOT COMPLETED|Period 1||1
8728654|NCT01049360|9775778|FG014|NOT COMPLETED|Period 1||0
8728655|NCT01049360|9775779|FG015|NOT COMPLETED|Period 1||0
8728656|NCT01049360|9775780|FG016|NOT COMPLETED|Period 1||1
8728657|NCT01049360|9775781|FG017|NOT COMPLETED|Period 1||0
8728658|NCT01049360|9775782|FG018|NOT COMPLETED|Period 1||1
8728659|NCT01049360|9775783|FG019|NOT COMPLETED|Period 1||0
8728660|NCT01049360|9775764|FG000|STARTED|Period 2||6
8728661|NCT01049360|9775765|FG001|STARTED|Period 2||5
8728662|NCT01049360|9775766|FG002|STARTED|Period 2||7
8728663|NCT01049360|9775767|FG003|STARTED|Period 2||6
8728664|NCT01049360|9775768|FG004|STARTED|Period 2||7
8728665|NCT01049360|9775769|FG005|STARTED|Period 2||6
8728666|NCT01049360|9775770|FG006|STARTED|Period 2||6
8728667|NCT01049360|9775771|FG007|STARTED|Period 2||4
8728668|NCT01049360|9775772|FG008|STARTED|Period 2||5
8728669|NCT01049360|9775773|FG009|STARTED|Period 2||6
8728670|NCT01049360|9775774|FG010|STARTED|Period 2||5
8728671|NCT01049360|9775775|FG011|STARTED|Period 2||6
8728672|NCT01049360|9775776|FG012|STARTED|Period 2||4
8728673|NCT01049360|9775777|FG013|STARTED|Period 2||6
8728674|NCT01049360|9775778|FG014|STARTED|Period 2||7
8728675|NCT01049360|9775779|FG015|STARTED|Period 2||7
8728676|NCT01049360|9775780|FG016|STARTED|Period 2||5
8728677|NCT01049360|9775781|FG017|STARTED|Period 2||6
8728678|NCT01049360|9775782|FG018|STARTED|Period 2||5
8728679|NCT01049360|9775783|FG019|STARTED|Period 2||7
8728680|NCT01049360|9775764|FG000|COMPLETED|Period 2||6
8728681|NCT01049360|9775765|FG001|COMPLETED|Period 2||4
8728682|NCT01049360|9775766|FG002|COMPLETED|Period 2||7
8728683|NCT01049360|9775767|FG003|COMPLETED|Period 2||4
8728684|NCT01049360|9775768|FG004|COMPLETED|Period 2||7
8728685|NCT01049360|9775769|FG005|COMPLETED|Period 2||5
8728686|NCT01049360|9775770|FG006|COMPLETED|Period 2||6
8728687|NCT01049360|9775771|FG007|COMPLETED|Period 2||4
8691918|NCT00857259|9737257|FG002|COMPLETED|Overall Study||6
8728688|NCT01049360|9775772|FG008|COMPLETED|Period 2||4
8728689|NCT01049360|9775773|FG009|COMPLETED|Period 2||6
8728690|NCT01049360|9775774|FG010|COMPLETED|Period 2||5
8728691|NCT01049360|9775775|FG011|COMPLETED|Period 2||6
8728692|NCT01049360|9775776|FG012|COMPLETED|Period 2||4
8653179|NCT00654901|9695136|FG000|STARTED|Overall Study||254
8653180|NCT00654901|9695137|FG001|STARTED|Overall Study||262
8653181|NCT00654901|9695138|FG002|STARTED|Overall Study||252
8653182|NCT00654901|9695139|FG003|STARTED|Overall Study||113
8653183|NCT00654901|9695136|FG000|COMPLETED|Overall Study||250
8653184|NCT00654901|9695137|FG001|COMPLETED|Overall Study||262
8653185|NCT00654901|9695138|FG002|COMPLETED|Overall Study||250
8653186|NCT00654901|9695139|FG003|COMPLETED|Overall Study||113
8653187|NCT00654901|9695136|FG000|NOT COMPLETED|Overall Study||4
8653188|NCT00654901|9695137|FG001|NOT COMPLETED|Overall Study||0
8653189|NCT00654901|9695138|FG002|NOT COMPLETED|Overall Study||2
8653190|NCT00654901|9695139|FG003|NOT COMPLETED|Overall Study||0
8653191|NCT00654927|9695149|FG000|STARTED|Overall Study||177
8653192|NCT00654927|9695149|FG000|COMPLETED|Overall Study||70
8653193|NCT00654927|9695149|FG000|NOT COMPLETED|Overall Study||107
8653194|NCT00654940|9695155|FG000|STARTED|Period 1|Assigned to study treatment.|13
8653195|NCT00654940|9695156|FG001|STARTED|Period 1|Assigned to study treatment.|12
8653196|NCT00654940|9695155|FG000|Received Study Treatment|Period 1||12
8653197|NCT00654940|9695156|FG001|Received Study Treatment|Period 1||12
8653198|NCT00654940|9695155|FG000|COMPLETED|Period 1||12
8728693|NCT01049360|9775777|FG013|COMPLETED|Period 2||6
8728694|NCT01049360|9775778|FG014|COMPLETED|Period 2||5
8728695|NCT01049360|9775779|FG015|COMPLETED|Period 2||6
8728696|NCT01049360|9775780|FG016|COMPLETED|Period 2||5
8728697|NCT01049360|9775781|FG017|COMPLETED|Period 2||6
8728698|NCT01049360|9775782|FG018|COMPLETED|Period 2||5
8728699|NCT01049360|9775783|FG019|COMPLETED|Period 2||5
8728700|NCT01049360|9775764|FG000|NOT COMPLETED|Period 2||0
8728701|NCT01049360|9775765|FG001|NOT COMPLETED|Period 2||1
8728702|NCT01049360|9775766|FG002|NOT COMPLETED|Period 2||0
8728703|NCT01049360|9775767|FG003|NOT COMPLETED|Period 2||2
8728704|NCT01049360|9775768|FG004|NOT COMPLETED|Period 2||0
8728705|NCT01049360|9775769|FG005|NOT COMPLETED|Period 2||1
8728706|NCT01049360|9775770|FG006|NOT COMPLETED|Period 2||0
8728707|NCT01049360|9775771|FG007|NOT COMPLETED|Period 2||0
8728708|NCT01049360|9775772|FG008|NOT COMPLETED|Period 2||1
8728709|NCT01049360|9775773|FG009|NOT COMPLETED|Period 2||0
8728710|NCT01049360|9775774|FG010|NOT COMPLETED|Period 2||0
8728711|NCT01049360|9775775|FG011|NOT COMPLETED|Period 2||0
8728712|NCT01049360|9775776|FG012|NOT COMPLETED|Period 2||0
8728713|NCT01049360|9775777|FG013|NOT COMPLETED|Period 2||0
8728714|NCT01049360|9775778|FG014|NOT COMPLETED|Period 2||2
8728715|NCT01049360|9775779|FG015|NOT COMPLETED|Period 2||1
8728716|NCT01049360|9775780|FG016|NOT COMPLETED|Period 2||0
8728717|NCT01049360|9775781|FG017|NOT COMPLETED|Period 2||0
8728718|NCT01049360|9775782|FG018|NOT COMPLETED|Period 2||0
8728719|NCT01049360|9775783|FG019|NOT COMPLETED|Period 2||2
8728720|NCT01049360|9775764|FG000|STARTED|Period 3||6
8728721|NCT01049360|9775765|FG001|STARTED|Period 3||4
8728722|NCT01049360|9775766|FG002|STARTED|Period 3||7
8728723|NCT01049360|9775767|FG003|STARTED|Period 3||4
8728724|NCT01049360|9775768|FG004|STARTED|Period 3||7
8728725|NCT01049360|9775769|FG005|STARTED|Period 3||5
8728726|NCT01049360|9775770|FG006|STARTED|Period 3||6
8728727|NCT01049360|9775771|FG007|STARTED|Period 3||4
8728728|NCT01049360|9775772|FG008|STARTED|Period 3||4
8728729|NCT01049360|9775773|FG009|STARTED|Period 3||6
8728730|NCT01049360|9775774|FG010|STARTED|Period 3||5
8728731|NCT01049360|9775775|FG011|STARTED|Period 3||6
8728732|NCT01049360|9775776|FG012|STARTED|Period 3||4
8728733|NCT01049360|9775777|FG013|STARTED|Period 3||6
8728734|NCT01049360|9775778|FG014|STARTED|Period 3||5
8728735|NCT01049360|9775779|FG015|STARTED|Period 3||6
8728736|NCT01049360|9775780|FG016|STARTED|Period 3||5
8728737|NCT01049360|9775781|FG017|STARTED|Period 3||6
8728738|NCT01049360|9775782|FG018|STARTED|Period 3||5
8728739|NCT01049360|9775783|FG019|STARTED|Period 3||5
8728740|NCT01049360|9775764|FG000|COMPLETED|Period 3||6
8728741|NCT01049360|9775765|FG001|COMPLETED|Period 3||4
8728742|NCT01049360|9775766|FG002|COMPLETED|Period 3||7
8728743|NCT01049360|9775767|FG003|COMPLETED|Period 3||4
8728744|NCT01049360|9775768|FG004|COMPLETED|Period 3||7
8728745|NCT01049360|9775769|FG005|COMPLETED|Period 3||5
8728746|NCT01049360|9775770|FG006|COMPLETED|Period 3||6
8728747|NCT01049360|9775771|FG007|COMPLETED|Period 3||4
8728748|NCT01049360|9775772|FG008|COMPLETED|Period 3||4
8728749|NCT01049360|9775773|FG009|COMPLETED|Period 3||6
8728750|NCT01049360|9775774|FG010|COMPLETED|Period 3||5
8728751|NCT01049360|9775775|FG011|COMPLETED|Period 3||6
8728752|NCT01049360|9775776|FG012|COMPLETED|Period 3||4
8728753|NCT01049360|9775777|FG013|COMPLETED|Period 3||6
8911244|NCT02144337|9970296|FG001|NOT COMPLETED|T3 Follow-up (3 Month Post-intervention)||0
8728754|NCT01049360|9775778|FG014|COMPLETED|Period 3||5
8728755|NCT01049360|9775779|FG015|COMPLETED|Period 3||6
8728756|NCT01049360|9775780|FG016|COMPLETED|Period 3||5
8728757|NCT01049360|9775781|FG017|COMPLETED|Period 3||6
8728758|NCT01049360|9775782|FG018|COMPLETED|Period 3||5
8728759|NCT01049360|9775783|FG019|COMPLETED|Period 3||5
8728760|NCT01049360|9775764|FG000|NOT COMPLETED|Period 3||0
8653199|NCT00654940|9695156|FG001|COMPLETED|Period 1||11
8728761|NCT01049360|9775765|FG001|NOT COMPLETED|Period 3||0
8728762|NCT01049360|9775766|FG002|NOT COMPLETED|Period 3||0
8728763|NCT01049360|9775767|FG003|NOT COMPLETED|Period 3||0
8728764|NCT01049360|9775768|FG004|NOT COMPLETED|Period 3||0
8728765|NCT01049360|9775769|FG005|NOT COMPLETED|Period 3||0
8728766|NCT01049360|9775770|FG006|NOT COMPLETED|Period 3||0
8728767|NCT01049360|9775771|FG007|NOT COMPLETED|Period 3||0
8653200|NCT00654940|9695155|FG000|NOT COMPLETED|Period 1||1
8653201|NCT00654940|9695156|FG001|NOT COMPLETED|Period 1||1
8653202|NCT00654940|9695155|FG000|STARTED|Washout Period of 2 Weeks||12
8653203|NCT00654940|9695156|FG001|STARTED|Washout Period of 2 Weeks||11
8653204|NCT00654940|9695155|FG000|COMPLETED|Washout Period of 2 Weeks||12
8653205|NCT00654940|9695156|FG001|COMPLETED|Washout Period of 2 Weeks||11
8653206|NCT00654940|9695155|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
8653207|NCT00654940|9695156|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
8653208|NCT00654940|9695155|FG000|STARTED|Period 2||12
8653209|NCT00654940|9695156|FG001|STARTED|Period 2||11
8653210|NCT00654940|9695155|FG000|COMPLETED|Period 2||12
8653211|NCT00654940|9695156|FG001|COMPLETED|Period 2||11
8653212|NCT00654940|9695155|FG000|NOT COMPLETED|Period 2||0
8653213|NCT00654940|9695156|FG001|NOT COMPLETED|Period 2||0
8653214|NCT00654953|9695171|FG000|STARTED|Overall Study||36
8728768|NCT01049360|9775772|FG008|NOT COMPLETED|Period 3||0
8728769|NCT01049360|9775773|FG009|NOT COMPLETED|Period 3||0
8728770|NCT01049360|9775774|FG010|NOT COMPLETED|Period 3||0
8728771|NCT01049360|9775775|FG011|NOT COMPLETED|Period 3||0
8728772|NCT01049360|9775776|FG012|NOT COMPLETED|Period 3||0
8728773|NCT01049360|9775777|FG013|NOT COMPLETED|Period 3||0
8728774|NCT01049360|9775778|FG014|NOT COMPLETED|Period 3||0
8728775|NCT01049360|9775779|FG015|NOT COMPLETED|Period 3||0
8728776|NCT01049360|9775780|FG016|NOT COMPLETED|Period 3||0
8653215|NCT00654953|9695172|FG001|STARTED|Overall Study||36
8653216|NCT00654953|9695173|FG002|STARTED|Overall Study||30
8653217|NCT00654953|9695171|FG000|COMPLETED|Overall Study||6
8653218|NCT00654953|9695172|FG001|COMPLETED|Overall Study||8
8653219|NCT00654953|9695173|FG002|COMPLETED|Overall Study||8
8653220|NCT00654953|9695171|FG000|NOT COMPLETED|Overall Study||30
8653221|NCT00654953|9695172|FG001|NOT COMPLETED|Overall Study||28
8653222|NCT00654953|9695173|FG002|NOT COMPLETED|Overall Study||22
8653223|NCT00655083|9695183|FG000|STARTED|Overall Study||12
8653224|NCT00655083|9695184|FG001|STARTED|Overall Study||8
8653225|NCT00655083|9695183|FG000|COMPLETED|Overall Study||12
8653226|NCT00655083|9695184|FG001|COMPLETED|Overall Study||8
8728777|NCT01049360|9775781|FG017|NOT COMPLETED|Period 3||0
8728778|NCT01049360|9775782|FG018|NOT COMPLETED|Period 3||0
8728779|NCT01049360|9775783|FG019|NOT COMPLETED|Period 3||0
8728780|NCT01049360|9775764|FG000|STARTED|Period 4||6
8728781|NCT01049360|9775765|FG001|STARTED|Period 4||4
8728782|NCT01049360|9775766|FG002|STARTED|Period 4||7
8728783|NCT01049360|9775767|FG003|STARTED|Period 4||4
8728784|NCT01049360|9775768|FG004|STARTED|Period 4||7
8653227|NCT00655083|9695183|FG000|NOT COMPLETED|Overall Study||0
8653228|NCT00655083|9695184|FG001|NOT COMPLETED|Overall Study||0
8653229|NCT00655356|9695192|FG000|STARTED|Overall Study||110
8653230|NCT00655356|9695193|FG001|STARTED|Overall Study||108
8653231|NCT00655356|9695192|FG000|COMPLETED|Overall Study||93
8653232|NCT00655356|9695193|FG001|COMPLETED|Overall Study||98
8653233|NCT00655356|9695192|FG000|NOT COMPLETED|Overall Study||17
8653234|NCT00655356|9695193|FG001|NOT COMPLETED|Overall Study||10
8653235|NCT00655473|9695201|FG000|STARTED|Overall Study||64
8653236|NCT00655473|9695202|FG001|STARTED|Overall Study||66
8653237|NCT00655473|9695201|FG000|COMPLETED|Overall Study||53
8653238|NCT00655473|9695202|FG001|COMPLETED|Overall Study||51
8653239|NCT00655473|9695201|FG000|NOT COMPLETED|Overall Study||11
8653240|NCT00655473|9695202|FG001|NOT COMPLETED|Overall Study||15
8653241|NCT00655486|9695208|FG000|STARTED|Overall Study||97
8653242|NCT00655486|9695208|FG000|COMPLETED|Overall Study||69
8653243|NCT00655486|9695208|FG000|NOT COMPLETED|Overall Study||28
8653244|NCT00655499|9695212|FG000|STARTED|Overall Study||69
8653245|NCT00655499|9695212|FG000|COMPLETED|Overall Study||65
8653246|NCT00655499|9695212|FG000|NOT COMPLETED|Overall Study||4
8653247|NCT00655538|9695219|FG000|STARTED|Overall Study||238
8653248|NCT00655538|9695220|FG001|STARTED|Overall Study||238
8653249|NCT00655538|9695219|FG000|COMPLETED|Overall Study||214
8653250|NCT00655538|9695220|FG001|COMPLETED|Overall Study||211
8653251|NCT00655538|9695219|FG000|NOT COMPLETED|Overall Study||24
8653252|NCT00655538|9695220|FG001|NOT COMPLETED|Overall Study||27
8653253|NCT00655551|9695229|FG000|STARTED|All Periods Combined||25
8653254|NCT00655551|9695230|FG001|STARTED|All Periods Combined||50
8653255|NCT00655551|9695231|FG002|STARTED|All Periods Combined||25
8653256|NCT00655551|9695229|FG000|COMPLETED|All Periods Combined||25
8653257|NCT00655551|9695230|FG001|COMPLETED|All Periods Combined||47
8653258|NCT00655551|9695231|FG002|COMPLETED|All Periods Combined||21
8653259|NCT00655551|9695229|FG000|NOT COMPLETED|All Periods Combined||0
8653260|NCT00655551|9695230|FG001|NOT COMPLETED|All Periods Combined||3
8653261|NCT00655551|9695231|FG002|NOT COMPLETED|All Periods Combined||4
8653262|NCT00655551|9695229|FG000|STARTED|Period 1 (up to 7 Days)||25
8653263|NCT00655551|9695230|FG001|STARTED|Period 1 (up to 7 Days)||0
8653264|NCT00655551|9695231|FG002|STARTED|Period 1 (up to 7 Days)||0
8728785|NCT01049360|9775769|FG005|STARTED|Period 4||5
8728786|NCT01049360|9775770|FG006|STARTED|Period 4||6
8653265|NCT00655551|9695229|FG000|COMPLETED|Period 1 (up to 7 Days)||25
8653266|NCT00655551|9695230|FG001|COMPLETED|Period 1 (up to 7 Days)||0
8653267|NCT00655551|9695231|FG002|COMPLETED|Period 1 (up to 7 Days)||0
8653268|NCT00655551|9695229|FG000|NOT COMPLETED|Period 1 (up to 7 Days)||0
8653269|NCT00655551|9695230|FG001|NOT COMPLETED|Period 1 (up to 7 Days)||0
8653270|NCT00655551|9695231|FG002|NOT COMPLETED|Period 1 (up to 7 Days)||0
8728787|NCT01049360|9775771|FG007|STARTED|Period 4||4
8728788|NCT01049360|9775772|FG008|STARTED|Period 4||4
8728789|NCT01049360|9775773|FG009|STARTED|Period 4||6
8653271|NCT00655551|9695229|FG000|STARTED|Period 2 (up to 7 Days)||0
8653272|NCT00655551|9695230|FG001|STARTED|Period 2 (up to 7 Days)||25
8653273|NCT00655551|9695231|FG002|STARTED|Period 2 (up to 7 Days)||0
8653274|NCT00655551|9695229|FG000|COMPLETED|Period 2 (up to 7 Days)||0
8653275|NCT00655551|9695230|FG001|COMPLETED|Period 2 (up to 7 Days)||24
8653276|NCT00655551|9695231|FG002|COMPLETED|Period 2 (up to 7 Days)||0
8653277|NCT00655551|9695229|FG000|NOT COMPLETED|Period 2 (up to 7 Days)||0
8653278|NCT00655551|9695230|FG001|NOT COMPLETED|Period 2 (up to 7 Days)||1
8653279|NCT00655551|9695231|FG002|NOT COMPLETED|Period 2 (up to 7 Days)||0
8653280|NCT00655551|9695229|FG000|STARTED|Period 3 (up to 7 Days)||0
8653281|NCT00655551|9695230|FG001|STARTED|Period 3 (up to 7 Days)||0
8653282|NCT00655551|9695231|FG002|STARTED|Period 3 (up to 7 Days)||25
8653283|NCT00655551|9695229|FG000|COMPLETED|Period 3 (up to 7 Days)||0
8653284|NCT00655551|9695230|FG001|COMPLETED|Period 3 (up to 7 Days)||0
8653285|NCT00655551|9695231|FG002|COMPLETED|Period 3 (up to 7 Days)||21
8653286|NCT00655551|9695229|FG000|NOT COMPLETED|Period 3 (up to 7 Days)||0
8653287|NCT00655551|9695230|FG001|NOT COMPLETED|Period 3 (up to 7 Days)||0
8653288|NCT00655551|9695231|FG002|NOT COMPLETED|Period 3 (up to 7 Days)||4
8653289|NCT00655551|9695229|FG000|STARTED|Period 4 (up to 7 Days)||0
8653290|NCT00655551|9695230|FG001|STARTED|Period 4 (up to 7 Days)||25
8653291|NCT00655551|9695231|FG002|STARTED|Period 4 (up to 7 Days)||0
8653292|NCT00655551|9695229|FG000|COMPLETED|Period 4 (up to 7 Days)||0
8653293|NCT00655551|9695230|FG001|COMPLETED|Period 4 (up to 7 Days)||23
8653294|NCT00655551|9695231|FG002|COMPLETED|Period 4 (up to 7 Days)||0
8653295|NCT00655551|9695229|FG000|NOT COMPLETED|Period 4 (up to 7 Days)||0
8653296|NCT00655551|9695230|FG001|NOT COMPLETED|Period 4 (up to 7 Days)||2
8653297|NCT00655551|9695231|FG002|NOT COMPLETED|Period 4 (up to 7 Days)||0
8653298|NCT00655564|9695239|FG000|STARTED|Overall Study||15
8653299|NCT00655564|9695239|FG000|COMPLETED|Overall Study||12
8653300|NCT00655564|9695239|FG000|NOT COMPLETED|Overall Study||3
8653301|NCT00655629|9695246|FG000|STARTED|Overall Study||172
8653302|NCT00655629|9695247|FG001|STARTED|Overall Study||167
8653303|NCT00655629|9695246|FG000|Participants Received Treatment|Overall Study|1 patient could not verify drug ingestion. (safety population)|171
8653304|NCT00655629|9695247|FG001|Participants Received Treatment|Overall Study|1 patient could not verify drug ingestion.(safety population)|166
8653305|NCT00655629|9695246|FG000|COMPLETED|Overall Study||151
8653306|NCT00655629|9695247|FG001|COMPLETED|Overall Study||144
8653307|NCT00655629|9695246|FG000|NOT COMPLETED|Overall Study||21
8653308|NCT00655629|9695247|FG001|NOT COMPLETED|Overall Study||23
8653309|NCT00655642|9695257|FG000|STARTED|Overall Study||42
8728790|NCT01049360|9775774|FG010|STARTED|Period 4||5
8728791|NCT01049360|9775775|FG011|STARTED|Period 4||6
8728792|NCT01049360|9775776|FG012|STARTED|Period 4||4
8728793|NCT01049360|9775777|FG013|STARTED|Period 4||6
8728794|NCT01049360|9775778|FG014|STARTED|Period 4||5
8728795|NCT01049360|9775779|FG015|STARTED|Period 4||6
8728796|NCT01049360|9775780|FG016|STARTED|Period 4||5
8728797|NCT01049360|9775781|FG017|STARTED|Period 4||6
8728798|NCT01049360|9775782|FG018|STARTED|Period 4||5
8728799|NCT01049360|9775783|FG019|STARTED|Period 4||5
8728800|NCT01049360|9775764|FG000|COMPLETED|Period 4||6
8728801|NCT01049360|9775765|FG001|COMPLETED|Period 4||4
8728802|NCT01049360|9775766|FG002|COMPLETED|Period 4||7
8728803|NCT01049360|9775767|FG003|COMPLETED|Period 4||3
8728804|NCT01049360|9775768|FG004|COMPLETED|Period 4||7
8728805|NCT01049360|9775769|FG005|COMPLETED|Period 4||5
8728806|NCT01049360|9775770|FG006|COMPLETED|Period 4||6
8728807|NCT01049360|9775771|FG007|COMPLETED|Period 4||4
8728808|NCT01049360|9775772|FG008|COMPLETED|Period 4||4
8728809|NCT01049360|9775773|FG009|COMPLETED|Period 4||6
8728810|NCT01049360|9775774|FG010|COMPLETED|Period 4||5
8728811|NCT01049360|9775775|FG011|COMPLETED|Period 4||6
8728812|NCT01049360|9775776|FG012|COMPLETED|Period 4||4
8728813|NCT01049360|9775777|FG013|COMPLETED|Period 4||6
8728814|NCT01049360|9775778|FG014|COMPLETED|Period 4||5
8728815|NCT01049360|9775779|FG015|COMPLETED|Period 4||6
8728816|NCT01049360|9775780|FG016|COMPLETED|Period 4||5
8728817|NCT01049360|9775781|FG017|COMPLETED|Period 4||5
8728818|NCT01049360|9775782|FG018|COMPLETED|Period 4||5
8728819|NCT01049360|9775783|FG019|COMPLETED|Period 4||5
8728820|NCT01049360|9775764|FG000|NOT COMPLETED|Period 4||0
8728821|NCT01049360|9775765|FG001|NOT COMPLETED|Period 4||0
8728822|NCT01049360|9775766|FG002|NOT COMPLETED|Period 4||0
8728823|NCT01049360|9775767|FG003|NOT COMPLETED|Period 4||1
8728824|NCT01049360|9775768|FG004|NOT COMPLETED|Period 4||0
8728825|NCT01049360|9775769|FG005|NOT COMPLETED|Period 4||0
8728826|NCT01049360|9775770|FG006|NOT COMPLETED|Period 4||0
8728827|NCT01049360|9775771|FG007|NOT COMPLETED|Period 4||0
8728828|NCT01049360|9775772|FG008|NOT COMPLETED|Period 4||0
8728829|NCT01049360|9775773|FG009|NOT COMPLETED|Period 4||0
8728830|NCT01049360|9775774|FG010|NOT COMPLETED|Period 4||0
8728831|NCT01049360|9775775|FG011|NOT COMPLETED|Period 4||0
8728832|NCT01049360|9775776|FG012|NOT COMPLETED|Period 4||0
8653310|NCT00655642|9695258|FG001|STARTED|Overall Study||43
8653311|NCT00655642|9695259|FG002|STARTED|Overall Study||45
8728833|NCT01049360|9775777|FG013|NOT COMPLETED|Period 4||0
8728834|NCT01049360|9775778|FG014|NOT COMPLETED|Period 4||0
8728835|NCT01049360|9775779|FG015|NOT COMPLETED|Period 4||0
8728836|NCT01049360|9775780|FG016|NOT COMPLETED|Period 4||0
8728837|NCT01049360|9775781|FG017|NOT COMPLETED|Period 4||1
8728838|NCT01049360|9775782|FG018|NOT COMPLETED|Period 4||0
8728839|NCT01049360|9775783|FG019|NOT COMPLETED|Period 4||0
8728840|NCT01049373|9775797|FG000|STARTED|Overall Study||112
8653312|NCT00655642|9695260|FG003|STARTED|Overall Study||41
8653313|NCT00655642|9695257|FG000|COMPLETED|Overall Study|1 patient withdrawn by treating physician after consent|41
8653314|NCT00655642|9695258|FG001|COMPLETED|Overall Study|1 patient given drug orally rather than intravenous(iv);1 patient refused iv; 1 pt lost to follow-up|40
8653315|NCT00655642|9695259|FG002|COMPLETED|Overall Study|1 patient left the ED prior to receiving drug; 1 patient's nausea resolved prior to receiving drug|43
8653316|NCT00655642|9695260|FG003|COMPLETED|Overall Study|1 patient's initial Visual analog scale (VAS)<40; 1 patient was withdrawn by treating physician|39
8653317|NCT00655642|9695257|FG000|NOT COMPLETED|Overall Study||1
8653318|NCT00655642|9695258|FG001|NOT COMPLETED|Overall Study||3
8653319|NCT00655642|9695259|FG002|NOT COMPLETED|Overall Study||2
8653320|NCT00655642|9695260|FG003|NOT COMPLETED|Overall Study||2
8653321|NCT00655668|9695270|FG000|STARTED|Overall Study|Planned enrollment: 80 participants|54
8653322|NCT00655668|9695270|FG000|COMPLETED|Overall Study|Participants dosed up to 24 months, disease progression or unacceptable adverse events developed.|0
8653323|NCT00655668|9695270|FG000|NOT COMPLETED|Overall Study||54
8653324|NCT00655707|9695274|FG000|STARTED|Overall Study||5
8653325|NCT00655707|9695274|FG000|COMPLETED|Overall Study||5
8653326|NCT00655707|9695274|FG000|NOT COMPLETED|Overall Study||0
8653327|NCT00655733|9695281|FG000|STARTED|Overall Study||51
8653328|NCT00655733|9695282|FG001|STARTED|Overall Study||50
8653329|NCT00655733|9695281|FG000|COMPLETED|Overall Study||44
8653330|NCT00655733|9695282|FG001|COMPLETED|Overall Study||42
8653331|NCT00655733|9695281|FG000|NOT COMPLETED|Overall Study||7
8653332|NCT00655733|9695282|FG001|NOT COMPLETED|Overall Study||8
8653333|NCT00655746|9695290|FG000|STARTED|Overall Study||14
8653334|NCT00655746|9695290|FG000|COMPLETED|Overall Study||13
8653335|NCT00655746|9695290|FG000|NOT COMPLETED|Overall Study||1
8653336|NCT00655811|9695298|FG000|STARTED|Overall Study||40
8653337|NCT00655811|9695298|FG000|COMPLETED|Overall Study||40
8653338|NCT00655811|9695298|FG000|NOT COMPLETED|Overall Study||0
8653339|NCT00655850|9695308|FG000|STARTED|Overall Study||39
8653340|NCT00655850|9695308|FG000|COMPLETED|Overall Study||36
8653341|NCT00655850|9695308|FG000|NOT COMPLETED|Overall Study||3
8653342|NCT00655863|9695317|FG000|STARTED|Overall Study||24
8653343|NCT00655863|9695318|FG001|STARTED|Overall Study||25
8653344|NCT00655863|9695319|FG002|STARTED|Overall Study||22
8653345|NCT00655863|9695317|FG000|COMPLETED|Overall Study||24
8653346|NCT00655863|9695318|FG001|COMPLETED|Overall Study||25
8653347|NCT00655863|9695319|FG002|COMPLETED|Overall Study||21
8653348|NCT00655863|9695317|FG000|NOT COMPLETED|Overall Study||0
8653349|NCT00655863|9695318|FG001|NOT COMPLETED|Overall Study||0
8653350|NCT00655863|9695319|FG002|NOT COMPLETED|Overall Study||1
8653351|NCT00655876|9695329|FG000|STARTED|Overall Study||168
8653352|NCT00655876|9695330|FG001|STARTED|Overall Study||176
8653353|NCT00655876|9695329|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|159
8653354|NCT00655876|9695330|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|169
8653355|NCT00655876|9695329|FG000|NOT COMPLETED|Overall Study||9
8653356|NCT00655876|9695330|FG001|NOT COMPLETED|Overall Study||7
8653357|NCT00655889|9695336|FG000|STARTED|Overall Study||13
8653358|NCT00655889|9695336|FG000|COMPLETED|Overall Study||11
8653359|NCT00655889|9695336|FG000|NOT COMPLETED|Overall Study||2
8653360|NCT00655928|9695342|FG000|STARTED|Overall Study||26
8653361|NCT00655928|9695343|FG001|STARTED|Overall Study||26
8653362|NCT00655928|9695342|FG000|COMPLETED|Overall Study||23
8653363|NCT00655928|9695343|FG001|COMPLETED|Overall Study||24
8653364|NCT00655928|9695342|FG000|NOT COMPLETED|Overall Study||3
8653365|NCT00655928|9695343|FG001|NOT COMPLETED|Overall Study||2
8653366|NCT00655980|9695352|FG000|STARTED|Overall Study||276
8653367|NCT00655980|9695353|FG001|STARTED|Overall Study||281
8653368|NCT00655980|9695354|FG002|STARTED|Overall Study||130
8653369|NCT00655980|9695352|FG000|COMPLETED|Overall Study||250
8653370|NCT00655980|9695353|FG001|COMPLETED|Overall Study||250
8653371|NCT00655980|9695354|FG002|COMPLETED|Overall Study||125
8653372|NCT00655980|9695352|FG000|NOT COMPLETED|Overall Study||26
8653373|NCT00655980|9695353|FG001|NOT COMPLETED|Overall Study||31
8653374|NCT00655980|9695354|FG002|NOT COMPLETED|Overall Study||5
8653375|NCT00656019|9695369|FG000|STARTED|Overall Study||29
8653376|NCT00656019|9695370|FG001|STARTED|Overall Study||19
8653377|NCT00656019|9695371|FG002|STARTED|Overall Study||11
8653378|NCT00656019|9695372|FG003|STARTED|Overall Study||4
8653379|NCT00656019|9695369|FG000|COMPLETED|Overall Study||15
8653380|NCT00656019|9695370|FG001|COMPLETED|Overall Study||18
8653381|NCT00656019|9695371|FG002|COMPLETED|Overall Study||11
8653382|NCT00656019|9695372|FG003|COMPLETED|Overall Study||4
8653383|NCT00656019|9695369|FG000|NOT COMPLETED|Overall Study||14
8653384|NCT00656019|9695370|FG001|NOT COMPLETED|Overall Study||1
8653385|NCT00656019|9695371|FG002|NOT COMPLETED|Overall Study||0
8653386|NCT00656019|9695372|FG003|NOT COMPLETED|Overall Study||0
8653387|NCT00656058|9695382|FG000|STARTED|Overall Study||25
8653388|NCT00656058|9695382|FG000|COMPLETED|Overall Study||19
8653389|NCT00656058|9695382|FG000|NOT COMPLETED|Overall Study||6
8653390|NCT00656084|9695386|FG000|STARTED|Overall Study||16
8653391|NCT00656084|9695386|FG000|COMPLETED|Overall Study||9
8653392|NCT00656084|9695386|FG000|NOT COMPLETED|Overall Study||7
8653393|NCT00656136|9695392|FG000|STARTED|Overall Study|Randomised patients.|195
8653394|NCT00656136|9695393|FG001|STARTED|Overall Study|Randomised patients.|390
8653395|NCT00656136|9695392|FG000|COMPLETED|Overall Study||0
8653396|NCT00656136|9695393|FG001|COMPLETED|Overall Study||0
8653397|NCT00656136|9695392|FG000|NOT COMPLETED|Overall Study||195
8653398|NCT00656136|9695393|FG001|NOT COMPLETED|Overall Study||390
8653399|NCT00656175|9695401|FG000|STARTED|Overall Study||18
8653400|NCT00656175|9695402|FG001|STARTED|Overall Study||21
8653401|NCT00656175|9695401|FG000|COMPLETED|Overall Study||17
8653402|NCT00656175|9695402|FG001|COMPLETED|Overall Study||20
8653403|NCT00656175|9695401|FG000|NOT COMPLETED|Overall Study||1
8653404|NCT00656175|9695402|FG001|NOT COMPLETED|Overall Study||1
8653405|NCT00656201|9695410|FG000|STARTED|Overall Study||235
8653406|NCT00656201|9695411|FG001|STARTED|Overall Study||233
8653407|NCT00656201|9695410|FG000|COMPLETED|Overall Study||206
8653408|NCT00656201|9695411|FG001|COMPLETED|Overall Study||201
8653409|NCT00656201|9695410|FG000|NOT COMPLETED|Overall Study||29
8653410|NCT00656201|9695411|FG001|NOT COMPLETED|Overall Study||32
8653411|NCT00656292|9695419|FG000|STARTED|Overall Study||32
8653412|NCT00656292|9695420|FG001|STARTED|Overall Study||29
8653413|NCT00656292|9695419|FG000|COMPLETED|Overall Study||29
8653414|NCT00656292|9695420|FG001|COMPLETED|Overall Study||24
8653415|NCT00656292|9695419|FG000|NOT COMPLETED|Overall Study||3
8653416|NCT00656292|9695420|FG001|NOT COMPLETED|Overall Study||5
8653417|NCT00656305|9695428|FG000|STARTED|Overall Study||87
8653418|NCT00656305|9695429|FG001|STARTED|Overall Study||28
8653419|NCT00656305|9695428|FG000|COMPLETED|Overall Study||65
8653420|NCT00656305|9695429|FG001|COMPLETED|Overall Study||21
8653421|NCT00656305|9695428|FG000|NOT COMPLETED|Overall Study||22
8653422|NCT00656305|9695429|FG001|NOT COMPLETED|Overall Study||7
8653423|NCT00656370|9695435|FG000|STARTED|Overall Study|25 subjects were assessed for eligibility and signed an Informed Consent Form.|25
8653424|NCT00656370|9695435|FG000|COMPLETED|Overall Study|15 subjects were randomized and completed stage 1 (received both NS and LR).|15
8653425|NCT00656370|9695435|FG000|NOT COMPLETED|Overall Study||10
8653426|NCT00656448|9695443|FG000|STARTED|Overall Study||25
8653427|NCT00656448|9695444|FG001|STARTED|Overall Study||25
8653428|NCT00656448|9695443|FG000|COMPLETED|Overall Study||25
8653429|NCT00656448|9695444|FG001|COMPLETED|Overall Study||25
8653430|NCT00656448|9695443|FG000|NOT COMPLETED|Overall Study||0
8653431|NCT00656448|9695444|FG001|NOT COMPLETED|Overall Study||0
8653432|NCT00656474|9695451|FG000|STARTED|Overall Study||12
8653433|NCT00656474|9695451|FG000|COMPLETED|Overall Study||11
8653434|NCT00656474|9695451|FG000|NOT COMPLETED|Overall Study||1
8653435|NCT00656487|9695459|FG000|STARTED|Overall Study||23
8653436|NCT00656487|9695460|FG001|STARTED|Overall Study||23
8653437|NCT00656487|9695461|FG002|STARTED|Overall Study||20
8653438|NCT00656487|9695459|FG000|COMPLETED|Overall Study||21
8653439|NCT00656487|9695460|FG001|COMPLETED|Overall Study||19
8653440|NCT00656487|9695461|FG002|COMPLETED|Overall Study||20
8653441|NCT00656487|9695459|FG000|NOT COMPLETED|Overall Study||2
8653442|NCT00656487|9695460|FG001|NOT COMPLETED|Overall Study||4
8653443|NCT00656487|9695461|FG002|NOT COMPLETED|Overall Study||0
8653444|NCT00656513|9695472|FG000|STARTED|Overall Study||48
8653445|NCT00656513|9695473|FG001|STARTED|Overall Study||73
8653446|NCT00656513|9695474|FG002|STARTED|Overall Study||75
8653447|NCT00656513|9695472|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|44
8653448|NCT00656513|9695473|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|43
8653449|NCT00656513|9695474|FG002|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|53
8653450|NCT00656513|9695472|FG000|NOT COMPLETED|Overall Study||4
8653451|NCT00656513|9695473|FG001|NOT COMPLETED|Overall Study||30
8653452|NCT00656513|9695474|FG002|NOT COMPLETED|Overall Study||22
8653453|NCT00656617|9695482|FG000|STARTED|Overall Study||106
8653454|NCT00656617|9695482|FG000|Run-in Induction Phase|Overall Study|Initial run-in: Vorinostat induction dose 500 mg orally three times daily for 3 days.|3
8653455|NCT00656617|9695482|FG000|Induction Phase|Overall Study|Induction phase following determination of safe combination Vorinostat with Idarubicin.|103
8653456|NCT00656617|9695482|FG000|COMPLETED|Overall Study||99
8653457|NCT00656617|9695482|FG000|NOT COMPLETED|Overall Study||7
8653458|NCT00656630|9695490|FG000|STARTED|Overall Study||22
8653459|NCT00656630|9695491|FG001|STARTED|Overall Study||27
8653460|NCT00656630|9695492|FG002|STARTED|Overall Study||19
8653461|NCT00656630|9695490|FG000|COMPLETED|Overall Study||20
8653462|NCT00656630|9695491|FG001|COMPLETED|Overall Study||25
8653463|NCT00656630|9695492|FG002|COMPLETED|Overall Study||17
8653464|NCT00656630|9695490|FG000|NOT COMPLETED|Overall Study||2
8653465|NCT00656630|9695491|FG001|NOT COMPLETED|Overall Study||2
8653466|NCT00656630|9695492|FG002|NOT COMPLETED|Overall Study||2
8653467|NCT00656656|9695500|FG000|STARTED|Overall Study||23
8653468|NCT00656656|9695500|FG000|COMPLETED|Overall Study||23
8653469|NCT00656656|9695500|FG000|NOT COMPLETED|Overall Study||0
8653470|NCT00656669|9695504|FG000|STARTED|Single Agent Sunitinib (Cycle 1)||23
8653471|NCT00656669|9695504|FG000|COMPLETED|Single Agent Sunitinib (Cycle 1)||23
8653472|NCT00656669|9695504|FG000|NOT COMPLETED|Single Agent Sunitinib (Cycle 1)||0
8653473|NCT00656669|9695504|FG000|STARTED|Paclitaxel/Sunitinib (Cycles 2-5)||23
8653474|NCT00656669|9695504|FG000|COMPLETED|Paclitaxel/Sunitinib (Cycles 2-5)||17
8653475|NCT00656669|9695504|FG000|NOT COMPLETED|Paclitaxel/Sunitinib (Cycles 2-5)||6
8653476|NCT00656669|9695504|FG000|STARTED|AC (Cycles 6-9)||17
8653477|NCT00656669|9695504|FG000|COMPLETED|AC (Cycles 6-9)||15
8653478|NCT00656669|9695504|FG000|NOT COMPLETED|AC (Cycles 6-9)||2
8653479|NCT00656799|9695513|FG000|STARTED|Overall Study||6
8653480|NCT00656799|9695513|FG000|COMPLETED|Overall Study||4
8653481|NCT00656799|9695513|FG000|NOT COMPLETED|Overall Study||2
8653482|NCT00656851|9695519|FG000|STARTED|Overall Study||12
8653483|NCT00656851|9695520|FG001|STARTED|Overall Study||12
8653484|NCT00656851|9695519|FG000|COMPLETED|Overall Study||12
8653485|NCT00656851|9695520|FG001|COMPLETED|Overall Study||8
8653486|NCT00656851|9695519|FG000|NOT COMPLETED|Overall Study||0
8653487|NCT00656851|9695520|FG001|NOT COMPLETED|Overall Study||4
8653488|NCT00656968|9695528|FG000|STARTED|Overall Study||115
8653489|NCT00656968|9695529|FG001|STARTED|Overall Study||117
8653490|NCT00656968|9695528|FG000|COMPLETED|Overall Study||115
8653491|NCT00656968|9695529|FG001|COMPLETED|Overall Study||117
8653492|NCT00656968|9695528|FG000|NOT COMPLETED|Overall Study||0
8653493|NCT00656968|9695529|FG001|NOT COMPLETED|Overall Study||0
8653494|NCT00657020|9695535|FG000|STARTED|PERIOD 1||11
8653495|NCT00657020|9695536|FG001|STARTED|PERIOD 1||12
8653496|NCT00657020|9695535|FG000|COMPLETED|PERIOD 1||11
8653497|NCT00657020|9695536|FG001|COMPLETED|PERIOD 1||11
8653498|NCT00657020|9695535|FG000|NOT COMPLETED|PERIOD 1||0
8653499|NCT00657020|9695536|FG001|NOT COMPLETED|PERIOD 1||1
8653500|NCT00657020|9695535|FG000|STARTED|PERIOD 2||11
8653501|NCT00657020|9695536|FG001|STARTED|PERIOD 2||11
8653502|NCT00657020|9695535|FG000|COMPLETED|PERIOD 2||11
8653503|NCT00657020|9695536|FG001|COMPLETED|PERIOD 2||11
8653504|NCT00657020|9695535|FG000|NOT COMPLETED|PERIOD 2||0
8653505|NCT00657020|9695536|FG001|NOT COMPLETED|PERIOD 2||0
8653506|NCT00657046|9695551|FG000|STARTED|Overall Study||30
8653507|NCT00657046|9695552|FG001|STARTED|Overall Study||32
8653508|NCT00657046|9695553|FG002|STARTED|Overall Study||23
8653509|NCT00657046|9695551|FG000|Had at Least 1 Post Baseline Visit|Overall Study||30
8653510|NCT00657046|9695552|FG001|Had at Least 1 Post Baseline Visit|Overall Study||31
8653511|NCT00657046|9695553|FG002|Had at Least 1 Post Baseline Visit|Overall Study||23
8653512|NCT00657046|9695551|FG000|Had Visits up to Visit 18|Overall Study||28
8653513|NCT00657046|9695552|FG001|Had Visits up to Visit 18|Overall Study||30
8653514|NCT00657046|9695553|FG002|Had Visits up to Visit 18|Overall Study||23
8653515|NCT00657046|9695551|FG000|COMPLETED|Overall Study||26
8653516|NCT00657046|9695552|FG001|COMPLETED|Overall Study||29
8653517|NCT00657046|9695553|FG002|COMPLETED|Overall Study||21
8653518|NCT00657046|9695551|FG000|NOT COMPLETED|Overall Study||4
8653519|NCT00657046|9695552|FG001|NOT COMPLETED|Overall Study||3
8653520|NCT00657046|9695553|FG002|NOT COMPLETED|Overall Study||2
8653521|NCT00657150|9695563|FG000|STARTED|Overall Study||1010
8653522|NCT00657150|9695564|FG001|STARTED|Overall Study||1003
8653523|NCT00657150|9695563|FG000|COMPLETED|Overall Study||895
8653524|NCT00657150|9695564|FG001|COMPLETED|Overall Study||910
8653525|NCT00657150|9695563|FG000|NOT COMPLETED|Overall Study||115
8653526|NCT00657150|9695564|FG001|NOT COMPLETED|Overall Study||93
8653527|NCT00657150|9695563|FG000|STARTED|Treatment||1010
8653528|NCT00657150|9695564|FG001|STARTED|Treatment||1003
8653529|NCT00657150|9695563|FG000|COMPLETED|Treatment||903
8653530|NCT00657150|9695564|FG001|COMPLETED|Treatment||906
8653531|NCT00657150|9695563|FG000|NOT COMPLETED|Treatment||107
8653532|NCT00657150|9695564|FG001|NOT COMPLETED|Treatment||97
8653533|NCT00657267|9695570|FG000|STARTED|Overall Study||58
8653534|NCT00657267|9695570|FG000|COMPLETED|Overall Study||4
8653535|NCT00657267|9695570|FG000|NOT COMPLETED|Overall Study||54
8653536|NCT00657280|9695576|FG000|STARTED|Overall Study||16
8653537|NCT00657280|9695576|FG000|COMPLETED|Overall Study||16
8653538|NCT00657280|9695576|FG000|NOT COMPLETED|Overall Study||0
8653539|NCT00657358|9695580|FG000|STARTED|Overall Study||22
8653540|NCT00657358|9695580|FG000|COMPLETED|Overall Study||16
8653541|NCT00657358|9695580|FG000|NOT COMPLETED|Overall Study||6
8653542|NCT00657371|9695585|FG000|STARTED|Overall Study||288
8653543|NCT00657371|9695585|FG000|COMPLETED|Overall Study||249
8653544|NCT00657371|9695585|FG000|NOT COMPLETED|Overall Study||39
8653545|NCT00657540|9695591|FG000|STARTED|Overall Study||29
8653546|NCT00657540|9695592|FG001|STARTED|Overall Study||31
8653547|NCT00657540|9695591|FG000|COMPLETED|Overall Study|All subjects had a known treatment failure disposition at time of loss to follow-up.|28
8653548|NCT00657540|9695592|FG001|COMPLETED|Overall Study|All subjects had a known treatment failure disposition at time of loss to follow-up.|27
8653549|NCT00657540|9695591|FG000|NOT COMPLETED|Overall Study||1
8653550|NCT00657540|9695592|FG001|NOT COMPLETED|Overall Study||4
8653551|NCT00657605|9695598|FG000|STARTED|Overall Study||3
8653552|NCT00657605|9695598|FG000|COMPLETED|Overall Study||3
8653553|NCT00657605|9695598|FG000|NOT COMPLETED|Overall Study||0
8653554|NCT00657618|9695602|FG000|STARTED|Overall Study||77
8653555|NCT00657618|9695602|FG000|COMPLETED|Overall Study||34
8653556|NCT00657618|9695602|FG000|NOT COMPLETED|Overall Study||43
8653557|NCT00657657|9695606|FG000|STARTED|Overall Study||29
8653558|NCT00657657|9695606|FG000|COMPLETED|Overall Study||29
8653559|NCT00657657|9695606|FG000|NOT COMPLETED|Overall Study||0
8653560|NCT00657709|9695615|FG000|STARTED|Overall Study||833
8653561|NCT00657709|9695616|FG001|STARTED|Overall Study||828
8653562|NCT00657709|9695617|FG002|STARTED|Overall Study||820
8653563|NCT00657709|9695618|FG003|STARTED|Overall Study||659
8653564|NCT00657709|9695619|FG004|STARTED|Overall Study||490
8653565|NCT00657709|9695615|FG000|COMPLETED|Overall Study||810
8653566|NCT00657709|9695616|FG001|COMPLETED|Overall Study||795
8653567|NCT00657709|9695617|FG002|COMPLETED|Overall Study||792
8653568|NCT00657709|9695618|FG003|COMPLETED|Overall Study||645
8653569|NCT00657709|9695619|FG004|COMPLETED|Overall Study||457
8653570|NCT00657709|9695615|FG000|NOT COMPLETED|Overall Study||23
8653571|NCT00657709|9695616|FG001|NOT COMPLETED|Overall Study||33
8653572|NCT00657709|9695617|FG002|NOT COMPLETED|Overall Study||28
8653573|NCT00657709|9695618|FG003|NOT COMPLETED|Overall Study||14
8653574|NCT00657709|9695619|FG004|NOT COMPLETED|Overall Study||33
8653575|NCT00657917|9695641|FG000|STARTED|Overall Study||1
8653576|NCT00657917|9695641|FG000|COMPLETED|Overall Study||1
8653577|NCT00657917|9695641|FG000|NOT COMPLETED|Overall Study||0
8653578|NCT00658021|9695648|FG000|STARTED|28-Week Treatment Period||42
8653579|NCT00658021|9695649|FG001|STARTED|28-Week Treatment Period||38
8653580|NCT00658021|9695650|FG002|STARTED|28-Week Treatment Period||42
8653581|NCT00658021|9695648|FG000|Received Treatment|28-Week Treatment Period||40
8653582|NCT00658021|9695649|FG001|Received Treatment|28-Week Treatment Period||38
8653583|NCT00658021|9695650|FG002|Received Treatment|28-Week Treatment Period||42
8653584|NCT00658021|9695648|FG000|COMPLETED|28-Week Treatment Period||31
8653585|NCT00658021|9695649|FG001|COMPLETED|28-Week Treatment Period||25
8653586|NCT00658021|9695650|FG002|COMPLETED|28-Week Treatment Period||25
8653587|NCT00658021|9695648|FG000|NOT COMPLETED|28-Week Treatment Period||11
8653588|NCT00658021|9695649|FG001|NOT COMPLETED|28-Week Treatment Period||13
8653589|NCT00658021|9695650|FG002|NOT COMPLETED|28-Week Treatment Period||17
8653590|NCT00658021|9695648|FG000|STARTED|Long-term Safety Follow-up Period|Entered safety follow-up period.|7
8653591|NCT00658021|9695649|FG001|STARTED|Long-term Safety Follow-up Period|Entered safety follow-up period.|5
8653592|NCT00658021|9695650|FG002|STARTED|Long-term Safety Follow-up Period|Entered safety follow-up period.|7
8653593|NCT00658021|9695648|FG000|COMPLETED|Long-term Safety Follow-up Period||7
8653594|NCT00658021|9695649|FG001|COMPLETED|Long-term Safety Follow-up Period||2
8653595|NCT00658021|9695650|FG002|COMPLETED|Long-term Safety Follow-up Period||7
8653596|NCT00658021|9695648|FG000|NOT COMPLETED|Long-term Safety Follow-up Period||0
8653597|NCT00658021|9695649|FG001|NOT COMPLETED|Long-term Safety Follow-up Period||3
8653598|NCT00658021|9695650|FG002|NOT COMPLETED|Long-term Safety Follow-up Period||0
8653599|NCT00658112|9695660|FG000|STARTED|Overall Study||20
8653600|NCT00658112|9695660|FG000|COMPLETED|Overall Study||11
8653601|NCT00658112|9695660|FG000|NOT COMPLETED|Overall Study||9
8653602|NCT00658138|9695664|FG000|STARTED|Overall Study||61
8653603|NCT00658138|9695664|FG000|COMPLETED|Overall Study||40
8653604|NCT00658138|9695664|FG000|NOT COMPLETED|Overall Study||21
8653605|NCT00658320|9695671|FG000|STARTED|Core Study: 12 Months||61
8653606|NCT00658320|9695672|FG001|STARTED|Core Study: 12 Months||61
8653607|NCT00658320|9695671|FG000|COMPLETED|Core Study: 12 Months||56
8653608|NCT00658320|9695672|FG001|COMPLETED|Core Study: 12 Months||58
8653609|NCT00658320|9695671|FG000|NOT COMPLETED|Core Study: 12 Months||5
8653610|NCT00658320|9695672|FG001|NOT COMPLETED|Core Study: 12 Months||3
8653611|NCT00658320|9695671|FG000|STARTED|Extension Study: Month 12 to Month 24||53
8653612|NCT00658320|9695672|FG001|STARTED|Extension Study: Month 12 to Month 24||57
8653613|NCT00658320|9695671|FG000|Extension ITT: Received Study Drug|Extension Study: Month 12 to Month 24||50
8653614|NCT00658320|9695672|FG001|Extension ITT: Received Study Drug|Extension Study: Month 12 to Month 24||50
8653615|NCT00658320|9695671|FG000|COMPLETED|Extension Study: Month 12 to Month 24||47
8653616|NCT00658320|9695672|FG001|COMPLETED|Extension Study: Month 12 to Month 24||50
8653617|NCT00658320|9695671|FG000|NOT COMPLETED|Extension Study: Month 12 to Month 24||6
8653618|NCT00658320|9695672|FG001|NOT COMPLETED|Extension Study: Month 12 to Month 24||7
8653619|NCT00658320|9695671|FG000|STARTED|Extension Study: After Month 24||44
8653620|NCT00658320|9695672|FG001|STARTED|Extension Study: After Month 24||0
8653621|NCT00658320|9695671|FG000|COMPLETED|Extension Study: After Month 24||42
8653622|NCT00658320|9695672|FG001|COMPLETED|Extension Study: After Month 24||0
8653623|NCT00658320|9695671|FG000|NOT COMPLETED|Extension Study: After Month 24||2
8653624|NCT00658320|9695672|FG001|NOT COMPLETED|Extension Study: After Month 24||0
8653625|NCT00658333|9695682|FG000|STARTED|Overall Study||15
8653626|NCT00658333|9695683|FG001|STARTED|Overall Study||15
8653627|NCT00658333|9695682|FG000|COMPLETED|Overall Study||13
8653628|NCT00658333|9695683|FG001|COMPLETED|Overall Study||14
8653629|NCT00658333|9695682|FG000|NOT COMPLETED|Overall Study||2
8653630|NCT00658333|9695683|FG001|NOT COMPLETED|Overall Study||1
8653631|NCT00658359|9695692|FG000|STARTED|Overall Study||64
8653632|NCT00658359|9695693|FG001|STARTED|Overall Study||60
8653633|NCT00658359|9695694|FG002|STARTED|Overall Study||54
8653634|NCT00658359|9695692|FG000|COMPLETED|Overall Study||36
8653635|NCT00658359|9695693|FG001|COMPLETED|Overall Study||15
8653636|NCT00658359|9695694|FG002|COMPLETED|Overall Study||8
8653637|NCT00658359|9695692|FG000|NOT COMPLETED|Overall Study||28
8653638|NCT00658359|9695693|FG001|NOT COMPLETED|Overall Study||45
8653639|NCT00658359|9695694|FG002|NOT COMPLETED|Overall Study||46
8653640|NCT00658385|9695704|FG000|STARTED|Overall Study||5
8653641|NCT00658385|9695704|FG000|COMPLETED|Overall Study||5
8653642|NCT00658385|9695704|FG000|NOT COMPLETED|Overall Study||0
8653643|NCT00658411|9695708|FG000|STARTED|Overall Study||5
8653644|NCT00658411|9695708|FG000|COMPLETED|Overall Study||5
8653645|NCT00658411|9695708|FG000|NOT COMPLETED|Overall Study||0
8653646|NCT00658515|9695718|FG000|STARTED|Overall Study||7938
8653647|NCT00658515|9695719|FG001|STARTED|Overall Study||7933
8653648|NCT00658515|9695718|FG000|COMPLETED|Overall Study||7626
8653649|NCT00658515|9695719|FG001|COMPLETED|Overall Study||7668
8653650|NCT00658515|9695718|FG000|NOT COMPLETED|Overall Study||312
8653651|NCT00658515|9695719|FG001|NOT COMPLETED|Overall Study||265
8653652|NCT00658528|9695727|FG000|STARTED|Overall Study|Treated|531
8653653|NCT00658528|9695728|FG001|STARTED|Overall Study|Treated|524
8653654|NCT00658528|9695727|FG000|COMPLETED|Overall Study||491
8653655|NCT00658528|9695728|FG001|COMPLETED|Overall Study||479
8653656|NCT00658528|9695727|FG000|NOT COMPLETED|Overall Study||40
8653657|NCT00658528|9695728|FG001|NOT COMPLETED|Overall Study||45
8653658|NCT00658541|9695734|FG000|STARTED|First Intervention||19
8653659|NCT00658541|9695735|FG001|STARTED|First Intervention||19
8653660|NCT00658541|9695734|FG000|COMPLETED|First Intervention||19
8653661|NCT00658541|9695735|FG001|COMPLETED|First Intervention||19
8653662|NCT00658541|9695734|FG000|NOT COMPLETED|First Intervention||0
8653663|NCT00658541|9695735|FG001|NOT COMPLETED|First Intervention||0
8653664|NCT00658541|9695734|FG000|STARTED|Washout Period of 7 Days||19
8653665|NCT00658541|9695735|FG001|STARTED|Washout Period of 7 Days||19
8653666|NCT00658541|9695734|FG000|COMPLETED|Washout Period of 7 Days||18
8653667|NCT00658541|9695735|FG001|COMPLETED|Washout Period of 7 Days||17
8653668|NCT00658541|9695734|FG000|NOT COMPLETED|Washout Period of 7 Days||1
8653669|NCT00658541|9695735|FG001|NOT COMPLETED|Washout Period of 7 Days||2
8653670|NCT00658541|9695734|FG000|STARTED|Second Intervention||18
8653671|NCT00658541|9695735|FG001|STARTED|Second Intervention||17
8653672|NCT00658541|9695734|FG000|COMPLETED|Second Intervention||18
8653673|NCT00658541|9695735|FG001|COMPLETED|Second Intervention||17
8653674|NCT00658541|9695734|FG000|NOT COMPLETED|Second Intervention||0
8653675|NCT00658541|9695735|FG001|NOT COMPLETED|Second Intervention||0
8653676|NCT00658567|9695744|FG000|STARTED|Overall Study||40
8653677|NCT00658567|9695745|FG001|STARTED|Overall Study||42
8653678|NCT00658567|9695746|FG002|STARTED|Overall Study||41
8653679|NCT00658567|9695744|FG000|COMPLETED|Overall Study||32
8653680|NCT00658567|9695745|FG001|COMPLETED|Overall Study||38
8653681|NCT00658567|9695746|FG002|COMPLETED|Overall Study||35
8653682|NCT00658567|9695744|FG000|NOT COMPLETED|Overall Study||8
8653683|NCT00658567|9695745|FG001|NOT COMPLETED|Overall Study||4
8653684|NCT00658567|9695746|FG002|NOT COMPLETED|Overall Study||6
8653685|NCT00658606|9695756|FG000|STARTED|Overall Study||49
8653686|NCT00658606|9695757|FG001|STARTED|Overall Study||49
8653687|NCT00658606|9695756|FG000|Completed Treatment|Overall Study||42
8653688|NCT00658606|9695757|FG001|Completed Treatment|Overall Study||44
8653689|NCT00658606|9695756|FG000|COMPLETED|Overall Study|Represents patients who completed follow-up|33
8653690|NCT00658606|9695757|FG001|COMPLETED|Overall Study|Represents patients who completed follow-up|26
8653691|NCT00658606|9695756|FG000|NOT COMPLETED|Overall Study||16
8653692|NCT00658606|9695757|FG001|NOT COMPLETED|Overall Study||23
8653693|NCT00658619|9695768|FG000|STARTED|Overall Study||3
8653694|NCT00658619|9695769|FG001|STARTED|Overall Study||3
8653695|NCT00658619|9695770|FG002|STARTED|Overall Study||41
8653696|NCT00658619|9695771|FG003|STARTED|Overall Study||49
8653697|NCT00658619|9695772|FG004|STARTED|Overall Study||23
8653698|NCT00658619|9695768|FG000|COMPLETED|Overall Study||3
8653699|NCT00658619|9695769|FG001|COMPLETED|Overall Study||2
8653700|NCT00658619|9695770|FG002|COMPLETED|Overall Study||31
8653701|NCT00658619|9695771|FG003|COMPLETED|Overall Study||37
8653702|NCT00658619|9695772|FG004|COMPLETED|Overall Study||21
8653703|NCT00658619|9695768|FG000|NOT COMPLETED|Overall Study||0
8653704|NCT00658619|9695769|FG001|NOT COMPLETED|Overall Study||1
8653705|NCT00658619|9695770|FG002|NOT COMPLETED|Overall Study||10
8653706|NCT00658619|9695771|FG003|NOT COMPLETED|Overall Study||12
8653707|NCT00658619|9695772|FG004|NOT COMPLETED|Overall Study||2
8653708|NCT00658632|9695783|FG000|STARTED|Overall Study|Treated|682
8653709|NCT00658632|9695784|FG001|STARTED|Overall Study|Treated|698
8653710|NCT00658632|9695783|FG000|COMPLETED|Overall Study||618
8653711|NCT00658632|9695784|FG001|COMPLETED|Overall Study||633
8653712|NCT00658632|9695783|FG000|NOT COMPLETED|Overall Study||64
8653713|NCT00658632|9695784|FG001|NOT COMPLETED|Overall Study||65
8653714|NCT00658658|9695795|FG000|STARTED|Overall Study||6
8653715|NCT00658658|9695796|FG001|STARTED|Overall Study||7
8653716|NCT00658658|9695797|FG002|STARTED|Overall Study||4
8653717|NCT00658658|9695798|FG003|STARTED|Overall Study||6
8653718|NCT00658658|9695799|FG004|STARTED|Overall Study||8
8653719|NCT00658658|9695795|FG000|COMPLETED|Overall Study||1
8653720|NCT00658658|9695796|FG001|COMPLETED|Overall Study||5
8653721|NCT00658658|9695797|FG002|COMPLETED|Overall Study||4
8653722|NCT00658658|9695798|FG003|COMPLETED|Overall Study||4
8653723|NCT00658658|9695799|FG004|COMPLETED|Overall Study||3
8653724|NCT00658658|9695795|FG000|NOT COMPLETED|Overall Study||5
8653725|NCT00658658|9695796|FG001|NOT COMPLETED|Overall Study||2
8653726|NCT00658658|9695797|FG002|NOT COMPLETED|Overall Study||0
8653727|NCT00658658|9695798|FG003|NOT COMPLETED|Overall Study||2
8653728|NCT00658658|9695799|FG004|NOT COMPLETED|Overall Study||5
8653729|NCT00658684|9695814|FG000|STARTED|Overall Study||152
8653730|NCT00658684|9695815|FG001|STARTED|Overall Study||99
8653731|NCT00658684|9695816|FG002|STARTED|Overall Study||25
8653732|NCT00658684|9695817|FG003|STARTED|Overall Study||28
8653733|NCT00658684|9695814|FG000|COMPLETED|Overall Study||133
8728841|NCT01049373|9775798|FG001|STARTED|Overall Study||109
8728842|NCT01049373|9775797|FG000|COMPLETED|Overall Study||73
8653734|NCT00658684|9695815|FG001|COMPLETED|Overall Study||84
8653735|NCT00658684|9695816|FG002|COMPLETED|Overall Study||22
8653736|NCT00658684|9695817|FG003|COMPLETED|Overall Study||27
8653737|NCT00658684|9695814|FG000|NOT COMPLETED|Overall Study||19
8653738|NCT00658684|9695815|FG001|NOT COMPLETED|Overall Study||15
8653739|NCT00658684|9695816|FG002|NOT COMPLETED|Overall Study||3
8653740|NCT00658684|9695817|FG003|NOT COMPLETED|Overall Study||1
8653741|NCT00658697|9695827|FG000|STARTED|Overall Study||41
8653742|NCT00658697|9695827|FG000|COMPLETED|Overall Study||41
8728843|NCT01049373|9775798|FG001|COMPLETED|Overall Study||65
8653743|NCT00658697|9695827|FG000|NOT COMPLETED|Overall Study||0
8653744|NCT00658723|9695835|FG000|STARTED|Overall Study||60
8653745|NCT00658723|9695836|FG001|STARTED|Overall Study||30
8653746|NCT00658723|9695837|FG002|STARTED|Overall Study||51
8653747|NCT00658723|9695835|FG000|COMPLETED|Overall Study||56
8653748|NCT00658723|9695836|FG001|COMPLETED|Overall Study||26
8653749|NCT00658723|9695837|FG002|COMPLETED|Overall Study||44
8653750|NCT00658723|9695835|FG000|NOT COMPLETED|Overall Study||4
8653751|NCT00658723|9695836|FG001|NOT COMPLETED|Overall Study||4
8653752|NCT00658723|9695837|FG002|NOT COMPLETED|Overall Study||7
8653753|NCT00658736|9695850|FG000|STARTED|Overall Study||19
8653754|NCT00658736|9695851|FG001|STARTED|Overall Study||21
8653755|NCT00658736|9695850|FG000|COMPLETED|Overall Study||13
8653756|NCT00658736|9695851|FG001|COMPLETED|Overall Study||19
8653757|NCT00658736|9695850|FG000|NOT COMPLETED|Overall Study||6
8653758|NCT00658736|9695851|FG001|NOT COMPLETED|Overall Study||2
8653759|NCT00658775|9695859|FG000|STARTED|Overall Study|Treated|537
8653760|NCT00658775|9695860|FG001|STARTED|Overall Study|Treated|528
8653761|NCT00658775|9695859|FG000|COMPLETED|Overall Study||495
8653762|NCT00658775|9695860|FG001|COMPLETED|Overall Study||485
8653763|NCT00658775|9695859|FG000|NOT COMPLETED|Overall Study||42
8653764|NCT00658775|9695860|FG001|NOT COMPLETED|Overall Study||43
8653765|NCT00658788|9695866|FG000|STARTED|Overall Study||305
8653766|NCT00658788|9695866|FG000|COMPLETED|Overall Study||231
8653767|NCT00658788|9695866|FG000|NOT COMPLETED|Overall Study||74
8653768|NCT00658879|9695879|FG000|STARTED|Overall Study||251
8653769|NCT00658879|9695879|FG000|COMPLETED|Overall Study||250
8653770|NCT00658879|9695879|FG000|NOT COMPLETED|Overall Study||1
8653771|NCT00658996|9695883|FG000|STARTED|First Intervention||109
8653772|NCT00658996|9695884|FG001|STARTED|First Intervention||107
8653773|NCT00658996|9695883|FG000|COMPLETED|First Intervention||108
8653774|NCT00658996|9695884|FG001|COMPLETED|First Intervention||106
8653775|NCT00658996|9695883|FG000|NOT COMPLETED|First Intervention||1
8653776|NCT00658996|9695884|FG001|NOT COMPLETED|First Intervention||1
8653777|NCT00658996|9695883|FG000|STARTED|Crossover Period||108
8653778|NCT00658996|9695884|FG001|STARTED|Crossover Period||106
8653779|NCT00658996|9695883|FG000|COMPLETED|Crossover Period||106
8653780|NCT00658996|9695884|FG001|COMPLETED|Crossover Period||105
8653781|NCT00658996|9695883|FG000|NOT COMPLETED|Crossover Period||2
8653782|NCT00658996|9695884|FG001|NOT COMPLETED|Crossover Period||1
8653783|NCT00658996|9695883|FG000|STARTED|Second Intervention||106
8653784|NCT00658996|9695884|FG001|STARTED|Second Intervention||105
8653785|NCT00658996|9695883|FG000|COMPLETED|Second Intervention||105
8653786|NCT00658996|9695884|FG001|COMPLETED|Second Intervention||104
8653787|NCT00658996|9695883|FG000|NOT COMPLETED|Second Intervention||1
8653788|NCT00658996|9695884|FG001|NOT COMPLETED|Second Intervention||1
8653789|NCT00659165|9695892|FG000|STARTED|Overall Study||5
8653790|NCT00659165|9695893|FG001|STARTED|Overall Study||5
8653791|NCT00659165|9695892|FG000|COMPLETED|Overall Study||5
8653792|NCT00659165|9695893|FG001|COMPLETED|Overall Study||5
8653793|NCT00659165|9695892|FG000|NOT COMPLETED|Overall Study||0
8728844|NCT01049373|9775797|FG000|NOT COMPLETED|Overall Study||39
8728845|NCT01049373|9775798|FG001|NOT COMPLETED|Overall Study||44
8728846|NCT01049412|9775808|FG000|STARTED|Period I||70
8653794|NCT00659165|9695893|FG001|NOT COMPLETED|Overall Study||0
8653795|NCT00659230|9695901|FG000|STARTED|Overall Study|2 did not return post-randomization, 5 lost source documents, thus 7 excluded from results analysis|51
8653796|NCT00659230|9695902|FG001|STARTED|Overall Study|3 did not return post-randomization, 4 lost source documents, thus 7 excluded from results analysis|49
8653797|NCT00659230|9695901|FG000|COMPLETED|Overall Study||42
8653798|NCT00659230|9695902|FG001|COMPLETED|Overall Study||37
8653799|NCT00659230|9695901|FG000|NOT COMPLETED|Overall Study||9
8653800|NCT00659230|9695902|FG001|NOT COMPLETED|Overall Study||12
8653801|NCT00659269|9695910|FG000|STARTED|Overall Study||157
8653802|NCT00659269|9695911|FG001|STARTED|Overall Study||162
8653803|NCT00659269|9695910|FG000|Group 1 (Heavy Metals)|Overall Study||52
8653804|NCT00659269|9695911|FG001|Group 1 (Heavy Metals)|Overall Study||52
8653805|NCT00659269|9695910|FG000|Group 2 (Vinca Alkaloids)|Overall Study||12
8653806|NCT00659269|9695911|FG001|Group 2 (Vinca Alkaloids)|Overall Study||12
8653807|NCT00659269|9695910|FG000|Group 3 (Taxanes)|Overall Study||92
8653808|NCT00659269|9695911|FG001|Group 3 (Taxanes)|Overall Study||97
8653809|NCT00659269|9695910|FG000|COMPLETED|Overall Study||156
8653810|NCT00659269|9695911|FG001|COMPLETED|Overall Study||161
8653811|NCT00659269|9695910|FG000|NOT COMPLETED|Overall Study||1
8653812|NCT00659269|9695911|FG001|NOT COMPLETED|Overall Study||1
8653813|NCT00659295|9695928|FG000|STARTED|Overall Study||13529
8653814|NCT00659295|9695929|FG001|STARTED|Overall Study||37641
8653815|NCT00659295|9695928|FG000|COMPLETED|Overall Study||10821
8653816|NCT00659295|9695929|FG001|COMPLETED|Overall Study||32038
8653817|NCT00659295|9695928|FG000|NOT COMPLETED|Overall Study||2708
8653818|NCT00659295|9695929|FG001|NOT COMPLETED|Overall Study||5603
8653819|NCT00659334|9695942|FG000|STARTED|Overall Study||46
8653820|NCT00659334|9695943|FG001|STARTED|Overall Study||41
8653821|NCT00659334|9695944|FG002|STARTED|Overall Study||5
8653822|NCT00659334|9695945|FG003|STARTED|Overall Study||2
8653823|NCT00659334|9695946|FG004|STARTED|Overall Study||1
8653824|NCT00659334|9695947|FG005|STARTED|Overall Study||0
8653825|NCT00659334|9695948|FG006|STARTED|Overall Study||21
8653826|NCT00659334|9695942|FG000|COMPLETED|Overall Study|8 Screen failures|38
8653827|NCT00659334|9695943|FG001|COMPLETED|Overall Study|5 Screen failures|36
8728847|NCT01049412|9775809|FG001|STARTED|Period I||68
8653828|NCT00659334|9695944|FG002|COMPLETED|Overall Study||5
8653829|NCT00659334|9695945|FG003|COMPLETED|Overall Study||2
8653830|NCT00659334|9695946|FG004|COMPLETED|Overall Study||1
8653831|NCT00659334|9695947|FG005|COMPLETED|Overall Study||0
8653832|NCT00659334|9695948|FG006|COMPLETED|Overall Study|1 screen failure|20
8653833|NCT00659334|9695942|FG000|NOT COMPLETED|Overall Study||8
8653834|NCT00659334|9695943|FG001|NOT COMPLETED|Overall Study||5
8653835|NCT00659334|9695944|FG002|NOT COMPLETED|Overall Study||0
8653836|NCT00659334|9695945|FG003|NOT COMPLETED|Overall Study||0
8653837|NCT00659334|9695946|FG004|NOT COMPLETED|Overall Study||0
8653838|NCT00659334|9695947|FG005|NOT COMPLETED|Overall Study||0
8653839|NCT00659334|9695948|FG006|NOT COMPLETED|Overall Study||1
8653840|NCT00659360|9695964|FG000|STARTED|Overall Study||17
8653841|NCT00659360|9695964|FG000|COMPLETED|Overall Study||17
8653842|NCT00659360|9695964|FG000|NOT COMPLETED|Overall Study||0
8653843|NCT00659373|9695972|FG000|STARTED|Overall Study||25
8653844|NCT00659373|9695973|FG001|STARTED|Overall Study||61
8653845|NCT00659373|9695972|FG000|COMPLETED|Overall Study||20
8653846|NCT00659373|9695973|FG001|COMPLETED|Overall Study||54
8653847|NCT00659373|9695972|FG000|NOT COMPLETED|Overall Study||5
8653848|NCT00659373|9695973|FG001|NOT COMPLETED|Overall Study||7
8653849|NCT00659425|9695989|FG000|STARTED|Overall Study||1
8653850|NCT00659425|9695990|FG001|STARTED|Overall Study||1
8653851|NCT00659425|9695991|FG002|STARTED|Overall Study||1
8653852|NCT00659425|9695992|FG003|STARTED|Overall Study||4
8653853|NCT00659425|9695993|FG004|STARTED|Overall Study||4
8653854|NCT00659425|9695994|FG005|STARTED|Overall Study||5
8653855|NCT00659425|9695995|FG006|STARTED|Overall Study||8
8653856|NCT00659425|9695996|FG007|STARTED|Overall Study||11
8653857|NCT00659425|9695997|FG008|STARTED|Overall Study||6
8653858|NCT00659425|9695998|FG009|STARTED|Overall Study||14
8653859|NCT00659425|9695989|FG000|COMPLETED|Overall Study||0
8653860|NCT00659425|9695990|FG001|COMPLETED|Overall Study||0
8653861|NCT00659425|9695991|FG002|COMPLETED|Overall Study||0
8653862|NCT00659425|9695992|FG003|COMPLETED|Overall Study||0
8653863|NCT00659425|9695993|FG004|COMPLETED|Overall Study||0
8653864|NCT00659425|9695994|FG005|COMPLETED|Overall Study||1
8653865|NCT00659425|9695995|FG006|COMPLETED|Overall Study||0
8653866|NCT00659425|9695996|FG007|COMPLETED|Overall Study||0
8653867|NCT00659425|9695997|FG008|COMPLETED|Overall Study||0
8653868|NCT00659425|9695998|FG009|COMPLETED|Overall Study||1
8653869|NCT00659425|9695989|FG000|NOT COMPLETED|Overall Study||1
8653870|NCT00659425|9695990|FG001|NOT COMPLETED|Overall Study||1
8653871|NCT00659425|9695991|FG002|NOT COMPLETED|Overall Study||1
8653872|NCT00659425|9695992|FG003|NOT COMPLETED|Overall Study||4
8653873|NCT00659425|9695993|FG004|NOT COMPLETED|Overall Study||4
8653874|NCT00659425|9695994|FG005|NOT COMPLETED|Overall Study||4
8653875|NCT00659425|9695995|FG006|NOT COMPLETED|Overall Study||8
8653876|NCT00659425|9695996|FG007|NOT COMPLETED|Overall Study||11
8653877|NCT00659425|9695997|FG008|NOT COMPLETED|Overall Study||6
8653878|NCT00659425|9695998|FG009|NOT COMPLETED|Overall Study||13
8653879|NCT00659438|9696035|FG000|STARTED|Overall Study||47
8653880|NCT00659438|9696036|FG001|STARTED|Overall Study||48
8653881|NCT00659438|9696035|FG000|Assessable Set : Primary Analysis|Overall Study||44
8653882|NCT00659438|9696036|FG001|Assessable Set : Primary Analysis|Overall Study||45
8653883|NCT00659438|9696035|FG000|Secondary Analysis Set|Overall Study||47
8653884|NCT00659438|9696036|FG001|Secondary Analysis Set|Overall Study||48
8653885|NCT00659438|9696035|FG000|Safety Analysis Set|Overall Study|One patient randomized to placebo was accounted in vandetanib group as he mistakenly received drug|48
8653886|NCT00659438|9696036|FG001|Safety Analysis Set|Overall Study||47
8653887|NCT00659438|9696035|FG000|COMPLETED|Overall Study||33
8653888|NCT00659438|9696036|FG001|COMPLETED|Overall Study||40
8653889|NCT00659438|9696035|FG000|NOT COMPLETED|Overall Study||14
8653890|NCT00659438|9696036|FG001|NOT COMPLETED|Overall Study||8
8653891|NCT00659490|9696045|FG000|STARTED|Overall Study||61
8653892|NCT00659490|9696046|FG001|STARTED|Overall Study||59
8653893|NCT00659490|9696047|FG002|STARTED|Overall Study||31
8653894|NCT00659490|9696045|FG000|COMPLETED|Overall Study||59
8653895|NCT00659490|9696046|FG001|COMPLETED|Overall Study||59
8653896|NCT00659490|9696047|FG002|COMPLETED|Overall Study||30
8653897|NCT00659490|9696045|FG000|NOT COMPLETED|Overall Study||2
8653898|NCT00659490|9696046|FG001|NOT COMPLETED|Overall Study||0
8653899|NCT00659490|9696047|FG002|NOT COMPLETED|Overall Study||1
8653900|NCT00659529|9696055|FG000|STARTED|Overall Study|There were 9 screen failures (subjects who did not meet inclusion/exclusion criteria)|36
8653901|NCT00659529|9696055|FG000|Received at Least One Dose of Study Drug|Overall Study|Received at least one dose of study drug|27
8653902|NCT00659529|9696055|FG000|COMPLETED|Overall Study|4 patients withdrew as a result of side effects. 3 subjects were withdrawn by the investigator.|20
8653903|NCT00659529|9696055|FG000|NOT COMPLETED|Overall Study||16
8653904|NCT00659581|9696059|FG000|STARTED|Overall Study||20994
8653905|NCT00659581|9696059|FG000|COMPLETED|Overall Study||12412
8653906|NCT00659581|9696059|FG000|NOT COMPLETED|Overall Study||8582
8653907|NCT00659607|9696063|FG000|STARTED|Overall Study||3932
8653908|NCT00659607|9696063|FG000|COMPLETED|Overall Study||3616
8653909|NCT00659607|9696063|FG000|NOT COMPLETED|Overall Study||316
8653910|NCT00659633|9696069|FG000|STARTED|Overall Study||10
8653911|NCT00659633|9696069|FG000|COMPLETED|Overall Study||10
8653912|NCT00659633|9696069|FG000|NOT COMPLETED|Overall Study||0
8653913|NCT00659724|9696073|FG000|STARTED|Weeks 1-2: Assessment of 180NR or 200NR||33
8653914|NCT00659724|9696073|FG000|COMPLETED|Weeks 1-2: Assessment of 180NR or 200NR||33
8653915|NCT00659724|9696073|FG000|NOT COMPLETED|Weeks 1-2: Assessment of 180NR or 200NR||0
8653916|NCT00659724|9696073|FG000|STARTED|Weeks 3-4: Assessment of HD-C4 Big||33
8653917|NCT00659724|9696073|FG000|COMPLETED|Weeks 3-4: Assessment of HD-C4 Big||33
8653918|NCT00659724|9696073|FG000|NOT COMPLETED|Weeks 3-4: Assessment of HD-C4 Big||0
8653919|NCT00659737|9696081|FG000|STARTED|Overall Study||57
8653920|NCT00659737|9696082|FG001|STARTED|Overall Study||58
8653921|NCT00659737|9696081|FG000|COMPLETED|Overall Study||57
8653922|NCT00659737|9696082|FG001|COMPLETED|Overall Study||58
8653923|NCT00659737|9696081|FG000|NOT COMPLETED|Overall Study||0
8653924|NCT00659737|9696082|FG001|NOT COMPLETED|Overall Study||0
8653925|NCT00659789|9696090|FG000|STARTED|Overall Study||93
8653926|NCT00659789|9696091|FG001|STARTED|Overall Study||43
8653927|NCT00659789|9696090|FG000|COMPLETED|Overall Study||86
8653928|NCT00659789|9696091|FG001|COMPLETED|Overall Study||36
8653929|NCT00659789|9696090|FG000|NOT COMPLETED|Overall Study||7
9022177|NCT03124459|10085071|FG001|STARTED|Phase 2- Randomized Doubled-blind|Participants in Part 1 Open-Label Dose escalation portion of the study were not the same participants that participated in the double-blind placebo controlled study.|0
9022178|NCT03124459|10085072|FG002|STARTED|Phase 2- Randomized Doubled-blind|Participants in Part 1 Open-Label Dose escalation portion of the study were not the same participants that participated in the double-blind placebo controlled study.|0
9022179|NCT03124459|10085073|FG003|STARTED|Phase 2- Randomized Doubled-blind|Participants in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study.|21
9022180|NCT03124459|10085074|FG004|STARTED|Phase 2- Randomized Doubled-blind|Participants in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study.|24
9022181|NCT03124459|10085075|FG005|STARTED|Phase 2- Randomized Doubled-blind|Participants in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study. Participants that completed the double-blind portion of the study then moved into this Part 2 open-label portion of the study.|0
9022182|NCT03124459|10085070|FG000|COMPLETED|Phase 2- Randomized Doubled-blind||0
9022183|NCT03124459|10085071|FG001|COMPLETED|Phase 2- Randomized Doubled-blind||0
8653930|NCT00659789|9696091|FG001|NOT COMPLETED|Overall Study||7
8653931|NCT00659802|9696100|FG000|STARTED|Overall Study||74
8653932|NCT00659802|9696101|FG001|STARTED|Overall Study|One patient was incorrectly randomized and was excluded from the efficacy analyses.|75
8653933|NCT00659802|9696102|FG002|STARTED|Overall Study||75
8653934|NCT00659802|9696100|FG000|COMPLETED|Overall Study||59
8653935|NCT00659802|9696101|FG001|COMPLETED|Overall Study||57
8653936|NCT00659802|9696102|FG002|COMPLETED|Overall Study||64
8653937|NCT00659802|9696100|FG000|NOT COMPLETED|Overall Study||15
8653938|NCT00659802|9696101|FG001|NOT COMPLETED|Overall Study||18
8653939|NCT00659802|9696102|FG002|NOT COMPLETED|Overall Study||11
8691919|NCT00857259|9737255|FG000|NOT COMPLETED|Overall Study||1
8691920|NCT00857259|9737256|FG001|NOT COMPLETED|Overall Study||0
8691921|NCT00857259|9737257|FG002|NOT COMPLETED|Overall Study||1
8691922|NCT00857272|9737269|FG000|STARTED|Overall Study|Includes 6 non-ITT patients that withdrew consent|154
8691923|NCT00857272|9737270|FG001|STARTED|Overall Study|Includes 7 non-ITT patients that withdrew consent|154
8691924|NCT00857272|9737269|FG000|COMPLETED|Overall Study||145
8691925|NCT00857272|9737270|FG001|COMPLETED|Overall Study||145
8691926|NCT00857272|9737269|FG000|NOT COMPLETED|Overall Study||9
8691927|NCT00857272|9737270|FG001|NOT COMPLETED|Overall Study||9
8691928|NCT00857311|9737280|FG000|STARTED|Overall Study||9
8691929|NCT00857311|9737281|FG001|STARTED|Overall Study||0
8691930|NCT00857311|9737282|FG002|STARTED|Overall Study||8
8691931|NCT00857311|9737283|FG003|STARTED|Overall Study||0
8691932|NCT00857311|9737280|FG000|COMPLETED|Overall Study||8
8691933|NCT00857311|9737281|FG001|COMPLETED|Overall Study||0
8691934|NCT00857311|9737282|FG002|COMPLETED|Overall Study||8
8691935|NCT00857311|9737283|FG003|COMPLETED|Overall Study||0
8691936|NCT00857311|9737280|FG000|NOT COMPLETED|Overall Study||1
8691937|NCT00857311|9737281|FG001|NOT COMPLETED|Overall Study||0
8691938|NCT00857311|9737282|FG002|NOT COMPLETED|Overall Study||0
8691939|NCT00857311|9737283|FG003|NOT COMPLETED|Overall Study||0
8691940|NCT00857389|9737289|FG000|STARTED|Overall Study||60
8691941|NCT00857389|9737289|FG000|COMPLETED|Overall Study||58
8691942|NCT00857389|9737289|FG000|NOT COMPLETED|Overall Study||2
8691943|NCT00857415|9737295|FG000|STARTED|Overall Study||152
8691944|NCT00857415|9737296|FG001|STARTED|Overall Study||74
8691945|NCT00857415|9737295|FG000|Deceased Within One Year of AV-45 Scan|Overall Study||37
8691946|NCT00857415|9737296|FG001|Deceased Within One Year of AV-45 Scan|Overall Study|Subjects in the specificity cohort were not followed to autopsy|0
8691947|NCT00857415|9737295|FG000|COMPLETED|Overall Study||35
8691948|NCT00857415|9737296|FG001|COMPLETED|Overall Study||74
8691949|NCT00857415|9737295|FG000|NOT COMPLETED|Overall Study||117
8691950|NCT00857415|9737296|FG001|NOT COMPLETED|Overall Study||0
8691951|NCT00857454|9737302|FG000|STARTED|Overall Study||71
8691952|NCT00857454|9737302|FG000|COMPLETED|Overall Study||51
8691953|NCT00857454|9737302|FG000|NOT COMPLETED|Overall Study||20
8691954|NCT00857493|9737308|FG000|STARTED|Overall Study||62
8691955|NCT00857493|9737309|FG001|STARTED|Overall Study||58
8691956|NCT00857493|9737308|FG000|COMPLETED|Overall Study||59
8691957|NCT00857493|9737309|FG001|COMPLETED|Overall Study||58
8691958|NCT00857493|9737308|FG000|NOT COMPLETED|Overall Study||3
8691959|NCT00857493|9737309|FG001|NOT COMPLETED|Overall Study||0
8691960|NCT00857506|9737318|FG000|STARTED|Overall Study||31
8691961|NCT00857506|9737319|FG001|STARTED|Overall Study||52
8653940|NCT00659815|9696112|FG000|STARTED|Overall Study||157
8653941|NCT00659815|9696113|FG001|STARTED|Overall Study||151
8653942|NCT00659815|9696112|FG000|COMPLETED|Overall Study||153
8653943|NCT00659815|9696113|FG001|COMPLETED|Overall Study||147
8653944|NCT00659815|9696112|FG000|NOT COMPLETED|Overall Study||4
8653945|NCT00659815|9696113|FG001|NOT COMPLETED|Overall Study||4
8653946|NCT00659828|9696119|FG000|STARTED|Overall Study||1
8653947|NCT00659828|9696119|FG000|COMPLETED|Overall Study||1
8653948|NCT00659828|9696119|FG000|NOT COMPLETED|Overall Study||0
8653949|NCT00659880|9696123|FG000|STARTED|Overall Study||9
8653950|NCT00659880|9696123|FG000|6 Weeks|Overall Study||9
8653951|NCT00659880|9696123|FG000|6 Months|Overall Study||9
8653952|NCT00659880|9696123|FG000|12 Months|Overall Study||7
8653953|NCT00659880|9696123|FG000|24 Months|Overall Study||6
8653954|NCT00659880|9696123|FG000|COMPLETED|Overall Study|60 months|4
8653955|NCT00659880|9696123|FG000|NOT COMPLETED|Overall Study||5
8653956|NCT00659945|9696130|FG000|STARTED|Overall Study||75
8653957|NCT00659945|9696131|FG001|STARTED|Overall Study||75
8653958|NCT00659945|9696130|FG000|COMPLETED|Overall Study||75
8653959|NCT00659945|9696131|FG001|COMPLETED|Overall Study||75
8653960|NCT00659945|9696130|FG000|NOT COMPLETED|Overall Study||0
8653961|NCT00659945|9696131|FG001|NOT COMPLETED|Overall Study||0
8653962|NCT00659984|9696137|FG000|STARTED|Overall Study||15
8653963|NCT00659984|9696137|FG000|COMPLETED|Overall Study||14
8653964|NCT00659984|9696137|FG000|NOT COMPLETED|Overall Study||1
8653965|NCT00660010|9696147|FG000|STARTED|Overall Study||55
8653966|NCT00660010|9696147|FG000|COMPLETED|Overall Study||46
8653967|NCT00660010|9696147|FG000|NOT COMPLETED|Overall Study||9
8653968|NCT00660023|9696151|FG000|STARTED|Overall Study||124
8653969|NCT00660023|9696151|FG000|Treated|Overall Study||114
8653970|NCT00660023|9696151|FG000|COMPLETED|Overall Study||95
8653971|NCT00660023|9696151|FG000|NOT COMPLETED|Overall Study||29
8653972|NCT00660049|9696155|FG000|STARTED|Overall Study||12
8653973|NCT00660049|9696155|FG000|COMPLETED|Overall Study||6
8653974|NCT00660049|9696155|FG000|NOT COMPLETED|Overall Study||6
8653975|NCT00660075|9696161|FG000|STARTED|First Intervention (Week 1 to Week 6)||18
8653976|NCT00660075|9696162|FG001|STARTED|First Intervention (Week 1 to Week 6)||18
8653977|NCT00660075|9696161|FG000|COMPLETED|First Intervention (Week 1 to Week 6)||18
8653978|NCT00660075|9696162|FG001|COMPLETED|First Intervention (Week 1 to Week 6)||18
8653979|NCT00660075|9696161|FG000|NOT COMPLETED|First Intervention (Week 1 to Week 6)||0
8653980|NCT00660075|9696162|FG001|NOT COMPLETED|First Intervention (Week 1 to Week 6)||0
8653981|NCT00660075|9696161|FG000|STARTED|Washout Period (Week 7 to Week 10)||18
8653982|NCT00660075|9696162|FG001|STARTED|Washout Period (Week 7 to Week 10)||18
8653983|NCT00660075|9696161|FG000|COMPLETED|Washout Period (Week 7 to Week 10)||18
8653984|NCT00660075|9696162|FG001|COMPLETED|Washout Period (Week 7 to Week 10)||18
8653985|NCT00660075|9696161|FG000|NOT COMPLETED|Washout Period (Week 7 to Week 10)||0
8653986|NCT00660075|9696162|FG001|NOT COMPLETED|Washout Period (Week 7 to Week 10)||0
8653987|NCT00660075|9696161|FG000|STARTED|Second Intervention (Week 11 to Week 16||18
8653988|NCT00660075|9696162|FG001|STARTED|Second Intervention (Week 11 to Week 16||18
8653989|NCT00660075|9696161|FG000|COMPLETED|Second Intervention (Week 11 to Week 16||18
8653990|NCT00660075|9696162|FG001|COMPLETED|Second Intervention (Week 11 to Week 16||18
8653991|NCT00660075|9696161|FG000|NOT COMPLETED|Second Intervention (Week 11 to Week 16||0
8653992|NCT00660075|9696162|FG001|NOT COMPLETED|Second Intervention (Week 11 to Week 16||0
8653993|NCT00660179|9696171|FG000|STARTED|Overall Study||250
8653994|NCT00660179|9696172|FG001|STARTED|Overall Study||250
8653995|NCT00660179|9696173|FG002|STARTED|Overall Study||242
8653996|NCT00660179|9696171|FG000|COMPLETED|Overall Study||194
8653997|NCT00660179|9696172|FG001|COMPLETED|Overall Study||192
8653998|NCT00660179|9696173|FG002|COMPLETED|Overall Study||201
8653999|NCT00660179|9696171|FG000|NOT COMPLETED|Overall Study||56
8654000|NCT00660179|9696172|FG001|NOT COMPLETED|Overall Study||58
8654001|NCT00660179|9696173|FG002|NOT COMPLETED|Overall Study||41
8654002|NCT00660192|9696183|FG000|STARTED|Overall Study||12
8654003|NCT00660192|9696184|FG001|STARTED|Overall Study||13
8654004|NCT00660192|9696183|FG000|COMPLETED|Overall Study||10
8654005|NCT00660192|9696184|FG001|COMPLETED|Overall Study||10
8654006|NCT00660192|9696183|FG000|NOT COMPLETED|Overall Study||2
8654007|NCT00660192|9696184|FG001|NOT COMPLETED|Overall Study||3
8654008|NCT00660309|9696192|FG000|STARTED|Overall Study|Represents participants who received one dose of Captopril.|23
8654009|NCT00660309|9696193|FG001|STARTED|Overall Study|Represents participants who received one dose of Captopril.|22
8654010|NCT00660309|9696192|FG000|Treated With Aliskiren or Irbesartan|Overall Study||22
8654011|NCT00660309|9696193|FG001|Treated With Aliskiren or Irbesartan|Overall Study||21
8654012|NCT00660309|9696192|FG000|Pharmacodynamic Analysis Set|Overall Study||22
8654013|NCT00660309|9696193|FG001|Pharmacodynamic Analysis Set|Overall Study||20
8654014|NCT00660309|9696192|FG000|COMPLETED|Overall Study||21
8654015|NCT00660309|9696193|FG001|COMPLETED|Overall Study||19
8654016|NCT00660309|9696192|FG000|NOT COMPLETED|Overall Study||2
8654017|NCT00660309|9696193|FG001|NOT COMPLETED|Overall Study||3
8654018|NCT00660387|9696202|FG000|STARTED|Overall Study||37
8654019|NCT00660387|9696203|FG001|STARTED|Overall Study||34
8654020|NCT00660387|9696202|FG000|COMPLETED|Overall Study||35
8654021|NCT00660387|9696203|FG001|COMPLETED|Overall Study||31
8654022|NCT00660387|9696202|FG000|NOT COMPLETED|Overall Study||2
8654023|NCT00660387|9696203|FG001|NOT COMPLETED|Overall Study||3
8654024|NCT00660400|9696209|FG000|STARTED|Overall Study||25
8654025|NCT00660400|9696209|FG000|COMPLETED|Overall Study||21
8654026|NCT00660400|9696209|FG000|NOT COMPLETED|Overall Study||4
8654027|NCT00660504|9696215|FG000|STARTED|Overall Study||149
8654028|NCT00660504|9696216|FG001|STARTED|Overall Study||151
8654029|NCT00660504|9696215|FG000|COMPLETED|Overall Study||149
8654030|NCT00660504|9696216|FG001|COMPLETED|Overall Study||150
8654031|NCT00660504|9696215|FG000|NOT COMPLETED|Overall Study||0
8654032|NCT00660504|9696216|FG001|NOT COMPLETED|Overall Study||1
8654033|NCT00660517|9696226|FG000|STARTED|Overall Study||153
8654034|NCT00660517|9696227|FG001|STARTED|Overall Study||152
8654035|NCT00660517|9696228|FG002|STARTED|Overall Study||151
8654036|NCT00660517|9696229|FG003|STARTED|Overall Study||151
8654037|NCT00660517|9696226|FG000|COMPLETED|Overall Study||145
8654038|NCT00660517|9696227|FG001|COMPLETED|Overall Study||144
8654039|NCT00660517|9696228|FG002|COMPLETED|Overall Study||144
8654040|NCT00660517|9696229|FG003|COMPLETED|Overall Study||144
8654041|NCT00660517|9696226|FG000|NOT COMPLETED|Overall Study||8
8654042|NCT00660517|9696227|FG001|NOT COMPLETED|Overall Study||8
8654043|NCT00660517|9696228|FG002|NOT COMPLETED|Overall Study||7
8654044|NCT00660517|9696229|FG003|NOT COMPLETED|Overall Study||7
8654045|NCT00660530|9696240|FG000|STARTED|Overall Study||11
8654046|NCT00660530|9696240|FG000|COMPLETED|Overall Study||11
8654047|NCT00660530|9696240|FG000|NOT COMPLETED|Overall Study||0
8654048|NCT00660543|9696246|FG000|STARTED|Overall Study||14
8654049|NCT00660543|9696246|FG000|COMPLETED|Overall Study||14
8654050|NCT00660543|9696246|FG000|NOT COMPLETED|Overall Study||0
8654051|NCT00660660|9696257|FG000|STARTED|Overall Study|Randomized|143
8654052|NCT00660660|9696258|FG001|STARTED|Overall Study|Randomized|133
8654053|NCT00660660|9696257|FG000|Met Criteria for MITT Population|Overall Study||137
8654054|NCT00660660|9696258|FG001|Met Criteria for MITT Population|Overall Study||125
8654055|NCT00660660|9696257|FG000|COMPLETED|Overall Study|Number of completed patients is based on randomized population (143) minus withdrawals (5).|138
8654056|NCT00660660|9696258|FG001|COMPLETED|Overall Study|Number of completed patients is based on randomized population (133) minus withdrawals (9).|124
8654057|NCT00660660|9696257|FG000|NOT COMPLETED|Overall Study||5
8654058|NCT00660660|9696258|FG001|NOT COMPLETED|Overall Study||9
8654059|NCT00660699|9696264|FG000|STARTED|Overall Study||50
8654060|NCT00660699|9696264|FG000|COMPLETED|Overall Study||48
8654061|NCT00660699|9696264|FG000|NOT COMPLETED|Overall Study||2
8654062|NCT00660790|9696268|FG000|STARTED|Baseline to 3 Months||97
8654063|NCT00660790|9696268|FG000|COMPLETED|Baseline to 3 Months||94
8654064|NCT00660790|9696268|FG000|NOT COMPLETED|Baseline to 3 Months||3
8654065|NCT00660790|9696268|FG000|STARTED|3 Months to 2 Years||94
8654066|NCT00660790|9696268|FG000|COMPLETED|3 Months to 2 Years||77
8654067|NCT00660790|9696268|FG000|NOT COMPLETED|3 Months to 2 Years||17
8654068|NCT00660816|9696274|FG000|STARTED|Overall Study||24
8654069|NCT00660816|9696275|FG001|STARTED|Overall Study||22
8654070|NCT00660816|9696274|FG000|COMPLETED|Overall Study||4
8654071|NCT00660816|9696275|FG001|COMPLETED|Overall Study||3
8654072|NCT00660816|9696274|FG000|NOT COMPLETED|Overall Study||20
8654073|NCT00660816|9696275|FG001|NOT COMPLETED|Overall Study||19
8654074|NCT00660829|9696283|FG000|STARTED|Overall Study|2 subjects were randomized in error|268
8654075|NCT00660829|9696284|FG001|STARTED|Overall Study|2 subjects were randomized in error|268
8654076|NCT00660829|9696283|FG000|COMPLETED|Overall Study||250
8654077|NCT00660829|9696284|FG001|COMPLETED|Overall Study||249
8728848|NCT01049412|9775808|FG000|Took at Least One Dose of Study Drug|Period I||69
8728849|NCT01049412|9775809|FG001|Took at Least One Dose of Study Drug|Period I||68
8728850|NCT01049412|9775808|FG000|COMPLETED|Period I||62
8728851|NCT01049412|9775809|FG001|COMPLETED|Period I||55
8728852|NCT01049412|9775808|FG000|NOT COMPLETED|Period I||8
8728853|NCT01049412|9775809|FG001|NOT COMPLETED|Period I||13
8728854|NCT01049412|9775808|FG000|STARTED|Period II||62
8728855|NCT01049412|9775809|FG001|STARTED|Period II||55
8728856|NCT01049412|9775808|FG000|COMPLETED|Period II||58
8728857|NCT01049412|9775809|FG001|COMPLETED|Period II||52
8728858|NCT01049412|9775808|FG000|NOT COMPLETED|Period II||4
8728859|NCT01049412|9775809|FG001|NOT COMPLETED|Period II||3
8728860|NCT01049503|9775823|FG000|STARTED|Overall Study||52
8728861|NCT01049503|9775824|FG001|STARTED|Overall Study||48
8728862|NCT01049503|9775825|FG002|STARTED|Overall Study||56
8728863|NCT01049503|9775826|FG003|STARTED|Overall Study||55
8728864|NCT01049503|9775827|FG004|STARTED|Overall Study||56
8728865|NCT01049503|9775828|FG005|STARTED|Overall Study||48
8728866|NCT01049503|9775823|FG000|COMPLETED|Overall Study||41
8728867|NCT01049503|9775824|FG001|COMPLETED|Overall Study||36
8728868|NCT01049503|9775825|FG002|COMPLETED|Overall Study||32
8728869|NCT01049503|9775826|FG003|COMPLETED|Overall Study||29
8728870|NCT01049503|9775827|FG004|COMPLETED|Overall Study||29
8728871|NCT01049503|9775828|FG005|COMPLETED|Overall Study||40
8728872|NCT01049503|9775823|FG000|NOT COMPLETED|Overall Study||11
8728873|NCT01049503|9775824|FG001|NOT COMPLETED|Overall Study||12
8728874|NCT01049503|9775825|FG002|NOT COMPLETED|Overall Study||24
8728875|NCT01049503|9775826|FG003|NOT COMPLETED|Overall Study||26
8728876|NCT01049503|9775827|FG004|NOT COMPLETED|Overall Study||27
8728877|NCT01049503|9775828|FG005|NOT COMPLETED|Overall Study||8
8728878|NCT01049581|9775853|FG000|STARTED|Overall Study||13
8654078|NCT00660829|9696283|FG000|NOT COMPLETED|Overall Study||18
8654079|NCT00660829|9696284|FG001|NOT COMPLETED|Overall Study||19
8654080|NCT00660907|9696292|FG000|STARTED|Overall Study|Of the 406 randomized participants only 400 were included in the full analysis set.|406
8654081|NCT00660907|9696293|FG001|STARTED|Overall Study|Of the 408 randomized participants only 401 were included in the full analysis set.|408
8728879|NCT01049581|9775854|FG001|STARTED|Overall Study||14
8654082|NCT00660907|9696292|FG000|COMPLETED|Overall Study||322
8654083|NCT00660907|9696293|FG001|COMPLETED|Overall Study||314
8654084|NCT00660907|9696292|FG000|NOT COMPLETED|Overall Study||84
8654085|NCT00660907|9696293|FG001|NOT COMPLETED|Overall Study||94
8654086|NCT00660985|9696301|FG000|STARTED|Overall Study||26
8654087|NCT00660985|9696302|FG001|STARTED|Overall Study||25
8654088|NCT00660985|9696301|FG000|COMPLETED|Overall Study||25
8654089|NCT00660985|9696302|FG001|COMPLETED|Overall Study||25
8654090|NCT00660985|9696301|FG000|NOT COMPLETED|Overall Study||1
8654091|NCT00660985|9696302|FG001|NOT COMPLETED|Overall Study||0
8654092|NCT00661037|9696310|FG000|STARTED|Overall Study||836
8654093|NCT00661037|9696311|FG001|STARTED|Overall Study||1284
8654094|NCT00661037|9696310|FG000|Witdrawn|Overall Study||47
8654095|NCT00661037|9696311|FG001|Witdrawn|Overall Study||68
8654096|NCT00661037|9696310|FG000|Deaths|Overall Study||108
8654097|NCT00661037|9696311|FG001|Deaths|Overall Study||188
8654098|NCT00661037|9696310|FG000|COMPLETED|Overall Study||682
8654099|NCT00661037|9696311|FG001|COMPLETED|Overall Study||1027
8654100|NCT00661037|9696310|FG000|NOT COMPLETED|Overall Study||154
8654101|NCT00661037|9696311|FG001|NOT COMPLETED|Overall Study||257
8654102|NCT00661089|9696321|FG000|STARTED|Overall Study||10
8654103|NCT00661089|9696322|FG001|STARTED|Overall Study||11
8654104|NCT00661089|9696321|FG000|COMPLETED|Overall Study||10
8654105|NCT00661089|9696322|FG001|COMPLETED|Overall Study||9
8654106|NCT00661089|9696321|FG000|NOT COMPLETED|Overall Study||0
8654107|NCT00661089|9696322|FG001|NOT COMPLETED|Overall Study||2
8654108|NCT00661141|9696332|FG000|STARTED|Overall Study||8
8654109|NCT00661141|9696333|FG001|STARTED|Overall Study||8
8654110|NCT00661141|9696334|FG002|STARTED|Overall Study||4
8654111|NCT00661141|9696335|FG003|STARTED|Overall Study||4
8654112|NCT00661141|9696336|FG004|STARTED|Overall Study||4
8654113|NCT00661141|9696337|FG005|STARTED|Overall Study||4
8654114|NCT00661141|9696332|FG000|Administered 30 Minutes Prior to Ethanol|Overall Study||6
8654115|NCT00661141|9696333|FG001|Administered 30 Minutes Prior to Ethanol|Overall Study||6
8654116|NCT00661141|9696334|FG002|Administered 30 Minutes Prior to Ethanol|Overall Study||2
8654117|NCT00661141|9696335|FG003|Administered 30 Minutes Prior to Ethanol|Overall Study||2
8654118|NCT00661141|9696336|FG004|Administered 30 Minutes Prior to Ethanol|Overall Study||4
8654119|NCT00661141|9696337|FG005|Administered 30 Minutes Prior to Ethanol|Overall Study||4
8654120|NCT00661141|9696332|FG000|Administered 30 Minutes After Ethanol|Overall Study||2
8654121|NCT00661141|9696333|FG001|Administered 30 Minutes After Ethanol|Overall Study||2
8654122|NCT00661141|9696334|FG002|Administered 30 Minutes After Ethanol|Overall Study||2
8654123|NCT00661141|9696335|FG003|Administered 30 Minutes After Ethanol|Overall Study||2
8654124|NCT00661141|9696336|FG004|Administered 30 Minutes After Ethanol|Overall Study||0
8654125|NCT00661141|9696337|FG005|Administered 30 Minutes After Ethanol|Overall Study||0
8654126|NCT00661141|9696332|FG000|COMPLETED|Overall Study||8
8654127|NCT00661141|9696333|FG001|COMPLETED|Overall Study||8
8654128|NCT00661141|9696334|FG002|COMPLETED|Overall Study||4
8654129|NCT00661141|9696335|FG003|COMPLETED|Overall Study||4
8654130|NCT00661141|9696336|FG004|COMPLETED|Overall Study||4
8654131|NCT00661141|9696337|FG005|COMPLETED|Overall Study||4
8654132|NCT00661141|9696332|FG000|NOT COMPLETED|Overall Study||0
8654133|NCT00661141|9696333|FG001|NOT COMPLETED|Overall Study||0
8654134|NCT00661141|9696334|FG002|NOT COMPLETED|Overall Study||0
8654135|NCT00661141|9696335|FG003|NOT COMPLETED|Overall Study||0
8654136|NCT00661141|9696336|FG004|NOT COMPLETED|Overall Study||0
8654137|NCT00661141|9696337|FG005|NOT COMPLETED|Overall Study||0
8654138|NCT00661193|9696358|FG000|STARTED|Overall Study||33
8654139|NCT00661193|9696359|FG001|STARTED|Overall Study||26
8728880|NCT01049581|9775853|FG000|COMPLETED|Overall Study||11
8728881|NCT01049581|9775854|FG001|COMPLETED|Overall Study||13
8728882|NCT01049581|9775853|FG000|NOT COMPLETED|Overall Study||2
8728883|NCT01049581|9775854|FG001|NOT COMPLETED|Overall Study||1
8728884|NCT01049776|9775863|FG000|STARTED|Overall Study||32
8728885|NCT01049776|9775863|FG000|COMPLETED|Overall Study||12
8728886|NCT01049776|9775863|FG000|NOT COMPLETED|Overall Study||20
8728887|NCT01049802|9775869|FG000|STARTED|Overall Study||20
8728888|NCT01049802|9775870|FG001|STARTED|Overall Study||10
8728889|NCT01049802|9775869|FG000|COMPLETED|Overall Study||20
8728890|NCT01049802|9775870|FG001|COMPLETED|Overall Study||10
8728891|NCT01049802|9775869|FG000|NOT COMPLETED|Overall Study||0
8728892|NCT01049802|9775870|FG001|NOT COMPLETED|Overall Study||0
8728893|NCT01049919|9775878|FG000|STARTED|Overall Study||117
8728894|NCT01049919|9775879|FG001|STARTED|Overall Study|One participant is counted in both treatment groups due to one leg being randomized to each group.|36
8728895|NCT01049919|9775878|FG000|COMPLETED|Overall Study||65
8728896|NCT01049919|9775879|FG001|COMPLETED|Overall Study|Incl. 11 participants that received crossover treatment after completing 52 week primary follow up.|19
8728897|NCT01049919|9775878|FG000|NOT COMPLETED|Overall Study||52
8728898|NCT01049919|9775879|FG001|NOT COMPLETED|Overall Study||17
8728899|NCT01049945|9775887|FG000|STARTED|Overall Study||3
8654140|NCT00661193|9696358|FG000|COMPLETED|Overall Study||0
8654141|NCT00661193|9696359|FG001|COMPLETED|Overall Study||0
8654142|NCT00661193|9696358|FG000|NOT COMPLETED|Overall Study||33
8654143|NCT00661193|9696359|FG001|NOT COMPLETED|Overall Study||26
8654144|NCT00661258|9696367|FG000|STARTED|Overall Study||34
8654145|NCT00661258|9696368|FG001|STARTED|Overall Study||34
8654146|NCT00661258|9696367|FG000|COMPLETED|Overall Study||31
8654147|NCT00661258|9696368|FG001|COMPLETED|Overall Study||33
8728900|NCT01049945|9775888|FG001|STARTED|Overall Study||6
8654148|NCT00661258|9696367|FG000|NOT COMPLETED|Overall Study||3
8654149|NCT00661258|9696368|FG001|NOT COMPLETED|Overall Study||1
8654150|NCT00661271|9696376|FG000|STARTED|Overall Study||48
8654151|NCT00661271|9696377|FG001|STARTED|Overall Study||45
8654152|NCT00661271|9696376|FG000|COMPLETED|Overall Study||20
8654153|NCT00661271|9696377|FG001|COMPLETED|Overall Study||20
8654154|NCT00661271|9696376|FG000|NOT COMPLETED|Overall Study||28
8654155|NCT00661271|9696377|FG001|NOT COMPLETED|Overall Study||25
8654156|NCT00661362|9696385|FG000|STARTED|Overall Study|Randomized and treated|283
8654157|NCT00661362|9696386|FG001|STARTED|Overall Study|Randomized and treated|287
8654158|NCT00661362|9696385|FG000|COMPLETED|Overall Study|Completed 24 Weeks of treatment|254
8654159|NCT00661362|9696386|FG001|COMPLETED|Overall Study|Completed 24 Weeks of treatment|247
8654160|NCT00661362|9696385|FG000|NOT COMPLETED|Overall Study||29
8654161|NCT00661362|9696386|FG001|NOT COMPLETED|Overall Study||40
8654162|NCT00661388|9696392|FG000|STARTED|Overall Study||75
8654163|NCT00661388|9696392|FG000|COMPLETED|Overall Study||51
8654164|NCT00661388|9696392|FG000|NOT COMPLETED|Overall Study||24
8654165|NCT00661427|9696398|FG000|STARTED|Overall Study||35
8654166|NCT00661427|9696399|FG001|STARTED|Overall Study||26
8654167|NCT00661427|9696398|FG000|COMPLETED|Overall Study||30
8654168|NCT00661427|9696399|FG001|COMPLETED|Overall Study||19
8654169|NCT00661427|9696398|FG000|NOT COMPLETED|Overall Study||5
8654170|NCT00661427|9696399|FG001|NOT COMPLETED|Overall Study||7
8654171|NCT00661453|9696405|FG000|STARTED|Overall Study||38
8654172|NCT00661453|9696405|FG000|COMPLETED|Overall Study||25
8654173|NCT00661453|9696405|FG000|NOT COMPLETED|Overall Study||13
8654174|NCT00661479|9696413|FG000|STARTED|Overall Study||12
8654175|NCT00661479|9696414|FG001|STARTED|Overall Study||3
8654176|NCT00661479|9696415|FG002|STARTED|Overall Study||3
8654177|NCT00661479|9696416|FG003|STARTED|Overall Study||3
8654178|NCT00661479|9696413|FG000|COMPLETED|Overall Study||12
8654179|NCT00661479|9696414|FG001|COMPLETED|Overall Study||3
8654180|NCT00661479|9696415|FG002|COMPLETED|Overall Study||3
8654181|NCT00661479|9696416|FG003|COMPLETED|Overall Study||3
8654182|NCT00661479|9696413|FG000|NOT COMPLETED|Overall Study||0
8654183|NCT00661479|9696414|FG001|NOT COMPLETED|Overall Study||0
8654184|NCT00661479|9696415|FG002|NOT COMPLETED|Overall Study||0
8654185|NCT00661479|9696416|FG003|NOT COMPLETED|Overall Study||0
8654186|NCT00661492|9696427|FG000|STARTED|Overall Study||75
8654187|NCT00661492|9696428|FG001|STARTED|Overall Study||40
8654188|NCT00661492|9696427|FG000|COMPLETED|Overall Study||7
8654189|NCT00661492|9696428|FG001|COMPLETED|Overall Study||11
8654190|NCT00661492|9696427|FG000|NOT COMPLETED|Overall Study||68
8654191|NCT00661492|9696428|FG001|NOT COMPLETED|Overall Study||29
8654192|NCT00661505|9696434|FG000|STARTED|Overall Study||132
8654193|NCT00661505|9696434|FG000|COMPLETED|Overall Study||102
8654194|NCT00661505|9696434|FG000|NOT COMPLETED|Overall Study||30
8654195|NCT00661531|9696439|FG000|STARTED|Overall Study||11
8654196|NCT00661531|9696439|FG000|COMPLETED|Overall Study||8
8654197|NCT00661531|9696439|FG000|NOT COMPLETED|Overall Study||3
8654198|NCT00661544|9696443|FG000|STARTED|Overall Study||48
8654199|NCT00661544|9696443|FG000|COMPLETED|Overall Study||48
8654200|NCT00661544|9696443|FG000|NOT COMPLETED|Overall Study||0
8654201|NCT00661557|9696449|FG000|STARTED|Overall Study||192
8654202|NCT00661557|9696450|FG001|STARTED|Overall Study||79
8654203|NCT00661557|9696449|FG000|COMPLETED|Overall Study||183
8654204|NCT00661557|9696450|FG001|COMPLETED|Overall Study||79
8654205|NCT00661557|9696449|FG000|NOT COMPLETED|Overall Study||9
8654206|NCT00661557|9696450|FG001|NOT COMPLETED|Overall Study||0
8654207|NCT00661570|9696456|FG000|STARTED|Overall Study||26
8654208|NCT00661570|9696456|FG000|COMPLETED|Overall Study||26
8654209|NCT00661570|9696456|FG000|NOT COMPLETED|Overall Study||0
8654210|NCT00661583|9696463|FG000|STARTED|Overall Study||10
8654211|NCT00661583|9696464|FG001|STARTED|Overall Study||10
8654212|NCT00661583|9696465|FG002|STARTED|Overall Study||10
8654213|NCT00661583|9696463|FG000|COMPLETED|Overall Study||10
8654214|NCT00661583|9696464|FG001|COMPLETED|Overall Study||10
8654215|NCT00661583|9696465|FG002|COMPLETED|Overall Study||10
8654216|NCT00661583|9696463|FG000|NOT COMPLETED|Overall Study||0
8654217|NCT00661583|9696464|FG001|NOT COMPLETED|Overall Study||0
8654218|NCT00661583|9696465|FG002|NOT COMPLETED|Overall Study||0
8654219|NCT00661609|9696473|FG000|STARTED|Overall Study|All dosed patients|41
8654220|NCT00661609|9696473|FG000|COMPLETED|Overall Study|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
8654221|NCT00661609|9696473|FG000|NOT COMPLETED|Overall Study||41
8654222|NCT00661622|9696479|FG000|STARTED|Overall Study||26
8654223|NCT00661622|9696480|FG001|STARTED|Overall Study||27
8654224|NCT00661622|9696479|FG000|COMPLETED|Overall Study||25
8654225|NCT00661622|9696480|FG001|COMPLETED|Overall Study||27
8654226|NCT00661622|9696479|FG000|NOT COMPLETED|Overall Study||1
8654227|NCT00661622|9696480|FG001|NOT COMPLETED|Overall Study||0
8654228|NCT00661661|9696489|FG000|STARTED|Overall Study||382
8654229|NCT00661661|9696490|FG001|STARTED|Overall Study||105
8654230|NCT00661661|9696489|FG000|COMPLETED|Overall Study||242
8654231|NCT00661661|9696490|FG001|COMPLETED|Overall Study||66
8654232|NCT00661661|9696489|FG000|NOT COMPLETED|Overall Study||140
8654233|NCT00661661|9696490|FG001|NOT COMPLETED|Overall Study||39
8654234|NCT00661674|9696498|FG000|STARTED|Overall Study|Participants 1 & 10 were assigned to sequence 1|2
8654235|NCT00661674|9696499|FG001|STARTED|Overall Study|Participants 2 & 3 were assigned to sequence 2|2
8654236|NCT00661674|9696500|FG002|STARTED|Overall Study|Participants 4 & 7 were assigned to sequence 3|2
8654237|NCT00661674|9696501|FG003|STARTED|Overall Study|Participant 5 was assigned to sequence 4|1
8654238|NCT00661674|9696502|FG004|STARTED|Overall Study|Participants 6 & 8 were assigned to sequence 5|2
8654239|NCT00661674|9696503|FG005|STARTED|Overall Study|Participant 9 was assigned to sequence 6|1
8654240|NCT00661674|9696498|FG000|COMPLETED|Overall Study|Participants 1 & 10 completed sequence 1|2
8654241|NCT00661674|9696499|FG001|COMPLETED|Overall Study|Participants 2 & 3 completed sequence 2|2
8654242|NCT00661674|9696500|FG002|COMPLETED|Overall Study|Participants 4 & 7 completed sequence 3|2
8654243|NCT00661674|9696501|FG003|COMPLETED|Overall Study|Participant 5 completed sequence 4|1
8654244|NCT00661674|9696502|FG004|COMPLETED|Overall Study|Participants 6 & 8 completed sequence 5|2
8654245|NCT00661674|9696503|FG005|COMPLETED|Overall Study|Participant 9 completed sequence 6|1
8654246|NCT00661674|9696498|FG000|NOT COMPLETED|Overall Study||0
8654247|NCT00661674|9696499|FG001|NOT COMPLETED|Overall Study||0
8654248|NCT00661674|9696500|FG002|NOT COMPLETED|Overall Study||0
8654249|NCT00661674|9696501|FG003|NOT COMPLETED|Overall Study||0
8654250|NCT00661674|9696502|FG004|NOT COMPLETED|Overall Study||0
8654251|NCT00661674|9696503|FG005|NOT COMPLETED|Overall Study||0
8654252|NCT00661687|9696511|FG000|STARTED|Overall Study|Contralateral study design, numbers indicate number of subjects.|204
8654253|NCT00661687|9696511|FG000|COMPLETED|Overall Study|Number indicates number of subjects successfully completing study.|189
8654254|NCT00661687|9696511|FG000|NOT COMPLETED|Overall Study||15
8654255|NCT00661713|9696525|FG000|STARTED|Overall Study||128
8654256|NCT00661713|9696526|FG001|STARTED|Overall Study||247
8654257|NCT00661713|9696527|FG002|STARTED|Overall Study||128
8654258|NCT00661713|9696528|FG003|STARTED|Overall Study||247
8654259|NCT00661713|9696529|FG004|STARTED|Overall Study||127
8654260|NCT00661713|9696530|FG005|STARTED|Overall Study||253
8654261|NCT00661713|9696531|FG006|STARTED|Overall Study||373
8654262|NCT00661713|9696532|FG007|STARTED|Overall Study||128
8654263|NCT00661713|9696525|FG000|COMPLETED|Overall Study||112
8654264|NCT00661713|9696526|FG001|COMPLETED|Overall Study||208
8654265|NCT00661713|9696527|FG002|COMPLETED|Overall Study||111
8654266|NCT00661713|9696528|FG003|COMPLETED|Overall Study||219
8654267|NCT00661713|9696529|FG004|COMPLETED|Overall Study||107
8654268|NCT00661713|9696530|FG005|COMPLETED|Overall Study||216
8654269|NCT00661713|9696531|FG006|COMPLETED|Overall Study||309
8654270|NCT00661713|9696532|FG007|COMPLETED|Overall Study||117
8654271|NCT00661713|9696525|FG000|NOT COMPLETED|Overall Study||16
8654272|NCT00661713|9696526|FG001|NOT COMPLETED|Overall Study||39
8654273|NCT00661713|9696527|FG002|NOT COMPLETED|Overall Study||17
8654274|NCT00661713|9696528|FG003|NOT COMPLETED|Overall Study||28
8654275|NCT00661713|9696529|FG004|NOT COMPLETED|Overall Study||20
8654276|NCT00661713|9696530|FG005|NOT COMPLETED|Overall Study||37
8654277|NCT00661713|9696531|FG006|NOT COMPLETED|Overall Study||64
8654278|NCT00661713|9696532|FG007|NOT COMPLETED|Overall Study||11
8654279|NCT00661726|9696552|FG000|STARTED|Overall Study||6
8654280|NCT00661726|9696552|FG000|COMPLETED|Overall Study||5
8654281|NCT00661726|9696552|FG000|NOT COMPLETED|Overall Study||1
8654282|NCT00661778|9696556|FG000|STARTED|Overall Study||50
8654283|NCT00661778|9696556|FG000|COMPLETED|Overall Study||0
8654284|NCT00661778|9696556|FG000|NOT COMPLETED|Overall Study||50
8654285|NCT00661830|9696562|FG000|STARTED|Overall Study||49
8654286|NCT00661830|9696563|FG001|STARTED|Overall Study||48
8654287|NCT00661830|9696562|FG000|COMPLETED|Overall Study||9
8654288|NCT00661830|9696563|FG001|COMPLETED|Overall Study||6
8654289|NCT00661830|9696562|FG000|NOT COMPLETED|Overall Study||40
8654290|NCT00661830|9696563|FG001|NOT COMPLETED|Overall Study||42
8654291|NCT00661895|9696571|FG000|STARTED|Overall Study||49
8654292|NCT00661895|9696572|FG001|STARTED|Overall Study||50
8654293|NCT00661895|9696571|FG000|COMPLETED|Overall Study||49
8654294|NCT00661895|9696572|FG001|COMPLETED|Overall Study||50
8654295|NCT00661895|9696571|FG000|NOT COMPLETED|Overall Study||0
8654296|NCT00661895|9696572|FG001|NOT COMPLETED|Overall Study||0
8654297|NCT00661960|9696581|FG000|STARTED|Overall Study||5
8654298|NCT00661960|9696582|FG001|STARTED|Overall Study||10
8654299|NCT00661960|9696583|FG002|STARTED|Overall Study||10
8654300|NCT00661960|9696581|FG000|COMPLETED|Overall Study||5
8654301|NCT00661960|9696582|FG001|COMPLETED|Overall Study||7
8654302|NCT00661960|9696583|FG002|COMPLETED|Overall Study||9
8654303|NCT00661960|9696581|FG000|NOT COMPLETED|Overall Study||0
8654304|NCT00661960|9696582|FG001|NOT COMPLETED|Overall Study||3
8654305|NCT00661960|9696583|FG002|NOT COMPLETED|Overall Study||1
8654306|NCT00661999|9696594|FG000|STARTED|Overall Study||164
8654307|NCT00661999|9696595|FG001|STARTED|Overall Study||163
8654308|NCT00661999|9696596|FG002|STARTED|Overall Study||163
8654309|NCT00661999|9696594|FG000|COMPLETED|Overall Study||105
8654310|NCT00661999|9696595|FG001|COMPLETED|Overall Study||113
8654311|NCT00661999|9696596|FG002|COMPLETED|Overall Study||106
8654312|NCT00661999|9696594|FG000|NOT COMPLETED|Overall Study||59
8654313|NCT00661999|9696595|FG001|NOT COMPLETED|Overall Study||50
8654314|NCT00661999|9696596|FG002|NOT COMPLETED|Overall Study||57
8654315|NCT00662012|9696604|FG000|STARTED|Overall Study||414
8654316|NCT00662012|9696604|FG000|COMPLETED|Overall Study||327
8654317|NCT00662012|9696604|FG000|NOT COMPLETED|Overall Study||87
8654318|NCT00662025|9696608|FG000|STARTED|Overall Study|All 63 participants were included in Full Analysis Set population.|63
8654319|NCT00662025|9696608|FG000|COMPLETED|Overall Study||0
8654320|NCT00662025|9696608|FG000|NOT COMPLETED|Overall Study||63
8654321|NCT00662038|9696612|FG000|STARTED|Overall Study||1058
8654322|NCT00662038|9696612|FG000|COMPLETED|Overall Study||427
8654323|NCT00662038|9696612|FG000|NOT COMPLETED|Overall Study||631
8654324|NCT00662129|9696616|FG000|STARTED|Overall Study||50
8654325|NCT00662129|9696616|FG000|COMPLETED|Overall Study||47
8654326|NCT00662129|9696616|FG000|NOT COMPLETED|Overall Study||3
8654327|NCT00662155|9696624|FG000|STARTED|Overall Study||16
8654328|NCT00662155|9696625|FG001|STARTED|Overall Study||20
8654329|NCT00662155|9696626|FG002|STARTED|Overall Study||20
8654330|NCT00662155|9696627|FG003|STARTED|Overall Study||18
8654331|NCT00662155|9696624|FG000|COMPLETED|Overall Study||13
8654332|NCT00662155|9696625|FG001|COMPLETED|Overall Study||15
8654333|NCT00662155|9696626|FG002|COMPLETED|Overall Study||13
8654334|NCT00662155|9696627|FG003|COMPLETED|Overall Study||14
8654335|NCT00662155|9696624|FG000|NOT COMPLETED|Overall Study||3
8654336|NCT00662155|9696625|FG001|NOT COMPLETED|Overall Study||5
8654337|NCT00662155|9696626|FG002|NOT COMPLETED|Overall Study||7
8654338|NCT00662155|9696627|FG003|NOT COMPLETED|Overall Study||4
8654339|NCT00662207|9696637|FG000|STARTED|Overall Study||3
8654340|NCT00662207|9696637|FG000|COMPLETED|Overall Study||3
8654341|NCT00662207|9696637|FG000|NOT COMPLETED|Overall Study||0
8654342|NCT00662259|9696643|FG000|STARTED|Overall Study||21
8654343|NCT00662259|9696644|FG001|STARTED|Overall Study||11
8654344|NCT00662259|9696643|FG000|COMPLETED|Overall Study||19
8654345|NCT00662259|9696644|FG001|COMPLETED|Overall Study||11
8654346|NCT00662259|9696643|FG000|NOT COMPLETED|Overall Study||2
8654347|NCT00662259|9696644|FG001|NOT COMPLETED|Overall Study||0
8654348|NCT00662298|9696650|FG000|STARTED|Overall Study||5
8654349|NCT00662298|9696650|FG000|COMPLETED|Overall Study||5
8654350|NCT00662298|9696650|FG000|NOT COMPLETED|Overall Study||0
8654351|NCT00662311|9696657|FG000|STARTED|Overall Study||5
8654352|NCT00662311|9696658|FG001|STARTED|Overall Study||0
8654353|NCT00662311|9696659|FG002|STARTED|Overall Study||0
8654354|NCT00662311|9696657|FG000|COMPLETED|Overall Study||4
8654355|NCT00662311|9696658|FG001|COMPLETED|Overall Study||0
8654356|NCT00662311|9696659|FG002|COMPLETED|Overall Study||0
8654357|NCT00662311|9696657|FG000|NOT COMPLETED|Overall Study||1
8654358|NCT00662311|9696658|FG001|NOT COMPLETED|Overall Study||0
8654359|NCT00662311|9696659|FG002|NOT COMPLETED|Overall Study||0
8654360|NCT00662363|9696669|FG000|STARTED|Overall Study||32
8654361|NCT00662363|9696670|FG001|STARTED|Overall Study||32
8654362|NCT00662363|9696669|FG000|COMPLETED|Overall Study|1 subject withdrew before taking any study medication|21
8654363|NCT00662363|9696670|FG001|COMPLETED|Overall Study|one subject died before receiving any study med 2 subjects withdrew before taking any study med|22
8654364|NCT00662363|9696669|FG000|NOT COMPLETED|Overall Study||11
8654365|NCT00662363|9696670|FG001|NOT COMPLETED|Overall Study||10
8654366|NCT00662532|9696680|FG000|STARTED|Overall Study||22
8654367|NCT00662532|9696681|FG001|STARTED|Overall Study||22
8654368|NCT00662532|9696680|FG000|COMPLETED|Overall Study||22
8654369|NCT00662532|9696681|FG001|COMPLETED|Overall Study||20
8654370|NCT00662532|9696680|FG000|NOT COMPLETED|Overall Study||0
8654371|NCT00662532|9696681|FG001|NOT COMPLETED|Overall Study||2
8654372|NCT00662545|9696689|FG000|STARTED|Overall Study||5
8654373|NCT00662545|9696690|FG001|STARTED|Overall Study||5
8654374|NCT00662545|9696689|FG000|COMPLETED|Overall Study||5
8654375|NCT00662545|9696690|FG001|COMPLETED|Overall Study||5
8654376|NCT00662545|9696689|FG000|NOT COMPLETED|Overall Study||0
8654377|NCT00662545|9696690|FG001|NOT COMPLETED|Overall Study||0
8654378|NCT00662558|9696698|FG000|STARTED|Overall Study||398
8654379|NCT00662558|9696699|FG001|STARTED|Overall Study||404
8654380|NCT00662558|9696698|FG000|Received Treatment|Overall Study||396
8654381|NCT00662558|9696699|FG001|Received Treatment|Overall Study||396
8654382|NCT00662558|9696698|FG000|COMPLETED|Overall Study||342
8654383|NCT00662558|9696699|FG001|COMPLETED|Overall Study||294
8654384|NCT00662558|9696698|FG000|NOT COMPLETED|Overall Study||56
8654385|NCT00662558|9696699|FG001|NOT COMPLETED|Overall Study||110
8654386|NCT00662649|9696709|FG000|STARTED|Core Study (24 Months)||429
8654387|NCT00662649|9696710|FG001|STARTED|Core Study (24 Months)||425
8654388|NCT00662649|9696711|FG002|STARTED|Core Study (24 Months)||418
8654389|NCT00662649|9696712|FG003|STARTED|Core Study (24 Months)|This reporting group is used only in extension study.|0
8654390|NCT00662649|9696713|FG004|STARTED|Core Study (24 Months)|This reporting group is used only in extension study.|0
8654391|NCT00662649|9696709|FG000|Intent to Treat (ITT)|Core Study (24 Months)||429
8654392|NCT00662649|9696710|FG001|Intent to Treat (ITT)|Core Study (24 Months)||425
8654393|NCT00662649|9696711|FG002|Intent to Treat (ITT)|Core Study (24 Months)||418
8654394|NCT00662649|9696712|FG003|Intent to Treat (ITT)|Core Study (24 Months)||0
8654395|NCT00662649|9696713|FG004|Intent to Treat (ITT)|Core Study (24 Months)||0
8654396|NCT00662649|9696709|FG000|COMPLETED|Core Study (24 Months)||332
8654397|NCT00662649|9696710|FG001|COMPLETED|Core Study (24 Months)||369
8654398|NCT00662649|9696711|FG002|COMPLETED|Core Study (24 Months)||332
8654399|NCT00662649|9696712|FG003|COMPLETED|Core Study (24 Months)||0
8728901|NCT01049945|9775889|FG002|STARTED|Overall Study||3
8654400|NCT00662649|9696713|FG004|COMPLETED|Core Study (24 Months)||0
8654401|NCT00662649|9696709|FG000|NOT COMPLETED|Core Study (24 Months)||97
8654402|NCT00662649|9696710|FG001|NOT COMPLETED|Core Study (24 Months)||56
8728902|NCT01049945|9775890|FG003|STARTED|Overall Study||6
8654403|NCT00662649|9696711|FG002|NOT COMPLETED|Core Study (24 Months)||86
8654404|NCT00662649|9696712|FG003|NOT COMPLETED|Core Study (24 Months)||0
8654405|NCT00662649|9696713|FG004|NOT COMPLETED|Core Study (24 Months)||0
8654406|NCT00662649|9696709|FG000|STARTED|Extension Study (Month 24 to 60)||289
8654407|NCT00662649|9696710|FG001|STARTED|Extension Study (Month 24 to 60)||331
8654408|NCT00662649|9696711|FG002|STARTED|Extension Study (Month 24 to 60)|This reporting group is used only for core study|0
8654409|NCT00662649|9696712|FG003|STARTED|Extension Study (Month 24 to 60)||145
8654410|NCT00662649|9696713|FG004|STARTED|Extension Study (Month 24 to 60)||155
8654411|NCT00662649|9696709|FG000|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||287
8654412|NCT00662649|9696710|FG001|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||330
8654413|NCT00662649|9696711|FG002|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||0
8654414|NCT00662649|9696712|FG003|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||145
8654415|NCT00662649|9696713|FG004|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||154
8654416|NCT00662649|9696709|FG000|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||289
8654417|NCT00662649|9696710|FG001|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||331
8654418|NCT00662649|9696711|FG002|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||0
8654419|NCT00662649|9696712|FG003|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||145
8654420|NCT00662649|9696713|FG004|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||155
8654421|NCT00662649|9696709|FG000|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||276
8654422|NCT00662649|9696710|FG001|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||324
8654423|NCT00662649|9696711|FG002|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||0
8654424|NCT00662649|9696712|FG003|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||136
8654425|NCT00662649|9696713|FG004|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||152
8654426|NCT00662649|9696709|FG000|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||270
8654427|NCT00662649|9696710|FG001|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||311
8654428|NCT00662649|9696711|FG002|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||0
8654429|NCT00662649|9696712|FG003|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||130
8654430|NCT00662649|9696713|FG004|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||145
8654431|NCT00662649|9696709|FG000|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||254
8654432|NCT00662649|9696710|FG001|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||301
8654433|NCT00662649|9696711|FG002|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||0
8654434|NCT00662649|9696712|FG003|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||120
8654435|NCT00662649|9696713|FG004|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||136
8654436|NCT00662649|9696709|FG000|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||125
8654437|NCT00662649|9696710|FG001|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||152
8654438|NCT00662649|9696711|FG002|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||0
8654439|NCT00662649|9696712|FG003|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||58
8654440|NCT00662649|9696713|FG004|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||67
8654441|NCT00662649|9696709|FG000|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||31
8654442|NCT00662649|9696710|FG001|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||32
8654443|NCT00662649|9696711|FG002|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||0
8654444|NCT00662649|9696712|FG003|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||11
8654445|NCT00662649|9696713|FG004|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||13
8654446|NCT00662649|9696709|FG000|COMPLETED|Extension Study (Month 24 to 60)|"completed refers to patients that completed extension study in different time points."|245
8654447|NCT00662649|9696710|FG001|COMPLETED|Extension Study (Month 24 to 60)||290
8654448|NCT00662649|9696711|FG002|COMPLETED|Extension Study (Month 24 to 60)||0
8654449|NCT00662649|9696712|FG003|COMPLETED|Extension Study (Month 24 to 60)||112
8654450|NCT00662649|9696713|FG004|COMPLETED|Extension Study (Month 24 to 60)||126
8654451|NCT00662649|9696709|FG000|NOT COMPLETED|Extension Study (Month 24 to 60)||44
8654452|NCT00662649|9696710|FG001|NOT COMPLETED|Extension Study (Month 24 to 60)||41
8654453|NCT00662649|9696711|FG002|NOT COMPLETED|Extension Study (Month 24 to 60)||0
8654454|NCT00662649|9696712|FG003|NOT COMPLETED|Extension Study (Month 24 to 60)||33
8654455|NCT00662649|9696713|FG004|NOT COMPLETED|Extension Study (Month 24 to 60)||29
8654456|NCT00662675|9696729|FG000|STARTED|Overall Study||20
8654457|NCT00662675|9696730|FG001|STARTED|Overall Study||20
8654458|NCT00662675|9696729|FG000|COMPLETED|Overall Study||20
8654459|NCT00662675|9696730|FG001|COMPLETED|Overall Study||20
8654460|NCT00662675|9696729|FG000|NOT COMPLETED|Overall Study||0
8654461|NCT00662675|9696730|FG001|NOT COMPLETED|Overall Study||0
8654462|NCT00662818|9696738|FG000|STARTED|Period 1 (6 Weeks)||84
8654463|NCT00662818|9696739|FG001|STARTED|Period 1 (6 Weeks)||81
8654464|NCT00662818|9696738|FG000|Treated|Period 1 (6 Weeks)||56
8654465|NCT00662818|9696739|FG001|Treated|Period 1 (6 Weeks)||58
8654466|NCT00662818|9696738|FG000|COMPLETED|Period 1 (6 Weeks)||56
8654467|NCT00662818|9696739|FG001|COMPLETED|Period 1 (6 Weeks)||58
8654468|NCT00662818|9696738|FG000|NOT COMPLETED|Period 1 (6 Weeks)||28
8654469|NCT00662818|9696739|FG001|NOT COMPLETED|Period 1 (6 Weeks)||23
8654470|NCT00662818|9696738|FG000|STARTED|Wash-Out (14 Days)||56
8654471|NCT00662818|9696739|FG001|STARTED|Wash-Out (14 Days)||58
8654472|NCT00662818|9696738|FG000|COMPLETED|Wash-Out (14 Days)||51
8654473|NCT00662818|9696739|FG001|COMPLETED|Wash-Out (14 Days)||53
8654474|NCT00662818|9696738|FG000|NOT COMPLETED|Wash-Out (14 Days)||5
8654475|NCT00662818|9696739|FG001|NOT COMPLETED|Wash-Out (14 Days)||5
8654476|NCT00662818|9696738|FG000|STARTED|Period 2 (6 Weeks)||51
8654477|NCT00662818|9696739|FG001|STARTED|Period 2 (6 Weeks)||53
8654478|NCT00662818|9696738|FG000|COMPLETED|Period 2 (6 Weeks)||38
8654479|NCT00662818|9696739|FG001|COMPLETED|Period 2 (6 Weeks)||41
8654480|NCT00662818|9696738|FG000|NOT COMPLETED|Period 2 (6 Weeks)||13
8654481|NCT00662818|9696739|FG001|NOT COMPLETED|Period 2 (6 Weeks)||12
8654482|NCT00662831|9696749|FG000|STARTED|Overall Study||184
8654483|NCT00662831|9696750|FG001|STARTED|Overall Study||92
8654484|NCT00662831|9696749|FG000|COMPLETED|Overall Study||78
8654485|NCT00662831|9696750|FG001|COMPLETED|Overall Study||33
8654486|NCT00662831|9696749|FG000|NOT COMPLETED|Overall Study||106
8654487|NCT00662831|9696750|FG001|NOT COMPLETED|Overall Study||59
8654488|NCT00662857|9696756|FG000|STARTED|TI Dosing Period 1 (1 Day)||13
8654489|NCT00662857|9696757|FG001|STARTED|TI Dosing Period 1 (1 Day)||16
8654490|NCT00662857|9696756|FG000|COMPLETED|TI Dosing Period 1 (1 Day)||13
8654491|NCT00662857|9696757|FG001|COMPLETED|TI Dosing Period 1 (1 Day)||16
8654492|NCT00662857|9696756|FG000|NOT COMPLETED|TI Dosing Period 1 (1 Day)||0
8654493|NCT00662857|9696757|FG001|NOT COMPLETED|TI Dosing Period 1 (1 Day)||0
8654494|NCT00662857|9696756|FG000|STARTED|Washout 1 (3 - 14 Days)||13
8654495|NCT00662857|9696757|FG001|STARTED|Washout 1 (3 - 14 Days)||16
8654496|NCT00662857|9696756|FG000|COMPLETED|Washout 1 (3 - 14 Days)||13
8654497|NCT00662857|9696757|FG001|COMPLETED|Washout 1 (3 - 14 Days)||14
8654498|NCT00662857|9696756|FG000|NOT COMPLETED|Washout 1 (3 - 14 Days)||0
8654499|NCT00662857|9696757|FG001|NOT COMPLETED|Washout 1 (3 - 14 Days)||2
8654500|NCT00662857|9696756|FG000|STARTED|TI Dosing Period 2 (1 Day)||13
8654501|NCT00662857|9696757|FG001|STARTED|TI Dosing Period 2 (1 Day)||14
8654502|NCT00662857|9696756|FG000|COMPLETED|TI Dosing Period 2 (1 Day)||13
8654503|NCT00662857|9696757|FG001|COMPLETED|TI Dosing Period 2 (1 Day)||14
8654504|NCT00662857|9696756|FG000|NOT COMPLETED|TI Dosing Period 2 (1 Day)||0
8654505|NCT00662857|9696757|FG001|NOT COMPLETED|TI Dosing Period 2 (1 Day)||0
8654506|NCT00662857|9696756|FG000|STARTED|Washout 2 (3 - 14 Days)||13
8654507|NCT00662857|9696757|FG001|STARTED|Washout 2 (3 - 14 Days)||14
8654508|NCT00662857|9696756|FG000|COMPLETED|Washout 2 (3 - 14 Days)||12
8654509|NCT00662857|9696757|FG001|COMPLETED|Washout 2 (3 - 14 Days)||14
8654510|NCT00662857|9696756|FG000|NOT COMPLETED|Washout 2 (3 - 14 Days)||1
8654511|NCT00662857|9696757|FG001|NOT COMPLETED|Washout 2 (3 - 14 Days)||0
8654512|NCT00662857|9696756|FG000|STARTED|Lispro Dosing Period (1 Day)||12
8654513|NCT00662857|9696757|FG001|STARTED|Lispro Dosing Period (1 Day)||14
8654514|NCT00662857|9696756|FG000|COMPLETED|Lispro Dosing Period (1 Day)||12
8654515|NCT00662857|9696757|FG001|COMPLETED|Lispro Dosing Period (1 Day)||14
8654516|NCT00662857|9696756|FG000|NOT COMPLETED|Lispro Dosing Period (1 Day)||0
8654517|NCT00662857|9696757|FG001|NOT COMPLETED|Lispro Dosing Period (1 Day)||0
8654518|NCT00662909|9696769|FG000|STARTED|Overall Study||454
8654519|NCT00662909|9696770|FG001|STARTED|Overall Study||442
8654520|NCT00662909|9696771|FG002|STARTED|Overall Study||433
8654521|NCT00662909|9696769|FG000|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|453
8654522|NCT00662909|9696770|FG001|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|442
8654523|NCT00662909|9696771|FG002|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|433
8654524|NCT00662909|9696769|FG000|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|433
8654525|NCT00662909|9696770|FG001|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|425
8654526|NCT00662909|9696771|FG002|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|412
8654527|NCT00662909|9696769|FG000|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|325
8654528|NCT00662909|9696770|FG001|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|312
8654529|NCT00662909|9696771|FG002|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|296
8654530|NCT00662909|9696769|FG000|COMPLETED|Overall Study||385
8654531|NCT00662909|9696770|FG001|COMPLETED|Overall Study||383
8654532|NCT00662909|9696771|FG002|COMPLETED|Overall Study||380
8654533|NCT00662909|9696769|FG000|NOT COMPLETED|Overall Study||69
8654534|NCT00662909|9696770|FG001|NOT COMPLETED|Overall Study||59
8654535|NCT00662909|9696771|FG002|NOT COMPLETED|Overall Study||53
8654536|NCT00663026|9696782|FG000|STARTED|Overall Study||19
8654537|NCT00663026|9696783|FG001|STARTED|Overall Study||29
8654538|NCT00663026|9696784|FG002|STARTED|Overall Study||31
8654539|NCT00663026|9696782|FG000|COMPLETED|Overall Study||17
8654540|NCT00663026|9696783|FG001|COMPLETED|Overall Study||23
8654541|NCT00663026|9696784|FG002|COMPLETED|Overall Study||27
8654542|NCT00663026|9696782|FG000|NOT COMPLETED|Overall Study||2
8654543|NCT00663026|9696783|FG001|NOT COMPLETED|Overall Study||6
8654544|NCT00663026|9696784|FG002|NOT COMPLETED|Overall Study||4
8654545|NCT00663039|9696794|FG000|STARTED|Overall Study||14
8654546|NCT00663039|9696795|FG001|STARTED|Overall Study||13
8654547|NCT00663039|9696794|FG000|COMPLETED|Overall Study||10
8654548|NCT00663039|9696795|FG001|COMPLETED|Overall Study||9
8654549|NCT00663039|9696794|FG000|NOT COMPLETED|Overall Study||4
8654550|NCT00663039|9696795|FG001|NOT COMPLETED|Overall Study||4
8654551|NCT00663117|9696803|FG000|STARTED|Overall Study||20
8654552|NCT00663117|9696804|FG001|STARTED|Overall Study||20
8654553|NCT00663117|9696803|FG000|COMPLETED|Overall Study|One patient in placebo flared and was unblinded and crossed over to active drug|19
8654554|NCT00663117|9696804|FG001|COMPLETED|Overall Study||20
8654555|NCT00663117|9696803|FG000|NOT COMPLETED|Overall Study||1
8654556|NCT00663117|9696804|FG001|NOT COMPLETED|Overall Study||0
8654557|NCT00663169|9696818|FG000|STARTED|Overall Study||3
8654558|NCT00663169|9696819|FG001|STARTED|Overall Study||3
8654559|NCT00663169|9696818|FG000|COMPLETED|Overall Study||3
8654560|NCT00663169|9696819|FG001|COMPLETED|Overall Study||3
8654561|NCT00663169|9696818|FG000|NOT COMPLETED|Overall Study||0
8654562|NCT00663169|9696819|FG001|NOT COMPLETED|Overall Study||0
8654563|NCT00663208|9696832|FG000|STARTED|Treatment Period||4
8654564|NCT00663208|9696833|FG001|STARTED|Treatment Period||4
8654565|NCT00663208|9696834|FG002|STARTED|Treatment Period||4
8654566|NCT00663208|9696835|FG003|STARTED|Treatment Period||4
8654567|NCT00663208|9696836|FG004|STARTED|Treatment Period||4
8654568|NCT00663208|9696837|FG005|STARTED|Treatment Period||4
8654569|NCT00663208|9696838|FG006|STARTED|Treatment Period||6
8728903|NCT01049945|9775891|FG004|STARTED|Overall Study||3
8728904|NCT01049945|9775892|FG005|STARTED|Overall Study||49
8728905|NCT01049945|9775887|FG000|COMPLETED|Overall Study||3
8728906|NCT01049945|9775888|FG001|COMPLETED|Overall Study||6
8728907|NCT01049945|9775889|FG002|COMPLETED|Overall Study||3
8728908|NCT01049945|9775890|FG003|COMPLETED|Overall Study||6
8728909|NCT01049945|9775891|FG004|COMPLETED|Overall Study||3
8728910|NCT01049945|9775892|FG005|COMPLETED|Overall Study||49
8728911|NCT01049945|9775887|FG000|NOT COMPLETED|Overall Study||0
8728912|NCT01049945|9775888|FG001|NOT COMPLETED|Overall Study||0
8728913|NCT01049945|9775889|FG002|NOT COMPLETED|Overall Study||0
9022184|NCT03124459|10085072|FG002|COMPLETED|Phase 2- Randomized Doubled-blind||0
9022185|NCT03124459|10085073|FG003|COMPLETED|Phase 2- Randomized Doubled-blind||9
9022186|NCT03124459|10085074|FG004|COMPLETED|Phase 2- Randomized Doubled-blind||5
9022187|NCT03124459|10085075|FG005|COMPLETED|Phase 2- Randomized Doubled-blind||0
9022188|NCT03124459|10085070|FG000|NOT COMPLETED|Phase 2- Randomized Doubled-blind||0
9022189|NCT03124459|10085071|FG001|NOT COMPLETED|Phase 2- Randomized Doubled-blind||0
9022190|NCT03124459|10085072|FG002|NOT COMPLETED|Phase 2- Randomized Doubled-blind||0
9022191|NCT03124459|10085073|FG003|NOT COMPLETED|Phase 2- Randomized Doubled-blind||12
9022192|NCT03124459|10085074|FG004|NOT COMPLETED|Phase 2- Randomized Doubled-blind||19
9022193|NCT03124459|10085075|FG005|NOT COMPLETED|Phase 2- Randomized Doubled-blind||0
9022194|NCT03124459|10085070|FG000|STARTED|Part 2- Open Label ACE-083||0
9022195|NCT03124459|10085071|FG001|STARTED|Part 2- Open Label ACE-083||0
9022196|NCT03124459|10085072|FG002|STARTED|Part 2- Open Label ACE-083||0
9022197|NCT03124459|10085073|FG003|STARTED|Part 2- Open Label ACE-083|Participants in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study. Participants that completed the double-blind placebo controlled portion of Part 2, moved into the open-label portion part 2 study.|0
9022198|NCT03124459|10085074|FG004|STARTED|Part 2- Open Label ACE-083|Participants in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study. Participants that completed the double-blind placebo controlled portion of Part 2, moved into the open-label portion part 2 study.|0
9022199|NCT03124459|10085075|FG005|STARTED|Part 2- Open Label ACE-083|The open-label portion of Part 2 are the participants that were enrolled in and completed the double-blind placebo-controlled portion of Part 2.|40
9022200|NCT03124459|10085070|FG000|COMPLETED|Part 2- Open Label ACE-083||0
9022201|NCT03124459|10085071|FG001|COMPLETED|Part 2- Open Label ACE-083||0
9022202|NCT03124459|10085072|FG002|COMPLETED|Part 2- Open Label ACE-083||0
9022203|NCT03124459|10085073|FG003|COMPLETED|Part 2- Open Label ACE-083||0
9022204|NCT03124459|10085074|FG004|COMPLETED|Part 2- Open Label ACE-083||0
9022205|NCT03124459|10085075|FG005|COMPLETED|Part 2- Open Label ACE-083||17
9022206|NCT03124459|10085070|FG000|NOT COMPLETED|Part 2- Open Label ACE-083||0
9022207|NCT03124459|10085071|FG001|NOT COMPLETED|Part 2- Open Label ACE-083||0
9022208|NCT03124459|10085072|FG002|NOT COMPLETED|Part 2- Open Label ACE-083||0
9022209|NCT03124459|10085073|FG003|NOT COMPLETED|Part 2- Open Label ACE-083||0
9022210|NCT03124459|10085074|FG004|NOT COMPLETED|Part 2- Open Label ACE-083||0
9022211|NCT03124459|10085075|FG005|NOT COMPLETED|Part 2- Open Label ACE-083||23
9022212|NCT03124537|10085090|FG000|STARTED|Overall Study||41
9022213|NCT03124537|10085091|FG001|STARTED|Overall Study||45
9022214|NCT03124537|10085090|FG000|COMPLETED|Overall Study||31
9022215|NCT03124537|10085091|FG001|COMPLETED|Overall Study||32
9022216|NCT03124537|10085090|FG000|NOT COMPLETED|Overall Study||10
9022217|NCT03124537|10085091|FG001|NOT COMPLETED|Overall Study||13
9022218|NCT03124550|10085097|FG000|STARTED|Overall Study||18
9022219|NCT03124550|10085097|FG000|COMPLETED|Overall Study||18
9022220|NCT03124550|10085097|FG000|NOT COMPLETED|Overall Study||0
9022221|NCT03124563|10085103|FG000|STARTED|Overall Study||32
9022222|NCT03124563|10085104|FG001|STARTED|Overall Study||31
9022223|NCT03124563|10085103|FG000|Pre-test|Overall Study||30
9022224|NCT03124563|10085104|FG001|Pre-test|Overall Study||30
9022225|NCT03124563|10085103|FG000|COMPLETED|Overall Study||30
9022226|NCT03124563|10085104|FG001|COMPLETED|Overall Study||29
9022227|NCT03124563|10085103|FG000|NOT COMPLETED|Overall Study||2
9022228|NCT03124563|10085104|FG001|NOT COMPLETED|Overall Study||2
9022229|NCT03124602|10085110|FG000|STARTED|Overall Study||35
9022230|NCT03124602|10085110|FG000|COMPLETED|Overall Study||25
9022231|NCT03124602|10085110|FG000|NOT COMPLETED|Overall Study||10
9022232|NCT03124693|10085114|FG000|STARTED|Overall Study||90
9022233|NCT03124693|10085114|FG000|COMPLETED|Overall Study||90
9022234|NCT03124693|10085114|FG000|NOT COMPLETED|Overall Study||0
8728914|NCT01049945|9775890|FG003|NOT COMPLETED|Overall Study||0
8654570|NCT00663208|9696832|FG000|COMPLETED|Treatment Period||4
9022235|NCT03124758|10085118|FG000|STARTED|Overall Study||354
9022236|NCT03124758|10085118|FG000|COMPLETED|Overall Study||354
9022237|NCT03124758|10085118|FG000|NOT COMPLETED|Overall Study||0
9022238|NCT03124771|10085122|FG000|STARTED|Overall Study||132
9022239|NCT03124771|10085122|FG000|COMPLETED|Overall Study||132
9022240|NCT03124771|10085122|FG000|NOT COMPLETED|Overall Study||0
9022241|NCT03124784|10085126|FG000|STARTED|Overall Study||27
9022242|NCT03124784|10085126|FG000|COMPLETED|Overall Study||25
9022243|NCT03124784|10085126|FG000|NOT COMPLETED|Overall Study||2
9022244|NCT03124797|10085130|FG000|STARTED|Overall Study||18
9022245|NCT03124797|10085130|FG000|COMPLETED|Overall Study||18
9022246|NCT03124797|10085130|FG000|NOT COMPLETED|Overall Study||0
9022247|NCT03124823|10085134|FG000|STARTED|Overall Study||11
9022248|NCT03124823|10085134|FG000|COMPLETED|Overall Study||11
9022249|NCT03124823|10085134|FG000|NOT COMPLETED|Overall Study||0
9022250|NCT03124836|10085138|FG000|STARTED|Overall Study||28
9022251|NCT03124836|10085138|FG000|COMPLETED|Overall Study||28
9022252|NCT03124836|10085138|FG000|NOT COMPLETED|Overall Study||0
9022253|NCT03124901|10085142|FG000|STARTED|Overall Study||147
9022254|NCT03124901|10085142|FG000|COMPLETED|Overall Study||147
9022255|NCT03124901|10085142|FG000|NOT COMPLETED|Overall Study||0
9022256|NCT03124927|10085146|FG000|STARTED|Overall Study||25
9022257|NCT03124927|10085146|FG000|COMPLETED|Overall Study||25
9022258|NCT03124927|10085146|FG000|NOT COMPLETED|Overall Study||0
9022259|NCT03124966|10085150|FG000|STARTED|Overall Study||118
9022260|NCT03124966|10085150|FG000|COMPLETED|Overall Study||118
9022261|NCT03124966|10085150|FG000|NOT COMPLETED|Overall Study||0
8654571|NCT00663208|9696833|FG001|COMPLETED|Treatment Period||3
8654572|NCT00663208|9696834|FG002|COMPLETED|Treatment Period||4
8654573|NCT00663208|9696835|FG003|COMPLETED|Treatment Period||4
8654574|NCT00663208|9696836|FG004|COMPLETED|Treatment Period||4
8654575|NCT00663208|9696837|FG005|COMPLETED|Treatment Period||4
8654576|NCT00663208|9696838|FG006|COMPLETED|Treatment Period||6
8654577|NCT00663208|9696832|FG000|NOT COMPLETED|Treatment Period||0
8654578|NCT00663208|9696833|FG001|NOT COMPLETED|Treatment Period||1
8654579|NCT00663208|9696834|FG002|NOT COMPLETED|Treatment Period||0
8654580|NCT00663208|9696835|FG003|NOT COMPLETED|Treatment Period||0
8654581|NCT00663208|9696836|FG004|NOT COMPLETED|Treatment Period||0
8654582|NCT00663208|9696837|FG005|NOT COMPLETED|Treatment Period||0
8654583|NCT00663208|9696838|FG006|NOT COMPLETED|Treatment Period||0
8654584|NCT00663208|9696832|FG000|STARTED|Follow-up Period||4
8654585|NCT00663208|9696833|FG001|STARTED|Follow-up Period||3
8654586|NCT00663208|9696834|FG002|STARTED|Follow-up Period||4
8654587|NCT00663208|9696835|FG003|STARTED|Follow-up Period||4
8654588|NCT00663208|9696836|FG004|STARTED|Follow-up Period||4
8654589|NCT00663208|9696837|FG005|STARTED|Follow-up Period||4
8654590|NCT00663208|9696838|FG006|STARTED|Follow-up Period||6
8654591|NCT00663208|9696832|FG000|COMPLETED|Follow-up Period||1
8654592|NCT00663208|9696833|FG001|COMPLETED|Follow-up Period||3
8654593|NCT00663208|9696834|FG002|COMPLETED|Follow-up Period||1
8654594|NCT00663208|9696835|FG003|COMPLETED|Follow-up Period||2
8654595|NCT00663208|9696836|FG004|COMPLETED|Follow-up Period||4
8654596|NCT00663208|9696837|FG005|COMPLETED|Follow-up Period||4
8654597|NCT00663208|9696838|FG006|COMPLETED|Follow-up Period||5
8654598|NCT00663208|9696832|FG000|NOT COMPLETED|Follow-up Period||3
8654599|NCT00663208|9696833|FG001|NOT COMPLETED|Follow-up Period||0
8654600|NCT00663208|9696834|FG002|NOT COMPLETED|Follow-up Period||3
8654601|NCT00663208|9696835|FG003|NOT COMPLETED|Follow-up Period||2
8654602|NCT00663208|9696836|FG004|NOT COMPLETED|Follow-up Period||0
8654603|NCT00663208|9696837|FG005|NOT COMPLETED|Follow-up Period||0
8654604|NCT00663208|9696838|FG006|NOT COMPLETED|Follow-up Period||1
8654605|NCT00663234|9696856|FG000|STARTED|Overall Study||28
8654606|NCT00663234|9696856|FG000|Dose Increased to 20 mg at Week 8|Overall Study||10
8654607|NCT00663234|9696856|FG000|COMPLETED|Overall Study||27
8654608|NCT00663234|9696856|FG000|NOT COMPLETED|Overall Study||1
8654609|NCT00663260|9696867|FG000|STARTED|Overall Study||84
8654610|NCT00663260|9696868|FG001|STARTED|Overall Study||83
8654611|NCT00663260|9696869|FG002|STARTED|Overall Study||85
8654612|NCT00663260|9696867|FG000|COMPLETED|Overall Study||63
8654613|NCT00663260|9696868|FG001|COMPLETED|Overall Study||72
8654614|NCT00663260|9696869|FG002|COMPLETED|Overall Study||69
8654615|NCT00663260|9696867|FG000|NOT COMPLETED|Overall Study||21
8654616|NCT00663260|9696868|FG001|NOT COMPLETED|Overall Study||11
8654617|NCT00663260|9696869|FG002|NOT COMPLETED|Overall Study||16
8654618|NCT00663403|9696877|FG000|STARTED|Overall Study||8
8654619|NCT00663403|9696877|FG000|COMPLETED|Overall Study||8
8654620|NCT00663403|9696877|FG000|NOT COMPLETED|Overall Study||0
8654621|NCT00663702|9696883|FG000|STARTED|Overall Study||52
8654622|NCT00663702|9696884|FG001|STARTED|Overall Study||71
8654623|NCT00663702|9696883|FG000|COMPLETED|Overall Study||34
8654624|NCT00663702|9696884|FG001|COMPLETED|Overall Study||61
8654625|NCT00663702|9696883|FG000|NOT COMPLETED|Overall Study||18
8654626|NCT00663702|9696884|FG001|NOT COMPLETED|Overall Study||10
9022262|NCT03124979|10085154|FG000|STARTED|Overall Study||13
9022263|NCT03124979|10085154|FG000|COMPLETED|Overall Study||13
9022264|NCT03124979|10085154|FG000|NOT COMPLETED|Overall Study||0
9022265|NCT03125005|10085158|FG000|STARTED|Overall Study||51
9022266|NCT03125005|10085158|FG000|COMPLETED|Overall Study||51
9022267|NCT03125005|10085158|FG000|NOT COMPLETED|Overall Study||0
9022268|NCT03125018|10085162|FG000|STARTED|Overall Study||13
9022269|NCT03125018|10085162|FG000|COMPLETED|Overall Study||13
9022270|NCT03125018|10085162|FG000|NOT COMPLETED|Overall Study||0
8654627|NCT00663793|9696892|FG000|STARTED|Overall Study||8
8654628|NCT00663793|9696893|FG001|STARTED|Overall Study||8
8654629|NCT00663793|9696892|FG000|COMPLETED|Overall Study||8
8654630|NCT00663793|9696893|FG001|COMPLETED|Overall Study||8
8654631|NCT00663793|9696892|FG000|NOT COMPLETED|Overall Study||0
8654632|NCT00663793|9696893|FG001|NOT COMPLETED|Overall Study||0
8654633|NCT00663819|9696901|FG000|STARTED|Overall Study||123
8654634|NCT00663819|9696902|FG001|STARTED|Overall Study||135
8654635|NCT00663819|9696901|FG000|COMPLETED|Overall Study||123
8654636|NCT00663819|9696902|FG001|COMPLETED|Overall Study||135
8654637|NCT00663819|9696901|FG000|NOT COMPLETED|Overall Study||0
8654638|NCT00663819|9696902|FG001|NOT COMPLETED|Overall Study||0
8654639|NCT00663858|9696913|FG000|STARTED|Overall Study||212
8654640|NCT00663858|9696914|FG001|STARTED|Overall Study||106
8654641|NCT00663858|9696915|FG002|STARTED|Overall Study||102
8654642|NCT00663858|9696913|FG000|COMPLETED|Overall Study||178
8654643|NCT00663858|9696914|FG001|COMPLETED|Overall Study||96
8654644|NCT00663858|9696915|FG002|COMPLETED|Overall Study||82
8654645|NCT00663858|9696913|FG000|NOT COMPLETED|Overall Study||34
8654646|NCT00663858|9696914|FG001|NOT COMPLETED|Overall Study||10
8654647|NCT00663858|9696915|FG002|NOT COMPLETED|Overall Study||20
8654648|NCT00663871|9696925|FG000|STARTED|Overall Study||134
8654649|NCT00663871|9696926|FG001|STARTED|Overall Study||138
8654650|NCT00663871|9696925|FG000|COMPLETED|Overall Study||124
8654651|NCT00663871|9696926|FG001|COMPLETED|Overall Study||131
8654652|NCT00663871|9696925|FG000|NOT COMPLETED|Overall Study||10
8654653|NCT00663871|9696926|FG001|NOT COMPLETED|Overall Study||7
8654654|NCT00663923|9696934|FG000|STARTED|Overall Study||50
8654655|NCT00663923|9696934|FG000|COMPLETED|Overall Study||48
8654656|NCT00663923|9696934|FG000|NOT COMPLETED|Overall Study||2
8654657|NCT00663962|9696942|FG000|STARTED|Overall Study||7
8654658|NCT00663962|9696943|FG001|STARTED|Overall Study||8
8654659|NCT00663962|9696942|FG000|COMPLETED|Overall Study|1 patient excluded for somnolence and unblinded--in 300mg group|6
8654660|NCT00663962|9696943|FG001|COMPLETED|Overall Study||8
8654661|NCT00663962|9696942|FG000|NOT COMPLETED|Overall Study||1
8654662|NCT00663962|9696943|FG001|NOT COMPLETED|Overall Study||0
8654663|NCT00664105|9696949|FG000|STARTED|Overall Study||63
8654664|NCT00664105|9696949|FG000|COMPLETED|Overall Study||39
8654665|NCT00664105|9696949|FG000|NOT COMPLETED|Overall Study||24
8654666|NCT00664209|9696954|FG000|STARTED|Motor Fluctuations Screen||13
8654667|NCT00664209|9696954|FG000|COMPLETED|Motor Fluctuations Screen||6
8654668|NCT00664209|9696954|FG000|NOT COMPLETED|Motor Fluctuations Screen||7
8654669|NCT00664209|9696954|FG000|STARTED|Study Treatment Period||6
8654670|NCT00664209|9696954|FG000|COMPLETED|Study Treatment Period||0
8654671|NCT00664209|9696954|FG000|NOT COMPLETED|Study Treatment Period||6
8654672|NCT00664326|9696959|FG000|STARTED|Overall Study||49
8654673|NCT00664326|9696959|FG000|COMPLETED|Overall Study|transitioned to rollover study|1
8654674|NCT00664326|9696959|FG000|NOT COMPLETED|Overall Study||48
8654675|NCT00664430|9696963|FG000|STARTED|Overall Study||13
8654676|NCT00664430|9696963|FG000|COMPLETED|Overall Study|Study terminated early due to low enrollment rate.|0
8654677|NCT00664430|9696963|FG000|NOT COMPLETED|Overall Study||13
8654678|NCT00664521|9696969|FG000|STARTED|Overall Study||18
8654679|NCT00664521|9696970|FG001|STARTED|Overall Study||9
8654680|NCT00664521|9696969|FG000|COMPLETED|Overall Study||12
8654681|NCT00664521|9696970|FG001|COMPLETED|Overall Study||8
8654682|NCT00664521|9696969|FG000|NOT COMPLETED|Overall Study||6
8654683|NCT00664521|9696970|FG001|NOT COMPLETED|Overall Study||1
8654684|NCT00664534|9696978|FG000|STARTED|Overall Study||173
8654685|NCT00664534|9696979|FG001|STARTED|Overall Study||171
8654686|NCT00664534|9696978|FG000|COMPLETED|Overall Study||132
8654687|NCT00664534|9696979|FG001|COMPLETED|Overall Study||138
8654688|NCT00664534|9696978|FG000|NOT COMPLETED|Overall Study||41
8654689|NCT00664534|9696979|FG001|NOT COMPLETED|Overall Study||33
8654690|NCT00664560|9696988|FG000|STARTED|Overall Study|Safety Population|247
8654691|NCT00664560|9696989|FG001|STARTED|Overall Study|Safety Population|243
8654692|NCT00664560|9696990|FG002|STARTED|Overall Study|Safety Population|124
8654693|NCT00664560|9696988|FG000|COMPLETED|Overall Study||208
8654694|NCT00664560|9696989|FG001|COMPLETED|Overall Study||208
8654695|NCT00664560|9696990|FG002|COMPLETED|Overall Study||105
8654696|NCT00664560|9696988|FG000|NOT COMPLETED|Overall Study||39
8654697|NCT00664560|9696989|FG001|NOT COMPLETED|Overall Study||35
8654698|NCT00664560|9696990|FG002|NOT COMPLETED|Overall Study||19
8654699|NCT00664742|9696998|FG000|STARTED|Overall Study||607
8654700|NCT00664742|9696998|FG000|COMPLETED|Overall Study||481
8654701|NCT00664742|9696998|FG000|NOT COMPLETED|Overall Study||126
8654702|NCT00664755|9697004|FG000|STARTED|Overall Study||67
8654703|NCT00664755|9697005|FG001|STARTED|Overall Study||73
8654704|NCT00664755|9697004|FG000|COMPLETED|Overall Study||67
8654705|NCT00664755|9697005|FG001|COMPLETED|Overall Study||73
8654706|NCT00664755|9697004|FG000|NOT COMPLETED|Overall Study||0
8654707|NCT00664755|9697005|FG001|NOT COMPLETED|Overall Study||0
8654708|NCT00664859|9697014|FG000|STARTED|Overall Study||51
8654709|NCT00664859|9697015|FG001|STARTED|Overall Study||45
8911245|NCT02139540|9970305|FG000|STARTED|Overall Study||11
8654710|NCT00664859|9697016|FG002|STARTED|Overall Study||44
8654711|NCT00664859|9697014|FG000|COMPLETED|Overall Study||34
8654712|NCT00664859|9697015|FG001|COMPLETED|Overall Study||35
8654713|NCT00664859|9697016|FG002|COMPLETED|Overall Study||23
8654714|NCT00664859|9697014|FG000|NOT COMPLETED|Overall Study||17
8654715|NCT00664859|9697015|FG001|NOT COMPLETED|Overall Study||10
8911246|NCT02139540|9970306|FG001|STARTED|Overall Study||10
8654716|NCT00664859|9697016|FG002|NOT COMPLETED|Overall Study||21
8654717|NCT00665002|9697024|FG000|STARTED|Overall Study||16
8654718|NCT00665002|9697024|FG000|COMPLETED|Overall Study||4
8654719|NCT00665002|9697024|FG000|NOT COMPLETED|Overall Study||12
8691962|NCT00857506|9737320|FG002|STARTED|Overall Study||69
8691963|NCT00857506|9737318|FG000|COMPLETED|Overall Study||16
8691964|NCT00857506|9737319|FG001|COMPLETED|Overall Study||37
8691965|NCT00857506|9737320|FG002|COMPLETED|Overall Study||51
8691966|NCT00857506|9737318|FG000|NOT COMPLETED|Overall Study||15
8691967|NCT00857506|9737319|FG001|NOT COMPLETED|Overall Study||15
8691968|NCT00857506|9737320|FG002|NOT COMPLETED|Overall Study||18
8691969|NCT00857532|9737340|FG000|STARTED|Overall Study||31
8691970|NCT00857532|9737340|FG000|COMPLETED|Overall Study||31
8691971|NCT00857532|9737340|FG000|NOT COMPLETED|Overall Study||0
8691972|NCT00857545|9737349|FG000|STARTED|Overall Study||86
8691973|NCT00857545|9737350|FG001|STARTED|Overall Study||85
8691974|NCT00857545|9737349|FG000|COMPLETED|Overall Study|Enrolled and randomized participants.|86
8691975|NCT00857545|9737350|FG001|COMPLETED|Overall Study||85
8691976|NCT00857545|9737349|FG000|NOT COMPLETED|Overall Study||0
8691977|NCT00857545|9737350|FG001|NOT COMPLETED|Overall Study||0
8691978|NCT00857584|9737358|FG000|STARTED|Overall Study||14
8691979|NCT00857584|9737359|FG001|STARTED|Overall Study||13
8691980|NCT00857584|9737358|FG000|Week 1|Overall Study||14
8691981|NCT00857584|9737359|FG001|Week 1|Overall Study||13
8691982|NCT00857584|9737358|FG000|Week 2|Overall Study||14
8691983|NCT00857584|9737359|FG001|Week 2|Overall Study||11
8691984|NCT00857584|9737358|FG000|Week 4|Overall Study||11
8691985|NCT00857584|9737359|FG001|Week 4|Overall Study||9
8691986|NCT00857584|9737358|FG000|Week 8|Overall Study||10
8691987|NCT00857584|9737359|FG001|Week 8|Overall Study||8
8691988|NCT00857584|9737358|FG000|COMPLETED|Overall Study||10
8691989|NCT00857584|9737359|FG001|COMPLETED|Overall Study||8
8691990|NCT00857584|9737358|FG000|NOT COMPLETED|Overall Study||4
8691991|NCT00857584|9737359|FG001|NOT COMPLETED|Overall Study||5
8691992|NCT00857623|9737367|FG000|STARTED|Overall Study||62
8691993|NCT00857623|9737368|FG001|STARTED|Overall Study||65
8691994|NCT00857623|9737367|FG000|COMPLETED|Overall Study||48
8691995|NCT00857623|9737368|FG001|COMPLETED|Overall Study||55
8691996|NCT00857623|9737367|FG000|NOT COMPLETED|Overall Study||14
8691997|NCT00857623|9737368|FG001|NOT COMPLETED|Overall Study||10
8691998|NCT00857649|9737376|FG000|STARTED|Overall Study||182
8691999|NCT00857649|9737377|FG001|STARTED|Overall Study||187
8692000|NCT00857649|9737376|FG000|COMPLETED|Overall Study||151
8692001|NCT00857649|9737377|FG001|COMPLETED|Overall Study||155
8692002|NCT00857649|9737376|FG000|NOT COMPLETED|Overall Study||31
8692003|NCT00857649|9737377|FG001|NOT COMPLETED|Overall Study||32
8692004|NCT00857714|9737383|FG000|STARTED|Overall Study||1
8692005|NCT00857714|9737383|FG000|COMPLETED|Overall Study||1
8692006|NCT00857714|9737383|FG000|NOT COMPLETED|Overall Study||0
8692007|NCT00857727|9737389|FG000|STARTED|Overall Study||14
8692008|NCT00857727|9737390|FG001|STARTED|Overall Study||14
8692009|NCT00857727|9737389|FG000|COMPLETED|Overall Study||14
8692010|NCT00857727|9737390|FG001|COMPLETED|Overall Study||14
8692011|NCT00857727|9737389|FG000|NOT COMPLETED|Overall Study||0
8692012|NCT00857727|9737390|FG001|NOT COMPLETED|Overall Study||0
8692013|NCT00857766|9737398|FG000|STARTED|Overall Study||123
8728915|NCT01049945|9775891|FG004|NOT COMPLETED|Overall Study||0
8728916|NCT01049945|9775892|FG005|NOT COMPLETED|Overall Study||0
8728917|NCT01049984|9775908|FG000|STARTED|Overall Study||163
8728918|NCT01049984|9775909|FG001|STARTED|Overall Study||165
8728919|NCT01049984|9775908|FG000|Safety Population|Overall Study|One patient was randomized but not dosed; omitted from safety population|162
8728920|NCT01049984|9775909|FG001|Safety Population|Overall Study|One patient was randomized but not dosed; omitted from safety population|164
8728921|NCT01049984|9775908|FG000|Modified Intent-to-treat Pop|Overall Study|Took >= 1 dose of study drug and had both baseline and at least 1 post-baseline efficacy assessment|159
8728922|NCT01049984|9775909|FG001|Modified Intent-to-treat Pop|Overall Study|Took >= 1 dose of study drug and had both baseline and at least 1 post-baseline efficacy assessment|162
8728923|NCT01049984|9775908|FG000|COMPLETED|Overall Study||144
8728924|NCT01049984|9775909|FG001|COMPLETED|Overall Study||146
8728925|NCT01049984|9775908|FG000|NOT COMPLETED|Overall Study||19
8728926|NCT01049984|9775909|FG001|NOT COMPLETED|Overall Study||19
8728927|NCT01050062|9775917|FG000|STARTED|Overall Study||1070
8728928|NCT01050062|9775918|FG001|STARTED|Overall Study||355
8728929|NCT01050062|9775917|FG000|COMPLETED|Overall Study||799
8728930|NCT01050062|9775918|FG001|COMPLETED|Overall Study||243
8728931|NCT01050062|9775917|FG000|NOT COMPLETED|Overall Study||271
8728932|NCT01050062|9775918|FG001|NOT COMPLETED|Overall Study||112
8728933|NCT01050153|9775928|FG000|STARTED|Overall Study||25
8728934|NCT01050153|9775929|FG001|STARTED|Overall Study||25
8728935|NCT01050153|9775928|FG000|COMPLETED|Overall Study||25
8728936|NCT01050153|9775929|FG001|COMPLETED|Overall Study||25
8692014|NCT00857766|9737399|FG001|STARTED|Overall Study||126
8692015|NCT00857766|9737398|FG000|COMPLETED|Overall Study||92
8692016|NCT00857766|9737399|FG001|COMPLETED|Overall Study||96
8692017|NCT00857766|9737398|FG000|NOT COMPLETED|Overall Study||31
8692018|NCT00857766|9737399|FG001|NOT COMPLETED|Overall Study||30
8692019|NCT00857792|9737405|FG000|STARTED|Overall Study||120
8692020|NCT00857792|9737405|FG000|COMPLETED|Overall Study||108
8692021|NCT00857792|9737405|FG000|NOT COMPLETED|Overall Study||12
8692022|NCT00857818|9737411|FG000|STARTED|Overall Study||14
8692023|NCT00857818|9737412|FG001|STARTED|Overall Study||14
8692024|NCT00857818|9737411|FG000|Received Treatment|Overall Study||14
8654720|NCT00665132|9697028|FG000|STARTED|Overall Study||10
8654721|NCT00665132|9697028|FG000|COMPLETED|Overall Study||10
8654722|NCT00665132|9697028|FG000|NOT COMPLETED|Overall Study||0
8654723|NCT00665353|9697032|FG000|STARTED|Study Step 1||19
8654724|NCT00665353|9697032|FG000|COMPLETED|Study Step 1||16
8654725|NCT00665353|9697032|FG000|NOT COMPLETED|Study Step 1||3
8654726|NCT00665353|9697032|FG000|STARTED|Study Step 2||16
8654727|NCT00665353|9697032|FG000|COMPLETED|Study Step 2||2
8654728|NCT00665353|9697032|FG000|NOT COMPLETED|Study Step 2||14
8654729|NCT00665366|9697038|FG000|STARTED|Overall Study|Participants randomized|189
8654730|NCT00665366|9697039|FG001|STARTED|Overall Study|Participants randomized|181
8654731|NCT00665366|9697038|FG000|COMPLETED|Overall Study||131
8654732|NCT00665366|9697039|FG001|COMPLETED|Overall Study||122
8654733|NCT00665366|9697038|FG000|NOT COMPLETED|Overall Study||58
8654734|NCT00665366|9697039|FG001|NOT COMPLETED|Overall Study||59
8654735|NCT00665392|9697045|FG000|STARTED|Overall Study||42
8654736|NCT00665392|9697045|FG000|COMPLETED|Overall Study||41
8654737|NCT00665392|9697045|FG000|NOT COMPLETED|Overall Study||1
8654738|NCT00665431|9697053|FG000|STARTED|Overall Study|Safety population|243
8654739|NCT00665431|9697054|FG001|STARTED|Overall Study|Safety population|245
8654740|NCT00665431|9697055|FG002|STARTED|Overall Study|Safety population|122
8654741|NCT00665431|9697053|FG000|COMPLETED|Overall Study||203
8654742|NCT00665431|9697054|FG001|COMPLETED|Overall Study||188
8654743|NCT00665431|9697055|FG002|COMPLETED|Overall Study||98
8654744|NCT00665431|9697053|FG000|NOT COMPLETED|Overall Study||40
8654745|NCT00665431|9697054|FG001|NOT COMPLETED|Overall Study||57
8654746|NCT00665431|9697055|FG002|NOT COMPLETED|Overall Study||24
8654747|NCT00665457|9697063|FG000|STARTED|Overall Study||3
8654748|NCT00665457|9697063|FG000|COMPLETED|Overall Study||3
8654749|NCT00665457|9697063|FG000|NOT COMPLETED|Overall Study||0
8654750|NCT00665470|9697069|FG000|STARTED|Overall Study||10
8654751|NCT00665470|9697070|FG001|STARTED|Overall Study||0
8654752|NCT00665470|9697069|FG000|COMPLETED|Overall Study||10
8654753|NCT00665470|9697070|FG001|COMPLETED|Overall Study||0
8654754|NCT00665470|9697069|FG000|NOT COMPLETED|Overall Study||0
8654755|NCT00665470|9697070|FG001|NOT COMPLETED|Overall Study||0
8654756|NCT00665561|9697078|FG000|STARTED|Overall Study||1316
8654757|NCT00665561|9697079|FG001|STARTED|Overall Study||1130
8654758|NCT00665561|9697078|FG000|COMPLETED|Overall Study||814
8654759|NCT00665561|9697079|FG001|COMPLETED|Overall Study||596
8654760|NCT00665561|9697078|FG000|NOT COMPLETED|Overall Study||502
8654761|NCT00665561|9697079|FG001|NOT COMPLETED|Overall Study||534
8654762|NCT00665626|9697087|FG000|STARTED|Overall Study|Participants randomized|73
8654763|NCT00665626|9697088|FG001|STARTED|Overall Study|Participants randomized|146
8654764|NCT00665626|9697087|FG000|COMPLETED|Overall Study|Participants completed the study|63
8654765|NCT00665626|9697088|FG001|COMPLETED|Overall Study|Participants completed the study|124
8654766|NCT00665626|9697087|FG000|NOT COMPLETED|Overall Study||10
8654767|NCT00665626|9697088|FG001|NOT COMPLETED|Overall Study||22
8654768|NCT00665652|9697094|FG000|STARTED|Overall Study||8
8654769|NCT00665652|9697094|FG000|COMPLETED|Overall Study||2
8654770|NCT00665652|9697094|FG000|NOT COMPLETED|Overall Study||6
8654771|NCT00665704|9697098|FG000|STARTED|Overall Study||9
8654772|NCT00665704|9697098|FG000|COMPLETED|Overall Study||9
8654773|NCT00665704|9697098|FG000|NOT COMPLETED|Overall Study||0
8654774|NCT00665847|9697102|FG000|STARTED|Overall Study||101
8654775|NCT00665847|9697102|FG000|COMPLETED|Overall Study||76
8654776|NCT00665847|9697102|FG000|NOT COMPLETED|Overall Study||25
8654777|NCT00665925|9697110|FG000|STARTED|Overall Study|Participants randomized|77
8654778|NCT00665925|9697111|FG001|STARTED|Overall Study|Participants randomized|76
8654779|NCT00665925|9697112|FG002|STARTED|Overall Study|Participants randomized|152
8654780|NCT00665925|9697113|FG003|STARTED|Overall Study|Participants randomized|152
8654781|NCT00665925|9697110|FG000|COMPLETED|Overall Study|Participants completed the study|62
8654782|NCT00665925|9697111|FG001|COMPLETED|Overall Study|Participants completed the study|59
8654783|NCT00665925|9697112|FG002|COMPLETED|Overall Study|Participants completed the study|126
8654784|NCT00665925|9697113|FG003|COMPLETED|Overall Study|Participants completed the study|131
8654785|NCT00665925|9697110|FG000|NOT COMPLETED|Overall Study||15
8654786|NCT00665925|9697111|FG001|NOT COMPLETED|Overall Study||17
8654787|NCT00665925|9697112|FG002|NOT COMPLETED|Overall Study||26
8654788|NCT00665925|9697113|FG003|NOT COMPLETED|Overall Study||21
8654789|NCT00666029|9697126|FG000|STARTED|Overall Study||20
8654790|NCT00666029|9697127|FG001|STARTED|Overall Study||20
8654791|NCT00666029|9697126|FG000|COMPLETED|Overall Study||19
8654792|NCT00666029|9697127|FG001|COMPLETED|Overall Study||20
8654793|NCT00666029|9697126|FG000|NOT COMPLETED|Overall Study||1
8654794|NCT00666029|9697127|FG001|NOT COMPLETED|Overall Study||0
8654795|NCT00666198|9697134|FG000|STARTED|Overall Study||3337
8654796|NCT00666198|9697134|FG000|COMPLETED|Overall Study||3304
8728937|NCT01050153|9775928|FG000|NOT COMPLETED|Overall Study||0
8728938|NCT01050153|9775929|FG001|NOT COMPLETED|Overall Study||0
8654797|NCT00666198|9697134|FG000|NOT COMPLETED|Overall Study||33
8654798|NCT00666211|9697140|FG000|STARTED|Overall Study||42
8654799|NCT00666211|9697141|FG001|STARTED|Overall Study||56
8654800|NCT00666211|9697140|FG000|COMPLETED|Overall Study||22
8654801|NCT00666211|9697141|FG001|COMPLETED|Overall Study||18
8654802|NCT00666211|9697140|FG000|NOT COMPLETED|Overall Study||20
8654803|NCT00666211|9697141|FG001|NOT COMPLETED|Overall Study||38
8654804|NCT00666224|9697149|FG000|STARTED|Double-Blind||243
8654805|NCT00666224|9697150|FG001|STARTED|Double-Blind||238
8654806|NCT00666224|9697149|FG000|COMPLETED|Double-Blind|78 completed 3 years treatment, 66 converted to CDMS, 54 switched to OL as per DMC|198
8654807|NCT00666224|9697150|FG001|COMPLETED|Double-Blind|55 completed 3 years treatment, 109 converted to CDMS, 47 switched to OL as per DMC|211
8654808|NCT00666224|9697149|FG000|NOT COMPLETED|Double-Blind||45
8654809|NCT00666224|9697150|FG001|NOT COMPLETED|Double-Blind||27
8654810|NCT00666224|9697149|FG000|STARTED|Open-Label|454 participants took at least one dose of GA including 45 who didn't continue into the OL.|198
8654811|NCT00666224|9697150|FG001|STARTED|Open-Label||211
8654812|NCT00666224|9697149|FG000|COMPLETED|Open-Label||163
8654813|NCT00666224|9697150|FG001|COMPLETED|Open-Label||126
8654814|NCT00666224|9697149|FG000|NOT COMPLETED|Open-Label||35
8654815|NCT00666224|9697150|FG001|NOT COMPLETED|Open-Label||85
8654816|NCT00666263|9697157|FG000|STARTED|Study Part 1 (Stabilization Phase 1)||22
8654817|NCT00666263|9697158|FG001|STARTED|Study Part 1 (Stabilization Phase 1)||22
8654818|NCT00666263|9697157|FG000|COMPLETED|Study Part 1 (Stabilization Phase 1)||22
8654819|NCT00666263|9697158|FG001|COMPLETED|Study Part 1 (Stabilization Phase 1)||21
8654820|NCT00666263|9697157|FG000|NOT COMPLETED|Study Part 1 (Stabilization Phase 1)||0
8654821|NCT00666263|9697158|FG001|NOT COMPLETED|Study Part 1 (Stabilization Phase 1)||1
8654822|NCT00666263|9697157|FG000|STARTED|Study Part 2 (Cross-over Period 1)||22
8654823|NCT00666263|9697158|FG001|STARTED|Study Part 2 (Cross-over Period 1)||21
8654824|NCT00666263|9697157|FG000|COMPLETED|Study Part 2 (Cross-over Period 1)||22
8654825|NCT00666263|9697158|FG001|COMPLETED|Study Part 2 (Cross-over Period 1)||21
8654826|NCT00666263|9697157|FG000|NOT COMPLETED|Study Part 2 (Cross-over Period 1)||0
8654827|NCT00666263|9697158|FG001|NOT COMPLETED|Study Part 2 (Cross-over Period 1)||0
8654828|NCT00666263|9697157|FG000|STARTED|Study Part 3 (Stabilization Phase 2)||22
8654829|NCT00666263|9697158|FG001|STARTED|Study Part 3 (Stabilization Phase 2)||21
8654830|NCT00666263|9697157|FG000|COMPLETED|Study Part 3 (Stabilization Phase 2)||22
8654831|NCT00666263|9697158|FG001|COMPLETED|Study Part 3 (Stabilization Phase 2)||21
8654832|NCT00666263|9697157|FG000|NOT COMPLETED|Study Part 3 (Stabilization Phase 2)||0
8654833|NCT00666263|9697158|FG001|NOT COMPLETED|Study Part 3 (Stabilization Phase 2)||0
8654834|NCT00666263|9697157|FG000|STARTED|Study Part 4 (Cross-over Period 2)||22
8654835|NCT00666263|9697158|FG001|STARTED|Study Part 4 (Cross-over Period 2)||21
8654836|NCT00666263|9697157|FG000|COMPLETED|Study Part 4 (Cross-over Period 2)||21
8654837|NCT00666263|9697158|FG001|COMPLETED|Study Part 4 (Cross-over Period 2)||21
8654838|NCT00666263|9697157|FG000|NOT COMPLETED|Study Part 4 (Cross-over Period 2)||1
8654839|NCT00666263|9697158|FG001|NOT COMPLETED|Study Part 4 (Cross-over Period 2)||0
8654840|NCT00666263|9697157|FG000|STARTED|Study Part 5 (Stabilization Phase 3)||21
8654841|NCT00666263|9697158|FG001|STARTED|Study Part 5 (Stabilization Phase 3)||21
8654842|NCT00666263|9697157|FG000|COMPLETED|Study Part 5 (Stabilization Phase 3)||21
8654843|NCT00666263|9697158|FG001|COMPLETED|Study Part 5 (Stabilization Phase 3)||20
8654844|NCT00666263|9697157|FG000|NOT COMPLETED|Study Part 5 (Stabilization Phase 3)||0
8654845|NCT00666263|9697158|FG001|NOT COMPLETED|Study Part 5 (Stabilization Phase 3)||1
8654846|NCT00666263|9697157|FG000|STARTED|End of Study Visit|End of Study Visit done on all 22 randomized regardless of participation in Study Parts|22
8654847|NCT00666263|9697158|FG001|STARTED|End of Study Visit|End of Study Visit done on all 22 randomized regardless of participation in Study Parts|22
8654848|NCT00666263|9697157|FG000|COMPLETED|End of Study Visit||22
8654849|NCT00666263|9697158|FG001|COMPLETED|End of Study Visit||22
8654850|NCT00666263|9697157|FG000|NOT COMPLETED|End of Study Visit||0
8654851|NCT00666263|9697158|FG001|NOT COMPLETED|End of Study Visit||0
8654852|NCT00666276|9697203|FG000|STARTED|Overall Study||1004
8654853|NCT00666276|9697203|FG000|COMPLETED|Overall Study||970
8654854|NCT00666276|9697203|FG000|NOT COMPLETED|Overall Study||34
8654855|NCT00666328|9697226|FG000|STARTED|Overall Study|Safety population: participants dosed with study drug (primary population for Safety analyses)|35
8654856|NCT00666328|9697226|FG000|Modified Intent To Treat (mITT)|Overall Study|mITT population: participants dosed and in whom all inclusion and no exclusion criteria were met|33
8654857|NCT00666328|9697226|FG000|COMPLETED|Overall Study|30/35 completed the study within the Safety population; 28/33 completed within the mITT population.|30
8654858|NCT00666328|9697226|FG000|NOT COMPLETED|Overall Study||5
8654859|NCT00666406|9697232|FG000|STARTED|First PK Infusion||6
8654860|NCT00666406|9697233|FG001|STARTED|First PK Infusion||3
8654861|NCT00666406|9697232|FG000|COMPLETED|First PK Infusion||6
8654862|NCT00666406|9697233|FG001|COMPLETED|First PK Infusion||3
8654863|NCT00666406|9697232|FG000|NOT COMPLETED|First PK Infusion||0
8654864|NCT00666406|9697233|FG001|NOT COMPLETED|First PK Infusion||0
8654865|NCT00666406|9697232|FG000|STARTED|Second PK Infusion||6
8654866|NCT00666406|9697233|FG001|STARTED|Second PK Infusion||3
8654867|NCT00666406|9697232|FG000|COMPLETED|Second PK Infusion||6
8654868|NCT00666406|9697233|FG001|COMPLETED|Second PK Infusion||3
8654869|NCT00666406|9697232|FG000|NOT COMPLETED|Second PK Infusion||0
8654870|NCT00666406|9697233|FG001|NOT COMPLETED|Second PK Infusion||0
8654871|NCT00666458|9697240|FG000|STARTED|Overall Study|Randomized and treated|403
8654872|NCT00666458|9697241|FG001|STARTED|Overall Study|Randomized and treated|398
8654873|NCT00666458|9697240|FG000|COMPLETED|Overall Study|Completed 18 weeks of treatment|365
8654874|NCT00666458|9697241|FG001|COMPLETED|Overall Study|Completed 18 weeks of treatment|374
8654875|NCT00666458|9697240|FG000|NOT COMPLETED|Overall Study||38
8654876|NCT00666458|9697241|FG001|NOT COMPLETED|Overall Study||24
8654877|NCT00666536|9697249|FG000|STARTED|Overall Study||369
8654878|NCT00666536|9697250|FG001|STARTED|Overall Study||359
8654879|NCT00666536|9697249|FG000|COMPLETED|Overall Study||336
8654880|NCT00666536|9697250|FG001|COMPLETED|Overall Study||322
8654881|NCT00666536|9697249|FG000|NOT COMPLETED|Overall Study||33
8654882|NCT00666536|9697250|FG001|NOT COMPLETED|Overall Study||37
8654883|NCT00666562|9697259|FG000|STARTED|Overall Study||11
8654884|NCT00666562|9697260|FG001|STARTED|Overall Study||10
8654885|NCT00666562|9697261|FG002|STARTED|Overall Study||10
8654886|NCT00666562|9697259|FG000|COMPLETED|Overall Study||11
8654887|NCT00666562|9697260|FG001|COMPLETED|Overall Study||8
8654888|NCT00666562|9697261|FG002|COMPLETED|Overall Study||10
8728939|NCT01050205|9775937|FG000|STARTED|Overall Study||148
8728940|NCT01050205|9775938|FG001|STARTED|Overall Study||75
8728941|NCT01050205|9775937|FG000|COMPLETED|Overall Study||137
8728942|NCT01050205|9775938|FG001|COMPLETED|Overall Study||71
8728943|NCT01050205|9775937|FG000|NOT COMPLETED|Overall Study||11
8728944|NCT01050205|9775938|FG001|NOT COMPLETED|Overall Study||4
8728945|NCT01050231|9775946|FG000|STARTED|Overall Study||10
8728946|NCT01050231|9775947|FG001|STARTED|Overall Study||10
9022271|NCT03125031|10085166|FG000|STARTED|Overall Study||44
9022272|NCT03125031|10085167|FG001|STARTED|Overall Study||44
8654889|NCT00666562|9697259|FG000|NOT COMPLETED|Overall Study||0
8654890|NCT00666562|9697260|FG001|NOT COMPLETED|Overall Study||2
8654891|NCT00666562|9697261|FG002|NOT COMPLETED|Overall Study||0
8654892|NCT00666588|9697280|FG000|STARTED|Overall Study||18
8654893|NCT00666588|9697281|FG001|STARTED|Overall Study||6
8654894|NCT00666588|9697282|FG002|STARTED|Overall Study||6
8654895|NCT00666588|9697283|FG003|STARTED|Overall Study||22
8654896|NCT00666588|9697280|FG000|COMPLETED|Overall Study||14
8654897|NCT00666588|9697281|FG001|COMPLETED|Overall Study||6
8654898|NCT00666588|9697282|FG002|COMPLETED|Overall Study||6
8654899|NCT00666588|9697283|FG003|COMPLETED|Overall Study||20
8654900|NCT00666588|9697280|FG000|NOT COMPLETED|Overall Study||4
8654901|NCT00666588|9697281|FG001|NOT COMPLETED|Overall Study||0
8654902|NCT00666588|9697282|FG002|NOT COMPLETED|Overall Study||0
8654903|NCT00666588|9697283|FG003|NOT COMPLETED|Overall Study||2
8654904|NCT00666666|9697293|FG000|STARTED|Overall Study||55
8654905|NCT00666666|9697293|FG000|COMPLETED|Overall Study||55
8654906|NCT00666666|9697293|FG000|NOT COMPLETED|Overall Study||0
8654907|NCT00666679|9697299|FG000|STARTED|First Intervention||66
8654908|NCT00666679|9697300|FG001|STARTED|First Intervention||68
8654909|NCT00666679|9697299|FG000|COMPLETED|First Intervention||62
8654910|NCT00666679|9697300|FG001|COMPLETED|First Intervention||67
8654911|NCT00666679|9697299|FG000|NOT COMPLETED|First Intervention||4
8654912|NCT00666679|9697300|FG001|NOT COMPLETED|First Intervention||1
8654913|NCT00666679|9697299|FG000|STARTED|Washout Period of 1 Week||62
8654914|NCT00666679|9697300|FG001|STARTED|Washout Period of 1 Week||67
8654915|NCT00666679|9697299|FG000|COMPLETED|Washout Period of 1 Week||62
8654916|NCT00666679|9697300|FG001|COMPLETED|Washout Period of 1 Week||65
8654917|NCT00666679|9697299|FG000|NOT COMPLETED|Washout Period of 1 Week||0
8654918|NCT00666679|9697300|FG001|NOT COMPLETED|Washout Period of 1 Week||2
8654919|NCT00666679|9697299|FG000|STARTED|Second Intervention||62
8654920|NCT00666679|9697300|FG001|STARTED|Second Intervention||65
8654921|NCT00666679|9697299|FG000|COMPLETED|Second Intervention||61
8654922|NCT00666679|9697300|FG001|COMPLETED|Second Intervention||64
8654923|NCT00666679|9697299|FG000|NOT COMPLETED|Second Intervention||1
8654924|NCT00666679|9697300|FG001|NOT COMPLETED|Second Intervention||1
8654925|NCT00666705|9697306|FG000|STARTED|Overall Study||18
8654926|NCT00666705|9697306|FG000|Raltegravir Alone (Days 1 - 3)|Overall Study|400 mg Raltegravir every 12 hours (AM dose on Day 3)|18
8654927|NCT00666705|9697306|FG000|Washout (Days 4 - 5)|Overall Study||18
8654928|NCT00666705|9697306|FG000|Maraviroc Alone (Days 6 - 11)|Overall Study|300 mg Maraviroc every 12 hours|18
8654929|NCT00666705|9697306|FG000|Raltegravir + Maraviroc (Days 12 - 14)|Overall Study|400 mg Raltegravir every 12 hours plus 300 mg Maraviroc every 12 hours (AM doses only on Day 14)|17
8654930|NCT00666705|9697306|FG000|COMPLETED|Overall Study||17
8654931|NCT00666705|9697306|FG000|NOT COMPLETED|Overall Study||1
8654932|NCT00666718|9697317|FG000|STARTED|Overall Study||187
8654933|NCT00666718|9697318|FG001|STARTED|Overall Study||187
8654934|NCT00666718|9697317|FG000|COMPLETED|Overall Study||175
8654935|NCT00666718|9697318|FG001|COMPLETED|Overall Study||169
8654936|NCT00666718|9697317|FG000|NOT COMPLETED|Overall Study||12
8654937|NCT00666718|9697318|FG001|NOT COMPLETED|Overall Study||18
8654938|NCT00666757|9697326|FG000|STARTED|Overall Study||372
8654939|NCT00666757|9697327|FG001|STARTED|Overall Study||378
8654940|NCT00666757|9697326|FG000|COMPLETED|Overall Study||272
8654941|NCT00666757|9697327|FG001|COMPLETED|Overall Study||281
8654942|NCT00666757|9697326|FG000|NOT COMPLETED|Overall Study||100
8654943|NCT00666757|9697327|FG001|NOT COMPLETED|Overall Study||97
8654944|NCT00666835|9697338|FG000|STARTED|Overall Study||314
8654945|NCT00666835|9697339|FG001|STARTED|Overall Study||164
8654946|NCT00666835|9697338|FG000|COMPLETED|Overall Study||261
8654947|NCT00666835|9697339|FG001|COMPLETED|Overall Study||142
8654948|NCT00666835|9697338|FG000|NOT COMPLETED|Overall Study||53
9022273|NCT03125031|10085166|FG000|COMPLETED|Overall Study||44
9022274|NCT03125031|10085167|FG001|COMPLETED|Overall Study||44
9022275|NCT03125031|10085166|FG000|NOT COMPLETED|Overall Study||0
9022276|NCT03125031|10085167|FG001|NOT COMPLETED|Overall Study||0
8654949|NCT00666835|9697339|FG001|NOT COMPLETED|Overall Study||22
8654950|NCT00666848|9697349|FG000|STARTED|Overall Study|15 didn't meet inclusion criteria. 3 withdrew before randomized. 1 withdrawn before randomized.|8
8728947|NCT01050231|9775946|FG000|COMPLETED|Overall Study||10
8728948|NCT01050231|9775947|FG001|COMPLETED|Overall Study||10
9022277|NCT03125200|10085179|FG000|STARTED|Overall Study||2
9022278|NCT03125200|10085180|FG001|STARTED|Overall Study||2
9022279|NCT03125200|10085181|FG002|STARTED|Overall Study||2
9022280|NCT03125200|10085182|FG003|STARTED|Overall Study||5
9022281|NCT03125200|10085183|FG004|STARTED|Overall Study||4
9022282|NCT03125200|10085184|FG005|STARTED|Overall Study||3
9022283|NCT03125200|10085185|FG006|STARTED|Overall Study||3
9022284|NCT03125200|10085179|FG000|COMPLETED|Overall Study||0
9022285|NCT03125200|10085180|FG001|COMPLETED|Overall Study||0
9022286|NCT03125200|10085181|FG002|COMPLETED|Overall Study||0
9022287|NCT03125200|10085182|FG003|COMPLETED|Overall Study||0
9022288|NCT03125200|10085183|FG004|COMPLETED|Overall Study||0
9022289|NCT03125200|10085184|FG005|COMPLETED|Overall Study||0
9022290|NCT03125200|10085185|FG006|COMPLETED|Overall Study||0
9022291|NCT03125200|10085179|FG000|NOT COMPLETED|Overall Study||2
9022292|NCT03125200|10085180|FG001|NOT COMPLETED|Overall Study||2
9022293|NCT03125200|10085181|FG002|NOT COMPLETED|Overall Study||2
9022294|NCT03125200|10085182|FG003|NOT COMPLETED|Overall Study||5
9022295|NCT03125200|10085183|FG004|NOT COMPLETED|Overall Study||4
9022296|NCT03125200|10085184|FG005|NOT COMPLETED|Overall Study||3
9022297|NCT03125200|10085185|FG006|NOT COMPLETED|Overall Study||3
9022298|NCT03125226|10085204|FG000|STARTED|Overall Study||12
9022299|NCT03125226|10085204|FG000|COMPLETED|Overall Study||12
9022300|NCT03125226|10085204|FG000|NOT COMPLETED|Overall Study||0
9022301|NCT03125395|10085208|FG000|STARTED|Overall Study||57
9022302|NCT03125395|10085208|FG000|Study 115B FAS|Overall Study||60
9022303|NCT03125395|10085208|FG000|Study 116 FAS|Overall Study||57
9022304|NCT03125395|10085208|FG000|Study 116 LCI Substudy Set|Overall Study||31
9022305|NCT03125395|10085208|FG000|COMPLETED|Overall Study||47
9022306|NCT03125395|10085208|FG000|NOT COMPLETED|Overall Study||10
9022307|NCT03125629|10085212|FG000|STARTED|Overall Study||53
9022308|NCT03125629|10085212|FG000|COMPLETED|Overall Study||50
9022309|NCT03125629|10085212|FG000|NOT COMPLETED|Overall Study||3
9022310|NCT03125915|10085228|FG000|STARTED|Baseline and Intervention||32
9022311|NCT03125915|10085229|FG001|STARTED|Baseline and Intervention||40
9022312|NCT03125915|10085230|FG002|STARTED|Baseline and Intervention||34
9022313|NCT03125915|10085231|FG003|STARTED|Baseline and Intervention||34
9022314|NCT03125915|10085228|FG000|COMPLETED|Baseline and Intervention||32
9022315|NCT03125915|10085229|FG001|COMPLETED|Baseline and Intervention||40
9022316|NCT03125915|10085230|FG002|COMPLETED|Baseline and Intervention||34
9022317|NCT03125915|10085231|FG003|COMPLETED|Baseline and Intervention||34
9022318|NCT03125915|10085228|FG000|NOT COMPLETED|Baseline and Intervention||0
9022319|NCT03125915|10085229|FG001|NOT COMPLETED|Baseline and Intervention||0
9022320|NCT03125915|10085230|FG002|NOT COMPLETED|Baseline and Intervention||0
9022321|NCT03125915|10085231|FG003|NOT COMPLETED|Baseline and Intervention||0
9022322|NCT03125915|10085228|FG000|STARTED|1 Month Follow up||32
9022323|NCT03125915|10085229|FG001|STARTED|1 Month Follow up||40
9022324|NCT03125915|10085230|FG002|STARTED|1 Month Follow up||34
9022325|NCT03125915|10085231|FG003|STARTED|1 Month Follow up||34
9022326|NCT03125915|10085228|FG000|COMPLETED|1 Month Follow up||29
9022327|NCT03125915|10085229|FG001|COMPLETED|1 Month Follow up||37
8654951|NCT00666848|9697350|FG001|STARTED|Overall Study|15 didn't meet inclusion criteria. 3 withdrew before randomized. 1 withdrawn before randomized.|9
8654952|NCT00666848|9697351|FG002|STARTED|Overall Study|15 didn't meet inclusion criteria. 3 withdrew before randomized. 1 withdrawn before randomized.|7
8654953|NCT00666848|9697349|FG000|COMPLETED|Overall Study|finished Aim 2|8
8654954|NCT00666848|9697350|FG001|COMPLETED|Overall Study|finished Aim 1|9
8654955|NCT00666848|9697351|FG002|COMPLETED|Overall Study|finished Aim 3|7
8654956|NCT00666848|9697349|FG000|NOT COMPLETED|Overall Study||0
8654957|NCT00666848|9697350|FG001|NOT COMPLETED|Overall Study||0
8654958|NCT00666848|9697351|FG002|NOT COMPLETED|Overall Study||0
8654959|NCT00666926|9697359|FG000|STARTED|Overall Study||2
8654960|NCT00666926|9697360|FG001|STARTED|Overall Study||4
8654961|NCT00666926|9697361|FG002|STARTED|Overall Study||3
8654962|NCT00666926|9697362|FG003|STARTED|Overall Study||4
8654963|NCT00666926|9697363|FG004|STARTED|Overall Study||3
8654964|NCT00666926|9697364|FG005|STARTED|Overall Study||4
8654965|NCT00666926|9697365|FG006|STARTED|Overall Study||4
8654966|NCT00666926|9697366|FG007|STARTED|Overall Study||1
8654967|NCT00666926|9697367|FG008|STARTED|Overall Study||3
8654968|NCT00666926|9697368|FG009|STARTED|Overall Study||10
8654969|NCT00666926|9697369|FG010|STARTED|Overall Study||6
8654970|NCT00666926|9697370|FG011|STARTED|Overall Study||33
8654971|NCT00666926|9697371|FG012|STARTED|Overall Study||3
9022328|NCT03125915|10085230|FG002|COMPLETED|1 Month Follow up||32
9022329|NCT03125915|10085231|FG003|COMPLETED|1 Month Follow up||31
9022330|NCT03125915|10085228|FG000|NOT COMPLETED|1 Month Follow up||3
9022331|NCT03125915|10085229|FG001|NOT COMPLETED|1 Month Follow up||3
9022332|NCT03125915|10085230|FG002|NOT COMPLETED|1 Month Follow up||2
9022333|NCT03125915|10085231|FG003|NOT COMPLETED|1 Month Follow up||3
9022334|NCT03125915|10085228|FG000|STARTED|3 Month Follow-up||32
9022335|NCT03125915|10085229|FG001|STARTED|3 Month Follow-up||40
9022336|NCT03125915|10085230|FG002|STARTED|3 Month Follow-up||34
9022337|NCT03125915|10085231|FG003|STARTED|3 Month Follow-up||34
9022338|NCT03125915|10085228|FG000|COMPLETED|3 Month Follow-up||26
9022339|NCT03125915|10085229|FG001|COMPLETED|3 Month Follow-up||36
9022340|NCT03125915|10085230|FG002|COMPLETED|3 Month Follow-up||30
8654972|NCT00666926|9697372|FG013|STARTED|Overall Study||4
8654973|NCT00666926|9697373|FG014|STARTED|Overall Study||7
9022341|NCT03125915|10085231|FG003|COMPLETED|3 Month Follow-up||32
9022342|NCT03125915|10085228|FG000|NOT COMPLETED|3 Month Follow-up||6
8654974|NCT00666926|9697374|FG015|STARTED|Overall Study||8
8654975|NCT00666926|9697359|FG000|COMPLETED|Overall Study||0
8654976|NCT00666926|9697360|FG001|COMPLETED|Overall Study||0
8654977|NCT00666926|9697361|FG002|COMPLETED|Overall Study||0
8654978|NCT00666926|9697362|FG003|COMPLETED|Overall Study||0
8654979|NCT00666926|9697363|FG004|COMPLETED|Overall Study||0
8654980|NCT00666926|9697364|FG005|COMPLETED|Overall Study||0
8654981|NCT00666926|9697365|FG006|COMPLETED|Overall Study||0
8654982|NCT00666926|9697366|FG007|COMPLETED|Overall Study||0
8654983|NCT00666926|9697367|FG008|COMPLETED|Overall Study||0
8654984|NCT00666926|9697368|FG009|COMPLETED|Overall Study||0
8654985|NCT00666926|9697369|FG010|COMPLETED|Overall Study||0
8654986|NCT00666926|9697370|FG011|COMPLETED|Overall Study||0
8654987|NCT00666926|9697371|FG012|COMPLETED|Overall Study||0
8654988|NCT00666926|9697372|FG013|COMPLETED|Overall Study||0
8654989|NCT00666926|9697373|FG014|COMPLETED|Overall Study||0
8654990|NCT00666926|9697374|FG015|COMPLETED|Overall Study||0
8654991|NCT00666926|9697359|FG000|NOT COMPLETED|Overall Study||2
8654992|NCT00666926|9697360|FG001|NOT COMPLETED|Overall Study||4
8654993|NCT00666926|9697361|FG002|NOT COMPLETED|Overall Study||3
8654994|NCT00666926|9697362|FG003|NOT COMPLETED|Overall Study||4
8654995|NCT00666926|9697363|FG004|NOT COMPLETED|Overall Study||3
8654996|NCT00666926|9697364|FG005|NOT COMPLETED|Overall Study||4
8654997|NCT00666926|9697365|FG006|NOT COMPLETED|Overall Study||4
8654998|NCT00666926|9697366|FG007|NOT COMPLETED|Overall Study||1
8654999|NCT00666926|9697367|FG008|NOT COMPLETED|Overall Study||3
8655000|NCT00666926|9697368|FG009|NOT COMPLETED|Overall Study||10
8655001|NCT00666926|9697369|FG010|NOT COMPLETED|Overall Study||6
8655002|NCT00666926|9697370|FG011|NOT COMPLETED|Overall Study||33
8655003|NCT00666926|9697371|FG012|NOT COMPLETED|Overall Study||3
8655004|NCT00666926|9697372|FG013|NOT COMPLETED|Overall Study||4
8655005|NCT00666926|9697373|FG014|NOT COMPLETED|Overall Study||7
8655006|NCT00666926|9697374|FG015|NOT COMPLETED|Overall Study||8
8655007|NCT00666965|9697429|FG000|STARTED|Overall Study||58
8655008|NCT00666965|9697430|FG001|STARTED|Overall Study||57
8655009|NCT00666965|9697431|FG002|STARTED|Overall Study||58
8655010|NCT00666965|9697432|FG003|STARTED|Overall Study||57
8655011|NCT00666965|9697429|FG000|COMPLETED|Overall Study||55
8655012|NCT00666965|9697430|FG001|COMPLETED|Overall Study||53
8655013|NCT00666965|9697431|FG002|COMPLETED|Overall Study||56
8655014|NCT00666965|9697432|FG003|COMPLETED|Overall Study||42
8655015|NCT00666965|9697429|FG000|NOT COMPLETED|Overall Study||3
8655016|NCT00666965|9697430|FG001|NOT COMPLETED|Overall Study||4
8655017|NCT00666965|9697431|FG002|NOT COMPLETED|Overall Study||2
8655018|NCT00666965|9697432|FG003|NOT COMPLETED|Overall Study||15
8655019|NCT00666978|9697444|FG000|STARTED|Overall Study||270
8655020|NCT00666978|9697445|FG001|STARTED|Overall Study||270
8655021|NCT00666978|9697444|FG000|COMPLETED|Overall Study||192
8655022|NCT00666978|9697445|FG001|COMPLETED|Overall Study||187
8655023|NCT00666978|9697444|FG000|NOT COMPLETED|Overall Study||78
8655024|NCT00666978|9697445|FG001|NOT COMPLETED|Overall Study||83
8655025|NCT00667004|9697455|FG000|STARTED|Overall Study||95
8655026|NCT00667004|9697456|FG001|STARTED|Overall Study||88
8655027|NCT00667004|9697455|FG000|COMPLETED|Overall Study||93
8655028|NCT00667004|9697456|FG001|COMPLETED|Overall Study||85
8655029|NCT00667004|9697455|FG000|NOT COMPLETED|Overall Study||2
8655030|NCT00667004|9697456|FG001|NOT COMPLETED|Overall Study||3
8655031|NCT00667095|9697464|FG000|STARTED|Overall Study||11
8655032|NCT00667095|9697465|FG001|STARTED|Overall Study||10
8655033|NCT00667095|9697464|FG000|COMPLETED|Overall Study||11
8655034|NCT00667095|9697465|FG001|COMPLETED|Overall Study||9
8655035|NCT00667095|9697464|FG000|NOT COMPLETED|Overall Study||0
8655036|NCT00667095|9697465|FG001|NOT COMPLETED|Overall Study||1
8655037|NCT00667186|9697473|FG000|STARTED|Overall Study||4692
8655038|NCT00667186|9697474|FG001|STARTED|Overall Study||4880
8655039|NCT00667186|9697473|FG000|COMPLETED|Overall Study||4692
8655040|NCT00667186|9697474|FG001|COMPLETED|Overall Study||4880
8655041|NCT00667186|9697473|FG000|NOT COMPLETED|Overall Study||0
8655042|NCT00667186|9697474|FG001|NOT COMPLETED|Overall Study||0
8655043|NCT00667225|9697482|FG000|STARTED|Overall Study||16
8655044|NCT00667225|9697483|FG001|STARTED|Overall Study||13
8655045|NCT00667225|9697482|FG000|COMPLETED|Overall Study||15
8655046|NCT00667225|9697483|FG001|COMPLETED|Overall Study||12
8655047|NCT00667225|9697482|FG000|NOT COMPLETED|Overall Study||1
8655048|NCT00667225|9697483|FG001|NOT COMPLETED|Overall Study||1
8655049|NCT00667277|9697489|FG000|STARTED|Overall Study||13
8655050|NCT00667277|9697489|FG000|COMPLETED|Overall Study||11
8655051|NCT00667277|9697489|FG000|NOT COMPLETED|Overall Study||2
8655052|NCT00667342|9697496|FG000|STARTED|Overall Study||31
8655053|NCT00667342|9697497|FG001|STARTED|Overall Study||0
8655054|NCT00667342|9697498|FG002|STARTED|Overall Study||12
8655055|NCT00667342|9697496|FG000|COMPLETED|Overall Study||17
8655056|NCT00667342|9697497|FG001|COMPLETED|Overall Study||0
8655057|NCT00667342|9697498|FG002|COMPLETED|Overall Study||3
8655058|NCT00667342|9697496|FG000|NOT COMPLETED|Overall Study||14
8655059|NCT00667342|9697497|FG001|NOT COMPLETED|Overall Study||0
8655060|NCT00667342|9697498|FG002|NOT COMPLETED|Overall Study||9
8655061|NCT00667355|9697512|FG000|STARTED|Overall Study||41
8655062|NCT00667355|9697512|FG000|COMPLETED|Overall Study||30
8655063|NCT00667355|9697512|FG000|NOT COMPLETED|Overall Study||11
8655064|NCT00667368|9697518|FG000|STARTED|Overall Study||682
8655065|NCT00667368|9697519|FG001|STARTED|Overall Study||683
8655066|NCT00667368|9697518|FG000|COMPLETED|Overall Study||482
8655067|NCT00667368|9697519|FG001|COMPLETED|Overall Study||511
8655068|NCT00667368|9697518|FG000|NOT COMPLETED|Overall Study||200
8655069|NCT00667368|9697519|FG001|NOT COMPLETED|Overall Study||172
8655070|NCT00667381|9697527|FG000|STARTED|Overall Study||501
8655071|NCT00667381|9697528|FG001|STARTED|Overall Study||503
8655072|NCT00667381|9697527|FG000|COMPLETED|Overall Study||501
8655073|NCT00667381|9697528|FG001|COMPLETED|Overall Study||503
8655074|NCT00667381|9697527|FG000|NOT COMPLETED|Overall Study||0
8655075|NCT00667381|9697528|FG001|NOT COMPLETED|Overall Study||0
8655076|NCT00667394|9697536|FG000|STARTED|Overall Study||41
8655077|NCT00667394|9697537|FG001|STARTED|Overall Study||1
8655078|NCT00667394|9697536|FG000|COMPLETED|Overall Study||37
8655079|NCT00667394|9697537|FG001|COMPLETED|Overall Study||1
8655080|NCT00667394|9697536|FG000|NOT COMPLETED|Overall Study||4
8655081|NCT00667394|9697537|FG001|NOT COMPLETED|Overall Study||0
8655082|NCT00667420|9697543|FG000|STARTED|Overall Study||17
8655083|NCT00667420|9697543|FG000|Completion of Pre-operative EOX-P|Overall Study||15
8655084|NCT00667420|9697543|FG000|Completion of Surgery/Re-staging|Overall Study||11
8655085|NCT00667420|9697543|FG000|COMPLETED|Overall Study||7
8655086|NCT00667420|9697543|FG000|NOT COMPLETED|Overall Study||10
8655087|NCT00667446|9697550|FG000|STARTED|Treatment Period (36 Months)||34
8655088|NCT00667446|9697551|FG001|STARTED|Treatment Period (36 Months)||38
8655089|NCT00667446|9697550|FG000|COMPLETED|Treatment Period (36 Months)||11
8655090|NCT00667446|9697551|FG001|COMPLETED|Treatment Period (36 Months)||13
8655091|NCT00667446|9697550|FG000|NOT COMPLETED|Treatment Period (36 Months)||23
8655092|NCT00667446|9697551|FG001|NOT COMPLETED|Treatment Period (36 Months)||25
8655093|NCT00667446|9697550|FG000|STARTED|Safety Follow-up Period (12 Weeks)||28
8655094|NCT00667446|9697551|FG001|STARTED|Safety Follow-up Period (12 Weeks)||26
8655095|NCT00667446|9697550|FG000|COMPLETED|Safety Follow-up Period (12 Weeks)||28
8655096|NCT00667446|9697551|FG001|COMPLETED|Safety Follow-up Period (12 Weeks)||25
8655097|NCT00667446|9697550|FG000|NOT COMPLETED|Safety Follow-up Period (12 Weeks)||0
8655098|NCT00667446|9697551|FG001|NOT COMPLETED|Safety Follow-up Period (12 Weeks)||1
8655099|NCT00667459|9697559|FG000|STARTED|Overall Study||280
8655100|NCT00667459|9697560|FG001|STARTED|Overall Study||265
8655101|NCT00667459|9697559|FG000|COMPLETED|Overall Study||272
8655102|NCT00667459|9697560|FG001|COMPLETED|Overall Study||220
8655103|NCT00667459|9697559|FG000|NOT COMPLETED|Overall Study||8
8655104|NCT00667459|9697560|FG001|NOT COMPLETED|Overall Study||45
8655105|NCT00667511|9697566|FG000|STARTED|Intervention 1: Home DHD||58
8655106|NCT00667511|9697566|FG000|COMPLETED|Intervention 1: Home DHD||51
8655107|NCT00667511|9697566|FG000|NOT COMPLETED|Intervention 1: Home DHD||7
8655108|NCT00667511|9697566|FG000|STARTED|Training/Transition Period||51
8655109|NCT00667511|9697566|FG000|COMPLETED|Training/Transition Period||43
8655110|NCT00667511|9697566|FG000|NOT COMPLETED|Training/Transition Period||8
8655111|NCT00667511|9697566|FG000|STARTED|Intervention 2: Home NHD||43
8655112|NCT00667511|9697566|FG000|COMPLETED|Intervention 2: Home NHD||39
8655113|NCT00667511|9697566|FG000|NOT COMPLETED|Intervention 2: Home NHD||4
8655114|NCT00667563|9697572|FG000|STARTED|Overall Study||150
8655115|NCT00667563|9697572|FG000|COMPLETED|Overall Study||126
8655116|NCT00667563|9697572|FG000|NOT COMPLETED|Overall Study||24
8655117|NCT00667576|9697581|FG000|STARTED|Overall Study||30
8655118|NCT00667576|9697582|FG001|STARTED|Overall Study||31
8655119|NCT00667576|9697583|FG002|STARTED|Overall Study||31
8655120|NCT00667576|9697584|FG003|STARTED|Overall Study||31
8655121|NCT00667576|9697585|FG004|STARTED|Overall Study||30
8655122|NCT00667576|9697581|FG000|COMPLETED|Overall Study||28
8655123|NCT00667576|9697582|FG001|COMPLETED|Overall Study||30
8655124|NCT00667576|9697583|FG002|COMPLETED|Overall Study||29
8655125|NCT00667576|9697584|FG003|COMPLETED|Overall Study||27
8655126|NCT00667576|9697585|FG004|COMPLETED|Overall Study||29
8728949|NCT01050231|9775946|FG000|NOT COMPLETED|Overall Study||0
8728950|NCT01050231|9775947|FG001|NOT COMPLETED|Overall Study||0
8728951|NCT01050257|9775956|FG000|STARTED|Overall Study||50
8728952|NCT01050257|9775957|FG001|STARTED|Overall Study||53
8728953|NCT01050257|9775958|FG002|STARTED|Overall Study||15
8728954|NCT01050257|9775956|FG000|Received Treatment|Overall Study||49
8728955|NCT01050257|9775957|FG001|Received Treatment|Overall Study||50
8728956|NCT01050257|9775958|FG002|Received Treatment|Overall Study||14
8728957|NCT01050257|9775956|FG000|Safety Population: Actual Dose Received|Overall Study||48
8728958|NCT01050257|9775957|FG001|Safety Population: Actual Dose Received|Overall Study|One participant randomized to 100 mg actually received the 200 mg doses.|51
8728959|NCT01050257|9775958|FG002|Safety Population: Actual Dose Received|Overall Study||14
8728960|NCT01050257|9775956|FG000|Intent-to-treat Infected Confirmed|Overall Study||30
8728961|NCT01050257|9775957|FG001|Intent-to-treat Infected Confirmed|Overall Study||32
8728962|NCT01050257|9775958|FG002|Intent-to-treat Infected Confirmed|Overall Study||10
8728963|NCT01050257|9775956|FG000|Switched to Oral Treatment|Overall Study||28
8728964|NCT01050257|9775957|FG001|Switched to Oral Treatment|Overall Study||31
8728965|NCT01050257|9775958|FG002|Switched to Oral Treatment|Overall Study||3
8728966|NCT01050257|9775956|FG000|COMPLETED|Overall Study|Completed 5 days of treatment either IV or Oral|39
8728967|NCT01050257|9775957|FG001|COMPLETED|Overall Study||40
8655127|NCT00667576|9697581|FG000|NOT COMPLETED|Overall Study||2
8655128|NCT00667576|9697582|FG001|NOT COMPLETED|Overall Study||1
8655129|NCT00667576|9697583|FG002|NOT COMPLETED|Overall Study||2
8655130|NCT00667576|9697584|FG003|NOT COMPLETED|Overall Study||4
8655131|NCT00667576|9697585|FG004|NOT COMPLETED|Overall Study||1
8655132|NCT00667589|9697601|FG000|STARTED|Overall Study||1
8655133|NCT00667589|9697602|FG001|STARTED|Overall Study||0
8655134|NCT00667589|9697603|FG002|STARTED|Overall Study||3
8655135|NCT00667589|9697604|FG003|STARTED|Overall Study||2
8655136|NCT00667589|9697601|FG000|COMPLETED|Overall Study||0
8655137|NCT00667589|9697602|FG001|COMPLETED|Overall Study||0
8655138|NCT00667589|9697603|FG002|COMPLETED|Overall Study||0
8655139|NCT00667589|9697604|FG003|COMPLETED|Overall Study||1
8655140|NCT00667589|9697601|FG000|NOT COMPLETED|Overall Study||1
8655141|NCT00667589|9697602|FG001|NOT COMPLETED|Overall Study||0
8655142|NCT00667589|9697603|FG002|NOT COMPLETED|Overall Study||3
8655143|NCT00667589|9697604|FG003|NOT COMPLETED|Overall Study||1
8655144|NCT00667602|9697617|FG000|STARTED|Overall Study||219
8655145|NCT00667602|9697618|FG001|STARTED|Overall Study||228
8655146|NCT00667602|9697619|FG002|STARTED|Overall Study||215
8655147|NCT00667602|9697617|FG000|COMPLETED|Overall Study||211
8655148|NCT00667602|9697618|FG001|COMPLETED|Overall Study||213
8655149|NCT00667602|9697619|FG002|COMPLETED|Overall Study||197
8655150|NCT00667602|9697617|FG000|NOT COMPLETED|Overall Study||8
8655151|NCT00667602|9697618|FG001|NOT COMPLETED|Overall Study||15
8655152|NCT00667602|9697619|FG002|NOT COMPLETED|Overall Study||18
8655153|NCT00667615|9697632|FG000|STARTED|Overall Study||30
8655154|NCT00667615|9697632|FG000|COMPLETED|Overall Study||30
8655155|NCT00667615|9697632|FG000|NOT COMPLETED|Overall Study||0
8655156|NCT00667693|9697638|FG000|STARTED|Overall Study||49
8655157|NCT00667693|9697639|FG001|STARTED|Overall Study||52
8655158|NCT00667693|9697638|FG000|COMPLETED|Overall Study||49
8655159|NCT00667693|9697639|FG001|COMPLETED|Overall Study||50
8655160|NCT00667693|9697638|FG000|NOT COMPLETED|Overall Study||0
8655161|NCT00667693|9697639|FG001|NOT COMPLETED|Overall Study||2
8655162|NCT00667719|9697645|FG000|STARTED|Overall Study||564
8655163|NCT00667719|9697645|FG000|COMPLETED|Overall Study||493
8655164|NCT00667719|9697645|FG000|NOT COMPLETED|Overall Study||71
8655165|NCT00667732|9697656|FG000|STARTED|Run -In (8 Weeks)||41
8655166|NCT00667732|9697657|FG001|STARTED|Run -In (8 Weeks)||0
8655167|NCT00667732|9697658|FG002|STARTED|Run -In (8 Weeks)||0
8655168|NCT00667732|9697656|FG000|Participants Enrolled in Substudy|Run -In (8 Weeks)||20
8655169|NCT00667732|9697657|FG001|Participants Enrolled in Substudy|Run -In (8 Weeks)||0
8655170|NCT00667732|9697658|FG002|Participants Enrolled in Substudy|Run -In (8 Weeks)||0
8655171|NCT00667732|9697656|FG000|COMPLETED|Run -In (8 Weeks)||34
8655172|NCT00667732|9697657|FG001|COMPLETED|Run -In (8 Weeks)||0
8655173|NCT00667732|9697658|FG002|COMPLETED|Run -In (8 Weeks)||0
8655174|NCT00667732|9697656|FG000|NOT COMPLETED|Run -In (8 Weeks)||7
8655175|NCT00667732|9697657|FG001|NOT COMPLETED|Run -In (8 Weeks)||0
8655176|NCT00667732|9697658|FG002|NOT COMPLETED|Run -In (8 Weeks)||0
8655177|NCT00667732|9697656|FG000|STARTED|Randomization (24 Weeks)||0
8655178|NCT00667732|9697657|FG001|STARTED|Randomization (24 Weeks)||17
8655179|NCT00667732|9697658|FG002|STARTED|Randomization (24 Weeks)||17
8655180|NCT00667732|9697656|FG000|Participants Enrolled in Substudy|Randomization (24 Weeks)||0
8655181|NCT00667732|9697657|FG001|Participants Enrolled in Substudy|Randomization (24 Weeks)||11
8655182|NCT00667732|9697658|FG002|Participants Enrolled in Substudy|Randomization (24 Weeks)||9
8655183|NCT00667732|9697656|FG000|COMPLETED|Randomization (24 Weeks)||0
8655184|NCT00667732|9697657|FG001|COMPLETED|Randomization (24 Weeks)||16
8655185|NCT00667732|9697658|FG002|COMPLETED|Randomization (24 Weeks)||17
8655186|NCT00667732|9697656|FG000|NOT COMPLETED|Randomization (24 Weeks)||0
8655187|NCT00667732|9697657|FG001|NOT COMPLETED|Randomization (24 Weeks)||1
8655188|NCT00667732|9697658|FG002|NOT COMPLETED|Randomization (24 Weeks)||0
8655189|NCT00667732|9697656|FG000|STARTED|Extension (26 Weeks)||0
8655190|NCT00667732|9697657|FG001|STARTED|Extension (26 Weeks)||14
8655191|NCT00667732|9697658|FG002|STARTED|Extension (26 Weeks)||17
8655192|NCT00667732|9697656|FG000|COMPLETED|Extension (26 Weeks)||0
8655193|NCT00667732|9697657|FG001|COMPLETED|Extension (26 Weeks)||14
8655194|NCT00667732|9697658|FG002|COMPLETED|Extension (26 Weeks)||17
8655195|NCT00667732|9697656|FG000|NOT COMPLETED|Extension (26 Weeks)||0
8655196|NCT00667732|9697657|FG001|NOT COMPLETED|Extension (26 Weeks)||0
8655197|NCT00667732|9697658|FG002|NOT COMPLETED|Extension (26 Weeks)||0
8655198|NCT00667745|9697670|FG000|STARTED|Overall Study||141
8655199|NCT00667745|9697671|FG001|STARTED|Overall Study||142
8655200|NCT00667745|9697670|FG000|COMPLETED|Overall Study||116
8655201|NCT00667745|9697671|FG001|COMPLETED|Overall Study||121
8655202|NCT00667745|9697670|FG000|NOT COMPLETED|Overall Study||25
8655203|NCT00667745|9697671|FG001|NOT COMPLETED|Overall Study||21
8655204|NCT00667810|9697682|FG000|STARTED|Overall Study||269
8655205|NCT00667810|9697683|FG001|STARTED|Overall Study||264
8655206|NCT00667810|9697684|FG002|STARTED|Overall Study||346
8655207|NCT00667810|9697685|FG003|STARTED|Overall Study||11
8655208|NCT00667810|9697682|FG000|Treated|Overall Study||267
8655209|NCT00667810|9697683|FG001|Treated|Overall Study||263
8655210|NCT00667810|9697684|FG002|Treated|Overall Study||344
8655211|NCT00667810|9697685|FG003|Treated|Overall Study||11
8655212|NCT00667810|9697682|FG000|COMPLETED|Overall Study||102
8655213|NCT00667810|9697683|FG001|COMPLETED|Overall Study||94
8655214|NCT00667810|9697684|FG002|COMPLETED|Overall Study||124
8655215|NCT00667810|9697685|FG003|COMPLETED|Overall Study||9
8655216|NCT00667810|9697682|FG000|NOT COMPLETED|Overall Study||167
8655217|NCT00667810|9697683|FG001|NOT COMPLETED|Overall Study||170
8655218|NCT00667810|9697684|FG002|NOT COMPLETED|Overall Study||222
8655219|NCT00667810|9697685|FG003|NOT COMPLETED|Overall Study||2
8655220|NCT00667849|9697702|FG000|STARTED|Overall Study||250
8655221|NCT00667849|9697703|FG001|STARTED|Overall Study||251
8655222|NCT00667849|9697702|FG000|COMPLETED|Overall Study||142
8655223|NCT00667849|9697703|FG001|COMPLETED|Overall Study||130
8655224|NCT00667849|9697702|FG000|NOT COMPLETED|Overall Study||108
8655225|NCT00667849|9697703|FG001|NOT COMPLETED|Overall Study||121
8655226|NCT00667862|9697712|FG000|STARTED|Overall Study||35
8655227|NCT00667862|9697712|FG000|COMPLETED|Overall Study||0
8655228|NCT00667862|9697712|FG000|NOT COMPLETED|Overall Study||35
8655229|NCT00667875|9697719|FG000|STARTED|Overall Study|3 subjects had no data after randomization and were excluded from analysis|23
8655230|NCT00667875|9697720|FG001|STARTED|Overall Study||21
8655231|NCT00667875|9697721|FG002|STARTED|Overall Study|2 subjects had no data following randomization and were excluded from the analysis.|21
8655232|NCT00667875|9697719|FG000|Subjects Included in Analysisd|Overall Study||20
8655233|NCT00667875|9697720|FG001|Subjects Included in Analysisd|Overall Study||21
8655234|NCT00667875|9697721|FG002|Subjects Included in Analysisd|Overall Study||19
8655235|NCT00667875|9697719|FG000|COMPLETED|Overall Study|Subjects who dropped out during treatment are considered completed if they provide end of study data|13
8655236|NCT00667875|9697720|FG001|COMPLETED|Overall Study||10
8655237|NCT00667875|9697721|FG002|COMPLETED|Overall Study||8
8655238|NCT00667875|9697719|FG000|NOT COMPLETED|Overall Study||10
8655239|NCT00667875|9697720|FG001|NOT COMPLETED|Overall Study||11
8655240|NCT00667875|9697721|FG002|NOT COMPLETED|Overall Study||13
8655241|NCT00667888|9697737|FG000|STARTED|Overall Study||111
8655242|NCT00667888|9697738|FG001|STARTED|Overall Study||111
8655243|NCT00667888|9697737|FG000|COMPLETED|Overall Study||101
8655244|NCT00667888|9697738|FG001|COMPLETED|Overall Study||102
8655245|NCT00667888|9697737|FG000|NOT COMPLETED|Overall Study||10
8655246|NCT00667888|9697738|FG001|NOT COMPLETED|Overall Study||9
8655247|NCT00667992|9697746|FG000|STARTED|First Intervention 100 Mcg Twice Daily||49
8655248|NCT00667992|9697747|FG001|STARTED|First Intervention 100 Mcg Twice Daily||50
8655249|NCT00667992|9697746|FG000|COMPLETED|First Intervention 100 Mcg Twice Daily||44
8655250|NCT00667992|9697747|FG001|COMPLETED|First Intervention 100 Mcg Twice Daily||45
8655251|NCT00667992|9697746|FG000|NOT COMPLETED|First Intervention 100 Mcg Twice Daily||5
8655252|NCT00667992|9697747|FG001|NOT COMPLETED|First Intervention 100 Mcg Twice Daily||5
8655253|NCT00667992|9697746|FG000|STARTED|Second Intervention 400 Mcg Twice Daily||44
8655254|NCT00667992|9697747|FG001|STARTED|Second Intervention 400 Mcg Twice Daily||45
8655255|NCT00667992|9697746|FG000|COMPLETED|Second Intervention 400 Mcg Twice Daily||41
8655256|NCT00667992|9697747|FG001|COMPLETED|Second Intervention 400 Mcg Twice Daily||41
8655257|NCT00667992|9697746|FG000|NOT COMPLETED|Second Intervention 400 Mcg Twice Daily||3
8655258|NCT00667992|9697747|FG001|NOT COMPLETED|Second Intervention 400 Mcg Twice Daily||4
8655259|NCT00667992|9697746|FG000|STARTED|Wash-out||41
8655260|NCT00667992|9697747|FG001|STARTED|Wash-out||41
8655261|NCT00667992|9697746|FG000|COMPLETED|Wash-out||34
8655262|NCT00667992|9697747|FG001|COMPLETED|Wash-out||36
8655263|NCT00667992|9697746|FG000|NOT COMPLETED|Wash-out||7
8655264|NCT00667992|9697747|FG001|NOT COMPLETED|Wash-out||5
8655265|NCT00667992|9697746|FG000|STARTED|Third Intervention 100 Mcg Twice Daily||34
8655266|NCT00667992|9697747|FG001|STARTED|Third Intervention 100 Mcg Twice Daily||36
8655267|NCT00667992|9697746|FG000|COMPLETED|Third Intervention 100 Mcg Twice Daily||33
8655268|NCT00667992|9697747|FG001|COMPLETED|Third Intervention 100 Mcg Twice Daily||35
8655269|NCT00667992|9697746|FG000|NOT COMPLETED|Third Intervention 100 Mcg Twice Daily||1
8655270|NCT00667992|9697747|FG001|NOT COMPLETED|Third Intervention 100 Mcg Twice Daily||1
8655271|NCT00667992|9697746|FG000|STARTED|Forth Intervention 400 Mcg Twice Daily||33
8655272|NCT00667992|9697747|FG001|STARTED|Forth Intervention 400 Mcg Twice Daily||35
8655273|NCT00667992|9697746|FG000|COMPLETED|Forth Intervention 400 Mcg Twice Daily||33
8655274|NCT00667992|9697747|FG001|COMPLETED|Forth Intervention 400 Mcg Twice Daily||35
8655275|NCT00667992|9697746|FG000|NOT COMPLETED|Forth Intervention 400 Mcg Twice Daily||0
8655276|NCT00667992|9697747|FG001|NOT COMPLETED|Forth Intervention 400 Mcg Twice Daily||0
8655277|NCT00668148|9697763|FG000|STARTED|Overall Study||113
8655278|NCT00668148|9697763|FG000|Received at Least 1 Dose of Study Drug|Overall Study||111
8655279|NCT00668148|9697763|FG000|COMPLETED|Overall Study||103
8655280|NCT00668148|9697763|FG000|NOT COMPLETED|Overall Study||10
8655281|NCT00668200|9697778|FG000|STARTED|Overall Study||80
8655282|NCT00668200|9697778|FG000|Safety Population|Overall Study|1 patient was not included in the ITT patient was enrolled in error|81
8655283|NCT00668200|9697778|FG000|Intent to Treat (ITT)|Overall Study||80
8655284|NCT00668200|9697778|FG000|COMPLETED|Overall Study||77
8655285|NCT00668200|9697778|FG000|NOT COMPLETED|Overall Study||3
8655286|NCT00668317|9697782|FG000|STARTED|Overall Study||5
8655287|NCT00668317|9697782|FG000|COMPLETED|Overall Study||3
8655288|NCT00668317|9697782|FG000|NOT COMPLETED|Overall Study||2
8655289|NCT00668382|9697786|FG000|STARTED|Overall Study|beginning of trial|11
8655290|NCT00668382|9697786|FG000|COMPLETED|Overall Study||11
8655291|NCT00668382|9697786|FG000|NOT COMPLETED|Overall Study||0
8655292|NCT00668395|9697793|FG000|STARTED|Overall Study||45
8655293|NCT00668395|9697794|FG001|STARTED|Overall Study||22
8655294|NCT00668395|9697795|FG002|STARTED|Overall Study||6
8655295|NCT00668395|9697793|FG000|COMPLETED|Overall Study||39
8655296|NCT00668395|9697794|FG001|COMPLETED|Overall Study||16
8655297|NCT00668395|9697795|FG002|COMPLETED|Overall Study||5
8728968|NCT01050257|9775958|FG002|COMPLETED|Overall Study||8
8655298|NCT00668395|9697793|FG000|NOT COMPLETED|Overall Study||6
8655299|NCT00668395|9697794|FG001|NOT COMPLETED|Overall Study||6
8655300|NCT00668395|9697795|FG002|NOT COMPLETED|Overall Study||1
8655301|NCT00668434|9697805|FG000|STARTED|Primary Outcome Time Point (3 Weeks)|Baseline|181
8655302|NCT00668434|9697806|FG001|STARTED|Primary Outcome Time Point (3 Weeks)|Baseline|88
8655303|NCT00668434|9697805|FG000|COMPLETED|Primary Outcome Time Point (3 Weeks)||179
8655304|NCT00668434|9697806|FG001|COMPLETED|Primary Outcome Time Point (3 Weeks)||88
8655305|NCT00668434|9697805|FG000|NOT COMPLETED|Primary Outcome Time Point (3 Weeks)||2
8655306|NCT00668434|9697806|FG001|NOT COMPLETED|Primary Outcome Time Point (3 Weeks)||0
8655307|NCT00668434|9697805|FG000|STARTED|Secondary Outcome Time Point (52 Weeks)|Baseline|179
8655308|NCT00668434|9697806|FG001|STARTED|Secondary Outcome Time Point (52 Weeks)|Baseline|88
8655309|NCT00668434|9697805|FG000|COMPLETED|Secondary Outcome Time Point (52 Weeks)||157
8655310|NCT00668434|9697806|FG001|COMPLETED|Secondary Outcome Time Point (52 Weeks)||77
8655311|NCT00668434|9697805|FG000|NOT COMPLETED|Secondary Outcome Time Point (52 Weeks)||22
8655312|NCT00668434|9697806|FG001|NOT COMPLETED|Secondary Outcome Time Point (52 Weeks)||11
8655313|NCT00668525|9697815|FG000|STARTED|Overall Study|The number of patients started are based on the Randomized Population.|325
8655314|NCT00668525|9697816|FG001|STARTED|Overall Study|The number of patients started are based on the Randomized Population.|332
8655315|NCT00668525|9697817|FG002|STARTED|Overall Study|The number of patients started are based on the Randomized Population.|220
8655316|NCT00668525|9697815|FG000|COMPLETED|Overall Study|The number of patients completed are based on the Randomized Population.|248
8655317|NCT00668525|9697816|FG001|COMPLETED|Overall Study|The number of patients completed are based on the Randomized Population.|239
8655318|NCT00668525|9697817|FG002|COMPLETED|Overall Study|The number of patients completed are based on the Randomized Population.|167
8655319|NCT00668525|9697815|FG000|NOT COMPLETED|Overall Study||77
8655320|NCT00668525|9697816|FG001|NOT COMPLETED|Overall Study||93
8655321|NCT00668525|9697817|FG002|NOT COMPLETED|Overall Study||53
8655322|NCT00668564|9697825|FG000|STARTED|Overall Study||18
8655323|NCT00668564|9697825|FG000|COMPLETED|Overall Study||18
8655324|NCT00668564|9697825|FG000|NOT COMPLETED|Overall Study||0
8655325|NCT00668707|9697831|FG000|STARTED|Overall Study||356
8655326|NCT00668707|9697832|FG001|STARTED|Overall Study||353
8655327|NCT00668707|9697831|FG000|COMPLETED|Overall Study||157
8655328|NCT00668707|9697832|FG001|COMPLETED|Overall Study||173
8655329|NCT00668707|9697831|FG000|NOT COMPLETED|Overall Study||199
8655330|NCT00668707|9697832|FG001|NOT COMPLETED|Overall Study||180
8655331|NCT00668733|9697845|FG000|STARTED|Overall Study||89
8655332|NCT00668733|9697846|FG001|STARTED|Overall Study||90
8655333|NCT00668733|9697845|FG000|COMPLETED|Overall Study||87
8655334|NCT00668733|9697846|FG001|COMPLETED|Overall Study||83
8655335|NCT00668733|9697845|FG000|NOT COMPLETED|Overall Study||2
8655336|NCT00668733|9697846|FG001|NOT COMPLETED|Overall Study||7
8655337|NCT00668746|9697854|FG000|STARTED|Overall Study||23
8655338|NCT00668746|9697855|FG001|STARTED|Overall Study||12
8655339|NCT00668746|9697854|FG000|COMPLETED|Overall Study||21
8655340|NCT00668746|9697855|FG001|COMPLETED|Overall Study||11
8655341|NCT00668746|9697854|FG000|NOT COMPLETED|Overall Study||2
8655342|NCT00668746|9697855|FG001|NOT COMPLETED|Overall Study||1
8655343|NCT00668811|9697871|FG000|STARTED|Overall Study||23
8655344|NCT00668811|9697871|FG000|COMPLETED|Overall Study||23
8655345|NCT00668811|9697871|FG000|NOT COMPLETED|Overall Study||0
8655346|NCT00668863|9697875|FG000|STARTED|Overall Study||71
8655347|NCT00668863|9697875|FG000|COMPLETED|Overall Study||0
8655348|NCT00668863|9697875|FG000|NOT COMPLETED|Overall Study||71
8655349|NCT00668902|9697882|FG000|STARTED|Overall Study||10
8655350|NCT00668902|9697883|FG001|STARTED|Overall Study||10
8655351|NCT00668902|9697884|FG002|STARTED|Overall Study||5
8655352|NCT00668902|9697882|FG000|COMPLETED|Overall Study||10
8655353|NCT00668902|9697883|FG001|COMPLETED|Overall Study||10
8655354|NCT00668902|9697884|FG002|COMPLETED|Overall Study||5
8655355|NCT00668902|9697882|FG000|NOT COMPLETED|Overall Study||0
8655356|NCT00668902|9697883|FG001|NOT COMPLETED|Overall Study||0
8655357|NCT00668902|9697884|FG002|NOT COMPLETED|Overall Study||0
8655358|NCT00669019|9697892|FG000|STARTED|Overall Study||23
8655359|NCT00669019|9697892|FG000|COMPLETED|Overall Study||23
8655360|NCT00669019|9697892|FG000|NOT COMPLETED|Overall Study||0
8655361|NCT00669032|9697898|FG000|STARTED|Overall Study||153
8655362|NCT00669032|9697899|FG001|STARTED|Overall Study||153
8655363|NCT00669032|9697898|FG000|COMPLETED|Overall Study||109
8655364|NCT00669032|9697899|FG001|COMPLETED|Overall Study||94
8655365|NCT00669032|9697898|FG000|NOT COMPLETED|Overall Study||44
8655366|NCT00669032|9697899|FG001|NOT COMPLETED|Overall Study||59
8655367|NCT00669071|9697905|FG000|STARTED|Overall Study||56
8655368|NCT00669071|9697905|FG000|COMPLETED|Overall Study||52
8655369|NCT00669071|9697905|FG000|NOT COMPLETED|Overall Study||4
8655370|NCT00669110|9697913|FG000|STARTED|Overall Study||20
8655371|NCT00669110|9697914|FG001|STARTED|Overall Study||20
8655372|NCT00669110|9697913|FG000|COMPLETED|Overall Study||12
8655373|NCT00669110|9697914|FG001|COMPLETED|Overall Study||7
8655374|NCT00669110|9697913|FG000|NOT COMPLETED|Overall Study||8
8655375|NCT00669110|9697914|FG001|NOT COMPLETED|Overall Study||13
8655376|NCT00669162|9697920|FG000|STARTED|Overall Study||27
8655377|NCT00669162|9697920|FG000|COMPLETED|Overall Study||26
8655378|NCT00669162|9697920|FG000|NOT COMPLETED|Overall Study||1
8655379|NCT00669214|9697926|FG000|STARTED|Double-Blind Treatment Period (Week 12)||27
8655380|NCT00669214|9697927|FG001|STARTED|Double-Blind Treatment Period (Week 12)||62
8655381|NCT00669214|9697926|FG000|COMPLETED|Double-Blind Treatment Period (Week 12)||22
8655382|NCT00669214|9697927|FG001|COMPLETED|Double-Blind Treatment Period (Week 12)||55
8655383|NCT00669214|9697926|FG000|NOT COMPLETED|Double-Blind Treatment Period (Week 12)||5
8655384|NCT00669214|9697927|FG001|NOT COMPLETED|Double-Blind Treatment Period (Week 12)||7
8692025|NCT00857818|9737412|FG001|Received Treatment|Overall Study||12
8655385|NCT00669214|9697926|FG000|STARTED|Open-Label Treatment Period (Week 24)||22
8655386|NCT00669214|9697927|FG001|STARTED|Open-Label Treatment Period (Week 24)||55
8655387|NCT00669214|9697926|FG000|COMPLETED|Open-Label Treatment Period (Week 24)||18
8655388|NCT00669214|9697927|FG001|COMPLETED|Open-Label Treatment Period (Week 24)||46
8655389|NCT00669214|9697926|FG000|NOT COMPLETED|Open-Label Treatment Period (Week 24)||4
8655390|NCT00669214|9697927|FG001|NOT COMPLETED|Open-Label Treatment Period (Week 24)||9
8655391|NCT00669240|9697937|FG000|STARTED|Overall Study||567
8655392|NCT00669240|9697937|FG000|Assigned to Treatment|Overall Study||566
8655393|NCT00669240|9697937|FG000|Received Treatment|Overall Study||551
8655394|NCT00669240|9697937|FG000|COMPLETED|Overall Study||402
8655395|NCT00669240|9697937|FG000|NOT COMPLETED|Overall Study||165
8728969|NCT01050257|9775956|FG000|NOT COMPLETED|Overall Study||11
8728970|NCT01050257|9775957|FG001|NOT COMPLETED|Overall Study||13
8728971|NCT01050257|9775958|FG002|NOT COMPLETED|Overall Study||7
8728972|NCT01050530|9775968|FG000|STARTED|Overall Study||82
8728973|NCT01050530|9775969|FG001|STARTED|Overall Study||80
8728974|NCT01050530|9775968|FG000|COMPLETED|Overall Study||74
8728975|NCT01050530|9775969|FG001|COMPLETED|Overall Study||70
8728976|NCT01050530|9775968|FG000|NOT COMPLETED|Overall Study||8
8728977|NCT01050530|9775969|FG001|NOT COMPLETED|Overall Study||10
8728978|NCT01050543|9775977|FG000|STARTED|Overall Study|Includes 4 participants who were randomized but discontinued before Treatment Phase.|64
8728979|NCT01050543|9775978|FG001|STARTED|Overall Study|Includes 4 participants who were randomized but discontinued before Treatment Phase.|64
8728980|NCT01050543|9775977|FG000|COMPLETED|Overall Study|Includes 1 participant who started & completed the study but was excluded from Full Analysis Set.|60
8728981|NCT01050543|9775978|FG001|COMPLETED|Overall Study|Includes 1 participant who started & completed the study but was excluded from Full Analysis Set.|60
8728982|NCT01050543|9775977|FG000|NOT COMPLETED|Overall Study||4
8728983|NCT01050543|9775978|FG001|NOT COMPLETED|Overall Study||4
8728984|NCT01050569|9775987|FG000|STARTED|Overall Study||79
8728985|NCT01050569|9775988|FG001|STARTED|Overall Study||76
8728986|NCT01050569|9775989|FG002|STARTED|Overall Study||80
8728987|NCT01050569|9775987|FG000|COMPLETED|Overall Study||41
8728988|NCT01050569|9775988|FG001|COMPLETED|Overall Study||52
8728989|NCT01050569|9775989|FG002|COMPLETED|Overall Study||47
8728990|NCT01050569|9775987|FG000|NOT COMPLETED|Overall Study||38
8728991|NCT01050569|9775988|FG001|NOT COMPLETED|Overall Study||24
8728992|NCT01050569|9775989|FG002|NOT COMPLETED|Overall Study||33
8728993|NCT01050582|9776003|FG000|STARTED|Overall Study||133
8728994|NCT01050582|9776004|FG001|STARTED|Overall Study||51
8728995|NCT01050582|9776003|FG000|COMPLETED|Overall Study||133
8728996|NCT01050582|9776004|FG001|COMPLETED|Overall Study||51
8728997|NCT01050582|9776003|FG000|NOT COMPLETED|Overall Study||0
8728998|NCT01050582|9776004|FG001|NOT COMPLETED|Overall Study||0
8728999|NCT01050634|9776010|FG000|STARTED|Overall Study||980
8729000|NCT01050634|9776010|FG000|Received Treatment|Overall Study||924
8729001|NCT01050634|9776010|FG000|COMPLETED|Overall Study||852
8729002|NCT01050634|9776010|FG000|NOT COMPLETED|Overall Study||128
8729003|NCT01050647|9776016|FG000|STARTED|Overall Study||10
8729004|NCT01050647|9776017|FG001|STARTED|Overall Study||11
8729005|NCT01050647|9776016|FG000|COMPLETED|Overall Study||10
8729006|NCT01050647|9776017|FG001|COMPLETED|Overall Study||11
8729007|NCT01050647|9776016|FG000|NOT COMPLETED|Overall Study||0
8729008|NCT01050647|9776017|FG001|NOT COMPLETED|Overall Study||0
8729009|NCT01050660|9776025|FG000|STARTED|Overall Study||67
8729010|NCT01050660|9776026|FG001|STARTED|Overall Study||69
8729011|NCT01050660|9776025|FG000|COMPLETED|Overall Study||67
8729012|NCT01050660|9776026|FG001|COMPLETED|Overall Study||69
8729013|NCT01050660|9776025|FG000|NOT COMPLETED|Overall Study||0
8729014|NCT01050660|9776026|FG001|NOT COMPLETED|Overall Study||0
8729015|NCT01050673|9776034|FG000|STARTED|Overall Study||21
8729016|NCT01050673|9776035|FG001|STARTED|Overall Study||19
8729017|NCT01050673|9776034|FG000|COMPLETED|Overall Study||17
8729018|NCT01050673|9776035|FG001|COMPLETED|Overall Study||14
8729019|NCT01050673|9776034|FG000|NOT COMPLETED|Overall Study||4
8729020|NCT01050673|9776035|FG001|NOT COMPLETED|Overall Study||5
8729021|NCT01050764|9776041|FG000|STARTED|Overall Study||10
8729022|NCT01050764|9776041|FG000|Received HSCT Graft|Overall Study||8
8729023|NCT01050764|9776041|FG000|Received Infusion of T-reg Cells|Overall Study||7
8729024|NCT01050764|9776041|FG000|Received Infusion of T-con Cells|Overall Study||7
8729025|NCT01050764|9776041|FG000|COMPLETED|Overall Study||7
8729026|NCT01050764|9776041|FG000|NOT COMPLETED|Overall Study||3
8729027|NCT01050790|9776045|FG000|STARTED|Overall Study||17
8729028|NCT01050790|9776045|FG000|COMPLETED|Overall Study||16
8729029|NCT01050790|9776045|FG000|NOT COMPLETED|Overall Study||1
8729030|NCT01050816|9776050|FG000|STARTED|Overall Study||30
8729031|NCT01050816|9776050|FG000|COMPLETED|Overall Study||26
8729032|NCT01050816|9776050|FG000|NOT COMPLETED|Overall Study||4
8729033|NCT01050907|9776054|FG000|STARTED|Overall Study||4
8729034|NCT01050907|9776054|FG000|COMPLETED|Overall Study||4
8729035|NCT01050907|9776054|FG000|NOT COMPLETED|Overall Study||0
8729036|NCT01050946|9776058|FG000|STARTED|Overall Study||1
8729037|NCT01050946|9776058|FG000|COMPLETED|Overall Study|Patient signed consent 2/3/2011. Patient had their transplant 2/15/2011. Patient died 9/2/2011|1
8655396|NCT00669279|9697943|FG000|STARTED|Overall Study||22
8655397|NCT00669279|9697944|FG001|STARTED|Overall Study||19
8729038|NCT01050946|9776058|FG000|NOT COMPLETED|Overall Study||0
8729039|NCT01050998|9776068|FG000|STARTED|Overall Study||48
8729040|NCT01050998|9776069|FG001|STARTED|Overall Study||49
8655398|NCT00669279|9697943|FG000|COMPLETED|Overall Study||22
8655399|NCT00669279|9697944|FG001|COMPLETED|Overall Study||19
8655400|NCT00669279|9697943|FG000|NOT COMPLETED|Overall Study||0
8655401|NCT00669279|9697944|FG001|NOT COMPLETED|Overall Study||0
8655402|NCT00669318|9697950|FG000|STARTED|Overall Study||41
8655403|NCT00669318|9697950|FG000|COMPLETED|Overall Study||39
8655404|NCT00669318|9697950|FG000|NOT COMPLETED|Overall Study||2
8655405|NCT00669331|9697956|FG000|STARTED|Randomisation to First Dose||244
8655406|NCT00669331|9697957|FG001|STARTED|Randomisation to First Dose||241
8655407|NCT00669331|9697956|FG000|COMPLETED|Randomisation to First Dose||233
8655408|NCT00669331|9697957|FG001|COMPLETED|Randomisation to First Dose||228
8655409|NCT00669331|9697956|FG000|NOT COMPLETED|Randomisation to First Dose||11
8655410|NCT00669331|9697957|FG001|NOT COMPLETED|Randomisation to First Dose||13
8655411|NCT00669331|9697956|FG000|STARTED|Blinded Treatment Period||233
8655412|NCT00669331|9697957|FG001|STARTED|Blinded Treatment Period||228
8655413|NCT00669331|9697956|FG000|COMPLETED|Blinded Treatment Period||191
8655414|NCT00669331|9697957|FG001|COMPLETED|Blinded Treatment Period||189
8655415|NCT00669331|9697956|FG000|NOT COMPLETED|Blinded Treatment Period||42
8655416|NCT00669331|9697957|FG001|NOT COMPLETED|Blinded Treatment Period||39
8655417|NCT00669383|9697967|FG000|STARTED|Overall Study||44
8655418|NCT00669383|9697968|FG001|STARTED|Overall Study||41
8655419|NCT00669383|9697967|FG000|COMPLETED|Overall Study||44
8655420|NCT00669383|9697968|FG001|COMPLETED|Overall Study||41
8655421|NCT00669383|9697967|FG000|NOT COMPLETED|Overall Study||0
8655422|NCT00669383|9697968|FG001|NOT COMPLETED|Overall Study||0
8655423|NCT00669396|9697976|FG000|STARTED|Overall Study||23
8655424|NCT00669396|9697977|FG001|STARTED|Overall Study||34
8655425|NCT00669396|9697976|FG000|COMPLETED|Overall Study||13
8655426|NCT00669396|9697977|FG001|COMPLETED|Overall Study||22
8655427|NCT00669396|9697976|FG000|NOT COMPLETED|Overall Study||10
8655428|NCT00669396|9697977|FG001|NOT COMPLETED|Overall Study||12
8655429|NCT00669409|9697989|FG000|STARTED|Part 1||6
8655430|NCT00669409|9697990|FG001|STARTED|Part 1||6
8655431|NCT00669409|9697991|FG002|STARTED|Part 1||6
8655432|NCT00669409|9697992|FG003|STARTED|Part 1||6
8655433|NCT00669409|9697993|FG004|STARTED|Part 1||6
8655434|NCT00669409|9697994|FG005|STARTED|Part 1||12
8655435|NCT00669409|9697995|FG006|STARTED|Part 1||0
8655436|NCT00669409|9697996|FG007|STARTED|Part 1||0
8655437|NCT00669409|9697997|FG008|STARTED|Part 1||0
8655438|NCT00669409|9697998|FG009|STARTED|Part 1||0
8655439|NCT00669409|9697999|FG010|STARTED|Part 1||0
8655440|NCT00669409|9697989|FG000|COMPLETED|Part 1||6
8655441|NCT00669409|9697990|FG001|COMPLETED|Part 1||6
8655442|NCT00669409|9697991|FG002|COMPLETED|Part 1||6
8655443|NCT00669409|9697992|FG003|COMPLETED|Part 1||6
8655444|NCT00669409|9697993|FG004|COMPLETED|Part 1||6
8655445|NCT00669409|9697994|FG005|COMPLETED|Part 1||12
8655446|NCT00669409|9697995|FG006|COMPLETED|Part 1||0
8655447|NCT00669409|9697996|FG007|COMPLETED|Part 1||0
8655448|NCT00669409|9697997|FG008|COMPLETED|Part 1||0
8655449|NCT00669409|9697998|FG009|COMPLETED|Part 1||0
8655450|NCT00669409|9697999|FG010|COMPLETED|Part 1||0
8655451|NCT00669409|9697989|FG000|NOT COMPLETED|Part 1||0
8655452|NCT00669409|9697990|FG001|NOT COMPLETED|Part 1||0
8655453|NCT00669409|9697991|FG002|NOT COMPLETED|Part 1||0
8655454|NCT00669409|9697992|FG003|NOT COMPLETED|Part 1||0
8655455|NCT00669409|9697993|FG004|NOT COMPLETED|Part 1||0
8655456|NCT00669409|9697994|FG005|NOT COMPLETED|Part 1||0
8655457|NCT00669409|9697995|FG006|NOT COMPLETED|Part 1||0
8655458|NCT00669409|9697996|FG007|NOT COMPLETED|Part 1||0
8655459|NCT00669409|9697997|FG008|NOT COMPLETED|Part 1||0
8655460|NCT00669409|9697998|FG009|NOT COMPLETED|Part 1||0
8655461|NCT00669409|9697999|FG010|NOT COMPLETED|Part 1||0
8655462|NCT00669409|9697989|FG000|STARTED|Part 2||0
8655463|NCT00669409|9697990|FG001|STARTED|Part 2||0
8655464|NCT00669409|9697991|FG002|STARTED|Part 2||0
8655465|NCT00669409|9697992|FG003|STARTED|Part 2||0
8655466|NCT00669409|9697993|FG004|STARTED|Part 2||0
8655467|NCT00669409|9697994|FG005|STARTED|Part 2||0
8655468|NCT00669409|9697995|FG006|STARTED|Part 2||9
8655469|NCT00669409|9697996|FG007|STARTED|Part 2||9
8655470|NCT00669409|9697997|FG008|STARTED|Part 2||9
8655471|NCT00669409|9697998|FG009|STARTED|Part 2||10
8655472|NCT00669409|9697999|FG010|STARTED|Part 2||4
8655473|NCT00669409|9697989|FG000|COMPLETED|Part 2||0
8655474|NCT00669409|9697990|FG001|COMPLETED|Part 2||0
8655475|NCT00669409|9697991|FG002|COMPLETED|Part 2||0
8655476|NCT00669409|9697992|FG003|COMPLETED|Part 2||0
8655477|NCT00669409|9697993|FG004|COMPLETED|Part 2||0
8655478|NCT00669409|9697994|FG005|COMPLETED|Part 2||0
8655479|NCT00669409|9697995|FG006|COMPLETED|Part 2||9
8655480|NCT00669409|9697996|FG007|COMPLETED|Part 2||9
8655481|NCT00669409|9697997|FG008|COMPLETED|Part 2||9
8655482|NCT00669409|9697998|FG009|COMPLETED|Part 2||9
8655483|NCT00669409|9697999|FG010|COMPLETED|Part 2||4
8655484|NCT00669409|9697989|FG000|NOT COMPLETED|Part 2||0
8655485|NCT00669409|9697990|FG001|NOT COMPLETED|Part 2||0
8655486|NCT00669409|9697991|FG002|NOT COMPLETED|Part 2||0
8655487|NCT00669409|9697992|FG003|NOT COMPLETED|Part 2||0
8655488|NCT00669409|9697993|FG004|NOT COMPLETED|Part 2||0
8655489|NCT00669409|9697994|FG005|NOT COMPLETED|Part 2||0
8655490|NCT00669409|9697995|FG006|NOT COMPLETED|Part 2||0
8655491|NCT00669409|9697996|FG007|NOT COMPLETED|Part 2||0
8655492|NCT00669409|9697997|FG008|NOT COMPLETED|Part 2||0
8655493|NCT00669409|9697998|FG009|NOT COMPLETED|Part 2||1
8655494|NCT00669409|9697999|FG010|NOT COMPLETED|Part 2||0
8655495|NCT00669539|9698028|FG000|STARTED|Overall Study||94
8655496|NCT00669539|9698029|FG001|STARTED|Overall Study||52
8655497|NCT00669539|9698028|FG000|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|86
8655498|NCT00669539|9698029|FG001|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|43
8655499|NCT00669539|9698028|FG000|NOT COMPLETED|Overall Study||8
8655500|NCT00669539|9698029|FG001|NOT COMPLETED|Overall Study||9
8655501|NCT00669552|9698035|FG000|STARTED|Overall Study||11
8655502|NCT00669552|9698035|FG000|COMPLETED|Overall Study||11
8655503|NCT00669552|9698035|FG000|NOT COMPLETED|Overall Study||0
8655504|NCT00669578|9698041|FG000|STARTED|Overall Study||12
8655505|NCT00669578|9698042|FG001|STARTED|Overall Study||65
8655506|NCT00669578|9698041|FG000|COMPLETED|Overall Study||12
8655507|NCT00669578|9698042|FG001|COMPLETED|Overall Study||65
8655508|NCT00669578|9698041|FG000|NOT COMPLETED|Overall Study||0
8655509|NCT00669578|9698042|FG001|NOT COMPLETED|Overall Study||0
8655510|NCT00669617|9698049|FG000|STARTED|Period 1||18
8655511|NCT00669617|9698050|FG001|STARTED|Period 1||17
8655512|NCT00669617|9698051|FG002|STARTED|Period 1||18
8655513|NCT00669617|9698052|FG003|STARTED|Period 1||18
8655514|NCT00669617|9698053|FG004|STARTED|Period 1||18
8655515|NCT00669617|9698049|FG000|COMPLETED|Period 1||18
8655516|NCT00669617|9698050|FG001|COMPLETED|Period 1||17
8655517|NCT00669617|9698051|FG002|COMPLETED|Period 1||17
8655518|NCT00669617|9698052|FG003|COMPLETED|Period 1||18
8655519|NCT00669617|9698053|FG004|COMPLETED|Period 1||17
8655520|NCT00669617|9698049|FG000|NOT COMPLETED|Period 1||0
8655521|NCT00669617|9698050|FG001|NOT COMPLETED|Period 1||0
8655522|NCT00669617|9698051|FG002|NOT COMPLETED|Period 1||1
8655523|NCT00669617|9698052|FG003|NOT COMPLETED|Period 1||0
8655524|NCT00669617|9698053|FG004|NOT COMPLETED|Period 1||1
8655525|NCT00669617|9698049|FG000|STARTED|Period 2||18
8655526|NCT00669617|9698050|FG001|STARTED|Period 2||17
8655527|NCT00669617|9698051|FG002|STARTED|Period 2||17
8655528|NCT00669617|9698052|FG003|STARTED|Period 2||18
8655529|NCT00669617|9698053|FG004|STARTED|Period 2||17
8655530|NCT00669617|9698049|FG000|COMPLETED|Period 2||18
8655531|NCT00669617|9698050|FG001|COMPLETED|Period 2||17
8655532|NCT00669617|9698051|FG002|COMPLETED|Period 2||17
8655533|NCT00669617|9698052|FG003|COMPLETED|Period 2||18
8655534|NCT00669617|9698053|FG004|COMPLETED|Period 2||17
8655535|NCT00669617|9698049|FG000|NOT COMPLETED|Period 2||0
8655536|NCT00669617|9698050|FG001|NOT COMPLETED|Period 2||0
8655537|NCT00669617|9698051|FG002|NOT COMPLETED|Period 2||0
8655538|NCT00669617|9698052|FG003|NOT COMPLETED|Period 2||0
8655539|NCT00669617|9698053|FG004|NOT COMPLETED|Period 2||0
8655540|NCT00669617|9698049|FG000|STARTED|Period 3||18
8655541|NCT00669617|9698050|FG001|STARTED|Period 3||17
8655542|NCT00669617|9698051|FG002|STARTED|Period 3||17
8655543|NCT00669617|9698052|FG003|STARTED|Period 3||18
8655544|NCT00669617|9698053|FG004|STARTED|Period 3||17
8655545|NCT00669617|9698049|FG000|COMPLETED|Period 3||17
8655546|NCT00669617|9698050|FG001|COMPLETED|Period 3||17
8655547|NCT00669617|9698051|FG002|COMPLETED|Period 3||17
8655548|NCT00669617|9698052|FG003|COMPLETED|Period 3||18
8655549|NCT00669617|9698053|FG004|COMPLETED|Period 3||17
8655550|NCT00669617|9698049|FG000|NOT COMPLETED|Period 3||1
8655551|NCT00669617|9698050|FG001|NOT COMPLETED|Period 3||0
8655552|NCT00669617|9698051|FG002|NOT COMPLETED|Period 3||0
8655553|NCT00669617|9698052|FG003|NOT COMPLETED|Period 3||0
8655554|NCT00669617|9698053|FG004|NOT COMPLETED|Period 3||0
8655555|NCT00669617|9698049|FG000|STARTED|Period 4||17
8655556|NCT00669617|9698050|FG001|STARTED|Period 4||17
8655557|NCT00669617|9698051|FG002|STARTED|Period 4||17
8655558|NCT00669617|9698052|FG003|STARTED|Period 4||18
8655559|NCT00669617|9698053|FG004|STARTED|Period 4||17
8655560|NCT00669617|9698049|FG000|COMPLETED|Period 4||17
8655561|NCT00669617|9698050|FG001|COMPLETED|Period 4||17
8655562|NCT00669617|9698051|FG002|COMPLETED|Period 4||17
8655563|NCT00669617|9698052|FG003|COMPLETED|Period 4||18
8655564|NCT00669617|9698053|FG004|COMPLETED|Period 4||17
8655565|NCT00669617|9698049|FG000|NOT COMPLETED|Period 4||0
8655566|NCT00669617|9698050|FG001|NOT COMPLETED|Period 4||0
8655567|NCT00669617|9698051|FG002|NOT COMPLETED|Period 4||0
8655568|NCT00669617|9698052|FG003|NOT COMPLETED|Period 4||0
8655569|NCT00669617|9698053|FG004|NOT COMPLETED|Period 4||0
8655570|NCT00669617|9698049|FG000|STARTED|Period 5||17
8655571|NCT00669617|9698050|FG001|STARTED|Period 5||17
8655572|NCT00669617|9698051|FG002|STARTED|Period 5||17
8655573|NCT00669617|9698052|FG003|STARTED|Period 5||18
8655574|NCT00669617|9698053|FG004|STARTED|Period 5||17
8655575|NCT00669617|9698049|FG000|COMPLETED|Period 5||17
8655576|NCT00669617|9698050|FG001|COMPLETED|Period 5||17
8655577|NCT00669617|9698051|FG002|COMPLETED|Period 5||17
8655578|NCT00669617|9698052|FG003|COMPLETED|Period 5||18
8655579|NCT00669617|9698053|FG004|COMPLETED|Period 5||17
8655580|NCT00669617|9698049|FG000|NOT COMPLETED|Period 5||0
8655581|NCT00669617|9698050|FG001|NOT COMPLETED|Period 5||0
8655582|NCT00669617|9698051|FG002|NOT COMPLETED|Period 5||0
8655583|NCT00669617|9698052|FG003|NOT COMPLETED|Period 5||0
8655584|NCT00669617|9698053|FG004|NOT COMPLETED|Period 5||0
8655585|NCT00669682|9698065|FG000|STARTED|Overall Study||9
8655586|NCT00669682|9698065|FG000|COMPLETED|Overall Study||9
8655587|NCT00669682|9698065|FG000|NOT COMPLETED|Overall Study||0
8655588|NCT00669864|9698070|FG000|STARTED|Overall Study||293
8655589|NCT00669864|9698070|FG000|COMPLETED|Overall Study||284
8655590|NCT00669864|9698070|FG000|NOT COMPLETED|Overall Study||9
8655591|NCT00669877|9698074|FG000|STARTED|Overall Study||56
8655592|NCT00669877|9698074|FG000|COMPLETED|Overall Study||52
8655593|NCT00669877|9698074|FG000|NOT COMPLETED|Overall Study||4
8655594|NCT00669903|9698082|FG000|STARTED|Overall Study||23
8655595|NCT00669903|9698083|FG001|STARTED|Overall Study||37
8655596|NCT00669903|9698084|FG002|STARTED|Overall Study||18
8655597|NCT00669903|9698085|FG003|STARTED|Overall Study||22
8655598|NCT00669903|9698082|FG000|Completed Treatment Period|Overall Study||23
8655599|NCT00669903|9698083|FG001|Completed Treatment Period|Overall Study||33
8655600|NCT00669903|9698084|FG002|Completed Treatment Period|Overall Study||13
8655601|NCT00669903|9698085|FG003|Completed Treatment Period|Overall Study||19
8655602|NCT00669903|9698082|FG000|COMPLETED|Overall Study||22
8655603|NCT00669903|9698083|FG001|COMPLETED|Overall Study||32
8655604|NCT00669903|9698084|FG002|COMPLETED|Overall Study||13
8655605|NCT00669903|9698085|FG003|COMPLETED|Overall Study||18
8655606|NCT00669903|9698082|FG000|NOT COMPLETED|Overall Study||1
8655607|NCT00669903|9698083|FG001|NOT COMPLETED|Overall Study||5
8655608|NCT00669903|9698084|FG002|NOT COMPLETED|Overall Study||5
8655609|NCT00669903|9698085|FG003|NOT COMPLETED|Overall Study||4
8655610|NCT00669916|9698097|FG000|STARTED|Overall Study||18
8655611|NCT00669916|9698098|FG001|STARTED|Overall Study||18
8655612|NCT00669916|9698097|FG000|COMPLETED|Overall Study||18
8655613|NCT00669916|9698098|FG001|COMPLETED|Overall Study||18
8655614|NCT00669916|9698097|FG000|NOT COMPLETED|Overall Study||0
8655615|NCT00669916|9698098|FG001|NOT COMPLETED|Overall Study||0
8692026|NCT00857818|9737411|FG000|COMPLETED|Overall Study||3
8692027|NCT00857818|9737412|FG001|COMPLETED|Overall Study||6
8692028|NCT00857818|9737411|FG000|NOT COMPLETED|Overall Study||11
8692029|NCT00857818|9737412|FG001|NOT COMPLETED|Overall Study||8
8692030|NCT00857857|9737418|FG000|STARTED|Overall Study||24
8692031|NCT00857857|9737418|FG000|COMPLETED|Overall Study||24
8692032|NCT00857857|9737418|FG000|NOT COMPLETED|Overall Study||0
8692033|NCT00857896|9737430|FG000|STARTED|Baseline to Week 4||21
8692034|NCT00857896|9737430|FG000|COMPLETED|Baseline to Week 4||20
8692035|NCT00857896|9737430|FG000|NOT COMPLETED|Baseline to Week 4||1
8692036|NCT00857896|9737430|FG000|STARTED|Week 5 to Week 8||20
8692037|NCT00857896|9737430|FG000|COMPLETED|Week 5 to Week 8||20
8692038|NCT00857896|9737430|FG000|NOT COMPLETED|Week 5 to Week 8||0
8692039|NCT00857948|9737439|FG000|STARTED|Overall Study||18
8692040|NCT00857948|9737440|FG001|STARTED|Overall Study||18
8692041|NCT00857948|9737441|FG002|STARTED|Overall Study||19
8692042|NCT00857948|9737442|FG003|STARTED|Overall Study||23
8692043|NCT00857948|9737439|FG000|COMPLETED|Overall Study||15
8692044|NCT00857948|9737440|FG001|COMPLETED|Overall Study||18
8692045|NCT00857948|9737441|FG002|COMPLETED|Overall Study||18
8692046|NCT00857948|9737442|FG003|COMPLETED|Overall Study||23
8692047|NCT00857948|9737439|FG000|NOT COMPLETED|Overall Study||3
8692048|NCT00857948|9737440|FG001|NOT COMPLETED|Overall Study||0
8692049|NCT00857948|9737441|FG002|NOT COMPLETED|Overall Study||1
8692050|NCT00857948|9737442|FG003|NOT COMPLETED|Overall Study||0
8692051|NCT00857961|9737452|FG000|STARTED|Overall Study||21
8692052|NCT00857961|9737452|FG000|COMPLETED|Overall Study||21
8692053|NCT00857961|9737452|FG000|NOT COMPLETED|Overall Study||0
8692054|NCT00858013|9737464|FG000|STARTED|Overall Study||46
8692055|NCT00858013|9737465|FG001|STARTED|Overall Study||42
8692056|NCT00858013|9737464|FG000|COMPLETED|Overall Study||24
8692057|NCT00858013|9737465|FG001|COMPLETED|Overall Study||23
8692058|NCT00858013|9737464|FG000|NOT COMPLETED|Overall Study||22
8692059|NCT00858013|9737465|FG001|NOT COMPLETED|Overall Study||19
8692060|NCT00858117|9737471|FG000|STARTED|Treatment on Study||30
8692061|NCT00858117|9737471|FG000|Completed 18 Weeks of Treatment|Treatment on Study||28
8692062|NCT00858117|9737471|FG000|COMPLETED|Treatment on Study||28
8692063|NCT00858117|9737471|FG000|NOT COMPLETED|Treatment on Study||2
8692064|NCT00858117|9737471|FG000|STARTED|Follow up for 5 Years|All patients who receive at least one dose of drug under the protocol go into follow up for survival|30
8692065|NCT00858117|9737471|FG000|COMPLETED|Follow up for 5 Years||17
8692066|NCT00858117|9737471|FG000|NOT COMPLETED|Follow up for 5 Years||13
8692067|NCT00858130|9737475|FG000|STARTED|Overall Study||12
8692068|NCT00858130|9737475|FG000|COMPLETED|Overall Study||12
8692069|NCT00858130|9737475|FG000|NOT COMPLETED|Overall Study||0
8692070|NCT00858143|9737480|FG000|STARTED|Overall Study|Baseline|311
8692071|NCT00858143|9737480|FG000|COMPLETED|Overall Study||261
8692072|NCT00858143|9737480|FG000|NOT COMPLETED|Overall Study||50
8692073|NCT00858208|9737484|FG000|STARTED|Overall Study||85
8692074|NCT00858208|9737484|FG000|COMPLETED|Overall Study||6
8692075|NCT00858208|9737484|FG000|NOT COMPLETED|Overall Study||79
8692076|NCT00858234|9737488|FG000|STARTED|Overall Study||9
8692077|NCT00858234|9737488|FG000|COMPLETED|Overall Study||0
8692078|NCT00858234|9737488|FG000|NOT COMPLETED|Overall Study||9
8692079|NCT00858247|9737494|FG000|STARTED|Baseline Assessment||25
8692080|NCT00858247|9737495|FG001|STARTED|Baseline Assessment||26
8692081|NCT00858247|9737494|FG000|COMPLETED|Baseline Assessment||23
8692082|NCT00858247|9737495|FG001|COMPLETED|Baseline Assessment||24
8692083|NCT00858247|9737494|FG000|NOT COMPLETED|Baseline Assessment||2
8692084|NCT00858247|9737495|FG001|NOT COMPLETED|Baseline Assessment||2
8692085|NCT00858247|9737494|FG000|STARTED|Week 12 Follow-up||23
8692086|NCT00858247|9737495|FG001|STARTED|Week 12 Follow-up||24
8692087|NCT00858247|9737494|FG000|COMPLETED|Week 12 Follow-up||23
8692088|NCT00858247|9737495|FG001|COMPLETED|Week 12 Follow-up||23
8692089|NCT00858247|9737494|FG000|NOT COMPLETED|Week 12 Follow-up||0
8692090|NCT00858247|9737495|FG001|NOT COMPLETED|Week 12 Follow-up||1
8692091|NCT00858364|9737503|FG000|STARTED|Overall Study||846
8692092|NCT00858364|9737504|FG001|STARTED|Overall Study||1703
8655616|NCT00669942|9698116|FG000|STARTED|Part 1||6
8655617|NCT00669942|9698117|FG001|STARTED|Part 1||6
8655618|NCT00669942|9698118|FG002|STARTED|Part 1||6
8655619|NCT00669942|9698119|FG003|STARTED|Part 1||6
8655620|NCT00669942|9698120|FG004|STARTED|Part 1||8
8655621|NCT00669942|9698121|FG005|STARTED|Part 1||0
8655622|NCT00669942|9698122|FG006|STARTED|Part 1||0
8655623|NCT00669942|9698123|FG007|STARTED|Part 1||0
8729041|NCT01050998|9776070|FG002|STARTED|Overall Study||49
8729042|NCT01050998|9776071|FG003|STARTED|Overall Study||48
8729043|NCT01050998|9776072|FG004|STARTED|Overall Study||96
8729044|NCT01050998|9776068|FG000|COMPLETED|Overall Study||44
8729045|NCT01050998|9776069|FG001|COMPLETED|Overall Study||47
8729046|NCT01050998|9776070|FG002|COMPLETED|Overall Study||46
8729047|NCT01050998|9776071|FG003|COMPLETED|Overall Study||45
8729048|NCT01050998|9776072|FG004|COMPLETED|Overall Study||82
8729049|NCT01050998|9776068|FG000|NOT COMPLETED|Overall Study||4
8729050|NCT01050998|9776069|FG001|NOT COMPLETED|Overall Study||2
8729051|NCT01050998|9776070|FG002|NOT COMPLETED|Overall Study||3
8729052|NCT01050998|9776071|FG003|NOT COMPLETED|Overall Study||3
8729053|NCT01050998|9776072|FG004|NOT COMPLETED|Overall Study||14
8729054|NCT01051063|9776090|FG000|STARTED|Overall Study||12
8729055|NCT01051063|9776091|FG001|STARTED|Overall Study||5
8729056|NCT01051063|9776090|FG000|COMPLETED|Overall Study||2
8729057|NCT01051063|9776091|FG001|COMPLETED|Overall Study||1
8729058|NCT01051063|9776090|FG000|NOT COMPLETED|Overall Study||10
8729059|NCT01051063|9776091|FG001|NOT COMPLETED|Overall Study||4
8729060|NCT01051310|9776098|FG000|STARTED|Overall Study||18
8729061|NCT01051310|9776098|FG000|COMPLETED|Overall Study||13
8729062|NCT01051310|9776098|FG000|NOT COMPLETED|Overall Study||5
8729063|NCT01051323|9776104|FG000|STARTED|Overall Study||1580
8729064|NCT01051323|9776104|FG000|Received at Least One Dose|Overall Study||1547
8729065|NCT01051323|9776104|FG000|COMPLETED|Overall Study||1041
8729066|NCT01051323|9776104|FG000|NOT COMPLETED|Overall Study||539
8729067|NCT01051349|9776112|FG000|STARTED|Overall Study||410
8729068|NCT01051349|9776112|FG000|COMPLETED|Overall Study||237
8729069|NCT01051349|9776112|FG000|NOT COMPLETED|Overall Study||173
8729070|NCT01051440|9776121|FG000|STARTED|Overall Study||1
8729071|NCT01051440|9776122|FG001|STARTED|Overall Study||1
8729072|NCT01051440|9776121|FG000|COMPLETED|Overall Study||1
8729073|NCT01051440|9776122|FG001|COMPLETED|Overall Study||1
8729074|NCT01051440|9776121|FG000|NOT COMPLETED|Overall Study||0
8729075|NCT01051440|9776122|FG001|NOT COMPLETED|Overall Study||0
8729076|NCT01051466|9776130|FG000|STARTED|Overall Study||32
8729077|NCT01051466|9776131|FG001|STARTED|Overall Study||28
8729078|NCT01051466|9776130|FG000|COMPLETED|Overall Study||24
8729079|NCT01051466|9776131|FG001|COMPLETED|Overall Study||23
8729080|NCT01051466|9776130|FG000|NOT COMPLETED|Overall Study||8
8911247|NCT02139540|9970305|FG000|COMPLETED|Overall Study||10
8911248|NCT02139540|9970306|FG001|COMPLETED|Overall Study||10
8911249|NCT02139540|9970305|FG000|NOT COMPLETED|Overall Study||1
8911250|NCT02139540|9970306|FG001|NOT COMPLETED|Overall Study||0
8911251|NCT02144519|9970314|FG000|STARTED|Year 1||895
8911252|NCT02144519|9970315|FG001|STARTED|Year 1||870
8911253|NCT02144519|9970314|FG000|COMPLETED|Year 1||895
8911254|NCT02144519|9970315|FG001|COMPLETED|Year 1||870
8911255|NCT02144519|9970314|FG000|NOT COMPLETED|Year 1||0
8911256|NCT02144519|9970315|FG001|NOT COMPLETED|Year 1||0
8911257|NCT02144519|9970314|FG000|STARTED|Year 2||763
8911258|NCT02144519|9970315|FG001|STARTED|Year 2||864
8911259|NCT02144519|9970314|FG000|COMPLETED|Year 2||763
8911260|NCT02144519|9970315|FG001|COMPLETED|Year 2||864
8911261|NCT02144519|9970314|FG000|NOT COMPLETED|Year 2||0
8911262|NCT02144519|9970315|FG001|NOT COMPLETED|Year 2||0
8911263|NCT02144519|9970314|FG000|STARTED|Year 3||894
8911264|NCT02144519|9970315|FG001|STARTED|Year 3||760
8911265|NCT02144519|9970314|FG000|COMPLETED|Year 3||894
8911266|NCT02144519|9970315|FG001|COMPLETED|Year 3||760
8911267|NCT02144519|9970314|FG000|NOT COMPLETED|Year 3||0
8729081|NCT01051466|9776131|FG001|NOT COMPLETED|Overall Study||5
8729082|NCT01051518|9776141|FG000|STARTED|Overall Study||126
8729083|NCT01051518|9776141|FG000|COMPLETED|Overall Study||53
8729084|NCT01051518|9776141|FG000|NOT COMPLETED|Overall Study||73
8911268|NCT02144519|9970315|FG001|NOT COMPLETED|Year 3||0
8729085|NCT01051557|9776157|FG000|STARTED|Overall Study||4
8729086|NCT01051557|9776158|FG001|STARTED|Overall Study||3
8729087|NCT01051557|9776159|FG002|STARTED|Overall Study||6
8729088|NCT01051557|9776160|FG003|STARTED|Overall Study||3
8729089|NCT01051557|9776161|FG004|STARTED|Overall Study||8
8911269|NCT02144597|9970324|FG000|STARTED|Overall Study||10
8911270|NCT02144597|9970325|FG001|STARTED|Overall Study||10
8655624|NCT00669942|9698124|FG008|STARTED|Part 1||0
8655625|NCT00669942|9698125|FG009|STARTED|Part 1||0
8655626|NCT00669942|9698126|FG010|STARTED|Part 1||0
8655627|NCT00669942|9698127|FG011|STARTED|Part 1||0
8729090|NCT01051557|9776162|FG005|STARTED|Overall Study||6
8729091|NCT01051557|9776163|FG006|STARTED|Overall Study||6
8729092|NCT01051557|9776157|FG000|COMPLETED|Overall Study||0
8729093|NCT01051557|9776158|FG001|COMPLETED|Overall Study||0
8729094|NCT01051557|9776159|FG002|COMPLETED|Overall Study||0
8729095|NCT01051557|9776160|FG003|COMPLETED|Overall Study||0
8729096|NCT01051557|9776161|FG004|COMPLETED|Overall Study||1
8729097|NCT01051557|9776162|FG005|COMPLETED|Overall Study||0
8911271|NCT02144597|9970326|FG002|STARTED|Overall Study||10
8911272|NCT02144597|9970324|FG000|COMPLETED|Overall Study||4
8911273|NCT02144597|9970325|FG001|COMPLETED|Overall Study||6
8911274|NCT02144597|9970326|FG002|COMPLETED|Overall Study||6
8655628|NCT00669942|9698116|FG000|COMPLETED|Part 1||6
8655629|NCT00669942|9698117|FG001|COMPLETED|Part 1||6
8655630|NCT00669942|9698118|FG002|COMPLETED|Part 1||6
8655631|NCT00669942|9698119|FG003|COMPLETED|Part 1||6
8655632|NCT00669942|9698120|FG004|COMPLETED|Part 1||8
8655633|NCT00669942|9698121|FG005|COMPLETED|Part 1||0
8655634|NCT00669942|9698122|FG006|COMPLETED|Part 1||0
8655635|NCT00669942|9698123|FG007|COMPLETED|Part 1||0
8655636|NCT00669942|9698124|FG008|COMPLETED|Part 1||0
8655637|NCT00669942|9698125|FG009|COMPLETED|Part 1||0
8655638|NCT00669942|9698126|FG010|COMPLETED|Part 1||0
8655639|NCT00669942|9698127|FG011|COMPLETED|Part 1||0
8655640|NCT00669942|9698116|FG000|NOT COMPLETED|Part 1||0
8655641|NCT00669942|9698117|FG001|NOT COMPLETED|Part 1||0
8655642|NCT00669942|9698118|FG002|NOT COMPLETED|Part 1||0
8655643|NCT00669942|9698119|FG003|NOT COMPLETED|Part 1||0
8655644|NCT00669942|9698120|FG004|NOT COMPLETED|Part 1||0
8655645|NCT00669942|9698121|FG005|NOT COMPLETED|Part 1||0
8655646|NCT00669942|9698122|FG006|NOT COMPLETED|Part 1||0
8655647|NCT00669942|9698123|FG007|NOT COMPLETED|Part 1||0
8655648|NCT00669942|9698124|FG008|NOT COMPLETED|Part 1||0
8655649|NCT00669942|9698125|FG009|NOT COMPLETED|Part 1||0
8655650|NCT00669942|9698126|FG010|NOT COMPLETED|Part 1||0
8655651|NCT00669942|9698127|FG011|NOT COMPLETED|Part 1||0
8655652|NCT00669942|9698116|FG000|STARTED|Parts 2 and 3||0
8655653|NCT00669942|9698117|FG001|STARTED|Parts 2 and 3||0
8655654|NCT00669942|9698118|FG002|STARTED|Parts 2 and 3||0
8655655|NCT00669942|9698119|FG003|STARTED|Parts 2 and 3||0
8655656|NCT00669942|9698120|FG004|STARTED|Parts 2 and 3||0
8655657|NCT00669942|9698121|FG005|STARTED|Parts 2 and 3||6
8655658|NCT00669942|9698122|FG006|STARTED|Parts 2 and 3||6
8655659|NCT00669942|9698123|FG007|STARTED|Parts 2 and 3||26
8655660|NCT00669942|9698124|FG008|STARTED|Parts 2 and 3||26
8655661|NCT00669942|9698125|FG009|STARTED|Parts 2 and 3||0
8655662|NCT00669942|9698126|FG010|STARTED|Parts 2 and 3||0
8655663|NCT00669942|9698127|FG011|STARTED|Parts 2 and 3||0
8655664|NCT00669942|9698116|FG000|COMPLETED|Parts 2 and 3||0
8655665|NCT00669942|9698117|FG001|COMPLETED|Parts 2 and 3||0
8655666|NCT00669942|9698118|FG002|COMPLETED|Parts 2 and 3||0
8655667|NCT00669942|9698119|FG003|COMPLETED|Parts 2 and 3||0
8655668|NCT00669942|9698120|FG004|COMPLETED|Parts 2 and 3||0
8655669|NCT00669942|9698121|FG005|COMPLETED|Parts 2 and 3||4
8655670|NCT00669942|9698122|FG006|COMPLETED|Parts 2 and 3||6
8655671|NCT00669942|9698123|FG007|COMPLETED|Parts 2 and 3||24
8655672|NCT00669942|9698124|FG008|COMPLETED|Parts 2 and 3||23
8655673|NCT00669942|9698125|FG009|COMPLETED|Parts 2 and 3||0
8655674|NCT00669942|9698126|FG010|COMPLETED|Parts 2 and 3||0
8655675|NCT00669942|9698127|FG011|COMPLETED|Parts 2 and 3||0
8655676|NCT00669942|9698116|FG000|NOT COMPLETED|Parts 2 and 3||0
8655677|NCT00669942|9698117|FG001|NOT COMPLETED|Parts 2 and 3||0
8655678|NCT00669942|9698118|FG002|NOT COMPLETED|Parts 2 and 3||0
8655679|NCT00669942|9698119|FG003|NOT COMPLETED|Parts 2 and 3||0
8655680|NCT00669942|9698120|FG004|NOT COMPLETED|Parts 2 and 3||0
8655681|NCT00669942|9698121|FG005|NOT COMPLETED|Parts 2 and 3||2
8655682|NCT00669942|9698122|FG006|NOT COMPLETED|Parts 2 and 3||0
8655683|NCT00669942|9698123|FG007|NOT COMPLETED|Parts 2 and 3||2
8655684|NCT00669942|9698124|FG008|NOT COMPLETED|Parts 2 and 3||3
8655685|NCT00669942|9698125|FG009|NOT COMPLETED|Parts 2 and 3||0
8655686|NCT00669942|9698126|FG010|NOT COMPLETED|Parts 2 and 3||0
8655687|NCT00669942|9698127|FG011|NOT COMPLETED|Parts 2 and 3||0
8655688|NCT00669942|9698116|FG000|STARTED|Healthy Volunteers||0
8655689|NCT00669942|9698117|FG001|STARTED|Healthy Volunteers||0
8655690|NCT00669942|9698118|FG002|STARTED|Healthy Volunteers||0
8655691|NCT00669942|9698119|FG003|STARTED|Healthy Volunteers||0
8655692|NCT00669942|9698120|FG004|STARTED|Healthy Volunteers||0
8655693|NCT00669942|9698121|FG005|STARTED|Healthy Volunteers||0
8655694|NCT00669942|9698122|FG006|STARTED|Healthy Volunteers||0
8655695|NCT00669942|9698123|FG007|STARTED|Healthy Volunteers||0
8655696|NCT00669942|9698124|FG008|STARTED|Healthy Volunteers||0
8655697|NCT00669942|9698125|FG009|STARTED|Healthy Volunteers||3
8655698|NCT00669942|9698126|FG010|STARTED|Healthy Volunteers||3
8655699|NCT00669942|9698127|FG011|STARTED|Healthy Volunteers||2
8655700|NCT00669942|9698116|FG000|COMPLETED|Healthy Volunteers||0
8655701|NCT00669942|9698117|FG001|COMPLETED|Healthy Volunteers||0
8655702|NCT00669942|9698118|FG002|COMPLETED|Healthy Volunteers||0
8655703|NCT00669942|9698119|FG003|COMPLETED|Healthy Volunteers||0
8655704|NCT00669942|9698120|FG004|COMPLETED|Healthy Volunteers||0
8655705|NCT00669942|9698121|FG005|COMPLETED|Healthy Volunteers||0
8655706|NCT00669942|9698122|FG006|COMPLETED|Healthy Volunteers||0
8655707|NCT00669942|9698123|FG007|COMPLETED|Healthy Volunteers||0
8655708|NCT00669942|9698124|FG008|COMPLETED|Healthy Volunteers||0
8655709|NCT00669942|9698125|FG009|COMPLETED|Healthy Volunteers||3
8655710|NCT00669942|9698126|FG010|COMPLETED|Healthy Volunteers||2
8655711|NCT00669942|9698127|FG011|COMPLETED|Healthy Volunteers||2
8655712|NCT00669942|9698116|FG000|NOT COMPLETED|Healthy Volunteers||0
8655713|NCT00669942|9698117|FG001|NOT COMPLETED|Healthy Volunteers||0
8655714|NCT00669942|9698118|FG002|NOT COMPLETED|Healthy Volunteers||0
8655715|NCT00669942|9698119|FG003|NOT COMPLETED|Healthy Volunteers||0
8655716|NCT00669942|9698120|FG004|NOT COMPLETED|Healthy Volunteers||0
8655717|NCT00669942|9698121|FG005|NOT COMPLETED|Healthy Volunteers||0
8655718|NCT00669942|9698122|FG006|NOT COMPLETED|Healthy Volunteers||0
8655719|NCT00669942|9698123|FG007|NOT COMPLETED|Healthy Volunteers||0
8655720|NCT00669942|9698124|FG008|NOT COMPLETED|Healthy Volunteers||0
8655721|NCT00669942|9698125|FG009|NOT COMPLETED|Healthy Volunteers||0
8655722|NCT00669942|9698126|FG010|NOT COMPLETED|Healthy Volunteers||1
8655723|NCT00669942|9698127|FG011|NOT COMPLETED|Healthy Volunteers||0
8655724|NCT00669955|9698152|FG000|STARTED|Overall Study|216 patients received study drug. 2 patients were dispensed study drug but did not take it|218
8655725|NCT00669955|9698153|FG001|STARTED|Overall Study||222
8655726|NCT00669955|9698152|FG000|COMPLETED|Overall Study||204
8655727|NCT00669955|9698153|FG001|COMPLETED|Overall Study||195
8655728|NCT00669955|9698152|FG000|NOT COMPLETED|Overall Study||14
8655729|NCT00669955|9698153|FG001|NOT COMPLETED|Overall Study||27
8655730|NCT00670007|9698159|FG000|STARTED|Overall Study||140
8655731|NCT00670007|9698159|FG000|COMPLETED|Overall Study||131
8655732|NCT00670007|9698159|FG000|NOT COMPLETED|Overall Study||9
8655733|NCT00670046|9698166|FG000|STARTED|Overall Study||7
8655734|NCT00670046|9698167|FG001|STARTED|Overall Study||8
8655735|NCT00670046|9698166|FG000|COMPLETED|Overall Study||6
8655736|NCT00670046|9698167|FG001|COMPLETED|Overall Study||6
8655737|NCT00670046|9698166|FG000|NOT COMPLETED|Overall Study||1
8655738|NCT00670046|9698167|FG001|NOT COMPLETED|Overall Study||2
8655739|NCT00670111|9698176|FG000|STARTED|Enrollment to One Month||5
8655740|NCT00670111|9698177|FG001|STARTED|Enrollment to One Month||8
8655741|NCT00670111|9698178|FG002|STARTED|Enrollment to One Month||19
8655742|NCT00670111|9698176|FG000|COMPLETED|Enrollment to One Month||4
8655743|NCT00670111|9698177|FG001|COMPLETED|Enrollment to One Month||8
8655744|NCT00670111|9698178|FG002|COMPLETED|Enrollment to One Month||0
8655745|NCT00670111|9698176|FG000|NOT COMPLETED|Enrollment to One Month||1
8655746|NCT00670111|9698177|FG001|NOT COMPLETED|Enrollment to One Month||0
8655747|NCT00670111|9698178|FG002|NOT COMPLETED|Enrollment to One Month||19
8655748|NCT00670111|9698176|FG000|STARTED|One Month Period A||4
8655749|NCT00670111|9698177|FG001|STARTED|One Month Period A||8
8655750|NCT00670111|9698178|FG002|STARTED|One Month Period A||0
8655751|NCT00670111|9698176|FG000|COMPLETED|One Month Period A||4
8655752|NCT00670111|9698177|FG001|COMPLETED|One Month Period A||8
8655753|NCT00670111|9698178|FG002|COMPLETED|One Month Period A||0
8655754|NCT00670111|9698176|FG000|NOT COMPLETED|One Month Period A||0
8655755|NCT00670111|9698177|FG001|NOT COMPLETED|One Month Period A||0
8655756|NCT00670111|9698178|FG002|NOT COMPLETED|One Month Period A||0
8655757|NCT00670111|9698176|FG000|STARTED|One Month Period B||4
8655758|NCT00670111|9698177|FG001|STARTED|One Month Period B||8
8655759|NCT00670111|9698178|FG002|STARTED|One Month Period B||0
8655760|NCT00670111|9698176|FG000|COMPLETED|One Month Period B|4 patients in this group completed the 1 month visit; 0 had data eligible for endpoint analysis.|4
8655761|NCT00670111|9698177|FG001|COMPLETED|One Month Period B|8 patients in this group completed the 1 month visit; 6 had data eligible for endpoint analysis.|8
8655762|NCT00670111|9698178|FG002|COMPLETED|One Month Period B||0
8655763|NCT00670111|9698176|FG000|NOT COMPLETED|One Month Period B||0
8655764|NCT00670111|9698177|FG001|NOT COMPLETED|One Month Period B||0
8655765|NCT00670111|9698178|FG002|NOT COMPLETED|One Month Period B||0
8655766|NCT00670111|9698176|FG000|STARTED|One Month to Six Months||4
8655767|NCT00670111|9698177|FG001|STARTED|One Month to Six Months||8
8655768|NCT00670111|9698178|FG002|STARTED|One Month to Six Months||0
8655769|NCT00670111|9698176|FG000|COMPLETED|One Month to Six Months|4 patients in this group completed the 1 month visit; 0 had data eligible for endpoint analysis.|4
8655770|NCT00670111|9698177|FG001|COMPLETED|One Month to Six Months|8 patients in this group completed the 1 month visit; 4 had data eligible for endpoint analysis.|8
8655771|NCT00670111|9698178|FG002|COMPLETED|One Month to Six Months||0
8655772|NCT00670111|9698176|FG000|NOT COMPLETED|One Month to Six Months||0
8655773|NCT00670111|9698177|FG001|NOT COMPLETED|One Month to Six Months||0
8655774|NCT00670111|9698178|FG002|NOT COMPLETED|One Month to Six Months||0
8655775|NCT00670111|9698176|FG000|STARTED|Six Months to Twelve Months||4
8655776|NCT00670111|9698177|FG001|STARTED|Six Months to Twelve Months||8
8655777|NCT00670111|9698178|FG002|STARTED|Six Months to Twelve Months||0
8655778|NCT00670111|9698176|FG000|COMPLETED|Six Months to Twelve Months||4
8655779|NCT00670111|9698177|FG001|COMPLETED|Six Months to Twelve Months||8
8655780|NCT00670111|9698178|FG002|COMPLETED|Six Months to Twelve Months||0
8655781|NCT00670111|9698176|FG000|NOT COMPLETED|Six Months to Twelve Months||0
8655782|NCT00670111|9698177|FG001|NOT COMPLETED|Six Months to Twelve Months||0
8655783|NCT00670111|9698178|FG002|NOT COMPLETED|Six Months to Twelve Months||0
8655784|NCT00670202|9698188|FG000|STARTED|Overall Study|Investigators blinded to study drug assignment due to early termination of study|2
8655785|NCT00670202|9698189|FG001|STARTED|Overall Study||0
8655786|NCT00670202|9698188|FG000|COMPLETED|Overall Study|Investigators blinded to study drug assignment due to early termination of study|2
8655787|NCT00670202|9698189|FG001|COMPLETED|Overall Study||0
8655788|NCT00670202|9698188|FG000|NOT COMPLETED|Overall Study||0
8655789|NCT00670202|9698189|FG001|NOT COMPLETED|Overall Study||0
8655790|NCT00670228|9698197|FG000|STARTED|Overall Study||18
8655791|NCT00670228|9698198|FG001|STARTED|Overall Study||15
8729098|NCT01051557|9776163|FG006|COMPLETED|Overall Study||0
8655792|NCT00670228|9698197|FG000|COMPLETED|Overall Study||13
8655793|NCT00670228|9698198|FG001|COMPLETED|Overall Study||12
8655794|NCT00670228|9698197|FG000|NOT COMPLETED|Overall Study||5
8655795|NCT00670228|9698198|FG001|NOT COMPLETED|Overall Study||3
8655796|NCT00670241|9698207|FG000|STARTED|Overall Study||183
8655797|NCT00670241|9698208|FG001|STARTED|Overall Study||184
8655798|NCT00670241|9698209|FG002|STARTED|Overall Study||91
8655799|NCT00670241|9698207|FG000|COMPLETED|Overall Study||171
8655800|NCT00670241|9698208|FG001|COMPLETED|Overall Study||163
8655801|NCT00670241|9698209|FG002|COMPLETED|Overall Study||64
8655802|NCT00670241|9698207|FG000|NOT COMPLETED|Overall Study||12
8655803|NCT00670241|9698208|FG001|NOT COMPLETED|Overall Study||21
8655804|NCT00670241|9698209|FG002|NOT COMPLETED|Overall Study||27
8655805|NCT00670267|9698217|FG000|STARTED|Overall Study||10
8655806|NCT00670267|9698217|FG000|COMPLETED|Overall Study||9
8655807|NCT00670267|9698217|FG000|NOT COMPLETED|Overall Study||1
8655808|NCT00670306|9698223|FG000|STARTED|Overall Study||528
8655809|NCT00670306|9698223|FG000|COMPLETED|Overall Study||473
8655810|NCT00670306|9698223|FG000|NOT COMPLETED|Overall Study||55
8655811|NCT00670449|9698231|FG000|STARTED|Overall Study||47
8655812|NCT00670449|9698232|FG001|STARTED|Overall Study||46
8655813|NCT00670449|9698233|FG002|STARTED|Overall Study||27
8655814|NCT00670449|9698234|FG003|STARTED|Overall Study||23
8655815|NCT00670449|9698231|FG000|Switched to 0.5mg (Open Label)|Overall Study||45
8655816|NCT00670449|9698232|FG001|Switched to 0.5mg (Open Label)|Overall Study|Following protocol amendment, study became open-label with all patients receiving FTY720 0.5 mg/day|41
8655817|NCT00670449|9698233|FG002|Switched to 0.5mg (Open Label)|Overall Study||23
8655818|NCT00670449|9698234|FG003|Switched to 0.5mg (Open Label)|Overall Study|Following protocol amendment, study became open-label with all patients receiving FTY720 0.5 mg/day|17
8655819|NCT00670449|9698231|FG000|COMPLETED|Overall Study||38
8655820|NCT00670449|9698232|FG001|COMPLETED|Overall Study||36
8655821|NCT00670449|9698233|FG002|COMPLETED|Overall Study||18
8655822|NCT00670449|9698234|FG003|COMPLETED|Overall Study||15
8655823|NCT00670449|9698231|FG000|NOT COMPLETED|Overall Study||9
8655824|NCT00670449|9698232|FG001|NOT COMPLETED|Overall Study||10
8655825|NCT00670449|9698233|FG002|NOT COMPLETED|Overall Study||9
8655826|NCT00670449|9698234|FG003|NOT COMPLETED|Overall Study||8
8655827|NCT00670462|9698245|FG000|STARTED|Overall Study||106
8655828|NCT00670462|9698246|FG001|STARTED|Overall Study||107
8655829|NCT00670462|9698245|FG000|COMPLETED|Overall Study||76
8655830|NCT00670462|9698246|FG001|COMPLETED|Overall Study||76
8655831|NCT00670462|9698245|FG000|NOT COMPLETED|Overall Study||30
8655832|NCT00670462|9698246|FG001|NOT COMPLETED|Overall Study||31
8655833|NCT00670488|9698264|FG000|STARTED|Overall Study||3
8655834|NCT00670488|9698265|FG001|STARTED|Overall Study||58
8655835|NCT00670488|9698266|FG002|STARTED|Overall Study||3
8655836|NCT00670488|9698267|FG003|STARTED|Overall Study||7
8655837|NCT00670488|9698268|FG004|STARTED|Overall Study||3
8655838|NCT00670488|9698269|FG005|STARTED|Overall Study||5
8655839|NCT00670488|9698270|FG006|STARTED|Overall Study||17
8655840|NCT00670488|9698271|FG007|STARTED|Overall Study||3
8655841|NCT00670488|9698272|FG008|STARTED|Overall Study||3
8655842|NCT00670488|9698273|FG009|STARTED|Overall Study||2
8655843|NCT00670488|9698264|FG000|COMPLETED|Overall Study||0
8655844|NCT00670488|9698265|FG001|COMPLETED|Overall Study||0
8655845|NCT00670488|9698266|FG002|COMPLETED|Overall Study||0
8655846|NCT00670488|9698267|FG003|COMPLETED|Overall Study||0
8655847|NCT00670488|9698268|FG004|COMPLETED|Overall Study||0
8655848|NCT00670488|9698269|FG005|COMPLETED|Overall Study||0
8655849|NCT00670488|9698270|FG006|COMPLETED|Overall Study||0
8655850|NCT00670488|9698271|FG007|COMPLETED|Overall Study||0
8655851|NCT00670488|9698272|FG008|COMPLETED|Overall Study||0
8655852|NCT00670488|9698273|FG009|COMPLETED|Overall Study||0
8655853|NCT00670488|9698264|FG000|NOT COMPLETED|Overall Study||3
8655854|NCT00670488|9698265|FG001|NOT COMPLETED|Overall Study||58
8655855|NCT00670488|9698266|FG002|NOT COMPLETED|Overall Study||3
8655856|NCT00670488|9698267|FG003|NOT COMPLETED|Overall Study||7
8655857|NCT00670488|9698268|FG004|NOT COMPLETED|Overall Study||3
8655858|NCT00670488|9698269|FG005|NOT COMPLETED|Overall Study||5
8655859|NCT00670488|9698270|FG006|NOT COMPLETED|Overall Study||17
8655860|NCT00670488|9698271|FG007|NOT COMPLETED|Overall Study||3
8655861|NCT00670488|9698272|FG008|NOT COMPLETED|Overall Study||3
8655862|NCT00670488|9698273|FG009|NOT COMPLETED|Overall Study||2
8655863|NCT00670540|9698295|FG000|STARTED|Overall Study||8256
8655864|NCT00670540|9698295|FG000|COMPLETED|Overall Study|total recruited for the follow up|4931
8655865|NCT00670540|9698295|FG000|NOT COMPLETED|Overall Study||3325
8655866|NCT00670709|9698301|FG000|STARTED|Overall Study||27
8655867|NCT00670709|9698302|FG001|STARTED|Overall Study||15
8655868|NCT00670709|9698301|FG000|COMPLETED|Overall Study||27
8655869|NCT00670709|9698302|FG001|COMPLETED|Overall Study||15
8655870|NCT00670709|9698301|FG000|NOT COMPLETED|Overall Study||0
8655871|NCT00670709|9698302|FG001|NOT COMPLETED|Overall Study||0
8655872|NCT00670748|9698312|FG000|STARTED|Overall Study||17
8655873|NCT00670748|9698313|FG001|STARTED|Overall Study||16
8655874|NCT00670748|9698314|FG002|STARTED|Overall Study||7
8655875|NCT00670748|9698315|FG003|STARTED|Overall Study||5
8655876|NCT00670748|9698312|FG000|COMPLETED|Overall Study||14
8655877|NCT00670748|9698313|FG001|COMPLETED|Overall Study||14
8655878|NCT00670748|9698314|FG002|COMPLETED|Overall Study||5
8655879|NCT00670748|9698315|FG003|COMPLETED|Overall Study||4
8655880|NCT00670748|9698312|FG000|NOT COMPLETED|Overall Study||3
8655881|NCT00670748|9698313|FG001|NOT COMPLETED|Overall Study||2
8655882|NCT00670748|9698314|FG002|NOT COMPLETED|Overall Study||2
8655883|NCT00670748|9698315|FG003|NOT COMPLETED|Overall Study||1
8655884|NCT00670774|9698325|FG000|STARTED|Overall Study||26
8655885|NCT00670774|9698325|FG000|COMPLETED|Overall Study||26
8655886|NCT00670774|9698325|FG000|NOT COMPLETED|Overall Study||0
8655887|NCT00670800|9698331|FG000|STARTED|Overall Study||7
8655888|NCT00670800|9698332|FG001|STARTED|Overall Study||7
8655889|NCT00670800|9698331|FG000|COMPLETED|Overall Study||7
8692093|NCT00858364|9737503|FG000|Received Study Drug|Overall Study||837
8655890|NCT00670800|9698332|FG001|COMPLETED|Overall Study|Two controls were found to have insulin resistance and were excluded from analysis.|5
8655891|NCT00670800|9698331|FG000|NOT COMPLETED|Overall Study||0
8655892|NCT00670800|9698332|FG001|NOT COMPLETED|Overall Study||2
8655893|NCT00670930|9698342|FG000|STARTED|Overall Study|"Started indicates Randomized and Safety populaiton"|23
8655894|NCT00670930|9698343|FG001|STARTED|Overall Study||13
8655895|NCT00670930|9698342|FG000|Intent to Treat (ITT) Population|Overall Study||23
8655896|NCT00670930|9698343|FG001|Intent to Treat (ITT) Population|Overall Study||12
8655897|NCT00670930|9698342|FG000|COMPLETED|Overall Study||22
8655898|NCT00670930|9698343|FG001|COMPLETED|Overall Study||12
8655899|NCT00670930|9698342|FG000|NOT COMPLETED|Overall Study||1
8655900|NCT00670930|9698343|FG001|NOT COMPLETED|Overall Study||1
8655901|NCT00670956|9698349|FG000|STARTED|Overall Study||1
8655902|NCT00670956|9698349|FG000|COMPLETED|Overall Study||1
8655903|NCT00670956|9698349|FG000|NOT COMPLETED|Overall Study||0
8655904|NCT00670982|9698355|FG000|STARTED|Overall Study||22
8655905|NCT00670982|9698356|FG001|STARTED|Overall Study||7
8655906|NCT00670982|9698355|FG000|COMPLETED|Overall Study||22
8655907|NCT00670982|9698356|FG001|COMPLETED|Overall Study||7
8655908|NCT00670982|9698355|FG000|NOT COMPLETED|Overall Study||0
8655909|NCT00670982|9698356|FG001|NOT COMPLETED|Overall Study||0
8655910|NCT00671034|9698364|FG000|STARTED|Overall Study||69
8655911|NCT00671034|9698365|FG001|STARTED|Overall Study||42
8655912|NCT00671034|9698366|FG002|STARTED|Overall Study||55
8655913|NCT00671034|9698364|FG000|COMPLETED|Overall Study||30
8655914|NCT00671034|9698365|FG001|COMPLETED|Overall Study||22
8655915|NCT00671034|9698366|FG002|COMPLETED|Overall Study||31
8655916|NCT00671034|9698364|FG000|NOT COMPLETED|Overall Study||39
8655917|NCT00671034|9698365|FG001|NOT COMPLETED|Overall Study||20
8655918|NCT00671034|9698366|FG002|NOT COMPLETED|Overall Study||24
8655919|NCT00671060|9698377|FG000|STARTED|Overall Study||77
8655920|NCT00671060|9698378|FG001|STARTED|Overall Study||76
8655921|NCT00671060|9698377|FG000|COMPLETED|Overall Study|1 woman completed study but was excluded from analysis because gestational age <14 weeks.|76
8655922|NCT00671060|9698378|FG001|COMPLETED|Overall Study|1 woman was withdrawn from the study due to preeclampsia.|75
8655923|NCT00671060|9698377|FG000|NOT COMPLETED|Overall Study||1
8655924|NCT00671060|9698378|FG001|NOT COMPLETED|Overall Study||1
8655925|NCT00671177|9698386|FG000|STARTED|Overall Study||114
8655926|NCT00671177|9698387|FG001|STARTED|Overall Study||115
8655927|NCT00671177|9698386|FG000|COMPLETED|Overall Study||112
8655928|NCT00671177|9698387|FG001|COMPLETED|Overall Study||114
8655929|NCT00671177|9698386|FG000|NOT COMPLETED|Overall Study||2
8655930|NCT00671177|9698387|FG001|NOT COMPLETED|Overall Study||1
8655931|NCT00671437|9698393|FG000|STARTED|Overall Study||42
8655932|NCT00671437|9698393|FG000|COMPLETED|Overall Study||27
8655933|NCT00671437|9698393|FG000|NOT COMPLETED|Overall Study||15
8655934|NCT00671502|9698408|FG000|STARTED|Overall Study||281
8655935|NCT00671502|9698409|FG001|STARTED|Overall Study||280
8655936|NCT00671502|9698410|FG002|STARTED|Overall Study||279
8729099|NCT01051557|9776157|FG000|NOT COMPLETED|Overall Study||4
8729100|NCT01051557|9776158|FG001|NOT COMPLETED|Overall Study||3
8729101|NCT01051557|9776159|FG002|NOT COMPLETED|Overall Study||6
8729102|NCT01051557|9776160|FG003|NOT COMPLETED|Overall Study||3
8729103|NCT01051557|9776161|FG004|NOT COMPLETED|Overall Study||7
8729104|NCT01051557|9776162|FG005|NOT COMPLETED|Overall Study||6
8729105|NCT01051557|9776163|FG006|NOT COMPLETED|Overall Study||6
8729106|NCT01051570|9776180|FG000|STARTED|Overall Study||26
8729107|NCT01051570|9776180|FG000|COMPLETED|Overall Study||26
8729108|NCT01051570|9776180|FG000|NOT COMPLETED|Overall Study||0
8729109|NCT01051596|9776184|FG000|STARTED|Overall Study||75
8729110|NCT01051596|9776184|FG000|COMPLETED|Overall Study||75
8655937|NCT00671502|9698408|FG000|COMPLETED|Overall Study||242
8655938|NCT00671502|9698409|FG001|COMPLETED|Overall Study||241
8655939|NCT00671502|9698410|FG002|COMPLETED|Overall Study||252
8655940|NCT00671502|9698408|FG000|NOT COMPLETED|Overall Study||39
8655941|NCT00671502|9698409|FG001|NOT COMPLETED|Overall Study||39
8655942|NCT00671502|9698410|FG002|NOT COMPLETED|Overall Study||27
8655943|NCT00671515|9698418|FG000|STARTED|Phase 1||23
8655944|NCT00671515|9698418|FG000|COMPLETED|Phase 1||20
8655945|NCT00671515|9698418|FG000|NOT COMPLETED|Phase 1||3
8655946|NCT00671515|9698418|FG000|STARTED|Phase 2||13
8655947|NCT00671515|9698418|FG000|COMPLETED|Phase 2||9
8655948|NCT00671515|9698418|FG000|NOT COMPLETED|Phase 2||4
8655949|NCT00671554|9698422|FG000|STARTED|Overall Study||3
8655950|NCT00671554|9698422|FG000|COMPLETED|Overall Study||0
8655951|NCT00671554|9698422|FG000|NOT COMPLETED|Overall Study||3
8655952|NCT00671658|9698427|FG000|STARTED|Overall Study||220
8655953|NCT00671658|9698427|FG000|COMPLETED|Overall Study||215
8655954|NCT00671658|9698427|FG000|NOT COMPLETED|Overall Study||5
8655955|NCT00671671|9698433|FG000|STARTED|Overall Study||10
8655956|NCT00671671|9698434|FG001|STARTED|Overall Study||10
8655957|NCT00671671|9698433|FG000|COMPLETED|Overall Study||10
8655958|NCT00671671|9698434|FG001|COMPLETED|Overall Study||10
8729111|NCT01051596|9776184|FG000|NOT COMPLETED|Overall Study||0
8655959|NCT00671671|9698433|FG000|NOT COMPLETED|Overall Study||0
8655960|NCT00671671|9698434|FG001|NOT COMPLETED|Overall Study||0
8655961|NCT00671723|9698444|FG000|STARTED|Overall Study||11
8655962|NCT00671723|9698445|FG001|STARTED|Overall Study||11
8655963|NCT00671723|9698446|FG002|STARTED|Overall Study||11
8655964|NCT00671723|9698444|FG000|COMPLETED|Overall Study||11
8655965|NCT00671723|9698445|FG001|COMPLETED|Overall Study||11
8729112|NCT01051661|9776194|FG000|STARTED|Overall Study||610
8655966|NCT00671723|9698446|FG002|COMPLETED|Overall Study||11
8655967|NCT00671723|9698444|FG000|NOT COMPLETED|Overall Study||0
8655968|NCT00671723|9698445|FG001|NOT COMPLETED|Overall Study||0
8655969|NCT00671723|9698446|FG002|NOT COMPLETED|Overall Study||0
8655970|NCT00671749|9698454|FG000|STARTED|Overall Study||100
8655971|NCT00671749|9698454|FG000|COMPLETED|Overall Study||92
8655972|NCT00671749|9698454|FG000|NOT COMPLETED|Overall Study||8
8655973|NCT00671788|9698458|FG000|STARTED|Overall Study||35
8655974|NCT00671788|9698458|FG000|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|21
8655975|NCT00671788|9698458|FG000|NOT COMPLETED|Overall Study||14
8655976|NCT00671853|9698464|FG000|STARTED|Overall Study||46
8655977|NCT00671853|9698465|FG001|STARTED|Overall Study||45
8655978|NCT00671853|9698464|FG000|COMPLETED|Overall Study||26
8655979|NCT00671853|9698465|FG001|COMPLETED|Overall Study||18
8655980|NCT00671853|9698464|FG000|NOT COMPLETED|Overall Study||20
8655981|NCT00671853|9698465|FG001|NOT COMPLETED|Overall Study||27
8655982|NCT00671879|9698476|FG000|STARTED|Overall Study||281
8655983|NCT00671879|9698477|FG001|STARTED|Overall Study||279
8655984|NCT00671879|9698478|FG002|STARTED|Overall Study||280
8655985|NCT00671879|9698476|FG000|COMPLETED|Overall Study||281
8655986|NCT00671879|9698477|FG001|COMPLETED|Overall Study||275
8655987|NCT00671879|9698478|FG002|COMPLETED|Overall Study||274
8655988|NCT00671879|9698476|FG000|NOT COMPLETED|Overall Study||0
8655989|NCT00671879|9698477|FG001|NOT COMPLETED|Overall Study||4
8655990|NCT00671879|9698478|FG002|NOT COMPLETED|Overall Study||6
8655991|NCT00671918|9698487|FG000|STARTED|Overall Study||186
8655992|NCT00671918|9698487|FG000|COMPLETED|Overall Study||169
8655993|NCT00671918|9698487|FG000|NOT COMPLETED|Overall Study||17
8655994|NCT00671931|9698497|FG000|STARTED|Overall Study||9
8655995|NCT00671931|9698498|FG001|STARTED|Overall Study||8
8655996|NCT00671931|9698499|FG002|STARTED|Overall Study||9
8655997|NCT00671931|9698500|FG003|STARTED|Overall Study||10
8655998|NCT00671931|9698501|FG004|STARTED|Overall Study||8
8655999|NCT00671931|9698497|FG000|COMPLETED|Overall Study|Nueromonitoring equipment falure|8
8656000|NCT00671931|9698498|FG001|COMPLETED|Overall Study|All completed|8
8656001|NCT00671931|9698499|FG002|COMPLETED|Overall Study|all completed|9
8656002|NCT00671931|9698500|FG003|COMPLETED|Overall Study|Prepositioning - Neuromonitoring required|8
8656003|NCT00671931|9698501|FG004|COMPLETED|Overall Study|Low heart rate requiring treatment|7
8656004|NCT00671931|9698497|FG000|NOT COMPLETED|Overall Study||1
8656005|NCT00671931|9698498|FG001|NOT COMPLETED|Overall Study||0
8656006|NCT00671931|9698499|FG002|NOT COMPLETED|Overall Study||0
8656007|NCT00671931|9698500|FG003|NOT COMPLETED|Overall Study||2
8656008|NCT00671931|9698501|FG004|NOT COMPLETED|Overall Study||1
8656009|NCT00671970|9698515|FG000|STARTED|Overall Study||32
8656010|NCT00671970|9698516|FG001|STARTED|Overall Study||25
8656011|NCT00671970|9698515|FG000|COMPLETED|Overall Study||32
8656012|NCT00671970|9698516|FG001|COMPLETED|Overall Study||25
8656013|NCT00671970|9698515|FG000|NOT COMPLETED|Overall Study||0
8656014|NCT00671970|9698516|FG001|NOT COMPLETED|Overall Study||0
8656015|NCT00672100|9698537|FG000|STARTED|Overall Study||12
8656016|NCT00672100|9698538|FG001|STARTED|Overall Study||12
8656017|NCT00672100|9698539|FG002|STARTED|Overall Study||12
8656018|NCT00672100|9698537|FG000|PACU (Within 8 Hours)|Overall Study||12
8656019|NCT00672100|9698538|FG001|PACU (Within 8 Hours)|Overall Study||12
8656020|NCT00672100|9698539|FG002|PACU (Within 8 Hours)|Overall Study||12
8656021|NCT00672100|9698537|FG000|COMPLETED|Overall Study||12
8656022|NCT00672100|9698538|FG001|COMPLETED|Overall Study||12
8656023|NCT00672100|9698539|FG002|COMPLETED|Overall Study||12
8656024|NCT00672100|9698537|FG000|NOT COMPLETED|Overall Study||0
8656025|NCT00672100|9698538|FG001|NOT COMPLETED|Overall Study||0
8656026|NCT00672100|9698539|FG002|NOT COMPLETED|Overall Study||0
8656027|NCT00672139|9698553|FG000|STARTED|Overall Study|Three of 60 enrolled subjects did not receive study drug.|57
8656028|NCT00672139|9698554|FG001|STARTED|Overall Study|Four of 96 enrolled subjects did not receive study drug.|92
8656029|NCT00672139|9698553|FG000|COMPLETED|Overall Study||27
8656030|NCT00672139|9698554|FG001|COMPLETED|Overall Study||47
8656031|NCT00672139|9698553|FG000|NOT COMPLETED|Overall Study||30
8656032|NCT00672139|9698554|FG001|NOT COMPLETED|Overall Study||45
8656033|NCT00672204|9698560|FG000|STARTED|Overall Study||23
8656034|NCT00672204|9698560|FG000|COMPLETED|Overall Study||3
8656035|NCT00672204|9698560|FG000|NOT COMPLETED|Overall Study||20
8656036|NCT00672243|9698564|FG000|STARTED|Overall Study||32
8656037|NCT00672243|9698564|FG000|COMPLETED|Overall Study||32
8656038|NCT00672243|9698564|FG000|NOT COMPLETED|Overall Study||0
8656039|NCT00672256|9698569|FG000|STARTED|Overall Study|January 2007|62
8656040|NCT00672256|9698569|FG000|COMPLETED|Overall Study||18
8656041|NCT00672256|9698569|FG000|NOT COMPLETED|Overall Study||44
8656042|NCT00672438|9698575|FG000|STARTED|Infusion 1||119
8656043|NCT00672438|9698576|FG001|STARTED|Infusion 1||118
8656044|NCT00672438|9698575|FG000|COMPLETED|Infusion 1||119
8656045|NCT00672438|9698576|FG001|COMPLETED|Infusion 1||118
8656046|NCT00672438|9698575|FG000|NOT COMPLETED|Infusion 1||0
8656047|NCT00672438|9698576|FG001|NOT COMPLETED|Infusion 1||0
8656048|NCT00672438|9698575|FG000|STARTED|Washout||119
8656049|NCT00672438|9698576|FG001|STARTED|Washout||118
8656050|NCT00672438|9698575|FG000|COMPLETED|Washout||119
8656051|NCT00672438|9698576|FG001|COMPLETED|Washout||118
8656052|NCT00672438|9698575|FG000|NOT COMPLETED|Washout||0
8656053|NCT00672438|9698576|FG001|NOT COMPLETED|Washout||0
8656054|NCT00672438|9698575|FG000|STARTED|Infusion 2||119
8656055|NCT00672438|9698576|FG001|STARTED|Infusion 2||118
8656056|NCT00672438|9698575|FG000|COMPLETED|Infusion 2||119
8656057|NCT00672438|9698576|FG001|COMPLETED|Infusion 2||118
8656058|NCT00672438|9698575|FG000|NOT COMPLETED|Infusion 2||0
8656059|NCT00672438|9698576|FG001|NOT COMPLETED|Infusion 2||0
8656060|NCT00672451|9698584|FG000|STARTED|Overall Study||1
8656061|NCT00672451|9698585|FG001|STARTED|Overall Study||2
8656062|NCT00672451|9698584|FG000|COMPLETED|Overall Study||1
8656063|NCT00672451|9698585|FG001|COMPLETED|Overall Study||2
8656064|NCT00672451|9698584|FG000|NOT COMPLETED|Overall Study||0
8656065|NCT00672451|9698585|FG001|NOT COMPLETED|Overall Study||0
8656066|NCT00672477|9698593|FG000|STARTED|Overall Study|120 subjects were randomized to this group, but only 116 subjects received study drug.|116
8656067|NCT00672477|9698594|FG001|STARTED|Overall Study|117 subjects were randomized to this group, but only 114 subjects received study drug.|114
8656068|NCT00672477|9698593|FG000|COMPLETED|Overall Study|One subject had missing data as reason for study termination - not counted as early termination.|89
8656069|NCT00672477|9698594|FG001|COMPLETED|Overall Study||88
8656070|NCT00672477|9698593|FG000|NOT COMPLETED|Overall Study||27
8656071|NCT00672477|9698594|FG001|NOT COMPLETED|Overall Study||26
8656072|NCT00672490|9698602|FG000|STARTED|Overall Study||187
8656073|NCT00672490|9698603|FG001|STARTED|Overall Study||189
8656074|NCT00672490|9698602|FG000|COMPLETED|Overall Study||163
8656075|NCT00672490|9698603|FG001|COMPLETED|Overall Study||157
8656076|NCT00672490|9698602|FG000|NOT COMPLETED|Overall Study||24
8656077|NCT00672490|9698603|FG001|NOT COMPLETED|Overall Study||32
8656078|NCT00672555|9698609|FG000|STARTED|Overall Study||70
8656079|NCT00672555|9698609|FG000|COMPLETED|Overall Study|All patients were seen at 3 weeks in the outpatient clinic.|64
8656080|NCT00672555|9698609|FG000|NOT COMPLETED|Overall Study||6
8656081|NCT00672594|9698613|FG000|STARTED|Overall Study||30
8656082|NCT00672594|9698613|FG000|COMPLETED|Overall Study||27
8656083|NCT00672594|9698613|FG000|NOT COMPLETED|Overall Study||3
8656084|NCT00672620|9698621|FG000|STARTED|Overall Study||153
8656085|NCT00672620|9698622|FG001|STARTED|Overall Study||153
8656086|NCT00672620|9698623|FG002|STARTED|Overall Study||153
8656087|NCT00672620|9698624|FG003|STARTED|Overall Study||152
8656088|NCT00672620|9698621|FG000|Treated|Overall Study||151
8656089|NCT00672620|9698622|FG001|Treated|Overall Study||149
8656090|NCT00672620|9698623|FG002|Treated|Overall Study||153
8656091|NCT00672620|9698624|FG003|Treated|Overall Study||150
8656092|NCT00672620|9698621|FG000|COMPLETED|Overall Study||120
8656093|NCT00672620|9698622|FG001|COMPLETED|Overall Study||99
8656094|NCT00672620|9698623|FG002|COMPLETED|Overall Study||122
8656095|NCT00672620|9698624|FG003|COMPLETED|Overall Study||110
8656096|NCT00672620|9698621|FG000|NOT COMPLETED|Overall Study||33
8656097|NCT00672620|9698622|FG001|NOT COMPLETED|Overall Study||54
8656098|NCT00672620|9698623|FG002|NOT COMPLETED|Overall Study||31
8656099|NCT00672620|9698624|FG003|NOT COMPLETED|Overall Study||42
8656100|NCT00672633|9698636|FG000|STARTED|Overall Study||12
8656101|NCT00672633|9698637|FG001|STARTED|Overall Study||13
8656102|NCT00672633|9698636|FG000|COMPLETED|Overall Study||12
8656103|NCT00672633|9698637|FG001|COMPLETED|Overall Study||12
8656104|NCT00672633|9698636|FG000|NOT COMPLETED|Overall Study||0
8656105|NCT00672633|9698637|FG001|NOT COMPLETED|Overall Study||1
8656106|NCT00672646|9698646|FG000|STARTED|Overall Study||40
8656107|NCT00672646|9698647|FG001|STARTED|Overall Study||23
8656108|NCT00672646|9698648|FG002|STARTED|Overall Study||40
8656109|NCT00672646|9698646|FG000|COMPLETED|Overall Study||40
8656110|NCT00672646|9698647|FG001|COMPLETED|Overall Study||22
8656111|NCT00672646|9698648|FG002|COMPLETED|Overall Study||37
8656112|NCT00672646|9698646|FG000|NOT COMPLETED|Overall Study||0
8656113|NCT00672646|9698647|FG001|NOT COMPLETED|Overall Study||1
8656114|NCT00672646|9698648|FG002|NOT COMPLETED|Overall Study||3
8656115|NCT00672737|9698656|FG000|STARTED|Overall Study||56
8656116|NCT00672737|9698656|FG000|COMPLETED|Overall Study||48
8656117|NCT00672737|9698656|FG000|NOT COMPLETED|Overall Study||8
8656118|NCT00672841|9698663|FG000|STARTED|Overall Study||17
8656119|NCT00672841|9698664|FG001|STARTED|Overall Study||47
8656120|NCT00672841|9698663|FG000|COMPLETED|Overall Study||16
8656121|NCT00672841|9698664|FG001|COMPLETED|Overall Study||32
8656122|NCT00672841|9698663|FG000|NOT COMPLETED|Overall Study||1
8656123|NCT00672841|9698664|FG001|NOT COMPLETED|Overall Study||15
8656124|NCT00672854|9698675|FG000|STARTED|Overall Study||49
8656125|NCT00672854|9698676|FG001|STARTED|Overall Study||51
8656126|NCT00672854|9698675|FG000|COMPLETED|Overall Study||49
8656127|NCT00672854|9698676|FG001|COMPLETED|Overall Study||51
8656128|NCT00672854|9698675|FG000|NOT COMPLETED|Overall Study||0
8656129|NCT00672854|9698676|FG001|NOT COMPLETED|Overall Study||0
8656130|NCT00672932|9698686|FG000|STARTED|Overall Study||9
8656131|NCT00672932|9698687|FG001|STARTED|Overall Study||9
8656132|NCT00672932|9698686|FG000|Completed Initial 12-week Assignment|Overall Study||9
8656133|NCT00672932|9698687|FG001|Completed Initial 12-week Assignment|Overall Study||9
8656134|NCT00672932|9698686|FG000|Provided Analyzable Blood and CSF Sample|Overall Study|one subject was censored when pharmacological study showed no drug in plasma or CSF|8
8656135|NCT00672932|9698687|FG001|Provided Analyzable Blood and CSF Sample|Overall Study||9
8656136|NCT00672932|9698686|FG000|Rolled Over to Raltegravir|Overall Study||0
8656137|NCT00672932|9698687|FG001|Rolled Over to Raltegravir|Overall Study|6 subjects randomized to no drug later rolled over to receive raltegravir|6
8656138|NCT00672932|9698686|FG000|COMPLETED|Overall Study||9
8656139|NCT00672932|9698687|FG001|COMPLETED|Overall Study||9
8656140|NCT00672932|9698686|FG000|NOT COMPLETED|Overall Study||0
8656141|NCT00672932|9698687|FG001|NOT COMPLETED|Overall Study||0
8656142|NCT00672958|9698695|FG000|STARTED|Overall Study||300
8656143|NCT00672958|9698696|FG001|STARTED|Overall Study||300
8656144|NCT00672958|9698695|FG000|Safety Set|Overall Study|All randomized patients who received at least 1 dose of double-blind study drug.|298
8656145|NCT00672958|9698696|FG001|Safety Set|Overall Study|All randomized patients who received at least 1 dose of double-blind study drug.|299
8656146|NCT00672958|9698695|FG000|Full Analysis Set|Overall Study|All safety set patients who had at least 1 valid postbaseline primary efficacy assessment.|286
8656147|NCT00672958|9698696|FG001|Full Analysis Set|Overall Study|All safety set patients who had at least 1 valid postbaseline primary efficacy assessment.|292
8656148|NCT00672958|9698695|FG000|COMPLETED|Overall Study||236
8656149|NCT00672958|9698696|FG001|COMPLETED|Overall Study||244
8656150|NCT00672958|9698695|FG000|NOT COMPLETED|Overall Study||64
8656151|NCT00672958|9698696|FG001|NOT COMPLETED|Overall Study||56
8656152|NCT00672984|9698705|FG000|STARTED|First Intervention||31
8656153|NCT00672984|9698706|FG001|STARTED|First Intervention||25
8656154|NCT00672984|9698707|FG002|STARTED|First Intervention||27
8656155|NCT00672984|9698705|FG000|COMPLETED|First Intervention||22
8656156|NCT00672984|9698706|FG001|COMPLETED|First Intervention||23
8656157|NCT00672984|9698707|FG002|COMPLETED|First Intervention||25
8656158|NCT00672984|9698705|FG000|NOT COMPLETED|First Intervention||9
8656159|NCT00672984|9698706|FG001|NOT COMPLETED|First Intervention||2
8656160|NCT00672984|9698707|FG002|NOT COMPLETED|First Intervention||2
8656161|NCT00672984|9698705|FG000|STARTED|Second Intervention||22
8656162|NCT00672984|9698706|FG001|STARTED|Second Intervention||23
8656163|NCT00672984|9698707|FG002|STARTED|Second Intervention||25
8656164|NCT00672984|9698705|FG000|COMPLETED|Second Intervention||22
8656165|NCT00672984|9698706|FG001|COMPLETED|Second Intervention||17
8656166|NCT00672984|9698707|FG002|COMPLETED|Second Intervention||24
8656167|NCT00672984|9698705|FG000|NOT COMPLETED|Second Intervention||0
8656168|NCT00672984|9698706|FG001|NOT COMPLETED|Second Intervention||6
8656169|NCT00672984|9698707|FG002|NOT COMPLETED|Second Intervention||1
8656170|NCT00672984|9698705|FG000|STARTED|Third Intervention||22
8656171|NCT00672984|9698706|FG001|STARTED|Third Intervention||17
8656172|NCT00672984|9698707|FG002|STARTED|Third Intervention||24
8656173|NCT00672984|9698705|FG000|COMPLETED|Third Intervention||21
8656174|NCT00672984|9698706|FG001|COMPLETED|Third Intervention||17
8656175|NCT00672984|9698707|FG002|COMPLETED|Third Intervention||23
8656176|NCT00672984|9698705|FG000|NOT COMPLETED|Third Intervention||1
8656177|NCT00672984|9698706|FG001|NOT COMPLETED|Third Intervention||0
8729113|NCT01051661|9776195|FG001|STARTED|Overall Study||1438
8729114|NCT01051661|9776196|FG002|STARTED|Overall Study||612
8729115|NCT01051661|9776197|FG003|STARTED|Overall Study||1436
8729116|NCT01051661|9776198|FG004|STARTED|Overall Study||613
8729117|NCT01051661|9776199|FG005|STARTED|Overall Study||1436
8729118|NCT01051661|9776194|FG000|COMPLETED|Overall Study||576
8729119|NCT01051661|9776195|FG001|COMPLETED|Overall Study||1375
8729120|NCT01051661|9776196|FG002|COMPLETED|Overall Study||573
8729121|NCT01051661|9776197|FG003|COMPLETED|Overall Study||1380
8729122|NCT01051661|9776198|FG004|COMPLETED|Overall Study||578
8729123|NCT01051661|9776199|FG005|COMPLETED|Overall Study||1369
8729124|NCT01051661|9776194|FG000|NOT COMPLETED|Overall Study||34
8729125|NCT01051661|9776195|FG001|NOT COMPLETED|Overall Study||63
8729126|NCT01051661|9776196|FG002|NOT COMPLETED|Overall Study||39
8729127|NCT01051661|9776197|FG003|NOT COMPLETED|Overall Study||56
8729128|NCT01051661|9776198|FG004|NOT COMPLETED|Overall Study||35
8729129|NCT01051661|9776199|FG005|NOT COMPLETED|Overall Study||67
8729130|NCT01051739|9776236|FG000|STARTED|Overall Study||120
8729131|NCT01051739|9776237|FG001|STARTED|Overall Study||60
8729132|NCT01051739|9776236|FG000|COMPLETED|Overall Study||92
8729133|NCT01051739|9776237|FG001|COMPLETED|Overall Study||47
8729134|NCT01051739|9776236|FG000|NOT COMPLETED|Overall Study||28
8729135|NCT01051739|9776237|FG001|NOT COMPLETED|Overall Study||13
8729136|NCT01051778|9776245|FG000|STARTED|Overall Study|June 2006|30
8729137|NCT01051778|9776246|FG001|STARTED|Overall Study|June 2006|30
8729138|NCT01051778|9776245|FG000|COMPLETED|Overall Study|November 2009|30
8729139|NCT01051778|9776246|FG001|COMPLETED|Overall Study|November 2009|30
8729140|NCT01051778|9776245|FG000|NOT COMPLETED|Overall Study||0
8729141|NCT01051778|9776246|FG001|NOT COMPLETED|Overall Study||0
8729142|NCT01051791|9776252|FG000|STARTED|Overall Study||13
8729143|NCT01051791|9776252|FG000|COMPLETED|Overall Study||9
8729144|NCT01051791|9776252|FG000|NOT COMPLETED|Overall Study||4
8729145|NCT01051817|9776259|FG000|STARTED|Overall Study||38
8729146|NCT01051817|9776260|FG001|STARTED|Overall Study||35
8729147|NCT01051817|9776259|FG000|COMPLETED|Overall Study||35
8729148|NCT01051817|9776260|FG001|COMPLETED|Overall Study||26
8729149|NCT01051817|9776259|FG000|NOT COMPLETED|Overall Study||3
8729150|NCT01051817|9776260|FG001|NOT COMPLETED|Overall Study||9
8729151|NCT01051856|9776268|FG000|STARTED|Overall Study||33
8729152|NCT01051856|9776269|FG001|STARTED|Overall Study||35
8729153|NCT01051856|9776268|FG000|COMPLETED|Overall Study||32
8729154|NCT01051856|9776269|FG001|COMPLETED|Overall Study||35
8729155|NCT01051856|9776268|FG000|NOT COMPLETED|Overall Study||1
8729156|NCT01051856|9776269|FG001|NOT COMPLETED|Overall Study||0
8729157|NCT01051960|9776275|FG000|STARTED|Overall Study||12
8729158|NCT01051960|9776275|FG000|COMPLETED|Overall Study||11
8729159|NCT01051960|9776275|FG000|NOT COMPLETED|Overall Study||1
8729160|NCT01051986|9776281|FG000|STARTED|Overall Study||112
8729161|NCT01051986|9776282|FG001|STARTED|Overall Study||112
8729162|NCT01051986|9776281|FG000|COMPLETED|Overall Study||107
8656178|NCT00672984|9698707|FG002|NOT COMPLETED|Third Intervention||1
8656179|NCT00673049|9698719|FG000|STARTED|Before Progression on Erlotinib||292
8656180|NCT00673049|9698720|FG001|STARTED|Before Progression on Erlotinib||290
8656181|NCT00673049|9698721|FG002|STARTED|Before Progression on Erlotinib||1
8656182|NCT00673049|9698722|FG003|STARTED|Before Progression on Erlotinib|Participants treated with erlo alone who subsequently received figi upon disease progression.|0
8656183|NCT00673049|9698719|FG000|Treated|Before Progression on Erlotinib||289
8656184|NCT00673049|9698720|FG001|Treated|Before Progression on Erlotinib||289
8656185|NCT00673049|9698721|FG002|Treated|Before Progression on Erlotinib||1
8656186|NCT00673049|9698722|FG003|Treated|Before Progression on Erlotinib||0
8656187|NCT00673049|9698719|FG000|COMPLETED|Before Progression on Erlotinib||0
8656188|NCT00673049|9698720|FG001|COMPLETED|Before Progression on Erlotinib||0
8656189|NCT00673049|9698721|FG002|COMPLETED|Before Progression on Erlotinib||0
8656190|NCT00673049|9698722|FG003|COMPLETED|Before Progression on Erlotinib||0
8656191|NCT00673049|9698719|FG000|NOT COMPLETED|Before Progression on Erlotinib||292
8656192|NCT00673049|9698720|FG001|NOT COMPLETED|Before Progression on Erlotinib||290
8656193|NCT00673049|9698721|FG002|NOT COMPLETED|Before Progression on Erlotinib||1
8656194|NCT00673049|9698722|FG003|NOT COMPLETED|Before Progression on Erlotinib||0
8656195|NCT00673049|9698719|FG000|STARTED|After Progression on Erlotinib||0
8656196|NCT00673049|9698720|FG001|STARTED|After Progression on Erlotinib||0
8656197|NCT00673049|9698721|FG002|STARTED|After Progression on Erlotinib||0
8656198|NCT00673049|9698722|FG003|STARTED|After Progression on Erlotinib||83
8656199|NCT00673049|9698719|FG000|COMPLETED|After Progression on Erlotinib||0
8656200|NCT00673049|9698720|FG001|COMPLETED|After Progression on Erlotinib||0
8656201|NCT00673049|9698721|FG002|COMPLETED|After Progression on Erlotinib||0
8656202|NCT00673049|9698722|FG003|COMPLETED|After Progression on Erlotinib||0
8656203|NCT00673049|9698719|FG000|NOT COMPLETED|After Progression on Erlotinib||0
8656204|NCT00673049|9698720|FG001|NOT COMPLETED|After Progression on Erlotinib||0
8656205|NCT00673049|9698721|FG002|NOT COMPLETED|After Progression on Erlotinib||0
8656206|NCT00673049|9698722|FG003|NOT COMPLETED|After Progression on Erlotinib||83
8656207|NCT00673075|9698732|FG000|STARTED|Overall Study||21
8656208|NCT00673075|9698733|FG001|STARTED|Overall Study||18
8656209|NCT00673075|9698732|FG000|COMPLETED|Overall Study||12
8656210|NCT00673075|9698733|FG001|COMPLETED|Overall Study||11
8656211|NCT00673075|9698732|FG000|NOT COMPLETED|Overall Study||9
8656212|NCT00673075|9698733|FG001|NOT COMPLETED|Overall Study||7
8656213|NCT00673114|9698741|FG000|STARTED|Overall Study||3
8656214|NCT00673114|9698741|FG000|COMPLETED|Overall Study||3
8656215|NCT00673114|9698741|FG000|NOT COMPLETED|Overall Study||0
8656216|NCT00673127|9698745|FG000|STARTED|Overall Study||57
8656217|NCT00673127|9698745|FG000|COMPLETED|Overall Study||57
8656218|NCT00673127|9698745|FG000|NOT COMPLETED|Overall Study||0
8656219|NCT00673153|9698750|FG000|STARTED|Overall Study||31
8656220|NCT00673153|9698750|FG000|COMPLETED|Overall Study||30
8656221|NCT00673153|9698750|FG000|NOT COMPLETED|Overall Study||1
8656222|NCT00673231|9698758|FG000|STARTED|Overall Study|Of the 197 randomized participants only 193 were included in the full analysis set|197
8656223|NCT00673231|9698759|FG001|STARTED|Overall Study|All 202 were included in the full analysis set|202
8656224|NCT00673231|9698760|FG002|STARTED|Overall Study|Of the 212 randomized participants only 211 were included in the full analysis set|212
8656225|NCT00673231|9698761|FG003|STARTED|Overall Study|Of the 196 randomized participants only 194 were included in the full analysis set|196
8656226|NCT00673231|9698758|FG000|COMPLETED|Overall Study||168
8656227|NCT00673231|9698759|FG001|COMPLETED|Overall Study||180
8656228|NCT00673231|9698760|FG002|COMPLETED|Overall Study||186
8656229|NCT00673231|9698761|FG003|COMPLETED|Overall Study||178
8656230|NCT00673231|9698758|FG000|NOT COMPLETED|Overall Study||29
8656231|NCT00673231|9698759|FG001|NOT COMPLETED|Overall Study||22
8656232|NCT00673231|9698760|FG002|NOT COMPLETED|Overall Study||26
8656233|NCT00673231|9698761|FG003|NOT COMPLETED|Overall Study||18
8656234|NCT00673244|9698773|FG000|STARTED|Overall Study||52
8656235|NCT00673244|9698774|FG001|STARTED|Overall Study||25
8656236|NCT00673244|9698773|FG000|COMPLETED|Overall Study||52
8656237|NCT00673244|9698774|FG001|COMPLETED|Overall Study||25
8656238|NCT00673244|9698773|FG000|NOT COMPLETED|Overall Study||0
8656239|NCT00673244|9698774|FG001|NOT COMPLETED|Overall Study||0
8656240|NCT00673257|9698780|FG000|STARTED|Overall Study||107
8656241|NCT00673257|9698780|FG000|COMPLETED|Overall Study||102
8656242|NCT00673257|9698780|FG000|NOT COMPLETED|Overall Study||5
8656243|NCT00673387|9698792|FG000|STARTED|Overall Study||75
8656244|NCT00673387|9698793|FG001|STARTED|Overall Study||77
8656245|NCT00673387|9698794|FG002|STARTED|Overall Study||72
8656246|NCT00673387|9698795|FG003|STARTED|Overall Study||75
8656247|NCT00673387|9698796|FG004|STARTED|Overall Study||78
8656248|NCT00673387|9698797|FG005|STARTED|Overall Study||78
8656249|NCT00673387|9698798|FG006|STARTED|Overall Study||78
8656250|NCT00673387|9698799|FG007|STARTED|Overall Study||75
8656251|NCT00673387|9698792|FG000|COMPLETED|Overall Study||46
8656252|NCT00673387|9698793|FG001|COMPLETED|Overall Study||54
8656253|NCT00673387|9698794|FG002|COMPLETED|Overall Study||41
8656254|NCT00673387|9698795|FG003|COMPLETED|Overall Study||49
8656255|NCT00673387|9698796|FG004|COMPLETED|Overall Study||48
8656256|NCT00673387|9698797|FG005|COMPLETED|Overall Study||44
8656257|NCT00673387|9698798|FG006|COMPLETED|Overall Study||48
8656258|NCT00673387|9698799|FG007|COMPLETED|Overall Study||40
8656259|NCT00673387|9698792|FG000|NOT COMPLETED|Overall Study||29
8656260|NCT00673387|9698793|FG001|NOT COMPLETED|Overall Study||23
8656261|NCT00673387|9698794|FG002|NOT COMPLETED|Overall Study||31
8656262|NCT00673387|9698795|FG003|NOT COMPLETED|Overall Study||26
8656263|NCT00673387|9698796|FG004|NOT COMPLETED|Overall Study||30
8656264|NCT00673387|9698797|FG005|NOT COMPLETED|Overall Study||34
8656265|NCT00673387|9698798|FG006|NOT COMPLETED|Overall Study||30
8656266|NCT00673387|9698799|FG007|NOT COMPLETED|Overall Study||35
8656267|NCT00673400|9698827|FG000|STARTED|Overall Study||52
8656268|NCT00673400|9698827|FG000|COMPLETED|Overall Study||52
8656269|NCT00673400|9698827|FG000|NOT COMPLETED|Overall Study||0
8656270|NCT00673439|9698837|FG000|STARTED|Overall Study||3
8656271|NCT00673439|9698837|FG000|COMPLETED|Overall Study||3
8656272|NCT00673439|9698837|FG000|NOT COMPLETED|Overall Study||0
8656273|NCT00673452|9698844|FG000|STARTED|Acute Double-Blind Phase||263
8656274|NCT00673452|9698845|FG001|STARTED|Acute Double-Blind Phase||267
8656275|NCT00673452|9698844|FG000|COMPLETED|Acute Double-Blind Phase||176
8656276|NCT00673452|9698845|FG001|COMPLETED|Acute Double-Blind Phase||187
8656277|NCT00673452|9698844|FG000|NOT COMPLETED|Acute Double-Blind Phase||87
8656278|NCT00673452|9698845|FG001|NOT COMPLETED|Acute Double-Blind Phase||80
8656279|NCT00673452|9698844|FG000|STARTED|Continuation Double-Blind Phase||176
8656280|NCT00673452|9698845|FG001|STARTED|Continuation Double-Blind Phase|Patients on placebo in acute phase received 60 mg duloxetine during the continuation phase.|187
8656281|NCT00673452|9698844|FG000|COMPLETED|Continuation Double-Blind Phase||151
8656282|NCT00673452|9698845|FG001|COMPLETED|Continuation Double-Blind Phase||153
8656283|NCT00673452|9698844|FG000|NOT COMPLETED|Continuation Double-Blind Phase||25
8656284|NCT00673452|9698845|FG001|NOT COMPLETED|Continuation Double-Blind Phase||34
8656285|NCT00673465|9698851|FG000|STARTED|Part 1/Period 1 (United States)||3
8656286|NCT00673465|9698852|FG001|STARTED|Part 1/Period 1 (United States)||3
8656287|NCT00673465|9698853|FG002|STARTED|Part 1/Period 1 (United States)||3
8656288|NCT00673465|9698854|FG003|STARTED|Part 1/Period 1 (United States)||3
8656289|NCT00673465|9698855|FG004|STARTED|Part 1/Period 1 (United States)||3
8656290|NCT00673465|9698856|FG005|STARTED|Part 1/Period 1 (United States)||2
8656291|NCT00673465|9698857|FG006|STARTED|Part 1/Period 1 (United States)||0
8656292|NCT00673465|9698858|FG007|STARTED|Part 1/Period 1 (United States)||0
8656293|NCT00673465|9698859|FG008|STARTED|Part 1/Period 1 (United States)||0
8656294|NCT00673465|9698860|FG009|STARTED|Part 1/Period 1 (United States)||0
8656295|NCT00673465|9698861|FG010|STARTED|Part 1/Period 1 (United States)||0
8656296|NCT00673465|9698862|FG011|STARTED|Part 1/Period 1 (United States)||0
8656297|NCT00673465|9698851|FG000|COMPLETED|Part 1/Period 1 (United States)||3
8656298|NCT00673465|9698852|FG001|COMPLETED|Part 1/Period 1 (United States)||3
8656299|NCT00673465|9698853|FG002|COMPLETED|Part 1/Period 1 (United States)||3
8656300|NCT00673465|9698854|FG003|COMPLETED|Part 1/Period 1 (United States)||3
8656301|NCT00673465|9698855|FG004|COMPLETED|Part 1/Period 1 (United States)||2
8656302|NCT00673465|9698856|FG005|COMPLETED|Part 1/Period 1 (United States)||1
8656303|NCT00673465|9698857|FG006|COMPLETED|Part 1/Period 1 (United States)||0
8656304|NCT00673465|9698858|FG007|COMPLETED|Part 1/Period 1 (United States)||0
8656305|NCT00673465|9698859|FG008|COMPLETED|Part 1/Period 1 (United States)||0
8656306|NCT00673465|9698860|FG009|COMPLETED|Part 1/Period 1 (United States)||0
8656307|NCT00673465|9698861|FG010|COMPLETED|Part 1/Period 1 (United States)||0
8656308|NCT00673465|9698862|FG011|COMPLETED|Part 1/Period 1 (United States)||0
8656309|NCT00673465|9698851|FG000|NOT COMPLETED|Part 1/Period 1 (United States)||0
8656310|NCT00673465|9698852|FG001|NOT COMPLETED|Part 1/Period 1 (United States)||0
8656311|NCT00673465|9698853|FG002|NOT COMPLETED|Part 1/Period 1 (United States)||0
8656312|NCT00673465|9698854|FG003|NOT COMPLETED|Part 1/Period 1 (United States)||0
8656313|NCT00673465|9698855|FG004|NOT COMPLETED|Part 1/Period 1 (United States)||1
8656314|NCT00673465|9698856|FG005|NOT COMPLETED|Part 1/Period 1 (United States)||1
8656315|NCT00673465|9698857|FG006|NOT COMPLETED|Part 1/Period 1 (United States)||0
8656316|NCT00673465|9698858|FG007|NOT COMPLETED|Part 1/Period 1 (United States)||0
8656317|NCT00673465|9698859|FG008|NOT COMPLETED|Part 1/Period 1 (United States)||0
8656318|NCT00673465|9698860|FG009|NOT COMPLETED|Part 1/Period 1 (United States)||0
8656319|NCT00673465|9698861|FG010|NOT COMPLETED|Part 1/Period 1 (United States)||0
8656320|NCT00673465|9698862|FG011|NOT COMPLETED|Part 1/Period 1 (United States)||0
8656321|NCT00673465|9698851|FG000|STARTED|Part 1/Period 2 (United States)||3
8656322|NCT00673465|9698852|FG001|STARTED|Part 1/Period 2 (United States)||3
8656323|NCT00673465|9698853|FG002|STARTED|Part 1/Period 2 (United States)||3
8656324|NCT00673465|9698854|FG003|STARTED|Part 1/Period 2 (United States)||3
8656325|NCT00673465|9698855|FG004|STARTED|Part 1/Period 2 (United States)||2
8656326|NCT00673465|9698856|FG005|STARTED|Part 1/Period 2 (United States)||1
8656327|NCT00673465|9698857|FG006|STARTED|Part 1/Period 2 (United States)||0
8656328|NCT00673465|9698858|FG007|STARTED|Part 1/Period 2 (United States)||0
8656329|NCT00673465|9698859|FG008|STARTED|Part 1/Period 2 (United States)||0
8656330|NCT00673465|9698860|FG009|STARTED|Part 1/Period 2 (United States)||0
8656331|NCT00673465|9698861|FG010|STARTED|Part 1/Period 2 (United States)||0
8656332|NCT00673465|9698862|FG011|STARTED|Part 1/Period 2 (United States)||0
8656333|NCT00673465|9698851|FG000|COMPLETED|Part 1/Period 2 (United States)||3
8656334|NCT00673465|9698852|FG001|COMPLETED|Part 1/Period 2 (United States)||3
8656335|NCT00673465|9698853|FG002|COMPLETED|Part 1/Period 2 (United States)||3
8656336|NCT00673465|9698854|FG003|COMPLETED|Part 1/Period 2 (United States)||3
8656337|NCT00673465|9698855|FG004|COMPLETED|Part 1/Period 2 (United States)||1
8656338|NCT00673465|9698856|FG005|COMPLETED|Part 1/Period 2 (United States)||1
8656339|NCT00673465|9698857|FG006|COMPLETED|Part 1/Period 2 (United States)||0
8656340|NCT00673465|9698858|FG007|COMPLETED|Part 1/Period 2 (United States)||0
8656341|NCT00673465|9698859|FG008|COMPLETED|Part 1/Period 2 (United States)||0
8656342|NCT00673465|9698860|FG009|COMPLETED|Part 1/Period 2 (United States)||0
8656343|NCT00673465|9698861|FG010|COMPLETED|Part 1/Period 2 (United States)||0
8656344|NCT00673465|9698862|FG011|COMPLETED|Part 1/Period 2 (United States)||0
8656345|NCT00673465|9698851|FG000|NOT COMPLETED|Part 1/Period 2 (United States)||0
8656346|NCT00673465|9698852|FG001|NOT COMPLETED|Part 1/Period 2 (United States)||0
8656347|NCT00673465|9698853|FG002|NOT COMPLETED|Part 1/Period 2 (United States)||0
8656348|NCT00673465|9698854|FG003|NOT COMPLETED|Part 1/Period 2 (United States)||0
8656349|NCT00673465|9698855|FG004|NOT COMPLETED|Part 1/Period 2 (United States)||1
8656350|NCT00673465|9698856|FG005|NOT COMPLETED|Part 1/Period 2 (United States)||0
8656351|NCT00673465|9698857|FG006|NOT COMPLETED|Part 1/Period 2 (United States)||0
8656352|NCT00673465|9698858|FG007|NOT COMPLETED|Part 1/Period 2 (United States)||0
8656353|NCT00673465|9698859|FG008|NOT COMPLETED|Part 1/Period 2 (United States)||0
8656354|NCT00673465|9698860|FG009|NOT COMPLETED|Part 1/Period 2 (United States)||0
8656355|NCT00673465|9698861|FG010|NOT COMPLETED|Part 1/Period 2 (United States)||0
8656356|NCT00673465|9698862|FG011|NOT COMPLETED|Part 1/Period 2 (United States)||0
8656357|NCT00673465|9698851|FG000|STARTED|Part 1/Period 3 (United States)||3
8656358|NCT00673465|9698852|FG001|STARTED|Part 1/Period 3 (United States)||3
8656359|NCT00673465|9698853|FG002|STARTED|Part 1/Period 3 (United States)||3
8656360|NCT00673465|9698854|FG003|STARTED|Part 1/Period 3 (United States)||3
8656361|NCT00673465|9698855|FG004|STARTED|Part 1/Period 3 (United States)||1
8656362|NCT00673465|9698856|FG005|STARTED|Part 1/Period 3 (United States)||1
8656363|NCT00673465|9698857|FG006|STARTED|Part 1/Period 3 (United States)||0
8656364|NCT00673465|9698858|FG007|STARTED|Part 1/Period 3 (United States)||0
8656365|NCT00673465|9698859|FG008|STARTED|Part 1/Period 3 (United States)||0
8656366|NCT00673465|9698860|FG009|STARTED|Part 1/Period 3 (United States)||0
8656367|NCT00673465|9698861|FG010|STARTED|Part 1/Period 3 (United States)||0
8656368|NCT00673465|9698862|FG011|STARTED|Part 1/Period 3 (United States)||0
8656369|NCT00673465|9698851|FG000|COMPLETED|Part 1/Period 3 (United States)||3
8656370|NCT00673465|9698852|FG001|COMPLETED|Part 1/Period 3 (United States)||3
8656371|NCT00673465|9698853|FG002|COMPLETED|Part 1/Period 3 (United States)||3
8656372|NCT00673465|9698854|FG003|COMPLETED|Part 1/Period 3 (United States)||3
8656373|NCT00673465|9698855|FG004|COMPLETED|Part 1/Period 3 (United States)||1
8656374|NCT00673465|9698856|FG005|COMPLETED|Part 1/Period 3 (United States)||1
8656375|NCT00673465|9698857|FG006|COMPLETED|Part 1/Period 3 (United States)||0
8656376|NCT00673465|9698858|FG007|COMPLETED|Part 1/Period 3 (United States)||0
8656377|NCT00673465|9698859|FG008|COMPLETED|Part 1/Period 3 (United States)||0
8656378|NCT00673465|9698860|FG009|COMPLETED|Part 1/Period 3 (United States)||0
8656379|NCT00673465|9698861|FG010|COMPLETED|Part 1/Period 3 (United States)||0
8656380|NCT00673465|9698862|FG011|COMPLETED|Part 1/Period 3 (United States)||0
8656381|NCT00673465|9698851|FG000|NOT COMPLETED|Part 1/Period 3 (United States)||0
8656382|NCT00673465|9698852|FG001|NOT COMPLETED|Part 1/Period 3 (United States)||0
8656383|NCT00673465|9698853|FG002|NOT COMPLETED|Part 1/Period 3 (United States)||0
8656384|NCT00673465|9698854|FG003|NOT COMPLETED|Part 1/Period 3 (United States)||0
8656385|NCT00673465|9698855|FG004|NOT COMPLETED|Part 1/Period 3 (United States)||0
8656386|NCT00673465|9698856|FG005|NOT COMPLETED|Part 1/Period 3 (United States)||0
8656387|NCT00673465|9698857|FG006|NOT COMPLETED|Part 1/Period 3 (United States)||0
8656388|NCT00673465|9698858|FG007|NOT COMPLETED|Part 1/Period 3 (United States)||0
8656389|NCT00673465|9698859|FG008|NOT COMPLETED|Part 1/Period 3 (United States)||0
8656390|NCT00673465|9698860|FG009|NOT COMPLETED|Part 1/Period 3 (United States)||0
8656391|NCT00673465|9698861|FG010|NOT COMPLETED|Part 1/Period 3 (United States)||0
8656392|NCT00673465|9698862|FG011|NOT COMPLETED|Part 1/Period 3 (United States)||0
8656393|NCT00673465|9698851|FG000|STARTED|Part 2 (India)||0
8656394|NCT00673465|9698852|FG001|STARTED|Part 2 (India)||0
8656395|NCT00673465|9698853|FG002|STARTED|Part 2 (India)||0
8656396|NCT00673465|9698854|FG003|STARTED|Part 2 (India)||0
8656397|NCT00673465|9698855|FG004|STARTED|Part 2 (India)||0
8656398|NCT00673465|9698856|FG005|STARTED|Part 2 (India)||0
8656399|NCT00673465|9698857|FG006|STARTED|Part 2 (India)||0
8656400|NCT00673465|9698858|FG007|STARTED|Part 2 (India)||0
8656401|NCT00673465|9698859|FG008|STARTED|Part 2 (India)||0
8656402|NCT00673465|9698860|FG009|STARTED|Part 2 (India)||0
8656403|NCT00673465|9698861|FG010|STARTED|Part 2 (India)||0
8656404|NCT00673465|9698862|FG011|STARTED|Part 2 (India)||0
8656405|NCT00673465|9698851|FG000|COMPLETED|Part 2 (India)||0
8656406|NCT00673465|9698852|FG001|COMPLETED|Part 2 (India)||0
8656407|NCT00673465|9698853|FG002|COMPLETED|Part 2 (India)||0
8656408|NCT00673465|9698854|FG003|COMPLETED|Part 2 (India)||0
8656409|NCT00673465|9698855|FG004|COMPLETED|Part 2 (India)||0
8656410|NCT00673465|9698856|FG005|COMPLETED|Part 2 (India)||0
8656411|NCT00673465|9698857|FG006|COMPLETED|Part 2 (India)||0
8656412|NCT00673465|9698858|FG007|COMPLETED|Part 2 (India)||0
8656413|NCT00673465|9698859|FG008|COMPLETED|Part 2 (India)||0
8656414|NCT00673465|9698860|FG009|COMPLETED|Part 2 (India)||0
8656415|NCT00673465|9698861|FG010|COMPLETED|Part 2 (India)||0
8656416|NCT00673465|9698862|FG011|COMPLETED|Part 2 (India)||0
8656417|NCT00673465|9698851|FG000|NOT COMPLETED|Part 2 (India)||0
8656418|NCT00673465|9698852|FG001|NOT COMPLETED|Part 2 (India)||0
8656419|NCT00673465|9698853|FG002|NOT COMPLETED|Part 2 (India)||0
8656420|NCT00673465|9698854|FG003|NOT COMPLETED|Part 2 (India)||0
8656421|NCT00673465|9698855|FG004|NOT COMPLETED|Part 2 (India)||0
8656422|NCT00673465|9698856|FG005|NOT COMPLETED|Part 2 (India)||0
8656423|NCT00673465|9698857|FG006|NOT COMPLETED|Part 2 (India)||0
8656424|NCT00673465|9698858|FG007|NOT COMPLETED|Part 2 (India)||0
8656425|NCT00673465|9698859|FG008|NOT COMPLETED|Part 2 (India)||0
8656426|NCT00673465|9698860|FG009|NOT COMPLETED|Part 2 (India)||0
8656427|NCT00673465|9698861|FG010|NOT COMPLETED|Part 2 (India)||0
8656428|NCT00673465|9698862|FG011|NOT COMPLETED|Part 2 (India)||0
8656429|NCT00673660|9698870|FG000|STARTED|Overall Study||375
8656430|NCT00673660|9698870|FG000|COMPLETED|Overall Study||268
8656431|NCT00673660|9698870|FG000|NOT COMPLETED|Overall Study||107
8656432|NCT00673673|9698879|FG000|STARTED|Overall Study||39
8656433|NCT00673673|9698879|FG000|COMPLETED|Overall Study||3
8656434|NCT00673673|9698879|FG000|NOT COMPLETED|Overall Study||36
8656435|NCT00673712|9698885|FG000|STARTED|Overall Study||321
8656436|NCT00673712|9698886|FG001|STARTED|Overall Study||326
8656437|NCT00673712|9698885|FG000|COMPLETED|Overall Study||321
8656438|NCT00673712|9698886|FG001|COMPLETED|Overall Study||326
8656439|NCT00673712|9698885|FG000|NOT COMPLETED|Overall Study||0
8656440|NCT00673712|9698886|FG001|NOT COMPLETED|Overall Study||0
8656441|NCT00673738|9698892|FG000|STARTED|Overall Study||27
8656442|NCT00673738|9698892|FG000|COMPLETED|Overall Study||27
8656443|NCT00673738|9698892|FG000|NOT COMPLETED|Overall Study||0
8656444|NCT00673764|9698896|FG000|STARTED|Overall Study||24
8656445|NCT00673764|9698897|FG001|STARTED|Overall Study||24
8656446|NCT00673764|9698896|FG000|COMPLETED|Overall Study||24
8656447|NCT00673764|9698897|FG001|COMPLETED|Overall Study||24
8656448|NCT00673764|9698896|FG000|NOT COMPLETED|Overall Study||0
8656449|NCT00673764|9698897|FG001|NOT COMPLETED|Overall Study||0
8656450|NCT00673790|9698906|FG000|STARTED|Overall Study||223
8656451|NCT00673790|9698907|FG001|STARTED|Overall Study||212
8656452|NCT00673790|9698908|FG002|STARTED|Overall Study||102
8656453|NCT00673790|9698906|FG000|COMPLETED|Overall Study||178
8656454|NCT00673790|9698907|FG001|COMPLETED|Overall Study||174
8656455|NCT00673790|9698908|FG002|COMPLETED|Overall Study||90
8656456|NCT00673790|9698906|FG000|NOT COMPLETED|Overall Study||45
8656457|NCT00673790|9698907|FG001|NOT COMPLETED|Overall Study||38
8656458|NCT00673790|9698908|FG002|NOT COMPLETED|Overall Study||12
8656459|NCT00673816|9698917|FG000|STARTED|Overall Study||2
8656460|NCT00673816|9698917|FG000|COMPLETED|Overall Study||0
8656461|NCT00673816|9698917|FG000|NOT COMPLETED|Overall Study||2
8656462|NCT00673855|9698922|FG000|STARTED|First Intervention||10
8656463|NCT00673855|9698923|FG001|STARTED|First Intervention||10
8656464|NCT00673855|9698922|FG000|COMPLETED|First Intervention||10
8656465|NCT00673855|9698923|FG001|COMPLETED|First Intervention||10
8656466|NCT00673855|9698922|FG000|NOT COMPLETED|First Intervention||0
8656467|NCT00673855|9698923|FG001|NOT COMPLETED|First Intervention||0
8656468|NCT00673855|9698922|FG000|STARTED|Second Intervention||10
8656469|NCT00673855|9698923|FG001|STARTED|Second Intervention||10
8656470|NCT00673855|9698922|FG000|COMPLETED|Second Intervention||10
8656471|NCT00673855|9698923|FG001|COMPLETED|Second Intervention||10
8656472|NCT00673855|9698922|FG000|NOT COMPLETED|Second Intervention||0
8656473|NCT00673855|9698923|FG001|NOT COMPLETED|Second Intervention||0
8656474|NCT00673881|9698929|FG000|STARTED|Overall Study||25
8656475|NCT00673881|9698929|FG000|COMPLETED|Overall Study||24
8656476|NCT00673881|9698929|FG000|NOT COMPLETED|Overall Study||1
8656477|NCT00673894|9698935|FG000|STARTED|First Intervention 4 Weeks||8
8656478|NCT00673894|9698936|FG001|STARTED|First Intervention 4 Weeks||7
8656479|NCT00673894|9698935|FG000|COMPLETED|First Intervention 4 Weeks||6
8656480|NCT00673894|9698936|FG001|COMPLETED|First Intervention 4 Weeks||7
8656481|NCT00673894|9698935|FG000|NOT COMPLETED|First Intervention 4 Weeks||2
8656482|NCT00673894|9698936|FG001|NOT COMPLETED|First Intervention 4 Weeks||0
8656483|NCT00673894|9698935|FG000|STARTED|Washout 4-6 Weeks||6
8656484|NCT00673894|9698936|FG001|STARTED|Washout 4-6 Weeks||7
8656485|NCT00673894|9698935|FG000|COMPLETED|Washout 4-6 Weeks||6
8656486|NCT00673894|9698936|FG001|COMPLETED|Washout 4-6 Weeks||7
8656487|NCT00673894|9698935|FG000|NOT COMPLETED|Washout 4-6 Weeks||0
8656488|NCT00673894|9698936|FG001|NOT COMPLETED|Washout 4-6 Weeks||0
8656489|NCT00673894|9698935|FG000|STARTED|Second Intervention 4 Weeks||6
8656490|NCT00673894|9698936|FG001|STARTED|Second Intervention 4 Weeks||7
8656491|NCT00673894|9698935|FG000|COMPLETED|Second Intervention 4 Weeks||6
8656492|NCT00673894|9698936|FG001|COMPLETED|Second Intervention 4 Weeks||7
8656493|NCT00673894|9698935|FG000|NOT COMPLETED|Second Intervention 4 Weeks||0
8656494|NCT00673894|9698936|FG001|NOT COMPLETED|Second Intervention 4 Weeks||0
8656495|NCT00673920|9698950|FG000|STARTED|Baseline up to Week 48||64
8656496|NCT00673920|9698951|FG001|STARTED|Baseline up to Week 48||117
8656497|NCT00673920|9698952|FG002|STARTED|Baseline up to Week 48||133
8656498|NCT00673920|9698953|FG003|STARTED|Baseline up to Week 48||0
8656499|NCT00673920|9698954|FG004|STARTED|Baseline up to Week 48||0
8656500|NCT00673920|9698955|FG005|STARTED|Baseline up to Week 48||0
8656501|NCT00673920|9698956|FG006|STARTED|Baseline up to Week 48||0
8656502|NCT00673920|9698957|FG007|STARTED|Baseline up to Week 48||0
8656503|NCT00673920|9698950|FG000|COMPLETED|Baseline up to Week 48||60
8656504|NCT00673920|9698951|FG001|COMPLETED|Baseline up to Week 48||114
8656505|NCT00673920|9698952|FG002|COMPLETED|Baseline up to Week 48||126
8656506|NCT00673920|9698953|FG003|COMPLETED|Baseline up to Week 48||0
8656507|NCT00673920|9698954|FG004|COMPLETED|Baseline up to Week 48||0
8656508|NCT00673920|9698955|FG005|COMPLETED|Baseline up to Week 48||0
8656509|NCT00673920|9698956|FG006|COMPLETED|Baseline up to Week 48||0
8656510|NCT00673920|9698957|FG007|COMPLETED|Baseline up to Week 48||0
8656511|NCT00673920|9698950|FG000|NOT COMPLETED|Baseline up to Week 48||4
8656512|NCT00673920|9698951|FG001|NOT COMPLETED|Baseline up to Week 48||3
8656513|NCT00673920|9698952|FG002|NOT COMPLETED|Baseline up to Week 48||7
8656514|NCT00673920|9698953|FG003|NOT COMPLETED|Baseline up to Week 48||0
8656515|NCT00673920|9698954|FG004|NOT COMPLETED|Baseline up to Week 48||0
8656516|NCT00673920|9698955|FG005|NOT COMPLETED|Baseline up to Week 48||0
8656517|NCT00673920|9698956|FG006|NOT COMPLETED|Baseline up to Week 48||0
8656518|NCT00673920|9698957|FG007|NOT COMPLETED|Baseline up to Week 48||0
8656519|NCT00673920|9698950|FG000|STARTED|Week 24 to Week 48||0
8656520|NCT00673920|9698951|FG001|STARTED|Week 24 to Week 48||0
8656521|NCT00673920|9698952|FG002|STARTED|Week 24 to Week 48||0
8656522|NCT00673920|9698953|FG003|STARTED|Week 24 to Week 48||61
8656523|NCT00673920|9698954|FG004|STARTED|Week 24 to Week 48||61
8656524|NCT00673920|9698955|FG005|STARTED|Week 24 to Week 48||109
8656525|NCT00673920|9698956|FG006|STARTED|Week 24 to Week 48||29
8656526|NCT00673920|9698957|FG007|STARTED|Week 24 to Week 48||28
8656527|NCT00673920|9698950|FG000|COMPLETED|Week 24 to Week 48||0
8656528|NCT00673920|9698951|FG001|COMPLETED|Week 24 to Week 48||0
8656529|NCT00673920|9698952|FG002|COMPLETED|Week 24 to Week 48||0
8656530|NCT00673920|9698953|FG003|COMPLETED|Week 24 to Week 48||60
8656531|NCT00673920|9698954|FG004|COMPLETED|Week 24 to Week 48||61
8656532|NCT00673920|9698955|FG005|COMPLETED|Week 24 to Week 48||106
8656533|NCT00673920|9698956|FG006|COMPLETED|Week 24 to Week 48||28
8656534|NCT00673920|9698957|FG007|COMPLETED|Week 24 to Week 48||28
8656535|NCT00673920|9698950|FG000|NOT COMPLETED|Week 24 to Week 48||0
8656536|NCT00673920|9698951|FG001|NOT COMPLETED|Week 24 to Week 48||0
8656537|NCT00673920|9698952|FG002|NOT COMPLETED|Week 24 to Week 48||0
8656538|NCT00673920|9698953|FG003|NOT COMPLETED|Week 24 to Week 48||1
8656539|NCT00673920|9698954|FG004|NOT COMPLETED|Week 24 to Week 48||0
8656540|NCT00673920|9698955|FG005|NOT COMPLETED|Week 24 to Week 48||3
8656541|NCT00673920|9698956|FG006|NOT COMPLETED|Week 24 to Week 48||1
8656542|NCT00673920|9698957|FG007|NOT COMPLETED|Week 24 to Week 48||0
8656543|NCT00673933|9698979|FG000|STARTED|Overall Study||20
8656544|NCT00673933|9698979|FG000|COMPLETED|Overall Study||17
8656545|NCT00673933|9698979|FG000|NOT COMPLETED|Overall Study||3
8656546|NCT00673959|9698985|FG000|STARTED|Overall Study||10
8656547|NCT00673959|9698986|FG001|STARTED|Overall Study||10
8656548|NCT00673959|9698985|FG000|COMPLETED|Overall Study||10
8656549|NCT00673959|9698986|FG001|COMPLETED|Overall Study||10
8656550|NCT00673959|9698985|FG000|NOT COMPLETED|Overall Study||0
8656551|NCT00673959|9698986|FG001|NOT COMPLETED|Overall Study||0
8656552|NCT00674115|9698992|FG000|STARTED|First Intervention||14
8656553|NCT00674115|9698993|FG001|STARTED|First Intervention||16
8656554|NCT00674115|9698994|FG002|STARTED|First Intervention||14
8656555|NCT00674115|9698995|FG003|STARTED|First Intervention||16
8656556|NCT00674115|9698992|FG000|COMPLETED|First Intervention||14
8656557|NCT00674115|9698993|FG001|COMPLETED|First Intervention||16
8656558|NCT00674115|9698994|FG002|COMPLETED|First Intervention||14
8656559|NCT00674115|9698995|FG003|COMPLETED|First Intervention||16
8656560|NCT00674115|9698992|FG000|NOT COMPLETED|First Intervention||0
8656561|NCT00674115|9698993|FG001|NOT COMPLETED|First Intervention||0
8656562|NCT00674115|9698994|FG002|NOT COMPLETED|First Intervention||0
8656563|NCT00674115|9698995|FG003|NOT COMPLETED|First Intervention||0
8656564|NCT00674115|9698992|FG000|STARTED|Washout Period of 2 Weeks||14
8656565|NCT00674115|9698993|FG001|STARTED|Washout Period of 2 Weeks||16
8656566|NCT00674115|9698994|FG002|STARTED|Washout Period of 2 Weeks||14
8656567|NCT00674115|9698995|FG003|STARTED|Washout Period of 2 Weeks||16
8656568|NCT00674115|9698992|FG000|COMPLETED|Washout Period of 2 Weeks||14
8656569|NCT00674115|9698993|FG001|COMPLETED|Washout Period of 2 Weeks||16
8656570|NCT00674115|9698994|FG002|COMPLETED|Washout Period of 2 Weeks||14
8656571|NCT00674115|9698995|FG003|COMPLETED|Washout Period of 2 Weeks||16
8656572|NCT00674115|9698992|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
8656573|NCT00674115|9698993|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
8656574|NCT00674115|9698994|FG002|NOT COMPLETED|Washout Period of 2 Weeks||0
8656575|NCT00674115|9698995|FG003|NOT COMPLETED|Washout Period of 2 Weeks||0
8656576|NCT00674115|9698992|FG000|STARTED|Second Intervention||14
8656577|NCT00674115|9698993|FG001|STARTED|Second Intervention||16
8656578|NCT00674115|9698994|FG002|STARTED|Second Intervention||14
8656579|NCT00674115|9698995|FG003|STARTED|Second Intervention||16
8656580|NCT00674115|9698992|FG000|COMPLETED|Second Intervention||14
8656581|NCT00674115|9698993|FG001|COMPLETED|Second Intervention||16
8656582|NCT00674115|9698994|FG002|COMPLETED|Second Intervention||14
8656583|NCT00674115|9698995|FG003|COMPLETED|Second Intervention||16
8656584|NCT00674115|9698992|FG000|NOT COMPLETED|Second Intervention||0
8656585|NCT00674115|9698993|FG001|NOT COMPLETED|Second Intervention||0
8656586|NCT00674115|9698994|FG002|NOT COMPLETED|Second Intervention||0
8656587|NCT00674115|9698995|FG003|NOT COMPLETED|Second Intervention||0
8656588|NCT00674115|9698992|FG000|STARTED|Washout Period of 2 Weeks||14
8656589|NCT00674115|9698993|FG001|STARTED|Washout Period of 2 Weeks||16
8656590|NCT00674115|9698994|FG002|STARTED|Washout Period of 2 Weeks||0
8656591|NCT00674115|9698995|FG003|STARTED|Washout Period of 2 Weeks||0
8656592|NCT00674115|9698992|FG000|COMPLETED|Washout Period of 2 Weeks||14
8656593|NCT00674115|9698993|FG001|COMPLETED|Washout Period of 2 Weeks||16
8656594|NCT00674115|9698994|FG002|COMPLETED|Washout Period of 2 Weeks||0
8656595|NCT00674115|9698995|FG003|COMPLETED|Washout Period of 2 Weeks||0
8656596|NCT00674115|9698992|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
8656597|NCT00674115|9698993|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
8656598|NCT00674115|9698994|FG002|NOT COMPLETED|Washout Period of 2 Weeks||0
8656599|NCT00674115|9698995|FG003|NOT COMPLETED|Washout Period of 2 Weeks||0
8656600|NCT00674115|9698992|FG000|STARTED|Third Intervention||14
8656601|NCT00674115|9698993|FG001|STARTED|Third Intervention||16
8656602|NCT00674115|9698994|FG002|STARTED|Third Intervention||0
8656603|NCT00674115|9698995|FG003|STARTED|Third Intervention||0
8656604|NCT00674115|9698992|FG000|COMPLETED|Third Intervention||14
8656605|NCT00674115|9698993|FG001|COMPLETED|Third Intervention||16
8656606|NCT00674115|9698994|FG002|COMPLETED|Third Intervention||0
8656607|NCT00674115|9698995|FG003|COMPLETED|Third Intervention||0
8656608|NCT00674115|9698992|FG000|NOT COMPLETED|Third Intervention||0
8656609|NCT00674115|9698993|FG001|NOT COMPLETED|Third Intervention||0
8656610|NCT00674115|9698994|FG002|NOT COMPLETED|Third Intervention||0
8656611|NCT00674115|9698995|FG003|NOT COMPLETED|Third Intervention||0
8656612|NCT00674128|9699006|FG000|STARTED|Overall Study||50
8656613|NCT00674128|9699007|FG001|STARTED|Overall Study||44
8656614|NCT00674128|9699006|FG000|COMPLETED|Overall Study||25
8656615|NCT00674128|9699007|FG001|COMPLETED|Overall Study||21
8656616|NCT00674128|9699006|FG000|NOT COMPLETED|Overall Study||25
8656617|NCT00674128|9699007|FG001|NOT COMPLETED|Overall Study||23
8656618|NCT00674154|9699015|FG000|STARTED|Overall Study||23
8656619|NCT00674154|9699016|FG001|STARTED|Overall Study||23
8656620|NCT00674154|9699015|FG000|COMPLETED|Overall Study||20
8656621|NCT00674154|9699016|FG001|COMPLETED|Overall Study||20
8656622|NCT00674154|9699015|FG000|NOT COMPLETED|Overall Study||3
8656623|NCT00674154|9699016|FG001|NOT COMPLETED|Overall Study||3
8656624|NCT00674206|9699022|FG000|STARTED|Overall Study||6
8656625|NCT00674206|9699022|FG000|COMPLETED|Overall Study||6
8656626|NCT00674206|9699022|FG000|NOT COMPLETED|Overall Study||0
8656627|NCT00674219|9699028|FG000|STARTED|Overall Study||10
8656628|NCT00674219|9699029|FG001|STARTED|Overall Study||7
8656629|NCT00674219|9699028|FG000|COMPLETED|Overall Study||10
8656630|NCT00674219|9699029|FG001|COMPLETED|Overall Study||7
8656631|NCT00674219|9699028|FG000|NOT COMPLETED|Overall Study||0
8656632|NCT00674219|9699029|FG001|NOT COMPLETED|Overall Study||0
8656633|NCT00674297|9699035|FG000|STARTED|Overall Study||18
8656634|NCT00674297|9699036|FG001|STARTED|Overall Study||7
8656635|NCT00674297|9699037|FG002|STARTED|Overall Study||9
8656636|NCT00674297|9699038|FG003|STARTED|Overall Study||7
8656637|NCT00674297|9699035|FG000|COMPLETED|Overall Study||8
8656638|NCT00674297|9699036|FG001|COMPLETED|Overall Study||7
8656639|NCT00674297|9699037|FG002|COMPLETED|Overall Study||5
8656640|NCT00674297|9699038|FG003|COMPLETED|Overall Study||4
8656641|NCT00674297|9699035|FG000|NOT COMPLETED|Overall Study||10
8656642|NCT00674297|9699036|FG001|NOT COMPLETED|Overall Study||0
8656643|NCT00674297|9699037|FG002|NOT COMPLETED|Overall Study||4
8656644|NCT00674297|9699038|FG003|NOT COMPLETED|Overall Study||3
8656645|NCT00674323|9699048|FG000|STARTED|Overall Study||19
8656646|NCT00674323|9699049|FG001|STARTED|Overall Study||21
8656647|NCT00674323|9699050|FG002|STARTED|Overall Study||21
8656648|NCT00674323|9699048|FG000|COMPLETED|Overall Study||18
8656649|NCT00674323|9699049|FG001|COMPLETED|Overall Study||20
8656650|NCT00674323|9699050|FG002|COMPLETED|Overall Study||21
8656651|NCT00674323|9699048|FG000|NOT COMPLETED|Overall Study||1
8656652|NCT00674323|9699049|FG001|NOT COMPLETED|Overall Study||1
8656653|NCT00674323|9699050|FG002|NOT COMPLETED|Overall Study||0
8656654|NCT00674362|9699060|FG000|STARTED|Double Blind||96
8656655|NCT00674362|9699061|FG001|STARTED|Double Blind||98
8656656|NCT00674362|9699060|FG000|COMPLETED|Double Blind||84
8656657|NCT00674362|9699061|FG001|COMPLETED|Double Blind||80
8656658|NCT00674362|9699060|FG000|NOT COMPLETED|Double Blind||12
8656659|NCT00674362|9699061|FG001|NOT COMPLETED|Double Blind||18
8656660|NCT00674362|9699060|FG000|STARTED|Open Label||20
8656661|NCT00674362|9699061|FG001|STARTED|Open Label||7
8656662|NCT00674362|9699060|FG000|COMPLETED|Open Label||18
8656663|NCT00674362|9699061|FG001|COMPLETED|Open Label||7
8656664|NCT00674362|9699060|FG000|NOT COMPLETED|Open Label||2
8656665|NCT00674362|9699061|FG001|NOT COMPLETED|Open Label||0
8656666|NCT00674466|9699071|FG000|STARTED|Overall Study||30
8656667|NCT00674466|9699072|FG001|STARTED|Overall Study||30
8656668|NCT00674466|9699073|FG002|STARTED|Overall Study||30
8656669|NCT00674466|9699071|FG000|COMPLETED|Overall Study||23
8656670|NCT00674466|9699072|FG001|COMPLETED|Overall Study||22
8656671|NCT00674466|9699073|FG002|COMPLETED|Overall Study||21
8656672|NCT00674466|9699071|FG000|NOT COMPLETED|Overall Study||7
8656673|NCT00674466|9699072|FG001|NOT COMPLETED|Overall Study||8
8656674|NCT00674466|9699073|FG002|NOT COMPLETED|Overall Study||9
8656675|NCT00674479|9699081|FG000|STARTED|Overall Study||51
8656676|NCT00674479|9699081|FG000|COMPLETED|Overall Study||51
8656677|NCT00674479|9699081|FG000|NOT COMPLETED|Overall Study||0
8656678|NCT00674492|9699085|FG000|STARTED|Overall Study||21
8656679|NCT00674492|9699085|FG000|COMPLETED|Overall Study||21
8656680|NCT00674492|9699085|FG000|NOT COMPLETED|Overall Study||0
8656681|NCT00674570|9699092|FG000|STARTED|Overall Study||37
8656682|NCT00674570|9699093|FG001|STARTED|Overall Study||34
8656683|NCT00674570|9699094|FG002|STARTED|Overall Study||35
8656684|NCT00674570|9699092|FG000|COMPLETED|Overall Study||37
8656685|NCT00674570|9699093|FG001|COMPLETED|Overall Study||32
8656686|NCT00674570|9699094|FG002|COMPLETED|Overall Study||35
8656687|NCT00674570|9699092|FG000|NOT COMPLETED|Overall Study||0
8656688|NCT00674570|9699093|FG001|NOT COMPLETED|Overall Study||2
8656689|NCT00674570|9699094|FG002|NOT COMPLETED|Overall Study||0
8656690|NCT00674583|9699104|FG000|STARTED|Overall Study||311
8656691|NCT00674583|9699105|FG001|STARTED|Overall Study||103
8656692|NCT00674583|9699104|FG000|COMPLETED|Overall Study||311
8656693|NCT00674583|9699105|FG001|COMPLETED|Overall Study||103
8656694|NCT00674583|9699104|FG000|NOT COMPLETED|Overall Study||0
8656695|NCT00674583|9699105|FG001|NOT COMPLETED|Overall Study||0
8656696|NCT00674609|9699118|FG000|STARTED|Overall Study||60
8656697|NCT00674609|9699119|FG001|STARTED|Overall Study||58
8656698|NCT00674609|9699120|FG002|STARTED|Overall Study||59
8656699|NCT00674609|9699118|FG000|COMPLETED|Overall Study||48
8656700|NCT00674609|9699119|FG001|COMPLETED|Overall Study||45
8656701|NCT00674609|9699120|FG002|COMPLETED|Overall Study||51
8656702|NCT00674609|9699118|FG000|NOT COMPLETED|Overall Study||12
8656703|NCT00674609|9699119|FG001|NOT COMPLETED|Overall Study||13
8656704|NCT00674609|9699120|FG002|NOT COMPLETED|Overall Study||8
8656705|NCT00674622|9699131|FG000|STARTED|Overall Study||22
8656706|NCT00674622|9699132|FG001|STARTED|Overall Study||22
8656707|NCT00674622|9699133|FG002|STARTED|Overall Study||22
8656708|NCT00674622|9699131|FG000|COMPLETED|Overall Study||21
8656709|NCT00674622|9699132|FG001|COMPLETED|Overall Study||18
8656710|NCT00674622|9699133|FG002|COMPLETED|Overall Study||22
8656711|NCT00674622|9699131|FG000|NOT COMPLETED|Overall Study||1
8656712|NCT00674622|9699132|FG001|NOT COMPLETED|Overall Study||4
8656713|NCT00674622|9699133|FG002|NOT COMPLETED|Overall Study||0
8656714|NCT00674661|9699143|FG000|STARTED|Overall Study||67
8656715|NCT00674661|9699144|FG001|STARTED|Overall Study||63
8656716|NCT00674661|9699143|FG000|COMPLETED|Overall Study||56
8656717|NCT00674661|9699144|FG001|COMPLETED|Overall Study||48
8656718|NCT00674661|9699143|FG000|NOT COMPLETED|Overall Study||11
8656719|NCT00674661|9699144|FG001|NOT COMPLETED|Overall Study||15
8692094|NCT00858364|9737504|FG001|Received Study Drug|Overall Study||1681
8692095|NCT00858364|9737503|FG000|COMPLETED|Overall Study||642
8692096|NCT00858364|9737504|FG001|COMPLETED|Overall Study||1246
8692097|NCT00858364|9737503|FG000|NOT COMPLETED|Overall Study||204
8692098|NCT00858364|9737504|FG001|NOT COMPLETED|Overall Study||457
8692099|NCT00858390|9737512|FG000|STARTED|Overall Study||18
8692100|NCT00858390|9737513|FG001|STARTED|Overall Study||18
8692101|NCT00858390|9737512|FG000|COMPLETED|Overall Study||18
8692102|NCT00858390|9737513|FG001|COMPLETED|Overall Study||18
8692103|NCT00858390|9737512|FG000|NOT COMPLETED|Overall Study||0
8692104|NCT00858390|9737513|FG001|NOT COMPLETED|Overall Study||0
8692105|NCT00858403|9737519|FG000|STARTED|Overall Study||7
8692106|NCT00858403|9737519|FG000|COMPLETED|Overall Study||2
8692107|NCT00858403|9737519|FG000|NOT COMPLETED|Overall Study||5
8692108|NCT00858442|9737525|FG000|STARTED|From Surgery to Start Compression;||21
8692109|NCT00858442|9737526|FG001|STARTED|From Surgery to Start Compression;||23
8692110|NCT00858442|9737525|FG000|COMPLETED|From Surgery to Start Compression;||21
8692111|NCT00858442|9737526|FG001|COMPLETED|From Surgery to Start Compression;||23
8692112|NCT00858442|9737525|FG000|NOT COMPLETED|From Surgery to Start Compression;||0
8692113|NCT00858442|9737526|FG001|NOT COMPLETED|From Surgery to Start Compression;||0
8692114|NCT00858442|9737525|FG000|STARTED|Compression:Start to Finish||21
8692115|NCT00858442|9737526|FG001|STARTED|Compression:Start to Finish||23
8692116|NCT00858442|9737525|FG000|COMPLETED|Compression:Start to Finish||20
8692117|NCT00858442|9737526|FG001|COMPLETED|Compression:Start to Finish||20
8692118|NCT00858442|9737525|FG000|NOT COMPLETED|Compression:Start to Finish||1
8692119|NCT00858442|9737526|FG001|NOT COMPLETED|Compression:Start to Finish||3
8692120|NCT00858468|9737535|FG000|STARTED|Overall Study|1 enrolled participant was not vaccinated and removed from analysis|201
8692121|NCT00858468|9737536|FG001|STARTED|Overall Study||192
8692122|NCT00858468|9737535|FG000|COMPLETED|Overall Study||201
8692123|NCT00858468|9737536|FG001|COMPLETED|Overall Study||192
8692124|NCT00858468|9737535|FG000|NOT COMPLETED|Overall Study||0
8692125|NCT00858468|9737536|FG001|NOT COMPLETED|Overall Study||0
8692126|NCT00858494|9737542|FG000|STARTED|Overall Study||49
8692127|NCT00858494|9737542|FG000|COMPLETED|Overall Study|2 participants dropped out before giving study medication. Symptoms resolved without a dose in 2.|45
8692128|NCT00858494|9737542|FG000|NOT COMPLETED|Overall Study||4
8692129|NCT00858507|9737548|FG000|STARTED|Overall Study||105
8692130|NCT00858507|9737549|FG001|STARTED|Overall Study||116
8692131|NCT00858507|9737548|FG000|COMPLETED|Overall Study||83
8692132|NCT00858507|9737549|FG001|COMPLETED|Overall Study||101
8692133|NCT00858507|9737548|FG000|NOT COMPLETED|Overall Study||22
8692134|NCT00858507|9737549|FG001|NOT COMPLETED|Overall Study||15
8692135|NCT00858637|9737557|FG000|STARTED|Active Comparison Phase||127
8692136|NCT00858637|9737558|FG001|STARTED|Active Comparison Phase||0
8692137|NCT00858637|9737559|FG002|STARTED|Active Comparison Phase||0
8692138|NCT00858637|9737560|FG003|STARTED|Active Comparison Phase||133
8692139|NCT00858637|9737561|FG004|STARTED|Active Comparison Phase||0
8692140|NCT00858637|9737562|FG005|STARTED|Active Comparison Phase||0
8692141|NCT00858637|9737557|FG000|COMPLETED|Active Comparison Phase||103
8692142|NCT00858637|9737558|FG001|COMPLETED|Active Comparison Phase||0
8692143|NCT00858637|9737559|FG002|COMPLETED|Active Comparison Phase||0
8692144|NCT00858637|9737560|FG003|COMPLETED|Active Comparison Phase||115
8692145|NCT00858637|9737561|FG004|COMPLETED|Active Comparison Phase||0
8692146|NCT00858637|9737562|FG005|COMPLETED|Active Comparison Phase||0
8692147|NCT00858637|9737557|FG000|NOT COMPLETED|Active Comparison Phase||24
8692148|NCT00858637|9737558|FG001|NOT COMPLETED|Active Comparison Phase||0
8692149|NCT00858637|9737559|FG002|NOT COMPLETED|Active Comparison Phase||0
8692150|NCT00858637|9737560|FG003|NOT COMPLETED|Active Comparison Phase||18
8692151|NCT00858637|9737561|FG004|NOT COMPLETED|Active Comparison Phase||0
8656720|NCT00674700|9699153|FG000|STARTED|Year 1||170
8656721|NCT00674700|9699154|FG001|STARTED|Year 1||169
8656722|NCT00674700|9699155|FG002|STARTED|Year 1||170
8656723|NCT00674700|9699153|FG000|COMPLETED|Year 1||139
8656724|NCT00674700|9699154|FG001|COMPLETED|Year 1||135
8656725|NCT00674700|9699155|FG002|COMPLETED|Year 1||153
8656726|NCT00674700|9699153|FG000|NOT COMPLETED|Year 1||31
8656727|NCT00674700|9699154|FG001|NOT COMPLETED|Year 1||34
8656728|NCT00674700|9699155|FG002|NOT COMPLETED|Year 1||17
8656729|NCT00674700|9699153|FG000|STARTED|Year 2 Follow-up Without Treatment||139
8656730|NCT00674700|9699154|FG001|STARTED|Year 2 Follow-up Without Treatment||135
8656731|NCT00674700|9699155|FG002|STARTED|Year 2 Follow-up Without Treatment||153
8656732|NCT00674700|9699153|FG000|COMPLETED|Year 2 Follow-up Without Treatment||133
8656733|NCT00674700|9699154|FG001|COMPLETED|Year 2 Follow-up Without Treatment||123
8656734|NCT00674700|9699155|FG002|COMPLETED|Year 2 Follow-up Without Treatment||141
8656735|NCT00674700|9699153|FG000|NOT COMPLETED|Year 2 Follow-up Without Treatment||6
8656736|NCT00674700|9699154|FG001|NOT COMPLETED|Year 2 Follow-up Without Treatment||12
8656737|NCT00674700|9699155|FG002|NOT COMPLETED|Year 2 Follow-up Without Treatment||12
8656738|NCT00674739|9699166|FG000|STARTED|Overall Study||178
8656739|NCT00674739|9699167|FG001|STARTED|Overall Study||195
8656740|NCT00674739|9699168|FG002|STARTED|Overall Study||97
8656741|NCT00674739|9699166|FG000|COMPLETED|Overall Study||121
8656742|NCT00674739|9699167|FG001|COMPLETED|Overall Study||136
8656743|NCT00674739|9699168|FG002|COMPLETED|Overall Study||65
8656744|NCT00674739|9699166|FG000|NOT COMPLETED|Overall Study||57
8656745|NCT00674739|9699167|FG001|NOT COMPLETED|Overall Study||59
8656746|NCT00674739|9699168|FG002|NOT COMPLETED|Overall Study||32
8656747|NCT00674765|9699178|FG000|STARTED|Overall Study||81
8656748|NCT00674765|9699179|FG001|STARTED|Overall Study||75
8656749|NCT00674765|9699178|FG000|COMPLETED|Overall Study||45
8656750|NCT00674765|9699179|FG001|COMPLETED|Overall Study||46
8656751|NCT00674765|9699178|FG000|NOT COMPLETED|Overall Study||36
8656752|NCT00674765|9699179|FG001|NOT COMPLETED|Overall Study||29
8656753|NCT00674817|9699185|FG000|STARTED|Period 1||44
8656754|NCT00674817|9699185|FG000|COMPLETED|Period 1||41
8656755|NCT00674817|9699185|FG000|NOT COMPLETED|Period 1||3
8656756|NCT00674817|9699185|FG000|STARTED|Period 2||41
8656757|NCT00674817|9699185|FG000|COMPLETED|Period 2||41
8656758|NCT00674817|9699185|FG000|NOT COMPLETED|Period 2||0
8656759|NCT00674817|9699185|FG000|STARTED|Period 3||41
8656760|NCT00674817|9699185|FG000|COMPLETED|Period 3||39
8656761|NCT00674817|9699185|FG000|NOT COMPLETED|Period 3||2
8656762|NCT00674817|9699185|FG000|STARTED|Period 4||39
8656763|NCT00674817|9699185|FG000|COMPLETED|Period 4||38
8656764|NCT00674817|9699185|FG000|NOT COMPLETED|Period 4||1
8656765|NCT00674817|9699185|FG000|STARTED|Period 5||38
8656766|NCT00674817|9699185|FG000|COMPLETED|Period 5||38
8656767|NCT00674817|9699185|FG000|NOT COMPLETED|Period 5||0
8656768|NCT00674817|9699185|FG000|STARTED|Period 6||38
8656769|NCT00674817|9699185|FG000|COMPLETED|Period 6||38
8656770|NCT00674817|9699185|FG000|NOT COMPLETED|Period 6||0
8656771|NCT00674973|9699201|FG000|STARTED|Overall Study||103
8656772|NCT00674973|9699202|FG001|STARTED|Overall Study||104
8656773|NCT00674973|9699201|FG000|Switch to Open-Label Erlotinib|Overall Study|Participants with PD were given opportunity to switch.|57
8656774|NCT00674973|9699202|FG001|Switch to Open-Label Erlotinib|Overall Study||0
8656775|NCT00674973|9699201|FG000|COMPLETED|Overall Study|Completed double-blind treatment.|3
8656776|NCT00674973|9699202|FG001|COMPLETED|Overall Study|Completed double-blind treatment.|2
8656777|NCT00674973|9699201|FG000|NOT COMPLETED|Overall Study||100
8656778|NCT00674973|9699202|FG001|NOT COMPLETED|Overall Study||102
8656779|NCT00674986|9699210|FG000|STARTED|Overall Study||230
8656780|NCT00674986|9699211|FG001|STARTED|Overall Study||269
8656781|NCT00674986|9699210|FG000|Intent to Treat Population|Overall Study||227
8656782|NCT00674986|9699211|FG001|Intent to Treat Population|Overall Study||256
8656783|NCT00674986|9699210|FG000|COMPLETED|Overall Study||187
8656784|NCT00674986|9699211|FG001|COMPLETED|Overall Study||188
8656785|NCT00674986|9699210|FG000|NOT COMPLETED|Overall Study||43
8656786|NCT00674986|9699211|FG001|NOT COMPLETED|Overall Study||81
8656787|NCT00675025|9699220|FG000|STARTED|Overall Study||54
8656788|NCT00675025|9699221|FG001|STARTED|Overall Study||63
8656789|NCT00675025|9699220|FG000|COMPLETED|Overall Study||0
8656790|NCT00675025|9699221|FG001|COMPLETED|Overall Study||0
8656791|NCT00675025|9699220|FG000|NOT COMPLETED|Overall Study||54
8656792|NCT00675025|9699221|FG001|NOT COMPLETED|Overall Study||63
8656793|NCT00675103|9699227|FG000|STARTED|Overall Study||7
8656794|NCT00675103|9699227|FG000|COMPLETED|Overall Study||4
8656795|NCT00675103|9699227|FG000|NOT COMPLETED|Overall Study||3
8656796|NCT00675259|9699231|FG000|STARTED|Overall Study||33
8656797|NCT00675259|9699231|FG000|COMPLETED|Overall Study||19
8656798|NCT00675259|9699231|FG000|NOT COMPLETED|Overall Study||14
8656799|NCT00675415|9699241|FG000|STARTED|Overall Study||132
8656800|NCT00675415|9699242|FG001|STARTED|Overall Study||131
8656801|NCT00675415|9699241|FG000|COMPLETED|Overall Study||124
8656802|NCT00675415|9699242|FG001|COMPLETED|Overall Study||123
8656803|NCT00675415|9699241|FG000|NOT COMPLETED|Overall Study||8
8656804|NCT00675415|9699242|FG001|NOT COMPLETED|Overall Study||8
8656805|NCT00675428|9699250|FG000|STARTED|Overall Study||3
8656806|NCT00675428|9699251|FG001|STARTED|Overall Study||3
8656807|NCT00675428|9699250|FG000|COMPLETED|Overall Study||0
8656808|NCT00675428|9699251|FG001|COMPLETED|Overall Study||0
8656809|NCT00675428|9699250|FG000|NOT COMPLETED|Overall Study||3
8656810|NCT00675428|9699251|FG001|NOT COMPLETED|Overall Study||3
8656811|NCT00675441|9699257|FG000|STARTED|Overall Study||5
8656812|NCT00675441|9699257|FG000|COMPLETED|Overall Study||2
8656813|NCT00675441|9699257|FG000|NOT COMPLETED|Overall Study||3
8656814|NCT00675506|9699263|FG000|STARTED|Overall Study||31
8656815|NCT00675506|9699264|FG001|STARTED|Overall Study||29
8656816|NCT00675506|9699263|FG000|Received Intervention|Overall Study|Two subjects did not start treatment: 1) disclosed cancer history, 2) declined participation.|29
8656817|NCT00675506|9699264|FG001|Received Intervention|Overall Study||29
8656818|NCT00675506|9699263|FG000|COMPLETED|Overall Study||19
8656819|NCT00675506|9699264|FG001|COMPLETED|Overall Study||17
8656820|NCT00675506|9699263|FG000|NOT COMPLETED|Overall Study||12
8656821|NCT00675506|9699264|FG001|NOT COMPLETED|Overall Study||12
8656822|NCT00675558|9699274|FG000|STARTED|Surgery||10
8656823|NCT00675558|9699275|FG001|STARTED|Surgery||10
8656824|NCT00675558|9699276|FG002|STARTED|Surgery||30
8656825|NCT00675558|9699274|FG000|COMPLETED|Surgery||10
8656826|NCT00675558|9699275|FG001|COMPLETED|Surgery||10
8656827|NCT00675558|9699276|FG002|COMPLETED|Surgery||30
8656828|NCT00675558|9699274|FG000|NOT COMPLETED|Surgery||0
8656829|NCT00675558|9699275|FG001|NOT COMPLETED|Surgery||0
8656830|NCT00675558|9699276|FG002|NOT COMPLETED|Surgery||0
8656831|NCT00675558|9699274|FG000|STARTED|Second Operation|No medical reason, and no study-related reason for non-obese pts to have a second procedure.|0
8656832|NCT00675558|9699275|FG001|STARTED|Second Operation|No medical reason, and none for the goals of the study, for MO pts to have a second procedure .|0
8656833|NCT00675558|9699276|FG002|STARTED|Second Operation|As predicted, only 10 SMO patients medically required a second operation, and thus met study goals.|10
8656834|NCT00675558|9699274|FG000|COMPLETED|Second Operation||0
8729163|NCT01051986|9776282|FG001|COMPLETED|Overall Study||108
8729164|NCT01051986|9776281|FG000|NOT COMPLETED|Overall Study||5
8729165|NCT01051986|9776282|FG001|NOT COMPLETED|Overall Study||4
8729166|NCT01052012|9776294|FG000|STARTED|Overall Study||32
8729167|NCT01052012|9776295|FG001|STARTED|Overall Study||23
8729168|NCT01052012|9776296|FG002|STARTED|Overall Study||30
8729169|NCT01052012|9776297|FG003|STARTED|Overall Study||20
8729170|NCT01052012|9776298|FG004|STARTED|Overall Study||140
8656835|NCT00675558|9699275|FG001|COMPLETED|Second Operation||0
8656836|NCT00675558|9699276|FG002|COMPLETED|Second Operation||10
8656837|NCT00675558|9699274|FG000|NOT COMPLETED|Second Operation||0
8656838|NCT00675558|9699275|FG001|NOT COMPLETED|Second Operation||0
8656839|NCT00675558|9699276|FG002|NOT COMPLETED|Second Operation||0
8656840|NCT00675584|9699286|FG000|STARTED|Overall Study||139
8656841|NCT00675584|9699287|FG001|STARTED|Overall Study||139
8656842|NCT00675584|9699286|FG000|COMPLETED|Overall Study||100
8656843|NCT00675584|9699287|FG001|COMPLETED|Overall Study||113
8656844|NCT00675584|9699286|FG000|NOT COMPLETED|Overall Study||39
8656845|NCT00675584|9699287|FG001|NOT COMPLETED|Overall Study||26
8656846|NCT00675597|9699293|FG000|STARTED|Overall Study||26
8656847|NCT00675597|9699293|FG000|COMPLETED|Overall Study||23
8656848|NCT00675597|9699293|FG000|NOT COMPLETED|Overall Study||3
8656849|NCT00675766|9699301|FG000|STARTED|Overall Study||106
8656850|NCT00675766|9699302|FG001|STARTED|Overall Study||30
8656851|NCT00675766|9699303|FG002|STARTED|Overall Study||50
8656852|NCT00675766|9699304|FG003|STARTED|Overall Study||37
8656853|NCT00675766|9699301|FG000|Year 2|Overall Study||105
8656854|NCT00675766|9699302|FG001|Year 2|Overall Study||28
8656855|NCT00675766|9699303|FG002|Year 2|Overall Study||34
8656856|NCT00675766|9699304|FG003|Year 2|Overall Study||20
8656857|NCT00675766|9699301|FG000|Year 3|Overall Study||100
8656858|NCT00675766|9699302|FG001|Year 3|Overall Study||25
8656859|NCT00675766|9699303|FG002|Year 3|Overall Study||29
8656860|NCT00675766|9699304|FG003|Year 3|Overall Study||11
8656861|NCT00675766|9699301|FG000|COMPLETED|Overall Study||100
8656862|NCT00675766|9699302|FG001|COMPLETED|Overall Study||25
8656863|NCT00675766|9699303|FG002|COMPLETED|Overall Study||29
8656864|NCT00675766|9699304|FG003|COMPLETED|Overall Study||11
8656865|NCT00675766|9699301|FG000|NOT COMPLETED|Overall Study||6
8656866|NCT00675766|9699302|FG001|NOT COMPLETED|Overall Study||5
8656867|NCT00675766|9699303|FG002|NOT COMPLETED|Overall Study||21
8656868|NCT00675766|9699304|FG003|NOT COMPLETED|Overall Study||26
8656869|NCT00675792|9699316|FG000|STARTED|Overall Study||51
8656870|NCT00675792|9699317|FG001|STARTED|Overall Study||49
8656871|NCT00675792|9699316|FG000|COMPLETED|Overall Study||51
8729171|NCT01052012|9776299|FG005|STARTED|Overall Study||86
8729172|NCT01052012|9776294|FG000|COMPLETED|Overall Study||28
8656872|NCT00675792|9699317|FG001|COMPLETED|Overall Study||49
8656873|NCT00675792|9699316|FG000|NOT COMPLETED|Overall Study||0
8656874|NCT00675792|9699317|FG001|NOT COMPLETED|Overall Study||0
8656875|NCT00675909|9699326|FG000|STARTED|Overall Study||60
8656876|NCT00675909|9699327|FG001|STARTED|Overall Study||60
8656877|NCT00675909|9699328|FG002|STARTED|Overall Study||60
8656878|NCT00675909|9699326|FG000|COMPLETED|Overall Study||60
8656879|NCT00675909|9699327|FG001|COMPLETED|Overall Study||60
8656880|NCT00675909|9699328|FG002|COMPLETED|Overall Study||60
8656881|NCT00675909|9699326|FG000|NOT COMPLETED|Overall Study||0
8656882|NCT00675909|9699327|FG001|NOT COMPLETED|Overall Study||0
8656883|NCT00675909|9699328|FG002|NOT COMPLETED|Overall Study||0
8656884|NCT00675922|9699336|FG000|STARTED|Overall Study||98
8656885|NCT00675922|9699336|FG000|COMPLETED|Overall Study||98
8656886|NCT00675922|9699336|FG000|NOT COMPLETED|Overall Study||0
8656887|NCT00675948|9699343|FG000|STARTED|Overall Study||39
8656888|NCT00675948|9699344|FG001|STARTED|Overall Study||4
8656889|NCT00675948|9699343|FG000|COMPLETED|Overall Study||0
8656890|NCT00675948|9699344|FG001|COMPLETED|Overall Study||1
8656891|NCT00675948|9699343|FG000|NOT COMPLETED|Overall Study||39
8656892|NCT00675948|9699344|FG001|NOT COMPLETED|Overall Study||3
8656893|NCT00675987|9699353|FG000|STARTED|Overall Study||26
8656894|NCT00675987|9699354|FG001|STARTED|Overall Study||27
8656895|NCT00675987|9699353|FG000|COMPLETED|Overall Study||26
8656896|NCT00675987|9699354|FG001|COMPLETED|Overall Study||27
8656897|NCT00675987|9699353|FG000|NOT COMPLETED|Overall Study||0
8656898|NCT00675987|9699354|FG001|NOT COMPLETED|Overall Study||0
8656899|NCT00676013|9699362|FG000|STARTED|Overall Study||158
8656900|NCT00676013|9699362|FG000|COMPLETED|Overall Study||157
8656901|NCT00676013|9699362|FG000|NOT COMPLETED|Overall Study||1
8656902|NCT00676052|9699375|FG000|STARTED|Overall Study||96
8656903|NCT00676052|9699376|FG001|STARTED|Overall Study||95
8656904|NCT00676052|9699377|FG002|STARTED|Overall Study||96
8656905|NCT00676052|9699378|FG003|STARTED|Overall Study||97
8656906|NCT00676052|9699379|FG004|STARTED|Overall Study||95
8656907|NCT00676052|9699380|FG005|STARTED|Overall Study||97
8656908|NCT00676052|9699375|FG000|COMPLETED|Overall Study||87
8656909|NCT00676052|9699376|FG001|COMPLETED|Overall Study||88
8656910|NCT00676052|9699377|FG002|COMPLETED|Overall Study||90
8656911|NCT00676052|9699378|FG003|COMPLETED|Overall Study||92
8656912|NCT00676052|9699379|FG004|COMPLETED|Overall Study||89
8656913|NCT00676052|9699380|FG005|COMPLETED|Overall Study||91
8656914|NCT00676052|9699375|FG000|NOT COMPLETED|Overall Study||9
8656915|NCT00676052|9699376|FG001|NOT COMPLETED|Overall Study||7
8656916|NCT00676052|9699377|FG002|NOT COMPLETED|Overall Study||6
8656917|NCT00676052|9699378|FG003|NOT COMPLETED|Overall Study||5
8656918|NCT00676052|9699379|FG004|NOT COMPLETED|Overall Study||6
8656919|NCT00676052|9699380|FG005|NOT COMPLETED|Overall Study||6
8656920|NCT00676065|9699397|FG000|STARTED|Overall Study||16534
8656921|NCT00676065|9699398|FG001|STARTED|Overall Study||15428
8656922|NCT00676065|9699399|FG002|STARTED|Overall Study||26341
8656923|NCT00676065|9699397|FG000|COMPLETED|Overall Study||16534
8656924|NCT00676065|9699398|FG001|COMPLETED|Overall Study||15428
8656925|NCT00676065|9699399|FG002|COMPLETED|Overall Study||26341
8656926|NCT00676065|9699397|FG000|NOT COMPLETED|Overall Study||0
8656927|NCT00676065|9699398|FG001|NOT COMPLETED|Overall Study||0
8656928|NCT00676065|9699399|FG002|NOT COMPLETED|Overall Study||0
8656929|NCT00676091|9699409|FG000|STARTED|Infant Series||177
8656930|NCT00676091|9699410|FG001|STARTED|Infant Series||177
8656931|NCT00676091|9699409|FG000|Vaccinated Dose 1|Infant Series||163
8656932|NCT00676091|9699410|FG001|Vaccinated Dose 1|Infant Series||162
8656933|NCT00676091|9699409|FG000|Vaccinated Dose 2|Infant Series||159
8656934|NCT00676091|9699410|FG001|Vaccinated Dose 2|Infant Series||162
8656935|NCT00676091|9699409|FG000|Vaccinated Dose 3|Infant Series||158
8656936|NCT00676091|9699410|FG001|Vaccinated Dose 3|Infant Series||161
8656937|NCT00676091|9699409|FG000|COMPLETED|Infant Series||157
8656938|NCT00676091|9699410|FG001|COMPLETED|Infant Series||159
8656939|NCT00676091|9699409|FG000|NOT COMPLETED|Infant Series||20
8656940|NCT00676091|9699410|FG001|NOT COMPLETED|Infant Series||18
8656941|NCT00676091|9699409|FG000|STARTED|After Infant Series||157
8656942|NCT00676091|9699410|FG001|STARTED|After Infant Series||159
8656943|NCT00676091|9699409|FG000|COMPLETED|After Infant Series||156
8656944|NCT00676091|9699410|FG001|COMPLETED|After Infant Series||156
8656945|NCT00676091|9699409|FG000|NOT COMPLETED|After Infant Series||1
8656946|NCT00676091|9699410|FG001|NOT COMPLETED|After Infant Series||3
8656947|NCT00676091|9699409|FG000|STARTED|Toddler Dose||156
8656948|NCT00676091|9699410|FG001|STARTED|Toddler Dose||156
8656949|NCT00676091|9699409|FG000|COMPLETED|Toddler Dose||153
8656950|NCT00676091|9699410|FG001|COMPLETED|Toddler Dose||156
8656951|NCT00676091|9699409|FG000|NOT COMPLETED|Toddler Dose||3
8656952|NCT00676091|9699410|FG001|NOT COMPLETED|Toddler Dose||0
8656953|NCT00676130|9699422|FG000|STARTED|Overall Study||76
8656954|NCT00676130|9699423|FG001|STARTED|Overall Study||77
8656955|NCT00676130|9699422|FG000|COMPLETED|Overall Study||73
8656956|NCT00676130|9699423|FG001|COMPLETED|Overall Study||73
8656957|NCT00676130|9699422|FG000|NOT COMPLETED|Overall Study||3
8656958|NCT00676130|9699423|FG001|NOT COMPLETED|Overall Study||4
8656959|NCT00676143|9699431|FG000|STARTED|Overall Study||441
8656960|NCT00676143|9699432|FG001|STARTED|Overall Study||658
8656961|NCT00676143|9699431|FG000|Treated|Overall Study||439
8656962|NCT00676143|9699432|FG001|Treated|Overall Study||654
8656963|NCT00676143|9699431|FG000|COMPLETED|Overall Study||285
8656964|NCT00676143|9699432|FG001|COMPLETED|Overall Study||398
8656965|NCT00676143|9699431|FG000|NOT COMPLETED|Overall Study||156
8656966|NCT00676143|9699432|FG001|NOT COMPLETED|Overall Study||260
8656967|NCT00676182|9699441|FG000|STARTED|Overall Study||75
8656968|NCT00676182|9699441|FG000|COMPLETED|Overall Study||75
8656969|NCT00676182|9699441|FG000|NOT COMPLETED|Overall Study||0
8656970|NCT00676195|9699451|FG000|STARTED|Overall Study||24
8656971|NCT00676195|9699451|FG000|COMPLETED|Overall Study||21
8656972|NCT00676195|9699451|FG000|NOT COMPLETED|Overall Study||3
8656973|NCT00676208|9699458|FG000|STARTED|Overall Study||14
8656974|NCT00676208|9699459|FG001|STARTED|Overall Study||19
8656975|NCT00676208|9699458|FG000|COMPLETED|Overall Study||12
8656976|NCT00676208|9699459|FG001|COMPLETED|Overall Study||13
8656977|NCT00676208|9699458|FG000|NOT COMPLETED|Overall Study||2
8656978|NCT00676208|9699459|FG001|NOT COMPLETED|Overall Study||6
8656979|NCT00676338|9699471|FG000|STARTED|Overall Study||248
8656980|NCT00676338|9699472|FG001|STARTED|Overall Study||246
8656981|NCT00676338|9699473|FG002|STARTED|Overall Study||163
8656982|NCT00676338|9699474|FG003|STARTED|Overall Study||163
8656983|NCT00676338|9699471|FG000|COMPLETED|Overall Study||210
8656984|NCT00676338|9699472|FG001|COMPLETED|Overall Study||213
8656985|NCT00676338|9699473|FG002|COMPLETED|Overall Study||133
8656986|NCT00676338|9699474|FG003|COMPLETED|Overall Study||140
8656987|NCT00676338|9699471|FG000|NOT COMPLETED|Overall Study||38
8656988|NCT00676338|9699472|FG001|NOT COMPLETED|Overall Study||33
8656989|NCT00676338|9699473|FG002|NOT COMPLETED|Overall Study||30
8656990|NCT00676338|9699474|FG003|NOT COMPLETED|Overall Study||23
8656991|NCT00676364|9699486|FG000|STARTED|Overall Study||57
8656992|NCT00676364|9699487|FG001|STARTED|Overall Study||57
8656993|NCT00676364|9699486|FG000|COMPLETED|Overall Study||57
8656994|NCT00676364|9699487|FG001|COMPLETED|Overall Study||57
8656995|NCT00676364|9699486|FG000|NOT COMPLETED|Overall Study||0
8656996|NCT00676364|9699487|FG001|NOT COMPLETED|Overall Study||0
8656997|NCT00676403|9699501|FG000|STARTED|Overall Study||23
8656998|NCT00676403|9699502|FG001|STARTED|Overall Study||22
8656999|NCT00676403|9699503|FG002|STARTED|Overall Study||23
8657000|NCT00676403|9699504|FG003|STARTED|Overall Study||22
8657001|NCT00676403|9699505|FG004|STARTED|Overall Study||24
8657002|NCT00676403|9699506|FG005|STARTED|Overall Study||23
8657003|NCT00676403|9699501|FG000|COMPLETED|Overall Study||21
8657004|NCT00676403|9699502|FG001|COMPLETED|Overall Study||20
8657005|NCT00676403|9699503|FG002|COMPLETED|Overall Study||22
8657006|NCT00676403|9699504|FG003|COMPLETED|Overall Study||17
8657007|NCT00676403|9699505|FG004|COMPLETED|Overall Study||23
8657008|NCT00676403|9699506|FG005|COMPLETED|Overall Study||18
8657009|NCT00676403|9699501|FG000|NOT COMPLETED|Overall Study||2
8657010|NCT00676403|9699502|FG001|NOT COMPLETED|Overall Study||2
8657011|NCT00676403|9699503|FG002|NOT COMPLETED|Overall Study||1
8657012|NCT00676403|9699504|FG003|NOT COMPLETED|Overall Study||5
8657013|NCT00676403|9699505|FG004|NOT COMPLETED|Overall Study||1
8657014|NCT00676403|9699506|FG005|NOT COMPLETED|Overall Study||5
8657015|NCT00676520|9699526|FG000|STARTED|Overall Study||8040
8657016|NCT00676520|9699526|FG000|COMPLETED|Overall Study||7309
8657017|NCT00676520|9699526|FG000|NOT COMPLETED|Overall Study||731
8657018|NCT00676572|9699537|FG000|STARTED|Overall Study||6
8657019|NCT00676572|9699538|FG001|STARTED|Overall Study||6
8657020|NCT00676572|9699537|FG000|COMPLETED|Overall Study||6
8657021|NCT00676572|9699538|FG001|COMPLETED|Overall Study||6
8657022|NCT00676572|9699537|FG000|NOT COMPLETED|Overall Study||0
8657023|NCT00676572|9699538|FG001|NOT COMPLETED|Overall Study||0
8657024|NCT00676585|9699546|FG000|STARTED|Overall Study||25
8657025|NCT00676585|9699547|FG001|STARTED|Overall Study||25
8657026|NCT00676585|9699546|FG000|COMPLETED|Overall Study||25
8657027|NCT00676585|9699547|FG001|COMPLETED|Overall Study||25
8657028|NCT00676585|9699546|FG000|NOT COMPLETED|Overall Study||0
8657029|NCT00676585|9699547|FG001|NOT COMPLETED|Overall Study||0
8657030|NCT00676650|9699555|FG000|STARTED|Overall Study||584
8657031|NCT00676650|9699556|FG001|STARTED|Overall Study||289
8657032|NCT00676650|9699555|FG000|Treated|Overall Study||581
8657033|NCT00676650|9699556|FG001|Treated|Overall Study||285
8657034|NCT00676650|9699555|FG000|COMPLETED|Overall Study||0
8657035|NCT00676650|9699556|FG001|COMPLETED|Overall Study||0
8657036|NCT00676650|9699555|FG000|NOT COMPLETED|Overall Study||584
8657037|NCT00676650|9699556|FG001|NOT COMPLETED|Overall Study||289
8657038|NCT00676676|9699562|FG000|STARTED|Overall Study||9
8657039|NCT00676676|9699562|FG000|COMPLETED|Overall Study||9
8657040|NCT00676676|9699562|FG000|NOT COMPLETED|Overall Study||0
8657041|NCT00676689|9699566|FG000|STARTED|Overall Study||81
8657042|NCT00676689|9699566|FG000|Procedure|Overall Study|Two enrolled patients did not meet eligibility criteria and did not undergo the study procedure.|79
8657043|NCT00676689|9699566|FG000|30 Day Follow-up|Overall Study||78
8657044|NCT00676689|9699566|FG000|1 Year Follow-up|Overall Study||64
8657045|NCT00676689|9699566|FG000|COMPLETED|Overall Study||20
8657046|NCT00676689|9699566|FG000|NOT COMPLETED|Overall Study||61
8657047|NCT00676780|9699570|FG000|STARTED|Overall Study||33
8657048|NCT00676780|9699570|FG000|COMPLETED|Overall Study||26
8657049|NCT00676780|9699570|FG000|NOT COMPLETED|Overall Study||7
8657050|NCT00676793|9699576|FG000|STARTED|Overall Study||32
8657051|NCT00676793|9699576|FG000|COMPLETED|Overall Study||19
8657052|NCT00676793|9699576|FG000|NOT COMPLETED|Overall Study||13
8657053|NCT00676806|9699583|FG000|STARTED|Overall Study||3
8657054|NCT00676806|9699584|FG001|STARTED|Overall Study||3
8657055|NCT00676806|9699583|FG000|COMPLETED|Overall Study||3
8657056|NCT00676806|9699584|FG001|COMPLETED|Overall Study||3
8657057|NCT00676806|9699583|FG000|NOT COMPLETED|Overall Study||0
8657058|NCT00676806|9699584|FG001|NOT COMPLETED|Overall Study||0
8657059|NCT00676897|9699596|FG000|STARTED|Overall Study||8
8657060|NCT00676897|9699597|FG001|STARTED|Overall Study||10
8657061|NCT00676897|9699596|FG000|COMPLETED|Overall Study||8
8657062|NCT00676897|9699597|FG001|COMPLETED|Overall Study||10
8657063|NCT00676897|9699596|FG000|NOT COMPLETED|Overall Study||0
8657064|NCT00676897|9699597|FG001|NOT COMPLETED|Overall Study||0
8657065|NCT00677014|9699606|FG000|STARTED|Overall Study||325
8657066|NCT00677014|9699607|FG001|STARTED|Overall Study||323
8657067|NCT00677014|9699608|FG002|STARTED|Overall Study||332
8657068|NCT00677014|9699606|FG000|COMPLETED|Overall Study||281
8657069|NCT00677014|9699607|FG001|COMPLETED|Overall Study||282
8657070|NCT00677014|9699608|FG002|COMPLETED|Overall Study||283
8657071|NCT00677014|9699606|FG000|NOT COMPLETED|Overall Study||44
8657072|NCT00677014|9699607|FG001|NOT COMPLETED|Overall Study||41
8657073|NCT00677014|9699608|FG002|NOT COMPLETED|Overall Study||49
8657074|NCT00677040|9699616|FG000|STARTED|Overall Study||20
8657075|NCT00677040|9699616|FG000|COMPLETED|Overall Study||20
8657076|NCT00677040|9699616|FG000|NOT COMPLETED|Overall Study||0
8657077|NCT00677092|9699621|FG000|STARTED|Overall Study||12
8657078|NCT00677092|9699621|FG000|Received Study Treatment|Overall Study||11
8657079|NCT00677092|9699621|FG000|COMPLETED|Overall Study||6
8657080|NCT00677092|9699621|FG000|NOT COMPLETED|Overall Study||6
8657081|NCT00677235|9699628|FG000|STARTED|Overall Study||138
8657082|NCT00677235|9699629|FG001|STARTED|Overall Study||132
8657083|NCT00677235|9699628|FG000|COMPLETED|Overall Study||97
8657084|NCT00677235|9699629|FG001|COMPLETED|Overall Study||94
8657085|NCT00677235|9699628|FG000|NOT COMPLETED|Overall Study||41
8729173|NCT01052012|9776295|FG001|COMPLETED|Overall Study||17
8729174|NCT01052012|9776296|FG002|COMPLETED|Overall Study||30
8729175|NCT01052012|9776297|FG003|COMPLETED|Overall Study||19
8729176|NCT01052012|9776298|FG004|COMPLETED|Overall Study||124
8729177|NCT01052012|9776299|FG005|COMPLETED|Overall Study||76
8729178|NCT01052012|9776294|FG000|NOT COMPLETED|Overall Study||4
8729179|NCT01052012|9776295|FG001|NOT COMPLETED|Overall Study||6
8729180|NCT01052012|9776296|FG002|NOT COMPLETED|Overall Study||0
8729181|NCT01052012|9776297|FG003|NOT COMPLETED|Overall Study||1
8729182|NCT01052012|9776298|FG004|NOT COMPLETED|Overall Study||16
8729183|NCT01052012|9776299|FG005|NOT COMPLETED|Overall Study||10
8729184|NCT01052038|9776316|FG000|STARTED|Overall Study||40
8729185|NCT01052038|9776317|FG001|STARTED|Overall Study||40
8729186|NCT01052038|9776318|FG002|STARTED|Overall Study||40
8729187|NCT01052038|9776316|FG000|COMPLETED|Overall Study||36
8729188|NCT01052038|9776317|FG001|COMPLETED|Overall Study||34
8729189|NCT01052038|9776318|FG002|COMPLETED|Overall Study||36
8729190|NCT01052038|9776316|FG000|NOT COMPLETED|Overall Study||4
8729191|NCT01052038|9776317|FG001|NOT COMPLETED|Overall Study||6
8729192|NCT01052038|9776318|FG002|NOT COMPLETED|Overall Study||4
8729193|NCT01052077|9776328|FG000|STARTED|Phase A||769
8729194|NCT01052077|9776329|FG001|STARTED|Phase A||0
8729195|NCT01052077|9776330|FG002|STARTED|Phase A||0
8729196|NCT01052077|9776331|FG003|STARTED|Phase A||0
8729197|NCT01052077|9776328|FG000|COMPLETED|Phase A||623
8729198|NCT01052077|9776329|FG001|COMPLETED|Phase A||0
8729199|NCT01052077|9776330|FG002|COMPLETED|Phase A||0
8657086|NCT00677235|9699629|FG001|NOT COMPLETED|Overall Study||38
8657087|NCT00677352|9699637|FG000|STARTED|Treatment Phase|All 157 subjects were treated with Sertraline.|157
8657088|NCT00677352|9699638|FG001|STARTED|Treatment Phase|2 subjects were not teated, therefore 162 subjects were treated with paroxetine.|164
8657089|NCT00677352|9699637|FG000|COMPLETED|Treatment Phase||132
8657090|NCT00677352|9699638|FG001|COMPLETED|Treatment Phase||122
8657091|NCT00677352|9699637|FG000|NOT COMPLETED|Treatment Phase||25
8657092|NCT00677352|9699638|FG001|NOT COMPLETED|Treatment Phase||42
8657093|NCT00677352|9699637|FG000|STARTED|Tapering Phase||132
8657094|NCT00677352|9699638|FG001|STARTED|Tapering Phase||122
8657095|NCT00677352|9699637|FG000|COMPLETED|Tapering Phase||126
8657096|NCT00677352|9699638|FG001|COMPLETED|Tapering Phase||112
8657097|NCT00677352|9699637|FG000|NOT COMPLETED|Tapering Phase||6
8657098|NCT00677352|9699638|FG001|NOT COMPLETED|Tapering Phase||10
8657099|NCT00677365|9699648|FG000|STARTED|Overall Study||37
8657100|NCT00677365|9699649|FG001|STARTED|Overall Study||38
8657101|NCT00677365|9699650|FG002|STARTED|Overall Study||37
8657102|NCT00677365|9699651|FG003|STARTED|Overall Study||39
8657103|NCT00677365|9699648|FG000|COMPLETED|Overall Study||35
8657104|NCT00677365|9699649|FG001|COMPLETED|Overall Study||37
8657105|NCT00677365|9699650|FG002|COMPLETED|Overall Study||35
8657106|NCT00677365|9699651|FG003|COMPLETED|Overall Study||36
8657107|NCT00677365|9699648|FG000|NOT COMPLETED|Overall Study||2
8657108|NCT00677365|9699649|FG001|NOT COMPLETED|Overall Study||1
8657109|NCT00677365|9699650|FG002|NOT COMPLETED|Overall Study||2
8657110|NCT00677365|9699651|FG003|NOT COMPLETED|Overall Study||3
8657111|NCT00677534|9699661|FG000|STARTED|Washout (Weeks 1-4)||10
8657112|NCT00677534|9699661|FG000|COMPLETED|Washout (Weeks 1-4)||7
8657113|NCT00677534|9699661|FG000|NOT COMPLETED|Washout (Weeks 1-4)||3
8657114|NCT00677534|9699661|FG000|STARTED|Cholecalciferol (Weeks 5-12)||7
8657115|NCT00677534|9699661|FG000|COMPLETED|Cholecalciferol (Weeks 5-12)||7
8657116|NCT00677534|9699661|FG000|NOT COMPLETED|Cholecalciferol (Weeks 5-12)||0
8657117|NCT00677534|9699661|FG000|STARTED|After Paricalcitol Restart (Weeks 13-14)||7
8657118|NCT00677534|9699661|FG000|COMPLETED|After Paricalcitol Restart (Weeks 13-14)||7
8657119|NCT00677534|9699661|FG000|NOT COMPLETED|After Paricalcitol Restart (Weeks 13-14)||0
8657120|NCT00677690|9699667|FG000|STARTED|Overall Study||42
8657121|NCT00677690|9699668|FG001|STARTED|Overall Study||41
8657122|NCT00677690|9699667|FG000|COMPLETED|Overall Study||42
8657123|NCT00677690|9699668|FG001|COMPLETED|Overall Study||41
8657124|NCT00677690|9699667|FG000|NOT COMPLETED|Overall Study||0
8657125|NCT00677690|9699668|FG001|NOT COMPLETED|Overall Study||0
8657126|NCT00677807|9699677|FG000|STARTED|Overall Study||144
8657127|NCT00677807|9699678|FG001|STARTED|Overall Study||146
8657128|NCT00677807|9699679|FG002|STARTED|Overall Study||125
8657129|NCT00677807|9699677|FG000|Safety/ITT: Received Study Drug|Overall Study||144
8657130|NCT00677807|9699678|FG001|Safety/ITT: Received Study Drug|Overall Study||146
8657131|NCT00677807|9699679|FG002|Safety/ITT: Received Study Drug|Overall Study|One patient did not take study medication.|124
8657132|NCT00677807|9699677|FG000|COMPLETED|Overall Study||126
8657133|NCT00677807|9699678|FG001|COMPLETED|Overall Study||135
8657134|NCT00677807|9699679|FG002|COMPLETED|Overall Study||105
8657135|NCT00677807|9699677|FG000|NOT COMPLETED|Overall Study||18
8729200|NCT01052077|9776331|FG003|COMPLETED|Phase A||0
8657136|NCT00677807|9699678|FG001|NOT COMPLETED|Overall Study||11
8657137|NCT00677807|9699679|FG002|NOT COMPLETED|Overall Study||20
8657138|NCT00677820|9699689|FG000|STARTED|Overall Study||240
8657139|NCT00677820|9699690|FG001|STARTED|Overall Study||60
8657140|NCT00677820|9699689|FG000|COMPLETED|Overall Study||239
8657141|NCT00677820|9699690|FG001|COMPLETED|Overall Study||60
8657142|NCT00677820|9699689|FG000|NOT COMPLETED|Overall Study||1
8657143|NCT00677820|9699690|FG001|NOT COMPLETED|Overall Study||0
8657144|NCT00677833|9699700|FG000|STARTED|Overall Study||55
8657145|NCT00677833|9699701|FG001|STARTED|Overall Study||51
8657146|NCT00677833|9699702|FG002|STARTED|Overall Study||124
8657147|NCT00677833|9699703|FG003|STARTED|Overall Study||131
8657148|NCT00677833|9699700|FG000|COMPLETED|Overall Study||51
8657149|NCT00677833|9699701|FG001|COMPLETED|Overall Study||51
8657150|NCT00677833|9699702|FG002|COMPLETED|Overall Study||122
8657151|NCT00677833|9699703|FG003|COMPLETED|Overall Study||128
8657152|NCT00677833|9699700|FG000|NOT COMPLETED|Overall Study||4
8657153|NCT00677833|9699701|FG001|NOT COMPLETED|Overall Study||0
8657154|NCT00677833|9699702|FG002|NOT COMPLETED|Overall Study||2
8657155|NCT00677833|9699703|FG003|NOT COMPLETED|Overall Study||3
8657156|NCT00677898|9699713|FG000|STARTED|Overall Study||119
8657157|NCT00677898|9699714|FG001|STARTED|Overall Study||120
8657158|NCT00677898|9699713|FG000|COMPLETED|Overall Study||99
8657159|NCT00677898|9699714|FG001|COMPLETED|Overall Study||102
8657160|NCT00677898|9699713|FG000|NOT COMPLETED|Overall Study||20
8657161|NCT00677898|9699714|FG001|NOT COMPLETED|Overall Study||18
8657162|NCT00677924|9699722|FG000|STARTED|Overall Study||3
8657163|NCT00677924|9699723|FG001|STARTED|Overall Study||6
8657164|NCT00677924|9699722|FG000|COMPLETED|Overall Study||3
8657165|NCT00677924|9699723|FG001|COMPLETED|Overall Study||6
8657166|NCT00677924|9699722|FG000|NOT COMPLETED|Overall Study||0
8657167|NCT00677924|9699723|FG001|NOT COMPLETED|Overall Study||0
8657168|NCT00678015|9699729|FG000|STARTED|Overall Study||12
8657169|NCT00678015|9699729|FG000|COMPLETED|Overall Study||12
8657170|NCT00678015|9699729|FG000|NOT COMPLETED|Overall Study||0
8657171|NCT00678080|9699735|FG000|STARTED|Overall Study||11
8657172|NCT00678080|9699736|FG001|STARTED|Overall Study||14
8657173|NCT00678080|9699735|FG000|COMPLETED|Overall Study||8
8657174|NCT00678080|9699736|FG001|COMPLETED|Overall Study||13
8657175|NCT00678080|9699735|FG000|NOT COMPLETED|Overall Study||3
8657176|NCT00678080|9699736|FG001|NOT COMPLETED|Overall Study||1
8657177|NCT00678210|9699746|FG000|STARTED|Overall Study||49
8657178|NCT00678210|9699747|FG001|STARTED|Overall Study||49
8657179|NCT00678210|9699748|FG002|STARTED|Overall Study||49
8657180|NCT00678210|9699749|FG003|STARTED|Overall Study||50
8657181|NCT00678210|9699746|FG000|COMPLETED|Overall Study||38
8657182|NCT00678210|9699747|FG001|COMPLETED|Overall Study||38
8657183|NCT00678210|9699748|FG002|COMPLETED|Overall Study||43
8657184|NCT00678210|9699749|FG003|COMPLETED|Overall Study||30
8657185|NCT00678210|9699746|FG000|NOT COMPLETED|Overall Study||11
8657186|NCT00678210|9699747|FG001|NOT COMPLETED|Overall Study||11
8657187|NCT00678210|9699748|FG002|NOT COMPLETED|Overall Study||6
8657188|NCT00678210|9699749|FG003|NOT COMPLETED|Overall Study||20
8657189|NCT00678249|9699762|FG000|STARTED|Overall Study||97
8657190|NCT00678249|9699763|FG001|STARTED|Overall Study||93
8657191|NCT00678249|9699764|FG002|STARTED|Overall Study||37
8657192|NCT00678249|9699762|FG000|COMPLETED|Overall Study||97
8657193|NCT00678249|9699763|FG001|COMPLETED|Overall Study||93
8657194|NCT00678249|9699764|FG002|COMPLETED|Overall Study||37
8657195|NCT00678249|9699762|FG000|NOT COMPLETED|Overall Study||0
8657196|NCT00678249|9699763|FG001|NOT COMPLETED|Overall Study||0
8729201|NCT01052077|9776328|FG000|NOT COMPLETED|Phase A||146
8657197|NCT00678249|9699764|FG002|NOT COMPLETED|Overall Study||0
8657198|NCT00678301|9699774|FG000|STARTED|Overall Study||239
8657199|NCT00678301|9699775|FG001|STARTED|Overall Study||118
8657200|NCT00678301|9699774|FG000|COMPLETED|Overall Study||231
8657201|NCT00678301|9699775|FG001|COMPLETED|Overall Study||116
8657202|NCT00678301|9699774|FG000|NOT COMPLETED|Overall Study||8
8657203|NCT00678301|9699775|FG001|NOT COMPLETED|Overall Study||2
8657204|NCT00678379|9699784|FG000|STARTED|Overall Study||40
8657205|NCT00678379|9699785|FG001|STARTED|Overall Study||40
8657206|NCT00678379|9699786|FG002|STARTED|Overall Study||40
8657207|NCT00678379|9699784|FG000|COMPLETED|Overall Study||34
8657208|NCT00678379|9699785|FG001|COMPLETED|Overall Study||37
8657209|NCT00678379|9699786|FG002|COMPLETED|Overall Study||36
8657210|NCT00678379|9699784|FG000|NOT COMPLETED|Overall Study||6
8657211|NCT00678379|9699785|FG001|NOT COMPLETED|Overall Study||3
8657212|NCT00678379|9699786|FG002|NOT COMPLETED|Overall Study||4
8657213|NCT00678392|9699796|FG000|STARTED|Overall Study||361
8657214|NCT00678392|9699797|FG001|STARTED|Overall Study||362
8657215|NCT00678392|9699796|FG000|Treated|Overall Study||359
8657216|NCT00678392|9699797|FG001|Treated|Overall Study||355
8657217|NCT00678392|9699796|FG000|COMPLETED|Overall Study||0
8657218|NCT00678392|9699797|FG001|COMPLETED|Overall Study||0
8657219|NCT00678392|9699796|FG000|NOT COMPLETED|Overall Study||361
8657220|NCT00678392|9699797|FG001|NOT COMPLETED|Overall Study||362
8657221|NCT00678418|9699805|FG000|STARTED|Part A (Double Blind)||126
8657222|NCT00678418|9699806|FG001|STARTED|Part A (Double Blind)||124
8657223|NCT00678418|9699805|FG000|COMPLETED|Part A (Double Blind)||67
8657224|NCT00678418|9699806|FG001|COMPLETED|Part A (Double Blind)||47
8657225|NCT00678418|9699805|FG000|NOT COMPLETED|Part A (Double Blind)||59
8657226|NCT00678418|9699806|FG001|NOT COMPLETED|Part A (Double Blind)||77
8692152|NCT00858637|9737562|FG005|NOT COMPLETED|Active Comparison Phase||0
8657227|NCT00678418|9699805|FG000|STARTED|Part B (Open Label)|All participants who received placebo in Part A were switched to open-label VIVITROL in Part B.|114
8657228|NCT00678418|9699806|FG001|STARTED|Part B (Open Label)||0
8657229|NCT00678418|9699805|FG000|COMPLETED|Part B (Open Label)||71
8657230|NCT00678418|9699806|FG001|COMPLETED|Part B (Open Label)||0
8657231|NCT00678418|9699805|FG000|NOT COMPLETED|Part B (Open Label)||43
8657232|NCT00678418|9699806|FG001|NOT COMPLETED|Part B (Open Label)||0
8657233|NCT00678444|9699814|FG000|STARTED|Overall Study||100
8657234|NCT00678444|9699815|FG001|STARTED|Overall Study||99
8657235|NCT00678444|9699814|FG000|COMPLETED|Overall Study||100
8657236|NCT00678444|9699815|FG001|COMPLETED|Overall Study||99
8657237|NCT00678444|9699814|FG000|NOT COMPLETED|Overall Study||0
8657238|NCT00678444|9699815|FG001|NOT COMPLETED|Overall Study||0
8657239|NCT00678470|9699821|FG000|STARTED|Overall Study||18
8657240|NCT00678470|9699821|FG000|COMPLETED|Overall Study||14
8657241|NCT00678470|9699821|FG000|NOT COMPLETED|Overall Study||4
8657242|NCT00678496|9699827|FG000|STARTED|Overall Study||12
8657243|NCT00678496|9699828|FG001|STARTED|Overall Study||12
8657244|NCT00678496|9699827|FG000|Completed 8 Weeks Follow-up|Overall Study||9
8657245|NCT00678496|9699828|FG001|Completed 8 Weeks Follow-up|Overall Study||12
8657246|NCT00678496|9699827|FG000|COMPLETED|Overall Study||10
8657247|NCT00678496|9699828|FG001|COMPLETED|Overall Study||8
8657248|NCT00678496|9699827|FG000|NOT COMPLETED|Overall Study||2
8657249|NCT00678496|9699828|FG001|NOT COMPLETED|Overall Study||4
8657250|NCT00678535|9699838|FG000|STARTED|Overall Study|ITT population|455
8657251|NCT00678535|9699839|FG001|STARTED|Overall Study|ITT population|449
8657252|NCT00678535|9699838|FG000|COMPLETED|Overall Study|subjects who died before or at 31 March 2012|362
8657253|NCT00678535|9699839|FG001|COMPLETED|Overall Study|subjects who died before or at 31 March 2012|351
8657254|NCT00678535|9699838|FG000|NOT COMPLETED|Overall Study||93
8657255|NCT00678535|9699839|FG001|NOT COMPLETED|Overall Study||98
8657256|NCT00678561|9699853|FG000|STARTED|Overall Study||6
8657257|NCT00678561|9699854|FG001|STARTED|Overall Study||6
8657258|NCT00678561|9699855|FG002|STARTED|Overall Study||8
8657259|NCT00678561|9699856|FG003|STARTED|Overall Study||4
8657260|NCT00678561|9699857|FG004|STARTED|Overall Study||17
8657261|NCT00678561|9699858|FG005|STARTED|Overall Study||17
8657262|NCT00678561|9699859|FG006|STARTED|Overall Study||15
8657263|NCT00678561|9699860|FG007|STARTED|Overall Study||8
8657264|NCT00678561|9699853|FG000|COMPLETED|Overall Study||6
8657265|NCT00678561|9699854|FG001|COMPLETED|Overall Study||5
8657266|NCT00678561|9699855|FG002|COMPLETED|Overall Study||7
8657267|NCT00678561|9699856|FG003|COMPLETED|Overall Study||4
8657268|NCT00678561|9699857|FG004|COMPLETED|Overall Study||15
8657269|NCT00678561|9699858|FG005|COMPLETED|Overall Study||16
8657270|NCT00678561|9699859|FG006|COMPLETED|Overall Study||15
8729202|NCT01052077|9776329|FG001|NOT COMPLETED|Phase A||0
8729203|NCT01052077|9776330|FG002|NOT COMPLETED|Phase A||0
8729204|NCT01052077|9776331|FG003|NOT COMPLETED|Phase A||0
8729205|NCT01052077|9776328|FG000|STARTED|Phase B||0
8729206|NCT01052077|9776329|FG001|STARTED|Phase B||185
8729207|NCT01052077|9776330|FG002|STARTED|Phase B||187
8729208|NCT01052077|9776331|FG003|STARTED|Phase B||0
8729209|NCT01052077|9776328|FG000|COMPLETED|Phase B||0
8729210|NCT01052077|9776329|FG001|COMPLETED|Phase B||167
8729211|NCT01052077|9776330|FG002|COMPLETED|Phase B||171
8729212|NCT01052077|9776331|FG003|COMPLETED|Phase B||0
8729213|NCT01052077|9776328|FG000|NOT COMPLETED|Phase B||0
8729214|NCT01052077|9776329|FG001|NOT COMPLETED|Phase B||18
8729215|NCT01052077|9776330|FG002|NOT COMPLETED|Phase B||16
8729216|NCT01052077|9776331|FG003|NOT COMPLETED|Phase B||0
8729217|NCT01052077|9776328|FG000|STARTED|Phase A+||0
8729218|NCT01052077|9776329|FG001|STARTED|Phase A+||0
8729219|NCT01052077|9776330|FG002|STARTED|Phase A+||0
8729220|NCT01052077|9776331|FG003|STARTED|Phase A+||251
8729221|NCT01052077|9776328|FG000|COMPLETED|Phase A+||0
8729222|NCT01052077|9776329|FG001|COMPLETED|Phase A+||0
8657271|NCT00678561|9699860|FG007|COMPLETED|Overall Study||7
8657272|NCT00678561|9699853|FG000|NOT COMPLETED|Overall Study||0
8657273|NCT00678561|9699854|FG001|NOT COMPLETED|Overall Study||1
8657274|NCT00678561|9699855|FG002|NOT COMPLETED|Overall Study||1
8657275|NCT00678561|9699856|FG003|NOT COMPLETED|Overall Study||0
8657276|NCT00678561|9699857|FG004|NOT COMPLETED|Overall Study||2
8657277|NCT00678561|9699858|FG005|NOT COMPLETED|Overall Study||1
8657278|NCT00678561|9699859|FG006|NOT COMPLETED|Overall Study||0
8657279|NCT00678561|9699860|FG007|NOT COMPLETED|Overall Study||1
8657280|NCT00678587|9699887|FG000|STARTED|Overall Study||147
8657281|NCT00678587|9699888|FG001|STARTED|Overall Study||145
8657282|NCT00678587|9699887|FG000|COMPLETED|Overall Study||127
8729223|NCT01052077|9776330|FG002|COMPLETED|Phase A+||0
8729224|NCT01052077|9776331|FG003|COMPLETED|Phase A+||230
8729225|NCT01052077|9776328|FG000|NOT COMPLETED|Phase A+||0
8729226|NCT01052077|9776329|FG001|NOT COMPLETED|Phase A+||0
8729227|NCT01052077|9776330|FG002|NOT COMPLETED|Phase A+||0
8657283|NCT00678587|9699888|FG001|COMPLETED|Overall Study||127
8657284|NCT00678587|9699887|FG000|NOT COMPLETED|Overall Study||20
8657285|NCT00678587|9699888|FG001|NOT COMPLETED|Overall Study||18
8657286|NCT00678639|9699897|FG000|STARTED|Overall Study||53
8657287|NCT00678639|9699898|FG001|STARTED|Overall Study||57
8657288|NCT00678639|9699897|FG000|Hospital Discharge|Overall Study||53
8657289|NCT00678639|9699898|FG001|Hospital Discharge|Overall Study||57
8657290|NCT00678639|9699897|FG000|COMPLETED|Overall Study||51
8729228|NCT01052077|9776331|FG003|NOT COMPLETED|Phase A+||21
8729229|NCT01052103|9776339|FG000|STARTED|Overall Study||84
8657291|NCT00678639|9699898|FG001|COMPLETED|Overall Study||57
8657292|NCT00678639|9699897|FG000|NOT COMPLETED|Overall Study||2
8657293|NCT00678639|9699898|FG001|NOT COMPLETED|Overall Study||0
8657294|NCT00678652|9699909|FG000|STARTED|Overall Study||9
8657295|NCT00678652|9699910|FG001|STARTED|Overall Study||9
8657296|NCT00678652|9699911|FG002|STARTED|Overall Study||9
8657297|NCT00678652|9699912|FG003|STARTED|Overall Study||9
8657298|NCT00678652|9699909|FG000|COMPLETED|Overall Study||6
8657299|NCT00678652|9699910|FG001|COMPLETED|Overall Study||9
8657300|NCT00678652|9699911|FG002|COMPLETED|Overall Study||8
8657301|NCT00678652|9699912|FG003|COMPLETED|Overall Study||9
8657302|NCT00678652|9699909|FG000|NOT COMPLETED|Overall Study||3
8657303|NCT00678652|9699910|FG001|NOT COMPLETED|Overall Study||0
8657304|NCT00678652|9699911|FG002|NOT COMPLETED|Overall Study||1
8657305|NCT00678652|9699912|FG003|NOT COMPLETED|Overall Study||0
8657306|NCT00678691|9699924|FG000|STARTED|Overall Study||27
8657307|NCT00678691|9699925|FG001|STARTED|Overall Study||28
8657308|NCT00678691|9699924|FG000|COMPLETED|Overall Study||21
8657309|NCT00678691|9699925|FG001|COMPLETED|Overall Study||24
8657310|NCT00678691|9699924|FG000|NOT COMPLETED|Overall Study||6
8657311|NCT00678691|9699925|FG001|NOT COMPLETED|Overall Study||4
8657312|NCT00678795|9699933|FG000|STARTED|Overall Study||67
8657313|NCT00678795|9699934|FG001|STARTED|Overall Study||68
8657314|NCT00678795|9699933|FG000|COMPLETED|Overall Study||56
8657315|NCT00678795|9699934|FG001|COMPLETED|Overall Study||62
8657316|NCT00678795|9699933|FG000|NOT COMPLETED|Overall Study||11
8657317|NCT00678795|9699934|FG001|NOT COMPLETED|Overall Study||6
8657318|NCT00678834|9699943|FG000|STARTED|Overall Study||40
8657319|NCT00678834|9699944|FG001|STARTED|Overall Study||15
8657320|NCT00678834|9699945|FG002|STARTED|Overall Study||25
8657321|NCT00678834|9699943|FG000|COMPLETED|Overall Study||24
8657322|NCT00678834|9699944|FG001|COMPLETED|Overall Study||15
8657323|NCT00678834|9699945|FG002|COMPLETED|Overall Study||16
8657324|NCT00678834|9699943|FG000|NOT COMPLETED|Overall Study||16
8657325|NCT00678834|9699944|FG001|NOT COMPLETED|Overall Study||0
8657326|NCT00678834|9699945|FG002|NOT COMPLETED|Overall Study||9
8657327|NCT00678886|9699965|FG000|STARTED|Overall Study||10
8657328|NCT00678886|9699966|FG001|STARTED|Overall Study||19
8657329|NCT00678886|9699967|FG002|STARTED|Overall Study||81
8657330|NCT00678886|9699968|FG003|STARTED|Overall Study||162
8657331|NCT00678886|9699965|FG000|COMPLETED|Overall Study||10
8657332|NCT00678886|9699966|FG001|COMPLETED|Overall Study||19
8657333|NCT00678886|9699967|FG002|COMPLETED|Overall Study||72
8657334|NCT00678886|9699968|FG003|COMPLETED|Overall Study||153
8657335|NCT00678886|9699965|FG000|NOT COMPLETED|Overall Study||0
8657336|NCT00678886|9699966|FG001|NOT COMPLETED|Overall Study||0
8657337|NCT00678886|9699967|FG002|NOT COMPLETED|Overall Study||9
8657338|NCT00678886|9699968|FG003|NOT COMPLETED|Overall Study||9
8657339|NCT00678899|9699977|FG000|STARTED|Overall Study||50
8657340|NCT00678899|9699977|FG000|COMPLETED|Overall Study||49
8657341|NCT00678899|9699977|FG000|NOT COMPLETED|Overall Study||1
8729230|NCT01052103|9776340|FG001|STARTED|Overall Study||83
8729231|NCT01052103|9776339|FG000|Received at Least 1 Dose of Study Drug|Overall Study||82
8729232|NCT01052103|9776340|FG001|Received at Least 1 Dose of Study Drug|Overall Study||82
8729233|NCT01052103|9776339|FG000|COMPLETED|Overall Study||50
8729234|NCT01052103|9776340|FG001|COMPLETED|Overall Study||60
8729235|NCT01052103|9776339|FG000|NOT COMPLETED|Overall Study||34
8729236|NCT01052103|9776340|FG001|NOT COMPLETED|Overall Study||23
9022343|NCT03125915|10085229|FG001|NOT COMPLETED|3 Month Follow-up||4
9022344|NCT03125915|10085230|FG002|NOT COMPLETED|3 Month Follow-up||4
9022345|NCT03125915|10085231|FG003|NOT COMPLETED|3 Month Follow-up||2
9022346|NCT03125915|10085228|FG000|STARTED|6 Month Follow-up||32
8729237|NCT01052116|9776349|FG000|STARTED|Overall Study||193
8729238|NCT01052116|9776350|FG001|STARTED|Overall Study||193
8729239|NCT01052116|9776349|FG000|COMPLETED|Overall Study|Completed: defined as having an FEV1 measurement at 24 weeks|179
8729240|NCT01052116|9776350|FG001|COMPLETED|Overall Study|Completed: defined as having an FEV1 measurement at 24 weeks|166
8729241|NCT01052116|9776349|FG000|NOT COMPLETED|Overall Study||14
8729242|NCT01052116|9776350|FG001|NOT COMPLETED|Overall Study||27
8729243|NCT01052207|9776358|FG000|STARTED|Overall Study||60
8729244|NCT01052207|9776359|FG001|STARTED|Overall Study||42
8729245|NCT01052207|9776358|FG000|COMPLETED|Overall Study||60
8729246|NCT01052207|9776359|FG001|COMPLETED|Overall Study||42
8729247|NCT01052207|9776358|FG000|NOT COMPLETED|Overall Study||0
8729248|NCT01052207|9776359|FG001|NOT COMPLETED|Overall Study||0
8729249|NCT01052272|9776369|FG000|STARTED|Overall Study||18
8729250|NCT01052272|9776370|FG001|STARTED|Overall Study||18
8729251|NCT01052272|9776371|FG002|STARTED|Overall Study||18
8729252|NCT01052272|9776372|FG003|STARTED|Overall Study||18
8729253|NCT01052272|9776369|FG000|COMPLETED|Overall Study||13
8729254|NCT01052272|9776370|FG001|COMPLETED|Overall Study||11
9022347|NCT03125915|10085229|FG001|STARTED|6 Month Follow-up||40
8657342|NCT00679029|9699982|FG000|STARTED|Overall Study||15
8657343|NCT00679029|9699982|FG000|COMPLETED|Overall Study||10
8657344|NCT00679029|9699982|FG000|NOT COMPLETED|Overall Study||5
8657345|NCT00679042|9699986|FG000|STARTED|Transplant + 1 Year Follow Up||21
8657346|NCT00679042|9699986|FG000|COMPLETED|Transplant + 1 Year Follow Up||19
8657347|NCT00679042|9699986|FG000|NOT COMPLETED|Transplant + 1 Year Follow Up||2
8657348|NCT00679042|9699986|FG000|STARTED|5-Year Follow Up||19
8657349|NCT00679042|9699986|FG000|COMPLETED|5-Year Follow Up||5
8657350|NCT00679042|9699986|FG000|NOT COMPLETED|5-Year Follow Up||14
9022348|NCT03125915|10085230|FG002|STARTED|6 Month Follow-up||34
8657351|NCT00679042|9699986|FG000|STARTED|10-Year Follow Up||5
8657352|NCT00679042|9699986|FG000|COMPLETED|10-Year Follow Up||0
8657353|NCT00679042|9699986|FG000|NOT COMPLETED|10-Year Follow Up||5
8657354|NCT00679055|9699992|FG000|STARTED|Overall Study||8
8657355|NCT00679055|9699993|FG001|STARTED|Overall Study||6
8657356|NCT00679055|9699992|FG000|COMPLETED|Overall Study||6
8657357|NCT00679055|9699993|FG001|COMPLETED|Overall Study||1
8657358|NCT00679055|9699992|FG000|NOT COMPLETED|Overall Study||2
8657359|NCT00679055|9699993|FG001|NOT COMPLETED|Overall Study||5
8657360|NCT00679081|9699999|FG000|STARTED|Overall Study|Study design was within-subject control.|15
8657361|NCT00679081|9699999|FG000|COMPLETED|Overall Study||14
8657362|NCT00679081|9699999|FG000|NOT COMPLETED|Overall Study||1
8657363|NCT00679172|9700012|FG000|STARTED|Overall Study||37
8657364|NCT00679172|9700013|FG001|STARTED|Overall Study||38
8657365|NCT00679172|9700014|FG002|STARTED|Overall Study||36
8657366|NCT00679172|9700015|FG003|STARTED|Overall Study||39
8657367|NCT00679172|9700016|FG004|STARTED|Overall Study||37
8657368|NCT00679172|9700012|FG000|COMPLETED|Overall Study||36
8657369|NCT00679172|9700013|FG001|COMPLETED|Overall Study||37
8657370|NCT00679172|9700014|FG002|COMPLETED|Overall Study||35
8657371|NCT00679172|9700015|FG003|COMPLETED|Overall Study||38
8657372|NCT00679172|9700016|FG004|COMPLETED|Overall Study||37
8657373|NCT00679172|9700012|FG000|NOT COMPLETED|Overall Study||1
8657374|NCT00679172|9700013|FG001|NOT COMPLETED|Overall Study||1
8657375|NCT00679172|9700014|FG002|NOT COMPLETED|Overall Study||1
8657376|NCT00679172|9700015|FG003|NOT COMPLETED|Overall Study||1
8657377|NCT00679172|9700016|FG004|NOT COMPLETED|Overall Study||0
8657378|NCT00679211|9700031|FG000|STARTED|Overall Study||110
8657379|NCT00679211|9700031|FG000|COMPLETED|Overall Study||0
8657380|NCT00679211|9700031|FG000|NOT COMPLETED|Overall Study||110
8657381|NCT00679263|9700040|FG000|STARTED|Visit 3/Dose 2||10
8657382|NCT00679263|9700041|FG001|STARTED|Visit 3/Dose 2||11
8657383|NCT00679263|9700042|FG002|STARTED|Visit 3/Dose 2||11
8657384|NCT00679263|9700040|FG000|COMPLETED|Visit 3/Dose 2||9
8657385|NCT00679263|9700041|FG001|COMPLETED|Visit 3/Dose 2||6
8657386|NCT00679263|9700042|FG002|COMPLETED|Visit 3/Dose 2||11
8657387|NCT00679263|9700040|FG000|NOT COMPLETED|Visit 3/Dose 2||1
8657388|NCT00679263|9700041|FG001|NOT COMPLETED|Visit 3/Dose 2||5
8657389|NCT00679263|9700042|FG002|NOT COMPLETED|Visit 3/Dose 2||0
8657390|NCT00679263|9700040|FG000|STARTED|Visit 2/Dose 1||11
8657391|NCT00679263|9700041|FG001|STARTED|Visit 2/Dose 1||6
8657392|NCT00679263|9700042|FG002|STARTED|Visit 2/Dose 1||11
8657393|NCT00679263|9700040|FG000|COMPLETED|Visit 2/Dose 1||9
8657394|NCT00679263|9700041|FG001|COMPLETED|Visit 2/Dose 1||5
8657395|NCT00679263|9700042|FG002|COMPLETED|Visit 2/Dose 1||11
8657396|NCT00679263|9700040|FG000|NOT COMPLETED|Visit 2/Dose 1||2
8657397|NCT00679263|9700041|FG001|NOT COMPLETED|Visit 2/Dose 1||1
8657398|NCT00679263|9700042|FG002|NOT COMPLETED|Visit 2/Dose 1||0
8657399|NCT00679289|9700053|FG000|STARTED|Overall Study||6
8657400|NCT00679289|9700054|FG001|STARTED|Overall Study||6
8657401|NCT00679289|9700055|FG002|STARTED|Overall Study||24
8657402|NCT00679289|9700053|FG000|COMPLETED|Overall Study||1
8657403|NCT00679289|9700054|FG001|COMPLETED|Overall Study||0
8657404|NCT00679289|9700055|FG002|COMPLETED|Overall Study||1
8657405|NCT00679289|9700053|FG000|NOT COMPLETED|Overall Study||5
8657406|NCT00679289|9700054|FG001|NOT COMPLETED|Overall Study||6
8657407|NCT00679289|9700055|FG002|NOT COMPLETED|Overall Study||23
8657408|NCT00679302|9700067|FG000|STARTED|Overall Study||84
8657409|NCT00679302|9700068|FG001|STARTED|Overall Study||77
8657410|NCT00679302|9700067|FG000|COMPLETED|Overall Study||76
8657411|NCT00679302|9700068|FG001|COMPLETED|Overall Study||73
8657412|NCT00679302|9700067|FG000|NOT COMPLETED|Overall Study||8
8657413|NCT00679302|9700068|FG001|NOT COMPLETED|Overall Study||4
8657414|NCT00679341|9700076|FG000|STARTED|Overall Study||67
8657415|NCT00679341|9700077|FG001|STARTED|Overall Study||70
8657416|NCT00679341|9700076|FG000|COMPLETED|Overall Study||14
8657417|NCT00679341|9700077|FG001|COMPLETED|Overall Study||19
8657418|NCT00679341|9700076|FG000|NOT COMPLETED|Overall Study||53
8657419|NCT00679341|9700077|FG001|NOT COMPLETED|Overall Study||51
8657420|NCT00679354|9700084|FG000|STARTED|Overall Study||30
8657421|NCT00679354|9700084|FG000|COMPLETED|Overall Study||0
8657422|NCT00679354|9700084|FG000|NOT COMPLETED|Overall Study||30
8657423|NCT00679367|9700089|FG000|STARTED|Overall Study||16
8657424|NCT00679367|9700089|FG000|COMPLETED|Overall Study||4
8657425|NCT00679367|9700089|FG000|NOT COMPLETED|Overall Study||12
8657426|NCT00679380|9700098|FG000|STARTED|Overall Study||109
8657427|NCT00679380|9700099|FG001|STARTED|Overall Study||109
8657428|NCT00679380|9700100|FG002|STARTED|Overall Study||103
8657429|NCT00679380|9700101|FG003|STARTED|Overall Study||89
8657430|NCT00679380|9700098|FG000|COMPLETED|Overall Study||67
8657431|NCT00679380|9700099|FG001|COMPLETED|Overall Study||76
8657432|NCT00679380|9700100|FG002|COMPLETED|Overall Study||68
8657433|NCT00679380|9700101|FG003|COMPLETED|Overall Study||61
8657434|NCT00679380|9700098|FG000|NOT COMPLETED|Overall Study||42
8657435|NCT00679380|9700099|FG001|NOT COMPLETED|Overall Study||33
8657436|NCT00679380|9700100|FG002|NOT COMPLETED|Overall Study||35
8657437|NCT00679380|9700101|FG003|NOT COMPLETED|Overall Study||28
8657438|NCT00679432|9700115|FG000|STARTED|Overall Study||126
8657439|NCT00679432|9700116|FG001|STARTED|Overall Study||127
8657440|NCT00679432|9700117|FG002|STARTED|Overall Study||129
8657441|NCT00679432|9700118|FG003|STARTED|Overall Study||127
8657442|NCT00679432|9700115|FG000|COMPLETED|Overall Study||89
8657443|NCT00679432|9700116|FG001|COMPLETED|Overall Study||89
8657444|NCT00679432|9700117|FG002|COMPLETED|Overall Study||76
8657445|NCT00679432|9700118|FG003|COMPLETED|Overall Study||95
8657446|NCT00679432|9700115|FG000|NOT COMPLETED|Overall Study||37
8657447|NCT00679432|9700116|FG001|NOT COMPLETED|Overall Study||38
8657448|NCT00679432|9700117|FG002|NOT COMPLETED|Overall Study||53
8657449|NCT00679432|9700118|FG003|NOT COMPLETED|Overall Study||32
8657450|NCT00679549|9700130|FG000|STARTED|Overall Study||75
8657451|NCT00679549|9700131|FG001|STARTED|Overall Study||75
8657452|NCT00679549|9700130|FG000|COMPLETED|Overall Study||69
8657453|NCT00679549|9700131|FG001|COMPLETED|Overall Study|4 dropouts in the control arm; 5 missing echocardiograms in the control arm|66
8657454|NCT00679549|9700130|FG000|NOT COMPLETED|Overall Study||6
8657455|NCT00679549|9700131|FG001|NOT COMPLETED|Overall Study||9
8657456|NCT00679627|9700139|FG000|STARTED|Overall Study||1021
8657457|NCT00679627|9700140|FG001|STARTED|Overall Study||1024
8657458|NCT00679627|9700139|FG000|COMPLETED|Overall Study||322
8657459|NCT00679627|9700140|FG001|COMPLETED|Overall Study||339
8657460|NCT00679627|9700139|FG000|NOT COMPLETED|Overall Study||699
8657461|NCT00679627|9700140|FG001|NOT COMPLETED|Overall Study||685
8657462|NCT00679913|9700148|FG000|STARTED|Overall Study||101
8657463|NCT00679913|9700149|FG001|STARTED|Overall Study||99
8657464|NCT00679913|9700148|FG000|COMPLETED|Overall Study||83
8657465|NCT00679913|9700149|FG001|COMPLETED|Overall Study||86
8657466|NCT00679913|9700148|FG000|NOT COMPLETED|Overall Study||18
8657467|NCT00679913|9700149|FG001|NOT COMPLETED|Overall Study||13
8657468|NCT00679939|9700158|FG000|STARTED|52-Week Double-Blind (DB) Period||114
8657469|NCT00679939|9700159|FG001|STARTED|52-Week Double-Blind (DB) Period||112
8657470|NCT00679939|9700158|FG000|COMPLETED|52-Week Double-Blind (DB) Period||77
8657471|NCT00679939|9700159|FG001|COMPLETED|52-Week Double-Blind (DB) Period||85
8657472|NCT00679939|9700158|FG000|NOT COMPLETED|52-Week Double-Blind (DB) Period||37
8657473|NCT00679939|9700159|FG001|NOT COMPLETED|52-Week Double-Blind (DB) Period||27
8657474|NCT00679939|9700158|FG000|STARTED|24-Week Open-Label (OL) Period|One participant who completed the DB Period did not receive the OL dose of MET.|76
8657475|NCT00679939|9700159|FG001|STARTED|24-Week Open-Label (OL) Period|One participant who completed the DB Period did not receive the OL dose of MET.|84
8657476|NCT00679939|9700158|FG000|COMPLETED|24-Week Open-Label (OL) Period||69
8657477|NCT00679939|9700159|FG001|COMPLETED|24-Week Open-Label (OL) Period||80
8657478|NCT00679939|9700158|FG000|NOT COMPLETED|24-Week Open-Label (OL) Period||7
8657479|NCT00679939|9700159|FG001|NOT COMPLETED|24-Week Open-Label (OL) Period||4
8657480|NCT00679952|9700171|FG000|STARTED|Overall Study||86
8657481|NCT00679952|9700172|FG001|STARTED|Overall Study||82
8657482|NCT00679952|9700171|FG000|COMPLETED|Overall Study||86
8657483|NCT00679952|9700172|FG001|COMPLETED|Overall Study||82
8657484|NCT00679952|9700171|FG000|NOT COMPLETED|Overall Study||0
8657485|NCT00679952|9700172|FG001|NOT COMPLETED|Overall Study||0
8657486|NCT00680017|9700180|FG000|STARTED|Overall Study||140
8657487|NCT00680017|9700181|FG001|STARTED|Overall Study||140
8657488|NCT00680017|9700180|FG000|COMPLETED|Overall Study||123
8657489|NCT00680017|9700181|FG001|COMPLETED|Overall Study||128
8657490|NCT00680017|9700180|FG000|NOT COMPLETED|Overall Study||17
8657491|NCT00680017|9700181|FG001|NOT COMPLETED|Overall Study||12
8657492|NCT00680043|9700190|FG000|STARTED|Overall Study||39
8657493|NCT00680043|9700191|FG001|STARTED|Overall Study||37
8657494|NCT00680043|9700192|FG002|STARTED|Overall Study||38
8657495|NCT00680043|9700190|FG000|COMPLETED|Overall Study||37
8657496|NCT00680043|9700191|FG001|COMPLETED|Overall Study||36
8657497|NCT00680043|9700192|FG002|COMPLETED|Overall Study||34
8657498|NCT00680043|9700190|FG000|NOT COMPLETED|Overall Study||2
8657499|NCT00680043|9700191|FG001|NOT COMPLETED|Overall Study||1
8657500|NCT00680043|9700192|FG002|NOT COMPLETED|Overall Study||4
8657501|NCT00680056|9700202|FG000|STARTED|First Intervention||16
8657502|NCT00680056|9700203|FG001|STARTED|First Intervention||17
8657503|NCT00680056|9700202|FG000|COMPLETED|First Intervention||15
8657504|NCT00680056|9700203|FG001|COMPLETED|First Intervention||15
8657505|NCT00680056|9700202|FG000|NOT COMPLETED|First Intervention||1
8657506|NCT00680056|9700203|FG001|NOT COMPLETED|First Intervention||2
8657507|NCT00680056|9700202|FG000|STARTED|Washout Period of One Week||15
8657508|NCT00680056|9700203|FG001|STARTED|Washout Period of One Week||15
8657509|NCT00680056|9700202|FG000|COMPLETED|Washout Period of One Week||15
8657510|NCT00680056|9700203|FG001|COMPLETED|Washout Period of One Week||15
8657511|NCT00680056|9700202|FG000|NOT COMPLETED|Washout Period of One Week||0
8657512|NCT00680056|9700203|FG001|NOT COMPLETED|Washout Period of One Week||0
8657513|NCT00680056|9700202|FG000|STARTED|Second Intervention||15
8657514|NCT00680056|9700203|FG001|STARTED|Second Intervention||15
8657515|NCT00680056|9700202|FG000|COMPLETED|Second Intervention||12
8657516|NCT00680056|9700203|FG001|COMPLETED|Second Intervention||14
8657517|NCT00680056|9700202|FG000|NOT COMPLETED|Second Intervention||3
8657518|NCT00680056|9700203|FG001|NOT COMPLETED|Second Intervention||1
8692153|NCT00858637|9737557|FG000|STARTED|Placebo-controlled Withdrawal Phase||0
8692154|NCT00858637|9737558|FG001|STARTED|Placebo-controlled Withdrawal Phase||49
8692155|NCT00858637|9737559|FG002|STARTED|Placebo-controlled Withdrawal Phase||54
8692156|NCT00858637|9737560|FG003|STARTED|Placebo-controlled Withdrawal Phase||0
8692157|NCT00858637|9737561|FG004|STARTED|Placebo-controlled Withdrawal Phase||56
8692158|NCT00858637|9737562|FG005|STARTED|Placebo-controlled Withdrawal Phase||59
8692159|NCT00858637|9737557|FG000|COMPLETED|Placebo-controlled Withdrawal Phase||0
8692160|NCT00858637|9737558|FG001|COMPLETED|Placebo-controlled Withdrawal Phase||49
8692161|NCT00858637|9737559|FG002|COMPLETED|Placebo-controlled Withdrawal Phase||53
8657519|NCT00680121|9700212|FG000|STARTED|Overall Study||60
8657520|NCT00680121|9700213|FG001|STARTED|Overall Study||60
8657521|NCT00680121|9700212|FG000|COMPLETED|Overall Study||33
8657522|NCT00680121|9700213|FG001|COMPLETED|Overall Study||37
8657523|NCT00680121|9700212|FG000|NOT COMPLETED|Overall Study||27
8657524|NCT00680121|9700213|FG001|NOT COMPLETED|Overall Study||23
8657525|NCT00680186|9700221|FG000|STARTED|Overall Study|Started treatment.|1280
8657526|NCT00680186|9700222|FG001|STARTED|Overall Study|Started treatment.|1288
8657527|NCT00680186|9700221|FG000|COMPLETED|Overall Study|Completed planned observation time.|1155
8657528|NCT00680186|9700222|FG001|COMPLETED|Overall Study|Completed planned observation time.|1172
8657529|NCT00680186|9700221|FG000|NOT COMPLETED|Overall Study||125
8657530|NCT00680186|9700222|FG001|NOT COMPLETED|Overall Study||116
8657531|NCT00680225|9700228|FG000|STARTED|Overall Study||10
8657532|NCT00680225|9700228|FG000|COMPLETED|Overall Study||8
8657533|NCT00680225|9700228|FG000|NOT COMPLETED|Overall Study||2
8657534|NCT00680368|9700232|FG000|STARTED|Overall Study||112
8657535|NCT00680368|9700232|FG000|COMPLETED|Overall Study|15 residents excluded because their attending physician was not participating in the study|97
8657536|NCT00680368|9700232|FG000|NOT COMPLETED|Overall Study||15
8657537|NCT00680407|9700241|FG000|STARTED|Overall Study||26
8657538|NCT00680407|9700242|FG001|STARTED|Overall Study||27
8657539|NCT00680407|9700243|FG002|STARTED|Overall Study||25
8657540|NCT00680407|9700241|FG000|COMPLETED|Overall Study||18
8657541|NCT00680407|9700242|FG001|COMPLETED|Overall Study||22
8657542|NCT00680407|9700243|FG002|COMPLETED|Overall Study||22
8657543|NCT00680407|9700241|FG000|NOT COMPLETED|Overall Study||8
8657544|NCT00680407|9700242|FG001|NOT COMPLETED|Overall Study||5
8657545|NCT00680407|9700243|FG002|NOT COMPLETED|Overall Study||3
8657546|NCT00680459|9700253|FG000|STARTED|Overall Study||7
8657547|NCT00680459|9700254|FG001|STARTED|Overall Study||6
8657548|NCT00680459|9700253|FG000|COMPLETED|Overall Study||7
8657549|NCT00680459|9700254|FG001|COMPLETED|Overall Study||6
8657550|NCT00680459|9700253|FG000|NOT COMPLETED|Overall Study||0
8657551|NCT00680459|9700254|FG001|NOT COMPLETED|Overall Study||0
8657552|NCT00680524|9700260|FG000|STARTED|Overall Study||20
8657553|NCT00680524|9700260|FG000|COMPLETED|Overall Study||17
8657554|NCT00680524|9700260|FG000|NOT COMPLETED|Overall Study||3
8657555|NCT00680628|9700266|FG000|STARTED|Overall Study||43
8657556|NCT00680628|9700267|FG001|STARTED|Overall Study||40
8657557|NCT00680628|9700266|FG000|COMPLETED|Overall Study||43
8657558|NCT00680628|9700267|FG001|COMPLETED|Overall Study||40
8657559|NCT00680628|9700266|FG000|NOT COMPLETED|Overall Study||0
8657560|NCT00680628|9700267|FG001|NOT COMPLETED|Overall Study||0
8657561|NCT00680706|9700275|FG000|STARTED|Overall Study||70
8657562|NCT00680706|9700276|FG001|STARTED|Overall Study||60
8657563|NCT00680706|9700275|FG000|COMPLETED|Overall Study||63
8657564|NCT00680706|9700276|FG001|COMPLETED|Overall Study||55
8657565|NCT00680706|9700275|FG000|NOT COMPLETED|Overall Study||7
8657566|NCT00680706|9700276|FG001|NOT COMPLETED|Overall Study||5
8657567|NCT00680745|9700286|FG000|STARTED|Overall Study|Safety Analysis Set|154
8657568|NCT00680745|9700287|FG001|STARTED|Overall Study|Safety Analysis Set|145
8657569|NCT00680745|9700288|FG002|STARTED|Overall Study|Safety Analysis Set|151
8657570|NCT00680745|9700289|FG003|STARTED|Overall Study|Safety Analysis Set|146
8657571|NCT00680745|9700286|FG000|COMPLETED|Overall Study||140
8657572|NCT00680745|9700287|FG001|COMPLETED|Overall Study||132
8657573|NCT00680745|9700288|FG002|COMPLETED|Overall Study||141
8657574|NCT00680745|9700289|FG003|COMPLETED|Overall Study||133
8657575|NCT00680745|9700286|FG000|NOT COMPLETED|Overall Study||14
8657576|NCT00680745|9700287|FG001|NOT COMPLETED|Overall Study||13
8657577|NCT00680745|9700288|FG002|NOT COMPLETED|Overall Study||10
8657578|NCT00680745|9700289|FG003|NOT COMPLETED|Overall Study||13
8657579|NCT00680771|9700302|FG000|STARTED|Overall Study||15
8657580|NCT00680771|9700303|FG001|STARTED|Overall Study||13
8657581|NCT00680771|9700302|FG000|COMPLETED|Overall Study||9
8657582|NCT00680771|9700303|FG001|COMPLETED|Overall Study||11
8657583|NCT00680771|9700302|FG000|NOT COMPLETED|Overall Study||6
8657584|NCT00680771|9700303|FG001|NOT COMPLETED|Overall Study||2
8657585|NCT00680797|9700313|FG000|STARTED|Overall Study||9
8657586|NCT00680797|9700314|FG001|STARTED|Overall Study||8
8657587|NCT00680797|9700315|FG002|STARTED|Overall Study||8
8657588|NCT00680797|9700316|FG003|STARTED|Overall Study||8
8657589|NCT00680797|9700313|FG000|COMPLETED|Overall Study||9
8657590|NCT00680797|9700314|FG001|COMPLETED|Overall Study||8
8657591|NCT00680797|9700315|FG002|COMPLETED|Overall Study||8
8657592|NCT00680797|9700316|FG003|COMPLETED|Overall Study||8
8657593|NCT00680797|9700313|FG000|NOT COMPLETED|Overall Study||0
8657594|NCT00680797|9700314|FG001|NOT COMPLETED|Overall Study||0
8657595|NCT00680797|9700315|FG002|NOT COMPLETED|Overall Study||0
8657596|NCT00680797|9700316|FG003|NOT COMPLETED|Overall Study||0
8657597|NCT00680823|9700329|FG000|STARTED|Overall Study||50
8657598|NCT00680823|9700330|FG001|STARTED|Overall Study||50
8657599|NCT00680823|9700331|FG002|STARTED|Overall Study||50
8657600|NCT00680823|9700329|FG000|COMPLETED|Overall Study||50
8657601|NCT00680823|9700330|FG001|COMPLETED|Overall Study||50
8657602|NCT00680823|9700331|FG002|COMPLETED|Overall Study||50
8657603|NCT00680823|9700329|FG000|NOT COMPLETED|Overall Study||0
8657604|NCT00680823|9700330|FG001|NOT COMPLETED|Overall Study||0
8657605|NCT00680823|9700331|FG002|NOT COMPLETED|Overall Study||0
8657606|NCT00680836|9700341|FG000|STARTED|Overall Study||27
8657607|NCT00680836|9700342|FG001|STARTED|Overall Study||27
8657608|NCT00680836|9700341|FG000|COMPLETED|Overall Study||19
8657609|NCT00680836|9700342|FG001|COMPLETED|Overall Study||25
8657610|NCT00680836|9700341|FG000|NOT COMPLETED|Overall Study||8
8657611|NCT00680836|9700342|FG001|NOT COMPLETED|Overall Study||2
8657612|NCT00680862|9700349|FG000|STARTED|Overall Study||25
8657613|NCT00680862|9700349|FG000|COMPLETED|Overall Study||25
8657614|NCT00680862|9700349|FG000|NOT COMPLETED|Overall Study||0
8657615|NCT00680914|9700355|FG000|STARTED|Overall Study||374
8657616|NCT00680914|9700356|FG001|STARTED|Overall Study||129
8657617|NCT00680914|9700355|FG000|COMPLETED|Overall Study||364
8657618|NCT00680914|9700356|FG001|COMPLETED|Overall Study||125
8657619|NCT00680914|9700355|FG000|NOT COMPLETED|Overall Study||10
8657620|NCT00680914|9700356|FG001|NOT COMPLETED|Overall Study||4
8657621|NCT00680953|9700365|FG000|STARTED|Overall Study||500
8657622|NCT00680953|9700366|FG001|STARTED|Overall Study||511
8657623|NCT00680953|9700367|FG002|STARTED|Overall Study||251
8657624|NCT00680953|9700365|FG000|COMPLETED|Overall Study||414
8657625|NCT00680953|9700366|FG001|COMPLETED|Overall Study||416
8657626|NCT00680953|9700367|FG002|COMPLETED|Overall Study||204
8657627|NCT00680953|9700365|FG000|NOT COMPLETED|Overall Study||86
8657628|NCT00680953|9700366|FG001|NOT COMPLETED|Overall Study||95
8657629|NCT00680953|9700367|FG002|NOT COMPLETED|Overall Study||47
8657630|NCT00680992|9700378|FG000|STARTED|Overall Study||268
8657631|NCT00680992|9700379|FG001|STARTED|Overall Study||252
8657632|NCT00680992|9700380|FG002|STARTED|Overall Study||12
8657633|NCT00680992|9700378|FG000|Safety Analysis Set|Overall Study||265
8657634|NCT00680992|9700379|FG001|Safety Analysis Set|Overall Study||249
8657635|NCT00680992|9700380|FG002|Safety Analysis Set|Overall Study||12
8657636|NCT00680992|9700378|FG000|Efficacy Analysis Set|Overall Study||260
8657637|NCT00680992|9700379|FG001|Efficacy Analysis Set|Overall Study||242
8657638|NCT00680992|9700380|FG002|Efficacy Analysis Set|Overall Study||11
8657639|NCT00680992|9700378|FG000|COMPLETED|Overall Study||0
8657640|NCT00680992|9700379|FG001|COMPLETED|Overall Study||0
8657641|NCT00680992|9700380|FG002|COMPLETED|Overall Study||0
8657642|NCT00680992|9700378|FG000|NOT COMPLETED|Overall Study||268
8657643|NCT00680992|9700379|FG001|NOT COMPLETED|Overall Study||252
8657644|NCT00680992|9700380|FG002|NOT COMPLETED|Overall Study||12
8657645|NCT00681031|9700389|FG000|STARTED|Overall Study||96
8657646|NCT00681031|9700389|FG000|COMPLETED|Overall Study||96
8657647|NCT00681031|9700389|FG000|NOT COMPLETED|Overall Study||0
8657648|NCT00681083|9700393|FG000|STARTED|Night 1|26 participants were initially consented (this is the total for the study).|13
8657649|NCT00681083|9700394|FG001|STARTED|Night 1|26 participants were initially consented (this is the total for the study).|13
8657650|NCT00681083|9700393|FG000|COMPLETED|Night 1|20 in total completed study. 10 randomized to arm 1 and arm 2 then crossed over to other arm.|10
8657651|NCT00681083|9700394|FG001|COMPLETED|Night 1|20 in total completed study. 10 randomized to arm 1 and arm 2 then crossed over to other arm.|10
8657652|NCT00681083|9700393|FG000|NOT COMPLETED|Night 1||3
8657653|NCT00681083|9700394|FG001|NOT COMPLETED|Night 1||3
8657654|NCT00681083|9700393|FG000|STARTED|Night 2 (Crossover of Night 1)||10
8657655|NCT00681083|9700394|FG001|STARTED|Night 2 (Crossover of Night 1)||10
8657656|NCT00681083|9700393|FG000|COMPLETED|Night 2 (Crossover of Night 1)||10
8657657|NCT00681083|9700394|FG001|COMPLETED|Night 2 (Crossover of Night 1)||10
8657658|NCT00681083|9700393|FG000|NOT COMPLETED|Night 2 (Crossover of Night 1)||0
8657659|NCT00681083|9700394|FG001|NOT COMPLETED|Night 2 (Crossover of Night 1)||0
8657660|NCT00681109|9700403|FG000|STARTED|Overall Study||30
8657661|NCT00681109|9700404|FG001|STARTED|Overall Study||30
8657662|NCT00681109|9700405|FG002|STARTED|Overall Study||15
8657663|NCT00681109|9700403|FG000|COMPLETED|Overall Study||28
8657664|NCT00681109|9700404|FG001|COMPLETED|Overall Study||24
8657665|NCT00681109|9700405|FG002|COMPLETED|Overall Study||15
8657666|NCT00681109|9700403|FG000|NOT COMPLETED|Overall Study||2
8657667|NCT00681109|9700404|FG001|NOT COMPLETED|Overall Study||6
8657668|NCT00681109|9700405|FG002|NOT COMPLETED|Overall Study||0
8657669|NCT00681187|9700418|FG000|STARTED|Overall Study||11
8657670|NCT00681187|9700419|FG001|STARTED|Overall Study||15
8657671|NCT00681187|9700418|FG000|COMPLETED|Overall Study||10
8657672|NCT00681187|9700419|FG001|COMPLETED|Overall Study||13
8657673|NCT00681187|9700418|FG000|NOT COMPLETED|Overall Study||1
8657674|NCT00681187|9700419|FG001|NOT COMPLETED|Overall Study||2
8657675|NCT00681265|9700438|FG000|STARTED|Overall Study||16
8657676|NCT00681265|9700438|FG000|COMPLETED|Overall Study||16
8657677|NCT00681265|9700438|FG000|NOT COMPLETED|Overall Study||0
8657678|NCT00681291|9700446|FG000|STARTED|Overall Study||88
8657679|NCT00681291|9700447|FG001|STARTED|Overall Study||84
8657680|NCT00681291|9700446|FG000|COMPLETED|Overall Study||75
8657681|NCT00681291|9700447|FG001|COMPLETED|Overall Study||57
8657682|NCT00681291|9700446|FG000|NOT COMPLETED|Overall Study||13
8657683|NCT00681291|9700447|FG001|NOT COMPLETED|Overall Study||27
8657684|NCT00681473|9700453|FG000|STARTED|Overall Study|20 patients with WHO Grade 2 Glioma were enrolled.|20
8657685|NCT00681473|9700453|FG000|COMPLETED|Overall Study|All 20 patients completed RT and tolerated treatment well.|20
8657686|NCT00681473|9700453|FG000|NOT COMPLETED|Overall Study||0
8657687|NCT00681538|9700459|FG000|STARTED|Phase A- 4 Weeks Single Blind||572
8657688|NCT00681538|9700460|FG001|STARTED|Phase A- 4 Weeks Single Blind||0
8657689|NCT00681538|9700459|FG000|COMPLETED|Phase A- 4 Weeks Single Blind||538
8657690|NCT00681538|9700460|FG001|COMPLETED|Phase A- 4 Weeks Single Blind||0
8657691|NCT00681538|9700459|FG000|NOT COMPLETED|Phase A- 4 Weeks Single Blind||34
8657692|NCT00681538|9700460|FG001|NOT COMPLETED|Phase A- 4 Weeks Single Blind||0
8657693|NCT00681538|9700459|FG000|STARTED|Phase B- Responders;12 Week Double-blind||124
8657694|NCT00681538|9700460|FG001|STARTED|Phase B- Responders;12 Week Double-blind||117
8657695|NCT00681538|9700459|FG000|COMPLETED|Phase B- Responders;12 Week Double-blind||109
8657696|NCT00681538|9700460|FG001|COMPLETED|Phase B- Responders;12 Week Double-blind||115
8657697|NCT00681538|9700459|FG000|NOT COMPLETED|Phase B- Responders;12 Week Double-blind||15
8657698|NCT00681538|9700460|FG001|NOT COMPLETED|Phase B- Responders;12 Week Double-blind||2
8657699|NCT00681564|9700468|FG000|STARTED|Overall Study||47
8657700|NCT00681564|9700469|FG001|STARTED|Overall Study||55
8657701|NCT00681564|9700468|FG000|COMPLETED|Overall Study||41
8657702|NCT00681564|9700469|FG001|COMPLETED|Overall Study||47
8657703|NCT00681564|9700468|FG000|NOT COMPLETED|Overall Study||6
8657704|NCT00681564|9700469|FG001|NOT COMPLETED|Overall Study||8
8657705|NCT00681590|9700477|FG000|STARTED|Overall Study||34
8657706|NCT00681590|9700478|FG001|STARTED|Overall Study||71
8657707|NCT00681590|9700477|FG000|COMPLETED|Overall Study||32
8657708|NCT00681590|9700478|FG001|COMPLETED|Overall Study||59
8657709|NCT00681590|9700477|FG000|NOT COMPLETED|Overall Study||2
8657710|NCT00681590|9700478|FG001|NOT COMPLETED|Overall Study||12
8657711|NCT00681668|9700484|FG000|STARTED|Overall Study||5
8657712|NCT00681668|9700484|FG000|COMPLETED|Overall Study||3
8657713|NCT00681668|9700484|FG000|NOT COMPLETED|Overall Study||2
8657714|NCT00681811|9700490|FG000|STARTED|Overall Study||6
8657715|NCT00681811|9700491|FG001|STARTED|Overall Study||5
8657716|NCT00681811|9700490|FG000|COMPLETED|Overall Study||3
8657717|NCT00681811|9700491|FG001|COMPLETED|Overall Study||1
8657718|NCT00681811|9700490|FG000|NOT COMPLETED|Overall Study||3
8657719|NCT00681811|9700491|FG001|NOT COMPLETED|Overall Study||4
8657720|NCT00681824|9700511|FG000|STARTED|Overall Study||28
8657721|NCT00681824|9700512|FG001|STARTED|Overall Study||13
8657722|NCT00681824|9700513|FG002|STARTED|Overall Study||34
8657723|NCT00681824|9700511|FG000|COMPLETED|Overall Study||27
8657724|NCT00681824|9700512|FG001|COMPLETED|Overall Study||12
8657725|NCT00681824|9700513|FG002|COMPLETED|Overall Study||33
8657726|NCT00681824|9700511|FG000|NOT COMPLETED|Overall Study||1
8657727|NCT00681824|9700512|FG001|NOT COMPLETED|Overall Study||1
8657728|NCT00681824|9700513|FG002|NOT COMPLETED|Overall Study||1
8657729|NCT00681863|9700521|FG000|STARTED|Overall Study||45
8657730|NCT00681863|9700521|FG000|COMPLETED|Overall Study||22
8657731|NCT00681863|9700521|FG000|NOT COMPLETED|Overall Study||23
8657732|NCT00681889|9700525|FG000|STARTED|Overall Study||9
8657733|NCT00681889|9700525|FG000|COMPLETED|Overall Study||9
8657734|NCT00681889|9700525|FG000|NOT COMPLETED|Overall Study||0
8657735|NCT00682357|9700532|FG000|STARTED|Overall Study||10
8657736|NCT00682357|9700533|FG001|STARTED|Overall Study||10
8657737|NCT00682357|9700534|FG002|STARTED|Overall Study||5
8657738|NCT00682357|9700532|FG000|COMPLETED|Overall Study||10
8657739|NCT00682357|9700533|FG001|COMPLETED|Overall Study||10
8657740|NCT00682357|9700534|FG002|COMPLETED|Overall Study||5
8657741|NCT00682357|9700532|FG000|NOT COMPLETED|Overall Study||0
8657742|NCT00682357|9700533|FG001|NOT COMPLETED|Overall Study||0
8657743|NCT00682357|9700534|FG002|NOT COMPLETED|Overall Study||0
8657744|NCT00682435|9700542|FG000|STARTED|Overall Study||230
8657745|NCT00682435|9700542|FG000|Ensured Enrolled Only Once|Overall Study||228
8657746|NCT00682435|9700542|FG000|Sufficient Data to Carry Out Analysis|Overall Study||223
8657747|NCT00682435|9700542|FG000|COMPLETED|Overall Study||223
8657748|NCT00682435|9700542|FG000|NOT COMPLETED|Overall Study||7
8657749|NCT00682448|9700548|FG000|STARTED|Overall Study||12
8657750|NCT00682448|9700549|FG001|STARTED|Overall Study||13
8657751|NCT00682448|9700548|FG000|COMPLETED|Overall Study||7
8657752|NCT00682448|9700549|FG001|COMPLETED|Overall Study||7
8657753|NCT00682448|9700548|FG000|NOT COMPLETED|Overall Study||5
8657754|NCT00682448|9700549|FG001|NOT COMPLETED|Overall Study||6
8657755|NCT00682539|9700558|FG000|STARTED|Bevacizumab vs Triamcinolone||18
8657756|NCT00682539|9700559|FG001|STARTED|Bevacizumab vs Triamcinolone||16
8657757|NCT00682539|9700560|FG002|STARTED|Bevacizumab vs Triamcinolone||0
8657758|NCT00682539|9700558|FG000|COMPLETED|Bevacizumab vs Triamcinolone||15
8657759|NCT00682539|9700559|FG001|COMPLETED|Bevacizumab vs Triamcinolone||15
8657760|NCT00682539|9700560|FG002|COMPLETED|Bevacizumab vs Triamcinolone||0
8657761|NCT00682539|9700558|FG000|NOT COMPLETED|Bevacizumab vs Triamcinolone||3
8657762|NCT00682539|9700559|FG001|NOT COMPLETED|Bevacizumab vs Triamcinolone||1
8657763|NCT00682539|9700560|FG002|NOT COMPLETED|Bevacizumab vs Triamcinolone||0
8657764|NCT00682539|9700558|FG000|STARTED|Ranibizumab vs Triamcinolone|Two independent periods.|0
8657765|NCT00682539|9700559|FG001|STARTED|Ranibizumab vs Triamcinolone|None of the patients of the 1st period was included in the second period.|18
8657766|NCT00682539|9700560|FG002|STARTED|Ranibizumab vs Triamcinolone|Both periods recruited independently following the same criteria.|18
8657767|NCT00682539|9700558|FG000|COMPLETED|Ranibizumab vs Triamcinolone||0
8657768|NCT00682539|9700559|FG001|COMPLETED|Ranibizumab vs Triamcinolone||15
8657769|NCT00682539|9700560|FG002|COMPLETED|Ranibizumab vs Triamcinolone||10
8657770|NCT00682539|9700558|FG000|NOT COMPLETED|Ranibizumab vs Triamcinolone||0
8657771|NCT00682539|9700559|FG001|NOT COMPLETED|Ranibizumab vs Triamcinolone||3
8657772|NCT00682539|9700560|FG002|NOT COMPLETED|Ranibizumab vs Triamcinolone||8
8657773|NCT00682565|9700571|FG000|STARTED|Overall Study||31
8657774|NCT00682565|9700572|FG001|STARTED|Overall Study||35
8657775|NCT00682565|9700573|FG002|STARTED|Overall Study||29
8657776|NCT00682565|9700571|FG000|COMPLETED|Overall Study||30
8657777|NCT00682565|9700572|FG001|COMPLETED|Overall Study||32
8657778|NCT00682565|9700573|FG002|COMPLETED|Overall Study||29
8657779|NCT00682565|9700571|FG000|NOT COMPLETED|Overall Study||1
8657780|NCT00682565|9700572|FG001|NOT COMPLETED|Overall Study||3
8657781|NCT00682565|9700573|FG002|NOT COMPLETED|Overall Study||0
8657782|NCT00682461|9700584|FG000|STARTED|Overall Study||100
8657783|NCT00682461|9700585|FG001|STARTED|Overall Study||100
8657784|NCT00682461|9700584|FG000|COMPLETED|Overall Study||75
8657785|NCT00682461|9700585|FG001|COMPLETED|Overall Study||69
8657786|NCT00682461|9700584|FG000|NOT COMPLETED|Overall Study||25
8657787|NCT00682461|9700585|FG001|NOT COMPLETED|Overall Study||31
8657788|NCT00682617|9700594|FG000|STARTED|Overall Study||13
8657789|NCT00682617|9700595|FG001|STARTED|Overall Study||28
8657790|NCT00682617|9700594|FG000|COMPLETED|Overall Study||10
8657791|NCT00682617|9700595|FG001|COMPLETED|Overall Study||21
8657792|NCT00682617|9700594|FG000|NOT COMPLETED|Overall Study||3
8657793|NCT00682617|9700595|FG001|NOT COMPLETED|Overall Study||7
8657794|NCT00682643|9700603|FG000|STARTED|Overall Study||182
8657795|NCT00682643|9700604|FG001|STARTED|Overall Study||368
8657796|NCT00682643|9700603|FG000|COMPLETED|Overall Study||104
8657797|NCT00682643|9700604|FG001|COMPLETED|Overall Study||199
8657798|NCT00682643|9700603|FG000|NOT COMPLETED|Overall Study||78
8657799|NCT00682643|9700604|FG001|NOT COMPLETED|Overall Study||169
8657800|NCT00682734|9700614|FG000|STARTED|Emergency Department Portion||113
8657801|NCT00682734|9700615|FG001|STARTED|Emergency Department Portion||118
8657802|NCT00682734|9700616|FG002|STARTED|Emergency Department Portion||118
8657803|NCT00682734|9700614|FG000|COMPLETED|Emergency Department Portion||113
8657804|NCT00682734|9700615|FG001|COMPLETED|Emergency Department Portion||117
8657805|NCT00682734|9700616|FG002|COMPLETED|Emergency Department Portion||117
8657806|NCT00682734|9700614|FG000|NOT COMPLETED|Emergency Department Portion||0
8657807|NCT00682734|9700615|FG001|NOT COMPLETED|Emergency Department Portion||1
8657808|NCT00682734|9700616|FG002|NOT COMPLETED|Emergency Department Portion||1
8657809|NCT00682734|9700614|FG000|STARTED|48 Hour Follow-up||113
8657810|NCT00682734|9700615|FG001|STARTED|48 Hour Follow-up||117
8657811|NCT00682734|9700616|FG002|STARTED|48 Hour Follow-up||117
8657812|NCT00682734|9700614|FG000|COMPLETED|48 Hour Follow-up||107
8657813|NCT00682734|9700615|FG001|COMPLETED|48 Hour Follow-up||111
8657814|NCT00682734|9700616|FG002|COMPLETED|48 Hour Follow-up||106
8657815|NCT00682734|9700614|FG000|NOT COMPLETED|48 Hour Follow-up||6
8657816|NCT00682734|9700615|FG001|NOT COMPLETED|48 Hour Follow-up||6
8657817|NCT00682734|9700616|FG002|NOT COMPLETED|48 Hour Follow-up||11
8657818|NCT00682786|9700626|FG000|STARTED|Overall Study||98
8657819|NCT00682786|9700627|FG001|STARTED|Overall Study||37
8657820|NCT00682786|9700626|FG000|COMPLETED|Overall Study||96
8657821|NCT00682786|9700627|FG001|COMPLETED|Overall Study||34
8657822|NCT00682786|9700626|FG000|NOT COMPLETED|Overall Study||2
8657823|NCT00682786|9700627|FG001|NOT COMPLETED|Overall Study||3
8657824|NCT00682838|9700643|FG000|STARTED|Overall Study||65
8657825|NCT00682838|9700644|FG001|STARTED|Overall Study||67
8657826|NCT00682838|9700645|FG002|STARTED|Overall Study||75
8657827|NCT00682838|9700646|FG003|STARTED|Overall Study||73
8657828|NCT00682838|9700643|FG000|COMPLETED|Overall Study||65
8657829|NCT00682838|9700644|FG001|COMPLETED|Overall Study||67
8657830|NCT00682838|9700645|FG002|COMPLETED|Overall Study||75
8657831|NCT00682838|9700646|FG003|COMPLETED|Overall Study||73
8657832|NCT00682838|9700643|FG000|NOT COMPLETED|Overall Study||0
8657833|NCT00682838|9700644|FG001|NOT COMPLETED|Overall Study||0
8657834|NCT00682838|9700645|FG002|NOT COMPLETED|Overall Study||0
8657835|NCT00682838|9700646|FG003|NOT COMPLETED|Overall Study||0
8657836|NCT00682851|9700658|FG000|STARTED|Overall Study||251
8657837|NCT00682851|9700659|FG001|STARTED|Overall Study||268
8657838|NCT00682851|9700658|FG000|COMPLETED|Overall Study||251
8657839|NCT00682851|9700659|FG001|COMPLETED|Overall Study||268
8657840|NCT00682851|9700658|FG000|NOT COMPLETED|Overall Study||0
8657841|NCT00682851|9700659|FG001|NOT COMPLETED|Overall Study||0
8657842|NCT00682890|9700667|FG000|STARTED|Overall Study||12
8657843|NCT00682890|9700668|FG001|STARTED|Overall Study||11
8657844|NCT00682890|9700667|FG000|COMPLETED|Overall Study||10
8657845|NCT00682890|9700668|FG001|COMPLETED|Overall Study||9
8657846|NCT00682890|9700667|FG000|NOT COMPLETED|Overall Study||2
8657847|NCT00682890|9700668|FG001|NOT COMPLETED|Overall Study||2
8657848|NCT00682929|9700677|FG000|STARTED|Overall Study||13
8657849|NCT00682929|9700678|FG001|STARTED|Overall Study||14
8657850|NCT00682929|9700679|FG002|STARTED|Overall Study||14
8657851|NCT00682929|9700677|FG000|COMPLETED|Overall Study||7
8657852|NCT00682929|9700678|FG001|COMPLETED|Overall Study||9
8657853|NCT00682929|9700679|FG002|COMPLETED|Overall Study||12
8657854|NCT00682929|9700677|FG000|NOT COMPLETED|Overall Study||6
8657855|NCT00682929|9700678|FG001|NOT COMPLETED|Overall Study||5
8657856|NCT00682929|9700679|FG002|NOT COMPLETED|Overall Study||2
8657857|NCT00683020|9700689|FG000|STARTED|Overall Study||182
8657858|NCT00683020|9700690|FG001|STARTED|Overall Study||180
8657859|NCT00683020|9700689|FG000|COMPLETED|Overall Study||127
8657860|NCT00683020|9700690|FG001|COMPLETED|Overall Study||125
8657861|NCT00683020|9700689|FG000|NOT COMPLETED|Overall Study||55
8657862|NCT00683020|9700690|FG001|NOT COMPLETED|Overall Study||55
8729255|NCT01052272|9776371|FG002|COMPLETED|Overall Study||10
8729256|NCT01052272|9776372|FG003|COMPLETED|Overall Study||11
8657863|NCT00683046|9700696|FG000|STARTED|Overall Study||204
8657864|NCT00683046|9700696|FG000|COMPLETED|Overall Study||204
8657865|NCT00683046|9700696|FG000|NOT COMPLETED|Overall Study||0
8657866|NCT00683085|9700700|FG000|STARTED|Overall Study||2
8657867|NCT00683085|9700700|FG000|COMPLETED|Overall Study||2
8657868|NCT00683085|9700700|FG000|NOT COMPLETED|Overall Study||0
8657869|NCT00683163|9700706|FG000|STARTED|Overall Study||22
8657870|NCT00683163|9700707|FG001|STARTED|Overall Study||22
8657871|NCT00683163|9700706|FG000|COMPLETED|Overall Study||22
8657872|NCT00683163|9700707|FG001|COMPLETED|Overall Study||22
8657873|NCT00683163|9700706|FG000|NOT COMPLETED|Overall Study||0
8657874|NCT00683163|9700707|FG001|NOT COMPLETED|Overall Study||0
8657875|NCT00683293|9700715|FG000|STARTED|Overall Study||50
8657876|NCT00683293|9700716|FG001|STARTED|Overall Study||50
8657877|NCT00683293|9700715|FG000|COMPLETED|Overall Study||48
8657878|NCT00683293|9700716|FG001|COMPLETED|Overall Study||47
8657879|NCT00683293|9700715|FG000|NOT COMPLETED|Overall Study||2
8657880|NCT00683293|9700716|FG001|NOT COMPLETED|Overall Study||3
8657881|NCT00683332|9700722|FG000|STARTED|Overall Study||621
8657882|NCT00683332|9700722|FG000|COMPLETED|Overall Study||621
8657883|NCT00683332|9700722|FG000|NOT COMPLETED|Overall Study||0
8657884|NCT00683384|9700726|FG000|STARTED|Overall Study||93
8657885|NCT00683384|9700726|FG000|COMPLETED|Overall Study||91
8657886|NCT00683384|9700726|FG000|NOT COMPLETED|Overall Study||2
8657887|NCT00683410|9700730|FG000|STARTED|Overall Study||3366
8657888|NCT00683410|9700730|FG000|Vaccinated Dose 1|Overall Study||3240
8657889|NCT00683410|9700730|FG000|Vaccinated Dose 2|Overall Study||1623
8657890|NCT00683410|9700730|FG000|Vaccinated Dose 3|Overall Study||817
8657891|NCT00683410|9700730|FG000|Vaccinated Dose 4|Overall Study||175
8657892|NCT00683410|9700730|FG000|COMPLETED|Overall Study||3366
8657893|NCT00683410|9700730|FG000|NOT COMPLETED|Overall Study||0
8657894|NCT00683449|9700739|FG000|STARTED|Overall Study||5
8657895|NCT00683449|9700740|FG001|STARTED|Overall Study||13
8657896|NCT00683449|9700741|FG002|STARTED|Overall Study||3
8657897|NCT00683449|9700742|FG003|STARTED|Overall Study||6
8657898|NCT00683449|9700743|FG004|STARTED|Overall Study||2
8657899|NCT00683449|9700739|FG000|COMPLETED|Overall Study||5
8657900|NCT00683449|9700740|FG001|COMPLETED|Overall Study||12
8657901|NCT00683449|9700741|FG002|COMPLETED|Overall Study||3
8657902|NCT00683449|9700742|FG003|COMPLETED|Overall Study||6
8657903|NCT00683449|9700743|FG004|COMPLETED|Overall Study||2
8657904|NCT00683449|9700739|FG000|NOT COMPLETED|Overall Study||0
8657905|NCT00683449|9700740|FG001|NOT COMPLETED|Overall Study||1
8657906|NCT00683449|9700741|FG002|NOT COMPLETED|Overall Study||0
8657907|NCT00683449|9700742|FG003|NOT COMPLETED|Overall Study||0
8657908|NCT00683449|9700743|FG004|NOT COMPLETED|Overall Study||0
8657909|NCT00683475|9700762|FG000|STARTED|Overall Study||69
8657910|NCT00683475|9700763|FG001|STARTED|Overall Study||69
8657911|NCT00683475|9700762|FG000|Received Any Quantity of Study Drug|Overall Study||66
8657912|NCT00683475|9700763|FG001|Received Any Quantity of Study Drug|Overall Study||66
8657913|NCT00683475|9700762|FG000|COMPLETED|Overall Study||65
8657914|NCT00683475|9700763|FG001|COMPLETED|Overall Study||66
8657915|NCT00683475|9700762|FG000|NOT COMPLETED|Overall Study||4
8657916|NCT00683475|9700763|FG001|NOT COMPLETED|Overall Study||3
8657917|NCT00683592|9700772|FG000|STARTED|Overall Study||240
8657918|NCT00683592|9700773|FG001|STARTED|Overall Study||241
8657919|NCT00683592|9700772|FG000|Intent to Treat Population|Overall Study||231
8657920|NCT00683592|9700773|FG001|Intent to Treat Population|Overall Study||232
8657921|NCT00683592|9700772|FG000|Safety Population|Overall Study||235
8657922|NCT00683592|9700773|FG001|Safety Population|Overall Study||233
8657923|NCT00683592|9700772|FG000|COMPLETED|Overall Study||193
8657924|NCT00683592|9700773|FG001|COMPLETED|Overall Study||195
8657925|NCT00683592|9700772|FG000|NOT COMPLETED|Overall Study||47
8657926|NCT00683592|9700773|FG001|NOT COMPLETED|Overall Study||46
8657927|NCT00683618|9700782|FG000|STARTED|Randomised Treatment Period||145
8657928|NCT00683618|9700783|FG001|STARTED|Randomised Treatment Period||145
8657929|NCT00683618|9700784|FG002|STARTED|Randomised Treatment Period||146
8657930|NCT00683618|9700782|FG000|COMPLETED|Randomised Treatment Period||139
8657931|NCT00683618|9700783|FG001|COMPLETED|Randomised Treatment Period||143
8657932|NCT00683618|9700784|FG002|COMPLETED|Randomised Treatment Period||140
8657933|NCT00683618|9700782|FG000|NOT COMPLETED|Randomised Treatment Period||6
8657934|NCT00683618|9700783|FG001|NOT COMPLETED|Randomised Treatment Period||2
8657935|NCT00683618|9700784|FG002|NOT COMPLETED|Randomised Treatment Period||6
8657936|NCT00683618|9700782|FG000|STARTED|Extension Treatment Period||36
8657937|NCT00683618|9700783|FG001|STARTED|Extension Treatment Period||23
8657938|NCT00683618|9700784|FG002|STARTED|Extension Treatment Period||0
8657939|NCT00683618|9700782|FG000|COMPLETED|Extension Treatment Period||33
8657940|NCT00683618|9700783|FG001|COMPLETED|Extension Treatment Period||23
8657941|NCT00683618|9700784|FG002|COMPLETED|Extension Treatment Period||0
8657942|NCT00683618|9700782|FG000|NOT COMPLETED|Extension Treatment Period||3
8657943|NCT00683618|9700783|FG001|NOT COMPLETED|Extension Treatment Period||0
8657944|NCT00683618|9700784|FG002|NOT COMPLETED|Extension Treatment Period||0
8657945|NCT00683644|9700796|FG000|STARTED|Overall Study||58
8657946|NCT00683644|9700797|FG001|STARTED|Overall Study||58
8657947|NCT00683644|9700796|FG000|COMPLETED|Overall Study||45
8657948|NCT00683644|9700797|FG001|COMPLETED|Overall Study||44
8657949|NCT00683644|9700796|FG000|NOT COMPLETED|Overall Study||13
8657950|NCT00683644|9700797|FG001|NOT COMPLETED|Overall Study||14
8657951|NCT00683657|9700809|FG000|STARTED|Overall Study||46
8657952|NCT00683657|9700810|FG001|STARTED|Overall Study||47
8657953|NCT00683657|9700809|FG000|Randomized Subjects Data Set|Overall Study|Randomized subjects who took at least 1 dose of double-blind study medication.|46
8657954|NCT00683657|9700810|FG001|Randomized Subjects Data Set|Overall Study|Randomized subjects who took at least 1 dose of double-blind study medication.|47
8657955|NCT00683657|9700809|FG000|COMPLETED|Overall Study||45
8657956|NCT00683657|9700810|FG001|COMPLETED|Overall Study||46
8657957|NCT00683657|9700809|FG000|NOT COMPLETED|Overall Study||1
8657958|NCT00683657|9700810|FG001|NOT COMPLETED|Overall Study||1
8657959|NCT00683696|9700818|FG000|STARTED|Overall Study||404
8657960|NCT00683696|9700819|FG001|STARTED|Overall Study||405
8657961|NCT00683696|9700818|FG000|COMPLETED|Overall Study||0
8657962|NCT00683696|9700819|FG001|COMPLETED|Overall Study||0
8657963|NCT00683696|9700818|FG000|NOT COMPLETED|Overall Study||404
8657964|NCT00683696|9700819|FG001|NOT COMPLETED|Overall Study||405
8657965|NCT00683774|9700828|FG000|STARTED|Overall Study||11
8657966|NCT00683774|9700829|FG001|STARTED|Overall Study||10
8657967|NCT00683774|9700828|FG000|COMPLETED|Overall Study||8
8657968|NCT00683774|9700829|FG001|COMPLETED|Overall Study||9
8657969|NCT00683774|9700828|FG000|NOT COMPLETED|Overall Study||3
8657970|NCT00683774|9700829|FG001|NOT COMPLETED|Overall Study||1
8657971|NCT00683800|9700837|FG000|STARTED|Overall Study||1101
8657972|NCT00683800|9700838|FG001|STARTED|Overall Study||1085
8657973|NCT00683800|9700837|FG000|Treated|Overall Study||1066
8657974|NCT00683800|9700838|FG001|Treated|Overall Study||1052
8657975|NCT00683800|9700837|FG000|COMPLETED|Overall Study||669
8657976|NCT00683800|9700838|FG001|COMPLETED|Overall Study||719
8657977|NCT00683800|9700837|FG000|NOT COMPLETED|Overall Study||432
8657978|NCT00683800|9700838|FG001|NOT COMPLETED|Overall Study||366
8657979|NCT00683826|9700847|FG000|STARTED|Overall Study||8
8657980|NCT00683826|9700847|FG000|0g Leucine|Overall Study||8
8657981|NCT00683826|9700847|FG000|8g Leucine|Overall Study||8
8657982|NCT00683826|9700847|FG000|4g Leucine|Overall Study||7
8657983|NCT00683826|9700847|FG000|COMPLETED|Overall Study||7
8657984|NCT00683826|9700847|FG000|NOT COMPLETED|Overall Study||1
8657985|NCT00683852|9700857|FG000|STARTED|30-Day Phase 1 Period||56
8657986|NCT00683852|9700858|FG001|STARTED|30-Day Phase 1 Period||84
8657987|NCT00683852|9700859|FG002|STARTED|30-Day Phase 1 Period||85
8657988|NCT00683852|9700857|FG000|COMPLETED|30-Day Phase 1 Period||54
8657989|NCT00683852|9700858|FG001|COMPLETED|30-Day Phase 1 Period||83
8657990|NCT00683852|9700859|FG002|COMPLETED|30-Day Phase 1 Period||84
8657991|NCT00683852|9700857|FG000|NOT COMPLETED|30-Day Phase 1 Period||2
8657992|NCT00683852|9700858|FG001|NOT COMPLETED|30-Day Phase 1 Period||1
8657993|NCT00683852|9700859|FG002|NOT COMPLETED|30-Day Phase 1 Period||1
8657994|NCT00683852|9700857|FG000|STARTED|30-Day Phase 2 Period||54
8657995|NCT00683852|9700858|FG001|STARTED|30-Day Phase 2 Period||83
8657996|NCT00683852|9700859|FG002|STARTED|30-Day Phase 2 Period||84
8657997|NCT00683852|9700857|FG000|COMPLETED|30-Day Phase 2 Period||48
8657998|NCT00683852|9700858|FG001|COMPLETED|30-Day Phase 2 Period||78
8657999|NCT00683852|9700859|FG002|COMPLETED|30-Day Phase 2 Period||75
8658000|NCT00683852|9700857|FG000|NOT COMPLETED|30-Day Phase 2 Period||6
8658001|NCT00683852|9700858|FG001|NOT COMPLETED|30-Day Phase 2 Period||5
8729257|NCT01052272|9776369|FG000|NOT COMPLETED|Overall Study||5
8729258|NCT01052272|9776370|FG001|NOT COMPLETED|Overall Study||7
8729259|NCT01052272|9776371|FG002|NOT COMPLETED|Overall Study||8
8729260|NCT01052272|9776372|FG003|NOT COMPLETED|Overall Study||7
8806603|NCT01478594|9858829|FG000|COMPLETED|Overall Study|Participants still on study as of 28 February 2014|112
8806604|NCT01478594|9858830|FG001|COMPLETED|Overall Study|Participants still on study as of 28 February 2014|60
8806605|NCT01478594|9858829|FG000|NOT COMPLETED|Overall Study||65
8806606|NCT01478594|9858830|FG001|NOT COMPLETED|Overall Study||28
8806607|NCT01478620|9858889|FG000|STARTED|Overall Study||125
8806608|NCT01478620|9858889|FG000|COMPLETED|Overall Study||119
8806609|NCT01478620|9858889|FG000|NOT COMPLETED|Overall Study||6
8806610|NCT01478828|9858893|FG000|STARTED|Overall Study||2
8806611|NCT01478828|9858893|FG000|COMPLETED|Overall Study||1
8806612|NCT01478828|9858893|FG000|NOT COMPLETED|Overall Study||1
8806613|NCT01478854|9858898|FG000|STARTED|Overall Study||30
8806614|NCT01478854|9858898|FG000|COMPLETED|Overall Study||30
8806615|NCT01478854|9858898|FG000|NOT COMPLETED|Overall Study||0
8806616|NCT01478958|9858905|FG000|STARTED|Overall Study||67
8806617|NCT01478958|9858906|FG001|STARTED|Overall Study||66
8806618|NCT01478958|9858907|FG002|STARTED|Overall Study||69
8806619|NCT01478958|9858905|FG000|COMPLETED|Overall Study||65
8806620|NCT01478958|9858906|FG001|COMPLETED|Overall Study||64
8806621|NCT01478958|9858907|FG002|COMPLETED|Overall Study||66
8806622|NCT01478958|9858905|FG000|NOT COMPLETED|Overall Study||2
8806623|NCT01478958|9858906|FG001|NOT COMPLETED|Overall Study||2
8806624|NCT01478958|9858907|FG002|NOT COMPLETED|Overall Study||3
8806625|NCT01478971|9858915|FG000|STARTED|Standard of Care Period||184
8806626|NCT01478971|9858915|FG000|Received Treatment|Standard of Care Period||178
8806627|NCT01478971|9858915|FG000|COMPLETED|Standard of Care Period||159
8806628|NCT01478971|9858915|FG000|NOT COMPLETED|Standard of Care Period||25
8806629|NCT01478971|9858915|FG000|STARTED|Peginesatide Treatment Period|2 participants terminated the study before transitioning to peginesatide for unknown reasons|157
8806630|NCT01478971|9858915|FG000|COMPLETED|Peginesatide Treatment Period||143
8806631|NCT01478971|9858915|FG000|NOT COMPLETED|Peginesatide Treatment Period||14
8806632|NCT01479127|9858923|FG000|STARTED|Overall Study|started oral study drug (full safety sample)|8
8806633|NCT01479127|9858923|FG000|Started LCIG|Overall Study||6
8806634|NCT01479127|9858923|FG000|COMPLETED|Overall Study||5
8806635|NCT01479127|9858923|FG000|NOT COMPLETED|Overall Study||3
8806636|NCT01479270|9858933|FG000|STARTED|Overall Study||28
8806637|NCT01479270|9858934|FG001|STARTED|Overall Study||28
8806638|NCT01479270|9858933|FG000|COMPLETED|Overall Study||28
8658002|NCT00683852|9700859|FG002|NOT COMPLETED|30-Day Phase 2 Period||9
8658003|NCT00683878|9700877|FG000|STARTED|Overall Study||139
8806639|NCT01479270|9858934|FG001|COMPLETED|Overall Study||28
8658004|NCT00683878|9700878|FG001|STARTED|Overall Study||141
8658005|NCT00683878|9700879|FG002|STARTED|Overall Study||140
8658006|NCT00683878|9700877|FG000|COMPLETED|Overall Study||116
8658007|NCT00683878|9700878|FG001|COMPLETED|Overall Study||125
8658008|NCT00683878|9700879|FG002|COMPLETED|Overall Study||126
8658009|NCT00683878|9700877|FG000|NOT COMPLETED|Overall Study||23
8658010|NCT00683878|9700878|FG001|NOT COMPLETED|Overall Study||16
8658011|NCT00683878|9700879|FG002|NOT COMPLETED|Overall Study||14
8658012|NCT00683904|9700889|FG000|STARTED|Dose Level 1||6
8658013|NCT00683904|9700890|FG001|STARTED|Dose Level 1||0
8658014|NCT00683904|9700889|FG000|COMPLETED|Dose Level 1||3
8658015|NCT00683904|9700890|FG001|COMPLETED|Dose Level 1||0
8658016|NCT00683904|9700889|FG000|NOT COMPLETED|Dose Level 1||3
8658017|NCT00683904|9700890|FG001|NOT COMPLETED|Dose Level 1||0
8658018|NCT00683904|9700889|FG000|STARTED|Dose Level 2||0
8658019|NCT00683904|9700890|FG001|STARTED|Dose Level 2||6
8658020|NCT00683904|9700889|FG000|COMPLETED|Dose Level 2||0
8658021|NCT00683904|9700890|FG001|COMPLETED|Dose Level 2||4
8658022|NCT00683904|9700889|FG000|NOT COMPLETED|Dose Level 2||0
8658023|NCT00683904|9700890|FG001|NOT COMPLETED|Dose Level 2||2
8658024|NCT00683930|9700905|FG000|STARTED|Overall Study|One subject not included: no study drug dispensed.|36
8658025|NCT00683930|9700906|FG001|STARTED|Overall Study|One subject not included: no study drug dispensed.|21
8658026|NCT00683930|9700907|FG002|STARTED|Overall Study||37
8658027|NCT00683930|9700905|FG000|COMPLETED|Overall Study||29
8658028|NCT00683930|9700906|FG001|COMPLETED|Overall Study||18
8658029|NCT00683930|9700907|FG002|COMPLETED|Overall Study||28
8658030|NCT00683930|9700905|FG000|NOT COMPLETED|Overall Study||7
8658031|NCT00683930|9700906|FG001|NOT COMPLETED|Overall Study||3
8658032|NCT00683930|9700907|FG002|NOT COMPLETED|Overall Study||9
8658033|NCT00684021|9700920|FG000|STARTED|Overall Study||43
8658034|NCT00684021|9700921|FG001|STARTED|Overall Study||24
8658035|NCT00684021|9700922|FG002|STARTED|Overall Study||36
8658036|NCT00684021|9700923|FG003|STARTED|Overall Study||17
8658037|NCT00684021|9700920|FG000|COMPLETED|Overall Study||41
8658038|NCT00684021|9700921|FG001|COMPLETED|Overall Study||22
8658039|NCT00684021|9700922|FG002|COMPLETED|Overall Study||34
8658040|NCT00684021|9700923|FG003|COMPLETED|Overall Study||15
8658041|NCT00684021|9700920|FG000|NOT COMPLETED|Overall Study||2
8658042|NCT00684021|9700921|FG001|NOT COMPLETED|Overall Study||2
8658043|NCT00684021|9700922|FG002|NOT COMPLETED|Overall Study||2
8658044|NCT00684021|9700923|FG003|NOT COMPLETED|Overall Study||2
8658045|NCT00684047|9700936|FG000|STARTED|Overall Study||72
8658046|NCT00684047|9700937|FG001|STARTED|Overall Study||110
8658047|NCT00684047|9700938|FG002|STARTED|Overall Study||57
8658048|NCT00684047|9700936|FG000|COMPLETED|Overall Study||59
8658049|NCT00684047|9700937|FG001|COMPLETED|Overall Study||94
8658050|NCT00684047|9700938|FG002|COMPLETED|Overall Study||52
8658051|NCT00684047|9700936|FG000|NOT COMPLETED|Overall Study||13
8658052|NCT00684047|9700937|FG001|NOT COMPLETED|Overall Study||16
8658053|NCT00684047|9700938|FG002|NOT COMPLETED|Overall Study||5
8658054|NCT00684060|9700948|FG000|STARTED|Overall Study||58
8658055|NCT00684060|9700949|FG001|STARTED|Overall Study||29
8658056|NCT00684060|9700948|FG000|COMPLETED|Overall Study||55
8658057|NCT00684060|9700949|FG001|COMPLETED|Overall Study||26
8658058|NCT00684060|9700948|FG000|NOT COMPLETED|Overall Study||3
8658059|NCT00684060|9700949|FG001|NOT COMPLETED|Overall Study||3
8658060|NCT00684073|9700955|FG000|STARTED|Selection||60
8658061|NCT00684073|9700955|FG000|COMPLETED|Selection|number of subjects who had a Day 1 visit|53
8658062|NCT00684073|9700955|FG000|NOT COMPLETED|Selection||7
8658063|NCT00684073|9700955|FG000|STARTED|Treatment (Days 1 Through 5)|number of subjects who had a Day 1 visit|53
8658064|NCT00684073|9700955|FG000|COMPLETED|Treatment (Days 1 Through 5)|number of subjects who had a Day 5 visit (and therefore completed study)|52
8658065|NCT00684073|9700955|FG000|NOT COMPLETED|Treatment (Days 1 Through 5)||1
8658066|NCT00684138|9700965|FG000|STARTED|Overall Study||141
8658067|NCT00684138|9700966|FG001|STARTED|Overall Study||139
8658068|NCT00684138|9700965|FG000|COMPLETED|Overall Study||138
8658069|NCT00684138|9700966|FG001|COMPLETED|Overall Study||131
8658070|NCT00684138|9700965|FG000|NOT COMPLETED|Overall Study||3
8658071|NCT00684138|9700966|FG001|NOT COMPLETED|Overall Study||8
8658072|NCT00684177|9700976|FG000|STARTED|Overall Study||343
8658073|NCT00684177|9700977|FG001|STARTED|Overall Study||164
8658074|NCT00684177|9700976|FG000|COMPLETED|Overall Study||322
8658075|NCT00684177|9700977|FG001|COMPLETED|Overall Study||141
8658076|NCT00684177|9700976|FG000|NOT COMPLETED|Overall Study||21
8658077|NCT00684177|9700977|FG001|NOT COMPLETED|Overall Study||23
8658078|NCT00684203|9700989|FG000|STARTED|Overall Study||40
8658079|NCT00684203|9700990|FG001|STARTED|Overall Study||31
8658080|NCT00684203|9700991|FG002|STARTED|Overall Study||21
8658081|NCT00684203|9700992|FG003|STARTED|Overall Study||6
8658082|NCT00684203|9700993|FG004|STARTED|Overall Study||17
8658083|NCT00684203|9700994|FG005|STARTED|Overall Study||2
8658084|NCT00684203|9700989|FG000|COMPLETED|Overall Study||31
8658085|NCT00684203|9700990|FG001|COMPLETED|Overall Study||23
8658086|NCT00684203|9700991|FG002|COMPLETED|Overall Study||12
8658087|NCT00684203|9700992|FG003|COMPLETED|Overall Study||6
8658088|NCT00684203|9700993|FG004|COMPLETED|Overall Study||17
8658089|NCT00684203|9700994|FG005|COMPLETED|Overall Study||2
8658090|NCT00684203|9700989|FG000|NOT COMPLETED|Overall Study||9
8658091|NCT00684203|9700990|FG001|NOT COMPLETED|Overall Study||8
8658092|NCT00684203|9700991|FG002|NOT COMPLETED|Overall Study||9
8658093|NCT00684203|9700992|FG003|NOT COMPLETED|Overall Study||0
8658094|NCT00684203|9700993|FG004|NOT COMPLETED|Overall Study||0
8658095|NCT00684203|9700994|FG005|NOT COMPLETED|Overall Study||0
8658096|NCT00684242|9701015|FG000|STARTED|Overall Study||3
8658097|NCT00684242|9701015|FG000|COMPLETED|Overall Study||3
8658098|NCT00684242|9701015|FG000|NOT COMPLETED|Overall Study||0
8658099|NCT00684307|9701024|FG000|STARTED|Overall Study|Patients who received treatment|164
8658100|NCT00684307|9701025|FG001|STARTED|Overall Study||151
8658101|NCT00684307|9701026|FG002|STARTED|Overall Study||156
8658102|NCT00684307|9701027|FG003|STARTED|Overall Study||160
8729261|NCT01052428|9776384|FG000|STARTED|Overall Study||19
8729262|NCT01052428|9776385|FG001|STARTED|Overall Study||19
8729263|NCT01052428|9776384|FG000|COMPLETED|Overall Study||18
8729264|NCT01052428|9776385|FG001|COMPLETED|Overall Study||18
8729265|NCT01052428|9776384|FG000|NOT COMPLETED|Overall Study||1
8729266|NCT01052428|9776385|FG001|NOT COMPLETED|Overall Study||1
8729267|NCT01052480|9776393|FG000|STARTED|Overall Study||49
8729268|NCT01052480|9776394|FG001|STARTED|Overall Study||49
8729269|NCT01052480|9776393|FG000|COMPLETED|Overall Study||41
8729270|NCT01052480|9776394|FG001|COMPLETED|Overall Study||32
8729271|NCT01052480|9776393|FG000|NOT COMPLETED|Overall Study||8
8729272|NCT01052480|9776394|FG001|NOT COMPLETED|Overall Study||17
8729273|NCT01052493|9776400|FG000|STARTED|Intervention 1 (Up to 10 Days)||4
8729274|NCT01052493|9776401|FG001|STARTED|Intervention 1 (Up to 10 Days)||4
8729275|NCT01052493|9776402|FG002|STARTED|Intervention 1 (Up to 10 Days)||4
8729276|NCT01052493|9776400|FG000|COMPLETED|Intervention 1 (Up to 10 Days)||3
8729277|NCT01052493|9776401|FG001|COMPLETED|Intervention 1 (Up to 10 Days)||4
8729278|NCT01052493|9776402|FG002|COMPLETED|Intervention 1 (Up to 10 Days)||4
8658103|NCT00684307|9701028|FG004|STARTED|Overall Study||318
8658104|NCT00684307|9701024|FG000|On Treatment Period Started|Overall Study||164
8658105|NCT00684307|9701025|FG001|On Treatment Period Started|Overall Study||151
8658106|NCT00684307|9701026|FG002|On Treatment Period Started|Overall Study||156
8658107|NCT00684307|9701027|FG003|On Treatment Period Started|Overall Study||160
8658108|NCT00684307|9701028|FG004|On Treatment Period Started|Overall Study||318
8658109|NCT00684307|9701024|FG000|On Treatment Period Completed|Overall Study|Patients who completed treatment|140
8658110|NCT00684307|9701025|FG001|On Treatment Period Completed|Overall Study||129
8658111|NCT00684307|9701026|FG002|On Treatment Period Completed|Overall Study||128
8658112|NCT00684307|9701027|FG003|On Treatment Period Completed|Overall Study||128
8658113|NCT00684307|9701028|FG004|On Treatment Period Completed|Overall Study||293
8658114|NCT00684307|9701024|FG000|COMPLETED|Overall Study||140
8658115|NCT00684307|9701025|FG001|COMPLETED|Overall Study||129
8658116|NCT00684307|9701026|FG002|COMPLETED|Overall Study||128
8658117|NCT00684307|9701027|FG003|COMPLETED|Overall Study||128
8658118|NCT00684307|9701028|FG004|COMPLETED|Overall Study||293
8658119|NCT00684307|9701024|FG000|NOT COMPLETED|Overall Study||24
8658120|NCT00684307|9701025|FG001|NOT COMPLETED|Overall Study||22
8658121|NCT00684307|9701026|FG002|NOT COMPLETED|Overall Study||28
8658122|NCT00684307|9701027|FG003|NOT COMPLETED|Overall Study||32
8658123|NCT00684307|9701028|FG004|NOT COMPLETED|Overall Study||25
8658124|NCT00684320|9701042|FG000|STARTED|Overall Study||26
8658125|NCT00684320|9701043|FG001|STARTED|Overall Study||22
8658126|NCT00684320|9701042|FG000|COMPLETED|Overall Study||22
8658127|NCT00684320|9701043|FG001|COMPLETED|Overall Study||22
8658128|NCT00684320|9701042|FG000|NOT COMPLETED|Overall Study||4
8658129|NCT00684320|9701043|FG001|NOT COMPLETED|Overall Study||0
8658130|NCT00684411|9701049|FG000|STARTED|Overall Study||12
8658131|NCT00684411|9701049|FG000|Disease Evaluable|Overall Study||11
8658132|NCT00684411|9701049|FG000|COMPLETED|Overall Study||0
8658133|NCT00684411|9701049|FG000|NOT COMPLETED|Overall Study||12
8658134|NCT00684424|9701053|FG000|STARTED|Overall Study||199
8658135|NCT00684424|9701053|FG000|COMPLETED|Overall Study||194
8729279|NCT01052493|9776400|FG000|NOT COMPLETED|Intervention 1 (Up to 10 Days)||1
8729280|NCT01052493|9776401|FG001|NOT COMPLETED|Intervention 1 (Up to 10 Days)||0
8729281|NCT01052493|9776402|FG002|NOT COMPLETED|Intervention 1 (Up to 10 Days)||0
8729282|NCT01052493|9776400|FG000|STARTED|Washout Period 1 (up to 5 Days)||3
8729283|NCT01052493|9776401|FG001|STARTED|Washout Period 1 (up to 5 Days)||4
8729284|NCT01052493|9776402|FG002|STARTED|Washout Period 1 (up to 5 Days)||4
8729285|NCT01052493|9776400|FG000|COMPLETED|Washout Period 1 (up to 5 Days)||3
8729286|NCT01052493|9776401|FG001|COMPLETED|Washout Period 1 (up to 5 Days)||4
8729287|NCT01052493|9776402|FG002|COMPLETED|Washout Period 1 (up to 5 Days)||4
8729288|NCT01052493|9776400|FG000|NOT COMPLETED|Washout Period 1 (up to 5 Days)||0
8729289|NCT01052493|9776401|FG001|NOT COMPLETED|Washout Period 1 (up to 5 Days)||0
8729290|NCT01052493|9776402|FG002|NOT COMPLETED|Washout Period 1 (up to 5 Days)||0
8658136|NCT00684424|9701053|FG000|NOT COMPLETED|Overall Study||5
8658137|NCT00684515|9701061|FG000|STARTED|Overall Study||33
8658138|NCT00684515|9701062|FG001|STARTED|Overall Study||29
8658139|NCT00684515|9701063|FG002|STARTED|Overall Study||28
8658140|NCT00684515|9701061|FG000|COMPLETED|Overall Study||29
8658141|NCT00684515|9701062|FG001|COMPLETED|Overall Study||26
8658142|NCT00684515|9701063|FG002|COMPLETED|Overall Study||27
8658143|NCT00684515|9701061|FG000|NOT COMPLETED|Overall Study||4
8658144|NCT00684515|9701062|FG001|NOT COMPLETED|Overall Study||3
8658145|NCT00684515|9701063|FG002|NOT COMPLETED|Overall Study||1
8729291|NCT01052493|9776400|FG000|STARTED|Intervention 2 (up to 10 Days)|Replacement subject recruited|4
8658146|NCT00684541|9701073|FG000|STARTED|Overall Study||23
8658147|NCT00684541|9701074|FG001|STARTED|Overall Study||26
8658148|NCT00684541|9701073|FG000|COMPLETED|Overall Study||20
8658149|NCT00684541|9701074|FG001|COMPLETED|Overall Study||23
8658150|NCT00684541|9701073|FG000|NOT COMPLETED|Overall Study||3
8658151|NCT00684541|9701074|FG001|NOT COMPLETED|Overall Study||3
8658152|NCT00684554|9701083|FG000|STARTED|Overall Study||10
8658153|NCT00684554|9701084|FG001|STARTED|Overall Study||10
8658154|NCT00684554|9701083|FG000|COMPLETED|Overall Study||10
8658155|NCT00684554|9701084|FG001|COMPLETED|Overall Study||10
8658156|NCT00684554|9701083|FG000|NOT COMPLETED|Overall Study||0
8658157|NCT00684554|9701084|FG001|NOT COMPLETED|Overall Study||0
8658158|NCT00684567|9701090|FG000|STARTED|Concomitant Radiotherapy Period||30
8658159|NCT00684567|9701090|FG000|COMPLETED|Concomitant Radiotherapy Period||28
8658160|NCT00684567|9701090|FG000|NOT COMPLETED|Concomitant Radiotherapy Period||2
8658161|NCT00684567|9701090|FG000|STARTED|Monotherapy Period|5 subjects completed radiotherapy combined therapy phase but did not proceed to monotherapy phase.|23
8658162|NCT00684567|9701090|FG000|COMPLETED|Monotherapy Period||9
8658163|NCT00684567|9701090|FG000|NOT COMPLETED|Monotherapy Period||14
8658164|NCT00684593|9701096|FG000|STARTED|Overall Study||21
8658165|NCT00684593|9701097|FG001|STARTED|Overall Study||10
8658166|NCT00684593|9701096|FG000|COMPLETED|Overall Study||21
8658167|NCT00684593|9701097|FG001|COMPLETED|Overall Study||8
8658168|NCT00684593|9701096|FG000|NOT COMPLETED|Overall Study||0
8658169|NCT00684593|9701097|FG001|NOT COMPLETED|Overall Study||2
8658170|NCT00684645|9701103|FG000|STARTED|Overall Study||186
8658171|NCT00684645|9701103|FG000|COMPLETED|Overall Study||72
8658172|NCT00684645|9701103|FG000|NOT COMPLETED|Overall Study||114
8658173|NCT00684671|9701110|FG000|STARTED|Overall Study||172
8658174|NCT00684671|9701111|FG001|STARTED|Overall Study||170
8658175|NCT00684671|9701112|FG002|STARTED|Overall Study||164
8658176|NCT00684671|9701110|FG000|COMPLETED|Overall Study||169
8658177|NCT00684671|9701111|FG001|COMPLETED|Overall Study||170
8658178|NCT00684671|9701112|FG002|COMPLETED|Overall Study||164
8658179|NCT00684671|9701110|FG000|NOT COMPLETED|Overall Study||3
8658180|NCT00684671|9701111|FG001|NOT COMPLETED|Overall Study||0
8658181|NCT00684671|9701112|FG002|NOT COMPLETED|Overall Study||0
8658182|NCT00684723|9701120|FG000|STARTED|First Intervention||27
8658183|NCT00684723|9701121|FG001|STARTED|First Intervention||27
8658184|NCT00684723|9701120|FG000|COMPLETED|First Intervention||27
8658185|NCT00684723|9701121|FG001|COMPLETED|First Intervention||27
8658186|NCT00684723|9701120|FG000|NOT COMPLETED|First Intervention||0
8658187|NCT00684723|9701121|FG001|NOT COMPLETED|First Intervention||0
8658188|NCT00684723|9701120|FG000|STARTED|Washout Period of 7 Days||27
8658189|NCT00684723|9701121|FG001|STARTED|Washout Period of 7 Days||27
8658190|NCT00684723|9701120|FG000|COMPLETED|Washout Period of 7 Days||27
8658191|NCT00684723|9701121|FG001|COMPLETED|Washout Period of 7 Days||27
8658192|NCT00684723|9701120|FG000|NOT COMPLETED|Washout Period of 7 Days||0
8658193|NCT00684723|9701121|FG001|NOT COMPLETED|Washout Period of 7 Days||0
8658194|NCT00684723|9701120|FG000|STARTED|Second Intervention||27
8658195|NCT00684723|9701121|FG001|STARTED|Second Intervention||27
8658196|NCT00684723|9701120|FG000|COMPLETED|Second Intervention||27
8658197|NCT00684723|9701121|FG001|COMPLETED|Second Intervention||27
8658198|NCT00684723|9701120|FG000|NOT COMPLETED|Second Intervention||0
8658199|NCT00684723|9701121|FG001|NOT COMPLETED|Second Intervention||0
8658200|NCT00684749|9701127|FG000|STARTED|Overall Study||142
8658201|NCT00684749|9701127|FG000|COMPLETED|Overall Study||142
8658202|NCT00684749|9701127|FG000|NOT COMPLETED|Overall Study||0
8658203|NCT00684762|9701131|FG000|STARTED|First Intervention||16
8658204|NCT00684762|9701132|FG001|STARTED|First Intervention||16
8658205|NCT00684762|9701131|FG000|COMPLETED|First Intervention||16
8658206|NCT00684762|9701132|FG001|COMPLETED|First Intervention||16
8658207|NCT00684762|9701131|FG000|NOT COMPLETED|First Intervention||0
8658208|NCT00684762|9701132|FG001|NOT COMPLETED|First Intervention||0
8658209|NCT00684762|9701131|FG000|STARTED|Washout Period of 7 Days||16
8658210|NCT00684762|9701132|FG001|STARTED|Washout Period of 7 Days||16
8658211|NCT00684762|9701131|FG000|COMPLETED|Washout Period of 7 Days||14
8658212|NCT00684762|9701132|FG001|COMPLETED|Washout Period of 7 Days||14
8658213|NCT00684762|9701131|FG000|NOT COMPLETED|Washout Period of 7 Days||2
8658214|NCT00684762|9701132|FG001|NOT COMPLETED|Washout Period of 7 Days||2
8658215|NCT00684762|9701131|FG000|STARTED|Second Intervention||14
8658216|NCT00684762|9701132|FG001|STARTED|Second Intervention||14
8658217|NCT00684762|9701131|FG000|COMPLETED|Second Intervention||14
8658218|NCT00684762|9701132|FG001|COMPLETED|Second Intervention||14
8658219|NCT00684762|9701131|FG000|NOT COMPLETED|Second Intervention||0
8658220|NCT00684762|9701132|FG001|NOT COMPLETED|Second Intervention||0
8658221|NCT00684775|9701140|FG000|STARTED|Overall Study||19
8658222|NCT00684775|9701141|FG001|STARTED|Overall Study||19
8658223|NCT00684775|9701140|FG000|COMPLETED|Overall Study||19
8658224|NCT00684775|9701141|FG001|COMPLETED|Overall Study||19
8658225|NCT00684775|9701140|FG000|NOT COMPLETED|Overall Study||0
8658226|NCT00684775|9701141|FG001|NOT COMPLETED|Overall Study||0
8658227|NCT00684788|9701157|FG000|STARTED|Overall Study||17
8658228|NCT00684788|9701158|FG001|STARTED|Overall Study||18
8658229|NCT00684788|9701157|FG000|COMPLETED|Overall Study||17
8658230|NCT00684788|9701158|FG001|COMPLETED|Overall Study||18
8658231|NCT00684788|9701157|FG000|NOT COMPLETED|Overall Study||0
8658232|NCT00684788|9701158|FG001|NOT COMPLETED|Overall Study||0
8658233|NCT00684814|9701170|FG000|STARTED|First Intervention||19
8658234|NCT00684814|9701171|FG001|STARTED|First Intervention||19
8658235|NCT00684814|9701170|FG000|COMPLETED|First Intervention||19
8658236|NCT00684814|9701171|FG001|COMPLETED|First Intervention||19
8658237|NCT00684814|9701170|FG000|NOT COMPLETED|First Intervention||0
8658238|NCT00684814|9701171|FG001|NOT COMPLETED|First Intervention||0
8658239|NCT00684814|9701170|FG000|STARTED|Washout Period of 7 Days||19
8658240|NCT00684814|9701171|FG001|STARTED|Washout Period of 7 Days||19
8658241|NCT00684814|9701170|FG000|COMPLETED|Washout Period of 7 Days||17
8658242|NCT00684814|9701171|FG001|COMPLETED|Washout Period of 7 Days||15
8658243|NCT00684814|9701170|FG000|NOT COMPLETED|Washout Period of 7 Days||2
8658244|NCT00684814|9701171|FG001|NOT COMPLETED|Washout Period of 7 Days||4
9022349|NCT03125915|10085231|FG003|STARTED|6 Month Follow-up||34
9022350|NCT03125915|10085228|FG000|COMPLETED|6 Month Follow-up||25
9022351|NCT03125915|10085229|FG001|COMPLETED|6 Month Follow-up||37
9022352|NCT03125915|10085230|FG002|COMPLETED|6 Month Follow-up||28
9022353|NCT03125915|10085231|FG003|COMPLETED|6 Month Follow-up||31
8658245|NCT00684814|9701170|FG000|STARTED|Second Intervention||17
8658246|NCT00684814|9701171|FG001|STARTED|Second Intervention||15
8658247|NCT00684814|9701170|FG000|COMPLETED|Second Intervention||16
8658248|NCT00684814|9701171|FG001|COMPLETED|Second Intervention||15
8729292|NCT01052493|9776401|FG001|STARTED|Intervention 2 (up to 10 Days)||4
8729293|NCT01052493|9776402|FG002|STARTED|Intervention 2 (up to 10 Days)||4
8729294|NCT01052493|9776400|FG000|COMPLETED|Intervention 2 (up to 10 Days)||4
8729295|NCT01052493|9776401|FG001|COMPLETED|Intervention 2 (up to 10 Days)||4
8729296|NCT01052493|9776402|FG002|COMPLETED|Intervention 2 (up to 10 Days)||4
8658249|NCT00684814|9701170|FG000|NOT COMPLETED|Second Intervention||1
8658250|NCT00684814|9701171|FG001|NOT COMPLETED|Second Intervention||0
8658251|NCT00684983|9701179|FG000|STARTED|Overall Study||19
8658252|NCT00684983|9701180|FG001|STARTED|Overall Study||45
8658253|NCT00684983|9701179|FG000|COMPLETED|Overall Study||19
8658254|NCT00684983|9701180|FG001|COMPLETED|Overall Study|One major violation patient in Arm B is included in the primary analysis per protocol.|45
8658255|NCT00684983|9701179|FG000|NOT COMPLETED|Overall Study||0
8658256|NCT00684983|9701180|FG001|NOT COMPLETED|Overall Study||0
8658257|NCT00684996|9701188|FG000|STARTED|Overall Study||5
8658258|NCT00684996|9701188|FG000|Eligible|Overall Study||5
8658259|NCT00684996|9701188|FG000|COMPLETED|Overall Study||0
8658260|NCT00684996|9701188|FG000|NOT COMPLETED|Overall Study||5
8658261|NCT00685035|9701195|FG000|STARTED|Period 1: First Intervention: 30 Minutes||9
8658262|NCT00685035|9701196|FG001|STARTED|Period 1: First Intervention: 30 Minutes||8
8658263|NCT00685035|9701195|FG000|COMPLETED|Period 1: First Intervention: 30 Minutes||8
8658264|NCT00685035|9701196|FG001|COMPLETED|Period 1: First Intervention: 30 Minutes||8
8658265|NCT00685035|9701195|FG000|NOT COMPLETED|Period 1: First Intervention: 30 Minutes||1
8658266|NCT00685035|9701196|FG001|NOT COMPLETED|Period 1: First Intervention: 30 Minutes||0
8658267|NCT00685035|9701195|FG000|STARTED|Period 2: 2-day Washout||8
8658268|NCT00685035|9701196|FG001|STARTED|Period 2: 2-day Washout||8
8658269|NCT00685035|9701195|FG000|COMPLETED|Period 2: 2-day Washout||8
8658270|NCT00685035|9701196|FG001|COMPLETED|Period 2: 2-day Washout||8
8658271|NCT00685035|9701195|FG000|NOT COMPLETED|Period 2: 2-day Washout||0
8658272|NCT00685035|9701196|FG001|NOT COMPLETED|Period 2: 2-day Washout||0
8658273|NCT00685035|9701195|FG000|STARTED|Period 3: 2nd Intervention||8
8658274|NCT00685035|9701196|FG001|STARTED|Period 3: 2nd Intervention||8
8658275|NCT00685035|9701195|FG000|COMPLETED|Period 3: 2nd Intervention||8
8658276|NCT00685035|9701196|FG001|COMPLETED|Period 3: 2nd Intervention||8
8658277|NCT00685035|9701195|FG000|NOT COMPLETED|Period 3: 2nd Intervention||0
8658278|NCT00685035|9701196|FG001|NOT COMPLETED|Period 3: 2nd Intervention||0
8658279|NCT00685139|9701220|FG000|STARTED|First Intervention||17
8658280|NCT00685139|9701221|FG001|STARTED|First Intervention||17
8658281|NCT00685139|9701220|FG000|COMPLETED|First Intervention||17
8658282|NCT00685139|9701221|FG001|COMPLETED|First Intervention||17
8658283|NCT00685139|9701220|FG000|NOT COMPLETED|First Intervention||0
8658284|NCT00685139|9701221|FG001|NOT COMPLETED|First Intervention||0
8658285|NCT00685139|9701220|FG000|STARTED|Washout Period of 28 Days||17
8658286|NCT00685139|9701221|FG001|STARTED|Washout Period of 28 Days||17
8658287|NCT00685139|9701220|FG000|COMPLETED|Washout Period of 28 Days||17
8658288|NCT00685139|9701221|FG001|COMPLETED|Washout Period of 28 Days||17
8658289|NCT00685139|9701220|FG000|NOT COMPLETED|Washout Period of 28 Days||0
8658290|NCT00685139|9701221|FG001|NOT COMPLETED|Washout Period of 28 Days||0
8658291|NCT00685139|9701220|FG000|STARTED|Second Intervention||17
8658292|NCT00685139|9701221|FG001|STARTED|Second Intervention||17
8658293|NCT00685139|9701220|FG000|COMPLETED|Second Intervention||17
8658294|NCT00685139|9701221|FG001|COMPLETED|Second Intervention||17
8658295|NCT00685139|9701220|FG000|NOT COMPLETED|Second Intervention||0
8658296|NCT00685139|9701221|FG001|NOT COMPLETED|Second Intervention||0
8658297|NCT00685165|9701227|FG000|STARTED|First Intervention||11
8658298|NCT00685165|9701228|FG001|STARTED|First Intervention||11
8658299|NCT00685165|9701227|FG000|COMPLETED|First Intervention||11
8658300|NCT00685165|9701228|FG001|COMPLETED|First Intervention||11
8658301|NCT00685165|9701227|FG000|NOT COMPLETED|First Intervention||0
9022354|NCT03125915|10085228|FG000|NOT COMPLETED|6 Month Follow-up||7
9022355|NCT03125915|10085229|FG001|NOT COMPLETED|6 Month Follow-up||3
8658302|NCT00685165|9701228|FG001|NOT COMPLETED|First Intervention||0
8658303|NCT00685165|9701227|FG000|STARTED|Washout Period of 14 Days||11
8658304|NCT00685165|9701228|FG001|STARTED|Washout Period of 14 Days||11
8658305|NCT00685165|9701227|FG000|COMPLETED|Washout Period of 14 Days|adverse event- possible upper respiratory infection|10
8658306|NCT00685165|9701228|FG001|COMPLETED|Washout Period of 14 Days||11
8658307|NCT00685165|9701227|FG000|NOT COMPLETED|Washout Period of 14 Days||1
8658308|NCT00685165|9701228|FG001|NOT COMPLETED|Washout Period of 14 Days||0
8658309|NCT00685165|9701227|FG000|STARTED|Second Intervention||10
8658310|NCT00685165|9701228|FG001|STARTED|Second Intervention||11
8658311|NCT00685165|9701227|FG000|COMPLETED|Second Intervention||10
8658312|NCT00685165|9701228|FG001|COMPLETED|Second Intervention||11
8658313|NCT00685165|9701227|FG000|NOT COMPLETED|Second Intervention||0
8658314|NCT00685165|9701228|FG001|NOT COMPLETED|Second Intervention||0
8658315|NCT00685178|9701238|FG000|STARTED|Overall Study||40
8658316|NCT00685178|9701239|FG001|STARTED|Overall Study||45
8658317|NCT00685178|9701240|FG002|STARTED|Overall Study||39
8658318|NCT00685178|9701241|FG003|STARTED|Overall Study||47
8658319|NCT00685178|9701238|FG000|COMPLETED|Overall Study||27
8658320|NCT00685178|9701239|FG001|COMPLETED|Overall Study||26
8658321|NCT00685178|9701240|FG002|COMPLETED|Overall Study||27
8658322|NCT00685178|9701241|FG003|COMPLETED|Overall Study||33
8658323|NCT00685178|9701238|FG000|NOT COMPLETED|Overall Study||13
8658324|NCT00685178|9701239|FG001|NOT COMPLETED|Overall Study||19
8658325|NCT00685178|9701240|FG002|NOT COMPLETED|Overall Study||12
8658326|NCT00685178|9701241|FG003|NOT COMPLETED|Overall Study||14
8692162|NCT00858637|9737560|FG003|COMPLETED|Placebo-controlled Withdrawal Phase||0
8692163|NCT00858637|9737561|FG004|COMPLETED|Placebo-controlled Withdrawal Phase||55
8692164|NCT00858637|9737562|FG005|COMPLETED|Placebo-controlled Withdrawal Phase||58
8692165|NCT00858637|9737557|FG000|NOT COMPLETED|Placebo-controlled Withdrawal Phase||0
8692166|NCT00858637|9737558|FG001|NOT COMPLETED|Placebo-controlled Withdrawal Phase||0
8692167|NCT00858637|9737559|FG002|NOT COMPLETED|Placebo-controlled Withdrawal Phase||1
8692168|NCT00858637|9737560|FG003|NOT COMPLETED|Placebo-controlled Withdrawal Phase||0
8692169|NCT00858637|9737561|FG004|NOT COMPLETED|Placebo-controlled Withdrawal Phase||1
8692170|NCT00858637|9737562|FG005|NOT COMPLETED|Placebo-controlled Withdrawal Phase||1
8692171|NCT00858689|9737572|FG000|STARTED|Overall Study||20
8692172|NCT00858689|9737572|FG000|COMPLETED|Overall Study||19
8692173|NCT00858689|9737572|FG000|NOT COMPLETED|Overall Study||1
8692174|NCT00858780|9737576|FG000|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||91
8692175|NCT00858780|9737577|FG001|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
8692176|NCT00858780|9737578|FG002|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
8692177|NCT00858780|9737579|FG003|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
8692178|NCT00858780|9737580|FG004|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
8692179|NCT00858780|9737576|FG000|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||73
8692180|NCT00858780|9737577|FG001|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
8692181|NCT00858780|9737578|FG002|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
8692182|NCT00858780|9737579|FG003|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
8692183|NCT00858780|9737580|FG004|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
8692184|NCT00858780|9737576|FG000|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||18
8692185|NCT00858780|9737577|FG001|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
8692186|NCT00858780|9737578|FG002|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
8692187|NCT00858780|9737579|FG003|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
8692188|NCT00858780|9737580|FG004|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
8692189|NCT00858780|9737576|FG000|STARTED|Double-Blind (Week 0 to Failure/Week 48)||0
8692190|NCT00858780|9737577|FG001|STARTED|Double-Blind (Week 0 to Failure/Week 48)||23
8692191|NCT00858780|9737578|FG002|STARTED|Double-Blind (Week 0 to Failure/Week 48)||27
8692192|NCT00858780|9737579|FG003|STARTED|Double-Blind (Week 0 to Failure/Week 48)||23
8692193|NCT00858780|9737580|FG004|STARTED|Double-Blind (Week 0 to Failure/Week 48)||0
8692194|NCT00858780|9737576|FG000|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
8692195|NCT00858780|9737577|FG001|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||21
8692196|NCT00858780|9737578|FG002|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||25
8692197|NCT00858780|9737579|FG003|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||22
8692198|NCT00858780|9737580|FG004|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
8692199|NCT00858780|9737576|FG000|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
8692200|NCT00858780|9737577|FG001|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||2
8692201|NCT00858780|9737578|FG002|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||2
8692202|NCT00858780|9737579|FG003|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||1
8692203|NCT00858780|9737580|FG004|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
8692204|NCT00858780|9737576|FG000|STARTED|OL Re-Treatment (Failure to Week 48)||0
8692205|NCT00858780|9737577|FG001|STARTED|OL Re-Treatment (Failure to Week 48)||0
8692206|NCT00858780|9737578|FG002|STARTED|OL Re-Treatment (Failure to Week 48)||0
8692207|NCT00858780|9737579|FG003|STARTED|OL Re-Treatment (Failure to Week 48)||0
8692208|NCT00858780|9737580|FG004|STARTED|OL Re-Treatment (Failure to Week 48)|43 participants showed treatment failure in Period 2 and entered in Period 3.|43
8692209|NCT00858780|9737576|FG000|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
8692210|NCT00858780|9737577|FG001|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
8692211|NCT00858780|9737578|FG002|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
8692212|NCT00858780|9737579|FG003|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
8692213|NCT00858780|9737580|FG004|COMPLETED|OL Re-Treatment (Failure to Week 48)||41
8692214|NCT00858780|9737576|FG000|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
8658327|NCT00685295|9701253|FG000|STARTED|Overall Study||30
8658328|NCT00685295|9701254|FG001|STARTED|Overall Study||30
8658329|NCT00685295|9701253|FG000|COMPLETED|Overall Study||30
8729297|NCT01052493|9776400|FG000|NOT COMPLETED|Intervention 2 (up to 10 Days)||0
8729298|NCT01052493|9776401|FG001|NOT COMPLETED|Intervention 2 (up to 10 Days)||0
8729299|NCT01052493|9776402|FG002|NOT COMPLETED|Intervention 2 (up to 10 Days)||0
8729300|NCT01052493|9776400|FG000|STARTED|Washout Period 2 (up to 5 Days)||4
8729301|NCT01052493|9776401|FG001|STARTED|Washout Period 2 (up to 5 Days)||4
8729302|NCT01052493|9776402|FG002|STARTED|Washout Period 2 (up to 5 Days)||4
8658330|NCT00685295|9701254|FG001|COMPLETED|Overall Study||30
8658331|NCT00685295|9701253|FG000|NOT COMPLETED|Overall Study||0
8658332|NCT00685295|9701254|FG001|NOT COMPLETED|Overall Study||0
8658333|NCT00685334|9701264|FG000|STARTED|Overall Study||12
8658334|NCT00685334|9701265|FG001|STARTED|Overall Study||10
8658335|NCT00685334|9701264|FG000|COMPLETED|Overall Study||2
8658336|NCT00685334|9701265|FG001|COMPLETED|Overall Study||3
8658337|NCT00685334|9701264|FG000|NOT COMPLETED|Overall Study||10
8658338|NCT00685334|9701265|FG001|NOT COMPLETED|Overall Study||7
8658339|NCT00685373|9701271|FG000|STARTED|Overall Study||166
8658340|NCT00685373|9701271|FG000|COMPLETED|Overall Study||151
8658341|NCT00685373|9701271|FG000|NOT COMPLETED|Overall Study||15
8658342|NCT00685399|9701282|FG000|STARTED|Treatment Period 1||16
8658343|NCT00685399|9701283|FG001|STARTED|Treatment Period 1||0
8658344|NCT00685399|9701284|FG002|STARTED|Treatment Period 1||0
8658345|NCT00685399|9701285|FG003|STARTED|Treatment Period 1||0
8658346|NCT00685399|9701286|FG004|STARTED|Treatment Period 1||0
8658347|NCT00685399|9701287|FG005|STARTED|Treatment Period 1||0
8658348|NCT00685399|9701288|FG006|STARTED|Treatment Period 1||0
8658349|NCT00685399|9701289|FG007|STARTED|Treatment Period 1||0
8658350|NCT00685399|9701282|FG000|COMPLETED|Treatment Period 1||10
8658351|NCT00685399|9701283|FG001|COMPLETED|Treatment Period 1||0
8658352|NCT00685399|9701284|FG002|COMPLETED|Treatment Period 1||0
8658353|NCT00685399|9701285|FG003|COMPLETED|Treatment Period 1||0
8658354|NCT00685399|9701286|FG004|COMPLETED|Treatment Period 1||0
8658355|NCT00685399|9701287|FG005|COMPLETED|Treatment Period 1||0
8658356|NCT00685399|9701288|FG006|COMPLETED|Treatment Period 1||0
8658357|NCT00685399|9701289|FG007|COMPLETED|Treatment Period 1||0
8658358|NCT00685399|9701282|FG000|NOT COMPLETED|Treatment Period 1||6
8658359|NCT00685399|9701283|FG001|NOT COMPLETED|Treatment Period 1||0
8658360|NCT00685399|9701284|FG002|NOT COMPLETED|Treatment Period 1||0
8658361|NCT00685399|9701285|FG003|NOT COMPLETED|Treatment Period 1||0
8658362|NCT00685399|9701286|FG004|NOT COMPLETED|Treatment Period 1||0
8658363|NCT00685399|9701287|FG005|NOT COMPLETED|Treatment Period 1||0
8729303|NCT01052493|9776400|FG000|COMPLETED|Washout Period 2 (up to 5 Days)||4
8729304|NCT01052493|9776401|FG001|COMPLETED|Washout Period 2 (up to 5 Days)||4
8729305|NCT01052493|9776402|FG002|COMPLETED|Washout Period 2 (up to 5 Days)||4
8729306|NCT01052493|9776400|FG000|NOT COMPLETED|Washout Period 2 (up to 5 Days)||0
8729307|NCT01052493|9776401|FG001|NOT COMPLETED|Washout Period 2 (up to 5 Days)||0
8729308|NCT01052493|9776402|FG002|NOT COMPLETED|Washout Period 2 (up to 5 Days)||0
8729309|NCT01052493|9776400|FG000|STARTED|Intervention 3 (up to 10 Days)||4
8729310|NCT01052493|9776401|FG001|STARTED|Intervention 3 (up to 10 Days)||4
8729311|NCT01052493|9776402|FG002|STARTED|Intervention 3 (up to 10 Days)||4
8729312|NCT01052493|9776400|FG000|COMPLETED|Intervention 3 (up to 10 Days)||4
8729313|NCT01052493|9776401|FG001|COMPLETED|Intervention 3 (up to 10 Days)||4
8729314|NCT01052493|9776402|FG002|COMPLETED|Intervention 3 (up to 10 Days)||4
8729315|NCT01052493|9776400|FG000|NOT COMPLETED|Intervention 3 (up to 10 Days)||0
8729316|NCT01052493|9776401|FG001|NOT COMPLETED|Intervention 3 (up to 10 Days)||0
8729317|NCT01052493|9776402|FG002|NOT COMPLETED|Intervention 3 (up to 10 Days)||0
8729318|NCT01052545|9776417|FG000|STARTED|Overall Study||867
8729319|NCT01052545|9776418|FG001|STARTED|Overall Study||731
8729320|NCT01052545|9776417|FG000|COMPLETED|Overall Study||867
8729321|NCT01052545|9776418|FG001|COMPLETED|Overall Study||731
8729322|NCT01052545|9776417|FG000|NOT COMPLETED|Overall Study||0
8729323|NCT01052545|9776418|FG001|NOT COMPLETED|Overall Study||0
8729324|NCT01052662|9776439|FG000|STARTED|Overall Study|1 subject excluded from Intent-to-treat sample for final analysis due to pharmacy issue.|28
8729325|NCT01052662|9776440|FG001|STARTED|Overall Study|3 subjects excluded from Intent-to-treat sample for final analysis due to pharmacy issue|27
8729326|NCT01052662|9776441|FG002|STARTED|Overall Study|3 subjects excluded from Intent-to-treat sample for final analysis due to pharmacy issue|32
8729327|NCT01052662|9776439|FG000|Stabilization Phase|Overall Study||21
8729328|NCT01052662|9776440|FG001|Stabilization Phase|Overall Study||21
8729329|NCT01052662|9776441|FG002|Stabilization Phase|Overall Study||26
8729330|NCT01052662|9776439|FG000|Discontinuation Phase|Overall Study||6
8729331|NCT01052662|9776440|FG001|Discontinuation Phase|Overall Study||5
8729332|NCT01052662|9776441|FG002|Discontinuation Phase|Overall Study||10
8658364|NCT00685399|9701288|FG006|NOT COMPLETED|Treatment Period 1||0
8658365|NCT00685399|9701289|FG007|NOT COMPLETED|Treatment Period 1||0
8658366|NCT00685399|9701282|FG000|STARTED|Treatment Period 2||0
8658367|NCT00685399|9701283|FG001|STARTED|Treatment Period 2||14
8658368|NCT00685399|9701284|FG002|STARTED|Treatment Period 2||5
8658369|NCT00685399|9701285|FG003|STARTED|Treatment Period 2|in extension period only|0
8658370|NCT00685399|9701286|FG004|STARTED|Treatment Period 2||4
8658371|NCT00685399|9701287|FG005|STARTED|Treatment Period 2||12
8658372|NCT00685399|9701288|FG006|STARTED|Treatment Period 2||13
8658373|NCT00685399|9701289|FG007|STARTED|Treatment Period 2||12
8658374|NCT00685399|9701282|FG000|COMPLETED|Treatment Period 2||0
8658375|NCT00685399|9701283|FG001|COMPLETED|Treatment Period 2||2
8658376|NCT00685399|9701284|FG002|COMPLETED|Treatment Period 2||2
8658377|NCT00685399|9701285|FG003|COMPLETED|Treatment Period 2|in extension period only|0
8658378|NCT00685399|9701286|FG004|COMPLETED|Treatment Period 2||4
8658379|NCT00685399|9701287|FG005|COMPLETED|Treatment Period 2||10
8658380|NCT00685399|9701288|FG006|COMPLETED|Treatment Period 2||13
8658381|NCT00685399|9701289|FG007|COMPLETED|Treatment Period 2||10
8658382|NCT00685399|9701282|FG000|NOT COMPLETED|Treatment Period 2||0
8658383|NCT00685399|9701283|FG001|NOT COMPLETED|Treatment Period 2||12
8658384|NCT00685399|9701284|FG002|NOT COMPLETED|Treatment Period 2||3
8658385|NCT00685399|9701285|FG003|NOT COMPLETED|Treatment Period 2||0
8658386|NCT00685399|9701286|FG004|NOT COMPLETED|Treatment Period 2||0
8658387|NCT00685399|9701287|FG005|NOT COMPLETED|Treatment Period 2||2
8658388|NCT00685399|9701288|FG006|NOT COMPLETED|Treatment Period 2||0
8658389|NCT00685399|9701289|FG007|NOT COMPLETED|Treatment Period 2||2
8658390|NCT00685399|9701282|FG000|STARTED|Extension||0
8658391|NCT00685399|9701283|FG001|STARTED|Extension||0
8658392|NCT00685399|9701284|FG002|STARTED|Extension||0
8658393|NCT00685399|9701285|FG003|STARTED|Extension||28
8658394|NCT00685399|9701286|FG004|STARTED|Extension||0
8658395|NCT00685399|9701287|FG005|STARTED|Extension||0
8658396|NCT00685399|9701288|FG006|STARTED|Extension||0
8658397|NCT00685399|9701289|FG007|STARTED|Extension||0
8658398|NCT00685399|9701282|FG000|COMPLETED|Extension||0
8658399|NCT00685399|9701283|FG001|COMPLETED|Extension||0
8658400|NCT00685399|9701284|FG002|COMPLETED|Extension||0
8658401|NCT00685399|9701285|FG003|COMPLETED|Extension||21
8658402|NCT00685399|9701286|FG004|COMPLETED|Extension||0
8658403|NCT00685399|9701287|FG005|COMPLETED|Extension||0
8658404|NCT00685399|9701288|FG006|COMPLETED|Extension||0
8658405|NCT00685399|9701289|FG007|COMPLETED|Extension||0
8658406|NCT00685399|9701282|FG000|NOT COMPLETED|Extension||0
8658407|NCT00685399|9701283|FG001|NOT COMPLETED|Extension||0
8658408|NCT00685399|9701284|FG002|NOT COMPLETED|Extension||0
8658409|NCT00685399|9701285|FG003|NOT COMPLETED|Extension||7
8658410|NCT00685399|9701286|FG004|NOT COMPLETED|Extension||0
8658411|NCT00685399|9701287|FG005|NOT COMPLETED|Extension||0
8658412|NCT00685399|9701288|FG006|NOT COMPLETED|Extension||0
8658413|NCT00685399|9701289|FG007|NOT COMPLETED|Extension||0
8658414|NCT00685477|9701316|FG000|STARTED|Overall Study||10
8658415|NCT00685477|9701317|FG001|STARTED|Overall Study||10
8658416|NCT00685477|9701318|FG002|STARTED|Overall Study||10
8658417|NCT00685477|9701319|FG003|STARTED|Overall Study||10
8658418|NCT00685477|9701320|FG004|STARTED|Overall Study||10
8658419|NCT00685477|9701321|FG005|STARTED|Overall Study||10
8658420|NCT00685477|9701316|FG000|COMPLETED|Overall Study||10
8658421|NCT00685477|9701317|FG001|COMPLETED|Overall Study||10
8658422|NCT00685477|9701318|FG002|COMPLETED|Overall Study||10
8729333|NCT01052662|9776439|FG000|COMPLETED|Overall Study||6
8729334|NCT01052662|9776440|FG001|COMPLETED|Overall Study||5
8729335|NCT01052662|9776441|FG002|COMPLETED|Overall Study||10
8729336|NCT01052662|9776439|FG000|NOT COMPLETED|Overall Study||22
8729337|NCT01052662|9776440|FG001|NOT COMPLETED|Overall Study||22
8729338|NCT01052662|9776441|FG002|NOT COMPLETED|Overall Study||22
8729339|NCT01052701|9776451|FG000|STARTED|Overall Study||14
8729340|NCT01052701|9776452|FG001|STARTED|Overall Study||12
8729341|NCT01052701|9776451|FG000|COMPLETED|Overall Study||14
8729342|NCT01052701|9776452|FG001|COMPLETED|Overall Study||12
8729343|NCT01052701|9776451|FG000|NOT COMPLETED|Overall Study||0
8911275|NCT02144597|9970324|FG000|NOT COMPLETED|Overall Study||6
8911276|NCT02144597|9970325|FG001|NOT COMPLETED|Overall Study||4
8911277|NCT02144597|9970326|FG002|NOT COMPLETED|Overall Study||4
8911278|NCT02144610|9970336|FG000|STARTED|Overall Study||23
8911279|NCT02144610|9970337|FG001|STARTED|Overall Study||23
8911280|NCT02144610|9970336|FG000|COMPLETED|Overall Study||0
8911281|NCT02144610|9970337|FG001|COMPLETED|Overall Study||1
8911282|NCT02144610|9970336|FG000|NOT COMPLETED|Overall Study||23
8911283|NCT02144610|9970337|FG001|NOT COMPLETED|Overall Study||22
8911284|NCT02144675|9970345|FG000|STARTED|Overall Study||13
8911285|NCT02144675|9970346|FG001|STARTED|Overall Study||14
8911286|NCT02144675|9970345|FG000|COMPLETED|Overall Study||13
8911287|NCT02144675|9970346|FG001|COMPLETED|Overall Study||14
8911288|NCT02144675|9970345|FG000|NOT COMPLETED|Overall Study||0
8911289|NCT02144675|9970346|FG001|NOT COMPLETED|Overall Study||0
8911290|NCT02144701|9970354|FG000|STARTED|Overall Study||22
8911291|NCT02144701|9970355|FG001|STARTED|Overall Study||11
8911292|NCT02144701|9970354|FG000|COMPLETED|Overall Study||13
8911293|NCT02144701|9970355|FG001|COMPLETED|Overall Study||8
8911294|NCT02144701|9970354|FG000|NOT COMPLETED|Overall Study||9
9022356|NCT03125915|10085230|FG002|NOT COMPLETED|6 Month Follow-up||6
8911295|NCT02144701|9970355|FG001|NOT COMPLETED|Overall Study||3
8911296|NCT02144714|9970364|FG000|STARTED|Overall Study||63
8658423|NCT00685477|9701319|FG003|COMPLETED|Overall Study||10
8658424|NCT00685477|9701320|FG004|COMPLETED|Overall Study||10
8658425|NCT00685477|9701321|FG005|COMPLETED|Overall Study||10
8658426|NCT00685477|9701316|FG000|NOT COMPLETED|Overall Study||0
8658427|NCT00685477|9701317|FG001|NOT COMPLETED|Overall Study||0
8658428|NCT00685477|9701318|FG002|NOT COMPLETED|Overall Study||0
8658429|NCT00685477|9701319|FG003|NOT COMPLETED|Overall Study||0
8658430|NCT00685477|9701320|FG004|NOT COMPLETED|Overall Study||0
8658431|NCT00685477|9701321|FG005|NOT COMPLETED|Overall Study||0
8658432|NCT00685516|9701333|FG000|STARTED|Overall Study||42
8658433|NCT00685516|9701334|FG001|STARTED|Overall Study||38
8658434|NCT00685516|9701335|FG002|STARTED|Overall Study||33
8658435|NCT00685516|9701333|FG000|COMPLETED|Overall Study||34
8658436|NCT00685516|9701334|FG001|COMPLETED|Overall Study||33
8658437|NCT00685516|9701335|FG002|COMPLETED|Overall Study||26
8658438|NCT00685516|9701333|FG000|NOT COMPLETED|Overall Study||8
8658439|NCT00685516|9701334|FG001|NOT COMPLETED|Overall Study||5
8658440|NCT00685516|9701335|FG002|NOT COMPLETED|Overall Study||7
8658441|NCT00685659|9701349|FG000|STARTED|Overall Study||108
8658442|NCT00685659|9701350|FG001|STARTED|Overall Study||106
8658443|NCT00685659|9701351|FG002|STARTED|Overall Study||107
8658444|NCT00685659|9701349|FG000|COMPLETED|Overall Study||77
8658445|NCT00685659|9701350|FG001|COMPLETED|Overall Study||81
8658446|NCT00685659|9701351|FG002|COMPLETED|Overall Study||92
8658447|NCT00685659|9701349|FG000|NOT COMPLETED|Overall Study||31
8658448|NCT00685659|9701350|FG001|NOT COMPLETED|Overall Study||25
8658449|NCT00685659|9701351|FG002|NOT COMPLETED|Overall Study||15
8658450|NCT00685685|9701359|FG000|STARTED|First Intervention||27
8658451|NCT00685685|9701360|FG001|STARTED|First Intervention||27
8658452|NCT00685685|9701359|FG000|COMPLETED|First Intervention||27
8658453|NCT00685685|9701360|FG001|COMPLETED|First Intervention||27
8658454|NCT00685685|9701359|FG000|NOT COMPLETED|First Intervention||0
8658455|NCT00685685|9701360|FG001|NOT COMPLETED|First Intervention||0
8658456|NCT00685685|9701359|FG000|STARTED|Washout Period of 7 Days||27
8658457|NCT00685685|9701360|FG001|STARTED|Washout Period of 7 Days||27
8658458|NCT00685685|9701359|FG000|COMPLETED|Washout Period of 7 Days||25
8658459|NCT00685685|9701360|FG001|COMPLETED|Washout Period of 7 Days||26
8658460|NCT00685685|9701359|FG000|NOT COMPLETED|Washout Period of 7 Days||2
8658461|NCT00685685|9701360|FG001|NOT COMPLETED|Washout Period of 7 Days||1
8658462|NCT00685685|9701359|FG000|STARTED|Second Intervention||25
8658463|NCT00685685|9701360|FG001|STARTED|Second Intervention||26
8658464|NCT00685685|9701359|FG000|COMPLETED|Second Intervention||25
8658465|NCT00685685|9701360|FG001|COMPLETED|Second Intervention||26
8658466|NCT00685685|9701359|FG000|NOT COMPLETED|Second Intervention||0
8658467|NCT00685685|9701360|FG001|NOT COMPLETED|Second Intervention||0
8658468|NCT00685698|9701366|FG000|STARTED|Overall Study||38
8658469|NCT00685698|9701366|FG000|COMPLETED|Overall Study||25
8658470|NCT00685698|9701366|FG000|NOT COMPLETED|Overall Study||13
8658471|NCT00685750|9701389|FG000|STARTED|Overall Study||17
8658472|NCT00685750|9701390|FG001|STARTED|Overall Study||3
8658473|NCT00685750|9701391|FG002|STARTED|Overall Study||21
8658474|NCT00685750|9701392|FG003|STARTED|Overall Study||2
8658475|NCT00685750|9701393|FG004|STARTED|Overall Study||15
8658476|NCT00685750|9701394|FG005|STARTED|Overall Study||20
8658477|NCT00685750|9701395|FG006|STARTED|Overall Study||10
8658478|NCT00685750|9701389|FG000|COMPLETED|Overall Study||17
8658479|NCT00685750|9701390|FG001|COMPLETED|Overall Study||3
8658480|NCT00685750|9701391|FG002|COMPLETED|Overall Study||19
8658481|NCT00685750|9701392|FG003|COMPLETED|Overall Study||2
8658482|NCT00685750|9701393|FG004|COMPLETED|Overall Study||15
8658483|NCT00685750|9701394|FG005|COMPLETED|Overall Study||20
8658484|NCT00685750|9701395|FG006|COMPLETED|Overall Study||9
8658485|NCT00685750|9701389|FG000|NOT COMPLETED|Overall Study||0
8658486|NCT00685750|9701390|FG001|NOT COMPLETED|Overall Study||0
8658487|NCT00685750|9701391|FG002|NOT COMPLETED|Overall Study||2
8658488|NCT00685750|9701392|FG003|NOT COMPLETED|Overall Study||0
8658489|NCT00685750|9701393|FG004|NOT COMPLETED|Overall Study||0
8658490|NCT00685750|9701394|FG005|NOT COMPLETED|Overall Study||0
8658491|NCT00685750|9701395|FG006|NOT COMPLETED|Overall Study||1
8658492|NCT00685763|9701415|FG000|STARTED|Overall Study||13
8658493|NCT00685763|9701415|FG000|COMPLETED|Overall Study||11
8658494|NCT00685763|9701415|FG000|NOT COMPLETED|Overall Study||2
8658495|NCT00685802|9701419|FG000|STARTED|First Intervention||16
8658496|NCT00685802|9701420|FG001|STARTED|First Intervention||16
8658497|NCT00685802|9701419|FG000|COMPLETED|First Intervention||16
8658498|NCT00685802|9701420|FG001|COMPLETED|First Intervention||16
8658499|NCT00685802|9701419|FG000|NOT COMPLETED|First Intervention||0
8658500|NCT00685802|9701420|FG001|NOT COMPLETED|First Intervention||0
8658501|NCT00685802|9701419|FG000|STARTED|Washout Period of 7 Days||16
8658502|NCT00685802|9701420|FG001|STARTED|Washout Period of 7 Days||16
8658503|NCT00685802|9701419|FG000|COMPLETED|Washout Period of 7 Days||14
8658504|NCT00685802|9701420|FG001|COMPLETED|Washout Period of 7 Days||15
8658505|NCT00685802|9701419|FG000|NOT COMPLETED|Washout Period of 7 Days||2
8658506|NCT00685802|9701420|FG001|NOT COMPLETED|Washout Period of 7 Days||1
8658507|NCT00685802|9701419|FG000|STARTED|Second Intervention||14
8658508|NCT00685802|9701420|FG001|STARTED|Second Intervention||15
8658509|NCT00685802|9701419|FG000|COMPLETED|Second Intervention||14
8658510|NCT00685802|9701420|FG001|COMPLETED|Second Intervention||15
8658511|NCT00685802|9701419|FG000|NOT COMPLETED|Second Intervention||0
8658512|NCT00685802|9701420|FG001|NOT COMPLETED|Second Intervention||0
8658513|NCT00685932|9701428|FG000|STARTED|Overall Study||76
8658514|NCT00685932|9701429|FG001|STARTED|Overall Study||78
8658515|NCT00685932|9701428|FG000|COMPLETED|Overall Study||55
8658516|NCT00685932|9701429|FG001|COMPLETED|Overall Study||58
8658517|NCT00685932|9701428|FG000|NOT COMPLETED|Overall Study||21
8658518|NCT00685932|9701429|FG001|NOT COMPLETED|Overall Study||20
8658519|NCT00685945|9701435|FG000|STARTED|Control (Bradykinin Infusion)|A total of 24 subjects received an infusion of bradykinin|24
8658520|NCT00685945|9701435|FG000|COMPLETED|Control (Bradykinin Infusion)||24
8658521|NCT00685945|9701435|FG000|NOT COMPLETED|Control (Bradykinin Infusion)||0
8658522|NCT00685945|9701435|FG000|STARTED|L-NMMA + Bradykinin||24
8658523|NCT00685945|9701435|FG000|COMPLETED|L-NMMA + Bradykinin||23
8658524|NCT00685945|9701435|FG000|NOT COMPLETED|L-NMMA + Bradykinin||1
8658525|NCT00685945|9701435|FG000|STARTED|Isosorbide + L-NMMA + Bradykinin||11
8658526|NCT00685945|9701435|FG000|COMPLETED|Isosorbide + L-NMMA + Bradykinin||11
8658527|NCT00685945|9701435|FG000|NOT COMPLETED|Isosorbide + L-NMMA + Bradykinin||0
8658528|NCT00685945|9701435|FG000|STARTED|Sildenafil + L-NMMA + Bradykinin||12
8658529|NCT00685945|9701435|FG000|COMPLETED|Sildenafil + L-NMMA + Bradykinin||12
8658530|NCT00685945|9701435|FG000|NOT COMPLETED|Sildenafil + L-NMMA + Bradykinin||0
8658531|NCT00686075|9701455|FG000|STARTED|Overall Study||79
8658532|NCT00686075|9701456|FG001|STARTED|Overall Study||81
8658533|NCT00686075|9701457|FG002|STARTED|Overall Study||80
8658534|NCT00686075|9701458|FG003|STARTED|Overall Study||80
8658535|NCT00686075|9701459|FG004|STARTED|Overall Study||40
8658536|NCT00686075|9701460|FG005|STARTED|Overall Study||40
8658537|NCT00686075|9701461|FG006|STARTED|Overall Study||82
8658538|NCT00686075|9701462|FG007|STARTED|Overall Study||78
8658539|NCT00686075|9701463|FG008|STARTED|Overall Study||81
8658540|NCT00686075|9701464|FG009|STARTED|Overall Study||79
8658541|NCT00686075|9701455|FG000|Treated|Overall Study||78
8658542|NCT00686075|9701456|FG001|Treated|Overall Study||79
8658543|NCT00686075|9701457|FG002|Treated|Overall Study||80
8658544|NCT00686075|9701458|FG003|Treated|Overall Study||80
8658545|NCT00686075|9701459|FG004|Treated|Overall Study||40
8658546|NCT00686075|9701460|FG005|Treated|Overall Study||40
8658547|NCT00686075|9701461|FG006|Treated|Overall Study||82
8658548|NCT00686075|9701462|FG007|Treated|Overall Study||77
8658549|NCT00686075|9701463|FG008|Treated|Overall Study||80
8658550|NCT00686075|9701464|FG009|Treated|Overall Study||78
8658551|NCT00686075|9701455|FG000|COMPLETED|Overall Study||71
8658552|NCT00686075|9701456|FG001|COMPLETED|Overall Study||71
8658553|NCT00686075|9701457|FG002|COMPLETED|Overall Study||74
8658554|NCT00686075|9701458|FG003|COMPLETED|Overall Study||71
8658555|NCT00686075|9701459|FG004|COMPLETED|Overall Study||36
8658556|NCT00686075|9701460|FG005|COMPLETED|Overall Study||37
8658557|NCT00686075|9701461|FG006|COMPLETED|Overall Study||82
8658558|NCT00686075|9701462|FG007|COMPLETED|Overall Study||76
8658559|NCT00686075|9701463|FG008|COMPLETED|Overall Study||75
8658560|NCT00686075|9701464|FG009|COMPLETED|Overall Study||69
8658561|NCT00686075|9701455|FG000|NOT COMPLETED|Overall Study||8
8658562|NCT00686075|9701456|FG001|NOT COMPLETED|Overall Study||10
8658563|NCT00686075|9701457|FG002|NOT COMPLETED|Overall Study||6
8658564|NCT00686075|9701458|FG003|NOT COMPLETED|Overall Study||9
8658565|NCT00686075|9701459|FG004|NOT COMPLETED|Overall Study||4
8658566|NCT00686075|9701460|FG005|NOT COMPLETED|Overall Study||3
8658567|NCT00686075|9701461|FG006|NOT COMPLETED|Overall Study||0
8658568|NCT00686075|9701462|FG007|NOT COMPLETED|Overall Study||2
8658569|NCT00686075|9701463|FG008|NOT COMPLETED|Overall Study||6
8658570|NCT00686075|9701464|FG009|NOT COMPLETED|Overall Study||10
8658571|NCT00686127|9701488|FG000|STARTED|Overall Study||14
8658572|NCT00686127|9701489|FG001|STARTED|Overall Study||7
8658573|NCT00686127|9701488|FG000|COMPLETED|Overall Study|Patients withdrew from the study because they did not like wearing the patch.|0
8658574|NCT00686127|9701489|FG001|COMPLETED|Overall Study||1
8658575|NCT00686127|9701488|FG000|NOT COMPLETED|Overall Study||14
8658576|NCT00686127|9701489|FG001|NOT COMPLETED|Overall Study||6
8658577|NCT00686166|9701495|FG000|STARTED|Overall Study||83
8658578|NCT00686166|9701495|FG000|Eligible|Overall Study||78
8658579|NCT00686166|9701495|FG000|Eligible and Began Protocol Therapy|Overall Study||74
8658580|NCT00686166|9701495|FG000|COMPLETED|Overall Study||63
8658581|NCT00686166|9701495|FG000|NOT COMPLETED|Overall Study||20
8658582|NCT00686205|9701506|FG000|STARTED|Overall Study||21606
8658583|NCT00686205|9701507|FG001|STARTED|Overall Study||2505
8658584|NCT00686205|9701506|FG000|COMPLETED|Overall Study||15599
8658585|NCT00686205|9701507|FG001|COMPLETED|Overall Study||1524
8658586|NCT00686205|9701506|FG000|NOT COMPLETED|Overall Study||6007
8658587|NCT00686205|9701507|FG001|NOT COMPLETED|Overall Study||981
8658588|NCT00686231|9701513|FG000|STARTED|Dose Test - Visit 1||12
8658589|NCT00686231|9701514|FG001|STARTED|Dose Test - Visit 1||7
8658590|NCT00686231|9701515|FG002|STARTED|Dose Test - Visit 1||0
8658591|NCT00686231|9701516|FG003|STARTED|Dose Test - Visit 1||0
8658592|NCT00686231|9701513|FG000|COMPLETED|Dose Test - Visit 1||12
8658593|NCT00686231|9701514|FG001|COMPLETED|Dose Test - Visit 1||7
8658594|NCT00686231|9701515|FG002|COMPLETED|Dose Test - Visit 1||0
8658595|NCT00686231|9701516|FG003|COMPLETED|Dose Test - Visit 1||0
8658596|NCT00686231|9701513|FG000|NOT COMPLETED|Dose Test - Visit 1||0
8658597|NCT00686231|9701514|FG001|NOT COMPLETED|Dose Test - Visit 1||0
8658598|NCT00686231|9701515|FG002|NOT COMPLETED|Dose Test - Visit 1||0
8658599|NCT00686231|9701516|FG003|NOT COMPLETED|Dose Test - Visit 1||0
8658600|NCT00686231|9701513|FG000|STARTED|Combination Test - Visit 2||0
8658601|NCT00686231|9701514|FG001|STARTED|Combination Test - Visit 2||0
8658602|NCT00686231|9701515|FG002|STARTED|Combination Test - Visit 2||10
8658603|NCT00686231|9701516|FG003|STARTED|Combination Test - Visit 2||9
8658604|NCT00686231|9701513|FG000|COMPLETED|Combination Test - Visit 2||0
8658605|NCT00686231|9701514|FG001|COMPLETED|Combination Test - Visit 2||0
8658606|NCT00686231|9701515|FG002|COMPLETED|Combination Test - Visit 2||10
8658607|NCT00686231|9701516|FG003|COMPLETED|Combination Test - Visit 2||9
8658608|NCT00686231|9701513|FG000|NOT COMPLETED|Combination Test - Visit 2||0
8729344|NCT01052701|9776452|FG001|NOT COMPLETED|Overall Study||0
8729345|NCT01052714|9776460|FG000|STARTED|Overall Study||42
8729346|NCT01052714|9776461|FG001|STARTED|Overall Study||62
8729347|NCT01052714|9776462|FG002|STARTED|Overall Study||17
8729348|NCT01052714|9776460|FG000|COMPLETED|Overall Study||17
8729349|NCT01052714|9776461|FG001|COMPLETED|Overall Study||33
8729350|NCT01052714|9776462|FG002|COMPLETED|Overall Study||15
8729351|NCT01052714|9776460|FG000|NOT COMPLETED|Overall Study||25
8729352|NCT01052714|9776461|FG001|NOT COMPLETED|Overall Study||29
8729353|NCT01052714|9776462|FG002|NOT COMPLETED|Overall Study||2
8729354|NCT01052779|9776470|FG000|STARTED|Overall Study||80
8729355|NCT01052779|9776471|FG001|STARTED|Overall Study||82
8729356|NCT01052779|9776470|FG000|Received at Least 1 Dose of Study Drug|Overall Study||80
8729357|NCT01052779|9776471|FG001|Received at Least 1 Dose of Study Drug|Overall Study||81
8729358|NCT01052779|9776470|FG000|COMPLETED|Overall Study||75
8729359|NCT01052779|9776471|FG001|COMPLETED|Overall Study||73
8729360|NCT01052779|9776470|FG000|NOT COMPLETED|Overall Study||5
8729361|NCT01052779|9776471|FG001|NOT COMPLETED|Overall Study||9
8658609|NCT00686231|9701514|FG001|NOT COMPLETED|Combination Test - Visit 2||0
8658610|NCT00686231|9701515|FG002|NOT COMPLETED|Combination Test - Visit 2||0
8658611|NCT00686231|9701516|FG003|NOT COMPLETED|Combination Test - Visit 2||0
8658612|NCT00686257|9701528|FG000|STARTED|Overall Study||29
8658613|NCT00686257|9701529|FG001|STARTED|Overall Study||31
8658614|NCT00686257|9701528|FG000|COMPLETED|Overall Study||29
8658615|NCT00686257|9701529|FG001|COMPLETED|Overall Study||31
8658616|NCT00686257|9701528|FG000|NOT COMPLETED|Overall Study||0
8658617|NCT00686257|9701529|FG001|NOT COMPLETED|Overall Study||0
8658618|NCT00686335|9701537|FG000|STARTED|Run-in Period||12
8658619|NCT00686335|9701537|FG000|COMPLETED|Run-in Period||7
8658620|NCT00686335|9701537|FG000|NOT COMPLETED|Run-in Period||5
8658621|NCT00686335|9701537|FG000|STARTED|Treatment Period||7
8658622|NCT00686335|9701537|FG000|COMPLETED|Treatment Period||7
8658623|NCT00686335|9701537|FG000|NOT COMPLETED|Treatment Period||0
8658624|NCT00686517|9701546|FG000|STARTED|Treatment||44
8658625|NCT00686517|9701547|FG001|STARTED|Treatment||43
8658626|NCT00686517|9701548|FG002|STARTED|Treatment||43
8658627|NCT00686517|9701546|FG000|Completed Final Treatment Visit|Treatment|Included 6 that discontinued the treatment before completion,but performed the Final Treatment Visit|44
8658628|NCT00686517|9701547|FG001|Completed Final Treatment Visit|Treatment|Included 3 that discontinued the treatment before completion,but performed the Final Treatment Visit|43
8658629|NCT00686517|9701548|FG002|Completed Final Treatment Visit|Treatment|Included 1 that discontinued the treatment before completion,but performed the Final Treatment Visit|43
8658630|NCT00686517|9701546|FG000|COMPLETED|Treatment||38
8658631|NCT00686517|9701547|FG001|COMPLETED|Treatment||40
8658632|NCT00686517|9701548|FG002|COMPLETED|Treatment||42
8658633|NCT00686517|9701546|FG000|NOT COMPLETED|Treatment||6
8658634|NCT00686517|9701547|FG001|NOT COMPLETED|Treatment||3
8658635|NCT00686517|9701548|FG002|NOT COMPLETED|Treatment||1
8658636|NCT00686517|9701546|FG000|STARTED|Follow-up||37
8658637|NCT00686517|9701547|FG001|STARTED|Follow-up||38
8658638|NCT00686517|9701548|FG002|STARTED|Follow-up||39
8658639|NCT00686517|9701546|FG000|COMPLETED|Follow-up||29
8658640|NCT00686517|9701547|FG001|COMPLETED|Follow-up||28
8658641|NCT00686517|9701548|FG002|COMPLETED|Follow-up||29
8658642|NCT00686517|9701546|FG000|NOT COMPLETED|Follow-up||8
8658643|NCT00686517|9701547|FG001|NOT COMPLETED|Follow-up||10
8658644|NCT00686517|9701548|FG002|NOT COMPLETED|Follow-up||10
8658645|NCT00686543|9701560|FG000|STARTED|Overall Study||14
8658646|NCT00686543|9701561|FG001|STARTED|Overall Study||21
8658647|NCT00686543|9701562|FG002|STARTED|Overall Study||20
8658648|NCT00686543|9701563|FG003|STARTED|Overall Study||20
8658649|NCT00686543|9701560|FG000|COMPLETED|Overall Study||0
8658650|NCT00686543|9701561|FG001|COMPLETED|Overall Study||20
8658651|NCT00686543|9701562|FG002|COMPLETED|Overall Study||15
8658652|NCT00686543|9701563|FG003|COMPLETED|Overall Study||17
8658653|NCT00686543|9701560|FG000|NOT COMPLETED|Overall Study||14
8658654|NCT00686543|9701561|FG001|NOT COMPLETED|Overall Study||1
8658655|NCT00686543|9701562|FG002|NOT COMPLETED|Overall Study||5
8658656|NCT00686543|9701563|FG003|NOT COMPLETED|Overall Study||3
8658657|NCT00686582|9701576|FG000|STARTED|Overall Study||92
8658658|NCT00686582|9701577|FG001|STARTED|Overall Study||91
8658659|NCT00686582|9701578|FG002|STARTED|Overall Study||121
8658660|NCT00686582|9701576|FG000|Booster Vaccination|Overall Study||75
8658661|NCT00686582|9701577|FG001|Booster Vaccination|Overall Study||77
8658662|NCT00686582|9701578|FG002|Booster Vaccination|Overall Study||0
8658663|NCT00686582|9701576|FG000|COMPLETED|Overall Study||74
8658664|NCT00686582|9701577|FG001|COMPLETED|Overall Study||77
8658665|NCT00686582|9701578|FG002|COMPLETED|Overall Study||121
8658666|NCT00686582|9701576|FG000|NOT COMPLETED|Overall Study||18
8658667|NCT00686582|9701577|FG001|NOT COMPLETED|Overall Study||14
8658668|NCT00686582|9701578|FG002|NOT COMPLETED|Overall Study||0
8658669|NCT00686595|9701584|FG000|STARTED|Overall Study||38
8658670|NCT00686595|9701584|FG000|COMPLETED|Overall Study||31
8658671|NCT00686595|9701584|FG000|NOT COMPLETED|Overall Study||7
8658672|NCT00686634|9701588|FG000|STARTED|Overall Study||108
8658673|NCT00686634|9701588|FG000|COMPLETED|Overall Study||102
8658674|NCT00686634|9701588|FG000|NOT COMPLETED|Overall Study||6
8658675|NCT00686647|9701593|FG000|STARTED|Overall Study||93
8658676|NCT00686647|9701593|FG000|COMPLETED|Overall Study||91
8658677|NCT00686647|9701593|FG000|NOT COMPLETED|Overall Study||2
8658678|NCT00686686|9701598|FG000|STARTED|Overall Study||23
8658679|NCT00686686|9701598|FG000|COMPLETED|Overall Study||17
8658680|NCT00686686|9701598|FG000|NOT COMPLETED|Overall Study||6
8658681|NCT00686699|9701604|FG000|STARTED|Treatment Period 1||4
8658682|NCT00686699|9701605|FG001|STARTED|Treatment Period 1||7
8658683|NCT00686699|9701604|FG000|COMPLETED|Treatment Period 1||4
8658684|NCT00686699|9701605|FG001|COMPLETED|Treatment Period 1||5
8658685|NCT00686699|9701604|FG000|NOT COMPLETED|Treatment Period 1||0
8658686|NCT00686699|9701605|FG001|NOT COMPLETED|Treatment Period 1||2
8658687|NCT00686699|9701604|FG000|STARTED|Treatment Period 2||4
8658688|NCT00686699|9701605|FG001|STARTED|Treatment Period 2||5
8658689|NCT00686699|9701604|FG000|COMPLETED|Treatment Period 2||4
8658690|NCT00686699|9701605|FG001|COMPLETED|Treatment Period 2||5
8658691|NCT00686699|9701604|FG000|NOT COMPLETED|Treatment Period 2||0
8658692|NCT00686699|9701605|FG001|NOT COMPLETED|Treatment Period 2||0
8658693|NCT00686712|9701614|FG000|STARTED|Overall Study||30
8658694|NCT00686712|9701615|FG001|STARTED|Overall Study||25
8658695|NCT00686712|9701616|FG002|STARTED|Overall Study||30
8658696|NCT00686712|9701614|FG000|COMPLETED|Overall Study||20
8658697|NCT00686712|9701615|FG001|COMPLETED|Overall Study||14
8658698|NCT00686712|9701616|FG002|COMPLETED|Overall Study||17
8658699|NCT00686712|9701614|FG000|NOT COMPLETED|Overall Study||10
8658700|NCT00686712|9701615|FG001|NOT COMPLETED|Overall Study||11
8658701|NCT00686712|9701616|FG002|NOT COMPLETED|Overall Study||13
8658702|NCT00686725|9701629|FG000|STARTED|Overall Study||47
8658703|NCT00686725|9701630|FG001|STARTED|Overall Study||52
8729362|NCT01052831|9776479|FG000|STARTED|Overall Study||26
8729363|NCT01052831|9776480|FG001|STARTED|Overall Study||24
8729364|NCT01052831|9776479|FG000|COMPLETED|Overall Study||22
8729365|NCT01052831|9776480|FG001|COMPLETED|Overall Study||23
8729366|NCT01052831|9776479|FG000|NOT COMPLETED|Overall Study||4
8729367|NCT01052831|9776480|FG001|NOT COMPLETED|Overall Study||1
8729368|NCT01052844|9776488|FG000|STARTED|Overall Study||40
8729369|NCT01052844|9776489|FG001|STARTED|Overall Study||40
8729370|NCT01052844|9776488|FG000|COMPLETED|Overall Study||40
8729371|NCT01052844|9776489|FG001|COMPLETED|Overall Study||39
8729372|NCT01052844|9776488|FG000|NOT COMPLETED|Overall Study||0
8729373|NCT01052844|9776489|FG001|NOT COMPLETED|Overall Study||1
8729374|NCT01052948|9776499|FG000|STARTED|Overall Study||27812
8729375|NCT01052948|9776500|FG001|STARTED|Overall Study||14669
8729376|NCT01052948|9776501|FG002|STARTED|Overall Study||15147
8729377|NCT01052948|9776502|FG003|STARTED|Overall Study||29311
8729378|NCT01052948|9776499|FG000|COMPLETED|Overall Study||27812
8729379|NCT01052948|9776500|FG001|COMPLETED|Overall Study||14669
8729380|NCT01052948|9776501|FG002|COMPLETED|Overall Study||15147
8729381|NCT01052948|9776502|FG003|COMPLETED|Overall Study||29311
8729382|NCT01052948|9776499|FG000|NOT COMPLETED|Overall Study||0
8729383|NCT01052948|9776500|FG001|NOT COMPLETED|Overall Study||0
8729384|NCT01052948|9776501|FG002|NOT COMPLETED|Overall Study||0
8729385|NCT01052948|9776502|FG003|NOT COMPLETED|Overall Study||0
8729386|NCT01053000|9776512|FG000|STARTED|Overall Study||5
8729387|NCT01053000|9776513|FG001|STARTED|Overall Study||5
8729388|NCT01053000|9776512|FG000|COMPLETED|Overall Study||5
8729389|NCT01053000|9776513|FG001|COMPLETED|Overall Study||5
8729390|NCT01053000|9776512|FG000|NOT COMPLETED|Overall Study||0
8729391|NCT01053000|9776513|FG001|NOT COMPLETED|Overall Study||0
8729392|NCT01053013|9776521|FG000|STARTED|Overall Study||24
8729393|NCT01053013|9776522|FG001|STARTED|Overall Study||34
8729394|NCT01053013|9776521|FG000|COMPLETED|Overall Study||24
8729395|NCT01053013|9776522|FG001|COMPLETED|Overall Study||34
8729396|NCT01053013|9776521|FG000|NOT COMPLETED|Overall Study||0
8729397|NCT01053013|9776522|FG001|NOT COMPLETED|Overall Study||0
8729398|NCT01053078|9776626|FG000|STARTED|Overall Study||14
8729399|NCT01053078|9776627|FG001|STARTED|Overall Study||15
8729400|NCT01053078|9776626|FG000|COMPLETED|Overall Study||10
8729401|NCT01053078|9776627|FG001|COMPLETED|Overall Study||12
8729402|NCT01053078|9776626|FG000|NOT COMPLETED|Overall Study||4
8729403|NCT01053078|9776627|FG001|NOT COMPLETED|Overall Study||3
8729404|NCT01053156|9776637|FG000|STARTED|First Intervention (Week 1-12)||33
8729405|NCT01053156|9776638|FG001|STARTED|First Intervention (Week 1-12)||33
8729406|NCT01053156|9776637|FG000|COMPLETED|First Intervention (Week 1-12)||28
8729407|NCT01053156|9776638|FG001|COMPLETED|First Intervention (Week 1-12)||27
8729408|NCT01053156|9776637|FG000|NOT COMPLETED|First Intervention (Week 1-12)||5
8729409|NCT01053156|9776638|FG001|NOT COMPLETED|First Intervention (Week 1-12)||6
8729410|NCT01053156|9776637|FG000|STARTED|Second Intervention (Week 13-24)||28
8729411|NCT01053156|9776638|FG001|STARTED|Second Intervention (Week 13-24)||27
8729412|NCT01053156|9776637|FG000|COMPLETED|Second Intervention (Week 13-24)||26
8729413|NCT01053156|9776638|FG001|COMPLETED|Second Intervention (Week 13-24)||22
8729414|NCT01053156|9776637|FG000|NOT COMPLETED|Second Intervention (Week 13-24)||2
8729415|NCT01053156|9776638|FG001|NOT COMPLETED|Second Intervention (Week 13-24)||5
8729416|NCT01053247|9776650|FG000|STARTED|Overall Study||269
8729417|NCT01053247|9776651|FG001|STARTED|Overall Study||260
8729418|NCT01053247|9776652|FG002|STARTED|Overall Study||264
8729419|NCT01053247|9776650|FG000|COMPLETED|Overall Study||249
8729420|NCT01053247|9776651|FG001|COMPLETED|Overall Study||241
8729421|NCT01053247|9776652|FG002|COMPLETED|Overall Study||236
8729422|NCT01053247|9776650|FG000|NOT COMPLETED|Overall Study||20
8729423|NCT01053247|9776651|FG001|NOT COMPLETED|Overall Study||19
8658704|NCT00686725|9701629|FG000|COMPLETED|Overall Study|Completers were defined as those who completed the established treatment.|1
8658705|NCT00686725|9701630|FG001|COMPLETED|Overall Study|Completers were defined as those who completed the established treatment.|10
8729424|NCT01053247|9776652|FG002|NOT COMPLETED|Overall Study||28
8658706|NCT00686725|9701629|FG000|NOT COMPLETED|Overall Study||46
8658707|NCT00686725|9701630|FG001|NOT COMPLETED|Overall Study||42
8658708|NCT00686777|9701636|FG000|STARTED|Overall Study||75
8658709|NCT00686777|9701636|FG000|Completed 24 Weeks of Treatment|Overall Study||69
8658710|NCT00686777|9701636|FG000|Completed 48 Weeks of Treatment|Overall Study||65
8658711|NCT00686777|9701636|FG000|Included in Follow-up (All Treated)|Overall Study||75
8658712|NCT00686777|9701636|FG000|Completed 24 Weeks of Follow-up|Overall Study||70
8658713|NCT00686777|9701636|FG000|COMPLETED|Overall Study|Of 10 noncompleters, 6 had AEs including 4 meeting protocol prespecified AE discontinuance criteria.|65
8658714|NCT00686777|9701636|FG000|NOT COMPLETED|Overall Study||10
8658715|NCT00686790|9701640|FG000|STARTED|Overall Study||48
8658716|NCT00686790|9701640|FG000|COMPLETED|Overall Study||32
8658717|NCT00686790|9701640|FG000|NOT COMPLETED|Overall Study||16
8658718|NCT00686803|9701647|FG000|STARTED|Overall Study||6
8658719|NCT00686803|9701648|FG001|STARTED|Overall Study||12
8658720|NCT00686803|9701649|FG002|STARTED|Overall Study||3
8658721|NCT00686803|9701647|FG000|COMPLETED|Overall Study||6
8658722|NCT00686803|9701648|FG001|COMPLETED|Overall Study||12
8658723|NCT00686803|9701649|FG002|COMPLETED|Overall Study||3
8658724|NCT00686803|9701647|FG000|NOT COMPLETED|Overall Study||0
8658725|NCT00686803|9701648|FG001|NOT COMPLETED|Overall Study||0
8658726|NCT00686803|9701649|FG002|NOT COMPLETED|Overall Study||0
8658727|NCT00686829|9701657|FG000|STARTED|Overall Study||79
8658728|NCT00686829|9701657|FG000|COMPLETED|Overall Study||0
8658729|NCT00686829|9701657|FG000|NOT COMPLETED|Overall Study||79
8658730|NCT00686842|9701661|FG000|STARTED|Overall Study||17
8658731|NCT00686842|9701661|FG000|COMPLETED|Overall Study||17
8658732|NCT00686842|9701661|FG000|NOT COMPLETED|Overall Study||0
8658733|NCT00686855|9701667|FG000|STARTED|Overall Study||28
8658734|NCT00686855|9701668|FG001|STARTED|Overall Study||18
8658735|NCT00686855|9701667|FG000|COMPLETED|Overall Study||27
8658736|NCT00686855|9701668|FG001|COMPLETED|Overall Study||17
8658737|NCT00686855|9701667|FG000|NOT COMPLETED|Overall Study||1
8658738|NCT00686855|9701668|FG001|NOT COMPLETED|Overall Study||1
8658739|NCT00686881|9701676|FG000|STARTED|Overall Study|After randomization, 2 participants withdrew consent and did not receive study drug.|127
8658740|NCT00686881|9701677|FG001|STARTED|Overall Study|After randomization, 6 participants withdrew consent and did not receive study drug.|134
8658741|NCT00686881|9701676|FG000|COMPLETED|Overall Study||45
8658742|NCT00686881|9701677|FG001|COMPLETED|Overall Study||53
8658743|NCT00686881|9701676|FG000|NOT COMPLETED|Overall Study||82
8658744|NCT00686881|9701677|FG001|NOT COMPLETED|Overall Study||81
8658745|NCT00686894|9701685|FG000|STARTED|Overall Study||7
8658746|NCT00686894|9701685|FG000|COMPLETED|Overall Study||1
8658747|NCT00686894|9701685|FG000|NOT COMPLETED|Overall Study||6
8658748|NCT00686920|9701691|FG000|STARTED|Overall Study||252
8658749|NCT00686920|9701692|FG001|STARTED|Overall Study||70
8658750|NCT00686920|9701691|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||252
8658751|NCT00686920|9701692|FG001|Received At Least 1 Dose Of Study Drug|Overall Study||70
8658752|NCT00686920|9701691|FG000|COMPLETED|Overall Study||120
8658753|NCT00686920|9701692|FG001|COMPLETED|Overall Study||34
8658754|NCT00686920|9701691|FG000|NOT COMPLETED|Overall Study||132
8658755|NCT00686920|9701692|FG001|NOT COMPLETED|Overall Study||36
8658756|NCT00686959|9701700|FG000|STARTED|Overall Study||301
8658757|NCT00686959|9701701|FG001|STARTED|Overall Study||297
8658758|NCT00686959|9701700|FG000|Received at Least One Dose of Study Drug|Overall Study||283
8658759|NCT00686959|9701701|FG001|Received at Least One Dose of Study Drug|Overall Study||272
8658760|NCT00686959|9701700|FG000|Entered Consolidation Phase|Overall Study||229
8658761|NCT00686959|9701701|FG001|Entered Consolidation Phase|Overall Study||202
8658762|NCT00686959|9701700|FG000|COMPLETED|Overall Study|Study completion includes death due to any cause|177
8658763|NCT00686959|9701701|FG001|COMPLETED|Overall Study|Study completion includes death due to any cause.|180
8658764|NCT00686959|9701700|FG000|NOT COMPLETED|Overall Study||124
8658765|NCT00686959|9701701|FG001|NOT COMPLETED|Overall Study||117
8658766|NCT00686998|9701710|FG000|STARTED|Overall Study|Randomized & received study medication|43
8658767|NCT00686998|9701711|FG001|STARTED|Overall Study|Randomized & received study medication|41
8658768|NCT00686998|9701712|FG002|STARTED|Overall Study|Randomized & received study medication|22
8658769|NCT00686998|9701710|FG000|Randomized|Overall Study||43
8658770|NCT00686998|9701711|FG001|Randomized|Overall Study||41
8658771|NCT00686998|9701712|FG002|Randomized|Overall Study||22
8658772|NCT00686998|9701710|FG000|Received Treatment|Overall Study||43
8658773|NCT00686998|9701711|FG001|Received Treatment|Overall Study||41
8658774|NCT00686998|9701712|FG002|Received Treatment|Overall Study||22
8658775|NCT00686998|9701710|FG000|Eligible for Efficacy Analysis|Overall Study||42
8658776|NCT00686998|9701711|FG001|Eligible for Efficacy Analysis|Overall Study||39
8658777|NCT00686998|9701712|FG002|Eligible for Efficacy Analysis|Overall Study||21
8729425|NCT01053312|9776660|FG000|STARTED|Overall Study||7
8729426|NCT01053312|9776660|FG000|COMPLETED|Overall Study||7
8729427|NCT01053312|9776660|FG000|NOT COMPLETED|Overall Study||0
8729428|NCT01053429|9776678|FG000|STARTED|Overall Study||3391
8729429|NCT01053429|9776678|FG000|COMPLETED|Overall Study||3018
8658778|NCT00686998|9701710|FG000|Completed Scheduled Treatment|Overall Study||30
8658779|NCT00686998|9701711|FG001|Completed Scheduled Treatment|Overall Study||33
8658780|NCT00686998|9701712|FG002|Completed Scheduled Treatment|Overall Study||18
8658781|NCT00686998|9701710|FG000|COMPLETED|Overall Study||30
8658782|NCT00686998|9701711|FG001|COMPLETED|Overall Study||33
8729430|NCT01053429|9776678|FG000|NOT COMPLETED|Overall Study||373
8658783|NCT00686998|9701712|FG002|COMPLETED|Overall Study||18
8658784|NCT00686998|9701710|FG000|NOT COMPLETED|Overall Study||13
8658785|NCT00686998|9701711|FG001|NOT COMPLETED|Overall Study||8
8658786|NCT00686998|9701712|FG002|NOT COMPLETED|Overall Study||4
8658787|NCT00687076|9701722|FG000|STARTED|Overall Study||51
8658788|NCT00687076|9701723|FG001|STARTED|Overall Study||51
8658789|NCT00687076|9701722|FG000|COMPLETED|Overall Study||19
8658790|NCT00687076|9701723|FG001|COMPLETED|Overall Study||21
8658791|NCT00687076|9701722|FG000|NOT COMPLETED|Overall Study||32
8658792|NCT00687076|9701723|FG001|NOT COMPLETED|Overall Study||30
8658793|NCT00687102|9701731|FG000|STARTED|Overall Study||733
8658794|NCT00687102|9701732|FG001|STARTED|Overall Study||765
8658795|NCT00687102|9701731|FG000|COMPLETED|Overall Study||733
8658796|NCT00687102|9701732|FG001|COMPLETED|Overall Study||765
8658797|NCT00687102|9701731|FG000|NOT COMPLETED|Overall Study||0
8658798|NCT00687102|9701732|FG001|NOT COMPLETED|Overall Study||0
8658799|NCT00687167|9701738|FG000|STARTED|First Intervention||17
8658800|NCT00687167|9701739|FG001|STARTED|First Intervention||17
8658801|NCT00687167|9701738|FG000|COMPLETED|First Intervention||17
8658802|NCT00687167|9701739|FG001|COMPLETED|First Intervention||17
8658803|NCT00687167|9701738|FG000|NOT COMPLETED|First Intervention||0
8658804|NCT00687167|9701739|FG001|NOT COMPLETED|First Intervention||0
8658805|NCT00687167|9701738|FG000|STARTED|Washout Period of 28 Days||17
8658806|NCT00687167|9701739|FG001|STARTED|Washout Period of 28 Days||17
8658807|NCT00687167|9701738|FG000|COMPLETED|Washout Period of 28 Days||17
8658808|NCT00687167|9701739|FG001|COMPLETED|Washout Period of 28 Days||17
8658809|NCT00687167|9701738|FG000|NOT COMPLETED|Washout Period of 28 Days||0
8658810|NCT00687167|9701739|FG001|NOT COMPLETED|Washout Period of 28 Days||0
8658811|NCT00687167|9701738|FG000|STARTED|Second Intervention||17
8658812|NCT00687167|9701739|FG001|STARTED|Second Intervention||17
8658813|NCT00687167|9701738|FG000|COMPLETED|Second Intervention||17
8658814|NCT00687167|9701739|FG001|COMPLETED|Second Intervention||17
8658815|NCT00687167|9701738|FG000|NOT COMPLETED|Second Intervention||0
8658816|NCT00687167|9701739|FG001|NOT COMPLETED|Second Intervention||0
8658817|NCT00687193|9701751|FG000|STARTED|Overall Study||53
8658818|NCT00687193|9701752|FG001|STARTED|Overall Study||53
8658819|NCT00687193|9701753|FG002|STARTED|Overall Study||52
8658820|NCT00687193|9701754|FG003|STARTED|Overall Study||53
8658821|NCT00687193|9701755|FG004|STARTED|Overall Study||54
8658822|NCT00687193|9701756|FG005|STARTED|Overall Study|One participant withdrew after randomization but prior to treatment.|52
8658823|NCT00687193|9701751|FG000|COMPLETED|Overall Study||51
8658824|NCT00687193|9701752|FG001|COMPLETED|Overall Study||49
8658825|NCT00687193|9701753|FG002|COMPLETED|Overall Study||50
8658826|NCT00687193|9701754|FG003|COMPLETED|Overall Study||49
8658827|NCT00687193|9701755|FG004|COMPLETED|Overall Study||52
8658828|NCT00687193|9701756|FG005|COMPLETED|Overall Study||48
8658829|NCT00687193|9701751|FG000|NOT COMPLETED|Overall Study||2
8658830|NCT00687193|9701752|FG001|NOT COMPLETED|Overall Study||4
8658831|NCT00687193|9701753|FG002|NOT COMPLETED|Overall Study||2
8658832|NCT00687193|9701754|FG003|NOT COMPLETED|Overall Study||4
8658833|NCT00687193|9701755|FG004|NOT COMPLETED|Overall Study||2
8658834|NCT00687193|9701756|FG005|NOT COMPLETED|Overall Study||4
8658835|NCT00687219|9701773|FG000|STARTED|Overall Study||102
8658836|NCT00687219|9701773|FG000|COMPLETED|Overall Study||51
8658837|NCT00687219|9701773|FG000|NOT COMPLETED|Overall Study||51
8658838|NCT00687271|9701781|FG000|STARTED|Overall Study||94
8658839|NCT00687271|9701782|FG001|STARTED|Overall Study||96
8658840|NCT00687271|9701783|FG002|STARTED|Overall Study||96
8658841|NCT00687271|9701784|FG003|STARTED|Overall Study||48
8658842|NCT00687271|9701781|FG000|Treated|Overall Study||94
8658843|NCT00687271|9701782|FG001|Treated|Overall Study||95
8658844|NCT00687271|9701783|FG002|Treated|Overall Study||96
8658845|NCT00687271|9701784|FG003|Treated|Overall Study||48
8658846|NCT00687271|9701781|FG000|COMPLETED|Overall Study||91
8658847|NCT00687271|9701782|FG001|COMPLETED|Overall Study||90
8658848|NCT00687271|9701783|FG002|COMPLETED|Overall Study||91
8658849|NCT00687271|9701784|FG003|COMPLETED|Overall Study||48
8658850|NCT00687271|9701781|FG000|NOT COMPLETED|Overall Study||3
8658851|NCT00687271|9701782|FG001|NOT COMPLETED|Overall Study||6
8658852|NCT00687271|9701783|FG002|NOT COMPLETED|Overall Study||5
8658853|NCT00687271|9701784|FG003|NOT COMPLETED|Overall Study||0
8658854|NCT00687297|9701796|FG000|STARTED|Randomization||80
8658855|NCT00687297|9701797|FG001|STARTED|Randomization||82
8658856|NCT00687297|9701796|FG000|COMPLETED|Randomization||77
8658857|NCT00687297|9701797|FG001|COMPLETED|Randomization||81
8658858|NCT00687297|9701796|FG000|NOT COMPLETED|Randomization||3
8658859|NCT00687297|9701797|FG001|NOT COMPLETED|Randomization||1
8658860|NCT00687297|9701796|FG000|STARTED|Induction||77
8658861|NCT00687297|9701797|FG001|STARTED|Induction||81
8658862|NCT00687297|9701796|FG000|COMPLETED|Induction||32
8658863|NCT00687297|9701797|FG001|COMPLETED|Induction||26
8658864|NCT00687297|9701796|FG000|NOT COMPLETED|Induction||45
8658865|NCT00687297|9701797|FG001|NOT COMPLETED|Induction||55
8658866|NCT00687297|9701796|FG000|STARTED|Maintenance||32
8658867|NCT00687297|9701797|FG001|STARTED|Maintenance||26
8658868|NCT00687297|9701796|FG000|COMPLETED|Maintenance||29
8658869|NCT00687297|9701797|FG001|COMPLETED|Maintenance||25
8658870|NCT00687297|9701796|FG000|NOT COMPLETED|Maintenance||3
8658871|NCT00687297|9701797|FG001|NOT COMPLETED|Maintenance||1
8658872|NCT00687323|9701805|FG000|STARTED|Overall Study|Number of screened participants|195
8658873|NCT00687323|9701805|FG000|Received Treatment|Overall Study||47
8658874|NCT00687323|9701805|FG000|COMPLETED|Overall Study|Number of participants alive at one year|15
8658875|NCT00687323|9701805|FG000|NOT COMPLETED|Overall Study||180
8658876|NCT00687362|9701809|FG000|STARTED|Overall Study||22
8658877|NCT00687362|9701809|FG000|COMPLETED|Overall Study|Completed protocol at Week 24|19
8658878|NCT00687362|9701809|FG000|NOT COMPLETED|Overall Study||3
8658879|NCT00687401|9701813|FG000|STARTED|Overall Study|215 participants enrolled in the study, of which 56 failed screening and did not receive study drug.|159
8658880|NCT00687401|9701813|FG000|COMPLETED|Overall Study||129
8658881|NCT00687401|9701813|FG000|NOT COMPLETED|Overall Study||30
8658882|NCT00687440|9701818|FG000|STARTED|Overall Study|Number of screened participants|27
8658883|NCT00687440|9701818|FG000|COMPLETED|Overall Study||15
8658884|NCT00687440|9701818|FG000|NOT COMPLETED|Overall Study||12
8658885|NCT00687453|9701824|FG000|STARTED|Overall Study||11
8658886|NCT00687453|9701825|FG001|STARTED|Overall Study||13
8658887|NCT00687453|9701824|FG000|COMPLETED|Overall Study||8
8658888|NCT00687453|9701825|FG001|COMPLETED|Overall Study||7
8658889|NCT00687453|9701824|FG000|NOT COMPLETED|Overall Study||3
8658890|NCT00687453|9701825|FG001|NOT COMPLETED|Overall Study||6
8658891|NCT00687544|9701831|FG000|STARTED|Overall Study||11
8658892|NCT00687544|9701831|FG000|COMPLETED|Overall Study||0
8658893|NCT00687544|9701831|FG000|NOT COMPLETED|Overall Study||11
8658894|NCT00687609|9701835|FG000|STARTED|Overall Study||7
8658895|NCT00687609|9701835|FG000|COMPLETED|Overall Study||4
8658896|NCT00687609|9701835|FG000|NOT COMPLETED|Overall Study||3
8658897|NCT00687674|9701839|FG000|STARTED|Overall Study||13
8658898|NCT00687674|9701839|FG000|COMPLETED|Overall Study||11
8658899|NCT00687674|9701839|FG000|NOT COMPLETED|Overall Study||2
8658900|NCT00687713|9701845|FG000|STARTED|Overall Study||100
8658901|NCT00687713|9701846|FG001|STARTED|Overall Study||104
8658902|NCT00687713|9701845|FG000|COMPLETED|Overall Study||68
8658903|NCT00687713|9701846|FG001|COMPLETED|Overall Study||64
8658904|NCT00687713|9701845|FG000|NOT COMPLETED|Overall Study||32
8658905|NCT00687713|9701846|FG001|NOT COMPLETED|Overall Study||40
8658906|NCT00687739|9701858|FG000|STARTED|Overall Study||25
8658907|NCT00687739|9701859|FG001|STARTED|Overall Study||15
8658908|NCT00687739|9701860|FG002|STARTED|Overall Study||25
8658909|NCT00687739|9701861|FG003|STARTED|Overall Study||14
8658910|NCT00687739|9701858|FG000|COMPLETED|Overall Study||23
8658911|NCT00687739|9701859|FG001|COMPLETED|Overall Study||12
8658912|NCT00687739|9701860|FG002|COMPLETED|Overall Study||23
8658913|NCT00687739|9701861|FG003|COMPLETED|Overall Study||12
8658914|NCT00687739|9701858|FG000|NOT COMPLETED|Overall Study||2
8658915|NCT00687739|9701859|FG001|NOT COMPLETED|Overall Study||3
8658916|NCT00687739|9701860|FG002|NOT COMPLETED|Overall Study||2
8658917|NCT00687739|9701861|FG003|NOT COMPLETED|Overall Study||2
8658918|NCT00687804|9701876|FG000|STARTED|Core Study||116
8658919|NCT00687804|9701877|FG001|STARTED|Core Study||118
8658920|NCT00687804|9701878|FG002|STARTED|Core Study||111
8658921|NCT00687804|9701876|FG000|COMPLETED|Core Study||102
8658922|NCT00687804|9701877|FG001|COMPLETED|Core Study||103
8658923|NCT00687804|9701878|FG002|COMPLETED|Core Study||98
8658924|NCT00687804|9701876|FG000|NOT COMPLETED|Core Study||14
8658925|NCT00687804|9701877|FG001|NOT COMPLETED|Core Study||15
8658926|NCT00687804|9701878|FG002|NOT COMPLETED|Core Study||13
8658927|NCT00687804|9701876|FG000|STARTED|Open-Label Extension Study||83
8658928|NCT00687804|9701877|FG001|STARTED|Open-Label Extension Study||83
8658929|NCT00687804|9701878|FG002|STARTED|Open-Label Extension Study||74
8658930|NCT00687804|9701876|FG000|Did Not Receive Ranibizumab in Extension|Open-Label Extension Study||16
8658931|NCT00687804|9701877|FG001|Did Not Receive Ranibizumab in Extension|Open-Label Extension Study||21
8658932|NCT00687804|9701878|FG002|Did Not Receive Ranibizumab in Extension|Open-Label Extension Study||15
8658933|NCT00687804|9701876|FG000|COMPLETED|Open-Label Extension Study||73
8658934|NCT00687804|9701877|FG001|COMPLETED|Open-Label Extension Study||72
8658935|NCT00687804|9701878|FG002|COMPLETED|Open-Label Extension Study||63
8658936|NCT00687804|9701876|FG000|NOT COMPLETED|Open-Label Extension Study||10
8658937|NCT00687804|9701877|FG001|NOT COMPLETED|Open-Label Extension Study||11
8658938|NCT00687804|9701878|FG002|NOT COMPLETED|Open-Label Extension Study||11
8658939|NCT00687830|9701894|FG000|STARTED|Overall Study||68
8658940|NCT00687830|9701895|FG001|STARTED|Overall Study||68
8658941|NCT00687830|9701894|FG000|COMPLETED|Overall Study||68
8658942|NCT00687830|9701895|FG001|COMPLETED|Overall Study||68
8658943|NCT00687830|9701894|FG000|NOT COMPLETED|Overall Study||0
8658944|NCT00687830|9701895|FG001|NOT COMPLETED|Overall Study||0
8658945|NCT00687856|9701901|FG000|STARTED|Overall Study||211
8658946|NCT00687856|9701901|FG000|COMPLETED|Overall Study||211
8658947|NCT00687856|9701901|FG000|NOT COMPLETED|Overall Study||0
8658948|NCT00687908|9701907|FG000|STARTED|Overall Study||123
8658949|NCT00687908|9701908|FG001|STARTED|Overall Study||120
8658950|NCT00687908|9701907|FG000|COMPLETED|Overall Study||105
8658951|NCT00687908|9701908|FG001|COMPLETED|Overall Study||78
8658952|NCT00687908|9701907|FG000|NOT COMPLETED|Overall Study||18
8658953|NCT00687908|9701908|FG001|NOT COMPLETED|Overall Study||42
8658954|NCT00687973|9701916|FG000|STARTED|Overall Study||193
8658955|NCT00687973|9701917|FG001|STARTED|Overall Study||200
8658956|NCT00687973|9701916|FG000|COMPLETED|Overall Study||169
8658957|NCT00687973|9701917|FG001|COMPLETED|Overall Study||162
8658958|NCT00687973|9701916|FG000|NOT COMPLETED|Overall Study||24
8658959|NCT00687973|9701917|FG001|NOT COMPLETED|Overall Study||38
8658960|NCT00688064|9701926|FG000|STARTED|Overall Study||232
8658961|NCT00688064|9701927|FG001|STARTED|Overall Study||227
8658962|NCT00688064|9701926|FG000|COMPLETED|Overall Study||211
8658963|NCT00688064|9701927|FG001|COMPLETED|Overall Study||201
8658964|NCT00688064|9701926|FG000|NOT COMPLETED|Overall Study||21
8658965|NCT00688064|9701927|FG001|NOT COMPLETED|Overall Study||26
8658966|NCT00688103|9701935|FG000|STARTED|Overall Study||74
8658967|NCT00688103|9701936|FG001|STARTED|Overall Study||77
8658968|NCT00688103|9701935|FG000|Actually Treated|Overall Study||71
8658969|NCT00688103|9701936|FG001|Actually Treated|Overall Study||76
8658970|NCT00688103|9701935|FG000|COMPLETED|Overall Study||44
8658971|NCT00688103|9701936|FG001|COMPLETED|Overall Study||64
8658972|NCT00688103|9701935|FG000|NOT COMPLETED|Overall Study||30
8658973|NCT00688103|9701936|FG001|NOT COMPLETED|Overall Study||13
8658974|NCT00688155|9701948|FG000|STARTED|Overall Study||18
8658975|NCT00688155|9701949|FG001|STARTED|Overall Study||18
8658976|NCT00688155|9701950|FG002|STARTED|Overall Study||19
8658977|NCT00688155|9701951|FG003|STARTED|Overall Study||18
8658978|NCT00688155|9701948|FG000|COMPLETED|Overall Study||16
8658979|NCT00688155|9701949|FG001|COMPLETED|Overall Study||16
8658980|NCT00688155|9701950|FG002|COMPLETED|Overall Study||18
8658981|NCT00688155|9701951|FG003|COMPLETED|Overall Study||17
8658982|NCT00688155|9701948|FG000|NOT COMPLETED|Overall Study||2
8658983|NCT00688155|9701949|FG001|NOT COMPLETED|Overall Study||2
8658984|NCT00688155|9701950|FG002|NOT COMPLETED|Overall Study||1
8658985|NCT00688155|9701951|FG003|NOT COMPLETED|Overall Study||1
8658986|NCT00688181|9701961|FG000|STARTED|Overall Study||36
8658987|NCT00688181|9701961|FG000|COMPLETED|Overall Study||13
8658988|NCT00688181|9701961|FG000|NOT COMPLETED|Overall Study||23
8658989|NCT00688259|9701969|FG000|STARTED|Overall Study||44
8658990|NCT00688259|9701970|FG001|STARTED|Overall Study||44
8658991|NCT00688259|9701969|FG000|End to Active Treatment,|Overall Study||37
8658992|NCT00688259|9701970|FG001|End to Active Treatment,|Overall Study||37
8658993|NCT00688259|9701969|FG000|COMPLETED|Overall Study||37
8658994|NCT00688259|9701970|FG001|COMPLETED|Overall Study||36
8658995|NCT00688259|9701969|FG000|NOT COMPLETED|Overall Study||7
8658996|NCT00688259|9701970|FG001|NOT COMPLETED|Overall Study||8
8658997|NCT00688324|9701976|FG000|STARTED|Overall Study||36
8658998|NCT00688324|9701976|FG000|COMPLETED|Overall Study||28
8658999|NCT00688324|9701976|FG000|NOT COMPLETED|Overall Study||8
8659000|NCT00688467|9701983|FG000|STARTED|Treatment Period 1||9
8659001|NCT00688467|9701984|FG001|STARTED|Treatment Period 1||10
8729431|NCT01053507|9776684|FG000|STARTED|Overall Study||11
8729432|NCT01053507|9776685|FG001|STARTED|Overall Study||12
8729433|NCT01053507|9776684|FG000|COMPLETED|Overall Study||8
8729434|NCT01053507|9776685|FG001|COMPLETED|Overall Study||11
8729435|NCT01053507|9776684|FG000|NOT COMPLETED|Overall Study||3
8729436|NCT01053507|9776685|FG001|NOT COMPLETED|Overall Study||1
8729437|NCT01053663|9776694|FG000|STARTED|Overall Study||9
8729438|NCT01053663|9776694|FG000|COMPLETED|Overall Study||3
8729439|NCT01053663|9776694|FG000|NOT COMPLETED|Overall Study||6
8729440|NCT01053741|9776706|FG000|STARTED|1st Intervention||5
8729441|NCT01053741|9776707|FG001|STARTED|1st Intervention||6
8729442|NCT01053741|9776706|FG000|COMPLETED|1st Intervention||5
8729443|NCT01053741|9776707|FG001|COMPLETED|1st Intervention||6
8729444|NCT01053741|9776706|FG000|NOT COMPLETED|1st Intervention||0
8729445|NCT01053741|9776707|FG001|NOT COMPLETED|1st Intervention||0
8729446|NCT01053741|9776706|FG000|STARTED|14 Day Washout||5
8729447|NCT01053741|9776707|FG001|STARTED|14 Day Washout||6
8729448|NCT01053741|9776706|FG000|COMPLETED|14 Day Washout||5
8729449|NCT01053741|9776707|FG001|COMPLETED|14 Day Washout||6
8729450|NCT01053741|9776706|FG000|NOT COMPLETED|14 Day Washout||0
8729451|NCT01053741|9776707|FG001|NOT COMPLETED|14 Day Washout||0
8729452|NCT01053741|9776706|FG000|STARTED|2nd Study Intervention||5
8729453|NCT01053741|9776707|FG001|STARTED|2nd Study Intervention||6
8729454|NCT01053741|9776706|FG000|COMPLETED|2nd Study Intervention||5
8729455|NCT01053741|9776707|FG001|COMPLETED|2nd Study Intervention||5
8729456|NCT01053741|9776706|FG000|NOT COMPLETED|2nd Study Intervention||0
8729457|NCT01053741|9776707|FG001|NOT COMPLETED|2nd Study Intervention||1
8729458|NCT01053819|9776713|FG000|STARTED|Overall Study||6
8729459|NCT01053819|9776713|FG000|COMPLETED|Overall Study||6
8729460|NCT01053819|9776713|FG000|NOT COMPLETED|Overall Study||0
8911297|NCT02144714|9970365|FG001|STARTED|Overall Study||63
9022357|NCT03125915|10085231|FG003|NOT COMPLETED|6 Month Follow-up||3
8659002|NCT00688467|9701983|FG000|COMPLETED|Treatment Period 1||7
8659003|NCT00688467|9701984|FG001|COMPLETED|Treatment Period 1||8
8659004|NCT00688467|9701983|FG000|NOT COMPLETED|Treatment Period 1||2
8659005|NCT00688467|9701984|FG001|NOT COMPLETED|Treatment Period 1||2
8659006|NCT00688467|9701983|FG000|STARTED|Treatment Period 2||7
8659007|NCT00688467|9701984|FG001|STARTED|Treatment Period 2||8
8659008|NCT00688467|9701983|FG000|COMPLETED|Treatment Period 2||7
8659009|NCT00688467|9701984|FG001|COMPLETED|Treatment Period 2||6
8659010|NCT00688467|9701983|FG000|NOT COMPLETED|Treatment Period 2||0
8659011|NCT00688467|9701984|FG001|NOT COMPLETED|Treatment Period 2||2
8659012|NCT00688519|9701992|FG000|STARTED|Overall Study||223
8659013|NCT00688519|9701993|FG001|STARTED|Overall Study||113
8659014|NCT00688519|9701992|FG000|COMPLETED|Overall Study||204
8659015|NCT00688519|9701993|FG001|COMPLETED|Overall Study||98
8659016|NCT00688519|9701992|FG000|NOT COMPLETED|Overall Study||19
8659017|NCT00688519|9701993|FG001|NOT COMPLETED|Overall Study||15
8659018|NCT00688545|9702001|FG000|STARTED|Overall Study||55
8659019|NCT00688545|9702002|FG001|STARTED|Overall Study||219
8659020|NCT00688545|9702001|FG000|Switched Treatment at Least Once|Overall Study||6
8659021|NCT00688545|9702002|FG001|Switched Treatment at Least Once|Overall Study||13
8659022|NCT00688545|9702001|FG000|COMPLETED|Overall Study||50
8659023|NCT00688545|9702002|FG001|COMPLETED|Overall Study||204
8659024|NCT00688545|9702001|FG000|NOT COMPLETED|Overall Study||5
8659025|NCT00688545|9702002|FG001|NOT COMPLETED|Overall Study||15
8659026|NCT00688597|9702013|FG000|STARTED|Overall Study||3
8659027|NCT00688597|9702014|FG001|STARTED|Overall Study||0
8659028|NCT00688597|9702015|FG002|STARTED|Overall Study||0
8659029|NCT00688597|9702013|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
8659030|NCT00688597|9702014|FG001|Received at Least 1 Dose of Study Drug|Overall Study||0
8659031|NCT00688597|9702015|FG002|Received at Least 1 Dose of Study Drug|Overall Study||0
8659032|NCT00688597|9702013|FG000|COMPLETED|Overall Study||0
8659033|NCT00688597|9702014|FG001|COMPLETED|Overall Study||0
8659034|NCT00688597|9702015|FG002|COMPLETED|Overall Study||0
8659035|NCT00688597|9702013|FG000|NOT COMPLETED|Overall Study||3
8659036|NCT00688597|9702014|FG001|NOT COMPLETED|Overall Study||0
8659037|NCT00688597|9702015|FG002|NOT COMPLETED|Overall Study||0
8659038|NCT00688623|9702023|FG000|STARTED|Overall Study|Intent to treat (ITT)|73
8659039|NCT00688623|9702023|FG000|Safety Analysis Set|Overall Study|received at least one dose of study drug and had at least one post-baseline safety assessment|73
8659040|NCT00688623|9702023|FG000|Per Protocol (PP)|Overall Study|no major protocol deviation and 50% of planned dose of 8 weeks or d/c due to disease progression|60
8659041|NCT00688623|9702023|FG000|COMPLETED|Overall Study||18
8659042|NCT00688623|9702023|FG000|NOT COMPLETED|Overall Study||55
8659043|NCT00688636|9702029|FG000|STARTED|Overall Study||11
8659044|NCT00688636|9702030|FG001|STARTED|Overall Study||13
8659045|NCT00688636|9702029|FG000|COMPLETED|Overall Study||9
8659046|NCT00688636|9702030|FG001|COMPLETED|Overall Study||12
8659047|NCT00688636|9702029|FG000|NOT COMPLETED|Overall Study||2
8659048|NCT00688636|9702030|FG001|NOT COMPLETED|Overall Study||1
8659049|NCT00688662|9702038|FG000|STARTED|Overall Study||141
8659050|NCT00688662|9702039|FG001|STARTED|Overall Study||73
8659051|NCT00688662|9702038|FG000|COMPLETED|Overall Study||118
8659052|NCT00688662|9702039|FG001|COMPLETED|Overall Study||55
8659053|NCT00688662|9702038|FG000|NOT COMPLETED|Overall Study||23
8659054|NCT00688662|9702039|FG001|NOT COMPLETED|Overall Study||18
8659055|NCT00688688|9702049|FG000|STARTED|Overall Study||815
8659056|NCT00688688|9702050|FG001|STARTED|Overall Study||824
8659057|NCT00688688|9702051|FG002|STARTED|Overall Study||813
8659058|NCT00688688|9702049|FG000|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|812
8659059|NCT00688688|9702050|FG001|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|820
8659060|NCT00688688|9702051|FG002|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|812
8659061|NCT00688688|9702049|FG000|Full Analysis Set (FAS)|Overall Study|All treated patients with a baseline and at least 1 post-baseline micturition measurement.|789
8659062|NCT00688688|9702050|FG001|Full Analysis Set (FAS)|Overall Study|All treated patients with a baseline and at least 1 post-baseline micturition measurement.|802
8659063|NCT00688688|9702051|FG002|Full Analysis Set (FAS)|Overall Study|All treated patients with a baseline and at least 1 post-baseline micturition measurement.|791
8659064|NCT00688688|9702049|FG000|Full Analysis Set Incontinence (FAS-I)|Overall Study|All FAS patients who had at least 1 incontinence episode at Baseline.|479
8659065|NCT00688688|9702050|FG001|Full Analysis Set Incontinence (FAS-I)|Overall Study|All FAS patients who had at least 1 incontinence episode at Baseline.|483
8659066|NCT00688688|9702051|FG002|Full Analysis Set Incontinence (FAS-I)|Overall Study|All FAS patients who had at least 1 incontinence episode at Baseline.|488
8659067|NCT00688688|9702049|FG000|COMPLETED|Overall Study||629
8659068|NCT00688688|9702050|FG001|COMPLETED|Overall Study||645
8659069|NCT00688688|9702051|FG002|COMPLETED|Overall Study||621
8659070|NCT00688688|9702049|FG000|NOT COMPLETED|Overall Study||186
8659071|NCT00688688|9702050|FG001|NOT COMPLETED|Overall Study||179
8659072|NCT00688688|9702051|FG002|NOT COMPLETED|Overall Study||192
8659073|NCT00688701|9702062|FG000|STARTED|Overall Study|Randomized|61
8659074|NCT00688701|9702063|FG001|STARTED|Overall Study||61
8659075|NCT00688701|9702064|FG002|STARTED|Overall Study||120
8659076|NCT00688701|9702065|FG003|STARTED|Overall Study||119
8659077|NCT00688701|9702062|FG000|Treated/Safety Population|Overall Study|All patients who received at least 1 dose, regardless of amount of treatment administered.|61
8659078|NCT00688701|9702063|FG001|Treated/Safety Population|Overall Study||61
8659079|NCT00688701|9702064|FG002|Treated/Safety Population|Overall Study||120
8659080|NCT00688701|9702065|FG003|Treated/Safety Population|Overall Study||119
8659081|NCT00688701|9702062|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|61
8659082|NCT00688701|9702063|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||60
8659083|NCT00688701|9702064|FG002|Modified Intent-to-Treat(mITT)Population|Overall Study||120
8659084|NCT00688701|9702065|FG003|Modified Intent-to-Treat(mITT)Population|Overall Study||118
8659085|NCT00688701|9702062|FG000|Subgroup for Standardized Meal Test|Overall Study|Patients at selected sites where standardized meal test was performed.|27
8659086|NCT00688701|9702063|FG001|Subgroup for Standardized Meal Test|Overall Study||35
8659087|NCT00688701|9702064|FG002|Subgroup for Standardized Meal Test|Overall Study||60
8659088|NCT00688701|9702065|FG003|Subgroup for Standardized Meal Test|Overall Study||65
8659089|NCT00688701|9702062|FG000|COMPLETED|Overall Study||57
8659090|NCT00688701|9702063|FG001|COMPLETED|Overall Study||56
8659091|NCT00688701|9702064|FG002|COMPLETED|Overall Study||110
8659092|NCT00688701|9702065|FG003|COMPLETED|Overall Study||108
8659093|NCT00688701|9702062|FG000|NOT COMPLETED|Overall Study||4
8659094|NCT00688701|9702063|FG001|NOT COMPLETED|Overall Study||5
8659095|NCT00688701|9702064|FG002|NOT COMPLETED|Overall Study||10
8659096|NCT00688701|9702065|FG003|NOT COMPLETED|Overall Study||11
8659097|NCT00688740|9702078|FG000|STARTED|Overall Study||745
8659098|NCT00688740|9702079|FG001|STARTED|Overall Study||746
8659099|NCT00688740|9702078|FG000|COMPLETED|Overall Study||679
8659100|NCT00688740|9702079|FG001|COMPLETED|Overall Study||711
8659101|NCT00688740|9702078|FG000|NOT COMPLETED|Overall Study||66
8659102|NCT00688740|9702079|FG001|NOT COMPLETED|Overall Study||35
8659103|NCT00688753|9702085|FG000|STARTED|Overall Study||92
8659104|NCT00688753|9702085|FG000|COMPLETED|Overall Study||0
8659105|NCT00688753|9702085|FG000|NOT COMPLETED|Overall Study||92
8659106|NCT00688844|9702089|FG000|STARTED|Overall Study||58
8659107|NCT00688844|9702089|FG000|COMPLETED|Overall Study||48
8659108|NCT00688844|9702089|FG000|NOT COMPLETED|Overall Study||10
8659109|NCT00688870|9702095|FG000|STARTED|Infant Series||84
8659110|NCT00688870|9702096|FG001|STARTED|Infant Series||84
8659111|NCT00688870|9702095|FG000|Vaccinated Dose 1|Infant Series||83
8659112|NCT00688870|9702096|FG001|Vaccinated Dose 1|Infant Series||84
8659113|NCT00688870|9702095|FG000|Vaccinated Dose 2|Infant Series||80
8659114|NCT00688870|9702096|FG001|Vaccinated Dose 2|Infant Series||84
8659115|NCT00688870|9702095|FG000|Vaccinated Dose 3|Infant Series||80
8659116|NCT00688870|9702096|FG001|Vaccinated Dose 3|Infant Series||84
8659117|NCT00688870|9702095|FG000|COMPLETED|Infant Series||80
8659118|NCT00688870|9702096|FG001|COMPLETED|Infant Series||84
8659119|NCT00688870|9702095|FG000|NOT COMPLETED|Infant Series||4
8659120|NCT00688870|9702096|FG001|NOT COMPLETED|Infant Series||0
8659121|NCT00688870|9702095|FG000|STARTED|After Infant Series||80
8659122|NCT00688870|9702096|FG001|STARTED|After Infant Series||84
8659123|NCT00688870|9702095|FG000|COMPLETED|After Infant Series||80
8659124|NCT00688870|9702096|FG001|COMPLETED|After Infant Series||84
8659125|NCT00688870|9702095|FG000|NOT COMPLETED|After Infant Series||0
8659126|NCT00688870|9702096|FG001|NOT COMPLETED|After Infant Series||0
8659127|NCT00688870|9702095|FG000|STARTED|Toddler Dose||80
8659128|NCT00688870|9702096|FG001|STARTED|Toddler Dose||84
8659129|NCT00688870|9702095|FG000|COMPLETED|Toddler Dose||80
8659130|NCT00688870|9702096|FG001|COMPLETED|Toddler Dose||84
8659131|NCT00688870|9702095|FG000|NOT COMPLETED|Toddler Dose||0
8659132|NCT00688870|9702096|FG001|NOT COMPLETED|Toddler Dose||0
8659133|NCT00688909|9702106|FG000|STARTED|Overall Study||261
8659134|NCT00688909|9702106|FG000|COMPLETED|Overall Study||228
8659135|NCT00688909|9702106|FG000|NOT COMPLETED|Overall Study||33
8659136|NCT00689026|9702113|FG000|STARTED|Overall Study||30
8659137|NCT00689026|9702114|FG001|STARTED|Overall Study||30
8659138|NCT00689026|9702113|FG000|COMPLETED|Overall Study||17
8729461|NCT01053897|9776718|FG000|STARTED|Overall Study||5
8729462|NCT01053897|9776718|FG000|COMPLETED|Overall Study||5
8729463|NCT01053897|9776718|FG000|NOT COMPLETED|Overall Study||0
8729464|NCT01053962|9776733|FG000|STARTED|Pretreatment Period||14
8729465|NCT01053962|9776734|FG001|STARTED|Pretreatment Period||15
8729466|NCT01053962|9776735|FG002|STARTED|Pretreatment Period||16
8729467|NCT01053962|9776736|FG003|STARTED|Pretreatment Period||17
8729468|NCT01053962|9776737|FG004|STARTED|Pretreatment Period||22
8729469|NCT01053962|9776733|FG000|COMPLETED|Pretreatment Period||14
8729470|NCT01053962|9776734|FG001|COMPLETED|Pretreatment Period||14
8729471|NCT01053962|9776735|FG002|COMPLETED|Pretreatment Period||15
8729472|NCT01053962|9776736|FG003|COMPLETED|Pretreatment Period||15
8729473|NCT01053962|9776737|FG004|COMPLETED|Pretreatment Period||20
8729474|NCT01053962|9776733|FG000|NOT COMPLETED|Pretreatment Period||0
8729475|NCT01053962|9776734|FG001|NOT COMPLETED|Pretreatment Period||1
8729476|NCT01053962|9776735|FG002|NOT COMPLETED|Pretreatment Period||1
8729477|NCT01053962|9776736|FG003|NOT COMPLETED|Pretreatment Period||2
8729478|NCT01053962|9776737|FG004|NOT COMPLETED|Pretreatment Period||2
8729479|NCT01053962|9776733|FG000|STARTED|Treatment Period||14
8729480|NCT01053962|9776734|FG001|STARTED|Treatment Period||14
8729481|NCT01053962|9776735|FG002|STARTED|Treatment Period||15
8729482|NCT01053962|9776736|FG003|STARTED|Treatment Period||15
8729483|NCT01053962|9776737|FG004|STARTED|Treatment Period||20
8729484|NCT01053962|9776733|FG000|COMPLETED|Treatment Period||13
8729485|NCT01053962|9776734|FG001|COMPLETED|Treatment Period||14
8729486|NCT01053962|9776735|FG002|COMPLETED|Treatment Period||15
8729487|NCT01053962|9776736|FG003|COMPLETED|Treatment Period||15
8729488|NCT01053962|9776737|FG004|COMPLETED|Treatment Period||17
8729489|NCT01053962|9776733|FG000|NOT COMPLETED|Treatment Period||1
8729490|NCT01053962|9776734|FG001|NOT COMPLETED|Treatment Period||0
8729491|NCT01053962|9776735|FG002|NOT COMPLETED|Treatment Period||0
8729492|NCT01053962|9776736|FG003|NOT COMPLETED|Treatment Period||0
8729493|NCT01053962|9776737|FG004|NOT COMPLETED|Treatment Period||3
8729494|NCT01053962|9776733|FG000|STARTED|Follow-up Period||13
8729495|NCT01053962|9776734|FG001|STARTED|Follow-up Period||14
8729496|NCT01053962|9776735|FG002|STARTED|Follow-up Period||15
8659139|NCT00689026|9702114|FG001|COMPLETED|Overall Study||24
8659140|NCT00689026|9702113|FG000|NOT COMPLETED|Overall Study||13
8659141|NCT00689026|9702114|FG001|NOT COMPLETED|Overall Study||6
8659142|NCT00689078|9702124|FG000|STARTED|Overall Study||9
8659143|NCT00689078|9702125|FG001|STARTED|Overall Study||9
8659144|NCT00689078|9702126|FG002|STARTED|Overall Study||9
8729497|NCT01053962|9776736|FG003|STARTED|Follow-up Period||15
8729498|NCT01053962|9776737|FG004|STARTED|Follow-up Period||17
8729499|NCT01053962|9776733|FG000|COMPLETED|Follow-up Period||13
8729500|NCT01053962|9776734|FG001|COMPLETED|Follow-up Period||14
8659145|NCT00689078|9702127|FG003|STARTED|Overall Study||9
8659146|NCT00689078|9702124|FG000|Intent to Treat|Overall Study||9
8659147|NCT00689078|9702125|FG001|Intent to Treat|Overall Study||7
8659148|NCT00689078|9702126|FG002|Intent to Treat|Overall Study||8
8659149|NCT00689078|9702127|FG003|Intent to Treat|Overall Study||8
8659150|NCT00689078|9702124|FG000|COMPLETED|Overall Study||9
8659151|NCT00689078|9702125|FG001|COMPLETED|Overall Study||7
8659152|NCT00689078|9702126|FG002|COMPLETED|Overall Study||8
8659153|NCT00689078|9702127|FG003|COMPLETED|Overall Study||8
8659154|NCT00689078|9702124|FG000|NOT COMPLETED|Overall Study||0
8659155|NCT00689078|9702125|FG001|NOT COMPLETED|Overall Study||2
8659156|NCT00689078|9702126|FG002|NOT COMPLETED|Overall Study||1
8659157|NCT00689078|9702127|FG003|NOT COMPLETED|Overall Study||1
8659158|NCT00689091|9702139|FG000|STARTED|Overall Study||10831
8659159|NCT00689091|9702140|FG001|STARTED|Overall Study||10770
8659160|NCT00689091|9702139|FG000|COMPLETED|Overall Study||9460
8659161|NCT00689091|9702140|FG001|COMPLETED|Overall Study||9376
8659162|NCT00689091|9702139|FG000|NOT COMPLETED|Overall Study||1371
8659163|NCT00689091|9702140|FG001|NOT COMPLETED|Overall Study||1394
8659164|NCT00689104|9702154|FG000|STARTED|Overall Study||497
8659165|NCT00689104|9702155|FG001|STARTED|Overall Study||497
8659166|NCT00689104|9702156|FG002|STARTED|Overall Study||498
8659167|NCT00689104|9702157|FG003|STARTED|Overall Study||495
8659168|NCT00689104|9702154|FG000|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|494
8659169|NCT00689104|9702155|FG001|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|493
8659170|NCT00689104|9702156|FG002|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|496
8659171|NCT00689104|9702157|FG003|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|495
8659172|NCT00689104|9702154|FG000|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|480
8659173|NCT00689104|9702155|FG001|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|473
8659174|NCT00689104|9702156|FG002|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|478
8659175|NCT00689104|9702157|FG003|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|475
8659176|NCT00689104|9702154|FG000|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|291
8659177|NCT00689104|9702155|FG001|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|293
8659178|NCT00689104|9702156|FG002|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|281
8659179|NCT00689104|9702157|FG003|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|300
8659180|NCT00689104|9702154|FG000|COMPLETED|Overall Study||453
8659181|NCT00689104|9702155|FG001|COMPLETED|Overall Study||440
8659182|NCT00689104|9702156|FG002|COMPLETED|Overall Study||453
8659183|NCT00689104|9702157|FG003|COMPLETED|Overall Study||445
8659184|NCT00689104|9702154|FG000|NOT COMPLETED|Overall Study||44
8659185|NCT00689104|9702155|FG001|NOT COMPLETED|Overall Study||57
8659186|NCT00689104|9702156|FG002|NOT COMPLETED|Overall Study||45
8659187|NCT00689104|9702157|FG003|NOT COMPLETED|Overall Study||50
8659188|NCT00689117|9702171|FG000|STARTED|Overall Study||476
8659189|NCT00689117|9702172|FG001|STARTED|Overall Study||467
8659190|NCT00689117|9702173|FG002|STARTED|Overall Study||464
8659191|NCT00689117|9702174|FG003|STARTED|Overall Study||242
8659192|NCT00689117|9702171|FG000|COMPLETED|Overall Study||414
8659193|NCT00689117|9702172|FG001|COMPLETED|Overall Study||416
8659194|NCT00689117|9702173|FG002|COMPLETED|Overall Study||405
8659195|NCT00689117|9702174|FG003|COMPLETED|Overall Study||211
8659196|NCT00689117|9702171|FG000|NOT COMPLETED|Overall Study||62
8659197|NCT00689117|9702172|FG001|NOT COMPLETED|Overall Study||51
8659198|NCT00689117|9702173|FG002|NOT COMPLETED|Overall Study||59
8659199|NCT00689117|9702174|FG003|NOT COMPLETED|Overall Study||31
8659200|NCT00689221|9702186|FG000|STARTED|Overall Study||272
8659201|NCT00689221|9702187|FG001|STARTED|Overall Study||273
8659202|NCT00689221|9702186|FG000|COMPLETED|Overall Study||233
8659203|NCT00689221|9702187|FG001|COMPLETED|Overall Study||237
8659204|NCT00689221|9702186|FG000|NOT COMPLETED|Overall Study||39
8659205|NCT00689221|9702187|FG001|NOT COMPLETED|Overall Study||36
8659206|NCT00689260|9702195|FG000|STARTED|Overall Study||21
8659207|NCT00689260|9702196|FG001|STARTED|Overall Study||21
8659208|NCT00689260|9702195|FG000|COMPLETED|Overall Study||19
8659209|NCT00689260|9702196|FG001|COMPLETED|Overall Study||21
8659210|NCT00689260|9702195|FG000|NOT COMPLETED|Overall Study||2
8659211|NCT00689260|9702196|FG001|NOT COMPLETED|Overall Study||0
8659212|NCT00689273|9702207|FG000|STARTED|Overall Study||79
8659213|NCT00689273|9702208|FG001|STARTED|Overall Study||78
8659214|NCT00689273|9702207|FG000|Treated|Overall Study||78
8659215|NCT00689273|9702208|FG001|Treated|Overall Study||78
8659216|NCT00689273|9702207|FG000|COMPLETED|Overall Study||66
8659217|NCT00689273|9702208|FG001|COMPLETED|Overall Study||73
8659218|NCT00689273|9702207|FG000|NOT COMPLETED|Overall Study||13
8659219|NCT00689273|9702208|FG001|NOT COMPLETED|Overall Study||5
8659220|NCT00689299|9702217|FG000|STARTED|Overall Study||58
8659221|NCT00689299|9702218|FG001|STARTED|Overall Study||57
8659222|NCT00689299|9702219|FG002|STARTED|Overall Study||54
8659223|NCT00689299|9702217|FG000|COMPLETED|Overall Study||51
8659224|NCT00689299|9702218|FG001|COMPLETED|Overall Study||54
8659225|NCT00689299|9702219|FG002|COMPLETED|Overall Study||49
8659226|NCT00689299|9702217|FG000|NOT COMPLETED|Overall Study||7
8659227|NCT00689299|9702218|FG001|NOT COMPLETED|Overall Study||3
8659228|NCT00689299|9702219|FG002|NOT COMPLETED|Overall Study||5
8659229|NCT00689338|9702227|FG000|STARTED|Overall Study||216
8659230|NCT00689338|9702227|FG000|COMPLETED|Overall Study||73
8659231|NCT00689338|9702227|FG000|NOT COMPLETED|Overall Study||143
8659232|NCT00689351|9702233|FG000|STARTED|Infant Series of Dosing||91
8659233|NCT00689351|9702234|FG001|STARTED|Infant Series of Dosing||89
8659234|NCT00689351|9702233|FG000|Vaccinated Dose 1|Infant Series of Dosing||88
8659235|NCT00689351|9702234|FG001|Vaccinated Dose 1|Infant Series of Dosing||89
8659236|NCT00689351|9702233|FG000|Vaccinated Dose 2|Infant Series of Dosing||86
8659237|NCT00689351|9702234|FG001|Vaccinated Dose 2|Infant Series of Dosing||88
8659238|NCT00689351|9702233|FG000|Vaccinated Dose 3|Infant Series of Dosing||85
8659239|NCT00689351|9702234|FG001|Vaccinated Dose 3|Infant Series of Dosing||88
8659240|NCT00689351|9702233|FG000|COMPLETED|Infant Series of Dosing||85
8659241|NCT00689351|9702234|FG001|COMPLETED|Infant Series of Dosing||88
8659242|NCT00689351|9702233|FG000|NOT COMPLETED|Infant Series of Dosing||6
8659243|NCT00689351|9702234|FG001|NOT COMPLETED|Infant Series of Dosing||1
8659244|NCT00689351|9702233|FG000|STARTED|After Infant Series||85
8659245|NCT00689351|9702234|FG001|STARTED|After Infant Series||88
8659246|NCT00689351|9702233|FG000|COMPLETED|After Infant Series||84
8659247|NCT00689351|9702234|FG001|COMPLETED|After Infant Series||88
8659248|NCT00689351|9702233|FG000|NOT COMPLETED|After Infant Series||1
8659249|NCT00689351|9702234|FG001|NOT COMPLETED|After Infant Series||0
8659250|NCT00689351|9702233|FG000|STARTED|Toddler Dose||84
8659251|NCT00689351|9702234|FG001|STARTED|Toddler Dose||88
8659252|NCT00689351|9702233|FG000|COMPLETED|Toddler Dose||84
8659253|NCT00689351|9702234|FG001|COMPLETED|Toddler Dose||88
8659254|NCT00689351|9702233|FG000|NOT COMPLETED|Toddler Dose||0
8659255|NCT00689351|9702234|FG001|NOT COMPLETED|Toddler Dose||0
8659256|NCT00689390|9702246|FG000|STARTED|Overall Study||1907
8659257|NCT00689390|9702247|FG001|STARTED|Overall Study||47
8659258|NCT00689390|9702246|FG000|COMPLETED|Overall Study||1481
8659259|NCT00689390|9702247|FG001|COMPLETED|Overall Study||37
8659260|NCT00689390|9702246|FG000|NOT COMPLETED|Overall Study||426
8659261|NCT00689390|9702247|FG001|NOT COMPLETED|Overall Study||10
8659262|NCT00689481|9702260|FG000|STARTED|Overall Study||214
8659263|NCT00689481|9702261|FG001|STARTED|Overall Study||109
8659264|NCT00689481|9702260|FG000|COMPLETED|Overall Study||190
8659265|NCT00689481|9702261|FG001|COMPLETED|Overall Study||95
8659266|NCT00689481|9702260|FG000|NOT COMPLETED|Overall Study||24
8659267|NCT00689481|9702261|FG001|NOT COMPLETED|Overall Study||14
8659268|NCT00689572|9702269|FG000|STARTED|Overall Study||53
8659269|NCT00689572|9702270|FG001|STARTED|Overall Study||55
8659270|NCT00689572|9702269|FG000|COMPLETED|Overall Study||39
8659271|NCT00689572|9702270|FG001|COMPLETED|Overall Study||34
8659272|NCT00689572|9702269|FG000|NOT COMPLETED|Overall Study||14
8659273|NCT00689572|9702270|FG001|NOT COMPLETED|Overall Study||21
8659274|NCT00689611|9702278|FG000|STARTED|Overall Study||200
8659275|NCT00689611|9702279|FG001|STARTED|Overall Study||192
8659276|NCT00689611|9702278|FG000|COMPLETED|Overall Study||159
8659277|NCT00689611|9702279|FG001|COMPLETED|Overall Study||146
8659278|NCT00689611|9702278|FG000|NOT COMPLETED|Overall Study||41
8659279|NCT00689611|9702279|FG001|NOT COMPLETED|Overall Study||46
8659280|NCT00689728|9702288|FG000|STARTED|Double-Blind Treatment||35
8659281|NCT00689728|9702289|FG001|STARTED|Double-Blind Treatment||30
8659282|NCT00689728|9702290|FG002|STARTED|Double-Blind Treatment||35
8659283|NCT00689728|9702288|FG000|COMPLETED|Double-Blind Treatment||31
8659284|NCT00689728|9702289|FG001|COMPLETED|Double-Blind Treatment||26
8659285|NCT00689728|9702290|FG002|COMPLETED|Double-Blind Treatment||30
8659286|NCT00689728|9702288|FG000|NOT COMPLETED|Double-Blind Treatment||4
8659287|NCT00689728|9702289|FG001|NOT COMPLETED|Double-Blind Treatment||4
8659288|NCT00689728|9702290|FG002|NOT COMPLETED|Double-Blind Treatment||5
8659289|NCT00689728|9702288|FG000|STARTED|Rescue||31
8659290|NCT00689728|9702289|FG001|STARTED|Rescue||26
8659291|NCT00689728|9702290|FG002|STARTED|Rescue||30
8659292|NCT00689728|9702288|FG000|COMPLETED|Rescue||30
8659293|NCT00689728|9702289|FG001|COMPLETED|Rescue||24
8729501|NCT01053962|9776735|FG002|COMPLETED|Follow-up Period||15
8659294|NCT00689728|9702290|FG002|COMPLETED|Rescue||29
8659295|NCT00689728|9702288|FG000|NOT COMPLETED|Rescue||1
8659296|NCT00689728|9702289|FG001|NOT COMPLETED|Rescue||2
8659297|NCT00689728|9702290|FG002|NOT COMPLETED|Rescue||1
8659298|NCT00689728|9702288|FG000|STARTED|Optional Follow-Up|21 participants who completed the rescue period did not enter the optional follow-up period.|9
8659299|NCT00689728|9702289|FG001|STARTED|Optional Follow-Up|13 participants who completed the rescue period did not enter the optional follow-up period.|11
8659300|NCT00689728|9702290|FG002|STARTED|Optional Follow-Up|19 participants who completed the rescue period did not enter the optional follow-up period.|10
8659301|NCT00689728|9702288|FG000|COMPLETED|Optional Follow-Up||6
8659302|NCT00689728|9702289|FG001|COMPLETED|Optional Follow-Up||5
8659303|NCT00689728|9702290|FG002|COMPLETED|Optional Follow-Up||4
8659304|NCT00689728|9702288|FG000|NOT COMPLETED|Optional Follow-Up||3
8659305|NCT00689728|9702289|FG001|NOT COMPLETED|Optional Follow-Up||6
8659306|NCT00689728|9702290|FG002|NOT COMPLETED|Optional Follow-Up||6
8692215|NCT00858780|9737577|FG001|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
8692216|NCT00858780|9737578|FG002|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
8692217|NCT00858780|9737579|FG003|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
8659307|NCT00689793|9702321|FG000|STARTED|Overall Study||78
8659308|NCT00689793|9702322|FG001|STARTED|Overall Study||76
8659309|NCT00689793|9702321|FG000|COMPLETED|Overall Study||74
8659310|NCT00689793|9702322|FG001|COMPLETED|Overall Study||71
8659311|NCT00689793|9702321|FG000|NOT COMPLETED|Overall Study||4
8659312|NCT00689793|9702322|FG001|NOT COMPLETED|Overall Study||5
8659313|NCT00689819|9702332|FG000|STARTED|Overall Study||65
8659314|NCT00689819|9702333|FG001|STARTED|Overall Study||58
8659315|NCT00689819|9702332|FG000|COMPLETED|Overall Study||45
8659316|NCT00689819|9702333|FG001|COMPLETED|Overall Study||43
8659317|NCT00689819|9702332|FG000|NOT COMPLETED|Overall Study||20
8659318|NCT00689819|9702333|FG001|NOT COMPLETED|Overall Study||15
8659319|NCT00689871|9702343|FG000|STARTED|Overall Study|908 Implants|455
8659320|NCT00689871|9702344|FG001|STARTED|Overall Study|127 Implants|98
8659321|NCT00689871|9702345|FG002|STARTED|Overall Study|288 Implants|147
8659322|NCT00689871|9702346|FG003|STARTED|Overall Study|25 Implants|15
8659323|NCT00689871|9702343|FG000|COMPLETED|Overall Study|35 Patients discontinued|280
8659324|NCT00689871|9702344|FG001|COMPLETED|Overall Study|35 Patients discontinued|46
8659325|NCT00689871|9702345|FG002|COMPLETED|Overall Study|28 Patients discontinued|74
8659326|NCT00689871|9702346|FG003|COMPLETED|Overall Study|4 Patients discontinued|8
8659327|NCT00689871|9702343|FG000|NOT COMPLETED|Overall Study||175
8659328|NCT00689871|9702344|FG001|NOT COMPLETED|Overall Study||52
8659329|NCT00689871|9702345|FG002|NOT COMPLETED|Overall Study||73
8659330|NCT00689871|9702346|FG003|NOT COMPLETED|Overall Study||7
8659331|NCT00689936|9702359|FG000|STARTED|Active Treatment Phase||535
8659332|NCT00689936|9702360|FG001|STARTED|Active Treatment Phase||541
8659333|NCT00689936|9702361|FG002|STARTED|Active Treatment Phase||547
8659334|NCT00689936|9702359|FG000|Safety Population|Active Treatment Phase|Safety population = all randomized participants who received at least 1 dose of study treatment.|532
8659335|NCT00689936|9702360|FG001|Safety Population|Active Treatment Phase|Safety population = all randomized participants who received at least 1 dose of study treatment.|540
8659336|NCT00689936|9702361|FG002|Safety Population|Active Treatment Phase|Safety population = all randomized participants who received at least 1 dose of study treatment.|541
8659337|NCT00689936|9702359|FG000|Untreated|Active Treatment Phase|Participants randomized, but did not receive any study drug treatment.|3
8659338|NCT00689936|9702360|FG001|Untreated|Active Treatment Phase|Participants randomized, but did not receive any study drug treatment.|1
8659339|NCT00689936|9702361|FG002|Untreated|Active Treatment Phase|Participants randomized, but did not receive any study drug treatment.|6
8659340|NCT00689936|9702359|FG000|COMPLETED|Active Treatment Phase||0
8659341|NCT00689936|9702360|FG001|COMPLETED|Active Treatment Phase||0
8659342|NCT00689936|9702361|FG002|COMPLETED|Active Treatment Phase||0
8659343|NCT00689936|9702359|FG000|NOT COMPLETED|Active Treatment Phase||535
8659344|NCT00689936|9702360|FG001|NOT COMPLETED|Active Treatment Phase||541
8659345|NCT00689936|9702361|FG002|NOT COMPLETED|Active Treatment Phase||547
8659346|NCT00689936|9702359|FG000|STARTED|Progression Free Survival-PFS-Follow-Up|Includes participants who discontinued treatment for reasons other than progressive disease.|87
8659347|NCT00689936|9702360|FG001|STARTED|Progression Free Survival-PFS-Follow-Up|Includes participants who completed 18 cycles (Rd18) and did not experience progressive disease.|300
8659348|NCT00689936|9702361|FG002|STARTED|Progression Free Survival-PFS-Follow-Up|Includes participants who completed 12 cycles MPT and did not experience progressive disease.|273
8659349|NCT00689936|9702359|FG000|COMPLETED|Progression Free Survival-PFS-Follow-Up||87
8659350|NCT00689936|9702360|FG001|COMPLETED|Progression Free Survival-PFS-Follow-Up||300
8659351|NCT00689936|9702361|FG002|COMPLETED|Progression Free Survival-PFS-Follow-Up||273
8659352|NCT00689936|9702359|FG000|NOT COMPLETED|Progression Free Survival-PFS-Follow-Up||0
8659353|NCT00689936|9702360|FG001|NOT COMPLETED|Progression Free Survival-PFS-Follow-Up||0
8659354|NCT00689936|9702361|FG002|NOT COMPLETED|Progression Free Survival-PFS-Follow-Up||0
8659355|NCT00689936|9702359|FG000|STARTED|Long-Term Follow Up Phase|Includes participants from both the active treatment phase and from the PFS follow-up phase.|382
8659356|NCT00689936|9702360|FG001|STARTED|Long-Term Follow Up Phase|Includes participants from both the active treatment phase and from the PFS follow-up phase.|463
8659357|NCT00689936|9702361|FG002|STARTED|Long-Term Follow Up Phase|Includes participants from both the active treatment phase and from the PFS follow-up phase.|459
8659358|NCT00689936|9702359|FG000|COMPLETED|Long-Term Follow Up Phase||255
8659359|NCT00689936|9702360|FG001|COMPLETED|Long-Term Follow Up Phase||275
8659360|NCT00689936|9702361|FG002|COMPLETED|Long-Term Follow Up Phase||315
8659361|NCT00689936|9702359|FG000|NOT COMPLETED|Long-Term Follow Up Phase||127
8659362|NCT00689936|9702360|FG001|NOT COMPLETED|Long-Term Follow Up Phase||188
8659363|NCT00689936|9702361|FG002|NOT COMPLETED|Long-Term Follow Up Phase||144
8659364|NCT00690040|9702371|FG000|STARTED|Overall Study||145
8659365|NCT00690040|9702372|FG001|STARTED|Overall Study||148
8659366|NCT00690040|9702371|FG000|COMPLETED|Overall Study||145
8659367|NCT00690040|9702372|FG001|COMPLETED|Overall Study||148
8659368|NCT00690040|9702371|FG000|NOT COMPLETED|Overall Study||0
8659369|NCT00690040|9702372|FG001|NOT COMPLETED|Overall Study||0
8659370|NCT00690235|9702380|FG000|STARTED|Overall Study||17
8659371|NCT00690235|9702381|FG001|STARTED|Overall Study||16
8659372|NCT00690235|9702380|FG000|COMPLETED|Overall Study||12
8659373|NCT00690235|9702381|FG001|COMPLETED|Overall Study||12
8659374|NCT00690235|9702380|FG000|NOT COMPLETED|Overall Study||5
8659375|NCT00690235|9702381|FG001|NOT COMPLETED|Overall Study||4
8659376|NCT00690274|9702389|FG000|STARTED|Overall Study||29
8659377|NCT00690274|9702390|FG001|STARTED|Overall Study||23
8659378|NCT00690274|9702389|FG000|COMPLETED|Overall Study||23
8659379|NCT00690274|9702390|FG001|COMPLETED|Overall Study||15
8659380|NCT00690274|9702389|FG000|NOT COMPLETED|Overall Study||6
8659381|NCT00690274|9702390|FG001|NOT COMPLETED|Overall Study||8
8659382|NCT00690339|9702400|FG000|STARTED|Overall Study||492
8659383|NCT00690339|9702401|FG001|STARTED|Overall Study||225
8659384|NCT00690339|9702402|FG002|STARTED|Overall Study||156
8659385|NCT00690339|9702403|FG003|STARTED|Overall Study||68
8659386|NCT00690339|9702400|FG000|COMPLETED|Overall Study||375
8659387|NCT00690339|9702401|FG001|COMPLETED|Overall Study||144
8659388|NCT00690339|9702402|FG002|COMPLETED|Overall Study||99
8659389|NCT00690339|9702403|FG003|COMPLETED|Overall Study||43
8659390|NCT00690339|9702400|FG000|NOT COMPLETED|Overall Study||117
8659391|NCT00690339|9702401|FG001|NOT COMPLETED|Overall Study||81
8659392|NCT00690339|9702402|FG002|NOT COMPLETED|Overall Study||57
8659393|NCT00690339|9702403|FG003|NOT COMPLETED|Overall Study||25
8659394|NCT00690378|9702415|FG000|STARTED|Overall Study|Randomized|69
8659395|NCT00690378|9702416|FG001|STARTED|Overall Study|Randomized|68
8659396|NCT00690378|9702415|FG000|Treated|Overall Study||68
8659397|NCT00690378|9702416|FG001|Treated|Overall Study||67
8659398|NCT00690378|9702415|FG000|COMPLETED|Overall Study|Up to Late follow up (LFU) visit|49
8659399|NCT00690378|9702416|FG001|COMPLETED|Overall Study|Up to LFU visit|54
8659400|NCT00690378|9702415|FG000|NOT COMPLETED|Overall Study||20
8659401|NCT00690378|9702416|FG001|NOT COMPLETED|Overall Study||14
8659402|NCT00690430|9702424|FG000|STARTED|Core Phase|"Started indicates Full Analysis Set (FAS) and Safety Set."|53
8659403|NCT00690430|9702425|FG001|STARTED|Core Phase||57
8659404|NCT00690430|9702426|FG002|STARTED|Core Phase|This arm belongs to Extension Phase.|0
8659405|NCT00690430|9702424|FG000|COMPLETED|Core Phase||35
8659406|NCT00690430|9702425|FG001|COMPLETED|Core Phase||34
8659407|NCT00690430|9702426|FG002|COMPLETED|Core Phase||0
8659408|NCT00690430|9702424|FG000|NOT COMPLETED|Core Phase||18
8659409|NCT00690430|9702425|FG001|NOT COMPLETED|Core Phase||23
8659410|NCT00690430|9702426|FG002|NOT COMPLETED|Core Phase||0
8659411|NCT00690430|9702424|FG000|STARTED|Extension Phase|Only those patients (except from UK) who received clinical benefit could extend therapy in extension|20
8659412|NCT00690430|9702425|FG001|STARTED|Extension Phase|Only those patients (except from UK) who received clinical benefit could extend therapy in extension|6
8659413|NCT00690430|9702426|FG002|STARTED|Extension Phase|Only those patients (except from UK) who received clinical benefit could extend therapy in extension|15
8659414|NCT00690430|9702424|FG000|COMPLETED|Extension Phase||2
8659415|NCT00690430|9702425|FG001|COMPLETED|Extension Phase||1
8659416|NCT00690430|9702426|FG002|COMPLETED|Extension Phase||2
8659417|NCT00690430|9702424|FG000|NOT COMPLETED|Extension Phase||18
8659418|NCT00690430|9702425|FG001|NOT COMPLETED|Extension Phase||5
8659419|NCT00690430|9702426|FG002|NOT COMPLETED|Extension Phase||13
8659420|NCT00690443|9702437|FG000|STARTED|Overall Study||23
8659421|NCT00690443|9702438|FG001|STARTED|Overall Study||21
8659422|NCT00690443|9702437|FG000|COMPLETED|Overall Study||22
8659423|NCT00690443|9702438|FG001|COMPLETED|Overall Study||19
8659424|NCT00690443|9702437|FG000|NOT COMPLETED|Overall Study||1
8659425|NCT00690443|9702438|FG001|NOT COMPLETED|Overall Study||2
8659426|NCT00690482|9702446|FG000|STARTED|Overall Study||61
8659427|NCT00690482|9702447|FG001|STARTED|Overall Study||57
8659428|NCT00690482|9702446|FG000|COMPLETED|Overall Study||57
8659429|NCT00690482|9702447|FG001|COMPLETED|Overall Study||54
8659430|NCT00690482|9702446|FG000|NOT COMPLETED|Overall Study||4
8659431|NCT00690482|9702447|FG001|NOT COMPLETED|Overall Study||3
8659432|NCT00690495|9702455|FG000|STARTED|Overall Study||50
8659433|NCT00690495|9702456|FG001|STARTED|Overall Study||50
8659434|NCT00690495|9702455|FG000|Primary Endpoint|Overall Study||50
8659435|NCT00690495|9702456|FG001|Primary Endpoint|Overall Study||50
8659436|NCT00690495|9702455|FG000|COMPLETED|Overall Study||50
8659437|NCT00690495|9702456|FG001|COMPLETED|Overall Study||50
8659438|NCT00690495|9702455|FG000|NOT COMPLETED|Overall Study||0
8659439|NCT00690495|9702456|FG001|NOT COMPLETED|Overall Study||0
8659440|NCT00690573|9702462|FG000|STARTED|Overall Study||25
8659441|NCT00690573|9702462|FG000|COMPLETED|Overall Study||16
8659442|NCT00690573|9702462|FG000|NOT COMPLETED|Overall Study||9
8659443|NCT00690612|9702466|FG000|STARTED|Overall Study||35
8659444|NCT00690612|9702466|FG000|COMPLETED|Overall Study||32
8659445|NCT00690612|9702466|FG000|NOT COMPLETED|Overall Study||3
8659446|NCT00690755|9702477|FG000|STARTED|Overall Study||30
8659447|NCT00690755|9702478|FG001|STARTED|Overall Study||0
8659448|NCT00690755|9702479|FG002|STARTED|Overall Study||97
8659449|NCT00690755|9702480|FG003|STARTED|Overall Study||20
8659450|NCT00690755|9702481|FG004|STARTED|Overall Study||0
8659451|NCT00690755|9702482|FG005|STARTED|Overall Study||10
8659452|NCT00690755|9702483|FG006|STARTED|Overall Study||0
8659453|NCT00690755|9702477|FG000|COMPLETED|Overall Study|Patient recruitment ended on 12/31/2010|28
8659454|NCT00690755|9702478|FG001|COMPLETED|Overall Study||0
8659455|NCT00690755|9702479|FG002|COMPLETED|Overall Study||51
8659456|NCT00690755|9702480|FG003|COMPLETED|Overall Study||15
8659457|NCT00690755|9702481|FG004|COMPLETED|Overall Study||0
8659458|NCT00690755|9702482|FG005|COMPLETED|Overall Study||6
8659459|NCT00690755|9702483|FG006|COMPLETED|Overall Study||0
8659460|NCT00690755|9702477|FG000|NOT COMPLETED|Overall Study||2
8659461|NCT00690755|9702478|FG001|NOT COMPLETED|Overall Study||0
8659462|NCT00690755|9702479|FG002|NOT COMPLETED|Overall Study||46
8659463|NCT00690755|9702480|FG003|NOT COMPLETED|Overall Study||5
8659464|NCT00690755|9702481|FG004|NOT COMPLETED|Overall Study||0
8659465|NCT00690755|9702482|FG005|NOT COMPLETED|Overall Study||4
8659466|NCT00690755|9702483|FG006|NOT COMPLETED|Overall Study||0
8659467|NCT00690794|9702501|FG000|STARTED|Overall Study||363
8659468|NCT00690794|9702502|FG001|STARTED|Overall Study||363
8659469|NCT00690794|9702501|FG000|COMPLETED|Overall Study||342
8659470|NCT00690794|9702502|FG001|COMPLETED|Overall Study||328
8659471|NCT00690794|9702501|FG000|NOT COMPLETED|Overall Study||21
8659472|NCT00690794|9702502|FG001|NOT COMPLETED|Overall Study||35
8659473|NCT00690820|9702510|FG000|STARTED|Period 1||8
8659474|NCT00690820|9702511|FG001|STARTED|Period 1||9
8659475|NCT00690820|9702510|FG000|COMPLETED|Period 1||8
8659476|NCT00690820|9702511|FG001|COMPLETED|Period 1||8
8659477|NCT00690820|9702510|FG000|NOT COMPLETED|Period 1||0
8659478|NCT00690820|9702511|FG001|NOT COMPLETED|Period 1||1
8659479|NCT00690820|9702510|FG000|STARTED|Period 2||8
8659480|NCT00690820|9702511|FG001|STARTED|Period 2||8
8659481|NCT00690820|9702510|FG000|COMPLETED|Period 2||8
8659482|NCT00690820|9702511|FG001|COMPLETED|Period 2||8
8659483|NCT00690820|9702510|FG000|NOT COMPLETED|Period 2||0
8659484|NCT00690820|9702511|FG001|NOT COMPLETED|Period 2||0
8659485|NCT00690833|9702517|FG000|STARTED|Overall Study||41
8659486|NCT00690833|9702517|FG000|COMPLETED|Overall Study||39
8659487|NCT00690833|9702517|FG000|NOT COMPLETED|Overall Study||2
8659488|NCT00690898|9702521|FG000|STARTED|SCREENING|Total of patients screened for the study.|108
8659489|NCT00690898|9702521|FG000|COMPLETED|SCREENING|Number of patients included in the study.|90
8659490|NCT00690898|9702521|FG000|NOT COMPLETED|SCREENING||18
8659491|NCT00690898|9702521|FG000|STARTED|TREATMENT|Total number of patients treated.|90
8659492|NCT00690898|9702521|FG000|COMPLETED|TREATMENT||64
8659493|NCT00690898|9702521|FG000|NOT COMPLETED|TREATMENT||26
8659494|NCT00690924|9702525|FG000|STARTED|Overall Study||16
8659495|NCT00690924|9702525|FG000|COMPLETED|Overall Study||16
8659496|NCT00690924|9702525|FG000|NOT COMPLETED|Overall Study||0
8659497|NCT00691002|9702533|FG000|STARTED|8-week, Double-blind, 4-arm||353
8659498|NCT00691002|9702534|FG001|STARTED|8-week, Double-blind, 4-arm||342
8659499|NCT00691002|9702535|FG002|STARTED|8-week, Double-blind, 4-arm||363
8659500|NCT00691002|9702536|FG003|STARTED|8-week, Double-blind, 4-arm||181
8659501|NCT00691002|9702537|FG004|STARTED|8-week, Double-blind, 4-arm||0
8659502|NCT00691002|9702533|FG000|COMPLETED|8-week, Double-blind, 4-arm||325
8659503|NCT00691002|9702534|FG001|COMPLETED|8-week, Double-blind, 4-arm||308
8659504|NCT00691002|9702535|FG002|COMPLETED|8-week, Double-blind, 4-arm||340
8659505|NCT00691002|9702536|FG003|COMPLETED|8-week, Double-blind, 4-arm||169
8659506|NCT00691002|9702537|FG004|COMPLETED|8-week, Double-blind, 4-arm||0
8659507|NCT00691002|9702533|FG000|NOT COMPLETED|8-week, Double-blind, 4-arm||28
8659508|NCT00691002|9702534|FG001|NOT COMPLETED|8-week, Double-blind, 4-arm||34
8659509|NCT00691002|9702535|FG002|NOT COMPLETED|8-week, Double-blind, 4-arm||23
8659510|NCT00691002|9702536|FG003|NOT COMPLETED|8-week, Double-blind, 4-arm||12
8659511|NCT00691002|9702537|FG004|NOT COMPLETED|8-week, Double-blind, 4-arm||0
8659512|NCT00691002|9702533|FG000|STARTED|52-week, Open-label, Single Arm||454
8659513|NCT00691002|9702534|FG001|STARTED|52-week, Open-label, Single Arm||0
8659514|NCT00691002|9702535|FG002|STARTED|52-week, Open-label, Single Arm||0
8659515|NCT00691002|9702536|FG003|STARTED|52-week, Open-label, Single Arm||0
8659516|NCT00691002|9702537|FG004|STARTED|52-week, Open-label, Single Arm||0
8659517|NCT00691002|9702533|FG000|COMPLETED|52-week, Open-label, Single Arm||403
8659518|NCT00691002|9702534|FG001|COMPLETED|52-week, Open-label, Single Arm||0
8659519|NCT00691002|9702535|FG002|COMPLETED|52-week, Open-label, Single Arm||0
8659520|NCT00691002|9702536|FG003|COMPLETED|52-week, Open-label, Single Arm||0
8659521|NCT00691002|9702537|FG004|COMPLETED|52-week, Open-label, Single Arm||0
8659522|NCT00691002|9702533|FG000|NOT COMPLETED|52-week, Open-label, Single Arm||51
8659523|NCT00691002|9702534|FG001|NOT COMPLETED|52-week, Open-label, Single Arm||0
8659524|NCT00691002|9702535|FG002|NOT COMPLETED|52-week, Open-label, Single Arm||0
8659525|NCT00691002|9702536|FG003|NOT COMPLETED|52-week, Open-label, Single Arm||0
8659526|NCT00691002|9702537|FG004|NOT COMPLETED|52-week, Open-label, Single Arm||0
8659527|NCT00691015|9702548|FG000|STARTED|Overall Study||48
8659528|NCT00691015|9702548|FG000|COMPLETED|Overall Study||47
8659529|NCT00691015|9702548|FG000|NOT COMPLETED|Overall Study||1
8659530|NCT00691028|9702555|FG000|STARTED|Open-label Period||0
8659531|NCT00691028|9702556|FG001|STARTED|Open-label Period||0
8659532|NCT00691028|9702557|FG002|STARTED|Open-label Period||0
8659533|NCT00691028|9702558|FG003|STARTED|Open-label Period||327
8659534|NCT00691028|9702555|FG000|COMPLETED|Open-label Period||0
8659535|NCT00691028|9702556|FG001|COMPLETED|Open-label Period||0
8659536|NCT00691028|9702557|FG002|COMPLETED|Open-label Period||0
8659537|NCT00691028|9702558|FG003|COMPLETED|Open-label Period||307
8659538|NCT00691028|9702555|FG000|NOT COMPLETED|Open-label Period||0
8659539|NCT00691028|9702556|FG001|NOT COMPLETED|Open-label Period||0
8659540|NCT00691028|9702557|FG002|NOT COMPLETED|Open-label Period||0
8659541|NCT00691028|9702558|FG003|NOT COMPLETED|Open-label Period||20
8729502|NCT01053962|9776736|FG003|COMPLETED|Follow-up Period||15
8659542|NCT00691028|9702555|FG000|STARTED|Double-blind Period||99
8659543|NCT00691028|9702556|FG001|STARTED|Double-blind Period||104
8659544|NCT00691028|9702557|FG002|STARTED|Double-blind Period||104
8659545|NCT00691028|9702558|FG003|STARTED|Double-blind Period||0
8659546|NCT00691028|9702555|FG000|COMPLETED|Double-blind Period||86
8659547|NCT00691028|9702556|FG001|COMPLETED|Double-blind Period||91
8659548|NCT00691028|9702557|FG002|COMPLETED|Double-blind Period||95
8659549|NCT00691028|9702558|FG003|COMPLETED|Double-blind Period||0
8659550|NCT00691028|9702555|FG000|NOT COMPLETED|Double-blind Period||13
8659551|NCT00691028|9702556|FG001|NOT COMPLETED|Double-blind Period||13
8659552|NCT00691028|9702557|FG002|NOT COMPLETED|Double-blind Period||9
8659553|NCT00691028|9702558|FG003|NOT COMPLETED|Double-blind Period||0
8659554|NCT00691054|9702570|FG000|STARTED|Overall Study||20
8659555|NCT00691054|9702570|FG000|COMPLETED|Overall Study||19
8659556|NCT00691054|9702570|FG000|NOT COMPLETED|Overall Study||1
8659557|NCT00691093|9702576|FG000|STARTED|Overall Study||823
8659558|NCT00691093|9702576|FG000|COMPLETED|Overall Study||816
8659559|NCT00691093|9702576|FG000|NOT COMPLETED|Overall Study||7
8659560|NCT00691132|9702587|FG000|STARTED|Overall Study||53
8659561|NCT00691132|9702588|FG001|STARTED|Overall Study|107 total randomized. Approximately 1/2 per arm.|54
8659562|NCT00691132|9702587|FG000|COMPLETED|Overall Study||41
8659563|NCT00691132|9702588|FG001|COMPLETED|Overall Study|45 completed, but 4 excluded b/c urinary measures indicated they did not smoke study cigarettes.|41
8659564|NCT00691132|9702587|FG000|NOT COMPLETED|Overall Study||12
8659565|NCT00691132|9702588|FG001|NOT COMPLETED|Overall Study||13
8659566|NCT00691197|9702606|FG000|STARTED|Overall Study||166
8659567|NCT00691197|9702607|FG001|STARTED|Overall Study||80
8659568|NCT00691197|9702606|FG000|COMPLETED|Overall Study||155
8659569|NCT00691197|9702607|FG001|COMPLETED|Overall Study||75
8659570|NCT00691197|9702606|FG000|NOT COMPLETED|Overall Study||11
8659571|NCT00691197|9702607|FG001|NOT COMPLETED|Overall Study||5
8659572|NCT00691210|9702621|FG000|STARTED|Overall Study||3
8659573|NCT00691210|9702622|FG001|STARTED|Overall Study||5
8659574|NCT00691210|9702623|FG002|STARTED|Overall Study||3
8659575|NCT00691210|9702624|FG003|STARTED|Overall Study||9
8659576|NCT00691210|9702625|FG004|STARTED|Overall Study||5
8659577|NCT00691210|9702626|FG005|STARTED|Overall Study||7
8659578|NCT00691210|9702627|FG006|STARTED|Overall Study||6
8659579|NCT00691210|9702628|FG007|STARTED|Overall Study||0
8659580|NCT00691210|9702621|FG000|COMPLETED|Overall Study||3
8659581|NCT00691210|9702622|FG001|COMPLETED|Overall Study||5
8659582|NCT00691210|9702623|FG002|COMPLETED|Overall Study||3
8659583|NCT00691210|9702624|FG003|COMPLETED|Overall Study||6
8659584|NCT00691210|9702625|FG004|COMPLETED|Overall Study||5
8659585|NCT00691210|9702626|FG005|COMPLETED|Overall Study||6
8659586|NCT00691210|9702627|FG006|COMPLETED|Overall Study||6
8659587|NCT00691210|9702628|FG007|COMPLETED|Overall Study||0
8659588|NCT00691210|9702621|FG000|NOT COMPLETED|Overall Study||0
8659589|NCT00691210|9702622|FG001|NOT COMPLETED|Overall Study||0
8659590|NCT00691210|9702623|FG002|NOT COMPLETED|Overall Study||0
8659591|NCT00691210|9702624|FG003|NOT COMPLETED|Overall Study||3
8659592|NCT00691210|9702625|FG004|NOT COMPLETED|Overall Study||0
8659593|NCT00691210|9702626|FG005|NOT COMPLETED|Overall Study||1
8659594|NCT00691210|9702627|FG006|NOT COMPLETED|Overall Study||0
8729503|NCT01053962|9776737|FG004|COMPLETED|Follow-up Period||17
8729504|NCT01053962|9776733|FG000|NOT COMPLETED|Follow-up Period||0
8729505|NCT01053962|9776734|FG001|NOT COMPLETED|Follow-up Period||0
8729506|NCT01053962|9776735|FG002|NOT COMPLETED|Follow-up Period||0
8729507|NCT01053962|9776736|FG003|NOT COMPLETED|Follow-up Period||0
8729508|NCT01053962|9776737|FG004|NOT COMPLETED|Follow-up Period||0
8729509|NCT01053988|9776759|FG000|STARTED|2-week, Single-blind Run-In Period||1390
8729510|NCT01053988|9776760|FG001|STARTED|2-week, Single-blind Run-In Period||0
8729511|NCT01053988|9776761|FG002|STARTED|2-week, Single-blind Run-In Period||0
8729512|NCT01053988|9776762|FG003|STARTED|2-week, Single-blind Run-In Period||0
8729513|NCT01053988|9776763|FG004|STARTED|2-week, Single-blind Run-In Period||0
8729514|NCT01053988|9776764|FG005|STARTED|2-week, Single-blind Run-In Period||0
8729515|NCT01053988|9776759|FG000|COMPLETED|2-week, Single-blind Run-In Period||1030
8729516|NCT01053988|9776760|FG001|COMPLETED|2-week, Single-blind Run-In Period||0
8729517|NCT01053988|9776761|FG002|COMPLETED|2-week, Single-blind Run-In Period||0
8729518|NCT01053988|9776762|FG003|COMPLETED|2-week, Single-blind Run-In Period||0
8729519|NCT01053988|9776763|FG004|COMPLETED|2-week, Single-blind Run-In Period||0
8729520|NCT01053988|9776764|FG005|COMPLETED|2-week, Single-blind Run-In Period||0
8729521|NCT01053988|9776759|FG000|NOT COMPLETED|2-week, Single-blind Run-In Period||360
8729522|NCT01053988|9776760|FG001|NOT COMPLETED|2-week, Single-blind Run-In Period||0
8729523|NCT01053988|9776761|FG002|NOT COMPLETED|2-week, Single-blind Run-In Period||0
8729524|NCT01053988|9776762|FG003|NOT COMPLETED|2-week, Single-blind Run-In Period||0
8729525|NCT01053988|9776763|FG004|NOT COMPLETED|2-week, Single-blind Run-In Period||0
8729526|NCT01053988|9776764|FG005|NOT COMPLETED|2-week, Single-blind Run-In Period||0
8729527|NCT01053988|9776759|FG000|STARTED|24-week, Double-blind Treatment Period||0
8729528|NCT01053988|9776760|FG001|STARTED|24-week, Double-blind Treatment Period||207
8729529|NCT01053988|9776761|FG002|STARTED|24-week, Double-blind Treatment Period||206
8729530|NCT01053988|9776762|FG003|STARTED|24-week, Double-blind Treatment Period||205
8729531|NCT01053988|9776763|FG004|STARTED|24-week, Double-blind Treatment Period||206
8729532|NCT01053988|9776764|FG005|STARTED|24-week, Double-blind Treatment Period||206
8729533|NCT01053988|9776759|FG000|COMPLETED|24-week, Double-blind Treatment Period||0
8729534|NCT01053988|9776760|FG001|COMPLETED|24-week, Double-blind Treatment Period||138
8729535|NCT01053988|9776761|FG002|COMPLETED|24-week, Double-blind Treatment Period||145
8729536|NCT01053988|9776762|FG003|COMPLETED|24-week, Double-blind Treatment Period||142
8729537|NCT01053988|9776763|FG004|COMPLETED|24-week, Double-blind Treatment Period||147
8729538|NCT01053988|9776764|FG005|COMPLETED|24-week, Double-blind Treatment Period||151
8659595|NCT00691210|9702628|FG007|NOT COMPLETED|Overall Study||0
8659596|NCT00691301|9702646|FG000|STARTED|Overall Study||55
8659597|NCT00691301|9702646|FG000|COMPLETED|Overall Study||1
8659598|NCT00691301|9702646|FG000|NOT COMPLETED|Overall Study||54
8659599|NCT00691327|9702658|FG000|STARTED|Overall Study||45055
8659600|NCT00691327|9702659|FG001|STARTED|Overall Study||39274
8659601|NCT00691327|9702658|FG000|COMPLETED|Overall Study||42214
8659602|NCT00691327|9702659|FG001|COMPLETED|Overall Study||36766
8659603|NCT00691327|9702658|FG000|NOT COMPLETED|Overall Study||2841
8659604|NCT00691327|9702659|FG001|NOT COMPLETED|Overall Study||2508
8659605|NCT00691483|9702667|FG000|STARTED|Overall Study||493
8659606|NCT00691483|9702668|FG001|STARTED|Overall Study||166
8659607|NCT00691483|9702667|FG000|Received Treatment|Overall Study||486
8659608|NCT00691483|9702668|FG001|Received Treatment|Overall Study||165
8659609|NCT00691483|9702667|FG000|COMPLETED|Overall Study|Completed refers to completion of the study.|425
8659610|NCT00691483|9702668|FG001|COMPLETED|Overall Study||141
8659611|NCT00691483|9702667|FG000|NOT COMPLETED|Overall Study||68
8659612|NCT00691483|9702668|FG001|NOT COMPLETED|Overall Study||25
8659613|NCT00691600|9702676|FG000|STARTED|Overall Study||12
8659614|NCT00691600|9702677|FG001|STARTED|Overall Study||11
8659615|NCT00691600|9702676|FG000|COMPLETED|Overall Study||12
8659616|NCT00691600|9702677|FG001|COMPLETED|Overall Study||11
8659617|NCT00691600|9702676|FG000|NOT COMPLETED|Overall Study||0
8659618|NCT00691600|9702677|FG001|NOT COMPLETED|Overall Study||0
8659619|NCT00691665|9702685|FG000|STARTED|Overall Study||65
8659620|NCT00691665|9702686|FG001|STARTED|Overall Study||65
8659621|NCT00691665|9702685|FG000|COMPLETED|Overall Study||65
8659622|NCT00691665|9702686|FG001|COMPLETED|Overall Study||65
8659623|NCT00691665|9702685|FG000|NOT COMPLETED|Overall Study||0
8659624|NCT00691665|9702686|FG001|NOT COMPLETED|Overall Study||0
8659625|NCT00691704|9702692|FG000|STARTED|Induction Therapy||18
8659626|NCT00691704|9702692|FG000|COMPLETED|Induction Therapy||16
8659627|NCT00691704|9702692|FG000|NOT COMPLETED|Induction Therapy||2
8659628|NCT00691704|9702692|FG000|STARTED|Two Years of Maintenance Therapy||16
8659629|NCT00691704|9702692|FG000|COMPLETED|Two Years of Maintenance Therapy||3
8659630|NCT00691704|9702692|FG000|NOT COMPLETED|Two Years of Maintenance Therapy||13
8659631|NCT00691808|9702699|FG000|STARTED|Overall Study||35
8659632|NCT00691808|9702700|FG001|STARTED|Overall Study||36
8659633|NCT00691808|9702701|FG002|STARTED|Overall Study||32
8659634|NCT00691808|9702699|FG000|COMPLETED|Overall Study||35
8659635|NCT00691808|9702700|FG001|COMPLETED|Overall Study||35
8659636|NCT00691808|9702701|FG002|COMPLETED|Overall Study||32
8659637|NCT00691808|9702699|FG000|NOT COMPLETED|Overall Study||0
8659638|NCT00691808|9702700|FG001|NOT COMPLETED|Overall Study||1
8659639|NCT00691808|9702701|FG002|NOT COMPLETED|Overall Study||0
8659640|NCT00691938|9702716|FG000|STARTED|Overall Study||5
8659641|NCT00691938|9702717|FG001|STARTED|Overall Study||3
8659642|NCT00691938|9702718|FG002|STARTED|Overall Study||6
8659643|NCT00691938|9702719|FG003|STARTED|Overall Study||8
8659644|NCT00691938|9702720|FG004|STARTED|Overall Study||10
8659645|NCT00691938|9702721|FG005|STARTED|Overall Study||6
8659646|NCT00691938|9702722|FG006|STARTED|Overall Study||14
8659647|NCT00691938|9702716|FG000|COMPLETED|Overall Study||4
8659648|NCT00691938|9702717|FG001|COMPLETED|Overall Study||3
8659649|NCT00691938|9702718|FG002|COMPLETED|Overall Study||6
8659650|NCT00691938|9702719|FG003|COMPLETED|Overall Study||8
8659651|NCT00691938|9702720|FG004|COMPLETED|Overall Study||10
8659652|NCT00691938|9702721|FG005|COMPLETED|Overall Study||6
8659653|NCT00691938|9702722|FG006|COMPLETED|Overall Study||14
8659654|NCT00691938|9702716|FG000|NOT COMPLETED|Overall Study||1
8659655|NCT00691938|9702717|FG001|NOT COMPLETED|Overall Study||0
8659656|NCT00691938|9702718|FG002|NOT COMPLETED|Overall Study||0
8659657|NCT00691938|9702719|FG003|NOT COMPLETED|Overall Study||0
8659658|NCT00691938|9702720|FG004|NOT COMPLETED|Overall Study||0
8911298|NCT02144714|9970366|FG002|STARTED|Overall Study||63
8911299|NCT02144714|9970364|FG000|COMPLETED|Overall Study||63
8911300|NCT02144714|9970365|FG001|COMPLETED|Overall Study||63
8911301|NCT02144714|9970366|FG002|COMPLETED|Overall Study||63
8911302|NCT02144714|9970364|FG000|NOT COMPLETED|Overall Study||0
8911303|NCT02144714|9970365|FG001|NOT COMPLETED|Overall Study||0
8911304|NCT02144714|9970366|FG002|NOT COMPLETED|Overall Study||0
8911305|NCT02145026|9970374|FG000|STARTED|Overall Study||100
8911306|NCT02145026|9970374|FG000|COMPLETED|Overall Study||88
8911307|NCT02145026|9970374|FG000|NOT COMPLETED|Overall Study||12
8911308|NCT02145039|9970378|FG000|STARTED|Overall Study||2
8911309|NCT02145039|9970378|FG000|COMPLETED|Overall Study||2
8911310|NCT02145039|9970378|FG000|NOT COMPLETED|Overall Study||0
8911311|NCT02145078|9970382|FG000|STARTED|Overall Study||4
8911312|NCT02145078|9970382|FG000|COMPLETED|Overall Study||0
8911313|NCT02145078|9970382|FG000|NOT COMPLETED|Overall Study||4
8911314|NCT02145156|9970389|FG000|STARTED|Overall Study||430
8911315|NCT02145156|9970390|FG001|STARTED|Overall Study||425
8911316|NCT02145156|9970391|FG002|STARTED|Overall Study||439
8911317|NCT02145156|9970389|FG000|COMPLETED|Overall Study||370
8911318|NCT02145156|9970390|FG001|COMPLETED|Overall Study||373
8911319|NCT02145156|9970391|FG002|COMPLETED|Overall Study||398
8911320|NCT02145156|9970389|FG000|NOT COMPLETED|Overall Study||60
8659659|NCT00691938|9702721|FG005|NOT COMPLETED|Overall Study||0
8659660|NCT00691938|9702722|FG006|NOT COMPLETED|Overall Study||0
8659661|NCT00692185|9702735|FG000|STARTED|Overall Study||11
8659662|NCT00692185|9702736|FG001|STARTED|Overall Study||12
8659663|NCT00692185|9702735|FG000|COMPLETED|Overall Study||8
8659664|NCT00692185|9702736|FG001|COMPLETED|Overall Study||9
8659665|NCT00692185|9702735|FG000|NOT COMPLETED|Overall Study||3
8659666|NCT00692185|9702736|FG001|NOT COMPLETED|Overall Study||3
8659667|NCT00692198|9702746|FG000|STARTED|Overall Study||368
8911321|NCT02145156|9970390|FG001|NOT COMPLETED|Overall Study||52
8911322|NCT02145156|9970391|FG002|NOT COMPLETED|Overall Study||41
8911323|NCT02145182|9970401|FG000|STARTED|Overall Study||142
8911324|NCT02145182|9970402|FG001|STARTED|Overall Study||146
8659668|NCT00692198|9702747|FG001|STARTED|Overall Study||370
8659669|NCT00692198|9702746|FG000|COMPLETED|Overall Study||368
8659670|NCT00692198|9702747|FG001|COMPLETED|Overall Study||370
8659671|NCT00692198|9702746|FG000|NOT COMPLETED|Overall Study||0
8659672|NCT00692198|9702747|FG001|NOT COMPLETED|Overall Study||0
8659673|NCT00692211|9702756|FG000|STARTED|Overall Study||202
8659674|NCT00692211|9702757|FG001|STARTED|Overall Study||202
8659675|NCT00692211|9702756|FG000|COMPLETED|Overall Study||202
8659676|NCT00692211|9702757|FG001|COMPLETED|Overall Study||202
8659677|NCT00692211|9702756|FG000|NOT COMPLETED|Overall Study||0
8659678|NCT00692211|9702757|FG001|NOT COMPLETED|Overall Study||0
8659679|NCT00692237|9702765|FG000|STARTED|Overall Study||30
8659680|NCT00692237|9702766|FG001|STARTED|Overall Study||29
8659681|NCT00692237|9702765|FG000|COMPLETED|Overall Study||29
8659682|NCT00692237|9702766|FG001|COMPLETED|Overall Study||25
8659683|NCT00692237|9702765|FG000|NOT COMPLETED|Overall Study||1
8659684|NCT00692237|9702766|FG001|NOT COMPLETED|Overall Study||4
8659685|NCT00692276|9702774|FG000|STARTED|Randomized Population||190
8659686|NCT00692276|9702775|FG001|STARTED|Randomized Population||201
8659687|NCT00692276|9702774|FG000|COMPLETED|Randomized Population||190
8659688|NCT00692276|9702775|FG001|COMPLETED|Randomized Population||201
8659689|NCT00692276|9702774|FG000|NOT COMPLETED|Randomized Population||0
8659690|NCT00692276|9702775|FG001|NOT COMPLETED|Randomized Population||0
8659691|NCT00692276|9702774|FG000|STARTED|Completed 24 Months||190
8659692|NCT00692276|9702775|FG001|STARTED|Completed 24 Months||201
8659693|NCT00692276|9702774|FG000|COMPLETED|Completed 24 Months||183
8659694|NCT00692276|9702775|FG001|COMPLETED|Completed 24 Months||187
8659695|NCT00692276|9702774|FG000|NOT COMPLETED|Completed 24 Months||7
8659696|NCT00692276|9702775|FG001|NOT COMPLETED|Completed 24 Months||14
8659697|NCT00692341|9702784|FG000|STARTED|Overall Study||8
8659698|NCT00692341|9702785|FG001|STARTED|Overall Study||8
8659699|NCT00692341|9702786|FG002|STARTED|Overall Study||8
8659700|NCT00692341|9702784|FG000|COMPLETED|Overall Study||8
8659701|NCT00692341|9702785|FG001|COMPLETED|Overall Study||8
8659702|NCT00692341|9702786|FG002|COMPLETED|Overall Study||8
8659703|NCT00692341|9702784|FG000|NOT COMPLETED|Overall Study||0
8659704|NCT00692341|9702785|FG001|NOT COMPLETED|Overall Study||0
8659705|NCT00692341|9702786|FG002|NOT COMPLETED|Overall Study||0
8659706|NCT00692406|9702794|FG000|STARTED|Overall Study|Initially this group was assigned to quit smoking before the second scan.|80
8659707|NCT00692406|9702794|FG000|COMPLETED|Overall Study|This group quit smoking before their second scan.|23
8659708|NCT00692406|9702794|FG000|NOT COMPLETED|Overall Study||57
8659709|NCT00692419|9702800|FG000|STARTED|Overall Study||100
8659710|NCT00692419|9702801|FG001|STARTED|Overall Study||120
8659711|NCT00692419|9702800|FG000|COMPLETED|Overall Study||84
8659712|NCT00692419|9702801|FG001|COMPLETED|Overall Study||102
8659713|NCT00692419|9702800|FG000|NOT COMPLETED|Overall Study||16
8659714|NCT00692419|9702801|FG001|NOT COMPLETED|Overall Study||18
8659715|NCT00692692|9702811|FG000|STARTED|Overall Study||20
8659716|NCT00692692|9702812|FG001|STARTED|Overall Study||16
8659717|NCT00692692|9702811|FG000|COMPLETED|Overall Study||20
8659718|NCT00692692|9702812|FG001|COMPLETED|Overall Study||16
8659719|NCT00692692|9702811|FG000|NOT COMPLETED|Overall Study||0
8659720|NCT00692692|9702812|FG001|NOT COMPLETED|Overall Study||0
8659721|NCT00692770|9702820|FG000|STARTED|Overall Study||556
8659722|NCT00692770|9702821|FG001|STARTED|Overall Study||558
8659723|NCT00692770|9702820|FG000|Participants Received Treatment|Overall Study||553
8659724|NCT00692770|9702821|FG001|Participants Received Treatment|Overall Study||554
8659725|NCT00692770|9702820|FG000|COMPLETED|Overall Study||0
8659726|NCT00692770|9702821|FG001|COMPLETED|Overall Study||0
8659727|NCT00692770|9702820|FG000|NOT COMPLETED|Overall Study||556
8659728|NCT00692770|9702821|FG001|NOT COMPLETED|Overall Study||558
8659729|NCT00692978|9702835|FG000|STARTED|FP From Active 250 ug MDI Inhaler||15
8659730|NCT00692978|9702836|FG001|STARTED|FP From Active 250 ug MDI Inhaler||15
8659731|NCT00692978|9702835|FG000|COMPLETED|FP From Active 250 ug MDI Inhaler||15
8659732|NCT00692978|9702836|FG001|COMPLETED|FP From Active 250 ug MDI Inhaler||15
8659733|NCT00692978|9702835|FG000|NOT COMPLETED|FP From Active 250 ug MDI Inhaler||0
8659734|NCT00692978|9702836|FG001|NOT COMPLETED|FP From Active 250 ug MDI Inhaler||0
8659735|NCT00692978|9702835|FG000|STARTED|FP1.5 Microns Size With MDI Inhaler||15
8659736|NCT00692978|9702836|FG001|STARTED|FP1.5 Microns Size With MDI Inhaler||15
8659737|NCT00692978|9702835|FG000|COMPLETED|FP1.5 Microns Size With MDI Inhaler||15
8659738|NCT00692978|9702836|FG001|COMPLETED|FP1.5 Microns Size With MDI Inhaler||15
8659739|NCT00692978|9702835|FG000|NOT COMPLETED|FP1.5 Microns Size With MDI Inhaler||0
8659740|NCT00692978|9702836|FG001|NOT COMPLETED|FP1.5 Microns Size With MDI Inhaler||0
8659741|NCT00692978|9702835|FG000|STARTED|FP 3 Microns Size With MDI Inhaler||15
8659742|NCT00692978|9702836|FG001|STARTED|FP 3 Microns Size With MDI Inhaler||15
8659743|NCT00692978|9702835|FG000|COMPLETED|FP 3 Microns Size With MDI Inhaler||15
8659744|NCT00692978|9702836|FG001|COMPLETED|FP 3 Microns Size With MDI Inhaler||15
8659745|NCT00692978|9702835|FG000|NOT COMPLETED|FP 3 Microns Size With MDI Inhaler||0
8659746|NCT00692978|9702836|FG001|NOT COMPLETED|FP 3 Microns Size With MDI Inhaler||0
8659747|NCT00692978|9702835|FG000|STARTED|FP 6 Microns Size With MDI Inhaler||15
8659748|NCT00692978|9702836|FG001|STARTED|FP 6 Microns Size With MDI Inhaler||15
8659749|NCT00692978|9702835|FG000|COMPLETED|FP 6 Microns Size With MDI Inhaler||15
8659750|NCT00692978|9702836|FG001|COMPLETED|FP 6 Microns Size With MDI Inhaler||15
8659751|NCT00692978|9702835|FG000|NOT COMPLETED|FP 6 Microns Size With MDI Inhaler||0
8659752|NCT00692978|9702836|FG001|NOT COMPLETED|FP 6 Microns Size With MDI Inhaler||0
8659753|NCT00693160|9702856|FG000|STARTED|Overall Study||14
8659754|NCT00693160|9702857|FG001|STARTED|Overall Study||16
8659755|NCT00693160|9702856|FG000|COMPLETED|Overall Study||14
8659756|NCT00693160|9702857|FG001|COMPLETED|Overall Study||16
8659757|NCT00693160|9702856|FG000|NOT COMPLETED|Overall Study||0
8659758|NCT00693160|9702857|FG001|NOT COMPLETED|Overall Study||0
8659759|NCT00693225|9702865|FG000|STARTED|Overall Study||43
8659760|NCT00693225|9702866|FG001|STARTED|Overall Study||48
8659761|NCT00693225|9702865|FG000|COMPLETED|Overall Study||41
8659762|NCT00693225|9702866|FG001|COMPLETED|Overall Study||43
8659763|NCT00693225|9702865|FG000|NOT COMPLETED|Overall Study||2
8659764|NCT00693225|9702866|FG001|NOT COMPLETED|Overall Study||5
8659765|NCT00693303|9702872|FG000|STARTED|Overall Study||21
8659766|NCT00693303|9702872|FG000|COMPLETED|Overall Study||21
8659767|NCT00693303|9702872|FG000|NOT COMPLETED|Overall Study||0
8659768|NCT00693420|9702878|FG000|STARTED|Overall Study||137
8659769|NCT00693420|9702879|FG001|STARTED|Overall Study||141
8659770|NCT00693420|9702878|FG000|COMPLETED|Overall Study||131
8659771|NCT00693420|9702879|FG001|COMPLETED|Overall Study||126
8659772|NCT00693420|9702878|FG000|NOT COMPLETED|Overall Study||6
8659773|NCT00693420|9702879|FG001|NOT COMPLETED|Overall Study||15
8659774|NCT00693472|9702889|FG000|STARTED|Part 1||19
8659775|NCT00693472|9702890|FG001|STARTED|Part 1||13
8659776|NCT00693472|9702891|FG002|STARTED|Part 1||0
8659777|NCT00693472|9702892|FG003|STARTED|Part 1||0
8659778|NCT00693472|9702889|FG000|COMPLETED|Part 1||13
8659779|NCT00693472|9702890|FG001|COMPLETED|Part 1||9
8659780|NCT00693472|9702891|FG002|COMPLETED|Part 1||0
8659781|NCT00693472|9702892|FG003|COMPLETED|Part 1||0
8659782|NCT00693472|9702889|FG000|NOT COMPLETED|Part 1||6
8659783|NCT00693472|9702890|FG001|NOT COMPLETED|Part 1||4
8659784|NCT00693472|9702891|FG002|NOT COMPLETED|Part 1||0
8659785|NCT00693472|9702892|FG003|NOT COMPLETED|Part 1||0
8659786|NCT00693472|9702889|FG000|STARTED|Part 2||0
8659787|NCT00693472|9702890|FG001|STARTED|Part 2||0
8659788|NCT00693472|9702891|FG002|STARTED|Part 2||8
8659789|NCT00693472|9702892|FG003|STARTED|Part 2||6
8659790|NCT00693472|9702889|FG000|COMPLETED|Part 2||0
8659791|NCT00693472|9702890|FG001|COMPLETED|Part 2||0
8659792|NCT00693472|9702891|FG002|COMPLETED|Part 2||6
8659793|NCT00693472|9702892|FG003|COMPLETED|Part 2||4
8659794|NCT00693472|9702889|FG000|NOT COMPLETED|Part 2||0
8659795|NCT00693472|9702890|FG001|NOT COMPLETED|Part 2||0
8659796|NCT00693472|9702891|FG002|NOT COMPLETED|Part 2||2
8659797|NCT00693472|9702892|FG003|NOT COMPLETED|Part 2||2
8659798|NCT00693485|9702905|FG000|STARTED|Overall Study||25
8659799|NCT00693485|9702906|FG001|STARTED|Overall Study||21
8659800|NCT00693485|9702907|FG002|STARTED|Overall Study||24
8659801|NCT00693485|9702905|FG000|COMPLETED|Overall Study||25
8659802|NCT00693485|9702906|FG001|COMPLETED|Overall Study||19
8659803|NCT00693485|9702907|FG002|COMPLETED|Overall Study||24
8659804|NCT00693485|9702905|FG000|NOT COMPLETED|Overall Study||0
8659805|NCT00693485|9702906|FG001|NOT COMPLETED|Overall Study||2
8659806|NCT00693485|9702907|FG002|NOT COMPLETED|Overall Study||0
8659807|NCT00693498|9702917|FG000|STARTED|Overall Study||81
8659808|NCT00693498|9702918|FG001|STARTED|Overall Study||81
8659809|NCT00693498|9702917|FG000|COMPLETED|Overall Study||81
8659810|NCT00693498|9702918|FG001|COMPLETED|Overall Study||81
8659811|NCT00693498|9702917|FG000|NOT COMPLETED|Overall Study||0
8659812|NCT00693498|9702918|FG001|NOT COMPLETED|Overall Study||0
8659813|NCT00693654|9702926|FG000|STARTED|Overall Study||14
8659814|NCT00693654|9702927|FG001|STARTED|Overall Study||14
8659815|NCT00693654|9702926|FG000|COMPLETED|Overall Study||14
8659816|NCT00693654|9702927|FG001|COMPLETED|Overall Study||14
8659817|NCT00693654|9702926|FG000|NOT COMPLETED|Overall Study||0
8659818|NCT00693654|9702927|FG001|NOT COMPLETED|Overall Study||0
8659819|NCT00693693|9702937|FG000|STARTED|Overall Study||7
8659820|NCT00693693|9702938|FG001|STARTED|Overall Study||9
8659821|NCT00693693|9702939|FG002|STARTED|Overall Study||9
8659822|NCT00693693|9702937|FG000|COMPLETED|Overall Study||6
8659823|NCT00693693|9702938|FG001|COMPLETED|Overall Study||8
8659824|NCT00693693|9702939|FG002|COMPLETED|Overall Study||7
8659825|NCT00693693|9702937|FG000|NOT COMPLETED|Overall Study||1
8659826|NCT00693693|9702938|FG001|NOT COMPLETED|Overall Study||1
8659827|NCT00693693|9702939|FG002|NOT COMPLETED|Overall Study||2
8659828|NCT00693706|9702949|FG000|STARTED|Overall Study||101
8659829|NCT00693706|9702950|FG001|STARTED|Overall Study||99
8659830|NCT00693706|9702949|FG000|COMPLETED|Overall Study||101
8659831|NCT00693706|9702950|FG001|COMPLETED|Overall Study||98
8659832|NCT00693706|9702949|FG000|NOT COMPLETED|Overall Study||0
8659833|NCT00693706|9702950|FG001|NOT COMPLETED|Overall Study||1
8659834|NCT00693719|9702956|FG000|STARTED|Overall Study||31
8659835|NCT00693719|9702956|FG000|COMPLETED|Overall Study||31
8659836|NCT00693719|9702956|FG000|NOT COMPLETED|Overall Study||0
8659837|NCT00693784|9702960|FG000|STARTED|Overall Study||15
8659838|NCT00693784|9702960|FG000|26-Week Primary Endpoint|Overall Study||15
8659839|NCT00693784|9702960|FG000|52-week Extended Follow-up|Overall Study||13
8659840|NCT00693784|9702960|FG000|104-week Extended Follow-up|Overall Study||11
8659841|NCT00693784|9702960|FG000|COMPLETED|Overall Study||11
8659842|NCT00693784|9702960|FG000|NOT COMPLETED|Overall Study||4
8659843|NCT00693992|9702966|FG000|STARTED|Overall Study||106
8659844|NCT00693992|9702967|FG001|STARTED|Overall Study||104
8659845|NCT00693992|9702966|FG000|COMPLETED|Overall Study||106
8659846|NCT00693992|9702967|FG001|COMPLETED|Overall Study||104
8659847|NCT00693992|9702966|FG000|NOT COMPLETED|Overall Study||0
8659848|NCT00693992|9702967|FG001|NOT COMPLETED|Overall Study||0
8659849|NCT00694018|9702975|FG000|STARTED|Overall Study||118
8659850|NCT00694018|9702976|FG001|STARTED|Overall Study||111
8659851|NCT00694018|9702975|FG000|6 Months|Overall Study||106
8659852|NCT00694018|9702976|FG001|6 Months|Overall Study||101
8659853|NCT00694018|9702975|FG000|COMPLETED|Overall Study||105
8659854|NCT00694018|9702976|FG001|COMPLETED|Overall Study||102
8659855|NCT00694018|9702975|FG000|NOT COMPLETED|Overall Study||13
8659856|NCT00694018|9702976|FG001|NOT COMPLETED|Overall Study||9
8659857|NCT00694070|9702982|FG000|STARTED|Overall Study||51
8659858|NCT00694070|9702982|FG000|COMPLETED|Overall Study||51
8659859|NCT00694070|9702982|FG000|NOT COMPLETED|Overall Study||0
8659860|NCT00694096|9702986|FG000|STARTED|Overall Study||25
8659861|NCT00694096|9702986|FG000|COMPLETED|Overall Study||20
8659862|NCT00694096|9702986|FG000|NOT COMPLETED|Overall Study||5
8659863|NCT00694109|9702990|FG000|STARTED|Overall Study|This does not include 2 patients from phase 2 trial with very different treatment experience.|142
8659864|NCT00694109|9702990|FG000|Treated|Overall Study||141
8659865|NCT00694109|9702990|FG000|Consented 2 Years Additional Treatment|Overall Study||42
8659866|NCT00694109|9702990|FG000|Completed Consented Length of Treatment|Overall Study||60
8659867|NCT00694109|9702990|FG000|COMPLETED|Overall Study||25
8659868|NCT00694109|9702990|FG000|NOT COMPLETED|Overall Study||117
8659869|NCT00694122|9702995|FG000|STARTED|First Intervention (3-4 Weeks)|Started Lantus then on NPH.|20
8659870|NCT00694122|9702996|FG001|STARTED|First Intervention (3-4 Weeks)|Started on NPH then on Lantus.|7
8659871|NCT00694122|9702995|FG000|COMPLETED|First Intervention (3-4 Weeks)||10
8659872|NCT00694122|9702996|FG001|COMPLETED|First Intervention (3-4 Weeks)||5
8659873|NCT00694122|9702995|FG000|NOT COMPLETED|First Intervention (3-4 Weeks)||10
8659874|NCT00694122|9702996|FG001|NOT COMPLETED|First Intervention (3-4 Weeks)||2
8659875|NCT00694122|9702995|FG000|STARTED|Washout (1 Day)||10
8659876|NCT00694122|9702996|FG001|STARTED|Washout (1 Day)||5
8659877|NCT00694122|9702995|FG000|COMPLETED|Washout (1 Day)||10
8659878|NCT00694122|9702996|FG001|COMPLETED|Washout (1 Day)||5
8659879|NCT00694122|9702995|FG000|NOT COMPLETED|Washout (1 Day)||0
8659880|NCT00694122|9702996|FG001|NOT COMPLETED|Washout (1 Day)||0
8659881|NCT00694122|9702995|FG000|STARTED|Second Intervention (3-4 Weeks)||10
8659882|NCT00694122|9702996|FG001|STARTED|Second Intervention (3-4 Weeks)||5
8659883|NCT00694122|9702995|FG000|COMPLETED|Second Intervention (3-4 Weeks)||10
8729539|NCT01053988|9776759|FG000|NOT COMPLETED|24-week, Double-blind Treatment Period||0
8729540|NCT01053988|9776760|FG001|NOT COMPLETED|24-week, Double-blind Treatment Period||69
8729541|NCT01053988|9776761|FG002|NOT COMPLETED|24-week, Double-blind Treatment Period||61
8729542|NCT01053988|9776762|FG003|NOT COMPLETED|24-week, Double-blind Treatment Period||63
8729543|NCT01053988|9776763|FG004|NOT COMPLETED|24-week, Double-blind Treatment Period||59
8729544|NCT01053988|9776764|FG005|NOT COMPLETED|24-week, Double-blind Treatment Period||55
8729545|NCT01054079|9776776|FG000|STARTED|Overall Study||20
8729546|NCT01054079|9776776|FG000|# Recieved Proper PSA Testing|Overall Study||10
8729547|NCT01054079|9776776|FG000|COMPLETED|Overall Study|while all 20 patients received at least some of the intervention, some did not get proper PSA tests.|20
8729548|NCT01054079|9776776|FG000|NOT COMPLETED|Overall Study||0
8729549|NCT01054144|9776780|FG000|STARTED|Overall Study||27
8729550|NCT01054144|9776780|FG000|COMPLETED|Overall Study||25
8729551|NCT01054144|9776780|FG000|NOT COMPLETED|Overall Study||2
8729552|NCT01054170|9776789|FG000|STARTED|Overall Study||25
8729553|NCT01054170|9776790|FG001|STARTED|Overall Study||27
8729554|NCT01054170|9776789|FG000|COMPLETED|Overall Study||21
8729555|NCT01054170|9776790|FG001|COMPLETED|Overall Study||21
8729556|NCT01054170|9776789|FG000|NOT COMPLETED|Overall Study||4
8729557|NCT01054170|9776790|FG001|NOT COMPLETED|Overall Study||6
8729558|NCT01054183|9776798|FG000|STARTED|Overall Study||10
8729559|NCT01054183|9776799|FG001|STARTED|Overall Study||12
8729560|NCT01054183|9776798|FG000|COMPLETED|Overall Study||10
8729561|NCT01054183|9776799|FG001|COMPLETED|Overall Study||12
8729562|NCT01054183|9776798|FG000|NOT COMPLETED|Overall Study||0
8729563|NCT01054183|9776799|FG001|NOT COMPLETED|Overall Study||0
8729564|NCT01054209|9776807|FG000|STARTED|Overall Study||58
8729565|NCT01054209|9776808|FG001|STARTED|Overall Study||58
8729566|NCT01054209|9776807|FG000|COMPLETED|Overall Study||58
8729567|NCT01054209|9776808|FG001|COMPLETED|Overall Study||58
8729568|NCT01054209|9776807|FG000|NOT COMPLETED|Overall Study||0
8659884|NCT00694122|9702996|FG001|COMPLETED|Second Intervention (3-4 Weeks)||5
8659885|NCT00694122|9702995|FG000|NOT COMPLETED|Second Intervention (3-4 Weeks)||0
8659886|NCT00694122|9702996|FG001|NOT COMPLETED|Second Intervention (3-4 Weeks)||0
8659887|NCT00694161|9703007|FG000|STARTED|Part 1 (up to Week 6)||35
8659888|NCT00694161|9703007|FG000|COMPLETED|Part 1 (up to Week 6)||35
8659889|NCT00694161|9703007|FG000|NOT COMPLETED|Part 1 (up to Week 6)||0
8659890|NCT00694161|9703007|FG000|STARTED|Part 2 (After Week 6 up to Month 12)||35
8659891|NCT00694161|9703007|FG000|COMPLETED|Part 2 (After Week 6 up to Month 12)||32
8659892|NCT00694161|9703007|FG000|NOT COMPLETED|Part 2 (After Week 6 up to Month 12)||3
8659893|NCT00694304|9703011|FG000|STARTED|Overall Study||535
8659894|NCT00694304|9703011|FG000|COMPLETED|Overall Study||328
8659895|NCT00694304|9703011|FG000|NOT COMPLETED|Overall Study||207
8659896|NCT00694356|9703018|FG000|STARTED|Overall Study||3
8729569|NCT01054209|9776808|FG001|NOT COMPLETED|Overall Study||0
8729570|NCT01054222|9776814|FG000|STARTED|Overall Study||31
8729571|NCT01054222|9776814|FG000|COMPLETED|Overall Study||20
8729572|NCT01054222|9776814|FG000|NOT COMPLETED|Overall Study||11
8729573|NCT01054300|9776820|FG000|STARTED|Period 1||13
8659897|NCT00694356|9703019|FG001|STARTED|Overall Study||6
8659898|NCT00694356|9703020|FG002|STARTED|Overall Study||6
8659899|NCT00694356|9703018|FG000|COMPLETED|Overall Study||0
8659900|NCT00694356|9703019|FG001|COMPLETED|Overall Study||0
8659901|NCT00694356|9703020|FG002|COMPLETED|Overall Study||0
8659902|NCT00694356|9703018|FG000|NOT COMPLETED|Overall Study||3
8659903|NCT00694356|9703019|FG001|NOT COMPLETED|Overall Study||6
8659904|NCT00694356|9703020|FG002|NOT COMPLETED|Overall Study||6
8659905|NCT00694473|9703028|FG000|STARTED|Overall Study|Aug 2008|76
8659906|NCT00694473|9703028|FG000|COMPLETED|Overall Study|Dec 2010|69
8659907|NCT00694473|9703028|FG000|NOT COMPLETED|Overall Study||7
8659908|NCT00694551|9703035|FG000|STARTED|Overall Study||10
8659909|NCT00694551|9703036|FG001|STARTED|Overall Study||10
8659910|NCT00694551|9703037|FG002|STARTED|Overall Study||9
8659911|NCT00694551|9703035|FG000|COMPLETED|Overall Study||9
8659912|NCT00694551|9703036|FG001|COMPLETED|Overall Study||10
8659913|NCT00694551|9703037|FG002|COMPLETED|Overall Study||8
8659914|NCT00694551|9703035|FG000|NOT COMPLETED|Overall Study||1
8659915|NCT00694551|9703036|FG001|NOT COMPLETED|Overall Study||0
8659916|NCT00694551|9703037|FG002|NOT COMPLETED|Overall Study||1
8659917|NCT00694564|9703046|FG000|STARTED|Overall Study||8
8659918|NCT00694564|9703046|FG000|COMPLETED|Overall Study||6
8659919|NCT00694564|9703046|FG000|NOT COMPLETED|Overall Study||2
8659920|NCT00694603|9703050|FG000|STARTED|Overall Study||18
8659921|NCT00694603|9703050|FG000|COMPLETED|Overall Study||18
8659922|NCT00694603|9703050|FG000|NOT COMPLETED|Overall Study||0
8659923|NCT00694707|9703059|FG000|STARTED|Overall Study||151
8659924|NCT00694707|9703060|FG001|STARTED|Overall Study||145
8659925|NCT00694707|9703061|FG002|STARTED|Overall Study||147
8659926|NCT00694707|9703062|FG003|STARTED|Overall Study||148
8659927|NCT00694707|9703063|FG004|STARTED|Overall Study||141
8659928|NCT00694707|9703059|FG000|COMPLETED|Overall Study||79
8659929|NCT00694707|9703060|FG001|COMPLETED|Overall Study||90
8659930|NCT00694707|9703061|FG002|COMPLETED|Overall Study||96
8659931|NCT00694707|9703062|FG003|COMPLETED|Overall Study||98
8659932|NCT00694707|9703063|FG004|COMPLETED|Overall Study||101
8659933|NCT00694707|9703059|FG000|NOT COMPLETED|Overall Study||72
8659934|NCT00694707|9703060|FG001|NOT COMPLETED|Overall Study||55
8659935|NCT00694707|9703061|FG002|NOT COMPLETED|Overall Study||51
8659936|NCT00694707|9703062|FG003|NOT COMPLETED|Overall Study||50
8659937|NCT00694707|9703063|FG004|NOT COMPLETED|Overall Study||40
8659938|NCT00695019|9703078|FG000|STARTED|Overall Study||59
8659939|NCT00695019|9703079|FG001|STARTED|Overall Study||53
8659940|NCT00695019|9703080|FG002|STARTED|Overall Study||57
8659941|NCT00695019|9703078|FG000|COMPLETED|Overall Study||46
8659942|NCT00695019|9703079|FG001|COMPLETED|Overall Study||39
8659943|NCT00695019|9703080|FG002|COMPLETED|Overall Study||47
8659944|NCT00695019|9703078|FG000|NOT COMPLETED|Overall Study||13
8659945|NCT00695019|9703079|FG001|NOT COMPLETED|Overall Study||14
8659946|NCT00695019|9703080|FG002|NOT COMPLETED|Overall Study||10
8659947|NCT00695097|9703090|FG000|STARTED|Overall Study||10
8659948|NCT00695097|9703091|FG001|STARTED|Overall Study||5
8659949|NCT00695097|9703090|FG000|COMPLETED|Overall Study||9
8659950|NCT00695097|9703091|FG001|COMPLETED|Overall Study||5
8659951|NCT00695097|9703090|FG000|NOT COMPLETED|Overall Study||1
8659952|NCT00695097|9703091|FG001|NOT COMPLETED|Overall Study||0
8659953|NCT00695110|9703097|FG000|STARTED|Treatment Period 1||29
8659954|NCT00695110|9703097|FG000|COMPLETED|Treatment Period 1||26
8659955|NCT00695110|9703097|FG000|NOT COMPLETED|Treatment Period 1||3
8659956|NCT00695110|9703097|FG000|STARTED|Treatment Period 2||26
8659957|NCT00695110|9703097|FG000|COMPLETED|Treatment Period 2||26
8659958|NCT00695110|9703097|FG000|NOT COMPLETED|Treatment Period 2||0
8659959|NCT00695110|9703097|FG000|STARTED|Treatment Period 3||26
8659960|NCT00695110|9703097|FG000|COMPLETED|Treatment Period 3||25
8659961|NCT00695110|9703097|FG000|NOT COMPLETED|Treatment Period 3||1
8659962|NCT00695110|9703097|FG000|STARTED|Treatment Period 4||25
8659963|NCT00695110|9703097|FG000|COMPLETED|Treatment Period 4||24
8659964|NCT00695110|9703097|FG000|NOT COMPLETED|Treatment Period 4||1
8659965|NCT00695136|9703104|FG000|STARTED|Overall Study|7|7
8659966|NCT00695136|9703104|FG000|COMPLETED|Overall Study||5
8659967|NCT00695136|9703104|FG000|NOT COMPLETED|Overall Study||2
8659968|NCT00695188|9703110|FG000|STARTED|Overall Study||10
8659969|NCT00695188|9703111|FG001|STARTED|Overall Study||9
8659970|NCT00695188|9703110|FG000|COMPLETED|Overall Study||10
8659971|NCT00695188|9703111|FG001|COMPLETED|Overall Study||9
8659972|NCT00695188|9703110|FG000|NOT COMPLETED|Overall Study||0
8659973|NCT00695188|9703111|FG001|NOT COMPLETED|Overall Study||0
8659974|NCT00695253|9703117|FG000|STARTED|Overall Study|75 patients were screened and a total of 49 were enrolled in the study.|49
8659975|NCT00695253|9703117|FG000|COMPLETED|Overall Study|Eighteen (18) completed the study up to the 5 year followup.|18
8659976|NCT00695253|9703117|FG000|NOT COMPLETED|Overall Study||31
8659977|NCT00695292|9703122|FG000|STARTED|Overall Study||37
8659978|NCT00695292|9703122|FG000|COMPLETED|Overall Study||37
8659979|NCT00695292|9703122|FG000|NOT COMPLETED|Overall Study||0
8659980|NCT00695318|9703128|FG000|STARTED|Overall Study||10
8659981|NCT00695318|9703129|FG001|STARTED|Overall Study||7
8659982|NCT00695318|9703128|FG000|COMPLETED|Overall Study||5
8659983|NCT00695318|9703129|FG001|COMPLETED|Overall Study||6
8659984|NCT00695318|9703128|FG000|NOT COMPLETED|Overall Study||5
8659985|NCT00695318|9703129|FG001|NOT COMPLETED|Overall Study||1
8659986|NCT00695396|9703143|FG000|STARTED|Overall Study||8
8659987|NCT00695396|9703144|FG001|STARTED|Overall Study||8
8659988|NCT00695396|9703145|FG002|STARTED|Overall Study||9
8659989|NCT00695396|9703143|FG000|COMPLETED|Overall Study||1
8659990|NCT00695396|9703144|FG001|COMPLETED|Overall Study||0
8659991|NCT00695396|9703145|FG002|COMPLETED|Overall Study||1
8659992|NCT00695396|9703143|FG000|NOT COMPLETED|Overall Study||7
8659993|NCT00695396|9703144|FG001|NOT COMPLETED|Overall Study||8
8659994|NCT00695396|9703145|FG002|NOT COMPLETED|Overall Study||8
8659995|NCT00695409|9703153|FG000|STARTED|Overall Study||122
8659996|NCT00695409|9703153|FG000|COMPLETED|Overall Study||122
8659997|NCT00695409|9703153|FG000|NOT COMPLETED|Overall Study||0
8659998|NCT00695435|9703158|FG000|STARTED|Overall Study||7
8659999|NCT00695435|9703159|FG001|STARTED|Overall Study||7
8660000|NCT00695435|9703160|FG002|STARTED|Overall Study||7
8660001|NCT00695435|9703158|FG000|COMPLETED|Overall Study||7
8660002|NCT00695435|9703159|FG001|COMPLETED|Overall Study||7
8660003|NCT00695435|9703160|FG002|COMPLETED|Overall Study||7
8660004|NCT00695435|9703158|FG000|NOT COMPLETED|Overall Study||0
8660005|NCT00695435|9703159|FG001|NOT COMPLETED|Overall Study||0
8660006|NCT00695435|9703160|FG002|NOT COMPLETED|Overall Study||0
8660007|NCT00695500|9703170|FG000|STARTED|Overall Study||24
8660008|NCT00695500|9703171|FG001|STARTED|Overall Study||22
8660009|NCT00695500|9703170|FG000|COMPLETED|Overall Study||21
8660010|NCT00695500|9703171|FG001|COMPLETED|Overall Study||17
8660011|NCT00695500|9703170|FG000|NOT COMPLETED|Overall Study||3
8660012|NCT00695500|9703171|FG001|NOT COMPLETED|Overall Study||5
8660013|NCT00695565|9703179|FG000|STARTED|Overall Study||90
8660014|NCT00695565|9703180|FG001|STARTED|Overall Study||90
8660015|NCT00695565|9703179|FG000|COMPLETED|Overall Study||77
8660016|NCT00695565|9703180|FG001|COMPLETED|Overall Study||81
8660017|NCT00695565|9703179|FG000|NOT COMPLETED|Overall Study||13
8660018|NCT00695565|9703180|FG001|NOT COMPLETED|Overall Study||9
8660019|NCT00695578|9703188|FG000|STARTED|Overall Study||10
8660020|NCT00695578|9703189|FG001|STARTED|Overall Study||10
8660021|NCT00695578|9703188|FG000|COMPLETED|Overall Study||10
8660022|NCT00695578|9703189|FG001|COMPLETED|Overall Study||10
8660023|NCT00695578|9703188|FG000|NOT COMPLETED|Overall Study||0
8660024|NCT00695578|9703189|FG001|NOT COMPLETED|Overall Study||0
8660025|NCT00695669|9703199|FG000|STARTED|Overall Study||78
8660026|NCT00695669|9703200|FG001|STARTED|Overall Study||78
8660027|NCT00695669|9703201|FG002|STARTED|Overall Study||78
8660028|NCT00695669|9703202|FG003|STARTED|Overall Study||78
8660029|NCT00695669|9703199|FG000|COMPLETED|Overall Study||74
8660030|NCT00695669|9703200|FG001|COMPLETED|Overall Study||74
8660031|NCT00695669|9703201|FG002|COMPLETED|Overall Study||75
8660032|NCT00695669|9703202|FG003|COMPLETED|Overall Study||74
8660033|NCT00695669|9703199|FG000|NOT COMPLETED|Overall Study||4
8660034|NCT00695669|9703200|FG001|NOT COMPLETED|Overall Study||4
8660035|NCT00695669|9703201|FG002|NOT COMPLETED|Overall Study||3
8660036|NCT00695669|9703202|FG003|NOT COMPLETED|Overall Study||4
8660037|NCT00695786|9703219|FG000|STARTED|Overall Study||2
8660038|NCT00695786|9703220|FG001|STARTED|Overall Study||79
8660039|NCT00695786|9703221|FG002|STARTED|Overall Study||31
8660040|NCT00695786|9703222|FG003|STARTED|Overall Study||44
8660041|NCT00695786|9703219|FG000|COMPLETED|Overall Study||1
8660042|NCT00695786|9703220|FG001|COMPLETED|Overall Study||67
8660043|NCT00695786|9703221|FG002|COMPLETED|Overall Study||23
8660044|NCT00695786|9703222|FG003|COMPLETED|Overall Study||36
8911325|NCT02145182|9970401|FG000|Received at Least 1 Dose of Study Drug|Overall Study||142
8911326|NCT02145182|9970402|FG001|Received at Least 1 Dose of Study Drug|Overall Study||146
8911327|NCT02145182|9970401|FG000|COMPLETED|Overall Study||124
8911328|NCT02145182|9970402|FG001|COMPLETED|Overall Study||130
8911329|NCT02145182|9970401|FG000|NOT COMPLETED|Overall Study||18
8911330|NCT02145182|9970402|FG001|NOT COMPLETED|Overall Study||16
8911331|NCT02145247|9970410|FG000|STARTED|Overall Study||20
8911332|NCT02145247|9970411|FG001|STARTED|Overall Study||19
8911333|NCT02145247|9970410|FG000|COMPLETED|Overall Study||20
8911334|NCT02145247|9970411|FG001|COMPLETED|Overall Study||19
8911335|NCT02145247|9970410|FG000|NOT COMPLETED|Overall Study||0
8911336|NCT02145247|9970411|FG001|NOT COMPLETED|Overall Study||0
8660045|NCT00695786|9703219|FG000|NOT COMPLETED|Overall Study||1
8660046|NCT00695786|9703220|FG001|NOT COMPLETED|Overall Study||12
8660047|NCT00695786|9703221|FG002|NOT COMPLETED|Overall Study||8
8660048|NCT00695786|9703222|FG003|NOT COMPLETED|Overall Study||8
8660049|NCT00695864|9703232|FG000|STARTED|Placebo||14
8660050|NCT00695864|9703232|FG000|COMPLETED|Placebo||9
8660051|NCT00695864|9703232|FG000|NOT COMPLETED|Placebo||5
8660052|NCT00695864|9703232|FG000|STARTED|Ondansetron||14
8660053|NCT00695864|9703232|FG000|COMPLETED|Ondansetron||9
8660054|NCT00695864|9703232|FG000|NOT COMPLETED|Ondansetron||5
8660055|NCT00695903|9703240|FG000|STARTED|Had End of Therapy (EOT) Assessment||19
8660056|NCT00695903|9703241|FG001|STARTED|Had End of Therapy (EOT) Assessment||19
8660057|NCT00695903|9703240|FG000|Met Continuation Criteria|Had End of Therapy (EOT) Assessment||9
8911337|NCT02145299|9970419|FG000|STARTED|Overall Study||6
8911338|NCT02145299|9970420|FG001|STARTED|Overall Study||2
8911339|NCT02145299|9970419|FG000|COMPLETED|Overall Study||6
8660058|NCT00695903|9703241|FG001|Met Continuation Criteria|Had End of Therapy (EOT) Assessment||6
8660059|NCT00695903|9703240|FG000|COMPLETED|Had End of Therapy (EOT) Assessment||7
8660060|NCT00695903|9703241|FG001|COMPLETED|Had End of Therapy (EOT) Assessment||4
8660061|NCT00695903|9703240|FG000|NOT COMPLETED|Had End of Therapy (EOT) Assessment||12
8660062|NCT00695903|9703241|FG001|NOT COMPLETED|Had End of Therapy (EOT) Assessment||15
8660063|NCT00695903|9703240|FG000|STARTED|Had Test of Cure (TOC) Assessment||7
8660064|NCT00695903|9703241|FG001|STARTED|Had Test of Cure (TOC) Assessment||4
8660065|NCT00695903|9703240|FG000|COMPLETED|Had Test of Cure (TOC) Assessment||5
8660066|NCT00695903|9703241|FG001|COMPLETED|Had Test of Cure (TOC) Assessment||3
8660067|NCT00695903|9703240|FG000|NOT COMPLETED|Had Test of Cure (TOC) Assessment||2
8660068|NCT00695903|9703241|FG001|NOT COMPLETED|Had Test of Cure (TOC) Assessment||1
8660069|NCT00695955|9703247|FG000|STARTED|Cohort 1||362
8660070|NCT00695955|9703247|FG000|COMPLETED|Cohort 1||260
8660071|NCT00695955|9703247|FG000|NOT COMPLETED|Cohort 1||102
8660072|NCT00695955|9703247|FG000|STARTED|Cohort 2||307
8660073|NCT00695955|9703247|FG000|COMPLETED|Cohort 2||203
8660074|NCT00695955|9703247|FG000|NOT COMPLETED|Cohort 2||104
8660075|NCT00696020|9703257|FG000|STARTED|Overall Study||90
8660076|NCT00696020|9703258|FG001|STARTED|Overall Study||89
8660077|NCT00696020|9703259|FG002|STARTED|Overall Study||93
8660078|NCT00696020|9703260|FG003|STARTED|Overall Study||88
8660079|NCT00696020|9703257|FG000|COMPLETED|Overall Study||86
8660080|NCT00696020|9703258|FG001|COMPLETED|Overall Study||87
8660081|NCT00696020|9703259|FG002|COMPLETED|Overall Study||90
8660082|NCT00696020|9703260|FG003|COMPLETED|Overall Study||84
8660083|NCT00696020|9703257|FG000|NOT COMPLETED|Overall Study||4
8660084|NCT00696020|9703258|FG001|NOT COMPLETED|Overall Study||2
8660085|NCT00696020|9703259|FG002|NOT COMPLETED|Overall Study||3
8660086|NCT00696020|9703260|FG003|NOT COMPLETED|Overall Study||4
8660087|NCT00696072|9703274|FG000|STARTED|Overall Study||57
8660088|NCT00696072|9703275|FG001|STARTED|Overall Study||63
8660089|NCT00696072|9703274|FG000|COMPLETED|Overall Study||0
8660090|NCT00696072|9703275|FG001|COMPLETED|Overall Study||0
8660091|NCT00696072|9703274|FG000|NOT COMPLETED|Overall Study||57
8660092|NCT00696072|9703275|FG001|NOT COMPLETED|Overall Study||63
8660093|NCT00696137|9703282|FG000|STARTED|Overall Study||5
8660094|NCT00696137|9703282|FG000|COMPLETED|Overall Study||3
8660095|NCT00696137|9703282|FG000|NOT COMPLETED|Overall Study||2
8660096|NCT00696241|9703291|FG000|STARTED|Overall Study||283
8660097|NCT00696241|9703292|FG001|STARTED|Overall Study||283
8660098|NCT00696241|9703293|FG002|STARTED|Overall Study||285
8660099|NCT00696241|9703294|FG003|STARTED|Overall Study||282
8660100|NCT00696241|9703295|FG004|STARTED|Overall Study||142
8660101|NCT00696241|9703291|FG000|COMPLETED|Overall Study||259
8660102|NCT00696241|9703292|FG001|COMPLETED|Overall Study||261
8660103|NCT00696241|9703293|FG002|COMPLETED|Overall Study||261
8660104|NCT00696241|9703294|FG003|COMPLETED|Overall Study||268
8660105|NCT00696241|9703295|FG004|COMPLETED|Overall Study||130
8660106|NCT00696241|9703291|FG000|NOT COMPLETED|Overall Study||24
8660107|NCT00696241|9703292|FG001|NOT COMPLETED|Overall Study||22
8660108|NCT00696241|9703293|FG002|NOT COMPLETED|Overall Study||24
8660109|NCT00696241|9703294|FG003|NOT COMPLETED|Overall Study||14
8660110|NCT00696241|9703295|FG004|NOT COMPLETED|Overall Study||12
8660111|NCT00696293|9703307|FG000|STARTED|Overall Study||30
8660112|NCT00696293|9703307|FG000|COMPLETED|Overall Study||28
8911340|NCT02145299|9970420|FG001|COMPLETED|Overall Study||2
8911341|NCT02145299|9970419|FG000|NOT COMPLETED|Overall Study||0
8911342|NCT02145299|9970420|FG001|NOT COMPLETED|Overall Study||0
8911343|NCT02145429|9970428|FG000|STARTED|Overall Study||91
8911344|NCT02145429|9970429|FG001|STARTED|Overall Study||90
8911345|NCT02145429|9970428|FG000|COMPLETED|Overall Study||75
8911346|NCT02145429|9970429|FG001|COMPLETED|Overall Study||79
8911347|NCT02145429|9970428|FG000|NOT COMPLETED|Overall Study||16
8911348|NCT02145429|9970429|FG001|NOT COMPLETED|Overall Study||11
8911349|NCT02145468|9970437|FG000|STARTED|Overall Study||1758
9022358|NCT03125941|10085243|FG000|STARTED|Overall Study||65
9022359|NCT03125941|10085244|FG001|STARTED|Overall Study||65
9022360|NCT03125941|10085243|FG000|Post-randomization Exclusion|Overall Study|procedure changed, did not receive intervention|1
9022361|NCT03125941|10085244|FG001|Post-randomization Exclusion|Overall Study|procedure changed, did not receive intervention|2
9022362|NCT03125941|10085243|FG000|COMPLETED|Overall Study||64
9022363|NCT03125941|10085244|FG001|COMPLETED|Overall Study||63
9022364|NCT03125941|10085243|FG000|NOT COMPLETED|Overall Study||1
8660113|NCT00696293|9703307|FG000|NOT COMPLETED|Overall Study||2
8660114|NCT00696384|9703312|FG000|STARTED|Open Label Phase||418
8660115|NCT00696384|9703313|FG001|STARTED|Open Label Phase||0
8660116|NCT00696384|9703314|FG002|STARTED|Open Label Phase||0
8660117|NCT00696384|9703312|FG000|COMPLETED|Open Label Phase||299
8660118|NCT00696384|9703313|FG001|COMPLETED|Open Label Phase||0
8660119|NCT00696384|9703314|FG002|COMPLETED|Open Label Phase||0
8660120|NCT00696384|9703312|FG000|NOT COMPLETED|Open Label Phase||119
8660121|NCT00696384|9703313|FG001|NOT COMPLETED|Open Label Phase||0
8660122|NCT00696384|9703314|FG002|NOT COMPLETED|Open Label Phase||0
8660123|NCT00696384|9703312|FG000|STARTED|Double Blind Phase||0
8660124|NCT00696384|9703313|FG001|STARTED|Double Blind Phase||148
8660125|NCT00696384|9703314|FG002|STARTED|Double Blind Phase||151
8660126|NCT00696384|9703312|FG000|COMPLETED|Double Blind Phase||0
8660127|NCT00696384|9703313|FG001|COMPLETED|Double Blind Phase||137
8660128|NCT00696384|9703314|FG002|COMPLETED|Double Blind Phase||145
8660129|NCT00696384|9703312|FG000|NOT COMPLETED|Double Blind Phase||0
8660130|NCT00696384|9703313|FG001|NOT COMPLETED|Double Blind Phase||11
8660131|NCT00696384|9703314|FG002|NOT COMPLETED|Double Blind Phase||6
8660132|NCT00696410|9703325|FG000|STARTED|Overall Study||38
8660133|NCT00696410|9703326|FG001|STARTED|Overall Study||10
8660134|NCT00696410|9703325|FG000|COMPLETED|Overall Study||25
8660135|NCT00696410|9703326|FG001|COMPLETED|Overall Study||10
8660136|NCT00696410|9703325|FG000|NOT COMPLETED|Overall Study||13
8660137|NCT00696410|9703326|FG001|NOT COMPLETED|Overall Study||0
8692218|NCT00858780|9737580|FG004|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||2
8692219|NCT00858832|9737592|FG000|STARTED|Overall Study|study terminated early due to enrollment deficiencies|21
8692220|NCT00858832|9737593|FG001|STARTED|Overall Study||23
8692221|NCT00858832|9737592|FG000|COMPLETED|Overall Study||20
8692222|NCT00858832|9737593|FG001|COMPLETED|Overall Study||22
8692223|NCT00858832|9737592|FG000|NOT COMPLETED|Overall Study||1
8692224|NCT00858832|9737593|FG001|NOT COMPLETED|Overall Study||1
8693650|NCT00867932|9739196|FG000|Received at Least 1 Dose of Study Drug|Overall Study||7
8693651|NCT00867932|9739196|FG000|Intent-to-Treat (ITT) Population|Overall Study||7
8693652|NCT00867932|9739196|FG000|COMPLETED|Overall Study||7
8693653|NCT00867932|9739196|FG000|NOT COMPLETED|Overall Study||0
8693654|NCT00868101|9739202|FG000|STARTED|Overall Study||12
8693655|NCT00868101|9739203|FG001|STARTED|Overall Study||10
8693656|NCT00868101|9739202|FG000|COMPLETED|Overall Study||12
8693657|NCT00868101|9739203|FG001|COMPLETED|Overall Study||10
8693658|NCT00868101|9739202|FG000|NOT COMPLETED|Overall Study||0
8693659|NCT00868101|9739203|FG001|NOT COMPLETED|Overall Study||0
8693660|NCT00868140|9739213|FG000|STARTED|Overall Study||26
8693661|NCT00868140|9739214|FG001|STARTED|Overall Study||25
8693662|NCT00868140|9739213|FG000|COMPLETED|Overall Study||26
8693663|NCT00868140|9739214|FG001|COMPLETED|Overall Study||25
8693664|NCT00868140|9739213|FG000|NOT COMPLETED|Overall Study||0
8693665|NCT00868140|9739214|FG001|NOT COMPLETED|Overall Study||0
8693666|NCT00868166|9739224|FG000|STARTED|Overall Study||259
8693667|NCT00868166|9739225|FG001|STARTED|Overall Study||253
8693668|NCT00868166|9739224|FG000|COMPLETED|Overall Study||147
8693669|NCT00868166|9739225|FG001|COMPLETED|Overall Study||139
8693670|NCT00868166|9739224|FG000|NOT COMPLETED|Overall Study||112
8693671|NCT00868166|9739225|FG001|NOT COMPLETED|Overall Study||114
8693672|NCT00868192|9739231|FG000|STARTED|Overall Study||38
8693673|NCT00868192|9739231|FG000|COMPLETED|Overall Study||34
8693674|NCT00868192|9739231|FG000|NOT COMPLETED|Overall Study||4
8693675|NCT00868218|9739239|FG000|STARTED|Overall Study||15
8693676|NCT00868218|9739240|FG001|STARTED|Overall Study||15
8693677|NCT00868218|9739241|FG002|STARTED|Overall Study||15
8693678|NCT00868218|9739242|FG003|STARTED|Overall Study||15
8693679|NCT00868218|9739239|FG000|COMPLETED|Overall Study||15
8693680|NCT00868218|9739240|FG001|COMPLETED|Overall Study||15
8693681|NCT00868218|9739241|FG002|COMPLETED|Overall Study||15
8693682|NCT00868218|9739242|FG003|COMPLETED|Overall Study||15
8693683|NCT00868218|9739239|FG000|NOT COMPLETED|Overall Study||0
8693684|NCT00868218|9739240|FG001|NOT COMPLETED|Overall Study||0
8693685|NCT00868218|9739241|FG002|NOT COMPLETED|Overall Study||0
8693686|NCT00868218|9739242|FG003|NOT COMPLETED|Overall Study||0
8693687|NCT00868231|9739256|FG000|STARTED|Treatment Period 1||5
8693688|NCT00868231|9739257|FG001|STARTED|Treatment Period 1||5
8693689|NCT00868231|9739258|FG002|STARTED|Treatment Period 1||5
8693690|NCT00868231|9739259|FG003|STARTED|Treatment Period 1||5
8693691|NCT00868231|9739260|FG004|STARTED|Treatment Period 1||5
8693692|NCT00868231|9739261|FG005|STARTED|Treatment Period 1||5
8693693|NCT00868231|9739256|FG000|COMPLETED|Treatment Period 1||5
8693694|NCT00868231|9739257|FG001|COMPLETED|Treatment Period 1||5
8693695|NCT00868231|9739258|FG002|COMPLETED|Treatment Period 1||5
8693696|NCT00868231|9739259|FG003|COMPLETED|Treatment Period 1||5
8693697|NCT00868231|9739260|FG004|COMPLETED|Treatment Period 1||4
8693698|NCT00868231|9739261|FG005|COMPLETED|Treatment Period 1||5
8693699|NCT00868231|9739256|FG000|NOT COMPLETED|Treatment Period 1||0
8693700|NCT00868231|9739257|FG001|NOT COMPLETED|Treatment Period 1||0
8693701|NCT00868231|9739258|FG002|NOT COMPLETED|Treatment Period 1||0
8693702|NCT00868231|9739259|FG003|NOT COMPLETED|Treatment Period 1||0
8693703|NCT00868231|9739260|FG004|NOT COMPLETED|Treatment Period 1||1
8693704|NCT00868231|9739261|FG005|NOT COMPLETED|Treatment Period 1||0
8693705|NCT00868231|9739256|FG000|STARTED|Treatment Period 2||5
8693706|NCT00868231|9739257|FG001|STARTED|Treatment Period 2||5
8693707|NCT00868231|9739258|FG002|STARTED|Treatment Period 2||5
8693708|NCT00868231|9739259|FG003|STARTED|Treatment Period 2||5
8693709|NCT00868231|9739260|FG004|STARTED|Treatment Period 2||4
8693710|NCT00868231|9739261|FG005|STARTED|Treatment Period 2||5
8693711|NCT00868231|9739256|FG000|COMPLETED|Treatment Period 2||4
8693712|NCT00868231|9739257|FG001|COMPLETED|Treatment Period 2||5
8693713|NCT00868231|9739258|FG002|COMPLETED|Treatment Period 2||5
8693714|NCT00868231|9739259|FG003|COMPLETED|Treatment Period 2||5
8693715|NCT00868231|9739260|FG004|COMPLETED|Treatment Period 2||4
8693716|NCT00868231|9739261|FG005|COMPLETED|Treatment Period 2||5
8693717|NCT00868231|9739256|FG000|NOT COMPLETED|Treatment Period 2||1
8693718|NCT00868231|9739257|FG001|NOT COMPLETED|Treatment Period 2||0
8693719|NCT00868231|9739258|FG002|NOT COMPLETED|Treatment Period 2||0
8693720|NCT00868231|9739259|FG003|NOT COMPLETED|Treatment Period 2||0
8693721|NCT00868231|9739260|FG004|NOT COMPLETED|Treatment Period 2||0
8693722|NCT00868231|9739261|FG005|NOT COMPLETED|Treatment Period 2||0
8693723|NCT00868231|9739256|FG000|STARTED|Treatment Period 3||4
8693724|NCT00868231|9739257|FG001|STARTED|Treatment Period 3||5
8693725|NCT00868231|9739258|FG002|STARTED|Treatment Period 3||5
8693726|NCT00868231|9739259|FG003|STARTED|Treatment Period 3||5
8693727|NCT00868231|9739260|FG004|STARTED|Treatment Period 3||4
8693728|NCT00868231|9739261|FG005|STARTED|Treatment Period 3||5
8693729|NCT00868231|9739256|FG000|COMPLETED|Treatment Period 3||4
8693730|NCT00868231|9739257|FG001|COMPLETED|Treatment Period 3||5
8660138|NCT00696423|9703339|FG000|STARTED|Overall Study||244
8660139|NCT00696423|9703340|FG001|STARTED|Overall Study||223
8660140|NCT00696423|9703339|FG000|COMPLETED|Overall Study||244
8660141|NCT00696423|9703340|FG001|COMPLETED|Overall Study||218
8660142|NCT00696423|9703339|FG000|NOT COMPLETED|Overall Study||0
8660143|NCT00696423|9703340|FG001|NOT COMPLETED|Overall Study||5
8660144|NCT00696436|9703351|FG000|STARTED|Overall Study|Randomized participants only.|280
8660145|NCT00696436|9703352|FG001|STARTED|Overall Study|Randomized participants only. One participant treated but not randomized and is not included.|285
8660146|NCT00696436|9703353|FG002|STARTED|Overall Study|Randomized participants only.|282
8660147|NCT00696436|9703354|FG003|STARTED|Overall Study|Randomized participants only.|290
8660148|NCT00696436|9703355|FG004|STARTED|Overall Study|Randomized participants only.|154
8660149|NCT00696436|9703351|FG000|COMPLETED|Overall Study||257
8660150|NCT00696436|9703352|FG001|COMPLETED|Overall Study||255
8660151|NCT00696436|9703353|FG002|COMPLETED|Overall Study||254
8660152|NCT00696436|9703354|FG003|COMPLETED|Overall Study||268
8660153|NCT00696436|9703355|FG004|COMPLETED|Overall Study||141
8660154|NCT00696436|9703351|FG000|NOT COMPLETED|Overall Study||23
8660155|NCT00696436|9703352|FG001|NOT COMPLETED|Overall Study||30
8660156|NCT00696436|9703353|FG002|NOT COMPLETED|Overall Study||28
8660157|NCT00696436|9703354|FG003|NOT COMPLETED|Overall Study||22
8660158|NCT00696436|9703355|FG004|NOT COMPLETED|Overall Study||13
8660159|NCT00696449|9703371|FG000|STARTED|Overall Study||15
8660160|NCT00696449|9703372|FG001|STARTED|Overall Study||15
8660161|NCT00696449|9703373|FG002|STARTED|Overall Study||15
8660162|NCT00696449|9703374|FG003|STARTED|Overall Study||16
8660163|NCT00696449|9703371|FG000|COMPLETED|Overall Study||12
8660164|NCT00696449|9703372|FG001|COMPLETED|Overall Study||9
8660165|NCT00696449|9703373|FG002|COMPLETED|Overall Study||14
8660166|NCT00696449|9703374|FG003|COMPLETED|Overall Study||13
8660167|NCT00696449|9703371|FG000|NOT COMPLETED|Overall Study||3
8660168|NCT00696449|9703372|FG001|NOT COMPLETED|Overall Study||6
8660169|NCT00696449|9703373|FG002|NOT COMPLETED|Overall Study||1
8660170|NCT00696449|9703374|FG003|NOT COMPLETED|Overall Study||3
8660171|NCT00696488|9703384|FG000|STARTED|Overall Study||20
8660172|NCT00696488|9703384|FG000|COMPLETED|Overall Study||20
8660173|NCT00696488|9703384|FG000|NOT COMPLETED|Overall Study||0
8660174|NCT00696618|9703391|FG000|STARTED|Overall Study||3
8660175|NCT00696618|9703392|FG001|STARTED|Overall Study||3
8660176|NCT00696618|9703393|FG002|STARTED|Overall Study||3
8660177|NCT00696618|9703391|FG000|COMPLETED|Overall Study||3
8660178|NCT00696618|9703392|FG001|COMPLETED|Overall Study||3
8660179|NCT00696618|9703393|FG002|COMPLETED|Overall Study||3
8660180|NCT00696618|9703391|FG000|NOT COMPLETED|Overall Study||0
8660181|NCT00696618|9703392|FG001|NOT COMPLETED|Overall Study||0
8660182|NCT00696618|9703393|FG002|NOT COMPLETED|Overall Study||0
8660183|NCT00696657|9703410|FG000|STARTED|Overall Study||46
8660184|NCT00696657|9703411|FG001|STARTED|Overall Study||47
8660185|NCT00696657|9703412|FG002|STARTED|Overall Study||44
8660186|NCT00696657|9703413|FG003|STARTED|Overall Study||49
8660187|NCT00696657|9703414|FG004|STARTED|Overall Study||44
8660188|NCT00696657|9703415|FG005|STARTED|Overall Study||45
8660189|NCT00696657|9703416|FG006|STARTED|Overall Study||45
8660190|NCT00696657|9703417|FG007|STARTED|Overall Study||45
8660191|NCT00696657|9703418|FG008|STARTED|Overall Study||50
8660192|NCT00696657|9703410|FG000|EXPOSED|Overall Study||46
8660193|NCT00696657|9703411|FG001|EXPOSED|Overall Study||47
8660194|NCT00696657|9703412|FG002|EXPOSED|Overall Study||43
8660195|NCT00696657|9703413|FG003|EXPOSED|Overall Study||48
8660196|NCT00696657|9703414|FG004|EXPOSED|Overall Study||44
8660197|NCT00696657|9703415|FG005|EXPOSED|Overall Study||43
8660198|NCT00696657|9703416|FG006|EXPOSED|Overall Study||45
8660199|NCT00696657|9703417|FG007|EXPOSED|Overall Study||45
8660200|NCT00696657|9703418|FG008|EXPOSED|Overall Study||50
8660201|NCT00696657|9703410|FG000|COMPLETED|Overall Study||45
8660202|NCT00696657|9703411|FG001|COMPLETED|Overall Study||42
8660203|NCT00696657|9703412|FG002|COMPLETED|Overall Study||36
8660204|NCT00696657|9703413|FG003|COMPLETED|Overall Study||38
8660205|NCT00696657|9703414|FG004|COMPLETED|Overall Study||34
8660206|NCT00696657|9703415|FG005|COMPLETED|Overall Study||33
8660207|NCT00696657|9703416|FG006|COMPLETED|Overall Study||30
8660208|NCT00696657|9703417|FG007|COMPLETED|Overall Study||42
8660209|NCT00696657|9703418|FG008|COMPLETED|Overall Study||41
8660210|NCT00696657|9703410|FG000|NOT COMPLETED|Overall Study||1
8660211|NCT00696657|9703411|FG001|NOT COMPLETED|Overall Study||5
8660212|NCT00696657|9703412|FG002|NOT COMPLETED|Overall Study||8
8660213|NCT00696657|9703413|FG003|NOT COMPLETED|Overall Study||11
8660214|NCT00696657|9703414|FG004|NOT COMPLETED|Overall Study||10
8660215|NCT00696657|9703415|FG005|NOT COMPLETED|Overall Study||12
8660216|NCT00696657|9703416|FG006|NOT COMPLETED|Overall Study||15
8660217|NCT00696657|9703417|FG007|NOT COMPLETED|Overall Study||3
8660218|NCT00696657|9703418|FG008|NOT COMPLETED|Overall Study||9
8660219|NCT00696696|9703438|FG000|STARTED|Overall Study||44
8660220|NCT00696696|9703438|FG000|COMPLETED|Overall Study|number of patients off treatment due to progression of disease only|26
8660221|NCT00696696|9703438|FG000|NOT COMPLETED|Overall Study||18
8660222|NCT00696709|9703447|FG000|STARTED|Overall Study||65
8660223|NCT00696709|9703448|FG001|STARTED|Overall Study||63
8660224|NCT00696709|9703449|FG002|STARTED|Overall Study||33
8660225|NCT00696709|9703450|FG003|STARTED|Overall Study||64
8660226|NCT00696709|9703451|FG004|STARTED|Overall Study||65
8660227|NCT00696709|9703447|FG000|Vaccination 1 (Day 1)|Overall Study||65
8660228|NCT00696709|9703448|FG001|Vaccination 1 (Day 1)|Overall Study||63
8660229|NCT00696709|9703449|FG002|Vaccination 1 (Day 1)|Overall Study||32
8660230|NCT00696709|9703450|FG003|Vaccination 1 (Day 1)|Overall Study||64
8660231|NCT00696709|9703451|FG004|Vaccination 1 (Day 1)|Overall Study||65
8660232|NCT00696709|9703447|FG000|Vaccination 2 (~Day 30)|Overall Study||64
8660233|NCT00696709|9703448|FG001|Vaccination 2 (~Day 30)|Overall Study||60
8660234|NCT00696709|9703449|FG002|Vaccination 2 (~Day 30)|Overall Study||32
8660235|NCT00696709|9703450|FG003|Vaccination 2 (~Day 30)|Overall Study||61
8660236|NCT00696709|9703451|FG004|Vaccination 2 (~Day 30)|Overall Study||64
8660237|NCT00696709|9703447|FG000|Vaccination 3 (~Day 60)|Overall Study||64
8660238|NCT00696709|9703448|FG001|Vaccination 3 (~Day 60)|Overall Study||60
8660239|NCT00696709|9703449|FG002|Vaccination 3 (~Day 60)|Overall Study||32
8660240|NCT00696709|9703450|FG003|Vaccination 3 (~Day 60)|Overall Study||59
8660241|NCT00696709|9703451|FG004|Vaccination 3 (~Day 60)|Overall Study||63
8660242|NCT00696709|9703447|FG000|Vaccination 4 (~Day 90)|Overall Study||62
8660243|NCT00696709|9703448|FG001|Vaccination 4 (~Day 90)|Overall Study||60
8660244|NCT00696709|9703449|FG002|Vaccination 4 (~Day 90)|Overall Study||32
8660245|NCT00696709|9703450|FG003|Vaccination 4 (~Day 90)|Overall Study||59
8660246|NCT00696709|9703451|FG004|Vaccination 4 (~Day 90)|Overall Study||63
8660247|NCT00696709|9703447|FG000|COMPLETED|Overall Study||62
8660248|NCT00696709|9703448|FG001|COMPLETED|Overall Study||60
8660249|NCT00696709|9703449|FG002|COMPLETED|Overall Study||32
8660250|NCT00696709|9703450|FG003|COMPLETED|Overall Study||59
8660251|NCT00696709|9703451|FG004|COMPLETED|Overall Study||62
8660252|NCT00696709|9703447|FG000|NOT COMPLETED|Overall Study||3
8660253|NCT00696709|9703448|FG001|NOT COMPLETED|Overall Study||3
8660254|NCT00696709|9703449|FG002|NOT COMPLETED|Overall Study||1
8660255|NCT00696709|9703450|FG003|NOT COMPLETED|Overall Study||5
8660256|NCT00696709|9703451|FG004|NOT COMPLETED|Overall Study||3
8660257|NCT00696761|9703471|FG000|STARTED|Overall Study||61
8660258|NCT00696761|9703472|FG001|STARTED|Overall Study||76
8660259|NCT00696761|9703473|FG002|STARTED|Overall Study||41
8660260|NCT00696761|9703474|FG003|STARTED|Overall Study||54
8660261|NCT00696761|9703471|FG000|COMPLETED|Overall Study||41
8660262|NCT00696761|9703472|FG001|COMPLETED|Overall Study||50
8660263|NCT00696761|9703473|FG002|COMPLETED|Overall Study||30
8660264|NCT00696761|9703474|FG003|COMPLETED|Overall Study||44
8660265|NCT00696761|9703471|FG000|NOT COMPLETED|Overall Study||20
8660266|NCT00696761|9703472|FG001|NOT COMPLETED|Overall Study||26
8660267|NCT00696761|9703473|FG002|NOT COMPLETED|Overall Study||11
8660268|NCT00696761|9703474|FG003|NOT COMPLETED|Overall Study||10
8660269|NCT00696774|9703495|FG000|STARTED|Period II||115
8660270|NCT00696774|9703496|FG001|STARTED|Period II||91
8660271|NCT00696774|9703497|FG002|STARTED|Period II|1 participant did not receive study drug and was not included in the safety analyses.|36
8660272|NCT00696774|9703495|FG000|COMPLETED|Period II||115
8660273|NCT00696774|9703496|FG001|COMPLETED|Period II||91
8660274|NCT00696774|9703497|FG002|COMPLETED|Period II||0
8660275|NCT00696774|9703495|FG000|NOT COMPLETED|Period II||0
8660276|NCT00696774|9703496|FG001|NOT COMPLETED|Period II||0
8660277|NCT00696774|9703497|FG002|NOT COMPLETED|Period II||36
8660278|NCT00696774|9703495|FG000|STARTED|Period III|115 reported at Week 4; 113 started Period 3 (1 lost to follow-up and 1 protocol violation).|113
8660279|NCT00696774|9703496|FG001|STARTED|Period III|91 reported at Week 4; 88 start Period 3 (1 adverse event, 1 protocol violation, 1 lack of efficacy)|88
8660280|NCT00696774|9703497|FG002|STARTED|Period III||0
8660281|NCT00696774|9703495|FG000|COMPLETED|Period III||106
8660282|NCT00696774|9703496|FG001|COMPLETED|Period III|82 participants were reported at Week 8; 81 completed Week 8 as 1 participant decided to withdraw.|81
8660283|NCT00696774|9703497|FG002|COMPLETED|Period III||0
8660284|NCT00696774|9703495|FG000|NOT COMPLETED|Period III||7
8660285|NCT00696774|9703496|FG001|NOT COMPLETED|Period III||7
8660286|NCT00696774|9703497|FG002|NOT COMPLETED|Period III||0
8660287|NCT00696787|9703508|FG000|STARTED|Overall Study||40
8660288|NCT00696787|9703509|FG001|STARTED|Overall Study||42
8660289|NCT00696787|9703510|FG002|STARTED|Overall Study||43
8660290|NCT00696787|9703508|FG000|COMPLETED|Overall Study||25
8660291|NCT00696787|9703509|FG001|COMPLETED|Overall Study||22
8660292|NCT00696787|9703510|FG002|COMPLETED|Overall Study||17
8660293|NCT00696787|9703508|FG000|NOT COMPLETED|Overall Study||15
8660294|NCT00696787|9703509|FG001|NOT COMPLETED|Overall Study||20
8660295|NCT00696787|9703510|FG002|NOT COMPLETED|Overall Study||26
8660296|NCT00697073|9703518|FG000|STARTED|Overall Study||68
8660297|NCT00697073|9703518|FG000|COMPLETED|Overall Study||59
8660298|NCT00697073|9703518|FG000|NOT COMPLETED|Overall Study||9
8660299|NCT00697112|9703522|FG000|STARTED|Overall Study||53
8660300|NCT00697112|9703522|FG000|Met the Inclusion Criteria|Overall Study||52
8660301|NCT00697112|9703522|FG000|COMPLETED|Overall Study||43
8660302|NCT00697112|9703522|FG000|NOT COMPLETED|Overall Study||10
8660303|NCT00697190|9703526|FG000|STARTED|First Intervention||19
8660304|NCT00697190|9703527|FG001|STARTED|First Intervention||20
8660305|NCT00697190|9703526|FG000|COMPLETED|First Intervention||19
8660306|NCT00697190|9703527|FG001|COMPLETED|First Intervention||20
8660307|NCT00697190|9703526|FG000|NOT COMPLETED|First Intervention||0
8660308|NCT00697190|9703527|FG001|NOT COMPLETED|First Intervention||0
8660309|NCT00697190|9703526|FG000|STARTED|Second Intervention|one subject moved away between the first period and second period.|18
8660310|NCT00697190|9703527|FG001|STARTED|Second Intervention||20
8660311|NCT00697190|9703526|FG000|COMPLETED|Second Intervention||18
8660312|NCT00697190|9703527|FG001|COMPLETED|Second Intervention||20
8660313|NCT00697190|9703526|FG000|NOT COMPLETED|Second Intervention||0
8660314|NCT00697190|9703527|FG001|NOT COMPLETED|Second Intervention||0
8660315|NCT00697203|9703541|FG000|STARTED|Overall Study||76
8660316|NCT00697203|9703542|FG001|STARTED|Overall Study||68
8660317|NCT00697203|9703543|FG002|STARTED|Overall Study||74
8660318|NCT00697203|9703544|FG003|STARTED|Overall Study||74
8660319|NCT00697203|9703541|FG000|COMPLETED|Overall Study||67
8660320|NCT00697203|9703542|FG001|COMPLETED|Overall Study||62
8660321|NCT00697203|9703543|FG002|COMPLETED|Overall Study||66
8660322|NCT00697203|9703544|FG003|COMPLETED|Overall Study||67
8660323|NCT00697203|9703541|FG000|NOT COMPLETED|Overall Study||9
8660324|NCT00697203|9703542|FG001|NOT COMPLETED|Overall Study||6
8660325|NCT00697203|9703543|FG002|NOT COMPLETED|Overall Study||8
8660326|NCT00697203|9703544|FG003|NOT COMPLETED|Overall Study||7
8660327|NCT00697346|9703557|FG000|STARTED|Overall Study||28
8660328|NCT00697346|9703558|FG001|STARTED|Overall Study||28
8660329|NCT00697346|9703559|FG002|STARTED|Overall Study||2
8660330|NCT00697346|9703557|FG000|COMPLETED|Overall Study|Completed = participants who completed study treatment.|0
8660331|NCT00697346|9703558|FG001|COMPLETED|Overall Study|2 participants were ongoing as of primary completion date 27 Dec 2011 and have now completed.|2
8660332|NCT00697346|9703559|FG002|COMPLETED|Overall Study|1 participant was ongoing as of primary completion date 27 Dec 2011 and has now completed.|1
8660333|NCT00697346|9703557|FG000|NOT COMPLETED|Overall Study||28
8660334|NCT00697346|9703558|FG001|NOT COMPLETED|Overall Study||26
8660335|NCT00697346|9703559|FG002|NOT COMPLETED|Overall Study||1
8660336|NCT00697463|9703586|FG000|STARTED|Overall Study||22
8660337|NCT00697463|9703586|FG000|COMPLETED|Overall Study||21
8660338|NCT00697463|9703586|FG000|NOT COMPLETED|Overall Study||1
8660339|NCT00697515|9703590|FG000|STARTED|Dose Optimization Period||142
8660340|NCT00697515|9703591|FG001|STARTED|Dose Optimization Period||0
8660341|NCT00697515|9703590|FG000|COMPLETED|Dose Optimization Period||127
8660342|NCT00697515|9703591|FG001|COMPLETED|Dose Optimization Period||0
8660343|NCT00697515|9703590|FG000|NOT COMPLETED|Dose Optimization Period||15
8660344|NCT00697515|9703591|FG001|NOT COMPLETED|Dose Optimization Period||0
8660345|NCT00697515|9703590|FG000|STARTED|First Intervention (Crossover Period)||63
8660346|NCT00697515|9703591|FG001|STARTED|First Intervention (Crossover Period)||64
8660347|NCT00697515|9703590|FG000|COMPLETED|First Intervention (Crossover Period)||53
8660348|NCT00697515|9703591|FG001|COMPLETED|First Intervention (Crossover Period)||52
8660349|NCT00697515|9703590|FG000|NOT COMPLETED|First Intervention (Crossover Period)||10
8660350|NCT00697515|9703591|FG001|NOT COMPLETED|First Intervention (Crossover Period)||12
8660351|NCT00697515|9703590|FG000|STARTED|Second Intervention (Crossover Period)||53
8660352|NCT00697515|9703591|FG001|STARTED|Second Intervention (Crossover Period)||52
8660353|NCT00697515|9703590|FG000|COMPLETED|Second Intervention (Crossover Period)||52
8660354|NCT00697515|9703591|FG001|COMPLETED|Second Intervention (Crossover Period)||51
8660355|NCT00697515|9703590|FG000|NOT COMPLETED|Second Intervention (Crossover Period)||1
8660356|NCT00697515|9703591|FG001|NOT COMPLETED|Second Intervention (Crossover Period)||1
8660357|NCT00697541|9703599|FG000|STARTED|Overall Study||10
8660358|NCT00697541|9703600|FG001|STARTED|Overall Study||10
8660359|NCT00697541|9703599|FG000|COMPLETED|Overall Study||8
8660360|NCT00697541|9703600|FG001|COMPLETED|Overall Study||9
8660361|NCT00697541|9703599|FG000|NOT COMPLETED|Overall Study||2
8660362|NCT00697541|9703600|FG001|NOT COMPLETED|Overall Study||1
8660363|NCT00697593|9703607|FG000|STARTED|Overall Study||70
8660364|NCT00697593|9703607|FG000|COMPLETED|Overall Study||51
8660365|NCT00697593|9703607|FG000|NOT COMPLETED|Overall Study||19
8660366|NCT00697619|9703613|FG000|STARTED|Overall Study||30
8660367|NCT00697619|9703614|FG001|STARTED|Overall Study||30
8660368|NCT00697619|9703613|FG000|COMPLETED|Overall Study||24
8660369|NCT00697619|9703614|FG001|COMPLETED|Overall Study||22
8660370|NCT00697619|9703613|FG000|NOT COMPLETED|Overall Study||6
8660371|NCT00697619|9703614|FG001|NOT COMPLETED|Overall Study||8
8660372|NCT00697697|9703622|FG000|STARTED|Overall Study||94
8660373|NCT00697697|9703623|FG001|STARTED|Overall Study||98
8660374|NCT00697697|9703622|FG000|COMPLETED|Overall Study||45
8660375|NCT00697697|9703623|FG001|COMPLETED|Overall Study||44
8660376|NCT00697697|9703622|FG000|NOT COMPLETED|Overall Study||49
8660377|NCT00697697|9703623|FG001|NOT COMPLETED|Overall Study||54
8660378|NCT00697788|9703629|FG000|STARTED|Dexmedetomidine Bolus 1 mcg/kg||8
8660379|NCT00697788|9703630|FG001|STARTED|Dexmedetomidine Bolus 1 mcg/kg|One participant did not begin infusion due to hypotension (mean pressure <50)|0
8660380|NCT00697788|9703631|FG002|STARTED|Dexmedetomidine Bolus 1 mcg/kg|2 participants did not begin the ascending (1.0 mcg/kg/hr) due to MAP<50|0
8660381|NCT00697788|9703632|FG003|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
8660382|NCT00697788|9703633|FG004|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
8660383|NCT00697788|9703634|FG005|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
8660384|NCT00697788|9703635|FG006|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
8660385|NCT00697788|9703636|FG007|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
8660386|NCT00697788|9703629|FG000|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||8
8660387|NCT00697788|9703630|FG001|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
8660388|NCT00697788|9703631|FG002|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
8660389|NCT00697788|9703632|FG003|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
8660390|NCT00697788|9703633|FG004|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
8660391|NCT00697788|9703634|FG005|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
8660392|NCT00697788|9703635|FG006|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
8660393|NCT00697788|9703636|FG007|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
8692225|NCT00858845|9737601|FG000|STARTED|Overall Study||5
8660394|NCT00697788|9703629|FG000|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
8660395|NCT00697788|9703630|FG001|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
8660396|NCT00697788|9703631|FG002|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
8660397|NCT00697788|9703632|FG003|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
8660398|NCT00697788|9703633|FG004|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
8660399|NCT00697788|9703634|FG005|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
8660400|NCT00697788|9703635|FG006|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
8660401|NCT00697788|9703636|FG007|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
8660402|NCT00697788|9703629|FG000|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
8660403|NCT00697788|9703630|FG001|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion|1 participant did not begin infusion due to hypotension (MAP<50)|7
8660404|NCT00697788|9703631|FG002|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
8660405|NCT00697788|9703632|FG003|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
8660406|NCT00697788|9703633|FG004|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
8660407|NCT00697788|9703634|FG005|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
8660408|NCT00697788|9703635|FG006|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
8660409|NCT00697788|9703636|FG007|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
8660410|NCT00697788|9703629|FG000|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
8660411|NCT00697788|9703630|FG001|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||5
8660412|NCT00697788|9703631|FG002|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
8660413|NCT00697788|9703632|FG003|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
8660414|NCT00697788|9703633|FG004|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
8660415|NCT00697788|9703634|FG005|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
8660416|NCT00697788|9703635|FG006|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
8660417|NCT00697788|9703636|FG007|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
8660418|NCT00697788|9703629|FG000|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
8660419|NCT00697788|9703630|FG001|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||2
8660420|NCT00697788|9703631|FG002|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
8660421|NCT00697788|9703632|FG003|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
8660422|NCT00697788|9703633|FG004|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
8660423|NCT00697788|9703634|FG005|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
8660424|NCT00697788|9703635|FG006|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
8660425|NCT00697788|9703636|FG007|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
8660426|NCT00697788|9703629|FG000|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
8660427|NCT00697788|9703630|FG001|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
8660428|NCT00697788|9703631|FG002|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion|2 participants did not begin this infusion due to hypotension (MAP<50)|3
8660429|NCT00697788|9703632|FG003|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
8660430|NCT00697788|9703633|FG004|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
8729574|NCT01054300|9776821|FG001|STARTED|Period 1||13
8729575|NCT01054300|9776822|FG002|STARTED|Period 1||13
8729576|NCT01054300|9776823|FG003|STARTED|Period 1||13
8729577|NCT01054300|9776820|FG000|COMPLETED|Period 1|Discontinuation occurred prior to Period 2 dose.|12
8729578|NCT01054300|9776821|FG001|COMPLETED|Period 1||13
8729579|NCT01054300|9776822|FG002|COMPLETED|Period 1||13
8729580|NCT01054300|9776823|FG003|COMPLETED|Period 1||13
8729581|NCT01054300|9776820|FG000|NOT COMPLETED|Period 1||1
8729582|NCT01054300|9776821|FG001|NOT COMPLETED|Period 1||0
8729583|NCT01054300|9776822|FG002|NOT COMPLETED|Period 1||0
8729584|NCT01054300|9776823|FG003|NOT COMPLETED|Period 1||0
8729585|NCT01054300|9776820|FG000|STARTED|Period 2||12
8729586|NCT01054300|9776821|FG001|STARTED|Period 2||13
8729587|NCT01054300|9776822|FG002|STARTED|Period 2||13
8729588|NCT01054300|9776823|FG003|STARTED|Period 2||13
8729589|NCT01054300|9776820|FG000|COMPLETED|Period 2||12
8729590|NCT01054300|9776821|FG001|COMPLETED|Period 2||13
8729591|NCT01054300|9776822|FG002|COMPLETED|Period 2||12
8729592|NCT01054300|9776823|FG003|COMPLETED|Period 2||13
8729593|NCT01054300|9776820|FG000|NOT COMPLETED|Period 2||0
8729594|NCT01054300|9776821|FG001|NOT COMPLETED|Period 2||0
8729595|NCT01054300|9776822|FG002|NOT COMPLETED|Period 2||1
8729596|NCT01054300|9776823|FG003|NOT COMPLETED|Period 2||0
8729597|NCT01054339|9776836|FG000|STARTED|Overall Study||3
8729598|NCT01054339|9776837|FG001|STARTED|Overall Study||3
8729599|NCT01054339|9776838|FG002|STARTED|Overall Study||3
8729600|NCT01054339|9776836|FG000|COMPLETED|Overall Study||3
8729601|NCT01054339|9776837|FG001|COMPLETED|Overall Study||3
8729602|NCT01054339|9776838|FG002|COMPLETED|Overall Study||3
8729603|NCT01054339|9776836|FG000|NOT COMPLETED|Overall Study||0
8729604|NCT01054339|9776837|FG001|NOT COMPLETED|Overall Study||0
8729605|NCT01054339|9776838|FG002|NOT COMPLETED|Overall Study||0
8729606|NCT01054404|9776850|FG000|STARTED|Overall Study||10
8729607|NCT01054404|9776851|FG001|STARTED|Overall Study||13
8729608|NCT01054404|9776850|FG000|COMPLETED|Overall Study||10
8729609|NCT01054404|9776851|FG001|COMPLETED|Overall Study||13
8729610|NCT01054404|9776850|FG000|NOT COMPLETED|Overall Study||0
8729611|NCT01054404|9776851|FG001|NOT COMPLETED|Overall Study||0
8729612|NCT01054443|9776861|FG000|STARTED|Overall Study||5
8729613|NCT01054443|9776862|FG001|STARTED|Overall Study||5
8729614|NCT01054443|9776863|FG002|STARTED|Overall Study||5
8729615|NCT01054443|9776864|FG003|STARTED|Overall Study||5
8729616|NCT01054443|9776861|FG000|COMPLETED|Overall Study||5
8729617|NCT01054443|9776862|FG001|COMPLETED|Overall Study||5
8729618|NCT01054443|9776863|FG002|COMPLETED|Overall Study||5
8729619|NCT01054443|9776864|FG003|COMPLETED|Overall Study||4
8660431|NCT00697788|9703634|FG005|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
8660432|NCT00697788|9703635|FG006|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
8660433|NCT00697788|9703636|FG007|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
8660434|NCT00697788|9703629|FG000|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
8660435|NCT00697788|9703630|FG001|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
8660436|NCT00697788|9703631|FG002|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||3
8660437|NCT00697788|9703632|FG003|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
8660438|NCT00697788|9703633|FG004|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
8660439|NCT00697788|9703634|FG005|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
8660440|NCT00697788|9703635|FG006|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
8660441|NCT00697788|9703636|FG007|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
8660442|NCT00697788|9703629|FG000|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
8660443|NCT00697788|9703630|FG001|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
8660444|NCT00697788|9703631|FG002|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
8660445|NCT00697788|9703632|FG003|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
8660446|NCT00697788|9703633|FG004|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
8660447|NCT00697788|9703634|FG005|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
8660448|NCT00697788|9703635|FG006|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
8660449|NCT00697788|9703636|FG007|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
8660450|NCT00697788|9703629|FG000|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
8660451|NCT00697788|9703630|FG001|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
8660452|NCT00697788|9703631|FG002|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
8660453|NCT00697788|9703632|FG003|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||3
8660454|NCT00697788|9703633|FG004|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
8660455|NCT00697788|9703634|FG005|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
8660456|NCT00697788|9703635|FG006|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
8660457|NCT00697788|9703636|FG007|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
8660458|NCT00697788|9703629|FG000|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
8660459|NCT00697788|9703630|FG001|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
8660460|NCT00697788|9703631|FG002|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
8660461|NCT00697788|9703632|FG003|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||3
8660462|NCT00697788|9703633|FG004|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
8660463|NCT00697788|9703634|FG005|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
8660464|NCT00697788|9703635|FG006|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
8660465|NCT00697788|9703636|FG007|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
8729620|NCT01054443|9776861|FG000|NOT COMPLETED|Overall Study||0
8729621|NCT01054443|9776862|FG001|NOT COMPLETED|Overall Study||0
8729622|NCT01054443|9776863|FG002|NOT COMPLETED|Overall Study||0
8729623|NCT01054443|9776864|FG003|NOT COMPLETED|Overall Study||1
8729624|NCT01054456|9776877|FG000|STARTED|Overall Study||36
8729625|NCT01054456|9776877|FG000|COMPLETED|Overall Study||35
8729626|NCT01054456|9776877|FG000|NOT COMPLETED|Overall Study||1
8729627|NCT01054560|9776883|FG000|STARTED|Overall Study||58
8729628|NCT01054560|9776884|FG001|STARTED|Overall Study||55
8729629|NCT01054560|9776883|FG000|COMPLETED|Overall Study||45
8729630|NCT01054560|9776884|FG001|COMPLETED|Overall Study||27
8729631|NCT01054560|9776883|FG000|NOT COMPLETED|Overall Study||13
8729632|NCT01054560|9776884|FG001|NOT COMPLETED|Overall Study||28
8729633|NCT01054573|9776896|FG000|STARTED|Overall Study||9
8729634|NCT01054573|9776897|FG001|STARTED|Overall Study||32
8729635|NCT01054573|9776898|FG002|STARTED|Overall Study||22
8729636|NCT01054573|9776899|FG003|STARTED|Overall Study||27
8729637|NCT01054573|9776896|FG000|COMPLETED|Overall Study||8
8729638|NCT01054573|9776897|FG001|COMPLETED|Overall Study||28
8729639|NCT01054573|9776898|FG002|COMPLETED|Overall Study||19
8729640|NCT01054573|9776899|FG003|COMPLETED|Overall Study||25
8729641|NCT01054573|9776896|FG000|NOT COMPLETED|Overall Study||1
8729642|NCT01054573|9776897|FG001|NOT COMPLETED|Overall Study||4
8729643|NCT01054573|9776898|FG002|NOT COMPLETED|Overall Study||3
8729644|NCT01054573|9776899|FG003|NOT COMPLETED|Overall Study||2
8729645|NCT01054586|9776922|FG000|STARTED|Overall Study||43
8729646|NCT01054586|9776923|FG001|STARTED|Overall Study||15
8729647|NCT01054586|9776924|FG002|STARTED|Overall Study||8
8729648|NCT01054586|9776925|FG003|STARTED|Overall Study||101
8729649|NCT01054586|9776922|FG000|COMPLETED|Overall Study||43
8729650|NCT01054586|9776923|FG001|COMPLETED|Overall Study||15
8729651|NCT01054586|9776924|FG002|COMPLETED|Overall Study||8
8729652|NCT01054586|9776925|FG003|COMPLETED|Overall Study||101
8729653|NCT01054586|9776922|FG000|NOT COMPLETED|Overall Study||0
8729654|NCT01054586|9776923|FG001|NOT COMPLETED|Overall Study||0
8729655|NCT01054586|9776924|FG002|NOT COMPLETED|Overall Study||0
8729656|NCT01054586|9776925|FG003|NOT COMPLETED|Overall Study||0
8729657|NCT01054599|9776947|FG000|STARTED|Overall Study||13
8729658|NCT01054599|9776948|FG001|STARTED|Overall Study||16
8729659|NCT01054599|9776947|FG000|COMPLETED|Overall Study||9
8729660|NCT01054599|9776948|FG001|COMPLETED|Overall Study||9
8729661|NCT01054599|9776947|FG000|NOT COMPLETED|Overall Study||4
8729662|NCT01054599|9776948|FG001|NOT COMPLETED|Overall Study||7
8729663|NCT01054625|9776957|FG000|STARTED|Overall Study|A total of 31 patients were enrolled, 1 patient died before receiving any zalutumumab|8
8729664|NCT01054625|9776958|FG001|STARTED|Overall Study||12
8729665|NCT01054625|9776959|FG002|STARTED|Overall Study||10
8729666|NCT01054625|9776957|FG000|COMPLETED|Overall Study||6
8729667|NCT01054625|9776958|FG001|COMPLETED|Overall Study||9
8660466|NCT00697788|9703629|FG000|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
8660467|NCT00697788|9703630|FG001|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
8660468|NCT00697788|9703631|FG002|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
8660469|NCT00697788|9703632|FG003|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
8660470|NCT00697788|9703633|FG004|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
8660471|NCT00697788|9703634|FG005|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
8660472|NCT00697788|9703635|FG006|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
8660473|NCT00697788|9703636|FG007|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
8660474|NCT00697788|9703629|FG000|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
8660475|NCT00697788|9703630|FG001|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
8660476|NCT00697788|9703631|FG002|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
8660477|NCT00697788|9703632|FG003|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
8660478|NCT00697788|9703633|FG004|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||3
8660479|NCT00697788|9703634|FG005|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
8660480|NCT00697788|9703635|FG006|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
8660481|NCT00697788|9703636|FG007|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
8660482|NCT00697788|9703629|FG000|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
8660483|NCT00697788|9703630|FG001|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
8660484|NCT00697788|9703631|FG002|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
8660485|NCT00697788|9703632|FG003|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
8660486|NCT00697788|9703633|FG004|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||2
8660487|NCT00697788|9703634|FG005|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
8660488|NCT00697788|9703635|FG006|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
8660489|NCT00697788|9703636|FG007|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
8660490|NCT00697788|9703629|FG000|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
8660491|NCT00697788|9703630|FG001|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
8660492|NCT00697788|9703631|FG002|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
8660493|NCT00697788|9703632|FG003|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
8660494|NCT00697788|9703633|FG004|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||1
8660495|NCT00697788|9703634|FG005|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
8660496|NCT00697788|9703635|FG006|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
8660497|NCT00697788|9703636|FG007|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
8660498|NCT00697788|9703629|FG000|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
8660499|NCT00697788|9703630|FG001|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
8660500|NCT00697788|9703631|FG002|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
8660501|NCT00697788|9703632|FG003|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
8660502|NCT00697788|9703633|FG004|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
8660503|NCT00697788|9703634|FG005|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||2
8660504|NCT00697788|9703635|FG006|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
8660505|NCT00697788|9703636|FG007|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
8660506|NCT00697788|9703629|FG000|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
8660507|NCT00697788|9703630|FG001|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
8660508|NCT00697788|9703631|FG002|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
8660509|NCT00697788|9703632|FG003|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
8660510|NCT00697788|9703633|FG004|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
8660511|NCT00697788|9703634|FG005|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||2
8660512|NCT00697788|9703635|FG006|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
8660513|NCT00697788|9703636|FG007|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
8660514|NCT00697788|9703629|FG000|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
8660515|NCT00697788|9703630|FG001|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
8660516|NCT00697788|9703631|FG002|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
8660517|NCT00697788|9703632|FG003|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
8660518|NCT00697788|9703633|FG004|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
8660519|NCT00697788|9703634|FG005|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
8660520|NCT00697788|9703635|FG006|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
8660521|NCT00697788|9703636|FG007|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
8660522|NCT00697788|9703629|FG000|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
8660523|NCT00697788|9703630|FG001|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
8660524|NCT00697788|9703631|FG002|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
8660525|NCT00697788|9703632|FG003|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
8660526|NCT00697788|9703633|FG004|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
8660527|NCT00697788|9703634|FG005|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
8660528|NCT00697788|9703635|FG006|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||2
8660529|NCT00697788|9703636|FG007|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
8660530|NCT00697788|9703629|FG000|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
8660531|NCT00697788|9703630|FG001|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
8660532|NCT00697788|9703631|FG002|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
8660533|NCT00697788|9703632|FG003|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
8660534|NCT00697788|9703633|FG004|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
8660535|NCT00697788|9703634|FG005|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
8660536|NCT00697788|9703635|FG006|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||2
8660537|NCT00697788|9703636|FG007|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
8660538|NCT00697788|9703629|FG000|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
8660539|NCT00697788|9703630|FG001|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
8660540|NCT00697788|9703631|FG002|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
8660541|NCT00697788|9703632|FG003|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
8660542|NCT00697788|9703633|FG004|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
8660543|NCT00697788|9703634|FG005|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
8660544|NCT00697788|9703635|FG006|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
8660545|NCT00697788|9703636|FG007|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
8660546|NCT00697788|9703629|FG000|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
8660547|NCT00697788|9703630|FG001|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
8660548|NCT00697788|9703631|FG002|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
8660549|NCT00697788|9703632|FG003|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
8660550|NCT00697788|9703633|FG004|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
8660551|NCT00697788|9703634|FG005|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
8660552|NCT00697788|9703635|FG006|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
8660553|NCT00697788|9703636|FG007|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||2
8660554|NCT00697788|9703629|FG000|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
8660555|NCT00697788|9703630|FG001|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
8660556|NCT00697788|9703631|FG002|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
8660557|NCT00697788|9703632|FG003|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
8660558|NCT00697788|9703633|FG004|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
8660559|NCT00697788|9703634|FG005|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
8660560|NCT00697788|9703635|FG006|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
8660561|NCT00697788|9703636|FG007|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||2
8660562|NCT00697788|9703629|FG000|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
8660563|NCT00697788|9703630|FG001|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
8660564|NCT00697788|9703631|FG002|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
8660565|NCT00697788|9703632|FG003|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
8660566|NCT00697788|9703633|FG004|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
8660567|NCT00697788|9703634|FG005|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
8660568|NCT00697788|9703635|FG006|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
8660569|NCT00697788|9703636|FG007|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
8660570|NCT00697801|9703666|FG000|STARTED|Overall Study||69
8660571|NCT00697801|9703667|FG001|STARTED|Overall Study||70
8660572|NCT00697801|9703668|FG002|STARTED|Overall Study||69
8660573|NCT00697801|9703666|FG000|COMPLETED|Overall Study||57
8660574|NCT00697801|9703667|FG001|COMPLETED|Overall Study||58
8660575|NCT00697801|9703668|FG002|COMPLETED|Overall Study||45
8660576|NCT00697801|9703666|FG000|NOT COMPLETED|Overall Study||12
8660577|NCT00697801|9703667|FG001|NOT COMPLETED|Overall Study||12
8660578|NCT00697801|9703668|FG002|NOT COMPLETED|Overall Study||24
8660579|NCT00697827|9703678|FG000|STARTED|Overall Study||28
8660580|NCT00697827|9703679|FG001|STARTED|Overall Study||16
8660581|NCT00697827|9703678|FG000|COMPLETED|Overall Study||26
8660582|NCT00697827|9703679|FG001|COMPLETED|Overall Study||15
8660583|NCT00697827|9703678|FG000|NOT COMPLETED|Overall Study||2
8660584|NCT00697827|9703679|FG001|NOT COMPLETED|Overall Study||1
8660585|NCT00698035|9703687|FG000|STARTED|Overall Study||39
8660586|NCT00698035|9703688|FG001|STARTED|Overall Study||36
8660587|NCT00698035|9703687|FG000|COMPLETED|Overall Study||35
8660588|NCT00698035|9703688|FG001|COMPLETED|Overall Study||34
8660589|NCT00698035|9703687|FG000|NOT COMPLETED|Overall Study||4
8660590|NCT00698035|9703688|FG001|NOT COMPLETED|Overall Study||2
8660591|NCT00698139|9703700|FG000|STARTED|Overall Study||1
8660592|NCT00698139|9703701|FG001|STARTED|Overall Study||1
8660593|NCT00698139|9703702|FG002|STARTED|Overall Study||1
8660594|NCT00698139|9703700|FG000|2nd Visit|Overall Study||1
8660595|NCT00698139|9703701|FG001|2nd Visit|Overall Study||1
8660596|NCT00698139|9703702|FG002|2nd Visit|Overall Study|1 subject in the Intervention Group did not have a 2nd visit (per design).|0
8660597|NCT00698139|9703700|FG000|COMPLETED|Overall Study||1
8660598|NCT00698139|9703701|FG001|COMPLETED|Overall Study||1
8660599|NCT00698139|9703702|FG002|COMPLETED|Overall Study||1
8660600|NCT00698139|9703700|FG000|NOT COMPLETED|Overall Study||0
8660601|NCT00698139|9703701|FG001|NOT COMPLETED|Overall Study||0
8660602|NCT00698139|9703702|FG002|NOT COMPLETED|Overall Study||0
8660603|NCT00698204|9703712|FG000|STARTED|Overall Study||20
8660604|NCT00698204|9703713|FG001|STARTED|Overall Study||20
8660605|NCT00698204|9703712|FG000|COMPLETED|Overall Study||19
8660606|NCT00698204|9703713|FG001|COMPLETED|Overall Study||20
8660607|NCT00698204|9703712|FG000|NOT COMPLETED|Overall Study||1
8660608|NCT00698204|9703713|FG001|NOT COMPLETED|Overall Study||0
8660609|NCT00698451|9703721|FG000|STARTED|Overall Study||54
8660610|NCT00698451|9703721|FG000|COMPLETED|Overall Study||15
8660611|NCT00698451|9703721|FG000|NOT COMPLETED|Overall Study||39
8660612|NCT00698516|9703725|FG000|STARTED|Overall Study||50
8660613|NCT00698516|9703725|FG000|COMPLETED|Overall Study||45
8660614|NCT00698516|9703725|FG000|NOT COMPLETED|Overall Study||5
8660615|NCT00698581|9703735|FG000|STARTED|Overall Study||68
8660616|NCT00698581|9703736|FG001|STARTED|Overall Study||20
8660617|NCT00698581|9703735|FG000|COMPLETED|Overall Study||23
8660618|NCT00698581|9703736|FG001|COMPLETED|Overall Study||8
8660619|NCT00698581|9703735|FG000|NOT COMPLETED|Overall Study||45
8660620|NCT00698581|9703736|FG001|NOT COMPLETED|Overall Study||12
8660621|NCT00698646|9703746|FG000|STARTED|Overall Study||128
8660622|NCT00698646|9703747|FG001|STARTED|Overall Study||128
8660623|NCT00698646|9703748|FG002|STARTED|Overall Study||128
8660624|NCT00698646|9703746|FG000|COMPLETED|Overall Study||92
8660625|NCT00698646|9703747|FG001|COMPLETED|Overall Study||97
8660626|NCT00698646|9703748|FG002|COMPLETED|Overall Study||99
8660627|NCT00698646|9703746|FG000|NOT COMPLETED|Overall Study||36
8660628|NCT00698646|9703747|FG001|NOT COMPLETED|Overall Study||31
8660629|NCT00698646|9703748|FG002|NOT COMPLETED|Overall Study||29
8660630|NCT00698685|9703756|FG000|STARTED|Overall Study||14
8660631|NCT00698685|9703756|FG000|COMPLETED|Overall Study||12
8660632|NCT00698685|9703756|FG000|NOT COMPLETED|Overall Study||2
8660633|NCT00698841|9703760|FG000|STARTED|Overall Study||51
8660634|NCT00698841|9703760|FG000|COMPLETED|Overall Study||33
8660635|NCT00698841|9703760|FG000|NOT COMPLETED|Overall Study||18
8660636|NCT00698867|9703764|FG000|STARTED|Overall Study||118
8660637|NCT00698867|9703764|FG000|Subjects With 1 Year Data|Overall Study||68
8660638|NCT00698867|9703764|FG000|Subjects With 2 Year Data|Overall Study||55
8660639|NCT00698867|9703764|FG000|Subjects With 3 Year Data|Overall Study||35
8660640|NCT00698867|9703764|FG000|Subjects With 4 Year Data|Overall Study||34
8660641|NCT00698867|9703764|FG000|COMPLETED|Overall Study||27
8660642|NCT00698867|9703764|FG000|NOT COMPLETED|Overall Study||91
8660643|NCT00698932|9703770|FG000|STARTED|Overall Study|Randomized and treated|284
8660644|NCT00698932|9703771|FG001|STARTED|Overall Study|Randomized and treated|284
8660645|NCT00698932|9703770|FG000|COMPLETED|Overall Study|Completed 24 Weeks of treatment|262
8660646|NCT00698932|9703771|FG001|COMPLETED|Overall Study|Completed 24 Weeks of treatment|248
8660647|NCT00698932|9703770|FG000|NOT COMPLETED|Overall Study||22
8660648|NCT00698932|9703771|FG001|NOT COMPLETED|Overall Study||36
8660649|NCT00698997|9703779|FG000|STARTED|Overall Study|1 enrollment|55
8660650|NCT00698997|9703780|FG001|STARTED|Overall Study|1 enrollment|63
8660651|NCT00698997|9703779|FG000|COMPLETED|Overall Study|45 - final participant assessment completed|45
8660652|NCT00698997|9703780|FG001|COMPLETED|Overall Study|36 - final assessment completed|36
8660653|NCT00698997|9703779|FG000|NOT COMPLETED|Overall Study||10
8660654|NCT00698997|9703780|FG001|NOT COMPLETED|Overall Study||27
8660655|NCT00699010|9703789|FG000|STARTED|Overall Study||15
8660656|NCT00699010|9703790|FG001|STARTED|Overall Study||15
8660657|NCT00699010|9703789|FG000|COMPLETED|Overall Study||15
8660658|NCT00699010|9703790|FG001|COMPLETED|Overall Study||15
8660659|NCT00699010|9703789|FG000|NOT COMPLETED|Overall Study||0
8660660|NCT00699010|9703790|FG001|NOT COMPLETED|Overall Study||0
8660661|NCT00699140|9703796|FG000|STARTED|Overall Study||18
8660662|NCT00699140|9703796|FG000|COMPLETED|Overall Study||18
8660663|NCT00699140|9703796|FG000|NOT COMPLETED|Overall Study||0
8660664|NCT00699153|9703806|FG000|STARTED|Overall Study|Intent to treat population|203
8660665|NCT00699153|9703807|FG001|STARTED|Overall Study|Intent to treat population|202
8660666|NCT00699153|9703806|FG000|COMPLETED|Overall Study||200
8660667|NCT00699153|9703807|FG001|COMPLETED|Overall Study||200
8660668|NCT00699153|9703806|FG000|NOT COMPLETED|Overall Study||3
8660669|NCT00699153|9703807|FG001|NOT COMPLETED|Overall Study||2
8660670|NCT00699192|9703816|FG000|STARTED|Overall Study||275
8660671|NCT00699192|9703817|FG001|STARTED|Overall Study||272
8660672|NCT00699192|9703818|FG002|STARTED|Overall Study||272
8660673|NCT00699192|9703816|FG000|COMPLETED|Overall Study||259
8660674|NCT00699192|9703817|FG001|COMPLETED|Overall Study||260
8660675|NCT00699192|9703818|FG002|COMPLETED|Overall Study||261
8660676|NCT00699192|9703816|FG000|NOT COMPLETED|Overall Study||16
8660677|NCT00699192|9703817|FG001|NOT COMPLETED|Overall Study||12
8660678|NCT00699192|9703818|FG002|NOT COMPLETED|Overall Study||11
8660679|NCT00699218|9703826|FG000|STARTED|Overall Study||15
8660680|NCT00699218|9703826|FG000|COMPLETED|Overall Study||15
8660681|NCT00699218|9703826|FG000|NOT COMPLETED|Overall Study||0
8660682|NCT00699283|9703832|FG000|STARTED|Overall Study||47
8660683|NCT00699283|9703833|FG001|STARTED|Overall Study||15
8660684|NCT00699283|9703832|FG000|COMPLETED|Overall Study||14
8660685|NCT00699283|9703833|FG001|COMPLETED|Overall Study||7
8660686|NCT00699283|9703832|FG000|NOT COMPLETED|Overall Study||33
8660687|NCT00699283|9703833|FG001|NOT COMPLETED|Overall Study||8
8660688|NCT00699335|9703838|FG000|STARTED|Overall Study||5308
8660689|NCT00699335|9703838|FG000|COMPLETED|Overall Study||5080
8660690|NCT00699335|9703838|FG000|NOT COMPLETED|Overall Study||228
8660691|NCT00699348|9703845|FG000|STARTED|Overall Study||351
8660692|NCT00699348|9703845|FG000|COMPLETED|Overall Study||261
8660693|NCT00699348|9703845|FG000|NOT COMPLETED|Overall Study||90
8660694|NCT00699374|9703851|FG000|STARTED|Overall Study||530
8660695|NCT00699374|9703852|FG001|STARTED|Overall Study||544
8660696|NCT00699374|9703851|FG000|Treated|Overall Study||526
8660697|NCT00699374|9703852|FG001|Treated|Overall Study||542
8660698|NCT00699374|9703851|FG000|COMPLETED|Overall Study||0
8660699|NCT00699374|9703852|FG001|COMPLETED|Overall Study||0
8660700|NCT00699374|9703851|FG000|NOT COMPLETED|Overall Study||530
8660701|NCT00699374|9703852|FG001|NOT COMPLETED|Overall Study||544
8660702|NCT00699400|9703861|FG000|STARTED|Overall Study||42
8660703|NCT00699400|9703862|FG001|STARTED|Overall Study||3
8660704|NCT00699400|9703863|FG002|STARTED|Overall Study||138
8660705|NCT00699400|9703864|FG003|STARTED|Overall Study||6
8660706|NCT00699400|9703865|FG004|STARTED|Overall Study||4
8660707|NCT00699400|9703866|FG005|STARTED|Overall Study||11
8660708|NCT00699400|9703861|FG000|COMPLETED|Overall Study||42
8660709|NCT00699400|9703862|FG001|COMPLETED|Overall Study||3
8660710|NCT00699400|9703863|FG002|COMPLETED|Overall Study||138
8660711|NCT00699400|9703864|FG003|COMPLETED|Overall Study||6
8660712|NCT00699400|9703865|FG004|COMPLETED|Overall Study||4
8660713|NCT00699400|9703866|FG005|COMPLETED|Overall Study||0
8660714|NCT00699400|9703861|FG000|NOT COMPLETED|Overall Study||0
8660715|NCT00699400|9703862|FG001|NOT COMPLETED|Overall Study||0
8660716|NCT00699400|9703863|FG002|NOT COMPLETED|Overall Study||0
8660717|NCT00699400|9703864|FG003|NOT COMPLETED|Overall Study||0
8660718|NCT00699400|9703865|FG004|NOT COMPLETED|Overall Study||0
8660719|NCT00699400|9703866|FG005|NOT COMPLETED|Overall Study||11
8660720|NCT00699491|9703880|FG000|STARTED|Overall Study||3
8660721|NCT00699491|9703881|FG001|STARTED|Overall Study||2
8660722|NCT00699491|9703882|FG002|STARTED|Overall Study||7
8660723|NCT00699491|9703883|FG003|STARTED|Overall Study||6
8660724|NCT00699491|9703884|FG004|STARTED|Overall Study||8
8660725|NCT00699491|9703885|FG005|STARTED|Overall Study||22
8660726|NCT00699491|9703880|FG000|COMPLETED|Overall Study||3
8660727|NCT00699491|9703881|FG001|COMPLETED|Overall Study||2
8660728|NCT00699491|9703882|FG002|COMPLETED|Overall Study||7
8660729|NCT00699491|9703883|FG003|COMPLETED|Overall Study||6
8660730|NCT00699491|9703884|FG004|COMPLETED|Overall Study||8
8660731|NCT00699491|9703885|FG005|COMPLETED|Overall Study||22
8660732|NCT00699491|9703880|FG000|NOT COMPLETED|Overall Study||0
8660733|NCT00699491|9703881|FG001|NOT COMPLETED|Overall Study||0
8660734|NCT00699491|9703882|FG002|NOT COMPLETED|Overall Study||0
8660735|NCT00699491|9703883|FG003|NOT COMPLETED|Overall Study||0
8660736|NCT00699491|9703884|FG004|NOT COMPLETED|Overall Study||0
8660737|NCT00699491|9703885|FG005|NOT COMPLETED|Overall Study||0
8660738|NCT00699556|9703899|FG000|STARTED|First Intervention (1 Day)||11
8660739|NCT00699556|9703900|FG001|STARTED|First Intervention (1 Day)||11
8660740|NCT00699556|9703899|FG000|COMPLETED|First Intervention (1 Day)||11
8660741|NCT00699556|9703900|FG001|COMPLETED|First Intervention (1 Day)||11
8660742|NCT00699556|9703899|FG000|NOT COMPLETED|First Intervention (1 Day)||0
8660743|NCT00699556|9703900|FG001|NOT COMPLETED|First Intervention (1 Day)||0
8660744|NCT00699556|9703899|FG000|STARTED|Second Intervention (1 Day)||11
8660745|NCT00699556|9703900|FG001|STARTED|Second Intervention (1 Day)||11
8660746|NCT00699556|9703899|FG000|COMPLETED|Second Intervention (1 Day)||11
8660747|NCT00699556|9703900|FG001|COMPLETED|Second Intervention (1 Day)||11
8660748|NCT00699556|9703899|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
8660749|NCT00699556|9703900|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
8660750|NCT00699582|9703910|FG000|STARTED|Overall Study||138
8660751|NCT00699582|9703911|FG001|STARTED|Overall Study||130
8660752|NCT00699582|9703912|FG002|STARTED|Overall Study||121
8660753|NCT00699582|9703910|FG000|COMPLETED|Overall Study||120
8660754|NCT00699582|9703911|FG001|COMPLETED|Overall Study||108
8660755|NCT00699582|9703912|FG002|COMPLETED|Overall Study||93
8660756|NCT00699582|9703910|FG000|NOT COMPLETED|Overall Study||18
8660757|NCT00699582|9703911|FG001|NOT COMPLETED|Overall Study||22
8660758|NCT00699582|9703912|FG002|NOT COMPLETED|Overall Study||28
8660759|NCT00699608|9703920|FG000|STARTED|First Intervention||16
8660760|NCT00699608|9703921|FG001|STARTED|First Intervention||15
8660761|NCT00699608|9703922|FG002|STARTED|First Intervention||15
8660762|NCT00699608|9703923|FG003|STARTED|First Intervention||15
8660763|NCT00699608|9703924|FG004|STARTED|First Intervention||15
8660764|NCT00699608|9703925|FG005|STARTED|First Intervention||15
8660765|NCT00699608|9703920|FG000|COMPLETED|First Intervention||16
8660766|NCT00699608|9703921|FG001|COMPLETED|First Intervention||15
8660767|NCT00699608|9703922|FG002|COMPLETED|First Intervention||14
8660768|NCT00699608|9703923|FG003|COMPLETED|First Intervention||15
8660769|NCT00699608|9703924|FG004|COMPLETED|First Intervention||14
8660770|NCT00699608|9703925|FG005|COMPLETED|First Intervention||15
8660771|NCT00699608|9703920|FG000|NOT COMPLETED|First Intervention||0
8660772|NCT00699608|9703921|FG001|NOT COMPLETED|First Intervention||0
8660773|NCT00699608|9703922|FG002|NOT COMPLETED|First Intervention||1
8660774|NCT00699608|9703923|FG003|NOT COMPLETED|First Intervention||0
8660775|NCT00699608|9703924|FG004|NOT COMPLETED|First Intervention||1
8660776|NCT00699608|9703925|FG005|NOT COMPLETED|First Intervention||0
8660777|NCT00699608|9703920|FG000|STARTED|First 4-14 Day Washout Period||16
8660778|NCT00699608|9703921|FG001|STARTED|First 4-14 Day Washout Period||15
8660779|NCT00699608|9703922|FG002|STARTED|First 4-14 Day Washout Period||14
8660780|NCT00699608|9703923|FG003|STARTED|First 4-14 Day Washout Period||15
8660781|NCT00699608|9703924|FG004|STARTED|First 4-14 Day Washout Period||14
8660782|NCT00699608|9703925|FG005|STARTED|First 4-14 Day Washout Period||15
8660783|NCT00699608|9703920|FG000|COMPLETED|First 4-14 Day Washout Period||16
8660784|NCT00699608|9703921|FG001|COMPLETED|First 4-14 Day Washout Period||15
8660785|NCT00699608|9703922|FG002|COMPLETED|First 4-14 Day Washout Period||14
8660786|NCT00699608|9703923|FG003|COMPLETED|First 4-14 Day Washout Period||15
8660787|NCT00699608|9703924|FG004|COMPLETED|First 4-14 Day Washout Period||14
8660788|NCT00699608|9703925|FG005|COMPLETED|First 4-14 Day Washout Period||15
8660789|NCT00699608|9703920|FG000|NOT COMPLETED|First 4-14 Day Washout Period||0
8660790|NCT00699608|9703921|FG001|NOT COMPLETED|First 4-14 Day Washout Period||0
8660791|NCT00699608|9703922|FG002|NOT COMPLETED|First 4-14 Day Washout Period||0
8660792|NCT00699608|9703923|FG003|NOT COMPLETED|First 4-14 Day Washout Period||0
8660793|NCT00699608|9703924|FG004|NOT COMPLETED|First 4-14 Day Washout Period||0
8660794|NCT00699608|9703925|FG005|NOT COMPLETED|First 4-14 Day Washout Period||0
8660795|NCT00699608|9703920|FG000|STARTED|Second Intervention||16
8660796|NCT00699608|9703921|FG001|STARTED|Second Intervention||15
8660797|NCT00699608|9703922|FG002|STARTED|Second Intervention||14
8660798|NCT00699608|9703923|FG003|STARTED|Second Intervention||15
8660799|NCT00699608|9703924|FG004|STARTED|Second Intervention||14
8660800|NCT00699608|9703925|FG005|STARTED|Second Intervention||15
8660801|NCT00699608|9703920|FG000|COMPLETED|Second Intervention||16
8660802|NCT00699608|9703921|FG001|COMPLETED|Second Intervention||15
8660803|NCT00699608|9703922|FG002|COMPLETED|Second Intervention||13
8660804|NCT00699608|9703923|FG003|COMPLETED|Second Intervention||14
8660805|NCT00699608|9703924|FG004|COMPLETED|Second Intervention||14
8660806|NCT00699608|9703925|FG005|COMPLETED|Second Intervention||15
8660807|NCT00699608|9703920|FG000|NOT COMPLETED|Second Intervention||0
8660808|NCT00699608|9703921|FG001|NOT COMPLETED|Second Intervention||0
8660809|NCT00699608|9703922|FG002|NOT COMPLETED|Second Intervention||1
8660810|NCT00699608|9703923|FG003|NOT COMPLETED|Second Intervention||1
8660811|NCT00699608|9703924|FG004|NOT COMPLETED|Second Intervention||0
8660812|NCT00699608|9703925|FG005|NOT COMPLETED|Second Intervention||0
8660813|NCT00699608|9703920|FG000|STARTED|Second 4-14 Day Washout Period||16
8660814|NCT00699608|9703921|FG001|STARTED|Second 4-14 Day Washout Period||15
8660815|NCT00699608|9703922|FG002|STARTED|Second 4-14 Day Washout Period||13
8660816|NCT00699608|9703923|FG003|STARTED|Second 4-14 Day Washout Period||14
8660817|NCT00699608|9703924|FG004|STARTED|Second 4-14 Day Washout Period||14
8660818|NCT00699608|9703925|FG005|STARTED|Second 4-14 Day Washout Period||15
8660819|NCT00699608|9703920|FG000|COMPLETED|Second 4-14 Day Washout Period||16
8660820|NCT00699608|9703921|FG001|COMPLETED|Second 4-14 Day Washout Period||15
8660821|NCT00699608|9703922|FG002|COMPLETED|Second 4-14 Day Washout Period||13
8660822|NCT00699608|9703923|FG003|COMPLETED|Second 4-14 Day Washout Period||14
8660823|NCT00699608|9703924|FG004|COMPLETED|Second 4-14 Day Washout Period||14
8660824|NCT00699608|9703925|FG005|COMPLETED|Second 4-14 Day Washout Period||15
8660825|NCT00699608|9703920|FG000|NOT COMPLETED|Second 4-14 Day Washout Period||0
8660826|NCT00699608|9703921|FG001|NOT COMPLETED|Second 4-14 Day Washout Period||0
8660827|NCT00699608|9703922|FG002|NOT COMPLETED|Second 4-14 Day Washout Period||0
8660828|NCT00699608|9703923|FG003|NOT COMPLETED|Second 4-14 Day Washout Period||0
8660829|NCT00699608|9703924|FG004|NOT COMPLETED|Second 4-14 Day Washout Period||0
8660830|NCT00699608|9703925|FG005|NOT COMPLETED|Second 4-14 Day Washout Period||0
8660831|NCT00699608|9703920|FG000|STARTED|Third Intervention||16
8660832|NCT00699608|9703921|FG001|STARTED|Third Intervention||15
8660833|NCT00699608|9703922|FG002|STARTED|Third Intervention||13
8660834|NCT00699608|9703923|FG003|STARTED|Third Intervention||14
8660835|NCT00699608|9703924|FG004|STARTED|Third Intervention||14
8660836|NCT00699608|9703925|FG005|STARTED|Third Intervention||15
8660837|NCT00699608|9703920|FG000|COMPLETED|Third Intervention||16
8660838|NCT00699608|9703921|FG001|COMPLETED|Third Intervention||15
8660839|NCT00699608|9703922|FG002|COMPLETED|Third Intervention||13
8660840|NCT00699608|9703923|FG003|COMPLETED|Third Intervention||14
8660841|NCT00699608|9703924|FG004|COMPLETED|Third Intervention||14
8660842|NCT00699608|9703925|FG005|COMPLETED|Third Intervention||15
8660843|NCT00699608|9703920|FG000|NOT COMPLETED|Third Intervention||0
8660844|NCT00699608|9703921|FG001|NOT COMPLETED|Third Intervention||0
8660845|NCT00699608|9703922|FG002|NOT COMPLETED|Third Intervention||0
8660846|NCT00699608|9703923|FG003|NOT COMPLETED|Third Intervention||0
8660847|NCT00699608|9703924|FG004|NOT COMPLETED|Third Intervention||0
8660848|NCT00699608|9703925|FG005|NOT COMPLETED|Third Intervention||0
8660849|NCT00699660|9703935|FG000|STARTED|Overall Study||190
8660850|NCT00699660|9703936|FG001|STARTED|Overall Study||216
8660851|NCT00699660|9703935|FG000|COMPLETED|Overall Study||176
8660852|NCT00699660|9703936|FG001|COMPLETED|Overall Study||208
8660853|NCT00699660|9703935|FG000|NOT COMPLETED|Overall Study||14
8660854|NCT00699660|9703936|FG001|NOT COMPLETED|Overall Study||8
8660855|NCT00699699|9703942|FG000|STARTED|Overall Study||1280
8660856|NCT00699699|9703942|FG000|COMPLETED|Overall Study||1223
8660857|NCT00699699|9703942|FG000|NOT COMPLETED|Overall Study||57
8660858|NCT00699751|9703948|FG000|STARTED|Period 1: Without/Before Drug Switch||614
8660859|NCT00699751|9703949|FG001|STARTED|Period 1: Without/Before Drug Switch||307
8660860|NCT00699751|9703948|FG000|Participants Received Treatment|Period 1: Without/Before Drug Switch||600
8660861|NCT00699751|9703949|FG001|Participants Received Treatment|Period 1: Without/Before Drug Switch||301
8660862|NCT00699751|9703948|FG000|Entered 3-Year Follow-up Period|Period 1: Without/Before Drug Switch|Participants were not required to complete all 6 injections to enter to 3-year follow-up period.|407
8660863|NCT00699751|9703949|FG001|Entered 3-Year Follow-up Period|Period 1: Without/Before Drug Switch|Participants were not required to complete all 6 injections to enter to 3-year follow-up period.|168
8660864|NCT00699751|9703948|FG000|Completed 3-Year Follow-up Period|Period 1: Without/Before Drug Switch||49
8660865|NCT00699751|9703949|FG001|Completed 3-Year Follow-up Period|Period 1: Without/Before Drug Switch||12
8660866|NCT00699751|9703948|FG000|COMPLETED|Period 1: Without/Before Drug Switch|Completed all 6 injections|389
8660867|NCT00699751|9703949|FG001|COMPLETED|Period 1: Without/Before Drug Switch|Completed all 6 injections|145
8660868|NCT00699751|9703948|FG000|NOT COMPLETED|Period 1: Without/Before Drug Switch||225
8660869|NCT00699751|9703949|FG001|NOT COMPLETED|Period 1: Without/Before Drug Switch||162
8660870|NCT00699751|9703948|FG000|STARTED|Period 2:Switched From Placebo to Xofigo||0
8660871|NCT00699751|9703949|FG001|STARTED|Period 2:Switched From Placebo to Xofigo|Participants in the placebo group switched to Xofigo treatment|26
8660872|NCT00699751|9703948|FG000|Participants Received Treatment|Period 2:Switched From Placebo to Xofigo||0
8660873|NCT00699751|9703949|FG001|Participants Received Treatment|Period 2:Switched From Placebo to Xofigo||24
8660874|NCT00699751|9703948|FG000|Entered 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||0
8660875|NCT00699751|9703949|FG001|Entered 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||15
8660876|NCT00699751|9703948|FG000|Completed 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||0
8660877|NCT00699751|9703949|FG001|Completed 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||0
8660878|NCT00699751|9703948|FG000|COMPLETED|Period 2:Switched From Placebo to Xofigo||0
8660879|NCT00699751|9703949|FG001|COMPLETED|Period 2:Switched From Placebo to Xofigo|Completed all 6 injections|17
8729668|NCT01054625|9776959|FG002|COMPLETED|Overall Study||9
8729669|NCT01054625|9776957|FG000|NOT COMPLETED|Overall Study||2
8729670|NCT01054625|9776958|FG001|NOT COMPLETED|Overall Study||3
8729671|NCT01054625|9776959|FG002|NOT COMPLETED|Overall Study||1
8729672|NCT01054703|9776967|FG000|STARTED|Overall Study||14
8729673|NCT01054703|9776967|FG000|COMPLETED|Overall Study||14
8729674|NCT01054703|9776967|FG000|NOT COMPLETED|Overall Study||0
8729675|NCT01054729|9776975|FG000|STARTED|Overall Study||16
8729676|NCT01054729|9776976|FG001|STARTED|Overall Study||19
8729677|NCT01054729|9776977|FG002|STARTED|Overall Study||15
8729678|NCT01054729|9776978|FG003|STARTED|Overall Study||14
8729679|NCT01054729|9776975|FG000|Randomized and Treated|Overall Study||16
8729680|NCT01054729|9776976|FG001|Randomized and Treated|Overall Study||18
8911350|NCT02145468|9970438|FG001|STARTED|Overall Study||1731
8660880|NCT00699751|9703948|FG000|NOT COMPLETED|Period 2:Switched From Placebo to Xofigo||0
8660881|NCT00699751|9703949|FG001|NOT COMPLETED|Period 2:Switched From Placebo to Xofigo||9
8660882|NCT00699803|9703958|FG000|STARTED|Overall Study||32
8660883|NCT00699803|9703959|FG001|STARTED|Overall Study||32
8660884|NCT00699803|9703958|FG000|COMPLETED|Overall Study||30
8660885|NCT00699803|9703959|FG001|COMPLETED|Overall Study||26
8660886|NCT00699803|9703958|FG000|NOT COMPLETED|Overall Study||2
8660887|NCT00699803|9703959|FG001|NOT COMPLETED|Overall Study||6
8660888|NCT00699816|9703967|FG000|STARTED|Overall Study||115
8660889|NCT00699816|9703968|FG001|STARTED|Overall Study||115
8660890|NCT00699816|9703967|FG000|COMPLETED|Overall Study||114
8660891|NCT00699816|9703968|FG001|COMPLETED|Overall Study||112
8660892|NCT00699816|9703967|FG000|NOT COMPLETED|Overall Study||1
8660893|NCT00699816|9703968|FG001|NOT COMPLETED|Overall Study||3
8660894|NCT00699907|9703977|FG000|STARTED|Overall Study||14
8660895|NCT00699907|9703978|FG001|STARTED|Overall Study||57
8660896|NCT00699907|9703979|FG002|STARTED|Overall Study||56
8660897|NCT00699907|9703977|FG000|COMPLETED|Overall Study||12
8660898|NCT00699907|9703978|FG001|COMPLETED|Overall Study||47
8660899|NCT00699907|9703979|FG002|COMPLETED|Overall Study||48
8660900|NCT00699907|9703977|FG000|NOT COMPLETED|Overall Study||2
8660901|NCT00699907|9703978|FG001|NOT COMPLETED|Overall Study||10
8660902|NCT00699907|9703979|FG002|NOT COMPLETED|Overall Study||8
8660903|NCT00699972|9703990|FG000|STARTED|Overall Study||122
8660904|NCT00699972|9703991|FG001|STARTED|Overall Study||133
8660905|NCT00699972|9703992|FG002|STARTED|Overall Study||135
8660906|NCT00699972|9703990|FG000|COMPLETED|Overall Study||106
8660907|NCT00699972|9703991|FG001|COMPLETED|Overall Study||114
8660908|NCT00699972|9703992|FG002|COMPLETED|Overall Study||100
8660909|NCT00699972|9703990|FG000|NOT COMPLETED|Overall Study||16
8660910|NCT00699972|9703991|FG001|NOT COMPLETED|Overall Study||19
8660911|NCT00699972|9703992|FG002|NOT COMPLETED|Overall Study||35
8660912|NCT00699998|9704004|FG000|STARTED|Overall Study||3620
8660913|NCT00699998|9704005|FG001|STARTED|Overall Study||1043
8660914|NCT00699998|9704006|FG002|STARTED|Overall Study||3623
8660915|NCT00699998|9704007|FG003|STARTED|Overall Study||1040
8660916|NCT00699998|9704004|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3590
8660917|NCT00699998|9704005|FG001|Received at Least 1 Dose of Study Drug|Overall Study||1033
8660918|NCT00699998|9704006|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3590
8660919|NCT00699998|9704007|FG003|Received at Least 1 Dose of Study Drug|Overall Study||1027
8660920|NCT00699998|9704004|FG000|COMPLETED|Overall Study||3421
8660921|NCT00699998|9704005|FG001|COMPLETED|Overall Study||957
8660922|NCT00699998|9704006|FG002|COMPLETED|Overall Study||3417
8660923|NCT00699998|9704007|FG003|COMPLETED|Overall Study||958
8660924|NCT00699998|9704004|FG000|NOT COMPLETED|Overall Study||199
8660925|NCT00699998|9704005|FG001|NOT COMPLETED|Overall Study||86
8660926|NCT00699998|9704006|FG002|NOT COMPLETED|Overall Study||206
8660927|NCT00699998|9704007|FG003|NOT COMPLETED|Overall Study||82
8729681|NCT01054729|9776977|FG002|Randomized and Treated|Overall Study||15
8729682|NCT01054729|9776978|FG003|Randomized and Treated|Overall Study||14
8729683|NCT01054729|9776975|FG000|COMPLETED|Overall Study||12
8729684|NCT01054729|9776976|FG001|COMPLETED|Overall Study||14
8729685|NCT01054729|9776977|FG002|COMPLETED|Overall Study||9
8729686|NCT01054729|9776978|FG003|COMPLETED|Overall Study||11
8729687|NCT01054729|9776975|FG000|NOT COMPLETED|Overall Study||4
8729688|NCT01054729|9776976|FG001|NOT COMPLETED|Overall Study||5
8729689|NCT01054729|9776977|FG002|NOT COMPLETED|Overall Study||6
8729690|NCT01054729|9776978|FG003|NOT COMPLETED|Overall Study||3
8729691|NCT01054742|9776988|FG000|STARTED|Overall Study||2
8729692|NCT01054742|9776988|FG000|COMPLETED|Overall Study||2
8729693|NCT01054742|9776988|FG000|NOT COMPLETED|Overall Study||0
8729694|NCT01054768|9776994|FG000|STARTED|Overall Study||17
8729695|NCT01054768|9776995|FG001|STARTED|Overall Study||20
8729696|NCT01054768|9776994|FG000|COMPLETED|Overall Study||9
8729697|NCT01054768|9776995|FG001|COMPLETED|Overall Study||17
8729698|NCT01054768|9776994|FG000|NOT COMPLETED|Overall Study||8
8729699|NCT01054768|9776995|FG001|NOT COMPLETED|Overall Study||3
8660928|NCT00700011|9704024|FG000|STARTED|Overall Study||8
8660929|NCT00700011|9704025|FG001|STARTED|Overall Study||2
8660930|NCT00700011|9704024|FG000|COMPLETED|Overall Study||8
8660931|NCT00700011|9704025|FG001|COMPLETED|Overall Study||1
8660932|NCT00700011|9704024|FG000|NOT COMPLETED|Overall Study||0
8660933|NCT00700011|9704025|FG001|NOT COMPLETED|Overall Study||1
8660934|NCT00700063|9704039|FG000|STARTED|Overall Study||33
8660935|NCT00700063|9704040|FG001|STARTED|Overall Study||34
8660936|NCT00700063|9704041|FG002|STARTED|Overall Study||33
8660937|NCT00700063|9704042|FG003|STARTED|Overall Study||33
8660938|NCT00700063|9704043|FG004|STARTED|Overall Study||33
8660939|NCT00700063|9704044|FG005|STARTED|Overall Study||34
8660940|NCT00700063|9704045|FG006|STARTED|Overall Study||32
8660941|NCT00700063|9704046|FG007|STARTED|Overall Study||33
8660942|NCT00700063|9704039|FG000|COMPLETED|Overall Study||32
8660943|NCT00700063|9704040|FG001|COMPLETED|Overall Study||34
8660944|NCT00700063|9704041|FG002|COMPLETED|Overall Study||33
8660945|NCT00700063|9704042|FG003|COMPLETED|Overall Study||31
8660946|NCT00700063|9704043|FG004|COMPLETED|Overall Study||31
8660947|NCT00700063|9704044|FG005|COMPLETED|Overall Study||34
8660948|NCT00700063|9704045|FG006|COMPLETED|Overall Study||32
8660949|NCT00700063|9704046|FG007|COMPLETED|Overall Study||33
8660950|NCT00700063|9704039|FG000|NOT COMPLETED|Overall Study||1
8660951|NCT00700063|9704040|FG001|NOT COMPLETED|Overall Study||0
8660952|NCT00700063|9704041|FG002|NOT COMPLETED|Overall Study||0
8660953|NCT00700063|9704042|FG003|NOT COMPLETED|Overall Study||2
8660954|NCT00700063|9704043|FG004|NOT COMPLETED|Overall Study||2
8660955|NCT00700063|9704044|FG005|NOT COMPLETED|Overall Study||0
8660956|NCT00700063|9704045|FG006|NOT COMPLETED|Overall Study||0
8660957|NCT00700063|9704046|FG007|NOT COMPLETED|Overall Study||0
8660958|NCT00700102|9704066|FG000|STARTED|Overall Study||411
8660959|NCT00700102|9704067|FG001|STARTED|Overall Study||409
8660960|NCT00700102|9704066|FG000|Intention to Treat|Overall Study||410
8660961|NCT00700102|9704067|FG001|Intention to Treat|Overall Study||409
8660962|NCT00700102|9704066|FG000|Received at Least One Dose|Overall Study||407
8660963|NCT00700102|9704067|FG001|Received at Least One Dose|Overall Study||403
8660964|NCT00700102|9704066|FG000|COMPLETED|Overall Study||9
8660965|NCT00700102|9704067|FG001|COMPLETED|Overall Study||14
8660966|NCT00700102|9704066|FG000|NOT COMPLETED|Overall Study||402
8660967|NCT00700102|9704067|FG001|NOT COMPLETED|Overall Study||395
8660968|NCT00700115|9704075|FG000|STARTED|Overall Study||40
8660969|NCT00700115|9704076|FG001|STARTED|Overall Study||20
8660970|NCT00700115|9704075|FG000|COMPLETED|Overall Study||39
8660971|NCT00700115|9704076|FG001|COMPLETED|Overall Study||19
8660972|NCT00700115|9704075|FG000|NOT COMPLETED|Overall Study||1
8660973|NCT00700115|9704076|FG001|NOT COMPLETED|Overall Study||1
8660974|NCT00700141|9704082|FG000|STARTED|Overall Study||482
8660975|NCT00700141|9704082|FG000|COMPLETED|Overall Study||482
8660976|NCT00700141|9704082|FG000|NOT COMPLETED|Overall Study||0
8660977|NCT00700180|9704088|FG000|STARTED|Overall Study||154
8660978|NCT00700180|9704089|FG001|STARTED|Overall Study||149
8660979|NCT00700180|9704088|FG000|COMPLETED|Overall Study|Clinical cutoff date: July 11, 2011|0
8660980|NCT00700180|9704089|FG001|COMPLETED|Overall Study|Clinical cutoff date: July 11, 2011|0
8660981|NCT00700180|9704088|FG000|NOT COMPLETED|Overall Study||154
8660982|NCT00700180|9704089|FG001|NOT COMPLETED|Overall Study||149
8660983|NCT00700271|9704097|FG000|STARTED|Overall Study||278
8660984|NCT00700271|9704098|FG001|STARTED|Overall Study||268
8660985|NCT00700271|9704097|FG000|COMPLETED|Overall Study||264
8660986|NCT00700271|9704098|FG001|COMPLETED|Overall Study||256
8660987|NCT00700271|9704097|FG000|NOT COMPLETED|Overall Study||14
8660988|NCT00700271|9704098|FG001|NOT COMPLETED|Overall Study||12
8660989|NCT00700310|9704108|FG000|STARTED|Overall Study||187
8660990|NCT00700310|9704109|FG001|STARTED|Overall Study||180
8660991|NCT00700310|9704110|FG002|STARTED|Overall Study||174
8660992|NCT00700310|9704111|FG003|STARTED|Overall Study||171
8660993|NCT00700310|9704108|FG000|COMPLETED|Overall Study||166
8660994|NCT00700310|9704109|FG001|COMPLETED|Overall Study||154
8660995|NCT00700310|9704110|FG002|COMPLETED|Overall Study||158
8660996|NCT00700310|9704111|FG003|COMPLETED|Overall Study||145
8660997|NCT00700310|9704108|FG000|NOT COMPLETED|Overall Study||21
8660998|NCT00700310|9704109|FG001|NOT COMPLETED|Overall Study||26
8660999|NCT00700310|9704110|FG002|NOT COMPLETED|Overall Study||16
8661000|NCT00700310|9704111|FG003|NOT COMPLETED|Overall Study||26
8661001|NCT00700336|9704124|FG000|STARTED|Overall Study||40
8661002|NCT00700336|9704125|FG001|STARTED|Overall Study||23
8661003|NCT00700336|9704126|FG002|STARTED|Overall Study||6
8661004|NCT00700336|9704124|FG000|COMPLETED|Overall Study||40
8661005|NCT00700336|9704125|FG001|COMPLETED|Overall Study||23
8661006|NCT00700336|9704126|FG002|COMPLETED|Overall Study||6
8661007|NCT00700336|9704124|FG000|NOT COMPLETED|Overall Study||0
8661008|NCT00700336|9704125|FG001|NOT COMPLETED|Overall Study||0
8661009|NCT00700336|9704126|FG002|NOT COMPLETED|Overall Study||0
8661010|NCT00700375|9704135|FG000|STARTED|Overall Study||30
8661011|NCT00700375|9704136|FG001|STARTED|Overall Study||29
8661012|NCT00700375|9704135|FG000|2 Days After Creatinine Mesurement|Overall Study||30
8661013|NCT00700375|9704136|FG001|2 Days After Creatinine Mesurement|Overall Study||29
8661014|NCT00700375|9704135|FG000|COMPLETED|Overall Study||30
8661015|NCT00700375|9704136|FG001|COMPLETED|Overall Study||29
8661016|NCT00700375|9704135|FG000|NOT COMPLETED|Overall Study||0
8661017|NCT00700375|9704136|FG001|NOT COMPLETED|Overall Study||0
8661018|NCT00700401|9704142|FG000|STARTED|Overall Study||262
8661019|NCT00700401|9704142|FG000|COMPLETED|Overall Study||168
8661020|NCT00700401|9704142|FG000|NOT COMPLETED|Overall Study||94
8661021|NCT00700427|9704146|FG000|STARTED|Study Period 2 (Open-Label Acute Trx)||2017
8661022|NCT00700427|9704147|FG001|STARTED|Study Period 2 (Open-Label Acute Trx)||0
8661023|NCT00700427|9704148|FG002|STARTED|Study Period 2 (Open-Label Acute Trx)||0
8661024|NCT00700427|9704149|FG003|STARTED|Study Period 2 (Open-Label Acute Trx)||0
8661025|NCT00700427|9704150|FG004|STARTED|Study Period 2 (Open-Label Acute Trx)||0
8661026|NCT00700427|9704146|FG000|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||2011
8661027|NCT00700427|9704147|FG001|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
8661028|NCT00700427|9704148|FG002|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
8661029|NCT00700427|9704149|FG003|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
8661030|NCT00700427|9704150|FG004|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
8661031|NCT00700427|9704146|FG000|COMPLETED|Study Period 2 (Open-Label Acute Trx)|One participant was mistakenly recorded as completed. The reason for discontinuation is unknown.|1006
8661032|NCT00700427|9704147|FG001|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
8661033|NCT00700427|9704148|FG002|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
8661034|NCT00700427|9704149|FG003|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
8661035|NCT00700427|9704150|FG004|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
8661036|NCT00700427|9704146|FG000|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||1011
8661037|NCT00700427|9704147|FG001|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
8661038|NCT00700427|9704148|FG002|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
8661039|NCT00700427|9704149|FG003|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
8661040|NCT00700427|9704150|FG004|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
8661041|NCT00700427|9704146|FG000|STARTED|Study Period 3A (Blinded Maintenance)||0
8661042|NCT00700427|9704147|FG001|STARTED|Study Period 3A (Blinded Maintenance)||1005
8661043|NCT00700427|9704148|FG002|STARTED|Study Period 3A (Blinded Maintenance)||0
8661044|NCT00700427|9704149|FG003|STARTED|Study Period 3A (Blinded Maintenance)||0
8661045|NCT00700427|9704150|FG004|STARTED|Study Period 3A (Blinded Maintenance)||0
8661046|NCT00700427|9704146|FG000|COMPLETED|Study Period 3A (Blinded Maintenance)||0
8661047|NCT00700427|9704147|FG001|COMPLETED|Study Period 3A (Blinded Maintenance)||524
8661048|NCT00700427|9704148|FG002|COMPLETED|Study Period 3A (Blinded Maintenance)||0
8661049|NCT00700427|9704149|FG003|COMPLETED|Study Period 3A (Blinded Maintenance)||0
8661050|NCT00700427|9704150|FG004|COMPLETED|Study Period 3A (Blinded Maintenance)||0
8661051|NCT00700427|9704146|FG000|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
8661052|NCT00700427|9704147|FG001|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||481
8661053|NCT00700427|9704148|FG002|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
8661054|NCT00700427|9704149|FG003|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
8661055|NCT00700427|9704150|FG004|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
8661056|NCT00700427|9704146|FG000|STARTED|Study Period 3B (Randomized Withdrawal)||0
8661057|NCT00700427|9704147|FG001|STARTED|Study Period 3B (Randomized Withdrawal)||0
8661058|NCT00700427|9704148|FG002|STARTED|Study Period 3B (Randomized Withdrawal)||266
8661059|NCT00700427|9704149|FG003|STARTED|Study Period 3B (Randomized Withdrawal)||258
8661060|NCT00700427|9704150|FG004|STARTED|Study Period 3B (Randomized Withdrawal)||0
8661061|NCT00700427|9704146|FG000|COMPLETED|Study Period 3B (Randomized Withdrawal)||0
8661062|NCT00700427|9704147|FG001|COMPLETED|Study Period 3B (Randomized Withdrawal)||0
8661063|NCT00700427|9704148|FG002|COMPLETED|Study Period 3B (Randomized Withdrawal)||184
8661064|NCT00700427|9704149|FG003|COMPLETED|Study Period 3B (Randomized Withdrawal)||165
8661065|NCT00700427|9704150|FG004|COMPLETED|Study Period 3B (Randomized Withdrawal)||0
8661066|NCT00700427|9704146|FG000|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||0
8661067|NCT00700427|9704147|FG001|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||0
8661068|NCT00700427|9704148|FG002|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||82
8661069|NCT00700427|9704149|FG003|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||93
8661070|NCT00700427|9704150|FG004|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||0
8661071|NCT00700427|9704146|FG000|STARTED|Study Period 4 (Open-Label Extension)||0
8661072|NCT00700427|9704147|FG001|STARTED|Study Period 4 (Open-Label Extension)||0
8661073|NCT00700427|9704148|FG002|STARTED|Study Period 4 (Open-Label Extension)||0
8661074|NCT00700427|9704149|FG003|STARTED|Study Period 4 (Open-Label Extension)||0
8661075|NCT00700427|9704150|FG004|STARTED|Study Period 4 (Open-Label Extension)||180
8661076|NCT00700427|9704146|FG000|COMPLETED|Study Period 4 (Open-Label Extension)||0
8661077|NCT00700427|9704147|FG001|COMPLETED|Study Period 4 (Open-Label Extension)||0
8661078|NCT00700427|9704148|FG002|COMPLETED|Study Period 4 (Open-Label Extension)||0
8661079|NCT00700427|9704149|FG003|COMPLETED|Study Period 4 (Open-Label Extension)||0
8661080|NCT00700427|9704150|FG004|COMPLETED|Study Period 4 (Open-Label Extension)||96
8661081|NCT00700427|9704146|FG000|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
8661082|NCT00700427|9704147|FG001|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
8661083|NCT00700427|9704148|FG002|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
8661084|NCT00700427|9704149|FG003|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
8661085|NCT00700427|9704150|FG004|NOT COMPLETED|Study Period 4 (Open-Label Extension)||84
8661086|NCT00700440|9704158|FG000|STARTED|Overall Study||100
8661087|NCT00700440|9704158|FG000|COMPLETED|Overall Study||100
8661088|NCT00700440|9704158|FG000|NOT COMPLETED|Overall Study||0
8661089|NCT00700570|9704164|FG000|STARTED|Overall Study||19
8661090|NCT00700570|9704165|FG001|STARTED|Overall Study||26
8729700|NCT01054820|9777001|FG000|STARTED|Overall Study||123
8661091|NCT00700570|9704164|FG000|COMPLETED|Overall Study||8
8661092|NCT00700570|9704165|FG001|COMPLETED|Overall Study||0
8661093|NCT00700570|9704164|FG000|NOT COMPLETED|Overall Study||11
8661094|NCT00700570|9704165|FG001|NOT COMPLETED|Overall Study||26
8661095|NCT00700622|9704173|FG000|STARTED|Overall Study||65
8661096|NCT00700622|9704174|FG001|STARTED|Overall Study||65
8661097|NCT00700622|9704173|FG000|COMPLETED|Overall Study||52
8661098|NCT00700622|9704174|FG001|COMPLETED|Overall Study||60
8661099|NCT00700622|9704173|FG000|NOT COMPLETED|Overall Study||13
8661100|NCT00700622|9704174|FG001|NOT COMPLETED|Overall Study||5
8661101|NCT00700635|9704183|FG000|STARTED|Overall Study||111
8661102|NCT00700635|9704184|FG001|STARTED|Overall Study||111
8661103|NCT00700635|9704185|FG002|STARTED|Overall Study||111
8661104|NCT00700635|9704183|FG000|COMPLETED|Overall Study||100
8661105|NCT00700635|9704184|FG001|COMPLETED|Overall Study||103
8661106|NCT00700635|9704185|FG002|COMPLETED|Overall Study||110
8661107|NCT00700635|9704183|FG000|NOT COMPLETED|Overall Study||11
8661108|NCT00700635|9704184|FG001|NOT COMPLETED|Overall Study||8
8661109|NCT00700635|9704185|FG002|NOT COMPLETED|Overall Study||1
8661110|NCT00700713|9704196|FG000|STARTED|Overall Study||48
8661111|NCT00700713|9704197|FG001|STARTED|Overall Study||66
8661112|NCT00700713|9704198|FG002|STARTED|Overall Study||67
8661113|NCT00700713|9704196|FG000|COMPLETED|Overall Study||47
8661114|NCT00700713|9704197|FG001|COMPLETED|Overall Study||66
8661115|NCT00700713|9704198|FG002|COMPLETED|Overall Study||65
8661116|NCT00700713|9704196|FG000|NOT COMPLETED|Overall Study||1
8661117|NCT00700713|9704197|FG001|NOT COMPLETED|Overall Study||0
8661118|NCT00700713|9704198|FG002|NOT COMPLETED|Overall Study||2
8661119|NCT00700739|9704208|FG000|STARTED|Overall Study||22
8661120|NCT00700739|9704209|FG001|STARTED|Overall Study||16
8661121|NCT00700739|9704208|FG000|COMPLETED|Overall Study||18
8661122|NCT00700739|9704209|FG001|COMPLETED|Overall Study||12
8661123|NCT00700739|9704208|FG000|NOT COMPLETED|Overall Study||4
8661124|NCT00700739|9704209|FG001|NOT COMPLETED|Overall Study||4
8661125|NCT00700752|9704216|FG000|STARTED|First Intervention||20
8661126|NCT00700752|9704217|FG001|STARTED|First Intervention||20
8661127|NCT00700752|9704216|FG000|COMPLETED|First Intervention||20
8661128|NCT00700752|9704217|FG001|COMPLETED|First Intervention||18
8661129|NCT00700752|9704216|FG000|NOT COMPLETED|First Intervention||0
8661130|NCT00700752|9704217|FG001|NOT COMPLETED|First Intervention||2
8661131|NCT00700752|9704216|FG000|STARTED|Second Intervention||20
8661132|NCT00700752|9704217|FG001|STARTED|Second Intervention||18
8661133|NCT00700752|9704216|FG000|COMPLETED|Second Intervention||20
8661134|NCT00700752|9704217|FG001|COMPLETED|Second Intervention||18
8661135|NCT00700752|9704216|FG000|NOT COMPLETED|Second Intervention||0
8661136|NCT00700752|9704217|FG001|NOT COMPLETED|Second Intervention||0
8661137|NCT00700804|9704225|FG000|STARTED|Overall Study||17
8661138|NCT00700804|9704226|FG001|STARTED|Overall Study||17
8661139|NCT00700804|9704225|FG000|COMPLETED|Overall Study||14
8661140|NCT00700804|9704226|FG001|COMPLETED|Overall Study||13
8661141|NCT00700804|9704225|FG000|NOT COMPLETED|Overall Study||3
8661142|NCT00700804|9704226|FG001|NOT COMPLETED|Overall Study||4
8661143|NCT00700817|9704237|FG000|STARTED|Week 0-26 (Main Period)|Randomised|225
8661144|NCT00700817|9704238|FG001|STARTED|Week 0-26 (Main Period)|Randomised|221
8661145|NCT00700817|9704239|FG002|STARTED|Week 0-26 (Main Period)|Randomised|219
8661146|NCT00700817|9704240|FG003|STARTED|Week 0-26 (Main Period)||0
8661147|NCT00700817|9704241|FG004|STARTED|Week 0-26 (Main Period)||0
8661148|NCT00700817|9704237|FG000|Exposed|Week 0-26 (Main Period)|4 subjects withdrew before exposure to trial drug and were not included in Full Analysis Set (FAS)|221
8661149|NCT00700817|9704238|FG001|Exposed|Week 0-26 (Main Period)|3 subjects withdrew before exposure to trial drug and were not included in Full Analysis Set (FAS)|218
8661150|NCT00700817|9704239|FG002|Exposed|Week 0-26 (Main Period)||219
8661151|NCT00700817|9704240|FG003|Exposed|Week 0-26 (Main Period)||0
8661152|NCT00700817|9704241|FG004|Exposed|Week 0-26 (Main Period)||0
8661153|NCT00700817|9704237|FG000|COMPLETED|Week 0-26 (Main Period)||169
8729701|NCT01054820|9777001|FG000|COMPLETED|Overall Study||121
8729702|NCT01054820|9777001|FG000|NOT COMPLETED|Overall Study||2
8729703|NCT01054846|9777007|FG000|STARTED|Overall Study||322
8729704|NCT01054846|9777008|FG001|STARTED|Overall Study||68
8729705|NCT01054846|9777007|FG000|COMPLETED|Overall Study||246
8729706|NCT01054846|9777008|FG001|COMPLETED|Overall Study||51
8729707|NCT01054846|9777007|FG000|NOT COMPLETED|Overall Study||76
8729708|NCT01054846|9777008|FG001|NOT COMPLETED|Overall Study||17
8729709|NCT01054885|9777019|FG000|STARTED|2-week, Single-blind Run-In Period||1577
8661154|NCT00700817|9704238|FG001|COMPLETED|Week 0-26 (Main Period)||191
8661155|NCT00700817|9704239|FG002|COMPLETED|Week 0-26 (Main Period)||194
8661156|NCT00700817|9704240|FG003|COMPLETED|Week 0-26 (Main Period)||0
8661157|NCT00700817|9704241|FG004|COMPLETED|Week 0-26 (Main Period)||0
8661158|NCT00700817|9704237|FG000|NOT COMPLETED|Week 0-26 (Main Period)||56
8661159|NCT00700817|9704238|FG001|NOT COMPLETED|Week 0-26 (Main Period)||30
8661160|NCT00700817|9704239|FG002|NOT COMPLETED|Week 0-26 (Main Period)||25
8661161|NCT00700817|9704240|FG003|NOT COMPLETED|Week 0-26 (Main Period)||0
8661162|NCT00700817|9704241|FG004|NOT COMPLETED|Week 0-26 (Main Period)||0
8661163|NCT00700817|9704237|FG000|STARTED|Week 26-52 (Extension Period 1)|Subjects withdrew before entry to extension period 1|155
8661164|NCT00700817|9704238|FG001|STARTED|Week 26-52 (Extension Period 1)|Subjects withdrew before entry to extension period 1|176
8661165|NCT00700817|9704239|FG002|STARTED|Week 26-52 (Extension Period 1)|Subjects withdrew before entry to extension period 1|166
8729710|NCT01054885|9777020|FG001|STARTED|2-week, Single-blind Run-In Period||0
8661166|NCT00700817|9704240|FG003|STARTED|Week 26-52 (Extension Period 1)||0
8661167|NCT00700817|9704241|FG004|STARTED|Week 26-52 (Extension Period 1)||0
8661168|NCT00700817|9704237|FG000|COMPLETED|Week 26-52 (Extension Period 1)||135
8661169|NCT00700817|9704238|FG001|COMPLETED|Week 26-52 (Extension Period 1)||150
8661170|NCT00700817|9704239|FG002|COMPLETED|Week 26-52 (Extension Period 1)||151
8661171|NCT00700817|9704240|FG003|COMPLETED|Week 26-52 (Extension Period 1)||0
8661172|NCT00700817|9704241|FG004|COMPLETED|Week 26-52 (Extension Period 1)||0
8661173|NCT00700817|9704237|FG000|NOT COMPLETED|Week 26-52 (Extension Period 1)||20
8661174|NCT00700817|9704238|FG001|NOT COMPLETED|Week 26-52 (Extension Period 1)||26
8661175|NCT00700817|9704239|FG002|NOT COMPLETED|Week 26-52 (Extension Period 1)||15
8661176|NCT00700817|9704240|FG003|NOT COMPLETED|Week 26-52 (Extension Period 1)||0
8661177|NCT00700817|9704241|FG004|NOT COMPLETED|Week 26-52 (Extension Period 1)||0
8661178|NCT00700817|9704237|FG000|STARTED|Week 52-78 (Extension Period 2)|Subject withdrew before entry to extension period 2|134
8661179|NCT00700817|9704238|FG001|STARTED|Week 52-78 (Extension Period 2)||150
8661180|NCT00700817|9704239|FG002|STARTED|Week 52-78 (Extension Period 2)|Re-randomised to lira 1.2 or 1.8 mg|0
8661181|NCT00700817|9704240|FG003|STARTED|Week 52-78 (Extension Period 2)|Re-randomised from sita treatment group. Some subjects withdrew before entry to extension period 2.|67
8661182|NCT00700817|9704241|FG004|STARTED|Week 52-78 (Extension Period 2)|Re-randomised from sita treatment group. Some subjects withdrew before entry to extension period 2.|68
8661183|NCT00700817|9704237|FG000|COMPLETED|Week 52-78 (Extension Period 2)||124
8661184|NCT00700817|9704238|FG001|COMPLETED|Week 52-78 (Extension Period 2)||135
8661185|NCT00700817|9704239|FG002|COMPLETED|Week 52-78 (Extension Period 2)||0
8661186|NCT00700817|9704240|FG003|COMPLETED|Week 52-78 (Extension Period 2)||59
8661187|NCT00700817|9704241|FG004|COMPLETED|Week 52-78 (Extension Period 2)||63
8661188|NCT00700817|9704237|FG000|NOT COMPLETED|Week 52-78 (Extension Period 2)||10
8661189|NCT00700817|9704238|FG001|NOT COMPLETED|Week 52-78 (Extension Period 2)||15
8661190|NCT00700817|9704239|FG002|NOT COMPLETED|Week 52-78 (Extension Period 2)||0
8661191|NCT00700817|9704240|FG003|NOT COMPLETED|Week 52-78 (Extension Period 2)||8
8661192|NCT00700817|9704241|FG004|NOT COMPLETED|Week 52-78 (Extension Period 2)||5
8661193|NCT00700882|9704251|FG000|STARTED|Overall Study||81
8661194|NCT00700882|9704251|FG000|Received Protocol Therapy|Overall Study||75
8661195|NCT00700882|9704251|FG000|Eligible and Treated Patients|Overall Study||73
8661196|NCT00700882|9704251|FG000|Eligible, Treated and KIT+ Patients|Overall Study||22
8661197|NCT00700882|9704251|FG000|COMPLETED|Overall Study||22
8661198|NCT00700882|9704251|FG000|NOT COMPLETED|Overall Study||59
8661199|NCT00700973|9704257|FG000|STARTED|Overall Study||71
8661200|NCT00700973|9704258|FG001|STARTED|Overall Study||70
8661201|NCT00700973|9704257|FG000|COMPLETED|Overall Study||63
8661202|NCT00700973|9704258|FG001|COMPLETED|Overall Study||63
8661203|NCT00700973|9704257|FG000|NOT COMPLETED|Overall Study||8
8661204|NCT00700973|9704258|FG001|NOT COMPLETED|Overall Study||7
8661205|NCT00700999|9704266|FG000|STARTED|Overall Study||36
8661206|NCT00700999|9704267|FG001|STARTED|Overall Study||29
8661207|NCT00700999|9704266|FG000|First MRI Scan|Overall Study||29
8661208|NCT00700999|9704267|FG001|First MRI Scan|Overall Study||22
8661209|NCT00700999|9704266|FG000|Second MRI Scan|Overall Study||19
8661210|NCT00700999|9704267|FG001|Second MRI Scan|Overall Study||18
8661211|NCT00700999|9704266|FG000|COMPLETED|Overall Study||21
8661212|NCT00700999|9704267|FG001|COMPLETED|Overall Study||20
8661213|NCT00700999|9704266|FG000|NOT COMPLETED|Overall Study||15
8661214|NCT00700999|9704267|FG001|NOT COMPLETED|Overall Study||9
8661215|NCT00701038|9704275|FG000|STARTED|Overall Study||27
8661216|NCT00701038|9704276|FG001|STARTED|Overall Study||27
8661217|NCT00701038|9704275|FG000|COMPLETED|Overall Study||23
8661218|NCT00701038|9704276|FG001|COMPLETED|Overall Study||23
8661219|NCT00701038|9704275|FG000|NOT COMPLETED|Overall Study||4
8661220|NCT00701038|9704276|FG001|NOT COMPLETED|Overall Study||4
8661221|NCT00701051|9704284|FG000|STARTED|Screening|Arm assignment not known until baseline testing; both arms included in this number|90
8661222|NCT00701051|9704285|FG001|STARTED|Screening||0
8661223|NCT00701051|9704286|FG002|STARTED|Screening||0
8661224|NCT00701051|9704284|FG000|COMPLETED|Screening|Arm assignment not known until baseline testing; both arms included in this number|31
8661225|NCT00701051|9704285|FG001|COMPLETED|Screening||0
8661226|NCT00701051|9704286|FG002|COMPLETED|Screening||0
8661227|NCT00701051|9704284|FG000|NOT COMPLETED|Screening||59
8661228|NCT00701051|9704285|FG001|NOT COMPLETED|Screening||0
8661229|NCT00701051|9704286|FG002|NOT COMPLETED|Screening||0
8661230|NCT00701051|9704284|FG000|STARTED|Exercise Intervention|Participants assigned to Normal or Impaired glucose tolerance arm after screening.|0
8661231|NCT00701051|9704285|FG001|STARTED|Exercise Intervention|Participants assigned to group after Period 1: Screening|19
9022365|NCT03125941|10085244|FG001|NOT COMPLETED|Overall Study||2
9039970|NCT03345108|10100892|FG003|COMPLETED|Period-1||8
9039971|NCT03345108|10100893|FG004|COMPLETED|Period-1||8
9039972|NCT03345108|10100894|FG005|COMPLETED|Period-1||8
9039973|NCT03345108|10100889|FG000|NOT COMPLETED|Period-1||0
9039974|NCT03345108|10100890|FG001|NOT COMPLETED|Period-1||0
8661232|NCT00701051|9704286|FG002|STARTED|Exercise Intervention|Participants assigned to group after Period 1: Screening|12
8661233|NCT00701051|9704284|FG000|COMPLETED|Exercise Intervention||0
8661234|NCT00701051|9704285|FG001|COMPLETED|Exercise Intervention||14
9039975|NCT03345108|10100891|FG002|NOT COMPLETED|Period-1||0
9039976|NCT03345108|10100892|FG003|NOT COMPLETED|Period-1||0
8661235|NCT00701051|9704286|FG002|COMPLETED|Exercise Intervention||9
8661236|NCT00701051|9704284|FG000|NOT COMPLETED|Exercise Intervention||0
9039977|NCT03345108|10100893|FG004|NOT COMPLETED|Period-1||0
8661237|NCT00701051|9704285|FG001|NOT COMPLETED|Exercise Intervention||5
8661238|NCT00701051|9704286|FG002|NOT COMPLETED|Exercise Intervention||3
8661239|NCT00701051|9704284|FG000|STARTED|Detraining Intervention (Optional)||0
8661240|NCT00701051|9704285|FG001|STARTED|Detraining Intervention (Optional)|Participation in this period was optional.|6
8661241|NCT00701051|9704286|FG002|STARTED|Detraining Intervention (Optional)|Participation in this period was optional.|6
8661242|NCT00701051|9704284|FG000|COMPLETED|Detraining Intervention (Optional)||0
8661243|NCT00701051|9704285|FG001|COMPLETED|Detraining Intervention (Optional)||6
8661244|NCT00701051|9704286|FG002|COMPLETED|Detraining Intervention (Optional)||6
8661245|NCT00701051|9704284|FG000|NOT COMPLETED|Detraining Intervention (Optional)||0
8661246|NCT00701051|9704285|FG001|NOT COMPLETED|Detraining Intervention (Optional)||0
8661247|NCT00701051|9704286|FG002|NOT COMPLETED|Detraining Intervention (Optional)||0
8661248|NCT00701064|9704294|FG000|STARTED|Overall Study||35
8661249|NCT00701064|9704295|FG001|STARTED|Overall Study||36
8661250|NCT00701064|9704294|FG000|COMPLETED|Overall Study||31
8661251|NCT00701064|9704295|FG001|COMPLETED|Overall Study||32
8661252|NCT00701064|9704294|FG000|NOT COMPLETED|Overall Study||4
8661253|NCT00701064|9704295|FG001|NOT COMPLETED|Overall Study||4
8661254|NCT00701090|9704303|FG000|STARTED|Overall Study||516
8661255|NCT00701090|9704304|FG001|STARTED|Overall Study||519
8661256|NCT00701090|9704303|FG000|COMPLETED|Overall Study||468
8661257|NCT00701090|9704304|FG001|COMPLETED|Overall Study||468
8661258|NCT00701090|9704303|FG000|NOT COMPLETED|Overall Study||48
8661259|NCT00701090|9704304|FG001|NOT COMPLETED|Overall Study||51
8661260|NCT00701103|9704321|FG000|STARTED|Overall Study||5
8661261|NCT00701103|9704322|FG001|STARTED|Overall Study||3
8661262|NCT00701103|9704323|FG002|STARTED|Overall Study||8
8661263|NCT00701103|9704324|FG003|STARTED|Overall Study||6
8661264|NCT00701103|9704325|FG004|STARTED|Overall Study||6
8661265|NCT00701103|9704326|FG005|STARTED|Overall Study||6
8661266|NCT00701103|9704327|FG006|STARTED|Overall Study||8
8661267|NCT00701103|9704328|FG007|STARTED|Overall Study||7
8661268|NCT00701103|9704329|FG008|STARTED|Overall Study||9
8661269|NCT00701103|9704330|FG009|STARTED|Overall Study||11
8661270|NCT00701103|9704331|FG010|STARTED|Overall Study||11
8661271|NCT00701103|9704321|FG000|COMPLETED|Overall Study||0
8661272|NCT00701103|9704322|FG001|COMPLETED|Overall Study||0
8661273|NCT00701103|9704323|FG002|COMPLETED|Overall Study||0
8661274|NCT00701103|9704324|FG003|COMPLETED|Overall Study||0
8661275|NCT00701103|9704325|FG004|COMPLETED|Overall Study||0
8661276|NCT00701103|9704326|FG005|COMPLETED|Overall Study||0
8661277|NCT00701103|9704327|FG006|COMPLETED|Overall Study||0
8661278|NCT00701103|9704328|FG007|COMPLETED|Overall Study||0
8661279|NCT00701103|9704329|FG008|COMPLETED|Overall Study||0
8661280|NCT00701103|9704330|FG009|COMPLETED|Overall Study||0
8661281|NCT00701103|9704331|FG010|COMPLETED|Overall Study||0
8661282|NCT00701103|9704321|FG000|NOT COMPLETED|Overall Study||5
8661283|NCT00701103|9704322|FG001|NOT COMPLETED|Overall Study||3
8661284|NCT00701103|9704323|FG002|NOT COMPLETED|Overall Study||8
8661285|NCT00701103|9704324|FG003|NOT COMPLETED|Overall Study||6
8661286|NCT00701103|9704325|FG004|NOT COMPLETED|Overall Study||6
8661287|NCT00701103|9704326|FG005|NOT COMPLETED|Overall Study||6
8661288|NCT00701103|9704327|FG006|NOT COMPLETED|Overall Study||8
8661289|NCT00701103|9704328|FG007|NOT COMPLETED|Overall Study||7
8661290|NCT00701103|9704329|FG008|NOT COMPLETED|Overall Study||9
8661291|NCT00701103|9704330|FG009|NOT COMPLETED|Overall Study||11
8661292|NCT00701103|9704331|FG010|NOT COMPLETED|Overall Study||11
8661293|NCT00701129|9704359|FG000|STARTED|Overall Study||4
8661294|NCT00701129|9704359|FG000|Full Analysis Set (FAS)|Overall Study|All enrolled patients who signed informed consent, received at least 1 dose of alglucosidase alfa.|4
8661295|NCT00701129|9704359|FG000|COMPLETED|Overall Study||2
8661296|NCT00701129|9704359|FG000|NOT COMPLETED|Overall Study||2
8729711|NCT01054885|9777021|FG002|STARTED|2-week, Single-blind Run-In Period||0
8729712|NCT01054885|9777022|FG003|STARTED|2-week, Single-blind Run-In Period||0
8729713|NCT01054885|9777023|FG004|STARTED|2-week, Single-blind Run-In Period||0
8729714|NCT01054885|9777024|FG005|STARTED|2-week, Single-blind Run-In Period||0
8729715|NCT01054885|9777025|FG006|STARTED|2-week, Single-blind Run-In Period||0
8729716|NCT01054885|9777019|FG000|COMPLETED|2-week, Single-blind Run-In Period||1226
8729717|NCT01054885|9777020|FG001|COMPLETED|2-week, Single-blind Run-In Period||0
8729718|NCT01054885|9777021|FG002|COMPLETED|2-week, Single-blind Run-In Period||0
8729719|NCT01054885|9777022|FG003|COMPLETED|2-week, Single-blind Run-In Period||0
8729720|NCT01054885|9777023|FG004|COMPLETED|2-week, Single-blind Run-In Period||0
8729721|NCT01054885|9777024|FG005|COMPLETED|2-week, Single-blind Run-In Period||0
8729722|NCT01054885|9777025|FG006|COMPLETED|2-week, Single-blind Run-In Period||0
8729723|NCT01054885|9777019|FG000|NOT COMPLETED|2-week, Single-blind Run-In Period||351
8729724|NCT01054885|9777020|FG001|NOT COMPLETED|2-week, Single-blind Run-In Period||0
8729725|NCT01054885|9777021|FG002|NOT COMPLETED|2-week, Single-blind Run-In Period||0
8729726|NCT01054885|9777022|FG003|NOT COMPLETED|2-week, Single-blind Run-In Period||0
8729727|NCT01054885|9777023|FG004|NOT COMPLETED|2-week, Single-blind Run-In Period||0
8729728|NCT01054885|9777024|FG005|NOT COMPLETED|2-week, Single-blind Run-In Period||0
8729729|NCT01054885|9777025|FG006|NOT COMPLETED|2-week, Single-blind Run-In Period||0
8729730|NCT01054885|9777019|FG000|STARTED|24-week, Double-blind Treatment Period||0
8661297|NCT00701311|9704363|FG000|STARTED|Overall Study||17
8661298|NCT00701311|9704363|FG000|COMPLETED|Overall Study|Eight subjects did not complete full period of treatment but their data was included in analysis.|9
8661299|NCT00701311|9704363|FG000|NOT COMPLETED|Overall Study||8
8661300|NCT00701363|9704371|FG000|STARTED|Screening (Pre-assignment) Phase||128
8661301|NCT00701363|9704372|FG001|STARTED|Screening (Pre-assignment) Phase||0
8661302|NCT00701363|9704373|FG002|STARTED|Screening (Pre-assignment) Phase||0
8661303|NCT00701363|9704374|FG003|STARTED|Screening (Pre-assignment) Phase||0
8661304|NCT00701363|9704371|FG000|COMPLETED|Screening (Pre-assignment) Phase||124
8661305|NCT00701363|9704372|FG001|COMPLETED|Screening (Pre-assignment) Phase||0
8661306|NCT00701363|9704373|FG002|COMPLETED|Screening (Pre-assignment) Phase||0
8661307|NCT00701363|9704374|FG003|COMPLETED|Screening (Pre-assignment) Phase||0
8661308|NCT00701363|9704371|FG000|NOT COMPLETED|Screening (Pre-assignment) Phase||4
8661309|NCT00701363|9704372|FG001|NOT COMPLETED|Screening (Pre-assignment) Phase||0
8661310|NCT00701363|9704373|FG002|NOT COMPLETED|Screening (Pre-assignment) Phase||0
8661311|NCT00701363|9704374|FG003|NOT COMPLETED|Screening (Pre-assignment) Phase||0
8661312|NCT00701363|9704371|FG000|STARTED|Treatment Phase 1||124
8661313|NCT00701363|9704372|FG001|STARTED|Treatment Phase 1||0
8661314|NCT00701363|9704373|FG002|STARTED|Treatment Phase 1||0
8661315|NCT00701363|9704374|FG003|STARTED|Treatment Phase 1||0
8661316|NCT00701363|9704371|FG000|COMPLETED|Treatment Phase 1||109
8661317|NCT00701363|9704372|FG001|COMPLETED|Treatment Phase 1||0
8661318|NCT00701363|9704373|FG002|COMPLETED|Treatment Phase 1||0
8661319|NCT00701363|9704374|FG003|COMPLETED|Treatment Phase 1||0
8729731|NCT01054885|9777020|FG001|STARTED|24-week, Double-blind Treatment Period||205
8729732|NCT01054885|9777021|FG002|STARTED|24-week, Double-blind Treatment Period||204
8729733|NCT01054885|9777022|FG003|STARTED|24-week, Double-blind Treatment Period||203
8729734|NCT01054885|9777023|FG004|STARTED|24-week, Double-blind Treatment Period||203
8729735|NCT01054885|9777024|FG005|STARTED|24-week, Double-blind Treatment Period||204
8729736|NCT01054885|9777025|FG006|STARTED|24-week, Double-blind Treatment Period||205
8729737|NCT01054885|9777019|FG000|COMPLETED|24-week, Double-blind Treatment Period||0
8729738|NCT01054885|9777020|FG001|COMPLETED|24-week, Double-blind Treatment Period||146
8729739|NCT01054885|9777021|FG002|COMPLETED|24-week, Double-blind Treatment Period||155
8729740|NCT01054885|9777022|FG003|COMPLETED|24-week, Double-blind Treatment Period||160
8729741|NCT01054885|9777023|FG004|COMPLETED|24-week, Double-blind Treatment Period||161
8729742|NCT01054885|9777024|FG005|COMPLETED|24-week, Double-blind Treatment Period||144
8729743|NCT01054885|9777025|FG006|COMPLETED|24-week, Double-blind Treatment Period||158
8729744|NCT01054885|9777019|FG000|NOT COMPLETED|24-week, Double-blind Treatment Period||0
8729745|NCT01054885|9777020|FG001|NOT COMPLETED|24-week, Double-blind Treatment Period||59
8729746|NCT01054885|9777021|FG002|NOT COMPLETED|24-week, Double-blind Treatment Period||49
8729747|NCT01054885|9777022|FG003|NOT COMPLETED|24-week, Double-blind Treatment Period||43
8729748|NCT01054885|9777023|FG004|NOT COMPLETED|24-week, Double-blind Treatment Period||42
8729749|NCT01054885|9777024|FG005|NOT COMPLETED|24-week, Double-blind Treatment Period||60
8729750|NCT01054885|9777025|FG006|NOT COMPLETED|24-week, Double-blind Treatment Period||47
8729751|NCT01054911|9777040|FG000|STARTED|Overall Study||5
8729752|NCT01054911|9777040|FG000|COMPLETED|Overall Study||5
8729753|NCT01054911|9777040|FG000|NOT COMPLETED|Overall Study||0
8729754|NCT01054976|9777046|FG000|STARTED|Overall Study||92
8729755|NCT01054976|9777046|FG000|COMPLETED|Overall Study||57
8729756|NCT01054976|9777046|FG000|NOT COMPLETED|Overall Study||35
8729757|NCT01055028|9777052|FG000|STARTED|Screening||9
8729758|NCT01055028|9777053|FG001|STARTED|Screening||9
8729759|NCT01055028|9777052|FG000|COMPLETED|Screening||8
8729760|NCT01055028|9777053|FG001|COMPLETED|Screening||8
8729761|NCT01055028|9777052|FG000|NOT COMPLETED|Screening||1
8729762|NCT01055028|9777053|FG001|NOT COMPLETED|Screening||1
8729763|NCT01055028|9777052|FG000|STARTED|Treatment Cycles 1 to 3||8
8729764|NCT01055028|9777053|FG001|STARTED|Treatment Cycles 1 to 3||8
8729765|NCT01055028|9777052|FG000|COMPLETED|Treatment Cycles 1 to 3||6
8729766|NCT01055028|9777053|FG001|COMPLETED|Treatment Cycles 1 to 3||5
8729767|NCT01055028|9777052|FG000|NOT COMPLETED|Treatment Cycles 1 to 3||2
8729768|NCT01055028|9777053|FG001|NOT COMPLETED|Treatment Cycles 1 to 3||3
8729769|NCT01055028|9777052|FG000|STARTED|Inter-treatment Period||6
8911351|NCT02145468|9970437|FG000|COMPLETED|Overall Study||1753
8911352|NCT02145468|9970438|FG001|COMPLETED|Overall Study||1723
8911353|NCT02145468|9970437|FG000|NOT COMPLETED|Overall Study||5
8911354|NCT02145468|9970438|FG001|NOT COMPLETED|Overall Study||8
8911355|NCT02145676|9970447|FG000|STARTED|Overall Study||17
8911356|NCT02145676|9970448|FG001|STARTED|Overall Study||18
8911357|NCT02145676|9970449|FG002|STARTED|Overall Study||18
8911358|NCT02145676|9970447|FG000|COMPLETED|Overall Study||17
8911359|NCT02145676|9970448|FG001|COMPLETED|Overall Study||18
8911360|NCT02145676|9970449|FG002|COMPLETED|Overall Study||18
8911361|NCT02145676|9970447|FG000|NOT COMPLETED|Overall Study||0
8911362|NCT02145676|9970448|FG001|NOT COMPLETED|Overall Study||0
8911363|NCT02145676|9970449|FG002|NOT COMPLETED|Overall Study||0
8911364|NCT02145754|9970457|FG000|STARTED|Overall Study||235
8911365|NCT02145754|9970457|FG000|COMPLETED|Overall Study||235
8911366|NCT02145754|9970457|FG000|NOT COMPLETED|Overall Study||0
8911367|NCT02146001|9970463|FG000|STARTED|Overall Study||19
8911368|NCT02146001|9970464|FG001|STARTED|Overall Study||19
8911369|NCT02146001|9970463|FG000|COMPLETED|Overall Study||19
8661320|NCT00701363|9704371|FG000|NOT COMPLETED|Treatment Phase 1||15
8661321|NCT00701363|9704372|FG001|NOT COMPLETED|Treatment Phase 1||0
8729770|NCT01055028|9777053|FG001|STARTED|Inter-treatment Period||5
8729771|NCT01055028|9777052|FG000|COMPLETED|Inter-treatment Period||6
8911370|NCT02146001|9970464|FG001|COMPLETED|Overall Study||19
8661322|NCT00701363|9704373|FG002|NOT COMPLETED|Treatment Phase 1||0
8661323|NCT00701363|9704374|FG003|NOT COMPLETED|Treatment Phase 1||0
8661324|NCT00701363|9704371|FG000|STARTED|Treatment Phase 2||0
8661325|NCT00701363|9704372|FG001|STARTED|Treatment Phase 2||13
8661326|NCT00701363|9704373|FG002|STARTED|Treatment Phase 2||70
8661327|NCT00701363|9704374|FG003|STARTED|Treatment Phase 2||26
8661328|NCT00701363|9704371|FG000|COMPLETED|Treatment Phase 2||0
8661329|NCT00701363|9704372|FG001|COMPLETED|Treatment Phase 2||13
8661330|NCT00701363|9704373|FG002|COMPLETED|Treatment Phase 2||68
8661331|NCT00701363|9704374|FG003|COMPLETED|Treatment Phase 2||26
8661332|NCT00701363|9704371|FG000|NOT COMPLETED|Treatment Phase 2||0
8661333|NCT00701363|9704372|FG001|NOT COMPLETED|Treatment Phase 2||0
8661334|NCT00701363|9704373|FG002|NOT COMPLETED|Treatment Phase 2||2
8661335|NCT00701363|9704374|FG003|NOT COMPLETED|Treatment Phase 2||0
8661336|NCT00701376|9704394|FG000|STARTED|Overall Study||106
8661337|NCT00701376|9704394|FG000|COMPLETED|Overall Study||105
8661338|NCT00701376|9704394|FG000|NOT COMPLETED|Overall Study||1
8661339|NCT00701389|9704399|FG000|STARTED|Period 1||6
8661340|NCT00701389|9704400|FG001|STARTED|Period 1||6
8661341|NCT00701389|9704401|FG002|STARTED|Period 1||6
8661342|NCT00701389|9704402|FG003|STARTED|Period 1||6
8661343|NCT00701389|9704399|FG000|COMPLETED|Period 1||6
8661344|NCT00701389|9704400|FG001|COMPLETED|Period 1||6
8661345|NCT00701389|9704401|FG002|COMPLETED|Period 1||6
8661346|NCT00701389|9704402|FG003|COMPLETED|Period 1||6
8661347|NCT00701389|9704399|FG000|NOT COMPLETED|Period 1||0
8661348|NCT00701389|9704400|FG001|NOT COMPLETED|Period 1||0
8661349|NCT00701389|9704401|FG002|NOT COMPLETED|Period 1||0
8661350|NCT00701389|9704402|FG003|NOT COMPLETED|Period 1||0
8661351|NCT00701389|9704399|FG000|STARTED|Period 2||6
8661352|NCT00701389|9704400|FG001|STARTED|Period 2||6
8661353|NCT00701389|9704401|FG002|STARTED|Period 2||6
8661354|NCT00701389|9704402|FG003|STARTED|Period 2||6
8661355|NCT00701389|9704399|FG000|COMPLETED|Period 2||6
8661356|NCT00701389|9704400|FG001|COMPLETED|Period 2||6
8661357|NCT00701389|9704401|FG002|COMPLETED|Period 2||6
8661358|NCT00701389|9704402|FG003|COMPLETED|Period 2||6
8661359|NCT00701389|9704399|FG000|NOT COMPLETED|Period 2||0
8661360|NCT00701389|9704400|FG001|NOT COMPLETED|Period 2||0
8661361|NCT00701389|9704401|FG002|NOT COMPLETED|Period 2||0
8661362|NCT00701389|9704402|FG003|NOT COMPLETED|Period 2||0
8661363|NCT00701389|9704399|FG000|STARTED|Period 3||6
8661364|NCT00701389|9704400|FG001|STARTED|Period 3||6
8661365|NCT00701389|9704401|FG002|STARTED|Period 3||6
8661366|NCT00701389|9704402|FG003|STARTED|Period 3||6
8661367|NCT00701389|9704399|FG000|COMPLETED|Period 3||6
8661368|NCT00701389|9704400|FG001|COMPLETED|Period 3||6
8661369|NCT00701389|9704401|FG002|COMPLETED|Period 3||6
8661370|NCT00701389|9704402|FG003|COMPLETED|Period 3||6
8661371|NCT00701389|9704399|FG000|NOT COMPLETED|Period 3||0
8661372|NCT00701389|9704400|FG001|NOT COMPLETED|Period 3||0
8661373|NCT00701389|9704401|FG002|NOT COMPLETED|Period 3||0
8661374|NCT00701389|9704402|FG003|NOT COMPLETED|Period 3||0
8661375|NCT00701389|9704399|FG000|STARTED|Period 4||6
8661376|NCT00701389|9704400|FG001|STARTED|Period 4||6
8661377|NCT00701389|9704401|FG002|STARTED|Period 4||6
8661378|NCT00701389|9704402|FG003|STARTED|Period 4||6
8661379|NCT00701389|9704399|FG000|COMPLETED|Period 4||6
8661380|NCT00701389|9704400|FG001|COMPLETED|Period 4||6
8661381|NCT00701389|9704401|FG002|COMPLETED|Period 4||6
8661382|NCT00701389|9704402|FG003|COMPLETED|Period 4||6
8661383|NCT00701389|9704399|FG000|NOT COMPLETED|Period 4||0
8661384|NCT00701389|9704400|FG001|NOT COMPLETED|Period 4||0
8661385|NCT00701389|9704401|FG002|NOT COMPLETED|Period 4||0
8661386|NCT00701389|9704402|FG003|NOT COMPLETED|Period 4||0
8661387|NCT00701415|9704418|FG000|STARTED|Overall Study||16
8661388|NCT00701415|9704419|FG001|STARTED|Overall Study||15
8661389|NCT00701415|9704418|FG000|COMPLETED|Overall Study||15
8661390|NCT00701415|9704419|FG001|COMPLETED|Overall Study||14
8661391|NCT00701415|9704418|FG000|NOT COMPLETED|Overall Study||1
8661392|NCT00701415|9704419|FG001|NOT COMPLETED|Overall Study||1
8661393|NCT00701441|9704427|FG000|STARTED|Overall Study||9
8661394|NCT00701441|9704428|FG001|STARTED|Overall Study||16
8661395|NCT00701441|9704427|FG000|COMPLETED|Overall Study||9
8661396|NCT00701441|9704428|FG001|COMPLETED|Overall Study||12
8661397|NCT00701441|9704427|FG000|NOT COMPLETED|Overall Study||0
8661398|NCT00701441|9704428|FG001|NOT COMPLETED|Overall Study||4
8661399|NCT00701558|9704438|FG000|STARTED|Overall Study||19
8661400|NCT00701558|9704438|FG000|COMPLETED|Overall Study||4
8661401|NCT00701558|9704438|FG000|NOT COMPLETED|Overall Study||15
8661402|NCT00701636|9704444|FG000|STARTED|Overall Study||15
8661403|NCT00701636|9704445|FG001|STARTED|Overall Study||15
8661404|NCT00701636|9704444|FG000|COMPLETED|Overall Study||15
8661405|NCT00701636|9704445|FG001|COMPLETED|Overall Study||15
8661406|NCT00701636|9704444|FG000|NOT COMPLETED|Overall Study||0
8661407|NCT00701636|9704445|FG001|NOT COMPLETED|Overall Study||0
8661408|NCT00701662|9704450|FG000|STARTED|Overall Study||8
8661409|NCT00701662|9704450|FG000|COMPLETED|Overall Study||7
8661410|NCT00701662|9704450|FG000|NOT COMPLETED|Overall Study||1
8661411|NCT00701675|9704457|FG000|STARTED|Overall Study||14
8661412|NCT00701675|9704458|FG001|STARTED|Overall Study||14
8661413|NCT00701675|9704459|FG002|STARTED|Overall Study||14
8661414|NCT00701675|9704457|FG000|COMPLETED|Overall Study||10
8661415|NCT00701675|9704458|FG001|COMPLETED|Overall Study||6
8661416|NCT00701675|9704459|FG002|COMPLETED|Overall Study||7
8661417|NCT00701675|9704457|FG000|NOT COMPLETED|Overall Study||4
8661418|NCT00701675|9704458|FG001|NOT COMPLETED|Overall Study||8
8661419|NCT00701675|9704459|FG002|NOT COMPLETED|Overall Study||7
8661420|NCT00701701|9704469|FG000|STARTED|Overall Study||1
8661421|NCT00701701|9704470|FG001|STARTED|Overall Study||3
8661422|NCT00701701|9704469|FG000|COMPLETED|Overall Study||1
8661423|NCT00701701|9704470|FG001|COMPLETED|Overall Study||1
8661424|NCT00701701|9704469|FG000|NOT COMPLETED|Overall Study||0
8661425|NCT00701701|9704470|FG001|NOT COMPLETED|Overall Study||2
8692226|NCT00858845|9737602|FG001|STARTED|Overall Study||6
8692227|NCT00858845|9737601|FG000|COMPLETED|Overall Study||5
8692228|NCT00858845|9737602|FG001|COMPLETED|Overall Study||5
8692229|NCT00858845|9737601|FG000|NOT COMPLETED|Overall Study||0
8692230|NCT00858845|9737602|FG001|NOT COMPLETED|Overall Study||1
8692231|NCT00858858|9737608|FG000|STARTED|Overall Study||60
8692232|NCT00858858|9737608|FG000|COMPLETED|Overall Study||42
8692233|NCT00858858|9737608|FG000|NOT COMPLETED|Overall Study||18
8692234|NCT00858962|9737612|FG000|STARTED|Overall Study||12
8692235|NCT00858962|9737612|FG000|COMPLETED|Overall Study||12
8692236|NCT00858962|9737612|FG000|NOT COMPLETED|Overall Study||0
8692237|NCT00858988|9737618|FG000|STARTED|Randomized and Allocation||74
8692238|NCT00858988|9737619|FG001|STARTED|Randomized and Allocation||73
8692239|NCT00858988|9737618|FG000|COMPLETED|Randomized and Allocation||74
8692240|NCT00858988|9737619|FG001|COMPLETED|Randomized and Allocation||73
8692241|NCT00858988|9737618|FG000|NOT COMPLETED|Randomized and Allocation||0
8692242|NCT00858988|9737619|FG001|NOT COMPLETED|Randomized and Allocation||0
8692243|NCT00858988|9737618|FG000|STARTED|Analysis||74
8692244|NCT00858988|9737619|FG001|STARTED|Analysis||73
8692245|NCT00858988|9737618|FG000|COMPLETED|Analysis||72
8692246|NCT00858988|9737619|FG001|COMPLETED|Analysis||72
8692247|NCT00858988|9737618|FG000|NOT COMPLETED|Analysis||2
8692248|NCT00858988|9737619|FG001|NOT COMPLETED|Analysis||1
8692249|NCT00859014|9737625|FG000|STARTED|Overall Study||25
8692250|NCT00859014|9737625|FG000|COMPLETED|Overall Study||20
8692251|NCT00859014|9737625|FG000|NOT COMPLETED|Overall Study||5
8692252|NCT00859027|9737631|FG000|STARTED|Overall Study||25
8692253|NCT00859027|9737632|FG001|STARTED|Overall Study||25
8692254|NCT00859027|9737631|FG000|COMPLETED|Overall Study||20
8692255|NCT00859027|9737632|FG001|COMPLETED|Overall Study||20
8692256|NCT00859027|9737631|FG000|NOT COMPLETED|Overall Study||5
8692257|NCT00859027|9737632|FG001|NOT COMPLETED|Overall Study||5
8692258|NCT00859040|9737640|FG000|STARTED|Overall Study||18
8692259|NCT00859040|9737641|FG001|STARTED|Overall Study||16
8692260|NCT00859040|9737640|FG000|COMPLETED|Overall Study||18
8692261|NCT00859040|9737641|FG001|COMPLETED|Overall Study||16
8692262|NCT00859040|9737640|FG000|NOT COMPLETED|Overall Study||0
8692263|NCT00859040|9737641|FG001|NOT COMPLETED|Overall Study||0
8692264|NCT00859053|9737651|FG000|STARTED|Overall Study||6
8692265|NCT00859053|9737652|FG001|STARTED|Overall Study||6
8692266|NCT00859053|9737653|FG002|STARTED|Overall Study||6
8692267|NCT00859053|9737654|FG003|STARTED|Overall Study||12
8692268|NCT00859053|9737651|FG000|COMPLETED|Overall Study||6
8692269|NCT00859053|9737652|FG001|COMPLETED|Overall Study||6
8692270|NCT00859053|9737653|FG002|COMPLETED|Overall Study||6
8692271|NCT00859053|9737654|FG003|COMPLETED|Overall Study||12
8692272|NCT00859053|9737651|FG000|NOT COMPLETED|Overall Study||0
8692273|NCT00859053|9737652|FG001|NOT COMPLETED|Overall Study||0
8692274|NCT00859053|9737653|FG002|NOT COMPLETED|Overall Study||0
8692275|NCT00859053|9737654|FG003|NOT COMPLETED|Overall Study||0
8692276|NCT00859131|9737666|FG000|STARTED|Overall Study||102
8692277|NCT00859131|9737667|FG001|STARTED|Overall Study||98
8692278|NCT00859131|9737666|FG000|COMPLETED|Overall Study||102
8692279|NCT00859131|9737667|FG001|COMPLETED|Overall Study||98
8692280|NCT00859131|9737666|FG000|NOT COMPLETED|Overall Study||0
8692281|NCT00859131|9737667|FG001|NOT COMPLETED|Overall Study||0
8692282|NCT00859222|9737676|FG000|STARTED|Overall Study||3
8692283|NCT00859222|9737677|FG001|STARTED|Overall Study||3
8692284|NCT00859222|9737678|FG002|STARTED|Overall Study||6
8692285|NCT00859222|9737679|FG003|STARTED|Overall Study||24
8692286|NCT00859222|9737680|FG004|STARTED|Overall Study||15
8692287|NCT00859222|9737676|FG000|COMPLETED|Overall Study||0
8692288|NCT00859222|9737677|FG001|COMPLETED|Overall Study||0
8692289|NCT00859222|9737678|FG002|COMPLETED|Overall Study||0
8692290|NCT00859222|9737679|FG003|COMPLETED|Overall Study||0
8692291|NCT00859222|9737680|FG004|COMPLETED|Overall Study||0
8692292|NCT00859222|9737676|FG000|NOT COMPLETED|Overall Study||3
8692293|NCT00859222|9737677|FG001|NOT COMPLETED|Overall Study||3
8692294|NCT00859222|9737678|FG002|NOT COMPLETED|Overall Study||6
8692295|NCT00859222|9737679|FG003|NOT COMPLETED|Overall Study||24
8692296|NCT00859222|9737680|FG004|NOT COMPLETED|Overall Study||15
8692297|NCT00859313|9737695|FG000|STARTED|Overall Study||30
8692298|NCT00859313|9737695|FG000|COMPLETED|Overall Study||26
8692299|NCT00859313|9737695|FG000|NOT COMPLETED|Overall Study||4
8692300|NCT00859339|9737699|FG000|STARTED|Overall Study||9
8692301|NCT00859339|9737699|FG000|COMPLETED|Overall Study||9
8692302|NCT00859339|9737699|FG000|NOT COMPLETED|Overall Study||0
8692303|NCT00859456|9737703|FG000|STARTED|Overall Study||9
8692304|NCT00859456|9737703|FG000|COMPLETED|Overall Study||1
8661426|NCT00701714|9704479|FG000|STARTED|Treatment Period (up to 1 Year)||174
8661427|NCT00701714|9704480|FG001|STARTED|Treatment Period (up to 1 Year)||163
8661428|NCT00701714|9704479|FG000|COMPLETED|Treatment Period (up to 1 Year)||37
8661429|NCT00701714|9704480|FG001|COMPLETED|Treatment Period (up to 1 Year)||29
8661430|NCT00701714|9704479|FG000|NOT COMPLETED|Treatment Period (up to 1 Year)||137
8661431|NCT00701714|9704480|FG001|NOT COMPLETED|Treatment Period (up to 1 Year)||134
8661432|NCT00701714|9704479|FG000|STARTED|Safety Follow-up Period (6 Months)|Study terminated prematurely, all available randomized patients followed-up 6 months for safety|151
8661433|NCT00701714|9704480|FG001|STARTED|Safety Follow-up Period (6 Months)|Study terminated prematurely, all available randomized patients followed-up 6 months for safety|119
8661434|NCT00701714|9704479|FG000|COMPLETED|Safety Follow-up Period (6 Months)||144
8661435|NCT00701714|9704480|FG001|COMPLETED|Safety Follow-up Period (6 Months)||112
8661436|NCT00701714|9704479|FG000|NOT COMPLETED|Safety Follow-up Period (6 Months)||7
8661437|NCT00701714|9704480|FG001|NOT COMPLETED|Safety Follow-up Period (6 Months)||7
8661438|NCT00701727|9704490|FG000|STARTED|First Treatment Period||16
8661439|NCT00701727|9704491|FG001|STARTED|First Treatment Period||15
8661440|NCT00701727|9704490|FG000|COMPLETED|First Treatment Period||15
8661441|NCT00701727|9704491|FG001|COMPLETED|First Treatment Period||13
8661442|NCT00701727|9704490|FG000|NOT COMPLETED|First Treatment Period||1
8661443|NCT00701727|9704491|FG001|NOT COMPLETED|First Treatment Period||2
8661444|NCT00701727|9704490|FG000|STARTED|Second Treatment Period||15
8661445|NCT00701727|9704491|FG001|STARTED|Second Treatment Period||13
8661446|NCT00701727|9704490|FG000|COMPLETED|Second Treatment Period||13
8661447|NCT00701727|9704491|FG001|COMPLETED|Second Treatment Period||13
8661448|NCT00701727|9704490|FG000|NOT COMPLETED|Second Treatment Period||2
8661449|NCT00701727|9704491|FG001|NOT COMPLETED|Second Treatment Period||0
8661450|NCT00701779|9704497|FG000|STARTED|Overall Study||63
8661451|NCT00701779|9704497|FG000|3 Month|Overall Study||60
8661452|NCT00701779|9704497|FG000|6 Month|Overall Study||58
8661453|NCT00701779|9704497|FG000|9 Month|Overall Study||56
8661454|NCT00701779|9704497|FG000|12 Month|Overall Study||54
8661455|NCT00701779|9704497|FG000|COMPLETED|Overall Study||54
8661456|NCT00701779|9704497|FG000|NOT COMPLETED|Overall Study||9
8661457|NCT00701805|9704505|FG000|STARTED|Overall Study||26
8661458|NCT00701805|9704506|FG001|STARTED|Overall Study||29
8661459|NCT00701805|9704507|FG002|STARTED|Overall Study||23
8661460|NCT00701805|9704508|FG003|STARTED|Overall Study||26
8661461|NCT00701805|9704505|FG000|COMPLETED|Overall Study||23
8661462|NCT00701805|9704506|FG001|COMPLETED|Overall Study||25
8661463|NCT00701805|9704507|FG002|COMPLETED|Overall Study||16
8661464|NCT00701805|9704508|FG003|COMPLETED|Overall Study||22
8661465|NCT00701805|9704505|FG000|NOT COMPLETED|Overall Study||3
8661466|NCT00701805|9704506|FG001|NOT COMPLETED|Overall Study||4
8661467|NCT00701805|9704507|FG002|NOT COMPLETED|Overall Study||7
8661468|NCT00701805|9704508|FG003|NOT COMPLETED|Overall Study||4
8661469|NCT00701896|9704520|FG000|STARTED|Overall Study|Includes those eligible but declined to participate|143
8661470|NCT00701896|9704521|FG001|STARTED|Overall Study|Includes those eligible but declined to participate|151
8661471|NCT00701896|9704520|FG000|COMPLETED|Overall Study||110
8661472|NCT00701896|9704521|FG001|COMPLETED|Overall Study||118
8661473|NCT00701896|9704520|FG000|NOT COMPLETED|Overall Study||33
8661474|NCT00701896|9704521|FG001|NOT COMPLETED|Overall Study||33
8661475|NCT00701935|9704529|FG000|STARTED|Overall Study||43
8661476|NCT00701935|9704530|FG001|STARTED|Overall Study||37
8661477|NCT00701935|9704529|FG000|COMPLETED|Overall Study||27
8661478|NCT00701935|9704530|FG001|COMPLETED|Overall Study||26
8661479|NCT00701935|9704529|FG000|NOT COMPLETED|Overall Study||16
8661480|NCT00701935|9704530|FG001|NOT COMPLETED|Overall Study||11
8661481|NCT00702052|9704536|FG000|STARTED|Overall Study||58
8661482|NCT00702052|9704536|FG000|COMPLETED|Overall Study||0
8661483|NCT00702052|9704536|FG000|NOT COMPLETED|Overall Study||58
8661484|NCT00702143|9704543|FG000|STARTED|Overall Study||45
8661485|NCT00702143|9704544|FG001|STARTED|Overall Study||60
8661486|NCT00702143|9704545|FG002|STARTED|Overall Study||79
8661487|NCT00702143|9704543|FG000|COMPLETED|Overall Study||45
8661488|NCT00702143|9704544|FG001|COMPLETED|Overall Study||60
8661489|NCT00702143|9704545|FG002|COMPLETED|Overall Study||78
8661490|NCT00702143|9704543|FG000|NOT COMPLETED|Overall Study||0
8661491|NCT00702143|9704544|FG001|NOT COMPLETED|Overall Study||0
8661492|NCT00702143|9704545|FG002|NOT COMPLETED|Overall Study||1
8661493|NCT00702208|9704551|FG000|STARTED|Overall Study||198
8661494|NCT00702208|9704551|FG000|COMPLETED|Overall Study||167
8661495|NCT00702208|9704551|FG000|NOT COMPLETED|Overall Study||31
8661496|NCT00702221|9704558|FG000|STARTED|Overall Study||10
8661497|NCT00702221|9704559|FG001|STARTED|Overall Study||10
8661498|NCT00702221|9704558|FG000|COMPLETED|Overall Study||6
8661499|NCT00702221|9704559|FG001|COMPLETED|Overall Study||7
8661500|NCT00702221|9704558|FG000|NOT COMPLETED|Overall Study||4
8661501|NCT00702221|9704559|FG001|NOT COMPLETED|Overall Study||3
8661502|NCT00702299|9704565|FG000|STARTED|Overall Study||15
8661503|NCT00702299|9704565|FG000|COMPLETED|Overall Study||15
8661504|NCT00702299|9704565|FG000|NOT COMPLETED|Overall Study||0
8661505|NCT00702325|9704574|FG000|STARTED|Overall Study|Randomized|156
8661506|NCT00702325|9704575|FG001|STARTED|Overall Study|Randomized|155
8661507|NCT00702325|9704574|FG000|COMPLETED|Overall Study|Completed participants based on randomized population (156) minus discontinued participants (38).|118
8661508|NCT00702325|9704575|FG001|COMPLETED|Overall Study|Completed participants based on randomized population (155) minus discontinued participants (53).|102
8661509|NCT00702325|9704574|FG000|NOT COMPLETED|Overall Study||38
8661510|NCT00702325|9704575|FG001|NOT COMPLETED|Overall Study||53
8661511|NCT00702364|9704583|FG000|STARTED|Overall Study||26
8661512|NCT00702364|9704584|FG001|STARTED|Overall Study||29
8661513|NCT00702364|9704583|FG000|COMPLETED|Overall Study||24
8661514|NCT00702364|9704584|FG001|COMPLETED|Overall Study||25
8661515|NCT00702364|9704583|FG000|NOT COMPLETED|Overall Study||2
8661516|NCT00702364|9704584|FG001|NOT COMPLETED|Overall Study||4
8661517|NCT00702377|9704592|FG000|STARTED|Overall Study||53
8661518|NCT00702377|9704593|FG001|STARTED|Overall Study||56
8661519|NCT00702377|9704592|FG000|COMPLETED|Overall Study||52
8661520|NCT00702377|9704593|FG001|COMPLETED|Overall Study||53
8661521|NCT00702377|9704592|FG000|NOT COMPLETED|Overall Study||1
8661522|NCT00702377|9704593|FG001|NOT COMPLETED|Overall Study||3
8661523|NCT00702403|9704599|FG000|STARTED|From Consent to Engraftment|"57 agreed to participate and completed informed consent (= the 1st intention to treat population)"|57
8661524|NCT00702403|9704599|FG000|Ineligible for Study Drug|From Consent to Engraftment||17
8661525|NCT00702403|9704599|FG000|COMPLETED|From Consent to Engraftment|40 of 57 originally consented subjects remained eligible at engraftment (= the 2nd ITT population)|40
8661526|NCT00702403|9704599|FG000|NOT COMPLETED|From Consent to Engraftment||17
8661527|NCT00702403|9704599|FG000|STARTED|From Engraftment to Study Completion||40
8661528|NCT00702403|9704599|FG000|Patient Drop-outs|From Engraftment to Study Completion||27
8661529|NCT00702403|9704599|FG000|COMPLETED|From Engraftment to Study Completion||13
8661530|NCT00702403|9704599|FG000|NOT COMPLETED|From Engraftment to Study Completion||27
8661531|NCT00702468|9704608|FG000|STARTED|Overall Study||18
8661532|NCT00702468|9704609|FG001|STARTED|Overall Study||18
8661533|NCT00702468|9704608|FG000|COMPLETED|Overall Study||15
8661534|NCT00702468|9704609|FG001|COMPLETED|Overall Study||2
8661535|NCT00702468|9704608|FG000|NOT COMPLETED|Overall Study||3
8661536|NCT00702468|9704609|FG001|NOT COMPLETED|Overall Study||16
8661537|NCT00702507|9704615|FG000|STARTED|Initial Treatment Phase||200
8661538|NCT00702507|9704615|FG000|COMPLETED|Initial Treatment Phase||159
8661539|NCT00702507|9704615|FG000|NOT COMPLETED|Initial Treatment Phase||41
8661540|NCT00702507|9704615|FG000|STARTED|Follow-up Phase||159
8661541|NCT00702507|9704615|FG000|COMPLETED|Follow-up Phase||132
8661542|NCT00702507|9704615|FG000|NOT COMPLETED|Follow-up Phase||27
8661543|NCT00702650|9704620|FG000|STARTED|Overall Study||155
8661544|NCT00702650|9704620|FG000|COMPLETED|Overall Study||135
8661545|NCT00702650|9704620|FG000|NOT COMPLETED|Overall Study||20
8661546|NCT00702689|9704624|FG000|STARTED|Overall Study||20
8661547|NCT00702689|9704624|FG000|COMPLETED|Overall Study||14
8661548|NCT00702689|9704624|FG000|NOT COMPLETED|Overall Study||6
8661549|NCT00702715|9704630|FG000|STARTED|Overall Study||35
8661550|NCT00702715|9704631|FG001|STARTED|Overall Study|One subject was enrolled but did not start study|33
8661551|NCT00702715|9704630|FG000|COMPLETED|Overall Study||34
8661552|NCT00702715|9704631|FG001|COMPLETED|Overall Study||33
8661553|NCT00702715|9704630|FG000|NOT COMPLETED|Overall Study||1
8661554|NCT00702715|9704631|FG001|NOT COMPLETED|Overall Study||0
8661555|NCT00702754|9704637|FG000|STARTED|MYOBLOC Treatment Session 1 (Time 0)||502
8661556|NCT00702754|9704637|FG000|COMPLETED|MYOBLOC Treatment Session 1 (Time 0)|Approximately 70% of subjects completed at least 2 years of treatment.|495
8661557|NCT00702754|9704637|FG000|NOT COMPLETED|MYOBLOC Treatment Session 1 (Time 0)||7
8661558|NCT00702754|9704637|FG000|STARTED|MYOBLOC Treatment Session 2 (App 12 Wks)||495
8661559|NCT00702754|9704637|FG000|COMPLETED|MYOBLOC Treatment Session 2 (App 12 Wks)||475
8661560|NCT00702754|9704637|FG000|NOT COMPLETED|MYOBLOC Treatment Session 2 (App 12 Wks)||20
8661561|NCT00702754|9704637|FG000|STARTED|MYOBLOC Treatment Session 3 (App 24 Wks)||475
8661562|NCT00702754|9704637|FG000|COMPLETED|MYOBLOC Treatment Session 3 (App 24 Wks)||450
8661563|NCT00702754|9704637|FG000|NOT COMPLETED|MYOBLOC Treatment Session 3 (App 24 Wks)||25
8661564|NCT00702754|9704637|FG000|STARTED|MYOBLOC Treatment Session 4 (App 36 Wks)||450
8661565|NCT00702754|9704637|FG000|COMPLETED|MYOBLOC Treatment Session 4 (App 36 Wks)||428
8661566|NCT00702754|9704637|FG000|NOT COMPLETED|MYOBLOC Treatment Session 4 (App 36 Wks)||22
8661567|NCT00702754|9704637|FG000|STARTED|MYOBLOC Treatment Session 5 (App 48 Wks)||428
8661568|NCT00702754|9704637|FG000|COMPLETED|MYOBLOC Treatment Session 5 (App 48 Wks)||396
8661569|NCT00702754|9704637|FG000|NOT COMPLETED|MYOBLOC Treatment Session 5 (App 48 Wks)||32
8661570|NCT00702754|9704637|FG000|STARTED|MYOBLOC Treatment Session 6 (App 60 Wks)||396
8661571|NCT00702754|9704637|FG000|COMPLETED|MYOBLOC Treatment Session 6 (App 60 Wks)||377
8661572|NCT00702754|9704637|FG000|NOT COMPLETED|MYOBLOC Treatment Session 6 (App 60 Wks)||19
8661573|NCT00702754|9704637|FG000|STARTED|MYOBLOC Treatment Session 7 (App 72 Wks)||377
8661574|NCT00702754|9704637|FG000|COMPLETED|MYOBLOC Treatment Session 7 (App 72 Wks)||353
8661575|NCT00702754|9704637|FG000|NOT COMPLETED|MYOBLOC Treatment Session 7 (App 72 Wks)||24
8661576|NCT00702754|9704637|FG000|STARTED|MYOBLOC Treatment Session 8 (App 84 Wks)||353
8661577|NCT00702754|9704637|FG000|COMPLETED|MYOBLOC Treatment Session 8 (App 84 Wks)||329
8661578|NCT00702754|9704637|FG000|NOT COMPLETED|MYOBLOC Treatment Session 8 (App 84 Wks)||24
8661579|NCT00702780|9704643|FG000|STARTED|Overall Study||37
8661580|NCT00702780|9704644|FG001|STARTED|Overall Study||37
8661581|NCT00702780|9704643|FG000|COMPLETED|Overall Study||28
8661582|NCT00702780|9704644|FG001|COMPLETED|Overall Study||29
8729772|NCT01055028|9777053|FG001|COMPLETED|Inter-treatment Period||2
8661583|NCT00702780|9704643|FG000|NOT COMPLETED|Overall Study||9
8661584|NCT00702780|9704644|FG001|NOT COMPLETED|Overall Study||8
8661585|NCT00702884|9704650|FG000|STARTED|Overall Study||25
8661586|NCT00702884|9704650|FG000|COMPLETED|Overall Study||25
8661587|NCT00702884|9704650|FG000|NOT COMPLETED|Overall Study||0
8661588|NCT00702923|9704657|FG000|STARTED|Overall Study||12
8661589|NCT00702923|9704657|FG000|COMPLETED|Overall Study||11
8661590|NCT00702923|9704657|FG000|NOT COMPLETED|Overall Study||1
8661591|NCT00702949|9704665|FG000|STARTED|Overall Study||63
8661592|NCT00702949|9704666|FG001|STARTED|Overall Study||66
8661593|NCT00702949|9704667|FG002|STARTED|Overall Study||62
8661594|NCT00702949|9704665|FG000|Evaluable for Primary Endpoint|Overall Study||56
8661595|NCT00702949|9704666|FG001|Evaluable for Primary Endpoint|Overall Study||56
8661596|NCT00702949|9704667|FG002|Evaluable for Primary Endpoint|Overall Study||51
8661597|NCT00702949|9704665|FG000|COMPLETED|Overall Study||58
8661598|NCT00702949|9704666|FG001|COMPLETED|Overall Study||57
8661599|NCT00702949|9704667|FG002|COMPLETED|Overall Study||54
8661600|NCT00702949|9704665|FG000|NOT COMPLETED|Overall Study||5
8661601|NCT00702949|9704666|FG001|NOT COMPLETED|Overall Study||9
8661602|NCT00702949|9704667|FG002|NOT COMPLETED|Overall Study||8
8661603|NCT00703053|9704686|FG000|STARTED|Overall Study||27
8661604|NCT00703053|9704687|FG001|STARTED|Overall Study||26
8661605|NCT00703053|9704688|FG002|STARTED|Overall Study||51
8661606|NCT00703053|9704689|FG003|STARTED|Overall Study||49
8661607|NCT00703053|9704690|FG004|STARTED|Overall Study||51
8661608|NCT00703053|9704691|FG005|STARTED|Overall Study||49
8661609|NCT00703053|9704692|FG006|STARTED|Overall Study||52
8661610|NCT00703053|9704693|FG007|STARTED|Overall Study||97
8661611|NCT00703053|9704694|FG008|STARTED|Overall Study||103
8661612|NCT00703053|9704686|FG000|COMPLETED|Overall Study||26
8661613|NCT00703053|9704687|FG001|COMPLETED|Overall Study||24
8661614|NCT00703053|9704688|FG002|COMPLETED|Overall Study||48
8661615|NCT00703053|9704689|FG003|COMPLETED|Overall Study||46
8661616|NCT00703053|9704690|FG004|COMPLETED|Overall Study||50
8661617|NCT00703053|9704691|FG005|COMPLETED|Overall Study||43
8661618|NCT00703053|9704692|FG006|COMPLETED|Overall Study||45
8661619|NCT00703053|9704693|FG007|COMPLETED|Overall Study||91
8661620|NCT00703053|9704694|FG008|COMPLETED|Overall Study||102
8661621|NCT00703053|9704686|FG000|NOT COMPLETED|Overall Study||1
8661622|NCT00703053|9704687|FG001|NOT COMPLETED|Overall Study||2
8661623|NCT00703053|9704688|FG002|NOT COMPLETED|Overall Study||3
8661624|NCT00703053|9704689|FG003|NOT COMPLETED|Overall Study||3
8661625|NCT00703053|9704690|FG004|NOT COMPLETED|Overall Study||1
8661626|NCT00703053|9704691|FG005|NOT COMPLETED|Overall Study||6
8661627|NCT00703053|9704692|FG006|NOT COMPLETED|Overall Study||7
8661628|NCT00703053|9704693|FG007|NOT COMPLETED|Overall Study||6
8661629|NCT00703053|9704694|FG008|NOT COMPLETED|Overall Study||1
8661630|NCT00703118|9704719|FG000|STARTED|Overall Study||266
8661631|NCT00703118|9704720|FG001|STARTED|Overall Study||264
8661632|NCT00703118|9704721|FG002|STARTED|Overall Study||132
8661633|NCT00703118|9704719|FG000|COMPLETED|Overall Study||245
8661634|NCT00703118|9704720|FG001|COMPLETED|Overall Study||248
8661635|NCT00703118|9704721|FG002|COMPLETED|Overall Study||110
8661636|NCT00703118|9704719|FG000|NOT COMPLETED|Overall Study||21
8661637|NCT00703118|9704720|FG001|NOT COMPLETED|Overall Study||16
8661638|NCT00703118|9704721|FG002|NOT COMPLETED|Overall Study||22
8661639|NCT00703157|9704734|FG000|STARTED|Overall Study||26
8661640|NCT00703157|9704735|FG001|STARTED|Overall Study||26
8661641|NCT00703157|9704734|FG000|6 Months FU|Overall Study||25
8661642|NCT00703157|9704735|FG001|6 Months FU|Overall Study||25
8661643|NCT00703157|9704734|FG000|24 Months FU|Overall Study||22
8661644|NCT00703157|9704735|FG001|24 Months FU|Overall Study||24
8661645|NCT00703157|9704734|FG000|COMPLETED|Overall Study||22
8661646|NCT00703157|9704735|FG001|COMPLETED|Overall Study||24
8661647|NCT00703157|9704734|FG000|NOT COMPLETED|Overall Study||4
8661648|NCT00703157|9704735|FG001|NOT COMPLETED|Overall Study||2
8661649|NCT00703261|9704745|FG000|STARTED|Overall Study||42
8661650|NCT00703261|9704746|FG001|STARTED|Overall Study||41
8661651|NCT00703261|9704745|FG000|COMPLETED|Overall Study||36
8661652|NCT00703261|9704746|FG001|COMPLETED|Overall Study||35
8661653|NCT00703261|9704745|FG000|NOT COMPLETED|Overall Study||6
8661654|NCT00703261|9704746|FG001|NOT COMPLETED|Overall Study||6
8661655|NCT00703391|9704755|FG000|STARTED|Overall Study||12
8661656|NCT00703391|9704756|FG001|STARTED|Overall Study||6
8661657|NCT00703391|9704755|FG000|COMPLETED|Overall Study||12
8661658|NCT00703391|9704756|FG001|COMPLETED|Overall Study||6
8661659|NCT00703391|9704755|FG000|NOT COMPLETED|Overall Study||0
8661660|NCT00703391|9704756|FG001|NOT COMPLETED|Overall Study||0
8661661|NCT00703508|9704762|FG000|STARTED|Overall Study||26
8661662|NCT00703508|9704762|FG000|COMPLETED|Overall Study||26
8661663|NCT00703508|9704762|FG000|NOT COMPLETED|Overall Study||0
8661664|NCT00703664|9704771|FG000|STARTED|Overall Study||22
8661665|NCT00703664|9704772|FG001|STARTED|Overall Study||4
8661666|NCT00703664|9704773|FG002|STARTED|Overall Study||39
8661667|NCT00703664|9704771|FG000|COMPLETED|Overall Study||22
8661668|NCT00703664|9704772|FG001|COMPLETED|Overall Study||4
8661669|NCT00703664|9704773|FG002|COMPLETED|Overall Study||39
8729773|NCT01055028|9777052|FG000|NOT COMPLETED|Inter-treatment Period||0
8729774|NCT01055028|9777053|FG001|NOT COMPLETED|Inter-treatment Period||3
8661670|NCT00703664|9704771|FG000|NOT COMPLETED|Overall Study||0
8661671|NCT00703664|9704772|FG001|NOT COMPLETED|Overall Study||0
8661672|NCT00703664|9704773|FG002|NOT COMPLETED|Overall Study||0
8661673|NCT00703677|9704781|FG000|STARTED|Overall Study||17
8661674|NCT00703677|9704781|FG000|COMPLETED|Overall Study||14
8729775|NCT01055028|9777052|FG000|STARTED|Treatment Cycles 4 to 6||6
8661675|NCT00703677|9704781|FG000|NOT COMPLETED|Overall Study||3
8661676|NCT00703729|9704787|FG000|STARTED|Overall Study||25
8661677|NCT00703729|9704788|FG001|STARTED|Overall Study||24
8661678|NCT00703729|9704787|FG000|COMPLETED|Overall Study||25
8661679|NCT00703729|9704788|FG001|COMPLETED|Overall Study||21
8661680|NCT00703729|9704787|FG000|NOT COMPLETED|Overall Study||0
8661681|NCT00703729|9704788|FG001|NOT COMPLETED|Overall Study||3
8661682|NCT00703781|9704796|FG000|STARTED|Overall Study||63
8661683|NCT00703781|9704797|FG001|STARTED|Overall Study||63
8661684|NCT00703781|9704796|FG000|COMPLETED|Overall Study||61
8661685|NCT00703781|9704797|FG001|COMPLETED|Overall Study||61
8661686|NCT00703781|9704796|FG000|NOT COMPLETED|Overall Study||2
8661687|NCT00703781|9704797|FG001|NOT COMPLETED|Overall Study||2
8661688|NCT00703820|9704805|FG000|STARTED|Overall Study||133
8661689|NCT00703820|9704806|FG001|STARTED|Overall Study||129
8661690|NCT00703820|9704805|FG000|COMPLETED|Overall Study||98
8661691|NCT00703820|9704806|FG001|COMPLETED|Overall Study||95
8661692|NCT00703820|9704805|FG000|NOT COMPLETED|Overall Study||35
8661693|NCT00703820|9704806|FG001|NOT COMPLETED|Overall Study||34
8661694|NCT00703846|9704814|FG000|STARTED|Overall Study||500
8661695|NCT00703846|9704814|FG000|COMPLETED|Overall Study||363
8661696|NCT00703846|9704814|FG000|NOT COMPLETED|Overall Study||137
8661697|NCT00703911|9704818|FG000|STARTED|Overall Study||102
8661698|NCT00703911|9704818|FG000|COMPLETED|Overall Study||92
8661699|NCT00703911|9704818|FG000|NOT COMPLETED|Overall Study||10
8661700|NCT00703924|9704824|FG000|STARTED|Overall Study||50
8661701|NCT00703924|9704825|FG001|STARTED|Overall Study||42
8661702|NCT00703924|9704824|FG000|COMPLETED|Overall Study||49
8661703|NCT00703924|9704825|FG001|COMPLETED|Overall Study||41
8661704|NCT00703924|9704824|FG000|NOT COMPLETED|Overall Study||1
8661705|NCT00703924|9704825|FG001|NOT COMPLETED|Overall Study||1
8661706|NCT00703937|9704837|FG000|STARTED|Overall Study||343
8661707|NCT00703937|9704838|FG001|STARTED|Overall Study||360
8661708|NCT00703937|9704837|FG000|COMPLETED|Overall Study||278
8661709|NCT00703937|9704838|FG001|COMPLETED|Overall Study||267
8661710|NCT00703937|9704837|FG000|NOT COMPLETED|Overall Study||65
8661711|NCT00703937|9704838|FG001|NOT COMPLETED|Overall Study||93
8661712|NCT00703963|9704846|FG000|STARTED|Overall Study||100
8661713|NCT00703963|9704847|FG001|STARTED|Overall Study||100
8661714|NCT00703963|9704846|FG000|COMPLETED|Overall Study||93
8661715|NCT00703963|9704847|FG001|COMPLETED|Overall Study||86
8661716|NCT00703963|9704846|FG000|NOT COMPLETED|Overall Study||7
8661717|NCT00703963|9704847|FG001|NOT COMPLETED|Overall Study||14
8661718|NCT00703976|9704855|FG000|STARTED|Overall Study||37
8661719|NCT00703976|9704856|FG001|STARTED|Overall Study||41
8661720|NCT00703976|9704855|FG000|COMPLETED|Overall Study||37
8661721|NCT00703976|9704856|FG001|COMPLETED|Overall Study||41
8661722|NCT00703976|9704855|FG000|NOT COMPLETED|Overall Study||0
8661723|NCT00703976|9704856|FG001|NOT COMPLETED|Overall Study||0
8661724|NCT00704028|9704866|FG000|STARTED|Overall Study||82
8661725|NCT00704028|9704867|FG001|STARTED|Overall Study|A subject randomized to iron dextran never received study drug and was d/c due to subject request.|78
8661726|NCT00704028|9704866|FG000|COMPLETED|Overall Study||70
8661727|NCT00704028|9704867|FG001|COMPLETED|Overall Study||57
8661728|NCT00704028|9704866|FG000|NOT COMPLETED|Overall Study||12
8661729|NCT00704028|9704867|FG001|NOT COMPLETED|Overall Study||21
8661730|NCT00704132|9704875|FG000|STARTED|Overall Study||26
8661731|NCT00704132|9704876|FG001|STARTED|Overall Study||24
8661732|NCT00704132|9704875|FG000|COMPLETED|Overall Study||25
8661733|NCT00704132|9704876|FG001|COMPLETED|Overall Study||22
8661734|NCT00704132|9704875|FG000|NOT COMPLETED|Overall Study||1
8661735|NCT00704132|9704876|FG001|NOT COMPLETED|Overall Study||2
8661736|NCT00704171|9704884|FG000|STARTED|Overall Study||62
8661737|NCT00704171|9704885|FG001|STARTED|Overall Study||59
8661738|NCT00704171|9704884|FG000|COMPLETED|Overall Study|One subject withdrew consent prior to study completion. No reason given.|61
8661739|NCT00704171|9704885|FG001|COMPLETED|Overall Study|All control subjects completed the study.|59
8661740|NCT00704171|9704884|FG000|NOT COMPLETED|Overall Study||1
8661741|NCT00704171|9704885|FG001|NOT COMPLETED|Overall Study||0
8661742|NCT00704184|9704896|FG000|STARTED|Double-Blind Treatment||20
8661743|NCT00704184|9704897|FG001|STARTED|Double-Blind Treatment||18
8661744|NCT00704184|9704898|FG002|STARTED|Double-Blind Treatment||20
8661745|NCT00704184|9704899|FG003|STARTED|Double-Blind Treatment||18
8661746|NCT00704184|9704900|FG004|STARTED|Double-Blind Treatment||19
8661747|NCT00704184|9704896|FG000|Treated|Double-Blind Treatment|One participant was randomized to placebo but withdrew prior to receiving study medication.|19
8661748|NCT00704184|9704897|FG001|Treated|Double-Blind Treatment||18
8661749|NCT00704184|9704898|FG002|Treated|Double-Blind Treatment||20
8661750|NCT00704184|9704899|FG003|Treated|Double-Blind Treatment||18
8661751|NCT00704184|9704900|FG004|Treated|Double-Blind Treatment||19
8661752|NCT00704184|9704896|FG000|COMPLETED|Double-Blind Treatment||19
8661753|NCT00704184|9704897|FG001|COMPLETED|Double-Blind Treatment||18
8661754|NCT00704184|9704898|FG002|COMPLETED|Double-Blind Treatment||20
8661755|NCT00704184|9704899|FG003|COMPLETED|Double-Blind Treatment||18
8661756|NCT00704184|9704900|FG004|COMPLETED|Double-Blind Treatment||19
8661757|NCT00704184|9704896|FG000|NOT COMPLETED|Double-Blind Treatment||1
8661758|NCT00704184|9704897|FG001|NOT COMPLETED|Double-Blind Treatment||0
8661759|NCT00704184|9704898|FG002|NOT COMPLETED|Double-Blind Treatment||0
8661760|NCT00704184|9704899|FG003|NOT COMPLETED|Double-Blind Treatment||0
8661761|NCT00704184|9704900|FG004|NOT COMPLETED|Double-Blind Treatment||0
8661762|NCT00704184|9704896|FG000|STARTED|Open-Label Treatment||19
8661763|NCT00704184|9704897|FG001|STARTED|Open-Label Treatment||18
8661764|NCT00704184|9704898|FG002|STARTED|Open-Label Treatment||20
8661765|NCT00704184|9704899|FG003|STARTED|Open-Label Treatment||18
8661766|NCT00704184|9704900|FG004|STARTED|Open-Label Treatment||19
8661767|NCT00704184|9704896|FG000|COMPLETED|Open-Label Treatment||18
8661768|NCT00704184|9704897|FG001|COMPLETED|Open-Label Treatment||16
8661769|NCT00704184|9704898|FG002|COMPLETED|Open-Label Treatment||16
8661770|NCT00704184|9704899|FG003|COMPLETED|Open-Label Treatment||13
8661771|NCT00704184|9704900|FG004|COMPLETED|Open-Label Treatment||16
8661772|NCT00704184|9704896|FG000|NOT COMPLETED|Open-Label Treatment||1
8661773|NCT00704184|9704897|FG001|NOT COMPLETED|Open-Label Treatment||2
8661774|NCT00704184|9704898|FG002|NOT COMPLETED|Open-Label Treatment||4
8661775|NCT00704184|9704899|FG003|NOT COMPLETED|Open-Label Treatment||5
8661776|NCT00704184|9704900|FG004|NOT COMPLETED|Open-Label Treatment||3
8661777|NCT00704262|9704912|FG000|STARTED|Overall Study||33
8661778|NCT00704262|9704912|FG000|COMPLETED|Overall Study||31
8661779|NCT00704262|9704912|FG000|NOT COMPLETED|Overall Study||2
8661780|NCT00704340|9704918|FG000|STARTED|Overall Study||120
8661781|NCT00704340|9704919|FG001|STARTED|Overall Study||117
8661782|NCT00704340|9704918|FG000|COMPLETED|Overall Study||118
8661783|NCT00704340|9704919|FG001|COMPLETED|Overall Study||115
8661784|NCT00704340|9704918|FG000|NOT COMPLETED|Overall Study||2
8661785|NCT00704340|9704919|FG001|NOT COMPLETED|Overall Study||2
8661786|NCT00704353|9704927|FG000|STARTED|Overall Study||366
8661787|NCT00704353|9704928|FG001|STARTED|Overall Study||369
8661788|NCT00704353|9704927|FG000|COMPLETED|Overall Study||268
8661789|NCT00704353|9704928|FG001|COMPLETED|Overall Study||255
8661790|NCT00704353|9704927|FG000|NOT COMPLETED|Overall Study||98
8661791|NCT00704353|9704928|FG001|NOT COMPLETED|Overall Study||114
8661792|NCT00704379|9704936|FG000|STARTED|Overall Study||46
8661793|NCT00704379|9704937|FG001|STARTED|Overall Study||48
8661794|NCT00704379|9704936|FG000|COMPLETED|Overall Study||39
8661795|NCT00704379|9704937|FG001|COMPLETED|Overall Study||41
8661796|NCT00704379|9704936|FG000|NOT COMPLETED|Overall Study||7
8661797|NCT00704379|9704937|FG001|NOT COMPLETED|Overall Study||7
8661798|NCT00704405|9704950|FG000|STARTED|Overall Study (NC Population)||42
8661799|NCT00704405|9704951|FG001|STARTED|Overall Study (NC Population)||44
8661800|NCT00704405|9704952|FG002|STARTED|Overall Study (NC Population)||41
8661801|NCT00704405|9704953|FG003|STARTED|Overall Study (NC Population)||42
8661802|NCT00704405|9704954|FG004|STARTED|Overall Study (NC Population)||42
8661803|NCT00704405|9704950|FG000|COMPLETED|Overall Study (NC Population)||37
8661804|NCT00704405|9704951|FG001|COMPLETED|Overall Study (NC Population)||40
8661805|NCT00704405|9704952|FG002|COMPLETED|Overall Study (NC Population)||38
8661806|NCT00704405|9704953|FG003|COMPLETED|Overall Study (NC Population)||38
8661807|NCT00704405|9704954|FG004|COMPLETED|Overall Study (NC Population)||37
8661808|NCT00704405|9704950|FG000|NOT COMPLETED|Overall Study (NC Population)||5
8661809|NCT00704405|9704951|FG001|NOT COMPLETED|Overall Study (NC Population)||4
8661810|NCT00704405|9704952|FG002|NOT COMPLETED|Overall Study (NC Population)||3
8661811|NCT00704405|9704953|FG003|NOT COMPLETED|Overall Study (NC Population)||4
8661812|NCT00704405|9704954|FG004|NOT COMPLETED|Overall Study (NC Population)||5
8661813|NCT00704405|9704950|FG000|STARTED|Overall Study (C Population)||16
8661814|NCT00704405|9704951|FG001|STARTED|Overall Study (C Population)||14
8661815|NCT00704405|9704952|FG002|STARTED|Overall Study (C Population)||15
8661816|NCT00704405|9704953|FG003|STARTED|Overall Study (C Population)||15
8661817|NCT00704405|9704954|FG004|STARTED|Overall Study (C Population)||14
8661818|NCT00704405|9704950|FG000|COMPLETED|Overall Study (C Population)||15
8661819|NCT00704405|9704951|FG001|COMPLETED|Overall Study (C Population)||11
8661820|NCT00704405|9704952|FG002|COMPLETED|Overall Study (C Population)||14
8661821|NCT00704405|9704953|FG003|COMPLETED|Overall Study (C Population)||14
8661822|NCT00704405|9704954|FG004|COMPLETED|Overall Study (C Population)||14
8661823|NCT00704405|9704950|FG000|NOT COMPLETED|Overall Study (C Population)||1
8661824|NCT00704405|9704951|FG001|NOT COMPLETED|Overall Study (C Population)||3
8729776|NCT01055028|9777053|FG001|STARTED|Treatment Cycles 4 to 6||2
8729777|NCT01055028|9777052|FG000|COMPLETED|Treatment Cycles 4 to 6||6
8729778|NCT01055028|9777053|FG001|COMPLETED|Treatment Cycles 4 to 6||2
8729779|NCT01055028|9777052|FG000|NOT COMPLETED|Treatment Cycles 4 to 6||0
8729780|NCT01055028|9777053|FG001|NOT COMPLETED|Treatment Cycles 4 to 6||0
8729781|NCT01055067|9777063|FG000|STARTED|Overall Study||27
8661825|NCT00704405|9704952|FG002|NOT COMPLETED|Overall Study (C Population)||1
8661826|NCT00704405|9704953|FG003|NOT COMPLETED|Overall Study (C Population)||1
8661827|NCT00704405|9704954|FG004|NOT COMPLETED|Overall Study (C Population)||0
8661828|NCT00704418|9704974|FG000|STARTED|Overall Study||78
8661829|NCT00704418|9704975|FG001|STARTED|Overall Study||78
8661830|NCT00704418|9704974|FG000|COMPLETED|Overall Study||73
8661831|NCT00704418|9704975|FG001|COMPLETED|Overall Study||72
8661832|NCT00704418|9704974|FG000|NOT COMPLETED|Overall Study||5
8661833|NCT00704418|9704975|FG001|NOT COMPLETED|Overall Study||6
8661834|NCT00704522|9704983|FG000|STARTED|Overall Study||481
8729782|NCT01055067|9777063|FG000|COMPLETED|Overall Study||27
8729783|NCT01055067|9777063|FG000|NOT COMPLETED|Overall Study||0
8729784|NCT01055132|9777069|FG000|STARTED|Period 1 (5-9 Days)||36
8729785|NCT01055132|9777070|FG001|STARTED|Period 1 (5-9 Days)||33
8729786|NCT01055132|9777069|FG000|COMPLETED|Period 1 (5-9 Days)||35
8729787|NCT01055132|9777070|FG001|COMPLETED|Period 1 (5-9 Days)||33
8729788|NCT01055132|9777069|FG000|NOT COMPLETED|Period 1 (5-9 Days)||1
8729789|NCT01055132|9777070|FG001|NOT COMPLETED|Period 1 (5-9 Days)||0
8729790|NCT01055132|9777069|FG000|STARTED|Period 2 (5-9 Days)||35
8729791|NCT01055132|9777070|FG001|STARTED|Period 2 (5-9 Days)||33
8729792|NCT01055132|9777069|FG000|COMPLETED|Period 2 (5-9 Days)||35
8729793|NCT01055132|9777070|FG001|COMPLETED|Period 2 (5-9 Days)||32
8661835|NCT00704522|9704984|FG001|STARTED|Overall Study||120
8661836|NCT00704522|9704983|FG000|COMPLETED|Overall Study||298
8661837|NCT00704522|9704984|FG001|COMPLETED|Overall Study||75
8661838|NCT00704522|9704983|FG000|NOT COMPLETED|Overall Study||183
8661839|NCT00704522|9704984|FG001|NOT COMPLETED|Overall Study||45
8661840|NCT00704717|9704989|FG000|STARTED|Overall Study||185
8661841|NCT00704717|9704989|FG000|COMPLETED|Overall Study||185
8661842|NCT00704717|9704989|FG000|NOT COMPLETED|Overall Study||0
8661843|NCT00704730|9704995|FG000|STARTED|Overall Study|Randomized|219
8661844|NCT00704730|9704996|FG001|STARTED|Overall Study|Randomized|111
8661845|NCT00704730|9704995|FG000|COMPLETED|Overall Study|Continuing treatment at data cutoff for primary analysis, but subsequently discontinued study|98
8661846|NCT00704730|9704996|FG001|COMPLETED|Overall Study|Continuing study treatment at the time of data cut-off.|15
8661847|NCT00704730|9704995|FG000|NOT COMPLETED|Overall Study||121
8661848|NCT00704730|9704996|FG001|NOT COMPLETED|Overall Study||96
8661849|NCT00704808|9705003|FG000|STARTED|Overall Study||180
8661850|NCT00704808|9705003|FG000|COMPLETED|Overall Study||49
8661851|NCT00704808|9705003|FG000|NOT COMPLETED|Overall Study||131
8661852|NCT00704847|9705009|FG000|STARTED|Overall Study||521
8661853|NCT00704847|9705010|FG001|STARTED|Overall Study||509
8661854|NCT00704847|9705009|FG000|COMPLETED|Overall Study||300
8661855|NCT00704847|9705010|FG001|COMPLETED|Overall Study||339
8661856|NCT00704847|9705009|FG000|NOT COMPLETED|Overall Study||221
8661857|NCT00704847|9705010|FG001|NOT COMPLETED|Overall Study||170
8661858|NCT00704912|9705019|FG000|STARTED|Overall Study||50
8661859|NCT00704912|9705020|FG001|STARTED|Overall Study||49
8661860|NCT00704912|9705021|FG002|STARTED|Overall Study||50
8661861|NCT00704912|9705019|FG000|COMPLETED|Overall Study||44
8661862|NCT00704912|9705020|FG001|COMPLETED|Overall Study||45
8661863|NCT00704912|9705021|FG002|COMPLETED|Overall Study||43
8661864|NCT00704912|9705019|FG000|NOT COMPLETED|Overall Study||6
8661865|NCT00704912|9705020|FG001|NOT COMPLETED|Overall Study||4
8661866|NCT00704912|9705021|FG002|NOT COMPLETED|Overall Study||7
8661867|NCT00704938|9705031|FG000|STARTED|Overall Study||2
8661868|NCT00704938|9705032|FG001|STARTED|Overall Study||1
8661869|NCT00704938|9705031|FG000|COMPLETED|Overall Study||2
8661870|NCT00704938|9705032|FG001|COMPLETED|Overall Study||1
8661871|NCT00704938|9705031|FG000|NOT COMPLETED|Overall Study||0
8661872|NCT00704938|9705032|FG001|NOT COMPLETED|Overall Study||0
8661873|NCT00704964|9705038|FG000|STARTED|Overall Study|Number of participants who took at least one dose of study medication.|746
8661874|NCT00704964|9705038|FG000|COMPLETED|Overall Study|Number of participants who completed therapy as scheduled.|418
8661875|NCT00704964|9705038|FG000|NOT COMPLETED|Overall Study||328
8661876|NCT00705003|9705045|FG000|STARTED|Enrolled||71
8661877|NCT00705003|9705046|FG001|STARTED|Enrolled||37
8661878|NCT00705003|9705047|FG002|STARTED|Enrolled||34
8661879|NCT00705003|9705045|FG000|COMPLETED|Enrolled||67
8661880|NCT00705003|9705046|FG001|COMPLETED|Enrolled||34
8661881|NCT00705003|9705047|FG002|COMPLETED|Enrolled||33
8661882|NCT00705003|9705045|FG000|NOT COMPLETED|Enrolled||4
8661883|NCT00705003|9705046|FG001|NOT COMPLETED|Enrolled||3
8661884|NCT00705003|9705047|FG002|NOT COMPLETED|Enrolled||1
8661885|NCT00705003|9705045|FG000|STARTED|Treated||67
8661886|NCT00705003|9705046|FG001|STARTED|Treated||34
8661887|NCT00705003|9705047|FG002|STARTED|Treated||33
8661888|NCT00705003|9705045|FG000|COMPLETED|Treated||54
8661889|NCT00705003|9705046|FG001|COMPLETED|Treated||28
8661890|NCT00705003|9705047|FG002|COMPLETED|Treated||30
8661891|NCT00705003|9705045|FG000|NOT COMPLETED|Treated||13
8661892|NCT00705003|9705046|FG001|NOT COMPLETED|Treated||6
8661893|NCT00705003|9705047|FG002|NOT COMPLETED|Treated||3
8661894|NCT00705016|9705059|FG000|STARTED|Overall Study||62
8661895|NCT00705016|9705060|FG001|STARTED|Overall Study||60
8661896|NCT00705016|9705061|FG002|STARTED|Overall Study||62
8661897|NCT00705016|9705059|FG000|COMPLETED|Overall Study||2
8661898|NCT00705016|9705060|FG001|COMPLETED|Overall Study||2
8661899|NCT00705016|9705061|FG002|COMPLETED|Overall Study||4
8661900|NCT00705016|9705059|FG000|NOT COMPLETED|Overall Study||60
8661901|NCT00705016|9705060|FG001|NOT COMPLETED|Overall Study||58
8661902|NCT00705016|9705061|FG002|NOT COMPLETED|Overall Study||58
8661903|NCT00705107|9705069|FG000|STARTED|Overall Study||267
8661904|NCT00705107|9705069|FG000|COMPLETED|Overall Study||218
8661905|NCT00705107|9705069|FG000|NOT COMPLETED|Overall Study||49
8661906|NCT00705133|9705073|FG000|STARTED|Overall Study||15
8661907|NCT00705133|9705073|FG000|COMPLETED|Overall Study||15
8661908|NCT00705133|9705073|FG000|NOT COMPLETED|Overall Study||0
8661909|NCT00705146|9705079|FG000|STARTED|Overall Study||32
8661910|NCT00705146|9705080|FG001|STARTED|Overall Study||24
8661911|NCT00705146|9705079|FG000|COMPLETED|Overall Study||31
8661912|NCT00705146|9705080|FG001|COMPLETED|Overall Study||23
8661913|NCT00705146|9705079|FG000|NOT COMPLETED|Overall Study||1
8661914|NCT00705146|9705080|FG001|NOT COMPLETED|Overall Study||1
8661915|NCT00705159|9705090|FG000|STARTED|Overall Study||34
8661916|NCT00705159|9705091|FG001|STARTED|Overall Study||35
8661917|NCT00705159|9705092|FG002|STARTED|Overall Study||34
8661918|NCT00705159|9705093|FG003|STARTED|Overall Study||34
8661919|NCT00705159|9705090|FG000|COMPLETED|Overall Study||34
8661920|NCT00705159|9705091|FG001|COMPLETED|Overall Study||33
8661921|NCT00705159|9705092|FG002|COMPLETED|Overall Study||29
8661922|NCT00705159|9705093|FG003|COMPLETED|Overall Study||30
8661923|NCT00705159|9705090|FG000|NOT COMPLETED|Overall Study||0
8661924|NCT00705159|9705091|FG001|NOT COMPLETED|Overall Study||2
8661925|NCT00705159|9705092|FG002|NOT COMPLETED|Overall Study||5
8661926|NCT00705159|9705093|FG003|NOT COMPLETED|Overall Study||4
8661927|NCT00705224|9705103|FG000|STARTED|Overall Study||250
8661928|NCT00705224|9705103|FG000|COMPLETED|Overall Study||239
8661929|NCT00705224|9705103|FG000|NOT COMPLETED|Overall Study||11
8661930|NCT00705250|9705110|FG000|STARTED|Overall Study||36
8661931|NCT00705250|9705110|FG000|COMPLETED|Overall Study||34
8661932|NCT00705250|9705110|FG000|NOT COMPLETED|Overall Study||2
8661933|NCT00705263|9705114|FG000|STARTED|Overall Study|113 patients started the treatment; however, data were available for only 110 patients.|110
8661934|NCT00705263|9705114|FG000|COMPLETED|Overall Study||108
8661935|NCT00705263|9705114|FG000|NOT COMPLETED|Overall Study||2
8661936|NCT00705289|9705118|FG000|STARTED|Overall Study||728
8661937|NCT00705289|9705118|FG000|COMPLETED|Overall Study||597
8661938|NCT00705289|9705118|FG000|NOT COMPLETED|Overall Study||131
8661939|NCT00705341|9705141|FG000|STARTED|Phase 1:Control Challenge||126
8661940|NCT00705341|9705142|FG001|STARTED|Phase 1:Control Challenge||93
8661941|NCT00705341|9705143|FG002|STARTED|Phase 1:Control Challenge||0
8661942|NCT00705341|9705144|FG003|STARTED|Phase 1:Control Challenge||0
8661943|NCT00705341|9705141|FG000|COMPLETED|Phase 1:Control Challenge|If participants in this group met criteria, they were randomized into phase 2|126
8661944|NCT00705341|9705142|FG001|COMPLETED|Phase 1:Control Challenge|Nonasthmatic controls did not advance to phase 2 due to design of study|93
8661945|NCT00705341|9705143|FG002|COMPLETED|Phase 1:Control Challenge||0
8661946|NCT00705341|9705144|FG003|COMPLETED|Phase 1:Control Challenge||0
8661947|NCT00705341|9705141|FG000|NOT COMPLETED|Phase 1:Control Challenge||0
8661948|NCT00705341|9705142|FG001|NOT COMPLETED|Phase 1:Control Challenge||0
8661949|NCT00705341|9705143|FG002|NOT COMPLETED|Phase 1:Control Challenge||0
8661950|NCT00705341|9705144|FG003|NOT COMPLETED|Phase 1:Control Challenge||0
8661951|NCT00705341|9705141|FG000|STARTED|Phase 2: Trial||0
8911371|NCT02146001|9970463|FG000|NOT COMPLETED|Overall Study||0
8911372|NCT02146001|9970464|FG001|NOT COMPLETED|Overall Study||0
8911373|NCT02146105|9970470|FG000|STARTED|Overall Study||45
8911374|NCT02146105|9970470|FG000|COMPLETED|Overall Study||39
8911375|NCT02146105|9970470|FG000|NOT COMPLETED|Overall Study||6
8911376|NCT02146131|9970476|FG000|STARTED|Overall Study||170
8911377|NCT02146131|9970477|FG001|STARTED|Overall Study||169
8911378|NCT02146131|9970476|FG000|COMPLETED|Overall Study||109
8911379|NCT02146131|9970477|FG001|COMPLETED|Overall Study||113
8911380|NCT02146131|9970476|FG000|NOT COMPLETED|Overall Study||61
8911381|NCT02146131|9970477|FG001|NOT COMPLETED|Overall Study||56
8911382|NCT02146248|9970483|FG000|STARTED|Overall Study||11
8911383|NCT02146248|9970483|FG000|Enrolled|Overall Study||11
8911384|NCT02146248|9970483|FG000|Uterine Sounding|Overall Study|one subject dropped out after uterine sound before HSG #1|11
8911385|NCT02146248|9970483|FG000|HSG 1|Overall Study||10
8911386|NCT02146248|9970483|FG000|HSG 2|Overall Study||10
8911387|NCT02146248|9970483|FG000|HSG 3|Overall Study||9
8911388|NCT02146248|9970483|FG000|HSG 4|Overall Study||7
8911389|NCT02146248|9970483|FG000|HSG 5|Overall Study||1
8911390|NCT02146248|9970483|FG000|COMPLETED|Overall Study||9
8911391|NCT02146248|9970483|FG000|NOT COMPLETED|Overall Study||2
9022366|NCT03126227|10085252|FG000|STARTED|Overall Study||338
9022367|NCT03126227|10085253|FG001|STARTED|Overall Study||168
9022368|NCT03126227|10085252|FG000|COMPLETED|Overall Study||260
9022369|NCT03126227|10085253|FG001|COMPLETED|Overall Study||158
9022370|NCT03126227|10085252|FG000|NOT COMPLETED|Overall Study||78
9022371|NCT03126227|10085253|FG001|NOT COMPLETED|Overall Study||10
9022372|NCT03126344|10085262|FG000|STARTED|Overall Study||33
9022373|NCT03126344|10085263|FG001|STARTED|Overall Study||33
9022374|NCT03126344|10085264|FG002|STARTED|Overall Study||33
9022375|NCT03126344|10085262|FG000|COMPLETED|Overall Study||33
9022376|NCT03126344|10085263|FG001|COMPLETED|Overall Study||33
9022377|NCT03126344|10085264|FG002|COMPLETED|Overall Study||28
9022378|NCT03126344|10085262|FG000|NOT COMPLETED|Overall Study||0
9022379|NCT03126344|10085263|FG001|NOT COMPLETED|Overall Study||0
9022380|NCT03126344|10085264|FG002|NOT COMPLETED|Overall Study||5
9022381|NCT03126370|10085272|FG000|STARTED|TDF With a Boosted PI||10
9022382|NCT03126370|10085272|FG000|COMPLETED|TDF With a Boosted PI||10
9022383|NCT03126370|10085272|FG000|NOT COMPLETED|TDF With a Boosted PI||0
9022384|NCT03126370|10085272|FG000|STARTED|TAF With a Boosted PI||10
9022385|NCT03126370|10085272|FG000|COMPLETED|TAF With a Boosted PI||10
9022386|NCT03126370|10085272|FG000|NOT COMPLETED|TAF With a Boosted PI||0
9022387|NCT03126370|10085272|FG000|STARTED|TAF With a Boosted PI and LDV/SOF||10
9022388|NCT03126370|10085272|FG000|COMPLETED|TAF With a Boosted PI and LDV/SOF||10
9022389|NCT03126370|10085272|FG000|NOT COMPLETED|TAF With a Boosted PI and LDV/SOF||0
9022390|NCT03126370|10085272|FG000|STARTED|TAF With a Boosted PI||10
9022391|NCT03126370|10085272|FG000|COMPLETED|TAF With a Boosted PI||10
9022392|NCT03126370|10085272|FG000|NOT COMPLETED|TAF With a Boosted PI||0
9022393|NCT03126448|10085283|FG000|STARTED|Overall Study||56
9022394|NCT03126448|10085284|FG001|STARTED|Overall Study||49
9022395|NCT03126448|10085285|FG002|STARTED|Overall Study||37
9022396|NCT03126448|10085283|FG000|COMPLETED|Overall Study||43
9022397|NCT03126448|10085284|FG001|COMPLETED|Overall Study||41
9022398|NCT03126448|10085285|FG002|COMPLETED|Overall Study||27
9022399|NCT03126448|10085283|FG000|NOT COMPLETED|Overall Study||13
9022400|NCT03126448|10085284|FG001|NOT COMPLETED|Overall Study||8
8661952|NCT00705341|9705142|FG001|STARTED|Phase 2: Trial||0
8692305|NCT00859456|9737703|FG000|NOT COMPLETED|Overall Study||8
9022401|NCT03126448|10085285|FG002|NOT COMPLETED|Overall Study||10
9022402|NCT03126539|10085295|FG000|STARTED|Overall Study||9
9022403|NCT03126539|10085296|FG001|STARTED|Overall Study||9
8661953|NCT00705341|9705143|FG002|STARTED|Phase 2: Trial|This group was randomized from asthmatic controls in phase 1 if they met criteria to be in phase 2|30
8661954|NCT00705341|9705144|FG003|STARTED|Phase 2: Trial|This group was randomized from asthmatic controls in phase 1 if they met criteria to be in phase 2|32
8661955|NCT00705341|9705141|FG000|COMPLETED|Phase 2: Trial||0
8661956|NCT00705341|9705142|FG001|COMPLETED|Phase 2: Trial||0
8661957|NCT00705341|9705143|FG002|COMPLETED|Phase 2: Trial||23
8661958|NCT00705341|9705144|FG003|COMPLETED|Phase 2: Trial||28
8661959|NCT00705341|9705141|FG000|NOT COMPLETED|Phase 2: Trial||0
8661960|NCT00705341|9705142|FG001|NOT COMPLETED|Phase 2: Trial||0
8661961|NCT00705341|9705143|FG002|NOT COMPLETED|Phase 2: Trial||7
8661962|NCT00705341|9705144|FG003|NOT COMPLETED|Phase 2: Trial||4
8661963|NCT00705367|9705154|FG000|STARTED|Short-term Period||6
8661964|NCT00705367|9705155|FG001|STARTED|Short-term Period||3
8661965|NCT00705367|9705154|FG000|COMPLETED|Short-term Period||6
8661966|NCT00705367|9705155|FG001|COMPLETED|Short-term Period||3
8661967|NCT00705367|9705154|FG000|NOT COMPLETED|Short-term Period||0
8661968|NCT00705367|9705155|FG001|NOT COMPLETED|Short-term Period||0
8661969|NCT00705367|9705154|FG000|STARTED|Long-term Extension Period||9
8661970|NCT00705367|9705155|FG001|STARTED|Long-term Extension Period||0
8661971|NCT00705367|9705154|FG000|COMPLETED|Long-term Extension Period||0
8661972|NCT00705367|9705155|FG001|COMPLETED|Long-term Extension Period||0
8661973|NCT00705367|9705154|FG000|NOT COMPLETED|Long-term Extension Period||9
8661974|NCT00705367|9705155|FG001|NOT COMPLETED|Long-term Extension Period||0
8661975|NCT00705406|9705165|FG000|STARTED|Overall Study||203
8661976|NCT00705406|9705166|FG001|STARTED|Overall Study||202
8661977|NCT00705406|9705165|FG000|COMPLETED|Overall Study||199
8661978|NCT00705406|9705166|FG001|COMPLETED|Overall Study||197
8661979|NCT00705406|9705165|FG000|NOT COMPLETED|Overall Study||4
8661980|NCT00705406|9705166|FG001|NOT COMPLETED|Overall Study||5
8661981|NCT00705432|9705179|FG000|STARTED|Treatment Period||311
8661982|NCT00705432|9705180|FG001|STARTED|Treatment Period||316
8661983|NCT00705432|9705181|FG002|STARTED|Treatment Period||311
8661984|NCT00705432|9705182|FG003|STARTED|Treatment Period||52
8661985|NCT00705432|9705183|FG004|STARTED|Treatment Period||52
8661986|NCT00705432|9705184|FG005|STARTED|Treatment Period||55
8661987|NCT00705432|9705179|FG000|STARTED BOCEPREVIR/PLACEBO|Treatment Period||297
8661988|NCT00705432|9705180|FG001|STARTED BOCEPREVIR/PLACEBO|Treatment Period||303
8661989|NCT00705432|9705181|FG002|STARTED BOCEPREVIR/PLACEBO|Treatment Period||299
8661990|NCT00705432|9705182|FG003|STARTED BOCEPREVIR/PLACEBO|Treatment Period||47
8661991|NCT00705432|9705183|FG004|STARTED BOCEPREVIR/PLACEBO|Treatment Period||47
8661992|NCT00705432|9705184|FG005|STARTED BOCEPREVIR/PLACEBO|Treatment Period||55
8661993|NCT00705432|9705179|FG000|COMPLETED|Treatment Period||148
8661994|NCT00705432|9705180|FG001|COMPLETED|Treatment Period||205
8661995|NCT00705432|9705181|FG002|COMPLETED|Treatment Period||190
8661996|NCT00705432|9705182|FG003|COMPLETED|Treatment Period||11
8661997|NCT00705432|9705183|FG004|COMPLETED|Treatment Period||24
8661998|NCT00705432|9705184|FG005|COMPLETED|Treatment Period||25
8661999|NCT00705432|9705179|FG000|NOT COMPLETED|Treatment Period||163
8662000|NCT00705432|9705180|FG001|NOT COMPLETED|Treatment Period||111
8662001|NCT00705432|9705181|FG002|NOT COMPLETED|Treatment Period||121
8662002|NCT00705432|9705182|FG003|NOT COMPLETED|Treatment Period||41
8662003|NCT00705432|9705183|FG004|NOT COMPLETED|Treatment Period||28
8662004|NCT00705432|9705184|FG005|NOT COMPLETED|Treatment Period||30
8662005|NCT00705432|9705179|FG000|STARTED|Follow-up Period (Upto Week 72)||278
8662006|NCT00705432|9705180|FG001|STARTED|Follow-up Period (Upto Week 72)||295
8662007|NCT00705432|9705181|FG002|STARTED|Follow-up Period (Upto Week 72)||291
8662008|NCT00705432|9705182|FG003|STARTED|Follow-up Period (Upto Week 72)||42
8662009|NCT00705432|9705183|FG004|STARTED|Follow-up Period (Upto Week 72)||44
8662010|NCT00705432|9705184|FG005|STARTED|Follow-up Period (Upto Week 72)||53
8662011|NCT00705432|9705179|FG000|COMPLETED|Follow-up Period (Upto Week 72)||207
8662012|NCT00705432|9705180|FG001|COMPLETED|Follow-up Period (Upto Week 72)||252
8662013|NCT00705432|9705181|FG002|COMPLETED|Follow-up Period (Upto Week 72)||266
8662014|NCT00705432|9705182|FG003|COMPLETED|Follow-up Period (Upto Week 72)||28
8662015|NCT00705432|9705183|FG004|COMPLETED|Follow-up Period (Upto Week 72)||38
8662016|NCT00705432|9705184|FG005|COMPLETED|Follow-up Period (Upto Week 72)||46
8662017|NCT00705432|9705179|FG000|NOT COMPLETED|Follow-up Period (Upto Week 72)||71
8662018|NCT00705432|9705180|FG001|NOT COMPLETED|Follow-up Period (Upto Week 72)||43
8662019|NCT00705432|9705181|FG002|NOT COMPLETED|Follow-up Period (Upto Week 72)||25
8662020|NCT00705432|9705182|FG003|NOT COMPLETED|Follow-up Period (Upto Week 72)||14
8662021|NCT00705432|9705183|FG004|NOT COMPLETED|Follow-up Period (Upto Week 72)||6
8662022|NCT00705432|9705184|FG005|NOT COMPLETED|Follow-up Period (Upto Week 72)||7
8662023|NCT00705484|9705197|FG000|STARTED|Overall Study|Number Enrolled|1059
8662024|NCT00705484|9705198|FG001|STARTED|Overall Study|Number Enrolled|1180
8662025|NCT00705484|9705197|FG000|Follow-up Period|Overall Study||1059
8662026|NCT00705484|9705198|FG001|Follow-up Period|Overall Study|Switched From Standard Therapy to Remicade|296
8662027|NCT00705484|9705197|FG000|COMPLETED|Overall Study||677
8662028|NCT00705484|9705198|FG001|COMPLETED|Overall Study||772
8662029|NCT00705484|9705197|FG000|NOT COMPLETED|Overall Study||382
8662030|NCT00705484|9705198|FG001|NOT COMPLETED|Overall Study||408
8662031|NCT00705523|9705208|FG000|STARTED|Overall Study||19
8662032|NCT00705523|9705209|FG001|STARTED|Overall Study||21
8662033|NCT00705523|9705208|FG000|COMPLETED|Overall Study||17
8662034|NCT00705523|9705209|FG001|COMPLETED|Overall Study||18
8662035|NCT00705523|9705208|FG000|NOT COMPLETED|Overall Study||2
8662036|NCT00705523|9705209|FG001|NOT COMPLETED|Overall Study||3
8662037|NCT00705536|9705217|FG000|STARTED|Start Period 1||6
8662038|NCT00705536|9705218|FG001|STARTED|Start Period 1||6
8662039|NCT00705536|9705219|FG002|STARTED|Start Period 1||7
8662040|NCT00705536|9705220|FG003|STARTED|Start Period 1||7
8662041|NCT00705536|9705217|FG000|Received at Least 1 Dose of Study Drug|Start Period 1||6
8662042|NCT00705536|9705218|FG001|Received at Least 1 Dose of Study Drug|Start Period 1||6
8662043|NCT00705536|9705219|FG002|Received at Least 1 Dose of Study Drug|Start Period 1||7
8662044|NCT00705536|9705220|FG003|Received at Least 1 Dose of Study Drug|Start Period 1||7
8662045|NCT00705536|9705217|FG000|COMPLETED|Start Period 1||6
8662046|NCT00705536|9705218|FG001|COMPLETED|Start Period 1||6
8662047|NCT00705536|9705219|FG002|COMPLETED|Start Period 1||7
8662048|NCT00705536|9705220|FG003|COMPLETED|Start Period 1||6
8662049|NCT00705536|9705217|FG000|NOT COMPLETED|Start Period 1||0
8662050|NCT00705536|9705218|FG001|NOT COMPLETED|Start Period 1||0
8662051|NCT00705536|9705219|FG002|NOT COMPLETED|Start Period 1||0
8662052|NCT00705536|9705220|FG003|NOT COMPLETED|Start Period 1||1
8662053|NCT00705536|9705217|FG000|STARTED|Washout Period of at Least 6 Days||6
8662054|NCT00705536|9705218|FG001|STARTED|Washout Period of at Least 6 Days||6
8662055|NCT00705536|9705219|FG002|STARTED|Washout Period of at Least 6 Days||7
8662056|NCT00705536|9705220|FG003|STARTED|Washout Period of at Least 6 Days||6
8662057|NCT00705536|9705217|FG000|COMPLETED|Washout Period of at Least 6 Days||6
8662058|NCT00705536|9705218|FG001|COMPLETED|Washout Period of at Least 6 Days||6
8662059|NCT00705536|9705219|FG002|COMPLETED|Washout Period of at Least 6 Days||7
8662060|NCT00705536|9705220|FG003|COMPLETED|Washout Period of at Least 6 Days||6
8662061|NCT00705536|9705217|FG000|NOT COMPLETED|Washout Period of at Least 6 Days||0
8662062|NCT00705536|9705218|FG001|NOT COMPLETED|Washout Period of at Least 6 Days||0
8662063|NCT00705536|9705219|FG002|NOT COMPLETED|Washout Period of at Least 6 Days||0
8662064|NCT00705536|9705220|FG003|NOT COMPLETED|Washout Period of at Least 6 Days||0
8662065|NCT00705536|9705217|FG000|STARTED|Start Period 2||6
8662066|NCT00705536|9705218|FG001|STARTED|Start Period 2||6
8662067|NCT00705536|9705219|FG002|STARTED|Start Period 2||7
8662068|NCT00705536|9705220|FG003|STARTED|Start Period 2||6
8662069|NCT00705536|9705217|FG000|COMPLETED|Start Period 2||6
8662070|NCT00705536|9705218|FG001|COMPLETED|Start Period 2||6
8662071|NCT00705536|9705219|FG002|COMPLETED|Start Period 2||7
8662072|NCT00705536|9705220|FG003|COMPLETED|Start Period 2||6
8662073|NCT00705536|9705217|FG000|NOT COMPLETED|Start Period 2||0
8662074|NCT00705536|9705218|FG001|NOT COMPLETED|Start Period 2||0
8662075|NCT00705536|9705219|FG002|NOT COMPLETED|Start Period 2||0
8662076|NCT00705536|9705220|FG003|NOT COMPLETED|Start Period 2||0
8662077|NCT00705536|9705217|FG000|STARTED|Completed Study||6
8662078|NCT00705536|9705218|FG001|STARTED|Completed Study||6
8662079|NCT00705536|9705219|FG002|STARTED|Completed Study||7
8662080|NCT00705536|9705220|FG003|STARTED|Completed Study||6
8662081|NCT00705536|9705217|FG000|COMPLETED|Completed Study||6
8662082|NCT00705536|9705218|FG001|COMPLETED|Completed Study||6
8662083|NCT00705536|9705219|FG002|COMPLETED|Completed Study||7
8662084|NCT00705536|9705220|FG003|COMPLETED|Completed Study||6
8662085|NCT00705536|9705217|FG000|NOT COMPLETED|Completed Study||0
8662086|NCT00705536|9705218|FG001|NOT COMPLETED|Completed Study||0
8662087|NCT00705536|9705219|FG002|NOT COMPLETED|Completed Study||0
8662088|NCT00705536|9705220|FG003|NOT COMPLETED|Completed Study||0
8662089|NCT00705575|9705241|FG000|STARTED|Overall Study||349
8662090|NCT00705575|9705242|FG001|STARTED|Overall Study||339
8662091|NCT00705575|9705241|FG000|COMPLETED|Overall Study||326
8662092|NCT00705575|9705242|FG001|COMPLETED|Overall Study||293
8662093|NCT00705575|9705241|FG000|NOT COMPLETED|Overall Study||23
8662094|NCT00705575|9705242|FG001|NOT COMPLETED|Overall Study||46
8662095|NCT00705614|9705250|FG000|STARTED|Initial Intervention||1541
8662096|NCT00705614|9705251|FG001|STARTED|Initial Intervention||1121
8662097|NCT00705614|9705250|FG000|COMPLETED|Initial Intervention||1023
8662098|NCT00705614|9705251|FG001|COMPLETED|Initial Intervention||800
8662099|NCT00705614|9705250|FG000|NOT COMPLETED|Initial Intervention||518
8662100|NCT00705614|9705251|FG001|NOT COMPLETED|Initial Intervention||321
8662101|NCT00705614|9705250|FG000|STARTED|Switch to Remicade||0
8662102|NCT00705614|9705251|FG001|STARTED|Switch to Remicade||298
8662103|NCT00705614|9705250|FG000|COMPLETED|Switch to Remicade||0
8662104|NCT00705614|9705251|FG001|COMPLETED|Switch to Remicade||249
8662105|NCT00705614|9705250|FG000|NOT COMPLETED|Switch to Remicade||0
8662106|NCT00705614|9705251|FG001|NOT COMPLETED|Switch to Remicade||49
8662107|NCT00705653|9705259|FG000|STARTED|Overall Study||46
8662108|NCT00705653|9705259|FG000|COMPLETED|Overall Study||46
8662109|NCT00705653|9705259|FG000|NOT COMPLETED|Overall Study||0
8662110|NCT00705666|9705263|FG000|STARTED|Overall Study||789
8662111|NCT00705666|9705263|FG000|COMPLETED|Overall Study||450
8662112|NCT00705666|9705263|FG000|NOT COMPLETED|Overall Study||339
8662113|NCT00705679|9705272|FG000|STARTED|Overall Study||1007
8729794|NCT01055132|9777069|FG000|NOT COMPLETED|Period 2 (5-9 Days)||0
8662114|NCT00705679|9705273|FG001|STARTED|Overall Study||1003
8662115|NCT00705679|9705274|FG002|STARTED|Overall Study||1009
8662116|NCT00705679|9705275|FG003|STARTED|Overall Study||1007
8662117|NCT00705679|9705276|FG004|STARTED|Overall Study||1003
8662118|NCT00705679|9705272|FG000|COMPLETED|Overall Study||942
8662119|NCT00705679|9705273|FG001|COMPLETED|Overall Study||864
8662120|NCT00705679|9705274|FG002|COMPLETED|Overall Study||894
8662121|NCT00705679|9705275|FG003|COMPLETED|Overall Study||927
8662122|NCT00705679|9705276|FG004|COMPLETED|Overall Study||934
8662123|NCT00705679|9705272|FG000|NOT COMPLETED|Overall Study||65
8662124|NCT00705679|9705273|FG001|NOT COMPLETED|Overall Study||139
8662125|NCT00705679|9705274|FG002|NOT COMPLETED|Overall Study||115
8662126|NCT00705679|9705275|FG003|NOT COMPLETED|Overall Study||80
8662127|NCT00705679|9705276|FG004|NOT COMPLETED|Overall Study||69
8662128|NCT00705718|9705295|FG000|STARTED|Overall Study||44
8662129|NCT00705718|9705296|FG001|STARTED|Overall Study||150
8662130|NCT00705718|9705295|FG000|1 Month Follow up|Overall Study|1 Death|43
8662131|NCT00705718|9705296|FG001|1 Month Follow up|Overall Study|1 Subject Missed Visit|149
8662132|NCT00705718|9705295|FG000|6 Month Follow up|Overall Study|3 Deaths|40
8662133|NCT00705718|9705296|FG001|6 Month Follow up|Overall Study|2 Deaths, 5 Subjects Missed Visit|143
8662134|NCT00705718|9705295|FG000|12 Month Follow up|Overall Study|2 Deaths|37
8662135|NCT00705718|9705296|FG001|12 Month Follow up|Overall Study|4 Deaths, 12 Subjects Not due for next visit, 4 Subjects Missed Visit|128
8662136|NCT00705718|9705295|FG000|COMPLETED|Overall Study||37
8662137|NCT00705718|9705296|FG001|COMPLETED|Overall Study||128
8662138|NCT00705718|9705295|FG000|NOT COMPLETED|Overall Study||7
8662139|NCT00705718|9705296|FG001|NOT COMPLETED|Overall Study||22
8662140|NCT00705757|9705305|FG000|STARTED|Overall Study||32
8662141|NCT00705757|9705306|FG001|STARTED|Overall Study||29
8662142|NCT00705757|9705307|FG002|STARTED|Overall Study||28
8662143|NCT00705757|9705305|FG000|COMPLETED|Overall Study||19
8662144|NCT00705757|9705306|FG001|COMPLETED|Overall Study||21
8662145|NCT00705757|9705307|FG002|COMPLETED|Overall Study||17
8662146|NCT00705757|9705305|FG000|NOT COMPLETED|Overall Study||13
8662147|NCT00705757|9705306|FG001|NOT COMPLETED|Overall Study||8
8662148|NCT00705757|9705307|FG002|NOT COMPLETED|Overall Study||11
8662149|NCT00705783|9705317|FG000|STARTED|Conversion Phase||633
8662150|NCT00705783|9705318|FG001|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
8662151|NCT00705783|9705319|FG002|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
8662152|NCT00705783|9705317|FG000|Received Study Medication|Conversion Phase||632
8662153|NCT00705783|9705318|FG001|Received Study Medication|Conversion Phase||0
8662154|NCT00705783|9705319|FG002|Received Study Medication|Conversion Phase||0
8662155|NCT00705783|9705317|FG000|COMPLETED|Conversion Phase||500
8662156|NCT00705783|9705318|FG001|COMPLETED|Conversion Phase||0
8662157|NCT00705783|9705319|FG002|COMPLETED|Conversion Phase||0
8662158|NCT00705783|9705317|FG000|NOT COMPLETED|Conversion Phase||133
8662159|NCT00705783|9705318|FG001|NOT COMPLETED|Conversion Phase||0
8662160|NCT00705783|9705319|FG002|NOT COMPLETED|Conversion Phase||0
8662161|NCT00705783|9705317|FG000|STARTED|Oral Stabilization Phase|210 of the 710 patients who started this phase enrolled in this study directly into this phase.|710
8662162|NCT00705783|9705318|FG001|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
8662163|NCT00705783|9705319|FG002|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
8662164|NCT00705783|9705317|FG000|Received Study Medication|Oral Stabilization Phase||709
8662165|NCT00705783|9705318|FG001|Received Study Medication|Oral Stabilization Phase||0
8662166|NCT00705783|9705319|FG002|Received Study Medication|Oral Stabilization Phase||0
8662167|NCT00705783|9705317|FG000|COMPLETED|Oral Stabilization Phase||576
8662168|NCT00705783|9705318|FG001|COMPLETED|Oral Stabilization Phase||0
8662169|NCT00705783|9705319|FG002|COMPLETED|Oral Stabilization Phase||0
8662170|NCT00705783|9705317|FG000|NOT COMPLETED|Oral Stabilization Phase||134
8662171|NCT00705783|9705318|FG001|NOT COMPLETED|Oral Stabilization Phase||0
8662172|NCT00705783|9705319|FG002|NOT COMPLETED|Oral Stabilization Phase||0
8662173|NCT00705783|9705317|FG000|STARTED|Depot Stabilization Phase||576
8662174|NCT00705783|9705318|FG001|STARTED|Depot Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
8662175|NCT00705783|9705319|FG002|STARTED|Depot Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
8662176|NCT00705783|9705317|FG000|COMPLETED|Depot Stabilization Phase||403
8662177|NCT00705783|9705318|FG001|COMPLETED|Depot Stabilization Phase||0
8662178|NCT00705783|9705319|FG002|COMPLETED|Depot Stabilization Phase||0
8662179|NCT00705783|9705317|FG000|NOT COMPLETED|Depot Stabilization Phase||173
8662180|NCT00705783|9705318|FG001|NOT COMPLETED|Depot Stabilization Phase||0
8662181|NCT00705783|9705319|FG002|NOT COMPLETED|Depot Stabilization Phase||0
8662182|NCT00705783|9705317|FG000|STARTED|Depot Maintenance Phase|Patients were randomized into the aripiprazole and placebo depot groups in this phase of the study.|0
8662183|NCT00705783|9705318|FG001|STARTED|Depot Maintenance Phase||269
8662184|NCT00705783|9705319|FG002|STARTED|Depot Maintenance Phase||134
8662185|NCT00705783|9705317|FG000|COMPLETED|Depot Maintenance Phase||0
8662186|NCT00705783|9705318|FG001|COMPLETED|Depot Maintenance Phase||23
8662187|NCT00705783|9705319|FG002|COMPLETED|Depot Maintenance Phase||3
8662188|NCT00705783|9705317|FG000|NOT COMPLETED|Depot Maintenance Phase||0
8662189|NCT00705783|9705318|FG001|NOT COMPLETED|Depot Maintenance Phase||246
8662190|NCT00705783|9705319|FG002|NOT COMPLETED|Depot Maintenance Phase||131
8662191|NCT00705874|9705335|FG000|STARTED|Overall Study||12
8662192|NCT00705874|9705336|FG001|STARTED|Overall Study||9
8662193|NCT00705874|9705337|FG002|STARTED|Overall Study||34
8662194|NCT00705874|9705338|FG003|STARTED|Overall Study||34
8662195|NCT00705874|9705339|FG004|STARTED|Overall Study||48
8662196|NCT00705874|9705340|FG005|STARTED|Overall Study||32
8662197|NCT00705874|9705341|FG006|STARTED|Overall Study||3
8662198|NCT00705874|9705335|FG000|COMPLETED|Overall Study||10
8662199|NCT00705874|9705336|FG001|COMPLETED|Overall Study||8
8662200|NCT00705874|9705337|FG002|COMPLETED|Overall Study||32
8662201|NCT00705874|9705338|FG003|COMPLETED|Overall Study||33
8662202|NCT00705874|9705339|FG004|COMPLETED|Overall Study||36
8662203|NCT00705874|9705340|FG005|COMPLETED|Overall Study||28
8662204|NCT00705874|9705341|FG006|COMPLETED|Overall Study||3
8662205|NCT00705874|9705335|FG000|NOT COMPLETED|Overall Study||2
8662206|NCT00705874|9705336|FG001|NOT COMPLETED|Overall Study||1
8662207|NCT00705874|9705337|FG002|NOT COMPLETED|Overall Study||2
8662208|NCT00705874|9705338|FG003|NOT COMPLETED|Overall Study||1
8662209|NCT00705874|9705339|FG004|NOT COMPLETED|Overall Study||12
8662210|NCT00705874|9705340|FG005|NOT COMPLETED|Overall Study||4
8662211|NCT00705874|9705341|FG006|NOT COMPLETED|Overall Study||0
8662212|NCT00705939|9705360|FG000|STARTED|Overall Study||12
8662213|NCT00705939|9705361|FG001|STARTED|Overall Study||14
8662214|NCT00705939|9705362|FG002|STARTED|Overall Study|1 subject enrolled but not treated in this protocol.|18
8662215|NCT00705939|9705360|FG000|COMPLETED|Overall Study||12
8729795|NCT01055132|9777070|FG001|NOT COMPLETED|Period 2 (5-9 Days)||1
8729796|NCT01055171|9777082|FG000|STARTED|Overall Study|Randomized to receive medication.|29
8729797|NCT01055171|9777083|FG001|STARTED|Overall Study|Randomized to receive placebo.|28
8729798|NCT01055171|9777082|FG000|Retrieval Completion|Overall Study|Received the medication and completed the retrieval session.|25
8729799|NCT01055171|9777083|FG001|Retrieval Completion|Overall Study|Received the sugar pill and completed the retrieval session.|24
8729800|NCT01055171|9777082|FG000|Test Procedure Completion|Overall Study|Received the medication and completed the first test session.|21
8729801|NCT01055171|9777083|FG001|Test Procedure Completion|Overall Study|Received the placebo and completed the first test session.|23
8729802|NCT01055171|9777082|FG000|COMPLETED|Overall Study|Received the medication and completed all visits including the one-week follow-up.|18
8729803|NCT01055171|9777083|FG001|COMPLETED|Overall Study|Received the sugar pill and completed all visits including the one-week follow-up.|21
8729804|NCT01055171|9777082|FG000|NOT COMPLETED|Overall Study||11
8729805|NCT01055171|9777083|FG001|NOT COMPLETED|Overall Study||7
8729806|NCT01055184|9777089|FG000|STARTED|Overall Study||34
8729807|NCT01055184|9777089|FG000|COMPLETED|Overall Study||34
8729808|NCT01055184|9777089|FG000|NOT COMPLETED|Overall Study||0
8729809|NCT01055197|9777095|FG000|STARTED|Overall Study||51
8729810|NCT01055197|9777096|FG001|STARTED|Overall Study||46
8729811|NCT01055197|9777095|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|42
8729812|NCT01055197|9777096|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|44
8729813|NCT01055197|9777095|FG000|NOT COMPLETED|Overall Study||9
8729814|NCT01055197|9777096|FG001|NOT COMPLETED|Overall Study||2
8729815|NCT01055223|9777102|FG000|STARTED|Overall Study||98483
8729816|NCT01055223|9777102|FG000|COMPLETED|Overall Study||98483
8729817|NCT01055223|9777102|FG000|NOT COMPLETED|Overall Study||0
8729818|NCT01055262|9777115|FG000|STARTED|Overall Study||169
8729819|NCT01055262|9777115|FG000|COMPLETED|Overall Study||160
8729820|NCT01055262|9777115|FG000|NOT COMPLETED|Overall Study||9
8729821|NCT01055314|9777121|FG000|STARTED|Overall Study||100
8729822|NCT01055314|9777122|FG001|STARTED|Overall Study||75
8729823|NCT01055314|9777121|FG000|COMPLETED|Overall Study||55
8729824|NCT01055314|9777122|FG001|COMPLETED|Overall Study||37
8729825|NCT01055314|9777121|FG000|NOT COMPLETED|Overall Study||45
8729826|NCT01055314|9777122|FG001|NOT COMPLETED|Overall Study||38
8729827|NCT01055457|9777139|FG000|STARTED|Overall Study||40
8729828|NCT01055457|9777140|FG001|STARTED|Overall Study||40
8729829|NCT01055457|9777141|FG002|STARTED|Overall Study||38
8729830|NCT01055457|9777142|FG003|STARTED|Overall Study||40
8729831|NCT01055457|9777143|FG004|STARTED|Overall Study||41
8729832|NCT01055457|9777144|FG005|STARTED|Overall Study||18
8729833|NCT01055457|9777145|FG006|STARTED|Overall Study||19
8729834|NCT01055457|9777146|FG007|STARTED|Overall Study||19
8729835|NCT01055457|9777147|FG008|STARTED|Overall Study||20
8729836|NCT01055457|9777148|FG009|STARTED|Overall Study||20
8729837|NCT01055457|9777139|FG000|COMPLETED|Overall Study||39
8729838|NCT01055457|9777140|FG001|COMPLETED|Overall Study||39
8729839|NCT01055457|9777141|FG002|COMPLETED|Overall Study||36
8729840|NCT01055457|9777142|FG003|COMPLETED|Overall Study||37
8729841|NCT01055457|9777143|FG004|COMPLETED|Overall Study||38
8729842|NCT01055457|9777144|FG005|COMPLETED|Overall Study||15
8729843|NCT01055457|9777145|FG006|COMPLETED|Overall Study||18
8729844|NCT01055457|9777146|FG007|COMPLETED|Overall Study||18
8729845|NCT01055457|9777147|FG008|COMPLETED|Overall Study||20
8729846|NCT01055457|9777148|FG009|COMPLETED|Overall Study||19
8729847|NCT01055457|9777139|FG000|NOT COMPLETED|Overall Study||1
8729848|NCT01055457|9777140|FG001|NOT COMPLETED|Overall Study||1
8729849|NCT01055457|9777141|FG002|NOT COMPLETED|Overall Study||2
8729850|NCT01055457|9777142|FG003|NOT COMPLETED|Overall Study||3
8729851|NCT01055457|9777143|FG004|NOT COMPLETED|Overall Study||3
8729852|NCT01055457|9777144|FG005|NOT COMPLETED|Overall Study||3
8729853|NCT01055457|9777145|FG006|NOT COMPLETED|Overall Study||1
8729854|NCT01055457|9777146|FG007|NOT COMPLETED|Overall Study||1
8729855|NCT01055457|9777147|FG008|NOT COMPLETED|Overall Study||0
8729856|NCT01055457|9777148|FG009|NOT COMPLETED|Overall Study||1
8729857|NCT01055496|9777172|FG000|STARTED|Overall Study||48
8729858|NCT01055496|9777173|FG001|STARTED|Overall Study||55
8729859|NCT01055496|9777172|FG000|COMPLETED|Overall Study||33
8729860|NCT01055496|9777173|FG001|COMPLETED|Overall Study||25
8729861|NCT01055496|9777172|FG000|NOT COMPLETED|Overall Study||15
8729862|NCT01055496|9777173|FG001|NOT COMPLETED|Overall Study||30
8729863|NCT01055613|9777202|FG000|STARTED|Overall Study||200
8729864|NCT01055613|9777203|FG001|STARTED|Overall Study||100
8729865|NCT01055613|9777202|FG000|COMPLETED|Overall Study||191
8662216|NCT00705939|9705361|FG001|COMPLETED|Overall Study||12
8662217|NCT00705939|9705362|FG002|COMPLETED|Overall Study||14
8662218|NCT00705939|9705360|FG000|NOT COMPLETED|Overall Study||0
8662219|NCT00705939|9705361|FG001|NOT COMPLETED|Overall Study||2
8662220|NCT00705939|9705362|FG002|NOT COMPLETED|Overall Study||4
8662221|NCT00706004|9705371|FG000|STARTED|Overall Study||9
8662222|NCT00706004|9705371|FG000|COMPLETED|Overall Study||7
8662223|NCT00706004|9705371|FG000|NOT COMPLETED|Overall Study||2
8662224|NCT00706030|9705380|FG000|STARTED|Overall Study||6
8662225|NCT00706030|9705381|FG001|STARTED|Overall Study||6
8662226|NCT00706030|9705382|FG002|STARTED|Overall Study||64
8662227|NCT00706030|9705383|FG003|STARTED|Overall Study||16
8662228|NCT00706030|9705380|FG000|Treated|Overall Study||6
8662229|NCT00706030|9705381|FG001|Treated|Overall Study||6
8662230|NCT00706030|9705382|FG002|Treated|Overall Study||64
8662231|NCT00706030|9705383|FG003|Treated|Overall Study||15
8662232|NCT00706030|9705380|FG000|COMPLETED|Overall Study||0
8729866|NCT01055613|9777203|FG001|COMPLETED|Overall Study||96
8729867|NCT01055613|9777202|FG000|NOT COMPLETED|Overall Study||9
8729868|NCT01055613|9777203|FG001|NOT COMPLETED|Overall Study||4
8729869|NCT01055639|9777211|FG000|STARTED|Overall Study||66
8729870|NCT01055639|9777212|FG001|STARTED|Overall Study||60
8729871|NCT01055639|9777211|FG000|COMPLETED|Overall Study||45
8729872|NCT01055639|9777212|FG001|COMPLETED|Overall Study||31
8729873|NCT01055639|9777211|FG000|NOT COMPLETED|Overall Study||21
8729874|NCT01055639|9777212|FG001|NOT COMPLETED|Overall Study||29
8729875|NCT01055704|9777222|FG000|STARTED|Overall Study||16
8729876|NCT01055704|9777223|FG001|STARTED|Overall Study||8
8729877|NCT01055704|9777224|FG002|STARTED|Overall Study||16
8729878|NCT01055704|9777225|FG003|STARTED|Overall Study||8
8729879|NCT01055704|9777222|FG000|COMPLETED|Overall Study||16
8729880|NCT01055704|9777223|FG001|COMPLETED|Overall Study||8
8729881|NCT01055704|9777224|FG002|COMPLETED|Overall Study||16
8729882|NCT01055704|9777225|FG003|COMPLETED|Overall Study||8
8729883|NCT01055704|9777222|FG000|NOT COMPLETED|Overall Study||0
8729884|NCT01055704|9777223|FG001|NOT COMPLETED|Overall Study||0
8729885|NCT01055704|9777224|FG002|NOT COMPLETED|Overall Study||0
8729886|NCT01055704|9777225|FG003|NOT COMPLETED|Overall Study||0
8729887|NCT01055769|9777235|FG000|STARTED|First Intervention||10
8729888|NCT01055769|9777236|FG001|STARTED|First Intervention||10
8729889|NCT01055769|9777235|FG000|COMPLETED|First Intervention||10
8729890|NCT01055769|9777236|FG001|COMPLETED|First Intervention||10
8729891|NCT01055769|9777235|FG000|NOT COMPLETED|First Intervention||0
8729892|NCT01055769|9777236|FG001|NOT COMPLETED|First Intervention||0
8729893|NCT01055769|9777235|FG000|STARTED|Washout Period of Atleast 4 Days||10
8729894|NCT01055769|9777236|FG001|STARTED|Washout Period of Atleast 4 Days||10
8729895|NCT01055769|9777235|FG000|COMPLETED|Washout Period of Atleast 4 Days||10
8729896|NCT01055769|9777236|FG001|COMPLETED|Washout Period of Atleast 4 Days||10
8729897|NCT01055769|9777235|FG000|NOT COMPLETED|Washout Period of Atleast 4 Days||0
8729898|NCT01055769|9777236|FG001|NOT COMPLETED|Washout Period of Atleast 4 Days||0
8729899|NCT01055769|9777235|FG000|STARTED|Second Intervention||10
8729900|NCT01055769|9777236|FG001|STARTED|Second Intervention||10
8729901|NCT01055769|9777235|FG000|COMPLETED|Second Intervention||10
8729902|NCT01055769|9777236|FG001|COMPLETED|Second Intervention||10
8729903|NCT01055769|9777235|FG000|NOT COMPLETED|Second Intervention||0
8729904|NCT01055769|9777236|FG001|NOT COMPLETED|Second Intervention||0
8729905|NCT01055782|9777245|FG000|STARTED|Overall Study||555
8729906|NCT01055782|9777246|FG001|STARTED|Overall Study||449
8729907|NCT01055782|9777245|FG000|COMPLETED|Overall Study||555
8729908|NCT01055782|9777246|FG001|COMPLETED|Overall Study||449
8729909|NCT01055782|9777245|FG000|NOT COMPLETED|Overall Study||0
8729910|NCT01055782|9777246|FG001|NOT COMPLETED|Overall Study||0
8729911|NCT01055834|9777256|FG000|STARTED|Treatment Period I||21
8729912|NCT01055834|9777257|FG001|STARTED|Treatment Period I||21
8729913|NCT01055834|9777256|FG000|COMPLETED|Treatment Period I||20
8729914|NCT01055834|9777257|FG001|COMPLETED|Treatment Period I||21
8729915|NCT01055834|9777256|FG000|NOT COMPLETED|Treatment Period I||1
8729916|NCT01055834|9777257|FG001|NOT COMPLETED|Treatment Period I||0
8729917|NCT01055834|9777256|FG000|STARTED|Treatment Period II||20
8729918|NCT01055834|9777257|FG001|STARTED|Treatment Period II||21
8729919|NCT01055834|9777256|FG000|COMPLETED|Treatment Period II||20
8729920|NCT01055834|9777257|FG001|COMPLETED|Treatment Period II||21
8729921|NCT01055834|9777256|FG000|NOT COMPLETED|Treatment Period II||0
8729922|NCT01055834|9777257|FG001|NOT COMPLETED|Treatment Period II||0
8729923|NCT01055834|9777256|FG000|STARTED|Treatment Period III|Participants from Group A did not continue into Period III.|0
8729924|NCT01055834|9777257|FG001|STARTED|Treatment Period III|14 of 21 participants in Group B who were treated in Period II participated in Period III.|14
8729925|NCT01055834|9777256|FG000|COMPLETED|Treatment Period III||0
8729926|NCT01055834|9777257|FG001|COMPLETED|Treatment Period III||14
8729927|NCT01055834|9777256|FG000|NOT COMPLETED|Treatment Period III||0
8662233|NCT00706030|9705381|FG001|COMPLETED|Overall Study||0
8729928|NCT01055834|9777257|FG001|NOT COMPLETED|Treatment Period III||0
8729929|NCT01055886|9777268|FG000|STARTED|Overall Study||33
8729930|NCT01055886|9777269|FG001|STARTED|Overall Study||32
8729931|NCT01055886|9777268|FG000|Reached Pre-quit Period|Overall Study|2 withdrawals, 1 lost to contact|30
8729932|NCT01055886|9777269|FG001|Reached Pre-quit Period|Overall Study|1 lost to contact|31
8729933|NCT01055886|9777268|FG000|COMPLETED|Overall Study|This includes those who completed all sessions and those with w/d post quit (missing = smoking).|28
8662234|NCT00706030|9705382|FG002|COMPLETED|Overall Study||4
8662235|NCT00706030|9705383|FG003|COMPLETED|Overall Study||0
8662236|NCT00706030|9705380|FG000|NOT COMPLETED|Overall Study||6
8662237|NCT00706030|9705381|FG001|NOT COMPLETED|Overall Study||6
8662238|NCT00706030|9705382|FG002|NOT COMPLETED|Overall Study||60
8662239|NCT00706030|9705383|FG003|NOT COMPLETED|Overall Study||16
8662240|NCT00706095|9705397|FG000|STARTED|Overall Study||6
8662241|NCT00706095|9705398|FG001|STARTED|Overall Study||7
8662242|NCT00706095|9705399|FG002|STARTED|Overall Study||5
8662243|NCT00706095|9705397|FG000|COMPLETED|Overall Study||0
8662244|NCT00706095|9705398|FG001|COMPLETED|Overall Study||0
8662245|NCT00706095|9705399|FG002|COMPLETED|Overall Study||0
8662246|NCT00706095|9705397|FG000|NOT COMPLETED|Overall Study||6
8662247|NCT00706095|9705398|FG001|NOT COMPLETED|Overall Study||7
8662248|NCT00706095|9705399|FG002|NOT COMPLETED|Overall Study||5
8662249|NCT00706121|9705411|FG000|STARTED|Overall Study||2039
8662250|NCT00706121|9705412|FG001|STARTED|Overall Study||2096
8662251|NCT00706121|9705413|FG002|STARTED|Overall Study||2030
8662252|NCT00706121|9705414|FG003|STARTED|Overall Study||1929
8662253|NCT00706121|9705411|FG000|COMPLETED|Overall Study||1643
8662254|NCT00706121|9705412|FG001|COMPLETED|Overall Study||1700
8662255|NCT00706121|9705413|FG002|COMPLETED|Overall Study||1626
8662256|NCT00706121|9705414|FG003|COMPLETED|Overall Study||1577
8662257|NCT00706121|9705411|FG000|NOT COMPLETED|Overall Study||396
8662258|NCT00706121|9705412|FG001|NOT COMPLETED|Overall Study||396
8662259|NCT00706121|9705413|FG002|NOT COMPLETED|Overall Study||404
8662260|NCT00706121|9705414|FG003|NOT COMPLETED|Overall Study||352
8662261|NCT00706134|9705436|FG000|STARTED|Overall Study||189
8662262|NCT00706134|9705437|FG001|STARTED|Overall Study||192
8662263|NCT00706134|9705438|FG002|STARTED|Overall Study||189
8662264|NCT00706134|9705439|FG003|STARTED|Overall Study||186
8662265|NCT00706134|9705436|FG000|Entered Double-blind Period|Overall Study||187
8911392|NCT02146274|9970491|FG000|STARTED|Overall Study||1877
8911393|NCT02146274|9970491|FG000|COMPLETED|Overall Study||1804
9022404|NCT03126539|10085297|FG002|STARTED|Overall Study||9
8662266|NCT00706134|9705437|FG001|Entered Double-blind Period|Overall Study||192
8662267|NCT00706134|9705438|FG002|Entered Double-blind Period|Overall Study||189
8662268|NCT00706134|9705439|FG003|Entered Double-blind Period|Overall Study||186
8662269|NCT00706134|9705436|FG000|COMPLETED|Overall Study||169
8662270|NCT00706134|9705437|FG001|COMPLETED|Overall Study||173
8662271|NCT00706134|9705438|FG002|COMPLETED|Overall Study||183
8662272|NCT00706134|9705439|FG003|COMPLETED|Overall Study||175
8662273|NCT00706134|9705436|FG000|NOT COMPLETED|Overall Study||20
8662274|NCT00706134|9705437|FG001|NOT COMPLETED|Overall Study||19
8662275|NCT00706134|9705438|FG002|NOT COMPLETED|Overall Study||6
8662276|NCT00706134|9705439|FG003|NOT COMPLETED|Overall Study||11
8662277|NCT00706238|9705449|FG000|STARTED|Overall Study||5
8662278|NCT00706238|9705449|FG000|COMPLETED|Overall Study||0
8729934|NCT01055886|9777269|FG001|COMPLETED|Overall Study|This includes those who completed all sessions and those with w/d post quit (missing = smoking).|21
8729935|NCT01055886|9777268|FG000|NOT COMPLETED|Overall Study||5
8729936|NCT01055886|9777269|FG001|NOT COMPLETED|Overall Study||11
8729937|NCT01056016|9777277|FG000|STARTED|Overall Study|22 pediatricians were at 4 practices; practices were unit of randomization|22
8806640|NCT01479270|9858933|FG000|NOT COMPLETED|Overall Study||0
8911394|NCT02146274|9970491|FG000|NOT COMPLETED|Overall Study||73
8911395|NCT02146326|9970502|FG000|STARTED|Overall Study||89
9022405|NCT03126539|10085298|FG003|STARTED|Overall Study|Group B was not done|0
8662279|NCT00706238|9705449|FG000|NOT COMPLETED|Overall Study||5
8662280|NCT00706264|9705455|FG000|STARTED|Overall Study||193
8662281|NCT00706264|9705456|FG001|STARTED|Overall Study||192
8662282|NCT00706264|9705455|FG000|COMPLETED|Overall Study||190
8662283|NCT00706264|9705456|FG001|COMPLETED|Overall Study||190
8662284|NCT00706264|9705455|FG000|NOT COMPLETED|Overall Study||3
8662285|NCT00706264|9705456|FG001|NOT COMPLETED|Overall Study||2
8662286|NCT00706342|9705464|FG000|STARTED|Overall Study||18
8662287|NCT00706342|9705464|FG000|COMPLETED|Overall Study||0
8662288|NCT00706342|9705464|FG000|NOT COMPLETED|Overall Study||18
8662289|NCT00706355|9705472|FG000|STARTED|Period 1: PF-04217903 50 mg||3
8662290|NCT00706355|9705473|FG001|STARTED|Period 1: PF-04217903 50 mg||0
8662291|NCT00706355|9705474|FG002|STARTED|Period 1: PF-04217903 50 mg||0
8662292|NCT00706355|9705475|FG003|STARTED|Period 1: PF-04217903 50 mg||0
8662293|NCT00706355|9705472|FG000|COMPLETED|Period 1: PF-04217903 50 mg||0
8662294|NCT00706355|9705473|FG001|COMPLETED|Period 1: PF-04217903 50 mg||0
8662295|NCT00706355|9705474|FG002|COMPLETED|Period 1: PF-04217903 50 mg||0
8662296|NCT00706355|9705475|FG003|COMPLETED|Period 1: PF-04217903 50 mg||0
8662297|NCT00706355|9705472|FG000|NOT COMPLETED|Period 1: PF-04217903 50 mg||3
8662298|NCT00706355|9705473|FG001|NOT COMPLETED|Period 1: PF-04217903 50 mg||0
8662299|NCT00706355|9705474|FG002|NOT COMPLETED|Period 1: PF-04217903 50 mg||0
8662300|NCT00706355|9705475|FG003|NOT COMPLETED|Period 1: PF-04217903 50 mg||0
8662301|NCT00706355|9705472|FG000|STARTED|Period 2: PF-04217903 100 mg||0
8662302|NCT00706355|9705473|FG001|STARTED|Period 2: PF-04217903 100 mg||7
8662303|NCT00706355|9705474|FG002|STARTED|Period 2: PF-04217903 100 mg||0
8662304|NCT00706355|9705475|FG003|STARTED|Period 2: PF-04217903 100 mg||0
8911396|NCT02146326|9970503|FG001|STARTED|Overall Study||103
8662305|NCT00706355|9705472|FG000|COMPLETED|Period 2: PF-04217903 100 mg||0
8662306|NCT00706355|9705473|FG001|COMPLETED|Period 2: PF-04217903 100 mg||0
8911397|NCT02146326|9970504|FG002|STARTED|Overall Study||211
8911398|NCT02146326|9970505|FG003|STARTED|Overall Study||258
8911399|NCT02146326|9970502|FG000|Baseline|Overall Study||89
9022406|NCT03126539|10085299|FG004|STARTED|Overall Study||0
9022407|NCT03126539|10085295|FG000|COMPLETED|Overall Study||8
8662307|NCT00706355|9705474|FG002|COMPLETED|Period 2: PF-04217903 100 mg||0
8662308|NCT00706355|9705475|FG003|COMPLETED|Period 2: PF-04217903 100 mg||0
8662309|NCT00706355|9705472|FG000|NOT COMPLETED|Period 2: PF-04217903 100 mg||0
8662310|NCT00706355|9705473|FG001|NOT COMPLETED|Period 2: PF-04217903 100 mg||7
8662311|NCT00706355|9705474|FG002|NOT COMPLETED|Period 2: PF-04217903 100 mg||0
8662312|NCT00706355|9705475|FG003|NOT COMPLETED|Period 2: PF-04217903 100 mg||0
8662313|NCT00706355|9705472|FG000|STARTED|Period 3: PF-04217903 200 mg||0
8662314|NCT00706355|9705473|FG001|STARTED|Period 3: PF-04217903 200 mg||0
8662315|NCT00706355|9705474|FG002|STARTED|Period 3: PF-04217903 200 mg||2
8662316|NCT00706355|9705475|FG003|STARTED|Period 3: PF-04217903 200 mg||0
8662317|NCT00706355|9705472|FG000|COMPLETED|Period 3: PF-04217903 200 mg||0
8662318|NCT00706355|9705473|FG001|COMPLETED|Period 3: PF-04217903 200 mg||0
8662319|NCT00706355|9705474|FG002|COMPLETED|Period 3: PF-04217903 200 mg||0
8662320|NCT00706355|9705475|FG003|COMPLETED|Period 3: PF-04217903 200 mg||0
8662321|NCT00706355|9705472|FG000|NOT COMPLETED|Period 3: PF-04217903 200 mg||0
8662322|NCT00706355|9705473|FG001|NOT COMPLETED|Period 3: PF-04217903 200 mg||0
8662323|NCT00706355|9705474|FG002|NOT COMPLETED|Period 3: PF-04217903 200 mg||2
8662324|NCT00706355|9705475|FG003|NOT COMPLETED|Period 3: PF-04217903 200 mg||0
8662325|NCT00706355|9705472|FG000|STARTED|Period 4: PF-04217903 150 mg||0
8662326|NCT00706355|9705473|FG001|STARTED|Period 4: PF-04217903 150 mg||0
8662327|NCT00706355|9705474|FG002|STARTED|Period 4: PF-04217903 150 mg||0
8662328|NCT00706355|9705475|FG003|STARTED|Period 4: PF-04217903 150 mg||4
8662329|NCT00706355|9705472|FG000|COMPLETED|Period 4: PF-04217903 150 mg||0
8662330|NCT00706355|9705473|FG001|COMPLETED|Period 4: PF-04217903 150 mg||0
8662331|NCT00706355|9705474|FG002|COMPLETED|Period 4: PF-04217903 150 mg||0
8662332|NCT00706355|9705475|FG003|COMPLETED|Period 4: PF-04217903 150 mg||0
8662333|NCT00706355|9705472|FG000|NOT COMPLETED|Period 4: PF-04217903 150 mg||0
8662334|NCT00706355|9705473|FG001|NOT COMPLETED|Period 4: PF-04217903 150 mg||0
8662335|NCT00706355|9705474|FG002|NOT COMPLETED|Period 4: PF-04217903 150 mg||0
8662336|NCT00706355|9705475|FG003|NOT COMPLETED|Period 4: PF-04217903 150 mg||4
8662337|NCT00706381|9705491|FG000|STARTED|Overall Study||10
8662338|NCT00706381|9705492|FG001|STARTED|Overall Study||6
8662339|NCT00706381|9705493|FG002|STARTED|Overall Study||6
8662340|NCT00706381|9705494|FG003|STARTED|Overall Study||9
8662341|NCT00706381|9705491|FG000|Intervention 1 (1 Day)|Overall Study||10
8662342|NCT00706381|9705492|FG001|Intervention 1 (1 Day)|Overall Study||6
8662343|NCT00706381|9705493|FG002|Intervention 1 (1 Day)|Overall Study||6
8662344|NCT00706381|9705494|FG003|Intervention 1 (1 Day)|Overall Study||9
8662345|NCT00706381|9705491|FG000|Intervention 2 (1 Day)|Overall Study||10
8662346|NCT00706381|9705492|FG001|Intervention 2 (1 Day)|Overall Study||6
8662347|NCT00706381|9705493|FG002|Intervention 2 (1 Day)|Overall Study||6
8662348|NCT00706381|9705494|FG003|Intervention 2 (1 Day)|Overall Study||9
8662349|NCT00706381|9705491|FG000|Intervention 3 (1 Day)|Overall Study||10
8662350|NCT00706381|9705492|FG001|Intervention 3 (1 Day)|Overall Study||6
8662351|NCT00706381|9705493|FG002|Intervention 3 (1 Day)|Overall Study||6
8662352|NCT00706381|9705494|FG003|Intervention 3 (1 Day)|Overall Study||9
8662353|NCT00706381|9705491|FG000|Intervention 4 (1 Day)|Overall Study||10
8662354|NCT00706381|9705492|FG001|Intervention 4 (1 Day)|Overall Study||5
8662355|NCT00706381|9705493|FG002|Intervention 4 (1 Day)|Overall Study||6
8662356|NCT00706381|9705494|FG003|Intervention 4 (1 Day)|Overall Study||9
8662357|NCT00706381|9705491|FG000|Intervention 5 (1 Day)|Overall Study||10
8662358|NCT00706381|9705492|FG001|Intervention 5 (1 Day)|Overall Study||5
8662359|NCT00706381|9705493|FG002|Intervention 5 (1 Day)|Overall Study||5
8662360|NCT00706381|9705494|FG003|Intervention 5 (1 Day)|Overall Study||9
8662361|NCT00706381|9705491|FG000|COMPLETED|Overall Study||10
8662362|NCT00706381|9705492|FG001|COMPLETED|Overall Study||5
8662363|NCT00706381|9705493|FG002|COMPLETED|Overall Study||5
8662364|NCT00706381|9705494|FG003|COMPLETED|Overall Study||9
8662365|NCT00706381|9705491|FG000|NOT COMPLETED|Overall Study||0
8662366|NCT00706381|9705492|FG001|NOT COMPLETED|Overall Study||1
8662367|NCT00706381|9705493|FG002|NOT COMPLETED|Overall Study||1
8662368|NCT00706381|9705494|FG003|NOT COMPLETED|Overall Study||0
8662369|NCT00706394|9705507|FG000|STARTED|Overall Study||19
8662370|NCT00706394|9705507|FG000|COMPLETED|Overall Study||8
8662371|NCT00706394|9705507|FG000|NOT COMPLETED|Overall Study||11
8662372|NCT00706407|9705513|FG000|STARTED|Overall Study||42
8662373|NCT00706407|9705513|FG000|COMPLETED|Overall Study||33
8662374|NCT00706407|9705513|FG000|NOT COMPLETED|Overall Study||9
8662375|NCT00706433|9705524|FG000|STARTED|Overall Study||68
8662376|NCT00706433|9705525|FG001|STARTED|Overall Study||65
8662377|NCT00706433|9705526|FG002|STARTED|Overall Study||67
8662378|NCT00706433|9705527|FG003|STARTED|Overall Study||66
8662379|NCT00706433|9705524|FG000|COMPLETED|Overall Study||63
8662380|NCT00706433|9705525|FG001|COMPLETED|Overall Study||62
8662381|NCT00706433|9705526|FG002|COMPLETED|Overall Study||57
8662382|NCT00706433|9705527|FG003|COMPLETED|Overall Study||64
8662383|NCT00706433|9705524|FG000|NOT COMPLETED|Overall Study||5
8662384|NCT00706433|9705525|FG001|NOT COMPLETED|Overall Study||3
8662385|NCT00706433|9705526|FG002|NOT COMPLETED|Overall Study||10
8662386|NCT00706433|9705527|FG003|NOT COMPLETED|Overall Study||2
8692306|NCT00859469|9737707|FG000|STARTED|Overall Study||29
8692307|NCT00859469|9737707|FG000|6 Cycles|Overall Study||16
8692308|NCT00859469|9737707|FG000|COMPLETED|Overall Study||1
8662387|NCT00706446|9705543|FG000|STARTED|Overall Study||29
8662388|NCT00706446|9705544|FG001|STARTED|Overall Study||57
8729938|NCT01056016|9777278|FG001|STARTED|Overall Study|27 pediatricians were at 4 practices; practices were unit of randomization|27
8729939|NCT01056016|9777277|FG000|COMPLETED|Overall Study||20
8729940|NCT01056016|9777278|FG001|COMPLETED|Overall Study||26
8662389|NCT00706446|9705545|FG002|STARTED|Overall Study||44
8662390|NCT00706446|9705546|FG003|STARTED|Overall Study||26
8662391|NCT00706446|9705547|FG004|STARTED|Overall Study||54
8662392|NCT00706446|9705548|FG005|STARTED|Overall Study||45
8662393|NCT00706446|9705543|FG000|COMPLETED|Overall Study||3
8662394|NCT00706446|9705544|FG001|COMPLETED|Overall Study||8
8662395|NCT00706446|9705545|FG002|COMPLETED|Overall Study||7
8662396|NCT00706446|9705546|FG003|COMPLETED|Overall Study||4
8662397|NCT00706446|9705547|FG004|COMPLETED|Overall Study||10
8662398|NCT00706446|9705548|FG005|COMPLETED|Overall Study||7
8662399|NCT00706446|9705543|FG000|NOT COMPLETED|Overall Study||26
8662400|NCT00706446|9705544|FG001|NOT COMPLETED|Overall Study||49
8662401|NCT00706446|9705545|FG002|NOT COMPLETED|Overall Study||37
8662402|NCT00706446|9705546|FG003|NOT COMPLETED|Overall Study||22
8662403|NCT00706446|9705547|FG004|NOT COMPLETED|Overall Study||44
8662404|NCT00706446|9705548|FG005|NOT COMPLETED|Overall Study||38
8662405|NCT00706485|9705562|FG000|STARTED|Overall Study||5
8662406|NCT00706485|9705562|FG000|COMPLETED|Overall Study||5
8662407|NCT00706485|9705562|FG000|NOT COMPLETED|Overall Study||0
8662408|NCT00706511|9705570|FG000|STARTED|Overall Study||10
8662409|NCT00706511|9705571|FG001|STARTED|Overall Study||4
8662410|NCT00706511|9705572|FG002|STARTED|Overall Study||3
8662411|NCT00706511|9705573|FG003|STARTED|Overall Study||10
8662412|NCT00706511|9705570|FG000|COMPLETED|Overall Study||9
8662413|NCT00706511|9705571|FG001|COMPLETED|Overall Study||4
8662414|NCT00706511|9705572|FG002|COMPLETED|Overall Study||3
8662415|NCT00706511|9705573|FG003|COMPLETED|Overall Study||10
8662416|NCT00706511|9705570|FG000|NOT COMPLETED|Overall Study||1
8662417|NCT00706511|9705571|FG001|NOT COMPLETED|Overall Study||0
8662418|NCT00706511|9705572|FG002|NOT COMPLETED|Overall Study||0
8662419|NCT00706511|9705573|FG003|NOT COMPLETED|Overall Study||0
8662420|NCT00706550|9705583|FG000|STARTED|Overall Study||43
8662421|NCT00706550|9705584|FG001|STARTED|Overall Study||64
8662422|NCT00706550|9705583|FG000|COMPLETED|Overall Study||36
8662423|NCT00706550|9705584|FG001|COMPLETED|Overall Study||36
8662424|NCT00706550|9705583|FG000|NOT COMPLETED|Overall Study||7
8662425|NCT00706550|9705584|FG001|NOT COMPLETED|Overall Study||28
8662426|NCT00706563|9705593|FG000|STARTED|Overall Study||61
8662427|NCT00706563|9705594|FG001|STARTED|Overall Study||59
8662428|NCT00706563|9705593|FG000|COMPLETED|Overall Study||61
8662429|NCT00706563|9705594|FG001|COMPLETED|Overall Study||59
8662430|NCT00706563|9705593|FG000|NOT COMPLETED|Overall Study||0
8662431|NCT00706563|9705594|FG001|NOT COMPLETED|Overall Study||0
8662432|NCT00706589|9705602|FG000|STARTED|Overall Study||32
8662433|NCT00706589|9705603|FG001|STARTED|Overall Study||29
8662434|NCT00706589|9705602|FG000|COMPLETED|Overall Study||29
8662435|NCT00706589|9705603|FG001|COMPLETED|Overall Study||25
8662436|NCT00706589|9705602|FG000|NOT COMPLETED|Overall Study||3
8662437|NCT00706589|9705603|FG001|NOT COMPLETED|Overall Study||4
8662438|NCT00706628|9705613|FG000|STARTED|Overall Study||47
8662439|NCT00706628|9705614|FG001|STARTED|Overall Study||21
8662440|NCT00706628|9705615|FG002|STARTED|Overall Study||16
8662441|NCT00706628|9705616|FG003|STARTED|Overall Study||3
8662442|NCT00706628|9705613|FG000|COMPLETED|Overall Study||0
8662443|NCT00706628|9705614|FG001|COMPLETED|Overall Study||0
8662444|NCT00706628|9705615|FG002|COMPLETED|Overall Study||0
8662445|NCT00706628|9705616|FG003|COMPLETED|Overall Study||0
8662446|NCT00706628|9705613|FG000|NOT COMPLETED|Overall Study||47
8662447|NCT00706628|9705614|FG001|NOT COMPLETED|Overall Study||21
8662448|NCT00706628|9705615|FG002|NOT COMPLETED|Overall Study||16
8662449|NCT00706628|9705616|FG003|NOT COMPLETED|Overall Study||3
8662450|NCT00706641|9705629|FG000|STARTED|Dasatinib Administration||25
8662451|NCT00706641|9705629|FG000|Toxicity Evaluation|Dasatinib Administration||24
8662452|NCT00706641|9705629|FG000|COMPLETED|Dasatinib Administration||23
8662453|NCT00706641|9705629|FG000|NOT COMPLETED|Dasatinib Administration||2
8662454|NCT00706641|9705629|FG000|STARTED|Radical Cystectomy||23
8662455|NCT00706641|9705629|FG000|COMPLETED|Radical Cystectomy||22
8662456|NCT00706641|9705629|FG000|NOT COMPLETED|Radical Cystectomy||1
8662457|NCT00706654|9705636|FG000|STARTED|Conversion Phase||709
8662458|NCT00706654|9705637|FG001|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
8662459|NCT00706654|9705638|FG002|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
8662460|NCT00706654|9705639|FG003|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
8662461|NCT00706654|9705636|FG000|COMPLETED|Conversion Phase||614
8662462|NCT00706654|9705637|FG001|COMPLETED|Conversion Phase||0
8662463|NCT00706654|9705638|FG002|COMPLETED|Conversion Phase||0
8662464|NCT00706654|9705639|FG003|COMPLETED|Conversion Phase||0
8662465|NCT00706654|9705636|FG000|NOT COMPLETED|Conversion Phase||95
8662466|NCT00706654|9705637|FG001|NOT COMPLETED|Conversion Phase||0
8662467|NCT00706654|9705638|FG002|NOT COMPLETED|Conversion Phase||0
8662468|NCT00706654|9705639|FG003|NOT COMPLETED|Conversion Phase||0
8662469|NCT00706654|9705636|FG000|STARTED|Oral Stabilization Phase|228 of the 842 patients who started this phase enrolled directly into this phase of the study.|842
8692309|NCT00859469|9737707|FG000|NOT COMPLETED|Overall Study||28
8662470|NCT00706654|9705637|FG001|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
8662471|NCT00706654|9705638|FG002|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
8662472|NCT00706654|9705639|FG003|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
8662473|NCT00706654|9705636|FG000|COMPLETED|Oral Stabilization Phase||662
8662474|NCT00706654|9705637|FG001|COMPLETED|Oral Stabilization Phase||0
8662475|NCT00706654|9705638|FG002|COMPLETED|Oral Stabilization Phase||0
8662476|NCT00706654|9705639|FG003|COMPLETED|Oral Stabilization Phase||0
8662477|NCT00706654|9705636|FG000|NOT COMPLETED|Oral Stabilization Phase||180
8662478|NCT00706654|9705637|FG001|NOT COMPLETED|Oral Stabilization Phase||0
8662479|NCT00706654|9705638|FG002|NOT COMPLETED|Oral Stabilization Phase||0
8662480|NCT00706654|9705639|FG003|NOT COMPLETED|Oral Stabilization Phase||0
8662481|NCT00706654|9705636|FG000|STARTED|Depot Maintenance Phase|Patients were randomized into the 3 aripiprazole treatment groups in this phase of the study.|0
8662482|NCT00706654|9705637|FG001|STARTED|Depot Maintenance Phase||265
8662483|NCT00706654|9705638|FG002|STARTED|Depot Maintenance Phase||266
8662484|NCT00706654|9705639|FG003|STARTED|Depot Maintenance Phase||131
8662485|NCT00706654|9705636|FG000|COMPLETED|Depot Maintenance Phase||0
8662486|NCT00706654|9705637|FG001|COMPLETED|Depot Maintenance Phase||196
8662487|NCT00706654|9705638|FG002|COMPLETED|Depot Maintenance Phase||178
8662488|NCT00706654|9705639|FG003|COMPLETED|Depot Maintenance Phase||61
8662489|NCT00706654|9705636|FG000|NOT COMPLETED|Depot Maintenance Phase||0
8662490|NCT00706654|9705637|FG001|NOT COMPLETED|Depot Maintenance Phase||69
8662491|NCT00706654|9705638|FG002|NOT COMPLETED|Depot Maintenance Phase||88
8662492|NCT00706654|9705639|FG003|NOT COMPLETED|Depot Maintenance Phase||70
8662493|NCT00706706|9705649|FG000|STARTED|Overall Study||105
8662494|NCT00706706|9705649|FG000|COMPLETED|Overall Study||0
8662495|NCT00706706|9705649|FG000|NOT COMPLETED|Overall Study||105
8662496|NCT00706719|9705656|FG000|STARTED|Overall Study||5
8662497|NCT00706719|9705657|FG001|STARTED|Overall Study||7
8662498|NCT00706719|9705658|FG002|STARTED|Overall Study||5
8662499|NCT00706719|9705656|FG000|COMPLETED|Overall Study||5
8662500|NCT00706719|9705657|FG001|COMPLETED|Overall Study||6
8662501|NCT00706719|9705658|FG002|COMPLETED|Overall Study||1
8662502|NCT00706719|9705656|FG000|NOT COMPLETED|Overall Study||0
8662503|NCT00706719|9705657|FG001|NOT COMPLETED|Overall Study||1
8662504|NCT00706719|9705658|FG002|NOT COMPLETED|Overall Study||4
8662505|NCT00706784|9705667|FG000|STARTED|Overall Study||3
8662506|NCT00706784|9705668|FG001|STARTED|Overall Study||3
8662507|NCT00706784|9705667|FG000|COMPLETED|Overall Study||3
8662508|NCT00706784|9705668|FG001|COMPLETED|Overall Study||3
8662509|NCT00706784|9705667|FG000|NOT COMPLETED|Overall Study||0
8662510|NCT00706784|9705668|FG001|NOT COMPLETED|Overall Study||0
8662511|NCT00706810|9705674|FG000|STARTED|Overall Study||8
8662512|NCT00706810|9705674|FG000|COMPLETED|Overall Study||7
8662513|NCT00706810|9705674|FG000|NOT COMPLETED|Overall Study||1
8662514|NCT00706823|9705681|FG000|STARTED|Overall Study||25
8662515|NCT00706823|9705682|FG001|STARTED|Overall Study||25
8662516|NCT00706823|9705681|FG000|COMPLETED|Overall Study||25
8662517|NCT00706823|9705682|FG001|COMPLETED|Overall Study||25
8662518|NCT00706823|9705681|FG000|NOT COMPLETED|Overall Study||0
8662519|NCT00706823|9705682|FG001|NOT COMPLETED|Overall Study||0
8662520|NCT00706836|9705688|FG000|STARTED|Overall Study||16
8662521|NCT00706836|9705688|FG000|COMPLETED|Overall Study||16
8662522|NCT00706836|9705688|FG000|NOT COMPLETED|Overall Study||0
8662523|NCT00706849|9705698|FG000|STARTED|Treatment Period||41
8662524|NCT00706849|9705699|FG001|STARTED|Treatment Period||83
8662525|NCT00706849|9705698|FG000|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement|41
8662526|NCT00706849|9705699|FG001|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement.|82
8662527|NCT00706849|9705698|FG000|COMPLETED|Treatment Period|38 patients entered the open-label extension study (301012-CS6; NCT00694109).|41
8662528|NCT00706849|9705699|FG001|COMPLETED|Treatment Period|55 patients entered the open-label extension study (301012-CS6; NCT00694109).|73
8662529|NCT00706849|9705698|FG000|NOT COMPLETED|Treatment Period||0
8662530|NCT00706849|9705699|FG001|NOT COMPLETED|Treatment Period||10
8662531|NCT00706849|9705698|FG000|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|3
8662532|NCT00706849|9705699|FG001|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|28
8662533|NCT00706849|9705698|FG000|COMPLETED|Follow-up Period||3
8662534|NCT00706849|9705699|FG001|COMPLETED|Follow-up Period||25
8662535|NCT00706849|9705698|FG000|NOT COMPLETED|Follow-up Period||0
8662536|NCT00706849|9705699|FG001|NOT COMPLETED|Follow-up Period||3
8662537|NCT00706901|9705708|FG000|STARTED|Overall Study||59
8662538|NCT00706901|9705709|FG001|STARTED|Overall Study||62
8662539|NCT00706901|9705710|FG002|STARTED|Overall Study||59
8662540|NCT00706901|9705708|FG000|COMPLETED|Overall Study||51
8662541|NCT00706901|9705709|FG001|COMPLETED|Overall Study||57
8662542|NCT00706901|9705710|FG002|COMPLETED|Overall Study||51
8662543|NCT00706901|9705708|FG000|NOT COMPLETED|Overall Study||8
8662544|NCT00706901|9705709|FG001|NOT COMPLETED|Overall Study||5
8662545|NCT00706901|9705710|FG002|NOT COMPLETED|Overall Study||8
8662546|NCT00706914|9705722|FG000|STARTED|Overall Study||63
8662547|NCT00706914|9705723|FG001|STARTED|Overall Study||62
8662548|NCT00706914|9705724|FG002|STARTED|Overall Study||31
8729941|NCT01056016|9777277|FG000|NOT COMPLETED|Overall Study||2
8662549|NCT00706914|9705722|FG000|COMPLETED|Overall Study||57
8662550|NCT00706914|9705723|FG001|COMPLETED|Overall Study||58
8662551|NCT00706914|9705724|FG002|COMPLETED|Overall Study||30
8662552|NCT00706914|9705722|FG000|NOT COMPLETED|Overall Study||6
8662553|NCT00706914|9705723|FG001|NOT COMPLETED|Overall Study||4
8662554|NCT00706914|9705724|FG002|NOT COMPLETED|Overall Study||1
8662555|NCT00706966|9705732|FG000|STARTED|Overall Study||10
8662556|NCT00706966|9705732|FG000|COMPLETED|Overall Study||9
8662557|NCT00706966|9705732|FG000|NOT COMPLETED|Overall Study||1
8662558|NCT00706979|9705766|FG000|STARTED|Overall Study||426
8662559|NCT00706979|9705767|FG001|STARTED|Overall Study||423
8662560|NCT00706979|9705766|FG000|COMPLETED|Overall Study||426
8662561|NCT00706979|9705767|FG001|COMPLETED|Overall Study||423
8662562|NCT00706979|9705766|FG000|NOT COMPLETED|Overall Study||0
8662563|NCT00706979|9705767|FG001|NOT COMPLETED|Overall Study||0
8662564|NCT00706992|9705780|FG000|STARTED|Overall Study||8
8662565|NCT00706992|9705781|FG001|STARTED|Overall Study||8
8662566|NCT00706992|9705782|FG002|STARTED|Overall Study||9
8729942|NCT01056016|9777278|FG001|NOT COMPLETED|Overall Study||1
8729943|NCT01056107|9777288|FG000|STARTED|Overall Study||11
8729944|NCT01056107|9777289|FG001|STARTED|Overall Study||11
8729945|NCT01056107|9777290|FG002|STARTED|Overall Study||12
8729946|NCT01056107|9777291|FG003|STARTED|Overall Study||12
8729947|NCT01056107|9777288|FG000|COMPLETED|Overall Study||11
8729948|NCT01056107|9777289|FG001|COMPLETED|Overall Study||10
8729949|NCT01056107|9777290|FG002|COMPLETED|Overall Study||9
8729950|NCT01056107|9777291|FG003|COMPLETED|Overall Study||12
8729951|NCT01056107|9777288|FG000|NOT COMPLETED|Overall Study||0
8729952|NCT01056107|9777289|FG001|NOT COMPLETED|Overall Study||1
8729953|NCT01056107|9777290|FG002|NOT COMPLETED|Overall Study||3
8729954|NCT01056107|9777291|FG003|NOT COMPLETED|Overall Study||0
8729955|NCT01056198|9777303|FG000|STARTED|Overall Study||24
8729956|NCT01056198|9777304|FG001|STARTED|Overall Study||24
8729957|NCT01056198|9777303|FG000|COMPLETED|Overall Study||24
8729958|NCT01056198|9777304|FG001|COMPLETED|Overall Study||24
8729959|NCT01056198|9777303|FG000|NOT COMPLETED|Overall Study||0
8729960|NCT01056198|9777304|FG001|NOT COMPLETED|Overall Study||0
8729961|NCT01056263|9777312|FG000|STARTED|Overall Study||52
8729962|NCT01056263|9777312|FG000|COMPLETED|Overall Study||0
8729963|NCT01056263|9777312|FG000|NOT COMPLETED|Overall Study||52
8729964|NCT01056276|9777318|FG000|STARTED|Treatment Period-Cycles 1-8||18
8729965|NCT01056276|9777319|FG001|STARTED|Treatment Period-Cycles 1-8||41
8729966|NCT01056276|9777318|FG000|COMPLETED|Treatment Period-Cycles 1-8||5
8729967|NCT01056276|9777319|FG001|COMPLETED|Treatment Period-Cycles 1-8||33
8729968|NCT01056276|9777318|FG000|NOT COMPLETED|Treatment Period-Cycles 1-8||13
8729969|NCT01056276|9777319|FG001|NOT COMPLETED|Treatment Period-Cycles 1-8||8
8729970|NCT01056276|9777318|FG000|STARTED|Maintenance Therapy|Original regimen did not include maintenance therapy.|0
8729971|NCT01056276|9777319|FG001|STARTED|Maintenance Therapy|5 patients completed 8 cycles but did not have maintenance therapy.|28
8729972|NCT01056276|9777318|FG000|COMPLETED|Maintenance Therapy||0
8729973|NCT01056276|9777319|FG001|COMPLETED|Maintenance Therapy|14 patients are continuing maintenance therapy.|0
8729974|NCT01056276|9777318|FG000|NOT COMPLETED|Maintenance Therapy||0
8729975|NCT01056276|9777319|FG001|NOT COMPLETED|Maintenance Therapy||28
8729976|NCT01056289|9777330|FG000|STARTED|Open-label Phase||480
8729977|NCT01056289|9777331|FG001|STARTED|Open-label Phase||0
8729978|NCT01056289|9777332|FG002|STARTED|Open-label Phase||0
8729979|NCT01056289|9777333|FG003|STARTED|Open-label Phase||0
8729980|NCT01056289|9777330|FG000|COMPLETED|Open-label Phase|Participants transitioned to Double-blind phase|361
8729981|NCT01056289|9777331|FG001|COMPLETED|Open-label Phase||0
8729982|NCT01056289|9777332|FG002|COMPLETED|Open-label Phase||0
8729983|NCT01056289|9777333|FG003|COMPLETED|Open-label Phase||0
8729984|NCT01056289|9777330|FG000|NOT COMPLETED|Open-label Phase||119
8729985|NCT01056289|9777331|FG001|NOT COMPLETED|Open-label Phase||0
8729986|NCT01056289|9777332|FG002|NOT COMPLETED|Open-label Phase||0
8729987|NCT01056289|9777333|FG003|NOT COMPLETED|Open-label Phase||0
8729988|NCT01056289|9777330|FG000|STARTED|Double-blind Phase||0
8729989|NCT01056289|9777331|FG001|STARTED|Double-blind Phase||73
8729990|NCT01056289|9777332|FG002|STARTED|Double-blind Phase||140
8729991|NCT01056289|9777333|FG003|STARTED|Double-blind Phase||148
8729992|NCT01056289|9777330|FG000|COMPLETED|Double-blind Phase||0
8729993|NCT01056289|9777331|FG001|COMPLETED|Double-blind Phase||69
8729994|NCT01056289|9777332|FG002|COMPLETED|Double-blind Phase||127
8729995|NCT01056289|9777333|FG003|COMPLETED|Double-blind Phase||138
8729996|NCT01056289|9777330|FG000|NOT COMPLETED|Double-blind Phase||0
8729997|NCT01056289|9777331|FG001|NOT COMPLETED|Double-blind Phase||4
8662567|NCT00706992|9705783|FG003|STARTED|Overall Study||8
8662568|NCT00706992|9705784|FG004|STARTED|Overall Study||6
8662569|NCT00706992|9705785|FG005|STARTED|Overall Study||5
8662570|NCT00706992|9705786|FG006|STARTED|Overall Study||6
8662571|NCT00706992|9705780|FG000|COMPLETED|Overall Study||3
8662572|NCT00706992|9705781|FG001|COMPLETED|Overall Study||3
8662573|NCT00706992|9705782|FG002|COMPLETED|Overall Study||3
8662574|NCT00706992|9705783|FG003|COMPLETED|Overall Study||6
8662575|NCT00706992|9705784|FG004|COMPLETED|Overall Study||2
8662576|NCT00706992|9705785|FG005|COMPLETED|Overall Study||3
8729998|NCT01056289|9777332|FG002|NOT COMPLETED|Double-blind Phase||13
8729999|NCT01056289|9777333|FG003|NOT COMPLETED|Double-blind Phase||10
8730000|NCT01056302|9777343|FG000|STARTED|Overall Study||3
8806641|NCT01479270|9858934|FG001|NOT COMPLETED|Overall Study||0
8806642|NCT01479348|9858943|FG000|STARTED|Overall Study||5
8662577|NCT00706992|9705786|FG006|COMPLETED|Overall Study||3
8662578|NCT00706992|9705780|FG000|NOT COMPLETED|Overall Study||5
8662579|NCT00706992|9705781|FG001|NOT COMPLETED|Overall Study||5
8662580|NCT00706992|9705782|FG002|NOT COMPLETED|Overall Study||6
8662581|NCT00706992|9705783|FG003|NOT COMPLETED|Overall Study||2
8662582|NCT00706992|9705784|FG004|NOT COMPLETED|Overall Study||4
8662583|NCT00706992|9705785|FG005|NOT COMPLETED|Overall Study||2
8662584|NCT00706992|9705786|FG006|NOT COMPLETED|Overall Study||3
8662585|NCT00707031|9705805|FG000|STARTED|Overall Study|Randomized|320
8662586|NCT00707031|9705806|FG001|STARTED|Overall Study||319
8662587|NCT00707031|9705805|FG000|Treated/Safety Population|Overall Study|All patients who received at least 1 dose, regardless of amount of treatment administered.|318
8662588|NCT00707031|9705806|FG001|Treated/Safety Population|Overall Study||316
8662589|NCT00707031|9705805|FG000|Modified Intent-to-Treat Population|Overall Study|All patients who received at least 1 dose;had baseline;at least 1 post-baseline efficacy assessment.|315
8662590|NCT00707031|9705806|FG001|Modified Intent-to-Treat Population|Overall Study||315
8662591|NCT00707031|9705805|FG000|COMPLETED|Overall Study||216
8662592|NCT00707031|9705806|FG001|COMPLETED|Overall Study||220
8662593|NCT00707031|9705805|FG000|NOT COMPLETED|Overall Study||104
8662594|NCT00707031|9705806|FG001|NOT COMPLETED|Overall Study||99
8662595|NCT00707057|9705815|FG000|STARTED|Overall Study||169
8662596|NCT00707057|9705816|FG001|STARTED|Overall Study||87
8662597|NCT00707057|9705815|FG000|COMPLETED|Overall Study||161
8662598|NCT00707057|9705816|FG001|COMPLETED|Overall Study||83
8662599|NCT00707057|9705815|FG000|NOT COMPLETED|Overall Study||8
8662600|NCT00707057|9705816|FG001|NOT COMPLETED|Overall Study||4
8662601|NCT00707174|9705824|FG000|STARTED|Overall Study||46
8662602|NCT00707174|9705825|FG001|STARTED|Overall Study||44
8662603|NCT00707174|9705824|FG000|COMPLETED|Overall Study||41
8662604|NCT00707174|9705825|FG001|COMPLETED|Overall Study||37
8662605|NCT00707174|9705824|FG000|NOT COMPLETED|Overall Study||5
8662606|NCT00707174|9705825|FG001|NOT COMPLETED|Overall Study||7
8662607|NCT00707239|9705834|FG000|STARTED|Overall Study||37
8662608|NCT00707239|9705835|FG001|STARTED|Overall Study||36
8662609|NCT00707239|9705836|FG002|STARTED|Overall Study||35
8662610|NCT00707239|9705834|FG000|Treated|Overall Study||36
8662611|NCT00707239|9705835|FG001|Treated|Overall Study||35
8662612|NCT00707239|9705836|FG002|Treated|Overall Study||34
8662613|NCT00707239|9705834|FG000|COMPLETED|Overall Study||18
8662614|NCT00707239|9705835|FG001|COMPLETED|Overall Study||25
8662615|NCT00707239|9705836|FG002|COMPLETED|Overall Study||21
8662616|NCT00707239|9705834|FG000|NOT COMPLETED|Overall Study||19
8662617|NCT00707239|9705835|FG001|NOT COMPLETED|Overall Study||11
8662618|NCT00707239|9705836|FG002|NOT COMPLETED|Overall Study||14
8662619|NCT00707343|9705847|FG000|STARTED|Overall Study||15
8662620|NCT00707343|9705847|FG000|COMPLETED|Overall Study||15
8662621|NCT00707343|9705847|FG000|NOT COMPLETED|Overall Study||0
8662622|NCT00707447|9705853|FG000|STARTED|Overall Study||89
8662623|NCT00707447|9705854|FG001|STARTED|Overall Study||93
8662624|NCT00707447|9705853|FG000|COMPLETED|Overall Study||81
8662625|NCT00707447|9705854|FG001|COMPLETED|Overall Study||85
8662626|NCT00707447|9705853|FG000|NOT COMPLETED|Overall Study||8
8662627|NCT00707447|9705854|FG001|NOT COMPLETED|Overall Study||8
8662628|NCT00707486|9705860|FG000|STARTED|Overall Study||72
8662629|NCT00707486|9705860|FG000|COMPLETED|Overall Study||71
8662630|NCT00707486|9705860|FG000|NOT COMPLETED|Overall Study||1
8662631|NCT00707577|9705868|FG000|STARTED|Overall Study||174
8662632|NCT00707577|9705869|FG001|STARTED|Overall Study||156
8662633|NCT00707577|9705868|FG000|COMPLETED|Overall Study||120
8662634|NCT00707577|9705869|FG001|COMPLETED|Overall Study||118
8662635|NCT00707577|9705868|FG000|NOT COMPLETED|Overall Study||54
8662636|NCT00707577|9705869|FG001|NOT COMPLETED|Overall Study||38
8662637|NCT00707655|9705877|FG000|STARTED|Overall Study||3
8662638|NCT00707655|9705878|FG001|STARTED|Overall Study||5
8662639|NCT00707655|9705877|FG000|COMPLETED|Overall Study||3
8662640|NCT00707655|9705878|FG001|COMPLETED|Overall Study||3
8662641|NCT00707655|9705877|FG000|NOT COMPLETED|Overall Study||0
8662642|NCT00707655|9705878|FG001|NOT COMPLETED|Overall Study||2
8662643|NCT00707746|9705888|FG000|STARTED|Treatment Period||12
8662644|NCT00707746|9705889|FG001|STARTED|Treatment Period||22
8662645|NCT00707746|9705888|FG000|Full Analysis Set (FAS) and Safety Set|Treatment Period|FAS: Treated patients with a valid baseline & post-baseline LDL-C measurement|12
8662646|NCT00707746|9705889|FG001|Full Analysis Set (FAS) and Safety Set|Treatment Period|FAS: Treated patients with a valid baseline & post-baseline LDL-C measurement|21
8662647|NCT00707746|9705888|FG000|COMPLETED|Treatment Period||10
8662648|NCT00707746|9705889|FG001|COMPLETED|Treatment Period||17
8662649|NCT00707746|9705888|FG000|NOT COMPLETED|Treatment Period||2
8662650|NCT00707746|9705889|FG001|NOT COMPLETED|Treatment Period||5
8662651|NCT00707746|9705888|FG000|STARTED|Follow-up Period||12
8662652|NCT00707746|9705889|FG001|STARTED|Follow-up Period||21
8662653|NCT00707746|9705888|FG000|COMPLETED|Follow-up Period||12
8662654|NCT00707746|9705889|FG001|COMPLETED|Follow-up Period||21
8662655|NCT00707746|9705888|FG000|NOT COMPLETED|Follow-up Period||0
8662656|NCT00707746|9705889|FG001|NOT COMPLETED|Follow-up Period||0
8662657|NCT00707759|9705897|FG000|STARTED|Overall Study||14
8662658|NCT00707759|9705898|FG001|STARTED|Overall Study||14
8662659|NCT00707759|9705897|FG000|COMPLETED|Overall Study||12
8662660|NCT00707759|9705898|FG001|COMPLETED|Overall Study||12
8662661|NCT00707759|9705897|FG000|NOT COMPLETED|Overall Study||2
8662662|NCT00707759|9705898|FG001|NOT COMPLETED|Overall Study||2
8662663|NCT00707863|9705906|FG000|STARTED|Overall Study||6
8662664|NCT00707863|9705907|FG001|STARTED|Overall Study||11
8662665|NCT00707863|9705906|FG000|COMPLETED|Overall Study||6
8662666|NCT00707863|9705907|FG001|COMPLETED|Overall Study||8
8662667|NCT00707863|9705906|FG000|NOT COMPLETED|Overall Study||0
8662668|NCT00707863|9705907|FG001|NOT COMPLETED|Overall Study||3
8662669|NCT00707915|9705913|FG000|STARTED|Overall Study||30
8662670|NCT00707915|9705913|FG000|Effects of Discontinuing Benzodiazepine|Overall Study||30
8662671|NCT00707915|9705913|FG000|COMPLETED|Overall Study||30
8662672|NCT00707915|9705913|FG000|NOT COMPLETED|Overall Study||0
8662673|NCT00707954|9705922|FG000|STARTED|Overall Study||12
8662674|NCT00707954|9705923|FG001|STARTED|Overall Study||12
8662675|NCT00707954|9705924|FG002|STARTED|Overall Study||14
8662676|NCT00707954|9705925|FG003|STARTED|Overall Study||13
8662677|NCT00707954|9705926|FG004|STARTED|Overall Study||10
8662678|NCT00707954|9705922|FG000|COMPLETED|Overall Study||12
8662679|NCT00707954|9705923|FG001|COMPLETED|Overall Study||12
8662680|NCT00707954|9705924|FG002|COMPLETED|Overall Study||14
8662681|NCT00707954|9705925|FG003|COMPLETED|Overall Study||13
8662682|NCT00707954|9705926|FG004|COMPLETED|Overall Study||9
8662683|NCT00707954|9705922|FG000|NOT COMPLETED|Overall Study||0
8662684|NCT00707954|9705923|FG001|NOT COMPLETED|Overall Study||0
8662685|NCT00707954|9705924|FG002|NOT COMPLETED|Overall Study||0
8662686|NCT00707954|9705925|FG003|NOT COMPLETED|Overall Study||0
8662687|NCT00707954|9705926|FG004|NOT COMPLETED|Overall Study||1
8662688|NCT00707967|9705941|FG000|STARTED|Overall Study||22
8662689|NCT00707967|9705942|FG001|STARTED|Overall Study||8
8662690|NCT00707967|9705943|FG002|STARTED|Overall Study||7
8662691|NCT00707967|9705941|FG000|COMPLETED|Overall Study||22
8662692|NCT00707967|9705942|FG001|COMPLETED|Overall Study||8
8662693|NCT00707967|9705943|FG002|COMPLETED|Overall Study||7
8662694|NCT00707967|9705941|FG000|NOT COMPLETED|Overall Study||0
8662695|NCT00707967|9705942|FG001|NOT COMPLETED|Overall Study||0
8662696|NCT00707967|9705943|FG002|NOT COMPLETED|Overall Study||0
8662697|NCT00707980|9705951|FG000|STARTED|Overall Study||836
8662698|NCT00707980|9705951|FG000|Received Treatment|Overall Study||834
8662699|NCT00707980|9705951|FG000|COMPLETED|Overall Study||526
8662700|NCT00707980|9705951|FG000|NOT COMPLETED|Overall Study||310
8662701|NCT00707993|9705957|FG000|STARTED|Overall Study||222
8662702|NCT00707993|9705958|FG001|STARTED|Overall Study||219
8662703|NCT00707993|9705957|FG000|COMPLETED|Overall Study||133
8662704|NCT00707993|9705958|FG001|COMPLETED|Overall Study||125
8662705|NCT00707993|9705957|FG000|NOT COMPLETED|Overall Study||89
8662706|NCT00707993|9705958|FG001|NOT COMPLETED|Overall Study||94
8662707|NCT00708019|9705966|FG000|STARTED|Overall Study||92
8662708|NCT00708019|9705967|FG001|STARTED|Overall Study||93
8662709|NCT00708019|9705966|FG000|COMPLETED|Overall Study||77
8662710|NCT00708019|9705967|FG001|COMPLETED|Overall Study||78
8662711|NCT00708019|9705966|FG000|NOT COMPLETED|Overall Study||15
8662712|NCT00708019|9705967|FG001|NOT COMPLETED|Overall Study||15
8662713|NCT00708032|9705975|FG000|STARTED|Overall Study||36
8662714|NCT00708032|9705976|FG001|STARTED|Overall Study||38
8662715|NCT00708032|9705975|FG000|COMPLETED|Overall Study||26
8662716|NCT00708032|9705976|FG001|COMPLETED|Overall Study||22
8662717|NCT00708032|9705975|FG000|NOT COMPLETED|Overall Study||10
8662718|NCT00708032|9705976|FG001|NOT COMPLETED|Overall Study||16
8662719|NCT00708071|9705982|FG000|STARTED|Overall Study|Randomized and treated|45
8662720|NCT00708071|9705982|FG000|COMPLETED|Overall Study||45
8662721|NCT00708071|9705982|FG000|NOT COMPLETED|Overall Study||0
8662722|NCT00708097|9706016|FG000|STARTED|Period 1||11
8662723|NCT00708097|9706017|FG001|STARTED|Period 1||12
8662724|NCT00708097|9706018|FG002|STARTED|Period 1||12
8662725|NCT00708097|9706019|FG003|STARTED|Period 1||11
8662726|NCT00708097|9706020|FG004|STARTED|Period 1||11
8662727|NCT00708097|9706016|FG000|COMPLETED|Period 1||11
8662728|NCT00708097|9706017|FG001|COMPLETED|Period 1||11
8662729|NCT00708097|9706018|FG002|COMPLETED|Period 1||12
8662730|NCT00708097|9706019|FG003|COMPLETED|Period 1||9
8662731|NCT00708097|9706020|FG004|COMPLETED|Period 1||10
8662732|NCT00708097|9706016|FG000|NOT COMPLETED|Period 1||0
8662733|NCT00708097|9706017|FG001|NOT COMPLETED|Period 1||1
8662734|NCT00708097|9706018|FG002|NOT COMPLETED|Period 1||0
8662735|NCT00708097|9706019|FG003|NOT COMPLETED|Period 1||2
8662736|NCT00708097|9706020|FG004|NOT COMPLETED|Period 1||1
8662737|NCT00708097|9706016|FG000|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|10
8662738|NCT00708097|9706017|FG001|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|12
8662739|NCT00708097|9706018|FG002|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|10
8662740|NCT00708097|9706019|FG003|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|11
8662741|NCT00708097|9706020|FG004|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|10
8662742|NCT00708097|9706016|FG000|COMPLETED|Period 2||10
8662743|NCT00708097|9706017|FG001|COMPLETED|Period 2||11
8662744|NCT00708097|9706018|FG002|COMPLETED|Period 2||9
8662745|NCT00708097|9706019|FG003|COMPLETED|Period 2||10
8662746|NCT00708097|9706020|FG004|COMPLETED|Period 2||10
8662747|NCT00708097|9706016|FG000|NOT COMPLETED|Period 2||0
8662748|NCT00708097|9706017|FG001|NOT COMPLETED|Period 2||1
8662749|NCT00708097|9706018|FG002|NOT COMPLETED|Period 2||1
8662750|NCT00708097|9706019|FG003|NOT COMPLETED|Period 2||1
8662751|NCT00708097|9706020|FG004|NOT COMPLETED|Period 2||0
8662752|NCT00708097|9706016|FG000|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|9
8662753|NCT00708097|9706017|FG001|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|11
8662754|NCT00708097|9706018|FG002|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|10
8662755|NCT00708097|9706019|FG003|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|10
8662756|NCT00708097|9706020|FG004|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|10
8662757|NCT00708097|9706016|FG000|COMPLETED|Period 3||9
8662758|NCT00708097|9706017|FG001|COMPLETED|Period 3||11
8662759|NCT00708097|9706018|FG002|COMPLETED|Period 3||10
8662760|NCT00708097|9706019|FG003|COMPLETED|Period 3||10
8662761|NCT00708097|9706020|FG004|COMPLETED|Period 3||10
8662762|NCT00708097|9706016|FG000|NOT COMPLETED|Period 3||0
8662763|NCT00708097|9706017|FG001|NOT COMPLETED|Period 3||0
8662764|NCT00708097|9706018|FG002|NOT COMPLETED|Period 3||0
8662765|NCT00708097|9706019|FG003|NOT COMPLETED|Period 3||0
8662766|NCT00708097|9706020|FG004|NOT COMPLETED|Period 3||0
8662767|NCT00708097|9706016|FG000|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|12
8662768|NCT00708097|9706017|FG001|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|9
8662769|NCT00708097|9706018|FG002|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|10
8662770|NCT00708097|9706019|FG003|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|11
8662771|NCT00708097|9706020|FG004|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|8
8662772|NCT00708097|9706016|FG000|COMPLETED|Period 4||12
8662773|NCT00708097|9706017|FG001|COMPLETED|Period 4||9
8662774|NCT00708097|9706018|FG002|COMPLETED|Period 4||10
8662775|NCT00708097|9706019|FG003|COMPLETED|Period 4||11
8662776|NCT00708097|9706020|FG004|COMPLETED|Period 4||8
8662777|NCT00708097|9706016|FG000|NOT COMPLETED|Period 4||0
8662778|NCT00708097|9706017|FG001|NOT COMPLETED|Period 4||0
8662779|NCT00708097|9706018|FG002|NOT COMPLETED|Period 4||0
8662780|NCT00708097|9706019|FG003|NOT COMPLETED|Period 4||0
8662781|NCT00708097|9706020|FG004|NOT COMPLETED|Period 4||0
8662782|NCT00708097|9706016|FG000|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|8
8662783|NCT00708097|9706017|FG001|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|9
8662784|NCT00708097|9706018|FG002|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|11
8662785|NCT00708097|9706019|FG003|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|10
8662786|NCT00708097|9706020|FG004|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|12
8662787|NCT00708097|9706016|FG000|COMPLETED|Period 5||8
8662788|NCT00708097|9706017|FG001|COMPLETED|Period 5||9
8662789|NCT00708097|9706018|FG002|COMPLETED|Period 5||11
8662790|NCT00708097|9706019|FG003|COMPLETED|Period 5||10
8662791|NCT00708097|9706020|FG004|COMPLETED|Period 5||12
8662792|NCT00708097|9706016|FG000|NOT COMPLETED|Period 5||0
8662793|NCT00708097|9706017|FG001|NOT COMPLETED|Period 5||0
8662794|NCT00708097|9706018|FG002|NOT COMPLETED|Period 5||0
8662795|NCT00708097|9706019|FG003|NOT COMPLETED|Period 5||0
8662796|NCT00708097|9706020|FG004|NOT COMPLETED|Period 5||0
8662797|NCT00708110|9706041|FG000|STARTED|Overall Study||7
8662798|NCT00708110|9706042|FG001|STARTED|Overall Study||9
8662799|NCT00708110|9706043|FG002|STARTED|Overall Study||9
8662800|NCT00708110|9706044|FG003|STARTED|Overall Study||10
8662801|NCT00708110|9706041|FG000|COMPLETED|Overall Study||7
8662802|NCT00708110|9706042|FG001|COMPLETED|Overall Study||9
8662803|NCT00708110|9706043|FG002|COMPLETED|Overall Study||9
8662804|NCT00708110|9706044|FG003|COMPLETED|Overall Study||10
8662805|NCT00708110|9706041|FG000|NOT COMPLETED|Overall Study||0
8662806|NCT00708110|9706042|FG001|NOT COMPLETED|Overall Study||0
8662807|NCT00708110|9706043|FG002|NOT COMPLETED|Overall Study||0
8662808|NCT00708110|9706044|FG003|NOT COMPLETED|Overall Study||0
8662809|NCT00708123|9706054|FG000|STARTED|Period 1||12
8662810|NCT00708123|9706055|FG001|STARTED|Period 1||12
8662811|NCT00708123|9706056|FG002|STARTED|Period 1||12
8662812|NCT00708123|9706057|FG003|STARTED|Period 1||12
8662813|NCT00708123|9706058|FG004|STARTED|Period 1||12
8662814|NCT00708123|9706054|FG000|COMPLETED|Period 1||12
8662815|NCT00708123|9706055|FG001|COMPLETED|Period 1||11
8662816|NCT00708123|9706056|FG002|COMPLETED|Period 1||11
8662817|NCT00708123|9706057|FG003|COMPLETED|Period 1||11
8662818|NCT00708123|9706058|FG004|COMPLETED|Period 1||12
8662819|NCT00708123|9706054|FG000|NOT COMPLETED|Period 1||0
8662820|NCT00708123|9706055|FG001|NOT COMPLETED|Period 1||1
8806643|NCT01479348|9858944|FG001|STARTED|Overall Study||0
8662821|NCT00708123|9706056|FG002|NOT COMPLETED|Period 1||1
8662822|NCT00708123|9706057|FG003|NOT COMPLETED|Period 1||1
8662823|NCT00708123|9706058|FG004|NOT COMPLETED|Period 1||0
8662824|NCT00708123|9706054|FG000|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|11
8692310|NCT00859495|9737711|FG000|STARTED|Overall Study||9
8692311|NCT00859495|9737711|FG000|COMPLETED|Overall Study||9
8662825|NCT00708123|9706055|FG001|STARTED|Period 2|Due to crossover design,different set of participants received this treatment compared to Period 1|12
8662826|NCT00708123|9706056|FG002|STARTED|Period 2|Due to crossover design,different set of participants received this treatment compared to Period 1|12
8662827|NCT00708123|9706057|FG003|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|11
8662828|NCT00708123|9706058|FG004|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|11
8662829|NCT00708123|9706054|FG000|COMPLETED|Period 2||10
8662830|NCT00708123|9706055|FG001|COMPLETED|Period 2||12
8662831|NCT00708123|9706056|FG002|COMPLETED|Period 2||12
8662832|NCT00708123|9706057|FG003|COMPLETED|Period 2||10
8662833|NCT00708123|9706058|FG004|COMPLETED|Period 2||11
8662834|NCT00708123|9706054|FG000|NOT COMPLETED|Period 2||1
8662835|NCT00708123|9706055|FG001|NOT COMPLETED|Period 2||0
8662836|NCT00708123|9706056|FG002|NOT COMPLETED|Period 2||0
8662837|NCT00708123|9706057|FG003|NOT COMPLETED|Period 2||1
8662838|NCT00708123|9706058|FG004|NOT COMPLETED|Period 2||0
8662839|NCT00708123|9706054|FG000|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|12
8662840|NCT00708123|9706055|FG001|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|10
8662841|NCT00708123|9706056|FG002|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|11
8662842|NCT00708123|9706057|FG003|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|12
8662843|NCT00708123|9706058|FG004|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|10
8662844|NCT00708123|9706054|FG000|COMPLETED|Period 3||12
8662845|NCT00708123|9706055|FG001|COMPLETED|Period 3||10
8662846|NCT00708123|9706056|FG002|COMPLETED|Period 3||10
8662847|NCT00708123|9706057|FG003|COMPLETED|Period 3||11
8662848|NCT00708123|9706058|FG004|COMPLETED|Period 3||10
8662849|NCT00708123|9706054|FG000|NOT COMPLETED|Period 3||0
8662850|NCT00708123|9706055|FG001|NOT COMPLETED|Period 3||0
8662851|NCT00708123|9706056|FG002|NOT COMPLETED|Period 3||1
8662852|NCT00708123|9706057|FG003|NOT COMPLETED|Period 3||1
8662853|NCT00708123|9706058|FG004|NOT COMPLETED|Period 3||0
8662854|NCT00708123|9706054|FG000|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|10
8662855|NCT00708123|9706055|FG001|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|12
8662856|NCT00708123|9706056|FG002|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|10
8662857|NCT00708123|9706057|FG003|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|10
8662858|NCT00708123|9706058|FG004|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|11
8662859|NCT00708123|9706054|FG000|COMPLETED|Period 4||10
8662860|NCT00708123|9706055|FG001|COMPLETED|Period 4||11
8662861|NCT00708123|9706056|FG002|COMPLETED|Period 4||10
8662862|NCT00708123|9706057|FG003|COMPLETED|Period 4||10
8662863|NCT00708123|9706058|FG004|COMPLETED|Period 4||11
8662864|NCT00708123|9706054|FG000|NOT COMPLETED|Period 4||0
8662865|NCT00708123|9706055|FG001|NOT COMPLETED|Period 4||1
8662866|NCT00708123|9706056|FG002|NOT COMPLETED|Period 4||0
8662867|NCT00708123|9706057|FG003|NOT COMPLETED|Period 4||0
8662868|NCT00708123|9706058|FG004|NOT COMPLETED|Period 4||0
8662869|NCT00708123|9706054|FG000|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|10
8662870|NCT00708123|9706055|FG001|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|10
8662871|NCT00708123|9706056|FG002|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|11
8662872|NCT00708123|9706057|FG003|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|11
8662873|NCT00708123|9706058|FG004|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|10
8662874|NCT00708123|9706054|FG000|COMPLETED|Period 5||10
8662875|NCT00708123|9706055|FG001|COMPLETED|Period 5||10
8662876|NCT00708123|9706056|FG002|COMPLETED|Period 5||11
8662877|NCT00708123|9706057|FG003|COMPLETED|Period 5||11
8662878|NCT00708123|9706058|FG004|COMPLETED|Period 5||10
8662879|NCT00708123|9706054|FG000|NOT COMPLETED|Period 5||0
8662880|NCT00708123|9706055|FG001|NOT COMPLETED|Period 5||0
8662881|NCT00708123|9706056|FG002|NOT COMPLETED|Period 5||0
8662882|NCT00708123|9706057|FG003|NOT COMPLETED|Period 5||0
8662883|NCT00708123|9706058|FG004|NOT COMPLETED|Period 5||0
8662884|NCT00708162|9706076|FG000|STARTED|Randomized Phase||361
8662885|NCT00708162|9706077|FG001|STARTED|Randomized Phase||363
8662886|NCT00708162|9706076|FG000|Randomized and Treated|Randomized Phase||354
8662887|NCT00708162|9706077|FG001|Randomized and Treated|Randomized Phase||358
8662888|NCT00708162|9706076|FG000|COMPLETED|Randomized Phase||205
8662889|NCT00708162|9706077|FG001|COMPLETED|Randomized Phase||209
8662890|NCT00708162|9706076|FG000|NOT COMPLETED|Randomized Phase||156
8662891|NCT00708162|9706077|FG001|NOT COMPLETED|Randomized Phase||154
8662892|NCT00708162|9706076|FG000|STARTED|Open-Label Phase|9 participants completing the Randomized Phase did not continue to the Open-Label Phase.|196
8662893|NCT00708162|9706077|FG001|STARTED|Open-Label Phase|58 participants completing the Randomized Phase did not continue to the Open-Label Phase.|151
8662894|NCT00708162|9706076|FG000|COMPLETED|Open-Label Phase||152
8806644|NCT01479348|9858943|FG000|COMPLETED|Overall Study||5
8662895|NCT00708162|9706077|FG001|COMPLETED|Open-Label Phase||121
8662896|NCT00708162|9706076|FG000|NOT COMPLETED|Open-Label Phase||44
8662897|NCT00708162|9706077|FG001|NOT COMPLETED|Open-Label Phase||30
8662898|NCT00708175|9706086|FG000|STARTED|Overall Study||78
8662899|NCT00708175|9706087|FG001|STARTED|Overall Study||78
8662900|NCT00708175|9706086|FG000|COMPLETED|Overall Study||60
8662901|NCT00708175|9706087|FG001|COMPLETED|Overall Study||57
8662902|NCT00708175|9706086|FG000|NOT COMPLETED|Overall Study||18
8662903|NCT00708175|9706087|FG001|NOT COMPLETED|Overall Study||21
8662904|NCT00708201|9706095|FG000|STARTED|Overall Study||137
8662905|NCT00708201|9706096|FG001|STARTED|Overall Study||143
8662906|NCT00708201|9706095|FG000|Received at Least 1 Dose of Study Drug|Overall Study||130
8662907|NCT00708201|9706096|FG001|Received at Least 1 Dose of Study Drug|Overall Study||137
8662908|NCT00708201|9706095|FG000|COMPLETED|Overall Study||130
8662909|NCT00708201|9706096|FG001|COMPLETED|Overall Study||137
8662910|NCT00708201|9706095|FG000|NOT COMPLETED|Overall Study||7
8662911|NCT00708201|9706096|FG001|NOT COMPLETED|Overall Study||6
8662912|NCT00708214|9706105|FG000|STARTED|Overall Study||7
8662913|NCT00708214|9706106|FG001|STARTED|Overall Study||13
8662914|NCT00708214|9706107|FG002|STARTED|Overall Study||8
8662915|NCT00708214|9706105|FG000|COMPLETED|Overall Study|On treatment at analysis cut-off date (04 Jan 2010)|0
8662916|NCT00708214|9706106|FG001|COMPLETED|Overall Study|On treatment at analysis cut-off date (04 Jan 2010)|0
8662917|NCT00708214|9706107|FG002|COMPLETED|Overall Study|On treatment at analysis cut-off date (04 Jan 2010)|0
8662918|NCT00708214|9706105|FG000|NOT COMPLETED|Overall Study||7
8662919|NCT00708214|9706106|FG001|NOT COMPLETED|Overall Study||13
8662920|NCT00708214|9706107|FG002|NOT COMPLETED|Overall Study||8
8662921|NCT00708227|9706124|FG000|STARTED|Overall Study||19
8662922|NCT00708227|9706125|FG001|STARTED|Overall Study||26
8662923|NCT00708227|9706126|FG002|STARTED|Overall Study||18
8662924|NCT00708227|9706127|FG003|STARTED|Overall Study||25
8662925|NCT00708227|9706124|FG000|COMPLETED|Overall Study||18
8662926|NCT00708227|9706125|FG001|COMPLETED|Overall Study||21
8662927|NCT00708227|9706126|FG002|COMPLETED|Overall Study||17
8662928|NCT00708227|9706127|FG003|COMPLETED|Overall Study||22
8662929|NCT00708227|9706124|FG000|NOT COMPLETED|Overall Study||1
8662930|NCT00708227|9706125|FG001|NOT COMPLETED|Overall Study||5
8662931|NCT00708227|9706126|FG002|NOT COMPLETED|Overall Study||1
8662932|NCT00708227|9706127|FG003|NOT COMPLETED|Overall Study||3
8662933|NCT00708305|9706157|FG000|STARTED|Period 1||16
8662934|NCT00708305|9706158|FG001|STARTED|Period 1||16
8662935|NCT00708305|9706159|FG002|STARTED|Period 1||17
8662936|NCT00708305|9706160|FG003|STARTED|Period 1||16
8662937|NCT00708305|9706157|FG000|COMPLETED|Period 1||15
8662938|NCT00708305|9706158|FG001|COMPLETED|Period 1||16
8662939|NCT00708305|9706159|FG002|COMPLETED|Period 1||16
8662940|NCT00708305|9706160|FG003|COMPLETED|Period 1||14
8662941|NCT00708305|9706157|FG000|NOT COMPLETED|Period 1||1
8662942|NCT00708305|9706158|FG001|NOT COMPLETED|Period 1||0
8662943|NCT00708305|9706159|FG002|NOT COMPLETED|Period 1||1
8662944|NCT00708305|9706160|FG003|NOT COMPLETED|Period 1||2
8662945|NCT00708305|9706157|FG000|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|15
8662946|NCT00708305|9706158|FG001|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|15
8662947|NCT00708305|9706159|FG002|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|16
8662948|NCT00708305|9706160|FG003|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|15
8662949|NCT00708305|9706157|FG000|COMPLETED|Period 2||14
8662950|NCT00708305|9706158|FG001|COMPLETED|Period 2||13
8662951|NCT00708305|9706159|FG002|COMPLETED|Period 2||16
8662952|NCT00708305|9706160|FG003|COMPLETED|Period 2||14
8662953|NCT00708305|9706157|FG000|NOT COMPLETED|Period 2||1
8662954|NCT00708305|9706158|FG001|NOT COMPLETED|Period 2||2
8662955|NCT00708305|9706159|FG002|NOT COMPLETED|Period 2||0
8662956|NCT00708305|9706160|FG003|NOT COMPLETED|Period 2||1
8662957|NCT00708305|9706157|FG000|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|15
8662958|NCT00708305|9706158|FG001|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|14
8662959|NCT00708305|9706159|FG002|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|14
8662960|NCT00708305|9706160|FG003|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|14
8662961|NCT00708305|9706157|FG000|COMPLETED|Period 3||14
8662962|NCT00708305|9706158|FG001|COMPLETED|Period 3||12
8662963|NCT00708305|9706159|FG002|COMPLETED|Period 3||14
8662964|NCT00708305|9706160|FG003|COMPLETED|Period 3||14
8662965|NCT00708305|9706157|FG000|NOT COMPLETED|Period 3||1
8662966|NCT00708305|9706158|FG001|NOT COMPLETED|Period 3||2
8662967|NCT00708305|9706159|FG002|NOT COMPLETED|Period 3||0
8662968|NCT00708305|9706160|FG003|NOT COMPLETED|Period 3||0
8662969|NCT00708305|9706157|FG000|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|12
8662970|NCT00708305|9706158|FG001|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|14
8662971|NCT00708305|9706159|FG002|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|14
8662972|NCT00708305|9706160|FG003|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|14
8662973|NCT00708305|9706157|FG000|COMPLETED|Period 4||12
8662974|NCT00708305|9706158|FG001|COMPLETED|Period 4||14
8662975|NCT00708305|9706159|FG002|COMPLETED|Period 4||14
8662976|NCT00708305|9706160|FG003|COMPLETED|Period 4||14
8662977|NCT00708305|9706157|FG000|NOT COMPLETED|Period 4||0
8662978|NCT00708305|9706158|FG001|NOT COMPLETED|Period 4||0
8662979|NCT00708305|9706159|FG002|NOT COMPLETED|Period 4||0
8662980|NCT00708305|9706160|FG003|NOT COMPLETED|Period 4||0
8662981|NCT00708422|9706175|FG000|STARTED|Overall Study||116
8662982|NCT00708422|9706176|FG001|STARTED|Overall Study||115
8662983|NCT00708422|9706175|FG000|COMPLETED|Overall Study||112
8662984|NCT00708422|9706176|FG001|COMPLETED|Overall Study||114
8662985|NCT00708422|9706175|FG000|NOT COMPLETED|Overall Study||4
8662986|NCT00708422|9706176|FG001|NOT COMPLETED|Overall Study||1
8662987|NCT00708435|9706184|FG000|STARTED|Overall Study||107
8662988|NCT00708435|9706185|FG001|STARTED|Overall Study||109
8662989|NCT00708435|9706184|FG000|COMPLETED|Overall Study|These data are 'on-study' results collected up to the subject's Day 45 visit.|82
8662990|NCT00708435|9706185|FG001|COMPLETED|Overall Study|These data are 'on-study' results collected up to the subject's Day 45 visit.|92
8662991|NCT00708435|9706184|FG000|NOT COMPLETED|Overall Study||25
8662992|NCT00708435|9706185|FG001|NOT COMPLETED|Overall Study||17
8662993|NCT00708461|9706195|FG000|STARTED|Overall Study||752
8662994|NCT00708461|9706196|FG001|STARTED|Overall Study||995
8662995|NCT00708461|9706195|FG000|COMPLETED|Overall Study||611
8662996|NCT00708461|9706196|FG001|COMPLETED|Overall Study||795
8662997|NCT00708461|9706195|FG000|NOT COMPLETED|Overall Study||141
8662998|NCT00708461|9706196|FG001|NOT COMPLETED|Overall Study||200
8662999|NCT00708500|9706205|FG000|STARTED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||80
8663000|NCT00708500|9706206|FG001|STARTED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||162
8663001|NCT00708500|9706207|FG002|STARTED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||162
8663002|NCT00708500|9706205|FG000|Treated With PEG2b + RBV|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||80
8663003|NCT00708500|9706206|FG001|Treated With PEG2b + RBV|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||162
8663004|NCT00708500|9706207|FG002|Treated With PEG2b + RBV|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||161
8663005|NCT00708500|9706205|FG000|COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||78
8663006|NCT00708500|9706206|FG001|COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||156
8663007|NCT00708500|9706207|FG002|COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||160
8663008|NCT00708500|9706205|FG000|NOT COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||2
8663009|NCT00708500|9706206|FG001|NOT COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||6
8663010|NCT00708500|9706207|FG002|NOT COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||2
8663011|NCT00708500|9706205|FG000|STARTED|Tx: RECEIVING BOCEPREVIR/PLACEBO||78
8663012|NCT00708500|9706206|FG001|STARTED|Tx: RECEIVING BOCEPREVIR/PLACEBO||156
8663013|NCT00708500|9706207|FG002|STARTED|Tx: RECEIVING BOCEPREVIR/PLACEBO||160
8663014|NCT00708500|9706205|FG000|COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||23
8663015|NCT00708500|9706206|FG001|COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||104
8663016|NCT00708500|9706207|FG002|COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||105
8663017|NCT00708500|9706205|FG000|NOT COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||55
8663018|NCT00708500|9706206|FG001|NOT COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||52
8663019|NCT00708500|9706207|FG002|NOT COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||55
8663020|NCT00708500|9706205|FG000|STARTED|FOLLOWUP||77
8663021|NCT00708500|9706206|FG001|STARTED|FOLLOWUP||151
8663022|NCT00708500|9706207|FG002|STARTED|FOLLOWUP||158
8663023|NCT00708500|9706205|FG000|COMPLETED|FOLLOWUP||37
8663024|NCT00708500|9706206|FG001|COMPLETED|FOLLOWUP||136
8663025|NCT00708500|9706207|FG002|COMPLETED|FOLLOWUP||143
8663026|NCT00708500|9706205|FG000|NOT COMPLETED|FOLLOWUP||40
8663027|NCT00708500|9706206|FG001|NOT COMPLETED|FOLLOWUP||15
8663028|NCT00708500|9706207|FG002|NOT COMPLETED|FOLLOWUP||15
8663029|NCT00708526|9706217|FG000|STARTED|Wake up After Anesthesia||11
8663030|NCT00708526|9706218|FG001|STARTED|Wake up After Anesthesia||11
8663031|NCT00708526|9706217|FG000|COMPLETED|Wake up After Anesthesia||11
8663032|NCT00708526|9706218|FG001|COMPLETED|Wake up After Anesthesia||11
8663033|NCT00708526|9706217|FG000|NOT COMPLETED|Wake up After Anesthesia||0
8663034|NCT00708526|9706218|FG001|NOT COMPLETED|Wake up After Anesthesia||0
8663035|NCT00708526|9706217|FG000|STARTED|Return of Cognitive Function||11
8663036|NCT00708526|9706218|FG001|STARTED|Return of Cognitive Function||11
8663037|NCT00708526|9706217|FG000|COMPLETED|Return of Cognitive Function||11
8663038|NCT00708526|9706218|FG001|COMPLETED|Return of Cognitive Function||11
8663039|NCT00708526|9706217|FG000|NOT COMPLETED|Return of Cognitive Function||0
8663040|NCT00708526|9706218|FG001|NOT COMPLETED|Return of Cognitive Function||0
8663041|NCT00708552|9706228|FG000|STARTED|Overall Study||145
8663042|NCT00708552|9706229|FG001|STARTED|Overall Study||145
8663043|NCT00708552|9706230|FG002|STARTED|Overall Study||133
8663044|NCT00708552|9706231|FG003|STARTED|Overall Study||151
8663045|NCT00708552|9706228|FG000|COMPLETED|Overall Study||118
8663046|NCT00708552|9706229|FG001|COMPLETED|Overall Study||127
8663047|NCT00708552|9706230|FG002|COMPLETED|Overall Study||118
8663048|NCT00708552|9706231|FG003|COMPLETED|Overall Study||130
8663049|NCT00708552|9706228|FG000|NOT COMPLETED|Overall Study||27
8663050|NCT00708552|9706229|FG001|NOT COMPLETED|Overall Study||18
8663051|NCT00708552|9706230|FG002|NOT COMPLETED|Overall Study||15
8663052|NCT00708552|9706231|FG003|NOT COMPLETED|Overall Study||21
8663053|NCT00708643|9706247|FG000|STARTED|Overall Study||40
8663054|NCT00708643|9706248|FG001|STARTED|Overall Study||40
8663055|NCT00708643|9706247|FG000|COMPLETED|Overall Study||40
8663056|NCT00708643|9706248|FG001|COMPLETED|Overall Study||39
8663057|NCT00708643|9706247|FG000|NOT COMPLETED|Overall Study||0
8663058|NCT00708643|9706248|FG001|NOT COMPLETED|Overall Study||1
8663059|NCT00708682|9706254|FG000|STARTED|Infant Series||225
8663060|NCT00708682|9706254|FG000|Vaccinated Dose 1|Infant Series||223
8663061|NCT00708682|9706254|FG000|Vaccinated Dose 2|Infant Series||214
8663062|NCT00708682|9706254|FG000|Vaccinated Dose 3|Infant Series||194
8663063|NCT00708682|9706254|FG000|COMPLETED|Infant Series||192
8663064|NCT00708682|9706254|FG000|NOT COMPLETED|Infant Series||33
8663065|NCT00708682|9706254|FG000|STARTED|After Infant Series||192
8663066|NCT00708682|9706254|FG000|COMPLETED|After Infant Series||191
8663067|NCT00708682|9706254|FG000|NOT COMPLETED|After Infant Series||1
8663068|NCT00708682|9706254|FG000|STARTED|Toddler Dose||191
8663069|NCT00708682|9706254|FG000|COMPLETED|Toddler Dose||183
8663070|NCT00708682|9706254|FG000|NOT COMPLETED|Toddler Dose||8
8663071|NCT00708708|9706260|FG000|STARTED|Overall Study||955
8663072|NCT00708708|9706260|FG000|COMPLETED|Overall Study|Included participants completed total observation period and participants with planned study end.|213
8663073|NCT00708708|9706260|FG000|NOT COMPLETED|Overall Study||742
8663074|NCT00708721|9706267|FG000|STARTED|Overall Study||2
8663075|NCT00708721|9706268|FG001|STARTED|Overall Study||4
8663076|NCT00708721|9706269|FG002|STARTED|Overall Study||3
8663077|NCT00708721|9706270|FG003|STARTED|Overall Study||2
8663078|NCT00708721|9706267|FG000|COMPLETED|Overall Study||2
8663079|NCT00708721|9706268|FG001|COMPLETED|Overall Study||4
8663080|NCT00708721|9706269|FG002|COMPLETED|Overall Study||3
8663081|NCT00708721|9706270|FG003|COMPLETED|Overall Study||2
8663082|NCT00708721|9706267|FG000|NOT COMPLETED|Overall Study||0
8663083|NCT00708721|9706268|FG001|NOT COMPLETED|Overall Study||0
8663084|NCT00708721|9706269|FG002|NOT COMPLETED|Overall Study||0
8663085|NCT00708721|9706270|FG003|NOT COMPLETED|Overall Study||0
8663086|NCT00708851|9706281|FG000|STARTED|Overall Study||12
8663087|NCT00708851|9706281|FG000|COMPLETED|Overall Study||12
8663088|NCT00708851|9706281|FG000|NOT COMPLETED|Overall Study||0
8663089|NCT00708877|9706287|FG000|STARTED|Overall Study||5
8663090|NCT00708877|9706287|FG000|COMPLETED|Overall Study||5
8663091|NCT00708877|9706287|FG000|NOT COMPLETED|Overall Study||0
8663092|NCT00708942|9706296|FG000|STARTED|Overall Study||47
8663093|NCT00708942|9706297|FG001|STARTED|Overall Study||12
8663094|NCT00708942|9706298|FG002|STARTED|Overall Study||11
8663095|NCT00708942|9706299|FG003|STARTED|Overall Study||10
8663096|NCT00708942|9706300|FG004|STARTED|Overall Study||3
8663097|NCT00708942|9706296|FG000|COMPLETED|Overall Study||40
8663098|NCT00708942|9706297|FG001|COMPLETED|Overall Study||11
8663099|NCT00708942|9706298|FG002|COMPLETED|Overall Study||9
8663100|NCT00708942|9706299|FG003|COMPLETED|Overall Study||10
8663101|NCT00708942|9706300|FG004|COMPLETED|Overall Study||2
8663102|NCT00708942|9706296|FG000|NOT COMPLETED|Overall Study||7
8663103|NCT00708942|9706297|FG001|NOT COMPLETED|Overall Study||1
8663104|NCT00708942|9706298|FG002|NOT COMPLETED|Overall Study||2
8663105|NCT00708942|9706299|FG003|NOT COMPLETED|Overall Study||0
8663106|NCT00708942|9706300|FG004|NOT COMPLETED|Overall Study||1
8663107|NCT00709059|9706312|FG000|STARTED|Overall Study||538
8663108|NCT00709059|9706312|FG000|COMPLETED|Overall Study||444
8663109|NCT00709059|9706312|FG000|NOT COMPLETED|Overall Study||94
8663110|NCT00709098|9706319|FG000|STARTED|Double-blind Period||25
8663111|NCT00709098|9706320|FG001|STARTED|Double-blind Period||24
8663112|NCT00709098|9706321|FG002|STARTED|Double-blind Period||0
8663113|NCT00709098|9706319|FG000|COMPLETED|Double-blind Period||19
8663114|NCT00709098|9706320|FG001|COMPLETED|Double-blind Period||16
8663115|NCT00709098|9706321|FG002|COMPLETED|Double-blind Period||0
8663116|NCT00709098|9706319|FG000|NOT COMPLETED|Double-blind Period||6
8663117|NCT00709098|9706320|FG001|NOT COMPLETED|Double-blind Period||8
8663118|NCT00709098|9706321|FG002|NOT COMPLETED|Double-blind Period||0
8663119|NCT00709098|9706319|FG000|STARTED|Open-label Period||0
8663120|NCT00709098|9706320|FG001|STARTED|Open-label Period||0
8663121|NCT00709098|9706321|FG002|STARTED|Open-label Period|The open-label period was only made available to patients in US centers|32
8663122|NCT00709098|9706319|FG000|COMPLETED|Open-label Period||0
8663123|NCT00709098|9706320|FG001|COMPLETED|Open-label Period||0
8663124|NCT00709098|9706321|FG002|COMPLETED|Open-label Period||18
8663125|NCT00709098|9706319|FG000|NOT COMPLETED|Open-label Period||0
8663126|NCT00709098|9706320|FG001|NOT COMPLETED|Open-label Period||0
8663127|NCT00709098|9706321|FG002|NOT COMPLETED|Open-label Period||14
8730001|NCT01056302|9777343|FG000|COMPLETED|Overall Study|The study was completed with 3 datasets from patients who had maxillofacial trauma and were treated|3
8730002|NCT01056302|9777343|FG000|NOT COMPLETED|Overall Study||0
8730003|NCT01056328|9777350|FG000|STARTED|Overall Study||164
8730004|NCT01056328|9777351|FG001|STARTED|Overall Study||160
8730005|NCT01056328|9777350|FG000|COMPLETED|Overall Study||147
8730006|NCT01056328|9777351|FG001|COMPLETED|Overall Study||144
8911400|NCT02146326|9970503|FG001|Baseline|Overall Study||103
8911401|NCT02146326|9970504|FG002|Baseline|Overall Study||211
8663128|NCT00709111|9706330|FG000|STARTED|Overall Study||34
8663129|NCT00709111|9706330|FG000|Week 22/24|Overall Study||33
8663130|NCT00709111|9706330|FG000|COMPLETED|Overall Study||32
8663131|NCT00709111|9706330|FG000|NOT COMPLETED|Overall Study||2
8663132|NCT00709124|9706336|FG000|STARTED|Overall Study||16
8663133|NCT00709124|9706337|FG001|STARTED|Overall Study||18
8663134|NCT00709124|9706336|FG000|COMPLETED|Overall Study||12
8663135|NCT00709124|9706337|FG001|COMPLETED|Overall Study||17
8663136|NCT00709124|9706336|FG000|NOT COMPLETED|Overall Study||4
8663137|NCT00709124|9706337|FG001|NOT COMPLETED|Overall Study||1
8663138|NCT00709202|9706349|FG000|STARTED|Overall Study||19
8730007|NCT01056328|9777350|FG000|NOT COMPLETED|Overall Study||17
8730008|NCT01056328|9777351|FG001|NOT COMPLETED|Overall Study||16
8730009|NCT01056341|9777365|FG000|STARTED|Overall Study||55
8730010|NCT01056341|9777366|FG001|STARTED|Overall Study||99
8730011|NCT01056341|9777367|FG002|STARTED|Overall Study||103
8730012|NCT01056341|9777368|FG003|STARTED|Overall Study||101
8730013|NCT01056341|9777369|FG004|STARTED|Overall Study||102
8730014|NCT01056341|9777365|FG000|Interim Analysis|Overall Study||25
8730015|NCT01056341|9777366|FG001|Interim Analysis|Overall Study||41
8730016|NCT01056341|9777367|FG002|Interim Analysis|Overall Study||41
8730017|NCT01056341|9777368|FG003|Interim Analysis|Overall Study||40
8730018|NCT01056341|9777369|FG004|Interim Analysis|Overall Study||43
8730019|NCT01056341|9777365|FG000|COMPLETED|Overall Study||19
8730020|NCT01056341|9777366|FG001|COMPLETED|Overall Study||63
8730021|NCT01056341|9777367|FG002|COMPLETED|Overall Study||88
8730022|NCT01056341|9777368|FG003|COMPLETED|Overall Study||65
8730023|NCT01056341|9777369|FG004|COMPLETED|Overall Study||88
8730024|NCT01056341|9777365|FG000|NOT COMPLETED|Overall Study||36
8730025|NCT01056341|9777366|FG001|NOT COMPLETED|Overall Study||36
8730026|NCT01056341|9777367|FG002|NOT COMPLETED|Overall Study||15
8730027|NCT01056341|9777368|FG003|NOT COMPLETED|Overall Study||36
8730028|NCT01056341|9777369|FG004|NOT COMPLETED|Overall Study||14
8730029|NCT01056380|9777389|FG000|STARTED|Overall Study||37
8730030|NCT01056380|9777390|FG001|STARTED|Overall Study||42
8730031|NCT01056380|9777389|FG000|COMPLETED|Overall Study||35
8730032|NCT01056380|9777390|FG001|COMPLETED|Overall Study||39
8730033|NCT01056380|9777389|FG000|NOT COMPLETED|Overall Study||2
8730034|NCT01056380|9777390|FG001|NOT COMPLETED|Overall Study||3
8730035|NCT01056484|9777400|FG000|STARTED|Randomized Controlled Trial||64
8730036|NCT01056484|9777401|FG001|STARTED|Randomized Controlled Trial||59
8730037|NCT01056484|9777400|FG000|COMPLETED|Randomized Controlled Trial||57
8730038|NCT01056484|9777401|FG001|COMPLETED|Randomized Controlled Trial||58
8730039|NCT01056484|9777400|FG000|NOT COMPLETED|Randomized Controlled Trial||7
8730040|NCT01056484|9777401|FG001|NOT COMPLETED|Randomized Controlled Trial||1
8730041|NCT01056484|9777400|FG000|STARTED|Follow up - Non-randomized|Out of the enrolled experimental subjects (N=64), 57 completed Period 1 and entered into Period 2.|57
8730042|NCT01056484|9777401|FG001|STARTED|Follow up - Non-randomized|Out of the enrolled control subjects (N=59), 58 completed Period 1 and entered into Period 2.|58
8730043|NCT01056484|9777400|FG000|COMPLETED|Follow up - Non-randomized||57
8730044|NCT01056484|9777401|FG001|COMPLETED|Follow up - Non-randomized||56
8730045|NCT01056484|9777400|FG000|NOT COMPLETED|Follow up - Non-randomized||0
8730046|NCT01056484|9777401|FG001|NOT COMPLETED|Follow up - Non-randomized||2
8730047|NCT01056510|9777410|FG000|STARTED|Overall Study||178
8730048|NCT01056510|9777411|FG001|STARTED|Overall Study||179
8730049|NCT01056510|9777410|FG000|COMPLETED|Overall Study||124
8730050|NCT01056510|9777411|FG001|COMPLETED|Overall Study||115
8730051|NCT01056510|9777410|FG000|NOT COMPLETED|Overall Study||54
8730052|NCT01056510|9777411|FG001|NOT COMPLETED|Overall Study||64
8730053|NCT01056523|9777417|FG000|STARTED|Overall Study||4
8730054|NCT01056523|9777418|FG001|STARTED|Overall Study||3
8730055|NCT01056523|9777419|FG002|STARTED|Overall Study||5
8730056|NCT01056523|9777420|FG003|STARTED|Overall Study||6
8730057|NCT01056523|9777421|FG004|STARTED|Overall Study||3
8730058|NCT01056523|9777422|FG005|STARTED|Overall Study||3
8730059|NCT01056523|9777423|FG006|STARTED|Overall Study||5
8730060|NCT01056523|9777417|FG000|COMPLETED|Overall Study||3
8730061|NCT01056523|9777418|FG001|COMPLETED|Overall Study||3
8730062|NCT01056523|9777419|FG002|COMPLETED|Overall Study||3
8730063|NCT01056523|9777420|FG003|COMPLETED|Overall Study||3
8730064|NCT01056523|9777421|FG004|COMPLETED|Overall Study||3
8730065|NCT01056523|9777422|FG005|COMPLETED|Overall Study||3
8730066|NCT01056523|9777423|FG006|COMPLETED|Overall Study||4
8730067|NCT01056523|9777417|FG000|NOT COMPLETED|Overall Study||1
8730068|NCT01056523|9777418|FG001|NOT COMPLETED|Overall Study||0
8730069|NCT01056523|9777419|FG002|NOT COMPLETED|Overall Study||2
8730070|NCT01056523|9777420|FG003|NOT COMPLETED|Overall Study||3
8730071|NCT01056523|9777421|FG004|NOT COMPLETED|Overall Study||0
8730072|NCT01056523|9777422|FG005|NOT COMPLETED|Overall Study||0
8730073|NCT01056523|9777423|FG006|NOT COMPLETED|Overall Study||1
8730074|NCT01056536|9777431|FG000|STARTED|Overall Study||596
8730075|NCT01056536|9777432|FG001|STARTED|Overall Study||356
8730076|NCT01056536|9777433|FG002|STARTED|Overall Study||729
8730077|NCT01056536|9777431|FG000|COMPLETED|Overall Study||394
8730078|NCT01056536|9777432|FG001|COMPLETED|Overall Study||240
8730079|NCT01056536|9777433|FG002|COMPLETED|Overall Study||481
8730080|NCT01056536|9777431|FG000|NOT COMPLETED|Overall Study||202
8730081|NCT01056536|9777432|FG001|NOT COMPLETED|Overall Study||116
8730082|NCT01056536|9777433|FG002|NOT COMPLETED|Overall Study||248
8730083|NCT01056601|9777441|FG000|STARTED|Overall Study||7
8730084|NCT01056601|9777441|FG000|COMPLETED|Overall Study||7
8730085|NCT01056601|9777441|FG000|NOT COMPLETED|Overall Study||0
8730086|NCT01056640|9777447|FG000|STARTED|Overall Study||102
8730087|NCT01056640|9777448|FG001|STARTED|Overall Study||103
8730088|NCT01056640|9777447|FG000|COMPLETED|Overall Study||76
8730089|NCT01056640|9777448|FG001|COMPLETED|Overall Study||91
8730090|NCT01056640|9777447|FG000|NOT COMPLETED|Overall Study||26
8730091|NCT01056640|9777448|FG001|NOT COMPLETED|Overall Study||12
8730092|NCT01056653|9777457|FG000|STARTED|Overall Study||46
8730093|NCT01056653|9777458|FG001|STARTED|Overall Study||23
8730094|NCT01056653|9777459|FG002|STARTED|Overall Study||44
8730095|NCT01056653|9777457|FG000|COMPLETED|Overall Study||46
8663139|NCT00709202|9706350|FG001|STARTED|Overall Study||21
8663140|NCT00709202|9706349|FG000|COMPLETED|Overall Study||13
8663141|NCT00709202|9706350|FG001|COMPLETED|Overall Study||15
8663142|NCT00709202|9706349|FG000|NOT COMPLETED|Overall Study||6
8663143|NCT00709202|9706350|FG001|NOT COMPLETED|Overall Study||6
8663144|NCT00709228|9706357|FG000|STARTED|Overall Study||496
8663145|NCT00709228|9706357|FG000|COMPLETED|Overall Study|Number completed is defined as participants who completed the follow-up period.|164
8663146|NCT00709228|9706357|FG000|NOT COMPLETED|Overall Study||332
8663147|NCT00709306|9706365|FG000|STARTED|Overall Study||48
8663148|NCT00709306|9706366|FG001|STARTED|Overall Study||44
8663149|NCT00709306|9706367|FG002|STARTED|Overall Study||58
8663150|NCT00709306|9706368|FG003|STARTED|Overall Study||47
8663151|NCT00709306|9706365|FG000|COMPLETED|Overall Study||39
8663152|NCT00709306|9706366|FG001|COMPLETED|Overall Study||30
8663153|NCT00709306|9706367|FG002|COMPLETED|Overall Study||48
8663154|NCT00709306|9706368|FG003|COMPLETED|Overall Study||37
8663155|NCT00709306|9706365|FG000|NOT COMPLETED|Overall Study||9
8663156|NCT00709306|9706366|FG001|NOT COMPLETED|Overall Study||14
8663157|NCT00709306|9706367|FG002|NOT COMPLETED|Overall Study||10
8663158|NCT00709306|9706368|FG003|NOT COMPLETED|Overall Study||10
8663159|NCT00709319|9706378|FG000|STARTED|Overall Study||87
8663160|NCT00709319|9706378|FG000|COMPLETED|Overall Study||81
8663161|NCT00709319|9706378|FG000|NOT COMPLETED|Overall Study||6
8692312|NCT00859495|9737711|FG000|NOT COMPLETED|Overall Study||0
8692313|NCT00859508|9737717|FG000|STARTED|Overall Study||68
8692314|NCT00859508|9737718|FG001|STARTED|Overall Study||37
8692315|NCT00859508|9737717|FG000|COMPLETED|Overall Study||62
8692316|NCT00859508|9737718|FG001|COMPLETED|Overall Study||37
8692317|NCT00859508|9737717|FG000|NOT COMPLETED|Overall Study||6
8692318|NCT00859508|9737718|FG001|NOT COMPLETED|Overall Study||0
8692319|NCT00859547|9737724|FG000|STARTED|Overall Study||30
8692320|NCT00859547|9737724|FG000|COMPLETED|Overall Study||28
8692321|NCT00859547|9737724|FG000|NOT COMPLETED|Overall Study||2
8692322|NCT00859573|9737730|FG000|STARTED|Overall Study||6
8692323|NCT00859573|9737731|FG001|STARTED|Overall Study||3
8692324|NCT00859573|9737730|FG000|COMPLETED|Overall Study||1
8692325|NCT00859573|9737731|FG001|COMPLETED|Overall Study||1
8692326|NCT00859573|9737730|FG000|NOT COMPLETED|Overall Study||5
8692327|NCT00859573|9737731|FG001|NOT COMPLETED|Overall Study||2
8692328|NCT00859586|9737737|FG000|STARTED|Overall Study||8
8692329|NCT00859586|9737737|FG000|COMPLETED|Overall Study||4
8692330|NCT00859586|9737737|FG000|NOT COMPLETED|Overall Study||4
8692331|NCT00859638|9737743|FG000|STARTED|Overall Study||65
8692332|NCT00859638|9737744|FG001|STARTED|Overall Study||59
8692333|NCT00859638|9737743|FG000|COMPLETED|Overall Study||55
8692334|NCT00859638|9737744|FG001|COMPLETED|Overall Study||55
8692335|NCT00859638|9737743|FG000|NOT COMPLETED|Overall Study||10
8692336|NCT00859638|9737744|FG001|NOT COMPLETED|Overall Study||4
8692337|NCT00859651|9737752|FG000|STARTED|Overall Study||18
8692338|NCT00859651|9737753|FG001|STARTED|Overall Study||22
8692339|NCT00859651|9737752|FG000|COMPLETED|Overall Study||18
8692340|NCT00859651|9737753|FG001|COMPLETED|Overall Study||22
8692341|NCT00859651|9737752|FG000|NOT COMPLETED|Overall Study||0
8692342|NCT00859651|9737753|FG001|NOT COMPLETED|Overall Study||0
8692343|NCT00859833|9737759|FG000|STARTED|Overall Study||30
8692344|NCT00859833|9737759|FG000|COMPLETED|Overall Study||30
8692345|NCT00859833|9737759|FG000|NOT COMPLETED|Overall Study||0
8692346|NCT00859898|9737767|FG000|STARTED|Overall Study||211
8692347|NCT00859898|9737768|FG001|STARTED|Overall Study||219
8692348|NCT00859898|9737769|FG002|STARTED|Overall Study||208
8692349|NCT00859898|9737767|FG000|COMPLETED|Overall Study||183
8692350|NCT00859898|9737768|FG001|COMPLETED|Overall Study||188
8692351|NCT00859898|9737769|FG002|COMPLETED|Overall Study||181
8692352|NCT00859898|9737767|FG000|NOT COMPLETED|Overall Study||28
8692353|NCT00859898|9737768|FG001|NOT COMPLETED|Overall Study||31
8692354|NCT00859898|9737769|FG002|NOT COMPLETED|Overall Study||27
8693731|NCT00868231|9739258|FG002|COMPLETED|Treatment Period 3||4
8693732|NCT00868231|9739259|FG003|COMPLETED|Treatment Period 3||5
8693733|NCT00868231|9739260|FG004|COMPLETED|Treatment Period 3||4
8693734|NCT00868231|9739261|FG005|COMPLETED|Treatment Period 3||5
8693735|NCT00868231|9739256|FG000|NOT COMPLETED|Treatment Period 3||0
8693736|NCT00868231|9739257|FG001|NOT COMPLETED|Treatment Period 3||0
8693737|NCT00868231|9739258|FG002|NOT COMPLETED|Treatment Period 3||1
8693738|NCT00868231|9739259|FG003|NOT COMPLETED|Treatment Period 3||0
8693739|NCT00868231|9739260|FG004|NOT COMPLETED|Treatment Period 3||0
8693740|NCT00868231|9739261|FG005|NOT COMPLETED|Treatment Period 3||0
8693741|NCT00868296|9739271|FG000|STARTED|Overall Study||12
8693742|NCT00868296|9739272|FG001|STARTED|Overall Study||46
8693743|NCT00868296|9739271|FG000|COMPLETED|Overall Study||12
8693744|NCT00868296|9739272|FG001|COMPLETED|Overall Study||43
8693745|NCT00868296|9739271|FG000|NOT COMPLETED|Overall Study||0
8693746|NCT00868296|9739272|FG001|NOT COMPLETED|Overall Study||3
8693747|NCT00868309|9739280|FG000|STARTED|Overall Study||6
8693748|NCT00868309|9739281|FG001|STARTED|Overall Study||6
8693749|NCT00868309|9739280|FG000|COMPLETED|Overall Study||6
8693750|NCT00868309|9739281|FG001|COMPLETED|Overall Study||6
8693751|NCT00868309|9739280|FG000|NOT COMPLETED|Overall Study||0
8693752|NCT00868309|9739281|FG001|NOT COMPLETED|Overall Study||0
8693753|NCT00868348|9739289|FG000|STARTED|Overall Study||30
8693754|NCT00868348|9739290|FG001|STARTED|Overall Study||30
8693755|NCT00868348|9739289|FG000|COMPLETED|Overall Study||30
8693756|NCT00868348|9739290|FG001|COMPLETED|Overall Study||30
8663162|NCT00709592|9706384|FG000|STARTED|Overall Study||19
8663163|NCT00709592|9706385|FG001|STARTED|Overall Study||23
8663164|NCT00709592|9706384|FG000|COMPLETED|Overall Study||19
8663165|NCT00709592|9706385|FG001|COMPLETED|Overall Study||22
8663166|NCT00709592|9706384|FG000|NOT COMPLETED|Overall Study||0
8663167|NCT00709592|9706385|FG001|NOT COMPLETED|Overall Study||1
8663168|NCT00709618|9706391|FG000|STARTED|Overall Study||44
8663169|NCT00709618|9706391|FG000|COMPLETED|Overall Study||14
8663170|NCT00709618|9706391|FG000|NOT COMPLETED|Overall Study||30
8663171|NCT00709696|9706397|FG000|STARTED|Overall Study||4
8663172|NCT00709696|9706398|FG001|STARTED|Overall Study||3
8663173|NCT00709696|9706397|FG000|COMPLETED|Overall Study||4
8663174|NCT00709696|9706398|FG001|COMPLETED|Overall Study||3
8663175|NCT00709696|9706397|FG000|NOT COMPLETED|Overall Study||0
8663176|NCT00709696|9706398|FG001|NOT COMPLETED|Overall Study||0
8663177|NCT00709722|9706404|FG000|STARTED|Overall Study||21
8663178|NCT00709722|9706404|FG000|COMPLETED|Overall Study||20
8663179|NCT00709722|9706404|FG000|NOT COMPLETED|Overall Study||1
8663180|NCT00709735|9706410|FG000|STARTED|Overall Study||11
8663181|NCT00709735|9706411|FG001|STARTED|Overall Study||12
8663182|NCT00709735|9706410|FG000|COMPLETED|Overall Study||8
8663183|NCT00709735|9706411|FG001|COMPLETED|Overall Study||10
8663184|NCT00709735|9706410|FG000|NOT COMPLETED|Overall Study||3
8663185|NCT00709735|9706411|FG001|NOT COMPLETED|Overall Study||2
8663186|NCT00709761|9706417|FG000|STARTED|Overall Study||60
8663187|NCT00709761|9706417|FG000|COMPLETED|Overall Study||33
8663188|NCT00709761|9706417|FG000|NOT COMPLETED|Overall Study||27
8663189|NCT00709826|9706423|FG000|STARTED|Overall Study||70
8663190|NCT00709826|9706424|FG001|STARTED|Overall Study||39
8663191|NCT00709826|9706423|FG000|COMPLETED|Overall Study||68
8663192|NCT00709826|9706424|FG001|COMPLETED|Overall Study||38
8663193|NCT00709826|9706423|FG000|NOT COMPLETED|Overall Study||2
8663194|NCT00709826|9706424|FG001|NOT COMPLETED|Overall Study||1
8663195|NCT00709852|9706430|FG000|STARTED|Period 1||228
8663196|NCT00709852|9706431|FG001|STARTED|Period 1||174
8663197|NCT00709852|9706430|FG000|COMPLETED|Period 1||220
8663198|NCT00709852|9706431|FG001|COMPLETED|Period 1||171
8663199|NCT00709852|9706430|FG000|NOT COMPLETED|Period 1||8
8663200|NCT00709852|9706431|FG001|NOT COMPLETED|Period 1||3
8663201|NCT00709852|9706430|FG000|STARTED|Period 2||220
8663202|NCT00709852|9706431|FG001|STARTED|Period 2||171
8663203|NCT00709852|9706430|FG000|COMPLETED|Period 2||211
8663204|NCT00709852|9706431|FG001|COMPLETED|Period 2||169
8663205|NCT00709852|9706430|FG000|NOT COMPLETED|Period 2||9
8663206|NCT00709852|9706431|FG001|NOT COMPLETED|Period 2||2
8663207|NCT00709878|9706450|FG000|STARTED|Overall Study||8
8663208|NCT00709878|9706451|FG001|STARTED|Overall Study||8
8663209|NCT00709878|9706452|FG002|STARTED|Overall Study||8
8663210|NCT00709878|9706453|FG003|STARTED|Overall Study||8
8663211|NCT00709878|9706450|FG000|COMPLETED|Overall Study||8
8663212|NCT00709878|9706451|FG001|COMPLETED|Overall Study||8
8663213|NCT00709878|9706452|FG002|COMPLETED|Overall Study||8
8663214|NCT00709878|9706453|FG003|COMPLETED|Overall Study||8
8663215|NCT00709878|9706450|FG000|NOT COMPLETED|Overall Study||0
8663216|NCT00709878|9706451|FG001|NOT COMPLETED|Overall Study||0
8663217|NCT00709878|9706452|FG002|NOT COMPLETED|Overall Study||0
8730096|NCT01056653|9777458|FG001|COMPLETED|Overall Study||23
8730097|NCT01056653|9777459|FG002|COMPLETED|Overall Study|2 were lost to follow-up because one mother left the country and one father was too busy.|42
8730098|NCT01056653|9777457|FG000|NOT COMPLETED|Overall Study||0
8730099|NCT01056653|9777458|FG001|NOT COMPLETED|Overall Study||0
8730100|NCT01056653|9777459|FG002|NOT COMPLETED|Overall Study||2
8730101|NCT01056718|9777468|FG000|STARTED|Overall Study||53
8730102|NCT01056718|9777468|FG000|COMPLETED|Overall Study||50
8730103|NCT01056718|9777468|FG000|NOT COMPLETED|Overall Study||3
8730104|NCT01056822|9777475|FG000|STARTED|Overall Study||47
8730105|NCT01056822|9777476|FG001|STARTED|Overall Study||42
8730106|NCT01056822|9777475|FG000|Intention-to-treat (ITT) Population: YES|Overall Study||43
8730107|NCT01056822|9777476|FG001|Intention-to-treat (ITT) Population: YES|Overall Study||38
8730108|NCT01056822|9777475|FG000|Intention-to-treat (ITT) Population: NO|Overall Study||4
8730109|NCT01056822|9777476|FG001|Intention-to-treat (ITT) Population: NO|Overall Study||4
8730110|NCT01056822|9777475|FG000|Per-protocol (PP) Population: YES|Overall Study||29
8730111|NCT01056822|9777476|FG001|Per-protocol (PP) Population: YES|Overall Study||25
8730112|NCT01056822|9777475|FG000|Per-protocol (PP) Population: NO|Overall Study||18
8730113|NCT01056822|9777476|FG001|Per-protocol (PP) Population: NO|Overall Study||17
8730114|NCT01056822|9777475|FG000|Safety (SAF) Population: YES|Overall Study||46
8730115|NCT01056822|9777476|FG001|Safety (SAF) Population: YES|Overall Study||40
8730116|NCT01056822|9777475|FG000|Safety (SAF) Population: NO|Overall Study||1
8663218|NCT00709878|9706453|FG003|NOT COMPLETED|Overall Study||0
8663219|NCT00709891|9706463|FG000|STARTED|Baseline, Cross-sectional Phase||47208
8663220|NCT00709891|9706463|FG000|COMPLETED|Baseline, Cross-sectional Phase||45758
8663221|NCT00709891|9706463|FG000|NOT COMPLETED|Baseline, Cross-sectional Phase||1450
8663222|NCT00709891|9706463|FG000|STARTED|Longitudinal Follow-up Phase|Only participants who met study criteria in the Baseline phase started the Follow-up phase.|10002
8663223|NCT00709891|9706463|FG000|COMPLETED|Longitudinal Follow-up Phase||5020
8663224|NCT00709891|9706463|FG000|NOT COMPLETED|Longitudinal Follow-up Phase||4982
8663225|NCT00709956|9706469|FG000|STARTED|Overall Study|Day 1 Single-blind placebo run-in|33
8663226|NCT00709956|9706470|FG001|STARTED|Overall Study|Day 1 Single-blind placebo run-in|37
8663227|NCT00709956|9706469|FG000|Double-blind Crossover-period|Overall Study|Days 2 and 3|31
8663228|NCT00709956|9706470|FG001|Double-blind Crossover-period|Overall Study|Days 2 and 3|33
8663229|NCT00709956|9706469|FG000|COMPLETED|Overall Study||30
8663230|NCT00709956|9706470|FG001|COMPLETED|Overall Study||33
8663231|NCT00709956|9706469|FG000|NOT COMPLETED|Overall Study||3
8663232|NCT00709956|9706470|FG001|NOT COMPLETED|Overall Study||4
8663233|NCT00709995|9706480|FG000|STARTED|Overall Study||11
8663234|NCT00709995|9706481|FG001|STARTED|Overall Study||6
8663235|NCT00709995|9706480|FG000|Progressive Disease|Overall Study||6
8663236|NCT00709995|9706481|FG001|Progressive Disease|Overall Study||1
8663237|NCT00709995|9706480|FG000|COMPLETED|Overall Study||6
8663238|NCT00709995|9706481|FG001|COMPLETED|Overall Study||1
8663239|NCT00709995|9706480|FG000|NOT COMPLETED|Overall Study||5
8663240|NCT00709995|9706481|FG001|NOT COMPLETED|Overall Study||5
8663241|NCT00710021|9706493|FG000|STARTED|Overall Study||19
8663242|NCT00710021|9706494|FG001|STARTED|Overall Study||19
8663243|NCT00710021|9706495|FG002|STARTED|Overall Study||19
8663244|NCT00710021|9706493|FG000|Modified Intent-to-Treat (mITT)|Overall Study||19
8663245|NCT00710021|9706494|FG001|Modified Intent-to-Treat (mITT)|Overall Study|2 subjects who did not take study drug were excluded from mITT|17
8663246|NCT00710021|9706495|FG002|Modified Intent-to-Treat (mITT)|Overall Study|1 subject who did not take study drug was excluded from mITT|18
8663247|NCT00710021|9706493|FG000|COMPLETED|Overall Study||18
8663248|NCT00710021|9706494|FG001|COMPLETED|Overall Study||16
8663249|NCT00710021|9706495|FG002|COMPLETED|Overall Study||18
8663250|NCT00710021|9706493|FG000|NOT COMPLETED|Overall Study||1
8663251|NCT00710021|9706494|FG001|NOT COMPLETED|Overall Study||3
8663252|NCT00710021|9706495|FG002|NOT COMPLETED|Overall Study||1
8663253|NCT00710034|9706506|FG000|STARTED|Completed 6 Weeks of Treatment||195
8663254|NCT00710034|9706507|FG001|STARTED|Completed 6 Weeks of Treatment||196
8663255|NCT00710034|9706506|FG000|COMPLETED|Completed 6 Weeks of Treatment|Completed 6 weeks of treatment for primary outcome assessment: N=154|154
8663256|NCT00710034|9706507|FG001|COMPLETED|Completed 6 Weeks of Treatment|Completed 6 weeks of treatment for primary outcome assessment: N=149|149
8663257|NCT00710034|9706506|FG000|NOT COMPLETED|Completed 6 Weeks of Treatment||41
8663258|NCT00710034|9706507|FG001|NOT COMPLETED|Completed 6 Weeks of Treatment||47
8663259|NCT00710034|9706506|FG000|STARTED|Completed 12 Weeks of Treatment||154
8663260|NCT00710034|9706507|FG001|STARTED|Completed 12 Weeks of Treatment||149
8663261|NCT00710034|9706506|FG000|COMPLETED|Completed 12 Weeks of Treatment||141
8663262|NCT00710034|9706507|FG001|COMPLETED|Completed 12 Weeks of Treatment||138
8663263|NCT00710034|9706506|FG000|NOT COMPLETED|Completed 12 Weeks of Treatment||13
8663264|NCT00710034|9706507|FG001|NOT COMPLETED|Completed 12 Weeks of Treatment||11
8663265|NCT00710203|9706513|FG000|STARTED|Overall Study||10
8663266|NCT00710203|9706513|FG000|COMPLETED|Overall Study||10
8663267|NCT00710203|9706513|FG000|NOT COMPLETED|Overall Study||0
8663268|NCT00710385|9706523|FG000|STARTED|Overall Study|19 participants signed consent for the study 2 withdrew before any study procedures were initiated.|17
8663269|NCT00710385|9706523|FG000|COMPLETED|Overall Study||12
8663270|NCT00710385|9706523|FG000|NOT COMPLETED|Overall Study||5
8663271|NCT00710424|9706535|FG000|STARTED|Overall Study||149
8663272|NCT00710424|9706536|FG001|STARTED|Overall Study||148
8663273|NCT00710424|9706535|FG000|COMPLETED|Overall Study||105
8663274|NCT00710424|9706536|FG001|COMPLETED|Overall Study||125
8663275|NCT00710424|9706535|FG000|NOT COMPLETED|Overall Study||44
8663276|NCT00710424|9706536|FG001|NOT COMPLETED|Overall Study||23
8663277|NCT00710554|9706544|FG000|STARTED|Overall Study||128
8663278|NCT00710554|9706545|FG001|STARTED|Overall Study||118
8663279|NCT00710554|9706544|FG000|COMPLETED|Overall Study||79
8663280|NCT00710554|9706545|FG001|COMPLETED|Overall Study||94
8663281|NCT00710554|9706544|FG000|NOT COMPLETED|Overall Study||49
8663282|NCT00710554|9706545|FG001|NOT COMPLETED|Overall Study||24
8663283|NCT00710593|9706553|FG000|STARTED|Overall Study||69
8663284|NCT00710593|9706554|FG001|STARTED|Overall Study||30
8663285|NCT00710593|9706553|FG000|COMPLETED|Overall Study|54 completed study and vaccine. 6 did not receive all vaccine, but completed all study visits.|54
8663286|NCT00710593|9706554|FG001|COMPLETED|Overall Study|25 completed study and vaccine. 2 did not receive all vaccine, but completed all study visits.|25
8663287|NCT00710593|9706553|FG000|NOT COMPLETED|Overall Study||15
8663288|NCT00710593|9706554|FG001|NOT COMPLETED|Overall Study||5
8663289|NCT00710606|9706578|FG000|STARTED|Overall Study||20
8663290|NCT00710606|9706579|FG001|STARTED|Overall Study||20
8663291|NCT00710606|9706578|FG000|COMPLETED|Overall Study||20
8663292|NCT00710606|9706579|FG001|COMPLETED|Overall Study||18
8663293|NCT00710606|9706578|FG000|NOT COMPLETED|Overall Study||0
8663294|NCT00710606|9706579|FG001|NOT COMPLETED|Overall Study||2
8663295|NCT00710684|9706590|FG000|STARTED|Overall Study||225
8663296|NCT00710684|9706591|FG001|STARTED|Overall Study||221
8663297|NCT00710684|9706592|FG002|STARTED|Overall Study||236
8663298|NCT00710684|9706590|FG000|COMPLETED|Overall Study||151
8663299|NCT00710684|9706591|FG001|COMPLETED|Overall Study||147
8663300|NCT00710684|9706592|FG002|COMPLETED|Overall Study||172
8663301|NCT00710684|9706590|FG000|NOT COMPLETED|Overall Study||74
8663302|NCT00710684|9706591|FG001|NOT COMPLETED|Overall Study||74
8663303|NCT00710684|9706592|FG002|NOT COMPLETED|Overall Study||64
8663304|NCT00710749|9706606|FG000|STARTED|Clinic Baseline Recording||30
8663305|NCT00710749|9706607|FG001|STARTED|Clinic Baseline Recording||30
8663306|NCT00710749|9706606|FG000|COMPLETED|Clinic Baseline Recording||30
8663307|NCT00710749|9706607|FG001|COMPLETED|Clinic Baseline Recording||30
8663308|NCT00710749|9706606|FG000|NOT COMPLETED|Clinic Baseline Recording||0
8663309|NCT00710749|9706607|FG001|NOT COMPLETED|Clinic Baseline Recording||0
8663310|NCT00710749|9706606|FG000|STARTED|First Intervention||30
8663311|NCT00710749|9706607|FG001|STARTED|First Intervention||30
8663312|NCT00710749|9706606|FG000|COMPLETED|First Intervention||29
8663313|NCT00710749|9706607|FG001|COMPLETED|First Intervention||30
8663314|NCT00710749|9706606|FG000|NOT COMPLETED|First Intervention||1
8663315|NCT00710749|9706607|FG001|NOT COMPLETED|First Intervention||0
8663316|NCT00710749|9706606|FG000|STARTED|Second Intervention||29
8663317|NCT00710749|9706607|FG001|STARTED|Second Intervention||30
8663318|NCT00710749|9706606|FG000|COMPLETED|Second Intervention||29
8663319|NCT00710749|9706607|FG001|COMPLETED|Second Intervention||30
8663320|NCT00710749|9706606|FG000|NOT COMPLETED|Second Intervention||0
8663321|NCT00710749|9706607|FG001|NOT COMPLETED|Second Intervention||0
8663322|NCT00710762|9706617|FG000|STARTED|Overall Study||44
8663323|NCT00710762|9706618|FG001|STARTED|Overall Study||40
8663324|NCT00710762|9706617|FG000|COMPLETED|Overall Study||5
8663325|NCT00710762|9706618|FG001|COMPLETED|Overall Study||0
8663326|NCT00710762|9706617|FG000|NOT COMPLETED|Overall Study||39
8663327|NCT00710762|9706618|FG001|NOT COMPLETED|Overall Study||40
8663328|NCT00710814|9706626|FG000|STARTED|Overall Study||15
8663329|NCT00710814|9706627|FG001|STARTED|Overall Study||16
8663330|NCT00710814|9706626|FG000|COMPLETED|Overall Study||14
8663331|NCT00710814|9706627|FG001|COMPLETED|Overall Study||13
8663332|NCT00710814|9706626|FG000|NOT COMPLETED|Overall Study||1
8663333|NCT00710814|9706627|FG001|NOT COMPLETED|Overall Study||3
8663334|NCT00710840|9706635|FG000|STARTED|Overall Study||22
8663335|NCT00710840|9706636|FG001|STARTED|Overall Study||22
8663336|NCT00710840|9706635|FG000|COMPLETED|Overall Study||22
8663337|NCT00710840|9706636|FG001|COMPLETED|Overall Study||19
8663338|NCT00710840|9706635|FG000|NOT COMPLETED|Overall Study||0
8663339|NCT00710840|9706636|FG001|NOT COMPLETED|Overall Study||3
8663340|NCT00710866|9706644|FG000|STARTED|Overall Study||133
8663341|NCT00710866|9706645|FG001|STARTED|Overall Study||134
8663342|NCT00710866|9706644|FG000|COMPLETED|Overall Study||124
8663343|NCT00710866|9706645|FG001|COMPLETED|Overall Study||128
8663344|NCT00710866|9706644|FG000|NOT COMPLETED|Overall Study||9
8663345|NCT00710866|9706645|FG001|NOT COMPLETED|Overall Study||6
8663346|NCT00710879|9706653|FG000|STARTED|Overall Study||60
8663347|NCT00710879|9706654|FG001|STARTED|Overall Study||117
8663348|NCT00710879|9706653|FG000|COMPLETED|Overall Study||58
8663349|NCT00710879|9706654|FG001|COMPLETED|Overall Study||113
8663350|NCT00710879|9706653|FG000|NOT COMPLETED|Overall Study||2
8663351|NCT00710879|9706654|FG001|NOT COMPLETED|Overall Study||4
8663352|NCT00710905|9706660|FG000|STARTED|Overall Study||50
8663353|NCT00710905|9706660|FG000|COMPLETED|Overall Study||34
8663354|NCT00710905|9706660|FG000|NOT COMPLETED|Overall Study||16
8663355|NCT00710931|9706664|FG000|STARTED|Overall Study||34
8663356|NCT00710931|9706664|FG000|COMPLETED|Overall Study||29
8663357|NCT00710931|9706664|FG000|NOT COMPLETED|Overall Study||5
8692355|NCT00859937|9737780|FG000|STARTED|Overall Study||41
8692356|NCT00859937|9737781|FG001|STARTED|Overall Study||14
8692357|NCT00859937|9737780|FG000|COMPLETED|Overall Study||40
8692358|NCT00859937|9737781|FG001|COMPLETED|Overall Study||14
8692359|NCT00859937|9737780|FG000|NOT COMPLETED|Overall Study||1
8692360|NCT00859937|9737781|FG001|NOT COMPLETED|Overall Study||0
8692361|NCT00859950|9737789|FG000|STARTED|Overall Study||49
8692362|NCT00859950|9737790|FG001|STARTED|Overall Study||21
8692363|NCT00859950|9737789|FG000|COMPLETED|Overall Study||49
8692364|NCT00859950|9737790|FG001|COMPLETED|Overall Study||21
8692365|NCT00859950|9737789|FG000|NOT COMPLETED|Overall Study||0
8692366|NCT00859950|9737790|FG001|NOT COMPLETED|Overall Study||0
8692367|NCT00859976|9737798|FG000|STARTED|Overall Study||82
8692368|NCT00859976|9737799|FG001|STARTED|Overall Study||85
8692369|NCT00859976|9737798|FG000|COMPLETED|Overall Study||66
8692370|NCT00859976|9737799|FG001|COMPLETED|Overall Study||67
8692371|NCT00859976|9737798|FG000|NOT COMPLETED|Overall Study||16
8692372|NCT00859976|9737799|FG001|NOT COMPLETED|Overall Study||18
8692373|NCT00860015|9737805|FG000|STARTED|Overall Study||12
8692374|NCT00860015|9737805|FG000|COMPLETED|Overall Study||12
8692375|NCT00860015|9737805|FG000|NOT COMPLETED|Overall Study||0
8692376|NCT00860028|9737811|FG000|STARTED|Placebo Controlled Pretreatment Period||15
8692377|NCT00860028|9737812|FG001|STARTED|Placebo Controlled Pretreatment Period||15
8692378|NCT00860028|9737811|FG000|COMPLETED|Placebo Controlled Pretreatment Period||13
8692379|NCT00860028|9737812|FG001|COMPLETED|Placebo Controlled Pretreatment Period||14
8692380|NCT00860028|9737811|FG000|NOT COMPLETED|Placebo Controlled Pretreatment Period||2
8692381|NCT00860028|9737812|FG001|NOT COMPLETED|Placebo Controlled Pretreatment Period||1
8692382|NCT00860028|9737811|FG000|STARTED|Smoking Cessation Phase||13
8692383|NCT00860028|9737812|FG001|STARTED|Smoking Cessation Phase||14
8692384|NCT00860028|9737811|FG000|COMPLETED|Smoking Cessation Phase||13
8692385|NCT00860028|9737812|FG001|COMPLETED|Smoking Cessation Phase||12
8692386|NCT00860028|9737811|FG000|NOT COMPLETED|Smoking Cessation Phase||0
8692387|NCT00860028|9737812|FG001|NOT COMPLETED|Smoking Cessation Phase||2
8692388|NCT00860067|9737823|FG000|STARTED|Overall Study||1200
8692389|NCT00860067|9737824|FG001|STARTED|Overall Study||299
8692390|NCT00860067|9737825|FG002|STARTED|Overall Study||301
8692391|NCT00860067|9737823|FG000|COMPLETED|Overall Study||1149
8692392|NCT00860067|9737824|FG001|COMPLETED|Overall Study||290
8692393|NCT00860067|9737825|FG002|COMPLETED|Overall Study||292
8692394|NCT00860067|9737823|FG000|NOT COMPLETED|Overall Study||51
8692395|NCT00860067|9737824|FG001|NOT COMPLETED|Overall Study||9
8692396|NCT00860067|9737825|FG002|NOT COMPLETED|Overall Study||9
8692397|NCT00860171|9737836|FG000|STARTED|Overall Study||16
8663358|NCT00710944|9706671|FG000|STARTED|Overall Study||55
8663359|NCT00710944|9706672|FG001|STARTED|Overall Study||58
8663360|NCT00710944|9706673|FG002|STARTED|Overall Study||19
8663361|NCT00710944|9706671|FG000|COMPLETED|Overall Study||45
8663362|NCT00710944|9706672|FG001|COMPLETED|Overall Study||49
8663363|NCT00710944|9706673|FG002|COMPLETED|Overall Study||17
8663364|NCT00710944|9706671|FG000|NOT COMPLETED|Overall Study||10
8663365|NCT00710944|9706672|FG001|NOT COMPLETED|Overall Study||9
8663366|NCT00710944|9706673|FG002|NOT COMPLETED|Overall Study||2
8663367|NCT00710996|9706684|FG000|STARTED|Overall Study||17
8663368|NCT00710996|9706685|FG001|STARTED|Overall Study||20
8663369|NCT00710996|9706686|FG002|STARTED|Overall Study||21
8663370|NCT00710996|9706684|FG000|COMPLETED|Overall Study||16
8663371|NCT00710996|9706685|FG001|COMPLETED|Overall Study||16
8663372|NCT00710996|9706686|FG002|COMPLETED|Overall Study||21
8730117|NCT01056822|9777476|FG001|Safety (SAF) Population: NO|Overall Study||2
8730118|NCT01056822|9777475|FG000|COMPLETED|Overall Study||39
8730119|NCT01056822|9777476|FG001|COMPLETED|Overall Study||35
8730120|NCT01056822|9777475|FG000|NOT COMPLETED|Overall Study||8
8730121|NCT01056822|9777476|FG001|NOT COMPLETED|Overall Study||7
8730122|NCT01056913|9777483|FG000|STARTED|Overall Study||62
8663373|NCT00710996|9706684|FG000|NOT COMPLETED|Overall Study||1
8663374|NCT00710996|9706685|FG001|NOT COMPLETED|Overall Study||4
8663375|NCT00710996|9706686|FG002|NOT COMPLETED|Overall Study||0
8663376|NCT00711009|9706696|FG000|STARTED|Overall Study||105
8663377|NCT00711009|9706697|FG001|STARTED|Overall Study||101
8663378|NCT00711009|9706696|FG000|COMPLETED|Overall Study||90
8663379|NCT00711009|9706697|FG001|COMPLETED|Overall Study||82
8663380|NCT00711009|9706696|FG000|NOT COMPLETED|Overall Study||15
8663381|NCT00711009|9706697|FG001|NOT COMPLETED|Overall Study||19
8663382|NCT00711022|9706703|FG000|STARTED|Overall Study||51
8663383|NCT00711022|9706703|FG000|COMPLETED|Overall Study||40
8663384|NCT00711022|9706703|FG000|NOT COMPLETED|Overall Study||11
8663385|NCT00711100|9706707|FG000|STARTED|Overall Study||104
8663386|NCT00711100|9706707|FG000|COMPLETED|Overall Study||91
8663387|NCT00711100|9706707|FG000|NOT COMPLETED|Overall Study||13
8663388|NCT00711113|9706723|FG000|STARTED|Overall Study||47
8663389|NCT00711113|9706723|FG000|COMPLETED|Overall Study||36
8663390|NCT00711113|9706723|FG000|NOT COMPLETED|Overall Study||11
8663391|NCT00711191|9706730|FG000|STARTED|Overall Study||3
8663392|NCT00711191|9706731|FG001|STARTED|Overall Study||6
8663393|NCT00711191|9706732|FG002|STARTED|Overall Study||13
8663394|NCT00711191|9706730|FG000|COMPLETED|Overall Study||0
8663395|NCT00711191|9706731|FG001|COMPLETED|Overall Study||1
8663396|NCT00711191|9706732|FG002|COMPLETED|Overall Study||1
8663397|NCT00711191|9706730|FG000|NOT COMPLETED|Overall Study||3
8663398|NCT00711191|9706731|FG001|NOT COMPLETED|Overall Study||5
8663399|NCT00711191|9706732|FG002|NOT COMPLETED|Overall Study||12
8663400|NCT00711243|9706749|FG000|STARTED|Registed and Started Treatment||3
8663401|NCT00711243|9706750|FG001|STARTED|Registed and Started Treatment||3
8663402|NCT00711243|9706751|FG002|STARTED|Registed and Started Treatment||3
8663403|NCT00711243|9706752|FG003|STARTED|Registed and Started Treatment||3
8663404|NCT00711243|9706753|FG004|STARTED|Registed and Started Treatment||3
8663405|NCT00711243|9706754|FG005|STARTED|Registed and Started Treatment||44
8663406|NCT00711243|9706749|FG000|Registered to Study|Registed and Started Treatment||3
8663407|NCT00711243|9706750|FG001|Registered to Study|Registed and Started Treatment||3
8663408|NCT00711243|9706751|FG002|Registered to Study|Registed and Started Treatment||3
8663409|NCT00711243|9706752|FG003|Registered to Study|Registed and Started Treatment||3
8663410|NCT00711243|9706753|FG004|Registered to Study|Registed and Started Treatment||3
8663411|NCT00711243|9706754|FG005|Registered to Study|Registed and Started Treatment||44
8663412|NCT00711243|9706749|FG000|Started Treatment|Registed and Started Treatment||3
8663413|NCT00711243|9706750|FG001|Started Treatment|Registed and Started Treatment||3
8663414|NCT00711243|9706751|FG002|Started Treatment|Registed and Started Treatment||3
8663415|NCT00711243|9706752|FG003|Started Treatment|Registed and Started Treatment||3
8663416|NCT00711243|9706753|FG004|Started Treatment|Registed and Started Treatment||3
8663417|NCT00711243|9706754|FG005|Started Treatment|Registed and Started Treatment||43
8663418|NCT00711243|9706749|FG000|COMPLETED|Registed and Started Treatment||3
8663419|NCT00711243|9706750|FG001|COMPLETED|Registed and Started Treatment||3
8663420|NCT00711243|9706751|FG002|COMPLETED|Registed and Started Treatment||3
8663421|NCT00711243|9706752|FG003|COMPLETED|Registed and Started Treatment||3
8663422|NCT00711243|9706753|FG004|COMPLETED|Registed and Started Treatment||3
8663423|NCT00711243|9706754|FG005|COMPLETED|Registed and Started Treatment||43
8663424|NCT00711243|9706749|FG000|NOT COMPLETED|Registed and Started Treatment||0
8663425|NCT00711243|9706750|FG001|NOT COMPLETED|Registed and Started Treatment||0
8663426|NCT00711243|9706751|FG002|NOT COMPLETED|Registed and Started Treatment||0
8663427|NCT00711243|9706752|FG003|NOT COMPLETED|Registed and Started Treatment||0
8663428|NCT00711243|9706753|FG004|NOT COMPLETED|Registed and Started Treatment||0
8663429|NCT00711243|9706754|FG005|NOT COMPLETED|Registed and Started Treatment||1
8663430|NCT00711243|9706749|FG000|STARTED|Reached First Response/4 Cycles||3
8663431|NCT00711243|9706750|FG001|STARTED|Reached First Response/4 Cycles||3
8663432|NCT00711243|9706751|FG002|STARTED|Reached First Response/4 Cycles||3
8663433|NCT00711243|9706752|FG003|STARTED|Reached First Response/4 Cycles||3
8663434|NCT00711243|9706753|FG004|STARTED|Reached First Response/4 Cycles||3
8663435|NCT00711243|9706754|FG005|STARTED|Reached First Response/4 Cycles||43
8663436|NCT00711243|9706749|FG000|COMPLETED|Reached First Response/4 Cycles||3
8663437|NCT00711243|9706750|FG001|COMPLETED|Reached First Response/4 Cycles||3
8663438|NCT00711243|9706751|FG002|COMPLETED|Reached First Response/4 Cycles||3
8663439|NCT00711243|9706752|FG003|COMPLETED|Reached First Response/4 Cycles||2
8663440|NCT00711243|9706753|FG004|COMPLETED|Reached First Response/4 Cycles||3
8663441|NCT00711243|9706754|FG005|COMPLETED|Reached First Response/4 Cycles||41
8663442|NCT00711243|9706749|FG000|NOT COMPLETED|Reached First Response/4 Cycles||0
8663443|NCT00711243|9706750|FG001|NOT COMPLETED|Reached First Response/4 Cycles||0
8663444|NCT00711243|9706751|FG002|NOT COMPLETED|Reached First Response/4 Cycles||0
8663445|NCT00711243|9706752|FG003|NOT COMPLETED|Reached First Response/4 Cycles||1
8663446|NCT00711243|9706753|FG004|NOT COMPLETED|Reached First Response/4 Cycles||0
8663447|NCT00711243|9706754|FG005|NOT COMPLETED|Reached First Response/4 Cycles||2
8663448|NCT00711243|9706749|FG000|STARTED|Treated Cycle 5 After First Response||3
8663449|NCT00711243|9706750|FG001|STARTED|Treated Cycle 5 After First Response||3
8663450|NCT00711243|9706751|FG002|STARTED|Treated Cycle 5 After First Response||3
8663451|NCT00711243|9706752|FG003|STARTED|Treated Cycle 5 After First Response||2
8663452|NCT00711243|9706753|FG004|STARTED|Treated Cycle 5 After First Response||3
8663453|NCT00711243|9706754|FG005|STARTED|Treated Cycle 5 After First Response||41
8663454|NCT00711243|9706749|FG000|COMPLETED|Treated Cycle 5 After First Response||2
8663455|NCT00711243|9706750|FG001|COMPLETED|Treated Cycle 5 After First Response||1
8663456|NCT00711243|9706751|FG002|COMPLETED|Treated Cycle 5 After First Response||3
8663457|NCT00711243|9706752|FG003|COMPLETED|Treated Cycle 5 After First Response||2
8663458|NCT00711243|9706753|FG004|COMPLETED|Treated Cycle 5 After First Response||2
8663459|NCT00711243|9706754|FG005|COMPLETED|Treated Cycle 5 After First Response||37
8663460|NCT00711243|9706749|FG000|NOT COMPLETED|Treated Cycle 5 After First Response||1
8663461|NCT00711243|9706750|FG001|NOT COMPLETED|Treated Cycle 5 After First Response||2
8663462|NCT00711243|9706751|FG002|NOT COMPLETED|Treated Cycle 5 After First Response||0
8663463|NCT00711243|9706752|FG003|NOT COMPLETED|Treated Cycle 5 After First Response||0
8663464|NCT00711243|9706753|FG004|NOT COMPLETED|Treated Cycle 5 After First Response||1
8663465|NCT00711243|9706754|FG005|NOT COMPLETED|Treated Cycle 5 After First Response||4
8663466|NCT00711243|9706749|FG000|STARTED|Follow up Every 3 Months Until Death||3
8663467|NCT00711243|9706750|FG001|STARTED|Follow up Every 3 Months Until Death||3
8663468|NCT00711243|9706751|FG002|STARTED|Follow up Every 3 Months Until Death||3
8663469|NCT00711243|9706752|FG003|STARTED|Follow up Every 3 Months Until Death||3
8663470|NCT00711243|9706753|FG004|STARTED|Follow up Every 3 Months Until Death||3
8663471|NCT00711243|9706754|FG005|STARTED|Follow up Every 3 Months Until Death|4 patients died whilst on study and 1 patient did not get treated on study|39
8663472|NCT00711243|9706749|FG000|COMPLETED|Follow up Every 3 Months Until Death||3
8663473|NCT00711243|9706750|FG001|COMPLETED|Follow up Every 3 Months Until Death||3
8663474|NCT00711243|9706751|FG002|COMPLETED|Follow up Every 3 Months Until Death||3
8663475|NCT00711243|9706752|FG003|COMPLETED|Follow up Every 3 Months Until Death||3
8663476|NCT00711243|9706753|FG004|COMPLETED|Follow up Every 3 Months Until Death||3
8663477|NCT00711243|9706754|FG005|COMPLETED|Follow up Every 3 Months Until Death||37
8663478|NCT00711243|9706749|FG000|NOT COMPLETED|Follow up Every 3 Months Until Death||0
8663479|NCT00711243|9706750|FG001|NOT COMPLETED|Follow up Every 3 Months Until Death||0
8663480|NCT00711243|9706751|FG002|NOT COMPLETED|Follow up Every 3 Months Until Death||0
8663481|NCT00711243|9706752|FG003|NOT COMPLETED|Follow up Every 3 Months Until Death||0
8663482|NCT00711243|9706753|FG004|NOT COMPLETED|Follow up Every 3 Months Until Death||0
8663483|NCT00711243|9706754|FG005|NOT COMPLETED|Follow up Every 3 Months Until Death||2
8663484|NCT00711347|9706772|FG000|STARTED|Overall Study||14
8663485|NCT00711347|9706773|FG001|STARTED|Overall Study||14
8663486|NCT00711347|9706772|FG000|COMPLETED|Overall Study||14
8663487|NCT00711347|9706773|FG001|COMPLETED|Overall Study||14
8663488|NCT00711347|9706772|FG000|NOT COMPLETED|Overall Study||0
8663489|NCT00711347|9706773|FG001|NOT COMPLETED|Overall Study||0
8663490|NCT00711412|9706779|FG000|STARTED|Induction Treatment||44
8663491|NCT00711412|9706779|FG000|Registered to Study|Induction Treatment||44
8663492|NCT00711412|9706779|FG000|Started Induction Treatment|Induction Treatment||43
8663493|NCT00711412|9706779|FG000|COMPLETED|Induction Treatment||40
8663494|NCT00711412|9706779|FG000|NOT COMPLETED|Induction Treatment||4
8663495|NCT00711412|9706779|FG000|STARTED|Evaluated for Combination Treatment||40
8663496|NCT00711412|9706779|FG000|COMPLETED|Evaluated for Combination Treatment||34
8663497|NCT00711412|9706779|FG000|NOT COMPLETED|Evaluated for Combination Treatment||6
8663498|NCT00711412|9706779|FG000|STARTED|Combination Treatment||34
8663499|NCT00711412|9706779|FG000|COMPLETED|Combination Treatment||33
8663500|NCT00711412|9706779|FG000|NOT COMPLETED|Combination Treatment||1
8663501|NCT00711412|9706779|FG000|STARTED|Evaluation for Response and Surgery|1 patient only completed 2 cycles of therapy was evaluated and eligible for surgical resection.|34
8663502|NCT00711412|9706779|FG000|COMPLETED|Evaluation for Response and Surgery||28
8663503|NCT00711412|9706779|FG000|NOT COMPLETED|Evaluation for Response and Surgery||6
8663504|NCT00711412|9706779|FG000|STARTED|Survival Follow up Until Death|All patients that received treatment went into follow up period.|38
8663505|NCT00711412|9706779|FG000|COMPLETED|Survival Follow up Until Death||26
8663506|NCT00711412|9706779|FG000|NOT COMPLETED|Survival Follow up Until Death||12
8663507|NCT00711425|9706784|FG000|STARTED|Overall Study|Implant placement in 45 patients. Implant loading (baseline) in 44 patients.|45
8663508|NCT00711425|9706784|FG000|COMPLETED|Overall Study||41
8663509|NCT00711425|9706784|FG000|NOT COMPLETED|Overall Study||4
8663510|NCT00711464|9706788|FG000|STARTED|Overall Study||29
8663511|NCT00711464|9706788|FG000|COMPLETED|Overall Study||29
8663512|NCT00711464|9706788|FG000|NOT COMPLETED|Overall Study||0
8663513|NCT00711477|9706800|FG000|STARTED|Overall Study||23
8663514|NCT00711477|9706801|FG001|STARTED|Overall Study||23
8663515|NCT00711477|9706800|FG000|COMPLETED|Overall Study||20
8663516|NCT00711477|9706801|FG001|COMPLETED|Overall Study||20
8663517|NCT00711477|9706800|FG000|NOT COMPLETED|Overall Study||3
8663518|NCT00711477|9706801|FG001|NOT COMPLETED|Overall Study||3
8663519|NCT00711490|9706809|FG000|STARTED|Overall Study||5
8663520|NCT00711490|9706809|FG000|COMPLETED|Overall Study||5
8663521|NCT00711490|9706809|FG000|NOT COMPLETED|Overall Study||0
8663522|NCT00711516|9706816|FG000|STARTED|Overall Study||21
8663523|NCT00711516|9706817|FG001|STARTED|Overall Study||19
8663524|NCT00711516|9706816|FG000|COMPLETED|Overall Study||20
8663525|NCT00711516|9706817|FG001|COMPLETED|Overall Study||16
8663526|NCT00711516|9706816|FG000|NOT COMPLETED|Overall Study||1
8663527|NCT00711516|9706817|FG001|NOT COMPLETED|Overall Study||3
8663528|NCT00711529|9706825|FG000|STARTED|Overall Study||13
8663529|NCT00711529|9706826|FG001|STARTED|Overall Study||14
8663530|NCT00711529|9706825|FG000|COMPLETED|Overall Study|2 women lost their hot flash diary, so only 7 patients were evaluable for primary endpoint.|9
8663531|NCT00711529|9706826|FG001|COMPLETED|Overall Study||8
8663532|NCT00711529|9706825|FG000|NOT COMPLETED|Overall Study||4
8663533|NCT00711529|9706826|FG001|NOT COMPLETED|Overall Study||6
8663534|NCT00711594|9706836|FG000|STARTED|Overall Study||3
8663535|NCT00711594|9706837|FG001|STARTED|Overall Study||3
8663536|NCT00711594|9706838|FG002|STARTED|Overall Study||6
8663537|NCT00711594|9706839|FG003|STARTED|Overall Study||62
8663538|NCT00711594|9706836|FG000|COMPLETED|Overall Study||0
8663539|NCT00711594|9706837|FG001|COMPLETED|Overall Study||0
8663540|NCT00711594|9706838|FG002|COMPLETED|Overall Study||0
8663541|NCT00711594|9706839|FG003|COMPLETED|Overall Study||0
8663542|NCT00711594|9706836|FG000|NOT COMPLETED|Overall Study||3
8663543|NCT00711594|9706837|FG001|NOT COMPLETED|Overall Study||3
8663544|NCT00711594|9706838|FG002|NOT COMPLETED|Overall Study||6
8663545|NCT00711594|9706839|FG003|NOT COMPLETED|Overall Study||62
8663546|NCT00711646|9706853|FG000|STARTED|Overall Study||124
8663547|NCT00711646|9706854|FG001|STARTED|Overall Study||65
8663548|NCT00711646|9706853|FG000|COMPLETED|Overall Study||112
8663549|NCT00711646|9706854|FG001|COMPLETED|Overall Study||62
8663550|NCT00711646|9706853|FG000|NOT COMPLETED|Overall Study||12
8663551|NCT00711646|9706854|FG001|NOT COMPLETED|Overall Study||3
8663552|NCT00711711|9706862|FG000|STARTED|Overall Study||30
8663553|NCT00711711|9706863|FG001|STARTED|Overall Study||30
8663554|NCT00711711|9706862|FG000|Second Postsurgical Day|Overall Study||30
8663555|NCT00711711|9706863|FG001|Second Postsurgical Day|Overall Study||30
8663556|NCT00711711|9706862|FG000|Seventh Postsurgical Day|Overall Study||29
8663557|NCT00711711|9706863|FG001|Seventh Postsurgical Day|Overall Study||27
8663558|NCT00711711|9706862|FG000|COMPLETED|Overall Study||29
8663559|NCT00711711|9706863|FG001|COMPLETED|Overall Study||24
8663560|NCT00711711|9706862|FG000|NOT COMPLETED|Overall Study||1
8663561|NCT00711711|9706863|FG001|NOT COMPLETED|Overall Study||6
8663562|NCT00711802|9706879|FG000|STARTED|Overall Study||75
8663563|NCT00711802|9706880|FG001|STARTED|Overall Study||38
8663564|NCT00711802|9706881|FG002|STARTED|Overall Study||75
8663565|NCT00711802|9706882|FG003|STARTED|Overall Study||38
8663566|NCT00711802|9706883|FG004|STARTED|Overall Study||83
8663567|NCT00711802|9706884|FG005|STARTED|Overall Study||42
8663568|NCT00711802|9706885|FG006|STARTED|Overall Study||30
8663569|NCT00711802|9706886|FG007|STARTED|Overall Study||15
8663570|NCT00711802|9706879|FG000|Received at Least 1 Dose of Study Drug|Overall Study||73
8663571|NCT00711802|9706880|FG001|Received at Least 1 Dose of Study Drug|Overall Study||37
8663572|NCT00711802|9706881|FG002|Received at Least 1 Dose of Study Drug|Overall Study||73
8663573|NCT00711802|9706882|FG003|Received at Least 1 Dose of Study Drug|Overall Study||38
8663574|NCT00711802|9706883|FG004|Received at Least 1 Dose of Study Drug|Overall Study||81
8663575|NCT00711802|9706884|FG005|Received at Least 1 Dose of Study Drug|Overall Study||42
8663576|NCT00711802|9706885|FG006|Received at Least 1 Dose of Study Drug|Overall Study||30
8663577|NCT00711802|9706886|FG007|Received at Least 1 Dose of Study Drug|Overall Study||15
8663578|NCT00711802|9706879|FG000|COMPLETED|Overall Study||73
8663579|NCT00711802|9706880|FG001|COMPLETED|Overall Study||32
8663580|NCT00711802|9706881|FG002|COMPLETED|Overall Study||69
8663581|NCT00711802|9706882|FG003|COMPLETED|Overall Study||35
8663582|NCT00711802|9706883|FG004|COMPLETED|Overall Study||69
8663583|NCT00711802|9706884|FG005|COMPLETED|Overall Study||34
8663584|NCT00711802|9706885|FG006|COMPLETED|Overall Study||25
8663585|NCT00711802|9706886|FG007|COMPLETED|Overall Study||13
8663586|NCT00711802|9706879|FG000|NOT COMPLETED|Overall Study||2
8663587|NCT00711802|9706880|FG001|NOT COMPLETED|Overall Study||6
8663588|NCT00711802|9706881|FG002|NOT COMPLETED|Overall Study||6
8663589|NCT00711802|9706882|FG003|NOT COMPLETED|Overall Study||3
8663590|NCT00711802|9706883|FG004|NOT COMPLETED|Overall Study||14
8663591|NCT00711802|9706884|FG005|NOT COMPLETED|Overall Study||8
8663592|NCT00711802|9706885|FG006|NOT COMPLETED|Overall Study||5
8663593|NCT00711802|9706886|FG007|NOT COMPLETED|Overall Study||2
8663594|NCT00711828|9706907|FG000|STARTED|Overall Study||21
8663595|NCT00711828|9706907|FG000|COMPLETED|Overall Study||21
8663596|NCT00711828|9706907|FG000|NOT COMPLETED|Overall Study||0
8663597|NCT00711867|9706913|FG000|STARTED|Overall Study||30
8663598|NCT00711867|9706914|FG001|STARTED|Overall Study||25
8663599|NCT00711867|9706913|FG000|COMPLETED|Overall Study|2 received additional warming. 3 missing primary measure.|25
8663600|NCT00711867|9706914|FG001|COMPLETED|Overall Study|3 received additional warming. 1 missing primary measure.|21
8663601|NCT00711867|9706913|FG000|NOT COMPLETED|Overall Study||5
8663602|NCT00711867|9706914|FG001|NOT COMPLETED|Overall Study||4
8663603|NCT00711880|9706922|FG000|STARTED|Overall Study||63
8663604|NCT00711880|9706923|FG001|STARTED|Overall Study||62
8663605|NCT00711880|9706922|FG000|COMPLETED|Overall Study||50
8663606|NCT00711880|9706923|FG001|COMPLETED|Overall Study||55
8663607|NCT00711880|9706922|FG000|NOT COMPLETED|Overall Study||13
8663608|NCT00711880|9706923|FG001|NOT COMPLETED|Overall Study||7
8663609|NCT00711958|9706931|FG000|STARTED|Overall Study||74
8663610|NCT00711958|9706932|FG001|STARTED|Overall Study||40
8663611|NCT00711958|9706931|FG000|COMPLETED|Overall Study||41
8663612|NCT00711958|9706932|FG001|COMPLETED|Overall Study||17
8663613|NCT00711958|9706931|FG000|NOT COMPLETED|Overall Study||33
8663614|NCT00711958|9706932|FG001|NOT COMPLETED|Overall Study||23
8663615|NCT00711971|9706941|FG000|STARTED|Overall Study||42
8663616|NCT00711971|9706942|FG001|STARTED|Overall Study||42
8663617|NCT00711971|9706943|FG002|STARTED|Overall Study||42
8663618|NCT00711971|9706941|FG000|COMPLETED|Overall Study||39
8663619|NCT00711971|9706942|FG001|COMPLETED|Overall Study||38
8663620|NCT00711971|9706943|FG002|COMPLETED|Overall Study||41
8663621|NCT00711971|9706941|FG000|NOT COMPLETED|Overall Study||3
8663622|NCT00711971|9706942|FG001|NOT COMPLETED|Overall Study||4
8663623|NCT00711971|9706943|FG002|NOT COMPLETED|Overall Study||1
8663624|NCT00711997|9706957|FG000|STARTED|Overall Study||3
8663625|NCT00711997|9706958|FG001|STARTED|Overall Study||6
8663626|NCT00711997|9706957|FG000|COMPLETED|Overall Study||3
8663627|NCT00711997|9706958|FG001|COMPLETED|Overall Study||6
8663628|NCT00711997|9706957|FG000|NOT COMPLETED|Overall Study||0
8663629|NCT00711997|9706958|FG001|NOT COMPLETED|Overall Study||0
8663630|NCT00712010|9706966|FG000|STARTED|1st Protein Testing (1 Day)|1 subject withdrew his consent form before to starting the 1st intervention|24
8663631|NCT00712010|9706966|FG000|COMPLETED|1st Protein Testing (1 Day)||24
8663632|NCT00712010|9706966|FG000|NOT COMPLETED|1st Protein Testing (1 Day)||0
8663633|NCT00712010|9706966|FG000|STARTED|Washout (7 Days)||24
8663634|NCT00712010|9706966|FG000|COMPLETED|Washout (7 Days)||24
8663635|NCT00712010|9706966|FG000|NOT COMPLETED|Washout (7 Days)||0
8663636|NCT00712010|9706966|FG000|STARTED|2nd Protein Testing (1 Day)||24
8663637|NCT00712010|9706966|FG000|COMPLETED|2nd Protein Testing (1 Day)||24
8663638|NCT00712010|9706966|FG000|NOT COMPLETED|2nd Protein Testing (1 Day)||0
8663639|NCT00712010|9706966|FG000|STARTED|Washout (7 Days)||24
8663640|NCT00712010|9706966|FG000|COMPLETED|Washout (7 Days)||24
8663641|NCT00712010|9706966|FG000|NOT COMPLETED|Washout (7 Days)||0
8663642|NCT00712010|9706966|FG000|STARTED|3rd Protein Testing (1 Day)||24
8663643|NCT00712010|9706966|FG000|COMPLETED|3rd Protein Testing (1 Day)||24
8663644|NCT00712010|9706966|FG000|NOT COMPLETED|3rd Protein Testing (1 Day)||0
8663645|NCT00712010|9706966|FG000|STARTED|Washout (7 Days)||24
8663646|NCT00712010|9706966|FG000|COMPLETED|Washout (7 Days)||24
8663647|NCT00712010|9706966|FG000|NOT COMPLETED|Washout (7 Days)||0
8663648|NCT00712010|9706966|FG000|STARTED|4th Protein Testing (1 Day)||24
8663649|NCT00712010|9706966|FG000|COMPLETED|4th Protein Testing (1 Day)||24
8663650|NCT00712010|9706966|FG000|NOT COMPLETED|4th Protein Testing (1 Day)||0
8663651|NCT00712010|9706966|FG000|STARTED|Washout (7 Days)||24
8663652|NCT00712010|9706966|FG000|COMPLETED|Washout (7 Days)||23
8663653|NCT00712010|9706966|FG000|NOT COMPLETED|Washout (7 Days)||1
8663654|NCT00712010|9706966|FG000|STARTED|5th Protein Testing (1 Day)||23
8663655|NCT00712010|9706966|FG000|COMPLETED|5th Protein Testing (1 Day)||23
8663656|NCT00712010|9706966|FG000|NOT COMPLETED|5th Protein Testing (1 Day)||0
8663657|NCT00712010|9706966|FG000|STARTED|Washout (7 Days)||23
8663658|NCT00712010|9706966|FG000|COMPLETED|Washout (7 Days)||23
8663659|NCT00712010|9706966|FG000|NOT COMPLETED|Washout (7 Days)||0
8663660|NCT00712010|9706966|FG000|STARTED|6th Protein Testing (1 Day)||23
8663661|NCT00712010|9706966|FG000|COMPLETED|6th Protein Testing (1 Day)||23
8663662|NCT00712010|9706966|FG000|NOT COMPLETED|6th Protein Testing (1 Day)||0
8663663|NCT00712010|9706966|FG000|STARTED|Washout (7 Days)||23
8663664|NCT00712010|9706966|FG000|COMPLETED|Washout (7 Days)||23
8663665|NCT00712010|9706966|FG000|NOT COMPLETED|Washout (7 Days)||0
8663666|NCT00712010|9706966|FG000|STARTED|7th and Last Protein Testing (1 Day)||23
8663667|NCT00712010|9706966|FG000|COMPLETED|7th and Last Protein Testing (1 Day)||23
8663668|NCT00712010|9706966|FG000|NOT COMPLETED|7th and Last Protein Testing (1 Day)||0
8663669|NCT00712075|9706985|FG000|STARTED|Overall Study||22
8663670|NCT00712075|9706986|FG001|STARTED|Overall Study||30
8730123|NCT01056913|9777483|FG000|COMPLETED|Overall Study||62
8663671|NCT00712075|9706987|FG002|STARTED|Overall Study||25
8663672|NCT00712075|9706985|FG000|COMPLETED|Overall Study||17
8663673|NCT00712075|9706986|FG001|COMPLETED|Overall Study||26
8663674|NCT00712075|9706987|FG002|COMPLETED|Overall Study||14
8663675|NCT00712075|9706985|FG000|NOT COMPLETED|Overall Study||5
8663676|NCT00712075|9706986|FG001|NOT COMPLETED|Overall Study||4
8663677|NCT00712075|9706987|FG002|NOT COMPLETED|Overall Study||11
8663678|NCT00712166|9706997|FG000|STARTED|Overall Study||81
8663679|NCT00712166|9706998|FG001|STARTED|Overall Study||76
8663680|NCT00712166|9706997|FG000|COMPLETED|Overall Study||81
8663681|NCT00712166|9706998|FG001|COMPLETED|Overall Study||75
8730124|NCT01056913|9777483|FG000|NOT COMPLETED|Overall Study||0
8663682|NCT00712166|9706997|FG000|NOT COMPLETED|Overall Study||0
8663683|NCT00712166|9706998|FG001|NOT COMPLETED|Overall Study||1
8663684|NCT00712179|9707006|FG000|STARTED|Overall Study||49
8663685|NCT00712179|9707006|FG000|COMPLETED|Overall Study|Data from 4 subjects was excluded due to noise in recorded EMG signal, so 33 subjects were analysed.|37
8663686|NCT00712179|9707006|FG000|NOT COMPLETED|Overall Study||12
8663687|NCT00712244|9707014|FG000|STARTED|Overall Study||29
8663688|NCT00712244|9707015|FG001|STARTED|Overall Study||29
8663689|NCT00712244|9707016|FG002|STARTED|Overall Study||27
8663690|NCT00712244|9707017|FG003|STARTED|Overall Study||27
8663691|NCT00712244|9707014|FG000|COMPLETED|Overall Study||25
8663692|NCT00712244|9707015|FG001|COMPLETED|Overall Study||28
8663693|NCT00712244|9707016|FG002|COMPLETED|Overall Study||25
8663694|NCT00712244|9707017|FG003|COMPLETED|Overall Study||26
8663695|NCT00712244|9707014|FG000|NOT COMPLETED|Overall Study||4
8663696|NCT00712244|9707015|FG001|NOT COMPLETED|Overall Study||1
8663697|NCT00712244|9707016|FG002|NOT COMPLETED|Overall Study||2
8663698|NCT00712244|9707017|FG003|NOT COMPLETED|Overall Study||1
8663699|NCT00712270|9707030|FG000|STARTED|Overall Study||21
8663700|NCT00712270|9707030|FG000|COMPLETED|Overall Study||7
8663701|NCT00712270|9707030|FG000|NOT COMPLETED|Overall Study||14
8663702|NCT00712296|9707044|FG000|STARTED|Phase I ( 1 Week)||12
8663703|NCT00712296|9707045|FG001|STARTED|Phase I ( 1 Week)||8
8663704|NCT00712296|9707046|FG002|STARTED|Phase I ( 1 Week)||0
8663705|NCT00712296|9707047|FG003|STARTED|Phase I ( 1 Week)||0
8663706|NCT00712296|9707048|FG004|STARTED|Phase I ( 1 Week)||0
8663707|NCT00712296|9707044|FG000|COMPLETED|Phase I ( 1 Week)||12
8663708|NCT00712296|9707045|FG001|COMPLETED|Phase I ( 1 Week)||8
8663709|NCT00712296|9707046|FG002|COMPLETED|Phase I ( 1 Week)||0
8663710|NCT00712296|9707047|FG003|COMPLETED|Phase I ( 1 Week)||0
8663711|NCT00712296|9707048|FG004|COMPLETED|Phase I ( 1 Week)||0
8663712|NCT00712296|9707044|FG000|NOT COMPLETED|Phase I ( 1 Week)||0
8663713|NCT00712296|9707045|FG001|NOT COMPLETED|Phase I ( 1 Week)||0
8663714|NCT00712296|9707046|FG002|NOT COMPLETED|Phase I ( 1 Week)||0
8663715|NCT00712296|9707047|FG003|NOT COMPLETED|Phase I ( 1 Week)||0
8663716|NCT00712296|9707048|FG004|NOT COMPLETED|Phase I ( 1 Week)||0
8663717|NCT00712296|9707044|FG000|STARTED|Phase II (28 Weeks)||0
8663718|NCT00712296|9707045|FG001|STARTED|Phase II (28 Weeks)||0
8663719|NCT00712296|9707046|FG002|STARTED|Phase II (28 Weeks)||15
8663720|NCT00712296|9707047|FG003|STARTED|Phase II (28 Weeks)||16
8663721|NCT00712296|9707048|FG004|STARTED|Phase II (28 Weeks)||15
8663722|NCT00712296|9707044|FG000|COMPLETED|Phase II (28 Weeks)||0
8663723|NCT00712296|9707045|FG001|COMPLETED|Phase II (28 Weeks)||0
8663724|NCT00712296|9707046|FG002|COMPLETED|Phase II (28 Weeks)|ASHMI/Placebo was discontinued on 9/29/10.20 participants were re-randomized into the Phase II.|2
8663725|NCT00712296|9707047|FG003|COMPLETED|Phase II (28 Weeks)||1
8663726|NCT00712296|9707048|FG004|COMPLETED|Phase II (28 Weeks)||3
8663727|NCT00712296|9707044|FG000|NOT COMPLETED|Phase II (28 Weeks)||0
8663728|NCT00712296|9707045|FG001|NOT COMPLETED|Phase II (28 Weeks)||0
8663729|NCT00712296|9707046|FG002|NOT COMPLETED|Phase II (28 Weeks)||13
8663730|NCT00712296|9707047|FG003|NOT COMPLETED|Phase II (28 Weeks)||15
8663731|NCT00712296|9707048|FG004|NOT COMPLETED|Phase II (28 Weeks)||12
8663732|NCT00712335|9707084|FG000|STARTED|Overall Study||8
8663733|NCT00712335|9707085|FG001|STARTED|Overall Study||32
8663734|NCT00712335|9707086|FG002|STARTED|Overall Study||11
8663735|NCT00712335|9707087|FG003|STARTED|Overall Study||24
8663736|NCT00712335|9707088|FG004|STARTED|Overall Study||30
8663737|NCT00712335|9707084|FG000|COMPLETED|Overall Study||5
8663738|NCT00712335|9707085|FG001|COMPLETED|Overall Study||15
8663739|NCT00712335|9707086|FG002|COMPLETED|Overall Study||6
8663740|NCT00712335|9707087|FG003|COMPLETED|Overall Study||19
8663741|NCT00712335|9707088|FG004|COMPLETED|Overall Study||30
8663742|NCT00712335|9707084|FG000|NOT COMPLETED|Overall Study||3
8663743|NCT00712335|9707085|FG001|NOT COMPLETED|Overall Study||17
8663744|NCT00712335|9707086|FG002|NOT COMPLETED|Overall Study||5
8663745|NCT00712335|9707087|FG003|NOT COMPLETED|Overall Study||5
8663746|NCT00712335|9707088|FG004|NOT COMPLETED|Overall Study||0
8663747|NCT00712348|9707100|FG000|STARTED|Overall Study||31
8663748|NCT00712348|9707100|FG000|COMPLETED|Overall Study||30
8663749|NCT00712348|9707100|FG000|NOT COMPLETED|Overall Study||1
8663750|NCT00712530|9707107|FG000|STARTED|Overall Study||3
8663751|NCT00712530|9707108|FG001|STARTED|Overall Study||3
8663752|NCT00712530|9707109|FG002|STARTED|Overall Study|Screened 4 patients, but one failed to meet entry criteria due to a history of bleeding and diabetes|3
8663753|NCT00712530|9707107|FG000|COMPLETED|Overall Study||3
8663754|NCT00712530|9707108|FG001|COMPLETED|Overall Study||3
8663755|NCT00712530|9707109|FG002|COMPLETED|Overall Study||3
8663756|NCT00712530|9707107|FG000|NOT COMPLETED|Overall Study||0
8663757|NCT00712530|9707108|FG001|NOT COMPLETED|Overall Study||0
8663758|NCT00712530|9707109|FG002|NOT COMPLETED|Overall Study||0
8663759|NCT00712543|9707119|FG000|STARTED|Day 1-7||23
8663760|NCT00712543|9707120|FG001|STARTED|Day 1-7||27
8663761|NCT00712543|9707119|FG000|COMPLETED|Day 1-7||23
8663762|NCT00712543|9707120|FG001|COMPLETED|Day 1-7||27
8663763|NCT00712543|9707119|FG000|NOT COMPLETED|Day 1-7||0
8663764|NCT00712543|9707120|FG001|NOT COMPLETED|Day 1-7||0
8663765|NCT00712543|9707119|FG000|STARTED|Day 8-14||23
8663766|NCT00712543|9707120|FG001|STARTED|Day 8-14||27
8663767|NCT00712543|9707119|FG000|COMPLETED|Day 8-14||23
8663768|NCT00712543|9707120|FG001|COMPLETED|Day 8-14||25
8663769|NCT00712543|9707119|FG000|NOT COMPLETED|Day 8-14||0
8663770|NCT00712543|9707120|FG001|NOT COMPLETED|Day 8-14||2
8663771|NCT00712673|9707129|FG000|STARTED|Overall Study|Randomized.|85
8663772|NCT00712673|9707130|FG001|STARTED|Overall Study||85
8663773|NCT00712673|9707131|FG002|STARTED|Overall Study||255
8663774|NCT00712673|9707132|FG003|STARTED|Overall Study||255
8663775|NCT00712673|9707129|FG000|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|85
8663776|NCT00712673|9707130|FG001|Safety Population|Overall Study||85
8663777|NCT00712673|9707131|FG002|Safety Population|Overall Study||255
8663778|NCT00712673|9707132|FG003|Safety Population|Overall Study||255
8663779|NCT00712673|9707129|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|85
8663780|NCT00712673|9707130|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||85
8663781|NCT00712673|9707131|FG002|Modified Intent-to-Treat(mITT)Population|Overall Study||255
8730125|NCT01057017|9777487|FG000|STARTED|Overall Study||5
8730126|NCT01057017|9777487|FG000|COMPLETED|Overall Study||5
8730127|NCT01057017|9777487|FG000|NOT COMPLETED|Overall Study||0
8730128|NCT01057225|9777491|FG000|STARTED|Overall Study||3
8911402|NCT02146326|9970505|FG003|Baseline|Overall Study||258
8911403|NCT02146326|9970502|FG000|3 Months|Overall Study||71
8911404|NCT02146326|9970503|FG001|3 Months|Overall Study||83
8911405|NCT02146326|9970504|FG002|3 Months|Overall Study||0
8911406|NCT02146326|9970505|FG003|3 Months|Overall Study||0
8911407|NCT02146326|9970502|FG000|6 Months|Overall Study||71
8911408|NCT02146326|9970503|FG001|6 Months|Overall Study||71
8911409|NCT02146326|9970504|FG002|6 Months|Overall Study||186
8911410|NCT02146326|9970505|FG003|6 Months|Overall Study||235
8911411|NCT02146326|9970502|FG000|12 Months|Overall Study||61
8911412|NCT02146326|9970503|FG001|12 Months|Overall Study||66
8911413|NCT02146326|9970504|FG002|12 Months|Overall Study||168
8911414|NCT02146326|9970505|FG003|12 Months|Overall Study||210
8911415|NCT02146326|9970502|FG000|COMPLETED|Overall Study||61
8911416|NCT02146326|9970503|FG001|COMPLETED|Overall Study||66
8911417|NCT02146326|9970504|FG002|COMPLETED|Overall Study||168
8911418|NCT02146326|9970505|FG003|COMPLETED|Overall Study||210
8911419|NCT02146326|9970502|FG000|NOT COMPLETED|Overall Study||28
8911420|NCT02146326|9970503|FG001|NOT COMPLETED|Overall Study||37
8911421|NCT02146326|9970504|FG002|NOT COMPLETED|Overall Study||43
8911422|NCT02146326|9970505|FG003|NOT COMPLETED|Overall Study||48
8911423|NCT02146352|9970521|FG000|STARTED|Overall Study||30
8911424|NCT02146352|9970521|FG000|30 or 60 Days Post-procedure|Overall Study||30
8911425|NCT02146352|9970521|FG000|7 Days Post-stent Removal|Overall Study||28
8911426|NCT02146352|9970521|FG000|COMPLETED|Overall Study||28
8911427|NCT02146352|9970521|FG000|NOT COMPLETED|Overall Study||2
8911428|NCT02146365|9970531|FG000|STARTED|Overall Study||49
8911429|NCT02146365|9970532|FG001|STARTED|Overall Study||49
8911430|NCT02146365|9970533|FG002|STARTED|Overall Study||50
8911431|NCT02146365|9970534|FG003|STARTED|Overall Study||50
8911432|NCT02146365|9970535|FG004|STARTED|Overall Study||24
8911433|NCT02146365|9970536|FG005|STARTED|Overall Study||25
8911434|NCT02146365|9970537|FG006|STARTED|Overall Study||25
8911435|NCT02146365|9970538|FG007|STARTED|Overall Study||25
8911436|NCT02146365|9970531|FG000|COMPLETED|Overall Study||45
8911437|NCT02146365|9970532|FG001|COMPLETED|Overall Study||45
8911438|NCT02146365|9970533|FG002|COMPLETED|Overall Study||43
8911439|NCT02146365|9970534|FG003|COMPLETED|Overall Study||41
9022408|NCT03126539|10085296|FG001|COMPLETED|Overall Study||8
8730129|NCT01057225|9777492|FG001|STARTED|Overall Study||3
8911440|NCT02146365|9970535|FG004|COMPLETED|Overall Study||22
8911441|NCT02146365|9970536|FG005|COMPLETED|Overall Study||24
8911442|NCT02146365|9970537|FG006|COMPLETED|Overall Study||25
8730130|NCT01057225|9777493|FG002|STARTED|Overall Study||6
8730131|NCT01057225|9777494|FG003|STARTED|Overall Study||7
8730132|NCT01057225|9777495|FG004|STARTED|Overall Study||22
8730133|NCT01057225|9777496|FG005|STARTED|Overall Study||23
8730134|NCT01057225|9777491|FG000|COMPLETED|Overall Study||3
8730135|NCT01057225|9777492|FG001|COMPLETED|Overall Study||3
8730136|NCT01057225|9777493|FG002|COMPLETED|Overall Study||6
8730137|NCT01057225|9777494|FG003|COMPLETED|Overall Study||7
8730138|NCT01057225|9777495|FG004|COMPLETED|Overall Study||22
8730139|NCT01057225|9777496|FG005|COMPLETED|Overall Study||23
8730140|NCT01057225|9777491|FG000|NOT COMPLETED|Overall Study||0
8730141|NCT01057225|9777492|FG001|NOT COMPLETED|Overall Study||0
8730142|NCT01057225|9777493|FG002|NOT COMPLETED|Overall Study||0
8730143|NCT01057225|9777494|FG003|NOT COMPLETED|Overall Study||0
8730144|NCT01057225|9777495|FG004|NOT COMPLETED|Overall Study||0
8730145|NCT01057225|9777496|FG005|NOT COMPLETED|Overall Study||0
8730146|NCT01057251|9777511|FG000|STARTED|Overall Study||290
8730147|NCT01057251|9777512|FG001|STARTED|Overall Study|The safety population is 142, as one patient was randomized, but never received study drug.|143
8730148|NCT01057251|9777511|FG000|COMPLETED|Overall Study||262
8730149|NCT01057251|9777512|FG001|COMPLETED|Overall Study||114
8730150|NCT01057251|9777511|FG000|NOT COMPLETED|Overall Study||28
8730151|NCT01057251|9777512|FG001|NOT COMPLETED|Overall Study||29
8730152|NCT01057277|9777518|FG000|STARTED|Overall Study||3
8730153|NCT01057277|9777518|FG000|COMPLETED|Overall Study||3
8730154|NCT01057277|9777518|FG000|NOT COMPLETED|Overall Study||0
8730155|NCT01057381|9777526|FG000|STARTED|Overall Study||26
8730156|NCT01057381|9777527|FG001|STARTED|Overall Study||27
8911443|NCT02146365|9970538|FG007|COMPLETED|Overall Study||24
8911444|NCT02146365|9970531|FG000|NOT COMPLETED|Overall Study||4
8911445|NCT02146365|9970532|FG001|NOT COMPLETED|Overall Study||4
8663782|NCT00712673|9707132|FG003|Modified Intent-to-Treat(mITT)Population|Overall Study||255
8663783|NCT00712673|9707129|FG000|Subgroup for Standardized Meal Test|Overall Study|Patients from morning injection arms where standardized meal test was performed.|85
8663784|NCT00712673|9707130|FG001|Subgroup for Standardized Meal Test|Overall Study||0
8663785|NCT00712673|9707131|FG002|Subgroup for Standardized Meal Test|Overall Study||255
8663786|NCT00712673|9707132|FG003|Subgroup for Standardized Meal Test|Overall Study||0
8663787|NCT00712673|9707129|FG000|COMPLETED|Overall Study||64
8663788|NCT00712673|9707130|FG001|COMPLETED|Overall Study||64
8663789|NCT00712673|9707131|FG002|COMPLETED|Overall Study||198
8663790|NCT00712673|9707132|FG003|COMPLETED|Overall Study||185
8663791|NCT00712673|9707129|FG000|NOT COMPLETED|Overall Study||21
8663792|NCT00712673|9707130|FG001|NOT COMPLETED|Overall Study||21
8663793|NCT00712673|9707131|FG002|NOT COMPLETED|Overall Study||57
8663794|NCT00712673|9707132|FG003|NOT COMPLETED|Overall Study||70
8663795|NCT00712712|9707151|FG000|STARTED|Overall Study||78
8663796|NCT00712712|9707151|FG000|COMPLETED|Overall Study||55
8663797|NCT00712712|9707151|FG000|NOT COMPLETED|Overall Study||23
8663798|NCT00712725|9707163|FG000|STARTED|Overall Study||169
8663799|NCT00712725|9707164|FG001|STARTED|Overall Study||39
8663800|NCT00712725|9707165|FG002|STARTED|Overall Study||57
8663801|NCT00712725|9707166|FG003|STARTED|Overall Study||84
8663802|NCT00712725|9707167|FG004|STARTED|Overall Study||86
8663803|NCT00712725|9707168|FG005|STARTED|Overall Study||84
8663804|NCT00712725|9707169|FG006|STARTED|Overall Study||83
8663805|NCT00712725|9707170|FG007|STARTED|Overall Study||74
8663806|NCT00712725|9707163|FG000|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|140
8663807|NCT00712725|9707164|FG001|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|33
8663808|NCT00712725|9707165|FG002|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|47
8663809|NCT00712725|9707166|FG003|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|67
8663810|NCT00712725|9707167|FG004|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|67
8663811|NCT00712725|9707168|FG005|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|68
8663812|NCT00712725|9707169|FG006|COMPLETED|Overall Study|One patient received study drug. The remaining patients discontinued prior to receiving study drug.|61
8663813|NCT00712725|9707170|FG007|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|63
8663814|NCT00712725|9707163|FG000|NOT COMPLETED|Overall Study||29
8663815|NCT00712725|9707164|FG001|NOT COMPLETED|Overall Study||6
8663816|NCT00712725|9707165|FG002|NOT COMPLETED|Overall Study||10
8663817|NCT00712725|9707166|FG003|NOT COMPLETED|Overall Study||17
8663818|NCT00712725|9707167|FG004|NOT COMPLETED|Overall Study||19
8663819|NCT00712725|9707168|FG005|NOT COMPLETED|Overall Study||16
8663820|NCT00712725|9707169|FG006|NOT COMPLETED|Overall Study||22
8663821|NCT00712725|9707170|FG007|NOT COMPLETED|Overall Study||11
8663822|NCT00712920|9707191|FG000|STARTED|Overall Study||192
8663823|NCT00712920|9707192|FG001|STARTED|Overall Study|3 subjects were randomized in error|197
8663824|NCT00712920|9707193|FG002|STARTED|Overall Study||192
8663825|NCT00712920|9707191|FG000|COMPLETED|Overall Study||175
8663826|NCT00712920|9707192|FG001|COMPLETED|Overall Study||180
8663827|NCT00712920|9707193|FG002|COMPLETED|Overall Study||180
8663828|NCT00712920|9707191|FG000|NOT COMPLETED|Overall Study||17
8663829|NCT00712920|9707192|FG001|NOT COMPLETED|Overall Study||17
8663830|NCT00712920|9707193|FG002|NOT COMPLETED|Overall Study||12
8663831|NCT00712959|9707203|FG000|STARTED|Overall Study||361
8663832|NCT00712959|9707204|FG001|STARTED|Overall Study||407
8663833|NCT00712959|9707203|FG000|COMPLETED|Overall Study||342
8663834|NCT00712959|9707204|FG001|COMPLETED|Overall Study||404
8663835|NCT00712959|9707203|FG000|NOT COMPLETED|Overall Study||19
8663836|NCT00712959|9707204|FG001|NOT COMPLETED|Overall Study||3
8663837|NCT00712985|9707210|FG000|STARTED|Overall Study||18
8663838|NCT00712985|9707210|FG000|COMPLETED|Overall Study||13
8663839|NCT00712985|9707210|FG000|NOT COMPLETED|Overall Study||5
8663840|NCT00713219|9707214|FG000|STARTED|Overall Study||14
8663841|NCT00713219|9707214|FG000|COMPLETED|Overall Study||12
8663842|NCT00713219|9707214|FG000|NOT COMPLETED|Overall Study||2
8663843|NCT00713284|9707218|FG000|STARTED|Overall Study|29 participants were screened but only 13 eligible for conversion and continue in the study.|29
8663844|NCT00713284|9707218|FG000|COMPLETED|Overall Study||13
8663845|NCT00713284|9707218|FG000|NOT COMPLETED|Overall Study||16
8663846|NCT00713310|9707224|FG000|STARTED|Overall Study||41
8663847|NCT00713310|9707225|FG001|STARTED|Overall Study||42
8663848|NCT00713310|9707224|FG000|mITT Population|Overall Study||41
8663849|NCT00713310|9707225|FG001|mITT Population|Overall Study|1 subject randomized to high dose not dosed so not included in the mITT population.|41
8663850|NCT00713310|9707224|FG000|COMPLETED|Overall Study||36
8663851|NCT00713310|9707225|FG001|COMPLETED|Overall Study||36
8663852|NCT00713310|9707224|FG000|NOT COMPLETED|Overall Study||5
8663853|NCT00713310|9707225|FG001|NOT COMPLETED|Overall Study||6
8663854|NCT00713323|9707231|FG000|STARTED|Overall Study||380
8663855|NCT00713323|9707231|FG000|COMPLETED|Overall Study||234
8663856|NCT00713323|9707231|FG000|NOT COMPLETED|Overall Study||146
8663857|NCT00713349|9707235|FG000|STARTED|Overall Study||25
8663858|NCT00713349|9707235|FG000|COMPLETED|Overall Study||24
8663859|NCT00713349|9707235|FG000|NOT COMPLETED|Overall Study||1
8663860|NCT00713427|9707241|FG000|STARTED|Overall Study||70
8730157|NCT01057381|9777528|FG002|STARTED|Overall Study||30
8663861|NCT00713427|9707241|FG000|COMPLETED|Overall Study||66
8663862|NCT00713427|9707241|FG000|NOT COMPLETED|Overall Study||4
8663863|NCT00713479|9707245|FG000|STARTED|First Medication Condition||6
8663864|NCT00713479|9707246|FG001|STARTED|First Medication Condition||6
8663865|NCT00713479|9707245|FG000|COMPLETED|First Medication Condition||2
8663866|NCT00713479|9707246|FG001|COMPLETED|First Medication Condition||6
8663867|NCT00713479|9707245|FG000|NOT COMPLETED|First Medication Condition||4
8663868|NCT00713479|9707246|FG001|NOT COMPLETED|First Medication Condition||0
8663869|NCT00713479|9707245|FG000|STARTED|Washout||2
8663870|NCT00713479|9707246|FG001|STARTED|Washout||6
8663871|NCT00713479|9707245|FG000|COMPLETED|Washout||2
8663872|NCT00713479|9707246|FG001|COMPLETED|Washout||6
8663873|NCT00713479|9707245|FG000|NOT COMPLETED|Washout||0
8663874|NCT00713479|9707246|FG001|NOT COMPLETED|Washout||0
8663875|NCT00713479|9707245|FG000|STARTED|Next Medication Condition||2
8663876|NCT00713479|9707246|FG001|STARTED|Next Medication Condition||6
8663877|NCT00713479|9707245|FG000|COMPLETED|Next Medication Condition||2
8663878|NCT00713479|9707246|FG001|COMPLETED|Next Medication Condition||6
8663879|NCT00713479|9707245|FG000|NOT COMPLETED|Next Medication Condition||0
8663880|NCT00713479|9707246|FG001|NOT COMPLETED|Next Medication Condition||0
8663881|NCT00713544|9707260|FG000|STARTED|Overall Study||52
8663882|NCT00713544|9707261|FG001|STARTED|Overall Study||52
8663883|NCT00713544|9707262|FG002|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|52
8663884|NCT00713544|9707263|FG003|STARTED|Overall Study||76
8663885|NCT00713544|9707264|FG004|STARTED|Overall Study||65
8663886|NCT00713544|9707265|FG005|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|76
8663887|NCT00713544|9707260|FG000|COMPLETED|Overall Study||45
8663888|NCT00713544|9707261|FG001|COMPLETED|Overall Study||46
8663889|NCT00713544|9707262|FG002|COMPLETED|Overall Study||41
8663890|NCT00713544|9707263|FG003|COMPLETED|Overall Study||66
8663891|NCT00713544|9707264|FG004|COMPLETED|Overall Study||57
8663892|NCT00713544|9707265|FG005|COMPLETED|Overall Study||67
8663893|NCT00713544|9707260|FG000|NOT COMPLETED|Overall Study||7
8663894|NCT00713544|9707261|FG001|NOT COMPLETED|Overall Study||6
8663895|NCT00713544|9707262|FG002|NOT COMPLETED|Overall Study||11
8663896|NCT00713544|9707263|FG003|NOT COMPLETED|Overall Study||10
8663897|NCT00713544|9707264|FG004|NOT COMPLETED|Overall Study||8
8663898|NCT00713544|9707265|FG005|NOT COMPLETED|Overall Study||9
8663899|NCT00713583|9707281|FG000|STARTED|Overall Study||45
8663900|NCT00713583|9707282|FG001|STARTED|Overall Study||40
8663901|NCT00713583|9707281|FG000|COMPLETED|Overall Study||45
8663902|NCT00713583|9707282|FG001|COMPLETED|Overall Study||40
8663903|NCT00713583|9707281|FG000|NOT COMPLETED|Overall Study||0
8663904|NCT00713583|9707282|FG001|NOT COMPLETED|Overall Study||0
8663905|NCT00713609|9707294|FG000|STARTED|Overall Study||106
8663906|NCT00713609|9707295|FG001|STARTED|Overall Study||105
8663907|NCT00713609|9707296|FG002|STARTED|Overall Study||107
8663908|NCT00713609|9707297|FG003|STARTED|Overall Study||108
8663909|NCT00713609|9707298|FG004|STARTED|Overall Study||106
8663910|NCT00713609|9707299|FG005|STARTED|Overall Study||55
8663911|NCT00713609|9707294|FG000|COMPLETED|Overall Study||85
8663912|NCT00713609|9707295|FG001|COMPLETED|Overall Study||90
8663913|NCT00713609|9707296|FG002|COMPLETED|Overall Study||92
8663914|NCT00713609|9707297|FG003|COMPLETED|Overall Study||99
8663915|NCT00713609|9707298|FG004|COMPLETED|Overall Study||87
8663916|NCT00713609|9707299|FG005|COMPLETED|Overall Study||47
8663917|NCT00713609|9707294|FG000|NOT COMPLETED|Overall Study||21
8663918|NCT00713609|9707295|FG001|NOT COMPLETED|Overall Study||15
8663919|NCT00713609|9707296|FG002|NOT COMPLETED|Overall Study||15
8663920|NCT00713609|9707297|FG003|NOT COMPLETED|Overall Study||9
8663921|NCT00713609|9707298|FG004|NOT COMPLETED|Overall Study||19
8663922|NCT00713609|9707299|FG005|NOT COMPLETED|Overall Study||8
8663923|NCT00713648|9707313|FG000|STARTED|Overall Study||41
8663924|NCT00713648|9707313|FG000|COMPLETED|Overall Study||33
8663925|NCT00713648|9707313|FG000|NOT COMPLETED|Overall Study||8
8663926|NCT00713661|9707321|FG000|STARTED|Overall Study||7
8663927|NCT00713661|9707322|FG001|STARTED|Overall Study||9
8663928|NCT00713661|9707323|FG002|STARTED|Overall Study||4
8663929|NCT00713661|9707324|FG003|STARTED|Overall Study||5
8663930|NCT00713661|9707321|FG000|COMPLETED|Overall Study||7
8663931|NCT00713661|9707322|FG001|COMPLETED|Overall Study||9
8663932|NCT00713661|9707323|FG002|COMPLETED|Overall Study||4
8663933|NCT00713661|9707324|FG003|COMPLETED|Overall Study||5
8663934|NCT00713661|9707321|FG000|NOT COMPLETED|Overall Study||0
8663935|NCT00713661|9707322|FG001|NOT COMPLETED|Overall Study||0
8663936|NCT00713661|9707323|FG002|NOT COMPLETED|Overall Study||0
8663937|NCT00713661|9707324|FG003|NOT COMPLETED|Overall Study||0
8663938|NCT00713700|9707334|FG000|STARTED|Overall Study||192
8663939|NCT00713700|9707334|FG000|COMPLETED|Overall Study||188
8663940|NCT00713700|9707334|FG000|NOT COMPLETED|Overall Study||4
8663941|NCT00713817|9707340|FG000|STARTED|Overall Study||10
8663942|NCT00713817|9707341|FG001|STARTED|Overall Study||9
8663943|NCT00713817|9707340|FG000|COMPLETED|Overall Study||10
8663944|NCT00713817|9707341|FG001|COMPLETED|Overall Study||9
8663945|NCT00713817|9707340|FG000|NOT COMPLETED|Overall Study||0
8663946|NCT00713817|9707341|FG001|NOT COMPLETED|Overall Study||0
8663947|NCT00713830|9707349|FG000|STARTED|Overall Study|Randomized.|286
8663948|NCT00713830|9707350|FG001|STARTED|Overall Study||573
8663949|NCT00713830|9707349|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|286
8663950|NCT00713830|9707350|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||570
8663951|NCT00713830|9707349|FG000|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|285
8663952|NCT00713830|9707350|FG001|Safety Population|Overall Study|1 patient randomized to placebo received Lixisenatide (at least one dose)|574
8663953|NCT00713830|9707349|FG000|Subgroup for Standardized Meal Test|Overall Study|Patients at selected sites where standardized meal challenge test was performed.|155
8663954|NCT00713830|9707350|FG001|Subgroup for Standardized Meal Test|Overall Study||313
8663955|NCT00713830|9707349|FG000|COMPLETED|Overall Study||204
8663956|NCT00713830|9707350|FG001|COMPLETED|Overall Study||396
8663957|NCT00713830|9707349|FG000|NOT COMPLETED|Overall Study||82
8663958|NCT00713830|9707350|FG001|NOT COMPLETED|Overall Study||177
8663959|NCT00714051|9707358|FG000|STARTED|Overall Study||27
8663960|NCT00714051|9707359|FG001|STARTED|Overall Study||28
8663961|NCT00714051|9707358|FG000|COMPLETED|Overall Study||26
8663962|NCT00714051|9707359|FG001|COMPLETED|Overall Study||27
8663963|NCT00714051|9707358|FG000|NOT COMPLETED|Overall Study||1
8663964|NCT00714051|9707359|FG001|NOT COMPLETED|Overall Study||1
8663965|NCT00714168|9707367|FG000|STARTED|Overall Study||165
8663966|NCT00714168|9707368|FG001|STARTED|Overall Study||198
8663967|NCT00714168|9707367|FG000|COMPLETED|Overall Study||121
8663968|NCT00714168|9707368|FG001|COMPLETED|Overall Study||139
8663969|NCT00714168|9707367|FG000|NOT COMPLETED|Overall Study||44
8663970|NCT00714168|9707368|FG001|NOT COMPLETED|Overall Study||59
8663971|NCT00714233|9707378|FG000|STARTED|Overall Study||10
8663972|NCT00714233|9707379|FG001|STARTED|Overall Study||11
8663973|NCT00714233|9707380|FG002|STARTED|Overall Study||11
8663974|NCT00714233|9707381|FG003|STARTED|Overall Study||10
8663975|NCT00714233|9707378|FG000|COMPLETED|Overall Study||6
8663976|NCT00714233|9707379|FG001|COMPLETED|Overall Study||10
8663977|NCT00714233|9707380|FG002|COMPLETED|Overall Study||10
8663978|NCT00714233|9707381|FG003|COMPLETED|Overall Study||6
8663979|NCT00714233|9707378|FG000|NOT COMPLETED|Overall Study||4
8663980|NCT00714233|9707379|FG001|NOT COMPLETED|Overall Study||1
8663981|NCT00714233|9707380|FG002|NOT COMPLETED|Overall Study||1
8663982|NCT00714233|9707381|FG003|NOT COMPLETED|Overall Study||4
8663983|NCT00714259|9707396|FG000|STARTED|Overall Study||5
8663984|NCT00714259|9707396|FG000|COMPLETED|Overall Study||3
8663985|NCT00714259|9707396|FG000|NOT COMPLETED|Overall Study||2
8663986|NCT00714272|9707402|FG000|STARTED|Overall Study||2
8663987|NCT00714272|9707403|FG001|STARTED|Overall Study||2
8663988|NCT00714272|9707402|FG000|COMPLETED|Overall Study||2
8663989|NCT00714272|9707403|FG001|COMPLETED|Overall Study||2
8663990|NCT00714272|9707402|FG000|NOT COMPLETED|Overall Study||0
8663991|NCT00714272|9707403|FG001|NOT COMPLETED|Overall Study||0
8663992|NCT00714285|9707413|FG000|STARTED|Overall Study||105
8663993|NCT00714285|9707414|FG001|STARTED|Overall Study||105
8663994|NCT00714285|9707415|FG002|STARTED|Overall Study||105
8663995|NCT00714285|9707416|FG003|STARTED|Overall Study||105
8663996|NCT00714285|9707413|FG000|COMPLETED|Overall Study|Completed upto Day 180|105
8663997|NCT00714285|9707414|FG001|COMPLETED|Overall Study|Completed upto Day 180|102
8663998|NCT00714285|9707415|FG002|COMPLETED|Overall Study|Completed upto Day 180|105
8663999|NCT00714285|9707416|FG003|COMPLETED|Overall Study|Completed upto Day 180|104
8664000|NCT00714285|9707413|FG000|NOT COMPLETED|Overall Study||0
8664001|NCT00714285|9707414|FG001|NOT COMPLETED|Overall Study||3
8664002|NCT00714285|9707415|FG002|NOT COMPLETED|Overall Study||0
8664003|NCT00714285|9707416|FG003|NOT COMPLETED|Overall Study||1
8664004|NCT00714311|9707430|FG000|STARTED|Overall Study||52
8664005|NCT00714311|9707431|FG001|STARTED|Overall Study||52
8664006|NCT00714311|9707430|FG000|COMPLETED|Overall Study||39
8664007|NCT00714311|9707431|FG001|COMPLETED|Overall Study||30
8664008|NCT00714311|9707430|FG000|NOT COMPLETED|Overall Study||13
8664009|NCT00714311|9707431|FG001|NOT COMPLETED|Overall Study||22
8664010|NCT00714389|9707437|FG000|STARTED|Overall Study||12
8664011|NCT00714389|9707437|FG000|COMPLETED|Overall Study||12
8664012|NCT00714389|9707437|FG000|NOT COMPLETED|Overall Study||0
8664013|NCT00714415|9707443|FG000|STARTED|Overall Study||25
8664014|NCT00714415|9707444|FG001|STARTED|Overall Study||55
8664015|NCT00714415|9707443|FG000|COMPLETED|Overall Study||23
8730158|NCT01057381|9777529|FG003|STARTED|Overall Study||26
8730159|NCT01057381|9777526|FG000|COMPLETED|Overall Study||26
8730160|NCT01057381|9777527|FG001|COMPLETED|Overall Study||27
8730161|NCT01057381|9777528|FG002|COMPLETED|Overall Study||30
8730162|NCT01057381|9777529|FG003|COMPLETED|Overall Study||26
8730163|NCT01057381|9777526|FG000|NOT COMPLETED|Overall Study||0
8730164|NCT01057381|9777527|FG001|NOT COMPLETED|Overall Study||0
8730165|NCT01057381|9777528|FG002|NOT COMPLETED|Overall Study||0
8911446|NCT02146365|9970533|FG002|NOT COMPLETED|Overall Study||7
8664016|NCT00714415|9707444|FG001|COMPLETED|Overall Study||55
8664017|NCT00714415|9707443|FG000|NOT COMPLETED|Overall Study||2
8664018|NCT00714415|9707444|FG001|NOT COMPLETED|Overall Study||0
8664019|NCT00714493|9707450|FG000|STARTED|Overall Study||203
8664020|NCT00714493|9707450|FG000|COMPLETED|Overall Study||154
8664021|NCT00714493|9707450|FG000|NOT COMPLETED|Overall Study||49
8664022|NCT00714571|9707460|FG000|STARTED|Stage 1||12
8664023|NCT00714571|9707461|FG001|STARTED|Stage 1|11 allocated to intervention, but 1 withdrew before the first intervention session|15
8664024|NCT00714571|9707462|FG002|STARTED|Stage 1||11
8664025|NCT00714571|9707463|FG003|STARTED|Stage 1||14
8664026|NCT00714571|9707464|FG004|STARTED|Stage 1||0
8664027|NCT00714571|9707465|FG005|STARTED|Stage 1||0
8692398|NCT00860171|9737836|FG000|COMPLETED|Overall Study||16
8664028|NCT00714571|9707460|FG000|COMPLETED|Stage 1|1 patient excluded who completed training but did not disclose ongoing chemotherapy for cancer|12
8664029|NCT00714571|9707461|FG001|COMPLETED|Stage 1||15
8664030|NCT00714571|9707462|FG002|COMPLETED|Stage 1||10
8664031|NCT00714571|9707463|FG003|COMPLETED|Stage 1||14
8664032|NCT00714571|9707464|FG004|COMPLETED|Stage 1||0
8664033|NCT00714571|9707465|FG005|COMPLETED|Stage 1||0
8664034|NCT00714571|9707460|FG000|NOT COMPLETED|Stage 1||0
8664035|NCT00714571|9707461|FG001|NOT COMPLETED|Stage 1||0
8664036|NCT00714571|9707462|FG002|NOT COMPLETED|Stage 1||1
8664037|NCT00714571|9707463|FG003|NOT COMPLETED|Stage 1||0
8664038|NCT00714571|9707464|FG004|NOT COMPLETED|Stage 1||0
8664039|NCT00714571|9707465|FG005|NOT COMPLETED|Stage 1||0
8664040|NCT00714571|9707460|FG000|STARTED|Stage 2||0
8664041|NCT00714571|9707461|FG001|STARTED|Stage 2||0
8664042|NCT00714571|9707462|FG002|STARTED|Stage 2||0
8664043|NCT00714571|9707463|FG003|STARTED|Stage 2||0
8664044|NCT00714571|9707464|FG004|STARTED|Stage 2||15
8664045|NCT00714571|9707465|FG005|STARTED|Stage 2||15
8664046|NCT00714571|9707460|FG000|COMPLETED|Stage 2||0
8664047|NCT00714571|9707461|FG001|COMPLETED|Stage 2||0
8664048|NCT00714571|9707462|FG002|COMPLETED|Stage 2||0
8664049|NCT00714571|9707463|FG003|COMPLETED|Stage 2||0
8664050|NCT00714571|9707464|FG004|COMPLETED|Stage 2||15
8664051|NCT00714571|9707465|FG005|COMPLETED|Stage 2||15
8664052|NCT00714571|9707460|FG000|NOT COMPLETED|Stage 2||0
8664053|NCT00714571|9707461|FG001|NOT COMPLETED|Stage 2||0
8664054|NCT00714571|9707462|FG002|NOT COMPLETED|Stage 2||0
8664055|NCT00714571|9707463|FG003|NOT COMPLETED|Stage 2||0
8664056|NCT00714571|9707464|FG004|NOT COMPLETED|Stage 2||0
8664057|NCT00714571|9707465|FG005|NOT COMPLETED|Stage 2||0
8664058|NCT00714688|9707482|FG000|STARTED|Overall Study||97
8664059|NCT00714688|9707483|FG001|STARTED|Overall Study||90
8664060|NCT00714688|9707484|FG002|STARTED|Overall Study||92
8664061|NCT00714688|9707482|FG000|COMPLETED|Overall Study||68
8664062|NCT00714688|9707483|FG001|COMPLETED|Overall Study||55
8664063|NCT00714688|9707484|FG002|COMPLETED|Overall Study||55
8664064|NCT00714688|9707482|FG000|NOT COMPLETED|Overall Study||29
8664065|NCT00714688|9707483|FG001|NOT COMPLETED|Overall Study||35
8664066|NCT00714688|9707484|FG002|NOT COMPLETED|Overall Study||37
8664067|NCT00714714|9707492|FG000|STARTED|Overall Study||25
8730166|NCT01057381|9777529|FG003|NOT COMPLETED|Overall Study||0
8730167|NCT01057394|9777539|FG000|STARTED|Overall Study||0
8730168|NCT01057394|9777540|FG001|STARTED|Overall Study|21 enrolled participants|21
8730169|NCT01057394|9777539|FG000|COMPLETED|Overall Study||0
8730170|NCT01057394|9777540|FG001|COMPLETED|Overall Study|19 treated participants|19
8730171|NCT01057394|9777539|FG000|NOT COMPLETED|Overall Study||0
8730172|NCT01057394|9777540|FG001|NOT COMPLETED|Overall Study||2
8730173|NCT01057433|9777544|FG000|STARTED|Overall Study||24
8730174|NCT01057433|9777544|FG000|COMPLETED|Overall Study||23
8730175|NCT01057433|9777544|FG000|NOT COMPLETED|Overall Study||1
8730176|NCT01057589|9777548|FG000|STARTED|Overall Study||66
8730177|NCT01057589|9777548|FG000|COMPLETED|Overall Study||0
8730178|NCT01057589|9777548|FG000|NOT COMPLETED|Overall Study||66
8730179|NCT01057693|9777552|FG000|STARTED|Single-Blind Phase (Up to Week 6)||665
8730180|NCT01057693|9777553|FG001|STARTED|Single-Blind Phase (Up to Week 6)||0
8730181|NCT01057693|9777554|FG002|STARTED|Single-Blind Phase (Up to Week 6)||0
8730182|NCT01057693|9777552|FG000|COMPLETED|Single-Blind Phase (Up to Week 6)||566
8730183|NCT01057693|9777553|FG001|COMPLETED|Single-Blind Phase (Up to Week 6)||0
8730184|NCT01057693|9777554|FG002|COMPLETED|Single-Blind Phase (Up to Week 6)||0
8730185|NCT01057693|9777552|FG000|NOT COMPLETED|Single-Blind Phase (Up to Week 6)||99
8730186|NCT01057693|9777553|FG001|NOT COMPLETED|Single-Blind Phase (Up to Week 6)||0
8730187|NCT01057693|9777554|FG002|NOT COMPLETED|Single-Blind Phase (Up to Week 6)||0
8730188|NCT01057693|9777552|FG000|STARTED|Between Single-Blind and Double-Blind||566
8730189|NCT01057693|9777553|FG001|STARTED|Between Single-Blind and Double-Blind||0
8730190|NCT01057693|9777554|FG002|STARTED|Between Single-Blind and Double-Blind||0
8730191|NCT01057693|9777552|FG000|COMPLETED|Between Single-Blind and Double-Blind||296
8730192|NCT01057693|9777553|FG001|COMPLETED|Between Single-Blind and Double-Blind||0
8730193|NCT01057693|9777554|FG002|COMPLETED|Between Single-Blind and Double-Blind||0
8730194|NCT01057693|9777552|FG000|NOT COMPLETED|Between Single-Blind and Double-Blind||270
8730195|NCT01057693|9777553|FG001|NOT COMPLETED|Between Single-Blind and Double-Blind||0
8730196|NCT01057693|9777554|FG002|NOT COMPLETED|Between Single-Blind and Double-Blind||0
8730197|NCT01057693|9777552|FG000|STARTED|Double-Blind Phase (Week 7 to Week 19)||0
8730198|NCT01057693|9777553|FG001|STARTED|Double-Blind Phase (Week 7 to Week 19)||147
8730199|NCT01057693|9777554|FG002|STARTED|Double-Blind Phase (Week 7 to Week 19)||149
8730200|NCT01057693|9777552|FG000|Treated|Double-Blind Phase (Week 7 to Week 19)||0
8664068|NCT00714714|9707492|FG000|COMPLETED|Overall Study||24
8664069|NCT00714714|9707492|FG000|NOT COMPLETED|Overall Study||1
8664070|NCT00714753|9707498|FG000|STARTED|Overall Study||5
8664071|NCT00714753|9707498|FG000|HDR Brachytherapy|Overall Study||5
8664072|NCT00714753|9707498|FG000|External Beam Radiotherapy (EBRT)|Overall Study||1
8664073|NCT00714753|9707498|FG000|COMPLETED|Overall Study||5
8664074|NCT00714753|9707498|FG000|NOT COMPLETED|Overall Study||0
8664075|NCT00714792|9707504|FG000|STARTED|Overall Study||10
8664076|NCT00714792|9707505|FG001|STARTED|Overall Study||8
8664077|NCT00714792|9707504|FG000|COMPLETED|Overall Study||10
8664078|NCT00714792|9707505|FG001|COMPLETED|Overall Study||8
8664079|NCT00714792|9707504|FG000|NOT COMPLETED|Overall Study||0
8664080|NCT00714792|9707505|FG001|NOT COMPLETED|Overall Study||0
8664081|NCT00714870|9707513|FG000|STARTED|Overall Study||49
8664082|NCT00714870|9707514|FG001|STARTED|Overall Study||27
8664083|NCT00714870|9707513|FG000|COMPLETED|Overall Study||22
8664084|NCT00714870|9707514|FG001|COMPLETED|Overall Study||22
8664085|NCT00714870|9707513|FG000|NOT COMPLETED|Overall Study||27
8664086|NCT00714870|9707514|FG001|NOT COMPLETED|Overall Study||5
8664087|NCT00715026|9707520|FG000|STARTED|Overall Study|30 unilateral subjects and 1 bilateral|31
8664088|NCT00715026|9707520|FG000|Subjects That Received Surgery|Overall Study|24 unilateral subjects and 1 bilateral|25
8664089|NCT00715026|9707520|FG000|COMPLETED|Overall Study|20 unilateral subjects and 1 bilateral|21
8664090|NCT00715026|9707520|FG000|NOT COMPLETED|Overall Study||10
8664091|NCT00715078|9707527|FG000|STARTED|Overall Study||41
8664092|NCT00715078|9707528|FG001|STARTED|Overall Study||40
8664093|NCT00715078|9707529|FG002|STARTED|Overall Study||41
8664094|NCT00715078|9707527|FG000|Received ≥ 1 Study Infusion|Overall Study||40
8664095|NCT00715078|9707528|FG001|Received ≥ 1 Study Infusion|Overall Study||40
8664096|NCT00715078|9707529|FG002|Received ≥ 1 Study Infusion|Overall Study||39
8664097|NCT00715078|9707527|FG000|Received ≥ 1 Leukapheresis|Overall Study||40
8664098|NCT00715078|9707528|FG001|Received ≥ 1 Leukapheresis|Overall Study||40
8664099|NCT00715078|9707529|FG002|Received ≥ 1 Leukapheresis|Overall Study||40
8664100|NCT00715078|9707527|FG000|COMPLETED|Overall Study||11
8664101|NCT00715078|9707528|FG001|COMPLETED|Overall Study||4
8664102|NCT00715078|9707529|FG002|COMPLETED|Overall Study||3
8664103|NCT00715078|9707527|FG000|NOT COMPLETED|Overall Study||30
8664104|NCT00715078|9707528|FG001|NOT COMPLETED|Overall Study||36
8664105|NCT00715078|9707529|FG002|NOT COMPLETED|Overall Study||38
8664106|NCT00715104|9707540|FG000|STARTED|Overall Study||18
8664107|NCT00715104|9707541|FG001|STARTED|Overall Study||16
8664108|NCT00715104|9707542|FG002|STARTED|Overall Study||8
8664109|NCT00715104|9707540|FG000|COMPLETED|Overall Study||18
8730201|NCT01057693|9777553|FG001|Treated|Double-Blind Phase (Week 7 to Week 19)||147
8730202|NCT01057693|9777554|FG002|Treated|Double-Blind Phase (Week 7 to Week 19)||147
8730203|NCT01057693|9777552|FG000|COMPLETED|Double-Blind Phase (Week 7 to Week 19)||0
8730204|NCT01057693|9777553|FG001|COMPLETED|Double-Blind Phase (Week 7 to Week 19)||125
8730205|NCT01057693|9777554|FG002|COMPLETED|Double-Blind Phase (Week 7 to Week 19)||113
8730206|NCT01057693|9777552|FG000|NOT COMPLETED|Double-Blind Phase (Week 7 to Week 19)||0
8730207|NCT01057693|9777553|FG001|NOT COMPLETED|Double-Blind Phase (Week 7 to Week 19)||22
8730208|NCT01057693|9777554|FG002|NOT COMPLETED|Double-Blind Phase (Week 7 to Week 19)||36
8730209|NCT01057810|9777564|FG000|STARTED|Overall Study||199
8730210|NCT01057810|9777565|FG001|STARTED|Overall Study||399
8730211|NCT01057810|9777564|FG000|COMPLETED|Overall Study||1
8730212|NCT01057810|9777565|FG001|COMPLETED|Overall Study||1
8730213|NCT01057810|9777564|FG000|NOT COMPLETED|Overall Study||198
8730214|NCT01057810|9777565|FG001|NOT COMPLETED|Overall Study||398
8730215|NCT01057862|9777573|FG000|STARTED|Overall Study||5
8730216|NCT01057862|9777574|FG001|STARTED|Overall Study||4
8730217|NCT01057862|9777573|FG000|COMPLETED|Overall Study||4
8730218|NCT01057862|9777574|FG001|COMPLETED|Overall Study||2
8730219|NCT01057862|9777573|FG000|NOT COMPLETED|Overall Study||1
8730220|NCT01057862|9777574|FG001|NOT COMPLETED|Overall Study||2
8730221|NCT01057888|9777583|FG000|STARTED|Overall Study||2504
8730222|NCT01057888|9777584|FG001|STARTED|Overall Study||2406
8730223|NCT01057888|9777585|FG002|STARTED|Overall Study||2494
8730224|NCT01057888|9777583|FG000|COMPLETED|Overall Study||2504
8730225|NCT01057888|9777584|FG001|COMPLETED|Overall Study||2406
8730226|NCT01057888|9777585|FG002|COMPLETED|Overall Study||2494
8730227|NCT01057888|9777583|FG000|NOT COMPLETED|Overall Study||0
8730228|NCT01057888|9777584|FG001|NOT COMPLETED|Overall Study||0
8730229|NCT01057888|9777585|FG002|NOT COMPLETED|Overall Study||0
8806645|NCT01479348|9858944|FG001|COMPLETED|Overall Study||0
8806646|NCT01479348|9858943|FG000|NOT COMPLETED|Overall Study||0
8806647|NCT01479348|9858944|FG001|NOT COMPLETED|Overall Study||0
8806648|NCT01479374|9858951|FG000|STARTED|Overall Study||66
8806649|NCT01479374|9858952|FG001|STARTED|Overall Study||68
8806650|NCT01479374|9858953|FG002|STARTED|Overall Study||68
8806651|NCT01479374|9858951|FG000|COMPLETED|Overall Study||63
8806652|NCT01479374|9858952|FG001|COMPLETED|Overall Study||60
8806653|NCT01479374|9858953|FG002|COMPLETED|Overall Study||63
8664110|NCT00715104|9707541|FG001|COMPLETED|Overall Study||16
8664111|NCT00715104|9707542|FG002|COMPLETED|Overall Study||8
8806654|NCT01479374|9858951|FG000|NOT COMPLETED|Overall Study||3
8806655|NCT01479374|9858952|FG001|NOT COMPLETED|Overall Study||8
8806656|NCT01479374|9858953|FG002|NOT COMPLETED|Overall Study||5
8806657|NCT01479426|9858963|FG000|STARTED|Overall Study||40
8806658|NCT01479426|9858964|FG001|STARTED|Overall Study||40
8806659|NCT01479426|9858963|FG000|COMPLETED|Overall Study||36
8806660|NCT01479426|9858964|FG001|COMPLETED|Overall Study||37
8806661|NCT01479426|9858963|FG000|NOT COMPLETED|Overall Study||4
8806662|NCT01479426|9858964|FG001|NOT COMPLETED|Overall Study||3
8806663|NCT01479439|9858973|FG000|STARTED|Overall Study||15
8806664|NCT01479439|9858974|FG001|STARTED|Overall Study||13
8806665|NCT01479439|9858975|FG002|STARTED|Overall Study||8
8806666|NCT01479439|9858973|FG000|COMPLETED|Overall Study||14
8806667|NCT01479439|9858974|FG001|COMPLETED|Overall Study||12
8806668|NCT01479439|9858975|FG002|COMPLETED|Overall Study||6
8806669|NCT01479439|9858973|FG000|NOT COMPLETED|Overall Study||1
8806670|NCT01479439|9858974|FG001|NOT COMPLETED|Overall Study||1
8806671|NCT01479439|9858975|FG002|NOT COMPLETED|Overall Study||2
8806672|NCT01479465|9858990|FG000|STARTED|Overall Study||11
8806673|NCT01479465|9858991|FG001|STARTED|Overall Study||84
8664112|NCT00715104|9707540|FG000|NOT COMPLETED|Overall Study||0
8664113|NCT00715104|9707541|FG001|NOT COMPLETED|Overall Study||0
8664114|NCT00715104|9707542|FG002|NOT COMPLETED|Overall Study||0
8664115|NCT00715117|9707586|FG000|STARTED|Overall Study||6
8664116|NCT00715117|9707587|FG001|STARTED|Overall Study||6
8664117|NCT00715117|9707586|FG000|Completion fo 8 Week Study|Overall Study||6
8664118|NCT00715117|9707587|FG001|Completion fo 8 Week Study|Overall Study||6
8664119|NCT00715117|9707586|FG000|COMPLETED|Overall Study||6
8664120|NCT00715117|9707587|FG001|COMPLETED|Overall Study|One subject flared and was rescued with steroids|5
8664121|NCT00715117|9707586|FG000|NOT COMPLETED|Overall Study||0
8664122|NCT00715117|9707587|FG001|NOT COMPLETED|Overall Study||1
8664123|NCT00715208|9707600|FG000|STARTED|Overall Study||7
8664124|NCT00715208|9707601|FG001|STARTED|Overall Study||48
8664125|NCT00715208|9707600|FG000|COMPLETED|Overall Study||6
8664126|NCT00715208|9707601|FG001|COMPLETED|Overall Study||39
8664127|NCT00715208|9707600|FG000|NOT COMPLETED|Overall Study||1
8664128|NCT00715208|9707601|FG001|NOT COMPLETED|Overall Study||9
8664129|NCT00715299|9707607|FG000|STARTED|Overall Study|A total of 38 participants were consented to the study, but only 36 made it to day one of testing.|36
8664130|NCT00715299|9707607|FG000|COMPLETED|Overall Study||30
8664131|NCT00715299|9707607|FG000|NOT COMPLETED|Overall Study||6
8664132|NCT00715390|9707611|FG000|STARTED|Overall Study|114,209 Anesthetic records were screened to identify 234 records.|234
8664133|NCT00715390|9707611|FG000|Eligible|Overall Study||234
8664134|NCT00715390|9707611|FG000|COMPLETED|Overall Study|These were broken down to different types of dysrhythymia.|234
8664135|NCT00715390|9707611|FG000|NOT COMPLETED|Overall Study||0
8664136|NCT00715403|9707622|FG000|STARTED|Overall Study||1
8664137|NCT00715403|9707623|FG001|STARTED|Overall Study||1
8664138|NCT00715403|9707624|FG002|STARTED|Overall Study||4
8664139|NCT00715403|9707625|FG003|STARTED|Overall Study||9
8664140|NCT00715403|9707626|FG004|STARTED|Overall Study||6
8664141|NCT00715403|9707627|FG005|STARTED|Overall Study||19
8664142|NCT00715403|9707628|FG006|STARTED|Overall Study||1
8664143|NCT00715403|9707622|FG000|COMPLETED|Overall Study||0
8664144|NCT00715403|9707623|FG001|COMPLETED|Overall Study||0
8664145|NCT00715403|9707624|FG002|COMPLETED|Overall Study||0
8664146|NCT00715403|9707625|FG003|COMPLETED|Overall Study||0
8664147|NCT00715403|9707626|FG004|COMPLETED|Overall Study||0
8664148|NCT00715403|9707627|FG005|COMPLETED|Overall Study||0
8664149|NCT00715403|9707628|FG006|COMPLETED|Overall Study||0
8664150|NCT00715403|9707622|FG000|NOT COMPLETED|Overall Study||1
8664151|NCT00715403|9707623|FG001|NOT COMPLETED|Overall Study||1
8664152|NCT00715403|9707624|FG002|NOT COMPLETED|Overall Study||4
8664153|NCT00715403|9707625|FG003|NOT COMPLETED|Overall Study||9
8664154|NCT00715403|9707626|FG004|NOT COMPLETED|Overall Study||6
8664155|NCT00715403|9707627|FG005|NOT COMPLETED|Overall Study||19
8664156|NCT00715403|9707628|FG006|NOT COMPLETED|Overall Study||1
8664157|NCT00715429|9707646|FG000|STARTED|Overall Study||7
8664158|NCT00715429|9707647|FG001|STARTED|Overall Study||7
8664159|NCT00715429|9707646|FG000|COMPLETED|Overall Study||7
8664160|NCT00715429|9707647|FG001|COMPLETED|Overall Study||6
8664161|NCT00715429|9707646|FG000|NOT COMPLETED|Overall Study||0
8664162|NCT00715429|9707647|FG001|NOT COMPLETED|Overall Study||1
8664163|NCT00715520|9707656|FG000|STARTED|Overall Study||20
8664164|NCT00715520|9707657|FG001|STARTED|Overall Study||10
8664165|NCT00715520|9707658|FG002|STARTED|Overall Study||3
8664166|NCT00715520|9707656|FG000|COMPLETED|Overall Study||10
8664167|NCT00715520|9707657|FG001|COMPLETED|Overall Study||9
8664168|NCT00715520|9707658|FG002|COMPLETED|Overall Study||1
8664169|NCT00715520|9707656|FG000|NOT COMPLETED|Overall Study||10
8664170|NCT00715520|9707657|FG001|NOT COMPLETED|Overall Study||1
8664171|NCT00715520|9707658|FG002|NOT COMPLETED|Overall Study||2
8664172|NCT00715559|9707666|FG000|STARTED|Overall Study||3
8664173|NCT00715559|9707666|FG000|COMPLETED|Overall Study||2
8664174|NCT00715559|9707666|FG000|NOT COMPLETED|Overall Study||1
8664175|NCT00715624|9707672|FG000|STARTED|Overall Study|Randomized|167
8664176|NCT00715624|9707673|FG001|STARTED|Overall Study||329
8664177|NCT00715624|9707672|FG000|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|167
8664178|NCT00715624|9707673|FG001|Treated/Safety Population|Overall Study||328
8664179|NCT00715624|9707672|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|166
8664180|NCT00715624|9707673|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||327
8664181|NCT00715624|9707672|FG000|COMPLETED|Overall Study||115
8664182|NCT00715624|9707673|FG001|COMPLETED|Overall Study||213
8664183|NCT00715624|9707672|FG000|NOT COMPLETED|Overall Study||52
8664184|NCT00715624|9707673|FG001|NOT COMPLETED|Overall Study||116
8664185|NCT00715650|9707681|FG000|STARTED|Intervention||47
8664186|NCT00715650|9707682|FG001|STARTED|Intervention||45
8664187|NCT00715650|9707681|FG000|Received Any Session|Intervention||39
8664188|NCT00715650|9707682|FG001|Received Any Session|Intervention||38
8664189|NCT00715650|9707681|FG000|Attended ≥ 2 Sessions|Intervention||36
8664190|NCT00715650|9707682|FG001|Attended ≥ 2 Sessions|Intervention||33
8664191|NCT00715650|9707681|FG000|Attended ≥ 3 Sessions|Intervention||23
8664192|NCT00715650|9707682|FG001|Attended ≥ 3 Sessions|Intervention||17
8664193|NCT00715650|9707681|FG000|COMPLETED|Intervention||42
8664194|NCT00715650|9707682|FG001|COMPLETED|Intervention||42
8664195|NCT00715650|9707681|FG000|NOT COMPLETED|Intervention||5
8664196|NCT00715650|9707682|FG001|NOT COMPLETED|Intervention||3
8664197|NCT00715650|9707681|FG000|STARTED|Follow-up||42
8664198|NCT00715650|9707682|FG001|STARTED|Follow-up||42
8664199|NCT00715650|9707681|FG000|Completed Month 1 Follow-up|Follow-up||40
8664200|NCT00715650|9707682|FG001|Completed Month 1 Follow-up|Follow-up||38
8664201|NCT00715650|9707681|FG000|Completed Month 3 Follow-up|Follow-up||35
8664202|NCT00715650|9707682|FG001|Completed Month 3 Follow-up|Follow-up||40
8664203|NCT00715650|9707681|FG000|Completed Month 6 Follow-up|Follow-up||29
8664204|NCT00715650|9707682|FG001|Completed Month 6 Follow-up|Follow-up||37
8664205|NCT00715650|9707681|FG000|COMPLETED|Follow-up||29
8664206|NCT00715650|9707682|FG001|COMPLETED|Follow-up||37
8664207|NCT00715650|9707681|FG000|NOT COMPLETED|Follow-up||13
8664208|NCT00715650|9707682|FG001|NOT COMPLETED|Follow-up||5
8664209|NCT00715676|9707691|FG000|STARTED|Overall Study|1 additional subject was enrolled in the placebo group but discontinued before taking any study drug|49
8664210|NCT00715676|9707692|FG001|STARTED|Overall Study||54
8664211|NCT00715676|9707693|FG002|STARTED|Overall Study||53
8664212|NCT00715676|9707691|FG000|COMPLETED|Overall Study||43
8664213|NCT00715676|9707692|FG001|COMPLETED|Overall Study||43
8730230|NCT01057901|9777593|FG000|STARTED|Overall Study||376
8730231|NCT01057901|9777594|FG001|STARTED|Overall Study||372
8730232|NCT01057901|9777593|FG000|COMPLETED|Overall Study||116
8730233|NCT01057901|9777594|FG001|COMPLETED|Overall Study||126
8730234|NCT01057901|9777593|FG000|NOT COMPLETED|Overall Study||260
8730235|NCT01057901|9777594|FG001|NOT COMPLETED|Overall Study||246
8730236|NCT01058005|9777603|FG000|STARTED|Overall Study||38
8730237|NCT01058005|9777604|FG001|STARTED|Overall Study||25
8730238|NCT01058005|9777605|FG002|STARTED|Overall Study||21
8730239|NCT01058005|9777603|FG000|Dosed With Study Treatment|Overall Study||36
8730240|NCT01058005|9777604|FG001|Dosed With Study Treatment|Overall Study||22
8730241|NCT01058005|9777605|FG002|Dosed With Study Treatment|Overall Study||17
8730242|NCT01058005|9777603|FG000|COMPLETED|Overall Study||0
8730243|NCT01058005|9777604|FG001|COMPLETED|Overall Study||0
8730244|NCT01058005|9777605|FG002|COMPLETED|Overall Study||1
8730245|NCT01058005|9777603|FG000|NOT COMPLETED|Overall Study||38
8730246|NCT01058005|9777604|FG001|NOT COMPLETED|Overall Study||25
8730247|NCT01058005|9777605|FG002|NOT COMPLETED|Overall Study||20
8730248|NCT01058070|9777613|FG000|STARTED|Overall Study||44
8730249|NCT01058070|9777613|FG000|COMPLETED|Overall Study||33
8730250|NCT01058070|9777613|FG000|NOT COMPLETED|Overall Study||11
8730251|NCT01058096|9777620|FG000|STARTED|Double-blind Treatment Phase||154
8730252|NCT01058096|9777621|FG001|STARTED|Double-blind Treatment Phase||158
8730253|NCT01058096|9777620|FG000|COMPLETED|Double-blind Treatment Phase||106
8730254|NCT01058096|9777621|FG001|COMPLETED|Double-blind Treatment Phase||108
8730255|NCT01058096|9777620|FG000|NOT COMPLETED|Double-blind Treatment Phase||48
8730256|NCT01058096|9777621|FG001|NOT COMPLETED|Double-blind Treatment Phase||50
8730257|NCT01058096|9777620|FG000|STARTED|Safety Follow-up|Not all participants continued to Safety Follow-up.|133
8730258|NCT01058096|9777621|FG001|STARTED|Safety Follow-up||134
8730259|NCT01058096|9777620|FG000|COMPLETED|Safety Follow-up||129
8730260|NCT01058096|9777621|FG001|COMPLETED|Safety Follow-up||130
8730261|NCT01058096|9777620|FG000|NOT COMPLETED|Safety Follow-up||4
8911447|NCT02146365|9970534|FG003|NOT COMPLETED|Overall Study||9
8911448|NCT02146365|9970535|FG004|NOT COMPLETED|Overall Study||2
8911449|NCT02146365|9970536|FG005|NOT COMPLETED|Overall Study||1
8911450|NCT02146365|9970537|FG006|NOT COMPLETED|Overall Study||0
8911451|NCT02146365|9970538|FG007|NOT COMPLETED|Overall Study||1
8911452|NCT02146430|9970560|FG000|STARTED|Overall Study||323
8911453|NCT02146430|9970561|FG001|STARTED|Overall Study||323
9022409|NCT03126539|10085297|FG002|COMPLETED|Overall Study||8
9022410|NCT03126539|10085298|FG003|COMPLETED|Overall Study||0
8730262|NCT01058096|9777621|FG001|NOT COMPLETED|Safety Follow-up||4
8730263|NCT01058239|9777627|FG000|STARTED|Overall Study||7
8730264|NCT01058239|9777627|FG000|COMPLETED|Overall Study||7
8730265|NCT01058239|9777627|FG000|NOT COMPLETED|Overall Study||0
8730266|NCT01058265|9777633|FG000|STARTED|Overall Study||22
8730267|NCT01058265|9777634|FG001|STARTED|Overall Study||25
8730268|NCT01058265|9777633|FG000|COMPLETED|Overall Study||11
8730269|NCT01058265|9777634|FG001|COMPLETED|Overall Study||13
8730270|NCT01058265|9777633|FG000|NOT COMPLETED|Overall Study||11
8730271|NCT01058265|9777634|FG001|NOT COMPLETED|Overall Study||12
8730272|NCT01058304|9777642|FG000|STARTED|Overall Study||159
8730273|NCT01058304|9777643|FG001|STARTED|Overall Study||161
8730274|NCT01058304|9777642|FG000|COMPLETED|Overall Study||132
8730275|NCT01058304|9777643|FG001|COMPLETED|Overall Study||128
8730276|NCT01058304|9777642|FG000|NOT COMPLETED|Overall Study||27
8730277|NCT01058304|9777643|FG001|NOT COMPLETED|Overall Study||33
8730278|NCT01058356|9777649|FG000|STARTED|Overall Study||214
8730279|NCT01058356|9777649|FG000|COMPLETED|Overall Study||172
8664214|NCT00715676|9707693|FG002|COMPLETED|Overall Study||21
8664215|NCT00715676|9707691|FG000|NOT COMPLETED|Overall Study||6
8664216|NCT00715676|9707692|FG001|NOT COMPLETED|Overall Study||11
8664217|NCT00715676|9707693|FG002|NOT COMPLETED|Overall Study||32
8730280|NCT01058356|9777649|FG000|NOT COMPLETED|Overall Study||42
8730281|NCT01058395|9777655|FG000|STARTED|Overall Study||7
8730282|NCT01058395|9777656|FG001|STARTED|Overall Study||8
8730283|NCT01058395|9777655|FG000|COMPLETED|Overall Study|Two died, and one was lost to followup.|4
8730284|NCT01058395|9777656|FG001|COMPLETED|Overall Study|One died after enrollment. The patient died in the first 48 hours.|7
8664218|NCT00715728|9707703|FG000|STARTED|Overall Study||14
8664219|NCT00715728|9707704|FG001|STARTED|Overall Study||14
8664220|NCT00715728|9707703|FG000|COMPLETED|Overall Study||14
8664221|NCT00715728|9707704|FG001|COMPLETED|Overall Study||14
8664222|NCT00715728|9707703|FG000|NOT COMPLETED|Overall Study||0
8664223|NCT00715728|9707704|FG001|NOT COMPLETED|Overall Study||0
8664224|NCT00715741|9707716|FG000|STARTED|Overall Study||25
8664225|NCT00715741|9707717|FG001|STARTED|Overall Study||25
8664226|NCT00715741|9707718|FG002|STARTED|Overall Study||25
8664227|NCT00715741|9707719|FG003|STARTED|Overall Study||25
8664228|NCT00715741|9707716|FG000|COMPLETED|Overall Study||25
8664229|NCT00715741|9707717|FG001|COMPLETED|Overall Study||25
8664230|NCT00715741|9707718|FG002|COMPLETED|Overall Study||25
8664231|NCT00715741|9707719|FG003|COMPLETED|Overall Study||25
8664232|NCT00715741|9707716|FG000|NOT COMPLETED|Overall Study||0
8664233|NCT00715741|9707717|FG001|NOT COMPLETED|Overall Study||0
8664234|NCT00715741|9707718|FG002|NOT COMPLETED|Overall Study||0
8664235|NCT00715741|9707719|FG003|NOT COMPLETED|Overall Study||0
8664236|NCT00715754|9707729|FG000|STARTED|Overall Study||47
8664237|NCT00715754|9707729|FG000|COMPLETED|Overall Study||47
8664238|NCT00715754|9707729|FG000|NOT COMPLETED|Overall Study||0
8664239|NCT00715793|9707733|FG000|STARTED|Phase 1 RP2D DAC + TMZ||4
8664240|NCT00715793|9707734|FG001|STARTED|Phase 1 RP2D DAC + TMZ||6
8664241|NCT00715793|9707733|FG000|COMPLETED|Phase 1 RP2D DAC + TMZ||3
8664242|NCT00715793|9707734|FG001|COMPLETED|Phase 1 RP2D DAC + TMZ||6
8664243|NCT00715793|9707733|FG000|NOT COMPLETED|Phase 1 RP2D DAC + TMZ||1
8664244|NCT00715793|9707734|FG001|NOT COMPLETED|Phase 1 RP2D DAC + TMZ||0
8730285|NCT01058395|9777655|FG000|NOT COMPLETED|Overall Study||3
8730286|NCT01058395|9777656|FG001|NOT COMPLETED|Overall Study||1
8730287|NCT01058421|9777664|FG000|STARTED|1 Month Outcomes||59
8664245|NCT00715793|9707733|FG000|STARTED|Phase 2 DAC (0.15 mg/kg) + TMZ||0
8664246|NCT00715793|9707734|FG001|STARTED|Phase 2 DAC (0.15 mg/kg) + TMZ||29
8664247|NCT00715793|9707733|FG000|COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||0
8664248|NCT00715793|9707734|FG001|COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||27
8664249|NCT00715793|9707733|FG000|NOT COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||0
8664250|NCT00715793|9707734|FG001|NOT COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||2
8664251|NCT00715884|9707743|FG000|STARTED|Overall Study||452
8664252|NCT00715884|9707744|FG001|STARTED|Overall Study||226
8664253|NCT00715884|9707743|FG000|COMPLETED|Overall Study||444
8664254|NCT00715884|9707744|FG001|COMPLETED|Overall Study||225
8664255|NCT00715884|9707743|FG000|NOT COMPLETED|Overall Study||8
8664256|NCT00715884|9707744|FG001|NOT COMPLETED|Overall Study||1
8664257|NCT00715910|9707754|FG000|STARTED|Year 1||433
8664258|NCT00715910|9707755|FG001|STARTED|Year 1||147
8664259|NCT00715910|9707756|FG002|STARTED|Year 1||68
8664260|NCT00715910|9707757|FG003|STARTED|Year 1|Group not applicable during Year 1 Persistence phase|0
8664261|NCT00715910|9707758|FG004|STARTED|Year 1|Group not applicable during Year 1 Persistence phase|0
8664262|NCT00715910|9707759|FG005|STARTED|Year 1|Group not applicable during Year 1 Persistence phase|0
8664263|NCT00715910|9707754|FG000|COMPLETED|Year 1||433
8730288|NCT01058421|9777665|FG001|STARTED|1 Month Outcomes||61
8730289|NCT01058421|9777664|FG000|COMPLETED|1 Month Outcomes||20
8730290|NCT01058421|9777665|FG001|COMPLETED|1 Month Outcomes||19
8730291|NCT01058421|9777664|FG000|NOT COMPLETED|1 Month Outcomes||39
8730292|NCT01058421|9777665|FG001|NOT COMPLETED|1 Month Outcomes||42
8730293|NCT01058421|9777664|FG000|STARTED|3 Month Outcomes|59 (Subjects started Period 1) minus 10 (deceased subjects during Period 1) = 49 started Period 2.|49
8730294|NCT01058421|9777665|FG001|STARTED|3 Month Outcomes|61 (Subjects started Period 1) minus 6 (deceased subjects during Period 1) = 55 started Period 2.|55
8730295|NCT01058421|9777664|FG000|COMPLETED|3 Month Outcomes||29
8730296|NCT01058421|9777665|FG001|COMPLETED|3 Month Outcomes||29
8730297|NCT01058421|9777664|FG000|NOT COMPLETED|3 Month Outcomes||20
8730298|NCT01058421|9777665|FG001|NOT COMPLETED|3 Month Outcomes||26
8730299|NCT01058421|9777664|FG000|STARTED|6 Month Outcomes|55 (subjects started Period 1) minus 13 (deceased subjects in Periods 1 & 2) = 46 started Period 3.|46
8730300|NCT01058421|9777665|FG001|STARTED|6 Month Outcomes|61 (subjects started Period 1) minus 11 (deceased subjects in Periods 1 & 2) = 50 started Period 3.|50
8730301|NCT01058421|9777664|FG000|COMPLETED|6 Month Outcomes||27
8730302|NCT01058421|9777665|FG001|COMPLETED|6 Month Outcomes||24
8730303|NCT01058421|9777664|FG000|NOT COMPLETED|6 Month Outcomes||19
8730304|NCT01058421|9777665|FG001|NOT COMPLETED|6 Month Outcomes||26
8730305|NCT01058655|9777675|FG000|STARTED|Overall Study||3
8730306|NCT01058655|9777676|FG001|STARTED|Overall Study||3
8730307|NCT01058655|9777677|FG002|STARTED|Overall Study||8
8664264|NCT00715910|9707755|FG001|COMPLETED|Year 1||147
8664265|NCT00715910|9707756|FG002|COMPLETED|Year 1||68
8664266|NCT00715910|9707757|FG003|COMPLETED|Year 1|Group not applicable during Year 1 Persistence phase|0
8664267|NCT00715910|9707758|FG004|COMPLETED|Year 1|Group not applicable during Year 1 Persistence phase|0
8664268|NCT00715910|9707759|FG005|COMPLETED|Year 1|Group not applicable during Year 1 Persistence phase|0
8664269|NCT00715910|9707754|FG000|NOT COMPLETED|Year 1||0
8664270|NCT00715910|9707755|FG001|NOT COMPLETED|Year 1||0
8664271|NCT00715910|9707756|FG002|NOT COMPLETED|Year 1||0
8664272|NCT00715910|9707757|FG003|NOT COMPLETED|Year 1||0
8664273|NCT00715910|9707758|FG004|NOT COMPLETED|Year 1||0
8664274|NCT00715910|9707759|FG005|NOT COMPLETED|Year 1||0
8664275|NCT00715910|9707754|FG000|STARTED|Year 3||345
8664276|NCT00715910|9707755|FG001|STARTED|Year 3||86
8664277|NCT00715910|9707756|FG002|STARTED|Year 3||56
8692399|NCT00860171|9737836|FG000|NOT COMPLETED|Overall Study||0
8664278|NCT00715910|9707757|FG003|STARTED|Year 3|Group not applicable during Year 3 Persistence phase|0
8664279|NCT00715910|9707758|FG004|STARTED|Year 3|Group not applicable during Year 3 Persistence phase|0
8664280|NCT00715910|9707759|FG005|STARTED|Year 3|Group not applicable during Year 3 Persistence phase|0
8664281|NCT00715910|9707754|FG000|COMPLETED|Year 3||345
8664282|NCT00715910|9707755|FG001|COMPLETED|Year 3||86
8664283|NCT00715910|9707756|FG002|COMPLETED|Year 3||56
8664284|NCT00715910|9707757|FG003|COMPLETED|Year 3|Group not applicable during Year 3 Persistence phase|0
8664285|NCT00715910|9707758|FG004|COMPLETED|Year 3|Group not applicable during Year 3 Persistence phase|0
8664286|NCT00715910|9707759|FG005|COMPLETED|Year 3|Group not applicable during Year 3 Persistence phase|0
8664287|NCT00715910|9707754|FG000|NOT COMPLETED|Year 3||0
8664288|NCT00715910|9707755|FG001|NOT COMPLETED|Year 3||0
8664289|NCT00715910|9707756|FG002|NOT COMPLETED|Year 3||0
8664290|NCT00715910|9707757|FG003|NOT COMPLETED|Year 3||0
8664291|NCT00715910|9707758|FG004|NOT COMPLETED|Year 3||0
8664292|NCT00715910|9707759|FG005|NOT COMPLETED|Year 3||0
8664293|NCT00715910|9707754|FG000|STARTED|Year 5||218
8664294|NCT00715910|9707755|FG001|STARTED|Year 5||56
8664295|NCT00715910|9707756|FG002|STARTED|Year 5||38
8664296|NCT00715910|9707757|FG003|STARTED|Year 5|Group not applicable during Year 5 Persistence phase|0
8664297|NCT00715910|9707758|FG004|STARTED|Year 5|Group not applicable during Year 5 Persistence phase|0
8664298|NCT00715910|9707759|FG005|STARTED|Year 5|Group not applicable during Year 5 Persistence phase|0
8664299|NCT00715910|9707754|FG000|COMPLETED|Year 5||218
8664300|NCT00715910|9707755|FG001|COMPLETED|Year 5||56
8664301|NCT00715910|9707756|FG002|COMPLETED|Year 5||38
8664302|NCT00715910|9707757|FG003|COMPLETED|Year 5|Group not applicable during Year 5 Persistence phase|0
8664303|NCT00715910|9707758|FG004|COMPLETED|Year 5|Group not applicable during Year 5 Persistence phase|0
8664304|NCT00715910|9707759|FG005|COMPLETED|Year 5|Group not applicable during Year 5 Persistence phase|0
8664305|NCT00715910|9707754|FG000|NOT COMPLETED|Year 5||0
8664306|NCT00715910|9707755|FG001|NOT COMPLETED|Year 5||0
8664307|NCT00715910|9707756|FG002|NOT COMPLETED|Year 5||0
8664308|NCT00715910|9707757|FG003|NOT COMPLETED|Year 5||0
8664309|NCT00715910|9707758|FG004|NOT COMPLETED|Year 5||0
8664310|NCT00715910|9707759|FG005|NOT COMPLETED|Year 5||0
8664311|NCT00715910|9707754|FG000|STARTED|Booster and ESFU Phase|Group not applicable during booster phase|0
8664312|NCT00715910|9707755|FG001|STARTED|Booster and ESFU Phase|Group not applicable during booster phase|0
8664313|NCT00715910|9707756|FG002|STARTED|Booster and ESFU Phase|Group not applicable during booster phase|0
8664314|NCT00715910|9707757|FG003|STARTED|Booster and ESFU Phase||183
8664315|NCT00715910|9707758|FG004|STARTED|Booster and ESFU Phase||38
8664316|NCT00715910|9707759|FG005|STARTED|Booster and ESFU Phase||101
8664317|NCT00715910|9707754|FG000|COMPLETED|Booster and ESFU Phase|Group not applicable during booster phase|0
8664318|NCT00715910|9707755|FG001|COMPLETED|Booster and ESFU Phase|Group not applicable during booster phase|0
8664319|NCT00715910|9707756|FG002|COMPLETED|Booster and ESFU Phase|Group not applicable during booster phase|0
8664320|NCT00715910|9707757|FG003|COMPLETED|Booster and ESFU Phase||172
8664321|NCT00715910|9707758|FG004|COMPLETED|Booster and ESFU Phase||36
8664322|NCT00715910|9707759|FG005|COMPLETED|Booster and ESFU Phase||88
8664323|NCT00715910|9707754|FG000|NOT COMPLETED|Booster and ESFU Phase||0
8664324|NCT00715910|9707755|FG001|NOT COMPLETED|Booster and ESFU Phase||0
8664325|NCT00715910|9707756|FG002|NOT COMPLETED|Booster and ESFU Phase||0
8664326|NCT00715910|9707757|FG003|NOT COMPLETED|Booster and ESFU Phase||11
8664327|NCT00715910|9707758|FG004|NOT COMPLETED|Booster and ESFU Phase||2
8664328|NCT00715910|9707759|FG005|NOT COMPLETED|Booster and ESFU Phase||13
8664329|NCT00715949|9707775|FG000|STARTED|Overall Study|4 dropped because could not finish first test|120
8664330|NCT00715949|9707775|FG000|COMPLETED|Overall Study|116 patients completed first test|116
8664331|NCT00715949|9707775|FG000|NOT COMPLETED|Overall Study||4
8664332|NCT00715962|9707781|FG000|STARTED|Overall Study||50
8664333|NCT00715962|9707782|FG001|STARTED|Overall Study||50
8664334|NCT00715962|9707781|FG000|COMPLETED|Overall Study||44
8664335|NCT00715962|9707782|FG001|COMPLETED|Overall Study||48
8664336|NCT00715962|9707781|FG000|NOT COMPLETED|Overall Study||6
8664337|NCT00715962|9707782|FG001|NOT COMPLETED|Overall Study||2
8664338|NCT00716079|9707791|FG000|STARTED|Overall Study||1403
8664339|NCT00716079|9707792|FG001|STARTED|Overall Study||1436
8664340|NCT00716079|9707791|FG000|COMPLETED|Overall Study||1394
8664341|NCT00716079|9707792|FG001|COMPLETED|Overall Study||1421
8664342|NCT00716079|9707791|FG000|NOT COMPLETED|Overall Study||9
8664343|NCT00716079|9707792|FG001|NOT COMPLETED|Overall Study||15
8664344|NCT00716092|9707801|FG000|STARTED|Overall Study||40
8664345|NCT00716092|9707802|FG001|STARTED|Overall Study||40
8664346|NCT00716092|9707803|FG002|STARTED|Overall Study||41
8664347|NCT00716092|9707801|FG000|COMPLETED|Overall Study||38
8664348|NCT00716092|9707802|FG001|COMPLETED|Overall Study||39
8664349|NCT00716092|9707803|FG002|COMPLETED|Overall Study||41
8664350|NCT00716092|9707801|FG000|NOT COMPLETED|Overall Study||2
8664351|NCT00716092|9707802|FG001|NOT COMPLETED|Overall Study||1
8664352|NCT00716092|9707803|FG002|NOT COMPLETED|Overall Study||0
8664353|NCT00716144|9707815|FG000|STARTED|Overall Study||41
8664354|NCT00716144|9707816|FG001|STARTED|Overall Study||45
8664355|NCT00716144|9707817|FG002|STARTED|Overall Study||45
8664356|NCT00716144|9707818|FG003|STARTED|Overall Study||45
8730308|NCT01058655|9777678|FG003|STARTED|Overall Study||42
8730309|NCT01058655|9777675|FG000|Evaluable|Overall Study||3
8730310|NCT01058655|9777676|FG001|Evaluable|Overall Study||3
8730311|NCT01058655|9777677|FG002|Evaluable|Overall Study||6
8664357|NCT00716144|9707815|FG000|COMPLETED|Overall Study||32
8664358|NCT00716144|9707816|FG001|COMPLETED|Overall Study||38
8664359|NCT00716144|9707817|FG002|COMPLETED|Overall Study||33
8664360|NCT00716144|9707818|FG003|COMPLETED|Overall Study||33
8664361|NCT00716144|9707815|FG000|NOT COMPLETED|Overall Study||9
8664362|NCT00716144|9707816|FG001|NOT COMPLETED|Overall Study||7
8664363|NCT00716144|9707817|FG002|NOT COMPLETED|Overall Study||12
8664364|NCT00716144|9707818|FG003|NOT COMPLETED|Overall Study||12
8664365|NCT00716274|9707831|FG000|STARTED|Study Period II (16-Weeks)||45
8664366|NCT00716274|9707832|FG001|STARTED|Study Period II (16-Weeks)||44
8664367|NCT00716274|9707833|FG002|STARTED|Study Period II (16-Weeks)||0
8664368|NCT00716274|9707834|FG003|STARTED|Study Period II (16-Weeks)||0
8664369|NCT00716274|9707835|FG004|STARTED|Study Period II (16-Weeks)||0
8664370|NCT00716274|9707836|FG005|STARTED|Study Period II (16-Weeks)||21
8664371|NCT00716274|9707831|FG000|COMPLETED|Study Period II (16-Weeks)||36
8664372|NCT00716274|9707832|FG001|COMPLETED|Study Period II (16-Weeks)||35
8664373|NCT00716274|9707833|FG002|COMPLETED|Study Period II (16-Weeks)||0
8664374|NCT00716274|9707834|FG003|COMPLETED|Study Period II (16-Weeks)||0
8664375|NCT00716274|9707835|FG004|COMPLETED|Study Period II (16-Weeks)||0
8664376|NCT00716274|9707836|FG005|COMPLETED|Study Period II (16-Weeks)||19
8664377|NCT00716274|9707831|FG000|NOT COMPLETED|Study Period II (16-Weeks)||9
8664378|NCT00716274|9707832|FG001|NOT COMPLETED|Study Period II (16-Weeks)||9
8664379|NCT00716274|9707833|FG002|NOT COMPLETED|Study Period II (16-Weeks)||0
8664380|NCT00716274|9707834|FG003|NOT COMPLETED|Study Period II (16-Weeks)||0
8664381|NCT00716274|9707835|FG004|NOT COMPLETED|Study Period II (16-Weeks)||0
8664382|NCT00716274|9707836|FG005|NOT COMPLETED|Study Period II (16-Weeks)||2
8664383|NCT00716274|9707831|FG000|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|0
8664384|NCT00716274|9707832|FG001|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|0
8664385|NCT00716274|9707833|FG002|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|18
8664386|NCT00716274|9707834|FG003|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|18
8664387|NCT00716274|9707835|FG004|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|35
8664388|NCT00716274|9707836|FG005|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|19
8664389|NCT00716274|9707831|FG000|COMPLETED|Study Period III (16-Weeks)||0
8664390|NCT00716274|9707832|FG001|COMPLETED|Study Period III (16-Weeks)||0
8664391|NCT00716274|9707833|FG002|COMPLETED|Study Period III (16-Weeks)||16
8664392|NCT00716274|9707834|FG003|COMPLETED|Study Period III (16-Weeks)||17
8664393|NCT00716274|9707835|FG004|COMPLETED|Study Period III (16-Weeks)||32
8664394|NCT00716274|9707836|FG005|COMPLETED|Study Period III (16-Weeks)||19
8664395|NCT00716274|9707831|FG000|NOT COMPLETED|Study Period III (16-Weeks)||0
8664396|NCT00716274|9707832|FG001|NOT COMPLETED|Study Period III (16-Weeks)||0
8664397|NCT00716274|9707833|FG002|NOT COMPLETED|Study Period III (16-Weeks)||2
8664398|NCT00716274|9707834|FG003|NOT COMPLETED|Study Period III (16-Weeks)||1
8664399|NCT00716274|9707835|FG004|NOT COMPLETED|Study Period III (16-Weeks)||3
8664400|NCT00716274|9707836|FG005|NOT COMPLETED|Study Period III (16-Weeks)||0
8692400|NCT00860262|9737843|FG000|STARTED|Overall Study||421
8692401|NCT00860262|9737844|FG001|STARTED|Overall Study||217
8730312|NCT01058655|9777678|FG003|Evaluable|Overall Study||40
8730313|NCT01058655|9777675|FG000|COMPLETED|Overall Study||0
8730314|NCT01058655|9777676|FG001|COMPLETED|Overall Study||0
8730315|NCT01058655|9777677|FG002|COMPLETED|Overall Study||0
8730316|NCT01058655|9777678|FG003|COMPLETED|Overall Study||0
8730317|NCT01058655|9777675|FG000|NOT COMPLETED|Overall Study||3
8730318|NCT01058655|9777676|FG001|NOT COMPLETED|Overall Study||3
8730319|NCT01058655|9777677|FG002|NOT COMPLETED|Overall Study||8
8730320|NCT01058655|9777678|FG003|NOT COMPLETED|Overall Study||42
8730321|NCT01058668|9777692|FG000|STARTED|Double-blind Treatment Phase||161
8730322|NCT01058668|9777693|FG001|STARTED|Double-blind Treatment Phase||167
8730323|NCT01058668|9777694|FG002|STARTED|Double-blind Treatment Phase||169
8730324|NCT01058668|9777692|FG000|COMPLETED|Double-blind Treatment Phase||122
8730325|NCT01058668|9777693|FG001|COMPLETED|Double-blind Treatment Phase||129
8730326|NCT01058668|9777694|FG002|COMPLETED|Double-blind Treatment Phase||119
8730327|NCT01058668|9777692|FG000|NOT COMPLETED|Double-blind Treatment Phase||39
8730328|NCT01058668|9777693|FG001|NOT COMPLETED|Double-blind Treatment Phase||38
8730329|NCT01058668|9777694|FG002|NOT COMPLETED|Double-blind Treatment Phase||50
8730330|NCT01058668|9777692|FG000|STARTED|Safety Follow-up|Not all participants entered the Safety-Follow-up|144
8730331|NCT01058668|9777693|FG001|STARTED|Safety Follow-up||146
8730332|NCT01058668|9777694|FG002|STARTED|Safety Follow-up||148
8730333|NCT01058668|9777692|FG000|COMPLETED|Safety Follow-up||139
8730334|NCT01058668|9777693|FG001|COMPLETED|Safety Follow-up||146
8730335|NCT01058668|9777694|FG002|COMPLETED|Safety Follow-up||141
8730336|NCT01058668|9777692|FG000|NOT COMPLETED|Safety Follow-up||5
8730337|NCT01058668|9777693|FG001|NOT COMPLETED|Safety Follow-up||0
8730338|NCT01058668|9777694|FG002|NOT COMPLETED|Safety Follow-up||7
8730339|NCT01058707|9777709|FG000|STARTED|Overall Study||31
8730340|NCT01058707|9777710|FG001|STARTED|Overall Study||30
8692402|NCT00860262|9737845|FG002|STARTED|Overall Study||220
8692403|NCT00860262|9737843|FG000|COMPLETED|Overall Study||401
8692404|NCT00860262|9737844|FG001|COMPLETED|Overall Study||195
8692405|NCT00860262|9737845|FG002|COMPLETED|Overall Study||202
8664401|NCT00716417|9707863|FG000|STARTED|Overall Study||3
8664402|NCT00716417|9707864|FG001|STARTED|Overall Study||6
8664403|NCT00716417|9707865|FG002|STARTED|Overall Study||5
8664404|NCT00716417|9707866|FG003|STARTED|Overall Study||11
8664405|NCT00716417|9707867|FG004|STARTED|Overall Study||1
8664406|NCT00716417|9707868|FG005|STARTED|Overall Study||3
8664407|NCT00716417|9707869|FG006|STARTED|Overall Study||7
8664408|NCT00716417|9707870|FG007|STARTED|Overall Study||3
8664409|NCT00716417|9707871|FG008|STARTED|Overall Study||5
8664410|NCT00716417|9707872|FG009|STARTED|Overall Study||3
8664411|NCT00716417|9707863|FG000|COMPLETED|Overall Study||0
8664412|NCT00716417|9707864|FG001|COMPLETED|Overall Study||0
8664413|NCT00716417|9707865|FG002|COMPLETED|Overall Study||0
8664414|NCT00716417|9707866|FG003|COMPLETED|Overall Study||0
8664415|NCT00716417|9707867|FG004|COMPLETED|Overall Study||0
8664416|NCT00716417|9707868|FG005|COMPLETED|Overall Study||0
8664417|NCT00716417|9707869|FG006|COMPLETED|Overall Study||0
8664418|NCT00716417|9707870|FG007|COMPLETED|Overall Study||0
8664419|NCT00716417|9707871|FG008|COMPLETED|Overall Study||0
8664420|NCT00716417|9707872|FG009|COMPLETED|Overall Study||0
8664421|NCT00716417|9707863|FG000|NOT COMPLETED|Overall Study||3
8664422|NCT00716417|9707864|FG001|NOT COMPLETED|Overall Study||6
8664423|NCT00716417|9707865|FG002|NOT COMPLETED|Overall Study||5
8664424|NCT00716417|9707866|FG003|NOT COMPLETED|Overall Study||11
8664425|NCT00716417|9707867|FG004|NOT COMPLETED|Overall Study||1
8664426|NCT00716417|9707868|FG005|NOT COMPLETED|Overall Study||3
8664427|NCT00716417|9707869|FG006|NOT COMPLETED|Overall Study||7
8664428|NCT00716417|9707870|FG007|NOT COMPLETED|Overall Study||3
8664429|NCT00716417|9707871|FG008|NOT COMPLETED|Overall Study||5
8664430|NCT00716417|9707872|FG009|NOT COMPLETED|Overall Study||3
8664431|NCT00716443|9707896|FG000|STARTED|Overall Study||51
8664432|NCT00716443|9707896|FG000|COMPLETED|Overall Study||51
8664433|NCT00716443|9707896|FG000|NOT COMPLETED|Overall Study||0
8664434|NCT00716456|9707904|FG000|STARTED|Overall Study||3
8664435|NCT00716456|9707905|FG001|STARTED|Overall Study||5
8664436|NCT00716456|9707906|FG002|STARTED|Overall Study||13
8664437|NCT00716456|9707904|FG000|COMPLETED|Overall Study||3
8664438|NCT00716456|9707905|FG001|COMPLETED|Overall Study||3
8664439|NCT00716456|9707906|FG002|COMPLETED|Overall Study||13
8664440|NCT00716456|9707904|FG000|NOT COMPLETED|Overall Study||0
8664441|NCT00716456|9707905|FG001|NOT COMPLETED|Overall Study||2
8664442|NCT00716456|9707906|FG002|NOT COMPLETED|Overall Study||0
8664443|NCT00716482|9707914|FG000|STARTED|Overall Study||1681
8664444|NCT00716482|9707914|FG000|COMPLETED|Overall Study||1562
8664445|NCT00716482|9707914|FG000|NOT COMPLETED|Overall Study||119
8664446|NCT00716586|9707924|FG000|STARTED|Overall Study||44
8664447|NCT00716586|9707924|FG000|COMPLETED|Overall Study||44
8664448|NCT00716586|9707924|FG000|NOT COMPLETED|Overall Study||0
8664449|NCT00716625|9707929|FG000|STARTED|Overall Study||1674
8664450|NCT00716625|9707929|FG000|COMPLETED|Overall Study||1673
8664451|NCT00716625|9707929|FG000|NOT COMPLETED|Overall Study||1
8664452|NCT00716742|9707950|FG000|STARTED|Baseline||364
8664453|NCT00716742|9707951|FG001|STARTED|Baseline||370
8664454|NCT00716742|9707952|FG002|STARTED|Baseline||365
8664455|NCT00716742|9707950|FG000|COMPLETED|Baseline||347
8664456|NCT00716742|9707951|FG001|COMPLETED|Baseline||356
8664457|NCT00716742|9707952|FG002|COMPLETED|Baseline||352
8664458|NCT00716742|9707950|FG000|NOT COMPLETED|Baseline||17
8664459|NCT00716742|9707951|FG001|NOT COMPLETED|Baseline||14
8664460|NCT00716742|9707952|FG002|NOT COMPLETED|Baseline||13
8664461|NCT00716742|9707950|FG000|STARTED|1 Year Follow-up||347
8664462|NCT00716742|9707951|FG001|STARTED|1 Year Follow-up||356
8664463|NCT00716742|9707952|FG002|STARTED|1 Year Follow-up||352
8664464|NCT00716742|9707950|FG000|COMPLETED|1 Year Follow-up||160
8664465|NCT00716742|9707951|FG001|COMPLETED|1 Year Follow-up||163
8664466|NCT00716742|9707952|FG002|COMPLETED|1 Year Follow-up||152
8664467|NCT00716742|9707950|FG000|NOT COMPLETED|1 Year Follow-up||187
8664468|NCT00716742|9707951|FG001|NOT COMPLETED|1 Year Follow-up||193
8664469|NCT00716742|9707952|FG002|NOT COMPLETED|1 Year Follow-up||200
8664470|NCT00716742|9707950|FG000|STARTED|2 Year Follow-up||160
8664471|NCT00716742|9707951|FG001|STARTED|2 Year Follow-up||163
8664472|NCT00716742|9707952|FG002|STARTED|2 Year Follow-up||152
8664473|NCT00716742|9707950|FG000|COMPLETED|2 Year Follow-up||56
8664474|NCT00716742|9707951|FG001|COMPLETED|2 Year Follow-up||67
8664475|NCT00716742|9707952|FG002|COMPLETED|2 Year Follow-up||50
8664476|NCT00716742|9707950|FG000|NOT COMPLETED|2 Year Follow-up||104
8664477|NCT00716742|9707951|FG001|NOT COMPLETED|2 Year Follow-up||96
8664478|NCT00716742|9707952|FG002|NOT COMPLETED|2 Year Follow-up||102
8664479|NCT00716742|9707950|FG000|STARTED|3 Year Follow-up||56
8664480|NCT00716742|9707951|FG001|STARTED|3 Year Follow-up||67
8664481|NCT00716742|9707952|FG002|STARTED|3 Year Follow-up||50
8664482|NCT00716742|9707950|FG000|COMPLETED|3 Year Follow-up||26
8664483|NCT00716742|9707951|FG001|COMPLETED|3 Year Follow-up||35
8664484|NCT00716742|9707952|FG002|COMPLETED|3 Year Follow-up||29
8664485|NCT00716742|9707950|FG000|NOT COMPLETED|3 Year Follow-up||30
8664486|NCT00716742|9707951|FG001|NOT COMPLETED|3 Year Follow-up||32
8664487|NCT00716742|9707952|FG002|NOT COMPLETED|3 Year Follow-up||21
8664488|NCT00716820|9707960|FG000|STARTED|Overall Study||472
8664489|NCT00716820|9707960|FG000|COMPLETED|Overall Study||472
8664490|NCT00716820|9707960|FG000|NOT COMPLETED|Overall Study||0
8664491|NCT00716859|9707987|FG000|STARTED|Overall Study||70
8664492|NCT00716859|9707988|FG001|STARTED|Overall Study||69
8664493|NCT00716859|9707987|FG000|Received Treatment|Overall Study||69
8664494|NCT00716859|9707988|FG001|Received Treatment|Overall Study||68
8664495|NCT00716859|9707987|FG000|COMPLETED|Overall Study||61
8664496|NCT00716859|9707988|FG001|COMPLETED|Overall Study||64
8664497|NCT00716859|9707987|FG000|NOT COMPLETED|Overall Study||9
8664498|NCT00716859|9707988|FG001|NOT COMPLETED|Overall Study||5
8664499|NCT00716963|9707994|FG000|STARTED|Overall Study||2
8664500|NCT00716963|9707995|FG001|STARTED|Overall Study||1
8664501|NCT00716963|9707996|FG002|STARTED|Overall Study||1
8664502|NCT00716963|9707997|FG003|STARTED|Overall Study||1
8664503|NCT00716963|9707998|FG004|STARTED|Overall Study||1
8664504|NCT00716963|9707999|FG005|STARTED|Overall Study||1
8664505|NCT00716963|9707994|FG000|COMPLETED|Overall Study||1
8664506|NCT00716963|9707995|FG001|COMPLETED|Overall Study||1
8664507|NCT00716963|9707996|FG002|COMPLETED|Overall Study||1
8664508|NCT00716963|9707997|FG003|COMPLETED|Overall Study||1
8664509|NCT00716963|9707998|FG004|COMPLETED|Overall Study||1
8664510|NCT00716963|9707999|FG005|COMPLETED|Overall Study||1
8664511|NCT00716963|9707994|FG000|NOT COMPLETED|Overall Study||1
8664512|NCT00716963|9707995|FG001|NOT COMPLETED|Overall Study||0
8664513|NCT00716963|9707996|FG002|NOT COMPLETED|Overall Study||0
8664514|NCT00716963|9707997|FG003|NOT COMPLETED|Overall Study||0
8664515|NCT00716963|9707998|FG004|NOT COMPLETED|Overall Study||0
8664516|NCT00716963|9707999|FG005|NOT COMPLETED|Overall Study||0
8664517|NCT00716976|9708009|FG000|STARTED|Overall Study||65
8664518|NCT00716976|9708010|FG001|STARTED|Overall Study||66
8664519|NCT00716976|9708009|FG000|COMPLETED|Overall Study||45
8664520|NCT00716976|9708010|FG001|COMPLETED|Overall Study||57
8664521|NCT00716976|9708009|FG000|NOT COMPLETED|Overall Study||20
8664522|NCT00716976|9708010|FG001|NOT COMPLETED|Overall Study||9
8664523|NCT00717041|9708018|FG000|STARTED|Overall Study||1206
8664524|NCT00717041|9708018|FG000|COMPLETED|Overall Study||1206
8664525|NCT00717041|9708018|FG000|NOT COMPLETED|Overall Study||0
8664526|NCT00717054|9708026|FG000|STARTED|Overall Study||58
8664527|NCT00717054|9708027|FG001|STARTED|Overall Study||57
8664528|NCT00717054|9708026|FG000|COMPLETED|Overall Study||58
8664529|NCT00717054|9708027|FG001|COMPLETED|Overall Study||57
8664530|NCT00717054|9708026|FG000|NOT COMPLETED|Overall Study||0
8664531|NCT00717054|9708027|FG001|NOT COMPLETED|Overall Study||0
8664532|NCT00717067|9708039|FG000|STARTED|Part 1a: Normal/Mild/Moderate Group||6
8664533|NCT00717067|9708040|FG001|STARTED|Part 1a: Normal/Mild/Moderate Group||6
8664534|NCT00717067|9708041|FG002|STARTED|Part 1a: Normal/Mild/Moderate Group||6
8664535|NCT00717067|9708042|FG003|STARTED|Part 1a: Normal/Mild/Moderate Group||0
8664536|NCT00717067|9708043|FG004|STARTED|Part 1a: Normal/Mild/Moderate Group||0
8664537|NCT00717067|9708039|FG000|COMPLETED|Part 1a: Normal/Mild/Moderate Group||6
8664538|NCT00717067|9708040|FG001|COMPLETED|Part 1a: Normal/Mild/Moderate Group||6
8664539|NCT00717067|9708041|FG002|COMPLETED|Part 1a: Normal/Mild/Moderate Group||5
8664540|NCT00717067|9708042|FG003|COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
8664541|NCT00717067|9708043|FG004|COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
8664542|NCT00717067|9708039|FG000|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
8664543|NCT00717067|9708040|FG001|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
8664544|NCT00717067|9708041|FG002|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||1
8664545|NCT00717067|9708042|FG003|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
8664546|NCT00717067|9708043|FG004|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
8664547|NCT00717067|9708039|FG000|STARTED|Part 1b: Severe Renal Impairment||0
8664548|NCT00717067|9708040|FG001|STARTED|Part 1b: Severe Renal Impairment||0
8664549|NCT00717067|9708041|FG002|STARTED|Part 1b: Severe Renal Impairment||0
8664550|NCT00717067|9708042|FG003|STARTED|Part 1b: Severe Renal Impairment||6
8664551|NCT00717067|9708043|FG004|STARTED|Part 1b: Severe Renal Impairment||0
8664552|NCT00717067|9708039|FG000|COMPLETED|Part 1b: Severe Renal Impairment||0
8664553|NCT00717067|9708040|FG001|COMPLETED|Part 1b: Severe Renal Impairment||0
8664554|NCT00717067|9708041|FG002|COMPLETED|Part 1b: Severe Renal Impairment||0
8664555|NCT00717067|9708042|FG003|COMPLETED|Part 1b: Severe Renal Impairment||6
8664556|NCT00717067|9708043|FG004|COMPLETED|Part 1b: Severe Renal Impairment||0
8664557|NCT00717067|9708039|FG000|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
8664558|NCT00717067|9708040|FG001|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
8664559|NCT00717067|9708041|FG002|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
8664560|NCT00717067|9708042|FG003|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
8664561|NCT00717067|9708043|FG004|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
8664562|NCT00717067|9708039|FG000|STARTED|Part 2: End Stage Renal Disease||0
8730341|NCT01058707|9777711|FG002|STARTED|Overall Study||33
8730342|NCT01058707|9777712|FG003|STARTED|Overall Study||22
8730343|NCT01058707|9777713|FG004|STARTED|Overall Study||39
8730344|NCT01058707|9777714|FG005|STARTED|Overall Study||17
8730345|NCT01058707|9777715|FG006|STARTED|Overall Study||26
8730346|NCT01058707|9777709|FG000|COMPLETED|Overall Study||0
8730347|NCT01058707|9777710|FG001|COMPLETED|Overall Study||0
8730348|NCT01058707|9777711|FG002|COMPLETED|Overall Study||0
8730349|NCT01058707|9777712|FG003|COMPLETED|Overall Study||0
8730350|NCT01058707|9777713|FG004|COMPLETED|Overall Study||0
8730351|NCT01058707|9777714|FG005|COMPLETED|Overall Study||0
8730352|NCT01058707|9777715|FG006|COMPLETED|Overall Study||0
8730353|NCT01058707|9777709|FG000|NOT COMPLETED|Overall Study||31
8664563|NCT00717067|9708040|FG001|STARTED|Part 2: End Stage Renal Disease||0
8730354|NCT01058707|9777710|FG001|NOT COMPLETED|Overall Study||30
8664564|NCT00717067|9708041|FG002|STARTED|Part 2: End Stage Renal Disease||0
8730355|NCT01058707|9777711|FG002|NOT COMPLETED|Overall Study||33
8664565|NCT00717067|9708042|FG003|STARTED|Part 2: End Stage Renal Disease||0
8664566|NCT00717067|9708043|FG004|STARTED|Part 2: End Stage Renal Disease||6
8664567|NCT00717067|9708039|FG000|COMPLETED|Part 2: End Stage Renal Disease||0
8664568|NCT00717067|9708040|FG001|COMPLETED|Part 2: End Stage Renal Disease||0
8664569|NCT00717067|9708041|FG002|COMPLETED|Part 2: End Stage Renal Disease||0
8664570|NCT00717067|9708042|FG003|COMPLETED|Part 2: End Stage Renal Disease||0
8664571|NCT00717067|9708043|FG004|COMPLETED|Part 2: End Stage Renal Disease||6
8664572|NCT00717067|9708039|FG000|NOT COMPLETED|Part 2: End Stage Renal Disease||0
8664573|NCT00717067|9708040|FG001|NOT COMPLETED|Part 2: End Stage Renal Disease||0
8664574|NCT00717067|9708041|FG002|NOT COMPLETED|Part 2: End Stage Renal Disease||0
8664575|NCT00717067|9708042|FG003|NOT COMPLETED|Part 2: End Stage Renal Disease||0
8664576|NCT00717067|9708043|FG004|NOT COMPLETED|Part 2: End Stage Renal Disease||0
8664577|NCT00717093|9708067|FG000|STARTED|Overall Study||214
8664578|NCT00717093|9708068|FG001|STARTED|Overall Study||218
8664579|NCT00717093|9708067|FG000|Received Treatment|Overall Study||213
8664580|NCT00717093|9708068|FG001|Received Treatment|Overall Study||218
8664581|NCT00717093|9708067|FG000|COMPLETED|Overall Study||170
8664582|NCT00717093|9708068|FG001|COMPLETED|Overall Study||170
8664583|NCT00717093|9708067|FG000|NOT COMPLETED|Overall Study||44
8664584|NCT00717093|9708068|FG001|NOT COMPLETED|Overall Study||48
8664585|NCT00717197|9708074|FG000|STARTED|Overall Study||30
8664586|NCT00717197|9708074|FG000|COMPLETED|Overall Study||23
8664587|NCT00717197|9708074|FG000|NOT COMPLETED|Overall Study||7
8664588|NCT00717236|9708080|FG000|STARTED|Double-Blind Period||851
8664589|NCT00717236|9708081|FG001|STARTED|Double-Blind Period||212
8664590|NCT00717236|9708080|FG000|COMPLETED|Double-Blind Period||771
8664591|NCT00717236|9708081|FG001|COMPLETED|Double-Blind Period||184
8664592|NCT00717236|9708080|FG000|NOT COMPLETED|Double-Blind Period||80
8664593|NCT00717236|9708081|FG001|NOT COMPLETED|Double-Blind Period||28
8664594|NCT00717236|9708080|FG000|STARTED|Open-Label Period||771
8664595|NCT00717236|9708081|FG001|STARTED|Open-Label Period||184
8664596|NCT00717236|9708080|FG000|COMPLETED|Open-Label Period||646
8664597|NCT00717236|9708081|FG001|COMPLETED|Open-Label Period||163
8664598|NCT00717236|9708080|FG000|NOT COMPLETED|Open-Label Period||125
8664599|NCT00717236|9708081|FG001|NOT COMPLETED|Open-Label Period||21
8664600|NCT00717249|9708091|FG000|STARTED|Overall Study||326
8664601|NCT00717249|9708092|FG001|STARTED|Overall Study||165
8664602|NCT00717249|9708091|FG000|COMPLETED|Overall Study||304
8730356|NCT01058707|9777712|FG003|NOT COMPLETED|Overall Study||22
8730357|NCT01058707|9777713|FG004|NOT COMPLETED|Overall Study||39
8730358|NCT01058707|9777714|FG005|NOT COMPLETED|Overall Study||17
8730359|NCT01058707|9777715|FG006|NOT COMPLETED|Overall Study||26
8730360|NCT01058863|9777753|FG000|STARTED|Overall Study||72
8730361|NCT01058863|9777753|FG000|Safety and ITT Populations|Overall Study|One patient was randomized in error and never received the study drug.|71
8730362|NCT01058863|9777753|FG000|Treated With Albuterol Spiromax® 90 mcg|Overall Study||68
8730363|NCT01058863|9777753|FG000|Treated With Albuterol Spiromax® 180 mcg|Overall Study||68
8730364|NCT01058863|9777753|FG000|Treated With ProAir® HFA 90 mcg|Overall Study||70
8730365|NCT01058863|9777753|FG000|Treated With ProAir® HFA 180 mcg|Overall Study||68
8730366|NCT01058863|9777753|FG000|Treated With Placebo Inhaler|Overall Study||69
8730367|NCT01058863|9777753|FG000|COMPLETED|Overall Study||68
8730368|NCT01058863|9777753|FG000|NOT COMPLETED|Overall Study||4
8730369|NCT01058941|9777768|FG000|STARTED|Overall Study||34
8730370|NCT01058941|9777769|FG001|STARTED|Overall Study||33
8730371|NCT01058941|9777768|FG000|COMPLETED|Overall Study||25
8730372|NCT01058941|9777769|FG001|COMPLETED|Overall Study||22
8730373|NCT01058941|9777768|FG000|NOT COMPLETED|Overall Study||9
8730374|NCT01058941|9777769|FG001|NOT COMPLETED|Overall Study||11
8730375|NCT01058993|9777775|FG000|STARTED|Overall Study||6
8730376|NCT01058993|9777775|FG000|COMPLETED|Overall Study||6
8730377|NCT01058993|9777775|FG000|NOT COMPLETED|Overall Study||0
8730378|NCT01059175|9777781|FG000|STARTED|Overall Study||43
8730379|NCT01059175|9777782|FG001|STARTED|Overall Study||41
8730380|NCT01059175|9777781|FG000|COMPLETED|Overall Study|17 patients deceased 4 additional patients were prematurely exited|22
8730381|NCT01059175|9777782|FG001|COMPLETED|Overall Study|17 patients deceased 3 patients were prematurely exited|21
8730382|NCT01059175|9777781|FG000|NOT COMPLETED|Overall Study||21
8730383|NCT01059175|9777782|FG001|NOT COMPLETED|Overall Study||20
8730384|NCT01059305|9777788|FG000|STARTED|Overall Study||10
8730385|NCT01059305|9777788|FG000|COMPLETED|Overall Study||10
8730386|NCT01059305|9777788|FG000|NOT COMPLETED|Overall Study||0
8730387|NCT01059318|9777792|FG000|STARTED|Core Study (26 Week)|This is safety set and Pharmacodynamic set|24
8730388|NCT01059318|9777792|FG000|Everolimus 2.5 mg for 4 Weeks|Core Study (26 Week)||24
8730389|NCT01059318|9777792|FG000|Everolimus 5 mg for 4 Weeks|Core Study (26 Week)||24
8730390|NCT01059318|9777792|FG000|Everolimus 10 mg for 18 Weeks|Core Study (26 Week)||24
8730391|NCT01059318|9777792|FG000|Pharmacokinetics (PK) Analysis Set|Core Study (26 Week)|For 8 patients plasma rather than whole blood sample was collected, hence excluded from PK set.|16
8730392|NCT01059318|9777792|FG000|COMPLETED|Core Study (26 Week)||20
8730393|NCT01059318|9777792|FG000|NOT COMPLETED|Core Study (26 Week)||4
8730394|NCT01059318|9777792|FG000|STARTED|Extension (36 Week)||20
8730395|NCT01059318|9777792|FG000|COMPLETED|Extension (36 Week)||17
8730396|NCT01059318|9777792|FG000|NOT COMPLETED|Extension (36 Week)||3
8730397|NCT01059344|9777801|FG000|STARTED|Overall Study||140
8730398|NCT01059344|9777802|FG001|STARTED|Overall Study||141
8664603|NCT00717249|9708092|FG001|COMPLETED|Overall Study||150
8664604|NCT00717249|9708091|FG000|NOT COMPLETED|Overall Study||22
8664605|NCT00717249|9708092|FG001|NOT COMPLETED|Overall Study||15
8664606|NCT00717288|9708101|FG000|STARTED|Overall Study||28
8664607|NCT00717288|9708102|FG001|STARTED|Overall Study||29
8664608|NCT00717288|9708103|FG002|STARTED|Overall Study||25
8664609|NCT00717288|9708101|FG000|COMPLETED|Overall Study||28
8664610|NCT00717288|9708102|FG001|COMPLETED|Overall Study||29
8664611|NCT00717288|9708103|FG002|COMPLETED|Overall Study||25
8664612|NCT00717288|9708101|FG000|NOT COMPLETED|Overall Study||0
8664613|NCT00717288|9708102|FG001|NOT COMPLETED|Overall Study||0
8664614|NCT00717288|9708103|FG002|NOT COMPLETED|Overall Study||0
8664615|NCT00717314|9708119|FG000|STARTED|Overall Study||43
8664616|NCT00717314|9708120|FG001|STARTED|Overall Study||44
8664617|NCT00717314|9708119|FG000|COMPLETED|Overall Study||37
8664618|NCT00717314|9708120|FG001|COMPLETED|Overall Study||34
8664619|NCT00717314|9708119|FG000|NOT COMPLETED|Overall Study||6
8664620|NCT00717314|9708120|FG001|NOT COMPLETED|Overall Study||10
8664621|NCT00717366|9708128|FG000|STARTED|Core Study Period (20 Weeks)||16
8664622|NCT00717366|9708129|FG001|STARTED|Core Study Period (20 Weeks)||48
8664623|NCT00717366|9708128|FG000|COMPLETED|Core Study Period (20 Weeks)||12
8664624|NCT00717366|9708129|FG001|COMPLETED|Core Study Period (20 Weeks)||35
8664625|NCT00717366|9708128|FG000|NOT COMPLETED|Core Study Period (20 Weeks)||4
8664626|NCT00717366|9708129|FG001|NOT COMPLETED|Core Study Period (20 Weeks)||13
8664627|NCT00717366|9708128|FG000|STARTED|Extension Period (52 Weeks)||9
8664628|NCT00717366|9708129|FG001|STARTED|Extension Period (52 Weeks)||28
8664629|NCT00717366|9708128|FG000|Received Visit/Week 21 Dose|Extension Period (52 Weeks)||8
8664630|NCT00717366|9708129|FG001|Received Visit/Week 21 Dose|Extension Period (52 Weeks)||28
8664631|NCT00717366|9708128|FG000|COMPLETED|Extension Period (52 Weeks)||5
8664632|NCT00717366|9708129|FG001|COMPLETED|Extension Period (52 Weeks)||12
8664633|NCT00717366|9708128|FG000|NOT COMPLETED|Extension Period (52 Weeks)||4
8664634|NCT00717366|9708129|FG001|NOT COMPLETED|Extension Period (52 Weeks)||16
8664635|NCT00717405|9708135|FG000|STARTED|Overall Study||52
8664636|NCT00717405|9708135|FG000|COMPLETED|Overall Study||52
8664637|NCT00717405|9708135|FG000|NOT COMPLETED|Overall Study||0
8664638|NCT00717418|9708143|FG000|STARTED|Baseline||180
8664639|NCT00717418|9708144|FG001|STARTED|Baseline||74
8664640|NCT00717418|9708145|FG002|STARTED|Baseline||508
8664641|NCT00717418|9708146|FG003|STARTED|Baseline||19
8664642|NCT00717418|9708143|FG000|COMPLETED|Baseline||180
8664643|NCT00717418|9708144|FG001|COMPLETED|Baseline||74
8664644|NCT00717418|9708145|FG002|COMPLETED|Baseline||508
8664645|NCT00717418|9708146|FG003|COMPLETED|Baseline||4
8664646|NCT00717418|9708143|FG000|NOT COMPLETED|Baseline||0
8664647|NCT00717418|9708144|FG001|NOT COMPLETED|Baseline||0
8664648|NCT00717418|9708145|FG002|NOT COMPLETED|Baseline||0
8664649|NCT00717418|9708146|FG003|NOT COMPLETED|Baseline||15
8664650|NCT00717418|9708143|FG000|STARTED|1-Year Follow-Up||180
8664651|NCT00717418|9708144|FG001|STARTED|1-Year Follow-Up||74
8664652|NCT00717418|9708145|FG002|STARTED|1-Year Follow-Up||508
8664653|NCT00717418|9708146|FG003|STARTED|1-Year Follow-Up||4
8664654|NCT00717418|9708143|FG000|COMPLETED|1-Year Follow-Up||33
8664655|NCT00717418|9708144|FG001|COMPLETED|1-Year Follow-Up||23
8664656|NCT00717418|9708145|FG002|COMPLETED|1-Year Follow-Up||74
8664657|NCT00717418|9708146|FG003|COMPLETED|1-Year Follow-Up||0
8664658|NCT00717418|9708143|FG000|NOT COMPLETED|1-Year Follow-Up||147
8664659|NCT00717418|9708144|FG001|NOT COMPLETED|1-Year Follow-Up||51
8664660|NCT00717418|9708145|FG002|NOT COMPLETED|1-Year Follow-Up||434
8664661|NCT00717418|9708146|FG003|NOT COMPLETED|1-Year Follow-Up||4
8664662|NCT00717522|9708150|FG000|STARTED|Overall Study||7
8664663|NCT00717522|9708150|FG000|COMPLETED|Overall Study||0
8664664|NCT00717522|9708150|FG000|NOT COMPLETED|Overall Study||7
8664665|NCT00717574|9708156|FG000|STARTED|Overall Study||16
8664666|NCT00717574|9708157|FG001|STARTED|Overall Study||16
8664667|NCT00717574|9708156|FG000|COMPLETED|Overall Study||14
8664668|NCT00717574|9708157|FG001|COMPLETED|Overall Study||14
8664669|NCT00717574|9708156|FG000|NOT COMPLETED|Overall Study||2
8664670|NCT00717574|9708157|FG001|NOT COMPLETED|Overall Study||2
8664671|NCT00717626|9708163|FG000|STARTED|Overall Study||14
8664672|NCT00717626|9708163|FG000|COMPLETED|Overall Study||14
8664673|NCT00717626|9708163|FG000|NOT COMPLETED|Overall Study||0
8664674|NCT00717756|9708167|FG000|STARTED|Overall Study||41
8664675|NCT00717756|9708167|FG000|COMPLETED|Overall Study||40
8664676|NCT00717756|9708167|FG000|NOT COMPLETED|Overall Study||1
8664677|NCT00717769|9708174|FG000|STARTED|Overall Study||120
8664678|NCT00717769|9708175|FG001|STARTED|Overall Study||120
8664679|NCT00717769|9708176|FG002|STARTED|Overall Study||30
8664680|NCT00717769|9708174|FG000|COMPLETED|Overall Study||104
8664681|NCT00717769|9708175|FG001|COMPLETED|Overall Study||102
8664682|NCT00717769|9708176|FG002|COMPLETED|Overall Study||19
8664683|NCT00717769|9708174|FG000|NOT COMPLETED|Overall Study||16
8664684|NCT00717769|9708175|FG001|NOT COMPLETED|Overall Study||18
8664685|NCT00717769|9708176|FG002|NOT COMPLETED|Overall Study||11
8664686|NCT00717860|9708188|FG000|STARTED|Overall Study||61
8664687|NCT00717860|9708189|FG001|STARTED|Overall Study||60
8664688|NCT00717860|9708188|FG000|COMPLETED|Overall Study||34
8664689|NCT00717860|9708189|FG001|COMPLETED|Overall Study||32
8664690|NCT00717860|9708188|FG000|NOT COMPLETED|Overall Study||27
8664691|NCT00717860|9708189|FG001|NOT COMPLETED|Overall Study||28
8664692|NCT00717873|9708197|FG000|STARTED|Overall Study||46
8664693|NCT00717873|9708198|FG001|STARTED|Overall Study||59
8664694|NCT00717873|9708197|FG000|COMPLETED|Overall Study||46
8664695|NCT00717873|9708198|FG001|COMPLETED|Overall Study||59
8664696|NCT00717873|9708197|FG000|NOT COMPLETED|Overall Study||0
8664697|NCT00717873|9708198|FG001|NOT COMPLETED|Overall Study||0
8664698|NCT00717886|9708204|FG000|STARTED|Overall Study||13
8664699|NCT00717886|9708204|FG000|COMPLETED|Overall Study||9
8664700|NCT00717886|9708204|FG000|NOT COMPLETED|Overall Study||4
8664701|NCT00717912|9708208|FG000|STARTED|Overall Study||1
8664702|NCT00717912|9708209|FG001|STARTED|Overall Study||1
8664703|NCT00717912|9708210|FG002|STARTED|Overall Study||1
8664704|NCT00717912|9708211|FG003|STARTED|Overall Study||1
8664705|NCT00717912|9708212|FG004|STARTED|Overall Study||1
8664706|NCT00717912|9708213|FG005|STARTED|Overall Study||1
8664707|NCT00717912|9708208|FG000|COMPLETED|Overall Study||1
8664708|NCT00717912|9708209|FG001|COMPLETED|Overall Study||1
8664709|NCT00717912|9708210|FG002|COMPLETED|Overall Study||1
8664710|NCT00717912|9708211|FG003|COMPLETED|Overall Study||1
8664711|NCT00717912|9708212|FG004|COMPLETED|Overall Study||1
8664712|NCT00717912|9708213|FG005|COMPLETED|Overall Study||1
8664713|NCT00717912|9708208|FG000|NOT COMPLETED|Overall Study||0
8664714|NCT00717912|9708209|FG001|NOT COMPLETED|Overall Study||0
8664715|NCT00717912|9708210|FG002|NOT COMPLETED|Overall Study||0
8664716|NCT00717912|9708211|FG003|NOT COMPLETED|Overall Study||0
8664717|NCT00717912|9708212|FG004|NOT COMPLETED|Overall Study||0
8664718|NCT00717912|9708213|FG005|NOT COMPLETED|Overall Study||0
8664719|NCT00717977|9708222|FG000|STARTED|Overall Study||74
8664720|NCT00717977|9708222|FG000|COMPLETED|Overall Study||74
8664721|NCT00717977|9708222|FG000|NOT COMPLETED|Overall Study||0
8664722|NCT00718042|9708232|FG000|STARTED|ABBOTT PRISM Chagas Testing||16313
8664723|NCT00718042|9708233|FG001|STARTED|ABBOTT PRISM Chagas Testing||289
8664724|NCT00718042|9708234|FG002|STARTED|ABBOTT PRISM Chagas Testing||525
8664725|NCT00718042|9708235|FG003|STARTED|ABBOTT PRISM Chagas Testing||110
8664726|NCT00718042|9708236|FG004|STARTED|ABBOTT PRISM Chagas Testing||25549
8664727|NCT00718042|9708237|FG005|STARTED|ABBOTT PRISM Chagas Testing|Specimens not screened with PRISM Chagas assay per protocol.|0
8664728|NCT00718042|9708232|FG000|COMPLETED|ABBOTT PRISM Chagas Testing||16249
8664729|NCT00718042|9708233|FG001|COMPLETED|ABBOTT PRISM Chagas Testing||287
8664730|NCT00718042|9708234|FG002|COMPLETED|ABBOTT PRISM Chagas Testing||524
8664731|NCT00718042|9708235|FG003|COMPLETED|ABBOTT PRISM Chagas Testing||110
8664732|NCT00718042|9708236|FG004|COMPLETED|ABBOTT PRISM Chagas Testing||25511
8664733|NCT00718042|9708237|FG005|COMPLETED|ABBOTT PRISM Chagas Testing||0
8664734|NCT00718042|9708232|FG000|NOT COMPLETED|ABBOTT PRISM Chagas Testing||64
8664735|NCT00718042|9708233|FG001|NOT COMPLETED|ABBOTT PRISM Chagas Testing||2
8664736|NCT00718042|9708234|FG002|NOT COMPLETED|ABBOTT PRISM Chagas Testing||1
8664737|NCT00718042|9708235|FG003|NOT COMPLETED|ABBOTT PRISM Chagas Testing||0
8664738|NCT00718042|9708236|FG004|NOT COMPLETED|ABBOTT PRISM Chagas Testing||38
8664739|NCT00718042|9708237|FG005|NOT COMPLETED|ABBOTT PRISM Chagas Testing||0
8664740|NCT00718042|9708232|FG000|STARTED|ESA Chagas Testing|Only specimens repeatedly reactive by screening assay or PRISM grayzone tested with ESA Chagas|36
8664741|NCT00718042|9708233|FG001|STARTED|ESA Chagas Testing||287
8664742|NCT00718042|9708234|FG002|STARTED|ESA Chagas Testing||524
8664743|NCT00718042|9708235|FG003|STARTED|ESA Chagas Testing||110
8664744|NCT00718042|9708236|FG004|STARTED|ESA Chagas Testing|Only specimens repeatedly reactive by screening assay or PRISM grayzone tested with ESA Chagas|43
8664745|NCT00718042|9708237|FG005|STARTED|ESA Chagas Testing|Specimens only tested with ESA Chagas|330
8664746|NCT00718042|9708232|FG000|COMPLETED|ESA Chagas Testing||36
8664747|NCT00718042|9708233|FG001|COMPLETED|ESA Chagas Testing||287
8664748|NCT00718042|9708234|FG002|COMPLETED|ESA Chagas Testing||524
8664749|NCT00718042|9708235|FG003|COMPLETED|ESA Chagas Testing||110
8664750|NCT00718042|9708236|FG004|COMPLETED|ESA Chagas Testing||43
8664751|NCT00718042|9708237|FG005|COMPLETED|ESA Chagas Testing||330
8664752|NCT00718042|9708232|FG000|NOT COMPLETED|ESA Chagas Testing||0
8664753|NCT00718042|9708233|FG001|NOT COMPLETED|ESA Chagas Testing||0
8664754|NCT00718042|9708234|FG002|NOT COMPLETED|ESA Chagas Testing||0
8664755|NCT00718042|9708235|FG003|NOT COMPLETED|ESA Chagas Testing||0
8664756|NCT00718042|9708236|FG004|NOT COMPLETED|ESA Chagas Testing||0
8664757|NCT00718042|9708237|FG005|NOT COMPLETED|ESA Chagas Testing||0
8664758|NCT00718042|9708232|FG000|STARTED|Donor Follow-up||36
8664759|NCT00718042|9708233|FG001|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
8664760|NCT00718042|9708234|FG002|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
8664761|NCT00718042|9708235|FG003|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
8664762|NCT00718042|9708236|FG004|STARTED|Donor Follow-up||43
8664763|NCT00718042|9708237|FG005|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
8664764|NCT00718042|9708232|FG000|COMPLETED|Donor Follow-up||23
8664765|NCT00718042|9708233|FG001|COMPLETED|Donor Follow-up||0
8664766|NCT00718042|9708234|FG002|COMPLETED|Donor Follow-up||0
8664767|NCT00718042|9708235|FG003|COMPLETED|Donor Follow-up||0
8664768|NCT00718042|9708236|FG004|COMPLETED|Donor Follow-up||24
8664769|NCT00718042|9708237|FG005|COMPLETED|Donor Follow-up||0
8664770|NCT00718042|9708232|FG000|NOT COMPLETED|Donor Follow-up||13
8664771|NCT00718042|9708233|FG001|NOT COMPLETED|Donor Follow-up||0
8664772|NCT00718042|9708234|FG002|NOT COMPLETED|Donor Follow-up||0
8664773|NCT00718042|9708235|FG003|NOT COMPLETED|Donor Follow-up||0
8664774|NCT00718042|9708236|FG004|NOT COMPLETED|Donor Follow-up||19
8664775|NCT00718042|9708237|FG005|NOT COMPLETED|Donor Follow-up||0
8664776|NCT00718081|9708252|FG000|STARTED|Overall Study||29
8664777|NCT00718081|9708253|FG001|STARTED|Overall Study||29
8664778|NCT00718081|9708254|FG002|STARTED|Overall Study||30
8664779|NCT00718081|9708252|FG000|COMPLETED|Overall Study||22
8664780|NCT00718081|9708253|FG001|COMPLETED|Overall Study||25
8664781|NCT00718081|9708254|FG002|COMPLETED|Overall Study||9
8664782|NCT00718081|9708252|FG000|NOT COMPLETED|Overall Study||7
8664783|NCT00718081|9708253|FG001|NOT COMPLETED|Overall Study||4
8664784|NCT00718081|9708254|FG002|NOT COMPLETED|Overall Study||21
8664785|NCT00718094|9708264|FG000|STARTED|Overall Study||15
8664786|NCT00718094|9708265|FG001|STARTED|Overall Study||5
8664787|NCT00718094|9708264|FG000|COMPLETED|Overall Study||15
8664788|NCT00718094|9708265|FG001|COMPLETED|Overall Study||5
8664789|NCT00718094|9708264|FG000|NOT COMPLETED|Overall Study||0
8664790|NCT00718094|9708265|FG001|NOT COMPLETED|Overall Study||0
8664791|NCT00718120|9708273|FG000|STARTED|Overall Study||55
8664792|NCT00718120|9708274|FG001|STARTED|Overall Study||55
8664793|NCT00718120|9708273|FG000|COMPLETED|Overall Study||55
8664794|NCT00718120|9708274|FG001|COMPLETED|Overall Study||55
8664795|NCT00718120|9708273|FG000|NOT COMPLETED|Overall Study||0
8664796|NCT00718120|9708274|FG001|NOT COMPLETED|Overall Study||0
8664797|NCT00718159|9708287|FG000|STARTED|Overall Study||3
8664798|NCT00718159|9708288|FG001|STARTED|Overall Study||3
8664799|NCT00718159|9708289|FG002|STARTED|Overall Study||3
8664800|NCT00718159|9708290|FG003|STARTED|Overall Study||4
8664801|NCT00718159|9708291|FG004|STARTED|Overall Study||8
8664802|NCT00718159|9708292|FG005|STARTED|Overall Study||1
8664803|NCT00718159|9708293|FG006|STARTED|Overall Study||1
8664804|NCT00718159|9708287|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
8664805|NCT00718159|9708288|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
8664806|NCT00718159|9708289|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
8664807|NCT00718159|9708290|FG003|Received at Least 1 Dose of Study Drug|Overall Study||4
8664808|NCT00718159|9708291|FG004|Received at Least 1 Dose of Study Drug|Overall Study||8
8664809|NCT00718159|9708292|FG005|Received at Least 1 Dose of Study Drug|Overall Study||1
8664810|NCT00718159|9708293|FG006|Received at Least 1 Dose of Study Drug|Overall Study||1
8664811|NCT00718159|9708287|FG000|COMPLETED|Overall Study||0
8664812|NCT00718159|9708288|FG001|COMPLETED|Overall Study||0
8664813|NCT00718159|9708289|FG002|COMPLETED|Overall Study||0
8664814|NCT00718159|9708290|FG003|COMPLETED|Overall Study||0
8664815|NCT00718159|9708291|FG004|COMPLETED|Overall Study||0
8664816|NCT00718159|9708292|FG005|COMPLETED|Overall Study||0
8664817|NCT00718159|9708293|FG006|COMPLETED|Overall Study||0
8664818|NCT00718159|9708287|FG000|NOT COMPLETED|Overall Study||3
8664819|NCT00718159|9708288|FG001|NOT COMPLETED|Overall Study||3
8664820|NCT00718159|9708289|FG002|NOT COMPLETED|Overall Study||3
8664821|NCT00718159|9708290|FG003|NOT COMPLETED|Overall Study||4
8664822|NCT00718159|9708291|FG004|NOT COMPLETED|Overall Study||8
8664823|NCT00718159|9708292|FG005|NOT COMPLETED|Overall Study||1
8664824|NCT00718159|9708293|FG006|NOT COMPLETED|Overall Study||1
8664825|NCT00718237|9708311|FG000|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized into the study|381
8664826|NCT00718237|9708312|FG001|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized into the study|381
8664827|NCT00718237|9708311|FG000|Vaccinated at Visit 1|Overall Study||380
8664828|NCT00718237|9708312|FG001|Vaccinated at Visit 1|Overall Study||381
8664829|NCT00718237|9708311|FG000|Vaccinated at Visit 2|Overall Study||373
8664830|NCT00718237|9708312|FG001|Vaccinated at Visit 2|Overall Study||374
8664831|NCT00718237|9708311|FG000|Vaccinated at Visit 3|Overall Study||371
8664832|NCT00718237|9708312|FG001|Vaccinated at Visit 3|Overall Study||369
8664833|NCT00718237|9708311|FG000|COMPLETED|Overall Study|Subjects who continued follow-up until the last visit, regardless of number of vaccinations received|368
8664834|NCT00718237|9708312|FG001|COMPLETED|Overall Study|Subjects who continued follow-up until the last visit, regardless of number of vaccinations received|366
8664835|NCT00718237|9708311|FG000|NOT COMPLETED|Overall Study||13
8664836|NCT00718237|9708312|FG001|NOT COMPLETED|Overall Study||15
8664837|NCT00718302|9708322|FG000|STARTED|Overall Study||119
8664838|NCT00718302|9708323|FG001|STARTED|Overall Study||114
8664839|NCT00718302|9708322|FG000|COMPLETED|Overall Study||119
8664840|NCT00718302|9708323|FG001|COMPLETED|Overall Study||114
8664841|NCT00718302|9708322|FG000|NOT COMPLETED|Overall Study||0
8664842|NCT00718302|9708323|FG001|NOT COMPLETED|Overall Study||0
8664843|NCT00718315|9708334|FG000|STARTED|Overall Study||67
8664844|NCT00718315|9708335|FG001|STARTED|Overall Study||67
8664845|NCT00718315|9708336|FG002|STARTED|Overall Study||67
8664846|NCT00718315|9708334|FG000|COMPLETED|Overall Study||48
8664847|NCT00718315|9708335|FG001|COMPLETED|Overall Study||45
8664848|NCT00718315|9708336|FG002|COMPLETED|Overall Study||46
8664849|NCT00718315|9708334|FG000|NOT COMPLETED|Overall Study||19
8664850|NCT00718315|9708335|FG001|NOT COMPLETED|Overall Study||22
8664851|NCT00718315|9708336|FG002|NOT COMPLETED|Overall Study||21
8664852|NCT00718328|9708346|FG000|STARTED|Overall Study||1
8664853|NCT00718328|9708347|FG001|STARTED|Overall Study||0
8664854|NCT00718328|9708346|FG000|COMPLETED|Overall Study|Prematurely terminated due to poor enrollment|0
8664855|NCT00718328|9708347|FG001|COMPLETED|Overall Study|Terminated due to poor enrollment|0
8664856|NCT00718328|9708346|FG000|NOT COMPLETED|Overall Study||1
8664857|NCT00718328|9708347|FG001|NOT COMPLETED|Overall Study||0
8664858|NCT00718419|9708355|FG000|STARTED|Overall Study||14
8664859|NCT00718419|9708356|FG001|STARTED|Overall Study||42
8664860|NCT00718419|9708355|FG000|Received at Least One Dose of Study Drug|Overall Study||14
8664861|NCT00718419|9708356|FG001|Received at Least One Dose of Study Drug|Overall Study||42
8664862|NCT00718419|9708355|FG000|COMPLETED|Overall Study|Participants who completed 8 cycles of treatment.|1
8664863|NCT00718419|9708356|FG001|COMPLETED|Overall Study|Participants who completed 8 cycles of treatment.|3
8664864|NCT00718419|9708355|FG000|NOT COMPLETED|Overall Study||13
8664865|NCT00718419|9708356|FG001|NOT COMPLETED|Overall Study||39
8664866|NCT00718510|9708364|FG000|STARTED|First Intervention (3 Weeks)||7
8664867|NCT00718510|9708365|FG001|STARTED|First Intervention (3 Weeks)||8
8664868|NCT00718510|9708364|FG000|Received Intervention|First Intervention (3 Weeks)||7
8664869|NCT00718510|9708365|FG001|Received Intervention|First Intervention (3 Weeks)||7
8664870|NCT00718510|9708364|FG000|COMPLETED|First Intervention (3 Weeks)||7
8664871|NCT00718510|9708365|FG001|COMPLETED|First Intervention (3 Weeks)||7
8664872|NCT00718510|9708364|FG000|NOT COMPLETED|First Intervention (3 Weeks)||0
8664873|NCT00718510|9708365|FG001|NOT COMPLETED|First Intervention (3 Weeks)||1
8664874|NCT00718510|9708364|FG000|STARTED|Washout (5 Days)||7
8664875|NCT00718510|9708365|FG001|STARTED|Washout (5 Days)||7
8664876|NCT00718510|9708364|FG000|COMPLETED|Washout (5 Days)||7
8664877|NCT00718510|9708365|FG001|COMPLETED|Washout (5 Days)||7
8664878|NCT00718510|9708364|FG000|NOT COMPLETED|Washout (5 Days)||0
8664879|NCT00718510|9708365|FG001|NOT COMPLETED|Washout (5 Days)||0
8664880|NCT00718510|9708364|FG000|STARTED|Second Intervention (3 Weeks)||7
8664881|NCT00718510|9708365|FG001|STARTED|Second Intervention (3 Weeks)||7
8664882|NCT00718510|9708364|FG000|COMPLETED|Second Intervention (3 Weeks)||6
8664883|NCT00718510|9708365|FG001|COMPLETED|Second Intervention (3 Weeks)||7
8664884|NCT00718510|9708364|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||1
8664885|NCT00718510|9708365|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
8664886|NCT00718523|9708373|FG000|STARTED|Overall Study||84
8664887|NCT00718523|9708374|FG001|STARTED|Overall Study||86
8664888|NCT00718523|9708373|FG000|COMPLETED|Overall Study||66
8664889|NCT00718523|9708374|FG001|COMPLETED|Overall Study||62
8664890|NCT00718523|9708373|FG000|NOT COMPLETED|Overall Study||18
8664891|NCT00718523|9708374|FG001|NOT COMPLETED|Overall Study||24
8664892|NCT00718549|9708380|FG000|STARTED|Induction Phase||128
8664893|NCT00718549|9708381|FG001|STARTED|Induction Phase||0
8664894|NCT00718549|9708382|FG002|STARTED|Induction Phase||0
8664895|NCT00718549|9708380|FG000|COMPLETED|Induction Phase||66
8730399|NCT01059344|9777801|FG000|COMPLETED|Overall Study||118
8730400|NCT01059344|9777802|FG001|COMPLETED|Overall Study||95
8730401|NCT01059344|9777801|FG000|NOT COMPLETED|Overall Study||22
8730402|NCT01059344|9777802|FG001|NOT COMPLETED|Overall Study||46
8730403|NCT01059357|9777810|FG000|STARTED|Overall Study||58
8730404|NCT01059357|9777810|FG000|COMPLETED|Overall Study||54
8730405|NCT01059357|9777810|FG000|NOT COMPLETED|Overall Study||4
8730406|NCT01059435|9777824|FG000|STARTED|Overall Study||14
8730407|NCT01059435|9777825|FG001|STARTED|Overall Study||6
8730408|NCT01059435|9777826|FG002|STARTED|Overall Study||8
8730409|NCT01059435|9777827|FG003|STARTED|Overall Study||9
8730410|NCT01059435|9777828|FG004|STARTED|Overall Study||6
8730411|NCT01059435|9777829|FG005|STARTED|Overall Study||9
8730412|NCT01059435|9777830|FG006|STARTED|Overall Study||6
8730413|NCT01059435|9777831|FG007|STARTED|Overall Study||4
8730414|NCT01059435|9777832|FG008|STARTED|Overall Study||6
8730415|NCT01059435|9777833|FG009|STARTED|Overall Study||6
8730416|NCT01059435|9777824|FG000|Received Study Drug|Overall Study||14
8730417|NCT01059435|9777825|FG001|Received Study Drug|Overall Study||6
8730418|NCT01059435|9777826|FG002|Received Study Drug|Overall Study||6
8730419|NCT01059435|9777827|FG003|Received Study Drug|Overall Study||9
8730420|NCT01059435|9777828|FG004|Received Study Drug|Overall Study||6
8730421|NCT01059435|9777829|FG005|Received Study Drug|Overall Study||9
8730422|NCT01059435|9777830|FG006|Received Study Drug|Overall Study||6
8730423|NCT01059435|9777831|FG007|Received Study Drug|Overall Study||4
8730424|NCT01059435|9777832|FG008|Received Study Drug|Overall Study||6
8730425|NCT01059435|9777833|FG009|Received Study Drug|Overall Study||6
8730426|NCT01059435|9777824|FG000|COMPLETED|Overall Study||14
8730427|NCT01059435|9777825|FG001|COMPLETED|Overall Study||6
8730428|NCT01059435|9777826|FG002|COMPLETED|Overall Study||6
8730429|NCT01059435|9777827|FG003|COMPLETED|Overall Study||9
8730430|NCT01059435|9777828|FG004|COMPLETED|Overall Study||6
8730431|NCT01059435|9777829|FG005|COMPLETED|Overall Study||9
8730432|NCT01059435|9777830|FG006|COMPLETED|Overall Study||6
8730433|NCT01059435|9777831|FG007|COMPLETED|Overall Study||4
8730434|NCT01059435|9777832|FG008|COMPLETED|Overall Study||6
8730435|NCT01059435|9777833|FG009|COMPLETED|Overall Study||6
8664896|NCT00718549|9708381|FG001|COMPLETED|Induction Phase||0
8664897|NCT00718549|9708382|FG002|COMPLETED|Induction Phase||0
8664898|NCT00718549|9708380|FG000|NOT COMPLETED|Induction Phase||62
8664899|NCT00718549|9708381|FG001|NOT COMPLETED|Induction Phase||0
8664900|NCT00718549|9708382|FG002|NOT COMPLETED|Induction Phase||0
8664901|NCT00718549|9708380|FG000|STARTED|Maintenance/ Observation Phase||0
8664902|NCT00718549|9708381|FG001|STARTED|Maintenance/ Observation Phase||33
8664903|NCT00718549|9708382|FG002|STARTED|Maintenance/ Observation Phase||33
8664904|NCT00718549|9708380|FG000|COMPLETED|Maintenance/ Observation Phase||0
8664905|NCT00718549|9708381|FG001|COMPLETED|Maintenance/ Observation Phase||5
8730436|NCT01059435|9777824|FG000|NOT COMPLETED|Overall Study||0
8730437|NCT01059435|9777825|FG001|NOT COMPLETED|Overall Study||0
8730438|NCT01059435|9777826|FG002|NOT COMPLETED|Overall Study||2
8730439|NCT01059435|9777827|FG003|NOT COMPLETED|Overall Study||0
8730440|NCT01059435|9777828|FG004|NOT COMPLETED|Overall Study||0
8730441|NCT01059435|9777829|FG005|NOT COMPLETED|Overall Study||0
8664906|NCT00718549|9708382|FG002|COMPLETED|Maintenance/ Observation Phase||3
8664907|NCT00718549|9708380|FG000|NOT COMPLETED|Maintenance/ Observation Phase||0
8664908|NCT00718549|9708381|FG001|NOT COMPLETED|Maintenance/ Observation Phase||28
8664909|NCT00718549|9708382|FG002|NOT COMPLETED|Maintenance/ Observation Phase||30
8664910|NCT00718666|9708398|FG000|STARTED|Persistence Phase Year 1||118
8664911|NCT00718666|9708399|FG001|STARTED|Persistence Phase Year 1||130
8664912|NCT00718666|9708400|FG002|STARTED|Persistence Phase Year 1||0
8664913|NCT00718666|9708398|FG000|COMPLETED|Persistence Phase Year 1||118
8664914|NCT00718666|9708399|FG001|COMPLETED|Persistence Phase Year 1||130
8664915|NCT00718666|9708400|FG002|COMPLETED|Persistence Phase Year 1|Subjects enrolled to receive Nimenrix vaccine as primary vaccination only at Booster Phase-Year 5.|0
8664916|NCT00718666|9708398|FG000|NOT COMPLETED|Persistence Phase Year 1||0
8664917|NCT00718666|9708399|FG001|NOT COMPLETED|Persistence Phase Year 1||0
8664918|NCT00718666|9708400|FG002|NOT COMPLETED|Persistence Phase Year 1||0
8664919|NCT00718666|9708398|FG000|STARTED|Persistence Phase Year 3||98
8664920|NCT00718666|9708399|FG001|STARTED|Persistence Phase Year 3||104
8664921|NCT00718666|9708400|FG002|STARTED|Persistence Phase Year 3||0
8730442|NCT01059435|9777830|FG006|NOT COMPLETED|Overall Study||0
8730443|NCT01059435|9777831|FG007|NOT COMPLETED|Overall Study||0
8730444|NCT01059435|9777832|FG008|NOT COMPLETED|Overall Study||0
8664922|NCT00718666|9708398|FG000|COMPLETED|Persistence Phase Year 3||98
8664923|NCT00718666|9708399|FG001|COMPLETED|Persistence Phase Year 3||104
8664924|NCT00718666|9708400|FG002|COMPLETED|Persistence Phase Year 3|Subjects enrolled to receive Nimenrix vaccine as primary vaccination only at Booster Phase-Year 5.|0
8664925|NCT00718666|9708398|FG000|NOT COMPLETED|Persistence Phase Year 3||0
8664926|NCT00718666|9708399|FG001|NOT COMPLETED|Persistence Phase Year 3||0
8664927|NCT00718666|9708400|FG002|NOT COMPLETED|Persistence Phase Year 3||0
8664928|NCT00718666|9708398|FG000|STARTED|Persistence Phase Year 5||70
8664929|NCT00718666|9708399|FG001|STARTED|Persistence Phase Year 5||82
8664930|NCT00718666|9708400|FG002|STARTED|Persistence Phase Year 5||0
8664931|NCT00718666|9708398|FG000|COMPLETED|Persistence Phase Year 5||70
8664932|NCT00718666|9708399|FG001|COMPLETED|Persistence Phase Year 5||82
8664933|NCT00718666|9708400|FG002|COMPLETED|Persistence Phase Year 5|Subjects enrolled to receive Nimenrix vaccine as primary vaccination only at Booster Phase-Year 5.|0
8664934|NCT00718666|9708398|FG000|NOT COMPLETED|Persistence Phase Year 5||0
8664935|NCT00718666|9708399|FG001|NOT COMPLETED|Persistence Phase Year 5||0
8664936|NCT00718666|9708400|FG002|NOT COMPLETED|Persistence Phase Year 5||0
8664937|NCT00718666|9708398|FG000|STARTED|Booster Phase Year 5||38
8664938|NCT00718666|9708399|FG001|STARTED|Booster Phase Year 5||46
8664939|NCT00718666|9708400|FG002|STARTED|Booster Phase Year 5||100
8664940|NCT00718666|9708398|FG000|COMPLETED|Booster Phase Year 5||36
8664941|NCT00718666|9708399|FG001|COMPLETED|Booster Phase Year 5||46
8664942|NCT00718666|9708400|FG002|COMPLETED|Booster Phase Year 5||94
8664943|NCT00718666|9708398|FG000|NOT COMPLETED|Booster Phase Year 5||2
8664944|NCT00718666|9708399|FG001|NOT COMPLETED|Booster Phase Year 5||0
8664945|NCT00718666|9708400|FG002|NOT COMPLETED|Booster Phase Year 5||6
8664946|NCT00718718|9708425|FG000|STARTED|Prior to Week 12||19
8664947|NCT00718718|9708426|FG001|STARTED|Prior to Week 12||0
8664948|NCT00718718|9708427|FG002|STARTED|Prior to Week 12||17
8664949|NCT00718718|9708428|FG003|STARTED|Prior to Week 12||0
8664950|NCT00718718|9708429|FG004|STARTED|Prior to Week 12||30
8730445|NCT01059435|9777833|FG009|NOT COMPLETED|Overall Study||0
8911454|NCT02146430|9970562|FG002|STARTED|Overall Study||324
8911455|NCT02146430|9970563|FG003|STARTED|Overall Study||323
8911456|NCT02146430|9970560|FG000|Safety Analysis Set|Overall Study||318
8911457|NCT02146430|9970561|FG001|Safety Analysis Set|Overall Study||318
8911458|NCT02146430|9970562|FG002|Safety Analysis Set|Overall Study||320
8911459|NCT02146430|9970563|FG003|Safety Analysis Set|Overall Study||320
8911460|NCT02146430|9970560|FG000|Modified Intent to Treat Set (mITT)|Overall Study||318
8911461|NCT02146430|9970561|FG001|Modified Intent to Treat Set (mITT)|Overall Study||317
8911462|NCT02146430|9970562|FG002|Modified Intent to Treat Set (mITT)|Overall Study||319
8911463|NCT02146430|9970563|FG003|Modified Intent to Treat Set (mITT)|Overall Study||319
8911464|NCT02146430|9970560|FG000|COMPLETED|Overall Study||256
8911465|NCT02146430|9970561|FG001|COMPLETED|Overall Study||236
8911466|NCT02146430|9970562|FG002|COMPLETED|Overall Study||242
8911467|NCT02146430|9970563|FG003|COMPLETED|Overall Study||224
8911468|NCT02146430|9970560|FG000|NOT COMPLETED|Overall Study||67
8911469|NCT02146430|9970561|FG001|NOT COMPLETED|Overall Study||87
8911470|NCT02146430|9970562|FG002|NOT COMPLETED|Overall Study||82
8911471|NCT02146430|9970563|FG003|NOT COMPLETED|Overall Study||99
8911472|NCT02146482|9970579|FG000|STARTED|Overall Study|11 participants total enrolled in study but withdrew prior to randomization|21
8911473|NCT02146482|9970580|FG001|STARTED|Overall Study|11 participants total enrolled in study but withdrew prior to randomization|25
8664951|NCT00718718|9708430|FG005|STARTED|Prior to Week 12||0
8664952|NCT00718718|9708431|FG006|STARTED|Prior to Week 12||30
8664953|NCT00718718|9708432|FG007|STARTED|Prior to Week 12||30
8664954|NCT00718718|9708433|FG008|STARTED|Prior to Week 12||30
8664955|NCT00718718|9708434|FG009|STARTED|Prior to Week 12||31
8664956|NCT00718718|9708425|FG000|COMPLETED|Prior to Week 12||18
8664957|NCT00718718|9708426|FG001|COMPLETED|Prior to Week 12||0
8664958|NCT00718718|9708427|FG002|COMPLETED|Prior to Week 12||16
8664959|NCT00718718|9708428|FG003|COMPLETED|Prior to Week 12||0
8664960|NCT00718718|9708429|FG004|COMPLETED|Prior to Week 12||27
8664961|NCT00718718|9708430|FG005|COMPLETED|Prior to Week 12||0
8806674|NCT01479465|9858992|FG002|STARTED|Overall Study||86
8911474|NCT02146482|9970579|FG000|COMPLETED|Overall Study||21
8664962|NCT00718718|9708431|FG006|COMPLETED|Prior to Week 12||29
8664963|NCT00718718|9708432|FG007|COMPLETED|Prior to Week 12||28
8664964|NCT00718718|9708433|FG008|COMPLETED|Prior to Week 12||28
8664965|NCT00718718|9708434|FG009|COMPLETED|Prior to Week 12||31
8664966|NCT00718718|9708425|FG000|NOT COMPLETED|Prior to Week 12||1
8664967|NCT00718718|9708426|FG001|NOT COMPLETED|Prior to Week 12||0
8664968|NCT00718718|9708427|FG002|NOT COMPLETED|Prior to Week 12||1
8664969|NCT00718718|9708428|FG003|NOT COMPLETED|Prior to Week 12||0
8664970|NCT00718718|9708429|FG004|NOT COMPLETED|Prior to Week 12||3
8664971|NCT00718718|9708430|FG005|NOT COMPLETED|Prior to Week 12||0
8664972|NCT00718718|9708431|FG006|NOT COMPLETED|Prior to Week 12||1
8664973|NCT00718718|9708432|FG007|NOT COMPLETED|Prior to Week 12||2
8664974|NCT00718718|9708433|FG008|NOT COMPLETED|Prior to Week 12||2
8664975|NCT00718718|9708434|FG009|NOT COMPLETED|Prior to Week 12||0
8664976|NCT00718718|9708425|FG000|STARTED|Week 12 to End of Study||0
8664977|NCT00718718|9708426|FG001|STARTED|Week 12 to End of Study||18
8664978|NCT00718718|9708427|FG002|STARTED|Week 12 to End of Study||0
8664979|NCT00718718|9708428|FG003|STARTED|Week 12 to End of Study||16
8664980|NCT00718718|9708429|FG004|STARTED|Week 12 to End of Study||0
8664981|NCT00718718|9708430|FG005|STARTED|Week 12 to End of Study||27
8664982|NCT00718718|9708431|FG006|STARTED|Week 12 to End of Study||29
8664983|NCT00718718|9708432|FG007|STARTED|Week 12 to End of Study||28
8664984|NCT00718718|9708433|FG008|STARTED|Week 12 to End of Study||28
8664985|NCT00718718|9708434|FG009|STARTED|Week 12 to End of Study||31
8664986|NCT00718718|9708425|FG000|Treated|Week 12 to End of Study||0
8664987|NCT00718718|9708426|FG001|Treated|Week 12 to End of Study||18
8664988|NCT00718718|9708427|FG002|Treated|Week 12 to End of Study||0
8664989|NCT00718718|9708428|FG003|Treated|Week 12 to End of Study||16
8664990|NCT00718718|9708429|FG004|Treated|Week 12 to End of Study||0
8664991|NCT00718718|9708430|FG005|Treated|Week 12 to End of Study||26
8664992|NCT00718718|9708431|FG006|Treated|Week 12 to End of Study||29
8664993|NCT00718718|9708432|FG007|Treated|Week 12 to End of Study||28
8664994|NCT00718718|9708433|FG008|Treated|Week 12 to End of Study||28
8664995|NCT00718718|9708434|FG009|Treated|Week 12 to End of Study||31
8664996|NCT00718718|9708425|FG000|COMPLETED|Week 12 to End of Study||0
8664997|NCT00718718|9708426|FG001|COMPLETED|Week 12 to End of Study||17
8664998|NCT00718718|9708427|FG002|COMPLETED|Week 12 to End of Study||0
8664999|NCT00718718|9708428|FG003|COMPLETED|Week 12 to End of Study||15
8665000|NCT00718718|9708429|FG004|COMPLETED|Week 12 to End of Study||0
8665001|NCT00718718|9708430|FG005|COMPLETED|Week 12 to End of Study||24
8665002|NCT00718718|9708431|FG006|COMPLETED|Week 12 to End of Study||27
8665003|NCT00718718|9708432|FG007|COMPLETED|Week 12 to End of Study||27
8665004|NCT00718718|9708433|FG008|COMPLETED|Week 12 to End of Study||27
8665005|NCT00718718|9708434|FG009|COMPLETED|Week 12 to End of Study||31
8665006|NCT00718718|9708425|FG000|NOT COMPLETED|Week 12 to End of Study||0
8665007|NCT00718718|9708426|FG001|NOT COMPLETED|Week 12 to End of Study||1
8665008|NCT00718718|9708427|FG002|NOT COMPLETED|Week 12 to End of Study||0
8665009|NCT00718718|9708428|FG003|NOT COMPLETED|Week 12 to End of Study||1
8665010|NCT00718718|9708429|FG004|NOT COMPLETED|Week 12 to End of Study||0
8665011|NCT00718718|9708430|FG005|NOT COMPLETED|Week 12 to End of Study||3
8665012|NCT00718718|9708431|FG006|NOT COMPLETED|Week 12 to End of Study||2
8665013|NCT00718718|9708432|FG007|NOT COMPLETED|Week 12 to End of Study||1
8665014|NCT00718718|9708433|FG008|NOT COMPLETED|Week 12 to End of Study||1
8665015|NCT00718718|9708434|FG009|NOT COMPLETED|Week 12 to End of Study||0
8665016|NCT00718770|9708460|FG000|STARTED|Overall Study||10
8665017|NCT00718770|9708460|FG000|COMPLETED|Overall Study||2
8665018|NCT00718770|9708460|FG000|NOT COMPLETED|Overall Study||8
8665019|NCT00718809|9708466|FG000|STARTED|Overall Study||12
8665020|NCT00718809|9708467|FG001|STARTED|Overall Study||9
8665021|NCT00718809|9708466|FG000|COMPLETED|Overall Study||0
8665022|NCT00718809|9708467|FG001|COMPLETED|Overall Study||0
8665023|NCT00718809|9708466|FG000|NOT COMPLETED|Overall Study||12
8665024|NCT00718809|9708467|FG001|NOT COMPLETED|Overall Study||9
8665025|NCT00718861|9708475|FG000|STARTED|Overall Study|"Started indicates Randomized and Intent-to Treat (ITT) population"|95
8665026|NCT00718861|9708476|FG001|STARTED|Overall Study||95
8665027|NCT00718861|9708475|FG000|Safety Set|Overall Study|3 patients randomized but never received study drug|92
8665028|NCT00718861|9708476|FG001|Safety Set|Overall Study||95
8665029|NCT00718861|9708475|FG000|Modified Intent to Treat|Overall Study|ITT patients with DXA total hip measure at extension 2 baseline and year 9|67
8665030|NCT00718861|9708476|FG001|Modified Intent to Treat|Overall Study|ITT patients with DXA total hip measure at extension 2 baseline and year 9|69
8665031|NCT00718861|9708475|FG000|COMPLETED|Overall Study||74
8665032|NCT00718861|9708476|FG001|COMPLETED|Overall Study||77
8665033|NCT00718861|9708475|FG000|NOT COMPLETED|Overall Study||21
8665034|NCT00718861|9708476|FG001|NOT COMPLETED|Overall Study||18
8665035|NCT00718887|9708484|FG000|STARTED|Overall Study|Participants who received treatment.|89
8665036|NCT00718887|9708485|FG001|STARTED|Overall Study|Participants who received treatment.|77
8665037|NCT00718887|9708484|FG000|COMPLETED|Overall Study|Continued in study after 48 weeks|84
8665038|NCT00718887|9708485|FG001|COMPLETED|Overall Study||68
8665039|NCT00718887|9708484|FG000|NOT COMPLETED|Overall Study||5
8665040|NCT00718887|9708485|FG001|NOT COMPLETED|Overall Study||9
8665041|NCT00719043|9708504|FG000|STARTED|Overall Study||120
8665042|NCT00719043|9708505|FG001|STARTED|Overall Study||121
8665043|NCT00719043|9708506|FG002|STARTED|Overall Study||119
8665044|NCT00719043|9708507|FG003|STARTED|Overall Study||119
8665045|NCT00719043|9708508|FG004|STARTED|Overall Study||122
8665046|NCT00719043|9708509|FG005|STARTED|Overall Study||120
8665047|NCT00719043|9708510|FG006|STARTED|Overall Study||120
8665048|NCT00719043|9708504|FG000|COMPLETED|Overall Study|Up to Day 909|88
8665049|NCT00719043|9708505|FG001|COMPLETED|Overall Study|Up to Day 909|96
8665050|NCT00719043|9708506|FG002|COMPLETED|Overall Study|Up to Day 909|99
8665051|NCT00719043|9708507|FG003|COMPLETED|Overall Study|Up to Day 909|96
8665052|NCT00719043|9708508|FG004|COMPLETED|Overall Study|Up to Day 909|95
8665053|NCT00719043|9708509|FG005|COMPLETED|Overall Study|Up to Day 909|86
8665054|NCT00719043|9708510|FG006|COMPLETED|Overall Study|Up to Day 909|92
8665055|NCT00719043|9708504|FG000|NOT COMPLETED|Overall Study||32
8665056|NCT00719043|9708505|FG001|NOT COMPLETED|Overall Study||25
8665057|NCT00719043|9708506|FG002|NOT COMPLETED|Overall Study||20
8665058|NCT00719043|9708507|FG003|NOT COMPLETED|Overall Study||23
8665059|NCT00719043|9708508|FG004|NOT COMPLETED|Overall Study||27
8665060|NCT00719043|9708509|FG005|NOT COMPLETED|Overall Study||34
8665061|NCT00719043|9708510|FG006|NOT COMPLETED|Overall Study||28
8665062|NCT00719134|9708538|FG000|STARTED|Overall Study||76
8665063|NCT00719134|9708538|FG000|COMPLETED|Overall Study||66
8665064|NCT00719134|9708538|FG000|NOT COMPLETED|Overall Study||10
8665065|NCT00719160|9708543|FG000|STARTED|Overall Study||6
8665066|NCT00719160|9708544|FG001|STARTED|Overall Study||6
8665067|NCT00719160|9708543|FG000|COMPLETED|Overall Study||6
8665068|NCT00719160|9708544|FG001|COMPLETED|Overall Study||6
8665069|NCT00719160|9708543|FG000|NOT COMPLETED|Overall Study||0
8665070|NCT00719160|9708544|FG001|NOT COMPLETED|Overall Study||0
8665071|NCT00719186|9708553|FG000|STARTED|Overall Study||376
8665072|NCT00719186|9708554|FG001|STARTED|Overall Study||374
8665073|NCT00719186|9708553|FG000|COMPLETED|Overall Study||376
8730446|NCT01059526|9777867|FG000|STARTED|Overall Study|ITT population; defined as signing informed consent and meeting all inclusion/ exclusion criteria|41
8730447|NCT01059526|9777868|FG001|STARTED|Overall Study|ITT population; defined as signing informed consent and meeting all inclusion/ exclusion criteria|40
8730448|NCT01059526|9777867|FG000|Treated|Overall Study|Safety population; defined as all patients who received at least 1 treatment dose of KALBITOR|21
8730449|NCT01059526|9777868|FG001|Treated|Overall Study|Safety population; defined as all patients who received at least 1 treatment dose of KALBITOR|23
8730450|NCT01059526|9777867|FG000|COMPLETED|Overall Study||11
8730451|NCT01059526|9777868|FG001|COMPLETED|Overall Study||18
8730452|NCT01059526|9777867|FG000|NOT COMPLETED|Overall Study||30
8730453|NCT01059526|9777868|FG001|NOT COMPLETED|Overall Study||22
8730454|NCT01059539|9777874|FG000|STARTED|Overall Study||403
8730455|NCT01059539|9777874|FG000|COMPLETED|Overall Study||132
8730456|NCT01059539|9777874|FG000|NOT COMPLETED|Overall Study||271
8730457|NCT01059565|9777880|FG000|STARTED|24-Week Randomized Phase||49
8730458|NCT01059565|9777881|FG001|STARTED|24-Week Randomized Phase||52
8730459|NCT01059565|9777880|FG000|Randomized and Treated|24-Week Randomized Phase||48
8730460|NCT01059565|9777881|FG001|Randomized and Treated|24-Week Randomized Phase||52
8730461|NCT01059565|9777880|FG000|COMPLETED|24-Week Randomized Phase||39
8730462|NCT01059565|9777881|FG001|COMPLETED|24-Week Randomized Phase||45
8730463|NCT01059565|9777880|FG000|NOT COMPLETED|24-Week Randomized Phase||10
8730464|NCT01059565|9777881|FG001|NOT COMPLETED|24-Week Randomized Phase||7
8730465|NCT01059565|9777880|FG000|STARTED|24-Week Open-Label Phase||39
8730466|NCT01059565|9777881|FG001|STARTED|24-Week Open-Label Phase||45
8730467|NCT01059565|9777880|FG000|COMPLETED|24-Week Open-Label Phase||34
8730468|NCT01059565|9777881|FG001|COMPLETED|24-Week Open-Label Phase||42
8730469|NCT01059565|9777880|FG000|NOT COMPLETED|24-Week Open-Label Phase||5
8730470|NCT01059565|9777881|FG001|NOT COMPLETED|24-Week Open-Label Phase||3
8730471|NCT01059617|9777893|FG000|STARTED|Overall Study||33
8730472|NCT01059617|9777894|FG001|STARTED|Overall Study||34
8730473|NCT01059617|9777895|FG002|STARTED|Overall Study||33
8730474|NCT01059617|9777896|FG003|STARTED|Overall Study||33
8730475|NCT01059617|9777893|FG000|COMPLETED|Overall Study||26
8730476|NCT01059617|9777894|FG001|COMPLETED|Overall Study||33
8730477|NCT01059617|9777895|FG002|COMPLETED|Overall Study||25
8730478|NCT01059617|9777896|FG003|COMPLETED|Overall Study||27
8730479|NCT01059617|9777893|FG000|NOT COMPLETED|Overall Study||7
8730480|NCT01059617|9777894|FG001|NOT COMPLETED|Overall Study||1
8730481|NCT01059617|9777895|FG002|NOT COMPLETED|Overall Study||8
8730482|NCT01059617|9777896|FG003|NOT COMPLETED|Overall Study||6
8730483|NCT01059630|9777916|FG000|STARTED|Overall Study||209
8730484|NCT01059630|9777917|FG001|STARTED|Overall Study||204
8730485|NCT01059630|9777916|FG000|COMPLETED|Overall Study||82
8730486|NCT01059630|9777917|FG001|COMPLETED|Overall Study||101
8730487|NCT01059630|9777916|FG000|NOT COMPLETED|Overall Study||127
8730488|NCT01059630|9777917|FG001|NOT COMPLETED|Overall Study||103
8730489|NCT01059643|9777923|FG000|STARTED|Overall Study||103
8730490|NCT01059643|9777923|FG000|Received at Least 1 Dose of Study Drug|Overall Study||103
8730491|NCT01059643|9777923|FG000|COMPLETED|Overall Study||97
8665074|NCT00719186|9708554|FG001|COMPLETED|Overall Study||374
8665075|NCT00719186|9708553|FG000|NOT COMPLETED|Overall Study||0
8665076|NCT00719186|9708554|FG001|NOT COMPLETED|Overall Study||0
8665077|NCT00719212|9708560|FG000|STARTED|Overall Study||61
8665078|NCT00719212|9708560|FG000|COMPLETED|Overall Study||17
8665079|NCT00719212|9708560|FG000|NOT COMPLETED|Overall Study||44
8665080|NCT00719264|9708566|FG000|STARTED|Overall Study||182
8665081|NCT00719264|9708567|FG001|STARTED|Overall Study||183
8665082|NCT00719264|9708566|FG000|Full Analysis Set|Overall Study||182
8665083|NCT00719264|9708567|FG001|Full Analysis Set|Overall Study||183
8730492|NCT01059643|9777923|FG000|NOT COMPLETED|Overall Study||6
8730493|NCT01059682|9777932|FG000|STARTED|Overall Study||474
8665084|NCT00719264|9708566|FG000|Safety Set|Overall Study||180
8665085|NCT00719264|9708567|FG001|Safety Set|Overall Study||181
8665086|NCT00719264|9708566|FG000|COMPLETED|Overall Study||0
8665087|NCT00719264|9708567|FG001|COMPLETED|Overall Study||0
8665088|NCT00719264|9708566|FG000|NOT COMPLETED|Overall Study||182
8665089|NCT00719264|9708567|FG001|NOT COMPLETED|Overall Study||183
8665090|NCT00719329|9708576|FG000|STARTED|Overall Study||705
8665091|NCT00719329|9708577|FG001|STARTED|Overall Study||571
8665092|NCT00719329|9708578|FG002|STARTED|Overall Study||647
8665093|NCT00719329|9708576|FG000|Day 1 Swab|Overall Study||705
8730494|NCT01059682|9777933|FG001|STARTED|Overall Study||462
8730495|NCT01059682|9777932|FG000|COMPLETED|Overall Study||464
8730496|NCT01059682|9777933|FG001|COMPLETED|Overall Study||444
8730497|NCT01059682|9777932|FG000|NOT COMPLETED|Overall Study||10
8730498|NCT01059682|9777933|FG001|NOT COMPLETED|Overall Study||18
8730499|NCT01059760|9777941|FG000|STARTED|Overall Study||16
8730500|NCT01059760|9777942|FG001|STARTED|Overall Study||14
8730501|NCT01059760|9777941|FG000|COMPLETED|Overall Study||16
8730502|NCT01059760|9777942|FG001|COMPLETED|Overall Study||14
8730503|NCT01059760|9777941|FG000|NOT COMPLETED|Overall Study||0
8730504|NCT01059760|9777942|FG001|NOT COMPLETED|Overall Study||0
8730505|NCT01059773|9777951|FG000|STARTED|Overall Study||244
8730506|NCT01059773|9777952|FG001|STARTED|Overall Study||245
8730507|NCT01059773|9777951|FG000|COMPLETED|Overall Study|Completed is refering to no Discontinuation of Study Agent Through Week 52|224
8730508|NCT01059773|9777952|FG001|COMPLETED|Overall Study|Completed is refering to no Discontinuation of Study Agent Through Week 52|221
8730509|NCT01059773|9777951|FG000|NOT COMPLETED|Overall Study||20
8730510|NCT01059773|9777952|FG001|NOT COMPLETED|Overall Study||24
8730511|NCT01059799|9777965|FG000|STARTED|Overall Study||289
8730512|NCT01059799|9777966|FG001|STARTED|Overall Study||146
8730513|NCT01059799|9777965|FG000|Exposed|Overall Study|Five subjects withdrew before exposure to trial drug|284
8730514|NCT01059799|9777966|FG001|Exposed|Overall Study||146
8730515|NCT01059799|9777965|FG000|COMPLETED|Overall Study||258
8730516|NCT01059799|9777966|FG001|COMPLETED|Overall Study||136
8730517|NCT01059799|9777965|FG000|NOT COMPLETED|Overall Study||31
8730518|NCT01059799|9777966|FG001|NOT COMPLETED|Overall Study||10
8730519|NCT01059812|9777974|FG000|STARTED|Overall Study||282
8730520|NCT01059812|9777975|FG001|STARTED|Overall Study||142
8730521|NCT01059812|9777974|FG000|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial drug|279
8730522|NCT01059812|9777975|FG001|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|141
8730523|NCT01059812|9777974|FG000|COMPLETED|Overall Study||245
8730524|NCT01059812|9777975|FG001|COMPLETED|Overall Study||126
8730525|NCT01059812|9777974|FG000|NOT COMPLETED|Overall Study||37
8730526|NCT01059812|9777975|FG001|NOT COMPLETED|Overall Study||16
8730527|NCT01059825|9777987|FG000|STARTED|Enrolled, Run-in Period||0
8730528|NCT01059825|9777988|FG001|STARTED|Enrolled, Run-in Period||0
8730529|NCT01059825|9777989|FG002|STARTED|Enrolled, Run-in Period||0
8730530|NCT01059825|9777990|FG003|STARTED|Enrolled, Run-in Period||0
8730531|NCT01059825|9777991|FG004|STARTED|Enrolled, Run-in Period||0
8730532|NCT01059825|9777992|FG005|STARTED|Enrolled, Run-in Period||0
8730533|NCT01059825|9777993|FG006|STARTED|Enrolled, Run-in Period||375
8730534|NCT01059825|9777987|FG000|COMPLETED|Enrolled, Run-in Period||0
8730535|NCT01059825|9777988|FG001|COMPLETED|Enrolled, Run-in Period||0
8730536|NCT01059825|9777989|FG002|COMPLETED|Enrolled, Run-in Period||0
8730537|NCT01059825|9777990|FG003|COMPLETED|Enrolled, Run-in Period||0
8730538|NCT01059825|9777991|FG004|COMPLETED|Enrolled, Run-in Period||0
8730539|NCT01059825|9777992|FG005|COMPLETED|Enrolled, Run-in Period||0
8730540|NCT01059825|9777993|FG006|COMPLETED|Enrolled, Run-in Period||328
8730541|NCT01059825|9777987|FG000|NOT COMPLETED|Enrolled, Run-in Period||0
8730542|NCT01059825|9777988|FG001|NOT COMPLETED|Enrolled, Run-in Period||0
8730543|NCT01059825|9777989|FG002|NOT COMPLETED|Enrolled, Run-in Period||0
8730544|NCT01059825|9777990|FG003|NOT COMPLETED|Enrolled, Run-in Period||0
8730545|NCT01059825|9777991|FG004|NOT COMPLETED|Enrolled, Run-in Period||0
8730546|NCT01059825|9777992|FG005|NOT COMPLETED|Enrolled, Run-in Period||0
8730547|NCT01059825|9777993|FG006|NOT COMPLETED|Enrolled, Run-in Period||47
8730548|NCT01059825|9777987|FG000|STARTED|Treatment Period|54 participants who completed the run-in period were randomized to this treatment group.|54
8730549|NCT01059825|9777988|FG001|STARTED|Treatment Period|54 participants who completed the run-in period were randomized to this treatment group.|54
8730550|NCT01059825|9777989|FG002|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55
8730551|NCT01059825|9777990|FG003|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55
8730552|NCT01059825|9777991|FG004|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55
8730553|NCT01059825|9777992|FG005|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55
8730554|NCT01059825|9777993|FG006|STARTED|Treatment Period|Participants who completed run-in were randomized to 1 of 6 treatment groups.|0
8730555|NCT01059825|9777987|FG000|COMPLETED|Treatment Period||44
8730556|NCT01059825|9777988|FG001|COMPLETED|Treatment Period||50
8730557|NCT01059825|9777989|FG002|COMPLETED|Treatment Period||49
8730558|NCT01059825|9777990|FG003|COMPLETED|Treatment Period||44
8730559|NCT01059825|9777991|FG004|COMPLETED|Treatment Period||47
8665094|NCT00719329|9708577|FG001|Day 1 Swab|Overall Study||569
8665095|NCT00719329|9708578|FG002|Day 1 Swab|Overall Study||646
8665096|NCT00719329|9708576|FG000|Day 3 Swab|Overall Study||614
8665097|NCT00719329|9708577|FG001|Day 3 Swab|Overall Study||501
8665098|NCT00719329|9708578|FG002|Day 3 Swab|Overall Study||578
8665099|NCT00719329|9708576|FG000|Day 7 Swab|Overall Study||593
8665100|NCT00719329|9708577|FG001|Day 7 Swab|Overall Study||467
8665101|NCT00719329|9708578|FG002|Day 7 Swab|Overall Study||561
8665102|NCT00719329|9708576|FG000|COMPLETED|Overall Study||705
8665103|NCT00719329|9708577|FG001|COMPLETED|Overall Study||569
8665104|NCT00719329|9708578|FG002|COMPLETED|Overall Study||646
8665105|NCT00719329|9708576|FG000|NOT COMPLETED|Overall Study||0
8665106|NCT00719329|9708577|FG001|NOT COMPLETED|Overall Study||2
8665107|NCT00719329|9708578|FG002|NOT COMPLETED|Overall Study||1
8665108|NCT00719355|9708591|FG000|STARTED|Overall Study||51
8665109|NCT00719355|9708592|FG001|STARTED|Overall Study||52
8665110|NCT00719355|9708591|FG000|Completed 6 Weeks|Overall Study||49
8665111|NCT00719355|9708592|FG001|Completed 6 Weeks|Overall Study||48
8665112|NCT00719355|9708591|FG000|Completed 12 Weeks|Overall Study||43
8665113|NCT00719355|9708592|FG001|Completed 12 Weeks|Overall Study||46
8665114|NCT00719355|9708591|FG000|Completed 24 Weeks|Overall Study||34
8665115|NCT00719355|9708592|FG001|Completed 24 Weeks|Overall Study||43
8665116|NCT00719355|9708591|FG000|Completed 32 Weeks|Overall Study||33
8665117|NCT00719355|9708592|FG001|Completed 32 Weeks|Overall Study||39
8665118|NCT00719355|9708591|FG000|COMPLETED|Overall Study||33
8665119|NCT00719355|9708592|FG001|COMPLETED|Overall Study||39
8665120|NCT00719355|9708591|FG000|NOT COMPLETED|Overall Study||18
8665121|NCT00719355|9708592|FG001|NOT COMPLETED|Overall Study||13
8665122|NCT00719472|9708598|FG000|STARTED|Enrolled in Study||451
8665123|NCT00719472|9708598|FG000|COMPLETED|Enrolled in Study||425
8665124|NCT00719472|9708598|FG000|NOT COMPLETED|Enrolled in Study||26
8665125|NCT00719472|9708598|FG000|STARTED|Received Cycle 1 Treatment||425
8665126|NCT00719472|9708598|FG000|COMPLETED|Received Cycle 1 Treatment||372
8665127|NCT00719472|9708598|FG000|NOT COMPLETED|Received Cycle 1 Treatment||53
8665128|NCT00719472|9708598|FG000|STARTED|Received Cycle 2 Treatment||372
8665129|NCT00719472|9708598|FG000|COMPLETED|Received Cycle 2 Treatment||304
8665130|NCT00719472|9708598|FG000|NOT COMPLETED|Received Cycle 2 Treatment||68
8665131|NCT00719537|9708604|FG000|STARTED|Overall Study||2
8665132|NCT00719537|9708605|FG001|STARTED|Overall Study||1
8665133|NCT00719537|9708604|FG000|COMPLETED|Overall Study||1
8665134|NCT00719537|9708605|FG001|COMPLETED|Overall Study||0
8665135|NCT00719537|9708604|FG000|NOT COMPLETED|Overall Study||1
8665136|NCT00719537|9708605|FG001|NOT COMPLETED|Overall Study||1
8665137|NCT00719563|9708613|FG000|STARTED|Overall Study||171
8665138|NCT00719563|9708614|FG001|STARTED|Overall Study||170
8665139|NCT00719563|9708613|FG000|COMPLETED|Overall Study||133
8665140|NCT00719563|9708614|FG001|COMPLETED|Overall Study||128
8665141|NCT00719563|9708613|FG000|NOT COMPLETED|Overall Study||38
8665142|NCT00719563|9708614|FG001|NOT COMPLETED|Overall Study||42
8665143|NCT00719576|9708623|FG000|STARTED|Overall Study||72
8665144|NCT00719576|9708624|FG001|STARTED|Overall Study||72
8665145|NCT00719576|9708623|FG000|COMPLETED|Overall Study||70
8665146|NCT00719576|9708624|FG001|COMPLETED|Overall Study||67
8665147|NCT00719576|9708623|FG000|NOT COMPLETED|Overall Study||2
8665148|NCT00719576|9708624|FG001|NOT COMPLETED|Overall Study||5
8665149|NCT00719615|9708635|FG000|STARTED|Overall Study||42
8665150|NCT00719615|9708636|FG001|STARTED|Overall Study||45
8665151|NCT00719615|9708637|FG002|STARTED|Overall Study||24
8665152|NCT00719615|9708635|FG000|COMPLETED|Overall Study||42
8665153|NCT00719615|9708636|FG001|COMPLETED|Overall Study||45
8665154|NCT00719615|9708637|FG002|COMPLETED|Overall Study||24
8665155|NCT00719615|9708635|FG000|NOT COMPLETED|Overall Study||0
8665156|NCT00719615|9708636|FG001|NOT COMPLETED|Overall Study||0
8665157|NCT00719615|9708637|FG002|NOT COMPLETED|Overall Study||0
8665158|NCT00719680|9708645|FG000|STARTED|Overall Study||21
8665159|NCT00719680|9708645|FG000|COMPLETED|Overall Study||16
8665160|NCT00719680|9708645|FG000|NOT COMPLETED|Overall Study||5
8665161|NCT00719706|9708651|FG000|STARTED|Overall Study||20
8665162|NCT00719706|9708652|FG001|STARTED|Overall Study||20
8665163|NCT00719706|9708651|FG000|COMPLETED|Overall Study||11
8665164|NCT00719706|9708652|FG001|COMPLETED|Overall Study||14
8665165|NCT00719706|9708651|FG000|NOT COMPLETED|Overall Study||9
8665166|NCT00719706|9708652|FG001|NOT COMPLETED|Overall Study||6
8911475|NCT02146482|9970580|FG001|COMPLETED|Overall Study||25
8911476|NCT02146482|9970579|FG000|NOT COMPLETED|Overall Study||0
8665167|NCT00719732|9708658|FG000|STARTED|Overall Study||218
8665168|NCT00719732|9708658|FG000|COMPLETED|Overall Study||196
8665169|NCT00719732|9708658|FG000|NOT COMPLETED|Overall Study||22
8665170|NCT00719810|9708665|FG000|STARTED|Overall Study||49
8665171|NCT00719810|9708666|FG001|STARTED|Overall Study||51
8665172|NCT00719810|9708667|FG002|STARTED|Overall Study||50
8665173|NCT00719810|9708665|FG000|COMPLETED|Overall Study||46
8665174|NCT00719810|9708666|FG001|COMPLETED|Overall Study||47
8665175|NCT00719810|9708667|FG002|COMPLETED|Overall Study||42
8665176|NCT00719810|9708665|FG000|NOT COMPLETED|Overall Study||3
8665177|NCT00719810|9708666|FG001|NOT COMPLETED|Overall Study||4
8665178|NCT00719810|9708667|FG002|NOT COMPLETED|Overall Study||8
8665179|NCT00719849|9708677|FG000|STARTED|Overall Study||4
8665180|NCT00719849|9708678|FG001|STARTED|Overall Study||9
8665181|NCT00719849|9708677|FG000|COMPLETED|Overall Study||4
8665182|NCT00719849|9708678|FG001|COMPLETED|Overall Study||8
8665183|NCT00719849|9708677|FG000|NOT COMPLETED|Overall Study||0
8665184|NCT00719849|9708678|FG001|NOT COMPLETED|Overall Study||1
8665185|NCT00719862|9708686|FG000|STARTED|Overall Study||242
8665186|NCT00719862|9708687|FG001|STARTED|Overall Study|1 subject was randomized in error|239
8665187|NCT00719862|9708686|FG000|COMPLETED|Overall Study||234
8665188|NCT00719862|9708687|FG001|COMPLETED|Overall Study||233
8665189|NCT00719862|9708686|FG000|NOT COMPLETED|Overall Study||8
8665190|NCT00719862|9708687|FG001|NOT COMPLETED|Overall Study||6
8665191|NCT00719901|9708693|FG000|STARTED|Overall Study||11
8665192|NCT00719901|9708693|FG000|COMPLETED|Overall Study||0
8665193|NCT00719901|9708693|FG000|NOT COMPLETED|Overall Study||11
8665194|NCT00719953|9708697|FG000|STARTED|Overall Study||30
8665195|NCT00719953|9708697|FG000|COMPLETED|Overall Study||26
8665196|NCT00719953|9708697|FG000|NOT COMPLETED|Overall Study||4
8665197|NCT00720057|9708703|FG000|STARTED|Overall Study||153
8665198|NCT00720057|9708704|FG001|STARTED|Overall Study||159
8665199|NCT00720057|9708703|FG000|COMPLETED|Overall Study||152
8665200|NCT00720057|9708704|FG001|COMPLETED|Overall Study||156
8665201|NCT00720057|9708703|FG000|NOT COMPLETED|Overall Study||1
8665202|NCT00720057|9708704|FG001|NOT COMPLETED|Overall Study||3
8665203|NCT00720096|9708712|FG000|STARTED|Overall Study||2
8665204|NCT00720096|9708713|FG001|STARTED|Overall Study||2
8665205|NCT00720096|9708712|FG000|COMPLETED|Overall Study||2
8665206|NCT00720096|9708713|FG001|COMPLETED|Overall Study||0
8665207|NCT00720096|9708712|FG000|NOT COMPLETED|Overall Study||0
8665208|NCT00720096|9708713|FG001|NOT COMPLETED|Overall Study||2
8665209|NCT00720109|9708719|FG000|STARTED|Induction Period||63
8665210|NCT00720109|9708720|FG001|STARTED|Induction Period||0
8665211|NCT00720109|9708721|FG002|STARTED|Induction Period||0
8665212|NCT00720109|9708719|FG000|COMPLETED|Induction Period||57
8665213|NCT00720109|9708720|FG001|COMPLETED|Induction Period||0
8665214|NCT00720109|9708721|FG002|COMPLETED|Induction Period||0
8665215|NCT00720109|9708719|FG000|NOT COMPLETED|Induction Period||6
8665216|NCT00720109|9708720|FG001|NOT COMPLETED|Induction Period||0
8665217|NCT00720109|9708721|FG002|NOT COMPLETED|Induction Period||0
8665218|NCT00720109|9708719|FG000|STARTED|Risk Stratification Period||0
8665219|NCT00720109|9708720|FG001|STARTED|Risk Stratification Period||48
8665220|NCT00720109|9708721|FG002|STARTED|Risk Stratification Period||9
8665221|NCT00720109|9708719|FG000|COMPLETED|Risk Stratification Period||0
8665222|NCT00720109|9708720|FG001|COMPLETED|Risk Stratification Period||33
8665223|NCT00720109|9708721|FG002|COMPLETED|Risk Stratification Period||1
8665224|NCT00720109|9708719|FG000|NOT COMPLETED|Risk Stratification Period||0
8665225|NCT00720109|9708720|FG001|NOT COMPLETED|Risk Stratification Period||15
8665226|NCT00720109|9708721|FG002|NOT COMPLETED|Risk Stratification Period||8
8665227|NCT00720122|9708730|FG000|STARTED|Overall Study||28
8665228|NCT00720122|9708730|FG000|COMPLETED|Overall Study||19
8665229|NCT00720122|9708730|FG000|NOT COMPLETED|Overall Study||9
8665230|NCT00720213|9708734|FG000|STARTED|Screening Phase With Diagnostic PSG||44
8665231|NCT00720213|9708735|FG001|STARTED|Screening Phase With Diagnostic PSG||0
8665232|NCT00720213|9708736|FG002|STARTED|Screening Phase With Diagnostic PSG||0
8665233|NCT00720213|9708734|FG000|COMPLETED|Screening Phase With Diagnostic PSG||37
8665234|NCT00720213|9708735|FG001|COMPLETED|Screening Phase With Diagnostic PSG||0
8665235|NCT00720213|9708736|FG002|COMPLETED|Screening Phase With Diagnostic PSG||0
8665236|NCT00720213|9708734|FG000|NOT COMPLETED|Screening Phase With Diagnostic PSG||7
8665237|NCT00720213|9708735|FG001|NOT COMPLETED|Screening Phase With Diagnostic PSG||0
8665238|NCT00720213|9708736|FG002|NOT COMPLETED|Screening Phase With Diagnostic PSG||0
8665239|NCT00720213|9708734|FG000|STARTED|Treatment Period||0
8665240|NCT00720213|9708735|FG001|STARTED|Treatment Period||20
8665241|NCT00720213|9708736|FG002|STARTED|Treatment Period||17
8665242|NCT00720213|9708734|FG000|COMPLETED|Treatment Period||0
8665243|NCT00720213|9708735|FG001|COMPLETED|Treatment Period||20
8665244|NCT00720213|9708736|FG002|COMPLETED|Treatment Period||17
8665245|NCT00720213|9708734|FG000|NOT COMPLETED|Treatment Period||0
8665246|NCT00720213|9708735|FG001|NOT COMPLETED|Treatment Period||0
8665247|NCT00720213|9708736|FG002|NOT COMPLETED|Treatment Period||0
8665248|NCT00720226|9708746|FG000|STARTED|Overall Study||54
8665249|NCT00720226|9708747|FG001|STARTED|Overall Study||52
8665250|NCT00720226|9708746|FG000|COMPLETED|Overall Study|Participants not completing did not have 12 month CT scan|47
8665251|NCT00720226|9708747|FG001|COMPLETED|Overall Study|Participants not completing did not have 12 month CT scan|48
8665252|NCT00720226|9708746|FG000|NOT COMPLETED|Overall Study||7
8665253|NCT00720226|9708747|FG001|NOT COMPLETED|Overall Study||4
8665254|NCT00720278|9708756|FG000|STARTED|Overall Study|1 subject was randomized in error|178
8665255|NCT00720278|9708757|FG001|STARTED|Overall Study|1 subject was randomized in error|170
8665256|NCT00720278|9708758|FG002|STARTED|Overall Study|1 subject was randomized in error|178
8665257|NCT00720278|9708756|FG000|COMPLETED|Overall Study||171
8665258|NCT00720278|9708757|FG001|COMPLETED|Overall Study||166
8665259|NCT00720278|9708758|FG002|COMPLETED|Overall Study||172
8665260|NCT00720278|9708756|FG000|NOT COMPLETED|Overall Study||7
8665261|NCT00720278|9708757|FG001|NOT COMPLETED|Overall Study||4
8665262|NCT00720278|9708758|FG002|NOT COMPLETED|Overall Study||6
8665263|NCT00720330|9708769|FG000|STARTED|Overall Study||5
8665264|NCT00720330|9708770|FG001|STARTED|Overall Study||4
8665265|NCT00720330|9708771|FG002|STARTED|Overall Study||3
8665266|NCT00720330|9708769|FG000|COMPLETED|Overall Study||5
8665267|NCT00720330|9708770|FG001|COMPLETED|Overall Study||4
8665268|NCT00720330|9708771|FG002|COMPLETED|Overall Study||3
8665269|NCT00720330|9708769|FG000|NOT COMPLETED|Overall Study||0
8665270|NCT00720330|9708770|FG001|NOT COMPLETED|Overall Study||0
8665271|NCT00720330|9708771|FG002|NOT COMPLETED|Overall Study||0
8665272|NCT00720356|9708779|FG000|STARTED|Registration to Study||115
8665273|NCT00720356|9708779|FG000|Completed Registration Step 1|Registration to Study||115
8665274|NCT00720356|9708779|FG000|Completed Registration Step 2|Registration to Study||48
8665275|NCT00720356|9708779|FG000|COMPLETED|Registration to Study||48
8665276|NCT00720356|9708779|FG000|NOT COMPLETED|Registration to Study||67
8665277|NCT00720356|9708779|FG000|STARTED|Reached 1st Response/2 Cycles||48
8665278|NCT00720356|9708779|FG000|COMPLETED|Reached 1st Response/2 Cycles||46
8665279|NCT00720356|9708779|FG000|NOT COMPLETED|Reached 1st Response/2 Cycles||2
8665280|NCT00720356|9708779|FG000|STARTED|Went on to be Treated Cycle 3||46
8665281|NCT00720356|9708779|FG000|COMPLETED|Went on to be Treated Cycle 3||44
8665282|NCT00720356|9708779|FG000|NOT COMPLETED|Went on to be Treated Cycle 3||2
8665283|NCT00720356|9708779|FG000|STARTED|Follow up Until Death|All patients that are treated on study go into the follow up period|48
8730560|NCT01059825|9777992|FG005|COMPLETED|Treatment Period||52
8730561|NCT01059825|9777993|FG006|COMPLETED|Treatment Period||0
8730562|NCT01059825|9777987|FG000|NOT COMPLETED|Treatment Period||10
8730563|NCT01059825|9777988|FG001|NOT COMPLETED|Treatment Period||4
8730564|NCT01059825|9777989|FG002|NOT COMPLETED|Treatment Period||6
8730565|NCT01059825|9777990|FG003|NOT COMPLETED|Treatment Period||11
8730566|NCT01059825|9777991|FG004|NOT COMPLETED|Treatment Period||8
8730567|NCT01059825|9777992|FG005|NOT COMPLETED|Treatment Period||3
8730568|NCT01059825|9777993|FG006|NOT COMPLETED|Treatment Period||0
8730569|NCT01059851|9778011|FG000|STARTED|Overall Study||8
8730570|NCT01059851|9778012|FG001|STARTED|Overall Study||8
8730571|NCT01059851|9778013|FG002|STARTED|Overall Study||0
8730572|NCT01059851|9778014|FG003|STARTED|Overall Study||0
8730573|NCT01059851|9778015|FG004|STARTED|Overall Study||0
8730574|NCT01059851|9778016|FG005|STARTED|Overall Study||0
8730575|NCT01059851|9778011|FG000|COMPLETED|Overall Study||8
8730576|NCT01059851|9778012|FG001|COMPLETED|Overall Study||8
8730577|NCT01059851|9778013|FG002|COMPLETED|Overall Study||0
8730578|NCT01059851|9778014|FG003|COMPLETED|Overall Study||0
8730579|NCT01059851|9778015|FG004|COMPLETED|Overall Study||0
8730580|NCT01059851|9778016|FG005|COMPLETED|Overall Study||0
8730581|NCT01059851|9778011|FG000|NOT COMPLETED|Overall Study||0
8730582|NCT01059851|9778012|FG001|NOT COMPLETED|Overall Study||0
8730583|NCT01059851|9778013|FG002|NOT COMPLETED|Overall Study||0
8730584|NCT01059851|9778014|FG003|NOT COMPLETED|Overall Study||0
8730585|NCT01059851|9778015|FG004|NOT COMPLETED|Overall Study||0
8730586|NCT01059851|9778016|FG005|NOT COMPLETED|Overall Study||0
8730587|NCT01059864|9778026|FG000|STARTED|Open-Label Run-In Phase||111
8730588|NCT01059864|9778027|FG001|STARTED|Open-Label Run-In Phase||0
8730589|NCT01059864|9778028|FG002|STARTED|Open-Label Run-In Phase||0
8730590|NCT01059864|9778026|FG000|COMPLETED|Open-Label Run-In Phase||98
8730591|NCT01059864|9778027|FG001|COMPLETED|Open-Label Run-In Phase||0
8730592|NCT01059864|9778028|FG002|COMPLETED|Open-Label Run-In Phase||0
8730593|NCT01059864|9778026|FG000|NOT COMPLETED|Open-Label Run-In Phase||13
8730594|NCT01059864|9778027|FG001|NOT COMPLETED|Open-Label Run-In Phase||0
8730595|NCT01059864|9778028|FG002|NOT COMPLETED|Open-Label Run-In Phase||0
8730596|NCT01059864|9778026|FG000|STARTED|Double-Blind Treatment Phase||0
8730597|NCT01059864|9778027|FG001|STARTED|Double-Blind Treatment Phase||50
8730598|NCT01059864|9778028|FG002|STARTED|Double-Blind Treatment Phase||48
8730599|NCT01059864|9778026|FG000|Treated|Double-Blind Treatment Phase||0
8730600|NCT01059864|9778027|FG001|Treated|Double-Blind Treatment Phase||50
8730601|NCT01059864|9778028|FG002|Treated|Double-Blind Treatment Phase||47
8730602|NCT01059864|9778026|FG000|COMPLETED|Double-Blind Treatment Phase||0
8730603|NCT01059864|9778027|FG001|COMPLETED|Double-Blind Treatment Phase||47
8730604|NCT01059864|9778028|FG002|COMPLETED|Double-Blind Treatment Phase||45
8730605|NCT01059864|9778026|FG000|NOT COMPLETED|Double-Blind Treatment Phase||0
8730606|NCT01059864|9778027|FG001|NOT COMPLETED|Double-Blind Treatment Phase||3
8730607|NCT01059864|9778028|FG002|NOT COMPLETED|Double-Blind Treatment Phase||3
8730608|NCT01059877|9778037|FG000|STARTED|Overall Study||6
8730609|NCT01059877|9778038|FG001|STARTED|Overall Study||5
8730610|NCT01059877|9778037|FG000|COMPLETED|Overall Study||6
8730611|NCT01059877|9778038|FG001|COMPLETED|Overall Study||3
8730612|NCT01059877|9778037|FG000|NOT COMPLETED|Overall Study||0
8730613|NCT01059877|9778038|FG001|NOT COMPLETED|Overall Study||2
8730614|NCT01059903|9778046|FG000|STARTED|Period 1: First Intervention- 24 Hours||25
8730615|NCT01059903|9778047|FG001|STARTED|Period 1: First Intervention- 24 Hours||25
8730616|NCT01059903|9778046|FG000|COMPLETED|Period 1: First Intervention- 24 Hours||24
8730617|NCT01059903|9778047|FG001|COMPLETED|Period 1: First Intervention- 24 Hours||24
8730618|NCT01059903|9778046|FG000|NOT COMPLETED|Period 1: First Intervention- 24 Hours||1
8730619|NCT01059903|9778047|FG001|NOT COMPLETED|Period 1: First Intervention- 24 Hours||1
8730620|NCT01059903|9778046|FG000|STARTED|Period 2: Washout Period (>= 5 Days)||24
8730621|NCT01059903|9778047|FG001|STARTED|Period 2: Washout Period (>= 5 Days)||24
8730622|NCT01059903|9778046|FG000|COMPLETED|Period 2: Washout Period (>= 5 Days)||24
8730623|NCT01059903|9778047|FG001|COMPLETED|Period 2: Washout Period (>= 5 Days)||24
8730624|NCT01059903|9778046|FG000|NOT COMPLETED|Period 2: Washout Period (>= 5 Days)||0
8730625|NCT01059903|9778047|FG001|NOT COMPLETED|Period 2: Washout Period (>= 5 Days)||0
8730626|NCT01059903|9778046|FG000|STARTED|Period 3: Second Intervention- 24 Hours||24
8730627|NCT01059903|9778047|FG001|STARTED|Period 3: Second Intervention- 24 Hours||24
8665284|NCT00720356|9708779|FG000|COMPLETED|Follow up Until Death||43
8806675|NCT01479465|9858993|FG003|STARTED|Overall Study||85
8806676|NCT01479465|9858990|FG000|COMPLETED|Overall Study||0
8665285|NCT00720356|9708779|FG000|NOT COMPLETED|Follow up Until Death||5
8665286|NCT00720369|9708785|FG000|STARTED|Overall Study||11
8665287|NCT00720369|9708786|FG001|STARTED|Overall Study||8
8665288|NCT00720369|9708785|FG000|COMPLETED|Overall Study|one subject discontinued due to an adverse event.|10
8665289|NCT00720369|9708786|FG001|COMPLETED|Overall Study||8
8665290|NCT00720369|9708785|FG000|NOT COMPLETED|Overall Study||1
8665291|NCT00720369|9708786|FG001|NOT COMPLETED|Overall Study||0
8665292|NCT00720382|9708796|FG000|STARTED|Overall Study||466
8665293|NCT00720382|9708797|FG001|STARTED|Overall Study||237
8665294|NCT00720382|9708796|FG000|COMPLETED|Overall Study||290
8665295|NCT00720382|9708797|FG001|COMPLETED|Overall Study||178
8665296|NCT00720382|9708796|FG000|NOT COMPLETED|Overall Study||176
8665297|NCT00720382|9708797|FG001|NOT COMPLETED|Overall Study||59
8665298|NCT00720434|9708807|FG000|STARTED|Double-Blind Period (Week 1-4)||10
8665299|NCT00720434|9708808|FG001|STARTED|Double-Blind Period (Week 1-4)||9
8665300|NCT00720434|9708809|FG002|STARTED|Double-Blind Period (Week 1-4)||8
8665301|NCT00720434|9708810|FG003|STARTED|Double-Blind Period (Week 1-4)||8
8665302|NCT00720434|9708807|FG000|COMPLETED|Double-Blind Period (Week 1-4)||10
8665303|NCT00720434|9708808|FG001|COMPLETED|Double-Blind Period (Week 1-4)||8
8665304|NCT00720434|9708809|FG002|COMPLETED|Double-Blind Period (Week 1-4)||8
8665305|NCT00720434|9708810|FG003|COMPLETED|Double-Blind Period (Week 1-4)||8
8665306|NCT00720434|9708807|FG000|NOT COMPLETED|Double-Blind Period (Week 1-4)||0
8665307|NCT00720434|9708808|FG001|NOT COMPLETED|Double-Blind Period (Week 1-4)||1
8665308|NCT00720434|9708809|FG002|NOT COMPLETED|Double-Blind Period (Week 1-4)||0
8665309|NCT00720434|9708810|FG003|NOT COMPLETED|Double-Blind Period (Week 1-4)||0
8665310|NCT00720434|9708807|FG000|STARTED|Open-Label Period (Week 5-72)||10
8665311|NCT00720434|9708808|FG001|STARTED|Open-Label Period (Week 5-72)||8
8665312|NCT00720434|9708809|FG002|STARTED|Open-Label Period (Week 5-72)||8
8665313|NCT00720434|9708810|FG003|STARTED|Open-Label Period (Week 5-72)||8
8665314|NCT00720434|9708807|FG000|COMPLETED|Open-Label Period (Week 5-72)||4
8665315|NCT00720434|9708808|FG001|COMPLETED|Open-Label Period (Week 5-72)||5
8665316|NCT00720434|9708809|FG002|COMPLETED|Open-Label Period (Week 5-72)||4
8665317|NCT00720434|9708810|FG003|COMPLETED|Open-Label Period (Week 5-72)||4
8665318|NCT00720434|9708807|FG000|NOT COMPLETED|Open-Label Period (Week 5-72)||6
8665319|NCT00720434|9708808|FG001|NOT COMPLETED|Open-Label Period (Week 5-72)||3
8665320|NCT00720434|9708809|FG002|NOT COMPLETED|Open-Label Period (Week 5-72)||4
8665321|NCT00720434|9708810|FG003|NOT COMPLETED|Open-Label Period (Week 5-72)||4
8665322|NCT00720473|9708822|FG000|STARTED|Overall Study||45
8665323|NCT00720473|9708823|FG001|STARTED|Overall Study||24
8665324|NCT00720473|9708822|FG000|COMPLETED|Overall Study||15
8665325|NCT00720473|9708823|FG001|COMPLETED|Overall Study||16
8665326|NCT00720473|9708822|FG000|NOT COMPLETED|Overall Study||30
8665327|NCT00720473|9708823|FG001|NOT COMPLETED|Overall Study||8
8665328|NCT00720499|9708830|FG000|STARTED|Treatment Period 1 (4 Weeks)||69
8665329|NCT00720499|9708831|FG001|STARTED|Treatment Period 1 (4 Weeks)||72
8665330|NCT00720499|9708830|FG000|COMPLETED|Treatment Period 1 (4 Weeks)||66
8665331|NCT00720499|9708831|FG001|COMPLETED|Treatment Period 1 (4 Weeks)||70
8665332|NCT00720499|9708830|FG000|NOT COMPLETED|Treatment Period 1 (4 Weeks)||3
8665333|NCT00720499|9708831|FG001|NOT COMPLETED|Treatment Period 1 (4 Weeks)||2
8665334|NCT00720499|9708830|FG000|STARTED|Washout Period (2 Weeks)||66
8665335|NCT00720499|9708831|FG001|STARTED|Washout Period (2 Weeks)||70
8665336|NCT00720499|9708830|FG000|COMPLETED|Washout Period (2 Weeks)||66
8665337|NCT00720499|9708831|FG001|COMPLETED|Washout Period (2 Weeks)||70
8665338|NCT00720499|9708830|FG000|NOT COMPLETED|Washout Period (2 Weeks)||0
8665339|NCT00720499|9708831|FG001|NOT COMPLETED|Washout Period (2 Weeks)||0
8665340|NCT00720499|9708830|FG000|STARTED|Treatment Period 2 (4 Weeks)||66
8665341|NCT00720499|9708831|FG001|STARTED|Treatment Period 2 (4 Weeks)||70
8665342|NCT00720499|9708830|FG000|COMPLETED|Treatment Period 2 (4 Weeks)||64
8665343|NCT00720499|9708831|FG001|COMPLETED|Treatment Period 2 (4 Weeks)||67
8665344|NCT00720499|9708830|FG000|NOT COMPLETED|Treatment Period 2 (4 Weeks)||2
8665345|NCT00720499|9708831|FG001|NOT COMPLETED|Treatment Period 2 (4 Weeks)||3
8665346|NCT00720629|9708838|FG000|STARTED|Overall Study||8
8665347|NCT00720629|9708838|FG000|COMPLETED|Overall Study||8
8665348|NCT00720629|9708838|FG000|NOT COMPLETED|Overall Study||0
8665349|NCT00720759|9708848|FG000|STARTED|Overall Study||6
8665350|NCT00720759|9708849|FG001|STARTED|Overall Study||6
8665351|NCT00720759|9708850|FG002|STARTED|Overall Study||6
8665352|NCT00720759|9708851|FG003|STARTED|Overall Study||6
8665353|NCT00720759|9708848|FG000|COMPLETED|Overall Study||6
8665354|NCT00720759|9708849|FG001|COMPLETED|Overall Study||5
8665355|NCT00720759|9708850|FG002|COMPLETED|Overall Study||5
8665356|NCT00720759|9708851|FG003|COMPLETED|Overall Study||6
8665357|NCT00720759|9708848|FG000|NOT COMPLETED|Overall Study||0
8665358|NCT00720759|9708849|FG001|NOT COMPLETED|Overall Study||1
8665359|NCT00720759|9708850|FG002|NOT COMPLETED|Overall Study||1
8665360|NCT00720759|9708851|FG003|NOT COMPLETED|Overall Study||0
8665361|NCT00720798|9708861|FG000|STARTED|Overall Study||2067
8665362|NCT00720798|9708861|FG000|COMPLETED|Overall Study||1311
8665363|NCT00720798|9708861|FG000|NOT COMPLETED|Overall Study||756
8665364|NCT00720876|9708865|FG000|STARTED|Overall Study||30
8665365|NCT00720876|9708865|FG000|COMPLETED|Overall Study||28
8665366|NCT00720876|9708865|FG000|NOT COMPLETED|Overall Study||2
8665367|NCT00720941|9708871|FG000|STARTED|Overall Study||557
8665368|NCT00720941|9708872|FG001|STARTED|Overall Study||553
8665369|NCT00720941|9708871|FG000|Ongoing|Overall Study||34
8665370|NCT00720941|9708872|FG001|Ongoing|Overall Study||23
8665371|NCT00720941|9708871|FG000|COMPLETED|Overall Study||144
8665372|NCT00720941|9708872|FG001|COMPLETED|Overall Study||138
8665373|NCT00720941|9708871|FG000|NOT COMPLETED|Overall Study||413
8665374|NCT00720941|9708872|FG001|NOT COMPLETED|Overall Study||415
8665375|NCT00721110|9708882|FG000|STARTED|Overall Study||16
8665376|NCT00721110|9708883|FG001|STARTED|Overall Study||16
8665377|NCT00721110|9708884|FG002|STARTED|Overall Study||16
8665378|NCT00721110|9708885|FG003|STARTED|Overall Study||16
8665379|NCT00721110|9708882|FG000|COMPLETED|Overall Study||15
8665380|NCT00721110|9708883|FG001|COMPLETED|Overall Study||16
8665381|NCT00721110|9708884|FG002|COMPLETED|Overall Study||15
8665382|NCT00721110|9708885|FG003|COMPLETED|Overall Study||16
8665383|NCT00721110|9708882|FG000|NOT COMPLETED|Overall Study||1
8665384|NCT00721110|9708883|FG001|NOT COMPLETED|Overall Study||0
8665385|NCT00721110|9708884|FG002|NOT COMPLETED|Overall Study||1
8665386|NCT00721110|9708885|FG003|NOT COMPLETED|Overall Study||0
8665387|NCT00721123|9708895|FG000|STARTED|Overall Study||538
8665388|NCT00721123|9708895|FG000|COMPLETED|Overall Study||355
8665389|NCT00721123|9708895|FG000|NOT COMPLETED|Overall Study||183
8665390|NCT00721136|9708919|FG000|STARTED|Overall Study||42
8665391|NCT00721136|9708920|FG001|STARTED|Overall Study||42
8665392|NCT00721136|9708921|FG002|STARTED|Overall Study||8
8665393|NCT00721136|9708922|FG003|STARTED|Overall Study||8
8730628|NCT01059903|9778046|FG000|Pharmacokinetic Set (PKS)|Period 3: Second Intervention- 24 Hours|Six subjects who fullfilled predefined criteria for patch adhesiveness were excluded from the PKS|18
8730629|NCT01059903|9778047|FG001|Pharmacokinetic Set (PKS)|Period 3: Second Intervention- 24 Hours|Two subjects who fullfilled predefined criteria for patch adhesiveness were excluded from the PKS|22
8730630|NCT01059903|9778046|FG000|COMPLETED|Period 3: Second Intervention- 24 Hours||24
8730631|NCT01059903|9778047|FG001|COMPLETED|Period 3: Second Intervention- 24 Hours||24
8730632|NCT01059903|9778046|FG000|NOT COMPLETED|Period 3: Second Intervention- 24 Hours||0
8665394|NCT00721136|9708919|FG000|COMPLETED|Overall Study||42
8665395|NCT00721136|9708920|FG001|COMPLETED|Overall Study||42
8665396|NCT00721136|9708921|FG002|COMPLETED|Overall Study||8
8665397|NCT00721136|9708922|FG003|COMPLETED|Overall Study||8
8665398|NCT00721136|9708919|FG000|NOT COMPLETED|Overall Study||0
8665399|NCT00721136|9708920|FG001|NOT COMPLETED|Overall Study||0
8665400|NCT00721136|9708921|FG002|NOT COMPLETED|Overall Study||0
8665401|NCT00721136|9708922|FG003|NOT COMPLETED|Overall Study||0
8665402|NCT00721149|9708936|FG000|STARTED|Overall Study|Enrollment was stopped after 10 subjects entered the trial.|10
8665403|NCT00721149|9708936|FG000|COMPLETED|Overall Study||9
8665404|NCT00721149|9708936|FG000|NOT COMPLETED|Overall Study||1
8665405|NCT00721162|9708940|FG000|STARTED|Overall Study||60
8665406|NCT00721162|9708940|FG000|Received Any Amount of Study Drug|Overall Study||60
8665407|NCT00721162|9708940|FG000|COMPLETED|Overall Study||60
8665408|NCT00721162|9708940|FG000|NOT COMPLETED|Overall Study||0
8665409|NCT00721175|9708946|FG000|STARTED|Overall Study||54
8665410|NCT00721175|9708947|FG001|STARTED|Overall Study||54
8665411|NCT00721175|9708946|FG000|COMPLETED|Overall Study||54
8665412|NCT00721175|9708947|FG001|COMPLETED|Overall Study||54
8665413|NCT00721175|9708946|FG000|NOT COMPLETED|Overall Study||0
8665414|NCT00721175|9708947|FG001|NOT COMPLETED|Overall Study||0
8665415|NCT00721188|9708953|FG000|STARTED|Overall Study||11
8665416|NCT00721188|9708953|FG000|COMPLETED|Overall Study||11
8665417|NCT00721188|9708953|FG000|NOT COMPLETED|Overall Study||0
8665418|NCT00721214|9708957|FG000|STARTED|Overall Study||16
8665419|NCT00721214|9708957|FG000|COMPLETED|Overall Study||12
8665420|NCT00721214|9708957|FG000|NOT COMPLETED|Overall Study||4
8692406|NCT00860262|9737843|FG000|NOT COMPLETED|Overall Study||20
8692407|NCT00860262|9737844|FG001|NOT COMPLETED|Overall Study||22
8692408|NCT00860262|9737845|FG002|NOT COMPLETED|Overall Study||18
8692409|NCT00860314|9737857|FG000|STARTED|Overall Study||48
8692410|NCT00860314|9737858|FG001|STARTED|Overall Study||48
8692411|NCT00860314|9737857|FG000|COMPLETED|Overall Study||48
8692412|NCT00860314|9737858|FG001|COMPLETED|Overall Study||48
8692413|NCT00860314|9737857|FG000|NOT COMPLETED|Overall Study||0
8692414|NCT00860314|9737858|FG001|NOT COMPLETED|Overall Study||0
8692415|NCT00860379|9737867|FG000|STARTED|Overall Study||4
8692416|NCT00860379|9737868|FG001|STARTED|Overall Study||6
8692417|NCT00860379|9737869|FG002|STARTED|Overall Study||4
8692418|NCT00860379|9737867|FG000|COMPLETED|Overall Study||4
8692419|NCT00860379|9737868|FG001|COMPLETED|Overall Study||6
8692420|NCT00860379|9737869|FG002|COMPLETED|Overall Study||4
8692421|NCT00860379|9737867|FG000|NOT COMPLETED|Overall Study||0
8692422|NCT00860379|9737868|FG001|NOT COMPLETED|Overall Study||0
8692423|NCT00860379|9737869|FG002|NOT COMPLETED|Overall Study||0
8692424|NCT00860405|9737879|FG000|STARTED|Overall Study||31
8692425|NCT00860405|9737880|FG001|STARTED|Overall Study||30
8692426|NCT00860405|9737879|FG000|Completed Treatment|Overall Study||31
8692427|NCT00860405|9737880|FG001|Completed Treatment|Overall Study||29
8692428|NCT00860405|9737879|FG000|Day 28 Follow-up Performed|Overall Study||31
8692429|NCT00860405|9737880|FG001|Day 28 Follow-up Performed|Overall Study||29
8692430|NCT00860405|9737879|FG000|COMPLETED|Overall Study|completed overall study|26
8692431|NCT00860405|9737880|FG001|COMPLETED|Overall Study||26
8692432|NCT00860405|9737879|FG000|NOT COMPLETED|Overall Study||5
8692433|NCT00860405|9737880|FG001|NOT COMPLETED|Overall Study||4
8692434|NCT00860457|9737886|FG000|STARTED|Overall Study||22
8692435|NCT00860457|9737886|FG000|COMPLETED|Overall Study||11
8692436|NCT00860457|9737886|FG000|NOT COMPLETED|Overall Study||11
8730633|NCT01059903|9778047|FG001|NOT COMPLETED|Period 3: Second Intervention- 24 Hours||0
8730634|NCT01059929|9778055|FG000|STARTED|Overall Study||20
8730635|NCT01059929|9778056|FG001|STARTED|Overall Study||21
8730636|NCT01059929|9778055|FG000|COMPLETED|Overall Study||20
8730637|NCT01059929|9778056|FG001|COMPLETED|Overall Study||21
8730638|NCT01059929|9778055|FG000|NOT COMPLETED|Overall Study||0
8665421|NCT00721227|9708963|FG000|STARTED|Overall Study||9
8665422|NCT00721227|9708964|FG001|STARTED|Overall Study||6
9022411|NCT03126539|10085299|FG004|COMPLETED|Overall Study||0
9022412|NCT03126539|10085295|FG000|NOT COMPLETED|Overall Study||1
9022413|NCT03126539|10085296|FG001|NOT COMPLETED|Overall Study||1
9022414|NCT03126539|10085297|FG002|NOT COMPLETED|Overall Study||1
9022415|NCT03126539|10085298|FG003|NOT COMPLETED|Overall Study||0
9022416|NCT03126539|10085299|FG004|NOT COMPLETED|Overall Study||0
8730639|NCT01059929|9778056|FG001|NOT COMPLETED|Overall Study||0
8730640|NCT01059994|9778066|FG000|STARTED|Overall Study||3
8730641|NCT01059994|9778067|FG001|STARTED|Overall Study||2
8730642|NCT01059994|9778068|FG002|STARTED|Overall Study||3
8730643|NCT01059994|9778069|FG003|STARTED|Overall Study||4
8730644|NCT01059994|9778066|FG000|COMPLETED|Overall Study||3
8730645|NCT01059994|9778067|FG001|COMPLETED|Overall Study||2
8730646|NCT01059994|9778068|FG002|COMPLETED|Overall Study||3
8730647|NCT01059994|9778069|FG003|COMPLETED|Overall Study||3
8730648|NCT01059994|9778066|FG000|NOT COMPLETED|Overall Study||0
8911477|NCT02146482|9970580|FG001|NOT COMPLETED|Overall Study||0
8911478|NCT02146599|9970586|FG000|STARTED|Overall Study||301
8911479|NCT02146599|9970586|FG000|COMPLETED|Overall Study||296
8911480|NCT02146599|9970586|FG000|NOT COMPLETED|Overall Study||5
8911481|NCT02146833|9970590|FG000|STARTED|Overall Study||20
8911482|NCT02146833|9970590|FG000|COMPLETED|Overall Study||9
8911483|NCT02146833|9970590|FG000|NOT COMPLETED|Overall Study||11
8911484|NCT02147067|9970596|FG000|STARTED|Overall Study||13
8911485|NCT02147067|9970597|FG001|STARTED|Overall Study||13
8911486|NCT02147067|9970596|FG000|COMPLETED|Overall Study||11
8911487|NCT02147067|9970597|FG001|COMPLETED|Overall Study||11
9022417|NCT03126682|10085314|FG000|STARTED|Overall Study||5
9022418|NCT03126682|10085315|FG001|STARTED|Overall Study||5
9022419|NCT03126682|10085314|FG000|COMPLETED|Overall Study||5
9022420|NCT03126682|10085315|FG001|COMPLETED|Overall Study||5
9022421|NCT03126682|10085314|FG000|NOT COMPLETED|Overall Study||0
8665423|NCT00721227|9708963|FG000|COMPLETED|Overall Study|3 subjects lost to follow up; 1 subject did not complete due to noncompliance of scheduled visits.|5
8665424|NCT00721227|9708964|FG001|COMPLETED|Overall Study||6
8665425|NCT00721227|9708963|FG000|NOT COMPLETED|Overall Study||4
8665426|NCT00721227|9708964|FG001|NOT COMPLETED|Overall Study||0
8665427|NCT00721253|9708972|FG000|STARTED|Overall Study||20
8665428|NCT00721253|9708973|FG001|STARTED|Overall Study||22
8665429|NCT00721253|9708974|FG002|STARTED|Overall Study|There were no subjects that were implanted with the Tecnis lens.|0
8665430|NCT00721253|9708972|FG000|COMPLETED|Overall Study||20
8665431|NCT00721253|9708973|FG001|COMPLETED|Overall Study||22
8665432|NCT00721253|9708974|FG002|COMPLETED|Overall Study||0
8665433|NCT00721253|9708972|FG000|NOT COMPLETED|Overall Study||0
8665434|NCT00721253|9708973|FG001|NOT COMPLETED|Overall Study||0
8665435|NCT00721253|9708974|FG002|NOT COMPLETED|Overall Study||0
8665436|NCT00721279|9708982|FG000|STARTED|Overall Study||452
8665437|NCT00721279|9708983|FG001|STARTED|Overall Study||97
8665438|NCT00721279|9708982|FG000|COMPLETED|Overall Study||416
8665439|NCT00721279|9708983|FG001|COMPLETED|Overall Study||73
8665440|NCT00721279|9708982|FG000|NOT COMPLETED|Overall Study||36
8665441|NCT00721279|9708983|FG001|NOT COMPLETED|Overall Study||24
8665442|NCT00721357|9708992|FG000|STARTED|Overall Study||15
8665443|NCT00721357|9708993|FG001|STARTED|Overall Study||15
8665444|NCT00721357|9708992|FG000|COMPLETED|Overall Study||15
8665445|NCT00721357|9708993|FG001|COMPLETED|Overall Study||15
8665446|NCT00721357|9708992|FG000|NOT COMPLETED|Overall Study||0
8665447|NCT00721357|9708993|FG001|NOT COMPLETED|Overall Study||0
8665448|NCT00721396|9709005|FG000|STARTED|Overall Study||627
8665449|NCT00721396|9709006|FG001|STARTED|Overall Study||628
8665450|NCT00721396|9709007|FG002|STARTED|Overall Study||318
8665451|NCT00721396|9709008|FG003|STARTED|Overall Study||312
8665452|NCT00721396|9709005|FG000|COMPLETED|Overall Study||597
8665453|NCT00721396|9709006|FG001|COMPLETED|Overall Study||592
8665454|NCT00721396|9709007|FG002|COMPLETED|Overall Study||308
8665455|NCT00721396|9709008|FG003|COMPLETED|Overall Study||302
8665456|NCT00721396|9709005|FG000|NOT COMPLETED|Overall Study||30
8665457|NCT00721396|9709006|FG001|NOT COMPLETED|Overall Study||36
8665458|NCT00721396|9709007|FG002|NOT COMPLETED|Overall Study||10
8665459|NCT00721396|9709008|FG003|NOT COMPLETED|Overall Study||10
8665460|NCT00721409|9709026|FG000|STARTED|Overall Study||12
8730649|NCT01059994|9778067|FG001|NOT COMPLETED|Overall Study||0
8665461|NCT00721409|9709027|FG001|STARTED|Overall Study||84
8665462|NCT00721409|9709028|FG002|STARTED|Overall Study||81
8665463|NCT00721409|9709026|FG000|Treated|Overall Study||12
8665464|NCT00721409|9709027|FG001|Treated|Overall Study||83
8730650|NCT01059994|9778068|FG002|NOT COMPLETED|Overall Study||0
8730651|NCT01059994|9778069|FG003|NOT COMPLETED|Overall Study||1
8730652|NCT01060007|9778079|FG000|STARTED|Overall Study||80
8730653|NCT01060007|9778079|FG000|COMPLETED|Overall Study||76
8730654|NCT01060007|9778079|FG000|NOT COMPLETED|Overall Study||4
8911488|NCT02147067|9970596|FG000|NOT COMPLETED|Overall Study||2
8911489|NCT02147067|9970597|FG001|NOT COMPLETED|Overall Study||2
8665465|NCT00721409|9709028|FG002|Treated|Overall Study||77
8665466|NCT00721409|9709026|FG000|COMPLETED|Overall Study||0
8665467|NCT00721409|9709027|FG001|COMPLETED|Overall Study||2
8665468|NCT00721409|9709028|FG002|COMPLETED|Overall Study||2
8665469|NCT00721409|9709026|FG000|NOT COMPLETED|Overall Study||12
8665470|NCT00721409|9709027|FG001|NOT COMPLETED|Overall Study||82
8665471|NCT00721409|9709028|FG002|NOT COMPLETED|Overall Study||79
8665472|NCT00721500|9709052|FG000|STARTED|Period One||6
8665473|NCT00721500|9709053|FG001|STARTED|Period One||7
8665474|NCT00721500|9709054|FG002|STARTED|Period One||6
8665475|NCT00721500|9709055|FG003|STARTED|Period One||6
8665476|NCT00721500|9709052|FG000|COMPLETED|Period One||6
8665477|NCT00721500|9709053|FG001|COMPLETED|Period One||7
8665478|NCT00721500|9709054|FG002|COMPLETED|Period One||6
8665479|NCT00721500|9709055|FG003|COMPLETED|Period One||6
8665480|NCT00721500|9709052|FG000|NOT COMPLETED|Period One||0
8665481|NCT00721500|9709053|FG001|NOT COMPLETED|Period One||0
8665482|NCT00721500|9709054|FG002|NOT COMPLETED|Period One||0
8665483|NCT00721500|9709055|FG003|NOT COMPLETED|Period One||0
8665484|NCT00721500|9709052|FG000|STARTED|Period Two||6
8665485|NCT00721500|9709053|FG001|STARTED|Period Two||7
8665486|NCT00721500|9709054|FG002|STARTED|Period Two||6
8665487|NCT00721500|9709055|FG003|STARTED|Period Two||6
8665488|NCT00721500|9709052|FG000|COMPLETED|Period Two||6
8665489|NCT00721500|9709053|FG001|COMPLETED|Period Two||7
8730655|NCT01060020|9778086|FG000|STARTED|Overall Study||20
8730656|NCT01060020|9778086|FG000|COMPLETED|Overall Study||20
8730657|NCT01060020|9778086|FG000|NOT COMPLETED|Overall Study||0
8730658|NCT01060059|9778093|FG000|STARTED|Overall Study||444
8730659|NCT01060059|9778094|FG001|STARTED|Overall Study||438
8730660|NCT01060059|9778093|FG000|COMPLETED|Overall Study||377
8730661|NCT01060059|9778094|FG001|COMPLETED|Overall Study||371
8730662|NCT01060059|9778093|FG000|NOT COMPLETED|Overall Study||67
8730663|NCT01060059|9778094|FG001|NOT COMPLETED|Overall Study||67
8730664|NCT01060072|9778104|FG000|STARTED|Overall Study||206
8730665|NCT01060072|9778105|FG001|STARTED|Overall Study||201
8730666|NCT01060072|9778104|FG000|COMPLETED|Overall Study||204
8730667|NCT01060072|9778105|FG001|COMPLETED|Overall Study||196
8730668|NCT01060072|9778104|FG000|NOT COMPLETED|Overall Study||2
8730669|NCT01060072|9778105|FG001|NOT COMPLETED|Overall Study||5
8730670|NCT01060098|9778114|FG000|STARTED|Overall Study||25
8730671|NCT01060098|9778115|FG001|STARTED|Overall Study||15
8730672|NCT01060098|9778116|FG002|STARTED|Overall Study||8
8730673|NCT01060098|9778114|FG000|COMPLETED|Overall Study||25
8730674|NCT01060098|9778115|FG001|COMPLETED|Overall Study||15
8730675|NCT01060098|9778116|FG002|COMPLETED|Overall Study||8
8730676|NCT01060098|9778114|FG000|NOT COMPLETED|Overall Study||0
8730677|NCT01060098|9778115|FG001|NOT COMPLETED|Overall Study||0
8730678|NCT01060098|9778116|FG002|NOT COMPLETED|Overall Study||0
8730679|NCT01060111|9778127|FG000|STARTED|Overall Study||81
8730680|NCT01060111|9778128|FG001|STARTED|Overall Study||84
8730681|NCT01060111|9778129|FG002|STARTED|Overall Study||80
8730682|NCT01060111|9778127|FG000|Treated|Overall Study||81
8730683|NCT01060111|9778128|FG001|Treated|Overall Study||83
8730684|NCT01060111|9778129|FG002|Treated|Overall Study||79
8730685|NCT01060111|9778127|FG000|COMPLETED|Overall Study||54
8730686|NCT01060111|9778128|FG001|COMPLETED|Overall Study||61
8730687|NCT01060111|9778129|FG002|COMPLETED|Overall Study||45
8730688|NCT01060111|9778127|FG000|NOT COMPLETED|Overall Study||27
8730689|NCT01060111|9778128|FG001|NOT COMPLETED|Overall Study||23
8730690|NCT01060111|9778129|FG002|NOT COMPLETED|Overall Study||35
8730691|NCT01060124|9778140|FG000|STARTED|Overall Study||103
8730692|NCT01060124|9778140|FG000|COMPLETED|Overall Study||66
8730693|NCT01060124|9778140|FG000|NOT COMPLETED|Overall Study||37
8730694|NCT01060150|9778144|FG000|STARTED|Overall Study||115
8730695|NCT01060150|9778144|FG000|Treated|Overall Study||113
8730696|NCT01060150|9778144|FG000|COMPLETED|Overall Study||92
8730697|NCT01060150|9778144|FG000|NOT COMPLETED|Overall Study||23
8730698|NCT01060345|9778148|FG000|STARTED|Overall Study||20
8730699|NCT01060345|9778148|FG000|COMPLETED|Overall Study||20
8730700|NCT01060345|9778148|FG000|NOT COMPLETED|Overall Study||0
8730701|NCT01060384|9778152|FG000|STARTED|Overall Study||6
8730702|NCT01060384|9778153|FG001|STARTED|Overall Study||4
8730703|NCT01060384|9778154|FG002|STARTED|Overall Study||0
8730704|NCT01060384|9778155|FG003|STARTED|Overall Study||0
8730705|NCT01060384|9778156|FG004|STARTED|Overall Study||36
8730706|NCT01060384|9778152|FG000|COMPLETED|Overall Study||6
8730707|NCT01060384|9778153|FG001|COMPLETED|Overall Study||3
8730708|NCT01060384|9778154|FG002|COMPLETED|Overall Study||0
8730709|NCT01060384|9778155|FG003|COMPLETED|Overall Study||0
8730710|NCT01060384|9778156|FG004|COMPLETED|Overall Study||34
8730711|NCT01060384|9778152|FG000|NOT COMPLETED|Overall Study||0
8730712|NCT01060384|9778153|FG001|NOT COMPLETED|Overall Study||1
8730713|NCT01060384|9778154|FG002|NOT COMPLETED|Overall Study||0
8730714|NCT01060384|9778155|FG003|NOT COMPLETED|Overall Study||0
8730715|NCT01060384|9778156|FG004|NOT COMPLETED|Overall Study||2
8730716|NCT01060540|9778167|FG000|STARTED|Overall Study||303
8730717|NCT01060540|9778168|FG001|STARTED|Overall Study||298
8665490|NCT00721500|9709054|FG002|COMPLETED|Period Two||6
8665491|NCT00721500|9709055|FG003|COMPLETED|Period Two||6
8730718|NCT01060540|9778167|FG000|COMPLETED|Overall Study||239
8730719|NCT01060540|9778168|FG001|COMPLETED|Overall Study||233
8730720|NCT01060540|9778167|FG000|NOT COMPLETED|Overall Study||64
8730721|NCT01060540|9778168|FG001|NOT COMPLETED|Overall Study||65
8665492|NCT00721500|9709052|FG000|NOT COMPLETED|Period Two||0
8730722|NCT01060553|9778176|FG000|STARTED|Overall Study||15
8730723|NCT01060553|9778177|FG001|STARTED|Overall Study||15
8730724|NCT01060553|9778176|FG000|COMPLETED|Overall Study|5 subjects completed more than half the sessions and midpoint outcome measures were obtained|6
8730725|NCT01060553|9778177|FG001|COMPLETED|Overall Study||5
8730726|NCT01060553|9778176|FG000|NOT COMPLETED|Overall Study||9
8665493|NCT00721500|9709053|FG001|NOT COMPLETED|Period Two||0
8665494|NCT00721500|9709054|FG002|NOT COMPLETED|Period Two||0
8665495|NCT00721500|9709055|FG003|NOT COMPLETED|Period Two||0
8665496|NCT00721500|9709052|FG000|STARTED|Period Three||6
8665497|NCT00721500|9709053|FG001|STARTED|Period Three||7
8665498|NCT00721500|9709054|FG002|STARTED|Period Three||6
8665499|NCT00721500|9709055|FG003|STARTED|Period Three||6
8665500|NCT00721500|9709052|FG000|COMPLETED|Period Three||6
8665501|NCT00721500|9709053|FG001|COMPLETED|Period Three||7
8665502|NCT00721500|9709054|FG002|COMPLETED|Period Three||6
8665503|NCT00721500|9709055|FG003|COMPLETED|Period Three||6
8665504|NCT00721500|9709052|FG000|NOT COMPLETED|Period Three||0
8665505|NCT00721500|9709053|FG001|NOT COMPLETED|Period Three||0
8665506|NCT00721500|9709054|FG002|NOT COMPLETED|Period Three||0
8665507|NCT00721500|9709055|FG003|NOT COMPLETED|Period Three||0
8665508|NCT00721513|9709067|FG000|STARTED|Overall Study||20
8665509|NCT00721513|9709067|FG000|COMPLETED|Overall Study||20
8665510|NCT00721513|9709067|FG000|NOT COMPLETED|Overall Study||0
8665511|NCT00721539|9709071|FG000|STARTED|Overall Study||9
8665512|NCT00721539|9709071|FG000|COMPLETED|Overall Study||9
8665513|NCT00721539|9709071|FG000|NOT COMPLETED|Overall Study||0
8665514|NCT00721578|9709075|FG000|STARTED|Overall Study||12
8665515|NCT00721578|9709076|FG001|STARTED|Overall Study||11
8665516|NCT00721578|9709075|FG000|COMPLETED|Overall Study||10
8665517|NCT00721578|9709076|FG001|COMPLETED|Overall Study||9
8665518|NCT00721578|9709075|FG000|NOT COMPLETED|Overall Study||2
8665519|NCT00721578|9709076|FG001|NOT COMPLETED|Overall Study||2
8665520|NCT00721617|9709082|FG000|STARTED|0 Hour (Baseline) of Saline Infusion||12
8665521|NCT00721617|9709082|FG000|COMPLETED|0 Hour (Baseline) of Saline Infusion||12
8665522|NCT00721617|9709082|FG000|NOT COMPLETED|0 Hour (Baseline) of Saline Infusion||0
8665523|NCT00721617|9709082|FG000|STARTED|4 Hours Into Saline Infusion||12
8665524|NCT00721617|9709082|FG000|COMPLETED|4 Hours Into Saline Infusion||12
8665525|NCT00721617|9709082|FG000|NOT COMPLETED|4 Hours Into Saline Infusion||0
8665526|NCT00721617|9709082|FG000|STARTED|8 Hours Into Saline Infusion||12
8665527|NCT00721617|9709082|FG000|COMPLETED|8 Hours Into Saline Infusion||12
8665528|NCT00721617|9709082|FG000|NOT COMPLETED|8 Hours Into Saline Infusion||0
8665529|NCT00721617|9709082|FG000|STARTED|0 Hour (Baseline) of Intralipid Infusion||12
8665530|NCT00721617|9709082|FG000|COMPLETED|0 Hour (Baseline) of Intralipid Infusion||12
8665531|NCT00721617|9709082|FG000|NOT COMPLETED|0 Hour (Baseline) of Intralipid Infusion||0
8665532|NCT00721617|9709082|FG000|STARTED|4 Hours Into Intralipid Infusion||12
8665533|NCT00721617|9709082|FG000|COMPLETED|4 Hours Into Intralipid Infusion||12
8665534|NCT00721617|9709082|FG000|NOT COMPLETED|4 Hours Into Intralipid Infusion||0
8665535|NCT00721617|9709082|FG000|STARTED|8 Hours Into Intralipid Infusion||12
8665536|NCT00721617|9709082|FG000|COMPLETED|8 Hours Into Intralipid Infusion||12
8665537|NCT00721617|9709082|FG000|NOT COMPLETED|8 Hours Into Intralipid Infusion||0
8665538|NCT00721617|9709082|FG000|STARTED|0 Hour (Baseline) of Dextrose Infusion||12
8665539|NCT00721617|9709082|FG000|COMPLETED|0 Hour (Baseline) of Dextrose Infusion||12
8665540|NCT00721617|9709082|FG000|NOT COMPLETED|0 Hour (Baseline) of Dextrose Infusion||0
8665541|NCT00721617|9709082|FG000|STARTED|4 Hours Into Dextrose Infusion||12
8665542|NCT00721617|9709082|FG000|COMPLETED|4 Hours Into Dextrose Infusion||12
8665543|NCT00721617|9709082|FG000|NOT COMPLETED|4 Hours Into Dextrose Infusion||0
8665544|NCT00721617|9709082|FG000|STARTED|8 Hours Into Dextrose Infusion||12
8665545|NCT00721617|9709082|FG000|COMPLETED|8 Hours Into Dextrose Infusion||12
8665546|NCT00721617|9709082|FG000|NOT COMPLETED|8 Hours Into Dextrose Infusion||0
8665547|NCT00721617|9709082|FG000|STARTED|0 Hour (Baseline) of Intralipid/Dextrose||12
8730727|NCT01060553|9778177|FG001|NOT COMPLETED|Overall Study||10
8730728|NCT01060592|9778184|FG000|STARTED|4-6w||35
8730729|NCT01060592|9778185|FG001|STARTED|4-6w||49
8730730|NCT01060592|9778184|FG000|COMPLETED|4-6w||23
8730731|NCT01060592|9778185|FG001|COMPLETED|4-6w||39
8730732|NCT01060592|9778184|FG000|NOT COMPLETED|4-6w||12
8730733|NCT01060592|9778185|FG001|NOT COMPLETED|4-6w||10
8730734|NCT01060592|9778184|FG000|STARTED|12m|For some pts, %EWL were not taken/available in the 4-6w period but were available for the 12m period|35
8730735|NCT01060592|9778185|FG001|STARTED|12m|For some pts, %EWL were not taken/available in the 4-6w period but were available for the 12m period|49
8730736|NCT01060592|9778184|FG000|COMPLETED|12m||35
8730737|NCT01060592|9778185|FG001|COMPLETED|12m|Historic data was not available at 12m for 18 of the historic controls|31
8730738|NCT01060592|9778184|FG000|NOT COMPLETED|12m||0
8730739|NCT01060592|9778185|FG001|NOT COMPLETED|12m||18
8730740|NCT01060670|9778193|FG000|STARTED|Run In||0
8730741|NCT01060670|9778194|FG001|STARTED|Run In||545
8730742|NCT01060670|9778193|FG000|COMPLETED|Run In||0
8730743|NCT01060670|9778194|FG001|COMPLETED|Run In||307
8730744|NCT01060670|9778193|FG000|NOT COMPLETED|Run In||0
8911490|NCT02147093|9970605|FG000|STARTED|Period 1||20
8665548|NCT00721617|9709082|FG000|COMPLETED|0 Hour (Baseline) of Intralipid/Dextrose||12
8665549|NCT00721617|9709082|FG000|NOT COMPLETED|0 Hour (Baseline) of Intralipid/Dextrose||0
8730745|NCT01060670|9778194|FG001|NOT COMPLETED|Run In||238
8730746|NCT01060670|9778193|FG000|STARTED|Treatment Phase||154
8665550|NCT00721617|9709082|FG000|STARTED|4 Hours Into Intralipid/Dextrose||12
8730747|NCT01060670|9778194|FG001|STARTED|Treatment Phase||153
8730748|NCT01060670|9778193|FG000|Healed at End of Treatment Phase|Treatment Phase||79
8730749|NCT01060670|9778194|FG001|Healed at End of Treatment Phase|Treatment Phase||49
8730750|NCT01060670|9778193|FG000|Did Not Heal by Treatment Visit 17|Treatment Phase||49
8730751|NCT01060670|9778194|FG001|Did Not Heal by Treatment Visit 17|Treatment Phase||68
8730752|NCT01060670|9778193|FG000|Withdrew From Treatment|Treatment Phase||26
8730753|NCT01060670|9778194|FG001|Withdrew From Treatment|Treatment Phase||36
8730754|NCT01060670|9778193|FG000|COMPLETED|Treatment Phase||128
8730755|NCT01060670|9778194|FG001|COMPLETED|Treatment Phase||117
8730756|NCT01060670|9778193|FG000|NOT COMPLETED|Treatment Phase||26
8730757|NCT01060670|9778194|FG001|NOT COMPLETED|Treatment Phase||36
8730758|NCT01060670|9778193|FG000|STARTED|Follow up Phase||128
8730759|NCT01060670|9778194|FG001|STARTED|Follow up Phase||117
8730760|NCT01060670|9778193|FG000|Recurrence|Follow up Phase||14
8730761|NCT01060670|9778194|FG001|Recurrence|Follow up Phase||9
8730762|NCT01060670|9778193|FG000|Withdrew From Follow up Phase|Follow up Phase||22
8730763|NCT01060670|9778194|FG001|Withdrew From Follow up Phase|Follow up Phase||35
8730764|NCT01060670|9778193|FG000|COMPLETED|Follow up Phase||106
8730765|NCT01060670|9778194|FG001|COMPLETED|Follow up Phase||82
8730766|NCT01060670|9778193|FG000|NOT COMPLETED|Follow up Phase||22
8730767|NCT01060670|9778194|FG001|NOT COMPLETED|Follow up Phase||35
8730768|NCT01061008|9778204|FG000|STARTED|Overall Study||16
8730769|NCT01061008|9778205|FG001|STARTED|Overall Study||15
8730770|NCT01061008|9778204|FG000|COMPLETED|Overall Study||10
8730771|NCT01061008|9778205|FG001|COMPLETED|Overall Study||9
8730772|NCT01061008|9778204|FG000|NOT COMPLETED|Overall Study||6
8730773|NCT01061008|9778205|FG001|NOT COMPLETED|Overall Study||6
8730774|NCT01061034|9778211|FG000|STARTED|Aspirin||9
8730775|NCT01061034|9778211|FG000|COMPLETED|Aspirin||9
8730776|NCT01061034|9778211|FG000|NOT COMPLETED|Aspirin||0
8730777|NCT01061034|9778211|FG000|STARTED|Aspirin Plus Omeprazole||9
8730778|NCT01061034|9778211|FG000|COMPLETED|Aspirin Plus Omeprazole||9
8730779|NCT01061034|9778211|FG000|NOT COMPLETED|Aspirin Plus Omeprazole||0
8730780|NCT01061177|9778215|FG000|STARTED|Overall Study||1089
8730781|NCT01061177|9778215|FG000|ITT_MR (b2a2 &/or b3a2 +ve Pts Only)|Overall Study||1056
8730782|NCT01061177|9778215|FG000|ITT_CyR (Ph+ Patients Only)|Overall Study||983
8730783|NCT01061177|9778215|FG000|COMPLETED|Overall Study||881
8730784|NCT01061177|9778215|FG000|NOT COMPLETED|Overall Study||208
8730785|NCT01061333|9778219|FG000|STARTED|Period 1: Placebo Run-in||8
8730786|NCT01061333|9778220|FG001|STARTED|Period 1: Placebo Run-in||8
8730787|NCT01061333|9778219|FG000|COMPLETED|Period 1: Placebo Run-in||8
8730788|NCT01061333|9778220|FG001|COMPLETED|Period 1: Placebo Run-in||8
8730789|NCT01061333|9778219|FG000|NOT COMPLETED|Period 1: Placebo Run-in||0
8730790|NCT01061333|9778220|FG001|NOT COMPLETED|Period 1: Placebo Run-in||0
8730791|NCT01061333|9778219|FG000|STARTED|Period 2: 20-day Washout||8
8730792|NCT01061333|9778220|FG001|STARTED|Period 2: 20-day Washout||8
8730793|NCT01061333|9778219|FG000|COMPLETED|Period 2: 20-day Washout||8
8730794|NCT01061333|9778220|FG001|COMPLETED|Period 2: 20-day Washout||8
8730795|NCT01061333|9778219|FG000|NOT COMPLETED|Period 2: 20-day Washout||0
8730796|NCT01061333|9778220|FG001|NOT COMPLETED|Period 2: 20-day Washout||0
8730797|NCT01061333|9778219|FG000|STARTED|Period 3: Nedocromil-Montelukast X-over||8
8730798|NCT01061333|9778220|FG001|STARTED|Period 3: Nedocromil-Montelukast X-over||8
8730799|NCT01061333|9778219|FG000|COMPLETED|Period 3: Nedocromil-Montelukast X-over||8
8730800|NCT01061333|9778220|FG001|COMPLETED|Period 3: Nedocromil-Montelukast X-over||8
8730801|NCT01061333|9778219|FG000|NOT COMPLETED|Period 3: Nedocromil-Montelukast X-over||0
8730802|NCT01061333|9778220|FG001|NOT COMPLETED|Period 3: Nedocromil-Montelukast X-over||0
8730803|NCT01061333|9778219|FG000|STARTED|Period 4: 20-day Washout||8
8730804|NCT01061333|9778220|FG001|STARTED|Period 4: 20-day Washout||8
8730805|NCT01061333|9778219|FG000|COMPLETED|Period 4: 20-day Washout||8
8730806|NCT01061333|9778220|FG001|COMPLETED|Period 4: 20-day Washout||7
8730807|NCT01061333|9778219|FG000|NOT COMPLETED|Period 4: 20-day Washout||0
8665551|NCT00721617|9709082|FG000|COMPLETED|4 Hours Into Intralipid/Dextrose||12
8665552|NCT00721617|9709082|FG000|NOT COMPLETED|4 Hours Into Intralipid/Dextrose||0
8665553|NCT00721617|9709082|FG000|STARTED|8 Hours Into Intralipid/Dextrose||12
8665554|NCT00721617|9709082|FG000|COMPLETED|8 Hours Into Intralipid/Dextrose||12
8665555|NCT00721617|9709082|FG000|NOT COMPLETED|8 Hours Into Intralipid/Dextrose||0
8665556|NCT00721630|9709087|FG000|STARTED|Overall Study||24
8665557|NCT00721630|9709087|FG000|COMPLETED|Overall Study||23
8665558|NCT00721630|9709087|FG000|NOT COMPLETED|Overall Study||1
8665559|NCT00721734|9709096|FG000|STARTED|Overall Study||12
8665560|NCT00721734|9709097|FG001|STARTED|Overall Study||12
8665561|NCT00721734|9709098|FG002|STARTED|Overall Study||10
8665562|NCT00721734|9709099|FG003|STARTED|Overall Study||8
8665563|NCT00721734|9709100|FG004|STARTED|Overall Study||8
8730808|NCT01061333|9778220|FG001|NOT COMPLETED|Period 4: 20-day Washout||1
8730809|NCT01061333|9778219|FG000|STARTED|Period 5: Nedocromil-Montelukast X-over||8
8730810|NCT01061333|9778220|FG001|STARTED|Period 5: Nedocromil-Montelukast X-over||7
8730811|NCT01061333|9778219|FG000|COMPLETED|Period 5: Nedocromil-Montelukast X-over||8
8730812|NCT01061333|9778220|FG001|COMPLETED|Period 5: Nedocromil-Montelukast X-over||7
8730813|NCT01061333|9778219|FG000|NOT COMPLETED|Period 5: Nedocromil-Montelukast X-over||0
8730814|NCT01061333|9778220|FG001|NOT COMPLETED|Period 5: Nedocromil-Montelukast X-over||0
8665564|NCT00721734|9709096|FG000|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|4
8665565|NCT00721734|9709097|FG001|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|0
8665566|NCT00721734|9709098|FG002|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|2
8665567|NCT00721734|9709099|FG003|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|2
8665568|NCT00721734|9709100|FG004|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|2
8665569|NCT00721734|9709096|FG000|NOT COMPLETED|Overall Study||8
8665570|NCT00721734|9709097|FG001|NOT COMPLETED|Overall Study||12
8665571|NCT00721734|9709098|FG002|NOT COMPLETED|Overall Study||8
8665572|NCT00721734|9709099|FG003|NOT COMPLETED|Overall Study||6
8665573|NCT00721734|9709100|FG004|NOT COMPLETED|Overall Study||6
8665574|NCT00721799|9709112|FG000|STARTED|Overall Study||33
8665575|NCT00721799|9709112|FG000|Recieved FLT PET Scan 1|Overall Study||26
8665576|NCT00721799|9709112|FG000|Received FLT PET Scan #2|Overall Study||25
8665577|NCT00721799|9709112|FG000|COMPLETED|Overall Study||25
8665578|NCT00721799|9709112|FG000|NOT COMPLETED|Overall Study||8
8665579|NCT00721955|9709119|FG000|STARTED|Overall Study||105
8665580|NCT00721955|9709120|FG001|STARTED|Overall Study||104
8665581|NCT00721955|9709121|FG002|STARTED|Overall Study||105
8665582|NCT00721955|9709119|FG000|COMPLETED|Overall Study||105
8665583|NCT00721955|9709120|FG001|COMPLETED|Overall Study||104
8665584|NCT00721955|9709121|FG002|COMPLETED|Overall Study||103
8665585|NCT00721955|9709119|FG000|NOT COMPLETED|Overall Study||0
8665586|NCT00721955|9709120|FG001|NOT COMPLETED|Overall Study||0
8665587|NCT00721955|9709121|FG002|NOT COMPLETED|Overall Study||2
8665588|NCT00721968|9709131|FG000|STARTED|Overall Study||27
8665589|NCT00721968|9709132|FG001|STARTED|Overall Study||17
8665590|NCT00721968|9709131|FG000|COMPLETED|Overall Study||25
8665591|NCT00721968|9709132|FG001|COMPLETED|Overall Study||17
8665592|NCT00721968|9709131|FG000|NOT COMPLETED|Overall Study||2
8665593|NCT00721968|9709132|FG001|NOT COMPLETED|Overall Study||0
8665594|NCT00722007|9709138|FG000|STARTED|Overall Study||147
8665595|NCT00722007|9709138|FG000|COMPLETED|Overall Study||117
8665596|NCT00722007|9709138|FG000|NOT COMPLETED|Overall Study||30
8665597|NCT00722020|9709145|FG000|STARTED|Overall Study||19
8665598|NCT00722020|9709146|FG001|STARTED|Overall Study||24
8665599|NCT00722020|9709145|FG000|COMPLETED|Overall Study||19
8665600|NCT00722020|9709146|FG001|COMPLETED|Overall Study||24
8665601|NCT00722020|9709145|FG000|NOT COMPLETED|Overall Study||0
8665602|NCT00722020|9709146|FG001|NOT COMPLETED|Overall Study||0
8665603|NCT00722072|9709154|FG000|STARTED|Overall Study||12
8665604|NCT00722072|9709154|FG000|COMPLETED|Overall Study||9
8665605|NCT00722072|9709154|FG000|NOT COMPLETED|Overall Study||3
8665606|NCT00722111|9709160|FG000|STARTED|Overall Study||11
8665607|NCT00722111|9709161|FG001|STARTED|Overall Study||72
8665608|NCT00722111|9709160|FG000|COMPLETED|Overall Study||11
8665609|NCT00722111|9709161|FG001|COMPLETED|Overall Study||72
8665610|NCT00722111|9709160|FG000|NOT COMPLETED|Overall Study||0
8665611|NCT00722111|9709161|FG001|NOT COMPLETED|Overall Study||0
8665612|NCT00722124|9709170|FG000|STARTED|Overall Study||40
8665613|NCT00722124|9709171|FG001|STARTED|Overall Study||40
8665614|NCT00722124|9709172|FG002|STARTED|Overall Study||40
8665615|NCT00722124|9709170|FG000|COMPLETED|Overall Study||23
8665616|NCT00722124|9709171|FG001|COMPLETED|Overall Study||26
8665617|NCT00722124|9709172|FG002|COMPLETED|Overall Study||20
8665618|NCT00722124|9709170|FG000|NOT COMPLETED|Overall Study||17
8665619|NCT00722124|9709171|FG001|NOT COMPLETED|Overall Study||14
8665620|NCT00722124|9709172|FG002|NOT COMPLETED|Overall Study||20
8665621|NCT00722137|9709182|FG000|STARTED|Overall Study||244
8730815|NCT01061333|9778219|FG000|STARTED|Period 6: 20-day Washout||8
8730816|NCT01061333|9778220|FG001|STARTED|Period 6: 20-day Washout||7
8730817|NCT01061333|9778219|FG000|COMPLETED|Period 6: 20-day Washout||8
8730818|NCT01061333|9778220|FG001|COMPLETED|Period 6: 20-day Washout||7
8730819|NCT01061333|9778219|FG000|NOT COMPLETED|Period 6: 20-day Washout||0
8730820|NCT01061333|9778220|FG001|NOT COMPLETED|Period 6: 20-day Washout||0
8730821|NCT01061333|9778219|FG000|STARTED|Period 7: Mometasone||8
8730822|NCT01061333|9778220|FG001|STARTED|Period 7: Mometasone||7
8730823|NCT01061333|9778219|FG000|COMPLETED|Period 7: Mometasone||8
8730824|NCT01061333|9778220|FG001|COMPLETED|Period 7: Mometasone||7
8730825|NCT01061333|9778219|FG000|NOT COMPLETED|Period 7: Mometasone||0
8730826|NCT01061333|9778220|FG001|NOT COMPLETED|Period 7: Mometasone||0
8730827|NCT01061359|9778231|FG000|STARTED|Overall Study||1972
8730828|NCT01061359|9778231|FG000|COMPLETED|Overall Study|Completed 5 years of follow-up: 668 Disease free and 2 Relapsed|670
8665622|NCT00722137|9709183|FG001|STARTED|Overall Study||243
8665623|NCT00722137|9709182|FG000|COMPLETED|Overall Study||199
8665624|NCT00722137|9709183|FG001|COMPLETED|Overall Study||195
8665625|NCT00722137|9709182|FG000|NOT COMPLETED|Overall Study||45
8665626|NCT00722137|9709183|FG001|NOT COMPLETED|Overall Study||48
8730829|NCT01061359|9778231|FG000|NOT COMPLETED|Overall Study||1302
8730830|NCT01061385|9778237|FG000|STARTED|Overall Study||21
8730831|NCT01061385|9778238|FG001|STARTED|Overall Study||9
8730832|NCT01061385|9778237|FG000|COMPLETED|Overall Study||20
8730833|NCT01061385|9778238|FG001|COMPLETED|Overall Study||8
8665627|NCT00722371|9709196|FG000|STARTED|Overall Study||231
8665628|NCT00722371|9709197|FG001|STARTED|Overall Study||230
8665629|NCT00722371|9709198|FG002|STARTED|Overall Study||233
8665630|NCT00722371|9709199|FG003|STARTED|Overall Study||230
8665631|NCT00722371|9709200|FG004|STARTED|Overall Study||230
8665632|NCT00722371|9709201|FG005|STARTED|Overall Study||231
8665633|NCT00722371|9709202|FG006|STARTED|Overall Study||230
8665634|NCT00722371|9709196|FG000|COMPLETED|Overall Study||175
8665635|NCT00722371|9709197|FG001|COMPLETED|Overall Study||158
8665636|NCT00722371|9709198|FG002|COMPLETED|Overall Study||168
8665637|NCT00722371|9709199|FG003|COMPLETED|Overall Study||167
8665638|NCT00722371|9709200|FG004|COMPLETED|Overall Study||182
8665639|NCT00722371|9709201|FG005|COMPLETED|Overall Study||178
8665640|NCT00722371|9709202|FG006|COMPLETED|Overall Study||179
8665641|NCT00722371|9709196|FG000|NOT COMPLETED|Overall Study||56
8665642|NCT00722371|9709197|FG001|NOT COMPLETED|Overall Study||72
8665643|NCT00722371|9709198|FG002|NOT COMPLETED|Overall Study||65
8665644|NCT00722371|9709199|FG003|NOT COMPLETED|Overall Study||63
8665645|NCT00722371|9709200|FG004|NOT COMPLETED|Overall Study||48
8665646|NCT00722371|9709201|FG005|NOT COMPLETED|Overall Study||53
8665647|NCT00722371|9709202|FG006|NOT COMPLETED|Overall Study||51
8665648|NCT00722423|9709220|FG000|STARTED|Overall Study||182
8665649|NCT00722423|9709221|FG001|STARTED|Overall Study||182
8665650|NCT00722423|9709220|FG000|COMPLETED|Overall Study||182
8665651|NCT00722423|9709221|FG001|COMPLETED|Overall Study||181
8665652|NCT00722423|9709220|FG000|NOT COMPLETED|Overall Study||0
8665653|NCT00722423|9709221|FG001|NOT COMPLETED|Overall Study||1
8665654|NCT00722436|9709231|FG000|STARTED|Overall Study||9
8665655|NCT00722436|9709232|FG001|STARTED|Overall Study||11
8665656|NCT00722436|9709231|FG000|COMPLETED|Overall Study||9
8665657|NCT00722436|9709232|FG001|COMPLETED|Overall Study||11
8665658|NCT00722436|9709231|FG000|NOT COMPLETED|Overall Study||0
8665659|NCT00722436|9709232|FG001|NOT COMPLETED|Overall Study||0
8665660|NCT00722553|9709238|FG000|STARTED|Overall Study||30
8665661|NCT00722553|9709238|FG000|COMPLETED|Overall Study||30
8665662|NCT00722553|9709238|FG000|NOT COMPLETED|Overall Study||0
8665663|NCT00722566|9709246|FG000|STARTED|Overall Study|One patient randomized and not dosed|148
8665664|NCT00722566|9709247|FG001|STARTED|Overall Study||74
8665665|NCT00722566|9709246|FG000|COMPLETED|Overall Study|Completed 8 cycles|81
8665666|NCT00722566|9709247|FG001|COMPLETED|Overall Study|Completed 8 cycles|39
8665667|NCT00722566|9709246|FG000|NOT COMPLETED|Overall Study||67
8665668|NCT00722566|9709247|FG001|NOT COMPLETED|Overall Study||35
8665669|NCT00722722|9709258|FG000|STARTED|Overall Study||3
8665670|NCT00722722|9709259|FG001|STARTED|Overall Study||5
8665671|NCT00722722|9709260|FG002|STARTED|Overall Study||10
8665672|NCT00722722|9709258|FG000|COMPLETED|Overall Study||3
8665673|NCT00722722|9709259|FG001|COMPLETED|Overall Study||5
8665674|NCT00722722|9709260|FG002|COMPLETED|Overall Study||10
8665675|NCT00722722|9709258|FG000|NOT COMPLETED|Overall Study||0
8665676|NCT00722722|9709259|FG001|NOT COMPLETED|Overall Study||0
8665677|NCT00722722|9709260|FG002|NOT COMPLETED|Overall Study||0
8665678|NCT00722761|9709270|FG000|STARTED|Overall Study||16
8665679|NCT00722761|9709271|FG001|STARTED|Overall Study||14
8665680|NCT00722761|9709270|FG000|COMPLETED AT LEAST 1 FOLLOW-UP VISIT|Overall Study||15
8665681|NCT00722761|9709271|FG001|COMPLETED AT LEAST 1 FOLLOW-UP VISIT|Overall Study||10
8665682|NCT00722761|9709270|FG000|COMPLETED|Overall Study||10
8665683|NCT00722761|9709271|FG001|COMPLETED|Overall Study||8
8665684|NCT00722761|9709270|FG000|NOT COMPLETED|Overall Study||6
8665685|NCT00722761|9709271|FG001|NOT COMPLETED|Overall Study||6
8665686|NCT00722800|9709279|FG000|STARTED|Overall Study||2
8665687|NCT00722800|9709280|FG001|STARTED|Overall Study||2
8665688|NCT00722800|9709279|FG000|COMPLETED|Overall Study||0
8665689|NCT00722800|9709280|FG001|COMPLETED|Overall Study||2
8665690|NCT00722800|9709279|FG000|NOT COMPLETED|Overall Study||2
8665691|NCT00722800|9709280|FG001|NOT COMPLETED|Overall Study||0
8665692|NCT00722865|9709286|FG000|STARTED|Overall Study||25
8665693|NCT00722865|9709286|FG000|COMPLETED|Overall Study||23
8665694|NCT00722865|9709286|FG000|NOT COMPLETED|Overall Study||2
8665695|NCT00723008|9709292|FG000|STARTED|Enrollment||11
8665696|NCT00723008|9709293|FG001|STARTED|Enrollment||9
8665697|NCT00723008|9709292|FG000|COMPLETED|Enrollment||10
8665698|NCT00723008|9709293|FG001|COMPLETED|Enrollment||9
8665699|NCT00723008|9709292|FG000|NOT COMPLETED|Enrollment||1
8665700|NCT00723008|9709293|FG001|NOT COMPLETED|Enrollment||0
8665701|NCT00723008|9709292|FG000|STARTED|4-Week Double Blinded||10
8665702|NCT00723008|9709293|FG001|STARTED|4-Week Double Blinded||9
8665703|NCT00723008|9709292|FG000|COMPLETED|4-Week Double Blinded||5
8665704|NCT00723008|9709293|FG001|COMPLETED|4-Week Double Blinded||4
8665705|NCT00723008|9709292|FG000|NOT COMPLETED|4-Week Double Blinded||5
8665706|NCT00723008|9709293|FG001|NOT COMPLETED|4-Week Double Blinded||5
8665707|NCT00723008|9709292|FG000|STARTED|4-Week Unblinded Treatment||5
8665708|NCT00723008|9709293|FG001|STARTED|4-Week Unblinded Treatment||4
8665709|NCT00723008|9709292|FG000|COMPLETED|4-Week Unblinded Treatment||4
8665710|NCT00723008|9709293|FG001|COMPLETED|4-Week Unblinded Treatment||3
8665711|NCT00723008|9709292|FG000|NOT COMPLETED|4-Week Unblinded Treatment||1
8665712|NCT00723008|9709293|FG001|NOT COMPLETED|4-Week Unblinded Treatment||1
8665713|NCT00723021|9709307|FG000|STARTED|Intervention Period 1||3
8665714|NCT00723021|9709308|FG001|STARTED|Intervention Period 1||3
8665715|NCT00723021|9709309|FG002|STARTED|Intervention Period 1||3
8665716|NCT00723021|9709310|FG003|STARTED|Intervention Period 1||3
8665717|NCT00723021|9709311|FG004|STARTED|Intervention Period 1||3
8665718|NCT00723021|9709307|FG000|COMPLETED|Intervention Period 1||3
8665719|NCT00723021|9709308|FG001|COMPLETED|Intervention Period 1||3
8665720|NCT00723021|9709309|FG002|COMPLETED|Intervention Period 1||3
8665721|NCT00723021|9709310|FG003|COMPLETED|Intervention Period 1||3
8665722|NCT00723021|9709311|FG004|COMPLETED|Intervention Period 1||3
8665723|NCT00723021|9709307|FG000|NOT COMPLETED|Intervention Period 1||0
8665724|NCT00723021|9709308|FG001|NOT COMPLETED|Intervention Period 1||0
8665725|NCT00723021|9709309|FG002|NOT COMPLETED|Intervention Period 1||0
8665726|NCT00723021|9709310|FG003|NOT COMPLETED|Intervention Period 1||0
8665727|NCT00723021|9709311|FG004|NOT COMPLETED|Intervention Period 1||0
8665728|NCT00723021|9709307|FG000|STARTED|Intervention Period 2||3
8665729|NCT00723021|9709308|FG001|STARTED|Intervention Period 2||3
8665730|NCT00723021|9709309|FG002|STARTED|Intervention Period 2||3
8665731|NCT00723021|9709310|FG003|STARTED|Intervention Period 2||3
8665732|NCT00723021|9709311|FG004|STARTED|Intervention Period 2||3
8665733|NCT00723021|9709307|FG000|COMPLETED|Intervention Period 2||3
8665734|NCT00723021|9709308|FG001|COMPLETED|Intervention Period 2||3
8665735|NCT00723021|9709309|FG002|COMPLETED|Intervention Period 2||3
8665736|NCT00723021|9709310|FG003|COMPLETED|Intervention Period 2||3
8665737|NCT00723021|9709311|FG004|COMPLETED|Intervention Period 2||3
8665738|NCT00723021|9709307|FG000|NOT COMPLETED|Intervention Period 2||0
8665739|NCT00723021|9709308|FG001|NOT COMPLETED|Intervention Period 2||0
8665740|NCT00723021|9709309|FG002|NOT COMPLETED|Intervention Period 2||0
8665741|NCT00723021|9709310|FG003|NOT COMPLETED|Intervention Period 2||0
8730834|NCT01061385|9778237|FG000|NOT COMPLETED|Overall Study||1
8730835|NCT01061385|9778238|FG001|NOT COMPLETED|Overall Study||1
8730836|NCT01061476|9778245|FG000|STARTED|Overall Study||12
8730837|NCT01061476|9778245|FG000|COMPLETED|Overall Study||12
8730838|NCT01061476|9778245|FG000|NOT COMPLETED|Overall Study||0
8730839|NCT01061528|9778251|FG000|STARTED|Overall Study||62
8730840|NCT01061528|9778252|FG001|STARTED|Overall Study||54
8730841|NCT01061528|9778251|FG000|COMPLETED|Overall Study||59
8730842|NCT01061528|9778252|FG001|COMPLETED|Overall Study||52
8730843|NCT01061528|9778251|FG000|NOT COMPLETED|Overall Study||3
8730844|NCT01061528|9778252|FG001|NOT COMPLETED|Overall Study||2
8730845|NCT01061567|9778258|FG000|STARTED|Overall Study||1814
8730846|NCT01061567|9778258|FG000|COMPLETED|Overall Study||1738
8730847|NCT01061567|9778258|FG000|NOT COMPLETED|Overall Study||76
8730848|NCT01061606|9778262|FG000|STARTED|Overall Study||8
8730849|NCT01061606|9778262|FG000|COMPLETED|Overall Study||0
8730850|NCT01061606|9778262|FG000|NOT COMPLETED|Overall Study||8
8730851|NCT01061671|9778268|FG000|STARTED|Overall Study||433
8730852|NCT01061671|9778269|FG001|STARTED|Overall Study||452
8730853|NCT01061671|9778268|FG000|COMPLETED|Overall Study||386
8730854|NCT01061671|9778269|FG001|COMPLETED|Overall Study||397
8730855|NCT01061671|9778268|FG000|NOT COMPLETED|Overall Study||47
8730856|NCT01061671|9778269|FG001|NOT COMPLETED|Overall Study||55
8730857|NCT01061710|9778275|FG000|STARTED|Overall Study||20
8730858|NCT01061710|9778275|FG000|COMPLETED|Overall Study||6
8730859|NCT01061710|9778275|FG000|NOT COMPLETED|Overall Study||14
8730860|NCT01061723|9778285|FG000|STARTED|Overall Study||50
8730861|NCT01061723|9778286|FG001|STARTED|Overall Study||49
8730862|NCT01061723|9778287|FG002|STARTED|Overall Study||50
8730863|NCT01061723|9778288|FG003|STARTED|Overall Study||52
8730864|NCT01061723|9778289|FG004|STARTED|Overall Study||50
8730865|NCT01061723|9778290|FG005|STARTED|Overall Study||50
8730866|NCT01061723|9778285|FG000|Treated|Overall Study||50
8730867|NCT01061723|9778286|FG001|Treated|Overall Study||49
8730868|NCT01061723|9778287|FG002|Treated|Overall Study||50
8730869|NCT01061723|9778288|FG003|Treated|Overall Study||52
8730870|NCT01061723|9778289|FG004|Treated|Overall Study||50
8730871|NCT01061723|9778290|FG005|Treated|Overall Study||49
8730872|NCT01061723|9778285|FG000|COMPLETED|Overall Study||46
8730873|NCT01061723|9778286|FG001|COMPLETED|Overall Study||43
8730874|NCT01061723|9778287|FG002|COMPLETED|Overall Study||40
8730875|NCT01061723|9778288|FG003|COMPLETED|Overall Study||44
8730876|NCT01061723|9778289|FG004|COMPLETED|Overall Study||47
8730877|NCT01061723|9778290|FG005|COMPLETED|Overall Study||41
8730878|NCT01061723|9778285|FG000|NOT COMPLETED|Overall Study||4
8730879|NCT01061723|9778286|FG001|NOT COMPLETED|Overall Study||6
8730880|NCT01061723|9778287|FG002|NOT COMPLETED|Overall Study||10
8730881|NCT01061723|9778288|FG003|NOT COMPLETED|Overall Study||8
8730882|NCT01061723|9778289|FG004|NOT COMPLETED|Overall Study||3
8730883|NCT01061723|9778290|FG005|NOT COMPLETED|Overall Study||9
8730884|NCT01061736|9778319|FG000|STARTED|Overall Study||50
8730885|NCT01061736|9778320|FG001|STARTED|Overall Study||50
8730886|NCT01061736|9778321|FG002|STARTED|Overall Study||51
8730887|NCT01061736|9778322|FG003|STARTED|Overall Study||51
8730888|NCT01061736|9778323|FG004|STARTED|Overall Study||52
8730889|NCT01061736|9778324|FG005|STARTED|Overall Study||52
8730890|NCT01061736|9778325|FG006|STARTED|Overall Study||84
8730891|NCT01061736|9778326|FG007|STARTED|Overall Study||430
8730892|NCT01061736|9778327|FG008|STARTED|Overall Study||427
8730893|NCT01061736|9778328|FG009|STARTED|Overall Study||428
8730894|NCT01061736|9778319|FG000|Treated|Overall Study||50
8730895|NCT01061736|9778320|FG001|Treated|Overall Study||50
8730896|NCT01061736|9778321|FG002|Treated|Overall Study||51
8730897|NCT01061736|9778322|FG003|Treated|Overall Study||51
8730898|NCT01061736|9778323|FG004|Treated|Overall Study||51
8730899|NCT01061736|9778324|FG005|Treated|Overall Study||52
8730900|NCT01061736|9778325|FG006|Treated|Overall Study||84
8730901|NCT01061736|9778326|FG007|Treated|Overall Study||428
8730902|NCT01061736|9778327|FG008|Treated|Overall Study||426
8665742|NCT00723021|9709311|FG004|NOT COMPLETED|Intervention Period 2||0
8730903|NCT01061736|9778328|FG009|Treated|Overall Study||428
8665743|NCT00723021|9709307|FG000|STARTED|Intervention Period 3||3
8730904|NCT01061736|9778319|FG000|Rescued|Overall Study||0
8730905|NCT01061736|9778320|FG001|Rescued|Overall Study||0
8665744|NCT00723021|9709308|FG001|STARTED|Intervention Period 3||3
8665745|NCT00723021|9709309|FG002|STARTED|Intervention Period 3||3
8665746|NCT00723021|9709310|FG003|STARTED|Intervention Period 3||3
8665747|NCT00723021|9709311|FG004|STARTED|Intervention Period 3||3
8665748|NCT00723021|9709307|FG000|COMPLETED|Intervention Period 3||3
8665749|NCT00723021|9709308|FG001|COMPLETED|Intervention Period 3||3
8665750|NCT00723021|9709309|FG002|COMPLETED|Intervention Period 3||3
8665751|NCT00723021|9709310|FG003|COMPLETED|Intervention Period 3||3
8665752|NCT00723021|9709311|FG004|COMPLETED|Intervention Period 3||3
8665753|NCT00723021|9709307|FG000|NOT COMPLETED|Intervention Period 3||0
8665754|NCT00723021|9709308|FG001|NOT COMPLETED|Intervention Period 3||0
8665755|NCT00723021|9709309|FG002|NOT COMPLETED|Intervention Period 3||0
8665756|NCT00723021|9709310|FG003|NOT COMPLETED|Intervention Period 3||0
8665757|NCT00723021|9709311|FG004|NOT COMPLETED|Intervention Period 3||0
8665758|NCT00723021|9709307|FG000|STARTED|Intervention Period 4||3
8665759|NCT00723021|9709308|FG001|STARTED|Intervention Period 4||3
8665760|NCT00723021|9709309|FG002|STARTED|Intervention Period 4||3
8665761|NCT00723021|9709310|FG003|STARTED|Intervention Period 4||3
8665762|NCT00723021|9709311|FG004|STARTED|Intervention Period 4||3
8665763|NCT00723021|9709307|FG000|COMPLETED|Intervention Period 4||3
8665764|NCT00723021|9709308|FG001|COMPLETED|Intervention Period 4||3
8665765|NCT00723021|9709309|FG002|COMPLETED|Intervention Period 4||3
8665766|NCT00723021|9709310|FG003|COMPLETED|Intervention Period 4||3
8665767|NCT00723021|9709311|FG004|COMPLETED|Intervention Period 4||2
8665768|NCT00723021|9709307|FG000|NOT COMPLETED|Intervention Period 4||0
8665769|NCT00723021|9709308|FG001|NOT COMPLETED|Intervention Period 4||0
8665770|NCT00723021|9709309|FG002|NOT COMPLETED|Intervention Period 4||0
8665771|NCT00723021|9709310|FG003|NOT COMPLETED|Intervention Period 4||0
8665772|NCT00723021|9709311|FG004|NOT COMPLETED|Intervention Period 4||1
8665773|NCT00723021|9709307|FG000|STARTED|Intervention Period 5||3
8665774|NCT00723021|9709308|FG001|STARTED|Intervention Period 5||3
8665775|NCT00723021|9709309|FG002|STARTED|Intervention Period 5||3
8665776|NCT00723021|9709310|FG003|STARTED|Intervention Period 5||3
8665777|NCT00723021|9709311|FG004|STARTED|Intervention Period 5||2
8665778|NCT00723021|9709307|FG000|COMPLETED|Intervention Period 5||3
8665779|NCT00723021|9709308|FG001|COMPLETED|Intervention Period 5||3
8665780|NCT00723021|9709309|FG002|COMPLETED|Intervention Period 5||3
8665781|NCT00723021|9709310|FG003|COMPLETED|Intervention Period 5||3
8665782|NCT00723021|9709311|FG004|COMPLETED|Intervention Period 5||2
8665783|NCT00723021|9709307|FG000|NOT COMPLETED|Intervention Period 5||0
8665784|NCT00723021|9709308|FG001|NOT COMPLETED|Intervention Period 5||0
8665785|NCT00723021|9709309|FG002|NOT COMPLETED|Intervention Period 5||0
8665786|NCT00723021|9709310|FG003|NOT COMPLETED|Intervention Period 5||0
8665787|NCT00723021|9709311|FG004|NOT COMPLETED|Intervention Period 5||0
8665788|NCT00723073|9709332|FG000|STARTED|Overall Study||149
8665789|NCT00723073|9709333|FG001|STARTED|Overall Study||174
8665790|NCT00723073|9709332|FG000|COMPLETED|Overall Study||149
8665791|NCT00723073|9709333|FG001|COMPLETED|Overall Study||174
8665792|NCT00723073|9709332|FG000|NOT COMPLETED|Overall Study||0
8665793|NCT00723073|9709333|FG001|NOT COMPLETED|Overall Study||0
8665794|NCT00723099|9709339|FG000|STARTED|Overall Study||73
8665795|NCT00723099|9709339|FG000|COMPLETED|Overall Study||72
8665796|NCT00723099|9709339|FG000|NOT COMPLETED|Overall Study||1
8665797|NCT00723125|9709346|FG000|STARTED|Overall Study|33 pts Neo-adjuvant, 28 evaluable,DDAC: Of 28 pts,27 treated DDAC Avastin:Of 27,15 Avastin post-op|33
8665798|NCT00723125|9709347|FG001|STARTED|Overall Study|27 evaluable Neo-adjuvant Of 27 patients neo-adjuvant, 24 DDAC Of 24 DDAC, 21 Avastin post-op|27
8665799|NCT00723125|9709346|FG000|COMPLETED|Overall Study||15
8665800|NCT00723125|9709347|FG001|COMPLETED|Overall Study||21
8665801|NCT00723125|9709346|FG000|NOT COMPLETED|Overall Study||18
8665802|NCT00723125|9709347|FG001|NOT COMPLETED|Overall Study||6
8665803|NCT00723177|9709362|FG000|STARTED|Overall Study||15
8665804|NCT00723177|9709363|FG001|STARTED|Overall Study||14
8665805|NCT00723177|9709364|FG002|STARTED|Overall Study||15
8665806|NCT00723177|9709362|FG000|COMPLETED|Overall Study||10
8665807|NCT00723177|9709363|FG001|COMPLETED|Overall Study||10
8665808|NCT00723177|9709364|FG002|COMPLETED|Overall Study||10
8665809|NCT00723177|9709362|FG000|NOT COMPLETED|Overall Study||5
8665810|NCT00723177|9709363|FG001|NOT COMPLETED|Overall Study||4
8665811|NCT00723177|9709364|FG002|NOT COMPLETED|Overall Study||5
8665812|NCT00723190|9709372|FG000|STARTED|Overall Study|Study CLON-301 (168 participants) and Study CLON-302 (135 participants)|303
8665813|NCT00723190|9709372|FG000|SAFETY POPULATION|Overall Study||301
8665814|NCT00723190|9709372|FG000|COMPLETED|Overall Study|53 participants completed 6-month protocol and 108 participants completed 12-month protocol|161
8665815|NCT00723190|9709372|FG000|NOT COMPLETED|Overall Study||142
8665816|NCT00723203|9709376|FG000|STARTED|Overall Study||16
8665817|NCT00723203|9709376|FG000|COMPLETED|Overall Study||13
8665818|NCT00723203|9709376|FG000|NOT COMPLETED|Overall Study||3
8665819|NCT00723229|9709382|FG000|STARTED|First Intervention||25
8665820|NCT00723229|9709383|FG001|STARTED|First Intervention||23
8665821|NCT00723229|9709382|FG000|COMPLETED|First Intervention||18
8665822|NCT00723229|9709383|FG001|COMPLETED|First Intervention||20
8665823|NCT00723229|9709382|FG000|NOT COMPLETED|First Intervention||7
8665824|NCT00723229|9709383|FG001|NOT COMPLETED|First Intervention||3
8665825|NCT00723229|9709382|FG000|STARTED|Second Intervention||18
8665826|NCT00723229|9709383|FG001|STARTED|Second Intervention||20
8665827|NCT00723229|9709382|FG000|COMPLETED|Second Intervention||18
8665828|NCT00723229|9709383|FG001|COMPLETED|Second Intervention||20
8665829|NCT00723229|9709382|FG000|NOT COMPLETED|Second Intervention||0
8665830|NCT00723229|9709383|FG001|NOT COMPLETED|Second Intervention||0
8665831|NCT00723255|9709389|FG000|STARTED|Overall Study||53
8665832|NCT00723255|9709389|FG000|COMPLETED|Overall Study|Eligible and treated patients|49
8665833|NCT00723255|9709389|FG000|NOT COMPLETED|Overall Study||4
8665834|NCT00723294|9709405|FG000|STARTED|Overall Study||99
8665835|NCT00723294|9709405|FG000|COMPLETED|Overall Study||86
8665836|NCT00723294|9709405|FG000|NOT COMPLETED|Overall Study||13
8665837|NCT00723398|9709414|FG000|STARTED|Overall Study||53
8665838|NCT00723398|9709415|FG001|STARTED|Overall Study||53
8665839|NCT00723398|9709416|FG002|STARTED|Overall Study||53
8665840|NCT00723398|9709417|FG003|STARTED|Overall Study||54
8665841|NCT00723398|9709418|FG004|STARTED|Overall Study||53
8665842|NCT00723398|9709414|FG000|COMPLETED|Overall Study||47
8665843|NCT00723398|9709415|FG001|COMPLETED|Overall Study||38
8730906|NCT01061736|9778321|FG002|Rescued|Overall Study||0
8730907|NCT01061736|9778322|FG003|Rescued|Overall Study||0
8730908|NCT01061736|9778323|FG004|Rescued|Overall Study||0
8730909|NCT01061736|9778324|FG005|Rescued|Overall Study||0
8730910|NCT01061736|9778325|FG006|Rescued|Overall Study||0
8730911|NCT01061736|9778326|FG007|Rescued|Overall Study|Included both participants who completed and did not complete the study.|61
8730912|NCT01061736|9778327|FG008|Rescued|Overall Study|Included both participants who completed and did not complete the study.|55
8730913|NCT01061736|9778328|FG009|Rescued|Overall Study|Included both participants who completed and did not complete the study.|168
8730914|NCT01061736|9778319|FG000|COMPLETED|Overall Study||37
8730915|NCT01061736|9778320|FG001|COMPLETED|Overall Study||46
8730916|NCT01061736|9778321|FG002|COMPLETED|Overall Study||45
8730917|NCT01061736|9778322|FG003|COMPLETED|Overall Study||48
8730918|NCT01061736|9778323|FG004|COMPLETED|Overall Study||45
8730919|NCT01061736|9778324|FG005|COMPLETED|Overall Study||49
8730920|NCT01061736|9778325|FG006|COMPLETED|Overall Study||0
8730921|NCT01061736|9778326|FG007|COMPLETED|Overall Study||336
8730922|NCT01061736|9778327|FG008|COMPLETED|Overall Study||330
8730923|NCT01061736|9778328|FG009|COMPLETED|Overall Study||354
8730924|NCT01061736|9778319|FG000|NOT COMPLETED|Overall Study||13
8730925|NCT01061736|9778320|FG001|NOT COMPLETED|Overall Study||4
8730926|NCT01061736|9778321|FG002|NOT COMPLETED|Overall Study||6
8730927|NCT01061736|9778322|FG003|NOT COMPLETED|Overall Study||3
8730928|NCT01061736|9778323|FG004|NOT COMPLETED|Overall Study||7
8730929|NCT01061736|9778324|FG005|NOT COMPLETED|Overall Study||3
8730930|NCT01061736|9778325|FG006|NOT COMPLETED|Overall Study||84
8730931|NCT01061736|9778326|FG007|NOT COMPLETED|Overall Study||94
8730932|NCT01061736|9778327|FG008|NOT COMPLETED|Overall Study||97
8730933|NCT01061736|9778328|FG009|NOT COMPLETED|Overall Study||74
8730934|NCT01061775|9778353|FG000|STARTED|Overall Study||19
8730935|NCT01061775|9778353|FG000|COMPLETED|Overall Study||16
8730936|NCT01061775|9778353|FG000|NOT COMPLETED|Overall Study||3
8730937|NCT01061866|9778358|FG000|STARTED|Overall Study||7
8730938|NCT01061866|9778358|FG000|COMPLETED|Overall Study||5
8730939|NCT01061866|9778358|FG000|NOT COMPLETED|Overall Study||2
8730940|NCT01062009|9778366|FG000|STARTED|Overall Study||7
8730941|NCT01062009|9778367|FG001|STARTED|Overall Study||6
8730942|NCT01062009|9778368|FG002|STARTED|Overall Study||6
8730943|NCT01062009|9778369|FG003|STARTED|Overall Study||6
8730944|NCT01062009|9778366|FG000|COMPLETED|Overall Study||6
8730945|NCT01062009|9778367|FG001|COMPLETED|Overall Study||6
8730946|NCT01062009|9778368|FG002|COMPLETED|Overall Study||6
8730947|NCT01062009|9778369|FG003|COMPLETED|Overall Study||6
8730948|NCT01062009|9778366|FG000|NOT COMPLETED|Overall Study||1
8730949|NCT01062009|9778367|FG001|NOT COMPLETED|Overall Study||0
8730950|NCT01062009|9778368|FG002|NOT COMPLETED|Overall Study||0
8730951|NCT01062009|9778369|FG003|NOT COMPLETED|Overall Study||0
8730952|NCT01062061|9778379|FG000|STARTED|Overall Study||754
8730953|NCT01062061|9778379|FG000|COMPLETED|Overall Study||727
8730954|NCT01062061|9778379|FG000|NOT COMPLETED|Overall Study||27
8730955|NCT01062074|9778387|FG000|STARTED|Overall Study||3605
8730956|NCT01062074|9778387|FG000|COMPLETED|Overall Study||3605
8730957|NCT01062074|9778387|FG000|NOT COMPLETED|Overall Study||0
8730958|NCT01062113|9778394|FG000|STARTED|Overall Study||133
8730959|NCT01062113|9778395|FG001|STARTED|Overall Study||64
8730960|NCT01062113|9778396|FG002|STARTED|Overall Study||58
8730961|NCT01062113|9778394|FG000|COMPLETED|Overall Study||93
8730962|NCT01062113|9778395|FG001|COMPLETED|Overall Study||42
8730963|NCT01062113|9778396|FG002|COMPLETED|Overall Study||27
8730964|NCT01062113|9778394|FG000|NOT COMPLETED|Overall Study||40
8730965|NCT01062113|9778395|FG001|NOT COMPLETED|Overall Study||22
8730966|NCT01062113|9778396|FG002|NOT COMPLETED|Overall Study||31
8730967|NCT01062126|9778404|FG000|STARTED|Overall Study||3389
8730968|NCT01062126|9778404|FG000|COMPLETED|Overall Study||2856
8665844|NCT00723398|9709416|FG002|COMPLETED|Overall Study||36
8665845|NCT00723398|9709417|FG003|COMPLETED|Overall Study||49
8665846|NCT00723398|9709418|FG004|COMPLETED|Overall Study||44
8665847|NCT00723398|9709414|FG000|NOT COMPLETED|Overall Study||6
8730969|NCT01062126|9778404|FG000|NOT COMPLETED|Overall Study||533
8730970|NCT01062165|9778408|FG000|STARTED|Overall Study||18
8730971|NCT01062165|9778408|FG000|COMPLETED|Overall Study||18
8730972|NCT01062165|9778408|FG000|NOT COMPLETED|Overall Study||0
8730973|NCT01062230|9778412|FG000|STARTED|Overall Study||6
8730974|NCT01062230|9778412|FG000|COMPLETED|Overall Study||6
8730975|NCT01062230|9778412|FG000|NOT COMPLETED|Overall Study||0
8730976|NCT01062256|9778419|FG000|STARTED|Overall Study||55
8665848|NCT00723398|9709415|FG001|NOT COMPLETED|Overall Study||15
8665849|NCT00723398|9709416|FG002|NOT COMPLETED|Overall Study||17
8665850|NCT00723398|9709417|FG003|NOT COMPLETED|Overall Study||5
8665851|NCT00723398|9709418|FG004|NOT COMPLETED|Overall Study||9
8730977|NCT01062256|9778420|FG001|STARTED|Overall Study||103
8730978|NCT01062256|9778421|FG002|STARTED|Overall Study||107
8730979|NCT01062256|9778419|FG000|COMPLETED|Overall Study||52
8730980|NCT01062256|9778420|FG001|COMPLETED|Overall Study||96
8665852|NCT00723450|9709432|FG000|STARTED|Open-Label Phase||298
8665853|NCT00723450|9709433|FG001|STARTED|Open-Label Phase||0
8665854|NCT00723450|9709434|FG002|STARTED|Open-Label Phase||0
8665855|NCT00723450|9709432|FG000|COMPLETED|Open-Label Phase||173
8665856|NCT00723450|9709433|FG001|COMPLETED|Open-Label Phase||0
8665857|NCT00723450|9709434|FG002|COMPLETED|Open-Label Phase||0
8665858|NCT00723450|9709432|FG000|NOT COMPLETED|Open-Label Phase||125
8665859|NCT00723450|9709433|FG001|NOT COMPLETED|Open-Label Phase||0
8665860|NCT00723450|9709434|FG002|NOT COMPLETED|Open-Label Phase||0
8665861|NCT00723450|9709432|FG000|STARTED|Randomized Phase||0
8665862|NCT00723450|9709433|FG001|STARTED|Randomized Phase||86
8665863|NCT00723450|9709434|FG002|STARTED|Randomized Phase||87
8665864|NCT00723450|9709432|FG000|COMPLETED|Randomized Phase||0
8665865|NCT00723450|9709433|FG001|COMPLETED|Randomized Phase||21
8665866|NCT00723450|9709434|FG002|COMPLETED|Randomized Phase||20
8665867|NCT00723450|9709432|FG000|NOT COMPLETED|Randomized Phase||0
8665868|NCT00723450|9709433|FG001|NOT COMPLETED|Randomized Phase||65
8665869|NCT00723450|9709434|FG002|NOT COMPLETED|Randomized Phase||67
8665870|NCT00723489|9709447|FG000|STARTED|Overall Study||21
8665871|NCT00723489|9709448|FG001|STARTED|Overall Study||19
8665872|NCT00723489|9709449|FG002|STARTED|Overall Study||19
8665873|NCT00723489|9709450|FG003|STARTED|Overall Study||23
8665874|NCT00723489|9709447|FG000|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|20
8665875|NCT00723489|9709448|FG001|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|15
8665876|NCT00723489|9709449|FG002|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|19
8665877|NCT00723489|9709450|FG003|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|20
8665878|NCT00723489|9709447|FG000|NOT COMPLETED|Overall Study||1
8665879|NCT00723489|9709448|FG001|NOT COMPLETED|Overall Study||4
8665880|NCT00723489|9709449|FG002|NOT COMPLETED|Overall Study||0
8665881|NCT00723489|9709450|FG003|NOT COMPLETED|Overall Study||3
8665882|NCT00723528|9709463|FG000|STARTED|Period 1: Controlled Period (CP)||32
8665883|NCT00723528|9709464|FG001|STARTED|Period 1: Controlled Period (CP)||64
8665884|NCT00723528|9709465|FG002|STARTED|Period 1: Controlled Period (CP)||62
8665885|NCT00723528|9709466|FG003|STARTED|Period 1: Controlled Period (CP)||0
8665886|NCT00723528|9709467|FG004|STARTED|Period 1: Controlled Period (CP)||0
8665887|NCT00723528|9709468|FG005|STARTED|Period 1: Controlled Period (CP)||0
8665888|NCT00723528|9709469|FG006|STARTED|Period 1: Controlled Period (CP)||0
8665889|NCT00723528|9709463|FG000|COMPLETED|Period 1: Controlled Period (CP)||28
8665890|NCT00723528|9709464|FG001|COMPLETED|Period 1: Controlled Period (CP)||64
8665891|NCT00723528|9709465|FG002|COMPLETED|Period 1: Controlled Period (CP)||58
8665892|NCT00723528|9709466|FG003|COMPLETED|Period 1: Controlled Period (CP)||0
8665893|NCT00723528|9709467|FG004|COMPLETED|Period 1: Controlled Period (CP)||0
8665894|NCT00723528|9709468|FG005|COMPLETED|Period 1: Controlled Period (CP)||0
8665895|NCT00723528|9709469|FG006|COMPLETED|Period 1: Controlled Period (CP)||0
8665896|NCT00723528|9709463|FG000|NOT COMPLETED|Period 1: Controlled Period (CP)||4
8665897|NCT00723528|9709464|FG001|NOT COMPLETED|Period 1: Controlled Period (CP)||0
8665898|NCT00723528|9709465|FG002|NOT COMPLETED|Period 1: Controlled Period (CP)||4
8665899|NCT00723528|9709466|FG003|NOT COMPLETED|Period 1: Controlled Period (CP)||0
8665900|NCT00723528|9709467|FG004|NOT COMPLETED|Period 1: Controlled Period (CP)||0
8665901|NCT00723528|9709468|FG005|NOT COMPLETED|Period 1: Controlled Period (CP)||0
8665902|NCT00723528|9709469|FG006|NOT COMPLETED|Period 1: Controlled Period (CP)||0
8665903|NCT00723528|9709463|FG000|STARTED|Period 2: After Controlled Period||0
8665904|NCT00723528|9709464|FG001|STARTED|Period 2: After Controlled Period||0
8665905|NCT00723528|9709465|FG002|STARTED|Period 2: After Controlled Period||0
8665906|NCT00723528|9709466|FG003|STARTED|Period 2: After Controlled Period||15
8665907|NCT00723528|9709467|FG004|STARTED|Period 2: After Controlled Period||13
8665908|NCT00723528|9709468|FG005|STARTED|Period 2: After Controlled Period||64
8665909|NCT00723528|9709469|FG006|STARTED|Period 2: After Controlled Period||58
8665910|NCT00723528|9709463|FG000|COMPLETED|Period 2: After Controlled Period||0
8665911|NCT00723528|9709464|FG001|COMPLETED|Period 2: After Controlled Period||0
8665912|NCT00723528|9709465|FG002|COMPLETED|Period 2: After Controlled Period||0
8665913|NCT00723528|9709466|FG003|COMPLETED|Period 2: After Controlled Period||14
8665914|NCT00723528|9709467|FG004|COMPLETED|Period 2: After Controlled Period||11
8665915|NCT00723528|9709468|FG005|COMPLETED|Period 2: After Controlled Period||58
8665916|NCT00723528|9709469|FG006|COMPLETED|Period 2: After Controlled Period||54
8665917|NCT00723528|9709463|FG000|NOT COMPLETED|Period 2: After Controlled Period||0
8665918|NCT00723528|9709464|FG001|NOT COMPLETED|Period 2: After Controlled Period||0
8665919|NCT00723528|9709465|FG002|NOT COMPLETED|Period 2: After Controlled Period||0
8665920|NCT00723528|9709466|FG003|NOT COMPLETED|Period 2: After Controlled Period||1
8730981|NCT01062256|9778421|FG002|COMPLETED|Overall Study||103
8665921|NCT00723528|9709467|FG004|NOT COMPLETED|Period 2: After Controlled Period||2
8665922|NCT00723528|9709468|FG005|NOT COMPLETED|Period 2: After Controlled Period||6
8665923|NCT00723528|9709469|FG006|NOT COMPLETED|Period 2: After Controlled Period||4
8665924|NCT00723554|9709485|FG000|STARTED|Overall Study||63
8665925|NCT00723554|9709485|FG000|COMPLETED|Overall Study||34
8665926|NCT00723554|9709485|FG000|NOT COMPLETED|Overall Study||29
8665927|NCT00723580|9709491|FG000|STARTED|Overall Study|Study was extended with continued repeated measurements.|1
8665928|NCT00723580|9709491|FG000|Baseline Measurements|Overall Study|Actigraphic, Psychometric and Observational Baseline Data Collected.|1
8665929|NCT00723580|9709491|FG000|COMPLETED|Overall Study|Completion of repeated Measurements|1
8665930|NCT00723580|9709491|FG000|NOT COMPLETED|Overall Study||0
8665931|NCT00723606|9709497|FG000|STARTED|Overall Study||189
8665932|NCT00723606|9709498|FG001|STARTED|Overall Study||187
8665933|NCT00723606|9709497|FG000|COMPLETED|Overall Study||185
8665934|NCT00723606|9709498|FG001|COMPLETED|Overall Study||180
8665935|NCT00723606|9709497|FG000|NOT COMPLETED|Overall Study||4
8665936|NCT00723606|9709498|FG001|NOT COMPLETED|Overall Study||7
8665937|NCT00723632|9709504|FG000|STARTED|Overall Study||901
8665938|NCT00723632|9709504|FG000|COMPLETED|Overall Study|Completed initial exam form and >= 1 follow up visit form; end of treatment and SVR status recorded|698
8665939|NCT00723632|9709504|FG000|NOT COMPLETED|Overall Study||203
8665940|NCT00723645|9709508|FG000|STARTED|Visit 1 (≤4 Weeks Post-treatment)||258
8665941|NCT00723645|9709508|FG000|COMPLETED|Visit 1 (≤4 Weeks Post-treatment)||258
8665942|NCT00723645|9709508|FG000|NOT COMPLETED|Visit 1 (≤4 Weeks Post-treatment)||0
8665943|NCT00723645|9709508|FG000|STARTED|Visit 2 (Week 24 Post-treatment)|10 discontinued before Visit 2; 7 lost to follow-up and 3 were HCV RNA+ before Wk 24|248
8665944|NCT00723645|9709508|FG000|COMPLETED|Visit 2 (Week 24 Post-treatment)||248
8665945|NCT00723645|9709508|FG000|NOT COMPLETED|Visit 2 (Week 24 Post-treatment)||0
8665946|NCT00723645|9709508|FG000|STARTED|Visit 3 (Week 72 Post-treatment)|61 discontinued before V3; 26 lost to followup, 34 HCV RNA+ at Wk 24,1 death,1 HCV RNA not available|187
8665947|NCT00723645|9709508|FG000|COMPLETED|Visit 3 (Week 72 Post-treatment)||187
8665948|NCT00723645|9709508|FG000|NOT COMPLETED|Visit 3 (Week 72 Post-treatment)||0
8730982|NCT01062256|9778419|FG000|NOT COMPLETED|Overall Study||3
8730983|NCT01062256|9778420|FG001|NOT COMPLETED|Overall Study||7
8730984|NCT01062256|9778421|FG002|NOT COMPLETED|Overall Study||4
8730985|NCT01062269|9778429|FG000|STARTED|Overall Study||42
8730986|NCT01062269|9778429|FG000|COMPLETED|Overall Study||42
8730987|NCT01062269|9778429|FG000|NOT COMPLETED|Overall Study||0
8730988|NCT01062308|9778439|FG000|STARTED|Overall Study||80
8730989|NCT01062308|9778440|FG001|STARTED|Overall Study||82
8730990|NCT01062308|9778439|FG000|COMPLETED|Overall Study||64
8730991|NCT01062308|9778440|FG001|COMPLETED|Overall Study||72
8730992|NCT01062308|9778439|FG000|NOT COMPLETED|Overall Study||16
8730993|NCT01062308|9778440|FG001|NOT COMPLETED|Overall Study||10
8730994|NCT01062399|9778451|FG000|STARTED|Overall Study||8
8730995|NCT01062399|9778452|FG001|STARTED|Overall Study||10
8730996|NCT01062399|9778453|FG002|STARTED|Overall Study||8
8730997|NCT01062399|9778454|FG003|STARTED|Overall Study||89
8730998|NCT01062399|9778455|FG004|STARTED|Overall Study||92
8730999|NCT01062399|9778451|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analyses are considered to have completed the study.|8
8731000|NCT01062399|9778452|FG001|COMPLETED|Overall Study||9
8731001|NCT01062399|9778453|FG002|COMPLETED|Overall Study||8
8731002|NCT01062399|9778454|FG003|COMPLETED|Overall Study||83
8731003|NCT01062399|9778455|FG004|COMPLETED|Overall Study||88
8731004|NCT01062399|9778451|FG000|NOT COMPLETED|Overall Study||0
8731005|NCT01062399|9778452|FG001|NOT COMPLETED|Overall Study||1
8731006|NCT01062399|9778453|FG002|NOT COMPLETED|Overall Study||0
8731007|NCT01062399|9778454|FG003|NOT COMPLETED|Overall Study||6
8731008|NCT01062399|9778455|FG004|NOT COMPLETED|Overall Study||4
8731009|NCT01062555|9778469|FG000|STARTED|Phase 1||266
8731010|NCT01062555|9778470|FG001|STARTED|Phase 1||261
8731011|NCT01062555|9778471|FG002|STARTED|Phase 1||0
8731012|NCT01062555|9778472|FG003|STARTED|Phase 1||0
8731013|NCT01062555|9778469|FG000|COMPLETED|Phase 1||243
8731014|NCT01062555|9778470|FG001|COMPLETED|Phase 1||235
8731015|NCT01062555|9778471|FG002|COMPLETED|Phase 1||0
8731016|NCT01062555|9778472|FG003|COMPLETED|Phase 1||0
8731017|NCT01062555|9778469|FG000|NOT COMPLETED|Phase 1||23
8731018|NCT01062555|9778470|FG001|NOT COMPLETED|Phase 1||26
8731019|NCT01062555|9778471|FG002|NOT COMPLETED|Phase 1||0
8731020|NCT01062555|9778472|FG003|NOT COMPLETED|Phase 1||0
8731021|NCT01062555|9778469|FG000|STARTED|Phase 2||0
8731022|NCT01062555|9778470|FG001|STARTED|Phase 2||0
8731023|NCT01062555|9778471|FG002|STARTED|Phase 2||86
8731024|NCT01062555|9778472|FG003|STARTED|Phase 2||87
8731025|NCT01062555|9778469|FG000|COMPLETED|Phase 2||0
8731026|NCT01062555|9778470|FG001|COMPLETED|Phase 2||0
8731027|NCT01062555|9778471|FG002|COMPLETED|Phase 2||71
8731028|NCT01062555|9778472|FG003|COMPLETED|Phase 2||53
8731029|NCT01062555|9778469|FG000|NOT COMPLETED|Phase 2||0
8731030|NCT01062555|9778470|FG001|NOT COMPLETED|Phase 2||0
8731031|NCT01062555|9778471|FG002|NOT COMPLETED|Phase 2||15
8731032|NCT01062555|9778472|FG003|NOT COMPLETED|Phase 2||34
8731033|NCT01062568|9778484|FG000|STARTED|Overall Study||10
8731034|NCT01062568|9778485|FG001|STARTED|Overall Study||40
8731035|NCT01062568|9778484|FG000|COMPLETED|Overall Study||10
8731036|NCT01062568|9778485|FG001|COMPLETED|Overall Study||40
8731037|NCT01062568|9778484|FG000|NOT COMPLETED|Overall Study||0
8731038|NCT01062568|9778485|FG001|NOT COMPLETED|Overall Study||0
8731039|NCT01062763|9778498|FG000|STARTED|Overall Study|119 randomized.|58
8665949|NCT00723697|9709512|FG000|STARTED|Overall Study||1307
8665950|NCT00723697|9709512|FG000|COMPLETED|Overall Study||1289
8665951|NCT00723697|9709512|FG000|NOT COMPLETED|Overall Study||18
8665952|NCT00723710|9709519|FG000|STARTED|Overall Study||294
8665953|NCT00723710|9709519|FG000|COMPLETED|Overall Study||120
8665954|NCT00723710|9709519|FG000|NOT COMPLETED|Overall Study||174
8665955|NCT00723749|9709523|FG000|STARTED|Overall Study|384 patients were enrolled, 36 non-eligible datasets were excluded from analysis|345
8665956|NCT00723749|9709523|FG000|COMPLETED|Overall Study||182
8665957|NCT00723749|9709523|FG000|NOT COMPLETED|Overall Study||163
8665958|NCT00723788|9709527|FG000|STARTED|Overall Study||21
8665959|NCT00723788|9709527|FG000|COMPLETED|Overall Study||21
8665960|NCT00723788|9709527|FG000|NOT COMPLETED|Overall Study||0
8665961|NCT00723801|9709535|FG000|STARTED|Overall Study||20
8665962|NCT00723801|9709536|FG001|STARTED|Overall Study||20
8665963|NCT00723801|9709535|FG000|COMPLETED|Overall Study||17
8665964|NCT00723801|9709536|FG001|COMPLETED|Overall Study||17
8665965|NCT00723801|9709535|FG000|NOT COMPLETED|Overall Study||3
8665966|NCT00723801|9709536|FG001|NOT COMPLETED|Overall Study||3
8665967|NCT00723827|9709542|FG000|STARTED|Overall Study||682
8665968|NCT00723827|9709542|FG000|COMPLETED|Overall Study||682
8665969|NCT00723827|9709542|FG000|NOT COMPLETED|Overall Study||0
8665970|NCT00723840|9709546|FG000|STARTED|Overall Study||245
8665971|NCT00723840|9709546|FG000|COMPLETED|Overall Study||163
8665972|NCT00723840|9709546|FG000|NOT COMPLETED|Overall Study||82
8665973|NCT00723892|9709559|FG000|STARTED|Overall Study||313
8665974|NCT00723892|9709560|FG001|STARTED|Overall Study||255
8731040|NCT01062763|9778499|FG001|STARTED|Overall Study||61
8731041|NCT01062763|9778498|FG000|COMPLETED|Overall Study||55
8731042|NCT01062763|9778499|FG001|COMPLETED|Overall Study||57
8731043|NCT01062763|9778498|FG000|NOT COMPLETED|Overall Study||3
8731044|NCT01062763|9778499|FG001|NOT COMPLETED|Overall Study||4
8731045|NCT01062841|9778507|FG000|STARTED|Overall Study||203
8731046|NCT01062841|9778508|FG001|STARTED|Overall Study||215
8731047|NCT01062841|9778507|FG000|COMPLETED|Overall Study||154
8731048|NCT01062841|9778508|FG001|COMPLETED|Overall Study||162
8731049|NCT01062841|9778507|FG000|NOT COMPLETED|Overall Study||49
8731050|NCT01062841|9778508|FG001|NOT COMPLETED|Overall Study||53
8731051|NCT01062893|9778516|FG000|STARTED|Overall Study||41
8731052|NCT01062893|9778517|FG001|STARTED|Overall Study||41
8731053|NCT01062893|9778516|FG000|COMPLETED|Overall Study||27
8731054|NCT01062893|9778517|FG001|COMPLETED|Overall Study||28
8731055|NCT01062893|9778516|FG000|NOT COMPLETED|Overall Study||14
8731056|NCT01062893|9778517|FG001|NOT COMPLETED|Overall Study||13
8731057|NCT01062971|9778525|FG000|STARTED|Overall Study||60
8731058|NCT01062971|9778526|FG001|STARTED|Overall Study||63
8731059|NCT01062971|9778525|FG000|COMPLETED|Overall Study||56
8731060|NCT01062971|9778526|FG001|COMPLETED|Overall Study||56
8731061|NCT01062971|9778525|FG000|NOT COMPLETED|Overall Study||4
8731062|NCT01062971|9778526|FG001|NOT COMPLETED|Overall Study||7
8731063|NCT01063036|9778532|FG000|STARTED|Participants Treated With Study Drug||92
8731064|NCT01063036|9778532|FG000|COMPLETED|Participants Treated With Study Drug||86
8731065|NCT01063036|9778532|FG000|NOT COMPLETED|Participants Treated With Study Drug||6
8731066|NCT01063036|9778532|FG000|STARTED|Post Dosing Follow-up Through 24 Weeks|2 included did not complete treatment; 3 completed treatment but not included (lost to follow-up).|85
8731067|NCT01063036|9778532|FG000|COMPLETED|Post Dosing Follow-up Through 24 Weeks||46
8731068|NCT01063036|9778532|FG000|NOT COMPLETED|Post Dosing Follow-up Through 24 Weeks||39
8731069|NCT01063049|9778539|FG000|STARTED|Overall Study||200
8731070|NCT01063049|9778540|FG001|STARTED|Overall Study||200
8731071|NCT01063049|9778541|FG002|STARTED|Overall Study||200
8731072|NCT01063049|9778539|FG000|COMPLETED|Overall Study||200
8731073|NCT01063049|9778540|FG001|COMPLETED|Overall Study||200
8731074|NCT01063049|9778541|FG002|COMPLETED|Overall Study||200
8731075|NCT01063049|9778539|FG000|NOT COMPLETED|Overall Study||0
8731076|NCT01063049|9778540|FG001|NOT COMPLETED|Overall Study||0
8731077|NCT01063049|9778541|FG002|NOT COMPLETED|Overall Study||0
8731078|NCT01063062|9778551|FG000|STARTED|Overall Study||30
8731079|NCT01063062|9778552|FG001|STARTED|Overall Study||77
8731080|NCT01063062|9778551|FG000|Received Study Drug|Overall Study||29
8731081|NCT01063062|9778552|FG001|Received Study Drug|Overall Study||76
8731082|NCT01063062|9778551|FG000|COMPLETED|Overall Study||22
8731083|NCT01063062|9778552|FG001|COMPLETED|Overall Study||65
8731084|NCT01063062|9778551|FG000|NOT COMPLETED|Overall Study||8
8731085|NCT01063062|9778552|FG001|NOT COMPLETED|Overall Study||12
8731086|NCT01063075|9778559|FG000|STARTED|Overall Study||2
8731087|NCT01063075|9778560|FG001|STARTED|Overall Study||3
8731088|NCT01063075|9778561|FG002|STARTED|Overall Study||14
8731089|NCT01063075|9778562|FG003|STARTED|Overall Study||15
8731090|NCT01063075|9778559|FG000|COMPLETED|Overall Study||1
8731091|NCT01063075|9778560|FG001|COMPLETED|Overall Study||1
8731092|NCT01063075|9778561|FG002|COMPLETED|Overall Study||9
8731093|NCT01063075|9778562|FG003|COMPLETED|Overall Study||14
8731094|NCT01063075|9778559|FG000|NOT COMPLETED|Overall Study||1
8731095|NCT01063075|9778560|FG001|NOT COMPLETED|Overall Study||2
8731096|NCT01063075|9778561|FG002|NOT COMPLETED|Overall Study||5
8731097|NCT01063075|9778562|FG003|NOT COMPLETED|Overall Study||1
8731098|NCT01063153|9778574|FG000|STARTED|Overall Study||33
8731099|NCT01063153|9778575|FG001|STARTED|Overall Study||38
8731100|NCT01063153|9778574|FG000|COMPLETED|Overall Study||31
8731101|NCT01063153|9778575|FG001|COMPLETED|Overall Study||26
8731102|NCT01063153|9778574|FG000|NOT COMPLETED|Overall Study||2
8731103|NCT01063153|9778575|FG001|NOT COMPLETED|Overall Study||12
8731104|NCT01063283|9778587|FG000|STARTED|Cycle 1||20
8731105|NCT01063283|9778588|FG001|STARTED|Cycle 1||0
8731106|NCT01063283|9778589|FG002|STARTED|Cycle 1||0
8731107|NCT01063283|9778587|FG000|COMPLETED|Cycle 1||17
8731108|NCT01063283|9778588|FG001|COMPLETED|Cycle 1||0
8665975|NCT00723892|9709559|FG000|COMPLETED|Overall Study||206
8665976|NCT00723892|9709560|FG001|COMPLETED|Overall Study||168
8665977|NCT00723892|9709559|FG000|NOT COMPLETED|Overall Study||107
8665978|NCT00723892|9709560|FG001|NOT COMPLETED|Overall Study||87
8665979|NCT00723931|9709566|FG000|STARTED|Overall Study||1267
8665980|NCT00723931|9709566|FG000|COMPLETED|Overall Study||1267
8665981|NCT00723931|9709566|FG000|NOT COMPLETED|Overall Study||0
8665982|NCT00723957|9709572|FG000|STARTED|Overall Study|Randomized|98
8665983|NCT00723957|9709573|FG001|STARTED|Overall Study|Randomized|99
8665984|NCT00723957|9709572|FG000|COMPLETED|Overall Study|Completed 6 cycles of study drug (maximum per protocol)|47
8665985|NCT00723957|9709573|FG001|COMPLETED|Overall Study|Completed 6 cycles of study drug (maximum per protocol)|46
8665986|NCT00723957|9709572|FG000|NOT COMPLETED|Overall Study||51
8665987|NCT00723957|9709573|FG001|NOT COMPLETED|Overall Study||53
8665988|NCT00724009|9709579|FG000|STARTED|Overall Study||29
8665989|NCT00724009|9709579|FG000|COMPLETED|Overall Study|One patient underwent conditioning but died 1 day before stem cell infusion due to sepsis.|29
8665990|NCT00724009|9709579|FG000|NOT COMPLETED|Overall Study||0
8665991|NCT00724061|9709583|FG000|STARTED|Dose Escalation Phase||7
8665992|NCT00724061|9709583|FG000|COMPLETED|Dose Escalation Phase||2
8665993|NCT00724061|9709583|FG000|NOT COMPLETED|Dose Escalation Phase||5
8665994|NCT00724061|9709583|FG000|STARTED|Maintenance Therapy||2
8665995|NCT00724061|9709583|FG000|COMPLETED|Maintenance Therapy||2
8665996|NCT00724061|9709583|FG000|NOT COMPLETED|Maintenance Therapy||0
8665997|NCT00724126|9709589|FG000|STARTED|Overall Study||321
8665998|NCT00724126|9709590|FG001|STARTED|Overall Study||316
8665999|NCT00724126|9709589|FG000|COMPLETED|Overall Study||302
8666000|NCT00724126|9709590|FG001|COMPLETED|Overall Study||301
8731109|NCT01063283|9778589|FG002|COMPLETED|Cycle 1||0
8731110|NCT01063283|9778587|FG000|NOT COMPLETED|Cycle 1||3
8731111|NCT01063283|9778588|FG001|NOT COMPLETED|Cycle 1||0
8666001|NCT00724126|9709589|FG000|NOT COMPLETED|Overall Study||19
8666002|NCT00724126|9709590|FG001|NOT COMPLETED|Overall Study||15
8666003|NCT00724152|9709601|FG000|STARTED|Two-arm Study Period||14
8666004|NCT00724152|9709602|FG001|STARTED|Two-arm Study Period||11
8666005|NCT00724152|9709603|FG002|STARTED|Two-arm Study Period|Standard Care arm was added later (Period 2)|0
8666006|NCT00724152|9709601|FG000|COMPLETED|Two-arm Study Period||11
8666007|NCT00724152|9709602|FG001|COMPLETED|Two-arm Study Period||9
8666008|NCT00724152|9709603|FG002|COMPLETED|Two-arm Study Period||0
8666009|NCT00724152|9709601|FG000|NOT COMPLETED|Two-arm Study Period||3
8666010|NCT00724152|9709602|FG001|NOT COMPLETED|Two-arm Study Period||2
8666011|NCT00724152|9709603|FG002|NOT COMPLETED|Two-arm Study Period||0
8666012|NCT00724152|9709601|FG000|STARTED|Three-arm Study Period (+Standard Care)||4
8666013|NCT00724152|9709602|FG001|STARTED|Three-arm Study Period (+Standard Care)||2
8666014|NCT00724152|9709603|FG002|STARTED|Three-arm Study Period (+Standard Care)|3-group randomization began|2
8666015|NCT00724152|9709601|FG000|COMPLETED|Three-arm Study Period (+Standard Care)||3
8666016|NCT00724152|9709602|FG001|COMPLETED|Three-arm Study Period (+Standard Care)||0
8666017|NCT00724152|9709603|FG002|COMPLETED|Three-arm Study Period (+Standard Care)||1
8666018|NCT00724152|9709601|FG000|NOT COMPLETED|Three-arm Study Period (+Standard Care)||1
8666019|NCT00724152|9709602|FG001|NOT COMPLETED|Three-arm Study Period (+Standard Care)||2
8666020|NCT00724152|9709603|FG002|NOT COMPLETED|Three-arm Study Period (+Standard Care)||1
8666021|NCT00724243|9709613|FG000|STARTED|Overall Study||33
8666022|NCT00724243|9709613|FG000|COMPLETED|Overall Study||18
8666023|NCT00724243|9709613|FG000|NOT COMPLETED|Overall Study||15
8666024|NCT00724308|9709619|FG000|STARTED|Overall Study||270
8666025|NCT00724308|9709620|FG001|STARTED|Overall Study||307
8666026|NCT00724308|9709619|FG000|COMPLETED|Overall Study||190
8666027|NCT00724308|9709620|FG001|COMPLETED|Overall Study||210
8731112|NCT01063283|9778589|FG002|NOT COMPLETED|Cycle 1||0
8731113|NCT01063283|9778587|FG000|STARTED|Randomized Phase (Cycle 2 and Beyond)||0
8731114|NCT01063283|9778588|FG001|STARTED|Randomized Phase (Cycle 2 and Beyond)||6
8731115|NCT01063283|9778589|FG002|STARTED|Randomized Phase (Cycle 2 and Beyond)||11
8731116|NCT01063283|9778587|FG000|COMPLETED|Randomized Phase (Cycle 2 and Beyond)||0
8731117|NCT01063283|9778588|FG001|COMPLETED|Randomized Phase (Cycle 2 and Beyond)||6
8731118|NCT01063283|9778589|FG002|COMPLETED|Randomized Phase (Cycle 2 and Beyond)||11
8731119|NCT01063283|9778587|FG000|NOT COMPLETED|Randomized Phase (Cycle 2 and Beyond)||0
8666028|NCT00724308|9709619|FG000|NOT COMPLETED|Overall Study||80
8666029|NCT00724308|9709620|FG001|NOT COMPLETED|Overall Study||97
8666030|NCT00724347|9709626|FG000|STARTED|Overall Study|Training was the final step in the program, once the outcome tests had been developed.|18
8666031|NCT00724347|9709626|FG000|Baseline Testing|Overall Study||18
8666032|NCT00724347|9709626|FG000|COMPLETED|Overall Study||16
8666033|NCT00724347|9709626|FG000|NOT COMPLETED|Overall Study||2
8666034|NCT00724373|9709630|FG000|STARTED|Overall Study||442
8666035|NCT00724373|9709630|FG000|COMPLETED|Overall Study||271
8666036|NCT00724373|9709630|FG000|NOT COMPLETED|Overall Study||171
8666037|NCT00724451|9709634|FG000|STARTED|Overall Study||1128
8666038|NCT00724451|9709634|FG000|Received Antiviral Treatment|Overall Study||500
8731120|NCT01063283|9778588|FG001|NOT COMPLETED|Randomized Phase (Cycle 2 and Beyond)||0
8731121|NCT01063283|9778589|FG002|NOT COMPLETED|Randomized Phase (Cycle 2 and Beyond)||0
8666039|NCT00724451|9709634|FG000|COMPLETED|Overall Study|Completed defined as participants who completed anti-viral treatment.|326
8666040|NCT00724451|9709634|FG000|NOT COMPLETED|Overall Study||802
8666041|NCT00724464|9709638|FG000|STARTED|Overall Study||332
8666042|NCT00724464|9709638|FG000|COMPLETED|Overall Study||309
8666043|NCT00724464|9709638|FG000|NOT COMPLETED|Overall Study||23
8666044|NCT00724503|9709645|FG000|STARTED|Overall Study||267
8666045|NCT00724503|9709646|FG001|STARTED|Overall Study||263
8666046|NCT00724503|9709645|FG000|COMPLETED|Overall Study||57
8666047|NCT00724503|9709646|FG001|COMPLETED|Overall Study||43
8666048|NCT00724503|9709645|FG000|NOT COMPLETED|Overall Study||210
8666049|NCT00724503|9709646|FG001|NOT COMPLETED|Overall Study||220
8666050|NCT00724568|9709654|FG000|STARTED|Overall Study||42
8666051|NCT00724568|9709655|FG001|STARTED|Overall Study||32
8666052|NCT00724568|9709654|FG000|COMPLETED|Overall Study||42
8666053|NCT00724568|9709655|FG001|COMPLETED|Overall Study||32
8666054|NCT00724568|9709654|FG000|NOT COMPLETED|Overall Study||0
8666055|NCT00724568|9709655|FG001|NOT COMPLETED|Overall Study||0
8666056|NCT00724594|9709663|FG000|STARTED|Overall Study||12
8666057|NCT00724594|9709664|FG001|STARTED|Overall Study||12
8666058|NCT00724594|9709665|FG002|STARTED|Overall Study||11
8666059|NCT00724594|9709666|FG003|STARTED|Overall Study||11
8666060|NCT00724594|9709663|FG000|COMPLETED|Overall Study||12
8666061|NCT00724594|9709664|FG001|COMPLETED|Overall Study||12
8666062|NCT00724594|9709665|FG002|COMPLETED|Overall Study||11
8666063|NCT00724594|9709666|FG003|COMPLETED|Overall Study||10
8666064|NCT00724594|9709663|FG000|NOT COMPLETED|Overall Study||0
8666065|NCT00724594|9709664|FG001|NOT COMPLETED|Overall Study||0
8666066|NCT00724594|9709665|FG002|NOT COMPLETED|Overall Study||0
8666067|NCT00724594|9709666|FG003|NOT COMPLETED|Overall Study||1
8666068|NCT00724711|9709693|FG000|STARTED|Overall Study||155
8666069|NCT00724711|9709694|FG001|STARTED|Overall Study||156
8666070|NCT00724711|9709693|FG000|COMPLETED|Overall Study||138
8666071|NCT00724711|9709694|FG001|COMPLETED|Overall Study||139
8666072|NCT00724711|9709693|FG000|NOT COMPLETED|Overall Study||17
8666073|NCT00724711|9709694|FG001|NOT COMPLETED|Overall Study||17
8666074|NCT00724750|9709702|FG000|STARTED|Overall Study||45
8666075|NCT00724750|9709703|FG001|STARTED|Overall Study||42
8666076|NCT00724750|9709702|FG000|COMPLETED|Overall Study||45
8666077|NCT00724750|9709703|FG001|COMPLETED|Overall Study||42
8666078|NCT00724750|9709702|FG000|NOT COMPLETED|Overall Study||0
8666079|NCT00724750|9709703|FG001|NOT COMPLETED|Overall Study||0
8666080|NCT00724815|9709711|FG000|STARTED|Overall Study|subjects randomized|265
8666081|NCT00724815|9709712|FG001|STARTED|Overall Study|subjects randomized|265
8666082|NCT00724815|9709711|FG000|COMPLETED|Overall Study||222
8666083|NCT00724815|9709712|FG001|COMPLETED|Overall Study||226
8666084|NCT00724815|9709711|FG000|NOT COMPLETED|Overall Study||43
8666085|NCT00724815|9709712|FG001|NOT COMPLETED|Overall Study||39
8666086|NCT00724854|9709720|FG000|STARTED|Overall Study|Number enrolled was 1146. 64 participants were screen failures.|1010
8666087|NCT00724854|9709721|FG001|STARTED|Overall Study|Number enrolled was 1146. 64 participants were screen failures.|72
8666088|NCT00724854|9709720|FG000|COMPLETED|Overall Study||607
8666089|NCT00724854|9709721|FG001|COMPLETED|Overall Study||41
8666090|NCT00724854|9709720|FG000|NOT COMPLETED|Overall Study||403
8666091|NCT00724854|9709721|FG001|NOT COMPLETED|Overall Study||31
8666092|NCT00724867|9709728|FG000|STARTED|Overall Study||268
8666093|NCT00724867|9709728|FG000|COMPLETED|Overall Study||140
8666094|NCT00724867|9709728|FG000|NOT COMPLETED|Overall Study||128
8666095|NCT00724893|9709737|FG000|STARTED|Overall Study||1302
8666096|NCT00724893|9709738|FG001|STARTED|Overall Study||1128
8666097|NCT00724893|9709737|FG000|COMPLETED|Overall Study||938
8666098|NCT00724893|9709738|FG001|COMPLETED|Overall Study||670
8666099|NCT00724893|9709737|FG000|NOT COMPLETED|Overall Study||364
8666100|NCT00724893|9709738|FG001|NOT COMPLETED|Overall Study||458
8666101|NCT00724932|9709761|FG000|STARTED|Overall Study||70
8666102|NCT00724932|9709762|FG001|STARTED|Overall Study||70
8666103|NCT00724932|9709761|FG000|COMPLETED|Overall Study||65
8666104|NCT00724932|9709762|FG001|COMPLETED|Overall Study||67
8666105|NCT00724932|9709761|FG000|NOT COMPLETED|Overall Study||5
8666106|NCT00724932|9709762|FG001|NOT COMPLETED|Overall Study||3
8666107|NCT00724945|9709770|FG000|STARTED|Period 1||58
8666108|NCT00724945|9709771|FG001|STARTED|Period 1||55
8666109|NCT00724945|9709770|FG000|COMPLETED|Period 1||55
8666110|NCT00724945|9709771|FG001|COMPLETED|Period 1||54
8666111|NCT00724945|9709770|FG000|NOT COMPLETED|Period 1||3
8666112|NCT00724945|9709771|FG001|NOT COMPLETED|Period 1||1
8666113|NCT00724945|9709770|FG000|STARTED|Period 2||55
8666114|NCT00724945|9709771|FG001|STARTED|Period 2||54
8666115|NCT00724945|9709770|FG000|COMPLETED|Period 2||51
8666116|NCT00724945|9709771|FG001|COMPLETED|Period 2||54
8666117|NCT00724945|9709770|FG000|NOT COMPLETED|Period 2||4
8666118|NCT00724945|9709771|FG001|NOT COMPLETED|Period 2||0
8666119|NCT00724958|9709777|FG000|STARTED|Overall Study||348
8666120|NCT00724958|9709777|FG000|COMPLETED|Overall Study||166
8666121|NCT00724958|9709777|FG000|NOT COMPLETED|Overall Study||182
8666122|NCT00724971|9709781|FG000|STARTED|Overall Study||10
8731122|NCT01063348|9778597|FG000|STARTED|Overall Study||35
8731123|NCT01063348|9778598|FG001|STARTED|Overall Study||31
8731124|NCT01063348|9778597|FG000|COMPLETED|Overall Study||32
8731125|NCT01063348|9778598|FG001|COMPLETED|Overall Study||21
8731126|NCT01063348|9778597|FG000|NOT COMPLETED|Overall Study||3
8731127|NCT01063348|9778598|FG001|NOT COMPLETED|Overall Study||10
8731128|NCT01063595|9778604|FG000|STARTED|Enrolled in Study and Randomized||32
8731129|NCT01063595|9778605|FG001|STARTED|Enrolled in Study and Randomized||31
8731130|NCT01063595|9778604|FG000|Received Treatment|Enrolled in Study and Randomized||31
8731131|NCT01063595|9778605|FG001|Received Treatment|Enrolled in Study and Randomized||29
8731132|NCT01063595|9778604|FG000|COMPLETED|Enrolled in Study and Randomized||31
8731133|NCT01063595|9778605|FG001|COMPLETED|Enrolled in Study and Randomized||29
8731134|NCT01063595|9778604|FG000|NOT COMPLETED|Enrolled in Study and Randomized||1
8731135|NCT01063595|9778605|FG001|NOT COMPLETED|Enrolled in Study and Randomized||2
8666123|NCT00724971|9709781|FG000|COMPLETED|Overall Study||4
8666124|NCT00724971|9709781|FG000|NOT COMPLETED|Overall Study||6
8666125|NCT00724984|9709791|FG000|STARTED|Overall Study||5
8666126|NCT00724984|9709792|FG001|STARTED|Overall Study||8
8666127|NCT00724984|9709793|FG002|STARTED|Overall Study||3
8666128|NCT00724984|9709794|FG003|STARTED|Overall Study||9
8666129|NCT00724984|9709795|FG004|STARTED|Overall Study||16
8666130|NCT00724984|9709796|FG005|STARTED|Overall Study||14
8666131|NCT00724984|9709791|FG000|COMPLETED|Overall Study||4
8666132|NCT00724984|9709792|FG001|COMPLETED|Overall Study||7
8666133|NCT00724984|9709793|FG002|COMPLETED|Overall Study||3
8666134|NCT00724984|9709794|FG003|COMPLETED|Overall Study||7
8666135|NCT00724984|9709795|FG004|COMPLETED|Overall Study||12
8666136|NCT00724984|9709796|FG005|COMPLETED|Overall Study||9
8666137|NCT00724984|9709791|FG000|NOT COMPLETED|Overall Study||1
8666138|NCT00724984|9709792|FG001|NOT COMPLETED|Overall Study||1
8666139|NCT00724984|9709793|FG002|NOT COMPLETED|Overall Study||0
8666140|NCT00724984|9709794|FG003|NOT COMPLETED|Overall Study||2
8666141|NCT00724984|9709795|FG004|NOT COMPLETED|Overall Study||4
8666142|NCT00724984|9709796|FG005|NOT COMPLETED|Overall Study||5
8666143|NCT00725010|9709810|FG000|STARTED|Overall Study|Only in 50 of 64 participants the documentation of therapy and follow-up was received and evaluated.|50
8666144|NCT00725010|9709810|FG000|COMPLETED|Overall Study||25
8666145|NCT00725010|9709810|FG000|NOT COMPLETED|Overall Study||25
8666146|NCT00725075|9709819|FG000|STARTED|Overall Study||72
8666147|NCT00725075|9709820|FG001|STARTED|Overall Study||73
8666148|NCT00725075|9709821|FG002|STARTED|Overall Study||70
8666149|NCT00725075|9709819|FG000|Treated|Overall Study||71
8666150|NCT00725075|9709820|FG001|Treated|Overall Study||73
8666151|NCT00725075|9709821|FG002|Treated|Overall Study||70
8666152|NCT00725075|9709819|FG000|COMPLETED|Overall Study||61
8666153|NCT00725075|9709820|FG001|COMPLETED|Overall Study||65
8666154|NCT00725075|9709821|FG002|COMPLETED|Overall Study||61
8666155|NCT00725075|9709819|FG000|NOT COMPLETED|Overall Study||11
8666156|NCT00725075|9709820|FG001|NOT COMPLETED|Overall Study||8
8666157|NCT00725075|9709821|FG002|NOT COMPLETED|Overall Study||9
8666158|NCT00725101|9709829|FG000|STARTED|Overall Study||1700
8666159|NCT00725101|9709829|FG000|COMPLETED|Overall Study||1205
8666160|NCT00725101|9709829|FG000|NOT COMPLETED|Overall Study||495
8666161|NCT00725153|9709833|FG000|STARTED|Period One, 10 Hours of Wear||27
8666162|NCT00725153|9709834|FG001|STARTED|Period One, 10 Hours of Wear||28
8666163|NCT00725153|9709833|FG000|COMPLETED|Period One, 10 Hours of Wear||27
8666164|NCT00725153|9709834|FG001|COMPLETED|Period One, 10 Hours of Wear||28
8666165|NCT00725153|9709833|FG000|NOT COMPLETED|Period One, 10 Hours of Wear||0
8666166|NCT00725153|9709834|FG001|NOT COMPLETED|Period One, 10 Hours of Wear||0
8666167|NCT00725153|9709833|FG000|STARTED|Period Two, 10 Hours of Wear||27
8666168|NCT00725153|9709834|FG001|STARTED|Period Two, 10 Hours of Wear||28
8666169|NCT00725153|9709833|FG000|COMPLETED|Period Two, 10 Hours of Wear||27
8666170|NCT00725153|9709834|FG001|COMPLETED|Period Two, 10 Hours of Wear||28
8666171|NCT00725153|9709833|FG000|NOT COMPLETED|Period Two, 10 Hours of Wear||0
8666172|NCT00725153|9709834|FG001|NOT COMPLETED|Period Two, 10 Hours of Wear||0
8666173|NCT00725205|9709840|FG000|STARTED|Overall Study||294
8666174|NCT00725205|9709840|FG000|COMPLETED|Overall Study||207
8666175|NCT00725205|9709840|FG000|NOT COMPLETED|Overall Study||87
8666176|NCT00725270|9709846|FG000|STARTED|Overall Study||5
8666177|NCT00725270|9709847|FG001|STARTED|Overall Study||7
8666178|NCT00725270|9709846|FG000|COMPLETED|Overall Study||5
8666179|NCT00725270|9709847|FG001|COMPLETED|Overall Study||7
8666180|NCT00725270|9709846|FG000|NOT COMPLETED|Overall Study||0
8666181|NCT00725270|9709847|FG001|NOT COMPLETED|Overall Study||0
8666182|NCT00725283|9709853|FG000|STARTED|Overall Study||34
8666183|NCT00725283|9709853|FG000|COMPLETED|Overall Study||10
8666184|NCT00725283|9709853|FG000|NOT COMPLETED|Overall Study||24
8666185|NCT00725296|9709857|FG000|STARTED|Overall Study|163 of the 178 enrolled participants received at least one dose of Infliximab.|163
8666186|NCT00725296|9709857|FG000|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive infusions.|101
8666187|NCT00725296|9709857|FG000|NOT COMPLETED|Overall Study||62
8666188|NCT00725322|9709864|FG000|STARTED|First Injection Visit||15
8666189|NCT00725322|9709865|FG001|STARTED|First Injection Visit||15
8666190|NCT00725322|9709864|FG000|COMPLETED|First Injection Visit||15
8666191|NCT00725322|9709865|FG001|COMPLETED|First Injection Visit||15
8731136|NCT01063595|9778604|FG000|STARTED|First Intervention||31
8731137|NCT01063595|9778605|FG001|STARTED|First Intervention||29
8731138|NCT01063595|9778604|FG000|COMPLETED|First Intervention||29
8666192|NCT00725322|9709864|FG000|NOT COMPLETED|First Injection Visit||0
8666193|NCT00725322|9709865|FG001|NOT COMPLETED|First Injection Visit||0
8666194|NCT00725322|9709864|FG000|STARTED|Washout (28 Days)||15
8666195|NCT00725322|9709865|FG001|STARTED|Washout (28 Days)||15
8666196|NCT00725322|9709864|FG000|COMPLETED|Washout (28 Days)||13
8666197|NCT00725322|9709865|FG001|COMPLETED|Washout (28 Days)||14
8666198|NCT00725322|9709864|FG000|NOT COMPLETED|Washout (28 Days)||2
8666199|NCT00725322|9709865|FG001|NOT COMPLETED|Washout (28 Days)||1
8666200|NCT00725322|9709864|FG000|STARTED|Second Injection Visit||13
8666201|NCT00725322|9709865|FG001|STARTED|Second Injection Visit||14
8666202|NCT00725322|9709864|FG000|COMPLETED|Second Injection Visit||13
8666203|NCT00725322|9709865|FG001|COMPLETED|Second Injection Visit||14
8666204|NCT00725322|9709864|FG000|NOT COMPLETED|Second Injection Visit||0
8666205|NCT00725322|9709865|FG001|NOT COMPLETED|Second Injection Visit||0
8666206|NCT00725361|9709871|FG000|STARTED|Overall Study||20
8666207|NCT00725361|9709871|FG000|COMPLETED|Overall Study||16
8666208|NCT00725361|9709871|FG000|NOT COMPLETED|Overall Study||4
8666209|NCT00725452|9709875|FG000|STARTED|Overall Study||26
8666210|NCT00725452|9709875|FG000|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive Infliximab infusions.|15
8666211|NCT00725452|9709875|FG000|NOT COMPLETED|Overall Study||11
8666212|NCT00725504|9709879|FG000|STARTED|Overall Study||71
8666213|NCT00725504|9709879|FG000|COMPLETED|Overall Study||71
8666214|NCT00725504|9709879|FG000|NOT COMPLETED|Overall Study||0
8666215|NCT00725530|9709886|FG000|STARTED|First Intervention, 7 Days (+0/-1)||27
8666216|NCT00725530|9709887|FG001|STARTED|First Intervention, 7 Days (+0/-1)||27
8666217|NCT00725530|9709886|FG000|COMPLETED|First Intervention, 7 Days (+0/-1)||27
8666218|NCT00725530|9709887|FG001|COMPLETED|First Intervention, 7 Days (+0/-1)||27
8666219|NCT00725530|9709886|FG000|NOT COMPLETED|First Intervention, 7 Days (+0/-1)||0
8692437|NCT00860470|9737892|FG000|STARTED|Overall Study||22162
8731139|NCT01063595|9778605|FG001|COMPLETED|First Intervention||24
8731140|NCT01063595|9778604|FG000|NOT COMPLETED|First Intervention||2
8731141|NCT01063595|9778605|FG001|NOT COMPLETED|First Intervention||5
8731142|NCT01063595|9778604|FG000|STARTED|Second Intervention||29
8731143|NCT01063595|9778605|FG001|STARTED|Second Intervention||24
8731144|NCT01063595|9778604|FG000|COMPLETED|Second Intervention||29
8731145|NCT01063595|9778605|FG001|COMPLETED|Second Intervention||24
8731146|NCT01063595|9778604|FG000|NOT COMPLETED|Second Intervention||0
8731147|NCT01063595|9778605|FG001|NOT COMPLETED|Second Intervention||0
8731148|NCT01063712|9778611|FG000|STARTED|Overall Study||29
8731149|NCT01063712|9778611|FG000|COMPLETED|Overall Study||29
8731150|NCT01063712|9778611|FG000|NOT COMPLETED|Overall Study||0
8731151|NCT01063764|9778616|FG000|STARTED|1st Period (From Week 8 to Week 22)||73
8731152|NCT01063764|9778616|FG000|COMPLETED|1st Period (From Week 8 to Week 22)|62 subjects completed the First Period, but 7 of these subjects did not enter the Second Period.|62
8731153|NCT01063764|9778616|FG000|NOT COMPLETED|1st Period (From Week 8 to Week 22)||11
8731154|NCT01063764|9778616|FG000|STARTED|2nd Period (Week 22 to the End of Study)|7 subjects who completed Period 1 did not enter the Second Period.|55
8731155|NCT01063764|9778616|FG000|COMPLETED|2nd Period (Week 22 to the End of Study)||35
8731156|NCT01063764|9778616|FG000|NOT COMPLETED|2nd Period (Week 22 to the End of Study)||20
8731157|NCT01063829|9778624|FG000|STARTED|Overall Study||33
8731158|NCT01063829|9778625|FG001|STARTED|Overall Study||31
8731159|NCT01063829|9778626|FG002|STARTED|Overall Study||34
8731160|NCT01063829|9778627|FG003|STARTED|Overall Study||33
8731161|NCT01063829|9778624|FG000|COMPLETED|Overall Study|Non-completers considered as failure; FAS|17
8731162|NCT01063829|9778625|FG001|COMPLETED|Overall Study|Non-completers considered as failure; FAS|21
8731163|NCT01063829|9778626|FG002|COMPLETED|Overall Study|Non-completers considered as failure; FAS|24
8731164|NCT01063829|9778627|FG003|COMPLETED|Overall Study|Non-completers considered as failure; FAS|12
8731165|NCT01063829|9778624|FG000|NOT COMPLETED|Overall Study||16
8731166|NCT01063829|9778625|FG001|NOT COMPLETED|Overall Study||10
8731167|NCT01063829|9778626|FG002|NOT COMPLETED|Overall Study||10
8731168|NCT01063829|9778627|FG003|NOT COMPLETED|Overall Study||21
8731169|NCT01063855|9778639|FG000|STARTED|Overall Study||245
8731170|NCT01063855|9778640|FG001|STARTED|Overall Study||250
8731171|NCT01063855|9778639|FG000|COMPLETED|Overall Study||208
8731172|NCT01063855|9778640|FG001|COMPLETED|Overall Study||221
8731173|NCT01063855|9778639|FG000|NOT COMPLETED|Overall Study||37
8731174|NCT01063855|9778640|FG001|NOT COMPLETED|Overall Study||29
8731175|NCT01063868|9778652|FG000|STARTED|Overall Study||35
8731176|NCT01063868|9778653|FG001|STARTED|Overall Study||12
8731177|NCT01063868|9778652|FG000|COMPLETED|Overall Study||0
8731178|NCT01063868|9778653|FG001|COMPLETED|Overall Study||0
8731179|NCT01063868|9778652|FG000|NOT COMPLETED|Overall Study||35
8731180|NCT01063868|9778653|FG001|NOT COMPLETED|Overall Study||12
8806677|NCT01479465|9858991|FG001|COMPLETED|Overall Study||0
8806678|NCT01479465|9858992|FG002|COMPLETED|Overall Study||0
8806679|NCT01479465|9858993|FG003|COMPLETED|Overall Study||0
8806680|NCT01479465|9858990|FG000|NOT COMPLETED|Overall Study||11
8806681|NCT01479465|9858991|FG001|NOT COMPLETED|Overall Study||84
8806682|NCT01479465|9858992|FG002|NOT COMPLETED|Overall Study||86
8806683|NCT01479465|9858993|FG003|NOT COMPLETED|Overall Study||85
8806684|NCT01479478|9859005|FG000|STARTED|Overall Study||125
8806685|NCT01479478|9859006|FG001|STARTED|Overall Study||126
8806686|NCT01479478|9859005|FG000|COMPLETED|Overall Study||125
8806687|NCT01479478|9859006|FG001|COMPLETED|Overall Study||126
8806688|NCT01479478|9859005|FG000|NOT COMPLETED|Overall Study||0
8806689|NCT01479478|9859006|FG001|NOT COMPLETED|Overall Study||0
8806690|NCT01479517|9859015|FG000|STARTED|Overall Study||10
8806691|NCT01479517|9859016|FG001|STARTED|Overall Study||10
8806692|NCT01479517|9859017|FG002|STARTED|Overall Study||10
8806693|NCT01479517|9859015|FG000|COMPLETED|Overall Study||10
8806694|NCT01479517|9859016|FG001|COMPLETED|Overall Study||10
8806695|NCT01479517|9859017|FG002|COMPLETED|Overall Study||10
8666220|NCT00725530|9709887|FG001|NOT COMPLETED|First Intervention, 7 Days (+0/-1)||0
8666221|NCT00725530|9709886|FG000|STARTED|Second Intervention, 7 Days (+0/-1)||27
8666222|NCT00725530|9709887|FG001|STARTED|Second Intervention, 7 Days (+0/-1)||27
8666223|NCT00725530|9709886|FG000|COMPLETED|Second Intervention, 7 Days (+0/-1)||27
8666224|NCT00725530|9709887|FG001|COMPLETED|Second Intervention, 7 Days (+0/-1)||27
8666225|NCT00725530|9709886|FG000|NOT COMPLETED|Second Intervention, 7 Days (+0/-1)||0
8666226|NCT00725530|9709887|FG001|NOT COMPLETED|Second Intervention, 7 Days (+0/-1)||0
8666227|NCT00725543|9709893|FG000|STARTED|Overall Study||358
8666228|NCT00725543|9709893|FG000|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive Remicade infusions.|205
8666229|NCT00725543|9709893|FG000|NOT COMPLETED|Overall Study||153
8666230|NCT00725608|9709897|FG000|STARTED|Overall Study|339 patients enrolled, 32 non-eligible datasets excluded from final general and safety analysis|307
8666231|NCT00725608|9709897|FG000|COMPLETED|Overall Study|1 patient terminated treatment at day 368 and was counted as dropout|140
8666232|NCT00725608|9709897|FG000|NOT COMPLETED|Overall Study||167
8692438|NCT00860470|9737893|FG001|STARTED|Overall Study||22405
8692439|NCT00860470|9737892|FG000|COMPLETED|Overall Study||22114
8692440|NCT00860470|9737893|FG001|COMPLETED|Overall Study||22346
8692441|NCT00860470|9737892|FG000|NOT COMPLETED|Overall Study||48
8692442|NCT00860470|9737893|FG001|NOT COMPLETED|Overall Study||59
8692443|NCT00860535|9737899|FG000|STARTED|Overall Study||9
8692444|NCT00860535|9737899|FG000|DISCONTINUED|Overall Study|Participant did not meet inclusion criteria and did not complete the study.|1
8692445|NCT00860535|9737899|FG000|COMPLETED|Overall Study||8
8692446|NCT00860535|9737899|FG000|NOT COMPLETED|Overall Study||1
8692447|NCT00860574|9737903|FG000|STARTED|Overall Study||96
8692448|NCT00860574|9737903|FG000|COMPLETED|Overall Study||93
8692449|NCT00860574|9737903|FG000|NOT COMPLETED|Overall Study||3
8692450|NCT00860743|9737913|FG000|STARTED|Overall Study||40
8692451|NCT00860743|9737914|FG001|STARTED|Overall Study||23
8692452|NCT00860743|9737913|FG000|COMPLETED|Overall Study||37
8692453|NCT00860743|9737914|FG001|COMPLETED|Overall Study||23
8692454|NCT00860743|9737913|FG000|NOT COMPLETED|Overall Study||3
8692455|NCT00860743|9737914|FG001|NOT COMPLETED|Overall Study||0
8692456|NCT00860795|9737922|FG000|STARTED|Overall Study||10
8692457|NCT00860795|9737923|FG001|STARTED|Overall Study||10
8692458|NCT00860795|9737922|FG000|Number to Complete Study Medication|Overall Study||9
8692459|NCT00860795|9737923|FG001|Number to Complete Study Medication|Overall Study||10
8692460|NCT00860795|9737922|FG000|COMPLETED|Overall Study|One participant discontinued study medication on day 5, but completed safety evaluations|10
8692461|NCT00860795|9737923|FG001|COMPLETED|Overall Study||10
8692462|NCT00860795|9737922|FG000|NOT COMPLETED|Overall Study||0
8692463|NCT00860795|9737923|FG001|NOT COMPLETED|Overall Study||0
8692464|NCT00860847|9737931|FG000|STARTED|Overall Study||32
8692465|NCT00860847|9737932|FG001|STARTED|Overall Study||33
8692466|NCT00860847|9737931|FG000|COMPLETED|Overall Study||28
8692467|NCT00860847|9737932|FG001|COMPLETED|Overall Study||28
8692468|NCT00860847|9737931|FG000|NOT COMPLETED|Overall Study||4
8692469|NCT00860847|9737932|FG001|NOT COMPLETED|Overall Study||5
8692470|NCT00860938|9737940|FG000|STARTED|Overall Study||45
8692471|NCT00860938|9737941|FG001|STARTED|Overall Study||45
8692472|NCT00860938|9737940|FG000|COMPLETED|Overall Study||31
8692473|NCT00860938|9737941|FG001|COMPLETED|Overall Study||37
8692474|NCT00860938|9737940|FG000|NOT COMPLETED|Overall Study||14
8692475|NCT00860938|9737941|FG001|NOT COMPLETED|Overall Study||8
8692476|NCT00860951|9737947|FG000|STARTED|Overall Study||29
8692477|NCT00860951|9737947|FG000|COMPLETED|Overall Study||22
8692478|NCT00860951|9737947|FG000|NOT COMPLETED|Overall Study||7
8692479|NCT00861146|9737955|FG000|STARTED|Overall Study||105
8692480|NCT00861146|9737956|FG001|STARTED|Overall Study||46
8692481|NCT00861146|9737955|FG000|Week 2 Assessment|Overall Study||97
8692482|NCT00861146|9737956|FG001|Week 2 Assessment|Overall Study||45
8692483|NCT00861146|9737955|FG000|Week 13 Assessment|Overall Study||85
8692484|NCT00861146|9737956|FG001|Week 13 Assessment|Overall Study||38
8692485|NCT00861146|9737955|FG000|COMPLETED|Overall Study||85
8692486|NCT00861146|9737956|FG001|COMPLETED|Overall Study||38
8692487|NCT00861146|9737955|FG000|NOT COMPLETED|Overall Study||20
8692488|NCT00861146|9737956|FG001|NOT COMPLETED|Overall Study||8
8692489|NCT00861198|9737962|FG000|STARTED|Overall Study||75
8692490|NCT00861198|9737962|FG000|COMPLETED|Overall Study||70
8692491|NCT00861198|9737962|FG000|NOT COMPLETED|Overall Study||5
8731181|NCT01063881|9778662|FG000|STARTED|Overall Study||147
8731182|NCT01063881|9778663|FG001|STARTED|Overall Study||125
8731183|NCT01063881|9778664|FG002|STARTED|Overall Study||13
8731184|NCT01063881|9778662|FG000|COMPLETED|Overall Study||92
8731185|NCT01063881|9778663|FG001|COMPLETED|Overall Study||114
8731186|NCT01063881|9778664|FG002|COMPLETED|Overall Study||12
8731187|NCT01063881|9778662|FG000|NOT COMPLETED|Overall Study||55
8731188|NCT01063881|9778663|FG001|NOT COMPLETED|Overall Study||11
8692492|NCT00861263|9737966|FG000|STARTED|Overall Study||193
8692493|NCT00861263|9737966|FG000|COMPLETED|Overall Study||193
8731189|NCT01063881|9778664|FG002|NOT COMPLETED|Overall Study||1
8731190|NCT01063907|9778679|FG000|STARTED|Overall Study||15
8731191|NCT01063907|9778680|FG001|STARTED|Overall Study||80
8692494|NCT00861263|9737966|FG000|NOT COMPLETED|Overall Study||0
8692495|NCT00861341|9737970|FG000|STARTED|Overall Study||40
8692496|NCT00861341|9737970|FG000|COMPLETED|Overall Study||38
8692497|NCT00861341|9737970|FG000|NOT COMPLETED|Overall Study||2
8692498|NCT00861380|9737981|FG000|STARTED|Overall Study||8427
8692499|NCT00861380|9737982|FG001|STARTED|Overall Study||9112
8666233|NCT00725621|9709901|FG000|STARTED|Overall Study|Started was defined as the number of participants who received at least one infusion of Remicade.|516
8666234|NCT00725621|9709901|FG000|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive Remicade infusions.|245
8666235|NCT00725621|9709901|FG000|NOT COMPLETED|Overall Study||271
8666236|NCT00725712|9709911|FG000|STARTED|Overall Study||48
8666237|NCT00725712|9709912|FG001|STARTED|Overall Study||26
8666238|NCT00725712|9709911|FG000|COMPLETED|Overall Study||0
8666239|NCT00725712|9709912|FG001|COMPLETED|Overall Study||0
8666240|NCT00725712|9709911|FG000|NOT COMPLETED|Overall Study||48
8666241|NCT00725712|9709912|FG001|NOT COMPLETED|Overall Study||26
8666242|NCT00725725|9709925|FG000|STARTED|Overall Study||14
8666243|NCT00725725|9709926|FG001|STARTED|Overall Study||15
8666244|NCT00725725|9709927|FG002|STARTED|Overall Study||17
8666245|NCT00725725|9709925|FG000|Treated|Overall Study||11
8666246|NCT00725725|9709926|FG001|Treated|Overall Study||15
8666247|NCT00725725|9709927|FG002|Treated|Overall Study||14
8666248|NCT00725725|9709925|FG000|COMPLETED|Overall Study||10
8666249|NCT00725725|9709926|FG001|COMPLETED|Overall Study||11
8666250|NCT00725725|9709927|FG002|COMPLETED|Overall Study||12
8666251|NCT00725725|9709925|FG000|NOT COMPLETED|Overall Study||4
8666252|NCT00725725|9709926|FG001|NOT COMPLETED|Overall Study||4
8666253|NCT00725725|9709927|FG002|NOT COMPLETED|Overall Study||5
8666254|NCT00725751|9709937|FG000|STARTED|Overall Study||90
8666255|NCT00725751|9709938|FG001|STARTED|Overall Study||258
8666256|NCT00725751|9709937|FG000|COMPLETED|Overall Study||56
8666257|NCT00725751|9709938|FG001|COMPLETED|Overall Study||150
8666258|NCT00725751|9709937|FG000|NOT COMPLETED|Overall Study||34
8666259|NCT00725751|9709938|FG001|NOT COMPLETED|Overall Study||108
8666260|NCT00725764|9709945|FG000|STARTED|Overall Study||14
8666261|NCT00725764|9709945|FG000|COMPLETED|Overall Study||0
8666262|NCT00725764|9709945|FG000|NOT COMPLETED|Overall Study||14
8666263|NCT00725842|9709950|FG000|STARTED|Overall Study||97
8666264|NCT00725842|9709950|FG000|Participants Eligible for Analysis|Overall Study||90
8666265|NCT00725842|9709950|FG000|COMPLETED|Overall Study||57
8666266|NCT00725842|9709950|FG000|NOT COMPLETED|Overall Study||40
8666267|NCT00725920|9709956|FG000|STARTED|Overall Study||17
8666268|NCT00725920|9709957|FG001|STARTED|Overall Study||18
8666269|NCT00725920|9709956|FG000|COMPLETED|Overall Study||14
8666270|NCT00725920|9709957|FG001|COMPLETED|Overall Study||12
8666271|NCT00725920|9709956|FG000|NOT COMPLETED|Overall Study||3
8666272|NCT00725920|9709957|FG001|NOT COMPLETED|Overall Study||6
8731192|NCT01063907|9778679|FG000|COMPLETED|Overall Study||15
8731193|NCT01063907|9778680|FG001|COMPLETED|Overall Study||80
8731194|NCT01063907|9778679|FG000|NOT COMPLETED|Overall Study||0
8731195|NCT01063907|9778680|FG001|NOT COMPLETED|Overall Study||0
8731196|NCT01063972|9778704|FG000|STARTED|Overall Study||310
8731197|NCT01063972|9778705|FG001|STARTED|Overall Study||296
8731198|NCT01063972|9778704|FG000|COMPLETED|Overall Study|Participants who were deceased or incarcerated were excluded.|296
8731199|NCT01063972|9778705|FG001|COMPLETED|Overall Study|Participants who were deceased or incarcerated were excluded.|284
8731200|NCT01063972|9778704|FG000|NOT COMPLETED|Overall Study||14
8731201|NCT01063972|9778705|FG001|NOT COMPLETED|Overall Study||12
8731202|NCT01064076|9778711|FG000|STARTED|Overall Study|321 subjects underwent an implant procedure for the S-ICD System|321
8731203|NCT01064076|9778711|FG000|COMPLETED|Overall Study|303 subjects completed a minimum of 180 days of follow up|303
8731204|NCT01064076|9778711|FG000|NOT COMPLETED|Overall Study||18
8731205|NCT01064167|9778718|FG000|STARTED|Overall Study||130
8731206|NCT01064167|9778719|FG001|STARTED|Overall Study||130
8731207|NCT01064167|9778718|FG000|COMPLETED|Overall Study||116
8731208|NCT01064167|9778719|FG001|COMPLETED|Overall Study||115
8731209|NCT01064167|9778718|FG000|NOT COMPLETED|Overall Study||14
8731210|NCT01064167|9778719|FG001|NOT COMPLETED|Overall Study||15
8731211|NCT01064284|9778727|FG000|STARTED|Overall Study|Taking into account the analyzed patients only|125
8731212|NCT01064284|9778728|FG001|STARTED|Overall Study|Taking into account the analyzed patients only|126
8731213|NCT01064284|9778727|FG000|COMPLETED|Overall Study||107
8731214|NCT01064284|9778728|FG001|COMPLETED|Overall Study||109
8731215|NCT01064284|9778727|FG000|NOT COMPLETED|Overall Study||18
8731216|NCT01064284|9778728|FG001|NOT COMPLETED|Overall Study||17
8731217|NCT01064297|9778738|FG000|STARTED|Overall Study||2567
8731218|NCT01064297|9778739|FG001|STARTED|Overall Study||219
8731219|NCT01064297|9778740|FG002|STARTED|Overall Study||630
8731220|NCT01064297|9778738|FG000|COMPLETED|Overall Study||1776
8731221|NCT01064297|9778739|FG001|COMPLETED|Overall Study||171
8731222|NCT01064297|9778740|FG002|COMPLETED|Overall Study||497
8731223|NCT01064297|9778738|FG000|NOT COMPLETED|Overall Study||791
8911491|NCT02147093|9970606|FG001|STARTED|Period 1||20
8666273|NCT00725959|9709965|FG000|STARTED|Overall Study||942
8666274|NCT00725959|9709966|FG001|STARTED|Overall Study||636
8666275|NCT00725959|9709965|FG000|COMPLETED|Overall Study||653
8731224|NCT01064297|9778739|FG001|NOT COMPLETED|Overall Study||48
8666276|NCT00725959|9709966|FG001|COMPLETED|Overall Study||439
8666277|NCT00725959|9709965|FG000|NOT COMPLETED|Overall Study||289
8666278|NCT00725959|9709966|FG001|NOT COMPLETED|Overall Study||197
8731225|NCT01064297|9778740|FG002|NOT COMPLETED|Overall Study||133
8731226|NCT01064310|9778757|FG000|STARTED|Period 1||82
8731227|NCT01064310|9778758|FG001|STARTED|Period 1||86
8731228|NCT01064310|9778759|FG002|STARTED|Period 1||0
8731229|NCT01064310|9778757|FG000|COMPLETED|Period 1||68
8731230|NCT01064310|9778758|FG001|COMPLETED|Period 1||68
8731231|NCT01064310|9778759|FG002|COMPLETED|Period 1||0
8911492|NCT02147093|9970605|FG000|COMPLETED|Period 1||20
8666279|NCT00726232|9709978|FG000|STARTED|Initial Phase (Dose-finding)|The starting dose selected for the PV expansion cohort was 10 mg bid hence the sample size is larger|19
8666280|NCT00726232|9709979|FG001|STARTED|Initial Phase (Dose-finding)||8
8666281|NCT00726232|9709980|FG002|STARTED|Initial Phase (Dose-finding)||7
8666282|NCT00726232|9709981|FG003|STARTED|Initial Phase (Dose-finding)||8
8666283|NCT00726232|9709982|FG004|STARTED|Initial Phase (Dose-finding)|The starting dose selected for the ET expansion cohort was 25 mg bid hence the sample size is larger|22
8911493|NCT02147093|9970606|FG001|COMPLETED|Period 1||19
8911494|NCT02147093|9970605|FG000|NOT COMPLETED|Period 1||0
8911495|NCT02147093|9970606|FG001|NOT COMPLETED|Period 1||1
8911496|NCT02147093|9970605|FG000|STARTED|Period 2||20
8911497|NCT02147093|9970606|FG001|STARTED|Period 2||19
8911498|NCT02147093|9970605|FG000|COMPLETED|Period 2||18
8911499|NCT02147093|9970606|FG001|COMPLETED|Period 2||19
8911500|NCT02147093|9970605|FG000|NOT COMPLETED|Period 2||2
8911501|NCT02147093|9970606|FG001|NOT COMPLETED|Period 2||0
8911502|NCT02147132|9970612|FG000|STARTED|Overall Study||2
8911503|NCT02147132|9970613|FG001|STARTED|Overall Study||2
8911504|NCT02147132|9970614|FG002|STARTED|Overall Study||1
8911505|NCT02147132|9970615|FG003|STARTED|Overall Study||2
8911506|NCT02147132|9970612|FG000|COMPLETED|Overall Study||1
8911507|NCT02147132|9970613|FG001|COMPLETED|Overall Study||2
8911508|NCT02147132|9970614|FG002|COMPLETED|Overall Study||1
8911509|NCT02147132|9970615|FG003|COMPLETED|Overall Study||2
8911510|NCT02147132|9970612|FG000|NOT COMPLETED|Overall Study||1
8911511|NCT02147132|9970613|FG001|NOT COMPLETED|Overall Study||0
8911512|NCT02147132|9970614|FG002|NOT COMPLETED|Overall Study||0
8911513|NCT02147132|9970615|FG003|NOT COMPLETED|Overall Study||0
8911514|NCT02147158|9970631|FG000|STARTED|Treatment Course 1||55
8911515|NCT02147158|9970632|FG001|STARTED|Treatment Course 1||47
8911516|NCT02147158|9970633|FG002|STARTED|Treatment Course 1||107
8911517|NCT02147158|9970634|FG003|STARTED|Treatment Course 1||110
8911518|NCT02147158|9970635|FG004|STARTED|Treatment Course 1||55
8911519|NCT02147158|9970636|FG005|STARTED|Treatment Course 1||58
8911520|NCT02147158|9970631|FG000|COMPLETED|Treatment Course 1||51
8911521|NCT02147158|9970632|FG001|COMPLETED|Treatment Course 1||38
8911522|NCT02147158|9970633|FG002|COMPLETED|Treatment Course 1||99
8911523|NCT02147158|9970634|FG003|COMPLETED|Treatment Course 1||97
8911524|NCT02147158|9970635|FG004|COMPLETED|Treatment Course 1||49
8666284|NCT00726232|9709983|FG005|STARTED|Initial Phase (Dose-finding)||9
8666285|NCT00726232|9709984|FG006|STARTED|Initial Phase (Dose-finding)||0
8666286|NCT00726232|9709985|FG007|STARTED|Initial Phase (Dose-finding)||0
8666287|NCT00726232|9709978|FG000|Safety Evaluable Participants|Initial Phase (Dose-finding)||19
8666288|NCT00726232|9709979|FG001|Safety Evaluable Participants|Initial Phase (Dose-finding)||8
8666289|NCT00726232|9709980|FG002|Safety Evaluable Participants|Initial Phase (Dose-finding)||7
8666290|NCT00726232|9709981|FG003|Safety Evaluable Participants|Initial Phase (Dose-finding)||8
8666291|NCT00726232|9709982|FG004|Safety Evaluable Participants|Initial Phase (Dose-finding)||22
8666292|NCT00726232|9709983|FG005|Safety Evaluable Participants|Initial Phase (Dose-finding)||9
8666293|NCT00726232|9709984|FG006|Safety Evaluable Participants|Initial Phase (Dose-finding)||0
8666294|NCT00726232|9709985|FG007|Safety Evaluable Participants|Initial Phase (Dose-finding)||0
8666295|NCT00726232|9709978|FG000|ITT Participants|Initial Phase (Dose-finding)||19
8666296|NCT00726232|9709979|FG001|ITT Participants|Initial Phase (Dose-finding)||8
8666297|NCT00726232|9709980|FG002|ITT Participants|Initial Phase (Dose-finding)||7
8666298|NCT00726232|9709981|FG003|ITT Participants|Initial Phase (Dose-finding)||8
8666299|NCT00726232|9709982|FG004|ITT Participants|Initial Phase (Dose-finding)||22
8666300|NCT00726232|9709983|FG005|ITT Participants|Initial Phase (Dose-finding)||9
8666301|NCT00726232|9709984|FG006|ITT Participants|Initial Phase (Dose-finding)||0
8666302|NCT00726232|9709985|FG007|ITT Participants|Initial Phase (Dose-finding)||0
8666303|NCT00726232|9709978|FG000|COMPLETED|Initial Phase (Dose-finding)||6
8666304|NCT00726232|9709979|FG001|COMPLETED|Initial Phase (Dose-finding)||2
8666305|NCT00726232|9709980|FG002|COMPLETED|Initial Phase (Dose-finding)||2
8666306|NCT00726232|9709981|FG003|COMPLETED|Initial Phase (Dose-finding)||0
8666307|NCT00726232|9709982|FG004|COMPLETED|Initial Phase (Dose-finding)||1
8666308|NCT00726232|9709983|FG005|COMPLETED|Initial Phase (Dose-finding)||0
8666309|NCT00726232|9709984|FG006|COMPLETED|Initial Phase (Dose-finding)||0
8666310|NCT00726232|9709985|FG007|COMPLETED|Initial Phase (Dose-finding)||0
8666311|NCT00726232|9709978|FG000|NOT COMPLETED|Initial Phase (Dose-finding)||13
8666312|NCT00726232|9709979|FG001|NOT COMPLETED|Initial Phase (Dose-finding)||6
8666313|NCT00726232|9709980|FG002|NOT COMPLETED|Initial Phase (Dose-finding)||5
8666314|NCT00726232|9709981|FG003|NOT COMPLETED|Initial Phase (Dose-finding)||8
8666315|NCT00726232|9709982|FG004|NOT COMPLETED|Initial Phase (Dose-finding)||21
8666316|NCT00726232|9709983|FG005|NOT COMPLETED|Initial Phase (Dose-finding)||9
8666317|NCT00726232|9709984|FG006|NOT COMPLETED|Initial Phase (Dose-finding)||0
8666318|NCT00726232|9709985|FG007|NOT COMPLETED|Initial Phase (Dose-finding)||0
8666319|NCT00726232|9709978|FG000|STARTED|Expansion Phase||0
8666320|NCT00726232|9709979|FG001|STARTED|Expansion Phase||0
8911525|NCT02147158|9970636|FG005|COMPLETED|Treatment Course 1||50
8911526|NCT02147158|9970631|FG000|NOT COMPLETED|Treatment Course 1||4
8911527|NCT02147158|9970632|FG001|NOT COMPLETED|Treatment Course 1||9
8911528|NCT02147158|9970633|FG002|NOT COMPLETED|Treatment Course 1||8
8911529|NCT02147158|9970634|FG003|NOT COMPLETED|Treatment Course 1||13
8666321|NCT00726232|9709980|FG002|STARTED|Expansion Phase||0
8666322|NCT00726232|9709981|FG003|STARTED|Expansion Phase||0
8666323|NCT00726232|9709982|FG004|STARTED|Expansion Phase||0
8666324|NCT00726232|9709983|FG005|STARTED|Expansion Phase||0
8666325|NCT00726232|9709984|FG006|STARTED|Expansion Phase||34
8666326|NCT00726232|9709985|FG007|STARTED|Expansion Phase||39
8666327|NCT00726232|9709978|FG000|Safety Evaluable Participants|Expansion Phase||0
8666328|NCT00726232|9709979|FG001|Safety Evaluable Participants|Expansion Phase||0
8666329|NCT00726232|9709980|FG002|Safety Evaluable Participants|Expansion Phase||0
8666330|NCT00726232|9709981|FG003|Safety Evaluable Participants|Expansion Phase||0
8666331|NCT00726232|9709982|FG004|Safety Evaluable Participants|Expansion Phase||0
8666332|NCT00726232|9709983|FG005|Safety Evaluable Participants|Expansion Phase||0
8666333|NCT00726232|9709984|FG006|Safety Evaluable Participants|Expansion Phase||34
8666334|NCT00726232|9709985|FG007|Safety Evaluable Participants|Expansion Phase||39
8666335|NCT00726232|9709978|FG000|ITT Participants|Expansion Phase||0
8666336|NCT00726232|9709979|FG001|ITT Participants|Expansion Phase||0
8666337|NCT00726232|9709980|FG002|ITT Participants|Expansion Phase||0
8666338|NCT00726232|9709981|FG003|ITT Participants|Expansion Phase||0
8666339|NCT00726232|9709982|FG004|ITT Participants|Expansion Phase||0
8666340|NCT00726232|9709983|FG005|ITT Participants|Expansion Phase||0
8666341|NCT00726232|9709984|FG006|ITT Participants|Expansion Phase||34
8666342|NCT00726232|9709985|FG007|ITT Participants|Expansion Phase||39
8666343|NCT00726232|9709978|FG000|COMPLETED|Expansion Phase||0
8666344|NCT00726232|9709979|FG001|COMPLETED|Expansion Phase||0
8666345|NCT00726232|9709980|FG002|COMPLETED|Expansion Phase||0
8666346|NCT00726232|9709981|FG003|COMPLETED|Expansion Phase||0
8666347|NCT00726232|9709982|FG004|COMPLETED|Expansion Phase||0
8666348|NCT00726232|9709983|FG005|COMPLETED|Expansion Phase||0
8666349|NCT00726232|9709984|FG006|COMPLETED|Expansion Phase||10
8666350|NCT00726232|9709985|FG007|COMPLETED|Expansion Phase||1
8666351|NCT00726232|9709978|FG000|NOT COMPLETED|Expansion Phase||0
8666352|NCT00726232|9709979|FG001|NOT COMPLETED|Expansion Phase||0
8666353|NCT00726232|9709980|FG002|NOT COMPLETED|Expansion Phase||0
8666354|NCT00726232|9709981|FG003|NOT COMPLETED|Expansion Phase||0
8666355|NCT00726232|9709982|FG004|NOT COMPLETED|Expansion Phase||0
8666356|NCT00726232|9709983|FG005|NOT COMPLETED|Expansion Phase||0
8666357|NCT00726232|9709984|FG006|NOT COMPLETED|Expansion Phase||24
8666358|NCT00726232|9709985|FG007|NOT COMPLETED|Expansion Phase||38
8666359|NCT00726323|9710006|FG000|STARTED|Overall Study||37
8666360|NCT00726323|9710007|FG001|STARTED|Overall Study||37
8666361|NCT00726323|9710006|FG000|COMPLETED|Overall Study||0
8666362|NCT00726323|9710007|FG001|COMPLETED|Overall Study||6
8666363|NCT00726323|9710006|FG000|NOT COMPLETED|Overall Study||37
8666364|NCT00726323|9710007|FG001|NOT COMPLETED|Overall Study||31
8666365|NCT00726375|9710013|FG000|STARTED|Overall Study||34
8666366|NCT00726375|9710013|FG000|COMPLETED|Overall Study||34
8666367|NCT00726375|9710013|FG000|NOT COMPLETED|Overall Study||0
8666368|NCT00726388|9710017|FG000|STARTED|Overall Study||1050
8666369|NCT00726388|9710017|FG000|Treated|Overall Study||971
8666370|NCT00726388|9710017|FG000|COMPLETED|Overall Study||943
8666371|NCT00726388|9710017|FG000|NOT COMPLETED|Overall Study||107
8666372|NCT00726414|9710021|FG000|STARTED|First Intervention||11
8666373|NCT00726414|9710022|FG001|STARTED|First Intervention||11
8666374|NCT00726414|9710021|FG000|COMPLETED|First Intervention||11
8666375|NCT00726414|9710022|FG001|COMPLETED|First Intervention||11
8666376|NCT00726414|9710021|FG000|NOT COMPLETED|First Intervention||0
8666377|NCT00726414|9710022|FG001|NOT COMPLETED|First Intervention||0
8666378|NCT00726414|9710021|FG000|STARTED|Washout Period of 7 Days||11
8666379|NCT00726414|9710022|FG001|STARTED|Washout Period of 7 Days||11
8666380|NCT00726414|9710021|FG000|COMPLETED|Washout Period of 7 Days||11
8666381|NCT00726414|9710022|FG001|COMPLETED|Washout Period of 7 Days||11
8666382|NCT00726414|9710021|FG000|NOT COMPLETED|Washout Period of 7 Days||0
8666383|NCT00726414|9710022|FG001|NOT COMPLETED|Washout Period of 7 Days||0
8666384|NCT00726414|9710021|FG000|STARTED|Second Intervention||11
8666385|NCT00726414|9710022|FG001|STARTED|Second Intervention||11
8666386|NCT00726414|9710021|FG000|COMPLETED|Second Intervention||11
8666387|NCT00726414|9710022|FG001|COMPLETED|Second Intervention||11
8666388|NCT00726414|9710021|FG000|NOT COMPLETED|Second Intervention||0
8666389|NCT00726414|9710022|FG001|NOT COMPLETED|Second Intervention||0
8666390|NCT00726453|9710030|FG000|STARTED|Primary Enrollment Group||1402
8666391|NCT00726453|9710031|FG001|STARTED|Primary Enrollment Group||0
8666392|NCT00726453|9710030|FG000|COMPLETED|Primary Enrollment Group||1371
8666393|NCT00726453|9710031|FG001|COMPLETED|Primary Enrollment Group||0
8666394|NCT00726453|9710030|FG000|NOT COMPLETED|Primary Enrollment Group||31
8666395|NCT00726453|9710031|FG001|NOT COMPLETED|Primary Enrollment Group||0
8666396|NCT00726453|9710030|FG000|STARTED|38 mm Length Group||0
8666397|NCT00726453|9710031|FG001|STARTED|38 mm Length Group||114
8666398|NCT00726453|9710030|FG000|COMPLETED|38 mm Length Group||0
8666399|NCT00726453|9710031|FG001|COMPLETED|38 mm Length Group|This sub-study completed the primary endpoint in March 2012 results not yet available.|111
8666400|NCT00726453|9710030|FG000|NOT COMPLETED|38 mm Length Group||0
8666401|NCT00726453|9710031|FG001|NOT COMPLETED|38 mm Length Group||3
8666402|NCT00726557|9710036|FG000|STARTED|Overall Study||246
8666403|NCT00726557|9710036|FG000|COMPLETED|Overall Study|Completed is defined as those who finished the follow-up period.|118
8666404|NCT00726557|9710036|FG000|NOT COMPLETED|Overall Study||128
8666405|NCT00726609|9710041|FG000|STARTED|Overall Study||214
8692500|NCT00861380|9737983|FG002|STARTED|Overall Study||8872
8692501|NCT00861380|9737984|FG003|STARTED|Overall Study||3689
8666406|NCT00726609|9710041|FG000|COMPLETED|Overall Study|For 26 participants in the Missing category, it is unknown if they completed the study.|116
8666407|NCT00726609|9710041|FG000|NOT COMPLETED|Overall Study||98
8666408|NCT00726622|9710047|FG000|STARTED|Overall Study||243
8666409|NCT00726622|9710048|FG001|STARTED|Overall Study||243
8666410|NCT00726622|9710047|FG000|COMPLETED|Overall Study||225
8666411|NCT00726622|9710048|FG001|COMPLETED|Overall Study||240
8666412|NCT00726622|9710047|FG000|NOT COMPLETED|Overall Study||18
8666413|NCT00726622|9710048|FG001|NOT COMPLETED|Overall Study||3
8666414|NCT00726661|9710056|FG000|STARTED|Overall Study||832
8666415|NCT00726661|9710057|FG001|STARTED|Overall Study||435
8666416|NCT00726661|9710056|FG000|COMPLETED|Overall Study||18
8666417|NCT00726661|9710057|FG001|COMPLETED|Overall Study||17
8666418|NCT00726661|9710056|FG000|NOT COMPLETED|Overall Study||814
8666419|NCT00726661|9710057|FG001|NOT COMPLETED|Overall Study||418
8666420|NCT00726713|9710066|FG000|STARTED|Overall Study||106
8666421|NCT00726713|9710067|FG001|STARTED|Overall Study||108
8666422|NCT00726713|9710066|FG000|COMPLETED|Overall Study||99
8666423|NCT00726713|9710067|FG001|COMPLETED|Overall Study||101
8666424|NCT00726713|9710066|FG000|NOT COMPLETED|Overall Study||7
8666425|NCT00726713|9710067|FG001|NOT COMPLETED|Overall Study||7
8666426|NCT00726739|9710076|FG000|STARTED|Overall Study||11
8911530|NCT02147158|9970635|FG004|NOT COMPLETED|Treatment Course 1||6
8911531|NCT02147158|9970636|FG005|NOT COMPLETED|Treatment Course 1||8
8911532|NCT02147158|9970631|FG000|STARTED|Off-Treatment Interval 1||51
8911533|NCT02147158|9970632|FG001|STARTED|Off-Treatment Interval 1||38
8911534|NCT02147158|9970633|FG002|STARTED|Off-Treatment Interval 1||99
8911535|NCT02147158|9970634|FG003|STARTED|Off-Treatment Interval 1||97
8911536|NCT02147158|9970635|FG004|STARTED|Off-Treatment Interval 1||49
8911537|NCT02147158|9970636|FG005|STARTED|Off-Treatment Interval 1||50
8911538|NCT02147158|9970631|FG000|COMPLETED|Off-Treatment Interval 1||41
8911539|NCT02147158|9970632|FG001|COMPLETED|Off-Treatment Interval 1||34
8911540|NCT02147158|9970633|FG002|COMPLETED|Off-Treatment Interval 1||84
8911541|NCT02147158|9970634|FG003|COMPLETED|Off-Treatment Interval 1||82
8911542|NCT02147158|9970635|FG004|COMPLETED|Off-Treatment Interval 1||41
8911543|NCT02147158|9970636|FG005|COMPLETED|Off-Treatment Interval 1||45
8911544|NCT02147158|9970631|FG000|NOT COMPLETED|Off-Treatment Interval 1||10
8911545|NCT02147158|9970632|FG001|NOT COMPLETED|Off-Treatment Interval 1||4
8911546|NCT02147158|9970633|FG002|NOT COMPLETED|Off-Treatment Interval 1||15
8911547|NCT02147158|9970634|FG003|NOT COMPLETED|Off-Treatment Interval 1||15
8911548|NCT02147158|9970635|FG004|NOT COMPLETED|Off-Treatment Interval 1||8
8911549|NCT02147158|9970636|FG005|NOT COMPLETED|Off-Treatment Interval 1||5
8911550|NCT02147158|9970631|FG000|STARTED|Treatment Course 2||41
8911551|NCT02147158|9970632|FG001|STARTED|Treatment Course 2||34
8666427|NCT00726739|9710077|FG001|STARTED|Overall Study||10
8666428|NCT00726739|9710076|FG000|COMPLETED|Overall Study|1 patient failed during screening due to brain metastasis.|10
8666429|NCT00726739|9710077|FG001|COMPLETED|Overall Study||10
8666430|NCT00726739|9710076|FG000|NOT COMPLETED|Overall Study||1
8666431|NCT00726739|9710077|FG001|NOT COMPLETED|Overall Study||0
8666432|NCT00726752|9710084|FG000|STARTED|Overall Study||6
8666433|NCT00726752|9710084|FG000|COMPLETED|Overall Study||0
8666434|NCT00726752|9710084|FG000|NOT COMPLETED|Overall Study||6
8666435|NCT00726882|9710088|FG000|STARTED|Overall Study||35
8666436|NCT00726882|9710088|FG000|Received ABT-333 in Study M10-380|Overall Study|Participants who received ABT-333 (and not placebo) in previous study (NCT00851890/M10-380).|22
8666437|NCT00726882|9710088|FG000|Received ABT-333 in Study M10-351|Overall Study|Participants who received ABT-333 (and not placebo) in previous study (NCT00696904/M10-351).|6
8666438|NCT00726882|9710088|FG000|COMPLETED|Overall Study||13
8666439|NCT00726882|9710088|FG000|NOT COMPLETED|Overall Study||22
8666440|NCT00726895|9710094|FG000|STARTED|First Intervention||12
8666441|NCT00726895|9710095|FG001|STARTED|First Intervention||12
8666442|NCT00726895|9710094|FG000|COMPLETED|First Intervention||12
8666443|NCT00726895|9710095|FG001|COMPLETED|First Intervention||12
8666444|NCT00726895|9710094|FG000|NOT COMPLETED|First Intervention||0
8666445|NCT00726895|9710095|FG001|NOT COMPLETED|First Intervention||0
8666446|NCT00726895|9710094|FG000|STARTED|Washout Period of 7 Days||12
8666447|NCT00726895|9710095|FG001|STARTED|Washout Period of 7 Days||12
8666448|NCT00726895|9710094|FG000|COMPLETED|Washout Period of 7 Days||12
8666449|NCT00726895|9710095|FG001|COMPLETED|Washout Period of 7 Days||11
8666450|NCT00726895|9710094|FG000|NOT COMPLETED|Washout Period of 7 Days||0
8666451|NCT00726895|9710095|FG001|NOT COMPLETED|Washout Period of 7 Days||1
8666452|NCT00726895|9710094|FG000|STARTED|Second Intervention||12
8666453|NCT00726895|9710095|FG001|STARTED|Second Intervention||11
8666454|NCT00726895|9710094|FG000|COMPLETED|Second Intervention||12
8666455|NCT00726895|9710095|FG001|COMPLETED|Second Intervention||11
8666456|NCT00726895|9710094|FG000|NOT COMPLETED|Second Intervention||0
8666457|NCT00726895|9710095|FG001|NOT COMPLETED|Second Intervention||0
8666458|NCT00726986|9710102|FG000|STARTED|Induction Phase||18
8666459|NCT00726986|9710102|FG000|Maintance|Induction Phase||3
8666460|NCT00726986|9710102|FG000|COMPLETED|Induction Phase||3
8666461|NCT00726986|9710102|FG000|NOT COMPLETED|Induction Phase||15
8666462|NCT00726986|9710102|FG000|STARTED|Maintenance Phase||3
8666463|NCT00726986|9710102|FG000|COMPLETED|Maintenance Phase||0
8666464|NCT00726986|9710102|FG000|NOT COMPLETED|Maintenance Phase||3
8666465|NCT00726999|9710108|FG000|STARTED|Overall Study||32
8666466|NCT00726999|9710109|FG001|STARTED|Overall Study||31
8666467|NCT00726999|9710108|FG000|COMPLETED|Overall Study||29
8666468|NCT00726999|9710109|FG001|COMPLETED|Overall Study||30
8666469|NCT00726999|9710108|FG000|NOT COMPLETED|Overall Study||3
8666470|NCT00726999|9710109|FG001|NOT COMPLETED|Overall Study||1
8666471|NCT00727025|9710117|FG000|STARTED|Overall Study||74
8666472|NCT00727025|9710117|FG000|COMPLETED|Overall Study||51
8666473|NCT00727025|9710117|FG000|NOT COMPLETED|Overall Study||23
8666474|NCT00727064|9710127|FG000|STARTED|Overall Study||7
8666475|NCT00727064|9710128|FG001|STARTED|Overall Study||7
8666476|NCT00727064|9710127|FG000|COMPLETED|Overall Study||7
8666477|NCT00727064|9710128|FG001|COMPLETED|Overall Study||7
8666478|NCT00727064|9710127|FG000|NOT COMPLETED|Overall Study||0
8666479|NCT00727064|9710128|FG001|NOT COMPLETED|Overall Study||0
8666480|NCT00727194|9710134|FG000|STARTED|Screening Period||7
8666481|NCT00727194|9710135|FG001|STARTED|Screening Period||7
8666482|NCT00727194|9710136|FG002|STARTED|Screening Period||16
8666483|NCT00727194|9710134|FG000|COMPLETED|Screening Period||7
8666484|NCT00727194|9710135|FG001|COMPLETED|Screening Period||7
8666485|NCT00727194|9710136|FG002|COMPLETED|Screening Period||0
8666486|NCT00727194|9710134|FG000|NOT COMPLETED|Screening Period||0
8666487|NCT00727194|9710135|FG001|NOT COMPLETED|Screening Period||0
8666488|NCT00727194|9710136|FG002|NOT COMPLETED|Screening Period||16
8666489|NCT00727194|9710134|FG000|STARTED|Treatment Period 1||7
8666490|NCT00727194|9710135|FG001|STARTED|Treatment Period 1||7
8666491|NCT00727194|9710136|FG002|STARTED|Treatment Period 1||0
8666492|NCT00727194|9710134|FG000|COMPLETED|Treatment Period 1||7
8666493|NCT00727194|9710135|FG001|COMPLETED|Treatment Period 1||7
8666494|NCT00727194|9710136|FG002|COMPLETED|Treatment Period 1||0
8666495|NCT00727194|9710134|FG000|NOT COMPLETED|Treatment Period 1||0
8666496|NCT00727194|9710135|FG001|NOT COMPLETED|Treatment Period 1||0
8666497|NCT00727194|9710136|FG002|NOT COMPLETED|Treatment Period 1||0
8666498|NCT00727194|9710134|FG000|STARTED|Washout Period||7
8666499|NCT00727194|9710135|FG001|STARTED|Washout Period||7
8666500|NCT00727194|9710136|FG002|STARTED|Washout Period||0
8666501|NCT00727194|9710134|FG000|COMPLETED|Washout Period||7
8666502|NCT00727194|9710135|FG001|COMPLETED|Washout Period||7
8666503|NCT00727194|9710136|FG002|COMPLETED|Washout Period||0
8666504|NCT00727194|9710134|FG000|NOT COMPLETED|Washout Period||0
8666505|NCT00727194|9710135|FG001|NOT COMPLETED|Washout Period||0
8666506|NCT00727194|9710136|FG002|NOT COMPLETED|Washout Period||0
8666507|NCT00727194|9710134|FG000|STARTED|Treatment Period 2|Sponsor terminated study early; 2 patients (total) exited study without starting Treatment Period 2.|6
8666508|NCT00727194|9710135|FG001|STARTED|Treatment Period 2|Sponsor terminated study early; 2 patients (total) exited study without starting Treatment Period 2.|6
8666509|NCT00727194|9710136|FG002|STARTED|Treatment Period 2||0
8666510|NCT00727194|9710134|FG000|COMPLETED|Treatment Period 2||6
8666511|NCT00727194|9710135|FG001|COMPLETED|Treatment Period 2||5
8666512|NCT00727194|9710136|FG002|COMPLETED|Treatment Period 2||0
8666513|NCT00727194|9710134|FG000|NOT COMPLETED|Treatment Period 2||0
8666514|NCT00727194|9710135|FG001|NOT COMPLETED|Treatment Period 2||1
8666515|NCT00727194|9710136|FG002|NOT COMPLETED|Treatment Period 2||0
8666516|NCT00727220|9710152|FG000|STARTED|Overall Study||21
8666517|NCT00727220|9710153|FG001|STARTED|Overall Study||21
8666518|NCT00727220|9710152|FG000|COMPLETED|Overall Study||20
8666519|NCT00727220|9710153|FG001|COMPLETED|Overall Study||17
8666520|NCT00727220|9710152|FG000|NOT COMPLETED|Overall Study||1
8666521|NCT00727220|9710153|FG001|NOT COMPLETED|Overall Study||4
8666522|NCT00727246|9710163|FG000|STARTED|Overall Study||3
8666523|NCT00727246|9710164|FG001|STARTED|Overall Study||3
8666524|NCT00727246|9710165|FG002|STARTED|Overall Study||8
8666525|NCT00727246|9710166|FG003|STARTED|Overall Study||5
8666526|NCT00727246|9710163|FG000|COMPLETED|Overall Study||3
8666527|NCT00727246|9710164|FG001|COMPLETED|Overall Study||2
8666528|NCT00727246|9710165|FG002|COMPLETED|Overall Study||7
8666529|NCT00727246|9710166|FG003|COMPLETED|Overall Study||3
8666530|NCT00727246|9710163|FG000|NOT COMPLETED|Overall Study||0
8666531|NCT00727246|9710164|FG001|NOT COMPLETED|Overall Study||1
8666532|NCT00727246|9710165|FG002|NOT COMPLETED|Overall Study||1
8666533|NCT00727246|9710166|FG003|NOT COMPLETED|Overall Study||2
8666534|NCT00727259|9710176|FG000|STARTED|Overall Study||1995
8666535|NCT00727259|9710176|FG000|COMPLETED|Overall Study||940
8666536|NCT00727259|9710176|FG000|NOT COMPLETED|Overall Study||1055
8666537|NCT00727272|9710181|FG000|STARTED|Period I||9
8666538|NCT00727272|9710182|FG001|STARTED|Period I||9
8666539|NCT00727272|9710183|FG002|STARTED|Period I||9
8666540|NCT00727272|9710181|FG000|COMPLETED|Period I||9
8666541|NCT00727272|9710182|FG001|COMPLETED|Period I||9
8666542|NCT00727272|9710183|FG002|COMPLETED|Period I||9
8666543|NCT00727272|9710181|FG000|NOT COMPLETED|Period I||0
8666544|NCT00727272|9710182|FG001|NOT COMPLETED|Period I||0
8666545|NCT00727272|9710183|FG002|NOT COMPLETED|Period I||0
8666546|NCT00727272|9710181|FG000|STARTED|Washout Period A||9
8666547|NCT00727272|9710182|FG001|STARTED|Washout Period A||9
8666548|NCT00727272|9710183|FG002|STARTED|Washout Period A||9
8666549|NCT00727272|9710181|FG000|COMPLETED|Washout Period A||9
8666550|NCT00727272|9710182|FG001|COMPLETED|Washout Period A||9
8666551|NCT00727272|9710183|FG002|COMPLETED|Washout Period A|positive pregnancy test - recorded as an adverse event|8
8666552|NCT00727272|9710181|FG000|NOT COMPLETED|Washout Period A||0
8666553|NCT00727272|9710182|FG001|NOT COMPLETED|Washout Period A||0
8666554|NCT00727272|9710183|FG002|NOT COMPLETED|Washout Period A||1
8666555|NCT00727272|9710181|FG000|STARTED|Period II||9
8666556|NCT00727272|9710182|FG001|STARTED|Period II||9
8666557|NCT00727272|9710183|FG002|STARTED|Period II||8
8666558|NCT00727272|9710181|FG000|COMPLETED|Period II||9
8666559|NCT00727272|9710182|FG001|COMPLETED|Period II||9
8666560|NCT00727272|9710183|FG002|COMPLETED|Period II||8
8666561|NCT00727272|9710181|FG000|NOT COMPLETED|Period II||0
8666562|NCT00727272|9710182|FG001|NOT COMPLETED|Period II||0
8666563|NCT00727272|9710183|FG002|NOT COMPLETED|Period II||0
8666564|NCT00727272|9710181|FG000|STARTED|Washout Period B||9
8666565|NCT00727272|9710182|FG001|STARTED|Washout Period B||9
8666566|NCT00727272|9710183|FG002|STARTED|Washout Period B||8
8666567|NCT00727272|9710181|FG000|COMPLETED|Washout Period B||9
8666568|NCT00727272|9710182|FG001|COMPLETED|Washout Period B||9
8666569|NCT00727272|9710183|FG002|COMPLETED|Washout Period B|personal reasons|7
8666570|NCT00727272|9710181|FG000|NOT COMPLETED|Washout Period B||0
8666571|NCT00727272|9710182|FG001|NOT COMPLETED|Washout Period B||0
8666572|NCT00727272|9710183|FG002|NOT COMPLETED|Washout Period B||1
8666573|NCT00727272|9710181|FG000|STARTED|Period III||9
8666574|NCT00727272|9710182|FG001|STARTED|Period III||9
8666575|NCT00727272|9710183|FG002|STARTED|Period III||7
8666576|NCT00727272|9710181|FG000|COMPLETED|Period III||9
8666577|NCT00727272|9710182|FG001|COMPLETED|Period III||9
8731232|NCT01064310|9778757|FG000|NOT COMPLETED|Period 1||14
8731233|NCT01064310|9778758|FG001|NOT COMPLETED|Period 1||18
8731234|NCT01064310|9778759|FG002|NOT COMPLETED|Period 1||0
8731235|NCT01064310|9778757|FG000|STARTED|Period 2||68
8731236|NCT01064310|9778758|FG001|STARTED|Period 2||68
8731237|NCT01064310|9778759|FG002|STARTED|Period 2||0
8731238|NCT01064310|9778757|FG000|COMPLETED|Period 2||64
8731239|NCT01064310|9778758|FG001|COMPLETED|Period 2||62
8731240|NCT01064310|9778759|FG002|COMPLETED|Period 2||0
8731241|NCT01064310|9778757|FG000|NOT COMPLETED|Period 2||4
8731242|NCT01064310|9778758|FG001|NOT COMPLETED|Period 2||6
8731243|NCT01064310|9778759|FG002|NOT COMPLETED|Period 2||0
8731244|NCT01064310|9778757|FG000|STARTED|Open Label Pazopinib||0
8731245|NCT01064310|9778758|FG001|STARTED|Open Label Pazopinib||0
8731246|NCT01064310|9778759|FG002|STARTED|Open Label Pazopinib||84
8731247|NCT01064310|9778757|FG000|COMPLETED|Open Label Pazopinib||0
8731248|NCT01064310|9778758|FG001|COMPLETED|Open Label Pazopinib||0
8731249|NCT01064310|9778759|FG002|COMPLETED|Open Label Pazopinib||0
8731250|NCT01064310|9778757|FG000|NOT COMPLETED|Open Label Pazopinib||0
8731251|NCT01064310|9778758|FG001|NOT COMPLETED|Open Label Pazopinib||0
8731252|NCT01064310|9778759|FG002|NOT COMPLETED|Open Label Pazopinib||84
8731253|NCT01064323|9778768|FG000|STARTED|Overall Study||10
8731254|NCT01064323|9778768|FG000|COMPLETED|Overall Study||10
8731255|NCT01064323|9778768|FG000|NOT COMPLETED|Overall Study||0
8731256|NCT01064362|9778774|FG000|STARTED|Overall Study||1559
8731257|NCT01064362|9778775|FG001|STARTED|Overall Study||11883
8731258|NCT01064362|9778774|FG000|COMPLETED|Overall Study||1559
8731259|NCT01064362|9778775|FG001|COMPLETED|Overall Study||11883
8731260|NCT01064362|9778774|FG000|NOT COMPLETED|Overall Study||0
8731261|NCT01064362|9778775|FG001|NOT COMPLETED|Overall Study||0
8731262|NCT01064401|9778783|FG000|STARTED|Overall Study||922
8731263|NCT01064401|9778784|FG001|STARTED|Overall Study||919
8731264|NCT01064401|9778783|FG000|COMPLETED|Overall Study||694
8731265|NCT01064401|9778784|FG001|COMPLETED|Overall Study||724
8731266|NCT01064401|9778783|FG000|NOT COMPLETED|Overall Study||228
8731267|NCT01064401|9778784|FG001|NOT COMPLETED|Overall Study||195
8731268|NCT01064414|9778794|FG000|STARTED|Core Period: Baseline to Week 26||90
8731269|NCT01064414|9778795|FG001|STARTED|Core Period: Baseline to Week 26||90
8731270|NCT01064414|9778796|FG002|STARTED|Core Period: Baseline to Week 26||89
8731271|NCT01064414|9778794|FG000|COMPLETED|Core Period: Baseline to Week 26||77
8731272|NCT01064414|9778795|FG001|COMPLETED|Core Period: Baseline to Week 26||75
8731273|NCT01064414|9778796|FG002|COMPLETED|Core Period: Baseline to Week 26||82
8731274|NCT01064414|9778794|FG000|NOT COMPLETED|Core Period: Baseline to Week 26||13
8731275|NCT01064414|9778795|FG001|NOT COMPLETED|Core Period: Baseline to Week 26||15
8731276|NCT01064414|9778796|FG002|NOT COMPLETED|Core Period: Baseline to Week 26||7
8666578|NCT00727272|9710183|FG002|COMPLETED|Period III||7
8666579|NCT00727272|9710181|FG000|NOT COMPLETED|Period III||0
8666580|NCT00727272|9710182|FG001|NOT COMPLETED|Period III||0
8666581|NCT00727272|9710183|FG002|NOT COMPLETED|Period III||0
8666582|NCT00727298|9710193|FG000|STARTED|Overall Study||4485
8666583|NCT00727298|9710193|FG000|COMPLETED|Overall Study||3228
8666584|NCT00727298|9710193|FG000|NOT COMPLETED|Overall Study||1257
8666585|NCT00727311|9710197|FG000|STARTED|Overall Study||2302
8666586|NCT00727311|9710197|FG000|COMPLETED|Overall Study||1195
8666587|NCT00727311|9710197|FG000|NOT COMPLETED|Overall Study||1107
8731277|NCT01064414|9778794|FG000|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext. Reason: other (not specified).|76
8731278|NCT01064414|9778795|FG001|STARTED|Extension Period: Week 26 to Week 52|3 pts completed core but did not enter ext. Reason: other (not specified) (3).|72
8731279|NCT01064414|9778796|FG002|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext. Reason: other (not specified).|81
8731280|NCT01064414|9778794|FG000|COMPLETED|Extension Period: Week 26 to Week 52||64
8731281|NCT01064414|9778795|FG001|COMPLETED|Extension Period: Week 26 to Week 52||67
8731282|NCT01064414|9778796|FG002|COMPLETED|Extension Period: Week 26 to Week 52||76
8731283|NCT01064414|9778794|FG000|NOT COMPLETED|Extension Period: Week 26 to Week 52||12
8666588|NCT00727337|9710205|FG000|STARTED|Overall Study||68
8666589|NCT00727337|9710206|FG001|STARTED|Overall Study||65
8666590|NCT00727337|9710207|FG002|STARTED|Overall Study||73
8731284|NCT01064414|9778795|FG001|NOT COMPLETED|Extension Period: Week 26 to Week 52||5
8806696|NCT01479517|9859015|FG000|NOT COMPLETED|Overall Study||0
8666591|NCT00727337|9710208|FG003|STARTED|Overall Study||73
8666592|NCT00727337|9710205|FG000|COMPLETED|Overall Study||61
8666593|NCT00727337|9710206|FG001|COMPLETED|Overall Study||55
8666594|NCT00727337|9710207|FG002|COMPLETED|Overall Study||63
8666595|NCT00727337|9710208|FG003|COMPLETED|Overall Study||64
8666596|NCT00727337|9710205|FG000|NOT COMPLETED|Overall Study||7
8666597|NCT00727337|9710206|FG001|NOT COMPLETED|Overall Study||10
8666598|NCT00727337|9710207|FG002|NOT COMPLETED|Overall Study||10
8666599|NCT00727337|9710208|FG003|NOT COMPLETED|Overall Study||9
8666600|NCT00727402|9710223|FG000|STARTED|Overall Study||205
8666601|NCT00727402|9710223|FG000|COMPLETED|Overall Study||89
8666602|NCT00727402|9710223|FG000|NOT COMPLETED|Overall Study||116
8666603|NCT00727415|9710227|FG000|STARTED|Phase I||9
8666604|NCT00727415|9710227|FG000|COMPLETED|Phase I||7
8666605|NCT00727415|9710227|FG000|NOT COMPLETED|Phase I||2
8666606|NCT00727415|9710227|FG000|STARTED|Phase II||33
8666607|NCT00727415|9710227|FG000|COMPLETED|Phase II||33
8666608|NCT00727415|9710227|FG000|NOT COMPLETED|Phase II||0
8666609|NCT00727441|9710234|FG000|STARTED|Overall Study||29
8666610|NCT00727441|9710235|FG001|STARTED|Overall Study||28
8666611|NCT00727441|9710236|FG002|STARTED|Overall Study||30
8666612|NCT00727441|9710234|FG000|COMPLETED|Overall Study||11
8666613|NCT00727441|9710235|FG001|COMPLETED|Overall Study||6
8666614|NCT00727441|9710236|FG002|COMPLETED|Overall Study||5
8666615|NCT00727441|9710234|FG000|NOT COMPLETED|Overall Study||18
8666616|NCT00727441|9710235|FG001|NOT COMPLETED|Overall Study||22
8666617|NCT00727441|9710236|FG002|NOT COMPLETED|Overall Study||25
8731285|NCT01064414|9778796|FG002|NOT COMPLETED|Extension Period: Week 26 to Week 52||5
8731286|NCT01064531|9778809|FG000|STARTED|Overall Study||21
8731287|NCT01064531|9778810|FG001|STARTED|Overall Study||20
8731288|NCT01064531|9778809|FG000|COMPLETED|Overall Study||18
8731289|NCT01064531|9778810|FG001|COMPLETED|Overall Study||13
8731290|NCT01064531|9778809|FG000|NOT COMPLETED|Overall Study||3
8731291|NCT01064531|9778810|FG001|NOT COMPLETED|Overall Study||7
8731292|NCT01064622|9778819|FG000|STARTED|Lead-in Phase I||0
8731293|NCT01064622|9778820|FG001|STARTED|Lead-in Phase I||7
8731294|NCT01064622|9778819|FG000|COMPLETED|Lead-in Phase I||0
8731295|NCT01064622|9778820|FG001|COMPLETED|Lead-in Phase I||7
8731296|NCT01064622|9778819|FG000|NOT COMPLETED|Lead-in Phase I||0
8731297|NCT01064622|9778820|FG001|NOT COMPLETED|Lead-in Phase I||0
8731298|NCT01064622|9778819|FG000|STARTED|Randomized Phase II||55
8731299|NCT01064622|9778820|FG001|STARTED|Randomized Phase II||56
8731300|NCT01064622|9778819|FG000|COMPLETED|Randomized Phase II||53
8731301|NCT01064622|9778820|FG001|COMPLETED|Randomized Phase II||53
8731302|NCT01064622|9778819|FG000|NOT COMPLETED|Randomized Phase II||2
8731303|NCT01064622|9778820|FG001|NOT COMPLETED|Randomized Phase II||3
8731304|NCT01064622|9778819|FG000|STARTED|Crossover of Arm I|Among 53 patients, 45 had disease progression; however 23 elected not to crossover to vismodegib.|22
8731305|NCT01064622|9778820|FG001|STARTED|Crossover of Arm I||0
8731306|NCT01064622|9778819|FG000|COMPLETED|Crossover of Arm I||22
8731307|NCT01064622|9778820|FG001|COMPLETED|Crossover of Arm I||0
8731308|NCT01064622|9778819|FG000|NOT COMPLETED|Crossover of Arm I||0
8731309|NCT01064622|9778820|FG001|NOT COMPLETED|Crossover of Arm I||0
8731310|NCT01064687|9778833|FG000|STARTED|Overall Study||279
8731311|NCT01064687|9778834|FG001|STARTED|Overall Study||280
8731312|NCT01064687|9778835|FG002|STARTED|Overall Study|Of 278 participants randomized to Exenatide, 2 chose not to take study drug.|278
8731313|NCT01064687|9778836|FG003|STARTED|Overall Study||141
8731314|NCT01064687|9778833|FG000|Received at Least 1 Dose of Study Drug|Overall Study||279
8731315|NCT01064687|9778834|FG001|Received at Least 1 Dose of Study Drug|Overall Study||280
8731316|NCT01064687|9778835|FG002|Received at Least 1 Dose of Study Drug|Overall Study||276
8731317|NCT01064687|9778836|FG003|Received at Least 1 Dose of Study Drug|Overall Study||141
8731318|NCT01064687|9778833|FG000|Completed 26 Weeks|Overall Study||260
8731319|NCT01064687|9778834|FG001|Completed 26 Weeks|Overall Study||263
8731320|NCT01064687|9778835|FG002|Completed 26 Weeks|Overall Study||252
8731321|NCT01064687|9778836|FG003|Completed 26 Weeks|Overall Study||124
8731322|NCT01064687|9778833|FG000|COMPLETED|Overall Study||245
8731323|NCT01064687|9778834|FG001|COMPLETED|Overall Study||254
8731324|NCT01064687|9778835|FG002|COMPLETED|Overall Study||237
8731325|NCT01064687|9778836|FG003|COMPLETED|Overall Study||124
8731326|NCT01064687|9778833|FG000|NOT COMPLETED|Overall Study||34
8731327|NCT01064687|9778834|FG001|NOT COMPLETED|Overall Study||26
8731328|NCT01064687|9778835|FG002|NOT COMPLETED|Overall Study||41
8731329|NCT01064687|9778836|FG003|NOT COMPLETED|Overall Study||17
8731330|NCT01064713|9778859|FG000|STARTED|Overall Study||13
8731331|NCT01064713|9778860|FG001|STARTED|Overall Study||4
8731332|NCT01064713|9778859|FG000|COMPLETED|Overall Study||13
8731333|NCT01064713|9778860|FG001|COMPLETED|Overall Study||4
8731334|NCT01064713|9778859|FG000|NOT COMPLETED|Overall Study||0
8731335|NCT01064713|9778860|FG001|NOT COMPLETED|Overall Study||0
8731336|NCT01064739|9778866|FG000|STARTED|Fixed Sodium Study Diet|14 participants consumed the fixed-sodium study diet prior to the fava bean supplement study day.|14
8731337|NCT01064739|9778866|FG000|COMPLETED|Fixed Sodium Study Diet||14
8731338|NCT01064739|9778866|FG000|NOT COMPLETED|Fixed Sodium Study Diet||0
8731339|NCT01064739|9778866|FG000|STARTED|Fixed Sodium Diet + Fava Beans||14
8806697|NCT01479517|9859016|FG001|NOT COMPLETED|Overall Study||0
8666618|NCT00727506|9710253|FG000|STARTED|Overall Study|Entered|6
8666619|NCT00727506|9710254|FG001|STARTED|Overall Study|Entered|8
8666620|NCT00727506|9710255|FG002|STARTED|Overall Study|Entered|18
8666621|NCT00727506|9710256|FG003|STARTED|Overall Study|Randomized|39
8666622|NCT00727506|9710257|FG004|STARTED|Overall Study|Randomized|41
8666623|NCT00727506|9710258|FG005|STARTED|Overall Study|Randomized|39
8666624|NCT00727506|9710253|FG000|COMPLETED|Overall Study||0
8666625|NCT00727506|9710254|FG001|COMPLETED|Overall Study||0
8666626|NCT00727506|9710255|FG002|COMPLETED|Overall Study||0
8666627|NCT00727506|9710256|FG003|COMPLETED|Overall Study||0
8666628|NCT00727506|9710257|FG004|COMPLETED|Overall Study||0
8666629|NCT00727506|9710258|FG005|COMPLETED|Overall Study||0
8666630|NCT00727506|9710253|FG000|NOT COMPLETED|Overall Study||6
8666631|NCT00727506|9710254|FG001|NOT COMPLETED|Overall Study||8
8666632|NCT00727506|9710255|FG002|NOT COMPLETED|Overall Study||18
8666633|NCT00727506|9710256|FG003|NOT COMPLETED|Overall Study||39
8666634|NCT00727506|9710257|FG004|NOT COMPLETED|Overall Study||41
8666635|NCT00727506|9710258|FG005|NOT COMPLETED|Overall Study||39
8666636|NCT00727532|9710278|FG000|STARTED|Overall Study||9
8666637|NCT00727532|9710278|FG000|COMPLETED|Overall Study||7
8666638|NCT00727532|9710278|FG000|NOT COMPLETED|Overall Study||2
8666639|NCT00727558|9710284|FG000|STARTED|Overall Study||127
8666640|NCT00727558|9710285|FG001|STARTED|Overall Study||121
8666641|NCT00727558|9710284|FG000|COMPLETED|Overall Study||125
8666642|NCT00727558|9710285|FG001|COMPLETED|Overall Study||118
8666643|NCT00727558|9710284|FG000|NOT COMPLETED|Overall Study||2
8666644|NCT00727558|9710285|FG001|NOT COMPLETED|Overall Study||3
8666645|NCT00727571|9710295|FG000|STARTED|Overall Study||232
8666646|NCT00727571|9710296|FG001|STARTED|Overall Study||228
8666647|NCT00727571|9710297|FG002|STARTED|Overall Study||165
8666648|NCT00727571|9710298|FG003|STARTED|Overall Study||169
8666649|NCT00727571|9710295|FG000|COMPLETED|Overall Study||231
8666650|NCT00727571|9710296|FG001|COMPLETED|Overall Study||173
8666651|NCT00727571|9710297|FG002|COMPLETED|Overall Study||135
8666652|NCT00727571|9710298|FG003|COMPLETED|Overall Study||163
8731340|NCT01064739|9778866|FG000|COMPLETED|Fixed Sodium Diet + Fava Beans|1 participant withdrew with blood in his urine on the fava bean study day.|13
8731341|NCT01064739|9778866|FG000|NOT COMPLETED|Fixed Sodium Diet + Fava Beans||1
8731342|NCT01064830|9778878|FG000|STARTED|Overall Study||10
8731343|NCT01064830|9778879|FG001|STARTED|Overall Study||11
8731344|NCT01064830|9778878|FG000|COMPLETED|Overall Study||8
8731345|NCT01064830|9778879|FG001|COMPLETED|Overall Study||7
8731346|NCT01064830|9778878|FG000|NOT COMPLETED|Overall Study||2
8731347|NCT01064830|9778879|FG001|NOT COMPLETED|Overall Study||4
8731348|NCT01064856|9778889|FG000|STARTED|Double-blind (DB) Period||84
8731349|NCT01064856|9778890|FG001|STARTED|Double-blind (DB) Period||81
8731350|NCT01064856|9778891|FG002|STARTED|Double-blind (DB) Period|This treatment group is not applicable for this period.|0
8731351|NCT01064856|9778892|FG003|STARTED|Double-blind (DB) Period|This treatment group is not applicable for this period.|0
8731352|NCT01064856|9778889|FG000|COMPLETED|Double-blind (DB) Period||82
8731353|NCT01064856|9778890|FG001|COMPLETED|Double-blind (DB) Period||81
8731354|NCT01064856|9778891|FG002|COMPLETED|Double-blind (DB) Period||0
8731355|NCT01064856|9778892|FG003|COMPLETED|Double-blind (DB) Period||0
8731356|NCT01064856|9778889|FG000|NOT COMPLETED|Double-blind (DB) Period||2
8731357|NCT01064856|9778890|FG001|NOT COMPLETED|Double-blind (DB) Period||0
8731358|NCT01064856|9778891|FG002|NOT COMPLETED|Double-blind (DB) Period||0
8731359|NCT01064856|9778892|FG003|NOT COMPLETED|Double-blind (DB) Period||0
8731360|NCT01064856|9778889|FG000|STARTED|Open-label (OL) Period|This treatment group is not applicable for this period.|0
8731361|NCT01064856|9778890|FG001|STARTED|Open-label (OL) Period|This treatment group is not applicable for this period.|0
8731362|NCT01064856|9778891|FG002|STARTED|Open-label (OL) Period||82
8731363|NCT01064856|9778892|FG003|STARTED|Open-label (OL) Period||81
8731364|NCT01064856|9778889|FG000|COMPLETED|Open-label (OL) Period||0
8731365|NCT01064856|9778890|FG001|COMPLETED|Open-label (OL) Period||0
8731366|NCT01064856|9778891|FG002|COMPLETED|Open-label (OL) Period||56
8731367|NCT01064856|9778892|FG003|COMPLETED|Open-label (OL) Period||61
8731368|NCT01064856|9778889|FG000|NOT COMPLETED|Open-label (OL) Period||0
8731369|NCT01064856|9778890|FG001|NOT COMPLETED|Open-label (OL) Period||0
8731370|NCT01064856|9778891|FG002|NOT COMPLETED|Open-label (OL) Period||26
8731371|NCT01064856|9778892|FG003|NOT COMPLETED|Open-label (OL) Period||20
8731372|NCT01064882|9778902|FG000|STARTED|Overall Study||36
8731373|NCT01064882|9778903|FG001|STARTED|Overall Study||34
8731374|NCT01064882|9778904|FG002|STARTED|Overall Study||34
8731375|NCT01064882|9778902|FG000|COMPLETED|Overall Study||34
8731376|NCT01064882|9778903|FG001|COMPLETED|Overall Study||32
8731377|NCT01064882|9778904|FG002|COMPLETED|Overall Study||32
8731378|NCT01064882|9778902|FG000|NOT COMPLETED|Overall Study||2
8731379|NCT01064882|9778903|FG001|NOT COMPLETED|Overall Study||2
8731380|NCT01064882|9778904|FG002|NOT COMPLETED|Overall Study||2
8731381|NCT01064947|9778912|FG000|STARTED|Overall Study||70
8731382|NCT01064947|9778912|FG000|COMPLETED|Overall Study||29
8731383|NCT01064947|9778912|FG000|NOT COMPLETED|Overall Study||41
8731384|NCT01065350|9778922|FG000|STARTED|Overall Study||43
8731385|NCT01065350|9778923|FG001|STARTED|Overall Study||42
8731386|NCT01065350|9778922|FG000|COMPLETED|Overall Study||43
8731387|NCT01065350|9778923|FG001|COMPLETED|Overall Study||41
8731388|NCT01065350|9778922|FG000|NOT COMPLETED|Overall Study||0
8731389|NCT01065350|9778923|FG001|NOT COMPLETED|Overall Study||1
8666653|NCT00727571|9710295|FG000|NOT COMPLETED|Overall Study||1
8666654|NCT00727571|9710296|FG001|NOT COMPLETED|Overall Study||55
8666655|NCT00727571|9710297|FG002|NOT COMPLETED|Overall Study||30
8666656|NCT00727571|9710298|FG003|NOT COMPLETED|Overall Study||6
8666657|NCT00727597|9710310|FG000|STARTED|Overall Study||51
8731390|NCT01065428|9778931|FG000|STARTED|Overall Study||17
8666658|NCT00727597|9710311|FG001|STARTED|Overall Study||50
8666659|NCT00727597|9710310|FG000|COMPLETED|Overall Study||51
8666660|NCT00727597|9710311|FG001|COMPLETED|Overall Study||50
8666661|NCT00727597|9710310|FG000|NOT COMPLETED|Overall Study||0
8666662|NCT00727597|9710311|FG001|NOT COMPLETED|Overall Study||0
8666663|NCT00727636|9710319|FG000|STARTED|Overall Study||37
8666664|NCT00727636|9710320|FG001|STARTED|Overall Study||15
8666665|NCT00727636|9710319|FG000|COMPLETED|Overall Study||33
8666666|NCT00727636|9710320|FG001|COMPLETED|Overall Study||15
8666667|NCT00727636|9710319|FG000|NOT COMPLETED|Overall Study||4
8666668|NCT00727636|9710320|FG001|NOT COMPLETED|Overall Study||0
8666669|NCT00727649|9710328|FG000|STARTED|First Intervention (4-weeks)||37
8666670|NCT00727649|9710329|FG001|STARTED|First Intervention (4-weeks)||43
8666671|NCT00727649|9710328|FG000|COMPLETED|First Intervention (4-weeks)||34
8666672|NCT00727649|9710329|FG001|COMPLETED|First Intervention (4-weeks)||40
8666673|NCT00727649|9710328|FG000|NOT COMPLETED|First Intervention (4-weeks)||3
8666674|NCT00727649|9710329|FG001|NOT COMPLETED|First Intervention (4-weeks)||3
8666675|NCT00727649|9710328|FG000|STARTED|Wash-out (2-weeks)||34
8666676|NCT00727649|9710329|FG001|STARTED|Wash-out (2-weeks)||40
8666677|NCT00727649|9710328|FG000|COMPLETED|Wash-out (2-weeks)||30
8666678|NCT00727649|9710329|FG001|COMPLETED|Wash-out (2-weeks)||37
8666679|NCT00727649|9710328|FG000|NOT COMPLETED|Wash-out (2-weeks)||4
8666680|NCT00727649|9710329|FG001|NOT COMPLETED|Wash-out (2-weeks)||3
8666681|NCT00727649|9710328|FG000|STARTED|Second Intervention (4-weeks)||30
8666682|NCT00727649|9710329|FG001|STARTED|Second Intervention (4-weeks)||37
8666683|NCT00727649|9710328|FG000|COMPLETED|Second Intervention (4-weeks)||29
8666684|NCT00727649|9710329|FG001|COMPLETED|Second Intervention (4-weeks)||34
8666685|NCT00727649|9710328|FG000|NOT COMPLETED|Second Intervention (4-weeks)||1
8731391|NCT01065428|9778932|FG001|STARTED|Overall Study||35
8731392|NCT01065428|9778931|FG000|COMPLETED|Overall Study||17
8731393|NCT01065428|9778932|FG001|COMPLETED|Overall Study||35
8731394|NCT01065428|9778931|FG000|NOT COMPLETED|Overall Study||0
8731395|NCT01065428|9778932|FG001|NOT COMPLETED|Overall Study||0
8731396|NCT01065480|9778940|FG000|STARTED|Overall Study||48
8731397|NCT01065480|9778941|FG001|STARTED|Overall Study||43
8731398|NCT01065480|9778940|FG000|COMPLETED|Overall Study||48
8731399|NCT01065480|9778941|FG001|COMPLETED|Overall Study||43
8731400|NCT01065480|9778940|FG000|NOT COMPLETED|Overall Study||0
8731401|NCT01065480|9778941|FG001|NOT COMPLETED|Overall Study||0
8731402|NCT01065506|9778949|FG000|STARTED|Overall Study||64
8731403|NCT01065506|9778950|FG001|STARTED|Overall Study||72
8731404|NCT01065506|9778949|FG000|End of Treatment|Overall Study||44
8731405|NCT01065506|9778950|FG001|End of Treatment|Overall Study||37
8731406|NCT01065506|9778949|FG000|4-Month Follow-Up|Overall Study||35
8731407|NCT01065506|9778950|FG001|4-Month Follow-Up|Overall Study||34
8731408|NCT01065506|9778949|FG000|COMPLETED|Overall Study||32
8731409|NCT01065506|9778950|FG001|COMPLETED|Overall Study||34
8731410|NCT01065506|9778949|FG000|NOT COMPLETED|Overall Study||32
8731411|NCT01065506|9778950|FG001|NOT COMPLETED|Overall Study||38
8731412|NCT01065558|9778956|FG000|STARTED|Overall Study||5
8731413|NCT01065558|9778956|FG000|COMPLETED|Overall Study||5
8731414|NCT01065558|9778956|FG000|NOT COMPLETED|Overall Study||0
8731415|NCT01065571|9778962|FG000|STARTED|Overall Study||10
8731416|NCT01065571|9778963|FG001|STARTED|Overall Study||5
8731417|NCT01065571|9778962|FG000|COMPLETED|Overall Study||7
8731418|NCT01065571|9778963|FG001|COMPLETED|Overall Study||5
8731419|NCT01065571|9778962|FG000|NOT COMPLETED|Overall Study||3
8911552|NCT02147158|9970633|FG002|STARTED|Treatment Course 2||84
8911553|NCT02147158|9970634|FG003|STARTED|Treatment Course 2||82
8911554|NCT02147158|9970635|FG004|STARTED|Treatment Course 2||41
8911555|NCT02147158|9970636|FG005|STARTED|Treatment Course 2||45
8911556|NCT02147158|9970631|FG000|COMPLETED|Treatment Course 2||40
8911557|NCT02147158|9970632|FG001|COMPLETED|Treatment Course 2||29
8911558|NCT02147158|9970633|FG002|COMPLETED|Treatment Course 2||79
8911559|NCT02147158|9970634|FG003|COMPLETED|Treatment Course 2||77
8911560|NCT02147158|9970635|FG004|COMPLETED|Treatment Course 2||41
8911561|NCT02147158|9970636|FG005|COMPLETED|Treatment Course 2||43
8911562|NCT02147158|9970631|FG000|NOT COMPLETED|Treatment Course 2||1
8911563|NCT02147158|9970632|FG001|NOT COMPLETED|Treatment Course 2||5
8911564|NCT02147158|9970633|FG002|NOT COMPLETED|Treatment Course 2||5
8911565|NCT02147158|9970634|FG003|NOT COMPLETED|Treatment Course 2||5
8666686|NCT00727649|9710329|FG001|NOT COMPLETED|Second Intervention (4-weeks)||3
8666687|NCT00727714|9710337|FG000|STARTED|Overall Study||95
8666688|NCT00727714|9710337|FG000|COMPLETED|Overall Study||93
8731420|NCT01065571|9778963|FG001|NOT COMPLETED|Overall Study||0
8731421|NCT01065597|9778971|FG000|STARTED|Overall Study||13
8731422|NCT01065597|9778971|FG000|COMPLETED|Overall Study||12
8731423|NCT01065597|9778971|FG000|NOT COMPLETED|Overall Study||1
8731424|NCT01065714|9778975|FG000|STARTED|Overall Study|"This was a split body Study. All participants used both Hydrogel and Eucerin"|20
8731425|NCT01065714|9778975|FG000|COMPLETED|Overall Study||20
8731426|NCT01065714|9778975|FG000|NOT COMPLETED|Overall Study||0
8731427|NCT01065766|9778982|FG000|STARTED|Overall Study||4065
8911566|NCT02147158|9970635|FG004|NOT COMPLETED|Treatment Course 2||0
8666689|NCT00727714|9710337|FG000|NOT COMPLETED|Overall Study||2
8666690|NCT00727740|9710343|FG000|STARTED|Overall Study||56
8731428|NCT01065766|9778982|FG000|COMPLETED|Overall Study||4033
8911567|NCT02147158|9970636|FG005|NOT COMPLETED|Treatment Course 2||2
8911568|NCT02147158|9970631|FG000|STARTED|Off-Treatment Interval 2||40
8911569|NCT02147158|9970632|FG001|STARTED|Off-Treatment Interval 2||29
8666691|NCT00727740|9710344|FG001|STARTED|Overall Study||61
8666692|NCT00727740|9710343|FG000|COMPLETED|Overall Study||56
8666693|NCT00727740|9710344|FG001|COMPLETED|Overall Study||61
8666694|NCT00727740|9710343|FG000|NOT COMPLETED|Overall Study||0
8666695|NCT00727740|9710344|FG001|NOT COMPLETED|Overall Study||0
8666696|NCT00727844|9710352|FG000|STARTED|Initial Randomization|2 patients withdrawn before receiving any linezolid owing to baseline neuropathy|21
8666697|NCT00727844|9710353|FG001|STARTED|Initial Randomization||20
8666698|NCT00727844|9710354|FG002|STARTED|Initial Randomization||0
8666699|NCT00727844|9710355|FG003|STARTED|Initial Randomization||0
8666700|NCT00727844|9710352|FG000|Included in MITT Analysis|Initial Randomization||19
8666701|NCT00727844|9710353|FG001|Included in MITT Analysis|Initial Randomization||20
8666702|NCT00727844|9710354|FG002|Included in MITT Analysis|Initial Randomization||0
8666703|NCT00727844|9710355|FG003|Included in MITT Analysis|Initial Randomization||0
8666704|NCT00727844|9710352|FG000|COMPLETED|Initial Randomization||19
8666705|NCT00727844|9710353|FG001|COMPLETED|Initial Randomization||20
8666706|NCT00727844|9710354|FG002|COMPLETED|Initial Randomization||0
8666707|NCT00727844|9710355|FG003|COMPLETED|Initial Randomization||0
8666708|NCT00727844|9710352|FG000|NOT COMPLETED|Initial Randomization||2
8666709|NCT00727844|9710353|FG001|NOT COMPLETED|Initial Randomization||0
8666710|NCT00727844|9710354|FG002|NOT COMPLETED|Initial Randomization||0
8666711|NCT00727844|9710355|FG003|NOT COMPLETED|Initial Randomization||0
8666712|NCT00727844|9710352|FG000|STARTED|Second Randomization||0
8666713|NCT00727844|9710353|FG001|STARTED|Second Randomization||0
8666714|NCT00727844|9710354|FG002|STARTED|Second Randomization|6 patients excluded before 2nd randomization: 2 had withdrawn and 4 already dose reduced due to AE|17
8666715|NCT00727844|9710355|FG003|STARTED|Second Randomization|6 patients excluded before 2nd randomization: 2 had withdrawn and 4 already dose reduced due to AE|16
8666716|NCT00727844|9710352|FG000|COMPLETED|Second Randomization||0
8666717|NCT00727844|9710353|FG001|COMPLETED|Second Randomization||0
8666718|NCT00727844|9710354|FG002|COMPLETED|Second Randomization||17
8666719|NCT00727844|9710355|FG003|COMPLETED|Second Randomization||16
8666720|NCT00727844|9710352|FG000|NOT COMPLETED|Second Randomization||0
8666721|NCT00727844|9710353|FG001|NOT COMPLETED|Second Randomization||0
8666722|NCT00727844|9710354|FG002|NOT COMPLETED|Second Randomization||0
8666723|NCT00727844|9710355|FG003|NOT COMPLETED|Second Randomization||0
8666724|NCT00727857|9710363|FG000|STARTED|Overall Study||201
8666725|NCT00727857|9710364|FG001|STARTED|Overall Study||189
8666726|NCT00727857|9710365|FG002|STARTED|Overall Study||210
8666727|NCT00727857|9710363|FG000|COMPLETED|Overall Study||157
8666728|NCT00727857|9710364|FG001|COMPLETED|Overall Study||125
8666729|NCT00727857|9710365|FG002|COMPLETED|Overall Study||142
8666730|NCT00727857|9710363|FG000|NOT COMPLETED|Overall Study||44
8666731|NCT00727857|9710364|FG001|NOT COMPLETED|Overall Study||64
8666732|NCT00727857|9710365|FG002|NOT COMPLETED|Overall Study||68
8666733|NCT00727909|9710374|FG000|STARTED|Overall Study||65
8666734|NCT00727909|9710375|FG001|STARTED|Overall Study||72
8666735|NCT00727909|9710376|FG002|STARTED|Overall Study||67
8666736|NCT00727909|9710377|FG003|STARTED|Overall Study||75
8666737|NCT00727909|9710374|FG000|COMPLETED|Overall Study||60
8666738|NCT00727909|9710375|FG001|COMPLETED|Overall Study||61
8666739|NCT00727909|9710376|FG002|COMPLETED|Overall Study||58
8666740|NCT00727909|9710377|FG003|COMPLETED|Overall Study||70
8666741|NCT00727909|9710374|FG000|NOT COMPLETED|Overall Study||5
8666742|NCT00727909|9710375|FG001|NOT COMPLETED|Overall Study||11
8666743|NCT00727909|9710376|FG002|NOT COMPLETED|Overall Study||9
8666744|NCT00727909|9710377|FG003|NOT COMPLETED|Overall Study||5
8666745|NCT00727961|9710381|FG000|STARTED|Overall Study||58
8666746|NCT00727961|9710381|FG000|COMPLETED|Overall Study||21
8666747|NCT00727961|9710381|FG000|NOT COMPLETED|Overall Study||37
8666748|NCT00728130|9710385|FG000|STARTED|Overall Study||22
8666749|NCT00728130|9710385|FG000|COMPLETED|Overall Study||19
8666750|NCT00728130|9710385|FG000|NOT COMPLETED|Overall Study||3
8666751|NCT00728182|9710391|FG000|STARTED|Overall Study||92
8666752|NCT00728182|9710392|FG001|STARTED|Overall Study||93
8666753|NCT00728182|9710391|FG000|COMPLETED|Overall Study||89
8666754|NCT00728182|9710392|FG001|COMPLETED|Overall Study||90
8666755|NCT00728182|9710391|FG000|NOT COMPLETED|Overall Study||3
8666756|NCT00728182|9710392|FG001|NOT COMPLETED|Overall Study||3
8666757|NCT00728260|9710400|FG000|STARTED|Overall Study||1421
8666758|NCT00728260|9710400|FG000|COMPLETED|Overall Study||1421
8666759|NCT00728260|9710400|FG000|NOT COMPLETED|Overall Study||0
8666760|NCT00728468|9710404|FG000|STARTED|Overall Study||16
8666761|NCT00728468|9710404|FG000|Treated|Overall Study||15
8666762|NCT00728468|9710404|FG000|COMPLETED|Overall Study||0
8666763|NCT00728468|9710404|FG000|NOT COMPLETED|Overall Study||16
8666764|NCT00728481|9710410|FG000|STARTED|Overall Study||19
8666765|NCT00728481|9710411|FG001|STARTED|Overall Study||32
8666766|NCT00728481|9710410|FG000|COMPLETED|Overall Study||18
8666767|NCT00728481|9710411|FG001|COMPLETED|Overall Study||28
8666768|NCT00728481|9710410|FG000|NOT COMPLETED|Overall Study||1
8666769|NCT00728481|9710411|FG001|NOT COMPLETED|Overall Study||4
8666770|NCT00728494|9710419|FG000|STARTED|Overall Study||60
8666771|NCT00728494|9710420|FG001|STARTED|Overall Study||39
8666772|NCT00728494|9710419|FG000|COMPLETED|Overall Study||51
8666773|NCT00728494|9710420|FG001|COMPLETED|Overall Study||32
8666774|NCT00728494|9710419|FG000|NOT COMPLETED|Overall Study||9
8666775|NCT00728494|9710420|FG001|NOT COMPLETED|Overall Study||7
8666776|NCT00728507|9710428|FG000|STARTED|Overall Study||62
8666777|NCT00728507|9710429|FG001|STARTED|Overall Study||59
8666778|NCT00728507|9710428|FG000|COMPLETED|Overall Study||60
8666779|NCT00728507|9710429|FG001|COMPLETED|Overall Study||51
8666780|NCT00728507|9710428|FG000|NOT COMPLETED|Overall Study||2
8666781|NCT00728507|9710429|FG001|NOT COMPLETED|Overall Study||8
8666782|NCT00728689|9710437|FG000|STARTED|First Intervention (Days 1 - 3)||6
8666783|NCT00728689|9710438|FG001|STARTED|First Intervention (Days 1 - 3)||6
8666784|NCT00728689|9710437|FG000|COMPLETED|First Intervention (Days 1 - 3)||6
8666785|NCT00728689|9710438|FG001|COMPLETED|First Intervention (Days 1 - 3)||6
8666786|NCT00728689|9710437|FG000|NOT COMPLETED|First Intervention (Days 1 - 3)||0
8666787|NCT00728689|9710438|FG001|NOT COMPLETED|First Intervention (Days 1 - 3)||0
8666788|NCT00728689|9710437|FG000|STARTED|Washout Period (Days 4 - 10)||6
8666789|NCT00728689|9710438|FG001|STARTED|Washout Period (Days 4 - 10)||6
8666790|NCT00728689|9710437|FG000|COMPLETED|Washout Period (Days 4 - 10)|Death in family during the Washout period. Completed First Intervention period with ST-246 Form I.|5
8666791|NCT00728689|9710438|FG001|COMPLETED|Washout Period (Days 4 - 10)||6
8666792|NCT00728689|9710437|FG000|NOT COMPLETED|Washout Period (Days 4 - 10)||1
8666793|NCT00728689|9710438|FG001|NOT COMPLETED|Washout Period (Days 4 - 10)||0
8666794|NCT00728689|9710437|FG000|STARTED|Second Intervention (Days 11 - 13)||5
8666795|NCT00728689|9710438|FG001|STARTED|Second Intervention (Days 11 - 13)||6
8666796|NCT00728689|9710437|FG000|COMPLETED|Second Intervention (Days 11 - 13)||5
8666797|NCT00728689|9710438|FG001|COMPLETED|Second Intervention (Days 11 - 13)||6
8666798|NCT00728689|9710437|FG000|NOT COMPLETED|Second Intervention (Days 11 - 13)||0
8666799|NCT00728689|9710438|FG001|NOT COMPLETED|Second Intervention (Days 11 - 13)||0
8666800|NCT00728728|9710448|FG000|STARTED|Overall Study||42
8666801|NCT00728728|9710449|FG001|STARTED|Overall Study||46
8666802|NCT00728728|9710448|FG000|COMPLETED|Overall Study||38
8666803|NCT00728728|9710449|FG001|COMPLETED|Overall Study||34
8666804|NCT00728728|9710448|FG000|NOT COMPLETED|Overall Study||4
8666805|NCT00728728|9710449|FG001|NOT COMPLETED|Overall Study||12
8731429|NCT01065766|9778982|FG000|NOT COMPLETED|Overall Study||32
8731430|NCT01065844|9778986|FG000|STARTED|Overall Study||15
8731431|NCT01065844|9778986|FG000|COMPLETED|Overall Study||10
8731432|NCT01065844|9778986|FG000|NOT COMPLETED|Overall Study||5
8731433|NCT01066000|9778990|FG000|STARTED|Overall Study||33
8731434|NCT01066000|9778990|FG000|COMPLETED|Overall Study||24
8731435|NCT01066000|9778990|FG000|NOT COMPLETED|Overall Study||9
8731436|NCT01066026|9778994|FG000|STARTED|Overall Study|Each patient was injected with hyaluronic acid in each nasolabial fold (total: 2 injections)|25
8731437|NCT01066026|9778994|FG000|COMPLETED|Overall Study||23
8731438|NCT01066026|9778994|FG000|NOT COMPLETED|Overall Study||2
8731439|NCT01066039|9779000|FG000|STARTED|Overall Study||202
8731440|NCT01066039|9779000|FG000|Treated|Overall Study||200
8731441|NCT01066039|9779000|FG000|COMPLETED|Overall Study||158
8731442|NCT01066039|9779000|FG000|NOT COMPLETED|Overall Study||44
8731443|NCT01066052|9779006|FG000|STARTED|Overall Study||64
8731444|NCT01066052|9779007|FG001|STARTED|Overall Study||51
8731445|NCT01066052|9779006|FG000|Treated|Overall Study||61
8731446|NCT01066052|9779007|FG001|Treated|Overall Study||0
8731447|NCT01066052|9779006|FG000|COMPLETED|Overall Study||61
8731448|NCT01066052|9779007|FG001|COMPLETED|Overall Study||51
8731449|NCT01066052|9779006|FG000|NOT COMPLETED|Overall Study||3
8731450|NCT01066052|9779007|FG001|NOT COMPLETED|Overall Study||0
8731451|NCT01066104|9779014|FG000|STARTED|Overall Study||14
8731452|NCT01066104|9779015|FG001|STARTED|Overall Study||13
8731453|NCT01066104|9779014|FG000|COMPLETED|Overall Study||12
8731454|NCT01066104|9779015|FG001|COMPLETED|Overall Study||12
8731455|NCT01066104|9779014|FG000|NOT COMPLETED|Overall Study||2
8731456|NCT01066104|9779015|FG001|NOT COMPLETED|Overall Study||1
8731457|NCT01066143|9779021|FG000|STARTED|Overall Study||8
8731458|NCT01066143|9779021|FG000|COMPLETED|Overall Study||0
8731459|NCT01066143|9779021|FG000|NOT COMPLETED|Overall Study||8
8731460|NCT01066156|9779025|FG000|STARTED|Overall Study||34
8731461|NCT01066156|9779025|FG000|COMPLETED|Overall Study||24
8731462|NCT01066156|9779025|FG000|NOT COMPLETED|Overall Study||10
8731463|NCT01066364|9779031|FG000|STARTED|Overall Study||25
8731464|NCT01066364|9779032|FG001|STARTED|Overall Study||25
8731465|NCT01066364|9779031|FG000|COMPLETED|Overall Study||22
8731466|NCT01066364|9779032|FG001|COMPLETED|Overall Study||23
8731467|NCT01066364|9779031|FG000|NOT COMPLETED|Overall Study||3
8731468|NCT01066364|9779032|FG001|NOT COMPLETED|Overall Study||2
8731469|NCT01066520|9779041|FG000|STARTED|Overall Study||143
8731470|NCT01066520|9779042|FG001|STARTED|Overall Study||140
8731471|NCT01066520|9779043|FG002|STARTED|Overall Study||137
8731472|NCT01066520|9779041|FG000|COMPLETED|Overall Study||143
8731473|NCT01066520|9779042|FG001|COMPLETED|Overall Study||140
8666806|NCT00728819|9710458|FG000|STARTED|Overall Study||171
8666807|NCT00728819|9710459|FG001|STARTED|Overall Study||168
8666808|NCT00728819|9710458|FG000|COMPLETED|Overall Study||135
8666809|NCT00728819|9710459|FG001|COMPLETED|Overall Study||139
8666810|NCT00728819|9710458|FG000|NOT COMPLETED|Overall Study||36
8731474|NCT01066520|9779043|FG002|COMPLETED|Overall Study||137
8731475|NCT01066520|9779041|FG000|NOT COMPLETED|Overall Study||0
8731476|NCT01066520|9779042|FG001|NOT COMPLETED|Overall Study||0
8731477|NCT01066520|9779043|FG002|NOT COMPLETED|Overall Study||0
8666811|NCT00728819|9710459|FG001|NOT COMPLETED|Overall Study||29
8666812|NCT00728910|9710465|FG000|STARTED|Atorvastatin||25
8666813|NCT00728910|9710465|FG000|COMPLETED|Atorvastatin||22
8666814|NCT00728910|9710465|FG000|NOT COMPLETED|Atorvastatin||3
8731478|NCT01066546|9779051|FG000|STARTED|Overall Study||5
8731479|NCT01066546|9779051|FG000|COMPLETED|Overall Study||0
8666815|NCT00728910|9710465|FG000|STARTED|Atorvastatin+ABT335||22
8666816|NCT00728910|9710465|FG000|COMPLETED|Atorvastatin+ABT335||22
8666817|NCT00728910|9710465|FG000|NOT COMPLETED|Atorvastatin+ABT335||0
8666818|NCT00728910|9710465|FG000|STARTED|Atorvastatin+ABT335+ER Niacin||22
8666819|NCT00728910|9710465|FG000|COMPLETED|Atorvastatin+ABT335+ER Niacin||22
8666820|NCT00728910|9710465|FG000|NOT COMPLETED|Atorvastatin+ABT335+ER Niacin||0
8666821|NCT00728923|9710474|FG000|STARTED|Overall Study||9
8666822|NCT00728923|9710474|FG000|COMPLETED|Overall Study||9
8666823|NCT00728923|9710474|FG000|NOT COMPLETED|Overall Study||0
8666824|NCT00728936|9710485|FG000|STARTED|Overall Study||10
8666825|NCT00728936|9710486|FG001|STARTED|Overall Study||8
8666826|NCT00728936|9710487|FG002|STARTED|Overall Study||9
8666827|NCT00728936|9710488|FG003|STARTED|Overall Study||8
8666828|NCT00728936|9710489|FG004|STARTED|Overall Study||8
8666829|NCT00728936|9710490|FG005|STARTED|Overall Study||8
8666830|NCT00728936|9710491|FG006|STARTED|Overall Study||7
8666831|NCT00728936|9710485|FG000|COMPLETED|Overall Study||10
8666832|NCT00728936|9710486|FG001|COMPLETED|Overall Study||8
8666833|NCT00728936|9710487|FG002|COMPLETED|Overall Study||9
8666834|NCT00728936|9710488|FG003|COMPLETED|Overall Study||8
8666835|NCT00728936|9710489|FG004|COMPLETED|Overall Study||8
8666836|NCT00728936|9710490|FG005|COMPLETED|Overall Study||7
8666837|NCT00728936|9710491|FG006|COMPLETED|Overall Study||7
8666838|NCT00728936|9710485|FG000|NOT COMPLETED|Overall Study||0
8666839|NCT00728936|9710486|FG001|NOT COMPLETED|Overall Study||0
8666840|NCT00728936|9710487|FG002|NOT COMPLETED|Overall Study||0
8666841|NCT00728936|9710488|FG003|NOT COMPLETED|Overall Study||0
8666842|NCT00728936|9710489|FG004|NOT COMPLETED|Overall Study||0
8666843|NCT00728936|9710490|FG005|NOT COMPLETED|Overall Study||1
8666844|NCT00728936|9710491|FG006|NOT COMPLETED|Overall Study||0
8666845|NCT00728949|9710509|FG000|STARTED|Overall Study||62
8666846|NCT00728949|9710510|FG001|STARTED|Overall Study||31
8666847|NCT00728949|9710509|FG000|COMPLETED|Overall Study||51
8666848|NCT00728949|9710510|FG001|COMPLETED|Overall Study||27
8666849|NCT00728949|9710509|FG000|NOT COMPLETED|Overall Study||11
8666850|NCT00728949|9710510|FG001|NOT COMPLETED|Overall Study||4
8666851|NCT00728988|9710518|FG000|STARTED|Overall Study||247
8666852|NCT00728988|9710519|FG001|STARTED|Overall Study||252
8666853|NCT00728988|9710518|FG000|Treated|Overall Study||245
8666854|NCT00728988|9710519|FG001|Treated|Overall Study||250
8666855|NCT00728988|9710518|FG000|Full Analysis Set|Overall Study||163
8666856|NCT00728988|9710519|FG001|Full Analysis Set|Overall Study||172
8666857|NCT00728988|9710518|FG000|COMPLETED|Overall Study||154
8666858|NCT00728988|9710519|FG001|COMPLETED|Overall Study||164
8666859|NCT00728988|9710518|FG000|NOT COMPLETED|Overall Study||93
8666860|NCT00728988|9710519|FG001|NOT COMPLETED|Overall Study||88
8731480|NCT01066546|9779051|FG000|NOT COMPLETED|Overall Study||5
8731481|NCT01066585|9779057|FG000|STARTED|Overall Study||211
8731482|NCT01066585|9779058|FG001|STARTED|Overall Study||199
8731483|NCT01066585|9779057|FG000|COMPLETED|Overall Study||210
8731484|NCT01066585|9779058|FG001|COMPLETED|Overall Study||196
8731485|NCT01066585|9779057|FG000|NOT COMPLETED|Overall Study||1
8731486|NCT01066585|9779058|FG001|NOT COMPLETED|Overall Study||3
8731487|NCT01066624|9779067|FG000|STARTED|Overall Study||38
8731488|NCT01066624|9779068|FG001|STARTED|Overall Study||40
8731489|NCT01066624|9779069|FG002|STARTED|Overall Study||39
8731490|NCT01066624|9779067|FG000|COMPLETED|Overall Study||38
8731491|NCT01066624|9779068|FG001|COMPLETED|Overall Study||40
8731492|NCT01066624|9779069|FG002|COMPLETED|Overall Study||39
8731493|NCT01066624|9779067|FG000|NOT COMPLETED|Overall Study||0
8731494|NCT01066624|9779068|FG001|NOT COMPLETED|Overall Study||0
8731495|NCT01066624|9779069|FG002|NOT COMPLETED|Overall Study||0
8731496|NCT01066780|9779077|FG000|STARTED|Overall Study||24
8731497|NCT01066780|9779078|FG001|STARTED|Overall Study||24
8731498|NCT01066780|9779077|FG000|COMPLETED|Overall Study||23
8731499|NCT01066780|9779078|FG001|COMPLETED|Overall Study||23
8731500|NCT01066780|9779077|FG000|NOT COMPLETED|Overall Study||1
8731501|NCT01066780|9779078|FG001|NOT COMPLETED|Overall Study||1
8731502|NCT01066793|9779088|FG000|STARTED|Overall Study||1128
8731503|NCT01066793|9779089|FG001|STARTED|Overall Study||572
8731504|NCT01066793|9779090|FG002|STARTED|Overall Study||484
8731505|NCT01066793|9779091|FG003|STARTED|Overall Study||143
8911570|NCT02147158|9970633|FG002|STARTED|Off-Treatment Interval 2||79
8911571|NCT02147158|9970634|FG003|STARTED|Off-Treatment Interval 2||77
8666861|NCT00729053|9710530|FG000|STARTED|Overall Study||23
8666862|NCT00729053|9710531|FG001|STARTED|Overall Study||23
8666863|NCT00729053|9710532|FG002|STARTED|Overall Study||23
8666864|NCT00729053|9710533|FG003|STARTED|Overall Study||23
8666865|NCT00729053|9710530|FG000|COMPLETED|Overall Study||23
8666866|NCT00729053|9710531|FG001|COMPLETED|Overall Study||23
8666867|NCT00729053|9710532|FG002|COMPLETED|Overall Study||23
8666868|NCT00729053|9710533|FG003|COMPLETED|Overall Study||23
8666869|NCT00729053|9710530|FG000|NOT COMPLETED|Overall Study||0
8666870|NCT00729053|9710531|FG001|NOT COMPLETED|Overall Study||0
8666871|NCT00729053|9710532|FG002|NOT COMPLETED|Overall Study||0
8666872|NCT00729053|9710533|FG003|NOT COMPLETED|Overall Study||0
8666873|NCT00729157|9710543|FG000|STARTED|Overall Study||41
8666874|NCT00729157|9710543|FG000|COMPLETED|Overall Study||40
8731506|NCT01066793|9779092|FG004|STARTED|Overall Study||11
8731507|NCT01066793|9779093|FG005|STARTED|Overall Study||5
8731508|NCT01066793|9779088|FG000|COMPLETED|Overall Study||754
8731509|NCT01066793|9779089|FG001|COMPLETED|Overall Study||495
8731510|NCT01066793|9779090|FG002|COMPLETED|Overall Study||369
8666875|NCT00729157|9710543|FG000|NOT COMPLETED|Overall Study||1
8666876|NCT00729183|9710549|FG000|STARTED|Overall Study||109
8666877|NCT00729183|9710550|FG001|STARTED|Overall Study||105
8666878|NCT00729183|9710549|FG000|COMPLETED|Overall Study|Completed 24 month visit|84
8666879|NCT00729183|9710550|FG001|COMPLETED|Overall Study|Completed 24 month visit|90
8666880|NCT00729183|9710549|FG000|NOT COMPLETED|Overall Study||25
8666881|NCT00729183|9710550|FG001|NOT COMPLETED|Overall Study||15
8666882|NCT00729248|9710556|FG000|STARTED|Overall Study||12
8666883|NCT00729248|9710556|FG000|COMPLETED|Overall Study||10
8666884|NCT00729248|9710556|FG000|NOT COMPLETED|Overall Study||2
8666885|NCT00729326|9710563|FG000|STARTED|Overall Study||41
8666886|NCT00729326|9710564|FG001|STARTED|Overall Study||42
8666887|NCT00729326|9710563|FG000|COMPLETED|Overall Study||31
8666888|NCT00729326|9710564|FG001|COMPLETED|Overall Study||33
8666889|NCT00729326|9710563|FG000|NOT COMPLETED|Overall Study||10
8666890|NCT00729326|9710564|FG001|NOT COMPLETED|Overall Study||9
8666891|NCT00729378|9710572|FG000|STARTED|Baseline||430
8666892|NCT00729378|9710573|FG001|STARTED|Baseline||309
8666893|NCT00729378|9710572|FG000|COMPLETED|Baseline||292
8666894|NCT00729378|9710573|FG001|COMPLETED|Baseline||217
8666895|NCT00729378|9710572|FG000|NOT COMPLETED|Baseline||138
8666896|NCT00729378|9710573|FG001|NOT COMPLETED|Baseline||92
8666897|NCT00729378|9710572|FG000|STARTED|12-months||292
8666898|NCT00729378|9710573|FG001|STARTED|12-months||217
8666899|NCT00729378|9710572|FG000|COMPLETED|12-months||192
8666900|NCT00729378|9710573|FG001|COMPLETED|12-months||152
8666901|NCT00729378|9710572|FG000|NOT COMPLETED|12-months||100
8666902|NCT00729378|9710573|FG001|NOT COMPLETED|12-months||65
8666903|NCT00729378|9710572|FG000|STARTED|24-months||192
8666904|NCT00729378|9710573|FG001|STARTED|24-months||152
8666905|NCT00729378|9710572|FG000|COMPLETED|24-months||120
8666906|NCT00729378|9710573|FG001|COMPLETED|24-months||101
8666907|NCT00729378|9710572|FG000|NOT COMPLETED|24-months||72
8666908|NCT00729378|9710573|FG001|NOT COMPLETED|24-months||51
8666909|NCT00729378|9710572|FG000|STARTED|36-months||120
8666910|NCT00729378|9710573|FG001|STARTED|36-months||101
8666911|NCT00729378|9710572|FG000|COMPLETED|36-months||105
8666912|NCT00729378|9710573|FG001|COMPLETED|36-months||95
8666913|NCT00729378|9710572|FG000|NOT COMPLETED|36-months||15
8666914|NCT00729378|9710573|FG001|NOT COMPLETED|36-months||6
8666915|NCT00729430|9710584|FG000|STARTED|Overall Study||180
8666916|NCT00729430|9710585|FG001|STARTED|Overall Study||178
8666917|NCT00729430|9710584|FG000|COMPLETED|Overall Study||133
8666918|NCT00729430|9710585|FG001|COMPLETED|Overall Study||128
8666919|NCT00729430|9710584|FG000|NOT COMPLETED|Overall Study||47
8666920|NCT00729430|9710585|FG001|NOT COMPLETED|Overall Study||50
8666921|NCT00729469|9710594|FG000|STARTED|Overall Study||456
8666922|NCT00729469|9710595|FG001|STARTED|Overall Study||463
8666923|NCT00729469|9710594|FG000|COMPLETED|Overall Study||403
8666924|NCT00729469|9710595|FG001|COMPLETED|Overall Study||416
8666925|NCT00729469|9710594|FG000|NOT COMPLETED|Overall Study||53
8666926|NCT00729469|9710595|FG001|NOT COMPLETED|Overall Study||47
8666927|NCT00729482|9710601|FG000|STARTED|Overall Study||54
8666928|NCT00729482|9710601|FG000|COMPLETED|Overall Study||54
8666929|NCT00729482|9710601|FG000|NOT COMPLETED|Overall Study||0
8666930|NCT00729521|9710608|FG000|STARTED|Overall Study|10 communities in Control with average annual population of 12,494 residents over 65 years old.|12494
8666931|NCT00729521|9710609|FG001|STARTED|Overall Study|Five communities with average annual population of 14,842 residents over 65 years old.|14842
8666932|NCT00729521|9710610|FG002|STARTED|Overall Study|5 communities in Facilitative System with average annual pop. of 7,701 residents over 65 years.|7701
8666933|NCT00729521|9710608|FG000|COMPLETED|Overall Study|Average annual population over 65 years old.|12494
8666934|NCT00729521|9710609|FG001|COMPLETED|Overall Study|Average annual population over 65 years old.|14842
8666935|NCT00729521|9710610|FG002|COMPLETED|Overall Study|Average annual population over 65 years old.|7701
8666936|NCT00729521|9710608|FG000|NOT COMPLETED|Overall Study||0
8666937|NCT00729521|9710609|FG001|NOT COMPLETED|Overall Study||0
8666938|NCT00729521|9710610|FG002|NOT COMPLETED|Overall Study||0
8666939|NCT00729586|9710620|FG000|STARTED|Overall Study||51
8666940|NCT00729586|9710621|FG001|STARTED|Overall Study||22
8666941|NCT00729586|9710620|FG000|COMPLETED|Overall Study|Eligible and treated patients|50
8731511|NCT01066793|9779091|FG003|COMPLETED|Overall Study||94
8731512|NCT01066793|9779092|FG004|COMPLETED|Overall Study||11
8731513|NCT01066793|9779093|FG005|COMPLETED|Overall Study||4
8731514|NCT01066793|9779088|FG000|NOT COMPLETED|Overall Study||374
8911572|NCT02147158|9970635|FG004|STARTED|Off-Treatment Interval 2||41
8911573|NCT02147158|9970636|FG005|STARTED|Off-Treatment Interval 2||43
8666942|NCT00729586|9710621|FG001|COMPLETED|Overall Study|Eligible and treated patients|21
8666943|NCT00729586|9710620|FG000|NOT COMPLETED|Overall Study||1
8666944|NCT00729586|9710621|FG001|NOT COMPLETED|Overall Study||1
8666945|NCT00729612|9710628|FG000|STARTED|Overall Study||63
8666946|NCT00729612|9710628|FG000|Died Before Cycle 1|Overall Study||1
8666947|NCT00729612|9710628|FG000|Received Cycle 1|Overall Study||62
8666948|NCT00729612|9710628|FG000|Did Not Receive Cycle 2|Overall Study||7
8666949|NCT00729612|9710628|FG000|Received Cycle 2|Overall Study||54
8666950|NCT00729612|9710628|FG000|Died After Cycle 2 Before Response Eval|Overall Study||1
8666951|NCT00729612|9710628|FG000|COMPLETED|Overall Study||53
8666952|NCT00729612|9710628|FG000|NOT COMPLETED|Overall Study||10
8666953|NCT00729677|9710632|FG000|STARTED|Overall Study||64
8666954|NCT00729677|9710632|FG000|COMPLETED|Overall Study||64
8666955|NCT00729677|9710632|FG000|NOT COMPLETED|Overall Study||0
8731515|NCT01066793|9779089|FG001|NOT COMPLETED|Overall Study||77
8666956|NCT00729690|9710646|FG000|STARTED|Overall Study||16
8666957|NCT00729690|9710647|FG001|STARTED|Overall Study||16
8666958|NCT00729690|9710648|FG002|STARTED|Overall Study||16
8666959|NCT00729690|9710646|FG000|COMPLETED|Overall Study||16
8666960|NCT00729690|9710647|FG001|COMPLETED|Overall Study||14
8666961|NCT00729690|9710648|FG002|COMPLETED|Overall Study||14
8666962|NCT00729690|9710646|FG000|NOT COMPLETED|Overall Study||0
8666963|NCT00729690|9710647|FG001|NOT COMPLETED|Overall Study||2
8666964|NCT00729690|9710648|FG002|NOT COMPLETED|Overall Study||2
8666965|NCT00729781|9710656|FG000|STARTED|Original Study||45
8666966|NCT00729781|9710656|FG000|COMPLETED|Original Study||45
8666967|NCT00729781|9710656|FG000|NOT COMPLETED|Original Study||0
8666968|NCT00729781|9710656|FG000|STARTED|Long-term Follow-up Study|Enrollment in the long-term follow-up required contact and a new Informed Consent.|42
8666969|NCT00729781|9710656|FG000|COMPLETED|Long-term Follow-up Study|All subjects completed the original study, but 3 did not consent to enroll in the follow-up study.|42
8666970|NCT00729781|9710656|FG000|NOT COMPLETED|Long-term Follow-up Study||0
8666971|NCT00729807|9710660|FG000|STARTED|Overall Study||6
8666972|NCT00729807|9710660|FG000|COMPLETED|Overall Study||6
8666973|NCT00729807|9710660|FG000|NOT COMPLETED|Overall Study||0
8666974|NCT00729833|9710664|FG000|STARTED|Overall Study||20
8666975|NCT00729833|9710665|FG001|STARTED|Overall Study||7
8666976|NCT00729833|9710666|FG002|STARTED|Overall Study||12
8666977|NCT00729833|9710667|FG003|STARTED|Overall Study||6
8666978|NCT00729833|9710664|FG000|COMPLETED|Overall Study||0
8666979|NCT00729833|9710665|FG001|COMPLETED|Overall Study||0
8666980|NCT00729833|9710666|FG002|COMPLETED|Overall Study||0
8666981|NCT00729833|9710667|FG003|COMPLETED|Overall Study||0
8666982|NCT00729833|9710664|FG000|NOT COMPLETED|Overall Study||20
8666983|NCT00729833|9710665|FG001|NOT COMPLETED|Overall Study||7
8666984|NCT00729833|9710666|FG002|NOT COMPLETED|Overall Study||12
8666985|NCT00729833|9710667|FG003|NOT COMPLETED|Overall Study||6
8666986|NCT00729846|9710680|FG000|STARTED|Overall Study||11
8666987|NCT00729846|9710681|FG001|STARTED|Overall Study||11
8666988|NCT00729846|9710680|FG000|COMPLETED|Overall Study||11
8666989|NCT00729846|9710681|FG001|COMPLETED|Overall Study||11
8666990|NCT00729846|9710680|FG000|NOT COMPLETED|Overall Study||0
8666991|NCT00729846|9710681|FG001|NOT COMPLETED|Overall Study||0
8666992|NCT00729859|9710690|FG000|STARTED|Overall Study||8
8666993|NCT00729859|9710691|FG001|STARTED|Overall Study||8
8666994|NCT00729859|9710692|FG002|STARTED|Overall Study||8
8666995|NCT00729859|9710690|FG000|COMPLETED|Overall Study||8
8666996|NCT00729859|9710691|FG001|COMPLETED|Overall Study||6
8666997|NCT00729859|9710692|FG002|COMPLETED|Overall Study||8
8666998|NCT00729859|9710690|FG000|NOT COMPLETED|Overall Study||0
8666999|NCT00729859|9710691|FG001|NOT COMPLETED|Overall Study||2
8667000|NCT00729859|9710692|FG002|NOT COMPLETED|Overall Study||0
8667001|NCT00729924|9710708|FG000|STARTED|Overall Study||40
8667002|NCT00729924|9710708|FG000|COMPLETED|Overall Study||40
8667003|NCT00729924|9710708|FG000|NOT COMPLETED|Overall Study||0
8667004|NCT00729937|9710721|FG000|STARTED|Overall Study||629
8667005|NCT00729937|9710722|FG001|STARTED|Overall Study||636
8667006|NCT00729937|9710723|FG002|STARTED|Overall Study||251
8667007|NCT00729937|9710724|FG003|STARTED|Overall Study||249
8667008|NCT00729937|9710725|FG004|STARTED|Overall Study||249
8667009|NCT00729937|9710726|FG005|STARTED|Overall Study||251
8667010|NCT00729937|9710721|FG000|COMPLETED|Overall Study||555
8667011|NCT00729937|9710722|FG001|COMPLETED|Overall Study||548
8667012|NCT00729937|9710723|FG002|COMPLETED|Overall Study||222
8667013|NCT00729937|9710724|FG003|COMPLETED|Overall Study||215
8667014|NCT00729937|9710725|FG004|COMPLETED|Overall Study||221
8667015|NCT00729937|9710726|FG005|COMPLETED|Overall Study||214
8667016|NCT00729937|9710721|FG000|NOT COMPLETED|Overall Study||74
8667017|NCT00729937|9710722|FG001|NOT COMPLETED|Overall Study||88
8667018|NCT00729937|9710723|FG002|NOT COMPLETED|Overall Study||29
8667019|NCT00729937|9710724|FG003|NOT COMPLETED|Overall Study||34
8667020|NCT00729937|9710725|FG004|NOT COMPLETED|Overall Study||28
8667021|NCT00729937|9710726|FG005|NOT COMPLETED|Overall Study||37
8667022|NCT00730015|9710743|FG000|STARTED|Overall Study||217
8667023|NCT00730015|9710744|FG001|STARTED|Overall Study||217
8667024|NCT00730015|9710745|FG002|STARTED|Overall Study||209
8667025|NCT00730015|9710743|FG000|COMPLETED|Overall Study||186
8731516|NCT01066793|9779090|FG002|NOT COMPLETED|Overall Study||115
8731517|NCT01066793|9779091|FG003|NOT COMPLETED|Overall Study||49
8667026|NCT00730015|9710744|FG001|COMPLETED|Overall Study||177
8667027|NCT00730015|9710745|FG002|COMPLETED|Overall Study||177
8667028|NCT00730015|9710743|FG000|NOT COMPLETED|Overall Study||31
8667029|NCT00730015|9710744|FG001|NOT COMPLETED|Overall Study||40
8731518|NCT01066793|9779092|FG004|NOT COMPLETED|Overall Study||0
8731519|NCT01066793|9779093|FG005|NOT COMPLETED|Overall Study||1
8667030|NCT00730015|9710745|FG002|NOT COMPLETED|Overall Study||32
8667031|NCT00730028|9710763|FG000|STARTED|Overall Study||264
8667032|NCT00730028|9710764|FG001|STARTED|Overall Study||260
8667033|NCT00730028|9710765|FG002|STARTED|Overall Study||266
8667034|NCT00730028|9710766|FG003|STARTED|Overall Study||263
8667035|NCT00730028|9710767|FG004|STARTED|Overall Study||257
8667036|NCT00730028|9710763|FG000|COMPLETED|Overall Study||204
8667037|NCT00730028|9710764|FG001|COMPLETED|Overall Study||194
8667038|NCT00730028|9710765|FG002|COMPLETED|Overall Study||221
8667039|NCT00730028|9710766|FG003|COMPLETED|Overall Study||207
8667040|NCT00730028|9710767|FG004|COMPLETED|Overall Study||175
8667041|NCT00730028|9710763|FG000|NOT COMPLETED|Overall Study||60
8667042|NCT00730028|9710764|FG001|NOT COMPLETED|Overall Study||66
8667043|NCT00730028|9710765|FG002|NOT COMPLETED|Overall Study||45
8667044|NCT00730028|9710766|FG003|NOT COMPLETED|Overall Study||56
8667045|NCT00730028|9710767|FG004|NOT COMPLETED|Overall Study||82
8667046|NCT00730041|9710781|FG000|STARTED|Overall Study|4/26 (15.4%) female, 22/26 (84.6%) male|26
8667047|NCT00730041|9710782|FG001|STARTED|Overall Study|4/25 (16.0%) female, 21/25 (84.0%) male|25
8667048|NCT00730041|9710781|FG000|COMPLETED|Overall Study||26
8667049|NCT00730041|9710782|FG001|COMPLETED|Overall Study|One subject did not return for the final PSG or final visit, and one missed only the final visit.|23
8667050|NCT00730041|9710781|FG000|NOT COMPLETED|Overall Study||0
8667051|NCT00730041|9710782|FG001|NOT COMPLETED|Overall Study||2
8667052|NCT00730158|9710790|FG000|STARTED|Overall Study||17
8667053|NCT00730158|9710791|FG001|STARTED|Overall Study||16
8667054|NCT00730158|9710790|FG000|COMPLETED|Overall Study||16
8667055|NCT00730158|9710791|FG001|COMPLETED|Overall Study||15
8667056|NCT00730158|9710790|FG000|NOT COMPLETED|Overall Study||1
8667057|NCT00730158|9710791|FG001|NOT COMPLETED|Overall Study||1
8667058|NCT00730171|9710801|FG000|STARTED|Overall Study||1725
8667059|NCT00730171|9710801|FG000|CC Safety Population|Overall Study||607
8667060|NCT00730171|9710801|FG000|IBS-C Safety Population|Overall Study||1119
8667061|NCT00730171|9710801|FG000|COMPLETED|Overall Study||954
8667062|NCT00730171|9710801|FG000|NOT COMPLETED|Overall Study||771
8667063|NCT00730236|9710809|FG000|STARTED|Overall Study||29
8667064|NCT00730236|9710809|FG000|COMPLETED|Overall Study||23
8667065|NCT00730236|9710809|FG000|NOT COMPLETED|Overall Study||6
8667066|NCT00730275|9710817|FG000|STARTED|Overall Study||9
8667067|NCT00730275|9710818|FG001|STARTED|Overall Study||9
8667068|NCT00730275|9710819|FG002|STARTED|Overall Study||8
8667069|NCT00730275|9710820|FG003|STARTED|Overall Study||9
8667070|NCT00730275|9710817|FG000|COMPLETED|Overall Study||9
8667071|NCT00730275|9710818|FG001|COMPLETED|Overall Study||9
8667072|NCT00730275|9710819|FG002|COMPLETED|Overall Study||8
8667073|NCT00730275|9710820|FG003|COMPLETED|Overall Study||8
8667074|NCT00730275|9710817|FG000|NOT COMPLETED|Overall Study||0
8667075|NCT00730275|9710818|FG001|NOT COMPLETED|Overall Study||0
8667076|NCT00730275|9710819|FG002|NOT COMPLETED|Overall Study||0
8667077|NCT00730275|9710820|FG003|NOT COMPLETED|Overall Study||1
8667078|NCT00730327|9710833|FG000|STARTED|Overall Study|Started is defined as subjects that began treatment.|125
8667079|NCT00730327|9710834|FG001|STARTED|Overall Study||130
8667080|NCT00730327|9710833|FG000|Completed Week 26|Overall Study|Week 26 was halfway through the study, at which point the BIB group had their balloon removed.|125
8667081|NCT00730327|9710834|FG001|Completed Week 26|Overall Study||99
8667082|NCT00730327|9710833|FG000|COMPLETED|Overall Study|Completed defined as subjects who completed the Week 52 follow-up visit.|98
8667083|NCT00730327|9710834|FG001|COMPLETED|Overall Study||93
8667084|NCT00730327|9710833|FG000|NOT COMPLETED|Overall Study||27
8667085|NCT00730327|9710834|FG001|NOT COMPLETED|Overall Study||37
8667086|NCT00730353|9710840|FG000|STARTED|Overall Study||28
8667087|NCT00730353|9710840|FG000|COMPLETED|Overall Study||28
8667088|NCT00730353|9710840|FG000|NOT COMPLETED|Overall Study||0
8667089|NCT00730405|9710849|FG000|STARTED|Overall Study-Treatment Phase||116
8667090|NCT00730405|9710850|FG001|STARTED|Overall Study-Treatment Phase||117
8667091|NCT00730405|9710851|FG002|STARTED|Overall Study-Treatment Phase||117
8667092|NCT00730405|9710852|FG003|STARTED|Overall Study-Treatment Phase||117
8667093|NCT00730405|9710853|FG004|STARTED|Overall Study-Treatment Phase||115
8667094|NCT00730405|9710849|FG000|COMPLETED|Overall Study-Treatment Phase||97
8667095|NCT00730405|9710850|FG001|COMPLETED|Overall Study-Treatment Phase||96
8667096|NCT00730405|9710851|FG002|COMPLETED|Overall Study-Treatment Phase||96
8667097|NCT00730405|9710852|FG003|COMPLETED|Overall Study-Treatment Phase||98
8667098|NCT00730405|9710853|FG004|COMPLETED|Overall Study-Treatment Phase||95
8667099|NCT00730405|9710849|FG000|NOT COMPLETED|Overall Study-Treatment Phase||19
8667100|NCT00730405|9710850|FG001|NOT COMPLETED|Overall Study-Treatment Phase||21
8667101|NCT00730405|9710851|FG002|NOT COMPLETED|Overall Study-Treatment Phase||21
8667102|NCT00730405|9710852|FG003|NOT COMPLETED|Overall Study-Treatment Phase||19
8667103|NCT00730405|9710853|FG004|NOT COMPLETED|Overall Study-Treatment Phase||20
8667104|NCT00730405|9710849|FG000|STARTED|Overall Study-follow-up Phase||116
8667105|NCT00730405|9710850|FG001|STARTED|Overall Study-follow-up Phase||117
8667106|NCT00730405|9710851|FG002|STARTED|Overall Study-follow-up Phase||117
8667107|NCT00730405|9710852|FG003|STARTED|Overall Study-follow-up Phase||117
8667108|NCT00730405|9710853|FG004|STARTED|Overall Study-follow-up Phase||115
8667109|NCT00730405|9710849|FG000|COMPLETED|Overall Study-follow-up Phase||95
8667110|NCT00730405|9710850|FG001|COMPLETED|Overall Study-follow-up Phase||96
8667111|NCT00730405|9710851|FG002|COMPLETED|Overall Study-follow-up Phase||94
8667112|NCT00730405|9710852|FG003|COMPLETED|Overall Study-follow-up Phase||100
8667113|NCT00730405|9710853|FG004|COMPLETED|Overall Study-follow-up Phase||93
8667114|NCT00730405|9710849|FG000|NOT COMPLETED|Overall Study-follow-up Phase||21
8667115|NCT00730405|9710850|FG001|NOT COMPLETED|Overall Study-follow-up Phase||21
8667116|NCT00730405|9710851|FG002|NOT COMPLETED|Overall Study-follow-up Phase||23
8667117|NCT00730405|9710852|FG003|NOT COMPLETED|Overall Study-follow-up Phase||17
8667118|NCT00730405|9710853|FG004|NOT COMPLETED|Overall Study-follow-up Phase||22
8667119|NCT00730483|9710867|FG000|STARTED|Overall Study||13
8667120|NCT00730483|9710867|FG000|1 Month After First DEB-TACE|Overall Study||13
8667121|NCT00730483|9710867|FG000|6 Months After First DEB-TACE|Overall Study||10
8667122|NCT00730483|9710867|FG000|COMPLETED|Overall Study||6
8667123|NCT00730483|9710867|FG000|NOT COMPLETED|Overall Study||7
8667124|NCT00730522|9710874|FG000|STARTED|Overall Study||28
8667125|NCT00730522|9710875|FG001|STARTED|Overall Study||27
8667126|NCT00730522|9710874|FG000|COMPLETED|Overall Study||28
8667127|NCT00730522|9710875|FG001|COMPLETED|Overall Study||27
8667128|NCT00730522|9710874|FG000|NOT COMPLETED|Overall Study||0
8667129|NCT00730522|9710875|FG001|NOT COMPLETED|Overall Study||0
8667130|NCT00730691|9710888|FG000|STARTED|Overall Study||157
8667131|NCT00730691|9710889|FG001|STARTED|Overall Study||156
8667132|NCT00730691|9710890|FG002|STARTED|Overall Study|One participant was randomized by error. Reason not completed is reported as Other.|156
8667133|NCT00730691|9710891|FG003|STARTED|Overall Study||156
8667134|NCT00730691|9710892|FG004|STARTED|Overall Study||156
8731520|NCT01066819|9779114|FG000|STARTED|Overall Study||1006
8731521|NCT01066819|9779115|FG001|STARTED|Overall Study||348
8731522|NCT01066819|9779116|FG002|STARTED|Overall Study||257
8731523|NCT01066819|9779117|FG003|STARTED|Overall Study||25
8731524|NCT01066819|9779118|FG004|STARTED|Overall Study||7
8731525|NCT01066819|9779119|FG005|STARTED|Overall Study||13
8731526|NCT01066819|9779114|FG000|COMPLETED|Overall Study||317
8731527|NCT01066819|9779115|FG001|COMPLETED|Overall Study||177
8731528|NCT01066819|9779116|FG002|COMPLETED|Overall Study||111
8731529|NCT01066819|9779117|FG003|COMPLETED|Overall Study||8
8731530|NCT01066819|9779118|FG004|COMPLETED|Overall Study||3
8731531|NCT01066819|9779119|FG005|COMPLETED|Overall Study||7
8731532|NCT01066819|9779114|FG000|NOT COMPLETED|Overall Study||689
8731533|NCT01066819|9779115|FG001|NOT COMPLETED|Overall Study||171
8731534|NCT01066819|9779116|FG002|NOT COMPLETED|Overall Study||146
8731535|NCT01066819|9779117|FG003|NOT COMPLETED|Overall Study||17
8731536|NCT01066819|9779118|FG004|NOT COMPLETED|Overall Study||4
8731537|NCT01066819|9779119|FG005|NOT COMPLETED|Overall Study||6
8731538|NCT01066871|9779135|FG000|STARTED|Overall Study||20
8731539|NCT01066871|9779136|FG001|STARTED|Overall Study||18
8731540|NCT01066871|9779137|FG002|STARTED|Overall Study||18
8731541|NCT01066871|9779138|FG003|STARTED|Overall Study||18
8731542|NCT01066871|9779135|FG000|COMPLETED|Overall Study||16
8731543|NCT01066871|9779136|FG001|COMPLETED|Overall Study||13
8731544|NCT01066871|9779137|FG002|COMPLETED|Overall Study||12
8731545|NCT01066871|9779138|FG003|COMPLETED|Overall Study||13
8731546|NCT01066871|9779135|FG000|NOT COMPLETED|Overall Study||4
8731547|NCT01066871|9779136|FG001|NOT COMPLETED|Overall Study||5
8731548|NCT01066871|9779137|FG002|NOT COMPLETED|Overall Study||6
8731549|NCT01066871|9779138|FG003|NOT COMPLETED|Overall Study||5
8731550|NCT01066897|9779155|FG000|STARTED|Overall Study||7
8731551|NCT01066897|9779156|FG001|STARTED|Overall Study||9
8731552|NCT01066897|9779155|FG000|COMPLETED|Overall Study||5
8731553|NCT01066897|9779156|FG001|COMPLETED|Overall Study||9
8731554|NCT01066897|9779155|FG000|NOT COMPLETED|Overall Study||2
8731555|NCT01066897|9779156|FG001|NOT COMPLETED|Overall Study||0
8731556|NCT01066923|9779167|FG000|STARTED|Overall Study||28
8731557|NCT01066923|9779168|FG001|STARTED|Overall Study||32
8731558|NCT01066923|9779169|FG002|STARTED|Overall Study||33
8731559|NCT01066923|9779170|FG003|STARTED|Overall Study||31
8731560|NCT01066923|9779167|FG000|Platelet Closure Time|Overall Study||25
8731561|NCT01066923|9779168|FG001|Platelet Closure Time|Overall Study||29
8731562|NCT01066923|9779169|FG002|Platelet Closure Time|Overall Study||25
8731563|NCT01066923|9779170|FG003|Platelet Closure Time|Overall Study||23
8731564|NCT01066923|9779167|FG000|Vascular Function|Overall Study||13
8731565|NCT01066923|9779168|FG001|Vascular Function|Overall Study||14
8731566|NCT01066923|9779169|FG002|Vascular Function|Overall Study||12
8731567|NCT01066923|9779170|FG003|Vascular Function|Overall Study||13
8731568|NCT01066923|9779167|FG000|Activation of Coagulation|Overall Study||0
8731569|NCT01066923|9779168|FG001|Activation of Coagulation|Overall Study||0
8731570|NCT01066923|9779169|FG002|Activation of Coagulation|Overall Study||0
8731571|NCT01066923|9779170|FG003|Activation of Coagulation|Overall Study||0
8731572|NCT01066923|9779167|FG000|Retinal Imaging|Overall Study||0
8731573|NCT01066923|9779168|FG001|Retinal Imaging|Overall Study||0
8731574|NCT01066923|9779169|FG002|Retinal Imaging|Overall Study||0
8731575|NCT01066923|9779170|FG003|Retinal Imaging|Overall Study||0
8731576|NCT01066923|9779167|FG000|COMPLETED|Overall Study||25
8731577|NCT01066923|9779168|FG001|COMPLETED|Overall Study||29
8667135|NCT00730691|9710888|FG000|COMPLETED|Overall Study||121
8731578|NCT01066923|9779169|FG002|COMPLETED|Overall Study||25
8731579|NCT01066923|9779170|FG003|COMPLETED|Overall Study||23
8731580|NCT01066923|9779167|FG000|NOT COMPLETED|Overall Study||3
8731581|NCT01066923|9779168|FG001|NOT COMPLETED|Overall Study||3
8731582|NCT01066923|9779169|FG002|NOT COMPLETED|Overall Study||8
8731583|NCT01066923|9779170|FG003|NOT COMPLETED|Overall Study||8
8731584|NCT01066936|9779180|FG000|STARTED|Overall Study||20
8731585|NCT01066936|9779180|FG000|COMPLETED|Overall Study||10
8731586|NCT01066936|9779180|FG000|NOT COMPLETED|Overall Study||10
8731587|NCT01067105|9779186|FG000|STARTED|Overall Study||824
8731588|NCT01067105|9779186|FG000|COMPLETED|Overall Study||683
8731589|NCT01067105|9779186|FG000|NOT COMPLETED|Overall Study||141
8731590|NCT01067326|9779192|FG000|STARTED|Overall Study||14
8731591|NCT01067326|9779193|FG001|STARTED|Overall Study||8
8667136|NCT00730691|9710889|FG001|COMPLETED|Overall Study||120
8667137|NCT00730691|9710890|FG002|COMPLETED|Overall Study||117
8731592|NCT01067326|9779192|FG000|COMPLETED|Overall Study||12
8731593|NCT01067326|9779193|FG001|COMPLETED|Overall Study||5
8731594|NCT01067326|9779192|FG000|NOT COMPLETED|Overall Study||2
8731595|NCT01067326|9779193|FG001|NOT COMPLETED|Overall Study||3
8731596|NCT01067339|9779201|FG000|STARTED|Overall Study||31
8731597|NCT01067339|9779202|FG001|STARTED|Overall Study||34
8667138|NCT00730691|9710891|FG003|COMPLETED|Overall Study||111
8667139|NCT00730691|9710892|FG004|COMPLETED|Overall Study||106
8667140|NCT00730691|9710888|FG000|NOT COMPLETED|Overall Study||36
8667141|NCT00730691|9710889|FG001|NOT COMPLETED|Overall Study||36
8667142|NCT00730691|9710890|FG002|NOT COMPLETED|Overall Study||39
8667143|NCT00730691|9710891|FG003|NOT COMPLETED|Overall Study||45
8667144|NCT00730691|9710892|FG004|NOT COMPLETED|Overall Study||50
8692502|NCT00861380|9737985|FG004|STARTED|Overall Study||1812
8692503|NCT00861380|9737986|FG005|STARTED|Overall Study||6249
8692504|NCT00861380|9737987|FG006|STARTED|Overall Study||3020
8692505|NCT00861380|9737981|FG000|COMPLETED|Overall Study||0
8692506|NCT00861380|9737982|FG001|COMPLETED|Overall Study||0
8692507|NCT00861380|9737983|FG002|COMPLETED|Overall Study||0
8692508|NCT00861380|9737984|FG003|COMPLETED|Overall Study||0
8692509|NCT00861380|9737985|FG004|COMPLETED|Overall Study||0
8692510|NCT00861380|9737986|FG005|COMPLETED|Overall Study||0
8692511|NCT00861380|9737987|FG006|COMPLETED|Overall Study||0
8692512|NCT00861380|9737981|FG000|NOT COMPLETED|Overall Study||8427
8692513|NCT00861380|9737982|FG001|NOT COMPLETED|Overall Study||9112
8692514|NCT00861380|9737983|FG002|NOT COMPLETED|Overall Study||8872
8692515|NCT00861380|9737984|FG003|NOT COMPLETED|Overall Study||3689
8692516|NCT00861380|9737985|FG004|NOT COMPLETED|Overall Study||1812
8692517|NCT00861380|9737986|FG005|NOT COMPLETED|Overall Study||6249
8692518|NCT00861380|9737987|FG006|NOT COMPLETED|Overall Study||3020
8692519|NCT00861471|9738020|FG000|STARTED|Overall Study||12
8692520|NCT00861471|9738020|FG000|COMPLETED|Overall Study||3
8692521|NCT00861471|9738020|FG000|NOT COMPLETED|Overall Study||9
8692522|NCT00861601|9738027|FG000|STARTED|Overall Study||12
8692523|NCT00861601|9738028|FG001|STARTED|Overall Study||14
8692524|NCT00861601|9738029|FG002|STARTED|Overall Study||12
8692525|NCT00861601|9738027|FG000|COMPLETED|Overall Study||12
8692526|NCT00861601|9738028|FG001|COMPLETED|Overall Study||14
8692527|NCT00861601|9738029|FG002|COMPLETED|Overall Study||12
8692528|NCT00861601|9738027|FG000|NOT COMPLETED|Overall Study||0
8692529|NCT00861601|9738028|FG001|NOT COMPLETED|Overall Study||0
8692530|NCT00861601|9738029|FG002|NOT COMPLETED|Overall Study||0
8692531|NCT00861614|9738042|FG000|STARTED|Overall Study||393
8692532|NCT00861614|9738043|FG001|STARTED|Overall Study||396
8692533|NCT00861614|9738042|FG000|COMPLETED|Overall Study||22
8692534|NCT00861614|9738043|FG001|COMPLETED|Overall Study||28
8692535|NCT00861614|9738042|FG000|NOT COMPLETED|Overall Study||371
8692536|NCT00861614|9738043|FG001|NOT COMPLETED|Overall Study||368
8692537|NCT00861692|9738049|FG000|STARTED|Overall Study||20
8692538|NCT00861692|9738049|FG000|COMPLETED|Overall Study||14
8692539|NCT00861692|9738049|FG000|NOT COMPLETED|Overall Study||6
8692540|NCT00861744|9738057|FG000|STARTED|Overall Study||304
8692541|NCT00861744|9738058|FG001|STARTED|Overall Study||304
8692542|NCT00861744|9738059|FG002|STARTED|Overall Study||304
8692543|NCT00861744|9738060|FG003|STARTED|Overall Study||308
8692544|NCT00861744|9738057|FG000|COMPLETED|Overall Study||287
8692545|NCT00861744|9738058|FG001|COMPLETED|Overall Study||275
8692546|NCT00861744|9738059|FG002|COMPLETED|Overall Study||280
8692547|NCT00861744|9738060|FG003|COMPLETED|Overall Study||275
8692548|NCT00861744|9738057|FG000|NOT COMPLETED|Overall Study||17
8692549|NCT00861744|9738058|FG001|NOT COMPLETED|Overall Study||29
8692550|NCT00861744|9738059|FG002|NOT COMPLETED|Overall Study||24
8692551|NCT00861744|9738060|FG003|NOT COMPLETED|Overall Study||33
8692552|NCT00861757|9738074|FG000|STARTED|Overall Study||154
8692553|NCT00861757|9738075|FG001|STARTED|Overall Study||151
8692554|NCT00861757|9738076|FG002|STARTED|Overall Study||155
8692555|NCT00861757|9738077|FG003|STARTED|Overall Study||152
8692556|NCT00861757|9738074|FG000|COMPLETED|Overall Study||145
8692557|NCT00861757|9738075|FG001|COMPLETED|Overall Study||136
8692558|NCT00861757|9738076|FG002|COMPLETED|Overall Study||137
8692559|NCT00861757|9738077|FG003|COMPLETED|Overall Study||143
8692560|NCT00861757|9738074|FG000|NOT COMPLETED|Overall Study||9
8692561|NCT00861757|9738075|FG001|NOT COMPLETED|Overall Study||15
8692562|NCT00861757|9738076|FG002|NOT COMPLETED|Overall Study||18
8692563|NCT00861757|9738077|FG003|NOT COMPLETED|Overall Study||9
8692564|NCT00861913|9738091|FG000|STARTED|Overall Study||13
8692565|NCT00861913|9738091|FG000|COMPLETED|Overall Study||13
8692566|NCT00861913|9738091|FG000|NOT COMPLETED|Overall Study||0
8692567|NCT00862082|9738097|FG000|STARTED|Overall Study||8
8692568|NCT00862082|9738098|FG001|STARTED|Overall Study||6
8692569|NCT00862082|9738097|FG000|COMPLETED|Overall Study||3
8692570|NCT00862082|9738098|FG001|COMPLETED|Overall Study||5
8692571|NCT00862082|9738097|FG000|NOT COMPLETED|Overall Study||5
8692572|NCT00862082|9738098|FG001|NOT COMPLETED|Overall Study||1
8692573|NCT00862121|9738113|FG000|STARTED|Overall Study||8
8692574|NCT00862121|9738114|FG001|STARTED|Overall Study|Randomised, intent-to-treat (ITT)|12
8692575|NCT00862121|9738113|FG000|Full Analysis Set (FAS)|Overall Study|One participant had no evaluable post-baseline CDAI score.|7
8692576|NCT00862121|9738114|FG001|Full Analysis Set (FAS)|Overall Study|One participant randomised in error (no IMP taken).|11
8692577|NCT00862121|9738113|FG000|Safety Analysis Set|Overall Study|The participant with no evaluable post-baseline CDAI score was included in the Safety Analysis Set.|8
8692578|NCT00862121|9738114|FG001|Safety Analysis Set|Overall Study||11
8692579|NCT00862121|9738113|FG000|COMPLETED|Overall Study||7
8692580|NCT00862121|9738114|FG001|COMPLETED|Overall Study||4
8692581|NCT00862121|9738113|FG000|NOT COMPLETED|Overall Study||1
8692582|NCT00862121|9738114|FG001|NOT COMPLETED|Overall Study||8
8692583|NCT00862134|9738122|FG000|STARTED|Overall Study||19
8692584|NCT00862134|9738123|FG001|STARTED|Overall Study||23
8667145|NCT00730730|9710904|FG000|STARTED|Overall Study||50
8667146|NCT00730730|9710904|FG000|COMPLETED|Overall Study||50
8667147|NCT00730730|9710904|FG000|NOT COMPLETED|Overall Study||0
8667148|NCT00730756|9710910|FG000|STARTED|Overall Study||49
8667149|NCT00730756|9710911|FG001|STARTED|Overall Study||53
8667150|NCT00730756|9710910|FG000|COMPLETED|Overall Study||45
8667151|NCT00730756|9710911|FG001|COMPLETED|Overall Study||48
8667152|NCT00730756|9710910|FG000|NOT COMPLETED|Overall Study||4
8667153|NCT00730756|9710911|FG001|NOT COMPLETED|Overall Study||5
8667154|NCT00730847|9710917|FG000|STARTED|Overall Study||596
8667155|NCT00730847|9710917|FG000|COMPLETED|Overall Study||465
8667156|NCT00730847|9710917|FG000|NOT COMPLETED|Overall Study||131
8667157|NCT00730912|9710924|FG000|STARTED|Overall Study||53
8667158|NCT00730912|9710925|FG001|STARTED|Overall Study||104
8667159|NCT00730912|9710926|FG002|STARTED|Overall Study||104
8667160|NCT00730912|9710924|FG000|COMPLETED|Overall Study||53
8667161|NCT00730912|9710925|FG001|COMPLETED|Overall Study||104
8667162|NCT00730912|9710926|FG002|COMPLETED|Overall Study||103
8667163|NCT00730912|9710924|FG000|NOT COMPLETED|Overall Study||0
8667164|NCT00730912|9710925|FG001|NOT COMPLETED|Overall Study||0
8667165|NCT00730912|9710926|FG002|NOT COMPLETED|Overall Study||1
8667166|NCT00730925|9710934|FG000|STARTED|Overall Study||41
8667167|NCT00730925|9710934|FG000|COMPLETED|Overall Study|On treatment at analysis cut-off date|0
8667168|NCT00730925|9710934|FG000|NOT COMPLETED|Overall Study||41
8667169|NCT00730964|9710938|FG000|STARTED|Overall Study||1039
8667170|NCT00730964|9710938|FG000|COMPLETED|Overall Study||1039
8667171|NCT00730964|9710938|FG000|NOT COMPLETED|Overall Study||0
8667172|NCT00731042|9710945|FG000|STARTED|First Intervention||16
8667173|NCT00731042|9710946|FG001|STARTED|First Intervention||17
8667174|NCT00731042|9710945|FG000|COMPLETED|First Intervention||16
8667175|NCT00731042|9710946|FG001|COMPLETED|First Intervention||17
8667176|NCT00731042|9710945|FG000|NOT COMPLETED|First Intervention||0
8667177|NCT00731042|9710946|FG001|NOT COMPLETED|First Intervention||0
8667178|NCT00731042|9710945|FG000|STARTED|Wash-out||16
8667179|NCT00731042|9710946|FG001|STARTED|Wash-out||17
8667180|NCT00731042|9710945|FG000|COMPLETED|Wash-out||16
8667181|NCT00731042|9710946|FG001|COMPLETED|Wash-out||17
8667182|NCT00731042|9710945|FG000|NOT COMPLETED|Wash-out||0
8667183|NCT00731042|9710946|FG001|NOT COMPLETED|Wash-out||0
8667184|NCT00731042|9710945|FG000|STARTED|Second Intervention||16
8667185|NCT00731042|9710946|FG001|STARTED|Second Intervention||17
8667186|NCT00731042|9710945|FG000|COMPLETED|Second Intervention||16
8667187|NCT00731042|9710946|FG001|COMPLETED|Second Intervention|2 subjects did not met inclusion criteria for Period 2 Visual scoring skin condition|15
8667188|NCT00731042|9710945|FG000|NOT COMPLETED|Second Intervention||0
8667189|NCT00731042|9710946|FG001|NOT COMPLETED|Second Intervention||2
8667190|NCT00731055|9710952|FG000|STARTED|Overall Study|This is a within-subjects study design.|16
8667191|NCT00731055|9710952|FG000|Received Placebo|Overall Study||16
8667192|NCT00731055|9710952|FG000|Received Varenicline 0.5 mg|Overall Study||16
8667193|NCT00731055|9710952|FG000|Received Varenicline 1.0 mg|Overall Study||16
8667194|NCT00731055|9710952|FG000|Received Varenicline 2.0 mg|Overall Study||16
8667195|NCT00731055|9710952|FG000|COMPLETED|Overall Study||16
8667196|NCT00731055|9710952|FG000|NOT COMPLETED|Overall Study||0
8667197|NCT00731094|9710961|FG000|STARTED|Overall Study||116
8667198|NCT00731094|9710962|FG001|STARTED|Overall Study||116
8667199|NCT00731094|9710961|FG000|Month 6|Overall Study||101
8667200|NCT00731094|9710962|FG001|Month 6|Overall Study||107
8667201|NCT00731094|9710961|FG000|COMPLETED|Overall Study||98
8667202|NCT00731094|9710962|FG001|COMPLETED|Overall Study||105
8667203|NCT00731094|9710961|FG000|NOT COMPLETED|Overall Study||18
8667204|NCT00731094|9710962|FG001|NOT COMPLETED|Overall Study||11
8667205|NCT00731120|9710971|FG000|STARTED|Overall Study||153
8667206|NCT00731120|9710972|FG001|STARTED|Overall Study||152
8667207|NCT00731120|9710973|FG002|STARTED|Overall Study||152
8667208|NCT00731120|9710971|FG000|Treated|Overall Study||153
8667209|NCT00731120|9710972|FG001|Treated|Overall Study||151
8667210|NCT00731120|9710973|FG002|Treated|Overall Study||152
8667211|NCT00731120|9710971|FG000|COMPLETED|Overall Study||111
8667212|NCT00731120|9710972|FG001|COMPLETED|Overall Study||109
8667213|NCT00731120|9710973|FG002|COMPLETED|Overall Study||116
8667214|NCT00731120|9710971|FG000|NOT COMPLETED|Overall Study||42
8667215|NCT00731120|9710972|FG001|NOT COMPLETED|Overall Study||43
8667216|NCT00731120|9710973|FG002|NOT COMPLETED|Overall Study||36
8667217|NCT00731133|9710981|FG000|STARTED|Overall Study||15
8667218|NCT00731133|9710981|FG000|COMPLETED|Overall Study||5
8667219|NCT00731133|9710981|FG000|NOT COMPLETED|Overall Study||10
8667220|NCT00731198|9710987|FG000|STARTED|Overall Study||325
8667221|NCT00731198|9710988|FG001|STARTED|Overall Study||325
8667222|NCT00731198|9710987|FG000|COMPLETED|Overall Study||319
8667223|NCT00731198|9710988|FG001|COMPLETED|Overall Study||319
8667224|NCT00731198|9710987|FG000|NOT COMPLETED|Overall Study||6
8667225|NCT00731198|9710988|FG001|NOT COMPLETED|Overall Study||6
8667226|NCT00731211|9710994|FG000|STARTED|Overall Study|2 patients ineligible (papillary histologic type-1 pt. Previous treatment with everolimus alone-1 pt|55
8667227|NCT00731211|9710994|FG000|COMPLETED|Overall Study||55
8667228|NCT00731211|9710994|FG000|NOT COMPLETED|Overall Study||0
8667229|NCT00731341|9710998|FG000|STARTED|Overall Study||3
8667230|NCT00731341|9710998|FG000|COMPLETED|Overall Study||3
8667231|NCT00731341|9710998|FG000|NOT COMPLETED|Overall Study||0
8667232|NCT00731484|9711002|FG000|STARTED|Overall Study||233
8667233|NCT00731484|9711002|FG000|COMPLETED|Overall Study||233
8667234|NCT00731484|9711002|FG000|NOT COMPLETED|Overall Study||0
8667235|NCT00731549|9711006|FG000|STARTED|Overall Study||1081
8667236|NCT00731549|9711006|FG000|COMPLETED|Overall Study||858
8667237|NCT00731549|9711006|FG000|NOT COMPLETED|Overall Study||223
8667238|NCT00731588|9711012|FG000|STARTED|Overall Study||9
8667239|NCT00731588|9711013|FG001|STARTED|Overall Study||95
8667240|NCT00731588|9711012|FG000|COMPLETED|Overall Study||9
8667241|NCT00731588|9711013|FG001|COMPLETED|Overall Study||53
8667242|NCT00731588|9711012|FG000|NOT COMPLETED|Overall Study||0
8667243|NCT00731588|9711013|FG001|NOT COMPLETED|Overall Study||42
8667244|NCT00731614|9711022|FG000|STARTED|Overall Study||23
8667245|NCT00731614|9711023|FG001|STARTED|Overall Study||31
8667246|NCT00731614|9711022|FG000|End of Treatment|Overall Study||16
8667247|NCT00731614|9711023|FG001|End of Treatment|Overall Study||24
8667248|NCT00731614|9711022|FG000|12 Weeks Posttreatment|Overall Study||18
8667249|NCT00731614|9711023|FG001|12 Weeks Posttreatment|Overall Study||23
8667250|NCT00731614|9711022|FG000|COMPLETED|Overall Study||16
8667251|NCT00731614|9711023|FG001|COMPLETED|Overall Study||18
8667252|NCT00731614|9711022|FG000|NOT COMPLETED|Overall Study||7
8667253|NCT00731614|9711023|FG001|NOT COMPLETED|Overall Study||13
8667254|NCT00731640|9711031|FG000|STARTED|Overall Study||20
8667255|NCT00731640|9711032|FG001|STARTED|Overall Study||32
8667256|NCT00731640|9711031|FG000|COMPLETED|Overall Study||20
8667257|NCT00731640|9711032|FG001|COMPLETED|Overall Study||32
8667258|NCT00731640|9711031|FG000|NOT COMPLETED|Overall Study||0
8667259|NCT00731640|9711032|FG001|NOT COMPLETED|Overall Study||0
8667260|NCT00731653|9711038|FG000|STARTED|Overall Study||81
8667261|NCT00731653|9711038|FG000|COMPLETED|Overall Study||72
8667262|NCT00731653|9711038|FG000|NOT COMPLETED|Overall Study||9
8667263|NCT00731666|9711042|FG000|STARTED|Overall Study||40
8667264|NCT00731666|9711042|FG000|COMPLETED|Overall Study||28
8667265|NCT00731666|9711042|FG000|NOT COMPLETED|Overall Study||12
8667266|NCT00731679|9711048|FG000|STARTED|Overall Study||314
8667267|NCT00731679|9711049|FG001|STARTED|Overall Study||309
8667268|NCT00731679|9711048|FG000|COMPLETED|Overall Study||292
8667269|NCT00731679|9711049|FG001|COMPLETED|Overall Study||283
8667270|NCT00731679|9711048|FG000|NOT COMPLETED|Overall Study||22
8667271|NCT00731679|9711049|FG001|NOT COMPLETED|Overall Study||26
8667272|NCT00731692|9711058|FG000|STARTED|Core Study (36 Months)||147
8667273|NCT00731692|9711059|FG001|STARTED|Core Study (36 Months)||336
8667274|NCT00731692|9711060|FG002|STARTED|Core Study (36 Months)||487
8667275|NCT00731692|9711058|FG000|Safety Set (SAF)|Core Study (36 Months)||0
8667276|NCT00731692|9711059|FG001|Safety Set (SAF)|Core Study (36 Months)||336
8667277|NCT00731692|9711060|FG002|Safety Set (SAF)|Core Study (36 Months)||487
8667278|NCT00731692|9711058|FG000|Full Analysis Set (FAS)|Core Study (36 Months)||0
8667279|NCT00731692|9711059|FG001|Full Analysis Set (FAS)|Core Study (36 Months)||336
8667280|NCT00731692|9711060|FG002|Full Analysis Set (FAS)|Core Study (36 Months)||487
8667281|NCT00731692|9711058|FG000|Pharmacokinetic Analysis Set|Core Study (36 Months)||102
8667282|NCT00731692|9711059|FG001|Pharmacokinetic Analysis Set|Core Study (36 Months)||249
8667283|NCT00731692|9711060|FG002|Pharmacokinetic Analysis Set|Core Study (36 Months)||0
8667284|NCT00731692|9711058|FG000|Post Protocol Amendment 5 Switch|Core Study (36 Months)||0
8667285|NCT00731692|9711059|FG001|Post Protocol Amendment 5 Switch|Core Study (36 Months)|post protocol amendment 121 patients switch to 0.5 mg dose from 125mg dose|121
8667286|NCT00731692|9711060|FG002|Post Protocol Amendment 5 Switch|Core Study (36 Months)||0
8667287|NCT00731692|9711058|FG000|COMPLETED|Core Study (36 Months)||79
8667288|NCT00731692|9711059|FG001|COMPLETED|Core Study (36 Months)||220
8667289|NCT00731692|9711060|FG002|COMPLETED|Core Study (36 Months)||317
8667290|NCT00731692|9711058|FG000|NOT COMPLETED|Core Study (36 Months)||68
8667291|NCT00731692|9711059|FG001|NOT COMPLETED|Core Study (36 Months)||116
8667292|NCT00731692|9711060|FG002|NOT COMPLETED|Core Study (36 Months)||170
8667293|NCT00731692|9711058|FG000|STARTED|Extension Phase||74
8667294|NCT00731692|9711059|FG001|STARTED|Extension Phase||196
8667295|NCT00731692|9711060|FG002|STARTED|Extension Phase||301
8667296|NCT00731692|9711058|FG000|COMPLETED|Extension Phase||0
8667297|NCT00731692|9711059|FG001|COMPLETED|Extension Phase||0
8667298|NCT00731692|9711060|FG002|COMPLETED|Extension Phase||0
8667299|NCT00731692|9711058|FG000|NOT COMPLETED|Extension Phase||74
8667300|NCT00731692|9711059|FG001|NOT COMPLETED|Extension Phase||196
8667301|NCT00731692|9711060|FG002|NOT COMPLETED|Extension Phase||301
8667302|NCT00731783|9711078|FG000|STARTED|One Month Follow-Up Visit||92
8667303|NCT00731783|9711079|FG001|STARTED|One Month Follow-Up Visit||91
8667304|NCT00731783|9711078|FG000|COMPLETED|One Month Follow-Up Visit||78
8667305|NCT00731783|9711079|FG001|COMPLETED|One Month Follow-Up Visit||69
8667306|NCT00731783|9711078|FG000|NOT COMPLETED|One Month Follow-Up Visit||14
8667307|NCT00731783|9711079|FG001|NOT COMPLETED|One Month Follow-Up Visit||22
8667308|NCT00731783|9711078|FG000|STARTED|Three Month Follow-Up Visit||79
8667309|NCT00731783|9711079|FG001|STARTED|Three Month Follow-Up Visit||73
8667310|NCT00731783|9711078|FG000|COMPLETED|Three Month Follow-Up Visit||72
8667311|NCT00731783|9711079|FG001|COMPLETED|Three Month Follow-Up Visit||57
8667312|NCT00731783|9711078|FG000|NOT COMPLETED|Three Month Follow-Up Visit||7
8667313|NCT00731783|9711079|FG001|NOT COMPLETED|Three Month Follow-Up Visit||16
8667314|NCT00731783|9711078|FG000|STARTED|Six Month Follow-Up Visit||77
8667315|NCT00731783|9711079|FG001|STARTED|Six Month Follow-Up Visit||67
8667316|NCT00731783|9711078|FG000|COMPLETED|Six Month Follow-Up Visit||71
8667317|NCT00731783|9711079|FG001|COMPLETED|Six Month Follow-Up Visit||64
8667318|NCT00731783|9711078|FG000|NOT COMPLETED|Six Month Follow-Up Visit||6
8667319|NCT00731783|9711079|FG001|NOT COMPLETED|Six Month Follow-Up Visit||3
8667320|NCT00731783|9711078|FG000|STARTED|12 Month Follow-Up Visit||74
8667321|NCT00731783|9711079|FG001|STARTED|12 Month Follow-Up Visit||65
8667322|NCT00731783|9711078|FG000|COMPLETED|12 Month Follow-Up Visit||68
8667323|NCT00731783|9711079|FG001|COMPLETED|12 Month Follow-Up Visit||58
8731598|NCT01067339|9779201|FG000|COMPLETED|Overall Study||25
8731599|NCT01067339|9779202|FG001|COMPLETED|Overall Study||29
8731600|NCT01067339|9779201|FG000|NOT COMPLETED|Overall Study||6
8731601|NCT01067339|9779202|FG001|NOT COMPLETED|Overall Study||5
8731602|NCT01067352|9779211|FG000|STARTED|Overall Study||9
8731603|NCT01067352|9779212|FG001|STARTED|Overall Study||6
8731604|NCT01067352|9779213|FG002|STARTED|Overall Study||10
8731605|NCT01067352|9779211|FG000|COMPLETED|Overall Study||8
8731606|NCT01067352|9779212|FG001|COMPLETED|Overall Study||3
8731607|NCT01067352|9779213|FG002|COMPLETED|Overall Study||9
8731608|NCT01067352|9779211|FG000|NOT COMPLETED|Overall Study||1
8731609|NCT01067352|9779212|FG001|NOT COMPLETED|Overall Study||3
8731610|NCT01067352|9779213|FG002|NOT COMPLETED|Overall Study||1
8731611|NCT01067456|9779223|FG000|STARTED|Overall Study||30
8731612|NCT01067456|9779224|FG001|STARTED|Overall Study||29
8731613|NCT01067456|9779223|FG000|COMPLETED|Overall Study||30
8731614|NCT01067456|9779224|FG001|COMPLETED|Overall Study||29
8731615|NCT01067456|9779223|FG000|NOT COMPLETED|Overall Study||0
8731616|NCT01067456|9779224|FG001|NOT COMPLETED|Overall Study||0
8731617|NCT01067469|9779234|FG000|STARTED|Overall Study||36
8731618|NCT01067469|9779235|FG001|STARTED|Overall Study||35
8731619|NCT01067469|9779234|FG000|90 mg/m^2|Overall Study||0
8731620|NCT01067469|9779235|FG001|90 mg/m^2|Overall Study||12
8731621|NCT01067469|9779234|FG000|75 mg/m^2|Overall Study||0
8731622|NCT01067469|9779235|FG001|75 mg/m^2|Overall Study||21
8731623|NCT01067469|9779234|FG000|COMPLETED|Overall Study||36
8731624|NCT01067469|9779235|FG001|COMPLETED|Overall Study||33
8731625|NCT01067469|9779234|FG000|NOT COMPLETED|Overall Study||0
8731626|NCT01067469|9779235|FG001|NOT COMPLETED|Overall Study||2
8731627|NCT01067508|9779243|FG000|STARTED|Overall Study||10
8731628|NCT01067508|9779244|FG001|STARTED|Overall Study||9
8731629|NCT01067508|9779243|FG000|COMPLETED|Overall Study||10
8731630|NCT01067508|9779244|FG001|COMPLETED|Overall Study||7
8731631|NCT01067508|9779243|FG000|NOT COMPLETED|Overall Study||0
8731632|NCT01067508|9779244|FG001|NOT COMPLETED|Overall Study||2
8731633|NCT01067716|9779253|FG000|STARTED|Overall Study|110 eyes|57
8731634|NCT01067716|9779254|FG001|STARTED|Overall Study|25 eyes|13
8731635|NCT01067716|9779255|FG002|STARTED|Overall Study|15 eyes|9
8731636|NCT01067716|9779253|FG000|COMPLETED|Overall Study|110 eyes|57
8731637|NCT01067716|9779254|FG001|COMPLETED|Overall Study|25 eyes|13
8731638|NCT01067716|9779255|FG002|COMPLETED|Overall Study|15 eyes|9
8731639|NCT01067716|9779253|FG000|NOT COMPLETED|Overall Study||0
8731640|NCT01067716|9779254|FG001|NOT COMPLETED|Overall Study||0
8731641|NCT01067716|9779255|FG002|NOT COMPLETED|Overall Study||0
8731642|NCT01067768|9779265|FG000|STARTED|Overall Study||604
8731643|NCT01067768|9779266|FG001|STARTED|Overall Study||605
8731644|NCT01067768|9779265|FG000|COMPLETED|Overall Study||604
8731645|NCT01067768|9779266|FG001|COMPLETED|Overall Study||605
8731646|NCT01067768|9779265|FG000|NOT COMPLETED|Overall Study||0
8731647|NCT01067768|9779266|FG001|NOT COMPLETED|Overall Study||0
8731648|NCT01067781|9779276|FG000|STARTED|Up to Day 180||203
8731649|NCT01067781|9779277|FG001|STARTED|Up to Day 180||199
8731650|NCT01067781|9779278|FG002|STARTED|Up to Day 180||97
8731651|NCT01067781|9779279|FG003|STARTED|Up to Day 180||101
8731652|NCT01067781|9779276|FG000|COMPLETED|Up to Day 180||173
8731653|NCT01067781|9779277|FG001|COMPLETED|Up to Day 180||168
8731654|NCT01067781|9779278|FG002|COMPLETED|Up to Day 180||89
8731655|NCT01067781|9779279|FG003|COMPLETED|Up to Day 180||89
8731656|NCT01067781|9779276|FG000|NOT COMPLETED|Up to Day 180||30
8731657|NCT01067781|9779277|FG001|NOT COMPLETED|Up to Day 180||31
8731658|NCT01067781|9779278|FG002|NOT COMPLETED|Up to Day 180||8
8731659|NCT01067781|9779279|FG003|NOT COMPLETED|Up to Day 180||12
8731660|NCT01067781|9779276|FG000|STARTED|180 to Day 720||173
8731661|NCT01067781|9779277|FG001|STARTED|180 to Day 720||168
8731662|NCT01067781|9779278|FG002|STARTED|180 to Day 720||89
8731663|NCT01067781|9779279|FG003|STARTED|180 to Day 720||89
8731664|NCT01067781|9779276|FG000|COMPLETED|180 to Day 720|all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|3
8731665|NCT01067781|9779277|FG001|COMPLETED|180 to Day 720|all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|4
8667324|NCT00731783|9711078|FG000|NOT COMPLETED|12 Month Follow-Up Visit||6
8667325|NCT00731783|9711079|FG001|NOT COMPLETED|12 Month Follow-Up Visit||7
8667326|NCT00731822|9711087|FG000|STARTED|Overall Study||20
8667327|NCT00731822|9711088|FG001|STARTED|Overall Study||40
8667328|NCT00731822|9711087|FG000|COMPLETED|Overall Study||16
8731666|NCT01067781|9779278|FG002|COMPLETED|180 to Day 720|all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|0
8731667|NCT01067781|9779279|FG003|COMPLETED|180 to Day 720|all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|0
8731668|NCT01067781|9779276|FG000|NOT COMPLETED|180 to Day 720||170
8731669|NCT01067781|9779277|FG001|NOT COMPLETED|180 to Day 720||164
8911574|NCT02147158|9970631|FG000|COMPLETED|Off-Treatment Interval 2||36
8911575|NCT02147158|9970632|FG001|COMPLETED|Off-Treatment Interval 2||25
8911576|NCT02147158|9970633|FG002|COMPLETED|Off-Treatment Interval 2||69
8911577|NCT02147158|9970634|FG003|COMPLETED|Off-Treatment Interval 2||66
8911578|NCT02147158|9970635|FG004|COMPLETED|Off-Treatment Interval 2||39
8667329|NCT00731822|9711088|FG001|COMPLETED|Overall Study||39
8667330|NCT00731822|9711087|FG000|NOT COMPLETED|Overall Study||4
8667331|NCT00731822|9711088|FG001|NOT COMPLETED|Overall Study||1
8667332|NCT00731874|9711096|FG000|STARTED|Overall Study||10
8667333|NCT00731874|9711097|FG001|STARTED|Overall Study||13
8667334|NCT00731874|9711096|FG000|COMPLETED|Overall Study||10
8667335|NCT00731874|9711097|FG001|COMPLETED|Overall Study||13
8667336|NCT00731874|9711096|FG000|NOT COMPLETED|Overall Study||0
8667337|NCT00731874|9711097|FG001|NOT COMPLETED|Overall Study||0
8667338|NCT00731939|9711103|FG000|STARTED|Overall Study||124
8667339|NCT00731939|9711103|FG000|COMPLETED|Overall Study||90
8667340|NCT00731939|9711103|FG000|NOT COMPLETED|Overall Study||34
8667341|NCT00732030|9711107|FG000|STARTED|Overall Study||26
8667342|NCT00732030|9711107|FG000|COMPLETED|Overall Study||24
8667343|NCT00732030|9711107|FG000|NOT COMPLETED|Overall Study||2
8667344|NCT00732069|9711111|FG000|STARTED|First Study Drug||3
8667345|NCT00732069|9711112|FG001|STARTED|First Study Drug||3
8667346|NCT00732069|9711113|FG002|STARTED|First Study Drug||3
8667347|NCT00732069|9711114|FG003|STARTED|First Study Drug||2
8667348|NCT00732069|9711115|FG004|STARTED|First Study Drug||3
8667349|NCT00732069|9711116|FG005|STARTED|First Study Drug||2
8667350|NCT00732069|9711111|FG000|COMPLETED|First Study Drug||3
8667351|NCT00732069|9711112|FG001|COMPLETED|First Study Drug||3
8667352|NCT00732069|9711113|FG002|COMPLETED|First Study Drug||3
8667353|NCT00732069|9711114|FG003|COMPLETED|First Study Drug||2
8667354|NCT00732069|9711115|FG004|COMPLETED|First Study Drug||3
8667355|NCT00732069|9711116|FG005|COMPLETED|First Study Drug||2
8667356|NCT00732069|9711111|FG000|NOT COMPLETED|First Study Drug||0
8667357|NCT00732069|9711112|FG001|NOT COMPLETED|First Study Drug||0
8667358|NCT00732069|9711113|FG002|NOT COMPLETED|First Study Drug||0
8667359|NCT00732069|9711114|FG003|NOT COMPLETED|First Study Drug||0
8667360|NCT00732069|9711115|FG004|NOT COMPLETED|First Study Drug||0
8667361|NCT00732069|9711116|FG005|NOT COMPLETED|First Study Drug||0
8667362|NCT00732069|9711111|FG000|STARTED|Washout After First Study Drug||3
8667363|NCT00732069|9711112|FG001|STARTED|Washout After First Study Drug||3
8667364|NCT00732069|9711113|FG002|STARTED|Washout After First Study Drug||3
8667365|NCT00732069|9711114|FG003|STARTED|Washout After First Study Drug||2
8667366|NCT00732069|9711115|FG004|STARTED|Washout After First Study Drug||3
8667367|NCT00732069|9711116|FG005|STARTED|Washout After First Study Drug||2
8667368|NCT00732069|9711111|FG000|COMPLETED|Washout After First Study Drug||2
8667369|NCT00732069|9711112|FG001|COMPLETED|Washout After First Study Drug||3
8667370|NCT00732069|9711113|FG002|COMPLETED|Washout After First Study Drug||3
8667371|NCT00732069|9711114|FG003|COMPLETED|Washout After First Study Drug||2
8667372|NCT00732069|9711115|FG004|COMPLETED|Washout After First Study Drug||3
8667373|NCT00732069|9711116|FG005|COMPLETED|Washout After First Study Drug||2
8667374|NCT00732069|9711111|FG000|NOT COMPLETED|Washout After First Study Drug||1
8667375|NCT00732069|9711112|FG001|NOT COMPLETED|Washout After First Study Drug||0
8667376|NCT00732069|9711113|FG002|NOT COMPLETED|Washout After First Study Drug||0
8667377|NCT00732069|9711114|FG003|NOT COMPLETED|Washout After First Study Drug||0
8667378|NCT00732069|9711115|FG004|NOT COMPLETED|Washout After First Study Drug||0
8667379|NCT00732069|9711116|FG005|NOT COMPLETED|Washout After First Study Drug||0
8667380|NCT00732069|9711111|FG000|STARTED|Second Study Drug||2
8667381|NCT00732069|9711112|FG001|STARTED|Second Study Drug||3
8667382|NCT00732069|9711113|FG002|STARTED|Second Study Drug||3
8667383|NCT00732069|9711114|FG003|STARTED|Second Study Drug||2
8667384|NCT00732069|9711115|FG004|STARTED|Second Study Drug||3
8667385|NCT00732069|9711116|FG005|STARTED|Second Study Drug||2
8667386|NCT00732069|9711111|FG000|COMPLETED|Second Study Drug||2
8667387|NCT00732069|9711112|FG001|COMPLETED|Second Study Drug||3
8667388|NCT00732069|9711113|FG002|COMPLETED|Second Study Drug||3
8667389|NCT00732069|9711114|FG003|COMPLETED|Second Study Drug||2
8667390|NCT00732069|9711115|FG004|COMPLETED|Second Study Drug||3
8667391|NCT00732069|9711116|FG005|COMPLETED|Second Study Drug||2
8667392|NCT00732069|9711111|FG000|NOT COMPLETED|Second Study Drug||0
8667393|NCT00732069|9711112|FG001|NOT COMPLETED|Second Study Drug||0
8667394|NCT00732069|9711113|FG002|NOT COMPLETED|Second Study Drug||0
8667395|NCT00732069|9711114|FG003|NOT COMPLETED|Second Study Drug||0
8667396|NCT00732069|9711115|FG004|NOT COMPLETED|Second Study Drug||0
8667397|NCT00732069|9711116|FG005|NOT COMPLETED|Second Study Drug||0
8667398|NCT00732069|9711111|FG000|STARTED|Washout After Second Study Drug||2
8667399|NCT00732069|9711112|FG001|STARTED|Washout After Second Study Drug||3
8667400|NCT00732069|9711113|FG002|STARTED|Washout After Second Study Drug||3
8667401|NCT00732069|9711114|FG003|STARTED|Washout After Second Study Drug||2
8667402|NCT00732069|9711115|FG004|STARTED|Washout After Second Study Drug||3
8667403|NCT00732069|9711116|FG005|STARTED|Washout After Second Study Drug||2
8667404|NCT00732069|9711111|FG000|COMPLETED|Washout After Second Study Drug||2
8667405|NCT00732069|9711112|FG001|COMPLETED|Washout After Second Study Drug||3
8667406|NCT00732069|9711113|FG002|COMPLETED|Washout After Second Study Drug||3
8667407|NCT00732069|9711114|FG003|COMPLETED|Washout After Second Study Drug||2
8667408|NCT00732069|9711115|FG004|COMPLETED|Washout After Second Study Drug||3
8667409|NCT00732069|9711116|FG005|COMPLETED|Washout After Second Study Drug||2
8667410|NCT00732069|9711111|FG000|NOT COMPLETED|Washout After Second Study Drug||0
8667411|NCT00732069|9711112|FG001|NOT COMPLETED|Washout After Second Study Drug||0
8667412|NCT00732069|9711113|FG002|NOT COMPLETED|Washout After Second Study Drug||0
8667413|NCT00732069|9711114|FG003|NOT COMPLETED|Washout After Second Study Drug||0
8667414|NCT00732069|9711115|FG004|NOT COMPLETED|Washout After Second Study Drug||0
8667415|NCT00732069|9711116|FG005|NOT COMPLETED|Washout After Second Study Drug||0
8667416|NCT00732069|9711111|FG000|STARTED|Third Study Drug||2
8667417|NCT00732069|9711112|FG001|STARTED|Third Study Drug||3
8667418|NCT00732069|9711113|FG002|STARTED|Third Study Drug||3
8667419|NCT00732069|9711114|FG003|STARTED|Third Study Drug||2
8667420|NCT00732069|9711115|FG004|STARTED|Third Study Drug||3
8667421|NCT00732069|9711116|FG005|STARTED|Third Study Drug||2
8667422|NCT00732069|9711111|FG000|COMPLETED|Third Study Drug||2
8667423|NCT00732069|9711112|FG001|COMPLETED|Third Study Drug||3
8667424|NCT00732069|9711113|FG002|COMPLETED|Third Study Drug||3
8667425|NCT00732069|9711114|FG003|COMPLETED|Third Study Drug||2
8667426|NCT00732069|9711115|FG004|COMPLETED|Third Study Drug||3
8667427|NCT00732069|9711116|FG005|COMPLETED|Third Study Drug||2
8667428|NCT00732069|9711111|FG000|NOT COMPLETED|Third Study Drug||0
8667429|NCT00732069|9711112|FG001|NOT COMPLETED|Third Study Drug||0
8667430|NCT00732069|9711113|FG002|NOT COMPLETED|Third Study Drug||0
8667431|NCT00732069|9711114|FG003|NOT COMPLETED|Third Study Drug||0
8667432|NCT00732069|9711115|FG004|NOT COMPLETED|Third Study Drug||0
8667433|NCT00732069|9711116|FG005|NOT COMPLETED|Third Study Drug||0
8667434|NCT00732160|9711128|FG000|STARTED|Overall Study||7
8667435|NCT00732160|9711129|FG001|STARTED|Overall Study||5
8667436|NCT00732160|9711130|FG002|STARTED|Overall Study||6
8667437|NCT00732160|9711131|FG003|STARTED|Overall Study||5
8667438|NCT00732160|9711128|FG000|HS Vehicle|Overall Study||7
8667439|NCT00732160|9711129|FG001|HS Vehicle|Overall Study||5
8667440|NCT00732160|9711130|FG002|HS Vehicle|Overall Study||3
8667441|NCT00732160|9711131|FG003|HS Vehicle|Overall Study||3
8667442|NCT00732160|9711128|FG000|HS Aldosterone|Overall Study||7
8667443|NCT00732160|9711129|FG001|HS Aldosterone|Overall Study||5
8667444|NCT00732160|9711130|FG002|HS Aldosterone|Overall Study||3
8667445|NCT00732160|9711131|FG003|HS Aldosterone|Overall Study||3
8667446|NCT00732160|9711128|FG000|LS Vehicle|Overall Study||2
8667447|NCT00732160|9711129|FG001|LS Vehicle|Overall Study||1
8667448|NCT00732160|9711130|FG002|LS Vehicle|Overall Study||6
8667449|NCT00732160|9711131|FG003|LS Vehicle|Overall Study||5
8667450|NCT00732160|9711128|FG000|LS Aldosterone|Overall Study||2
8667451|NCT00732160|9711129|FG001|LS Aldosterone|Overall Study||1
8667452|NCT00732160|9711130|FG002|LS Aldosterone|Overall Study||6
8667453|NCT00732160|9711131|FG003|LS Aldosterone|Overall Study||5
8667454|NCT00732160|9711128|FG000|COMPLETED|Overall Study||2
8667455|NCT00732160|9711129|FG001|COMPLETED|Overall Study||1
8667456|NCT00732160|9711130|FG002|COMPLETED|Overall Study||3
8667457|NCT00732160|9711131|FG003|COMPLETED|Overall Study||3
8731670|NCT01067781|9779278|FG002|NOT COMPLETED|180 to Day 720||89
8731671|NCT01067781|9779279|FG003|NOT COMPLETED|180 to Day 720||89
8731672|NCT01067846|9779293|FG000|STARTED|Overall Study|Due to exclusion prior to group assignment, Study Enrollment will not equal Total # of Participants.|29
8731673|NCT01067846|9779294|FG001|STARTED|Overall Study|Due to exclusion prior to group assignment, Study Enrollment will not equal Total # of Participants.|30
8731674|NCT01067846|9779293|FG000|Completed 3 Tx Sessions|Overall Study|Our final analysis includes these participants.|15
8731675|NCT01067846|9779294|FG001|Completed 3 Tx Sessions|Overall Study|Our final analysis includes these participants.|15
8731676|NCT01067846|9779293|FG000|COMPLETED|Overall Study|Participants that completed all 4 weeks of treatment.|10
8731677|NCT01067846|9779294|FG001|COMPLETED|Overall Study|Participants that completed all 4 weeks of treatment.|11
8731678|NCT01067846|9779293|FG000|NOT COMPLETED|Overall Study||19
8731679|NCT01067846|9779294|FG001|NOT COMPLETED|Overall Study||19
8731680|NCT01067976|9779300|FG000|STARTED|Overall Study|screened and enrolled|446
8731681|NCT01067976|9779300|FG000|Received Treatment|Overall Study|treatment started|426
8731682|NCT01067976|9779300|FG000|Fulfilled Requirements of FAS Population|Overall Study||390
8731683|NCT01067976|9779300|FG000|COMPLETED|Overall Study|study course completed|424
8731684|NCT01067976|9779300|FG000|NOT COMPLETED|Overall Study||22
8731685|NCT01068158|9779320|FG000|STARTED|Overall Study||169
8731686|NCT01068158|9779321|FG001|STARTED|Overall Study||202
8731687|NCT01068158|9779320|FG000|COMPLETED|Overall Study||161
8731688|NCT01068158|9779321|FG001|COMPLETED|Overall Study||198
8731689|NCT01068158|9779320|FG000|NOT COMPLETED|Overall Study||8
8731690|NCT01068158|9779321|FG001|NOT COMPLETED|Overall Study||4
8731691|NCT01068262|9779331|FG000|STARTED|Overall Study||23
8731692|NCT01068262|9779332|FG001|STARTED|Overall Study||9
8731693|NCT01068262|9779333|FG002|STARTED|Overall Study||10
8731694|NCT01068262|9779334|FG003|STARTED|Overall Study||2
8731695|NCT01068262|9779331|FG000|COMPLETED|Overall Study||20
8731696|NCT01068262|9779332|FG001|COMPLETED|Overall Study||8
8731697|NCT01068262|9779333|FG002|COMPLETED|Overall Study||9
8731698|NCT01068262|9779334|FG003|COMPLETED|Overall Study||2
8731699|NCT01068262|9779331|FG000|NOT COMPLETED|Overall Study||3
8731700|NCT01068262|9779332|FG001|NOT COMPLETED|Overall Study||1
8731701|NCT01068262|9779333|FG002|NOT COMPLETED|Overall Study||1
8731702|NCT01068262|9779334|FG003|NOT COMPLETED|Overall Study||0
8731703|NCT01068418|9779347|FG000|STARTED|Overall Study|26 participants found to be eligible|26
8806698|NCT01479517|9859017|FG002|NOT COMPLETED|Overall Study||0
8667458|NCT00732160|9711128|FG000|NOT COMPLETED|Overall Study||5
8667459|NCT00732160|9711129|FG001|NOT COMPLETED|Overall Study||4
8667460|NCT00732160|9711130|FG002|NOT COMPLETED|Overall Study||3
8667461|NCT00732160|9711131|FG003|NOT COMPLETED|Overall Study||2
8667462|NCT00732199|9711143|FG000|STARTED|Overall Study||50
8667463|NCT00732199|9711144|FG001|STARTED|Overall Study||42
8667464|NCT00732199|9711143|FG000|COMPLETED|Overall Study||16
8667465|NCT00732199|9711144|FG001|COMPLETED|Overall Study||16
8667466|NCT00732199|9711143|FG000|NOT COMPLETED|Overall Study||34
8667467|NCT00732199|9711144|FG001|NOT COMPLETED|Overall Study||26
8667468|NCT00732225|9711158|FG000|STARTED|Overall Study|76 eyes of 71 patients|71
8667469|NCT00732225|9711159|FG001|STARTED|Overall Study|41 eyes of 40 patients|40
8667470|NCT00732225|9711160|FG002|STARTED|Overall Study|26 eyes of 26 patients|26
8667471|NCT00732225|9711161|FG003|STARTED|Overall Study|33 eyes of 33 patients|33
8667472|NCT00732225|9711162|FG004|STARTED|Overall Study|55 eyes of 54 patients|54
8667473|NCT00732225|9711158|FG000|COMPLETED|Overall Study|64 eyes of 60 patients|60
8667474|NCT00732225|9711159|FG001|COMPLETED|Overall Study|33 eyes of 32 patients|32
8667475|NCT00732225|9711160|FG002|COMPLETED|Overall Study|23 eyes of 23 patients|23
8667476|NCT00732225|9711161|FG003|COMPLETED|Overall Study|29 eyes of 29 patients|29
8667477|NCT00732225|9711162|FG004|COMPLETED|Overall Study|48 eyes of 48 patients|48
8667478|NCT00732225|9711158|FG000|NOT COMPLETED|Overall Study||11
8667479|NCT00732225|9711159|FG001|NOT COMPLETED|Overall Study||8
8667480|NCT00732225|9711160|FG002|NOT COMPLETED|Overall Study||3
8667481|NCT00732225|9711161|FG003|NOT COMPLETED|Overall Study||4
8667482|NCT00732225|9711162|FG004|NOT COMPLETED|Overall Study||6
8667483|NCT00732238|9711176|FG000|STARTED|Overall Study||33
8667484|NCT00732238|9711177|FG001|STARTED|Overall Study||28
8667485|NCT00732238|9711176|FG000|COMPLETED|Overall Study||28
8667486|NCT00732238|9711177|FG001|COMPLETED|Overall Study||27
8667487|NCT00732238|9711176|FG000|NOT COMPLETED|Overall Study||5
8667488|NCT00732238|9711177|FG001|NOT COMPLETED|Overall Study||1
8667489|NCT00732251|9711185|FG000|STARTED|Overall Study||8
8667490|NCT00732251|9711185|FG000|COMPLETED|Overall Study||1
8667491|NCT00732251|9711185|FG000|NOT COMPLETED|Overall Study||7
8667492|NCT00732303|9711189|FG000|STARTED|Overall Study||8
8667493|NCT00732303|9711189|FG000|COMPLETED|Overall Study||6
8667494|NCT00732303|9711189|FG000|NOT COMPLETED|Overall Study||2
8667495|NCT00732472|9711197|FG000|STARTED|Overall Study||9
8667496|NCT00732472|9711198|FG001|STARTED|Overall Study|One par. (counted as 2 on outputs) was randomized/dosed with UMEC 250 µg on 2 separate occasions.|10
8667497|NCT00732472|9711199|FG002|STARTED|Overall Study||10
8667498|NCT00732472|9711200|FG003|STARTED|Overall Study||9
8667499|NCT00732472|9711197|FG000|COMPLETED|Overall Study||9
8667500|NCT00732472|9711198|FG001|COMPLETED|Overall Study||7
8667501|NCT00732472|9711199|FG002|COMPLETED|Overall Study||9
8667502|NCT00732472|9711200|FG003|COMPLETED|Overall Study||6
8667503|NCT00732472|9711197|FG000|NOT COMPLETED|Overall Study||0
8667504|NCT00732472|9711198|FG001|NOT COMPLETED|Overall Study||3
8667505|NCT00732472|9711199|FG002|NOT COMPLETED|Overall Study||1
8667506|NCT00732472|9711200|FG003|NOT COMPLETED|Overall Study||3
8667507|NCT00732498|9711211|FG000|STARTED|Overall Study||28
8667508|NCT00732498|9711211|FG000|COMPLETED|Overall Study||22
8667509|NCT00732498|9711211|FG000|NOT COMPLETED|Overall Study||6
8667510|NCT00732615|9711217|FG000|STARTED|Overall Study||40
8667511|NCT00732615|9711218|FG001|STARTED|Overall Study||84
8667512|NCT00732615|9711217|FG000|COMPLETED|Overall Study||33
8667513|NCT00732615|9711218|FG001|COMPLETED|Overall Study||79
8667514|NCT00732615|9711217|FG000|NOT COMPLETED|Overall Study||7
8667515|NCT00732615|9711218|FG001|NOT COMPLETED|Overall Study||5
8667516|NCT00732641|9711227|FG000|STARTED|Overall Study||123
8667517|NCT00732641|9711228|FG001|STARTED|Overall Study||121
8667518|NCT00732641|9711227|FG000|COMPLETED|Overall Study||17
8667519|NCT00732641|9711228|FG001|COMPLETED|Overall Study||9
8667520|NCT00732641|9711227|FG000|NOT COMPLETED|Overall Study||106
8667521|NCT00732641|9711228|FG001|NOT COMPLETED|Overall Study||112
8667522|NCT00732654|9711237|FG000|STARTED|Overall Study||10
8667523|NCT00732654|9711238|FG001|STARTED|Overall Study||10
8731704|NCT01068418|9779347|FG000|Medication Washout|Overall Study|9 participants were disempaneled during the medication washout phase due to noncompliance or high BP|17
8731705|NCT01068418|9779347|FG000|COMPLETED|Overall Study|14 participants completed all study procedures.|14
8731706|NCT01068418|9779347|FG000|NOT COMPLETED|Overall Study||12
8731707|NCT01068509|9779354|FG000|STARTED|Overall Study||7
8731708|NCT01068509|9779355|FG001|STARTED|Overall Study||29
8731709|NCT01068509|9779356|FG002|STARTED|Overall Study||27
8731710|NCT01068509|9779354|FG000|COMPLETED|Overall Study||1
8731711|NCT01068509|9779355|FG001|COMPLETED|Overall Study||7
8731712|NCT01068509|9779356|FG002|COMPLETED|Overall Study||6
8731713|NCT01068509|9779354|FG000|NOT COMPLETED|Overall Study||6
8731714|NCT01068509|9779355|FG001|NOT COMPLETED|Overall Study||22
8731715|NCT01068509|9779356|FG002|NOT COMPLETED|Overall Study||21
8731716|NCT01068548|9779365|FG000|STARTED|Overall Study||66
8731717|NCT01068548|9779366|FG001|STARTED|Overall Study||63
8731718|NCT01068548|9779365|FG000|COMPLETED|Overall Study||66
8731719|NCT01068548|9779366|FG001|COMPLETED|Overall Study||63
8731720|NCT01068548|9779365|FG000|NOT COMPLETED|Overall Study||0
8667524|NCT00732654|9711239|FG002|STARTED|Overall Study||10
8731721|NCT01068548|9779366|FG001|NOT COMPLETED|Overall Study||0
8731722|NCT01068600|9779375|FG000|STARTED|Overall Study||159
8731723|NCT01068600|9779376|FG001|STARTED|Overall Study||159
8731724|NCT01068600|9779375|FG000|COMPLETED|Overall Study||148
8731725|NCT01068600|9779376|FG001|COMPLETED|Overall Study||142
8731726|NCT01068600|9779375|FG000|NOT COMPLETED|Overall Study||11
8731727|NCT01068600|9779376|FG001|NOT COMPLETED|Overall Study||17
8731728|NCT01068626|9779384|FG000|STARTED|Overall Study||30
8667525|NCT00732654|9711237|FG000|COMPLETED|Overall Study||10
8667526|NCT00732654|9711238|FG001|COMPLETED|Overall Study||9
8667527|NCT00732654|9711239|FG002|COMPLETED|Overall Study||10
8667528|NCT00732654|9711237|FG000|NOT COMPLETED|Overall Study||0
8667529|NCT00732654|9711238|FG001|NOT COMPLETED|Overall Study||1
8667530|NCT00732654|9711239|FG002|NOT COMPLETED|Overall Study||0
8731729|NCT01068626|9779385|FG001|STARTED|Overall Study||29
8731730|NCT01068626|9779384|FG000|COMPLETED|Overall Study||27
8731731|NCT01068626|9779385|FG001|COMPLETED|Overall Study||27
8731732|NCT01068626|9779384|FG000|NOT COMPLETED|Overall Study||3
8731733|NCT01068626|9779385|FG001|NOT COMPLETED|Overall Study||2
8731734|NCT01068652|9779393|FG000|STARTED|Overall Study||200
8731735|NCT01068652|9779394|FG001|STARTED|Overall Study||203
8731736|NCT01068652|9779393|FG000|COMPLETED|Overall Study||182
8731737|NCT01068652|9779394|FG001|COMPLETED|Overall Study||188
8731738|NCT01068652|9779393|FG000|NOT COMPLETED|Overall Study||18
8731739|NCT01068652|9779394|FG001|NOT COMPLETED|Overall Study||15
8731740|NCT01068665|9779402|FG000|STARTED|Overall Study||230
8731741|NCT01068665|9779403|FG001|STARTED|Overall Study||230
8731742|NCT01068665|9779402|FG000|Full Analysis Set|Overall Study|Two subjects were withdrawn because the subjects were randomised in error.|228
8731743|NCT01068665|9779403|FG001|Full Analysis Set|Overall Study|One subject was withdrawn because the subject was randomised in error.|229
8731744|NCT01068665|9779402|FG000|Exposed|Overall Study||228
8731745|NCT01068665|9779403|FG001|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug.|228
8731746|NCT01068665|9779402|FG000|COMPLETED|Overall Study||200
8731747|NCT01068665|9779403|FG001|COMPLETED|Overall Study||201
8731748|NCT01068665|9779402|FG000|NOT COMPLETED|Overall Study||30
8731749|NCT01068665|9779403|FG001|NOT COMPLETED|Overall Study||29
8731750|NCT01068678|9779411|FG000|STARTED|Overall Study||230
8731751|NCT01068678|9779412|FG001|STARTED|Overall Study||230
8731752|NCT01068678|9779411|FG000|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial product.|227
8731753|NCT01068678|9779412|FG001|Exposed|Overall Study|one subject withdrew prior to exposure to trial product|229
8731754|NCT01068678|9779411|FG000|COMPLETED|Overall Study||192
8731755|NCT01068678|9779412|FG001|COMPLETED|Overall Study||206
8731756|NCT01068678|9779411|FG000|NOT COMPLETED|Overall Study||38
8911579|NCT02147158|9970636|FG005|COMPLETED|Off-Treatment Interval 2||39
8911580|NCT02147158|9970631|FG000|NOT COMPLETED|Off-Treatment Interval 2||4
8911581|NCT02147158|9970632|FG001|NOT COMPLETED|Off-Treatment Interval 2||4
8911582|NCT02147158|9970633|FG002|NOT COMPLETED|Off-Treatment Interval 2||10
8911583|NCT02147158|9970634|FG003|NOT COMPLETED|Off-Treatment Interval 2||11
8911584|NCT02147158|9970635|FG004|NOT COMPLETED|Off-Treatment Interval 2||2
8911585|NCT02147158|9970636|FG005|NOT COMPLETED|Off-Treatment Interval 2||4
8911586|NCT02147197|9970656|FG000|STARTED|Overall Study||56
8911587|NCT02147197|9970657|FG001|STARTED|Overall Study||53
8911588|NCT02147197|9970658|FG002|STARTED|Overall Study||48
8911589|NCT02147197|9970656|FG000|COMPLETED|Overall Study||47
8911590|NCT02147197|9970657|FG001|COMPLETED|Overall Study||47
8911591|NCT02147197|9970658|FG002|COMPLETED|Overall Study||39
8911592|NCT02147197|9970656|FG000|NOT COMPLETED|Overall Study||9
8911593|NCT02147197|9970657|FG001|NOT COMPLETED|Overall Study||6
8911594|NCT02147197|9970658|FG002|NOT COMPLETED|Overall Study||9
8911595|NCT02147288|9970668|FG000|STARTED|Overall Study||22
8911596|NCT02147288|9970669|FG001|STARTED|Overall Study||24
8911597|NCT02147288|9970670|FG002|STARTED|Overall Study||0
8911598|NCT02147288|9970671|FG003|STARTED|Overall Study||0
8911599|NCT02147288|9970672|FG004|STARTED|Overall Study||0
8911600|NCT02147288|9970673|FG005|STARTED|Overall Study||0
8911601|NCT02147288|9970674|FG006|STARTED|Overall Study||0
8911602|NCT02147288|9970675|FG007|STARTED|Overall Study||0
8911603|NCT02147288|9970676|FG008|STARTED|Overall Study||0
8911604|NCT02147288|9970677|FG009|STARTED|Overall Study||0
8911605|NCT02147288|9970668|FG000|COMPLETED|Overall Study||21
8911606|NCT02147288|9970669|FG001|COMPLETED|Overall Study||22
8911607|NCT02147288|9970670|FG002|COMPLETED|Overall Study||0
8911608|NCT02147288|9970671|FG003|COMPLETED|Overall Study||0
8667531|NCT00732758|9711249|FG000|STARTED|Overall Study||78
8667532|NCT00732758|9711250|FG001|STARTED|Overall Study||79
8667533|NCT00732758|9711249|FG000|COMPLETED|Overall Study||70
8667534|NCT00732758|9711250|FG001|COMPLETED|Overall Study||63
8667535|NCT00732758|9711249|FG000|NOT COMPLETED|Overall Study||8
8667536|NCT00732758|9711250|FG001|NOT COMPLETED|Overall Study||16
8667537|NCT00732875|9711256|FG000|STARTED|Overall Study||92
8667538|NCT00732875|9711256|FG000|COMPLETED|Overall Study|These participants continued treatment until trial was completed by Sponsor.|57
8667539|NCT00732875|9711256|FG000|NOT COMPLETED|Overall Study||35
8667540|NCT00732901|9711262|FG000|STARTED|Overall Study||11
8731757|NCT01068678|9779412|FG001|NOT COMPLETED|Overall Study||24
8731758|NCT01068717|9779418|FG000|STARTED|Period 1: Treatment Schedule Phase 1||7
8731759|NCT01068717|9779419|FG001|STARTED|Period 1: Treatment Schedule Phase 1||6
8731760|NCT01068717|9779420|FG002|STARTED|Period 1: Treatment Schedule Phase 1||7
8731761|NCT01068717|9779421|FG003|STARTED|Period 1: Treatment Schedule Phase 1||7
8806699|NCT01479530|9859027|FG000|STARTED|Overall Study||158
8911609|NCT02147288|9970672|FG004|COMPLETED|Overall Study||0
8911610|NCT02147288|9970673|FG005|COMPLETED|Overall Study||0
8911611|NCT02147288|9970674|FG006|COMPLETED|Overall Study||0
8911612|NCT02147288|9970675|FG007|COMPLETED|Overall Study||0
8911613|NCT02147288|9970676|FG008|COMPLETED|Overall Study||0
8911614|NCT02147288|9970677|FG009|COMPLETED|Overall Study||0
8911615|NCT02147288|9970668|FG000|NOT COMPLETED|Overall Study||1
8911616|NCT02147288|9970669|FG001|NOT COMPLETED|Overall Study||2
8667541|NCT00732901|9711263|FG001|STARTED|Overall Study||12
8667542|NCT00732901|9711262|FG000|COMPLETED|Overall Study||11
8667543|NCT00732901|9711263|FG001|COMPLETED|Overall Study||12
8667544|NCT00732901|9711262|FG000|NOT COMPLETED|Overall Study||0
8667545|NCT00732901|9711263|FG001|NOT COMPLETED|Overall Study||0
8667546|NCT00732940|9711271|FG000|STARTED|Overall Study||28
8731762|NCT01068717|9779418|FG000|COMPLETED|Period 1: Treatment Schedule Phase 1|Patient who withdrew returned for Treatment Periods 3 and 4.|6
8731763|NCT01068717|9779419|FG001|COMPLETED|Period 1: Treatment Schedule Phase 1||6
8731764|NCT01068717|9779420|FG002|COMPLETED|Period 1: Treatment Schedule Phase 1||7
8731765|NCT01068717|9779421|FG003|COMPLETED|Period 1: Treatment Schedule Phase 1||7
8731766|NCT01068717|9779418|FG000|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||1
8731767|NCT01068717|9779419|FG001|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||0
8731768|NCT01068717|9779420|FG002|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||0
8731769|NCT01068717|9779421|FG003|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||0
8731770|NCT01068717|9779418|FG000|STARTED|Period 2: Treatment Schedule Phase 2||6
8731771|NCT01068717|9779419|FG001|STARTED|Period 2: Treatment Schedule Phase 2||6
8731772|NCT01068717|9779420|FG002|STARTED|Period 2: Treatment Schedule Phase 2||7
8731773|NCT01068717|9779421|FG003|STARTED|Period 2: Treatment Schedule Phase 2||7
8731774|NCT01068717|9779418|FG000|COMPLETED|Period 2: Treatment Schedule Phase 2||6
8731775|NCT01068717|9779419|FG001|COMPLETED|Period 2: Treatment Schedule Phase 2||6
8731776|NCT01068717|9779420|FG002|COMPLETED|Period 2: Treatment Schedule Phase 2||7
8731777|NCT01068717|9779421|FG003|COMPLETED|Period 2: Treatment Schedule Phase 2||7
8731778|NCT01068717|9779418|FG000|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
8731779|NCT01068717|9779419|FG001|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
8731780|NCT01068717|9779420|FG002|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
8731781|NCT01068717|9779421|FG003|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
8731782|NCT01068717|9779418|FG000|STARTED|Period 3: Treatment Schedule Phase 3|Patient who withdrew during Treatment Period 1 returned for Treatment Periods 3 and 4.|7
8731783|NCT01068717|9779419|FG001|STARTED|Period 3: Treatment Schedule Phase 3||6
8731784|NCT01068717|9779420|FG002|STARTED|Period 3: Treatment Schedule Phase 3||7
8731785|NCT01068717|9779421|FG003|STARTED|Period 3: Treatment Schedule Phase 3||7
8731786|NCT01068717|9779418|FG000|COMPLETED|Period 3: Treatment Schedule Phase 3||7
8731787|NCT01068717|9779419|FG001|COMPLETED|Period 3: Treatment Schedule Phase 3||6
8731788|NCT01068717|9779420|FG002|COMPLETED|Period 3: Treatment Schedule Phase 3||7
8731789|NCT01068717|9779421|FG003|COMPLETED|Period 3: Treatment Schedule Phase 3||7
8731790|NCT01068717|9779418|FG000|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
8731791|NCT01068717|9779419|FG001|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
8731792|NCT01068717|9779420|FG002|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
8731793|NCT01068717|9779421|FG003|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
8731794|NCT01068717|9779418|FG000|STARTED|Period 4: Treatment Schedule Phase 4|Patient who withdrew during Treatment Period 1 returned for Treatment Periods 3 and 4.|7
8731795|NCT01068717|9779419|FG001|STARTED|Period 4: Treatment Schedule Phase 4||6
8731796|NCT01068717|9779420|FG002|STARTED|Period 4: Treatment Schedule Phase 4||7
8731797|NCT01068717|9779421|FG003|STARTED|Period 4: Treatment Schedule Phase 4||7
8731798|NCT01068717|9779418|FG000|COMPLETED|Period 4: Treatment Schedule Phase 4||7
8731799|NCT01068717|9779419|FG001|COMPLETED|Period 4: Treatment Schedule Phase 4||6
8731800|NCT01068717|9779420|FG002|COMPLETED|Period 4: Treatment Schedule Phase 4||7
8731801|NCT01068717|9779421|FG003|COMPLETED|Period 4: Treatment Schedule Phase 4||7
8731802|NCT01068717|9779418|FG000|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
8731803|NCT01068717|9779419|FG001|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
8731804|NCT01068717|9779420|FG002|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
8731805|NCT01068717|9779421|FG003|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
8731806|NCT01068730|9779435|FG000|STARTED|Period 1||7
8731807|NCT01068730|9779436|FG001|STARTED|Period 1||7
8731808|NCT01068730|9779437|FG002|STARTED|Period 1||7
8731809|NCT01068730|9779438|FG003|STARTED|Period 1||7
8731810|NCT01068730|9779435|FG000|COMPLETED|Period 1||7
8731811|NCT01068730|9779436|FG001|COMPLETED|Period 1||7
8731812|NCT01068730|9779437|FG002|COMPLETED|Period 1||7
8731813|NCT01068730|9779438|FG003|COMPLETED|Period 1||7
8731814|NCT01068730|9779435|FG000|NOT COMPLETED|Period 1||0
8731815|NCT01068730|9779436|FG001|NOT COMPLETED|Period 1||0
8731816|NCT01068730|9779437|FG002|NOT COMPLETED|Period 1||0
8731817|NCT01068730|9779438|FG003|NOT COMPLETED|Period 1||0
8731818|NCT01068730|9779435|FG000|STARTED|Period 2||7
8731819|NCT01068730|9779436|FG001|STARTED|Period 2||7
8731820|NCT01068730|9779437|FG002|STARTED|Period 2||7
8731821|NCT01068730|9779438|FG003|STARTED|Period 2||7
8731822|NCT01068730|9779435|FG000|COMPLETED|Period 2||7
8731823|NCT01068730|9779436|FG001|COMPLETED|Period 2||7
8731824|NCT01068730|9779437|FG002|COMPLETED|Period 2||7
8731825|NCT01068730|9779438|FG003|COMPLETED|Period 2||7
8731826|NCT01068730|9779435|FG000|NOT COMPLETED|Period 2||0
8731827|NCT01068730|9779436|FG001|NOT COMPLETED|Period 2||0
8731828|NCT01068730|9779437|FG002|NOT COMPLETED|Period 2||0
8731829|NCT01068730|9779438|FG003|NOT COMPLETED|Period 2||0
8731830|NCT01068730|9779435|FG000|STARTED|Period 3||7
8731831|NCT01068730|9779436|FG001|STARTED|Period 3||7
8667547|NCT00732940|9711272|FG001|STARTED|Overall Study||28
8667548|NCT00732940|9711271|FG000|COMPLETED|Overall Study||26
8667549|NCT00732940|9711272|FG001|COMPLETED|Overall Study||25
8667550|NCT00732940|9711271|FG000|NOT COMPLETED|Overall Study||2
8667551|NCT00732940|9711272|FG001|NOT COMPLETED|Overall Study||3
8667552|NCT00732992|9711280|FG000|STARTED|Overall Study||6
8667553|NCT00732992|9711281|FG001|STARTED|Overall Study||6
8667554|NCT00732992|9711280|FG000|COMPLETED|Overall Study||0
8667555|NCT00732992|9711281|FG001|COMPLETED|Overall Study||0
8667556|NCT00732992|9711280|FG000|NOT COMPLETED|Overall Study||6
8667557|NCT00732992|9711281|FG001|NOT COMPLETED|Overall Study||6
8667558|NCT00733096|9711291|FG000|STARTED|Overall Study||28
8667559|NCT00733096|9711292|FG001|STARTED|Overall Study||26
8667560|NCT00733096|9711293|FG002|STARTED|Overall Study||30
8667561|NCT00733096|9711291|FG000|COMPLETED|Overall Study||28
8667562|NCT00733096|9711292|FG001|COMPLETED|Overall Study||26
8667563|NCT00733096|9711293|FG002|COMPLETED|Overall Study||30
8667564|NCT00733096|9711291|FG000|NOT COMPLETED|Overall Study||0
8667565|NCT00733096|9711292|FG001|NOT COMPLETED|Overall Study||0
8667566|NCT00733096|9711293|FG002|NOT COMPLETED|Overall Study||0
8667567|NCT00733135|9711301|FG000|STARTED|Overall Study||133
8667568|NCT00733135|9711301|FG000|COMPLETED|Overall Study||131
8667569|NCT00733135|9711301|FG000|NOT COMPLETED|Overall Study||2
8667570|NCT00733226|9711309|FG000|STARTED|Overall Study||40
8667571|NCT00733226|9711310|FG001|STARTED|Overall Study||40
8667572|NCT00733226|9711309|FG000|COMPLETED|Overall Study||35
8667573|NCT00733226|9711310|FG001|COMPLETED|Overall Study||40
8667574|NCT00733226|9711309|FG000|NOT COMPLETED|Overall Study||5
8667575|NCT00733226|9711310|FG001|NOT COMPLETED|Overall Study||0
8667576|NCT00733278|9711316|FG000|STARTED|Overall Study||7
8667577|NCT00733278|9711316|FG000|COMPLETED|Overall Study||7
8667578|NCT00733278|9711316|FG000|NOT COMPLETED|Overall Study||0
8667579|NCT00733291|9711323|FG000|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||13
8667580|NCT00733291|9711324|FG001|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||17
8667581|NCT00733291|9711325|FG002|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||17
8667582|NCT00733291|9711326|FG003|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||17
8667583|NCT00733291|9711323|FG000|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||13
8667584|NCT00733291|9711324|FG001|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||17
8667585|NCT00733291|9711325|FG002|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||17
8667586|NCT00733291|9711326|FG003|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||17
8667587|NCT00733291|9711323|FG000|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
8667588|NCT00733291|9711324|FG001|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
8667589|NCT00733291|9711325|FG002|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
8667590|NCT00733291|9711326|FG003|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
8667591|NCT00733291|9711323|FG000|STARTED|Washout Period, 3 Days (+/-1 Day)||13
8667592|NCT00733291|9711324|FG001|STARTED|Washout Period, 3 Days (+/-1 Day)||17
8667593|NCT00733291|9711325|FG002|STARTED|Washout Period, 3 Days (+/-1 Day)||17
8667594|NCT00733291|9711326|FG003|STARTED|Washout Period, 3 Days (+/-1 Day)||17
8667595|NCT00733291|9711323|FG000|COMPLETED|Washout Period, 3 Days (+/-1 Day)||12
8667596|NCT00733291|9711324|FG001|COMPLETED|Washout Period, 3 Days (+/-1 Day)||17
8667597|NCT00733291|9711325|FG002|COMPLETED|Washout Period, 3 Days (+/-1 Day)||17
8667598|NCT00733291|9711326|FG003|COMPLETED|Washout Period, 3 Days (+/-1 Day)||17
8667599|NCT00733291|9711323|FG000|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||1
8667600|NCT00733291|9711324|FG001|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||0
8667601|NCT00733291|9711325|FG002|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||0
8667602|NCT00733291|9711326|FG003|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||0
8667603|NCT00733291|9711323|FG000|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||12
8667604|NCT00733291|9711324|FG001|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||17
8667605|NCT00733291|9711325|FG002|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||17
8667606|NCT00733291|9711326|FG003|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||17
8667607|NCT00733291|9711323|FG000|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||12
8667608|NCT00733291|9711324|FG001|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||17
8667609|NCT00733291|9711325|FG002|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||17
8667610|NCT00733291|9711326|FG003|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||17
8667611|NCT00733291|9711323|FG000|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
8667612|NCT00733291|9711324|FG001|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
8667613|NCT00733291|9711325|FG002|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
8731832|NCT01068730|9779437|FG002|STARTED|Period 3||7
8731833|NCT01068730|9779438|FG003|STARTED|Period 3||7
8911617|NCT02147288|9970670|FG002|NOT COMPLETED|Overall Study||0
8911618|NCT02147288|9970671|FG003|NOT COMPLETED|Overall Study||0
8667614|NCT00733291|9711326|FG003|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
8667615|NCT00733304|9711340|FG000|STARTED|Overall Study||19
8667616|NCT00733304|9711341|FG001|STARTED|Overall Study||15
8667617|NCT00733304|9711342|FG002|STARTED|Overall Study||8
8667618|NCT00733304|9711340|FG000|COMPLETED|Overall Study||12
8667619|NCT00733304|9711341|FG001|COMPLETED|Overall Study||12
8667620|NCT00733304|9711342|FG002|COMPLETED|Overall Study||3
8667621|NCT00733304|9711340|FG000|NOT COMPLETED|Overall Study||7
8667622|NCT00733304|9711341|FG001|NOT COMPLETED|Overall Study||3
8667623|NCT00733304|9711342|FG002|NOT COMPLETED|Overall Study||5
8667624|NCT00733330|9711352|FG000|STARTED|Overall Study||32
8667625|NCT00733330|9711353|FG001|STARTED|Overall Study||52
8667626|NCT00733330|9711352|FG000|COMPLETED|Overall Study||30
8667627|NCT00733330|9711353|FG001|COMPLETED|Overall Study||48
8731834|NCT01068730|9779435|FG000|COMPLETED|Period 3||6
8731835|NCT01068730|9779436|FG001|COMPLETED|Period 3||7
8731836|NCT01068730|9779437|FG002|COMPLETED|Period 3||7
8667628|NCT00733330|9711352|FG000|NOT COMPLETED|Overall Study||2
8667629|NCT00733330|9711353|FG001|NOT COMPLETED|Overall Study||4
8667630|NCT00733343|9711363|FG000|STARTED|Overall Study||666
8667631|NCT00733343|9711364|FG001|STARTED|Overall Study||659
8667632|NCT00733343|9711363|FG000|COMPLETED|Overall Study||583
8667633|NCT00733343|9711364|FG001|COMPLETED|Overall Study||578
8667634|NCT00733343|9711363|FG000|NOT COMPLETED|Overall Study||83
8667635|NCT00733343|9711364|FG001|NOT COMPLETED|Overall Study||81
8667636|NCT00733356|9711371|FG000|STARTED|Vyvanse Dose Titration||28
8667637|NCT00733356|9711371|FG000|COMPLETED|Vyvanse Dose Titration||26
8667638|NCT00733356|9711371|FG000|NOT COMPLETED|Vyvanse Dose Titration||2
8667639|NCT00733356|9711371|FG000|STARTED|Modified Lab School, Reading Evaluation||26
8667640|NCT00733356|9711371|FG000|COMPLETED|Modified Lab School, Reading Evaluation||26
8667641|NCT00733356|9711371|FG000|NOT COMPLETED|Modified Lab School, Reading Evaluation||0
8667642|NCT00733369|9711377|FG000|STARTED|Overall Study||50
8667643|NCT00733369|9711378|FG001|STARTED|Overall Study||56
8667644|NCT00733369|9711377|FG000|COMPLETED|Overall Study||40
8667645|NCT00733369|9711378|FG001|COMPLETED|Overall Study||47
8667646|NCT00733369|9711377|FG000|NOT COMPLETED|Overall Study||10
8667647|NCT00733369|9711378|FG001|NOT COMPLETED|Overall Study||9
8667648|NCT00733408|9711384|FG000|STARTED|Overall Study||59
8667649|NCT00733408|9711384|FG000|COMPLETED|Overall Study||55
8667650|NCT00733408|9711384|FG000|NOT COMPLETED|Overall Study||4
8667651|NCT00733421|9711390|FG000|STARTED|Overall Study|November 2008|50
8667652|NCT00733421|9711391|FG001|STARTED|Overall Study|November 2008|50
8667653|NCT00733421|9711390|FG000|COMPLETED|Overall Study|All but one randomsied patient|49
8667654|NCT00733421|9711391|FG001|COMPLETED|Overall Study|All but one randomised patient|49
8667655|NCT00733421|9711390|FG000|NOT COMPLETED|Overall Study||1
8667656|NCT00733421|9711391|FG001|NOT COMPLETED|Overall Study||1
8667657|NCT00733499|9711399|FG000|STARTED|Pre-operative||102
8667658|NCT00733499|9711400|FG001|STARTED|Pre-operative|A death occurred prior to surgery which left a total of 102 participants|103
8667659|NCT00733499|9711399|FG000|COMPLETED|Pre-operative||102
8667660|NCT00733499|9711400|FG001|COMPLETED|Pre-operative||102
8667661|NCT00733499|9711399|FG000|NOT COMPLETED|Pre-operative||0
8667662|NCT00733499|9711400|FG001|NOT COMPLETED|Pre-operative||1
8667663|NCT00733499|9711399|FG000|STARTED|3 Months Follow-up||102
8667664|NCT00733499|9711400|FG001|STARTED|3 Months Follow-up||102
8667665|NCT00733499|9711399|FG000|COMPLETED|3 Months Follow-up||101
8667666|NCT00733499|9711400|FG001|COMPLETED|3 Months Follow-up||100
8667667|NCT00733499|9711399|FG000|NOT COMPLETED|3 Months Follow-up||1
8667668|NCT00733499|9711400|FG001|NOT COMPLETED|3 Months Follow-up||2
8667669|NCT00733499|9711399|FG000|STARTED|6 Months Follow-up||101
8667670|NCT00733499|9711400|FG001|STARTED|6 Months Follow-up||100
8667671|NCT00733499|9711399|FG000|COMPLETED|6 Months Follow-up||101
8667672|NCT00733499|9711400|FG001|COMPLETED|6 Months Follow-up||97
8667673|NCT00733499|9711399|FG000|NOT COMPLETED|6 Months Follow-up||0
8667674|NCT00733499|9711400|FG001|NOT COMPLETED|6 Months Follow-up||3
8667675|NCT00733499|9711399|FG000|STARTED|12 Months Follow-up||101
8667676|NCT00733499|9711400|FG001|STARTED|12 Months Follow-up||97
8667677|NCT00733499|9711399|FG000|COMPLETED|12 Months Follow-up||99
8667678|NCT00733499|9711400|FG001|COMPLETED|12 Months Follow-up||96
8667679|NCT00733499|9711399|FG000|NOT COMPLETED|12 Months Follow-up||2
8667680|NCT00733499|9711400|FG001|NOT COMPLETED|12 Months Follow-up||1
8667681|NCT00733499|9711399|FG000|STARTED|24 Months Follow-up||99
8667682|NCT00733499|9711400|FG001|STARTED|24 Months Follow-up||96
8667683|NCT00733499|9711399|FG000|COMPLETED|24 Months Follow-up||99
8667684|NCT00733499|9711400|FG001|COMPLETED|24 Months Follow-up||95
8667685|NCT00733499|9711399|FG000|NOT COMPLETED|24 Months Follow-up||0
8667686|NCT00733499|9711400|FG001|NOT COMPLETED|24 Months Follow-up||1
8667687|NCT00733499|9711399|FG000|STARTED|5 Year Followup||91
8667688|NCT00733499|9711400|FG001|STARTED|5 Year Followup||78
8667689|NCT00733499|9711399|FG000|COMPLETED|5 Year Followup||70
8667690|NCT00733499|9711400|FG001|COMPLETED|5 Year Followup||53
8667691|NCT00733499|9711399|FG000|NOT COMPLETED|5 Year Followup||21
8667692|NCT00733499|9711400|FG001|NOT COMPLETED|5 Year Followup||25
8667693|NCT00733499|9711399|FG000|STARTED|10 Year Followup||46
8667694|NCT00733499|9711400|FG001|STARTED|10 Year Followup||32
8731837|NCT01068730|9779438|FG003|COMPLETED|Period 3||7
8667695|NCT00733499|9711399|FG000|COMPLETED|10 Year Followup||26
8667696|NCT00733499|9711400|FG001|COMPLETED|10 Year Followup||13
8667697|NCT00733499|9711399|FG000|NOT COMPLETED|10 Year Followup||20
8667698|NCT00733499|9711400|FG001|NOT COMPLETED|10 Year Followup||19
8667699|NCT00733512|9711406|FG000|STARTED|Overall Study||146
8667700|NCT00733512|9711406|FG000|COMPLETED|Overall Study||146
8667701|NCT00733512|9711406|FG000|NOT COMPLETED|Overall Study||0
8667702|NCT00733746|9711410|FG000|STARTED|Overall Study||119
8667703|NCT00733746|9711410|FG000|COMPLETED|Overall Study||114
8667704|NCT00733746|9711410|FG000|NOT COMPLETED|Overall Study||5
8667705|NCT00733824|9711419|FG000|STARTED|Phase I||10
8667706|NCT00733824|9711420|FG001|STARTED|Phase I||3
8667707|NCT00733824|9711421|FG002|STARTED|Phase I||6
8667708|NCT00733824|9711422|FG003|STARTED|Phase I||6
8667709|NCT00733824|9711423|FG004|STARTED|Phase I||0
8667710|NCT00733824|9711419|FG000|COMPLETED|Phase I||9
8667711|NCT00733824|9711420|FG001|COMPLETED|Phase I||3
8667712|NCT00733824|9711421|FG002|COMPLETED|Phase I||6
8667713|NCT00733824|9711422|FG003|COMPLETED|Phase I||6
8667714|NCT00733824|9711423|FG004|COMPLETED|Phase I||0
8667715|NCT00733824|9711419|FG000|NOT COMPLETED|Phase I||1
8731838|NCT01068730|9779435|FG000|NOT COMPLETED|Period 3||1
8667716|NCT00733824|9711420|FG001|NOT COMPLETED|Phase I||0
8667717|NCT00733824|9711421|FG002|NOT COMPLETED|Phase I||0
8667718|NCT00733824|9711422|FG003|NOT COMPLETED|Phase I||0
8667719|NCT00733824|9711423|FG004|NOT COMPLETED|Phase I||0
8667720|NCT00733824|9711419|FG000|STARTED|Phase II||0
8667721|NCT00733824|9711420|FG001|STARTED|Phase II||0
8667722|NCT00733824|9711421|FG002|STARTED|Phase II||0
8667723|NCT00733824|9711422|FG003|STARTED|Phase II||0
8667724|NCT00733824|9711423|FG004|STARTED|Phase II||36
8667725|NCT00733824|9711419|FG000|COMPLETED|Phase II||0
8667726|NCT00733824|9711420|FG001|COMPLETED|Phase II||0
8667727|NCT00733824|9711421|FG002|COMPLETED|Phase II||0
8667728|NCT00733824|9711422|FG003|COMPLETED|Phase II||0
8667729|NCT00733824|9711423|FG004|COMPLETED|Phase II||36
8667730|NCT00733824|9711419|FG000|NOT COMPLETED|Phase II||0
8667731|NCT00733824|9711420|FG001|NOT COMPLETED|Phase II||0
8667732|NCT00733824|9711421|FG002|NOT COMPLETED|Phase II||0
8667733|NCT00733824|9711422|FG003|NOT COMPLETED|Phase II||0
8667734|NCT00733824|9711423|FG004|NOT COMPLETED|Phase II||0
8667735|NCT00733902|9711441|FG000|STARTED|Overall Study||174
8731839|NCT01068730|9779436|FG001|NOT COMPLETED|Period 3||0
8731840|NCT01068730|9779437|FG002|NOT COMPLETED|Period 3||0
8731841|NCT01068730|9779438|FG003|NOT COMPLETED|Period 3||0
8731842|NCT01068730|9779435|FG000|STARTED|Period 4||6
8731843|NCT01068730|9779436|FG001|STARTED|Period 4||7
8731844|NCT01068730|9779437|FG002|STARTED|Period 4||7
8731845|NCT01068730|9779438|FG003|STARTED|Period 4||7
8731846|NCT01068730|9779435|FG000|COMPLETED|Period 4||6
8731847|NCT01068730|9779436|FG001|COMPLETED|Period 4||6
8731848|NCT01068730|9779437|FG002|COMPLETED|Period 4||7
8731849|NCT01068730|9779438|FG003|COMPLETED|Period 4||7
8731850|NCT01068730|9779435|FG000|NOT COMPLETED|Period 4||0
8731851|NCT01068730|9779436|FG001|NOT COMPLETED|Period 4||1
8731852|NCT01068730|9779437|FG002|NOT COMPLETED|Period 4||0
8731853|NCT01068730|9779438|FG003|NOT COMPLETED|Period 4||0
8731854|NCT01068743|9779455|FG000|STARTED|Period 1||6
8731855|NCT01068743|9779456|FG001|STARTED|Period 1||6
8731856|NCT01068743|9779457|FG002|STARTED|Period 1||6
8731857|NCT01068743|9779458|FG003|STARTED|Period 1||6
8731858|NCT01068743|9779455|FG000|COMPLETED|Period 1||6
8731859|NCT01068743|9779456|FG001|COMPLETED|Period 1||6
8731860|NCT01068743|9779457|FG002|COMPLETED|Period 1||6
8731861|NCT01068743|9779458|FG003|COMPLETED|Period 1||6
8731862|NCT01068743|9779455|FG000|NOT COMPLETED|Period 1||0
8731863|NCT01068743|9779456|FG001|NOT COMPLETED|Period 1||0
8731864|NCT01068743|9779457|FG002|NOT COMPLETED|Period 1||0
8731865|NCT01068743|9779458|FG003|NOT COMPLETED|Period 1||0
8731866|NCT01068743|9779455|FG000|STARTED|Period 2||6
8731867|NCT01068743|9779456|FG001|STARTED|Period 2||6
8731868|NCT01068743|9779457|FG002|STARTED|Period 2||6
8731869|NCT01068743|9779458|FG003|STARTED|Period 2||6
8731870|NCT01068743|9779455|FG000|COMPLETED|Period 2||6
8731871|NCT01068743|9779456|FG001|COMPLETED|Period 2||6
8731872|NCT01068743|9779457|FG002|COMPLETED|Period 2||6
8731873|NCT01068743|9779458|FG003|COMPLETED|Period 2||6
8731874|NCT01068743|9779455|FG000|NOT COMPLETED|Period 2||0
8731875|NCT01068743|9779456|FG001|NOT COMPLETED|Period 2||0
8731876|NCT01068743|9779457|FG002|NOT COMPLETED|Period 2||0
8731877|NCT01068743|9779458|FG003|NOT COMPLETED|Period 2||0
8731878|NCT01068743|9779455|FG000|STARTED|Period 3||6
8731879|NCT01068743|9779456|FG001|STARTED|Period 3||6
8731880|NCT01068743|9779457|FG002|STARTED|Period 3||6
8731881|NCT01068743|9779458|FG003|STARTED|Period 3||6
8731882|NCT01068743|9779455|FG000|COMPLETED|Period 3||6
8731883|NCT01068743|9779456|FG001|COMPLETED|Period 3||5
8731884|NCT01068743|9779457|FG002|COMPLETED|Period 3||6
8731885|NCT01068743|9779458|FG003|COMPLETED|Period 3||6
8731886|NCT01068743|9779455|FG000|NOT COMPLETED|Period 3||0
8731887|NCT01068743|9779456|FG001|NOT COMPLETED|Period 3||1
8731888|NCT01068743|9779457|FG002|NOT COMPLETED|Period 3||0
8731889|NCT01068743|9779458|FG003|NOT COMPLETED|Period 3||0
8731890|NCT01068743|9779455|FG000|STARTED|Period 4||6
8731891|NCT01068743|9779456|FG001|STARTED|Period 4||5
8731892|NCT01068743|9779457|FG002|STARTED|Period 4||6
8731893|NCT01068743|9779458|FG003|STARTED|Period 4||6
8731894|NCT01068743|9779455|FG000|COMPLETED|Period 4||6
8731895|NCT01068743|9779456|FG001|COMPLETED|Period 4||5
8731896|NCT01068743|9779457|FG002|COMPLETED|Period 4||6
8731897|NCT01068743|9779458|FG003|COMPLETED|Period 4||6
8731898|NCT01068743|9779455|FG000|NOT COMPLETED|Period 4||0
8731899|NCT01068743|9779456|FG001|NOT COMPLETED|Period 4||0
8731900|NCT01068743|9779457|FG002|NOT COMPLETED|Period 4||0
8731901|NCT01068743|9779458|FG003|NOT COMPLETED|Period 4||0
8731902|NCT01068769|9779471|FG000|STARTED|Overall Study||34
8731903|NCT01068769|9779471|FG000|COMPLETED|Overall Study||33
8667736|NCT00733902|9711442|FG001|STARTED|Overall Study||174
8731904|NCT01068769|9779471|FG000|NOT COMPLETED|Overall Study||1
8731905|NCT01068821|9779477|FG000|STARTED|Overall Study||31
8731906|NCT01068821|9779478|FG001|STARTED|Overall Study||29
8731907|NCT01068821|9779477|FG000|COMPLETED|Overall Study|1 patient had slide measured, but her patient ID not listed; couldn't do postoperative followup.|30
8731908|NCT01068821|9779478|FG001|COMPLETED|Overall Study||29
8731909|NCT01068821|9779477|FG000|NOT COMPLETED|Overall Study||1
8731910|NCT01068821|9779478|FG001|NOT COMPLETED|Overall Study||0
8731911|NCT01068860|9779494|FG000|STARTED|Overall Study||33
8731912|NCT01068860|9779495|FG001|STARTED|Overall Study||17
8731913|NCT01068860|9779496|FG002|STARTED|Overall Study||33
8731914|NCT01068860|9779497|FG003|STARTED|Overall Study||17
8731915|NCT01068860|9779498|FG004|STARTED|Overall Study||32
8667737|NCT00733902|9711443|FG002|STARTED|Overall Study||174
8667738|NCT00733902|9711444|FG003|STARTED|Overall Study||175
8667739|NCT00733902|9711441|FG000|Treated|Overall Study||172
8667740|NCT00733902|9711442|FG001|Treated|Overall Study||172
8667741|NCT00733902|9711443|FG002|Treated|Overall Study||172
8667742|NCT00733902|9711444|FG003|Treated|Overall Study||174
8667743|NCT00733902|9711441|FG000|COMPLETED|Overall Study||10
8667744|NCT00733902|9711442|FG001|COMPLETED|Overall Study||12
8667745|NCT00733902|9711443|FG002|COMPLETED|Overall Study||13
8667746|NCT00733902|9711444|FG003|COMPLETED|Overall Study||11
8667747|NCT00733902|9711441|FG000|NOT COMPLETED|Overall Study||164
8667748|NCT00733902|9711442|FG001|NOT COMPLETED|Overall Study||162
8667749|NCT00733902|9711443|FG002|NOT COMPLETED|Overall Study||161
8731916|NCT01068860|9779499|FG005|STARTED|Overall Study||16
8731917|NCT01068860|9779500|FG006|STARTED|Overall Study||28
8731918|NCT01068860|9779501|FG007|STARTED|Overall Study||15
8731919|NCT01068860|9779502|FG008|STARTED|Overall Study||28
8731920|NCT01068860|9779503|FG009|STARTED|Overall Study||27
8731921|NCT01068860|9779494|FG000|COMPLETED|Overall Study||33
8731922|NCT01068860|9779495|FG001|COMPLETED|Overall Study||16
8731923|NCT01068860|9779496|FG002|COMPLETED|Overall Study||33
8731924|NCT01068860|9779497|FG003|COMPLETED|Overall Study||16
8731925|NCT01068860|9779498|FG004|COMPLETED|Overall Study||32
8731926|NCT01068860|9779499|FG005|COMPLETED|Overall Study||14
8731927|NCT01068860|9779500|FG006|COMPLETED|Overall Study||28
8731928|NCT01068860|9779501|FG007|COMPLETED|Overall Study||15
8731929|NCT01068860|9779502|FG008|COMPLETED|Overall Study||28
8731930|NCT01068860|9779503|FG009|COMPLETED|Overall Study||23
8731931|NCT01068860|9779494|FG000|NOT COMPLETED|Overall Study||0
8731932|NCT01068860|9779495|FG001|NOT COMPLETED|Overall Study||1
8731933|NCT01068860|9779496|FG002|NOT COMPLETED|Overall Study||0
8731934|NCT01068860|9779497|FG003|NOT COMPLETED|Overall Study||1
8731935|NCT01068860|9779498|FG004|NOT COMPLETED|Overall Study||0
8731936|NCT01068860|9779499|FG005|NOT COMPLETED|Overall Study||2
8731937|NCT01068860|9779500|FG006|NOT COMPLETED|Overall Study||0
8731938|NCT01068860|9779501|FG007|NOT COMPLETED|Overall Study||0
8731939|NCT01068860|9779502|FG008|NOT COMPLETED|Overall Study||0
8731940|NCT01068860|9779503|FG009|NOT COMPLETED|Overall Study||4
8731941|NCT01068873|9779525|FG000|STARTED|Overall Study||1
8731942|NCT01068873|9779525|FG000|COMPLETED|Overall Study||1
8731943|NCT01068873|9779525|FG000|NOT COMPLETED|Overall Study||0
8731944|NCT01068912|9779532|FG000|STARTED|Overall Study||134
8731945|NCT01068912|9779533|FG001|STARTED|Overall Study||195
8731946|NCT01068912|9779534|FG002|STARTED|Overall Study||201
8731947|NCT01068912|9779532|FG000|COMPLETED|Overall Study||123
8731948|NCT01068912|9779533|FG001|COMPLETED|Overall Study||173
8731949|NCT01068912|9779534|FG002|COMPLETED|Overall Study||186
8731950|NCT01068912|9779532|FG000|NOT COMPLETED|Overall Study||11
8731951|NCT01068912|9779533|FG001|NOT COMPLETED|Overall Study||22
8731952|NCT01068912|9779534|FG002|NOT COMPLETED|Overall Study||15
8731953|NCT01068964|9779544|FG000|STARTED|Overall Study||121
8731954|NCT01068964|9779545|FG001|STARTED|Overall Study||114
8731955|NCT01068964|9779544|FG000|COMPLETED|Overall Study||113
8731956|NCT01068964|9779545|FG001|COMPLETED|Overall Study||104
8731957|NCT01068964|9779544|FG000|NOT COMPLETED|Overall Study||8
8731958|NCT01068964|9779545|FG001|NOT COMPLETED|Overall Study||10
8731959|NCT01069003|9779554|FG000|STARTED|Overall Study||399
8731960|NCT01069003|9779555|FG001|STARTED|Overall Study||412
8731961|NCT01069003|9779556|FG002|STARTED|Overall Study||1451
8731962|NCT01069003|9779554|FG000|COMPLETED|Overall Study||353
8731963|NCT01069003|9779555|FG001|COMPLETED|Overall Study||358
8731964|NCT01069003|9779556|FG002|COMPLETED|Overall Study||976
8731965|NCT01069003|9779554|FG000|NOT COMPLETED|Overall Study||46
8731966|NCT01069003|9779555|FG001|NOT COMPLETED|Overall Study||54
8731967|NCT01069003|9779556|FG002|NOT COMPLETED|Overall Study||475
8731968|NCT01069172|9779566|FG000|STARTED|Overall Study|30 eyes|30
8731969|NCT01069172|9779567|FG001|STARTED|Overall Study|30 eyes|30
8731970|NCT01069172|9779566|FG000|COMPLETED|Overall Study|29 eyes|29
8731971|NCT01069172|9779567|FG001|COMPLETED|Overall Study|30 eyes|30
8731972|NCT01069172|9779566|FG000|NOT COMPLETED|Overall Study||1
8731973|NCT01069172|9779567|FG001|NOT COMPLETED|Overall Study||0
8731974|NCT01069185|9779576|FG000|STARTED|Overall Study||47
8731975|NCT01069185|9779577|FG001|STARTED|Overall Study||45
8731976|NCT01069185|9779576|FG000|COMPLETED|Overall Study||47
8731977|NCT01069185|9779577|FG001|COMPLETED|Overall Study||45
8731978|NCT01069185|9779576|FG000|NOT COMPLETED|Overall Study||0
8731979|NCT01069185|9779577|FG001|NOT COMPLETED|Overall Study||0
8731980|NCT01069289|9779585|FG000|STARTED|Overall Study||636
8731981|NCT01069289|9779586|FG001|STARTED|Overall Study||657
8731982|NCT01069289|9779585|FG000|COMPLETED|Overall Study||594
8731983|NCT01069289|9779586|FG001|COMPLETED|Overall Study||601
8731984|NCT01069289|9779585|FG000|NOT COMPLETED|Overall Study||42
8731985|NCT01069289|9779586|FG001|NOT COMPLETED|Overall Study||56
8731986|NCT01069315|9779596|FG000|STARTED|Overall Study||27
8731987|NCT01069315|9779597|FG001|STARTED|Overall Study||30
8731988|NCT01069315|9779598|FG002|STARTED|Overall Study||28
8731989|NCT01069315|9779599|FG003|STARTED|Overall Study||26
8667750|NCT00733902|9711444|FG003|NOT COMPLETED|Overall Study||164
8667751|NCT00733954|9711456|FG000|STARTED|Overall Study||124
8731990|NCT01069315|9779596|FG000|COMPLETED|Overall Study||23
8731991|NCT01069315|9779597|FG001|COMPLETED|Overall Study||24
8731992|NCT01069315|9779598|FG002|COMPLETED|Overall Study||23
8731993|NCT01069315|9779599|FG003|COMPLETED|Overall Study||19
8667752|NCT00733954|9711457|FG001|STARTED|Overall Study||125
8667753|NCT00733954|9711456|FG000|COMPLETED|Overall Study||116
8667754|NCT00733954|9711457|FG001|COMPLETED|Overall Study||123
8667755|NCT00733954|9711456|FG000|NOT COMPLETED|Overall Study||8
8667756|NCT00733954|9711457|FG001|NOT COMPLETED|Overall Study||2
8667757|NCT00733980|9711465|FG000|STARTED|Overall Study||74
8667758|NCT00733980|9711466|FG001|STARTED|Overall Study||76
8667759|NCT00733980|9711465|FG000|COMPLETED|Overall Study||52
8667760|NCT00733980|9711466|FG001|COMPLETED|Overall Study||55
8667761|NCT00733980|9711465|FG000|NOT COMPLETED|Overall Study||22
8667762|NCT00733980|9711466|FG001|NOT COMPLETED|Overall Study||21
8667763|NCT00733993|9711475|FG000|STARTED|Overall Study||13
8667764|NCT00733993|9711476|FG001|STARTED|Overall Study||10
8667765|NCT00733993|9711475|FG000|COMPLETED|Overall Study||13
8667766|NCT00733993|9711476|FG001|COMPLETED|Overall Study||10
8667767|NCT00733993|9711475|FG000|NOT COMPLETED|Overall Study||0
8667768|NCT00733993|9711476|FG001|NOT COMPLETED|Overall Study||0
8667769|NCT00734032|9711491|FG000|STARTED|Overall Study||25
8667770|NCT00734032|9711492|FG001|STARTED|Overall Study||28
8667771|NCT00734032|9711493|FG002|STARTED|Overall Study||28
8667772|NCT00734032|9711494|FG003|STARTED|Overall Study||26
8667773|NCT00734032|9711491|FG000|COMPLETED|Overall Study||25
8667774|NCT00734032|9711492|FG001|COMPLETED|Overall Study||27
8667775|NCT00734032|9711493|FG002|COMPLETED|Overall Study||28
8667776|NCT00734032|9711494|FG003|COMPLETED|Overall Study||26
8667777|NCT00734032|9711491|FG000|NOT COMPLETED|Overall Study||0
8667778|NCT00734032|9711492|FG001|NOT COMPLETED|Overall Study||1
8667779|NCT00734032|9711493|FG002|NOT COMPLETED|Overall Study||0
8667780|NCT00734032|9711494|FG003|NOT COMPLETED|Overall Study||0
8667781|NCT00734071|9711506|FG000|STARTED|Overall Study||152
8667782|NCT00734071|9711507|FG001|STARTED|Overall Study||152
8667783|NCT00734071|9711506|FG000|Treated|Overall Study||151
8667784|NCT00734071|9711507|FG001|Treated|Overall Study||148
8667785|NCT00734071|9711506|FG000|COMPLETED|Overall Study||114
8667786|NCT00734071|9711507|FG001|COMPLETED|Overall Study||125
8667787|NCT00734071|9711506|FG000|NOT COMPLETED|Overall Study||38
8667788|NCT00734071|9711507|FG001|NOT COMPLETED|Overall Study||27
8667789|NCT00734097|9711513|FG000|STARTED|Screening||337
8667790|NCT00734097|9711513|FG000|COMPLETED|Screening|20 participants were screening failure.|317
8667791|NCT00734097|9711513|FG000|NOT COMPLETED|Screening||20
8667792|NCT00734097|9711513|FG000|STARTED|Open Label|Full analysis performed in 311|317
8667793|NCT00734097|9711513|FG000|Safety Analysis|Open Label||317
8667794|NCT00734097|9711513|FG000|Full Analysis|Open Label||311
8731994|NCT01069315|9779596|FG000|NOT COMPLETED|Overall Study||4
8731995|NCT01069315|9779597|FG001|NOT COMPLETED|Overall Study||6
8731996|NCT01069315|9779598|FG002|NOT COMPLETED|Overall Study||5
8731997|NCT01069315|9779599|FG003|NOT COMPLETED|Overall Study||7
8731998|NCT01069341|9779613|FG000|STARTED|Overall Study||4
8731999|NCT01069341|9779613|FG000|COMPLETED|Overall Study||3
8732000|NCT01069341|9779613|FG000|NOT COMPLETED|Overall Study||1
8732001|NCT01069354|9779617|FG000|STARTED|Overall Study||102
8732002|NCT01069354|9779617|FG000|COMPLETED|Overall Study|One subject's treatment fold not injected due to adverse event during control fold injection|101
8732003|NCT01069354|9779617|FG000|NOT COMPLETED|Overall Study||1
8732004|NCT01069419|9779625|FG000|STARTED|Overall Study||1117
8732005|NCT01069419|9779625|FG000|Safety Set|Overall Study||1111
8732006|NCT01069419|9779625|FG000|Full Analysis Set|Overall Study||851
8732007|NCT01069419|9779625|FG000|COMPLETED|Overall Study||402
8732008|NCT01069419|9779625|FG000|NOT COMPLETED|Overall Study||715
8732009|NCT01069484|9779631|FG000|STARTED|Overall Study|27 in the stratum with major levator ani muscle defects and 60 in the stratum without such defects.|87
8732010|NCT01069484|9779632|FG001|STARTED|Overall Study|28 in the stratum with major levator ani muscle defects and 60 in the stratum without such defects.|88
8732011|NCT01069484|9779631|FG000|COMPLETED|Overall Study|24 in the stratum with major levator ani muscle defects and 51 in the stratum without such defects.|75
8732012|NCT01069484|9779632|FG001|COMPLETED|Overall Study|27 in the stratum with major levator ani muscle defects and 58 in the stratum without such defects.|85
8732013|NCT01069484|9779631|FG000|NOT COMPLETED|Overall Study||12
8667795|NCT00734097|9711513|FG000|Per Protocol|Open Label||301
8667796|NCT00734097|9711513|FG000|COMPLETED|Open Label|16 patients discontinued after randomization|301
8667797|NCT00734097|9711513|FG000|NOT COMPLETED|Open Label||16
8667798|NCT00734149|9711517|FG000|STARTED|Overall Study||45
8667799|NCT00734149|9711517|FG000|COMPLETED|Overall Study||44
8667800|NCT00734149|9711517|FG000|NOT COMPLETED|Overall Study||1
8667801|NCT00734162|9711527|FG000|STARTED|Randomized Phase (Through Week 72)||10
8667802|NCT00734162|9711528|FG001|STARTED|Randomized Phase (Through Week 72)||42
8667803|NCT00734162|9711529|FG002|STARTED|Randomized Phase (Through Week 72)||13
8667804|NCT00734162|9711530|FG003|STARTED|Randomized Phase (Through Week 72)||41
8667805|NCT00734162|9711527|FG000|COMPLETED|Randomized Phase (Through Week 72)||10
8667806|NCT00734162|9711528|FG001|COMPLETED|Randomized Phase (Through Week 72)||41
8667807|NCT00734162|9711529|FG002|COMPLETED|Randomized Phase (Through Week 72)||13
8667808|NCT00734162|9711530|FG003|COMPLETED|Randomized Phase (Through Week 72)||37
8667809|NCT00734162|9711527|FG000|NOT COMPLETED|Randomized Phase (Through Week 72)||0
8667810|NCT00734162|9711528|FG001|NOT COMPLETED|Randomized Phase (Through Week 72)||1
8667811|NCT00734162|9711529|FG002|NOT COMPLETED|Randomized Phase (Through Week 72)||0
8667812|NCT00734162|9711530|FG003|NOT COMPLETED|Randomized Phase (Through Week 72)||4
8667813|NCT00734162|9711527|FG000|STARTED|Open-Label Phase||10
8667814|NCT00734162|9711528|FG001|STARTED|Open-Label Phase||41
8667815|NCT00734162|9711529|FG002|STARTED|Open-Label Phase||13
8667816|NCT00734162|9711530|FG003|STARTED|Open-Label Phase|2 participants switched to open-label treatment before completing double-blind period (elevated ALT)|39
8667817|NCT00734162|9711527|FG000|COMPLETED|Open-Label Phase||7
8667818|NCT00734162|9711528|FG001|COMPLETED|Open-Label Phase||39
8667819|NCT00734162|9711529|FG002|COMPLETED|Open-Label Phase||12
8667820|NCT00734162|9711530|FG003|COMPLETED|Open-Label Phase||36
8667821|NCT00734162|9711527|FG000|NOT COMPLETED|Open-Label Phase||3
8667822|NCT00734162|9711528|FG001|NOT COMPLETED|Open-Label Phase||2
8667823|NCT00734162|9711529|FG002|NOT COMPLETED|Open-Label Phase||1
8667824|NCT00734162|9711530|FG003|NOT COMPLETED|Open-Label Phase||3
8667825|NCT00734214|9711546|FG000|STARTED|Overall Study||128
8667826|NCT00734214|9711547|FG001|STARTED|Overall Study||130
8667827|NCT00734214|9711546|FG000|COMPLETED|Overall Study||124
8667828|NCT00734214|9711547|FG001|COMPLETED|Overall Study||126
8667829|NCT00734214|9711546|FG000|NOT COMPLETED|Overall Study||4
8667830|NCT00734214|9711547|FG001|NOT COMPLETED|Overall Study||4
8667831|NCT00734305|9711555|FG000|STARTED|Overall Study||7
8667832|NCT00734305|9711556|FG001|STARTED|Overall Study||3
8667833|NCT00734305|9711557|FG002|STARTED|Overall Study||4
8667834|NCT00734305|9711558|FG003|STARTED|Overall Study||3
8667835|NCT00734305|9711559|FG004|STARTED|Overall Study||5
8667836|NCT00734305|9711560|FG005|STARTED|Overall Study||4
8667837|NCT00734305|9711561|FG006|STARTED|Overall Study||18
8667838|NCT00734305|9711555|FG000|COMPLETED|Overall Study|1 patient was enrolled but did not meet eligibility criteria at C1W1, and thus was never dosed|6
8667839|NCT00734305|9711556|FG001|COMPLETED|Overall Study||3
8667840|NCT00734305|9711557|FG002|COMPLETED|Overall Study||4
8667841|NCT00734305|9711558|FG003|COMPLETED|Overall Study||3
8667842|NCT00734305|9711559|FG004|COMPLETED|Overall Study||5
8667843|NCT00734305|9711560|FG005|COMPLETED|Overall Study||4
8667844|NCT00734305|9711561|FG006|COMPLETED|Overall Study||18
8667845|NCT00734305|9711555|FG000|NOT COMPLETED|Overall Study||1
8667846|NCT00734305|9711556|FG001|NOT COMPLETED|Overall Study||0
8667847|NCT00734305|9711557|FG002|NOT COMPLETED|Overall Study||0
8667848|NCT00734305|9711558|FG003|NOT COMPLETED|Overall Study||0
8667849|NCT00734305|9711559|FG004|NOT COMPLETED|Overall Study||0
8667850|NCT00734305|9711560|FG005|NOT COMPLETED|Overall Study||0
8667851|NCT00734305|9711561|FG006|NOT COMPLETED|Overall Study||0
8667852|NCT00734344|9711581|FG000|STARTED|Overall Study||9
8667853|NCT00734344|9711582|FG001|STARTED|Overall Study||9
8667854|NCT00734344|9711581|FG000|COMPLETED|Overall Study||9
8667855|NCT00734344|9711582|FG001|COMPLETED|Overall Study||9
8667856|NCT00734344|9711581|FG000|NOT COMPLETED|Overall Study||0
8667857|NCT00734344|9711582|FG001|NOT COMPLETED|Overall Study||0
8667858|NCT00734409|9711592|FG000|STARTED|Overall Study||155
8667859|NCT00734409|9711593|FG001|STARTED|Overall Study||145
8667860|NCT00734409|9711592|FG000|COMPLETED|Overall Study||155
8667861|NCT00734409|9711593|FG001|COMPLETED|Overall Study||145
8667862|NCT00734409|9711592|FG000|NOT COMPLETED|Overall Study||0
8667863|NCT00734409|9711593|FG001|NOT COMPLETED|Overall Study||0
8667864|NCT00734474|9711608|FG000|STARTED|Overall Study||15
8667865|NCT00734474|9711609|FG001|STARTED|Overall Study||30
8667866|NCT00734474|9711610|FG002|STARTED|Overall Study||304
8667867|NCT00734474|9711611|FG003|STARTED|Overall Study||10
8667868|NCT00734474|9711612|FG004|STARTED|Overall Study||302
8667869|NCT00734474|9711613|FG005|STARTED|Overall Study||25
8667870|NCT00734474|9711614|FG006|STARTED|Overall Study||24
8667871|NCT00734474|9711615|FG007|STARTED|Overall Study||315
8667872|NCT00734474|9711616|FG008|STARTED|Overall Study||177
8667873|NCT00734474|9711608|FG000|Received at Least 1 Dose of Study Drug|Overall Study||15
8667874|NCT00734474|9711609|FG001|Received at Least 1 Dose of Study Drug|Overall Study||30
8667875|NCT00734474|9711610|FG002|Received at Least 1 Dose of Study Drug|Overall Study||304
8667876|NCT00734474|9711611|FG003|Received at Least 1 Dose of Study Drug|Overall Study||10
8667877|NCT00734474|9711612|FG004|Received at Least 1 Dose of Study Drug|Overall Study||302
8667878|NCT00734474|9711613|FG005|Received at Least 1 Dose of Study Drug|Overall Study||25
8667879|NCT00734474|9711614|FG006|Received at Least 1 Dose of Study Drug|Overall Study||24
8667880|NCT00734474|9711615|FG007|Received at Least 1 Dose of Study Drug|Overall Study||315
8667881|NCT00734474|9711616|FG008|Received at Least 1 Dose of Study Drug|Overall Study||177
8667882|NCT00734474|9711608|FG000|Entered Study Before Dose Decision Point|Overall Study||15
8667883|NCT00734474|9711609|FG001|Entered Study Before Dose Decision Point|Overall Study||30
8667884|NCT00734474|9711610|FG002|Entered Study Before Dose Decision Point|Overall Study||25
8667885|NCT00734474|9711611|FG003|Entered Study Before Dose Decision Point|Overall Study||10
8667886|NCT00734474|9711612|FG004|Entered Study Before Dose Decision Point|Overall Study||21
8667887|NCT00734474|9711613|FG005|Entered Study Before Dose Decision Point|Overall Study||25
8667888|NCT00734474|9711614|FG006|Entered Study Before Dose Decision Point|Overall Study||24
8667889|NCT00734474|9711615|FG007|Entered Study Before Dose Decision Point|Overall Study||42
8667890|NCT00734474|9711616|FG008|Entered Study Before Dose Decision Point|Overall Study||38
8667891|NCT00734474|9711608|FG000|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|8
8667892|NCT00734474|9711609|FG001|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|25
8667893|NCT00734474|9711610|FG002|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (selected arm).|24
8667894|NCT00734474|9711611|FG003|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|8
8667895|NCT00734474|9711612|FG004|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (selected arm).|21
8667896|NCT00734474|9711613|FG005|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|21
8667897|NCT00734474|9711614|FG006|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|23
8667898|NCT00734474|9711615|FG007|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (comparator arm).|42
8667899|NCT00734474|9711616|FG008|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (comparator arm).|34
8667900|NCT00734474|9711608|FG000|Entered Study After Dose Decision Point|Overall Study||0
8667901|NCT00734474|9711609|FG001|Entered Study After Dose Decision Point|Overall Study||0
8667902|NCT00734474|9711610|FG002|Entered Study After Dose Decision Point|Overall Study||279
8667903|NCT00734474|9711611|FG003|Entered Study After Dose Decision Point|Overall Study||0
8667904|NCT00734474|9711612|FG004|Entered Study After Dose Decision Point|Overall Study||281
8667905|NCT00734474|9711613|FG005|Entered Study After Dose Decision Point|Overall Study||0
8667906|NCT00734474|9711614|FG006|Entered Study After Dose Decision Point|Overall Study||0
8667907|NCT00734474|9711615|FG007|Entered Study After Dose Decision Point|Overall Study||273
8667908|NCT00734474|9711616|FG008|Entered Study After Dose Decision Point|Overall Study||139
8667909|NCT00734474|9711608|FG000|Completed 26-Week Visit|Overall Study||0
8667910|NCT00734474|9711609|FG001|Completed 26-Week Visit|Overall Study||0
8667911|NCT00734474|9711610|FG002|Completed 26-Week Visit|Overall Study||258
8732014|NCT01069484|9779632|FG001|NOT COMPLETED|Overall Study||3
8732015|NCT01069510|9779641|FG000|STARTED|Overall Study||8
8732016|NCT01069510|9779642|FG001|STARTED|Overall Study||7
8732017|NCT01069510|9779641|FG000|COMPLETED|Overall Study||8
8732018|NCT01069510|9779642|FG001|COMPLETED|Overall Study||7
8732019|NCT01069510|9779641|FG000|NOT COMPLETED|Overall Study||0
8732020|NCT01069510|9779642|FG001|NOT COMPLETED|Overall Study||0
8732021|NCT01069523|9779650|FG000|STARTED|Overall Study||13
8732022|NCT01069523|9779651|FG001|STARTED|Overall Study||16
8732023|NCT01069523|9779650|FG000|COMPLETED|Overall Study||9
8732024|NCT01069523|9779651|FG001|COMPLETED|Overall Study||9
8732025|NCT01069523|9779650|FG000|NOT COMPLETED|Overall Study||4
8732026|NCT01069523|9779651|FG001|NOT COMPLETED|Overall Study||7
8732027|NCT01069562|9779661|FG000|STARTED|Overall Study||20
8732028|NCT01069562|9779662|FG001|STARTED|Overall Study||20
8732029|NCT01069562|9779661|FG000|COMPLETED|Overall Study||20
8732030|NCT01069562|9779662|FG001|COMPLETED|Overall Study||20
8732031|NCT01069562|9779661|FG000|NOT COMPLETED|Overall Study||0
8732032|NCT01069562|9779662|FG001|NOT COMPLETED|Overall Study||0
8732033|NCT01069627|9779668|FG000|STARTED|Overall Study||20
8732034|NCT01069627|9779668|FG000|COMPLETED|Overall Study||0
8732035|NCT01069627|9779668|FG000|NOT COMPLETED|Overall Study||20
8732036|NCT01069705|9779672|FG000|STARTED|Overall Study||49
8732037|NCT01069705|9779672|FG000|COMPLETED|Overall Study||46
8732038|NCT01069705|9779672|FG000|NOT COMPLETED|Overall Study||3
8732039|NCT01069900|9779678|FG000|STARTED|Overall Study||305
8732040|NCT01069900|9779679|FG001|STARTED|Overall Study||153
8732041|NCT01069900|9779678|FG000|Treated|Overall Study||301
8732042|NCT01069900|9779679|FG001|Treated|Overall Study||150
8732043|NCT01069900|9779678|FG000|COMPLETED|Overall Study||287
8732044|NCT01069900|9779679|FG001|COMPLETED|Overall Study||149
8732045|NCT01069900|9779678|FG000|NOT COMPLETED|Overall Study||18
8732046|NCT01069900|9779679|FG001|NOT COMPLETED|Overall Study||4
8732047|NCT01069939|9779687|FG000|STARTED|Randomised and Included in the Analyses||213
8732048|NCT01069939|9779688|FG001|STARTED|Randomised and Included in the Analyses||214
8732049|NCT01069939|9779687|FG000|COMPLETED|Randomised and Included in the Analyses||164
8732050|NCT01069939|9779688|FG001|COMPLETED|Randomised and Included in the Analyses||137
8732051|NCT01069939|9779687|FG000|NOT COMPLETED|Randomised and Included in the Analyses||49
8732052|NCT01069939|9779688|FG001|NOT COMPLETED|Randomised and Included in the Analyses||77
8732053|NCT01069939|9779687|FG000|STARTED|At Data Cut Off Date (26 Feb 2011)||213
8732054|NCT01069939|9779688|FG001|STARTED|At Data Cut Off Date (26 Feb 2011)||214
8732055|NCT01069939|9779687|FG000|COMPLETED|At Data Cut Off Date (26 Feb 2011)||182
8732056|NCT01069939|9779688|FG001|COMPLETED|At Data Cut Off Date (26 Feb 2011)||182
8732057|NCT01069939|9779687|FG000|NOT COMPLETED|At Data Cut Off Date (26 Feb 2011)||31
8732058|NCT01069939|9779688|FG001|NOT COMPLETED|At Data Cut Off Date (26 Feb 2011)||32
8732059|NCT01070043|9779696|FG000|STARTED|Run-In Phase||60
8732060|NCT01070043|9779697|FG001|STARTED|Run-In Phase|This combination therapy arm is used only for double-blind phase.|0
8732061|NCT01070043|9779698|FG002|STARTED|Run-In Phase|This monotherapy (Valsartan 160 mg) treatment arm is used only for double-blind phase.|0
8732062|NCT01070043|9779696|FG000|COMPLETED|Run-In Phase||42
8732063|NCT01070043|9779697|FG001|COMPLETED|Run-In Phase||0
8732064|NCT01070043|9779698|FG002|COMPLETED|Run-In Phase||0
8732065|NCT01070043|9779696|FG000|NOT COMPLETED|Run-In Phase||18
8732066|NCT01070043|9779697|FG001|NOT COMPLETED|Run-In Phase||0
8732067|NCT01070043|9779698|FG002|NOT COMPLETED|Run-In Phase||0
8732068|NCT01070043|9779696|FG000|STARTED|Double-Blind Treatment||0
8732069|NCT01070043|9779697|FG001|STARTED|Double-Blind Treatment||21
8732070|NCT01070043|9779698|FG002|STARTED|Double-Blind Treatment||21
8732071|NCT01070043|9779696|FG000|COMPLETED|Double-Blind Treatment||0
8732072|NCT01070043|9779697|FG001|COMPLETED|Double-Blind Treatment||21
8732073|NCT01070043|9779698|FG002|COMPLETED|Double-Blind Treatment||19
8732074|NCT01070043|9779696|FG000|NOT COMPLETED|Double-Blind Treatment||0
8667912|NCT00734474|9711611|FG003|Completed 26-Week Visit|Overall Study||2
8667913|NCT00734474|9711612|FG004|Completed 26-Week Visit|Overall Study||268
8667914|NCT00734474|9711613|FG005|Completed 26-Week Visit|Overall Study||2
8667915|NCT00734474|9711614|FG006|Completed 26-Week Visit|Overall Study||2
8667916|NCT00734474|9711615|FG007|Completed 26-Week Visit|Overall Study||270
8667917|NCT00734474|9711616|FG008|Completed 26-Week Visit|Overall Study||124
8667918|NCT00734474|9711608|FG000|Completed 52-Week Visit|Overall Study||0
8667919|NCT00734474|9711609|FG001|Completed 52-Week Visit|Overall Study||0
8667920|NCT00734474|9711610|FG002|Completed 52-Week Visit|Overall Study||238
8667921|NCT00734474|9711611|FG003|Completed 52-Week Visit|Overall Study||0
8667922|NCT00734474|9711612|FG004|Completed 52-Week Visit|Overall Study||243
8667923|NCT00734474|9711613|FG005|Completed 52-Week Visit|Overall Study||0
8667924|NCT00734474|9711614|FG006|Completed 52-Week Visit|Overall Study||0
8667925|NCT00734474|9711615|FG007|Completed 52-Week Visit|Overall Study||238
8667926|NCT00734474|9711616|FG008|Completed 52-Week Visit|Overall Study||112
8667927|NCT00734474|9711608|FG000|COMPLETED|Overall Study||0
8667928|NCT00734474|9711609|FG001|COMPLETED|Overall Study||0
8667929|NCT00734474|9711610|FG002|COMPLETED|Overall Study||192
8667930|NCT00734474|9711611|FG003|COMPLETED|Overall Study||0
8667931|NCT00734474|9711612|FG004|COMPLETED|Overall Study||184
8667932|NCT00734474|9711613|FG005|COMPLETED|Overall Study||0
8667933|NCT00734474|9711614|FG006|COMPLETED|Overall Study||0
8667934|NCT00734474|9711615|FG007|COMPLETED|Overall Study||186
8667935|NCT00734474|9711616|FG008|COMPLETED|Overall Study||95
8667936|NCT00734474|9711608|FG000|NOT COMPLETED|Overall Study||15
8667937|NCT00734474|9711609|FG001|NOT COMPLETED|Overall Study||30
8667938|NCT00734474|9711610|FG002|NOT COMPLETED|Overall Study||112
8667939|NCT00734474|9711611|FG003|NOT COMPLETED|Overall Study||10
8667940|NCT00734474|9711612|FG004|NOT COMPLETED|Overall Study||118
8667941|NCT00734474|9711613|FG005|NOT COMPLETED|Overall Study||25
8667942|NCT00734474|9711614|FG006|NOT COMPLETED|Overall Study||24
8667943|NCT00734474|9711615|FG007|NOT COMPLETED|Overall Study||129
8667944|NCT00734474|9711616|FG008|NOT COMPLETED|Overall Study||82
8667945|NCT00734500|9711642|FG000|STARTED|Overall Study||15
8667946|NCT00734500|9711642|FG000|COMPLETED|Overall Study||14
8667947|NCT00734500|9711642|FG000|NOT COMPLETED|Overall Study||1
8667948|NCT00734539|9711648|FG000|STARTED|Main Study||189
8667949|NCT00734539|9711649|FG001|STARTED|Main Study||173
8667950|NCT00734539|9711648|FG000|COMPLETED|Main Study|Number of subjects who participated through hospital discharge or study end|152
8667951|NCT00734539|9711649|FG001|COMPLETED|Main Study|Number of subjects who participated through hospital discharge or study end|138
8667952|NCT00734539|9711648|FG000|NOT COMPLETED|Main Study||37
8667953|NCT00734539|9711649|FG001|NOT COMPLETED|Main Study||35
8667954|NCT00734539|9711648|FG000|STARTED|Long Term Follow up||152
8667955|NCT00734539|9711649|FG001|STARTED|Long Term Follow up||138
8667956|NCT00734539|9711648|FG000|COMPLETED|Long Term Follow up|Number of participants who completed the 18-22 months follow-up|118
8667957|NCT00734539|9711649|FG001|COMPLETED|Long Term Follow up|Number of participants who completed the 18-22 months follow-up|107
8667958|NCT00734539|9711648|FG000|NOT COMPLETED|Long Term Follow up||34
8667959|NCT00734539|9711649|FG001|NOT COMPLETED|Long Term Follow up||31
8667960|NCT00734578|9711661|FG000|STARTED|Overall Study||154
8667961|NCT00734578|9711662|FG001|STARTED|Overall Study||153
8667962|NCT00734578|9711663|FG002|STARTED|Overall Study||154
8667963|NCT00734578|9711661|FG000|COMPLETED|Overall Study||121
8667964|NCT00734578|9711662|FG001|COMPLETED|Overall Study||128
8667965|NCT00734578|9711663|FG002|COMPLETED|Overall Study||129
8667966|NCT00734578|9711661|FG000|NOT COMPLETED|Overall Study||33
8667967|NCT00734578|9711662|FG001|NOT COMPLETED|Overall Study||25
8667968|NCT00734578|9711663|FG002|NOT COMPLETED|Overall Study||25
8667969|NCT00734591|9711673|FG000|STARTED|Retrospective Period||3875
8667970|NCT00734591|9711674|FG001|STARTED|Retrospective Period||3564
8667971|NCT00734591|9711673|FG000|COMPLETED|Retrospective Period||3875
8667972|NCT00734591|9711674|FG001|COMPLETED|Retrospective Period||3564
8667973|NCT00734591|9711673|FG000|NOT COMPLETED|Retrospective Period||0
8667974|NCT00734591|9711674|FG001|NOT COMPLETED|Retrospective Period||0
8667975|NCT00734591|9711673|FG000|STARTED|Screening for Prospective Period||3875
8667976|NCT00734591|9711674|FG001|STARTED|Screening for Prospective Period||3564
8667977|NCT00734591|9711673|FG000|COMPLETED|Screening for Prospective Period||1358
8667978|NCT00734591|9711674|FG001|COMPLETED|Screening for Prospective Period||1273
8667979|NCT00734591|9711673|FG000|NOT COMPLETED|Screening for Prospective Period||2517
8667980|NCT00734591|9711674|FG001|NOT COMPLETED|Screening for Prospective Period||2291
8667981|NCT00734591|9711673|FG000|STARTED|Prospective Period||1358
8667982|NCT00734591|9711674|FG001|STARTED|Prospective Period||1273
8667983|NCT00734591|9711673|FG000|COMPLETED|Prospective Period||1307
8667984|NCT00734591|9711674|FG001|COMPLETED|Prospective Period||1229
8667985|NCT00734591|9711673|FG000|NOT COMPLETED|Prospective Period||51
8667986|NCT00734591|9711674|FG001|NOT COMPLETED|Prospective Period||44
8667987|NCT00734604|9711686|FG000|STARTED|Overall Study||62
8667988|NCT00734604|9711687|FG001|STARTED|Overall Study||63
8667989|NCT00734604|9711688|FG002|STARTED|Overall Study||63
8667990|NCT00734604|9711689|FG003|STARTED|Overall Study||63
8667991|NCT00734604|9711690|FG004|STARTED|Overall Study||63
8667992|NCT00734604|9711691|FG005|STARTED|Overall Study||64
8667993|NCT00734604|9711686|FG000|COMPLETED|Overall Study||59
8667994|NCT00734604|9711687|FG001|COMPLETED|Overall Study||51
8667995|NCT00734604|9711688|FG002|COMPLETED|Overall Study||57
8667996|NCT00734604|9711689|FG003|COMPLETED|Overall Study||54
8667997|NCT00734604|9711690|FG004|COMPLETED|Overall Study||55
8667998|NCT00734604|9711691|FG005|COMPLETED|Overall Study||58
8667999|NCT00734604|9711686|FG000|NOT COMPLETED|Overall Study||3
8668000|NCT00734604|9711687|FG001|NOT COMPLETED|Overall Study||12
8668001|NCT00734604|9711688|FG002|NOT COMPLETED|Overall Study||6
8668002|NCT00734604|9711689|FG003|NOT COMPLETED|Overall Study||9
8668003|NCT00734604|9711690|FG004|NOT COMPLETED|Overall Study||8
8668004|NCT00734604|9711691|FG005|NOT COMPLETED|Overall Study||6
8668005|NCT00734617|9711704|FG000|STARTED|Overall Study||249
8668006|NCT00734617|9711705|FG001|STARTED|Overall Study||230
8668007|NCT00734617|9711704|FG000|COMPLETED|Overall Study||142
8668008|NCT00734617|9711705|FG001|COMPLETED|Overall Study||128
8668009|NCT00734617|9711704|FG000|NOT COMPLETED|Overall Study||107
8668010|NCT00734617|9711705|FG001|NOT COMPLETED|Overall Study||102
8668011|NCT00734630|9711713|FG000|STARTED|Overall Study||258
8668012|NCT00734630|9711714|FG001|STARTED|Overall Study||233
8668013|NCT00734630|9711713|FG000|COMPLETED|Overall Study||229
8668014|NCT00734630|9711714|FG001|COMPLETED|Overall Study||200
8668015|NCT00734630|9711713|FG000|NOT COMPLETED|Overall Study||29
8668016|NCT00734630|9711714|FG001|NOT COMPLETED|Overall Study||33
8668017|NCT00734656|9711720|FG000|STARTED|Lab Session 1||24
8668018|NCT00734656|9711721|FG001|STARTED|Lab Session 1||23
8732075|NCT01070043|9779697|FG001|NOT COMPLETED|Double-Blind Treatment||0
8732076|NCT01070043|9779698|FG002|NOT COMPLETED|Double-Blind Treatment||2
8732077|NCT01070095|9779704|FG000|STARTED|Baseline Period||19
8732078|NCT01070095|9779705|FG001|STARTED|Baseline Period||830
8732079|NCT01070095|9779704|FG000|COMPLETED|Baseline Period||18
8732080|NCT01070095|9779705|FG001|COMPLETED|Baseline Period||830
8732081|NCT01070095|9779704|FG000|NOT COMPLETED|Baseline Period||1
8732082|NCT01070095|9779705|FG001|NOT COMPLETED|Baseline Period||0
8732083|NCT01070095|9779704|FG000|STARTED|Intervention Period||18
8732084|NCT01070095|9779705|FG001|STARTED|Intervention Period||890
8732085|NCT01070095|9779704|FG000|COMPLETED|Intervention Period||18
8732086|NCT01070095|9779705|FG001|COMPLETED|Intervention Period||890
8732087|NCT01070095|9779704|FG000|NOT COMPLETED|Intervention Period||0
8732088|NCT01070095|9779705|FG001|NOT COMPLETED|Intervention Period||0
8732089|NCT01070173|9779715|FG000|STARTED|Overall Study||33
8732090|NCT01070173|9779716|FG001|STARTED|Overall Study||8
8732091|NCT01070173|9779717|FG002|STARTED|Overall Study||11
8732092|NCT01070173|9779715|FG000|COMPLETED|Overall Study||33
8732093|NCT01070173|9779716|FG001|COMPLETED|Overall Study||8
8732094|NCT01070173|9779717|FG002|COMPLETED|Overall Study||11
8732095|NCT01070173|9779715|FG000|NOT COMPLETED|Overall Study||0
8732096|NCT01070173|9779716|FG001|NOT COMPLETED|Overall Study||0
8732097|NCT01070173|9779717|FG002|NOT COMPLETED|Overall Study||0
8806700|NCT01479530|9859028|FG001|STARTED|Overall Study||163
8806701|NCT01479530|9859027|FG000|COMPLETED|Overall Study||148
8806702|NCT01479530|9859028|FG001|COMPLETED|Overall Study||151
8806703|NCT01479530|9859027|FG000|NOT COMPLETED|Overall Study||10
8806704|NCT01479530|9859028|FG001|NOT COMPLETED|Overall Study||12
8806705|NCT01479543|9859039|FG000|STARTED|Overall Study||21
8806706|NCT01479543|9859040|FG001|STARTED|Overall Study||20
8806707|NCT01479543|9859041|FG002|STARTED|Overall Study||21
8806708|NCT01479543|9859042|FG003|STARTED|Overall Study||20
8806709|NCT01479543|9859043|FG004|STARTED|Overall Study||21
8806710|NCT01479543|9859039|FG000|COMPLETED|Overall Study||20
8806711|NCT01479543|9859040|FG001|COMPLETED|Overall Study||20
8806712|NCT01479543|9859041|FG002|COMPLETED|Overall Study||20
8806713|NCT01479543|9859042|FG003|COMPLETED|Overall Study||20
8806714|NCT01479543|9859043|FG004|COMPLETED|Overall Study||20
8806715|NCT01479543|9859039|FG000|NOT COMPLETED|Overall Study||1
8806716|NCT01479543|9859040|FG001|NOT COMPLETED|Overall Study||0
8806717|NCT01479543|9859041|FG002|NOT COMPLETED|Overall Study||1
8806718|NCT01479543|9859042|FG003|NOT COMPLETED|Overall Study||0
8806719|NCT01479543|9859043|FG004|NOT COMPLETED|Overall Study||1
8806720|NCT01479595|9859057|FG000|STARTED|Overall Study||44
8806721|NCT01479595|9859058|FG001|STARTED|Overall Study||21
8911619|NCT02147288|9970672|FG004|NOT COMPLETED|Overall Study||0
8911620|NCT02147288|9970673|FG005|NOT COMPLETED|Overall Study||0
8911621|NCT02147288|9970674|FG006|NOT COMPLETED|Overall Study||0
8911622|NCT02147288|9970675|FG007|NOT COMPLETED|Overall Study||0
8911623|NCT02147288|9970676|FG008|NOT COMPLETED|Overall Study||0
8911624|NCT02147288|9970677|FG009|NOT COMPLETED|Overall Study||0
8911625|NCT02147301|9970683|FG000|STARTED|Overall Study||17
8911626|NCT02147301|9970683|FG000|COMPLETED|Overall Study||17
8911627|NCT02147301|9970683|FG000|NOT COMPLETED|Overall Study||0
8911628|NCT02147353|9970689|FG000|STARTED|Overall Study||21
8911629|NCT02147353|9970690|FG001|STARTED|Overall Study||21
8911630|NCT02147353|9970689|FG000|COMPLETED|Overall Study||12
8911631|NCT02147353|9970690|FG001|COMPLETED|Overall Study||21
8911632|NCT02147353|9970689|FG000|NOT COMPLETED|Overall Study||9
8668019|NCT00734656|9711722|FG002|STARTED|Lab Session 1||26
8668020|NCT00734656|9711723|FG003|STARTED|Lab Session 1||21
8668021|NCT00734656|9711720|FG000|COMPLETED|Lab Session 1||22
8668022|NCT00734656|9711721|FG001|COMPLETED|Lab Session 1||23
8806722|NCT01479595|9859057|FG000|PK Analysis Set|Overall Study||42
8806723|NCT01479595|9859058|FG001|PK Analysis Set|Overall Study||0
8806724|NCT01479595|9859057|FG000|Per Protocol Analysis Set|Overall Study||41
8806725|NCT01479595|9859058|FG001|Per Protocol Analysis Set|Overall Study||20
8806726|NCT01479595|9859057|FG000|COMPLETED|Overall Study||42
8806727|NCT01479595|9859058|FG001|COMPLETED|Overall Study||19
8911633|NCT02147353|9970690|FG001|NOT COMPLETED|Overall Study||0
8911634|NCT02147522|9970698|FG000|STARTED|Overall Study||178
8668023|NCT00734656|9711722|FG002|COMPLETED|Lab Session 1||26
8668024|NCT00734656|9711723|FG003|COMPLETED|Lab Session 1||21
8668025|NCT00734656|9711720|FG000|NOT COMPLETED|Lab Session 1||2
8668026|NCT00734656|9711721|FG001|NOT COMPLETED|Lab Session 1||0
8668027|NCT00734656|9711722|FG002|NOT COMPLETED|Lab Session 1||0
8668028|NCT00734656|9711723|FG003|NOT COMPLETED|Lab Session 1||0
8668029|NCT00734656|9711720|FG000|STARTED|Washout 1||22
8668030|NCT00734656|9711721|FG001|STARTED|Washout 1||23
8668031|NCT00734656|9711722|FG002|STARTED|Washout 1||26
8668032|NCT00734656|9711723|FG003|STARTED|Washout 1||21
8668033|NCT00734656|9711720|FG000|COMPLETED|Washout 1||21
8668034|NCT00734656|9711721|FG001|COMPLETED|Washout 1||18
8668035|NCT00734656|9711722|FG002|COMPLETED|Washout 1||24
8668036|NCT00734656|9711723|FG003|COMPLETED|Washout 1||18
8668037|NCT00734656|9711720|FG000|NOT COMPLETED|Washout 1||1
8668038|NCT00734656|9711721|FG001|NOT COMPLETED|Washout 1||5
8668039|NCT00734656|9711722|FG002|NOT COMPLETED|Washout 1||2
8668040|NCT00734656|9711723|FG003|NOT COMPLETED|Washout 1||3
8668041|NCT00734656|9711720|FG000|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|19
8668042|NCT00734656|9711721|FG001|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|21
8668043|NCT00734656|9711722|FG002|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|21
8668044|NCT00734656|9711723|FG003|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|20
8668045|NCT00734656|9711720|FG000|COMPLETED|Lab Session 2||18
8668046|NCT00734656|9711721|FG001|COMPLETED|Lab Session 2||21
8668047|NCT00734656|9711722|FG002|COMPLETED|Lab Session 2||21
8668048|NCT00734656|9711723|FG003|COMPLETED|Lab Session 2||19
8668049|NCT00734656|9711720|FG000|NOT COMPLETED|Lab Session 2||1
8668050|NCT00734656|9711721|FG001|NOT COMPLETED|Lab Session 2||0
8668051|NCT00734656|9711722|FG002|NOT COMPLETED|Lab Session 2||0
8668052|NCT00734656|9711723|FG003|NOT COMPLETED|Lab Session 2||1
8668053|NCT00734656|9711720|FG000|STARTED|Washout 2||18
8668054|NCT00734656|9711721|FG001|STARTED|Washout 2||21
8668055|NCT00734656|9711722|FG002|STARTED|Washout 2||21
8668056|NCT00734656|9711723|FG003|STARTED|Washout 2||19
8668057|NCT00734656|9711720|FG000|COMPLETED|Washout 2||17
8668058|NCT00734656|9711721|FG001|COMPLETED|Washout 2||20
8668059|NCT00734656|9711722|FG002|COMPLETED|Washout 2||20
8668060|NCT00734656|9711723|FG003|COMPLETED|Washout 2||19
8668061|NCT00734656|9711720|FG000|NOT COMPLETED|Washout 2||1
8668062|NCT00734656|9711721|FG001|NOT COMPLETED|Washout 2||1
8668063|NCT00734656|9711722|FG002|NOT COMPLETED|Washout 2||1
8668064|NCT00734656|9711723|FG003|NOT COMPLETED|Washout 2||0
8668065|NCT00734656|9711720|FG000|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|18
8668066|NCT00734656|9711721|FG001|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|19
8668067|NCT00734656|9711722|FG002|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|20
8668068|NCT00734656|9711723|FG003|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|19
8668069|NCT00734656|9711720|FG000|COMPLETED|Lab Session 3||18
8668070|NCT00734656|9711721|FG001|COMPLETED|Lab Session 3||19
8668071|NCT00734656|9711722|FG002|COMPLETED|Lab Session 3||20
8668072|NCT00734656|9711723|FG003|COMPLETED|Lab Session 3||19
8668073|NCT00734656|9711720|FG000|NOT COMPLETED|Lab Session 3||0
8668074|NCT00734656|9711721|FG001|NOT COMPLETED|Lab Session 3||0
8668075|NCT00734656|9711722|FG002|NOT COMPLETED|Lab Session 3||0
8668076|NCT00734656|9711723|FG003|NOT COMPLETED|Lab Session 3||0
8668077|NCT00734656|9711720|FG000|STARTED|Washout 3||18
8668078|NCT00734656|9711721|FG001|STARTED|Washout 3||19
8668079|NCT00734656|9711722|FG002|STARTED|Washout 3||20
8668080|NCT00734656|9711723|FG003|STARTED|Washout 3||19
8668081|NCT00734656|9711720|FG000|COMPLETED|Washout 3||17
8668082|NCT00734656|9711721|FG001|COMPLETED|Washout 3||19
8668083|NCT00734656|9711722|FG002|COMPLETED|Washout 3||20
8668084|NCT00734656|9711723|FG003|COMPLETED|Washout 3||18
8668085|NCT00734656|9711720|FG000|NOT COMPLETED|Washout 3||1
8668086|NCT00734656|9711721|FG001|NOT COMPLETED|Washout 3||0
8668087|NCT00734656|9711722|FG002|NOT COMPLETED|Washout 3||0
8668088|NCT00734656|9711723|FG003|NOT COMPLETED|Washout 3||1
8668089|NCT00734656|9711720|FG000|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|20
8668090|NCT00734656|9711721|FG001|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|18
8668091|NCT00734656|9711722|FG002|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|16
8668092|NCT00734656|9711723|FG003|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|20
8668093|NCT00734656|9711720|FG000|COMPLETED|Lab Session 4||20
8668094|NCT00734656|9711721|FG001|COMPLETED|Lab Session 4||18
8668095|NCT00734656|9711722|FG002|COMPLETED|Lab Session 4||16
8668096|NCT00734656|9711723|FG003|COMPLETED|Lab Session 4||19
8668097|NCT00734656|9711720|FG000|NOT COMPLETED|Lab Session 4||0
8668098|NCT00734656|9711721|FG001|NOT COMPLETED|Lab Session 4||0
8668099|NCT00734656|9711722|FG002|NOT COMPLETED|Lab Session 4||0
8668100|NCT00734656|9711723|FG003|NOT COMPLETED|Lab Session 4||1
8668101|NCT00734734|9711733|FG000|STARTED|Overall Study||64
8668102|NCT00734734|9711733|FG000|COMPLETED|Overall Study||64
8668103|NCT00734734|9711733|FG000|NOT COMPLETED|Overall Study||0
8668104|NCT00734747|9711738|FG000|STARTED|SRS Procedure||72
8668105|NCT00734747|9711738|FG000|COMPLETED|SRS Procedure||69
8668106|NCT00734747|9711738|FG000|NOT COMPLETED|SRS Procedure||3
8668107|NCT00734747|9711738|FG000|STARTED|6 Month Follow-up||69
8668108|NCT00734747|9711738|FG000|COMPLETED|6 Month Follow-up||66
8668109|NCT00734747|9711738|FG000|NOT COMPLETED|6 Month Follow-up||3
8668110|NCT00734799|9711744|FG000|STARTED|Overall Study||9
8668111|NCT00734799|9711745|FG001|STARTED|Overall Study||13
8668112|NCT00734799|9711744|FG000|COMPLETED|Overall Study||9
8668113|NCT00734799|9711745|FG001|COMPLETED|Overall Study||9
8668114|NCT00734799|9711744|FG000|NOT COMPLETED|Overall Study||0
8668115|NCT00734799|9711745|FG001|NOT COMPLETED|Overall Study||4
8668116|NCT00734851|9711751|FG000|STARTED|Overall Study||34
8668117|NCT00734851|9711751|FG000|COMPLETED|Overall Study||13
8668118|NCT00734851|9711751|FG000|NOT COMPLETED|Overall Study||21
8668119|NCT00734903|9711757|FG000|STARTED|Overall Study||33
8668120|NCT00734903|9711758|FG001|STARTED|Overall Study||33
8668121|NCT00734903|9711757|FG000|Completed End of Treatment Assessment|Overall Study||21
8668122|NCT00734903|9711758|FG001|Completed End of Treatment Assessment|Overall Study||23
8668123|NCT00734903|9711757|FG000|Completed 3-month Followup|Overall Study||14
8668124|NCT00734903|9711758|FG001|Completed 3-month Followup|Overall Study||15
8668125|NCT00734903|9711757|FG000|COMPLETED|Overall Study||30
8668126|NCT00734903|9711758|FG001|COMPLETED|Overall Study||32
8668127|NCT00734903|9711757|FG000|NOT COMPLETED|Overall Study||3
8668128|NCT00734903|9711758|FG001|NOT COMPLETED|Overall Study||1
8668129|NCT00734929|9711766|FG000|STARTED|Overall Study||57
8668130|NCT00734929|9711767|FG001|STARTED|Overall Study||58
8668131|NCT00734929|9711766|FG000|COMPLETED|Overall Study||51
8668132|NCT00734929|9711767|FG001|COMPLETED|Overall Study||53
8668133|NCT00734929|9711766|FG000|NOT COMPLETED|Overall Study||6
8732098|NCT01070303|9779727|FG000|STARTED|Overall Study||177
8732099|NCT01070303|9779727|FG000|COMPLETED|Overall Study||88
8732100|NCT01070303|9779727|FG000|NOT COMPLETED|Overall Study||89
8732101|NCT01070316|9779737|FG000|STARTED|Main Phase||20
8732102|NCT01070316|9779737|FG000|COMPLETED|Main Phase||20
8732103|NCT01070316|9779737|FG000|NOT COMPLETED|Main Phase||0
8732104|NCT01070316|9779737|FG000|STARTED|Extension Phase|Two participants did not qualify for Extension Phase as defined by protocol|18
8732105|NCT01070316|9779737|FG000|COMPLETED|Extension Phase||14
8732106|NCT01070316|9779737|FG000|NOT COMPLETED|Extension Phase||4
8732107|NCT01070329|9779743|FG000|STARTED|Overall Study||261
8732108|NCT01070329|9779744|FG001|STARTED|Overall Study||266
8732109|NCT01070329|9779743|FG000|COMPLETED|Overall Study||209
8732110|NCT01070329|9779744|FG001|COMPLETED|Overall Study||217
8732111|NCT01070329|9779743|FG000|NOT COMPLETED|Overall Study||52
8732112|NCT01070329|9779744|FG001|NOT COMPLETED|Overall Study||49
8732113|NCT01070381|9779750|FG000|STARTED|Period 1, 1 Week of Wear|One subject could not be dispensed into Period 1 product. Subject started Period 2 wear.|109
8732114|NCT01070381|9779751|FG001|STARTED|Period 1, 1 Week of Wear||107
8732115|NCT01070381|9779750|FG000|COMPLETED|Period 1, 1 Week of Wear|One subject could not continue into Period 2 due to product unavailability.|109
8732116|NCT01070381|9779751|FG001|COMPLETED|Period 1, 1 Week of Wear||107
8732117|NCT01070381|9779750|FG000|NOT COMPLETED|Period 1, 1 Week of Wear||0
8732118|NCT01070381|9779751|FG001|NOT COMPLETED|Period 1, 1 Week of Wear||0
8732119|NCT01070381|9779750|FG000|STARTED|Period 2, 1 Week of Wear||109
8732120|NCT01070381|9779751|FG001|STARTED|Period 2, 1 Week of Wear||107
8732121|NCT01070381|9779750|FG000|COMPLETED|Period 2, 1 Week of Wear||108
8732122|NCT01070381|9779751|FG001|COMPLETED|Period 2, 1 Week of Wear||106
8732123|NCT01070381|9779750|FG000|NOT COMPLETED|Period 2, 1 Week of Wear||1
8732124|NCT01070381|9779751|FG001|NOT COMPLETED|Period 2, 1 Week of Wear||1
8732125|NCT01070394|9779757|FG000|STARTED|Overall Study||40
8732126|NCT01070394|9779757|FG000|COMPLETED|Overall Study||33
8911635|NCT02147522|9970699|FG001|STARTED|Overall Study||170
8911636|NCT02147522|9970698|FG000|COMPLETED|Overall Study||122
8911637|NCT02147522|9970699|FG001|COMPLETED|Overall Study||122
8911638|NCT02147522|9970698|FG000|NOT COMPLETED|Overall Study||56
8911639|NCT02147522|9970699|FG001|NOT COMPLETED|Overall Study||48
8911640|NCT02147561|9970705|FG000|STARTED|Overall Study||280
8911641|NCT02147561|9970705|FG000|COMPLETED|Overall Study||276
8911642|NCT02147561|9970705|FG000|NOT COMPLETED|Overall Study||4
8911643|NCT02147587|9970711|FG000|STARTED|Overall Study||57
8911644|NCT02147587|9970712|FG001|STARTED|Overall Study||55
8911645|NCT02147587|9970711|FG000|COMPLETED|Overall Study||46
8911646|NCT02147587|9970712|FG001|COMPLETED|Overall Study||50
8911647|NCT02147587|9970711|FG000|NOT COMPLETED|Overall Study||11
8911648|NCT02147587|9970712|FG001|NOT COMPLETED|Overall Study||5
8911649|NCT02147613|9970720|FG000|STARTED|Overall Study||10
8911650|NCT02147613|9970721|FG001|STARTED|Overall Study||9
8911651|NCT02147613|9970720|FG000|COMPLETED|Overall Study||9
8732127|NCT01070394|9779757|FG000|NOT COMPLETED|Overall Study||7
8911652|NCT02147613|9970721|FG001|COMPLETED|Overall Study||6
8911653|NCT02147613|9970720|FG000|NOT COMPLETED|Overall Study||1
8911654|NCT02147613|9970721|FG001|NOT COMPLETED|Overall Study||3
8911655|NCT02147626|9970729|FG000|STARTED|Overall Study||75
8911656|NCT02147626|9970730|FG001|STARTED|Overall Study||76
8911657|NCT02147626|9970729|FG000|COMPLETED|Overall Study||70
8668134|NCT00734929|9711767|FG001|NOT COMPLETED|Overall Study||5
8668135|NCT00734968|9711777|FG000|STARTED|Overall Study||77
8668136|NCT00734968|9711778|FG001|STARTED|Overall Study||76
8911658|NCT02147626|9970730|FG001|COMPLETED|Overall Study||69
8911659|NCT02147626|9970729|FG000|NOT COMPLETED|Overall Study||5
8911660|NCT02147626|9970730|FG001|NOT COMPLETED|Overall Study||7
8668137|NCT00734968|9711777|FG000|COMPLETED|Overall Study||76
8668138|NCT00734968|9711778|FG001|COMPLETED|Overall Study||75
8668139|NCT00734968|9711777|FG000|NOT COMPLETED|Overall Study||1
8668140|NCT00734968|9711778|FG001|NOT COMPLETED|Overall Study||1
8668141|NCT00734994|9711784|FG000|STARTED|Overall Study||15
8668142|NCT00734994|9711784|FG000|COMPLETED|Overall Study||14
8668143|NCT00734994|9711784|FG000|NOT COMPLETED|Overall Study||1
8668144|NCT00735007|9711789|FG000|STARTED|Overall Study||106
8668145|NCT00735007|9711789|FG000|COMPLETED|Overall Study||101
8668146|NCT00735007|9711789|FG000|NOT COMPLETED|Overall Study||5
8668147|NCT00735072|9711795|FG000|STARTED|Overall Study||23
8668148|NCT00735072|9711796|FG001|STARTED|Overall Study||22
8668149|NCT00735072|9711795|FG000|COMPLETED|Overall Study||22
8668150|NCT00735072|9711796|FG001|COMPLETED|Overall Study||21
8668151|NCT00735072|9711795|FG000|NOT COMPLETED|Overall Study||1
8668152|NCT00735072|9711796|FG001|NOT COMPLETED|Overall Study||1
8668153|NCT00735306|9711804|FG000|STARTED|Overall Study||12
8668154|NCT00735306|9711804|FG000|COMPLETED|Overall Study||12
8668155|NCT00735306|9711804|FG000|NOT COMPLETED|Overall Study||0
8668156|NCT00735371|9711813|FG000|STARTED|Overall Study||78
8668157|NCT00735371|9711814|FG001|STARTED|Overall Study||79
8668158|NCT00735371|9711815|FG002|STARTED|Overall Study||78
8668159|NCT00735371|9711816|FG003|STARTED|Overall Study||79
8668160|NCT00735371|9711813|FG000|COMPLETED|Overall Study||63
8668161|NCT00735371|9711814|FG001|COMPLETED|Overall Study||66
8668162|NCT00735371|9711815|FG002|COMPLETED|Overall Study||67
8668163|NCT00735371|9711816|FG003|COMPLETED|Overall Study||69
8668164|NCT00735371|9711813|FG000|NOT COMPLETED|Overall Study||15
8668165|NCT00735371|9711814|FG001|NOT COMPLETED|Overall Study||13
8668166|NCT00735371|9711815|FG002|NOT COMPLETED|Overall Study||11
8668167|NCT00735371|9711816|FG003|NOT COMPLETED|Overall Study||10
8668168|NCT00735397|9711826|FG000|STARTED|Overall Study||1218
8668169|NCT00735397|9711826|FG000|COMPLETED|Overall Study||35
8668170|NCT00735397|9711826|FG000|NOT COMPLETED|Overall Study||1183
8668171|NCT00735436|9711833|FG000|STARTED|Overall Study||18
8668172|NCT00735436|9711833|FG000|COMPLETED|Overall Study||18
8668173|NCT00735436|9711833|FG000|NOT COMPLETED|Overall Study||0
8668174|NCT00735449|9711840|FG000|STARTED|Overall Study||102
8668175|NCT00735449|9711841|FG001|STARTED|Overall Study||102
8668176|NCT00735449|9711840|FG000|COMPLETED|Overall Study||95
8668177|NCT00735449|9711841|FG001|COMPLETED|Overall Study||96
8668178|NCT00735449|9711840|FG000|NOT COMPLETED|Overall Study||7
8668179|NCT00735449|9711841|FG001|NOT COMPLETED|Overall Study||6
8668180|NCT00735462|9711850|FG000|STARTED|Overall Study||202
8668181|NCT00735462|9711851|FG001|STARTED|Overall Study||204
8668182|NCT00735462|9711852|FG002|STARTED|Overall Study||105
8732128|NCT01070550|9779769|FG000|STARTED|Overall Study||3356
8732129|NCT01070550|9779770|FG001|STARTED|Overall Study||316
8732130|NCT01070550|9779771|FG002|STARTED|Overall Study||744
8732131|NCT01070550|9779772|FG003|STARTED|Overall Study||201
8732132|NCT01070550|9779773|FG004|STARTED|Overall Study||21
8732133|NCT01070550|9779774|FG005|STARTED|Overall Study||42
8732134|NCT01070550|9779769|FG000|COMPLETED|Overall Study||2071
8732135|NCT01070550|9779770|FG001|COMPLETED|Overall Study||254
8732136|NCT01070550|9779771|FG002|COMPLETED|Overall Study||528
8732137|NCT01070550|9779772|FG003|COMPLETED|Overall Study||124
8732138|NCT01070550|9779773|FG004|COMPLETED|Overall Study||20
8732139|NCT01070550|9779774|FG005|COMPLETED|Overall Study||35
8732140|NCT01070550|9779769|FG000|NOT COMPLETED|Overall Study||1285
8732141|NCT01070550|9779770|FG001|NOT COMPLETED|Overall Study||62
8732142|NCT01070550|9779771|FG002|NOT COMPLETED|Overall Study||216
8732143|NCT01070550|9779772|FG003|NOT COMPLETED|Overall Study||77
8732144|NCT01070550|9779773|FG004|NOT COMPLETED|Overall Study||1
8732145|NCT01070550|9779774|FG005|NOT COMPLETED|Overall Study||7
8732146|NCT01070693|9779791|FG000|STARTED|Overall Study||150
8732147|NCT01070693|9779792|FG001|STARTED|Overall Study||149
8732148|NCT01070693|9779791|FG000|COMPLETED|Overall Study||122
8732149|NCT01070693|9779792|FG001|COMPLETED|Overall Study||110
8732150|NCT01070693|9779791|FG000|NOT COMPLETED|Overall Study||28
8732151|NCT01070693|9779792|FG001|NOT COMPLETED|Overall Study||39
8732152|NCT01070771|9779798|FG000|STARTED|Overall Study|September 2008|203
8732153|NCT01070771|9779798|FG000|COMPLETED|Overall Study|August 2012|200
8732154|NCT01070771|9779798|FG000|NOT COMPLETED|Overall Study||3
8732155|NCT01070784|9779805|FG000|STARTED|Overall Study||130
8732156|NCT01070784|9779806|FG001|STARTED|Overall Study||130
8732157|NCT01070784|9779805|FG000|COMPLETED|Overall Study||110
8732158|NCT01070784|9779806|FG001|COMPLETED|Overall Study||112
8732159|NCT01070784|9779805|FG000|NOT COMPLETED|Overall Study||20
8732160|NCT01070784|9779806|FG001|NOT COMPLETED|Overall Study||18
8732161|NCT01070810|9779814|FG000|STARTED|Overall Study||45
8732162|NCT01070810|9779815|FG001|STARTED|Overall Study||43
8732163|NCT01070810|9779814|FG000|COMPLETED|Overall Study||45
8732164|NCT01070810|9779815|FG001|COMPLETED|Overall Study||43
8732165|NCT01070810|9779814|FG000|NOT COMPLETED|Overall Study||0
8668183|NCT00735462|9711850|FG000|COMPLETED|Overall Study||139
8668184|NCT00735462|9711851|FG001|COMPLETED|Overall Study||149
8668185|NCT00735462|9711852|FG002|COMPLETED|Overall Study||77
8732166|NCT01070810|9779815|FG001|NOT COMPLETED|Overall Study||0
8668186|NCT00735462|9711850|FG000|NOT COMPLETED|Overall Study||63
8732167|NCT01070888|9779825|FG000|STARTED|First Intervention (14 Days)||2
8732168|NCT01070888|9779826|FG001|STARTED|First Intervention (14 Days)||4
8732169|NCT01070888|9779825|FG000|COMPLETED|First Intervention (14 Days)||2
8732170|NCT01070888|9779826|FG001|COMPLETED|First Intervention (14 Days)||2
8668187|NCT00735462|9711851|FG001|NOT COMPLETED|Overall Study||55
8668188|NCT00735462|9711852|FG002|NOT COMPLETED|Overall Study||28
8668189|NCT00735475|9711862|FG000|STARTED|Overall Study||631
8668190|NCT00735475|9711863|FG001|STARTED|Overall Study||637
8668191|NCT00735475|9711862|FG000|COMPLETED|Overall Study||623
8668192|NCT00735475|9711863|FG001|COMPLETED|Overall Study||626
8668193|NCT00735475|9711862|FG000|NOT COMPLETED|Overall Study||8
8668194|NCT00735475|9711863|FG001|NOT COMPLETED|Overall Study||11
8692585|NCT00862134|9738122|FG000|COMPLETED|Overall Study||8
8692586|NCT00862134|9738123|FG001|COMPLETED|Overall Study||11
8692587|NCT00862134|9738122|FG000|NOT COMPLETED|Overall Study||11
8692588|NCT00862134|9738123|FG001|NOT COMPLETED|Overall Study||12
8692589|NCT00862186|9738129|FG000|STARTED|Overall Study||15
8692590|NCT00862186|9738129|FG000|COMPLETED|Overall Study||15
8692591|NCT00862186|9738129|FG000|NOT COMPLETED|Overall Study||0
8692592|NCT00862277|9738137|FG000|STARTED|Overall Study||561
8692593|NCT00862277|9738138|FG001|STARTED|Overall Study||96
8692594|NCT00862277|9738139|FG002|STARTED|Overall Study||105
8692595|NCT00862277|9738137|FG000|COMPLETED|Overall Study||560
8692596|NCT00862277|9738138|FG001|COMPLETED|Overall Study||94
8692597|NCT00862277|9738139|FG002|COMPLETED|Overall Study||100
8692598|NCT00862277|9738137|FG000|NOT COMPLETED|Overall Study||1
8692599|NCT00862277|9738138|FG001|NOT COMPLETED|Overall Study||2
8732171|NCT01070888|9779825|FG000|NOT COMPLETED|First Intervention (14 Days)||0
8732172|NCT01070888|9779826|FG001|NOT COMPLETED|First Intervention (14 Days)||2
8732173|NCT01070888|9779825|FG000|STARTED|Washout (14 Days)||2
8732174|NCT01070888|9779826|FG001|STARTED|Washout (14 Days)||2
8732175|NCT01070888|9779825|FG000|COMPLETED|Washout (14 Days)||1
8732176|NCT01070888|9779826|FG001|COMPLETED|Washout (14 Days)||2
8732177|NCT01070888|9779825|FG000|NOT COMPLETED|Washout (14 Days)||1
8732178|NCT01070888|9779826|FG001|NOT COMPLETED|Washout (14 Days)||0
8732179|NCT01070888|9779825|FG000|STARTED|Second Intervention (14 Days)||1
8732180|NCT01070888|9779826|FG001|STARTED|Second Intervention (14 Days)||2
8732181|NCT01070888|9779825|FG000|COMPLETED|Second Intervention (14 Days)||1
8732182|NCT01070888|9779826|FG001|COMPLETED|Second Intervention (14 Days)||2
8732183|NCT01070888|9779825|FG000|NOT COMPLETED|Second Intervention (14 Days)||0
8732184|NCT01070888|9779826|FG001|NOT COMPLETED|Second Intervention (14 Days)||0
8732185|NCT01070979|9779835|FG000|STARTED|Overall Study||79
8732186|NCT01070979|9779836|FG001|STARTED|Overall Study||85
8732187|NCT01070979|9779837|FG002|STARTED|Overall Study||85
8732188|NCT01070979|9779835|FG000|COMPLETED|Overall Study||68
8732189|NCT01070979|9779836|FG001|COMPLETED|Overall Study||73
8732190|NCT01070979|9779837|FG002|COMPLETED|Overall Study||72
8732191|NCT01070979|9779835|FG000|NOT COMPLETED|Overall Study||11
8732192|NCT01070979|9779836|FG001|NOT COMPLETED|Overall Study||12
8732193|NCT01070979|9779837|FG002|NOT COMPLETED|Overall Study||13
8732194|NCT01071044|9779847|FG000|STARTED|Overall Study||15
8732195|NCT01071044|9779848|FG001|STARTED|Overall Study||11
8732196|NCT01071044|9779847|FG000|COMPLETED|Overall Study||13
8732197|NCT01071044|9779848|FG001|COMPLETED|Overall Study||11
8732198|NCT01071044|9779847|FG000|NOT COMPLETED|Overall Study||2
8732199|NCT01071044|9779848|FG001|NOT COMPLETED|Overall Study||0
8732200|NCT01071070|9779859|FG000|STARTED|Overall Study||108
8732201|NCT01071070|9779860|FG001|STARTED|Overall Study||108
8732202|NCT01071070|9779859|FG000|COMPLETED|Overall Study||104
8732203|NCT01071070|9779860|FG001|COMPLETED|Overall Study||105
8732204|NCT01071070|9779859|FG000|NOT COMPLETED|Overall Study||4
8732205|NCT01071070|9779860|FG001|NOT COMPLETED|Overall Study||3
8732206|NCT01071083|9779871|FG000|STARTED|Overall Study||42
8732207|NCT01071083|9779872|FG001|STARTED|Overall Study||45
8732208|NCT01071083|9779873|FG002|STARTED|Overall Study||17
8732209|NCT01071083|9779874|FG003|STARTED|Overall Study||17
8732210|NCT01071083|9779875|FG004|STARTED|Overall Study||54
8732211|NCT01071083|9779871|FG000|COMPLETED|Overall Study||35
8732212|NCT01071083|9779872|FG001|COMPLETED|Overall Study||43
8732213|NCT01071083|9779873|FG002|COMPLETED|Overall Study||12
8732214|NCT01071083|9779874|FG003|COMPLETED|Overall Study||15
8732215|NCT01071083|9779875|FG004|COMPLETED|Overall Study||46
8732216|NCT01071083|9779871|FG000|NOT COMPLETED|Overall Study||7
8732217|NCT01071083|9779872|FG001|NOT COMPLETED|Overall Study||2
8732218|NCT01071083|9779873|FG002|NOT COMPLETED|Overall Study||5
8732219|NCT01071083|9779874|FG003|NOT COMPLETED|Overall Study||2
8732220|NCT01071083|9779875|FG004|NOT COMPLETED|Overall Study||8
8732221|NCT01071096|9779887|FG000|STARTED|First Intervention (90 Days)||10
8732222|NCT01071096|9779888|FG001|STARTED|First Intervention (90 Days)||10
8732223|NCT01071096|9779887|FG000|COMPLETED|First Intervention (90 Days)||9
8732224|NCT01071096|9779888|FG001|COMPLETED|First Intervention (90 Days)||10
8732225|NCT01071096|9779887|FG000|NOT COMPLETED|First Intervention (90 Days)||1
8732226|NCT01071096|9779888|FG001|NOT COMPLETED|First Intervention (90 Days)||0
8732227|NCT01071096|9779887|FG000|STARTED|Washout Period (30 Days)||9
8911661|NCT02147691|9970738|FG000|STARTED|Overall Study||10
8732228|NCT01071096|9779888|FG001|STARTED|Washout Period (30 Days)||10
8732229|NCT01071096|9779887|FG000|COMPLETED|Washout Period (30 Days)||9
8732230|NCT01071096|9779888|FG001|COMPLETED|Washout Period (30 Days)||10
8732231|NCT01071096|9779887|FG000|NOT COMPLETED|Washout Period (30 Days)||0
8732232|NCT01071096|9779888|FG001|NOT COMPLETED|Washout Period (30 Days)||0
8732233|NCT01071096|9779887|FG000|STARTED|Second Intervention (90 Days)||9
8911662|NCT02147691|9970739|FG001|STARTED|Overall Study||12
8692600|NCT00862277|9738139|FG002|NOT COMPLETED|Overall Study||5
8692601|NCT00862446|9738147|FG000|STARTED|Overall Study||48
8668195|NCT00735618|9711869|FG000|STARTED|Overall Study||19
8668196|NCT00735618|9711869|FG000|COMPLETED|Overall Study||19
8668197|NCT00735618|9711869|FG000|NOT COMPLETED|Overall Study||0
8668198|NCT00735644|9711878|FG000|STARTED|Overall Study||303
8668199|NCT00735644|9711879|FG001|STARTED|Overall Study||300
8668200|NCT00735644|9711880|FG002|STARTED|Overall Study||296
8668201|NCT00735644|9711881|FG003|STARTED|Overall Study||199
8668202|NCT00735644|9711882|FG004|STARTED|Overall Study||102
8668203|NCT00735644|9711878|FG000|COMPLETED|Overall Study||303
8668204|NCT00735644|9711879|FG001|COMPLETED|Overall Study||298
8668205|NCT00735644|9711880|FG002|COMPLETED|Overall Study||295
8668206|NCT00735644|9711881|FG003|COMPLETED|Overall Study||198
8668207|NCT00735644|9711882|FG004|COMPLETED|Overall Study||102
8668208|NCT00735644|9711878|FG000|NOT COMPLETED|Overall Study||0
8668209|NCT00735644|9711879|FG001|NOT COMPLETED|Overall Study||2
8668210|NCT00735644|9711880|FG002|NOT COMPLETED|Overall Study||1
8668211|NCT00735644|9711881|FG003|NOT COMPLETED|Overall Study||1
8668212|NCT00735644|9711882|FG004|NOT COMPLETED|Overall Study||0
8668213|NCT00735670|9711903|FG000|STARTED|Overall Study||10
8668214|NCT00735670|9711904|FG001|STARTED|Overall Study||11
8668215|NCT00735670|9711903|FG000|COMPLETED|Overall Study||6
8732234|NCT01071096|9779888|FG001|STARTED|Second Intervention (90 Days)||10
8732235|NCT01071096|9779887|FG000|COMPLETED|Second Intervention (90 Days)||9
8732236|NCT01071096|9779888|FG001|COMPLETED|Second Intervention (90 Days)||10
8732237|NCT01071096|9779887|FG000|NOT COMPLETED|Second Intervention (90 Days)||0
8732238|NCT01071096|9779888|FG001|NOT COMPLETED|Second Intervention (90 Days)||0
8732239|NCT01071200|9779907|FG000|STARTED|Overall Study||67
8732240|NCT01071200|9779908|FG001|STARTED|Overall Study||66
8732241|NCT01071200|9779907|FG000|COMPLETED|Overall Study||60
8732242|NCT01071200|9779908|FG001|COMPLETED|Overall Study||63
8732243|NCT01071200|9779907|FG000|NOT COMPLETED|Overall Study||7
8732244|NCT01071200|9779908|FG001|NOT COMPLETED|Overall Study||3
8732245|NCT01071252|9779919|FG000|STARTED|Overall Study||29
8732246|NCT01071252|9779920|FG001|STARTED|Overall Study||26
8732247|NCT01071252|9779921|FG002|STARTED|Overall Study||21
8732248|NCT01071252|9779922|FG003|STARTED|Overall Study||27
8732249|NCT01071252|9779923|FG004|STARTED|Overall Study||22
8732250|NCT01071252|9779919|FG000|COMPLETED|Overall Study||14
8732251|NCT01071252|9779920|FG001|COMPLETED|Overall Study||16
8732252|NCT01071252|9779921|FG002|COMPLETED|Overall Study||17
8732253|NCT01071252|9779922|FG003|COMPLETED|Overall Study||20
8732254|NCT01071252|9779923|FG004|COMPLETED|Overall Study||11
8732255|NCT01071252|9779919|FG000|NOT COMPLETED|Overall Study||15
8732256|NCT01071252|9779920|FG001|NOT COMPLETED|Overall Study||10
8732257|NCT01071252|9779921|FG002|NOT COMPLETED|Overall Study||4
8732258|NCT01071252|9779922|FG003|NOT COMPLETED|Overall Study||7
8732259|NCT01071252|9779923|FG004|NOT COMPLETED|Overall Study||11
8732260|NCT01071278|9779935|FG000|STARTED|Overall Study||2390
8732261|NCT01071278|9779935|FG000|COMPLETED|Overall Study||1677
8732262|NCT01071278|9779935|FG000|NOT COMPLETED|Overall Study||713
8732263|NCT01071317|9779943|FG000|STARTED|Overall Study||25
8732264|NCT01071317|9779944|FG001|STARTED|Overall Study||25
8732265|NCT01071317|9779943|FG000|COMPLETED|Overall Study||23
8732266|NCT01071317|9779944|FG001|COMPLETED|Overall Study||23
8732267|NCT01071317|9779943|FG000|NOT COMPLETED|Overall Study||2
8732268|NCT01071317|9779944|FG001|NOT COMPLETED|Overall Study||2
8732269|NCT01071356|9779952|FG000|STARTED|Overall Study||111
8732270|NCT01071356|9779953|FG001|STARTED|Overall Study||106
8732271|NCT01071356|9779952|FG000|COMPLETED|Overall Study||104
8732272|NCT01071356|9779953|FG001|COMPLETED|Overall Study||97
8732273|NCT01071356|9779952|FG000|NOT COMPLETED|Overall Study||7
8732274|NCT01071356|9779953|FG001|NOT COMPLETED|Overall Study||9
8732275|NCT01071395|9779961|FG000|STARTED|Overall Study||36
8732276|NCT01071395|9779962|FG001|STARTED|Overall Study||32
8732277|NCT01071395|9779961|FG000|COMPLETED|Overall Study||31
8732278|NCT01071395|9779962|FG001|COMPLETED|Overall Study||30
8732279|NCT01071395|9779961|FG000|NOT COMPLETED|Overall Study||5
8732280|NCT01071395|9779962|FG001|NOT COMPLETED|Overall Study||2
8732281|NCT01071512|9779968|FG000|STARTED|Overall Study||20
8732282|NCT01071512|9779968|FG000|COMPLETED|Overall Study||15
8732283|NCT01071512|9779968|FG000|NOT COMPLETED|Overall Study||5
8732284|NCT01071538|9779972|FG000|STARTED|Overall Study||15
8732285|NCT01071538|9779972|FG000|COMPLETED|Overall Study||13
8732286|NCT01071538|9779972|FG000|NOT COMPLETED|Overall Study||2
8732287|NCT01071798|9779976|FG000|STARTED|Participants Who Received One Cycle||1653
8732288|NCT01071798|9779976|FG000|Baseline and Safety Analysis Set|Participants Who Received One Cycle||1653
8732289|NCT01071798|9779976|FG000|COMPLETED|Participants Who Received One Cycle||1588
8732290|NCT01071798|9779976|FG000|NOT COMPLETED|Participants Who Received One Cycle||65
8732291|NCT01071798|9779976|FG000|STARTED|Subpopulation Who Received Two Cycles||820
8911663|NCT02147691|9970738|FG000|COMPLETED|Overall Study||6
8668216|NCT00735670|9711904|FG001|COMPLETED|Overall Study||6
8668217|NCT00735670|9711903|FG000|NOT COMPLETED|Overall Study||4
8732292|NCT01071798|9779976|FG000|Baseline and Safety Analysis Set|Subpopulation Who Received Two Cycles||820
8732293|NCT01071798|9779976|FG000|COMPLETED|Subpopulation Who Received Two Cycles||805
8732294|NCT01071798|9779976|FG000|NOT COMPLETED|Subpopulation Who Received Two Cycles||15
8732295|NCT01071915|9779990|FG000|STARTED|Overall Study|Intention to Treat Analysis Set|157
8732296|NCT01071915|9779990|FG000|Full Analysis Set (FAS)|Overall Study||155
8732297|NCT01071915|9779990|FG000|Safety Analysis Set|Overall Study||156
8732298|NCT01071915|9779990|FG000|COMPLETED|Overall Study||148
8911664|NCT02147691|9970739|FG001|COMPLETED|Overall Study||11
8668218|NCT00735670|9711904|FG001|NOT COMPLETED|Overall Study||5
8668219|NCT00735696|9711910|FG000|STARTED|Overall Study||41
8668220|NCT00735696|9711910|FG000|Received Any Quantity of Study Drug|Overall Study||40
8668221|NCT00735696|9711910|FG000|COMPLETED|Overall Study||39
8668222|NCT00735696|9711910|FG000|NOT COMPLETED|Overall Study||2
8668223|NCT00735709|9711918|FG000|STARTED|Overall Study||140
8668224|NCT00735709|9711919|FG001|STARTED|Overall Study||140
8668225|NCT00735709|9711920|FG002|STARTED|Overall Study||140
8668226|NCT00735709|9711921|FG003|STARTED|Overall Study||140
8668227|NCT00735709|9711918|FG000|Treated|Overall Study||140
8668228|NCT00735709|9711919|FG001|Treated|Overall Study||140
8732299|NCT01071915|9779990|FG000|NOT COMPLETED|Overall Study||9
8732300|NCT01071954|9779994|FG000|STARTED|Overall Study||66
8732301|NCT01071954|9779994|FG000|Received Treatment|Overall Study||65
8732302|NCT01071954|9779994|FG000|COMPLETED|Overall Study||39
8732303|NCT01071954|9779994|FG000|NOT COMPLETED|Overall Study||27
8732304|NCT01072006|9780002|FG000|STARTED|Overall Study||14
8732305|NCT01072006|9780003|FG001|STARTED|Overall Study||5
8732306|NCT01072006|9780004|FG002|STARTED|Overall Study||0
8732307|NCT01072006|9780005|FG003|STARTED|Overall Study||11
8732308|NCT01072006|9780002|FG000|COMPLETED|Overall Study||14
8732309|NCT01072006|9780003|FG001|COMPLETED|Overall Study||5
8732310|NCT01072006|9780004|FG002|COMPLETED|Overall Study||0
8732311|NCT01072006|9780005|FG003|COMPLETED|Overall Study||11
8732312|NCT01072006|9780002|FG000|NOT COMPLETED|Overall Study||0
8732313|NCT01072006|9780003|FG001|NOT COMPLETED|Overall Study||0
8732314|NCT01072006|9780004|FG002|NOT COMPLETED|Overall Study||0
8732315|NCT01072006|9780005|FG003|NOT COMPLETED|Overall Study||0
8732316|NCT01072032|9780018|FG000|STARTED|Overall Study||13
8732317|NCT01072032|9780019|FG001|STARTED|Overall Study||14
8732318|NCT01072032|9780018|FG000|COMPLETED|Overall Study||5
8732319|NCT01072032|9780019|FG001|COMPLETED|Overall Study||5
8732320|NCT01072032|9780018|FG000|NOT COMPLETED|Overall Study||8
8732321|NCT01072032|9780019|FG001|NOT COMPLETED|Overall Study||9
8732322|NCT01072136|9780028|FG000|STARTED|Overall Study||44
8732323|NCT01072136|9780029|FG001|STARTED|Overall Study||43
8732324|NCT01072136|9780028|FG000|Met All Enrollment Criteria|Overall Study|Some eligibility test results were not available until after randomization.|30
8732325|NCT01072136|9780029|FG001|Met All Enrollment Criteria|Overall Study||25
8732326|NCT01072136|9780028|FG000|COMPLETED|Overall Study||21
8732327|NCT01072136|9780029|FG001|COMPLETED|Overall Study||12
8732328|NCT01072136|9780028|FG000|NOT COMPLETED|Overall Study||23
8732329|NCT01072136|9780029|FG001|NOT COMPLETED|Overall Study||31
8732330|NCT01072149|9780038|FG000|STARTED|Treatment Period 1 (28 Days)||3
8732331|NCT01072149|9780039|FG001|STARTED|Treatment Period 1 (28 Days)||3
8732332|NCT01072149|9780040|FG002|STARTED|Treatment Period 1 (28 Days)||3
8732333|NCT01072149|9780041|FG003|STARTED|Treatment Period 1 (28 Days)||3
8732334|NCT01072149|9780042|FG004|STARTED|Treatment Period 1 (28 Days)||3
8732335|NCT01072149|9780043|FG005|STARTED|Treatment Period 1 (28 Days)||3
8732336|NCT01072149|9780044|FG006|STARTED|Treatment Period 1 (28 Days)||3
8732337|NCT01072149|9780045|FG007|STARTED|Treatment Period 1 (28 Days)||3
8732338|NCT01072149|9780046|FG008|STARTED|Treatment Period 1 (28 Days)||3
8732339|NCT01072149|9780047|FG009|STARTED|Treatment Period 1 (28 Days)||3
8732340|NCT01072149|9780048|FG010|STARTED|Treatment Period 1 (28 Days)||3
8732341|NCT01072149|9780049|FG011|STARTED|Treatment Period 1 (28 Days)||3
8732342|NCT01072149|9780050|FG012|STARTED|Treatment Period 1 (28 Days)||3
8732343|NCT01072149|9780051|FG013|STARTED|Treatment Period 1 (28 Days)||3
8732344|NCT01072149|9780052|FG014|STARTED|Treatment Period 1 (28 Days)||3
8732345|NCT01072149|9780053|FG015|STARTED|Treatment Period 1 (28 Days)||3
8732346|NCT01072149|9780054|FG016|STARTED|Treatment Period 1 (28 Days)||3
8732347|NCT01072149|9780055|FG017|STARTED|Treatment Period 1 (28 Days)||3
8732348|NCT01072149|9780038|FG000|COMPLETED|Treatment Period 1 (28 Days)||3
8732349|NCT01072149|9780039|FG001|COMPLETED|Treatment Period 1 (28 Days)||3
8732350|NCT01072149|9780040|FG002|COMPLETED|Treatment Period 1 (28 Days)||2
8732351|NCT01072149|9780041|FG003|COMPLETED|Treatment Period 1 (28 Days)||3
8732352|NCT01072149|9780042|FG004|COMPLETED|Treatment Period 1 (28 Days)||3
8732353|NCT01072149|9780043|FG005|COMPLETED|Treatment Period 1 (28 Days)||3
8732354|NCT01072149|9780044|FG006|COMPLETED|Treatment Period 1 (28 Days)||3
8732355|NCT01072149|9780045|FG007|COMPLETED|Treatment Period 1 (28 Days)||3
8732356|NCT01072149|9780046|FG008|COMPLETED|Treatment Period 1 (28 Days)||3
8732357|NCT01072149|9780047|FG009|COMPLETED|Treatment Period 1 (28 Days)||3
8732358|NCT01072149|9780048|FG010|COMPLETED|Treatment Period 1 (28 Days)||2
8732359|NCT01072149|9780049|FG011|COMPLETED|Treatment Period 1 (28 Days)||3
8732360|NCT01072149|9780050|FG012|COMPLETED|Treatment Period 1 (28 Days)||3
8732361|NCT01072149|9780051|FG013|COMPLETED|Treatment Period 1 (28 Days)||3
8732362|NCT01072149|9780052|FG014|COMPLETED|Treatment Period 1 (28 Days)||3
8732363|NCT01072149|9780053|FG015|COMPLETED|Treatment Period 1 (28 Days)||3
8732364|NCT01072149|9780054|FG016|COMPLETED|Treatment Period 1 (28 Days)||3
8732365|NCT01072149|9780055|FG017|COMPLETED|Treatment Period 1 (28 Days)||2
8732366|NCT01072149|9780038|FG000|NOT COMPLETED|Treatment Period 1 (28 Days)||0
8911665|NCT02147691|9970738|FG000|NOT COMPLETED|Overall Study||4
8911666|NCT02147691|9970739|FG001|NOT COMPLETED|Overall Study||1
8732367|NCT01072149|9780039|FG001|NOT COMPLETED|Treatment Period 1 (28 Days)||0
8732368|NCT01072149|9780040|FG002|NOT COMPLETED|Treatment Period 1 (28 Days)||1
8732369|NCT01072149|9780041|FG003|NOT COMPLETED|Treatment Period 1 (28 Days)||0
8668229|NCT00735709|9711920|FG002|Treated|Overall Study||140
8668230|NCT00735709|9711921|FG003|Treated|Overall Study||139
8732370|NCT01072149|9780042|FG004|NOT COMPLETED|Treatment Period 1 (28 Days)||0
8732371|NCT01072149|9780043|FG005|NOT COMPLETED|Treatment Period 1 (28 Days)||0
8732372|NCT01072149|9780044|FG006|NOT COMPLETED|Treatment Period 1 (28 Days)||0
8732373|NCT01072149|9780045|FG007|NOT COMPLETED|Treatment Period 1 (28 Days)||0
8732374|NCT01072149|9780046|FG008|NOT COMPLETED|Treatment Period 1 (28 Days)||0
8732375|NCT01072149|9780047|FG009|NOT COMPLETED|Treatment Period 1 (28 Days)||0
8732376|NCT01072149|9780048|FG010|NOT COMPLETED|Treatment Period 1 (28 Days)||1
8732377|NCT01072149|9780049|FG011|NOT COMPLETED|Treatment Period 1 (28 Days)||0
8732378|NCT01072149|9780050|FG012|NOT COMPLETED|Treatment Period 1 (28 Days)||0
8911667|NCT02147769|9970745|FG000|STARTED|Overall Study||111
8911668|NCT02147769|9970745|FG000|COMPLETED|Overall Study||111
8911669|NCT02147769|9970745|FG000|NOT COMPLETED|Overall Study||0
8911670|NCT02147899|9970752|FG000|STARTED|Overall Study||71
8911671|NCT02147899|9970753|FG001|STARTED|Overall Study||72
8911672|NCT02147899|9970754|FG002|STARTED|Overall Study||72
8911673|NCT02147899|9970752|FG000|COMPLETED|Overall Study||71
8911674|NCT02147899|9970753|FG001|COMPLETED|Overall Study||72
8911675|NCT02147899|9970754|FG002|COMPLETED|Overall Study||72
8911676|NCT02147899|9970752|FG000|NOT COMPLETED|Overall Study||0
8911677|NCT02147899|9970753|FG001|NOT COMPLETED|Overall Study||0
8911678|NCT02147899|9970754|FG002|NOT COMPLETED|Overall Study||0
8911679|NCT02147990|9970765|FG000|STARTED|Overall Study||154
8911680|NCT02147990|9970766|FG001|STARTED|Overall Study||100
8911681|NCT02147990|9970767|FG002|STARTED|Overall Study||63
8911682|NCT02147990|9970765|FG000|COMPLETED|Overall Study||154
8911683|NCT02147990|9970766|FG001|COMPLETED|Overall Study||100
8911684|NCT02147990|9970767|FG002|COMPLETED|Overall Study||63
8911685|NCT02147990|9970765|FG000|NOT COMPLETED|Overall Study||0
8911686|NCT02147990|9970766|FG001|NOT COMPLETED|Overall Study||0
8911687|NCT02147990|9970767|FG002|NOT COMPLETED|Overall Study||0
8911688|NCT02148107|9970779|FG000|STARTED|Overall Study||8
8911689|NCT02148107|9970780|FG001|STARTED|Overall Study||7
8911690|NCT02148107|9970781|FG002|STARTED|Overall Study||3
8732379|NCT01072149|9780051|FG013|NOT COMPLETED|Treatment Period 1 (28 Days)||0
8732380|NCT01072149|9780052|FG014|NOT COMPLETED|Treatment Period 1 (28 Days)||0
8732381|NCT01072149|9780053|FG015|NOT COMPLETED|Treatment Period 1 (28 Days)||0
8732382|NCT01072149|9780054|FG016|NOT COMPLETED|Treatment Period 1 (28 Days)||0
8732383|NCT01072149|9780055|FG017|NOT COMPLETED|Treatment Period 1 (28 Days)||1
8732384|NCT01072149|9780038|FG000|STARTED|Washout Period 1 (14 Days)||3
8732385|NCT01072149|9780039|FG001|STARTED|Washout Period 1 (14 Days)||3
8732386|NCT01072149|9780040|FG002|STARTED|Washout Period 1 (14 Days)||2
8732387|NCT01072149|9780041|FG003|STARTED|Washout Period 1 (14 Days)||3
8732388|NCT01072149|9780042|FG004|STARTED|Washout Period 1 (14 Days)||3
8732389|NCT01072149|9780043|FG005|STARTED|Washout Period 1 (14 Days)||3
8732390|NCT01072149|9780044|FG006|STARTED|Washout Period 1 (14 Days)||3
8732391|NCT01072149|9780045|FG007|STARTED|Washout Period 1 (14 Days)||3
8732392|NCT01072149|9780046|FG008|STARTED|Washout Period 1 (14 Days)||3
8732393|NCT01072149|9780047|FG009|STARTED|Washout Period 1 (14 Days)||3
8732394|NCT01072149|9780048|FG010|STARTED|Washout Period 1 (14 Days)||2
8732395|NCT01072149|9780049|FG011|STARTED|Washout Period 1 (14 Days)||3
8732396|NCT01072149|9780050|FG012|STARTED|Washout Period 1 (14 Days)||3
8732397|NCT01072149|9780051|FG013|STARTED|Washout Period 1 (14 Days)||3
8732398|NCT01072149|9780052|FG014|STARTED|Washout Period 1 (14 Days)||3
8732399|NCT01072149|9780053|FG015|STARTED|Washout Period 1 (14 Days)||3
8732400|NCT01072149|9780054|FG016|STARTED|Washout Period 1 (14 Days)||3
8732401|NCT01072149|9780055|FG017|STARTED|Washout Period 1 (14 Days)||2
8732402|NCT01072149|9780038|FG000|COMPLETED|Washout Period 1 (14 Days)||3
8732403|NCT01072149|9780039|FG001|COMPLETED|Washout Period 1 (14 Days)||3
8732404|NCT01072149|9780040|FG002|COMPLETED|Washout Period 1 (14 Days)||2
8732405|NCT01072149|9780041|FG003|COMPLETED|Washout Period 1 (14 Days)||3
8732406|NCT01072149|9780042|FG004|COMPLETED|Washout Period 1 (14 Days)||3
8732407|NCT01072149|9780043|FG005|COMPLETED|Washout Period 1 (14 Days)||3
8732408|NCT01072149|9780044|FG006|COMPLETED|Washout Period 1 (14 Days)||3
8732409|NCT01072149|9780045|FG007|COMPLETED|Washout Period 1 (14 Days)||3
8732410|NCT01072149|9780046|FG008|COMPLETED|Washout Period 1 (14 Days)||3
8668231|NCT00735709|9711918|FG000|COMPLETED|Overall Study||127
8668232|NCT00735709|9711919|FG001|COMPLETED|Overall Study||127
8668233|NCT00735709|9711920|FG002|COMPLETED|Overall Study||129
8668234|NCT00735709|9711921|FG003|COMPLETED|Overall Study||122
8668235|NCT00735709|9711918|FG000|NOT COMPLETED|Overall Study||13
8668236|NCT00735709|9711919|FG001|NOT COMPLETED|Overall Study||13
8668237|NCT00735709|9711920|FG002|NOT COMPLETED|Overall Study||11
8668238|NCT00735709|9711921|FG003|NOT COMPLETED|Overall Study||18
8668239|NCT00735787|9711933|FG000|STARTED|Period 1||23
8668240|NCT00735787|9711934|FG001|STARTED|Period 1||49
8668241|NCT00735787|9711933|FG000|COMPLETED|Period 1|Per visit window, 18 completed; 17 completed per subject case report form.|17
8668242|NCT00735787|9711934|FG001|COMPLETED|Period 1||41
8732411|NCT01072149|9780047|FG009|COMPLETED|Washout Period 1 (14 Days)||3
8732412|NCT01072149|9780048|FG010|COMPLETED|Washout Period 1 (14 Days)||2
8732413|NCT01072149|9780049|FG011|COMPLETED|Washout Period 1 (14 Days)||3
8911691|NCT02148107|9970779|FG000|COMPLETED|Overall Study||8
8911692|NCT02148107|9970780|FG001|COMPLETED|Overall Study||7
8911693|NCT02148107|9970781|FG002|COMPLETED|Overall Study||3
8911694|NCT02148107|9970779|FG000|NOT COMPLETED|Overall Study||0
8668243|NCT00735787|9711933|FG000|NOT COMPLETED|Period 1||6
8668244|NCT00735787|9711934|FG001|NOT COMPLETED|Period 1||8
8668245|NCT00735787|9711933|FG000|STARTED|Period 2||18
8668246|NCT00735787|9711934|FG001|STARTED|Period 2||41
8668247|NCT00735787|9711933|FG000|COMPLETED|Period 2||13
8668248|NCT00735787|9711934|FG001|COMPLETED|Period 2||40
8668249|NCT00735787|9711933|FG000|NOT COMPLETED|Period 2||5
8668250|NCT00735787|9711934|FG001|NOT COMPLETED|Period 2||1
8668251|NCT00735826|9711940|FG000|STARTED|Overall Study||10
8668252|NCT00735826|9711940|FG000|COMPLETED|Overall Study||10
8668253|NCT00735826|9711940|FG000|NOT COMPLETED|Overall Study||0
8668254|NCT00735839|9711948|FG000|STARTED|Overall Study||30
8668255|NCT00735839|9711949|FG001|STARTED|Overall Study||10
8668256|NCT00735839|9711948|FG000|COMPLETED|Overall Study||30
8668257|NCT00735839|9711949|FG001|COMPLETED|Overall Study||10
8668258|NCT00735839|9711948|FG000|NOT COMPLETED|Overall Study||0
8668259|NCT00735839|9711949|FG001|NOT COMPLETED|Overall Study||0
8668260|NCT00735878|9711958|FG000|STARTED|Phase I- Dose Determination|13 subjects enrolled. One subject withdrew consent prior to receiving therapy & was replaced.|1
8668261|NCT00735878|9711959|FG001|STARTED|Phase I- Dose Determination||7
8668262|NCT00735878|9711960|FG002|STARTED|Phase I- Dose Determination||5
8668263|NCT00735878|9711958|FG000|COMPLETED|Phase I- Dose Determination|12 subjects received at least one cycle of treatment and were evaluable per the protocol.|1
8668264|NCT00735878|9711959|FG001|COMPLETED|Phase I- Dose Determination||7
8668265|NCT00735878|9711960|FG002|COMPLETED|Phase I- Dose Determination||4
8668266|NCT00735878|9711958|FG000|NOT COMPLETED|Phase I- Dose Determination||0
8668267|NCT00735878|9711959|FG001|NOT COMPLETED|Phase I- Dose Determination||0
8668268|NCT00735878|9711960|FG002|NOT COMPLETED|Phase I- Dose Determination||1
8668269|NCT00735878|9711958|FG000|STARTED|Phase II- Determined Dose||0
8668270|NCT00735878|9711959|FG001|STARTED|Phase II- Determined Dose||7
8668271|NCT00735878|9711960|FG002|STARTED|Phase II- Determined Dose||0
8668272|NCT00735878|9711958|FG000|COMPLETED|Phase II- Determined Dose|Seven subjects completed therapy within the Phase II portion of the trial.|0
8668273|NCT00735878|9711959|FG001|COMPLETED|Phase II- Determined Dose||7
8668274|NCT00735878|9711960|FG002|COMPLETED|Phase II- Determined Dose||0
8668275|NCT00735878|9711958|FG000|NOT COMPLETED|Phase II- Determined Dose||0
8668276|NCT00735878|9711959|FG001|NOT COMPLETED|Phase II- Determined Dose||0
8668277|NCT00735878|9711960|FG002|NOT COMPLETED|Phase II- Determined Dose||0
8668278|NCT00735904|9711971|FG000|STARTED|Overall Study||38
8668279|NCT00735904|9711971|FG000|COMPLETED|Overall Study||0
8668280|NCT00735904|9711971|FG000|NOT COMPLETED|Overall Study||38
8668281|NCT00735917|9711975|FG000|STARTED|Overall Study||19
8668282|NCT00735917|9711975|FG000|COMPLETED|Overall Study||19
8668283|NCT00735917|9711975|FG000|NOT COMPLETED|Overall Study||0
8668284|NCT00735943|9711979|FG000|STARTED|Overall Study||22
8668285|NCT00735943|9711979|FG000|COMPLETED|Overall Study||20
8668286|NCT00735943|9711979|FG000|NOT COMPLETED|Overall Study||2
8668287|NCT00735969|9711983|FG000|STARTED|Overall Study||21
8668288|NCT00735969|9711983|FG000|COMPLETED|Overall Study||21
8668289|NCT00735969|9711983|FG000|NOT COMPLETED|Overall Study||0
8668290|NCT00736034|9711987|FG000|STARTED|Overall Study||18
8668291|NCT00736034|9711987|FG000|COMPLETED|Overall Study||16
8668292|NCT00736034|9711987|FG000|NOT COMPLETED|Overall Study||2
8668293|NCT00736073|9711993|FG000|STARTED|Overall Study||34
8668294|NCT00736073|9711994|FG001|STARTED|Overall Study||39
8668295|NCT00736073|9711993|FG000|COMPLETED|Overall Study||34
8668296|NCT00736073|9711994|FG001|COMPLETED|Overall Study||39
8668297|NCT00736073|9711993|FG000|NOT COMPLETED|Overall Study||0
8668298|NCT00736073|9711994|FG001|NOT COMPLETED|Overall Study||0
8668299|NCT00736099|9712003|FG000|STARTED|Overall Study|Number who started treatment.|1532
8668300|NCT00736099|9712004|FG001|STARTED|Overall Study|Number who started treatment.|589
8668301|NCT00736099|9712003|FG000|COMPLETED|Overall Study|Number who completed treatment.|1349
8668302|NCT00736099|9712004|FG001|COMPLETED|Overall Study|Number who completed treatment.|531
8668303|NCT00736099|9712003|FG000|NOT COMPLETED|Overall Study||183
8668304|NCT00736099|9712004|FG001|NOT COMPLETED|Overall Study||58
8668305|NCT00736125|9712012|FG000|STARTED|Overall Study||10
8668306|NCT00736125|9712013|FG001|STARTED|Overall Study||10
8668307|NCT00736125|9712012|FG000|COMPLETED|Overall Study||9
8668308|NCT00736125|9712013|FG001|COMPLETED|Overall Study||8
8668309|NCT00736125|9712012|FG000|NOT COMPLETED|Overall Study||1
8668310|NCT00736125|9712013|FG001|NOT COMPLETED|Overall Study||2
8668311|NCT00736190|9712019|FG000|STARTED|Overall Study||90
8668312|NCT00736190|9712019|FG000|COMPLETED|Overall Study||87
8668313|NCT00736190|9712019|FG000|NOT COMPLETED|Overall Study||3
8668314|NCT00736229|9712026|FG000|STARTED|Overall Study|Actively Enrolled|40
8668315|NCT00736229|9712027|FG001|STARTED|Overall Study|Historic control|71
8668316|NCT00736229|9712028|FG002|STARTED|Overall Study|Historic Control|84
8668317|NCT00736229|9712026|FG000|COMPLETED|Overall Study|All patients received bolus and fixed infusion of study drug, thus completed the study|40
8668318|NCT00736229|9712027|FG001|COMPLETED|Overall Study||71
8668319|NCT00736229|9712028|FG002|COMPLETED|Overall Study||84
8668320|NCT00736229|9712026|FG000|NOT COMPLETED|Overall Study||0
8668321|NCT00736229|9712027|FG001|NOT COMPLETED|Overall Study||0
8668322|NCT00736229|9712028|FG002|NOT COMPLETED|Overall Study||0
8668323|NCT00736242|9712037|FG000|STARTED|Overall Study||232
8668324|NCT00736242|9712037|FG000|Participants in Safety Analysis Set|Overall Study||229
8668325|NCT00736242|9712037|FG000|COMPLETED|Overall Study||107
8668326|NCT00736242|9712037|FG000|NOT COMPLETED|Overall Study||125
8668327|NCT00736255|9712043|FG000|STARTED|Overall Study||17
8668328|NCT00736255|9712044|FG001|STARTED|Overall Study||15
8668329|NCT00736255|9712043|FG000|COMPLETED|Overall Study||14
8668330|NCT00736255|9712044|FG001|COMPLETED|Overall Study||14
8668331|NCT00736255|9712043|FG000|NOT COMPLETED|Overall Study||3
8668332|NCT00736255|9712044|FG001|NOT COMPLETED|Overall Study||1
8668333|NCT00736333|9712050|FG000|STARTED|Overall Study||167
8668334|NCT00736333|9712050|FG000|COMPLETED|Overall Study||56
8668335|NCT00736333|9712050|FG000|NOT COMPLETED|Overall Study||111
8668336|NCT00736450|9712054|FG000|STARTED|Overall Study||37
8668337|NCT00736450|9712054|FG000|COMPLETED|Overall Study||12
8668338|NCT00736450|9712054|FG000|NOT COMPLETED|Overall Study||25
8668339|NCT00736476|9712060|FG000|STARTED|Overall Study||36
8668340|NCT00736476|9712061|FG001|STARTED|Overall Study||27
8668341|NCT00736476|9712060|FG000|COMPLETED|Overall Study||35
8668342|NCT00736476|9712061|FG001|COMPLETED|Overall Study||27
8668343|NCT00736476|9712060|FG000|NOT COMPLETED|Overall Study||1
8668344|NCT00736476|9712061|FG001|NOT COMPLETED|Overall Study||0
8668345|NCT00736489|9712073|FG000|STARTED|Period 1|Cross-over study|6
8668346|NCT00736489|9712074|FG001|STARTED|Period 1||5
8668347|NCT00736489|9712075|FG002|STARTED|Period 1||6
8668348|NCT00736489|9712076|FG003|STARTED|Period 1||7
8668349|NCT00736489|9712077|FG004|STARTED|Period 1||7
8668350|NCT00736489|9712078|FG005|STARTED|Period 1||6
8668351|NCT00736489|9712073|FG000|COMPLETED|Period 1||5
8668352|NCT00736489|9712074|FG001|COMPLETED|Period 1||5
8668353|NCT00736489|9712075|FG002|COMPLETED|Period 1||6
8668354|NCT00736489|9712076|FG003|COMPLETED|Period 1||7
8668355|NCT00736489|9712077|FG004|COMPLETED|Period 1||7
8668356|NCT00736489|9712078|FG005|COMPLETED|Period 1||5
8668357|NCT00736489|9712073|FG000|NOT COMPLETED|Period 1||1
8668358|NCT00736489|9712074|FG001|NOT COMPLETED|Period 1||0
8668359|NCT00736489|9712075|FG002|NOT COMPLETED|Period 1||0
8668360|NCT00736489|9712076|FG003|NOT COMPLETED|Period 1||0
8668361|NCT00736489|9712077|FG004|NOT COMPLETED|Period 1||0
8668362|NCT00736489|9712078|FG005|NOT COMPLETED|Period 1||1
8668363|NCT00736489|9712073|FG000|STARTED|Period 2||5
8668364|NCT00736489|9712074|FG001|STARTED|Period 2||5
8668365|NCT00736489|9712075|FG002|STARTED|Period 2||6
8668366|NCT00736489|9712076|FG003|STARTED|Period 2||7
8668367|NCT00736489|9712077|FG004|STARTED|Period 2||7
8668368|NCT00736489|9712078|FG005|STARTED|Period 2||5
8668369|NCT00736489|9712073|FG000|COMPLETED|Period 2||5
8668370|NCT00736489|9712074|FG001|COMPLETED|Period 2||5
8668371|NCT00736489|9712075|FG002|COMPLETED|Period 2||6
8668372|NCT00736489|9712076|FG003|COMPLETED|Period 2||7
8668373|NCT00736489|9712077|FG004|COMPLETED|Period 2||7
8668374|NCT00736489|9712078|FG005|COMPLETED|Period 2||5
8668375|NCT00736489|9712073|FG000|NOT COMPLETED|Period 2||0
8668376|NCT00736489|9712074|FG001|NOT COMPLETED|Period 2||0
8668377|NCT00736489|9712075|FG002|NOT COMPLETED|Period 2||0
8668378|NCT00736489|9712076|FG003|NOT COMPLETED|Period 2||0
8668379|NCT00736489|9712077|FG004|NOT COMPLETED|Period 2||0
8668380|NCT00736489|9712078|FG005|NOT COMPLETED|Period 2||0
8668381|NCT00736489|9712073|FG000|STARTED|Period 3||5
8668382|NCT00736489|9712074|FG001|STARTED|Period 3||5
8668383|NCT00736489|9712075|FG002|STARTED|Period 3||6
8668384|NCT00736489|9712076|FG003|STARTED|Period 3||7
8668385|NCT00736489|9712077|FG004|STARTED|Period 3||7
8668386|NCT00736489|9712078|FG005|STARTED|Period 3||5
8668387|NCT00736489|9712073|FG000|COMPLETED|Period 3||5
8668388|NCT00736489|9712074|FG001|COMPLETED|Period 3||5
8668389|NCT00736489|9712075|FG002|COMPLETED|Period 3||6
8668390|NCT00736489|9712076|FG003|COMPLETED|Period 3||7
8668391|NCT00736489|9712077|FG004|COMPLETED|Period 3||7
8668392|NCT00736489|9712078|FG005|COMPLETED|Period 3||5
8668393|NCT00736489|9712073|FG000|NOT COMPLETED|Period 3||0
8668394|NCT00736489|9712074|FG001|NOT COMPLETED|Period 3||0
8668395|NCT00736489|9712075|FG002|NOT COMPLETED|Period 3||0
8668396|NCT00736489|9712076|FG003|NOT COMPLETED|Period 3||0
8668397|NCT00736489|9712077|FG004|NOT COMPLETED|Period 3||0
8668398|NCT00736489|9712078|FG005|NOT COMPLETED|Period 3||0
8668399|NCT00736489|9712073|FG000|STARTED|Period 4||5
8668400|NCT00736489|9712074|FG001|STARTED|Period 4||5
8668401|NCT00736489|9712075|FG002|STARTED|Period 4||6
8668402|NCT00736489|9712076|FG003|STARTED|Period 4||7
8668403|NCT00736489|9712077|FG004|STARTED|Period 4||7
8668404|NCT00736489|9712078|FG005|STARTED|Period 4||5
8668405|NCT00736489|9712073|FG000|COMPLETED|Period 4||5
8668406|NCT00736489|9712074|FG001|COMPLETED|Period 4||5
8668407|NCT00736489|9712075|FG002|COMPLETED|Period 4||6
8668408|NCT00736489|9712076|FG003|COMPLETED|Period 4||7
8668409|NCT00736489|9712077|FG004|COMPLETED|Period 4||7
8668410|NCT00736489|9712078|FG005|COMPLETED|Period 4||5
8668411|NCT00736489|9712073|FG000|NOT COMPLETED|Period 4||0
8668412|NCT00736489|9712074|FG001|NOT COMPLETED|Period 4||0
8668413|NCT00736489|9712075|FG002|NOT COMPLETED|Period 4||0
8668414|NCT00736489|9712076|FG003|NOT COMPLETED|Period 4||0
8668415|NCT00736489|9712077|FG004|NOT COMPLETED|Period 4||0
8668416|NCT00736489|9712078|FG005|NOT COMPLETED|Period 4||0
8668417|NCT00736489|9712073|FG000|STARTED|Period 5||5
8668418|NCT00736489|9712074|FG001|STARTED|Period 5||5
8668419|NCT00736489|9712075|FG002|STARTED|Period 5||6
8668420|NCT00736489|9712076|FG003|STARTED|Period 5||7
8668421|NCT00736489|9712077|FG004|STARTED|Period 5||7
8668422|NCT00736489|9712078|FG005|STARTED|Period 5||5
8668423|NCT00736489|9712073|FG000|COMPLETED|Period 5||5
8668424|NCT00736489|9712074|FG001|COMPLETED|Period 5||5
8668425|NCT00736489|9712075|FG002|COMPLETED|Period 5||6
8668426|NCT00736489|9712076|FG003|COMPLETED|Period 5||7
8668427|NCT00736489|9712077|FG004|COMPLETED|Period 5||7
8668428|NCT00736489|9712078|FG005|COMPLETED|Period 5||5
8668429|NCT00736489|9712073|FG000|NOT COMPLETED|Period 5||0
8668430|NCT00736489|9712074|FG001|NOT COMPLETED|Period 5||0
8668431|NCT00736489|9712075|FG002|NOT COMPLETED|Period 5||0
8668432|NCT00736489|9712076|FG003|NOT COMPLETED|Period 5||0
8668433|NCT00736489|9712077|FG004|NOT COMPLETED|Period 5||0
8668434|NCT00736489|9712078|FG005|NOT COMPLETED|Period 5||0
8668435|NCT00736489|9712073|FG000|STARTED|Period 6||5
8668436|NCT00736489|9712074|FG001|STARTED|Period 6||5
8668437|NCT00736489|9712075|FG002|STARTED|Period 6||6
8668438|NCT00736489|9712076|FG003|STARTED|Period 6||7
8668439|NCT00736489|9712077|FG004|STARTED|Period 6||7
8668440|NCT00736489|9712078|FG005|STARTED|Period 6||5
8668441|NCT00736489|9712073|FG000|COMPLETED|Period 6||5
8668442|NCT00736489|9712074|FG001|COMPLETED|Period 6||5
8668443|NCT00736489|9712075|FG002|COMPLETED|Period 6||6
8668444|NCT00736489|9712076|FG003|COMPLETED|Period 6||7
8668445|NCT00736489|9712077|FG004|COMPLETED|Period 6||7
8668446|NCT00736489|9712078|FG005|COMPLETED|Period 6||5
8668447|NCT00736489|9712073|FG000|NOT COMPLETED|Period 6||0
8668448|NCT00736489|9712074|FG001|NOT COMPLETED|Period 6||0
8668449|NCT00736489|9712075|FG002|NOT COMPLETED|Period 6||0
8668450|NCT00736489|9712076|FG003|NOT COMPLETED|Period 6||0
8668451|NCT00736489|9712077|FG004|NOT COMPLETED|Period 6||0
8668452|NCT00736489|9712078|FG005|NOT COMPLETED|Period 6||0
8668453|NCT00736502|9712092|FG000|STARTED|Overall Study|Entered and treated.|278
8668454|NCT00736502|9712092|FG000|COMPLETED|Overall Study||213
8668455|NCT00736502|9712092|FG000|NOT COMPLETED|Overall Study||65
8668456|NCT00736580|9712098|FG000|STARTED|Overall Study||117
8668457|NCT00736580|9712099|FG001|STARTED|Overall Study||123
8668458|NCT00736580|9712098|FG000|COMPLETED|Overall Study||117
8668459|NCT00736580|9712099|FG001|COMPLETED|Overall Study||123
8668460|NCT00736580|9712098|FG000|NOT COMPLETED|Overall Study||0
8668461|NCT00736580|9712099|FG001|NOT COMPLETED|Overall Study||0
8668462|NCT00736632|9712108|FG000|STARTED|Overall Study||44
8668463|NCT00736632|9712109|FG001|STARTED|Overall Study||50
8668464|NCT00736632|9712110|FG002|STARTED|Overall Study||31
8668465|NCT00736632|9712108|FG000|COMPLETED|Overall Study||44
8668466|NCT00736632|9712109|FG001|COMPLETED|Overall Study||50
8668467|NCT00736632|9712110|FG002|COMPLETED|Overall Study||31
8668468|NCT00736632|9712108|FG000|NOT COMPLETED|Overall Study||0
8668469|NCT00736632|9712109|FG001|NOT COMPLETED|Overall Study||0
8668470|NCT00736632|9712110|FG002|NOT COMPLETED|Overall Study||0
8668471|NCT00736645|9712120|FG000|STARTED|Overall Study||13
8668472|NCT00736645|9712121|FG001|STARTED|Overall Study||15
8668473|NCT00736645|9712122|FG002|STARTED|Overall Study||14
8668474|NCT00736645|9712123|FG003|STARTED|Overall Study||13
8668475|NCT00736645|9712120|FG000|COMPLETED|Overall Study||13
8668476|NCT00736645|9712121|FG001|COMPLETED|Overall Study||13
8668477|NCT00736645|9712122|FG002|COMPLETED|Overall Study||14
8668478|NCT00736645|9712123|FG003|COMPLETED|Overall Study||13
8668479|NCT00736645|9712120|FG000|NOT COMPLETED|Overall Study||0
8668480|NCT00736645|9712121|FG001|NOT COMPLETED|Overall Study||2
8668481|NCT00736645|9712122|FG002|NOT COMPLETED|Overall Study||0
8668482|NCT00736645|9712123|FG003|NOT COMPLETED|Overall Study||0
8668483|NCT00736723|9712135|FG000|STARTED|Overall Study||30
8668484|NCT00736723|9712136|FG001|STARTED|Overall Study||21
8668485|NCT00736723|9712135|FG000|COMPLETED|Overall Study||26
8668486|NCT00736723|9712136|FG001|COMPLETED|Overall Study||18
8668487|NCT00736723|9712135|FG000|NOT COMPLETED|Overall Study||4
8668488|NCT00736723|9712136|FG001|NOT COMPLETED|Overall Study||3
8668489|NCT00736840|9712142|FG000|STARTED|Overall Study||414
8668490|NCT00736840|9712142|FG000|COMPLETED|Overall Study|9 subjects-no biopsy results, 2-no breath test, 2 no biopsy results and no complete breath test|401
8668491|NCT00736840|9712142|FG000|NOT COMPLETED|Overall Study||13
8668492|NCT00736853|9712146|FG000|STARTED|Open-Label Period||319
8668493|NCT00736853|9712147|FG001|STARTED|Open-Label Period||0
8668494|NCT00736853|9712148|FG002|STARTED|Open-Label Period||0
8668495|NCT00736853|9712146|FG000|Treated|Open-Label Period||277
8668496|NCT00736853|9712147|FG001|Treated|Open-Label Period||0
8668497|NCT00736853|9712148|FG002|Treated|Open-Label Period||0
8668498|NCT00736853|9712146|FG000|COMPLETED|Open-Label Period||187
8668499|NCT00736853|9712147|FG001|COMPLETED|Open-Label Period||0
8668500|NCT00736853|9712148|FG002|COMPLETED|Open-Label Period||0
8668501|NCT00736853|9712146|FG000|NOT COMPLETED|Open-Label Period||132
8668502|NCT00736853|9712147|FG001|NOT COMPLETED|Open-Label Period||0
8668503|NCT00736853|9712148|FG002|NOT COMPLETED|Open-Label Period||0
8668504|NCT00736853|9712146|FG000|STARTED|Double-Blind Period||0
8668505|NCT00736853|9712147|FG001|STARTED|Double-Blind Period||94
8668506|NCT00736853|9712148|FG002|STARTED|Double-Blind Period||93
8668507|NCT00736853|9712146|FG000|COMPLETED|Double-Blind Period||0
8668508|NCT00736853|9712147|FG001|COMPLETED|Double-Blind Period||70
8668509|NCT00736853|9712148|FG002|COMPLETED|Double-Blind Period||45
8668510|NCT00736853|9712146|FG000|NOT COMPLETED|Double-Blind Period||0
8668511|NCT00736853|9712147|FG001|NOT COMPLETED|Double-Blind Period||24
8668512|NCT00736853|9712148|FG002|NOT COMPLETED|Double-Blind Period||48
8668513|NCT00736879|9712161|FG000|STARTED|Double Blind Treatment Period||68
8668514|NCT00736879|9712162|FG001|STARTED|Double Blind Treatment Period||72
8668515|NCT00736879|9712163|FG002|STARTED|Double Blind Treatment Period||74
8668516|NCT00736879|9712164|FG003|STARTED|Double Blind Treatment Period||68
8668517|NCT00736879|9712161|FG000|COMPLETED|Double Blind Treatment Period||65
8668518|NCT00736879|9712162|FG001|COMPLETED|Double Blind Treatment Period||68
8732414|NCT01072149|9780050|FG012|COMPLETED|Washout Period 1 (14 Days)||3
8732415|NCT01072149|9780051|FG013|COMPLETED|Washout Period 1 (14 Days)||3
8732416|NCT01072149|9780052|FG014|COMPLETED|Washout Period 1 (14 Days)||3
8732417|NCT01072149|9780053|FG015|COMPLETED|Washout Period 1 (14 Days)||3
8732418|NCT01072149|9780054|FG016|COMPLETED|Washout Period 1 (14 Days)||3
8732419|NCT01072149|9780055|FG017|COMPLETED|Washout Period 1 (14 Days)||2
8732420|NCT01072149|9780038|FG000|NOT COMPLETED|Washout Period 1 (14 Days)||0
8732421|NCT01072149|9780039|FG001|NOT COMPLETED|Washout Period 1 (14 Days)||0
8732422|NCT01072149|9780040|FG002|NOT COMPLETED|Washout Period 1 (14 Days)||0
8732423|NCT01072149|9780041|FG003|NOT COMPLETED|Washout Period 1 (14 Days)||0
8732424|NCT01072149|9780042|FG004|NOT COMPLETED|Washout Period 1 (14 Days)||0
8732425|NCT01072149|9780043|FG005|NOT COMPLETED|Washout Period 1 (14 Days)||0
8732426|NCT01072149|9780044|FG006|NOT COMPLETED|Washout Period 1 (14 Days)||0
8732427|NCT01072149|9780045|FG007|NOT COMPLETED|Washout Period 1 (14 Days)||0
8732428|NCT01072149|9780046|FG008|NOT COMPLETED|Washout Period 1 (14 Days)||0
8732429|NCT01072149|9780047|FG009|NOT COMPLETED|Washout Period 1 (14 Days)||0
8732430|NCT01072149|9780048|FG010|NOT COMPLETED|Washout Period 1 (14 Days)||0
8732431|NCT01072149|9780049|FG011|NOT COMPLETED|Washout Period 1 (14 Days)||0
8732432|NCT01072149|9780050|FG012|NOT COMPLETED|Washout Period 1 (14 Days)||0
8732433|NCT01072149|9780051|FG013|NOT COMPLETED|Washout Period 1 (14 Days)||0
8732434|NCT01072149|9780052|FG014|NOT COMPLETED|Washout Period 1 (14 Days)||0
8732435|NCT01072149|9780053|FG015|NOT COMPLETED|Washout Period 1 (14 Days)||0
8732436|NCT01072149|9780054|FG016|NOT COMPLETED|Washout Period 1 (14 Days)||0
8732437|NCT01072149|9780055|FG017|NOT COMPLETED|Washout Period 1 (14 Days)||0
8732438|NCT01072149|9780038|FG000|STARTED|Treatment Period 2 (28 Days)||3
8732439|NCT01072149|9780039|FG001|STARTED|Treatment Period 2 (28 Days)||3
8732440|NCT01072149|9780040|FG002|STARTED|Treatment Period 2 (28 Days)||2
8732441|NCT01072149|9780041|FG003|STARTED|Treatment Period 2 (28 Days)||3
8732442|NCT01072149|9780042|FG004|STARTED|Treatment Period 2 (28 Days)||3
8732443|NCT01072149|9780043|FG005|STARTED|Treatment Period 2 (28 Days)||3
8732444|NCT01072149|9780044|FG006|STARTED|Treatment Period 2 (28 Days)||3
8732445|NCT01072149|9780045|FG007|STARTED|Treatment Period 2 (28 Days)||3
8732446|NCT01072149|9780046|FG008|STARTED|Treatment Period 2 (28 Days)||3
8732447|NCT01072149|9780047|FG009|STARTED|Treatment Period 2 (28 Days)||3
8732448|NCT01072149|9780048|FG010|STARTED|Treatment Period 2 (28 Days)||2
8732449|NCT01072149|9780049|FG011|STARTED|Treatment Period 2 (28 Days)||3
8732450|NCT01072149|9780050|FG012|STARTED|Treatment Period 2 (28 Days)||3
8732451|NCT01072149|9780051|FG013|STARTED|Treatment Period 2 (28 Days)||3
8732452|NCT01072149|9780052|FG014|STARTED|Treatment Period 2 (28 Days)||3
8732453|NCT01072149|9780053|FG015|STARTED|Treatment Period 2 (28 Days)||3
8732454|NCT01072149|9780054|FG016|STARTED|Treatment Period 2 (28 Days)||3
8732455|NCT01072149|9780055|FG017|STARTED|Treatment Period 2 (28 Days)||2
8732456|NCT01072149|9780038|FG000|COMPLETED|Treatment Period 2 (28 Days)||3
8732457|NCT01072149|9780039|FG001|COMPLETED|Treatment Period 2 (28 Days)||2
8732458|NCT01072149|9780040|FG002|COMPLETED|Treatment Period 2 (28 Days)||1
8732459|NCT01072149|9780041|FG003|COMPLETED|Treatment Period 2 (28 Days)||3
8732460|NCT01072149|9780042|FG004|COMPLETED|Treatment Period 2 (28 Days)||3
8732461|NCT01072149|9780043|FG005|COMPLETED|Treatment Period 2 (28 Days)||3
8732462|NCT01072149|9780044|FG006|COMPLETED|Treatment Period 2 (28 Days)||3
8732463|NCT01072149|9780045|FG007|COMPLETED|Treatment Period 2 (28 Days)||2
8732464|NCT01072149|9780046|FG008|COMPLETED|Treatment Period 2 (28 Days)||3
8732465|NCT01072149|9780047|FG009|COMPLETED|Treatment Period 2 (28 Days)||3
8732466|NCT01072149|9780048|FG010|COMPLETED|Treatment Period 2 (28 Days)||2
8732467|NCT01072149|9780049|FG011|COMPLETED|Treatment Period 2 (28 Days)||3
8732468|NCT01072149|9780050|FG012|COMPLETED|Treatment Period 2 (28 Days)||3
8732469|NCT01072149|9780051|FG013|COMPLETED|Treatment Period 2 (28 Days)||3
8732470|NCT01072149|9780052|FG014|COMPLETED|Treatment Period 2 (28 Days)||3
8732471|NCT01072149|9780053|FG015|COMPLETED|Treatment Period 2 (28 Days)||3
8732472|NCT01072149|9780054|FG016|COMPLETED|Treatment Period 2 (28 Days)||3
8732473|NCT01072149|9780055|FG017|COMPLETED|Treatment Period 2 (28 Days)||2
8732474|NCT01072149|9780038|FG000|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8668519|NCT00736879|9712163|FG002|COMPLETED|Double Blind Treatment Period||67
8668520|NCT00736879|9712164|FG003|COMPLETED|Double Blind Treatment Period||63
8668521|NCT00736879|9712161|FG000|NOT COMPLETED|Double Blind Treatment Period||3
8668522|NCT00736879|9712162|FG001|NOT COMPLETED|Double Blind Treatment Period||4
8668523|NCT00736879|9712163|FG002|NOT COMPLETED|Double Blind Treatment Period||7
8668524|NCT00736879|9712164|FG003|NOT COMPLETED|Double Blind Treatment Period||5
8668525|NCT00736879|9712161|FG000|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|66
8668526|NCT00736879|9712162|FG001|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|70
8692602|NCT00862446|9738147|FG000|COMPLETED|Overall Study||48
8732475|NCT01072149|9780039|FG001|NOT COMPLETED|Treatment Period 2 (28 Days)||1
8732476|NCT01072149|9780040|FG002|NOT COMPLETED|Treatment Period 2 (28 Days)||1
8732477|NCT01072149|9780041|FG003|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8732478|NCT01072149|9780042|FG004|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8668527|NCT00736879|9712163|FG002|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|66
8668528|NCT00736879|9712164|FG003|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|62
8668529|NCT00736879|9712161|FG000|COMPLETED|Follow up Period - No Drug Treatment||65
8668530|NCT00736879|9712162|FG001|COMPLETED|Follow up Period - No Drug Treatment||67
8668531|NCT00736879|9712163|FG002|COMPLETED|Follow up Period - No Drug Treatment||66
8668532|NCT00736879|9712164|FG003|COMPLETED|Follow up Period - No Drug Treatment||62
8668533|NCT00736879|9712161|FG000|NOT COMPLETED|Follow up Period - No Drug Treatment||1
8668534|NCT00736879|9712162|FG001|NOT COMPLETED|Follow up Period - No Drug Treatment||3
8668535|NCT00736879|9712163|FG002|NOT COMPLETED|Follow up Period - No Drug Treatment||0
8668536|NCT00736879|9712164|FG003|NOT COMPLETED|Follow up Period - No Drug Treatment||0
8668537|NCT00736944|9712177|FG000|STARTED|Induction||30
8668538|NCT00736944|9712177|FG000|COMPLETED|Induction||29
8668539|NCT00736944|9712177|FG000|NOT COMPLETED|Induction||1
8668540|NCT00736944|9712177|FG000|STARTED|Definitive Treatment||29
8668541|NCT00736944|9712177|FG000|COMPLETED|Definitive Treatment||28
8668542|NCT00736944|9712177|FG000|NOT COMPLETED|Definitive Treatment||1
8668543|NCT00736957|9712184|FG000|STARTED|Overall Study||219
8668544|NCT00736957|9712184|FG000|Treated|Overall Study||190
8668545|NCT00736957|9712184|FG000|COMPLETED|Overall Study||97
8668546|NCT00736957|9712184|FG000|NOT COMPLETED|Overall Study||122
8668547|NCT00736996|9712191|FG000|STARTED|Overall Study||25
8668548|NCT00736996|9712192|FG001|STARTED|Overall Study||26
8668549|NCT00736996|9712193|FG002|STARTED|Overall Study||27
8668550|NCT00736996|9712191|FG000|COMPLETED|Overall Study||24
8668551|NCT00736996|9712192|FG001|COMPLETED|Overall Study||17
8668552|NCT00736996|9712193|FG002|COMPLETED|Overall Study||25
8668553|NCT00736996|9712191|FG000|NOT COMPLETED|Overall Study||1
8668554|NCT00736996|9712192|FG001|NOT COMPLETED|Overall Study||9
8668555|NCT00736996|9712193|FG002|NOT COMPLETED|Overall Study||2
8668556|NCT00737048|9712204|FG000|STARTED|Overall Study||132
8668557|NCT00737048|9712205|FG001|STARTED|Overall Study||66
8668558|NCT00737048|9712206|FG002|STARTED|Overall Study||130
8668559|NCT00737048|9712204|FG000|COMPLETED|Overall Study||129
8668560|NCT00737048|9712205|FG001|COMPLETED|Overall Study||60
8668561|NCT00737048|9712206|FG002|COMPLETED|Overall Study||126
8668562|NCT00737048|9712204|FG000|NOT COMPLETED|Overall Study||3
8668563|NCT00737048|9712205|FG001|NOT COMPLETED|Overall Study||6
8668564|NCT00737048|9712206|FG002|NOT COMPLETED|Overall Study||4
8668565|NCT00737061|9712214|FG000|STARTED|Waiting Period||645
8668566|NCT00737061|9712214|FG000|COMPLETED|Waiting Period||570
8668567|NCT00737061|9712214|FG000|NOT COMPLETED|Waiting Period||75
8668568|NCT00737061|9712214|FG000|STARTED|1 Year Wearing Period||570
8668569|NCT00737061|9712214|FG000|COMPLETED|1 Year Wearing Period||553
8668570|NCT00737061|9712214|FG000|NOT COMPLETED|1 Year Wearing Period||17
8668571|NCT00737100|9712221|FG000|STARTED|Overall Study||168
8668572|NCT00737100|9712222|FG001|STARTED|Overall Study||166
8668573|NCT00737100|9712223|FG002|STARTED|Overall Study||176
8668574|NCT00737100|9712221|FG000|COMPLETED|Overall Study||161
8668575|NCT00737100|9712222|FG001|COMPLETED|Overall Study||159
8668576|NCT00737100|9712223|FG002|COMPLETED|Overall Study||169
8668577|NCT00737100|9712221|FG000|NOT COMPLETED|Overall Study||7
8668578|NCT00737100|9712222|FG001|NOT COMPLETED|Overall Study||7
8668579|NCT00737100|9712223|FG002|NOT COMPLETED|Overall Study||7
8668580|NCT00737178|9712235|FG000|STARTED|Overall Study||71
8668581|NCT00737178|9712236|FG001|STARTED|Overall Study||85
8668582|NCT00737178|9712235|FG000|COMPLETED|Overall Study||66
8668583|NCT00737178|9712236|FG001|COMPLETED|Overall Study||76
8668584|NCT00737178|9712235|FG000|NOT COMPLETED|Overall Study||5
8668585|NCT00737178|9712236|FG001|NOT COMPLETED|Overall Study||9
8668586|NCT00737204|9712244|FG000|STARTED|Overall Study||36
8668587|NCT00737204|9712245|FG001|STARTED|Overall Study||34
8668588|NCT00737204|9712244|FG000|COMPLETED|Overall Study||36
8668589|NCT00737204|9712245|FG001|COMPLETED|Overall Study||28
8668590|NCT00737204|9712244|FG000|NOT COMPLETED|Overall Study||0
8668591|NCT00737204|9712245|FG001|NOT COMPLETED|Overall Study||6
8668592|NCT00737243|9712251|FG000|STARTED|Overall Study||289
8668593|NCT00737243|9712251|FG000|Successful Assay Performed|Overall Study||252
8668594|NCT00737243|9712251|FG000|Insufficient Tissue for Assay, Withdrawn|Overall Study||37
8668595|NCT00737243|9712251|FG000|Treated|Overall Study||223
8668596|NCT00737243|9712251|FG000|Not Treated|Overall Study|16 pts no longer met eligibility criteria; 13 came off study due to physician or pt preference.|29
8668597|NCT00737243|9712251|FG000|Site Specific Therapy More Responsive|Overall Study||115
8668598|NCT00737243|9712251|FG000|Site Specific Therapy Less Responsive|Overall Study||79
8668599|NCT00737243|9712251|FG000|Empiric CUP Therapy|Overall Study||29
8668600|NCT00737243|9712251|FG000|COMPLETED|Overall Study||194
8668601|NCT00737243|9712251|FG000|NOT COMPLETED|Overall Study||95
8668602|NCT00737360|9712257|FG000|STARTED|Overall Study||27
8668603|NCT00737360|9712257|FG000|COMPLETED|Overall Study||27
8668604|NCT00737360|9712257|FG000|NOT COMPLETED|Overall Study||0
8668605|NCT00737438|9712261|FG000|STARTED|Overall Study||23
8668606|NCT00737438|9712261|FG000|COMPLETED|Overall Study||20
8668607|NCT00737438|9712261|FG000|NOT COMPLETED|Overall Study||3
8668608|NCT00737464|9712265|FG000|STARTED|Overall Study||132
8668609|NCT00737464|9712265|FG000|COMPLETED|Overall Study||114
8668610|NCT00737464|9712265|FG000|NOT COMPLETED|Overall Study||18
8668611|NCT00737477|9712269|FG000|STARTED|Overall Study||96
8668612|NCT00737477|9712269|FG000|COMPLETED|Overall Study||62
8668613|NCT00737477|9712269|FG000|NOT COMPLETED|Overall Study||34
8668614|NCT00737529|9712273|FG000|STARTED|Overall Study||134
8668615|NCT00737529|9712273|FG000|COMPLETED|Overall Study|Completed equals participants ongoing on treatment at the time of the data cut-off of 30 March 2017|1
8668616|NCT00737529|9712273|FG000|NOT COMPLETED|Overall Study||133
8668617|NCT00737568|9712279|FG000|STARTED|Treatment Period Through Week 240||141
8668618|NCT00737568|9712280|FG001|STARTED|Treatment Period Through Week 240||139
8668619|NCT00737568|9712279|FG000|COMPLETED|Treatment Period Through Week 240||121
8668620|NCT00737568|9712280|FG001|COMPLETED|Treatment Period Through Week 240||118
8668621|NCT00737568|9712279|FG000|NOT COMPLETED|Treatment Period Through Week 240||20
8668622|NCT00737568|9712280|FG001|NOT COMPLETED|Treatment Period Through Week 240||21
8668623|NCT00737568|9712279|FG000|STARTED|Treatment-Free Follow-up (TFFU) Period|1 participant not completing the 240 week treatment period enrolled in the TFFU period.|38
8668624|NCT00737568|9712280|FG001|STARTED|Treatment-Free Follow-up (TFFU) Period|4 participants not completing the 240 week treatment period enrolled in the TFFU period.|37
8668625|NCT00737568|9712279|FG000|COMPLETED|Treatment-Free Follow-up (TFFU) Period||12
8668626|NCT00737568|9712280|FG001|COMPLETED|Treatment-Free Follow-up (TFFU) Period||19
8668627|NCT00737568|9712279|FG000|NOT COMPLETED|Treatment-Free Follow-up (TFFU) Period||26
8668628|NCT00737568|9712280|FG001|NOT COMPLETED|Treatment-Free Follow-up (TFFU) Period||18
8668629|NCT00737633|9712288|FG000|STARTED|Overall Study||44
8668630|NCT00737633|9712289|FG001|STARTED|Overall Study||57
8668631|NCT00737633|9712288|FG000|COMPLETED|Overall Study||0
8668632|NCT00737633|9712289|FG001|COMPLETED|Overall Study||0
8668633|NCT00737633|9712288|FG000|NOT COMPLETED|Overall Study||44
8668634|NCT00737633|9712289|FG001|NOT COMPLETED|Overall Study||57
8668635|NCT00737672|9712297|FG000|STARTED|Overall Study||145
8668636|NCT00737672|9712298|FG001|STARTED|Overall Study||148
8668637|NCT00737672|9712297|FG000|Exclusions Due to Protocol Deviations|Overall Study||14
8668638|NCT00737672|9712298|FG001|Exclusions Due to Protocol Deviations|Overall Study||10
8668639|NCT00737672|9712297|FG000|Per Protocol Population|Overall Study||131
8668640|NCT00737672|9712298|FG001|Per Protocol Population|Overall Study||138
8668641|NCT00737672|9712297|FG000|COMPLETED|Overall Study||65
8668642|NCT00737672|9712298|FG001|COMPLETED|Overall Study||65
8668643|NCT00737672|9712297|FG000|NOT COMPLETED|Overall Study||80
8668644|NCT00737672|9712298|FG001|NOT COMPLETED|Overall Study||83
8668645|NCT00737698|9712307|FG000|STARTED|Overall Study||23
8668646|NCT00737698|9712308|FG001|STARTED|Overall Study||42
8668647|NCT00737698|9712309|FG002|STARTED|Overall Study||21
8668648|NCT00737698|9712307|FG000|COMPLETED|Overall Study||17
8668649|NCT00737698|9712308|FG001|COMPLETED|Overall Study||37
8668650|NCT00737698|9712309|FG002|COMPLETED|Overall Study||17
8668651|NCT00737698|9712307|FG000|NOT COMPLETED|Overall Study||6
8668652|NCT00737698|9712308|FG001|NOT COMPLETED|Overall Study||5
8668653|NCT00737698|9712309|FG002|NOT COMPLETED|Overall Study||4
8668654|NCT00737711|9712317|FG000|STARTED|Overall Study||189
8668655|NCT00737711|9712317|FG000|COMPLETED|Overall Study||158
8668656|NCT00737711|9712317|FG000|NOT COMPLETED|Overall Study||31
8668657|NCT00737737|9712323|FG000|STARTED|Overall Study||2
8668658|NCT00737737|9712324|FG001|STARTED|Overall Study||2
8668659|NCT00737737|9712323|FG000|COMPLETED|Overall Study||2
8668660|NCT00737737|9712324|FG001|COMPLETED|Overall Study||2
8668661|NCT00737737|9712323|FG000|NOT COMPLETED|Overall Study||0
8668662|NCT00737737|9712324|FG001|NOT COMPLETED|Overall Study||0
8668663|NCT00737893|9712332|FG000|STARTED|Overall Study||29
8668664|NCT00737893|9712333|FG001|STARTED|Overall Study||27
8668665|NCT00737893|9712332|FG000|COMPLETED|Overall Study||29
8668666|NCT00737893|9712333|FG001|COMPLETED|Overall Study||27
8668667|NCT00737893|9712332|FG000|NOT COMPLETED|Overall Study||0
8668668|NCT00737893|9712333|FG001|NOT COMPLETED|Overall Study||0
8732479|NCT01072149|9780043|FG005|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8732480|NCT01072149|9780044|FG006|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8732481|NCT01072149|9780045|FG007|NOT COMPLETED|Treatment Period 2 (28 Days)||1
8732482|NCT01072149|9780046|FG008|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8732483|NCT01072149|9780047|FG009|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8732484|NCT01072149|9780048|FG010|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8732485|NCT01072149|9780049|FG011|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8732486|NCT01072149|9780050|FG012|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8732487|NCT01072149|9780051|FG013|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8732488|NCT01072149|9780052|FG014|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8732489|NCT01072149|9780053|FG015|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8732490|NCT01072149|9780054|FG016|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8732491|NCT01072149|9780055|FG017|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8732492|NCT01072149|9780038|FG000|STARTED|Washout Period 2 (14 Days)||3
8732493|NCT01072149|9780039|FG001|STARTED|Washout Period 2 (14 Days)||2
8732494|NCT01072149|9780040|FG002|STARTED|Washout Period 2 (14 Days)||1
8732495|NCT01072149|9780041|FG003|STARTED|Washout Period 2 (14 Days)||3
8732496|NCT01072149|9780042|FG004|STARTED|Washout Period 2 (14 Days)||3
8732497|NCT01072149|9780043|FG005|STARTED|Washout Period 2 (14 Days)||3
8732498|NCT01072149|9780044|FG006|STARTED|Washout Period 2 (14 Days)||3
8668669|NCT00738023|9712341|FG000|STARTED|Intralipid Infusion||19
8668670|NCT00738023|9712342|FG001|STARTED|Intralipid Infusion||13
8668671|NCT00738023|9712341|FG000|COMPLETED|Intralipid Infusion||19
8668672|NCT00738023|9712342|FG001|COMPLETED|Intralipid Infusion||13
8668673|NCT00738023|9712341|FG000|NOT COMPLETED|Intralipid Infusion||0
8668674|NCT00738023|9712342|FG001|NOT COMPLETED|Intralipid Infusion||0
8668675|NCT00738023|9712341|FG000|STARTED|Saline Infusion||19
8668676|NCT00738023|9712342|FG001|STARTED|Saline Infusion||0
8668677|NCT00738023|9712341|FG000|COMPLETED|Saline Infusion||19
8668678|NCT00738023|9712342|FG001|COMPLETED|Saline Infusion||0
8668679|NCT00738023|9712341|FG000|NOT COMPLETED|Saline Infusion||0
8668680|NCT00738023|9712342|FG001|NOT COMPLETED|Saline Infusion||0
8668681|NCT00738023|9712341|FG000|STARTED|Intralipid Infusion (Post 6 Wks of Drug)||19
8668682|NCT00738023|9712342|FG001|STARTED|Intralipid Infusion (Post 6 Wks of Drug)||0
8668683|NCT00738023|9712341|FG000|COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||19
8668684|NCT00738023|9712342|FG001|COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||0
8668685|NCT00738023|9712341|FG000|NOT COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||0
8668686|NCT00738023|9712342|FG001|NOT COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||0
8668687|NCT00738049|9712351|FG000|STARTED|1st Intervention(14 Days)||13
8668688|NCT00738049|9712352|FG001|STARTED|1st Intervention(14 Days)||7
8668689|NCT00738049|9712351|FG000|COMPLETED|1st Intervention(14 Days)||13
8668690|NCT00738049|9712352|FG001|COMPLETED|1st Intervention(14 Days)||7
8668691|NCT00738049|9712351|FG000|NOT COMPLETED|1st Intervention(14 Days)||0
8668692|NCT00738049|9712352|FG001|NOT COMPLETED|1st Intervention(14 Days)||0
8668693|NCT00738049|9712351|FG000|STARTED|2nd Intervention(14 Days)||13
8668694|NCT00738049|9712352|FG001|STARTED|2nd Intervention(14 Days)||7
8668695|NCT00738049|9712351|FG000|COMPLETED|2nd Intervention(14 Days)||13
8668696|NCT00738049|9712352|FG001|COMPLETED|2nd Intervention(14 Days)||7
8668697|NCT00738049|9712351|FG000|NOT COMPLETED|2nd Intervention(14 Days)||0
8668698|NCT00738049|9712352|FG001|NOT COMPLETED|2nd Intervention(14 Days)||0
8668699|NCT00738049|9712351|FG000|STARTED|Washout||13
8668700|NCT00738049|9712352|FG001|STARTED|Washout||7
8668701|NCT00738049|9712351|FG000|COMPLETED|Washout||13
8668702|NCT00738049|9712352|FG001|COMPLETED|Washout||7
8668703|NCT00738049|9712351|FG000|NOT COMPLETED|Washout||0
8668704|NCT00738049|9712352|FG001|NOT COMPLETED|Washout||0
8668705|NCT00738062|9712367|FG000|STARTED|Open Label Treatment||103
8668706|NCT00738062|9712368|FG001|STARTED|Open Label Treatment||0
8668707|NCT00738062|9712369|FG002|STARTED|Open Label Treatment||0
8668708|NCT00738062|9712367|FG000|COMPLETED|Open Label Treatment||75
8668709|NCT00738062|9712368|FG001|COMPLETED|Open Label Treatment||0
8668710|NCT00738062|9712369|FG002|COMPLETED|Open Label Treatment||0
8668711|NCT00738062|9712367|FG000|NOT COMPLETED|Open Label Treatment||28
8668712|NCT00738062|9712368|FG001|NOT COMPLETED|Open Label Treatment||0
8668713|NCT00738062|9712369|FG002|NOT COMPLETED|Open Label Treatment||0
8668714|NCT00738062|9712367|FG000|STARTED|2 Week Randomized Withdrawal|Patients completing the open label titration phase were randomized to either Droxidopa or Placebo|0
8668715|NCT00738062|9712368|FG001|STARTED|2 Week Randomized Withdrawal||38
8668716|NCT00738062|9712369|FG002|STARTED|2 Week Randomized Withdrawal||37
8668717|NCT00738062|9712367|FG000|COMPLETED|2 Week Randomized Withdrawal||0
8668718|NCT00738062|9712368|FG001|COMPLETED|2 Week Randomized Withdrawal||38
8668719|NCT00738062|9712369|FG002|COMPLETED|2 Week Randomized Withdrawal||37
8668720|NCT00738062|9712367|FG000|NOT COMPLETED|2 Week Randomized Withdrawal||0
8668721|NCT00738062|9712368|FG001|NOT COMPLETED|2 Week Randomized Withdrawal||0
8668722|NCT00738062|9712369|FG002|NOT COMPLETED|2 Week Randomized Withdrawal||0
8668723|NCT00738062|9712367|FG000|STARTED|Open-Label Extension|One patient completed double blind randomization but did not enter the open label extension|74
8668724|NCT00738062|9712368|FG001|STARTED|Open-Label Extension||0
8668725|NCT00738062|9712369|FG002|STARTED|Open-Label Extension||0
8668726|NCT00738062|9712367|FG000|COMPLETED|Open-Label Extension||57
8668727|NCT00738062|9712368|FG001|COMPLETED|Open-Label Extension||0
8732499|NCT01072149|9780045|FG007|STARTED|Washout Period 2 (14 Days)||2
8732500|NCT01072149|9780046|FG008|STARTED|Washout Period 2 (14 Days)||3
8732501|NCT01072149|9780047|FG009|STARTED|Washout Period 2 (14 Days)||3
8732502|NCT01072149|9780048|FG010|STARTED|Washout Period 2 (14 Days)||2
8732503|NCT01072149|9780049|FG011|STARTED|Washout Period 2 (14 Days)||3
8732504|NCT01072149|9780050|FG012|STARTED|Washout Period 2 (14 Days)||3
8911695|NCT02148107|9970780|FG001|NOT COMPLETED|Overall Study||0
8911696|NCT02148107|9970781|FG002|NOT COMPLETED|Overall Study||0
8911697|NCT02148211|9970789|FG000|STARTED|Overall Study||507
8911698|NCT02148211|9970789|FG000|COMPLETED|Overall Study||155
8911699|NCT02148211|9970789|FG000|NOT COMPLETED|Overall Study||352
8911700|NCT02148250|9970793|FG000|STARTED|Screening||17
8911701|NCT02148250|9970794|FG001|STARTED|Screening||0
8911702|NCT02148250|9970793|FG000|COMPLETED|Screening||12
8911703|NCT02148250|9970794|FG001|COMPLETED|Screening||0
8911704|NCT02148250|9970793|FG000|NOT COMPLETED|Screening||5
8911705|NCT02148250|9970794|FG001|NOT COMPLETED|Screening||0
8911706|NCT02148250|9970793|FG000|STARTED|Period 1||6
8911707|NCT02148250|9970794|FG001|STARTED|Period 1||6
8911708|NCT02148250|9970793|FG000|COMPLETED|Period 1||6
8911709|NCT02148250|9970794|FG001|COMPLETED|Period 1||6
8911710|NCT02148250|9970793|FG000|NOT COMPLETED|Period 1||0
8911711|NCT02148250|9970794|FG001|NOT COMPLETED|Period 1||0
8668728|NCT00738062|9712369|FG002|COMPLETED|Open-Label Extension||0
8668729|NCT00738062|9712367|FG000|NOT COMPLETED|Open-Label Extension||17
8668730|NCT00738062|9712368|FG001|NOT COMPLETED|Open-Label Extension||0
8911712|NCT02148250|9970793|FG000|STARTED|Period 2||6
8911713|NCT02148250|9970794|FG001|STARTED|Period 2||6
8911714|NCT02148250|9970793|FG000|COMPLETED|Period 2||6
8911715|NCT02148250|9970794|FG001|COMPLETED|Period 2||6
8668731|NCT00738062|9712369|FG002|NOT COMPLETED|Open-Label Extension||0
8668732|NCT00738101|9712378|FG000|STARTED|Overall Study||293
8668733|NCT00738101|9712378|FG000|COMPLETED|Overall Study|7 exclusions. 5 primary liver or unrelated disease, 1 died before Omegaven, 1 repeat enrollment|286
8668734|NCT00738101|9712378|FG000|NOT COMPLETED|Overall Study||7
8668735|NCT00738283|9712382|FG000|STARTED|Overall Study||17
8668736|NCT00738283|9712382|FG000|COMPLETED|Overall Study||13
8668737|NCT00738283|9712382|FG000|NOT COMPLETED|Overall Study||4
8668738|NCT00738361|9712386|FG000|STARTED|Overall Study||4
8668739|NCT00738361|9712386|FG000|COMPLETED|Overall Study||4
8668740|NCT00738361|9712386|FG000|NOT COMPLETED|Overall Study||0
8668741|NCT00738374|9712394|FG000|STARTED|Induction Treatment Phase||97
8668742|NCT00738374|9712395|FG001|STARTED|Induction Treatment Phase||0
8668743|NCT00738374|9712396|FG002|STARTED|Induction Treatment Phase|Participants were randomized at the end of the Induction Treatment Phase.|0
8668744|NCT00738374|9712397|FG003|STARTED|Induction Treatment Phase|Participants were randomized at the end of the Induction Treatment Phase.|0
8668745|NCT00738374|9712394|FG000|COMPLETED|Induction Treatment Phase||73
8668746|NCT00738374|9712395|FG001|COMPLETED|Induction Treatment Phase||0
8668747|NCT00738374|9712396|FG002|COMPLETED|Induction Treatment Phase||0
8668748|NCT00738374|9712397|FG003|COMPLETED|Induction Treatment Phase||0
8668749|NCT00738374|9712394|FG000|NOT COMPLETED|Induction Treatment Phase||24
8668750|NCT00738374|9712395|FG001|NOT COMPLETED|Induction Treatment Phase||0
8668751|NCT00738374|9712396|FG002|NOT COMPLETED|Induction Treatment Phase||0
8668752|NCT00738374|9712397|FG003|NOT COMPLETED|Induction Treatment Phase||0
8668753|NCT00738374|9712394|FG000|STARTED|Maintenance Treatment/Observation Phase|Participants were randomized to either maintenance therapy or observation at the end of induction.|0
8668754|NCT00738374|9712395|FG001|STARTED|Maintenance Treatment/Observation Phase||7
8668755|NCT00738374|9712396|FG002|STARTED|Maintenance Treatment/Observation Phase||34
8668756|NCT00738374|9712397|FG003|STARTED|Maintenance Treatment/Observation Phase||32
8668757|NCT00738374|9712394|FG000|COMPLETED|Maintenance Treatment/Observation Phase||0
8668758|NCT00738374|9712395|FG001|COMPLETED|Maintenance Treatment/Observation Phase||0
8668759|NCT00738374|9712396|FG002|COMPLETED|Maintenance Treatment/Observation Phase||27
8668760|NCT00738374|9712397|FG003|COMPLETED|Maintenance Treatment/Observation Phase||20
8668761|NCT00738374|9712394|FG000|NOT COMPLETED|Maintenance Treatment/Observation Phase||0
8668762|NCT00738374|9712395|FG001|NOT COMPLETED|Maintenance Treatment/Observation Phase||7
8668763|NCT00738374|9712396|FG002|NOT COMPLETED|Maintenance Treatment/Observation Phase||7
8668764|NCT00738374|9712397|FG003|NOT COMPLETED|Maintenance Treatment/Observation Phase||12
8668765|NCT00738400|9712408|FG000|STARTED|Overall Study||76
8668766|NCT00738400|9712409|FG001|STARTED|Overall Study||74
8668767|NCT00738400|9712408|FG000|Received Treatment, Safety Population|Overall Study|One invalid participant (no evidence that this randomized participant took study medication).|75
8668768|NCT00738400|9712409|FG001|Received Treatment, Safety Population|Overall Study|Two invalid participants (no evidence that these randomized participants took study medication).|72
8668769|NCT00738400|9712408|FG000|ITT (Intent To Treatment) Population|Overall Study||75
8668770|NCT00738400|9712409|FG001|ITT (Intent To Treatment) Population|Overall Study|No post-baseline efficacy measurement in 2 participants|70
8668771|NCT00738400|9712408|FG000|COMPLETED|Overall Study||72
8668772|NCT00738400|9712409|FG001|COMPLETED|Overall Study||67
8668773|NCT00738400|9712408|FG000|NOT COMPLETED|Overall Study||4
8668774|NCT00738400|9712409|FG001|NOT COMPLETED|Overall Study||7
8668775|NCT00738426|9712417|FG000|STARTED|Overall Study||37
8668776|NCT00738426|9712418|FG001|STARTED|Overall Study||35
8668777|NCT00738426|9712417|FG000|COMPLETED|Overall Study||35
8668778|NCT00738426|9712418|FG001|COMPLETED|Overall Study||32
8668779|NCT00738426|9712417|FG000|NOT COMPLETED|Overall Study||2
8668780|NCT00738426|9712418|FG001|NOT COMPLETED|Overall Study||3
8668781|NCT00738530|9712426|FG000|STARTED|Overall Study||327
8668782|NCT00738530|9712427|FG001|STARTED|Overall Study||322
8668783|NCT00738530|9712426|FG000|Treated|Overall Study||325
8668784|NCT00738530|9712427|FG001|Treated|Overall Study||316
8668785|NCT00738530|9712426|FG000|COMPLETED|Overall Study||93
8668786|NCT00738530|9712427|FG001|COMPLETED|Overall Study||84
8668787|NCT00738530|9712426|FG000|NOT COMPLETED|Overall Study||234
8668788|NCT00738530|9712427|FG001|NOT COMPLETED|Overall Study||238
8668789|NCT00738543|9712433|FG000|STARTED|Povidone Iodine||48
8668790|NCT00738543|9712433|FG000|COMPLETED|Povidone Iodine||48
8668791|NCT00738543|9712433|FG000|NOT COMPLETED|Povidone Iodine||0
8668792|NCT00738543|9712433|FG000|STARTED|Sodium Hypochlorite||48
8668793|NCT00738543|9712433|FG000|COMPLETED|Sodium Hypochlorite||48
8668794|NCT00738543|9712433|FG000|NOT COMPLETED|Sodium Hypochlorite||0
8668795|NCT00738543|9712433|FG000|STARTED|Control||48
8911716|NCT02148250|9970793|FG000|NOT COMPLETED|Period 2||0
8911717|NCT02148250|9970794|FG001|NOT COMPLETED|Period 2||0
8732505|NCT01072149|9780051|FG013|STARTED|Washout Period 2 (14 Days)||3
8732506|NCT01072149|9780052|FG014|STARTED|Washout Period 2 (14 Days)||3
8732507|NCT01072149|9780053|FG015|STARTED|Washout Period 2 (14 Days)||3
8732508|NCT01072149|9780054|FG016|STARTED|Washout Period 2 (14 Days)||3
8732509|NCT01072149|9780055|FG017|STARTED|Washout Period 2 (14 Days)||2
8732510|NCT01072149|9780038|FG000|COMPLETED|Washout Period 2 (14 Days)||2
8732511|NCT01072149|9780039|FG001|COMPLETED|Washout Period 2 (14 Days)||2
8732512|NCT01072149|9780040|FG002|COMPLETED|Washout Period 2 (14 Days)||1
8732513|NCT01072149|9780041|FG003|COMPLETED|Washout Period 2 (14 Days)||3
8732514|NCT01072149|9780042|FG004|COMPLETED|Washout Period 2 (14 Days)||3
8732515|NCT01072149|9780043|FG005|COMPLETED|Washout Period 2 (14 Days)||3
8668796|NCT00738543|9712433|FG000|COMPLETED|Control||48
8668797|NCT00738543|9712433|FG000|NOT COMPLETED|Control||0
8668798|NCT00738673|9712439|FG000|STARTED|Overall Study||25
8668799|NCT00738673|9712440|FG001|STARTED|Overall Study||12
8668800|NCT00738673|9712439|FG000|Intent to Treat Population|Overall Study||24
8668801|NCT00738673|9712440|FG001|Intent to Treat Population|Overall Study||12
8668802|NCT00738673|9712439|FG000|COMPLETED|Overall Study||1
8668803|NCT00738673|9712440|FG001|COMPLETED|Overall Study||1
8668804|NCT00738673|9712439|FG000|NOT COMPLETED|Overall Study||24
8668805|NCT00738673|9712440|FG001|NOT COMPLETED|Overall Study||11
8668806|NCT00738699|9712448|FG000|STARTED|Overall Study||275
8668807|NCT00738699|9712449|FG001|STARTED|Overall Study||140
8668808|NCT00738699|9712448|FG000|Participants Not Treated|Overall Study||2
8668809|NCT00738699|9712449|FG001|Participants Not Treated|Overall Study||1
8668810|NCT00738699|9712448|FG000|Participants Treated|Overall Study||273
8668811|NCT00738699|9712449|FG001|Participants Treated|Overall Study||139
8668812|NCT00738699|9712448|FG000|COMPLETED|Overall Study||0
8668813|NCT00738699|9712449|FG001|COMPLETED|Overall Study||0
8668814|NCT00738699|9712448|FG000|NOT COMPLETED|Overall Study||275
8668815|NCT00738699|9712449|FG001|NOT COMPLETED|Overall Study||140
8668816|NCT00738881|9712457|FG000|STARTED|Overall Study||11
8668817|NCT00738881|9712458|FG001|STARTED|Overall Study||12
8668818|NCT00738881|9712457|FG000|COMPLETED|Overall Study||11
8668819|NCT00738881|9712458|FG001|COMPLETED|Overall Study||10
8668820|NCT00738881|9712457|FG000|NOT COMPLETED|Overall Study||0
8668821|NCT00738881|9712458|FG001|NOT COMPLETED|Overall Study||2
8668822|NCT00738894|9712466|FG000|STARTED|Overall Study||441
8668823|NCT00738894|9712467|FG001|STARTED|Overall Study||223
8668824|NCT00738894|9712466|FG000|COMPLETED|Overall Study||402
8668825|NCT00738894|9712467|FG001|COMPLETED|Overall Study||190
8668826|NCT00738894|9712466|FG000|NOT COMPLETED|Overall Study||39
8668827|NCT00738894|9712467|FG001|NOT COMPLETED|Overall Study||33
8668828|NCT00739102|9712473|FG000|STARTED|Overall Study||250
8668829|NCT00739102|9712473|FG000|COMPLETED|Overall Study|Completed 12-Month Follow-up|235
8668830|NCT00739102|9712473|FG000|NOT COMPLETED|Overall Study||15
8668831|NCT00739297|9712477|FG000|STARTED|First Intervention (Visit 3 to Visit 4)||17
8668832|NCT00739297|9712478|FG001|STARTED|First Intervention (Visit 3 to Visit 4)||11
8668833|NCT00739297|9712479|FG002|STARTED|First Intervention (Visit 3 to Visit 4)||6
8668834|NCT00739297|9712480|FG003|STARTED|First Intervention (Visit 3 to Visit 4)||19
8668835|NCT00739297|9712481|FG004|STARTED|First Intervention (Visit 3 to Visit 4)||6
8668836|NCT00739297|9712482|FG005|STARTED|First Intervention (Visit 3 to Visit 4)||9
8668837|NCT00739297|9712483|FG006|STARTED|First Intervention (Visit 3 to Visit 4)||68
8668838|NCT00739297|9712477|FG000|COMPLETED|First Intervention (Visit 3 to Visit 4)||17
8668839|NCT00739297|9712478|FG001|COMPLETED|First Intervention (Visit 3 to Visit 4)||11
8668840|NCT00739297|9712479|FG002|COMPLETED|First Intervention (Visit 3 to Visit 4)||6
8668841|NCT00739297|9712480|FG003|COMPLETED|First Intervention (Visit 3 to Visit 4)||19
8668842|NCT00739297|9712481|FG004|COMPLETED|First Intervention (Visit 3 to Visit 4)||6
8668843|NCT00739297|9712482|FG005|COMPLETED|First Intervention (Visit 3 to Visit 4)||9
8668844|NCT00739297|9712483|FG006|COMPLETED|First Intervention (Visit 3 to Visit 4)||68
8668845|NCT00739297|9712477|FG000|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
8668846|NCT00739297|9712478|FG001|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
8668847|NCT00739297|9712479|FG002|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
8668848|NCT00739297|9712480|FG003|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
8668849|NCT00739297|9712481|FG004|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
8668850|NCT00739297|9712482|FG005|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
8668851|NCT00739297|9712483|FG006|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
8668852|NCT00739297|9712477|FG000|STARTED|First Washout Period of 4-7 Days||17
8668853|NCT00739297|9712478|FG001|STARTED|First Washout Period of 4-7 Days||11
8668854|NCT00739297|9712479|FG002|STARTED|First Washout Period of 4-7 Days||6
8668855|NCT00739297|9712480|FG003|STARTED|First Washout Period of 4-7 Days||19
8668856|NCT00739297|9712481|FG004|STARTED|First Washout Period of 4-7 Days||6
8668857|NCT00739297|9712482|FG005|STARTED|First Washout Period of 4-7 Days||9
8668858|NCT00739297|9712483|FG006|STARTED|First Washout Period of 4-7 Days||68
8668859|NCT00739297|9712477|FG000|COMPLETED|First Washout Period of 4-7 Days||17
8668860|NCT00739297|9712478|FG001|COMPLETED|First Washout Period of 4-7 Days||11
8668861|NCT00739297|9712479|FG002|COMPLETED|First Washout Period of 4-7 Days||6
8668862|NCT00739297|9712480|FG003|COMPLETED|First Washout Period of 4-7 Days||17
8668863|NCT00739297|9712481|FG004|COMPLETED|First Washout Period of 4-7 Days||6
8668864|NCT00739297|9712482|FG005|COMPLETED|First Washout Period of 4-7 Days||9
8668865|NCT00739297|9712483|FG006|COMPLETED|First Washout Period of 4-7 Days||66
8668866|NCT00739297|9712477|FG000|NOT COMPLETED|First Washout Period of 4-7 Days||0
8668867|NCT00739297|9712478|FG001|NOT COMPLETED|First Washout Period of 4-7 Days||0
8668868|NCT00739297|9712479|FG002|NOT COMPLETED|First Washout Period of 4-7 Days||0
8668869|NCT00739297|9712480|FG003|NOT COMPLETED|First Washout Period of 4-7 Days||2
8668870|NCT00739297|9712481|FG004|NOT COMPLETED|First Washout Period of 4-7 Days||0
8668871|NCT00739297|9712482|FG005|NOT COMPLETED|First Washout Period of 4-7 Days||0
8668872|NCT00739297|9712483|FG006|NOT COMPLETED|First Washout Period of 4-7 Days||2
8668873|NCT00739297|9712477|FG000|STARTED|Second Intervention (Visit 5 to Visit 6)||18
8668874|NCT00739297|9712478|FG001|STARTED|Second Intervention (Visit 5 to Visit 6)||8
8668875|NCT00739297|9712479|FG002|STARTED|Second Intervention (Visit 5 to Visit 6)||10
8668876|NCT00739297|9712480|FG003|STARTED|Second Intervention (Visit 5 to Visit 6)||14
8668877|NCT00739297|9712481|FG004|STARTED|Second Intervention (Visit 5 to Visit 6)||6
8668878|NCT00739297|9712482|FG005|STARTED|Second Intervention (Visit 5 to Visit 6)||10
8668879|NCT00739297|9712483|FG006|STARTED|Second Intervention (Visit 5 to Visit 6)||66
8668880|NCT00739297|9712477|FG000|COMPLETED|Second Intervention (Visit 5 to Visit 6)||18
8668881|NCT00739297|9712478|FG001|COMPLETED|Second Intervention (Visit 5 to Visit 6)||8
8668882|NCT00739297|9712479|FG002|COMPLETED|Second Intervention (Visit 5 to Visit 6)||10
8668883|NCT00739297|9712480|FG003|COMPLETED|Second Intervention (Visit 5 to Visit 6)||14
8668884|NCT00739297|9712481|FG004|COMPLETED|Second Intervention (Visit 5 to Visit 6)||6
8668885|NCT00739297|9712482|FG005|COMPLETED|Second Intervention (Visit 5 to Visit 6)||10
8668886|NCT00739297|9712483|FG006|COMPLETED|Second Intervention (Visit 5 to Visit 6)||66
8668887|NCT00739297|9712477|FG000|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
8668888|NCT00739297|9712478|FG001|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
8668889|NCT00739297|9712479|FG002|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
8668890|NCT00739297|9712480|FG003|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
8668891|NCT00739297|9712481|FG004|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
8668892|NCT00739297|9712482|FG005|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
8668893|NCT00739297|9712483|FG006|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
8668894|NCT00739297|9712477|FG000|STARTED|Second Washout Period of 4-7 Days||18
8668895|NCT00739297|9712478|FG001|STARTED|Second Washout Period of 4-7 Days||8
8668896|NCT00739297|9712479|FG002|STARTED|Second Washout Period of 4-7 Days||10
8668897|NCT00739297|9712480|FG003|STARTED|Second Washout Period of 4-7 Days||14
8668898|NCT00739297|9712481|FG004|STARTED|Second Washout Period of 4-7 Days||6
8668899|NCT00739297|9712482|FG005|STARTED|Second Washout Period of 4-7 Days||10
8668900|NCT00739297|9712483|FG006|STARTED|Second Washout Period of 4-7 Days||66
8668901|NCT00739297|9712477|FG000|COMPLETED|Second Washout Period of 4-7 Days||18
8668902|NCT00739297|9712478|FG001|COMPLETED|Second Washout Period of 4-7 Days||8
8668903|NCT00739297|9712479|FG002|COMPLETED|Second Washout Period of 4-7 Days||10
8668904|NCT00739297|9712480|FG003|COMPLETED|Second Washout Period of 4-7 Days||14
8668905|NCT00739297|9712481|FG004|COMPLETED|Second Washout Period of 4-7 Days||6
8668906|NCT00739297|9712482|FG005|COMPLETED|Second Washout Period of 4-7 Days||10
8668907|NCT00739297|9712483|FG006|COMPLETED|Second Washout Period of 4-7 Days||66
8668908|NCT00739297|9712477|FG000|NOT COMPLETED|Second Washout Period of 4-7 Days||0
8668909|NCT00739297|9712478|FG001|NOT COMPLETED|Second Washout Period of 4-7 Days||0
8668910|NCT00739297|9712479|FG002|NOT COMPLETED|Second Washout Period of 4-7 Days||0
8668911|NCT00739297|9712480|FG003|NOT COMPLETED|Second Washout Period of 4-7 Days||0
8668912|NCT00739297|9712481|FG004|NOT COMPLETED|Second Washout Period of 4-7 Days||0
8668913|NCT00739297|9712482|FG005|NOT COMPLETED|Second Washout Period of 4-7 Days||0
8668914|NCT00739297|9712483|FG006|NOT COMPLETED|Second Washout Period of 4-7 Days||0
8732516|NCT01072149|9780044|FG006|COMPLETED|Washout Period 2 (14 Days)||3
8732517|NCT01072149|9780045|FG007|COMPLETED|Washout Period 2 (14 Days)||2
8732518|NCT01072149|9780046|FG008|COMPLETED|Washout Period 2 (14 Days)||3
8732519|NCT01072149|9780047|FG009|COMPLETED|Washout Period 2 (14 Days)||3
8732520|NCT01072149|9780048|FG010|COMPLETED|Washout Period 2 (14 Days)||2
8732521|NCT01072149|9780049|FG011|COMPLETED|Washout Period 2 (14 Days)||3
8732522|NCT01072149|9780050|FG012|COMPLETED|Washout Period 2 (14 Days)||2
8732523|NCT01072149|9780051|FG013|COMPLETED|Washout Period 2 (14 Days)||3
8732524|NCT01072149|9780052|FG014|COMPLETED|Washout Period 2 (14 Days)||3
8732525|NCT01072149|9780053|FG015|COMPLETED|Washout Period 2 (14 Days)||1
8732526|NCT01072149|9780054|FG016|COMPLETED|Washout Period 2 (14 Days)||3
8732527|NCT01072149|9780055|FG017|COMPLETED|Washout Period 2 (14 Days)||2
8732528|NCT01072149|9780038|FG000|NOT COMPLETED|Washout Period 2 (14 Days)||1
8732529|NCT01072149|9780039|FG001|NOT COMPLETED|Washout Period 2 (14 Days)||0
8732530|NCT01072149|9780040|FG002|NOT COMPLETED|Washout Period 2 (14 Days)||0
8732531|NCT01072149|9780041|FG003|NOT COMPLETED|Washout Period 2 (14 Days)||0
8732532|NCT01072149|9780042|FG004|NOT COMPLETED|Washout Period 2 (14 Days)||0
8732533|NCT01072149|9780043|FG005|NOT COMPLETED|Washout Period 2 (14 Days)||0
8732534|NCT01072149|9780044|FG006|NOT COMPLETED|Washout Period 2 (14 Days)||0
8732535|NCT01072149|9780045|FG007|NOT COMPLETED|Washout Period 2 (14 Days)||0
8732536|NCT01072149|9780046|FG008|NOT COMPLETED|Washout Period 2 (14 Days)||0
8732537|NCT01072149|9780047|FG009|NOT COMPLETED|Washout Period 2 (14 Days)||0
8732538|NCT01072149|9780048|FG010|NOT COMPLETED|Washout Period 2 (14 Days)||0
8732539|NCT01072149|9780049|FG011|NOT COMPLETED|Washout Period 2 (14 Days)||0
8732540|NCT01072149|9780050|FG012|NOT COMPLETED|Washout Period 2 (14 Days)||1
8732541|NCT01072149|9780051|FG013|NOT COMPLETED|Washout Period 2 (14 Days)||0
8732542|NCT01072149|9780052|FG014|NOT COMPLETED|Washout Period 2 (14 Days)||0
8732543|NCT01072149|9780053|FG015|NOT COMPLETED|Washout Period 2 (14 Days)||2
8732544|NCT01072149|9780054|FG016|NOT COMPLETED|Washout Period 2 (14 Days)||0
8732545|NCT01072149|9780055|FG017|NOT COMPLETED|Washout Period 2 (14 Days)||0
8732546|NCT01072149|9780038|FG000|STARTED|Treatment Period 3 (28 Days)||2
8732547|NCT01072149|9780039|FG001|STARTED|Treatment Period 3 (28 Days)||2
8732548|NCT01072149|9780040|FG002|STARTED|Treatment Period 3 (28 Days)||1
8668915|NCT00739297|9712477|FG000|STARTED|Third Intervention (Visit 7 to Visit 8)||16
8732549|NCT01072149|9780041|FG003|STARTED|Treatment Period 3 (28 Days)||3
8732550|NCT01072149|9780042|FG004|STARTED|Treatment Period 3 (28 Days)||3
8668916|NCT00739297|9712478|FG001|STARTED|Third Intervention (Visit 7 to Visit 8)||12
8668917|NCT00739297|9712479|FG002|STARTED|Third Intervention (Visit 7 to Visit 8)||6
8668918|NCT00739297|9712480|FG003|STARTED|Third Intervention (Visit 7 to Visit 8)||18
8668919|NCT00739297|9712481|FG004|STARTED|Third Intervention (Visit 7 to Visit 8)||6
8668920|NCT00739297|9712482|FG005|STARTED|Third Intervention (Visit 7 to Visit 8)||8
8668921|NCT00739297|9712483|FG006|STARTED|Third Intervention (Visit 7 to Visit 8)||66
8668922|NCT00739297|9712477|FG000|COMPLETED|Third Intervention (Visit 7 to Visit 8)||16
8668923|NCT00739297|9712478|FG001|COMPLETED|Third Intervention (Visit 7 to Visit 8)||12
8668924|NCT00739297|9712479|FG002|COMPLETED|Third Intervention (Visit 7 to Visit 8)||6
8668925|NCT00739297|9712480|FG003|COMPLETED|Third Intervention (Visit 7 to Visit 8)||18
8668926|NCT00739297|9712481|FG004|COMPLETED|Third Intervention (Visit 7 to Visit 8)||6
8668927|NCT00739297|9712482|FG005|COMPLETED|Third Intervention (Visit 7 to Visit 8)||8
8668928|NCT00739297|9712483|FG006|COMPLETED|Third Intervention (Visit 7 to Visit 8)||66
8668929|NCT00739297|9712477|FG000|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
8668930|NCT00739297|9712478|FG001|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
8668931|NCT00739297|9712479|FG002|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
8668932|NCT00739297|9712480|FG003|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
8668933|NCT00739297|9712481|FG004|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
8668934|NCT00739297|9712482|FG005|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
8668935|NCT00739297|9712483|FG006|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
8668936|NCT00739297|9712477|FG000|STARTED|Third Washout Period of 4-7 Days||16
8668937|NCT00739297|9712478|FG001|STARTED|Third Washout Period of 4-7 Days||12
8668938|NCT00739297|9712479|FG002|STARTED|Third Washout Period of 4-7 Days||6
8668939|NCT00739297|9712480|FG003|STARTED|Third Washout Period of 4-7 Days||18
8668940|NCT00739297|9712481|FG004|STARTED|Third Washout Period of 4-7 Days||6
8668941|NCT00739297|9712482|FG005|STARTED|Third Washout Period of 4-7 Days||8
8668942|NCT00739297|9712483|FG006|STARTED|Third Washout Period of 4-7 Days||66
8668943|NCT00739297|9712477|FG000|COMPLETED|Third Washout Period of 4-7 Days||16
8668944|NCT00739297|9712478|FG001|COMPLETED|Third Washout Period of 4-7 Days||12
8668945|NCT00739297|9712479|FG002|COMPLETED|Third Washout Period of 4-7 Days||6
8668946|NCT00739297|9712480|FG003|COMPLETED|Third Washout Period of 4-7 Days||18
8668947|NCT00739297|9712481|FG004|COMPLETED|Third Washout Period of 4-7 Days||6
8668948|NCT00739297|9712482|FG005|COMPLETED|Third Washout Period of 4-7 Days||8
8668949|NCT00739297|9712483|FG006|COMPLETED|Third Washout Period of 4-7 Days||66
8668950|NCT00739297|9712477|FG000|NOT COMPLETED|Third Washout Period of 4-7 Days||0
8668951|NCT00739297|9712478|FG001|NOT COMPLETED|Third Washout Period of 4-7 Days||0
8668952|NCT00739297|9712479|FG002|NOT COMPLETED|Third Washout Period of 4-7 Days||0
8668953|NCT00739297|9712480|FG003|NOT COMPLETED|Third Washout Period of 4-7 Days||0
8668954|NCT00739297|9712481|FG004|NOT COMPLETED|Third Washout Period of 4-7 Days||0
8668955|NCT00739297|9712482|FG005|NOT COMPLETED|Third Washout Period of 4-7 Days||0
8668956|NCT00739297|9712483|FG006|NOT COMPLETED|Third Washout Period of 4-7 Days||0
8668957|NCT00739297|9712477|FG000|STARTED|Fourth Intervention(Visit 9 to Visit 10)||16
8668958|NCT00739297|9712478|FG001|STARTED|Fourth Intervention(Visit 9 to Visit 10)||11
8668959|NCT00739297|9712479|FG002|STARTED|Fourth Intervention(Visit 9 to Visit 10)||8
8668960|NCT00739297|9712480|FG003|STARTED|Fourth Intervention(Visit 9 to Visit 10)||15
8668961|NCT00739297|9712481|FG004|STARTED|Fourth Intervention(Visit 9 to Visit 10)||7
8668962|NCT00739297|9712482|FG005|STARTED|Fourth Intervention(Visit 9 to Visit 10)||9
8668963|NCT00739297|9712483|FG006|STARTED|Fourth Intervention(Visit 9 to Visit 10)||66
8668964|NCT00739297|9712477|FG000|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||16
8668965|NCT00739297|9712478|FG001|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||11
8668966|NCT00739297|9712479|FG002|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||8
8668967|NCT00739297|9712480|FG003|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||15
8668968|NCT00739297|9712481|FG004|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||7
8668969|NCT00739297|9712482|FG005|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||8
8668970|NCT00739297|9712483|FG006|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||65
8732551|NCT01072149|9780043|FG005|STARTED|Treatment Period 3 (28 Days)||3
8732552|NCT01072149|9780044|FG006|STARTED|Treatment Period 3 (28 Days)||3
8732553|NCT01072149|9780045|FG007|STARTED|Treatment Period 3 (28 Days)||2
8732554|NCT01072149|9780046|FG008|STARTED|Treatment Period 3 (28 Days)||3
8732555|NCT01072149|9780047|FG009|STARTED|Treatment Period 3 (28 Days)||3
8732556|NCT01072149|9780048|FG010|STARTED|Treatment Period 3 (28 Days)||2
8732557|NCT01072149|9780049|FG011|STARTED|Treatment Period 3 (28 Days)||3
8732558|NCT01072149|9780050|FG012|STARTED|Treatment Period 3 (28 Days)||2
8732559|NCT01072149|9780051|FG013|STARTED|Treatment Period 3 (28 Days)||3
8732560|NCT01072149|9780052|FG014|STARTED|Treatment Period 3 (28 Days)||3
8732561|NCT01072149|9780053|FG015|STARTED|Treatment Period 3 (28 Days)||1
8732562|NCT01072149|9780054|FG016|STARTED|Treatment Period 3 (28 Days)||3
8732563|NCT01072149|9780055|FG017|STARTED|Treatment Period 3 (28 Days)||2
8732564|NCT01072149|9780038|FG000|COMPLETED|Treatment Period 3 (28 Days)||2
8732565|NCT01072149|9780039|FG001|COMPLETED|Treatment Period 3 (28 Days)||2
8732566|NCT01072149|9780040|FG002|COMPLETED|Treatment Period 3 (28 Days)||0
8732567|NCT01072149|9780041|FG003|COMPLETED|Treatment Period 3 (28 Days)||3
8732568|NCT01072149|9780042|FG004|COMPLETED|Treatment Period 3 (28 Days)||3
8732569|NCT01072149|9780043|FG005|COMPLETED|Treatment Period 3 (28 Days)||3
8732570|NCT01072149|9780044|FG006|COMPLETED|Treatment Period 3 (28 Days)||3
8668971|NCT00739297|9712477|FG000|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
8668972|NCT00739297|9712478|FG001|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
8668973|NCT00739297|9712479|FG002|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
8668974|NCT00739297|9712480|FG003|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
8668975|NCT00739297|9712481|FG004|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
8668976|NCT00739297|9712482|FG005|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||1
8668977|NCT00739297|9712483|FG006|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||1
8668978|NCT00739310|9712499|FG000|STARTED|Overall Study||29
8668979|NCT00739310|9712499|FG000|COMPLETED|Overall Study||22
8668980|NCT00739310|9712499|FG000|NOT COMPLETED|Overall Study||7
8668981|NCT00739336|9712506|FG000|STARTED|Overall Study||21
8668982|NCT00739336|9712507|FG001|STARTED|Overall Study||24
8668983|NCT00739336|9712506|FG000|COMPLETED|Overall Study||17
8668984|NCT00739336|9712507|FG001|COMPLETED|Overall Study||24
8668985|NCT00739336|9712506|FG000|NOT COMPLETED|Overall Study||4
8732571|NCT01072149|9780045|FG007|COMPLETED|Treatment Period 3 (28 Days)||2
8732572|NCT01072149|9780046|FG008|COMPLETED|Treatment Period 3 (28 Days)||3
8732573|NCT01072149|9780047|FG009|COMPLETED|Treatment Period 3 (28 Days)||3
8732574|NCT01072149|9780048|FG010|COMPLETED|Treatment Period 3 (28 Days)||2
8732575|NCT01072149|9780049|FG011|COMPLETED|Treatment Period 3 (28 Days)||3
8732576|NCT01072149|9780050|FG012|COMPLETED|Treatment Period 3 (28 Days)||2
8732577|NCT01072149|9780051|FG013|COMPLETED|Treatment Period 3 (28 Days)||2
8732578|NCT01072149|9780052|FG014|COMPLETED|Treatment Period 3 (28 Days)||3
8732579|NCT01072149|9780053|FG015|COMPLETED|Treatment Period 3 (28 Days)||1
8732580|NCT01072149|9780054|FG016|COMPLETED|Treatment Period 3 (28 Days)||3
8732581|NCT01072149|9780055|FG017|COMPLETED|Treatment Period 3 (28 Days)||2
8732582|NCT01072149|9780038|FG000|NOT COMPLETED|Treatment Period 3 (28 Days)||0
8732583|NCT01072149|9780039|FG001|NOT COMPLETED|Treatment Period 3 (28 Days)||0
8732584|NCT01072149|9780040|FG002|NOT COMPLETED|Treatment Period 3 (28 Days)||1
8732585|NCT01072149|9780041|FG003|NOT COMPLETED|Treatment Period 3 (28 Days)||0
8732586|NCT01072149|9780042|FG004|NOT COMPLETED|Treatment Period 3 (28 Days)||0
8732587|NCT01072149|9780043|FG005|NOT COMPLETED|Treatment Period 3 (28 Days)||0
8732588|NCT01072149|9780044|FG006|NOT COMPLETED|Treatment Period 3 (28 Days)||0
8732589|NCT01072149|9780045|FG007|NOT COMPLETED|Treatment Period 3 (28 Days)||0
8732590|NCT01072149|9780046|FG008|NOT COMPLETED|Treatment Period 3 (28 Days)||0
8732591|NCT01072149|9780047|FG009|NOT COMPLETED|Treatment Period 3 (28 Days)||0
8732592|NCT01072149|9780048|FG010|NOT COMPLETED|Treatment Period 3 (28 Days)||0
8732593|NCT01072149|9780049|FG011|NOT COMPLETED|Treatment Period 3 (28 Days)||0
8732594|NCT01072149|9780050|FG012|NOT COMPLETED|Treatment Period 3 (28 Days)||0
8732595|NCT01072149|9780051|FG013|NOT COMPLETED|Treatment Period 3 (28 Days)||1
8732596|NCT01072149|9780052|FG014|NOT COMPLETED|Treatment Period 3 (28 Days)||0
8732597|NCT01072149|9780053|FG015|NOT COMPLETED|Treatment Period 3 (28 Days)||0
8732598|NCT01072149|9780054|FG016|NOT COMPLETED|Treatment Period 3 (28 Days)||0
8732599|NCT01072149|9780055|FG017|NOT COMPLETED|Treatment Period 3 (28 Days)||0
8732600|NCT01072188|9780067|FG000|STARTED|Overall Study||22
8732601|NCT01072188|9780068|FG001|STARTED|Overall Study||23
8732602|NCT01072188|9780067|FG000|COMPLETED|Overall Study||22
8732603|NCT01072188|9780068|FG001|COMPLETED|Overall Study||23
8732604|NCT01072188|9780067|FG000|NOT COMPLETED|Overall Study||0
8732605|NCT01072188|9780068|FG001|NOT COMPLETED|Overall Study||0
8732606|NCT01072201|9780076|FG000|STARTED|Overall Study||30
8732607|NCT01072201|9780077|FG001|STARTED|Overall Study||30
8732608|NCT01072201|9780076|FG000|COMPLETED|Overall Study||30
8732609|NCT01072201|9780077|FG001|COMPLETED|Overall Study||29
8732610|NCT01072201|9780076|FG000|NOT COMPLETED|Overall Study||0
8732611|NCT01072201|9780077|FG001|NOT COMPLETED|Overall Study||1
8732612|NCT01072331|9780086|FG000|STARTED|Overall Study||34
8732613|NCT01072331|9780087|FG001|STARTED|Overall Study||33
8732614|NCT01072331|9780088|FG002|STARTED|Overall Study||32
8732615|NCT01072331|9780086|FG000|COMPLETED|Overall Study||34
8732616|NCT01072331|9780087|FG001|COMPLETED|Overall Study||33
8732617|NCT01072331|9780088|FG002|COMPLETED|Overall Study||32
8732618|NCT01072331|9780086|FG000|NOT COMPLETED|Overall Study||0
8732619|NCT01072331|9780087|FG001|NOT COMPLETED|Overall Study||0
8732620|NCT01072331|9780088|FG002|NOT COMPLETED|Overall Study||0
8732621|NCT01072344|9780098|FG000|STARTED|Overall Study||46
8732622|NCT01072344|9780099|FG001|STARTED|Overall Study||47
8732623|NCT01072344|9780098|FG000|COMPLETED|Overall Study||35
8732624|NCT01072344|9780099|FG001|COMPLETED|Overall Study||29
8732625|NCT01072344|9780098|FG000|NOT COMPLETED|Overall Study||11
8732626|NCT01072344|9780099|FG001|NOT COMPLETED|Overall Study||18
8732627|NCT01072357|9780107|FG000|STARTED|Overall Study||15
8732628|NCT01072357|9780108|FG001|STARTED|Overall Study||15
8732629|NCT01072357|9780107|FG000|COMPLETED|Overall Study||15
8668986|NCT00739336|9712507|FG001|NOT COMPLETED|Overall Study||0
8668987|NCT00739583|9712515|FG000|STARTED|Overall Study||10
8668988|NCT00739583|9712516|FG001|STARTED|Overall Study||10
8732630|NCT01072357|9780108|FG001|COMPLETED|Overall Study||14
8732631|NCT01072357|9780107|FG000|NOT COMPLETED|Overall Study||0
8732632|NCT01072357|9780108|FG001|NOT COMPLETED|Overall Study||1
8732633|NCT01072396|9780116|FG000|STARTED|Period One||63
8732634|NCT01072396|9780117|FG001|STARTED|Period One||63
8732635|NCT01072396|9780116|FG000|COMPLETED|Period One||58
8668989|NCT00739583|9712515|FG000|COMPLETED|Overall Study||10
8668990|NCT00739583|9712516|FG001|COMPLETED|Overall Study||10
8668991|NCT00739583|9712515|FG000|NOT COMPLETED|Overall Study||0
8668992|NCT00739583|9712516|FG001|NOT COMPLETED|Overall Study||0
8668993|NCT00739596|9712524|FG000|STARTED|Overall Study||166
8668994|NCT00739596|9712525|FG001|STARTED|Overall Study||166
8668995|NCT00739596|9712524|FG000|COMPLETED|Overall Study||141
8668996|NCT00739596|9712525|FG001|COMPLETED|Overall Study||149
8668997|NCT00739596|9712524|FG000|NOT COMPLETED|Overall Study||25
8668998|NCT00739596|9712525|FG001|NOT COMPLETED|Overall Study||17
8668999|NCT00739648|9712533|FG000|STARTED|Overall Study||108
8669000|NCT00739648|9712534|FG001|STARTED|Overall Study||214
8669001|NCT00739648|9712533|FG000|COMPLETED|Overall Study||82
8669002|NCT00739648|9712534|FG001|COMPLETED|Overall Study||161
8669003|NCT00739648|9712533|FG000|NOT COMPLETED|Overall Study||26
8669004|NCT00739648|9712534|FG001|NOT COMPLETED|Overall Study||53
8669005|NCT00739661|9712546|FG000|STARTED|Overall Study||52
8669006|NCT00739661|9712547|FG001|STARTED|Overall Study||52
8669007|NCT00739661|9712546|FG000|COMPLETED|Overall Study||6
8669008|NCT00739661|9712547|FG001|COMPLETED|Overall Study||10
8669009|NCT00739661|9712546|FG000|NOT COMPLETED|Overall Study||46
8669010|NCT00739661|9712547|FG001|NOT COMPLETED|Overall Study||42
8669011|NCT00739752|9712559|FG000|STARTED|Overall Study||299
8669012|NCT00739752|9712560|FG001|STARTED|Overall Study||284
8669013|NCT00739752|9712561|FG002|STARTED|Overall Study||292
8669014|NCT00739752|9712562|FG003|STARTED|Overall Study||288
8669015|NCT00739752|9712563|FG004|STARTED|Overall Study||291
8669016|NCT00739752|9712564|FG005|STARTED|Overall Study||293
8669017|NCT00739752|9712559|FG000|COMPLETED|Overall Study||299
8669018|NCT00739752|9712560|FG001|COMPLETED|Overall Study||284
8669019|NCT00739752|9712561|FG002|COMPLETED|Overall Study||292
8669020|NCT00739752|9712562|FG003|COMPLETED|Overall Study||288
8669021|NCT00739752|9712563|FG004|COMPLETED|Overall Study||291
8669022|NCT00739752|9712564|FG005|COMPLETED|Overall Study||293
8669023|NCT00739752|9712559|FG000|NOT COMPLETED|Overall Study||0
8669024|NCT00739752|9712560|FG001|NOT COMPLETED|Overall Study||0
8669025|NCT00739752|9712561|FG002|NOT COMPLETED|Overall Study||0
8669026|NCT00739752|9712562|FG003|NOT COMPLETED|Overall Study||0
8669027|NCT00739752|9712563|FG004|NOT COMPLETED|Overall Study||0
8669028|NCT00739752|9712564|FG005|NOT COMPLETED|Overall Study||0
8669029|NCT00739765|9712581|FG000|STARTED|Overall Study||40
8669030|NCT00739765|9712582|FG001|STARTED|Overall Study||38
8669031|NCT00739765|9712583|FG002|STARTED|Overall Study||32
8669032|NCT00739765|9712581|FG000|COMPLETED|Overall Study||34
8669033|NCT00739765|9712582|FG001|COMPLETED|Overall Study||27
8669034|NCT00739765|9712583|FG002|COMPLETED|Overall Study||21
8732636|NCT01072396|9780117|FG001|COMPLETED|Period One||61
8732637|NCT01072396|9780116|FG000|NOT COMPLETED|Period One||5
8732638|NCT01072396|9780117|FG001|NOT COMPLETED|Period One||2
8732639|NCT01072396|9780116|FG000|STARTED|Washout Period||58
8732640|NCT01072396|9780117|FG001|STARTED|Washout Period||61
8732641|NCT01072396|9780116|FG000|COMPLETED|Washout Period||58
8732642|NCT01072396|9780117|FG001|COMPLETED|Washout Period||60
8732643|NCT01072396|9780116|FG000|NOT COMPLETED|Washout Period||0
8732644|NCT01072396|9780117|FG001|NOT COMPLETED|Washout Period||1
8732645|NCT01072396|9780116|FG000|STARTED|Period Two||58
8732646|NCT01072396|9780117|FG001|STARTED|Period Two||60
8732647|NCT01072396|9780116|FG000|COMPLETED|Period Two||57
8732648|NCT01072396|9780117|FG001|COMPLETED|Period Two||57
8732649|NCT01072396|9780116|FG000|NOT COMPLETED|Period Two||1
8732650|NCT01072396|9780117|FG001|NOT COMPLETED|Period Two||3
8732651|NCT01072409|9780123|FG000|STARTED|Overall Study||45
8732652|NCT01072409|9780123|FG000|COMPLETED|Overall Study||38
8732653|NCT01072409|9780123|FG000|NOT COMPLETED|Overall Study||7
8732654|NCT01072448|9780129|FG000|STARTED|Overall Study||163
8732655|NCT01072448|9780130|FG001|STARTED|Overall Study||160
8732656|NCT01072448|9780129|FG000|COMPLETED|Overall Study||144
8732657|NCT01072448|9780130|FG001|COMPLETED|Overall Study||130
8732658|NCT01072448|9780129|FG000|NOT COMPLETED|Overall Study||19
8732659|NCT01072448|9780130|FG001|NOT COMPLETED|Overall Study||30
8732660|NCT01072500|9780138|FG000|STARTED|Overall Study||818
8732661|NCT01072500|9780139|FG001|STARTED|Overall Study||817
8732662|NCT01072500|9780138|FG000|COMPLETED|Overall Study||794
8732663|NCT01072500|9780139|FG001|COMPLETED|Overall Study||803
8732664|NCT01072500|9780138|FG000|NOT COMPLETED|Overall Study||24
8732665|NCT01072500|9780139|FG001|NOT COMPLETED|Overall Study||14
8732666|NCT01072539|9780147|FG000|STARTED|Overall Study||3172
8732667|NCT01072539|9780147|FG000|COMPLETED|Overall Study|Refer to the Safety Analysis Set. Data for completion were not collected.|3169
8669035|NCT00739765|9712581|FG000|NOT COMPLETED|Overall Study||6
8669036|NCT00739765|9712582|FG001|NOT COMPLETED|Overall Study||11
8669037|NCT00739765|9712583|FG002|NOT COMPLETED|Overall Study||11
8732668|NCT01072539|9780147|FG000|NOT COMPLETED|Overall Study||3
8669038|NCT00739908|9712593|FG000|STARTED|Overall Study||142
8669039|NCT00739908|9712594|FG001|STARTED|Overall Study||143
8669040|NCT00739908|9712593|FG000|COMPLETED|Overall Study||117
8669041|NCT00739908|9712594|FG001|COMPLETED|Overall Study||118
8669042|NCT00739908|9712593|FG000|NOT COMPLETED|Overall Study||25
8669043|NCT00739908|9712594|FG001|NOT COMPLETED|Overall Study||25
8669044|NCT00739934|9712602|FG000|STARTED|Voriconazole IV||40
8669045|NCT00739934|9712602|FG000|COMPLETED|Voriconazole IV||34
8669046|NCT00739934|9712602|FG000|NOT COMPLETED|Voriconazole IV||6
8669047|NCT00739934|9712602|FG000|STARTED|Voriconazole Oral||34
8669048|NCT00739934|9712602|FG000|COMPLETED|Voriconazole Oral||31
8669049|NCT00739934|9712602|FG000|NOT COMPLETED|Voriconazole Oral||3
8669050|NCT00739960|9712611|FG000|STARTED|Overall Study||1
8669051|NCT00739960|9712611|FG000|COMPLETED|Overall Study||1
8669052|NCT00739960|9712611|FG000|NOT COMPLETED|Overall Study||0
8669053|NCT00739973|9712624|FG000|STARTED|Single-blind Period (2 to 4 Weeks)|In this period, participants were enrolled to only Placebo arm.|2694
8669054|NCT00739973|9712625|FG001|STARTED|Single-blind Period (2 to 4 Weeks)||0
8669055|NCT00739973|9712626|FG002|STARTED|Single-blind Period (2 to 4 Weeks)||0
8669056|NCT00739973|9712627|FG003|STARTED|Single-blind Period (2 to 4 Weeks)||0
8669057|NCT00739973|9712628|FG004|STARTED|Single-blind Period (2 to 4 Weeks)||0
8669058|NCT00739973|9712629|FG005|STARTED|Single-blind Period (2 to 4 Weeks)||0
8669059|NCT00739973|9712630|FG006|STARTED|Single-blind Period (2 to 4 Weeks)||0
8669060|NCT00739973|9712631|FG007|STARTED|Single-blind Period (2 to 4 Weeks)||0
8669061|NCT00739973|9712632|FG008|STARTED|Single-blind Period (2 to 4 Weeks)||0
8669062|NCT00739973|9712624|FG000|COMPLETED|Single-blind Period (2 to 4 Weeks)||1685
8669063|NCT00739973|9712625|FG001|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
8669064|NCT00739973|9712626|FG002|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
8669065|NCT00739973|9712627|FG003|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
8669066|NCT00739973|9712628|FG004|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
8669067|NCT00739973|9712629|FG005|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
8669068|NCT00739973|9712630|FG006|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
8669069|NCT00739973|9712631|FG007|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
8669070|NCT00739973|9712632|FG008|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
8669071|NCT00739973|9712624|FG000|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||1009
8669072|NCT00739973|9712625|FG001|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
8669073|NCT00739973|9712626|FG002|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
8669074|NCT00739973|9712627|FG003|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
8669075|NCT00739973|9712628|FG004|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
8669076|NCT00739973|9712629|FG005|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
8669077|NCT00739973|9712630|FG006|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
8669078|NCT00739973|9712631|FG007|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
8669079|NCT00739973|9712632|FG008|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
8669080|NCT00739973|9712624|FG000|STARTED|Double-blind:Randomized Period (8 Weeks)||198
8669081|NCT00739973|9712625|FG001|STARTED|Double-blind:Randomized Period (8 Weeks)|One pt. was mis-randomized, so discontinued from single-blind and was untreated in the double-blind.|195
8669082|NCT00739973|9712626|FG002|STARTED|Double-blind:Randomized Period (8 Weeks)||203
8669083|NCT00739973|9712627|FG003|STARTED|Double-blind:Randomized Period (8 Weeks)||185
8669084|NCT00739973|9712628|FG004|STARTED|Double-blind:Randomized Period (8 Weeks)||181
8669085|NCT00739973|9712629|FG005|STARTED|Double-blind:Randomized Period (8 Weeks)||181
8669086|NCT00739973|9712630|FG006|STARTED|Double-blind:Randomized Period (8 Weeks)|2 pts. were mis-randomized, so discontinued from single-blind and were untreated in double-blind.|183
8669087|NCT00739973|9712631|FG007|STARTED|Double-blind:Randomized Period (8 Weeks)||178
8669088|NCT00739973|9712632|FG008|STARTED|Double-blind:Randomized Period (8 Weeks)||184
8669089|NCT00739973|9712624|FG000|COMPLETED|Double-blind:Randomized Period (8 Weeks)||168
8669090|NCT00739973|9712625|FG001|COMPLETED|Double-blind:Randomized Period (8 Weeks)||175
8669091|NCT00739973|9712626|FG002|COMPLETED|Double-blind:Randomized Period (8 Weeks)||184
8669092|NCT00739973|9712627|FG003|COMPLETED|Double-blind:Randomized Period (8 Weeks)||173
8669093|NCT00739973|9712628|FG004|COMPLETED|Double-blind:Randomized Period (8 Weeks)||162
8669094|NCT00739973|9712629|FG005|COMPLETED|Double-blind:Randomized Period (8 Weeks)||169
8669095|NCT00739973|9712630|FG006|COMPLETED|Double-blind:Randomized Period (8 Weeks)||170
8669096|NCT00739973|9712631|FG007|COMPLETED|Double-blind:Randomized Period (8 Weeks)||168
8669097|NCT00739973|9712632|FG008|COMPLETED|Double-blind:Randomized Period (8 Weeks)||170
8669098|NCT00739973|9712624|FG000|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||30
8669099|NCT00739973|9712625|FG001|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||20
8669100|NCT00739973|9712626|FG002|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||19
8669101|NCT00739973|9712627|FG003|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||12
8669102|NCT00739973|9712628|FG004|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||19
8669103|NCT00739973|9712629|FG005|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||12
8669104|NCT00739973|9712630|FG006|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||13
8669105|NCT00739973|9712631|FG007|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||10
8669106|NCT00739973|9712632|FG008|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||14
8669107|NCT00739999|9712662|FG000|STARTED|Overall Study||15
8669108|NCT00739999|9712663|FG001|STARTED|Overall Study||24
8669109|NCT00739999|9712662|FG000|COMPLETED|Overall Study||15
8669110|NCT00739999|9712663|FG001|COMPLETED|Overall Study||24
8669111|NCT00739999|9712662|FG000|NOT COMPLETED|Overall Study||0
8669112|NCT00739999|9712663|FG001|NOT COMPLETED|Overall Study||0
8669113|NCT00740051|9712676|FG000|STARTED|Overall Study||76
8669114|NCT00740051|9712677|FG001|STARTED|Overall Study||151
8669115|NCT00740051|9712676|FG000|COMPLETED|Overall Study||58
8669116|NCT00740051|9712677|FG001|COMPLETED|Overall Study||119
8669117|NCT00740051|9712676|FG000|NOT COMPLETED|Overall Study||18
8669118|NCT00740051|9712677|FG001|NOT COMPLETED|Overall Study||32
8669119|NCT00740129|9712684|FG000|STARTED|Overall Study||6
8669120|NCT00740129|9712684|FG000|COMPLETED|Overall Study||6
8669121|NCT00740129|9712684|FG000|NOT COMPLETED|Overall Study||0
8669122|NCT00740207|9712691|FG000|STARTED|Overall Study||17
8669123|NCT00740207|9712692|FG001|STARTED|Overall Study||16
8669124|NCT00740207|9712691|FG000|COMPLETED|Overall Study||17
8669125|NCT00740207|9712692|FG001|COMPLETED|Overall Study||16
8669126|NCT00740207|9712691|FG000|NOT COMPLETED|Overall Study||0
8669127|NCT00740207|9712692|FG001|NOT COMPLETED|Overall Study||0
8669128|NCT00740220|9712702|FG000|STARTED|Overall Study||97
8669129|NCT00740220|9712702|FG000|COMPLETED|Overall Study||88
8669130|NCT00740220|9712702|FG000|NOT COMPLETED|Overall Study||9
8669131|NCT00740376|9712708|FG000|STARTED|Overall Study||22
8669132|NCT00740376|9712709|FG001|STARTED|Overall Study||15
8669133|NCT00740376|9712708|FG000|COMPLETED|Overall Study||19
8669134|NCT00740376|9712709|FG001|COMPLETED|Overall Study||12
8669135|NCT00740376|9712708|FG000|NOT COMPLETED|Overall Study||3
8669136|NCT00740376|9712709|FG001|NOT COMPLETED|Overall Study||3
8669137|NCT00740584|9712715|FG000|STARTED|Overall Study||12
8669138|NCT00740584|9712715|FG000|COMPLETED|Overall Study||11
8669139|NCT00740584|9712715|FG000|NOT COMPLETED|Overall Study||1
8669140|NCT00740636|9712722|FG000|STARTED|Overall Study||25
8669141|NCT00740636|9712723|FG001|STARTED|Overall Study||67
8732669|NCT01072617|9780151|FG000|STARTED|Overall Study||8
8732670|NCT01072617|9780151|FG000|COMPLETED|Overall Study||8
8732671|NCT01072617|9780151|FG000|NOT COMPLETED|Overall Study||0
8732672|NCT01072630|9780159|FG000|STARTED|Overall Study||230
8732673|NCT01072630|9780160|FG001|STARTED|Overall Study||232
8732674|NCT01072630|9780161|FG002|STARTED|Overall Study||30
8669142|NCT00740636|9712722|FG000|COMPLETED|Overall Study||23
8669143|NCT00740636|9712723|FG001|COMPLETED|Overall Study||63
8669144|NCT00740636|9712722|FG000|NOT COMPLETED|Overall Study||2
8669145|NCT00740636|9712723|FG001|NOT COMPLETED|Overall Study||4
8669146|NCT00740714|9712732|FG000|STARTED|Overall Study|Randomized throughout the recruitment period|196
8669147|NCT00740714|9712733|FG001|STARTED|Overall Study|Randomized throughout the recruitment period|201
8669148|NCT00740714|9712734|FG002|STARTED|Overall Study|Randomized throughout the recruitment period|203
8669149|NCT00740714|9712732|FG000|Reaching Endpoint Before May 6, 2011|Overall Study||86
8669150|NCT00740714|9712733|FG001|Reaching Endpoint Before May 6, 2011|Overall Study||87
8669151|NCT00740714|9712734|FG002|Reaching Endpoint Before May 6, 2011|Overall Study||94
8669152|NCT00740714|9712732|FG000|Active Patients at Study Termination|Overall Study||24
8669153|NCT00740714|9712733|FG001|Active Patients at Study Termination|Overall Study||12
8669154|NCT00740714|9712734|FG002|Active Patients at Study Termination|Overall Study||33
8669155|NCT00740714|9712732|FG000|COMPLETED|Overall Study||179
8669156|NCT00740714|9712733|FG001|COMPLETED|Overall Study||182
8669157|NCT00740714|9712734|FG002|COMPLETED|Overall Study||174
8669158|NCT00740714|9712732|FG000|NOT COMPLETED|Overall Study||17
8669159|NCT00740714|9712733|FG001|NOT COMPLETED|Overall Study||19
8669160|NCT00740714|9712734|FG002|NOT COMPLETED|Overall Study||29
8669161|NCT00740779|9712745|FG000|STARTED|Overall Study||52
8669162|NCT00740779|9712746|FG001|STARTED|Overall Study||45
8669163|NCT00740779|9712747|FG002|STARTED|Overall Study||54
8669164|NCT00740779|9712745|FG000|COMPLETED|Overall Study||43
8669165|NCT00740779|9712746|FG001|COMPLETED|Overall Study||31
8669166|NCT00740779|9712747|FG002|COMPLETED|Overall Study||41
8669167|NCT00740779|9712745|FG000|NOT COMPLETED|Overall Study||9
8669168|NCT00740779|9712746|FG001|NOT COMPLETED|Overall Study||14
8732675|NCT01072630|9780159|FG000|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|229
8732676|NCT01072630|9780160|FG001|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|231
8732677|NCT01072630|9780161|FG002|Safety Population|Overall Study|Treated participants.|30
8732678|NCT01072630|9780159|FG000|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|224
8732679|NCT01072630|9780160|FG001|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|230
8732680|NCT01072630|9780161|FG002|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|28
8732681|NCT01072630|9780159|FG000|COMPLETED|Overall Study||175
8732682|NCT01072630|9780160|FG001|COMPLETED|Overall Study||172
8669169|NCT00740779|9712747|FG002|NOT COMPLETED|Overall Study||13
8669170|NCT00740792|9712759|FG000|STARTED|Overall Study||193
8669171|NCT00740792|9712760|FG001|STARTED|Overall Study||194
8669172|NCT00740792|9712761|FG002|STARTED|Overall Study||189
8669173|NCT00740792|9712762|FG003|STARTED|Overall Study||200
8669174|NCT00740792|9712759|FG000|COMPLETED|Overall Study||183
8669175|NCT00740792|9712760|FG001|COMPLETED|Overall Study||186
8732683|NCT01072630|9780161|FG002|COMPLETED|Overall Study||17
8732684|NCT01072630|9780159|FG000|NOT COMPLETED|Overall Study||55
8732685|NCT01072630|9780160|FG001|NOT COMPLETED|Overall Study||60
8732686|NCT01072630|9780161|FG002|NOT COMPLETED|Overall Study||13
8732687|NCT01072643|9780170|FG000|STARTED|Overall Study||4
8669176|NCT00740792|9712761|FG002|COMPLETED|Overall Study||180
8669177|NCT00740792|9712762|FG003|COMPLETED|Overall Study||190
8669178|NCT00740792|9712759|FG000|NOT COMPLETED|Overall Study||10
8669179|NCT00740792|9712760|FG001|NOT COMPLETED|Overall Study||8
8669180|NCT00740792|9712761|FG002|NOT COMPLETED|Overall Study||9
8669181|NCT00740792|9712762|FG003|NOT COMPLETED|Overall Study||10
8669182|NCT00740831|9712775|FG000|STARTED|Overall Study|Safety population|97
8669183|NCT00740831|9712776|FG001|STARTED|Overall Study|Safety population|103
8669184|NCT00740831|9712777|FG002|STARTED|Overall Study|Safety population|101
8669185|NCT00740831|9712775|FG000|COMPLETED|Overall Study|Patients who completed part A (visit 6)|93
8669186|NCT00740831|9712776|FG001|COMPLETED|Overall Study|Patients who completed part A (visit 6)|100
8669187|NCT00740831|9712777|FG002|COMPLETED|Overall Study|Patients who completed part A (visit 6)|95
8669188|NCT00740831|9712775|FG000|NOT COMPLETED|Overall Study||4
8669189|NCT00740831|9712776|FG001|NOT COMPLETED|Overall Study||3
8669190|NCT00740831|9712777|FG002|NOT COMPLETED|Overall Study||6
8669191|NCT00740857|9712788|FG000|STARTED|Overall Study||33
8669192|NCT00740857|9712789|FG001|STARTED|Overall Study||88
8669193|NCT00740857|9712790|FG002|STARTED|Overall Study||90
8669194|NCT00740857|9712788|FG000|COMPLETED|Overall Study||32
8669195|NCT00740857|9712789|FG001|COMPLETED|Overall Study||88
8669196|NCT00740857|9712790|FG002|COMPLETED|Overall Study||90
8669197|NCT00740857|9712788|FG000|NOT COMPLETED|Overall Study||1
8669198|NCT00740857|9712789|FG001|NOT COMPLETED|Overall Study||0
8669199|NCT00740857|9712790|FG002|NOT COMPLETED|Overall Study||0
8669200|NCT00740870|9712798|FG000|STARTED|Overall Study||171
8669201|NCT00740870|9712798|FG000|COMPLETED|Overall Study||150
8669202|NCT00740870|9712798|FG000|NOT COMPLETED|Overall Study||21
8669203|NCT00741013|9712808|FG000|STARTED|Overall Study||7
8669204|NCT00741013|9712809|FG001|STARTED|Overall Study||8
8669205|NCT00741013|9712810|FG002|STARTED|Overall Study||7
8669206|NCT00741013|9712808|FG000|COMPLETED|Overall Study||6
8669207|NCT00741013|9712809|FG001|COMPLETED|Overall Study||6
8669208|NCT00741013|9712810|FG002|COMPLETED|Overall Study||6
8669209|NCT00741013|9712808|FG000|NOT COMPLETED|Overall Study||1
8669210|NCT00741013|9712809|FG001|NOT COMPLETED|Overall Study||2
8669211|NCT00741013|9712810|FG002|NOT COMPLETED|Overall Study||1
8669212|NCT00741026|9712818|FG000|STARTED|Overall Study||15
8669213|NCT00741026|9712818|FG000|COMPLETED|Overall Study||15
8669214|NCT00741026|9712818|FG000|NOT COMPLETED|Overall Study||0
8669215|NCT00741039|9712826|FG000|STARTED|Overall Study||102
8669216|NCT00741039|9712827|FG001|STARTED|Overall Study||25
8669217|NCT00741039|9712826|FG000|COMPLETED|Overall Study||100
8669218|NCT00741039|9712827|FG001|COMPLETED|Overall Study||25
8669219|NCT00741039|9712826|FG000|NOT COMPLETED|Overall Study||2
8669220|NCT00741039|9712827|FG001|NOT COMPLETED|Overall Study||0
8692603|NCT00862446|9738147|FG000|NOT COMPLETED|Overall Study||0
8692604|NCT00862459|9738154|FG000|STARTED|Overall Study||72
8692605|NCT00862459|9738155|FG001|STARTED|Overall Study||93
8692606|NCT00862459|9738156|FG002|STARTED|Overall Study||72
8692607|NCT00862459|9738154|FG000|Participants Received Treatment|Overall Study|Number reflects all treated participants of whom 67 received Gadobutrol and 70 received OptiMARK|70
8692608|NCT00862459|9738155|FG001|Participants Received Treatment|Overall Study|Number reflects all treated participants of whom 90 received Gadobutrol and 88 received OptiMARK|90
8692609|NCT00862459|9738156|FG002|Participants Received Treatment|Overall Study|Number reflects all treated participants of whom 68 received Gadobutrol and 69 received OptiMARK|69
8692610|NCT00862459|9738154|FG000|COMPLETED|Overall Study||66
8692611|NCT00862459|9738155|FG001|COMPLETED|Overall Study||85
8692612|NCT00862459|9738156|FG002|COMPLETED|Overall Study||66
8692613|NCT00862459|9738154|FG000|NOT COMPLETED|Overall Study||6
8692614|NCT00862459|9738155|FG001|NOT COMPLETED|Overall Study||8
8692615|NCT00862459|9738156|FG002|NOT COMPLETED|Overall Study||6
8692616|NCT00862537|9738165|FG000|STARTED|Overall Study||18
8692617|NCT00862537|9738165|FG000|COMPLETED|Overall Study||11
8692618|NCT00862537|9738165|FG000|NOT COMPLETED|Overall Study||7
8692619|NCT00862563|9738173|FG000|STARTED|Overall Study||19
8692620|NCT00862563|9738174|FG001|STARTED|Overall Study||21
8692621|NCT00862563|9738175|FG002|STARTED|Overall Study||21
8692622|NCT00862563|9738176|FG003|STARTED|Overall Study||24
8692623|NCT00862563|9738173|FG000|COMPLETED|Overall Study||15
8692624|NCT00862563|9738174|FG001|COMPLETED|Overall Study||17
8692625|NCT00862563|9738175|FG002|COMPLETED|Overall Study||15
8692626|NCT00862563|9738176|FG003|COMPLETED|Overall Study||19
8692627|NCT00862563|9738173|FG000|NOT COMPLETED|Overall Study||4
8692628|NCT00862563|9738174|FG001|NOT COMPLETED|Overall Study||4
8692629|NCT00862563|9738175|FG002|NOT COMPLETED|Overall Study||6
8692630|NCT00862563|9738176|FG003|NOT COMPLETED|Overall Study||5
8692631|NCT00862641|9738199|FG000|STARTED|Overall Study||177
8692632|NCT00862641|9738200|FG001|STARTED|Overall Study||360
8692633|NCT00862641|9738201|FG002|STARTED|Overall Study||152
8692634|NCT00862641|9738202|FG003|STARTED|Overall Study||320
8693757|NCT00868348|9739289|FG000|NOT COMPLETED|Overall Study||0
8693758|NCT00868348|9739290|FG001|NOT COMPLETED|Overall Study||0
8693759|NCT00868374|9739298|FG000|STARTED|Overall Study||12
8693760|NCT00868374|9739299|FG001|STARTED|Overall Study||11
8693761|NCT00868374|9739298|FG000|COMPLETED|Overall Study||5
8693762|NCT00868374|9739299|FG001|COMPLETED|Overall Study||4
8693763|NCT00868374|9739298|FG000|NOT COMPLETED|Overall Study||7
8693764|NCT00868374|9739299|FG001|NOT COMPLETED|Overall Study||7
8693765|NCT00868439|9739307|FG000|STARTED|Overall Study||56
8693766|NCT00868439|9739308|FG001|STARTED|Overall Study||49
8693767|NCT00868439|9739307|FG000|COMPLETED|Overall Study||48
8693768|NCT00868439|9739308|FG001|COMPLETED|Overall Study||40
8669221|NCT00741091|9712833|FG000|STARTED|Overall Study||1097
8669222|NCT00741091|9712833|FG000|COMPLETED|Overall Study||1040
8669223|NCT00741091|9712833|FG000|NOT COMPLETED|Overall Study||57
8669224|NCT00741104|9712837|FG000|STARTED|Overall Study||363
8669225|NCT00741104|9712837|FG000|COMPLETED|Overall Study||363
8669226|NCT00741104|9712837|FG000|NOT COMPLETED|Overall Study||0
8669227|NCT00741156|9712841|FG000|STARTED|Overall Study||12
8669228|NCT00741156|9712841|FG000|COMPLETED|Overall Study||12
8669229|NCT00741156|9712841|FG000|NOT COMPLETED|Overall Study||0
8669230|NCT00741260|9712863|FG000|STARTED|Overall Study||6
8669231|NCT00741260|9712864|FG001|STARTED|Overall Study||8
8669232|NCT00741260|9712865|FG002|STARTED|Overall Study||4
8669233|NCT00741260|9712866|FG003|STARTED|Overall Study||6
8669234|NCT00741260|9712867|FG004|STARTED|Overall Study||9
8669235|NCT00741260|9712868|FG005|STARTED|Overall Study||65
8669236|NCT00741260|9712869|FG006|STARTED|Overall Study||7
8669237|NCT00741260|9712863|FG000|COMPLETED|Overall Study||0
8669238|NCT00741260|9712864|FG001|COMPLETED|Overall Study||0
8669239|NCT00741260|9712865|FG002|COMPLETED|Overall Study||0
8669240|NCT00741260|9712866|FG003|COMPLETED|Overall Study||0
8669241|NCT00741260|9712867|FG004|COMPLETED|Overall Study||0
8669242|NCT00741260|9712868|FG005|COMPLETED|Overall Study||20
8669243|NCT00741260|9712869|FG006|COMPLETED|Overall Study||0
8669244|NCT00741260|9712863|FG000|NOT COMPLETED|Overall Study||6
8669245|NCT00741260|9712864|FG001|NOT COMPLETED|Overall Study||8
8669246|NCT00741260|9712865|FG002|NOT COMPLETED|Overall Study||4
8669247|NCT00741260|9712866|FG003|NOT COMPLETED|Overall Study||6
8669248|NCT00741260|9712867|FG004|NOT COMPLETED|Overall Study||9
8669249|NCT00741260|9712868|FG005|NOT COMPLETED|Overall Study||45
8669250|NCT00741260|9712869|FG006|NOT COMPLETED|Overall Study||7
8669251|NCT00741273|9712892|FG000|STARTED|Overall Study||8
8669252|NCT00741273|9712893|FG001|STARTED|Overall Study||8
8669253|NCT00741273|9712892|FG000|COMPLETED|Overall Study||8
8669254|NCT00741273|9712893|FG001|COMPLETED|Overall Study||8
8669255|NCT00741273|9712892|FG000|NOT COMPLETED|Overall Study||0
8669256|NCT00741273|9712893|FG001|NOT COMPLETED|Overall Study||0
8669257|NCT00741286|9712905|FG000|STARTED|Overall Study||103
8669258|NCT00741286|9712906|FG001|STARTED|Overall Study||100
8669259|NCT00741286|9712905|FG000|COMPLETED|Overall Study||83
8669260|NCT00741286|9712906|FG001|COMPLETED|Overall Study||81
8669261|NCT00741286|9712905|FG000|NOT COMPLETED|Overall Study||20
8669262|NCT00741286|9712906|FG001|NOT COMPLETED|Overall Study||19
8669263|NCT00741338|9712914|FG000|STARTED|Overall Study||3
8669264|NCT00741338|9712915|FG001|STARTED|Overall Study||3
8669265|NCT00741338|9712914|FG000|COMPLETED|Overall Study||3
8669266|NCT00741338|9712915|FG001|COMPLETED|Overall Study||2
8669267|NCT00741338|9712914|FG000|NOT COMPLETED|Overall Study||0
8669268|NCT00741338|9712915|FG001|NOT COMPLETED|Overall Study||1
8669269|NCT00741390|9712921|FG000|STARTED|Visit 1||62
8669270|NCT00741390|9712922|FG001|STARTED|Visit 1||63
8669271|NCT00741390|9712923|FG002|STARTED|Visit 1||62
8669272|NCT00741390|9712924|FG003|STARTED|Visit 1||63
8669273|NCT00741390|9712921|FG000|COMPLETED|Visit 1||60
8669274|NCT00741390|9712922|FG001|COMPLETED|Visit 1||63
8669275|NCT00741390|9712923|FG002|COMPLETED|Visit 1||55
8669276|NCT00741390|9712924|FG003|COMPLETED|Visit 1||62
8669277|NCT00741390|9712921|FG000|NOT COMPLETED|Visit 1||2
8669278|NCT00741390|9712922|FG001|NOT COMPLETED|Visit 1||0
8669279|NCT00741390|9712923|FG002|NOT COMPLETED|Visit 1||7
8669280|NCT00741390|9712924|FG003|NOT COMPLETED|Visit 1||1
8669281|NCT00741390|9712921|FG000|STARTED|Visit 2|1 subject lost to follow-up between Visit 1 and Visit 2.|59
8669282|NCT00741390|9712922|FG001|STARTED|Visit 2|2 subjects lost to follow-up between Visit 1 and Visit 2.|61
8669283|NCT00741390|9712923|FG002|STARTED|Visit 2||55
8669284|NCT00741390|9712924|FG003|STARTED|Visit 2|1 subject lost to follow-up between Visit 1 and Visit 2.|61
8669285|NCT00741390|9712921|FG000|COMPLETED|Visit 2||59
8669286|NCT00741390|9712922|FG001|COMPLETED|Visit 2||61
8669287|NCT00741390|9712923|FG002|COMPLETED|Visit 2||54
8669288|NCT00741390|9712924|FG003|COMPLETED|Visit 2||60
8669289|NCT00741390|9712921|FG000|NOT COMPLETED|Visit 2||0
8669290|NCT00741390|9712922|FG001|NOT COMPLETED|Visit 2||0
8669291|NCT00741390|9712923|FG002|NOT COMPLETED|Visit 2||1
8669292|NCT00741390|9712924|FG003|NOT COMPLETED|Visit 2||1
8669293|NCT00741455|9712943|FG000|STARTED|Overall Study||18
8669294|NCT00741455|9712943|FG000|COMPLETED|Overall Study||17
8669295|NCT00741455|9712943|FG000|NOT COMPLETED|Overall Study||1
8669296|NCT00741468|9712947|FG000|STARTED|Overall Study||18
8669297|NCT00741468|9712947|FG000|COMPLETED|Overall Study||18
8669298|NCT00741468|9712947|FG000|NOT COMPLETED|Overall Study||0
8669299|NCT00741598|9712957|FG000|STARTED|Overall Study||33
8669300|NCT00741598|9712958|FG001|STARTED|Overall Study||39
8669301|NCT00741598|9712957|FG000|COMPLETED|Overall Study||24
8669302|NCT00741598|9712958|FG001|COMPLETED|Overall Study||30
8669303|NCT00741598|9712957|FG000|NOT COMPLETED|Overall Study||9
8669304|NCT00741598|9712958|FG001|NOT COMPLETED|Overall Study||9
8669305|NCT00741611|9712968|FG000|STARTED|Overall Study||4
8669306|NCT00741611|9712969|FG001|STARTED|Overall Study||3
8669307|NCT00741611|9712970|FG002|STARTED|Overall Study||29
8669308|NCT00741611|9712968|FG000|COMPLETED|Overall Study||4
8669309|NCT00741611|9712969|FG001|COMPLETED|Overall Study||1
8669310|NCT00741611|9712970|FG002|COMPLETED|Overall Study||26
8669311|NCT00741611|9712968|FG000|NOT COMPLETED|Overall Study||0
8669312|NCT00741611|9712969|FG001|NOT COMPLETED|Overall Study||2
8669313|NCT00741611|9712970|FG002|NOT COMPLETED|Overall Study||3
8669314|NCT00741819|9712979|FG000|STARTED|Overall Study||73
8669315|NCT00741819|9712979|FG000|COMPLETED|Overall Study||65
8669316|NCT00741819|9712979|FG000|NOT COMPLETED|Overall Study||8
8669317|NCT00741858|9712987|FG000|STARTED|Overall Study||16
8669318|NCT00741858|9712988|FG001|STARTED|Overall Study||18
8669319|NCT00741858|9712987|FG000|COMPLETED|Overall Study||16
8669320|NCT00741858|9712988|FG001|COMPLETED|Overall Study||18
8669321|NCT00741858|9712987|FG000|NOT COMPLETED|Overall Study||0
8669322|NCT00741858|9712988|FG001|NOT COMPLETED|Overall Study||0
8669323|NCT00741936|9712996|FG000|STARTED|Overall Study||60
8669324|NCT00741936|9712997|FG001|STARTED|Overall Study||60
8669325|NCT00741936|9712996|FG000|COMPLETED|Overall Study||51
8669326|NCT00741936|9712997|FG001|COMPLETED|Overall Study||52
8669327|NCT00741936|9712996|FG000|NOT COMPLETED|Overall Study||9
8669328|NCT00741936|9712997|FG001|NOT COMPLETED|Overall Study||8
8669329|NCT00742001|9713006|FG000|STARTED|Overall Study||4
8669330|NCT00742001|9713007|FG001|STARTED|Overall Study||4
8669331|NCT00742001|9713008|FG002|STARTED|Overall Study||4
8669332|NCT00742001|9713006|FG000|COMPLETED|Overall Study||4
8669333|NCT00742001|9713007|FG001|COMPLETED|Overall Study||4
8669334|NCT00742001|9713008|FG002|COMPLETED|Overall Study||3
8669335|NCT00742001|9713006|FG000|NOT COMPLETED|Overall Study||0
8669336|NCT00742001|9713007|FG001|NOT COMPLETED|Overall Study||0
8669337|NCT00742001|9713008|FG002|NOT COMPLETED|Overall Study||1
8669338|NCT00742027|9713019|FG000|STARTED|Overall Study||129
8669339|NCT00742027|9713019|FG000|COMPLETED|Overall Study||0
8669340|NCT00742027|9713019|FG000|NOT COMPLETED|Overall Study||129
8669341|NCT00742053|9713023|FG000|STARTED|Overall Study||7
8669342|NCT00742053|9713023|FG000|COMPLETED|Overall Study||7
8669343|NCT00742053|9713023|FG000|NOT COMPLETED|Overall Study||0
8669344|NCT00742079|9713029|FG000|STARTED|Overall Study||11
8669345|NCT00742079|9713030|FG001|STARTED|Overall Study||10
8669346|NCT00742079|9713029|FG000|Baseline/Week 1 (Received Dose 1)|Overall Study||11
8669347|NCT00742079|9713030|FG001|Baseline/Week 1 (Received Dose 1)|Overall Study||9
8669348|NCT00742079|9713029|FG000|Week 2 (Received Dose 2)|Overall Study||11
8669349|NCT00742079|9713030|FG001|Week 2 (Received Dose 2)|Overall Study||9
8669350|NCT00742079|9713029|FG000|COMPLETED|Overall Study||11
8669351|NCT00742079|9713030|FG001|COMPLETED|Overall Study||9
8669352|NCT00742079|9713029|FG000|NOT COMPLETED|Overall Study||0
8669353|NCT00742079|9713030|FG001|NOT COMPLETED|Overall Study||1
8669354|NCT00742170|9713038|FG000|STARTED|Overall Study||26
8669355|NCT00742170|9713039|FG001|STARTED|Overall Study||29
8669356|NCT00742170|9713038|FG000|COMPLETED|Overall Study||24
8669357|NCT00742170|9713039|FG001|COMPLETED|Overall Study||24
8669358|NCT00742170|9713038|FG000|NOT COMPLETED|Overall Study||2
8669359|NCT00742170|9713039|FG001|NOT COMPLETED|Overall Study||5
8669360|NCT00742183|9713047|FG000|STARTED|Overall Study|50 subjects randomised, one of them did not receive any treatment.|49
8669361|NCT00742183|9713048|FG001|STARTED|Overall Study||51
8669362|NCT00742183|9713047|FG000|COMPLETED|Overall Study||40
8669363|NCT00742183|9713048|FG001|COMPLETED|Overall Study||39
8669364|NCT00742183|9713047|FG000|NOT COMPLETED|Overall Study||9
8669365|NCT00742183|9713048|FG001|NOT COMPLETED|Overall Study||12
8669366|NCT00742209|9713059|FG000|STARTED|Overall Study||129
8669367|NCT00742209|9713060|FG001|STARTED|Overall Study||67
8669368|NCT00742209|9713061|FG002|STARTED|Overall Study||134
8669369|NCT00742209|9713062|FG003|STARTED|Overall Study||134
8669370|NCT00742209|9713063|FG004|STARTED|Overall Study||62
8669371|NCT00742209|9713059|FG000|COMPLETED|Overall Study||95
8669372|NCT00742209|9713060|FG001|COMPLETED|Overall Study||49
8669373|NCT00742209|9713061|FG002|COMPLETED|Overall Study||88
8669374|NCT00742209|9713062|FG003|COMPLETED|Overall Study||97
8669375|NCT00742209|9713063|FG004|COMPLETED|Overall Study||37
8669376|NCT00742209|9713059|FG000|NOT COMPLETED|Overall Study||34
8669377|NCT00742209|9713060|FG001|NOT COMPLETED|Overall Study||18
8669378|NCT00742209|9713061|FG002|NOT COMPLETED|Overall Study||46
8669379|NCT00742209|9713062|FG003|NOT COMPLETED|Overall Study||37
8669380|NCT00742209|9713063|FG004|NOT COMPLETED|Overall Study||25
8669381|NCT00742235|9713078|FG000|STARTED|Overall Study||32
8669382|NCT00742235|9713079|FG001|STARTED|Overall Study||67
8669383|NCT00742235|9713078|FG000|COMPLETED|Overall Study||32
8669384|NCT00742235|9713079|FG001|COMPLETED|Overall Study||36
8669385|NCT00742235|9713078|FG000|NOT COMPLETED|Overall Study||0
8669386|NCT00742235|9713079|FG001|NOT COMPLETED|Overall Study||31
8669387|NCT00742274|9713087|FG000|STARTED|Overall Study||30
8669388|NCT00742274|9713088|FG001|STARTED|Overall Study||31
8669389|NCT00742274|9713087|FG000|COMPLETED|Overall Study||27
8669390|NCT00742274|9713088|FG001|COMPLETED|Overall Study||28
8669391|NCT00742274|9713087|FG000|NOT COMPLETED|Overall Study||3
8669392|NCT00742274|9713088|FG001|NOT COMPLETED|Overall Study||3
8669393|NCT00742313|9713096|FG000|STARTED|Overall Study||25
8669394|NCT00742313|9713097|FG001|STARTED|Overall Study||19
8669395|NCT00742313|9713096|FG000|COMPLETED|Overall Study||24
8669396|NCT00742313|9713097|FG001|COMPLETED|Overall Study||19
8669397|NCT00742313|9713096|FG000|NOT COMPLETED|Overall Study||1
8669398|NCT00742313|9713097|FG001|NOT COMPLETED|Overall Study||0
8669399|NCT00742326|9713105|FG000|STARTED|Overall Study||6
8669400|NCT00742326|9713106|FG001|STARTED|Overall Study||7
8669401|NCT00742326|9713105|FG000|COMPLETED|Overall Study||6
8669402|NCT00742326|9713106|FG001|COMPLETED|Overall Study||6
8669403|NCT00742326|9713105|FG000|NOT COMPLETED|Overall Study||0
8669404|NCT00742326|9713106|FG001|NOT COMPLETED|Overall Study||1
8669405|NCT00742391|9713114|FG000|STARTED|Overall Study||126
8669406|NCT00742391|9713115|FG001|STARTED|Overall Study||129
8669407|NCT00742391|9713114|FG000|COMPLETED|Overall Study||122
8669408|NCT00742391|9713115|FG001|COMPLETED|Overall Study||128
8669409|NCT00742391|9713114|FG000|NOT COMPLETED|Overall Study||4
8669410|NCT00742391|9713115|FG001|NOT COMPLETED|Overall Study||1
8669411|NCT00742417|9713123|FG000|STARTED|Randomized||21
8669412|NCT00742417|9713124|FG001|STARTED|Randomized||21
8669413|NCT00742417|9713123|FG000|COMPLETED|Randomized||19
8669414|NCT00742417|9713124|FG001|COMPLETED|Randomized||20
8669415|NCT00742417|9713123|FG000|NOT COMPLETED|Randomized||2
8669416|NCT00742417|9713124|FG001|NOT COMPLETED|Randomized||1
8669417|NCT00742417|9713123|FG000|STARTED|Intensive Period||19
8669418|NCT00742417|9713124|FG001|STARTED|Intensive Period||20
8669419|NCT00742417|9713123|FG000|COMPLETED|Intensive Period|16 patients completed all the 6 plasma exchange with Albutein 5% during the Intensive Period|16
8669420|NCT00742417|9713124|FG001|COMPLETED|Intensive Period|19 control patients completed all the 6 plasma exchange during the Intensive Period|19
8669421|NCT00742417|9713123|FG000|NOT COMPLETED|Intensive Period||3
8669422|NCT00742417|9713124|FG001|NOT COMPLETED|Intensive Period||1
8669423|NCT00742417|9713123|FG000|STARTED|Maintenance I||16
8669424|NCT00742417|9713124|FG001|STARTED|Maintenance I||19
8669425|NCT00742417|9713123|FG000|COMPLETED|Maintenance I||16
8669426|NCT00742417|9713124|FG001|COMPLETED|Maintenance I||19
8669427|NCT00742417|9713123|FG000|NOT COMPLETED|Maintenance I||0
8669428|NCT00742417|9713124|FG001|NOT COMPLETED|Maintenance I||0
8669429|NCT00742417|9713123|FG000|STARTED|Maintenance II||16
8669430|NCT00742417|9713124|FG001|STARTED|Maintenance II||19
8669431|NCT00742417|9713123|FG000|COMPLETED|Maintenance II||16
8669432|NCT00742417|9713124|FG001|COMPLETED|Maintenance II||19
8669433|NCT00742417|9713123|FG000|NOT COMPLETED|Maintenance II||0
8669434|NCT00742417|9713124|FG001|NOT COMPLETED|Maintenance II||0
8669435|NCT00742469|9713134|FG000|STARTED|Overall Study||106
8669436|NCT00742469|9713135|FG001|STARTED|Overall Study||104
8669437|NCT00742469|9713134|FG000|COMPLETED|Overall Study||88
8669438|NCT00742469|9713135|FG001|COMPLETED|Overall Study||69
8669439|NCT00742469|9713134|FG000|NOT COMPLETED|Overall Study||18
8669440|NCT00742469|9713135|FG001|NOT COMPLETED|Overall Study||35
8669441|NCT00742508|9713143|FG000|STARTED|8-Week Primary Evaluation Period||22
8669442|NCT00742508|9713144|FG001|STARTED|8-Week Primary Evaluation Period||19
8669443|NCT00742508|9713143|FG000|COMPLETED|8-Week Primary Evaluation Period||11
8669444|NCT00742508|9713144|FG001|COMPLETED|8-Week Primary Evaluation Period||8
8669445|NCT00742508|9713143|FG000|NOT COMPLETED|8-Week Primary Evaluation Period||11
8669446|NCT00742508|9713144|FG001|NOT COMPLETED|8-Week Primary Evaluation Period||11
8669447|NCT00742508|9713143|FG000|STARTED|4-Week Exploratory Evaluation Period||0
8669448|NCT00742508|9713144|FG001|STARTED|4-Week Exploratory Evaluation Period||8
8669449|NCT00742508|9713143|FG000|COMPLETED|4-Week Exploratory Evaluation Period||0
8669450|NCT00742508|9713144|FG001|COMPLETED|4-Week Exploratory Evaluation Period||7
8669451|NCT00742508|9713143|FG000|NOT COMPLETED|4-Week Exploratory Evaluation Period||0
8669452|NCT00742508|9713144|FG001|NOT COMPLETED|4-Week Exploratory Evaluation Period||1
8669453|NCT00742560|9713155|FG000|STARTED|Overall Study||3
8669454|NCT00742560|9713156|FG001|STARTED|Overall Study||3
8669455|NCT00742560|9713157|FG002|STARTED|Overall Study||22
8669456|NCT00742560|9713158|FG003|STARTED|Overall Study||36
8669457|NCT00742560|9713159|FG004|STARTED|Overall Study||37
8669458|NCT00742560|9713155|FG000|COMPLETED|Overall Study||0
8669459|NCT00742560|9713156|FG001|COMPLETED|Overall Study||0
8669460|NCT00742560|9713157|FG002|COMPLETED|Overall Study||0
8669461|NCT00742560|9713158|FG003|COMPLETED|Overall Study||0
8669462|NCT00742560|9713159|FG004|COMPLETED|Overall Study||0
8669463|NCT00742560|9713155|FG000|NOT COMPLETED|Overall Study||3
8669464|NCT00742560|9713156|FG001|NOT COMPLETED|Overall Study||3
8669465|NCT00742560|9713157|FG002|NOT COMPLETED|Overall Study||22
8669466|NCT00742560|9713158|FG003|NOT COMPLETED|Overall Study||36
8669467|NCT00742560|9713159|FG004|NOT COMPLETED|Overall Study||37
8669468|NCT00742573|9713192|FG000|STARTED|Overall Study||83
8669469|NCT00742573|9713193|FG001|STARTED|Overall Study||87
8669470|NCT00742573|9713192|FG000|Week 12|Overall Study||46
8669471|NCT00742573|9713193|FG001|Week 12|Overall Study||51
8669472|NCT00742573|9713192|FG000|Week 24|Overall Study||39
8669473|NCT00742573|9713193|FG001|Week 24|Overall Study||37
8669474|NCT00742573|9713192|FG000|Week 52|Overall Study||26
8669475|NCT00742573|9713193|FG001|Week 52|Overall Study||25
8669476|NCT00742573|9713192|FG000|COMPLETED|Overall Study||26
8669477|NCT00742573|9713193|FG001|COMPLETED|Overall Study||25
8669478|NCT00742573|9713192|FG000|NOT COMPLETED|Overall Study||57
8669479|NCT00742573|9713193|FG001|NOT COMPLETED|Overall Study||62
8669480|NCT00742625|9713199|FG000|STARTED|Remission Induction||95
8669481|NCT00742625|9713199|FG000|COMPLETED|Remission Induction||41
8669482|NCT00742625|9713199|FG000|NOT COMPLETED|Remission Induction||54
8669483|NCT00742625|9713199|FG000|STARTED|Consolidation||41
8669484|NCT00742625|9713199|FG000|COMPLETED|Consolidation||20
8669485|NCT00742625|9713199|FG000|NOT COMPLETED|Consolidation||21
8669486|NCT00742781|9713206|FG000|STARTED|Overall Study||21
8669487|NCT00742781|9713206|FG000|COMPLETED|Overall Study||18
8669488|NCT00742781|9713206|FG000|NOT COMPLETED|Overall Study||3
8669489|NCT00742859|9713215|FG000|STARTED|Overall Study||127
8669490|NCT00742859|9713216|FG001|STARTED|Overall Study||127
8669491|NCT00742859|9713217|FG002|STARTED|Overall Study||127
8669492|NCT00742859|9713218|FG003|STARTED|Overall Study||127
8669493|NCT00742859|9713215|FG000|COMPLETED|Overall Study||116
8669494|NCT00742859|9713216|FG001|COMPLETED|Overall Study||115
8669495|NCT00742859|9713217|FG002|COMPLETED|Overall Study||116
8669496|NCT00742859|9713218|FG003|COMPLETED|Overall Study||119
8669497|NCT00742859|9713215|FG000|NOT COMPLETED|Overall Study||11
8669498|NCT00742859|9713216|FG001|NOT COMPLETED|Overall Study||12
8669499|NCT00742859|9713217|FG002|NOT COMPLETED|Overall Study||11
8669500|NCT00742859|9713218|FG003|NOT COMPLETED|Overall Study||8
8669501|NCT00742872|9713230|FG000|STARTED|Overall Study||21
8669502|NCT00742872|9713231|FG001|STARTED|Overall Study||20
8669503|NCT00742872|9713230|FG000|COMPLETED|Overall Study||9
8669504|NCT00742872|9713231|FG001|COMPLETED|Overall Study||12
8669505|NCT00742872|9713230|FG000|NOT COMPLETED|Overall Study||12
8669506|NCT00742872|9713231|FG001|NOT COMPLETED|Overall Study||8
8669507|NCT00742885|9713239|FG000|STARTED|Overall Study||50
8669508|NCT00742885|9713240|FG001|STARTED|Overall Study||50
8669509|NCT00742885|9713239|FG000|COMPLETED|Overall Study|to Day 182|49
8669510|NCT00742885|9713240|FG001|COMPLETED|Overall Study|to Day 182|50
8669511|NCT00742885|9713239|FG000|NOT COMPLETED|Overall Study||1
8669512|NCT00742885|9713240|FG001|NOT COMPLETED|Overall Study||0
8669513|NCT00742924|9713253|FG000|STARTED|Overall Study||6
8669514|NCT00742924|9713254|FG001|STARTED|Overall Study||6
8669515|NCT00742924|9713255|FG002|STARTED|Overall Study||6
8669516|NCT00742924|9713256|FG003|STARTED|Overall Study||6
8669517|NCT00742924|9713253|FG000|COMPLETED|Overall Study||1
8732688|NCT01072643|9780170|FG000|COMPLETED|Overall Study||4
8732689|NCT01072643|9780170|FG000|NOT COMPLETED|Overall Study||0
8732690|NCT01072656|9780195|FG000|STARTED|First Intervention||5
8732691|NCT01072656|9780196|FG001|STARTED|First Intervention||4
8732692|NCT01072656|9780195|FG000|COMPLETED|First Intervention||5
8732693|NCT01072656|9780196|FG001|COMPLETED|First Intervention||4
8732694|NCT01072656|9780195|FG000|NOT COMPLETED|First Intervention||0
8732695|NCT01072656|9780196|FG001|NOT COMPLETED|First Intervention||0
8732696|NCT01072656|9780195|FG000|STARTED|Second Intervention||5
8732697|NCT01072656|9780196|FG001|STARTED|Second Intervention||4
8732698|NCT01072656|9780195|FG000|COMPLETED|Second Intervention||5
8732699|NCT01072656|9780196|FG001|COMPLETED|Second Intervention||4
8732700|NCT01072656|9780195|FG000|NOT COMPLETED|Second Intervention||0
8732701|NCT01072656|9780196|FG001|NOT COMPLETED|Second Intervention||0
8732702|NCT01072669|9780205|FG000|STARTED|Overall Study||15
8732703|NCT01072669|9780206|FG001|STARTED|Overall Study||5
8732704|NCT01072669|9780205|FG000|COMPLETED|Overall Study||15
8732705|NCT01072669|9780206|FG001|COMPLETED|Overall Study||5
8732706|NCT01072669|9780205|FG000|NOT COMPLETED|Overall Study||0
8732707|NCT01072669|9780206|FG001|NOT COMPLETED|Overall Study||0
8732708|NCT01072773|9780212|FG000|STARTED|Overall Study||2
8732709|NCT01072773|9780212|FG000|COMPLETED|Overall Study||2
8732710|NCT01072773|9780212|FG000|NOT COMPLETED|Overall Study||0
8732711|NCT01072877|9780221|FG000|STARTED|Overall Study||56
8732712|NCT01072877|9780222|FG001|STARTED|Overall Study||57
8732713|NCT01072877|9780223|FG002|STARTED|Overall Study||51
8732714|NCT01072877|9780224|FG003|STARTED|Overall Study||52
8732715|NCT01072877|9780225|FG004|STARTED|Overall Study||63
8732716|NCT01072877|9780221|FG000|COMPLETED|Overall Study||55
8732717|NCT01072877|9780222|FG001|COMPLETED|Overall Study||56
8732718|NCT01072877|9780223|FG002|COMPLETED|Overall Study||51
8732719|NCT01072877|9780224|FG003|COMPLETED|Overall Study||50
8732720|NCT01072877|9780225|FG004|COMPLETED|Overall Study||63
8732721|NCT01072877|9780221|FG000|NOT COMPLETED|Overall Study||1
8732722|NCT01072877|9780222|FG001|NOT COMPLETED|Overall Study||1
8732723|NCT01072877|9780223|FG002|NOT COMPLETED|Overall Study||0
8732724|NCT01072877|9780224|FG003|NOT COMPLETED|Overall Study||2
8732725|NCT01072877|9780225|FG004|NOT COMPLETED|Overall Study||0
8732726|NCT01072929|9780242|FG000|STARTED|Overall Study||199
8732727|NCT01072929|9780243|FG001|STARTED|Overall Study||201
8732728|NCT01072929|9780244|FG002|STARTED|Overall Study||33
8732729|NCT01072929|9780242|FG000|Safety Population|Overall Study|Treated participants|199
8732730|NCT01072929|9780243|FG001|Safety Population|Overall Study|Treated participants. Three participants were randomized but not treated.|198
8732731|NCT01072929|9780244|FG002|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|32
8732732|NCT01072929|9780242|FG000|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|196
8732733|NCT01072929|9780243|FG001|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|197
8732734|NCT01072929|9780244|FG002|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|31
8732735|NCT01072929|9780242|FG000|COMPLETED|Overall Study||155
8732736|NCT01072929|9780243|FG001|COMPLETED|Overall Study||150
8732737|NCT01072929|9780244|FG002|COMPLETED|Overall Study||24
8732738|NCT01072929|9780242|FG000|NOT COMPLETED|Overall Study||44
8732739|NCT01072929|9780243|FG001|NOT COMPLETED|Overall Study||51
8911718|NCT02148302|9970803|FG000|STARTED|Overall Study||57
8911719|NCT02148302|9970804|FG001|STARTED|Overall Study||66
8911720|NCT02148302|9970803|FG000|COMPLETED|Overall Study||57
8732740|NCT01072929|9780244|FG002|NOT COMPLETED|Overall Study||9
8911721|NCT02148302|9970804|FG001|COMPLETED|Overall Study||66
8911722|NCT02148302|9970803|FG000|NOT COMPLETED|Overall Study||0
8911723|NCT02148302|9970804|FG001|NOT COMPLETED|Overall Study||0
8911724|NCT02148445|9970812|FG000|STARTED|Overall Study||198
8669518|NCT00742924|9713254|FG001|COMPLETED|Overall Study||4
8669519|NCT00742924|9713255|FG002|COMPLETED|Overall Study||2
8911725|NCT02148445|9970813|FG001|STARTED|Overall Study||200
8911726|NCT02148445|9970812|FG000|COMPLETED|Overall Study||197
8669520|NCT00742924|9713256|FG003|COMPLETED|Overall Study||0
8669521|NCT00742924|9713253|FG000|NOT COMPLETED|Overall Study||5
8669522|NCT00742924|9713254|FG001|NOT COMPLETED|Overall Study||2
8669523|NCT00742924|9713255|FG002|NOT COMPLETED|Overall Study||4
8669524|NCT00742924|9713256|FG003|NOT COMPLETED|Overall Study||6
8669525|NCT00742963|9713266|FG000|STARTED|Overall Study||101
8669526|NCT00742963|9713266|FG000|Completed All Treatment Cycles|Overall Study||68
8669527|NCT00742963|9713266|FG000|COMPLETED|Overall Study||68
8669528|NCT00742963|9713266|FG000|NOT COMPLETED|Overall Study||33
8669529|NCT00743093|9713272|FG000|STARTED|Base Study Period||224
8669530|NCT00743093|9713273|FG001|STARTED|Base Study Period||52
8669531|NCT00743093|9713272|FG000|COMPLETED|Base Study Period||205
8669532|NCT00743093|9713273|FG001|COMPLETED|Base Study Period||47
8669533|NCT00743093|9713272|FG000|NOT COMPLETED|Base Study Period||19
8669534|NCT00743093|9713273|FG001|NOT COMPLETED|Base Study Period||5
8669535|NCT00743093|9713272|FG000|STARTED|Extended Dosing Period|Subjects not meeting stopping criteria after base continued into the extended dosing.|51
8669536|NCT00743093|9713273|FG001|STARTED|Extended Dosing Period|Subjects not meeting stopping criteria after base continued into the extended dosing.|1
8669537|NCT00743093|9713272|FG000|COMPLETED|Extended Dosing Period||48
8669538|NCT00743093|9713273|FG001|COMPLETED|Extended Dosing Period||1
8669539|NCT00743093|9713272|FG000|NOT COMPLETED|Extended Dosing Period||3
8669540|NCT00743093|9713273|FG001|NOT COMPLETED|Extended Dosing Period||0
8669541|NCT00743106|9713281|FG000|STARTED|Overall Study||42
8669542|NCT00743106|9713282|FG001|STARTED|Overall Study||48
8669543|NCT00743106|9713281|FG000|COMPLETED|Overall Study||34
8669544|NCT00743106|9713282|FG001|COMPLETED|Overall Study||43
8669545|NCT00743106|9713281|FG000|NOT COMPLETED|Overall Study||8
8669546|NCT00743106|9713282|FG001|NOT COMPLETED|Overall Study||5
8732741|NCT01073020|9780257|FG000|STARTED|Overall Study||23
8732742|NCT01073020|9780258|FG001|STARTED|Overall Study||22
8732743|NCT01073020|9780259|FG002|STARTED|Overall Study||22
8732744|NCT01073020|9780260|FG003|STARTED|Overall Study||21
8732745|NCT01073020|9780257|FG000|COMPLETED|Overall Study||16
8732746|NCT01073020|9780258|FG001|COMPLETED|Overall Study||17
8732747|NCT01073020|9780259|FG002|COMPLETED|Overall Study||19
8732748|NCT01073020|9780260|FG003|COMPLETED|Overall Study||19
8732749|NCT01073020|9780257|FG000|NOT COMPLETED|Overall Study||7
8732750|NCT01073020|9780258|FG001|NOT COMPLETED|Overall Study||5
8732751|NCT01073020|9780259|FG002|NOT COMPLETED|Overall Study||3
8732752|NCT01073020|9780260|FG003|NOT COMPLETED|Overall Study||2
8732753|NCT01073163|9780270|FG000|STARTED|Overall Study||54
8732754|NCT01073163|9780270|FG000|Enrolled But Not Treated|Overall Study||1
8732755|NCT01073163|9780270|FG000|Treated With <6 Cycles|Overall Study||4
8732756|NCT01073163|9780270|FG000|Treated With >=6 Cycles|Overall Study||49
8732757|NCT01073163|9780270|FG000|COMPLETED|Overall Study|Patients completed study|51
8732758|NCT01073163|9780270|FG000|NOT COMPLETED|Overall Study||3
8732759|NCT01073267|9780278|FG000|STARTED|Overall Study||4
8732760|NCT01073267|9780278|FG000|COMPLETED|Overall Study||1
8732761|NCT01073267|9780278|FG000|NOT COMPLETED|Overall Study||3
8732762|NCT01073293|9780284|FG000|STARTED|Overall Study||526
8732763|NCT01073293|9780285|FG001|STARTED|Overall Study||528
8732764|NCT01073293|9780284|FG000|COMPLETED|Overall Study||521
8732765|NCT01073293|9780285|FG001|COMPLETED|Overall Study||517
8732766|NCT01073293|9780284|FG000|NOT COMPLETED|Overall Study||5
8732767|NCT01073293|9780285|FG001|NOT COMPLETED|Overall Study||11
8732768|NCT01073449|9780291|FG000|STARTED|Overall Study||3362
8732769|NCT01073449|9780291|FG000|COMPLETED|Overall Study||3362
8732770|NCT01073449|9780291|FG000|NOT COMPLETED|Overall Study||0
8732771|NCT01073462|9780295|FG000|STARTED|Overall Study||67
8732772|NCT01073462|9780295|FG000|COMPLETED|Overall Study||26
8732773|NCT01073462|9780295|FG000|NOT COMPLETED|Overall Study||41
8732774|NCT01073566|9780301|FG000|STARTED|Period 1 (6 Weeks)||19
8732775|NCT01073566|9780302|FG001|STARTED|Period 1 (6 Weeks)||19
8732776|NCT01073566|9780301|FG000|COMPLETED|Period 1 (6 Weeks)||19
8732777|NCT01073566|9780302|FG001|COMPLETED|Period 1 (6 Weeks)||19
8732778|NCT01073566|9780301|FG000|NOT COMPLETED|Period 1 (6 Weeks)||0
8732779|NCT01073566|9780302|FG001|NOT COMPLETED|Period 1 (6 Weeks)||0
8732780|NCT01073566|9780301|FG000|STARTED|Period 2 (6 Weeks)||19
8732781|NCT01073566|9780302|FG001|STARTED|Period 2 (6 Weeks)||19
8732782|NCT01073566|9780301|FG000|COMPLETED|Period 2 (6 Weeks)||18
8732783|NCT01073566|9780302|FG001|COMPLETED|Period 2 (6 Weeks)||19
8732784|NCT01073566|9780301|FG000|NOT COMPLETED|Period 2 (6 Weeks)||1
8732785|NCT01073566|9780302|FG001|NOT COMPLETED|Period 2 (6 Weeks)||0
8732786|NCT01073605|9780311|FG000|STARTED|Overall Study||68
8732787|NCT01073605|9780312|FG001|STARTED|Overall Study||71
8732788|NCT01073605|9780313|FG002|STARTED|Overall Study||69
8732789|NCT01073605|9780311|FG000|Received Treatment|Overall Study||68
8732790|NCT01073605|9780312|FG001|Received Treatment|Overall Study||70
8732791|NCT01073605|9780313|FG002|Received Treatment|Overall Study||68
8732792|NCT01073605|9780311|FG000|COMPLETED|Overall Study|Corresponds to follow-up until final height|6
8732793|NCT01073605|9780312|FG001|COMPLETED|Overall Study|Corresponds to follow-up until final height|4
8911727|NCT02148445|9970813|FG001|COMPLETED|Overall Study||197
8669547|NCT00743119|9713288|FG000|STARTED|Overall Study||34
8732794|NCT01073605|9780313|FG002|COMPLETED|Overall Study|Corresponds to follow-up until final height|8
8732795|NCT01073605|9780311|FG000|NOT COMPLETED|Overall Study||62
8732796|NCT01073605|9780312|FG001|NOT COMPLETED|Overall Study||67
8669548|NCT00743119|9713288|FG000|COMPLETED|Overall Study||30
8669549|NCT00743119|9713288|FG000|NOT COMPLETED|Overall Study||4
8669550|NCT00743145|9713300|FG000|STARTED|Overall Study||23
8669551|NCT00743145|9713300|FG000|COMPLETED|Overall Study||19
8669552|NCT00743145|9713300|FG000|NOT COMPLETED|Overall Study||4
8669553|NCT00743249|9713316|FG000|STARTED|Overall Study||30
8732797|NCT01073605|9780313|FG002|NOT COMPLETED|Overall Study||61
8732798|NCT01073618|9780321|FG000|STARTED|Overall Study||692
8732799|NCT01073618|9780321|FG000|COMPLETED|Overall Study||385
8732800|NCT01073618|9780321|FG000|NOT COMPLETED|Overall Study||307
8732801|NCT01073631|9780325|FG000|STARTED|Overall Study||543
8732802|NCT01073631|9780325|FG000|COMPLETED|Overall Study||374
8732803|NCT01073631|9780325|FG000|NOT COMPLETED|Overall Study||169
8732804|NCT01073657|9780331|FG000|STARTED|Overall Study||17
8732805|NCT01073657|9780332|FG001|STARTED|Overall Study||16
8732806|NCT01073657|9780331|FG000|COMPLETED|Overall Study||17
8732807|NCT01073657|9780332|FG001|COMPLETED|Overall Study||16
8732808|NCT01073657|9780331|FG000|NOT COMPLETED|Overall Study||0
8732809|NCT01073657|9780332|FG001|NOT COMPLETED|Overall Study||0
8732810|NCT01073865|9780340|FG000|STARTED|Overall Study|Number of patients randomised|109
8732811|NCT01073865|9780341|FG001|STARTED|Overall Study|Number of patients randomised|113
8732812|NCT01073865|9780340|FG000|Received Randomised Treatment|Overall Study|Number of patients received randomised treatment|108
8732813|NCT01073865|9780341|FG001|Received Randomised Treatment|Overall Study|Number of patients received randomised treatment|113
8732814|NCT01073865|9780340|FG000|COMPLETED|Overall Study|Number of patients completed the study|81
8732815|NCT01073865|9780341|FG001|COMPLETED|Overall Study|Number of patients completed the study|74
8732816|NCT01073865|9780340|FG000|NOT COMPLETED|Overall Study||28
8732817|NCT01073865|9780341|FG001|NOT COMPLETED|Overall Study||39
8732818|NCT01073930|9780349|FG000|STARTED|Overall Study||307
8732819|NCT01073930|9780350|FG001|STARTED|Overall Study||301
8732820|NCT01073930|9780349|FG000|Safety Population (Treated)|Overall Study||305
8732821|NCT01073930|9780350|FG001|Safety Population (Treated)|Overall Study||298
8732822|NCT01073930|9780349|FG000|Intent to Treat Population|Overall Study|One treated participant did not have an efficacy assessment performed.|304
8732823|NCT01073930|9780350|FG001|Intent to Treat Population|Overall Study|One treated participant did not have an efficacy assessment performed.|297
8732824|NCT01073930|9780349|FG000|COMPLETED|Overall Study||304
8732825|NCT01073930|9780350|FG001|COMPLETED|Overall Study||295
8732826|NCT01073930|9780349|FG000|NOT COMPLETED|Overall Study||3
8732827|NCT01073930|9780350|FG001|NOT COMPLETED|Overall Study||6
8732828|NCT01073943|9780358|FG000|STARTED|Overall Study||300
8732829|NCT01073943|9780359|FG001|STARTED|Overall Study||303
8732830|NCT01073943|9780358|FG000|Safety Population (Treated)|Overall Study||296
8732831|NCT01073943|9780359|FG001|Safety Population (Treated)|Overall Study||302
8732832|NCT01073943|9780358|FG000|Intent to Treat Population|Overall Study|Two treated participants did not have an efficacy assessment performed.|294
8732833|NCT01073943|9780359|FG001|Intent to Treat Population|Overall Study|Two treated participants did not have an efficacy assessment performed.|300
8732834|NCT01073943|9780358|FG000|COMPLETED|Overall Study||287
8732835|NCT01073943|9780359|FG001|COMPLETED|Overall Study||295
8732836|NCT01073943|9780358|FG000|NOT COMPLETED|Overall Study||13
8732837|NCT01073943|9780359|FG001|NOT COMPLETED|Overall Study||8
8732838|NCT01074008|9780374|FG000|STARTED|Overall Study||8
8732839|NCT01074008|9780375|FG001|STARTED|Overall Study||8
8732840|NCT01074008|9780376|FG002|STARTED|Overall Study||8
8732841|NCT01074008|9780377|FG003|STARTED|Overall Study||8
8732842|NCT01074008|9780378|FG004|STARTED|Overall Study||8
8732843|NCT01074008|9780379|FG005|STARTED|Overall Study||7
8732844|NCT01074008|9780380|FG006|STARTED|Overall Study||8
8732845|NCT01074008|9780381|FG007|STARTED|Overall Study||8
8732846|NCT01074008|9780382|FG008|STARTED|Overall Study||11
8732847|NCT01074008|9780374|FG000|Completed Direct-acting Antiviral Agent|Overall Study||8
8732848|NCT01074008|9780375|FG001|Completed Direct-acting Antiviral Agent|Overall Study||7
8732849|NCT01074008|9780376|FG002|Completed Direct-acting Antiviral Agent|Overall Study||7
8732850|NCT01074008|9780377|FG003|Completed Direct-acting Antiviral Agent|Overall Study||8
8732851|NCT01074008|9780378|FG004|Completed Direct-acting Antiviral Agent|Overall Study||8
8732852|NCT01074008|9780379|FG005|Completed Direct-acting Antiviral Agent|Overall Study||5
8732853|NCT01074008|9780380|FG006|Completed Direct-acting Antiviral Agent|Overall Study||8
8732854|NCT01074008|9780381|FG007|Completed Direct-acting Antiviral Agent|Overall Study||7
8732855|NCT01074008|9780382|FG008|Completed Direct-acting Antiviral Agent|Overall Study||5
8732856|NCT01074008|9780374|FG000|COMPLETED|Overall Study||7
8732857|NCT01074008|9780375|FG001|COMPLETED|Overall Study||5
8732858|NCT01074008|9780376|FG002|COMPLETED|Overall Study||6
8732859|NCT01074008|9780377|FG003|COMPLETED|Overall Study||7
8732860|NCT01074008|9780378|FG004|COMPLETED|Overall Study||6
8732861|NCT01074008|9780379|FG005|COMPLETED|Overall Study||7
8732862|NCT01074008|9780380|FG006|COMPLETED|Overall Study||7
8669554|NCT00743249|9713317|FG001|STARTED|Overall Study||30
8669555|NCT00743249|9713316|FG000|COMPLETED|Overall Study||28
8669556|NCT00743249|9713317|FG001|COMPLETED|Overall Study||24
8669557|NCT00743249|9713316|FG000|NOT COMPLETED|Overall Study||2
8669558|NCT00743249|9713317|FG001|NOT COMPLETED|Overall Study||6
8669559|NCT00743262|9713323|FG000|STARTED|Overall Study||15
8732863|NCT01074008|9780381|FG007|COMPLETED|Overall Study||8
8732864|NCT01074008|9780382|FG008|COMPLETED|Overall Study||7
8669560|NCT00743262|9713323|FG000|COMPLETED|Overall Study||15
8669561|NCT00743262|9713323|FG000|NOT COMPLETED|Overall Study||0
8669562|NCT00743275|9713329|FG000|STARTED|Overall Study||59
8669563|NCT00743275|9713330|FG001|STARTED|Overall Study||61
8669564|NCT00743275|9713329|FG000|COMPLETED|Overall Study||59
8669565|NCT00743275|9713330|FG001|COMPLETED|Overall Study||60
8669566|NCT00743275|9713329|FG000|NOT COMPLETED|Overall Study||0
8669567|NCT00743275|9713330|FG001|NOT COMPLETED|Overall Study||1
8669568|NCT00743288|9713336|FG000|STARTED|Overall Study||3
8669569|NCT00743288|9713337|FG001|STARTED|Overall Study||3
8669570|NCT00743288|9713338|FG002|STARTED|Overall Study||6
8669571|NCT00743288|9713339|FG003|STARTED|Overall Study||7
8669572|NCT00743288|9713340|FG004|STARTED|Overall Study||6
8669573|NCT00743288|9713341|FG005|STARTED|Overall Study||6
8669574|NCT00743288|9713342|FG006|STARTED|Overall Study|6 subjects were enrolled in phase 1 and 3 subjects were enrolled as part of the phase 2 expansion.|9
8669575|NCT00743288|9713336|FG000|COMPLETED|Overall Study||0
8669576|NCT00743288|9713337|FG001|COMPLETED|Overall Study||0
8669577|NCT00743288|9713338|FG002|COMPLETED|Overall Study||1
8669578|NCT00743288|9713339|FG003|COMPLETED|Overall Study||0
8669579|NCT00743288|9713340|FG004|COMPLETED|Overall Study||0
8669580|NCT00743288|9713341|FG005|COMPLETED|Overall Study||1
8669581|NCT00743288|9713342|FG006|COMPLETED|Overall Study||0
8669582|NCT00743288|9713336|FG000|NOT COMPLETED|Overall Study||3
8669583|NCT00743288|9713337|FG001|NOT COMPLETED|Overall Study||3
8669584|NCT00743288|9713338|FG002|NOT COMPLETED|Overall Study||5
8669585|NCT00743288|9713339|FG003|NOT COMPLETED|Overall Study||7
8669586|NCT00743288|9713340|FG004|NOT COMPLETED|Overall Study||6
8669587|NCT00743288|9713341|FG005|NOT COMPLETED|Overall Study||5
8669588|NCT00743288|9713342|FG006|NOT COMPLETED|Overall Study||9
8669589|NCT00743340|9713353|FG000|STARTED|Overall Study||50
8669590|NCT00743340|9713353|FG000|COMPLETED|Overall Study||9
8669591|NCT00743340|9713353|FG000|NOT COMPLETED|Overall Study||41
8669592|NCT00743366|9713357|FG000|STARTED|Intervention 1 (8 Days)||10
8669593|NCT00743366|9713358|FG001|STARTED|Intervention 1 (8 Days)||10
8669594|NCT00743366|9713357|FG000|COMPLETED|Intervention 1 (8 Days)|A total of 6 participants withdrew before completion of the final inpatient phase|7
8669595|NCT00743366|9713358|FG001|COMPLETED|Intervention 1 (8 Days)|A total of 6 participants withdrew before completion of the final inpatient phase|7
8669596|NCT00743366|9713357|FG000|NOT COMPLETED|Intervention 1 (8 Days)||3
8669597|NCT00743366|9713358|FG001|NOT COMPLETED|Intervention 1 (8 Days)||3
8669598|NCT00743366|9713357|FG000|STARTED|Intervention 2 (8 Days)||7
8669599|NCT00743366|9713358|FG001|STARTED|Intervention 2 (8 Days)||7
8669600|NCT00743366|9713357|FG000|COMPLETED|Intervention 2 (8 Days)||7
8669601|NCT00743366|9713358|FG001|COMPLETED|Intervention 2 (8 Days)||7
8669602|NCT00743366|9713357|FG000|NOT COMPLETED|Intervention 2 (8 Days)||0
8669603|NCT00743366|9713358|FG001|NOT COMPLETED|Intervention 2 (8 Days)||0
8669604|NCT00743431|9713364|FG000|STARTED|Overall Study||224
8669605|NCT00743431|9713364|FG000|COMPLETED|Overall Study||98
8669606|NCT00743431|9713364|FG000|NOT COMPLETED|Overall Study||126
8669607|NCT00743444|9713368|FG000|STARTED|First Intervention||14
8669608|NCT00743444|9713369|FG001|STARTED|First Intervention||13
8669609|NCT00743444|9713368|FG000|COMPLETED|First Intervention||14
8669610|NCT00743444|9713369|FG001|COMPLETED|First Intervention||12
8669611|NCT00743444|9713368|FG000|NOT COMPLETED|First Intervention||0
8669612|NCT00743444|9713369|FG001|NOT COMPLETED|First Intervention||1
8669613|NCT00743444|9713368|FG000|STARTED|Washout Period||14
8669614|NCT00743444|9713369|FG001|STARTED|Washout Period||12
8669615|NCT00743444|9713368|FG000|COMPLETED|Washout Period||14
8669616|NCT00743444|9713369|FG001|COMPLETED|Washout Period||11
8669617|NCT00743444|9713368|FG000|NOT COMPLETED|Washout Period||0
8669618|NCT00743444|9713369|FG001|NOT COMPLETED|Washout Period||1
8669619|NCT00743444|9713368|FG000|STARTED|Second Intervention||14
8669620|NCT00743444|9713369|FG001|STARTED|Second Intervention||11
8669621|NCT00743444|9713368|FG000|COMPLETED|Second Intervention||14
8669622|NCT00743444|9713369|FG001|COMPLETED|Second Intervention||11
8669623|NCT00743444|9713368|FG000|NOT COMPLETED|Second Intervention||0
8669624|NCT00743444|9713369|FG001|NOT COMPLETED|Second Intervention||0
8669625|NCT00743483|9713375|FG000|STARTED|Baseline Period||15
8669626|NCT00743483|9713375|FG000|COMPLETED|Baseline Period||14
8669627|NCT00743483|9713375|FG000|NOT COMPLETED|Baseline Period||1
8669628|NCT00743483|9713375|FG000|STARTED|Treatment Period||14
8669629|NCT00743483|9713375|FG000|COMPLETED|Treatment Period||13
8669630|NCT00743483|9713375|FG000|NOT COMPLETED|Treatment Period||1
8669631|NCT00743509|9713379|FG000|STARTED|Overall Study||49
8669632|NCT00743509|9713379|FG000|COMPLETED|Overall Study||47
8669633|NCT00743509|9713379|FG000|NOT COMPLETED|Overall Study||2
8669634|NCT00743574|9713383|FG000|STARTED|Overall Study||36
8669635|NCT00743574|9713383|FG000|Dropped Out Before Eligibility Testing|Overall Study||13
8669636|NCT00743574|9713383|FG000|Further Exclusions|Overall Study||8
8669637|NCT00743574|9713383|FG000|Dropped Out After Initiating Trial|Overall Study||3
8669638|NCT00743574|9713383|FG000|COMPLETED|Overall Study||12
8669639|NCT00743574|9713383|FG000|NOT COMPLETED|Overall Study||24
8669640|NCT00743652|9713392|FG000|STARTED|Overall Study||151
8669641|NCT00743652|9713393|FG001|STARTED|Overall Study||51
8669642|NCT00743652|9713394|FG002|STARTED|Overall Study||25
8669643|NCT00743652|9713395|FG003|STARTED|Overall Study||67
8669644|NCT00743652|9713396|FG004|STARTED|Overall Study||79
8669645|NCT00743652|9713392|FG000|Vaccinated Dose 1|Overall Study||151
8669646|NCT00743652|9713393|FG001|Vaccinated Dose 1|Overall Study||51
8669647|NCT00743652|9713394|FG002|Vaccinated Dose 1|Overall Study||25
8669648|NCT00743652|9713395|FG003|Vaccinated Dose 1|Overall Study||66
8669649|NCT00743652|9713396|FG004|Vaccinated Dose 1|Overall Study||79
8669650|NCT00743652|9713392|FG000|Vaccinated Dose 2|Overall Study||112
8669651|NCT00743652|9713393|FG001|Vaccinated Dose 2|Overall Study||41
8669652|NCT00743652|9713394|FG002|Vaccinated Dose 2|Overall Study||0
8669653|NCT00743652|9713395|FG003|Vaccinated Dose 2|Overall Study||49
8669654|NCT00743652|9713396|FG004|Vaccinated Dose 2|Overall Study||0
8669655|NCT00743652|9713392|FG000|Vaccinated Dose 3|Overall Study||74
8669656|NCT00743652|9713393|FG001|Vaccinated Dose 3|Overall Study||0
8669657|NCT00743652|9713394|FG002|Vaccinated Dose 3|Overall Study||0
8669658|NCT00743652|9713395|FG003|Vaccinated Dose 3|Overall Study||0
8669659|NCT00743652|9713396|FG004|Vaccinated Dose 3|Overall Study||0
8669660|NCT00743652|9713392|FG000|Toddler Dose|Overall Study||15
8669661|NCT00743652|9713393|FG001|Toddler Dose|Overall Study||23
8669662|NCT00743652|9713394|FG002|Toddler Dose|Overall Study||16
8669663|NCT00743652|9713395|FG003|Toddler Dose|Overall Study||0
8669664|NCT00743652|9713396|FG004|Toddler Dose|Overall Study||0
8669665|NCT00743652|9713392|FG000|COMPLETED|Overall Study||141
8669666|NCT00743652|9713393|FG001|COMPLETED|Overall Study||48
8669667|NCT00743652|9713394|FG002|COMPLETED|Overall Study||23
8669668|NCT00743652|9713395|FG003|COMPLETED|Overall Study||63
8669669|NCT00743652|9713396|FG004|COMPLETED|Overall Study||79
8669670|NCT00743652|9713392|FG000|NOT COMPLETED|Overall Study||10
8669671|NCT00743652|9713393|FG001|NOT COMPLETED|Overall Study||3
8669672|NCT00743652|9713394|FG002|NOT COMPLETED|Overall Study||2
8669673|NCT00743652|9713395|FG003|NOT COMPLETED|Overall Study||4
8669674|NCT00743652|9713396|FG004|NOT COMPLETED|Overall Study||0
8732865|NCT01074008|9780374|FG000|NOT COMPLETED|Overall Study||1
8732866|NCT01074008|9780375|FG001|NOT COMPLETED|Overall Study||3
8732867|NCT01074008|9780376|FG002|NOT COMPLETED|Overall Study||2
8732868|NCT01074008|9780377|FG003|NOT COMPLETED|Overall Study||1
8732869|NCT01074008|9780378|FG004|NOT COMPLETED|Overall Study||2
8732870|NCT01074008|9780379|FG005|NOT COMPLETED|Overall Study||0
8732871|NCT01074008|9780380|FG006|NOT COMPLETED|Overall Study||1
8732872|NCT01074008|9780381|FG007|NOT COMPLETED|Overall Study||0
8732873|NCT01074008|9780382|FG008|NOT COMPLETED|Overall Study||4
8732874|NCT01074034|9780411|FG000|STARTED|Overall Study||211
8732875|NCT01074034|9780411|FG000|COMPLETED|Overall Study||205
8732876|NCT01074034|9780411|FG000|NOT COMPLETED|Overall Study||6
8732877|NCT01074047|9780418|FG000|STARTED|Treatment Phase||241
8732878|NCT01074047|9780419|FG001|STARTED|Treatment Phase||247
8732879|NCT01074047|9780418|FG000|Treated Population|Treatment Phase|5 patients not treated with any drug regimen|236
8732880|NCT01074047|9780419|FG001|Treated Population|Treatment Phase|7 patients not treated with any drug regimen|240
8732881|NCT01074047|9780418|FG000|Safety Population|Treatment Phase|Received at least one dose of study medication and had at least 1 post dose safety assessment|236
8732882|NCT01074047|9780419|FG001|Safety Population|Treatment Phase|Received at least one dose of study medication and had at least 1 post dose safety assessment|235
8732883|NCT01074047|9780418|FG000|Evaluable Population|Treatment Phase|Did not meet criteria for exclusion, received ≥1 cycle of treatment and had ≥ 1 efficacy assessment|179
8732884|NCT01074047|9780419|FG001|Evaluable Population|Treatment Phase|Did not meet criteria for exclusion, received ≥1 cycle of treatment and had ≥ 1 efficacy assessment|191
8732885|NCT01074047|9780418|FG000|COMPLETED|Treatment Phase|Participants who were continuing study treatment at the time of study closure|24
8732886|NCT01074047|9780419|FG001|COMPLETED|Treatment Phase|Participants who were continuing study treatment at the time of study closure|13
8732887|NCT01074047|9780418|FG000|NOT COMPLETED|Treatment Phase||217
8732888|NCT01074047|9780419|FG001|NOT COMPLETED|Treatment Phase||234
8732889|NCT01074047|9780418|FG000|STARTED|Survival Follow-Up Phase||140
8732890|NCT01074047|9780419|FG001|STARTED|Survival Follow-Up Phase||163
8732891|NCT01074047|9780418|FG000|COMPLETED|Survival Follow-Up Phase||16
8732892|NCT01074047|9780419|FG001|COMPLETED|Survival Follow-Up Phase||27
8732893|NCT01074047|9780418|FG000|NOT COMPLETED|Survival Follow-Up Phase||124
8732894|NCT01074047|9780419|FG001|NOT COMPLETED|Survival Follow-Up Phase||136
8732895|NCT01074047|9780418|FG000|STARTED|Extension Phase|2 participants did not enroll in the extension period.|22
8732896|NCT01074047|9780419|FG001|STARTED|Extension Phase||0
8732897|NCT01074047|9780418|FG000|Safety Population|Extension Phase|Participants who enrolled in the extension phase|22
8732898|NCT01074047|9780419|FG001|Safety Population|Extension Phase||0
8732899|NCT01074047|9780418|FG000|COMPLETED|Extension Phase||0
8732900|NCT01074047|9780419|FG001|COMPLETED|Extension Phase||0
8732901|NCT01074047|9780418|FG000|NOT COMPLETED|Extension Phase||22
8732902|NCT01074047|9780419|FG001|NOT COMPLETED|Extension Phase||0
8732903|NCT01074099|9780434|FG000|STARTED|Overall Study||2
8732904|NCT01074099|9780435|FG001|STARTED|Overall Study||3
8732905|NCT01074099|9780434|FG000|COMPLETED|Overall Study||2
8732906|NCT01074099|9780435|FG001|COMPLETED|Overall Study||3
8732907|NCT01074099|9780434|FG000|NOT COMPLETED|Overall Study||0
8732908|NCT01074099|9780435|FG001|NOT COMPLETED|Overall Study||0
8732909|NCT01074125|9780444|FG000|STARTED|Overall Study||51
8911728|NCT02148445|9970812|FG000|NOT COMPLETED|Overall Study||1
8911729|NCT02148445|9970813|FG001|NOT COMPLETED|Overall Study||3
8911730|NCT02148523|9970824|FG000|STARTED|Overall Study||67
8911731|NCT02148523|9970825|FG001|STARTED|Overall Study||67
8669675|NCT00743717|9713414|FG000|STARTED|Overall Study||2
8669676|NCT00743717|9713415|FG001|STARTED|Overall Study||2
8669677|NCT00743717|9713414|FG000|COMPLETED|Overall Study||2
8669678|NCT00743717|9713415|FG001|COMPLETED|Overall Study||2
8669679|NCT00743717|9713414|FG000|NOT COMPLETED|Overall Study||0
8669680|NCT00743717|9713415|FG001|NOT COMPLETED|Overall Study||0
8669681|NCT00743730|9713424|FG000|STARTED|Overall Study||27
8669682|NCT00743730|9713425|FG001|STARTED|Overall Study||34
8669683|NCT00743730|9713426|FG002|STARTED|Overall Study||33
8669684|NCT00743730|9713424|FG000|COMPLETED|Overall Study||22
8669685|NCT00743730|9713425|FG001|COMPLETED|Overall Study||30
8669686|NCT00743730|9713426|FG002|COMPLETED|Overall Study||28
8669687|NCT00743730|9713424|FG000|NOT COMPLETED|Overall Study||5
8669688|NCT00743730|9713425|FG001|NOT COMPLETED|Overall Study||4
8669689|NCT00743730|9713426|FG002|NOT COMPLETED|Overall Study||5
8669690|NCT00744042|9713438|FG000|STARTED|Overall Study||11
8669691|NCT00744042|9713438|FG000|COMPLETED|Overall Study||10
8669692|NCT00744042|9713438|FG000|NOT COMPLETED|Overall Study||1
8669693|NCT00744055|9713450|FG000|STARTED|Overall Study||50
8669694|NCT00744055|9713451|FG001|STARTED|Overall Study||46
8669695|NCT00744055|9713450|FG000|COMPLETED|Overall Study||43
8669696|NCT00744055|9713451|FG001|COMPLETED|Overall Study||32
8669697|NCT00744055|9713450|FG000|NOT COMPLETED|Overall Study||7
8669698|NCT00744055|9713451|FG001|NOT COMPLETED|Overall Study||14
8669699|NCT00744211|9713460|FG000|STARTED|Baseline||10
8669700|NCT00744211|9713461|FG001|STARTED|Baseline||9
8669701|NCT00744211|9713462|FG002|STARTED|Baseline||10
8669702|NCT00744211|9713460|FG000|COMPLETED|Baseline||10
8669703|NCT00744211|9713461|FG001|COMPLETED|Baseline||9
8669704|NCT00744211|9713462|FG002|COMPLETED|Baseline||10
8669705|NCT00744211|9713460|FG000|NOT COMPLETED|Baseline||0
8669706|NCT00744211|9713461|FG001|NOT COMPLETED|Baseline||0
8669707|NCT00744211|9713462|FG002|NOT COMPLETED|Baseline||0
8669708|NCT00744211|9713460|FG000|STARTED|0.5 Hours After Cardiopulmonary Bypass||10
8669709|NCT00744211|9713461|FG001|STARTED|0.5 Hours After Cardiopulmonary Bypass||9
8669710|NCT00744211|9713462|FG002|STARTED|0.5 Hours After Cardiopulmonary Bypass||10
8669711|NCT00744211|9713460|FG000|COMPLETED|0.5 Hours After Cardiopulmonary Bypass||10
8669712|NCT00744211|9713461|FG001|COMPLETED|0.5 Hours After Cardiopulmonary Bypass||9
8669713|NCT00744211|9713462|FG002|COMPLETED|0.5 Hours After Cardiopulmonary Bypass||10
8669714|NCT00744211|9713460|FG000|NOT COMPLETED|0.5 Hours After Cardiopulmonary Bypass||0
8669715|NCT00744211|9713461|FG001|NOT COMPLETED|0.5 Hours After Cardiopulmonary Bypass||0
8669716|NCT00744211|9713462|FG002|NOT COMPLETED|0.5 Hours After Cardiopulmonary Bypass||0
8669717|NCT00744211|9713460|FG000|STARTED|6 Hours After Cardiopulmonary Bypass||10
8669718|NCT00744211|9713461|FG001|STARTED|6 Hours After Cardiopulmonary Bypass||9
8669719|NCT00744211|9713462|FG002|STARTED|6 Hours After Cardiopulmonary Bypass||10
8669720|NCT00744211|9713460|FG000|COMPLETED|6 Hours After Cardiopulmonary Bypass||10
8669721|NCT00744211|9713461|FG001|COMPLETED|6 Hours After Cardiopulmonary Bypass||9
8669722|NCT00744211|9713462|FG002|COMPLETED|6 Hours After Cardiopulmonary Bypass||10
8669723|NCT00744211|9713460|FG000|NOT COMPLETED|6 Hours After Cardiopulmonary Bypass||0
8669724|NCT00744211|9713461|FG001|NOT COMPLETED|6 Hours After Cardiopulmonary Bypass||0
8669725|NCT00744211|9713462|FG002|NOT COMPLETED|6 Hours After Cardiopulmonary Bypass||0
8669726|NCT00744211|9713460|FG000|STARTED|12 Hours After Cardiopulmonary Bypass||10
8669727|NCT00744211|9713461|FG001|STARTED|12 Hours After Cardiopulmonary Bypass||9
8669728|NCT00744211|9713462|FG002|STARTED|12 Hours After Cardiopulmonary Bypass||10
8669729|NCT00744211|9713460|FG000|COMPLETED|12 Hours After Cardiopulmonary Bypass||10
8669730|NCT00744211|9713461|FG001|COMPLETED|12 Hours After Cardiopulmonary Bypass||9
8669731|NCT00744211|9713462|FG002|COMPLETED|12 Hours After Cardiopulmonary Bypass||10
8669732|NCT00744211|9713460|FG000|NOT COMPLETED|12 Hours After Cardiopulmonary Bypass||0
8669733|NCT00744211|9713461|FG001|NOT COMPLETED|12 Hours After Cardiopulmonary Bypass||0
8669734|NCT00744211|9713462|FG002|NOT COMPLETED|12 Hours After Cardiopulmonary Bypass||0
8669735|NCT00744211|9713460|FG000|STARTED|24 Hours After Cardiopulmonary Bypass||10
8669736|NCT00744211|9713461|FG001|STARTED|24 Hours After Cardiopulmonary Bypass||9
8669737|NCT00744211|9713462|FG002|STARTED|24 Hours After Cardiopulmonary Bypass||10
8669738|NCT00744211|9713460|FG000|COMPLETED|24 Hours After Cardiopulmonary Bypass||10
8669739|NCT00744211|9713461|FG001|COMPLETED|24 Hours After Cardiopulmonary Bypass||9
8669740|NCT00744211|9713462|FG002|COMPLETED|24 Hours After Cardiopulmonary Bypass||10
8669741|NCT00744211|9713460|FG000|NOT COMPLETED|24 Hours After Cardiopulmonary Bypass||0
8669742|NCT00744211|9713461|FG001|NOT COMPLETED|24 Hours After Cardiopulmonary Bypass||0
8669743|NCT00744211|9713462|FG002|NOT COMPLETED|24 Hours After Cardiopulmonary Bypass||0
8669744|NCT00744237|9713476|FG000|STARTED|Overall Study||83
8669745|NCT00744237|9713477|FG001|STARTED|Overall Study||73
8669746|NCT00744237|9713478|FG002|STARTED|Overall Study||74
8669747|NCT00744237|9713476|FG000|COMPLETED|Overall Study||56
8669748|NCT00744237|9713477|FG001|COMPLETED|Overall Study||46
8669749|NCT00744237|9713478|FG002|COMPLETED|Overall Study||59
8669750|NCT00744237|9713476|FG000|NOT COMPLETED|Overall Study||27
8669751|NCT00744237|9713477|FG001|NOT COMPLETED|Overall Study||27
8669752|NCT00744237|9713478|FG002|NOT COMPLETED|Overall Study||15
8669753|NCT00744263|9713488|FG000|STARTED|Overall Study||42240
8669754|NCT00744263|9713489|FG001|STARTED|Overall Study||42256
8669755|NCT00744263|9713488|FG000|COMPLETED|Overall Study||37004
8669756|NCT00744263|9713489|FG001|COMPLETED|Overall Study||36936
8669757|NCT00744263|9713488|FG000|NOT COMPLETED|Overall Study||5236
8669758|NCT00744263|9713489|FG001|NOT COMPLETED|Overall Study||5320
8669759|NCT00744328|9713500|FG000|STARTED|Overall Study||26
8669760|NCT00744328|9713501|FG001|STARTED|Overall Study||30
8669761|NCT00744328|9713502|FG002|STARTED|Overall Study||29
8669762|NCT00744328|9713500|FG000|COMPLETED|Overall Study||19
8669763|NCT00744328|9713501|FG001|COMPLETED|Overall Study||22
8669764|NCT00744328|9713502|FG002|COMPLETED|Overall Study||21
8669765|NCT00744328|9713500|FG000|NOT COMPLETED|Overall Study||7
8669766|NCT00744328|9713501|FG001|NOT COMPLETED|Overall Study||8
8669767|NCT00744328|9713502|FG002|NOT COMPLETED|Overall Study||8
8669768|NCT00744380|9713512|FG000|STARTED|Overall Study||12
8669769|NCT00744380|9713513|FG001|STARTED|Overall Study||11
8669770|NCT00744380|9713512|FG000|COMPLETED|Overall Study||12
8669771|NCT00744380|9713513|FG001|COMPLETED|Overall Study||11
8669772|NCT00744380|9713512|FG000|NOT COMPLETED|Overall Study||0
8669773|NCT00744380|9713513|FG001|NOT COMPLETED|Overall Study||0
8669774|NCT00744471|9713524|FG000|STARTED|Overall Study||156
8669775|NCT00744471|9713525|FG001|STARTED|Overall Study||156
8669776|NCT00744471|9713526|FG002|STARTED|Overall Study||158
8669777|NCT00744471|9713527|FG003|STARTED|Overall Study||157
8669778|NCT00744471|9713524|FG000|Treated|Overall Study||155
8669779|NCT00744471|9713525|FG001|Treated|Overall Study||155
8669780|NCT00744471|9713526|FG002|Treated|Overall Study||154
8669781|NCT00744471|9713527|FG003|Treated|Overall Study||157
8669782|NCT00744471|9713524|FG000|COMPLETED|Overall Study||13
8669783|NCT00744471|9713525|FG001|COMPLETED|Overall Study||11
8669784|NCT00744471|9713526|FG002|COMPLETED|Overall Study||6
8669785|NCT00744471|9713527|FG003|COMPLETED|Overall Study||9
8669786|NCT00744471|9713524|FG000|NOT COMPLETED|Overall Study||143
8669787|NCT00744471|9713525|FG001|NOT COMPLETED|Overall Study||145
8669788|NCT00744471|9713526|FG002|NOT COMPLETED|Overall Study||152
8669789|NCT00744471|9713527|FG003|NOT COMPLETED|Overall Study||148
8669790|NCT00744497|9713539|FG000|STARTED|Overall Study|Randomized|760
8669791|NCT00744497|9713540|FG001|STARTED|Overall Study|Randomized|762
8669792|NCT00744497|9713539|FG000|Received Treatment|Overall Study||757
8669793|NCT00744497|9713540|FG001|Received Treatment|Overall Study||761
8669794|NCT00744497|9713539|FG000|COMPLETED|Overall Study||0
8669795|NCT00744497|9713540|FG001|COMPLETED|Overall Study||0
8669796|NCT00744497|9713539|FG000|NOT COMPLETED|Overall Study||760
8669797|NCT00744497|9713540|FG001|NOT COMPLETED|Overall Study||762
8669798|NCT00744523|9713548|FG000|STARTED|Procedure||37
8669799|NCT00744523|9713549|FG001|STARTED|Procedure||225
8669800|NCT00744523|9713548|FG000|COMPLETED|Procedure||37
8669801|NCT00744523|9713549|FG001|COMPLETED|Procedure||225
8669802|NCT00744523|9713548|FG000|NOT COMPLETED|Procedure||0
8669803|NCT00744523|9713549|FG001|NOT COMPLETED|Procedure||0
8669804|NCT00744523|9713548|FG000|STARTED|30 Days After the Procedure||37
8669805|NCT00744523|9713549|FG001|STARTED|30 Days After the Procedure||225
8669806|NCT00744523|9713548|FG000|COMPLETED|30 Days After the Procedure||37
8669807|NCT00744523|9713549|FG001|COMPLETED|30 Days After the Procedure||220
8669808|NCT00744523|9713548|FG000|NOT COMPLETED|30 Days After the Procedure||0
8669809|NCT00744523|9713549|FG001|NOT COMPLETED|30 Days After the Procedure||5
8669810|NCT00744627|9713559|FG000|STARTED|Overall Study||151
8669811|NCT00744627|9713560|FG001|STARTED|Overall Study||150
8732910|NCT01074125|9780445|FG001|STARTED|Overall Study||52
8732911|NCT01074125|9780446|FG002|STARTED|Overall Study||48
8911732|NCT02148523|9970826|FG002|STARTED|Overall Study||67
8911733|NCT02148523|9970824|FG000|COMPLETED|Overall Study||67
8911734|NCT02148523|9970825|FG001|COMPLETED|Overall Study||67
8911735|NCT02148523|9970826|FG002|COMPLETED|Overall Study||67
8911736|NCT02148523|9970824|FG000|NOT COMPLETED|Overall Study||0
8911737|NCT02148523|9970825|FG001|NOT COMPLETED|Overall Study||0
8911738|NCT02148523|9970826|FG002|NOT COMPLETED|Overall Study||0
8911739|NCT02148588|9970834|FG000|STARTED|Overall Study||8
8911740|NCT02148588|9970834|FG000|COMPLETED|Overall Study||8
8911741|NCT02148588|9970834|FG000|NOT COMPLETED|Overall Study||0
8911742|NCT02148718|9970838|FG000|STARTED|Overall Study||86
8911743|NCT02148718|9970838|FG000|COMPLETED|Overall Study||55
8911744|NCT02148718|9970838|FG000|NOT COMPLETED|Overall Study||31
8911745|NCT02148809|9970842|FG000|STARTED|Overall Study||14
8911746|NCT02148809|9970842|FG000|COMPLETED|Overall Study||14
8911747|NCT02148809|9970842|FG000|NOT COMPLETED|Overall Study||0
8911748|NCT02148835|9970849|FG000|STARTED|Overall Study||22
8911749|NCT02148835|9970850|FG001|STARTED|Overall Study||22
8911750|NCT02148835|9970849|FG000|COMPLETED|Overall Study||22
8911751|NCT02148835|9970850|FG001|COMPLETED|Overall Study||22
8911752|NCT02148835|9970849|FG000|NOT COMPLETED|Overall Study||0
8911753|NCT02148835|9970850|FG001|NOT COMPLETED|Overall Study||0
8911754|NCT02148874|9970858|FG000|STARTED|Overall Study||201
8911755|NCT02148874|9970859|FG001|STARTED|Overall Study||86
8911756|NCT02148874|9970858|FG000|COMPLETED|Overall Study||194
8911757|NCT02148874|9970859|FG001|COMPLETED|Overall Study||84
8911758|NCT02148874|9970858|FG000|NOT COMPLETED|Overall Study||7
8911759|NCT02148874|9970859|FG001|NOT COMPLETED|Overall Study||2
8911760|NCT02148952|9970867|FG000|STARTED|Assessing Eligibility and Consent||83166
8669812|NCT00744627|9713559|FG000|Treated|Overall Study||150
8669813|NCT00744627|9713560|FG001|Treated|Overall Study||150
8732912|NCT01074125|9780444|FG000|COMPLETED|Overall Study||39
8732913|NCT01074125|9780445|FG001|COMPLETED|Overall Study||47
8911761|NCT02148952|9970868|FG001|STARTED|Assessing Eligibility and Consent||80773
8911762|NCT02148952|9970867|FG000|COMPLETED|Assessing Eligibility and Consent||80063
8669814|NCT00744627|9713559|FG000|COMPLETED|Overall Study||126
8669815|NCT00744627|9713560|FG001|COMPLETED|Overall Study||128
8669816|NCT00744627|9713559|FG000|NOT COMPLETED|Overall Study||25
8669817|NCT00744627|9713560|FG001|NOT COMPLETED|Overall Study||22
8669818|NCT00744653|9713566|FG000|STARTED|Overall Study||17
8669819|NCT00744653|9713566|FG000|COMPLETED|Overall Study||1
8911763|NCT02148952|9970868|FG001|COMPLETED|Assessing Eligibility and Consent||77626
8911764|NCT02148952|9970867|FG000|NOT COMPLETED|Assessing Eligibility and Consent||3103
8911765|NCT02148952|9970868|FG001|NOT COMPLETED|Assessing Eligibility and Consent||3147
8911766|NCT02148952|9970867|FG000|STARTED|Follow-Up||80063
8669820|NCT00744653|9713566|FG000|NOT COMPLETED|Overall Study||16
8669821|NCT00744692|9713571|FG000|STARTED|Overall Study||22
8669822|NCT00744692|9713571|FG000|COMPLETED|Overall Study||22
8669823|NCT00744692|9713571|FG000|NOT COMPLETED|Overall Study||0
8669824|NCT00744757|9713575|FG000|STARTED|Overall Study||37
8669825|NCT00744757|9713575|FG000|COMPLETED|Overall Study||16
8669826|NCT00744757|9713575|FG000|NOT COMPLETED|Overall Study||21
8669827|NCT00744796|9713579|FG000|STARTED|Pre-operative||21
8669828|NCT00744796|9713579|FG000|COMPLETED|Pre-operative||21
8669829|NCT00744796|9713579|FG000|NOT COMPLETED|Pre-operative||0
8669830|NCT00744796|9713579|FG000|STARTED|Post-Operative Day 1||21
8669831|NCT00744796|9713579|FG000|COMPLETED|Post-Operative Day 1||21
8669832|NCT00744796|9713579|FG000|NOT COMPLETED|Post-Operative Day 1||0
8669833|NCT00744796|9713579|FG000|STARTED|Post-Operative 3-6 Months||21
8669834|NCT00744796|9713579|FG000|COMPLETED|Post-Operative 3-6 Months||21
8669835|NCT00744796|9713579|FG000|NOT COMPLETED|Post-Operative 3-6 Months||0
8669836|NCT00744796|9713579|FG000|STARTED|Post-Operative 6-9 Months||21
8669837|NCT00744796|9713579|FG000|COMPLETED|Post-Operative 6-9 Months||9
8669838|NCT00744796|9713579|FG000|NOT COMPLETED|Post-Operative 6-9 Months||12
8669839|NCT00744848|9713585|FG000|STARTED|Overall Study||103
8669840|NCT00744848|9713586|FG001|STARTED|Overall Study||101
8669841|NCT00744848|9713585|FG000|COMPLETED|Overall Study||103
8669842|NCT00744848|9713586|FG001|COMPLETED|Overall Study||101
8669843|NCT00744848|9713585|FG000|NOT COMPLETED|Overall Study||0
8669844|NCT00744848|9713586|FG001|NOT COMPLETED|Overall Study||0
8669845|NCT00744861|9713596|FG000|STARTED|Feasibility Stage 1|Stage 1: Study phase to determine the feasibility of the study treatment and assessments|8
8669846|NCT00744861|9713597|FG001|STARTED|Feasibility Stage 1|Stage 1: Study phase to determine the feasibility of the study treatment and assessments|10
8669847|NCT00744861|9713598|FG002|STARTED|Feasibility Stage 1|No subjects enrolled in Stage 1/Feasibility study|0
8669848|NCT00744861|9713599|FG003|STARTED|Feasibility Stage 1|No subjects enrolled in Stage 1/Feasibility study|0
8669849|NCT00744861|9713596|FG000|COMPLETED|Feasibility Stage 1||7
8669850|NCT00744861|9713597|FG001|COMPLETED|Feasibility Stage 1||8
8669851|NCT00744861|9713598|FG002|COMPLETED|Feasibility Stage 1||0
8669852|NCT00744861|9713599|FG003|COMPLETED|Feasibility Stage 1||0
8669853|NCT00744861|9713596|FG000|NOT COMPLETED|Feasibility Stage 1||1
8669854|NCT00744861|9713597|FG001|NOT COMPLETED|Feasibility Stage 1||2
8669855|NCT00744861|9713598|FG002|NOT COMPLETED|Feasibility Stage 1||0
8669856|NCT00744861|9713599|FG003|NOT COMPLETED|Feasibility Stage 1||0
8669857|NCT00744861|9713596|FG000|STARTED|Pivotal Stage 2|No subjects enrolled in Stage 2 pivotal study phase|0
8669858|NCT00744861|9713597|FG001|STARTED|Pivotal Stage 2|No subjects enrolled in Stage 2 pivotal study phase|0
8669859|NCT00744861|9713598|FG002|STARTED|Pivotal Stage 2|Stage 2 pivotal study phase assessed safety and effectiveness of LIPUS treatment via Exospine device|154
8669860|NCT00744861|9713599|FG003|STARTED|Pivotal Stage 2|Stage 2 pivotal study phase assessed safety and effectiveness of LIPUS treatment via Exospine device|156
8669861|NCT00744861|9713596|FG000|COMPLETED|Pivotal Stage 2||0
8669862|NCT00744861|9713597|FG001|COMPLETED|Pivotal Stage 2||0
8669863|NCT00744861|9713598|FG002|COMPLETED|Pivotal Stage 2||52
8669864|NCT00744861|9713599|FG003|COMPLETED|Pivotal Stage 2||51
8669865|NCT00744861|9713596|FG000|NOT COMPLETED|Pivotal Stage 2||0
8669866|NCT00744861|9713597|FG001|NOT COMPLETED|Pivotal Stage 2||0
8669867|NCT00744861|9713598|FG002|NOT COMPLETED|Pivotal Stage 2||102
8669868|NCT00744861|9713599|FG003|NOT COMPLETED|Pivotal Stage 2||105
8669869|NCT00744874|9713607|FG000|STARTED|Overall Study||55
8669870|NCT00744874|9713607|FG000|COMPLETED|Overall Study||51
8669871|NCT00744874|9713607|FG000|NOT COMPLETED|Overall Study||4
8669872|NCT00744939|9713622|FG000|STARTED|Overall Study||168
8669873|NCT00744939|9713622|FG000|Treatment Received|Overall Study||141
8669874|NCT00744939|9713622|FG000|COMPLETED|Overall Study||77
8669875|NCT00744939|9713622|FG000|NOT COMPLETED|Overall Study||91
8669876|NCT00744965|9713636|FG000|STARTED|Overall Study||197
8669877|NCT00744965|9713637|FG001|STARTED|Overall Study||198
8669878|NCT00744965|9713636|FG000|COMPLETED|Overall Study||186
8669879|NCT00744965|9713637|FG001|COMPLETED|Overall Study||189
8669880|NCT00744965|9713636|FG000|NOT COMPLETED|Overall Study||11
8669881|NCT00744965|9713637|FG001|NOT COMPLETED|Overall Study||9
8669882|NCT00744978|9713645|FG000|STARTED|Period 1||32
8669883|NCT00744978|9713646|FG001|STARTED|Period 1||34
8669884|NCT00744978|9713645|FG000|Treated|Period 1||31
8669885|NCT00744978|9713646|FG001|Treated|Period 1||33
8732914|NCT01074125|9780446|FG002|COMPLETED|Overall Study||36
8732915|NCT01074125|9780444|FG000|NOT COMPLETED|Overall Study||12
8669886|NCT00744978|9713645|FG000|COMPLETED|Period 1||26
8669887|NCT00744978|9713646|FG001|COMPLETED|Period 1||29
8669888|NCT00744978|9713645|FG000|NOT COMPLETED|Period 1||6
8669889|NCT00744978|9713646|FG001|NOT COMPLETED|Period 1||5
8669890|NCT00744978|9713645|FG000|STARTED|Placebo Washout||26
8669891|NCT00744978|9713646|FG001|STARTED|Placebo Washout||29
8669892|NCT00744978|9713645|FG000|COMPLETED|Placebo Washout||26
8669893|NCT00744978|9713646|FG001|COMPLETED|Placebo Washout||29
8669894|NCT00744978|9713645|FG000|NOT COMPLETED|Placebo Washout||0
8669895|NCT00744978|9713646|FG001|NOT COMPLETED|Placebo Washout||0
8669896|NCT00744978|9713645|FG000|STARTED|Period 2||26
8669897|NCT00744978|9713646|FG001|STARTED|Period 2||29
8669898|NCT00744978|9713645|FG000|COMPLETED|Period 2||26
8669899|NCT00744978|9713646|FG001|COMPLETED|Period 2||28
8669900|NCT00744978|9713645|FG000|NOT COMPLETED|Period 2||0
8732916|NCT01074125|9780445|FG001|NOT COMPLETED|Overall Study||5
8732917|NCT01074125|9780446|FG002|NOT COMPLETED|Overall Study||12
8669901|NCT00744978|9713646|FG001|NOT COMPLETED|Period 2||1
8669902|NCT00744991|9713652|FG000|STARTED|Overall Study||25
8669903|NCT00744991|9713652|FG000|Received at Least 1 Dose|Overall Study||25
8669904|NCT00744991|9713652|FG000|COMPLETED|Overall Study||0
8669905|NCT00744991|9713652|FG000|NOT COMPLETED|Overall Study||25
8669906|NCT00745095|9713665|FG000|STARTED|Overall Study||15
8669907|NCT00745095|9713666|FG001|STARTED|Overall Study||15
8669908|NCT00745095|9713667|FG002|STARTED|Overall Study||15
8669909|NCT00745095|9713668|FG003|STARTED|Overall Study||15
8669910|NCT00745095|9713669|FG004|STARTED|Overall Study||150
8669911|NCT00745095|9713670|FG005|STARTED|Overall Study||150
8669912|NCT00745095|9713665|FG000|COMPLETED|Overall Study||14
8669913|NCT00745095|9713666|FG001|COMPLETED|Overall Study||13
8669914|NCT00745095|9713667|FG002|COMPLETED|Overall Study||12
8669915|NCT00745095|9713668|FG003|COMPLETED|Overall Study||12
8669916|NCT00745095|9713669|FG004|COMPLETED|Overall Study||28
8669917|NCT00745095|9713670|FG005|COMPLETED|Overall Study||27
8732918|NCT01074164|9780459|FG000|STARTED|Overall Study||7
8732919|NCT01074164|9780460|FG001|STARTED|Overall Study||8
8732920|NCT01074164|9780459|FG000|COMPLETED|Overall Study||4
8732921|NCT01074164|9780460|FG001|COMPLETED|Overall Study||7
8732922|NCT01074164|9780459|FG000|NOT COMPLETED|Overall Study||3
8732923|NCT01074164|9780460|FG001|NOT COMPLETED|Overall Study||1
8732924|NCT01074177|9780466|FG000|STARTED|Overall Study||24
8732925|NCT01074177|9780466|FG000|COMPLETED|Overall Study||24
8732926|NCT01074177|9780466|FG000|NOT COMPLETED|Overall Study||0
8732927|NCT01074216|9780470|FG000|STARTED|Overall Study||54
8732928|NCT01074216|9780470|FG000|COMPLETED|Overall Study||41
8732929|NCT01074216|9780470|FG000|NOT COMPLETED|Overall Study||13
8732930|NCT01074229|9780477|FG000|STARTED|Overall Study||25
8732931|NCT01074229|9780478|FG001|STARTED|Overall Study||25
8732932|NCT01074229|9780479|FG002|STARTED|Overall Study||25
8732933|NCT01074229|9780477|FG000|COMPLETED|Overall Study||23
8732934|NCT01074229|9780478|FG001|COMPLETED|Overall Study||22
8732935|NCT01074229|9780479|FG002|COMPLETED|Overall Study||21
8732936|NCT01074229|9780477|FG000|NOT COMPLETED|Overall Study||2
8732937|NCT01074229|9780478|FG001|NOT COMPLETED|Overall Study||3
8732938|NCT01074229|9780479|FG002|NOT COMPLETED|Overall Study||4
8732939|NCT01074242|9780489|FG000|STARTED|Overall Study||3798
8732940|NCT01074242|9780489|FG000|Received at Least 1 Dose of Vaccine|Overall Study||3395
8732941|NCT01074242|9780489|FG000|COMPLETED|Overall Study||3395
8732942|NCT01074242|9780489|FG000|NOT COMPLETED|Overall Study||403
8732943|NCT01074255|9780493|FG000|STARTED|Overall Study||3141
8732944|NCT01074255|9780493|FG000|Treated|Overall Study||3139
8732945|NCT01074255|9780493|FG000|COMPLETED|Overall Study||3139
8732946|NCT01074255|9780493|FG000|NOT COMPLETED|Overall Study||2
8732947|NCT01074268|9780499|FG000|STARTED|Main: Week 0 to 26 (NN1250-3585)||303
8732948|NCT01074268|9780500|FG001|STARTED|Main: Week 0 to 26 (NN1250-3585)||153
8732949|NCT01074268|9780499|FG000|Full Analysis Set|Main: Week 0 to 26 (NN1250-3585)|One subject was withdrawn because the subject was randomised in error (screening failure)|302
8732950|NCT01074268|9780500|FG001|Full Analysis Set|Main: Week 0 to 26 (NN1250-3585)||153
8732951|NCT01074268|9780499|FG000|Exposed|Main: Week 0 to 26 (NN1250-3585)|Two subjects withdrew prior to exposure to trial drugs|301
8732952|NCT01074268|9780500|FG001|Exposed|Main: Week 0 to 26 (NN1250-3585)|One subject withdrew prior to exposure to trial drugs|152
8732953|NCT01074268|9780499|FG000|COMPLETED|Main: Week 0 to 26 (NN1250-3585)||283
8732954|NCT01074268|9780500|FG001|COMPLETED|Main: Week 0 to 26 (NN1250-3585)||138
8732955|NCT01074268|9780499|FG000|NOT COMPLETED|Main: Week 0 to 26 (NN1250-3585)||20
8732956|NCT01074268|9780500|FG001|NOT COMPLETED|Main: Week 0 to 26 (NN1250-3585)||15
8732957|NCT01074268|9780499|FG000|STARTED|Extension: Week 27 to 52 (NN1250-3725)|Thirty five subjects from main trial did not continue into the extension|248
8732958|NCT01074268|9780500|FG001|STARTED|Extension: Week 27 to 52 (NN1250-3725)|Sixteen subjects from main trial did not continue into the extension|122
8732959|NCT01074268|9780499|FG000|COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||242
8732960|NCT01074268|9780500|FG001|COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||115
8732961|NCT01074268|9780499|FG000|NOT COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||6
8732962|NCT01074268|9780500|FG001|NOT COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||7
8732963|NCT01074307|9780508|FG000|STARTED|Overall Study||66
8732964|NCT01074307|9780509|FG001|STARTED|Overall Study||114
8732965|NCT01074307|9780508|FG000|COMPLETED|Overall Study||44
8732966|NCT01074307|9780509|FG001|COMPLETED|Overall Study||102
8732967|NCT01074307|9780508|FG000|NOT COMPLETED|Overall Study||22
8732968|NCT01074307|9780509|FG001|NOT COMPLETED|Overall Study||12
8732969|NCT01074450|9780517|FG000|STARTED|First Intervention||12
8732970|NCT01074450|9780518|FG001|STARTED|First Intervention||12
8732971|NCT01074450|9780517|FG000|COMPLETED|First Intervention||12
8732972|NCT01074450|9780518|FG001|COMPLETED|First Intervention||10
8732973|NCT01074450|9780517|FG000|NOT COMPLETED|First Intervention||0
8732974|NCT01074450|9780518|FG001|NOT COMPLETED|First Intervention||2
8732975|NCT01074450|9780517|FG000|STARTED|Washout of 7 Days||12
8732976|NCT01074450|9780518|FG001|STARTED|Washout of 7 Days||10
8732977|NCT01074450|9780517|FG000|COMPLETED|Washout of 7 Days||12
8732978|NCT01074450|9780518|FG001|COMPLETED|Washout of 7 Days||10
8732979|NCT01074450|9780517|FG000|NOT COMPLETED|Washout of 7 Days||0
8732980|NCT01074450|9780518|FG001|NOT COMPLETED|Washout of 7 Days||0
8732981|NCT01074450|9780517|FG000|STARTED|Second Intervention||12
8732982|NCT01074450|9780518|FG001|STARTED|Second Intervention||10
8669918|NCT00745095|9713665|FG000|NOT COMPLETED|Overall Study||1
8669919|NCT00745095|9713666|FG001|NOT COMPLETED|Overall Study||2
8669920|NCT00745095|9713667|FG002|NOT COMPLETED|Overall Study||3
8732983|NCT01074450|9780517|FG000|COMPLETED|Second Intervention|Positive Drug Screen at Check in.|11
8732984|NCT01074450|9780518|FG001|COMPLETED|Second Intervention|Influenze Symptoms Present at Check in.|9
8732985|NCT01074450|9780517|FG000|NOT COMPLETED|Second Intervention||1
8669921|NCT00745095|9713668|FG003|NOT COMPLETED|Overall Study||3
8669922|NCT00745095|9713669|FG004|NOT COMPLETED|Overall Study||122
8669923|NCT00745095|9713670|FG005|NOT COMPLETED|Overall Study||123
8669924|NCT00745121|9713689|FG000|STARTED|Overall Study||20
8669925|NCT00745121|9713690|FG001|STARTED|Overall Study||28
8669926|NCT00745121|9713689|FG000|COMPLETED|Overall Study||11
8669927|NCT00745121|9713690|FG001|COMPLETED|Overall Study||26
8669928|NCT00745121|9713689|FG000|NOT COMPLETED|Overall Study||9
8669929|NCT00745121|9713690|FG001|NOT COMPLETED|Overall Study||2
8669930|NCT00745251|9713698|FG000|STARTED|Overall Study||23
8669931|NCT00745251|9713699|FG001|STARTED|Overall Study||22
8669932|NCT00745251|9713698|FG000|COMPLETED|Overall Study||21
8669933|NCT00745251|9713699|FG001|COMPLETED|Overall Study||19
8669934|NCT00745251|9713698|FG000|NOT COMPLETED|Overall Study||2
8669935|NCT00745251|9713699|FG001|NOT COMPLETED|Overall Study||3
8669936|NCT00745290|9713707|FG000|STARTED|Overall Study||123
8669937|NCT00745290|9713708|FG001|STARTED|Overall Study||122
8669938|NCT00745290|9713707|FG000|COMPLETED|Overall Study||123
8669939|NCT00745290|9713708|FG001|COMPLETED|Overall Study||122
8669940|NCT00745290|9713707|FG000|NOT COMPLETED|Overall Study||0
8669941|NCT00745290|9713708|FG001|NOT COMPLETED|Overall Study||0
8669942|NCT00745368|9713714|FG000|STARTED|Overall Study|Of the 28 subjects who enrolled, 19 participated in a study visit|19
8669943|NCT00745368|9713714|FG000|COMPLETED|Overall Study|3 male subjects were unable to provide a sample and are not included in the results|16
8669944|NCT00745368|9713714|FG000|NOT COMPLETED|Overall Study||3
8669945|NCT00745420|9713718|FG000|STARTED|Overall Study||30
8669946|NCT00745420|9713718|FG000|COMPLETED|Overall Study||29
8669947|NCT00745420|9713718|FG000|NOT COMPLETED|Overall Study||1
8669948|NCT00745498|9713725|FG000|STARTED|Overall Study||41
8669949|NCT00745498|9713726|FG001|STARTED|Overall Study||43
8669950|NCT00745498|9713727|FG002|STARTED|Overall Study||42
8669951|NCT00745498|9713725|FG000|COMPLETED|Overall Study||36
8669952|NCT00745498|9713726|FG001|COMPLETED|Overall Study||37
8669953|NCT00745498|9713727|FG002|COMPLETED|Overall Study||34
8669954|NCT00745498|9713725|FG000|NOT COMPLETED|Overall Study||5
8669955|NCT00745498|9713726|FG001|NOT COMPLETED|Overall Study||6
8669956|NCT00745498|9713727|FG002|NOT COMPLETED|Overall Study||8
8669957|NCT00745615|9713739|FG000|STARTED|Double-Blind Extension (36 Weeks)||80
8669958|NCT00745615|9713740|FG001|STARTED|Double-Blind Extension (36 Weeks)||94
8669959|NCT00745615|9713741|FG002|STARTED|Double-Blind Extension (36 Weeks)||39
8669960|NCT00745615|9713742|FG003|STARTED|Double-Blind Extension (36 Weeks)||44
8669961|NCT00745615|9713743|FG004|STARTED|Double-Blind Extension (36 Weeks)||0
8732986|NCT01074450|9780518|FG001|NOT COMPLETED|Second Intervention||1
8732987|NCT01074463|9780526|FG000|STARTED|First Intervention||12
8732988|NCT01074463|9780527|FG001|STARTED|First Intervention||12
8732989|NCT01074463|9780526|FG000|COMPLETED|First Intervention||12
8732990|NCT01074463|9780527|FG001|COMPLETED|First Intervention||12
8732991|NCT01074463|9780526|FG000|NOT COMPLETED|First Intervention||0
8732992|NCT01074463|9780527|FG001|NOT COMPLETED|First Intervention||0
8732993|NCT01074463|9780526|FG000|STARTED|Washout of 7 Days||12
8732994|NCT01074463|9780527|FG001|STARTED|Washout of 7 Days||12
8732995|NCT01074463|9780526|FG000|COMPLETED|Washout of 7 Days||12
8732996|NCT01074463|9780527|FG001|COMPLETED|Washout of 7 Days||12
8732997|NCT01074463|9780526|FG000|NOT COMPLETED|Washout of 7 Days||0
8732998|NCT01074463|9780527|FG001|NOT COMPLETED|Washout of 7 Days||0
8732999|NCT01074463|9780526|FG000|STARTED|Second Intervention||12
8733000|NCT01074463|9780527|FG001|STARTED|Second Intervention||12
8733001|NCT01074463|9780526|FG000|COMPLETED|Second Intervention||12
8733002|NCT01074463|9780527|FG001|COMPLETED|Second Intervention||12
8733003|NCT01074463|9780526|FG000|NOT COMPLETED|Second Intervention||0
8733004|NCT01074463|9780527|FG001|NOT COMPLETED|Second Intervention||0
8733005|NCT01074554|9780535|FG000|STARTED|Overall Study||14
8733006|NCT01074554|9780536|FG001|STARTED|Overall Study||15
8733007|NCT01074554|9780535|FG000|COMPLETED|Overall Study||11
8733008|NCT01074554|9780536|FG001|COMPLETED|Overall Study||11
8733009|NCT01074554|9780535|FG000|NOT COMPLETED|Overall Study||3
8733010|NCT01074554|9780536|FG001|NOT COMPLETED|Overall Study||4
8733011|NCT01074658|9780542|FG000|STARTED|Overall Study||1015
8733012|NCT01074658|9780542|FG000|Attempted Implant|Overall Study||996
8733013|NCT01074658|9780542|FG000|COMPLETED|Overall Study||996
8733014|NCT01074658|9780542|FG000|NOT COMPLETED|Overall Study||19
8733015|NCT01074931|9780546|FG000|STARTED|Overall Study||98
8733016|NCT01074931|9780546|FG000|COMPLETED|Overall Study||92
8733017|NCT01074931|9780546|FG000|NOT COMPLETED|Overall Study||6
8733018|NCT01074944|9780554|FG000|STARTED|Lead-in Period (up to 78 Weeks)|LIP conducted to assess randomization criteria of all participants in single reporting arm.|170
8733019|NCT01074944|9780555|FG001|STARTED|Lead-in Period (up to 78 Weeks)||0
8733020|NCT01074944|9780556|FG002|STARTED|Lead-in Period (up to 78 Weeks)||0
8669962|NCT00745615|9713744|FG005|STARTED|Double-Blind Extension (36 Weeks)||0
8669963|NCT00745615|9713739|FG000|COMPLETED|Double-Blind Extension (36 Weeks)||75
8669964|NCT00745615|9713740|FG001|COMPLETED|Double-Blind Extension (36 Weeks)||87
8669965|NCT00745615|9713741|FG002|COMPLETED|Double-Blind Extension (36 Weeks)||38
8669966|NCT00745615|9713742|FG003|COMPLETED|Double-Blind Extension (36 Weeks)||39
8669967|NCT00745615|9713743|FG004|COMPLETED|Double-Blind Extension (36 Weeks)||0
8669968|NCT00745615|9713744|FG005|COMPLETED|Double-Blind Extension (36 Weeks)||0
8669969|NCT00745615|9713739|FG000|NOT COMPLETED|Double-Blind Extension (36 Weeks)||5
8669970|NCT00745615|9713740|FG001|NOT COMPLETED|Double-Blind Extension (36 Weeks)||7
8669971|NCT00745615|9713741|FG002|NOT COMPLETED|Double-Blind Extension (36 Weeks)||1
8669972|NCT00745615|9713742|FG003|NOT COMPLETED|Double-Blind Extension (36 Weeks)||5
8669973|NCT00745615|9713743|FG004|NOT COMPLETED|Double-Blind Extension (36 Weeks)||0
8669974|NCT00745615|9713744|FG005|NOT COMPLETED|Double-Blind Extension (36 Weeks)||0
8733021|NCT01074944|9780557|FG003|STARTED|Lead-in Period (up to 78 Weeks)||0
8733022|NCT01074944|9780558|FG004|STARTED|Lead-in Period (up to 78 Weeks)||0
8733023|NCT01074944|9780554|FG000|COMPLETED|Lead-in Period (up to 78 Weeks)||157
8733024|NCT01074944|9780555|FG001|COMPLETED|Lead-in Period (up to 78 Weeks)||0
8733025|NCT01074944|9780556|FG002|COMPLETED|Lead-in Period (up to 78 Weeks)||0
8733026|NCT01074944|9780557|FG003|COMPLETED|Lead-in Period (up to 78 Weeks)||0
8733027|NCT01074944|9780558|FG004|COMPLETED|Lead-in Period (up to 78 Weeks)||0
8733028|NCT01074944|9780554|FG000|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||13
8733029|NCT01074944|9780555|FG001|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
8733030|NCT01074944|9780556|FG002|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
8733031|NCT01074944|9780557|FG003|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
8733032|NCT01074944|9780558|FG004|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
8733033|NCT01074944|9780554|FG000|STARTED|Primary Analysis Period (up to 52 Weeks)||0
8733034|NCT01074944|9780555|FG001|STARTED|Primary Analysis Period (up to 52 Weeks)|Participants who were randomized after LIP received treatment in PAP.|65
8733035|NCT01074944|9780556|FG002|STARTED|Primary Analysis Period (up to 52 Weeks)|Participants who were randomized after LIP received treatment in PAP.|66
8733036|NCT01074944|9780557|FG003|STARTED|Primary Analysis Period (up to 52 Weeks)||0
8733037|NCT01074944|9780558|FG004|STARTED|Primary Analysis Period (up to 52 Weeks)||0
8733038|NCT01074944|9780554|FG000|COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
8733039|NCT01074944|9780555|FG001|COMPLETED|Primary Analysis Period (up to 52 Weeks)||54
8733040|NCT01074944|9780556|FG002|COMPLETED|Primary Analysis Period (up to 52 Weeks)||60
8733041|NCT01074944|9780557|FG003|COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
8733042|NCT01074944|9780558|FG004|COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
8733043|NCT01074944|9780554|FG000|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
8733044|NCT01074944|9780555|FG001|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||11
8733045|NCT01074944|9780556|FG002|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||6
8733046|NCT01074944|9780557|FG003|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
8733047|NCT01074944|9780558|FG004|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
8733048|NCT01074944|9780554|FG000|STARTED|Long Term Treatment||0
8733049|NCT01074944|9780555|FG001|STARTED|Long Term Treatment||0
8733050|NCT01074944|9780556|FG002|STARTED|Long Term Treatment||0
8733051|NCT01074944|9780557|FG003|STARTED|Long Term Treatment|Participants who completed PAP (114) including those who considered as treatment failure in PAP (7).|121
8733052|NCT01074944|9780558|FG004|STARTED|Long Term Treatment||0
8733053|NCT01074944|9780554|FG000|COMPLETED|Long Term Treatment||0
8733054|NCT01074944|9780555|FG001|COMPLETED|Long Term Treatment||0
8733055|NCT01074944|9780556|FG002|COMPLETED|Long Term Treatment||0
8733056|NCT01074944|9780557|FG003|COMPLETED|Long Term Treatment||95
8669975|NCT00745615|9713739|FG000|STARTED|Open-Label (up to Approx 10.5 Years)||0
8733057|NCT01074944|9780558|FG004|COMPLETED|Long Term Treatment||0
8733058|NCT01074944|9780554|FG000|NOT COMPLETED|Long Term Treatment||0
8733059|NCT01074944|9780555|FG001|NOT COMPLETED|Long Term Treatment||0
8733060|NCT01074944|9780556|FG002|NOT COMPLETED|Long Term Treatment||0
8733061|NCT01074944|9780557|FG003|NOT COMPLETED|Long Term Treatment||26
8733062|NCT01074944|9780558|FG004|NOT COMPLETED|Long Term Treatment||0
8733063|NCT01074944|9780554|FG000|STARTED|Extended Treatment (up to 42 Months)||0
8733064|NCT01074944|9780555|FG001|STARTED|Extended Treatment (up to 42 Months)||0
8733065|NCT01074944|9780556|FG002|STARTED|Extended Treatment (up to 42 Months)||0
8733066|NCT01074944|9780557|FG003|STARTED|Extended Treatment (up to 42 Months)||0
8733067|NCT01074944|9780558|FG004|STARTED|Extended Treatment (up to 42 Months)|Participants who were failed to meet the randomization criteria during the lead-in period.|25
8733068|NCT01074944|9780554|FG000|COMPLETED|Extended Treatment (up to 42 Months)||0
8733069|NCT01074944|9780555|FG001|COMPLETED|Extended Treatment (up to 42 Months)||0
8733070|NCT01074944|9780556|FG002|COMPLETED|Extended Treatment (up to 42 Months)||0
8733071|NCT01074944|9780557|FG003|COMPLETED|Extended Treatment (up to 42 Months)||0
8733072|NCT01074944|9780558|FG004|COMPLETED|Extended Treatment (up to 42 Months)||20
8733073|NCT01074944|9780554|FG000|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
8733074|NCT01074944|9780555|FG001|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
8733075|NCT01074944|9780556|FG002|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
8733076|NCT01074944|9780557|FG003|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
8733077|NCT01074944|9780558|FG004|NOT COMPLETED|Extended Treatment (up to 42 Months)||5
8733078|NCT01075048|9780569|FG000|STARTED|Overall Study||9
8733079|NCT01075048|9780570|FG001|STARTED|Overall Study||60
8733080|NCT01075048|9780571|FG002|STARTED|Overall Study||62
8733081|NCT01075048|9780569|FG000|Did Not Receive Treatment|Overall Study||0
8669976|NCT00745615|9713740|FG001|STARTED|Open-Label (up to Approx 10.5 Years)||0
8669977|NCT00745615|9713741|FG002|STARTED|Open-Label (up to Approx 10.5 Years)||0
8669978|NCT00745615|9713742|FG003|STARTED|Open-Label (up to Approx 10.5 Years)||0
8669979|NCT00745615|9713743|FG004|STARTED|Open-Label (up to Approx 10.5 Years)||96
8669980|NCT00745615|9713744|FG005|STARTED|Open-Label (up to Approx 10.5 Years)||113
8669981|NCT00745615|9713739|FG000|COMPLETED|Open-Label (up to Approx 10.5 Years)||0
8669982|NCT00745615|9713740|FG001|COMPLETED|Open-Label (up to Approx 10.5 Years)||0
8669983|NCT00745615|9713741|FG002|COMPLETED|Open-Label (up to Approx 10.5 Years)||0
8669984|NCT00745615|9713742|FG003|COMPLETED|Open-Label (up to Approx 10.5 Years)||0
8669985|NCT00745615|9713743|FG004|COMPLETED|Open-Label (up to Approx 10.5 Years)||5
8669986|NCT00745615|9713744|FG005|COMPLETED|Open-Label (up to Approx 10.5 Years)||5
8669987|NCT00745615|9713739|FG000|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||0
8669988|NCT00745615|9713740|FG001|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||0
8669989|NCT00745615|9713741|FG002|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||0
8669990|NCT00745615|9713742|FG003|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||0
8669991|NCT00745615|9713743|FG004|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||91
8669992|NCT00745615|9713744|FG005|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||108
8669993|NCT00745823|9713758|FG000|STARTED|Overall Study||386
8669994|NCT00745823|9713759|FG001|STARTED|Overall Study||389
8669995|NCT00745823|9713758|FG000|TREATED Week 0 - 96|Overall Study||382
8669996|NCT00745823|9713759|FG001|TREATED Week 0 - 96|Overall Study||388
8669997|NCT00745823|9713758|FG000|COMPLETED|Overall Study||1
8669998|NCT00745823|9713759|FG001|COMPLETED|Overall Study||3
8669999|NCT00745823|9713758|FG000|NOT COMPLETED|Overall Study||385
8670000|NCT00745823|9713759|FG001|NOT COMPLETED|Overall Study||386
8670001|NCT00745849|9713767|FG000|STARTED|First Intervention||21
8670002|NCT00745849|9713768|FG001|STARTED|First Intervention||22
8670003|NCT00745849|9713767|FG000|COMPLETED|First Intervention||20
8670004|NCT00745849|9713768|FG001|COMPLETED|First Intervention||20
8670005|NCT00745849|9713767|FG000|NOT COMPLETED|First Intervention||1
8670006|NCT00745849|9713768|FG001|NOT COMPLETED|First Intervention||2
8670007|NCT00745849|9713767|FG000|STARTED|Washout Period||20
8670008|NCT00745849|9713768|FG001|STARTED|Washout Period||20
8670009|NCT00745849|9713767|FG000|COMPLETED|Washout Period||20
8670010|NCT00745849|9713768|FG001|COMPLETED|Washout Period||20
8670011|NCT00745849|9713767|FG000|NOT COMPLETED|Washout Period||0
8670012|NCT00745849|9713768|FG001|NOT COMPLETED|Washout Period||0
8670013|NCT00745849|9713767|FG000|STARTED|Second Intervention||20
8670014|NCT00745849|9713768|FG001|STARTED|Second Intervention||20
8670015|NCT00745849|9713767|FG000|COMPLETED|Second Intervention||18
8670016|NCT00745849|9713768|FG001|COMPLETED|Second Intervention||19
8670017|NCT00745849|9713767|FG000|NOT COMPLETED|Second Intervention||2
8670018|NCT00745849|9713768|FG001|NOT COMPLETED|Second Intervention||1
8670019|NCT00745875|9713776|FG000|STARTED|Overall Study|Started - Number of patients randomised|36
8670020|NCT00745875|9713777|FG001|STARTED|Overall Study|Started - Number of patients randomised|30
8670021|NCT00745875|9713776|FG000|COMPLETED|Overall Study|Completed - Number of patients discontinued study treatment at data cut-off (17th January 2010)|32
8670022|NCT00745875|9713777|FG001|COMPLETED|Overall Study|Completed - Number of patients discontinued study treatment at data cut-off (17th January 2010)|26
8670023|NCT00745875|9713776|FG000|NOT COMPLETED|Overall Study||4
8670024|NCT00745875|9713777|FG001|NOT COMPLETED|Overall Study||4
8670025|NCT00745901|9713785|FG000|STARTED|Overall Study|Number of Patients Randomized|178
8670026|NCT00745901|9713786|FG001|STARTED|Overall Study|Number of Patients Randomized|177
8670027|NCT00745901|9713785|FG000|COMPLETED|Overall Study||154
8670028|NCT00745901|9713786|FG001|COMPLETED|Overall Study||156
8670029|NCT00745901|9713785|FG000|NOT COMPLETED|Overall Study||24
8670030|NCT00745901|9713786|FG001|NOT COMPLETED|Overall Study||21
8670031|NCT00745940|9713794|FG000|STARTED|Overall Study||57
8670032|NCT00745940|9713795|FG001|STARTED|Overall Study||48
8670033|NCT00745940|9713794|FG000|COMPLETED|Overall Study||38
8670034|NCT00745940|9713795|FG001|COMPLETED|Overall Study||38
8670035|NCT00745940|9713794|FG000|NOT COMPLETED|Overall Study||19
8670036|NCT00745940|9713795|FG001|NOT COMPLETED|Overall Study||10
8670037|NCT00746096|9713803|FG000|STARTED|Overall Study||58
8670038|NCT00746096|9713804|FG001|STARTED|Overall Study||57
8670039|NCT00746096|9713803|FG000|COMPLETED|Overall Study||48
8670040|NCT00746096|9713804|FG001|COMPLETED|Overall Study||54
8670041|NCT00746096|9713803|FG000|NOT COMPLETED|Overall Study||10
8670042|NCT00746096|9713804|FG001|NOT COMPLETED|Overall Study||3
8670043|NCT00746122|9713812|FG000|STARTED|Overall Study||297
8733082|NCT01075048|9780570|FG001|Did Not Receive Treatment|Overall Study||1
8733083|NCT01075048|9780571|FG002|Did Not Receive Treatment|Overall Study||0
8733084|NCT01075048|9780569|FG000|COMPLETED|Overall Study||0
8670044|NCT00746122|9713813|FG001|STARTED|Overall Study|After 600 recruitment target 13 more patients were randomised before sites could be closed down.|316
8670045|NCT00746122|9713812|FG000|COMPLETED|Overall Study||297
8670046|NCT00746122|9713813|FG001|COMPLETED|Overall Study||316
8670047|NCT00746122|9713812|FG000|NOT COMPLETED|Overall Study||0
8670048|NCT00746122|9713813|FG001|NOT COMPLETED|Overall Study||0
8670049|NCT00746187|9713821|FG000|STARTED|Overall Study||18
8670050|NCT00746187|9713822|FG001|STARTED|Overall Study||18
8670051|NCT00746187|9713821|FG000|COMPLETED|Overall Study||15
8670052|NCT00746187|9713822|FG001|COMPLETED|Overall Study||16
8670053|NCT00746187|9713821|FG000|NOT COMPLETED|Overall Study||3
8670054|NCT00746187|9713822|FG001|NOT COMPLETED|Overall Study||2
8670055|NCT00746252|9713830|FG000|STARTED|Overall Study||1
8670056|NCT00746252|9713831|FG001|STARTED|Overall Study||2
8670057|NCT00746252|9713830|FG000|COMPLETED|Overall Study||0
8670058|NCT00746252|9713831|FG001|COMPLETED|Overall Study||0
8670059|NCT00746252|9713830|FG000|NOT COMPLETED|Overall Study||1
8670060|NCT00746252|9713831|FG001|NOT COMPLETED|Overall Study||2
8670061|NCT00746330|9713841|FG000|STARTED|Period 1||7
8670062|NCT00746330|9713842|FG001|STARTED|Period 1||9
8670063|NCT00746330|9713843|FG002|STARTED|Period 1||9
8670064|NCT00746330|9713844|FG003|STARTED|Period 1||7
8670065|NCT00746330|9713841|FG000|COMPLETED|Period 1||7
8670066|NCT00746330|9713842|FG001|COMPLETED|Period 1||9
8670067|NCT00746330|9713843|FG002|COMPLETED|Period 1||8
8670068|NCT00746330|9713844|FG003|COMPLETED|Period 1||7
8670069|NCT00746330|9713841|FG000|NOT COMPLETED|Period 1||0
8670070|NCT00746330|9713842|FG001|NOT COMPLETED|Period 1||0
8670071|NCT00746330|9713843|FG002|NOT COMPLETED|Period 1||1
8670072|NCT00746330|9713844|FG003|NOT COMPLETED|Period 1||0
8670073|NCT00746330|9713841|FG000|STARTED|Period 2||7
8670074|NCT00746330|9713842|FG001|STARTED|Period 2||9
8670075|NCT00746330|9713843|FG002|STARTED|Period 2||8
8670076|NCT00746330|9713844|FG003|STARTED|Period 2||7
8670077|NCT00746330|9713841|FG000|COMPLETED|Period 2||7
8670078|NCT00746330|9713842|FG001|COMPLETED|Period 2||9
8670079|NCT00746330|9713843|FG002|COMPLETED|Period 2||8
8670080|NCT00746330|9713844|FG003|COMPLETED|Period 2||7
8670081|NCT00746330|9713841|FG000|NOT COMPLETED|Period 2||0
8670082|NCT00746330|9713842|FG001|NOT COMPLETED|Period 2||0
8670083|NCT00746330|9713843|FG002|NOT COMPLETED|Period 2||0
8670084|NCT00746330|9713844|FG003|NOT COMPLETED|Period 2||0
8670085|NCT00746330|9713841|FG000|STARTED|Period 3||7
8670086|NCT00746330|9713842|FG001|STARTED|Period 3||9
8670087|NCT00746330|9713843|FG002|STARTED|Period 3||8
8670088|NCT00746330|9713844|FG003|STARTED|Period 3||7
8670089|NCT00746330|9713841|FG000|COMPLETED|Period 3||7
8670090|NCT00746330|9713842|FG001|COMPLETED|Period 3||9
8670091|NCT00746330|9713843|FG002|COMPLETED|Period 3||8
8670092|NCT00746330|9713844|FG003|COMPLETED|Period 3||7
8670093|NCT00746330|9713841|FG000|NOT COMPLETED|Period 3||0
8670094|NCT00746330|9713842|FG001|NOT COMPLETED|Period 3||0
8670095|NCT00746330|9713843|FG002|NOT COMPLETED|Period 3||0
8670096|NCT00746330|9713844|FG003|NOT COMPLETED|Period 3||0
8670097|NCT00746330|9713841|FG000|STARTED|Period 4||7
8670098|NCT00746330|9713842|FG001|STARTED|Period 4||9
8670099|NCT00746330|9713843|FG002|STARTED|Period 4||8
8670100|NCT00746330|9713844|FG003|STARTED|Period 4||7
8670101|NCT00746330|9713841|FG000|COMPLETED|Period 4||7
8670102|NCT00746330|9713842|FG001|COMPLETED|Period 4||9
8670103|NCT00746330|9713843|FG002|COMPLETED|Period 4||8
8670104|NCT00746330|9713844|FG003|COMPLETED|Period 4||7
8670105|NCT00746330|9713841|FG000|NOT COMPLETED|Period 4||0
8670106|NCT00746330|9713842|FG001|NOT COMPLETED|Period 4||0
8670107|NCT00746330|9713843|FG002|NOT COMPLETED|Period 4||0
8670108|NCT00746330|9713844|FG003|NOT COMPLETED|Period 4||0
8670109|NCT00746356|9713855|FG000|STARTED|Overall Study||81
8670110|NCT00746356|9713856|FG001|STARTED|Overall Study||47
8670111|NCT00746356|9713855|FG000|COMPLETED|Overall Study||70
8670112|NCT00746356|9713856|FG001|COMPLETED|Overall Study||40
8670113|NCT00746356|9713855|FG000|NOT COMPLETED|Overall Study||11
8670114|NCT00746356|9713856|FG001|NOT COMPLETED|Overall Study||7
8670115|NCT00746395|9713866|FG000|STARTED|Overall Study||20
8670116|NCT00746395|9713867|FG001|STARTED|Overall Study||20
8911767|NCT02148952|9970868|FG001|STARTED|Follow-Up||77626
8911768|NCT02148952|9970867|FG000|COMPLETED|Follow-Up||79798
8911769|NCT02148952|9970868|FG001|COMPLETED|Follow-Up||77347
8670117|NCT00746395|9713866|FG000|COMPLETED|Overall Study||20
8670118|NCT00746395|9713867|FG001|COMPLETED|Overall Study||20
8670119|NCT00746395|9713866|FG000|NOT COMPLETED|Overall Study||0
8670120|NCT00746395|9713867|FG001|NOT COMPLETED|Overall Study||0
8670121|NCT00746421|9713875|FG000|STARTED|Overall Study||12
8670122|NCT00746421|9713876|FG001|STARTED|Overall Study||11
8670123|NCT00746421|9713875|FG000|COMPLETED|Overall Study||5
8670124|NCT00746421|9713876|FG001|COMPLETED|Overall Study||9
8670125|NCT00746421|9713875|FG000|NOT COMPLETED|Overall Study||7
8670126|NCT00746421|9713876|FG001|NOT COMPLETED|Overall Study||2
8692635|NCT00862641|9738199|FG000|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|176
8692636|NCT00862641|9738200|FG001|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|356
8692637|NCT00862641|9738201|FG002|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|151
8692638|NCT00862641|9738202|FG003|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|316
8692639|NCT00862641|9738199|FG000|NOT COMPLETED|Overall Study||1
8692640|NCT00862641|9738200|FG001|NOT COMPLETED|Overall Study||4
8692641|NCT00862641|9738201|FG002|NOT COMPLETED|Overall Study||1
8733085|NCT01075048|9780570|FG001|COMPLETED|Overall Study||0
8692642|NCT00862641|9738202|FG003|NOT COMPLETED|Overall Study||4
8692643|NCT00862654|9738216|FG000|STARTED|Overall Study||82
8692644|NCT00862654|9738217|FG001|STARTED|Overall Study||82
8692645|NCT00862654|9738218|FG002|STARTED|Overall Study||82
8692646|NCT00862654|9738219|FG003|STARTED|Overall Study||80
8692647|NCT00862654|9738216|FG000|COMPLETED|Overall Study||76
8692648|NCT00862654|9738217|FG001|COMPLETED|Overall Study||74
8692649|NCT00862654|9738218|FG002|COMPLETED|Overall Study||76
8692650|NCT00862654|9738219|FG003|COMPLETED|Overall Study||74
8692651|NCT00862654|9738216|FG000|NOT COMPLETED|Overall Study||6
8911770|NCT02148952|9970867|FG000|NOT COMPLETED|Follow-Up||265
8670127|NCT00746512|9713886|FG000|STARTED|Overall Study||8
8670128|NCT00746512|9713887|FG001|STARTED|Overall Study||10
8670129|NCT00746512|9713888|FG002|STARTED|Overall Study||18
8670130|NCT00746512|9713889|FG003|STARTED|Overall Study||9
8670131|NCT00746512|9713886|FG000|COMPLETED|Overall Study||8
8670132|NCT00746512|9713887|FG001|COMPLETED|Overall Study||10
8670133|NCT00746512|9713888|FG002|COMPLETED|Overall Study||18
8670134|NCT00746512|9713889|FG003|COMPLETED|Overall Study||9
8670135|NCT00746512|9713886|FG000|NOT COMPLETED|Overall Study||0
8670136|NCT00746512|9713887|FG001|NOT COMPLETED|Overall Study||0
8670137|NCT00746512|9713888|FG002|NOT COMPLETED|Overall Study||0
8670138|NCT00746512|9713889|FG003|NOT COMPLETED|Overall Study||0
8670139|NCT00746551|9713901|FG000|STARTED|At Gestational Age of 36 Weeks||40
8670140|NCT00746551|9713902|FG001|STARTED|At Gestational Age of 36 Weeks||40
8670141|NCT00746551|9713901|FG000|COMPLETED|At Gestational Age of 36 Weeks||38
8670142|NCT00746551|9713902|FG001|COMPLETED|At Gestational Age of 36 Weeks||36
8670143|NCT00746551|9713901|FG000|NOT COMPLETED|At Gestational Age of 36 Weeks||2
8670144|NCT00746551|9713902|FG001|NOT COMPLETED|At Gestational Age of 36 Weeks||4
8670145|NCT00746551|9713901|FG000|STARTED|At Delivery (GA of 39 Weeks)||40
8670146|NCT00746551|9713902|FG001|STARTED|At Delivery (GA of 39 Weeks)||40
8670147|NCT00746551|9713901|FG000|COMPLETED|At Delivery (GA of 39 Weeks)||25
8670148|NCT00746551|9713902|FG001|COMPLETED|At Delivery (GA of 39 Weeks)||25
8670149|NCT00746551|9713901|FG000|NOT COMPLETED|At Delivery (GA of 39 Weeks)||15
8670150|NCT00746551|9713902|FG001|NOT COMPLETED|At Delivery (GA of 39 Weeks)||15
8670151|NCT00746564|9713908|FG000|STARTED|Overall Study||75
8670152|NCT00746564|9713908|FG000|COMPLETED|Overall Study||73
8670153|NCT00746564|9713908|FG000|NOT COMPLETED|Overall Study||2
8670154|NCT00746668|9713914|FG000|STARTED|Overall Study||6
8670155|NCT00746668|9713915|FG001|STARTED|Overall Study||5
8670156|NCT00746668|9713916|FG002|STARTED|Overall Study||5
8670157|NCT00746668|9713917|FG003|STARTED|Overall Study||5
8670158|NCT00746668|9713918|FG004|STARTED|Overall Study||5
8670159|NCT00746668|9713919|FG005|STARTED|Overall Study||5
8670160|NCT00746668|9713920|FG006|STARTED|Overall Study||5
8670161|NCT00746668|9713914|FG000|COMPLETED|Overall Study||6
8670162|NCT00746668|9713915|FG001|COMPLETED|Overall Study||5
8670163|NCT00746668|9713916|FG002|COMPLETED|Overall Study||5
8670164|NCT00746668|9713917|FG003|COMPLETED|Overall Study||5
8670165|NCT00746668|9713918|FG004|COMPLETED|Overall Study||5
8670166|NCT00746668|9713919|FG005|COMPLETED|Overall Study||5
8670167|NCT00746668|9713920|FG006|COMPLETED|Overall Study||5
8670168|NCT00746668|9713914|FG000|NOT COMPLETED|Overall Study||0
8670169|NCT00746668|9713915|FG001|NOT COMPLETED|Overall Study||0
8670170|NCT00746668|9713916|FG002|NOT COMPLETED|Overall Study||0
8670171|NCT00746668|9713917|FG003|NOT COMPLETED|Overall Study||0
8670172|NCT00746668|9713918|FG004|NOT COMPLETED|Overall Study||0
8670173|NCT00746668|9713919|FG005|NOT COMPLETED|Overall Study||0
8670174|NCT00746668|9713920|FG006|NOT COMPLETED|Overall Study||0
8670175|NCT00746694|9713933|FG000|STARTED|Overall Study||154
8670176|NCT00746694|9713933|FG000|COMPLETED|Overall Study||154
8670177|NCT00746694|9713933|FG000|NOT COMPLETED|Overall Study||0
8670178|NCT00746733|9713937|FG000|STARTED|First Intervention||12
8670179|NCT00746733|9713938|FG001|STARTED|First Intervention||12
8670180|NCT00746733|9713937|FG000|COMPLETED|First Intervention||12
8670181|NCT00746733|9713938|FG001|COMPLETED|First Intervention||12
8670182|NCT00746733|9713937|FG000|NOT COMPLETED|First Intervention||0
8670183|NCT00746733|9713938|FG001|NOT COMPLETED|First Intervention||0
8670184|NCT00746733|9713937|FG000|STARTED|Second Intervention||12
8670185|NCT00746733|9713938|FG001|STARTED|Second Intervention||12
8670186|NCT00746733|9713937|FG000|COMPLETED|Second Intervention||11
8670187|NCT00746733|9713938|FG001|COMPLETED|Second Intervention||12
8670188|NCT00746733|9713937|FG000|NOT COMPLETED|Second Intervention||1
8670189|NCT00746733|9713938|FG001|NOT COMPLETED|Second Intervention||0
8670190|NCT00746733|9713937|FG000|STARTED|Third Intervention||11
8670191|NCT00746733|9713938|FG001|STARTED|Third Intervention||12
8670192|NCT00746733|9713937|FG000|COMPLETED|Third Intervention||10
8670193|NCT00746733|9713938|FG001|COMPLETED|Third Intervention||11
8670194|NCT00746733|9713937|FG000|NOT COMPLETED|Third Intervention||1
8670195|NCT00746733|9713938|FG001|NOT COMPLETED|Third Intervention||1
8670196|NCT00746733|9713937|FG000|STARTED|Fourth Intervention||10
8670197|NCT00746733|9713938|FG001|STARTED|Fourth Intervention||11
8670198|NCT00746733|9713937|FG000|COMPLETED|Fourth Intervention||10
8670199|NCT00746733|9713938|FG001|COMPLETED|Fourth Intervention||11
8670200|NCT00746733|9713937|FG000|NOT COMPLETED|Fourth Intervention||0
8670201|NCT00746733|9713938|FG001|NOT COMPLETED|Fourth Intervention||0
8670202|NCT00746785|9713954|FG000|STARTED|Overall Study||43
8670203|NCT00746785|9713955|FG001|STARTED|Overall Study||46
8670204|NCT00746785|9713956|FG002|STARTED|Overall Study||40
8670205|NCT00746785|9713954|FG000|COMPLETED|Overall Study||14
8670206|NCT00746785|9713955|FG001|COMPLETED|Overall Study||21
8670207|NCT00746785|9713956|FG002|COMPLETED|Overall Study||13
8670208|NCT00746785|9713954|FG000|NOT COMPLETED|Overall Study||29
8670209|NCT00746785|9713955|FG001|NOT COMPLETED|Overall Study||25
8670210|NCT00746785|9713956|FG002|NOT COMPLETED|Overall Study||27
8670211|NCT00746798|9713968|FG000|STARTED|Overall Study||122
8670212|NCT00746798|9713969|FG001|STARTED|Overall Study||124
8670213|NCT00746798|9713970|FG002|STARTED|Overall Study||113
8670214|NCT00746798|9713971|FG003|STARTED|Overall Study||120
8670215|NCT00746798|9713968|FG000|COMPLETED|Overall Study||121
8670216|NCT00746798|9713969|FG001|COMPLETED|Overall Study||122
8670217|NCT00746798|9713970|FG002|COMPLETED|Overall Study||110
8670218|NCT00746798|9713971|FG003|COMPLETED|Overall Study||120
8670219|NCT00746798|9713968|FG000|NOT COMPLETED|Overall Study||1
8670220|NCT00746798|9713969|FG001|NOT COMPLETED|Overall Study||2
8670221|NCT00746798|9713970|FG002|NOT COMPLETED|Overall Study||3
8670222|NCT00746798|9713971|FG003|NOT COMPLETED|Overall Study||0
8670223|NCT00746863|9713983|FG000|STARTED|Overall Study||21
8670224|NCT00746863|9713984|FG001|STARTED|Overall Study||21
8670225|NCT00746863|9713983|FG000|COMPLETED|Overall Study||21
8733086|NCT01075048|9780571|FG002|COMPLETED|Overall Study||0
8733087|NCT01075048|9780569|FG000|NOT COMPLETED|Overall Study||9
8733088|NCT01075048|9780570|FG001|NOT COMPLETED|Overall Study||60
8733089|NCT01075048|9780571|FG002|NOT COMPLETED|Overall Study||62
8733090|NCT01075074|9780585|FG000|STARTED|Overall Study||25
8733091|NCT01075074|9780586|FG001|STARTED|Overall Study||25
8733092|NCT01075074|9780587|FG002|STARTED|Overall Study||25
8733093|NCT01075074|9780585|FG000|COMPLETED|Overall Study||24
8733094|NCT01075074|9780586|FG001|COMPLETED|Overall Study||23
8733095|NCT01075074|9780587|FG002|COMPLETED|Overall Study||23
8733096|NCT01075074|9780585|FG000|NOT COMPLETED|Overall Study||1
8733097|NCT01075074|9780586|FG001|NOT COMPLETED|Overall Study||2
8733098|NCT01075074|9780587|FG002|NOT COMPLETED|Overall Study||2
8733099|NCT01075087|9780601|FG000|STARTED|Overall Study||9
8733100|NCT01075087|9780602|FG001|STARTED|Overall Study||10
8733101|NCT01075087|9780601|FG000|COMPLETED|Overall Study||9
8733102|NCT01075087|9780602|FG001|COMPLETED|Overall Study||10
8733103|NCT01075087|9780601|FG000|NOT COMPLETED|Overall Study||0
8733104|NCT01075087|9780602|FG001|NOT COMPLETED|Overall Study||0
8733105|NCT01075100|9780610|FG000|STARTED|Overall Study||49
8733106|NCT01075100|9780611|FG001|STARTED|Overall Study||54
8733107|NCT01075100|9780610|FG000|COMPLETED|Overall Study||0
8733108|NCT01075100|9780611|FG001|COMPLETED|Overall Study||1
8733109|NCT01075100|9780610|FG000|NOT COMPLETED|Overall Study||49
8733110|NCT01075100|9780611|FG001|NOT COMPLETED|Overall Study||53
8733111|NCT01075152|9780621|FG000|STARTED|Overall Study|randomized|88
8733112|NCT01075152|9780622|FG001|STARTED|Overall Study|randomized|89
8733113|NCT01075152|9780621|FG000|COMPLETED|Overall Study||87
8733114|NCT01075152|9780622|FG001|COMPLETED|Overall Study||89
8733115|NCT01075152|9780621|FG000|NOT COMPLETED|Overall Study||1
8733116|NCT01075152|9780622|FG001|NOT COMPLETED|Overall Study||0
8733117|NCT01075178|9780632|FG000|STARTED|Subject Matching|eligible for matching|1148
8733118|NCT01075178|9780633|FG001|STARTED|Subject Matching|eligible for matching|1421
8733119|NCT01075178|9780632|FG000|COMPLETED|Subject Matching|subjects matched|1018
8733120|NCT01075178|9780633|FG001|COMPLETED|Subject Matching|subjects matched|1018
8733121|NCT01075178|9780632|FG000|NOT COMPLETED|Subject Matching||130
8733122|NCT01075178|9780633|FG001|NOT COMPLETED|Subject Matching||403
8733123|NCT01075178|9780632|FG000|STARTED|Subject Chart Review|subjects matched|1018
8733124|NCT01075178|9780633|FG001|STARTED|Subject Chart Review|subjects matched|1018
8733125|NCT01075178|9780632|FG000|COMPLETED|Subject Chart Review|subjects in full analysis set|1009
8733126|NCT01075178|9780633|FG001|COMPLETED|Subject Chart Review|subjects in full analysis set|1009
8733127|NCT01075178|9780632|FG000|NOT COMPLETED|Subject Chart Review||9
8733128|NCT01075178|9780633|FG001|NOT COMPLETED|Subject Chart Review||9
8733129|NCT01075191|9780639|FG000|STARTED|Overall Study|65 participants were enrolled; 5 protocol violations were excluded from all analyses except safety.|60
8733130|NCT01075191|9780639|FG000|Discontinued Year 1|Overall Study||7
8733131|NCT01075191|9780639|FG000|Discontinued Year 2|Overall Study||6
8733132|NCT01075191|9780639|FG000|Discontinued Year 3|Overall Study||5
8733133|NCT01075191|9780639|FG000|COMPLETED|Overall Study||42
8733134|NCT01075191|9780639|FG000|NOT COMPLETED|Overall Study||18
8733135|NCT01075204|9780643|FG000|STARTED|Overall Study||335
8733136|NCT01075204|9780643|FG000|COMPLETED|Overall Study||335
8733137|NCT01075204|9780643|FG000|NOT COMPLETED|Overall Study||0
8733138|NCT01075217|9780649|FG000|STARTED|Overall Study|88 patients randomized to receive Isovue; 4 of the patients did not meet entry requirements|84
8733139|NCT01075217|9780650|FG001|STARTED|Overall Study|86 patients randomized to receive Visipaque; 1 of the patients did not meet entry requirements|85
8733140|NCT01075217|9780649|FG000|COMPLETED|Overall Study||82
8733141|NCT01075217|9780650|FG001|COMPLETED|Overall Study||84
8733142|NCT01075217|9780649|FG000|NOT COMPLETED|Overall Study||2
8733143|NCT01075217|9780650|FG001|NOT COMPLETED|Overall Study||1
8733144|NCT01075243|9780667|FG000|STARTED|Overall Study||163
8733145|NCT01075243|9780668|FG001|STARTED|Overall Study||158
8733146|NCT01075243|9780669|FG002|STARTED|Overall Study||80
8733147|NCT01075243|9780667|FG000|COMPLETED|Overall Study||157
8733148|NCT01075243|9780668|FG001|COMPLETED|Overall Study||155
8733149|NCT01075243|9780669|FG002|COMPLETED|Overall Study||80
8733150|NCT01075243|9780667|FG000|NOT COMPLETED|Overall Study||6
8733151|NCT01075243|9780668|FG001|NOT COMPLETED|Overall Study||3
8733152|NCT01075243|9780669|FG002|NOT COMPLETED|Overall Study||0
8733153|NCT01075256|9780682|FG000|STARTED|Overall Study||64
8733154|NCT01075256|9780683|FG001|STARTED|Overall Study||66
8670226|NCT00746863|9713984|FG001|COMPLETED|Overall Study||21
8670227|NCT00746863|9713983|FG000|NOT COMPLETED|Overall Study||0
8733155|NCT01075256|9780684|FG002|STARTED|Overall Study||65
8670228|NCT00746863|9713984|FG001|NOT COMPLETED|Overall Study||0
8670229|NCT00746889|9713992|FG000|STARTED|Overall Study||40
8733156|NCT01075256|9780682|FG000|COMPLETED|Overall Study||63
8670230|NCT00746889|9713993|FG001|STARTED|Overall Study||39
8670231|NCT00746889|9713992|FG000|COMPLETED|Overall Study||36
8670232|NCT00746889|9713993|FG001|COMPLETED|Overall Study||35
8670233|NCT00746889|9713992|FG000|NOT COMPLETED|Overall Study||4
8670234|NCT00746889|9713993|FG001|NOT COMPLETED|Overall Study||4
8670235|NCT00746941|9714005|FG000|STARTED|Overall Study||7
8670236|NCT00746941|9714006|FG001|STARTED|Overall Study||5
8670237|NCT00746941|9714007|FG002|STARTED|Overall Study||5
8670238|NCT00746941|9714008|FG003|STARTED|Overall Study||20
8670239|NCT00746941|9714005|FG000|COMPLETED|Overall Study||0
8670240|NCT00746941|9714006|FG001|COMPLETED|Overall Study||1
8670241|NCT00746941|9714007|FG002|COMPLETED|Overall Study||3
8670242|NCT00746941|9714008|FG003|COMPLETED|Overall Study||7
8670243|NCT00746941|9714005|FG000|NOT COMPLETED|Overall Study||7
8670244|NCT00746941|9714006|FG001|NOT COMPLETED|Overall Study||4
8670245|NCT00746941|9714007|FG002|NOT COMPLETED|Overall Study||2
8670246|NCT00746941|9714008|FG003|NOT COMPLETED|Overall Study||13
8670247|NCT00746954|9714017|FG000|STARTED|Overall Study||3
8670248|NCT00746954|9714018|FG001|STARTED|Overall Study||3
8670249|NCT00746954|9714019|FG002|STARTED|Overall Study||2
8670250|NCT00746954|9714017|FG000|COMPLETED|Overall Study||3
8670251|NCT00746954|9714018|FG001|COMPLETED|Overall Study||3
8670252|NCT00746954|9714019|FG002|COMPLETED|Overall Study||2
8670253|NCT00746954|9714017|FG000|NOT COMPLETED|Overall Study||0
8670254|NCT00746954|9714018|FG001|NOT COMPLETED|Overall Study||0
8670255|NCT00746954|9714019|FG002|NOT COMPLETED|Overall Study||0
8670256|NCT00747006|9714028|FG000|STARTED|Overall Study||7
8670257|NCT00747006|9714029|FG001|STARTED|Overall Study||8
8670258|NCT00747006|9714030|FG002|STARTED|Overall Study||3
8670259|NCT00747006|9714028|FG000|COMPLETED|Overall Study||4
8670260|NCT00747006|9714029|FG001|COMPLETED|Overall Study||7
8670261|NCT00747006|9714030|FG002|COMPLETED|Overall Study||2
8670262|NCT00747006|9714028|FG000|NOT COMPLETED|Overall Study||3
8670263|NCT00747006|9714029|FG001|NOT COMPLETED|Overall Study||1
8670264|NCT00747006|9714030|FG002|NOT COMPLETED|Overall Study||1
8670265|NCT00747149|9714043|FG000|STARTED|Overall Study||154
8670266|NCT00747149|9714044|FG001|STARTED|Overall Study||444
8670267|NCT00747149|9714043|FG000|COMPLETED|Overall Study||153
8670268|NCT00747149|9714044|FG001|COMPLETED|Overall Study||401
8670269|NCT00747149|9714043|FG000|NOT COMPLETED|Overall Study||1
8670270|NCT00747149|9714044|FG001|NOT COMPLETED|Overall Study||43
8670271|NCT00747214|9714058|FG000|STARTED|Overall Study||27
8670272|NCT00747214|9714059|FG001|STARTED|Overall Study||32
8670273|NCT00747214|9714058|FG000|COMPLETED|Overall Study||19
8670274|NCT00747214|9714059|FG001|COMPLETED|Overall Study||29
8670275|NCT00747214|9714058|FG000|NOT COMPLETED|Overall Study||8
8670276|NCT00747214|9714059|FG001|NOT COMPLETED|Overall Study||3
8670277|NCT00747227|9714067|FG000|STARTED|Overall Study||126
8670278|NCT00747227|9714068|FG001|STARTED|Overall Study||124
8670279|NCT00747227|9714067|FG000|COMPLETED|Overall Study||120
8670280|NCT00747227|9714068|FG001|COMPLETED|Overall Study||120
8670281|NCT00747227|9714067|FG000|NOT COMPLETED|Overall Study||6
8670282|NCT00747227|9714068|FG001|NOT COMPLETED|Overall Study||4
8733157|NCT01075256|9780683|FG001|COMPLETED|Overall Study||66
8733158|NCT01075256|9780684|FG002|COMPLETED|Overall Study||65
8733159|NCT01075256|9780682|FG000|NOT COMPLETED|Overall Study||1
8733160|NCT01075256|9780683|FG001|NOT COMPLETED|Overall Study||0
8733161|NCT01075256|9780684|FG002|NOT COMPLETED|Overall Study||0
8733162|NCT01075282|9780700|FG000|STARTED|Overall Study||273
8733163|NCT01075282|9780701|FG001|STARTED|Overall Study||272
8733164|NCT01075282|9780702|FG002|STARTED|Overall Study|Of 265 participants randomized to Insulin Glargine, 3 chose not to take study drug.|265
8733165|NCT01075282|9780700|FG000|Received at Least One Dose of Study Drug|Overall Study||273
8733166|NCT01075282|9780701|FG001|Received at Least One Dose of Study Drug|Overall Study||272
8733167|NCT01075282|9780702|FG002|Received at Least One Dose of Study Drug|Overall Study||262
8733168|NCT01075282|9780700|FG000|COMPLETED|Overall Study||242
8733169|NCT01075282|9780701|FG001|COMPLETED|Overall Study||243
8733170|NCT01075282|9780702|FG002|COMPLETED|Overall Study||238
8733171|NCT01075282|9780700|FG000|NOT COMPLETED|Overall Study||31
8733172|NCT01075282|9780701|FG001|NOT COMPLETED|Overall Study||29
8733173|NCT01075282|9780702|FG002|NOT COMPLETED|Overall Study||27
8733174|NCT01075321|9780711|FG000|STARTED|Overall Study||7
8733175|NCT01075321|9780712|FG001|STARTED|Overall Study||9
8733176|NCT01075321|9780713|FG002|STARTED|Overall Study||9
8733177|NCT01075321|9780714|FG003|STARTED|Overall Study||33
8733178|NCT01075321|9780711|FG000|COMPLETED|Overall Study||6
8733179|NCT01075321|9780712|FG001|COMPLETED|Overall Study||9
8733180|NCT01075321|9780713|FG002|COMPLETED|Overall Study||7
8733181|NCT01075321|9780714|FG003|COMPLETED|Overall Study||31
8733182|NCT01075321|9780711|FG000|NOT COMPLETED|Overall Study||1
8733183|NCT01075321|9780712|FG001|NOT COMPLETED|Overall Study||0
8733184|NCT01075321|9780713|FG002|NOT COMPLETED|Overall Study||2
8733185|NCT01075321|9780714|FG003|NOT COMPLETED|Overall Study||2
8733186|NCT01075347|9780728|FG000|STARTED|Overall Study||82
8733187|NCT01075347|9780729|FG001|STARTED|Overall Study||83
8733188|NCT01075347|9780728|FG000|COMPLETED|Overall Study||82
8670283|NCT00747344|9714076|FG000|STARTED|Controlled Period||60
8670284|NCT00747344|9714077|FG001|STARTED|Controlled Period||61
8670285|NCT00747344|9714078|FG002|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
8670286|NCT00747344|9714079|FG003|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
8670287|NCT00747344|9714076|FG000|COMPLETED|Controlled Period||55
8670288|NCT00747344|9714077|FG001|COMPLETED|Controlled Period||57
8670289|NCT00747344|9714078|FG002|COMPLETED|Controlled Period||0
8733189|NCT01075347|9780729|FG001|COMPLETED|Overall Study||83
8733190|NCT01075347|9780728|FG000|NOT COMPLETED|Overall Study||0
8733191|NCT01075347|9780729|FG001|NOT COMPLETED|Overall Study||0
8733192|NCT01075399|9780735|FG000|STARTED|Overall Study|A total of 50 patients were enrolled into the study.|50
8733193|NCT01075399|9780735|FG000|COMPLETED|Overall Study|42 of 50 patients received at least one dose and 39 of 50 patients completed two pre-treatment scan|42
8733194|NCT01075399|9780735|FG000|NOT COMPLETED|Overall Study||8
8733195|NCT01075412|9780741|FG000|STARTED|Overall Study||4
8733196|NCT01075412|9780742|FG001|STARTED|Overall Study||2
8733197|NCT01075412|9780741|FG000|COMPLETED|Overall Study||4
8733198|NCT01075412|9780742|FG001|COMPLETED|Overall Study||1
8733199|NCT01075412|9780741|FG000|NOT COMPLETED|Overall Study||0
8733200|NCT01075412|9780742|FG001|NOT COMPLETED|Overall Study||1
8733201|NCT01075516|9780749|FG000|STARTED|Overall Study||107
8733202|NCT01075516|9780750|FG001|STARTED|Overall Study||102
8733203|NCT01075516|9780749|FG000|COMPLETED|Overall Study||89
8733204|NCT01075516|9780750|FG001|COMPLETED|Overall Study||86
8733205|NCT01075516|9780749|FG000|NOT COMPLETED|Overall Study||18
8733206|NCT01075516|9780750|FG001|NOT COMPLETED|Overall Study||16
8733207|NCT01075646|9780760|FG000|STARTED|Overall Study||33
8733208|NCT01075646|9780761|FG001|STARTED|Overall Study||34
8733209|NCT01075646|9780762|FG002|STARTED|Overall Study||53
8733210|NCT01075646|9780763|FG003|STARTED|Overall Study||46
8733211|NCT01075646|9780760|FG000|COMPLETED|Overall Study||29
8733212|NCT01075646|9780761|FG001|COMPLETED|Overall Study||31
8733213|NCT01075646|9780762|FG002|COMPLETED|Overall Study||52
8733214|NCT01075646|9780763|FG003|COMPLETED|Overall Study||44
8733215|NCT01075646|9780760|FG000|NOT COMPLETED|Overall Study||4
8733216|NCT01075646|9780761|FG001|NOT COMPLETED|Overall Study||3
8733217|NCT01075646|9780762|FG002|NOT COMPLETED|Overall Study||1
8733218|NCT01075646|9780763|FG003|NOT COMPLETED|Overall Study||2
8806728|NCT01479595|9859057|FG000|NOT COMPLETED|Overall Study||2
8670290|NCT00747344|9714079|FG003|COMPLETED|Controlled Period||0
8670291|NCT00747344|9714076|FG000|NOT COMPLETED|Controlled Period||5
8670292|NCT00747344|9714077|FG001|NOT COMPLETED|Controlled Period||4
8670293|NCT00747344|9714078|FG002|NOT COMPLETED|Controlled Period||0
8670294|NCT00747344|9714079|FG003|NOT COMPLETED|Controlled Period||0
8670295|NCT00747344|9714076|FG000|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
8670296|NCT00747344|9714077|FG001|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
8670297|NCT00747344|9714078|FG002|STARTED|After Controlled Period||55
8806729|NCT01479595|9859058|FG001|NOT COMPLETED|Overall Study||2
8806730|NCT01479621|9859070|FG000|STARTED|Pre-Assignment Period (Run-In Placebo)||909
8806731|NCT01479621|9859071|FG001|STARTED|Pre-Assignment Period (Run-In Placebo)||0
8806732|NCT01479621|9859072|FG002|STARTED|Pre-Assignment Period (Run-In Placebo)||0
8806733|NCT01479621|9859073|FG003|STARTED|Pre-Assignment Period (Run-In Placebo)||0
8806734|NCT01479621|9859074|FG004|STARTED|Pre-Assignment Period (Run-In Placebo)||0
8806735|NCT01479621|9859075|FG005|STARTED|Pre-Assignment Period (Run-In Placebo)||0
8806736|NCT01479621|9859076|FG006|STARTED|Pre-Assignment Period (Run-In Placebo)||0
8806737|NCT01479621|9859070|FG000|COMPLETED|Pre-Assignment Period (Run-In Placebo)||622
8806738|NCT01479621|9859071|FG001|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
8806739|NCT01479621|9859072|FG002|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
8806740|NCT01479621|9859073|FG003|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
8806741|NCT01479621|9859074|FG004|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
8806742|NCT01479621|9859075|FG005|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
8806743|NCT01479621|9859076|FG006|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
8806744|NCT01479621|9859070|FG000|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||287
8806745|NCT01479621|9859071|FG001|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
8806746|NCT01479621|9859072|FG002|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
8806747|NCT01479621|9859073|FG003|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
8806748|NCT01479621|9859074|FG004|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
8806749|NCT01479621|9859075|FG005|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
8806750|NCT01479621|9859076|FG006|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
8806751|NCT01479621|9859070|FG000|STARTED|Treatment Period||0
8806752|NCT01479621|9859071|FG001|STARTED|Treatment Period||103
8806753|NCT01479621|9859072|FG002|STARTED|Treatment Period||104
8806754|NCT01479621|9859073|FG003|STARTED|Treatment Period||104
8806755|NCT01479621|9859074|FG004|STARTED|Treatment Period||103
8806756|NCT01479621|9859075|FG005|STARTED|Treatment Period||104
8806757|NCT01479621|9859076|FG006|STARTED|Treatment Period||104
8806758|NCT01479621|9859070|FG000|Safety Population|Treatment Period||0
8806759|NCT01479621|9859071|FG001|Safety Population|Treatment Period||103
8806760|NCT01479621|9859072|FG002|Safety Population|Treatment Period||104
8806761|NCT01479621|9859073|FG003|Safety Population|Treatment Period||104
8806762|NCT01479621|9859074|FG004|Safety Population|Treatment Period||103
8806763|NCT01479621|9859075|FG005|Safety Population|Treatment Period||104
8806764|NCT01479621|9859076|FG006|Safety Population|Treatment Period||104
8806765|NCT01479621|9859070|FG000|Full Analysis Set|Treatment Period||0
8806766|NCT01479621|9859071|FG001|Full Analysis Set|Treatment Period||102
8806767|NCT01479621|9859072|FG002|Full Analysis Set|Treatment Period||101
8670298|NCT00747344|9714079|FG003|STARTED|After Controlled Period|2 participants discontinued in CP, had follow-up, and are among frequent and serious adverse events.|57
8670299|NCT00747344|9714076|FG000|COMPLETED|After Controlled Period||0
8670300|NCT00747344|9714077|FG001|COMPLETED|After Controlled Period||0
8670301|NCT00747344|9714078|FG002|COMPLETED|After Controlled Period||55
8670302|NCT00747344|9714079|FG003|COMPLETED|After Controlled Period||56
8670303|NCT00747344|9714076|FG000|NOT COMPLETED|After Controlled Period||0
8670304|NCT00747344|9714077|FG001|NOT COMPLETED|After Controlled Period||0
8670305|NCT00747344|9714078|FG002|NOT COMPLETED|After Controlled Period||0
8670306|NCT00747344|9714079|FG003|NOT COMPLETED|After Controlled Period||1
8670307|NCT00747435|9714087|FG000|STARTED|Overall Study||73
8670308|NCT00747435|9714087|FG000|COMPLETED|Overall Study||67
8670309|NCT00747435|9714087|FG000|NOT COMPLETED|Overall Study||6
8670310|NCT00747474|9714091|FG000|STARTED|Cohort 1 (1.5 mg/m^2) Period||3
8670311|NCT00747474|9714092|FG001|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
8670312|NCT00747474|9714093|FG002|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
8670313|NCT00747474|9714094|FG003|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
8670314|NCT00747474|9714095|FG004|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
8670315|NCT00747474|9714096|FG005|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
8670316|NCT00747474|9714097|FG006|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
8670317|NCT00747474|9714098|FG007|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
8670318|NCT00747474|9714099|FG008|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
8670319|NCT00747474|9714100|FG009|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
8670320|NCT00747474|9714101|FG010|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
8670321|NCT00747474|9714102|FG011|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
8670322|NCT00747474|9714091|FG000|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||3
8670323|NCT00747474|9714092|FG001|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
8670324|NCT00747474|9714093|FG002|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
8670325|NCT00747474|9714094|FG003|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
8670326|NCT00747474|9714095|FG004|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
8670327|NCT00747474|9714096|FG005|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
8670328|NCT00747474|9714097|FG006|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
8670329|NCT00747474|9714098|FG007|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
8670330|NCT00747474|9714099|FG008|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
8670331|NCT00747474|9714100|FG009|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
8670332|NCT00747474|9714101|FG010|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
8670333|NCT00747474|9714102|FG011|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
8670334|NCT00747474|9714091|FG000|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
8670335|NCT00747474|9714092|FG001|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
8670336|NCT00747474|9714093|FG002|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
8670337|NCT00747474|9714094|FG003|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
8670338|NCT00747474|9714095|FG004|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
8670339|NCT00747474|9714096|FG005|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
8670340|NCT00747474|9714097|FG006|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
8670341|NCT00747474|9714098|FG007|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
8670342|NCT00747474|9714099|FG008|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
8670343|NCT00747474|9714100|FG009|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
8670344|NCT00747474|9714101|FG010|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
8670345|NCT00747474|9714102|FG011|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
8670346|NCT00747474|9714091|FG000|STARTED|Cohort 2 (3 mg/m^2) Period||0
8670347|NCT00747474|9714092|FG001|STARTED|Cohort 2 (3 mg/m^2) Period||4
8670348|NCT00747474|9714093|FG002|STARTED|Cohort 2 (3 mg/m^2) Period||0
8670349|NCT00747474|9714094|FG003|STARTED|Cohort 2 (3 mg/m^2) Period||0
8670350|NCT00747474|9714095|FG004|STARTED|Cohort 2 (3 mg/m^2) Period||0
8670351|NCT00747474|9714096|FG005|STARTED|Cohort 2 (3 mg/m^2) Period||0
8670352|NCT00747474|9714097|FG006|STARTED|Cohort 2 (3 mg/m^2) Period||0
8670353|NCT00747474|9714098|FG007|STARTED|Cohort 2 (3 mg/m^2) Period||0
8670354|NCT00747474|9714099|FG008|STARTED|Cohort 2 (3 mg/m^2) Period||0
8670355|NCT00747474|9714100|FG009|STARTED|Cohort 2 (3 mg/m^2) Period||0
8670356|NCT00747474|9714101|FG010|STARTED|Cohort 2 (3 mg/m^2) Period||0
8670357|NCT00747474|9714102|FG011|STARTED|Cohort 2 (3 mg/m^2) Period||0
8670358|NCT00747474|9714091|FG000|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
8670359|NCT00747474|9714092|FG001|COMPLETED|Cohort 2 (3 mg/m^2) Period||4
8670360|NCT00747474|9714093|FG002|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
8670361|NCT00747474|9714094|FG003|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
8670362|NCT00747474|9714095|FG004|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
8670363|NCT00747474|9714096|FG005|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
8670364|NCT00747474|9714097|FG006|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
8670365|NCT00747474|9714098|FG007|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
8670366|NCT00747474|9714099|FG008|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
8670367|NCT00747474|9714100|FG009|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
8670368|NCT00747474|9714101|FG010|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
8670369|NCT00747474|9714102|FG011|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
8670370|NCT00747474|9714091|FG000|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
8670371|NCT00747474|9714092|FG001|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
8670372|NCT00747474|9714093|FG002|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
8670373|NCT00747474|9714094|FG003|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
8670374|NCT00747474|9714095|FG004|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
8670375|NCT00747474|9714096|FG005|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
8670376|NCT00747474|9714097|FG006|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
8670377|NCT00747474|9714098|FG007|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
8670378|NCT00747474|9714099|FG008|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
8670379|NCT00747474|9714100|FG009|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
8670380|NCT00747474|9714101|FG010|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
8670381|NCT00747474|9714102|FG011|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
8670382|NCT00747474|9714091|FG000|STARTED|Cohort 3 (6 mg/m^2) Period||0
8670383|NCT00747474|9714092|FG001|STARTED|Cohort 3 (6 mg/m^2) Period||0
8670384|NCT00747474|9714093|FG002|STARTED|Cohort 3 (6 mg/m^2) Period||3
8670385|NCT00747474|9714094|FG003|STARTED|Cohort 3 (6 mg/m^2) Period||0
8670386|NCT00747474|9714095|FG004|STARTED|Cohort 3 (6 mg/m^2) Period||0
8670387|NCT00747474|9714096|FG005|STARTED|Cohort 3 (6 mg/m^2) Period||0
8670388|NCT00747474|9714097|FG006|STARTED|Cohort 3 (6 mg/m^2) Period||0
8670389|NCT00747474|9714098|FG007|STARTED|Cohort 3 (6 mg/m^2) Period||0
8670390|NCT00747474|9714099|FG008|STARTED|Cohort 3 (6 mg/m^2) Period||0
8670391|NCT00747474|9714100|FG009|STARTED|Cohort 3 (6 mg/m^2) Period||0
8670392|NCT00747474|9714101|FG010|STARTED|Cohort 3 (6 mg/m^2) Period||0
8670393|NCT00747474|9714102|FG011|STARTED|Cohort 3 (6 mg/m^2) Period||0
8670394|NCT00747474|9714091|FG000|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
8670395|NCT00747474|9714092|FG001|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
8670396|NCT00747474|9714093|FG002|COMPLETED|Cohort 3 (6 mg/m^2) Period||3
8670397|NCT00747474|9714094|FG003|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
8670398|NCT00747474|9714095|FG004|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
8670399|NCT00747474|9714096|FG005|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
8670400|NCT00747474|9714097|FG006|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
8670401|NCT00747474|9714098|FG007|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
8670402|NCT00747474|9714099|FG008|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
8670403|NCT00747474|9714100|FG009|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
8670404|NCT00747474|9714101|FG010|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
8670405|NCT00747474|9714102|FG011|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
8670406|NCT00747474|9714091|FG000|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
8670407|NCT00747474|9714092|FG001|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
8670408|NCT00747474|9714093|FG002|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
8733219|NCT01075685|9780775|FG000|STARTED|Overall Study||743
8733220|NCT01075685|9780776|FG001|STARTED|Overall Study||414
8733221|NCT01075685|9780775|FG000|Met Inclusion Criteria|Overall Study||734
8733222|NCT01075685|9780776|FG001|Met Inclusion Criteria|Overall Study||413
8733223|NCT01075685|9780775|FG000|Completed Baseline Measures|Overall Study||225
8733224|NCT01075685|9780776|FG001|Completed Baseline Measures|Overall Study||263
8733225|NCT01075685|9780775|FG000|COMPLETED|Overall Study||151
8733226|NCT01075685|9780776|FG001|COMPLETED|Overall Study||188
8733227|NCT01075685|9780775|FG000|NOT COMPLETED|Overall Study||592
8733228|NCT01075685|9780776|FG001|NOT COMPLETED|Overall Study||226
8733229|NCT01075763|9780784|FG000|STARTED|Overall Study||23
8733230|NCT01075763|9780785|FG001|STARTED|Overall Study||19
8733231|NCT01075763|9780784|FG000|COMPLETED|Overall Study||19
8733232|NCT01075763|9780785|FG001|COMPLETED|Overall Study||15
8733233|NCT01075763|9780784|FG000|NOT COMPLETED|Overall Study||4
8733234|NCT01075763|9780785|FG001|NOT COMPLETED|Overall Study||4
8733235|NCT01075815|9780793|FG000|STARTED|Overall Study|Number of participants treated.|40
8733236|NCT01075815|9780794|FG001|STARTED|Overall Study|Number of participants treated.|35
8733237|NCT01075815|9780793|FG000|COMPLETED|Overall Study||30
8733238|NCT01075815|9780794|FG001|COMPLETED|Overall Study||31
8733239|NCT01075815|9780793|FG000|NOT COMPLETED|Overall Study||10
8733240|NCT01075815|9780794|FG001|NOT COMPLETED|Overall Study||4
8733241|NCT01075958|9780800|FG000|STARTED|Overall Study||283
8733242|NCT01075958|9780800|FG000|COMPLETED|Overall Study||239
8733243|NCT01075958|9780800|FG000|NOT COMPLETED|Overall Study||44
8733244|NCT01075971|9780804|FG000|STARTED|Overall Study||52
8733245|NCT01075971|9780804|FG000|COMPLETED|Overall Study||52
8733246|NCT01075971|9780804|FG000|NOT COMPLETED|Overall Study||0
8733247|NCT01075984|9780813|FG000|STARTED|Treatment Phase||10
8733248|NCT01075984|9780814|FG001|STARTED|Treatment Phase||11
8733249|NCT01075984|9780815|FG002|STARTED|Treatment Phase||21
8733250|NCT01075984|9780816|FG003|STARTED|Treatment Phase||24
8733251|NCT01075984|9780817|FG004|STARTED|Treatment Phase||213
8733252|NCT01075984|9780813|FG000|COMPLETED|Treatment Phase||10
8733253|NCT01075984|9780814|FG001|COMPLETED|Treatment Phase||10
8733254|NCT01075984|9780815|FG002|COMPLETED|Treatment Phase||14
8733255|NCT01075984|9780816|FG003|COMPLETED|Treatment Phase||17
8733256|NCT01075984|9780817|FG004|COMPLETED|Treatment Phase||153
8733257|NCT01075984|9780813|FG000|NOT COMPLETED|Treatment Phase||0
8733258|NCT01075984|9780814|FG001|NOT COMPLETED|Treatment Phase||1
8733259|NCT01075984|9780815|FG002|NOT COMPLETED|Treatment Phase||7
8733260|NCT01075984|9780816|FG003|NOT COMPLETED|Treatment Phase||7
8733261|NCT01075984|9780817|FG004|NOT COMPLETED|Treatment Phase||60
8670409|NCT00747474|9714094|FG003|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
8670410|NCT00747474|9714095|FG004|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
8733262|NCT01075984|9780813|FG000|STARTED|Follow-up Phase||10
8733263|NCT01075984|9780814|FG001|STARTED|Follow-up Phase||10
8733264|NCT01075984|9780815|FG002|STARTED|Follow-up Phase|One participant did not start the follow-up phase for reasons unrelated to study procedures.|20
8733265|NCT01075984|9780816|FG003|STARTED|Follow-up Phase|Three participants did not start the follow-up phase: one died and two were lost to follow-up.|21
8733266|NCT01075984|9780817|FG004|STARTED|Follow-up Phase|One participant withdrew consent before the start of the follow-up phase.|212
8733267|NCT01075984|9780813|FG000|COMPLETED|Follow-up Phase||10
8733268|NCT01075984|9780814|FG001|COMPLETED|Follow-up Phase||10
8670411|NCT00747474|9714096|FG005|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
8670412|NCT00747474|9714097|FG006|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
8670413|NCT00747474|9714098|FG007|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
8670414|NCT00747474|9714099|FG008|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
8670415|NCT00747474|9714100|FG009|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
8670416|NCT00747474|9714101|FG010|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
8670417|NCT00747474|9714102|FG011|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
8670418|NCT00747474|9714091|FG000|STARTED|Cohort 4 (9 mg/m^2) Period||0
8670419|NCT00747474|9714092|FG001|STARTED|Cohort 4 (9 mg/m^2) Period||0
8670420|NCT00747474|9714093|FG002|STARTED|Cohort 4 (9 mg/m^2) Period||0
8670421|NCT00747474|9714094|FG003|STARTED|Cohort 4 (9 mg/m^2) Period||4
8670422|NCT00747474|9714095|FG004|STARTED|Cohort 4 (9 mg/m^2) Period||0
8670423|NCT00747474|9714096|FG005|STARTED|Cohort 4 (9 mg/m^2) Period||0
8670424|NCT00747474|9714097|FG006|STARTED|Cohort 4 (9 mg/m^2) Period||0
8670425|NCT00747474|9714098|FG007|STARTED|Cohort 4 (9 mg/m^2) Period||0
8670426|NCT00747474|9714099|FG008|STARTED|Cohort 4 (9 mg/m^2) Period||0
8670427|NCT00747474|9714100|FG009|STARTED|Cohort 4 (9 mg/m^2) Period||0
8670428|NCT00747474|9714101|FG010|STARTED|Cohort 4 (9 mg/m^2) Period||0
8670429|NCT00747474|9714102|FG011|STARTED|Cohort 4 (9 mg/m^2) Period||0
8670430|NCT00747474|9714091|FG000|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
8670431|NCT00747474|9714092|FG001|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
8670432|NCT00747474|9714093|FG002|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
8670433|NCT00747474|9714094|FG003|COMPLETED|Cohort 4 (9 mg/m^2) Period||4
8670434|NCT00747474|9714095|FG004|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
8670435|NCT00747474|9714096|FG005|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
8670436|NCT00747474|9714097|FG006|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
8670437|NCT00747474|9714098|FG007|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
8670438|NCT00747474|9714099|FG008|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
8670439|NCT00747474|9714100|FG009|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
8670440|NCT00747474|9714101|FG010|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
8670441|NCT00747474|9714102|FG011|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
8670442|NCT00747474|9714091|FG000|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
8670443|NCT00747474|9714092|FG001|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
8670444|NCT00747474|9714093|FG002|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
8670445|NCT00747474|9714094|FG003|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
8670446|NCT00747474|9714095|FG004|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
8670447|NCT00747474|9714096|FG005|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
8670448|NCT00747474|9714097|FG006|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
8670449|NCT00747474|9714098|FG007|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
8670450|NCT00747474|9714099|FG008|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
8670451|NCT00747474|9714100|FG009|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
8670452|NCT00747474|9714101|FG010|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
8670453|NCT00747474|9714102|FG011|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
8670454|NCT00747474|9714091|FG000|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
8670455|NCT00747474|9714092|FG001|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
8670456|NCT00747474|9714093|FG002|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
8670457|NCT00747474|9714094|FG003|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
8670458|NCT00747474|9714095|FG004|STARTED|Cohort 5 (13.5 mg/m^2) Period||4
8670459|NCT00747474|9714096|FG005|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
8670460|NCT00747474|9714097|FG006|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
8670461|NCT00747474|9714098|FG007|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
8670462|NCT00747474|9714099|FG008|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
8670463|NCT00747474|9714100|FG009|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
8670464|NCT00747474|9714101|FG010|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
8670465|NCT00747474|9714102|FG011|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
8670466|NCT00747474|9714091|FG000|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
8670467|NCT00747474|9714092|FG001|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
8670468|NCT00747474|9714093|FG002|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
8670469|NCT00747474|9714094|FG003|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
8670470|NCT00747474|9714095|FG004|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||4
8670471|NCT00747474|9714096|FG005|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
8670472|NCT00747474|9714097|FG006|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
8670473|NCT00747474|9714098|FG007|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
8670474|NCT00747474|9714099|FG008|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
8670475|NCT00747474|9714100|FG009|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
8670476|NCT00747474|9714101|FG010|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
8670477|NCT00747474|9714102|FG011|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
8670478|NCT00747474|9714091|FG000|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
8670479|NCT00747474|9714092|FG001|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
8670480|NCT00747474|9714093|FG002|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
8670481|NCT00747474|9714094|FG003|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
8670482|NCT00747474|9714095|FG004|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
8670483|NCT00747474|9714096|FG005|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
8670484|NCT00747474|9714097|FG006|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
8670485|NCT00747474|9714098|FG007|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
8670486|NCT00747474|9714099|FG008|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
8670487|NCT00747474|9714100|FG009|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
8670488|NCT00747474|9714101|FG010|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
8670489|NCT00747474|9714102|FG011|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
8670490|NCT00747474|9714091|FG000|STARTED|Cohort 6 (20 mg/m^2) Period||0
8670491|NCT00747474|9714092|FG001|STARTED|Cohort 6 (20 mg/m^2) Period||0
8670492|NCT00747474|9714093|FG002|STARTED|Cohort 6 (20 mg/m^2) Period||0
8670493|NCT00747474|9714094|FG003|STARTED|Cohort 6 (20 mg/m^2) Period||0
8670494|NCT00747474|9714095|FG004|STARTED|Cohort 6 (20 mg/m^2) Period||0
8670495|NCT00747474|9714096|FG005|STARTED|Cohort 6 (20 mg/m^2) Period||4
8670496|NCT00747474|9714097|FG006|STARTED|Cohort 6 (20 mg/m^2) Period||0
8670497|NCT00747474|9714098|FG007|STARTED|Cohort 6 (20 mg/m^2) Period||0
8670498|NCT00747474|9714099|FG008|STARTED|Cohort 6 (20 mg/m^2) Period||0
8670499|NCT00747474|9714100|FG009|STARTED|Cohort 6 (20 mg/m^2) Period||0
8670500|NCT00747474|9714101|FG010|STARTED|Cohort 6 (20 mg/m^2) Period||0
8670501|NCT00747474|9714102|FG011|STARTED|Cohort 6 (20 mg/m^2) Period||0
8670502|NCT00747474|9714091|FG000|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
8670503|NCT00747474|9714092|FG001|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
8670504|NCT00747474|9714093|FG002|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
8670505|NCT00747474|9714094|FG003|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
8670506|NCT00747474|9714095|FG004|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
8670507|NCT00747474|9714096|FG005|COMPLETED|Cohort 6 (20 mg/m^2) Period||4
8670508|NCT00747474|9714097|FG006|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
8670509|NCT00747474|9714098|FG007|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
8670510|NCT00747474|9714099|FG008|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
8670511|NCT00747474|9714100|FG009|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
8670512|NCT00747474|9714101|FG010|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
8670513|NCT00747474|9714102|FG011|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
8670514|NCT00747474|9714091|FG000|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
8670515|NCT00747474|9714092|FG001|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
8670516|NCT00747474|9714093|FG002|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
8670517|NCT00747474|9714094|FG003|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
8670518|NCT00747474|9714095|FG004|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
8670519|NCT00747474|9714096|FG005|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
8670520|NCT00747474|9714097|FG006|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
8670521|NCT00747474|9714098|FG007|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
8670522|NCT00747474|9714099|FG008|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
8670523|NCT00747474|9714100|FG009|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
8670524|NCT00747474|9714101|FG010|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
8670525|NCT00747474|9714102|FG011|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
8670526|NCT00747474|9714091|FG000|STARTED|Cohort 7 (30 mg/m^2) Period||0
8670527|NCT00747474|9714092|FG001|STARTED|Cohort 7 (30 mg/m^2) Period||0
8670528|NCT00747474|9714093|FG002|STARTED|Cohort 7 (30 mg/m^2) Period||0
8670529|NCT00747474|9714094|FG003|STARTED|Cohort 7 (30 mg/m^2) Period||0
8670530|NCT00747474|9714095|FG004|STARTED|Cohort 7 (30 mg/m^2) Period||0
8670531|NCT00747474|9714096|FG005|STARTED|Cohort 7 (30 mg/m^2) Period||0
8670532|NCT00747474|9714097|FG006|STARTED|Cohort 7 (30 mg/m^2) Period||4
8670533|NCT00747474|9714098|FG007|STARTED|Cohort 7 (30 mg/m^2) Period||0
8670534|NCT00747474|9714099|FG008|STARTED|Cohort 7 (30 mg/m^2) Period||0
8670535|NCT00747474|9714100|FG009|STARTED|Cohort 7 (30 mg/m^2) Period||0
8670536|NCT00747474|9714101|FG010|STARTED|Cohort 7 (30 mg/m^2) Period||0
8670537|NCT00747474|9714102|FG011|STARTED|Cohort 7 (30 mg/m^2) Period||0
8670538|NCT00747474|9714091|FG000|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
8670539|NCT00747474|9714092|FG001|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
8670540|NCT00747474|9714093|FG002|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
8670541|NCT00747474|9714094|FG003|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
8670542|NCT00747474|9714095|FG004|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
8670543|NCT00747474|9714096|FG005|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
8670544|NCT00747474|9714097|FG006|COMPLETED|Cohort 7 (30 mg/m^2) Period||4
8670545|NCT00747474|9714098|FG007|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
8670546|NCT00747474|9714099|FG008|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
8670547|NCT00747474|9714100|FG009|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
8670548|NCT00747474|9714101|FG010|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
8670549|NCT00747474|9714102|FG011|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
8670550|NCT00747474|9714091|FG000|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
8670551|NCT00747474|9714092|FG001|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
8670552|NCT00747474|9714093|FG002|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
8670553|NCT00747474|9714094|FG003|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
8670554|NCT00747474|9714095|FG004|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
8670555|NCT00747474|9714096|FG005|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
8670556|NCT00747474|9714097|FG006|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
8670557|NCT00747474|9714098|FG007|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
8670558|NCT00747474|9714099|FG008|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
8670559|NCT00747474|9714100|FG009|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
8670560|NCT00747474|9714101|FG010|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
8670561|NCT00747474|9714102|FG011|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
8670562|NCT00747474|9714091|FG000|STARTED|Cohort 8 (40 mg/m^2) Period||0
8670563|NCT00747474|9714092|FG001|STARTED|Cohort 8 (40 mg/m^2) Period||0
8670564|NCT00747474|9714093|FG002|STARTED|Cohort 8 (40 mg/m^2) Period||0
8670565|NCT00747474|9714094|FG003|STARTED|Cohort 8 (40 mg/m^2) Period||0
8670566|NCT00747474|9714095|FG004|STARTED|Cohort 8 (40 mg/m^2) Period||0
8670567|NCT00747474|9714096|FG005|STARTED|Cohort 8 (40 mg/m^2) Period||0
8670568|NCT00747474|9714097|FG006|STARTED|Cohort 8 (40 mg/m^2) Period||0
8670569|NCT00747474|9714098|FG007|STARTED|Cohort 8 (40 mg/m^2) Period||6
8670570|NCT00747474|9714099|FG008|STARTED|Cohort 8 (40 mg/m^2) Period||0
8670571|NCT00747474|9714100|FG009|STARTED|Cohort 8 (40 mg/m^2) Period||0
8670572|NCT00747474|9714101|FG010|STARTED|Cohort 8 (40 mg/m^2) Period||0
8670573|NCT00747474|9714102|FG011|STARTED|Cohort 8 (40 mg/m^2) Period||0
8670574|NCT00747474|9714091|FG000|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
8670575|NCT00747474|9714092|FG001|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
8670576|NCT00747474|9714093|FG002|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
8670577|NCT00747474|9714094|FG003|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
8670578|NCT00747474|9714095|FG004|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
8670579|NCT00747474|9714096|FG005|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
8670580|NCT00747474|9714097|FG006|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
8670581|NCT00747474|9714098|FG007|COMPLETED|Cohort 8 (40 mg/m^2) Period||5
8670582|NCT00747474|9714099|FG008|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
8670583|NCT00747474|9714100|FG009|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
8670584|NCT00747474|9714101|FG010|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
8670585|NCT00747474|9714102|FG011|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
8670586|NCT00747474|9714091|FG000|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
8670587|NCT00747474|9714092|FG001|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
8670588|NCT00747474|9714093|FG002|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
8670589|NCT00747474|9714094|FG003|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
8670590|NCT00747474|9714095|FG004|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
8670591|NCT00747474|9714096|FG005|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
8670592|NCT00747474|9714097|FG006|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
8670593|NCT00747474|9714098|FG007|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||1
8670594|NCT00747474|9714099|FG008|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
8670595|NCT00747474|9714100|FG009|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
8670596|NCT00747474|9714101|FG010|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
8670597|NCT00747474|9714102|FG011|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
8670598|NCT00747474|9714091|FG000|STARTED|Cohort 9 (35 mg/m^2) Period||0
8670599|NCT00747474|9714092|FG001|STARTED|Cohort 9 (35 mg/m^2) Period||0
8670600|NCT00747474|9714093|FG002|STARTED|Cohort 9 (35 mg/m^2) Period||0
8670601|NCT00747474|9714094|FG003|STARTED|Cohort 9 (35 mg/m^2) Period||0
8670602|NCT00747474|9714095|FG004|STARTED|Cohort 9 (35 mg/m^2) Period||0
8670603|NCT00747474|9714096|FG005|STARTED|Cohort 9 (35 mg/m^2) Period||0
8670604|NCT00747474|9714097|FG006|STARTED|Cohort 9 (35 mg/m^2) Period||0
8670605|NCT00747474|9714098|FG007|STARTED|Cohort 9 (35 mg/m^2) Period||0
8670606|NCT00747474|9714099|FG008|STARTED|Cohort 9 (35 mg/m^2) Period||4
8670607|NCT00747474|9714100|FG009|STARTED|Cohort 9 (35 mg/m^2) Period||0
8670608|NCT00747474|9714101|FG010|STARTED|Cohort 9 (35 mg/m^2) Period||0
8670609|NCT00747474|9714102|FG011|STARTED|Cohort 9 (35 mg/m^2) Period||0
8670610|NCT00747474|9714091|FG000|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
8670611|NCT00747474|9714092|FG001|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
8733269|NCT01075984|9780815|FG002|COMPLETED|Follow-up Phase||19
8733270|NCT01075984|9780816|FG003|COMPLETED|Follow-up Phase||19
8733271|NCT01075984|9780817|FG004|COMPLETED|Follow-up Phase||165
8733272|NCT01075984|9780813|FG000|NOT COMPLETED|Follow-up Phase||0
8733273|NCT01075984|9780814|FG001|NOT COMPLETED|Follow-up Phase||0
8733274|NCT01075984|9780815|FG002|NOT COMPLETED|Follow-up Phase||1
8733275|NCT01075984|9780816|FG003|NOT COMPLETED|Follow-up Phase||2
8733276|NCT01075984|9780817|FG004|NOT COMPLETED|Follow-up Phase||47
8733277|NCT01076010|9780832|FG000|STARTED|Overall Study||161
8733278|NCT01076010|9780833|FG001|STARTED|Overall Study||88
8733279|NCT01076010|9780834|FG002|STARTED|Overall Study||28
8733280|NCT01076010|9780832|FG000|COMPLETED|Overall Study||36
8733281|NCT01076010|9780833|FG001|COMPLETED|Overall Study||49
8733282|NCT01076010|9780834|FG002|COMPLETED|Overall Study||26
8733283|NCT01076010|9780832|FG000|NOT COMPLETED|Overall Study||125
8733284|NCT01076010|9780833|FG001|NOT COMPLETED|Overall Study||39
8733285|NCT01076010|9780834|FG002|NOT COMPLETED|Overall Study||2
8733286|NCT01076036|9780842|FG000|STARTED|Overall Study||10
8733287|NCT01076036|9780842|FG000|# of Procedures|Overall Study||8
8733288|NCT01076036|9780842|FG000|Complete CorPath Procedures|Overall Study||8
8733289|NCT01076036|9780842|FG000|COMPLETED|Overall Study||8
8733290|NCT01076036|9780842|FG000|NOT COMPLETED|Overall Study||2
8733291|NCT01076049|9780849|FG000|STARTED|Overall Study||52
8733292|NCT01076049|9780850|FG001|STARTED|Overall Study||55
8733293|NCT01076049|9780851|FG002|STARTED|Overall Study||1
8733294|NCT01076049|9780849|FG000|COMPLETED|Overall Study||45
8733295|NCT01076049|9780850|FG001|COMPLETED|Overall Study||52
8733296|NCT01076049|9780851|FG002|COMPLETED|Overall Study||1
8733297|NCT01076049|9780849|FG000|NOT COMPLETED|Overall Study||7
8733298|NCT01076049|9780850|FG001|NOT COMPLETED|Overall Study||3
8733299|NCT01076049|9780851|FG002|NOT COMPLETED|Overall Study||0
8733300|NCT01076075|9780863|FG000|STARTED|Overall Study|3 participants were excluded from safety and efficacy analyses due to one site's non-compliance|213
8733301|NCT01076075|9780864|FG001|STARTED|Overall Study|2 participants were excluded from safety and efficacy analyses due to one site's non-compliance|214
8733302|NCT01076075|9780863|FG000|Completed Phase A|Overall Study||199
8733303|NCT01076075|9780864|FG001|Completed Phase A|Overall Study||189
8733304|NCT01076075|9780863|FG000|COMPLETED|Overall Study||172
8733305|NCT01076075|9780864|FG001|COMPLETED|Overall Study||167
8733306|NCT01076075|9780863|FG000|NOT COMPLETED|Overall Study||41
8733307|NCT01076075|9780864|FG001|NOT COMPLETED|Overall Study||47
8733308|NCT01076088|9780879|FG000|STARTED|Overall Study||122
8733309|NCT01076088|9780880|FG001|STARTED|Overall Study||125
8733310|NCT01076088|9780881|FG002|STARTED|Overall Study||126
8733311|NCT01076088|9780882|FG003|STARTED|Overall Study||124
8733312|NCT01076088|9780883|FG004|STARTED|Overall Study||120
8733313|NCT01076088|9780884|FG005|STARTED|Overall Study||127
8733314|NCT01076088|9780879|FG000|COMPLETED|Overall Study||111
8733315|NCT01076088|9780880|FG001|COMPLETED|Overall Study||107
8733316|NCT01076088|9780881|FG002|COMPLETED|Overall Study||109
8733317|NCT01076088|9780882|FG003|COMPLETED|Overall Study||109
8733318|NCT01076088|9780883|FG004|COMPLETED|Overall Study||104
8733319|NCT01076088|9780884|FG005|COMPLETED|Overall Study||104
8733320|NCT01076088|9780879|FG000|NOT COMPLETED|Overall Study||11
8733321|NCT01076088|9780880|FG001|NOT COMPLETED|Overall Study||18
8733322|NCT01076088|9780881|FG002|NOT COMPLETED|Overall Study||17
8733323|NCT01076088|9780882|FG003|NOT COMPLETED|Overall Study||15
8733324|NCT01076088|9780883|FG004|NOT COMPLETED|Overall Study||16
8733325|NCT01076088|9780884|FG005|NOT COMPLETED|Overall Study||23
8733326|NCT01076153|9780899|FG000|STARTED|Overall Study||760
8733327|NCT01076153|9780899|FG000|COMPLETED|Overall Study||749
8733328|NCT01076153|9780899|FG000|NOT COMPLETED|Overall Study||11
8733329|NCT01076166|9780907|FG000|STARTED|Overall Study||337
8733330|NCT01076166|9780907|FG000|COMPLETED|Overall Study||328
8733331|NCT01076166|9780907|FG000|NOT COMPLETED|Overall Study||9
8733332|NCT01076179|9780914|FG000|STARTED|Overall Study||502
8733333|NCT01076179|9780914|FG000|COMPLETED|Overall Study||501
8733334|NCT01076179|9780914|FG000|NOT COMPLETED|Overall Study||1
8733335|NCT01076192|9780919|FG000|STARTED|Overall Study||547
8733336|NCT01076192|9780919|FG000|COMPLETED|Overall Study||350
8733337|NCT01076192|9780919|FG000|NOT COMPLETED|Overall Study||197
8733338|NCT01076205|9780924|FG000|STARTED|Overall Study||7229
8733339|NCT01076205|9780924|FG000|COMPLETED|Overall Study||1210
8733340|NCT01076205|9780924|FG000|NOT COMPLETED|Overall Study||6019
8733341|NCT01076231|9780944|FG000|STARTED|Overall Study||34
8733342|NCT01076231|9780944|FG000|COMPLETED|Overall Study||0
8733343|NCT01076231|9780944|FG000|NOT COMPLETED|Overall Study||34
8733344|NCT01076244|9780948|FG000|STARTED|Overall Study||46
8733345|NCT01076244|9780948|FG000|COMPLETED|Overall Study||42
8733346|NCT01076244|9780948|FG000|NOT COMPLETED|Overall Study||4
8733347|NCT01076270|9780952|FG000|STARTED|Overall Study||1
8733348|NCT01076270|9780952|FG000|COMPLETED|Overall Study||1
8733349|NCT01076270|9780952|FG000|NOT COMPLETED|Overall Study||0
8733350|NCT01076283|9780958|FG000|STARTED|Overall Study||7
8733351|NCT01076283|9780959|FG001|STARTED|Overall Study||7
8733352|NCT01076283|9780958|FG000|COMPLETED|Overall Study||6
8733353|NCT01076283|9780959|FG001|COMPLETED|Overall Study||7
8733354|NCT01076283|9780958|FG000|NOT COMPLETED|Overall Study||1
8733355|NCT01076283|9780959|FG001|NOT COMPLETED|Overall Study||0
8733356|NCT01076296|9780965|FG000|STARTED|Overall Study||54
8733357|NCT01076296|9780966|FG001|STARTED|Overall Study||196
8733358|NCT01076296|9780967|FG002|STARTED|Overall Study||51
8733359|NCT01076296|9780968|FG003|STARTED|Overall Study||199
8733360|NCT01076296|9780969|FG004|STARTED|Overall Study||59
8733361|NCT01076296|9780970|FG005|STARTED|Overall Study||191
8733362|NCT01076296|9780971|FG006|STARTED|Overall Study||51
8733363|NCT01076296|9780972|FG007|STARTED|Overall Study||199
8733364|NCT01076296|9780965|FG000|COMPLETED|Overall Study||54
8733365|NCT01076296|9780966|FG001|COMPLETED|Overall Study||196
8733366|NCT01076296|9780967|FG002|COMPLETED|Overall Study||51
8733367|NCT01076296|9780968|FG003|COMPLETED|Overall Study||199
8733368|NCT01076296|9780969|FG004|COMPLETED|Overall Study||59
8733369|NCT01076296|9780970|FG005|COMPLETED|Overall Study||191
8733370|NCT01076296|9780971|FG006|COMPLETED|Overall Study||51
8733371|NCT01076296|9780972|FG007|COMPLETED|Overall Study||199
8733372|NCT01076296|9780965|FG000|NOT COMPLETED|Overall Study||0
8733373|NCT01076296|9780966|FG001|NOT COMPLETED|Overall Study||0
8733374|NCT01076296|9780967|FG002|NOT COMPLETED|Overall Study||0
8733375|NCT01076296|9780968|FG003|NOT COMPLETED|Overall Study||0
8733376|NCT01076296|9780969|FG004|NOT COMPLETED|Overall Study||0
8733377|NCT01076296|9780970|FG005|NOT COMPLETED|Overall Study||0
8733378|NCT01076296|9780971|FG006|NOT COMPLETED|Overall Study||0
8733379|NCT01076296|9780972|FG007|NOT COMPLETED|Overall Study||0
8733380|NCT01076335|9780990|FG000|STARTED|Overall Study||40
8733381|NCT01076335|9780990|FG000|COMPLETED|Overall Study||36
8733382|NCT01076335|9780990|FG000|NOT COMPLETED|Overall Study||4
8733383|NCT01076348|9780994|FG000|STARTED|Overall Study||73
8733384|NCT01076348|9780994|FG000|COMPLETED|Overall Study||51
8733385|NCT01076348|9780994|FG000|NOT COMPLETED|Overall Study||22
8733386|NCT01076361|9780998|FG000|STARTED|Overall Study|631 leads were implanted in 370 patients. 22 leads in 21 patients were excluded from analysis.|370
8733387|NCT01076361|9780998|FG000|COMPLETED|Overall Study|Follow-up data was not available for 21 participants (22 leads)|349
8733388|NCT01076361|9780998|FG000|NOT COMPLETED|Overall Study||21
8733389|NCT01076400|9781002|FG000|STARTED|Overall Study||7
8733390|NCT01076400|9781003|FG001|STARTED|Overall Study|No participants were enrolled in Part 2 of the study.|0
8733391|NCT01076400|9781004|FG002|STARTED|Overall Study|No participants were enrolled in Part 2 of the study.|0
8733392|NCT01076400|9781002|FG000|COMPLETED|Overall Study||0
8733393|NCT01076400|9781003|FG001|COMPLETED|Overall Study||0
8733394|NCT01076400|9781004|FG002|COMPLETED|Overall Study||0
8733395|NCT01076400|9781002|FG000|NOT COMPLETED|Overall Study||7
8733396|NCT01076400|9781003|FG001|NOT COMPLETED|Overall Study||0
8733397|NCT01076400|9781004|FG002|NOT COMPLETED|Overall Study||0
8733398|NCT01076452|9781010|FG000|STARTED|Overall Study||147
8733399|NCT01076452|9781011|FG001|STARTED|Overall Study||152
8733400|NCT01076452|9781010|FG000|COMPLETED|Overall Study||123
8733401|NCT01076452|9781011|FG001|COMPLETED|Overall Study||138
8733402|NCT01076452|9781010|FG000|NOT COMPLETED|Overall Study||24
8733403|NCT01076452|9781011|FG001|NOT COMPLETED|Overall Study||14
8733404|NCT01076504|9781017|FG000|STARTED|Overall Study||80
8733405|NCT01076504|9781017|FG000|COMPLETED|Overall Study|Patients remained on study until disease progression or withdrawal for any other reason|0
8733406|NCT01076504|9781017|FG000|NOT COMPLETED|Overall Study||80
8733407|NCT01076543|9781027|FG000|STARTED|Overall Study||8
8733408|NCT01076543|9781028|FG001|STARTED|Overall Study||3
8733409|NCT01076543|9781029|FG002|STARTED|Overall Study||6
8733410|NCT01076543|9781030|FG003|STARTED|Overall Study||39
8733411|NCT01076543|9781031|FG004|STARTED|Overall Study||15
8733412|NCT01076543|9781032|FG005|STARTED|Overall Study||39
8733413|NCT01076543|9781027|FG000|COMPLETED|Overall Study||6
8733414|NCT01076543|9781028|FG001|COMPLETED|Overall Study||3
8733415|NCT01076543|9781029|FG002|COMPLETED|Overall Study||6
8733416|NCT01076543|9781030|FG003|COMPLETED|Overall Study||39
8733417|NCT01076543|9781031|FG004|COMPLETED|Overall Study||15
8733418|NCT01076543|9781032|FG005|COMPLETED|Overall Study||39
8733419|NCT01076543|9781027|FG000|NOT COMPLETED|Overall Study||2
8733420|NCT01076543|9781028|FG001|NOT COMPLETED|Overall Study||0
8733421|NCT01076543|9781029|FG002|NOT COMPLETED|Overall Study||0
8733422|NCT01076543|9781030|FG003|NOT COMPLETED|Overall Study||0
8733423|NCT01076543|9781031|FG004|NOT COMPLETED|Overall Study||0
8733424|NCT01076543|9781032|FG005|NOT COMPLETED|Overall Study||0
8733425|NCT01076647|9781049|FG000|STARTED|Overall Study||233
8733426|NCT01076647|9781050|FG001|STARTED|Overall Study||234
8733427|NCT01076647|9781049|FG000|COMPLETED|Overall Study||208
8733428|NCT01076647|9781050|FG001|COMPLETED|Overall Study||209
8733429|NCT01076647|9781049|FG000|NOT COMPLETED|Overall Study||25
8733430|NCT01076647|9781050|FG001|NOT COMPLETED|Overall Study||25
8733431|NCT01076686|9781060|FG000|STARTED|Overall Study||17
8733432|NCT01076686|9781061|FG001|STARTED|Overall Study||14
8733433|NCT01076686|9781062|FG002|STARTED|Overall Study||32
8733434|NCT01076686|9781063|FG003|STARTED|Overall Study||31
8733435|NCT01076686|9781060|FG000|COMPLETED|Overall Study||17
8733436|NCT01076686|9781061|FG001|COMPLETED|Overall Study||14
8733437|NCT01076686|9781062|FG002|COMPLETED|Overall Study||32
8733438|NCT01076686|9781063|FG003|COMPLETED|Overall Study||31
8733439|NCT01076686|9781060|FG000|NOT COMPLETED|Overall Study||0
8733440|NCT01076686|9781061|FG001|NOT COMPLETED|Overall Study||0
8733441|NCT01076686|9781062|FG002|NOT COMPLETED|Overall Study||0
8733442|NCT01076686|9781063|FG003|NOT COMPLETED|Overall Study||0
8733443|NCT01076959|9781073|FG000|STARTED|Overall Study||7740
8733444|NCT01076959|9781073|FG000|COMPLETED|Overall Study||5490
8733445|NCT01076959|9781073|FG000|NOT COMPLETED|Overall Study||2250
8733446|NCT01076972|9781090|FG000|STARTED|Overall Study||1184
8733447|NCT01076972|9781090|FG000|COMPLETED|Overall Study||1184
8733448|NCT01076972|9781090|FG000|NOT COMPLETED|Overall Study||0
8733449|NCT01076985|9781104|FG000|STARTED|Overall Study||24
8733450|NCT01076985|9781104|FG000|COMPLETED|Overall Study||24
8733451|NCT01076985|9781104|FG000|NOT COMPLETED|Overall Study||0
8733452|NCT01077024|9781112|FG000|STARTED|Overall Study||267
8733453|NCT01077024|9781113|FG001|STARTED|Overall Study||271
8733454|NCT01077024|9781112|FG000|COMPLETED|Overall Study||236
8733455|NCT01077024|9781113|FG001|COMPLETED|Overall Study||243
8733456|NCT01077024|9781112|FG000|NOT COMPLETED|Overall Study||31
8733457|NCT01077024|9781113|FG001|NOT COMPLETED|Overall Study||28
8733458|NCT01077050|9781119|FG000|STARTED|Overall Study||1951
8733459|NCT01077050|9781119|FG000|COMPLETED|Overall Study||1942
8733460|NCT01077050|9781119|FG000|NOT COMPLETED|Overall Study||9
8733461|NCT01077063|9781125|FG000|STARTED|Overall Study||4
8733462|NCT01077063|9781126|FG001|STARTED|Overall Study||3
8733463|NCT01077063|9781125|FG000|COMPLETED|Overall Study||0
8733464|NCT01077063|9781126|FG001|COMPLETED|Overall Study||0
8733465|NCT01077063|9781125|FG000|NOT COMPLETED|Overall Study||4
8733466|NCT01077063|9781126|FG001|NOT COMPLETED|Overall Study||3
8733467|NCT01077076|9781132|FG000|STARTED|First Intervention||5
8733468|NCT01077076|9781133|FG001|STARTED|First Intervention||5
8733469|NCT01077076|9781134|FG002|STARTED|First Intervention||5
8733470|NCT01077076|9781135|FG003|STARTED|First Intervention||5
8733471|NCT01077076|9781136|FG004|STARTED|First Intervention||5
8911771|NCT02148952|9970868|FG001|NOT COMPLETED|Follow-Up||279
8911772|NCT02149108|9970884|FG000|STARTED|Overall Study|Randomised patients.|382
8733472|NCT01077076|9781137|FG005|STARTED|First Intervention||5
8733473|NCT01077076|9781132|FG000|COMPLETED|First Intervention||4
8733474|NCT01077076|9781133|FG001|COMPLETED|First Intervention||5
8733475|NCT01077076|9781134|FG002|COMPLETED|First Intervention||5
8733476|NCT01077076|9781135|FG003|COMPLETED|First Intervention||5
8733477|NCT01077076|9781136|FG004|COMPLETED|First Intervention||5
8733478|NCT01077076|9781137|FG005|COMPLETED|First Intervention||5
8733479|NCT01077076|9781132|FG000|NOT COMPLETED|First Intervention||1
8733480|NCT01077076|9781133|FG001|NOT COMPLETED|First Intervention||0
8911773|NCT02149108|9970885|FG001|STARTED|Overall Study|Randomised patients.|386
8733481|NCT01077076|9781134|FG002|NOT COMPLETED|First Intervention||0
8733482|NCT01077076|9781135|FG003|NOT COMPLETED|First Intervention||0
8733483|NCT01077076|9781136|FG004|NOT COMPLETED|First Intervention||0
8733484|NCT01077076|9781137|FG005|NOT COMPLETED|First Intervention||0
8733485|NCT01077076|9781132|FG000|STARTED|Washout Period of 2 Weeks||4
8733486|NCT01077076|9781133|FG001|STARTED|Washout Period of 2 Weeks||5
8733487|NCT01077076|9781134|FG002|STARTED|Washout Period of 2 Weeks||5
8733488|NCT01077076|9781135|FG003|STARTED|Washout Period of 2 Weeks||5
8733489|NCT01077076|9781136|FG004|STARTED|Washout Period of 2 Weeks||5
8733490|NCT01077076|9781137|FG005|STARTED|Washout Period of 2 Weeks||5
8733491|NCT01077076|9781132|FG000|COMPLETED|Washout Period of 2 Weeks||4
8733492|NCT01077076|9781133|FG001|COMPLETED|Washout Period of 2 Weeks||5
8733493|NCT01077076|9781134|FG002|COMPLETED|Washout Period of 2 Weeks||5
8733494|NCT01077076|9781135|FG003|COMPLETED|Washout Period of 2 Weeks||5
8733495|NCT01077076|9781136|FG004|COMPLETED|Washout Period of 2 Weeks||5
8733496|NCT01077076|9781137|FG005|COMPLETED|Washout Period of 2 Weeks||5
8733497|NCT01077076|9781132|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
8733498|NCT01077076|9781133|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
8733499|NCT01077076|9781134|FG002|NOT COMPLETED|Washout Period of 2 Weeks||0
8733500|NCT01077076|9781135|FG003|NOT COMPLETED|Washout Period of 2 Weeks||0
8733501|NCT01077076|9781136|FG004|NOT COMPLETED|Washout Period of 2 Weeks||0
8733502|NCT01077076|9781137|FG005|NOT COMPLETED|Washout Period of 2 Weeks||0
8733503|NCT01077076|9781132|FG000|STARTED|Second Intervention||4
8733504|NCT01077076|9781133|FG001|STARTED|Second Intervention||5
8733505|NCT01077076|9781134|FG002|STARTED|Second Intervention||5
8733506|NCT01077076|9781135|FG003|STARTED|Second Intervention||5
8733507|NCT01077076|9781136|FG004|STARTED|Second Intervention||5
8733508|NCT01077076|9781137|FG005|STARTED|Second Intervention||5
8733509|NCT01077076|9781132|FG000|COMPLETED|Second Intervention||4
8733510|NCT01077076|9781133|FG001|COMPLETED|Second Intervention||5
8733511|NCT01077076|9781134|FG002|COMPLETED|Second Intervention||5
8733512|NCT01077076|9781135|FG003|COMPLETED|Second Intervention||5
8733513|NCT01077076|9781136|FG004|COMPLETED|Second Intervention||5
8733514|NCT01077076|9781137|FG005|COMPLETED|Second Intervention||5
8733515|NCT01077076|9781132|FG000|NOT COMPLETED|Second Intervention||0
8733516|NCT01077076|9781133|FG001|NOT COMPLETED|Second Intervention||0
8733517|NCT01077076|9781134|FG002|NOT COMPLETED|Second Intervention||0
8733518|NCT01077076|9781135|FG003|NOT COMPLETED|Second Intervention||0
8733519|NCT01077076|9781136|FG004|NOT COMPLETED|Second Intervention||0
8733520|NCT01077076|9781137|FG005|NOT COMPLETED|Second Intervention||0
8733521|NCT01077076|9781132|FG000|STARTED|Washout Period of 2 Weeks||4
8733522|NCT01077076|9781133|FG001|STARTED|Washout Period of 2 Weeks||5
8733523|NCT01077076|9781134|FG002|STARTED|Washout Period of 2 Weeks||5
8733524|NCT01077076|9781135|FG003|STARTED|Washout Period of 2 Weeks||5
8733525|NCT01077076|9781136|FG004|STARTED|Washout Period of 2 Weeks||5
8733526|NCT01077076|9781137|FG005|STARTED|Washout Period of 2 Weeks||5
8733527|NCT01077076|9781132|FG000|COMPLETED|Washout Period of 2 Weeks||4
8733528|NCT01077076|9781133|FG001|COMPLETED|Washout Period of 2 Weeks||5
8733529|NCT01077076|9781134|FG002|COMPLETED|Washout Period of 2 Weeks||5
8733530|NCT01077076|9781135|FG003|COMPLETED|Washout Period of 2 Weeks||5
8733531|NCT01077076|9781136|FG004|COMPLETED|Washout Period of 2 Weeks||5
8733532|NCT01077076|9781137|FG005|COMPLETED|Washout Period of 2 Weeks||5
8733533|NCT01077076|9781132|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
8733534|NCT01077076|9781133|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
8733535|NCT01077076|9781134|FG002|NOT COMPLETED|Washout Period of 2 Weeks||0
8733536|NCT01077076|9781135|FG003|NOT COMPLETED|Washout Period of 2 Weeks||0
8733537|NCT01077076|9781136|FG004|NOT COMPLETED|Washout Period of 2 Weeks||0
8733538|NCT01077076|9781137|FG005|NOT COMPLETED|Washout Period of 2 Weeks||0
8733539|NCT01077076|9781132|FG000|STARTED|Third Intervention||4
8733540|NCT01077076|9781133|FG001|STARTED|Third Intervention||5
8733541|NCT01077076|9781134|FG002|STARTED|Third Intervention||5
8733542|NCT01077076|9781135|FG003|STARTED|Third Intervention||5
8733543|NCT01077076|9781136|FG004|STARTED|Third Intervention||5
8733544|NCT01077076|9781137|FG005|STARTED|Third Intervention||5
8733545|NCT01077076|9781132|FG000|COMPLETED|Third Intervention||4
8733546|NCT01077076|9781133|FG001|COMPLETED|Third Intervention||5
8733547|NCT01077076|9781134|FG002|COMPLETED|Third Intervention||5
8733548|NCT01077076|9781135|FG003|COMPLETED|Third Intervention||5
8733549|NCT01077076|9781136|FG004|COMPLETED|Third Intervention||5
8733550|NCT01077076|9781137|FG005|COMPLETED|Third Intervention||4
8733551|NCT01077076|9781132|FG000|NOT COMPLETED|Third Intervention||0
8733552|NCT01077076|9781133|FG001|NOT COMPLETED|Third Intervention||0
8733553|NCT01077076|9781134|FG002|NOT COMPLETED|Third Intervention||0
8733554|NCT01077076|9781135|FG003|NOT COMPLETED|Third Intervention||0
8733555|NCT01077076|9781136|FG004|NOT COMPLETED|Third Intervention||0
8733556|NCT01077076|9781137|FG005|NOT COMPLETED|Third Intervention||1
8733557|NCT01077128|9781145|FG000|STARTED|Overall Study||500
8733558|NCT01077128|9781145|FG000|COMPLETED|Overall Study||433
8733559|NCT01077128|9781145|FG000|NOT COMPLETED|Overall Study||67
8733560|NCT01077154|9781201|FG000|STARTED|Overall Study||2253
8733561|NCT01077154|9781202|FG001|STARTED|Overall Study||2256
8733562|NCT01077154|9781201|FG000|Received Study Drug|Overall Study||2229
8733563|NCT01077154|9781202|FG001|Received Study Drug|Overall Study||2230
8733564|NCT01077154|9781201|FG000|COMPLETED|Overall Study||27
8733565|NCT01077154|9781202|FG001|COMPLETED|Overall Study||28
8733566|NCT01077154|9781201|FG000|NOT COMPLETED|Overall Study||2226
8733567|NCT01077154|9781202|FG001|NOT COMPLETED|Overall Study||2228
8733568|NCT01077193|9781208|FG000|STARTED|Overall Study||44
8733569|NCT01077193|9781208|FG000|COMPLETED|Overall Study||0
8733570|NCT01077193|9781208|FG000|NOT COMPLETED|Overall Study||44
8733571|NCT01077258|9781212|FG000|STARTED|Overall Study||4208
8733572|NCT01077258|9781212|FG000|COMPLETED|Overall Study||1640
8733573|NCT01077258|9781212|FG000|NOT COMPLETED|Overall Study||2568
8733574|NCT01077271|9781229|FG000|STARTED|Overall Study||124
8733575|NCT01077271|9781229|FG000|Participants Treated With Palivizumab|Overall Study||120
8911774|NCT02149108|9970884|FG000|COMPLETED|Overall Study|On-treatment at analysis cut-off date (14JUN2016).|2
8911775|NCT02149108|9970885|FG001|COMPLETED|Overall Study|On-treatment at analysis cut-off date (14JUN2016).|3
8911776|NCT02149108|9970884|FG000|NOT COMPLETED|Overall Study||380
8911777|NCT02149108|9970885|FG001|NOT COMPLETED|Overall Study||383
8911778|NCT02149173|9970891|FG000|STARTED|Overall Study||29
8911779|NCT02149173|9970891|FG000|COMPLETED|Overall Study||29
8911780|NCT02149173|9970891|FG000|NOT COMPLETED|Overall Study||0
8911781|NCT02149199|9970904|FG000|STARTED|Overall Study||1277
8911782|NCT02149199|9970905|FG001|STARTED|Overall Study||1277
8911783|NCT02149199|9970906|FG002|STARTED|Overall Study||1282
8911784|NCT02149199|9970904|FG000|COMPLETED|Overall Study||1144
8911785|NCT02149199|9970905|FG001|COMPLETED|Overall Study||1084
8911786|NCT02149199|9970906|FG002|COMPLETED|Overall Study||1135
8911787|NCT02149199|9970904|FG000|NOT COMPLETED|Overall Study||133
8911788|NCT02149199|9970905|FG001|NOT COMPLETED|Overall Study||193
8911789|NCT02149199|9970906|FG002|NOT COMPLETED|Overall Study||147
8911790|NCT02149264|9970914|FG000|STARTED|Overall Study|Of the 160 enrolled subjects, one discontinued before receiving treatment.|159
8911791|NCT02149264|9970914|FG000|COMPLETED|Overall Study||139
8911792|NCT02149264|9970914|FG000|NOT COMPLETED|Overall Study||20
8911793|NCT02149290|9970918|FG000|STARTED|Overall Study||198
8911794|NCT02149290|9970918|FG000|COMPLETED|Overall Study||198
8911795|NCT02149290|9970918|FG000|NOT COMPLETED|Overall Study||0
8911796|NCT02149303|9970924|FG000|STARTED|Overall Study||191
8911797|NCT02149303|9970924|FG000|COMPLETED|Overall Study||191
8911798|NCT02149303|9970924|FG000|NOT COMPLETED|Overall Study||0
8911799|NCT02149342|9970928|FG000|STARTED|Overall Study|14 patients|14
8911800|NCT02149342|9970928|FG000|COMPLETED|Overall Study|14 patients|14
8911801|NCT02149342|9970928|FG000|NOT COMPLETED|Overall Study||0
8911802|NCT02149420|9970938|FG000|STARTED|Core Study||9
8911803|NCT02149420|9970939|FG001|STARTED|Core Study||6
8911804|NCT02149420|9970940|FG002|STARTED|Core Study||12
8911805|NCT02149420|9970938|FG000|Safety Analysis Set|Core Study||9
8911806|NCT02149420|9970939|FG001|Safety Analysis Set|Core Study||6
8911807|NCT02149420|9970940|FG002|Safety Analysis Set|Core Study||12
8911808|NCT02149420|9970938|FG000|PK Analysis Set|Core Study|for patients entering open label VAY736 10 mg/kg at Week 24|5
8911809|NCT02149420|9970939|FG001|PK Analysis Set|Core Study||6
8911810|NCT02149420|9970940|FG002|PK Analysis Set|Core Study||12
8911811|NCT02149420|9970938|FG000|PD (Pharmacodynamics) Analysis Set|Core Study||9
8911812|NCT02149420|9970939|FG001|PD (Pharmacodynamics) Analysis Set|Core Study||6
8911813|NCT02149420|9970940|FG002|PD (Pharmacodynamics) Analysis Set|Core Study||12
8911814|NCT02149420|9970938|FG000|COMPLETED|Core Study||9
8911815|NCT02149420|9970939|FG001|COMPLETED|Core Study||5
8911816|NCT02149420|9970940|FG002|COMPLETED|Core Study||10
8911817|NCT02149420|9970938|FG000|NOT COMPLETED|Core Study||0
8911818|NCT02149420|9970939|FG001|NOT COMPLETED|Core Study||1
8911819|NCT02149420|9970940|FG002|NOT COMPLETED|Core Study||2
8911820|NCT02149420|9970938|FG000|STARTED|Open Label VAY736 10 mg/kg Extension|Patients received single dose of VAY736 10mg/kg at Week 24.|5
8911821|NCT02149420|9970939|FG001|STARTED|Open Label VAY736 10 mg/kg Extension|Only patients origianally randomized to Placebo were allowed to enter this Period.|0
8911822|NCT02149420|9970940|FG002|STARTED|Open Label VAY736 10 mg/kg Extension|Only patients origianally randomized to Placebo were allowed to enter this Period.|0
8911823|NCT02149420|9970938|FG000|COMPLETED|Open Label VAY736 10 mg/kg Extension||4
8911824|NCT02149420|9970939|FG001|COMPLETED|Open Label VAY736 10 mg/kg Extension||0
8911825|NCT02149420|9970940|FG002|COMPLETED|Open Label VAY736 10 mg/kg Extension||0
8911826|NCT02149420|9970938|FG000|NOT COMPLETED|Open Label VAY736 10 mg/kg Extension||1
8911827|NCT02149420|9970939|FG001|NOT COMPLETED|Open Label VAY736 10 mg/kg Extension||0
8911828|NCT02149420|9970940|FG002|NOT COMPLETED|Open Label VAY736 10 mg/kg Extension||0
8911829|NCT02149524|9970955|FG000|STARTED|Overall Study||438
8911830|NCT02149524|9970956|FG001|STARTED|Overall Study||437
8911831|NCT02149524|9970955|FG000|COMPLETED|Overall Study||384
8911832|NCT02149524|9970956|FG001|COMPLETED|Overall Study||380
8911833|NCT02149524|9970955|FG000|NOT COMPLETED|Overall Study||54
8911834|NCT02149524|9970956|FG001|NOT COMPLETED|Overall Study||57
8911835|NCT02149810|9970964|FG000|STARTED|Overall Study||48
8911836|NCT02149810|9970965|FG001|STARTED|Overall Study||47
8911837|NCT02149810|9970964|FG000|Baseline|Overall Study||47
8911838|NCT02149810|9970965|FG001|Baseline|Overall Study||44
8911839|NCT02149810|9970964|FG000|Week 4|Overall Study||43
8911840|NCT02149810|9970965|FG001|Week 4|Overall Study||42
8911841|NCT02149810|9970964|FG000|Week 8|Overall Study||40
8911842|NCT02149810|9970965|FG001|Week 8|Overall Study||43
8911843|NCT02149810|9970964|FG000|Week 12|Overall Study||40
8911844|NCT02149810|9970965|FG001|Week 12|Overall Study||43
8911845|NCT02149810|9970964|FG000|Week 24|Overall Study||31
8911846|NCT02149810|9970965|FG001|Week 24|Overall Study|Not applicable study was amended such that week 24 data was not collected for TAU participants.|0
8911847|NCT02149810|9970964|FG000|COMPLETED|Overall Study||40
8911848|NCT02149810|9970965|FG001|COMPLETED|Overall Study||43
8911849|NCT02149810|9970964|FG000|NOT COMPLETED|Overall Study||8
8911850|NCT02149810|9970965|FG001|NOT COMPLETED|Overall Study||4
8911851|NCT02149836|9970971|FG000|STARTED|Overall Study||18
8911852|NCT02149836|9970971|FG000|COMPLETED|Overall Study||17
8733576|NCT01077271|9781229|FG000|Number of Participants Analyzed|Overall Study||120
8911853|NCT02149836|9970971|FG000|NOT COMPLETED|Overall Study||1
8911854|NCT02149875|9970978|FG000|STARTED|Overall Study||27
8733577|NCT01077271|9781229|FG000|COMPLETED|Overall Study||102
8733578|NCT01077271|9781229|FG000|NOT COMPLETED|Overall Study||22
8733579|NCT01077284|9781244|FG000|STARTED|Overall Study||33
8733580|NCT01077284|9781245|FG001|STARTED|Overall Study||33
8733581|NCT01077284|9781246|FG002|STARTED|Overall Study||33
8733582|NCT01077284|9781244|FG000|COMPLETED|Overall Study||28
8733583|NCT01077284|9781245|FG001|COMPLETED|Overall Study||28
8733584|NCT01077284|9781246|FG002|COMPLETED|Overall Study||30
8733585|NCT01077284|9781244|FG000|NOT COMPLETED|Overall Study||5
8733586|NCT01077284|9781245|FG001|NOT COMPLETED|Overall Study||5
8733587|NCT01077284|9781246|FG002|NOT COMPLETED|Overall Study||3
8733588|NCT01077310|9781256|FG000|STARTED|Overall Study||67
8733589|NCT01077310|9781257|FG001|STARTED|Overall Study||33
8733590|NCT01077310|9781256|FG000|COMPLETED|Overall Study||67
8733591|NCT01077310|9781257|FG001|COMPLETED|Overall Study||33
8733592|NCT01077310|9781256|FG000|NOT COMPLETED|Overall Study||0
8733593|NCT01077310|9781257|FG001|NOT COMPLETED|Overall Study||0
8733594|NCT01077323|9781271|FG000|STARTED|Overall Study|STARTED = Number of subjects considered for inclusion in this cohort.|37097
8733595|NCT01077323|9781272|FG001|STARTED|Overall Study|STARTED = Number of subjects considered for inclusion in this cohort.|620799
8733596|NCT01077323|9781273|FG002|STARTED|Overall Study|STARTED = Number of subjects considered for inclusion in this cohort.|12015600
8733597|NCT01077323|9781271|FG000|COMPLETED|Overall Study|COMPLETED = Group of subjects for whom data in outcome measures is presented.|25719
8733598|NCT01077323|9781272|FG001|COMPLETED|Overall Study|COMPLETED = Group of subjects for whom data in outcome measures is presented.|234536
8733599|NCT01077323|9781273|FG002|COMPLETED|Overall Study|COMPLETED = Group of subjects for whom data in outcome measures is presented.|103511
8733600|NCT01077323|9781271|FG000|NOT COMPLETED|Overall Study||11378
8733601|NCT01077323|9781272|FG001|NOT COMPLETED|Overall Study||386263
8733602|NCT01077323|9781273|FG002|NOT COMPLETED|Overall Study||11912089
8733603|NCT01077362|9781284|FG000|STARTED|Overall Study||104
8733604|NCT01077362|9781285|FG001|STARTED|Overall Study||103
8733605|NCT01077362|9781286|FG002|STARTED|Overall Study||105
8733606|NCT01077362|9781284|FG000|COMPLETED|Overall Study||73
8733607|NCT01077362|9781285|FG001|COMPLETED|Overall Study||84
8733608|NCT01077362|9781286|FG002|COMPLETED|Overall Study||81
8733609|NCT01077362|9781284|FG000|NOT COMPLETED|Overall Study||31
8733610|NCT01077362|9781285|FG001|NOT COMPLETED|Overall Study||19
8733611|NCT01077362|9781286|FG002|NOT COMPLETED|Overall Study||24
8733612|NCT01077375|9781301|FG000|STARTED|Overall Study||21
8733613|NCT01077375|9781302|FG001|STARTED|Overall Study|One randomized patient not taking study drug was excluded from the Double-blind Safety Population.|86
8733614|NCT01077375|9781301|FG000|COMPLETED|Overall Study||11
8733615|NCT01077375|9781302|FG001|COMPLETED|Overall Study||51
8733616|NCT01077375|9781301|FG000|NOT COMPLETED|Overall Study||10
8733617|NCT01077375|9781302|FG001|NOT COMPLETED|Overall Study||35
8733618|NCT01077401|9781312|FG000|STARTED|Overall Study||77
8733619|NCT01077401|9781313|FG001|STARTED|Overall Study||75
8733620|NCT01077401|9781312|FG000|COMPLETED|Overall Study||59
8733621|NCT01077401|9781313|FG001|COMPLETED|Overall Study||54
8733622|NCT01077401|9781312|FG000|NOT COMPLETED|Overall Study||18
8733623|NCT01077401|9781313|FG001|NOT COMPLETED|Overall Study||21
8733624|NCT01077518|9781321|FG000|STARTED|Treatment Phase - no Optional Ofa||173
8733625|NCT01077518|9781322|FG001|STARTED|Treatment Phase - no Optional Ofa||173
8733626|NCT01077518|9781323|FG002|STARTED|Treatment Phase - no Optional Ofa||0
8733627|NCT01077518|9781321|FG000|Completed 5-year Follow-up|Treatment Phase - no Optional Ofa||64
8733628|NCT01077518|9781322|FG001|Completed 5-year Follow-up|Treatment Phase - no Optional Ofa||64
8733629|NCT01077518|9781323|FG002|Completed 5-year Follow-up|Treatment Phase - no Optional Ofa||0
8733630|NCT01077518|9781321|FG000|Safety Population|Treatment Phase - no Optional Ofa||172
8733631|NCT01077518|9781322|FG001|Safety Population|Treatment Phase - no Optional Ofa||170
8733632|NCT01077518|9781323|FG002|Safety Population|Treatment Phase - no Optional Ofa||0
8733633|NCT01077518|9781321|FG000|COMPLETED|Treatment Phase - no Optional Ofa||95
8733634|NCT01077518|9781322|FG001|COMPLETED|Treatment Phase - no Optional Ofa||108
8733635|NCT01077518|9781323|FG002|COMPLETED|Treatment Phase - no Optional Ofa||0
8733636|NCT01077518|9781321|FG000|NOT COMPLETED|Treatment Phase - no Optional Ofa||78
8733637|NCT01077518|9781322|FG001|NOT COMPLETED|Treatment Phase - no Optional Ofa||65
8733638|NCT01077518|9781323|FG002|NOT COMPLETED|Treatment Phase - no Optional Ofa||0
8733639|NCT01077518|9781321|FG000|STARTED|Optional Ofa Phase||0
8733640|NCT01077518|9781322|FG001|STARTED|Optional Ofa Phase||0
8733641|NCT01077518|9781323|FG002|STARTED|Optional Ofa Phase||32
8733642|NCT01077518|9781321|FG000|Completed 5-year Follow-up|Optional Ofa Phase||0
8733643|NCT01077518|9781322|FG001|Completed 5-year Follow-up|Optional Ofa Phase||0
8733644|NCT01077518|9781323|FG002|Completed 5-year Follow-up|Optional Ofa Phase||12
8733645|NCT01077518|9781321|FG000|COMPLETED|Optional Ofa Phase||0
8733646|NCT01077518|9781322|FG001|COMPLETED|Optional Ofa Phase||0
8733647|NCT01077518|9781323|FG002|COMPLETED|Optional Ofa Phase||16
8733648|NCT01077518|9781321|FG000|NOT COMPLETED|Optional Ofa Phase||0
8733649|NCT01077518|9781322|FG001|NOT COMPLETED|Optional Ofa Phase||0
8733650|NCT01077518|9781323|FG002|NOT COMPLETED|Optional Ofa Phase||16
8733651|NCT01077544|9781334|FG000|STARTED|Overall Study||8
8733652|NCT01077544|9781335|FG001|STARTED|Overall Study||7
8733653|NCT01077544|9781334|FG000|COMPLETED|Overall Study||5
8733654|NCT01077544|9781335|FG001|COMPLETED|Overall Study||2
8733655|NCT01077544|9781334|FG000|NOT COMPLETED|Overall Study||3
8733656|NCT01077544|9781335|FG001|NOT COMPLETED|Overall Study||5
8733657|NCT01077596|9781353|FG000|STARTED|Overall Study||350
8733658|NCT01077596|9781354|FG001|STARTED|Overall Study||1050
8733659|NCT01077596|9781355|FG002|STARTED|Overall Study||457
8733660|NCT01077596|9781356|FG003|STARTED|Overall Study||1370
8733661|NCT01077596|9781357|FG004|STARTED|Overall Study||294
8733662|NCT01077596|9781358|FG005|STARTED|Overall Study||882
8733663|NCT01077596|9781359|FG006|STARTED|Overall Study||308
8733664|NCT01077596|9781360|FG007|STARTED|Overall Study||837
8733665|NCT01077596|9781361|FG008|STARTED|Overall Study||2842
8733666|NCT01077596|9781362|FG009|STARTED|Overall Study||28420
8733667|NCT01077596|9781363|FG010|STARTED|Overall Study||2215
8733668|NCT01077596|9781364|FG011|STARTED|Overall Study||22150
8733669|NCT01077596|9781353|FG000|COMPLETED|Overall Study||350
8733670|NCT01077596|9781354|FG001|COMPLETED|Overall Study||1050
8733671|NCT01077596|9781355|FG002|COMPLETED|Overall Study||457
8733672|NCT01077596|9781356|FG003|COMPLETED|Overall Study||1370
8733673|NCT01077596|9781357|FG004|COMPLETED|Overall Study||294
8733674|NCT01077596|9781358|FG005|COMPLETED|Overall Study||882
8733675|NCT01077596|9781359|FG006|COMPLETED|Overall Study||308
8733676|NCT01077596|9781360|FG007|COMPLETED|Overall Study||837
8733677|NCT01077596|9781361|FG008|COMPLETED|Overall Study||2842
8733678|NCT01077596|9781362|FG009|COMPLETED|Overall Study||28420
8733679|NCT01077596|9781363|FG010|COMPLETED|Overall Study||2215
8733680|NCT01077596|9781364|FG011|COMPLETED|Overall Study||22150
8733681|NCT01077596|9781353|FG000|NOT COMPLETED|Overall Study||0
8733682|NCT01077596|9781354|FG001|NOT COMPLETED|Overall Study||0
8733683|NCT01077596|9781355|FG002|NOT COMPLETED|Overall Study||0
8733684|NCT01077596|9781356|FG003|NOT COMPLETED|Overall Study||0
8733685|NCT01077596|9781357|FG004|NOT COMPLETED|Overall Study||0
8733686|NCT01077596|9781358|FG005|NOT COMPLETED|Overall Study||0
8733687|NCT01077596|9781359|FG006|NOT COMPLETED|Overall Study||0
8733688|NCT01077596|9781360|FG007|NOT COMPLETED|Overall Study||0
8733689|NCT01077596|9781361|FG008|NOT COMPLETED|Overall Study||0
8733690|NCT01077596|9781362|FG009|NOT COMPLETED|Overall Study||0
8733691|NCT01077596|9781363|FG010|NOT COMPLETED|Overall Study||0
8733692|NCT01077596|9781364|FG011|NOT COMPLETED|Overall Study||0
8733693|NCT01077622|9781385|FG000|STARTED|Overall Study||10
8733694|NCT01077622|9781385|FG000|COMPLETED|Overall Study||7
8733695|NCT01077622|9781385|FG000|NOT COMPLETED|Overall Study||3
8733696|NCT01077713|9781391|FG000|STARTED|Overall Study||44
8733697|NCT01077713|9781392|FG001|STARTED|Overall Study||42
8733698|NCT01077713|9781391|FG000|COMPLETED|Overall Study||8
8733699|NCT01077713|9781392|FG001|COMPLETED|Overall Study||6
8733700|NCT01077713|9781391|FG000|NOT COMPLETED|Overall Study||36
8733701|NCT01077713|9781392|FG001|NOT COMPLETED|Overall Study||36
8733702|NCT01077739|9781400|FG000|STARTED|Overall Study||25
8733703|NCT01077739|9781401|FG001|STARTED|Overall Study||50
8733704|NCT01077739|9781400|FG000|COMPLETED|Overall Study||20
8733705|NCT01077739|9781401|FG001|COMPLETED|Overall Study||40
8733706|NCT01077739|9781400|FG000|NOT COMPLETED|Overall Study||5
8733707|NCT01077739|9781401|FG001|NOT COMPLETED|Overall Study||10
8733708|NCT01077804|9781407|FG000|STARTED|Overall Study||7585
8733709|NCT01077804|9781407|FG000|COMPLETED|Overall Study||7386
8733710|NCT01077804|9781407|FG000|NOT COMPLETED|Overall Study||199
8733711|NCT01077856|9781414|FG000|STARTED|Overall Study||22199
8733712|NCT01077856|9781415|FG001|STARTED|Overall Study||16604
8733713|NCT01077856|9781416|FG002|STARTED|Overall Study||15713
8733714|NCT01077856|9781414|FG000|COMPLETED|Overall Study||22199
8733715|NCT01077856|9781415|FG001|COMPLETED|Overall Study||16604
8733716|NCT01077856|9781416|FG002|COMPLETED|Overall Study||15713
8733717|NCT01077856|9781414|FG000|NOT COMPLETED|Overall Study||0
8733718|NCT01077856|9781415|FG001|NOT COMPLETED|Overall Study||0
8733719|NCT01077856|9781416|FG002|NOT COMPLETED|Overall Study||0
8733720|NCT01077921|9781458|FG000|STARTED|First Intervention||14
8733721|NCT01077921|9781459|FG001|STARTED|First Intervention||13
8733722|NCT01077921|9781458|FG000|COMPLETED|First Intervention||13
8733723|NCT01077921|9781459|FG001|COMPLETED|First Intervention||12
8733724|NCT01077921|9781458|FG000|NOT COMPLETED|First Intervention||1
8733725|NCT01077921|9781459|FG001|NOT COMPLETED|First Intervention||1
8733726|NCT01077921|9781458|FG000|STARTED|Washout||13
8733727|NCT01077921|9781459|FG001|STARTED|Washout||12
8733728|NCT01077921|9781458|FG000|COMPLETED|Washout||13
8733729|NCT01077921|9781459|FG001|COMPLETED|Washout||10
8733730|NCT01077921|9781458|FG000|NOT COMPLETED|Washout||0
8733731|NCT01077921|9781459|FG001|NOT COMPLETED|Washout||2
8733732|NCT01077921|9781458|FG000|STARTED|Second Intervention||13
8733733|NCT01077921|9781459|FG001|STARTED|Second Intervention||10
8733734|NCT01077921|9781458|FG000|COMPLETED|Second Intervention||13
8733735|NCT01077921|9781459|FG001|COMPLETED|Second Intervention||9
8733736|NCT01077921|9781458|FG000|NOT COMPLETED|Second Intervention||0
8733737|NCT01077921|9781459|FG001|NOT COMPLETED|Second Intervention||1
8733738|NCT01077960|9781466|FG000|STARTED|Overall Study|130 subjects consented to participate, 129 enrolled in the study, and 126 received study drug|126
8733739|NCT01077960|9781466|FG000|COMPLETED|Overall Study|Modified Intent To Treat (ITT) Population|110
8733740|NCT01077960|9781466|FG000|NOT COMPLETED|Overall Study||16
8733741|NCT01077973|9781473|FG000|STARTED|Overall Study||41
8733742|NCT01077973|9781474|FG001|STARTED|Overall Study||79
8733743|NCT01077973|9781475|FG002|STARTED|Overall Study||80
8733744|NCT01077973|9781473|FG000|COMPLETED|Overall Study||41
8733745|NCT01077973|9781474|FG001|COMPLETED|Overall Study||79
8733746|NCT01077973|9781475|FG002|COMPLETED|Overall Study||80
8733747|NCT01077973|9781473|FG000|NOT COMPLETED|Overall Study||0
8733748|NCT01077973|9781474|FG001|NOT COMPLETED|Overall Study||0
8733749|NCT01077973|9781475|FG002|NOT COMPLETED|Overall Study||0
8733750|NCT01078090|9781485|FG000|STARTED|Overall Study||5745
8733751|NCT01078090|9781485|FG000|COMPLETED|Overall Study||1152
8733752|NCT01078090|9781485|FG000|NOT COMPLETED|Overall Study||4593
8733753|NCT01078116|9781503|FG000|STARTED|Overall Study|121 participants were included in analysis (3 were excluded due to missing case report form data).|124
8733754|NCT01078116|9781503|FG000|COMPLETED|Overall Study||76
8733755|NCT01078116|9781503|FG000|NOT COMPLETED|Overall Study||48
8733756|NCT01078155|9781507|FG000|STARTED|Overall Study||131
8733757|NCT01078155|9781507|FG000|COMPLETED|Overall Study||87
8733758|NCT01078155|9781507|FG000|NOT COMPLETED|Overall Study||44
8733759|NCT01078168|9781513|FG000|STARTED|Overall Study||11
8733760|NCT01078168|9781514|FG001|STARTED|Overall Study||11
8733761|NCT01078168|9781513|FG000|COMPLETED|Overall Study||11
8733762|NCT01078168|9781514|FG001|COMPLETED|Overall Study||10
8733763|NCT01078168|9781513|FG000|NOT COMPLETED|Overall Study||0
8733764|NCT01078168|9781514|FG001|NOT COMPLETED|Overall Study||1
8733765|NCT01078207|9781520|FG000|STARTED|Overall Study||100
8733766|NCT01078207|9781520|FG000|COMPLETED|Overall Study||100
8733767|NCT01078207|9781520|FG000|NOT COMPLETED|Overall Study||0
8733768|NCT01078220|9781524|FG000|STARTED|Overall Study||189629
8733769|NCT01078220|9781524|FG000|COMPLETED|Overall Study||189629
8733770|NCT01078220|9781524|FG000|NOT COMPLETED|Overall Study||0
8733771|NCT01078233|9781537|FG000|STARTED|Overall Study||656
8733772|NCT01078233|9781538|FG001|STARTED|Overall Study||296
8733773|NCT01078233|9781539|FG002|STARTED|Overall Study||1681
8733774|NCT01078233|9781540|FG003|STARTED|Overall Study||631
8733775|NCT01078233|9781541|FG004|STARTED|Overall Study||3199
8733776|NCT01078233|9781542|FG005|STARTED|Overall Study||154
8733777|NCT01078233|9781537|FG000|COMPLETED|Overall Study||656
8733778|NCT01078233|9781538|FG001|COMPLETED|Overall Study||296
8733779|NCT01078233|9781539|FG002|COMPLETED|Overall Study||1681
8733780|NCT01078233|9781540|FG003|COMPLETED|Overall Study||631
8733781|NCT01078233|9781541|FG004|COMPLETED|Overall Study||3199
8733782|NCT01078233|9781542|FG005|COMPLETED|Overall Study||154
8733783|NCT01078233|9781537|FG000|NOT COMPLETED|Overall Study||0
8733784|NCT01078233|9781538|FG001|NOT COMPLETED|Overall Study||0
8733785|NCT01078233|9781539|FG002|NOT COMPLETED|Overall Study||0
8733786|NCT01078233|9781540|FG003|NOT COMPLETED|Overall Study||0
8733787|NCT01078233|9781541|FG004|NOT COMPLETED|Overall Study||0
8733788|NCT01078233|9781542|FG005|NOT COMPLETED|Overall Study||0
8733789|NCT01078246|9781557|FG000|STARTED|Overall Study||1041
8911855|NCT02149875|9970979|FG001|STARTED|Overall Study||28
8911856|NCT02149875|9970980|FG002|STARTED|Overall Study||29
8911857|NCT02149875|9970978|FG000|COMPLETED|Overall Study||20
8911858|NCT02149875|9970979|FG001|COMPLETED|Overall Study||20
8911859|NCT02149875|9970980|FG002|COMPLETED|Overall Study||20
8911860|NCT02149875|9970978|FG000|NOT COMPLETED|Overall Study||7
8911861|NCT02149875|9970979|FG001|NOT COMPLETED|Overall Study||8
8911862|NCT02149875|9970980|FG002|NOT COMPLETED|Overall Study||9
8911863|NCT02150044|9970988|FG000|STARTED|Overall Study||29
8911864|NCT02150044|9970988|FG000|Lead-In Subjects|Overall Study||16
8911865|NCT02150044|9970988|FG000|Study Cohort|Overall Study||13
8911866|NCT02150044|9970988|FG000|COMPLETED|Overall Study||29
8911867|NCT02150044|9970988|FG000|NOT COMPLETED|Overall Study||0
8911868|NCT02150057|9970994|FG000|STARTED|Overall Study||25
8911869|NCT02150057|9970995|FG001|STARTED|Overall Study||26
8911870|NCT02150057|9970994|FG000|COMPLETED|Overall Study||19
8911871|NCT02150057|9970995|FG001|COMPLETED|Overall Study||22
8911872|NCT02150057|9970994|FG000|NOT COMPLETED|Overall Study||6
8911873|NCT02150057|9970995|FG001|NOT COMPLETED|Overall Study||4
8911874|NCT02150109|9971001|FG000|STARTED|Overall Study||372
8911875|NCT02150109|9971001|FG000|COMPLETED|Overall Study||372
8911876|NCT02150109|9971001|FG000|NOT COMPLETED|Overall Study||0
8911877|NCT02150213|9971011|FG000|STARTED|Overall Study||59
8911878|NCT02150213|9971011|FG000|COMPLETED|Overall Study||57
8911879|NCT02150213|9971011|FG000|NOT COMPLETED|Overall Study||2
8911880|NCT02150343|9971019|FG000|STARTED|Overall Study||180
8911881|NCT02150343|9971020|FG001|STARTED|Overall Study||178
8911882|NCT02150343|9971021|FG002|STARTED|Overall Study||178
8911883|NCT02150343|9971022|FG003|STARTED|Overall Study||178
8911884|NCT02150343|9971019|FG000|COMPLETED|Overall Study||159
8911885|NCT02150343|9971020|FG001|COMPLETED|Overall Study||158
8911886|NCT02150343|9971021|FG002|COMPLETED|Overall Study||166
8733790|NCT01078246|9781558|FG001|STARTED|Overall Study||405
8733791|NCT01078246|9781559|FG002|STARTED|Overall Study||1963
8733792|NCT01078246|9781560|FG003|STARTED|Overall Study||152
8733793|NCT01078246|9781561|FG004|STARTED|Overall Study||3310
8733794|NCT01078246|9781562|FG005|STARTED|Overall Study||231
8733795|NCT01078246|9781563|FG006|STARTED|Overall Study||22
8733796|NCT01078246|9781557|FG000|COMPLETED|Overall Study||1041
8733797|NCT01078246|9781558|FG001|COMPLETED|Overall Study||405
8733798|NCT01078246|9781559|FG002|COMPLETED|Overall Study||1963
8733799|NCT01078246|9781560|FG003|COMPLETED|Overall Study||152
8733800|NCT01078246|9781561|FG004|COMPLETED|Overall Study||3310
8733801|NCT01078246|9781562|FG005|COMPLETED|Overall Study||231
8733802|NCT01078246|9781563|FG006|COMPLETED|Overall Study||22
8733803|NCT01078246|9781557|FG000|NOT COMPLETED|Overall Study||0
8911887|NCT02150343|9971022|FG003|COMPLETED|Overall Study||168
8911888|NCT02150343|9971019|FG000|NOT COMPLETED|Overall Study||21
8911889|NCT02150343|9971020|FG001|NOT COMPLETED|Overall Study||20
8911890|NCT02150343|9971021|FG002|NOT COMPLETED|Overall Study||12
8911891|NCT02150343|9971022|FG003|NOT COMPLETED|Overall Study||10
8733804|NCT01078246|9781558|FG001|NOT COMPLETED|Overall Study||0
8733805|NCT01078246|9781559|FG002|NOT COMPLETED|Overall Study||0
8733806|NCT01078246|9781560|FG003|NOT COMPLETED|Overall Study||0
8733807|NCT01078246|9781561|FG004|NOT COMPLETED|Overall Study||0
8733808|NCT01078246|9781562|FG005|NOT COMPLETED|Overall Study||0
8733809|NCT01078246|9781563|FG006|NOT COMPLETED|Overall Study||0
8733810|NCT01078298|9781573|FG000|STARTED|Overall Study||256
8733811|NCT01078298|9781574|FG001|STARTED|Overall Study||269
8733812|NCT01078298|9781573|FG000|COMPLETED|Overall Study||175
8733813|NCT01078298|9781574|FG001|COMPLETED|Overall Study||179
8733814|NCT01078298|9781573|FG000|NOT COMPLETED|Overall Study||81
8733815|NCT01078298|9781574|FG001|NOT COMPLETED|Overall Study||90
8733816|NCT01078363|9781582|FG000|STARTED|Overall Study||47
8733817|NCT01078363|9781583|FG001|STARTED|Overall Study||49
8733818|NCT01078363|9781582|FG000|COMPLETED|Overall Study||47
8733819|NCT01078363|9781583|FG001|COMPLETED|Overall Study||49
8733820|NCT01078363|9781582|FG000|NOT COMPLETED|Overall Study||0
8733821|NCT01078363|9781583|FG001|NOT COMPLETED|Overall Study||0
8733822|NCT01078376|9781595|FG000|STARTED|Overall Study||9
8733823|NCT01078376|9781596|FG001|STARTED|Overall Study||9
8733824|NCT01078376|9781597|FG002|STARTED|Overall Study||8
8733825|NCT01078376|9781598|FG003|STARTED|Overall Study||3
8733826|NCT01078376|9781595|FG000|COMPLETED|Overall Study||9
8733827|NCT01078376|9781596|FG001|COMPLETED|Overall Study||9
8733828|NCT01078376|9781597|FG002|COMPLETED|Overall Study||8
8733829|NCT01078376|9781598|FG003|COMPLETED|Overall Study||3
8733830|NCT01078376|9781595|FG000|NOT COMPLETED|Overall Study||0
8733831|NCT01078376|9781596|FG001|NOT COMPLETED|Overall Study||0
8733832|NCT01078376|9781597|FG002|NOT COMPLETED|Overall Study||0
8733833|NCT01078376|9781598|FG003|NOT COMPLETED|Overall Study||0
8733834|NCT01078389|9781613|FG000|STARTED|Overall Study||157
8733835|NCT01078389|9781614|FG001|STARTED|Overall Study||157
8733836|NCT01078389|9781613|FG000|COMPLETED|Overall Study||93
8733837|NCT01078389|9781614|FG001|COMPLETED|Overall Study||90
8733838|NCT01078389|9781613|FG000|NOT COMPLETED|Overall Study||64
8733839|NCT01078389|9781614|FG001|NOT COMPLETED|Overall Study||67
8733840|NCT01078402|9781623|FG000|STARTED|Overall Study||431
8733841|NCT01078402|9781624|FG001|STARTED|Overall Study||124
8733842|NCT01078402|9781625|FG002|STARTED|Overall Study||234
8733843|NCT01078402|9781623|FG000|COMPLETED|Overall Study||324
8733844|NCT01078402|9781624|FG001|COMPLETED|Overall Study||95
8733845|NCT01078402|9781625|FG002|COMPLETED|Overall Study||166
8733846|NCT01078402|9781623|FG000|NOT COMPLETED|Overall Study||107
8733847|NCT01078402|9781624|FG001|NOT COMPLETED|Overall Study||29
8733848|NCT01078402|9781625|FG002|NOT COMPLETED|Overall Study||68
8733849|NCT01078441|9781637|FG000|STARTED|Overall Study||2
8733850|NCT01078441|9781637|FG000|COMPLETED|Overall Study||1
8733851|NCT01078441|9781637|FG000|NOT COMPLETED|Overall Study||1
8733852|NCT01078545|9781641|FG000|STARTED|Overall Study||729
8733853|NCT01078545|9781641|FG000|Intent-to-treat Population|Overall Study||729
8733854|NCT01078545|9781641|FG000|Per Protocol Population|Overall Study||661
8733855|NCT01078545|9781641|FG000|COMPLETED|Overall Study||703
8733856|NCT01078545|9781641|FG000|NOT COMPLETED|Overall Study||26
8733857|NCT01078558|9781648|FG000|STARTED|Overall Study||2836
8733858|NCT01078558|9781649|FG001|STARTED|Overall Study||1127
8733859|NCT01078558|9781650|FG002|STARTED|Overall Study||1957
8733860|NCT01078558|9781648|FG000|Oligoarticular PsA|Overall Study||0
8733861|NCT01078558|9781649|FG001|Oligoarticular PsA|Overall Study||197
8733862|NCT01078558|9781650|FG002|Oligoarticular PsA|Overall Study||0
8733863|NCT01078558|9781648|FG000|COMPLETED|Overall Study||818
8733864|NCT01078558|9781649|FG001|COMPLETED|Overall Study||372
8733865|NCT01078558|9781650|FG002|COMPLETED|Overall Study||596
8733866|NCT01078558|9781648|FG000|NOT COMPLETED|Overall Study||2018
8733867|NCT01078558|9781649|FG001|NOT COMPLETED|Overall Study||755
8733868|NCT01078558|9781650|FG002|NOT COMPLETED|Overall Study||1361
8733869|NCT01078571|9781658|FG000|STARTED|Overall Study||705
8733870|NCT01078571|9781658|FG000|Safety Population|Overall Study||675
8733871|NCT01078571|9781658|FG000|Intent-to-treat (ITT) Population|Overall Study||591
8733872|NCT01078571|9781658|FG000|COMPLETED|Overall Study||590
8733873|NCT01078571|9781658|FG000|NOT COMPLETED|Overall Study||115
8733874|NCT01078584|9781667|FG000|STARTED|Overall Study||7993
8733875|NCT01078584|9781667|FG000|Participants Conducted Visit 2 (3-month)|Overall Study||7125
8733876|NCT01078584|9781667|FG000|Participants Conducted Visit 3 (6-month)|Overall Study||5833
8733877|NCT01078584|9781667|FG000|Participants Conducted Visit 4(12-month)|Overall Study||4983
8733878|NCT01078584|9781667|FG000|COMPLETED|Overall Study||4983
8733879|NCT01078584|9781667|FG000|NOT COMPLETED|Overall Study||3010
8733880|NCT01078623|9781684|FG000|STARTED|Treatment Period 1||6
8733881|NCT01078623|9781685|FG001|STARTED|Treatment Period 1||6
8733882|NCT01078623|9781686|FG002|STARTED|Treatment Period 1||7
8733883|NCT01078623|9781687|FG003|STARTED|Treatment Period 1||6
8733884|NCT01078623|9781688|FG004|STARTED|Treatment Period 1||7
8733885|NCT01078623|9781689|FG005|STARTED|Treatment Period 1||6
8733886|NCT01078623|9781690|FG006|STARTED|Treatment Period 1||7
8733887|NCT01078623|9781691|FG007|STARTED|Treatment Period 1||7
8733888|NCT01078623|9781692|FG008|STARTED|Treatment Period 1||6
8733889|NCT01078623|9781693|FG009|STARTED|Treatment Period 1||7
8733890|NCT01078623|9781694|FG010|STARTED|Treatment Period 1||7
8733891|NCT01078623|9781695|FG011|STARTED|Treatment Period 1||7
8733892|NCT01078623|9781696|FG012|STARTED|Treatment Period 1||7
8733893|NCT01078623|9781697|FG013|STARTED|Treatment Period 1||7
8733894|NCT01078623|9781698|FG014|STARTED|Treatment Period 1||7
8733895|NCT01078623|9781699|FG015|STARTED|Treatment Period 1||7
8733896|NCT01078623|9781700|FG016|STARTED|Treatment Period 1||7
8733897|NCT01078623|9781701|FG017|STARTED|Treatment Period 1||7
8733898|NCT01078623|9781702|FG018|STARTED|Treatment Period 1||7
8733899|NCT01078623|9781703|FG019|STARTED|Treatment Period 1||7
8733900|NCT01078623|9781684|FG000|COMPLETED|Treatment Period 1||5
8733901|NCT01078623|9781685|FG001|COMPLETED|Treatment Period 1||5
8733902|NCT01078623|9781686|FG002|COMPLETED|Treatment Period 1||6
8733903|NCT01078623|9781687|FG003|COMPLETED|Treatment Period 1||6
8733904|NCT01078623|9781688|FG004|COMPLETED|Treatment Period 1||7
8733905|NCT01078623|9781689|FG005|COMPLETED|Treatment Period 1||5
8733906|NCT01078623|9781690|FG006|COMPLETED|Treatment Period 1||6
8733907|NCT01078623|9781691|FG007|COMPLETED|Treatment Period 1||6
8733908|NCT01078623|9781692|FG008|COMPLETED|Treatment Period 1||5
8733909|NCT01078623|9781693|FG009|COMPLETED|Treatment Period 1||6
8733910|NCT01078623|9781694|FG010|COMPLETED|Treatment Period 1||6
8733911|NCT01078623|9781695|FG011|COMPLETED|Treatment Period 1||7
8733912|NCT01078623|9781696|FG012|COMPLETED|Treatment Period 1||7
8733913|NCT01078623|9781697|FG013|COMPLETED|Treatment Period 1||7
8733914|NCT01078623|9781698|FG014|COMPLETED|Treatment Period 1||7
8733915|NCT01078623|9781699|FG015|COMPLETED|Treatment Period 1||7
8733916|NCT01078623|9781700|FG016|COMPLETED|Treatment Period 1||7
8733917|NCT01078623|9781701|FG017|COMPLETED|Treatment Period 1||7
8733918|NCT01078623|9781702|FG018|COMPLETED|Treatment Period 1||7
8733919|NCT01078623|9781703|FG019|COMPLETED|Treatment Period 1||7
8733920|NCT01078623|9781684|FG000|NOT COMPLETED|Treatment Period 1||1
8733921|NCT01078623|9781685|FG001|NOT COMPLETED|Treatment Period 1||1
8733922|NCT01078623|9781686|FG002|NOT COMPLETED|Treatment Period 1||1
8733923|NCT01078623|9781687|FG003|NOT COMPLETED|Treatment Period 1||0
8733924|NCT01078623|9781688|FG004|NOT COMPLETED|Treatment Period 1||0
8733925|NCT01078623|9781689|FG005|NOT COMPLETED|Treatment Period 1||1
8733926|NCT01078623|9781690|FG006|NOT COMPLETED|Treatment Period 1||1
8733927|NCT01078623|9781691|FG007|NOT COMPLETED|Treatment Period 1||1
8733928|NCT01078623|9781692|FG008|NOT COMPLETED|Treatment Period 1||1
8733929|NCT01078623|9781693|FG009|NOT COMPLETED|Treatment Period 1||1
8733930|NCT01078623|9781694|FG010|NOT COMPLETED|Treatment Period 1||1
8733931|NCT01078623|9781695|FG011|NOT COMPLETED|Treatment Period 1||0
8733932|NCT01078623|9781696|FG012|NOT COMPLETED|Treatment Period 1||0
8733933|NCT01078623|9781697|FG013|NOT COMPLETED|Treatment Period 1||0
8733934|NCT01078623|9781698|FG014|NOT COMPLETED|Treatment Period 1||0
8733935|NCT01078623|9781699|FG015|NOT COMPLETED|Treatment Period 1||0
8733936|NCT01078623|9781700|FG016|NOT COMPLETED|Treatment Period 1||0
8733937|NCT01078623|9781701|FG017|NOT COMPLETED|Treatment Period 1||0
8733938|NCT01078623|9781702|FG018|NOT COMPLETED|Treatment Period 1||0
8733939|NCT01078623|9781703|FG019|NOT COMPLETED|Treatment Period 1||0
8733940|NCT01078623|9781684|FG000|STARTED|Treatment Period 2||5
8733941|NCT01078623|9781685|FG001|STARTED|Treatment Period 2||5
8733942|NCT01078623|9781686|FG002|STARTED|Treatment Period 2||6
8733943|NCT01078623|9781687|FG003|STARTED|Treatment Period 2||6
8733944|NCT01078623|9781688|FG004|STARTED|Treatment Period 2||7
8733945|NCT01078623|9781689|FG005|STARTED|Treatment Period 2||5
8733946|NCT01078623|9781690|FG006|STARTED|Treatment Period 2||6
8733947|NCT01078623|9781691|FG007|STARTED|Treatment Period 2||6
8733948|NCT01078623|9781692|FG008|STARTED|Treatment Period 2||5
8733949|NCT01078623|9781693|FG009|STARTED|Treatment Period 2||6
8733950|NCT01078623|9781694|FG010|STARTED|Treatment Period 2||6
8733951|NCT01078623|9781695|FG011|STARTED|Treatment Period 2||7
8733952|NCT01078623|9781696|FG012|STARTED|Treatment Period 2||7
8733953|NCT01078623|9781697|FG013|STARTED|Treatment Period 2||7
8733954|NCT01078623|9781698|FG014|STARTED|Treatment Period 2||7
8733955|NCT01078623|9781699|FG015|STARTED|Treatment Period 2||7
8733956|NCT01078623|9781700|FG016|STARTED|Treatment Period 2||7
8733957|NCT01078623|9781701|FG017|STARTED|Treatment Period 2||7
8733958|NCT01078623|9781702|FG018|STARTED|Treatment Period 2||7
8733959|NCT01078623|9781703|FG019|STARTED|Treatment Period 2||7
8733960|NCT01078623|9781684|FG000|COMPLETED|Treatment Period 2||5
8733961|NCT01078623|9781685|FG001|COMPLETED|Treatment Period 2||5
8733962|NCT01078623|9781686|FG002|COMPLETED|Treatment Period 2||6
8733963|NCT01078623|9781687|FG003|COMPLETED|Treatment Period 2||6
8733964|NCT01078623|9781688|FG004|COMPLETED|Treatment Period 2||7
8733965|NCT01078623|9781689|FG005|COMPLETED|Treatment Period 2||4
8733966|NCT01078623|9781690|FG006|COMPLETED|Treatment Period 2||5
8733967|NCT01078623|9781691|FG007|COMPLETED|Treatment Period 2||6
8733968|NCT01078623|9781692|FG008|COMPLETED|Treatment Period 2||5
8733969|NCT01078623|9781693|FG009|COMPLETED|Treatment Period 2||6
8733970|NCT01078623|9781694|FG010|COMPLETED|Treatment Period 2||6
8733971|NCT01078623|9781695|FG011|COMPLETED|Treatment Period 2||7
8733972|NCT01078623|9781696|FG012|COMPLETED|Treatment Period 2||7
8733973|NCT01078623|9781697|FG013|COMPLETED|Treatment Period 2||7
8733974|NCT01078623|9781698|FG014|COMPLETED|Treatment Period 2||7
8733975|NCT01078623|9781699|FG015|COMPLETED|Treatment Period 2||7
8733976|NCT01078623|9781700|FG016|COMPLETED|Treatment Period 2||7
8733977|NCT01078623|9781701|FG017|COMPLETED|Treatment Period 2||7
8733978|NCT01078623|9781702|FG018|COMPLETED|Treatment Period 2||6
8733979|NCT01078623|9781703|FG019|COMPLETED|Treatment Period 2||7
8733980|NCT01078623|9781684|FG000|NOT COMPLETED|Treatment Period 2||0
8733981|NCT01078623|9781685|FG001|NOT COMPLETED|Treatment Period 2||0
8733982|NCT01078623|9781686|FG002|NOT COMPLETED|Treatment Period 2||0
8733983|NCT01078623|9781687|FG003|NOT COMPLETED|Treatment Period 2||0
8733984|NCT01078623|9781688|FG004|NOT COMPLETED|Treatment Period 2||0
8733985|NCT01078623|9781689|FG005|NOT COMPLETED|Treatment Period 2||1
8733986|NCT01078623|9781690|FG006|NOT COMPLETED|Treatment Period 2||1
8733987|NCT01078623|9781691|FG007|NOT COMPLETED|Treatment Period 2||0
8733988|NCT01078623|9781692|FG008|NOT COMPLETED|Treatment Period 2||0
8733989|NCT01078623|9781693|FG009|NOT COMPLETED|Treatment Period 2||0
8733990|NCT01078623|9781694|FG010|NOT COMPLETED|Treatment Period 2||0
8733991|NCT01078623|9781695|FG011|NOT COMPLETED|Treatment Period 2||0
8733992|NCT01078623|9781696|FG012|NOT COMPLETED|Treatment Period 2||0
8733993|NCT01078623|9781697|FG013|NOT COMPLETED|Treatment Period 2||0
8733994|NCT01078623|9781698|FG014|NOT COMPLETED|Treatment Period 2||0
8733995|NCT01078623|9781699|FG015|NOT COMPLETED|Treatment Period 2||0
8733996|NCT01078623|9781700|FG016|NOT COMPLETED|Treatment Period 2||0
8733997|NCT01078623|9781701|FG017|NOT COMPLETED|Treatment Period 2||0
8733998|NCT01078623|9781702|FG018|NOT COMPLETED|Treatment Period 2||1
8733999|NCT01078623|9781703|FG019|NOT COMPLETED|Treatment Period 2||0
8734000|NCT01078623|9781684|FG000|STARTED|Treatment Period 3||5
8734001|NCT01078623|9781685|FG001|STARTED|Treatment Period 3||5
8734002|NCT01078623|9781686|FG002|STARTED|Treatment Period 3||6
8734003|NCT01078623|9781687|FG003|STARTED|Treatment Period 3||6
8734004|NCT01078623|9781688|FG004|STARTED|Treatment Period 3||7
8734005|NCT01078623|9781689|FG005|STARTED|Treatment Period 3||4
8734006|NCT01078623|9781690|FG006|STARTED|Treatment Period 3||5
8734007|NCT01078623|9781691|FG007|STARTED|Treatment Period 3||6
8734008|NCT01078623|9781692|FG008|STARTED|Treatment Period 3||5
8734009|NCT01078623|9781693|FG009|STARTED|Treatment Period 3||6
8734010|NCT01078623|9781694|FG010|STARTED|Treatment Period 3||6
8734011|NCT01078623|9781695|FG011|STARTED|Treatment Period 3||7
8734012|NCT01078623|9781696|FG012|STARTED|Treatment Period 3||7
8734013|NCT01078623|9781697|FG013|STARTED|Treatment Period 3||7
8734014|NCT01078623|9781698|FG014|STARTED|Treatment Period 3||7
8734015|NCT01078623|9781699|FG015|STARTED|Treatment Period 3||7
8734016|NCT01078623|9781700|FG016|STARTED|Treatment Period 3||7
8734017|NCT01078623|9781701|FG017|STARTED|Treatment Period 3||7
8734018|NCT01078623|9781702|FG018|STARTED|Treatment Period 3||6
8734019|NCT01078623|9781703|FG019|STARTED|Treatment Period 3||7
8734020|NCT01078623|9781684|FG000|COMPLETED|Treatment Period 3||5
8734021|NCT01078623|9781685|FG001|COMPLETED|Treatment Period 3||5
8734022|NCT01078623|9781686|FG002|COMPLETED|Treatment Period 3||6
8734023|NCT01078623|9781687|FG003|COMPLETED|Treatment Period 3||6
8734024|NCT01078623|9781688|FG004|COMPLETED|Treatment Period 3||6
8734025|NCT01078623|9781689|FG005|COMPLETED|Treatment Period 3||4
8734026|NCT01078623|9781690|FG006|COMPLETED|Treatment Period 3||5
8734027|NCT01078623|9781691|FG007|COMPLETED|Treatment Period 3||6
8734028|NCT01078623|9781692|FG008|COMPLETED|Treatment Period 3||5
8734029|NCT01078623|9781693|FG009|COMPLETED|Treatment Period 3||6
8734030|NCT01078623|9781694|FG010|COMPLETED|Treatment Period 3||6
8734031|NCT01078623|9781695|FG011|COMPLETED|Treatment Period 3||7
8734032|NCT01078623|9781696|FG012|COMPLETED|Treatment Period 3||7
8734033|NCT01078623|9781697|FG013|COMPLETED|Treatment Period 3||6
8734034|NCT01078623|9781698|FG014|COMPLETED|Treatment Period 3||7
8734035|NCT01078623|9781699|FG015|COMPLETED|Treatment Period 3||7
8734036|NCT01078623|9781700|FG016|COMPLETED|Treatment Period 3||7
8734037|NCT01078623|9781701|FG017|COMPLETED|Treatment Period 3||7
8734038|NCT01078623|9781702|FG018|COMPLETED|Treatment Period 3||6
8734039|NCT01078623|9781703|FG019|COMPLETED|Treatment Period 3||7
8734040|NCT01078623|9781684|FG000|NOT COMPLETED|Treatment Period 3||0
8734041|NCT01078623|9781685|FG001|NOT COMPLETED|Treatment Period 3||0
8734042|NCT01078623|9781686|FG002|NOT COMPLETED|Treatment Period 3||0
8734043|NCT01078623|9781687|FG003|NOT COMPLETED|Treatment Period 3||0
8734044|NCT01078623|9781688|FG004|NOT COMPLETED|Treatment Period 3||1
8734045|NCT01078623|9781689|FG005|NOT COMPLETED|Treatment Period 3||0
8734046|NCT01078623|9781690|FG006|NOT COMPLETED|Treatment Period 3||0
8734047|NCT01078623|9781691|FG007|NOT COMPLETED|Treatment Period 3||0
8734048|NCT01078623|9781692|FG008|NOT COMPLETED|Treatment Period 3||0
8734049|NCT01078623|9781693|FG009|NOT COMPLETED|Treatment Period 3||0
8734050|NCT01078623|9781694|FG010|NOT COMPLETED|Treatment Period 3||0
8734051|NCT01078623|9781695|FG011|NOT COMPLETED|Treatment Period 3||0
8734052|NCT01078623|9781696|FG012|NOT COMPLETED|Treatment Period 3||0
8734053|NCT01078623|9781697|FG013|NOT COMPLETED|Treatment Period 3||1
8734054|NCT01078623|9781698|FG014|NOT COMPLETED|Treatment Period 3||0
8734055|NCT01078623|9781699|FG015|NOT COMPLETED|Treatment Period 3||0
8734056|NCT01078623|9781700|FG016|NOT COMPLETED|Treatment Period 3||0
8734057|NCT01078623|9781701|FG017|NOT COMPLETED|Treatment Period 3||0
8734058|NCT01078623|9781702|FG018|NOT COMPLETED|Treatment Period 3||0
8734059|NCT01078623|9781703|FG019|NOT COMPLETED|Treatment Period 3||0
8734060|NCT01078623|9781684|FG000|STARTED|Treatment Period 4||5
8734061|NCT01078623|9781685|FG001|STARTED|Treatment Period 4||5
8734062|NCT01078623|9781686|FG002|STARTED|Treatment Period 4||6
8734063|NCT01078623|9781687|FG003|STARTED|Treatment Period 4||6
8734064|NCT01078623|9781688|FG004|STARTED|Treatment Period 4||6
8734065|NCT01078623|9781689|FG005|STARTED|Treatment Period 4||4
8734066|NCT01078623|9781690|FG006|STARTED|Treatment Period 4||5
8734067|NCT01078623|9781691|FG007|STARTED|Treatment Period 4||6
8734068|NCT01078623|9781692|FG008|STARTED|Treatment Period 4||5
8911892|NCT02150460|9971034|FG000|STARTED|Overall Study||50
8734069|NCT01078623|9781693|FG009|STARTED|Treatment Period 4||6
8734070|NCT01078623|9781694|FG010|STARTED|Treatment Period 4||6
8734071|NCT01078623|9781695|FG011|STARTED|Treatment Period 4||7
8734072|NCT01078623|9781696|FG012|STARTED|Treatment Period 4||7
8734073|NCT01078623|9781697|FG013|STARTED|Treatment Period 4||6
8734074|NCT01078623|9781698|FG014|STARTED|Treatment Period 4||7
8734075|NCT01078623|9781699|FG015|STARTED|Treatment Period 4||7
8734076|NCT01078623|9781700|FG016|STARTED|Treatment Period 4||7
8734077|NCT01078623|9781701|FG017|STARTED|Treatment Period 4||7
8734078|NCT01078623|9781702|FG018|STARTED|Treatment Period 4||6
8734079|NCT01078623|9781703|FG019|STARTED|Treatment Period 4||7
8734080|NCT01078623|9781684|FG000|COMPLETED|Treatment Period 4||5
8734081|NCT01078623|9781685|FG001|COMPLETED|Treatment Period 4||5
8734082|NCT01078623|9781686|FG002|COMPLETED|Treatment Period 4||5
8734083|NCT01078623|9781687|FG003|COMPLETED|Treatment Period 4||6
8734084|NCT01078623|9781688|FG004|COMPLETED|Treatment Period 4||6
8734085|NCT01078623|9781689|FG005|COMPLETED|Treatment Period 4||4
8734086|NCT01078623|9781690|FG006|COMPLETED|Treatment Period 4||5
8734087|NCT01078623|9781691|FG007|COMPLETED|Treatment Period 4||6
8734088|NCT01078623|9781692|FG008|COMPLETED|Treatment Period 4||5
8734089|NCT01078623|9781693|FG009|COMPLETED|Treatment Period 4||6
8734090|NCT01078623|9781694|FG010|COMPLETED|Treatment Period 4||6
8734091|NCT01078623|9781695|FG011|COMPLETED|Treatment Period 4||7
8734092|NCT01078623|9781696|FG012|COMPLETED|Treatment Period 4||7
8734093|NCT01078623|9781697|FG013|COMPLETED|Treatment Period 4||6
8734094|NCT01078623|9781698|FG014|COMPLETED|Treatment Period 4||7
8734095|NCT01078623|9781699|FG015|COMPLETED|Treatment Period 4||6
8734096|NCT01078623|9781700|FG016|COMPLETED|Treatment Period 4||7
8734097|NCT01078623|9781701|FG017|COMPLETED|Treatment Period 4||7
8734098|NCT01078623|9781702|FG018|COMPLETED|Treatment Period 4||6
8734099|NCT01078623|9781703|FG019|COMPLETED|Treatment Period 4||7
8734100|NCT01078623|9781684|FG000|NOT COMPLETED|Treatment Period 4||0
8734101|NCT01078623|9781685|FG001|NOT COMPLETED|Treatment Period 4||0
8734102|NCT01078623|9781686|FG002|NOT COMPLETED|Treatment Period 4||1
8734103|NCT01078623|9781687|FG003|NOT COMPLETED|Treatment Period 4||0
8734104|NCT01078623|9781688|FG004|NOT COMPLETED|Treatment Period 4||0
8734105|NCT01078623|9781689|FG005|NOT COMPLETED|Treatment Period 4||0
8734106|NCT01078623|9781690|FG006|NOT COMPLETED|Treatment Period 4||0
8734107|NCT01078623|9781691|FG007|NOT COMPLETED|Treatment Period 4||0
8734108|NCT01078623|9781692|FG008|NOT COMPLETED|Treatment Period 4||0
8734109|NCT01078623|9781693|FG009|NOT COMPLETED|Treatment Period 4||0
8734110|NCT01078623|9781694|FG010|NOT COMPLETED|Treatment Period 4||0
8734111|NCT01078623|9781695|FG011|NOT COMPLETED|Treatment Period 4||0
8734112|NCT01078623|9781696|FG012|NOT COMPLETED|Treatment Period 4||0
8734113|NCT01078623|9781697|FG013|NOT COMPLETED|Treatment Period 4||0
8734114|NCT01078623|9781698|FG014|NOT COMPLETED|Treatment Period 4||0
8734115|NCT01078623|9781699|FG015|NOT COMPLETED|Treatment Period 4||1
8734116|NCT01078623|9781700|FG016|NOT COMPLETED|Treatment Period 4||0
8734117|NCT01078623|9781701|FG017|NOT COMPLETED|Treatment Period 4||0
8734118|NCT01078623|9781702|FG018|NOT COMPLETED|Treatment Period 4||0
8734119|NCT01078623|9781703|FG019|NOT COMPLETED|Treatment Period 4||0
8734120|NCT01078675|9781717|FG000|STARTED|Overall Study||250
8734121|NCT01078675|9781718|FG001|STARTED|Overall Study||65
8734122|NCT01078675|9781717|FG000|Patients Treated|Overall Study||198
8734123|NCT01078675|9781718|FG001|Patients Treated|Overall Study||0
8734124|NCT01078675|9781717|FG000|COMPLETED|Overall Study||182
8734125|NCT01078675|9781718|FG001|COMPLETED|Overall Study|Healthy siblings did not participate in investigational product administration.|59
8734126|NCT01078675|9781717|FG000|NOT COMPLETED|Overall Study||68
8734127|NCT01078675|9781718|FG001|NOT COMPLETED|Overall Study||6
8734128|NCT01078753|9781726|FG000|STARTED|Treatment Period I||45
8734129|NCT01078753|9781727|FG001|STARTED|Treatment Period I||44
8734130|NCT01078753|9781726|FG000|Full Analysis Set|Treatment Period I|One patient was excluded from the full analysis set due to failure to satisfy the entry criteria.|44
8734131|NCT01078753|9781727|FG001|Full Analysis Set|Treatment Period I||44
8734132|NCT01078753|9781726|FG000|COMPLETED|Treatment Period I||45
8734133|NCT01078753|9781727|FG001|COMPLETED|Treatment Period I||44
8734134|NCT01078753|9781726|FG000|NOT COMPLETED|Treatment Period I||0
8734135|NCT01078753|9781727|FG001|NOT COMPLETED|Treatment Period I||0
8734136|NCT01078753|9781726|FG000|STARTED|Treatment Period II|Desmopressin 120 µg - 4 participants Desmopressin 240 µg - 41 participants|45
8734137|NCT01078753|9781727|FG001|STARTED|Treatment Period II||44
8734138|NCT01078753|9781726|FG000|Full Analysis Set|Treatment Period II|One patient was excluded from the full analysis set due to failure to satisfy the entry criteria.|44
8734139|NCT01078753|9781727|FG001|Full Analysis Set|Treatment Period II||44
8734140|NCT01078753|9781726|FG000|COMPLETED|Treatment Period II||45
8734141|NCT01078753|9781727|FG001|COMPLETED|Treatment Period II||44
8734142|NCT01078753|9781726|FG000|NOT COMPLETED|Treatment Period II||0
8734143|NCT01078753|9781727|FG001|NOT COMPLETED|Treatment Period II||0
8734144|NCT01078805|9781733|FG000|STARTED|Overall Study||4167
8734145|NCT01078805|9781733|FG000|Took at Least 1 Dose of Study Drug|Overall Study||4085
8734146|NCT01078805|9781733|FG000|Modified Intent-To-Treat|Overall Study|≥1 dose of study drug (SD) and didn't discontinue SD more than 3 consecutive months during treatment|3720
8734147|NCT01078805|9781733|FG000|COMPLETED|Overall Study||2117
8734148|NCT01078805|9781733|FG000|NOT COMPLETED|Overall Study||2050
8734149|NCT01078909|9781742|FG000|STARTED|Overall Study||25
8734150|NCT01078909|9781743|FG001|STARTED|Overall Study||25
8734151|NCT01078909|9781744|FG002|STARTED|Overall Study||25
8734152|NCT01078909|9781745|FG003|STARTED|Overall Study||25
8734153|NCT01078909|9781746|FG004|STARTED|Overall Study||25
8734154|NCT01078909|9781742|FG000|COMPLETED|Overall Study||23
8734155|NCT01078909|9781743|FG001|COMPLETED|Overall Study||21
8734156|NCT01078909|9781744|FG002|COMPLETED|Overall Study||24
8734157|NCT01078909|9781745|FG003|COMPLETED|Overall Study||24
8734158|NCT01078909|9781746|FG004|COMPLETED|Overall Study||23
8734159|NCT01078909|9781742|FG000|NOT COMPLETED|Overall Study||2
8734160|NCT01078909|9781743|FG001|NOT COMPLETED|Overall Study||4
8734161|NCT01078909|9781744|FG002|NOT COMPLETED|Overall Study||1
8734162|NCT01078909|9781745|FG003|NOT COMPLETED|Overall Study||1
8734163|NCT01078909|9781746|FG004|NOT COMPLETED|Overall Study||2
8734164|NCT01078922|9781758|FG000|STARTED|Overall Study||11
8734165|NCT01078922|9781758|FG000|COMPLETED|Overall Study||10
8734166|NCT01078922|9781758|FG000|NOT COMPLETED|Overall Study||1
8734167|NCT01078974|9781763|FG000|STARTED|Overall Study||7
8734168|NCT01078974|9781763|FG000|COMPLETED|Overall Study||4
8734169|NCT01078974|9781763|FG000|NOT COMPLETED|Overall Study||3
8734170|NCT01079130|9781773|FG000|STARTED|Overall Study||85
8734171|NCT01079130|9781774|FG001|STARTED|Overall Study||85
8734172|NCT01079130|9781775|FG002|STARTED|Overall Study||84
8734173|NCT01079130|9781776|FG003|STARTED|Overall Study||86
8734174|NCT01079130|9781777|FG004|STARTED|Overall Study||86
8734175|NCT01079130|9781778|FG005|STARTED|Overall Study||85
8734176|NCT01079130|9781773|FG000|Safety Set: Received Study Drug|Overall Study||84
8734177|NCT01079130|9781774|FG001|Safety Set: Received Study Drug|Overall Study||81
8734178|NCT01079130|9781775|FG002|Safety Set: Received Study Drug|Overall Study||84
8734179|NCT01079130|9781776|FG003|Safety Set: Received Study Drug|Overall Study||85
8734180|NCT01079130|9781777|FG004|Safety Set: Received Study Drug|Overall Study||84
8734181|NCT01079130|9781778|FG005|Safety Set: Received Study Drug|Overall Study||84
8734182|NCT01079130|9781773|FG000|Full Analysis Set (FAS)|Overall Study||84
8734183|NCT01079130|9781774|FG001|Full Analysis Set (FAS)|Overall Study|2 patients (1 in 37.5 µg;1 in 75 µg group) randomized more than once and were excluded from the FAS.|80
8734184|NCT01079130|9781775|FG002|Full Analysis Set (FAS)|Overall Study||83
8734185|NCT01079130|9781776|FG003|Full Analysis Set (FAS)|Overall Study||85
8734186|NCT01079130|9781777|FG004|Full Analysis Set (FAS)|Overall Study||84
8734187|NCT01079130|9781778|FG005|Full Analysis Set (FAS)|Overall Study||84
8734188|NCT01079130|9781773|FG000|COMPLETED|Overall Study||83
8734189|NCT01079130|9781774|FG001|COMPLETED|Overall Study||78
8734190|NCT01079130|9781775|FG002|COMPLETED|Overall Study||83
8734191|NCT01079130|9781776|FG003|COMPLETED|Overall Study||81
8734192|NCT01079130|9781777|FG004|COMPLETED|Overall Study||78
8734193|NCT01079130|9781778|FG005|COMPLETED|Overall Study||80
8734194|NCT01079130|9781773|FG000|NOT COMPLETED|Overall Study||2
8734195|NCT01079130|9781774|FG001|NOT COMPLETED|Overall Study||7
8734196|NCT01079130|9781775|FG002|NOT COMPLETED|Overall Study||1
8734197|NCT01079130|9781776|FG003|NOT COMPLETED|Overall Study||5
8734198|NCT01079130|9781777|FG004|NOT COMPLETED|Overall Study||8
8734199|NCT01079130|9781778|FG005|NOT COMPLETED|Overall Study||5
8734200|NCT01079143|9781796|FG000|STARTED|Overall Study||36
8734201|NCT01079143|9781797|FG001|STARTED|Overall Study||60
8734202|NCT01079143|9781798|FG002|STARTED|Overall Study||39
8734203|NCT01079143|9781799|FG003|STARTED|Overall Study||59
8734204|NCT01079143|9781796|FG000|Exposed|Overall Study||36
8734205|NCT01079143|9781797|FG001|Exposed|Overall Study||60
8734206|NCT01079143|9781798|FG002|Exposed|Overall Study||39
8734207|NCT01079143|9781799|FG003|Exposed|Overall Study||59
8734208|NCT01079143|9781796|FG000|Month 3 (M3) Biopsies|Overall Study||36
8734209|NCT01079143|9781797|FG001|Month 3 (M3) Biopsies|Overall Study|1 patient was excluded due to an IF/TA Grade of III at the M3 Biopsy|59
8734210|NCT01079143|9781798|FG002|Month 3 (M3) Biopsies|Overall Study||39
8734211|NCT01079143|9781799|FG003|Month 3 (M3) Biopsies|Overall Study||59
8734212|NCT01079143|9781796|FG000|Month 12 (M12) Biopsies|Overall Study|Only 26 out of 36 participants in this group had graft biopsy that was eligible for analysis.|26
8734213|NCT01079143|9781797|FG001|Month 12 (M12) Biopsies|Overall Study||43
8734214|NCT01079143|9781798|FG002|Month 12 (M12) Biopsies|Overall Study|Only 32 out of 39 participants in this group had graft biopsy that was eligible for analysis.|32
8734215|NCT01079143|9781799|FG003|Month 12 (M12) Biopsies|Overall Study|Only 53 out of 59 participants in this group had graft biopsy that was eligible for analysis.|53
8734216|NCT01079143|9781796|FG000|M3 and M12 Biopsies|Overall Study|Only 26 out of 36 participants in this group had graft biopsy that was eligible for analysis.|26
8734217|NCT01079143|9781797|FG001|M3 and M12 Biopsies|Overall Study||43
8734218|NCT01079143|9781798|FG002|M3 and M12 Biopsies|Overall Study|Only 32 out of 39 participants in this group had graft biopsy that was eligible for analysis.|32
8734219|NCT01079143|9781799|FG003|M3 and M12 Biopsies|Overall Study|Only 53 out of 59 participants in this group had graft biopsy that was eligible for analysis.|53
8734220|NCT01079143|9781796|FG000|COMPLETED|Overall Study||27
8734221|NCT01079143|9781797|FG001|COMPLETED|Overall Study||43
8734222|NCT01079143|9781798|FG002|COMPLETED|Overall Study||34
8734223|NCT01079143|9781799|FG003|COMPLETED|Overall Study||54
8734224|NCT01079143|9781796|FG000|NOT COMPLETED|Overall Study||9
8734225|NCT01079143|9781797|FG001|NOT COMPLETED|Overall Study||17
8734226|NCT01079143|9781798|FG002|NOT COMPLETED|Overall Study||5
8734227|NCT01079143|9781799|FG003|NOT COMPLETED|Overall Study||5
8734228|NCT01079182|9781813|FG000|STARTED|Overall Study||4681
8734229|NCT01079182|9781813|FG000|COMPLETED|Overall Study||1962
8734230|NCT01079182|9781813|FG000|NOT COMPLETED|Overall Study||2719
8734231|NCT01079195|9781817|FG000|STARTED|Overall Study||15873
8734232|NCT01079195|9781817|FG000|COMPLETED|Overall Study||14442
8734233|NCT01079195|9781817|FG000|NOT COMPLETED|Overall Study||1431
8734234|NCT01079234|9781824|FG000|STARTED|Main: Week 0 to 26||164
8734235|NCT01079234|9781825|FG001|STARTED|Main: Week 0 to 26||165
8734236|NCT01079234|9781826|FG002|STARTED|Main: Week 0 to 26||164
8734237|NCT01079234|9781827|FG003|STARTED|Main: Week 0 to 26||0
8734238|NCT01079234|9781824|FG000|Exposed|Main: Week 0 to 26||164
8734239|NCT01079234|9781825|FG001|Exposed|Main: Week 0 to 26||165
8734240|NCT01079234|9781826|FG002|Exposed|Main: Week 0 to 26|Three subjects withdrew prior to exposure to trial drug.|161
8734241|NCT01079234|9781827|FG003|Exposed|Main: Week 0 to 26||0
8734242|NCT01079234|9781824|FG000|COMPLETED|Main: Week 0 to 26||138
8734243|NCT01079234|9781825|FG001|COMPLETED|Main: Week 0 to 26||139
8734244|NCT01079234|9781826|FG002|COMPLETED|Main: Week 0 to 26||152
8734245|NCT01079234|9781827|FG003|COMPLETED|Main: Week 0 to 26||0
8734246|NCT01079234|9781824|FG000|NOT COMPLETED|Main: Week 0 to 26||26
8734247|NCT01079234|9781825|FG001|NOT COMPLETED|Main: Week 0 to 26||26
8734248|NCT01079234|9781826|FG002|NOT COMPLETED|Main: Week 0 to 26||12
8734249|NCT01079234|9781827|FG003|NOT COMPLETED|Main: Week 0 to 26||0
8734250|NCT01079234|9781824|FG000|STARTED|Extension: Week 27 to 52||0
8734251|NCT01079234|9781825|FG001|STARTED|Extension: Week 27 to 52||0
8734252|NCT01079234|9781826|FG002|STARTED|Extension: Week 27 to 52|Nineteen subjects from main trial did not continue into extension trial|133
8734253|NCT01079234|9781827|FG003|STARTED|Extension: Week 27 to 52|Thirty eight subjects did not continue into extension trial.|239
8734254|NCT01079234|9781824|FG000|COMPLETED|Extension: Week 27 to 52||0
8734255|NCT01079234|9781825|FG001|COMPLETED|Extension: Week 27 to 52||0
8734256|NCT01079234|9781826|FG002|COMPLETED|Extension: Week 27 to 52||122
8734257|NCT01079234|9781827|FG003|COMPLETED|Extension: Week 27 to 52||223
8734258|NCT01079234|9781824|FG000|NOT COMPLETED|Extension: Week 27 to 52||0
8734259|NCT01079234|9781825|FG001|NOT COMPLETED|Extension: Week 27 to 52||0
8734260|NCT01079234|9781826|FG002|NOT COMPLETED|Extension: Week 27 to 52||11
8734261|NCT01079234|9781827|FG003|NOT COMPLETED|Extension: Week 27 to 52||16
8734262|NCT01079299|9781838|FG000|STARTED|Overall Study||27
8734263|NCT01079299|9781839|FG001|STARTED|Overall Study||25
8734264|NCT01079299|9781838|FG000|COMPLETED|Overall Study||27
8734265|NCT01079299|9781839|FG001|COMPLETED|Overall Study||25
8734266|NCT01079299|9781838|FG000|NOT COMPLETED|Overall Study||0
8734267|NCT01079299|9781839|FG001|NOT COMPLETED|Overall Study||0
8734268|NCT01079390|9781848|FG000|STARTED|Overall Study||15
8734269|NCT01079390|9781849|FG001|STARTED|Overall Study||15
8734270|NCT01079390|9781850|FG002|STARTED|Overall Study||14
8734271|NCT01079390|9781848|FG000|COMPLETED|Overall Study||10
8734272|NCT01079390|9781849|FG001|COMPLETED|Overall Study||10
8734273|NCT01079390|9781850|FG002|COMPLETED|Overall Study||10
8734274|NCT01079390|9781848|FG000|NOT COMPLETED|Overall Study||5
8734275|NCT01079390|9781849|FG001|NOT COMPLETED|Overall Study||5
8734276|NCT01079390|9781850|FG002|NOT COMPLETED|Overall Study||4
8734277|NCT01079663|9781862|FG000|STARTED|Overall Study||30
8734278|NCT01079663|9781863|FG001|STARTED|Overall Study||30
8734279|NCT01079663|9781862|FG000|COMPLETED|Overall Study||30
8734280|NCT01079663|9781863|FG001|COMPLETED|Overall Study||26
8734281|NCT01079663|9781862|FG000|NOT COMPLETED|Overall Study||0
8734282|NCT01079663|9781863|FG001|NOT COMPLETED|Overall Study||4
8734283|NCT01079741|9781874|FG000|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||3
8734284|NCT01079741|9781875|FG001|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
8734285|NCT01079741|9781876|FG002|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
8734286|NCT01079741|9781877|FG003|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
8734287|NCT01079741|9781878|FG004|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
8734288|NCT01079741|9781874|FG000|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||3
8734289|NCT01079741|9781875|FG001|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
8734290|NCT01079741|9781876|FG002|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
8734291|NCT01079741|9781877|FG003|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
8734292|NCT01079741|9781878|FG004|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
8734293|NCT01079741|9781874|FG000|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
8734294|NCT01079741|9781875|FG001|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
8734295|NCT01079741|9781876|FG002|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
8734296|NCT01079741|9781877|FG003|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
8734297|NCT01079741|9781878|FG004|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
8734298|NCT01079741|9781874|FG000|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
8734299|NCT01079741|9781875|FG001|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||4
8734300|NCT01079741|9781876|FG002|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
8734301|NCT01079741|9781877|FG003|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
8734302|NCT01079741|9781878|FG004|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
8734303|NCT01079741|9781874|FG000|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
8734304|NCT01079741|9781875|FG001|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||3
8734305|NCT01079741|9781876|FG002|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
8734306|NCT01079741|9781877|FG003|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
8734307|NCT01079741|9781878|FG004|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
8734308|NCT01079741|9781874|FG000|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
8734309|NCT01079741|9781875|FG001|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||1
8734310|NCT01079741|9781876|FG002|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
8734311|NCT01079741|9781877|FG003|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
8734312|NCT01079741|9781878|FG004|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
8734313|NCT01079741|9781874|FG000|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
8734314|NCT01079741|9781875|FG001|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
8734315|NCT01079741|9781876|FG002|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||3
8734316|NCT01079741|9781877|FG003|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
8734317|NCT01079741|9781878|FG004|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
8734318|NCT01079741|9781874|FG000|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
8734319|NCT01079741|9781875|FG001|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
8734320|NCT01079741|9781876|FG002|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
8734321|NCT01079741|9781877|FG003|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
8734322|NCT01079741|9781878|FG004|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
8734323|NCT01079741|9781874|FG000|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
8734324|NCT01079741|9781875|FG001|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
8734325|NCT01079741|9781876|FG002|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||3
8734326|NCT01079741|9781877|FG003|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
8734327|NCT01079741|9781878|FG004|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
8734328|NCT01079741|9781874|FG000|STARTED|Phase 2 (Weeks 37-48)||0
8734329|NCT01079741|9781875|FG001|STARTED|Phase 2 (Weeks 37-48)||0
8734330|NCT01079741|9781876|FG002|STARTED|Phase 2 (Weeks 37-48)||0
8734331|NCT01079741|9781877|FG003|STARTED|Phase 2 (Weeks 37-48)||12
8734332|NCT01079741|9781878|FG004|STARTED|Phase 2 (Weeks 37-48)||12
8734333|NCT01079741|9781874|FG000|COMPLETED|Phase 2 (Weeks 37-48)||0
8734334|NCT01079741|9781875|FG001|COMPLETED|Phase 2 (Weeks 37-48)||0
8734335|NCT01079741|9781876|FG002|COMPLETED|Phase 2 (Weeks 37-48)||0
8734336|NCT01079741|9781877|FG003|COMPLETED|Phase 2 (Weeks 37-48)||12
8734337|NCT01079741|9781878|FG004|COMPLETED|Phase 2 (Weeks 37-48)||9
8734338|NCT01079741|9781874|FG000|NOT COMPLETED|Phase 2 (Weeks 37-48)||0
8734339|NCT01079741|9781875|FG001|NOT COMPLETED|Phase 2 (Weeks 37-48)||0
8734340|NCT01079741|9781876|FG002|NOT COMPLETED|Phase 2 (Weeks 37-48)||0
8734341|NCT01079741|9781877|FG003|NOT COMPLETED|Phase 2 (Weeks 37-48)||0
8734342|NCT01079741|9781878|FG004|NOT COMPLETED|Phase 2 (Weeks 37-48)||3
8734343|NCT01079806|9781892|FG000|STARTED|Day 1 to Week 96||120
8734344|NCT01079806|9781893|FG001|STARTED|Day 1 to Week 96||60
8734345|NCT01079806|9781892|FG000|Received Treatment|Day 1 to Week 96||120
8734346|NCT01079806|9781893|FG001|Received Treatment|Day 1 to Week 96||60
8734347|NCT01079806|9781892|FG000|Primary Endpoint Cohort|Day 1 to Week 96||82
8734348|NCT01079806|9781893|FG001|Primary Endpoint Cohort|Day 1 to Week 96||41
8734349|NCT01079806|9781892|FG000|COMPLETED|Day 1 to Week 96||113
8734350|NCT01079806|9781893|FG001|COMPLETED|Day 1 to Week 96||53
8734351|NCT01079806|9781892|FG000|NOT COMPLETED|Day 1 to Week 96||7
8734352|NCT01079806|9781893|FG001|NOT COMPLETED|Day 1 to Week 96||7
8734353|NCT01079806|9781892|FG000|STARTED|Long-term Follow-up: Day 1-End of Study||111
8734354|NCT01079806|9781893|FG001|STARTED|Long-term Follow-up: Day 1-End of Study||58
8734355|NCT01079806|9781892|FG000|COMPLETED|Long-term Follow-up: Day 1-End of Study||92
8734356|NCT01079806|9781893|FG001|COMPLETED|Long-term Follow-up: Day 1-End of Study||43
8734357|NCT01079806|9781892|FG000|NOT COMPLETED|Long-term Follow-up: Day 1-End of Study||19
8734358|NCT01079806|9781893|FG001|NOT COMPLETED|Long-term Follow-up: Day 1-End of Study||15
8734359|NCT01079832|9781901|FG000|STARTED|Overall Study||50
8734360|NCT01079832|9781901|FG000|COMPLETED|Overall Study||49
8734361|NCT01079832|9781901|FG000|NOT COMPLETED|Overall Study||1
8734362|NCT01079936|9781909|FG000|STARTED|Phase I: MTD||16
8734363|NCT01079936|9781910|FG001|STARTED|Phase I: MTD||0
8734364|NCT01079936|9781911|FG002|STARTED|Phase I: MTD||0
8734365|NCT01079936|9781912|FG003|STARTED|Phase I: MTD||0
8734366|NCT01079936|9781913|FG004|STARTED|Phase I: MTD||0
8734367|NCT01079936|9781909|FG000|COMPLETED|Phase I: MTD|The 12 Phase I participants were randomized across 4 dose arms for Phase II.|12
8734368|NCT01079936|9781910|FG001|COMPLETED|Phase I: MTD||0
8734369|NCT01079936|9781911|FG002|COMPLETED|Phase I: MTD||0
8734370|NCT01079936|9781912|FG003|COMPLETED|Phase I: MTD||0
8734371|NCT01079936|9781913|FG004|COMPLETED|Phase I: MTD||0
8734372|NCT01079936|9781909|FG000|NOT COMPLETED|Phase I: MTD||4
8734373|NCT01079936|9781910|FG001|NOT COMPLETED|Phase I: MTD||0
8734374|NCT01079936|9781911|FG002|NOT COMPLETED|Phase I: MTD||0
8734375|NCT01079936|9781912|FG003|NOT COMPLETED|Phase I: MTD||0
8734376|NCT01079936|9781913|FG004|NOT COMPLETED|Phase I: MTD||0
8734377|NCT01079936|9781909|FG000|STARTED|Phase II||0
8734378|NCT01079936|9781910|FG001|STARTED|Phase II||3
8734379|NCT01079936|9781911|FG002|STARTED|Phase II||6
8734380|NCT01079936|9781912|FG003|STARTED|Phase II||24
8734381|NCT01079936|9781913|FG004|STARTED|Phase II||26
8734382|NCT01079936|9781909|FG000|COMPLETED|Phase II||0
8734383|NCT01079936|9781910|FG001|COMPLETED|Phase II||3
8734384|NCT01079936|9781911|FG002|COMPLETED|Phase II||5
8734385|NCT01079936|9781912|FG003|COMPLETED|Phase II||24
8734386|NCT01079936|9781913|FG004|COMPLETED|Phase II||25
8734387|NCT01079936|9781909|FG000|NOT COMPLETED|Phase II||0
8734388|NCT01079936|9781910|FG001|NOT COMPLETED|Phase II||0
8734389|NCT01079936|9781911|FG002|NOT COMPLETED|Phase II||1
8734390|NCT01079936|9781912|FG003|NOT COMPLETED|Phase II||0
8734391|NCT01079936|9781913|FG004|NOT COMPLETED|Phase II||1
8734392|NCT01079949|9781926|FG000|STARTED|Overall Study||46
8734393|NCT01079949|9781927|FG001|STARTED|Overall Study||47
8734394|NCT01079949|9781926|FG000|COMPLETED|Overall Study||31
8734395|NCT01079949|9781927|FG001|COMPLETED|Overall Study||34
8734396|NCT01079949|9781926|FG000|NOT COMPLETED|Overall Study||15
8734397|NCT01079949|9781927|FG001|NOT COMPLETED|Overall Study||13
8734398|NCT01079962|9781935|FG000|STARTED|Overall Study||105
8734399|NCT01079962|9781936|FG001|STARTED|Overall Study||104
8734400|NCT01079962|9781935|FG000|COMPLETED|Overall Study||90
8734401|NCT01079962|9781936|FG001|COMPLETED|Overall Study||89
8734402|NCT01079962|9781935|FG000|NOT COMPLETED|Overall Study||15
8734403|NCT01079962|9781936|FG001|NOT COMPLETED|Overall Study||15
8734404|NCT01079988|9781947|FG000|STARTED|Overall Study||10
8734405|NCT01079988|9781948|FG001|STARTED|Overall Study||1
8734406|NCT01079988|9781949|FG002|STARTED|Overall Study||8
8734407|NCT01079988|9781950|FG003|STARTED|Overall Study||20
8734408|NCT01079988|9781951|FG004|STARTED|Overall Study||2
8734409|NCT01079988|9781947|FG000|COMPLETED|Overall Study||9
8734410|NCT01079988|9781948|FG001|COMPLETED|Overall Study||1
8734411|NCT01079988|9781949|FG002|COMPLETED|Overall Study||8
8734412|NCT01079988|9781950|FG003|COMPLETED|Overall Study||17
8734413|NCT01079988|9781951|FG004|COMPLETED|Overall Study||1
8734414|NCT01079988|9781947|FG000|NOT COMPLETED|Overall Study||1
8734415|NCT01079988|9781948|FG001|NOT COMPLETED|Overall Study||0
8734416|NCT01079988|9781949|FG002|NOT COMPLETED|Overall Study||0
8734417|NCT01079988|9781950|FG003|NOT COMPLETED|Overall Study||3
8734418|NCT01079988|9781951|FG004|NOT COMPLETED|Overall Study||1
8734419|NCT01080118|9781965|FG000|STARTED|Overall Study||15
8734420|NCT01080118|9781966|FG001|STARTED|Overall Study||15
8734421|NCT01080118|9781967|FG002|STARTED|Overall Study||30
8734422|NCT01080118|9781968|FG003|STARTED|Overall Study||30
8734423|NCT01080118|9781965|FG000|COMPLETED|Overall Study||15
8734424|NCT01080118|9781966|FG001|COMPLETED|Overall Study||15
8734425|NCT01080118|9781967|FG002|COMPLETED|Overall Study||30
8734426|NCT01080118|9781968|FG003|COMPLETED|Overall Study||30
8734427|NCT01080118|9781965|FG000|NOT COMPLETED|Overall Study||0
8734428|NCT01080118|9781966|FG001|NOT COMPLETED|Overall Study||0
8734429|NCT01080118|9781967|FG002|NOT COMPLETED|Overall Study||0
8734430|NCT01080118|9781968|FG003|NOT COMPLETED|Overall Study||0
8806768|NCT01479621|9859073|FG003|Full Analysis Set|Treatment Period||102
8806769|NCT01479621|9859074|FG004|Full Analysis Set|Treatment Period||102
8806770|NCT01479621|9859075|FG005|Full Analysis Set|Treatment Period||102
8806771|NCT01479621|9859076|FG006|Full Analysis Set|Treatment Period||102
8806772|NCT01479621|9859070|FG000|COMPLETED|Treatment Period||0
8806773|NCT01479621|9859071|FG001|COMPLETED|Treatment Period||79
8806774|NCT01479621|9859072|FG002|COMPLETED|Treatment Period||83
8806775|NCT01479621|9859073|FG003|COMPLETED|Treatment Period||92
8806776|NCT01479621|9859074|FG004|COMPLETED|Treatment Period||82
8806777|NCT01479621|9859075|FG005|COMPLETED|Treatment Period||63
8806778|NCT01479621|9859076|FG006|COMPLETED|Treatment Period||84
8806779|NCT01479621|9859070|FG000|NOT COMPLETED|Treatment Period||0
8806780|NCT01479621|9859071|FG001|NOT COMPLETED|Treatment Period||24
8806781|NCT01479621|9859072|FG002|NOT COMPLETED|Treatment Period||21
8806782|NCT01479621|9859073|FG003|NOT COMPLETED|Treatment Period||12
8806783|NCT01479621|9859074|FG004|NOT COMPLETED|Treatment Period||21
8806784|NCT01479621|9859075|FG005|NOT COMPLETED|Treatment Period||41
8806785|NCT01479621|9859076|FG006|NOT COMPLETED|Treatment Period||20
8806786|NCT01479725|9859092|FG000|STARTED|Overall Study||6
8806787|NCT01479725|9859093|FG001|STARTED|Overall Study||2
8806788|NCT01479725|9859092|FG000|COMPLETED|Overall Study||4
8806789|NCT01479725|9859093|FG001|COMPLETED|Overall Study||1
8806790|NCT01479725|9859092|FG000|NOT COMPLETED|Overall Study||2
8806791|NCT01479725|9859093|FG001|NOT COMPLETED|Overall Study||1
8806792|NCT01479764|9859101|FG000|STARTED|Randomized||76
8806793|NCT01479764|9859102|FG001|STARTED|Randomized||78
8806794|NCT01479764|9859101|FG000|COMPLETED|Randomized|2 randomized participants did not receive study drug|74
8806795|NCT01479764|9859102|FG001|COMPLETED|Randomized|1 randomized participant did not receive study drug|77
8806796|NCT01479764|9859101|FG000|NOT COMPLETED|Randomized||2
8806797|NCT01479764|9859102|FG001|NOT COMPLETED|Randomized||1
8806798|NCT01479764|9859101|FG000|STARTED|Treated||74
8806799|NCT01479764|9859102|FG001|STARTED|Treated||77
8806800|NCT01479764|9859101|FG000|COMPLETED|Treated||74
8806801|NCT01479764|9859102|FG001|COMPLETED|Treated||75
8806802|NCT01479764|9859101|FG000|NOT COMPLETED|Treated||0
8806803|NCT01479764|9859102|FG001|NOT COMPLETED|Treated||2
8806804|NCT01479777|9859108|FG000|STARTED|Overall Study||12
8806805|NCT01479777|9859108|FG000|COMPLETED|Overall Study||10
8806806|NCT01479777|9859108|FG000|NOT COMPLETED|Overall Study||2
8806807|NCT01479868|9859112|FG000|STARTED|Overall Study|Restricted to subject who received at least one dose of treatment (TMC435/RBV/PegIFN).|106
8806808|NCT01479868|9859112|FG000|COMPLETED|Overall Study||97
8806809|NCT01479868|9859112|FG000|NOT COMPLETED|Overall Study||9
8911893|NCT02150460|9971035|FG001|STARTED|Overall Study||50
8911894|NCT02150460|9971034|FG000|COMPLETED|Overall Study||50
8911895|NCT02150460|9971035|FG001|COMPLETED|Overall Study||50
8911896|NCT02150460|9971034|FG000|NOT COMPLETED|Overall Study||0
8911897|NCT02150460|9971035|FG001|NOT COMPLETED|Overall Study||0
8911898|NCT02150499|9971043|FG000|STARTED|Overall Study||9
8911899|NCT02150499|9971044|FG001|STARTED|Overall Study||9
8911900|NCT02150499|9971043|FG000|COMPLETED|Overall Study||9
8911901|NCT02150499|9971044|FG001|COMPLETED|Overall Study||9
8911902|NCT02150499|9971043|FG000|NOT COMPLETED|Overall Study||0
8911903|NCT02150499|9971044|FG001|NOT COMPLETED|Overall Study||0
8911904|NCT02150759|9971052|FG000|STARTED|Overall Study||23
8911905|NCT02150759|9971053|FG001|STARTED|Overall Study||23
8911906|NCT02150759|9971052|FG000|COMPLETED|Overall Study||22
8911907|NCT02150759|9971053|FG001|COMPLETED|Overall Study||21
8911908|NCT02150759|9971052|FG000|NOT COMPLETED|Overall Study||1
8911909|NCT02150759|9971053|FG001|NOT COMPLETED|Overall Study||2
8734431|NCT01080131|9781976|FG000|STARTED|Core Study (0- 12 Weeks)||112
8734432|NCT01080131|9781977|FG001|STARTED|Core Study (0- 12 Weeks)||114
8734433|NCT01080131|9781976|FG000|COMPLETED|Core Study (0- 12 Weeks)||99
8734434|NCT01080131|9781977|FG001|COMPLETED|Core Study (0- 12 Weeks)||103
8734435|NCT01080131|9781976|FG000|NOT COMPLETED|Core Study (0- 12 Weeks)||13
8734436|NCT01080131|9781977|FG001|NOT COMPLETED|Core Study (0- 12 Weeks)||11
8734437|NCT01080131|9781976|FG000|STARTED|Extension Study 1 (12 -24 Weeks)||84
8734438|NCT01080131|9781977|FG001|STARTED|Extension Study 1 (12 -24 Weeks)||76
8734439|NCT01080131|9781976|FG000|COMPLETED|Extension Study 1 (12 -24 Weeks)||78
8734440|NCT01080131|9781977|FG001|COMPLETED|Extension Study 1 (12 -24 Weeks)||72
8734441|NCT01080131|9781976|FG000|NOT COMPLETED|Extension Study 1 (12 -24 Weeks)||6
8734442|NCT01080131|9781977|FG001|NOT COMPLETED|Extension Study 1 (12 -24 Weeks)||4
8734443|NCT01080131|9781976|FG000|STARTED|Extension Study 2 (25-72 Weeks)||72
8734444|NCT01080131|9781977|FG001|STARTED|Extension Study 2 (25-72 Weeks)||65
8734445|NCT01080131|9781976|FG000|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients re-treated with canakinumab at any time during the 72 weeks|62
8734446|NCT01080131|9781977|FG001|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients switched to canakinumab from Week 25 - Week 72|41
8734447|NCT01080131|9781976|FG000|COMPLETED|Extension Study 2 (25-72 Weeks)||64
8734448|NCT01080131|9781977|FG001|COMPLETED|Extension Study 2 (25-72 Weeks)||54
8734449|NCT01080131|9781976|FG000|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||8
8734450|NCT01080131|9781977|FG001|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||11
8734451|NCT01080196|9782003|FG000|STARTED|Overall Study||68
8734452|NCT01080196|9782004|FG001|STARTED|Overall Study||66
8734453|NCT01080196|9782003|FG000|COMPLETED|Overall Study||68
8734454|NCT01080196|9782004|FG001|COMPLETED|Overall Study||66
8734455|NCT01080196|9782003|FG000|NOT COMPLETED|Overall Study||0
8734456|NCT01080196|9782004|FG001|NOT COMPLETED|Overall Study||0
8734457|NCT01080209|9782019|FG000|STARTED|Overall Study||28
8734458|NCT01080209|9782020|FG001|STARTED|Overall Study||53
8734459|NCT01080209|9782021|FG002|STARTED|Overall Study||33
8734460|NCT01080209|9782022|FG003|STARTED|Overall Study||42
8734461|NCT01080209|9782023|FG004|STARTED|Overall Study||6
8734462|NCT01080209|9782024|FG005|STARTED|Overall Study||2
8734463|NCT01080209|9782025|FG006|STARTED|Overall Study||51
8734464|NCT01080209|9782019|FG000|COMPLETED|Overall Study||22
8734465|NCT01080209|9782020|FG001|COMPLETED|Overall Study||42
8734466|NCT01080209|9782021|FG002|COMPLETED|Overall Study||28
8734467|NCT01080209|9782022|FG003|COMPLETED|Overall Study||37
8734468|NCT01080209|9782023|FG004|COMPLETED|Overall Study||6
8734469|NCT01080209|9782024|FG005|COMPLETED|Overall Study||2
8734470|NCT01080209|9782025|FG006|COMPLETED|Overall Study||44
8734471|NCT01080209|9782019|FG000|NOT COMPLETED|Overall Study||6
8734472|NCT01080209|9782020|FG001|NOT COMPLETED|Overall Study||11
8734473|NCT01080209|9782021|FG002|NOT COMPLETED|Overall Study||5
8734474|NCT01080209|9782022|FG003|NOT COMPLETED|Overall Study||5
8734475|NCT01080209|9782023|FG004|NOT COMPLETED|Overall Study||0
8734476|NCT01080209|9782024|FG005|NOT COMPLETED|Overall Study||0
8734477|NCT01080209|9782025|FG006|NOT COMPLETED|Overall Study||7
8734478|NCT01080248|9782041|FG000|STARTED|Overall Study||2
8734479|NCT01080248|9782041|FG000|COMPLETED|Overall Study||2
8734480|NCT01080248|9782041|FG000|NOT COMPLETED|Overall Study||0
8734481|NCT01080261|9782045|FG000|STARTED|Overall Study||60
8734482|NCT01080261|9782045|FG000|COMPLETED|Overall Study||60
8734483|NCT01080261|9782045|FG000|NOT COMPLETED|Overall Study||0
8734484|NCT01080300|9782051|FG000|STARTED|Overall Study|302 subjects were randomized, but only 300 received study treatment.|300
8734485|NCT01080300|9782052|FG001|STARTED|Overall Study|298 subjects were randomized, but only 295 received study treatment.|295
8734486|NCT01080300|9782051|FG000|COMPLETED|Overall Study||206
8734487|NCT01080300|9782052|FG001|COMPLETED|Overall Study||191
8734488|NCT01080300|9782051|FG000|NOT COMPLETED|Overall Study||94
8734489|NCT01080300|9782052|FG001|NOT COMPLETED|Overall Study||104
8734490|NCT01080326|9782060|FG000|STARTED|Overall Study||7
8734491|NCT01080326|9782060|FG000|COMPLETED|Overall Study||3
8734492|NCT01080326|9782060|FG000|NOT COMPLETED|Overall Study||4
8734493|NCT01080391|9782066|FG000|STARTED|Overall Study||396
8734494|NCT01080391|9782067|FG001|STARTED|Overall Study||396
8734495|NCT01080391|9782066|FG000|Treated|Overall Study||389
8734496|NCT01080391|9782067|FG001|Treated|Overall Study||392
8734497|NCT01080391|9782066|FG000|COMPLETED|Overall Study||389
8734498|NCT01080391|9782067|FG001|COMPLETED|Overall Study||392
8734499|NCT01080391|9782066|FG000|NOT COMPLETED|Overall Study||7
8734500|NCT01080391|9782067|FG001|NOT COMPLETED|Overall Study||4
8734501|NCT01080625|9782076|FG000|STARTED|Overall Study||31
8734502|NCT01080625|9782077|FG001|STARTED|Overall Study||33
8734503|NCT01080625|9782078|FG002|STARTED|Overall Study||32
8734504|NCT01080625|9782076|FG000|COMPLETED|Overall Study||31
8734505|NCT01080625|9782077|FG001|COMPLETED|Overall Study||31
8734506|NCT01080625|9782078|FG002|COMPLETED|Overall Study||31
8734507|NCT01080625|9782076|FG000|NOT COMPLETED|Overall Study||0
8734508|NCT01080625|9782077|FG001|NOT COMPLETED|Overall Study||2
8734509|NCT01080625|9782078|FG002|NOT COMPLETED|Overall Study||1
8734510|NCT01080677|9782089|FG000|STARTED|Overall Study||20
8734511|NCT01080677|9782090|FG001|STARTED|Overall Study||20
8734512|NCT01080677|9782091|FG002|STARTED|Overall Study||20
8734513|NCT01080677|9782089|FG000|COMPLETED|Overall Study||20
8734514|NCT01080677|9782090|FG001|COMPLETED|Overall Study||20
8734515|NCT01080677|9782091|FG002|COMPLETED|Overall Study||20
8734516|NCT01080677|9782089|FG000|NOT COMPLETED|Overall Study||0
8734517|NCT01080677|9782090|FG001|NOT COMPLETED|Overall Study||0
8734518|NCT01080677|9782091|FG002|NOT COMPLETED|Overall Study||0
8734519|NCT01080716|9782103|FG000|STARTED|Part 1||14
8734520|NCT01080716|9782104|FG001|STARTED|Part 1||6
8734521|NCT01080716|9782105|FG002|STARTED|Part 1||0
8734522|NCT01080716|9782106|FG003|STARTED|Part 1||0
8734523|NCT01080716|9782103|FG000|COMPLETED|Part 1||13
8734524|NCT01080716|9782104|FG001|COMPLETED|Part 1||6
8734525|NCT01080716|9782105|FG002|COMPLETED|Part 1||0
8734526|NCT01080716|9782106|FG003|COMPLETED|Part 1||0
8734527|NCT01080716|9782103|FG000|NOT COMPLETED|Part 1||1
8734528|NCT01080716|9782104|FG001|NOT COMPLETED|Part 1||0
8734529|NCT01080716|9782105|FG002|NOT COMPLETED|Part 1||0
8734530|NCT01080716|9782106|FG003|NOT COMPLETED|Part 1||0
8734531|NCT01080716|9782103|FG000|STARTED|Part 2||0
8734532|NCT01080716|9782104|FG001|STARTED|Part 2||0
8734533|NCT01080716|9782105|FG002|STARTED|Part 2||10
8734534|NCT01080716|9782106|FG003|STARTED|Part 2||10
8734535|NCT01080716|9782103|FG000|COMPLETED|Part 2||0
8734536|NCT01080716|9782104|FG001|COMPLETED|Part 2||0
8734537|NCT01080716|9782105|FG002|COMPLETED|Part 2||10
8734538|NCT01080716|9782106|FG003|COMPLETED|Part 2||10
8734539|NCT01080716|9782103|FG000|NOT COMPLETED|Part 2||0
8734540|NCT01080716|9782104|FG001|NOT COMPLETED|Part 2||0
8734541|NCT01080716|9782105|FG002|NOT COMPLETED|Part 2||0
8734542|NCT01080716|9782106|FG003|NOT COMPLETED|Part 2||0
8734543|NCT01080794|9782124|FG000|STARTED|Overall Study||20
8734544|NCT01080794|9782125|FG001|STARTED|Overall Study||14
8734545|NCT01080794|9782126|FG002|STARTED|Overall Study||12
8734546|NCT01080794|9782127|FG003|STARTED|Overall Study||15
8734547|NCT01080794|9782124|FG000|COMPLETED|Overall Study||15
8734548|NCT01080794|9782125|FG001|COMPLETED|Overall Study||12
8734549|NCT01080794|9782126|FG002|COMPLETED|Overall Study||10
8734550|NCT01080794|9782127|FG003|COMPLETED|Overall Study||13
8734551|NCT01080794|9782124|FG000|NOT COMPLETED|Overall Study||5
8734552|NCT01080794|9782125|FG001|NOT COMPLETED|Overall Study||2
8734553|NCT01080794|9782126|FG002|NOT COMPLETED|Overall Study||2
8734554|NCT01080794|9782127|FG003|NOT COMPLETED|Overall Study||2
8734555|NCT01080807|9782139|FG000|STARTED|Overall Study|Nine patients randomly assigned to the armodafinil treatment group did not receive study drug.|193
8734556|NCT01080807|9782140|FG001|STARTED|Overall Study|Three patients randomly assigned to the placebo treatment group did not receive study drug.|190
8734557|NCT01080807|9782139|FG000|COMPLETED|Overall Study||158
8734558|NCT01080807|9782140|FG001|COMPLETED|Overall Study||167
8734559|NCT01080807|9782139|FG000|NOT COMPLETED|Overall Study||35
8734560|NCT01080807|9782140|FG001|NOT COMPLETED|Overall Study||23
8734561|NCT01080976|9782148|FG000|STARTED|Overall Study||5
8734562|NCT01080976|9782149|FG001|STARTED|Overall Study||5
8734563|NCT01080976|9782148|FG000|COMPLETED|Overall Study||5
8734564|NCT01080976|9782149|FG001|COMPLETED|Overall Study||5
8734565|NCT01080976|9782148|FG000|NOT COMPLETED|Overall Study||0
8734566|NCT01080976|9782149|FG001|NOT COMPLETED|Overall Study||0
8734567|NCT01081041|9782158|FG000|STARTED|Overall Study||33
8734568|NCT01081041|9782159|FG001|STARTED|Overall Study||81
8734569|NCT01081041|9782160|FG002|STARTED|Overall Study||73
8734570|NCT01081041|9782158|FG000|Received at Least 1 Dose of Study Drug|Overall Study||33
8734571|NCT01081041|9782159|FG001|Received at Least 1 Dose of Study Drug|Overall Study||77
8734572|NCT01081041|9782160|FG002|Received at Least 1 Dose of Study Drug|Overall Study||71
8734573|NCT01081041|9782158|FG000|COMPLETED|Overall Study||33
8734574|NCT01081041|9782159|FG001|COMPLETED|Overall Study||77
8734575|NCT01081041|9782160|FG002|COMPLETED|Overall Study||71
8734576|NCT01081041|9782158|FG000|NOT COMPLETED|Overall Study||0
8734577|NCT01081041|9782159|FG001|NOT COMPLETED|Overall Study||4
8734578|NCT01081041|9782160|FG002|NOT COMPLETED|Overall Study||2
8734579|NCT01081132|9782175|FG000|STARTED|Overall Study||157
8734580|NCT01081132|9782176|FG001|STARTED|Overall Study||157
8734581|NCT01081132|9782175|FG000|COMPLETED|Overall Study||102
8734582|NCT01081132|9782176|FG001|COMPLETED|Overall Study||105
8734583|NCT01081132|9782175|FG000|NOT COMPLETED|Overall Study||55
8734584|NCT01081132|9782176|FG001|NOT COMPLETED|Overall Study||52
8734585|NCT01081145|9782182|FG000|STARTED|Open-Label Phase||528
8734586|NCT01081145|9782183|FG001|STARTED|Open-Label Phase||0
8734587|NCT01081145|9782182|FG000|COMPLETED|Open-Label Phase||316
8734588|NCT01081145|9782183|FG001|COMPLETED|Open-Label Phase||0
8734589|NCT01081145|9782182|FG000|NOT COMPLETED|Open-Label Phase||212
8734590|NCT01081145|9782183|FG001|NOT COMPLETED|Open-Label Phase||0
8734591|NCT01081145|9782182|FG000|STARTED|Double-Blind Randomized-Withdrawal Phase||157
8734592|NCT01081145|9782183|FG001|STARTED|Double-Blind Randomized-Withdrawal Phase||159
8734593|NCT01081145|9782182|FG000|COMPLETED|Double-Blind Randomized-Withdrawal Phase||76
8734594|NCT01081145|9782183|FG001|COMPLETED|Double-Blind Randomized-Withdrawal Phase||53
8734595|NCT01081145|9782182|FG000|NOT COMPLETED|Double-Blind Randomized-Withdrawal Phase||81
8734596|NCT01081145|9782183|FG001|NOT COMPLETED|Double-Blind Randomized-Withdrawal Phase||106
8734597|NCT01081249|9782191|FG000|STARTED|Overall Study||11
8734598|NCT01081249|9782192|FG001|STARTED|Overall Study||7
8734599|NCT01081249|9782191|FG000|First Psychotherapy Appointment (1 Day)|Overall Study||11
8734600|NCT01081249|9782192|FG001|First Psychotherapy Appointment (1 Day)|Overall Study||6
8734601|NCT01081249|9782191|FG000|Washout (5-10 Days)|Overall Study||11
8734602|NCT01081249|9782192|FG001|Washout (5-10 Days)|Overall Study||6
8734603|NCT01081249|9782191|FG000|Second Psychotherapy Appointment (1 Day)|Overall Study||11
8734604|NCT01081249|9782192|FG001|Second Psychotherapy Appointment (1 Day)|Overall Study||6
8734605|NCT01081249|9782191|FG000|COMPLETED|Overall Study||11
8734606|NCT01081249|9782192|FG001|COMPLETED|Overall Study||6
8734607|NCT01081249|9782191|FG000|NOT COMPLETED|Overall Study||0
8734608|NCT01081249|9782192|FG001|NOT COMPLETED|Overall Study||1
8670612|NCT00747474|9714093|FG002|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
8670613|NCT00747474|9714094|FG003|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
8670614|NCT00747474|9714095|FG004|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
9022422|NCT03126682|10085315|FG001|NOT COMPLETED|Overall Study||0
9022423|NCT03126760|10085323|FG000|STARTED|Overall Study||18
9022424|NCT03126760|10085324|FG001|STARTED|Overall Study||17
9022425|NCT03126760|10085323|FG000|Modified Intent to Treat (mITT)|Overall Study||18
9022426|NCT03126760|10085324|FG001|Modified Intent to Treat (mITT)|Overall Study||17
9022427|NCT03126760|10085323|FG000|Completed Treatment|Overall Study|One participant halted treatment for adverse event, but completed the study|17
9022428|NCT03126760|10085324|FG001|Completed Treatment|Overall Study||17
9022429|NCT03126760|10085323|FG000|COMPLETED|Overall Study||18
9022430|NCT03126760|10085324|FG001|COMPLETED|Overall Study||17
9022431|NCT03126760|10085323|FG000|NOT COMPLETED|Overall Study||0
9022432|NCT03126760|10085324|FG001|NOT COMPLETED|Overall Study||0
9022433|NCT03126786|10085332|FG000|STARTED|Overall Study||36
9022434|NCT03126786|10085333|FG001|STARTED|Overall Study||35
9022435|NCT03126786|10085332|FG000|COMPLETED|Overall Study||30
9022436|NCT03126786|10085333|FG001|COMPLETED|Overall Study||33
9022437|NCT03126786|10085332|FG000|NOT COMPLETED|Overall Study||6
9022438|NCT03126786|10085333|FG001|NOT COMPLETED|Overall Study||2
9022439|NCT03127228|10085341|FG000|STARTED|Overall Study||12
9022440|NCT03127228|10085342|FG001|STARTED|Overall Study||12
9022441|NCT03127228|10085341|FG000|COMPLETED|Overall Study||12
9022442|NCT03127228|10085342|FG001|COMPLETED|Overall Study||12
9022443|NCT03127228|10085341|FG000|NOT COMPLETED|Overall Study||0
9022444|NCT03127228|10085342|FG001|NOT COMPLETED|Overall Study||0
9022445|NCT03127358|10085351|FG000|STARTED|Overall Study|3/9/18:Date first participant was randomized to this arm.|3
9022446|NCT03127358|10085352|FG001|STARTED|Overall Study|3/22/18: Date first participant randomized to this arm.|3
9022447|NCT03127358|10085353|FG002|STARTED|Overall Study|3/14/18: Date first participant randomized to this arm..|5
9022448|NCT03127358|10085351|FG000|COMPLETED|Overall Study|12/26/18: Date of SVR for last participant randomized to this arm.|3
9022449|NCT03127358|10085352|FG001|COMPLETED|Overall Study|2/6/19: Date of SVR for last participant randomized to this arm.|3
9022450|NCT03127358|10085353|FG002|COMPLETED|Overall Study|11/20/18: Date of SVR for last participant randomized to this arm.|5
8734609|NCT01081301|9782198|FG000|STARTED|Overall Study||36
8734610|NCT01081301|9782198|FG000|COMPLETED|Overall Study||22
8734611|NCT01081301|9782198|FG000|NOT COMPLETED|Overall Study||14
8734612|NCT01081626|9782221|FG000|STARTED|Overall Study||155
8734613|NCT01081626|9782222|FG001|STARTED|Overall Study||155
8734614|NCT01081626|9782221|FG000|Assessed for Efficacy|Overall Study||122
8734615|NCT01081626|9782222|FG001|Assessed for Efficacy|Overall Study||125
8734616|NCT01081626|9782221|FG000|COMPLETED|Overall Study||95
8734617|NCT01081626|9782222|FG001|COMPLETED|Overall Study||94
8734618|NCT01081626|9782221|FG000|NOT COMPLETED|Overall Study||60
8734619|NCT01081626|9782222|FG001|NOT COMPLETED|Overall Study||61
8734620|NCT01081665|9782228|FG000|STARTED|Overall Study||237
8734621|NCT01081665|9782228|FG000|Full Analysis Set|Overall Study||237
8734622|NCT01081665|9782228|FG000|Evaluable Population|Overall Study|Participants with baseline and at least 2 post-baseline parathormone measurements at 24 months.|212
8734623|NCT01081665|9782228|FG000|COMPLETED|Overall Study||142
8734624|NCT01081665|9782228|FG000|NOT COMPLETED|Overall Study||95
8734625|NCT01081678|9782236|FG000|STARTED|Overall Study||89
8734626|NCT01081678|9782237|FG001|STARTED|Overall Study||60
8734627|NCT01081678|9782238|FG002|STARTED|Overall Study||93
8734628|NCT01081678|9782239|FG003|STARTED|Overall Study||90
8734629|NCT01081678|9782236|FG000|Received Study Drug|Overall Study||87
8734630|NCT01081678|9782237|FG001|Received Study Drug|Overall Study||60
8734631|NCT01081678|9782238|FG002|Received Study Drug|Overall Study||89
8734632|NCT01081678|9782239|FG003|Received Study Drug|Overall Study||89
8734633|NCT01081678|9782236|FG000|Completed 24 Weeks of Study|Overall Study||73
8734634|NCT01081678|9782237|FG001|Completed 24 Weeks of Study|Overall Study||50
8734635|NCT01081678|9782238|FG002|Completed 24 Weeks of Study|Overall Study||72
8734636|NCT01081678|9782239|FG003|Completed 24 Weeks of Study|Overall Study||68
8734637|NCT01081678|9782236|FG000|COMPLETED|Overall Study||62
8734638|NCT01081678|9782237|FG001|COMPLETED|Overall Study||44
8734639|NCT01081678|9782238|FG002|COMPLETED|Overall Study||62
8734640|NCT01081678|9782239|FG003|COMPLETED|Overall Study||61
8734641|NCT01081678|9782236|FG000|NOT COMPLETED|Overall Study||27
8734642|NCT01081678|9782237|FG001|NOT COMPLETED|Overall Study||16
8734643|NCT01081678|9782238|FG002|NOT COMPLETED|Overall Study||31
8734644|NCT01081678|9782239|FG003|NOT COMPLETED|Overall Study||29
8734645|NCT01081769|9782251|FG000|STARTED|Whole Intent-to-Treat||376
8734646|NCT01081769|9782252|FG001|STARTED|Whole Intent-to-Treat||388
8734647|NCT01081769|9782251|FG000|COMPLETED|Whole Intent-to-Treat||352
8734648|NCT01081769|9782252|FG001|COMPLETED|Whole Intent-to-Treat||363
8734649|NCT01081769|9782251|FG000|NOT COMPLETED|Whole Intent-to-Treat||24
8734650|NCT01081769|9782252|FG001|NOT COMPLETED|Whole Intent-to-Treat||25
8734651|NCT01081769|9782251|FG000|STARTED|CORE Intent-To-Treat||352
8734652|NCT01081769|9782252|FG001|STARTED|CORE Intent-To-Treat||363
8734653|NCT01081769|9782251|FG000|COMPLETED|CORE Intent-To-Treat||272
8734654|NCT01081769|9782252|FG001|COMPLETED|CORE Intent-To-Treat||266
8734655|NCT01081769|9782251|FG000|NOT COMPLETED|CORE Intent-To-Treat||80
8734656|NCT01081769|9782252|FG001|NOT COMPLETED|CORE Intent-To-Treat||97
8734657|NCT01081795|9782261|FG000|STARTED|Overall Study||130
8734658|NCT01081795|9782262|FG001|STARTED|Overall Study||130
8734659|NCT01081795|9782263|FG002|STARTED|Overall Study||127
8734660|NCT01081795|9782261|FG000|COMPLETED|Overall Study||97
8734661|NCT01081795|9782262|FG001|COMPLETED|Overall Study||95
8734662|NCT01081795|9782263|FG002|COMPLETED|Overall Study||97
8734663|NCT01081795|9782261|FG000|NOT COMPLETED|Overall Study||33
8734664|NCT01081795|9782262|FG001|NOT COMPLETED|Overall Study||35
8734665|NCT01081795|9782263|FG002|NOT COMPLETED|Overall Study||30
8734666|NCT01081834|9782276|FG000|STARTED|Core Period: Baseline to Week 26||192
8734667|NCT01081834|9782277|FG001|STARTED|Core Period: Baseline to Week 26||195
8734668|NCT01081834|9782278|FG002|STARTED|Core Period: Baseline to Week 26||197
8734669|NCT01081834|9782279|FG003|STARTED|Core Period: Baseline to Week 26||47
8734670|NCT01081834|9782280|FG004|STARTED|Core Period: Baseline to Week 26||44
8734671|NCT01081834|9782276|FG000|COMPLETED|Core Period: Baseline to Week 26||160
8734672|NCT01081834|9782277|FG001|COMPLETED|Core Period: Baseline to Week 26||172
8734673|NCT01081834|9782278|FG002|COMPLETED|Core Period: Baseline to Week 26||175
8734674|NCT01081834|9782279|FG003|COMPLETED|Core Period: Baseline to Week 26||40
8734675|NCT01081834|9782280|FG004|COMPLETED|Core Period: Baseline to Week 26||40
8911910|NCT02150837|9971061|FG000|STARTED|Overall Study|87 Charts were screened with 25 screen failures due to exclusion criteria.|62
8911911|NCT02150837|9971062|FG001|STARTED|Overall Study|478 charts were screened with 168 screen failures due to exclusion criteria.|310
8911912|NCT02150837|9971061|FG000|COMPLETED|Overall Study|There was no predefined study period to complete. 37 remained through the 12 wk primary endpoint.|37
8911913|NCT02150837|9971062|FG001|COMPLETED|Overall Study|There was no predefined study period to complete. 185 remained through the 12 wk primary endpoint.|185
8911914|NCT02150837|9971061|FG000|NOT COMPLETED|Overall Study||25
8911915|NCT02150837|9971062|FG001|NOT COMPLETED|Overall Study||125
8911916|NCT02150954|9971070|FG000|STARTED|Overall Study||58
8911917|NCT02150954|9971071|FG001|STARTED|Overall Study||59
8911918|NCT02150954|9971070|FG000|COMPLETED|Overall Study||57
8911919|NCT02150954|9971071|FG001|COMPLETED|Overall Study||59
8911920|NCT02150954|9971070|FG000|NOT COMPLETED|Overall Study||1
8911921|NCT02150954|9971071|FG001|NOT COMPLETED|Overall Study||0
8911922|NCT02151058|9971080|FG000|STARTED|Overall Study||45
8911923|NCT02151058|9971081|FG001|STARTED|Overall Study||91
8911924|NCT02151058|9971082|FG002|STARTED|Overall Study||91
8911925|NCT02151058|9971080|FG000|COMPLETED|Overall Study||43
8911926|NCT02151058|9971081|FG001|COMPLETED|Overall Study||90
8911927|NCT02151058|9971082|FG002|COMPLETED|Overall Study||86
8911928|NCT02151058|9971080|FG000|NOT COMPLETED|Overall Study||2
8911929|NCT02151058|9971081|FG001|NOT COMPLETED|Overall Study||1
8911930|NCT02151058|9971082|FG002|NOT COMPLETED|Overall Study||5
8911931|NCT02151110|9971098|FG000|STARTED|Overall Study||12
8911932|NCT02151110|9971099|FG001|STARTED|Overall Study||2
8911933|NCT02151110|9971100|FG002|STARTED|Overall Study||2
8911934|NCT02151110|9971101|FG003|STARTED|Overall Study||8
8911935|NCT02151110|9971102|FG004|STARTED|Overall Study||8
8911936|NCT02151110|9971103|FG005|STARTED|Overall Study||8
8911937|NCT02151110|9971104|FG006|STARTED|Overall Study||8
8911938|NCT02151110|9971105|FG007|STARTED|Overall Study||8
8911939|NCT02151110|9971098|FG000|COMPLETED|Overall Study||12
8911940|NCT02151110|9971099|FG001|COMPLETED|Overall Study||2
8911941|NCT02151110|9971100|FG002|COMPLETED|Overall Study||2
8911942|NCT02151110|9971101|FG003|COMPLETED|Overall Study||8
8911943|NCT02151110|9971102|FG004|COMPLETED|Overall Study||8
8911944|NCT02151110|9971103|FG005|COMPLETED|Overall Study||8
8911945|NCT02151110|9971104|FG006|COMPLETED|Overall Study||8
8911946|NCT02151110|9971105|FG007|COMPLETED|Overall Study||5
8911947|NCT02151110|9971098|FG000|NOT COMPLETED|Overall Study||0
8911948|NCT02151110|9971099|FG001|NOT COMPLETED|Overall Study||0
8911949|NCT02151110|9971100|FG002|NOT COMPLETED|Overall Study||0
8911950|NCT02151110|9971101|FG003|NOT COMPLETED|Overall Study||0
8911951|NCT02151110|9971102|FG004|NOT COMPLETED|Overall Study||0
8911952|NCT02151110|9971103|FG005|NOT COMPLETED|Overall Study||0
8911953|NCT02151110|9971104|FG006|NOT COMPLETED|Overall Study||0
8911954|NCT02151110|9971105|FG007|NOT COMPLETED|Overall Study||3
8911955|NCT02151149|9971132|FG000|STARTED|Treatment Period|3 participants did not receive treatment|71
8911956|NCT02151149|9971133|FG001|STARTED|Treatment Period|2 participants did not receive treatment|72
8911957|NCT02151149|9971132|FG000|Treated Population|Treatment Period||68
8911958|NCT02151149|9971133|FG001|Treated Population|Treatment Period||70
8911959|NCT02151149|9971132|FG000|COMPLETED|Treatment Period||1
8911960|NCT02151149|9971133|FG001|COMPLETED|Treatment Period||1
8911961|NCT02151149|9971132|FG000|NOT COMPLETED|Treatment Period||70
8911962|NCT02151149|9971133|FG001|NOT COMPLETED|Treatment Period||71
8911963|NCT02151149|9971132|FG000|STARTED|Follow-Up Period||58
8911964|NCT02151149|9971133|FG001|STARTED|Follow-Up Period||55
8911965|NCT02151149|9971132|FG000|COMPLETED|Follow-Up Period|Completed = participants alive at final data cut-off date|19
8911966|NCT02151149|9971133|FG001|COMPLETED|Follow-Up Period|Completed = participants alive at final data cut-off date|18
8911967|NCT02151149|9971132|FG000|NOT COMPLETED|Follow-Up Period||39
8911968|NCT02151149|9971133|FG001|NOT COMPLETED|Follow-Up Period||37
8911969|NCT02151253|9971139|FG000|STARTED|Overall Study||13
8911970|NCT02151253|9971140|FG001|STARTED|Overall Study||15
8911971|NCT02151253|9971139|FG000|COMPLETED|Overall Study||13
8734676|NCT01081834|9782276|FG000|NOT COMPLETED|Core Period: Baseline to Week 26||32
8911972|NCT02151253|9971140|FG001|COMPLETED|Overall Study||15
8734677|NCT01081834|9782277|FG001|NOT COMPLETED|Core Period: Baseline to Week 26||23
8734678|NCT01081834|9782278|FG002|NOT COMPLETED|Core Period: Baseline to Week 26||22
8734679|NCT01081834|9782279|FG003|NOT COMPLETED|Core Period: Baseline to Week 26||7
8734680|NCT01081834|9782280|FG004|NOT COMPLETED|Core Period: Baseline to Week 26||4
8734681|NCT01081834|9782276|FG000|STARTED|Extension Period: Week 26 to Week 52|5 pts discontinued on last day of core: lack of efficacy on rescue (2), not specified (NS) (3).|155
8734682|NCT01081834|9782277|FG001|STARTED|Extension Period: Week 26 to Week 52|2 pts discontinued on last day of core: adverse event (AE) (1), protocol violation (PV) (1).|170
8734683|NCT01081834|9782278|FG002|STARTED|Extension Period: Week 26 to Week 52|5 pts discontinued last day of core: AE (1), lost f/u (1), PV (1), NS (1), physician decision (1).|170
8734684|NCT01081834|9782279|FG003|STARTED|Extension Period: Week 26 to Week 52|The treatment duration for the High Glycemic Substudy was 26 weeks only.|0
8734685|NCT01081834|9782280|FG004|STARTED|Extension Period: Week 26 to Week 52|The treatment duration for the High Glycemic Substudy was 26 weeks only.|0
8734686|NCT01081834|9782276|FG000|COMPLETED|Extension Period: Week 26 to Week 52||135
8734687|NCT01081834|9782277|FG001|COMPLETED|Extension Period: Week 26 to Week 52||152
8734688|NCT01081834|9782278|FG002|COMPLETED|Extension Period: Week 26 to Week 52||165
8734689|NCT01081834|9782279|FG003|COMPLETED|Extension Period: Week 26 to Week 52||0
8734690|NCT01081834|9782280|FG004|COMPLETED|Extension Period: Week 26 to Week 52||0
8734691|NCT01081834|9782276|FG000|NOT COMPLETED|Extension Period: Week 26 to Week 52||20
8734692|NCT01081834|9782277|FG001|NOT COMPLETED|Extension Period: Week 26 to Week 52||18
8734693|NCT01081834|9782278|FG002|NOT COMPLETED|Extension Period: Week 26 to Week 52||5
8734694|NCT01081834|9782279|FG003|NOT COMPLETED|Extension Period: Week 26 to Week 52||0
8734695|NCT01081834|9782280|FG004|NOT COMPLETED|Extension Period: Week 26 to Week 52||0
8734696|NCT01081873|9782299|FG000|STARTED|Overall Study|3 patients were excluded from this and all analyses due to no available data from Baseline.|2714
8734697|NCT01081873|9782299|FG000|COMPLETED|Overall Study||2416
8734698|NCT01081873|9782299|FG000|NOT COMPLETED|Overall Study||298
8734699|NCT01081912|9782328|FG000|STARTED|Conversion/Titration||510
8734700|NCT01081912|9782329|FG001|STARTED|Conversion/Titration||0
8734701|NCT01081912|9782330|FG002|STARTED|Conversion/Titration||0
8734702|NCT01081912|9782328|FG000|COMPLETED|Conversion/Titration||302
8734703|NCT01081912|9782329|FG001|COMPLETED|Conversion/Titration||0
8734704|NCT01081912|9782330|FG002|COMPLETED|Conversion/Titration||0
8734705|NCT01081912|9782328|FG000|NOT COMPLETED|Conversion/Titration||208
8734706|NCT01081912|9782329|FG001|NOT COMPLETED|Conversion/Titration||0
8734707|NCT01081912|9782330|FG002|NOT COMPLETED|Conversion/Titration||0
8734708|NCT01081912|9782328|FG000|STARTED|Maintenance Treatment||0
8734709|NCT01081912|9782329|FG001|STARTED|Maintenance Treatment||151
8734710|NCT01081912|9782330|FG002|STARTED|Maintenance Treatment||151
8734711|NCT01081912|9782328|FG000|COMPLETED|Maintenance Treatment||0
8734712|NCT01081912|9782329|FG001|COMPLETED|Maintenance Treatment||124
8734713|NCT01081912|9782330|FG002|COMPLETED|Maintenance Treatment||59
8734714|NCT01081912|9782328|FG000|NOT COMPLETED|Maintenance Treatment||0
8734715|NCT01081912|9782329|FG001|NOT COMPLETED|Maintenance Treatment||27
8734716|NCT01081912|9782330|FG002|NOT COMPLETED|Maintenance Treatment||92
8734717|NCT01082081|9782340|FG000|STARTED|Overall Study||121
8734718|NCT01082081|9782341|FG001|STARTED|Overall Study||119
8734719|NCT01082081|9782342|FG002|STARTED|Overall Study||60
8734720|NCT01082081|9782340|FG000|COMPLETED|Overall Study||121
8734721|NCT01082081|9782341|FG001|COMPLETED|Overall Study||118
8734722|NCT01082081|9782342|FG002|COMPLETED|Overall Study||58
8734723|NCT01082081|9782340|FG000|NOT COMPLETED|Overall Study||0
8734724|NCT01082081|9782341|FG001|NOT COMPLETED|Overall Study||1
8734725|NCT01082081|9782342|FG002|NOT COMPLETED|Overall Study||2
8734726|NCT01082159|9782350|FG000|STARTED|Overall Study||55
8734727|NCT01082159|9782350|FG000|COMPLETED|Overall Study||46
8734728|NCT01082159|9782350|FG000|NOT COMPLETED|Overall Study||9
8734729|NCT01082211|9782355|FG000|STARTED|Overall Study||65
8734730|NCT01082211|9782355|FG000|Has Baseline PT QOL Data|Overall Study||46
8734731|NCT01082211|9782355|FG000|Has Baseline MD QOL Data|Overall Study||44
8734732|NCT01082211|9782355|FG000|Has Baseline/12-month PT QOL Data|Overall Study||36
8734733|NCT01082211|9782355|FG000|Has Baseline/12-Month MD QOL Data|Overall Study||35
8734734|NCT01082211|9782355|FG000|Has Baseline/36-month PT QOL Data|Overall Study||32
8734735|NCT01082211|9782355|FG000|Has Baseline/36-Month MD QOL Data|Overall Study||27
8734736|NCT01082211|9782355|FG000|All Eligible Patients|Overall Study||58
8734737|NCT01082211|9782355|FG000|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|58
8734738|NCT01082211|9782355|FG000|NOT COMPLETED|Overall Study||7
8734739|NCT01082328|9782362|FG000|STARTED|Overall Study||59
8734740|NCT01082328|9782362|FG000|COMPLETED|Overall Study||58
8734741|NCT01082328|9782362|FG000|NOT COMPLETED|Overall Study||1
8734742|NCT01082367|9782368|FG000|STARTED|Double-blind Period||26
8734743|NCT01082367|9782369|FG001|STARTED|Double-blind Period||25
8734744|NCT01082367|9782368|FG000|Stage 1:1st Treatment (tx) Cycle|Double-blind Period||26
8734745|NCT01082367|9782369|FG001|Stage 1:1st Treatment (tx) Cycle|Double-blind Period|1 participant discontinued after cycle 1 due to an SAE|25
8734746|NCT01082367|9782368|FG000|Stage 2:no tx|Double-blind Period||0
8734747|NCT01082367|9782369|FG001|Stage 2:no tx|Double-blind Period||0
8734748|NCT01082367|9782368|FG000|Entered OL TOBI|Double-blind Period||4
8734749|NCT01082367|9782369|FG001|Entered OL TOBI|Double-blind Period||18
8734750|NCT01082367|9782368|FG000|P.A-free,Day 29 w/ no Cross-over|Double-blind Period||9
8734751|NCT01082367|9782369|FG001|P.A-free,Day 29 w/ no Cross-over|Double-blind Period||0
8734752|NCT01082367|9782368|FG000|Stage 3: Cross-over (co) tx|Double-blind Period||13
8734753|NCT01082367|9782369|FG001|Stage 3: Cross-over (co) tx|Double-blind Period||6
8734754|NCT01082367|9782368|FG000|Stage 4:no tx for Patients Not in co|Double-blind Period||0
8734755|NCT01082367|9782369|FG001|Stage 4:no tx for Patients Not in co|Double-blind Period||0
8734756|NCT01082367|9782368|FG000|COMPLETED|Double-blind Period||21
8734757|NCT01082367|9782369|FG001|COMPLETED|Double-blind Period||12
8734758|NCT01082367|9782368|FG000|NOT COMPLETED|Double-blind Period||5
8734759|NCT01082367|9782369|FG001|NOT COMPLETED|Double-blind Period||13
8734760|NCT01082367|9782368|FG000|STARTED|Follow-up (F-U) Period||19
8734761|NCT01082367|9782369|FG001|STARTED|Follow-up (F-U) Period||10
8734762|NCT01082367|9782368|FG000|Treated in F-U|Follow-up (F-U) Period||5
8734763|NCT01082367|9782369|FG001|Treated in F-U|Follow-up (F-U) Period||5
8734764|NCT01082367|9782368|FG000|COMPLETED|Follow-up (F-U) Period||17
8734765|NCT01082367|9782369|FG001|COMPLETED|Follow-up (F-U) Period||9
8734766|NCT01082367|9782368|FG000|NOT COMPLETED|Follow-up (F-U) Period||2
8734767|NCT01082367|9782369|FG001|NOT COMPLETED|Follow-up (F-U) Period||1
8734768|NCT01082380|9782379|FG000|STARTED|Overall Study||6
8734769|NCT01082380|9782379|FG000|COMPLETED|Overall Study||6
8734770|NCT01082380|9782379|FG000|NOT COMPLETED|Overall Study||0
8734771|NCT01082575|9782383|FG000|STARTED|Overall Study||100
8734772|NCT01082575|9782383|FG000|COMPLETED|Overall Study||100
8734773|NCT01082575|9782383|FG000|NOT COMPLETED|Overall Study||0
8734774|NCT01082588|9782389|FG000|STARTED|Overall Study||30
8734775|NCT01082588|9782390|FG001|STARTED|Overall Study||30
8734776|NCT01082588|9782389|FG000|COMPLETED|Overall Study||24
8734777|NCT01082588|9782390|FG001|COMPLETED|Overall Study||25
8734778|NCT01082588|9782389|FG000|NOT COMPLETED|Overall Study||6
8734779|NCT01082588|9782390|FG001|NOT COMPLETED|Overall Study||5
8734780|NCT01082614|9782398|FG000|STARTED|Overall Study||23
8734781|NCT01082614|9782399|FG001|STARTED|Overall Study||23
8734782|NCT01082614|9782398|FG000|COMPLETED|Overall Study||20
8734783|NCT01082614|9782399|FG001|COMPLETED|Overall Study||18
8734784|NCT01082614|9782398|FG000|NOT COMPLETED|Overall Study||3
8734785|NCT01082614|9782399|FG001|NOT COMPLETED|Overall Study||5
8734786|NCT01082640|9782408|FG000|STARTED|Overall Study||32
8734787|NCT01082640|9782409|FG001|STARTED|Overall Study||32
8734788|NCT01082640|9782410|FG002|STARTED|Overall Study||32
8734789|NCT01082640|9782408|FG000|COMPLETED|Overall Study||15
8734790|NCT01082640|9782409|FG001|COMPLETED|Overall Study||17
8734791|NCT01082640|9782410|FG002|COMPLETED|Overall Study||24
8734792|NCT01082640|9782408|FG000|NOT COMPLETED|Overall Study||17
8734793|NCT01082640|9782409|FG001|NOT COMPLETED|Overall Study||15
8734794|NCT01082640|9782410|FG002|NOT COMPLETED|Overall Study||8
8734795|NCT01082874|9782425|FG000|STARTED|Overall Study||2499
8734796|NCT01082874|9782426|FG001|STARTED|Overall Study||2510
8734797|NCT01082874|9782427|FG002|STARTED|Overall Study||2499
8734798|NCT01082874|9782428|FG003|STARTED|Overall Study||2502
8734799|NCT01082874|9782425|FG000|COMPLETED|Overall Study||2488
8734800|NCT01082874|9782426|FG001|COMPLETED|Overall Study||2498
8734801|NCT01082874|9782427|FG002|COMPLETED|Overall Study||2488
8734802|NCT01082874|9782428|FG003|COMPLETED|Overall Study||2489
8734803|NCT01082874|9782425|FG000|NOT COMPLETED|Overall Study||11
8734804|NCT01082874|9782426|FG001|NOT COMPLETED|Overall Study||12
8734805|NCT01082874|9782427|FG002|NOT COMPLETED|Overall Study||11
8734806|NCT01082874|9782428|FG003|NOT COMPLETED|Overall Study||13
8734807|NCT01082939|9782438|FG000|STARTED|Overall Study||80
8734808|NCT01082939|9782438|FG000|COMPLETED|Overall Study||80
8734809|NCT01082939|9782438|FG000|NOT COMPLETED|Overall Study||0
8734810|NCT01082952|9782444|FG000|STARTED|Overall Study||6
8734811|NCT01082952|9782445|FG001|STARTED|Overall Study||6
8734812|NCT01082952|9782444|FG000|COMPLETED|Overall Study||6
8734813|NCT01082952|9782445|FG001|COMPLETED|Overall Study||6
8734814|NCT01082952|9782444|FG000|NOT COMPLETED|Overall Study||0
8734815|NCT01082952|9782445|FG001|NOT COMPLETED|Overall Study||0
8734816|NCT01082965|9782453|FG000|STARTED|Overall Study||10
8734817|NCT01082965|9782454|FG001|STARTED|Overall Study||8
8734818|NCT01082965|9782453|FG000|COMPLETED|Overall Study||9
8734819|NCT01082965|9782454|FG001|COMPLETED|Overall Study||6
8734820|NCT01082965|9782453|FG000|NOT COMPLETED|Overall Study||1
8734821|NCT01082965|9782454|FG001|NOT COMPLETED|Overall Study||2
8734822|NCT01083121|9782460|FG000|STARTED|Overall Study|Participants who were enrolled in the study|1779
8734823|NCT01083121|9782460|FG000|COMPLETED|Overall Study|Participants included in the analysis|1698
8734824|NCT01083121|9782460|FG000|NOT COMPLETED|Overall Study||81
8734825|NCT01083160|9782468|FG000|STARTED|Overall Study||82
8734826|NCT01083160|9782468|FG000|Evaluable Population|Overall Study||71
8734827|NCT01083160|9782468|FG000|COMPLETED|Overall Study||81
8734828|NCT01083160|9782468|FG000|NOT COMPLETED|Overall Study||1
8734829|NCT01083173|9782472|FG000|STARTED|Main Surveillance: Safety Group||595
8734830|NCT01083173|9782473|FG001|STARTED|Main Surveillance: Safety Group||0
8734831|NCT01083173|9782472|FG000|COMPLETED|Main Surveillance: Safety Group||580
8734832|NCT01083173|9782473|FG001|COMPLETED|Main Surveillance: Safety Group||0
8734833|NCT01083173|9782472|FG000|NOT COMPLETED|Main Surveillance: Safety Group||15
8734834|NCT01083173|9782473|FG001|NOT COMPLETED|Main Surveillance: Safety Group||0
8734835|NCT01083173|9782472|FG000|STARTED|Main Surveillance: Effectiveness Group||580
8734836|NCT01083173|9782473|FG001|STARTED|Main Surveillance: Effectiveness Group||0
8734837|NCT01083173|9782472|FG000|COMPLETED|Main Surveillance: Effectiveness Group||198
8734838|NCT01083173|9782473|FG001|COMPLETED|Main Surveillance: Effectiveness Group||0
8734839|NCT01083173|9782472|FG000|NOT COMPLETED|Main Surveillance: Effectiveness Group||382
8734840|NCT01083173|9782473|FG001|NOT COMPLETED|Main Surveillance: Effectiveness Group||0
8734841|NCT01083173|9782472|FG000|STARTED|Long-term Surveillance: Safety Group||0
8734842|NCT01083173|9782473|FG001|STARTED|Long-term Surveillance: Safety Group||595
8734843|NCT01083173|9782472|FG000|COMPLETED|Long-term Surveillance: Safety Group||0
8734844|NCT01083173|9782473|FG001|COMPLETED|Long-term Surveillance: Safety Group||479
8734845|NCT01083173|9782472|FG000|NOT COMPLETED|Long-term Surveillance: Safety Group||0
8734846|NCT01083173|9782473|FG001|NOT COMPLETED|Long-term Surveillance: Safety Group||116
8734847|NCT01083173|9782472|FG000|STARTED|Long-term Surveillance: Effectiveness Gr||0
8734848|NCT01083173|9782473|FG001|STARTED|Long-term Surveillance: Effectiveness Gr||479
8734849|NCT01083173|9782472|FG000|COMPLETED|Long-term Surveillance: Effectiveness Gr||0
8734850|NCT01083173|9782473|FG001|COMPLETED|Long-term Surveillance: Effectiveness Gr||102
8734851|NCT01083173|9782472|FG000|NOT COMPLETED|Long-term Surveillance: Effectiveness Gr||0
8734852|NCT01083173|9782473|FG001|NOT COMPLETED|Long-term Surveillance: Effectiveness Gr||377
8734853|NCT01083186|9782482|FG000|STARTED|Overall Study||500
8734854|NCT01083186|9782482|FG000|COMPLETED|Overall Study||406
8734855|NCT01083186|9782482|FG000|NOT COMPLETED|Overall Study||94
8734856|NCT01083199|9782506|FG000|STARTED|Overall Study||10
8734857|NCT01083199|9782506|FG000|COMPLETED|Overall Study||10
8734858|NCT01083199|9782506|FG000|NOT COMPLETED|Overall Study||0
8734859|NCT01083316|9782511|FG000|STARTED|Overall Study||35
8734860|NCT01083316|9782511|FG000|COMPLETED|Overall Study||32
8734861|NCT01083316|9782511|FG000|NOT COMPLETED|Overall Study||3
8734862|NCT01083368|9782518|FG000|STARTED|Dose Escalation Weeks 1-4||0
8734863|NCT01083368|9782519|FG001|STARTED|Dose Escalation Weeks 1-4||0
8734864|NCT01083368|9782520|FG002|STARTED|Dose Escalation Weeks 1-4||4
8734865|NCT01083368|9782521|FG003|STARTED|Dose Escalation Weeks 1-4||0
8734866|NCT01083368|9782518|FG000|Disease Progression|Dose Escalation Weeks 1-4||0
8734867|NCT01083368|9782519|FG001|Disease Progression|Dose Escalation Weeks 1-4||0
8734868|NCT01083368|9782520|FG002|Disease Progression|Dose Escalation Weeks 1-4||1
8734869|NCT01083368|9782521|FG003|Disease Progression|Dose Escalation Weeks 1-4||0
8734870|NCT01083368|9782518|FG000|COMPLETED|Dose Escalation Weeks 1-4||0
8734871|NCT01083368|9782519|FG001|COMPLETED|Dose Escalation Weeks 1-4||0
8734872|NCT01083368|9782520|FG002|COMPLETED|Dose Escalation Weeks 1-4||4
8734873|NCT01083368|9782521|FG003|COMPLETED|Dose Escalation Weeks 1-4||0
8734874|NCT01083368|9782518|FG000|NOT COMPLETED|Dose Escalation Weeks 1-4||0
8734875|NCT01083368|9782519|FG001|NOT COMPLETED|Dose Escalation Weeks 1-4||0
8734876|NCT01083368|9782520|FG002|NOT COMPLETED|Dose Escalation Weeks 1-4||0
8734877|NCT01083368|9782521|FG003|NOT COMPLETED|Dose Escalation Weeks 1-4||0
8734878|NCT01083368|9782518|FG000|STARTED|Dose Escalation Weeks 5-9||0
8734879|NCT01083368|9782519|FG001|STARTED|Dose Escalation Weeks 5-9||0
8734880|NCT01083368|9782520|FG002|STARTED|Dose Escalation Weeks 5-9|Participant on DL1 did not move to dose level 2 because of disease progression.|1
8734881|NCT01083368|9782521|FG003|STARTED|Dose Escalation Weeks 5-9||6
8734882|NCT01083368|9782518|FG000|COMPLETED|Dose Escalation Weeks 5-9||0
8734883|NCT01083368|9782519|FG001|COMPLETED|Dose Escalation Weeks 5-9||0
8734884|NCT01083368|9782520|FG002|COMPLETED|Dose Escalation Weeks 5-9||1
8734885|NCT01083368|9782521|FG003|COMPLETED|Dose Escalation Weeks 5-9|3 participants on dose level 1 moved to dose level 2, 3 more new participants joined.|6
8734886|NCT01083368|9782518|FG000|NOT COMPLETED|Dose Escalation Weeks 5-9||0
8734887|NCT01083368|9782519|FG001|NOT COMPLETED|Dose Escalation Weeks 5-9||0
8734888|NCT01083368|9782520|FG002|NOT COMPLETED|Dose Escalation Weeks 5-9||0
8734889|NCT01083368|9782521|FG003|NOT COMPLETED|Dose Escalation Weeks 5-9||0
8734890|NCT01083368|9782518|FG000|STARTED|Phase II - Efficacy/Safety||0
8734891|NCT01083368|9782519|FG001|STARTED|Phase II - Efficacy/Safety||0
8734892|NCT01083368|9782520|FG002|STARTED|Phase II - Efficacy/Safety||0
8734893|NCT01083368|9782521|FG003|STARTED|Phase II - Efficacy/Safety||20
8734894|NCT01083368|9782518|FG000|COMPLETED|Phase II - Efficacy/Safety||0
8734895|NCT01083368|9782519|FG001|COMPLETED|Phase II - Efficacy/Safety||0
8734896|NCT01083368|9782520|FG002|COMPLETED|Phase II - Efficacy/Safety||0
8734897|NCT01083368|9782521|FG003|COMPLETED|Phase II - Efficacy/Safety|14 plus 6 participants from previous period|20
8734898|NCT01083368|9782518|FG000|NOT COMPLETED|Phase II - Efficacy/Safety||0
8734899|NCT01083368|9782519|FG001|NOT COMPLETED|Phase II - Efficacy/Safety||0
8734900|NCT01083368|9782520|FG002|NOT COMPLETED|Phase II - Efficacy/Safety||0
8734901|NCT01083368|9782521|FG003|NOT COMPLETED|Phase II - Efficacy/Safety||0
8734902|NCT01083485|9782531|FG000|STARTED|Overall Study||70
8734903|NCT01083485|9782532|FG001|STARTED|Overall Study||67
8734904|NCT01083485|9782531|FG000|COMPLETED|Overall Study||63
8734905|NCT01083485|9782532|FG001|COMPLETED|Overall Study||64
8734906|NCT01083485|9782531|FG000|NOT COMPLETED|Overall Study||7
8734907|NCT01083485|9782532|FG001|NOT COMPLETED|Overall Study||3
8734908|NCT01083576|9782542|FG000|STARTED|Overall Study||15
8734909|NCT01083576|9782543|FG001|STARTED|Overall Study||15
8734910|NCT01083576|9782542|FG000|COMPLETED|Overall Study||9
8734911|NCT01083576|9782543|FG001|COMPLETED|Overall Study||14
8734912|NCT01083576|9782542|FG000|NOT COMPLETED|Overall Study||6
8734913|NCT01083576|9782543|FG001|NOT COMPLETED|Overall Study||1
8734914|NCT01083602|9782550|FG000|STARTED|Overall Study||55
8734915|NCT01083602|9782550|FG000|COMPLETED|Overall Study||0
8734916|NCT01083602|9782550|FG000|NOT COMPLETED|Overall Study||55
8734917|NCT01083628|9782556|FG000|STARTED|Overall Study||45
8734918|NCT01083628|9782557|FG001|STARTED|Overall Study||40
8734919|NCT01083628|9782556|FG000|COMPLETED|Overall Study||45
8734920|NCT01083628|9782557|FG001|COMPLETED|Overall Study||40
8734921|NCT01083628|9782556|FG000|NOT COMPLETED|Overall Study||0
8734922|NCT01083628|9782557|FG001|NOT COMPLETED|Overall Study||0
8734923|NCT01083641|9782563|FG000|STARTED|Overall Study||17
8734924|NCT01083641|9782563|FG000|COMPLETED|Overall Study||15
8734925|NCT01083641|9782563|FG000|NOT COMPLETED|Overall Study||2
8734926|NCT01083654|9782569|FG000|STARTED|Overall Study||53
8734927|NCT01083654|9782570|FG001|STARTED|Overall Study||50
8734928|NCT01083654|9782569|FG000|COMPLETED|Overall Study||53
8734929|NCT01083654|9782570|FG001|COMPLETED|Overall Study||50
8734930|NCT01083654|9782569|FG000|NOT COMPLETED|Overall Study||0
8734931|NCT01083654|9782570|FG001|NOT COMPLETED|Overall Study||0
8734932|NCT01083667|9782576|FG000|STARTED|Overall Study|enrolled|32
8734933|NCT01083667|9782576|FG000|COMPLETED|Overall Study|22 completed to visit 9, the last visit on study.|22
8734934|NCT01083667|9782576|FG000|NOT COMPLETED|Overall Study||10
8734935|NCT01083680|9782580|FG000|STARTED|Overall Study||4107
8734936|NCT01083680|9782580|FG000|Full Analysis Set (FAS), Efficacy|Overall Study||1621
8734937|NCT01083680|9782580|FG000|COMPLETED|Overall Study||263
8734938|NCT01083680|9782580|FG000|NOT COMPLETED|Overall Study||3844
8734939|NCT01083693|9782587|FG000|STARTED|Overall Study||93
8734940|NCT01083693|9782588|FG001|STARTED|Overall Study||28
8734941|NCT01083693|9782589|FG002|STARTED|Overall Study||40
8734942|NCT01083693|9782587|FG000|COMPLETED|Overall Study||73
8734943|NCT01083693|9782588|FG001|COMPLETED|Overall Study||22
8734944|NCT01083693|9782589|FG002|COMPLETED|Overall Study||33
8911973|NCT02151253|9971139|FG000|NOT COMPLETED|Overall Study||0
8911974|NCT02151253|9971140|FG001|NOT COMPLETED|Overall Study||0
8911975|NCT02151266|9971149|FG000|STARTED|Overall Study||19
8911976|NCT02151266|9971150|FG001|STARTED|Overall Study||29
8911977|NCT02151266|9971151|FG002|STARTED|Overall Study||21
8911978|NCT02151266|9971149|FG000|COMPLETED|Overall Study||11
8911979|NCT02151266|9971150|FG001|COMPLETED|Overall Study||14
9022451|NCT03127358|10085351|FG000|NOT COMPLETED|Overall Study||0
9022452|NCT03127358|10085352|FG001|NOT COMPLETED|Overall Study||0
9022453|NCT03127358|10085353|FG002|NOT COMPLETED|Overall Study||0
9022454|NCT03127384|10085367|FG000|STARTED|Overall Study||49
9022455|NCT03127384|10085367|FG000|Completed 3 Month Visit|Overall Study||47
9022456|NCT03127384|10085367|FG000|COMPLETED|Overall Study||43
9022457|NCT03127384|10085367|FG000|NOT COMPLETED|Overall Study||6
9022458|NCT03127514|10085375|FG000|STARTED|Overall Study||48
9022459|NCT03127514|10085376|FG001|STARTED|Overall Study||89
9022460|NCT03127514|10085375|FG000|COMPLETED|Overall Study||38
9022461|NCT03127514|10085376|FG001|COMPLETED|Overall Study||67
9022462|NCT03127514|10085375|FG000|NOT COMPLETED|Overall Study||10
8734945|NCT01083693|9782587|FG000|NOT COMPLETED|Overall Study||20
8734946|NCT01083693|9782588|FG001|NOT COMPLETED|Overall Study||6
8734947|NCT01083693|9782589|FG002|NOT COMPLETED|Overall Study||7
8734948|NCT01083706|9782601|FG000|STARTED|Overall Study||39
8734949|NCT01083706|9782601|FG000|COMPLETED|Overall Study||39
8734950|NCT01083706|9782601|FG000|NOT COMPLETED|Overall Study||0
8734951|NCT01083732|9782608|FG000|STARTED|Overall Study||6
8734952|NCT01083732|9782609|FG001|STARTED|Overall Study||9
8734953|NCT01083732|9782610|FG002|STARTED|Overall Study||3
8734954|NCT01083732|9782608|FG000|COMPLETED|Overall Study||6
8734955|NCT01083732|9782609|FG001|COMPLETED|Overall Study||9
8734956|NCT01083732|9782610|FG002|COMPLETED|Overall Study||3
8734957|NCT01083732|9782608|FG000|NOT COMPLETED|Overall Study||0
8734958|NCT01083732|9782609|FG001|NOT COMPLETED|Overall Study||0
8734959|NCT01083732|9782610|FG002|NOT COMPLETED|Overall Study||0
8734960|NCT01083758|9782621|FG000|STARTED|Overall Study||31
8734961|NCT01083758|9782621|FG000|COMPLETED|Overall Study||29
8734962|NCT01083758|9782621|FG000|NOT COMPLETED|Overall Study||2
8734963|NCT01083810|9782628|FG000|STARTED|Overall Study||137
8734964|NCT01083810|9782629|FG001|STARTED|Overall Study||92
8734965|NCT01083810|9782630|FG002|STARTED|Overall Study||55
8734966|NCT01083810|9782628|FG000|COMPLETED|Overall Study||72
8734967|NCT01083810|9782629|FG001|COMPLETED|Overall Study||47
8734968|NCT01083810|9782630|FG002|COMPLETED|Overall Study||35
8734969|NCT01083810|9782628|FG000|NOT COMPLETED|Overall Study||65
8734970|NCT01083810|9782629|FG001|NOT COMPLETED|Overall Study||45
8734971|NCT01083810|9782630|FG002|NOT COMPLETED|Overall Study||20
8734972|NCT01083849|9782638|FG000|STARTED|Overall Study||121
8734973|NCT01083849|9782639|FG001|STARTED|Overall Study||638
8734974|NCT01083849|9782638|FG000|COMPLETED|Overall Study||61
8734975|NCT01083849|9782639|FG001|COMPLETED|Overall Study||527
8734976|NCT01083849|9782638|FG000|NOT COMPLETED|Overall Study||60
8734977|NCT01083849|9782639|FG001|NOT COMPLETED|Overall Study||111
8734978|NCT01083901|9782651|FG000|STARTED|Overall Study||13
8734979|NCT01083901|9782652|FG001|STARTED|Overall Study||8
8911980|NCT02151266|9971151|FG002|COMPLETED|Overall Study||14
9022463|NCT03127514|10085376|FG001|NOT COMPLETED|Overall Study||22
9022464|NCT03127644|10085385|FG000|STARTED|Overall Study||34
8734980|NCT01083901|9782653|FG002|STARTED|Overall Study||13
8734981|NCT01083901|9782651|FG000|COMPLETED|Overall Study||12
8734982|NCT01083901|9782652|FG001|COMPLETED|Overall Study||6
8734983|NCT01083901|9782653|FG002|COMPLETED|Overall Study||11
8734984|NCT01083901|9782651|FG000|NOT COMPLETED|Overall Study||1
8734985|NCT01083901|9782652|FG001|NOT COMPLETED|Overall Study||2
8734986|NCT01083901|9782653|FG002|NOT COMPLETED|Overall Study||2
8734987|NCT01083979|9782661|FG000|STARTED|Overall Study||1
8911981|NCT02151266|9971149|FG000|NOT COMPLETED|Overall Study||8
8734988|NCT01083979|9782661|FG000|COMPLETED|Overall Study||1
8734989|NCT01083979|9782661|FG000|NOT COMPLETED|Overall Study||0
8734990|NCT01084005|9782667|FG000|STARTED|Overall Study||79
8734991|NCT01084005|9782668|FG001|STARTED|Overall Study||162
8734992|NCT01084005|9782667|FG000|COMPLETED|Overall Study||74
8734993|NCT01084005|9782668|FG001|COMPLETED|Overall Study||146
8734994|NCT01084005|9782667|FG000|NOT COMPLETED|Overall Study||5
8734995|NCT01084005|9782668|FG001|NOT COMPLETED|Overall Study||16
8734996|NCT01084083|9782674|FG000|STARTED|Overall Study||90
8734997|NCT01084083|9782674|FG000|Treated|Overall Study|This is the all treated patients for toxicity analysis|89
8734998|NCT01084083|9782674|FG000|Eligible|Overall Study||81
8734999|NCT01084083|9782674|FG000|Eligible and Treated|Overall Study|This is the eligible and treated patients for secondary efficacy endpoints|80
8735000|NCT01084083|9782674|FG000|CR to Induction Therapy|Overall Study||56
8735001|NCT01084083|9782674|FG000|CR and Treated With 5400 cGy IMRT|Overall Study|This is the primary study population for the primary endpoint (24-month PFS).|44
8735002|NCT01084083|9782674|FG000|COMPLETED|Overall Study||78
8735003|NCT01084083|9782674|FG000|NOT COMPLETED|Overall Study||12
8735004|NCT01084135|9782683|FG000|STARTED|12 Week||4
8735005|NCT01084135|9782684|FG001|STARTED|12 Week||4
8735006|NCT01084135|9782683|FG000|COMPLETED|12 Week||4
8735007|NCT01084135|9782684|FG001|COMPLETED|12 Week||4
8735008|NCT01084135|9782683|FG000|NOT COMPLETED|12 Week||0
8735009|NCT01084135|9782684|FG001|NOT COMPLETED|12 Week||0
8735010|NCT01084135|9782683|FG000|STARTED|20 Week||12
8735011|NCT01084135|9782684|FG001|STARTED|20 Week||11
8735012|NCT01084135|9782683|FG000|COMPLETED|20 Week||12
8735013|NCT01084135|9782684|FG001|COMPLETED|20 Week||10
8735014|NCT01084135|9782683|FG000|NOT COMPLETED|20 Week||0
8735015|NCT01084135|9782684|FG001|NOT COMPLETED|20 Week||1
8735016|NCT01084148|9782694|FG000|STARTED|Overall Study||118
8735017|NCT01084148|9782695|FG001|STARTED|Overall Study|Among those 118 patients randomized into V0034 CR 01B vehicle arm, one patient not treated.|118
8735018|NCT01084148|9782694|FG000|Treated Patients|Overall Study||118
8735019|NCT01084148|9782695|FG001|Treated Patients|Overall Study|Patients who received test product at least once|117
8735020|NCT01084148|9782694|FG000|COMPLETED|Overall Study||88
8735021|NCT01084148|9782695|FG001|COMPLETED|Overall Study||102
8735022|NCT01084148|9782694|FG000|NOT COMPLETED|Overall Study||30
8735023|NCT01084148|9782695|FG001|NOT COMPLETED|Overall Study||16
8735024|NCT01084174|9782705|FG000|STARTED|Overall Study||10
8735025|NCT01084174|9782706|FG001|STARTED|Overall Study||11
8735026|NCT01084174|9782705|FG000|COMPLETED|Overall Study||9
8735027|NCT01084174|9782706|FG001|COMPLETED|Overall Study||7
8735028|NCT01084174|9782705|FG000|NOT COMPLETED|Overall Study||1
8735029|NCT01084174|9782706|FG001|NOT COMPLETED|Overall Study||4
8735030|NCT01084239|9782714|FG000|STARTED|Randomization - Index Hospitalization||501
8735031|NCT01084239|9782715|FG001|STARTED|Randomization - Index Hospitalization||499
8735032|NCT01084239|9782714|FG000|COMPLETED|Randomization - Index Hospitalization||501
8735033|NCT01084239|9782715|FG001|COMPLETED|Randomization - Index Hospitalization||499
8735034|NCT01084239|9782714|FG000|NOT COMPLETED|Randomization - Index Hospitalization||0
8735035|NCT01084239|9782715|FG001|NOT COMPLETED|Randomization - Index Hospitalization||0
8735036|NCT01084239|9782714|FG000|STARTED|28-Day Follow-up|All 501 patients enrolled were evaluated for follow-up at 28 days.|501
8735037|NCT01084239|9782715|FG001|STARTED|28-Day Follow-up||499
8735038|NCT01084239|9782714|FG000|COMPLETED|28-Day Follow-up||497
8735039|NCT01084239|9782715|FG001|COMPLETED|28-Day Follow-up||490
8735040|NCT01084239|9782714|FG000|NOT COMPLETED|28-Day Follow-up||4
8735041|NCT01084239|9782715|FG001|NOT COMPLETED|28-Day Follow-up||9
8735042|NCT01084265|9782723|FG000|STARTED|Overall Study||31
8735043|NCT01084265|9782723|FG000|COMPLETED|Overall Study||31
8735044|NCT01084265|9782723|FG000|NOT COMPLETED|Overall Study||0
8735045|NCT01084278|9782732|FG000|STARTED|Overall Study||8
8735046|NCT01084278|9782733|FG001|STARTED|Overall Study||8
8735047|NCT01084278|9782734|FG002|STARTED|Overall Study||8
8735048|NCT01084278|9782735|FG003|STARTED|Overall Study||8
8735049|NCT01084278|9782736|FG004|STARTED|Overall Study||8
8735050|NCT01084278|9782732|FG000|COMPLETED|Overall Study||8
8735051|NCT01084278|9782733|FG001|COMPLETED|Overall Study||8
8735052|NCT01084278|9782734|FG002|COMPLETED|Overall Study||8
8735053|NCT01084278|9782735|FG003|COMPLETED|Overall Study||8
8735054|NCT01084278|9782736|FG004|COMPLETED|Overall Study||8
8735055|NCT01084278|9782732|FG000|NOT COMPLETED|Overall Study||0
8735056|NCT01084278|9782733|FG001|NOT COMPLETED|Overall Study||0
8735057|NCT01084278|9782734|FG002|NOT COMPLETED|Overall Study||0
8735058|NCT01084278|9782735|FG003|NOT COMPLETED|Overall Study||0
8735059|NCT01084278|9782736|FG004|NOT COMPLETED|Overall Study||0
8735060|NCT01084499|9782752|FG000|STARTED|Overall Study|First Intervention (Sequence 1) : Femara (1 Day)|13
8735061|NCT01084499|9782753|FG001|STARTED|Overall Study|First Intervention (Sequence 2) : Peratra (1 Day)|13
8735062|NCT01084499|9782752|FG000|Washout (5 Weeks)|Overall Study||13
8735063|NCT01084499|9782753|FG001|Washout (5 Weeks)|Overall Study||13
8735064|NCT01084499|9782752|FG000|COMPLETED|Overall Study|Second Intervention (Sequence 1) : Peratra (1 Day)|13
8735065|NCT01084499|9782753|FG001|COMPLETED|Overall Study|Second Intervention (Sequence 2) : Femara (1 Day)|13
8735066|NCT01084499|9782752|FG000|NOT COMPLETED|Overall Study||0
8735067|NCT01084499|9782753|FG001|NOT COMPLETED|Overall Study||0
8735068|NCT01084538|9782759|FG000|STARTED|Overall Study||181
8735069|NCT01084538|9782759|FG000|COMPLETED|Overall Study||113
8735070|NCT01084538|9782759|FG000|NOT COMPLETED|Overall Study||68
8735071|NCT01084551|9782766|FG000|STARTED|Overall Study||95
8735072|NCT01084551|9782767|FG001|STARTED|Overall Study||95
8735073|NCT01084551|9782768|FG002|STARTED|Overall Study||94
8735074|NCT01084551|9782766|FG000|COMPLETED|Overall Study||86
8735075|NCT01084551|9782767|FG001|COMPLETED|Overall Study||81
8735076|NCT01084551|9782768|FG002|COMPLETED|Overall Study||86
8735077|NCT01084551|9782766|FG000|NOT COMPLETED|Overall Study||9
8735078|NCT01084551|9782767|FG001|NOT COMPLETED|Overall Study||14
8735079|NCT01084551|9782768|FG002|NOT COMPLETED|Overall Study||8
8735080|NCT01084603|9782776|FG000|STARTED|Baseline||45
8735081|NCT01084603|9782776|FG000|COMPLETED|Baseline||43
8735082|NCT01084603|9782776|FG000|NOT COMPLETED|Baseline||2
8735083|NCT01084603|9782776|FG000|STARTED|NiQuitinTM Lozenge||43
8735084|NCT01084603|9782776|FG000|COMPLETED|NiQuitinTM Lozenge||42
8735085|NCT01084603|9782776|FG000|NOT COMPLETED|NiQuitinTM Lozenge||1
8735086|NCT01084603|9782776|FG000|STARTED|Washout Period 1||42
8735087|NCT01084603|9782776|FG000|COMPLETED|Washout Period 1||42
8735088|NCT01084603|9782776|FG000|NOT COMPLETED|Washout Period 1||0
8735089|NCT01084603|9782776|FG000|STARTED|Nicorette® Gum||42
8735090|NCT01084603|9782776|FG000|COMPLETED|Nicorette® Gum||41
8735091|NCT01084603|9782776|FG000|NOT COMPLETED|Nicorette® Gum||1
8735092|NCT01084603|9782776|FG000|STARTED|Washout Period 2||41
8735093|NCT01084603|9782776|FG000|COMPLETED|Washout Period 2||41
8735094|NCT01084603|9782776|FG000|NOT COMPLETED|Washout Period 2||0
8735095|NCT01084603|9782776|FG000|STARTED|Oral Nicotine 1||41
8735096|NCT01084603|9782776|FG000|COMPLETED|Oral Nicotine 1||40
8735097|NCT01084603|9782776|FG000|NOT COMPLETED|Oral Nicotine 1||1
8735098|NCT01084603|9782776|FG000|STARTED|Washout Period 3||40
8735099|NCT01084603|9782776|FG000|COMPLETED|Washout Period 3||40
8735100|NCT01084603|9782776|FG000|NOT COMPLETED|Washout Period 3||0
8735101|NCT01084603|9782776|FG000|STARTED|Oral Nicotine 2||40
8735102|NCT01084603|9782776|FG000|COMPLETED|Oral Nicotine 2||40
8735103|NCT01084603|9782776|FG000|NOT COMPLETED|Oral Nicotine 2||0
8735104|NCT01084603|9782776|FG000|STARTED|Washout Period 4||40
8735105|NCT01084603|9782776|FG000|COMPLETED|Washout Period 4||39
8735106|NCT01084603|9782776|FG000|NOT COMPLETED|Washout Period 4||1
8735107|NCT01084603|9782776|FG000|STARTED|Oral Nicotine 4||39
8735108|NCT01084603|9782776|FG000|COMPLETED|Oral Nicotine 4||39
8735109|NCT01084603|9782776|FG000|NOT COMPLETED|Oral Nicotine 4||0
8735110|NCT01084655|9782792|FG000|STARTED|Overall Study||6
8735111|NCT01084655|9782793|FG001|STARTED|Overall Study||8
8735112|NCT01084655|9782794|FG002|STARTED|Overall Study||24
8735113|NCT01084655|9782792|FG000|Treated|Overall Study||6
8735114|NCT01084655|9782793|FG001|Treated|Overall Study||8
8735115|NCT01084655|9782794|FG002|Treated|Overall Study||23
8735116|NCT01084655|9782792|FG000|COMPLETED|Overall Study||0
8735117|NCT01084655|9782793|FG001|COMPLETED|Overall Study||2
8735118|NCT01084655|9782794|FG002|COMPLETED|Overall Study||5
8735119|NCT01084655|9782792|FG000|NOT COMPLETED|Overall Study||6
8735120|NCT01084655|9782793|FG001|NOT COMPLETED|Overall Study||6
8735121|NCT01084655|9782794|FG002|NOT COMPLETED|Overall Study||19
8735122|NCT01084668|9782806|FG000|STARTED|Overall Study|Three participants who took Humira prior to study entry have been excluded from the database.|42
8735123|NCT01084668|9782806|FG000|COMPLETED|Overall Study||33
8735124|NCT01084668|9782806|FG000|NOT COMPLETED|Overall Study||9
8735125|NCT01084694|9782814|FG000|STARTED|Overall Study||50
8735126|NCT01084694|9782815|FG001|STARTED|Overall Study||50
8735127|NCT01084694|9782814|FG000|COMPLETED|Overall Study||44
8735128|NCT01084694|9782815|FG001|COMPLETED|Overall Study||30
8735129|NCT01084694|9782814|FG000|NOT COMPLETED|Overall Study||6
8735130|NCT01084694|9782815|FG001|NOT COMPLETED|Overall Study||20
8735131|NCT01084707|9782829|FG000|STARTED|Overall Study||40
8735132|NCT01084707|9782829|FG000|COMPLETED|Overall Study||34
8735133|NCT01084707|9782829|FG000|NOT COMPLETED|Overall Study||6
8735134|NCT01084759|9782841|FG000|STARTED|Overall Study||16
8735135|NCT01084759|9782841|FG000|COMPLETED|Overall Study||14
8735136|NCT01084759|9782841|FG000|NOT COMPLETED|Overall Study||2
8735137|NCT01084772|9782847|FG000|STARTED|Baseline||68
8735138|NCT01084772|9782848|FG001|STARTED|Baseline||66
8735139|NCT01084772|9782847|FG000|COMPLETED|Baseline||61
8735140|NCT01084772|9782848|FG001|COMPLETED|Baseline||60
8735141|NCT01084772|9782847|FG000|NOT COMPLETED|Baseline||7
8735142|NCT01084772|9782848|FG001|NOT COMPLETED|Baseline||6
8735143|NCT01084772|9782847|FG000|STARTED|3 Months||61
8735144|NCT01084772|9782848|FG001|STARTED|3 Months||60
8735145|NCT01084772|9782847|FG000|COMPLETED|3 Months||58
8735146|NCT01084772|9782848|FG001|COMPLETED|3 Months||58
8735147|NCT01084772|9782847|FG000|NOT COMPLETED|3 Months||3
8735148|NCT01084772|9782848|FG001|NOT COMPLETED|3 Months||2
8735149|NCT01084772|9782847|FG000|STARTED|1 Year||58
8735150|NCT01084772|9782848|FG001|STARTED|1 Year||58
8735151|NCT01084772|9782847|FG000|COMPLETED|1 Year||55
8735152|NCT01084772|9782848|FG001|COMPLETED|1 Year||50
8735153|NCT01084772|9782847|FG000|NOT COMPLETED|1 Year||3
8735154|NCT01084772|9782848|FG001|NOT COMPLETED|1 Year||8
8735155|NCT01084772|9782847|FG000|STARTED|2 Years||55
8735156|NCT01084772|9782848|FG001|STARTED|2 Years||50
8735157|NCT01084772|9782847|FG000|COMPLETED|2 Years||46
8735158|NCT01084772|9782848|FG001|COMPLETED|2 Years||46
8735159|NCT01084772|9782847|FG000|NOT COMPLETED|2 Years||9
8735160|NCT01084772|9782848|FG001|NOT COMPLETED|2 Years||4
8735161|NCT01085006|9782856|FG000|STARTED|Overall Study||50
8735162|NCT01085006|9782857|FG001|STARTED|Overall Study||50
8735163|NCT01085006|9782856|FG000|COMPLETED|Overall Study||50
8735164|NCT01085006|9782857|FG001|COMPLETED|Overall Study||50
8735165|NCT01085006|9782856|FG000|NOT COMPLETED|Overall Study||0
8735166|NCT01085006|9782857|FG001|NOT COMPLETED|Overall Study||0
8735167|NCT01085045|9782863|FG000|STARTED|Part A||122
8735168|NCT01085045|9782863|FG000|GFF MDI 72/9.6mcg|Part A||40
8735169|NCT01085045|9782863|FG000|GFF MDI 36/9.6 µg (PT003)|Part A||42
8735170|NCT01085045|9782863|FG000|GP MDI 36 µg (PT001)|Part A||40
8735171|NCT01085045|9782863|FG000|Spiriva 18 µg|Part A||58
8735172|NCT01085045|9782863|FG000|FF MDI 9.6 µg (PT005)|Part A||20
8735173|NCT01085045|9782863|FG000|FF MDI 7.2 µg (PT005)|Part A||21
8735174|NCT01085045|9782863|FG000|Placebo MDI|Part A||5
8735175|NCT01085045|9782863|FG000|Foradil 12 µg|Part A||14
8735176|NCT01085045|9782863|FG000|COMPLETED|Part A||104
8735177|NCT01085045|9782863|FG000|NOT COMPLETED|Part A||18
8735178|NCT01085045|9782863|FG000|STARTED|Part B||104
8735179|NCT01085045|9782863|FG000|GFF MDI 72/9.6mcg (PT003)|Part B||0
8735180|NCT01085045|9782863|FG000|GFF MDI 36/9.6 µg|Part B||0
8735181|NCT01085045|9782863|FG000|Spiriva 18 µg|Part B||0
8735182|NCT01085045|9782863|FG000|FF MDI 9.6 µg (PT005)|Part B||43
8735183|NCT01085045|9782863|FG000|FF MDI 7.2 µg (PT005)|Part B||43
8735184|NCT01085045|9782863|FG000|Placebo MDI|Part B||47
8735185|NCT01085045|9782863|FG000|Foradil 12 µg|Part B||41
8735186|NCT01085045|9782863|FG000|GP MDI 36 µg (PT001)|Part B||0
8735187|NCT01085045|9782863|FG000|COMPLETED|Part B||89
8735188|NCT01085045|9782863|FG000|NOT COMPLETED|Part B||15
8735189|NCT01085136|9782883|FG000|STARTED|Part A||1154
8735190|NCT01085136|9782884|FG001|STARTED|Part A|Only Afatinib monotherapy administered in Part A|0
8735191|NCT01085136|9782885|FG002|STARTED|Part A||0
8735192|NCT01085136|9782883|FG000|Randomized to Part B|Part A|Discontinued Part A -Randomized to Part B|206
8735193|NCT01085136|9782884|FG001|Randomized to Part B|Part A||0
8735194|NCT01085136|9782885|FG002|Randomized to Part B|Part A||0
8735195|NCT01085136|9782883|FG000|COMPLETED|Part A|Randomized to Part B & completed trial as per protocol, had PD, clinical progression.|831
8735196|NCT01085136|9782884|FG001|COMPLETED|Part A||0
8735197|NCT01085136|9782885|FG002|COMPLETED|Part A||0
8735198|NCT01085136|9782883|FG000|NOT COMPLETED|Part A||323
8735199|NCT01085136|9782884|FG001|NOT COMPLETED|Part A||0
8735200|NCT01085136|9782885|FG002|NOT COMPLETED|Part A||0
8735201|NCT01085136|9782883|FG000|STARTED|Part B|Afatinib monotherapy not administered in Part B|0
8735202|NCT01085136|9782884|FG001|STARTED|Part B||138
8735203|NCT01085136|9782885|FG002|STARTED|Part B||68
8735204|NCT01085136|9782883|FG000|COMPLETED|Part B|Afatinib monotherapy not administered in Part B|0
8735205|NCT01085136|9782884|FG001|COMPLETED|Part B|Completed trial as per protocol, had progressive disease, clinical signs or symptoms of progression|87
8735206|NCT01085136|9782885|FG002|COMPLETED|Part B|Completed trial as per protocol, had progressive disease, clinical signs or symptoms of progression|42
8735207|NCT01085136|9782883|FG000|NOT COMPLETED|Part B||0
8735208|NCT01085136|9782884|FG001|NOT COMPLETED|Part B||51
8735209|NCT01085136|9782885|FG002|NOT COMPLETED|Part B||26
8735210|NCT01085201|9782900|FG000|STARTED|Overall Study||18
8735211|NCT01085201|9782901|FG001|STARTED|Overall Study||7
8735212|NCT01085201|9782902|FG002|STARTED|Overall Study||5
8735213|NCT01085201|9782903|FG003|STARTED|Overall Study||6
8735214|NCT01085201|9782904|FG004|STARTED|Overall Study||3
8735215|NCT01085201|9782900|FG000|COMPLETED|Overall Study||15
8735216|NCT01085201|9782901|FG001|COMPLETED|Overall Study||6
8735217|NCT01085201|9782902|FG002|COMPLETED|Overall Study||3
8735218|NCT01085201|9782903|FG003|COMPLETED|Overall Study||6
8735219|NCT01085201|9782904|FG004|COMPLETED|Overall Study||3
8735220|NCT01085201|9782900|FG000|NOT COMPLETED|Overall Study||3
8735221|NCT01085201|9782901|FG001|NOT COMPLETED|Overall Study||1
8735222|NCT01085201|9782902|FG002|NOT COMPLETED|Overall Study||2
8735223|NCT01085201|9782903|FG003|NOT COMPLETED|Overall Study||0
8735224|NCT01085201|9782904|FG004|NOT COMPLETED|Overall Study||0
8735225|NCT01085214|9782921|FG000|STARTED|Overall Study||37
8735226|NCT01085214|9782921|FG000|COMPLETED|Overall Study||36
8735227|NCT01085214|9782921|FG000|NOT COMPLETED|Overall Study||1
8735228|NCT01085318|9782927|FG000|STARTED|Overall Study||23
8735229|NCT01085318|9782928|FG001|STARTED|Overall Study||15
8735230|NCT01085318|9782927|FG000|COMPLETED|Overall Study||21
8735231|NCT01085318|9782928|FG001|COMPLETED|Overall Study||15
8735232|NCT01085318|9782927|FG000|NOT COMPLETED|Overall Study||2
8735233|NCT01085318|9782928|FG001|NOT COMPLETED|Overall Study||0
8735234|NCT01085331|9782936|FG000|STARTED|Overall Study||10
8735235|NCT01085331|9782937|FG001|STARTED|Overall Study||6
8735236|NCT01085331|9782936|FG000|COMPLETED|Overall Study||10
8735237|NCT01085331|9782937|FG001|COMPLETED|Overall Study||6
8735238|NCT01085331|9782936|FG000|NOT COMPLETED|Overall Study||0
8735239|NCT01085331|9782937|FG001|NOT COMPLETED|Overall Study||0
8735240|NCT01085344|9782947|FG000|STARTED|Overall Study||56
8735241|NCT01085344|9782947|FG000|COMPLETED|Overall Study||50
8735242|NCT01085344|9782947|FG000|NOT COMPLETED|Overall Study||6
8735243|NCT01085357|9782953|FG000|STARTED|Overall Study||374
8735244|NCT01085357|9782954|FG001|STARTED|Overall Study||131
8735245|NCT01085357|9782953|FG000|COMPLETED|Overall Study||355
8735246|NCT01085357|9782954|FG001|COMPLETED|Overall Study||125
8735247|NCT01085357|9782953|FG000|NOT COMPLETED|Overall Study||19
8735248|NCT01085357|9782954|FG001|NOT COMPLETED|Overall Study||6
8735249|NCT01085500|9782962|FG000|STARTED|Overall Study||26
8735250|NCT01085500|9782963|FG001|STARTED|Overall Study||24
8735251|NCT01085500|9782962|FG000|COMPLETED|Overall Study||26
8735252|NCT01085500|9782963|FG001|COMPLETED|Overall Study||24
8735253|NCT01085500|9782962|FG000|NOT COMPLETED|Overall Study||0
8735254|NCT01085500|9782963|FG001|NOT COMPLETED|Overall Study||0
8735255|NCT01085513|9782971|FG000|STARTED|Phase I - Development Phase||54
8735256|NCT01085513|9782972|FG001|STARTED|Phase I - Development Phase||52
8735257|NCT01085513|9782971|FG000|COMPLETED|Phase I - Development Phase|recruitment was premature terminated|54
8735258|NCT01085513|9782972|FG001|COMPLETED|Phase I - Development Phase||52
8735259|NCT01085513|9782971|FG000|NOT COMPLETED|Phase I - Development Phase||0
8735260|NCT01085513|9782972|FG001|NOT COMPLETED|Phase I - Development Phase||0
8735261|NCT01085513|9782971|FG000|STARTED|Phase II - Validation Phase||21
8735262|NCT01085513|9782972|FG001|STARTED|Phase II - Validation Phase||16
8735263|NCT01085513|9782971|FG000|COMPLETED|Phase II - Validation Phase||21
8735264|NCT01085513|9782972|FG001|COMPLETED|Phase II - Validation Phase||16
8735265|NCT01085513|9782971|FG000|NOT COMPLETED|Phase II - Validation Phase||0
8735266|NCT01085513|9782972|FG001|NOT COMPLETED|Phase II - Validation Phase||0
8735267|NCT01085539|9782978|FG000|STARTED|Sat Secs Off--No Alarm Evaluation||50
8735268|NCT01085539|9782978|FG000|COMPLETED|Sat Secs Off--No Alarm Evaluation||50
8735269|NCT01085539|9782978|FG000|NOT COMPLETED|Sat Secs Off--No Alarm Evaluation||0
8735270|NCT01085539|9782978|FG000|STARTED|10 Sat Secs--10 Second Alarm Evaluation||50
8735271|NCT01085539|9782978|FG000|COMPLETED|10 Sat Secs--10 Second Alarm Evaluation||50
8735272|NCT01085539|9782978|FG000|NOT COMPLETED|10 Sat Secs--10 Second Alarm Evaluation||0
8735273|NCT01085539|9782978|FG000|STARTED|25 Sat Secs--25 Second Alarm Evaluation||50
8735274|NCT01085539|9782978|FG000|COMPLETED|25 Sat Secs--25 Second Alarm Evaluation||50
8735275|NCT01085539|9782978|FG000|NOT COMPLETED|25 Sat Secs--25 Second Alarm Evaluation||0
8735276|NCT01085539|9782978|FG000|STARTED|50 Sat Secs--50 Second Alarm Evaluation||50
8735277|NCT01085539|9782978|FG000|COMPLETED|50 Sat Secs--50 Second Alarm Evaluation||50
8735278|NCT01085539|9782978|FG000|NOT COMPLETED|50 Sat Secs--50 Second Alarm Evaluation||0
8735279|NCT01085539|9782978|FG000|STARTED|100Sat Secs-100 Second Alarm Evaluation||50
8735280|NCT01085539|9782978|FG000|COMPLETED|100Sat Secs-100 Second Alarm Evaluation||50
8735281|NCT01085539|9782978|FG000|NOT COMPLETED|100Sat Secs-100 Second Alarm Evaluation||0
8735282|NCT01085591|9782985|FG000|STARTED|Overall Study||69
8735283|NCT01085591|9782986|FG001|STARTED|Overall Study||71
8735284|NCT01085591|9782987|FG002|STARTED|Overall Study||70
8735285|NCT01085591|9782985|FG000|Received at Least 1 Dose of Study Drug|Overall Study||68
8735286|NCT01085591|9782986|FG001|Received at Least 1 Dose of Study Drug|Overall Study||69
8735287|NCT01085591|9782987|FG002|Received at Least 1 Dose of Study Drug|Overall Study||70
8735288|NCT01085591|9782985|FG000|COMPLETED|Overall Study||66
8735289|NCT01085591|9782986|FG001|COMPLETED|Overall Study||65
8735290|NCT01085591|9782987|FG002|COMPLETED|Overall Study||63
8735291|NCT01085591|9782985|FG000|NOT COMPLETED|Overall Study||3
8735292|NCT01085591|9782986|FG001|NOT COMPLETED|Overall Study||6
8735293|NCT01085591|9782987|FG002|NOT COMPLETED|Overall Study||7
8735294|NCT01085630|9782998|FG000|STARTED|Overall Study||26
8735295|NCT01085630|9782999|FG001|STARTED|Overall Study||27
8735296|NCT01085630|9782998|FG000|COMPLETED|Overall Study||22
8735297|NCT01085630|9782999|FG001|COMPLETED|Overall Study||27
8735298|NCT01085630|9782998|FG000|NOT COMPLETED|Overall Study||4
8735299|NCT01085630|9782999|FG001|NOT COMPLETED|Overall Study||0
8735300|NCT01085682|9783007|FG000|STARTED|Overall Study||31
8735301|NCT01085682|9783008|FG001|STARTED|Overall Study||28
8735302|NCT01085682|9783007|FG000|COMPLETED|Overall Study||6
8735303|NCT01085682|9783008|FG001|COMPLETED|Overall Study||3
8735304|NCT01085682|9783007|FG000|NOT COMPLETED|Overall Study||25
8735305|NCT01085682|9783008|FG001|NOT COMPLETED|Overall Study||25
8735306|NCT01085734|9783016|FG000|STARTED|Overall Study||15
8735307|NCT01085734|9783017|FG001|STARTED|Overall Study||15
8735308|NCT01085734|9783016|FG000|COMPLETED|Overall Study||14
8735309|NCT01085734|9783017|FG001|COMPLETED|Overall Study||11
8735310|NCT01085734|9783016|FG000|NOT COMPLETED|Overall Study||1
8735311|NCT01085734|9783017|FG001|NOT COMPLETED|Overall Study||4
8735312|NCT01085760|9783028|FG000|STARTED|Overall Study||8
8735313|NCT01085760|9783029|FG001|STARTED|Overall Study||9
8735314|NCT01085760|9783030|FG002|STARTED|Overall Study||9
8735315|NCT01085760|9783031|FG003|STARTED|Overall Study||9
8735316|NCT01085760|9783028|FG000|COMPLETED|Overall Study||7
8735317|NCT01085760|9783029|FG001|COMPLETED|Overall Study||8
8735318|NCT01085760|9783030|FG002|COMPLETED|Overall Study||7
8735319|NCT01085760|9783031|FG003|COMPLETED|Overall Study||6
8735320|NCT01085760|9783028|FG000|NOT COMPLETED|Overall Study||1
8735321|NCT01085760|9783029|FG001|NOT COMPLETED|Overall Study||1
8735322|NCT01085760|9783030|FG002|NOT COMPLETED|Overall Study||2
8735323|NCT01085760|9783031|FG003|NOT COMPLETED|Overall Study||3
8735324|NCT01085786|9783043|FG000|STARTED|Overall Study||123
8735325|NCT01085786|9783044|FG001|STARTED|Overall Study||117
8735326|NCT01085786|9783043|FG000|COMPLETED|Overall Study||123
8735327|NCT01085786|9783044|FG001|COMPLETED|Overall Study||117
8735328|NCT01085786|9783043|FG000|NOT COMPLETED|Overall Study||0
8735329|NCT01085786|9783044|FG001|NOT COMPLETED|Overall Study||0
8806810|NCT01479985|9859118|FG000|STARTED|Overall Study||167
8806811|NCT01479985|9859119|FG001|STARTED|Overall Study||86
8806812|NCT01479985|9859118|FG000|Baseline Survey|Overall Study||166
8806813|NCT01479985|9859119|FG001|Baseline Survey|Overall Study||85
8806814|NCT01479985|9859118|FG000|COMPLETED|Overall Study||161
8806815|NCT01479985|9859119|FG001|COMPLETED|Overall Study||80
8806816|NCT01479985|9859118|FG000|NOT COMPLETED|Overall Study||6
8806817|NCT01479985|9859119|FG001|NOT COMPLETED|Overall Study||6
8806818|NCT01480076|9859127|FG000|STARTED|Overall Study|enrolled and started run-in treatment|901
8806819|NCT01480076|9859127|FG000|Intent to Treat Population|Overall Study|Received ≥1 dose of study drug & provided ≥1 efficacy assessment at Baseline & the 3-month visit.|835
8735330|NCT01085812|9783050|FG000|STARTED|Open-Label Period||0
8735331|NCT01085812|9783051|FG001|STARTED|Open-Label Period||734
8735332|NCT01085812|9783050|FG000|COMPLETED|Open-Label Period||0
8735333|NCT01085812|9783051|FG001|COMPLETED|Open-Label Period||494
8735334|NCT01085812|9783050|FG000|NOT COMPLETED|Open-Label Period||0
8735335|NCT01085812|9783051|FG001|NOT COMPLETED|Open-Label Period||240
8735336|NCT01085812|9783050|FG000|STARTED|Double-Blind Period||113
8735337|NCT01085812|9783051|FG001|STARTED|Double-Blind Period||235
8735338|NCT01085812|9783050|FG000|COMPLETED|Double-Blind Period||92
8735339|NCT01085812|9783051|FG001|COMPLETED|Double-Blind Period||177
8735340|NCT01085812|9783050|FG000|NOT COMPLETED|Double-Blind Period||21
8735341|NCT01085812|9783051|FG001|NOT COMPLETED|Double-Blind Period||58
8735342|NCT01085812|9783050|FG000|STARTED|Double-blind Intent-to-treat Population||112
8735343|NCT01085812|9783051|FG001|STARTED|Double-blind Intent-to-treat Population||230
8735344|NCT01085812|9783050|FG000|COMPLETED|Double-blind Intent-to-treat Population||92
8735345|NCT01085812|9783051|FG001|COMPLETED|Double-blind Intent-to-treat Population||174
8735346|NCT01085812|9783050|FG000|NOT COMPLETED|Double-blind Intent-to-treat Population||20
8735347|NCT01085812|9783051|FG001|NOT COMPLETED|Double-blind Intent-to-treat Population||56
8735348|NCT01085825|9783060|FG000|STARTED|Overall Study|1st participant enrolled|252
8735349|NCT01085825|9783061|FG001|STARTED|Overall Study||248
8735350|NCT01085825|9783060|FG000|COMPLETED|Overall Study||251
8735351|NCT01085825|9783061|FG001|COMPLETED|Overall Study||247
8735352|NCT01085825|9783060|FG000|NOT COMPLETED|Overall Study||1
8735353|NCT01085825|9783061|FG001|NOT COMPLETED|Overall Study||1
8735354|NCT01085903|9783069|FG000|STARTED|Overall Study||21
8735355|NCT01085903|9783070|FG001|STARTED|Overall Study||4
8735356|NCT01085903|9783071|FG002|STARTED|Overall Study||3
8735357|NCT01085903|9783069|FG000|COMPLETED|Overall Study||21
8735358|NCT01085903|9783070|FG001|COMPLETED|Overall Study||4
8735359|NCT01085903|9783071|FG002|COMPLETED|Overall Study||3
8735360|NCT01085903|9783069|FG000|NOT COMPLETED|Overall Study||0
8735361|NCT01085903|9783070|FG001|NOT COMPLETED|Overall Study||0
8735362|NCT01085903|9783071|FG002|NOT COMPLETED|Overall Study||0
8735363|NCT01085968|9783092|FG000|STARTED|Overall Study||29
8735364|NCT01085968|9783093|FG001|STARTED|Overall Study||25
8735365|NCT01085968|9783092|FG000|COMPLETED|Overall Study||19
8735366|NCT01085968|9783093|FG001|COMPLETED|Overall Study||21
8735367|NCT01085968|9783092|FG000|NOT COMPLETED|Overall Study||10
8735368|NCT01085968|9783093|FG001|NOT COMPLETED|Overall Study||4
8735369|NCT01086033|9783099|FG000|STARTED|Overall Study||566
8735370|NCT01086033|9783099|FG000|COMPLETED|Overall Study||262
8735371|NCT01086033|9783099|FG000|NOT COMPLETED|Overall Study||304
8735372|NCT01086150|9783109|FG000|STARTED|Overall Study||11
8735373|NCT01086150|9783110|FG001|STARTED|Overall Study||27
8735374|NCT01086150|9783111|FG002|STARTED|Overall Study||13
8735375|NCT01086150|9783109|FG000|COMPLETED|Overall Study||11
8735376|NCT01086150|9783110|FG001|COMPLETED|Overall Study||21
8735377|NCT01086150|9783111|FG002|COMPLETED|Overall Study||12
8735378|NCT01086150|9783109|FG000|NOT COMPLETED|Overall Study||0
8735379|NCT01086150|9783110|FG001|NOT COMPLETED|Overall Study||6
8735380|NCT01086150|9783111|FG002|NOT COMPLETED|Overall Study||1
8735381|NCT01086215|9783123|FG000|STARTED|Overall Study||212
8735382|NCT01086215|9783124|FG001|STARTED|Overall Study||201
8735383|NCT01086215|9783125|FG002|STARTED|Overall Study||73
8735384|NCT01086215|9783126|FG003|STARTED|Overall Study||14
8735385|NCT01086215|9783123|FG000|3 Month Follow Up|Overall Study|7 LTF; 4 Deaths|201
8735386|NCT01086215|9783124|FG001|3 Month Follow Up|Overall Study|10 LTF; 4 Deaths|187
8735387|NCT01086215|9783125|FG002|3 Month Follow Up|Overall Study|5 LTF; 4 Deaths|64
8735388|NCT01086215|9783126|FG003|3 Month Follow Up|Overall Study|1 LTF; 0 Deaths|13
8735389|NCT01086215|9783123|FG000|6 Month Follow Up|Overall Study|5 LTF; 4 Deaths|192
8735390|NCT01086215|9783124|FG001|6 Month Follow Up|Overall Study|13 LTF; 2 Deaths|172
8735391|NCT01086215|9783125|FG002|6 Month Follow Up|Overall Study|4 LTF; 0 Deaths|60
8735392|NCT01086215|9783126|FG003|6 Month Follow Up|Overall Study|1 LTF; 0 Deaths|12
8735393|NCT01086215|9783123|FG000|12 Month Follow Up|Overall Study|10 LTF; 6 Deaths|176
8735394|NCT01086215|9783124|FG001|12 Month Follow Up|Overall Study|16 LTF; 2 Deaths|154
8735395|NCT01086215|9783125|FG002|12 Month Follow Up|Overall Study|9 LTF; 4 Deaths|47
8735396|NCT01086215|9783126|FG003|12 Month Follow Up|Overall Study|0 LTF; 1 Death|11
8735397|NCT01086215|9783123|FG000|COMPLETED|Overall Study||176
8735398|NCT01086215|9783124|FG001|COMPLETED|Overall Study||154
8735399|NCT01086215|9783125|FG002|COMPLETED|Overall Study||47
8735400|NCT01086215|9783126|FG003|COMPLETED|Overall Study||11
8735401|NCT01086215|9783123|FG000|NOT COMPLETED|Overall Study||36
8735402|NCT01086215|9783124|FG001|NOT COMPLETED|Overall Study||47
8735403|NCT01086215|9783125|FG002|NOT COMPLETED|Overall Study||26
8735404|NCT01086215|9783126|FG003|NOT COMPLETED|Overall Study||3
8735405|NCT01086228|9783136|FG000|STARTED|8 Month Follow-up|Analysis population|2009
8735406|NCT01086228|9783136|FG000|COMPLETED|8 Month Follow-up||1938
8735407|NCT01086228|9783136|FG000|NOT COMPLETED|8 Month Follow-up||71
8735408|NCT01086228|9783136|FG000|STARTED|1-year Follow-up||1938
8735409|NCT01086228|9783136|FG000|COMPLETED|1-year Follow-up||1894
8735410|NCT01086228|9783136|FG000|NOT COMPLETED|1-year Follow-up||44
8735411|NCT01086228|9783136|FG000|STARTED|2-year Follow-up||1894
8735412|NCT01086228|9783136|FG000|COMPLETED|2-year Follow-up||1834
8735413|NCT01086228|9783136|FG000|NOT COMPLETED|2-year Follow-up||60
8735414|NCT01086228|9783136|FG000|STARTED|3-year Follow-up||1834
8735415|NCT01086228|9783136|FG000|COMPLETED|3-year Follow-up||1767
8735416|NCT01086228|9783136|FG000|NOT COMPLETED|3-year Follow-up||67
8735417|NCT01086228|9783136|FG000|STARTED|4-year Follow-up||1767
8735418|NCT01086228|9783136|FG000|COMPLETED|4-year Follow-up||1664
8735419|NCT01086228|9783136|FG000|NOT COMPLETED|4-year Follow-up||103
8735420|NCT01086228|9783136|FG000|STARTED|5-year Follow-up||1664
8735421|NCT01086228|9783136|FG000|COMPLETED|5-year Follow-up||1012
8735422|NCT01086228|9783136|FG000|NOT COMPLETED|5-year Follow-up||652
8735423|NCT01086358|9783140|FG000|STARTED|First Intervention|30 subjects enrolled.|30
8735424|NCT01086358|9783141|FG001|STARTED|First Intervention|30 subjects enrolled, 1 withdrew before randomization|29
8735425|NCT01086358|9783140|FG000|COMPLETED|First Intervention||21
8735426|NCT01086358|9783141|FG001|COMPLETED|First Intervention||24
8735427|NCT01086358|9783140|FG000|NOT COMPLETED|First Intervention||9
8735428|NCT01086358|9783141|FG001|NOT COMPLETED|First Intervention||5
8735429|NCT01086358|9783140|FG000|STARTED|Second Intervention||21
8735430|NCT01086358|9783141|FG001|STARTED|Second Intervention||24
8735431|NCT01086358|9783140|FG000|COMPLETED|Second Intervention||17
8735432|NCT01086358|9783141|FG001|COMPLETED|Second Intervention||20
8735433|NCT01086358|9783140|FG000|NOT COMPLETED|Second Intervention||4
8735434|NCT01086358|9783141|FG001|NOT COMPLETED|Second Intervention||4
8735435|NCT01086384|9783149|FG000|STARTED|2-week Run-in Period||2183
8735436|NCT01086384|9783150|FG001|STARTED|2-week Run-in Period||0
8735437|NCT01086384|9783151|FG002|STARTED|2-week Run-in Period||0
8735438|NCT01086384|9783149|FG000|COMPLETED|2-week Run-in Period||2020
8735439|NCT01086384|9783150|FG001|COMPLETED|2-week Run-in Period||0
8735440|NCT01086384|9783151|FG002|COMPLETED|2-week Run-in Period||0
8735441|NCT01086384|9783149|FG000|NOT COMPLETED|2-week Run-in Period||163
8735442|NCT01086384|9783150|FG001|NOT COMPLETED|2-week Run-in Period||0
8735443|NCT01086384|9783151|FG002|NOT COMPLETED|2-week Run-in Period||0
8735444|NCT01086384|9783149|FG000|STARTED|Treatment Period||0
8735445|NCT01086384|9783150|FG001|STARTED|Treatment Period||1011
8735446|NCT01086384|9783151|FG002|STARTED|Treatment Period||1009
8735447|NCT01086384|9783149|FG000|COMPLETED|Treatment Period||0
8735448|NCT01086384|9783150|FG001|COMPLETED|Treatment Period||863
8735449|NCT01086384|9783151|FG002|COMPLETED|Treatment Period||885
8735450|NCT01086384|9783149|FG000|NOT COMPLETED|Treatment Period||0
8735451|NCT01086384|9783150|FG001|NOT COMPLETED|Treatment Period||148
8735452|NCT01086384|9783151|FG002|NOT COMPLETED|Treatment Period||124
8735453|NCT01086410|9783161|FG000|STARTED|Overall Study||58
8735454|NCT01086410|9783162|FG001|STARTED|Overall Study||56
8735455|NCT01086410|9783163|FG002|STARTED|Overall Study||56
8735456|NCT01086410|9783164|FG003|STARTED|Overall Study||15
8735457|NCT01086410|9783161|FG000|COMPLETED|Overall Study||55
8735458|NCT01086410|9783162|FG001|COMPLETED|Overall Study||54
8735459|NCT01086410|9783163|FG002|COMPLETED|Overall Study||55
8735460|NCT01086410|9783164|FG003|COMPLETED|Overall Study||13
8735461|NCT01086410|9783161|FG000|NOT COMPLETED|Overall Study||3
8735462|NCT01086410|9783162|FG001|NOT COMPLETED|Overall Study||2
8735463|NCT01086410|9783163|FG002|NOT COMPLETED|Overall Study||1
8735464|NCT01086410|9783164|FG003|NOT COMPLETED|Overall Study||2
8735465|NCT01086423|9783177|FG000|STARTED|Overall Study||330
8735466|NCT01086423|9783178|FG001|STARTED|Overall Study||324
8735467|NCT01086423|9783179|FG002|STARTED|Overall Study||330
8735468|NCT01086423|9783177|FG000|COMPLETED|Overall Study||320
8735469|NCT01086423|9783178|FG001|COMPLETED|Overall Study||321
8735470|NCT01086423|9783179|FG002|COMPLETED|Overall Study||321
8735471|NCT01086423|9783177|FG000|NOT COMPLETED|Overall Study||10
8735472|NCT01086423|9783178|FG001|NOT COMPLETED|Overall Study||3
8735473|NCT01086423|9783179|FG002|NOT COMPLETED|Overall Study||9
8735474|NCT01086475|9783189|FG000|STARTED|Overall Study||34
8735475|NCT01086475|9783190|FG001|STARTED|Overall Study||33
8735476|NCT01086475|9783189|FG000|COMPLETED|Overall Study||34
8735477|NCT01086475|9783190|FG001|COMPLETED|Overall Study||33
8735478|NCT01086475|9783189|FG000|NOT COMPLETED|Overall Study||0
8735479|NCT01086475|9783190|FG001|NOT COMPLETED|Overall Study||0
8735480|NCT01086540|9783198|FG000|STARTED|Overall Study||29
8735481|NCT01086540|9783199|FG001|STARTED|Overall Study||28
8735482|NCT01086540|9783198|FG000|COMPLETED|Overall Study||23
8735483|NCT01086540|9783199|FG001|COMPLETED|Overall Study||26
8735484|NCT01086540|9783198|FG000|NOT COMPLETED|Overall Study||6
8735485|NCT01086540|9783199|FG001|NOT COMPLETED|Overall Study||2
8735486|NCT01086605|9783207|FG000|STARTED|Overall Study||24
8735487|NCT01086605|9783208|FG001|STARTED|Overall Study||22
8735488|NCT01086605|9783207|FG000|COMPLETED|Overall Study||24
8735489|NCT01086605|9783208|FG001|COMPLETED|Overall Study||22
8735490|NCT01086605|9783207|FG000|NOT COMPLETED|Overall Study||0
8735491|NCT01086605|9783208|FG001|NOT COMPLETED|Overall Study||0
8735492|NCT01086761|9783220|FG000|STARTED|Overall Study||9
8735493|NCT01086761|9783221|FG001|STARTED|Overall Study||7
8735494|NCT01086761|9783222|FG002|STARTED|Overall Study||6
8735495|NCT01086761|9783223|FG003|STARTED|Overall Study||6
8735496|NCT01086761|9783224|FG004|STARTED|Overall Study||4
8735497|NCT01086761|9783225|FG005|STARTED|Overall Study||0
8735498|NCT01086761|9783220|FG000|COMPLETED|Overall Study||9
8735499|NCT01086761|9783221|FG001|COMPLETED|Overall Study||7
8735500|NCT01086761|9783222|FG002|COMPLETED|Overall Study||6
8735501|NCT01086761|9783223|FG003|COMPLETED|Overall Study||6
8735502|NCT01086761|9783224|FG004|COMPLETED|Overall Study||4
8735503|NCT01086761|9783225|FG005|COMPLETED|Overall Study||0
8735504|NCT01086761|9783220|FG000|NOT COMPLETED|Overall Study||0
8735505|NCT01086761|9783221|FG001|NOT COMPLETED|Overall Study||0
8735506|NCT01086761|9783222|FG002|NOT COMPLETED|Overall Study||0
8735507|NCT01086761|9783223|FG003|NOT COMPLETED|Overall Study||0
8735508|NCT01086761|9783224|FG004|NOT COMPLETED|Overall Study||0
8735509|NCT01086761|9783225|FG005|NOT COMPLETED|Overall Study||0
8735510|NCT01086852|9783238|FG000|STARTED|Overall Study||4
8735511|NCT01086852|9783238|FG000|COMPLETED|Overall Study||4
8735512|NCT01086852|9783238|FG000|NOT COMPLETED|Overall Study||0
8735513|NCT01086969|9783246|FG000|STARTED|Overall Study||100
8735514|NCT01086969|9783247|FG001|STARTED|Overall Study||100
8735515|NCT01086969|9783248|FG002|STARTED|Overall Study||100
8735516|NCT01086969|9783246|FG000|COMPLETED|Overall Study||99
8735517|NCT01086969|9783247|FG001|COMPLETED|Overall Study||98
8735518|NCT01086969|9783248|FG002|COMPLETED|Overall Study||100
8735519|NCT01086969|9783246|FG000|NOT COMPLETED|Overall Study||1
8735520|NCT01086969|9783247|FG001|NOT COMPLETED|Overall Study||2
8735521|NCT01086969|9783248|FG002|NOT COMPLETED|Overall Study||0
8735522|NCT01087489|9783256|FG000|STARTED|Overall Study||19
8735523|NCT01087489|9783257|FG001|STARTED|Overall Study||34
8735524|NCT01087489|9783256|FG000|COMPLETED|Overall Study||19
8735525|NCT01087489|9783257|FG001|COMPLETED|Overall Study||31
8735526|NCT01087489|9783256|FG000|NOT COMPLETED|Overall Study||0
8735527|NCT01087489|9783257|FG001|NOT COMPLETED|Overall Study||3
8735528|NCT01087502|9783265|FG000|STARTED|Up to Interim Analysis (Week 12)||123
8735529|NCT01087502|9783266|FG001|STARTED|Up to Interim Analysis (Week 12)||118
8735530|NCT01087502|9783265|FG000|COMPLETED|Up to Interim Analysis (Week 12)||114
8735531|NCT01087502|9783266|FG001|COMPLETED|Up to Interim Analysis (Week 12)||110
8735532|NCT01087502|9783265|FG000|NOT COMPLETED|Up to Interim Analysis (Week 12)||9
8735533|NCT01087502|9783266|FG001|NOT COMPLETED|Up to Interim Analysis (Week 12)||8
8735534|NCT01087502|9783265|FG000|STARTED|Up to Final Analysis (Week 52)||123
8735535|NCT01087502|9783266|FG001|STARTED|Up to Final Analysis (Week 52)||118
8735536|NCT01087502|9783265|FG000|COMPLETED|Up to Final Analysis (Week 52)||90
8735537|NCT01087502|9783266|FG001|COMPLETED|Up to Final Analysis (Week 52)||95
8735538|NCT01087502|9783265|FG000|NOT COMPLETED|Up to Final Analysis (Week 52)||33
8735539|NCT01087502|9783266|FG001|NOT COMPLETED|Up to Final Analysis (Week 52)||23
8735540|NCT01087528|9783274|FG000|STARTED|Overall Study||51
8735541|NCT01087528|9783274|FG000|COMPLETED|Overall Study|withdrawn from the study prior to any procedure|44
8735542|NCT01087528|9783274|FG000|NOT COMPLETED|Overall Study||7
8735543|NCT01087541|9783282|FG000|STARTED|Overall Study||3307
8735544|NCT01087541|9783283|FG001|STARTED|Overall Study||3523
8735545|NCT01087541|9783282|FG000|COMPLETED|Overall Study||3307
8735546|NCT01087541|9783283|FG001|COMPLETED|Overall Study||3523
8735547|NCT01087541|9783282|FG000|NOT COMPLETED|Overall Study||0
8735548|NCT01087541|9783283|FG001|NOT COMPLETED|Overall Study||0
8735549|NCT01087723|9783291|FG000|STARTED|Overall Study|Randomized participants who signed an informed consent form (ICF); Intent-to-treat (ITT) population|1089
8735550|NCT01087723|9783292|FG001|STARTED|Overall Study|Randomized participants who signed an informed consent form (ICF); Intent-to-treat (ITT) population|1109
8735551|NCT01087723|9783291|FG000|Received at Least 1 Dose of Study Drug|Overall Study|Participants who were randomized with signed ICF by treatment actually received; Safety population|1099
8735552|NCT01087723|9783292|FG001|Received at Least 1 Dose of Study Drug|Overall Study|Participants who were randomized with signed ICF by treatment actually received; Safety population|1094
8735553|NCT01087723|9783291|FG000|COMPLETED|Overall Study|Completed 1-year follow-up in the study|1075
8735554|NCT01087723|9783292|FG001|COMPLETED|Overall Study|Completed 1-year follow-up in the study|1089
8735555|NCT01087723|9783291|FG000|NOT COMPLETED|Overall Study||14
8735556|NCT01087723|9783292|FG001|NOT COMPLETED|Overall Study||20
8735557|NCT01087736|9783300|FG000|STARTED|Overall Study||14
8735558|NCT01087736|9783301|FG001|STARTED|Overall Study||16
8735559|NCT01087736|9783300|FG000|COMPLETED|Overall Study||13
8735560|NCT01087736|9783301|FG001|COMPLETED|Overall Study||14
8735561|NCT01087736|9783300|FG000|NOT COMPLETED|Overall Study||1
8735562|NCT01087736|9783301|FG001|NOT COMPLETED|Overall Study||2
8735563|NCT01087762|9783310|FG000|STARTED|Double Blind Period (Weeks 0-24)|Completed 24-weeks Double-blind Period|107
8735564|NCT01087762|9783311|FG001|STARTED|Double Blind Period (Weeks 0-24)|Completed 24-weeks Double-blind Period|111
8735565|NCT01087762|9783312|FG002|STARTED|Double Blind Period (Weeks 0-24)|Completed 24-weeks Double-blind Period|107
8735566|NCT01087762|9783313|FG003|STARTED|Double Blind Period (Weeks 0-24)||0
8735567|NCT01087762|9783314|FG004|STARTED|Double Blind Period (Weeks 0-24)||0
8735568|NCT01087762|9783310|FG000|COMPLETED|Double Blind Period (Weeks 0-24)||95
8735569|NCT01087762|9783311|FG001|COMPLETED|Double Blind Period (Weeks 0-24)||105
8735570|NCT01087762|9783312|FG002|COMPLETED|Double Blind Period (Weeks 0-24)||98
8735571|NCT01087762|9783313|FG003|COMPLETED|Double Blind Period (Weeks 0-24)||0
8735572|NCT01087762|9783314|FG004|COMPLETED|Double Blind Period (Weeks 0-24)||0
8735573|NCT01087762|9783310|FG000|NOT COMPLETED|Double Blind Period (Weeks 0-24)||12
8735574|NCT01087762|9783311|FG001|NOT COMPLETED|Double Blind Period (Weeks 0-24)||6
8735575|NCT01087762|9783312|FG002|NOT COMPLETED|Double Blind Period (Weeks 0-24)||9
8735576|NCT01087762|9783313|FG003|NOT COMPLETED|Double Blind Period (Weeks 0-24)||0
8735577|NCT01087762|9783314|FG004|NOT COMPLETED|Double Blind Period (Weeks 0-24)||0
8735578|NCT01087762|9783310|FG000|STARTED|Open-Label Period (Weeks 48-204)||0
8735579|NCT01087762|9783311|FG001|STARTED|Open-Label Period (Weeks 48-204)||0
8735580|NCT01087762|9783312|FG002|STARTED|Open-Label Period (Weeks 48-204)||0
8735581|NCT01087762|9783313|FG003|STARTED|Open-Label Period (Weeks 48-204)||158
8735582|NCT01087762|9783314|FG004|STARTED|Open-Label Period (Weeks 48-204)||157
8735583|NCT01087762|9783310|FG000|COMPLETED|Open-Label Period (Weeks 48-204)||0
8735584|NCT01087762|9783311|FG001|COMPLETED|Open-Label Period (Weeks 48-204)||0
8735585|NCT01087762|9783312|FG002|COMPLETED|Open-Label Period (Weeks 48-204)||0
8735586|NCT01087762|9783313|FG003|COMPLETED|Open-Label Period (Weeks 48-204)||99
8735587|NCT01087762|9783314|FG004|COMPLETED|Open-Label Period (Weeks 48-204)||100
8735588|NCT01087762|9783310|FG000|NOT COMPLETED|Open-Label Period (Weeks 48-204)||0
8735589|NCT01087762|9783311|FG001|NOT COMPLETED|Open-Label Period (Weeks 48-204)||0
8735590|NCT01087762|9783312|FG002|NOT COMPLETED|Open-Label Period (Weeks 48-204)||0
8735591|NCT01087762|9783313|FG003|NOT COMPLETED|Open-Label Period (Weeks 48-204)||59
8735592|NCT01087762|9783314|FG004|NOT COMPLETED|Open-Label Period (Weeks 48-204)||57
8735593|NCT01087775|9783324|FG000|STARTED|Overall Study||25
8735594|NCT01087775|9783324|FG000|COMPLETED|Overall Study|2 subjects were found to be ineligible for the study|23
8735595|NCT01087775|9783324|FG000|NOT COMPLETED|Overall Study||2
8735596|NCT01087788|9783332|FG000|STARTED|24-weeks Double-blind Period||136
8735597|NCT01087788|9783333|FG001|STARTED|24-weeks Double-blind Period||138
8735598|NCT01087788|9783334|FG002|STARTED|24-weeks Double-blind Period||135
8735599|NCT01087788|9783332|FG000|Received CZP 200 mg Q2W at 16 Weeks|24-weeks Double-blind Period|30 subjects left the Placebo group and were re-randomized to CZP 200 mg Q2W on Week 16.|30
8735600|NCT01087788|9783333|FG001|Received CZP 200 mg Q2W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
8735601|NCT01087788|9783334|FG002|Received CZP 200 mg Q2W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
8735602|NCT01087788|9783332|FG000|Received CZP 400 mg Q4W at 16 Weeks|24-weeks Double-blind Period|29 subjects left the Placebo group and were re-randomized to CZP 400 mg Q4W on Week 16.|29
8735603|NCT01087788|9783333|FG001|Received CZP 400 mg Q4W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
8735604|NCT01087788|9783334|FG002|Received CZP 400 mg Q4W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
8735605|NCT01087788|9783332|FG000|COMPLETED|24-weeks Double-blind Period||120
8735606|NCT01087788|9783333|FG001|COMPLETED|24-weeks Double-blind Period||128
8735607|NCT01087788|9783334|FG002|COMPLETED|24-weeks Double-blind Period||120
8735608|NCT01087788|9783332|FG000|NOT COMPLETED|24-weeks Double-blind Period||16
8735609|NCT01087788|9783333|FG001|NOT COMPLETED|24-weeks Double-blind Period||10
8735610|NCT01087788|9783334|FG002|NOT COMPLETED|24-weeks Double-blind Period||15
8735611|NCT01087788|9783332|FG000|STARTED|24-weeks Dose-blind Period||120
8735612|NCT01087788|9783333|FG001|STARTED|24-weeks Dose-blind Period||128
8735613|NCT01087788|9783334|FG002|STARTED|24-weeks Dose-blind Period||120
8735614|NCT01087788|9783332|FG000|Received CZP 200 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|Sum of subjects re-randomized to CZP 200mg Q2W at week 16 (30 subjects) and at week 24 (30 subjects)|60
8735615|NCT01087788|9783333|FG001|Received CZP 200 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
8735616|NCT01087788|9783334|FG002|Received CZP 200 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
8735617|NCT01087788|9783332|FG000|Received CZP 400 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|Sum of subjects re-randomized to CZP 400mg Q2W at week 16 (29 subjects) and at week 24 (31 subjects)|60
8735618|NCT01087788|9783333|FG001|Received CZP 400 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
8735619|NCT01087788|9783334|FG002|Received CZP 400 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
8735620|NCT01087788|9783332|FG000|COMPLETED|24-weeks Dose-blind Period||113
8735621|NCT01087788|9783333|FG001|COMPLETED|24-weeks Dose-blind Period||123
8735622|NCT01087788|9783334|FG002|COMPLETED|24-weeks Dose-blind Period||114
8735623|NCT01087788|9783332|FG000|NOT COMPLETED|24-weeks Dose-blind Period||7
8735624|NCT01087788|9783333|FG001|NOT COMPLETED|24-weeks Dose-blind Period||5
8735625|NCT01087788|9783334|FG002|NOT COMPLETED|24-weeks Dose-blind Period||6
8735626|NCT01087788|9783332|FG000|STARTED|Open-Label Period (OL-P)|2 subj. completed the Dose-Blind Period, then withdrew from the study rather than entering the OL-P.|111
8735627|NCT01087788|9783333|FG001|STARTED|Open-Label Period (OL-P)|2 subj. completed the Dose-Blind Period, then withdrew from the study rather than entering the OL-P.|121
8735628|NCT01087788|9783334|FG002|STARTED|Open-Label Period (OL-P)||114
8735629|NCT01087788|9783332|FG000|COMPLETED|Open-Label Period (OL-P)||81
8735630|NCT01087788|9783333|FG001|COMPLETED|Open-Label Period (OL-P)||97
8735631|NCT01087788|9783334|FG002|COMPLETED|Open-Label Period (OL-P)||86
8735632|NCT01087788|9783332|FG000|NOT COMPLETED|Open-Label Period (OL-P)||30
8735633|NCT01087788|9783333|FG001|NOT COMPLETED|Open-Label Period (OL-P)||24
8735634|NCT01087788|9783334|FG002|NOT COMPLETED|Open-Label Period (OL-P)||28
8735635|NCT01087801|9783345|FG000|STARTED|Overall Study||30
8735636|NCT01087801|9783346|FG001|STARTED|Overall Study||34
8735637|NCT01087801|9783345|FG000|COMPLETED|Overall Study||26
8735638|NCT01087801|9783346|FG001|COMPLETED|Overall Study||29
8735639|NCT01087801|9783345|FG000|NOT COMPLETED|Overall Study||4
9022465|NCT03127644|10085386|FG001|STARTED|Overall Study||36
9022466|NCT03127644|10085387|FG002|STARTED|Overall Study||33
9022467|NCT03127644|10085385|FG000|COMPLETED|Overall Study||34
9022468|NCT03127644|10085386|FG001|COMPLETED|Overall Study||36
9022469|NCT03127644|10085387|FG002|COMPLETED|Overall Study||31
9022470|NCT03127644|10085385|FG000|NOT COMPLETED|Overall Study||0
9022471|NCT03127644|10085386|FG001|NOT COMPLETED|Overall Study||0
9022472|NCT03127644|10085387|FG002|NOT COMPLETED|Overall Study||2
9022473|NCT03127943|10085397|FG000|STARTED|First Intervention||12
9022474|NCT03127943|10085398|FG001|STARTED|First Intervention||12
9022475|NCT03127943|10085397|FG000|COMPLETED|First Intervention||12
9022476|NCT03127943|10085398|FG001|COMPLETED|First Intervention||12
9022477|NCT03127943|10085397|FG000|NOT COMPLETED|First Intervention||0
9022478|NCT03127943|10085398|FG001|NOT COMPLETED|First Intervention||0
9022479|NCT03127943|10085397|FG000|STARTED|Washout (1 Week)||12
9022480|NCT03127943|10085398|FG001|STARTED|Washout (1 Week)||12
9022481|NCT03127943|10085397|FG000|COMPLETED|Washout (1 Week)||12
8735640|NCT01087801|9783346|FG001|NOT COMPLETED|Overall Study||5
8735641|NCT01087814|9783354|FG000|STARTED|First Intervention (5 Days)||8
8735642|NCT01087814|9783355|FG001|STARTED|First Intervention (5 Days)||7
8735643|NCT01087814|9783354|FG000|COMPLETED|First Intervention (5 Days)||5
8735644|NCT01087814|9783355|FG001|COMPLETED|First Intervention (5 Days)||6
8735645|NCT01087814|9783354|FG000|NOT COMPLETED|First Intervention (5 Days)||3
8735646|NCT01087814|9783355|FG001|NOT COMPLETED|First Intervention (5 Days)||1
8735647|NCT01087814|9783354|FG000|STARTED|Second Intervention (5 Days)||5
8735648|NCT01087814|9783355|FG001|STARTED|Second Intervention (5 Days)||6
8735649|NCT01087814|9783354|FG000|COMPLETED|Second Intervention (5 Days)||4
8735650|NCT01087814|9783355|FG001|COMPLETED|Second Intervention (5 Days)||6
8735651|NCT01087814|9783354|FG000|NOT COMPLETED|Second Intervention (5 Days)||1
8735652|NCT01087814|9783355|FG001|NOT COMPLETED|Second Intervention (5 Days)||0
8735653|NCT01087905|9783369|FG000|STARTED|Overall Study||119
8735654|NCT01087905|9783370|FG001|STARTED|Overall Study||126
8735655|NCT01087905|9783371|FG002|STARTED|Overall Study||123
8735656|NCT01087905|9783372|FG003|STARTED|Overall Study||122
8735657|NCT01087905|9783373|FG004|STARTED|Overall Study||122
8735658|NCT01087905|9783374|FG005|STARTED|Overall Study||127
8735659|NCT01087905|9783375|FG006|STARTED|Overall Study||121
8735660|NCT01087905|9783376|FG007|STARTED|Overall Study||127
8735661|NCT01087905|9783369|FG000|COMPLETED|Overall Study||90
8735662|NCT01087905|9783370|FG001|COMPLETED|Overall Study||94
8735663|NCT01087905|9783371|FG002|COMPLETED|Overall Study||101
8735664|NCT01087905|9783372|FG003|COMPLETED|Overall Study||86
8735665|NCT01087905|9783373|FG004|COMPLETED|Overall Study||91
8735666|NCT01087905|9783374|FG005|COMPLETED|Overall Study||99
8735667|NCT01087905|9783375|FG006|COMPLETED|Overall Study||98
8735668|NCT01087905|9783376|FG007|COMPLETED|Overall Study||98
8735669|NCT01087905|9783369|FG000|NOT COMPLETED|Overall Study||29
8735670|NCT01087905|9783370|FG001|NOT COMPLETED|Overall Study||32
8735671|NCT01087905|9783371|FG002|NOT COMPLETED|Overall Study||22
8735672|NCT01087905|9783372|FG003|NOT COMPLETED|Overall Study||36
8911982|NCT02151266|9971150|FG001|NOT COMPLETED|Overall Study||15
8911983|NCT02151266|9971151|FG002|NOT COMPLETED|Overall Study||7
8911984|NCT02151331|9971161|FG000|STARTED|Overall Study||77
8911985|NCT02151331|9971162|FG001|STARTED|Overall Study||92
8911986|NCT02151331|9971161|FG000|COMPLETED|Overall Study||45
8911987|NCT02151331|9971162|FG001|COMPLETED|Overall Study||52
8911988|NCT02151331|9971161|FG000|NOT COMPLETED|Overall Study||32
8911989|NCT02151331|9971162|FG001|NOT COMPLETED|Overall Study||40
8911990|NCT02151448|9971168|FG000|STARTED|Phase 1||9
8911991|NCT02151448|9971168|FG000|COMPLETED|Phase 1||9
8911992|NCT02151448|9971168|FG000|NOT COMPLETED|Phase 1||0
8911993|NCT02151448|9971168|FG000|STARTED|Phase 2||55
8911994|NCT02151448|9971168|FG000|COMPLETED|Phase 2||55
8911995|NCT02151448|9971168|FG000|NOT COMPLETED|Phase 2||0
8911996|NCT02151461|9971180|FG000|STARTED|Overall Study||24
8911997|NCT02151461|9971181|FG001|STARTED|Overall Study||25
8911998|NCT02151461|9971182|FG002|STARTED|Overall Study||24
8911999|NCT02151461|9971183|FG003|STARTED|Overall Study||23
8912000|NCT02151461|9971180|FG000|COMPLETED|Overall Study||18
8912001|NCT02151461|9971181|FG001|COMPLETED|Overall Study||24
8912002|NCT02151461|9971182|FG002|COMPLETED|Overall Study||21
8912003|NCT02151461|9971183|FG003|COMPLETED|Overall Study||19
8912004|NCT02151461|9971180|FG000|NOT COMPLETED|Overall Study||6
8912005|NCT02151461|9971181|FG001|NOT COMPLETED|Overall Study||1
8912006|NCT02151461|9971182|FG002|NOT COMPLETED|Overall Study||3
8912007|NCT02151461|9971183|FG003|NOT COMPLETED|Overall Study||4
8912008|NCT02151487|9971197|FG000|STARTED|Overall Study||27
8912009|NCT02151487|9971198|FG001|STARTED|Overall Study||27
8912010|NCT02151487|9971199|FG002|STARTED|Overall Study||20
8912011|NCT02151487|9971200|FG003|STARTED|Overall Study||23
8912012|NCT02151487|9971197|FG000|COMPLETED|Overall Study||25
8912013|NCT02151487|9971198|FG001|COMPLETED|Overall Study||22
8912014|NCT02151487|9971199|FG002|COMPLETED|Overall Study||16
8735673|NCT01087905|9783373|FG004|NOT COMPLETED|Overall Study||31
8735674|NCT01087905|9783374|FG005|NOT COMPLETED|Overall Study||28
8735675|NCT01087905|9783375|FG006|NOT COMPLETED|Overall Study||23
8735676|NCT01087905|9783376|FG007|NOT COMPLETED|Overall Study||29
8735677|NCT01087918|9783394|FG000|STARTED|Overall Study||5
8735678|NCT01087918|9783395|FG001|STARTED|Overall Study||4
8735679|NCT01087918|9783394|FG000|COMPLETED|Overall Study||5
8912015|NCT02151487|9971200|FG003|COMPLETED|Overall Study||20
8912016|NCT02151487|9971197|FG000|NOT COMPLETED|Overall Study||2
8735680|NCT01087918|9783395|FG001|COMPLETED|Overall Study||4
8735681|NCT01087918|9783394|FG000|NOT COMPLETED|Overall Study||0
8735682|NCT01087918|9783395|FG001|NOT COMPLETED|Overall Study||0
8735683|NCT01087931|9783407|FG000|STARTED|Overall Study||20
8735684|NCT01087931|9783408|FG001|STARTED|Overall Study||20
8735685|NCT01087931|9783407|FG000|1st Follow up|Overall Study||20
8735686|NCT01087931|9783408|FG001|1st Follow up|Overall Study||19
8735687|NCT01087931|9783407|FG000|Final Follow up|Overall Study||19
8735688|NCT01087931|9783408|FG001|Final Follow up|Overall Study||17
8735689|NCT01087931|9783407|FG000|COMPLETED|Overall Study||20
8735690|NCT01087931|9783408|FG001|COMPLETED|Overall Study||20
8735691|NCT01087931|9783407|FG000|NOT COMPLETED|Overall Study||0
8735692|NCT01087931|9783408|FG001|NOT COMPLETED|Overall Study||0
8735693|NCT01087944|9783414|FG000|STARTED|Period 1 (Week 1-3)||30
8912017|NCT02151487|9971198|FG001|NOT COMPLETED|Overall Study||5
8912018|NCT02151487|9971199|FG002|NOT COMPLETED|Overall Study||4
8735694|NCT01087944|9783415|FG001|STARTED|Period 1 (Week 1-3)||30
8735695|NCT01087944|9783414|FG000|COMPLETED|Period 1 (Week 1-3)||29
8735696|NCT01087944|9783415|FG001|COMPLETED|Period 1 (Week 1-3)||30
8735697|NCT01087944|9783414|FG000|NOT COMPLETED|Period 1 (Week 1-3)||1
8735698|NCT01087944|9783415|FG001|NOT COMPLETED|Period 1 (Week 1-3)||0
8735699|NCT01087944|9783414|FG000|STARTED|Period 2 (Week 4-6)||29
8735700|NCT01087944|9783415|FG001|STARTED|Period 2 (Week 4-6)||30
8735701|NCT01087944|9783414|FG000|COMPLETED|Period 2 (Week 4-6)||29
8735702|NCT01087944|9783415|FG001|COMPLETED|Period 2 (Week 4-6)||28
8735703|NCT01087944|9783414|FG000|NOT COMPLETED|Period 2 (Week 4-6)||0
8735704|NCT01087944|9783415|FG001|NOT COMPLETED|Period 2 (Week 4-6)||2
8735705|NCT01087957|9783423|FG000|STARTED|Overall Study||253
8735706|NCT01087957|9783424|FG001|STARTED|Overall Study||242
8735707|NCT01087957|9783423|FG000|COMPLETED|Overall Study||212
8735708|NCT01087957|9783424|FG001|COMPLETED|Overall Study||187
8735709|NCT01087957|9783423|FG000|NOT COMPLETED|Overall Study||41
8735710|NCT01087957|9783424|FG001|NOT COMPLETED|Overall Study||55
8735711|NCT01087970|9783430|FG000|STARTED|Overall Study||69
8735712|NCT01087970|9783430|FG000|Received ≥1 Dose of Any Study Drug|Overall Study||69
8735713|NCT01087970|9783430|FG000|Completed 6 Cycles|Overall Study||69
8735714|NCT01087970|9783430|FG000|Efficacy Population|Overall Study|All treated participants excluding those from a noncompliant study site.|58
8735715|NCT01087970|9783430|FG000|Received Carboplatin|Overall Study||63
8735716|NCT01087970|9783430|FG000|COMPLETED|Overall Study||67
8735717|NCT01087970|9783430|FG000|NOT COMPLETED|Overall Study||2
8735718|NCT01087996|9783437|FG000|STARTED|Overall Study||15
8735719|NCT01087996|9783438|FG001|STARTED|Overall Study||15
8735720|NCT01087996|9783437|FG000|COMPLETED|Overall Study||15
8735721|NCT01087996|9783438|FG001|COMPLETED|Overall Study||15
8735722|NCT01087996|9783437|FG000|NOT COMPLETED|Overall Study||0
8735723|NCT01087996|9783438|FG001|NOT COMPLETED|Overall Study||0
8735724|NCT01088048|9783454|FG000|STARTED|Overall Study||51
8735725|NCT01088048|9783455|FG001|STARTED|Overall Study||51
8735726|NCT01088048|9783456|FG002|STARTED|Overall Study||18
8735727|NCT01088048|9783457|FG003|STARTED|Overall Study||18
8735728|NCT01088048|9783458|FG004|STARTED|Overall Study||33
8735729|NCT01088048|9783459|FG005|STARTED|Overall Study||21
8735730|NCT01088048|9783460|FG006|STARTED|Overall Study||12
8735731|NCT01088048|9783461|FG007|STARTED|Overall Study||15
8735732|NCT01088048|9783462|FG008|STARTED|Overall Study||15
8735733|NCT01088048|9783463|FG009|STARTED|Overall Study||7
8735734|NCT01088048|9783454|FG000|Participants With CLL|Overall Study||19
8912019|NCT02151487|9971200|FG003|NOT COMPLETED|Overall Study||3
8912020|NCT02151591|9971212|FG000|STARTED|Overall Study||13
8912021|NCT02151591|9971213|FG001|STARTED|Overall Study||13
8912022|NCT02151591|9971212|FG000|COMPLETED|Overall Study||7
8912023|NCT02151591|9971213|FG001|COMPLETED|Overall Study||10
8912024|NCT02151591|9971212|FG000|NOT COMPLETED|Overall Study||6
8912025|NCT02151591|9971213|FG001|NOT COMPLETED|Overall Study||3
8912026|NCT02151643|9971224|FG000|STARTED|Overall Study||26
8912027|NCT02151643|9971225|FG001|STARTED|Overall Study||25
8912028|NCT02151643|9971226|FG002|STARTED|Overall Study||25
8912029|NCT02151643|9971227|FG003|STARTED|Overall Study||39
8912030|NCT02151643|9971228|FG004|STARTED|Overall Study||38
8912031|NCT02151643|9971224|FG000|COMPLETED|Overall Study||20
8912032|NCT02151643|9971225|FG001|COMPLETED|Overall Study||21
8912033|NCT02151643|9971226|FG002|COMPLETED|Overall Study||21
8912034|NCT02151643|9971227|FG003|COMPLETED|Overall Study||32
8912035|NCT02151643|9971228|FG004|COMPLETED|Overall Study||35
8912036|NCT02151643|9971224|FG000|NOT COMPLETED|Overall Study||6
8912037|NCT02151643|9971225|FG001|NOT COMPLETED|Overall Study||4
8912038|NCT02151643|9971226|FG002|NOT COMPLETED|Overall Study||4
8912039|NCT02151643|9971227|FG003|NOT COMPLETED|Overall Study||7
8912040|NCT02151643|9971228|FG004|NOT COMPLETED|Overall Study||3
8912041|NCT02151682|9971242|FG000|STARTED|Part 1: 14 Days Morphine or Tapentadol||24
8912042|NCT02151682|9971243|FG001|STARTED|Part 1: 14 Days Morphine or Tapentadol||45
8912043|NCT02151682|9971244|FG002|STARTED|Part 1: 14 Days Morphine or Tapentadol|Group not defined for Part 1.|0
8912044|NCT02151682|9971245|FG003|STARTED|Part 1: 14 Days Morphine or Tapentadol|Group not defined for Part 1.|0
8912045|NCT02151682|9971246|FG004|STARTED|Part 1: 14 Days Morphine or Tapentadol|Group not defined for Part 1.|0
8912046|NCT02151682|9971247|FG005|STARTED|Part 1: 14 Days Morphine or Tapentadol|Group not defined for Part 1.|0
8912047|NCT02151682|9971242|FG000|COMPLETED|Part 1: 14 Days Morphine or Tapentadol|14-Day treatment and final post-treatment visit completed or tapentadol treatment in Part 2 entered.|22
8912048|NCT02151682|9971243|FG001|COMPLETED|Part 1: 14 Days Morphine or Tapentadol|14-Day treatment and final post-treatment visit completed or tapentadol treatment in Part 2 entered.|40
8912049|NCT02151682|9971244|FG002|COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
8912050|NCT02151682|9971245|FG003|COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
8912051|NCT02151682|9971246|FG004|COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
8735735|NCT01088048|9783455|FG001|Participants With CLL|Overall Study||18
8735736|NCT01088048|9783456|FG002|Participants With CLL|Overall Study||0
8735737|NCT01088048|9783457|FG003|Participants With CLL|Overall Study||0
8735738|NCT01088048|9783458|FG004|Participants With CLL|Overall Study||15
8735739|NCT01088048|9783459|FG005|Participants With CLL|Overall Study||21
8735740|NCT01088048|9783460|FG006|Participants With CLL|Overall Study||12
8735741|NCT01088048|9783461|FG007|Participants With CLL|Overall Study||15
8735742|NCT01088048|9783462|FG008|Participants With CLL|Overall Study||14
8735743|NCT01088048|9783463|FG009|Participants With CLL|Overall Study||1
8735744|NCT01088048|9783454|FG000|Participants With Indolent NHL|Overall Study||32
8735745|NCT01088048|9783455|FG001|Participants With Indolent NHL|Overall Study||33
8735746|NCT01088048|9783456|FG002|Participants With Indolent NHL|Overall Study||0
8735747|NCT01088048|9783457|FG003|Participants With Indolent NHL|Overall Study||0
8735748|NCT01088048|9783458|FG004|Participants With Indolent NHL|Overall Study||14
8735749|NCT01088048|9783459|FG005|Participants With Indolent NHL|Overall Study||0
8735750|NCT01088048|9783460|FG006|Participants With Indolent NHL|Overall Study||0
8735751|NCT01088048|9783461|FG007|Participants With Indolent NHL|Overall Study||0
8735752|NCT01088048|9783462|FG008|Participants With Indolent NHL|Overall Study||1
8735753|NCT01088048|9783463|FG009|Participants With Indolent NHL|Overall Study||6
8735754|NCT01088048|9783454|FG000|Participants With MCL|Overall Study||0
8735755|NCT01088048|9783455|FG001|Participants With MCL|Overall Study||0
8735756|NCT01088048|9783456|FG002|Participants With MCL|Overall Study||18
8735757|NCT01088048|9783457|FG003|Participants With MCL|Overall Study||18
8735758|NCT01088048|9783458|FG004|Participants With MCL|Overall Study||4
8735759|NCT01088048|9783459|FG005|Participants With MCL|Overall Study||0
8735760|NCT01088048|9783460|FG006|Participants With MCL|Overall Study||0
8735761|NCT01088048|9783461|FG007|Participants With MCL|Overall Study||0
8735762|NCT01088048|9783462|FG008|Participants With MCL|Overall Study||0
8735763|NCT01088048|9783463|FG009|Participants With MCL|Overall Study||0
8735764|NCT01088048|9783454|FG000|COMPLETED|Overall Study||29
8735765|NCT01088048|9783455|FG001|COMPLETED|Overall Study||24
8735766|NCT01088048|9783456|FG002|COMPLETED|Overall Study||4
8735767|NCT01088048|9783457|FG003|COMPLETED|Overall Study||4
8735768|NCT01088048|9783458|FG004|COMPLETED|Overall Study||16
8735769|NCT01088048|9783459|FG005|COMPLETED|Overall Study||10
8735770|NCT01088048|9783460|FG006|COMPLETED|Overall Study||6
8735771|NCT01088048|9783461|FG007|COMPLETED|Overall Study||10
8735772|NCT01088048|9783462|FG008|COMPLETED|Overall Study||8
8735773|NCT01088048|9783463|FG009|COMPLETED|Overall Study||3
8735774|NCT01088048|9783454|FG000|NOT COMPLETED|Overall Study||22
8735775|NCT01088048|9783455|FG001|NOT COMPLETED|Overall Study||27
8735776|NCT01088048|9783456|FG002|NOT COMPLETED|Overall Study||14
8735777|NCT01088048|9783457|FG003|NOT COMPLETED|Overall Study||14
8735778|NCT01088048|9783458|FG004|NOT COMPLETED|Overall Study||17
8735779|NCT01088048|9783459|FG005|NOT COMPLETED|Overall Study||11
8735780|NCT01088048|9783460|FG006|NOT COMPLETED|Overall Study||6
8735781|NCT01088048|9783461|FG007|NOT COMPLETED|Overall Study||5
8735782|NCT01088048|9783462|FG008|NOT COMPLETED|Overall Study||7
8735783|NCT01088048|9783463|FG009|NOT COMPLETED|Overall Study||4
8735784|NCT01088243|9783498|FG000|STARTED|Overall Study||13
8735785|NCT01088243|9783499|FG001|STARTED|Overall Study||5
8735786|NCT01088243|9783498|FG000|COMPLETED|Overall Study||12
8735787|NCT01088243|9783499|FG001|COMPLETED|Overall Study||5
8912052|NCT02151682|9971247|FG005|COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
8912053|NCT02151682|9971242|FG000|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||2
8912054|NCT02151682|9971243|FG001|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||5
8912055|NCT02151682|9971244|FG002|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
8912056|NCT02151682|9971245|FG003|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
8912057|NCT02151682|9971246|FG004|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
8912058|NCT02151682|9971247|FG005|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
8912059|NCT02151682|9971242|FG000|STARTED|Part 2: Tapent. Extension or Observation|Group not defined for Part 2.|0
8912060|NCT02151682|9971243|FG001|STARTED|Part 2: Tapent. Extension or Observation|Group not defined for Part 2.|0
8912061|NCT02151682|9971244|FG002|STARTED|Part 2: Tapent. Extension or Observation|26 Completers on tapentadol PR and 10 completers on morphine PR from Part 1.|36
8912062|NCT02151682|9971245|FG003|STARTED|Part 2: Tapent. Extension or Observation|14 Completers and 4 of 5 non-completers on tapentadol in Part 1.|18
8912063|NCT02151682|9971246|FG004|STARTED|Part 2: Tapent. Extension or Observation|12 Completers and 2 non-completers from morphine treatment in Part 1.|14
8912064|NCT02151682|9971247|FG005|STARTED|Part 2: Tapent. Extension or Observation||0
8912065|NCT02151682|9971242|FG000|COMPLETED|Part 2: Tapent. Extension or Observation||0
8912066|NCT02151682|9971243|FG001|COMPLETED|Part 2: Tapent. Extension or Observation||0
8912067|NCT02151682|9971244|FG002|COMPLETED|Part 2: Tapent. Extension or Observation|12 Month of tapentadol treatment completed and final visit of Part 2 performed.|8
8912068|NCT02151682|9971245|FG003|COMPLETED|Part 2: Tapent. Extension or Observation||14
8912069|NCT02151682|9971246|FG004|COMPLETED|Part 2: Tapent. Extension or Observation||14
8912070|NCT02151682|9971247|FG005|COMPLETED|Part 2: Tapent. Extension or Observation||0
8912071|NCT02151682|9971242|FG000|NOT COMPLETED|Part 2: Tapent. Extension or Observation||0
8912072|NCT02151682|9971243|FG001|NOT COMPLETED|Part 2: Tapent. Extension or Observation||0
8912073|NCT02151682|9971244|FG002|NOT COMPLETED|Part 2: Tapent. Extension or Observation||28
8912074|NCT02151682|9971245|FG003|NOT COMPLETED|Part 2: Tapent. Extension or Observation||4
8912075|NCT02151682|9971246|FG004|NOT COMPLETED|Part 2: Tapent. Extension or Observation||0
9022482|NCT03127943|10085398|FG001|COMPLETED|Washout (1 Week)||12
9022483|NCT03127943|10085397|FG000|NOT COMPLETED|Washout (1 Week)||0
9022484|NCT03127943|10085398|FG001|NOT COMPLETED|Washout (1 Week)||0
8735788|NCT01088243|9783498|FG000|NOT COMPLETED|Overall Study||1
8735789|NCT01088243|9783499|FG001|NOT COMPLETED|Overall Study||0
8735790|NCT01088295|9783505|FG000|STARTED|Overall Study||36
8735791|NCT01088295|9783505|FG000|COMPLETED|Overall Study||35
8735792|NCT01088295|9783505|FG000|NOT COMPLETED|Overall Study||1
8735793|NCT01088399|9783512|FG000|STARTED|Overall Study||8716
8735794|NCT01088399|9783513|FG001|STARTED|Overall Study||1655
8735795|NCT01088399|9783514|FG002|STARTED|Overall Study||302
8735796|NCT01088399|9783512|FG000|COMPLETED|Overall Study||1595
8735797|NCT01088399|9783513|FG001|COMPLETED|Overall Study||308
8735798|NCT01088399|9783514|FG002|COMPLETED|Overall Study||21
8735799|NCT01088399|9783512|FG000|NOT COMPLETED|Overall Study||7121
8735800|NCT01088399|9783513|FG001|NOT COMPLETED|Overall Study||1347
8735801|NCT01088399|9783514|FG002|NOT COMPLETED|Overall Study||281
8735802|NCT01088412|9783525|FG000|STARTED|Overall Study||22311
8735803|NCT01088412|9783526|FG001|STARTED|Overall Study||457
8735804|NCT01088412|9783527|FG002|STARTED|Overall Study||77
8735805|NCT01088412|9783525|FG000|Safety Modified Evaluable (SME)|Overall Study||22294
8735806|NCT01088412|9783526|FG001|Safety Modified Evaluable (SME)|Overall Study||456
8735807|NCT01088412|9783527|FG002|Safety Modified Evaluable (SME)|Overall Study||0
8735808|NCT01088412|9783525|FG000|SME With at Least 1 Follow Up (FU)|Overall Study||21178
8735809|NCT01088412|9783526|FG001|SME With at Least 1 Follow Up (FU)|Overall Study||306
8735810|NCT01088412|9783527|FG002|SME With at Least 1 Follow Up (FU)|Overall Study||0
8735811|NCT01088412|9783525|FG000|SME+ >= 1 FU and Unknown Arm|Overall Study||21177
8735812|NCT01088412|9783526|FG001|SME+ >= 1 FU and Unknown Arm|Overall Study||306
8735813|NCT01088412|9783527|FG002|SME+ >= 1 FU and Unknown Arm|Overall Study||40
8735814|NCT01088412|9783525|FG000|SME+ >= 1 FU and No Previous Cancer|Overall Study||20556
8735815|NCT01088412|9783526|FG001|SME+ >= 1 FU and No Previous Cancer|Overall Study||192
8735816|NCT01088412|9783527|FG002|SME+ >= 1 FU and No Previous Cancer|Overall Study||0
8735817|NCT01088412|9783525|FG000|SME+ >= 1 FU and Previous Cancer|Overall Study||622
8735818|NCT01088412|9783526|FG001|SME+ >= 1 FU and Previous Cancer|Overall Study||114
8735819|NCT01088412|9783527|FG002|SME+ >= 1 FU and Previous Cancer|Overall Study||0
8735820|NCT01088412|9783525|FG000|COMPLETED|Overall Study||4294
8735821|NCT01088412|9783526|FG001|COMPLETED|Overall Study||21
8735822|NCT01088412|9783527|FG002|COMPLETED|Overall Study||5
8735823|NCT01088412|9783525|FG000|NOT COMPLETED|Overall Study||18017
8735824|NCT01088412|9783526|FG001|NOT COMPLETED|Overall Study||436
8735825|NCT01088412|9783527|FG002|NOT COMPLETED|Overall Study||72
8735826|NCT01088438|9783540|FG000|STARTED|Overall Study||94
8735827|NCT01088438|9783541|FG001|STARTED|Overall Study||95
8735828|NCT01088438|9783540|FG000|COMPLETED|Overall Study||65
8735829|NCT01088438|9783541|FG001|COMPLETED|Overall Study||59
8670615|NCT00747474|9714096|FG005|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
8670616|NCT00747474|9714097|FG006|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
8670617|NCT00747474|9714098|FG007|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
8670618|NCT00747474|9714099|FG008|COMPLETED|Cohort 9 (35 mg/m^2) Period||4
8670619|NCT00747474|9714100|FG009|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
8670620|NCT00747474|9714101|FG010|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
8670621|NCT00747474|9714102|FG011|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
8670622|NCT00747474|9714091|FG000|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
8670623|NCT00747474|9714092|FG001|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
8670624|NCT00747474|9714093|FG002|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
8670625|NCT00747474|9714094|FG003|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
8670626|NCT00747474|9714095|FG004|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
8735830|NCT01088438|9783540|FG000|NOT COMPLETED|Overall Study||29
8735831|NCT01088438|9783541|FG001|NOT COMPLETED|Overall Study||36
8735832|NCT01088464|9783550|FG000|STARTED|Overall Study||3
8735833|NCT01088464|9783551|FG001|STARTED|Overall Study||6
8735834|NCT01088464|9783552|FG002|STARTED|Overall Study||6
8735835|NCT01088464|9783550|FG000|Received Any Quantity of Study Drug|Overall Study||3
8735836|NCT01088464|9783551|FG001|Received Any Quantity of Study Drug|Overall Study||6
8735837|NCT01088464|9783552|FG002|Received Any Quantity of Study Drug|Overall Study||6
8735838|NCT01088464|9783550|FG000|COMPLETED|Overall Study||3
8735839|NCT01088464|9783551|FG001|COMPLETED|Overall Study||6
8735840|NCT01088464|9783552|FG002|COMPLETED|Overall Study||6
8735841|NCT01088464|9783550|FG000|NOT COMPLETED|Overall Study||0
8735842|NCT01088464|9783551|FG001|NOT COMPLETED|Overall Study||0
8735843|NCT01088464|9783552|FG002|NOT COMPLETED|Overall Study||0
8735844|NCT01088503|9783563|FG000|STARTED|Overall Study||3123
8735845|NCT01088503|9783564|FG001|STARTED|Overall Study||8846
8735846|NCT01088503|9783565|FG002|STARTED|Overall Study||258
8735847|NCT01088503|9783563|FG000|COMPLETED|Overall Study||2941
8735848|NCT01088503|9783564|FG001|COMPLETED|Overall Study||8161
8735849|NCT01088503|9783565|FG002|COMPLETED|Overall Study||241
8735850|NCT01088503|9783563|FG000|NOT COMPLETED|Overall Study||182
8735851|NCT01088503|9783564|FG001|NOT COMPLETED|Overall Study||685
8735852|NCT01088503|9783565|FG002|NOT COMPLETED|Overall Study||17
8735853|NCT01088529|9783573|FG000|STARTED|Overall Study||44
8735854|NCT01088529|9783574|FG001|STARTED|Overall Study||22
8735855|NCT01088529|9783573|FG000|Received Treatment|Overall Study||44
8735856|NCT01088529|9783574|FG001|Received Treatment|Overall Study||21
8735857|NCT01088529|9783573|FG000|COMPLETED|Overall Study||44
8735858|NCT01088529|9783574|FG001|COMPLETED|Overall Study||21
8735859|NCT01088529|9783573|FG000|NOT COMPLETED|Overall Study||0
8735860|NCT01088529|9783574|FG001|NOT COMPLETED|Overall Study||1
8735861|NCT01088646|9783580|FG000|STARTED|Overall Study||25
8735862|NCT01088646|9783580|FG000|COMPLETED|Overall Study||25
8735863|NCT01088646|9783580|FG000|NOT COMPLETED|Overall Study||0
8735864|NCT01088672|9783585|FG000|STARTED|Overall Study||60
8735865|NCT01088672|9783585|FG000|COMPLETED|Overall Study||60
8735866|NCT01088672|9783585|FG000|NOT COMPLETED|Overall Study||0
8735867|NCT01088711|9783593|FG000|STARTED|Overall Study||18
8735868|NCT01088711|9783594|FG001|STARTED|Overall Study||6
8735869|NCT01088711|9783595|FG002|STARTED|Overall Study||6
8735870|NCT01088711|9783596|FG003|STARTED|Overall Study||2
8735871|NCT01088711|9783593|FG000|COMPLETED|Overall Study||18
8735872|NCT01088711|9783594|FG001|COMPLETED|Overall Study||6
8735873|NCT01088711|9783595|FG002|COMPLETED|Overall Study||6
8735874|NCT01088711|9783596|FG003|COMPLETED|Overall Study||2
8735875|NCT01088711|9783593|FG000|NOT COMPLETED|Overall Study||0
8735876|NCT01088711|9783594|FG001|NOT COMPLETED|Overall Study||0
8735877|NCT01088711|9783595|FG002|NOT COMPLETED|Overall Study||0
8735878|NCT01088711|9783596|FG003|NOT COMPLETED|Overall Study||0
8735879|NCT01088984|9783610|FG000|STARTED|Phase 1||5
8735880|NCT01088984|9783611|FG001|STARTED|Phase 1||6
8735881|NCT01088984|9783610|FG000|COMPLETED|Phase 1|completed follow-up up to 12 month from last dose of study drug|0
8735882|NCT01088984|9783611|FG001|COMPLETED|Phase 1|completed follow-up up to 12 month from last dose of study drug|0
8735883|NCT01088984|9783610|FG000|NOT COMPLETED|Phase 1||5
8735884|NCT01088984|9783611|FG001|NOT COMPLETED|Phase 1||6
8735885|NCT01088984|9783610|FG000|STARTED|Phase 2||0
8735886|NCT01088984|9783611|FG001|STARTED|Phase 2||32
8735887|NCT01088984|9783610|FG000|COMPLETED|Phase 2|completed follow-up up to 12 month from last dose of study drug|0
8735888|NCT01088984|9783611|FG001|COMPLETED|Phase 2|completed follow-up up to 12 month from last dose of study drug|0
8735889|NCT01088984|9783610|FG000|NOT COMPLETED|Phase 2||0
8735890|NCT01088984|9783611|FG001|NOT COMPLETED|Phase 2||32
8735891|NCT01088997|9783622|FG000|STARTED|Overall Study||7
8735892|NCT01088997|9783623|FG001|STARTED|Overall Study||5
8735893|NCT01088997|9783622|FG000|COMPLETED|Overall Study||4
8735894|NCT01088997|9783623|FG001|COMPLETED|Overall Study||2
8735895|NCT01088997|9783622|FG000|NOT COMPLETED|Overall Study||3
8735896|NCT01088997|9783623|FG001|NOT COMPLETED|Overall Study||3
8735897|NCT01089023|9783632|FG000|STARTED|Overall Study||95
8735898|NCT01089023|9783632|FG000|COMPLETED|Overall Study||88
8735899|NCT01089023|9783632|FG000|NOT COMPLETED|Overall Study||7
8735900|NCT01089062|9783642|FG000|STARTED|Visit 2 (Randomization)||4
8735901|NCT01089062|9783643|FG001|STARTED|Visit 2 (Randomization)||4
8735902|NCT01089062|9783644|FG002|STARTED|Visit 2 (Randomization)||4
8735903|NCT01089062|9783645|FG003|STARTED|Visit 2 (Randomization)||4
8735904|NCT01089062|9783646|FG004|STARTED|Visit 2 (Randomization)||4
8735905|NCT01089062|9783647|FG005|STARTED|Visit 2 (Randomization)||4
8735906|NCT01089062|9783642|FG000|COMPLETED|Visit 2 (Randomization)||3
8735907|NCT01089062|9783643|FG001|COMPLETED|Visit 2 (Randomization)||3
8735908|NCT01089062|9783644|FG002|COMPLETED|Visit 2 (Randomization)||3
8735909|NCT01089062|9783645|FG003|COMPLETED|Visit 2 (Randomization)||4
8735910|NCT01089062|9783646|FG004|COMPLETED|Visit 2 (Randomization)||3
8735911|NCT01089062|9783647|FG005|COMPLETED|Visit 2 (Randomization)||3
8735912|NCT01089062|9783642|FG000|NOT COMPLETED|Visit 2 (Randomization)||1
8735913|NCT01089062|9783643|FG001|NOT COMPLETED|Visit 2 (Randomization)||1
8735914|NCT01089062|9783644|FG002|NOT COMPLETED|Visit 2 (Randomization)||1
8735915|NCT01089062|9783645|FG003|NOT COMPLETED|Visit 2 (Randomization)||0
8735916|NCT01089062|9783646|FG004|NOT COMPLETED|Visit 2 (Randomization)||1
8735917|NCT01089062|9783647|FG005|NOT COMPLETED|Visit 2 (Randomization)||1
8735918|NCT01089062|9783642|FG000|STARTED|Visit 3||3
8735919|NCT01089062|9783643|FG001|STARTED|Visit 3||3
8735920|NCT01089062|9783644|FG002|STARTED|Visit 3||3
8735921|NCT01089062|9783645|FG003|STARTED|Visit 3||4
8735922|NCT01089062|9783646|FG004|STARTED|Visit 3||3
8735923|NCT01089062|9783647|FG005|STARTED|Visit 3||3
8735924|NCT01089062|9783642|FG000|COMPLETED|Visit 3||3
8735925|NCT01089062|9783643|FG001|COMPLETED|Visit 3||3
8735926|NCT01089062|9783644|FG002|COMPLETED|Visit 3||3
8735927|NCT01089062|9783645|FG003|COMPLETED|Visit 3||3
8735928|NCT01089062|9783646|FG004|COMPLETED|Visit 3||3
8735929|NCT01089062|9783647|FG005|COMPLETED|Visit 3||3
8735930|NCT01089062|9783642|FG000|NOT COMPLETED|Visit 3||0
8735931|NCT01089062|9783643|FG001|NOT COMPLETED|Visit 3||0
8735932|NCT01089062|9783644|FG002|NOT COMPLETED|Visit 3||0
8735933|NCT01089062|9783645|FG003|NOT COMPLETED|Visit 3||1
8735934|NCT01089062|9783646|FG004|NOT COMPLETED|Visit 3||0
8735935|NCT01089062|9783647|FG005|NOT COMPLETED|Visit 3||0
8735936|NCT01089062|9783642|FG000|STARTED|Visit 4||3
8735937|NCT01089062|9783643|FG001|STARTED|Visit 4||3
8735938|NCT01089062|9783644|FG002|STARTED|Visit 4||3
8735939|NCT01089062|9783645|FG003|STARTED|Visit 4||3
8735940|NCT01089062|9783646|FG004|STARTED|Visit 4||3
8735941|NCT01089062|9783647|FG005|STARTED|Visit 4||3
8735942|NCT01089062|9783642|FG000|COMPLETED|Visit 4||3
8735943|NCT01089062|9783643|FG001|COMPLETED|Visit 4||3
8735944|NCT01089062|9783644|FG002|COMPLETED|Visit 4||3
8735945|NCT01089062|9783645|FG003|COMPLETED|Visit 4||3
8735946|NCT01089062|9783646|FG004|COMPLETED|Visit 4||3
8735947|NCT01089062|9783647|FG005|COMPLETED|Visit 4||3
8735948|NCT01089062|9783642|FG000|NOT COMPLETED|Visit 4||0
8735949|NCT01089062|9783643|FG001|NOT COMPLETED|Visit 4||0
8735950|NCT01089062|9783644|FG002|NOT COMPLETED|Visit 4||0
8735951|NCT01089062|9783645|FG003|NOT COMPLETED|Visit 4||0
8735952|NCT01089062|9783646|FG004|NOT COMPLETED|Visit 4||0
8735953|NCT01089062|9783647|FG005|NOT COMPLETED|Visit 4||0
8735954|NCT01089062|9783642|FG000|STARTED|Follow-up Visit (Final Visit)||3
8735955|NCT01089062|9783643|FG001|STARTED|Follow-up Visit (Final Visit)||3
8735956|NCT01089062|9783644|FG002|STARTED|Follow-up Visit (Final Visit)||3
8735957|NCT01089062|9783645|FG003|STARTED|Follow-up Visit (Final Visit)||3
8735958|NCT01089062|9783646|FG004|STARTED|Follow-up Visit (Final Visit)||3
8735959|NCT01089062|9783647|FG005|STARTED|Follow-up Visit (Final Visit)||3
8735960|NCT01089062|9783642|FG000|COMPLETED|Follow-up Visit (Final Visit)||3
8735961|NCT01089062|9783643|FG001|COMPLETED|Follow-up Visit (Final Visit)||3
8735962|NCT01089062|9783644|FG002|COMPLETED|Follow-up Visit (Final Visit)||3
8735963|NCT01089062|9783645|FG003|COMPLETED|Follow-up Visit (Final Visit)||3
8735964|NCT01089062|9783646|FG004|COMPLETED|Follow-up Visit (Final Visit)||3
8735965|NCT01089062|9783647|FG005|COMPLETED|Follow-up Visit (Final Visit)||3
8735966|NCT01089062|9783642|FG000|NOT COMPLETED|Follow-up Visit (Final Visit)||0
8735967|NCT01089062|9783643|FG001|NOT COMPLETED|Follow-up Visit (Final Visit)||0
8735968|NCT01089062|9783644|FG002|NOT COMPLETED|Follow-up Visit (Final Visit)||0
8735969|NCT01089062|9783645|FG003|NOT COMPLETED|Follow-up Visit (Final Visit)||0
8735970|NCT01089062|9783646|FG004|NOT COMPLETED|Follow-up Visit (Final Visit)||0
8735971|NCT01089062|9783647|FG005|NOT COMPLETED|Follow-up Visit (Final Visit)||0
8735972|NCT01089127|9783662|FG000|STARTED|Overall Study||92
8735973|NCT01089127|9783663|FG001|STARTED|Overall Study||91
8735974|NCT01089127|9783664|FG002|STARTED|Overall Study||94
8735975|NCT01089127|9783665|FG003|STARTED|Overall Study||92
8735976|NCT01089127|9783666|FG004|STARTED|Overall Study||92
8735977|NCT01089127|9783667|FG005|STARTED|Overall Study||91
8735978|NCT01089127|9783662|FG000|Exposed to Study Drug|Overall Study|3 randomized patients in this group were not exposed to study treatment.|89
8735979|NCT01089127|9783663|FG001|Exposed to Study Drug|Overall Study|1 randomized patient in this group was not exposed to study treatment.|90
8735980|NCT01089127|9783664|FG002|Exposed to Study Drug|Overall Study||94
8735981|NCT01089127|9783665|FG003|Exposed to Study Drug|Overall Study||92
8735982|NCT01089127|9783666|FG004|Exposed to Study Drug|Overall Study|1 randomized patient in this group was not exposed to study treatment.|91
8735983|NCT01089127|9783667|FG005|Exposed to Study Drug|Overall Study||91
8735984|NCT01089127|9783662|FG000|COMPLETED|Overall Study||84
8735985|NCT01089127|9783663|FG001|COMPLETED|Overall Study||86
8735986|NCT01089127|9783664|FG002|COMPLETED|Overall Study||92
8735987|NCT01089127|9783665|FG003|COMPLETED|Overall Study||91
8735988|NCT01089127|9783666|FG004|COMPLETED|Overall Study||90
8735989|NCT01089127|9783667|FG005|COMPLETED|Overall Study||88
8735990|NCT01089127|9783662|FG000|NOT COMPLETED|Overall Study||8
8735991|NCT01089127|9783663|FG001|NOT COMPLETED|Overall Study||5
8735992|NCT01089127|9783664|FG002|NOT COMPLETED|Overall Study||2
8735993|NCT01089127|9783665|FG003|NOT COMPLETED|Overall Study||1
8735994|NCT01089127|9783666|FG004|NOT COMPLETED|Overall Study||2
8735995|NCT01089127|9783667|FG005|NOT COMPLETED|Overall Study||3
8735996|NCT01089231|9783685|FG000|STARTED|Overall Study||10
8735997|NCT01089231|9783686|FG001|STARTED|Overall Study||10
8735998|NCT01089231|9783687|FG002|STARTED|Overall Study||10
8735999|NCT01089231|9783688|FG003|STARTED|Overall Study||10
8736000|NCT01089231|9783685|FG000|COMPLETED|Overall Study|4 subjects excluded (2 alcohol use / TG level changes; 1 use of not allowed drugs; 1 low RNA yield)|6
8736001|NCT01089231|9783686|FG001|COMPLETED|Overall Study|2 subjects excluded (1 highly elevated TG and TC data; 1 elevated inflammation (CRP level))|8
8736002|NCT01089231|9783687|FG002|COMPLETED|Overall Study|2 subject excluded (1 use of not allowed drugs; 1 low RNA yield)|8
8736003|NCT01089231|9783688|FG003|COMPLETED|Overall Study|1 subject excluded (low RNA yield)|9
8736004|NCT01089231|9783685|FG000|NOT COMPLETED|Overall Study||4
8736005|NCT01089231|9783686|FG001|NOT COMPLETED|Overall Study||2
8736006|NCT01089231|9783687|FG002|NOT COMPLETED|Overall Study||2
8736007|NCT01089231|9783688|FG003|NOT COMPLETED|Overall Study||1
8736008|NCT01089361|9783700|FG000|STARTED|Overall Study||9
8736009|NCT01089361|9783701|FG001|STARTED|Overall Study||10
8736010|NCT01089361|9783700|FG000|COMPLETED|Overall Study||8
8736011|NCT01089361|9783701|FG001|COMPLETED|Overall Study||10
8736012|NCT01089361|9783700|FG000|NOT COMPLETED|Overall Study||1
8736013|NCT01089361|9783701|FG001|NOT COMPLETED|Overall Study||0
8736014|NCT01089413|9783712|FG000|STARTED|Overall Study||201
8736015|NCT01089413|9783712|FG000|Received Bevacizumab in First Line|Overall Study||199
8736016|NCT01089413|9783712|FG000|COMPLETED|Overall Study||0
8736017|NCT01089413|9783712|FG000|NOT COMPLETED|Overall Study||201
8736018|NCT01089504|9783724|FG000|STARTED|Overall Study||8
8736019|NCT01089504|9783725|FG001|STARTED|Overall Study||5
8736020|NCT01089504|9783724|FG000|COMPLETED|Overall Study||5
8736021|NCT01089504|9783725|FG001|COMPLETED|Overall Study||4
8736022|NCT01089504|9783724|FG000|NOT COMPLETED|Overall Study||3
8736023|NCT01089504|9783725|FG001|NOT COMPLETED|Overall Study||1
8736024|NCT01089517|9783734|FG000|STARTED|Overall Study||148
8736025|NCT01089517|9783735|FG001|STARTED|Overall Study||149
8736026|NCT01089517|9783736|FG002|STARTED|Overall Study||152
8736027|NCT01089517|9783734|FG000|COMPLETED|Overall Study||144
8736028|NCT01089517|9783735|FG001|COMPLETED|Overall Study||144
8736029|NCT01089517|9783736|FG002|COMPLETED|Overall Study||147
8736030|NCT01089517|9783734|FG000|NOT COMPLETED|Overall Study||4
8736031|NCT01089517|9783735|FG001|NOT COMPLETED|Overall Study||5
8736032|NCT01089517|9783736|FG002|NOT COMPLETED|Overall Study||5
8736033|NCT01089543|9783748|FG000|STARTED|Overall Study||84
8736034|NCT01089543|9783749|FG001|STARTED|Overall Study||85
8736035|NCT01089543|9783750|FG002|STARTED|Overall Study||84
8736036|NCT01089543|9783751|FG003|STARTED|Overall Study||85
8736037|NCT01089543|9783748|FG000|COMPLETED|Overall Study||81
8736038|NCT01089543|9783749|FG001|COMPLETED|Overall Study||81
8736039|NCT01089543|9783750|FG002|COMPLETED|Overall Study||81
8736040|NCT01089543|9783751|FG003|COMPLETED|Overall Study||83
8736041|NCT01089543|9783748|FG000|NOT COMPLETED|Overall Study||3
8736042|NCT01089543|9783749|FG001|NOT COMPLETED|Overall Study||4
8736043|NCT01089543|9783750|FG002|NOT COMPLETED|Overall Study||3
8736044|NCT01089543|9783751|FG003|NOT COMPLETED|Overall Study||2
8736045|NCT01089556|9783763|FG000|STARTED|Study Period II (Weeks 1-8)||404
8736046|NCT01089556|9783764|FG001|STARTED|Study Period II (Weeks 1-8)||407
8736047|NCT01089556|9783765|FG002|STARTED|Study Period II (Weeks 1-8)||0
8736048|NCT01089556|9783766|FG003|STARTED|Study Period II (Weeks 1-8)||0
8736049|NCT01089556|9783767|FG004|STARTED|Study Period II (Weeks 1-8)||0
8736050|NCT01089556|9783768|FG005|STARTED|Study Period II (Weeks 1-8)||0
8736051|NCT01089556|9783763|FG000|Safety Population|Study Period II (Weeks 1-8)|Received at least 1 dose of study drug.|401
8736052|NCT01089556|9783764|FG001|Safety Population|Study Period II (Weeks 1-8)|Received at least 1 dose of study drug.|403
8736053|NCT01089556|9783765|FG002|Safety Population|Study Period II (Weeks 1-8)||0
8736054|NCT01089556|9783766|FG003|Safety Population|Study Period II (Weeks 1-8)||0
8736055|NCT01089556|9783767|FG004|Safety Population|Study Period II (Weeks 1-8)||0
8736056|NCT01089556|9783768|FG005|Safety Population|Study Period II (Weeks 1-8)||0
8736057|NCT01089556|9783763|FG000|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||158
8736058|NCT01089556|9783764|FG001|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||205
8736059|NCT01089556|9783765|FG002|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
8736060|NCT01089556|9783766|FG003|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
8736061|NCT01089556|9783767|FG004|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
8736062|NCT01089556|9783768|FG005|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
8736063|NCT01089556|9783763|FG000|COMPLETED|Study Period II (Weeks 1-8)||333
8736064|NCT01089556|9783764|FG001|COMPLETED|Study Period II (Weeks 1-8)||333
8736065|NCT01089556|9783765|FG002|COMPLETED|Study Period II (Weeks 1-8)||0
8736066|NCT01089556|9783766|FG003|COMPLETED|Study Period II (Weeks 1-8)||0
8736067|NCT01089556|9783767|FG004|COMPLETED|Study Period II (Weeks 1-8)||0
8736068|NCT01089556|9783768|FG005|COMPLETED|Study Period II (Weeks 1-8)||0
8736069|NCT01089556|9783763|FG000|NOT COMPLETED|Study Period II (Weeks 1-8)||71
8736070|NCT01089556|9783764|FG001|NOT COMPLETED|Study Period II (Weeks 1-8)||74
8736071|NCT01089556|9783765|FG002|NOT COMPLETED|Study Period II (Weeks 1-8)||0
8736072|NCT01089556|9783766|FG003|NOT COMPLETED|Study Period II (Weeks 1-8)||0
8736073|NCT01089556|9783767|FG004|NOT COMPLETED|Study Period II (Weeks 1-8)||0
8736074|NCT01089556|9783768|FG005|NOT COMPLETED|Study Period II (Weeks 1-8)||0
8736075|NCT01089556|9783763|FG000|STARTED|Study Period III (Weeks 9-16)||0
8736076|NCT01089556|9783764|FG001|STARTED|Study Period III (Weeks 9-16)||0
8736077|NCT01089556|9783765|FG002|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 10 non-responders did not enter SPIII, while 4 responders entered SPIII|74
8736078|NCT01089556|9783766|FG003|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 6 non-responders did not enter SPIII, while 3 responders entered SPIII|75
8736079|NCT01089556|9783767|FG004|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 10 non-responders did not enter SPIII, while 4 responders entered SPIII|95
8736080|NCT01089556|9783768|FG005|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 6 non-responders did not enter SPIII, while 1 responders entered SPIII|99
8736081|NCT01089556|9783763|FG000|Efficacy and Safety Population|Study Period III (Weeks 9-16)||0
8736082|NCT01089556|9783764|FG001|Efficacy and Safety Population|Study Period III (Weeks 9-16)||0
8806820|NCT01480076|9859127|FG000|COMPLETED|Overall Study||611
8806821|NCT01480076|9859127|FG000|NOT COMPLETED|Overall Study||290
8806822|NCT01480089|9859145|FG000|STARTED|Overall Study||25
8806823|NCT01480089|9859146|FG001|STARTED|Overall Study||30
8806824|NCT01480089|9859145|FG000|COMPLETED|Overall Study||25
8806825|NCT01480089|9859146|FG001|COMPLETED|Overall Study||30
8806826|NCT01480089|9859145|FG000|NOT COMPLETED|Overall Study||0
8806827|NCT01480089|9859146|FG001|NOT COMPLETED|Overall Study||0
8806828|NCT01480219|9859154|FG000|STARTED|Overall Study||325
8806829|NCT01480219|9859155|FG001|STARTED|Overall Study||142
8912076|NCT02151682|9971247|FG005|NOT COMPLETED|Part 2: Tapent. Extension or Observation||0
8806830|NCT01480219|9859154|FG000|COMPLETED|Overall Study||325
8806831|NCT01480219|9859155|FG001|COMPLETED|Overall Study||142
8806832|NCT01480219|9859154|FG000|NOT COMPLETED|Overall Study||0
8806833|NCT01480219|9859155|FG001|NOT COMPLETED|Overall Study||0
8806834|NCT01480232|9859165|FG000|STARTED|Overall Study||40
8806835|NCT01480232|9859166|FG001|STARTED|Overall Study||41
8736083|NCT01089556|9783765|FG002|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|73
8736084|NCT01089556|9783766|FG003|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|75
8736085|NCT01089556|9783767|FG004|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|94
8736086|NCT01089556|9783768|FG005|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|97
8736087|NCT01089556|9783763|FG000|COMPLETED|Study Period III (Weeks 9-16)||0
8736088|NCT01089556|9783764|FG001|COMPLETED|Study Period III (Weeks 9-16)||0
8736089|NCT01089556|9783765|FG002|COMPLETED|Study Period III (Weeks 9-16)||60
8736090|NCT01089556|9783766|FG003|COMPLETED|Study Period III (Weeks 9-16)||66
8736091|NCT01089556|9783767|FG004|COMPLETED|Study Period III (Weeks 9-16)||83
8736092|NCT01089556|9783768|FG005|COMPLETED|Study Period III (Weeks 9-16)||92
8736093|NCT01089556|9783763|FG000|NOT COMPLETED|Study Period III (Weeks 9-16)||0
8736094|NCT01089556|9783764|FG001|NOT COMPLETED|Study Period III (Weeks 9-16)||0
8736095|NCT01089556|9783765|FG002|NOT COMPLETED|Study Period III (Weeks 9-16)||14
8736096|NCT01089556|9783766|FG003|NOT COMPLETED|Study Period III (Weeks 9-16)||9
8736097|NCT01089556|9783767|FG004|NOT COMPLETED|Study Period III (Weeks 9-16)||12
8736098|NCT01089556|9783768|FG005|NOT COMPLETED|Study Period III (Weeks 9-16)||7
8736099|NCT01089569|9783783|FG000|STARTED|Overall Study||20
8736100|NCT01089569|9783784|FG001|STARTED|Overall Study||20
8736101|NCT01089569|9783785|FG002|STARTED|Overall Study||20
8736102|NCT01089569|9783783|FG000|COMPLETED|Overall Study||16
8736103|NCT01089569|9783784|FG001|COMPLETED|Overall Study||17
8736104|NCT01089569|9783785|FG002|COMPLETED|Overall Study||16
8736105|NCT01089569|9783783|FG000|NOT COMPLETED|Overall Study||4
8736106|NCT01089569|9783784|FG001|NOT COMPLETED|Overall Study||3
8736107|NCT01089569|9783785|FG002|NOT COMPLETED|Overall Study||4
8736108|NCT01089582|9783793|FG000|STARTED|Overall Study||603
8736109|NCT01089582|9783793|FG000|COMPLETED|Overall Study|1 subject died during the study; 1 subject died following permanent discontinuation from the study.|573
8736110|NCT01089582|9783793|FG000|NOT COMPLETED|Overall Study||30
8736111|NCT01089595|9783799|FG000|STARTED|Overall Study||2
8736112|NCT01089595|9783800|FG001|STARTED|Overall Study||3
8736113|NCT01089595|9783799|FG000|COMPLETED|Overall Study||2
8736114|NCT01089595|9783800|FG001|COMPLETED|Overall Study||3
8736115|NCT01089595|9783799|FG000|NOT COMPLETED|Overall Study||0
8736116|NCT01089595|9783800|FG001|NOT COMPLETED|Overall Study||0
8736117|NCT01089608|9783810|FG000|STARTED|Overall Study||43
8736118|NCT01089608|9783811|FG001|STARTED|Overall Study||50
8736119|NCT01089608|9783810|FG000|COMPLETED|Overall Study||43
8736120|NCT01089608|9783811|FG001|COMPLETED|Overall Study||44
8736121|NCT01089608|9783810|FG000|NOT COMPLETED|Overall Study||0
8736122|NCT01089608|9783811|FG001|NOT COMPLETED|Overall Study||6
8736123|NCT01089647|9783819|FG000|STARTED|Overall Study||17
8736124|NCT01089647|9783820|FG001|STARTED|Overall Study||17
8736125|NCT01089647|9783819|FG000|COMPLETED|Overall Study||13
8736126|NCT01089647|9783820|FG001|COMPLETED|Overall Study||13
8736127|NCT01089647|9783819|FG000|NOT COMPLETED|Overall Study||4
8736128|NCT01089647|9783820|FG001|NOT COMPLETED|Overall Study||4
8736129|NCT01089725|9783831|FG000|STARTED|Overall Study||72
8736130|NCT01089725|9783832|FG001|STARTED|Overall Study||75
8736131|NCT01089725|9783833|FG002|STARTED|Overall Study||65
8736132|NCT01089725|9783834|FG003|STARTED|Overall Study||87
8736133|NCT01089725|9783835|FG004|STARTED|Overall Study||86
8736134|NCT01089725|9783831|FG000|Treated|Overall Study||72
8736135|NCT01089725|9783832|FG001|Treated|Overall Study||74
8736136|NCT01089725|9783833|FG002|Treated|Overall Study||63
8736137|NCT01089725|9783834|FG003|Treated|Overall Study||86
8736138|NCT01089725|9783835|FG004|Treated|Overall Study||84
8736139|NCT01089725|9783831|FG000|COMPLETED|Overall Study||6
8736140|NCT01089725|9783832|FG001|COMPLETED|Overall Study||7
8736141|NCT01089725|9783833|FG002|COMPLETED|Overall Study||4
8736142|NCT01089725|9783834|FG003|COMPLETED|Overall Study||8
8736143|NCT01089725|9783835|FG004|COMPLETED|Overall Study||6
8736144|NCT01089725|9783831|FG000|NOT COMPLETED|Overall Study||66
8736145|NCT01089725|9783832|FG001|NOT COMPLETED|Overall Study||68
8736146|NCT01089725|9783833|FG002|NOT COMPLETED|Overall Study||61
8736147|NCT01089725|9783834|FG003|NOT COMPLETED|Overall Study||79
8736148|NCT01089725|9783835|FG004|NOT COMPLETED|Overall Study||80
8736149|NCT01089751|9783853|FG000|STARTED|Overall Study||163
8736150|NCT01089751|9783854|FG001|STARTED|Overall Study||159
8736151|NCT01089751|9783853|FG000|COMPLETED|Overall Study||129
8736152|NCT01089751|9783854|FG001|COMPLETED|Overall Study||132
8736153|NCT01089751|9783853|FG000|NOT COMPLETED|Overall Study||34
8736154|NCT01089751|9783854|FG001|NOT COMPLETED|Overall Study||27
8736155|NCT01090011|9783860|FG000|STARTED|Overall Study||171
8736156|NCT01090011|9783860|FG000|COMPLETED|Overall Study||0
8736157|NCT01090011|9783860|FG000|NOT COMPLETED|Overall Study||171
8736158|NCT01090050|9783874|FG000|STARTED|Overall Study||16
8736159|NCT01090050|9783875|FG001|STARTED|Overall Study||12
8736160|NCT01090050|9783874|FG000|COMPLETED|Overall Study||15
8912077|NCT02151682|9971242|FG000|STARTED|Part 2: Observ. Aft. Tapent. Extension|Group not defined for Part 2.|0
8912078|NCT02151682|9971243|FG001|STARTED|Part 2: Observ. Aft. Tapent. Extension|Group not defined for Part 2.|0
8912079|NCT02151682|9971244|FG002|STARTED|Part 2: Observ. Aft. Tapent. Extension|Not applicable for this period.|0
8736161|NCT01090050|9783875|FG001|COMPLETED|Overall Study||5
8736162|NCT01090050|9783874|FG000|NOT COMPLETED|Overall Study||1
8736163|NCT01090050|9783875|FG001|NOT COMPLETED|Overall Study||7
8736164|NCT01090063|9783885|FG000|STARTED|Screen||28
8736165|NCT01090063|9783885|FG000|COMPLETED|Screen||24
8736166|NCT01090063|9783885|FG000|NOT COMPLETED|Screen||4
8736167|NCT01090063|9783885|FG000|STARTED|Treatment||24
8736168|NCT01090063|9783885|FG000|COMPLETED|Treatment||20
8736169|NCT01090063|9783885|FG000|NOT COMPLETED|Treatment||4
8736170|NCT01090076|9783901|FG000|STARTED|Overall Study||12
8736171|NCT01090076|9783902|FG001|STARTED|Overall Study||14
8736172|NCT01090076|9783901|FG000|COMPLETED|Overall Study||11
8736173|NCT01090076|9783902|FG001|COMPLETED|Overall Study||12
8736174|NCT01090076|9783901|FG000|NOT COMPLETED|Overall Study||1
8736175|NCT01090076|9783902|FG001|NOT COMPLETED|Overall Study||2
8736176|NCT01090102|9783912|FG000|STARTED|First 12 Weeks||15
8736177|NCT01090102|9783913|FG001|STARTED|First 12 Weeks||18
8736178|NCT01090102|9783912|FG000|COMPLETED|First 12 Weeks||11
8736179|NCT01090102|9783913|FG001|COMPLETED|First 12 Weeks||16
8736180|NCT01090102|9783912|FG000|NOT COMPLETED|First 12 Weeks||4
8736181|NCT01090102|9783913|FG001|NOT COMPLETED|First 12 Weeks||2
8736182|NCT01090102|9783912|FG000|STARTED|Second 12 Weeks||11
8736183|NCT01090102|9783913|FG001|STARTED|Second 12 Weeks||16
8736184|NCT01090102|9783912|FG000|COMPLETED|Second 12 Weeks||11
8736185|NCT01090102|9783913|FG001|COMPLETED|Second 12 Weeks||15
8736186|NCT01090102|9783912|FG000|NOT COMPLETED|Second 12 Weeks||0
8736187|NCT01090102|9783913|FG001|NOT COMPLETED|Second 12 Weeks||1
8736188|NCT01090180|9783921|FG000|STARTED|Overall Study||33
8736189|NCT01090180|9783922|FG001|STARTED|Overall Study||29
8736190|NCT01090180|9783921|FG000|COMPLETED|Overall Study||22
8736191|NCT01090180|9783922|FG001|COMPLETED|Overall Study||21
8736192|NCT01090180|9783921|FG000|NOT COMPLETED|Overall Study||11
8736193|NCT01090180|9783922|FG001|NOT COMPLETED|Overall Study||8
8736194|NCT01090310|9783932|FG000|STARTED|Core Study||29
8736195|NCT01090310|9783933|FG001|STARTED|Core Study||31
8736196|NCT01090310|9783934|FG002|STARTED|Core Study||31
8736197|NCT01090310|9783935|FG003|STARTED|Core Study||34
8736198|NCT01090310|9783932|FG000|COMPLETED|Core Study||21
8736199|NCT01090310|9783933|FG001|COMPLETED|Core Study||20
8736200|NCT01090310|9783934|FG002|COMPLETED|Core Study||24
8736201|NCT01090310|9783935|FG003|COMPLETED|Core Study||27
8736202|NCT01090310|9783932|FG000|NOT COMPLETED|Core Study||8
8736203|NCT01090310|9783933|FG001|NOT COMPLETED|Core Study||11
8736204|NCT01090310|9783934|FG002|NOT COMPLETED|Core Study||7
8736205|NCT01090310|9783935|FG003|NOT COMPLETED|Core Study||7
8736206|NCT01090310|9783932|FG000|STARTED|Extension Study||17
8736207|NCT01090310|9783933|FG001|STARTED|Extension Study||16
8736208|NCT01090310|9783934|FG002|STARTED|Extension Study||16
8736209|NCT01090310|9783935|FG003|STARTED|Extension Study||21
8736210|NCT01090310|9783932|FG000|COMPLETED|Extension Study||3
8736211|NCT01090310|9783933|FG001|COMPLETED|Extension Study||0
8736212|NCT01090310|9783934|FG002|COMPLETED|Extension Study||1
8736213|NCT01090310|9783935|FG003|COMPLETED|Extension Study||1
8736214|NCT01090310|9783932|FG000|NOT COMPLETED|Extension Study||14
8736215|NCT01090310|9783933|FG001|NOT COMPLETED|Extension Study||16
8736216|NCT01090310|9783934|FG002|NOT COMPLETED|Extension Study||15
8736217|NCT01090310|9783935|FG003|NOT COMPLETED|Extension Study||20
8736218|NCT01090323|9783947|FG000|STARTED|Overall Study||132
8736219|NCT01090323|9783948|FG001|STARTED|Overall Study||53
8736220|NCT01090323|9783947|FG000|COMPLETED|Overall Study||43
8736221|NCT01090323|9783948|FG001|COMPLETED|Overall Study||19
8736222|NCT01090323|9783947|FG000|NOT COMPLETED|Overall Study||89
8736223|NCT01090323|9783948|FG001|NOT COMPLETED|Overall Study||34
8736224|NCT01090414|9783958|FG000|STARTED|Parent Studies||191
8736225|NCT01090414|9783959|FG001|STARTED|Parent Studies||241
8736226|NCT01090414|9783960|FG002|STARTED|Parent Studies||64
8736227|NCT01090414|9783961|FG003|STARTED|Parent Studies||18
8736228|NCT01090414|9783958|FG000|COMPLETED|Parent Studies||50
8736229|NCT01090414|9783959|FG001|COMPLETED|Parent Studies||114
8736230|NCT01090414|9783960|FG002|COMPLETED|Parent Studies||43
8736231|NCT01090414|9783961|FG003|COMPLETED|Parent Studies||5
8736232|NCT01090414|9783958|FG000|NOT COMPLETED|Parent Studies||141
8736233|NCT01090414|9783959|FG001|NOT COMPLETED|Parent Studies||127
8736234|NCT01090414|9783960|FG002|NOT COMPLETED|Parent Studies||21
8736235|NCT01090414|9783961|FG003|NOT COMPLETED|Parent Studies||13
8736236|NCT01090414|9783958|FG000|STARTED|Study 101-99|50 participants completed the parent study, but only 48 participants enrolled into Study 101-99.|48
8736237|NCT01090414|9783959|FG001|STARTED|Study 101-99|114 participants completed the parent study, but only 108 participants enrolled into Study 101-99.|108
8736238|NCT01090414|9783960|FG002|STARTED|Study 101-99|43 participants completed the parent study, but only 41 participants enrolled into Study 101-99.|41
8736239|NCT01090414|9783961|FG003|STARTED|Study 101-99||5
8736240|NCT01090414|9783958|FG000|COMPLETED|Study 101-99||0
8736241|NCT01090414|9783959|FG001|COMPLETED|Study 101-99||0
8736242|NCT01090414|9783960|FG002|COMPLETED|Study 101-99||0
8736243|NCT01090414|9783961|FG003|COMPLETED|Study 101-99||0
8736244|NCT01090414|9783958|FG000|NOT COMPLETED|Study 101-99||48
8736245|NCT01090414|9783959|FG001|NOT COMPLETED|Study 101-99||108
8736246|NCT01090414|9783960|FG002|NOT COMPLETED|Study 101-99||41
8736247|NCT01090414|9783961|FG003|NOT COMPLETED|Study 101-99||5
8736248|NCT01090427|9783986|FG000|STARTED|Controlled Period||37
8736249|NCT01090427|9783987|FG001|STARTED|Controlled Period||37
8736250|NCT01090427|9783988|FG002|STARTED|Controlled Period||36
8806836|NCT01480232|9859167|FG002|STARTED|Overall Study||38
8736251|NCT01090427|9783989|FG003|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
8736252|NCT01090427|9783990|FG004|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
8736253|NCT01090427|9783991|FG005|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
8736254|NCT01090427|9783992|FG006|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
8736255|NCT01090427|9783986|FG000|COMPLETED|Controlled Period||37
8736256|NCT01090427|9783987|FG001|COMPLETED|Controlled Period||37
8736257|NCT01090427|9783988|FG002|COMPLETED|Controlled Period||36
8736258|NCT01090427|9783989|FG003|COMPLETED|Controlled Period||0
8736259|NCT01090427|9783990|FG004|COMPLETED|Controlled Period||0
8736260|NCT01090427|9783991|FG005|COMPLETED|Controlled Period||0
8736261|NCT01090427|9783992|FG006|COMPLETED|Controlled Period||0
8736262|NCT01090427|9783986|FG000|NOT COMPLETED|Controlled Period||0
8736263|NCT01090427|9783987|FG001|NOT COMPLETED|Controlled Period||0
8736264|NCT01090427|9783988|FG002|NOT COMPLETED|Controlled Period||0
8736265|NCT01090427|9783989|FG003|NOT COMPLETED|Controlled Period||0
8736266|NCT01090427|9783990|FG004|NOT COMPLETED|Controlled Period||0
8736267|NCT01090427|9783991|FG005|NOT COMPLETED|Controlled Period||0
8736268|NCT01090427|9783992|FG006|NOT COMPLETED|Controlled Period||0
8736269|NCT01090427|9783986|FG000|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
8736270|NCT01090427|9783987|FG001|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
8736271|NCT01090427|9783988|FG002|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
8736272|NCT01090427|9783989|FG003|STARTED|After Controlled Period||19
8736273|NCT01090427|9783990|FG004|STARTED|After Controlled Period||18
8736274|NCT01090427|9783991|FG005|STARTED|After Controlled Period||37
8736275|NCT01090427|9783992|FG006|STARTED|After Controlled Period||36
8736276|NCT01090427|9783986|FG000|COMPLETED|After Controlled Period||0
8736277|NCT01090427|9783987|FG001|COMPLETED|After Controlled Period||0
8736278|NCT01090427|9783988|FG002|COMPLETED|After Controlled Period||0
8736279|NCT01090427|9783989|FG003|COMPLETED|After Controlled Period||17
8736280|NCT01090427|9783990|FG004|COMPLETED|After Controlled Period||18
8736281|NCT01090427|9783991|FG005|COMPLETED|After Controlled Period||32
8736282|NCT01090427|9783992|FG006|COMPLETED|After Controlled Period||34
8736283|NCT01090427|9783986|FG000|NOT COMPLETED|After Controlled Period||0
8736284|NCT01090427|9783987|FG001|NOT COMPLETED|After Controlled Period||0
8736285|NCT01090427|9783988|FG002|NOT COMPLETED|After Controlled Period||0
8736286|NCT01090427|9783989|FG003|NOT COMPLETED|After Controlled Period||2
8736287|NCT01090427|9783990|FG004|NOT COMPLETED|After Controlled Period||0
8736288|NCT01090427|9783991|FG005|NOT COMPLETED|After Controlled Period||5
8736289|NCT01090427|9783992|FG006|NOT COMPLETED|After Controlled Period||2
8736290|NCT01090453|9784006|FG000|STARTED|Overall Study||238
8736291|NCT01090453|9784007|FG001|STARTED|Overall Study||242
8736292|NCT01090453|9784006|FG000|COMPLETED|Overall Study||225
8736293|NCT01090453|9784007|FG001|COMPLETED|Overall Study||228
8736294|NCT01090453|9784006|FG000|NOT COMPLETED|Overall Study||13
8736295|NCT01090453|9784007|FG001|NOT COMPLETED|Overall Study||14
8736296|NCT01090479|9784015|FG000|STARTED|Overall Study||50
8736297|NCT01090479|9784016|FG001|STARTED|Overall Study||50
8736298|NCT01090479|9784015|FG000|COMPLETED|Overall Study||50
8736299|NCT01090479|9784016|FG001|COMPLETED|Overall Study||50
8736300|NCT01090479|9784015|FG000|NOT COMPLETED|Overall Study||0
8736301|NCT01090479|9784016|FG001|NOT COMPLETED|Overall Study||0
8736302|NCT01090492|9784030|FG000|STARTED|First Intervention Period (4 Weeks)||27
8736303|NCT01090492|9784031|FG001|STARTED|First Intervention Period (4 Weeks)||29
8736304|NCT01090492|9784032|FG002|STARTED|First Intervention Period (4 Weeks)||29
8736305|NCT01090492|9784033|FG003|STARTED|First Intervention Period (4 Weeks)||28
8736306|NCT01090492|9784034|FG004|STARTED|First Intervention Period (4 Weeks)||33
8736307|NCT01090492|9784035|FG005|STARTED|First Intervention Period (4 Weeks)||32
8736308|NCT01090492|9784036|FG006|STARTED|First Intervention Period (4 Weeks)||32
8736309|NCT01090492|9784037|FG007|STARTED|First Intervention Period (4 Weeks)||33
8736310|NCT01090492|9784030|FG000|COMPLETED|First Intervention Period (4 Weeks)||26
8736311|NCT01090492|9784031|FG001|COMPLETED|First Intervention Period (4 Weeks)||24
8736312|NCT01090492|9784032|FG002|COMPLETED|First Intervention Period (4 Weeks)||26
8736313|NCT01090492|9784033|FG003|COMPLETED|First Intervention Period (4 Weeks)||22
8736314|NCT01090492|9784034|FG004|COMPLETED|First Intervention Period (4 Weeks)||29
8736315|NCT01090492|9784035|FG005|COMPLETED|First Intervention Period (4 Weeks)||30
8736316|NCT01090492|9784036|FG006|COMPLETED|First Intervention Period (4 Weeks)||31
8736317|NCT01090492|9784037|FG007|COMPLETED|First Intervention Period (4 Weeks)||27
8736318|NCT01090492|9784030|FG000|NOT COMPLETED|First Intervention Period (4 Weeks)||1
8736319|NCT01090492|9784031|FG001|NOT COMPLETED|First Intervention Period (4 Weeks)||5
8736320|NCT01090492|9784032|FG002|NOT COMPLETED|First Intervention Period (4 Weeks)||3
8736321|NCT01090492|9784033|FG003|NOT COMPLETED|First Intervention Period (4 Weeks)||6
8736322|NCT01090492|9784034|FG004|NOT COMPLETED|First Intervention Period (4 Weeks)||4
8736323|NCT01090492|9784035|FG005|NOT COMPLETED|First Intervention Period (4 Weeks)||2
8736324|NCT01090492|9784036|FG006|NOT COMPLETED|First Intervention Period (4 Weeks)||1
8736325|NCT01090492|9784037|FG007|NOT COMPLETED|First Intervention Period (4 Weeks)||6
8736326|NCT01090492|9784030|FG000|STARTED|Placebo Washout Period ( 2 Weeks)||26
8736327|NCT01090492|9784031|FG001|STARTED|Placebo Washout Period ( 2 Weeks)||24
8736328|NCT01090492|9784032|FG002|STARTED|Placebo Washout Period ( 2 Weeks)||26
8736329|NCT01090492|9784033|FG003|STARTED|Placebo Washout Period ( 2 Weeks)||22
8736330|NCT01090492|9784034|FG004|STARTED|Placebo Washout Period ( 2 Weeks)||29
8736331|NCT01090492|9784035|FG005|STARTED|Placebo Washout Period ( 2 Weeks)||30
8736332|NCT01090492|9784036|FG006|STARTED|Placebo Washout Period ( 2 Weeks)||31
8736333|NCT01090492|9784037|FG007|STARTED|Placebo Washout Period ( 2 Weeks)||27
8736334|NCT01090492|9784030|FG000|COMPLETED|Placebo Washout Period ( 2 Weeks)||26
8736335|NCT01090492|9784031|FG001|COMPLETED|Placebo Washout Period ( 2 Weeks)||24
8736336|NCT01090492|9784032|FG002|COMPLETED|Placebo Washout Period ( 2 Weeks)||26
8736337|NCT01090492|9784033|FG003|COMPLETED|Placebo Washout Period ( 2 Weeks)||22
8736338|NCT01090492|9784034|FG004|COMPLETED|Placebo Washout Period ( 2 Weeks)||29
8736339|NCT01090492|9784035|FG005|COMPLETED|Placebo Washout Period ( 2 Weeks)||30
8736340|NCT01090492|9784036|FG006|COMPLETED|Placebo Washout Period ( 2 Weeks)||31
8736341|NCT01090492|9784037|FG007|COMPLETED|Placebo Washout Period ( 2 Weeks)||27
8736342|NCT01090492|9784030|FG000|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
8736343|NCT01090492|9784031|FG001|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
8736344|NCT01090492|9784032|FG002|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
8736345|NCT01090492|9784033|FG003|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
8736346|NCT01090492|9784034|FG004|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
8736347|NCT01090492|9784035|FG005|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
8736348|NCT01090492|9784036|FG006|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
8736349|NCT01090492|9784037|FG007|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
8736350|NCT01090492|9784030|FG000|STARTED|Second Intervention Period (4 Weeks)||26
8736351|NCT01090492|9784031|FG001|STARTED|Second Intervention Period (4 Weeks)||24
8736352|NCT01090492|9784032|FG002|STARTED|Second Intervention Period (4 Weeks)||26
8736353|NCT01090492|9784033|FG003|STARTED|Second Intervention Period (4 Weeks)||22
8736354|NCT01090492|9784034|FG004|STARTED|Second Intervention Period (4 Weeks)||29
8736355|NCT01090492|9784035|FG005|STARTED|Second Intervention Period (4 Weeks)||30
8736356|NCT01090492|9784036|FG006|STARTED|Second Intervention Period (4 Weeks)||31
8736357|NCT01090492|9784037|FG007|STARTED|Second Intervention Period (4 Weeks)||27
8736358|NCT01090492|9784030|FG000|COMPLETED|Second Intervention Period (4 Weeks)||25
8736359|NCT01090492|9784031|FG001|COMPLETED|Second Intervention Period (4 Weeks)||22
8736360|NCT01090492|9784032|FG002|COMPLETED|Second Intervention Period (4 Weeks)||24
8736361|NCT01090492|9784033|FG003|COMPLETED|Second Intervention Period (4 Weeks)||22
8736362|NCT01090492|9784034|FG004|COMPLETED|Second Intervention Period (4 Weeks)||27
8736363|NCT01090492|9784035|FG005|COMPLETED|Second Intervention Period (4 Weeks)||29
8736364|NCT01090492|9784036|FG006|COMPLETED|Second Intervention Period (4 Weeks)||22
8736365|NCT01090492|9784037|FG007|COMPLETED|Second Intervention Period (4 Weeks)||25
8736366|NCT01090492|9784030|FG000|NOT COMPLETED|Second Intervention Period (4 Weeks)||1
8736367|NCT01090492|9784031|FG001|NOT COMPLETED|Second Intervention Period (4 Weeks)||2
8736368|NCT01090492|9784032|FG002|NOT COMPLETED|Second Intervention Period (4 Weeks)||2
8736369|NCT01090492|9784033|FG003|NOT COMPLETED|Second Intervention Period (4 Weeks)||0
8736370|NCT01090492|9784034|FG004|NOT COMPLETED|Second Intervention Period (4 Weeks)||2
8736371|NCT01090492|9784035|FG005|NOT COMPLETED|Second Intervention Period (4 Weeks)||1
8736372|NCT01090492|9784036|FG006|NOT COMPLETED|Second Intervention Period (4 Weeks)||9
8736373|NCT01090492|9784037|FG007|NOT COMPLETED|Second Intervention Period (4 Weeks)||2
8736374|NCT01090739|9784056|FG000|STARTED|Enrollment|Subject enrollment = signed informed consent form|207
8736375|NCT01090739|9784056|FG000|COMPLETED|Enrollment||152
8736376|NCT01090739|9784056|FG000|NOT COMPLETED|Enrollment||55
8736377|NCT01090739|9784056|FG000|STARTED|12 Month Follow-up||152
8736378|NCT01090739|9784056|FG000|COMPLETED|12 Month Follow-up||147
8736379|NCT01090739|9784056|FG000|NOT COMPLETED|12 Month Follow-up||5
8736380|NCT01090739|9784056|FG000|STARTED|24 Month Follow-up||147
8736381|NCT01090739|9784056|FG000|COMPLETED|24 Month Follow-up||138
8736382|NCT01090739|9784056|FG000|NOT COMPLETED|24 Month Follow-up||9
8736383|NCT01090739|9784056|FG000|STARTED|36 Month Follow-up||138
8736384|NCT01090739|9784056|FG000|COMPLETED|36 Month Follow-up||115
8736385|NCT01090739|9784056|FG000|NOT COMPLETED|36 Month Follow-up||23
8736386|NCT01090752|9784063|FG000|STARTED|Overall Study||8
8736387|NCT01090752|9784064|FG001|STARTED|Overall Study||8
8736388|NCT01090752|9784063|FG000|COMPLETED|Overall Study||8
8736389|NCT01090752|9784064|FG001|COMPLETED|Overall Study||8
8736390|NCT01090752|9784063|FG000|NOT COMPLETED|Overall Study||0
8736391|NCT01090752|9784064|FG001|NOT COMPLETED|Overall Study||0
8736392|NCT01090765|9784076|FG000|STARTED|Overall Study||3
8736393|NCT01090765|9784077|FG001|STARTED|Overall Study||3
8736394|NCT01090765|9784078|FG002|STARTED|Overall Study||3
8736395|NCT01090765|9784079|FG003|STARTED|Overall Study||2
8736396|NCT01090765|9784080|FG004|STARTED|Overall Study||6
8736397|NCT01090765|9784081|FG005|STARTED|Overall Study||4
8736398|NCT01090765|9784076|FG000|COMPLETED|Overall Study||3
8736399|NCT01090765|9784077|FG001|COMPLETED|Overall Study||3
8736400|NCT01090765|9784078|FG002|COMPLETED|Overall Study||3
8736401|NCT01090765|9784079|FG003|COMPLETED|Overall Study||1
8736402|NCT01090765|9784080|FG004|COMPLETED|Overall Study||4
8736403|NCT01090765|9784081|FG005|COMPLETED|Overall Study||3
8736404|NCT01090765|9784076|FG000|NOT COMPLETED|Overall Study||0
8736405|NCT01090765|9784077|FG001|NOT COMPLETED|Overall Study||0
8736406|NCT01090765|9784078|FG002|NOT COMPLETED|Overall Study||0
8736407|NCT01090765|9784079|FG003|NOT COMPLETED|Overall Study||1
8736408|NCT01090765|9784080|FG004|NOT COMPLETED|Overall Study||2
8736409|NCT01090765|9784081|FG005|NOT COMPLETED|Overall Study||1
8736410|NCT01090921|9784096|FG000|STARTED|Overall Study||50
8736411|NCT01090921|9784096|FG000|COMPLETED|Overall Study||23
8736412|NCT01090921|9784096|FG000|NOT COMPLETED|Overall Study||27
8736413|NCT01090973|9784100|FG000|STARTED|Overall Study||1
8736414|NCT01090973|9784100|FG000|COMPLETED|Overall Study||0
8736415|NCT01090973|9784100|FG000|NOT COMPLETED|Overall Study||1
8736416|NCT01091103|9784104|FG000|STARTED|Overall Study||60
8736417|NCT01091103|9784104|FG000|COMPLETED|Overall Study|Patients on study drug and completed Week 9 visit assessments.|56
8736418|NCT01091103|9784104|FG000|NOT COMPLETED|Overall Study||4
8736419|NCT01091116|9784115|FG000|STARTED|Overall Study||83
8736420|NCT01091116|9784116|FG001|STARTED|Overall Study||88
8736421|NCT01091116|9784117|FG002|STARTED|Overall Study||84
8736422|NCT01091116|9784118|FG003|STARTED|Overall Study||84
8736423|NCT01091116|9784119|FG004|STARTED|Overall Study||84
8736424|NCT01091116|9784115|FG000|COMPLETED|Overall Study||77
8736425|NCT01091116|9784116|FG001|COMPLETED|Overall Study||80
8736426|NCT01091116|9784117|FG002|COMPLETED|Overall Study||73
8736427|NCT01091116|9784118|FG003|COMPLETED|Overall Study||80
8736428|NCT01091116|9784119|FG004|COMPLETED|Overall Study||73
8736429|NCT01091116|9784115|FG000|NOT COMPLETED|Overall Study||6
8736430|NCT01091116|9784116|FG001|NOT COMPLETED|Overall Study||8
8736431|NCT01091116|9784117|FG002|NOT COMPLETED|Overall Study||11
8736432|NCT01091116|9784118|FG003|NOT COMPLETED|Overall Study||4
8736433|NCT01091116|9784119|FG004|NOT COMPLETED|Overall Study||11
8736434|NCT01091155|9784131|FG000|STARTED|Overall Study||288
8736435|NCT01091155|9784131|FG000|COMPLETED|Overall Study||279
8736436|NCT01091155|9784131|FG000|NOT COMPLETED|Overall Study||9
8736437|NCT01091168|9784137|FG000|STARTED|Overall Study||298
8736438|NCT01091168|9784138|FG001|STARTED|Overall Study||296
8736439|NCT01091168|9784137|FG000|COMPLETED|Overall Study||0
8736440|NCT01091168|9784138|FG001|COMPLETED|Overall Study||0
8736441|NCT01091168|9784137|FG000|NOT COMPLETED|Overall Study||298
8736442|NCT01091168|9784138|FG001|NOT COMPLETED|Overall Study||296
8736443|NCT01091246|9784147|FG000|STARTED|Overall Study||1385
8736444|NCT01091246|9784148|FG001|STARTED|Overall Study||464
8736445|NCT01091246|9784149|FG002|STARTED|Overall Study||463
8736446|NCT01091246|9784147|FG000|COMPLETED|Overall Study||1350
8736447|NCT01091246|9784148|FG001|COMPLETED|Overall Study||448
8736448|NCT01091246|9784149|FG002|COMPLETED|Overall Study||450
8736449|NCT01091246|9784147|FG000|NOT COMPLETED|Overall Study||35
8736450|NCT01091246|9784148|FG001|NOT COMPLETED|Overall Study||16
8736451|NCT01091246|9784149|FG002|NOT COMPLETED|Overall Study||13
8736452|NCT01091259|9784159|FG000|STARTED|Overall Study||29
8736453|NCT01091259|9784159|FG000|COMPLETED|Overall Study|Number of patients who had at least 2 cycles of treatments|24
8736454|NCT01091259|9784159|FG000|NOT COMPLETED|Overall Study||5
8736455|NCT01091363|9784165|FG000|STARTED|Overall Study||55
8736456|NCT01091363|9784166|FG001|STARTED|Overall Study||54
8736457|NCT01091363|9784165|FG000|COMPLETED|Overall Study||42
8736458|NCT01091363|9784166|FG001|COMPLETED|Overall Study||37
8736459|NCT01091363|9784165|FG000|NOT COMPLETED|Overall Study||13
8736460|NCT01091363|9784166|FG001|NOT COMPLETED|Overall Study||17
8736461|NCT01091428|9784176|FG000|STARTED|Phase 1||38
8736462|NCT01091428|9784177|FG001|STARTED|Phase 1||11
8736463|NCT01091428|9784178|FG002|STARTED|Phase 1||0
8736464|NCT01091428|9784179|FG003|STARTED|Phase 1||0
8736465|NCT01091428|9784176|FG000|COMPLETED|Phase 1|Completed = participants who completed the treatment.|0
8736466|NCT01091428|9784177|FG001|COMPLETED|Phase 1||0
8736467|NCT01091428|9784178|FG002|COMPLETED|Phase 1||0
8736468|NCT01091428|9784179|FG003|COMPLETED|Phase 1||0
8736469|NCT01091428|9784176|FG000|NOT COMPLETED|Phase 1||38
8736470|NCT01091428|9784177|FG001|NOT COMPLETED|Phase 1||11
8736471|NCT01091428|9784178|FG002|NOT COMPLETED|Phase 1||0
8736472|NCT01091428|9784179|FG003|NOT COMPLETED|Phase 1||0
8736473|NCT01091428|9784176|FG000|STARTED|Phase 2||0
8736474|NCT01091428|9784177|FG001|STARTED|Phase 2||0
8736475|NCT01091428|9784178|FG002|STARTED|Phase 2||73
8736476|NCT01091428|9784179|FG003|STARTED|Phase 2||69
8736477|NCT01091428|9784176|FG000|COMPLETED|Phase 2||0
8736478|NCT01091428|9784177|FG001|COMPLETED|Phase 2||0
8736479|NCT01091428|9784178|FG002|COMPLETED|Phase 2||0
8736480|NCT01091428|9784179|FG003|COMPLETED|Phase 2||0
8736481|NCT01091428|9784176|FG000|NOT COMPLETED|Phase 2||0
8736482|NCT01091428|9784177|FG001|NOT COMPLETED|Phase 2||0
8736483|NCT01091428|9784178|FG002|NOT COMPLETED|Phase 2||73
8736484|NCT01091428|9784179|FG003|NOT COMPLETED|Phase 2||69
8736485|NCT01091454|9784198|FG000|STARTED|Overall Study||48
8736486|NCT01091454|9784198|FG000|COMPLETED|Overall Study||47
8736487|NCT01091454|9784198|FG000|NOT COMPLETED|Overall Study||1
8736488|NCT01091519|9784204|FG000|STARTED|Overall Study||346
8736489|NCT01091519|9784205|FG001|STARTED|Overall Study||435
8736490|NCT01091519|9784204|FG000|Treated|Overall Study||342
8736491|NCT01091519|9784205|FG001|Treated|Overall Study||431
8736492|NCT01091519|9784204|FG000|COMPLETED|Overall Study||291
8736493|NCT01091519|9784205|FG001|COMPLETED|Overall Study||362
8736494|NCT01091519|9784204|FG000|NOT COMPLETED|Overall Study||55
8736495|NCT01091519|9784205|FG001|NOT COMPLETED|Overall Study||73
8736496|NCT01091662|9784213|FG000|STARTED|Overall Study||58
8736497|NCT01091662|9784214|FG001|STARTED|Overall Study||114
8736498|NCT01091662|9784213|FG000|COMPLETED|Overall Study||41
8736499|NCT01091662|9784214|FG001|COMPLETED|Overall Study||80
8736500|NCT01091662|9784213|FG000|NOT COMPLETED|Overall Study||17
8736501|NCT01091662|9784214|FG001|NOT COMPLETED|Overall Study||34
8736502|NCT01091675|9784225|FG000|STARTED|Overall Study|7 patients leave the study due to hypertension, 27 patients withdrew due to lack of efficacy|57
8736503|NCT01091675|9784225|FG000|COMPLETED|Overall Study||23
8736504|NCT01091675|9784225|FG000|NOT COMPLETED|Overall Study||34
8736505|NCT01091948|9784231|FG000|STARTED|Overall Study||37
8736506|NCT01091948|9784232|FG001|STARTED|Overall Study||38
8736507|NCT01091948|9784231|FG000|COMPLETED|Overall Study||37
8736508|NCT01091948|9784232|FG001|COMPLETED|Overall Study||38
8736509|NCT01091948|9784231|FG000|NOT COMPLETED|Overall Study||0
8736510|NCT01091948|9784232|FG001|NOT COMPLETED|Overall Study||0
8736511|NCT01091974|9784243|FG000|STARTED|Overall Study||24
8736512|NCT01091974|9784244|FG001|STARTED|Overall Study||23
8736513|NCT01091974|9784245|FG002|STARTED|Overall Study||25
8736514|NCT01091974|9784246|FG003|STARTED|Overall Study||24
8736515|NCT01091974|9784243|FG000|COMPLETED|Overall Study||19
8736516|NCT01091974|9784244|FG001|COMPLETED|Overall Study||18
8736517|NCT01091974|9784245|FG002|COMPLETED|Overall Study||19
8736518|NCT01091974|9784246|FG003|COMPLETED|Overall Study||17
8736519|NCT01091974|9784243|FG000|NOT COMPLETED|Overall Study||5
8736520|NCT01091974|9784244|FG001|NOT COMPLETED|Overall Study||5
8736521|NCT01091974|9784245|FG002|NOT COMPLETED|Overall Study||6
8736522|NCT01091974|9784246|FG003|NOT COMPLETED|Overall Study||7
8736523|NCT01092182|9784259|FG000|STARTED|Overall Study||15
8736524|NCT01092182|9784260|FG001|STARTED|Overall Study||98
8736525|NCT01092182|9784261|FG002|STARTED|Overall Study||81
8736526|NCT01092182|9784259|FG000|COMPLETED|Overall Study||14
8736527|NCT01092182|9784260|FG001|COMPLETED|Overall Study||80
8736528|NCT01092182|9784261|FG002|COMPLETED|Overall Study||53
8736529|NCT01092182|9784259|FG000|NOT COMPLETED|Overall Study||1
8736530|NCT01092182|9784260|FG001|NOT COMPLETED|Overall Study||18
8736531|NCT01092182|9784261|FG002|NOT COMPLETED|Overall Study||28
8806837|NCT01480232|9859168|FG003|STARTED|Overall Study||41
8806838|NCT01480232|9859165|FG000|COMPLETED|Overall Study||22
8806839|NCT01480232|9859166|FG001|COMPLETED|Overall Study||19
8806840|NCT01480232|9859167|FG002|COMPLETED|Overall Study||21
8806841|NCT01480232|9859168|FG003|COMPLETED|Overall Study||22
8806842|NCT01480232|9859165|FG000|NOT COMPLETED|Overall Study||18
8806843|NCT01480232|9859166|FG001|NOT COMPLETED|Overall Study||22
8806844|NCT01480232|9859167|FG002|NOT COMPLETED|Overall Study||17
8806845|NCT01480232|9859168|FG003|NOT COMPLETED|Overall Study||19
8806846|NCT01480258|9859180|FG000|STARTED|Infant Series||656
8806847|NCT01480258|9859181|FG001|STARTED|Infant Series||659
8806848|NCT01480258|9859180|FG000|Vaccinated|Infant Series||653
8806849|NCT01480258|9859181|FG001|Vaccinated|Infant Series||659
8806850|NCT01480258|9859180|FG000|COMPLETED|Infant Series||649
8806851|NCT01480258|9859181|FG001|COMPLETED|Infant Series||651
8806852|NCT01480258|9859180|FG000|NOT COMPLETED|Infant Series||7
8806853|NCT01480258|9859181|FG001|NOT COMPLETED|Infant Series||8
8806854|NCT01480258|9859180|FG000|STARTED|Interim Period||649
8806855|NCT01480258|9859181|FG001|STARTED|Interim Period||651
8806856|NCT01480258|9859180|FG000|COMPLETED|Interim Period||639
8806857|NCT01480258|9859181|FG001|COMPLETED|Interim Period||642
8806858|NCT01480258|9859180|FG000|NOT COMPLETED|Interim Period||10
8806859|NCT01480258|9859181|FG001|NOT COMPLETED|Interim Period||9
8806860|NCT01480258|9859180|FG000|STARTED|Toddler Dose||639
8806861|NCT01480258|9859181|FG001|STARTED|Toddler Dose||642
8806862|NCT01480258|9859180|FG000|COMPLETED|Toddler Dose||639
8806863|NCT01480258|9859181|FG001|COMPLETED|Toddler Dose||642
8806864|NCT01480258|9859180|FG000|NOT COMPLETED|Toddler Dose||0
8806865|NCT01480258|9859181|FG001|NOT COMPLETED|Toddler Dose||0
8806866|NCT01480284|9859189|FG000|STARTED|Overall Study||110
8806867|NCT01480284|9859190|FG001|STARTED|Overall Study||56
8806868|NCT01480284|9859189|FG000|COMPLETED|Overall Study||102
8806869|NCT01480284|9859190|FG001|COMPLETED|Overall Study||56
8806870|NCT01480284|9859189|FG000|NOT COMPLETED|Overall Study||8
8806871|NCT01480284|9859190|FG001|NOT COMPLETED|Overall Study||0
8806872|NCT01480297|9859196|FG000|STARTED|Overall Study||8
9022485|NCT03127943|10085397|FG000|STARTED|Second Intervention||12
9022486|NCT03127943|10085398|FG001|STARTED|Second Intervention||12
9022487|NCT03127943|10085397|FG000|COMPLETED|Second Intervention||12
9022488|NCT03127943|10085398|FG001|COMPLETED|Second Intervention||12
9022489|NCT03127943|10085397|FG000|NOT COMPLETED|Second Intervention||0
9022490|NCT03127943|10085398|FG001|NOT COMPLETED|Second Intervention||0
8806873|NCT01480297|9859196|FG000|COMPLETED|Overall Study||8
8806874|NCT01480297|9859196|FG000|NOT COMPLETED|Overall Study||0
8806875|NCT01480596|9859202|FG000|STARTED|Overall Study||22
8806876|NCT01480596|9859203|FG001|STARTED|Overall Study||18
8806877|NCT01480596|9859202|FG000|COMPLETED|Overall Study||17
8806878|NCT01480596|9859203|FG001|COMPLETED|Overall Study||16
8806879|NCT01480596|9859202|FG000|NOT COMPLETED|Overall Study||5
8806880|NCT01480596|9859203|FG001|NOT COMPLETED|Overall Study||2
8806881|NCT01480674|9859209|FG000|STARTED|Overall Study||160
8806882|NCT01480674|9859209|FG000|Safety Set|Overall Study||154
8806883|NCT01480674|9859209|FG000|Analysed Set|Overall Study||128
8806884|NCT01480674|9859209|FG000|COMPLETED|Overall Study||125
8806885|NCT01480674|9859209|FG000|NOT COMPLETED|Overall Study||35
8806886|NCT01480843|9859213|FG000|STARTED|Overall Study||65
8806887|NCT01480843|9859213|FG000|COMPLETED|Overall Study||60
8806888|NCT01480843|9859213|FG000|NOT COMPLETED|Overall Study||5
8806889|NCT01481116|9859220|FG000|STARTED|Overall Study||824
8806890|NCT01481116|9859221|FG001|STARTED|Overall Study||817
8806891|NCT01481116|9859222|FG002|STARTED|Overall Study||813
8806892|NCT01481116|9859220|FG000|Treated|Overall Study||822
8736532|NCT01092195|9784272|FG000|STARTED|Overall Study||23
8736533|NCT01092195|9784273|FG001|STARTED|Overall Study||21
8736534|NCT01092195|9784274|FG002|STARTED|Overall Study||20
8736535|NCT01092195|9784272|FG000|COMPLETED|Overall Study||23
8736536|NCT01092195|9784273|FG001|COMPLETED|Overall Study||21
8736537|NCT01092195|9784274|FG002|COMPLETED|Overall Study||20
8736538|NCT01092195|9784272|FG000|NOT COMPLETED|Overall Study||0
8736539|NCT01092195|9784273|FG001|NOT COMPLETED|Overall Study||0
8736540|NCT01092195|9784274|FG002|NOT COMPLETED|Overall Study||0
8736541|NCT01092338|9784284|FG000|STARTED|Overall Study||22
8736542|NCT01092338|9784285|FG001|STARTED|Overall Study||22
8736543|NCT01092338|9784284|FG000|COMPLETED|Overall Study||21
8736544|NCT01092338|9784285|FG001|COMPLETED|Overall Study||21
8736545|NCT01092338|9784284|FG000|NOT COMPLETED|Overall Study||1
8736546|NCT01092338|9784285|FG001|NOT COMPLETED|Overall Study||1
8736547|NCT01092364|9784294|FG000|STARTED|Overall Study||122
8736548|NCT01092364|9784295|FG001|STARTED|Overall Study||120
8736549|NCT01092364|9784296|FG002|STARTED|Overall Study||123
8736550|NCT01092364|9784294|FG000|COMPLETED|Overall Study||104
8736551|NCT01092364|9784295|FG001|COMPLETED|Overall Study||104
8736552|NCT01092364|9784296|FG002|COMPLETED|Overall Study||105
8736553|NCT01092364|9784294|FG000|NOT COMPLETED|Overall Study||18
8736554|NCT01092364|9784295|FG001|NOT COMPLETED|Overall Study||16
8736555|NCT01092364|9784296|FG002|NOT COMPLETED|Overall Study||18
8736556|NCT01092416|9784304|FG000|STARTED|Enrollment||443
8736557|NCT01092416|9784304|FG000|COMPLETED|Enrollment||440
8736558|NCT01092416|9784304|FG000|NOT COMPLETED|Enrollment||3
8736559|NCT01092416|9784304|FG000|STARTED|30-Day Follow-up||440
8736560|NCT01092416|9784304|FG000|COMPLETED|30-Day Follow-up||430
8736561|NCT01092416|9784304|FG000|NOT COMPLETED|30-Day Follow-up||10
8736562|NCT01092416|9784304|FG000|STARTED|12-Month Follow-up||438
8736563|NCT01092416|9784304|FG000|COMPLETED|12-Month Follow-up||413
8736564|NCT01092416|9784304|FG000|NOT COMPLETED|12-Month Follow-up||25
8736565|NCT01092442|9784313|FG000|STARTED|Overall Study||80
8736566|NCT01092442|9784314|FG001|STARTED|Overall Study||60
8736567|NCT01092442|9784313|FG000|COMPLETED|Overall Study||80
8736568|NCT01092442|9784314|FG001|COMPLETED|Overall Study||60
8736569|NCT01092442|9784313|FG000|NOT COMPLETED|Overall Study||0
8736570|NCT01092442|9784314|FG001|NOT COMPLETED|Overall Study||0
8912080|NCT02151682|9971245|FG003|STARTED|Part 2: Observ. Aft. Tapent. Extension|Not applicable for this period.|0
8912081|NCT02151682|9971246|FG004|STARTED|Part 2: Observ. Aft. Tapent. Extension|Not applicable for this period.|0
8912082|NCT02151682|9971247|FG005|STARTED|Part 2: Observ. Aft. Tapent. Extension|19 tapentadol and 7 morphine completers (Part 1) who discontinued from tapentadol treatm. in Part 2.|26
8912083|NCT02151682|9971242|FG000|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
8912084|NCT02151682|9971243|FG001|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
8912085|NCT02151682|9971244|FG002|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
8912086|NCT02151682|9971245|FG003|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
8912087|NCT02151682|9971246|FG004|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
8912088|NCT02151682|9971247|FG005|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||19
8912089|NCT02151682|9971242|FG000|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
8912090|NCT02151682|9971243|FG001|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
8912091|NCT02151682|9971244|FG002|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
8912092|NCT02151682|9971245|FG003|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
8912093|NCT02151682|9971246|FG004|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
8912094|NCT02151682|9971247|FG005|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||7
8912095|NCT02151773|9971265|FG000|STARTED|Overall Study||3493
8912096|NCT02151773|9971265|FG000|COMPLETED|Overall Study||3429
8912097|NCT02151773|9971265|FG000|NOT COMPLETED|Overall Study||64
8912098|NCT02151786|9971269|FG000|STARTED|Overall Study||1120
8912099|NCT02151786|9971269|FG000|COMPLETED|Overall Study||1084
8912100|NCT02151786|9971269|FG000|NOT COMPLETED|Overall Study||36
8912101|NCT02151851|9971275|FG000|STARTED|Overall Study||114
8912102|NCT02151851|9971276|FG001|STARTED|Overall Study||316
8912103|NCT02151851|9971275|FG000|Included in the Safety Set|Overall Study||113
8912104|NCT02151851|9971276|FG001|Included in the Safety Set|Overall Study||316
8912105|NCT02151851|9971275|FG000|COMPLETED|Overall Study||38
8912106|NCT02151851|9971276|FG001|COMPLETED|Overall Study||186
8912107|NCT02151851|9971275|FG000|NOT COMPLETED|Overall Study||76
8912108|NCT02151851|9971276|FG001|NOT COMPLETED|Overall Study||130
8912109|NCT02151877|9971284|FG000|STARTED|Overall Study||12
8912110|NCT02151877|9971285|FG001|STARTED|Overall Study||12
8912111|NCT02151877|9971284|FG000|COMPLETED|Overall Study||12
8912112|NCT02151877|9971285|FG001|COMPLETED|Overall Study||12
8912113|NCT02151877|9971284|FG000|NOT COMPLETED|Overall Study||0
8912114|NCT02151877|9971285|FG001|NOT COMPLETED|Overall Study||0
8912115|NCT02151903|9971295|FG000|STARTED|Overall Study||3
8912116|NCT02151903|9971296|FG001|STARTED|Overall Study||2
8912117|NCT02151903|9971295|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
8912118|NCT02151903|9971296|FG001|Received at Least 1 Dose of Study Drug|Overall Study||2
8912119|NCT02151903|9971295|FG000|COMPLETED|Overall Study||0
8912120|NCT02151903|9971296|FG001|COMPLETED|Overall Study||1
8736571|NCT01092507|9784327|FG000|STARTED|Overall Study||149
8736572|NCT01092507|9784328|FG001|STARTED|Overall Study||150
8736573|NCT01092507|9784327|FG000|COMPLETED|Overall Study||147
8736574|NCT01092507|9784328|FG001|COMPLETED|Overall Study||150
8736575|NCT01092507|9784327|FG000|NOT COMPLETED|Overall Study||2
8736576|NCT01092507|9784328|FG001|NOT COMPLETED|Overall Study||0
8736577|NCT01092546|9784334|FG000|STARTED|Overall Study||16
8736578|NCT01092546|9784334|FG000|COMPLETED|Overall Study||12
8736579|NCT01092546|9784334|FG000|NOT COMPLETED|Overall Study||4
8736580|NCT01092559|9784338|FG000|STARTED|Overall Study||10
8736581|NCT01092559|9784338|FG000|COMPLETED|Overall Study||10
8736582|NCT01092559|9784338|FG000|NOT COMPLETED|Overall Study||0
8736583|NCT01092637|9784344|FG000|STARTED|Overall Study||145
8736584|NCT01092637|9784345|FG001|STARTED|Overall Study||135
8736585|NCT01092637|9784344|FG000|COMPLETED|Overall Study||98
8736586|NCT01092637|9784345|FG001|COMPLETED|Overall Study||86
8736587|NCT01092637|9784344|FG000|NOT COMPLETED|Overall Study||47
8736588|NCT01092637|9784345|FG001|NOT COMPLETED|Overall Study||49
8736589|NCT01092663|9784354|FG000|STARTED|Overall Study||31
8736590|NCT01092663|9784355|FG001|STARTED|Overall Study||30
8736591|NCT01092663|9784354|FG000|COMPLETED|Overall Study||24
8736592|NCT01092663|9784355|FG001|COMPLETED|Overall Study||26
8736593|NCT01092663|9784354|FG000|NOT COMPLETED|Overall Study||7
8736594|NCT01092663|9784355|FG001|NOT COMPLETED|Overall Study||4
8736595|NCT01092676|9784368|FG000|STARTED|Overall Study||50
8736596|NCT01092676|9784369|FG001|STARTED|Overall Study||49
8736597|NCT01092676|9784368|FG000|COMPLETED|Overall Study||50
8736598|NCT01092676|9784369|FG001|COMPLETED|Overall Study||49
8736599|NCT01092676|9784368|FG000|NOT COMPLETED|Overall Study||0
8736600|NCT01092676|9784369|FG001|NOT COMPLETED|Overall Study||0
8736601|NCT01092702|9784375|FG000|STARTED|Overall Study||32
8736602|NCT01092702|9784375|FG000|COMPLETED|Overall Study||23
8736603|NCT01092702|9784375|FG000|NOT COMPLETED|Overall Study||9
8736604|NCT01092728|9784381|FG000|STARTED|Overall Study||4
8736605|NCT01092728|9784382|FG001|STARTED|Overall Study||14
8736606|NCT01092728|9784381|FG000|COMPLETED|Overall Study||0
8912121|NCT02151903|9971295|FG000|NOT COMPLETED|Overall Study||3
8912122|NCT02151903|9971296|FG001|NOT COMPLETED|Overall Study||1
8912123|NCT02151994|9971305|FG000|STARTED|Single Ascending Dose (SAD)||18
8912124|NCT02151994|9971306|FG001|STARTED|Single Ascending Dose (SAD)||6
8912125|NCT02151994|9971307|FG002|STARTED|Single Ascending Dose (SAD)||6
8912126|NCT02151994|9971308|FG003|STARTED|Single Ascending Dose (SAD)||6
8912127|NCT02151994|9971309|FG004|STARTED|Single Ascending Dose (SAD)||6
8912128|NCT02151994|9971310|FG005|STARTED|Single Ascending Dose (SAD)||6
8912129|NCT02151994|9971311|FG006|STARTED|Single Ascending Dose (SAD)||6
8912130|NCT02151994|9971312|FG007|STARTED|Single Ascending Dose (SAD)||6
8912131|NCT02151994|9971313|FG008|STARTED|Single Ascending Dose (SAD)||0
8912132|NCT02151994|9971314|FG009|STARTED|Single Ascending Dose (SAD)||6
8912133|NCT02151994|9971315|FG010|STARTED|Single Ascending Dose (SAD)||6
8912134|NCT02151994|9971316|FG011|STARTED|Single Ascending Dose (SAD)||0
8912135|NCT02151994|9971317|FG012|STARTED|Single Ascending Dose (SAD)||0
8912136|NCT02151994|9971305|FG000|COMPLETED|Single Ascending Dose (SAD)||18
8912137|NCT02151994|9971306|FG001|COMPLETED|Single Ascending Dose (SAD)||6
8912138|NCT02151994|9971307|FG002|COMPLETED|Single Ascending Dose (SAD)||6
8912139|NCT02151994|9971308|FG003|COMPLETED|Single Ascending Dose (SAD)||6
8912140|NCT02151994|9971309|FG004|COMPLETED|Single Ascending Dose (SAD)||6
8912141|NCT02151994|9971310|FG005|COMPLETED|Single Ascending Dose (SAD)||6
8912142|NCT02151994|9971311|FG006|COMPLETED|Single Ascending Dose (SAD)||6
8912143|NCT02151994|9971312|FG007|COMPLETED|Single Ascending Dose (SAD)||6
8912144|NCT02151994|9971313|FG008|COMPLETED|Single Ascending Dose (SAD)||0
8912145|NCT02151994|9971314|FG009|COMPLETED|Single Ascending Dose (SAD)||6
8912146|NCT02151994|9971315|FG010|COMPLETED|Single Ascending Dose (SAD)||6
8912147|NCT02151994|9971316|FG011|COMPLETED|Single Ascending Dose (SAD)||0
8912148|NCT02151994|9971317|FG012|COMPLETED|Single Ascending Dose (SAD)||0
8912149|NCT02151994|9971305|FG000|NOT COMPLETED|Single Ascending Dose (SAD)||0
8912150|NCT02151994|9971306|FG001|NOT COMPLETED|Single Ascending Dose (SAD)||0
8912151|NCT02151994|9971307|FG002|NOT COMPLETED|Single Ascending Dose (SAD)||0
8912152|NCT02151994|9971308|FG003|NOT COMPLETED|Single Ascending Dose (SAD)||0
8912153|NCT02151994|9971309|FG004|NOT COMPLETED|Single Ascending Dose (SAD)||0
8912154|NCT02151994|9971310|FG005|NOT COMPLETED|Single Ascending Dose (SAD)||0
8912155|NCT02151994|9971311|FG006|NOT COMPLETED|Single Ascending Dose (SAD)||0
8912156|NCT02151994|9971312|FG007|NOT COMPLETED|Single Ascending Dose (SAD)||0
8912157|NCT02151994|9971313|FG008|NOT COMPLETED|Single Ascending Dose (SAD)||0
8912158|NCT02151994|9971314|FG009|NOT COMPLETED|Single Ascending Dose (SAD)||0
8912159|NCT02151994|9971315|FG010|NOT COMPLETED|Single Ascending Dose (SAD)||0
8912160|NCT02151994|9971316|FG011|NOT COMPLETED|Single Ascending Dose (SAD)||0
8912161|NCT02151994|9971317|FG012|NOT COMPLETED|Single Ascending Dose (SAD)||0
8912162|NCT02151994|9971305|FG000|STARTED|Multiple Ascending Dose (MAD)||10
8912163|NCT02151994|9971306|FG001|STARTED|Multiple Ascending Dose (MAD)||0
8912164|NCT02151994|9971307|FG002|STARTED|Multiple Ascending Dose (MAD)||0
8912165|NCT02151994|9971308|FG003|STARTED|Multiple Ascending Dose (MAD)||6
8912166|NCT02151994|9971309|FG004|STARTED|Multiple Ascending Dose (MAD)||6
8912167|NCT02151994|9971310|FG005|STARTED|Multiple Ascending Dose (MAD)||6
8912168|NCT02151994|9971311|FG006|STARTED|Multiple Ascending Dose (MAD)||6
8912169|NCT02151994|9971312|FG007|STARTED|Multiple Ascending Dose (MAD)||0
8912170|NCT02151994|9971313|FG008|STARTED|Multiple Ascending Dose (MAD)||6
8912171|NCT02151994|9971314|FG009|STARTED|Multiple Ascending Dose (MAD)||0
8736607|NCT01092728|9784382|FG001|COMPLETED|Overall Study||0
8736608|NCT01092728|9784381|FG000|NOT COMPLETED|Overall Study||4
8736609|NCT01092728|9784382|FG001|NOT COMPLETED|Overall Study||14
8736610|NCT01092767|9784388|FG000|STARTED|Overall Study||50
8736611|NCT01092767|9784388|FG000|COMPLETED|Overall Study||45
8736612|NCT01092767|9784388|FG000|NOT COMPLETED|Overall Study||5
8736613|NCT01092780|9784392|FG000|STARTED|Treatment Period 1||14
8736614|NCT01092780|9784393|FG001|STARTED|Treatment Period 1||15
8736615|NCT01092780|9784394|FG002|STARTED|Treatment Period 1||14
8736616|NCT01092780|9784395|FG003|STARTED|Treatment Period 1||13
8736617|NCT01092780|9784392|FG000|COMPLETED|Treatment Period 1||14
8736618|NCT01092780|9784393|FG001|COMPLETED|Treatment Period 1||15
8736619|NCT01092780|9784394|FG002|COMPLETED|Treatment Period 1||14
8736620|NCT01092780|9784395|FG003|COMPLETED|Treatment Period 1||13
8736621|NCT01092780|9784392|FG000|NOT COMPLETED|Treatment Period 1||0
8736622|NCT01092780|9784393|FG001|NOT COMPLETED|Treatment Period 1||0
8736623|NCT01092780|9784394|FG002|NOT COMPLETED|Treatment Period 1||0
8736624|NCT01092780|9784395|FG003|NOT COMPLETED|Treatment Period 1||0
8736625|NCT01092780|9784392|FG000|STARTED|Washout Period 1||14
8736626|NCT01092780|9784393|FG001|STARTED|Washout Period 1||15
8736627|NCT01092780|9784394|FG002|STARTED|Washout Period 1||14
8736628|NCT01092780|9784395|FG003|STARTED|Washout Period 1||13
8736629|NCT01092780|9784392|FG000|COMPLETED|Washout Period 1||13
8736630|NCT01092780|9784393|FG001|COMPLETED|Washout Period 1||14
8736631|NCT01092780|9784394|FG002|COMPLETED|Washout Period 1||14
8736632|NCT01092780|9784395|FG003|COMPLETED|Washout Period 1||13
8736633|NCT01092780|9784392|FG000|NOT COMPLETED|Washout Period 1||1
8736634|NCT01092780|9784393|FG001|NOT COMPLETED|Washout Period 1||1
8736635|NCT01092780|9784394|FG002|NOT COMPLETED|Washout Period 1||0
8736636|NCT01092780|9784395|FG003|NOT COMPLETED|Washout Period 1||0
8736637|NCT01092780|9784392|FG000|STARTED|Treatment Period 2||13
8736638|NCT01092780|9784393|FG001|STARTED|Treatment Period 2||14
8736639|NCT01092780|9784394|FG002|STARTED|Treatment Period 2||14
8736640|NCT01092780|9784395|FG003|STARTED|Treatment Period 2||13
8736641|NCT01092780|9784392|FG000|COMPLETED|Treatment Period 2||13
8736642|NCT01092780|9784393|FG001|COMPLETED|Treatment Period 2||14
8736643|NCT01092780|9784394|FG002|COMPLETED|Treatment Period 2||14
8736644|NCT01092780|9784395|FG003|COMPLETED|Treatment Period 2||13
8736645|NCT01092780|9784392|FG000|NOT COMPLETED|Treatment Period 2||0
8736646|NCT01092780|9784393|FG001|NOT COMPLETED|Treatment Period 2||0
8736647|NCT01092780|9784394|FG002|NOT COMPLETED|Treatment Period 2||0
8736648|NCT01092780|9784395|FG003|NOT COMPLETED|Treatment Period 2||0
8736649|NCT01092780|9784392|FG000|STARTED|Washout Period 2||13
8736650|NCT01092780|9784393|FG001|STARTED|Washout Period 2||14
8736651|NCT01092780|9784394|FG002|STARTED|Washout Period 2||14
8736652|NCT01092780|9784395|FG003|STARTED|Washout Period 2||13
8736653|NCT01092780|9784392|FG000|COMPLETED|Washout Period 2||13
8736654|NCT01092780|9784393|FG001|COMPLETED|Washout Period 2||13
8736655|NCT01092780|9784394|FG002|COMPLETED|Washout Period 2||13
8736656|NCT01092780|9784395|FG003|COMPLETED|Washout Period 2||13
8736657|NCT01092780|9784392|FG000|NOT COMPLETED|Washout Period 2||0
8736658|NCT01092780|9784393|FG001|NOT COMPLETED|Washout Period 2||1
8736659|NCT01092780|9784394|FG002|NOT COMPLETED|Washout Period 2||1
8736660|NCT01092780|9784395|FG003|NOT COMPLETED|Washout Period 2||0
8736661|NCT01092780|9784392|FG000|STARTED|Treatment Period 3||13
8736662|NCT01092780|9784393|FG001|STARTED|Treatment Period 3||13
8736663|NCT01092780|9784394|FG002|STARTED|Treatment Period 3||13
8736664|NCT01092780|9784395|FG003|STARTED|Treatment Period 3||13
8736665|NCT01092780|9784392|FG000|COMPLETED|Treatment Period 3||13
8736666|NCT01092780|9784393|FG001|COMPLETED|Treatment Period 3||13
8736667|NCT01092780|9784394|FG002|COMPLETED|Treatment Period 3||13
8736668|NCT01092780|9784395|FG003|COMPLETED|Treatment Period 3||13
8736669|NCT01092780|9784392|FG000|NOT COMPLETED|Treatment Period 3||0
8736670|NCT01092780|9784393|FG001|NOT COMPLETED|Treatment Period 3||0
8736671|NCT01092780|9784394|FG002|NOT COMPLETED|Treatment Period 3||0
8736672|NCT01092780|9784395|FG003|NOT COMPLETED|Treatment Period 3||0
8736673|NCT01092780|9784392|FG000|STARTED|Washout Period 3||13
8736674|NCT01092780|9784393|FG001|STARTED|Washout Period 3||13
8736675|NCT01092780|9784394|FG002|STARTED|Washout Period 3||13
8736676|NCT01092780|9784395|FG003|STARTED|Washout Period 3||13
8736677|NCT01092780|9784392|FG000|COMPLETED|Washout Period 3||13
8736678|NCT01092780|9784393|FG001|COMPLETED|Washout Period 3||13
8736679|NCT01092780|9784394|FG002|COMPLETED|Washout Period 3||13
8736680|NCT01092780|9784395|FG003|COMPLETED|Washout Period 3||13
8736681|NCT01092780|9784392|FG000|NOT COMPLETED|Washout Period 3||0
8736682|NCT01092780|9784393|FG001|NOT COMPLETED|Washout Period 3||0
8736683|NCT01092780|9784394|FG002|NOT COMPLETED|Washout Period 3||0
8736684|NCT01092780|9784395|FG003|NOT COMPLETED|Washout Period 3||0
8736685|NCT01092780|9784392|FG000|STARTED|Treatment Period 4||13
8736686|NCT01092780|9784393|FG001|STARTED|Treatment Period 4||13
8736687|NCT01092780|9784394|FG002|STARTED|Treatment Period 4||13
8736688|NCT01092780|9784395|FG003|STARTED|Treatment Period 4||13
8736689|NCT01092780|9784392|FG000|COMPLETED|Treatment Period 4||13
8736690|NCT01092780|9784393|FG001|COMPLETED|Treatment Period 4||13
8736691|NCT01092780|9784394|FG002|COMPLETED|Treatment Period 4||13
8736692|NCT01092780|9784395|FG003|COMPLETED|Treatment Period 4||13
8736693|NCT01092780|9784392|FG000|NOT COMPLETED|Treatment Period 4||0
8736694|NCT01092780|9784393|FG001|NOT COMPLETED|Treatment Period 4||0
8736695|NCT01092780|9784394|FG002|NOT COMPLETED|Treatment Period 4||0
8736696|NCT01092780|9784395|FG003|NOT COMPLETED|Treatment Period 4||0
8736697|NCT01092832|9784407|FG000|STARTED|Overall Study||14
8736698|NCT01092832|9784408|FG001|STARTED|Overall Study||8
8736699|NCT01092832|9784407|FG000|COMPLETED|Overall Study||13
8736700|NCT01092832|9784408|FG001|COMPLETED|Overall Study||8
8736701|NCT01092832|9784407|FG000|NOT COMPLETED|Overall Study||1
8736702|NCT01092832|9784408|FG001|NOT COMPLETED|Overall Study||0
8736703|NCT01092910|9784414|FG000|STARTED|Overall Study||57
8736704|NCT01092910|9784414|FG000|4 Month Follow-up|Overall Study||54
8736705|NCT01092910|9784414|FG000|10 Month Follow-up|Overall Study||52
8736706|NCT01092910|9784414|FG000|COMPLETED|Overall Study||52
8736707|NCT01092910|9784414|FG000|NOT COMPLETED|Overall Study||5
8736708|NCT01092923|9784421|FG000|STARTED|Overall Study||10
8736709|NCT01092923|9784422|FG001|STARTED|Overall Study||10
8736710|NCT01092923|9784421|FG000|COMPLETED|Overall Study||10
8736711|NCT01092923|9784422|FG001|COMPLETED|Overall Study||10
8736712|NCT01092923|9784421|FG000|NOT COMPLETED|Overall Study||0
8736713|NCT01092923|9784422|FG001|NOT COMPLETED|Overall Study||0
8736714|NCT01093014|9784432|FG000|STARTED|Overall Study||12
8736715|NCT01093014|9784433|FG001|STARTED|Overall Study||9
8736716|NCT01093014|9784434|FG002|STARTED|Overall Study||12
8736717|NCT01093014|9784432|FG000|COMPLETED|Overall Study||12
8736718|NCT01093014|9784433|FG001|COMPLETED|Overall Study||9
8736719|NCT01093014|9784434|FG002|COMPLETED|Overall Study||12
8736720|NCT01093014|9784432|FG000|NOT COMPLETED|Overall Study||0
8736721|NCT01093014|9784433|FG001|NOT COMPLETED|Overall Study||0
8736722|NCT01093014|9784434|FG002|NOT COMPLETED|Overall Study||0
8736723|NCT01093027|9784447|FG000|STARTED|Visit 1||10
8736724|NCT01093027|9784448|FG001|STARTED|Visit 1||10
8736725|NCT01093027|9784447|FG000|COMPLETED|Visit 1||10
8736726|NCT01093027|9784448|FG001|COMPLETED|Visit 1||10
8736727|NCT01093027|9784447|FG000|NOT COMPLETED|Visit 1||0
8736728|NCT01093027|9784448|FG001|NOT COMPLETED|Visit 1||0
8736729|NCT01093027|9784447|FG000|STARTED|Visit 2||10
8736730|NCT01093027|9784448|FG001|STARTED|Visit 2||10
8736731|NCT01093027|9784447|FG000|COMPLETED|Visit 2||10
8736732|NCT01093027|9784448|FG001|COMPLETED|Visit 2||10
8736733|NCT01093027|9784447|FG000|NOT COMPLETED|Visit 2||0
8736734|NCT01093027|9784448|FG001|NOT COMPLETED|Visit 2||0
8736735|NCT01093183|9784454|FG000|STARTED|Overall Study||19
8736736|NCT01093183|9784455|FG001|STARTED|Overall Study||6
8736737|NCT01093183|9784454|FG000|COMPLETED|Overall Study||18
8736738|NCT01093183|9784455|FG001|COMPLETED|Overall Study||4
8736739|NCT01093183|9784454|FG000|NOT COMPLETED|Overall Study||1
8736740|NCT01093183|9784455|FG001|NOT COMPLETED|Overall Study||2
8736741|NCT01093222|9784459|FG000|STARTED|Overall Study||40
8736742|NCT01093222|9784459|FG000|Eligible and Began Protocol Therapy|Overall Study||34
8736743|NCT01093222|9784459|FG000|COMPLETED|Overall Study||0
8736744|NCT01093222|9784459|FG000|NOT COMPLETED|Overall Study||40
8736745|NCT01093417|9784465|FG000|STARTED|Overall Study||15
8736746|NCT01093417|9784466|FG001|STARTED|Overall Study||30
8736747|NCT01093417|9784465|FG000|COMPLETED|Overall Study||15
8736748|NCT01093417|9784466|FG001|COMPLETED|Overall Study||29
8736749|NCT01093417|9784465|FG000|NOT COMPLETED|Overall Study||0
8736750|NCT01093417|9784466|FG001|NOT COMPLETED|Overall Study||1
8736751|NCT01093469|9784475|FG000|STARTED|Overall Study||13
8736752|NCT01093469|9784476|FG001|STARTED|Overall Study||13
8736753|NCT01093469|9784477|FG002|STARTED|Overall Study||13
8736754|NCT01093469|9784475|FG000|COMPLETED|Overall Study||13
8736755|NCT01093469|9784476|FG001|COMPLETED|Overall Study||13
8736756|NCT01093469|9784477|FG002|COMPLETED|Overall Study||12
8736757|NCT01093469|9784475|FG000|NOT COMPLETED|Overall Study||0
8736758|NCT01093469|9784476|FG001|NOT COMPLETED|Overall Study||0
8736759|NCT01093469|9784477|FG002|NOT COMPLETED|Overall Study||1
8736760|NCT01093482|9784485|FG000|STARTED|Overall Study||8151
8736761|NCT01093482|9784485|FG000|COMPLETED|Overall Study||8151
8736762|NCT01093482|9784485|FG000|NOT COMPLETED|Overall Study||0
8736763|NCT01093521|9784489|FG000|STARTED|Overall Study||20
8736764|NCT01093521|9784489|FG000|COMPLETED|Overall Study||20
8736765|NCT01093521|9784489|FG000|NOT COMPLETED|Overall Study||0
8736766|NCT01093534|9784498|FG000|STARTED|Overall Study||186
8736767|NCT01093534|9784499|FG001|STARTED|Overall Study||183
8736768|NCT01093534|9784500|FG002|STARTED|Overall Study||178
8736769|NCT01093534|9784498|FG000|Received Study Treatment|Overall Study||186
8736770|NCT01093534|9784499|FG001|Received Study Treatment|Overall Study||182
8736771|NCT01093534|9784500|FG002|Received Study Treatment|Overall Study||175
8736772|NCT01093534|9784498|FG000|COMPLETED|Overall Study||176
8736773|NCT01093534|9784499|FG001|COMPLETED|Overall Study||167
8736774|NCT01093534|9784500|FG002|COMPLETED|Overall Study||169
8736775|NCT01093534|9784498|FG000|NOT COMPLETED|Overall Study||10
8736776|NCT01093534|9784499|FG001|NOT COMPLETED|Overall Study||16
8736777|NCT01093534|9784500|FG002|NOT COMPLETED|Overall Study||9
8736778|NCT01093573|9784512|FG000|STARTED|Overall Study||3
8736779|NCT01093573|9784513|FG001|STARTED|Overall Study||3
8736780|NCT01093573|9784514|FG002|STARTED|Overall Study||28
8736781|NCT01093573|9784512|FG000|COMPLETED|Overall Study||3
8736782|NCT01093573|9784513|FG001|COMPLETED|Overall Study||3
8736783|NCT01093573|9784514|FG002|COMPLETED|Overall Study||26
8736784|NCT01093573|9784512|FG000|NOT COMPLETED|Overall Study||0
8736785|NCT01093573|9784513|FG001|NOT COMPLETED|Overall Study||0
8736786|NCT01093573|9784514|FG002|NOT COMPLETED|Overall Study||2
8736787|NCT01093586|9784525|FG000|STARTED|Overall Study||14
8736788|NCT01093586|9784525|FG000|COMPLETED|Overall Study||11
8736789|NCT01093586|9784525|FG000|NOT COMPLETED|Overall Study||3
8736790|NCT01093599|9784531|FG000|STARTED|Overall Study||91
8736791|NCT01093599|9784532|FG001|STARTED|Overall Study||105
8736792|NCT01093599|9784531|FG000|COMPLETED|Overall Study||59
8736793|NCT01093599|9784532|FG001|COMPLETED|Overall Study||59
8736794|NCT01093599|9784531|FG000|NOT COMPLETED|Overall Study||32
8736795|NCT01093599|9784532|FG001|NOT COMPLETED|Overall Study||46
8736796|NCT01093625|9784540|FG000|STARTED|Baseline and Dispensed||49
8736797|NCT01093625|9784541|FG001|STARTED|Baseline and Dispensed||49
8736798|NCT01093625|9784540|FG000|COMPLETED|Baseline and Dispensed||47
8736799|NCT01093625|9784541|FG001|COMPLETED|Baseline and Dispensed||49
8736800|NCT01093625|9784540|FG000|NOT COMPLETED|Baseline and Dispensed||2
8736801|NCT01093625|9784541|FG001|NOT COMPLETED|Baseline and Dispensed||0
8736802|NCT01093625|9784540|FG000|STARTED|2-Week Visit||47
8736803|NCT01093625|9784541|FG001|STARTED|2-Week Visit||49
8736804|NCT01093625|9784540|FG000|COMPLETED|2-Week Visit||46
8736805|NCT01093625|9784541|FG001|COMPLETED|2-Week Visit||49
8736806|NCT01093625|9784540|FG000|NOT COMPLETED|2-Week Visit||1
8736807|NCT01093625|9784541|FG001|NOT COMPLETED|2-Week Visit||0
8736808|NCT01093625|9784540|FG000|STARTED|1-Month Visit||46
8736809|NCT01093625|9784541|FG001|STARTED|1-Month Visit||49
8736810|NCT01093625|9784540|FG000|COMPLETED|1-Month Visit||44
8736811|NCT01093625|9784541|FG001|COMPLETED|1-Month Visit||49
8736812|NCT01093625|9784540|FG000|NOT COMPLETED|1-Month Visit||2
8736813|NCT01093625|9784541|FG001|NOT COMPLETED|1-Month Visit||0
8736814|NCT01093625|9784540|FG000|STARTED|3-Month Visit||44
8736815|NCT01093625|9784541|FG001|STARTED|3-Month Visit||49
8736816|NCT01093625|9784540|FG000|COMPLETED|3-Month Visit||42
8736817|NCT01093625|9784541|FG001|COMPLETED|3-Month Visit||49
8736818|NCT01093625|9784540|FG000|NOT COMPLETED|3-Month Visit||2
8736819|NCT01093625|9784541|FG001|NOT COMPLETED|3-Month Visit||0
8736820|NCT01093625|9784540|FG000|STARTED|6-Month Visit||42
8736821|NCT01093625|9784541|FG001|STARTED|6-Month Visit||49
8736822|NCT01093625|9784540|FG000|COMPLETED|6-Month Visit||34
8736823|NCT01093625|9784541|FG001|COMPLETED|6-Month Visit||40
8736824|NCT01093625|9784540|FG000|NOT COMPLETED|6-Month Visit||8
8736825|NCT01093625|9784541|FG001|NOT COMPLETED|6-Month Visit||9
8736826|NCT01093625|9784540|FG000|STARTED|1-Year Visit||34
8736827|NCT01093625|9784541|FG001|STARTED|1-Year Visit||40
8736828|NCT01093625|9784540|FG000|COMPLETED|1-Year Visit||29
8736829|NCT01093625|9784541|FG001|COMPLETED|1-Year Visit||37
8736830|NCT01093625|9784540|FG000|NOT COMPLETED|1-Year Visit||5
8736831|NCT01093625|9784541|FG001|NOT COMPLETED|1-Year Visit||3
8736832|NCT01093651|9784549|FG000|STARTED|Overall Study||10
8736833|NCT01093651|9784550|FG001|STARTED|Overall Study||10
8736834|NCT01093651|9784549|FG000|COMPLETED|Overall Study||10
8736835|NCT01093651|9784550|FG001|COMPLETED|Overall Study||10
8736836|NCT01093651|9784549|FG000|NOT COMPLETED|Overall Study||0
8736837|NCT01093651|9784550|FG001|NOT COMPLETED|Overall Study||0
8736838|NCT01093690|9784558|FG000|STARTED|Overall Study||83
8736839|NCT01093690|9784559|FG001|STARTED|Overall Study||79
8736840|NCT01093690|9784558|FG000|COMPLETED|Overall Study||83
8736841|NCT01093690|9784559|FG001|COMPLETED|Overall Study||79
8736842|NCT01093690|9784558|FG000|NOT COMPLETED|Overall Study||0
8736843|NCT01093690|9784559|FG001|NOT COMPLETED|Overall Study||0
8736844|NCT01093755|9784567|FG000|STARTED|Overall Study||16
8736845|NCT01093755|9784568|FG001|STARTED|Overall Study||14
8736846|NCT01093755|9784567|FG000|COMPLETED|Overall Study||13
8736847|NCT01093755|9784568|FG001|COMPLETED|Overall Study||10
8736848|NCT01093755|9784567|FG000|NOT COMPLETED|Overall Study||3
8736849|NCT01093755|9784568|FG001|NOT COMPLETED|Overall Study||4
8736850|NCT01093794|9784574|FG000|STARTED|Treatment Period 1||7
8736851|NCT01093794|9784575|FG001|STARTED|Treatment Period 1||7
8736852|NCT01093794|9784576|FG002|STARTED|Treatment Period 1||7
8736853|NCT01093794|9784577|FG003|STARTED|Treatment Period 1||7
8736854|NCT01093794|9784574|FG000|COMPLETED|Treatment Period 1||7
8736855|NCT01093794|9784575|FG001|COMPLETED|Treatment Period 1||7
8736856|NCT01093794|9784576|FG002|COMPLETED|Treatment Period 1||7
8736857|NCT01093794|9784577|FG003|COMPLETED|Treatment Period 1||7
8736858|NCT01093794|9784574|FG000|NOT COMPLETED|Treatment Period 1||0
8736859|NCT01093794|9784575|FG001|NOT COMPLETED|Treatment Period 1||0
8736860|NCT01093794|9784576|FG002|NOT COMPLETED|Treatment Period 1||0
8736861|NCT01093794|9784577|FG003|NOT COMPLETED|Treatment Period 1||0
8736862|NCT01093794|9784574|FG000|STARTED|Treatment Period 2||7
8736863|NCT01093794|9784575|FG001|STARTED|Treatment Period 2||7
8736864|NCT01093794|9784576|FG002|STARTED|Treatment Period 2|After period 1, one participant was discontinued by the investigator due to a protocol deviation.|6
8736865|NCT01093794|9784577|FG003|STARTED|Treatment Period 2||7
8736866|NCT01093794|9784574|FG000|COMPLETED|Treatment Period 2||7
8736867|NCT01093794|9784575|FG001|COMPLETED|Treatment Period 2||7
8736868|NCT01093794|9784576|FG002|COMPLETED|Treatment Period 2||6
8736869|NCT01093794|9784577|FG003|COMPLETED|Treatment Period 2||7
8736870|NCT01093794|9784574|FG000|NOT COMPLETED|Treatment Period 2||0
8736871|NCT01093794|9784575|FG001|NOT COMPLETED|Treatment Period 2||0
8736872|NCT01093794|9784576|FG002|NOT COMPLETED|Treatment Period 2||0
8736873|NCT01093794|9784577|FG003|NOT COMPLETED|Treatment Period 2||0
8736874|NCT01093794|9784574|FG000|STARTED|Treatment Period 3||7
8736875|NCT01093794|9784575|FG001|STARTED|Treatment Period 3||7
8736876|NCT01093794|9784576|FG002|STARTED|Treatment Period 3||6
8736877|NCT01093794|9784577|FG003|STARTED|Treatment Period 3||7
8736878|NCT01093794|9784574|FG000|COMPLETED|Treatment Period 3||7
8736879|NCT01093794|9784575|FG001|COMPLETED|Treatment Period 3||7
8736880|NCT01093794|9784576|FG002|COMPLETED|Treatment Period 3||6
8736881|NCT01093794|9784577|FG003|COMPLETED|Treatment Period 3||7
8736882|NCT01093794|9784574|FG000|NOT COMPLETED|Treatment Period 3||0
8736883|NCT01093794|9784575|FG001|NOT COMPLETED|Treatment Period 3||0
8736884|NCT01093794|9784576|FG002|NOT COMPLETED|Treatment Period 3||0
8736885|NCT01093794|9784577|FG003|NOT COMPLETED|Treatment Period 3||0
8736886|NCT01093794|9784574|FG000|STARTED|Treatment Period 4||7
8736887|NCT01093794|9784575|FG001|STARTED|Treatment Period 4||7
8736888|NCT01093794|9784576|FG002|STARTED|Treatment Period 4||6
8736889|NCT01093794|9784577|FG003|STARTED|Treatment Period 4||7
8736890|NCT01093794|9784574|FG000|COMPLETED|Treatment Period 4||7
8736891|NCT01093794|9784575|FG001|COMPLETED|Treatment Period 4||7
8736892|NCT01093794|9784576|FG002|COMPLETED|Treatment Period 4||6
8736893|NCT01093794|9784577|FG003|COMPLETED|Treatment Period 4||7
8736894|NCT01093794|9784574|FG000|NOT COMPLETED|Treatment Period 4||0
8736895|NCT01093794|9784575|FG001|NOT COMPLETED|Treatment Period 4||0
8736896|NCT01093794|9784576|FG002|NOT COMPLETED|Treatment Period 4||0
8736897|NCT01093794|9784577|FG003|NOT COMPLETED|Treatment Period 4||0
8736898|NCT01093885|9784587|FG000|STARTED|Overall Study||15
8736899|NCT01093885|9784587|FG000|COMPLETED|Overall Study||10
8736900|NCT01093885|9784587|FG000|NOT COMPLETED|Overall Study||5
8736901|NCT01093976|9784592|FG000|STARTED|Overall Study||14
8736902|NCT01093976|9784592|FG000|COMPLETED|Overall Study||14
8736903|NCT01093976|9784592|FG000|NOT COMPLETED|Overall Study||0
8736904|NCT01094106|9784598|FG000|STARTED|Overall Study||33
8736905|NCT01094106|9784599|FG001|STARTED|Overall Study||34
8736906|NCT01094106|9784598|FG000|COMPLETED|Overall Study||33
8736907|NCT01094106|9784599|FG001|COMPLETED|Overall Study||34
8736908|NCT01094106|9784598|FG000|NOT COMPLETED|Overall Study||0
8736909|NCT01094106|9784599|FG001|NOT COMPLETED|Overall Study||0
8736910|NCT01094119|9784607|FG000|STARTED|Overall Study||34
8736911|NCT01094119|9784608|FG001|STARTED|Overall Study||36
8736912|NCT01094119|9784607|FG000|COMPLETED|Overall Study||32
8736913|NCT01094119|9784608|FG001|COMPLETED|Overall Study||32
8736914|NCT01094119|9784607|FG000|NOT COMPLETED|Overall Study||2
8736915|NCT01094119|9784608|FG001|NOT COMPLETED|Overall Study||4
8736916|NCT01094171|9784614|FG000|STARTED|Overall Study||400
8736917|NCT01094171|9784614|FG000|COMPLETED|Overall Study||390
8736918|NCT01094171|9784614|FG000|NOT COMPLETED|Overall Study||10
8736919|NCT01094184|9784620|FG000|STARTED|Overall Study||36
8736920|NCT01094184|9784621|FG001|STARTED|Overall Study||13
8736921|NCT01094184|9784620|FG000|COMPLETED|Overall Study||1
8736922|NCT01094184|9784621|FG001|COMPLETED|Overall Study||2
8736923|NCT01094184|9784620|FG000|NOT COMPLETED|Overall Study||35
8736924|NCT01094184|9784621|FG001|NOT COMPLETED|Overall Study||11
8736925|NCT01094288|9784635|FG000|STARTED|Overall Study||6
8736926|NCT01094288|9784636|FG001|STARTED|Overall Study||15
8736927|NCT01094288|9784637|FG002|STARTED|Overall Study||5
8736928|NCT01094288|9784638|FG003|STARTED|Overall Study||3
8736929|NCT01094288|9784639|FG004|STARTED|Overall Study||2
8736930|NCT01094288|9784640|FG005|STARTED|Overall Study||4
8736931|NCT01094288|9784641|FG006|STARTED|Overall Study||2
8736932|NCT01094288|9784642|FG007|STARTED|Overall Study||4
8736933|NCT01094288|9784635|FG000|COMPLETED|Overall Study|Completed=Completed Treatment|4
8736934|NCT01094288|9784636|FG001|COMPLETED|Overall Study||5
8736935|NCT01094288|9784637|FG002|COMPLETED|Overall Study||1
8736936|NCT01094288|9784638|FG003|COMPLETED|Overall Study||1
8736937|NCT01094288|9784639|FG004|COMPLETED|Overall Study||2
8736938|NCT01094288|9784640|FG005|COMPLETED|Overall Study||4
8736939|NCT01094288|9784641|FG006|COMPLETED|Overall Study||2
8736940|NCT01094288|9784642|FG007|COMPLETED|Overall Study||2
8736941|NCT01094288|9784635|FG000|NOT COMPLETED|Overall Study||2
8736942|NCT01094288|9784636|FG001|NOT COMPLETED|Overall Study||10
8736943|NCT01094288|9784637|FG002|NOT COMPLETED|Overall Study||4
8736944|NCT01094288|9784638|FG003|NOT COMPLETED|Overall Study||2
8736945|NCT01094288|9784639|FG004|NOT COMPLETED|Overall Study||0
8736946|NCT01094288|9784640|FG005|NOT COMPLETED|Overall Study||0
8736947|NCT01094288|9784641|FG006|NOT COMPLETED|Overall Study||0
8736948|NCT01094288|9784642|FG007|NOT COMPLETED|Overall Study||2
8736949|NCT01094301|9784664|FG000|STARTED|Trial Stage||28
8736950|NCT01094301|9784664|FG000|Subjects Who Received Smartpatch Lead|Trial Stage||28
8736951|NCT01094301|9784664|FG000|COMPLETED|Trial Stage||27
8736952|NCT01094301|9784664|FG000|NOT COMPLETED|Trial Stage||1
8736953|NCT01094301|9784664|FG000|STARTED|Implant Stage||13
8736954|NCT01094301|9784664|FG000|Met Criteria for Implant Stage|Implant Stage||7
8736955|NCT01094301|9784664|FG000|Subjects Who Received SPR IPG|Implant Stage||5
8736956|NCT01094301|9784664|FG000|COMPLETED|Implant Stage||5
8736957|NCT01094301|9784664|FG000|NOT COMPLETED|Implant Stage||8
8736958|NCT01094522|9784672|FG000|STARTED|Overall Study||20
8736959|NCT01094522|9784673|FG001|STARTED|Overall Study||20
8736960|NCT01094522|9784672|FG000|COMPLETED|Overall Study||20
8736961|NCT01094522|9784673|FG001|COMPLETED|Overall Study||20
8736962|NCT01094522|9784672|FG000|NOT COMPLETED|Overall Study||0
8736963|NCT01094522|9784673|FG001|NOT COMPLETED|Overall Study||0
8736964|NCT01094548|9784682|FG000|STARTED|Overall Study||17
8736965|NCT01094548|9784683|FG001|STARTED|Overall Study||17
8736966|NCT01094548|9784682|FG000|COMPLETED|Overall Study||17
8736967|NCT01094548|9784683|FG001|COMPLETED|Overall Study||17
8736968|NCT01094548|9784682|FG000|NOT COMPLETED|Overall Study||0
8736969|NCT01094548|9784683|FG001|NOT COMPLETED|Overall Study||0
8736970|NCT01094574|9784697|FG000|STARTED|Overall Study||1
8736971|NCT01094574|9784698|FG001|STARTED|Overall Study||1
8736972|NCT01094574|9784699|FG002|STARTED|Overall Study||2
8736973|NCT01094574|9784700|FG003|STARTED|Overall Study||2
8736974|NCT01094574|9784701|FG004|STARTED|Overall Study||2
8736975|NCT01094574|9784702|FG005|STARTED|Overall Study||2
8736976|NCT01094574|9784697|FG000|COMPLETED|Overall Study||1
8736977|NCT01094574|9784698|FG001|COMPLETED|Overall Study||1
8736978|NCT01094574|9784699|FG002|COMPLETED|Overall Study||2
8736979|NCT01094574|9784700|FG003|COMPLETED|Overall Study||2
8736980|NCT01094574|9784701|FG004|COMPLETED|Overall Study||2
8736981|NCT01094574|9784702|FG005|COMPLETED|Overall Study||2
8736982|NCT01094574|9784697|FG000|NOT COMPLETED|Overall Study||0
8736983|NCT01094574|9784698|FG001|NOT COMPLETED|Overall Study||0
8736984|NCT01094574|9784699|FG002|NOT COMPLETED|Overall Study||0
8736985|NCT01094574|9784700|FG003|NOT COMPLETED|Overall Study||0
8736986|NCT01094574|9784701|FG004|NOT COMPLETED|Overall Study||0
8736987|NCT01094574|9784702|FG005|NOT COMPLETED|Overall Study||0
8736988|NCT01094704|9784715|FG000|STARTED|Overall Study||8
8736989|NCT01094704|9784716|FG001|STARTED|Overall Study||8
8736990|NCT01094704|9784715|FG000|COMPLETED|Overall Study||8
8736991|NCT01094704|9784716|FG001|COMPLETED|Overall Study||8
8736992|NCT01094704|9784715|FG000|NOT COMPLETED|Overall Study||0
8736993|NCT01094704|9784716|FG001|NOT COMPLETED|Overall Study||0
8736994|NCT01094717|9784724|FG000|STARTED|Overall Study||3
8736995|NCT01094717|9784725|FG001|STARTED|Overall Study||10
8736996|NCT01094717|9784724|FG000|COMPLETED|Overall Study||3
8736997|NCT01094717|9784725|FG001|COMPLETED|Overall Study||10
8736998|NCT01094717|9784724|FG000|NOT COMPLETED|Overall Study||0
8736999|NCT01094717|9784725|FG001|NOT COMPLETED|Overall Study||0
8737000|NCT01094730|9784741|FG000|STARTED|Period 1 (14 Days)||92
8737001|NCT01094730|9784742|FG001|STARTED|Period 1 (14 Days)||88
8737002|NCT01094730|9784741|FG000|COMPLETED|Period 1 (14 Days)||90
8737003|NCT01094730|9784742|FG001|COMPLETED|Period 1 (14 Days)||86
8737004|NCT01094730|9784741|FG000|NOT COMPLETED|Period 1 (14 Days)||2
8737005|NCT01094730|9784742|FG001|NOT COMPLETED|Period 1 (14 Days)||2
8737006|NCT01094730|9784741|FG000|STARTED|Period 2 (14 Days)||90
8737007|NCT01094730|9784742|FG001|STARTED|Period 2 (14 Days)||86
8737008|NCT01094730|9784741|FG000|COMPLETED|Period 2 (14 Days)||87
8737009|NCT01094730|9784742|FG001|COMPLETED|Period 2 (14 Days)||84
8737010|NCT01094730|9784741|FG000|NOT COMPLETED|Period 2 (14 Days)||3
8737011|NCT01094730|9784742|FG001|NOT COMPLETED|Period 2 (14 Days)||2
8737012|NCT01094743|9784749|FG000|STARTED|Period 1||52
8737013|NCT01094743|9784749|FG000|COMPLETED|Period 1||50
8737014|NCT01094743|9784749|FG000|NOT COMPLETED|Period 1||2
8737015|NCT01094743|9784749|FG000|STARTED|Period 2||50
8737016|NCT01094743|9784749|FG000|COMPLETED|Period 2||50
8737017|NCT01094743|9784749|FG000|NOT COMPLETED|Period 2||0
8737018|NCT01094808|9784757|FG000|STARTED|Overall Study||21
8737019|NCT01094808|9784758|FG001|STARTED|Overall Study||20
8737020|NCT01094808|9784759|FG002|STARTED|Overall Study||21
8737021|NCT01094808|9784757|FG000|COMPLETED|Overall Study||20
8737022|NCT01094808|9784758|FG001|COMPLETED|Overall Study||19
8737023|NCT01094808|9784759|FG002|COMPLETED|Overall Study||21
8737024|NCT01094808|9784757|FG000|NOT COMPLETED|Overall Study||1
8737025|NCT01094808|9784758|FG001|NOT COMPLETED|Overall Study||1
8737026|NCT01094808|9784759|FG002|NOT COMPLETED|Overall Study||0
8737027|NCT01094886|9784767|FG000|STARTED|Overall Study||53
8737028|NCT01094886|9784767|FG000|COMPLETED|Overall Study||46
8737029|NCT01094886|9784767|FG000|NOT COMPLETED|Overall Study||7
8737030|NCT01095094|9784771|FG000|STARTED|Overall Study||19
8737031|NCT01095094|9784771|FG000|COMPLETED|Overall Study||16
8737032|NCT01095094|9784771|FG000|NOT COMPLETED|Overall Study||3
8737033|NCT01095497|9784777|FG000|STARTED|Intravenous CINRYZE||14
8737034|NCT01095497|9784778|FG001|STARTED|Intravenous CINRYZE||12
8737035|NCT01095497|9784777|FG000|COMPLETED|Intravenous CINRYZE||13
8737036|NCT01095497|9784778|FG001|COMPLETED|Intravenous CINRYZE||12
8737037|NCT01095497|9784777|FG000|NOT COMPLETED|Intravenous CINRYZE||1
8737038|NCT01095497|9784778|FG001|NOT COMPLETED|Intravenous CINRYZE||0
8737039|NCT01095497|9784777|FG000|STARTED|Subcutaneous CINRYZE||13
8737040|NCT01095497|9784778|FG001|STARTED|Subcutaneous CINRYZE||12
8737041|NCT01095497|9784777|FG000|COMPLETED|Subcutaneous CINRYZE||12
8737042|NCT01095497|9784778|FG001|COMPLETED|Subcutaneous CINRYZE||12
8737043|NCT01095497|9784777|FG000|NOT COMPLETED|Subcutaneous CINRYZE||1
8737044|NCT01095497|9784778|FG001|NOT COMPLETED|Subcutaneous CINRYZE||0
8737045|NCT01095510|9784792|FG000|STARTED|Overall Study||3
8737046|NCT01095510|9784793|FG001|STARTED|Overall Study||0
8912172|NCT02151994|9971315|FG010|STARTED|Multiple Ascending Dose (MAD)||0
8912173|NCT02151994|9971316|FG011|STARTED|Multiple Ascending Dose (MAD)||0
8912174|NCT02151994|9971317|FG012|STARTED|Multiple Ascending Dose (MAD)||0
9022491|NCT03127956|10085404|FG000|STARTED|Overall Study||748
9022492|NCT03127956|10085404|FG000|COMPLETED|Overall Study||431
8737047|NCT01095510|9784794|FG002|STARTED|Overall Study||3
8737048|NCT01095510|9784795|FG003|STARTED|Overall Study||3
8737049|NCT01095510|9784792|FG000|COMPLETED|Overall Study||3
8737050|NCT01095510|9784793|FG001|COMPLETED|Overall Study||0
8737051|NCT01095510|9784794|FG002|COMPLETED|Overall Study||3
8737052|NCT01095510|9784795|FG003|COMPLETED|Overall Study||3
8737053|NCT01095510|9784792|FG000|NOT COMPLETED|Overall Study||0
8737054|NCT01095510|9784793|FG001|NOT COMPLETED|Overall Study||0
8737055|NCT01095510|9784794|FG002|NOT COMPLETED|Overall Study||0
8737056|NCT01095510|9784795|FG003|NOT COMPLETED|Overall Study||0
8737057|NCT01095653|9784806|FG000|STARTED|Overall Study||132
8737058|NCT01095653|9784807|FG001|STARTED|Overall Study||128
8737059|NCT01095653|9784808|FG002|STARTED|Overall Study||133
8737060|NCT01095653|9784806|FG000|COMPLETED|Overall Study||113
8737061|NCT01095653|9784807|FG001|COMPLETED|Overall Study||113
8737062|NCT01095653|9784808|FG002|COMPLETED|Overall Study||117
8737063|NCT01095653|9784806|FG000|NOT COMPLETED|Overall Study||19
8737064|NCT01095653|9784807|FG001|NOT COMPLETED|Overall Study||15
8737065|NCT01095653|9784808|FG002|NOT COMPLETED|Overall Study||16
8737066|NCT01095666|9784819|FG000|STARTED|Overall Study||145
8737067|NCT01095666|9784820|FG001|STARTED|Overall Study||147
8737068|NCT01095666|9784821|FG002|STARTED|Overall Study||152
8737069|NCT01095666|9784819|FG000|COMPLETED|Overall Study||128
8737070|NCT01095666|9784820|FG001|COMPLETED|Overall Study||136
8737071|NCT01095666|9784821|FG002|COMPLETED|Overall Study||145
8737072|NCT01095666|9784819|FG000|NOT COMPLETED|Overall Study||17
8737073|NCT01095666|9784820|FG001|NOT COMPLETED|Overall Study||11
8737074|NCT01095666|9784821|FG002|NOT COMPLETED|Overall Study||7
8737075|NCT01095757|9784829|FG000|STARTED|Overall Study||45
8737076|NCT01095757|9784829|FG000|COMPLETED|Overall Study||45
8737077|NCT01095757|9784829|FG000|NOT COMPLETED|Overall Study||0
8737078|NCT01095796|9784836|FG000|STARTED|Overall Study||353
8737079|NCT01095796|9784837|FG001|STARTED|Overall Study||354
8737080|NCT01095796|9784836|FG000|COMPLETED|Overall Study||58
8737081|NCT01095796|9784837|FG001|COMPLETED|Overall Study||65
8737082|NCT01095796|9784836|FG000|NOT COMPLETED|Overall Study||295
8737083|NCT01095796|9784837|FG001|NOT COMPLETED|Overall Study||289
8737084|NCT01095835|9784846|FG000|STARTED|Overall Study||51
8737085|NCT01095835|9784847|FG001|STARTED|Overall Study||52
8737086|NCT01095835|9784848|FG002|STARTED|Overall Study||25
8737087|NCT01095835|9784846|FG000|COMPLETED|Overall Study||41
8737088|NCT01095835|9784847|FG001|COMPLETED|Overall Study||40
8737089|NCT01095835|9784848|FG002|COMPLETED|Overall Study||17
8737090|NCT01095835|9784846|FG000|NOT COMPLETED|Overall Study||10
8737091|NCT01095835|9784847|FG001|NOT COMPLETED|Overall Study||12
8737092|NCT01095835|9784848|FG002|NOT COMPLETED|Overall Study||8
8737093|NCT01095887|9784857|FG000|STARTED|Overall Study||6
8737094|NCT01095887|9784857|FG000|COMPLETED|Overall Study||6
8737095|NCT01095887|9784857|FG000|NOT COMPLETED|Overall Study||0
8737096|NCT01095978|9784861|FG000|STARTED|Overall Study||2822
8737097|NCT01095978|9784861|FG000|COMPLETED|Overall Study||2819
8737098|NCT01095978|9784861|FG000|NOT COMPLETED|Overall Study||3
8737099|NCT01096017|9784867|FG000|STARTED|Treatment Period 1||12
8737100|NCT01096017|9784868|FG001|STARTED|Treatment Period 1||12
8912175|NCT02151994|9971305|FG000|COMPLETED|Multiple Ascending Dose (MAD)||10
8912176|NCT02151994|9971306|FG001|COMPLETED|Multiple Ascending Dose (MAD)||0
8912177|NCT02151994|9971307|FG002|COMPLETED|Multiple Ascending Dose (MAD)||0
8912178|NCT02151994|9971308|FG003|COMPLETED|Multiple Ascending Dose (MAD)||6
8912179|NCT02151994|9971309|FG004|COMPLETED|Multiple Ascending Dose (MAD)||6
8912180|NCT02151994|9971310|FG005|COMPLETED|Multiple Ascending Dose (MAD)||6
8912181|NCT02151994|9971311|FG006|COMPLETED|Multiple Ascending Dose (MAD)||6
8912182|NCT02151994|9971312|FG007|COMPLETED|Multiple Ascending Dose (MAD)||0
8912183|NCT02151994|9971313|FG008|COMPLETED|Multiple Ascending Dose (MAD)||6
8912184|NCT02151994|9971314|FG009|COMPLETED|Multiple Ascending Dose (MAD)||0
8912185|NCT02151994|9971315|FG010|COMPLETED|Multiple Ascending Dose (MAD)||0
8912186|NCT02151994|9971316|FG011|COMPLETED|Multiple Ascending Dose (MAD)||0
8912187|NCT02151994|9971317|FG012|COMPLETED|Multiple Ascending Dose (MAD)||0
8912188|NCT02151994|9971305|FG000|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
8912189|NCT02151994|9971306|FG001|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
8912190|NCT02151994|9971307|FG002|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
8912191|NCT02151994|9971308|FG003|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
8912192|NCT02151994|9971309|FG004|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
8912193|NCT02151994|9971310|FG005|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
8912194|NCT02151994|9971311|FG006|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
8912195|NCT02151994|9971312|FG007|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
8912196|NCT02151994|9971313|FG008|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
8912197|NCT02151994|9971314|FG009|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
8912198|NCT02151994|9971315|FG010|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
8912199|NCT02151994|9971316|FG011|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
8912200|NCT02151994|9971317|FG012|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
9022493|NCT03127956|10085404|FG000|NOT COMPLETED|Overall Study||317
9022494|NCT03128008|10085408|FG000|STARTED|Overall Study||10
9022495|NCT03128008|10085408|FG000|COMPLETED|Overall Study|9 participants are in follow up|1
9022496|NCT03128008|10085408|FG000|NOT COMPLETED|Overall Study||9
9022497|NCT03128086|10085415|FG000|STARTED|Overall Study||50
9022498|NCT03128086|10085416|FG001|STARTED|Overall Study||44
9022499|NCT03128086|10085415|FG000|COMPLETED|Overall Study||50
9022500|NCT03128086|10085416|FG001|COMPLETED|Overall Study||44
9022501|NCT03128086|10085415|FG000|NOT COMPLETED|Overall Study||0
9022502|NCT03128086|10085416|FG001|NOT COMPLETED|Overall Study||0
9022503|NCT03128099|10085425|FG000|STARTED|Overall Study||21
9022504|NCT03128099|10085426|FG001|STARTED|Overall Study||4
9022505|NCT03128099|10085427|FG002|STARTED|Overall Study||22
9022506|NCT03128099|10085425|FG000|Hour 1 (Low Dose) Started|Overall Study||21
9022507|NCT03128099|10085426|FG001|Hour 1 (Low Dose) Started|Overall Study||4
8737101|NCT01096017|9784867|FG000|COMPLETED|Treatment Period 1||12
8737102|NCT01096017|9784868|FG001|COMPLETED|Treatment Period 1||12
8737103|NCT01096017|9784867|FG000|NOT COMPLETED|Treatment Period 1||0
8737104|NCT01096017|9784868|FG001|NOT COMPLETED|Treatment Period 1||0
8737105|NCT01096017|9784867|FG000|STARTED|Washout 1 - 14 Days||12
8737106|NCT01096017|9784868|FG001|STARTED|Washout 1 - 14 Days||12
8737107|NCT01096017|9784867|FG000|COMPLETED|Washout 1 - 14 Days||12
8737108|NCT01096017|9784868|FG001|COMPLETED|Washout 1 - 14 Days||12
8737109|NCT01096017|9784867|FG000|NOT COMPLETED|Washout 1 - 14 Days||0
8737110|NCT01096017|9784868|FG001|NOT COMPLETED|Washout 1 - 14 Days||0
8737111|NCT01096017|9784867|FG000|STARTED|Treatment Period 2||12
8737112|NCT01096017|9784868|FG001|STARTED|Treatment Period 2||12
8737113|NCT01096017|9784867|FG000|COMPLETED|Treatment Period 2||11
8737114|NCT01096017|9784868|FG001|COMPLETED|Treatment Period 2||11
8737115|NCT01096017|9784867|FG000|NOT COMPLETED|Treatment Period 2||1
8737116|NCT01096017|9784868|FG001|NOT COMPLETED|Treatment Period 2||1
8737117|NCT01096056|9784876|FG000|STARTED|Overall Study||20
8737118|NCT01096056|9784877|FG001|STARTED|Overall Study||20
8737119|NCT01096056|9784876|FG000|Completed at Day 42|Overall Study||20
8737120|NCT01096056|9784877|FG001|Completed at Day 42|Overall Study||20
8737121|NCT01096056|9784876|FG000|COMPLETED|Overall Study||20
8737122|NCT01096056|9784877|FG001|COMPLETED|Overall Study||19
8737123|NCT01096056|9784876|FG000|NOT COMPLETED|Overall Study||0
8737124|NCT01096056|9784877|FG001|NOT COMPLETED|Overall Study||1
8737125|NCT01096160|9784893|FG000|STARTED|Overall Study||6
8737126|NCT01096160|9784894|FG001|STARTED|Overall Study||2
8737127|NCT01096160|9784895|FG002|STARTED|Overall Study||6
8737128|NCT01096160|9784896|FG003|STARTED|Overall Study||2
8737129|NCT01096160|9784897|FG004|STARTED|Overall Study||6
8737130|NCT01096160|9784898|FG005|STARTED|Overall Study||2
8737131|NCT01096160|9784899|FG006|STARTED|Overall Study||6
8737132|NCT01096160|9784900|FG007|STARTED|Overall Study||2
8737133|NCT01096160|9784901|FG008|STARTED|Overall Study||6
8737134|NCT01096160|9784902|FG009|STARTED|Overall Study||2
8737135|NCT01096160|9784893|FG000|COMPLETED|Overall Study||6
8737136|NCT01096160|9784894|FG001|COMPLETED|Overall Study||2
8737137|NCT01096160|9784895|FG002|COMPLETED|Overall Study||5
8737138|NCT01096160|9784896|FG003|COMPLETED|Overall Study||2
8737139|NCT01096160|9784897|FG004|COMPLETED|Overall Study||5
8737140|NCT01096160|9784898|FG005|COMPLETED|Overall Study||2
8737141|NCT01096160|9784899|FG006|COMPLETED|Overall Study||4
8737142|NCT01096160|9784900|FG007|COMPLETED|Overall Study||2
8737143|NCT01096160|9784901|FG008|COMPLETED|Overall Study||4
8737144|NCT01096160|9784902|FG009|COMPLETED|Overall Study||1
8737145|NCT01096160|9784893|FG000|NOT COMPLETED|Overall Study||0
8737146|NCT01096160|9784894|FG001|NOT COMPLETED|Overall Study||0
8912201|NCT02151994|9971305|FG000|STARTED|Food Effect (FE): Fasted||0
8912202|NCT02151994|9971306|FG001|STARTED|Food Effect (FE): Fasted||0
8737147|NCT01096160|9784895|FG002|NOT COMPLETED|Overall Study||1
8737148|NCT01096160|9784896|FG003|NOT COMPLETED|Overall Study||0
8737149|NCT01096160|9784897|FG004|NOT COMPLETED|Overall Study||1
8737150|NCT01096160|9784898|FG005|NOT COMPLETED|Overall Study||0
8737151|NCT01096160|9784899|FG006|NOT COMPLETED|Overall Study||2
8737152|NCT01096160|9784900|FG007|NOT COMPLETED|Overall Study||0
8737153|NCT01096160|9784901|FG008|NOT COMPLETED|Overall Study||2
8737154|NCT01096160|9784902|FG009|NOT COMPLETED|Overall Study||1
8737155|NCT01096186|9784937|FG000|STARTED|Overall Study||617
8737156|NCT01096186|9784937|FG000|COMPLETED|Overall Study||567
8737157|NCT01096186|9784937|FG000|NOT COMPLETED|Overall Study||50
8737158|NCT01096290|9784943|FG000|STARTED|Overall Study||9
8737159|NCT01096290|9784944|FG001|STARTED|Overall Study||14
8737160|NCT01096290|9784943|FG000|COMPLETED|Overall Study||9
8737161|NCT01096290|9784944|FG001|COMPLETED|Overall Study||14
8737162|NCT01096290|9784943|FG000|NOT COMPLETED|Overall Study||0
8737163|NCT01096290|9784944|FG001|NOT COMPLETED|Overall Study||0
8737164|NCT01096316|9784952|FG000|STARTED|Overall Study||102
8737165|NCT01096316|9784953|FG001|STARTED|Overall Study||103
8737166|NCT01096316|9784952|FG000|COMPLETED|Overall Study||87
8737167|NCT01096316|9784953|FG001|COMPLETED|Overall Study||94
8737168|NCT01096316|9784952|FG000|NOT COMPLETED|Overall Study||15
8737169|NCT01096316|9784953|FG001|NOT COMPLETED|Overall Study||9
8737170|NCT01096342|9784959|FG000|STARTED|Overall Study||16
8737171|NCT01096342|9784959|FG000|COMPLETED|Overall Study||15
8737172|NCT01096342|9784959|FG000|NOT COMPLETED|Overall Study||1
8737173|NCT01096446|9784965|FG000|STARTED|Overall Study||12
8737174|NCT01096446|9784966|FG001|STARTED|Overall Study||10
8737175|NCT01096446|9784965|FG000|COMPLETED|Overall Study|One infant was SGA; one infant had a congenital anomaly; and one discontinued medical management|9
8737176|NCT01096446|9784966|FG001|COMPLETED|Overall Study||10
8737177|NCT01096446|9784965|FG000|NOT COMPLETED|Overall Study||3
8737178|NCT01096446|9784966|FG001|NOT COMPLETED|Overall Study||0
8737179|NCT01096550|9784973|FG000|STARTED|Overall Study||170
8737180|NCT01096550|9784974|FG001|STARTED|Overall Study||175
8737181|NCT01096550|9784973|FG000|COMPLETED|Overall Study||133
8737182|NCT01096550|9784974|FG001|COMPLETED|Overall Study||146
8737183|NCT01096550|9784973|FG000|NOT COMPLETED|Overall Study||37
8737184|NCT01096550|9784974|FG001|NOT COMPLETED|Overall Study||29
8737185|NCT01096589|9784984|FG000|STARTED|Overall Study||22
8737186|NCT01096589|9784985|FG001|STARTED|Overall Study||20
8737187|NCT01096589|9784986|FG002|STARTED|Overall Study||22
8737188|NCT01096589|9784987|FG003|STARTED|Overall Study||18
8912203|NCT02151994|9971307|FG002|STARTED|Food Effect (FE): Fasted||0
8737189|NCT01096589|9784984|FG000|COMPLETED|Overall Study||18
8737190|NCT01096589|9784985|FG001|COMPLETED|Overall Study||18
8737191|NCT01096589|9784986|FG002|COMPLETED|Overall Study||18
8737192|NCT01096589|9784987|FG003|COMPLETED|Overall Study||15
8737193|NCT01096589|9784984|FG000|NOT COMPLETED|Overall Study||4
8737194|NCT01096589|9784985|FG001|NOT COMPLETED|Overall Study||2
8737195|NCT01096589|9784986|FG002|NOT COMPLETED|Overall Study||4
8737196|NCT01096589|9784987|FG003|NOT COMPLETED|Overall Study||3
8737197|NCT01096667|9785006|FG000|STARTED|Overall Study||39
8737198|NCT01096667|9785007|FG001|STARTED|Overall Study||39
8737199|NCT01096667|9785008|FG002|STARTED|Overall Study||38
8737200|NCT01096667|9785009|FG003|STARTED|Overall Study||39
8737201|NCT01096667|9785010|FG004|STARTED|Overall Study||39
8737202|NCT01096667|9785006|FG000|Treated|Overall Study||38
8737203|NCT01096667|9785007|FG001|Treated|Overall Study||39
8737204|NCT01096667|9785008|FG002|Treated|Overall Study||38
8737205|NCT01096667|9785009|FG003|Treated|Overall Study||39
8737206|NCT01096667|9785010|FG004|Treated|Overall Study||39
8737207|NCT01096667|9785006|FG000|COMPLETED|Overall Study||36
8737208|NCT01096667|9785007|FG001|COMPLETED|Overall Study||37
8737209|NCT01096667|9785008|FG002|COMPLETED|Overall Study||36
8737210|NCT01096667|9785009|FG003|COMPLETED|Overall Study||36
8737211|NCT01096667|9785010|FG004|COMPLETED|Overall Study||39
8737212|NCT01096667|9785006|FG000|NOT COMPLETED|Overall Study||3
8737213|NCT01096667|9785007|FG001|NOT COMPLETED|Overall Study||2
8737214|NCT01096667|9785008|FG002|NOT COMPLETED|Overall Study||2
8737215|NCT01096667|9785009|FG003|NOT COMPLETED|Overall Study||3
8737216|NCT01096667|9785010|FG004|NOT COMPLETED|Overall Study||0
8737217|NCT01096680|9785028|FG000|STARTED|Overall Study||27
8737218|NCT01096680|9785029|FG001|STARTED|Overall Study||27
8737219|NCT01096680|9785030|FG002|STARTED|Overall Study||27
8737220|NCT01096680|9785031|FG003|STARTED|Overall Study||27
8912204|NCT02151994|9971308|FG003|STARTED|Food Effect (FE): Fasted||0
8912205|NCT02151994|9971309|FG004|STARTED|Food Effect (FE): Fasted||0
8912206|NCT02151994|9971310|FG005|STARTED|Food Effect (FE): Fasted||0
8912207|NCT02151994|9971311|FG006|STARTED|Food Effect (FE): Fasted||0
8912208|NCT02151994|9971312|FG007|STARTED|Food Effect (FE): Fasted||0
8912209|NCT02151994|9971313|FG008|STARTED|Food Effect (FE): Fasted||0
8912210|NCT02151994|9971314|FG009|STARTED|Food Effect (FE): Fasted||0
8912211|NCT02151994|9971315|FG010|STARTED|Food Effect (FE): Fasted||0
8912212|NCT02151994|9971316|FG011|STARTED|Food Effect (FE): Fasted||12
8912213|NCT02151994|9971317|FG012|STARTED|Food Effect (FE): Fasted||0
8912214|NCT02151994|9971305|FG000|COMPLETED|Food Effect (FE): Fasted||0
8912215|NCT02151994|9971306|FG001|COMPLETED|Food Effect (FE): Fasted||0
8912216|NCT02151994|9971307|FG002|COMPLETED|Food Effect (FE): Fasted||0
8912217|NCT02151994|9971308|FG003|COMPLETED|Food Effect (FE): Fasted||0
8912218|NCT02151994|9971309|FG004|COMPLETED|Food Effect (FE): Fasted||0
8912219|NCT02151994|9971310|FG005|COMPLETED|Food Effect (FE): Fasted||0
8912220|NCT02151994|9971311|FG006|COMPLETED|Food Effect (FE): Fasted||0
8912221|NCT02151994|9971312|FG007|COMPLETED|Food Effect (FE): Fasted||0
8912222|NCT02151994|9971313|FG008|COMPLETED|Food Effect (FE): Fasted||0
8912223|NCT02151994|9971314|FG009|COMPLETED|Food Effect (FE): Fasted||0
8912224|NCT02151994|9971315|FG010|COMPLETED|Food Effect (FE): Fasted||0
8912225|NCT02151994|9971316|FG011|COMPLETED|Food Effect (FE): Fasted||12
8912226|NCT02151994|9971317|FG012|COMPLETED|Food Effect (FE): Fasted||0
8912227|NCT02151994|9971305|FG000|NOT COMPLETED|Food Effect (FE): Fasted||0
8912228|NCT02151994|9971306|FG001|NOT COMPLETED|Food Effect (FE): Fasted||0
8912229|NCT02151994|9971307|FG002|NOT COMPLETED|Food Effect (FE): Fasted||0
8912230|NCT02151994|9971308|FG003|NOT COMPLETED|Food Effect (FE): Fasted||0
8912231|NCT02151994|9971309|FG004|NOT COMPLETED|Food Effect (FE): Fasted||0
8912232|NCT02151994|9971310|FG005|NOT COMPLETED|Food Effect (FE): Fasted||0
8912233|NCT02151994|9971311|FG006|NOT COMPLETED|Food Effect (FE): Fasted||0
8912234|NCT02151994|9971312|FG007|NOT COMPLETED|Food Effect (FE): Fasted||0
8912235|NCT02151994|9971313|FG008|NOT COMPLETED|Food Effect (FE): Fasted||0
8912236|NCT02151994|9971314|FG009|NOT COMPLETED|Food Effect (FE): Fasted||0
8912237|NCT02151994|9971315|FG010|NOT COMPLETED|Food Effect (FE): Fasted||0
8912238|NCT02151994|9971316|FG011|NOT COMPLETED|Food Effect (FE): Fasted||0
8912239|NCT02151994|9971317|FG012|NOT COMPLETED|Food Effect (FE): Fasted||0
8912240|NCT02151994|9971305|FG000|STARTED|Food Effect (FE): Fed||0
8912241|NCT02151994|9971306|FG001|STARTED|Food Effect (FE): Fed||0
8912242|NCT02151994|9971307|FG002|STARTED|Food Effect (FE): Fed||0
8912243|NCT02151994|9971308|FG003|STARTED|Food Effect (FE): Fed||0
8912244|NCT02151994|9971309|FG004|STARTED|Food Effect (FE): Fed||0
8912245|NCT02151994|9971310|FG005|STARTED|Food Effect (FE): Fed||0
8912246|NCT02151994|9971311|FG006|STARTED|Food Effect (FE): Fed||0
8912247|NCT02151994|9971312|FG007|STARTED|Food Effect (FE): Fed||0
8912248|NCT02151994|9971313|FG008|STARTED|Food Effect (FE): Fed||0
8912249|NCT02151994|9971314|FG009|STARTED|Food Effect (FE): Fed||0
8912250|NCT02151994|9971315|FG010|STARTED|Food Effect (FE): Fed||0
8912251|NCT02151994|9971316|FG011|STARTED|Food Effect (FE): Fed||0
8912252|NCT02151994|9971317|FG012|STARTED|Food Effect (FE): Fed||12
8912253|NCT02151994|9971305|FG000|COMPLETED|Food Effect (FE): Fed||0
8912254|NCT02151994|9971306|FG001|COMPLETED|Food Effect (FE): Fed||0
8912255|NCT02151994|9971307|FG002|COMPLETED|Food Effect (FE): Fed||0
8912256|NCT02151994|9971308|FG003|COMPLETED|Food Effect (FE): Fed||0
8912257|NCT02151994|9971309|FG004|COMPLETED|Food Effect (FE): Fed||0
8912258|NCT02151994|9971310|FG005|COMPLETED|Food Effect (FE): Fed||0
8912259|NCT02151994|9971311|FG006|COMPLETED|Food Effect (FE): Fed||0
8912260|NCT02151994|9971312|FG007|COMPLETED|Food Effect (FE): Fed||0
8912261|NCT02151994|9971313|FG008|COMPLETED|Food Effect (FE): Fed||0
8912262|NCT02151994|9971314|FG009|COMPLETED|Food Effect (FE): Fed||0
8912263|NCT02151994|9971315|FG010|COMPLETED|Food Effect (FE): Fed||0
8912264|NCT02151994|9971316|FG011|COMPLETED|Food Effect (FE): Fed||0
8737221|NCT01096680|9785032|FG004|STARTED|Overall Study||27
8737222|NCT01096680|9785028|FG000|COMPLETED|Overall Study||27
8737223|NCT01096680|9785029|FG001|COMPLETED|Overall Study||27
8737224|NCT01096680|9785030|FG002|COMPLETED|Overall Study||27
8737225|NCT01096680|9785031|FG003|COMPLETED|Overall Study||27
8737226|NCT01096680|9785032|FG004|COMPLETED|Overall Study||27
8737227|NCT01096680|9785028|FG000|NOT COMPLETED|Overall Study||0
8737228|NCT01096680|9785029|FG001|NOT COMPLETED|Overall Study||0
8737229|NCT01096680|9785030|FG002|NOT COMPLETED|Overall Study||0
8737230|NCT01096680|9785031|FG003|NOT COMPLETED|Overall Study||0
8737231|NCT01096680|9785032|FG004|NOT COMPLETED|Overall Study||0
8737232|NCT01096771|9785046|FG000|STARTED|Overall Study||7
8737233|NCT01096771|9785047|FG001|STARTED|Overall Study||7
8737234|NCT01096771|9785046|FG000|COMPLETED|Overall Study||7
8737235|NCT01096771|9785047|FG001|COMPLETED|Overall Study||7
8737236|NCT01096771|9785046|FG000|NOT COMPLETED|Overall Study||0
8737237|NCT01096771|9785047|FG001|NOT COMPLETED|Overall Study||0
8737238|NCT01096784|9785055|FG000|STARTED|Overall Study||61
8737239|NCT01096784|9785056|FG001|STARTED|Overall Study||60
8737240|NCT01096784|9785055|FG000|COMPLETED|Overall Study||46
8737241|NCT01096784|9785056|FG001|COMPLETED|Overall Study||46
8737242|NCT01096784|9785055|FG000|NOT COMPLETED|Overall Study||15
8737243|NCT01096784|9785056|FG001|NOT COMPLETED|Overall Study||14
8737244|NCT01096810|9785064|FG000|STARTED|Overall Study||20
8737245|NCT01096810|9785064|FG000|COMPLETED|Overall Study||20
8737246|NCT01096810|9785064|FG000|NOT COMPLETED|Overall Study||0
8737247|NCT01096823|9785070|FG000|STARTED|Overall Study||14
8737248|NCT01096823|9785071|FG001|STARTED|Overall Study||16
8737249|NCT01096823|9785070|FG000|COMPLETED|Overall Study||11
8737250|NCT01096823|9785071|FG001|COMPLETED|Overall Study||15
8737251|NCT01096823|9785070|FG000|NOT COMPLETED|Overall Study||3
8737252|NCT01096823|9785071|FG001|NOT COMPLETED|Overall Study||1
8737253|NCT01096849|9785080|FG000|STARTED|Overall Study||22
8737254|NCT01096849|9785081|FG001|STARTED|Overall Study||76
8737255|NCT01096849|9785082|FG002|STARTED|Overall Study||47
8737256|NCT01096849|9785080|FG000|COMPLETED|Overall Study||20
8737257|NCT01096849|9785081|FG001|COMPLETED|Overall Study||64
8737258|NCT01096849|9785082|FG002|COMPLETED|Overall Study||41
8737259|NCT01096849|9785080|FG000|NOT COMPLETED|Overall Study||2
8737260|NCT01096849|9785081|FG001|NOT COMPLETED|Overall Study||12
8737261|NCT01096849|9785082|FG002|NOT COMPLETED|Overall Study||6
8737262|NCT01096875|9785092|FG000|STARTED|Overall Study||30
8737263|NCT01096875|9785093|FG001|STARTED|Overall Study||30
8737264|NCT01096875|9785092|FG000|COMPLETED|Overall Study||30
8737265|NCT01096875|9785093|FG001|COMPLETED|Overall Study||29
8737266|NCT01096875|9785092|FG000|NOT COMPLETED|Overall Study||0
8737267|NCT01096875|9785093|FG001|NOT COMPLETED|Overall Study||1
8737268|NCT01096992|9785106|FG000|STARTED|Overall Study||6
8737269|NCT01096992|9785107|FG001|STARTED|Overall Study||3
8737270|NCT01096992|9785108|FG002|STARTED|Overall Study||6
8737271|NCT01096992|9785109|FG003|STARTED|Overall Study||6
8737272|NCT01096992|9785110|FG004|STARTED|Overall Study||30
8737273|NCT01096992|9785106|FG000|COMPLETED|Overall Study||6
8737274|NCT01096992|9785107|FG001|COMPLETED|Overall Study||3
8737275|NCT01096992|9785108|FG002|COMPLETED|Overall Study||6
8737276|NCT01096992|9785109|FG003|COMPLETED|Overall Study||6
8737277|NCT01096992|9785110|FG004|COMPLETED|Overall Study||30
8737278|NCT01096992|9785106|FG000|NOT COMPLETED|Overall Study||0
8737279|NCT01096992|9785107|FG001|NOT COMPLETED|Overall Study||0
8737280|NCT01096992|9785108|FG002|NOT COMPLETED|Overall Study||0
8737281|NCT01096992|9785109|FG003|NOT COMPLETED|Overall Study||0
8737282|NCT01096992|9785110|FG004|NOT COMPLETED|Overall Study||0
8737283|NCT01097044|9785125|FG000|STARTED|Overall Study||39
8737284|NCT01097044|9785126|FG001|STARTED|Overall Study||38
8737285|NCT01097044|9785125|FG000|COMPLETED|Overall Study||34
8737286|NCT01097044|9785126|FG001|COMPLETED|Overall Study||33
8737287|NCT01097044|9785125|FG000|NOT COMPLETED|Overall Study||5
8737288|NCT01097044|9785126|FG001|NOT COMPLETED|Overall Study||5
8737289|NCT01097057|9785134|FG000|STARTED|Overall Study||20
8737290|NCT01097057|9785134|FG000|COMPLETED|Overall Study||17
8737291|NCT01097057|9785134|FG000|NOT COMPLETED|Overall Study||3
8737292|NCT01097304|9785138|FG000|STARTED|Overall Study||36
8737293|NCT01097304|9785138|FG000|COMPLETED|Overall Study||29
8737294|NCT01097304|9785138|FG000|NOT COMPLETED|Overall Study||7
8737295|NCT01097330|9785145|FG000|STARTED|Overall Study||7
8737296|NCT01097330|9785146|FG001|STARTED|Overall Study||5
8737297|NCT01097330|9785145|FG000|COMPLETED|Overall Study||0
8737298|NCT01097330|9785146|FG001|COMPLETED|Overall Study||0
8737299|NCT01097330|9785145|FG000|NOT COMPLETED|Overall Study||7
8737300|NCT01097330|9785146|FG001|NOT COMPLETED|Overall Study||5
8737301|NCT01097343|9785152|FG000|STARTED|First Intervention- 30 Days||25
8737302|NCT01097343|9785153|FG001|STARTED|First Intervention- 30 Days||25
8737303|NCT01097343|9785152|FG000|COMPLETED|First Intervention- 30 Days||25
8737304|NCT01097343|9785153|FG001|COMPLETED|First Intervention- 30 Days||25
8737305|NCT01097343|9785152|FG000|NOT COMPLETED|First Intervention- 30 Days||0
8737306|NCT01097343|9785153|FG001|NOT COMPLETED|First Intervention- 30 Days||0
8737307|NCT01097343|9785152|FG000|STARTED|Second Intervention- 30 Days||25
8737308|NCT01097343|9785153|FG001|STARTED|Second Intervention- 30 Days||25
8737309|NCT01097343|9785152|FG000|COMPLETED|Second Intervention- 30 Days||25
8737310|NCT01097343|9785153|FG001|COMPLETED|Second Intervention- 30 Days||25
8737311|NCT01097343|9785152|FG000|NOT COMPLETED|Second Intervention- 30 Days||0
8737312|NCT01097343|9785153|FG001|NOT COMPLETED|Second Intervention- 30 Days||0
8737313|NCT01097395|9785161|FG000|STARTED|Overall Study||17
8737314|NCT01097395|9785162|FG001|STARTED|Overall Study||18
8737315|NCT01097395|9785161|FG000|COMPLETED|Overall Study||14
8737316|NCT01097395|9785162|FG001|COMPLETED|Overall Study||14
8737317|NCT01097395|9785161|FG000|NOT COMPLETED|Overall Study||3
8737318|NCT01097395|9785162|FG001|NOT COMPLETED|Overall Study||4
8737319|NCT01097421|9785168|FG000|STARTED|Overall Study||328
8737320|NCT01097421|9785168|FG000|COMPLETED|Overall Study||314
8737321|NCT01097421|9785168|FG000|NOT COMPLETED|Overall Study||14
8737322|NCT01097460|9785172|FG000|STARTED|Overall Study||16
8737323|NCT01097460|9785172|FG000|COMPLETED|Overall Study||16
8737324|NCT01097460|9785172|FG000|NOT COMPLETED|Overall Study||0
8737325|NCT01097577|9785178|FG000|STARTED|Overall Study||67
8737326|NCT01097577|9785179|FG001|STARTED|Overall Study||63
8737327|NCT01097577|9785178|FG000|COMPLETED|Overall Study||67
8737328|NCT01097577|9785179|FG001|COMPLETED|Overall Study||62
8737329|NCT01097577|9785178|FG000|NOT COMPLETED|Overall Study||0
8737330|NCT01097577|9785179|FG001|NOT COMPLETED|Overall Study||1
8737331|NCT01097616|9785188|FG000|STARTED|Double-Blind (DB) Treatment (TRT) Phase||254
8737332|NCT01097616|9785189|FG001|STARTED|Double-Blind (DB) Treatment (TRT) Phase||383
8737333|NCT01097616|9785190|FG002|STARTED|Double-Blind (DB) Treatment (TRT) Phase||385
8737334|NCT01097616|9785191|FG003|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
8737335|NCT01097616|9785192|FG004|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
8737336|NCT01097616|9785193|FG005|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
8737337|NCT01097616|9785194|FG006|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
8737338|NCT01097616|9785195|FG007|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
8737339|NCT01097616|9785188|FG000|Treated|Double-Blind (DB) Treatment (TRT) Phase||254
8737340|NCT01097616|9785189|FG001|Treated|Double-Blind (DB) Treatment (TRT) Phase||383
8737341|NCT01097616|9785190|FG002|Treated|Double-Blind (DB) Treatment (TRT) Phase||384
8737342|NCT01097616|9785191|FG003|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
8737343|NCT01097616|9785192|FG004|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
8737344|NCT01097616|9785193|FG005|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
8737345|NCT01097616|9785194|FG006|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
8737346|NCT01097616|9785195|FG007|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
8737347|NCT01097616|9785188|FG000|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|100 continued into EXT, 128 continued directly into RO, 2 did not continue into either Phase|230
8737348|NCT01097616|9785189|FG001|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|172 continued into EXT, 172 continued directly into RO, 1 did not continue into either Phase|345
8737349|NCT01097616|9785190|FG002|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|151 continued into EXT, 186 continued directly into RO, 4 did not continue into either Phase|341
8737350|NCT01097616|9785191|FG003|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
8737351|NCT01097616|9785192|FG004|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
8737352|NCT01097616|9785193|FG005|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
8737353|NCT01097616|9785194|FG006|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
8737354|NCT01097616|9785195|FG007|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
8737355|NCT01097616|9785188|FG000|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||24
8737356|NCT01097616|9785189|FG001|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||38
8737357|NCT01097616|9785190|FG002|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||44
8737358|NCT01097616|9785191|FG003|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
8737359|NCT01097616|9785192|FG004|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
8737360|NCT01097616|9785193|FG005|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
8737361|NCT01097616|9785194|FG006|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
8737362|NCT01097616|9785195|FG007|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
8737363|NCT01097616|9785188|FG000|STARTED|Optional DB EXT Phase||100
8737364|NCT01097616|9785189|FG001|STARTED|Optional DB EXT Phase||172
8737365|NCT01097616|9785190|FG002|STARTED|Optional DB EXT Phase||151
8737366|NCT01097616|9785191|FG003|STARTED|Optional DB EXT Phase||0
8737367|NCT01097616|9785192|FG004|STARTED|Optional DB EXT Phase||0
8737368|NCT01097616|9785193|FG005|STARTED|Optional DB EXT Phase||0
8737369|NCT01097616|9785194|FG006|STARTED|Optional DB EXT Phase||0
8737370|NCT01097616|9785195|FG007|STARTED|Optional DB EXT Phase||0
8737371|NCT01097616|9785188|FG000|COMPLETED|Optional DB EXT Phase|All 85 continued into RO|85
8737372|NCT01097616|9785189|FG001|COMPLETED|Optional DB EXT Phase|All 151 continued into RO|151
8737373|NCT01097616|9785190|FG002|COMPLETED|Optional DB EXT Phase|All 141 continued into RO|141
8737374|NCT01097616|9785191|FG003|COMPLETED|Optional DB EXT Phase||0
8737375|NCT01097616|9785192|FG004|COMPLETED|Optional DB EXT Phase||0
8737376|NCT01097616|9785193|FG005|COMPLETED|Optional DB EXT Phase||0
8737377|NCT01097616|9785194|FG006|COMPLETED|Optional DB EXT Phase||0
8737378|NCT01097616|9785195|FG007|COMPLETED|Optional DB EXT Phase||0
8737379|NCT01097616|9785188|FG000|NOT COMPLETED|Optional DB EXT Phase||15
8737380|NCT01097616|9785189|FG001|NOT COMPLETED|Optional DB EXT Phase||21
8737381|NCT01097616|9785190|FG002|NOT COMPLETED|Optional DB EXT Phase||10
8737382|NCT01097616|9785191|FG003|NOT COMPLETED|Optional DB EXT Phase||0
8737383|NCT01097616|9785192|FG004|NOT COMPLETED|Optional DB EXT Phase||0
8737384|NCT01097616|9785193|FG005|NOT COMPLETED|Optional DB EXT Phase||0
8737385|NCT01097616|9785194|FG006|NOT COMPLETED|Optional DB EXT Phase||0
8737386|NCT01097616|9785195|FG007|NOT COMPLETED|Optional DB EXT Phase||0
8737387|NCT01097616|9785188|FG000|STARTED|DB RO Phase||0
8737388|NCT01097616|9785189|FG001|STARTED|DB RO Phase||0
8737389|NCT01097616|9785190|FG002|STARTED|DB RO Phase||0
8737390|NCT01097616|9785191|FG003|STARTED|DB RO Phase||101
8737391|NCT01097616|9785192|FG004|STARTED|DB RO Phase|1 was randomized to this group but actually received suvorexant LD during RO|112
8737392|NCT01097616|9785193|FG005|STARTED|DB RO Phase|1 entered RO but was not treated during RO|161
8737393|NCT01097616|9785194|FG006|STARTED|DB RO Phase||162
8737394|NCT01097616|9785195|FG007|STARTED|DB RO Phase||327
8737395|NCT01097616|9785188|FG000|COMPLETED|DB RO Phase||0
8737396|NCT01097616|9785189|FG001|COMPLETED|DB RO Phase||0
8737397|NCT01097616|9785190|FG002|COMPLETED|DB RO Phase||0
8737398|NCT01097616|9785191|FG003|COMPLETED|DB RO Phase||100
8737399|NCT01097616|9785192|FG004|COMPLETED|DB RO Phase||111
8737400|NCT01097616|9785193|FG005|COMPLETED|DB RO Phase||159
8737401|NCT01097616|9785194|FG006|COMPLETED|DB RO Phase||161
8737402|NCT01097616|9785195|FG007|COMPLETED|DB RO Phase||326
8737403|NCT01097616|9785188|FG000|NOT COMPLETED|DB RO Phase||0
8737404|NCT01097616|9785189|FG001|NOT COMPLETED|DB RO Phase||0
8737405|NCT01097616|9785190|FG002|NOT COMPLETED|DB RO Phase||0
8737406|NCT01097616|9785191|FG003|NOT COMPLETED|DB RO Phase||1
8737407|NCT01097616|9785192|FG004|NOT COMPLETED|DB RO Phase||1
8737408|NCT01097616|9785193|FG005|NOT COMPLETED|DB RO Phase||2
8737409|NCT01097616|9785194|FG006|NOT COMPLETED|DB RO Phase||1
8737410|NCT01097616|9785195|FG007|NOT COMPLETED|DB RO Phase||1
8737411|NCT01097629|9785224|FG000|STARTED|Double-Blind (DB) Treatment (TRT) Phase||240
8737412|NCT01097629|9785225|FG001|STARTED|Double-Blind (DB) Treatment (TRT) Phase||392
8737413|NCT01097629|9785226|FG002|STARTED|Double-Blind (DB) Treatment (TRT) Phase||387
8737414|NCT01097629|9785227|FG003|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
8737415|NCT01097629|9785228|FG004|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
8737416|NCT01097629|9785229|FG005|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
8737417|NCT01097629|9785230|FG006|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
8737418|NCT01097629|9785231|FG007|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
8737419|NCT01097629|9785224|FG000|Treated|Double-Blind (DB) Treatment (TRT) Phase||239
8912265|NCT02151994|9971317|FG012|COMPLETED|Food Effect (FE): Fed||12
8912266|NCT02151994|9971305|FG000|NOT COMPLETED|Food Effect (FE): Fed||0
8912267|NCT02151994|9971306|FG001|NOT COMPLETED|Food Effect (FE): Fed||0
8912268|NCT02151994|9971307|FG002|NOT COMPLETED|Food Effect (FE): Fed||0
8912269|NCT02151994|9971308|FG003|NOT COMPLETED|Food Effect (FE): Fed||0
8912270|NCT02151994|9971309|FG004|NOT COMPLETED|Food Effect (FE): Fed||0
8912271|NCT02151994|9971310|FG005|NOT COMPLETED|Food Effect (FE): Fed||0
8912272|NCT02151994|9971311|FG006|NOT COMPLETED|Food Effect (FE): Fed||0
8912273|NCT02151994|9971312|FG007|NOT COMPLETED|Food Effect (FE): Fed||0
8912274|NCT02151994|9971313|FG008|NOT COMPLETED|Food Effect (FE): Fed||0
8912275|NCT02151994|9971314|FG009|NOT COMPLETED|Food Effect (FE): Fed||0
8912276|NCT02151994|9971315|FG010|NOT COMPLETED|Food Effect (FE): Fed||0
8912277|NCT02151994|9971316|FG011|NOT COMPLETED|Food Effect (FE): Fed||0
8912278|NCT02151994|9971317|FG012|NOT COMPLETED|Food Effect (FE): Fed||0
8912279|NCT02152007|9971354|FG000|STARTED|Overall Study||15
8912280|NCT02152007|9971354|FG000|COMPLETED|Overall Study||14
8912281|NCT02152007|9971354|FG000|NOT COMPLETED|Overall Study||1
8912282|NCT02152085|9971361|FG000|STARTED|Overall Study||14
8912283|NCT02152085|9971362|FG001|STARTED|Overall Study||15
8912284|NCT02152085|9971361|FG000|COMPLETED|Overall Study||13
8912285|NCT02152085|9971362|FG001|COMPLETED|Overall Study||14
8912286|NCT02152085|9971361|FG000|NOT COMPLETED|Overall Study||1
8912287|NCT02152085|9971362|FG001|NOT COMPLETED|Overall Study||1
8912288|NCT02152137|9971368|FG000|STARTED|Overall Study||19
8912289|NCT02152137|9971368|FG000|Originally Assigned to Arm A|Overall Study||16
8912290|NCT02152137|9971368|FG000|Originally Assigned to Arm B|Overall Study|With update #2, Arm B is closed and all patients should receive paclitaxel and efatutazone.|3
8912291|NCT02152137|9971368|FG000|COMPLETED|Overall Study||15
8912292|NCT02152137|9971368|FG000|NOT COMPLETED|Overall Study||4
8912293|NCT02152163|9971374|FG000|STARTED|Overall Study||51
8912294|NCT02152163|9971375|FG001|STARTED|Overall Study||48
8912295|NCT02152163|9971374|FG000|COMPLETED|Overall Study||39
8912296|NCT02152163|9971375|FG001|COMPLETED|Overall Study||35
8912297|NCT02152163|9971374|FG000|NOT COMPLETED|Overall Study||12
8912298|NCT02152163|9971375|FG001|NOT COMPLETED|Overall Study||13
8912299|NCT02152345|9971383|FG000|STARTED|Overall Study|The first subject randomized to Belatacept was on 15-Sep-2014.|28
8912300|NCT02152345|9971384|FG001|STARTED|Overall Study|The first subject randomized to Standard Immunosuppression was on 14-Jun-2014.|29
8912301|NCT02152345|9971383|FG000|COMPLETED|Overall Study|The last subject randomized to Belatacept was on 29-Dec-2016.|24
8912302|NCT02152345|9971384|FG001|COMPLETED|Overall Study|The last subject randomized to Standard Immunosuppression was on 25-Dec-2016.|24
8912303|NCT02152345|9971383|FG000|NOT COMPLETED|Overall Study||4
8912304|NCT02152345|9971384|FG001|NOT COMPLETED|Overall Study||5
8912305|NCT02152371|9971392|FG000|STARTED|Overall Study||150
8912306|NCT02152371|9971393|FG001|STARTED|Overall Study||150
8912307|NCT02152371|9971392|FG000|Received at Least 1 Dose of Study Drug.|Overall Study||150
8912308|NCT02152371|9971393|FG001|Received at Least 1 Dose of Study Drug.|Overall Study||150
8912309|NCT02152371|9971392|FG000|COMPLETED|Overall Study||138
8737420|NCT01097629|9785225|FG001|Treated|Double-Blind (DB) Treatment (TRT) Phase||387
8737421|NCT01097629|9785226|FG002|Treated|Double-Blind (DB) Treatment (TRT) Phase||383
8737422|NCT01097629|9785227|FG003|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
8737423|NCT01097629|9785228|FG004|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
8737424|NCT01097629|9785229|FG005|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
8737425|NCT01097629|9785230|FG006|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
8912310|NCT02152371|9971393|FG001|COMPLETED|Overall Study||134
8912311|NCT02152371|9971392|FG000|NOT COMPLETED|Overall Study||12
8912312|NCT02152371|9971393|FG001|NOT COMPLETED|Overall Study||16
8737426|NCT01097629|9785231|FG007|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
8737427|NCT01097629|9785224|FG000|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||205
8737428|NCT01097629|9785225|FG001|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|2 did not continue into RO|346
8737429|NCT01097629|9785226|FG002|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|3 did not continue into RO|330
8737430|NCT01097629|9785227|FG003|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
8737431|NCT01097629|9785228|FG004|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
8737432|NCT01097629|9785229|FG005|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
8737433|NCT01097629|9785230|FG006|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
8737434|NCT01097629|9785231|FG007|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
8737435|NCT01097629|9785224|FG000|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||35
8737436|NCT01097629|9785225|FG001|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||46
8737437|NCT01097629|9785226|FG002|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||57
8737438|NCT01097629|9785227|FG003|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
8737439|NCT01097629|9785228|FG004|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
8737440|NCT01097629|9785229|FG005|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
8737441|NCT01097629|9785230|FG006|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
8737442|NCT01097629|9785231|FG007|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
8737443|NCT01097629|9785224|FG000|STARTED|DB RO Phase||0
8737444|NCT01097629|9785225|FG001|STARTED|DB RO Phase||0
8737445|NCT01097629|9785226|FG002|STARTED|DB RO Phase||0
8737446|NCT01097629|9785227|FG003|STARTED|DB RO Phase||97
8737447|NCT01097629|9785228|FG004|STARTED|DB RO Phase||108
8737448|NCT01097629|9785229|FG005|STARTED|DB RO Phase||173
8737449|NCT01097629|9785230|FG006|STARTED|DB RO Phase||171
8737450|NCT01097629|9785231|FG007|STARTED|DB RO Phase||327
8737451|NCT01097629|9785224|FG000|COMPLETED|DB RO Phase||0
8737452|NCT01097629|9785225|FG001|COMPLETED|DB RO Phase||0
8737453|NCT01097629|9785226|FG002|COMPLETED|DB RO Phase||0
8737454|NCT01097629|9785227|FG003|COMPLETED|DB RO Phase||96
8737455|NCT01097629|9785228|FG004|COMPLETED|DB RO Phase||108
8737456|NCT01097629|9785229|FG005|COMPLETED|DB RO Phase||172
8737457|NCT01097629|9785230|FG006|COMPLETED|DB RO Phase||168
8737458|NCT01097629|9785231|FG007|COMPLETED|DB RO Phase||326
8737459|NCT01097629|9785224|FG000|NOT COMPLETED|DB RO Phase||0
8737460|NCT01097629|9785225|FG001|NOT COMPLETED|DB RO Phase||0
8737461|NCT01097629|9785226|FG002|NOT COMPLETED|DB RO Phase||0
8737462|NCT01097629|9785227|FG003|NOT COMPLETED|DB RO Phase||1
8737463|NCT01097629|9785228|FG004|NOT COMPLETED|DB RO Phase||0
8737464|NCT01097629|9785229|FG005|NOT COMPLETED|DB RO Phase||1
8737465|NCT01097629|9785230|FG006|NOT COMPLETED|DB RO Phase||3
8737466|NCT01097629|9785231|FG007|NOT COMPLETED|DB RO Phase||1
8737467|NCT01097642|9785256|FG000|STARTED|Overall Study||15
8737468|NCT01097642|9785257|FG001|STARTED|Overall Study||25
8737469|NCT01097642|9785256|FG000|COMPLETED|Overall Study||15
8737470|NCT01097642|9785257|FG001|COMPLETED|Overall Study||25
8737471|NCT01097642|9785256|FG000|NOT COMPLETED|Overall Study||0
8737472|NCT01097642|9785257|FG001|NOT COMPLETED|Overall Study||0
8737473|NCT01097655|9785263|FG000|STARTED|Overall Study||3049
8737474|NCT01097655|9785263|FG000|COMPLETED|Overall Study|participants included for analysis|3039
8737475|NCT01097655|9785263|FG000|NOT COMPLETED|Overall Study||10
8737476|NCT01097668|9785269|FG000|STARTED|Overall Study||21
8737477|NCT01097668|9785270|FG001|STARTED|Overall Study||22
8737478|NCT01097668|9785269|FG000|Week 20|Overall Study|Patient evaluability time point = week 20|21
8737479|NCT01097668|9785270|FG001|Week 20|Overall Study|Patient evaluability time point = week 20|22
8737480|NCT01097668|9785269|FG000|Week 48|Overall Study||19
8737481|NCT01097668|9785270|FG001|Week 48|Overall Study||20
8737482|NCT01097668|9785269|FG000|COMPLETED|Overall Study||19
8737483|NCT01097668|9785270|FG001|COMPLETED|Overall Study||20
8737484|NCT01097668|9785269|FG000|NOT COMPLETED|Overall Study||2
8737485|NCT01097668|9785270|FG001|NOT COMPLETED|Overall Study||2
8737486|NCT01097694|9785282|FG000|STARTED|Overall Study||32
8737487|NCT01097694|9785283|FG001|STARTED|Overall Study||30
8737488|NCT01097694|9785282|FG000|COMPLETED|Overall Study||24
8737489|NCT01097694|9785283|FG001|COMPLETED|Overall Study||26
8737490|NCT01097694|9785282|FG000|NOT COMPLETED|Overall Study||8
8737491|NCT01097694|9785283|FG001|NOT COMPLETED|Overall Study||4
8737492|NCT01097707|9785294|FG000|STARTED|Overall Study||83
8737493|NCT01097707|9785295|FG001|STARTED|Overall Study||80
8737494|NCT01097707|9785296|FG002|STARTED|Overall Study||82
8737495|NCT01097707|9785297|FG003|STARTED|Overall Study||84
8737496|NCT01097707|9785298|FG004|STARTED|Overall Study||85
8737497|NCT01097707|9785294|FG000|COMPLETED|Overall Study||39
8737498|NCT01097707|9785295|FG001|COMPLETED|Overall Study||37
8737499|NCT01097707|9785296|FG002|COMPLETED|Overall Study||37
8737500|NCT01097707|9785297|FG003|COMPLETED|Overall Study||40
8737501|NCT01097707|9785298|FG004|COMPLETED|Overall Study||35
8737502|NCT01097707|9785294|FG000|NOT COMPLETED|Overall Study||44
8737503|NCT01097707|9785295|FG001|NOT COMPLETED|Overall Study||43
8737504|NCT01097707|9785296|FG002|NOT COMPLETED|Overall Study||45
8737505|NCT01097707|9785297|FG003|NOT COMPLETED|Overall Study||44
8737506|NCT01097707|9785298|FG004|NOT COMPLETED|Overall Study||50
8737507|NCT01097785|9785312|FG000|STARTED|Cycle 1 (30 Days)||6
8737508|NCT01097785|9785313|FG001|STARTED|Cycle 1 (30 Days)||6
8737509|NCT01097785|9785312|FG000|COMPLETED|Cycle 1 (30 Days)||6
8737510|NCT01097785|9785313|FG001|COMPLETED|Cycle 1 (30 Days)||6
8737511|NCT01097785|9785312|FG000|NOT COMPLETED|Cycle 1 (30 Days)||0
8737512|NCT01097785|9785313|FG001|NOT COMPLETED|Cycle 1 (30 Days)||0
8737513|NCT01097785|9785312|FG000|STARTED|Washout (2 Weeks)||6
8737514|NCT01097785|9785313|FG001|STARTED|Washout (2 Weeks)||6
8737515|NCT01097785|9785312|FG000|COMPLETED|Washout (2 Weeks)||6
8737516|NCT01097785|9785313|FG001|COMPLETED|Washout (2 Weeks)||6
8737517|NCT01097785|9785312|FG000|NOT COMPLETED|Washout (2 Weeks)||0
8737518|NCT01097785|9785313|FG001|NOT COMPLETED|Washout (2 Weeks)||0
8737519|NCT01097785|9785312|FG000|STARTED|Cycle 3 (30 Days)||6
8737520|NCT01097785|9785313|FG001|STARTED|Cycle 3 (30 Days)||6
8737521|NCT01097785|9785312|FG000|COMPLETED|Cycle 3 (30 Days)||6
8737522|NCT01097785|9785313|FG001|COMPLETED|Cycle 3 (30 Days)||6
8737523|NCT01097785|9785312|FG000|NOT COMPLETED|Cycle 3 (30 Days)||0
8737524|NCT01097785|9785313|FG001|NOT COMPLETED|Cycle 3 (30 Days)||0
8737525|NCT01097863|9785323|FG000|STARTED|Overall Study||90
8737526|NCT01097863|9785324|FG001|STARTED|Overall Study||98
8737527|NCT01097863|9785325|FG002|STARTED|Overall Study||91
8737528|NCT01097863|9785323|FG000|COMPLETED|Overall Study||89
8737529|NCT01097863|9785324|FG001|COMPLETED|Overall Study||98
8737530|NCT01097863|9785325|FG002|COMPLETED|Overall Study||89
8737531|NCT01097863|9785323|FG000|NOT COMPLETED|Overall Study||1
8737532|NCT01097863|9785324|FG001|NOT COMPLETED|Overall Study||0
8737533|NCT01097863|9785325|FG002|NOT COMPLETED|Overall Study||2
8737534|NCT01097915|9785336|FG000|STARTED|Overall Study||50
8737535|NCT01097915|9785337|FG001|STARTED|Overall Study||70
8737536|NCT01097915|9785338|FG002|STARTED|Overall Study||50
8737537|NCT01097915|9785336|FG000|COMPLETED|Overall Study||27
8737538|NCT01097915|9785337|FG001|COMPLETED|Overall Study||28
8737539|NCT01097915|9785338|FG002|COMPLETED|Overall Study||20
8737540|NCT01097915|9785336|FG000|NOT COMPLETED|Overall Study||23
8737541|NCT01097915|9785337|FG001|NOT COMPLETED|Overall Study||42
8737542|NCT01097915|9785338|FG002|NOT COMPLETED|Overall Study||30
8806893|NCT01481116|9859221|FG001|Treated|Overall Study||816
8806894|NCT01481116|9859222|FG002|Treated|Overall Study||813
8806895|NCT01481116|9859220|FG000|COMPLETED|Overall Study||0
8806896|NCT01481116|9859221|FG001|COMPLETED|Overall Study||0
8806897|NCT01481116|9859222|FG002|COMPLETED|Overall Study||0
8806898|NCT01481116|9859220|FG000|NOT COMPLETED|Overall Study||824
8806899|NCT01481116|9859221|FG001|NOT COMPLETED|Overall Study||817
8806900|NCT01481116|9859222|FG002|NOT COMPLETED|Overall Study||813
8806901|NCT01481129|9859230|FG000|STARTED|Overall Study||22
8806902|NCT01481129|9859230|FG000|COMPLETED|Overall Study||22
8806903|NCT01481129|9859230|FG000|NOT COMPLETED|Overall Study||0
8806904|NCT01481324|9859237|FG000|STARTED|Overall Study||21
8806905|NCT01481324|9859238|FG001|STARTED|Overall Study||24
8806906|NCT01481324|9859239|FG002|STARTED|Overall Study||22
8806907|NCT01481324|9859237|FG000|Month 1-Wear Rate Data|Overall Study||15
8806908|NCT01481324|9859238|FG001|Month 1-Wear Rate Data|Overall Study||16
8806909|NCT01481324|9859239|FG002|Month 1-Wear Rate Data|Overall Study||8
8806910|NCT01481324|9859237|FG000|Month 2-Wear Rate Data|Overall Study||9
8806911|NCT01481324|9859238|FG001|Month 2-Wear Rate Data|Overall Study||13
8806912|NCT01481324|9859239|FG002|Month 2-Wear Rate Data|Overall Study||7
8806913|NCT01481324|9859237|FG000|Month 3-Wear Rate Data|Overall Study||7
8806914|NCT01481324|9859238|FG001|Month 3-Wear Rate Data|Overall Study||11
8806915|NCT01481324|9859239|FG002|Month 3-Wear Rate Data|Overall Study||6
8806916|NCT01481324|9859237|FG000|COMPLETED|Overall Study||21
8806917|NCT01481324|9859238|FG001|COMPLETED|Overall Study||22
8806918|NCT01481324|9859239|FG002|COMPLETED|Overall Study||20
8806919|NCT01481324|9859237|FG000|NOT COMPLETED|Overall Study||0
8806920|NCT01481324|9859238|FG001|NOT COMPLETED|Overall Study||2
8806921|NCT01481324|9859239|FG002|NOT COMPLETED|Overall Study||2
8806922|NCT01481376|9859247|FG000|STARTED|Overall Study||200
8806923|NCT01481376|9859247|FG000|COMPLETED|Overall Study||169
8806924|NCT01481376|9859247|FG000|NOT COMPLETED|Overall Study||31
8806925|NCT01481545|9859253|FG000|STARTED|Overall Study||16
8806926|NCT01481545|9859254|FG001|STARTED|Overall Study||46
8806927|NCT01481545|9859253|FG000|COMPLETED|Overall Study||11
8806928|NCT01481545|9859254|FG001|COMPLETED|Overall Study||40
8806929|NCT01481545|9859253|FG000|NOT COMPLETED|Overall Study||5
8806930|NCT01481545|9859254|FG001|NOT COMPLETED|Overall Study||6
8806931|NCT01481558|9859264|FG000|STARTED|Overall Study||20
8806932|NCT01481558|9859265|FG001|STARTED|Overall Study||20
8806933|NCT01481558|9859264|FG000|COMPLETED|Overall Study||20
8806934|NCT01481558|9859265|FG001|COMPLETED|Overall Study||20
8806935|NCT01481558|9859264|FG000|NOT COMPLETED|Overall Study||0
8806936|NCT01481558|9859265|FG001|NOT COMPLETED|Overall Study||0
8806937|NCT01481740|9859273|FG000|STARTED|Overall Study||90
8806938|NCT01481740|9859274|FG001|STARTED|Overall Study||88
8806939|NCT01481740|9859273|FG000|COMPLETED|Overall Study||79
8806940|NCT01481740|9859274|FG001|COMPLETED|Overall Study||81
8806941|NCT01481740|9859273|FG000|NOT COMPLETED|Overall Study||11
8806942|NCT01481740|9859274|FG001|NOT COMPLETED|Overall Study||7
8806943|NCT01481779|9859282|FG000|STARTED|Overall Study||295
8806944|NCT01481779|9859283|FG001|STARTED|Overall Study||160
8806945|NCT01481779|9859282|FG000|Received at Least 1 Dose of Study Drug|Overall Study||294
8806946|NCT01481779|9859283|FG001|Received at Least 1 Dose of Study Drug|Overall Study||159
8806947|NCT01481779|9859282|FG000|COMPLETED|Overall Study||225
8806948|NCT01481779|9859283|FG001|COMPLETED|Overall Study||132
8806949|NCT01481779|9859282|FG000|NOT COMPLETED|Overall Study||70
8806950|NCT01481779|9859283|FG001|NOT COMPLETED|Overall Study||28
8806951|NCT01481896|9859289|FG000|STARTED|Overall Study|The 126 participants includes 5 participants with bilateral hip replacements for a total of 131 THAs|126
8912313|NCT02152384|9971399|FG000|STARTED|Run In (1-5 Week Transition)||14
8737543|NCT01098006|9785357|FG000|STARTED|Overall Study||7
8737544|NCT01098006|9785358|FG001|STARTED|Overall Study||11
8737545|NCT01098006|9785359|FG002|STARTED|Overall Study||60
8737546|NCT01098006|9785360|FG003|STARTED|Overall Study||21
8737547|NCT01098006|9785357|FG000|COMPLETED|Overall Study||7
8737548|NCT01098006|9785358|FG001|COMPLETED|Overall Study||11
8737549|NCT01098006|9785359|FG002|COMPLETED|Overall Study||60
8737550|NCT01098006|9785360|FG003|COMPLETED|Overall Study||21
8737551|NCT01098006|9785357|FG000|NOT COMPLETED|Overall Study||0
8737552|NCT01098006|9785358|FG001|NOT COMPLETED|Overall Study||0
8737553|NCT01098006|9785359|FG002|NOT COMPLETED|Overall Study||0
8737554|NCT01098006|9785360|FG003|NOT COMPLETED|Overall Study||0
8737555|NCT01098097|9785370|FG000|STARTED|Overall Study||963
8737556|NCT01098097|9785370|FG000|COMPLETED|Overall Study|Participants completing the study received at least 12 weeks of treatment|881
8737557|NCT01098097|9785370|FG000|NOT COMPLETED|Overall Study||82
8737558|NCT01098162|9785374|FG000|STARTED|Overall Study||573
8737559|NCT01098162|9785374|FG000|COMPLETED|Overall Study||461
8737560|NCT01098162|9785374|FG000|NOT COMPLETED|Overall Study||112
8737561|NCT01098240|9785378|FG000|STARTED|Open-Label Phase||297
8737562|NCT01098240|9785379|FG001|STARTED|Open-Label Phase||0
8737563|NCT01098240|9785380|FG002|STARTED|Open-Label Phase||0
8737564|NCT01098240|9785378|FG000|COMPLETED|Open-Label Phase||162
8737565|NCT01098240|9785379|FG001|COMPLETED|Open-Label Phase||0
8737566|NCT01098240|9785380|FG002|COMPLETED|Open-Label Phase||0
8737567|NCT01098240|9785378|FG000|NOT COMPLETED|Open-Label Phase||135
8737568|NCT01098240|9785379|FG001|NOT COMPLETED|Open-Label Phase||0
8737569|NCT01098240|9785380|FG002|NOT COMPLETED|Open-Label Phase||0
8737570|NCT01098240|9785378|FG000|STARTED|Double-Blind Phase||0
8737571|NCT01098240|9785379|FG001|STARTED|Double-Blind Phase||77
8737572|NCT01098240|9785380|FG002|STARTED|Double-Blind Phase||85
8737573|NCT01098240|9785378|FG000|COMPLETED|Double-Blind Phase||0
8737574|NCT01098240|9785379|FG001|COMPLETED|Double-Blind Phase||60
8737575|NCT01098240|9785380|FG002|COMPLETED|Double-Blind Phase||63
8737576|NCT01098240|9785378|FG000|NOT COMPLETED|Double-Blind Phase||0
8737577|NCT01098240|9785379|FG001|NOT COMPLETED|Double-Blind Phase||17
8737578|NCT01098240|9785380|FG002|NOT COMPLETED|Double-Blind Phase||22
8737579|NCT01098253|9785389|FG000|STARTED|Overall Study||94
8737580|NCT01098253|9785390|FG001|STARTED|Overall Study||88
8737581|NCT01098253|9785389|FG000|COMPLETED|Overall Study||92
8737582|NCT01098253|9785390|FG001|COMPLETED|Overall Study||88
8737583|NCT01098253|9785389|FG000|NOT COMPLETED|Overall Study||2
8737584|NCT01098253|9785390|FG001|NOT COMPLETED|Overall Study||0
8737585|NCT01098266|9785398|FG000|STARTED|Overall Study||200
8737586|NCT01098266|9785399|FG001|STARTED|Overall Study||200
8737587|NCT01098266|9785398|FG000|COMPLETED|Overall Study||193
8737588|NCT01098266|9785399|FG001|COMPLETED|Overall Study||193
8737589|NCT01098266|9785398|FG000|NOT COMPLETED|Overall Study||7
8737590|NCT01098266|9785399|FG001|NOT COMPLETED|Overall Study||7
8737591|NCT01098305|9785407|FG000|STARTED|Overall Study||119
8737592|NCT01098305|9785408|FG001|STARTED|Overall Study||118
8737593|NCT01098305|9785407|FG000|COMPLETED|Overall Study||88
8737594|NCT01098305|9785408|FG001|COMPLETED|Overall Study||85
8737595|NCT01098305|9785407|FG000|NOT COMPLETED|Overall Study||31
8737596|NCT01098305|9785408|FG001|NOT COMPLETED|Overall Study||33
8737597|NCT01098318|9785417|FG000|STARTED|Overall Study||20
8737598|NCT01098318|9785418|FG001|STARTED|Overall Study||19
8737599|NCT01098318|9785419|FG002|STARTED|Overall Study||18
8737600|NCT01098318|9785417|FG000|COMPLETED|Overall Study||17
8737601|NCT01098318|9785418|FG001|COMPLETED|Overall Study||12
8737602|NCT01098318|9785419|FG002|COMPLETED|Overall Study||15
8737603|NCT01098318|9785417|FG000|NOT COMPLETED|Overall Study||3
8737604|NCT01098318|9785418|FG001|NOT COMPLETED|Overall Study||7
8737605|NCT01098318|9785419|FG002|NOT COMPLETED|Overall Study||3
8737606|NCT01098422|9785427|FG000|STARTED|Overall Study||10
8737607|NCT01098422|9785427|FG000|COMPLETED|Overall Study||9
8737608|NCT01098422|9785427|FG000|NOT COMPLETED|Overall Study||1
8737609|NCT01098461|9785435|FG000|STARTED|Treatment Period (TP) (16 Weeks)||53
8737610|NCT01098461|9785436|FG001|STARTED|Treatment Period (TP) (16 Weeks)||52
8737611|NCT01098461|9785437|FG002|STARTED|Treatment Period (TP) (16 Weeks)||54
8737612|NCT01098461|9785438|FG003|STARTED|Treatment Period (TP) (16 Weeks)||53
8737613|NCT01098461|9785435|FG000|COMPLETED|Treatment Period (TP) (16 Weeks)||41
8737614|NCT01098461|9785436|FG001|COMPLETED|Treatment Period (TP) (16 Weeks)||45
8737615|NCT01098461|9785437|FG002|COMPLETED|Treatment Period (TP) (16 Weeks)||53
8737616|NCT01098461|9785438|FG003|COMPLETED|Treatment Period (TP) (16 Weeks)||50
8737617|NCT01098461|9785435|FG000|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||12
8737618|NCT01098461|9785436|FG001|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||7
8737619|NCT01098461|9785437|FG002|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||1
8737620|NCT01098461|9785438|FG003|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||3
8737621|NCT01098461|9785435|FG000|STARTED|Follow-up (FU) Period (8 Weeks)|Par. withdrawing from the TP could enter the FU Period. One par. did not participate in the FU.|52
8737622|NCT01098461|9785436|FG001|STARTED|Follow-up (FU) Period (8 Weeks)||52
8737623|NCT01098461|9785437|FG002|STARTED|Follow-up (FU) Period (8 Weeks)|Par. withdrawing from the TP could enter the FU Period. One par. did not participate in the FU.|53
8737624|NCT01098461|9785438|FG003|STARTED|Follow-up (FU) Period (8 Weeks)|Par. withdrawing from the TP could enter the FU Period. One par. did not participate in the FU.|52
8737625|NCT01098461|9785435|FG000|COMPLETED|Follow-up (FU) Period (8 Weeks)||52
8737626|NCT01098461|9785436|FG001|COMPLETED|Follow-up (FU) Period (8 Weeks)||49
8737627|NCT01098461|9785437|FG002|COMPLETED|Follow-up (FU) Period (8 Weeks)||52
8737628|NCT01098461|9785438|FG003|COMPLETED|Follow-up (FU) Period (8 Weeks)||52
8737629|NCT01098461|9785435|FG000|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||0
8737630|NCT01098461|9785436|FG001|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||3
8737631|NCT01098461|9785437|FG002|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||1
8737632|NCT01098461|9785438|FG003|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||0
8737633|NCT01098474|9785455|FG000|STARTED|Active Phase||50
8737634|NCT01098474|9785456|FG001|STARTED|Active Phase||50
8737635|NCT01098474|9785457|FG002|STARTED|Active Phase||50
8737636|NCT01098474|9785458|FG003|STARTED|Active Phase||49
8737637|NCT01098474|9785459|FG004|STARTED|Active Phase||52
8737638|NCT01098474|9785460|FG005|STARTED|Active Phase||49
8737639|NCT01098474|9785455|FG000|COMPLETED|Active Phase||48
8737640|NCT01098474|9785456|FG001|COMPLETED|Active Phase||49
8737641|NCT01098474|9785457|FG002|COMPLETED|Active Phase||45
8737642|NCT01098474|9785458|FG003|COMPLETED|Active Phase||49
8737643|NCT01098474|9785459|FG004|COMPLETED|Active Phase||52
8737644|NCT01098474|9785460|FG005|COMPLETED|Active Phase||49
8737645|NCT01098474|9785455|FG000|NOT COMPLETED|Active Phase||2
8737646|NCT01098474|9785456|FG001|NOT COMPLETED|Active Phase||1
8737647|NCT01098474|9785457|FG002|NOT COMPLETED|Active Phase||5
8737648|NCT01098474|9785458|FG003|NOT COMPLETED|Active Phase||0
8737649|NCT01098474|9785459|FG004|NOT COMPLETED|Active Phase||0
8737650|NCT01098474|9785460|FG005|NOT COMPLETED|Active Phase||0
8737651|NCT01098474|9785455|FG000|STARTED|Follow Up Phase||48
8737652|NCT01098474|9785456|FG001|STARTED|Follow Up Phase||49
8737653|NCT01098474|9785457|FG002|STARTED|Follow Up Phase||45
8737654|NCT01098474|9785458|FG003|STARTED|Follow Up Phase||49
8737655|NCT01098474|9785459|FG004|STARTED|Follow Up Phase||52
8737656|NCT01098474|9785460|FG005|STARTED|Follow Up Phase||49
8737657|NCT01098474|9785455|FG000|COMPLETED|Follow Up Phase||48
8737658|NCT01098474|9785456|FG001|COMPLETED|Follow Up Phase||49
8737659|NCT01098474|9785457|FG002|COMPLETED|Follow Up Phase||45
8737660|NCT01098474|9785458|FG003|COMPLETED|Follow Up Phase||47
8737661|NCT01098474|9785459|FG004|COMPLETED|Follow Up Phase||50
8737662|NCT01098474|9785460|FG005|COMPLETED|Follow Up Phase||44
8737663|NCT01098474|9785455|FG000|NOT COMPLETED|Follow Up Phase||0
8737664|NCT01098474|9785456|FG001|NOT COMPLETED|Follow Up Phase||0
8737665|NCT01098474|9785457|FG002|NOT COMPLETED|Follow Up Phase||0
8737666|NCT01098474|9785458|FG003|NOT COMPLETED|Follow Up Phase||2
8737667|NCT01098474|9785459|FG004|NOT COMPLETED|Follow Up Phase||2
8737668|NCT01098474|9785460|FG005|NOT COMPLETED|Follow Up Phase||5
8737669|NCT01098487|9785484|FG000|STARTED|Overall Study||162
8737670|NCT01098487|9785484|FG000|COMPLETED|Overall Study||118
8737671|NCT01098487|9785484|FG000|NOT COMPLETED|Overall Study||44
8737672|NCT01098500|9785488|FG000|STARTED|Overall Study||3800
8737673|NCT01098500|9785488|FG000|COMPLETED|Overall Study||3800
8737674|NCT01098500|9785488|FG000|NOT COMPLETED|Overall Study||0
8737675|NCT01098539|9785494|FG000|STARTED|Overall Study||249
8737676|NCT01098539|9785495|FG001|STARTED|Overall Study||246
8737677|NCT01098539|9785494|FG000|COMPLETED|Overall Study||198
8737678|NCT01098539|9785495|FG001|COMPLETED|Overall Study||178
8737679|NCT01098539|9785494|FG000|NOT COMPLETED|Overall Study||51
8737680|NCT01098539|9785495|FG001|NOT COMPLETED|Overall Study||68
8737681|NCT01098578|9785501|FG000|STARTED|Overall Study||20
8737682|NCT01098578|9785501|FG000|COMPLETED|Overall Study||20
8737683|NCT01098578|9785501|FG000|NOT COMPLETED|Overall Study||0
8737684|NCT01098747|9785511|FG000|STARTED|Overall Study||48
8737685|NCT01098747|9785512|FG001|STARTED|Overall Study||95
8737686|NCT01098747|9785513|FG002|STARTED|Overall Study||86
8737687|NCT01098747|9785514|FG003|STARTED|Overall Study||87
8737688|NCT01098747|9785511|FG000|COMPLETED|Overall Study||48
8737689|NCT01098747|9785512|FG001|COMPLETED|Overall Study||95
8737690|NCT01098747|9785513|FG002|COMPLETED|Overall Study||86
8737691|NCT01098747|9785514|FG003|COMPLETED|Overall Study||87
8737692|NCT01098747|9785511|FG000|NOT COMPLETED|Overall Study||0
8737693|NCT01098747|9785512|FG001|NOT COMPLETED|Overall Study||0
8737694|NCT01098747|9785513|FG002|NOT COMPLETED|Overall Study||0
8737695|NCT01098747|9785514|FG003|NOT COMPLETED|Overall Study||0
8737696|NCT01098812|9785526|FG000|STARTED|Overall Study||95
8737697|NCT01098812|9785527|FG001|STARTED|Overall Study||102
8737698|NCT01098812|9785528|FG002|STARTED|Overall Study||72
8737699|NCT01098812|9785526|FG000|COMPLETED|Overall Study||93
8737700|NCT01098812|9785527|FG001|COMPLETED|Overall Study||101
8737701|NCT01098812|9785528|FG002|COMPLETED|Overall Study||71
8737702|NCT01098812|9785526|FG000|NOT COMPLETED|Overall Study||2
8737703|NCT01098812|9785527|FG001|NOT COMPLETED|Overall Study||1
8737704|NCT01098812|9785528|FG002|NOT COMPLETED|Overall Study||1
8737705|NCT01098851|9785537|FG000|STARTED|Overall Study||11
8737706|NCT01098851|9785538|FG001|STARTED|Overall Study||10
8737707|NCT01098851|9785537|FG000|COMPLETED|Overall Study||10
8737708|NCT01098851|9785538|FG001|COMPLETED|Overall Study||10
8737709|NCT01098851|9785537|FG000|NOT COMPLETED|Overall Study||1
8737710|NCT01098851|9785538|FG001|NOT COMPLETED|Overall Study||0
8737711|NCT01099111|9785549|FG000|STARTED|Overall Study||50
8737712|NCT01099111|9785550|FG001|STARTED|Overall Study||50
8737713|NCT01099111|9785551|FG002|STARTED|Overall Study||46
8737714|NCT01099111|9785552|FG003|STARTED|Overall Study||29
8737715|NCT01099111|9785553|FG004|STARTED|Overall Study||50
8737716|NCT01099111|9785549|FG000|COMPLETED|Overall Study|5 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|50
8912314|NCT02152384|9971400|FG001|STARTED|Run In (1-5 Week Transition)||14
8737717|NCT01099111|9785550|FG001|COMPLETED|Overall Study|3 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|50
8737718|NCT01099111|9785551|FG002|COMPLETED|Overall Study|2 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|46
8737719|NCT01099111|9785552|FG003|COMPLETED|Overall Study||29
8737720|NCT01099111|9785553|FG004|COMPLETED|Overall Study|6 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|50
8737721|NCT01099111|9785549|FG000|NOT COMPLETED|Overall Study||0
8737722|NCT01099111|9785550|FG001|NOT COMPLETED|Overall Study||0
8737723|NCT01099111|9785551|FG002|NOT COMPLETED|Overall Study||0
8737724|NCT01099111|9785552|FG003|NOT COMPLETED|Overall Study||0
8737725|NCT01099111|9785553|FG004|NOT COMPLETED|Overall Study||0
8737726|NCT01099202|9785567|FG000|STARTED|Overall Study||55
8737727|NCT01099202|9785568|FG001|STARTED|Overall Study||54
8737728|NCT01099202|9785567|FG000|COMPLETED|Overall Study||55
8737729|NCT01099202|9785568|FG001|COMPLETED|Overall Study||54
8737730|NCT01099202|9785567|FG000|NOT COMPLETED|Overall Study||0
8737731|NCT01099202|9785568|FG001|NOT COMPLETED|Overall Study||0
8737732|NCT01099215|9785577|FG000|STARTED|Overall Study||11
8737733|NCT01099215|9785578|FG001|STARTED|Overall Study||10
8737734|NCT01099215|9785577|FG000|COMPLETED|Overall Study||10
8737735|NCT01099215|9785578|FG001|COMPLETED|Overall Study||9
8737736|NCT01099215|9785577|FG000|NOT COMPLETED|Overall Study||1
8737737|NCT01099215|9785578|FG001|NOT COMPLETED|Overall Study||1
8737738|NCT01099267|9785584|FG000|STARTED|MDS-003 Study|This information duplicates results in NCT00065156.|148
8737739|NCT01099267|9785584|FG000|COMPLETED|MDS-003 Study||24
8737740|NCT01099267|9785584|FG000|NOT COMPLETED|MDS-003 Study||124
8737741|NCT01099267|9785584|FG000|STARTED|MDS-009 Extension Follow-up|Participants from MDS-003 (including some who did not complete) at sites participating in MDS-009.|54
8737742|NCT01099267|9785584|FG000|Informed Consent Given|MDS-009 Extension Follow-up||33
8737743|NCT01099267|9785584|FG000|Other Source of Follow-up Info Used|MDS-009 Extension Follow-up|Social Security Death Index, public records, verbal reports from health providers and next of kin.|21
8737744|NCT01099267|9785584|FG000|COMPLETED|MDS-009 Extension Follow-up||54
8737745|NCT01099267|9785584|FG000|NOT COMPLETED|MDS-009 Extension Follow-up||0
8737746|NCT01099358|9785588|FG000|STARTED|Overall Study||4
8737747|NCT01099358|9785589|FG001|STARTED|Overall Study||6
8737748|NCT01099358|9785590|FG002|STARTED|Overall Study||21
8737749|NCT01099358|9785591|FG003|STARTED|Overall Study||16
8737750|NCT01099358|9785588|FG000|Received at Least One Dose of Study Drug|Overall Study||3
8737751|NCT01099358|9785589|FG001|Received at Least One Dose of Study Drug|Overall Study||6
8737752|NCT01099358|9785590|FG002|Received at Least One Dose of Study Drug|Overall Study||20
8737753|NCT01099358|9785591|FG003|Received at Least One Dose of Study Drug|Overall Study||15
8737754|NCT01099358|9785588|FG000|COMPLETED|Overall Study||1
8737755|NCT01099358|9785589|FG001|COMPLETED|Overall Study||5
8737756|NCT01099358|9785590|FG002|COMPLETED|Overall Study||13
8737757|NCT01099358|9785591|FG003|COMPLETED|Overall Study||12
8737758|NCT01099358|9785588|FG000|NOT COMPLETED|Overall Study||3
8737759|NCT01099358|9785589|FG001|NOT COMPLETED|Overall Study||1
8737760|NCT01099358|9785590|FG002|NOT COMPLETED|Overall Study||8
8737761|NCT01099358|9785591|FG003|NOT COMPLETED|Overall Study||4
8737762|NCT01099397|9785602|FG000|STARTED|Overall Study||39
8737763|NCT01099397|9785602|FG000|COMPLETED|Overall Study||26
8737764|NCT01099397|9785602|FG000|NOT COMPLETED|Overall Study||13
8737765|NCT01099449|9785610|FG000|STARTED|Overall Study||118
8737766|NCT01099449|9785611|FG001|STARTED|Overall Study||119
8737767|NCT01099449|9785612|FG002|STARTED|Overall Study||116
8737768|NCT01099449|9785610|FG000|COMPLETED|Overall Study||118
8737769|NCT01099449|9785611|FG001|COMPLETED|Overall Study||119
8737770|NCT01099449|9785612|FG002|COMPLETED|Overall Study||116
8737771|NCT01099449|9785610|FG000|NOT COMPLETED|Overall Study||0
8737772|NCT01099449|9785611|FG001|NOT COMPLETED|Overall Study||0
8737773|NCT01099449|9785612|FG002|NOT COMPLETED|Overall Study||0
8737774|NCT01099475|9785635|FG000|STARTED|Overall Study||10
8737775|NCT01099475|9785636|FG001|STARTED|Overall Study||10
8737776|NCT01099475|9785635|FG000|COMPLETED|Overall Study||10
8737777|NCT01099475|9785636|FG001|COMPLETED|Overall Study||10
8737778|NCT01099475|9785635|FG000|NOT COMPLETED|Overall Study||0
8737779|NCT01099475|9785636|FG001|NOT COMPLETED|Overall Study||0
8737780|NCT01099579|9785645|FG000|STARTED|Stage 1 (ATV Powder Formulation)||21
8737781|NCT01099579|9785646|FG001|STARTED|Stage 1 (ATV Powder Formulation)||19
8737782|NCT01099579|9785647|FG002|STARTED|Stage 1 (ATV Powder Formulation)||16
8737783|NCT01099579|9785645|FG000|COMPLETED|Stage 1 (ATV Powder Formulation)|Completed Stage 1|17
8737784|NCT01099579|9785646|FG001|COMPLETED|Stage 1 (ATV Powder Formulation)|Completed Stage 1|14
8737785|NCT01099579|9785647|FG002|COMPLETED|Stage 1 (ATV Powder Formulation)|Completed Stage 1|15
8737786|NCT01099579|9785645|FG000|NOT COMPLETED|Stage 1 (ATV Powder Formulation)||4
8737787|NCT01099579|9785646|FG001|NOT COMPLETED|Stage 1 (ATV Powder Formulation)||5
8737788|NCT01099579|9785647|FG002|NOT COMPLETED|Stage 1 (ATV Powder Formulation)||1
8737789|NCT01099579|9785645|FG000|STARTED|Stage 2 (ATV Capsule)||16
8737790|NCT01099579|9785646|FG001|STARTED|Stage 2 (ATV Capsule)||14
8737791|NCT01099579|9785647|FG002|STARTED|Stage 2 (ATV Capsule)||15
8737792|NCT01099579|9785645|FG000|COMPLETED|Stage 2 (ATV Capsule)||10
8737793|NCT01099579|9785646|FG001|COMPLETED|Stage 2 (ATV Capsule)||9
8737794|NCT01099579|9785647|FG002|COMPLETED|Stage 2 (ATV Capsule)||9
8737795|NCT01099579|9785645|FG000|NOT COMPLETED|Stage 2 (ATV Capsule)||6
8737796|NCT01099579|9785646|FG001|NOT COMPLETED|Stage 2 (ATV Capsule)||5
8737797|NCT01099579|9785647|FG002|NOT COMPLETED|Stage 2 (ATV Capsule)||6
8737798|NCT01099618|9785660|FG000|STARTED|Overall Study||17
8737799|NCT01099618|9785661|FG001|STARTED|Overall Study||16
8737800|NCT01099618|9785662|FG002|STARTED|Overall Study||15
8737801|NCT01099618|9785660|FG000|COMPLETED|Overall Study||17
8737802|NCT01099618|9785661|FG001|COMPLETED|Overall Study||16
8737803|NCT01099618|9785662|FG002|COMPLETED|Overall Study||15
8737804|NCT01099618|9785660|FG000|NOT COMPLETED|Overall Study||0
8737805|NCT01099618|9785661|FG001|NOT COMPLETED|Overall Study||0
8737806|NCT01099618|9785662|FG002|NOT COMPLETED|Overall Study||0
8737807|NCT01099631|9785676|FG000|STARTED|Overall Study||6
8737808|NCT01099631|9785677|FG001|STARTED|Overall Study||3
8737809|NCT01099631|9785678|FG002|STARTED|Overall Study||3
8737810|NCT01099631|9785679|FG003|STARTED|Overall Study||3
8737811|NCT01099631|9785680|FG004|STARTED|Overall Study||3
8737812|NCT01099631|9785681|FG005|STARTED|Overall Study||4
8737813|NCT01099631|9785676|FG000|COMPLETED|Overall Study||6
8737814|NCT01099631|9785677|FG001|COMPLETED|Overall Study||3
8737815|NCT01099631|9785678|FG002|COMPLETED|Overall Study||3
8737816|NCT01099631|9785679|FG003|COMPLETED|Overall Study||3
8737817|NCT01099631|9785680|FG004|COMPLETED|Overall Study||3
8737818|NCT01099631|9785681|FG005|COMPLETED|Overall Study||4
8737819|NCT01099631|9785676|FG000|NOT COMPLETED|Overall Study||0
8737820|NCT01099631|9785677|FG001|NOT COMPLETED|Overall Study||0
8737821|NCT01099631|9785678|FG002|NOT COMPLETED|Overall Study||0
9022508|NCT03128099|10085427|FG002|Hour 1 (Low Dose) Started|Overall Study||22
9022509|NCT03128099|10085425|FG000|Hour 1 (Low Dose) Completed|Overall Study||19
9022510|NCT03128099|10085426|FG001|Hour 1 (Low Dose) Completed|Overall Study||4
9022511|NCT03128099|10085427|FG002|Hour 1 (Low Dose) Completed|Overall Study||21
9022512|NCT03128099|10085425|FG000|Hour 2 (High Dose)Started|Overall Study|Hour 2 of training not available to these participants|0
9022513|NCT03128099|10085426|FG001|Hour 2 (High Dose)Started|Overall Study||4
9022514|NCT03128099|10085427|FG002|Hour 2 (High Dose)Started|Overall Study|Hour 2 of training not available to these participants|0
9022515|NCT03128099|10085425|FG000|Hour 2 (High Dose) Completed|Overall Study||0
9022516|NCT03128099|10085426|FG001|Hour 2 (High Dose) Completed|Overall Study||0
9022517|NCT03128099|10085427|FG002|Hour 2 (High Dose) Completed|Overall Study||0
9022518|NCT03128099|10085425|FG000|COMPLETED|Overall Study||19
9022519|NCT03128099|10085426|FG001|COMPLETED|Overall Study|hour 2 training was completed by 0 participants|0
9022520|NCT03128099|10085427|FG002|COMPLETED|Overall Study||21
9022521|NCT03128099|10085425|FG000|NOT COMPLETED|Overall Study||2
9022522|NCT03128099|10085426|FG001|NOT COMPLETED|Overall Study||4
9022523|NCT03128099|10085427|FG002|NOT COMPLETED|Overall Study||1
9022524|NCT03128307|10085433|FG000|STARTED|Overall Study||604
9022525|NCT03128307|10085433|FG000|COMPLETED|Overall Study||570
9022526|NCT03128307|10085433|FG000|NOT COMPLETED|Overall Study||34
9022527|NCT03128372|10085437|FG000|STARTED|Overall Study||32
9022528|NCT03128372|10085437|FG000|COMPLETED|Overall Study||32
9022529|NCT03128372|10085437|FG000|NOT COMPLETED|Overall Study||0
9022530|NCT03128723|10085441|FG000|STARTED|Overall Study||45
9022531|NCT03128723|10085441|FG000|COMPLETED|Overall Study||43
8737822|NCT01099631|9785679|FG003|NOT COMPLETED|Overall Study||0
8737823|NCT01099631|9785680|FG004|NOT COMPLETED|Overall Study||0
8737824|NCT01099631|9785681|FG005|NOT COMPLETED|Overall Study||0
8737825|NCT01099709|9785701|FG000|STARTED|Period 1||42
8737826|NCT01099709|9785702|FG001|STARTED|Period 1||43
8737827|NCT01099709|9785701|FG000|COMPLETED|Period 1||41
8737828|NCT01099709|9785702|FG001|COMPLETED|Period 1||41
8737829|NCT01099709|9785701|FG000|NOT COMPLETED|Period 1||1
8737830|NCT01099709|9785702|FG001|NOT COMPLETED|Period 1||2
8737831|NCT01099709|9785701|FG000|STARTED|Period 2||41
8737832|NCT01099709|9785702|FG001|STARTED|Period 2||41
8737833|NCT01099709|9785701|FG000|COMPLETED|Period 2||41
8737834|NCT01099709|9785702|FG001|COMPLETED|Period 2||41
8737835|NCT01099709|9785701|FG000|NOT COMPLETED|Period 2||0
8737836|NCT01099709|9785702|FG001|NOT COMPLETED|Period 2||0
8737837|NCT01099761|9785713|FG000|STARTED|Overall Study||9
8737838|NCT01099761|9785714|FG001|STARTED|Overall Study||9
8737839|NCT01099761|9785715|FG002|STARTED|Overall Study|Study terminated prior to enrolling cohort 3|0
8737840|NCT01099761|9785716|FG003|STARTED|Overall Study||6
8737841|NCT01099761|9785713|FG000|COMPLETED|Overall Study||9
8737842|NCT01099761|9785714|FG001|COMPLETED|Overall Study||9
8737843|NCT01099761|9785715|FG002|COMPLETED|Overall Study||0
8737844|NCT01099761|9785716|FG003|COMPLETED|Overall Study||6
8737845|NCT01099761|9785713|FG000|NOT COMPLETED|Overall Study||0
8737846|NCT01099761|9785714|FG001|NOT COMPLETED|Overall Study||0
8737847|NCT01099761|9785715|FG002|NOT COMPLETED|Overall Study||0
8737848|NCT01099761|9785716|FG003|NOT COMPLETED|Overall Study||0
8737849|NCT01099774|9785727|FG000|STARTED|Overall Study||302
8737850|NCT01099774|9785728|FG001|STARTED|Overall Study||295
8737851|NCT01099774|9785727|FG000|COMPLETED|Overall Study||296
8737852|NCT01099774|9785728|FG001|COMPLETED|Overall Study||289
8737853|NCT01099774|9785727|FG000|NOT COMPLETED|Overall Study||6
8737854|NCT01099774|9785728|FG001|NOT COMPLETED|Overall Study||6
8737855|NCT01099917|9785734|FG000|STARTED|Overall Study||45
8737856|NCT01099917|9785734|FG000|COMPLETED|Overall Study||18
8737857|NCT01099917|9785734|FG000|NOT COMPLETED|Overall Study||27
8737858|NCT01099969|9785742|FG000|STARTED|Overall Study||15
8737859|NCT01099969|9785743|FG001|STARTED|Overall Study||15
9022532|NCT03128723|10085441|FG000|NOT COMPLETED|Overall Study||2
8737860|NCT01099969|9785744|FG002|STARTED|Overall Study||15
8737861|NCT01099969|9785745|FG003|STARTED|Overall Study||15
8737862|NCT01099969|9785742|FG000|COMPLETED|Overall Study||15
8737863|NCT01099969|9785743|FG001|COMPLETED|Overall Study||15
8737864|NCT01099969|9785744|FG002|COMPLETED|Overall Study||15
8737865|NCT01099969|9785745|FG003|COMPLETED|Overall Study||15
8737866|NCT01099969|9785742|FG000|NOT COMPLETED|Overall Study||0
8737867|NCT01099969|9785743|FG001|NOT COMPLETED|Overall Study||0
8737868|NCT01099969|9785744|FG002|NOT COMPLETED|Overall Study||0
8737869|NCT01099969|9785745|FG003|NOT COMPLETED|Overall Study||0
8737870|NCT01100034|9785755|FG000|STARTED|Overall Study||72
8737871|NCT01100034|9785755|FG000|COMPLETED|Overall Study||29
8737872|NCT01100034|9785755|FG000|NOT COMPLETED|Overall Study||43
8737873|NCT01100073|9785759|FG000|STARTED|Overall Study|Baseline (Visit 1)|1699
8737874|NCT01100073|9785759|FG000|COMPLETED|Overall Study|End of study (Visit 3)|1599
8737875|NCT01100073|9785759|FG000|NOT COMPLETED|Overall Study||100
8737876|NCT01100086|9785763|FG000|STARTED|Period 1||43
8737877|NCT01100086|9785764|FG001|STARTED|Period 1||41
8737878|NCT01100086|9785763|FG000|COMPLETED|Period 1||42
8737879|NCT01100086|9785764|FG001|COMPLETED|Period 1||41
8737880|NCT01100086|9785763|FG000|NOT COMPLETED|Period 1||1
8737881|NCT01100086|9785764|FG001|NOT COMPLETED|Period 1||0
8737882|NCT01100086|9785763|FG000|STARTED|Period 2||42
8737883|NCT01100086|9785764|FG001|STARTED|Period 2||41
8737884|NCT01100086|9785763|FG000|COMPLETED|Period 2||42
8737885|NCT01100086|9785764|FG001|COMPLETED|Period 2||41
8737886|NCT01100086|9785763|FG000|NOT COMPLETED|Period 2||0
8737887|NCT01100086|9785764|FG001|NOT COMPLETED|Period 2||0
8737888|NCT01100112|9785770|FG000|STARTED|Overall Study||60
8737889|NCT01100112|9785770|FG000|COMPLETED|Overall Study||52
8737890|NCT01100112|9785770|FG000|NOT COMPLETED|Overall Study||8
8737891|NCT01100242|9785774|FG000|STARTED|Overall Study||17
8737892|NCT01100242|9785774|FG000|COMPLETED|Overall Study||17
8737893|NCT01100242|9785774|FG000|NOT COMPLETED|Overall Study||0
8737894|NCT01100255|9785780|FG000|STARTED|Overall Study||8
8737895|NCT01100255|9785781|FG001|STARTED|Overall Study||7
8737896|NCT01100255|9785780|FG000|COMPLETED|Overall Study||8
8737897|NCT01100255|9785781|FG001|COMPLETED|Overall Study||7
8737898|NCT01100255|9785780|FG000|NOT COMPLETED|Overall Study||0
8737899|NCT01100255|9785781|FG001|NOT COMPLETED|Overall Study||0
8737900|NCT01100268|9785787|FG000|STARTED|Overall Study||4
8737901|NCT01100268|9785787|FG000|COMPLETED|Overall Study||4
8737902|NCT01100268|9785787|FG000|NOT COMPLETED|Overall Study||0
8737903|NCT01100307|9785793|FG000|STARTED|Double Masked Phase (Up to Week 24)||123
8737904|NCT01100307|9785794|FG001|STARTED|Double Masked Phase (Up to Week 24)||120
8737905|NCT01100307|9785793|FG000|COMPLETED|Double Masked Phase (Up to Week 24)||117
8737906|NCT01100307|9785794|FG001|COMPLETED|Double Masked Phase (Up to Week 24)||116
8737907|NCT01100307|9785793|FG000|NOT COMPLETED|Double Masked Phase (Up to Week 24)||6
8737908|NCT01100307|9785794|FG001|NOT COMPLETED|Double Masked Phase (Up to Week 24)||4
8737909|NCT01100307|9785793|FG000|STARTED|Open Phase (Week 24 up to Week 54)|One participant discontinued from the study due to adverse event before study drug administration.|116
8737910|NCT01100307|9785794|FG001|STARTED|Open Phase (Week 24 up to Week 54)|Four participants did not enter to the open phase after completing the double masked phase.|112
8737911|NCT01100307|9785793|FG000|COMPLETED|Open Phase (Week 24 up to Week 54)||110
8737912|NCT01100307|9785794|FG001|COMPLETED|Open Phase (Week 24 up to Week 54)||99
8737913|NCT01100307|9785793|FG000|NOT COMPLETED|Open Phase (Week 24 up to Week 54)||6
8737914|NCT01100307|9785794|FG001|NOT COMPLETED|Open Phase (Week 24 up to Week 54)||13
8737915|NCT01100320|9785802|FG000|STARTED|Period 1||43
8737916|NCT01100320|9785803|FG001|STARTED|Period 1||45
8737917|NCT01100320|9785802|FG000|COMPLETED|Period 1||38
8737918|NCT01100320|9785803|FG001|COMPLETED|Period 1||38
8737919|NCT01100320|9785802|FG000|NOT COMPLETED|Period 1||5
8737920|NCT01100320|9785803|FG001|NOT COMPLETED|Period 1||7
8737921|NCT01100320|9785802|FG000|STARTED|Period 2||38
8737922|NCT01100320|9785803|FG001|STARTED|Period 2||38
8737923|NCT01100320|9785802|FG000|COMPLETED|Period 2||37
8737924|NCT01100320|9785803|FG001|COMPLETED|Period 2||37
8737925|NCT01100320|9785802|FG000|NOT COMPLETED|Period 2||1
8737926|NCT01100320|9785803|FG001|NOT COMPLETED|Period 2||1
8737927|NCT01100437|9785809|FG000|STARTED|Screening||4
8737928|NCT01100437|9785810|FG001|STARTED|Screening||2
8737929|NCT01100437|9785811|FG002|STARTED|Screening||8
8737930|NCT01100437|9785809|FG000|COMPLETED|Screening||4
8737931|NCT01100437|9785810|FG001|COMPLETED|Screening||2
8737932|NCT01100437|9785811|FG002|COMPLETED|Screening||8
8737933|NCT01100437|9785809|FG000|NOT COMPLETED|Screening||0
8737934|NCT01100437|9785810|FG001|NOT COMPLETED|Screening||0
8737935|NCT01100437|9785811|FG002|NOT COMPLETED|Screening||0
8737936|NCT01100437|9785809|FG000|STARTED|Titration/Stabilization||4
8737937|NCT01100437|9785810|FG001|STARTED|Titration/Stabilization||2
8737938|NCT01100437|9785811|FG002|STARTED|Titration/Stabilization||8
8737939|NCT01100437|9785809|FG000|COMPLETED|Titration/Stabilization||4
8737940|NCT01100437|9785810|FG001|COMPLETED|Titration/Stabilization||2
8737941|NCT01100437|9785811|FG002|COMPLETED|Titration/Stabilization||2
8737942|NCT01100437|9785809|FG000|NOT COMPLETED|Titration/Stabilization||0
8737943|NCT01100437|9785810|FG001|NOT COMPLETED|Titration/Stabilization||0
8737944|NCT01100437|9785811|FG002|NOT COMPLETED|Titration/Stabilization||6
8737945|NCT01100437|9785809|FG000|STARTED|Maintenance||4
8737946|NCT01100437|9785810|FG001|STARTED|Maintenance||2
8737947|NCT01100437|9785811|FG002|STARTED|Maintenance||2
8737948|NCT01100437|9785809|FG000|COMPLETED|Maintenance||4
8737949|NCT01100437|9785810|FG001|COMPLETED|Maintenance||2
8737950|NCT01100437|9785811|FG002|COMPLETED|Maintenance||0
8737951|NCT01100437|9785809|FG000|NOT COMPLETED|Maintenance||0
8737952|NCT01100437|9785810|FG001|NOT COMPLETED|Maintenance||0
8737953|NCT01100437|9785811|FG002|NOT COMPLETED|Maintenance||2
8737954|NCT01100437|9785809|FG000|STARTED|Treatment 1||4
8737955|NCT01100437|9785810|FG001|STARTED|Treatment 1||2
8737956|NCT01100437|9785811|FG002|STARTED|Treatment 1||0
8737957|NCT01100437|9785809|FG000|COMPLETED|Treatment 1||4
8737958|NCT01100437|9785810|FG001|COMPLETED|Treatment 1||2
8737959|NCT01100437|9785811|FG002|COMPLETED|Treatment 1||0
8737960|NCT01100437|9785809|FG000|NOT COMPLETED|Treatment 1||0
8737961|NCT01100437|9785810|FG001|NOT COMPLETED|Treatment 1||0
8737962|NCT01100437|9785811|FG002|NOT COMPLETED|Treatment 1||0
8737963|NCT01100437|9785809|FG000|STARTED|Washout (4 Days)||4
8737964|NCT01100437|9785810|FG001|STARTED|Washout (4 Days)||2
8737965|NCT01100437|9785811|FG002|STARTED|Washout (4 Days)||0
8737966|NCT01100437|9785809|FG000|COMPLETED|Washout (4 Days)||4
8737967|NCT01100437|9785810|FG001|COMPLETED|Washout (4 Days)||2
8737968|NCT01100437|9785811|FG002|COMPLETED|Washout (4 Days)||0
8737969|NCT01100437|9785809|FG000|NOT COMPLETED|Washout (4 Days)||0
8737970|NCT01100437|9785810|FG001|NOT COMPLETED|Washout (4 Days)||0
8737971|NCT01100437|9785811|FG002|NOT COMPLETED|Washout (4 Days)||0
8737972|NCT01100437|9785809|FG000|STARTED|Treatment 2||4
8737973|NCT01100437|9785810|FG001|STARTED|Treatment 2||2
8737974|NCT01100437|9785811|FG002|STARTED|Treatment 2||0
8737975|NCT01100437|9785809|FG000|COMPLETED|Treatment 2||4
8737976|NCT01100437|9785810|FG001|COMPLETED|Treatment 2||2
8737977|NCT01100437|9785811|FG002|COMPLETED|Treatment 2||0
8737978|NCT01100437|9785809|FG000|NOT COMPLETED|Treatment 2||0
8737979|NCT01100437|9785810|FG001|NOT COMPLETED|Treatment 2||0
8737980|NCT01100437|9785811|FG002|NOT COMPLETED|Treatment 2||0
8737981|NCT01100502|9785822|FG000|STARTED|Overall Study||165
8737982|NCT01100502|9785823|FG001|STARTED|Overall Study||164
8737983|NCT01100502|9785822|FG000|COMPLETED|Overall Study|Completed due to study closure by sponsor|89
8737984|NCT01100502|9785823|FG001|COMPLETED|Overall Study|Completed due to study closure by sponsor|70
8737985|NCT01100502|9785822|FG000|NOT COMPLETED|Overall Study||76
8737986|NCT01100502|9785823|FG001|NOT COMPLETED|Overall Study||94
8737987|NCT01100528|9785829|FG000|STARTED|Overall Study||38
8737988|NCT01100528|9785829|FG000|COMPLETED|Overall Study||35
8737989|NCT01100528|9785829|FG000|NOT COMPLETED|Overall Study||3
8737990|NCT01100567|9785835|FG000|STARTED|Overall Study||50
8737991|NCT01100567|9785836|FG001|STARTED|Overall Study||51
8737992|NCT01100567|9785835|FG000|COMPLETED|Overall Study||38
8737993|NCT01100567|9785836|FG001|COMPLETED|Overall Study||35
8737994|NCT01100567|9785835|FG000|NOT COMPLETED|Overall Study||12
8737995|NCT01100567|9785836|FG001|NOT COMPLETED|Overall Study||16
8737996|NCT01100606|9785842|FG000|STARTED|First Treatment Period||8
8737997|NCT01100606|9785843|FG001|STARTED|First Treatment Period||7
8737998|NCT01100606|9785842|FG000|COMPLETED|First Treatment Period|Due to difficulty with syringe nurser,1 participant completed study with apple sauce,not apple juice|8
8737999|NCT01100606|9785843|FG001|COMPLETED|First Treatment Period||7
8738000|NCT01100606|9785842|FG000|NOT COMPLETED|First Treatment Period||0
8738001|NCT01100606|9785843|FG001|NOT COMPLETED|First Treatment Period||0
8738002|NCT01100606|9785842|FG000|STARTED|Second Treatment Period||8
8738003|NCT01100606|9785843|FG001|STARTED|Second Treatment Period||7
8738004|NCT01100606|9785842|FG000|COMPLETED|Second Treatment Period|Due to intolerance to apple sauce & apple juice,1 participant completed study with banana-based food|8
8738005|NCT01100606|9785843|FG001|COMPLETED|Second Treatment Period|Due to difficulty with syringe nurser, 1 participant completed study using apple sauce|7
8738006|NCT01100606|9785842|FG000|NOT COMPLETED|Second Treatment Period||0
8738007|NCT01100606|9785843|FG001|NOT COMPLETED|Second Treatment Period||0
8738008|NCT01100723|9785853|FG000|STARTED|Overall Study||92
8738009|NCT01100723|9785853|FG000|6 Month Analysis|Overall Study|85 subjects had laboratory data at the 6 month analysis and were compared to their baseline data.|85
8738010|NCT01100723|9785853|FG000|COMPLETED|Overall Study|78 subjects had laboratory data at the 12 month analysis and were compared to their baseline data.|78
8738011|NCT01100723|9785853|FG000|NOT COMPLETED|Overall Study||14
8738012|NCT01100762|9785858|FG000|STARTED|Overall Study||10
8738013|NCT01100762|9785858|FG000|COMPLETED|Overall Study||10
8738014|NCT01100762|9785858|FG000|NOT COMPLETED|Overall Study||0
8738015|NCT01100853|9785866|FG000|STARTED|Overall Study||51
8738016|NCT01100853|9785867|FG001|STARTED|Overall Study||49
8738017|NCT01100853|9785866|FG000|COMPLETED|Overall Study||24
8738018|NCT01100853|9785867|FG001|COMPLETED|Overall Study||26
8738019|NCT01100853|9785866|FG000|NOT COMPLETED|Overall Study||27
8738020|NCT01100853|9785867|FG001|NOT COMPLETED|Overall Study||23
8738021|NCT01100931|9785875|FG000|STARTED|Phase I||22
8738022|NCT01100931|9785876|FG001|STARTED|Phase I||0
8738023|NCT01100931|9785875|FG000|COMPLETED|Phase I||22
8738024|NCT01100931|9785876|FG001|COMPLETED|Phase I||0
8738025|NCT01100931|9785875|FG000|NOT COMPLETED|Phase I||0
8738026|NCT01100931|9785876|FG001|NOT COMPLETED|Phase I||0
8738027|NCT01100931|9785875|FG000|STARTED|Phase II||0
8738028|NCT01100931|9785876|FG001|STARTED|Phase II||19
8738029|NCT01100931|9785875|FG000|COMPLETED|Phase II||0
8738030|NCT01100931|9785876|FG001|COMPLETED|Phase II||19
8738031|NCT01100931|9785875|FG000|NOT COMPLETED|Phase II||0
8738032|NCT01100931|9785876|FG001|NOT COMPLETED|Phase II||0
8738033|NCT01100944|9785883|FG000|STARTED|Dose Escalation Phase 1 Dose Level 1||6
8738034|NCT01100944|9785884|FG001|STARTED|Dose Escalation Phase 1 Dose Level 1||0
8738035|NCT01100944|9785885|FG002|STARTED|Dose Escalation Phase 1 Dose Level 1||0
8738036|NCT01100944|9785883|FG000|COMPLETED|Dose Escalation Phase 1 Dose Level 1||2
8738037|NCT01100944|9785884|FG001|COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
8738038|NCT01100944|9785885|FG002|COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
8738039|NCT01100944|9785883|FG000|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 1||4
8738040|NCT01100944|9785884|FG001|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
8738041|NCT01100944|9785885|FG002|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
8738042|NCT01100944|9785883|FG000|STARTED|Dose Escalation Phase 1 Dose Level 2||0
8738043|NCT01100944|9785884|FG001|STARTED|Dose Escalation Phase 1 Dose Level 2||2
8738044|NCT01100944|9785885|FG002|STARTED|Dose Escalation Phase 1 Dose Level 2||0
8738045|NCT01100944|9785883|FG000|COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
8738046|NCT01100944|9785884|FG001|COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
8738047|NCT01100944|9785885|FG002|COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
8738048|NCT01100944|9785883|FG000|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
8738049|NCT01100944|9785884|FG001|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 2||2
8738050|NCT01100944|9785885|FG002|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
8738051|NCT01100944|9785883|FG000|STARTED|Expansion Phase - Phase 2||0
8738052|NCT01100944|9785884|FG001|STARTED|Expansion Phase - Phase 2||0
8738053|NCT01100944|9785885|FG002|STARTED|Expansion Phase - Phase 2||18
8738054|NCT01100944|9785883|FG000|COMPLETED|Expansion Phase - Phase 2||0
8738055|NCT01100944|9785884|FG001|COMPLETED|Expansion Phase - Phase 2||0
8738056|NCT01100944|9785885|FG002|COMPLETED|Expansion Phase - Phase 2||18
8738057|NCT01100944|9785883|FG000|NOT COMPLETED|Expansion Phase - Phase 2||0
8738058|NCT01100944|9785884|FG001|NOT COMPLETED|Expansion Phase - Phase 2||0
8738059|NCT01100944|9785885|FG002|NOT COMPLETED|Expansion Phase - Phase 2||0
8738060|NCT01101022|9785908|FG000|STARTED|Overall Study||79
8738061|NCT01101022|9785909|FG001|STARTED|Overall Study||80
8738062|NCT01101022|9785908|FG000|COMPLETED|Overall Study||62
8738063|NCT01101022|9785909|FG001|COMPLETED|Overall Study||53
8738064|NCT01101022|9785908|FG000|NOT COMPLETED|Overall Study||17
8738065|NCT01101022|9785909|FG001|NOT COMPLETED|Overall Study||27
8738066|NCT01101035|9785917|FG000|STARTED|Overall Study||3101
8738067|NCT01101035|9785918|FG001|STARTED|Overall Study||3097
8738068|NCT01101035|9785917|FG000|COMPLETED|Overall Study||1704
8738069|NCT01101035|9785918|FG001|COMPLETED|Overall Study||1706
8738070|NCT01101035|9785917|FG000|NOT COMPLETED|Overall Study||1397
8738071|NCT01101035|9785918|FG001|NOT COMPLETED|Overall Study||1391
8738072|NCT01101061|9785930|FG000|STARTED|Overall Study||6
8738073|NCT01101061|9785931|FG001|STARTED|Overall Study||6
8738074|NCT01101061|9785932|FG002|STARTED|Overall Study||7
8738075|NCT01101061|9785933|FG003|STARTED|Overall Study||6
8738076|NCT01101061|9785934|FG004|STARTED|Overall Study||2
8738077|NCT01101061|9785935|FG005|STARTED|Overall Study||4
8738078|NCT01101061|9785930|FG000|Received Study Drug|Overall Study||6
8738079|NCT01101061|9785931|FG001|Received Study Drug|Overall Study||6
8738080|NCT01101061|9785932|FG002|Received Study Drug|Overall Study||6
8738081|NCT01101061|9785933|FG003|Received Study Drug|Overall Study||6
8738082|NCT01101061|9785934|FG004|Received Study Drug|Overall Study||2
8738083|NCT01101061|9785935|FG005|Received Study Drug|Overall Study||4
8738084|NCT01101061|9785930|FG000|COMPLETED|Overall Study||6
8738085|NCT01101061|9785931|FG001|COMPLETED|Overall Study||6
8738086|NCT01101061|9785932|FG002|COMPLETED|Overall Study||6
8738087|NCT01101061|9785933|FG003|COMPLETED|Overall Study||6
8738088|NCT01101061|9785934|FG004|COMPLETED|Overall Study||2
8738089|NCT01101061|9785935|FG005|COMPLETED|Overall Study||4
8738090|NCT01101061|9785930|FG000|NOT COMPLETED|Overall Study||0
8738091|NCT01101061|9785931|FG001|NOT COMPLETED|Overall Study||0
8738092|NCT01101061|9785932|FG002|NOT COMPLETED|Overall Study||1
8738093|NCT01101061|9785933|FG003|NOT COMPLETED|Overall Study||0
8738094|NCT01101061|9785934|FG004|NOT COMPLETED|Overall Study||0
8738095|NCT01101061|9785935|FG005|NOT COMPLETED|Overall Study||0
8738096|NCT01101100|9785953|FG000|STARTED|Overall Study||181
8738097|NCT01101100|9785953|FG000|COMPLETED|Overall Study||126
8738098|NCT01101100|9785953|FG000|NOT COMPLETED|Overall Study||55
8738099|NCT01101165|9785958|FG000|STARTED|Period 1||47
8738100|NCT01101165|9785959|FG001|STARTED|Period 1||45
8738101|NCT01101165|9785958|FG000|COMPLETED|Period 1||45
8738102|NCT01101165|9785959|FG001|COMPLETED|Period 1||40
8738103|NCT01101165|9785958|FG000|NOT COMPLETED|Period 1||2
8738104|NCT01101165|9785959|FG001|NOT COMPLETED|Period 1||5
8738105|NCT01101165|9785958|FG000|STARTED|Period 2||45
8738106|NCT01101165|9785959|FG001|STARTED|Period 2||40
8738107|NCT01101165|9785958|FG000|COMPLETED|Period 2||41
8738108|NCT01101165|9785959|FG001|COMPLETED|Period 2||39
8738109|NCT01101165|9785958|FG000|NOT COMPLETED|Period 2||4
8738110|NCT01101165|9785959|FG001|NOT COMPLETED|Period 2||1
8738111|NCT01101178|9785965|FG000|STARTED|Period 1||40
8738112|NCT01101178|9785966|FG001|STARTED|Period 1||39
8738113|NCT01101178|9785965|FG000|COMPLETED|Period 1||36
8738114|NCT01101178|9785966|FG001|COMPLETED|Period 1||35
8738115|NCT01101178|9785965|FG000|NOT COMPLETED|Period 1||4
8738116|NCT01101178|9785966|FG001|NOT COMPLETED|Period 1||4
8738117|NCT01101178|9785965|FG000|STARTED|Period 2||36
8738118|NCT01101178|9785966|FG001|STARTED|Period 2||35
8738119|NCT01101178|9785965|FG000|COMPLETED|Period 2||36
8738120|NCT01101178|9785966|FG001|COMPLETED|Period 2||34
8738121|NCT01101178|9785965|FG000|NOT COMPLETED|Period 2||0
8738122|NCT01101178|9785966|FG001|NOT COMPLETED|Period 2||1
8738123|NCT01101191|9785973|FG000|STARTED|Period 1||42
8738124|NCT01101191|9785974|FG001|STARTED|Period 1||42
8738125|NCT01101191|9785973|FG000|COMPLETED|Period 1||40
8738126|NCT01101191|9785974|FG001|COMPLETED|Period 1||40
8738127|NCT01101191|9785973|FG000|NOT COMPLETED|Period 1||2
8738128|NCT01101191|9785974|FG001|NOT COMPLETED|Period 1||2
8738129|NCT01101191|9785973|FG000|STARTED|Period 2||40
8738130|NCT01101191|9785974|FG001|STARTED|Period 2||40
8738131|NCT01101191|9785973|FG000|COMPLETED|Period 2||40
8738132|NCT01101191|9785974|FG001|COMPLETED|Period 2||40
8738133|NCT01101191|9785973|FG000|NOT COMPLETED|Period 2||0
8738134|NCT01101191|9785974|FG001|NOT COMPLETED|Period 2||0
8738135|NCT01101308|9785981|FG000|STARTED|Period 1||27
8738136|NCT01101308|9785982|FG001|STARTED|Period 1||28
8738137|NCT01101308|9785981|FG000|COMPLETED|Period 1||24
8738138|NCT01101308|9785982|FG001|COMPLETED|Period 1||27
8738139|NCT01101308|9785981|FG000|NOT COMPLETED|Period 1||3
8738140|NCT01101308|9785982|FG001|NOT COMPLETED|Period 1||1
8738141|NCT01101308|9785981|FG000|STARTED|Period 2||24
8738142|NCT01101308|9785982|FG001|STARTED|Period 2||27
8738143|NCT01101308|9785981|FG000|COMPLETED|Period 2||24
8738144|NCT01101308|9785982|FG001|COMPLETED|Period 2||27
8738145|NCT01101308|9785981|FG000|NOT COMPLETED|Period 2||0
8738146|NCT01101308|9785982|FG001|NOT COMPLETED|Period 2||0
8738147|NCT01101321|9785989|FG000|STARTED|Period 1||30
8738148|NCT01101321|9785990|FG001|STARTED|Period 1||28
8738149|NCT01101321|9785989|FG000|COMPLETED|Period 1||26
8738150|NCT01101321|9785990|FG001|COMPLETED|Period 1||24
8738151|NCT01101321|9785989|FG000|NOT COMPLETED|Period 1||4
8738152|NCT01101321|9785990|FG001|NOT COMPLETED|Period 1||4
8738153|NCT01101321|9785989|FG000|STARTED|Period 2||26
8738154|NCT01101321|9785990|FG001|STARTED|Period 2||24
8738155|NCT01101321|9785989|FG000|COMPLETED|Period 2||26
8738156|NCT01101321|9785990|FG001|COMPLETED|Period 2||24
8738157|NCT01101321|9785989|FG000|NOT COMPLETED|Period 2||0
8738158|NCT01101321|9785990|FG001|NOT COMPLETED|Period 2||0
8738159|NCT01101334|9785998|FG000|STARTED|Overall Study||45
8738160|NCT01101334|9785999|FG001|STARTED|Overall Study||45
8738161|NCT01101334|9785998|FG000|Received Study Treatment|Overall Study||44
8738162|NCT01101334|9785999|FG001|Received Study Treatment|Overall Study||45
8738163|NCT01101334|9785998|FG000|COMPLETED|Overall Study||0
8738164|NCT01101334|9785999|FG001|COMPLETED|Overall Study||0
8738165|NCT01101334|9785998|FG000|NOT COMPLETED|Overall Study||45
8738166|NCT01101334|9785999|FG001|NOT COMPLETED|Overall Study||45
8738167|NCT01101477|9786008|FG000|STARTED|Overall Study||49
8738168|NCT01101477|9786009|FG001|STARTED|Overall Study||49
8738169|NCT01101477|9786010|FG002|STARTED|Overall Study||46
8738170|NCT01101477|9786008|FG000|COMPLETED|Overall Study||44
8738171|NCT01101477|9786009|FG001|COMPLETED|Overall Study||46
8738172|NCT01101477|9786010|FG002|COMPLETED|Overall Study||45
8738173|NCT01101477|9786008|FG000|NOT COMPLETED|Overall Study||5
8738174|NCT01101477|9786009|FG001|NOT COMPLETED|Overall Study||3
8738175|NCT01101477|9786010|FG002|NOT COMPLETED|Overall Study||1
8738176|NCT01101542|9786018|FG000|STARTED|Year 3 Surveillance Period||105
8738177|NCT01101542|9786018|FG000|COMPLETED|Year 3 Surveillance Period||94
8738178|NCT01101542|9786018|FG000|NOT COMPLETED|Year 3 Surveillance Period||11
8738179|NCT01101542|9786018|FG000|STARTED|Year 4 Surveillance Period||569
8738180|NCT01101542|9786018|FG000|COMPLETED|Year 4 Surveillance Period||282
8738181|NCT01101542|9786018|FG000|NOT COMPLETED|Year 4 Surveillance Period||287
8738182|NCT01101542|9786018|FG000|STARTED|Year 5 Surveillance Period||809
8738183|NCT01101542|9786018|FG000|COMPLETED|Year 5 Surveillance Period||668
8738184|NCT01101542|9786018|FG000|NOT COMPLETED|Year 5 Surveillance Period||141
8738185|NCT01101542|9786018|FG000|STARTED|Year 6 Surveillance Period||3091
8738186|NCT01101542|9786018|FG000|COMPLETED|Year 6 Surveillance Period||2100
8738187|NCT01101542|9786018|FG000|NOT COMPLETED|Year 6 Surveillance Period||991
8738188|NCT01101750|9786022|FG000|STARTED|Overall Study||25
8738189|NCT01101750|9786022|FG000|COMPLETED|Overall Study||9
8738190|NCT01101750|9786022|FG000|NOT COMPLETED|Overall Study||16
8738191|NCT01101841|9786028|FG000|STARTED|Overall Study||285
8738192|NCT01101841|9786029|FG001|STARTED|Overall Study||285
8738193|NCT01101841|9786028|FG000|COMPLETED|Overall Study||235
8738194|NCT01101841|9786029|FG001|COMPLETED|Overall Study||218
8738195|NCT01101841|9786028|FG000|NOT COMPLETED|Overall Study||50
8738196|NCT01101841|9786029|FG001|NOT COMPLETED|Overall Study||67
8738197|NCT01101867|9786038|FG000|STARTED|Overall Study||63
8738198|NCT01101867|9786039|FG001|STARTED|Overall Study||63
8738199|NCT01101867|9786038|FG000|COMPLETED|Overall Study||62
8738200|NCT01101867|9786039|FG001|COMPLETED|Overall Study||59
8738201|NCT01101867|9786038|FG000|NOT COMPLETED|Overall Study||1
8738202|NCT01101867|9786039|FG001|NOT COMPLETED|Overall Study||4
8738203|NCT01101880|9786049|FG000|STARTED|Overall Study||50
8738204|NCT01101880|9786049|FG000|COMPLETED|Overall Study||50
8738205|NCT01101880|9786049|FG000|NOT COMPLETED|Overall Study||0
8738206|NCT01101958|9786055|FG000|STARTED|Overall Study||62
8738207|NCT01101958|9786056|FG001|STARTED|Overall Study||34
8738208|NCT01101958|9786055|FG000|COMPLETED|Overall Study||51
8738209|NCT01101958|9786056|FG001|COMPLETED|Overall Study||29
8738210|NCT01101958|9786055|FG000|NOT COMPLETED|Overall Study||11
8738211|NCT01101958|9786056|FG001|NOT COMPLETED|Overall Study||5
8738212|NCT01101971|9786062|FG000|STARTED|Overall Study||45
8738213|NCT01101971|9786062|FG000|COMPLETED|Overall Study||45
8738214|NCT01101971|9786062|FG000|NOT COMPLETED|Overall Study||0
8738215|NCT01101997|9786066|FG000|STARTED|Overall Study||60
8738216|NCT01101997|9786066|FG000|COMPLETED|Overall Study||58
8738217|NCT01101997|9786066|FG000|NOT COMPLETED|Overall Study||2
8738218|NCT01102218|9786074|FG000|STARTED|Overall Study||24
8738219|NCT01102218|9786075|FG001|STARTED|Overall Study||24
8738220|NCT01102218|9786074|FG000|COMPLETED|Overall Study||13
8738221|NCT01102218|9786075|FG001|COMPLETED|Overall Study||14
8738222|NCT01102218|9786074|FG000|NOT COMPLETED|Overall Study||11
8738223|NCT01102218|9786075|FG001|NOT COMPLETED|Overall Study||10
8738224|NCT01102231|9786081|FG000|STARTED|Overall Study||106
8738225|NCT01102231|9786081|FG000|COMPLETED|Overall Study||91
8738226|NCT01102231|9786081|FG000|NOT COMPLETED|Overall Study||15
8738227|NCT01102257|9786088|FG000|STARTED|Overall Study||9
8738228|NCT01102257|9786089|FG001|STARTED|Overall Study||9
8738229|NCT01102257|9786088|FG000|COMPLETED|Overall Study|2 withdrew from the study d/t adverse events. 1 had shortness of breath and the other had chest pain|7
8738230|NCT01102257|9786089|FG001|COMPLETED|Overall Study||9
8738231|NCT01102257|9786088|FG000|NOT COMPLETED|Overall Study||2
8738232|NCT01102257|9786089|FG001|NOT COMPLETED|Overall Study||0
8738233|NCT01102270|9786095|FG000|STARTED|Overall Study||8
8738234|NCT01102270|9786096|FG001|STARTED|Overall Study||9
8738235|NCT01102270|9786095|FG000|COMPLETED|Overall Study||8
8738236|NCT01102270|9786096|FG001|COMPLETED|Overall Study||9
8738237|NCT01102270|9786095|FG000|NOT COMPLETED|Overall Study||0
8738238|NCT01102270|9786096|FG001|NOT COMPLETED|Overall Study||0
8738239|NCT01102374|9786104|FG000|STARTED|Overall Study||55
8738240|NCT01102374|9786105|FG001|STARTED|Overall Study||52
8738241|NCT01102374|9786104|FG000|COMPLETED|Overall Study||39
8738242|NCT01102374|9786105|FG001|COMPLETED|Overall Study||33
8738243|NCT01102374|9786104|FG000|NOT COMPLETED|Overall Study||16
8738244|NCT01102374|9786105|FG001|NOT COMPLETED|Overall Study||19
8738245|NCT01102413|9786113|FG000|STARTED|Overall Study||233
8738246|NCT01102413|9786114|FG001|STARTED|Overall Study||118
8738247|NCT01102413|9786113|FG000|COMPLETED|Overall Study||208
8738248|NCT01102413|9786114|FG001|COMPLETED|Overall Study||106
8738249|NCT01102413|9786113|FG000|NOT COMPLETED|Overall Study||25
8738250|NCT01102413|9786114|FG001|NOT COMPLETED|Overall Study||12
8738251|NCT01102426|9786122|FG000|STARTED|Overall Study||171
8738252|NCT01102426|9786123|FG001|STARTED|Overall Study||84
8738253|NCT01102426|9786122|FG000|COMPLETED|Overall Study||6
8738254|NCT01102426|9786123|FG001|COMPLETED|Overall Study||3
8738255|NCT01102426|9786122|FG000|NOT COMPLETED|Overall Study||165
8738256|NCT01102426|9786123|FG001|NOT COMPLETED|Overall Study||81
8738257|NCT01102491|9786131|FG000|STARTED|Overall Study||71
8738258|NCT01102491|9786132|FG001|STARTED|Overall Study||71
8738259|NCT01102491|9786131|FG000|COMPLETED|Overall Study|11 patient excluded|60
8738260|NCT01102491|9786132|FG001|COMPLETED|Overall Study|12 patients were excluded|59
8738261|NCT01102491|9786131|FG000|NOT COMPLETED|Overall Study||11
8738262|NCT01102491|9786132|FG001|NOT COMPLETED|Overall Study||12
8738263|NCT01102738|9786138|FG000|STARTED|Overall Study||369
8738264|NCT01102738|9786138|FG000|COMPLETED|Overall Study||369
8738265|NCT01102738|9786138|FG000|NOT COMPLETED|Overall Study||0
8738266|NCT01102764|9786144|FG000|STARTED|Overall Study||64
8738267|NCT01102764|9786145|FG001|STARTED|Overall Study||68
8738268|NCT01102764|9786144|FG000|COMPLETED|Overall Study||43
8738269|NCT01102764|9786145|FG001|COMPLETED|Overall Study||55
8738270|NCT01102764|9786144|FG000|NOT COMPLETED|Overall Study||21
8738271|NCT01102764|9786145|FG001|NOT COMPLETED|Overall Study||13
8738272|NCT01102777|9786153|FG000|STARTED|Overall Study||84
8738273|NCT01102777|9786154|FG001|STARTED|Overall Study||155
8738274|NCT01102777|9786153|FG000|COMPLETED|Overall Study||75
8738275|NCT01102777|9786154|FG001|COMPLETED|Overall Study||139
8738276|NCT01102777|9786153|FG000|NOT COMPLETED|Overall Study||9
8738277|NCT01102777|9786154|FG001|NOT COMPLETED|Overall Study||16
8738278|NCT01102803|9786163|FG000|STARTED|Baseline to Post-Treatment||14
8738279|NCT01102803|9786164|FG001|STARTED|Baseline to Post-Treatment||15
8738280|NCT01102803|9786163|FG000|COMPLETED|Baseline to Post-Treatment||11
8738281|NCT01102803|9786164|FG001|COMPLETED|Baseline to Post-Treatment||15
8738282|NCT01102803|9786163|FG000|NOT COMPLETED|Baseline to Post-Treatment||3
8738283|NCT01102803|9786164|FG001|NOT COMPLETED|Baseline to Post-Treatment||0
8738284|NCT01102803|9786163|FG000|STARTED|Post to Follow-Up||11
8738285|NCT01102803|9786164|FG001|STARTED|Post to Follow-Up||15
8738286|NCT01102803|9786163|FG000|COMPLETED|Post to Follow-Up||10
8738287|NCT01102803|9786164|FG001|COMPLETED|Post to Follow-Up||12
8738288|NCT01102803|9786163|FG000|NOT COMPLETED|Post to Follow-Up||1
8738289|NCT01102803|9786164|FG001|NOT COMPLETED|Post to Follow-Up||3
8738290|NCT01102894|9786172|FG000|STARTED|Overall Study||10
8738291|NCT01102894|9786172|FG000|COMPLETED|Overall Study||10
8738292|NCT01102894|9786172|FG000|NOT COMPLETED|Overall Study||0
8738293|NCT01102972|9786180|FG000|STARTED|Overall Study|"297 PAR enrolled. 1 PAR withdrew before taking investigational product and didn't start the study."|199
8738294|NCT01102972|9786181|FG001|STARTED|Overall Study|"297 PAR enrolled. 1 PAR withdrew before taking investigational product and didn't start the study."|97
8738295|NCT01102972|9786180|FG000|Completed Week 24|Overall Study||180
8738296|NCT01102972|9786181|FG001|Completed Week 24|Overall Study||88
8738297|NCT01102972|9786180|FG000|COMPLETED|Overall Study|These participants completed Study Week 48.|170
8738298|NCT01102972|9786181|FG001|COMPLETED|Overall Study|These participants completed Study Week 48.|83
8738299|NCT01102972|9786180|FG000|NOT COMPLETED|Overall Study||29
8738300|NCT01102972|9786181|FG001|NOT COMPLETED|Overall Study||14
8738301|NCT01103063|9786189|FG000|STARTED|Overall Study||1446
8738302|NCT01103063|9786190|FG001|STARTED|Overall Study||1445
9022533|NCT03128892|10085445|FG000|STARTED|Overall Study||34
9022534|NCT03128892|10085445|FG000|COMPLETED|Overall Study||31
9022535|NCT03128892|10085445|FG000|NOT COMPLETED|Overall Study||3
9022536|NCT03129100|10085454|FG000|STARTED|Lead-In Period (Period 1)||350
9022537|NCT03129100|10085455|FG001|STARTED|Lead-In Period (Period 1)||423
9022538|NCT03129100|10085456|FG002|STARTED|Lead-In Period (Period 1)||0
9022539|NCT03129100|10085457|FG003|STARTED|Lead-In Period (Period 1)||0
9022540|NCT03129100|10085458|FG004|STARTED|Lead-In Period (Period 1)||0
9022541|NCT03129100|10085459|FG005|STARTED|Lead-In Period (Period 1)||0
9022542|NCT03129100|10085460|FG006|STARTED|Lead-In Period (Period 1)||0
9022543|NCT03129100|10085461|FG007|STARTED|Lead-In Period (Period 1)||0
8738303|NCT01103063|9786189|FG000|COMPLETED|Overall Study||969
8738304|NCT01103063|9786190|FG001|COMPLETED|Overall Study||1024
8738305|NCT01103063|9786189|FG000|NOT COMPLETED|Overall Study||477
8738306|NCT01103063|9786190|FG001|NOT COMPLETED|Overall Study||421
8738307|NCT01103141|9786200|FG000|STARTED|Overall Study||67
8738308|NCT01103141|9786201|FG001|STARTED|Overall Study||76
8738309|NCT01103141|9786200|FG000|COMPLETED|Overall Study||65
8738310|NCT01103141|9786201|FG001|COMPLETED|Overall Study||74
8738311|NCT01103141|9786200|FG000|NOT COMPLETED|Overall Study||2
8738312|NCT01103141|9786201|FG001|NOT COMPLETED|Overall Study||2
8738313|NCT01103232|9786209|FG000|STARTED|Overall Study||13
8738314|NCT01103232|9786210|FG001|STARTED|Overall Study||13
8738315|NCT01103232|9786209|FG000|COMPLETED|Overall Study||12
8738316|NCT01103232|9786210|FG001|COMPLETED|Overall Study||11
8738317|NCT01103232|9786209|FG000|NOT COMPLETED|Overall Study||1
8738318|NCT01103232|9786210|FG001|NOT COMPLETED|Overall Study||2
8738319|NCT01103245|9786220|FG000|STARTED|Overall Study||13
8738320|NCT01103245|9786221|FG001|STARTED|Overall Study||7
8738321|NCT01103245|9786222|FG002|STARTED|Overall Study||12
8738322|NCT01103245|9786223|FG003|STARTED|Overall Study||6
8738323|NCT01103245|9786220|FG000|COMPLETED|Overall Study||10
8738324|NCT01103245|9786221|FG001|COMPLETED|Overall Study||5
8738325|NCT01103245|9786222|FG002|COMPLETED|Overall Study||8
8738326|NCT01103245|9786223|FG003|COMPLETED|Overall Study||6
8738327|NCT01103245|9786220|FG000|NOT COMPLETED|Overall Study||3
8738328|NCT01103245|9786221|FG001|NOT COMPLETED|Overall Study||2
8738329|NCT01103245|9786222|FG002|NOT COMPLETED|Overall Study||4
8738330|NCT01103245|9786223|FG003|NOT COMPLETED|Overall Study||0
8738331|NCT01103271|9786235|FG000|STARTED|Overall Study||11
8738332|NCT01103271|9786236|FG001|STARTED|Overall Study||9
8738333|NCT01103271|9786235|FG000|COMPLETED|Overall Study||10
8738334|NCT01103271|9786236|FG001|COMPLETED|Overall Study||5
8738335|NCT01103271|9786235|FG000|NOT COMPLETED|Overall Study||1
8738336|NCT01103271|9786236|FG001|NOT COMPLETED|Overall Study||4
8738337|NCT01103284|9786245|FG000|STARTED|Overall Study||236
8738338|NCT01103284|9786246|FG001|STARTED|Overall Study||239
8738339|NCT01103284|9786245|FG000|Treated|Overall Study||236
8738340|NCT01103284|9786246|FG001|Treated|Overall Study||238
8738341|NCT01103284|9786245|FG000|At Least One Post-baseline Visit (FAS)|Overall Study|Patients reaching this milestone were included in the Full Analysis Set (FAS) population|233
8738342|NCT01103284|9786246|FG001|At Least One Post-baseline Visit (FAS)|Overall Study|Patients reaching this milestone were included in the Full Analysis Set (FAS)|235
8738343|NCT01103284|9786245|FG000|COMPLETED|Overall Study||194
8738344|NCT01103284|9786246|FG001|COMPLETED|Overall Study||195
8738345|NCT01103284|9786245|FG000|NOT COMPLETED|Overall Study||42
8738346|NCT01103284|9786246|FG001|NOT COMPLETED|Overall Study||44
8738347|NCT01103323|9786254|FG000|STARTED|Without/Before Drug Switch||505
8738348|NCT01103323|9786255|FG001|STARTED|Without/Before Drug Switch||255
8738349|NCT01103323|9786254|FG000|Participants Received Treatment|Without/Before Drug Switch||500
8738350|NCT01103323|9786255|FG001|Participants Received Treatment|Without/Before Drug Switch||253
8738351|NCT01103323|9786254|FG000|COMPLETED|Without/Before Drug Switch||429
8738352|NCT01103323|9786255|FG001|COMPLETED|Without/Before Drug Switch||237
8738353|NCT01103323|9786254|FG000|NOT COMPLETED|Without/Before Drug Switch||76
8738354|NCT01103323|9786255|FG001|NOT COMPLETED|Without/Before Drug Switch||18
8738355|NCT01103323|9786254|FG000|STARTED|Switched From Placebo to Regorafenib||0
8738356|NCT01103323|9786255|FG001|STARTED|Switched From Placebo to Regorafenib|Participants in the placebo+BSC group switched to Regorafenib treatment after unblinding.|4
8738357|NCT01103323|9786254|FG000|COMPLETED|Switched From Placebo to Regorafenib||0
8738358|NCT01103323|9786255|FG001|COMPLETED|Switched From Placebo to Regorafenib||3
8738359|NCT01103323|9786254|FG000|NOT COMPLETED|Switched From Placebo to Regorafenib||0
8738360|NCT01103323|9786255|FG001|NOT COMPLETED|Switched From Placebo to Regorafenib||1
8738361|NCT01103362|9786262|FG000|STARTED|Overall Study||596
8738362|NCT01103362|9786262|FG000|COMPLETED|Overall Study||0
8738363|NCT01103362|9786262|FG000|NOT COMPLETED|Overall Study||596
8738364|NCT01103414|9786271|FG000|STARTED|Overall Study||72
8738365|NCT01103414|9786272|FG001|STARTED|Overall Study||71
8738366|NCT01103414|9786273|FG002|STARTED|Overall Study||71
8738367|NCT01103414|9786274|FG003|STARTED|Overall Study||71
8738368|NCT01103414|9786275|FG004|STARTED|Overall Study||71
8738369|NCT01103414|9786271|FG000|COMPLETED|Overall Study||59
8738370|NCT01103414|9786272|FG001|COMPLETED|Overall Study||62
8738371|NCT01103414|9786273|FG002|COMPLETED|Overall Study||56
8738372|NCT01103414|9786274|FG003|COMPLETED|Overall Study||64
8738373|NCT01103414|9786275|FG004|COMPLETED|Overall Study||56
8738374|NCT01103414|9786271|FG000|NOT COMPLETED|Overall Study||13
8738375|NCT01103414|9786272|FG001|NOT COMPLETED|Overall Study||9
8738376|NCT01103414|9786273|FG002|NOT COMPLETED|Overall Study||15
8738377|NCT01103414|9786274|FG003|NOT COMPLETED|Overall Study||7
8738378|NCT01103414|9786275|FG004|NOT COMPLETED|Overall Study||15
8738379|NCT01103440|9786289|FG000|STARTED|Overall Study||18
9022544|NCT03129100|10085462|FG008|STARTED|Lead-In Period (Period 1)||0
8738380|NCT01103440|9786290|FG001|STARTED|Overall Study||18
8738381|NCT01103440|9786289|FG000|COMPLETED|Overall Study||18
8738382|NCT01103440|9786290|FG001|COMPLETED|Overall Study||18
8738383|NCT01103440|9786289|FG000|NOT COMPLETED|Overall Study||0
8738384|NCT01103440|9786290|FG001|NOT COMPLETED|Overall Study||0
8738385|NCT01103466|9786296|FG000|STARTED|First Period (14 +/- 3 Days)||12
8738386|NCT01103466|9786297|FG001|STARTED|First Period (14 +/- 3 Days)||12
8738387|NCT01103466|9786298|FG002|STARTED|First Period (14 +/- 3 Days)||13
8738388|NCT01103466|9786296|FG000|COMPLETED|First Period (14 +/- 3 Days)||10
8738389|NCT01103466|9786297|FG001|COMPLETED|First Period (14 +/- 3 Days)||12
8738390|NCT01103466|9786298|FG002|COMPLETED|First Period (14 +/- 3 Days)||13
8738391|NCT01103466|9786296|FG000|NOT COMPLETED|First Period (14 +/- 3 Days)||2
8738392|NCT01103466|9786297|FG001|NOT COMPLETED|First Period (14 +/- 3 Days)||0
8738393|NCT01103466|9786298|FG002|NOT COMPLETED|First Period (14 +/- 3 Days)||0
8738394|NCT01103466|9786296|FG000|STARTED|Second Period (14 +/- 3 Days)||15
8738395|NCT01103466|9786297|FG001|STARTED|Second Period (14 +/- 3 Days)||13
8738396|NCT01103466|9786298|FG002|STARTED|Second Period (14 +/- 3 Days)||7
8738397|NCT01103466|9786296|FG000|COMPLETED|Second Period (14 +/- 3 Days)||13
8738398|NCT01103466|9786297|FG001|COMPLETED|Second Period (14 +/- 3 Days)||11
8738399|NCT01103466|9786298|FG002|COMPLETED|Second Period (14 +/- 3 Days)||6
8738400|NCT01103466|9786296|FG000|NOT COMPLETED|Second Period (14 +/- 3 Days)||2
8738401|NCT01103466|9786297|FG001|NOT COMPLETED|Second Period (14 +/- 3 Days)||2
8738402|NCT01103466|9786298|FG002|NOT COMPLETED|Second Period (14 +/- 3 Days)||1
8738403|NCT01103466|9786296|FG000|STARTED|Third Period (14 +/- 3 Days)||8
8738404|NCT01103466|9786297|FG001|STARTED|Third Period (14 +/- 3 Days)||8
8738405|NCT01103466|9786298|FG002|STARTED|Third Period (14 +/- 3 Days)||14
8738406|NCT01103466|9786296|FG000|COMPLETED|Third Period (14 +/- 3 Days)||6
8738407|NCT01103466|9786297|FG001|COMPLETED|Third Period (14 +/- 3 Days)||8
8738408|NCT01103466|9786298|FG002|COMPLETED|Third Period (14 +/- 3 Days)||13
8738409|NCT01103466|9786296|FG000|NOT COMPLETED|Third Period (14 +/- 3 Days)||2
8738410|NCT01103466|9786297|FG001|NOT COMPLETED|Third Period (14 +/- 3 Days)||0
8738411|NCT01103466|9786298|FG002|NOT COMPLETED|Third Period (14 +/- 3 Days)||1
8738412|NCT01103479|9786309|FG000|STARTED|Overall Study||168
8912315|NCT02152384|9971399|FG000|COMPLETED|Run In (1-5 Week Transition)||14
8912316|NCT02152384|9971400|FG001|COMPLETED|Run In (1-5 Week Transition)||14
8912317|NCT02152384|9971399|FG000|NOT COMPLETED|Run In (1-5 Week Transition)||0
8912318|NCT02152384|9971400|FG001|NOT COMPLETED|Run In (1-5 Week Transition)||0
8912319|NCT02152384|9971399|FG000|STARTED|Period 1||14
8912320|NCT02152384|9971400|FG001|STARTED|Period 1||14
8912321|NCT02152384|9971399|FG000|Received at Least 1 Dose of Study Drug|Period 1||14
8912322|NCT02152384|9971400|FG001|Received at Least 1 Dose of Study Drug|Period 1||14
8912323|NCT02152384|9971399|FG000|COMPLETED|Period 1||13
8912324|NCT02152384|9971400|FG001|COMPLETED|Period 1||12
8912325|NCT02152384|9971399|FG000|NOT COMPLETED|Period 1||1
8912326|NCT02152384|9971400|FG001|NOT COMPLETED|Period 1||2
8912327|NCT02152384|9971399|FG000|STARTED|Period 2||13
8912328|NCT02152384|9971400|FG001|STARTED|Period 2||12
8912329|NCT02152384|9971399|FG000|COMPLETED|Period 2||13
8912330|NCT02152384|9971400|FG001|COMPLETED|Period 2||12
8912331|NCT02152384|9971399|FG000|NOT COMPLETED|Period 2||0
8912332|NCT02152384|9971400|FG001|NOT COMPLETED|Period 2||0
8912333|NCT02152540|9971412|FG000|STARTED|Overall Study||17
8912334|NCT02152540|9971413|FG001|STARTED|Overall Study||16
8912335|NCT02152540|9971412|FG000|COMPLETED|Overall Study||17
8912336|NCT02152540|9971413|FG001|COMPLETED|Overall Study||16
8912337|NCT02152540|9971412|FG000|NOT COMPLETED|Overall Study||0
8912338|NCT02152540|9971413|FG001|NOT COMPLETED|Overall Study||0
8912339|NCT02152605|9971428|FG000|STARTED|Overall Study||248
9022545|NCT03129100|10085463|FG009|STARTED|Lead-In Period (Period 1)||0
9022546|NCT03129100|10085464|FG010|STARTED|Lead-In Period (Period 1)||0
8912340|NCT02152605|9971429|FG001|STARTED|Overall Study||248
8912341|NCT02152605|9971428|FG000|COMPLETED|Overall Study||229
8912342|NCT02152605|9971429|FG001|COMPLETED|Overall Study||230
8912343|NCT02152605|9971428|FG000|NOT COMPLETED|Overall Study||19
8912344|NCT02152605|9971429|FG001|NOT COMPLETED|Overall Study||18
8912345|NCT02152631|9971438|FG000|STARTED|Overall Study||270
8912346|NCT02152631|9971439|FG001|STARTED|Overall Study||183
8912347|NCT02152631|9971438|FG000|Received at Least One Dose of Study Drug|Overall Study||265
8912348|NCT02152631|9971439|FG001|Received at Least One Dose of Study Drug|Overall Study||175
8912349|NCT02152631|9971438|FG000|Off Treatment|Overall Study||246
8912350|NCT02152631|9971439|FG001|Off Treatment|Overall Study||172
8912351|NCT02152631|9971438|FG000|Death Due to Any Cause|Overall Study||30
8912352|NCT02152631|9971439|FG001|Death Due to Any Cause|Overall Study||20
8912353|NCT02152631|9971438|FG000|Progressive Disease|Overall Study||174
8738413|NCT01103479|9786310|FG001|STARTED|Overall Study||210
8738414|NCT01103479|9786311|FG002|STARTED|Overall Study||188
8738415|NCT01103479|9786309|FG000|COMPLETED|Overall Study||163
8738416|NCT01103479|9786310|FG001|COMPLETED|Overall Study||201
8738417|NCT01103479|9786311|FG002|COMPLETED|Overall Study||174
8738418|NCT01103479|9786309|FG000|NOT COMPLETED|Overall Study||5
8912354|NCT02152631|9971439|FG001|Progressive Disease|Overall Study||137
8912355|NCT02152631|9971438|FG000|COMPLETED|Overall Study||204
8912356|NCT02152631|9971439|FG001|COMPLETED|Overall Study||157
8912357|NCT02152631|9971438|FG000|NOT COMPLETED|Overall Study||66
8912358|NCT02152631|9971439|FG001|NOT COMPLETED|Overall Study||26
8738419|NCT01103479|9786310|FG001|NOT COMPLETED|Overall Study||9
8738420|NCT01103479|9786311|FG002|NOT COMPLETED|Overall Study||14
8738421|NCT01103492|9786320|FG000|STARTED|Overall Study||1
8738422|NCT01103492|9786320|FG000|COMPLETED|Overall Study||1
8738423|NCT01103492|9786320|FG000|NOT COMPLETED|Overall Study||0
8738424|NCT01103505|9786326|FG000|STARTED|Overall Study||763
8738425|NCT01103505|9786327|FG001|STARTED|Overall Study||757
8738426|NCT01103505|9786326|FG000|COMPLETED|Overall Study||739
8738427|NCT01103505|9786327|FG001|COMPLETED|Overall Study||737
8738428|NCT01103505|9786326|FG000|NOT COMPLETED|Overall Study||24
8738429|NCT01103505|9786327|FG001|NOT COMPLETED|Overall Study||20
8806952|NCT01481896|9859289|FG000|Min 4.75 yr Follow-up, Revised or Dead|Overall Study|114 participants with 119 THAs had at least 4.75 year follow-up or were known revised or deceased|114
8806953|NCT01481896|9859289|FG000|COMPLETED|Overall Study|The 114 participants includes 5 participants with bilateral hip replacements for a total of 119 THAs|114
8806954|NCT01481896|9859289|FG000|NOT COMPLETED|Overall Study||12
8806955|NCT01482065|9859305|FG000|STARTED|Overall Study||4
8806956|NCT01482065|9859306|FG001|STARTED|Overall Study||5
8806957|NCT01482065|9859305|FG000|COMPLETED|Overall Study||4
8806958|NCT01482065|9859306|FG001|COMPLETED|Overall Study||4
8806959|NCT01482065|9859305|FG000|NOT COMPLETED|Overall Study||0
8806960|NCT01482065|9859306|FG001|NOT COMPLETED|Overall Study||1
8806961|NCT01482091|9859314|FG000|STARTED|Overall Study||25
8806962|NCT01482091|9859315|FG001|STARTED|Overall Study||24
8806963|NCT01482091|9859314|FG000|COMPLETED|Overall Study||25
8806964|NCT01482091|9859315|FG001|COMPLETED|Overall Study||24
8806965|NCT01482091|9859314|FG000|NOT COMPLETED|Overall Study||0
8806966|NCT01482091|9859315|FG001|NOT COMPLETED|Overall Study||0
8806967|NCT01482169|9859321|FG000|STARTED|Overall Study||48
8806968|NCT01482169|9859321|FG000|COMPLETED|Overall Study||46
8806969|NCT01482169|9859321|FG000|NOT COMPLETED|Overall Study||2
8806970|NCT01482221|9859331|FG000|STARTED|Overall Study||101
8806971|NCT01482221|9859332|FG001|STARTED|Overall Study||101
8806972|NCT01482221|9859333|FG002|STARTED|Overall Study||100
8806973|NCT01482221|9859331|FG000|COMPLETED|Overall Study||80
8806974|NCT01482221|9859332|FG001|COMPLETED|Overall Study||81
8806975|NCT01482221|9859333|FG002|COMPLETED|Overall Study||77
8806976|NCT01482221|9859331|FG000|NOT COMPLETED|Overall Study||21
8806977|NCT01482221|9859332|FG001|NOT COMPLETED|Overall Study||20
8806978|NCT01482221|9859333|FG002|NOT COMPLETED|Overall Study||23
8806979|NCT01482312|9859341|FG000|STARTED|Period 1, 90 Minutes of Wear||10
8806980|NCT01482312|9859342|FG001|STARTED|Period 1, 90 Minutes of Wear||9
8806981|NCT01482312|9859343|FG002|STARTED|Period 1, 90 Minutes of Wear||10
8806982|NCT01482312|9859341|FG000|COMPLETED|Period 1, 90 Minutes of Wear||9
8806983|NCT01482312|9859342|FG001|COMPLETED|Period 1, 90 Minutes of Wear||9
8806984|NCT01482312|9859343|FG002|COMPLETED|Period 1, 90 Minutes of Wear||10
8806985|NCT01482312|9859341|FG000|NOT COMPLETED|Period 1, 90 Minutes of Wear||1
8806986|NCT01482312|9859342|FG001|NOT COMPLETED|Period 1, 90 Minutes of Wear||0
8806987|NCT01482312|9859343|FG002|NOT COMPLETED|Period 1, 90 Minutes of Wear||0
8806988|NCT01482312|9859341|FG000|STARTED|Period 2, 90 Minutes of Wear||9
8806989|NCT01482312|9859342|FG001|STARTED|Period 2, 90 Minutes of Wear||9
8806990|NCT01482312|9859343|FG002|STARTED|Period 2, 90 Minutes of Wear|One participant discontinued between Period 1 and Period 2|9
8806991|NCT01482312|9859341|FG000|COMPLETED|Period 2, 90 Minutes of Wear||8
8806992|NCT01482312|9859342|FG001|COMPLETED|Period 2, 90 Minutes of Wear||9
8806993|NCT01482312|9859343|FG002|COMPLETED|Period 2, 90 Minutes of Wear||9
8806994|NCT01482312|9859341|FG000|NOT COMPLETED|Period 2, 90 Minutes of Wear||1
8806995|NCT01482312|9859342|FG001|NOT COMPLETED|Period 2, 90 Minutes of Wear||0
8806996|NCT01482312|9859343|FG002|NOT COMPLETED|Period 2, 90 Minutes of Wear||0
8806997|NCT01482312|9859341|FG000|STARTED|Period 3, 90 Minutes of Wear||8
8806998|NCT01482312|9859342|FG001|STARTED|Period 3, 90 Minutes of Wear||9
8806999|NCT01482312|9859343|FG002|STARTED|Period 3, 90 Minutes of Wear||9
8807000|NCT01482312|9859341|FG000|COMPLETED|Period 3, 90 Minutes of Wear||8
8807001|NCT01482312|9859342|FG001|COMPLETED|Period 3, 90 Minutes of Wear||9
8807002|NCT01482312|9859343|FG002|COMPLETED|Period 3, 90 Minutes of Wear||9
8807003|NCT01482312|9859341|FG000|NOT COMPLETED|Period 3, 90 Minutes of Wear||0
8807004|NCT01482312|9859342|FG001|NOT COMPLETED|Period 3, 90 Minutes of Wear||0
8807005|NCT01482312|9859343|FG002|NOT COMPLETED|Period 3, 90 Minutes of Wear||0
8807006|NCT01482351|9859353|FG000|STARTED|Overall Study||68
8807007|NCT01482351|9859353|FG000|6 Months|Overall Study|14 dropped out|54
8807008|NCT01482351|9859353|FG000|12 Months|Overall Study||54
8807009|NCT01482351|9859353|FG000|COMPLETED|Overall Study||54
8807010|NCT01482351|9859353|FG000|NOT COMPLETED|Overall Study||14
8807011|NCT01482429|9859363|FG000|STARTED|Care Usual||0
8807012|NCT01482429|9859364|FG001|STARTED|Care Usual||269
8807013|NCT01482429|9859363|FG000|COMPLETED|Care Usual||0
8807014|NCT01482429|9859364|FG001|COMPLETED|Care Usual||96
8807015|NCT01482429|9859363|FG000|NOT COMPLETED|Care Usual||0
8807016|NCT01482429|9859364|FG001|NOT COMPLETED|Care Usual||173
8807017|NCT01482429|9859363|FG000|STARTED|Protocol||414
8807018|NCT01482429|9859364|FG001|STARTED|Protocol||0
8807019|NCT01482429|9859363|FG000|COMPLETED|Protocol||139
8807020|NCT01482429|9859364|FG001|COMPLETED|Protocol||0
8807021|NCT01482429|9859363|FG000|NOT COMPLETED|Protocol||275
8807022|NCT01482429|9859364|FG001|NOT COMPLETED|Protocol||0
8807023|NCT01482715|9859383|FG000|STARTED|Overall Study||6
8807024|NCT01482715|9859384|FG001|STARTED|Overall Study||3
8807025|NCT01482715|9859385|FG002|STARTED|Overall Study||4
8807026|NCT01482715|9859386|FG003|STARTED|Overall Study||9
8738430|NCT01103713|9786341|FG000|STARTED|Overall Study||168
8738431|NCT01103713|9786341|FG000|COMPLETED|Overall Study||155
8738432|NCT01103713|9786341|FG000|NOT COMPLETED|Overall Study||13
8738433|NCT01103778|9786348|FG000|STARTED|Overall Study||11
8738434|NCT01103778|9786348|FG000|COMPLETED|Overall Study||8
8738435|NCT01103778|9786348|FG000|NOT COMPLETED|Overall Study||3
8738436|NCT01103934|9786356|FG000|STARTED|Overall Study||17
8738437|NCT01103934|9786357|FG001|STARTED|Overall Study||18
8738438|NCT01103934|9786356|FG000|COMPLETED|Overall Study||17
8738439|NCT01103934|9786357|FG001|COMPLETED|Overall Study||18
8738440|NCT01103934|9786356|FG000|NOT COMPLETED|Overall Study||0
8738441|NCT01103934|9786357|FG001|NOT COMPLETED|Overall Study||0
8738442|NCT01103960|9786365|FG000|STARTED|Overall Study|Randomised and treated.|164
8738443|NCT01103960|9786366|FG001|STARTED|Overall Study|Randomised and treated.|160
8738444|NCT01103960|9786365|FG000|COMPLETED|Overall Study|Completed study medication.|159
8738445|NCT01103960|9786366|FG001|COMPLETED|Overall Study|Completed study medication.|158
8738446|NCT01103960|9786365|FG000|NOT COMPLETED|Overall Study||5
8738447|NCT01103960|9786366|FG001|NOT COMPLETED|Overall Study||2
8738448|NCT01103973|9786374|FG000|STARTED|Overall Study||51
8738449|NCT01103973|9786375|FG001|STARTED|Overall Study||46
8738450|NCT01103973|9786374|FG000|COMPLETED|Overall Study||51
8738451|NCT01103973|9786375|FG001|COMPLETED|Overall Study||46
8738452|NCT01103973|9786374|FG000|NOT COMPLETED|Overall Study||0
8738453|NCT01103973|9786375|FG001|NOT COMPLETED|Overall Study||0
8738454|NCT01104025|9786381|FG000|STARTED|Treatment Period||31
8738455|NCT01104025|9786381|FG000|COMPLETED|Treatment Period||25
8738456|NCT01104025|9786381|FG000|NOT COMPLETED|Treatment Period||6
8738457|NCT01104025|9786381|FG000|STARTED|Follow up Until BMT OR 6 Months||25
8738458|NCT01104025|9786381|FG000|COMPLETED|Follow up Until BMT OR 6 Months||22
8738459|NCT01104025|9786381|FG000|NOT COMPLETED|Follow up Until BMT OR 6 Months||3
8738460|NCT01104025|9786381|FG000|STARTED|Follow up Until Day 100 Post BMT|only 11 participants proceeded to BMT; 14 did not|11
8738461|NCT01104025|9786381|FG000|COMPLETED|Follow up Until Day 100 Post BMT||9
8738462|NCT01104025|9786381|FG000|NOT COMPLETED|Follow up Until Day 100 Post BMT||2
8738463|NCT01104090|9786387|FG000|STARTED|Overall Study||25
8738464|NCT01104090|9786388|FG001|STARTED|Overall Study||25
8738465|NCT01104090|9786387|FG000|COMPLETED|Overall Study||25
8738466|NCT01104090|9786388|FG001|COMPLETED|Overall Study||25
8738467|NCT01104090|9786387|FG000|NOT COMPLETED|Overall Study||0
8738468|NCT01104090|9786388|FG001|NOT COMPLETED|Overall Study||0
8738469|NCT01104103|9786398|FG000|STARTED|Overall Study||243
8738470|NCT01104103|9786399|FG001|STARTED|Overall Study||224
8738471|NCT01104103|9786398|FG000|COMPLETED|Overall Study||243
8738472|NCT01104103|9786399|FG001|COMPLETED|Overall Study||224
8738473|NCT01104103|9786398|FG000|NOT COMPLETED|Overall Study||0
8738474|NCT01104103|9786399|FG001|NOT COMPLETED|Overall Study||0
8738475|NCT01104155|9786407|FG000|STARTED|Overall Study||63
8738476|NCT01104155|9786408|FG001|STARTED|Overall Study||60
8738477|NCT01104155|9786407|FG000|COMPLETED|Overall Study||38
8738478|NCT01104155|9786408|FG001|COMPLETED|Overall Study||42
8738479|NCT01104155|9786407|FG000|NOT COMPLETED|Overall Study||25
8738480|NCT01104155|9786408|FG001|NOT COMPLETED|Overall Study||18
8738481|NCT01104207|9786416|FG000|STARTED|Overall Study||35
8738482|NCT01104207|9786417|FG001|STARTED|Overall Study||35
8738483|NCT01104207|9786416|FG000|COMPLETED|Overall Study||32
8738484|NCT01104207|9786417|FG001|COMPLETED|Overall Study||32
8738485|NCT01104207|9786416|FG000|NOT COMPLETED|Overall Study||3
8738486|NCT01104207|9786417|FG001|NOT COMPLETED|Overall Study||3
8738487|NCT01104246|9786423|FG000|STARTED|Overall Study||40
8738488|NCT01104246|9786423|FG000|Baseline Characteristics Measured|Overall Study||35
8738489|NCT01104246|9786423|FG000|COMPLETED|Overall Study||35
8738490|NCT01104246|9786423|FG000|NOT COMPLETED|Overall Study||5
8738491|NCT01104285|9786429|FG000|STARTED|Overall Study||112
8738492|NCT01104285|9786430|FG001|STARTED|Overall Study||86
8738493|NCT01104285|9786429|FG000|COMPLETED|Overall Study||112
8738494|NCT01104285|9786430|FG001|COMPLETED|Overall Study||86
8738495|NCT01104285|9786429|FG000|NOT COMPLETED|Overall Study||0
8738496|NCT01104285|9786430|FG001|NOT COMPLETED|Overall Study||0
8738497|NCT01104311|9786438|FG000|STARTED|Overall Study||66
8738498|NCT01104311|9786439|FG001|STARTED|Overall Study||66
8738499|NCT01104311|9786438|FG000|COMPLETED|Overall Study||56
8738500|NCT01104311|9786439|FG001|COMPLETED|Overall Study||54
8738501|NCT01104311|9786438|FG000|NOT COMPLETED|Overall Study||10
8738502|NCT01104311|9786439|FG001|NOT COMPLETED|Overall Study||12
8738503|NCT01104376|9786449|FG000|STARTED|Overall Study||89
8738504|NCT01104376|9786449|FG000|COMPLETED|Overall Study||61
8738505|NCT01104376|9786449|FG000|NOT COMPLETED|Overall Study||28
8738506|NCT01104402|9786455|FG000|STARTED|Overall Study||132
8738507|NCT01104402|9786456|FG001|STARTED|Overall Study||135
8738508|NCT01104402|9786455|FG000|COMPLETED|Overall Study||111
8738509|NCT01104402|9786456|FG001|COMPLETED|Overall Study||102
8738510|NCT01104402|9786455|FG000|NOT COMPLETED|Overall Study||21
8738511|NCT01104402|9786456|FG001|NOT COMPLETED|Overall Study||33
8738512|NCT01104415|9786462|FG000|STARTED|Core Phase||15
8738513|NCT01104415|9786463|FG001|STARTED|Core Phase||0
8738514|NCT01104415|9786462|FG000|COMPLETED|Core Phase||14
8738515|NCT01104415|9786463|FG001|COMPLETED|Core Phase||0
8738516|NCT01104415|9786462|FG000|NOT COMPLETED|Core Phase||1
8738517|NCT01104415|9786463|FG001|NOT COMPLETED|Core Phase||0
8738518|NCT01104415|9786462|FG000|STARTED|Extension Period||0
8807027|NCT01482715|9859387|FG004|STARTED|Overall Study||4
8738519|NCT01104415|9786463|FG001|STARTED|Extension Period|Out of 14 participants who completed Core Phase, 3 were not eligible to enter the Extension Period.|11
8738520|NCT01104415|9786462|FG000|COMPLETED|Extension Period||0
8738521|NCT01104415|9786463|FG001|COMPLETED|Extension Period||0
8738522|NCT01104415|9786462|FG000|NOT COMPLETED|Extension Period||0
8738523|NCT01104415|9786463|FG001|NOT COMPLETED|Extension Period||11
8738524|NCT01104493|9786472|FG000|STARTED|Overall Study||240
8738525|NCT01104493|9786473|FG001|STARTED|Overall Study||60
8738526|NCT01104493|9786472|FG000|COMPLETED|Overall Study||240
8738527|NCT01104493|9786473|FG001|COMPLETED|Overall Study||58
8738528|NCT01104493|9786472|FG000|NOT COMPLETED|Overall Study||0
8738529|NCT01104493|9786473|FG001|NOT COMPLETED|Overall Study||2
8738530|NCT01104545|9786482|FG000|STARTED|Overall Study||8
8738531|NCT01104545|9786483|FG001|STARTED|Overall Study||8
8738532|NCT01104545|9786484|FG002|STARTED|Overall Study|1 participant received 0.50 mg of MK-3614 or placebo in Periods 3 and 4 instead of planned 0.75 mg|8
8738533|NCT01104545|9786482|FG000|COMPLETED|Overall Study||8
8738534|NCT01104545|9786483|FG001|COMPLETED|Overall Study|Participant discontinued after receiving 0.75 mg MK-3614 in Period 1|7
8738535|NCT01104545|9786484|FG002|COMPLETED|Overall Study|Participants discontinued after receiving MK-3614 0.75 mg (Period 1)and placebo (Period 2)|6
8738536|NCT01104545|9786482|FG000|NOT COMPLETED|Overall Study||0
8738537|NCT01104545|9786483|FG001|NOT COMPLETED|Overall Study||1
8738538|NCT01104545|9786484|FG002|NOT COMPLETED|Overall Study||2
8738539|NCT01104558|9786529|FG000|STARTED|Overall Study||100
8738540|NCT01104558|9786529|FG000|COMPLETED|Overall Study||83
8738541|NCT01104558|9786529|FG000|NOT COMPLETED|Overall Study||17
8738542|NCT01104584|9786533|FG000|STARTED|Overall Study|screened and enrolled|460
8738543|NCT01104584|9786533|FG000|Received Treatment|Overall Study|treatment started|439
8738544|NCT01104584|9786533|FG000|Fulfilled Requirements of FAS Population|Overall Study||397
8738545|NCT01104584|9786533|FG000|COMPLETED|Overall Study|study course completed|437
8738546|NCT01104584|9786533|FG000|NOT COMPLETED|Overall Study||23
8738547|NCT01104636|9786555|FG000|STARTED|Overall Study||1177
8738548|NCT01104636|9786555|FG000|COMPLETED|Overall Study||999
8738549|NCT01104636|9786555|FG000|NOT COMPLETED|Overall Study||178
8738550|NCT01104662|9786567|FG000|STARTED|Overall Study||20
8738551|NCT01104662|9786568|FG001|STARTED|Overall Study||21
8738552|NCT01104662|9786569|FG002|STARTED|Overall Study||5
8738553|NCT01104662|9786570|FG003|STARTED|Overall Study||4
8738554|NCT01104662|9786571|FG004|STARTED|Overall Study||15
8738555|NCT01104662|9786572|FG005|STARTED|Overall Study||16
8738556|NCT01104662|9786573|FG006|STARTED|Overall Study||5
8738557|NCT01104662|9786574|FG007|STARTED|Overall Study||6
8738558|NCT01104662|9786567|FG000|Received at Least 1 Dose of Study Drug|Overall Study||17
8738559|NCT01104662|9786568|FG001|Received at Least 1 Dose of Study Drug|Overall Study||17
8738560|NCT01104662|9786569|FG002|Received at Least 1 Dose of Study Drug|Overall Study||4
8738561|NCT01104662|9786570|FG003|Received at Least 1 Dose of Study Drug|Overall Study||4
8738562|NCT01104662|9786571|FG004|Received at Least 1 Dose of Study Drug|Overall Study||15
8738563|NCT01104662|9786572|FG005|Received at Least 1 Dose of Study Drug|Overall Study||15
8738564|NCT01104662|9786573|FG006|Received at Least 1 Dose of Study Drug|Overall Study||5
8738565|NCT01104662|9786574|FG007|Received at Least 1 Dose of Study Drug|Overall Study||6
8738566|NCT01104662|9786567|FG000|COMPLETED|Overall Study||10
8738567|NCT01104662|9786568|FG001|COMPLETED|Overall Study||11
8738568|NCT01104662|9786569|FG002|COMPLETED|Overall Study||4
8738569|NCT01104662|9786570|FG003|COMPLETED|Overall Study||3
8738570|NCT01104662|9786571|FG004|COMPLETED|Overall Study||14
8738571|NCT01104662|9786572|FG005|COMPLETED|Overall Study||12
8738572|NCT01104662|9786573|FG006|COMPLETED|Overall Study||5
8738573|NCT01104662|9786574|FG007|COMPLETED|Overall Study||6
8738574|NCT01104662|9786567|FG000|NOT COMPLETED|Overall Study||10
8738575|NCT01104662|9786568|FG001|NOT COMPLETED|Overall Study||10
8738576|NCT01104662|9786569|FG002|NOT COMPLETED|Overall Study||1
8738577|NCT01104662|9786570|FG003|NOT COMPLETED|Overall Study||1
8738578|NCT01104662|9786571|FG004|NOT COMPLETED|Overall Study||1
8738579|NCT01104662|9786572|FG005|NOT COMPLETED|Overall Study||4
8738580|NCT01104662|9786573|FG006|NOT COMPLETED|Overall Study||0
8738581|NCT01104662|9786574|FG007|NOT COMPLETED|Overall Study||0
8738582|NCT01104701|9786597|FG000|STARTED|Overall Study||30
8738583|NCT01104701|9786598|FG001|STARTED|Overall Study||30
8738584|NCT01104701|9786599|FG002|STARTED|Overall Study||31
8738585|NCT01104701|9786600|FG003|STARTED|Overall Study||30
8738586|NCT01104701|9786597|FG000|COMPLETED|Overall Study||30
8738587|NCT01104701|9786598|FG001|COMPLETED|Overall Study||27
8738588|NCT01104701|9786599|FG002|COMPLETED|Overall Study||29
8738589|NCT01104701|9786600|FG003|COMPLETED|Overall Study||28
8738590|NCT01104701|9786597|FG000|NOT COMPLETED|Overall Study||0
8738591|NCT01104701|9786598|FG001|NOT COMPLETED|Overall Study||3
8738592|NCT01104701|9786599|FG002|NOT COMPLETED|Overall Study||2
8738593|NCT01104701|9786600|FG003|NOT COMPLETED|Overall Study||2
8738594|NCT01104766|9786614|FG000|STARTED|Overall Study||153
8738595|NCT01104766|9786615|FG001|STARTED|Overall Study||155
8738596|NCT01104766|9786616|FG002|STARTED|Overall Study||157
8738597|NCT01104766|9786617|FG003|STARTED|Overall Study||152
8738598|NCT01104766|9786614|FG000|COMPLETED|Overall Study||95
8738599|NCT01104766|9786615|FG001|COMPLETED|Overall Study||104
8738600|NCT01104766|9786616|FG002|COMPLETED|Overall Study||97
8738601|NCT01104766|9786617|FG003|COMPLETED|Overall Study||114
8738602|NCT01104766|9786614|FG000|NOT COMPLETED|Overall Study||58
8738603|NCT01104766|9786615|FG001|NOT COMPLETED|Overall Study||51
8738604|NCT01104766|9786616|FG002|NOT COMPLETED|Overall Study||60
8738605|NCT01104766|9786617|FG003|NOT COMPLETED|Overall Study||38
8738606|NCT01104779|9786630|FG000|STARTED|Overall Study||147
8738607|NCT01104779|9786631|FG001|STARTED|Overall Study||151
8738608|NCT01104779|9786632|FG002|STARTED|Overall Study||148
8738609|NCT01104779|9786630|FG000|COMPLETED|Overall Study||88
8738610|NCT01104779|9786631|FG001|COMPLETED|Overall Study||96
8738611|NCT01104779|9786632|FG002|COMPLETED|Overall Study||86
8738612|NCT01104779|9786630|FG000|NOT COMPLETED|Overall Study||59
8738613|NCT01104779|9786631|FG001|NOT COMPLETED|Overall Study||55
8738614|NCT01104779|9786632|FG002|NOT COMPLETED|Overall Study||62
8738615|NCT01104792|9786640|FG000|STARTED|Overall Study||752
8738616|NCT01104792|9786640|FG000|COMPLETED|Overall Study||226
8738617|NCT01104792|9786640|FG000|NOT COMPLETED|Overall Study||526
8738618|NCT01104870|9786647|FG000|STARTED|Overall Study||11
8738619|NCT01104870|9786648|FG001|STARTED|Overall Study||19
8738620|NCT01104870|9786649|FG002|STARTED|Overall Study||20
8738621|NCT01104870|9786647|FG000|COMPLETED|Overall Study||10
8738622|NCT01104870|9786648|FG001|COMPLETED|Overall Study||18
8738623|NCT01104870|9786649|FG002|COMPLETED|Overall Study||18
8738624|NCT01104870|9786647|FG000|NOT COMPLETED|Overall Study||1
8738625|NCT01104870|9786648|FG001|NOT COMPLETED|Overall Study||1
8738626|NCT01104870|9786649|FG002|NOT COMPLETED|Overall Study||2
8738627|NCT01105065|9786657|FG000|STARTED|Overall Study||23
8738628|NCT01105065|9786657|FG000|COMPLETED|Overall Study||17
8738629|NCT01105065|9786657|FG000|NOT COMPLETED|Overall Study||6
8738630|NCT01105091|9786665|FG000|STARTED|Overall Study||20
8738631|NCT01105091|9786666|FG001|STARTED|Overall Study||10
8738632|NCT01105091|9786665|FG000|COMPLETED|Overall Study||18
8738633|NCT01105091|9786666|FG001|COMPLETED|Overall Study||10
8738634|NCT01105091|9786665|FG000|NOT COMPLETED|Overall Study||2
8738635|NCT01105091|9786666|FG001|NOT COMPLETED|Overall Study||0
8738636|NCT01105117|9786676|FG000|STARTED|Overall Study||1
8738637|NCT01105117|9786677|FG001|STARTED|Overall Study||1
8738638|NCT01105117|9786676|FG000|COMPLETED|Overall Study||1
8738639|NCT01105117|9786677|FG001|COMPLETED|Overall Study||1
8738640|NCT01105117|9786676|FG000|NOT COMPLETED|Overall Study||0
8738641|NCT01105117|9786677|FG001|NOT COMPLETED|Overall Study||0
8738642|NCT01105130|9786686|FG000|STARTED|Overall Study||48
8738643|NCT01105130|9786687|FG001|STARTED|Overall Study||45
8738644|NCT01105130|9786688|FG002|STARTED|Overall Study||47
8738645|NCT01105130|9786686|FG000|COMPLETED|Overall Study||38
8738646|NCT01105130|9786687|FG001|COMPLETED|Overall Study||34
8738647|NCT01105130|9786688|FG002|COMPLETED|Overall Study||37
8738648|NCT01105130|9786686|FG000|NOT COMPLETED|Overall Study||10
8738649|NCT01105130|9786687|FG001|NOT COMPLETED|Overall Study||11
8738650|NCT01105130|9786688|FG002|NOT COMPLETED|Overall Study||10
8738651|NCT01105247|9786698|FG000|STARTED|Overall Study||116
8738652|NCT01105247|9786699|FG001|STARTED|Overall Study||16
8738653|NCT01105247|9786698|FG000|COMPLETED|Overall Study||79
8738654|NCT01105247|9786699|FG001|COMPLETED|Overall Study||16
8738655|NCT01105247|9786698|FG000|NOT COMPLETED|Overall Study||37
8738656|NCT01105247|9786699|FG001|NOT COMPLETED|Overall Study||0
8738657|NCT01105312|9786713|FG000|STARTED|Overall Study||16
8738658|NCT01105312|9786714|FG001|STARTED|Overall Study||6
8738659|NCT01105312|9786715|FG002|STARTED|Overall Study||6
8738660|NCT01105312|9786713|FG000|COMPLETED|Overall Study||13
8738661|NCT01105312|9786714|FG001|COMPLETED|Overall Study||6
8738662|NCT01105312|9786715|FG002|COMPLETED|Overall Study||6
8738663|NCT01105312|9786713|FG000|NOT COMPLETED|Overall Study||3
8738664|NCT01105312|9786714|FG001|NOT COMPLETED|Overall Study||0
8738665|NCT01105312|9786715|FG002|NOT COMPLETED|Overall Study||0
8738666|NCT01105377|9786725|FG000|STARTED|Overall Study||24
8738667|NCT01105377|9786726|FG001|STARTED|Overall Study||23
8738668|NCT01105377|9786725|FG000|COMPLETED|Overall Study||24
8738669|NCT01105377|9786726|FG001|COMPLETED|Overall Study||22
8738670|NCT01105377|9786725|FG000|NOT COMPLETED|Overall Study||0
8738671|NCT01105377|9786726|FG001|NOT COMPLETED|Overall Study||1
8738672|NCT01105533|9786732|FG000|STARTED|Overall Study||1
8738673|NCT01105533|9786733|FG001|STARTED|Overall Study||1
8738674|NCT01105533|9786734|FG002|STARTED|Overall Study||3
8738675|NCT01105533|9786735|FG003|STARTED|Overall Study||3
8738676|NCT01105533|9786736|FG004|STARTED|Overall Study||7
8738677|NCT01105533|9786737|FG005|STARTED|Overall Study||7
8738678|NCT01105533|9786738|FG006|STARTED|Overall Study||8
8738679|NCT01105533|9786739|FG007|STARTED|Overall Study||4
8738680|NCT01105533|9786740|FG008|STARTED|Overall Study||12
8738681|NCT01105533|9786732|FG000|COMPLETED|Overall Study||0
8738682|NCT01105533|9786733|FG001|COMPLETED|Overall Study||0
8738683|NCT01105533|9786734|FG002|COMPLETED|Overall Study||0
8738684|NCT01105533|9786735|FG003|COMPLETED|Overall Study||0
8738685|NCT01105533|9786736|FG004|COMPLETED|Overall Study||0
8738686|NCT01105533|9786737|FG005|COMPLETED|Overall Study||0
8738687|NCT01105533|9786738|FG006|COMPLETED|Overall Study||0
8738688|NCT01105533|9786739|FG007|COMPLETED|Overall Study||0
8738689|NCT01105533|9786740|FG008|COMPLETED|Overall Study||0
8738690|NCT01105533|9786732|FG000|NOT COMPLETED|Overall Study||1
8738691|NCT01105533|9786733|FG001|NOT COMPLETED|Overall Study||1
8738692|NCT01105533|9786734|FG002|NOT COMPLETED|Overall Study||3
8738693|NCT01105533|9786735|FG003|NOT COMPLETED|Overall Study||3
8738694|NCT01105533|9786736|FG004|NOT COMPLETED|Overall Study||7
8738695|NCT01105533|9786737|FG005|NOT COMPLETED|Overall Study||7
8738696|NCT01105533|9786738|FG006|NOT COMPLETED|Overall Study||8
8738697|NCT01105533|9786739|FG007|NOT COMPLETED|Overall Study||4
8738698|NCT01105533|9786740|FG008|NOT COMPLETED|Overall Study||12
8738699|NCT01105650|9786756|FG000|STARTED|Overall Study||3
8738700|NCT01105650|9786757|FG001|STARTED|Overall Study||3
8738701|NCT01105650|9786758|FG002|STARTED|Overall Study||7
8738702|NCT01105650|9786759|FG003|STARTED|Overall Study|Arm 3 was determined to be successful, thus eliminating the need to test Arm 4.|0
8738703|NCT01105650|9786756|FG000|COMPLETED|Overall Study||3
8738704|NCT01105650|9786757|FG001|COMPLETED|Overall Study||3
8738705|NCT01105650|9786758|FG002|COMPLETED|Overall Study||7
8738706|NCT01105650|9786759|FG003|COMPLETED|Overall Study||0
8738707|NCT01105650|9786756|FG000|NOT COMPLETED|Overall Study||0
8738708|NCT01105650|9786757|FG001|NOT COMPLETED|Overall Study||0
8738709|NCT01105650|9786758|FG002|NOT COMPLETED|Overall Study||0
8738710|NCT01105650|9786759|FG003|NOT COMPLETED|Overall Study||0
8738711|NCT01105702|9786767|FG000|STARTED|Overall Study||28
8738712|NCT01105702|9786767|FG000|COMPLETED|Overall Study||10
8738713|NCT01105702|9786767|FG000|NOT COMPLETED|Overall Study||18
8738714|NCT01105754|9786775|FG000|STARTED|Overall Study||319
8738715|NCT01105754|9786776|FG001|STARTED|Overall Study||319
8738716|NCT01105754|9786775|FG000|COMPLETED|Overall Study||304
8738717|NCT01105754|9786776|FG001|COMPLETED|Overall Study||307
8738718|NCT01105754|9786775|FG000|NOT COMPLETED|Overall Study||15
8738719|NCT01105754|9786776|FG001|NOT COMPLETED|Overall Study||12
8738720|NCT01105767|9786785|FG000|STARTED|Overall Study||9315
8738721|NCT01105767|9786786|FG001|STARTED|Overall Study||10864
8738722|NCT01105767|9786787|FG002|STARTED|Overall Study||10030
8738723|NCT01105767|9786785|FG000|COMPLETED|Overall Study||8155
8738724|NCT01105767|9786786|FG001|COMPLETED|Overall Study||9250
8738725|NCT01105767|9786787|FG002|COMPLETED|Overall Study||8846
8738726|NCT01105767|9786785|FG000|NOT COMPLETED|Overall Study||1160
8738727|NCT01105767|9786786|FG001|NOT COMPLETED|Overall Study||1614
8738728|NCT01105767|9786787|FG002|NOT COMPLETED|Overall Study||1184
8738729|NCT01105936|9786795|FG000|STARTED|Period 1||8
8738730|NCT01105936|9786796|FG001|STARTED|Period 1||8
8738731|NCT01105936|9786797|FG002|STARTED|Period 1||7
8738732|NCT01105936|9786798|FG003|STARTED|Period 1||8
8738733|NCT01105936|9786795|FG000|COMPLETED|Period 1||8
8738734|NCT01105936|9786796|FG001|COMPLETED|Period 1||8
8738735|NCT01105936|9786797|FG002|COMPLETED|Period 1||7
8738736|NCT01105936|9786798|FG003|COMPLETED|Period 1||7
8738737|NCT01105936|9786795|FG000|NOT COMPLETED|Period 1||0
8738738|NCT01105936|9786796|FG001|NOT COMPLETED|Period 1||0
8738739|NCT01105936|9786797|FG002|NOT COMPLETED|Period 1||0
8738740|NCT01105936|9786798|FG003|NOT COMPLETED|Period 1||1
8738741|NCT01105936|9786795|FG000|STARTED|Wash-out Period 1||8
8738742|NCT01105936|9786796|FG001|STARTED|Wash-out Period 1||8
8738743|NCT01105936|9786797|FG002|STARTED|Wash-out Period 1||7
8738744|NCT01105936|9786798|FG003|STARTED|Wash-out Period 1||7
8738745|NCT01105936|9786795|FG000|COMPLETED|Wash-out Period 1||8
8738746|NCT01105936|9786796|FG001|COMPLETED|Wash-out Period 1||8
8738747|NCT01105936|9786797|FG002|COMPLETED|Wash-out Period 1||7
8738748|NCT01105936|9786798|FG003|COMPLETED|Wash-out Period 1||7
9022547|NCT03129100|10085454|FG000|COMPLETED|Lead-In Period (Period 1)||335
9022548|NCT03129100|10085455|FG001|COMPLETED|Lead-In Period (Period 1)||406
9022549|NCT03129100|10085456|FG002|COMPLETED|Lead-In Period (Period 1)||0
9022550|NCT03129100|10085457|FG003|COMPLETED|Lead-In Period (Period 1)||0
9022551|NCT03129100|10085458|FG004|COMPLETED|Lead-In Period (Period 1)||0
9022552|NCT03129100|10085459|FG005|COMPLETED|Lead-In Period (Period 1)||0
9022553|NCT03129100|10085460|FG006|COMPLETED|Lead-In Period (Period 1)||0
8738749|NCT01105936|9786795|FG000|NOT COMPLETED|Wash-out Period 1||0
8738750|NCT01105936|9786796|FG001|NOT COMPLETED|Wash-out Period 1||0
8738751|NCT01105936|9786797|FG002|NOT COMPLETED|Wash-out Period 1||0
8738752|NCT01105936|9786798|FG003|NOT COMPLETED|Wash-out Period 1||0
8738753|NCT01105936|9786795|FG000|STARTED|Period 2||8
8738754|NCT01105936|9786796|FG001|STARTED|Period 2||8
8738755|NCT01105936|9786797|FG002|STARTED|Period 2||7
8738756|NCT01105936|9786798|FG003|STARTED|Period 2||7
8738757|NCT01105936|9786795|FG000|COMPLETED|Period 2||7
8738758|NCT01105936|9786796|FG001|COMPLETED|Period 2||8
8738759|NCT01105936|9786797|FG002|COMPLETED|Period 2||7
8738760|NCT01105936|9786798|FG003|COMPLETED|Period 2||7
8738761|NCT01105936|9786795|FG000|NOT COMPLETED|Period 2||1
8738762|NCT01105936|9786796|FG001|NOT COMPLETED|Period 2||0
8738763|NCT01105936|9786797|FG002|NOT COMPLETED|Period 2||0
8738764|NCT01105936|9786798|FG003|NOT COMPLETED|Period 2||0
8738765|NCT01105936|9786795|FG000|STARTED|Wash-out Period 2||7
8738766|NCT01105936|9786796|FG001|STARTED|Wash-out Period 2||8
8738767|NCT01105936|9786797|FG002|STARTED|Wash-out Period 2||7
8738768|NCT01105936|9786798|FG003|STARTED|Wash-out Period 2||7
9022554|NCT03129100|10085461|FG007|COMPLETED|Lead-In Period (Period 1)||0
8738769|NCT01105936|9786795|FG000|COMPLETED|Wash-out Period 2||7
8738770|NCT01105936|9786796|FG001|COMPLETED|Wash-out Period 2||8
8738771|NCT01105936|9786797|FG002|COMPLETED|Wash-out Period 2||7
8738772|NCT01105936|9786798|FG003|COMPLETED|Wash-out Period 2||7
8738773|NCT01105936|9786795|FG000|NOT COMPLETED|Wash-out Period 2||0
8738774|NCT01105936|9786796|FG001|NOT COMPLETED|Wash-out Period 2||0
8738775|NCT01105936|9786797|FG002|NOT COMPLETED|Wash-out Period 2||0
8738776|NCT01105936|9786798|FG003|NOT COMPLETED|Wash-out Period 2||0
8738777|NCT01105936|9786795|FG000|STARTED|Period 3||7
8738778|NCT01105936|9786796|FG001|STARTED|Period 3||8
8738779|NCT01105936|9786797|FG002|STARTED|Period 3||7
8738780|NCT01105936|9786798|FG003|STARTED|Period 3||7
8738781|NCT01105936|9786795|FG000|COMPLETED|Period 3||7
8738782|NCT01105936|9786796|FG001|COMPLETED|Period 3||6
8738783|NCT01105936|9786797|FG002|COMPLETED|Period 3||7
8738784|NCT01105936|9786798|FG003|COMPLETED|Period 3||7
8738785|NCT01105936|9786795|FG000|NOT COMPLETED|Period 3||0
8738786|NCT01105936|9786796|FG001|NOT COMPLETED|Period 3||2
8738787|NCT01105936|9786797|FG002|NOT COMPLETED|Period 3||0
8738788|NCT01105936|9786798|FG003|NOT COMPLETED|Period 3||0
8738789|NCT01105975|9786817|FG000|STARTED|Overall Study||40
8738790|NCT01105975|9786818|FG001|STARTED|Overall Study||39
8738791|NCT01105975|9786819|FG002|STARTED|Overall Study||42
8738792|NCT01105975|9786820|FG003|STARTED|Overall Study||38
8738793|NCT01105975|9786821|FG004|STARTED|Overall Study||41
8738794|NCT01105975|9786822|FG005|STARTED|Overall Study||35
8738795|NCT01105975|9786823|FG006|STARTED|Overall Study||42
8738796|NCT01105975|9786824|FG007|STARTED|Overall Study||40
8738797|NCT01105975|9786825|FG008|STARTED|Overall Study||40
8738798|NCT01105975|9786826|FG009|STARTED|Overall Study||41
8738799|NCT01105975|9786817|FG000|Took at Least One Dose of Study Drug|Overall Study||40
8738800|NCT01105975|9786818|FG001|Took at Least One Dose of Study Drug|Overall Study||38
8738801|NCT01105975|9786819|FG002|Took at Least One Dose of Study Drug|Overall Study||40
8738802|NCT01105975|9786820|FG003|Took at Least One Dose of Study Drug|Overall Study||38
8738803|NCT01105975|9786821|FG004|Took at Least One Dose of Study Drug|Overall Study||41
8738804|NCT01105975|9786822|FG005|Took at Least One Dose of Study Drug|Overall Study||35
8738805|NCT01105975|9786823|FG006|Took at Least One Dose of Study Drug|Overall Study||41
8738806|NCT01105975|9786824|FG007|Took at Least One Dose of Study Drug|Overall Study||40
8738807|NCT01105975|9786825|FG008|Took at Least One Dose of Study Drug|Overall Study||39
8738808|NCT01105975|9786826|FG009|Took at Least One Dose of Study Drug|Overall Study||41
8738809|NCT01105975|9786817|FG000|COMPLETED|Overall Study||35
8738810|NCT01105975|9786818|FG001|COMPLETED|Overall Study||34
8738811|NCT01105975|9786819|FG002|COMPLETED|Overall Study||32
8738812|NCT01105975|9786820|FG003|COMPLETED|Overall Study||36
8738813|NCT01105975|9786821|FG004|COMPLETED|Overall Study||35
8738814|NCT01105975|9786822|FG005|COMPLETED|Overall Study||30
8738815|NCT01105975|9786823|FG006|COMPLETED|Overall Study||34
8738816|NCT01105975|9786824|FG007|COMPLETED|Overall Study||33
8738817|NCT01105975|9786825|FG008|COMPLETED|Overall Study||34
8738818|NCT01105975|9786826|FG009|COMPLETED|Overall Study||32
8738819|NCT01105975|9786817|FG000|NOT COMPLETED|Overall Study||5
8738820|NCT01105975|9786818|FG001|NOT COMPLETED|Overall Study||5
8738821|NCT01105975|9786819|FG002|NOT COMPLETED|Overall Study||10
8738822|NCT01105975|9786820|FG003|NOT COMPLETED|Overall Study||2
8738823|NCT01105975|9786821|FG004|NOT COMPLETED|Overall Study||6
8738824|NCT01105975|9786822|FG005|NOT COMPLETED|Overall Study||5
8738825|NCT01105975|9786823|FG006|NOT COMPLETED|Overall Study||8
8738826|NCT01105975|9786824|FG007|NOT COMPLETED|Overall Study||7
8738827|NCT01105975|9786825|FG008|NOT COMPLETED|Overall Study||6
8738828|NCT01105975|9786826|FG009|NOT COMPLETED|Overall Study||9
8738829|NCT01106014|9786869|FG000|STARTED|Overall Study||574
8738830|NCT01106014|9786870|FG001|STARTED|Overall Study||582
8738831|NCT01106014|9786869|FG000|COMPLETED|Overall Study||289
8738832|NCT01106014|9786870|FG001|COMPLETED|Overall Study||252
8738833|NCT01106014|9786869|FG000|NOT COMPLETED|Overall Study||285
8738834|NCT01106014|9786870|FG001|NOT COMPLETED|Overall Study||330
8738835|NCT01106027|9786876|FG000|STARTED|Overall Study||2
8738836|NCT01106027|9786876|FG000|COMPLETED|Overall Study||1
8738837|NCT01106027|9786876|FG000|NOT COMPLETED|Overall Study||1
8738838|NCT01106040|9786880|FG000|STARTED|Overall Study||163
8738839|NCT01106040|9786880|FG000|COMPLETED|Overall Study||152
8738840|NCT01106040|9786880|FG000|NOT COMPLETED|Overall Study||11
8738841|NCT01106092|9786889|FG000|STARTED|Overall Study||78
8738842|NCT01106092|9786890|FG001|STARTED|Overall Study||78
8738843|NCT01106092|9786891|FG002|STARTED|Overall Study||78
8738844|NCT01106092|9786892|FG003|STARTED|Overall Study||78
8738845|NCT01106092|9786889|FG000|COMPLETED|Overall Study||78
8738846|NCT01106092|9786890|FG001|COMPLETED|Overall Study||78
8738847|NCT01106092|9786891|FG002|COMPLETED|Overall Study||78
8738848|NCT01106092|9786892|FG003|COMPLETED|Overall Study||77
8738849|NCT01106092|9786889|FG000|NOT COMPLETED|Overall Study||0
8738850|NCT01106092|9786890|FG001|NOT COMPLETED|Overall Study||0
8738851|NCT01106092|9786891|FG002|NOT COMPLETED|Overall Study||0
8738852|NCT01106092|9786892|FG003|NOT COMPLETED|Overall Study||1
8738853|NCT01106157|9786904|FG000|STARTED|Overall Study||17
8738854|NCT01106157|9786905|FG001|STARTED|Overall Study||8
8738855|NCT01106157|9786904|FG000|COMPLETED|Overall Study||16
8738856|NCT01106157|9786905|FG001|COMPLETED|Overall Study||8
8738857|NCT01106157|9786904|FG000|NOT COMPLETED|Overall Study||1
8738858|NCT01106157|9786905|FG001|NOT COMPLETED|Overall Study||0
8738859|NCT01106248|9786911|FG000|STARTED|Overall Study||26
8738860|NCT01106248|9786911|FG000|COMPLETED|Overall Study||23
8738861|NCT01106248|9786911|FG000|NOT COMPLETED|Overall Study||3
8738862|NCT01106287|9786919|FG000|STARTED|Overall Study|One participant that discontinued the study due to a pre-treatment adverse event was replaced.|4
8738863|NCT01106287|9786920|FG001|STARTED|Overall Study||3
8738864|NCT01106287|9786921|FG002|STARTED|Overall Study||3
8738865|NCT01106287|9786922|FG003|STARTED|Overall Study||3
8738866|NCT01106287|9786919|FG000|COMPLETED|Overall Study||3
8738867|NCT01106287|9786920|FG001|COMPLETED|Overall Study||3
8738868|NCT01106287|9786921|FG002|COMPLETED|Overall Study||3
8738869|NCT01106287|9786922|FG003|COMPLETED|Overall Study||3
8738870|NCT01106287|9786919|FG000|NOT COMPLETED|Overall Study||1
8738871|NCT01106287|9786920|FG001|NOT COMPLETED|Overall Study||0
8738872|NCT01106287|9786921|FG002|NOT COMPLETED|Overall Study||0
8738873|NCT01106287|9786922|FG003|NOT COMPLETED|Overall Study||0
8738874|NCT01106326|9786936|FG000|STARTED|Overall Study||30
8738875|NCT01106326|9786936|FG000|COMPLETED|Overall Study||28
8738876|NCT01106326|9786936|FG000|NOT COMPLETED|Overall Study||2
8738877|NCT01106352|9786947|FG000|STARTED|Overall Study||7
8738878|NCT01106352|9786948|FG001|STARTED|Overall Study||3
8738879|NCT01106352|9786949|FG002|STARTED|Overall Study||7
8738880|NCT01106352|9786950|FG003|STARTED|Overall Study||36
8738881|NCT01106352|9786951|FG004|STARTED|Overall Study||17
8738882|NCT01106352|9786947|FG000|Started Dose Escalation|Overall Study|Number of subjects for safety analysis set.|7
8738883|NCT01106352|9786948|FG001|Started Dose Escalation|Overall Study|Number of subjects for safety analysis set.|3
8738884|NCT01106352|9786949|FG002|Started Dose Escalation|Overall Study|Number of subjects for safety analysis set.|7
8738885|NCT01106352|9786950|FG003|Started Dose Escalation|Overall Study||0
8738886|NCT01106352|9786951|FG004|Started Dose Escalation|Overall Study||0
8738887|NCT01106352|9786947|FG000|Completed Dose Escalation|Overall Study||6
8738888|NCT01106352|9786948|FG001|Completed Dose Escalation|Overall Study||3
8738889|NCT01106352|9786949|FG002|Completed Dose Escalation|Overall Study||5
8738890|NCT01106352|9786950|FG003|Completed Dose Escalation|Overall Study||0
8738891|NCT01106352|9786951|FG004|Completed Dose Escalation|Overall Study||0
8738892|NCT01106352|9786947|FG000|Started Safety Cohort|Overall Study||0
8738893|NCT01106352|9786948|FG001|Started Safety Cohort|Overall Study||0
8738894|NCT01106352|9786949|FG002|Started Safety Cohort|Overall Study||0
8738895|NCT01106352|9786950|FG003|Started Safety Cohort|Overall Study||36
8738896|NCT01106352|9786951|FG004|Started Safety Cohort|Overall Study||17
8738897|NCT01106352|9786947|FG000|Treated Safety Cohort|Overall Study||0
8738898|NCT01106352|9786948|FG001|Treated Safety Cohort|Overall Study||0
8738899|NCT01106352|9786949|FG002|Treated Safety Cohort|Overall Study||0
8738900|NCT01106352|9786950|FG003|Treated Safety Cohort|Overall Study|Number of subjects for safety analysis set.|33
8738901|NCT01106352|9786951|FG004|Treated Safety Cohort|Overall Study|Number of subjects for safety analysis set.|13
8738902|NCT01106352|9786947|FG000|Completed Safety Cohort|Overall Study||0
8738903|NCT01106352|9786948|FG001|Completed Safety Cohort|Overall Study||0
8738904|NCT01106352|9786949|FG002|Completed Safety Cohort|Overall Study||0
8738905|NCT01106352|9786950|FG003|Completed Safety Cohort|Overall Study||23
8738906|NCT01106352|9786951|FG004|Completed Safety Cohort|Overall Study||9
8738907|NCT01106352|9786947|FG000|COMPLETED|Overall Study||6
8738908|NCT01106352|9786948|FG001|COMPLETED|Overall Study||3
8738909|NCT01106352|9786949|FG002|COMPLETED|Overall Study||5
8738910|NCT01106352|9786950|FG003|COMPLETED|Overall Study|This group is only applicable for Safety cohort period.|23
8738911|NCT01106352|9786951|FG004|COMPLETED|Overall Study|This group is only applicable for Safety cohort period.|9
8738912|NCT01106352|9786947|FG000|NOT COMPLETED|Overall Study||1
8738913|NCT01106352|9786948|FG001|NOT COMPLETED|Overall Study||0
8738914|NCT01106352|9786949|FG002|NOT COMPLETED|Overall Study||2
8738915|NCT01106352|9786950|FG003|NOT COMPLETED|Overall Study||13
8738916|NCT01106352|9786951|FG004|NOT COMPLETED|Overall Study||8
8738917|NCT01106391|9786967|FG000|STARTED|Overall Study||60
8738918|NCT01106391|9786967|FG000|COMPLETED|Overall Study||60
8738919|NCT01106391|9786967|FG000|NOT COMPLETED|Overall Study||0
8738920|NCT01106404|9786973|FG000|STARTED|Period I (First 6 Weeks)||36
8738921|NCT01106404|9786974|FG001|STARTED|Period I (First 6 Weeks)||40
8738922|NCT01106404|9786973|FG000|COMPLETED|Period I (First 6 Weeks)||33
8738923|NCT01106404|9786974|FG001|COMPLETED|Period I (First 6 Weeks)||38
8738924|NCT01106404|9786973|FG000|NOT COMPLETED|Period I (First 6 Weeks)||3
8738925|NCT01106404|9786974|FG001|NOT COMPLETED|Period I (First 6 Weeks)||2
8738926|NCT01106404|9786973|FG000|STARTED|Period II (Second 6 Weeks)||33
8738927|NCT01106404|9786974|FG001|STARTED|Period II (Second 6 Weeks)||38
8738928|NCT01106404|9786973|FG000|COMPLETED|Period II (Second 6 Weeks)||33
8738929|NCT01106404|9786974|FG001|COMPLETED|Period II (Second 6 Weeks)||38
8738930|NCT01106404|9786973|FG000|NOT COMPLETED|Period II (Second 6 Weeks)||0
9022555|NCT03129100|10085462|FG008|COMPLETED|Lead-In Period (Period 1)||0
8738931|NCT01106404|9786974|FG001|NOT COMPLETED|Period II (Second 6 Weeks)||0
8738932|NCT01106430|9786988|FG000|STARTED|Overall Study||133
8738933|NCT01106430|9786989|FG001|STARTED|Overall Study||134
8738934|NCT01106430|9786988|FG000|COMPLETED|Overall Study||100
8738935|NCT01106430|9786989|FG001|COMPLETED|Overall Study||101
8738936|NCT01106430|9786988|FG000|NOT COMPLETED|Overall Study||33
8738937|NCT01106430|9786989|FG001|NOT COMPLETED|Overall Study||33
8738938|NCT01106456|9786997|FG000|STARTED|Overall Study||243
8738939|NCT01106456|9786998|FG001|STARTED|Overall Study||220
8738940|NCT01106456|9786997|FG000|COMPLETED|Overall Study||140
8738941|NCT01106456|9786998|FG001|COMPLETED|Overall Study||96
8738942|NCT01106456|9786997|FG000|NOT COMPLETED|Overall Study||103
8738943|NCT01106456|9786998|FG001|NOT COMPLETED|Overall Study||124
8738944|NCT01106586|9787006|FG000|STARTED|Overall Study||353
8738945|NCT01106586|9787007|FG001|STARTED|Overall Study||355
8738946|NCT01106586|9787006|FG000|COMPLETED|Overall Study||68
8738947|NCT01106586|9787007|FG001|COMPLETED|Overall Study||70
8738948|NCT01106586|9787006|FG000|NOT COMPLETED|Overall Study||285
8738949|NCT01106586|9787007|FG001|NOT COMPLETED|Overall Study||285
8738950|NCT01106625|9787016|FG000|STARTED|Core Period: Baseline to Week 26||156
8738951|NCT01106625|9787017|FG001|STARTED|Core Period: Baseline to Week 26||157
8738952|NCT01106625|9787018|FG002|STARTED|Core Period: Baseline to Week 26||156
8738953|NCT01106625|9787016|FG000|COMPLETED|Core Period: Baseline to Week 26||123
8738954|NCT01106625|9787017|FG001|COMPLETED|Core Period: Baseline to Week 26||129
8738955|NCT01106625|9787018|FG002|COMPLETED|Core Period: Baseline to Week 26||129
8738956|NCT01106625|9787016|FG000|NOT COMPLETED|Core Period: Baseline to Week 26||33
8738957|NCT01106625|9787017|FG001|NOT COMPLETED|Core Period: Baseline to Week 26||28
8738958|NCT01106625|9787018|FG002|NOT COMPLETED|Core Period: Baseline to Week 26||27
8738959|NCT01106625|9787016|FG000|STARTED|Extension Period: Week 26 to Week 52|4 pts discontinued last day of core: physician decision (1), noncompliance (1), not specified (2).|119
8738960|NCT01106625|9787017|FG001|STARTED|Extension Period: Week 26 to Week 52|2 pts discontinued last day of core: adverse event (1), not specified (1).|127
8738961|NCT01106625|9787018|FG002|STARTED|Extension Period: Week 26 to Week 52|1 pt discontinued last day of core: withdrawal by subject (1).|128
8738962|NCT01106625|9787016|FG000|COMPLETED|Extension Period: Week 26 to Week 52||90
8738963|NCT01106625|9787017|FG001|COMPLETED|Extension Period: Week 26 to Week 52||109
8738964|NCT01106625|9787018|FG002|COMPLETED|Extension Period: Week 26 to Week 52||111
8738965|NCT01106625|9787016|FG000|NOT COMPLETED|Extension Period: Week 26 to Week 52||29
8738966|NCT01106625|9787017|FG001|NOT COMPLETED|Extension Period: Week 26 to Week 52||18
8738967|NCT01106625|9787018|FG002|NOT COMPLETED|Extension Period: Week 26 to Week 52||17
8738968|NCT01106651|9787032|FG000|STARTED|Overall Study||237
8738969|NCT01106651|9787033|FG001|STARTED|Overall Study||241
8738970|NCT01106651|9787034|FG002|STARTED|Overall Study||236
8738971|NCT01106651|9787032|FG000|COMPLETED|Overall Study||158
8738972|NCT01106651|9787033|FG001|COMPLETED|Overall Study||184
8738973|NCT01106651|9787034|FG002|COMPLETED|Overall Study||178
8738974|NCT01106651|9787032|FG000|NOT COMPLETED|Overall Study||79
8738975|NCT01106651|9787033|FG001|NOT COMPLETED|Overall Study||57
8738976|NCT01106651|9787034|FG002|NOT COMPLETED|Overall Study||58
8738977|NCT01106677|9787049|FG000|STARTED|Core Period: Baseline to Week 26||183
8738978|NCT01106677|9787050|FG001|STARTED|Core Period: Baseline to Week 26||368
8738979|NCT01106677|9787051|FG002|STARTED|Core Period: Baseline to Week 26||367
8738980|NCT01106677|9787052|FG003|STARTED|Core Period: Baseline to Week 26||366
8738981|NCT01106677|9787049|FG000|COMPLETED|Core Period: Baseline to Week 26||155
8738982|NCT01106677|9787050|FG001|COMPLETED|Core Period: Baseline to Week 26||322
8738983|NCT01106677|9787051|FG002|COMPLETED|Core Period: Baseline to Week 26||323
8738984|NCT01106677|9787052|FG003|COMPLETED|Core Period: Baseline to Week 26||319
8738985|NCT01106677|9787049|FG000|NOT COMPLETED|Core Period: Baseline to Week 26||28
8738986|NCT01106677|9787050|FG001|NOT COMPLETED|Core Period: Baseline to Week 26||46
8738987|NCT01106677|9787051|FG002|NOT COMPLETED|Core Period: Baseline to Week 26||44
8738988|NCT01106677|9787052|FG003|NOT COMPLETED|Core Period: Baseline to Week 26||47
8738989|NCT01106677|9787049|FG000|STARTED|Extension Period: Week 26 to Week 52|2 pts completed core but did not enter ext: protcol violation(1), lost to f/u(1).|153
8738990|NCT01106677|9787050|FG001|STARTED|Extension Period: Week 26 to Week 52|6 pts completed core but did not enter ext: not specified(5), withdrawal by subject(1).|316
8738991|NCT01106677|9787051|FG002|STARTED|Extension Period: Week 26 to Week 52|2 pts completed core but did not enter ext: not specified(1), withdrawal by subject(1).|321
8738992|NCT01106677|9787052|FG003|STARTED|Extension Period: Week 26 to Week 52|6 pts completed core but did not enter ext: not specified(3), physician decision(2), lost to f/u(1).|313
8738993|NCT01106677|9787049|FG000|COMPLETED|Extension Period: Week 26 to Week 52||138
8738994|NCT01106677|9787050|FG001|COMPLETED|Extension Period: Week 26 to Week 52||298
8738995|NCT01106677|9787051|FG002|COMPLETED|Extension Period: Week 26 to Week 52||299
8738996|NCT01106677|9787052|FG003|COMPLETED|Extension Period: Week 26 to Week 52||285
8738997|NCT01106677|9787049|FG000|NOT COMPLETED|Extension Period: Week 26 to Week 52||15
8738998|NCT01106677|9787050|FG001|NOT COMPLETED|Extension Period: Week 26 to Week 52||18
8738999|NCT01106677|9787051|FG002|NOT COMPLETED|Extension Period: Week 26 to Week 52||22
8739000|NCT01106677|9787052|FG003|NOT COMPLETED|Extension Period: Week 26 to Week 52||28
8739001|NCT01106690|9787072|FG000|STARTED|Core Period: Baseline to Week 26||115
8739002|NCT01106690|9787073|FG001|STARTED|Core Period: Baseline to Week 26||113
8739003|NCT01106690|9787074|FG002|STARTED|Core Period: Baseline to Week 26||114
8739004|NCT01106690|9787072|FG000|COMPLETED|Core Period: Baseline to Week 26||91
8739005|NCT01106690|9787073|FG001|COMPLETED|Core Period: Baseline to Week 26||104
8739006|NCT01106690|9787074|FG002|COMPLETED|Core Period: Baseline to Week 26||101
8739007|NCT01106690|9787072|FG000|NOT COMPLETED|Core Period: Baseline to Week 26||24
8739008|NCT01106690|9787073|FG001|NOT COMPLETED|Core Period: Baseline to Week 26||9
8739009|NCT01106690|9787074|FG002|NOT COMPLETED|Core Period: Baseline to Week 26||13
8739010|NCT01106690|9787072|FG000|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext: physician decision(1).|90
8739011|NCT01106690|9787073|FG001|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext: physician decision(1).|103
8739012|NCT01106690|9787074|FG002|STARTED|Extension Period: Week 26 to Week 52|5 pts completed core but did not exter ext: lost to f/u(1), not spec(2), AE(1), eGFR criteria(1).|96
8739013|NCT01106690|9787072|FG000|COMPLETED|Extension Period: Week 26 to Week 52||78
8739014|NCT01106690|9787073|FG001|COMPLETED|Extension Period: Week 26 to Week 52||96
8739015|NCT01106690|9787074|FG002|COMPLETED|Extension Period: Week 26 to Week 52||89
8739016|NCT01106690|9787072|FG000|NOT COMPLETED|Extension Period: Week 26 to Week 52||12
8739017|NCT01106690|9787073|FG001|NOT COMPLETED|Extension Period: Week 26 to Week 52||7
8739018|NCT01106690|9787074|FG002|NOT COMPLETED|Extension Period: Week 26 to Week 52||7
8739019|NCT01106833|9787087|FG000|STARTED|Overall Study||74
8739020|NCT01106833|9787088|FG001|STARTED|Overall Study||77
8739021|NCT01106833|9787087|FG000|COMPLETED|Overall Study||74
8739022|NCT01106833|9787088|FG001|COMPLETED|Overall Study||77
8739023|NCT01106833|9787087|FG000|NOT COMPLETED|Overall Study||0
8739024|NCT01106833|9787088|FG001|NOT COMPLETED|Overall Study||0
8739025|NCT01106846|9787096|FG000|STARTED|Overall Study||12
8739026|NCT01106846|9787097|FG001|STARTED|Overall Study||10
8739027|NCT01106846|9787096|FG000|COMPLETED|Overall Study||12
8739028|NCT01106846|9787097|FG001|COMPLETED|Overall Study||9
8739029|NCT01106846|9787096|FG000|NOT COMPLETED|Overall Study||0
8739030|NCT01106846|9787097|FG001|NOT COMPLETED|Overall Study||1
8739031|NCT01106859|9787103|FG000|STARTED|Overall Study|Intent to treat population and safety population are the same (40 participants)|40
8739032|NCT01106859|9787103|FG000|COMPLETED|Overall Study||40
8739033|NCT01106859|9787103|FG000|NOT COMPLETED|Overall Study||0
8739034|NCT01106898|9787114|FG000|STARTED|Overall Study||100
8739035|NCT01106898|9787114|FG000|COMPLETED|Overall Study||94
8739036|NCT01106898|9787114|FG000|NOT COMPLETED|Overall Study||6
8739037|NCT01106911|9787118|FG000|STARTED|Overall Study||1085
8739038|NCT01106911|9787118|FG000|COMPLETED|Overall Study||1080
8739039|NCT01106911|9787118|FG000|NOT COMPLETED|Overall Study||5
8739040|NCT01106950|9787122|FG000|STARTED|Overall Study||15
8739041|NCT01106950|9787122|FG000|COMPLETED|Overall Study||15
8739042|NCT01106950|9787122|FG000|NOT COMPLETED|Overall Study||0
8739043|NCT01106976|9787128|FG000|STARTED|Overall Study||67
8739044|NCT01106976|9787128|FG000|COMPLETED|Overall Study||59
8739045|NCT01106976|9787128|FG000|NOT COMPLETED|Overall Study||8
8739046|NCT01107015|9787136|FG000|STARTED|Overall Study||62
8739047|NCT01107015|9787137|FG001|STARTED|Overall Study||38
8739048|NCT01107015|9787138|FG002|STARTED|Overall Study||33
8739049|NCT01107015|9787139|FG003|STARTED|Overall Study||80
8739050|NCT01107015|9787136|FG000|COMPLETED|Overall Study||56
8739051|NCT01107015|9787137|FG001|COMPLETED|Overall Study||23
8739052|NCT01107015|9787138|FG002|COMPLETED|Overall Study||22
8739053|NCT01107015|9787139|FG003|COMPLETED|Overall Study||62
8739054|NCT01107015|9787136|FG000|NOT COMPLETED|Overall Study||6
8739055|NCT01107015|9787137|FG001|NOT COMPLETED|Overall Study||15
8739056|NCT01107015|9787138|FG002|NOT COMPLETED|Overall Study||11
8739057|NCT01107015|9787139|FG003|NOT COMPLETED|Overall Study||18
8739058|NCT01107197|9787151|FG000|STARTED|Overall Study||99
8739059|NCT01107197|9787152|FG001|STARTED|Overall Study||101
8739060|NCT01107197|9787151|FG000|COMPLETED|Overall Study|Included in intention-to-treat efficacy analyses (per-protocol analyses were based on 67 patients )|79
8739061|NCT01107197|9787152|FG001|COMPLETED|Overall Study|Included in intention-to-treat efficacy analyses (per-protocol analyses were based on 64 patients )|78
8739062|NCT01107197|9787151|FG000|NOT COMPLETED|Overall Study||20
8739063|NCT01107197|9787152|FG001|NOT COMPLETED|Overall Study||23
8739064|NCT01107353|9787160|FG000|STARTED|Overall Study||20
8739065|NCT01107353|9787161|FG001|STARTED|Overall Study||20
8739066|NCT01107353|9787160|FG000|COMPLETED|Overall Study||19
8739067|NCT01107353|9787161|FG001|COMPLETED|Overall Study||20
8739068|NCT01107353|9787160|FG000|NOT COMPLETED|Overall Study||1
8739069|NCT01107353|9787161|FG001|NOT COMPLETED|Overall Study||0
8739070|NCT01107379|9787167|FG000|STARTED|Overall Study||203
8739071|NCT01107379|9787167|FG000|COMPLETED|Overall Study||182
8739072|NCT01107379|9787167|FG000|NOT COMPLETED|Overall Study||21
8739073|NCT01107392|9787173|FG000|STARTED|Overall Study||158
8739074|NCT01107392|9787174|FG001|STARTED|Overall Study||157
8739075|NCT01107392|9787173|FG000|COMPLETED|Overall Study||153
8739076|NCT01107392|9787174|FG001|COMPLETED|Overall Study||154
8739077|NCT01107392|9787173|FG000|NOT COMPLETED|Overall Study||5
8739078|NCT01107392|9787174|FG001|NOT COMPLETED|Overall Study||3
8739079|NCT01107405|9787185|FG000|STARTED|Overall Study||21
8739080|NCT01107405|9787186|FG001|STARTED|Overall Study||20
8739081|NCT01107405|9787187|FG002|STARTED|Overall Study||20
8739082|NCT01107405|9787188|FG003|STARTED|Overall Study||20
8739083|NCT01107405|9787189|FG004|STARTED|Overall Study||20
8739084|NCT01107405|9787185|FG000|COMPLETED|Overall Study||19
8739085|NCT01107405|9787186|FG001|COMPLETED|Overall Study||19
8739086|NCT01107405|9787187|FG002|COMPLETED|Overall Study||18
8739087|NCT01107405|9787188|FG003|COMPLETED|Overall Study||17
8739088|NCT01107405|9787189|FG004|COMPLETED|Overall Study||17
8739089|NCT01107405|9787185|FG000|NOT COMPLETED|Overall Study||2
8739090|NCT01107405|9787186|FG001|NOT COMPLETED|Overall Study||1
8739091|NCT01107405|9787187|FG002|NOT COMPLETED|Overall Study||2
8739092|NCT01107405|9787188|FG003|NOT COMPLETED|Overall Study||3
8739093|NCT01107405|9787189|FG004|NOT COMPLETED|Overall Study||3
8739094|NCT01107418|9787205|FG000|STARTED|Overall Study||52
8739095|NCT01107418|9787205|FG000|COMPLETED|Overall Study||0
8739096|NCT01107418|9787205|FG000|NOT COMPLETED|Overall Study||52
8739097|NCT01107444|9787222|FG000|STARTED|Overall Study||120
8739098|NCT01107444|9787223|FG001|STARTED|Overall Study||60
8739099|NCT01107444|9787222|FG000|Received At Least 1 Dose of Study Drug|Overall Study||114
8739100|NCT01107444|9787223|FG001|Received At Least 1 Dose of Study Drug|Overall Study||48
8739101|NCT01107444|9787222|FG000|COMPLETED|Overall Study||112
8739102|NCT01107444|9787223|FG001|COMPLETED|Overall Study||47
8739103|NCT01107444|9787222|FG000|NOT COMPLETED|Overall Study||8
8739104|NCT01107444|9787223|FG001|NOT COMPLETED|Overall Study||13
8739105|NCT01107457|9787237|FG000|STARTED|Part A||27
8739106|NCT01107457|9787238|FG001|STARTED|Part A||28
8739107|NCT01107457|9787239|FG002|STARTED|Part A||30
8739108|NCT01107457|9787240|FG003|STARTED|Part A||29
8739109|NCT01107457|9787241|FG004|STARTED|Part A||28
8807028|NCT01482715|9859388|FG005|STARTED|Overall Study||3
8739110|NCT01107457|9787242|FG005|STARTED|Part A|120 mg and 80 mg ixekizumab were administered during Part B and C.|0
8739111|NCT01107457|9787237|FG000|Received at Least 1 Dose of Study Drug|Part A||27
8739112|NCT01107457|9787238|FG001|Received at Least 1 Dose of Study Drug|Part A||28
8739113|NCT01107457|9787239|FG002|Received at Least 1 Dose of Study Drug|Part A||30
8739114|NCT01107457|9787240|FG003|Received at Least 1 Dose of Study Drug|Part A||29
8739115|NCT01107457|9787241|FG004|Received at Least 1 Dose of Study Drug|Part A||28
8739116|NCT01107457|9787242|FG005|Received at Least 1 Dose of Study Drug|Part A|120 mg and 80 mg ixekizumab were administered during Part B and C.|0
8739117|NCT01107457|9787237|FG000|COMPLETED|Part A||22
8739118|NCT01107457|9787238|FG001|COMPLETED|Part A||21
8739119|NCT01107457|9787239|FG002|COMPLETED|Part A||29
8739120|NCT01107457|9787240|FG003|COMPLETED|Part A||26
8739121|NCT01107457|9787241|FG004|COMPLETED|Part A||27
8739122|NCT01107457|9787242|FG005|COMPLETED|Part A|120 mg and 80 mg ixekizumab were administered during Part B and C.|0
8739123|NCT01107457|9787237|FG000|NOT COMPLETED|Part A||5
8739124|NCT01107457|9787238|FG001|NOT COMPLETED|Part A||7
8739125|NCT01107457|9787239|FG002|NOT COMPLETED|Part A||1
8739126|NCT01107457|9787240|FG003|NOT COMPLETED|Part A||3
8739127|NCT01107457|9787241|FG004|NOT COMPLETED|Part A||1
8739128|NCT01107457|9787242|FG005|NOT COMPLETED|Part A||0
8739129|NCT01107457|9787237|FG000|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
8739130|NCT01107457|9787238|FG001|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
8739131|NCT01107457|9787239|FG002|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
8739132|NCT01107457|9787240|FG003|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
8739133|NCT01107457|9787241|FG004|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
8739134|NCT01107457|9787242|FG005|STARTED|Part B and C|80 and 120 mg ixekizumab were administered during Part B and C.|120
8739135|NCT01107457|9787237|FG000|Completed Part B (Week 240)|Part B and C||0
8739136|NCT01107457|9787238|FG001|Completed Part B (Week 240)|Part B and C||0
8739137|NCT01107457|9787239|FG002|Completed Part B (Week 240)|Part B and C||0
8739138|NCT01107457|9787240|FG003|Completed Part B (Week 240)|Part B and C||0
8739139|NCT01107457|9787241|FG004|Completed Part B (Week 240)|Part B and C||0
8739140|NCT01107457|9787242|FG005|Completed Part B (Week 240)|Part B and C||74
8739141|NCT01107457|9787237|FG000|Completed Part C|Part B and C||0
8739142|NCT01107457|9787238|FG001|Completed Part C|Part B and C||0
8739143|NCT01107457|9787239|FG002|Completed Part C|Part B and C||0
8739144|NCT01107457|9787240|FG003|Completed Part C|Part B and C||0
8739145|NCT01107457|9787241|FG004|Completed Part C|Part B and C||0
8739146|NCT01107457|9787242|FG005|Completed Part C|Part B and C|Part C was stopped once ixekizumab became available through marketing authorization.|0
8739147|NCT01107457|9787237|FG000|Post Treatment Safety Visits|Part B and C||0
8739148|NCT01107457|9787238|FG001|Post Treatment Safety Visits|Part B and C||0
8739149|NCT01107457|9787239|FG002|Post Treatment Safety Visits|Part B and C||0
8739150|NCT01107457|9787240|FG003|Post Treatment Safety Visits|Part B and C||0
8739151|NCT01107457|9787241|FG004|Post Treatment Safety Visits|Part B and C||0
8739152|NCT01107457|9787242|FG005|Post Treatment Safety Visits|Part B and C|Only participants with neutropenia entered the post treatment safety visits.|6
8739153|NCT01107457|9787237|FG000|COMPLETED|Part B and C||0
8739154|NCT01107457|9787238|FG001|COMPLETED|Part B and C||0
8739155|NCT01107457|9787239|FG002|COMPLETED|Part B and C||0
8739156|NCT01107457|9787240|FG003|COMPLETED|Part B and C||0
8739157|NCT01107457|9787241|FG004|COMPLETED|Part B and C||0
8739158|NCT01107457|9787242|FG005|COMPLETED|Part B and C|No participants completed the study as Part C was stopped.|0
8739159|NCT01107457|9787237|FG000|NOT COMPLETED|Part B and C||0
8739160|NCT01107457|9787238|FG001|NOT COMPLETED|Part B and C||0
8739161|NCT01107457|9787239|FG002|NOT COMPLETED|Part B and C||0
8739162|NCT01107457|9787240|FG003|NOT COMPLETED|Part B and C||0
8739163|NCT01107457|9787241|FG004|NOT COMPLETED|Part B and C||0
8739164|NCT01107457|9787242|FG005|NOT COMPLETED|Part B and C||120
8739165|NCT01107535|9787260|FG000|STARTED|Overall Study||82
8739166|NCT01107535|9787260|FG000|Number of Participants Analyzed|Overall Study||82
8739167|NCT01107535|9787260|FG000|COMPLETED|Overall Study||77
8739168|NCT01107535|9787260|FG000|NOT COMPLETED|Overall Study||5
8739169|NCT01107626|9787268|FG000|STARTED|Step 1: Induction Therapy||642
8739170|NCT01107626|9787269|FG001|STARTED|Step 1: Induction Therapy||287
8739171|NCT01107626|9787270|FG002|STARTED|Step 1: Induction Therapy||294
8739172|NCT01107626|9787271|FG003|STARTED|Step 1: Induction Therapy||293
8739173|NCT01107626|9787268|FG000|COMPLETED|Step 1: Induction Therapy||65
8739174|NCT01107626|9787269|FG001|COMPLETED|Step 1: Induction Therapy||287
8739175|NCT01107626|9787270|FG002|COMPLETED|Step 1: Induction Therapy||294
8739176|NCT01107626|9787271|FG003|COMPLETED|Step 1: Induction Therapy||293
8739177|NCT01107626|9787268|FG000|NOT COMPLETED|Step 1: Induction Therapy||577
8739178|NCT01107626|9787269|FG001|NOT COMPLETED|Step 1: Induction Therapy||0
8739179|NCT01107626|9787270|FG002|NOT COMPLETED|Step 1: Induction Therapy||0
8739180|NCT01107626|9787271|FG003|NOT COMPLETED|Step 1: Induction Therapy||0
8739181|NCT01107626|9787268|FG000|STARTED|Step 2: Maintenance Therapy|Patients without complete/partial response or stable disease post induction phase weren't randomized|0
8739182|NCT01107626|9787269|FG001|STARTED|Step 2: Maintenance Therapy||287
8739183|NCT01107626|9787270|FG002|STARTED|Step 2: Maintenance Therapy||294
8739184|NCT01107626|9787271|FG003|STARTED|Step 2: Maintenance Therapy||293
8807029|NCT01482715|9859389|FG006|STARTED|Overall Study||8
8807030|NCT01482715|9859390|FG007|STARTED|Overall Study||9
8739185|NCT01107626|9787268|FG000|COMPLETED|Step 2: Maintenance Therapy|Patients without complete/partial response or stable disease post induction phase weren't randomized|0
8739186|NCT01107626|9787269|FG001|COMPLETED|Step 2: Maintenance Therapy||1
8739187|NCT01107626|9787270|FG002|COMPLETED|Step 2: Maintenance Therapy||0
8739188|NCT01107626|9787271|FG003|COMPLETED|Step 2: Maintenance Therapy||1
8739189|NCT01107626|9787268|FG000|NOT COMPLETED|Step 2: Maintenance Therapy||0
8739190|NCT01107626|9787269|FG001|NOT COMPLETED|Step 2: Maintenance Therapy||286
8739191|NCT01107626|9787270|FG002|NOT COMPLETED|Step 2: Maintenance Therapy||294
8739192|NCT01107626|9787271|FG003|NOT COMPLETED|Step 2: Maintenance Therapy||292
8739193|NCT01107665|9787280|FG000|STARTED|Overall Study||60
8739194|NCT01107665|9787280|FG000|COMPLETED|Overall Study||11
8739195|NCT01107665|9787280|FG000|NOT COMPLETED|Overall Study||49
8739196|NCT01107730|9787289|FG000|STARTED|Overall Study||11
8739197|NCT01107730|9787290|FG001|STARTED|Overall Study||11
8739198|NCT01107730|9787291|FG002|STARTED|Overall Study||11
8739199|NCT01107730|9787289|FG000|COMPLETED|Overall Study||11
8739200|NCT01107730|9787290|FG001|COMPLETED|Overall Study||11
8739201|NCT01107730|9787291|FG002|COMPLETED|Overall Study||11
8739202|NCT01107730|9787289|FG000|NOT COMPLETED|Overall Study||0
8739203|NCT01107730|9787290|FG001|NOT COMPLETED|Overall Study||0
8739204|NCT01107730|9787291|FG002|NOT COMPLETED|Overall Study||0
8739205|NCT01107743|9787299|FG000|STARTED|Overall Study||1291
8739206|NCT01107743|9787299|FG000|COMPLETED|Overall Study||1245
8739207|NCT01107743|9787299|FG000|NOT COMPLETED|Overall Study||46
8739208|NCT01107834|9787350|FG000|STARTED|Overall Study||30
8739209|NCT01107834|9787351|FG001|STARTED|Overall Study||30
8739210|NCT01107834|9787350|FG000|COMPLETED|Overall Study||30
8739211|NCT01107834|9787351|FG001|COMPLETED|Overall Study||30
8739212|NCT01107834|9787350|FG000|NOT COMPLETED|Overall Study||0
8739213|NCT01107834|9787351|FG001|NOT COMPLETED|Overall Study||0
8739214|NCT01107886|9787359|FG000|STARTED|Overall Study|Randomized subjects|8280
8739215|NCT01107886|9787360|FG001|STARTED|Overall Study|Randomized subjects|8212
8739216|NCT01107886|9787359|FG000|COMPLETED|Overall Study|Completed subjects|8078
8739217|NCT01107886|9787360|FG001|COMPLETED|Overall Study|Completed subjects|7998
8739218|NCT01107886|9787359|FG000|NOT COMPLETED|Overall Study||202
8739219|NCT01107886|9787360|FG001|NOT COMPLETED|Overall Study||214
8739220|NCT01107899|9787369|FG000|STARTED|Overall Study||10
8739221|NCT01107899|9787370|FG001|STARTED|Overall Study||10
8739222|NCT01107899|9787371|FG002|STARTED|Overall Study||9
8739223|NCT01107899|9787369|FG000|Received at Least One Dose of Study Drug|Overall Study||10
8739224|NCT01107899|9787370|FG001|Received at Least One Dose of Study Drug|Overall Study||10
8739225|NCT01107899|9787371|FG002|Received at Least One Dose of Study Drug|Overall Study||8
8739226|NCT01107899|9787369|FG000|Loading Dose (LD) Intent to Treat (ITT)|Overall Study|Received LD and had evaluable pharmacodynamic (PD) measurements 24-hours post-LD.|5
8912359|NCT02152696|9971448|FG000|STARTED|Overall Study||86
8912360|NCT02152696|9971449|FG001|STARTED|Overall Study||87
8912361|NCT02152696|9971450|FG002|STARTED|Overall Study||82
8912362|NCT02152696|9971448|FG000|COMPLETED|Overall Study||86
8912363|NCT02152696|9971449|FG001|COMPLETED|Overall Study||86
8912364|NCT02152696|9971450|FG002|COMPLETED|Overall Study||81
8912365|NCT02152696|9971448|FG000|NOT COMPLETED|Overall Study||0
8912366|NCT02152696|9971449|FG001|NOT COMPLETED|Overall Study||1
8912367|NCT02152696|9971450|FG002|NOT COMPLETED|Overall Study||1
8912368|NCT02152761|9971462|FG000|STARTED|Epoch: Treatment Epoch||75
8912369|NCT02152761|9971463|FG001|STARTED|Epoch: Treatment Epoch||70
8912370|NCT02152761|9971464|FG002|STARTED|Epoch: Treatment Epoch||34
8912371|NCT02152761|9971465|FG003|STARTED|Epoch: Treatment Epoch||72
8912372|NCT02152761|9971462|FG000|COMPLETED|Epoch: Treatment Epoch||64
8912373|NCT02152761|9971463|FG001|COMPLETED|Epoch: Treatment Epoch||50
8912374|NCT02152761|9971464|FG002|COMPLETED|Epoch: Treatment Epoch||29
8912375|NCT02152761|9971465|FG003|COMPLETED|Epoch: Treatment Epoch||64
8912376|NCT02152761|9971462|FG000|NOT COMPLETED|Epoch: Treatment Epoch||11
8912377|NCT02152761|9971463|FG001|NOT COMPLETED|Epoch: Treatment Epoch||20
8912378|NCT02152761|9971464|FG002|NOT COMPLETED|Epoch: Treatment Epoch||5
8912379|NCT02152761|9971465|FG003|NOT COMPLETED|Epoch: Treatment Epoch||8
8912380|NCT02152761|9971462|FG000|STARTED|Epoch: Post-treatment Follow-up Epoch||67
8912381|NCT02152761|9971463|FG001|STARTED|Epoch: Post-treatment Follow-up Epoch||54
9022556|NCT03129100|10085463|FG009|COMPLETED|Lead-In Period (Period 1)||0
9022557|NCT03129100|10085464|FG010|COMPLETED|Lead-In Period (Period 1)||0
8739227|NCT01107899|9787370|FG001|Loading Dose (LD) Intent to Treat (ITT)|Overall Study|Received LD and had evaluable pharmacodynamic (PD) measurements 24-hours post-LD.|10
8739228|NCT01107899|9787371|FG002|Loading Dose (LD) Intent to Treat (ITT)|Overall Study|Received LD and had evaluable pharmacodynamic (PD) measurements 24-hours post-LD.|6
8739229|NCT01107899|9787369|FG000|ITT Washout Population|Overall Study|ITT Washout Population (WP): Received LD, had evaluable baseline PD data (pre-LD) and post-LD.|5
8807031|NCT01482715|9859391|FG008|STARTED|Overall Study||7
8807032|NCT01482715|9859392|FG009|STARTED|Overall Study||3
8807033|NCT01482715|9859393|FG010|STARTED|Overall Study||42
8807034|NCT01482715|9859394|FG011|STARTED|Overall Study||12
8807035|NCT01482715|9859395|FG012|STARTED|Overall Study||26
8807036|NCT01482715|9859383|FG000|COMPLETED|Overall Study||6
8807037|NCT01482715|9859384|FG001|COMPLETED|Overall Study||3
8807038|NCT01482715|9859385|FG002|COMPLETED|Overall Study||4
8807039|NCT01482715|9859386|FG003|COMPLETED|Overall Study||9
8807040|NCT01482715|9859387|FG004|COMPLETED|Overall Study||4
8807041|NCT01482715|9859388|FG005|COMPLETED|Overall Study||3
8807042|NCT01482715|9859389|FG006|COMPLETED|Overall Study||8
8739230|NCT01107899|9787370|FG001|ITT Washout Population|Overall Study|ITT Washout Population (WP): Received LD, had evaluable baseline PD data (pre-LD) and post-LD.|10
8739231|NCT01107899|9787371|FG002|ITT Washout Population|Overall Study|ITT Washout Population (WP): Received LD, had evaluable baseline PD data (pre-LD) and post-LD.|6
8739232|NCT01107899|9787369|FG000|Primary Washout Population|Overall Study|Primary WP: Completed study with no missed visits, had evaluable PD data through Day 11.|5
8739233|NCT01107899|9787370|FG001|Primary Washout Population|Overall Study|Primary WP: Completed study with no missed visits, had evaluable PD data through Day 11.|10
8739234|NCT01107899|9787371|FG002|Primary Washout Population|Overall Study|Primary WP: Completed study with no missed visits, had evaluable PD data through Day 11.|4
8739235|NCT01107899|9787369|FG000|COMPLETED|Overall Study||5
8739236|NCT01107899|9787370|FG001|COMPLETED|Overall Study||10
8739237|NCT01107899|9787371|FG002|COMPLETED|Overall Study||5
8739238|NCT01107899|9787369|FG000|NOT COMPLETED|Overall Study||5
8739239|NCT01107899|9787370|FG001|NOT COMPLETED|Overall Study||0
8739240|NCT01107899|9787371|FG002|NOT COMPLETED|Overall Study||4
8739241|NCT01107912|9787386|FG000|STARTED|Period 1||73
8739242|NCT01107912|9787387|FG001|STARTED|Period 1||0
8739243|NCT01107912|9787388|FG002|STARTED|Period 1||0
8739244|NCT01107912|9787389|FG003|STARTED|Period 1||0
8739245|NCT01107912|9787390|FG004|STARTED|Period 1||82
8739246|NCT01107912|9787391|FG005|STARTED|Period 1||0
8739247|NCT01107912|9787386|FG000|Received at Least 1 Dose of Study Drug|Period 1||73
8739248|NCT01107912|9787387|FG001|Received at Least 1 Dose of Study Drug|Period 1||0
8739249|NCT01107912|9787388|FG002|Received at Least 1 Dose of Study Drug|Period 1||0
8739250|NCT01107912|9787389|FG003|Received at Least 1 Dose of Study Drug|Period 1||0
8739251|NCT01107912|9787390|FG004|Received at Least 1 Dose of Study Drug|Period 1||82
8739252|NCT01107912|9787391|FG005|Received at Least 1 Dose of Study Drug|Period 1||0
8739253|NCT01107912|9787386|FG000|COMPLETED|Period 1||72
8739254|NCT01107912|9787387|FG001|COMPLETED|Period 1||0
8739255|NCT01107912|9787388|FG002|COMPLETED|Period 1||0
8739256|NCT01107912|9787389|FG003|COMPLETED|Period 1||0
8739257|NCT01107912|9787390|FG004|COMPLETED|Period 1||79
8739258|NCT01107912|9787391|FG005|COMPLETED|Period 1||0
8739259|NCT01107912|9787386|FG000|NOT COMPLETED|Period 1||1
8739260|NCT01107912|9787387|FG001|NOT COMPLETED|Period 1||0
8739261|NCT01107912|9787388|FG002|NOT COMPLETED|Period 1||0
8739262|NCT01107912|9787389|FG003|NOT COMPLETED|Period 1||0
8739263|NCT01107912|9787390|FG004|NOT COMPLETED|Period 1||3
8739264|NCT01107912|9787391|FG005|NOT COMPLETED|Period 1||0
8739265|NCT01107912|9787386|FG000|STARTED|Period 2|Participants switched to either 10 mg prasugrel or 75 mg clopidogrel in Period 2.|0
8739266|NCT01107912|9787387|FG001|STARTED|Period 2||36
8739267|NCT01107912|9787388|FG002|STARTED|Period 2||36
8739268|NCT01107912|9787389|FG003|STARTED|Period 2||41
8739269|NCT01107912|9787390|FG004|STARTED|Period 2|Participants switched to either 5 mg prasugrel or 75 mg clopidogrel in Period 2.|0
8739270|NCT01107912|9787391|FG005|STARTED|Period 2||38
8739271|NCT01107912|9787386|FG000|COMPLETED|Period 2||0
8739272|NCT01107912|9787387|FG001|COMPLETED|Period 2||36
8739273|NCT01107912|9787388|FG002|COMPLETED|Period 2||35
8739274|NCT01107912|9787389|FG003|COMPLETED|Period 2||41
8739275|NCT01107912|9787390|FG004|COMPLETED|Period 2||0
8739276|NCT01107912|9787391|FG005|COMPLETED|Period 2||38
8739277|NCT01107912|9787386|FG000|NOT COMPLETED|Period 2||0
8739278|NCT01107912|9787387|FG001|NOT COMPLETED|Period 2||0
8739279|NCT01107912|9787388|FG002|NOT COMPLETED|Period 2||1
8739280|NCT01107912|9787389|FG003|NOT COMPLETED|Period 2||0
8739281|NCT01107912|9787390|FG004|NOT COMPLETED|Period 2||0
8739282|NCT01107912|9787391|FG005|NOT COMPLETED|Period 2||0
8739283|NCT01107912|9787386|FG000|STARTED|Period 3||0
8739284|NCT01107912|9787387|FG001|STARTED|Period 3|Participants who received 75 mg clopidogrel in Period 2 received 10 mg prasugrel in Period 3|35
8739285|NCT01107912|9787388|FG002|STARTED|Period 3|Participants who received 10 mg prasugrel in Period 2 received 75 mg clopidogrel in Period 3|36
8739286|NCT01107912|9787389|FG003|STARTED|Period 3|Participants who received 75 mg clopidogrel in Period 2 received 5 mg prasugrel in Period 3|38
8739287|NCT01107912|9787390|FG004|STARTED|Period 3||0
8739288|NCT01107912|9787391|FG005|STARTED|Period 3|Participants who received 5 mg prasugrel in Period 2 received 75 mg clopidogrel in Period 3|41
8739289|NCT01107912|9787386|FG000|COMPLETED|Period 3||0
8739290|NCT01107912|9787387|FG001|COMPLETED|Period 3||34
8739291|NCT01107912|9787388|FG002|COMPLETED|Period 3||35
8739292|NCT01107912|9787389|FG003|COMPLETED|Period 3||37
8739293|NCT01107912|9787390|FG004|COMPLETED|Period 3||0
8739294|NCT01107912|9787391|FG005|COMPLETED|Period 3||41
8739295|NCT01107912|9787386|FG000|NOT COMPLETED|Period 3||0
8739296|NCT01107912|9787387|FG001|NOT COMPLETED|Period 3||1
8739297|NCT01107912|9787388|FG002|NOT COMPLETED|Period 3||1
8739298|NCT01107912|9787389|FG003|NOT COMPLETED|Period 3||1
8912382|NCT02152761|9971464|FG002|STARTED|Epoch: Post-treatment Follow-up Epoch||30
8912383|NCT02152761|9971465|FG003|STARTED|Epoch: Post-treatment Follow-up Epoch||68
8912384|NCT02152761|9971462|FG000|COMPLETED|Epoch: Post-treatment Follow-up Epoch||63
8912385|NCT02152761|9971463|FG001|COMPLETED|Epoch: Post-treatment Follow-up Epoch||47
9022558|NCT03129100|10085454|FG000|NOT COMPLETED|Lead-In Period (Period 1)||15
8739299|NCT01107912|9787390|FG004|NOT COMPLETED|Period 3||0
8739300|NCT01107912|9787391|FG005|NOT COMPLETED|Period 3||0
8739301|NCT01107925|9787410|FG000|STARTED|Period 1-Randomization up Through Day 12||34
8739302|NCT01107925|9787411|FG001|STARTED|Period 1-Randomization up Through Day 12||0
8739303|NCT01107925|9787412|FG002|STARTED|Period 1-Randomization up Through Day 12||0
8739304|NCT01107925|9787413|FG003|STARTED|Period 1-Randomization up Through Day 12||0
8739305|NCT01107925|9787414|FG004|STARTED|Period 1-Randomization up Through Day 12||38
8739306|NCT01107925|9787415|FG005|STARTED|Period 1-Randomization up Through Day 12||0
8739307|NCT01107925|9787410|FG000|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||34
8739308|NCT01107925|9787411|FG001|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
8739309|NCT01107925|9787412|FG002|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
8739310|NCT01107925|9787413|FG003|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
8739311|NCT01107925|9787414|FG004|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||38
8739312|NCT01107925|9787415|FG005|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
8739313|NCT01107925|9787410|FG000|COMPLETED|Period 1-Randomization up Through Day 12||33
8739314|NCT01107925|9787411|FG001|COMPLETED|Period 1-Randomization up Through Day 12||0
8739315|NCT01107925|9787412|FG002|COMPLETED|Period 1-Randomization up Through Day 12||0
8739316|NCT01107925|9787413|FG003|COMPLETED|Period 1-Randomization up Through Day 12||0
8739317|NCT01107925|9787414|FG004|COMPLETED|Period 1-Randomization up Through Day 12||37
8739318|NCT01107925|9787415|FG005|COMPLETED|Period 1-Randomization up Through Day 12||0
8739319|NCT01107925|9787410|FG000|NOT COMPLETED|Period 1-Randomization up Through Day 12||1
8739320|NCT01107925|9787411|FG001|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
8739321|NCT01107925|9787412|FG002|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
8739322|NCT01107925|9787413|FG003|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
8739323|NCT01107925|9787414|FG004|NOT COMPLETED|Period 1-Randomization up Through Day 12||1
8739324|NCT01107925|9787415|FG005|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
8739325|NCT01107925|9787410|FG000|STARTED|Period 2|5 mg prasugrel (Period 1, LBW treatment) switched to 10 mg prasugrel or 75 mg clopidogrel (Period 2)|0
8739326|NCT01107925|9787411|FG001|STARTED|Period 2||16
8739327|NCT01107925|9787412|FG002|STARTED|Period 2||17
8739328|NCT01107925|9787413|FG003|STARTED|Period 2||20
8739329|NCT01107925|9787414|FG004|STARTED|Period 2|10 mg prasugrel (Period 1, HBW treatment) switched to 5 mg prasugrel or 75 mg clopidogrel (Period 2)|0
8739330|NCT01107925|9787415|FG005|STARTED|Period 2||17
8739331|NCT01107925|9787410|FG000|Took at Least 1 Dose of Study Drug|Period 2||0
8739332|NCT01107925|9787411|FG001|Took at Least 1 Dose of Study Drug|Period 2||16
8739333|NCT01107925|9787412|FG002|Took at Least 1 Dose of Study Drug|Period 2||17
8739334|NCT01107925|9787413|FG003|Took at Least 1 Dose of Study Drug|Period 2||20
8739335|NCT01107925|9787414|FG004|Took at Least 1 Dose of Study Drug|Period 2||0
8739336|NCT01107925|9787415|FG005|Took at Least 1 Dose of Study Drug|Period 2||17
8739337|NCT01107925|9787410|FG000|COMPLETED|Period 2||0
8739338|NCT01107925|9787411|FG001|COMPLETED|Period 2||15
8739339|NCT01107925|9787412|FG002|COMPLETED|Period 2||17
8739340|NCT01107925|9787413|FG003|COMPLETED|Period 2||20
8739341|NCT01107925|9787414|FG004|COMPLETED|Period 2||0
8739342|NCT01107925|9787415|FG005|COMPLETED|Period 2||16
8739343|NCT01107925|9787410|FG000|NOT COMPLETED|Period 2||0
8739344|NCT01107925|9787411|FG001|NOT COMPLETED|Period 2||1
8739345|NCT01107925|9787412|FG002|NOT COMPLETED|Period 2||0
8739346|NCT01107925|9787413|FG003|NOT COMPLETED|Period 2||0
8739347|NCT01107925|9787414|FG004|NOT COMPLETED|Period 2||0
8739348|NCT01107925|9787415|FG005|NOT COMPLETED|Period 2||1
8739349|NCT01107925|9787410|FG000|STARTED|Period 3||0
8739350|NCT01107925|9787411|FG001|STARTED|Period 3|75 mg clopidogrel (Period 2, LBW treatment sequence) crossed over to 10 mg prasugrel (Period 3).|17
8739351|NCT01107925|9787412|FG002|STARTED|Period 3|10 mg prasugrel (Period 2, LBW treatment sequence) crossed over to 75 mg clopidogrel (Period 3).|15
8739352|NCT01107925|9787413|FG003|STARTED|Period 3|75 mg clopidogrel (Period 2, HBW treatment sequence) crossed over to 5 mg prasugrel (Period 3).|16
8739353|NCT01107925|9787414|FG004|STARTED|Period 3||0
8739354|NCT01107925|9787415|FG005|STARTED|Period 3|5 mg prasugrel (Period 2, HBW treatment sequence) crossed over to 75 mg clopidogrel (Period 3).|20
8739355|NCT01107925|9787410|FG000|Took at Least 1 Dose of Study Drug|Period 3||0
8739356|NCT01107925|9787411|FG001|Took at Least 1 Dose of Study Drug|Period 3||17
8739357|NCT01107925|9787412|FG002|Took at Least 1 Dose of Study Drug|Period 3||15
8739358|NCT01107925|9787413|FG003|Took at Least 1 Dose of Study Drug|Period 3||16
8739359|NCT01107925|9787414|FG004|Took at Least 1 Dose of Study Drug|Period 3||0
8739360|NCT01107925|9787415|FG005|Took at Least 1 Dose of Study Drug|Period 3||20
8739361|NCT01107925|9787410|FG000|COMPLETED|Period 3||0
8739362|NCT01107925|9787411|FG001|COMPLETED|Period 3||17
8739363|NCT01107925|9787412|FG002|COMPLETED|Period 3||15
8739364|NCT01107925|9787413|FG003|COMPLETED|Period 3||16
8739365|NCT01107925|9787414|FG004|COMPLETED|Period 3||0
8739366|NCT01107925|9787415|FG005|COMPLETED|Period 3||20
8739367|NCT01107925|9787410|FG000|NOT COMPLETED|Period 3||0
8739368|NCT01107925|9787411|FG001|NOT COMPLETED|Period 3||0
8739369|NCT01107925|9787412|FG002|NOT COMPLETED|Period 3||0
8739370|NCT01107925|9787413|FG003|NOT COMPLETED|Period 3||0
8739371|NCT01107925|9787414|FG004|NOT COMPLETED|Period 3||0
8739372|NCT01107925|9787415|FG005|NOT COMPLETED|Period 3||0
8739373|NCT01107964|9787445|FG000|STARTED|Overall Study||13
8739374|NCT01107964|9787446|FG001|STARTED|Overall Study||14
8739375|NCT01107964|9787445|FG000|COMPLETED|Overall Study||12
8739376|NCT01107964|9787446|FG001|COMPLETED|Overall Study||13
8739377|NCT01107964|9787445|FG000|NOT COMPLETED|Overall Study||1
8739378|NCT01107964|9787446|FG001|NOT COMPLETED|Overall Study||1
8739379|NCT01108003|9787454|FG000|STARTED|Overall Study||4
8739380|NCT01108003|9787455|FG001|STARTED|Overall Study||3
8739381|NCT01108003|9787454|FG000|COMPLETED|Overall Study||4
8739382|NCT01108003|9787455|FG001|COMPLETED|Overall Study||3
8739383|NCT01108003|9787454|FG000|NOT COMPLETED|Overall Study||0
8739384|NCT01108003|9787455|FG001|NOT COMPLETED|Overall Study||0
8739385|NCT01108068|9787463|FG000|STARTED|Overall Study||10
8739386|NCT01108068|9787464|FG001|STARTED|Overall Study||16
8739387|NCT01108068|9787463|FG000|COMPLETED|Overall Study|Only 5 individuals were recruited into the Lithium treatment arm|4
8739388|NCT01108068|9787464|FG001|COMPLETED|Overall Study||16
8739389|NCT01108068|9787463|FG000|NOT COMPLETED|Overall Study||6
8739390|NCT01108068|9787464|FG001|NOT COMPLETED|Overall Study||0
8739391|NCT01108081|9787475|FG000|STARTED|Overall Study||46
8739392|NCT01108081|9787476|FG001|STARTED|Overall Study||42
8739393|NCT01108081|9787477|FG002|STARTED|Overall Study||38
8739394|NCT01108081|9787478|FG003|STARTED|Overall Study||43
8739395|NCT01108081|9787475|FG000|COMPLETED|Overall Study||44
8739396|NCT01108081|9787476|FG001|COMPLETED|Overall Study||40
8739397|NCT01108081|9787477|FG002|COMPLETED|Overall Study||38
8739398|NCT01108081|9787478|FG003|COMPLETED|Overall Study||39
8739399|NCT01108081|9787475|FG000|NOT COMPLETED|Overall Study||2
8739400|NCT01108081|9787476|FG001|NOT COMPLETED|Overall Study||2
8739401|NCT01108081|9787477|FG002|NOT COMPLETED|Overall Study||0
8739402|NCT01108081|9787478|FG003|NOT COMPLETED|Overall Study||4
8739403|NCT01108094|9787492|FG000|STARTED|Overall Study||12
8739404|NCT01108094|9787493|FG001|STARTED|Overall Study||3
8739405|NCT01108094|9787494|FG002|STARTED|Overall Study||4
8739406|NCT01108094|9787495|FG003|STARTED|Overall Study||10
8739407|NCT01108094|9787492|FG000|COMPLETED|Overall Study||9
8739408|NCT01108094|9787493|FG001|COMPLETED|Overall Study||3
8739409|NCT01108094|9787494|FG002|COMPLETED|Overall Study||4
8739410|NCT01108094|9787495|FG003|COMPLETED|Overall Study||10
8739411|NCT01108094|9787492|FG000|NOT COMPLETED|Overall Study||3
8739412|NCT01108094|9787493|FG001|NOT COMPLETED|Overall Study||0
8739413|NCT01108094|9787494|FG002|NOT COMPLETED|Overall Study||0
8739414|NCT01108094|9787495|FG003|NOT COMPLETED|Overall Study||0
8739415|NCT01108185|9787508|FG000|STARTED|Overall Study||3181
8739416|NCT01108185|9787508|FG000|Per Protocol Population|Overall Study||3181
8739417|NCT01108185|9787508|FG000|COMPLETED|Overall Study||3154
8739418|NCT01108185|9787508|FG000|NOT COMPLETED|Overall Study||27
8739419|NCT01108237|9787514|FG000|STARTED|Overall Study|78 subjects were consented with intent to treat, however, 73 had surgery.|73
8739420|NCT01108237|9787515|FG001|STARTED|Overall Study||101
8739421|NCT01108237|9787514|FG000|COMPLETED|Overall Study|66 subjects underwent surgery per the protocol, however, only 64 met the primary end point.|64
8739422|NCT01108237|9787515|FG001|COMPLETED|Overall Study||84
8739423|NCT01108237|9787514|FG000|NOT COMPLETED|Overall Study||9
8739424|NCT01108237|9787515|FG001|NOT COMPLETED|Overall Study||17
8739425|NCT01108263|9787523|FG000|STARTED|Overall Study||2
8739426|NCT01108263|9787524|FG001|STARTED|Overall Study||3
8739427|NCT01108263|9787523|FG000|COMPLETED|Overall Study||2
8739428|NCT01108263|9787524|FG001|COMPLETED|Overall Study||2
8739429|NCT01108263|9787523|FG000|NOT COMPLETED|Overall Study||0
8739430|NCT01108263|9787524|FG001|NOT COMPLETED|Overall Study||1
8739431|NCT01108341|9787530|FG000|STARTED|Overall Study||50
8739432|NCT01108341|9787530|FG000|Safety Set (Enrolled and Treated)|Overall Study||49
8739433|NCT01108341|9787530|FG000|COMPLETED|Overall Study||45
8739434|NCT01108341|9787530|FG000|NOT COMPLETED|Overall Study||5
8739435|NCT01108406|9787534|FG000|STARTED|Overall Study||22
8739436|NCT01108406|9787534|FG000|COMPLETED|Overall Study||22
8739437|NCT01108406|9787534|FG000|NOT COMPLETED|Overall Study||0
8739438|NCT01108445|9787542|FG000|STARTED|Overall Study||57
8739439|NCT01108445|9787543|FG001|STARTED|Overall Study||51
8739440|NCT01108445|9787542|FG000|COMPLETED|Overall Study||1
8739441|NCT01108445|9787543|FG001|COMPLETED|Overall Study||2
8739442|NCT01108445|9787542|FG000|NOT COMPLETED|Overall Study||56
8739443|NCT01108445|9787543|FG001|NOT COMPLETED|Overall Study||49
8739444|NCT01108458|9787549|FG000|STARTED|Overall Study||1
8739445|NCT01108458|9787549|FG000|COMPLETED|Overall Study||0
8739446|NCT01108458|9787549|FG000|NOT COMPLETED|Overall Study||1
8739447|NCT01108510|9787555|FG000|STARTED|Overall Study||349
8739448|NCT01108510|9787556|FG001|STARTED|Overall Study||349
8739449|NCT01108510|9787555|FG000|COMPLETED|Overall Study||70
8739450|NCT01108510|9787556|FG001|COMPLETED|Overall Study||81
8739451|NCT01108510|9787555|FG000|NOT COMPLETED|Overall Study||279
8739452|NCT01108510|9787556|FG001|NOT COMPLETED|Overall Study||268
8739453|NCT01108718|9787564|FG000|STARTED|Received First Intervention (2 Months)||5
8739454|NCT01108718|9787565|FG001|STARTED|Received First Intervention (2 Months)||7
8739455|NCT01108718|9787564|FG000|COMPLETED|Received First Intervention (2 Months)||5
8739456|NCT01108718|9787565|FG001|COMPLETED|Received First Intervention (2 Months)||7
8739457|NCT01108718|9787564|FG000|NOT COMPLETED|Received First Intervention (2 Months)||0
8739458|NCT01108718|9787565|FG001|NOT COMPLETED|Received First Intervention (2 Months)||0
8739459|NCT01108718|9787564|FG000|STARTED|Received Second Intervention (2 Months)|Used control mattress was delivered to participant at crossover causing her to withdraw.|5
8739460|NCT01108718|9787565|FG001|STARTED|Received Second Intervention (2 Months)||7
8739461|NCT01108718|9787564|FG000|COMPLETED|Received Second Intervention (2 Months)||4
8739462|NCT01108718|9787565|FG001|COMPLETED|Received Second Intervention (2 Months)||7
8739463|NCT01108718|9787564|FG000|NOT COMPLETED|Received Second Intervention (2 Months)||1
8739464|NCT01108718|9787565|FG001|NOT COMPLETED|Received Second Intervention (2 Months)||0
8739465|NCT01108731|9787572|FG000|STARTED|Overall Study||17
8739466|NCT01108731|9787573|FG001|STARTED|Overall Study||17
8739467|NCT01108731|9787572|FG000|COMPLETED|Overall Study||13
8739468|NCT01108731|9787573|FG001|COMPLETED|Overall Study||13
8739469|NCT01108731|9787572|FG000|NOT COMPLETED|Overall Study||4
8739470|NCT01108731|9787573|FG001|NOT COMPLETED|Overall Study||4
8807043|NCT01482715|9859390|FG007|COMPLETED|Overall Study||9
8807044|NCT01482715|9859391|FG008|COMPLETED|Overall Study||7
8807045|NCT01482715|9859392|FG009|COMPLETED|Overall Study||3
8807046|NCT01482715|9859393|FG010|COMPLETED|Overall Study||42
8807047|NCT01482715|9859394|FG011|COMPLETED|Overall Study||12
8807048|NCT01482715|9859395|FG012|COMPLETED|Overall Study||26
8807049|NCT01482715|9859383|FG000|NOT COMPLETED|Overall Study||0
8807050|NCT01482715|9859384|FG001|NOT COMPLETED|Overall Study||0
8807051|NCT01482715|9859385|FG002|NOT COMPLETED|Overall Study||0
8807052|NCT01482715|9859386|FG003|NOT COMPLETED|Overall Study||0
8807053|NCT01482715|9859387|FG004|NOT COMPLETED|Overall Study||0
8807054|NCT01482715|9859388|FG005|NOT COMPLETED|Overall Study||0
8807055|NCT01482715|9859389|FG006|NOT COMPLETED|Overall Study||0
8807056|NCT01482715|9859390|FG007|NOT COMPLETED|Overall Study||0
8807057|NCT01482715|9859391|FG008|NOT COMPLETED|Overall Study||0
8807058|NCT01482715|9859392|FG009|NOT COMPLETED|Overall Study||0
8807059|NCT01482715|9859393|FG010|NOT COMPLETED|Overall Study||0
8807060|NCT01482715|9859394|FG011|NOT COMPLETED|Overall Study||0
8807061|NCT01482715|9859395|FG012|NOT COMPLETED|Overall Study||0
8807062|NCT01482767|9859438|FG000|STARTED|Overall Study||135
8807063|NCT01482767|9859439|FG001|STARTED|Overall Study||127
8807064|NCT01482767|9859438|FG000|COMPLETED|Overall Study||81
8807065|NCT01482767|9859439|FG001|COMPLETED|Overall Study||78
8807066|NCT01482767|9859438|FG000|NOT COMPLETED|Overall Study||54
8807067|NCT01482767|9859439|FG001|NOT COMPLETED|Overall Study||49
8807068|NCT01482819|9859445|FG000|STARTED|Overall Study||21
8807069|NCT01482819|9859445|FG000|COMPLETED|Overall Study||19
8807070|NCT01482819|9859445|FG000|NOT COMPLETED|Overall Study||2
8807071|NCT01482884|9859455|FG000|STARTED|Overall Study|One participant did not receive study treatment|56
8807072|NCT01482884|9859456|FG001|STARTED|Overall Study||55
8807073|NCT01482884|9859455|FG000|COMPLETED|Overall Study||43
8807074|NCT01482884|9859456|FG001|COMPLETED|Overall Study||37
8807075|NCT01482884|9859455|FG000|NOT COMPLETED|Overall Study||13
8807076|NCT01482884|9859456|FG001|NOT COMPLETED|Overall Study||18
8807077|NCT01482910|9859464|FG000|STARTED|Overall Study||228
8807078|NCT01482910|9859465|FG001|STARTED|Overall Study||76
8807079|NCT01482910|9859464|FG000|Completed Week 28|Overall Study||216
8807080|NCT01482910|9859465|FG001|Completed Week 28|Overall Study||71
8807081|NCT01482910|9859464|FG000|COMPLETED|Overall Study||213
8807082|NCT01482910|9859465|FG001|COMPLETED|Overall Study||67
8807083|NCT01482910|9859464|FG000|NOT COMPLETED|Overall Study||15
8807084|NCT01482910|9859465|FG001|NOT COMPLETED|Overall Study||9
8807085|NCT01482962|9859475|FG000|STARTED|Overall Study||138
8807086|NCT01482962|9859476|FG001|STARTED|Overall Study||133
8807087|NCT01482962|9859475|FG000|Safety Population: Received Study Drug|Overall Study||137
8807088|NCT01482962|9859476|FG001|Safety Population: Received Study Drug|Overall Study||127
8807089|NCT01482962|9859475|FG000|COMPLETED|Overall Study||0
8807090|NCT01482962|9859476|FG001|COMPLETED|Overall Study||0
8807091|NCT01482962|9859475|FG000|NOT COMPLETED|Overall Study||138
8807092|NCT01482962|9859476|FG001|NOT COMPLETED|Overall Study||133
8807093|NCT01483118|9859486|FG000|STARTED|Overall Study||23
8807094|NCT01483118|9859487|FG001|STARTED|Overall Study||22
8807095|NCT01483118|9859486|FG000|Completed 3 Months|Overall Study||15
8807096|NCT01483118|9859487|FG001|Completed 3 Months|Overall Study||11
8807097|NCT01483118|9859486|FG000|COMPLETED|Overall Study||11
8807098|NCT01483118|9859487|FG001|COMPLETED|Overall Study||6
8807099|NCT01483118|9859486|FG000|NOT COMPLETED|Overall Study||12
8807100|NCT01483118|9859487|FG001|NOT COMPLETED|Overall Study||16
8807101|NCT01483144|9859498|FG000|STARTED|Overall Study||56
8807102|NCT01483144|9859499|FG001|STARTED|Overall Study||57
8807103|NCT01483144|9859500|FG002|STARTED|Overall Study||58
8807104|NCT01483144|9859498|FG000|COMPLETED|Overall Study||41
8807105|NCT01483144|9859499|FG001|COMPLETED|Overall Study||44
8807106|NCT01483144|9859500|FG002|COMPLETED|Overall Study||43
8807107|NCT01483144|9859498|FG000|NOT COMPLETED|Overall Study||15
8807108|NCT01483144|9859499|FG001|NOT COMPLETED|Overall Study||13
8807109|NCT01483144|9859500|FG002|NOT COMPLETED|Overall Study||15
8807110|NCT01483183|9859518|FG000|STARTED|Overall Study||4
8807111|NCT01483183|9859519|FG001|STARTED|Overall Study||1
8807112|NCT01483183|9859520|FG002|STARTED|Overall Study||5
8807113|NCT01483183|9859521|FG003|STARTED|Overall Study||3
8807114|NCT01483183|9859522|FG004|STARTED|Overall Study||4
8807115|NCT01483183|9859523|FG005|STARTED|Overall Study||4
8807116|NCT01483183|9859524|FG006|STARTED|Overall Study||6
8807117|NCT01483183|9859525|FG007|STARTED|Overall Study||4
8807118|NCT01483183|9859526|FG008|STARTED|Overall Study||4
8807119|NCT01483183|9859527|FG009|STARTED|Overall Study||5
8807120|NCT01483183|9859518|FG000|COMPLETED|Overall Study||4
8807121|NCT01483183|9859519|FG001|COMPLETED|Overall Study||1
8807122|NCT01483183|9859520|FG002|COMPLETED|Overall Study||5
8807123|NCT01483183|9859521|FG003|COMPLETED|Overall Study||3
8807124|NCT01483183|9859522|FG004|COMPLETED|Overall Study||4
8807125|NCT01483183|9859523|FG005|COMPLETED|Overall Study||4
8807126|NCT01483183|9859524|FG006|COMPLETED|Overall Study||4
8807127|NCT01483183|9859525|FG007|COMPLETED|Overall Study||4
8807128|NCT01483183|9859526|FG008|COMPLETED|Overall Study||4
8807129|NCT01483183|9859527|FG009|COMPLETED|Overall Study||4
8807130|NCT01483183|9859518|FG000|NOT COMPLETED|Overall Study||0
8739471|NCT01108757|9787581|FG000|STARTED|Overall Study||26
8739472|NCT01108757|9787582|FG001|STARTED|Overall Study||26
8739473|NCT01108757|9787581|FG000|COMPLETED|Overall Study||26
8739474|NCT01108757|9787582|FG001|COMPLETED|Overall Study||26
8739475|NCT01108757|9787581|FG000|NOT COMPLETED|Overall Study||0
8739476|NCT01108757|9787582|FG001|NOT COMPLETED|Overall Study||0
8739477|NCT01108796|9787592|FG000|STARTED|Overall Study||774
8739478|NCT01108796|9787593|FG001|STARTED|Overall Study||1067
8739479|NCT01108796|9787592|FG000|COMPLETED|Overall Study||767
8739480|NCT01108796|9787593|FG001|COMPLETED|Overall Study||1060
8739481|NCT01108796|9787592|FG000|NOT COMPLETED|Overall Study||7
8739482|NCT01108796|9787593|FG001|NOT COMPLETED|Overall Study||7
8739483|NCT01108809|9787601|FG000|STARTED|Overall Study||295
8739484|NCT01108809|9787601|FG000|COMPLETED|Overall Study||291
8739485|NCT01108809|9787601|FG000|NOT COMPLETED|Overall Study||4
8739486|NCT01108835|9787608|FG000|STARTED|Overall Study||90
8739487|NCT01108835|9787609|FG001|STARTED|Overall Study||90
8739488|NCT01108835|9787608|FG000|COMPLETED|Overall Study||73
8739489|NCT01108835|9787609|FG001|COMPLETED|Overall Study||69
8739490|NCT01108835|9787608|FG000|NOT COMPLETED|Overall Study||17
8739491|NCT01108835|9787609|FG001|NOT COMPLETED|Overall Study||21
8739492|NCT01109056|9787618|FG000|STARTED|Overall Study||57
8739493|NCT01109056|9787619|FG001|STARTED|Overall Study||58
8739494|NCT01109056|9787618|FG000|COMPLETED|Overall Study||50
8739495|NCT01109056|9787619|FG001|COMPLETED|Overall Study||53
8739496|NCT01109056|9787618|FG000|NOT COMPLETED|Overall Study||7
8739497|NCT01109056|9787619|FG001|NOT COMPLETED|Overall Study||5
8739498|NCT01109069|9787625|FG000|STARTED|Overall Study||199
8739499|NCT01109069|9787625|FG000|COMPLETED|Overall Study||106
8739500|NCT01109069|9787625|FG000|NOT COMPLETED|Overall Study||93
8739501|NCT01109108|9787632|FG000|STARTED|Overall Study||4035
8739502|NCT01109108|9787633|FG001|STARTED|Overall Study||4755
8739503|NCT01109108|9787632|FG000|COMPLETED|Overall Study||4035
8739504|NCT01109108|9787633|FG001|COMPLETED|Overall Study||4755
8739505|NCT01109108|9787632|FG000|NOT COMPLETED|Overall Study||0
8739506|NCT01109108|9787633|FG001|NOT COMPLETED|Overall Study||0
8739507|NCT01109147|9787642|FG000|STARTED|Overall Study||17
8739508|NCT01109147|9787643|FG001|STARTED|Overall Study||14
8739509|NCT01109147|9787644|FG002|STARTED|Overall Study||36
8739510|NCT01109147|9787642|FG000|COMPLETED|Overall Study|2 have been excluded of the results|15
8739511|NCT01109147|9787643|FG001|COMPLETED|Overall Study|3 have been excluded of the results|11
8739512|NCT01109147|9787644|FG002|COMPLETED|Overall Study|10 have been excluded of the results|26
8739513|NCT01109147|9787642|FG000|NOT COMPLETED|Overall Study||2
8739514|NCT01109147|9787643|FG001|NOT COMPLETED|Overall Study||3
8739515|NCT01109147|9787644|FG002|NOT COMPLETED|Overall Study||10
8739516|NCT01109173|9787656|FG000|STARTED|Overall Study||851
8739517|NCT01109173|9787657|FG001|STARTED|Overall Study||845
8739518|NCT01109173|9787658|FG002|STARTED|Overall Study||211
8739519|NCT01109173|9787659|FG003|STARTED|Overall Study||213
8739520|NCT01109173|9787656|FG000|COMPLETED|Overall Study||763
8739521|NCT01109173|9787657|FG001|COMPLETED|Overall Study||759
8739522|NCT01109173|9787658|FG002|COMPLETED|Overall Study||110
8739523|NCT01109173|9787659|FG003|COMPLETED|Overall Study||120
8739524|NCT01109173|9787656|FG000|NOT COMPLETED|Overall Study||88
8739525|NCT01109173|9787657|FG001|NOT COMPLETED|Overall Study||86
8739526|NCT01109173|9787658|FG002|NOT COMPLETED|Overall Study||101
8739527|NCT01109173|9787659|FG003|NOT COMPLETED|Overall Study||93
8912386|NCT02152761|9971464|FG002|COMPLETED|Epoch: Post-treatment Follow-up Epoch||30
8912387|NCT02152761|9971465|FG003|COMPLETED|Epoch: Post-treatment Follow-up Epoch||66
8912388|NCT02152761|9971462|FG000|NOT COMPLETED|Epoch: Post-treatment Follow-up Epoch||4
8912389|NCT02152761|9971463|FG001|NOT COMPLETED|Epoch: Post-treatment Follow-up Epoch||7
8912390|NCT02152761|9971464|FG002|NOT COMPLETED|Epoch: Post-treatment Follow-up Epoch||0
8912391|NCT02152761|9971465|FG003|NOT COMPLETED|Epoch: Post-treatment Follow-up Epoch||2
8912392|NCT02152826|9971483|FG000|STARTED|Overall Study||45
8912393|NCT02152826|9971484|FG001|STARTED|Overall Study||35
8912394|NCT02152826|9971483|FG000|COMPLETED|Overall Study||44
8912395|NCT02152826|9971484|FG001|COMPLETED|Overall Study||34
8912396|NCT02152826|9971483|FG000|NOT COMPLETED|Overall Study||1
8912397|NCT02152826|9971484|FG001|NOT COMPLETED|Overall Study||1
8912398|NCT02153073|9971490|FG000|STARTED|Overall Study||3084
8912399|NCT02153073|9971490|FG000|COMPLETED|Overall Study||2786
8912400|NCT02153073|9971490|FG000|NOT COMPLETED|Overall Study||298
8912401|NCT02153086|9971494|FG000|STARTED|Overall Study||236
8912402|NCT02153086|9971494|FG000|COMPLETED|Overall Study||232
8912403|NCT02153086|9971494|FG000|NOT COMPLETED|Overall Study||4
8912404|NCT02153099|9971505|FG000|STARTED|Overall Study||6
8912405|NCT02153099|9971506|FG001|STARTED|Overall Study||6
8912406|NCT02153099|9971507|FG002|STARTED|Overall Study||6
8912407|NCT02153099|9971508|FG003|STARTED|Overall Study||6
8912408|NCT02153099|9971509|FG004|STARTED|Overall Study||6
8912409|NCT02153099|9971510|FG005|STARTED|Overall Study||6
8912410|NCT02153099|9971511|FG006|STARTED|Overall Study||12
8912411|NCT02153099|9971505|FG000|COMPLETED|Overall Study||6
8912412|NCT02153099|9971506|FG001|COMPLETED|Overall Study||6
8912413|NCT02153099|9971507|FG002|COMPLETED|Overall Study||6
8912414|NCT02153099|9971508|FG003|COMPLETED|Overall Study||6
8739528|NCT01109316|9787675|FG000|STARTED|Study Period 1||22
8739529|NCT01109316|9787676|FG001|STARTED|Study Period 1||22
8912415|NCT02153099|9971509|FG004|COMPLETED|Overall Study||6
8739530|NCT01109316|9787677|FG002|STARTED|Study Period 1||22
8739531|NCT01109316|9787678|FG003|STARTED|Study Period 1||22
8739532|NCT01109316|9787679|FG004|STARTED|Study Period 1||22
8739533|NCT01109316|9787680|FG005|STARTED|Study Period 1||22
8739534|NCT01109316|9787675|FG000|Received at Least One Dose of Study Drug|Study Period 1||22
8739535|NCT01109316|9787676|FG001|Received at Least One Dose of Study Drug|Study Period 1||22
8739536|NCT01109316|9787677|FG002|Received at Least One Dose of Study Drug|Study Period 1||22
8739537|NCT01109316|9787678|FG003|Received at Least One Dose of Study Drug|Study Period 1||22
8739538|NCT01109316|9787679|FG004|Received at Least One Dose of Study Drug|Study Period 1||22
8739539|NCT01109316|9787680|FG005|Received at Least One Dose of Study Drug|Study Period 1||20
8739540|NCT01109316|9787675|FG000|COMPLETED|Study Period 1||22
8739541|NCT01109316|9787676|FG001|COMPLETED|Study Period 1||22
8739542|NCT01109316|9787677|FG002|COMPLETED|Study Period 1||19
8739543|NCT01109316|9787678|FG003|COMPLETED|Study Period 1||21
8739544|NCT01109316|9787679|FG004|COMPLETED|Study Period 1||20
8739545|NCT01109316|9787680|FG005|COMPLETED|Study Period 1||20
8739546|NCT01109316|9787675|FG000|NOT COMPLETED|Study Period 1||0
8739547|NCT01109316|9787676|FG001|NOT COMPLETED|Study Period 1||0
8739548|NCT01109316|9787677|FG002|NOT COMPLETED|Study Period 1||3
8739549|NCT01109316|9787678|FG003|NOT COMPLETED|Study Period 1||1
8739550|NCT01109316|9787679|FG004|NOT COMPLETED|Study Period 1||2
8739551|NCT01109316|9787680|FG005|NOT COMPLETED|Study Period 1||2
8739552|NCT01109316|9787675|FG000|STARTED|Study Period 2||22
8739553|NCT01109316|9787676|FG001|STARTED|Study Period 2||22
8739554|NCT01109316|9787677|FG002|STARTED|Study Period 2||19
8739555|NCT01109316|9787678|FG003|STARTED|Study Period 2||21
8739556|NCT01109316|9787679|FG004|STARTED|Study Period 2||20
8739557|NCT01109316|9787680|FG005|STARTED|Study Period 2||20
8739558|NCT01109316|9787675|FG000|COMPLETED|Study Period 2||21
8739559|NCT01109316|9787676|FG001|COMPLETED|Study Period 2||21
8739560|NCT01109316|9787677|FG002|COMPLETED|Study Period 2||18
8739561|NCT01109316|9787678|FG003|COMPLETED|Study Period 2||20
8739562|NCT01109316|9787679|FG004|COMPLETED|Study Period 2||20
8739563|NCT01109316|9787680|FG005|COMPLETED|Study Period 2||19
8739564|NCT01109316|9787675|FG000|NOT COMPLETED|Study Period 2||1
8739565|NCT01109316|9787676|FG001|NOT COMPLETED|Study Period 2||1
8739566|NCT01109316|9787677|FG002|NOT COMPLETED|Study Period 2||1
8739567|NCT01109316|9787678|FG003|NOT COMPLETED|Study Period 2||1
8739568|NCT01109316|9787679|FG004|NOT COMPLETED|Study Period 2||0
8739569|NCT01109316|9787680|FG005|NOT COMPLETED|Study Period 2||1
8739570|NCT01109316|9787675|FG000|STARTED|Study Period 3||21
8739571|NCT01109316|9787676|FG001|STARTED|Study Period 3||21
8739572|NCT01109316|9787677|FG002|STARTED|Study Period 3||18
8739573|NCT01109316|9787678|FG003|STARTED|Study Period 3||20
8739574|NCT01109316|9787679|FG004|STARTED|Study Period 3||20
8739575|NCT01109316|9787680|FG005|STARTED|Study Period 3||19
8739576|NCT01109316|9787675|FG000|COMPLETED|Study Period 3||20
8739577|NCT01109316|9787676|FG001|COMPLETED|Study Period 3||21
8739578|NCT01109316|9787677|FG002|COMPLETED|Study Period 3||18
8739579|NCT01109316|9787678|FG003|COMPLETED|Study Period 3||20
8739580|NCT01109316|9787679|FG004|COMPLETED|Study Period 3||18
8739581|NCT01109316|9787680|FG005|COMPLETED|Study Period 3||19
8739582|NCT01109316|9787675|FG000|NOT COMPLETED|Study Period 3||1
8739583|NCT01109316|9787676|FG001|NOT COMPLETED|Study Period 3||0
8739584|NCT01109316|9787677|FG002|NOT COMPLETED|Study Period 3||0
8739585|NCT01109316|9787678|FG003|NOT COMPLETED|Study Period 3||0
8739586|NCT01109316|9787679|FG004|NOT COMPLETED|Study Period 3||2
8739587|NCT01109316|9787680|FG005|NOT COMPLETED|Study Period 3||0
8739588|NCT01109381|9787688|FG000|STARTED|Overall Study||33
8739589|NCT01109381|9787688|FG000|COMPLETED|Overall Study||31
8739590|NCT01109381|9787688|FG000|NOT COMPLETED|Overall Study||2
8739591|NCT01109524|9787694|FG000|STARTED|Overall Study||60
8739592|NCT01109524|9787694|FG000|COMPLETED|Overall Study||3
8739593|NCT01109524|9787694|FG000|NOT COMPLETED|Overall Study||57
8739594|NCT01109576|9787698|FG000|STARTED|Overall Study||13
8739595|NCT01109576|9787698|FG000|COMPLETED|Overall Study||12
8739596|NCT01109576|9787698|FG000|NOT COMPLETED|Overall Study||1
8739597|NCT01109602|9787705|FG000|STARTED|Overall Study||14
8739598|NCT01109602|9787706|FG001|STARTED|Overall Study||23
8739599|NCT01109602|9787707|FG002|STARTED|Overall Study||10
8739600|NCT01109602|9787705|FG000|COMPLETED|Overall Study||13
8739601|NCT01109602|9787706|FG001|COMPLETED|Overall Study||21
8739602|NCT01109602|9787707|FG002|COMPLETED|Overall Study||9
8739603|NCT01109602|9787705|FG000|NOT COMPLETED|Overall Study||1
8739604|NCT01109602|9787706|FG001|NOT COMPLETED|Overall Study||2
9022559|NCT03129100|10085455|FG001|NOT COMPLETED|Lead-In Period (Period 1)||17
9022560|NCT03129100|10085456|FG002|NOT COMPLETED|Lead-In Period (Period 1)||0
8739605|NCT01109602|9787707|FG002|NOT COMPLETED|Overall Study||1
8739606|NCT01109849|9787716|FG000|STARTED|Initial Randomization: ADHD Treatment||50
8739607|NCT01109849|9787717|FG001|STARTED|Initial Randomization: ADHD Treatment||180
8739608|NCT01109849|9787718|FG002|STARTED|Initial Randomization: ADHD Treatment||0
8739609|NCT01109849|9787719|FG003|STARTED|Initial Randomization: ADHD Treatment||0
8739610|NCT01109849|9787720|FG004|STARTED|Initial Randomization: ADHD Treatment||0
8739611|NCT01109849|9787716|FG000|COMPLETED|Initial Randomization: ADHD Treatment||32
8739612|NCT01109849|9787717|FG001|COMPLETED|Initial Randomization: ADHD Treatment||131
8739613|NCT01109849|9787718|FG002|COMPLETED|Initial Randomization: ADHD Treatment||0
8739614|NCT01109849|9787719|FG003|COMPLETED|Initial Randomization: ADHD Treatment||0
8739615|NCT01109849|9787720|FG004|COMPLETED|Initial Randomization: ADHD Treatment||0
8739616|NCT01109849|9787716|FG000|NOT COMPLETED|Initial Randomization: ADHD Treatment||18
8739617|NCT01109849|9787717|FG001|NOT COMPLETED|Initial Randomization: ADHD Treatment||49
9022561|NCT03129100|10085457|FG003|NOT COMPLETED|Lead-In Period (Period 1)||0
9022562|NCT03129100|10085458|FG004|NOT COMPLETED|Lead-In Period (Period 1)||0
9022563|NCT03129100|10085459|FG005|NOT COMPLETED|Lead-In Period (Period 1)||0
9022564|NCT03129100|10085460|FG006|NOT COMPLETED|Lead-In Period (Period 1)||0
9022565|NCT03129100|10085461|FG007|NOT COMPLETED|Lead-In Period (Period 1)||0
9022566|NCT03129100|10085462|FG008|NOT COMPLETED|Lead-In Period (Period 1)||0
9022567|NCT03129100|10085463|FG009|NOT COMPLETED|Lead-In Period (Period 1)||0
9022568|NCT03129100|10085464|FG010|NOT COMPLETED|Lead-In Period (Period 1)||0
8739618|NCT01109849|9787718|FG002|NOT COMPLETED|Initial Randomization: ADHD Treatment||0
8739619|NCT01109849|9787719|FG003|NOT COMPLETED|Initial Randomization: ADHD Treatment||0
8739620|NCT01109849|9787720|FG004|NOT COMPLETED|Initial Randomization: ADHD Treatment||0
8739621|NCT01109849|9787716|FG000|STARTED|Adaptive Randomization: Weight Recovery||0
8739622|NCT01109849|9787717|FG001|STARTED|Adaptive Randomization: Weight Recovery||0
8739623|NCT01109849|9787718|FG002|STARTED|Adaptive Randomization: Weight Recovery||24
8739624|NCT01109849|9787719|FG003|STARTED|Adaptive Randomization: Weight Recovery||23
8739625|NCT01109849|9787720|FG004|STARTED|Adaptive Randomization: Weight Recovery||25
8739626|NCT01109849|9787716|FG000|COMPLETED|Adaptive Randomization: Weight Recovery||0
8739627|NCT01109849|9787717|FG001|COMPLETED|Adaptive Randomization: Weight Recovery||0
8739628|NCT01109849|9787718|FG002|COMPLETED|Adaptive Randomization: Weight Recovery||23
8739629|NCT01109849|9787719|FG003|COMPLETED|Adaptive Randomization: Weight Recovery||20
8739630|NCT01109849|9787720|FG004|COMPLETED|Adaptive Randomization: Weight Recovery||24
8739631|NCT01109849|9787716|FG000|NOT COMPLETED|Adaptive Randomization: Weight Recovery||0
8739632|NCT01109849|9787717|FG001|NOT COMPLETED|Adaptive Randomization: Weight Recovery||0
8739633|NCT01109849|9787718|FG002|NOT COMPLETED|Adaptive Randomization: Weight Recovery||1
8739634|NCT01109849|9787719|FG003|NOT COMPLETED|Adaptive Randomization: Weight Recovery||3
8739635|NCT01109849|9787720|FG004|NOT COMPLETED|Adaptive Randomization: Weight Recovery||1
8739636|NCT01109940|9787744|FG000|STARTED|Overall Study||21
8739637|NCT01109940|9787745|FG001|STARTED|Overall Study||8
8739638|NCT01109940|9787746|FG002|STARTED|Overall Study||7
8739639|NCT01109940|9787747|FG003|STARTED|Overall Study||3
8739640|NCT01109940|9787744|FG000|COMPLETED|Overall Study||13
8739641|NCT01109940|9787745|FG001|COMPLETED|Overall Study||6
8739642|NCT01109940|9787746|FG002|COMPLETED|Overall Study||6
8739643|NCT01109940|9787747|FG003|COMPLETED|Overall Study||3
8739644|NCT01109940|9787744|FG000|NOT COMPLETED|Overall Study||8
8739645|NCT01109940|9787745|FG001|NOT COMPLETED|Overall Study||2
8739646|NCT01109940|9787746|FG002|NOT COMPLETED|Overall Study||1
8739647|NCT01109940|9787747|FG003|NOT COMPLETED|Overall Study||0
8739648|NCT01109979|9787759|FG000|STARTED|Overall Study||12
8739649|NCT01109979|9787760|FG001|STARTED|Overall Study||12
8739650|NCT01109979|9787759|FG000|COMPLETED|Overall Study||10
8739651|NCT01109979|9787760|FG001|COMPLETED|Overall Study||11
8739652|NCT01109979|9787759|FG000|NOT COMPLETED|Overall Study||2
8739653|NCT01109979|9787760|FG001|NOT COMPLETED|Overall Study||1
8739654|NCT01109992|9787768|FG000|STARTED|Overall Study||11
8739655|NCT01109992|9787769|FG001|STARTED|Overall Study||32
8739656|NCT01109992|9787768|FG000|Subjects Enrolled|Overall Study||11
8739657|NCT01109992|9787769|FG001|Subjects Enrolled|Overall Study||32
8739658|NCT01109992|9787768|FG000|COMPLETED|Overall Study||11
8739659|NCT01109992|9787769|FG001|COMPLETED|Overall Study||30
8739660|NCT01109992|9787768|FG000|NOT COMPLETED|Overall Study||0
8739661|NCT01109992|9787769|FG001|NOT COMPLETED|Overall Study||2
8739662|NCT01110005|9787780|FG000|STARTED|Overall Study||157
8739663|NCT01110005|9787781|FG001|STARTED|Overall Study||161
8739664|NCT01110005|9787780|FG000|COMPLETED|Overall Study||153
8739665|NCT01110005|9787781|FG001|COMPLETED|Overall Study||156
8739666|NCT01110005|9787780|FG000|NOT COMPLETED|Overall Study||4
8739667|NCT01110005|9787781|FG001|NOT COMPLETED|Overall Study||5
8739668|NCT01110135|9787787|FG000|STARTED|Overall Study||43
8739669|NCT01110135|9787787|FG000|COMPLETED|Overall Study||34
8739670|NCT01110135|9787787|FG000|NOT COMPLETED|Overall Study||9
8739671|NCT01110187|9787793|FG000|STARTED|Overall Study||7
8739672|NCT01110187|9787794|FG001|STARTED|Overall Study||4
8739673|NCT01110187|9787793|FG000|COMPLETED|Overall Study|completed 7 day treatment|7
8739674|NCT01110187|9787794|FG001|COMPLETED|Overall Study|completed 7 day treatment|4
8739675|NCT01110187|9787793|FG000|NOT COMPLETED|Overall Study||0
8739676|NCT01110187|9787794|FG001|NOT COMPLETED|Overall Study||0
8739677|NCT01110200|9787804|FG000|STARTED|Overall Study||314
8739678|NCT01110200|9787805|FG001|STARTED|Overall Study||325
8739679|NCT01110200|9787804|FG000|COMPLETED|Overall Study||208
8739680|NCT01110200|9787805|FG001|COMPLETED|Overall Study||204
8739681|NCT01110200|9787804|FG000|NOT COMPLETED|Overall Study||106
8739682|NCT01110200|9787805|FG001|NOT COMPLETED|Overall Study||121
8739683|NCT01110239|9787815|FG000|STARTED|Sham Preconditioning||7
8739684|NCT01110239|9787816|FG001|STARTED|Sham Preconditioning||14
8739685|NCT01110239|9787817|FG002|STARTED|Sham Preconditioning||7
8739686|NCT01110239|9787818|FG003|STARTED|Sham Preconditioning||6
8739687|NCT01110239|9787815|FG000|COMPLETED|Sham Preconditioning||7
8739688|NCT01110239|9787816|FG001|COMPLETED|Sham Preconditioning||14
8739689|NCT01110239|9787817|FG002|COMPLETED|Sham Preconditioning||6
8739690|NCT01110239|9787818|FG003|COMPLETED|Sham Preconditioning||6
8739691|NCT01110239|9787815|FG000|NOT COMPLETED|Sham Preconditioning||0
8739692|NCT01110239|9787816|FG001|NOT COMPLETED|Sham Preconditioning||0
8739693|NCT01110239|9787817|FG002|NOT COMPLETED|Sham Preconditioning||1
9039978|NCT03345108|10100894|FG005|NOT COMPLETED|Period-1||0
8739694|NCT01110239|9787818|FG003|NOT COMPLETED|Sham Preconditioning||0
8739695|NCT01110239|9787815|FG000|STARTED|5 Min Ischemia||0
8739696|NCT01110239|9787816|FG001|STARTED|5 Min Ischemia||14
8739697|NCT01110239|9787817|FG002|STARTED|5 Min Ischemia||0
8739698|NCT01110239|9787818|FG003|STARTED|5 Min Ischemia||0
8739699|NCT01110239|9787815|FG000|COMPLETED|5 Min Ischemia||0
8739700|NCT01110239|9787816|FG001|COMPLETED|5 Min Ischemia||0
8739701|NCT01110239|9787817|FG002|COMPLETED|5 Min Ischemia||0
8739702|NCT01110239|9787818|FG003|COMPLETED|5 Min Ischemia||0
8739703|NCT01110239|9787815|FG000|NOT COMPLETED|5 Min Ischemia||0
8739704|NCT01110239|9787816|FG001|NOT COMPLETED|5 Min Ischemia||14
8739705|NCT01110239|9787817|FG002|NOT COMPLETED|5 Min Ischemia||0
8739706|NCT01110239|9787818|FG003|NOT COMPLETED|5 Min Ischemia||0
8739707|NCT01110239|9787815|FG000|STARTED|7.5 Min Ischemia||0
8739708|NCT01110239|9787816|FG001|STARTED|7.5 Min Ischemia||0
8739709|NCT01110239|9787817|FG002|STARTED|7.5 Min Ischemia||7
8739710|NCT01110239|9787818|FG003|STARTED|7.5 Min Ischemia||0
8739711|NCT01110239|9787815|FG000|COMPLETED|7.5 Min Ischemia||0
8739712|NCT01110239|9787816|FG001|COMPLETED|7.5 Min Ischemia||0
8739713|NCT01110239|9787817|FG002|COMPLETED|7.5 Min Ischemia||6
8739714|NCT01110239|9787818|FG003|COMPLETED|7.5 Min Ischemia||0
8739715|NCT01110239|9787815|FG000|NOT COMPLETED|7.5 Min Ischemia||0
8739716|NCT01110239|9787816|FG001|NOT COMPLETED|7.5 Min Ischemia||0
8739717|NCT01110239|9787817|FG002|NOT COMPLETED|7.5 Min Ischemia||1
8739718|NCT01110239|9787818|FG003|NOT COMPLETED|7.5 Min Ischemia||0
8739719|NCT01110239|9787815|FG000|STARTED|10 Min Ischemia||0
8739720|NCT01110239|9787816|FG001|STARTED|10 Min Ischemia||0
8739721|NCT01110239|9787817|FG002|STARTED|10 Min Ischemia||0
8739722|NCT01110239|9787818|FG003|STARTED|10 Min Ischemia||6
8739723|NCT01110239|9787815|FG000|COMPLETED|10 Min Ischemia||0
8739724|NCT01110239|9787816|FG001|COMPLETED|10 Min Ischemia||0
8739725|NCT01110239|9787817|FG002|COMPLETED|10 Min Ischemia||0
8739726|NCT01110239|9787818|FG003|COMPLETED|10 Min Ischemia||6
8739727|NCT01110239|9787815|FG000|NOT COMPLETED|10 Min Ischemia||0
8739728|NCT01110239|9787816|FG001|NOT COMPLETED|10 Min Ischemia||0
8739729|NCT01110239|9787817|FG002|NOT COMPLETED|10 Min Ischemia||0
8739730|NCT01110239|9787818|FG003|NOT COMPLETED|10 Min Ischemia||0
8739731|NCT01110252|9787829|FG000|STARTED|Pre-procedure (Stem Cells Infusion)||4
8739732|NCT01110252|9787829|FG000|COMPLETED|Pre-procedure (Stem Cells Infusion)||4
8739733|NCT01110252|9787829|FG000|NOT COMPLETED|Pre-procedure (Stem Cells Infusion)||0
8739734|NCT01110252|9787829|FG000|STARTED|Post-procedure (Stem Cells Infusion)||4
8739735|NCT01110252|9787829|FG000|COMPLETED|Post-procedure (Stem Cells Infusion)||4
8739736|NCT01110252|9787829|FG000|NOT COMPLETED|Post-procedure (Stem Cells Infusion)||0
8739737|NCT01110330|9787837|FG000|STARTED|Overall Study||119
9022569|NCT03129100|10085454|FG000|STARTED|Period2 Extension Period (Group A and B)|Only Extension Period participants were included.|0
9022570|NCT03129100|10085455|FG001|STARTED|Period2 Extension Period (Group A and B)|Only Extension Period participants were included.|0
9022571|NCT03129100|10085456|FG002|STARTED|Period2 Extension Period (Group A and B)|Participants who entered extension period (Group A).|255
8739738|NCT01110330|9787838|FG001|STARTED|Overall Study||230
8739739|NCT01110330|9787839|FG002|STARTED|Overall Study||234
8739740|NCT01110330|9787837|FG000|Positive Baseline Culture Set|Overall Study||56
8739741|NCT01110330|9787838|FG001|Positive Baseline Culture Set|Overall Study||111
8739742|NCT01110330|9787839|FG002|Positive Baseline Culture Set|Overall Study||114
8739743|NCT01110330|9787837|FG000|COMPLETED|Overall Study||104
8739744|NCT01110330|9787838|FG001|COMPLETED|Overall Study||207
8739745|NCT01110330|9787839|FG002|COMPLETED|Overall Study||208
8739746|NCT01110330|9787837|FG000|NOT COMPLETED|Overall Study||15
8739747|NCT01110330|9787838|FG001|NOT COMPLETED|Overall Study||23
8739748|NCT01110330|9787839|FG002|NOT COMPLETED|Overall Study||26
8739749|NCT01110382|9787849|FG000|STARTED|Overall Study||31
8739750|NCT01110382|9787850|FG001|STARTED|Overall Study||10
8739751|NCT01110382|9787849|FG000|COMPLETED|Overall Study||31
8739752|NCT01110382|9787850|FG001|COMPLETED|Overall Study||8
8739753|NCT01110382|9787849|FG000|NOT COMPLETED|Overall Study||0
8739754|NCT01110382|9787850|FG001|NOT COMPLETED|Overall Study||2
8739755|NCT01110395|9787856|FG000|STARTED|Overall Study||15
8739756|NCT01110395|9787856|FG000|COMPLETED|Overall Study||15
8739757|NCT01110395|9787856|FG000|NOT COMPLETED|Overall Study||0
8739758|NCT01110408|9787862|FG000|STARTED|Overall Study||31
8739759|NCT01110408|9787863|FG001|STARTED|Overall Study||10
8739760|NCT01110408|9787862|FG000|COMPLETED|Overall Study||30
8739761|NCT01110408|9787863|FG001|COMPLETED|Overall Study||10
8739762|NCT01110408|9787862|FG000|NOT COMPLETED|Overall Study||1
8739763|NCT01110408|9787863|FG001|NOT COMPLETED|Overall Study||0
8739764|NCT01110421|9787871|FG000|STARTED|Overall Study||5
8739765|NCT01110421|9787872|FG001|STARTED|Overall Study||2
8739766|NCT01110421|9787871|FG000|COMPLETED|Overall Study|Includes 1 participant who discontinued study drug due to an adverse event of empyema on Days 9-13.|5
8739767|NCT01110421|9787872|FG001|COMPLETED|Overall Study||2
8739768|NCT01110421|9787871|FG000|NOT COMPLETED|Overall Study||0
8739769|NCT01110421|9787872|FG001|NOT COMPLETED|Overall Study||0
8739770|NCT01110434|9787880|FG000|STARTED|Overall Study||40
8739771|NCT01110434|9787881|FG001|STARTED|Overall Study||26
8739772|NCT01110434|9787880|FG000|COMPLETED|Overall Study||29
8739773|NCT01110434|9787881|FG001|COMPLETED|Overall Study||20
8739774|NCT01110434|9787880|FG000|NOT COMPLETED|Overall Study||11
8739775|NCT01110434|9787881|FG001|NOT COMPLETED|Overall Study||6
8739776|NCT01110499|9787895|FG000|STARTED|Overall Study||14
8739777|NCT01110499|9787896|FG001|STARTED|Overall Study||14
8739778|NCT01110499|9787897|FG002|STARTED|Overall Study||14
8739779|NCT01110499|9787898|FG003|STARTED|Overall Study||14
8739780|NCT01110499|9787899|FG004|STARTED|Overall Study||14
8739781|NCT01110499|9787900|FG005|STARTED|Overall Study||14
8739782|NCT01110499|9787901|FG006|STARTED|Overall Study||39
8739783|NCT01110499|9787902|FG007|STARTED|Overall Study||40
8739784|NCT01110499|9787895|FG000|COMPLETED|Overall Study||14
8739785|NCT01110499|9787896|FG001|COMPLETED|Overall Study||14
8739786|NCT01110499|9787897|FG002|COMPLETED|Overall Study||14
8739787|NCT01110499|9787898|FG003|COMPLETED|Overall Study||14
8739788|NCT01110499|9787899|FG004|COMPLETED|Overall Study||14
8739789|NCT01110499|9787900|FG005|COMPLETED|Overall Study||14
8739790|NCT01110499|9787901|FG006|COMPLETED|Overall Study||39
8739791|NCT01110499|9787902|FG007|COMPLETED|Overall Study||40
8739792|NCT01110499|9787895|FG000|NOT COMPLETED|Overall Study||0
8739793|NCT01110499|9787896|FG001|NOT COMPLETED|Overall Study||0
8739794|NCT01110499|9787897|FG002|NOT COMPLETED|Overall Study||0
8739795|NCT01110499|9787898|FG003|NOT COMPLETED|Overall Study||0
8739796|NCT01110499|9787899|FG004|NOT COMPLETED|Overall Study||0
8739797|NCT01110499|9787900|FG005|NOT COMPLETED|Overall Study||0
8739798|NCT01110499|9787901|FG006|NOT COMPLETED|Overall Study||0
8739799|NCT01110499|9787902|FG007|NOT COMPLETED|Overall Study||0
8739800|NCT01110681|9787922|FG000|STARTED|Overall Study||115
8739801|NCT01110681|9787922|FG000|COMPLETED|Overall Study||83
8739802|NCT01110681|9787922|FG000|NOT COMPLETED|Overall Study||32
8739803|NCT01110707|9787928|FG000|STARTED|Overall Study||63
8739804|NCT01110707|9787929|FG001|STARTED|Overall Study||68
8739805|NCT01110707|9787928|FG000|COMPLETED|Overall Study||63
8739806|NCT01110707|9787929|FG001|COMPLETED|Overall Study||65
8739807|NCT01110707|9787928|FG000|NOT COMPLETED|Overall Study||0
8739808|NCT01110707|9787929|FG001|NOT COMPLETED|Overall Study||3
8739809|NCT01110876|9787938|FG000|STARTED|Overall Study|One received 400 mg Erlotinib dose as result of enzyme inducing anticonvulsants (EIACs)|13
8739810|NCT01110876|9787939|FG001|STARTED|Overall Study||5
8739811|NCT01110876|9787938|FG000|COMPLETED|Overall Study||13
8739812|NCT01110876|9787939|FG001|COMPLETED|Overall Study||5
8739813|NCT01110876|9787938|FG000|NOT COMPLETED|Overall Study||0
8739814|NCT01110876|9787939|FG001|NOT COMPLETED|Overall Study||0
8739815|NCT01110915|9787948|FG000|STARTED|Overall Study|Subjects being randomized to the MRI group.|177
8739816|NCT01110915|9787949|FG001|STARTED|Overall Study|Subjects being randomized to the Control group.|86
8739817|NCT01110915|9787948|FG000|COMPLETED|Overall Study|Subjects completing at least 4 months of follow-up.|167
8739818|NCT01110915|9787949|FG001|COMPLETED|Overall Study|Subjects completing at least 4 months of follow-up.|84
8739819|NCT01110915|9787948|FG000|NOT COMPLETED|Overall Study||10
8739820|NCT01110915|9787949|FG001|NOT COMPLETED|Overall Study||2
8739821|NCT01110967|9787956|FG000|STARTED|Overall Study||40
8739822|NCT01110967|9787956|FG000|Surgery|Overall Study||40
8739823|NCT01110967|9787956|FG000|1 Month Follow up|Overall Study||26
8739824|NCT01110967|9787956|FG000|3 Months Follow up|Overall Study||28
8739825|NCT01110967|9787956|FG000|6 Months Follow up|Overall Study||24
8739826|NCT01110967|9787956|FG000|12 Months Follow up|Overall Study||31
8739827|NCT01110967|9787956|FG000|COMPLETED|Overall Study||31
8739828|NCT01110967|9787956|FG000|NOT COMPLETED|Overall Study||9
8739829|NCT01111058|9787962|FG000|STARTED|Overall Study||28
8739830|NCT01111058|9787963|FG001|STARTED|Overall Study||24
8739831|NCT01111058|9787962|FG000|COMPLETED|Overall Study||28
8739832|NCT01111058|9787963|FG001|COMPLETED|Overall Study||24
8739833|NCT01111058|9787962|FG000|NOT COMPLETED|Overall Study||0
8739834|NCT01111058|9787963|FG001|NOT COMPLETED|Overall Study||0
8739835|NCT01111123|9787971|FG000|STARTED|Open- Label Phase||55
8739836|NCT01111123|9787972|FG001|STARTED|Open- Label Phase||0
8739837|NCT01111123|9787971|FG000|COMPLETED|Open- Label Phase||41
8739838|NCT01111123|9787972|FG001|COMPLETED|Open- Label Phase||0
8739839|NCT01111123|9787971|FG000|NOT COMPLETED|Open- Label Phase||14
8739840|NCT01111123|9787972|FG001|NOT COMPLETED|Open- Label Phase||0
8739841|NCT01111123|9787971|FG000|STARTED|Maintenance Phase||21
8739842|NCT01111123|9787972|FG001|STARTED|Maintenance Phase||20
8739843|NCT01111123|9787971|FG000|COMPLETED|Maintenance Phase||21
8739844|NCT01111123|9787972|FG001|COMPLETED|Maintenance Phase||18
8739845|NCT01111123|9787971|FG000|NOT COMPLETED|Maintenance Phase||0
8739846|NCT01111123|9787972|FG001|NOT COMPLETED|Maintenance Phase||2
8739847|NCT01111149|9787983|FG000|STARTED|Overall Study||9
8739848|NCT01111149|9787984|FG001|STARTED|Overall Study||6
8739849|NCT01111149|9787985|FG002|STARTED|Overall Study||9
8739850|NCT01111149|9787983|FG000|COMPLETED|Overall Study||7
8739851|NCT01111149|9787984|FG001|COMPLETED|Overall Study||5
8739852|NCT01111149|9787985|FG002|COMPLETED|Overall Study||5
8739853|NCT01111149|9787983|FG000|NOT COMPLETED|Overall Study||2
8739854|NCT01111149|9787984|FG001|NOT COMPLETED|Overall Study||1
8739855|NCT01111149|9787985|FG002|NOT COMPLETED|Overall Study||4
8739856|NCT01111162|9787993|FG000|STARTED|Overall Study||120
8739857|NCT01111162|9787993|FG000|COMPLETED|Overall Study||120
8739858|NCT01111162|9787993|FG000|NOT COMPLETED|Overall Study||0
8912416|NCT02153099|9971510|FG005|COMPLETED|Overall Study||6
8912417|NCT02153099|9971511|FG006|COMPLETED|Overall Study||12
8739859|NCT01111240|9787998|FG000|STARTED|Overall Study||4635
8739860|NCT01111240|9787998|FG000|COMPLETED|Overall Study||3569
8739861|NCT01111240|9787998|FG000|NOT COMPLETED|Overall Study||1066
8739862|NCT01111292|9788004|FG000|STARTED|Randomization||3
8739863|NCT01111292|9788005|FG001|STARTED|Randomization||2
8739864|NCT01111292|9788004|FG000|COMPLETED|Randomization||3
8739865|NCT01111292|9788005|FG001|COMPLETED|Randomization||2
8739866|NCT01111292|9788004|FG000|NOT COMPLETED|Randomization||0
8739867|NCT01111292|9788005|FG001|NOT COMPLETED|Randomization||0
8739868|NCT01111292|9788004|FG000|STARTED|Treatment||3
8739869|NCT01111292|9788005|FG001|STARTED|Treatment||2
8739870|NCT01111292|9788004|FG000|COMPLETED|Treatment||2
8739871|NCT01111292|9788005|FG001|COMPLETED|Treatment||1
8739872|NCT01111292|9788004|FG000|NOT COMPLETED|Treatment||1
8739873|NCT01111292|9788005|FG001|NOT COMPLETED|Treatment||1
8739874|NCT01111292|9788004|FG000|STARTED|Post Treatment Biopsy||2
8739875|NCT01111292|9788005|FG001|STARTED|Post Treatment Biopsy||1
8739876|NCT01111292|9788004|FG000|COMPLETED|Post Treatment Biopsy||2
8739877|NCT01111292|9788005|FG001|COMPLETED|Post Treatment Biopsy||1
8739878|NCT01111292|9788004|FG000|NOT COMPLETED|Post Treatment Biopsy||0
8739879|NCT01111292|9788005|FG001|NOT COMPLETED|Post Treatment Biopsy||0
8739880|NCT01111292|9788004|FG000|STARTED|Follow-Up||2
8739881|NCT01111292|9788005|FG001|STARTED|Follow-Up||1
8739882|NCT01111292|9788004|FG000|COMPLETED|Follow-Up||2
8739883|NCT01111292|9788005|FG001|COMPLETED|Follow-Up||1
8739884|NCT01111292|9788004|FG000|NOT COMPLETED|Follow-Up||0
8739885|NCT01111292|9788005|FG001|NOT COMPLETED|Follow-Up||0
8739886|NCT01111318|9788015|FG000|STARTED|Overall Study||12
8739887|NCT01111318|9788016|FG001|STARTED|Overall Study||8
8739888|NCT01111318|9788017|FG002|STARTED|Overall Study||8
8739889|NCT01111318|9788018|FG003|STARTED|Overall Study||8
8739890|NCT01111318|9788015|FG000|COMPLETED|Overall Study||12
8739891|NCT01111318|9788016|FG001|COMPLETED|Overall Study||8
8739892|NCT01111318|9788017|FG002|COMPLETED|Overall Study||8
8739893|NCT01111318|9788018|FG003|COMPLETED|Overall Study||8
8739894|NCT01111318|9788015|FG000|NOT COMPLETED|Overall Study||0
8739895|NCT01111318|9788016|FG001|NOT COMPLETED|Overall Study||0
8739896|NCT01111318|9788017|FG002|NOT COMPLETED|Overall Study||0
8739897|NCT01111318|9788018|FG003|NOT COMPLETED|Overall Study||0
8739898|NCT01111331|9788028|FG000|STARTED|Overall Study||9
8739899|NCT01111331|9788029|FG001|STARTED|Overall Study||9
8739900|NCT01111331|9788028|FG000|COMPLETED|Overall Study||9
8739901|NCT01111331|9788029|FG001|COMPLETED|Overall Study||9
8739902|NCT01111331|9788028|FG000|NOT COMPLETED|Overall Study||0
8739903|NCT01111331|9788029|FG001|NOT COMPLETED|Overall Study||0
8739904|NCT01111370|9788039|FG000|STARTED|Overall Study||60
8739905|NCT01111370|9788039|FG000|COMPLETED|Overall Study||58
8739906|NCT01111370|9788039|FG000|NOT COMPLETED|Overall Study||2
8739907|NCT01111461|9788043|FG000|STARTED|Overall Study||133
8739908|NCT01111461|9788043|FG000|COMPLETED|Overall Study|On treatment at data cut-off or on treatment until disease progression|82
8739909|NCT01111461|9788043|FG000|NOT COMPLETED|Overall Study||51
8739910|NCT01111474|9788047|FG000|STARTED|Overall Study|593 teeth from 74 participants: 296 teeth treated with cyanoacrylate and 297 teeth with LILT|74
8739911|NCT01111474|9788047|FG000|COMPLETED|Overall Study|434 teeth from 62 participants: 218 teeth teated with cyanoacrylate and 216 teeth with LILT|62
8739912|NCT01111474|9788047|FG000|NOT COMPLETED|Overall Study||12
8739913|NCT01111526|9788053|FG000|STARTED|Overall Study||4
8739914|NCT01111526|9788054|FG001|STARTED|Overall Study||8
8739915|NCT01111526|9788055|FG002|STARTED|Overall Study||10
8739916|NCT01111526|9788053|FG000|COMPLETED|Overall Study||4
8739917|NCT01111526|9788054|FG001|COMPLETED|Overall Study||7
8739918|NCT01111526|9788055|FG002|COMPLETED|Overall Study||8
8739919|NCT01111526|9788053|FG000|NOT COMPLETED|Overall Study||0
8739920|NCT01111526|9788054|FG001|NOT COMPLETED|Overall Study||1
8739921|NCT01111526|9788055|FG002|NOT COMPLETED|Overall Study||2
8739922|NCT01111539|9788059|FG000|STARTED|Phase B (Day 1 to Week 8)||211
8739923|NCT01111539|9788060|FG001|STARTED|Phase B (Day 1 to Week 8)||0
8739924|NCT01111539|9788061|FG002|STARTED|Phase B (Day 1 to Week 8)||0
8739925|NCT01111539|9788062|FG003|STARTED|Phase B (Day 1 to Week 8)||0
8739926|NCT01111539|9788063|FG004|STARTED|Phase B (Day 1 to Week 8)||0
8739927|NCT01111539|9788059|FG000|COMPLETED|Phase B (Day 1 to Week 8)||129
8739928|NCT01111539|9788060|FG001|COMPLETED|Phase B (Day 1 to Week 8)||0
8739929|NCT01111539|9788061|FG002|COMPLETED|Phase B (Day 1 to Week 8)||0
8739930|NCT01111539|9788062|FG003|COMPLETED|Phase B (Day 1 to Week 8)||0
8739931|NCT01111539|9788063|FG004|COMPLETED|Phase B (Day 1 to Week 8)||0
8739932|NCT01111539|9788059|FG000|NOT COMPLETED|Phase B (Day 1 to Week 8)||82
8739933|NCT01111539|9788060|FG001|NOT COMPLETED|Phase B (Day 1 to Week 8)||0
8739934|NCT01111539|9788061|FG002|NOT COMPLETED|Phase B (Day 1 to Week 8)||0
8739935|NCT01111539|9788062|FG003|NOT COMPLETED|Phase B (Day 1 to Week 8)||0
8739936|NCT01111539|9788063|FG004|NOT COMPLETED|Phase B (Day 1 to Week 8)||0
8739937|NCT01111539|9788059|FG000|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||0
8739938|NCT01111539|9788060|FG001|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||45
8739939|NCT01111539|9788061|FG002|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||28
8739940|NCT01111539|9788062|FG003|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||28
8739941|NCT01111539|9788063|FG004|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||28
8739942|NCT01111539|9788059|FG000|Intent-to-treat (ITT) Sample|Phase B+ and Phase C (Weeks 9 to 14)||0
8739943|NCT01111539|9788060|FG001|Intent-to-treat (ITT) Sample|Phase B+ and Phase C (Weeks 9 to 14)||45
8739944|NCT01111539|9788061|FG002|Intent-to-treat (ITT) Sample|Phase B+ and Phase C (Weeks 9 to 14)||28
8739945|NCT01111539|9788062|FG003|Intent-to-treat (ITT) Sample|Phase B+ and Phase C (Weeks 9 to 14)||27
8739946|NCT01111539|9788063|FG004|Intent-to-treat (ITT) Sample|Phase B+ and Phase C (Weeks 9 to 14)||28
8739947|NCT01111539|9788059|FG000|Safety Sample|Phase B+ and Phase C (Weeks 9 to 14)||0
8739948|NCT01111539|9788060|FG001|Safety Sample|Phase B+ and Phase C (Weeks 9 to 14)||45
8739949|NCT01111539|9788061|FG002|Safety Sample|Phase B+ and Phase C (Weeks 9 to 14)||28
8739950|NCT01111539|9788062|FG003|Safety Sample|Phase B+ and Phase C (Weeks 9 to 14)||27
8739951|NCT01111539|9788063|FG004|Safety Sample|Phase B+ and Phase C (Weeks 9 to 14)||28
8739952|NCT01111539|9788059|FG000|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||0
8739953|NCT01111539|9788060|FG001|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||38
8739954|NCT01111539|9788061|FG002|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||22
8739955|NCT01111539|9788062|FG003|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||20
8739956|NCT01111539|9788063|FG004|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||18
8739957|NCT01111539|9788059|FG000|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||0
8739958|NCT01111539|9788060|FG001|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||7
8739959|NCT01111539|9788061|FG002|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||6
8739960|NCT01111539|9788062|FG003|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||8
8739961|NCT01111539|9788063|FG004|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||10
8739962|NCT01111552|9788073|FG000|STARTED|Phase B (Day 1 to Week 8)||237
8739963|NCT01111552|9788074|FG001|STARTED|Phase B (Day 1 to Week 8)||0
8739964|NCT01111552|9788075|FG002|STARTED|Phase B (Day 1 to Week 8)||0
8739965|NCT01111552|9788076|FG003|STARTED|Phase B (Day 1 to Week 8)||0
8739966|NCT01111552|9788077|FG004|STARTED|Phase B (Day 1 to Week 8)||0
8739967|NCT01111552|9788073|FG000|COMPLETED|Phase B (Day 1 to Week 8)||120
8739968|NCT01111552|9788074|FG001|COMPLETED|Phase B (Day 1 to Week 8)||0
8739969|NCT01111552|9788075|FG002|COMPLETED|Phase B (Day 1 to Week 8)||0
8739970|NCT01111552|9788076|FG003|COMPLETED|Phase B (Day 1 to Week 8)||0
8912418|NCT02153099|9971505|FG000|NOT COMPLETED|Overall Study||0
8912419|NCT02153099|9971506|FG001|NOT COMPLETED|Overall Study||0
8912420|NCT02153099|9971507|FG002|NOT COMPLETED|Overall Study||0
8912421|NCT02153099|9971508|FG003|NOT COMPLETED|Overall Study||0
8912422|NCT02153099|9971509|FG004|NOT COMPLETED|Overall Study||0
8912423|NCT02153099|9971510|FG005|NOT COMPLETED|Overall Study||0
8912424|NCT02153099|9971511|FG006|NOT COMPLETED|Overall Study||0
8912425|NCT02153112|9971537|FG000|STARTED|Overall Study||61
8912426|NCT02153112|9971538|FG001|STARTED|Overall Study||59
8912427|NCT02153112|9971539|FG002|STARTED|Overall Study||61
8912428|NCT02153112|9971540|FG003|STARTED|Overall Study||59
8912429|NCT02153112|9971541|FG004|STARTED|Overall Study||60
8912430|NCT02153112|9971542|FG005|STARTED|Overall Study||60
8912431|NCT02153112|9971543|FG006|STARTED|Overall Study||60
8912432|NCT02153112|9971544|FG007|STARTED|Overall Study||60
8912433|NCT02153112|9971545|FG008|STARTED|Overall Study||180
8912434|NCT02153112|9971546|FG009|STARTED|Overall Study||180
8912435|NCT02153112|9971537|FG000|COMPLETED|Overall Study||57
8912436|NCT02153112|9971538|FG001|COMPLETED|Overall Study||57
8912437|NCT02153112|9971539|FG002|COMPLETED|Overall Study||58
8912438|NCT02153112|9971540|FG003|COMPLETED|Overall Study||57
8912439|NCT02153112|9971541|FG004|COMPLETED|Overall Study||57
8912440|NCT02153112|9971542|FG005|COMPLETED|Overall Study||58
8912441|NCT02153112|9971543|FG006|COMPLETED|Overall Study||52
8912442|NCT02153112|9971544|FG007|COMPLETED|Overall Study||58
8912443|NCT02153112|9971545|FG008|COMPLETED|Overall Study||165
8912444|NCT02153112|9971546|FG009|COMPLETED|Overall Study||166
8912445|NCT02153112|9971537|FG000|NOT COMPLETED|Overall Study||4
8912446|NCT02153112|9971538|FG001|NOT COMPLETED|Overall Study||2
8912447|NCT02153112|9971539|FG002|NOT COMPLETED|Overall Study||3
8912448|NCT02153112|9971540|FG003|NOT COMPLETED|Overall Study||2
8912449|NCT02153112|9971541|FG004|NOT COMPLETED|Overall Study||3
8912450|NCT02153112|9971542|FG005|NOT COMPLETED|Overall Study||2
8912451|NCT02153112|9971543|FG006|NOT COMPLETED|Overall Study||8
8912452|NCT02153112|9971544|FG007|NOT COMPLETED|Overall Study||2
8912453|NCT02153112|9971545|FG008|NOT COMPLETED|Overall Study||15
8912454|NCT02153112|9971546|FG009|NOT COMPLETED|Overall Study||14
8912455|NCT02153346|9971570|FG000|STARTED|Overall Study||101
8912456|NCT02153346|9971570|FG000|COMPLETED|Overall Study||90
8912457|NCT02153346|9971570|FG000|NOT COMPLETED|Overall Study||11
8912458|NCT02153359|9971575|FG000|STARTED|Intervention 1 (1 Month)||11
8912459|NCT02153359|9971576|FG001|STARTED|Intervention 1 (1 Month)||12
8912460|NCT02153359|9971575|FG000|COMPLETED|Intervention 1 (1 Month)||11
8912461|NCT02153359|9971576|FG001|COMPLETED|Intervention 1 (1 Month)||12
8912462|NCT02153359|9971575|FG000|NOT COMPLETED|Intervention 1 (1 Month)||0
8912463|NCT02153359|9971576|FG001|NOT COMPLETED|Intervention 1 (1 Month)||0
8912464|NCT02153359|9971575|FG000|STARTED|Washout (at Least 1 Month)||11
8912465|NCT02153359|9971576|FG001|STARTED|Washout (at Least 1 Month)||12
8912466|NCT02153359|9971575|FG000|COMPLETED|Washout (at Least 1 Month)||11
8912467|NCT02153359|9971576|FG001|COMPLETED|Washout (at Least 1 Month)||12
8912468|NCT02153359|9971575|FG000|NOT COMPLETED|Washout (at Least 1 Month)||0
8912469|NCT02153359|9971576|FG001|NOT COMPLETED|Washout (at Least 1 Month)||0
8912470|NCT02153359|9971575|FG000|STARTED|Intervention 2 (1 Month)||11
8912471|NCT02153359|9971576|FG001|STARTED|Intervention 2 (1 Month)||12
8912472|NCT02153359|9971575|FG000|COMPLETED|Intervention 2 (1 Month)||11
8912473|NCT02153359|9971576|FG001|COMPLETED|Intervention 2 (1 Month)||10
8912474|NCT02153359|9971575|FG000|NOT COMPLETED|Intervention 2 (1 Month)||0
8912475|NCT02153359|9971576|FG001|NOT COMPLETED|Intervention 2 (1 Month)||2
8912476|NCT02153398|9971590|FG000|STARTED|Overall Study||10
8912477|NCT02153398|9971591|FG001|STARTED|Overall Study||10
8912478|NCT02153398|9971592|FG002|STARTED|Overall Study||10
8912479|NCT02153398|9971593|FG003|STARTED|Overall Study||10
8912480|NCT02153398|9971594|FG004|STARTED|Overall Study||10
8912481|NCT02153398|9971590|FG000|COMPLETED|Overall Study||9
8912482|NCT02153398|9971591|FG001|COMPLETED|Overall Study||10
8739971|NCT01111552|9788077|FG004|COMPLETED|Phase B (Day 1 to Week 8)||0
8739972|NCT01111552|9788073|FG000|NOT COMPLETED|Phase B (Day 1 to Week 8)||117
8739973|NCT01111552|9788074|FG001|NOT COMPLETED|Phase B (Day 1 to Week 8)||0
8739974|NCT01111552|9788075|FG002|NOT COMPLETED|Phase B (Day 1 to Week 8)||0
8739975|NCT01111552|9788076|FG003|NOT COMPLETED|Phase B (Day 1 to Week 8)||0
8739976|NCT01111552|9788077|FG004|NOT COMPLETED|Phase B (Day 1 to Week 8)||0
8739977|NCT01111552|9788073|FG000|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||0
8739978|NCT01111552|9788074|FG001|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||54
8739979|NCT01111552|9788075|FG002|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||22
8739980|NCT01111552|9788076|FG003|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||21
8739981|NCT01111552|9788077|FG004|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||23
8739982|NCT01111552|9788073|FG000|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||0
8739983|NCT01111552|9788074|FG001|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||45
8739984|NCT01111552|9788075|FG002|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||17
8739985|NCT01111552|9788076|FG003|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||17
8739986|NCT01111552|9788077|FG004|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||18
8739987|NCT01111552|9788073|FG000|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||0
8739988|NCT01111552|9788074|FG001|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||9
8739989|NCT01111552|9788075|FG002|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||5
8739990|NCT01111552|9788076|FG003|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||4
8739991|NCT01111552|9788077|FG004|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||5
8739992|NCT01111604|9788090|FG000|STARTED|Overall Study||54
8739993|NCT01111604|9788091|FG001|STARTED|Overall Study||52
8739994|NCT01111604|9788092|FG002|STARTED|Overall Study||52
8739995|NCT01111604|9788090|FG000|Received at Least One Dose of Study Drug|Overall Study||49
8739996|NCT01111604|9788091|FG001|Received at Least One Dose of Study Drug|Overall Study||52
8739997|NCT01111604|9788092|FG002|Received at Least One Dose of Study Drug|Overall Study||52
8739998|NCT01111604|9788090|FG000|COMPLETED|Overall Study||46
8739999|NCT01111604|9788091|FG001|COMPLETED|Overall Study||52
8740000|NCT01111604|9788092|FG002|COMPLETED|Overall Study||49
8740001|NCT01111604|9788090|FG000|NOT COMPLETED|Overall Study||8
8740002|NCT01111604|9788091|FG001|NOT COMPLETED|Overall Study||0
8740003|NCT01111604|9788092|FG002|NOT COMPLETED|Overall Study||3
8740004|NCT01111825|9788122|FG000|STARTED|Overall Study||8
8740005|NCT01111825|9788123|FG001|STARTED|Overall Study||6
8740006|NCT01111825|9788124|FG002|STARTED|Overall Study||37
8740007|NCT01111825|9788125|FG003|STARTED|Overall Study||48
8740008|NCT01111825|9788122|FG000|COMPLETED|Overall Study||5
8740009|NCT01111825|9788123|FG001|COMPLETED|Overall Study||5
8740010|NCT01111825|9788124|FG002|COMPLETED|Overall Study||29
8740011|NCT01111825|9788125|FG003|COMPLETED|Overall Study||27
8740012|NCT01111825|9788122|FG000|NOT COMPLETED|Overall Study||3
8740013|NCT01111825|9788123|FG001|NOT COMPLETED|Overall Study||1
8740014|NCT01111825|9788124|FG002|NOT COMPLETED|Overall Study||8
8740015|NCT01111825|9788125|FG003|NOT COMPLETED|Overall Study||21
8740016|NCT01111838|9788135|FG000|STARTED|Overall Study||22
8740017|NCT01111838|9788135|FG000|COMPLETED|Overall Study||15
8740018|NCT01111838|9788135|FG000|NOT COMPLETED|Overall Study||7
8740019|NCT01111851|9788141|FG000|STARTED|Overall Study||8
8740020|NCT01111851|9788142|FG001|STARTED|Overall Study||8
8740021|NCT01111851|9788141|FG000|COMPLETED|Overall Study||6
8740022|NCT01111851|9788142|FG001|COMPLETED|Overall Study||8
8740023|NCT01111851|9788141|FG000|NOT COMPLETED|Overall Study||2
8740024|NCT01111851|9788142|FG001|NOT COMPLETED|Overall Study||0
8740025|NCT01112059|9788150|FG000|STARTED|Overall Study||20
8740026|NCT01112059|9788151|FG001|STARTED|Overall Study||20
8740027|NCT01112059|9788150|FG000|COMPLETED|Overall Study||19
8740028|NCT01112059|9788151|FG001|COMPLETED|Overall Study||20
8740029|NCT01112059|9788150|FG000|NOT COMPLETED|Overall Study||1
8740030|NCT01112059|9788151|FG001|NOT COMPLETED|Overall Study||0
8740031|NCT01112228|9788160|FG000|STARTED|Overall Study||600
8740032|NCT01112228|9788160|FG000|COMPLETED|Overall Study||600
8740033|NCT01112228|9788160|FG000|NOT COMPLETED|Overall Study||0
8740034|NCT01112241|9788166|FG000|STARTED|Overall Study||17
8740035|NCT01112241|9788166|FG000|COMPLETED|Overall Study||17
8740036|NCT01112241|9788166|FG000|NOT COMPLETED|Overall Study||0
8740037|NCT01112267|9788172|FG000|STARTED|Overall Study||126
8740038|NCT01112267|9788173|FG001|STARTED|Overall Study||122
8740039|NCT01112267|9788172|FG000|Treated|Overall Study||125
8740040|NCT01112267|9788173|FG001|Treated|Overall Study||120
8740041|NCT01112267|9788172|FG000|COMPLETED|Overall Study||92
8740042|NCT01112267|9788173|FG001|COMPLETED|Overall Study||104
8740043|NCT01112267|9788172|FG000|NOT COMPLETED|Overall Study||34
8740044|NCT01112267|9788173|FG001|NOT COMPLETED|Overall Study||18
8740045|NCT01112293|9788179|FG000|STARTED|Overall Study||14
8740046|NCT01112293|9788179|FG000|COMPLETED|Overall Study||14
8740047|NCT01112293|9788179|FG000|NOT COMPLETED|Overall Study||0
8740048|NCT01112358|9788185|FG000|STARTED|Overall Study||25
8740049|NCT01112358|9788186|FG001|STARTED|Overall Study||33
8740050|NCT01112358|9788185|FG000|COMPLETED|Overall Study||25
8740051|NCT01112358|9788186|FG001|COMPLETED|Overall Study||33
8740052|NCT01112358|9788185|FG000|NOT COMPLETED|Overall Study||0
8740053|NCT01112358|9788186|FG001|NOT COMPLETED|Overall Study||0
8740054|NCT01112514|9788192|FG000|STARTED|Overall Study||4
8740055|NCT01112514|9788192|FG000|COMPLETED|Overall Study||3
8740056|NCT01112514|9788192|FG000|NOT COMPLETED|Overall Study||1
8740057|NCT01112579|9788198|FG000|STARTED|Overall Study||42
8740058|NCT01112579|9788199|FG001|STARTED|Overall Study||24
8740059|NCT01112579|9788198|FG000|COMPLETED|Overall Study||41
8740060|NCT01112579|9788199|FG001|COMPLETED|Overall Study||21
8740061|NCT01112579|9788198|FG000|NOT COMPLETED|Overall Study||1
8740062|NCT01112579|9788199|FG001|NOT COMPLETED|Overall Study||3
8740063|NCT01112670|9788205|FG000|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||8
8740064|NCT01112670|9788206|FG001|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||0
8740065|NCT01112670|9788207|FG002|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||7
8740066|NCT01112670|9788208|FG003|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||0
8740067|NCT01112670|9788209|FG004|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||6
8740068|NCT01112670|9788210|FG005|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||0
8740069|NCT01112670|9788205|FG000|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||7
8740070|NCT01112670|9788206|FG001|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
8740071|NCT01112670|9788207|FG002|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||6
8740072|NCT01112670|9788208|FG003|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
8740073|NCT01112670|9788209|FG004|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||5
8740074|NCT01112670|9788210|FG005|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
8740075|NCT01112670|9788205|FG000|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||1
8740076|NCT01112670|9788206|FG001|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
8912483|NCT02153398|9971592|FG002|COMPLETED|Overall Study||9
8912484|NCT02153398|9971593|FG003|COMPLETED|Overall Study||9
8912485|NCT02153398|9971594|FG004|COMPLETED|Overall Study||10
8912486|NCT02153398|9971590|FG000|NOT COMPLETED|Overall Study||1
8912487|NCT02153398|9971591|FG001|NOT COMPLETED|Overall Study||0
8912488|NCT02153398|9971592|FG002|NOT COMPLETED|Overall Study||1
8912489|NCT02153398|9971593|FG003|NOT COMPLETED|Overall Study||1
8912490|NCT02153398|9971594|FG004|NOT COMPLETED|Overall Study||0
8912491|NCT02153476|9971608|FG000|STARTED|Overall Study||23
8912492|NCT02153476|9971609|FG001|STARTED|Overall Study||22
8912493|NCT02153476|9971608|FG000|COMPLETED|Overall Study||22
8912494|NCT02153476|9971609|FG001|COMPLETED|Overall Study||22
8912495|NCT02153476|9971608|FG000|NOT COMPLETED|Overall Study||1
8912496|NCT02153476|9971609|FG001|NOT COMPLETED|Overall Study||0
8912497|NCT02153489|9971615|FG000|STARTED|Period 1||15
8912498|NCT02153489|9971616|FG001|STARTED|Period 1||15
8912499|NCT02153489|9971615|FG000|COMPLETED|Period 1||15
8912500|NCT02153489|9971616|FG001|COMPLETED|Period 1||15
8912501|NCT02153489|9971615|FG000|NOT COMPLETED|Period 1||0
8912502|NCT02153489|9971616|FG001|NOT COMPLETED|Period 1||0
8912503|NCT02153489|9971615|FG000|STARTED|Period 2||15
8912504|NCT02153489|9971616|FG001|STARTED|Period 2||15
8912505|NCT02153489|9971615|FG000|COMPLETED|Period 2||15
8912506|NCT02153489|9971616|FG001|COMPLETED|Period 2||15
8912507|NCT02153489|9971615|FG000|NOT COMPLETED|Period 2||0
8912508|NCT02153489|9971616|FG001|NOT COMPLETED|Period 2||0
8912509|NCT02153528|9971624|FG000|STARTED|Overall Study||348
8912510|NCT02153528|9971625|FG001|STARTED|Overall Study||353
8912511|NCT02153528|9971624|FG000|COMPLETED|Overall Study||348
8912512|NCT02153528|9971625|FG001|COMPLETED|Overall Study||353
8912513|NCT02153528|9971624|FG000|NOT COMPLETED|Overall Study||0
8912514|NCT02153528|9971625|FG001|NOT COMPLETED|Overall Study||0
9022572|NCT03129100|10085457|FG003|STARTED|Period2 Extension Period (Group A and B)|Participants who entered extension period (Group A).|318
9022573|NCT03129100|10085458|FG004|STARTED|Period2 Extension Period (Group A and B)|Participants who entered extension period (Group B).|48
9022574|NCT03129100|10085459|FG005|STARTED|Period2 Extension Period (Group A and B)|Participants who entered extension period (Group B).|54
9022575|NCT03129100|10085460|FG006|STARTED|Period2 Extension Period (Group A and B)|Participants who entered extension period (Group B).|53
8740077|NCT01112670|9788207|FG002|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||1
9022576|NCT03129100|10085461|FG007|STARTED|Period2 Extension Period (Group A and B)||0
9022577|NCT03129100|10085462|FG008|STARTED|Period2 Extension Period (Group A and B)||0
8740078|NCT01112670|9788208|FG003|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
8740079|NCT01112670|9788209|FG004|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||1
8740080|NCT01112670|9788210|FG005|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
8740081|NCT01112670|9788205|FG000|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||0
8740082|NCT01112670|9788206|FG001|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||3
8740083|NCT01112670|9788207|FG002|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||0
8740084|NCT01112670|9788208|FG003|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||4
8740085|NCT01112670|9788209|FG004|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||0
8740086|NCT01112670|9788210|FG005|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||5
8740087|NCT01112670|9788205|FG000|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
8740088|NCT01112670|9788206|FG001|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||3
8740089|NCT01112670|9788207|FG002|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
8740090|NCT01112670|9788208|FG003|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||4
8740091|NCT01112670|9788209|FG004|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
8740092|NCT01112670|9788210|FG005|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||5
8740093|NCT01112670|9788205|FG000|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
8740094|NCT01112670|9788206|FG001|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
8740095|NCT01112670|9788207|FG002|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
8740096|NCT01112670|9788208|FG003|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
8740097|NCT01112670|9788209|FG004|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
8740098|NCT01112670|9788210|FG005|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
8740099|NCT01112683|9788219|FG000|STARTED|Overall Study||19
8740100|NCT01112683|9788220|FG001|STARTED|Overall Study||20
8740101|NCT01112683|9788219|FG000|COMPLETED|Overall Study||18
8740102|NCT01112683|9788220|FG001|COMPLETED|Overall Study||19
8740103|NCT01112683|9788219|FG000|NOT COMPLETED|Overall Study||1
8740104|NCT01112683|9788220|FG001|NOT COMPLETED|Overall Study||1
8740105|NCT01112696|9788226|FG000|STARTED|Overall Study||100
8740106|NCT01112696|9788226|FG000|COMPLETED|Overall Study||98
8740107|NCT01112696|9788226|FG000|NOT COMPLETED|Overall Study||2
8740108|NCT01112735|9788233|FG000|STARTED|Overall Study||20
8740109|NCT01112735|9788234|FG001|STARTED|Overall Study||20
8740110|NCT01112735|9788233|FG000|COMPLETED|Overall Study||20
8740111|NCT01112735|9788234|FG001|COMPLETED|Overall Study||20
8740112|NCT01112735|9788233|FG000|NOT COMPLETED|Overall Study||0
8740113|NCT01112735|9788234|FG001|NOT COMPLETED|Overall Study||0
8740114|NCT01112865|9788240|FG000|STARTED|First Intervention||59
8740115|NCT01112865|9788241|FG001|STARTED|First Intervention||61
8740116|NCT01112865|9788240|FG000|COMPLETED|First Intervention||59
8740117|NCT01112865|9788241|FG001|COMPLETED|First Intervention||61
8740118|NCT01112865|9788240|FG000|NOT COMPLETED|First Intervention||0
8740119|NCT01112865|9788241|FG001|NOT COMPLETED|First Intervention||0
8740120|NCT01112865|9788240|FG000|STARTED|Second Intervention||59
8740121|NCT01112865|9788241|FG001|STARTED|Second Intervention||61
8740122|NCT01112865|9788240|FG000|COMPLETED|Second Intervention||59
8740123|NCT01112865|9788241|FG001|COMPLETED|Second Intervention||61
8740124|NCT01112865|9788240|FG000|NOT COMPLETED|Second Intervention||0
8740125|NCT01112865|9788241|FG001|NOT COMPLETED|Second Intervention||0
8740126|NCT01112917|9788247|FG000|STARTED|Overall Study||96
8740127|NCT01112917|9788248|FG001|STARTED|Overall Study||53
8740128|NCT01112917|9788247|FG000|COMPLETED|Overall Study||89
8740129|NCT01112917|9788248|FG001|COMPLETED|Overall Study||38
8740130|NCT01112917|9788247|FG000|NOT COMPLETED|Overall Study||7
8740131|NCT01112917|9788248|FG001|NOT COMPLETED|Overall Study||15
8740132|NCT01112982|9788252|FG000|STARTED|Overall Study||74
8740133|NCT01112982|9788252|FG000|COMPLETED|Overall Study||72
8740134|NCT01112982|9788252|FG000|NOT COMPLETED|Overall Study||2
8740135|NCT01113008|9788261|FG000|STARTED|Overall Study||133
8740136|NCT01113008|9788262|FG001|STARTED|Overall Study||133
8740137|NCT01113008|9788261|FG000|COMPLETED|Overall Study||133
8740138|NCT01113008|9788262|FG001|COMPLETED|Overall Study||133
8740139|NCT01113008|9788261|FG000|NOT COMPLETED|Overall Study||0
8740140|NCT01113008|9788262|FG001|NOT COMPLETED|Overall Study||0
8740141|NCT01113385|9788268|FG000|STARTED|Overall Study||7
8740142|NCT01113385|9788268|FG000|COMPLETED|Overall Study||7
8740143|NCT01113385|9788268|FG000|NOT COMPLETED|Overall Study||0
8740144|NCT01113398|9788272|FG000|STARTED|Overall Study||36
8740145|NCT01113398|9788272|FG000|COMPLETED|Overall Study|Completed= Discontinued study drug due to disease progression, death, toxicity or any other reason|36
8740146|NCT01113398|9788272|FG000|NOT COMPLETED|Overall Study||0
8740147|NCT01113463|9788276|FG000|STARTED|Overall Study||17
8740148|NCT01113463|9788276|FG000|COMPLETED|Overall Study||12
8740149|NCT01113463|9788276|FG000|NOT COMPLETED|Overall Study||5
8740150|NCT01113502|9788285|FG000|STARTED|Overall Study||4
8740151|NCT01113502|9788286|FG001|STARTED|Overall Study||3
8740152|NCT01113502|9788287|FG002|STARTED|Overall Study||7
8740153|NCT01113502|9788288|FG003|STARTED|Overall Study||9
8740154|NCT01113502|9788289|FG004|STARTED|Overall Study||21
8740155|NCT01113502|9788285|FG000|COMPLETED|Overall Study||3
8740156|NCT01113502|9788286|FG001|COMPLETED|Overall Study||3
8740157|NCT01113502|9788287|FG002|COMPLETED|Overall Study||3
8740158|NCT01113502|9788288|FG003|COMPLETED|Overall Study||6
8740159|NCT01113502|9788289|FG004|COMPLETED|Overall Study||21
8740160|NCT01113502|9788285|FG000|NOT COMPLETED|Overall Study||1
8740161|NCT01113502|9788286|FG001|NOT COMPLETED|Overall Study||0
8740162|NCT01113502|9788287|FG002|NOT COMPLETED|Overall Study||4
8740163|NCT01113502|9788288|FG003|NOT COMPLETED|Overall Study||3
8740164|NCT01113502|9788289|FG004|NOT COMPLETED|Overall Study||0
8740165|NCT01113541|9788302|FG000|STARTED|Overall Study||13
8740166|NCT01113541|9788302|FG000|COMPLETED|Overall Study||0
8740167|NCT01113541|9788302|FG000|NOT COMPLETED|Overall Study||13
8740168|NCT01113580|9788308|FG000|STARTED|Overall Study||60
8740169|NCT01113580|9788309|FG001|STARTED|Overall Study||60
8740170|NCT01113580|9788308|FG000|COMPLETED|Overall Study||59
8740171|NCT01113580|9788309|FG001|COMPLETED|Overall Study||60
8740172|NCT01113580|9788308|FG000|NOT COMPLETED|Overall Study||1
8740173|NCT01113580|9788309|FG001|NOT COMPLETED|Overall Study||0
8740174|NCT01113632|9788317|FG000|STARTED|Overall Study||33
8740175|NCT01113632|9788318|FG001|STARTED|Overall Study||44
8740176|NCT01113632|9788317|FG000|COMPLETED|Overall Study||2
8740177|NCT01113632|9788318|FG001|COMPLETED|Overall Study||19
8740178|NCT01113632|9788317|FG000|NOT COMPLETED|Overall Study||31
8740179|NCT01113632|9788318|FG001|NOT COMPLETED|Overall Study||25
8740180|NCT01113710|9788324|FG000|STARTED|Overall Study|See Additional Study Description for further information regarding withdrawal due to Adverse Event.|687
8740181|NCT01113710|9788324|FG000|COMPLETED|Overall Study|"Discontinued reasons for Other are listed in the Participant Flow."|418
8740182|NCT01113710|9788324|FG000|NOT COMPLETED|Overall Study||269
8740183|NCT01113723|9788330|FG000|STARTED|Overall Study||70
8740184|NCT01113723|9788331|FG001|STARTED|Overall Study||70
8740185|NCT01113723|9788330|FG000|COMPLETED|Overall Study||70
8740186|NCT01113723|9788331|FG001|COMPLETED|Overall Study||70
8740187|NCT01113723|9788330|FG000|NOT COMPLETED|Overall Study||0
8740188|NCT01113723|9788331|FG001|NOT COMPLETED|Overall Study||0
8740189|NCT01113749|9788341|FG000|STARTED|Overall Study||127
8740190|NCT01113749|9788342|FG001|STARTED|Overall Study||129
8740191|NCT01113749|9788341|FG000|COMPLETED|Overall Study||126
8740192|NCT01113749|9788342|FG001|COMPLETED|Overall Study||127
8740193|NCT01113749|9788341|FG000|NOT COMPLETED|Overall Study||1
8740194|NCT01113749|9788342|FG001|NOT COMPLETED|Overall Study||2
8740195|NCT01113801|9788352|FG000|STARTED|Overall Study||103
8740196|NCT01113801|9788353|FG001|STARTED|Overall Study||105
8740197|NCT01113801|9788354|FG002|STARTED|Overall Study||103
8740198|NCT01113801|9788355|FG003|STARTED|Overall Study||106
8740199|NCT01113801|9788352|FG000|Received at Least One Dose of Drug|Overall Study||103
8740200|NCT01113801|9788353|FG001|Received at Least One Dose of Drug|Overall Study||105
8740201|NCT01113801|9788354|FG002|Received at Least One Dose of Drug|Overall Study||103
8740202|NCT01113801|9788355|FG003|Received at Least One Dose of Drug|Overall Study||105
8740203|NCT01113801|9788352|FG000|COMPLETED|Overall Study||62
8740204|NCT01113801|9788353|FG001|COMPLETED|Overall Study||65
8740205|NCT01113801|9788354|FG002|COMPLETED|Overall Study||66
8740206|NCT01113801|9788355|FG003|COMPLETED|Overall Study||65
8740207|NCT01113801|9788352|FG000|NOT COMPLETED|Overall Study||41
8740208|NCT01113801|9788353|FG001|NOT COMPLETED|Overall Study||40
8740209|NCT01113801|9788354|FG002|NOT COMPLETED|Overall Study||37
8740210|NCT01113801|9788355|FG003|NOT COMPLETED|Overall Study||41
8740211|NCT01113879|9788367|FG000|STARTED|Period 1: Block 1||7
8740212|NCT01113879|9788368|FG001|STARTED|Period 1: Block 1||2
8740213|NCT01113879|9788367|FG000|COMPLETED|Period 1: Block 1||5
8740214|NCT01113879|9788368|FG001|COMPLETED|Period 1: Block 1||2
8740215|NCT01113879|9788367|FG000|NOT COMPLETED|Period 1: Block 1||2
8740216|NCT01113879|9788368|FG001|NOT COMPLETED|Period 1: Block 1||0
8740217|NCT01113879|9788367|FG000|STARTED|Period 2: Block 2||5
8740218|NCT01113879|9788368|FG001|STARTED|Period 2: Block 2||2
8740219|NCT01113879|9788367|FG000|COMPLETED|Period 2: Block 2||5
8740220|NCT01113879|9788368|FG001|COMPLETED|Period 2: Block 2||2
8740221|NCT01113879|9788367|FG000|NOT COMPLETED|Period 2: Block 2||0
8740222|NCT01113879|9788368|FG001|NOT COMPLETED|Period 2: Block 2||0
8740223|NCT01113892|9788378|FG000|STARTED|Overall Study||101
8740224|NCT01113892|9788379|FG001|STARTED|Overall Study||106
8740225|NCT01113892|9788378|FG000|COMPLETED|Overall Study||87
8740226|NCT01113892|9788379|FG001|COMPLETED|Overall Study||90
8740227|NCT01113892|9788378|FG000|NOT COMPLETED|Overall Study||14
8740228|NCT01113892|9788379|FG001|NOT COMPLETED|Overall Study||16
8740229|NCT01113931|9788387|FG000|STARTED|Overall Study||247
8740230|NCT01113931|9788388|FG001|STARTED|Overall Study||248
8740231|NCT01113931|9788387|FG000|Safety Population|Overall Study|1 subject did not take any study medication|246
8740232|NCT01113931|9788388|FG001|Safety Population|Overall Study||248
8740233|NCT01113931|9788387|FG000|mITT Population|Overall Study||188
8740234|NCT01113931|9788388|FG001|mITT Population|Overall Study||190
8740235|NCT01113931|9788387|FG000|COMPLETED|Overall Study||228
8740236|NCT01113931|9788388|FG001|COMPLETED|Overall Study||231
8740237|NCT01113931|9788387|FG000|NOT COMPLETED|Overall Study||19
8740238|NCT01113931|9788388|FG001|NOT COMPLETED|Overall Study||17
8740239|NCT01113983|9788396|FG000|STARTED|Overall Study||37
8740240|NCT01113983|9788397|FG001|STARTED|Overall Study||27
8740241|NCT01113983|9788396|FG000|COMPLETED|Overall Study||12
8740242|NCT01113983|9788397|FG001|COMPLETED|Overall Study||10
8740243|NCT01113983|9788396|FG000|NOT COMPLETED|Overall Study||25
8740244|NCT01113983|9788397|FG001|NOT COMPLETED|Overall Study||17
8740245|NCT01114334|9788405|FG000|STARTED|Overall Study||88
8740246|NCT01114334|9788406|FG001|STARTED|Overall Study||80
8740247|NCT01114334|9788405|FG000|COMPLETED|Overall Study||67
8740248|NCT01114334|9788406|FG001|COMPLETED|Overall Study||58
8740249|NCT01114334|9788405|FG000|NOT COMPLETED|Overall Study||21
8740250|NCT01114334|9788406|FG001|NOT COMPLETED|Overall Study||22
8740251|NCT01114360|9788413|FG000|STARTED|Intervention 1 (4 Weeks)||18
8740252|NCT01114360|9788414|FG001|STARTED|Intervention 1 (4 Weeks)||19
8740253|NCT01114360|9788413|FG000|COMPLETED|Intervention 1 (4 Weeks)||18
8740254|NCT01114360|9788414|FG001|COMPLETED|Intervention 1 (4 Weeks)||18
8740255|NCT01114360|9788413|FG000|NOT COMPLETED|Intervention 1 (4 Weeks)||0
8740256|NCT01114360|9788414|FG001|NOT COMPLETED|Intervention 1 (4 Weeks)||1
8740257|NCT01114360|9788413|FG000|STARTED|Intervention 2 (4 Weeks)||18
8740258|NCT01114360|9788414|FG001|STARTED|Intervention 2 (4 Weeks)||18
8740259|NCT01114360|9788413|FG000|COMPLETED|Intervention 2 (4 Weeks)||18
8740260|NCT01114360|9788414|FG001|COMPLETED|Intervention 2 (4 Weeks)||18
8740261|NCT01114360|9788413|FG000|NOT COMPLETED|Intervention 2 (4 Weeks)||0
8740262|NCT01114360|9788414|FG001|NOT COMPLETED|Intervention 2 (4 Weeks)||0
8740263|NCT01114373|9788434|FG000|STARTED|Intervention 1 (4 Weeks)||21
8740264|NCT01114373|9788435|FG001|STARTED|Intervention 1 (4 Weeks)||19
8740265|NCT01114373|9788434|FG000|COMPLETED|Intervention 1 (4 Weeks)||18
8740266|NCT01114373|9788435|FG001|COMPLETED|Intervention 1 (4 Weeks)||19
8740267|NCT01114373|9788434|FG000|NOT COMPLETED|Intervention 1 (4 Weeks)||3
8740268|NCT01114373|9788435|FG001|NOT COMPLETED|Intervention 1 (4 Weeks)||0
8740269|NCT01114373|9788434|FG000|STARTED|Intervention 2 (4 Weeks)||18
8740270|NCT01114373|9788435|FG001|STARTED|Intervention 2 (4 Weeks)||19
8740271|NCT01114373|9788434|FG000|COMPLETED|Intervention 2 (4 Weeks)||18
8740272|NCT01114373|9788435|FG001|COMPLETED|Intervention 2 (4 Weeks)||18
8740273|NCT01114373|9788434|FG000|NOT COMPLETED|Intervention 2 (4 Weeks)||0
8740274|NCT01114373|9788435|FG001|NOT COMPLETED|Intervention 2 (4 Weeks)||1
8740275|NCT01114438|9788445|FG000|STARTED|Overall Study||45
8740276|NCT01114438|9788445|FG000|COMPLETED|Overall Study||31
8740277|NCT01114438|9788445|FG000|NOT COMPLETED|Overall Study||14
8740278|NCT01114503|9788454|FG000|STARTED|Overall Study||2
8740279|NCT01114503|9788454|FG000|COMPLETED|Overall Study||2
8740280|NCT01114503|9788454|FG000|NOT COMPLETED|Overall Study||0
8740281|NCT01114516|9788460|FG000|STARTED|Overall Study||26
8740282|NCT01114516|9788461|FG001|STARTED|Overall Study||27
8740283|NCT01114516|9788460|FG000|COMPLETED|Overall Study||24
8740284|NCT01114516|9788461|FG001|COMPLETED|Overall Study||26
8740285|NCT01114516|9788460|FG000|NOT COMPLETED|Overall Study||2
8740286|NCT01114516|9788461|FG001|NOT COMPLETED|Overall Study||1
8740287|NCT01114529|9788470|FG000|STARTED|Completed Study Medication at Month 24|Randomized set - 360 Full analysis set - 353 Safety analysis set -346*|353
8740288|NCT01114529|9788471|FG001|STARTED|Completed Study Medication at Month 24|Randomized set -231 Full analysis set -231 Safety analysis set -238**|231
8740289|NCT01114529|9788472|FG002|STARTED|Completed Study Medication at Month 24|Randomized set-125 Full analysis set -125 Safety analysis set -121***|125
8740290|NCT01114529|9788470|FG000|COMPLETED|Completed Study Medication at Month 24|completed at month 24|229
8740291|NCT01114529|9788471|FG001|COMPLETED|Completed Study Medication at Month 24|completed at month 24|190
8740292|NCT01114529|9788472|FG002|COMPLETED|Completed Study Medication at Month 24|completed at month 24|93
8740293|NCT01114529|9788470|FG000|NOT COMPLETED|Completed Study Medication at Month 24||124
8740294|NCT01114529|9788471|FG001|NOT COMPLETED|Completed Study Medication at Month 24||41
8740295|NCT01114529|9788472|FG002|NOT COMPLETED|Completed Study Medication at Month 24||32
8740296|NCT01114529|9788470|FG000|STARTED|Completed Study Phase at Month 24|It includes those discontinued treatment|353
8740297|NCT01114529|9788471|FG001|STARTED|Completed Study Phase at Month 24|It includes those discontinued treatment|231
8740298|NCT01114529|9788472|FG002|STARTED|Completed Study Phase at Month 24|It includes those discontinued treatment|125
8740299|NCT01114529|9788470|FG000|COMPLETED|Completed Study Phase at Month 24|at month 24|313
8740300|NCT01114529|9788471|FG001|COMPLETED|Completed Study Phase at Month 24|at month 24|215
8740301|NCT01114529|9788472|FG002|COMPLETED|Completed Study Phase at Month 24|at month 24|111
8740302|NCT01114529|9788470|FG000|NOT COMPLETED|Completed Study Phase at Month 24||40
8740303|NCT01114529|9788471|FG001|NOT COMPLETED|Completed Study Phase at Month 24||16
8740304|NCT01114529|9788472|FG002|NOT COMPLETED|Completed Study Phase at Month 24||14
8740305|NCT01114555|9788482|FG000|STARTED|Overall Study||34
8740306|NCT01114555|9788482|FG000|COMPLETED|Overall Study||34
8740307|NCT01114555|9788482|FG000|NOT COMPLETED|Overall Study||0
8740308|NCT01114581|9788488|FG000|STARTED|Overall Study||19
8740309|NCT01114581|9788489|FG001|STARTED|Overall Study||19
8740310|NCT01114581|9788488|FG000|COMPLETED|Overall Study||19
8740311|NCT01114581|9788489|FG001|COMPLETED|Overall Study||19
8740312|NCT01114581|9788488|FG000|NOT COMPLETED|Overall Study||0
8740313|NCT01114581|9788489|FG001|NOT COMPLETED|Overall Study||0
8740314|NCT01114620|9788495|FG000|STARTED|Overall Study||50
8740315|NCT01114620|9788495|FG000|COMPLETED|Overall Study||50
8740316|NCT01114620|9788495|FG000|NOT COMPLETED|Overall Study||0
8740317|NCT01114646|9788501|FG000|STARTED|Overall Study||66
8740318|NCT01114646|9788502|FG001|STARTED|Overall Study||64
8740319|NCT01114646|9788501|FG000|COMPLETED|Overall Study||63
8740320|NCT01114646|9788502|FG001|COMPLETED|Overall Study||62
8740321|NCT01114646|9788501|FG000|NOT COMPLETED|Overall Study||3
8740322|NCT01114646|9788502|FG001|NOT COMPLETED|Overall Study||2
8740323|NCT01114672|9788510|FG000|STARTED|Overall Study||25
8740324|NCT01114672|9788511|FG001|STARTED|Overall Study||25
8740325|NCT01114672|9788510|FG000|COMPLETED|Overall Study||21
8740326|NCT01114672|9788511|FG001|COMPLETED|Overall Study||23
8740327|NCT01114672|9788510|FG000|NOT COMPLETED|Overall Study||4
8740328|NCT01114672|9788511|FG001|NOT COMPLETED|Overall Study||2
8740329|NCT01114724|9788517|FG000|STARTED|Overall Study||50
8740330|NCT01114724|9788517|FG000|COMPLETED|Overall Study||40
8740331|NCT01114724|9788517|FG000|NOT COMPLETED|Overall Study||10
8912515|NCT02153671|9971635|FG000|STARTED|Overall Study||19
8912516|NCT02153671|9971636|FG001|STARTED|Overall Study||24
8912517|NCT02153671|9971635|FG000|COMPLETED|Overall Study||19
8912518|NCT02153671|9971636|FG001|COMPLETED|Overall Study||24
8912519|NCT02153671|9971635|FG000|NOT COMPLETED|Overall Study||0
8912520|NCT02153671|9971636|FG001|NOT COMPLETED|Overall Study||0
8912521|NCT02153710|9971644|FG000|STARTED|Overall Study||28
8670627|NCT00747474|9714096|FG005|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
8670628|NCT00747474|9714097|FG006|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
8670629|NCT00747474|9714098|FG007|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
8670630|NCT00747474|9714099|FG008|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
8670631|NCT00747474|9714100|FG009|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
8670632|NCT00747474|9714101|FG010|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
8670633|NCT00747474|9714102|FG011|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
8670634|NCT00747474|9714091|FG000|STARTED|Cohort 10 (40 mg/m^2) Period||0
8670635|NCT00747474|9714092|FG001|STARTED|Cohort 10 (40 mg/m^2) Period||0
8670636|NCT00747474|9714093|FG002|STARTED|Cohort 10 (40 mg/m^2) Period||0
8670637|NCT00747474|9714094|FG003|STARTED|Cohort 10 (40 mg/m^2) Period||0
8670638|NCT00747474|9714095|FG004|STARTED|Cohort 10 (40 mg/m^2) Period||0
8670639|NCT00747474|9714096|FG005|STARTED|Cohort 10 (40 mg/m^2) Period||0
8670640|NCT00747474|9714097|FG006|STARTED|Cohort 10 (40 mg/m^2) Period||0
8670641|NCT00747474|9714098|FG007|STARTED|Cohort 10 (40 mg/m^2) Period||0
8670642|NCT00747474|9714099|FG008|STARTED|Cohort 10 (40 mg/m^2) Period||0
8670643|NCT00747474|9714100|FG009|STARTED|Cohort 10 (40 mg/m^2) Period||7
8670644|NCT00747474|9714101|FG010|STARTED|Cohort 10 (40 mg/m^2) Period||0
8670645|NCT00747474|9714102|FG011|STARTED|Cohort 10 (40 mg/m^2) Period||0
8670646|NCT00747474|9714091|FG000|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
8670647|NCT00747474|9714092|FG001|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
8670648|NCT00747474|9714093|FG002|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
8670649|NCT00747474|9714094|FG003|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
8670650|NCT00747474|9714095|FG004|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
8670651|NCT00747474|9714096|FG005|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
8670652|NCT00747474|9714097|FG006|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
8670653|NCT00747474|9714098|FG007|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
8670654|NCT00747474|9714099|FG008|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
8670655|NCT00747474|9714100|FG009|COMPLETED|Cohort 10 (40 mg/m^2) Period||7
8670656|NCT00747474|9714101|FG010|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
8912522|NCT02153710|9971645|FG001|STARTED|Overall Study||30
8740332|NCT01114737|9788524|FG000|STARTED|Randomized Treatment Period||108
8740333|NCT01114737|9788525|FG001|STARTED|Randomized Treatment Period||98
8740334|NCT01114737|9788524|FG000|COMPLETED|Randomized Treatment Period||105
8740335|NCT01114737|9788525|FG001|COMPLETED|Randomized Treatment Period||97
8740336|NCT01114737|9788524|FG000|NOT COMPLETED|Randomized Treatment Period||3
8740337|NCT01114737|9788525|FG001|NOT COMPLETED|Randomized Treatment Period||1
8740338|NCT01114737|9788524|FG000|STARTED|Open-Label Treatment Period|One subject did not receive a single dose of the study drug|105
8740339|NCT01114737|9788525|FG001|STARTED|Open-Label Treatment Period|Two subjects did not receive a single dose of the study drug|97
8740340|NCT01114737|9788524|FG000|COMPLETED|Open-Label Treatment Period||100
8740341|NCT01114737|9788525|FG001|COMPLETED|Open-Label Treatment Period||95
8740342|NCT01114737|9788524|FG000|NOT COMPLETED|Open-Label Treatment Period||5
8740343|NCT01114737|9788525|FG001|NOT COMPLETED|Open-Label Treatment Period||2
8740344|NCT01114828|9788544|FG000|STARTED|Overall Study||19
8740345|NCT01114828|9788545|FG001|STARTED|Overall Study||21
8740346|NCT01114828|9788544|FG000|COMPLETED|Overall Study||16
8740347|NCT01114828|9788545|FG001|COMPLETED|Overall Study||17
8740348|NCT01114828|9788544|FG000|NOT COMPLETED|Overall Study||3
8740349|NCT01114828|9788545|FG001|NOT COMPLETED|Overall Study||4
8807131|NCT01483183|9859519|FG001|NOT COMPLETED|Overall Study||0
8807132|NCT01483183|9859520|FG002|NOT COMPLETED|Overall Study||0
8807133|NCT01483183|9859521|FG003|NOT COMPLETED|Overall Study||0
8807134|NCT01483183|9859522|FG004|NOT COMPLETED|Overall Study||0
8807135|NCT01483183|9859523|FG005|NOT COMPLETED|Overall Study||0
8807136|NCT01483183|9859524|FG006|NOT COMPLETED|Overall Study||2
8807137|NCT01483183|9859525|FG007|NOT COMPLETED|Overall Study||0
8807138|NCT01483183|9859526|FG008|NOT COMPLETED|Overall Study||0
8807139|NCT01483183|9859527|FG009|NOT COMPLETED|Overall Study||1
8807140|NCT01483352|9859555|FG000|STARTED|Overall Study||12
8807141|NCT01483352|9859555|FG000|COMPLETED|Overall Study||12
8807142|NCT01483352|9859555|FG000|NOT COMPLETED|Overall Study||0
8807143|NCT01483378|9859559|FG000|STARTED|Overall Study||100
8807144|NCT01483378|9859560|FG001|STARTED|Overall Study||66
8807145|NCT01483378|9859559|FG000|COMPLETED|Overall Study||100
8807146|NCT01483378|9859560|FG001|COMPLETED|Overall Study||66
8807147|NCT01483378|9859559|FG000|NOT COMPLETED|Overall Study||0
8807148|NCT01483378|9859560|FG001|NOT COMPLETED|Overall Study||0
8807149|NCT01483560|9859568|FG000|STARTED|Overall Study||219
8807150|NCT01483560|9859569|FG001|STARTED|Overall Study||209
8807151|NCT01483560|9859568|FG000|COMPLETED|Overall Study||193
8807152|NCT01483560|9859569|FG001|COMPLETED|Overall Study||194
8807153|NCT01483560|9859568|FG000|NOT COMPLETED|Overall Study||26
8807154|NCT01483560|9859569|FG001|NOT COMPLETED|Overall Study||15
8807155|NCT01483599|9859582|FG000|STARTED|Controlled Period (CP) (up to Week 16)||42
8807156|NCT01483599|9859583|FG001|STARTED|Controlled Period (CP) (up to Week 16)||41
8807157|NCT01483599|9859584|FG002|STARTED|Controlled Period (CP) (up to Week 16)||41
8807158|NCT01483599|9859585|FG003|STARTED|Controlled Period (CP) (up to Week 16)||42
8807159|NCT01483599|9859586|FG004|STARTED|Controlled Period (CP) (up to Week 16)||42
8807160|NCT01483599|9859587|FG005|STARTED|Controlled Period (CP) (up to Week 16)||42
8807161|NCT01483599|9859588|FG006|STARTED|Controlled Period (CP) (up to Week 16)||43
8807162|NCT01483599|9859589|FG007|STARTED|Controlled Period (CP) (up to Week 16)||0
8807163|NCT01483599|9859590|FG008|STARTED|Controlled Period (CP) (up to Week 16)||0
8807164|NCT01483599|9859591|FG009|STARTED|Controlled Period (CP) (up to Week 16)||0
8807165|NCT01483599|9859592|FG010|STARTED|Controlled Period (CP) (up to Week 16)||0
8807166|NCT01483599|9859593|FG011|STARTED|Controlled Period (CP) (up to Week 16)||0
8807167|NCT01483599|9859594|FG012|STARTED|Controlled Period (CP) (up to Week 16)||0
8807168|NCT01483599|9859595|FG013|STARTED|Controlled Period (CP) (up to Week 16)||0
8807169|NCT01483599|9859582|FG000|Treated|Controlled Period (CP) (up to Week 16)||42
8807170|NCT01483599|9859583|FG001|Treated|Controlled Period (CP) (up to Week 16)||41
8807171|NCT01483599|9859584|FG002|Treated|Controlled Period (CP) (up to Week 16)||41
8807172|NCT01483599|9859585|FG003|Treated|Controlled Period (CP) (up to Week 16)||42
8807173|NCT01483599|9859586|FG004|Treated|Controlled Period (CP) (up to Week 16)||42
8807174|NCT01483599|9859587|FG005|Treated|Controlled Period (CP) (up to Week 16)||41
8807175|NCT01483599|9859588|FG006|Treated|Controlled Period (CP) (up to Week 16)||43
8807176|NCT01483599|9859589|FG007|Treated|Controlled Period (CP) (up to Week 16)||0
8807177|NCT01483599|9859590|FG008|Treated|Controlled Period (CP) (up to Week 16)||0
8807178|NCT01483599|9859591|FG009|Treated|Controlled Period (CP) (up to Week 16)||0
8807179|NCT01483599|9859592|FG010|Treated|Controlled Period (CP) (up to Week 16)||0
8807180|NCT01483599|9859593|FG011|Treated|Controlled Period (CP) (up to Week 16)||0
8807181|NCT01483599|9859594|FG012|Treated|Controlled Period (CP) (up to Week 16)||0
8807182|NCT01483599|9859595|FG013|Treated|Controlled Period (CP) (up to Week 16)||0
8807183|NCT01483599|9859582|FG000|COMPLETED|Controlled Period (CP) (up to Week 16)||39
8807184|NCT01483599|9859583|FG001|COMPLETED|Controlled Period (CP) (up to Week 16)||38
8807185|NCT01483599|9859584|FG002|COMPLETED|Controlled Period (CP) (up to Week 16)||41
8807186|NCT01483599|9859585|FG003|COMPLETED|Controlled Period (CP) (up to Week 16)||39
8807187|NCT01483599|9859586|FG004|COMPLETED|Controlled Period (CP) (up to Week 16)||40
8807188|NCT01483599|9859587|FG005|COMPLETED|Controlled Period (CP) (up to Week 16)||38
8807189|NCT01483599|9859588|FG006|COMPLETED|Controlled Period (CP) (up to Week 16)||39
8807190|NCT01483599|9859589|FG007|COMPLETED|Controlled Period (CP) (up to Week 16)||0
8807191|NCT01483599|9859590|FG008|COMPLETED|Controlled Period (CP) (up to Week 16)||0
8807192|NCT01483599|9859591|FG009|COMPLETED|Controlled Period (CP) (up to Week 16)||0
8740350|NCT01114880|9788553|FG000|STARTED|Period 1 (Week 0 to Week 12)||229
8740351|NCT01114880|9788554|FG001|STARTED|Period 1 (Week 0 to Week 12)||115
8740352|NCT01114880|9788553|FG000|COMPLETED|Period 1 (Week 0 to Week 12)||224
8740353|NCT01114880|9788554|FG001|COMPLETED|Period 1 (Week 0 to Week 12)||113
8740354|NCT01114880|9788553|FG000|NOT COMPLETED|Period 1 (Week 0 to Week 12)||5
8740355|NCT01114880|9788554|FG001|NOT COMPLETED|Period 1 (Week 0 to Week 12)||2
8740356|NCT01114880|9788553|FG000|STARTED|Period 2 (Week 12 to Week 24)||224
8740357|NCT01114880|9788554|FG001|STARTED|Period 2 (Week 12 to Week 24)||113
8740358|NCT01114880|9788553|FG000|COMPLETED|Period 2 (Week 12 to Week 24)||221
8740359|NCT01114880|9788554|FG001|COMPLETED|Period 2 (Week 12 to Week 24)||111
8740360|NCT01114880|9788553|FG000|NOT COMPLETED|Period 2 (Week 12 to Week 24)||3
8740361|NCT01114880|9788554|FG001|NOT COMPLETED|Period 2 (Week 12 to Week 24)||2
8740362|NCT01114893|9788567|FG000|STARTED|Overall Study||14
8740363|NCT01114893|9788568|FG001|STARTED|Overall Study||14
8740364|NCT01114893|9788569|FG002|STARTED|Overall Study||14
8740365|NCT01114893|9788570|FG003|STARTED|Overall Study||13
8740366|NCT01114893|9788571|FG004|STARTED|Overall Study||12
8740367|NCT01114893|9788567|FG000|COMPLETED|Overall Study||14
8740368|NCT01114893|9788568|FG001|COMPLETED|Overall Study||14
8740369|NCT01114893|9788569|FG002|COMPLETED|Overall Study||14
8740370|NCT01114893|9788570|FG003|COMPLETED|Overall Study||13
8740371|NCT01114893|9788571|FG004|COMPLETED|Overall Study||12
8740372|NCT01114893|9788567|FG000|NOT COMPLETED|Overall Study||0
8740373|NCT01114893|9788568|FG001|NOT COMPLETED|Overall Study||0
8740374|NCT01114893|9788569|FG002|NOT COMPLETED|Overall Study||0
8740375|NCT01114893|9788570|FG003|NOT COMPLETED|Overall Study||0
8740376|NCT01114893|9788571|FG004|NOT COMPLETED|Overall Study||0
8740377|NCT01114945|9788587|FG000|STARTED|Overall Study||30
8740378|NCT01114945|9788588|FG001|STARTED|Overall Study||30
8740379|NCT01114945|9788589|FG002|STARTED|Overall Study||30
8740380|NCT01114945|9788590|FG003|STARTED|Overall Study||31
8740381|NCT01114945|9788587|FG000|COMPLETED|Overall Study||30
8740382|NCT01114945|9788588|FG001|COMPLETED|Overall Study||30
8740383|NCT01114945|9788589|FG002|COMPLETED|Overall Study||30
8740384|NCT01114945|9788590|FG003|COMPLETED|Overall Study||31
8740385|NCT01114945|9788587|FG000|NOT COMPLETED|Overall Study||0
8740386|NCT01114945|9788588|FG001|NOT COMPLETED|Overall Study||0
8740387|NCT01114945|9788589|FG002|NOT COMPLETED|Overall Study||0
8740388|NCT01114945|9788590|FG003|NOT COMPLETED|Overall Study||0
8740389|NCT01114971|9788604|FG000|STARTED|Overall Study||25
8740390|NCT01114971|9788605|FG001|STARTED|Overall Study||25
8740391|NCT01114971|9788606|FG002|STARTED|Overall Study||25
8740392|NCT01114971|9788604|FG000|COMPLETED|Overall Study||25
8740393|NCT01114971|9788605|FG001|COMPLETED|Overall Study||25
8740394|NCT01114971|9788606|FG002|COMPLETED|Overall Study||25
8740395|NCT01114971|9788604|FG000|NOT COMPLETED|Overall Study||0
8740396|NCT01114971|9788605|FG001|NOT COMPLETED|Overall Study||0
8740397|NCT01114971|9788606|FG002|NOT COMPLETED|Overall Study||0
8740398|NCT01114997|9788617|FG000|STARTED|Overall Study||11
8740399|NCT01114997|9788618|FG001|STARTED|Overall Study||10
8740400|NCT01114997|9788619|FG002|STARTED|Overall Study||11
8740401|NCT01114997|9788617|FG000|COMPLETED|Overall Study||11
8740402|NCT01114997|9788618|FG001|COMPLETED|Overall Study||10
8740403|NCT01114997|9788619|FG002|COMPLETED|Overall Study||11
8740404|NCT01114997|9788617|FG000|NOT COMPLETED|Overall Study||0
8740405|NCT01114997|9788618|FG001|NOT COMPLETED|Overall Study||0
8740406|NCT01114997|9788619|FG002|NOT COMPLETED|Overall Study||0
8740407|NCT01115101|9788630|FG000|STARTED|Overall Study||113
8740408|NCT01115101|9788631|FG001|STARTED|Overall Study||126
8740409|NCT01115101|9788630|FG000|COMPLETED|Overall Study||113
8740410|NCT01115101|9788631|FG001|COMPLETED|Overall Study||126
8740411|NCT01115101|9788630|FG000|NOT COMPLETED|Overall Study||0
8740412|NCT01115101|9788631|FG001|NOT COMPLETED|Overall Study||0
8740413|NCT01115166|9788637|FG000|STARTED|Overall Study||10
8740414|NCT01115166|9788637|FG000|COMPLETED|Overall Study||10
8740415|NCT01115166|9788637|FG000|NOT COMPLETED|Overall Study||0
8740416|NCT01115231|9788643|FG000|STARTED|Overall Study||133
8740417|NCT01115231|9788644|FG001|STARTED|Overall Study||90
8740418|NCT01115231|9788643|FG000|COMPLETED|Overall Study||133
8740419|NCT01115231|9788644|FG001|COMPLETED|Overall Study||90
8740420|NCT01115231|9788643|FG000|NOT COMPLETED|Overall Study||0
8740421|NCT01115231|9788644|FG001|NOT COMPLETED|Overall Study||0
8740422|NCT01115309|9788651|FG000|STARTED|Procedure Safety (1-Month)||175
8740423|NCT01115309|9788651|FG000|COMPLETED|Procedure Safety (1-Month)||172
8740424|NCT01115309|9788651|FG000|NOT COMPLETED|Procedure Safety (1-Month)||3
8740425|NCT01115309|9788651|FG000|STARTED|Long-term Follow-up||50
8740426|NCT01115309|9788651|FG000|6-Month Follow-up|Long-term Follow-up||46
8740427|NCT01115309|9788651|FG000|12-Month Follow-up|Long-term Follow-up||44
8740428|NCT01115309|9788651|FG000|COMPLETED|Long-term Follow-up||44
8740429|NCT01115309|9788651|FG000|NOT COMPLETED|Long-term Follow-up||6
8740430|NCT01115452|9788656|FG000|STARTED|Overall Study||32
8740431|NCT01115452|9788656|FG000|COMPLETED|Overall Study||32
8740432|NCT01115452|9788656|FG000|NOT COMPLETED|Overall Study||0
8740433|NCT01115491|9788664|FG000|STARTED|Overall Study||32
8740434|NCT01115491|9788664|FG000|COMPLETED|Overall Study||2
8740435|NCT01115491|9788664|FG000|NOT COMPLETED|Overall Study||30
8740436|NCT01115517|9788670|FG000|STARTED|Overall Study||18
8740437|NCT01115517|9788671|FG001|STARTED|Overall Study||21
8740438|NCT01115517|9788670|FG000|COMPLETED|Overall Study||14
8740439|NCT01115517|9788671|FG001|COMPLETED|Overall Study||16
8740440|NCT01115517|9788670|FG000|NOT COMPLETED|Overall Study||4
8740441|NCT01115517|9788671|FG001|NOT COMPLETED|Overall Study||5
8740442|NCT01115556|9788679|FG000|STARTED|Overall Study||7
8740443|NCT01115556|9788680|FG001|STARTED|Overall Study||2
8740444|NCT01115556|9788679|FG000|COMPLETED|Overall Study||7
8740445|NCT01115556|9788680|FG001|COMPLETED|Overall Study||2
8740446|NCT01115556|9788679|FG000|NOT COMPLETED|Overall Study||0
8740447|NCT01115556|9788680|FG001|NOT COMPLETED|Overall Study||0
8740448|NCT01115569|9788688|FG000|STARTED|Conversion/Titration Phase||638
8740449|NCT01115569|9788689|FG001|STARTED|Conversion/Titration Phase||0
8740450|NCT01115569|9788688|FG000|COMPLETED|Conversion/Titration Phase||424
8740451|NCT01115569|9788689|FG001|COMPLETED|Conversion/Titration Phase||0
8740452|NCT01115569|9788688|FG000|NOT COMPLETED|Conversion/Titration Phase||214
8740453|NCT01115569|9788689|FG001|NOT COMPLETED|Conversion/Titration Phase||0
8740454|NCT01115569|9788688|FG000|STARTED|Maintenance Phase||0
8740455|NCT01115569|9788689|FG001|STARTED|Maintenance Phase||424
8740456|NCT01115569|9788688|FG000|COMPLETED|Maintenance Phase||0
8740457|NCT01115569|9788689|FG001|COMPLETED|Maintenance Phase||285
8740458|NCT01115569|9788688|FG000|NOT COMPLETED|Maintenance Phase||0
8740459|NCT01115569|9788689|FG001|NOT COMPLETED|Maintenance Phase||139
8740460|NCT01115582|9788694|FG000|STARTED|Overall Study||16
8740461|NCT01115582|9788694|FG000|COMPLETED|Overall Study||16
8740462|NCT01115582|9788694|FG000|NOT COMPLETED|Overall Study||0
8740463|NCT01115660|9788700|FG000|STARTED|Overall Study||20
8740464|NCT01115660|9788701|FG001|STARTED|Overall Study||10
8740465|NCT01115660|9788700|FG000|COMPLETED|Overall Study||19
8740466|NCT01115660|9788701|FG001|COMPLETED|Overall Study||10
8740467|NCT01115660|9788700|FG000|NOT COMPLETED|Overall Study||1
8740468|NCT01115660|9788701|FG001|NOT COMPLETED|Overall Study||0
8740469|NCT01115673|9788710|FG000|STARTED|Overall Study||239
8740470|NCT01115673|9788711|FG001|STARTED|Overall Study||241
8740471|NCT01115673|9788712|FG002|STARTED|Overall Study||60
8740472|NCT01115673|9788710|FG000|COMPLETED|Overall Study||239
8740473|NCT01115673|9788711|FG001|COMPLETED|Overall Study||241
8740474|NCT01115673|9788712|FG002|COMPLETED|Overall Study||60
8740475|NCT01115673|9788710|FG000|NOT COMPLETED|Overall Study||0
8740476|NCT01115673|9788711|FG001|NOT COMPLETED|Overall Study||0
8740477|NCT01115673|9788712|FG002|NOT COMPLETED|Overall Study||0
8740478|NCT01115738|9788723|FG000|STARTED|Overall Study||110
8740479|NCT01115738|9788724|FG001|STARTED|Overall Study||83
8740480|NCT01115738|9788725|FG002|STARTED|Overall Study||89
8740481|NCT01115738|9788723|FG000|Received Any Treatment|Overall Study||109
8740482|NCT01115738|9788724|FG001|Received Any Treatment|Overall Study||79
8740483|NCT01115738|9788725|FG002|Received Any Treatment|Overall Study||88
8740484|NCT01115738|9788723|FG000|Pharmacodynamic (PD) Population|Overall Study|Received prasugrel LD and had at least one evaluable PD measurement after prasugrel LD.|52
8740485|NCT01115738|9788724|FG001|Pharmacodynamic (PD) Population|Overall Study|Received prasugrel LD and had at least one evaluable PD measurement after prasugrel LD.|47
8740486|NCT01115738|9788725|FG002|Pharmacodynamic (PD) Population|Overall Study|Received prasugrel LD and had at least one evaluable PD measurement after prasugrel LD.|50
8740487|NCT01115738|9788723|FG000|COMPLETED|Overall Study||85
8740488|NCT01115738|9788724|FG001|COMPLETED|Overall Study||62
8740489|NCT01115738|9788725|FG002|COMPLETED|Overall Study||62
8740490|NCT01115738|9788723|FG000|NOT COMPLETED|Overall Study||25
8740491|NCT01115738|9788724|FG001|NOT COMPLETED|Overall Study||21
8740492|NCT01115738|9788725|FG002|NOT COMPLETED|Overall Study||27
8740493|NCT01115803|9788748|FG000|STARTED|Overall Study||4
8740494|NCT01115803|9788749|FG001|STARTED|Overall Study||5
8740495|NCT01115803|9788750|FG002|STARTED|Overall Study||3
8740496|NCT01115803|9788751|FG003|STARTED|Overall Study||5
8740497|NCT01115803|9788752|FG004|STARTED|Overall Study||3
8740498|NCT01115803|9788753|FG005|STARTED|Overall Study||3
8740499|NCT01115803|9788754|FG006|STARTED|Overall Study||6
8740500|NCT01115803|9788748|FG000|Received at Least 1 Dose of Study Drug|Overall Study||4
8740501|NCT01115803|9788749|FG001|Received at Least 1 Dose of Study Drug|Overall Study||5
8740502|NCT01115803|9788750|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
8740503|NCT01115803|9788751|FG003|Received at Least 1 Dose of Study Drug|Overall Study||5
8740504|NCT01115803|9788752|FG004|Received at Least 1 Dose of Study Drug|Overall Study||3
8740505|NCT01115803|9788753|FG005|Received at Least 1 Dose of Study Drug|Overall Study||3
8740506|NCT01115803|9788754|FG006|Received at Least 1 Dose of Study Drug|Overall Study||6
8740507|NCT01115803|9788748|FG000|COMPLETED|Overall Study||4
8740508|NCT01115803|9788749|FG001|COMPLETED|Overall Study||5
8740509|NCT01115803|9788750|FG002|COMPLETED|Overall Study||2
8740510|NCT01115803|9788751|FG003|COMPLETED|Overall Study||5
8740511|NCT01115803|9788752|FG004|COMPLETED|Overall Study||3
8740512|NCT01115803|9788753|FG005|COMPLETED|Overall Study||3
8740513|NCT01115803|9788754|FG006|COMPLETED|Overall Study||4
8740514|NCT01115803|9788748|FG000|NOT COMPLETED|Overall Study||0
8740515|NCT01115803|9788749|FG001|NOT COMPLETED|Overall Study||0
8740516|NCT01115803|9788750|FG002|NOT COMPLETED|Overall Study||1
8740517|NCT01115803|9788751|FG003|NOT COMPLETED|Overall Study||0
8740518|NCT01115803|9788752|FG004|NOT COMPLETED|Overall Study||0
8740519|NCT01115803|9788753|FG005|NOT COMPLETED|Overall Study||0
8740520|NCT01115803|9788754|FG006|NOT COMPLETED|Overall Study||2
8740521|NCT01115855|9788777|FG000|STARTED|Overall Study||111
8740522|NCT01115855|9788778|FG001|STARTED|Overall Study||110
8740523|NCT01115855|9788777|FG000|COMPLETED|Overall Study||75
8740524|NCT01115855|9788778|FG001|COMPLETED|Overall Study||74
8740525|NCT01115855|9788777|FG000|NOT COMPLETED|Overall Study||36
8740526|NCT01115855|9788778|FG001|NOT COMPLETED|Overall Study||36
8740527|NCT01115933|9788784|FG000|STARTED|Overall Study||65
8740528|NCT01115933|9788784|FG000|COMPLETED|Overall Study||64
8740529|NCT01115933|9788784|FG000|NOT COMPLETED|Overall Study||1
8740530|NCT01115998|9788843|FG000|STARTED|Overall Study||17
8740531|NCT01115998|9788844|FG001|STARTED|Overall Study||17
8740532|NCT01115998|9788843|FG000|COMPLETED|Overall Study||11
8740533|NCT01115998|9788844|FG001|COMPLETED|Overall Study||11
8740534|NCT01115998|9788843|FG000|NOT COMPLETED|Overall Study||6
8740535|NCT01115998|9788844|FG001|NOT COMPLETED|Overall Study||6
8740536|NCT01116024|9788850|FG000|STARTED|Overall Study|148 subjects left operating room with the device implanted and were included in the analysis.|148
8740537|NCT01116024|9788850|FG000|COMPLETED|Overall Study|Patient Enrollment stop date|96
8740538|NCT01116024|9788850|FG000|NOT COMPLETED|Overall Study||52
8740539|NCT01116037|9788876|FG000|STARTED|Overall Study||26
8740540|NCT01116037|9788876|FG000|COMPLETED|Overall Study||1
8740541|NCT01116037|9788876|FG000|NOT COMPLETED|Overall Study||25
8740542|NCT01116102|9788888|FG000|STARTED|Overall Study||2
8740543|NCT01116102|9788889|FG001|STARTED|Overall Study||3
8740544|NCT01116102|9788890|FG002|STARTED|Overall Study||3
8740545|NCT01116102|9788891|FG003|STARTED|Overall Study||3
8740546|NCT01116102|9788892|FG004|STARTED|Overall Study||2
8740547|NCT01116102|9788893|FG005|STARTED|Overall Study||2
8740548|NCT01116102|9788894|FG006|STARTED|Overall Study||2
8740549|NCT01116102|9788895|FG007|STARTED|Overall Study||3
8740550|NCT01116102|9788888|FG000|COMPLETED|Overall Study||2
8740551|NCT01116102|9788889|FG001|COMPLETED|Overall Study||3
8740552|NCT01116102|9788890|FG002|COMPLETED|Overall Study||3
8740553|NCT01116102|9788891|FG003|COMPLETED|Overall Study||3
8740554|NCT01116102|9788892|FG004|COMPLETED|Overall Study||2
8740555|NCT01116102|9788893|FG005|COMPLETED|Overall Study||2
8740556|NCT01116102|9788894|FG006|COMPLETED|Overall Study||2
8740557|NCT01116102|9788895|FG007|COMPLETED|Overall Study||3
8740558|NCT01116102|9788888|FG000|NOT COMPLETED|Overall Study||0
8740559|NCT01116102|9788889|FG001|NOT COMPLETED|Overall Study||0
8740560|NCT01116102|9788890|FG002|NOT COMPLETED|Overall Study||0
8740561|NCT01116102|9788891|FG003|NOT COMPLETED|Overall Study||0
8740562|NCT01116102|9788892|FG004|NOT COMPLETED|Overall Study||0
8740563|NCT01116102|9788893|FG005|NOT COMPLETED|Overall Study||0
8740564|NCT01116102|9788894|FG006|NOT COMPLETED|Overall Study||0
8740565|NCT01116102|9788895|FG007|NOT COMPLETED|Overall Study||0
8740566|NCT01116401|9788913|FG000|STARTED|Overall Study||29
8740567|NCT01116401|9788913|FG000|COMPLETED|Overall Study||29
8740568|NCT01116401|9788913|FG000|NOT COMPLETED|Overall Study||0
8740569|NCT01116427|9788919|FG000|STARTED|Core Phase||44
8740570|NCT01116427|9788920|FG001|STARTED|Core Phase||21
8740571|NCT01116427|9788919|FG000|COMPLETED|Core Phase||39
8740572|NCT01116427|9788920|FG001|COMPLETED|Core Phase||20
8740573|NCT01116427|9788919|FG000|NOT COMPLETED|Core Phase||5
8740574|NCT01116427|9788920|FG001|NOT COMPLETED|Core Phase||1
8740575|NCT01116427|9788919|FG000|STARTED|Extension Phase|One participant that completed core phase did not meet eligibility for Extension Phase|38
8740576|NCT01116427|9788920|FG001|STARTED|Extension Phase||20
8740577|NCT01116427|9788919|FG000|COMPLETED|Extension Phase||29
8740578|NCT01116427|9788920|FG001|COMPLETED|Extension Phase||18
8740579|NCT01116427|9788919|FG000|NOT COMPLETED|Extension Phase||9
8740580|NCT01116427|9788920|FG001|NOT COMPLETED|Extension Phase||2
8740581|NCT01116440|9788932|FG000|STARTED|Treatment||11
8740582|NCT01116440|9788933|FG001|STARTED|Treatment||16
8740583|NCT01116440|9788932|FG000|COMPLETED|Treatment||8
8740584|NCT01116440|9788933|FG001|COMPLETED|Treatment||9
8740585|NCT01116440|9788932|FG000|NOT COMPLETED|Treatment||3
8740586|NCT01116440|9788933|FG001|NOT COMPLETED|Treatment||7
8740587|NCT01116440|9788932|FG000|STARTED|Withdrawal||8
8740588|NCT01116440|9788933|FG001|STARTED|Withdrawal||9
8740589|NCT01116440|9788932|FG000|COMPLETED|Withdrawal||8
8740590|NCT01116440|9788933|FG001|COMPLETED|Withdrawal||7
8740591|NCT01116440|9788932|FG000|NOT COMPLETED|Withdrawal||0
8740592|NCT01116440|9788933|FG001|NOT COMPLETED|Withdrawal||2
8740593|NCT01116440|9788932|FG000|STARTED|Follow-up||8
8740594|NCT01116440|9788933|FG001|STARTED|Follow-up||7
8740595|NCT01116440|9788932|FG000|COMPLETED|Follow-up||8
8740596|NCT01116440|9788933|FG001|COMPLETED|Follow-up||5
8740597|NCT01116440|9788932|FG000|NOT COMPLETED|Follow-up||0
8740598|NCT01116440|9788933|FG001|NOT COMPLETED|Follow-up||2
8740599|NCT01116466|9788941|FG000|STARTED|Overall Study||5
8740600|NCT01116466|9788941|FG000|COMPLETED|Overall Study||5
8740601|NCT01116466|9788941|FG000|NOT COMPLETED|Overall Study||0
8740602|NCT01116544|9788948|FG000|STARTED|Overall Study||23
8740603|NCT01116544|9788949|FG001|STARTED|Overall Study||23
8740604|NCT01116544|9788948|FG000|COMPLETED|Overall Study||21
8740605|NCT01116544|9788949|FG001|COMPLETED|Overall Study||22
8740606|NCT01116544|9788948|FG000|NOT COMPLETED|Overall Study||2
8740607|NCT01116544|9788949|FG001|NOT COMPLETED|Overall Study||1
8740608|NCT01116661|9788955|FG000|STARTED|Overall Study||199
8740609|NCT01116661|9788955|FG000|COMPLETED|Overall Study||197
8740610|NCT01116661|9788955|FG000|NOT COMPLETED|Overall Study||2
8740611|NCT01116687|9788959|FG000|STARTED|Overall Study||37
8740612|NCT01116687|9788959|FG000|COMPLETED|Overall Study||33
8740613|NCT01116687|9788959|FG000|NOT COMPLETED|Overall Study||4
8740614|NCT01116739|9788965|FG000|STARTED|Overall Study||1056
8740615|NCT01116739|9788966|FG001|STARTED|Overall Study||1004
8740616|NCT01116739|9788965|FG000|COMPLETED|Overall Study||926
8740617|NCT01116739|9788966|FG001|COMPLETED|Overall Study||868
8740618|NCT01116739|9788965|FG000|NOT COMPLETED|Overall Study||130
8740619|NCT01116739|9788966|FG001|NOT COMPLETED|Overall Study||136
8740620|NCT01116882|9788974|FG000|STARTED|30-day||2774
8740621|NCT01116882|9788975|FG001|STARTED|30-day||917
8740622|NCT01116882|9788974|FG000|COMPLETED|30-day||2706
8740623|NCT01116882|9788975|FG001|COMPLETED|30-day||886
8740624|NCT01116882|9788974|FG000|NOT COMPLETED|30-day||68
8740625|NCT01116882|9788975|FG001|NOT COMPLETED|30-day||31
8740626|NCT01116882|9788974|FG000|STARTED|12-month||2706
8740627|NCT01116882|9788975|FG001|STARTED|12-month||886
8740628|NCT01116882|9788974|FG000|COMPLETED|12-month||2439
8740629|NCT01116882|9788975|FG001|COMPLETED|12-month||787
8740630|NCT01116882|9788974|FG000|NOT COMPLETED|12-month||267
8740631|NCT01116882|9788975|FG001|NOT COMPLETED|12-month||99
8740632|NCT01116895|9788988|FG000|STARTED|Overall Study||16
8740633|NCT01116895|9788989|FG001|STARTED|Overall Study||15
8740634|NCT01116895|9788990|FG002|STARTED|Overall Study||18
8740635|NCT01116895|9788991|FG003|STARTED|Overall Study||14
8740636|NCT01116895|9788988|FG000|COMPLETED|Overall Study||12
8740637|NCT01116895|9788989|FG001|COMPLETED|Overall Study||8
8740638|NCT01116895|9788990|FG002|COMPLETED|Overall Study||14
8740639|NCT01116895|9788991|FG003|COMPLETED|Overall Study||11
8740640|NCT01116895|9788988|FG000|NOT COMPLETED|Overall Study||4
8740641|NCT01116895|9788989|FG001|NOT COMPLETED|Overall Study||7
8740642|NCT01116895|9788990|FG002|NOT COMPLETED|Overall Study||4
8740643|NCT01116895|9788991|FG003|NOT COMPLETED|Overall Study||3
8740644|NCT01116921|9789003|FG000|STARTED|Overall Study||53
8740645|NCT01116921|9789004|FG001|STARTED|Overall Study||50
8740646|NCT01116921|9789003|FG000|COMPLETED|Overall Study||53
8740647|NCT01116921|9789004|FG001|COMPLETED|Overall Study||50
8740648|NCT01116921|9789003|FG000|NOT COMPLETED|Overall Study||0
8740649|NCT01116921|9789004|FG001|NOT COMPLETED|Overall Study||0
8740650|NCT01116934|9789012|FG000|STARTED|Overall Study||8
8740651|NCT01116934|9789013|FG001|STARTED|Overall Study||9
8740652|NCT01116934|9789012|FG000|COMPLETED|Overall Study||8
8740653|NCT01116934|9789013|FG001|COMPLETED|Overall Study||9
8740654|NCT01116934|9789012|FG000|NOT COMPLETED|Overall Study||0
8740655|NCT01116934|9789013|FG001|NOT COMPLETED|Overall Study||0
8740656|NCT01116986|9789051|FG000|STARTED|Overall Study||24
8740657|NCT01116986|9789052|FG001|STARTED|Overall Study||19
8740658|NCT01116986|9789053|FG002|STARTED|Overall Study||18
8740659|NCT01116986|9789054|FG003|STARTED|Overall Study||22
8740660|NCT01116986|9789055|FG004|STARTED|Overall Study||24
8740661|NCT01116986|9789056|FG005|STARTED|Overall Study||22
8740662|NCT01116986|9789057|FG006|STARTED|Overall Study||22
8740663|NCT01116986|9789058|FG007|STARTED|Overall Study||22
8740664|NCT01116986|9789059|FG008|STARTED|Overall Study||20
8740665|NCT01116986|9789060|FG009|STARTED|Overall Study||23
8740666|NCT01116986|9789061|FG010|STARTED|Overall Study||19
8740667|NCT01116986|9789062|FG011|STARTED|Overall Study||20
8740668|NCT01116986|9789063|FG012|STARTED|Overall Study||17
8740669|NCT01116986|9789064|FG013|STARTED|Overall Study||19
8740670|NCT01116986|9789065|FG014|STARTED|Overall Study||17
8740671|NCT01116986|9789066|FG015|STARTED|Overall Study||21
8740672|NCT01116986|9789067|FG016|STARTED|Overall Study||16
8740673|NCT01116986|9789068|FG017|STARTED|Overall Study||24
8740674|NCT01116986|9789069|FG018|STARTED|Overall Study||23
8740675|NCT01116986|9789070|FG019|STARTED|Overall Study||15
8740676|NCT01116986|9789071|FG020|STARTED|Overall Study||24
8740677|NCT01116986|9789072|FG021|STARTED|Overall Study||20
8740678|NCT01116986|9789073|FG022|STARTED|Overall Study||23
8740679|NCT01116986|9789074|FG023|STARTED|Overall Study||21
8740680|NCT01116986|9789075|FG024|STARTED|Overall Study||18
8740681|NCT01116986|9789076|FG025|STARTED|Overall Study||19
8740682|NCT01116986|9789077|FG026|STARTED|Overall Study||18
8740683|NCT01116986|9789078|FG027|STARTED|Overall Study||19
8740684|NCT01116986|9789079|FG028|STARTED|Overall Study||17
8740685|NCT01116986|9789080|FG029|STARTED|Overall Study||17
8740686|NCT01116986|9789081|FG030|STARTED|Overall Study||17
8740687|NCT01116986|9789082|FG031|STARTED|Overall Study||17
8740688|NCT01116986|9789051|FG000|COMPLETED|Overall Study||22
8740689|NCT01116986|9789052|FG001|COMPLETED|Overall Study||16
8740690|NCT01116986|9789053|FG002|COMPLETED|Overall Study||16
8740691|NCT01116986|9789054|FG003|COMPLETED|Overall Study||20
8740692|NCT01116986|9789055|FG004|COMPLETED|Overall Study||20
8740693|NCT01116986|9789056|FG005|COMPLETED|Overall Study||20
8740694|NCT01116986|9789057|FG006|COMPLETED|Overall Study||20
8740695|NCT01116986|9789058|FG007|COMPLETED|Overall Study||20
8740696|NCT01116986|9789059|FG008|COMPLETED|Overall Study||19
8740697|NCT01116986|9789060|FG009|COMPLETED|Overall Study||19
8740698|NCT01116986|9789061|FG010|COMPLETED|Overall Study||18
8740699|NCT01116986|9789062|FG011|COMPLETED|Overall Study||20
8740700|NCT01116986|9789063|FG012|COMPLETED|Overall Study||16
8740701|NCT01116986|9789064|FG013|COMPLETED|Overall Study||16
8740702|NCT01116986|9789065|FG014|COMPLETED|Overall Study||17
8740703|NCT01116986|9789066|FG015|COMPLETED|Overall Study||15
8740704|NCT01116986|9789067|FG016|COMPLETED|Overall Study||13
8740705|NCT01116986|9789068|FG017|COMPLETED|Overall Study||19
8740706|NCT01116986|9789069|FG018|COMPLETED|Overall Study||20
8740707|NCT01116986|9789070|FG019|COMPLETED|Overall Study||13
8740708|NCT01116986|9789071|FG020|COMPLETED|Overall Study||22
8740709|NCT01116986|9789072|FG021|COMPLETED|Overall Study||18
8740710|NCT01116986|9789073|FG022|COMPLETED|Overall Study||19
8740711|NCT01116986|9789074|FG023|COMPLETED|Overall Study||19
8740712|NCT01116986|9789075|FG024|COMPLETED|Overall Study||15
8740713|NCT01116986|9789076|FG025|COMPLETED|Overall Study||19
8740714|NCT01116986|9789077|FG026|COMPLETED|Overall Study||14
8740715|NCT01116986|9789078|FG027|COMPLETED|Overall Study||18
8740716|NCT01116986|9789079|FG028|COMPLETED|Overall Study||17
8740717|NCT01116986|9789080|FG029|COMPLETED|Overall Study||17
8740718|NCT01116986|9789081|FG030|COMPLETED|Overall Study||16
8740719|NCT01116986|9789082|FG031|COMPLETED|Overall Study||14
8740720|NCT01116986|9789051|FG000|NOT COMPLETED|Overall Study||2
8740721|NCT01116986|9789052|FG001|NOT COMPLETED|Overall Study||3
8740722|NCT01116986|9789053|FG002|NOT COMPLETED|Overall Study||2
8740723|NCT01116986|9789054|FG003|NOT COMPLETED|Overall Study||2
8740724|NCT01116986|9789055|FG004|NOT COMPLETED|Overall Study||4
8740725|NCT01116986|9789056|FG005|NOT COMPLETED|Overall Study||2
8740726|NCT01116986|9789057|FG006|NOT COMPLETED|Overall Study||2
8740727|NCT01116986|9789058|FG007|NOT COMPLETED|Overall Study||2
8740728|NCT01116986|9789059|FG008|NOT COMPLETED|Overall Study||1
8740729|NCT01116986|9789060|FG009|NOT COMPLETED|Overall Study||4
8740730|NCT01116986|9789061|FG010|NOT COMPLETED|Overall Study||1
8740731|NCT01116986|9789062|FG011|NOT COMPLETED|Overall Study||0
8740732|NCT01116986|9789063|FG012|NOT COMPLETED|Overall Study||1
8740733|NCT01116986|9789064|FG013|NOT COMPLETED|Overall Study||3
8740734|NCT01116986|9789065|FG014|NOT COMPLETED|Overall Study||0
8740735|NCT01116986|9789066|FG015|NOT COMPLETED|Overall Study||6
8740736|NCT01116986|9789067|FG016|NOT COMPLETED|Overall Study||3
8740737|NCT01116986|9789068|FG017|NOT COMPLETED|Overall Study||5
8740738|NCT01116986|9789069|FG018|NOT COMPLETED|Overall Study||3
8740739|NCT01116986|9789070|FG019|NOT COMPLETED|Overall Study||2
8740740|NCT01116986|9789071|FG020|NOT COMPLETED|Overall Study||2
8740741|NCT01116986|9789072|FG021|NOT COMPLETED|Overall Study||2
8740742|NCT01116986|9789073|FG022|NOT COMPLETED|Overall Study||4
8740743|NCT01116986|9789074|FG023|NOT COMPLETED|Overall Study||2
8740744|NCT01116986|9789075|FG024|NOT COMPLETED|Overall Study||3
8740745|NCT01116986|9789076|FG025|NOT COMPLETED|Overall Study||0
8740746|NCT01116986|9789077|FG026|NOT COMPLETED|Overall Study||4
8740747|NCT01116986|9789078|FG027|NOT COMPLETED|Overall Study||1
8740748|NCT01116986|9789079|FG028|NOT COMPLETED|Overall Study||0
8912523|NCT02153710|9971644|FG000|COMPLETED|Overall Study||28
8912524|NCT02153710|9971645|FG001|COMPLETED|Overall Study||30
8912525|NCT02153710|9971644|FG000|NOT COMPLETED|Overall Study||0
8912526|NCT02153710|9971645|FG001|NOT COMPLETED|Overall Study||0
8912527|NCT02153723|9971651|FG000|STARTED|Overall Study||10
8912528|NCT02153723|9971651|FG000|COMPLETED|Overall Study||10
8912529|NCT02153723|9971651|FG000|NOT COMPLETED|Overall Study||0
8912530|NCT02153736|9971657|FG000|STARTED|Overall Study||7
8912531|NCT02153736|9971658|FG001|STARTED|Overall Study||7
8912532|NCT02153736|9971657|FG000|COMPLETED|Overall Study||5
8912533|NCT02153736|9971658|FG001|COMPLETED|Overall Study||5
8912534|NCT02153736|9971657|FG000|NOT COMPLETED|Overall Study||2
8912535|NCT02153736|9971658|FG001|NOT COMPLETED|Overall Study||2
8912536|NCT02153788|9971666|FG000|STARTED|Overall Study||25
8912537|NCT02153788|9971667|FG001|STARTED|Overall Study||19
8912538|NCT02153788|9971666|FG000|COMPLETED|Overall Study||23
8912539|NCT02153788|9971667|FG001|COMPLETED|Overall Study||18
8912540|NCT02153788|9971666|FG000|NOT COMPLETED|Overall Study||2
8912541|NCT02153788|9971667|FG001|NOT COMPLETED|Overall Study||1
8912542|NCT02153827|9971675|FG000|STARTED|Overall Study||25
8912543|NCT02153827|9971676|FG001|STARTED|Overall Study||23
8912544|NCT02153827|9971675|FG000|COMPLETED|Overall Study||22
8912545|NCT02153827|9971676|FG001|COMPLETED|Overall Study||14
8912546|NCT02153827|9971675|FG000|NOT COMPLETED|Overall Study||3
8912547|NCT02153827|9971676|FG001|NOT COMPLETED|Overall Study||9
8912548|NCT02153905|9971684|FG000|STARTED|Overall Study||1
8912549|NCT02153905|9971685|FG001|STARTED|Overall Study||2
8912550|NCT02153905|9971684|FG000|COMPLETED|Overall Study||0
8912551|NCT02153905|9971685|FG001|COMPLETED|Overall Study||2
8912552|NCT02153905|9971684|FG000|NOT COMPLETED|Overall Study||1
8912553|NCT02153905|9971685|FG001|NOT COMPLETED|Overall Study||0
8912554|NCT02153918|9971691|FG000|STARTED|Overall Study||27
8912555|NCT02153918|9971691|FG000|COMPLETED|Overall Study||26
8912556|NCT02153918|9971691|FG000|NOT COMPLETED|Overall Study||1
8912557|NCT02153983|9971701|FG000|STARTED|Overall Study||19
8912558|NCT02153983|9971702|FG001|STARTED|Overall Study||21
8912559|NCT02153983|9971703|FG002|STARTED|Overall Study||4
8912560|NCT02153983|9971704|FG003|STARTED|Overall Study||13
9022578|NCT03129100|10085463|FG009|STARTED|Period2 Extension Period (Group A and B)||0
9022579|NCT03129100|10085464|FG010|STARTED|Period2 Extension Period (Group A and B)||0
8740749|NCT01116986|9789080|FG029|NOT COMPLETED|Overall Study||0
8740750|NCT01116986|9789081|FG030|NOT COMPLETED|Overall Study||1
8912561|NCT02153983|9971705|FG004|STARTED|Overall Study||19
8912562|NCT02153983|9971706|FG005|STARTED|Overall Study||1
8912563|NCT02153983|9971701|FG000|COMPLETED|Overall Study||19
8740751|NCT01116986|9789082|FG031|NOT COMPLETED|Overall Study||3
8740752|NCT01117012|9789104|FG000|STARTED|Overall Study||89
8740753|NCT01117012|9789105|FG001|STARTED|Overall Study||103
8740754|NCT01117012|9789104|FG000|COMPLETED|Overall Study||81
8740755|NCT01117012|9789105|FG001|COMPLETED|Overall Study||98
8740756|NCT01117012|9789104|FG000|NOT COMPLETED|Overall Study||8
8912564|NCT02153983|9971702|FG001|COMPLETED|Overall Study||18
8912565|NCT02153983|9971703|FG002|COMPLETED|Overall Study||2
8912566|NCT02153983|9971704|FG003|COMPLETED|Overall Study||13
8912567|NCT02153983|9971705|FG004|COMPLETED|Overall Study||19
8912568|NCT02153983|9971706|FG005|COMPLETED|Overall Study||1
8912569|NCT02153983|9971701|FG000|NOT COMPLETED|Overall Study||0
8912570|NCT02153983|9971702|FG001|NOT COMPLETED|Overall Study||3
8740757|NCT01117012|9789105|FG001|NOT COMPLETED|Overall Study||5
8740758|NCT01117051|9789113|FG000|STARTED|Overall Study||86
8740759|NCT01117051|9789114|FG001|STARTED|Overall Study||88
8740760|NCT01117051|9789113|FG000|COMPLETED|Overall Study||73
8740761|NCT01117051|9789114|FG001|COMPLETED|Overall Study||77
8740762|NCT01117051|9789113|FG000|NOT COMPLETED|Overall Study||13
8740763|NCT01117051|9789114|FG001|NOT COMPLETED|Overall Study||11
8740764|NCT01117090|9789121|FG000|STARTED|Overall Study||47
8740765|NCT01117090|9789121|FG000|COMPLETED|Overall Study||47
8740766|NCT01117090|9789121|FG000|NOT COMPLETED|Overall Study||0
8740767|NCT01117181|9789134|FG000|STARTED|Overall Study||29
8740768|NCT01117181|9789135|FG001|STARTED|Overall Study||31
8740769|NCT01117181|9789134|FG000|COMPLETED|Overall Study||28
8740770|NCT01117181|9789135|FG001|COMPLETED|Overall Study||29
8740771|NCT01117181|9789134|FG000|NOT COMPLETED|Overall Study||1
8740772|NCT01117181|9789135|FG001|NOT COMPLETED|Overall Study||2
8740773|NCT01117311|9789143|FG000|STARTED|Lead-in Mixed Meal 1||3
8740774|NCT01117311|9789144|FG001|STARTED|Lead-in Mixed Meal 1||4
8740775|NCT01117311|9789143|FG000|COMPLETED|Lead-in Mixed Meal 1||3
8740776|NCT01117311|9789144|FG001|COMPLETED|Lead-in Mixed Meal 1||4
8740777|NCT01117311|9789143|FG000|NOT COMPLETED|Lead-in Mixed Meal 1||0
8740778|NCT01117311|9789144|FG001|NOT COMPLETED|Lead-in Mixed Meal 1||0
8740779|NCT01117311|9789143|FG000|STARTED|First Intervention - Mixed Meal 2||3
8740780|NCT01117311|9789144|FG001|STARTED|First Intervention - Mixed Meal 2||4
8740781|NCT01117311|9789143|FG000|COMPLETED|First Intervention - Mixed Meal 2||3
8740782|NCT01117311|9789144|FG001|COMPLETED|First Intervention - Mixed Meal 2||4
8740783|NCT01117311|9789143|FG000|NOT COMPLETED|First Intervention - Mixed Meal 2||0
8740784|NCT01117311|9789144|FG001|NOT COMPLETED|First Intervention - Mixed Meal 2||0
8740785|NCT01117311|9789143|FG000|STARTED|Second Intervention - Mixed Meal 3||3
8740786|NCT01117311|9789144|FG001|STARTED|Second Intervention - Mixed Meal 3||4
8740787|NCT01117311|9789143|FG000|COMPLETED|Second Intervention - Mixed Meal 3||3
8740788|NCT01117311|9789144|FG001|COMPLETED|Second Intervention - Mixed Meal 3||4
8740789|NCT01117311|9789143|FG000|NOT COMPLETED|Second Intervention - Mixed Meal 3||0
8740790|NCT01117311|9789144|FG001|NOT COMPLETED|Second Intervention - Mixed Meal 3||0
8740791|NCT01117337|9789152|FG000|STARTED|Overall Study|52 pateints on inguinal hernia were randomized to mesh fixation group|52
8740792|NCT01117337|9789153|FG001|STARTED|Overall Study||52
8740793|NCT01117337|9789152|FG000|Underwent Surgery|Overall Study|52 patients underwent surgery|52
8740794|NCT01117337|9789153|FG001|Underwent Surgery|Overall Study||52
8740795|NCT01117337|9789152|FG000|COMPLETED|Overall Study|48 completed one year follow-up. 4 lost to follow-up.|48
8740796|NCT01117337|9789153|FG001|COMPLETED|Overall Study||52
8740797|NCT01117337|9789152|FG000|NOT COMPLETED|Overall Study||4
8740798|NCT01117337|9789153|FG001|NOT COMPLETED|Overall Study||0
8740799|NCT01117350|9789161|FG000|STARTED|Comparative Period|STARTED: randomized|489
8740800|NCT01117350|9789162|FG001|STARTED|Comparative Period||489
8740801|NCT01117350|9789161|FG000|TREATED = Safety Population|Comparative Period|Safety population: all randomized and treated patients (received at least one dose)|484
8740802|NCT01117350|9789162|FG001|TREATED = Safety Population|Comparative Period||481
8740803|NCT01117350|9789161|FG000|mITT Population|Comparative Period|modified Intent-To-Treat population: treated patients with at least one efficacy post-baseline value|474
8740804|NCT01117350|9789162|FG001|mITT Population|Comparative Period||470
8740805|NCT01117350|9789161|FG000|COMPLETED|Comparative Period||447
8740806|NCT01117350|9789162|FG001|COMPLETED|Comparative Period||414
8740807|NCT01117350|9789161|FG000|NOT COMPLETED|Comparative Period||42
8740808|NCT01117350|9789162|FG001|NOT COMPLETED|Comparative Period||75
8740809|NCT01117350|9789161|FG000|STARTED|Extension Period||0
8740810|NCT01117350|9789162|FG001|STARTED|Extension Period|STARTED: patients having completed the comparative period and eligible for the extension period|210
8740811|NCT01117350|9789161|FG000|TREATED = Safety Population (Extension)|Extension Period||0
8740812|NCT01117350|9789162|FG001|TREATED = Safety Population (Extension)|Extension Period|Safety population (extension): treated with insulin glargine during the extension period|160
8740813|NCT01117350|9789161|FG000|mITT Population (Extension)|Extension Period||0
8740814|NCT01117350|9789162|FG001|mITT Population (Extension)|Extension Period|mITT (extension): treated patients with at least 1 efficacy value both at entry and during extension|154
8740815|NCT01117350|9789161|FG000|COMPLETED|Extension Period||0
8912571|NCT02153983|9971703|FG002|NOT COMPLETED|Overall Study||2
8912572|NCT02153983|9971704|FG003|NOT COMPLETED|Overall Study||0
8912573|NCT02153983|9971705|FG004|NOT COMPLETED|Overall Study||0
8912574|NCT02153983|9971706|FG005|NOT COMPLETED|Overall Study||0
8912575|NCT02154048|9971723|FG000|STARTED|Overall Study||2
8912576|NCT02154048|9971724|FG001|STARTED|Overall Study||2
8912577|NCT02154048|9971725|FG002|STARTED|Overall Study||1
8912578|NCT02154048|9971723|FG000|COMPLETED|Overall Study||2
8912579|NCT02154048|9971724|FG001|COMPLETED|Overall Study||2
8912580|NCT02154048|9971725|FG002|COMPLETED|Overall Study||1
8912581|NCT02154048|9971723|FG000|NOT COMPLETED|Overall Study||0
8912582|NCT02154048|9971724|FG001|NOT COMPLETED|Overall Study||0
8912583|NCT02154048|9971725|FG002|NOT COMPLETED|Overall Study||0
8912584|NCT02154061|9971735|FG000|STARTED|Overall Study||16
9022580|NCT03129100|10085454|FG000|COMPLETED|Period2 Extension Period (Group A and B)||0
9022581|NCT03129100|10085455|FG001|COMPLETED|Period2 Extension Period (Group A and B)||0
9022582|NCT03129100|10085456|FG002|COMPLETED|Period2 Extension Period (Group A and B)||234
9022583|NCT03129100|10085457|FG003|COMPLETED|Period2 Extension Period (Group A and B)||312
9022584|NCT03129100|10085458|FG004|COMPLETED|Period2 Extension Period (Group A and B)||42
8740816|NCT01117350|9789162|FG001|COMPLETED|Extension Period||147
8740817|NCT01117350|9789161|FG000|NOT COMPLETED|Extension Period||0
8740818|NCT01117350|9789162|FG001|NOT COMPLETED|Extension Period||63
8740819|NCT01117428|9789177|FG000|STARTED|Overall Study|"0.4 mg/kg=1~0.75 mg/kg=1~1.5 mg/kg=3~3 mg/kg=3~6 mg/kg=3~9 mg/kg=6~12 mg/kg=3"|20
8740820|NCT01117428|9789178|FG001|STARTED|Overall Study||29
8740821|NCT01117428|9789179|FG002|STARTED|Overall Study||13
8740822|NCT01117428|9789180|FG003|STARTED|Overall Study||12
8740823|NCT01117428|9789181|FG004|STARTED|Overall Study||17
8740824|NCT01117428|9789182|FG005|STARTED|Overall Study||20
8740825|NCT01117428|9789177|FG000|COMPLETED|Overall Study||0
8740826|NCT01117428|9789178|FG001|COMPLETED|Overall Study||0
8740827|NCT01117428|9789179|FG002|COMPLETED|Overall Study||0
8740828|NCT01117428|9789180|FG003|COMPLETED|Overall Study||0
8740829|NCT01117428|9789181|FG004|COMPLETED|Overall Study||0
8740830|NCT01117428|9789182|FG005|COMPLETED|Overall Study||0
8740831|NCT01117428|9789177|FG000|NOT COMPLETED|Overall Study||20
8740832|NCT01117428|9789178|FG001|NOT COMPLETED|Overall Study||29
8740833|NCT01117428|9789179|FG002|NOT COMPLETED|Overall Study||13
8740834|NCT01117428|9789180|FG003|NOT COMPLETED|Overall Study||12
8740835|NCT01117428|9789181|FG004|NOT COMPLETED|Overall Study||17
8740836|NCT01117428|9789182|FG005|NOT COMPLETED|Overall Study||20
8740837|NCT01117454|9789200|FG000|STARTED|Overall Study||6
8740838|NCT01117454|9789201|FG001|STARTED|Overall Study||8
8740839|NCT01117454|9789200|FG000|COMPLETED|Overall Study||6
8740840|NCT01117454|9789201|FG001|COMPLETED|Overall Study||7
8740841|NCT01117454|9789200|FG000|NOT COMPLETED|Overall Study||0
8740842|NCT01117454|9789201|FG001|NOT COMPLETED|Overall Study||1
8740843|NCT01117480|9789207|FG000|STARTED|Overall Study||1013
8740844|NCT01117480|9789207|FG000|COMPLETED|Overall Study||985
8740845|NCT01117480|9789207|FG000|NOT COMPLETED|Overall Study||28
8740846|NCT01117623|9789219|FG000|STARTED|Overall Study||3
8740847|NCT01117623|9789220|FG001|STARTED|Overall Study||8
8740848|NCT01117623|9789221|FG002|STARTED|Overall Study||11
8740849|NCT01117623|9789222|FG003|STARTED|Overall Study||6
8740850|NCT01117623|9789223|FG004|STARTED|Overall Study||10
8740851|NCT01117623|9789224|FG005|STARTED|Overall Study||16
8740852|NCT01117623|9789225|FG006|STARTED|Overall Study||6
8740853|NCT01117623|9789226|FG007|STARTED|Overall Study||26
8740854|NCT01117623|9789219|FG000|ITT Efficacy Analysis Population|Overall Study||3
8740855|NCT01117623|9789220|FG001|ITT Efficacy Analysis Population|Overall Study||8
8740856|NCT01117623|9789221|FG002|ITT Efficacy Analysis Population|Overall Study||11
8740857|NCT01117623|9789222|FG003|ITT Efficacy Analysis Population|Overall Study||5
8740858|NCT01117623|9789223|FG004|ITT Efficacy Analysis Population|Overall Study||10
8740859|NCT01117623|9789224|FG005|ITT Efficacy Analysis Population|Overall Study||16
8740860|NCT01117623|9789225|FG006|ITT Efficacy Analysis Population|Overall Study||6
8740861|NCT01117623|9789226|FG007|ITT Efficacy Analysis Population|Overall Study||22
8740862|NCT01117623|9789219|FG000|PK Population|Overall Study||3
8740863|NCT01117623|9789220|FG001|PK Population|Overall Study||8
8740864|NCT01117623|9789221|FG002|PK Population|Overall Study||10
8740865|NCT01117623|9789222|FG003|PK Population|Overall Study||6
8740866|NCT01117623|9789223|FG004|PK Population|Overall Study||10
8740867|NCT01117623|9789224|FG005|PK Population|Overall Study||14
8740868|NCT01117623|9789225|FG006|PK Population|Overall Study||6
8740869|NCT01117623|9789226|FG007|PK Population|Overall Study||24
8740870|NCT01117623|9789219|FG000|COMPLETED|Overall Study||0
8740871|NCT01117623|9789220|FG001|COMPLETED|Overall Study||0
8740872|NCT01117623|9789221|FG002|COMPLETED|Overall Study||0
8740873|NCT01117623|9789222|FG003|COMPLETED|Overall Study||0
8740874|NCT01117623|9789223|FG004|COMPLETED|Overall Study||0
8740875|NCT01117623|9789224|FG005|COMPLETED|Overall Study||0
8740876|NCT01117623|9789225|FG006|COMPLETED|Overall Study||0
8740877|NCT01117623|9789226|FG007|COMPLETED|Overall Study||0
8740878|NCT01117623|9789219|FG000|NOT COMPLETED|Overall Study||3
8740879|NCT01117623|9789220|FG001|NOT COMPLETED|Overall Study||8
8740880|NCT01117623|9789221|FG002|NOT COMPLETED|Overall Study||11
8740881|NCT01117623|9789222|FG003|NOT COMPLETED|Overall Study||6
8740882|NCT01117623|9789223|FG004|NOT COMPLETED|Overall Study||10
8740883|NCT01117623|9789224|FG005|NOT COMPLETED|Overall Study||16
8740884|NCT01117623|9789225|FG006|NOT COMPLETED|Overall Study||6
8740885|NCT01117623|9789226|FG007|NOT COMPLETED|Overall Study||26
8740886|NCT01117727|9789246|FG000|STARTED|Overall Study||1
8740887|NCT01117727|9789246|FG000|COMPLETED|Overall Study||1
8740888|NCT01117727|9789246|FG000|NOT COMPLETED|Overall Study||0
8740889|NCT01117766|9789251|FG000|STARTED|First Intervention||14
8740890|NCT01117766|9789252|FG001|STARTED|First Intervention||17
8740891|NCT01117766|9789251|FG000|Received Treatment|First Intervention||14
8740892|NCT01117766|9789252|FG001|Received Treatment|First Intervention||17
8740893|NCT01117766|9789251|FG000|COMPLETED|First Intervention||13
8740894|NCT01117766|9789252|FG001|COMPLETED|First Intervention||16
8740895|NCT01117766|9789251|FG000|NOT COMPLETED|First Intervention||1
8740896|NCT01117766|9789252|FG001|NOT COMPLETED|First Intervention||1
8740897|NCT01117766|9789251|FG000|STARTED|Washout Period||13
8740898|NCT01117766|9789252|FG001|STARTED|Washout Period||16
8740899|NCT01117766|9789251|FG000|COMPLETED|Washout Period||13
8740900|NCT01117766|9789252|FG001|COMPLETED|Washout Period||14
8740901|NCT01117766|9789251|FG000|NOT COMPLETED|Washout Period||0
8740902|NCT01117766|9789252|FG001|NOT COMPLETED|Washout Period||2
8740903|NCT01117766|9789251|FG000|STARTED|Second Intervention||13
8740904|NCT01117766|9789252|FG001|STARTED|Second Intervention||14
8740905|NCT01117766|9789251|FG000|COMPLETED|Second Intervention||11
8740906|NCT01117766|9789252|FG001|COMPLETED|Second Intervention||9
8740907|NCT01117766|9789251|FG000|NOT COMPLETED|Second Intervention||2
8740908|NCT01117766|9789252|FG001|NOT COMPLETED|Second Intervention||5
8740909|NCT01117792|9789258|FG000|STARTED|Overall Study||55
8740910|NCT01117792|9789258|FG000|COMPLETED|Overall Study||51
8740911|NCT01117792|9789258|FG000|NOT COMPLETED|Overall Study||4
8740912|NCT01117857|9789262|FG000|STARTED|Overall Study||22
8740913|NCT01117857|9789262|FG000|COMPLETED|Overall Study||13
8740914|NCT01117857|9789262|FG000|NOT COMPLETED|Overall Study||9
8740915|NCT01117870|9789268|FG000|STARTED|Overall Study||15
8740916|NCT01117870|9789269|FG001|STARTED|Overall Study||16
8740917|NCT01117870|9789268|FG000|COMPLETED|Overall Study|One did not receive the allocated intervention; (degenerate spine/inability to place needle).|14
8740918|NCT01117870|9789269|FG001|COMPLETED|Overall Study||16
8740919|NCT01117870|9789268|FG000|NOT COMPLETED|Overall Study||1
8740920|NCT01117870|9789269|FG001|NOT COMPLETED|Overall Study||0
8740921|NCT01117948|9789281|FG000|STARTED|Double Blind||111
8740922|NCT01117948|9789282|FG001|STARTED|Double Blind||108
8740923|NCT01117948|9789281|FG000|COMPLETED|Double Blind||93
8740924|NCT01117948|9789282|FG001|COMPLETED|Double Blind||98
8740925|NCT01117948|9789281|FG000|NOT COMPLETED|Double Blind||18
8740926|NCT01117948|9789282|FG001|NOT COMPLETED|Double Blind||10
8740927|NCT01117948|9789281|FG000|STARTED|Open Label||93
8740928|NCT01117948|9789282|FG001|STARTED|Open Label||98
8740929|NCT01117948|9789281|FG000|COMPLETED|Open Label||41
8740930|NCT01117948|9789282|FG001|COMPLETED|Open Label||51
8740931|NCT01117948|9789281|FG000|NOT COMPLETED|Open Label||52
8740932|NCT01117948|9789282|FG001|NOT COMPLETED|Open Label||47
8740933|NCT01117987|9789290|FG000|STARTED|Overall Study||66
8740934|NCT01117987|9789291|FG001|STARTED|Overall Study||78
8740935|NCT01117987|9789290|FG000|COMPLETED|Overall Study||5
8740936|NCT01117987|9789291|FG001|COMPLETED|Overall Study||4
8740937|NCT01117987|9789290|FG000|NOT COMPLETED|Overall Study||61
8740938|NCT01117987|9789291|FG001|NOT COMPLETED|Overall Study||74
8740939|NCT01118052|9789297|FG000|STARTED|Overall Study||22
8740940|NCT01118052|9789297|FG000|COMPLETED|Overall Study||20
8740941|NCT01118052|9789297|FG000|NOT COMPLETED|Overall Study||2
8740942|NCT01118091|9789309|FG000|STARTED|Overall Study|2pts were randomized to Arm 2, were not able to grow cell product, were treated with Arm 1 regimen.|7
8740943|NCT01118091|9789310|FG001|STARTED|Overall Study||5
8740944|NCT01118091|9789309|FG000|COMPLETED|Overall Study|Continued from above: These 2 pts are only represented in Arm 1 (and not Arm 2).|7
8740945|NCT01118091|9789310|FG001|COMPLETED|Overall Study||5
8740946|NCT01118091|9789309|FG000|NOT COMPLETED|Overall Study||0
8740947|NCT01118091|9789310|FG001|NOT COMPLETED|Overall Study||0
8740948|NCT01118117|9789318|FG000|STARTED|Overall Study||261
8740949|NCT01118117|9789319|FG001|STARTED|Overall Study||15
8740950|NCT01118117|9789318|FG000|COMPLETED|Overall Study||240
8740951|NCT01118117|9789319|FG001|COMPLETED|Overall Study||15
8740952|NCT01118117|9789318|FG000|NOT COMPLETED|Overall Study||21
8740953|NCT01118117|9789319|FG001|NOT COMPLETED|Overall Study||0
8740954|NCT01118143|9789327|FG000|STARTED|Overall Study||64
8740955|NCT01118143|9789328|FG001|STARTED|Overall Study||69
8740956|NCT01118143|9789327|FG000|COMPLETED|Overall Study||62
8740957|NCT01118143|9789328|FG001|COMPLETED|Overall Study||64
8740958|NCT01118143|9789327|FG000|NOT COMPLETED|Overall Study||2
8740959|NCT01118143|9789328|FG001|NOT COMPLETED|Overall Study||5
8740960|NCT01118221|9789338|FG000|STARTED|Overall Study||14
8740961|NCT01118221|9789339|FG001|STARTED|Overall Study||11
8740962|NCT01118221|9789338|FG000|COMPLETED|Overall Study||11
8740963|NCT01118221|9789339|FG001|COMPLETED|Overall Study||10
8740964|NCT01118221|9789338|FG000|NOT COMPLETED|Overall Study||3
8740965|NCT01118221|9789339|FG001|NOT COMPLETED|Overall Study||1
8740966|NCT01118273|9789355|FG000|STARTED|Overall Study||27
8740967|NCT01118273|9789356|FG001|STARTED|Overall Study||27
8740968|NCT01118273|9789357|FG002|STARTED|Overall Study||27
8740969|NCT01118273|9789358|FG003|STARTED|Overall Study||27
8740970|NCT01118273|9789359|FG004|STARTED|Overall Study||27
8740971|NCT01118273|9789360|FG005|STARTED|Overall Study||27
8740972|NCT01118273|9789355|FG000|COMPLETED|Overall Study||27
8740973|NCT01118273|9789356|FG001|COMPLETED|Overall Study||27
8740974|NCT01118273|9789357|FG002|COMPLETED|Overall Study||27
8740975|NCT01118273|9789358|FG003|COMPLETED|Overall Study||27
8740976|NCT01118273|9789359|FG004|COMPLETED|Overall Study||27
8740977|NCT01118273|9789360|FG005|COMPLETED|Overall Study||27
8740978|NCT01118273|9789355|FG000|NOT COMPLETED|Overall Study||0
8740979|NCT01118273|9789356|FG001|NOT COMPLETED|Overall Study||0
8740980|NCT01118273|9789357|FG002|NOT COMPLETED|Overall Study||0
8740981|NCT01118273|9789358|FG003|NOT COMPLETED|Overall Study||0
8740982|NCT01118273|9789359|FG004|NOT COMPLETED|Overall Study||0
8740983|NCT01118273|9789360|FG005|NOT COMPLETED|Overall Study||0
8740984|NCT01118299|9789376|FG000|STARTED|Overall Study||68
8740985|NCT01118299|9789377|FG001|STARTED|Overall Study||29
8740986|NCT01118299|9789376|FG000|COMPLETED|Overall Study||45
8740987|NCT01118299|9789377|FG001|COMPLETED|Overall Study||0
8740988|NCT01118299|9789376|FG000|NOT COMPLETED|Overall Study||23
8740989|NCT01118299|9789377|FG001|NOT COMPLETED|Overall Study||29
8740990|NCT01118312|9789384|FG000|STARTED|Overall Study||189
8740991|NCT01118312|9789385|FG001|STARTED|Overall Study||199
8740992|NCT01118312|9789384|FG000|COMPLETED|Overall Study||155
8740993|NCT01118312|9789385|FG001|COMPLETED|Overall Study||164
8740994|NCT01118312|9789384|FG000|NOT COMPLETED|Overall Study||34
8740995|NCT01118312|9789385|FG001|NOT COMPLETED|Overall Study||35
8740996|NCT01118325|9789394|FG000|STARTED|Overall Study||50
8740997|NCT01118325|9789395|FG001|STARTED|Overall Study||43
8912585|NCT02154061|9971736|FG001|STARTED|Overall Study||17
8912586|NCT02154061|9971735|FG000|COMPLETED|Overall Study||14
8912587|NCT02154061|9971736|FG001|COMPLETED|Overall Study||17
8912588|NCT02154061|9971735|FG000|NOT COMPLETED|Overall Study||2
8912589|NCT02154061|9971736|FG001|NOT COMPLETED|Overall Study||0
8912590|NCT02154139|9971742|FG000|STARTED|Overall Study||651
8912591|NCT02154139|9971742|FG000|COMPLETED|Overall Study||644
8912592|NCT02154139|9971742|FG000|NOT COMPLETED|Overall Study||7
8912593|NCT02154243|9971749|FG000|STARTED|Overall Study||5
8912594|NCT02154243|9971750|FG001|STARTED|Overall Study||4
8912595|NCT02154243|9971751|FG002|STARTED|Overall Study||4
8912596|NCT02154243|9971749|FG000|COMPLETED|Overall Study||5
8912597|NCT02154243|9971750|FG001|COMPLETED|Overall Study||4
8912598|NCT02154243|9971751|FG002|COMPLETED|Overall Study||4
8912599|NCT02154243|9971749|FG000|NOT COMPLETED|Overall Study||0
8912600|NCT02154243|9971750|FG001|NOT COMPLETED|Overall Study||0
8912601|NCT02154243|9971751|FG002|NOT COMPLETED|Overall Study||0
8912602|NCT02154347|9971761|FG000|STARTED|Double-blind Period||60
8912603|NCT02154347|9971762|FG001|STARTED|Double-blind Period||118
8912604|NCT02154347|9971761|FG000|COMPLETED|Double-blind Period||57
8912605|NCT02154347|9971762|FG001|COMPLETED|Double-blind Period||114
8912606|NCT02154347|9971761|FG000|NOT COMPLETED|Double-blind Period||3
8912607|NCT02154347|9971762|FG001|NOT COMPLETED|Double-blind Period||4
8912608|NCT02154347|9971761|FG000|STARTED|Open-label Period||57
8912609|NCT02154347|9971762|FG001|STARTED|Open-label Period||113
8912610|NCT02154347|9971761|FG000|COMPLETED|Open-label Period||50
8912611|NCT02154347|9971762|FG001|COMPLETED|Open-label Period||88
8912612|NCT02154347|9971761|FG000|NOT COMPLETED|Open-label Period||7
8912613|NCT02154347|9971762|FG001|NOT COMPLETED|Open-label Period||25
8912614|NCT02154386|9971771|FG000|STARTED|Overall Study||23
8740998|NCT01118325|9789396|FG002|STARTED|Overall Study||46
8912615|NCT02154386|9971772|FG001|STARTED|Overall Study||23
8912616|NCT02154386|9971771|FG000|COMPLETED|Overall Study||22
8912617|NCT02154386|9971772|FG001|COMPLETED|Overall Study||21
8912618|NCT02154386|9971771|FG000|NOT COMPLETED|Overall Study||1
8912619|NCT02154386|9971772|FG001|NOT COMPLETED|Overall Study||2
8912620|NCT02154425|9971778|FG000|STARTED|Screening Period||18
8912621|NCT02154425|9971778|FG000|COMPLETED|Screening Period||17
8912622|NCT02154425|9971778|FG000|NOT COMPLETED|Screening Period||1
8912623|NCT02154425|9971778|FG000|STARTED|Sampling Period||17
8912624|NCT02154425|9971778|FG000|COMPLETED|Sampling Period||17
9022585|NCT03129100|10085459|FG005|COMPLETED|Period2 Extension Period (Group A and B)||45
9022586|NCT03129100|10085460|FG006|COMPLETED|Period2 Extension Period (Group A and B)||32
9022587|NCT03129100|10085461|FG007|COMPLETED|Period2 Extension Period (Group A and B)||0
9022588|NCT03129100|10085462|FG008|COMPLETED|Period2 Extension Period (Group A and B)||0
9022589|NCT03129100|10085463|FG009|COMPLETED|Period2 Extension Period (Group A and B)||0
9022590|NCT03129100|10085464|FG010|COMPLETED|Period2 Extension Period (Group A and B)||0
9022591|NCT03129100|10085454|FG000|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
9022592|NCT03129100|10085455|FG001|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
9022593|NCT03129100|10085456|FG002|NOT COMPLETED|Period2 Extension Period (Group A and B)||21
9022594|NCT03129100|10085457|FG003|NOT COMPLETED|Period2 Extension Period (Group A and B)||6
9022595|NCT03129100|10085458|FG004|NOT COMPLETED|Period2 Extension Period (Group A and B)||6
9022596|NCT03129100|10085459|FG005|NOT COMPLETED|Period2 Extension Period (Group A and B)||9
9022597|NCT03129100|10085460|FG006|NOT COMPLETED|Period2 Extension Period (Group A and B)||21
9022598|NCT03129100|10085461|FG007|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
9022599|NCT03129100|10085462|FG008|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
9022600|NCT03129100|10085463|FG009|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
9022601|NCT03129100|10085464|FG010|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
9022602|NCT03129100|10085454|FG000|STARTED|Period 2 (Retreatment Extension Period)||0
9022603|NCT03129100|10085455|FG001|STARTED|Period 2 (Retreatment Extension Period)||0
9022604|NCT03129100|10085456|FG002|STARTED|Period 2 (Retreatment Extension Period)||0
9022605|NCT03129100|10085457|FG003|STARTED|Period 2 (Retreatment Extension Period)||0
9022606|NCT03129100|10085458|FG004|STARTED|Period 2 (Retreatment Extension Period)||0
9022607|NCT03129100|10085459|FG005|STARTED|Period 2 (Retreatment Extension Period)||0
9022608|NCT03129100|10085460|FG006|STARTED|Period 2 (Retreatment Extension Period)||0
9022609|NCT03129100|10085461|FG007|STARTED|Period 2 (Retreatment Extension Period)|Participants who experienced flare in Group B Extension period.|6
9022610|NCT03129100|10085462|FG008|STARTED|Period 2 (Retreatment Extension Period)|Participants who experienced flare in Group B Extension period.|5
9022611|NCT03129100|10085463|FG009|STARTED|Period 2 (Retreatment Extension Period)|Participants who experienced flare in Group B Extension period.|9
9022612|NCT03129100|10085464|FG010|STARTED|Period 2 (Retreatment Extension Period)|Participants who experienced flare in Group B Extension period.|10
9022613|NCT03129100|10085454|FG000|COMPLETED|Period 2 (Retreatment Extension Period)||0
9022614|NCT03129100|10085455|FG001|COMPLETED|Period 2 (Retreatment Extension Period)||0
9022615|NCT03129100|10085456|FG002|COMPLETED|Period 2 (Retreatment Extension Period)||0
9022616|NCT03129100|10085457|FG003|COMPLETED|Period 2 (Retreatment Extension Period)||0
9022617|NCT03129100|10085458|FG004|COMPLETED|Period 2 (Retreatment Extension Period)||0
9022618|NCT03129100|10085459|FG005|COMPLETED|Period 2 (Retreatment Extension Period)||0
8740999|NCT01118325|9789394|FG000|COMPLETED|Overall Study||49
8741000|NCT01118325|9789395|FG001|COMPLETED|Overall Study||43
8741001|NCT01118325|9789396|FG002|COMPLETED|Overall Study||45
8741002|NCT01118325|9789394|FG000|NOT COMPLETED|Overall Study||1
8741003|NCT01118325|9789395|FG001|NOT COMPLETED|Overall Study||0
8741004|NCT01118325|9789396|FG002|NOT COMPLETED|Overall Study||1
8741005|NCT01118338|9789419|FG000|STARTED|Overall Study||185
8741006|NCT01118338|9789420|FG001|STARTED|Overall Study||183
8741007|NCT01118338|9789419|FG000|COMPLETED|Overall Study||182
8741008|NCT01118338|9789420|FG001|COMPLETED|Overall Study||174
8741009|NCT01118338|9789419|FG000|NOT COMPLETED|Overall Study||3
8741010|NCT01118338|9789420|FG001|NOT COMPLETED|Overall Study||9
8741011|NCT01118351|9789426|FG000|STARTED|Overall Study||19
8741012|NCT01118351|9789426|FG000|COMPLETED|Overall Study||15
8741013|NCT01118351|9789426|FG000|NOT COMPLETED|Overall Study||4
8741014|NCT01118377|9789430|FG000|STARTED|Overall Study||45
8741015|NCT01118377|9789430|FG000|COMPLETED|Overall Study||3
8741016|NCT01118377|9789430|FG000|NOT COMPLETED|Overall Study||42
8741017|NCT01118455|9789436|FG000|STARTED|Baseline [Visits 1 & 2]||66
8741018|NCT01118455|9789437|FG001|STARTED|Baseline [Visits 1 & 2]||69
8741019|NCT01118455|9789436|FG000|Actual Patients Treated|Baseline [Visits 1 & 2]||65
8741020|NCT01118455|9789437|FG001|Actual Patients Treated|Baseline [Visits 1 & 2]||69
8741021|NCT01118455|9789436|FG000|COMPLETED|Baseline [Visits 1 & 2]||65
8741022|NCT01118455|9789437|FG001|COMPLETED|Baseline [Visits 1 & 2]||69
8741023|NCT01118455|9789436|FG000|NOT COMPLETED|Baseline [Visits 1 & 2]||1
8741024|NCT01118455|9789437|FG001|NOT COMPLETED|Baseline [Visits 1 & 2]||0
8741025|NCT01118455|9789436|FG000|STARTED|Treatment Phase (VNS/AED) [Visits 3-10]||65
8741026|NCT01118455|9789437|FG001|STARTED|Treatment Phase (VNS/AED) [Visits 3-10]||69
8741027|NCT01118455|9789436|FG000|COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||65
8741028|NCT01118455|9789437|FG001|COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||69
8741029|NCT01118455|9789436|FG000|NOT COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||0
8741030|NCT01118455|9789437|FG001|NOT COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||0
8741031|NCT01118520|9789454|FG000|STARTED|Overall Study||73
8741032|NCT01118520|9789455|FG001|STARTED|Overall Study||72
8741033|NCT01118520|9789456|FG002|STARTED|Overall Study||79
8741034|NCT01118520|9789454|FG000|COMPLETED|Overall Study||53
8741035|NCT01118520|9789455|FG001|COMPLETED|Overall Study||49
8741036|NCT01118520|9789456|FG002|COMPLETED|Overall Study||59
8741037|NCT01118520|9789454|FG000|NOT COMPLETED|Overall Study||20
8741038|NCT01118520|9789455|FG001|NOT COMPLETED|Overall Study||23
8741039|NCT01118520|9789456|FG002|NOT COMPLETED|Overall Study||20
8741040|NCT01118624|9789464|FG000|STARTED|Overall Study||22
8741041|NCT01118624|9789464|FG000|COMPLETED|Overall Study||0
8741042|NCT01118624|9789464|FG000|NOT COMPLETED|Overall Study||22
8741043|NCT01118663|9789470|FG000|STARTED|Overall Study||7
8741044|NCT01118663|9789471|FG001|STARTED|Overall Study||10
8741045|NCT01118663|9789470|FG000|COMPLETED|Overall Study||5
8741046|NCT01118663|9789471|FG001|COMPLETED|Overall Study||8
8741047|NCT01118663|9789470|FG000|NOT COMPLETED|Overall Study||2
8741048|NCT01118663|9789471|FG001|NOT COMPLETED|Overall Study||2
8741049|NCT01118715|9789479|FG000|STARTED|Overall Study||68
8741050|NCT01118715|9789480|FG001|STARTED|Overall Study||60
8741051|NCT01118715|9789479|FG000|COMPLETED|Overall Study||68
8741052|NCT01118715|9789480|FG001|COMPLETED|Overall Study||60
8741053|NCT01118715|9789479|FG000|NOT COMPLETED|Overall Study||0
8741054|NCT01118715|9789480|FG001|NOT COMPLETED|Overall Study||0
8741055|NCT01118728|9789507|FG000|STARTED|Overall Study||223
8741056|NCT01118728|9789507|FG000|COMPLETED|Overall Study||0
8741057|NCT01118728|9789507|FG000|NOT COMPLETED|Overall Study||223
8741058|NCT01118741|9789513|FG000|STARTED|Overall Study||9
8741059|NCT01118741|9789514|FG001|STARTED|Overall Study||10
8741060|NCT01118741|9789513|FG000|COMPLETED|Overall Study||9
8741061|NCT01118741|9789514|FG001|COMPLETED|Overall Study||10
8741062|NCT01118741|9789513|FG000|NOT COMPLETED|Overall Study||0
8741063|NCT01118741|9789514|FG001|NOT COMPLETED|Overall Study||0
8741064|NCT01118780|9789524|FG000|STARTED|Overall Study||151
8741065|NCT01118780|9789525|FG001|STARTED|Overall Study||140
8741066|NCT01118780|9789524|FG000|COMPLETED|Overall Study||115
8741067|NCT01118780|9789525|FG001|COMPLETED|Overall Study||105
8741068|NCT01118780|9789524|FG000|NOT COMPLETED|Overall Study||36
8741069|NCT01118780|9789525|FG001|NOT COMPLETED|Overall Study||35
8741070|NCT01118845|9789534|FG000|STARTED|Overall Study||59
8741071|NCT01118845|9789534|FG000|COMPLETED|Overall Study||17
8741072|NCT01118845|9789534|FG000|NOT COMPLETED|Overall Study||42
8741073|NCT01118949|9789538|FG000|STARTED|Overall Study||49
8912625|NCT02154425|9971778|FG000|NOT COMPLETED|Sampling Period||0
8912626|NCT02154477|9971788|FG000|STARTED|Overall Study||6
8912627|NCT02154477|9971789|FG001|STARTED|Overall Study||8
8912628|NCT02154477|9971788|FG000|COMPLETED|Overall Study||6
8912629|NCT02154477|9971789|FG001|COMPLETED|Overall Study||8
8912630|NCT02154477|9971788|FG000|NOT COMPLETED|Overall Study||0
8912631|NCT02154477|9971789|FG001|NOT COMPLETED|Overall Study||0
8741074|NCT01118949|9789538|FG000|COMPLETED|Overall Study||40
8741075|NCT01118949|9789538|FG000|NOT COMPLETED|Overall Study||9
8741076|NCT01118962|9789542|FG000|STARTED|Overall Study||39
8741077|NCT01118962|9789542|FG000|COMPLETED|Overall Study||29
8741078|NCT01118962|9789542|FG000|NOT COMPLETED|Overall Study||10
8741079|NCT01118975|9789548|FG000|STARTED|Overall Study||9
8741080|NCT01118975|9789549|FG001|STARTED|Overall Study||3
8741081|NCT01118975|9789548|FG000|COMPLETED|Overall Study||9
8741082|NCT01118975|9789549|FG001|COMPLETED|Overall Study||2
8741083|NCT01118975|9789548|FG000|NOT COMPLETED|Overall Study||0
8741084|NCT01118975|9789549|FG001|NOT COMPLETED|Overall Study||1
8741085|NCT01118988|9789558|FG000|STARTED|Overall Study||16
8741086|NCT01118988|9789559|FG001|STARTED|Overall Study||4
8741087|NCT01118988|9789560|FG002|STARTED|Overall Study||7
8741088|NCT01118988|9789558|FG000|COMPLETED|Overall Study||11
8741089|NCT01118988|9789559|FG001|COMPLETED|Overall Study||3
8741090|NCT01118988|9789560|FG002|COMPLETED|Overall Study||3
8741091|NCT01118988|9789558|FG000|NOT COMPLETED|Overall Study||5
8741092|NCT01118988|9789559|FG001|NOT COMPLETED|Overall Study||1
8741093|NCT01118988|9789560|FG002|NOT COMPLETED|Overall Study||4
8741094|NCT01119001|9789567|FG000|STARTED|Overall Study||13
8741095|NCT01119001|9789567|FG000|COMPLETED|Overall Study||11
8741096|NCT01119001|9789567|FG000|NOT COMPLETED|Overall Study||2
8741097|NCT01119040|9789573|FG000|STARTED|Overall Study||1
8741098|NCT01119040|9789573|FG000|COMPLETED|Overall Study||0
8741099|NCT01119040|9789573|FG000|NOT COMPLETED|Overall Study||1
8741100|NCT01119105|9789580|FG000|STARTED|Overall Study||70
8741101|NCT01119105|9789581|FG001|STARTED|Overall Study||72
8741102|NCT01119105|9789582|FG002|STARTED|Overall Study||68
8741103|NCT01119105|9789580|FG000|COMPLETED|Overall Study||66
8741104|NCT01119105|9789581|FG001|COMPLETED|Overall Study||66
8741105|NCT01119105|9789582|FG002|COMPLETED|Overall Study||60
8741106|NCT01119105|9789580|FG000|NOT COMPLETED|Overall Study||4
8741107|NCT01119105|9789581|FG001|NOT COMPLETED|Overall Study||6
8741108|NCT01119105|9789582|FG002|NOT COMPLETED|Overall Study||8
8741109|NCT01119118|9789590|FG000|STARTED|Overall Study||6
8741110|NCT01119118|9789590|FG000|COMPLETED|Overall Study||5
8741111|NCT01119118|9789590|FG000|NOT COMPLETED|Overall Study||1
8741112|NCT01119131|9789597|FG000|STARTED|Overall Study||10
8741113|NCT01119131|9789598|FG001|STARTED|Overall Study||28
8741114|NCT01119131|9789599|FG002|STARTED|Overall Study||30
8741115|NCT01119131|9789597|FG000|COMPLETED|Overall Study||8
8741116|NCT01119131|9789598|FG001|COMPLETED|Overall Study||27
8741117|NCT01119131|9789599|FG002|COMPLETED|Overall Study||24
8741118|NCT01119131|9789597|FG000|NOT COMPLETED|Overall Study||2
8741119|NCT01119131|9789598|FG001|NOT COMPLETED|Overall Study||1
8741120|NCT01119131|9789599|FG002|NOT COMPLETED|Overall Study||6
8741121|NCT01119222|9789607|FG000|STARTED|Overall Study||5
8741122|NCT01119222|9789608|FG001|STARTED|Overall Study||5
8741123|NCT01119222|9789609|FG002|STARTED|Overall Study||5
8741124|NCT01119222|9789610|FG003|STARTED|Overall Study||4
8741125|NCT01119222|9789607|FG000|COMPLETED|Overall Study||5
8741126|NCT01119222|9789608|FG001|COMPLETED|Overall Study||5
8741127|NCT01119222|9789609|FG002|COMPLETED|Overall Study||5
8741128|NCT01119222|9789610|FG003|COMPLETED|Overall Study||4
8741129|NCT01119222|9789607|FG000|NOT COMPLETED|Overall Study||0
8741130|NCT01119222|9789608|FG001|NOT COMPLETED|Overall Study||0
8741131|NCT01119222|9789609|FG002|NOT COMPLETED|Overall Study||0
8741132|NCT01119222|9789610|FG003|NOT COMPLETED|Overall Study||0
8741133|NCT01119248|9789623|FG000|STARTED|Overall Study||120
8741134|NCT01119248|9789623|FG000|COMPLETED|Overall Study||115
8741135|NCT01119248|9789623|FG000|NOT COMPLETED|Overall Study||5
8741136|NCT01119287|9789634|FG000|STARTED|Overall Study||26
8741137|NCT01119287|9789635|FG001|STARTED|Overall Study||24
8741138|NCT01119287|9789636|FG002|STARTED|Overall Study||26
8741139|NCT01119287|9789637|FG003|STARTED|Overall Study||31
8741140|NCT01119287|9789638|FG004|STARTED|Overall Study||31
8741141|NCT01119287|9789639|FG005|STARTED|Overall Study||32
8741142|NCT01119287|9789634|FG000|COMPLETED|Overall Study||26
8741143|NCT01119287|9789635|FG001|COMPLETED|Overall Study||24
8741144|NCT01119287|9789636|FG002|COMPLETED|Overall Study||24
8741145|NCT01119287|9789637|FG003|COMPLETED|Overall Study||29
8741146|NCT01119287|9789638|FG004|COMPLETED|Overall Study||30
8741147|NCT01119287|9789639|FG005|COMPLETED|Overall Study||32
8741148|NCT01119287|9789634|FG000|NOT COMPLETED|Overall Study||0
8741149|NCT01119287|9789635|FG001|NOT COMPLETED|Overall Study||0
8741150|NCT01119287|9789636|FG002|NOT COMPLETED|Overall Study||2
8741151|NCT01119287|9789637|FG003|NOT COMPLETED|Overall Study||2
8741152|NCT01119287|9789638|FG004|NOT COMPLETED|Overall Study||1
8741153|NCT01119287|9789639|FG005|NOT COMPLETED|Overall Study||0
8741154|NCT01119443|9789653|FG000|STARTED|Up-titration Period (10 Days)||14
8741155|NCT01119443|9789654|FG001|STARTED|Up-titration Period (10 Days)||14
8741156|NCT01119443|9789653|FG000|COMPLETED|Up-titration Period (10 Days)||14
8741157|NCT01119443|9789654|FG001|COMPLETED|Up-titration Period (10 Days)||14
8741158|NCT01119443|9789653|FG000|NOT COMPLETED|Up-titration Period (10 Days)||0
8741159|NCT01119443|9789654|FG001|NOT COMPLETED|Up-titration Period (10 Days)||0
8741160|NCT01119443|9789653|FG000|STARTED|Crossover Period 1 (5 Days)||14
8741161|NCT01119443|9789654|FG001|STARTED|Crossover Period 1 (5 Days)||14
8741162|NCT01119443|9789653|FG000|COMPLETED|Crossover Period 1 (5 Days)||14
8741163|NCT01119443|9789654|FG001|COMPLETED|Crossover Period 1 (5 Days)||13
8741164|NCT01119443|9789653|FG000|NOT COMPLETED|Crossover Period 1 (5 Days)||0
8741165|NCT01119443|9789654|FG001|NOT COMPLETED|Crossover Period 1 (5 Days)||1
8741166|NCT01119443|9789653|FG000|STARTED|Crossover Period 2 (5 Days)||14
8741167|NCT01119443|9789654|FG001|STARTED|Crossover Period 2 (5 Days)||13
8741168|NCT01119443|9789653|FG000|COMPLETED|Crossover Period 2 (5 Days)||14
8741169|NCT01119443|9789654|FG001|COMPLETED|Crossover Period 2 (5 Days)||13
8741170|NCT01119443|9789653|FG000|NOT COMPLETED|Crossover Period 2 (5 Days)||0
8741171|NCT01119443|9789654|FG001|NOT COMPLETED|Crossover Period 2 (5 Days)||0
8741172|NCT01119443|9789653|FG000|STARTED|Crossover Period 3 (5 Days)||14
8741173|NCT01119443|9789654|FG001|STARTED|Crossover Period 3 (5 Days)||13
8741174|NCT01119443|9789653|FG000|COMPLETED|Crossover Period 3 (5 Days)||14
8741175|NCT01119443|9789654|FG001|COMPLETED|Crossover Period 3 (5 Days)||13
8741176|NCT01119443|9789653|FG000|NOT COMPLETED|Crossover Period 3 (5 Days)||0
8741177|NCT01119443|9789654|FG001|NOT COMPLETED|Crossover Period 3 (5 Days)||0
8741178|NCT01119443|9789653|FG000|STARTED|Crossover Period 4 (5 Days)||14
8741179|NCT01119443|9789654|FG001|STARTED|Crossover Period 4 (5 Days)||13
8741180|NCT01119443|9789653|FG000|COMPLETED|Crossover Period 4 (5 Days)||14
8741181|NCT01119443|9789654|FG001|COMPLETED|Crossover Period 4 (5 Days)||13
8741182|NCT01119443|9789653|FG000|NOT COMPLETED|Crossover Period 4 (5 Days)||0
8741183|NCT01119443|9789654|FG001|NOT COMPLETED|Crossover Period 4 (5 Days)||0
8741184|NCT01119443|9789653|FG000|STARTED|Down-titration Period (1 Day)||14
8741185|NCT01119443|9789654|FG001|STARTED|Down-titration Period (1 Day)||13
8741186|NCT01119443|9789653|FG000|COMPLETED|Down-titration Period (1 Day)||14
8741187|NCT01119443|9789654|FG001|COMPLETED|Down-titration Period (1 Day)||13
8741188|NCT01119443|9789653|FG000|NOT COMPLETED|Down-titration Period (1 Day)||0
8741189|NCT01119443|9789654|FG001|NOT COMPLETED|Down-titration Period (1 Day)||0
8741190|NCT01119443|9789653|FG000|STARTED|End of Study (All Patients)||14
8741191|NCT01119443|9789654|FG001|STARTED|End of Study (All Patients)||14
8741192|NCT01119443|9789653|FG000|COMPLETED|End of Study (All Patients)||14
8741193|NCT01119443|9789654|FG001|COMPLETED|End of Study (All Patients)||14
8741194|NCT01119443|9789653|FG000|NOT COMPLETED|End of Study (All Patients)||0
8741195|NCT01119443|9789654|FG001|NOT COMPLETED|End of Study (All Patients)||0
8741196|NCT01119456|9789671|FG000|STARTED|Overall Study||7
8741197|NCT01119456|9789672|FG001|STARTED|Overall Study||3
8741198|NCT01119456|9789673|FG002|STARTED|Overall Study||3
8741199|NCT01119456|9789674|FG003|STARTED|Overall Study||13
8741200|NCT01119456|9789675|FG004|STARTED|Overall Study||4
8741201|NCT01119456|9789676|FG005|STARTED|Overall Study||3
8741202|NCT01119456|9789677|FG006|STARTED|Overall Study||3
8741203|NCT01119456|9789678|FG007|STARTED|Overall Study||3
8741204|NCT01119456|9789671|FG000|Received at Least 1 Dose of Study Drug|Overall Study||7
8741205|NCT01119456|9789672|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
8741206|NCT01119456|9789673|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
8741207|NCT01119456|9789674|FG003|Received at Least 1 Dose of Study Drug|Overall Study||13
8741208|NCT01119456|9789675|FG004|Received at Least 1 Dose of Study Drug|Overall Study||4
8741209|NCT01119456|9789676|FG005|Received at Least 1 Dose of Study Drug|Overall Study||3
8741210|NCT01119456|9789677|FG006|Received at Least 1 Dose of Study Drug|Overall Study||3
8741211|NCT01119456|9789678|FG007|Received at Least 1 Dose of Study Drug|Overall Study||3
8741212|NCT01119456|9789671|FG000|COMPLETED|Overall Study||7
8741213|NCT01119456|9789672|FG001|COMPLETED|Overall Study||3
8741214|NCT01119456|9789673|FG002|COMPLETED|Overall Study||3
8741215|NCT01119456|9789674|FG003|COMPLETED|Overall Study||13
8741216|NCT01119456|9789675|FG004|COMPLETED|Overall Study||4
8741217|NCT01119456|9789676|FG005|COMPLETED|Overall Study||3
8741218|NCT01119456|9789677|FG006|COMPLETED|Overall Study||3
8741219|NCT01119456|9789678|FG007|COMPLETED|Overall Study||3
8741220|NCT01119456|9789671|FG000|NOT COMPLETED|Overall Study||0
8741221|NCT01119456|9789672|FG001|NOT COMPLETED|Overall Study||0
8741222|NCT01119456|9789673|FG002|NOT COMPLETED|Overall Study||0
8741223|NCT01119456|9789674|FG003|NOT COMPLETED|Overall Study||0
8741224|NCT01119456|9789675|FG004|NOT COMPLETED|Overall Study||0
8741225|NCT01119456|9789676|FG005|NOT COMPLETED|Overall Study||0
8741226|NCT01119456|9789677|FG006|NOT COMPLETED|Overall Study||0
8741227|NCT01119456|9789678|FG007|NOT COMPLETED|Overall Study||0
8741228|NCT01119508|9789703|FG000|STARTED|Overall Study||64
8741229|NCT01119508|9789703|FG000|Received Four Induction Doses|Overall Study||45
8741230|NCT01119508|9789703|FG000|Received Fifth Consolidation Dose week12|Overall Study||32
8741231|NCT01119508|9789703|FG000|COMPLETED|Overall Study||5
8741232|NCT01119508|9789703|FG000|NOT COMPLETED|Overall Study||59
8741233|NCT01119625|9789709|FG000|STARTED|Overall Study||118
8741234|NCT01119625|9789710|FG001|STARTED|Overall Study||120
8741235|NCT01119625|9789709|FG000|COMPLETED|Overall Study||115
8741236|NCT01119625|9789710|FG001|COMPLETED|Overall Study||116
8741237|NCT01119625|9789709|FG000|NOT COMPLETED|Overall Study||3
8741238|NCT01119625|9789710|FG001|NOT COMPLETED|Overall Study||4
8741239|NCT01119703|9789718|FG000|STARTED|Overall Study||30
8741240|NCT01119703|9789719|FG001|STARTED|Overall Study||144
8741241|NCT01119703|9789718|FG000|COMPLETED|Overall Study||30
8741242|NCT01119703|9789719|FG001|COMPLETED|Overall Study||143
8741243|NCT01119703|9789718|FG000|NOT COMPLETED|Overall Study||0
8741244|NCT01119703|9789719|FG001|NOT COMPLETED|Overall Study||1
8741245|NCT01119716|9789724|FG000|STARTED|Overall Study||4658
8741246|NCT01119716|9789724|FG000|COMPLETED|Overall Study||4658
8741247|NCT01119716|9789724|FG000|NOT COMPLETED|Overall Study||0
8741248|NCT01119755|9789732|FG000|STARTED|Overall Study||80
8741249|NCT01119755|9789732|FG000|COMPLETED|Overall Study||80
8741250|NCT01119755|9789732|FG000|NOT COMPLETED|Overall Study||0
8741251|NCT01119768|9789738|FG000|STARTED|Treatment Period||154
8741252|NCT01119768|9789739|FG001|STARTED|Treatment Period||151
8741253|NCT01119768|9789738|FG000|COMPLETED|Treatment Period||136
8741254|NCT01119768|9789739|FG001|COMPLETED|Treatment Period||126
8741255|NCT01119768|9789738|FG000|NOT COMPLETED|Treatment Period||18
8741256|NCT01119768|9789739|FG001|NOT COMPLETED|Treatment Period||25
8741257|NCT01119768|9789738|FG000|STARTED|Follow-up||136
8741258|NCT01119768|9789739|FG001|STARTED|Follow-up||124
8741259|NCT01119768|9789738|FG000|COMPLETED|Follow-up||135
8741260|NCT01119768|9789739|FG001|COMPLETED|Follow-up||122
8741261|NCT01119768|9789738|FG000|NOT COMPLETED|Follow-up||1
8741262|NCT01119768|9789739|FG001|NOT COMPLETED|Follow-up||2
8741263|NCT01119794|9789745|FG000|STARTED|Overall Study||10
8741264|NCT01119794|9789745|FG000|COMPLETED|Overall Study||10
8741265|NCT01119794|9789745|FG000|NOT COMPLETED|Overall Study||0
8741266|NCT01119846|9789752|FG000|STARTED|Overall Study||13
8741267|NCT01119846|9789753|FG001|STARTED|Overall Study||4
8741268|NCT01119846|9789754|FG002|STARTED|Overall Study||83
8741269|NCT01119846|9789752|FG000|COMPLETED|Overall Study||11
8741270|NCT01119846|9789753|FG001|COMPLETED|Overall Study||4
8741271|NCT01119846|9789754|FG002|COMPLETED|Overall Study||72
8741272|NCT01119846|9789752|FG000|NOT COMPLETED|Overall Study||2
8741273|NCT01119846|9789753|FG001|NOT COMPLETED|Overall Study||0
8741274|NCT01119846|9789754|FG002|NOT COMPLETED|Overall Study||11
8741275|NCT01119859|9789791|FG000|STARTED|Overall Study||163
8741276|NCT01119859|9789792|FG001|STARTED|Overall Study||163
8741277|NCT01119859|9789791|FG000|COMPLETED|Overall Study||139
8741278|NCT01119859|9789792|FG001|COMPLETED|Overall Study||133
8741279|NCT01119859|9789791|FG000|NOT COMPLETED|Overall Study||24
8741280|NCT01119859|9789792|FG001|NOT COMPLETED|Overall Study||30
8807193|NCT01483599|9859592|FG010|COMPLETED|Controlled Period (CP) (up to Week 16)||0
8807194|NCT01483599|9859593|FG011|COMPLETED|Controlled Period (CP) (up to Week 16)||0
8807195|NCT01483599|9859594|FG012|COMPLETED|Controlled Period (CP) (up to Week 16)||0
8807196|NCT01483599|9859595|FG013|COMPLETED|Controlled Period (CP) (up to Week 16)||0
8807197|NCT01483599|9859582|FG000|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||3
8807198|NCT01483599|9859583|FG001|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||3
8807199|NCT01483599|9859584|FG002|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
8807200|NCT01483599|9859585|FG003|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||3
8807201|NCT01483599|9859586|FG004|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||2
8807202|NCT01483599|9859587|FG005|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||4
8807203|NCT01483599|9859588|FG006|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||4
8807204|NCT01483599|9859589|FG007|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
8807205|NCT01483599|9859590|FG008|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
8807206|NCT01483599|9859591|FG009|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
8807207|NCT01483599|9859592|FG010|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
8807208|NCT01483599|9859593|FG011|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
8807209|NCT01483599|9859594|FG012|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
8807210|NCT01483599|9859595|FG013|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
8807211|NCT01483599|9859582|FG000|STARTED|After Controlled Period(Week 16-Week 40)||0
8807212|NCT01483599|9859583|FG001|STARTED|After Controlled Period(Week 16-Week 40)||0
8807213|NCT01483599|9859584|FG002|STARTED|After Controlled Period(Week 16-Week 40)||0
8807214|NCT01483599|9859585|FG003|STARTED|After Controlled Period(Week 16-Week 40)||0
8807215|NCT01483599|9859586|FG004|STARTED|After Controlled Period(Week 16-Week 40)||0
8807216|NCT01483599|9859587|FG005|STARTED|After Controlled Period(Week 16-Week 40)||0
8807217|NCT01483599|9859588|FG006|STARTED|After Controlled Period(Week 16-Week 40)||0
8807218|NCT01483599|9859589|FG007|STARTED|After Controlled Period(Week 16-Week 40)||39
8807219|NCT01483599|9859590|FG008|STARTED|After Controlled Period(Week 16-Week 40)||38
8807220|NCT01483599|9859591|FG009|STARTED|After Controlled Period(Week 16-Week 40)||41
8807221|NCT01483599|9859592|FG010|STARTED|After Controlled Period(Week 16-Week 40)||39
8807222|NCT01483599|9859593|FG011|STARTED|After Controlled Period(Week 16-Week 40)||40
8807223|NCT01483599|9859594|FG012|STARTED|After Controlled Period(Week 16-Week 40)||38
8807224|NCT01483599|9859595|FG013|STARTED|After Controlled Period(Week 16-Week 40)||39
8807225|NCT01483599|9859582|FG000|COMPLETED|After Controlled Period(Week 16-Week 40)||0
8807226|NCT01483599|9859583|FG001|COMPLETED|After Controlled Period(Week 16-Week 40)||0
8807227|NCT01483599|9859584|FG002|COMPLETED|After Controlled Period(Week 16-Week 40)||0
8807228|NCT01483599|9859585|FG003|COMPLETED|After Controlled Period(Week 16-Week 40)||0
8807229|NCT01483599|9859586|FG004|COMPLETED|After Controlled Period(Week 16-Week 40)||0
8807230|NCT01483599|9859587|FG005|COMPLETED|After Controlled Period(Week 16-Week 40)||0
8807231|NCT01483599|9859588|FG006|COMPLETED|After Controlled Period(Week 16-Week 40)||0
8807232|NCT01483599|9859589|FG007|COMPLETED|After Controlled Period(Week 16-Week 40)||37
8807233|NCT01483599|9859590|FG008|COMPLETED|After Controlled Period(Week 16-Week 40)||29
8807234|NCT01483599|9859591|FG009|COMPLETED|After Controlled Period(Week 16-Week 40)||37
8807235|NCT01483599|9859592|FG010|COMPLETED|After Controlled Period(Week 16-Week 40)||37
8807236|NCT01483599|9859593|FG011|COMPLETED|After Controlled Period(Week 16-Week 40)||39
8807237|NCT01483599|9859594|FG012|COMPLETED|After Controlled Period(Week 16-Week 40)||35
8807238|NCT01483599|9859595|FG013|COMPLETED|After Controlled Period(Week 16-Week 40)||32
8807239|NCT01483599|9859582|FG000|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
8807240|NCT01483599|9859583|FG001|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
8807241|NCT01483599|9859584|FG002|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
8807242|NCT01483599|9859585|FG003|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
8807243|NCT01483599|9859586|FG004|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
8807244|NCT01483599|9859587|FG005|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
8807245|NCT01483599|9859588|FG006|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
8807246|NCT01483599|9859589|FG007|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||2
8807247|NCT01483599|9859590|FG008|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||9
8807248|NCT01483599|9859591|FG009|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||4
8741281|NCT01119898|9789800|FG000|STARTED|Overall Study||131
8741282|NCT01119898|9789801|FG001|STARTED|Overall Study||129
8741283|NCT01119898|9789800|FG000|Received Study Drug (mITT)|Overall Study||130
8741284|NCT01119898|9789801|FG001|Received Study Drug (mITT)|Overall Study||129
8741285|NCT01119898|9789800|FG000|COMPLETED|Overall Study||123
8741286|NCT01119898|9789801|FG001|COMPLETED|Overall Study||117
8741287|NCT01119898|9789800|FG000|NOT COMPLETED|Overall Study||8
8741288|NCT01119898|9789801|FG001|NOT COMPLETED|Overall Study||12
8741289|NCT01119937|9789809|FG000|STARTED|Overall Study||123
8741290|NCT01119937|9789810|FG001|STARTED|Overall Study||40
8741291|NCT01119937|9789809|FG000|COMPLETED|Overall Study||104
8741292|NCT01119937|9789810|FG001|COMPLETED|Overall Study||33
8741293|NCT01119937|9789809|FG000|NOT COMPLETED|Overall Study||19
8741294|NCT01119937|9789810|FG001|NOT COMPLETED|Overall Study||7
8741295|NCT01119950|9789816|FG000|STARTED|Overall Study|These participants were randomized to 2 different treatment sequences during period 1 and 2.|388
8741296|NCT01119950|9789816|FG000|NVA237 12.5 ug q.d.|Overall Study|5 randomized and 2 misrandomized patients did not receive study drug, 80 completed, 9 discontinued.|96
8741297|NCT01119950|9789816|FG000|NVA237 25 ug q.d.|Overall Study|3 randomized participants did not receive study drug, 91 completed treatment, 5 discontinued.|99
8741298|NCT01119950|9789816|FG000|NVA237 12.5 ug b.i.d.|Overall Study|4 randomized participants did not receive study drug, 93 completed treatment, 2 discontinued.|99
8741299|NCT01119950|9789816|FG000|NVA237 50 ug q.d.|Overall Study|4 randomized participants did not receive study drug, 89 completed treatment, 3 discontinued.|96
8741300|NCT01119950|9789816|FG000|NVA237 25 ug b.i.d.|Overall Study|4 randomized participants did not receive study drug, 89 completed treatment, 7 discontinued.|100
8741301|NCT01119950|9789816|FG000|NVA237 100 ug q.d.|Overall Study|2 randomized participants did not receive study drug, 92 completed treatment, 4 discontinued.|98
8741302|NCT01119950|9789816|FG000|NVA237 50 ug b.i.d.|Overall Study|6 randomized and 1 misrandomized patients did not receive study drug, 82 completed, 5 discontinued.|94
8741303|NCT01119950|9789816|FG000|Placebo|Overall Study|3 randomized participants did not receive study drug, 82 completed treatment, 5 discontinued.|94
8741304|NCT01119950|9789816|FG000|COMPLETED|Overall Study|These participants completed both periods 1 and 2|341
8741305|NCT01119950|9789816|FG000|NOT COMPLETED|Overall Study||47
8741306|NCT01119963|9789844|FG000|STARTED|Overall Study||74
8741307|NCT01119963|9789845|FG001|STARTED|Overall Study||78
8741308|NCT01119963|9789844|FG000|COMPLETED|Overall Study||73
8741309|NCT01119963|9789845|FG001|COMPLETED|Overall Study||77
8741310|NCT01119963|9789844|FG000|NOT COMPLETED|Overall Study||1
8741311|NCT01119963|9789845|FG001|NOT COMPLETED|Overall Study||1
8741312|NCT01120028|9789857|FG000|STARTED|Period 1: Alemtuzumab or Basiliximab||426
8741313|NCT01120028|9789858|FG001|STARTED|Period 1: Alemtuzumab or Basiliximab||426
8741314|NCT01120028|9789859|FG002|STARTED|Period 1: Alemtuzumab or Basiliximab||0
8741315|NCT01120028|9789860|FG003|STARTED|Period 1: Alemtuzumab or Basiliximab||0
8741316|NCT01120028|9789857|FG000|COMPLETED|Period 1: Alemtuzumab or Basiliximab||412
8741317|NCT01120028|9789858|FG001|COMPLETED|Period 1: Alemtuzumab or Basiliximab||403
8741318|NCT01120028|9789859|FG002|COMPLETED|Period 1: Alemtuzumab or Basiliximab||0
8741319|NCT01120028|9789860|FG003|COMPLETED|Period 1: Alemtuzumab or Basiliximab||0
8741320|NCT01120028|9789857|FG000|NOT COMPLETED|Period 1: Alemtuzumab or Basiliximab||14
8741321|NCT01120028|9789858|FG001|NOT COMPLETED|Period 1: Alemtuzumab or Basiliximab||23
8741322|NCT01120028|9789859|FG002|NOT COMPLETED|Period 1: Alemtuzumab or Basiliximab||0
8741323|NCT01120028|9789860|FG003|NOT COMPLETED|Period 1: Alemtuzumab or Basiliximab||0
8741324|NCT01120028|9789857|FG000|STARTED|Period 2: Tacrolimus or Sirolimus||0
8741325|NCT01120028|9789858|FG001|STARTED|Period 2: Tacrolimus or Sirolimus||0
8741326|NCT01120028|9789859|FG002|STARTED|Period 2: Tacrolimus or Sirolimus||197
8741327|NCT01120028|9789860|FG003|STARTED|Period 2: Tacrolimus or Sirolimus||197
8741328|NCT01120028|9789857|FG000|COMPLETED|Period 2: Tacrolimus or Sirolimus||0
8741329|NCT01120028|9789858|FG001|COMPLETED|Period 2: Tacrolimus or Sirolimus||0
8741330|NCT01120028|9789859|FG002|COMPLETED|Period 2: Tacrolimus or Sirolimus||197
8741331|NCT01120028|9789860|FG003|COMPLETED|Period 2: Tacrolimus or Sirolimus||197
8741332|NCT01120028|9789857|FG000|NOT COMPLETED|Period 2: Tacrolimus or Sirolimus||0
8741333|NCT01120028|9789858|FG001|NOT COMPLETED|Period 2: Tacrolimus or Sirolimus||0
8741334|NCT01120028|9789859|FG002|NOT COMPLETED|Period 2: Tacrolimus or Sirolimus||0
8741335|NCT01120028|9789860|FG003|NOT COMPLETED|Period 2: Tacrolimus or Sirolimus||0
8741336|NCT01120067|9789873|FG000|STARTED|Overall Study||12
8741337|NCT01120067|9789874|FG001|STARTED|Overall Study||11
8741338|NCT01120067|9789873|FG000|COMPLETED|Overall Study||7
8741339|NCT01120067|9789874|FG001|COMPLETED|Overall Study||10
8741340|NCT01120067|9789873|FG000|NOT COMPLETED|Overall Study||5
8741341|NCT01120067|9789874|FG001|NOT COMPLETED|Overall Study||1
8741342|NCT01120093|9789880|FG000|STARTED|Treatment Period 1||18
8741343|NCT01120093|9789881|FG001|STARTED|Treatment Period 1||14
8741344|NCT01120093|9789882|FG002|STARTED|Treatment Period 1||17
8741345|NCT01120093|9789883|FG003|STARTED|Treatment Period 1||14
8741346|NCT01120093|9789884|FG004|STARTED|Treatment Period 1||16
8741347|NCT01120093|9789880|FG000|COMPLETED|Treatment Period 1||18
8741348|NCT01120093|9789881|FG001|COMPLETED|Treatment Period 1||13
8741349|NCT01120093|9789882|FG002|COMPLETED|Treatment Period 1||16
8741350|NCT01120093|9789883|FG003|COMPLETED|Treatment Period 1||14
8741351|NCT01120093|9789884|FG004|COMPLETED|Treatment Period 1||15
8741352|NCT01120093|9789880|FG000|NOT COMPLETED|Treatment Period 1||0
8741353|NCT01120093|9789881|FG001|NOT COMPLETED|Treatment Period 1||1
8741354|NCT01120093|9789882|FG002|NOT COMPLETED|Treatment Period 1||1
8741355|NCT01120093|9789883|FG003|NOT COMPLETED|Treatment Period 1||0
8741356|NCT01120093|9789884|FG004|NOT COMPLETED|Treatment Period 1||1
8741357|NCT01120093|9789880|FG000|STARTED|Treatment Period 2||18
8741358|NCT01120093|9789881|FG001|STARTED|Treatment Period 2||13
8741359|NCT01120093|9789882|FG002|STARTED|Treatment Period 2||16
8741360|NCT01120093|9789883|FG003|STARTED|Treatment Period 2||14
8741361|NCT01120093|9789884|FG004|STARTED|Treatment Period 2||15
8741362|NCT01120093|9789880|FG000|COMPLETED|Treatment Period 2||18
8741363|NCT01120093|9789881|FG001|COMPLETED|Treatment Period 2||13
8741364|NCT01120093|9789882|FG002|COMPLETED|Treatment Period 2||16
8741365|NCT01120093|9789883|FG003|COMPLETED|Treatment Period 2||13
8741366|NCT01120093|9789884|FG004|COMPLETED|Treatment Period 2||14
8741367|NCT01120093|9789880|FG000|NOT COMPLETED|Treatment Period 2||0
8741368|NCT01120093|9789881|FG001|NOT COMPLETED|Treatment Period 2||0
8741369|NCT01120093|9789882|FG002|NOT COMPLETED|Treatment Period 2||0
8741370|NCT01120093|9789883|FG003|NOT COMPLETED|Treatment Period 2||1
8741371|NCT01120093|9789884|FG004|NOT COMPLETED|Treatment Period 2||1
8741372|NCT01120093|9789880|FG000|STARTED|Treatment Period 3||18
8741373|NCT01120093|9789881|FG001|STARTED|Treatment Period 3||13
8741374|NCT01120093|9789882|FG002|STARTED|Treatment Period 3||16
8741375|NCT01120093|9789883|FG003|STARTED|Treatment Period 3||13
8741376|NCT01120093|9789884|FG004|STARTED|Treatment Period 3||14
8741377|NCT01120093|9789880|FG000|COMPLETED|Treatment Period 3||18
8741378|NCT01120093|9789881|FG001|COMPLETED|Treatment Period 3||13
8741379|NCT01120093|9789882|FG002|COMPLETED|Treatment Period 3||15
8741380|NCT01120093|9789883|FG003|COMPLETED|Treatment Period 3||12
8741381|NCT01120093|9789884|FG004|COMPLETED|Treatment Period 3||13
8741382|NCT01120093|9789880|FG000|NOT COMPLETED|Treatment Period 3||0
8741383|NCT01120093|9789881|FG001|NOT COMPLETED|Treatment Period 3||0
8741384|NCT01120093|9789882|FG002|NOT COMPLETED|Treatment Period 3||1
8741385|NCT01120093|9789883|FG003|NOT COMPLETED|Treatment Period 3||1
8741386|NCT01120093|9789884|FG004|NOT COMPLETED|Treatment Period 3||1
8741387|NCT01120093|9789880|FG000|STARTED|Treatment Period 4||18
8741388|NCT01120093|9789881|FG001|STARTED|Treatment Period 4||13
8741389|NCT01120093|9789882|FG002|STARTED|Treatment Period 4||15
8741390|NCT01120093|9789883|FG003|STARTED|Treatment Period 4||12
8741391|NCT01120093|9789884|FG004|STARTED|Treatment Period 4||13
8741392|NCT01120093|9789880|FG000|COMPLETED|Treatment Period 4||17
8741393|NCT01120093|9789881|FG001|COMPLETED|Treatment Period 4||13
8741394|NCT01120093|9789882|FG002|COMPLETED|Treatment Period 4||15
8741395|NCT01120093|9789883|FG003|COMPLETED|Treatment Period 4||12
8741396|NCT01120093|9789884|FG004|COMPLETED|Treatment Period 4||13
8741397|NCT01120093|9789880|FG000|NOT COMPLETED|Treatment Period 4||1
8741398|NCT01120093|9789881|FG001|NOT COMPLETED|Treatment Period 4||0
8741399|NCT01120093|9789882|FG002|NOT COMPLETED|Treatment Period 4||0
8912632|NCT02154581|9971797|FG000|STARTED|Overall Study||21
8912633|NCT02154581|9971798|FG001|STARTED|Overall Study||20
8912634|NCT02154581|9971797|FG000|COMPLETED|Overall Study||14
8912635|NCT02154581|9971798|FG001|COMPLETED|Overall Study||12
8912636|NCT02154581|9971797|FG000|NOT COMPLETED|Overall Study||7
8912637|NCT02154581|9971798|FG001|NOT COMPLETED|Overall Study||8
8912638|NCT02154672|9971806|FG000|STARTED|Overall Study||1
8912639|NCT02154672|9971806|FG000|COMPLETED|Overall Study||1
8912640|NCT02154672|9971806|FG000|NOT COMPLETED|Overall Study||0
8912641|NCT02154763|9971812|FG000|STARTED|Overall Study||60
8912642|NCT02154763|9971813|FG001|STARTED|Overall Study||60
8912643|NCT02154763|9971812|FG000|COMPLETED|Overall Study||46
8912644|NCT02154763|9971813|FG001|COMPLETED|Overall Study||46
8912645|NCT02154763|9971812|FG000|NOT COMPLETED|Overall Study||14
8912646|NCT02154763|9971813|FG001|NOT COMPLETED|Overall Study||14
8912647|NCT02154906|9971823|FG000|STARTED|Overall Study||21
8912648|NCT02154906|9971824|FG001|STARTED|Overall Study||20
8912649|NCT02154906|9971823|FG000|COMPLETED|Overall Study||19
8912650|NCT02154906|9971824|FG001|COMPLETED|Overall Study||17
8912651|NCT02154906|9971823|FG000|NOT COMPLETED|Overall Study||2
8912652|NCT02154906|9971824|FG001|NOT COMPLETED|Overall Study||3
8912653|NCT02155010|9971832|FG000|STARTED|Overall Study||37
8912654|NCT02155010|9971833|FG001|STARTED|Overall Study||37
8912655|NCT02155010|9971832|FG000|COMPLETED|Overall Study||31
8912656|NCT02155010|9971833|FG001|COMPLETED|Overall Study||31
8912657|NCT02155010|9971832|FG000|NOT COMPLETED|Overall Study||6
8912658|NCT02155010|9971833|FG001|NOT COMPLETED|Overall Study||6
8912659|NCT02155101|9971841|FG000|STARTED|Overall Study||39
8912660|NCT02155101|9971842|FG001|STARTED|Overall Study||81
8912661|NCT02155101|9971841|FG000|COMPLETED|Overall Study||39
8741400|NCT01120093|9789883|FG003|NOT COMPLETED|Treatment Period 4||0
8741401|NCT01120093|9789884|FG004|NOT COMPLETED|Treatment Period 4||0
8741402|NCT01120093|9789880|FG000|STARTED|Treatment Period 5||17
8741403|NCT01120093|9789881|FG001|STARTED|Treatment Period 5||13
8741404|NCT01120093|9789882|FG002|STARTED|Treatment Period 5||15
8741405|NCT01120093|9789883|FG003|STARTED|Treatment Period 5||12
8741406|NCT01120093|9789884|FG004|STARTED|Treatment Period 5||13
8912662|NCT02155101|9971842|FG001|COMPLETED|Overall Study||80
8912663|NCT02155101|9971841|FG000|NOT COMPLETED|Overall Study||0
8912664|NCT02155101|9971842|FG001|NOT COMPLETED|Overall Study||1
8741407|NCT01120093|9789880|FG000|COMPLETED|Treatment Period 5||17
8741408|NCT01120093|9789881|FG001|COMPLETED|Treatment Period 5||12
8912665|NCT02155257|9971851|FG000|STARTED|Overall Study||10
8912666|NCT02155257|9971852|FG001|STARTED|Overall Study||10
8912667|NCT02155257|9971853|FG002|STARTED|Overall Study||10
8912668|NCT02155257|9971851|FG000|COMPLETED|Overall Study||10
8912669|NCT02155257|9971852|FG001|COMPLETED|Overall Study||10
8741409|NCT01120093|9789882|FG002|COMPLETED|Treatment Period 5||15
8741410|NCT01120093|9789883|FG003|COMPLETED|Treatment Period 5||11
8741411|NCT01120093|9789884|FG004|COMPLETED|Treatment Period 5||13
8741412|NCT01120093|9789880|FG000|NOT COMPLETED|Treatment Period 5||0
8741413|NCT01120093|9789881|FG001|NOT COMPLETED|Treatment Period 5||1
8741414|NCT01120093|9789882|FG002|NOT COMPLETED|Treatment Period 5||0
8741415|NCT01120093|9789883|FG003|NOT COMPLETED|Treatment Period 5||1
8741416|NCT01120093|9789884|FG004|NOT COMPLETED|Treatment Period 5||0
8741417|NCT01120184|9789899|FG000|STARTED|Overall Study||365
8741418|NCT01120184|9789900|FG001|STARTED|Overall Study||367
8741419|NCT01120184|9789901|FG002|STARTED|Overall Study||363
8741420|NCT01120184|9789899|FG000|Treated|Overall Study||355
8741421|NCT01120184|9789900|FG001|Treated|Overall Study||365
8741422|NCT01120184|9789901|FG002|Treated|Overall Study||360
8741423|NCT01120184|9789899|FG000|COMPLETED|Overall Study||0
8741424|NCT01120184|9789900|FG001|COMPLETED|Overall Study||0
8741425|NCT01120184|9789901|FG002|COMPLETED|Overall Study||0
8741426|NCT01120184|9789899|FG000|NOT COMPLETED|Overall Study||365
8741427|NCT01120184|9789900|FG001|NOT COMPLETED|Overall Study||367
8741428|NCT01120184|9789901|FG002|NOT COMPLETED|Overall Study||363
8741429|NCT01120197|9789911|FG000|STARTED|Overall Study||47
8741430|NCT01120197|9789912|FG001|STARTED|Overall Study||42
8741431|NCT01120197|9789911|FG000|COMPLETED|Overall Study||38
8741432|NCT01120197|9789912|FG001|COMPLETED|Overall Study||32
8741433|NCT01120197|9789911|FG000|NOT COMPLETED|Overall Study||9
8741434|NCT01120197|9789912|FG001|NOT COMPLETED|Overall Study||10
8741435|NCT01120210|9789921|FG000|STARTED|MAIN INFUSION||16
8741436|NCT01120210|9789922|FG001|STARTED|MAIN INFUSION||46
8741437|NCT01120210|9789921|FG000|COMPLETED|MAIN INFUSION||15
8741438|NCT01120210|9789922|FG001|COMPLETED|MAIN INFUSION||45
8741439|NCT01120210|9789921|FG000|NOT COMPLETED|MAIN INFUSION||1
8741440|NCT01120210|9789922|FG001|NOT COMPLETED|MAIN INFUSION||1
8741441|NCT01120210|9789921|FG000|STARTED|18-HOUR EXTENDED INFUSION SUBSTUDY||3
8741442|NCT01120210|9789922|FG001|STARTED|18-HOUR EXTENDED INFUSION SUBSTUDY||7
8741443|NCT01120210|9789921|FG000|COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||3
8741444|NCT01120210|9789922|FG001|COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||7
8741445|NCT01120210|9789921|FG000|NOT COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||0
8741446|NCT01120210|9789922|FG001|NOT COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||0
8741447|NCT01120223|9789928|FG000|STARTED|Overall Study||78
8741448|NCT01120223|9789928|FG000|COMPLETED|Overall Study||74
8741449|NCT01120223|9789928|FG000|NOT COMPLETED|Overall Study||4
8741450|NCT01120236|9789934|FG000|STARTED|Overall Study||105
8741451|NCT01120236|9789935|FG001|STARTED|Overall Study||106
8741452|NCT01120236|9789934|FG000|Ineligble|Overall Study||0
8741453|NCT01120236|9789935|FG001|Ineligble|Overall Study|Patient ineligible due to no demonstable radiographic metastasis and is excluded from all analyses.|1
8741454|NCT01120236|9789934|FG000|COMPLETED|Overall Study||105
8741455|NCT01120236|9789935|FG001|COMPLETED|Overall Study||105
8741456|NCT01120236|9789934|FG000|NOT COMPLETED|Overall Study||0
8741457|NCT01120236|9789935|FG001|NOT COMPLETED|Overall Study||1
8741458|NCT01120275|9789949|FG000|STARTED|Overall Study||36
8741459|NCT01120275|9789949|FG000|Eligible and Treated|Overall Study||32
8741460|NCT01120275|9789949|FG000|COMPLETED|Overall Study||0
8741461|NCT01120275|9789949|FG000|NOT COMPLETED|Overall Study||36
8741462|NCT01120379|9789954|FG000|STARTED|One Year Timepoint||5020
8741463|NCT01120379|9789954|FG000|COMPLETED|One Year Timepoint||4742
8741464|NCT01120379|9789954|FG000|NOT COMPLETED|One Year Timepoint||278
8741465|NCT01120379|9789954|FG000|STARTED|Two Year Timepoint||4742
8741466|NCT01120379|9789954|FG000|COMPLETED|Two Year Timepoint||4505
8741467|NCT01120379|9789954|FG000|NOT COMPLETED|Two Year Timepoint||237
8741468|NCT01120379|9789954|FG000|STARTED|Three Year Timepoint||4505
8741469|NCT01120379|9789954|FG000|COMPLETED|Three Year Timepoint||4291
8741470|NCT01120379|9789954|FG000|NOT COMPLETED|Three Year Timepoint||214
8741471|NCT01120379|9789954|FG000|STARTED|Four Year Timepoint||4291
8741472|NCT01120379|9789954|FG000|COMPLETED|Four Year Timepoint||3923
8741473|NCT01120379|9789954|FG000|NOT COMPLETED|Four Year Timepoint||368
8741474|NCT01120405|9789960|FG000|STARTED|Overall Study||298
8741475|NCT01120405|9789961|FG001|STARTED|Overall Study||302
8741476|NCT01120405|9789960|FG000|COMPLETED|Overall Study||271
8741477|NCT01120405|9789961|FG001|COMPLETED|Overall Study||269
8741478|NCT01120405|9789960|FG000|NOT COMPLETED|Overall Study||27
8741479|NCT01120405|9789961|FG001|NOT COMPLETED|Overall Study||33
8741480|NCT01120600|9789971|FG000|STARTED|Overall Study||147
8741481|NCT01120600|9789972|FG001|STARTED|Overall Study||147
8741482|NCT01120600|9789971|FG000|Treated|Overall Study||146
8741483|NCT01120600|9789972|FG001|Treated|Overall Study||146
8741484|NCT01120600|9789971|FG000|COMPLETED|Overall Study||128
8741485|NCT01120600|9789972|FG001|COMPLETED|Overall Study||115
8741486|NCT01120600|9789971|FG000|NOT COMPLETED|Overall Study||19
8741487|NCT01120600|9789972|FG001|NOT COMPLETED|Overall Study||32
8741488|NCT01120626|9789980|FG000|STARTED|Overall Study||20
8741489|NCT01120626|9789981|FG001|STARTED|Overall Study||22
8741490|NCT01120626|9789980|FG000|COMPLETED|Overall Study||19
8741491|NCT01120626|9789981|FG001|COMPLETED|Overall Study||22
8741492|NCT01120626|9789980|FG000|NOT COMPLETED|Overall Study||1
8741493|NCT01120626|9789981|FG001|NOT COMPLETED|Overall Study||0
8741494|NCT01120639|9789991|FG000|STARTED|Overall Study||6
8741495|NCT01120639|9789992|FG001|STARTED|Overall Study||6
8741496|NCT01120639|9789993|FG002|STARTED|Overall Study||6
8741497|NCT01120639|9789994|FG003|STARTED|Overall Study||12
8741498|NCT01120639|9789991|FG000|COMPLETED|Overall Study||6
8741499|NCT01120639|9789992|FG001|COMPLETED|Overall Study||6
8741500|NCT01120639|9789993|FG002|COMPLETED|Overall Study||6
8741501|NCT01120639|9789994|FG003|COMPLETED|Overall Study||12
8741502|NCT01120639|9789991|FG000|NOT COMPLETED|Overall Study||0
8741503|NCT01120639|9789992|FG001|NOT COMPLETED|Overall Study||0
8912670|NCT02155257|9971853|FG002|COMPLETED|Overall Study||10
8912671|NCT02155257|9971851|FG000|NOT COMPLETED|Overall Study||0
8912672|NCT02155257|9971852|FG001|NOT COMPLETED|Overall Study||0
8912673|NCT02155257|9971853|FG002|NOT COMPLETED|Overall Study||0
8912674|NCT02155283|9971861|FG000|STARTED|Overall Study||16
8912675|NCT02155283|9971861|FG000|COMPLETED|Overall Study||9
8912676|NCT02155283|9971861|FG000|NOT COMPLETED|Overall Study||7
8912677|NCT02155309|9971867|FG000|STARTED|Overall Study||13
8912678|NCT02155309|9971868|FG001|STARTED|Overall Study||10
8912679|NCT02155309|9971869|FG002|STARTED|Overall Study||13
8912680|NCT02155309|9971867|FG000|COMPLETED|Overall Study||13
8912681|NCT02155309|9971868|FG001|COMPLETED|Overall Study||10
8912682|NCT02155309|9971869|FG002|COMPLETED|Overall Study||12
8912683|NCT02155309|9971867|FG000|NOT COMPLETED|Overall Study||0
8912684|NCT02155309|9971868|FG001|NOT COMPLETED|Overall Study||0
8912685|NCT02155309|9971869|FG002|NOT COMPLETED|Overall Study||1
8912686|NCT02155322|9971876|FG000|STARTED|Overall Study||33
8912687|NCT02155322|9971876|FG000|Treated|Overall Study|32 of 33 participants treated. 1 participant not treated at the discretion of the investigator.|32
8912688|NCT02155322|9971876|FG000|COMPLETED|Overall Study||19
8912689|NCT02155322|9971876|FG000|NOT COMPLETED|Overall Study||14
8912690|NCT02155335|9971880|FG000|STARTED|Period 1||50
8912691|NCT02155335|9971881|FG001|STARTED|Period 1||50
8912692|NCT02155335|9971880|FG000|Treated|Period 1||50
8912693|NCT02155335|9971881|FG001|Treated|Period 1||49
8912694|NCT02155335|9971880|FG000|COMPLETED|Period 1||50
8912695|NCT02155335|9971881|FG001|COMPLETED|Period 1||49
8912696|NCT02155335|9971880|FG000|NOT COMPLETED|Period 1||0
8912697|NCT02155335|9971881|FG001|NOT COMPLETED|Period 1||1
8912698|NCT02155335|9971880|FG000|STARTED|Period 2||50
8912699|NCT02155335|9971881|FG001|STARTED|Period 2||49
8912700|NCT02155335|9971880|FG000|COMPLETED|Period 2||50
8912701|NCT02155335|9971881|FG001|COMPLETED|Period 2||49
8912702|NCT02155335|9971880|FG000|NOT COMPLETED|Period 2||0
8912703|NCT02155335|9971881|FG001|NOT COMPLETED|Period 2||0
8912704|NCT02155465|9971892|FG000|STARTED|Overall Study||3
8912705|NCT02155465|9971893|FG001|STARTED|Overall Study||3
8912706|NCT02155465|9971894|FG002|STARTED|Overall Study||6
8912707|NCT02155465|9971895|FG003|STARTED|Overall Study||2
8912708|NCT02155465|9971896|FG004|STARTED|Overall Study||1
8912709|NCT02155465|9971897|FG005|STARTED|Overall Study||2
8912710|NCT02155465|9971898|FG006|STARTED|Overall Study||5
8912711|NCT02155465|9971892|FG000|COMPLETED|Overall Study||3
8912712|NCT02155465|9971893|FG001|COMPLETED|Overall Study||3
8912713|NCT02155465|9971894|FG002|COMPLETED|Overall Study||6
8912714|NCT02155465|9971895|FG003|COMPLETED|Overall Study||2
8912715|NCT02155465|9971896|FG004|COMPLETED|Overall Study||1
8912716|NCT02155465|9971897|FG005|COMPLETED|Overall Study||2
8912717|NCT02155465|9971898|FG006|COMPLETED|Overall Study||5
8912718|NCT02155465|9971892|FG000|NOT COMPLETED|Overall Study||0
8912719|NCT02155465|9971893|FG001|NOT COMPLETED|Overall Study||0
8912720|NCT02155465|9971894|FG002|NOT COMPLETED|Overall Study||0
8912721|NCT02155465|9971895|FG003|NOT COMPLETED|Overall Study||0
8912722|NCT02155465|9971896|FG004|NOT COMPLETED|Overall Study||0
8912723|NCT02155465|9971897|FG005|NOT COMPLETED|Overall Study||0
8912724|NCT02155465|9971898|FG006|NOT COMPLETED|Overall Study||0
8912725|NCT02155543|9971924|FG000|STARTED|Overall Study||9
8912726|NCT02155543|9971925|FG001|STARTED|Overall Study||9
8912727|NCT02155543|9971926|FG002|STARTED|Overall Study||9
8912728|NCT02155543|9971927|FG003|STARTED|Overall Study||9
8912729|NCT02155543|9971928|FG004|STARTED|Overall Study||3
8912730|NCT02155543|9971929|FG005|STARTED|Overall Study||3
8912731|NCT02155543|9971930|FG006|STARTED|Overall Study||9
8912732|NCT02155543|9971924|FG000|COMPLETED|Overall Study||9
8912733|NCT02155543|9971925|FG001|COMPLETED|Overall Study||9
8912734|NCT02155543|9971926|FG002|COMPLETED|Overall Study||9
8912735|NCT02155543|9971927|FG003|COMPLETED|Overall Study||9
8912736|NCT02155543|9971928|FG004|COMPLETED|Overall Study||3
8912737|NCT02155543|9971929|FG005|COMPLETED|Overall Study||3
8912738|NCT02155543|9971930|FG006|COMPLETED|Overall Study||9
8912739|NCT02155543|9971924|FG000|NOT COMPLETED|Overall Study||0
8912740|NCT02155543|9971925|FG001|NOT COMPLETED|Overall Study||0
9022619|NCT03129100|10085460|FG006|COMPLETED|Period 2 (Retreatment Extension Period)||0
8912741|NCT02155543|9971926|FG002|NOT COMPLETED|Overall Study||0
8912742|NCT02155543|9971927|FG003|NOT COMPLETED|Overall Study||0
8912743|NCT02155543|9971928|FG004|NOT COMPLETED|Overall Study||0
8912744|NCT02155543|9971929|FG005|NOT COMPLETED|Overall Study||0
8912745|NCT02155543|9971930|FG006|NOT COMPLETED|Overall Study||0
8912746|NCT02155608|9971945|FG000|STARTED|1a: 4 Week Double Blind Sham Controlled||32
8912747|NCT02155608|9971946|FG001|STARTED|1a: 4 Week Double Blind Sham Controlled||30
8912748|NCT02155608|9971945|FG000|COMPLETED|1a: 4 Week Double Blind Sham Controlled||32
8912749|NCT02155608|9971946|FG001|COMPLETED|1a: 4 Week Double Blind Sham Controlled||29
8912750|NCT02155608|9971945|FG000|NOT COMPLETED|1a: 4 Week Double Blind Sham Controlled||0
8912751|NCT02155608|9971946|FG001|NOT COMPLETED|1a: 4 Week Double Blind Sham Controlled||1
8912752|NCT02155608|9971945|FG000|STARTED|1b: 1 Week Blinded Post Treatment||32
8741504|NCT01120639|9789993|FG002|NOT COMPLETED|Overall Study||0
8912753|NCT02155608|9971946|FG001|STARTED|1b: 1 Week Blinded Post Treatment||29
8741505|NCT01120639|9789994|FG003|NOT COMPLETED|Overall Study||0
8741506|NCT01120691|9790007|FG000|STARTED|Overall Study||741
8741507|NCT01120691|9790008|FG001|STARTED|Overall Study||741
8741508|NCT01120691|9790009|FG002|STARTED|Overall Study||742
8741509|NCT01120691|9790007|FG000|Full Analysis Set (FAS)|Overall Study||736
8741510|NCT01120691|9790008|FG001|Full Analysis Set (FAS)|Overall Study||739
8741511|NCT01120691|9790009|FG002|Full Analysis Set (FAS)|Overall Study||739
8741512|NCT01120691|9790007|FG000|Safety Set (SAF)|Overall Study||736
8741513|NCT01120691|9790008|FG001|Safety Set (SAF)|Overall Study||740
8741514|NCT01120691|9790009|FG002|Safety Set (SAF)|Overall Study||739
8741515|NCT01120691|9790007|FG000|Modified Safety Set (mSAF)|Overall Study||729
8741516|NCT01120691|9790008|FG001|Modified Safety Set (mSAF)|Overall Study||740
8741517|NCT01120691|9790009|FG002|Modified Safety Set (mSAF)|Overall Study||737
8741518|NCT01120691|9790007|FG000|Modified Full Analysis Set (mFAS)|Overall Study||729
8741519|NCT01120691|9790008|FG001|Modified Full Analysis Set (mFAS)|Overall Study||739
8741520|NCT01120691|9790009|FG002|Modified Full Analysis Set (mFAS)|Overall Study||737
8741521|NCT01120691|9790007|FG000|COMPLETED|Overall Study||570
8741522|NCT01120691|9790008|FG001|COMPLETED|Overall Study||538
8741523|NCT01120691|9790009|FG002|COMPLETED|Overall Study||559
8741524|NCT01120691|9790007|FG000|NOT COMPLETED|Overall Study||171
8741525|NCT01120691|9790008|FG001|NOT COMPLETED|Overall Study||203
8741526|NCT01120691|9790009|FG002|NOT COMPLETED|Overall Study||183
8741527|NCT01120704|9790053|FG000|STARTED|Overall Study||13
8741528|NCT01120704|9790054|FG001|STARTED|Overall Study||17
8741529|NCT01120704|9790055|FG002|STARTED|Overall Study||14
8741530|NCT01120704|9790056|FG003|STARTED|Overall Study||19
8741531|NCT01120704|9790057|FG004|STARTED|Overall Study||16
8741532|NCT01120704|9790058|FG005|STARTED|Overall Study||19
8741533|NCT01120704|9790059|FG006|STARTED|Overall Study||15
8741534|NCT01120704|9790060|FG007|STARTED|Overall Study||15
8741535|NCT01120704|9790061|FG008|STARTED|Overall Study||22
8741536|NCT01120704|9790062|FG009|STARTED|Overall Study||20
8741537|NCT01120704|9790063|FG010|STARTED|Overall Study||17
8741538|NCT01120704|9790064|FG011|STARTED|Overall Study||16
8741539|NCT01120704|9790065|FG012|STARTED|Overall Study||17
8741540|NCT01120704|9790066|FG013|STARTED|Overall Study||19
8741541|NCT01120704|9790067|FG014|STARTED|Overall Study||18
8741542|NCT01120704|9790068|FG015|STARTED|Overall Study||18
8741543|NCT01120704|9790069|FG016|STARTED|Overall Study||14
8741544|NCT01120704|9790070|FG017|STARTED|Overall Study||16
8741545|NCT01120704|9790071|FG018|STARTED|Overall Study||17
8741546|NCT01120704|9790072|FG019|STARTED|Overall Study||18
8741547|NCT01120704|9790073|FG020|STARTED|Overall Study||17
8741548|NCT01120704|9790074|FG021|STARTED|Overall Study||16
8741549|NCT01120704|9790075|FG022|STARTED|Overall Study||21
8741550|NCT01120704|9790076|FG023|STARTED|Overall Study||16
8741551|NCT01120704|9790077|FG024|STARTED|Overall Study||18
8741552|NCT01120704|9790078|FG025|STARTED|Overall Study||14
8741553|NCT01120704|9790079|FG026|STARTED|Overall Study||18
8741554|NCT01120704|9790080|FG027|STARTED|Overall Study||18
8741555|NCT01120704|9790081|FG028|STARTED|Overall Study||19
8741556|NCT01120704|9790082|FG029|STARTED|Overall Study||15
8741557|NCT01120704|9790083|FG030|STARTED|Overall Study||14
8741558|NCT01120704|9790084|FG031|STARTED|Overall Study||18
8741559|NCT01120704|9790053|FG000|COMPLETED|Overall Study||10
8741560|NCT01120704|9790054|FG001|COMPLETED|Overall Study||13
8741561|NCT01120704|9790055|FG002|COMPLETED|Overall Study||13
8741562|NCT01120704|9790056|FG003|COMPLETED|Overall Study||15
8741563|NCT01120704|9790057|FG004|COMPLETED|Overall Study||14
8741564|NCT01120704|9790058|FG005|COMPLETED|Overall Study||18
8741565|NCT01120704|9790059|FG006|COMPLETED|Overall Study||12
8741566|NCT01120704|9790060|FG007|COMPLETED|Overall Study||13
8741567|NCT01120704|9790061|FG008|COMPLETED|Overall Study||19
8741568|NCT01120704|9790062|FG009|COMPLETED|Overall Study||19
8741569|NCT01120704|9790063|FG010|COMPLETED|Overall Study||16
8741570|NCT01120704|9790064|FG011|COMPLETED|Overall Study||14
8741571|NCT01120704|9790065|FG012|COMPLETED|Overall Study||14
8741572|NCT01120704|9790066|FG013|COMPLETED|Overall Study||15
8741573|NCT01120704|9790067|FG014|COMPLETED|Overall Study||17
8741574|NCT01120704|9790068|FG015|COMPLETED|Overall Study||16
8741575|NCT01120704|9790069|FG016|COMPLETED|Overall Study||13
8741576|NCT01120704|9790070|FG017|COMPLETED|Overall Study||16
8741577|NCT01120704|9790071|FG018|COMPLETED|Overall Study||15
8741578|NCT01120704|9790072|FG019|COMPLETED|Overall Study||15
8741579|NCT01120704|9790073|FG020|COMPLETED|Overall Study||14
8741580|NCT01120704|9790074|FG021|COMPLETED|Overall Study||16
8741581|NCT01120704|9790075|FG022|COMPLETED|Overall Study||17
8741582|NCT01120704|9790076|FG023|COMPLETED|Overall Study||13
8741583|NCT01120704|9790077|FG024|COMPLETED|Overall Study||16
8741584|NCT01120704|9790078|FG025|COMPLETED|Overall Study||14
8741585|NCT01120704|9790079|FG026|COMPLETED|Overall Study||15
8741586|NCT01120704|9790080|FG027|COMPLETED|Overall Study||16
8741587|NCT01120704|9790081|FG028|COMPLETED|Overall Study||14
8741588|NCT01120704|9790082|FG029|COMPLETED|Overall Study||12
8741589|NCT01120704|9790083|FG030|COMPLETED|Overall Study||12
8741590|NCT01120704|9790084|FG031|COMPLETED|Overall Study||17
8741591|NCT01120704|9790053|FG000|NOT COMPLETED|Overall Study||3
8741592|NCT01120704|9790054|FG001|NOT COMPLETED|Overall Study||4
8741593|NCT01120704|9790055|FG002|NOT COMPLETED|Overall Study||1
8741594|NCT01120704|9790056|FG003|NOT COMPLETED|Overall Study||4
8741595|NCT01120704|9790057|FG004|NOT COMPLETED|Overall Study||2
8741596|NCT01120704|9790058|FG005|NOT COMPLETED|Overall Study||1
8741597|NCT01120704|9790059|FG006|NOT COMPLETED|Overall Study||3
8741598|NCT01120704|9790060|FG007|NOT COMPLETED|Overall Study||2
8741599|NCT01120704|9790061|FG008|NOT COMPLETED|Overall Study||3
8741600|NCT01120704|9790062|FG009|NOT COMPLETED|Overall Study||1
8741601|NCT01120704|9790063|FG010|NOT COMPLETED|Overall Study||1
8741602|NCT01120704|9790064|FG011|NOT COMPLETED|Overall Study||2
8741603|NCT01120704|9790065|FG012|NOT COMPLETED|Overall Study||3
8741604|NCT01120704|9790066|FG013|NOT COMPLETED|Overall Study||4
8741605|NCT01120704|9790067|FG014|NOT COMPLETED|Overall Study||1
8741606|NCT01120704|9790068|FG015|NOT COMPLETED|Overall Study||2
8741607|NCT01120704|9790069|FG016|NOT COMPLETED|Overall Study||1
8741608|NCT01120704|9790070|FG017|NOT COMPLETED|Overall Study||0
8741609|NCT01120704|9790071|FG018|NOT COMPLETED|Overall Study||2
8741610|NCT01120704|9790072|FG019|NOT COMPLETED|Overall Study||3
8741611|NCT01120704|9790073|FG020|NOT COMPLETED|Overall Study||3
8741612|NCT01120704|9790074|FG021|NOT COMPLETED|Overall Study||0
8741613|NCT01120704|9790075|FG022|NOT COMPLETED|Overall Study||4
8741614|NCT01120704|9790076|FG023|NOT COMPLETED|Overall Study||3
8741615|NCT01120704|9790077|FG024|NOT COMPLETED|Overall Study||2
8741616|NCT01120704|9790078|FG025|NOT COMPLETED|Overall Study||0
8741617|NCT01120704|9790079|FG026|NOT COMPLETED|Overall Study||3
8741618|NCT01120704|9790080|FG027|NOT COMPLETED|Overall Study||2
8741619|NCT01120704|9790081|FG028|NOT COMPLETED|Overall Study||5
8741620|NCT01120704|9790082|FG029|NOT COMPLETED|Overall Study||3
8741621|NCT01120704|9790083|FG030|NOT COMPLETED|Overall Study||2
8741622|NCT01120704|9790084|FG031|NOT COMPLETED|Overall Study||1
8741623|NCT01120717|9790100|FG000|STARTED|Overall Study||226
8741624|NCT01120717|9790101|FG001|STARTED|Overall Study||113
8741625|NCT01120717|9790100|FG000|Safety Population: Received Study Drug|Overall Study||225
8741626|NCT01120717|9790101|FG001|Safety Population: Received Study Drug|Overall Study||113
8741627|NCT01120717|9790100|FG000|COMPLETED|Overall Study||194
8741628|NCT01120717|9790101|FG001|COMPLETED|Overall Study||89
8741629|NCT01120717|9790100|FG000|NOT COMPLETED|Overall Study||32
8741630|NCT01120717|9790101|FG001|NOT COMPLETED|Overall Study||24
8741631|NCT01120756|9790109|FG000|STARTED|Overall Study||21
8741632|NCT01120756|9790110|FG001|STARTED|Overall Study||14
8741633|NCT01120756|9790109|FG000|COMPLETED|Overall Study||20
8741634|NCT01120756|9790110|FG001|COMPLETED|Overall Study||13
8741635|NCT01120756|9790109|FG000|NOT COMPLETED|Overall Study||1
8741636|NCT01120756|9790110|FG001|NOT COMPLETED|Overall Study||1
8741637|NCT01120782|9790116|FG000|STARTED|Overall Study||45
8741638|NCT01120782|9790116|FG000|COMPLETED|Overall Study||34
8741639|NCT01120782|9790116|FG000|NOT COMPLETED|Overall Study||11
8741640|NCT01120808|9790120|FG000|STARTED|Overall Study||136
8741641|NCT01120808|9790120|FG000|COMPLETED|Overall Study||90
8741642|NCT01120808|9790120|FG000|NOT COMPLETED|Overall Study||46
8741643|NCT01120834|9790124|FG000|STARTED|Overall Study||18
8741644|NCT01120834|9790124|FG000|COMPLETED|Overall Study||18
8741645|NCT01120834|9790124|FG000|NOT COMPLETED|Overall Study||0
8741646|NCT01120899|9790128|FG000|STARTED|Overall Study||6
8741647|NCT01120899|9790128|FG000|Month 6|Overall Study||5
8741648|NCT01120899|9790128|FG000|Month 12|Overall Study||3
8741649|NCT01120899|9790128|FG000|Month 18|Overall Study||3
8741650|NCT01120899|9790128|FG000|COMPLETED|Overall Study||3
8741651|NCT01120899|9790128|FG000|NOT COMPLETED|Overall Study||3
8741652|NCT01120990|9790132|FG000|STARTED|Overall Study||51
8741653|NCT01120990|9790132|FG000|COMPLETED|Overall Study||51
8741654|NCT01120990|9790132|FG000|NOT COMPLETED|Overall Study||0
8741655|NCT01121146|9790138|FG000|STARTED|Overall Study||116
8741656|NCT01121146|9790139|FG001|STARTED|Overall Study||114
8741657|NCT01121146|9790138|FG000|COMPLETED|Overall Study|The 90 hips include those that were not revised and had a minimum 9-year questionnaire or radiograph|90
8741658|NCT01121146|9790139|FG001|COMPLETED|Overall Study|The 72 hips include those that were not revised and had a minimum 9-year questionnaire or radiograph|72
8741659|NCT01121146|9790138|FG000|NOT COMPLETED|Overall Study||26
8741660|NCT01121146|9790139|FG001|NOT COMPLETED|Overall Study||42
8741661|NCT01121172|9790148|FG000|STARTED|Overall Study||90
8741662|NCT01121172|9790149|FG001|STARTED|Overall Study||90
8741663|NCT01121172|9790148|FG000|COMPLETED|Overall Study||90
8741664|NCT01121172|9790149|FG001|COMPLETED|Overall Study||90
8741665|NCT01121172|9790148|FG000|NOT COMPLETED|Overall Study||0
8741666|NCT01121172|9790149|FG001|NOT COMPLETED|Overall Study||0
8741667|NCT01121185|9790158|FG000|STARTED|Overall Study||7
8741668|NCT01121185|9790159|FG001|STARTED|Overall Study||6
8741669|NCT01121185|9790158|FG000|Infused|Overall Study||7
8741670|NCT01121185|9790159|FG001|Infused|Overall Study|Excluded medical condition identified in one subject after randomization but before study infusion.|5
8741671|NCT01121185|9790158|FG000|Transplanted|Overall Study|One subject initiated the first study infusion, but transplant surgery was subsequently cancelled.|6
8741672|NCT01121185|9790159|FG001|Transplanted|Overall Study||5
8741673|NCT01121185|9790158|FG000|COMPLETED|Overall Study||6
8741674|NCT01121185|9790159|FG001|COMPLETED|Overall Study||5
8741675|NCT01121185|9790158|FG000|NOT COMPLETED|Overall Study||1
8741676|NCT01121185|9790159|FG001|NOT COMPLETED|Overall Study||1
8741677|NCT01121211|9790167|FG000|STARTED|Overall Study||43
8741678|NCT01121211|9790168|FG001|STARTED|Overall Study||47
8741679|NCT01121211|9790167|FG000|COMPLETED|Overall Study||32
8741680|NCT01121211|9790168|FG001|COMPLETED|Overall Study||35
8741681|NCT01121211|9790167|FG000|NOT COMPLETED|Overall Study||11
8741682|NCT01121211|9790168|FG001|NOT COMPLETED|Overall Study||12
8741683|NCT01121224|9790176|FG000|STARTED|Overall Study||305
8741684|NCT01121224|9790177|FG001|STARTED|Overall Study||292
8741685|NCT01121224|9790176|FG000|COMPLETED|Overall Study||280
8741686|NCT01121224|9790177|FG001|COMPLETED|Overall Study||275
8741687|NCT01121224|9790176|FG000|NOT COMPLETED|Overall Study||25
8741688|NCT01121224|9790177|FG001|NOT COMPLETED|Overall Study||17
8741689|NCT01121250|9790188|FG000|STARTED|Overall Study||76
8741690|NCT01121250|9790189|FG001|STARTED|Overall Study||76
8741691|NCT01121250|9790190|FG002|STARTED|Overall Study||76
8741692|NCT01121250|9790188|FG000|COMPLETED|Overall Study||76
8741693|NCT01121250|9790189|FG001|COMPLETED|Overall Study||76
8741694|NCT01121250|9790190|FG002|COMPLETED|Overall Study||75
8741695|NCT01121250|9790188|FG000|NOT COMPLETED|Overall Study||0
8741696|NCT01121250|9790189|FG001|NOT COMPLETED|Overall Study||0
8741697|NCT01121250|9790190|FG002|NOT COMPLETED|Overall Study||1
8741698|NCT01121263|9790200|FG000|STARTED|Overall Study||200
8741699|NCT01121263|9790201|FG001|STARTED|Overall Study||98
8741700|NCT01121263|9790200|FG000|COMPLETED|Overall Study||175
8741701|NCT01121263|9790201|FG001|COMPLETED|Overall Study||83
8741702|NCT01121263|9790200|FG000|NOT COMPLETED|Overall Study||25
8741703|NCT01121263|9790201|FG001|NOT COMPLETED|Overall Study||15
8741704|NCT01121393|9790211|FG000|STARTED|Overall Study|Randomised|242
8741705|NCT01121393|9790212|FG001|STARTED|Overall Study|Randomised|122
8741706|NCT01121393|9790211|FG000|Treated|Overall Study|Treated|239
8741707|NCT01121393|9790212|FG001|Treated|Overall Study|Treated|113
8741708|NCT01121393|9790211|FG000|COMPLETED|Overall Study|At the time of data cut-off for last-patient out (07 December 2017)|0
8741709|NCT01121393|9790212|FG001|COMPLETED|Overall Study|Completed 6 courses of chemotherapy|38
8741710|NCT01121393|9790211|FG000|NOT COMPLETED|Overall Study||242
8741711|NCT01121393|9790212|FG001|NOT COMPLETED|Overall Study||84
8741712|NCT01121406|9790226|FG000|STARTED|Overall Study||55
8741713|NCT01121406|9790227|FG001|STARTED|Overall Study|24 patients switched to Volasertib (BI 6727) due to disease progression or occurrence of toxicity|55
8741714|NCT01121406|9790226|FG000|COMPLETED|Overall Study||0
8741715|NCT01121406|9790227|FG001|COMPLETED|Overall Study||0
8741716|NCT01121406|9790226|FG000|NOT COMPLETED|Overall Study||55
8741717|NCT01121406|9790227|FG001|NOT COMPLETED|Overall Study||55
8741718|NCT01121484|9790238|FG000|STARTED|Overall Study||218
8741719|NCT01121484|9790239|FG001|STARTED|Overall Study||221
8741720|NCT01121484|9790238|FG000|Treated|Overall Study||217
8741721|NCT01121484|9790239|FG001|Treated|Overall Study||217
8741722|NCT01121484|9790238|FG000|COMPLETED|Overall Study||185
8741723|NCT01121484|9790239|FG001|COMPLETED|Overall Study||178
8741724|NCT01121484|9790238|FG000|NOT COMPLETED|Overall Study||33
8741725|NCT01121484|9790239|FG001|NOT COMPLETED|Overall Study||43
8741726|NCT01121536|9790245|FG000|STARTED|Overall Study||867
8741727|NCT01121536|9790245|FG000|Safety Population|Overall Study|Participants treated|863
8741728|NCT01121536|9790245|FG000|Full Analysis Population|Overall Study|Treated participants who had at least 1 post-baseline efficacy assessment.|859
8741729|NCT01121536|9790245|FG000|COMPLETED|Overall Study|One participant 'completed' early due to study closeout.|506
8741730|NCT01121536|9790245|FG000|NOT COMPLETED|Overall Study||361
8741731|NCT01121549|9790249|FG000|STARTED|Overall Study||378
8741732|NCT01121549|9790249|FG000|COMPLETED|Overall Study||31
8741733|NCT01121549|9790249|FG000|NOT COMPLETED|Overall Study||347
8741734|NCT01121562|9790253|FG000|STARTED|Overall Study||12
8741735|NCT01121562|9790253|FG000|COMPLETED|Overall Study||0
8741736|NCT01121562|9790253|FG000|NOT COMPLETED|Overall Study||12
8741737|NCT01121575|9790263|FG000|STARTED|Overall Study||14
8741738|NCT01121575|9790264|FG001|STARTED|Overall Study||6
8741739|NCT01121575|9790265|FG002|STARTED|Overall Study||7
8741740|NCT01121575|9790266|FG003|STARTED|Overall Study||6
8741741|NCT01121575|9790267|FG004|STARTED|Overall Study||25
8741742|NCT01121575|9790268|FG005|STARTED|Overall Study||12
8741743|NCT01121575|9790263|FG000|Treated|Overall Study||14
8741744|NCT01121575|9790264|FG001|Treated|Overall Study||6
8741745|NCT01121575|9790265|FG002|Treated|Overall Study||7
8741746|NCT01121575|9790266|FG003|Treated|Overall Study||6
8741747|NCT01121575|9790267|FG004|Treated|Overall Study||25
8741748|NCT01121575|9790268|FG005|Treated|Overall Study||12
8741749|NCT01121575|9790263|FG000|COMPLETED|Overall Study||0
8741750|NCT01121575|9790264|FG001|COMPLETED|Overall Study||0
8741751|NCT01121575|9790265|FG002|COMPLETED|Overall Study||0
8741752|NCT01121575|9790266|FG003|COMPLETED|Overall Study||0
8741753|NCT01121575|9790267|FG004|COMPLETED|Overall Study||0
8741754|NCT01121575|9790268|FG005|COMPLETED|Overall Study||0
8741755|NCT01121575|9790263|FG000|NOT COMPLETED|Overall Study||14
8741756|NCT01121575|9790264|FG001|NOT COMPLETED|Overall Study||6
8741757|NCT01121575|9790265|FG002|NOT COMPLETED|Overall Study||7
8741758|NCT01121575|9790266|FG003|NOT COMPLETED|Overall Study||6
8741759|NCT01121575|9790267|FG004|NOT COMPLETED|Overall Study||25
8741760|NCT01121575|9790268|FG005|NOT COMPLETED|Overall Study||12
8741761|NCT01121666|9790289|FG000|STARTED|Overall Study||249
8741762|NCT01121666|9790290|FG001|STARTED|Overall Study||123
8741763|NCT01121666|9790289|FG000|COMPLETED|Overall Study||220
8741764|NCT01121666|9790290|FG001|COMPLETED|Overall Study||113
8741765|NCT01121666|9790289|FG000|NOT COMPLETED|Overall Study||29
8741766|NCT01121666|9790290|FG001|NOT COMPLETED|Overall Study||10
8741767|NCT01121757|9790298|FG000|STARTED|First Drug||6
8741768|NCT01121757|9790299|FG001|STARTED|First Drug||3
8741769|NCT01121757|9790298|FG000|COMPLETED|First Drug|Completed a minimum of 4 cycles of Azacitidine.|5
8741770|NCT01121757|9790299|FG001|COMPLETED|First Drug|Completed a minimum of 4 cycles of Lenalidomide|1
8741771|NCT01121757|9790298|FG000|NOT COMPLETED|First Drug||1
8741772|NCT01121757|9790299|FG001|NOT COMPLETED|First Drug||2
8741773|NCT01121757|9790298|FG000|STARTED|Second Drug|1 subject did not start drug 2 due to disease progression|4
8741774|NCT01121757|9790299|FG001|STARTED|Second Drug||1
8741775|NCT01121757|9790298|FG000|COMPLETED|Second Drug||4
8912754|NCT02155608|9971945|FG000|COMPLETED|1b: 1 Week Blinded Post Treatment||31
8912755|NCT02155608|9971946|FG001|COMPLETED|1b: 1 Week Blinded Post Treatment||28
8912756|NCT02155608|9971945|FG000|NOT COMPLETED|1b: 1 Week Blinded Post Treatment||1
8912757|NCT02155608|9971946|FG001|NOT COMPLETED|1b: 1 Week Blinded Post Treatment||1
8912758|NCT02155660|9971962|FG000|STARTED|Overall Study||562
8912759|NCT02155660|9971963|FG001|STARTED|Overall Study||562
8912760|NCT02155660|9971964|FG002|STARTED|Overall Study||562
9022620|NCT03129100|10085461|FG007|COMPLETED|Period 2 (Retreatment Extension Period)||6
9022621|NCT03129100|10085462|FG008|COMPLETED|Period 2 (Retreatment Extension Period)||5
9022622|NCT03129100|10085463|FG009|COMPLETED|Period 2 (Retreatment Extension Period)||8
9022623|NCT03129100|10085464|FG010|COMPLETED|Period 2 (Retreatment Extension Period)||10
9022624|NCT03129100|10085454|FG000|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
9022625|NCT03129100|10085455|FG001|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
9022626|NCT03129100|10085456|FG002|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
9022627|NCT03129100|10085457|FG003|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
9022628|NCT03129100|10085458|FG004|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
9022629|NCT03129100|10085459|FG005|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
9022630|NCT03129100|10085460|FG006|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
9022631|NCT03129100|10085461|FG007|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
9022632|NCT03129100|10085462|FG008|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
9022633|NCT03129100|10085463|FG009|NOT COMPLETED|Period 2 (Retreatment Extension Period)||1
9022634|NCT03129100|10085464|FG010|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
9022635|NCT03129178|10085488|FG000|STARTED|Overall Study||13
9022636|NCT03129178|10085489|FG001|STARTED|Overall Study||13
9022637|NCT03129178|10085488|FG000|COMPLETED|Overall Study||12
9022638|NCT03129178|10085489|FG001|COMPLETED|Overall Study||11
9022639|NCT03129178|10085488|FG000|NOT COMPLETED|Overall Study||1
9022640|NCT03129178|10085489|FG001|NOT COMPLETED|Overall Study||2
9022641|NCT03129568|10085496|FG000|STARTED|Overall Study||5
9022642|NCT03129568|10085496|FG000|COMPLETED|Overall Study||5
9022643|NCT03129568|10085496|FG000|NOT COMPLETED|Overall Study||0
9022644|NCT03129945|10085502|FG000|STARTED|Overall Study||15
9022645|NCT03129945|10085503|FG001|STARTED|Overall Study||21
9022646|NCT03129945|10085502|FG000|COMPLETED|Overall Study||15
9022647|NCT03129945|10085503|FG001|COMPLETED|Overall Study||21
9022648|NCT03129945|10085502|FG000|NOT COMPLETED|Overall Study||0
9022649|NCT03129945|10085503|FG001|NOT COMPLETED|Overall Study||0
9022650|NCT03130257|10085512|FG000|STARTED|Overall Study||172
9022651|NCT03130257|10085513|FG001|STARTED|Overall Study||170
9022652|NCT03130257|10085514|FG002|STARTED|Overall Study||168
9022653|NCT03130257|10085512|FG000|COMPLETED|Overall Study||171
9022654|NCT03130257|10085513|FG001|COMPLETED|Overall Study||170
9022655|NCT03130257|10085514|FG002|COMPLETED|Overall Study||166
9022656|NCT03130257|10085512|FG000|NOT COMPLETED|Overall Study||1
9022657|NCT03130257|10085513|FG001|NOT COMPLETED|Overall Study||0
9022658|NCT03130257|10085514|FG002|NOT COMPLETED|Overall Study||2
9022659|NCT03130738|10085525|FG000|STARTED|Overall Study||23
9022660|NCT03130738|10085526|FG001|STARTED|Overall Study||22
9022661|NCT03130738|10085527|FG002|STARTED|Overall Study||20
9022662|NCT03130738|10085525|FG000|COMPLETED|Overall Study||20
9022663|NCT03130738|10085526|FG001|COMPLETED|Overall Study||20
9022664|NCT03130738|10085527|FG002|COMPLETED|Overall Study||14
9022665|NCT03130738|10085525|FG000|NOT COMPLETED|Overall Study||3
9022666|NCT03130738|10085526|FG001|NOT COMPLETED|Overall Study||2
9022667|NCT03130738|10085527|FG002|NOT COMPLETED|Overall Study||6
9022668|NCT03131167|10085548|FG000|STARTED|Overall Study||6
9022669|NCT03131167|10085549|FG001|STARTED|Overall Study||5
9022670|NCT03131167|10085550|FG002|STARTED|Overall Study||5
9022671|NCT03131167|10085551|FG003|STARTED|Overall Study||5
9022672|NCT03131167|10085552|FG004|STARTED|Overall Study||6
9022673|NCT03131167|10085553|FG005|STARTED|Overall Study||5
9022674|NCT03131167|10085554|FG006|STARTED|Overall Study||5
9022675|NCT03131167|10085555|FG007|STARTED|Overall Study||5
9022676|NCT03131167|10085556|FG008|STARTED|Overall Study||2
9022677|NCT03131167|10085557|FG009|STARTED|Overall Study||5
9022678|NCT03131167|10085558|FG010|STARTED|Overall Study||4
9022679|NCT03131167|10085559|FG011|STARTED|Overall Study||5
9022680|NCT03131167|10085560|FG012|STARTED|Overall Study||5
9022681|NCT03131167|10085548|FG000|COMPLETED|Overall Study||6
9022682|NCT03131167|10085549|FG001|COMPLETED|Overall Study||5
9022683|NCT03131167|10085550|FG002|COMPLETED|Overall Study||5
9022684|NCT03131167|10085551|FG003|COMPLETED|Overall Study||5
9022685|NCT03131167|10085552|FG004|COMPLETED|Overall Study||6
9022686|NCT03131167|10085553|FG005|COMPLETED|Overall Study||4
9022687|NCT03131167|10085554|FG006|COMPLETED|Overall Study||5
8912761|NCT02155660|9971965|FG003|STARTED|Overall Study||568
8912762|NCT02155660|9971962|FG000|COMPLETED|Overall Study||504
8912763|NCT02155660|9971963|FG001|COMPLETED|Overall Study||489
9022688|NCT03131167|10085555|FG007|COMPLETED|Overall Study||5
9022689|NCT03131167|10085556|FG008|COMPLETED|Overall Study||2
9022690|NCT03131167|10085557|FG009|COMPLETED|Overall Study||5
9022691|NCT03131167|10085558|FG010|COMPLETED|Overall Study||4
9022692|NCT03131167|10085559|FG011|COMPLETED|Overall Study||5
9022693|NCT03131167|10085560|FG012|COMPLETED|Overall Study||5
9022694|NCT03131167|10085548|FG000|NOT COMPLETED|Overall Study||0
8741776|NCT01121757|9790299|FG001|COMPLETED|Second Drug||1
8741777|NCT01121757|9790298|FG000|NOT COMPLETED|Second Drug||0
8741778|NCT01121757|9790299|FG001|NOT COMPLETED|Second Drug||0
8741779|NCT01121757|9790298|FG000|STARTED|Combination|2 subjects did not start combination drug. 1 elected surgery 1 had a complete response after drug 2.|2
8741780|NCT01121757|9790299|FG001|STARTED|Combination||1
8741781|NCT01121757|9790298|FG000|COMPLETED|Combination||0
8741782|NCT01121757|9790299|FG001|COMPLETED|Combination||0
8741783|NCT01121757|9790298|FG000|NOT COMPLETED|Combination||2
8741784|NCT01121757|9790299|FG001|NOT COMPLETED|Combination||1
8741785|NCT01121900|9790307|FG000|STARTED|First Intervention Period||13
8741786|NCT01121900|9790308|FG001|STARTED|First Intervention Period||13
8741787|NCT01121900|9790307|FG000|COMPLETED|First Intervention Period||12
8741788|NCT01121900|9790308|FG001|COMPLETED|First Intervention Period||12
8741789|NCT01121900|9790307|FG000|NOT COMPLETED|First Intervention Period||1
8741790|NCT01121900|9790308|FG001|NOT COMPLETED|First Intervention Period||1
8741791|NCT01121900|9790307|FG000|STARTED|Washout Period of 7 Days||12
8741792|NCT01121900|9790308|FG001|STARTED|Washout Period of 7 Days||12
8741793|NCT01121900|9790307|FG000|COMPLETED|Washout Period of 7 Days||12
8741794|NCT01121900|9790308|FG001|COMPLETED|Washout Period of 7 Days||11
8741795|NCT01121900|9790307|FG000|NOT COMPLETED|Washout Period of 7 Days||0
8741796|NCT01121900|9790308|FG001|NOT COMPLETED|Washout Period of 7 Days||1
8741797|NCT01121900|9790307|FG000|STARTED|Second Intervention Period||12
8741798|NCT01121900|9790308|FG001|STARTED|Second Intervention Period||11
8741799|NCT01121900|9790307|FG000|COMPLETED|Second Intervention Period||12
8741800|NCT01121900|9790308|FG001|COMPLETED|Second Intervention Period||11
8741801|NCT01121900|9790307|FG000|NOT COMPLETED|Second Intervention Period||0
8741802|NCT01121900|9790308|FG001|NOT COMPLETED|Second Intervention Period||0
8741803|NCT01121913|9790314|FG000|STARTED|First Intervention Period||6
8741804|NCT01121913|9790315|FG001|STARTED|First Intervention Period||6
8741805|NCT01121913|9790316|FG002|STARTED|First Intervention Period||6
8741806|NCT01121913|9790317|FG003|STARTED|First Intervention Period||6
8741807|NCT01121913|9790314|FG000|COMPLETED|First Intervention Period||6
8741808|NCT01121913|9790315|FG001|COMPLETED|First Intervention Period||6
8741809|NCT01121913|9790316|FG002|COMPLETED|First Intervention Period||5
8741810|NCT01121913|9790317|FG003|COMPLETED|First Intervention Period||6
8741811|NCT01121913|9790314|FG000|NOT COMPLETED|First Intervention Period||0
8741812|NCT01121913|9790315|FG001|NOT COMPLETED|First Intervention Period||0
8741813|NCT01121913|9790316|FG002|NOT COMPLETED|First Intervention Period||1
8741814|NCT01121913|9790317|FG003|NOT COMPLETED|First Intervention Period||0
8912764|NCT02155660|9971964|FG002|COMPLETED|Overall Study||502
8912765|NCT02155660|9971965|FG003|COMPLETED|Overall Study||507
8912766|NCT02155660|9971962|FG000|NOT COMPLETED|Overall Study||58
8912767|NCT02155660|9971963|FG001|NOT COMPLETED|Overall Study||73
8912768|NCT02155660|9971964|FG002|NOT COMPLETED|Overall Study||60
8912769|NCT02155660|9971965|FG003|NOT COMPLETED|Overall Study||61
8912770|NCT02155712|9971977|FG000|STARTED|Primary Objective||319
8912771|NCT02155712|9971978|FG001|STARTED|Primary Objective|Cohort 2 isn't included in primary obj analysis|0
8912772|NCT02155712|9971977|FG000|COMPLETED|Primary Objective||259
8912773|NCT02155712|9971978|FG001|COMPLETED|Primary Objective||0
8912774|NCT02155712|9971977|FG000|NOT COMPLETED|Primary Objective||60
8912775|NCT02155712|9971978|FG001|NOT COMPLETED|Primary Objective||0
8912776|NCT02155712|9971977|FG000|STARTED|Secondary Objectives||319
8912777|NCT02155712|9971978|FG001|STARTED|Secondary Objectives|This period will be updated when posting secondary objective results.|134
8912778|NCT02155712|9971977|FG000|COMPLETED|Secondary Objectives||0
8912779|NCT02155712|9971978|FG001|COMPLETED|Secondary Objectives||0
8912780|NCT02155712|9971977|FG000|NOT COMPLETED|Secondary Objectives||319
8912781|NCT02155712|9971978|FG001|NOT COMPLETED|Secondary Objectives||134
8912782|NCT02155725|9971986|FG000|STARTED|Treatment Period||224
8912783|NCT02155725|9971987|FG001|STARTED|Treatment Period||213
8912784|NCT02155725|9971986|FG000|COMPLETED|Treatment Period||224
8912785|NCT02155725|9971987|FG001|COMPLETED|Treatment Period||213
8912786|NCT02155725|9971986|FG000|NOT COMPLETED|Treatment Period||0
8912787|NCT02155725|9971987|FG001|NOT COMPLETED|Treatment Period||0
8912788|NCT02155725|9971986|FG000|STARTED|Follow-up Period||224
8912789|NCT02155725|9971987|FG001|STARTED|Follow-up Period||213
8741815|NCT01121913|9790314|FG000|STARTED|First Washout Period||6
8741816|NCT01121913|9790315|FG001|STARTED|First Washout Period||6
8741817|NCT01121913|9790316|FG002|STARTED|First Washout Period||5
8912790|NCT02155725|9971986|FG000|COMPLETED|Follow-up Period||207
8912791|NCT02155725|9971987|FG001|COMPLETED|Follow-up Period||202
8912792|NCT02155725|9971986|FG000|NOT COMPLETED|Follow-up Period||17
8912793|NCT02155725|9971987|FG001|NOT COMPLETED|Follow-up Period||11
8912794|NCT02155738|9972003|FG000|STARTED|Overall Study||50
8912795|NCT02155738|9972004|FG001|STARTED|Overall Study||52
8912796|NCT02155738|9972005|FG002|STARTED|Overall Study||51
8912797|NCT02155738|9972006|FG003|STARTED|Overall Study||51
8912798|NCT02155738|9972003|FG000|COMPLETED|Overall Study||49
8912799|NCT02155738|9972004|FG001|COMPLETED|Overall Study||52
8912800|NCT02155738|9972005|FG002|COMPLETED|Overall Study||51
8741818|NCT01121913|9790317|FG003|STARTED|First Washout Period||6
8741819|NCT01121913|9790314|FG000|COMPLETED|First Washout Period||5
8741820|NCT01121913|9790315|FG001|COMPLETED|First Washout Period||6
8741821|NCT01121913|9790316|FG002|COMPLETED|First Washout Period||5
8912801|NCT02155738|9972006|FG003|COMPLETED|Overall Study||50
8912802|NCT02155738|9972003|FG000|NOT COMPLETED|Overall Study||1
8912803|NCT02155738|9972004|FG001|NOT COMPLETED|Overall Study||0
8741822|NCT01121913|9790317|FG003|COMPLETED|First Washout Period||6
8741823|NCT01121913|9790314|FG000|NOT COMPLETED|First Washout Period||1
8741824|NCT01121913|9790315|FG001|NOT COMPLETED|First Washout Period||0
8741825|NCT01121913|9790316|FG002|NOT COMPLETED|First Washout Period||0
8741826|NCT01121913|9790317|FG003|NOT COMPLETED|First Washout Period||0
8741827|NCT01121913|9790314|FG000|STARTED|Second Intervention Period||5
8741828|NCT01121913|9790315|FG001|STARTED|Second Intervention Period||6
8741829|NCT01121913|9790316|FG002|STARTED|Second Intervention Period||5
8741830|NCT01121913|9790317|FG003|STARTED|Second Intervention Period||6
8741831|NCT01121913|9790314|FG000|COMPLETED|Second Intervention Period||5
8741832|NCT01121913|9790315|FG001|COMPLETED|Second Intervention Period||6
8741833|NCT01121913|9790316|FG002|COMPLETED|Second Intervention Period||4
8741834|NCT01121913|9790317|FG003|COMPLETED|Second Intervention Period||6
8741835|NCT01121913|9790314|FG000|NOT COMPLETED|Second Intervention Period||0
8741836|NCT01121913|9790315|FG001|NOT COMPLETED|Second Intervention Period||0
8741837|NCT01121913|9790316|FG002|NOT COMPLETED|Second Intervention Period||1
8741838|NCT01121913|9790317|FG003|NOT COMPLETED|Second Intervention Period||0
8741839|NCT01121913|9790314|FG000|STARTED|Second Washout Period||5
8741840|NCT01121913|9790315|FG001|STARTED|Second Washout Period||6
8741841|NCT01121913|9790316|FG002|STARTED|Second Washout Period||4
8741842|NCT01121913|9790317|FG003|STARTED|Second Washout Period||6
8741843|NCT01121913|9790314|FG000|COMPLETED|Second Washout Period||5
8741844|NCT01121913|9790315|FG001|COMPLETED|Second Washout Period||6
8741845|NCT01121913|9790316|FG002|COMPLETED|Second Washout Period||3
8741846|NCT01121913|9790317|FG003|COMPLETED|Second Washout Period||6
8741847|NCT01121913|9790314|FG000|NOT COMPLETED|Second Washout Period||0
8741848|NCT01121913|9790315|FG001|NOT COMPLETED|Second Washout Period||0
8741849|NCT01121913|9790316|FG002|NOT COMPLETED|Second Washout Period||1
8741850|NCT01121913|9790317|FG003|NOT COMPLETED|Second Washout Period||0
8741851|NCT01121913|9790314|FG000|STARTED|Third Intervention Period||5
8741852|NCT01121913|9790315|FG001|STARTED|Third Intervention Period||6
8741853|NCT01121913|9790316|FG002|STARTED|Third Intervention Period||3
8741854|NCT01121913|9790317|FG003|STARTED|Third Intervention Period||6
8741855|NCT01121913|9790314|FG000|COMPLETED|Third Intervention Period||5
8741856|NCT01121913|9790315|FG001|COMPLETED|Third Intervention Period||6
8741857|NCT01121913|9790316|FG002|COMPLETED|Third Intervention Period||3
8741858|NCT01121913|9790317|FG003|COMPLETED|Third Intervention Period||6
8741859|NCT01121913|9790314|FG000|NOT COMPLETED|Third Intervention Period||0
8741860|NCT01121913|9790315|FG001|NOT COMPLETED|Third Intervention Period||0
8741861|NCT01121913|9790316|FG002|NOT COMPLETED|Third Intervention Period||0
8741862|NCT01121913|9790317|FG003|NOT COMPLETED|Third Intervention Period||0
8741863|NCT01121913|9790314|FG000|STARTED|Third Washout Period||5
8741864|NCT01121913|9790315|FG001|STARTED|Third Washout Period||6
8741865|NCT01121913|9790316|FG002|STARTED|Third Washout Period||3
8741866|NCT01121913|9790317|FG003|STARTED|Third Washout Period||6
8741867|NCT01121913|9790314|FG000|COMPLETED|Third Washout Period||4
8741868|NCT01121913|9790315|FG001|COMPLETED|Third Washout Period||6
8741869|NCT01121913|9790316|FG002|COMPLETED|Third Washout Period||3
8741870|NCT01121913|9790317|FG003|COMPLETED|Third Washout Period||6
8741871|NCT01121913|9790314|FG000|NOT COMPLETED|Third Washout Period||1
8912804|NCT02155738|9972005|FG002|NOT COMPLETED|Overall Study||0
8912805|NCT02155738|9972006|FG003|NOT COMPLETED|Overall Study||1
8912806|NCT02155829|9972018|FG000|STARTED|Overall Study||37
8912807|NCT02155829|9972019|FG001|STARTED|Overall Study||38
8912808|NCT02155829|9972018|FG000|COMPLETED|Overall Study||31
8912809|NCT02155829|9972019|FG001|COMPLETED|Overall Study||35
8912810|NCT02155829|9972018|FG000|NOT COMPLETED|Overall Study||6
8912811|NCT02155829|9972019|FG001|NOT COMPLETED|Overall Study||3
8912812|NCT02155881|9972028|FG000|STARTED|Overall Study||40
8912813|NCT02155881|9972029|FG001|STARTED|Overall Study||40
8912814|NCT02155881|9972028|FG000|COMPLETED|Overall Study||38
8912815|NCT02155881|9972029|FG001|COMPLETED|Overall Study||36
8912816|NCT02155881|9972028|FG000|NOT COMPLETED|Overall Study||2
8912817|NCT02155881|9972029|FG001|NOT COMPLETED|Overall Study||4
8912818|NCT02155985|9972038|FG000|STARTED|Overall Study||40
8912819|NCT02155985|9972039|FG001|STARTED|Overall Study||41
8912820|NCT02155985|9972040|FG002|STARTED|Overall Study||40
8912821|NCT02155985|9972038|FG000|COMPLETED|Overall Study||39
8912822|NCT02155985|9972039|FG001|COMPLETED|Overall Study||41
8912823|NCT02155985|9972040|FG002|COMPLETED|Overall Study||39
8912824|NCT02155985|9972038|FG000|NOT COMPLETED|Overall Study||1
8912825|NCT02155985|9972039|FG001|NOT COMPLETED|Overall Study||0
8912826|NCT02155985|9972040|FG002|NOT COMPLETED|Overall Study||1
8912827|NCT02156076|9972052|FG000|STARTED|Treatment Period||7
8912828|NCT02156076|9972053|FG001|STARTED|Treatment Period||7
8912829|NCT02156076|9972054|FG002|STARTED|Treatment Period||6
8912830|NCT02156076|9972055|FG003|STARTED|Treatment Period||6
8912831|NCT02156076|9972052|FG000|COMPLETED|Treatment Period||7
8912832|NCT02156076|9972053|FG001|COMPLETED|Treatment Period||5
8912833|NCT02156076|9972054|FG002|COMPLETED|Treatment Period||4
8912834|NCT02156076|9972055|FG003|COMPLETED|Treatment Period||4
8912835|NCT02156076|9972052|FG000|NOT COMPLETED|Treatment Period||0
8912836|NCT02156076|9972053|FG001|NOT COMPLETED|Treatment Period||2
8912837|NCT02156076|9972054|FG002|NOT COMPLETED|Treatment Period||2
8912838|NCT02156076|9972055|FG003|NOT COMPLETED|Treatment Period||2
8912839|NCT02156076|9972052|FG000|STARTED|Follow-up Period||7
8912840|NCT02156076|9972053|FG001|STARTED|Follow-up Period||5
8741872|NCT01121913|9790315|FG001|NOT COMPLETED|Third Washout Period||0
8741873|NCT01121913|9790316|FG002|NOT COMPLETED|Third Washout Period||0
8741874|NCT01121913|9790317|FG003|NOT COMPLETED|Third Washout Period||0
8741875|NCT01121913|9790314|FG000|STARTED|Fourth Intervention Period||4
8741876|NCT01121913|9790315|FG001|STARTED|Fourth Intervention Period||6
8741877|NCT01121913|9790316|FG002|STARTED|Fourth Intervention Period||3
8741878|NCT01121913|9790317|FG003|STARTED|Fourth Intervention Period||6
8741879|NCT01121913|9790314|FG000|COMPLETED|Fourth Intervention Period||4
8741880|NCT01121913|9790315|FG001|COMPLETED|Fourth Intervention Period||6
8741881|NCT01121913|9790316|FG002|COMPLETED|Fourth Intervention Period||3
8741882|NCT01121913|9790317|FG003|COMPLETED|Fourth Intervention Period||6
8741883|NCT01121913|9790314|FG000|NOT COMPLETED|Fourth Intervention Period||0
8741884|NCT01121913|9790315|FG001|NOT COMPLETED|Fourth Intervention Period||0
8741885|NCT01121913|9790316|FG002|NOT COMPLETED|Fourth Intervention Period||0
8741886|NCT01121913|9790317|FG003|NOT COMPLETED|Fourth Intervention Period||0
8741887|NCT01121926|9790327|FG000|STARTED|First Intervention Period||15
8741888|NCT01121926|9790328|FG001|STARTED|First Intervention Period||15
8741889|NCT01121926|9790327|FG000|COMPLETED|First Intervention Period||14
8741890|NCT01121926|9790328|FG001|COMPLETED|First Intervention Period||15
8741891|NCT01121926|9790327|FG000|NOT COMPLETED|First Intervention Period||1
8741892|NCT01121926|9790328|FG001|NOT COMPLETED|First Intervention Period||0
8741893|NCT01121926|9790327|FG000|STARTED|Washout Period||14
8741894|NCT01121926|9790328|FG001|STARTED|Washout Period||15
8741895|NCT01121926|9790327|FG000|COMPLETED|Washout Period||14
8741896|NCT01121926|9790328|FG001|COMPLETED|Washout Period||13
8741897|NCT01121926|9790327|FG000|NOT COMPLETED|Washout Period||0
8741898|NCT01121926|9790328|FG001|NOT COMPLETED|Washout Period||2
8741899|NCT01121926|9790327|FG000|STARTED|Second Intervention Period||14
8741900|NCT01121926|9790328|FG001|STARTED|Second Intervention Period||13
8741901|NCT01121926|9790327|FG000|COMPLETED|Second Intervention Period||14
8741902|NCT01121926|9790328|FG001|COMPLETED|Second Intervention Period||13
8741903|NCT01121926|9790327|FG000|NOT COMPLETED|Second Intervention Period||0
8741904|NCT01121926|9790328|FG001|NOT COMPLETED|Second Intervention Period||0
8741905|NCT01121939|9790334|FG000|STARTED|Overall Study||43
8741906|NCT01121939|9790334|FG000|COMPLETED|Overall Study|Patients remained on-study until disease progression or unacceptable toxicity occurred.|0
8741907|NCT01121939|9790334|FG000|NOT COMPLETED|Overall Study||43
8741908|NCT01121991|9790341|FG000|STARTED|Overall Study|Number of participants treated|52
8741909|NCT01121991|9790341|FG000|COMPLETED|Overall Study||46
8741910|NCT01121991|9790341|FG000|NOT COMPLETED|Overall Study||6
8741911|NCT01122030|9790352|FG000|STARTED|Overall Study||18
8741912|NCT01122030|9790353|FG001|STARTED|Overall Study||9
8741913|NCT01122030|9790354|FG002|STARTED|Overall Study||9
8741914|NCT01122030|9790355|FG003|STARTED|Overall Study||9
8741915|NCT01122030|9790356|FG004|STARTED|Overall Study||9
8741916|NCT01122030|9790357|FG005|STARTED|Overall Study||9
8741917|NCT01122030|9790358|FG006|STARTED|Overall Study||9
8741918|NCT01122030|9790352|FG000|Received Treatment|Overall Study||18
8741919|NCT01122030|9790353|FG001|Received Treatment|Overall Study||9
8741920|NCT01122030|9790354|FG002|Received Treatment|Overall Study||9
8741921|NCT01122030|9790355|FG003|Received Treatment|Overall Study||9
8741922|NCT01122030|9790356|FG004|Received Treatment|Overall Study||9
8741923|NCT01122030|9790357|FG005|Received Treatment|Overall Study||9
8741924|NCT01122030|9790358|FG006|Received Treatment|Overall Study||9
8741925|NCT01122030|9790352|FG000|COMPLETED|Overall Study||18
8741926|NCT01122030|9790353|FG001|COMPLETED|Overall Study||9
8741927|NCT01122030|9790354|FG002|COMPLETED|Overall Study||9
8741928|NCT01122030|9790355|FG003|COMPLETED|Overall Study||9
8741929|NCT01122030|9790356|FG004|COMPLETED|Overall Study||9
8741930|NCT01122030|9790357|FG005|COMPLETED|Overall Study||9
8741931|NCT01122030|9790358|FG006|COMPLETED|Overall Study||9
8741932|NCT01122030|9790352|FG000|NOT COMPLETED|Overall Study||0
8741933|NCT01122030|9790353|FG001|NOT COMPLETED|Overall Study||0
8741934|NCT01122030|9790354|FG002|NOT COMPLETED|Overall Study||0
8741935|NCT01122030|9790355|FG003|NOT COMPLETED|Overall Study||0
8741936|NCT01122030|9790356|FG004|NOT COMPLETED|Overall Study||0
8741937|NCT01122030|9790357|FG005|NOT COMPLETED|Overall Study||0
8741938|NCT01122030|9790358|FG006|NOT COMPLETED|Overall Study||0
8741939|NCT01122108|9790380|FG000|STARTED|Overall Study||21
8741940|NCT01122108|9790381|FG001|STARTED|Overall Study||21
8741941|NCT01122108|9790380|FG000|COMPLETED|Overall Study||21
8741942|NCT01122108|9790381|FG001|COMPLETED|Overall Study||21
8741943|NCT01122108|9790380|FG000|NOT COMPLETED|Overall Study||0
8741944|NCT01122108|9790381|FG001|NOT COMPLETED|Overall Study||0
8741945|NCT01122160|9790389|FG000|STARTED|First Intervention (7 Days)||6
8741946|NCT01122160|9790390|FG001|STARTED|First Intervention (7 Days)||5
8741947|NCT01122160|9790389|FG000|COMPLETED|First Intervention (7 Days)||6
8741948|NCT01122160|9790390|FG001|COMPLETED|First Intervention (7 Days)||5
8741949|NCT01122160|9790389|FG000|NOT COMPLETED|First Intervention (7 Days)||0
8741950|NCT01122160|9790390|FG001|NOT COMPLETED|First Intervention (7 Days)||0
8741951|NCT01122160|9790389|FG000|STARTED|Washout (7-14 Days)||6
8741952|NCT01122160|9790390|FG001|STARTED|Washout (7-14 Days)||5
8741953|NCT01122160|9790389|FG000|COMPLETED|Washout (7-14 Days)||6
8741954|NCT01122160|9790390|FG001|COMPLETED|Washout (7-14 Days)||5
8741955|NCT01122160|9790389|FG000|NOT COMPLETED|Washout (7-14 Days)||0
8741956|NCT01122160|9790390|FG001|NOT COMPLETED|Washout (7-14 Days)||0
8741957|NCT01122160|9790389|FG000|STARTED|Second Intervention (7 Days)||6
8741958|NCT01122160|9790390|FG001|STARTED|Second Intervention (7 Days)||5
8741959|NCT01122160|9790389|FG000|COMPLETED|Second Intervention (7 Days)||6
8741960|NCT01122160|9790390|FG001|COMPLETED|Second Intervention (7 Days)||5
8741961|NCT01122160|9790389|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
8741962|NCT01122160|9790390|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
8741963|NCT01122173|9790396|FG000|STARTED|Overall Study||150
8741964|NCT01122173|9790396|FG000|COMPLETED|Overall Study||141
8741965|NCT01122173|9790396|FG000|NOT COMPLETED|Overall Study||9
8741966|NCT01122238|9790417|FG000|STARTED|Overall Study||30
8741967|NCT01122238|9790418|FG001|STARTED|Overall Study||37
8741968|NCT01122238|9790419|FG002|STARTED|Overall Study||33
8741969|NCT01122238|9790420|FG003|STARTED|Overall Study||33
8741970|NCT01122238|9790421|FG004|STARTED|Overall Study||33
8741971|NCT01122238|9790422|FG005|STARTED|Overall Study||32
8741972|NCT01122238|9790423|FG006|STARTED|Overall Study||35
8741973|NCT01122238|9790424|FG007|STARTED|Overall Study||32
8741974|NCT01122238|9790425|FG008|STARTED|Overall Study||32
8741975|NCT01122238|9790426|FG009|STARTED|Overall Study||34
8741976|NCT01122238|9790427|FG010|STARTED|Overall Study||32
8741977|NCT01122238|9790428|FG011|STARTED|Overall Study||33
8741978|NCT01122238|9790429|FG012|STARTED|Overall Study||30
8741979|NCT01122238|9790430|FG013|STARTED|Overall Study||32
8741980|NCT01122238|9790431|FG014|STARTED|Overall Study||28
8741981|NCT01122238|9790432|FG015|STARTED|Overall Study||31
8741982|NCT01122238|9790417|FG000|COMPLETED|Overall Study||28
8741983|NCT01122238|9790418|FG001|COMPLETED|Overall Study||36
8741984|NCT01122238|9790419|FG002|COMPLETED|Overall Study||28
8741985|NCT01122238|9790420|FG003|COMPLETED|Overall Study||33
8741986|NCT01122238|9790421|FG004|COMPLETED|Overall Study||33
8741987|NCT01122238|9790422|FG005|COMPLETED|Overall Study||31
8741988|NCT01122238|9790423|FG006|COMPLETED|Overall Study||34
8741989|NCT01122238|9790424|FG007|COMPLETED|Overall Study||32
8741990|NCT01122238|9790425|FG008|COMPLETED|Overall Study||31
8741991|NCT01122238|9790426|FG009|COMPLETED|Overall Study||33
8741992|NCT01122238|9790427|FG010|COMPLETED|Overall Study||32
8741993|NCT01122238|9790428|FG011|COMPLETED|Overall Study||31
8741994|NCT01122238|9790429|FG012|COMPLETED|Overall Study||28
8741995|NCT01122238|9790430|FG013|COMPLETED|Overall Study||31
8741996|NCT01122238|9790431|FG014|COMPLETED|Overall Study||28
8741997|NCT01122238|9790432|FG015|COMPLETED|Overall Study||31
8741998|NCT01122238|9790417|FG000|NOT COMPLETED|Overall Study||2
8741999|NCT01122238|9790418|FG001|NOT COMPLETED|Overall Study||1
8742000|NCT01122238|9790419|FG002|NOT COMPLETED|Overall Study||5
8742001|NCT01122238|9790420|FG003|NOT COMPLETED|Overall Study||0
8742002|NCT01122238|9790421|FG004|NOT COMPLETED|Overall Study||0
8742003|NCT01122238|9790422|FG005|NOT COMPLETED|Overall Study||1
8742004|NCT01122238|9790423|FG006|NOT COMPLETED|Overall Study||1
8742005|NCT01122238|9790424|FG007|NOT COMPLETED|Overall Study||0
8742006|NCT01122238|9790425|FG008|NOT COMPLETED|Overall Study||1
8742007|NCT01122238|9790426|FG009|NOT COMPLETED|Overall Study||1
8742008|NCT01122238|9790427|FG010|NOT COMPLETED|Overall Study||0
8742009|NCT01122238|9790428|FG011|NOT COMPLETED|Overall Study||2
8742010|NCT01122238|9790429|FG012|NOT COMPLETED|Overall Study||2
8742011|NCT01122238|9790430|FG013|NOT COMPLETED|Overall Study||1
8742012|NCT01122238|9790431|FG014|NOT COMPLETED|Overall Study||0
8742013|NCT01122238|9790432|FG015|NOT COMPLETED|Overall Study||0
8742014|NCT01122264|9790449|FG000|STARTED|Overall Study||252
8742015|NCT01122264|9790450|FG001|STARTED|Overall Study||257
8742016|NCT01122264|9790451|FG002|STARTED|Overall Study||261
8742017|NCT01122264|9790449|FG000|Received at Least 1 Dose of Study Drug|Overall Study||250
8742018|NCT01122264|9790450|FG001|Received at Least 1 Dose of Study Drug|Overall Study||257
8742019|NCT01122264|9790451|FG002|Received at Least 1 Dose of Study Drug|Overall Study||260
8742020|NCT01122264|9790449|FG000|COMPLETED|Overall Study||220
8742021|NCT01122264|9790450|FG001|COMPLETED|Overall Study||228
8742022|NCT01122264|9790451|FG002|COMPLETED|Overall Study||214
8742023|NCT01122264|9790449|FG000|NOT COMPLETED|Overall Study||32
8742024|NCT01122264|9790450|FG001|NOT COMPLETED|Overall Study||29
8742025|NCT01122264|9790451|FG002|NOT COMPLETED|Overall Study||47
8742026|NCT01122316|9790463|FG000|STARTED|Overall Study||10
8742027|NCT01122316|9790463|FG000|COMPLETED|Overall Study||8
8742028|NCT01122316|9790463|FG000|NOT COMPLETED|Overall Study||2
8742029|NCT01122394|9790469|FG000|STARTED|Overall Study||66
8742030|NCT01122394|9790470|FG001|STARTED|Overall Study||74
8742031|NCT01122394|9790469|FG000|COMPLETED|Overall Study||63
8742032|NCT01122394|9790470|FG001|COMPLETED|Overall Study||70
8742033|NCT01122394|9790469|FG000|NOT COMPLETED|Overall Study||3
8742034|NCT01122394|9790470|FG001|NOT COMPLETED|Overall Study||4
8742035|NCT01122446|9790480|FG000|STARTED|Overall Study||25
8742036|NCT01122446|9790481|FG001|STARTED|Overall Study||25
8742037|NCT01122446|9790480|FG000|COMPLETED|Overall Study||25
8742038|NCT01122446|9790481|FG001|COMPLETED|Overall Study||25
8912841|NCT02156076|9972054|FG002|STARTED|Follow-up Period||4
8742039|NCT01122446|9790480|FG000|NOT COMPLETED|Overall Study||0
8742040|NCT01122446|9790481|FG001|NOT COMPLETED|Overall Study||0
8742041|NCT01122576|9790490|FG000|STARTED|Pre-Cataract Surgery||26
8742042|NCT01122576|9790491|FG001|STARTED|Pre-Cataract Surgery||26
8742043|NCT01122576|9790492|FG002|STARTED|Pre-Cataract Surgery||26
8742044|NCT01122576|9790490|FG000|COMPLETED|Pre-Cataract Surgery||26
8742045|NCT01122576|9790491|FG001|COMPLETED|Pre-Cataract Surgery||25
8742046|NCT01122576|9790492|FG002|COMPLETED|Pre-Cataract Surgery||24
8742047|NCT01122576|9790490|FG000|NOT COMPLETED|Pre-Cataract Surgery||0
8742048|NCT01122576|9790491|FG001|NOT COMPLETED|Pre-Cataract Surgery||1
8742049|NCT01122576|9790492|FG002|NOT COMPLETED|Pre-Cataract Surgery||2
8742050|NCT01122576|9790490|FG000|STARTED|Post-Cataract Surgery||26
8742051|NCT01122576|9790491|FG001|STARTED|Post-Cataract Surgery||25
8742052|NCT01122576|9790492|FG002|STARTED|Post-Cataract Surgery||24
8742053|NCT01122576|9790490|FG000|COMPLETED|Post-Cataract Surgery||26
8742054|NCT01122576|9790491|FG001|COMPLETED|Post-Cataract Surgery||25
8742055|NCT01122576|9790492|FG002|COMPLETED|Post-Cataract Surgery||22
8742056|NCT01122576|9790490|FG000|NOT COMPLETED|Post-Cataract Surgery||0
8742057|NCT01122576|9790491|FG001|NOT COMPLETED|Post-Cataract Surgery||0
8742058|NCT01122576|9790492|FG002|NOT COMPLETED|Post-Cataract Surgery||2
8742059|NCT01122680|9790503|FG000|STARTED|Period 1 (4 Weeks)|Entered this study period.|29
8742060|NCT01122680|9790504|FG001|STARTED|Period 1 (4 Weeks)|Entered this study period.|26
8742061|NCT01122680|9790505|FG002|STARTED|Period 1 (4 Weeks)|Entered this study period.|26
8742062|NCT01122680|9790506|FG003|STARTED|Period 1 (4 Weeks)|Entered this study period.|24
8742063|NCT01122680|9790503|FG000|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|26
8742064|NCT01122680|9790504|FG001|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|25
8742065|NCT01122680|9790505|FG002|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|26
8742066|NCT01122680|9790506|FG003|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|24
8742067|NCT01122680|9790503|FG000|NOT COMPLETED|Period 1 (4 Weeks)||3
8742068|NCT01122680|9790504|FG001|NOT COMPLETED|Period 1 (4 Weeks)||1
8742069|NCT01122680|9790505|FG002|NOT COMPLETED|Period 1 (4 Weeks)||0
8742070|NCT01122680|9790506|FG003|NOT COMPLETED|Period 1 (4 Weeks)||0
8742071|NCT01122680|9790503|FG000|STARTED|Period 2 (4 Weeks)|Entered this study period.|26
8742072|NCT01122680|9790504|FG001|STARTED|Period 2 (4 Weeks)|Entered this study period.|25
8742073|NCT01122680|9790505|FG002|STARTED|Period 2 (4 Weeks)|Entered this study period.|26
8742074|NCT01122680|9790506|FG003|STARTED|Period 2 (4 Weeks)|Entered this study period.|24
8742075|NCT01122680|9790503|FG000|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|25
8742076|NCT01122680|9790504|FG001|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|25
8742077|NCT01122680|9790505|FG002|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|26
8742078|NCT01122680|9790506|FG003|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|23
8742079|NCT01122680|9790503|FG000|NOT COMPLETED|Period 2 (4 Weeks)||1
8742080|NCT01122680|9790504|FG001|NOT COMPLETED|Period 2 (4 Weeks)||0
8742081|NCT01122680|9790505|FG002|NOT COMPLETED|Period 2 (4 Weeks)||0
8742082|NCT01122680|9790506|FG003|NOT COMPLETED|Period 2 (4 Weeks)||1
8742083|NCT01122680|9790503|FG000|STARTED|Period 3 (4 Weeks)|Entered this study period.|25
8742084|NCT01122680|9790504|FG001|STARTED|Period 3 (4 Weeks)|Entered this study period.|25
8742085|NCT01122680|9790505|FG002|STARTED|Period 3 (4 Weeks)|Entered this study period.|26
8742086|NCT01122680|9790506|FG003|STARTED|Period 3 (4 Weeks)|Entered this study period.|23
8742087|NCT01122680|9790503|FG000|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|24
8742088|NCT01122680|9790504|FG001|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|24
8742089|NCT01122680|9790505|FG002|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|26
8742090|NCT01122680|9790506|FG003|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|23
8742091|NCT01122680|9790503|FG000|NOT COMPLETED|Period 3 (4 Weeks)||1
8742092|NCT01122680|9790504|FG001|NOT COMPLETED|Period 3 (4 Weeks)||1
8742093|NCT01122680|9790505|FG002|NOT COMPLETED|Period 3 (4 Weeks)||0
8742094|NCT01122680|9790506|FG003|NOT COMPLETED|Period 3 (4 Weeks)||0
8742095|NCT01122849|9790519|FG000|STARTED|Overall Study||20
8742096|NCT01122849|9790520|FG001|STARTED|Overall Study||21
8742097|NCT01122849|9790521|FG002|STARTED|Overall Study||20
8742098|NCT01122849|9790519|FG000|COMPLETED|Overall Study||20
8742099|NCT01122849|9790520|FG001|COMPLETED|Overall Study||21
8742100|NCT01122849|9790521|FG002|COMPLETED|Overall Study||20
8742101|NCT01122849|9790519|FG000|NOT COMPLETED|Overall Study||0
8742102|NCT01122849|9790520|FG001|NOT COMPLETED|Overall Study||0
8742103|NCT01122849|9790521|FG002|NOT COMPLETED|Overall Study||0
8742104|NCT01122862|9790539|FG000|STARTED|Period 1||8
8742105|NCT01122862|9790540|FG001|STARTED|Period 1||8
8742106|NCT01122862|9790541|FG002|STARTED|Period 1||7
8742107|NCT01122862|9790539|FG000|COMPLETED|Period 1||8
8742108|NCT01122862|9790540|FG001|COMPLETED|Period 1||7
8742109|NCT01122862|9790541|FG002|COMPLETED|Period 1||7
8742110|NCT01122862|9790539|FG000|NOT COMPLETED|Period 1||0
8742111|NCT01122862|9790540|FG001|NOT COMPLETED|Period 1||1
8742112|NCT01122862|9790541|FG002|NOT COMPLETED|Period 1||0
8742113|NCT01122862|9790539|FG000|STARTED|Period 2|Due to crossover design,a different set of participants received this treatment compared to Period 1|8
8742114|NCT01122862|9790540|FG001|STARTED|Period 2|Due to crossover design,a different set of participants received this treatment compared to Period 1|7
8742115|NCT01122862|9790541|FG002|STARTED|Period 2|Due to crossover design,a different set of participants received this treatment compared to Period 1|7
8742116|NCT01122862|9790539|FG000|COMPLETED|Period 2||8
8742117|NCT01122862|9790540|FG001|COMPLETED|Period 2||7
8742118|NCT01122862|9790541|FG002|COMPLETED|Period 2||6
8742119|NCT01122862|9790539|FG000|NOT COMPLETED|Period 2||0
8742120|NCT01122862|9790540|FG001|NOT COMPLETED|Period 2||0
8742121|NCT01122862|9790541|FG002|NOT COMPLETED|Period 2||1
8742122|NCT01122862|9790539|FG000|STARTED|Period 3|Due to crossover design,a different set of participants received this treatment compared to Period 2|6
8807249|NCT01483599|9859592|FG010|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||2
8742123|NCT01122862|9790540|FG001|STARTED|Period 3|Due to crossover design,a different set of participants received this treatment compared to Period 2|7
8742124|NCT01122862|9790541|FG002|STARTED|Period 3|Due to crossover design,a different set of participants received this treatment compared to Period 2|8
8742125|NCT01122862|9790539|FG000|COMPLETED|Period 3||6
8742126|NCT01122862|9790540|FG001|COMPLETED|Period 3||7
8742127|NCT01122862|9790541|FG002|COMPLETED|Period 3||8
8742128|NCT01122862|9790539|FG000|NOT COMPLETED|Period 3||0
8742129|NCT01122862|9790540|FG001|NOT COMPLETED|Period 3||0
8742130|NCT01122862|9790541|FG002|NOT COMPLETED|Period 3||0
8742131|NCT01122901|9790552|FG000|STARTED|Overall Study||40
8742132|NCT01122901|9790553|FG001|STARTED|Overall Study||7
8742133|NCT01122901|9790552|FG000|COMPLETED|Overall Study||40
8742134|NCT01122901|9790553|FG001|COMPLETED|Overall Study||7
8742135|NCT01122901|9790552|FG000|NOT COMPLETED|Overall Study||0
8742136|NCT01122901|9790553|FG001|NOT COMPLETED|Overall Study||0
8742137|NCT01122927|9790564|FG000|STARTED|Period 1 - Conversion Phase||297
8742138|NCT01122927|9790565|FG001|STARTED|Period 1 - Conversion Phase||0
8742139|NCT01122927|9790564|FG000|COMPLETED|Period 1 - Conversion Phase||283
8742140|NCT01122927|9790565|FG001|COMPLETED|Period 1 - Conversion Phase||0
8742141|NCT01122927|9790564|FG000|NOT COMPLETED|Period 1 - Conversion Phase||14
8742142|NCT01122927|9790565|FG001|NOT COMPLETED|Period 1 - Conversion Phase||0
8742143|NCT01122927|9790564|FG000|STARTED|Period 2- Open-label Treatment Phase||0
8742144|NCT01122927|9790565|FG001|STARTED|Period 2- Open-label Treatment Phase|362 were de novo participants and 148 had rolled over from study NCT01149655.|510
8742145|NCT01122927|9790564|FG000|COMPLETED|Period 2- Open-label Treatment Phase||0
8742146|NCT01122927|9790565|FG001|COMPLETED|Period 2- Open-label Treatment Phase|De novo participants who completed Month 24 visit or rolled over from study NCT01149655.|198
8742147|NCT01122927|9790564|FG000|NOT COMPLETED|Period 2- Open-label Treatment Phase||0
8742148|NCT01122927|9790565|FG001|NOT COMPLETED|Period 2- Open-label Treatment Phase||312
8742149|NCT01123070|9790579|FG000|STARTED|Part A Cohort 1 Open Label Period||3
8742150|NCT01123070|9790580|FG001|STARTED|Part A Cohort 1 Open Label Period||0
8742151|NCT01123070|9790581|FG002|STARTED|Part A Cohort 1 Open Label Period||0
8742152|NCT01123070|9790582|FG003|STARTED|Part A Cohort 1 Open Label Period||0
8742153|NCT01123070|9790579|FG000|COMPLETED|Part A Cohort 1 Open Label Period||3
8742154|NCT01123070|9790580|FG001|COMPLETED|Part A Cohort 1 Open Label Period||0
8742155|NCT01123070|9790581|FG002|COMPLETED|Part A Cohort 1 Open Label Period||0
8742156|NCT01123070|9790582|FG003|COMPLETED|Part A Cohort 1 Open Label Period||0
8742157|NCT01123070|9790579|FG000|NOT COMPLETED|Part A Cohort 1 Open Label Period||0
8742158|NCT01123070|9790580|FG001|NOT COMPLETED|Part A Cohort 1 Open Label Period||0
8742159|NCT01123070|9790581|FG002|NOT COMPLETED|Part A Cohort 1 Open Label Period||0
8742160|NCT01123070|9790582|FG003|NOT COMPLETED|Part A Cohort 1 Open Label Period||0
8742161|NCT01123070|9790579|FG000|STARTED|Part A Cohort 2 Open Label Period||0
8742162|NCT01123070|9790580|FG001|STARTED|Part A Cohort 2 Open Label Period||3
8742163|NCT01123070|9790581|FG002|STARTED|Part A Cohort 2 Open Label Period||0
8742164|NCT01123070|9790582|FG003|STARTED|Part A Cohort 2 Open Label Period||0
8742165|NCT01123070|9790579|FG000|COMPLETED|Part A Cohort 2 Open Label Period||0
8742166|NCT01123070|9790580|FG001|COMPLETED|Part A Cohort 2 Open Label Period||3
8742167|NCT01123070|9790581|FG002|COMPLETED|Part A Cohort 2 Open Label Period||0
8742168|NCT01123070|9790582|FG003|COMPLETED|Part A Cohort 2 Open Label Period||0
8742169|NCT01123070|9790579|FG000|NOT COMPLETED|Part A Cohort 2 Open Label Period||0
8742170|NCT01123070|9790580|FG001|NOT COMPLETED|Part A Cohort 2 Open Label Period||0
8742171|NCT01123070|9790581|FG002|NOT COMPLETED|Part A Cohort 2 Open Label Period||0
8742172|NCT01123070|9790582|FG003|NOT COMPLETED|Part A Cohort 2 Open Label Period||0
8742173|NCT01123070|9790579|FG000|STARTED|Part B Double Blind Period||0
8742174|NCT01123070|9790580|FG001|STARTED|Part B Double Blind Period||0
8742175|NCT01123070|9790581|FG002|STARTED|Part B Double Blind Period||25
8742176|NCT01123070|9790582|FG003|STARTED|Part B Double Blind Period||23
8742177|NCT01123070|9790579|FG000|COMPLETED|Part B Double Blind Period||0
8742178|NCT01123070|9790580|FG001|COMPLETED|Part B Double Blind Period||0
8742179|NCT01123070|9790581|FG002|COMPLETED|Part B Double Blind Period||21
8742180|NCT01123070|9790582|FG003|COMPLETED|Part B Double Blind Period||20
8742181|NCT01123070|9790579|FG000|NOT COMPLETED|Part B Double Blind Period||0
8742182|NCT01123070|9790580|FG001|NOT COMPLETED|Part B Double Blind Period||0
8742183|NCT01123070|9790581|FG002|NOT COMPLETED|Part B Double Blind Period||4
8742184|NCT01123070|9790582|FG003|NOT COMPLETED|Part B Double Blind Period||3
8742185|NCT01123083|9790595|FG000|STARTED|Overall Study||61
8742186|NCT01123083|9790596|FG001|STARTED|Overall Study||118
8742187|NCT01123083|9790595|FG000|COMPLETED|Overall Study||50
8742188|NCT01123083|9790596|FG001|COMPLETED|Overall Study||103
8742189|NCT01123083|9790595|FG000|NOT COMPLETED|Overall Study||11
8742190|NCT01123083|9790596|FG001|NOT COMPLETED|Overall Study||15
8742191|NCT01123148|9790602|FG000|STARTED|Overall Study||14
8742192|NCT01123148|9790602|FG000|BCI Calibration >50% Accuracy|Overall Study||13
8742193|NCT01123148|9790602|FG000|COMPLETED|Overall Study||12
8742194|NCT01123148|9790602|FG000|NOT COMPLETED|Overall Study||2
8742195|NCT01123161|9790608|FG000|STARTED|Overall Study||57
8742196|NCT01123161|9790609|FG001|STARTED|Overall Study||63
8742197|NCT01123161|9790608|FG000|COMPLETED|Overall Study||55
8742198|NCT01123161|9790609|FG001|COMPLETED|Overall Study||63
8742199|NCT01123161|9790608|FG000|NOT COMPLETED|Overall Study||2
8742200|NCT01123161|9790609|FG001|NOT COMPLETED|Overall Study||0
8742201|NCT01123200|9790618|FG000|STARTED|Overall Study||1
8742202|NCT01123200|9790618|FG000|COMPLETED|Overall Study||0
8742203|NCT01123200|9790618|FG000|NOT COMPLETED|Overall Study||1
8742204|NCT01123356|9790622|FG000|STARTED|Overall Study||21
8742205|NCT01123356|9790622|FG000|COMPLETED|Overall Study||14
8742206|NCT01123356|9790622|FG000|NOT COMPLETED|Overall Study||7
8742207|NCT01123382|9790629|FG000|STARTED|Overall Study||13
8742208|NCT01123382|9790630|FG001|STARTED|Overall Study||12
8742209|NCT01123382|9790629|FG000|Received Intervention|Overall Study||12
8742210|NCT01123382|9790630|FG001|Received Intervention|Overall Study||10
8742211|NCT01123382|9790629|FG000|COMPLETED|Overall Study||11
8742212|NCT01123382|9790630|FG001|COMPLETED|Overall Study||6
8742213|NCT01123382|9790629|FG000|NOT COMPLETED|Overall Study||2
8742214|NCT01123382|9790630|FG001|NOT COMPLETED|Overall Study||6
8742215|NCT01123395|9790636|FG000|STARTED|Period 1||8
8742216|NCT01123395|9790637|FG001|STARTED|Period 1||8
8742217|NCT01123395|9790636|FG000|COMPLETED|Period 1||8
8742218|NCT01123395|9790637|FG001|COMPLETED|Period 1||8
8742219|NCT01123395|9790636|FG000|NOT COMPLETED|Period 1||0
8742220|NCT01123395|9790637|FG001|NOT COMPLETED|Period 1||0
8742221|NCT01123395|9790636|FG000|STARTED|Washout Period of 14 Days||8
8742222|NCT01123395|9790637|FG001|STARTED|Washout Period of 14 Days||8
8742223|NCT01123395|9790636|FG000|COMPLETED|Washout Period of 14 Days||8
8742224|NCT01123395|9790637|FG001|COMPLETED|Washout Period of 14 Days||7
8742225|NCT01123395|9790636|FG000|NOT COMPLETED|Washout Period of 14 Days||0
8742226|NCT01123395|9790637|FG001|NOT COMPLETED|Washout Period of 14 Days||1
8742227|NCT01123395|9790636|FG000|STARTED|Period 2||8
8742228|NCT01123395|9790637|FG001|STARTED|Period 2||7
8742229|NCT01123395|9790636|FG000|COMPLETED|Period 2||8
8742230|NCT01123395|9790637|FG001|COMPLETED|Period 2||7
8742231|NCT01123395|9790636|FG000|NOT COMPLETED|Period 2||0
8742232|NCT01123395|9790637|FG001|NOT COMPLETED|Period 2||0
8742233|NCT01123512|9790645|FG000|STARTED|Overall Study||153
8742234|NCT01123512|9790646|FG001|STARTED|Overall Study||147
8742235|NCT01123512|9790645|FG000|COMPLETED|Overall Study||127
8742236|NCT01123512|9790646|FG001|COMPLETED|Overall Study||126
8742237|NCT01123512|9790645|FG000|NOT COMPLETED|Overall Study||26
8742238|NCT01123512|9790646|FG001|NOT COMPLETED|Overall Study||21
8742239|NCT01123642|9790652|FG000|STARTED|Overall Study||345
8742240|NCT01123642|9790652|FG000|COMPLETED|Overall Study||277
8742241|NCT01123642|9790652|FG000|NOT COMPLETED|Overall Study||68
8742242|NCT01123655|9790659|FG000|STARTED|Overall Study||10
8742243|NCT01123655|9790660|FG001|STARTED|Overall Study||4
8742244|NCT01123655|9790661|FG002|STARTED|Overall Study||8
8742245|NCT01123655|9790659|FG000|COMPLETED|Overall Study||9
8742246|NCT01123655|9790660|FG001|COMPLETED|Overall Study||3
8742247|NCT01123655|9790661|FG002|COMPLETED|Overall Study||7
8742248|NCT01123655|9790659|FG000|NOT COMPLETED|Overall Study||1
8742249|NCT01123655|9790660|FG001|NOT COMPLETED|Overall Study||1
8742250|NCT01123655|9790661|FG002|NOT COMPLETED|Overall Study||1
8742251|NCT01123889|9790669|FG000|STARTED|Overall Study||5
8742252|NCT01123889|9790670|FG001|STARTED|Overall Study||7
8742253|NCT01123889|9790669|FG000|COMPLETED|Overall Study||2
8742254|NCT01123889|9790670|FG001|COMPLETED|Overall Study||6
8742255|NCT01123889|9790669|FG000|NOT COMPLETED|Overall Study||3
8742256|NCT01123889|9790670|FG001|NOT COMPLETED|Overall Study||1
8742257|NCT01123928|9790678|FG000|STARTED|Overall Study||212
8742258|NCT01123928|9790679|FG001|STARTED|Overall Study||222
8742259|NCT01123928|9790678|FG000|COMPLETED|Overall Study||212
8742260|NCT01123928|9790679|FG001|COMPLETED|Overall Study||222
8742261|NCT01123928|9790678|FG000|NOT COMPLETED|Overall Study||0
8742262|NCT01123928|9790679|FG001|NOT COMPLETED|Overall Study||0
8742263|NCT01123941|9790687|FG000|STARTED|Overall Study||25
8742264|NCT01123941|9790688|FG001|STARTED|Overall Study||25
8742265|NCT01123941|9790687|FG000|COMPLETED|Overall Study||23
8742266|NCT01123941|9790688|FG001|COMPLETED|Overall Study||24
8742267|NCT01123941|9790687|FG000|NOT COMPLETED|Overall Study||2
8742268|NCT01123941|9790688|FG001|NOT COMPLETED|Overall Study||1
8742269|NCT01123980|9790696|FG000|STARTED|Overall Study||261
8742270|NCT01123980|9790697|FG001|STARTED|Overall Study||260
8742271|NCT01123980|9790696|FG000|COMPLETED|Overall Study||242
8742272|NCT01123980|9790697|FG001|COMPLETED|Overall Study||236
8742273|NCT01123980|9790696|FG000|NOT COMPLETED|Overall Study||19
8742274|NCT01123980|9790697|FG001|NOT COMPLETED|Overall Study||24
8742275|NCT01124006|9790706|FG000|STARTED|Overall Study||10
8742276|NCT01124006|9790707|FG001|STARTED|Overall Study||10
8742277|NCT01124006|9790708|FG002|STARTED|Overall Study||4
8742278|NCT01124006|9790706|FG000|COMPLETED|Overall Study||7
8742279|NCT01124006|9790707|FG001|COMPLETED|Overall Study||8
8742280|NCT01124006|9790708|FG002|COMPLETED|Overall Study||2
8742281|NCT01124006|9790706|FG000|NOT COMPLETED|Overall Study||3
8742282|NCT01124006|9790707|FG001|NOT COMPLETED|Overall Study||2
8742283|NCT01124006|9790708|FG002|NOT COMPLETED|Overall Study||2
8742284|NCT01124045|9790718|FG000|STARTED|Overall Study||39
8742285|NCT01124045|9790719|FG001|STARTED|Overall Study||40
8742286|NCT01124045|9790718|FG000|COMPLETED|Overall Study||39
8742287|NCT01124045|9790719|FG001|COMPLETED|Overall Study||37
8742288|NCT01124045|9790718|FG000|NOT COMPLETED|Overall Study||0
8742289|NCT01124045|9790719|FG001|NOT COMPLETED|Overall Study||3
8742290|NCT01124097|9790729|FG000|STARTED|Overall Study||60
8742291|NCT01124097|9790730|FG001|STARTED|Overall Study||60
8742292|NCT01124097|9790731|FG002|STARTED|Overall Study||60
8742293|NCT01124097|9790732|FG003|STARTED|Overall Study||60
8742294|NCT01124097|9790729|FG000|Safety Population|Overall Study||60
8742295|NCT01124097|9790730|FG001|Safety Population|Overall Study||60
8742296|NCT01124097|9790731|FG002|Safety Population|Overall Study||60
8742297|NCT01124097|9790732|FG003|Safety Population|Overall Study||60
8742298|NCT01124097|9790729|FG000|Efficacy Population|Overall Study||52
8742299|NCT01124097|9790730|FG001|Efficacy Population|Overall Study||53
8742300|NCT01124097|9790731|FG002|Efficacy Population|Overall Study||53
8742301|NCT01124097|9790732|FG003|Efficacy Population|Overall Study||51
8742302|NCT01124097|9790729|FG000|COMPLETED|Overall Study||26
8742303|NCT01124097|9790730|FG001|COMPLETED|Overall Study||38
8742304|NCT01124097|9790731|FG002|COMPLETED|Overall Study||40
8742305|NCT01124097|9790732|FG003|COMPLETED|Overall Study||46
8742306|NCT01124097|9790729|FG000|NOT COMPLETED|Overall Study||34
8742307|NCT01124097|9790730|FG001|NOT COMPLETED|Overall Study||22
8742308|NCT01124097|9790731|FG002|NOT COMPLETED|Overall Study||20
8742309|NCT01124097|9790732|FG003|NOT COMPLETED|Overall Study||14
8742310|NCT01124149|9790742|FG000|STARTED|Acute Phase||722
8742311|NCT01124149|9790742|FG000|COMPLETED|Acute Phase||639
8742312|NCT01124149|9790742|FG000|NOT COMPLETED|Acute Phase||83
8742313|NCT01124149|9790742|FG000|STARTED|Maintenance Phase||469
8742314|NCT01124149|9790742|FG000|COMPLETED|Maintenance Phase||373
8742315|NCT01124149|9790742|FG000|NOT COMPLETED|Maintenance Phase||96
8742316|NCT01124162|9790751|FG000|STARTED|First Intervention||40
8742317|NCT01124162|9790752|FG001|STARTED|First Intervention||40
8742318|NCT01124162|9790751|FG000|COMPLETED|First Intervention||38
8742319|NCT01124162|9790752|FG001|COMPLETED|First Intervention||40
8742320|NCT01124162|9790751|FG000|NOT COMPLETED|First Intervention||2
8742321|NCT01124162|9790752|FG001|NOT COMPLETED|First Intervention||0
8742322|NCT01124162|9790751|FG000|STARTED|Washout of 7 Days||38
8742323|NCT01124162|9790752|FG001|STARTED|Washout of 7 Days||40
8742324|NCT01124162|9790751|FG000|COMPLETED|Washout of 7 Days||37
8742325|NCT01124162|9790752|FG001|COMPLETED|Washout of 7 Days||40
8742326|NCT01124162|9790751|FG000|NOT COMPLETED|Washout of 7 Days||1
8742327|NCT01124162|9790752|FG001|NOT COMPLETED|Washout of 7 Days||0
8742328|NCT01124162|9790751|FG000|STARTED|Second Intervention||37
8742329|NCT01124162|9790752|FG001|STARTED|Second Intervention||40
8742330|NCT01124162|9790751|FG000|COMPLETED|Second Intervention||37
8742331|NCT01124162|9790752|FG001|COMPLETED|Second Intervention||40
8742332|NCT01124162|9790751|FG000|NOT COMPLETED|Second Intervention||0
8742333|NCT01124162|9790752|FG001|NOT COMPLETED|Second Intervention||0
8742334|NCT01124175|9790760|FG000|STARTED|First Intervention||40
8742335|NCT01124175|9790761|FG001|STARTED|First Intervention||40
8742336|NCT01124175|9790760|FG000|COMPLETED|First Intervention||40
8742337|NCT01124175|9790761|FG001|COMPLETED|First Intervention||40
8742338|NCT01124175|9790760|FG000|NOT COMPLETED|First Intervention||0
8742339|NCT01124175|9790761|FG001|NOT COMPLETED|First Intervention||0
8742340|NCT01124175|9790760|FG000|STARTED|Washout of 7 Days||40
8742341|NCT01124175|9790761|FG001|STARTED|Washout of 7 Days||40
8742342|NCT01124175|9790760|FG000|COMPLETED|Washout of 7 Days||40
8742343|NCT01124175|9790761|FG001|COMPLETED|Washout of 7 Days||38
8742344|NCT01124175|9790760|FG000|NOT COMPLETED|Washout of 7 Days||0
8742345|NCT01124175|9790761|FG001|NOT COMPLETED|Washout of 7 Days||2
8742346|NCT01124175|9790760|FG000|STARTED|Second Intervention||40
8742347|NCT01124175|9790761|FG001|STARTED|Second Intervention||38
8742348|NCT01124175|9790760|FG000|COMPLETED|Second Intervention||40
8742349|NCT01124175|9790761|FG001|COMPLETED|Second Intervention||38
8742350|NCT01124175|9790760|FG000|NOT COMPLETED|Second Intervention||0
8742351|NCT01124175|9790761|FG001|NOT COMPLETED|Second Intervention||0
8742352|NCT01124188|9790769|FG000|STARTED|Overall Study||68
8742353|NCT01124188|9790770|FG001|STARTED|Overall Study||71
8742354|NCT01124188|9790769|FG000|COMPLETED|Overall Study||60
8742355|NCT01124188|9790770|FG001|COMPLETED|Overall Study||65
8742356|NCT01124188|9790769|FG000|NOT COMPLETED|Overall Study||8
8742357|NCT01124188|9790770|FG001|NOT COMPLETED|Overall Study||6
8742358|NCT01124292|9790779|FG000|STARTED|Overall Study||16
8742359|NCT01124292|9790780|FG001|STARTED|Overall Study||24
8742360|NCT01124292|9790781|FG002|STARTED|Overall Study||21
8742361|NCT01124292|9790779|FG000|COMPLETED|Overall Study||14
8742362|NCT01124292|9790780|FG001|COMPLETED|Overall Study||9
8742363|NCT01124292|9790781|FG002|COMPLETED|Overall Study||11
8742364|NCT01124292|9790779|FG000|NOT COMPLETED|Overall Study||2
8742365|NCT01124292|9790780|FG001|NOT COMPLETED|Overall Study||15
8742366|NCT01124292|9790781|FG002|NOT COMPLETED|Overall Study||10
8742367|NCT01124305|9790794|FG000|STARTED|Overall Study||34
8742368|NCT01124305|9790795|FG001|STARTED|Overall Study||36
8742369|NCT01124305|9790794|FG000|COMPLETED|Overall Study||26
8912842|NCT02156076|9972055|FG003|STARTED|Follow-up Period||4
9022695|NCT03131167|10085549|FG001|NOT COMPLETED|Overall Study||0
8742370|NCT01124305|9790795|FG001|COMPLETED|Overall Study||26
8742371|NCT01124305|9790794|FG000|NOT COMPLETED|Overall Study||8
8742372|NCT01124305|9790795|FG001|NOT COMPLETED|Overall Study||10
8742373|NCT01124370|9790801|FG000|STARTED|Overall Study|Underwent implant attempt|57
8742374|NCT01124370|9790801|FG000|Successfully Implanted|Overall Study||50
8742375|NCT01124370|9790801|FG000|Therapy Initiated|Overall Study||48
8742376|NCT01124370|9790801|FG000|3 Month Visit|Overall Study|Defines evaluable population|47
8742377|NCT01124370|9790801|FG000|COMPLETED|Overall Study|Completed 2 year post-implant follow-up|37
8742378|NCT01124370|9790801|FG000|NOT COMPLETED|Overall Study||20
8742379|NCT01124422|9790807|FG000|STARTED|4-Week Open-label Run-in Phase||338
8742380|NCT01124422|9790808|FG001|STARTED|4-Week Open-label Run-in Phase||0
8742381|NCT01124422|9790809|FG002|STARTED|4-Week Open-label Run-in Phase||0
8742382|NCT01124422|9790807|FG000|COMPLETED|4-Week Open-label Run-in Phase||255
8742383|NCT01124422|9790808|FG001|COMPLETED|4-Week Open-label Run-in Phase||0
8742384|NCT01124422|9790809|FG002|COMPLETED|4-Week Open-label Run-in Phase||0
8742385|NCT01124422|9790807|FG000|NOT COMPLETED|4-Week Open-label Run-in Phase||83
8742386|NCT01124422|9790808|FG001|NOT COMPLETED|4-Week Open-label Run-in Phase||0
8742387|NCT01124422|9790809|FG002|NOT COMPLETED|4-Week Open-label Run-in Phase||0
8742388|NCT01124422|9790807|FG000|STARTED|4-Week Double-blind Treatment Phase||0
8742389|NCT01124422|9790808|FG001|STARTED|4-Week Double-blind Treatment Phase||131
8742390|NCT01124422|9790809|FG002|STARTED|4-Week Double-blind Treatment Phase||124
8742391|NCT01124422|9790807|FG000|COMPLETED|4-Week Double-blind Treatment Phase||0
8742392|NCT01124422|9790808|FG001|COMPLETED|4-Week Double-blind Treatment Phase||120
8742393|NCT01124422|9790809|FG002|COMPLETED|4-Week Double-blind Treatment Phase||115
8742394|NCT01124422|9790807|FG000|NOT COMPLETED|4-Week Double-blind Treatment Phase||0
8742395|NCT01124422|9790808|FG001|NOT COMPLETED|4-Week Double-blind Treatment Phase||11
8742396|NCT01124422|9790809|FG002|NOT COMPLETED|4-Week Double-blind Treatment Phase||9
8742397|NCT01124448|9790818|FG000|STARTED|Overall Study||25
8742398|NCT01124448|9790819|FG001|STARTED|Overall Study||15
8742399|NCT01124448|9790818|FG000|COMPLETED|Overall Study||23
8742400|NCT01124448|9790819|FG001|COMPLETED|Overall Study||12
8742401|NCT01124448|9790818|FG000|NOT COMPLETED|Overall Study||2
8742402|NCT01124448|9790819|FG001|NOT COMPLETED|Overall Study||3
8742403|NCT01124604|9790827|FG000|STARTED|Overall Study||60
8742404|NCT01124604|9790828|FG001|STARTED|Overall Study||31
8742405|NCT01124604|9790827|FG000|COMPLETED|Overall Study||45
8742406|NCT01124604|9790828|FG001|COMPLETED|Overall Study||29
8742407|NCT01124604|9790827|FG000|NOT COMPLETED|Overall Study||15
8742408|NCT01124604|9790828|FG001|NOT COMPLETED|Overall Study||2
8742409|NCT01124617|9790836|FG000|STARTED|Overall Study||60
8742410|NCT01124617|9790837|FG001|STARTED|Overall Study||31
8742411|NCT01124617|9790836|FG000|COMPLETED|Overall Study||41
8742412|NCT01124617|9790837|FG001|COMPLETED|Overall Study||25
8742413|NCT01124617|9790836|FG000|NOT COMPLETED|Overall Study||19
8742414|NCT01124617|9790837|FG001|NOT COMPLETED|Overall Study||6
8742415|NCT01124643|9790843|FG000|STARTED|Overall Study||35
8742416|NCT01124643|9790843|FG000|COMPLETED|Overall Study||34
8742417|NCT01124643|9790843|FG000|NOT COMPLETED|Overall Study||1
8742418|NCT01124734|9790847|FG000|STARTED|Overall Study||17
8742419|NCT01124734|9790847|FG000|Completion of Course 1 Cycle 1|Overall Study|All 17 participants successfully completed Course 1 Cycle 1|17
8742420|NCT01124734|9790847|FG000|Initiation of Course 1 Cycle 2|Overall Study||17
8742421|NCT01124734|9790847|FG000|COMPLETED|Overall Study|Closed to accrual|0
8742422|NCT01124734|9790847|FG000|NOT COMPLETED|Overall Study||17
8742423|NCT01124786|9790858|FG000|STARTED|Overall Study||182
8742424|NCT01124786|9790859|FG001|STARTED|Overall Study||185
8742425|NCT01124786|9790858|FG000|Intent-to-Treat (ITT) Population|Overall Study|All randomized patients (pts)|182
8742426|NCT01124786|9790859|FG001|Intent-to-Treat (ITT) Population|Overall Study||185
8742427|NCT01124786|9790858|FG000|Safety Population|Overall Study|All pts who received at least one dose of study drug|179
8742428|NCT01124786|9790859|FG001|Safety Population|Overall Study||181
8742429|NCT01124786|9790858|FG000|Tumor Evaluable Population|Overall Study|All pts with measurable/evaluable tumor at baseline per RECIST and have received ≥ one dose of drug|178
8742430|NCT01124786|9790859|FG001|Tumor Evaluable Population|Overall Study||180
8742431|NCT01124786|9790858|FG000|COMPLETED|Overall Study||178
8742432|NCT01124786|9790859|FG001|COMPLETED|Overall Study||180
8742433|NCT01124786|9790858|FG000|NOT COMPLETED|Overall Study||4
8742434|NCT01124786|9790859|FG001|NOT COMPLETED|Overall Study||5
8742435|NCT01124838|9790867|FG000|STARTED|Overall Study||130
8742436|NCT01124838|9790868|FG001|STARTED|Overall Study||131
8742437|NCT01124838|9790867|FG000|Enrolled in Main Study|Overall Study||114
8742438|NCT01124838|9790868|FG001|Enrolled in Main Study|Overall Study||115
8742439|NCT01124838|9790867|FG000|Enrolled in Japan Sub-study|Overall Study||16
8742440|NCT01124838|9790868|FG001|Enrolled in Japan Sub-study|Overall Study||16
8742441|NCT01124838|9790867|FG000|COMPLETED|Overall Study||112
8742442|NCT01124838|9790868|FG001|COMPLETED|Overall Study||116
8742443|NCT01124838|9790867|FG000|NOT COMPLETED|Overall Study||18
8742444|NCT01124838|9790868|FG001|NOT COMPLETED|Overall Study||15
8742445|NCT01124864|9790882|FG000|STARTED|Overall Study||28
8742446|NCT01124864|9790883|FG001|STARTED|Overall Study||35
8742447|NCT01124864|9790884|FG002|STARTED|Overall Study||34
8742448|NCT01124864|9790885|FG003|STARTED|Overall Study||22
8742449|NCT01124864|9790886|FG004|STARTED|Overall Study||31
8742450|NCT01124864|9790887|FG005|STARTED|Overall Study||3
8742451|NCT01124864|9790882|FG000|COMPLETED|Overall Study||0
8742452|NCT01124864|9790883|FG001|COMPLETED|Overall Study||0
8742453|NCT01124864|9790884|FG002|COMPLETED|Overall Study||0
8742454|NCT01124864|9790885|FG003|COMPLETED|Overall Study|1 patient ongoing at time of data cut-off 30-Jul-2013|1
8742455|NCT01124864|9790886|FG004|COMPLETED|Overall Study|1 patient ongoing at time of data cut-off 30-Jul-2013|1
8742456|NCT01124864|9790887|FG005|COMPLETED|Overall Study||0
8742457|NCT01124864|9790882|FG000|NOT COMPLETED|Overall Study||28
8742458|NCT01124864|9790883|FG001|NOT COMPLETED|Overall Study||35
8742459|NCT01124864|9790884|FG002|NOT COMPLETED|Overall Study||34
8742460|NCT01124864|9790885|FG003|NOT COMPLETED|Overall Study||21
8742461|NCT01124864|9790886|FG004|NOT COMPLETED|Overall Study||30
8742462|NCT01124864|9790887|FG005|NOT COMPLETED|Overall Study||3
8742463|NCT01124916|9790905|FG000|STARTED|Overall Study||38
8742464|NCT01124916|9790906|FG001|STARTED|Overall Study||40
8742465|NCT01124916|9790905|FG000|COMPLETED|Overall Study||35
8742466|NCT01124916|9790906|FG001|COMPLETED|Overall Study||38
8742467|NCT01124916|9790905|FG000|NOT COMPLETED|Overall Study||3
8742468|NCT01124916|9790906|FG001|NOT COMPLETED|Overall Study||2
8742469|NCT01124955|9790914|FG000|STARTED|Overall Study||40
8742470|NCT01124955|9790915|FG001|STARTED|Overall Study||40
8742471|NCT01124955|9790914|FG000|COMPLETED|Overall Study||40
8742472|NCT01124955|9790915|FG001|COMPLETED|Overall Study||40
8742473|NCT01124955|9790914|FG000|NOT COMPLETED|Overall Study||0
8742474|NCT01124955|9790915|FG001|NOT COMPLETED|Overall Study||0
8742475|NCT01125046|9790921|FG000|STARTED|First 6 Months of Treatment||50
8742476|NCT01125046|9790921|FG000|COMPLETED|First 6 Months of Treatment||36
8742477|NCT01125046|9790921|FG000|NOT COMPLETED|First 6 Months of Treatment||14
8742478|NCT01125046|9790921|FG000|STARTED|Continued Treatment After 6 Months||36
8742479|NCT01125046|9790921|FG000|COMPLETED|Continued Treatment After 6 Months||33
8742480|NCT01125046|9790921|FG000|NOT COMPLETED|Continued Treatment After 6 Months||3
8742481|NCT01125046|9790921|FG000|STARTED|Follow-up/Data Cut Off Point||49
8742482|NCT01125046|9790921|FG000|COMPLETED|Follow-up/Data Cut Off Point||16
8742483|NCT01125046|9790921|FG000|NOT COMPLETED|Follow-up/Data Cut Off Point||33
8807250|NCT01483599|9859593|FG011|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||1
8807251|NCT01483599|9859594|FG012|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||3
8807252|NCT01483599|9859595|FG013|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||7
8807253|NCT01483625|9859626|FG000|STARTED|Overall Study||72
8807254|NCT01483625|9859627|FG001|STARTED|Overall Study||68
8807255|NCT01483625|9859626|FG000|COMPLETED|Overall Study||68
8807256|NCT01483625|9859627|FG001|COMPLETED|Overall Study||66
8807257|NCT01483625|9859626|FG000|NOT COMPLETED|Overall Study||4
8807258|NCT01483625|9859627|FG001|NOT COMPLETED|Overall Study||2
8807259|NCT01483651|9859633|FG000|STARTED|Overall Study||1
8807260|NCT01483651|9859634|FG001|STARTED|Overall Study||3
8807261|NCT01483651|9859635|FG002|STARTED|Overall Study||2
8807262|NCT01483651|9859636|FG003|STARTED|Overall Study||1
8807263|NCT01483651|9859637|FG004|STARTED|Overall Study||2
8807264|NCT01483651|9859638|FG005|STARTED|Overall Study||2
8807265|NCT01483651|9859633|FG000|COMPLETED|Overall Study||1
8807266|NCT01483651|9859634|FG001|COMPLETED|Overall Study||2
8807267|NCT01483651|9859635|FG002|COMPLETED|Overall Study||1
8807268|NCT01483651|9859636|FG003|COMPLETED|Overall Study||1
8807269|NCT01483651|9859637|FG004|COMPLETED|Overall Study||2
8807270|NCT01483651|9859638|FG005|COMPLETED|Overall Study||1
8807271|NCT01483651|9859633|FG000|NOT COMPLETED|Overall Study||0
8807272|NCT01483651|9859634|FG001|NOT COMPLETED|Overall Study||1
8807273|NCT01483651|9859635|FG002|NOT COMPLETED|Overall Study||1
8807274|NCT01483651|9859636|FG003|NOT COMPLETED|Overall Study||0
8807275|NCT01483651|9859637|FG004|NOT COMPLETED|Overall Study||0
8807276|NCT01483651|9859638|FG005|NOT COMPLETED|Overall Study||1
8807277|NCT01483690|9859648|FG000|STARTED|Overall Study||5
8807278|NCT01483690|9859649|FG001|STARTED|Overall Study||18
8807279|NCT01483690|9859648|FG000|COMPLETED|Overall Study||3
8807280|NCT01483690|9859649|FG001|COMPLETED|Overall Study||13
8807281|NCT01483690|9859648|FG000|NOT COMPLETED|Overall Study||2
8807282|NCT01483690|9859649|FG001|NOT COMPLETED|Overall Study||5
8807283|NCT01483807|9859655|FG000|STARTED|First Treatment Phase (7 Weeks)||10
8807284|NCT01483807|9859656|FG001|STARTED|First Treatment Phase (7 Weeks)||10
8807285|NCT01483807|9859655|FG000|COMPLETED|First Treatment Phase (7 Weeks)||10
8807286|NCT01483807|9859656|FG001|COMPLETED|First Treatment Phase (7 Weeks)||10
8807287|NCT01483807|9859655|FG000|NOT COMPLETED|First Treatment Phase (7 Weeks)||0
8807288|NCT01483807|9859656|FG001|NOT COMPLETED|First Treatment Phase (7 Weeks)||0
8807289|NCT01483807|9859655|FG000|STARTED|Washout (2 Weeks)||10
8807290|NCT01483807|9859656|FG001|STARTED|Washout (2 Weeks)||10
8807291|NCT01483807|9859655|FG000|COMPLETED|Washout (2 Weeks)||10
8807292|NCT01483807|9859656|FG001|COMPLETED|Washout (2 Weeks)||10
8807293|NCT01483807|9859655|FG000|NOT COMPLETED|Washout (2 Weeks)||0
8807294|NCT01483807|9859656|FG001|NOT COMPLETED|Washout (2 Weeks)||0
8807295|NCT01483807|9859655|FG000|STARTED|Second Treatment Phase (7 Weeks)||10
8807296|NCT01483807|9859656|FG001|STARTED|Second Treatment Phase (7 Weeks)||10
8807297|NCT01483807|9859655|FG000|COMPLETED|Second Treatment Phase (7 Weeks)||10
8807298|NCT01483807|9859656|FG001|COMPLETED|Second Treatment Phase (7 Weeks)||10
8807299|NCT01483807|9859655|FG000|NOT COMPLETED|Second Treatment Phase (7 Weeks)||0
8807300|NCT01483807|9859656|FG001|NOT COMPLETED|Second Treatment Phase (7 Weeks)||0
8807301|NCT01483924|9859669|FG000|STARTED|Overall Study||12
8807302|NCT01483924|9859670|FG001|STARTED|Overall Study||12
8807303|NCT01483924|9859671|FG002|STARTED|Overall Study||12
8807304|NCT01483924|9859672|FG003|STARTED|Overall Study||12
8807305|NCT01483924|9859673|FG004|STARTED|Overall Study||12
8807306|NCT01483924|9859669|FG000|COMPLETED|Overall Study||10
8807307|NCT01483924|9859670|FG001|COMPLETED|Overall Study||12
8807308|NCT01483924|9859671|FG002|COMPLETED|Overall Study||11
8807309|NCT01483924|9859672|FG003|COMPLETED|Overall Study||8
8807310|NCT01483924|9859673|FG004|COMPLETED|Overall Study||10
8807311|NCT01483924|9859669|FG000|NOT COMPLETED|Overall Study||2
8807312|NCT01483924|9859670|FG001|NOT COMPLETED|Overall Study||0
8807313|NCT01483924|9859671|FG002|NOT COMPLETED|Overall Study||1
8807314|NCT01483924|9859672|FG003|NOT COMPLETED|Overall Study||4
8807315|NCT01483924|9859673|FG004|NOT COMPLETED|Overall Study||2
8807316|NCT01483937|9859696|FG000|STARTED|Overall Study||15
8807317|NCT01483937|9859697|FG001|STARTED|Overall Study||17
8807318|NCT01483937|9859696|FG000|COMPLETED|Overall Study||11
8807319|NCT01483937|9859697|FG001|COMPLETED|Overall Study||14
8742484|NCT01125098|9790927|FG000|STARTED|Overall Study||91
8742485|NCT01125098|9790928|FG001|STARTED|Overall Study||90
8742486|NCT01125098|9790927|FG000|COMPLETED|Overall Study||88
8742487|NCT01125098|9790928|FG001|COMPLETED|Overall Study||90
8742488|NCT01125098|9790927|FG000|NOT COMPLETED|Overall Study||3
8742489|NCT01125098|9790928|FG001|NOT COMPLETED|Overall Study||0
8742490|NCT01125163|9790936|FG000|STARTED|Overall Study||76
8742491|NCT01125163|9790937|FG001|STARTED|Overall Study||74
8742492|NCT01125163|9790936|FG000|COMPLETED|Overall Study||76
8742493|NCT01125163|9790937|FG001|COMPLETED|Overall Study||74
8742494|NCT01125163|9790936|FG000|NOT COMPLETED|Overall Study||0
8742495|NCT01125163|9790937|FG001|NOT COMPLETED|Overall Study||0
8742496|NCT01125189|9790947|FG000|STARTED|Treatment Period||159
8742497|NCT01125189|9790948|FG001|STARTED|Treatment Period||158
8742498|NCT01125189|9790949|FG002|STARTED|Treatment Period||78
8742499|NCT01125189|9790947|FG000|COMPLETED|Treatment Period||128
8742500|NCT01125189|9790948|FG001|COMPLETED|Treatment Period||123
8742501|NCT01125189|9790949|FG002|COMPLETED|Treatment Period||37
8742502|NCT01125189|9790947|FG000|NOT COMPLETED|Treatment Period||31
8742503|NCT01125189|9790948|FG001|NOT COMPLETED|Treatment Period||35
8742504|NCT01125189|9790949|FG002|NOT COMPLETED|Treatment Period||41
8742505|NCT01125189|9790947|FG000|STARTED|Follow up Period|All participants who received treatment continued in the follow-up phase.|152
8742506|NCT01125189|9790948|FG001|STARTED|Follow up Period|All participants who received treatment continued in the follow-up phase.|153
8742507|NCT01125189|9790949|FG002|STARTED|Follow up Period|All participants who received treatment continued in the follow-up phase.|74
8742508|NCT01125189|9790947|FG000|COMPLETED|Follow up Period||132
8742509|NCT01125189|9790948|FG001|COMPLETED|Follow up Period||138
8742510|NCT01125189|9790949|FG002|COMPLETED|Follow up Period||58
8742511|NCT01125189|9790947|FG000|NOT COMPLETED|Follow up Period||20
8742512|NCT01125189|9790948|FG001|NOT COMPLETED|Follow up Period||15
8742513|NCT01125189|9790949|FG002|NOT COMPLETED|Follow up Period||16
8742514|NCT01125202|9790962|FG000|STARTED|Overall Study||93
8742515|NCT01125202|9790963|FG001|STARTED|Overall Study||86
8742516|NCT01125202|9790962|FG000|COMPLETED|Overall Study||81
8742517|NCT01125202|9790963|FG001|COMPLETED|Overall Study||79
8742518|NCT01125202|9790962|FG000|NOT COMPLETED|Overall Study||12
8742519|NCT01125202|9790963|FG001|NOT COMPLETED|Overall Study||7
8742520|NCT01125293|9790975|FG000|STARTED|Overall Study||3
8742521|NCT01125293|9790976|FG001|STARTED|Overall Study||3
8742522|NCT01125293|9790977|FG002|STARTED|Overall Study||4
8742523|NCT01125293|9790978|FG003|STARTED|Overall Study||3
8742524|NCT01125293|9790979|FG004|STARTED|Overall Study|Per protocol, a 10 patient expansion cohort is used to confirm the MTD determined in Stage B .|10
8912843|NCT02156076|9972052|FG000|COMPLETED|Follow-up Period||6
8912844|NCT02156076|9972053|FG001|COMPLETED|Follow-up Period||5
8912845|NCT02156076|9972054|FG002|COMPLETED|Follow-up Period||4
8912846|NCT02156076|9972055|FG003|COMPLETED|Follow-up Period||4
8912847|NCT02156076|9972052|FG000|NOT COMPLETED|Follow-up Period||1
8912848|NCT02156076|9972053|FG001|NOT COMPLETED|Follow-up Period||0
8912849|NCT02156076|9972054|FG002|NOT COMPLETED|Follow-up Period||0
8912850|NCT02156076|9972055|FG003|NOT COMPLETED|Follow-up Period||0
8912851|NCT02156154|9972067|FG000|STARTED|Overall Study||291
8912852|NCT02156154|9972068|FG001|STARTED|Overall Study||289
8912853|NCT02156154|9972067|FG000|COMPLETED|Overall Study||287
8912854|NCT02156154|9972068|FG001|COMPLETED|Overall Study||283
8912855|NCT02156154|9972067|FG000|NOT COMPLETED|Overall Study||4
8912856|NCT02156154|9972068|FG001|NOT COMPLETED|Overall Study||6
8912857|NCT02156167|9972074|FG000|STARTED|Overall Study||15
8912858|NCT02156167|9972074|FG000|COMPLETED|Overall Study||15
8912859|NCT02156167|9972074|FG000|NOT COMPLETED|Overall Study||0
8912860|NCT02156258|9972081|FG000|STARTED|Overall Study||674
8912861|NCT02156258|9972082|FG001|STARTED|Overall Study||203
8912862|NCT02156258|9972083|FG002|STARTED|Overall Study||355
8912863|NCT02156258|9972081|FG000|COMPLETED|Overall Study||642
8912864|NCT02156258|9972082|FG001|COMPLETED|Overall Study||124
8912865|NCT02156258|9972083|FG002|COMPLETED|Overall Study||244
8912866|NCT02156258|9972081|FG000|NOT COMPLETED|Overall Study||32
8912867|NCT02156258|9972082|FG001|NOT COMPLETED|Overall Study||79
8912868|NCT02156258|9972083|FG002|NOT COMPLETED|Overall Study||111
8912869|NCT02156271|9972093|FG000|STARTED|Overall Study||26
8912870|NCT02156271|9972094|FG001|STARTED|Overall Study||13
8912871|NCT02156271|9972093|FG000|COMPLETED|Overall Study||22
8912872|NCT02156271|9972094|FG001|COMPLETED|Overall Study||10
8912873|NCT02156271|9972093|FG000|NOT COMPLETED|Overall Study||4
8912874|NCT02156271|9972094|FG001|NOT COMPLETED|Overall Study||3
8912875|NCT02156466|9972105|FG000|STARTED|Overall Study||8
8912876|NCT02156466|9972106|FG001|STARTED|Overall Study||8
8912877|NCT02156466|9972107|FG002|STARTED|Overall Study||8
8912878|NCT02156466|9972108|FG003|STARTED|Overall Study||9
8912879|NCT02156466|9972109|FG004|STARTED|Overall Study||8
8912880|NCT02156466|9972105|FG000|COMPLETED|Overall Study||8
8912881|NCT02156466|9972106|FG001|COMPLETED|Overall Study||8
8742525|NCT01125293|9790980|FG005|STARTED|Overall Study||23
8742526|NCT01125293|9790975|FG000|Evaluable for Phase I Dose-Limiting Toxicity|Overall Study||3
8742527|NCT01125293|9790976|FG001|Evaluable for Phase I Dose-Limiting Toxicity|Overall Study||3
8912882|NCT02156466|9972107|FG002|COMPLETED|Overall Study||7
8912883|NCT02156466|9972108|FG003|COMPLETED|Overall Study||7
8912884|NCT02156466|9972109|FG004|COMPLETED|Overall Study||8
8912885|NCT02156466|9972105|FG000|NOT COMPLETED|Overall Study||0
8912886|NCT02156466|9972106|FG001|NOT COMPLETED|Overall Study||0
8742528|NCT01125293|9790977|FG002|Evaluable for Phase I Dose-Limiting Toxicity|Overall Study||3
8742529|NCT01125293|9790978|FG003|Evaluable for Phase I Dose-Limiting Toxicity|Overall Study||3
8742530|NCT01125293|9790979|FG004|Evaluable for Phase I Dose-Limiting Toxicity|Overall Study|The Phase I dose expansion cohort was not evaluated for cycle 1 dose-limiting toxicity.|0
8742531|NCT01125293|9790980|FG005|Evaluable for Phase I Dose-Limiting Toxicity|Overall Study|The Phase II cohort was not evaluated for cycle 1 dose-limiting toxicity.|0
8742532|NCT01125293|9790975|FG000|COMPLETED|Overall Study||0
8742533|NCT01125293|9790976|FG001|COMPLETED|Overall Study||0
8742534|NCT01125293|9790977|FG002|COMPLETED|Overall Study||0
8742535|NCT01125293|9790978|FG003|COMPLETED|Overall Study||0
8742536|NCT01125293|9790979|FG004|COMPLETED|Overall Study||0
8742537|NCT01125293|9790980|FG005|COMPLETED|Overall Study||0
8742538|NCT01125293|9790975|FG000|NOT COMPLETED|Overall Study||3
8742539|NCT01125293|9790976|FG001|NOT COMPLETED|Overall Study||3
8742540|NCT01125293|9790977|FG002|NOT COMPLETED|Overall Study||4
8742541|NCT01125293|9790978|FG003|NOT COMPLETED|Overall Study||3
8742542|NCT01125293|9790979|FG004|NOT COMPLETED|Overall Study||10
8742543|NCT01125293|9790980|FG005|NOT COMPLETED|Overall Study||23
8742544|NCT01125358|9791001|FG000|STARTED|Overall Study||21
8742545|NCT01125358|9791002|FG001|STARTED|Overall Study||21
8742546|NCT01125358|9791003|FG002|STARTED|Overall Study||20
8742547|NCT01125358|9791004|FG003|STARTED|Overall Study||20
8742548|NCT01125358|9791001|FG000|Received at Least 1 Dose of Study Drug|Overall Study||21
8742549|NCT01125358|9791002|FG001|Received at Least 1 Dose of Study Drug|Overall Study||21
8742550|NCT01125358|9791003|FG002|Received at Least 1 Dose of Study Drug|Overall Study||20
8742551|NCT01125358|9791004|FG003|Received at Least 1 Dose of Study Drug|Overall Study||20
8742552|NCT01125358|9791001|FG000|Placebo Responder|Overall Study||1
8742553|NCT01125358|9791002|FG001|Placebo Responder|Overall Study||0
8742554|NCT01125358|9791003|FG002|Placebo Responder|Overall Study||0
8742555|NCT01125358|9791004|FG003|Placebo Responder|Overall Study||0
8742556|NCT01125358|9791001|FG000|COMPLETED|Overall Study||9
8742557|NCT01125358|9791002|FG001|COMPLETED|Overall Study||17
8742558|NCT01125358|9791003|FG002|COMPLETED|Overall Study||11
8742559|NCT01125358|9791004|FG003|COMPLETED|Overall Study||12
8742560|NCT01125358|9791001|FG000|NOT COMPLETED|Overall Study||12
8742561|NCT01125358|9791002|FG001|NOT COMPLETED|Overall Study||4
8742562|NCT01125358|9791003|FG002|NOT COMPLETED|Overall Study||9
8742563|NCT01125358|9791004|FG003|NOT COMPLETED|Overall Study||8
8807320|NCT01483937|9859696|FG000|NOT COMPLETED|Overall Study||4
8807321|NCT01483937|9859697|FG001|NOT COMPLETED|Overall Study||3
8912887|NCT02156466|9972107|FG002|NOT COMPLETED|Overall Study||1
8912888|NCT02156466|9972108|FG003|NOT COMPLETED|Overall Study||2
8912889|NCT02156466|9972109|FG004|NOT COMPLETED|Overall Study||0
8912890|NCT02156492|9972133|FG000|STARTED|Period 1||16
8912891|NCT02156492|9972134|FG001|STARTED|Period 1||24
8912892|NCT02156492|9972135|FG002|STARTED|Period 1||22
8912893|NCT02156492|9972133|FG000|Received at Least One Dose of Study Drug|Period 1||16
8912894|NCT02156492|9972134|FG001|Received at Least One Dose of Study Drug|Period 1||24
8912895|NCT02156492|9972135|FG002|Received at Least One Dose of Study Drug|Period 1||22
8912896|NCT02156492|9972133|FG000|COMPLETED|Period 1||16
8912897|NCT02156492|9972134|FG001|COMPLETED|Period 1||23
8912898|NCT02156492|9972135|FG002|COMPLETED|Period 1||22
8912899|NCT02156492|9972133|FG000|NOT COMPLETED|Period 1||0
8912900|NCT02156492|9972134|FG001|NOT COMPLETED|Period 1||1
8912901|NCT02156492|9972135|FG002|NOT COMPLETED|Period 1||0
8912902|NCT02156492|9972133|FG000|STARTED|Period 2||16
8912903|NCT02156492|9972134|FG001|STARTED|Period 2||23
8912904|NCT02156492|9972135|FG002|STARTED|Period 2||22
8912905|NCT02156492|9972133|FG000|COMPLETED|Period 2||16
8912906|NCT02156492|9972134|FG001|COMPLETED|Period 2||23
8912907|NCT02156492|9972135|FG002|COMPLETED|Period 2||22
8912908|NCT02156492|9972133|FG000|NOT COMPLETED|Period 2||0
8912909|NCT02156492|9972134|FG001|NOT COMPLETED|Period 2||0
8912910|NCT02156492|9972135|FG002|NOT COMPLETED|Period 2||0
8912911|NCT02156492|9972133|FG000|STARTED|Period 3|Cohort A participated in Period 1 and Period 2 only.|0
8912912|NCT02156492|9972134|FG001|STARTED|Period 3||23
8912913|NCT02156492|9972135|FG002|STARTED|Period 3||22
8912914|NCT02156492|9972133|FG000|COMPLETED|Period 3||0
8912915|NCT02156492|9972134|FG001|COMPLETED|Period 3||22
8912916|NCT02156492|9972135|FG002|COMPLETED|Period 3||22
8912917|NCT02156492|9972133|FG000|NOT COMPLETED|Period 3||0
8912918|NCT02156492|9972134|FG001|NOT COMPLETED|Period 3||1
8912919|NCT02156492|9972135|FG002|NOT COMPLETED|Period 3||0
8807322|NCT01483963|9859711|FG000|STARTED|Overall Study||10
8807323|NCT01483963|9859712|FG001|STARTED|Overall Study||10
8807324|NCT01483963|9859713|FG002|STARTED|Overall Study||10
8807325|NCT01483963|9859714|FG003|STARTED|Overall Study||10
8807326|NCT01483963|9859715|FG004|STARTED|Overall Study||10
8807327|NCT01483963|9859711|FG000|COMPLETED|Overall Study||10
8807328|NCT01483963|9859712|FG001|COMPLETED|Overall Study||10
8807329|NCT01483963|9859713|FG002|COMPLETED|Overall Study||10
8807330|NCT01483963|9859714|FG003|COMPLETED|Overall Study||10
8807331|NCT01483963|9859715|FG004|COMPLETED|Overall Study||10
8807332|NCT01483963|9859711|FG000|NOT COMPLETED|Overall Study||0
8807333|NCT01483963|9859712|FG001|NOT COMPLETED|Overall Study||0
8807334|NCT01483963|9859713|FG002|NOT COMPLETED|Overall Study||0
8807335|NCT01483963|9859714|FG003|NOT COMPLETED|Overall Study||0
8912920|NCT02156674|9972153|FG000|STARTED|Overall Study||1
8912921|NCT02156674|9972153|FG000|COMPLETED|Overall Study||1
8912922|NCT02156674|9972153|FG000|NOT COMPLETED|Overall Study||0
8742564|NCT04733664|9791014|FG000|STARTED|Overall Study||10
8742565|NCT04733664|9791014|FG000|COMPLETED|Overall Study||10
8742566|NCT04733664|9791014|FG000|NOT COMPLETED|Overall Study||0
8742567|NCT04573322|9791022|FG000|STARTED|Overall Study||6
8742568|NCT04573322|9791023|FG001|STARTED|Overall Study||6
8742569|NCT04573322|9791024|FG002|STARTED|Overall Study||7
8742570|NCT04573322|9791025|FG003|STARTED|Overall Study||6
8742571|NCT04573322|9791022|FG000|COMPLETED|Overall Study||5
8742572|NCT04573322|9791023|FG001|COMPLETED|Overall Study||4
8742573|NCT04573322|9791024|FG002|COMPLETED|Overall Study||5
8742574|NCT04573322|9791025|FG003|COMPLETED|Overall Study||3
8742575|NCT04573322|9791022|FG000|NOT COMPLETED|Overall Study||1
8742576|NCT04573322|9791023|FG001|NOT COMPLETED|Overall Study||2
8742577|NCT04573322|9791024|FG002|NOT COMPLETED|Overall Study||2
8742578|NCT04573322|9791025|FG003|NOT COMPLETED|Overall Study||3
8742579|NCT04516746|9791037|FG000|STARTED|Overall Study||21635
8742580|NCT04516746|9791038|FG001|STARTED|Overall Study||10816
8742581|NCT04516746|9791037|FG000|Participants Who Received First Dose|Overall Study||21583
8742582|NCT04516746|9791038|FG001|Participants Who Received First Dose|Overall Study||10796
8742583|NCT04516746|9791037|FG000|Participants Who Received Second Dose|Overall Study||20769
8742584|NCT04516746|9791038|FG001|Participants Who Received Second Dose|Overall Study||9951
8742585|NCT04516746|9791037|FG000|COMPLETED|Overall Study||0
8742586|NCT04516746|9791038|FG001|COMPLETED|Overall Study||0
8742587|NCT04516746|9791037|FG000|NOT COMPLETED|Overall Study||21635
8742588|NCT04516746|9791038|FG001|NOT COMPLETED|Overall Study||10816
8742589|NCT04374565|9791044|FG000|STARTED|Overall Study||29
8742590|NCT04374565|9791044|FG000|COMPLETED|Overall Study||29
8742591|NCT04374565|9791044|FG000|NOT COMPLETED|Overall Study||0
8742592|NCT04364737|9791050|FG000|STARTED|Overall Study||468
8742593|NCT04364737|9791051|FG001|STARTED|Overall Study||473
8742594|NCT04364737|9791050|FG000|COMPLETED|Overall Study||463
8742595|NCT04364737|9791051|FG001|COMPLETED|Overall Study||463
8742596|NCT04364737|9791050|FG000|NOT COMPLETED|Overall Study||5
8742597|NCT04364737|9791051|FG001|NOT COMPLETED|Overall Study||10
8742598|NCT04354155|9791057|FG000|STARTED|Overall Study||40
8742599|NCT04354155|9791057|FG000|COMPLETED|Overall Study||38
8742600|NCT04354155|9791057|FG000|NOT COMPLETED|Overall Study||2
8742601|NCT04085367|9791063|FG000|STARTED|Overall Study||364
8742602|NCT04085367|9791064|FG001|STARTED|Overall Study||193
8742603|NCT04085367|9791063|FG000|COMPLETED|Overall Study||344
8742604|NCT04085367|9791064|FG001|COMPLETED|Overall Study||185
8742605|NCT04085367|9791063|FG000|NOT COMPLETED|Overall Study||20
8742606|NCT04085367|9791064|FG001|NOT COMPLETED|Overall Study||8
8742607|NCT03884270|9791070|FG000|STARTED|Overall Study||23
8742608|NCT03884270|9791070|FG000|COMPLETED|Overall Study||22
8742609|NCT03884270|9791070|FG000|NOT COMPLETED|Overall Study||1
8742610|NCT03621696|9791078|FG000|STARTED|Overall Study||21
8742611|NCT03621696|9791079|FG001|STARTED|Overall Study||31
8742612|NCT03621696|9791080|FG002|STARTED|Overall Study||6
8742613|NCT03621696|9791081|FG003|STARTED|Overall Study||5
8742614|NCT03621696|9791078|FG000|COMPLETED|Overall Study||20
8742615|NCT03621696|9791079|FG001|COMPLETED|Overall Study||30
8742616|NCT03621696|9791080|FG002|COMPLETED|Overall Study||4
8742617|NCT03621696|9791081|FG003|COMPLETED|Overall Study||0
8742618|NCT03621696|9791078|FG000|NOT COMPLETED|Overall Study||1
8742619|NCT03621696|9791079|FG001|NOT COMPLETED|Overall Study||1
8742620|NCT03621696|9791080|FG002|NOT COMPLETED|Overall Study||2
8742621|NCT03621696|9791081|FG003|NOT COMPLETED|Overall Study||5
8742622|NCT03544268|9791091|FG000|STARTED|Overall Study||5
8742623|NCT03544268|9791092|FG001|STARTED|Overall Study||15
8742624|NCT03544268|9791091|FG000|COMPLETED|Overall Study||3
8742625|NCT03544268|9791092|FG001|COMPLETED|Overall Study||15
8742626|NCT03544268|9791091|FG000|NOT COMPLETED|Overall Study||2
8742627|NCT03544268|9791092|FG001|NOT COMPLETED|Overall Study||0
8742628|NCT03421197|9791102|FG000|STARTED|Overall Study||105
8742629|NCT03421197|9791103|FG001|STARTED|Overall Study||107
8742630|NCT03421197|9791104|FG002|STARTED|Overall Study||107
8742631|NCT03421197|9791105|FG003|STARTED|Overall Study||107
8742632|NCT03421197|9791102|FG000|COMPLETED|Overall Study||67
8742633|NCT03421197|9791103|FG001|COMPLETED|Overall Study||68
8742634|NCT03421197|9791104|FG002|COMPLETED|Overall Study||56
8742635|NCT03421197|9791105|FG003|COMPLETED|Overall Study||62
8742636|NCT03421197|9791102|FG000|NOT COMPLETED|Overall Study||38
8912923|NCT02156687|9972159|FG000|STARTED|Overall Study||30
8912924|NCT02156687|9972160|FG001|STARTED|Overall Study||29
9022696|NCT03131167|10085550|FG002|NOT COMPLETED|Overall Study||0
8742637|NCT03421197|9791103|FG001|NOT COMPLETED|Overall Study||39
8742638|NCT03421197|9791104|FG002|NOT COMPLETED|Overall Study||51
8742639|NCT03421197|9791105|FG003|NOT COMPLETED|Overall Study||45
8742640|NCT03371108|9791117|FG000|STARTED|Safety Analysis Set||284
8742641|NCT03371108|9791118|FG001|STARTED|Safety Analysis Set||283
8742642|NCT03371108|9791117|FG000|COMPLETED|Safety Analysis Set||281
8742643|NCT03371108|9791118|FG001|COMPLETED|Safety Analysis Set||282
8742644|NCT03371108|9791117|FG000|NOT COMPLETED|Safety Analysis Set||3
8742645|NCT03371108|9791118|FG001|NOT COMPLETED|Safety Analysis Set||1
8742646|NCT03371108|9791117|FG000|STARTED|Completers||281
8742647|NCT03371108|9791118|FG001|STARTED|Completers||282
8742648|NCT03371108|9791117|FG000|COMPLETED|Completers||259
8742649|NCT03371108|9791118|FG001|COMPLETED|Completers||256
8742650|NCT03371108|9791117|FG000|NOT COMPLETED|Completers||22
8742651|NCT03371108|9791118|FG001|NOT COMPLETED|Completers||26
8742652|NCT03112993|9791126|FG000|STARTED|Overall Study||19
8742653|NCT03112993|9791127|FG001|STARTED|Overall Study||21
8742654|NCT03112993|9791126|FG000|COMPLETED|Overall Study||19
8742655|NCT03112993|9791127|FG001|COMPLETED|Overall Study||21
8742656|NCT03112993|9791126|FG000|NOT COMPLETED|Overall Study||0
8742657|NCT03112993|9791127|FG001|NOT COMPLETED|Overall Study||0
8742658|NCT03088137|9791137|FG000|STARTED|Overall Study||55
8742659|NCT03088137|9791138|FG001|STARTED|Overall Study||55
8742660|NCT03088137|9791137|FG000|COMPLETED|Overall Study||55
8742661|NCT03088137|9791138|FG001|COMPLETED|Overall Study||55
8742662|NCT03088137|9791137|FG000|NOT COMPLETED|Overall Study||0
8742663|NCT03088137|9791138|FG001|NOT COMPLETED|Overall Study||0
8742664|NCT03038438|9791144|FG000|STARTED|Overall Study||200
8742665|NCT03038438|9791144|FG000|30-Day Follow-Up|Overall Study||198
8742666|NCT03038438|9791144|FG000|6-Month Follow-up|Overall Study||193
8742667|NCT03038438|9791144|FG000|12-Month Follow-up|Overall Study||191
8742668|NCT03038438|9791144|FG000|24-Month Follow-up|Overall Study||148
8742669|NCT03038438|9791144|FG000|COMPLETED|Overall Study||148
8742670|NCT03038438|9791144|FG000|NOT COMPLETED|Overall Study||52
8742671|NCT02951481|9791150|FG000|STARTED|Overall Study||231
8742672|NCT02951481|9791151|FG001|STARTED|Overall Study||172
8742673|NCT02951481|9791150|FG000|COMPLETED|Overall Study||231
8742674|NCT02951481|9791151|FG001|COMPLETED|Overall Study||172
8742675|NCT02951481|9791150|FG000|NOT COMPLETED|Overall Study||0
8742676|NCT02951481|9791151|FG001|NOT COMPLETED|Overall Study||0
8807336|NCT01483963|9859715|FG004|NOT COMPLETED|Overall Study||0
8807337|NCT01484028|9859728|FG000|STARTED|Period 1||66
8807338|NCT01484028|9859729|FG001|STARTED|Period 1||70
8807339|NCT01484028|9859730|FG002|STARTED|Period 1||64
8807340|NCT01484028|9859731|FG003|STARTED|Period 1||67
8807341|NCT01484028|9859728|FG000|COMPLETED|Period 1||66
8807342|NCT01484028|9859729|FG001|COMPLETED|Period 1||67
8807343|NCT01484028|9859730|FG002|COMPLETED|Period 1||64
8807344|NCT01484028|9859731|FG003|COMPLETED|Period 1||66
8807345|NCT01484028|9859728|FG000|NOT COMPLETED|Period 1||0
8807346|NCT01484028|9859729|FG001|NOT COMPLETED|Period 1||3
8807347|NCT01484028|9859730|FG002|NOT COMPLETED|Period 1||0
8807348|NCT01484028|9859731|FG003|NOT COMPLETED|Period 1||1
8807349|NCT01484028|9859728|FG000|STARTED|Period 2||66
8807350|NCT01484028|9859729|FG001|STARTED|Period 2||67
8807351|NCT01484028|9859730|FG002|STARTED|Period 2||64
8807352|NCT01484028|9859731|FG003|STARTED|Period 2||66
8807353|NCT01484028|9859728|FG000|COMPLETED|Period 2||66
8807354|NCT01484028|9859729|FG001|COMPLETED|Period 2||67
8807355|NCT01484028|9859730|FG002|COMPLETED|Period 2||64
8807356|NCT01484028|9859731|FG003|COMPLETED|Period 2||66
8807357|NCT01484028|9859728|FG000|NOT COMPLETED|Period 2||0
8807358|NCT01484028|9859729|FG001|NOT COMPLETED|Period 2||0
8807359|NCT01484028|9859730|FG002|NOT COMPLETED|Period 2||0
8807360|NCT01484028|9859731|FG003|NOT COMPLETED|Period 2||0
8807361|NCT01484041|9859739|FG000|STARTED|Overall Study||12
8807362|NCT01484041|9859739|FG000|COMPLETED|Overall Study||12
8807363|NCT01484041|9859739|FG000|NOT COMPLETED|Overall Study||0
8807364|NCT01484054|9859743|FG000|STARTED|Period 1||50
8807365|NCT01484054|9859744|FG001|STARTED|Period 1||50
8807366|NCT01484054|9859743|FG000|COMPLETED|Period 1||50
8807367|NCT01484054|9859744|FG001|COMPLETED|Period 1||49
8807368|NCT01484054|9859743|FG000|NOT COMPLETED|Period 1||0
8807369|NCT01484054|9859744|FG001|NOT COMPLETED|Period 1||1
8807370|NCT01484054|9859743|FG000|STARTED|Period 2||50
8807371|NCT01484054|9859744|FG001|STARTED|Period 2||49
8807372|NCT01484054|9859743|FG000|COMPLETED|Period 2||50
8807373|NCT01484054|9859744|FG001|COMPLETED|Period 2||49
8807374|NCT01484054|9859743|FG000|NOT COMPLETED|Period 2||0
8807375|NCT01484054|9859744|FG001|NOT COMPLETED|Period 2||0
8807376|NCT01484132|9859751|FG000|STARTED|Overall Study||113
8807377|NCT01484132|9859751|FG000|Pre-treatment Urine Sample|Overall Study|Urine samples were collected twice pre-treatment. 101 subjects completed at least one urine sample.|101
8807378|NCT01484132|9859751|FG000|COMPLETED|Overall Study|91 subjects had at least one pre-treatment and at least one post-treatment urine sample.|91
8807379|NCT01484132|9859751|FG000|NOT COMPLETED|Overall Study||22
8807380|NCT01484197|9859755|FG000|STARTED|Treatment Period 1||9
8807381|NCT01484197|9859756|FG001|STARTED|Treatment Period 1||9
8807382|NCT01484197|9859757|FG002|STARTED|Treatment Period 1||9
8807383|NCT01484197|9859758|FG003|STARTED|Treatment Period 1||9
8807384|NCT01484197|9859755|FG000|COMPLETED|Treatment Period 1||8
8807385|NCT01484197|9859756|FG001|COMPLETED|Treatment Period 1||9
8807386|NCT01484197|9859757|FG002|COMPLETED|Treatment Period 1||9
8807387|NCT01484197|9859758|FG003|COMPLETED|Treatment Period 1||9
8807388|NCT01484197|9859755|FG000|NOT COMPLETED|Treatment Period 1||1
8807389|NCT01484197|9859756|FG001|NOT COMPLETED|Treatment Period 1||0
8807390|NCT01484197|9859757|FG002|NOT COMPLETED|Treatment Period 1||0
8807391|NCT01484197|9859758|FG003|NOT COMPLETED|Treatment Period 1||0
8807392|NCT01484197|9859755|FG000|STARTED|Treatment Period 2|1 patient completed Period 1 but did not enter Period 2 due to a Protocol deviation.|7
8807393|NCT01484197|9859756|FG001|STARTED|Treatment Period 2|1 patient completed Period 1 but did not enter Period 2 due to an Adverse event (AE).|8
8807394|NCT01484197|9859757|FG002|STARTED|Treatment Period 2||9
8807395|NCT01484197|9859758|FG003|STARTED|Treatment Period 2||9
8807396|NCT01484197|9859755|FG000|COMPLETED|Treatment Period 2||7
8807397|NCT01484197|9859756|FG001|COMPLETED|Treatment Period 2||8
8807398|NCT01484197|9859757|FG002|COMPLETED|Treatment Period 2||9
8807399|NCT01484197|9859758|FG003|COMPLETED|Treatment Period 2||8
8807400|NCT01484197|9859755|FG000|NOT COMPLETED|Treatment Period 2||0
8807401|NCT01484197|9859756|FG001|NOT COMPLETED|Treatment Period 2||0
8742677|NCT02451943|9791159|FG000|STARTED|Overall Study||258
8742678|NCT02451943|9791160|FG001|STARTED|Overall Study||251
8742679|NCT02451943|9791159|FG000|Received at Least One Dose of Study Drug|Overall Study||257
8742680|NCT02451943|9791160|FG001|Received at Least One Dose of Study Drug|Overall Study||249
8742681|NCT02451943|9791159|FG000|Leiomyosarcoma (LMS) Population|Overall Study||119
8742682|NCT02451943|9791160|FG001|Leiomyosarcoma (LMS) Population|Overall Study||115
8742683|NCT02451943|9791159|FG000|COMPLETED|Overall Study||238
8742684|NCT02451943|9791160|FG001|COMPLETED|Overall Study||227
8742685|NCT02451943|9791159|FG000|NOT COMPLETED|Overall Study||20
8742686|NCT02451943|9791160|FG001|NOT COMPLETED|Overall Study||24
8742687|NCT02242942|9791169|FG000|STARTED|Overall Study||216
8742688|NCT02242942|9791170|FG001|STARTED|Overall Study||216
8742689|NCT02242942|9791171|FG002|STARTED|Overall Study||13
8742690|NCT02242942|9791169|FG000|Treated|Overall Study||214
8742691|NCT02242942|9791170|FG001|Treated|Overall Study||212
8742692|NCT02242942|9791171|FG002|Treated|Overall Study||13
8742693|NCT02242942|9791169|FG000|COMPLETED|Overall Study||0
8742694|NCT02242942|9791170|FG001|COMPLETED|Overall Study||0
8742695|NCT02242942|9791171|FG002|COMPLETED|Overall Study||0
8742696|NCT02242942|9791169|FG000|NOT COMPLETED|Overall Study||216
8742697|NCT02242942|9791170|FG001|NOT COMPLETED|Overall Study||216
8742698|NCT02242942|9791171|FG002|NOT COMPLETED|Overall Study||13
8742699|NCT02198794|9791181|FG000|STARTED|Part A: Open-Label (158 Weeks)||337
8742700|NCT02198794|9791182|FG001|STARTED|Part A: Open-Label (158 Weeks)||0
8742701|NCT02198794|9791183|FG002|STARTED|Part A: Open-Label (158 Weeks)||0
8742702|NCT02198794|9791184|FG003|STARTED|Part A: Open-Label (158 Weeks)||0
8742703|NCT02198794|9791181|FG000|Received at Least 1 Dose of Study Drug|Part A: Open-Label (158 Weeks)||337
8742704|NCT02198794|9791182|FG001|Received at Least 1 Dose of Study Drug|Part A: Open-Label (158 Weeks)||0
8742705|NCT02198794|9791183|FG002|Received at Least 1 Dose of Study Drug|Part A: Open-Label (158 Weeks)||0
8742706|NCT02198794|9791184|FG003|Received at Least 1 Dose of Study Drug|Part A: Open-Label (158 Weeks)||0
8742707|NCT02198794|9791181|FG000|Intent-to-Treat (ITT) Population|Part A: Open-Label (158 Weeks)||337
8742708|NCT02198794|9791182|FG001|Intent-to-Treat (ITT) Population|Part A: Open-Label (158 Weeks)||0
8742709|NCT02198794|9791183|FG002|Intent-to-Treat (ITT) Population|Part A: Open-Label (158 Weeks)||0
8742710|NCT02198794|9791184|FG003|Intent-to-Treat (ITT) Population|Part A: Open-Label (158 Weeks)||0
8742711|NCT02198794|9791181|FG000|Participants Who Participated in Part A But Not in Part B|Part A: Open-Label (158 Weeks)||195
8742712|NCT02198794|9791182|FG001|Participants Who Participated in Part A But Not in Part B|Part A: Open-Label (158 Weeks)||0
8742713|NCT02198794|9791183|FG002|Participants Who Participated in Part A But Not in Part B|Part A: Open-Label (158 Weeks)||0
8742714|NCT02198794|9791184|FG003|Participants Who Participated in Part A But Not in Part B|Part A: Open-Label (158 Weeks)||0
8742715|NCT02198794|9791181|FG000|Participants Who Agreed to Continue in Part B|Part A: Open-Label (158 Weeks)||142
8742716|NCT02198794|9791182|FG001|Participants Who Agreed to Continue in Part B|Part A: Open-Label (158 Weeks)||0
8742717|NCT02198794|9791183|FG002|Participants Who Agreed to Continue in Part B|Part A: Open-Label (158 Weeks)||0
8742718|NCT02198794|9791184|FG003|Participants Who Agreed to Continue in Part B|Part A: Open-Label (158 Weeks)||0
8742719|NCT02198794|9791181|FG000|COMPLETED|Part A: Open-Label (158 Weeks)||32
8742720|NCT02198794|9791182|FG001|COMPLETED|Part A: Open-Label (158 Weeks)||0
8742721|NCT02198794|9791183|FG002|COMPLETED|Part A: Open-Label (158 Weeks)||0
8742722|NCT02198794|9791184|FG003|COMPLETED|Part A: Open-Label (158 Weeks)||0
8742723|NCT02198794|9791181|FG000|NOT COMPLETED|Part A: Open-Label (158 Weeks)||305
8742724|NCT02198794|9791182|FG001|NOT COMPLETED|Part A: Open-Label (158 Weeks)||0
8742725|NCT02198794|9791183|FG002|NOT COMPLETED|Part A: Open-Label (158 Weeks)||0
8742726|NCT02198794|9791184|FG003|NOT COMPLETED|Part A: Open-Label (158 Weeks)||0
8742727|NCT02198794|9791181|FG000|STARTED|Part B: Randomized (13 Weeks)||0
8742728|NCT02198794|9791182|FG001|STARTED|Part B: Randomized (13 Weeks)|Participants of Part A who agreed to participate in Part B|71
8742729|NCT02198794|9791183|FG002|STARTED|Part B: Randomized (13 Weeks)|Participants of Part A who agreed to participate in Part B|71
8742730|NCT02198794|9791184|FG003|STARTED|Part B: Randomized (13 Weeks)||0
8742731|NCT02198794|9791181|FG000|Randomized Withdrawal mITT Population|Part B: Randomized (13 Weeks)||0
8742732|NCT02198794|9791182|FG001|Randomized Withdrawal mITT Population|Part B: Randomized (13 Weeks)||63
8742733|NCT02198794|9791183|FG002|Randomized Withdrawal mITT Population|Part B: Randomized (13 Weeks)||65
8742734|NCT02198794|9791184|FG003|Randomized Withdrawal mITT Population|Part B: Randomized (13 Weeks)||0
8742735|NCT02198794|9791181|FG000|COMPLETED|Part B: Randomized (13 Weeks)||0
8742736|NCT02198794|9791182|FG001|COMPLETED|Part B: Randomized (13 Weeks)||66
8742737|NCT02198794|9791183|FG002|COMPLETED|Part B: Randomized (13 Weeks)||68
8742738|NCT02198794|9791184|FG003|COMPLETED|Part B: Randomized (13 Weeks)||0
8742739|NCT02198794|9791181|FG000|NOT COMPLETED|Part B: Randomized (13 Weeks)||0
8742740|NCT02198794|9791182|FG001|NOT COMPLETED|Part B: Randomized (13 Weeks)||5
8742741|NCT02198794|9791183|FG002|NOT COMPLETED|Part B: Randomized (13 Weeks)||3
8742742|NCT02198794|9791184|FG003|NOT COMPLETED|Part B: Randomized (13 Weeks)||0
8742743|NCT02198794|9791181|FG000|STARTED|Part C: Safety Assessment (52 Weeks)||0
8742744|NCT02198794|9791182|FG001|STARTED|Part C: Safety Assessment (52 Weeks)||0
8742745|NCT02198794|9791183|FG002|STARTED|Part C: Safety Assessment (52 Weeks)||0
8742746|NCT02198794|9791184|FG003|STARTED|Part C: Safety Assessment (52 Weeks)||80
8742747|NCT02198794|9791181|FG000|COMPLETED|Part C: Safety Assessment (52 Weeks)||0
8742748|NCT02198794|9791182|FG001|COMPLETED|Part C: Safety Assessment (52 Weeks)||0
8742749|NCT02198794|9791183|FG002|COMPLETED|Part C: Safety Assessment (52 Weeks)||0
8742750|NCT02198794|9791184|FG003|COMPLETED|Part C: Safety Assessment (52 Weeks)||73
8742751|NCT02198794|9791181|FG000|NOT COMPLETED|Part C: Safety Assessment (52 Weeks)||0
8742752|NCT02198794|9791182|FG001|NOT COMPLETED|Part C: Safety Assessment (52 Weeks)||0
8742753|NCT02198794|9791183|FG002|NOT COMPLETED|Part C: Safety Assessment (52 Weeks)||0
8912925|NCT02156687|9972159|FG000|COMPLETED|Overall Study||20
8912926|NCT02156687|9972160|FG001|COMPLETED|Overall Study||24
8912927|NCT02156687|9972159|FG000|NOT COMPLETED|Overall Study||10
8912928|NCT02156687|9972160|FG001|NOT COMPLETED|Overall Study||5
8912929|NCT02156804|9972166|FG000|STARTED|Overall Study||1009
8912930|NCT02156804|9972166|FG000|COMPLETED|Overall Study||1008
8912931|NCT02156804|9972166|FG000|NOT COMPLETED|Overall Study||1
8912932|NCT02156908|9972172|FG000|STARTED|Overall Study||5
8912933|NCT02156908|9972173|FG001|STARTED|Overall Study||3
8912934|NCT02156908|9972172|FG000|COMPLETED|Overall Study||5
8912935|NCT02156908|9972173|FG001|COMPLETED|Overall Study||3
8912936|NCT02156908|9972172|FG000|NOT COMPLETED|Overall Study||0
8912937|NCT02156908|9972173|FG001|NOT COMPLETED|Overall Study||0
8912938|NCT02157103|9972180|FG000|STARTED|Overall Study||3
8912939|NCT02157103|9972180|FG000|COMPLETED|Overall Study||3
8912940|NCT02157103|9972180|FG000|NOT COMPLETED|Overall Study||0
8912941|NCT02157168|9972187|FG000|STARTED|Overall Study||746
8912942|NCT02157168|9972188|FG001|STARTED|Overall Study||159
8912943|NCT02157168|9972189|FG002|STARTED|Overall Study||1362
8912944|NCT02157168|9972187|FG000|COMPLETED|Overall Study||746
8912945|NCT02157168|9972188|FG001|COMPLETED|Overall Study||159
8912946|NCT02157168|9972189|FG002|COMPLETED|Overall Study||1362
8912947|NCT02157168|9972187|FG000|NOT COMPLETED|Overall Study||0
8912948|NCT02157168|9972188|FG001|NOT COMPLETED|Overall Study||0
8912949|NCT02157168|9972189|FG002|NOT COMPLETED|Overall Study||0
8912950|NCT02157298|9972202|FG000|STARTED|Overall Study||123
8912951|NCT02157298|9972203|FG001|STARTED|Overall Study||60
8912952|NCT02157298|9972202|FG000|COMPLETED|Overall Study||119
8912953|NCT02157298|9972203|FG001|COMPLETED|Overall Study||58
8912954|NCT02157298|9972202|FG000|NOT COMPLETED|Overall Study||4
8912955|NCT02157298|9972203|FG001|NOT COMPLETED|Overall Study||2
8912956|NCT02157376|9972211|FG000|STARTED|Overall Study||155
8912957|NCT02157376|9972212|FG001|STARTED|Overall Study||156
8912958|NCT02157376|9972211|FG000|COMPLETED|Overall Study||133
8912959|NCT02157376|9972212|FG001|COMPLETED|Overall Study||138
8912960|NCT02157376|9972211|FG000|NOT COMPLETED|Overall Study||22
8912961|NCT02157376|9972212|FG001|NOT COMPLETED|Overall Study||18
8912962|NCT02157506|9972223|FG000|STARTED|Overall Study||12
8912963|NCT02157506|9972224|FG001|STARTED|Overall Study||6
8912964|NCT02157506|9972225|FG002|STARTED|Overall Study||9
8912965|NCT02157506|9972226|FG003|STARTED|Overall Study||12
8912966|NCT02157506|9972227|FG004|STARTED|Overall Study||7
8912967|NCT02157506|9972223|FG000|COMPLETED|Overall Study||12
8912968|NCT02157506|9972224|FG001|COMPLETED|Overall Study||5
8912969|NCT02157506|9972225|FG002|COMPLETED|Overall Study||8
8912970|NCT02157506|9972226|FG003|COMPLETED|Overall Study||12
8912971|NCT02157506|9972227|FG004|COMPLETED|Overall Study||7
8912972|NCT02157506|9972223|FG000|NOT COMPLETED|Overall Study||0
8912973|NCT02157506|9972224|FG001|NOT COMPLETED|Overall Study||1
8912974|NCT02157506|9972225|FG002|NOT COMPLETED|Overall Study||1
8742754|NCT02198794|9791184|FG003|NOT COMPLETED|Part C: Safety Assessment (52 Weeks)||7
8742755|NCT01877655|9791195|FG000|STARTED|Overall Study||263
8742756|NCT01877655|9791196|FG001|STARTED|Overall Study||251
8742757|NCT01877655|9791195|FG000|Received Treatment|Overall Study||255
8742758|NCT01877655|9791196|FG001|Received Treatment|Overall Study||246
8742759|NCT01877655|9791195|FG000|COMPLETED|Overall Study||165
8742760|NCT01877655|9791196|FG001|COMPLETED|Overall Study||154
8742761|NCT01877655|9791195|FG000|NOT COMPLETED|Overall Study||98
8742762|NCT01877655|9791196|FG001|NOT COMPLETED|Overall Study||97
8742763|NCT00308685|9791204|FG000|STARTED|Overall Study||50
8912975|NCT02157506|9972226|FG003|NOT COMPLETED|Overall Study||0
8912976|NCT02157506|9972227|FG004|NOT COMPLETED|Overall Study||0
8912977|NCT02157519|9972241|FG000|STARTED|Overall Study||91
8912978|NCT02157519|9972242|FG001|STARTED|Overall Study||90
8912979|NCT02157519|9972241|FG000|MEMScap Collected|Overall Study||84
8912980|NCT02157519|9972242|FG001|MEMScap Collected|Overall Study||86
8912981|NCT02157519|9972241|FG000|COMPLETED|Overall Study||80
8912982|NCT02157519|9972242|FG001|COMPLETED|Overall Study||89
8912983|NCT02157519|9972241|FG000|NOT COMPLETED|Overall Study||11
8912984|NCT02157519|9972242|FG001|NOT COMPLETED|Overall Study||1
8912985|NCT02157623|9972248|FG000|STARTED|Overall Study|3 patients, each received red light on half of body and blue light on the contralateral side.|3
8912986|NCT02157623|9972248|FG000|COMPLETED|Overall Study||3
8912987|NCT02157623|9972248|FG000|NOT COMPLETED|Overall Study||0
8912988|NCT02157779|9972260|FG000|STARTED|Overall Study||47
8912989|NCT02157779|9972261|FG001|STARTED|Overall Study||45
8912990|NCT02157779|9972260|FG000|COMPLETED|Overall Study||23
8912991|NCT02157779|9972261|FG001|COMPLETED|Overall Study||34
8912992|NCT02157779|9972260|FG000|NOT COMPLETED|Overall Study||24
8912993|NCT02157779|9972261|FG001|NOT COMPLETED|Overall Study||11
8912994|NCT02157909|9972272|FG000|STARTED|Overall Study||66
8912995|NCT02157909|9972273|FG001|STARTED|Overall Study||66
8912996|NCT02157909|9972272|FG000|COMPLETED|Overall Study||66
8912997|NCT02157909|9972273|FG001|COMPLETED|Overall Study||66
8912998|NCT02157909|9972272|FG000|NOT COMPLETED|Overall Study||0
8912999|NCT02157909|9972273|FG001|NOT COMPLETED|Overall Study||0
8913000|NCT02157935|9972282|FG000|STARTED|Overall Study||606
8742764|NCT00308685|9791205|FG001|STARTED|Overall Study||45
8742765|NCT00308685|9791204|FG000|Received at Least 1 Dose of Study Drug|Overall Study||50
8742766|NCT00308685|9791205|FG001|Received at Least 1 Dose of Study Drug|Overall Study||45
8742767|NCT00308685|9791204|FG000|COMPLETED|Overall Study||47
8742768|NCT00308685|9791205|FG001|COMPLETED|Overall Study||40
8742769|NCT00308685|9791204|FG000|NOT COMPLETED|Overall Study||3
8742770|NCT00308685|9791205|FG001|NOT COMPLETED|Overall Study||5
8742771|NCT01125514|9791211|FG000|STARTED|Treatment Period 1 (Day 1 - Day 7)|Randomized and safety population|37
8742772|NCT01125514|9791211|FG000|COMPLETED|Treatment Period 1 (Day 1 - Day 7)||35
8742773|NCT01125514|9791211|FG000|NOT COMPLETED|Treatment Period 1 (Day 1 - Day 7)||2
8742774|NCT01125514|9791211|FG000|STARTED|Treatment Period 2 (Day 8 - Day 17)||35
8742775|NCT01125514|9791211|FG000|Pharmacokinetic (PK) Analysis Set|Treatment Period 2 (Day 8 - Day 17)||33
8742776|NCT01125514|9791211|FG000|Pharmacodynamics (PD) Analysis Set|Treatment Period 2 (Day 8 - Day 17)||33
8742777|NCT01125514|9791211|FG000|COMPLETED|Treatment Period 2 (Day 8 - Day 17)||32
8742778|NCT01125514|9791211|FG000|NOT COMPLETED|Treatment Period 2 (Day 8 - Day 17)||3
8742779|NCT01125514|9791211|FG000|STARTED|Treatment Period2(Day9-Day27) and Day 28||32
8742780|NCT01125514|9791211|FG000|COMPLETED|Treatment Period2(Day9-Day27) and Day 28||28
8742781|NCT01125514|9791211|FG000|NOT COMPLETED|Treatment Period2(Day9-Day27) and Day 28||4
8742782|NCT01125566|9791227|FG000|STARTED|Patients Before the Switch (26Apr2013)||339
8742783|NCT01125566|9791228|FG001|STARTED|Patients Before the Switch (26Apr2013)||169
8742784|NCT01125566|9791229|FG002|STARTED|Patients Before the Switch (26Apr2013)||0
8742785|NCT01125566|9791227|FG000|Treated|Patients Before the Switch (26Apr2013)||337
8742786|NCT01125566|9791228|FG001|Treated|Patients Before the Switch (26Apr2013)||169
8742787|NCT01125566|9791229|FG002|Treated|Patients Before the Switch (26Apr2013)||0
8742788|NCT01125566|9791227|FG000|COMPLETED|Patients Before the Switch (26Apr2013)||74
8742789|NCT01125566|9791228|FG001|COMPLETED|Patients Before the Switch (26Apr2013)||0
8742790|NCT01125566|9791229|FG002|COMPLETED|Patients Before the Switch (26Apr2013)||0
8742791|NCT01125566|9791227|FG000|NOT COMPLETED|Patients Before the Switch (26Apr2013)||265
8742792|NCT01125566|9791228|FG001|NOT COMPLETED|Patients Before the Switch (26Apr2013)||169
8742793|NCT01125566|9791229|FG002|NOT COMPLETED|Patients Before the Switch (26Apr2013)||0
8742794|NCT01125566|9791227|FG000|STARTED|Patients Who Switched From AV to TV||0
8742795|NCT01125566|9791228|FG001|STARTED|Patients Who Switched From AV to TV||0
8742796|NCT01125566|9791229|FG002|STARTED|Patients Who Switched From AV to TV||75
8742797|NCT01125566|9791227|FG000|COMPLETED|Patients Who Switched From AV to TV||0
8742798|NCT01125566|9791228|FG001|COMPLETED|Patients Who Switched From AV to TV||0
8742799|NCT01125566|9791229|FG002|COMPLETED|Patients Who Switched From AV to TV||2
8742800|NCT01125566|9791227|FG000|NOT COMPLETED|Patients Who Switched From AV to TV||0
8742801|NCT01125566|9791228|FG001|NOT COMPLETED|Patients Who Switched From AV to TV||0
8742802|NCT01125566|9791229|FG002|NOT COMPLETED|Patients Who Switched From AV to TV||73
8742803|NCT01125605|9791236|FG000|STARTED|Overall Study|started = had baseline values|325
8742804|NCT01125605|9791236|FG000|Safety|Overall Study|1 patient was only analysed for safety|326
8742805|NCT01125605|9791236|FG000|COMPLETED|Overall Study||325
8742806|NCT01125605|9791236|FG000|NOT COMPLETED|Overall Study||0
8742807|NCT01125722|9791255|FG000|STARTED|Overall Study||37
8742808|NCT01125722|9791256|FG001|STARTED|Overall Study||37
8742809|NCT01125722|9791255|FG000|COMPLETED|Overall Study||34
8742810|NCT01125722|9791256|FG001|COMPLETED|Overall Study||36
8742811|NCT01125722|9791255|FG000|NOT COMPLETED|Overall Study||3
8742812|NCT01125722|9791256|FG001|NOT COMPLETED|Overall Study||1
8742813|NCT01125748|9791264|FG000|STARTED|Overall Study||88
8742814|NCT01125748|9791265|FG001|STARTED|Overall Study||88
8742815|NCT01125748|9791264|FG000|COMPLETED|Overall Study||78
8742816|NCT01125748|9791265|FG001|COMPLETED|Overall Study||74
8742817|NCT01125748|9791264|FG000|NOT COMPLETED|Overall Study||10
8742818|NCT01125748|9791265|FG001|NOT COMPLETED|Overall Study||14
8742819|NCT01125774|9791273|FG000|STARTED|Overall Study|Randomized|3018
8742820|NCT01125774|9791274|FG001|STARTED|Overall Study|Randomized|1502
8742821|NCT01125774|9791275|FG002|STARTED|Overall Study|Unique participants randomized|22
8742822|NCT01125774|9791276|FG003|STARTED|Overall Study|Unique participants randomized|6
8742823|NCT01125774|9791273|FG000|Treated|Overall Study||2638
8742824|NCT01125774|9791274|FG001|Treated|Overall Study|1 mistakenly took telcagepant and is included with telcagepant group for adverse event analysis|1322
8742825|NCT01125774|9791275|FG002|Treated|Overall Study|Received telcagepant|21
8742826|NCT01125774|9791276|FG003|Treated|Overall Study||5
8742827|NCT01125774|9791273|FG000|COMPLETED|Overall Study||1893
8742828|NCT01125774|9791274|FG001|COMPLETED|Overall Study||948
8742829|NCT01125774|9791275|FG002|COMPLETED|Overall Study|"Completed study at least once while treated with telcagepant (otherwise counted Not Completed)"|13
8742830|NCT01125774|9791276|FG003|COMPLETED|Overall Study|Completed study at least once|3
8742831|NCT01125774|9791273|FG000|NOT COMPLETED|Overall Study||1125
8742832|NCT01125774|9791274|FG001|NOT COMPLETED|Overall Study||554
8742833|NCT01125774|9791275|FG002|NOT COMPLETED|Overall Study||9
8742834|NCT01125774|9791276|FG003|NOT COMPLETED|Overall Study||3
8742835|NCT01125800|9791287|FG000|STARTED|Phase I||11
8742836|NCT01125800|9791288|FG001|STARTED|Phase I||16
8742837|NCT01125800|9791289|FG002|STARTED|Phase I||11
8742838|NCT01125800|9791290|FG003|STARTED|Phase I||21
8742839|NCT01125800|9791291|FG004|STARTED|Phase I|None of participants were enrolled to this treatment in this period.|0
8742840|NCT01125800|9791287|FG000|COMPLETED|Phase I||3
8742841|NCT01125800|9791288|FG001|COMPLETED|Phase I||7
8742842|NCT01125800|9791289|FG002|COMPLETED|Phase I||7
8742843|NCT01125800|9791290|FG003|COMPLETED|Phase I||10
8742844|NCT01125800|9791291|FG004|COMPLETED|Phase I||0
8742845|NCT01125800|9791287|FG000|NOT COMPLETED|Phase I||8
8742846|NCT01125800|9791288|FG001|NOT COMPLETED|Phase I||9
8742847|NCT01125800|9791289|FG002|NOT COMPLETED|Phase I||4
8742848|NCT01125800|9791290|FG003|NOT COMPLETED|Phase I||11
8742849|NCT01125800|9791291|FG004|NOT COMPLETED|Phase I||0
8742850|NCT01125800|9791287|FG000|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|0
8742851|NCT01125800|9791288|FG001|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|0
8742852|NCT01125800|9791289|FG002|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|0
8742853|NCT01125800|9791290|FG003|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|1
8742854|NCT01125800|9791291|FG004|STARTED|Phase II|Additional participants were enrolled to this treatment in this period.|16
8742855|NCT01125800|9791287|FG000|COMPLETED|Phase II||0
8742856|NCT01125800|9791288|FG001|COMPLETED|Phase II||0
8742857|NCT01125800|9791289|FG002|COMPLETED|Phase II||0
8742858|NCT01125800|9791290|FG003|COMPLETED|Phase II||0
8742859|NCT01125800|9791291|FG004|COMPLETED|Phase II||5
8742860|NCT01125800|9791287|FG000|NOT COMPLETED|Phase II||0
8742861|NCT01125800|9791288|FG001|NOT COMPLETED|Phase II||0
8742862|NCT01125800|9791289|FG002|NOT COMPLETED|Phase II||0
8742863|NCT01125800|9791290|FG003|NOT COMPLETED|Phase II||1
8742864|NCT01125800|9791291|FG004|NOT COMPLETED|Phase II||11
8742865|NCT01125813|9791306|FG000|STARTED|Overall Study||36
8742866|NCT01125813|9791306|FG000|COMPLETED|Overall Study||30
8742867|NCT01125813|9791306|FG000|NOT COMPLETED|Overall Study||6
8742868|NCT01125917|9791310|FG000|STARTED|Overall Study||354
8742869|NCT01125917|9791310|FG000|COMPLETED|Overall Study||15
8742870|NCT01125917|9791310|FG000|NOT COMPLETED|Overall Study||339
8742871|NCT01125930|9791316|FG000|STARTED|Overall Study||22
8742872|NCT01125930|9791317|FG001|STARTED|Overall Study||46
8742873|NCT01125930|9791316|FG000|COMPLETED|Overall Study||21
8742874|NCT01125930|9791317|FG001|COMPLETED|Overall Study||36
8742875|NCT01125930|9791316|FG000|NOT COMPLETED|Overall Study||1
8742876|NCT01125930|9791317|FG001|NOT COMPLETED|Overall Study||10
8742877|NCT01126060|9791341|FG000|STARTED|Overall Study||40
8742878|NCT01126060|9791342|FG001|STARTED|Overall Study||40
8742879|NCT01126060|9791341|FG000|COMPLETED|Overall Study||40
8742880|NCT01126060|9791342|FG001|COMPLETED|Overall Study||38
8742881|NCT01126060|9791341|FG000|NOT COMPLETED|Overall Study||0
8742882|NCT01126060|9791342|FG001|NOT COMPLETED|Overall Study||2
8742883|NCT01126099|9791350|FG000|STARTED|Double Blind Phase||11
8742884|NCT01126099|9791351|FG001|STARTED|Double Blind Phase||9
8742885|NCT01126099|9791350|FG000|COMPLETED|Double Blind Phase||7
8742886|NCT01126099|9791351|FG001|COMPLETED|Double Blind Phase||7
8742887|NCT01126099|9791350|FG000|NOT COMPLETED|Double Blind Phase||4
8742888|NCT01126099|9791351|FG001|NOT COMPLETED|Double Blind Phase||2
8742889|NCT01126099|9791350|FG000|STARTED|Open-label Extension|2 in the Prazosin arm of the Double Blind Phase elected not to enter the Open-Label extension|5
8742890|NCT01126099|9791351|FG001|STARTED|Open-label Extension||7
8742891|NCT01126099|9791350|FG000|COMPLETED|Open-label Extension||4
8742892|NCT01126099|9791351|FG001|COMPLETED|Open-label Extension||6
8742893|NCT01126099|9791350|FG000|NOT COMPLETED|Open-label Extension||1
8742894|NCT01126099|9791351|FG001|NOT COMPLETED|Open-label Extension||1
8742895|NCT01126268|9791357|FG000|STARTED|Overall Study||38
8742896|NCT01126268|9791357|FG000|COMPLETED|Overall Study||37
8742897|NCT01126268|9791357|FG000|NOT COMPLETED|Overall Study||1
8742898|NCT01126359|9791361|FG000|STARTED|First Intervention (20-minutes)||5
8742899|NCT01126359|9791362|FG001|STARTED|First Intervention (20-minutes)||6
8742900|NCT01126359|9791361|FG000|COMPLETED|First Intervention (20-minutes)||5
8742901|NCT01126359|9791362|FG001|COMPLETED|First Intervention (20-minutes)||5
8742902|NCT01126359|9791361|FG000|NOT COMPLETED|First Intervention (20-minutes)||0
8742903|NCT01126359|9791362|FG001|NOT COMPLETED|First Intervention (20-minutes)||1
8742904|NCT01126359|9791361|FG000|STARTED|Dressing Replacement/Healing (48-hours)||5
8742905|NCT01126359|9791362|FG001|STARTED|Dressing Replacement/Healing (48-hours)||5
8742906|NCT01126359|9791361|FG000|COMPLETED|Dressing Replacement/Healing (48-hours)||5
8742907|NCT01126359|9791362|FG001|COMPLETED|Dressing Replacement/Healing (48-hours)||5
8742908|NCT01126359|9791361|FG000|NOT COMPLETED|Dressing Replacement/Healing (48-hours)||0
8742909|NCT01126359|9791362|FG001|NOT COMPLETED|Dressing Replacement/Healing (48-hours)||0
8742910|NCT01126359|9791361|FG000|STARTED|Second Intervention (20-minutes)||5
8742911|NCT01126359|9791362|FG001|STARTED|Second Intervention (20-minutes)||5
8742912|NCT01126359|9791361|FG000|COMPLETED|Second Intervention (20-minutes)||5
8742913|NCT01126359|9791362|FG001|COMPLETED|Second Intervention (20-minutes)||5
8742914|NCT01126359|9791361|FG000|NOT COMPLETED|Second Intervention (20-minutes)||0
8742915|NCT01126359|9791362|FG001|NOT COMPLETED|Second Intervention (20-minutes)||0
8742916|NCT01126424|9791378|FG000|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|3
8742917|NCT01126424|9791379|FG001|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|4
8742918|NCT01126424|9791380|FG002|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|5
8742919|NCT01126424|9791381|FG003|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|6
8742920|NCT01126424|9791382|FG004|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|4
8742921|NCT01126424|9791383|FG005|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|4
8807402|NCT01484197|9859757|FG002|NOT COMPLETED|Treatment Period 2||0
8742922|NCT01126424|9791378|FG000|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|3
8742923|NCT01126424|9791379|FG001|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
8742924|NCT01126424|9791380|FG002|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
8742925|NCT01126424|9791381|FG003|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
8742926|NCT01126424|9791382|FG004|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
8742927|NCT01126424|9791383|FG005|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
8742928|NCT01126424|9791378|FG000|COMPLETED|Overall Study||3
8742929|NCT01126424|9791379|FG001|COMPLETED|Overall Study||4
8742930|NCT01126424|9791380|FG002|COMPLETED|Overall Study||4
8742931|NCT01126424|9791381|FG003|COMPLETED|Overall Study||3
8742932|NCT01126424|9791382|FG004|COMPLETED|Overall Study||2
8742933|NCT01126424|9791383|FG005|COMPLETED|Overall Study||4
8742934|NCT01126424|9791378|FG000|NOT COMPLETED|Overall Study||0
8742935|NCT01126424|9791379|FG001|NOT COMPLETED|Overall Study||0
8742936|NCT01126424|9791380|FG002|NOT COMPLETED|Overall Study||1
8742937|NCT01126424|9791381|FG003|NOT COMPLETED|Overall Study||3
8742938|NCT01126424|9791382|FG004|NOT COMPLETED|Overall Study||2
8742939|NCT01126424|9791383|FG005|NOT COMPLETED|Overall Study||0
8742940|NCT01126437|9791394|FG000|STARTED|Overall Study||5741
8742941|NCT01126437|9791395|FG001|STARTED|Overall Study||5729
8742942|NCT01126437|9791396|FG002|STARTED|Overall Study||5713
8742943|NCT01126437|9791394|FG000|COMPLETED|Overall Study|See Pre-Assignment Details above for comments.|4400
8742944|NCT01126437|9791395|FG001|COMPLETED|Overall Study|See Pre-Assignment Details above for comments.|4399
8742945|NCT01126437|9791396|FG002|COMPLETED|Overall Study|See Pre-Assignment Details above for comments.|4400
8742946|NCT01126437|9791394|FG000|NOT COMPLETED|Overall Study||1341
8742947|NCT01126437|9791395|FG001|NOT COMPLETED|Overall Study||1330
8742948|NCT01126437|9791396|FG002|NOT COMPLETED|Overall Study||1313
8742949|NCT01126541|9791407|FG000|STARTED|Overall Study||70
8742950|NCT01126541|9791408|FG001|STARTED|Overall Study||73
8742951|NCT01126541|9791409|FG002|STARTED|Overall Study||81
8742952|NCT01126541|9791407|FG000|COMPLETED|Overall Study||60
8742953|NCT01126541|9791408|FG001|COMPLETED|Overall Study||61
8742954|NCT01126541|9791409|FG002|COMPLETED|Overall Study||55
8742955|NCT01126541|9791407|FG000|NOT COMPLETED|Overall Study||10
8742956|NCT01126541|9791408|FG001|NOT COMPLETED|Overall Study||12
8742957|NCT01126541|9791409|FG002|NOT COMPLETED|Overall Study||26
8742958|NCT01126580|9791422|FG000|STARTED|Overall Study||269
8742959|NCT01126580|9791423|FG001|STARTED|Overall Study||270
8742960|NCT01126580|9791424|FG002|STARTED|Overall Study||268
8742961|NCT01126580|9791422|FG000|Received at Least 1 Dose of Study Drug|Overall Study||269
8742962|NCT01126580|9791423|FG001|Received at Least 1 Dose of Study Drug|Overall Study||270
8742963|NCT01126580|9791424|FG002|Received at Least 1 Dose of Study Drug|Overall Study||268
8742964|NCT01126580|9791422|FG000|Completed 26 Weeks|Overall Study||233
8742965|NCT01126580|9791423|FG001|Completed 26 Weeks|Overall Study||242
8742966|NCT01126580|9791424|FG002|Completed 26 Weeks|Overall Study||226
8742967|NCT01126580|9791422|FG000|COMPLETED|Overall Study||220
8742968|NCT01126580|9791423|FG001|COMPLETED|Overall Study||218
8742969|NCT01126580|9791424|FG002|COMPLETED|Overall Study||213
8742970|NCT01126580|9791422|FG000|NOT COMPLETED|Overall Study||49
8742971|NCT01126580|9791423|FG001|NOT COMPLETED|Overall Study||52
8742972|NCT01126580|9791424|FG002|NOT COMPLETED|Overall Study||55
8742973|NCT01126593|9791436|FG000|STARTED|Overall Study||33
8742974|NCT01126593|9791437|FG001|STARTED|Overall Study||29
8742975|NCT01126593|9791438|FG002|STARTED|Overall Study||34
8742976|NCT01126593|9791436|FG000|COMPLETED|Overall Study||29
8742977|NCT01126593|9791437|FG001|COMPLETED|Overall Study||27
8742978|NCT01126593|9791438|FG002|COMPLETED|Overall Study||32
8742979|NCT01126593|9791436|FG000|NOT COMPLETED|Overall Study||4
8742980|NCT01126593|9791437|FG001|NOT COMPLETED|Overall Study||2
8742981|NCT01126593|9791438|FG002|NOT COMPLETED|Overall Study||2
8742982|NCT01126619|9791446|FG000|STARTED|Overall Study||103
8742983|NCT01126619|9791446|FG000|COMPLETED|Overall Study|The completed population was used for all effectiveness analyses.|86
8742984|NCT01126619|9791446|FG000|NOT COMPLETED|Overall Study||17
8742985|NCT01126671|9791454|FG000|STARTED|Overall Study||26
8742986|NCT01126671|9791455|FG001|STARTED|Overall Study||30
8742987|NCT01126671|9791454|FG000|COMPLETED|Overall Study||24
8742988|NCT01126671|9791455|FG001|COMPLETED|Overall Study||29
8742989|NCT01126671|9791454|FG000|NOT COMPLETED|Overall Study||2
8742990|NCT01126671|9791455|FG001|NOT COMPLETED|Overall Study||1
8742991|NCT01126723|9791465|FG000|STARTED|Overall Study||35
8742992|NCT01126723|9791466|FG001|STARTED|Overall Study||31
8742993|NCT01126723|9791465|FG000|COMPLETED|Overall Study||29
8742994|NCT01126723|9791466|FG001|COMPLETED|Overall Study||28
8742995|NCT01126723|9791465|FG000|NOT COMPLETED|Overall Study||6
8742996|NCT01126723|9791466|FG001|NOT COMPLETED|Overall Study||3
8742997|NCT01127061|9791474|FG000|STARTED|Overall Study||67
8742998|NCT01127061|9791475|FG001|STARTED|Overall Study||69
8742999|NCT01127061|9791474|FG000|COMPLETED|Overall Study||57
8743000|NCT01127061|9791475|FG001|COMPLETED|Overall Study||56
8743001|NCT01127061|9791474|FG000|NOT COMPLETED|Overall Study||10
8743002|NCT01127061|9791475|FG001|NOT COMPLETED|Overall Study||13
8743003|NCT01127087|9791483|FG000|STARTED|Overall Study||8
8743004|NCT01127087|9791484|FG001|STARTED|Overall Study||2
8743005|NCT01127087|9791483|FG000|COMPLETED|Overall Study||8
8743006|NCT01127087|9791484|FG001|COMPLETED|Overall Study||2
8743007|NCT01127087|9791483|FG000|NOT COMPLETED|Overall Study||0
8743008|NCT01127087|9791484|FG001|NOT COMPLETED|Overall Study||0
8743009|NCT01127139|9791492|FG000|STARTED|Overall Study||3828
8743010|NCT01127139|9791492|FG000|Number of Participants Analyzed|Overall Study||3828
8743011|NCT01127139|9791492|FG000|COMPLETED|Overall Study||3771
8743012|NCT01127139|9791492|FG000|NOT COMPLETED|Overall Study||57
8743013|NCT01127165|9791501|FG000|STARTED|Overall Study||65
8743014|NCT01127165|9791502|FG001|STARTED|Overall Study||60
8743015|NCT01127165|9791501|FG000|COMPLETED|Overall Study||49
8743016|NCT01127165|9791502|FG001|COMPLETED|Overall Study||41
8743017|NCT01127165|9791501|FG000|NOT COMPLETED|Overall Study||16
8743018|NCT01127165|9791502|FG001|NOT COMPLETED|Overall Study||19
8743019|NCT01127321|9791513|FG000|STARTED|Overall Study||3
8743020|NCT01127321|9791514|FG001|STARTED|Overall Study||1
8743021|NCT01127321|9791515|FG002|STARTED|Overall Study||1
8743022|NCT01127321|9791516|FG003|STARTED|Overall Study||7
8743023|NCT01127321|9791517|FG004|STARTED|Overall Study||5
8743024|NCT01127321|9791513|FG000|COMPLETED|Overall Study||3
8743025|NCT01127321|9791514|FG001|COMPLETED|Overall Study||1
8743026|NCT01127321|9791515|FG002|COMPLETED|Overall Study||1
8743027|NCT01127321|9791516|FG003|COMPLETED|Overall Study||7
8743028|NCT01127321|9791517|FG004|COMPLETED|Overall Study||5
8743029|NCT01127321|9791513|FG000|NOT COMPLETED|Overall Study||0
8743030|NCT01127321|9791514|FG001|NOT COMPLETED|Overall Study||0
8743031|NCT01127321|9791515|FG002|NOT COMPLETED|Overall Study||0
8743032|NCT01127321|9791516|FG003|NOT COMPLETED|Overall Study||0
8743033|NCT01127321|9791517|FG004|NOT COMPLETED|Overall Study||0
8743034|NCT01127373|9791529|FG000|STARTED|Overall Study||116
8743035|NCT01127373|9791529|FG000|COMPLETED|Overall Study||104
8743036|NCT01127373|9791529|FG000|NOT COMPLETED|Overall Study||12
8743037|NCT01127438|9791539|FG000|STARTED|Overall Study||25
8743038|NCT01127438|9791540|FG001|STARTED|Overall Study||25
8743039|NCT01127438|9791541|FG002|STARTED|Overall Study||26
8743040|NCT01127438|9791542|FG003|STARTED|Overall Study||24
8743041|NCT01127438|9791543|FG004|STARTED|Overall Study||28
8743042|NCT01127438|9791544|FG005|STARTED|Overall Study||25
8743043|NCT01127438|9791539|FG000|COMPLETED|Overall Study||25
8743044|NCT01127438|9791540|FG001|COMPLETED|Overall Study||25
8743045|NCT01127438|9791541|FG002|COMPLETED|Overall Study|(n=25) One subject randomized to the approved dose group received a lower dose in error.|26
8743046|NCT01127438|9791542|FG003|COMPLETED|Overall Study|(n=25) One subject randomized to the approved dose group received a lower dose in error.|24
8743047|NCT01127438|9791543|FG004|COMPLETED|Overall Study||28
8743048|NCT01127438|9791544|FG005|COMPLETED|Overall Study||25
8743049|NCT01127438|9791539|FG000|NOT COMPLETED|Overall Study||0
8743050|NCT01127438|9791540|FG001|NOT COMPLETED|Overall Study||0
8743051|NCT01127438|9791541|FG002|NOT COMPLETED|Overall Study||0
8743052|NCT01127438|9791542|FG003|NOT COMPLETED|Overall Study||0
8743053|NCT01127438|9791543|FG004|NOT COMPLETED|Overall Study||0
8743054|NCT01127438|9791544|FG005|NOT COMPLETED|Overall Study||0
8743055|NCT01127581|9791556|FG000|STARTED|Overall Study||678
8743056|NCT01127581|9791557|FG001|STARTED|Overall Study||680
8743057|NCT01127581|9791556|FG000|COMPLETED|Overall Study||678
8743058|NCT01127581|9791557|FG001|COMPLETED|Overall Study||680
8743059|NCT01127581|9791556|FG000|NOT COMPLETED|Overall Study||0
8743060|NCT01127581|9791557|FG001|NOT COMPLETED|Overall Study||0
8743061|NCT01127607|9791565|FG000|STARTED|Phase I (Within Subjects)||14
8743062|NCT01127607|9791566|FG001|STARTED|Phase I (Within Subjects)||13
8743063|NCT01127607|9791565|FG000|COMPLETED|Phase I (Within Subjects)||14
8743064|NCT01127607|9791566|FG001|COMPLETED|Phase I (Within Subjects)||13
8743065|NCT01127607|9791565|FG000|NOT COMPLETED|Phase I (Within Subjects)||0
8743066|NCT01127607|9791566|FG001|NOT COMPLETED|Phase I (Within Subjects)||0
8743067|NCT01127607|9791565|FG000|STARTED|Phase II (Between Subjects)||14
8743068|NCT01127607|9791566|FG001|STARTED|Phase II (Between Subjects)||13
8743069|NCT01127607|9791565|FG000|COMPLETED|Phase II (Between Subjects)||13
8743070|NCT01127607|9791566|FG001|COMPLETED|Phase II (Between Subjects)||11
8743071|NCT01127607|9791565|FG000|NOT COMPLETED|Phase II (Between Subjects)||1
8743072|NCT01127607|9791566|FG001|NOT COMPLETED|Phase II (Between Subjects)||2
8743073|NCT01127633|9791591|FG000|STARTED|Overall Study||723
8743074|NCT01127633|9791592|FG001|STARTED|Overall Study||734
8743075|NCT01127633|9791591|FG000|Received at Least 1 Dose of Study Drug|Overall Study||723
8743076|NCT01127633|9791592|FG001|Received at Least 1 Dose of Study Drug|Overall Study||734
8743077|NCT01127633|9791591|FG000|COMPLETED|Overall Study||70
8743078|NCT01127633|9791592|FG001|COMPLETED|Overall Study||61
8743079|NCT01127633|9791591|FG000|NOT COMPLETED|Overall Study||653
8743080|NCT01127633|9791592|FG001|NOT COMPLETED|Overall Study||673
8743081|NCT01127646|9791600|FG000|STARTED|Overall Study||15
8743082|NCT01127646|9791601|FG001|STARTED|Overall Study||8
8743083|NCT01127646|9791600|FG000|COMPLETED|Overall Study||14
8743084|NCT01127646|9791601|FG001|COMPLETED|Overall Study||7
8743085|NCT01127646|9791600|FG000|NOT COMPLETED|Overall Study||1
8743086|NCT01127646|9791601|FG001|NOT COMPLETED|Overall Study||1
8743087|NCT01127659|9791615|FG000|STARTED|Overall Study||22
8743088|NCT01127659|9791616|FG001|STARTED|Overall Study||22
8743089|NCT01127659|9791617|FG002|STARTED|Overall Study||12
8743090|NCT01127659|9791618|FG003|STARTED|Overall Study||10
8743091|NCT01127659|9791619|FG004|STARTED|Overall Study||50
8743092|NCT01127659|9791620|FG005|STARTED|Overall Study||21
8743093|NCT01127659|9791615|FG000|COMPLETED|Overall Study||20
8743094|NCT01127659|9791616|FG001|COMPLETED|Overall Study||14
8743095|NCT01127659|9791617|FG002|COMPLETED|Overall Study||10
8743096|NCT01127659|9791618|FG003|COMPLETED|Overall Study||6
8743097|NCT01127659|9791619|FG004|COMPLETED|Overall Study||50
8743098|NCT01127659|9791620|FG005|COMPLETED|Overall Study||21
8743099|NCT01127659|9791615|FG000|NOT COMPLETED|Overall Study||2
8743100|NCT01127659|9791616|FG001|NOT COMPLETED|Overall Study||8
8743101|NCT01127659|9791617|FG002|NOT COMPLETED|Overall Study||2
8743102|NCT01127659|9791618|FG003|NOT COMPLETED|Overall Study||4
8743103|NCT01127659|9791619|FG004|NOT COMPLETED|Overall Study||0
8743104|NCT01127659|9791620|FG005|NOT COMPLETED|Overall Study||0
8743105|NCT01127737|9791636|FG000|STARTED|Overall Study||37
8743106|NCT01127737|9791637|FG001|STARTED|Overall Study||38
8743107|NCT01127737|9791636|FG000|COMPLETED|Overall Study||37
8743108|NCT01127737|9791637|FG001|COMPLETED|Overall Study||38
8743109|NCT01127737|9791636|FG000|NOT COMPLETED|Overall Study||0
8743110|NCT01127737|9791637|FG001|NOT COMPLETED|Overall Study||0
8743111|NCT01127763|9791643|FG000|STARTED|Overall Study||25
8743112|NCT01127763|9791643|FG000|COMPLETED|Overall Study|Patients off study due to disease progression were considered to have completed the study.|20
8743113|NCT01127763|9791643|FG000|NOT COMPLETED|Overall Study||5
8743114|NCT01127893|9791651|FG000|STARTED|Overall Study||1
8743115|NCT01127893|9791651|FG000|COMPLETED|Overall Study||0
8743116|NCT01127893|9791651|FG000|NOT COMPLETED|Overall Study||1
8743117|NCT01128049|9791658|FG000|STARTED|Overall Study||5
8743118|NCT01128049|9791659|FG001|STARTED|Overall Study||5
8743119|NCT01128049|9791660|FG002|STARTED|Overall Study||5
8743120|NCT01128049|9791658|FG000|COMPLETED|Overall Study||5
8743121|NCT01128049|9791659|FG001|COMPLETED|Overall Study||5
8743122|NCT01128049|9791660|FG002|COMPLETED|Overall Study||5
8743123|NCT01128049|9791658|FG000|NOT COMPLETED|Overall Study||0
8743124|NCT01128049|9791659|FG001|NOT COMPLETED|Overall Study||0
8743125|NCT01128049|9791660|FG002|NOT COMPLETED|Overall Study||0
8743126|NCT01128153|9791670|FG000|STARTED|Overall Study|Randomised|129
8743127|NCT01128153|9791671|FG001|STARTED|Overall Study|Randomised|128
8743128|NCT01128153|9791670|FG000|Full Analysis Set|Overall Study|Received at least 1 dose of investigational product during 24 week blinded period|127
8743129|NCT01128153|9791671|FG001|Full Analysis Set|Overall Study|Received at least 1 dose of investigational product during 24 week blinded period|128
8743130|NCT01128153|9791670|FG000|COMPLETED|Overall Study|Completed 24 weeks|113
8743131|NCT01128153|9791671|FG001|COMPLETED|Overall Study|Completed 24 weeks|113
8743132|NCT01128153|9791670|FG000|NOT COMPLETED|Overall Study||16
8743133|NCT01128153|9791671|FG001|NOT COMPLETED|Overall Study||15
8743134|NCT01128179|9791679|FG000|STARTED|Overall Study||23
8743135|NCT01128179|9791680|FG001|STARTED|Overall Study||12
8743136|NCT01128179|9791679|FG000|COMPLETED|Overall Study||21
8743137|NCT01128179|9791680|FG001|COMPLETED|Overall Study||12
8743138|NCT01128179|9791679|FG000|NOT COMPLETED|Overall Study||2
8743139|NCT01128179|9791680|FG001|NOT COMPLETED|Overall Study||0
8743140|NCT01128192|9791688|FG000|STARTED|Overall Study||19
8743141|NCT01128192|9791689|FG001|STARTED|Overall Study||19
8743142|NCT01128192|9791690|FG002|STARTED|Overall Study||7
8743143|NCT01128192|9791688|FG000|COMPLETED|Overall Study||19
8743144|NCT01128192|9791689|FG001|COMPLETED|Overall Study||19
8743145|NCT01128192|9791690|FG002|COMPLETED|Overall Study||7
8743146|NCT01128192|9791688|FG000|NOT COMPLETED|Overall Study||0
8743147|NCT01128192|9791689|FG001|NOT COMPLETED|Overall Study||0
8743148|NCT01128192|9791690|FG002|NOT COMPLETED|Overall Study||0
8743149|NCT01128244|9791701|FG000|STARTED|Overall Study||13
8743150|NCT01128244|9791701|FG000|COMPLETED|Overall Study||10
8743151|NCT01128244|9791701|FG000|NOT COMPLETED|Overall Study||3
8743152|NCT01128270|9791709|FG000|STARTED|Environment Chloral Hydrate and DCA (1A)||7
8743153|NCT01128270|9791709|FG000|COMPLETED|Environment Chloral Hydrate and DCA (1A)||7
8743154|NCT01128270|9791709|FG000|NOT COMPLETED|Environment Chloral Hydrate and DCA (1A)||0
8743155|NCT01128270|9791709|FG000|STARTED|Environmental Chloral Hydrate (1B)|Per the suggestion from Heather, periods are not in chronological order, but defined by treatment.|8
8743156|NCT01128270|9791709|FG000|COMPLETED|Environmental Chloral Hydrate (1B)||8
8743157|NCT01128270|9791709|FG000|NOT COMPLETED|Environmental Chloral Hydrate (1B)||0
8743158|NCT01128270|9791709|FG000|STARTED|Therapeutic Chloral Hydrate and DCA (2A)||8
8743159|NCT01128270|9791709|FG000|COMPLETED|Therapeutic Chloral Hydrate and DCA (2A)||8
8743160|NCT01128270|9791709|FG000|NOT COMPLETED|Therapeutic Chloral Hydrate and DCA (2A)||0
8743161|NCT01128270|9791709|FG000|STARTED|Therapeutic Chloral Hydrate (2B)||8
8743162|NCT01128270|9791709|FG000|COMPLETED|Therapeutic Chloral Hydrate (2B)||8
8743163|NCT01128270|9791709|FG000|NOT COMPLETED|Therapeutic Chloral Hydrate (2B)||0
8743164|NCT01128296|9791721|FG000|STARTED|Overall Study||1
8743165|NCT01128296|9791722|FG001|STARTED|Overall Study||1
8743166|NCT01128296|9791723|FG002|STARTED|Overall Study||1
8743167|NCT01128296|9791724|FG003|STARTED|Overall Study||1
8743168|NCT01128296|9791725|FG004|STARTED|Overall Study||1
8743169|NCT01128296|9791726|FG005|STARTED|Overall Study||26
8743170|NCT01128296|9791721|FG000|COMPLETED|Overall Study||1
8743171|NCT01128296|9791722|FG001|COMPLETED|Overall Study||1
8743172|NCT01128296|9791723|FG002|COMPLETED|Overall Study||1
8743173|NCT01128296|9791724|FG003|COMPLETED|Overall Study||1
8743174|NCT01128296|9791725|FG004|COMPLETED|Overall Study||1
8743175|NCT01128296|9791726|FG005|COMPLETED|Overall Study||21
8743176|NCT01128296|9791721|FG000|NOT COMPLETED|Overall Study||0
8743177|NCT01128296|9791722|FG001|NOT COMPLETED|Overall Study||0
8743178|NCT01128296|9791723|FG002|NOT COMPLETED|Overall Study||0
8743179|NCT01128296|9791724|FG003|NOT COMPLETED|Overall Study||0
8743180|NCT01128296|9791725|FG004|NOT COMPLETED|Overall Study||0
8743181|NCT01128296|9791726|FG005|NOT COMPLETED|Overall Study||5
8743182|NCT01128361|9791739|FG000|STARTED|Overall Study||39
8743183|NCT01128361|9791740|FG001|STARTED|Overall Study||37
8743184|NCT01128361|9791739|FG000|COMPLETED|Overall Study||34
8743185|NCT01128361|9791740|FG001|COMPLETED|Overall Study||34
8743186|NCT01128361|9791739|FG000|NOT COMPLETED|Overall Study||5
8743187|NCT01128361|9791740|FG001|NOT COMPLETED|Overall Study||3
8743188|NCT01128387|9791748|FG000|STARTED|Overall Study||5
8743189|NCT01128387|9791749|FG001|STARTED|Overall Study||6
8743190|NCT01128387|9791748|FG000|COMPLETED|Overall Study||5
8743191|NCT01128387|9791749|FG001|COMPLETED|Overall Study||5
8743192|NCT01128387|9791748|FG000|NOT COMPLETED|Overall Study||0
8743193|NCT01128387|9791749|FG001|NOT COMPLETED|Overall Study||1
8743194|NCT01128400|9791758|FG000|STARTED|Overall Study||8
8743195|NCT01128400|9791759|FG001|STARTED|Overall Study||9
8743196|NCT01128400|9791760|FG002|STARTED|Overall Study||23
8743197|NCT01128400|9791758|FG000|COMPLETED|Overall Study||6
8743198|NCT01128400|9791759|FG001|COMPLETED|Overall Study||8
8743199|NCT01128400|9791760|FG002|COMPLETED|Overall Study||7
8743200|NCT01128400|9791758|FG000|NOT COMPLETED|Overall Study||2
8743201|NCT01128400|9791759|FG001|NOT COMPLETED|Overall Study||1
8743202|NCT01128400|9791760|FG002|NOT COMPLETED|Overall Study||16
8743203|NCT01128413|9791770|FG000|STARTED|Overall Study||11
8743204|NCT01128413|9791771|FG001|STARTED|Overall Study||11
8743205|NCT01128413|9791770|FG000|COMPLETED|Overall Study||7
8743206|NCT01128413|9791771|FG001|COMPLETED|Overall Study||10
8743207|NCT01128413|9791770|FG000|NOT COMPLETED|Overall Study||4
8743208|NCT01128413|9791771|FG001|NOT COMPLETED|Overall Study||1
8743209|NCT01128426|9791777|FG000|STARTED|Overall Study||53902
8743210|NCT01128426|9791777|FG000|COMPLETED|Overall Study||53902
8743211|NCT01128426|9791777|FG000|NOT COMPLETED|Overall Study||0
8743212|NCT01128543|9791783|FG000|STARTED|Overall Study||29
8743213|NCT01128543|9791783|FG000|COMPLETED|Overall Study||25
8743214|NCT01128543|9791783|FG000|NOT COMPLETED|Overall Study||4
8743215|NCT01128569|9791787|FG000|STARTED|Treatment Period 1||9
8743216|NCT01128569|9791788|FG001|STARTED|Treatment Period 1||8
8743217|NCT01128569|9791789|FG002|STARTED|Treatment Period 1||9
8743218|NCT01128569|9791790|FG003|STARTED|Treatment Period 1||8
8743219|NCT01128569|9791791|FG004|STARTED|Treatment Period 1||9
8743220|NCT01128569|9791792|FG005|STARTED|Treatment Period 1||9
8743221|NCT01128569|9791787|FG000|COMPLETED|Treatment Period 1||9
8743222|NCT01128569|9791788|FG001|COMPLETED|Treatment Period 1||8
8743223|NCT01128569|9791789|FG002|COMPLETED|Treatment Period 1||9
8743224|NCT01128569|9791790|FG003|COMPLETED|Treatment Period 1||8
8743225|NCT01128569|9791791|FG004|COMPLETED|Treatment Period 1||9
8743226|NCT01128569|9791792|FG005|COMPLETED|Treatment Period 1||9
8743227|NCT01128569|9791787|FG000|NOT COMPLETED|Treatment Period 1||0
8743228|NCT01128569|9791788|FG001|NOT COMPLETED|Treatment Period 1||0
8743229|NCT01128569|9791789|FG002|NOT COMPLETED|Treatment Period 1||0
8743230|NCT01128569|9791790|FG003|NOT COMPLETED|Treatment Period 1||0
8743231|NCT01128569|9791791|FG004|NOT COMPLETED|Treatment Period 1||0
8743232|NCT01128569|9791792|FG005|NOT COMPLETED|Treatment Period 1||0
8743233|NCT01128569|9791787|FG000|STARTED|Washout Period 1||9
8743234|NCT01128569|9791788|FG001|STARTED|Washout Period 1||8
8743235|NCT01128569|9791789|FG002|STARTED|Washout Period 1||9
8743236|NCT01128569|9791790|FG003|STARTED|Washout Period 1||8
8743237|NCT01128569|9791791|FG004|STARTED|Washout Period 1||9
8743238|NCT01128569|9791792|FG005|STARTED|Washout Period 1||9
8743239|NCT01128569|9791787|FG000|COMPLETED|Washout Period 1||9
8743240|NCT01128569|9791788|FG001|COMPLETED|Washout Period 1||8
8743241|NCT01128569|9791789|FG002|COMPLETED|Washout Period 1||8
8743242|NCT01128569|9791790|FG003|COMPLETED|Washout Period 1||8
8913001|NCT02157935|9972283|FG001|STARTED|Overall Study||613
8913002|NCT02157935|9972282|FG000|COMPLETED|Overall Study||567
8913003|NCT02157935|9972283|FG001|COMPLETED|Overall Study||548
8913004|NCT02157935|9972282|FG000|NOT COMPLETED|Overall Study||39
8913005|NCT02157935|9972283|FG001|NOT COMPLETED|Overall Study||65
8913006|NCT02157948|9972291|FG000|STARTED|Overall Study||197
8913007|NCT02157948|9972292|FG001|STARTED|Overall Study||197
8913008|NCT02157948|9972291|FG000|Received Treatment|Overall Study||196
8913009|NCT02157948|9972292|FG001|Received Treatment|Overall Study||196
8913010|NCT02157948|9972291|FG000|COMPLETED|Overall Study||188
8913011|NCT02157948|9972292|FG001|COMPLETED|Overall Study||188
8913012|NCT02157948|9972291|FG000|NOT COMPLETED|Overall Study||9
8913013|NCT02157948|9972292|FG001|NOT COMPLETED|Overall Study||9
8913014|NCT02158039|9972298|FG000|STARTED|Overall Study||33
8913015|NCT02158039|9972298|FG000|COMPLETED|Overall Study||23
8913016|NCT02158039|9972298|FG000|NOT COMPLETED|Overall Study||10
8743243|NCT01128569|9791791|FG004|COMPLETED|Washout Period 1||9
8743244|NCT01128569|9791792|FG005|COMPLETED|Washout Period 1||9
8913017|NCT02158247|9972304|FG000|STARTED|Overall Study||181
8913018|NCT02158247|9972304|FG000|COMPLETED|Overall Study||176
8913019|NCT02158247|9972304|FG000|NOT COMPLETED|Overall Study||5
8913020|NCT02158273|9972322|FG000|STARTED|Overall Study||25
8913021|NCT02158273|9972323|FG001|STARTED|Overall Study||25
8743245|NCT01128569|9791787|FG000|NOT COMPLETED|Washout Period 1||0
8913022|NCT02158273|9972322|FG000|COMPLETED|Overall Study||22
8743246|NCT01128569|9791788|FG001|NOT COMPLETED|Washout Period 1||0
8743247|NCT01128569|9791789|FG002|NOT COMPLETED|Washout Period 1||1
8743248|NCT01128569|9791790|FG003|NOT COMPLETED|Washout Period 1||0
8743249|NCT01128569|9791791|FG004|NOT COMPLETED|Washout Period 1||0
8743250|NCT01128569|9791792|FG005|NOT COMPLETED|Washout Period 1||0
8743251|NCT01128569|9791787|FG000|STARTED|Treatment Period 2||9
8743252|NCT01128569|9791788|FG001|STARTED|Treatment Period 2||8
8743253|NCT01128569|9791789|FG002|STARTED|Treatment Period 2||8
8743254|NCT01128569|9791790|FG003|STARTED|Treatment Period 2||8
8743255|NCT01128569|9791791|FG004|STARTED|Treatment Period 2||9
8743256|NCT01128569|9791792|FG005|STARTED|Treatment Period 2||9
8743257|NCT01128569|9791787|FG000|COMPLETED|Treatment Period 2||9
8743258|NCT01128569|9791788|FG001|COMPLETED|Treatment Period 2||7
8743259|NCT01128569|9791789|FG002|COMPLETED|Treatment Period 2||8
8743260|NCT01128569|9791790|FG003|COMPLETED|Treatment Period 2||8
8743261|NCT01128569|9791791|FG004|COMPLETED|Treatment Period 2||9
8743262|NCT01128569|9791792|FG005|COMPLETED|Treatment Period 2||9
8743263|NCT01128569|9791787|FG000|NOT COMPLETED|Treatment Period 2||0
8743264|NCT01128569|9791788|FG001|NOT COMPLETED|Treatment Period 2||1
8743265|NCT01128569|9791789|FG002|NOT COMPLETED|Treatment Period 2||0
8743266|NCT01128569|9791790|FG003|NOT COMPLETED|Treatment Period 2||0
8743267|NCT01128569|9791791|FG004|NOT COMPLETED|Treatment Period 2||0
8743268|NCT01128569|9791792|FG005|NOT COMPLETED|Treatment Period 2||0
8743269|NCT01128569|9791787|FG000|STARTED|Washout Period 2||9
8743270|NCT01128569|9791788|FG001|STARTED|Washout Period 2||7
8743271|NCT01128569|9791789|FG002|STARTED|Washout Period 2||8
8743272|NCT01128569|9791790|FG003|STARTED|Washout Period 2||8
8743273|NCT01128569|9791791|FG004|STARTED|Washout Period 2||9
8743274|NCT01128569|9791792|FG005|STARTED|Washout Period 2||9
8743275|NCT01128569|9791787|FG000|COMPLETED|Washout Period 2||9
8743276|NCT01128569|9791788|FG001|COMPLETED|Washout Period 2||7
8743277|NCT01128569|9791789|FG002|COMPLETED|Washout Period 2||8
8743278|NCT01128569|9791790|FG003|COMPLETED|Washout Period 2||8
8743279|NCT01128569|9791791|FG004|COMPLETED|Washout Period 2||9
8743280|NCT01128569|9791792|FG005|COMPLETED|Washout Period 2||9
8743281|NCT01128569|9791787|FG000|NOT COMPLETED|Washout Period 2||0
8743282|NCT01128569|9791788|FG001|NOT COMPLETED|Washout Period 2||0
8743283|NCT01128569|9791789|FG002|NOT COMPLETED|Washout Period 2||0
8743284|NCT01128569|9791790|FG003|NOT COMPLETED|Washout Period 2||0
8743285|NCT01128569|9791791|FG004|NOT COMPLETED|Washout Period 2||0
8743286|NCT01128569|9791792|FG005|NOT COMPLETED|Washout Period 2||0
8743287|NCT01128569|9791787|FG000|STARTED|Treatment Period 3||9
8913023|NCT02158273|9972323|FG001|COMPLETED|Overall Study||22
8913024|NCT02158273|9972322|FG000|NOT COMPLETED|Overall Study||3
8913025|NCT02158273|9972323|FG001|NOT COMPLETED|Overall Study||3
8913026|NCT02158364|9972329|FG000|STARTED|Overall Study||3331
8913027|NCT02158364|9972329|FG000|COMPLETED|Overall Study||3271
8913028|NCT02158364|9972329|FG000|NOT COMPLETED|Overall Study||60
8913029|NCT02158442|9972335|FG000|STARTED|Overall Study||8
8913030|NCT02158442|9972336|FG001|STARTED|Overall Study||7
8913031|NCT02158442|9972335|FG000|COMPLETED|Overall Study||6
8913032|NCT02158442|9972336|FG001|COMPLETED|Overall Study||7
8913033|NCT02158442|9972335|FG000|NOT COMPLETED|Overall Study||2
8913034|NCT02158442|9972336|FG001|NOT COMPLETED|Overall Study||0
8913035|NCT02158494|9972344|FG000|STARTED|Overall Study||22
8913036|NCT02158494|9972345|FG001|STARTED|Overall Study||22
8913037|NCT02158494|9972344|FG000|COMPLETED|Overall Study||22
8913038|NCT02158494|9972345|FG001|COMPLETED|Overall Study||21
8913039|NCT02158494|9972344|FG000|NOT COMPLETED|Overall Study||0
8913040|NCT02158494|9972345|FG001|NOT COMPLETED|Overall Study||1
8913041|NCT02158520|9972358|FG000|STARTED|Overall Study||12
8913042|NCT02158520|9972359|FG001|STARTED|Overall Study||12
8913043|NCT02158520|9972358|FG000|AE Evaluated Prior to Crossover|Overall Study||12
8913044|NCT02158520|9972359|FG001|AE Evaluated Prior to Crossover|Overall Study||12
8913045|NCT02158520|9972358|FG000|Eligible for Crossover|Overall Study||8
8913046|NCT02158520|9972359|FG001|Eligible for Crossover|Overall Study||8
8913047|NCT02158520|9972358|FG000|Eligible for Crossover With AE Evaluated|Overall Study||7
8913048|NCT02158520|9972359|FG001|Eligible for Crossover With AE Evaluated|Overall Study||7
8913049|NCT02158520|9972358|FG000|Crossover Cohort|Overall Study||4
8913050|NCT02158520|9972359|FG001|Crossover Cohort|Overall Study||6
8913051|NCT02158520|9972358|FG000|COMPLETED|Overall Study||12
8913052|NCT02158520|9972359|FG001|COMPLETED|Overall Study||12
8913053|NCT02158520|9972358|FG000|NOT COMPLETED|Overall Study||0
8913054|NCT02158520|9972359|FG001|NOT COMPLETED|Overall Study||0
8913055|NCT02158533|9972370|FG000|STARTED|Stage 1||265
8913056|NCT02158533|9972371|FG001|STARTED|Stage 1||59
8913057|NCT02158533|9972372|FG002|STARTED|Stage 1||60
8913058|NCT02158533|9972373|FG003|STARTED|Stage 1||0
8913059|NCT02158533|9972374|FG004|STARTED|Stage 1||0
8743288|NCT01128569|9791788|FG001|STARTED|Treatment Period 3||7
8913060|NCT02158533|9972375|FG005|STARTED|Stage 1||0
8913061|NCT02158533|9972370|FG000|COMPLETED|Stage 1||251
8743289|NCT01128569|9791789|FG002|STARTED|Treatment Period 3||8
8913062|NCT02158533|9972371|FG001|COMPLETED|Stage 1||51
8913063|NCT02158533|9972372|FG002|COMPLETED|Stage 1||52
8913064|NCT02158533|9972373|FG003|COMPLETED|Stage 1||0
8913065|NCT02158533|9972374|FG004|COMPLETED|Stage 1||0
8913066|NCT02158533|9972375|FG005|COMPLETED|Stage 1||0
8913067|NCT02158533|9972370|FG000|NOT COMPLETED|Stage 1||14
8913068|NCT02158533|9972371|FG001|NOT COMPLETED|Stage 1||8
8913069|NCT02158533|9972372|FG002|NOT COMPLETED|Stage 1||8
8913070|NCT02158533|9972373|FG003|NOT COMPLETED|Stage 1||0
8743290|NCT01128569|9791790|FG003|STARTED|Treatment Period 3||8
8743291|NCT01128569|9791791|FG004|STARTED|Treatment Period 3||9
8743292|NCT01128569|9791792|FG005|STARTED|Treatment Period 3||9
8743293|NCT01128569|9791787|FG000|COMPLETED|Treatment Period 3||9
8743294|NCT01128569|9791788|FG001|COMPLETED|Treatment Period 3||7
8743295|NCT01128569|9791789|FG002|COMPLETED|Treatment Period 3||8
8743296|NCT01128569|9791790|FG003|COMPLETED|Treatment Period 3||8
8743297|NCT01128569|9791791|FG004|COMPLETED|Treatment Period 3||9
8743298|NCT01128569|9791792|FG005|COMPLETED|Treatment Period 3||9
8743299|NCT01128569|9791787|FG000|NOT COMPLETED|Treatment Period 3||0
8743300|NCT01128569|9791788|FG001|NOT COMPLETED|Treatment Period 3||0
8743301|NCT01128569|9791789|FG002|NOT COMPLETED|Treatment Period 3||0
8743302|NCT01128569|9791790|FG003|NOT COMPLETED|Treatment Period 3||0
8743303|NCT01128569|9791791|FG004|NOT COMPLETED|Treatment Period 3||0
8743304|NCT01128569|9791792|FG005|NOT COMPLETED|Treatment Period 3||0
8743305|NCT01128595|9791800|FG000|STARTED|Treatment Period 1||7
8743306|NCT01128595|9791801|FG001|STARTED|Treatment Period 1||6
8743307|NCT01128595|9791802|FG002|STARTED|Treatment Period 1||7
8743308|NCT01128595|9791803|FG003|STARTED|Treatment Period 1||7
8743309|NCT01128595|9791800|FG000|COMPLETED|Treatment Period 1||7
8743310|NCT01128595|9791801|FG001|COMPLETED|Treatment Period 1||6
8743311|NCT01128595|9791802|FG002|COMPLETED|Treatment Period 1||7
8743312|NCT01128595|9791803|FG003|COMPLETED|Treatment Period 1||7
8743313|NCT01128595|9791800|FG000|NOT COMPLETED|Treatment Period 1||0
8743314|NCT01128595|9791801|FG001|NOT COMPLETED|Treatment Period 1||0
8743315|NCT01128595|9791802|FG002|NOT COMPLETED|Treatment Period 1||0
8743316|NCT01128595|9791803|FG003|NOT COMPLETED|Treatment Period 1||0
8743317|NCT01128595|9791800|FG000|STARTED|Washout Period 1||7
8743318|NCT01128595|9791801|FG001|STARTED|Washout Period 1||6
8743319|NCT01128595|9791802|FG002|STARTED|Washout Period 1||7
8743320|NCT01128595|9791803|FG003|STARTED|Washout Period 1||7
8743321|NCT01128595|9791800|FG000|COMPLETED|Washout Period 1||7
8743322|NCT01128595|9791801|FG001|COMPLETED|Washout Period 1||6
8743323|NCT01128595|9791802|FG002|COMPLETED|Washout Period 1||7
8743324|NCT01128595|9791803|FG003|COMPLETED|Washout Period 1||7
8743325|NCT01128595|9791800|FG000|NOT COMPLETED|Washout Period 1||0
8743326|NCT01128595|9791801|FG001|NOT COMPLETED|Washout Period 1||0
8743327|NCT01128595|9791802|FG002|NOT COMPLETED|Washout Period 1||0
8743328|NCT01128595|9791803|FG003|NOT COMPLETED|Washout Period 1||0
8743329|NCT01128595|9791800|FG000|STARTED|Treatment Period 2||7
8743330|NCT01128595|9791801|FG001|STARTED|Treatment Period 2||6
8743331|NCT01128595|9791802|FG002|STARTED|Treatment Period 2||7
8743332|NCT01128595|9791803|FG003|STARTED|Treatment Period 2||7
8743333|NCT01128595|9791800|FG000|COMPLETED|Treatment Period 2||7
8743334|NCT01128595|9791801|FG001|COMPLETED|Treatment Period 2||6
8743335|NCT01128595|9791802|FG002|COMPLETED|Treatment Period 2||7
8743336|NCT01128595|9791803|FG003|COMPLETED|Treatment Period 2||7
8743337|NCT01128595|9791800|FG000|NOT COMPLETED|Treatment Period 2||0
8743338|NCT01128595|9791801|FG001|NOT COMPLETED|Treatment Period 2||0
8743339|NCT01128595|9791802|FG002|NOT COMPLETED|Treatment Period 2||0
8743340|NCT01128595|9791803|FG003|NOT COMPLETED|Treatment Period 2||0
8743341|NCT01128595|9791800|FG000|STARTED|Washout Period 2||7
8743342|NCT01128595|9791801|FG001|STARTED|Washout Period 2||6
8743343|NCT01128595|9791802|FG002|STARTED|Washout Period 2||7
8743344|NCT01128595|9791803|FG003|STARTED|Washout Period 2||7
8743345|NCT01128595|9791800|FG000|COMPLETED|Washout Period 2||7
8743346|NCT01128595|9791801|FG001|COMPLETED|Washout Period 2||6
8743347|NCT01128595|9791802|FG002|COMPLETED|Washout Period 2||7
8743348|NCT01128595|9791803|FG003|COMPLETED|Washout Period 2||7
8743349|NCT01128595|9791800|FG000|NOT COMPLETED|Washout Period 2||0
8743350|NCT01128595|9791801|FG001|NOT COMPLETED|Washout Period 2||0
8743351|NCT01128595|9791802|FG002|NOT COMPLETED|Washout Period 2||0
8743352|NCT01128595|9791803|FG003|NOT COMPLETED|Washout Period 2||0
8743353|NCT01128595|9791800|FG000|STARTED|Treatment Period 3||7
8743354|NCT01128595|9791801|FG001|STARTED|Treatment Period 3||6
8743355|NCT01128595|9791802|FG002|STARTED|Treatment Period 3||7
8743356|NCT01128595|9791803|FG003|STARTED|Treatment Period 3||7
8743357|NCT01128595|9791800|FG000|COMPLETED|Treatment Period 3||7
8743358|NCT01128595|9791801|FG001|COMPLETED|Treatment Period 3||5
8743359|NCT01128595|9791802|FG002|COMPLETED|Treatment Period 3||7
8743360|NCT01128595|9791803|FG003|COMPLETED|Treatment Period 3||7
8743361|NCT01128595|9791800|FG000|NOT COMPLETED|Treatment Period 3||0
8743362|NCT01128595|9791801|FG001|NOT COMPLETED|Treatment Period 3||1
8743363|NCT01128595|9791802|FG002|NOT COMPLETED|Treatment Period 3||0
8743364|NCT01128595|9791803|FG003|NOT COMPLETED|Treatment Period 3||0
8743365|NCT01128595|9791800|FG000|STARTED|Washout Period 3||7
8743366|NCT01128595|9791801|FG001|STARTED|Washout Period 3||5
8743367|NCT01128595|9791802|FG002|STARTED|Washout Period 3||7
8743368|NCT01128595|9791803|FG003|STARTED|Washout Period 3||7
8743369|NCT01128595|9791800|FG000|COMPLETED|Washout Period 3||7
8743370|NCT01128595|9791801|FG001|COMPLETED|Washout Period 3||5
8743371|NCT01128595|9791802|FG002|COMPLETED|Washout Period 3||7
8743372|NCT01128595|9791803|FG003|COMPLETED|Washout Period 3||7
8743373|NCT01128595|9791800|FG000|NOT COMPLETED|Washout Period 3||0
8743374|NCT01128595|9791801|FG001|NOT COMPLETED|Washout Period 3||0
8743375|NCT01128595|9791802|FG002|NOT COMPLETED|Washout Period 3||0
8743376|NCT01128595|9791803|FG003|NOT COMPLETED|Washout Period 3||0
8743377|NCT01128595|9791800|FG000|STARTED|Treatment Period 4||7
8743378|NCT01128595|9791801|FG001|STARTED|Treatment Period 4||5
8743379|NCT01128595|9791802|FG002|STARTED|Treatment Period 4||7
8743380|NCT01128595|9791803|FG003|STARTED|Treatment Period 4||7
8743381|NCT01128595|9791800|FG000|COMPLETED|Treatment Period 4||7
8743382|NCT01128595|9791801|FG001|COMPLETED|Treatment Period 4||5
8743383|NCT01128595|9791802|FG002|COMPLETED|Treatment Period 4||7
8743384|NCT01128595|9791803|FG003|COMPLETED|Treatment Period 4||7
8743385|NCT01128595|9791800|FG000|NOT COMPLETED|Treatment Period 4||0
8743386|NCT01128595|9791801|FG001|NOT COMPLETED|Treatment Period 4||0
8743387|NCT01128595|9791802|FG002|NOT COMPLETED|Treatment Period 4||0
8743388|NCT01128595|9791803|FG003|NOT COMPLETED|Treatment Period 4||0
8743389|NCT01128621|9791816|FG000|STARTED|Part A: GSK1292263 300 mg||6
8743390|NCT01128621|9791817|FG001|STARTED|Part A: GSK1292263 300 mg||0
8743391|NCT01128621|9791816|FG000|COMPLETED|Part A: GSK1292263 300 mg||6
8743392|NCT01128621|9791817|FG001|COMPLETED|Part A: GSK1292263 300 mg||0
8743393|NCT01128621|9791816|FG000|NOT COMPLETED|Part A: GSK1292263 300 mg||0
8743394|NCT01128621|9791817|FG001|NOT COMPLETED|Part A: GSK1292263 300 mg||0
8743395|NCT01128621|9791816|FG000|STARTED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||0
8743396|NCT01128621|9791817|FG001|STARTED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||67
8743397|NCT01128621|9791816|FG000|COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||0
8743398|NCT01128621|9791817|FG001|COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||65
8743399|NCT01128621|9791816|FG000|NOT COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||0
8743400|NCT01128621|9791817|FG001|NOT COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||2
8743401|NCT01128738|9791841|FG000|STARTED|First Treatment Phase (TP)||78
8743402|NCT01128738|9791842|FG001|STARTED|First Treatment Phase (TP)||74
8743403|NCT01128738|9791841|FG000|COMPLETED|First Treatment Phase (TP)||74
8743404|NCT01128738|9791842|FG001|COMPLETED|First Treatment Phase (TP)||73
8743405|NCT01128738|9791841|FG000|NOT COMPLETED|First Treatment Phase (TP)||4
8743406|NCT01128738|9791842|FG001|NOT COMPLETED|First Treatment Phase (TP)||1
8743407|NCT01128738|9791841|FG000|STARTED|Second TP|Only participants who received a second treatment entered this phase.|34
8743408|NCT01128738|9791842|FG001|STARTED|Second TP|Only participants who received a second treatment entered this phase.|66
8743409|NCT01128738|9791841|FG000|COMPLETED|Second TP||34
8743410|NCT01128738|9791842|FG001|COMPLETED|Second TP||63
8743411|NCT01128738|9791841|FG000|NOT COMPLETED|Second TP||0
8743412|NCT01128738|9791842|FG001|NOT COMPLETED|Second TP||3
8743413|NCT01128829|9791849|FG000|STARTED|Overall Study||6
8743414|NCT01128829|9791850|FG001|STARTED|Overall Study||11
8743415|NCT01128829|9791849|FG000|COMPLETED|Overall Study||6
8743416|NCT01128829|9791850|FG001|COMPLETED|Overall Study||11
8743417|NCT01128829|9791849|FG000|NOT COMPLETED|Overall Study||0
8743418|NCT01128829|9791850|FG001|NOT COMPLETED|Overall Study||0
8743419|NCT01128842|9791854|FG000|STARTED|Overall Study||7
8743420|NCT01128842|9791854|FG000|COMPLETED|Overall Study||0
8743421|NCT01128842|9791854|FG000|NOT COMPLETED|Overall Study||7
8743422|NCT01128894|9791861|FG000|STARTED|Overall Study||404
8743423|NCT01128894|9791862|FG001|STARTED|Overall Study||408
8743424|NCT01128894|9791861|FG000|COMPLETED|Overall Study||346
8743425|NCT01128894|9791862|FG001|COMPLETED|Overall Study||340
8743426|NCT01128894|9791861|FG000|NOT COMPLETED|Overall Study||58
8743427|NCT01128894|9791862|FG001|NOT COMPLETED|Overall Study||68
8743428|NCT01128946|9791868|FG000|STARTED|Period I||20
8743429|NCT01128946|9791869|FG001|STARTED|Period I||21
8743430|NCT01128946|9791870|FG002|STARTED|Period I||21
8743431|NCT01128946|9791871|FG003|STARTED|Period I||21
8743432|NCT01128946|9791868|FG000|COMPLETED|Period I||20
8743433|NCT01128946|9791869|FG001|COMPLETED|Period I||20
8743434|NCT01128946|9791870|FG002|COMPLETED|Period I||20
8743435|NCT01128946|9791871|FG003|COMPLETED|Period I||20
8743436|NCT01128946|9791868|FG000|NOT COMPLETED|Period I||0
8743437|NCT01128946|9791869|FG001|NOT COMPLETED|Period I||1
8743438|NCT01128946|9791870|FG002|NOT COMPLETED|Period I||1
8743439|NCT01128946|9791871|FG003|NOT COMPLETED|Period I||1
8743440|NCT01128946|9791868|FG000|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
8743441|NCT01128946|9791869|FG001|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
8743442|NCT01128946|9791870|FG002|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
8743443|NCT01128946|9791871|FG003|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
8743444|NCT01128946|9791868|FG000|COMPLETED|Period II||20
8743445|NCT01128946|9791869|FG001|COMPLETED|Period II||19
8743446|NCT01128946|9791870|FG002|COMPLETED|Period II||20
8743447|NCT01128946|9791871|FG003|COMPLETED|Period II||19
8743448|NCT01128946|9791868|FG000|NOT COMPLETED|Period II||0
8743449|NCT01128946|9791869|FG001|NOT COMPLETED|Period II||1
8743450|NCT01128946|9791870|FG002|NOT COMPLETED|Period II||0
8743451|NCT01128946|9791871|FG003|NOT COMPLETED|Period II||1
8743452|NCT01128946|9791868|FG000|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|20
8743453|NCT01128946|9791869|FG001|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|19
8743454|NCT01128946|9791870|FG002|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|20
8743455|NCT01128946|9791871|FG003|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|19
8743456|NCT01128946|9791868|FG000|COMPLETED|Period III||19
8743457|NCT01128946|9791869|FG001|COMPLETED|Period III||19
8743458|NCT01128946|9791870|FG002|COMPLETED|Period III||20
8743459|NCT01128946|9791871|FG003|COMPLETED|Period III||19
8743460|NCT01128946|9791868|FG000|NOT COMPLETED|Period III||1
8743461|NCT01128946|9791869|FG001|NOT COMPLETED|Period III||0
8743462|NCT01128946|9791870|FG002|NOT COMPLETED|Period III||0
8743463|NCT01128946|9791871|FG003|NOT COMPLETED|Period III||0
8743464|NCT01128946|9791868|FG000|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|19
8743465|NCT01128946|9791869|FG001|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|20
8743466|NCT01128946|9791870|FG002|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|19
8743467|NCT01128946|9791871|FG003|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|19
8743468|NCT01128946|9791868|FG000|COMPLETED|Period IV||19
8743469|NCT01128946|9791869|FG001|COMPLETED|Period IV||20
8743470|NCT01128946|9791870|FG002|COMPLETED|Period IV||19
8743471|NCT01128946|9791871|FG003|COMPLETED|Period IV||19
8743472|NCT01128946|9791868|FG000|NOT COMPLETED|Period IV||0
8743473|NCT01128946|9791869|FG001|NOT COMPLETED|Period IV||0
8743474|NCT01128946|9791870|FG002|NOT COMPLETED|Period IV||0
8743475|NCT01128946|9791871|FG003|NOT COMPLETED|Period IV||0
8913071|NCT02158533|9972374|FG004|NOT COMPLETED|Stage 1||0
8913072|NCT02158533|9972375|FG005|NOT COMPLETED|Stage 1||0
8913073|NCT02158533|9972370|FG000|STARTED|Stage 2||0
8913074|NCT02158533|9972371|FG001|STARTED|Stage 2||0
8913075|NCT02158533|9972372|FG002|STARTED|Stage 2||0
8913076|NCT02158533|9972373|FG003|STARTED|Stage 2||56
8913077|NCT02158533|9972374|FG004|STARTED|Stage 2||56
8913078|NCT02158533|9972375|FG005|STARTED|Stage 2||56
8913079|NCT02158533|9972370|FG000|COMPLETED|Stage 2||0
8913080|NCT02158533|9972371|FG001|COMPLETED|Stage 2||0
8913081|NCT02158533|9972372|FG002|COMPLETED|Stage 2||0
8913082|NCT02158533|9972373|FG003|COMPLETED|Stage 2||53
8913083|NCT02158533|9972374|FG004|COMPLETED|Stage 2||52
8913084|NCT02158533|9972375|FG005|COMPLETED|Stage 2||50
8913085|NCT02158533|9972370|FG000|NOT COMPLETED|Stage 2||0
8913086|NCT02158533|9972371|FG001|NOT COMPLETED|Stage 2||0
8913087|NCT02158533|9972372|FG002|NOT COMPLETED|Stage 2||0
8913088|NCT02158533|9972373|FG003|NOT COMPLETED|Stage 2||3
8913089|NCT02158533|9972374|FG004|NOT COMPLETED|Stage 2||4
8913090|NCT02158533|9972375|FG005|NOT COMPLETED|Stage 2||6
8913091|NCT02158546|9972393|FG000|STARTED|Overall Study||152
8913092|NCT02158546|9972394|FG001|STARTED|Overall Study||153
8913093|NCT02158546|9972395|FG002|STARTED|Overall Study||18
8913094|NCT02158546|9972396|FG003|STARTED|Overall Study||19
8913095|NCT02158546|9972393|FG000|COMPLETED|Overall Study||133
9022697|NCT03131167|10085551|FG003|NOT COMPLETED|Overall Study||0
9022698|NCT03131167|10085552|FG004|NOT COMPLETED|Overall Study||0
9022699|NCT03131167|10085553|FG005|NOT COMPLETED|Overall Study||1
9022700|NCT03131167|10085554|FG006|NOT COMPLETED|Overall Study||0
9022701|NCT03131167|10085555|FG007|NOT COMPLETED|Overall Study||0
9022702|NCT03131167|10085556|FG008|NOT COMPLETED|Overall Study||0
9022703|NCT03131167|10085557|FG009|NOT COMPLETED|Overall Study||0
9022704|NCT03131167|10085558|FG010|NOT COMPLETED|Overall Study||0
9022705|NCT03131167|10085559|FG011|NOT COMPLETED|Overall Study||0
9022706|NCT03131167|10085560|FG012|NOT COMPLETED|Overall Study||0
9022707|NCT03131206|10085593|FG000|STARTED|Dose Level 1 (600mg BID 7d, 900mg BID)||5
9022708|NCT03131206|10085594|FG001|STARTED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
9022709|NCT03131206|10085595|FG002|STARTED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
9022710|NCT03131206|10085596|FG003|STARTED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
9022711|NCT03131206|10085593|FG000|COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||5
9022712|NCT03131206|10085594|FG001|COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
9022713|NCT03131206|10085595|FG002|COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
9022714|NCT03131206|10085596|FG003|COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
9022715|NCT03131206|10085593|FG000|NOT COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
9022716|NCT03131206|10085594|FG001|NOT COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
9022717|NCT03131206|10085595|FG002|NOT COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
9022718|NCT03131206|10085596|FG003|NOT COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
9022719|NCT03131206|10085593|FG000|STARTED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
9022720|NCT03131206|10085594|FG001|STARTED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
9022721|NCT03131206|10085595|FG002|STARTED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
9022722|NCT03131206|10085596|FG003|STARTED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
9022723|NCT03131206|10085593|FG000|COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
9022724|NCT03131206|10085594|FG001|COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
9022725|NCT03131206|10085595|FG002|COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
9022726|NCT03131206|10085596|FG003|COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
9022727|NCT03131206|10085593|FG000|NOT COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
9022728|NCT03131206|10085594|FG001|NOT COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
9022729|NCT03131206|10085595|FG002|NOT COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
9022730|NCT03131206|10085596|FG003|NOT COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
9022731|NCT03131453|10085613|FG000|STARTED|Overall Study||456
9022732|NCT03131453|10085614|FG001|STARTED|Overall Study||233
8913096|NCT02158546|9972394|FG001|COMPLETED|Overall Study||136
8913097|NCT02158546|9972395|FG002|COMPLETED|Overall Study||14
8913098|NCT02158546|9972396|FG003|COMPLETED|Overall Study||13
8913099|NCT02158546|9972393|FG000|NOT COMPLETED|Overall Study||19
8913100|NCT02158546|9972394|FG001|NOT COMPLETED|Overall Study||17
8913101|NCT02158546|9972395|FG002|NOT COMPLETED|Overall Study||4
8743476|NCT01128959|9791882|FG000|STARTED|Lead in Period||108
8743477|NCT01128959|9791882|FG000|COMPLETED|Lead in Period||105
8743478|NCT01128959|9791882|FG000|NOT COMPLETED|Lead in Period||3
8743479|NCT01128959|9791882|FG000|STARTED|Treatment Period||105
8743480|NCT01128959|9791882|FG000|COMPLETED|Treatment Period||101
8743481|NCT01128959|9791882|FG000|NOT COMPLETED|Treatment Period||4
8807403|NCT01484197|9859758|FG003|NOT COMPLETED|Treatment Period 2||1
8807404|NCT01484197|9859755|FG000|STARTED|Treatment Period 3||7
8807405|NCT01484197|9859756|FG001|STARTED|Treatment Period 3||8
8807406|NCT01484197|9859757|FG002|STARTED|Treatment Period 3||9
8807407|NCT01484197|9859758|FG003|STARTED|Treatment Period 3||8
8807408|NCT01484197|9859755|FG000|COMPLETED|Treatment Period 3||7
8807409|NCT01484197|9859756|FG001|COMPLETED|Treatment Period 3||8
8807410|NCT01484197|9859757|FG002|COMPLETED|Treatment Period 3||9
8807411|NCT01484197|9859758|FG003|COMPLETED|Treatment Period 3||8
8807412|NCT01484197|9859755|FG000|NOT COMPLETED|Treatment Period 3||0
8807413|NCT01484197|9859756|FG001|NOT COMPLETED|Treatment Period 3||0
8807414|NCT01484197|9859757|FG002|NOT COMPLETED|Treatment Period 3||0
8807415|NCT01484197|9859758|FG003|NOT COMPLETED|Treatment Period 3||0
8807416|NCT01484197|9859755|FG000|STARTED|Treatment Period 4||7
8807417|NCT01484197|9859756|FG001|STARTED|Treatment Period 4||8
8807418|NCT01484197|9859757|FG002|STARTED|Treatment Period 4||9
8807419|NCT01484197|9859758|FG003|STARTED|Treatment Period 4|2 patients completed Period 3 but did not enter Period 4 due to a Protocol deviation and an AE.|6
8807420|NCT01484197|9859755|FG000|COMPLETED|Treatment Period 4||7
8807421|NCT01484197|9859756|FG001|COMPLETED|Treatment Period 4||8
8807422|NCT01484197|9859757|FG002|COMPLETED|Treatment Period 4||9
8807423|NCT01484197|9859758|FG003|COMPLETED|Treatment Period 4||6
8807424|NCT01484197|9859755|FG000|NOT COMPLETED|Treatment Period 4||0
8807425|NCT01484197|9859756|FG001|NOT COMPLETED|Treatment Period 4||0
8807426|NCT01484197|9859757|FG002|NOT COMPLETED|Treatment Period 4||0
8807427|NCT01484197|9859758|FG003|NOT COMPLETED|Treatment Period 4||0
8807428|NCT01484275|9859770|FG000|STARTED|Overall Study||43
8807429|NCT01484275|9859771|FG001|STARTED|Overall Study||42
8807430|NCT01484275|9859770|FG000|COMPLETED|Overall Study||0
8807431|NCT01484275|9859771|FG001|COMPLETED|Overall Study||0
8807432|NCT01484275|9859770|FG000|NOT COMPLETED|Overall Study||43
8807433|NCT01484275|9859771|FG001|NOT COMPLETED|Overall Study||42
8807434|NCT01484288|9859777|FG000|STARTED|Overall Study||11
8807435|NCT01484288|9859777|FG000|COMPLETED|Overall Study||11
8807436|NCT01484288|9859777|FG000|NOT COMPLETED|Overall Study||0
8807437|NCT01484340|9859783|FG000|STARTED|Overall Study||281
8807438|NCT01484340|9859784|FG001|STARTED|Overall Study||279
8807439|NCT01484340|9859783|FG000|COMPLETED|Overall Study||281
8807440|NCT01484340|9859784|FG001|COMPLETED|Overall Study||279
8807441|NCT01484340|9859783|FG000|NOT COMPLETED|Overall Study||0
8807442|NCT01484340|9859784|FG001|NOT COMPLETED|Overall Study||0
8807443|NCT01484431|9859793|FG000|STARTED|Period 1: Low Dose||6
8807444|NCT01484431|9859794|FG001|STARTED|Period 1: Low Dose||7
8807445|NCT01484431|9859795|FG002|STARTED|Period 1: Low Dose||6
8807446|NCT01484431|9859793|FG000|Received 2 mg|Period 1: Low Dose||1
8807447|NCT01484431|9859794|FG001|Received 2 mg|Period 1: Low Dose||0
8807448|NCT01484431|9859795|FG002|Received 2 mg|Period 1: Low Dose||0
8807449|NCT01484431|9859793|FG000|Received 4 mg|Period 1: Low Dose||5
8807450|NCT01484431|9859794|FG001|Received 4 mg|Period 1: Low Dose||0
8807451|NCT01484431|9859795|FG002|Received 4 mg|Period 1: Low Dose||0
8807452|NCT01484431|9859793|FG000|Received 5 mg|Period 1: Low Dose||0
8807453|NCT01484431|9859794|FG001|Received 5 mg|Period 1: Low Dose||7
8807454|NCT01484431|9859795|FG002|Received 5 mg|Period 1: Low Dose||0
8807455|NCT01484431|9859793|FG000|Received 10 mg|Period 1: Low Dose||0
8807456|NCT01484431|9859794|FG001|Received 10 mg|Period 1: Low Dose||0
8807457|NCT01484431|9859795|FG002|Received 10 mg|Period 1: Low Dose||6
8807458|NCT01484431|9859793|FG000|COMPLETED|Period 1: Low Dose||6
8807459|NCT01484431|9859794|FG001|COMPLETED|Period 1: Low Dose||7
8807460|NCT01484431|9859795|FG002|COMPLETED|Period 1: Low Dose||6
8807461|NCT01484431|9859793|FG000|NOT COMPLETED|Period 1: Low Dose||0
8807462|NCT01484431|9859794|FG001|NOT COMPLETED|Period 1: Low Dose||0
8807463|NCT01484431|9859795|FG002|NOT COMPLETED|Period 1: Low Dose||0
8807464|NCT01484431|9859793|FG000|STARTED|Period 1: High Dose||6
8807465|NCT01484431|9859794|FG001|STARTED|Period 1: High Dose||7
8807466|NCT01484431|9859795|FG002|STARTED|Period 1: High Dose||6
8807467|NCT01484431|9859793|FG000|Received 8 mg|Period 1: High Dose||1
8807468|NCT01484431|9859794|FG001|Received 8 mg|Period 1: High Dose||0
8807469|NCT01484431|9859795|FG002|Received 8 mg|Period 1: High Dose||0
8807470|NCT01484431|9859793|FG000|Received 10 mg|Period 1: High Dose||1
8807471|NCT01484431|9859794|FG001|Received 10 mg|Period 1: High Dose||1
8807472|NCT01484431|9859795|FG002|Received 10 mg|Period 1: High Dose||0
8807473|NCT01484431|9859793|FG000|Received 15 mg|Period 1: High Dose||1
8807474|NCT01484431|9859794|FG001|Received 15 mg|Period 1: High Dose||1
8807475|NCT01484431|9859795|FG002|Received 15 mg|Period 1: High Dose||0
8807476|NCT01484431|9859793|FG000|Received 20 mg|Period 1: High Dose||3
8807477|NCT01484431|9859794|FG001|Received 20 mg|Period 1: High Dose||5
8807478|NCT01484431|9859795|FG002|Received 20 mg|Period 1: High Dose||1
8807479|NCT01484431|9859793|FG000|Received 40 mg|Period 1: High Dose||0
8807480|NCT01484431|9859794|FG001|Received 40 mg|Period 1: High Dose||0
8807481|NCT01484431|9859795|FG002|Received 40 mg|Period 1: High Dose||5
8807482|NCT01484431|9859793|FG000|COMPLETED|Period 1: High Dose||6
8807483|NCT01484431|9859794|FG001|COMPLETED|Period 1: High Dose||6
8743482|NCT01128972|9791888|FG000|STARTED|Period I||7
8743483|NCT01128972|9791889|FG001|STARTED|Period I||7
8743484|NCT01128972|9791890|FG002|STARTED|Period I||7
8743485|NCT01128972|9791891|FG003|STARTED|Period I||7
8743486|NCT01128972|9791892|FG004|STARTED|Period I||8
8743487|NCT01128972|9791888|FG000|COMPLETED|Period I||7
8743488|NCT01128972|9791889|FG001|COMPLETED|Period I||7
8743489|NCT01128972|9791890|FG002|COMPLETED|Period I||7
8743490|NCT01128972|9791891|FG003|COMPLETED|Period I||7
8743491|NCT01128972|9791892|FG004|COMPLETED|Period I||8
8743492|NCT01128972|9791888|FG000|NOT COMPLETED|Period I||0
8743493|NCT01128972|9791889|FG001|NOT COMPLETED|Period I||0
8743494|NCT01128972|9791890|FG002|NOT COMPLETED|Period I||0
8743495|NCT01128972|9791891|FG003|NOT COMPLETED|Period I||0
8743496|NCT01128972|9791892|FG004|NOT COMPLETED|Period I||0
8743497|NCT01128972|9791888|FG000|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
8743498|NCT01128972|9791889|FG001|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
8743499|NCT01128972|9791890|FG002|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
8743500|NCT01128972|9791891|FG003|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|8
8743501|NCT01128972|9791892|FG004|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
8743502|NCT01128972|9791888|FG000|COMPLETED|Period II||7
8743503|NCT01128972|9791889|FG001|COMPLETED|Period II||7
8743504|NCT01128972|9791890|FG002|COMPLETED|Period II||7
8743505|NCT01128972|9791891|FG003|COMPLETED|Period II||8
8743506|NCT01128972|9791892|FG004|COMPLETED|Period II||7
8743507|NCT01128972|9791888|FG000|NOT COMPLETED|Period II||0
8743508|NCT01128972|9791889|FG001|NOT COMPLETED|Period II||0
8743509|NCT01128972|9791890|FG002|NOT COMPLETED|Period II||0
8743510|NCT01128972|9791891|FG003|NOT COMPLETED|Period II||0
8743511|NCT01128972|9791892|FG004|NOT COMPLETED|Period II||0
8743512|NCT01128972|9791888|FG000|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
8743513|NCT01128972|9791889|FG001|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
8743514|NCT01128972|9791890|FG002|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|8
8743515|NCT01128972|9791891|FG003|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
8743516|NCT01128972|9791892|FG004|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
8743517|NCT01128972|9791888|FG000|COMPLETED|Period III||7
8743518|NCT01128972|9791889|FG001|COMPLETED|Period III||7
8743519|NCT01128972|9791890|FG002|COMPLETED|Period III||8
8743520|NCT01128972|9791891|FG003|COMPLETED|Period III||7
8743521|NCT01128972|9791892|FG004|COMPLETED|Period III||7
8743522|NCT01128972|9791888|FG000|NOT COMPLETED|Period III||0
8743523|NCT01128972|9791889|FG001|NOT COMPLETED|Period III||0
8743524|NCT01128972|9791890|FG002|NOT COMPLETED|Period III||0
8743525|NCT01128972|9791891|FG003|NOT COMPLETED|Period III||0
8743526|NCT01128972|9791892|FG004|NOT COMPLETED|Period III||0
8743527|NCT01128972|9791888|FG000|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
8743528|NCT01128972|9791889|FG001|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|8
8743529|NCT01128972|9791890|FG002|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
8743530|NCT01128972|9791891|FG003|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
8743531|NCT01128972|9791892|FG004|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
8743532|NCT01128972|9791888|FG000|COMPLETED|Period IV||7
8743533|NCT01128972|9791889|FG001|COMPLETED|Period IV||8
8743534|NCT01128972|9791890|FG002|COMPLETED|Period IV||7
8743535|NCT01128972|9791891|FG003|COMPLETED|Period IV||7
8743536|NCT01128972|9791892|FG004|COMPLETED|Period IV||7
8743537|NCT01128972|9791888|FG000|NOT COMPLETED|Period IV||0
8743538|NCT01128972|9791889|FG001|NOT COMPLETED|Period IV||0
8743539|NCT01128972|9791890|FG002|NOT COMPLETED|Period IV||0
8743540|NCT01128972|9791891|FG003|NOT COMPLETED|Period IV||0
8743541|NCT01128972|9791892|FG004|NOT COMPLETED|Period IV||0
8743542|NCT01128972|9791888|FG000|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|8
8743543|NCT01128972|9791889|FG001|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
8743544|NCT01128972|9791890|FG002|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
8743545|NCT01128972|9791891|FG003|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
8743546|NCT01128972|9791892|FG004|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
8743547|NCT01128972|9791888|FG000|COMPLETED|Period V||8
8743548|NCT01128972|9791889|FG001|COMPLETED|Period V||7
8743549|NCT01128972|9791890|FG002|COMPLETED|Period V||7
8743550|NCT01128972|9791891|FG003|COMPLETED|Period V||7
8743551|NCT01128972|9791892|FG004|COMPLETED|Period V||7
8743552|NCT01128972|9791888|FG000|NOT COMPLETED|Period V||0
8743553|NCT01128972|9791889|FG001|NOT COMPLETED|Period V||0
8743554|NCT01128972|9791890|FG002|NOT COMPLETED|Period V||0
8743555|NCT01128972|9791891|FG003|NOT COMPLETED|Period V||0
8743556|NCT01128972|9791892|FG004|NOT COMPLETED|Period V||0
8743557|NCT01129024|9791910|FG000|STARTED|Overall Study||19
8743558|NCT01129024|9791910|FG000|COMPLETED|Overall Study||0
8743559|NCT01129024|9791910|FG000|NOT COMPLETED|Overall Study||19
8743560|NCT01129102|9791917|FG000|STARTED|Overall Study||110
8743561|NCT01129102|9791918|FG001|STARTED|Overall Study||50
8743562|NCT01129102|9791919|FG002|STARTED|Overall Study||55
8743563|NCT01129102|9791917|FG000|COMPLETED|Overall Study||102
8743564|NCT01129102|9791918|FG001|COMPLETED|Overall Study||44
8743565|NCT01129102|9791919|FG002|COMPLETED|Overall Study||48
8743566|NCT01129102|9791917|FG000|NOT COMPLETED|Overall Study||8
8743567|NCT01129102|9791918|FG001|NOT COMPLETED|Overall Study||6
8743568|NCT01129102|9791919|FG002|NOT COMPLETED|Overall Study||7
8743569|NCT01129115|9791930|FG000|STARTED|Overall Study||25
8743570|NCT01129115|9791931|FG001|STARTED|Overall Study||25
8743571|NCT01129115|9791932|FG002|STARTED|Overall Study||27
8743572|NCT01129115|9791933|FG003|STARTED|Overall Study||24
8743573|NCT01129115|9791930|FG000|COMPLETED|Overall Study||23
8743574|NCT01129115|9791931|FG001|COMPLETED|Overall Study||18
8743575|NCT01129115|9791932|FG002|COMPLETED|Overall Study||21
8743576|NCT01129115|9791933|FG003|COMPLETED|Overall Study||15
8743577|NCT01129115|9791930|FG000|NOT COMPLETED|Overall Study||2
8743578|NCT01129115|9791931|FG001|NOT COMPLETED|Overall Study||7
8743579|NCT01129115|9791932|FG002|NOT COMPLETED|Overall Study||6
8743580|NCT01129115|9791933|FG003|NOT COMPLETED|Overall Study||9
8743581|NCT01129128|9791946|FG000|STARTED|Overall Study||22
8743582|NCT01129128|9791947|FG001|STARTED|Overall Study||22
8743583|NCT01129128|9791948|FG002|STARTED|Overall Study||23
8743584|NCT01129128|9791946|FG000|COMPLETED|Overall Study||19
8743585|NCT01129128|9791947|FG001|COMPLETED|Overall Study||18
8743586|NCT01129128|9791948|FG002|COMPLETED|Overall Study||19
8743587|NCT01129128|9791946|FG000|NOT COMPLETED|Overall Study||3
8743588|NCT01129128|9791947|FG001|NOT COMPLETED|Overall Study||4
8743589|NCT01129128|9791948|FG002|NOT COMPLETED|Overall Study||4
8743590|NCT01129141|9791958|FG000|STARTED|Overall Study||101
8743591|NCT01129141|9791959|FG001|STARTED|Overall Study||104
8743592|NCT01129141|9791958|FG000|COMPLETED|Overall Study||86
8743593|NCT01129141|9791959|FG001|COMPLETED|Overall Study||91
8743594|NCT01129141|9791958|FG000|NOT COMPLETED|Overall Study||15
8743595|NCT01129141|9791959|FG001|NOT COMPLETED|Overall Study||13
8743596|NCT01129206|9791965|FG000|STARTED|Overall Study||6
8743597|NCT01129206|9791965|FG000|COMPLETED|Overall Study||6
8743598|NCT01129206|9791965|FG000|NOT COMPLETED|Overall Study||0
8743599|NCT01129245|9791974|FG000|STARTED|Control Cycle (no Celecoxib or Placebo)||10
8743600|NCT01129245|9791975|FG001|STARTED|Control Cycle (no Celecoxib or Placebo)||10
8743601|NCT01129245|9791974|FG000|COMPLETED|Control Cycle (no Celecoxib or Placebo)||10
8743602|NCT01129245|9791975|FG001|COMPLETED|Control Cycle (no Celecoxib or Placebo)||10
8743603|NCT01129245|9791974|FG000|NOT COMPLETED|Control Cycle (no Celecoxib or Placebo)||0
8743604|NCT01129245|9791975|FG001|NOT COMPLETED|Control Cycle (no Celecoxib or Placebo)||0
8743605|NCT01129245|9791974|FG000|STARTED|Treatment Cycle 1||10
8743606|NCT01129245|9791975|FG001|STARTED|Treatment Cycle 1||10
8743607|NCT01129245|9791974|FG000|COMPLETED|Treatment Cycle 1||10
8743608|NCT01129245|9791975|FG001|COMPLETED|Treatment Cycle 1||10
8743609|NCT01129245|9791974|FG000|NOT COMPLETED|Treatment Cycle 1||0
8743610|NCT01129245|9791975|FG001|NOT COMPLETED|Treatment Cycle 1||0
8743611|NCT01129245|9791974|FG000|STARTED|Washout Cycle||10
8743612|NCT01129245|9791975|FG001|STARTED|Washout Cycle||10
8743613|NCT01129245|9791974|FG000|COMPLETED|Washout Cycle||10
8743614|NCT01129245|9791975|FG001|COMPLETED|Washout Cycle||10
8743615|NCT01129245|9791974|FG000|NOT COMPLETED|Washout Cycle||0
8743616|NCT01129245|9791975|FG001|NOT COMPLETED|Washout Cycle||0
8743617|NCT01129245|9791974|FG000|STARTED|Treatment Cycle 2||10
8743618|NCT01129245|9791975|FG001|STARTED|Treatment Cycle 2||10
8743619|NCT01129245|9791974|FG000|COMPLETED|Treatment Cycle 2||10
8743620|NCT01129245|9791975|FG001|COMPLETED|Treatment Cycle 2||10
8743621|NCT01129245|9791974|FG000|NOT COMPLETED|Treatment Cycle 2||0
8743622|NCT01129245|9791975|FG001|NOT COMPLETED|Treatment Cycle 2||0
8743623|NCT01129284|9791987|FG000|STARTED|Overall Study||5
8743624|NCT01129284|9791988|FG001|STARTED|Overall Study||5
8743625|NCT01129284|9791989|FG002|STARTED|Overall Study||5
8743626|NCT01129284|9791987|FG000|COMPLETED|Overall Study||3
8743627|NCT01129284|9791988|FG001|COMPLETED|Overall Study||5
8743628|NCT01129284|9791989|FG002|COMPLETED|Overall Study||4
8743629|NCT01129284|9791987|FG000|NOT COMPLETED|Overall Study||2
8743630|NCT01129284|9791988|FG001|NOT COMPLETED|Overall Study||0
8913102|NCT02158546|9972396|FG003|NOT COMPLETED|Overall Study||6
8913103|NCT02158572|9972406|FG000|STARTED|Overall Study||2032
9022733|NCT03131453|10085615|FG002|STARTED|Overall Study||456
8743631|NCT01129284|9791989|FG002|NOT COMPLETED|Overall Study||1
8743632|NCT01129336|9791999|FG000|STARTED|Overall Study||15
8743633|NCT01129336|9792000|FG001|STARTED|Overall Study||29
8743634|NCT01129336|9791999|FG000|Completed Treatment|Overall Study||1
8743635|NCT01129336|9792000|FG001|Completed Treatment|Overall Study||3
8743636|NCT01129336|9791999|FG000|COMPLETED|Overall Study|Completed indicates Completed Study as per protocol.|3
8743637|NCT01129336|9792000|FG001|COMPLETED|Overall Study|Completed indicates Completed Study as per protocol.|13
8913104|NCT02158572|9972406|FG000|COMPLETED|Overall Study||989
8913105|NCT02158572|9972406|FG000|NOT COMPLETED|Overall Study||1043
8743638|NCT01129336|9791999|FG000|NOT COMPLETED|Overall Study||12
8743639|NCT01129336|9792000|FG001|NOT COMPLETED|Overall Study||16
8743640|NCT01129440|9792008|FG000|STARTED|Overall Study||297
8743641|NCT01129440|9792009|FG001|STARTED|Overall Study||300
8743642|NCT01129440|9792008|FG000|12 Month Follow-up|Overall Study||249
8743643|NCT01129440|9792009|FG001|12 Month Follow-up|Overall Study||256
8743644|NCT01129440|9792008|FG000|24 Month Follow-up|Overall Study||239
8743645|NCT01129440|9792009|FG001|24 Month Follow-up|Overall Study||258
8743646|NCT01129440|9792008|FG000|COMPLETED|Overall Study||246
8743647|NCT01129440|9792009|FG001|COMPLETED|Overall Study||258
8743648|NCT01129440|9792008|FG000|NOT COMPLETED|Overall Study||51
8743649|NCT01129440|9792009|FG001|NOT COMPLETED|Overall Study||42
8743650|NCT01129531|9792019|FG000|STARTED|Treatment Cycle 1||84
8743651|NCT01129531|9792020|FG001|STARTED|Treatment Cycle 1||84
8743652|NCT01129531|9792021|FG002|STARTED|Treatment Cycle 1||126
8743653|NCT01129531|9792019|FG000|COMPLETED|Treatment Cycle 1||80
8743654|NCT01129531|9792020|FG001|COMPLETED|Treatment Cycle 1||78
8743655|NCT01129531|9792021|FG002|COMPLETED|Treatment Cycle 1||110
8743656|NCT01129531|9792019|FG000|NOT COMPLETED|Treatment Cycle 1||4
8743657|NCT01129531|9792020|FG001|NOT COMPLETED|Treatment Cycle 1||6
8743658|NCT01129531|9792021|FG002|NOT COMPLETED|Treatment Cycle 1||16
8743659|NCT01129531|9792019|FG000|STARTED|Treatment Cycle 2|Participants who completed Treatment Cycle 1 were re-randomized.|94
8743660|NCT01129531|9792020|FG001|STARTED|Treatment Cycle 2|Participants who completed Treatment Cycle 1 were re-randomized.|95
8743661|NCT01129531|9792021|FG002|STARTED|Treatment Cycle 2|Participants who completed Treatment Cycle 1 were re-randomized.|79
8743662|NCT01129531|9792019|FG000|COMPLETED|Treatment Cycle 2||88
8743663|NCT01129531|9792020|FG001|COMPLETED|Treatment Cycle 2||92
8743664|NCT01129531|9792021|FG002|COMPLETED|Treatment Cycle 2||74
8743665|NCT01129531|9792019|FG000|NOT COMPLETED|Treatment Cycle 2||6
8913106|NCT02158663|9972412|FG000|STARTED|Overall Study||22
8913107|NCT02158663|9972413|FG001|STARTED|Overall Study||22
8913108|NCT02158663|9972412|FG000|COMPLETED|Overall Study||17
8913109|NCT02158663|9972413|FG001|COMPLETED|Overall Study||18
8913110|NCT02158663|9972412|FG000|NOT COMPLETED|Overall Study||5
8913111|NCT02158663|9972413|FG001|NOT COMPLETED|Overall Study||4
8913112|NCT02158728|9972421|FG000|STARTED|Overall Study||80
8913113|NCT02158728|9972421|FG000|COMPLETED|Overall Study||53
8913114|NCT02158728|9972421|FG000|NOT COMPLETED|Overall Study||27
8913115|NCT02158806|9972427|FG000|STARTED|Overall Study||125
8913116|NCT02158806|9972428|FG001|STARTED|Overall Study||126
8913117|NCT02158806|9972427|FG000|COMPLETED|Overall Study|We had information on all participants for the primary outcome (time to complete healing).|121
8913118|NCT02158806|9972428|FG001|COMPLETED|Overall Study|We had information on all participants for the primary outcome (time to complete healing).|121
8913119|NCT02158806|9972427|FG000|NOT COMPLETED|Overall Study||4
8913120|NCT02158806|9972428|FG001|NOT COMPLETED|Overall Study||5
8913121|NCT02158884|9972434|FG000|STARTED|Baseline Assessment||91
8913122|NCT02158884|9972434|FG000|COMPLETED|Baseline Assessment||87
8913123|NCT02158884|9972434|FG000|NOT COMPLETED|Baseline Assessment||4
8913124|NCT02158884|9972434|FG000|STARTED|Intervention: IDEO and PT Program||87
8913125|NCT02158884|9972434|FG000|COMPLETED|Intervention: IDEO and PT Program||81
8913126|NCT02158884|9972434|FG000|NOT COMPLETED|Intervention: IDEO and PT Program||6
8913127|NCT02158884|9972434|FG000|STARTED|Post Intervention (~4 Weeks)||81
8913128|NCT02158884|9972434|FG000|COMPLETED|Post Intervention (~4 Weeks)||71
8913129|NCT02158884|9972434|FG000|NOT COMPLETED|Post Intervention (~4 Weeks)||10
8913130|NCT02158884|9972434|FG000|STARTED|6 Month Assessment||81
8913131|NCT02158884|9972434|FG000|COMPLETED|6 Month Assessment||61
8913132|NCT02158884|9972434|FG000|NOT COMPLETED|6 Month Assessment||20
8913133|NCT02158884|9972434|FG000|STARTED|12 Month Assessment||81
8913134|NCT02158884|9972434|FG000|COMPLETED|12 Month Assessment||64
8913135|NCT02158884|9972434|FG000|NOT COMPLETED|12 Month Assessment||17
8913136|NCT02158936|9972441|FG000|STARTED|Overall Study||179
8913137|NCT02158936|9972442|FG001|STARTED|Overall Study||177
8913138|NCT02158936|9972441|FG000|Treated|Overall Study||177
8913139|NCT02158936|9972442|FG001|Treated|Overall Study||177
8913140|NCT02158936|9972441|FG000|Untreated|Overall Study||2
8913141|NCT02158936|9972442|FG001|Untreated|Overall Study||0
8913142|NCT02158936|9972441|FG000|COMPLETED|Overall Study||0
8913143|NCT02158936|9972442|FG001|COMPLETED|Overall Study||0
8913144|NCT02158936|9972441|FG000|NOT COMPLETED|Overall Study||179
9022734|NCT03131453|10085613|FG000|Patient Misrandomized|Overall Study||1
9022735|NCT03131453|10085614|FG001|Patient Misrandomized|Overall Study||0
9022736|NCT03131453|10085615|FG002|Patient Misrandomized|Overall Study||0
9022737|NCT03131453|10085613|FG000|COMPLETED|Overall Study||0
9022738|NCT03131453|10085614|FG001|COMPLETED|Overall Study||0
9022739|NCT03131453|10085615|FG002|COMPLETED|Overall Study||0
9022740|NCT03131453|10085613|FG000|NOT COMPLETED|Overall Study||456
9022741|NCT03131453|10085614|FG001|NOT COMPLETED|Overall Study||233
9022742|NCT03131453|10085615|FG002|NOT COMPLETED|Overall Study||456
8913145|NCT02158936|9972442|FG001|NOT COMPLETED|Overall Study||177
8913146|NCT02158949|9972450|FG000|STARTED|Overall Study||24
8913147|NCT02158949|9972451|FG001|STARTED|Overall Study||24
8913148|NCT02158949|9972450|FG000|COMPLETED|Overall Study||18
8913149|NCT02158949|9972451|FG001|COMPLETED|Overall Study||13
8913150|NCT02158949|9972450|FG000|NOT COMPLETED|Overall Study||6
8913151|NCT02158949|9972451|FG001|NOT COMPLETED|Overall Study||11
8913152|NCT02158975|9972457|FG000|STARTED|Overall Study||13
9022743|NCT03131479|10085628|FG000|STARTED|Overall Study||10
9022744|NCT03131479|10085629|FG001|STARTED|Overall Study||10
8743666|NCT01129531|9792020|FG001|NOT COMPLETED|Treatment Cycle 2||3
8743667|NCT01129531|9792021|FG002|NOT COMPLETED|Treatment Cycle 2||5
8743668|NCT01129557|9792036|FG000|STARTED|Overall Study||15
8743669|NCT01129557|9792037|FG001|STARTED|Overall Study||17
8743670|NCT01129557|9792038|FG002|STARTED|Overall Study||14
8743671|NCT01129557|9792036|FG000|COMPLETED|Overall Study||11
8743672|NCT01129557|9792037|FG001|COMPLETED|Overall Study||12
8743673|NCT01129557|9792038|FG002|COMPLETED|Overall Study||10
8743674|NCT01129557|9792036|FG000|NOT COMPLETED|Overall Study||4
8743675|NCT01129557|9792037|FG001|NOT COMPLETED|Overall Study||5
8743676|NCT01129557|9792038|FG002|NOT COMPLETED|Overall Study||4
8743677|NCT01129583|9792059|FG000|STARTED|Overall Study||9
8743678|NCT01129583|9792060|FG001|STARTED|Overall Study||9
8743679|NCT01129583|9792059|FG000|COMPLETED|Overall Study||6
8743680|NCT01129583|9792060|FG001|COMPLETED|Overall Study||7
8743681|NCT01129583|9792059|FG000|NOT COMPLETED|Overall Study||3
8743682|NCT01129583|9792060|FG001|NOT COMPLETED|Overall Study||2
8743683|NCT01129609|9792066|FG000|STARTED|Overall Study||20
8743684|NCT01129609|9792066|FG000|COMPLETED|Overall Study||18
8743685|NCT01129609|9792066|FG000|NOT COMPLETED|Overall Study||2
8743686|NCT01129622|9792070|FG000|STARTED|Overall Study||16
8743687|NCT01129622|9792070|FG000|COMPLETED|Overall Study||14
8743688|NCT01129622|9792070|FG000|NOT COMPLETED|Overall Study||2
8743689|NCT01129765|9792075|FG000|STARTED|Overall Study||30
8743690|NCT01129765|9792075|FG000|COMPLETED|Overall Study||30
8743691|NCT01129765|9792075|FG000|NOT COMPLETED|Overall Study||0
8743692|NCT01129778|9792079|FG000|STARTED|Overall Study||22
8743693|NCT01129778|9792079|FG000|COMPLETED|Overall Study||15
8743694|NCT01129778|9792079|FG000|NOT COMPLETED|Overall Study||7
8743695|NCT01129804|9792085|FG000|STARTED|Overall Study||96
8743696|NCT01129804|9792086|FG001|STARTED|Overall Study||97
8743697|NCT01129804|9792085|FG000|COMPLETED|Overall Study||64
8743698|NCT01129804|9792086|FG001|COMPLETED|Overall Study||66
8743699|NCT01129804|9792085|FG000|NOT COMPLETED|Overall Study||32
8743700|NCT01129804|9792086|FG001|NOT COMPLETED|Overall Study||31
8743701|NCT01129882|9792092|FG000|STARTED|Overall Study||709
8743702|NCT01129882|9792092|FG000|Received at Least 1 Dose of Study Drug|Overall Study||709
8743703|NCT01129882|9792092|FG000|COMPLETED|Overall Study||431
8743704|NCT01129882|9792092|FG000|NOT COMPLETED|Overall Study||278
8743705|NCT01129921|9792098|FG000|STARTED|Prior to Sham Cross-over, 6-12 Weeks||20
8743706|NCT01129921|9792099|FG001|STARTED|Prior to Sham Cross-over, 6-12 Weeks||20
8743707|NCT01129921|9792098|FG000|COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||20
8743708|NCT01129921|9792099|FG001|COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||20
8743709|NCT01129921|9792098|FG000|NOT COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||0
8743710|NCT01129921|9792099|FG001|NOT COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||0
8743711|NCT01129921|9792098|FG000|STARTED|After Sham Cross-over to Mild, One Year||20
8743712|NCT01129921|9792099|FG001|STARTED|After Sham Cross-over to Mild, One Year||20
8743713|NCT01129921|9792098|FG000|COMPLETED|After Sham Cross-over to Mild, One Year|All 20 completed Wk 6-12 Intent to Treat analysis. Eighteen reported Year 1 outcomes.|18
8743714|NCT01129921|9792099|FG001|COMPLETED|After Sham Cross-over to Mild, One Year|All 20 completed Wk 6-12 Intent to Treat analysis prior to x-over. After x-over 13 reported Year 1.|13
8743715|NCT01129921|9792098|FG000|NOT COMPLETED|After Sham Cross-over to Mild, One Year||2
8743716|NCT01129921|9792099|FG001|NOT COMPLETED|After Sham Cross-over to Mild, One Year||7
8743717|NCT01129960|9792113|FG000|STARTED|Overall Study||84
8743718|NCT01129960|9792114|FG001|STARTED|Overall Study||83
8743719|NCT01129960|9792115|FG002|STARTED|Overall Study||82
8743720|NCT01129960|9792116|FG003|STARTED|Overall Study||83
8743721|NCT01129960|9792113|FG000|Safety|Overall Study||84
8743722|NCT01129960|9792114|FG001|Safety|Overall Study||83
8743723|NCT01129960|9792115|FG002|Safety|Overall Study|One subject was randomized to placebo, but was dispensed in error with an ESL 800 mg kit at DB Visit|83
8743724|NCT01129960|9792116|FG003|Safety|Overall Study||82
8743725|NCT01129960|9792113|FG000|Intent-to-Treat|Overall Study||84
8743726|NCT01129960|9792114|FG001|Intent-to-Treat|Overall Study||83
8743727|NCT01129960|9792115|FG002|Intent-to-Treat|Overall Study||82
8743728|NCT01129960|9792116|FG003|Intent-to-Treat|Overall Study||83
8743729|NCT01129960|9792113|FG000|Per-Protocol|Overall Study||34
8743730|NCT01129960|9792114|FG001|Per-Protocol|Overall Study||52
8913153|NCT02158975|9972457|FG000|COMPLETED|Overall Study||12
8913154|NCT02158975|9972457|FG000|NOT COMPLETED|Overall Study||1
8913155|NCT02159053|9972465|FG000|STARTED|Overall Study||116
8913156|NCT02159053|9972466|FG001|STARTED|Overall Study||117
8913157|NCT02159053|9972467|FG002|STARTED|Overall Study||117
8913158|NCT02159053|9972465|FG000|Paticipants Week 16 Onwards|Overall Study||116
8913159|NCT02159053|9972466|FG001|Paticipants Week 16 Onwards|Overall Study||117
8913160|NCT02159053|9972467|FG002|Paticipants Week 16 Onwards|Overall Study||113
8913161|NCT02159053|9972465|FG000|COMPLETED|Overall Study||96
8913162|NCT02159053|9972466|FG001|COMPLETED|Overall Study||96
8913163|NCT02159053|9972467|FG002|COMPLETED|Overall Study||97
8913164|NCT02159053|9972465|FG000|NOT COMPLETED|Overall Study||20
8913165|NCT02159053|9972466|FG001|NOT COMPLETED|Overall Study||21
8743731|NCT01129960|9792115|FG002|Per-Protocol|Overall Study||49
8913166|NCT02159053|9972467|FG002|NOT COMPLETED|Overall Study||20
8913167|NCT02159079|9972479|FG000|STARTED|Overall Study||15
8913168|NCT02159079|9972480|FG001|STARTED|Overall Study||15
8913169|NCT02159079|9972479|FG000|COMPLETED|Overall Study||15
8913170|NCT02159079|9972480|FG001|COMPLETED|Overall Study||15
8743732|NCT01129960|9792116|FG003|Per-Protocol|Overall Study||55
8743733|NCT01129960|9792113|FG000|Full Analysis Set (FAS|Overall Study||71
8743734|NCT01129960|9792114|FG001|Full Analysis Set (FAS|Overall Study||67
8743735|NCT01129960|9792115|FG002|Full Analysis Set (FAS|Overall Study||68
8743736|NCT01129960|9792116|FG003|Full Analysis Set (FAS|Overall Study||71
8743737|NCT01129960|9792113|FG000|COMPLETED|Overall Study||54
8743738|NCT01129960|9792114|FG001|COMPLETED|Overall Study||61
8743739|NCT01129960|9792115|FG002|COMPLETED|Overall Study||56
8743740|NCT01129960|9792116|FG003|COMPLETED|Overall Study||70
8743741|NCT01129960|9792113|FG000|NOT COMPLETED|Overall Study||30
8743742|NCT01129960|9792114|FG001|NOT COMPLETED|Overall Study||22
8743743|NCT01129960|9792115|FG002|NOT COMPLETED|Overall Study||26
8743744|NCT01129960|9792116|FG003|NOT COMPLETED|Overall Study||13
8743745|NCT01130051|9792126|FG000|STARTED|Period 1||8
8743746|NCT01130051|9792127|FG001|STARTED|Period 1||8
8743747|NCT01130051|9792126|FG000|COMPLETED|Period 1||8
8743748|NCT01130051|9792127|FG001|COMPLETED|Period 1||8
8743749|NCT01130051|9792126|FG000|NOT COMPLETED|Period 1||0
8743750|NCT01130051|9792127|FG001|NOT COMPLETED|Period 1||0
8743751|NCT01130051|9792126|FG000|STARTED|Washout Period of 14 Days||8
8743752|NCT01130051|9792127|FG001|STARTED|Washout Period of 14 Days||8
8743753|NCT01130051|9792126|FG000|COMPLETED|Washout Period of 14 Days||7
8743754|NCT01130051|9792127|FG001|COMPLETED|Washout Period of 14 Days||6
8743755|NCT01130051|9792126|FG000|NOT COMPLETED|Washout Period of 14 Days||1
8743756|NCT01130051|9792127|FG001|NOT COMPLETED|Washout Period of 14 Days||2
8743757|NCT01130051|9792126|FG000|STARTED|Period 2||7
8743758|NCT01130051|9792127|FG001|STARTED|Period 2||6
8743759|NCT01130051|9792126|FG000|COMPLETED|Period 2||7
8743760|NCT01130051|9792127|FG001|COMPLETED|Period 2||6
8743761|NCT01130051|9792126|FG000|NOT COMPLETED|Period 2||0
8743762|NCT01130051|9792127|FG001|NOT COMPLETED|Period 2||0
8743763|NCT01130103|9792135|FG000|STARTED|Randomized Treatment||19
8743764|NCT01130103|9792136|FG001|STARTED|Randomized Treatment||18
8743765|NCT01130103|9792135|FG000|COMPLETED|Randomized Treatment||13
8743766|NCT01130103|9792136|FG001|COMPLETED|Randomized Treatment||13
8743767|NCT01130103|9792135|FG000|NOT COMPLETED|Randomized Treatment||6
8743768|NCT01130103|9792136|FG001|NOT COMPLETED|Randomized Treatment||5
8743769|NCT01130103|9792135|FG000|STARTED|Maintenance Treatment||13
8743770|NCT01130103|9792136|FG001|STARTED|Maintenance Treatment||13
8743771|NCT01130103|9792135|FG000|COMPLETED|Maintenance Treatment||11
8743772|NCT01130103|9792136|FG001|COMPLETED|Maintenance Treatment||11
8743773|NCT01130103|9792135|FG000|NOT COMPLETED|Maintenance Treatment||2
8743774|NCT01130103|9792136|FG001|NOT COMPLETED|Maintenance Treatment||2
8743775|NCT01130168|9792142|FG000|STARTED|Period 1||6
8743776|NCT01130168|9792143|FG001|STARTED|Period 1||7
8743777|NCT01130168|9792144|FG002|STARTED|Period 1||6
8743778|NCT01130168|9792145|FG003|STARTED|Period 1||8
8743779|NCT01130168|9792146|FG004|STARTED|Period 1||5
8743780|NCT01130168|9792147|FG005|STARTED|Period 1||6
8743781|NCT01130168|9792142|FG000|COMPLETED|Period 1||6
9022745|NCT03131479|10085630|FG002|STARTED|Overall Study||11
9022746|NCT03131479|10085631|FG003|STARTED|Overall Study||12
9022747|NCT03131479|10085632|FG004|STARTED|Overall Study||10
9022748|NCT03131479|10085628|FG000|Safety Analysis Set (SS)|Overall Study||10
8743782|NCT01130168|9792143|FG001|COMPLETED|Period 1||6
8743783|NCT01130168|9792144|FG002|COMPLETED|Period 1||5
8743784|NCT01130168|9792145|FG003|COMPLETED|Period 1||5
8743785|NCT01130168|9792146|FG004|COMPLETED|Period 1||5
8743786|NCT01130168|9792147|FG005|COMPLETED|Period 1||6
8743787|NCT01130168|9792142|FG000|NOT COMPLETED|Period 1||0
8743788|NCT01130168|9792143|FG001|NOT COMPLETED|Period 1||1
8743789|NCT01130168|9792144|FG002|NOT COMPLETED|Period 1||1
8743790|NCT01130168|9792145|FG003|NOT COMPLETED|Period 1||3
8743791|NCT01130168|9792146|FG004|NOT COMPLETED|Period 1||0
8743792|NCT01130168|9792147|FG005|NOT COMPLETED|Period 1||0
8743793|NCT01130168|9792142|FG000|STARTED|Period 2||6
8743794|NCT01130168|9792143|FG001|STARTED|Period 2||6
8743795|NCT01130168|9792144|FG002|STARTED|Period 2||5
8743796|NCT01130168|9792145|FG003|STARTED|Period 2||5
8743797|NCT01130168|9792146|FG004|STARTED|Period 2||5
8743798|NCT01130168|9792147|FG005|STARTED|Period 2||6
8743799|NCT01130168|9792142|FG000|COMPLETED|Period 2||6
8743800|NCT01130168|9792143|FG001|COMPLETED|Period 2||6
8743801|NCT01130168|9792144|FG002|COMPLETED|Period 2||5
8743802|NCT01130168|9792145|FG003|COMPLETED|Period 2||5
8743803|NCT01130168|9792146|FG004|COMPLETED|Period 2||5
8743804|NCT01130168|9792147|FG005|COMPLETED|Period 2||6
8743805|NCT01130168|9792142|FG000|NOT COMPLETED|Period 2||0
8743806|NCT01130168|9792143|FG001|NOT COMPLETED|Period 2||0
8743807|NCT01130168|9792144|FG002|NOT COMPLETED|Period 2||0
8743808|NCT01130168|9792145|FG003|NOT COMPLETED|Period 2||0
8743809|NCT01130168|9792146|FG004|NOT COMPLETED|Period 2||0
8743810|NCT01130168|9792147|FG005|NOT COMPLETED|Period 2||0
8743811|NCT01130168|9792142|FG000|STARTED|Period 3||6
8743812|NCT01130168|9792143|FG001|STARTED|Period 3||6
8743813|NCT01130168|9792144|FG002|STARTED|Period 3||5
8743814|NCT01130168|9792145|FG003|STARTED|Period 3||5
8743815|NCT01130168|9792146|FG004|STARTED|Period 3||5
8743816|NCT01130168|9792147|FG005|STARTED|Period 3||6
8743817|NCT01130168|9792142|FG000|COMPLETED|Period 3||6
8743818|NCT01130168|9792143|FG001|COMPLETED|Period 3||6
8743819|NCT01130168|9792144|FG002|COMPLETED|Period 3||5
8743820|NCT01130168|9792145|FG003|COMPLETED|Period 3||5
8743821|NCT01130168|9792146|FG004|COMPLETED|Period 3||5
8743822|NCT01130168|9792147|FG005|COMPLETED|Period 3||6
9022749|NCT03131479|10085629|FG001|Safety Analysis Set (SS)|Overall Study||10
8743823|NCT01130168|9792142|FG000|NOT COMPLETED|Period 3||0
8743824|NCT01130168|9792143|FG001|NOT COMPLETED|Period 3||0
8743825|NCT01130168|9792144|FG002|NOT COMPLETED|Period 3||0
8743826|NCT01130168|9792145|FG003|NOT COMPLETED|Period 3||0
8743827|NCT01130168|9792146|FG004|NOT COMPLETED|Period 3||0
8743828|NCT01130168|9792147|FG005|NOT COMPLETED|Period 3||0
8743829|NCT01130272|9792161|FG000|STARTED|Overall Study||107
8743830|NCT01130272|9792162|FG001|STARTED|Overall Study||173
8743831|NCT01130272|9792163|FG002|STARTED|Overall Study||169
8743832|NCT01130272|9792164|FG003|STARTED|Overall Study||171
8743833|NCT01130272|9792165|FG004|STARTED|Overall Study||169
8743834|NCT01130272|9792161|FG000|Safety Analysis Set: as Randomized|Overall Study||105
8743835|NCT01130272|9792162|FG001|Safety Analysis Set: as Randomized|Overall Study||171
8743836|NCT01130272|9792163|FG002|Safety Analysis Set: as Randomized|Overall Study||166
8743837|NCT01130272|9792164|FG003|Safety Analysis Set: as Randomized|Overall Study||167
8743838|NCT01130272|9792165|FG004|Safety Analysis Set: as Randomized|Overall Study||162
8743839|NCT01130272|9792161|FG000|Safety Analysis Set: Highest Dose Level|Overall Study|105 total represents 1 patient in from Placebo arm; 1 patient out to 200 mg arm.|105
8743840|NCT01130272|9792162|FG001|Safety Analysis Set: Highest Dose Level|Overall Study|170 total represents 2 patients in from Placebo arm; 3 patients out to 200 mg arm.|170
8743841|NCT01130272|9792163|FG002|Safety Analysis Set: Highest Dose Level|Overall Study|165 total represents 1 patient out to 200 mg arm.|165
8743842|NCT01130272|9792164|FG003|Safety Analysis Set: Highest Dose Level|Overall Study|172 total represents 1 patient in from 5 mg; 3 patients in from 25 mg;1 patient in from 100 mg arms.|172
8743843|NCT01130272|9792165|FG004|Safety Analysis Set: Highest Dose Level|Overall Study|159 total represents 2 patients out to 25 mg arm; 1 patient out to 5 mg arm.|159
8743844|NCT01130272|9792161|FG000|COMPLETED|Overall Study||48
8743845|NCT01130272|9792162|FG001|COMPLETED|Overall Study||131
8743846|NCT01130272|9792163|FG002|COMPLETED|Overall Study||121
8743847|NCT01130272|9792164|FG003|COMPLETED|Overall Study||103
8743848|NCT01130272|9792165|FG004|COMPLETED|Overall Study||117
8743849|NCT01130272|9792161|FG000|NOT COMPLETED|Overall Study||59
8743850|NCT01130272|9792162|FG001|NOT COMPLETED|Overall Study||42
8743851|NCT01130272|9792163|FG002|NOT COMPLETED|Overall Study||48
8743852|NCT01130272|9792164|FG003|NOT COMPLETED|Overall Study||68
8743853|NCT01130272|9792165|FG004|NOT COMPLETED|Overall Study||52
8743854|NCT01130337|9792177|FG000|STARTED|Overall Study||36
8743855|NCT01130337|9792177|FG000|COMPLETED|Overall Study||22
8743856|NCT01130337|9792177|FG000|NOT COMPLETED|Overall Study||14
8743857|NCT01130493|9792181|FG000|STARTED|Open-label Dose Conversion to IPX066|During the open-label dose conversion to IPX066, all subjects received IPX066|110
8743858|NCT01130493|9792182|FG001|STARTED|Open-label Dose Conversion to IPX066||0
8743859|NCT01130493|9792183|FG002|STARTED|Open-label Dose Conversion to IPX066||0
8743860|NCT01130493|9792181|FG000|COMPLETED|Open-label Dose Conversion to IPX066||91
8743861|NCT01130493|9792182|FG001|COMPLETED|Open-label Dose Conversion to IPX066||0
8743862|NCT01130493|9792183|FG002|COMPLETED|Open-label Dose Conversion to IPX066||0
8743863|NCT01130493|9792181|FG000|NOT COMPLETED|Open-label Dose Conversion to IPX066||19
8743864|NCT01130493|9792182|FG001|NOT COMPLETED|Open-label Dose Conversion to IPX066||0
8743865|NCT01130493|9792183|FG002|NOT COMPLETED|Open-label Dose Conversion to IPX066||0
8743866|NCT01130493|9792181|FG000|STARTED|Part 1: Double-blind Treatment Period 1|91 subjects completed IPX066 dose conversion and were then randomized to the two treatment sequences|0
8913171|NCT02159079|9972479|FG000|NOT COMPLETED|Overall Study||0
8913172|NCT02159079|9972480|FG001|NOT COMPLETED|Overall Study||0
8913173|NCT02159118|9972488|FG000|STARTED|Overall Study||22
8913174|NCT02159118|9972489|FG001|STARTED|Overall Study||22
8913175|NCT02159118|9972488|FG000|COMPLETED|Overall Study||22
8913176|NCT02159118|9972489|FG001|COMPLETED|Overall Study||22
8913177|NCT02159118|9972488|FG000|NOT COMPLETED|Overall Study||0
8913178|NCT02159118|9972489|FG001|NOT COMPLETED|Overall Study||0
8913179|NCT02159183|9972497|FG000|STARTED|Analysis After the 36 Months Follow-up||22
8913180|NCT02159183|9972498|FG001|STARTED|Analysis After the 36 Months Follow-up||21
8913181|NCT02159183|9972497|FG000|COMPLETED|Analysis After the 36 Months Follow-up||19
8913182|NCT02159183|9972498|FG001|COMPLETED|Analysis After the 36 Months Follow-up||19
8913183|NCT02159183|9972497|FG000|NOT COMPLETED|Analysis After the 36 Months Follow-up||3
8913184|NCT02159183|9972498|FG001|NOT COMPLETED|Analysis After the 36 Months Follow-up||2
8913185|NCT02159183|9972497|FG000|STARTED|Analysis of Primary Endpoint (12 Mts)||22
8913186|NCT02159183|9972498|FG001|STARTED|Analysis of Primary Endpoint (12 Mts)||21
8913187|NCT02159183|9972497|FG000|COMPLETED|Analysis of Primary Endpoint (12 Mts)||19
8913188|NCT02159183|9972498|FG001|COMPLETED|Analysis of Primary Endpoint (12 Mts)||20
8913189|NCT02159183|9972497|FG000|NOT COMPLETED|Analysis of Primary Endpoint (12 Mts)||3
8913190|NCT02159183|9972498|FG001|NOT COMPLETED|Analysis of Primary Endpoint (12 Mts)||1
8913191|NCT02159352|9972506|FG000|STARTED|Overall Study||14
8913192|NCT02159352|9972507|FG001|STARTED|Overall Study||14
8913193|NCT02159352|9972506|FG000|Phase 1 (Day 1- 4)|Overall Study||14
8913194|NCT02159352|9972507|FG001|Phase 1 (Day 1- 4)|Overall Study||14
8913195|NCT02159352|9972506|FG000|Phase 2 (Day 5-14)|Overall Study||11
8913196|NCT02159352|9972507|FG001|Phase 2 (Day 5-14)|Overall Study||12
8913197|NCT02159352|9972506|FG000|COMPLETED|Overall Study||11
8913198|NCT02159352|9972507|FG001|COMPLETED|Overall Study||12
8913199|NCT02159352|9972506|FG000|NOT COMPLETED|Overall Study||3
8913200|NCT02159352|9972507|FG001|NOT COMPLETED|Overall Study||2
8913201|NCT02159365|9972532|FG000|STARTED|Overall Study||70
8913202|NCT02159365|9972532|FG000|COMPLETED|Overall Study|Completed = Still on treatment|0
8913203|NCT02159365|9972532|FG000|NOT COMPLETED|Overall Study||70
8743867|NCT01130493|9792182|FG001|STARTED|Part 1: Double-blind Treatment Period 1|48 were randomized to IPX066-CLE double-blind treatment sequence|48
8743868|NCT01130493|9792183|FG002|STARTED|Part 1: Double-blind Treatment Period 1|43 were randomized to CLE-IPX066 double-blind treatment sequence|43
8743869|NCT01130493|9792181|FG000|COMPLETED|Part 1: Double-blind Treatment Period 1||0
8743870|NCT01130493|9792182|FG001|COMPLETED|Part 1: Double-blind Treatment Period 1||46
8743871|NCT01130493|9792183|FG002|COMPLETED|Part 1: Double-blind Treatment Period 1||43
8743872|NCT01130493|9792181|FG000|NOT COMPLETED|Part 1: Double-blind Treatment Period 1||0
8743873|NCT01130493|9792182|FG001|NOT COMPLETED|Part 1: Double-blind Treatment Period 1||2
8743874|NCT01130493|9792183|FG002|NOT COMPLETED|Part 1: Double-blind Treatment Period 1||0
8743875|NCT01130493|9792181|FG000|STARTED|Part 1: Open-Label IPX066 Washout||0
8743876|NCT01130493|9792182|FG001|STARTED|Part 1: Open-Label IPX066 Washout||46
8743877|NCT01130493|9792183|FG002|STARTED|Part 1: Open-Label IPX066 Washout||43
8743878|NCT01130493|9792181|FG000|COMPLETED|Part 1: Open-Label IPX066 Washout||0
8743879|NCT01130493|9792182|FG001|COMPLETED|Part 1: Open-Label IPX066 Washout||45
8743880|NCT01130493|9792183|FG002|COMPLETED|Part 1: Open-Label IPX066 Washout||41
8743881|NCT01130493|9792181|FG000|NOT COMPLETED|Part 1: Open-Label IPX066 Washout||0
8743882|NCT01130493|9792182|FG001|NOT COMPLETED|Part 1: Open-Label IPX066 Washout||1
8743883|NCT01130493|9792183|FG002|NOT COMPLETED|Part 1: Open-Label IPX066 Washout||2
8743884|NCT01130493|9792181|FG000|STARTED|Part 1: Double-blind Treatment Period 2||0
8743885|NCT01130493|9792182|FG001|STARTED|Part 1: Double-blind Treatment Period 2||45
8743886|NCT01130493|9792183|FG002|STARTED|Part 1: Double-blind Treatment Period 2||41
8743887|NCT01130493|9792181|FG000|COMPLETED|Part 1: Double-blind Treatment Period 2||0
8743888|NCT01130493|9792182|FG001|COMPLETED|Part 1: Double-blind Treatment Period 2||45
8743889|NCT01130493|9792183|FG002|COMPLETED|Part 1: Double-blind Treatment Period 2||39
8743890|NCT01130493|9792181|FG000|NOT COMPLETED|Part 1: Double-blind Treatment Period 2||0
8743891|NCT01130493|9792182|FG001|NOT COMPLETED|Part 1: Double-blind Treatment Period 2||0
8743892|NCT01130493|9792183|FG002|NOT COMPLETED|Part 1: Double-blind Treatment Period 2||2
8743893|NCT01130493|9792181|FG000|STARTED|Part 2: OLE||0
8743894|NCT01130493|9792182|FG001|STARTED|Part 2: OLE|All subjects received IPX066 during OLE|39
8743895|NCT01130493|9792183|FG002|STARTED|Part 2: OLE|No subjects received CLE during OLE|35
8743896|NCT01130493|9792181|FG000|COMPLETED|Part 2: OLE||0
8743897|NCT01130493|9792182|FG001|COMPLETED|Part 2: OLE||36
8743898|NCT01130493|9792183|FG002|COMPLETED|Part 2: OLE||30
8743899|NCT01130493|9792181|FG000|NOT COMPLETED|Part 2: OLE||0
8743900|NCT01130493|9792182|FG001|NOT COMPLETED|Part 2: OLE||3
8743901|NCT01130493|9792183|FG002|NOT COMPLETED|Part 2: OLE||5
8743902|NCT01130532|9792197|FG000|STARTED|Period III (Weeks 0-12)||207
8743903|NCT01130532|9792198|FG001|STARTED|Period III (Weeks 0-12)||207
8743904|NCT01130532|9792199|FG002|STARTED|Period III (Weeks 0-12)||209
8743905|NCT01130532|9792200|FG003|STARTED|Period III (Weeks 0-12)||0
8743906|NCT01130532|9792197|FG000|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||205
8743907|NCT01130532|9792198|FG001|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||205
8743908|NCT01130532|9792199|FG002|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||207
8743909|NCT01130532|9792200|FG003|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||0
8743910|NCT01130532|9792197|FG000|COMPLETED|Period III (Weeks 0-12)||186
8743911|NCT01130532|9792198|FG001|COMPLETED|Period III (Weeks 0-12)||189
8743912|NCT01130532|9792199|FG002|COMPLETED|Period III (Weeks 0-12)||190
8743913|NCT01130532|9792200|FG003|COMPLETED|Period III (Weeks 0-12)||0
8743914|NCT01130532|9792197|FG000|NOT COMPLETED|Period III (Weeks 0-12)||21
8743915|NCT01130532|9792198|FG001|NOT COMPLETED|Period III (Weeks 0-12)||18
8743916|NCT01130532|9792199|FG002|NOT COMPLETED|Period III (Weeks 0-12)||19
8743917|NCT01130532|9792200|FG003|NOT COMPLETED|Period III (Weeks 0-12)||0
8743918|NCT01130532|9792197|FG000|STARTED|Period IV (Weeks 13-16)||0
8743919|NCT01130532|9792198|FG001|STARTED|Period IV (Weeks 13-16)||0
8743920|NCT01130532|9792199|FG002|STARTED|Period IV (Weeks 13-16)||0
8743921|NCT01130532|9792200|FG003|STARTED|Period IV (Weeks 13-16)|Three participants who completed Period III chose not to continue into Period IV.|562
8743922|NCT01130532|9792197|FG000|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||0
8743923|NCT01130532|9792198|FG001|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||0
8743924|NCT01130532|9792199|FG002|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||0
8743925|NCT01130532|9792200|FG003|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||546
8743926|NCT01130532|9792197|FG000|COMPLETED|Period IV (Weeks 13-16)||0
8743927|NCT01130532|9792198|FG001|COMPLETED|Period IV (Weeks 13-16)||0
8743928|NCT01130532|9792199|FG002|COMPLETED|Period IV (Weeks 13-16)||0
8743929|NCT01130532|9792200|FG003|COMPLETED|Period IV (Weeks 13-16)||552
8743930|NCT01130532|9792197|FG000|NOT COMPLETED|Period IV (Weeks 13-16)||0
8743931|NCT01130532|9792198|FG001|NOT COMPLETED|Period IV (Weeks 13-16)||0
8743932|NCT01130532|9792199|FG002|NOT COMPLETED|Period IV (Weeks 13-16)||0
8743933|NCT01130532|9792200|FG003|NOT COMPLETED|Period IV (Weeks 13-16)||10
8743934|NCT01130597|9792212|FG000|STARTED|Overall Study||63
8743935|NCT01130597|9792212|FG000|COMPLETED|Overall Study||56
8743936|NCT01130597|9792212|FG000|NOT COMPLETED|Overall Study||7
8743937|NCT01130740|9792218|FG000|STARTED|Overall Study||149
8743938|NCT01130740|9792219|FG001|STARTED|Overall Study||151
8743939|NCT01130740|9792218|FG000|COMPLETED|Overall Study||137
8743940|NCT01130740|9792219|FG001|COMPLETED|Overall Study||136
8743941|NCT01130740|9792218|FG000|NOT COMPLETED|Overall Study||12
8743942|NCT01130740|9792219|FG001|NOT COMPLETED|Overall Study||15
8743943|NCT01130831|9792225|FG000|STARTED|Overall Study||66
8743944|NCT01130831|9792225|FG000|COMPLETED|Overall Study||52
8743945|NCT01130831|9792225|FG000|NOT COMPLETED|Overall Study||14
8743946|NCT01130844|9792244|FG000|STARTED|Overall Study||21
8743947|NCT01130844|9792245|FG001|STARTED|Overall Study||22
8743948|NCT01130844|9792246|FG002|STARTED|Overall Study||9
8743949|NCT01130844|9792244|FG000|COMPLETED|Overall Study||21
8743950|NCT01130844|9792245|FG001|COMPLETED|Overall Study||22
8743951|NCT01130844|9792246|FG002|COMPLETED|Overall Study||9
8743952|NCT01130844|9792244|FG000|NOT COMPLETED|Overall Study||0
8743953|NCT01130844|9792245|FG001|NOT COMPLETED|Overall Study||0
8743954|NCT01130844|9792246|FG002|NOT COMPLETED|Overall Study||0
8743955|NCT01130883|9792257|FG000|STARTED|Overall Study||3130
8743956|NCT01130883|9792257|FG000|Participants Analyzed|Overall Study||3128
8743957|NCT01130883|9792257|FG000|COMPLETED|Overall Study||3120
8743958|NCT01130883|9792257|FG000|NOT COMPLETED|Overall Study||10
8743959|NCT01130896|9792261|FG000|STARTED|Overall Study||1509
8743960|NCT01130896|9792261|FG000|COMPLETED|Overall Study||1509
8743961|NCT01130896|9792261|FG000|NOT COMPLETED|Overall Study||0
8743962|NCT01130974|9792267|FG000|STARTED|Overall Study||100
8743963|NCT01130974|9792268|FG001|STARTED|Overall Study||100
8743964|NCT01130974|9792267|FG000|COMPLETED|Overall Study||85
8743965|NCT01130974|9792268|FG001|COMPLETED|Overall Study||87
8743966|NCT01130974|9792267|FG000|NOT COMPLETED|Overall Study||15
8743967|NCT01130974|9792268|FG001|NOT COMPLETED|Overall Study||13
8743968|NCT01131052|9792277|FG000|STARTED|Overall Study||75
8743969|NCT01131052|9792278|FG001|STARTED|Overall Study||75
8913204|NCT02159469|9972536|FG000|STARTED|Overall Study||150
8670657|NCT00747474|9714102|FG011|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
8670658|NCT00747474|9714091|FG000|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
8670659|NCT00747474|9714092|FG001|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
8670660|NCT00747474|9714093|FG002|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
8670661|NCT00747474|9714094|FG003|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
8670662|NCT00747474|9714095|FG004|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
8670663|NCT00747474|9714096|FG005|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
8670664|NCT00747474|9714097|FG006|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
8913205|NCT02159469|9972536|FG000|Completed 12 Week|Overall Study||137
8913206|NCT02159469|9972536|FG000|COMPLETED|Overall Study||97
8913207|NCT02159469|9972536|FG000|NOT COMPLETED|Overall Study||53
8913208|NCT02159482|9972541|FG000|STARTED|Overall Study||11
8913209|NCT02159482|9972541|FG000|COMPLETED|Overall Study||6
8913210|NCT02159482|9972541|FG000|NOT COMPLETED|Overall Study||5
8670665|NCT00747474|9714098|FG007|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
8670666|NCT00747474|9714099|FG008|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
8670667|NCT00747474|9714100|FG009|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
8670668|NCT00747474|9714101|FG010|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
8670669|NCT00747474|9714102|FG011|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
8670670|NCT00747474|9714091|FG000|STARTED|Cohort 11 (50 mg/m^2) Period||0
8670671|NCT00747474|9714092|FG001|STARTED|Cohort 11 (50 mg/m^2) Period||0
8670672|NCT00747474|9714093|FG002|STARTED|Cohort 11 (50 mg/m^2) Period||0
8670673|NCT00747474|9714094|FG003|STARTED|Cohort 11 (50 mg/m^2) Period||0
8670674|NCT00747474|9714095|FG004|STARTED|Cohort 11 (50 mg/m^2) Period||0
8670675|NCT00747474|9714096|FG005|STARTED|Cohort 11 (50 mg/m^2) Period||0
8670676|NCT00747474|9714097|FG006|STARTED|Cohort 11 (50 mg/m^2) Period||0
8670677|NCT00747474|9714098|FG007|STARTED|Cohort 11 (50 mg/m^2) Period||0
8670678|NCT00747474|9714099|FG008|STARTED|Cohort 11 (50 mg/m^2) Period||0
8670679|NCT00747474|9714100|FG009|STARTED|Cohort 11 (50 mg/m^2) Period||0
8670680|NCT00747474|9714101|FG010|STARTED|Cohort 11 (50 mg/m^2) Period||5
8670681|NCT00747474|9714102|FG011|STARTED|Cohort 11 (50 mg/m^2) Period||0
8670682|NCT00747474|9714091|FG000|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
8670683|NCT00747474|9714092|FG001|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
8670684|NCT00747474|9714093|FG002|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
8670685|NCT00747474|9714094|FG003|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
8670686|NCT00747474|9714095|FG004|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
8670687|NCT00747474|9714096|FG005|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
8670688|NCT00747474|9714097|FG006|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
8670689|NCT00747474|9714098|FG007|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
8670690|NCT00747474|9714099|FG008|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
8670691|NCT00747474|9714100|FG009|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
8670692|NCT00747474|9714101|FG010|COMPLETED|Cohort 11 (50 mg/m^2) Period||5
8670693|NCT00747474|9714102|FG011|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
8670694|NCT00747474|9714091|FG000|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
8670695|NCT00747474|9714092|FG001|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
8670696|NCT00747474|9714093|FG002|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
8670697|NCT00747474|9714094|FG003|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
8670698|NCT00747474|9714095|FG004|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
8670699|NCT00747474|9714096|FG005|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
8670700|NCT00747474|9714097|FG006|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
8670701|NCT00747474|9714098|FG007|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
8670702|NCT00747474|9714099|FG008|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
8670703|NCT00747474|9714100|FG009|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
8670704|NCT00747474|9714101|FG010|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
8670705|NCT00747474|9714102|FG011|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
8743970|NCT01131052|9792277|FG000|COMPLETED|Overall Study||75
8743971|NCT01131052|9792278|FG001|COMPLETED|Overall Study||75
8743972|NCT01131052|9792277|FG000|NOT COMPLETED|Overall Study||0
8743973|NCT01131052|9792278|FG001|NOT COMPLETED|Overall Study||0
8743974|NCT01131065|9792284|FG000|STARTED|Overall Study||15
8743975|NCT01131065|9792284|FG000|COMPLETED|Overall Study||15
8743976|NCT01131065|9792284|FG000|NOT COMPLETED|Overall Study||0
8743977|NCT01131078|9792291|FG000|STARTED|Overall Study||101
8743978|NCT01131078|9792292|FG001|STARTED|Overall Study||102
8743979|NCT01131078|9792293|FG002|STARTED|Overall Study||103
8743980|NCT01131078|9792291|FG000|COMPLETED|Overall Study||0
8743981|NCT01131078|9792292|FG001|COMPLETED|Overall Study||1
8743982|NCT01131078|9792293|FG002|COMPLETED|Overall Study||1
8743983|NCT01131078|9792291|FG000|NOT COMPLETED|Overall Study||101
8743984|NCT01131078|9792292|FG001|NOT COMPLETED|Overall Study||101
8743985|NCT01131078|9792293|FG002|NOT COMPLETED|Overall Study||102
8743986|NCT01131104|9792303|FG000|STARTED|Overall Study||345
8743987|NCT01131104|9792303|FG000|Study Set|Overall Study||344
8743988|NCT01131104|9792303|FG000|Adjudication-Confirmed NAION Set|Overall Study||279
8743989|NCT01131104|9792303|FG000|30-Day Analysis Set|Overall Study||24
8743990|NCT01131104|9792303|FG000|42-Day Analysis Set|Overall Study||28
8743991|NCT01131104|9792303|FG000|12-Month Analysis Set|Overall Study||26
8743992|NCT01131104|9792303|FG000|COMPLETED|Overall Study||332
8743993|NCT01131104|9792303|FG000|NOT COMPLETED|Overall Study||13
8743994|NCT01131130|9792307|FG000|STARTED|Period 1 - Baseline||118
8743995|NCT01131130|9792307|FG000|COMPLETED|Period 1 - Baseline|Participant was discontinued 1 day following dispensing and not reported in result tables|117
8743996|NCT01131130|9792307|FG000|NOT COMPLETED|Period 1 - Baseline||1
8743997|NCT01131130|9792307|FG000|STARTED|Period 2 - Crossover||117
8743998|NCT01131130|9792307|FG000|COMPLETED|Period 2 - Crossover||117
8743999|NCT01131130|9792307|FG000|NOT COMPLETED|Period 2 - Crossover||0
8744000|NCT01131130|9792307|FG000|STARTED|Period 3- Crossover||117
8744001|NCT01131130|9792307|FG000|COMPLETED|Period 3- Crossover||116
8744002|NCT01131130|9792307|FG000|NOT COMPLETED|Period 3- Crossover||1
8744003|NCT01131182|9792317|FG000|STARTED|Overall Study||529
8744004|NCT01131182|9792318|FG001|STARTED|Overall Study||537
8744005|NCT01131182|9792317|FG000|COMPLETED|Overall Study||513
8744006|NCT01131182|9792318|FG001|COMPLETED|Overall Study||521
8744007|NCT01131182|9792317|FG000|NOT COMPLETED|Overall Study||16
8744008|NCT01131182|9792318|FG001|NOT COMPLETED|Overall Study||16
8744009|NCT01131260|9792326|FG000|STARTED|Overall Study||5532
8744010|NCT01131260|9792327|FG001|STARTED|Overall Study||5576
8744011|NCT01131260|9792326|FG000|COMPLETED|Overall Study||5488
8744012|NCT01131260|9792327|FG001|COMPLETED|Overall Study||5529
8744013|NCT01131260|9792326|FG000|NOT COMPLETED|Overall Study||44
8744014|NCT01131260|9792327|FG001|NOT COMPLETED|Overall Study||47
8744015|NCT01131299|9792335|FG000|STARTED|Overall Study||42
8744016|NCT01131299|9792336|FG001|STARTED|Overall Study||44
8744017|NCT01131299|9792335|FG000|COMPLETED|Overall Study||38
8744018|NCT01131299|9792336|FG001|COMPLETED|Overall Study||37
8744019|NCT01131299|9792335|FG000|NOT COMPLETED|Overall Study||4
8744020|NCT01131299|9792336|FG001|NOT COMPLETED|Overall Study||7
8744021|NCT01131312|9792344|FG000|STARTED|Overall Study||1839
8744022|NCT01131312|9792345|FG001|STARTED|Overall Study||1385
8744023|NCT01131312|9792346|FG002|STARTED|Overall Study||1836
8744024|NCT01131312|9792344|FG000|COMPLETED|Overall Study||1414
8744025|NCT01131312|9792345|FG001|COMPLETED|Overall Study||1156
8744026|NCT01131312|9792346|FG002|COMPLETED|Overall Study||1485
8744027|NCT01131312|9792344|FG000|NOT COMPLETED|Overall Study||425
8913211|NCT02159521|9972545|FG000|STARTED|Overall Study|4 participants had both limbs treated.|81
8913212|NCT02159521|9972545|FG000|Received EkoSonic® Treatment|Overall Study||78
8913213|NCT02159521|9972545|FG000|COMPLETED|Overall Study||63
8913214|NCT02159521|9972545|FG000|NOT COMPLETED|Overall Study||18
8913215|NCT02159547|9972551|FG000|STARTED|Overall Study||112
8913216|NCT02159547|9972552|FG001|STARTED|Overall Study||112
8913217|NCT02159547|9972551|FG000|COMPLETED|Overall Study||112
8913218|NCT02159547|9972552|FG001|COMPLETED|Overall Study||112
8913219|NCT02159547|9972551|FG000|NOT COMPLETED|Overall Study||0
8913220|NCT02159547|9972552|FG001|NOT COMPLETED|Overall Study||0
8913221|NCT02159703|9972559|FG000|STARTED|Overall Study||60
8913222|NCT02159703|9972559|FG000|COMPLETED|Overall Study||60
8913223|NCT02159703|9972559|FG000|NOT COMPLETED|Overall Study||0
8913224|NCT02159729|9972565|FG000|STARTED|Overall Study||140
8913225|NCT02159729|9972566|FG001|STARTED|Overall Study||65
8913226|NCT02159729|9972565|FG000|COMPLETED|Overall Study||98
8913227|NCT02159729|9972566|FG001|COMPLETED|Overall Study||44
8913228|NCT02159729|9972565|FG000|NOT COMPLETED|Overall Study||42
8913229|NCT02159729|9972566|FG001|NOT COMPLETED|Overall Study||21
8913230|NCT02159768|9972572|FG000|STARTED|Overall Study|Started 16 July 2014|30
8913231|NCT02159768|9972572|FG000|COMPLETED|Overall Study|Completed 27 July 2015|30
8913232|NCT02159768|9972572|FG000|NOT COMPLETED|Overall Study||0
8744028|NCT01131312|9792345|FG001|NOT COMPLETED|Overall Study||229
8744029|NCT01131312|9792346|FG002|NOT COMPLETED|Overall Study||351
8744030|NCT01131325|9792354|FG000|STARTED|Overall Study||3
8744031|NCT01131325|9792354|FG000|COMPLETED|Overall Study||0
8744032|NCT01131325|9792354|FG000|NOT COMPLETED|Overall Study||3
8744033|NCT01131351|9792360|FG000|STARTED|Overall Study||5
8744034|NCT01131351|9792361|FG001|STARTED|Overall Study||5
8744035|NCT01131351|9792360|FG000|COMPLETED|Overall Study||5
8744036|NCT01131351|9792361|FG001|COMPLETED|Overall Study||2
8913233|NCT02159807|9972579|FG000|STARTED|Overall Study||67
8744037|NCT01131351|9792360|FG000|NOT COMPLETED|Overall Study||0
8744038|NCT01131351|9792361|FG001|NOT COMPLETED|Overall Study||3
8744039|NCT01131494|9792367|FG000|STARTED|Overall Study||17
8744040|NCT01131494|9792367|FG000|COMPLETED|Overall Study||15
8744041|NCT01131494|9792367|FG000|NOT COMPLETED|Overall Study||2
8744042|NCT01131507|9792372|FG000|STARTED|Overall Study||15
8744043|NCT01131507|9792372|FG000|COMPLETED|Overall Study||12
8744044|NCT01131507|9792372|FG000|NOT COMPLETED|Overall Study||3
8744045|NCT01131520|9792378|FG000|STARTED|Overall Study||180
8744046|NCT01131520|9792379|FG001|STARTED|Overall Study||180
8913234|NCT02159807|9972580|FG001|STARTED|Overall Study||52
8913235|NCT02159807|9972581|FG002|STARTED|Overall Study||51
8913236|NCT02159807|9972579|FG000|COMPLETED|Overall Study||66
8913237|NCT02159807|9972580|FG001|COMPLETED|Overall Study||51
8913238|NCT02159807|9972581|FG002|COMPLETED|Overall Study||48
8913239|NCT02159807|9972579|FG000|NOT COMPLETED|Overall Study||1
8744047|NCT01131520|9792378|FG000|COMPLETED|Overall Study||179
8744048|NCT01131520|9792379|FG001|COMPLETED|Overall Study||176
8744049|NCT01131520|9792378|FG000|NOT COMPLETED|Overall Study||1
8744050|NCT01131520|9792379|FG001|NOT COMPLETED|Overall Study||4
8744051|NCT01131585|9792387|FG000|STARTED|Overall Study||85
8744052|NCT01131585|9792388|FG001|STARTED|Overall Study||43
8744053|NCT01131585|9792387|FG000|COMPLETED|Overall Study||0
8744054|NCT01131585|9792388|FG001|COMPLETED|Overall Study||0
8744055|NCT01131585|9792387|FG000|NOT COMPLETED|Overall Study||85
8744056|NCT01131585|9792388|FG001|NOT COMPLETED|Overall Study||43
8744057|NCT01131676|9792397|FG000|STARTED|Discontinuation From Treatment|Randomised|2337
8744058|NCT01131676|9792398|FG001|STARTED|Discontinuation From Treatment|Randomised|2347
8744059|NCT01131676|9792399|FG002|STARTED|Discontinuation From Treatment|Randomised|2344
8744060|NCT01131676|9792397|FG000|COMPLETED|Discontinuation From Treatment|Not prematurely discontinued from trial medication|1650
8744061|NCT01131676|9792398|FG001|COMPLETED|Discontinuation From Treatment|Not prematurely discontinued from trial medication|1790
8744062|NCT01131676|9792399|FG002|COMPLETED|Discontinuation From Treatment|Not prematurely discontinued from trial medication|1800
8744063|NCT01131676|9792397|FG000|NOT COMPLETED|Discontinuation From Treatment||687
8744064|NCT01131676|9792398|FG001|NOT COMPLETED|Discontinuation From Treatment||557
8744065|NCT01131676|9792399|FG002|NOT COMPLETED|Discontinuation From Treatment||544
8744066|NCT01131676|9792397|FG000|STARTED|Discontinuation From Study (Treated Set)||2333
8744067|NCT01131676|9792398|FG001|STARTED|Discontinuation From Study (Treated Set)||2345
8744068|NCT01131676|9792399|FG002|STARTED|Discontinuation From Study (Treated Set)||2342
8744069|NCT01131676|9792397|FG000|Final Vital Status (VS) Available|Discontinuation From Study (Treated Set)||2316
8744070|NCT01131676|9792398|FG001|Final Vital Status (VS) Available|Discontinuation From Study (Treated Set)||2324
8744071|NCT01131676|9792399|FG002|Final Vital Status (VS) Available|Discontinuation From Study (Treated Set)||2327
8744072|NCT01131676|9792397|FG000|COMPLETED|Discontinuation From Study (Treated Set)|Completed the trial or died|2266
8744073|NCT01131676|9792398|FG001|COMPLETED|Discontinuation From Study (Treated Set)|Completed the trial or died|2264
8744074|NCT01131676|9792399|FG002|COMPLETED|Discontinuation From Study (Treated Set)|Completed the trial or died|2279
8744075|NCT01131676|9792397|FG000|NOT COMPLETED|Discontinuation From Study (Treated Set)||67
8744076|NCT01131676|9792398|FG001|NOT COMPLETED|Discontinuation From Study (Treated Set)||81
8744077|NCT01131676|9792399|FG002|NOT COMPLETED|Discontinuation From Study (Treated Set)||63
8744078|NCT01132118|9792410|FG000|STARTED|First Intervention (8 Weeks)||15
8744079|NCT01132118|9792411|FG001|STARTED|First Intervention (8 Weeks)||15
8744080|NCT01132118|9792410|FG000|COMPLETED|First Intervention (8 Weeks)||12
8744081|NCT01132118|9792411|FG001|COMPLETED|First Intervention (8 Weeks)||12
8744082|NCT01132118|9792410|FG000|NOT COMPLETED|First Intervention (8 Weeks)||3
8744083|NCT01132118|9792411|FG001|NOT COMPLETED|First Intervention (8 Weeks)||3
8744084|NCT01132118|9792410|FG000|STARTED|Second Intervention (8 Weeks)||12
8744085|NCT01132118|9792411|FG001|STARTED|Second Intervention (8 Weeks)||12
8744086|NCT01132118|9792410|FG000|COMPLETED|Second Intervention (8 Weeks)||12
8744087|NCT01132118|9792411|FG001|COMPLETED|Second Intervention (8 Weeks)||11
8744088|NCT01132118|9792410|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||0
8744089|NCT01132118|9792411|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||1
8744090|NCT01132144|9792419|FG000|STARTED|Overall Study||79
8744091|NCT01132144|9792420|FG001|STARTED|Overall Study||79
8744092|NCT01132144|9792419|FG000|COMPLETED|Overall Study||79
8744093|NCT01132144|9792420|FG001|COMPLETED|Overall Study||79
8744094|NCT01132144|9792419|FG000|NOT COMPLETED|Overall Study||0
8744095|NCT01132144|9792420|FG001|NOT COMPLETED|Overall Study||0
8744096|NCT01132313|9792440|FG000|STARTED|Overall Study||17
8744097|NCT01132313|9792441|FG001|STARTED|Overall Study||17
8744098|NCT01132313|9792442|FG002|STARTED|Overall Study||81
8744099|NCT01132313|9792443|FG003|STARTED|Overall Study||80
8744100|NCT01132313|9792444|FG004|STARTED|Overall Study||79
8744101|NCT01132313|9792445|FG005|STARTED|Overall Study||79
8744102|NCT01132313|9792446|FG006|STARTED|Overall Study||49
8744103|NCT01132313|9792447|FG007|STARTED|Overall Study||32
8744104|NCT01132313|9792448|FG008|STARTED|Overall Study||26
8744105|NCT01132313|9792449|FG009|STARTED|Overall Study||25
8744106|NCT01132313|9792450|FG010|STARTED|Overall Study||1
8744107|NCT01132313|9792451|FG011|STARTED|Overall Study||2
8744108|NCT01132313|9792440|FG000|COMPLETED|Overall Study||14
8744109|NCT01132313|9792441|FG001|COMPLETED|Overall Study||17
8744110|NCT01132313|9792442|FG002|COMPLETED|Overall Study||61
8744111|NCT01132313|9792443|FG003|COMPLETED|Overall Study||48
8913240|NCT02159807|9972580|FG001|NOT COMPLETED|Overall Study||1
8744112|NCT01132313|9792444|FG004|COMPLETED|Overall Study||34
8744113|NCT01132313|9792445|FG005|COMPLETED|Overall Study||54
8744114|NCT01132313|9792446|FG006|COMPLETED|Overall Study||19
8913241|NCT02159807|9972581|FG002|NOT COMPLETED|Overall Study||3
8913242|NCT02159859|9972589|FG000|STARTED|Overall Study||7
8913243|NCT02159859|9972589|FG000|COMPLETED|Overall Study||7
8913244|NCT02159859|9972589|FG000|NOT COMPLETED|Overall Study||0
8913245|NCT02159872|9972593|FG000|STARTED|Overall Study||48
8913246|NCT02159872|9972593|FG000|COMPLETED|Overall Study||48
8913247|NCT02159872|9972593|FG000|NOT COMPLETED|Overall Study||0
8913248|NCT02159898|9972599|FG000|STARTED|Overall Study||30
8913249|NCT02159898|9972600|FG001|STARTED|Overall Study||30
8913250|NCT02159898|9972599|FG000|COMPLETED|Overall Study||29
8913251|NCT02159898|9972600|FG001|COMPLETED|Overall Study||30
8913252|NCT02159898|9972599|FG000|NOT COMPLETED|Overall Study||1
8913253|NCT02159898|9972600|FG001|NOT COMPLETED|Overall Study||0
8913254|NCT02159950|9972610|FG000|STARTED|Overall Study||0
8913255|NCT02159950|9972611|FG001|STARTED|Overall Study||2
8913256|NCT02159950|9972610|FG000|COMPLETED|Overall Study||0
8913257|NCT02159950|9972611|FG001|COMPLETED|Overall Study||0
8913258|NCT02159950|9972610|FG000|NOT COMPLETED|Overall Study||0
8913259|NCT02159950|9972611|FG001|NOT COMPLETED|Overall Study||2
8913260|NCT02159976|9972619|FG000|STARTED|Overall Study||195
8913261|NCT02159976|9972620|FG001|STARTED|Overall Study||195
8913262|NCT02159976|9972619|FG000|COMPLETED|Overall Study||165
8913263|NCT02159976|9972620|FG001|COMPLETED|Overall Study||170
8913264|NCT02159976|9972619|FG000|NOT COMPLETED|Overall Study||30
8913265|NCT02159976|9972620|FG001|NOT COMPLETED|Overall Study||25
8913266|NCT02160002|9972630|FG000|STARTED|Overall Study||187
8913267|NCT02160002|9972631|FG001|STARTED|Overall Study||179
8913268|NCT02160002|9972630|FG000|Primary Outcome|Overall Study||185
8913269|NCT02160002|9972631|FG001|Primary Outcome|Overall Study||178
8913270|NCT02160002|9972630|FG000|COMPLETED|Overall Study||185
8913271|NCT02160002|9972631|FG001|COMPLETED|Overall Study||178
8913272|NCT02160002|9972630|FG000|NOT COMPLETED|Overall Study||2
8913273|NCT02160002|9972631|FG001|NOT COMPLETED|Overall Study||1
8913274|NCT02160041|9972637|FG000|STARTED|Overall Study||84
8913275|NCT02160041|9972637|FG000|COMPLETED|Overall Study||0
8913276|NCT02160041|9972637|FG000|NOT COMPLETED|Overall Study||84
8913277|NCT02160145|9972643|FG000|STARTED|Prerandomization Single-blind Period||1519
8913278|NCT02160145|9972644|FG001|STARTED|Prerandomization Single-blind Period||0
8913279|NCT02160145|9972645|FG002|STARTED|Prerandomization Single-blind Period||0
8913280|NCT02160145|9972643|FG000|Treated in Placebo Run-in|Prerandomization Single-blind Period||1514
8913281|NCT02160145|9972644|FG001|Treated in Placebo Run-in|Prerandomization Single-blind Period||0
8913282|NCT02160145|9972645|FG002|Treated in Placebo Run-in|Prerandomization Single-blind Period||0
8913283|NCT02160145|9972643|FG000|Treated in Tolvaptan Titration/Run-in|Prerandomization Single-blind Period||1491
8913284|NCT02160145|9972644|FG001|Treated in Tolvaptan Titration/Run-in|Prerandomization Single-blind Period||0
8913285|NCT02160145|9972645|FG002|Treated in Tolvaptan Titration/Run-in|Prerandomization Single-blind Period||0
8913286|NCT02160145|9972643|FG000|Randomized|Prerandomization Single-blind Period||1370
8913287|NCT02160145|9972644|FG001|Randomized|Prerandomization Single-blind Period||0
8913288|NCT02160145|9972645|FG002|Randomized|Prerandomization Single-blind Period||0
8913289|NCT02160145|9972643|FG000|COMPLETED|Prerandomization Single-blind Period||1370
8913290|NCT02160145|9972644|FG001|COMPLETED|Prerandomization Single-blind Period||0
8913291|NCT02160145|9972645|FG002|COMPLETED|Prerandomization Single-blind Period||0
8913292|NCT02160145|9972643|FG000|NOT COMPLETED|Prerandomization Single-blind Period||149
8913293|NCT02160145|9972644|FG001|NOT COMPLETED|Prerandomization Single-blind Period||0
8913294|NCT02160145|9972645|FG002|NOT COMPLETED|Prerandomization Single-blind Period||0
8913295|NCT02160145|9972643|FG000|STARTED|Randomized Double-blind Period|1370 subjects were randomized to receive tolvaptan or placebo in the double-blind period.|0
8913296|NCT02160145|9972644|FG001|STARTED|Randomized Double-blind Period|Subjects completed the single-blind period and were randomized to receive tolvaptan.|683
8913297|NCT02160145|9972645|FG002|STARTED|Randomized Double-blind Period|Subjects completed the single-blind period and were randomized to receive placebo.|687
8913298|NCT02160145|9972643|FG000|On-treatment Completers|Randomized Double-blind Period||0
8913299|NCT02160145|9972644|FG001|On-treatment Completers|Randomized Double-blind Period||578
8913300|NCT02160145|9972645|FG002|On-treatment Completers|Randomized Double-blind Period||637
8913301|NCT02160145|9972643|FG000|Off-treatment Completers|Randomized Double-blind Period||0
8913302|NCT02160145|9972644|FG001|Off-treatment Completers|Randomized Double-blind Period||76
8913303|NCT02160145|9972645|FG002|Off-treatment Completers|Randomized Double-blind Period||22
8913304|NCT02160145|9972643|FG000|COMPLETED|Randomized Double-blind Period||0
8913305|NCT02160145|9972644|FG001|COMPLETED|Randomized Double-blind Period||654
8913306|NCT02160145|9972645|FG002|COMPLETED|Randomized Double-blind Period||659
8913307|NCT02160145|9972643|FG000|NOT COMPLETED|Randomized Double-blind Period||0
9022750|NCT03131479|10085630|FG002|Safety Analysis Set (SS)|Overall Study||11
9022751|NCT03131479|10085631|FG003|Safety Analysis Set (SS)|Overall Study||12
8577607|NCT00159874|9610369|FG002|Treated|Overall Study||77
8913308|NCT02160145|9972644|FG001|NOT COMPLETED|Randomized Double-blind Period||29
8913309|NCT02160145|9972645|FG002|NOT COMPLETED|Randomized Double-blind Period||28
8913310|NCT02160288|9972654|FG000|STARTED|Overall Study||1
8913311|NCT02160288|9972655|FG001|STARTED|Overall Study||0
8913312|NCT02160288|9972654|FG000|COMPLETED|Overall Study||1
8913313|NCT02160288|9972655|FG001|COMPLETED|Overall Study||0
8913314|NCT02160288|9972654|FG000|NOT COMPLETED|Overall Study||0
8744115|NCT01132313|9792447|FG007|COMPLETED|Overall Study||24
8913315|NCT02160288|9972655|FG001|NOT COMPLETED|Overall Study||0
9022752|NCT03131479|10085632|FG004|Safety Analysis Set (SS)|Overall Study||10
9022753|NCT03131479|10085628|FG000|Pharmacokinetic Analysis Set (PAS)|Overall Study||10
9022754|NCT03131479|10085629|FG001|Pharmacokinetic Analysis Set (PAS)|Overall Study||10
9022755|NCT03131479|10085630|FG002|Pharmacokinetic Analysis Set (PAS)|Overall Study||11
9022756|NCT03131479|10085631|FG003|Pharmacokinetic Analysis Set (PAS)|Overall Study||12
9022757|NCT03131479|10085632|FG004|Pharmacokinetic Analysis Set (PAS)|Overall Study||10
9022758|NCT03131479|10085628|FG000|Pharcodynamic Analysis Set (PD)|Overall Study||10
9022759|NCT03131479|10085629|FG001|Pharcodynamic Analysis Set (PD)|Overall Study||10
9022760|NCT03131479|10085630|FG002|Pharcodynamic Analysis Set (PD)|Overall Study||11
9022761|NCT03131479|10085631|FG003|Pharcodynamic Analysis Set (PD)|Overall Study||12
9022762|NCT03131479|10085632|FG004|Pharcodynamic Analysis Set (PD)|Overall Study||10
9022763|NCT03131479|10085628|FG000|COMPLETED|Overall Study||10
9022764|NCT03131479|10085629|FG001|COMPLETED|Overall Study||10
9022765|NCT03131479|10085630|FG002|COMPLETED|Overall Study||10
9022766|NCT03131479|10085631|FG003|COMPLETED|Overall Study||10
9022767|NCT03131479|10085632|FG004|COMPLETED|Overall Study||10
9022768|NCT03131479|10085628|FG000|NOT COMPLETED|Overall Study||0
9022769|NCT03131479|10085629|FG001|NOT COMPLETED|Overall Study||0
9022770|NCT03131479|10085630|FG002|NOT COMPLETED|Overall Study||1
9022771|NCT03131479|10085631|FG003|NOT COMPLETED|Overall Study||2
9022772|NCT03131479|10085632|FG004|NOT COMPLETED|Overall Study||0
9022773|NCT03131570|10085646|FG000|STARTED|Overall Study||12
9022774|NCT03131570|10085647|FG001|STARTED|Overall Study||11
9022775|NCT03131570|10085646|FG000|COMPLETED|Overall Study||11
9022776|NCT03131570|10085647|FG001|COMPLETED|Overall Study||11
9022777|NCT03131570|10085646|FG000|NOT COMPLETED|Overall Study||1
9022778|NCT03131570|10085647|FG001|NOT COMPLETED|Overall Study||0
9022779|NCT03131596|10085655|FG000|STARTED|Overall Study||100
9022780|NCT03131596|10085656|FG001|STARTED|Overall Study||100
9022781|NCT03131596|10085655|FG000|COMPLETED|Overall Study||94
9022782|NCT03131596|10085656|FG001|COMPLETED|Overall Study||97
9022783|NCT03131596|10085655|FG000|NOT COMPLETED|Overall Study||6
9022784|NCT03131596|10085656|FG001|NOT COMPLETED|Overall Study||3
9022785|NCT03131648|10085664|FG000|STARTED|Initial Treatment Period||603
9022786|NCT03131648|10085665|FG001|STARTED|Initial Treatment Period||199
9022787|NCT03131648|10085666|FG002|STARTED|Initial Treatment Period||0
9022788|NCT03131648|10085667|FG003|STARTED|Initial Treatment Period||0
9022789|NCT03131648|10085668|FG004|STARTED|Initial Treatment Period||0
9022790|NCT03131648|10085669|FG005|STARTED|Initial Treatment Period||0
9022791|NCT03131648|10085670|FG006|STARTED|Initial Treatment Period||0
9022792|NCT03131648|10085671|FG007|STARTED|Initial Treatment Period||0
9022793|NCT03131648|10085664|FG000|COMPLETED|Initial Treatment Period||550
9022794|NCT03131648|10085665|FG001|COMPLETED|Initial Treatment Period||179
9022795|NCT03131648|10085666|FG002|COMPLETED|Initial Treatment Period||0
9022796|NCT03131648|10085667|FG003|COMPLETED|Initial Treatment Period||0
9022797|NCT03131648|10085668|FG004|COMPLETED|Initial Treatment Period||0
9022798|NCT03131648|10085669|FG005|COMPLETED|Initial Treatment Period||0
9022799|NCT03131648|10085670|FG006|COMPLETED|Initial Treatment Period||0
9022800|NCT03131648|10085671|FG007|COMPLETED|Initial Treatment Period||0
9022801|NCT03131648|10085664|FG000|NOT COMPLETED|Initial Treatment Period||53
9022802|NCT03131648|10085665|FG001|NOT COMPLETED|Initial Treatment Period||20
9022803|NCT03131648|10085666|FG002|NOT COMPLETED|Initial Treatment Period||0
9022804|NCT03131648|10085667|FG003|NOT COMPLETED|Initial Treatment Period||0
9022805|NCT03131648|10085668|FG004|NOT COMPLETED|Initial Treatment Period||0
9022806|NCT03131648|10085669|FG005|NOT COMPLETED|Initial Treatment Period||0
9022807|NCT03131648|10085670|FG006|NOT COMPLETED|Initial Treatment Period||0
9022808|NCT03131648|10085671|FG007|NOT COMPLETED|Initial Treatment Period||0
9022809|NCT03131648|10085664|FG000|STARTED|Open-label Treatment||0
9022810|NCT03131648|10085665|FG001|STARTED|Open-label Treatment||0
9022811|NCT03131648|10085666|FG002|STARTED|Open-label Treatment||0
9022812|NCT03131648|10085667|FG003|STARTED|Open-label Treatment||0
8744116|NCT01132313|9792448|FG008|COMPLETED|Overall Study||5
8744117|NCT01132313|9792449|FG009|COMPLETED|Overall Study||5
8744118|NCT01132313|9792450|FG010|COMPLETED|Overall Study||0
8744119|NCT01132313|9792451|FG011|COMPLETED|Overall Study||2
8744120|NCT01132313|9792440|FG000|NOT COMPLETED|Overall Study||3
8744121|NCT01132313|9792441|FG001|NOT COMPLETED|Overall Study||0
8744122|NCT01132313|9792442|FG002|NOT COMPLETED|Overall Study||20
8744123|NCT01132313|9792443|FG003|NOT COMPLETED|Overall Study||32
8744124|NCT01132313|9792444|FG004|NOT COMPLETED|Overall Study||45
8744125|NCT01132313|9792445|FG005|NOT COMPLETED|Overall Study||25
8744126|NCT01132313|9792446|FG006|NOT COMPLETED|Overall Study||30
8744127|NCT01132313|9792447|FG007|NOT COMPLETED|Overall Study||8
8744128|NCT01132313|9792448|FG008|NOT COMPLETED|Overall Study||21
8744129|NCT01132313|9792449|FG009|NOT COMPLETED|Overall Study||20
8744130|NCT01132313|9792450|FG010|NOT COMPLETED|Overall Study||1
8744131|NCT01132313|9792451|FG011|NOT COMPLETED|Overall Study||0
8744132|NCT01132326|9792482|FG000|STARTED|Overall Study||350
9022813|NCT03131648|10085668|FG004|STARTED|Open-label Treatment||0
9022814|NCT03131648|10085669|FG005|STARTED|Open-label Treatment||0
9022815|NCT03131648|10085670|FG006|STARTED|Open-label Treatment||564
9022816|NCT03131648|10085671|FG007|STARTED|Open-label Treatment||0
9022817|NCT03131648|10085664|FG000|COMPLETED|Open-label Treatment||0
9022818|NCT03131648|10085665|FG001|COMPLETED|Open-label Treatment||0
8744133|NCT01132326|9792482|FG000|COMPLETED|Overall Study||132
8744134|NCT01132326|9792482|FG000|NOT COMPLETED|Overall Study||218
8744135|NCT01132378|9792486|FG000|STARTED|Overall Study||40
8744136|NCT01132378|9792486|FG000|COMPLETED|Overall Study||40
8744137|NCT01132378|9792486|FG000|NOT COMPLETED|Overall Study||0
8744138|NCT01132482|9792493|FG000|STARTED|Overall Study||13
8744139|NCT01132482|9792494|FG001|STARTED|Overall Study||6
8744140|NCT01132482|9792493|FG000|COMPLETED|Overall Study||12
8744141|NCT01132482|9792494|FG001|COMPLETED|Overall Study||6
8744142|NCT01132482|9792493|FG000|NOT COMPLETED|Overall Study||1
8744143|NCT01132482|9792494|FG001|NOT COMPLETED|Overall Study||0
8744144|NCT01132495|9792504|FG000|STARTED|Overall Study||447
8744145|NCT01132495|9792505|FG001|STARTED|Overall Study||441
8744146|NCT01132495|9792506|FG002|STARTED|Overall Study||166
8744147|NCT01132495|9792507|FG003|STARTED|Overall Study||116
8744148|NCT01132495|9792504|FG000|COMPLETED|Overall Study||407
8744149|NCT01132495|9792505|FG001|COMPLETED|Overall Study||403
8744150|NCT01132495|9792506|FG002|COMPLETED|Overall Study||146
8744151|NCT01132495|9792507|FG003|COMPLETED|Overall Study||104
8744152|NCT01132495|9792504|FG000|NOT COMPLETED|Overall Study||40
8744153|NCT01132495|9792505|FG001|NOT COMPLETED|Overall Study||38
8744154|NCT01132495|9792506|FG002|NOT COMPLETED|Overall Study||20
8744155|NCT01132495|9792507|FG003|NOT COMPLETED|Overall Study||12
8744156|NCT01132508|9792518|FG000|STARTED|Overall Study||33
8744157|NCT01132508|9792518|FG000|Treated at Baseline|Overall Study||33
8744158|NCT01132508|9792518|FG000|6 Weeks|Overall Study||33
8744159|NCT01132508|9792518|FG000|12 Weeks|Overall Study||33
8744160|NCT01132508|9792518|FG000|26 Weeks|Overall Study||33
8744161|NCT01132508|9792518|FG000|52 Weeks|Overall Study||30
8744162|NCT01132508|9792518|FG000|78 Weeks|Overall Study||28
8744163|NCT01132508|9792518|FG000|104 Weeks|Overall Study||27
8744164|NCT01132508|9792518|FG000|COMPLETED|Overall Study||24
8744165|NCT01132508|9792518|FG000|NOT COMPLETED|Overall Study||9
8744166|NCT01132547|9792524|FG000|STARTED|Overall Study||9
8744167|NCT01132547|9792525|FG001|STARTED|Overall Study||13
8744168|NCT01132547|9792524|FG000|COMPLETED|Overall Study||5
8744169|NCT01132547|9792525|FG001|COMPLETED|Overall Study||12
8744170|NCT01132547|9792524|FG000|NOT COMPLETED|Overall Study||4
8744171|NCT01132547|9792525|FG001|NOT COMPLETED|Overall Study||1
8744172|NCT01132612|9792534|FG000|STARTED|Overall Study||46
8744173|NCT01132612|9792535|FG001|STARTED|Overall Study||42
8744174|NCT01132612|9792536|FG002|STARTED|Overall Study||187
8744175|NCT01132612|9792534|FG000|COMPLETED|Overall Study||6
8744176|NCT01132612|9792535|FG001|COMPLETED|Overall Study||7
8744177|NCT01132612|9792536|FG002|COMPLETED|Overall Study||17
8744178|NCT01132612|9792534|FG000|NOT COMPLETED|Overall Study||40
8744179|NCT01132612|9792535|FG001|NOT COMPLETED|Overall Study||35
8744180|NCT01132612|9792536|FG002|NOT COMPLETED|Overall Study||170
8744181|NCT01132651|9792546|FG000|STARTED|Overall Study||4
8744182|NCT01132651|9792547|FG001|STARTED|Overall Study||5
8744183|NCT01132651|9792546|FG000|COMPLETED|Overall Study||3
8744184|NCT01132651|9792547|FG001|COMPLETED|Overall Study||4
8744185|NCT01132651|9792546|FG000|NOT COMPLETED|Overall Study||1
8744186|NCT01132651|9792547|FG001|NOT COMPLETED|Overall Study||1
8744187|NCT01132664|9792558|FG000|STARTED|Phase lb||5
8744188|NCT01132664|9792559|FG001|STARTED|Phase lb||12
8744189|NCT01132664|9792560|FG002|STARTED|Phase lb||0
8744190|NCT01132664|9792561|FG003|STARTED|Phase lb||0
8744191|NCT01132664|9792562|FG004|STARTED|Phase lb||0
8744192|NCT01132664|9792558|FG000|COMPLETED|Phase lb||0
8744193|NCT01132664|9792559|FG001|COMPLETED|Phase lb||0
8744194|NCT01132664|9792560|FG002|COMPLETED|Phase lb||0
8744195|NCT01132664|9792561|FG003|COMPLETED|Phase lb||0
8744196|NCT01132664|9792562|FG004|COMPLETED|Phase lb||0
8744197|NCT01132664|9792558|FG000|NOT COMPLETED|Phase lb||5
8744198|NCT01132664|9792559|FG001|NOT COMPLETED|Phase lb||12
8744199|NCT01132664|9792560|FG002|NOT COMPLETED|Phase lb||0
8913316|NCT02160314|9972663|FG000|STARTED|Overall Study||73
8913317|NCT02160314|9972664|FG001|STARTED|Overall Study||72
8913318|NCT02160314|9972663|FG000|COMPLETED|Overall Study||72
8913319|NCT02160314|9972664|FG001|COMPLETED|Overall Study||59
8913320|NCT02160314|9972663|FG000|NOT COMPLETED|Overall Study||1
8913321|NCT02160314|9972664|FG001|NOT COMPLETED|Overall Study||13
8913322|NCT02160535|9972670|FG000|STARTED|Overall Study||13
8913323|NCT02160535|9972670|FG000|COMPLETED|Overall Study||10
9022819|NCT03131648|10085666|FG002|COMPLETED|Open-label Treatment||0
9022820|NCT03131648|10085667|FG003|COMPLETED|Open-label Treatment||0
8744200|NCT01132664|9792561|FG003|NOT COMPLETED|Phase lb||0
8744201|NCT01132664|9792562|FG004|NOT COMPLETED|Phase lb||0
8744202|NCT01132664|9792558|FG000|STARTED|Phase ll||0
8744203|NCT01132664|9792559|FG001|STARTED|Phase ll||0
8744204|NCT01132664|9792560|FG002|STARTED|Phase ll|Of the 50 patients, 8 were from phase lb & were eligible for inclusion in Phase II|50
8744205|NCT01132664|9792561|FG003|STARTED|Phase ll||0
8744206|NCT01132664|9792562|FG004|STARTED|Phase ll||0
8913324|NCT02160535|9972670|FG000|NOT COMPLETED|Overall Study||3
8744207|NCT01132664|9792558|FG000|COMPLETED|Phase ll||0
8744208|NCT01132664|9792559|FG001|COMPLETED|Phase ll||0
8744209|NCT01132664|9792560|FG002|COMPLETED|Phase ll||0
8744210|NCT01132664|9792561|FG003|COMPLETED|Phase ll||0
8913325|NCT02160626|9972677|FG000|STARTED|Overall Study||58
8744211|NCT01132664|9792562|FG004|COMPLETED|Phase ll||0
8744212|NCT01132664|9792558|FG000|NOT COMPLETED|Phase ll||0
8744213|NCT01132664|9792559|FG001|NOT COMPLETED|Phase ll||0
8913326|NCT02160626|9972678|FG001|STARTED|Overall Study||57
8744214|NCT01132664|9792560|FG002|NOT COMPLETED|Phase ll||50
8744215|NCT01132664|9792561|FG003|NOT COMPLETED|Phase ll||0
8744216|NCT01132664|9792562|FG004|NOT COMPLETED|Phase ll||0
8744217|NCT01132664|9792558|FG000|STARTED|BM Cohort||0
8744218|NCT01132664|9792559|FG001|STARTED|BM Cohort||0
8744219|NCT01132664|9792560|FG002|STARTED|BM Cohort||0
8744220|NCT01132664|9792561|FG003|STARTED|BM Cohort||3
8744221|NCT01132664|9792562|FG004|STARTED|BM Cohort||6
8744222|NCT01132664|9792558|FG000|COMPLETED|BM Cohort||0
8744223|NCT01132664|9792559|FG001|COMPLETED|BM Cohort||0
8744224|NCT01132664|9792560|FG002|COMPLETED|BM Cohort||0
8744225|NCT01132664|9792561|FG003|COMPLETED|BM Cohort||0
8744226|NCT01132664|9792562|FG004|COMPLETED|BM Cohort||0
8744227|NCT01132664|9792558|FG000|NOT COMPLETED|BM Cohort||0
8744228|NCT01132664|9792559|FG001|NOT COMPLETED|BM Cohort||0
8744229|NCT01132664|9792560|FG002|NOT COMPLETED|BM Cohort||0
8744230|NCT01132664|9792561|FG003|NOT COMPLETED|BM Cohort||3
8744231|NCT01132664|9792562|FG004|NOT COMPLETED|BM Cohort||6
8744232|NCT01132690|9792576|FG000|STARTED|Overall Study||6
8744233|NCT01132690|9792577|FG001|STARTED|Overall Study||5
8744234|NCT01132690|9792576|FG000|COMPLETED|Overall Study||6
8744235|NCT01132690|9792577|FG001|COMPLETED|Overall Study||5
8744236|NCT01132690|9792576|FG000|NOT COMPLETED|Overall Study||0
8744237|NCT01132690|9792577|FG001|NOT COMPLETED|Overall Study||0
8744238|NCT01132755|9792583|FG000|STARTED|Overall Study||112
8744239|NCT01132755|9792583|FG000|COMPLETED|Overall Study||70
8744240|NCT01132755|9792583|FG000|NOT COMPLETED|Overall Study||42
8744241|NCT01132807|9792587|FG000|STARTED|Initial ABVD Treatment (2 Cycles)||15
8744242|NCT01132807|9792588|FG001|STARTED|Initial ABVD Treatment (2 Cycles)||135
8744243|NCT01132807|9792589|FG002|STARTED|Initial ABVD Treatment (2 Cycles)||14
8744244|NCT01132807|9792587|FG000|COMPLETED|Initial ABVD Treatment (2 Cycles)||0
8744245|NCT01132807|9792588|FG001|COMPLETED|Initial ABVD Treatment (2 Cycles)||135
8744246|NCT01132807|9792589|FG002|COMPLETED|Initial ABVD Treatment (2 Cycles)||14
8744247|NCT01132807|9792587|FG000|NOT COMPLETED|Initial ABVD Treatment (2 Cycles)||15
8744248|NCT01132807|9792588|FG001|NOT COMPLETED|Initial ABVD Treatment (2 Cycles)||0
8744249|NCT01132807|9792589|FG002|NOT COMPLETED|Initial ABVD Treatment (2 Cycles)||0
8744250|NCT01132807|9792587|FG000|STARTED|Post-Cycle 2 PET Assessment||0
8744251|NCT01132807|9792588|FG001|STARTED|Post-Cycle 2 PET Assessment||135
8744252|NCT01132807|9792589|FG002|STARTED|Post-Cycle 2 PET Assessment||14
8744253|NCT01132807|9792587|FG000|COMPLETED|Post-Cycle 2 PET Assessment||0
8744254|NCT01132807|9792588|FG001|COMPLETED|Post-Cycle 2 PET Assessment||135
8744255|NCT01132807|9792589|FG002|COMPLETED|Post-Cycle 2 PET Assessment||14
8744256|NCT01132807|9792587|FG000|NOT COMPLETED|Post-Cycle 2 PET Assessment||0
8744257|NCT01132807|9792588|FG001|NOT COMPLETED|Post-Cycle 2 PET Assessment||0
8744258|NCT01132807|9792589|FG002|NOT COMPLETED|Post-Cycle 2 PET Assessment||0
8744259|NCT01132820|9792597|FG000|STARTED|Overall Study||53
8744260|NCT01132820|9792597|FG000|COMPLETED|Overall Study||48
8744261|NCT01132820|9792597|FG000|NOT COMPLETED|Overall Study||5
8744262|NCT01132846|9792604|FG000|STARTED|Overall Study||122
8744263|NCT01132846|9792605|FG001|STARTED|Overall Study||119
8744264|NCT01132846|9792606|FG002|STARTED|Overall Study||119
8744265|NCT01132846|9792604|FG000|COMPLETED|Overall Study||106
8744266|NCT01132846|9792605|FG001|COMPLETED|Overall Study||101
8744267|NCT01132846|9792606|FG002|COMPLETED|Overall Study||108
8744268|NCT01132846|9792604|FG000|NOT COMPLETED|Overall Study||16
8744269|NCT01132846|9792605|FG001|NOT COMPLETED|Overall Study||18
8744270|NCT01132846|9792606|FG002|NOT COMPLETED|Overall Study||11
8744271|NCT01133067|9792616|FG000|STARTED|Overall Study||200
8744272|NCT01133067|9792616|FG000|COMPLETED|Overall Study||61
8744273|NCT01133067|9792616|FG000|NOT COMPLETED|Overall Study||139
8744274|NCT01133158|9792620|FG000|STARTED|Overall Study||60
8744275|NCT01133158|9792620|FG000|COMPLETED|Overall Study||43
8744276|NCT01133158|9792620|FG000|NOT COMPLETED|Overall Study||17
8744277|NCT01133171|9792629|FG000|STARTED|Overall Study||25
8744278|NCT01133171|9792630|FG001|STARTED|Overall Study||27
8744279|NCT01133171|9792631|FG002|STARTED|Overall Study||25
8744280|NCT01133171|9792629|FG000|COMPLETED|Overall Study||24
8744281|NCT01133171|9792630|FG001|COMPLETED|Overall Study||25
8744282|NCT01133171|9792631|FG002|COMPLETED|Overall Study||25
8744283|NCT01133171|9792629|FG000|NOT COMPLETED|Overall Study||1
8744284|NCT01133171|9792630|FG001|NOT COMPLETED|Overall Study||2
8744285|NCT01133171|9792631|FG002|NOT COMPLETED|Overall Study||0
8744286|NCT01133275|9792639|FG000|STARTED|Overall Study||28
8744287|NCT01133275|9792639|FG000|COMPLETED|Overall Study||26
8744288|NCT01133275|9792639|FG000|NOT COMPLETED|Overall Study||2
8744289|NCT01133379|9792646|FG000|STARTED|Overall Study||58
8744290|NCT01133379|9792647|FG001|STARTED|Overall Study||58
8744291|NCT01133379|9792648|FG002|STARTED|Overall Study||58
8744292|NCT01133379|9792646|FG000|COMPLETED|Overall Study||57
8744293|NCT01133379|9792647|FG001|COMPLETED|Overall Study||56
8744294|NCT01133379|9792648|FG002|COMPLETED|Overall Study||56
8744295|NCT01133379|9792646|FG000|NOT COMPLETED|Overall Study||1
8744296|NCT01133379|9792647|FG001|NOT COMPLETED|Overall Study||2
8744297|NCT01133379|9792648|FG002|NOT COMPLETED|Overall Study||2
8744298|NCT01133392|9792658|FG000|STARTED|First Intervention (1 Day )||20
8744299|NCT01133392|9792659|FG001|STARTED|First Intervention (1 Day )||18
8744300|NCT01133392|9792658|FG000|COMPLETED|First Intervention (1 Day )||20
8744301|NCT01133392|9792659|FG001|COMPLETED|First Intervention (1 Day )||18
8744302|NCT01133392|9792658|FG000|NOT COMPLETED|First Intervention (1 Day )||0
8744303|NCT01133392|9792659|FG001|NOT COMPLETED|First Intervention (1 Day )||0
8744304|NCT01133392|9792658|FG000|STARTED|Interval Between Dosing (4-7 Days)||20
8744305|NCT01133392|9792659|FG001|STARTED|Interval Between Dosing (4-7 Days)||18
8744306|NCT01133392|9792658|FG000|COMPLETED|Interval Between Dosing (4-7 Days)||20
8744307|NCT01133392|9792659|FG001|COMPLETED|Interval Between Dosing (4-7 Days)||17
8744308|NCT01133392|9792658|FG000|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
8744309|NCT01133392|9792659|FG001|NOT COMPLETED|Interval Between Dosing (4-7 Days)||1
8744310|NCT01133392|9792658|FG000|STARTED|Second Intervention (1 Day)||20
8744311|NCT01133392|9792659|FG001|STARTED|Second Intervention (1 Day)||17
8744312|NCT01133392|9792658|FG000|COMPLETED|Second Intervention (1 Day)||20
8744313|NCT01133392|9792659|FG001|COMPLETED|Second Intervention (1 Day)||17
8744314|NCT01133392|9792658|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
8744315|NCT01133392|9792659|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
8744316|NCT01133392|9792658|FG000|STARTED|Interval Between Dosing (4-7 Days)||20
8744317|NCT01133392|9792659|FG001|STARTED|Interval Between Dosing (4-7 Days)||17
8744318|NCT01133392|9792658|FG000|COMPLETED|Interval Between Dosing (4-7 Days)||20
8744319|NCT01133392|9792659|FG001|COMPLETED|Interval Between Dosing (4-7 Days)||17
8744320|NCT01133392|9792658|FG000|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
8744321|NCT01133392|9792659|FG001|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
8744322|NCT01133392|9792658|FG000|STARTED|Third Intervention (1 Day)||20
8744323|NCT01133392|9792659|FG001|STARTED|Third Intervention (1 Day)||17
8744324|NCT01133392|9792658|FG000|COMPLETED|Third Intervention (1 Day)||20
8744325|NCT01133392|9792659|FG001|COMPLETED|Third Intervention (1 Day)||17
8744326|NCT01133392|9792658|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
8744327|NCT01133392|9792659|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
8744328|NCT01133392|9792658|FG000|STARTED|Interval Between Dosing (4-7 Days)||20
8744329|NCT01133392|9792659|FG001|STARTED|Interval Between Dosing (4-7 Days)||17
8744330|NCT01133392|9792658|FG000|COMPLETED|Interval Between Dosing (4-7 Days)||20
8744331|NCT01133392|9792659|FG001|COMPLETED|Interval Between Dosing (4-7 Days)||16
8744332|NCT01133392|9792658|FG000|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
8744333|NCT01133392|9792659|FG001|NOT COMPLETED|Interval Between Dosing (4-7 Days)||1
8744334|NCT01133392|9792658|FG000|STARTED|Fourth Intervention (1 Day)||20
8744335|NCT01133392|9792659|FG001|STARTED|Fourth Intervention (1 Day)||16
8744336|NCT01133392|9792658|FG000|COMPLETED|Fourth Intervention (1 Day)||20
8744337|NCT01133392|9792659|FG001|COMPLETED|Fourth Intervention (1 Day)||16
8744338|NCT01133392|9792658|FG000|NOT COMPLETED|Fourth Intervention (1 Day)||0
8744339|NCT01133392|9792659|FG001|NOT COMPLETED|Fourth Intervention (1 Day)||0
8744340|NCT01133405|9792675|FG000|STARTED|Period 1||3
8744341|NCT01133405|9792676|FG001|STARTED|Period 1||6
8744342|NCT01133405|9792677|FG002|STARTED|Period 1||5
8744343|NCT01133405|9792678|FG003|STARTED|Period 1||5
8744344|NCT01133405|9792679|FG004|STARTED|Period 1||3
8744345|NCT01133405|9792680|FG005|STARTED|Period 1||5
8744346|NCT01133405|9792681|FG006|STARTED|Period 1||5
8744347|NCT01133405|9792682|FG007|STARTED|Period 1||2
8744348|NCT01133405|9792683|FG008|STARTED|Period 1||4
8744349|NCT01133405|9792684|FG009|STARTED|Period 1||2
8744350|NCT01133405|9792675|FG000|Safety Analysis Population|Period 1|One discontinued from study after randomization but before any study procedures.|2
8744351|NCT01133405|9792676|FG001|Safety Analysis Population|Period 1||6
8744352|NCT01133405|9792677|FG002|Safety Analysis Population|Period 1||5
8744353|NCT01133405|9792678|FG003|Safety Analysis Population|Period 1||5
8744354|NCT01133405|9792679|FG004|Safety Analysis Population|Period 1||3
8744355|NCT01133405|9792680|FG005|Safety Analysis Population|Period 1||5
8744356|NCT01133405|9792681|FG006|Safety Analysis Population|Period 1||5
8744357|NCT01133405|9792682|FG007|Safety Analysis Population|Period 1||2
8744358|NCT01133405|9792683|FG008|Safety Analysis Population|Period 1||4
8744359|NCT01133405|9792684|FG009|Safety Analysis Population|Period 1||2
8744360|NCT01133405|9792675|FG000|Received at Least 1 Dose of Drug|Period 1||2
8744361|NCT01133405|9792676|FG001|Received at Least 1 Dose of Drug|Period 1||4
8744362|NCT01133405|9792677|FG002|Received at Least 1 Dose of Drug|Period 1||4
8744363|NCT01133405|9792678|FG003|Received at Least 1 Dose of Drug|Period 1||3
8744364|NCT01133405|9792679|FG004|Received at Least 1 Dose of Drug|Period 1||3
8744365|NCT01133405|9792680|FG005|Received at Least 1 Dose of Drug|Period 1||4
8744366|NCT01133405|9792681|FG006|Received at Least 1 Dose of Drug|Period 1||4
8744367|NCT01133405|9792682|FG007|Received at Least 1 Dose of Drug|Period 1||2
8744368|NCT01133405|9792683|FG008|Received at Least 1 Dose of Drug|Period 1||4
8744369|NCT01133405|9792684|FG009|Received at Least 1 Dose of Drug|Period 1||2
8744370|NCT01133405|9792675|FG000|COMPLETED|Period 1||2
8744371|NCT01133405|9792676|FG001|COMPLETED|Period 1||3
8744372|NCT01133405|9792677|FG002|COMPLETED|Period 1||4
8744373|NCT01133405|9792678|FG003|COMPLETED|Period 1||1
8744374|NCT01133405|9792679|FG004|COMPLETED|Period 1||3
8744375|NCT01133405|9792680|FG005|COMPLETED|Period 1||3
8744376|NCT01133405|9792681|FG006|COMPLETED|Period 1||4
8744377|NCT01133405|9792682|FG007|COMPLETED|Period 1||2
8744378|NCT01133405|9792683|FG008|COMPLETED|Period 1||4
8744379|NCT01133405|9792684|FG009|COMPLETED|Period 1||2
8744380|NCT01133405|9792675|FG000|NOT COMPLETED|Period 1||1
8744381|NCT01133405|9792676|FG001|NOT COMPLETED|Period 1||3
8744382|NCT01133405|9792677|FG002|NOT COMPLETED|Period 1||1
8744383|NCT01133405|9792678|FG003|NOT COMPLETED|Period 1||4
8744384|NCT01133405|9792679|FG004|NOT COMPLETED|Period 1||0
8744385|NCT01133405|9792680|FG005|NOT COMPLETED|Period 1||2
8744386|NCT01133405|9792681|FG006|NOT COMPLETED|Period 1||1
8744387|NCT01133405|9792682|FG007|NOT COMPLETED|Period 1||0
8744388|NCT01133405|9792683|FG008|NOT COMPLETED|Period 1||0
8744389|NCT01133405|9792684|FG009|NOT COMPLETED|Period 1||0
8744390|NCT01133405|9792675|FG000|STARTED|Period 2||2
8744391|NCT01133405|9792676|FG001|STARTED|Period 2|One participant started and received 15 mg LY2886721 only in period 2.|4
8744392|NCT01133405|9792677|FG002|STARTED|Period 2||4
8744393|NCT01133405|9792678|FG003|STARTED|Period 2|Two participants started and received 25 mg LY2886721 only in period 2.|3
8744394|NCT01133405|9792679|FG004|STARTED|Period 2||3
8744395|NCT01133405|9792680|FG005|STARTED|Period 2|One participant started and received 25 mg LY2886721 only in period 2.|4
8744396|NCT01133405|9792681|FG006|STARTED|Period 2|Cohort C was planned only for single period.|0
8744397|NCT01133405|9792682|FG007|STARTED|Period 2|Cohort C was planned only for single period.|0
8744398|NCT01133405|9792683|FG008|STARTED|Period 2|Cohort D was planned only for single period.|0
8744399|NCT01133405|9792684|FG009|STARTED|Period 2|Cohort D was planned only for single period.|0
8744400|NCT01133405|9792675|FG000|Received at Least 1 Dose of Study Drug|Period 2||2
8744401|NCT01133405|9792676|FG001|Received at Least 1 Dose of Study Drug|Period 2||4
8744402|NCT01133405|9792677|FG002|Received at Least 1 Dose of Study Drug|Period 2||4
8744403|NCT01133405|9792678|FG003|Received at Least 1 Dose of Study Drug|Period 2||3
8744404|NCT01133405|9792679|FG004|Received at Least 1 Dose of Study Drug|Period 2||3
8744405|NCT01133405|9792680|FG005|Received at Least 1 Dose of Study Drug|Period 2||4
8744406|NCT01133405|9792681|FG006|Received at Least 1 Dose of Study Drug|Period 2||0
8744407|NCT01133405|9792682|FG007|Received at Least 1 Dose of Study Drug|Period 2||0
8744408|NCT01133405|9792683|FG008|Received at Least 1 Dose of Study Drug|Period 2||0
8744409|NCT01133405|9792684|FG009|Received at Least 1 Dose of Study Drug|Period 2||0
8744410|NCT01133405|9792675|FG000|COMPLETED|Period 2||2
8744411|NCT01133405|9792676|FG001|COMPLETED|Period 2||3
8744412|NCT01133405|9792677|FG002|COMPLETED|Period 2||3
8744413|NCT01133405|9792678|FG003|COMPLETED|Period 2||2
8744414|NCT01133405|9792679|FG004|COMPLETED|Period 2||3
8744415|NCT01133405|9792680|FG005|COMPLETED|Period 2||2
8744416|NCT01133405|9792681|FG006|COMPLETED|Period 2||0
8744417|NCT01133405|9792682|FG007|COMPLETED|Period 2||0
8744418|NCT01133405|9792683|FG008|COMPLETED|Period 2||0
8744419|NCT01133405|9792684|FG009|COMPLETED|Period 2||0
8744420|NCT01133405|9792675|FG000|NOT COMPLETED|Period 2||0
8744421|NCT01133405|9792676|FG001|NOT COMPLETED|Period 2||1
8744422|NCT01133405|9792677|FG002|NOT COMPLETED|Period 2||1
8744423|NCT01133405|9792678|FG003|NOT COMPLETED|Period 2||1
8744424|NCT01133405|9792679|FG004|NOT COMPLETED|Period 2||0
8744425|NCT01133405|9792680|FG005|NOT COMPLETED|Period 2||2
8744426|NCT01133405|9792681|FG006|NOT COMPLETED|Period 2||0
8744427|NCT01133405|9792682|FG007|NOT COMPLETED|Period 2||0
8744428|NCT01133405|9792683|FG008|NOT COMPLETED|Period 2||0
8744429|NCT01133405|9792684|FG009|NOT COMPLETED|Period 2||0
8744430|NCT01133405|9792675|FG000|STARTED|Period 3||2
8744431|NCT01133405|9792676|FG001|STARTED|Period 3|One participant started and received placebo only in period 3.|4
8744432|NCT01133405|9792677|FG002|STARTED|Period 3|One participant started and received 35 mg LY2886721 only in period 3.|4
8744433|NCT01133405|9792678|FG003|STARTED|Period 3||2
8744434|NCT01133405|9792679|FG004|STARTED|Period 3||3
8744435|NCT01133405|9792680|FG005|STARTED|Period 3||2
8744436|NCT01133405|9792681|FG006|STARTED|Period 3||0
8744437|NCT01133405|9792682|FG007|STARTED|Period 3||0
8744438|NCT01133405|9792683|FG008|STARTED|Period 3||0
8744439|NCT01133405|9792684|FG009|STARTED|Period 3||0
8744440|NCT01133405|9792675|FG000|Received at Least 1 Dose of Study Drug|Period 3||2
8744441|NCT01133405|9792676|FG001|Received at Least 1 Dose of Study Drug|Period 3||4
8744442|NCT01133405|9792677|FG002|Received at Least 1 Dose of Study Drug|Period 3||4
8744443|NCT01133405|9792678|FG003|Received at Least 1 Dose of Study Drug|Period 3||2
8744444|NCT01133405|9792679|FG004|Received at Least 1 Dose of Study Drug|Period 3||3
8744445|NCT01133405|9792680|FG005|Received at Least 1 Dose of Study Drug|Period 3||2
8744446|NCT01133405|9792681|FG006|Received at Least 1 Dose of Study Drug|Period 3||0
8744447|NCT01133405|9792682|FG007|Received at Least 1 Dose of Study Drug|Period 3||0
8744448|NCT01133405|9792683|FG008|Received at Least 1 Dose of Study Drug|Period 3||0
8744449|NCT01133405|9792684|FG009|Received at Least 1 Dose of Study Drug|Period 3||0
8744450|NCT01133405|9792675|FG000|COMPLETED|Period 3||2
8744451|NCT01133405|9792676|FG001|COMPLETED|Period 3||4
8744452|NCT01133405|9792677|FG002|COMPLETED|Period 3||4
8744453|NCT01133405|9792678|FG003|COMPLETED|Period 3||2
8744454|NCT01133405|9792679|FG004|COMPLETED|Period 3||3
8744455|NCT01133405|9792680|FG005|COMPLETED|Period 3||2
8744456|NCT01133405|9792681|FG006|COMPLETED|Period 3||0
8744457|NCT01133405|9792682|FG007|COMPLETED|Period 3||0
8744458|NCT01133405|9792683|FG008|COMPLETED|Period 3||0
8744459|NCT01133405|9792684|FG009|COMPLETED|Period 3||0
8744460|NCT01133405|9792675|FG000|NOT COMPLETED|Period 3||0
8744461|NCT01133405|9792676|FG001|NOT COMPLETED|Period 3||0
8744462|NCT01133405|9792677|FG002|NOT COMPLETED|Period 3||0
8744463|NCT01133405|9792678|FG003|NOT COMPLETED|Period 3||0
8744464|NCT01133405|9792679|FG004|NOT COMPLETED|Period 3||0
8744465|NCT01133405|9792680|FG005|NOT COMPLETED|Period 3||0
8744466|NCT01133405|9792681|FG006|NOT COMPLETED|Period 3||0
8744467|NCT01133405|9792682|FG007|NOT COMPLETED|Period 3||0
8744468|NCT01133405|9792683|FG008|NOT COMPLETED|Period 3||0
8744469|NCT01133405|9792684|FG009|NOT COMPLETED|Period 3||0
8744470|NCT01133418|9792716|FG000|STARTED|Overall Study||34
8744471|NCT01133418|9792717|FG001|STARTED|Overall Study||38
8744472|NCT01133418|9792716|FG000|COMPLETED|Overall Study||29
8744473|NCT01133418|9792717|FG001|COMPLETED|Overall Study||32
8744474|NCT01133418|9792716|FG000|NOT COMPLETED|Overall Study||5
8744475|NCT01133418|9792717|FG001|NOT COMPLETED|Overall Study||6
8744476|NCT01133522|9792733|FG000|STARTED|Overall Study||10
8744477|NCT01133522|9792734|FG001|STARTED|Overall Study||7
8744478|NCT01133522|9792735|FG002|STARTED|Overall Study||6
8744479|NCT01133522|9792736|FG003|STARTED|Overall Study||7
8744480|NCT01133522|9792737|FG004|STARTED|Overall Study||7
8744481|NCT01133522|9792738|FG005|STARTED|Overall Study||6
8744482|NCT01133522|9792739|FG006|STARTED|Overall Study||2
8744483|NCT01133522|9792740|FG007|STARTED|Overall Study||9
8744484|NCT01133522|9792741|FG008|STARTED|Overall Study||2
8744485|NCT01133522|9792742|FG009|STARTED|Overall Study||4
8744486|NCT01133522|9792733|FG000|Received Treatment|Overall Study||10
8744487|NCT01133522|9792734|FG001|Received Treatment|Overall Study||6
8744488|NCT01133522|9792735|FG002|Received Treatment|Overall Study||6
8744489|NCT01133522|9792736|FG003|Received Treatment|Overall Study||6
8744490|NCT01133522|9792737|FG004|Received Treatment|Overall Study||6
8744491|NCT01133522|9792738|FG005|Received Treatment|Overall Study||6
8744492|NCT01133522|9792739|FG006|Received Treatment|Overall Study||2
8744493|NCT01133522|9792740|FG007|Received Treatment|Overall Study||9
8744494|NCT01133522|9792741|FG008|Received Treatment|Overall Study||2
8744495|NCT01133522|9792742|FG009|Received Treatment|Overall Study||4
8744496|NCT01133522|9792733|FG000|COMPLETED|Overall Study||10
8744497|NCT01133522|9792734|FG001|COMPLETED|Overall Study||6
8744498|NCT01133522|9792735|FG002|COMPLETED|Overall Study||6
8744499|NCT01133522|9792736|FG003|COMPLETED|Overall Study||6
8744500|NCT01133522|9792737|FG004|COMPLETED|Overall Study||6
8744501|NCT01133522|9792738|FG005|COMPLETED|Overall Study||6
8744502|NCT01133522|9792739|FG006|COMPLETED|Overall Study||2
8744503|NCT01133522|9792740|FG007|COMPLETED|Overall Study||9
8744504|NCT01133522|9792741|FG008|COMPLETED|Overall Study||2
8744505|NCT01133522|9792742|FG009|COMPLETED|Overall Study||4
8744506|NCT01133522|9792733|FG000|NOT COMPLETED|Overall Study||0
8744507|NCT01133522|9792734|FG001|NOT COMPLETED|Overall Study||1
8744508|NCT01133522|9792735|FG002|NOT COMPLETED|Overall Study||0
8744509|NCT01133522|9792736|FG003|NOT COMPLETED|Overall Study||1
8744510|NCT01133522|9792737|FG004|NOT COMPLETED|Overall Study||1
8744511|NCT01133522|9792738|FG005|NOT COMPLETED|Overall Study||0
8744512|NCT01133522|9792739|FG006|NOT COMPLETED|Overall Study||0
8744513|NCT01133522|9792740|FG007|NOT COMPLETED|Overall Study||0
8744514|NCT01133522|9792741|FG008|NOT COMPLETED|Overall Study||0
8744515|NCT01133522|9792742|FG009|NOT COMPLETED|Overall Study||0
8744516|NCT01133626|9792774|FG000|STARTED|Overall Study||50
8744517|NCT01133626|9792775|FG001|STARTED|Overall Study||46
8744518|NCT01133626|9792776|FG002|STARTED|Overall Study||11
8744519|NCT01133626|9792774|FG000|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|50
8744520|NCT01133626|9792775|FG001|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|46
8744521|NCT01133626|9792776|FG002|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|11
8744522|NCT01133626|9792774|FG000|Per Protocol Population|Overall Study|Received >=1 dose of study drug and >=1 post-baseline assessment prior to major protocol deviation.|48
8744523|NCT01133626|9792775|FG001|Per Protocol Population|Overall Study|Received >=1 dose of study drug and >=1 post-baseline assessment prior to major protocol deviation.|41
8744524|NCT01133626|9792776|FG002|Per Protocol Population|Overall Study|Received >=1 dose of study drug and >=1 post-baseline assessment prior to major protocol deviation.|9
8744525|NCT01133626|9792774|FG000|COMPLETED|Overall Study||49
8744526|NCT01133626|9792775|FG001|COMPLETED|Overall Study||41
8744527|NCT01133626|9792776|FG002|COMPLETED|Overall Study||9
8744528|NCT01133626|9792774|FG000|NOT COMPLETED|Overall Study||1
8744529|NCT01133626|9792775|FG001|NOT COMPLETED|Overall Study||5
8744530|NCT01133626|9792776|FG002|NOT COMPLETED|Overall Study||2
8744531|NCT01133665|9792784|FG000|STARTED|Overall Study||42
8744532|NCT01133665|9792784|FG000|COMPLETED|Overall Study||40
8744533|NCT01133665|9792784|FG000|NOT COMPLETED|Overall Study||2
8744534|NCT01133678|9792790|FG000|STARTED|Overall Study||25
8744535|NCT01133678|9792791|FG001|STARTED|Overall Study||25
8744536|NCT01133678|9792790|FG000|COMPLETED|Overall Study||24
8744537|NCT01133678|9792791|FG001|COMPLETED|Overall Study||24
8744538|NCT01133678|9792790|FG000|NOT COMPLETED|Overall Study||1
8744539|NCT01133678|9792791|FG001|NOT COMPLETED|Overall Study||1
8744540|NCT01133704|9792799|FG000|STARTED|Overall Study||65
8744541|NCT01133704|9792800|FG001|STARTED|Overall Study||33
8744542|NCT01133704|9792799|FG000|COMPLETED|Overall Study|(including 3 year follow-up)|16
8744543|NCT01133704|9792800|FG001|COMPLETED|Overall Study|(including 3 year follow-up)|7
9022821|NCT03131648|10085668|FG004|COMPLETED|Open-label Treatment||0
8744544|NCT01133704|9792799|FG000|NOT COMPLETED|Overall Study||49
8744545|NCT01133704|9792800|FG001|NOT COMPLETED|Overall Study||26
8744546|NCT01133756|9792809|FG000|STARTED|Overall Study||2
8744547|NCT01133756|9792810|FG001|STARTED|Overall Study||3
8744548|NCT01133756|9792811|FG002|STARTED|Overall Study||2
8744549|NCT01133756|9792809|FG000|Completed 6 Cycles|Overall Study|One participant completed 6 cycles and remained in the study until 18 Sep 2012.|1
8744550|NCT01133756|9792810|FG001|Completed 6 Cycles|Overall Study||0
8744551|NCT01133756|9792811|FG002|Completed 6 Cycles|Overall Study||0
8744552|NCT01133756|9792809|FG000|COMPLETED|Overall Study||0
8744553|NCT01133756|9792810|FG001|COMPLETED|Overall Study||0
8744554|NCT01133756|9792811|FG002|COMPLETED|Overall Study||0
8744555|NCT01133756|9792809|FG000|NOT COMPLETED|Overall Study||2
8744556|NCT01133756|9792810|FG001|NOT COMPLETED|Overall Study||3
8744557|NCT01133756|9792811|FG002|NOT COMPLETED|Overall Study||2
8744558|NCT01133821|9792821|FG000|STARTED|Overall Study||45
8744559|NCT01133821|9792822|FG001|STARTED|Overall Study||47
8744560|NCT01133821|9792821|FG000|COMPLETED|Overall Study||27
8744561|NCT01133821|9792822|FG001|COMPLETED|Overall Study||28
8744562|NCT01133821|9792821|FG000|NOT COMPLETED|Overall Study||18
8744563|NCT01133821|9792822|FG001|NOT COMPLETED|Overall Study||19
8744564|NCT01133847|9792831|FG000|STARTED|Active Treatment Phase (Weeks 1-16)||78
8744565|NCT01133847|9792832|FG001|STARTED|Active Treatment Phase (Weeks 1-16)||74
8744566|NCT01133847|9792833|FG002|STARTED|Active Treatment Phase (Weeks 1-16)||70
8744567|NCT01133847|9792831|FG000|COMPLETED|Active Treatment Phase (Weeks 1-16)||73
8744568|NCT01133847|9792832|FG001|COMPLETED|Active Treatment Phase (Weeks 1-16)||73
8744569|NCT01133847|9792833|FG002|COMPLETED|Active Treatment Phase (Weeks 1-16)||67
8744570|NCT01133847|9792831|FG000|NOT COMPLETED|Active Treatment Phase (Weeks 1-16)||5
8744571|NCT01133847|9792832|FG001|NOT COMPLETED|Active Treatment Phase (Weeks 1-16)||1
8744572|NCT01133847|9792833|FG002|NOT COMPLETED|Active Treatment Phase (Weeks 1-16)||3
8744573|NCT01133847|9792831|FG000|STARTED|Follow-Up Phase||73
8744574|NCT01133847|9792832|FG001|STARTED|Follow-Up Phase||73
8744575|NCT01133847|9792833|FG002|STARTED|Follow-Up Phase||67
8744576|NCT01133847|9792831|FG000|COMPLETED|Follow-Up Phase||72
8744577|NCT01133847|9792832|FG001|COMPLETED|Follow-Up Phase||70
8744578|NCT01133847|9792833|FG002|COMPLETED|Follow-Up Phase||60
8744579|NCT01133847|9792831|FG000|NOT COMPLETED|Follow-Up Phase||1
8744580|NCT01133847|9792832|FG001|NOT COMPLETED|Follow-Up Phase||3
8744581|NCT01133847|9792833|FG002|NOT COMPLETED|Follow-Up Phase||7
8744582|NCT01133860|9792842|FG000|STARTED|Overall Study||12
8744583|NCT01133860|9792842|FG000|COMPLETED|Overall Study||12
8744584|NCT01133860|9792842|FG000|NOT COMPLETED|Overall Study||0
8744585|NCT01133977|9792852|FG000|STARTED|Overall Study|Treated|3
8744586|NCT01133977|9792853|FG001|STARTED|Overall Study|Treated|7
8744587|NCT01133977|9792854|FG002|STARTED|Overall Study|Treated|6
8744588|NCT01133977|9792855|FG003|STARTED|Overall Study|Treated|42
8744589|NCT01133977|9792856|FG004|STARTED|Overall Study|Treated|39
8744590|NCT01133977|9792852|FG000|COMPLETED|Overall Study||0
8744591|NCT01133977|9792853|FG001|COMPLETED|Overall Study||0
8744592|NCT01133977|9792854|FG002|COMPLETED|Overall Study||0
8744593|NCT01133977|9792855|FG003|COMPLETED|Overall Study||3
8744594|NCT01133977|9792856|FG004|COMPLETED|Overall Study||1
8744595|NCT01133977|9792852|FG000|NOT COMPLETED|Overall Study||3
8744596|NCT01133977|9792853|FG001|NOT COMPLETED|Overall Study||7
8744597|NCT01133977|9792854|FG002|NOT COMPLETED|Overall Study||6
8744598|NCT01133977|9792855|FG003|NOT COMPLETED|Overall Study||39
8744599|NCT01133977|9792856|FG004|NOT COMPLETED|Overall Study||38
8744600|NCT01134016|9792871|FG000|STARTED|Overall Study||13
8744601|NCT01134016|9792871|FG000|COMPLETED|Overall Study||10
8744602|NCT01134016|9792871|FG000|NOT COMPLETED|Overall Study||3
8744603|NCT01134042|9792907|FG000|STARTED|Overall Study||194
8744604|NCT01134042|9792908|FG001|STARTED|Overall Study||197
8744605|NCT01134042|9792909|FG002|STARTED|Overall Study||195
8744606|NCT01134042|9792907|FG000|COMPLETED|Overall Study||146
8744607|NCT01134042|9792908|FG001|COMPLETED|Overall Study||169
8744608|NCT01134042|9792909|FG002|COMPLETED|Overall Study||161
8744609|NCT01134042|9792907|FG000|NOT COMPLETED|Overall Study||48
8744610|NCT01134042|9792908|FG001|NOT COMPLETED|Overall Study||28
8744611|NCT01134042|9792909|FG002|NOT COMPLETED|Overall Study||34
8744612|NCT01134055|9792925|FG000|STARTED|Overall Study||73
8744613|NCT01134055|9792926|FG001|STARTED|Overall Study||72
8744614|NCT01134055|9792927|FG002|STARTED|Overall Study||74
8744615|NCT01134055|9792928|FG003|STARTED|Overall Study||73
8744616|NCT01134055|9792929|FG004|STARTED|Overall Study||73
8744617|NCT01134055|9792930|FG005|STARTED|Overall Study||72
8744618|NCT01134055|9792931|FG006|STARTED|Overall Study||73
8744619|NCT01134055|9792925|FG000|COMPLETED|Overall Study||65
8744620|NCT01134055|9792926|FG001|COMPLETED|Overall Study||66
8744621|NCT01134055|9792927|FG002|COMPLETED|Overall Study||71
8744622|NCT01134055|9792928|FG003|COMPLETED|Overall Study||67
8744623|NCT01134055|9792929|FG004|COMPLETED|Overall Study||67
8744624|NCT01134055|9792930|FG005|COMPLETED|Overall Study||65
8744625|NCT01134055|9792931|FG006|COMPLETED|Overall Study||62
8744626|NCT01134055|9792925|FG000|NOT COMPLETED|Overall Study||8
8744627|NCT01134055|9792926|FG001|NOT COMPLETED|Overall Study||6
8744628|NCT01134055|9792927|FG002|NOT COMPLETED|Overall Study||3
8744629|NCT01134055|9792928|FG003|NOT COMPLETED|Overall Study||6
8744630|NCT01134055|9792929|FG004|NOT COMPLETED|Overall Study||6
8744631|NCT01134055|9792930|FG005|NOT COMPLETED|Overall Study||7
8744632|NCT01134055|9792931|FG006|NOT COMPLETED|Overall Study||11
8744633|NCT01134081|9792953|FG000|STARTED|Overall Study||44
8744634|NCT01134081|9792953|FG000|COMPLETED|Overall Study||44
8744635|NCT01134081|9792953|FG000|NOT COMPLETED|Overall Study||0
8744636|NCT01134107|9792963|FG000|STARTED|Period 1-First Treatment Intervention||67
8744637|NCT01134107|9792964|FG001|STARTED|Period 1-First Treatment Intervention||66
8744638|NCT01134107|9792963|FG000|Received at Least One Dose of Study Drug|Period 1-First Treatment Intervention||66
8744639|NCT01134107|9792964|FG001|Received at Least One Dose of Study Drug|Period 1-First Treatment Intervention||66
8744640|NCT01134107|9792963|FG000|COMPLETED|Period 1-First Treatment Intervention||61
8744641|NCT01134107|9792964|FG001|COMPLETED|Period 1-First Treatment Intervention||61
8744642|NCT01134107|9792963|FG000|NOT COMPLETED|Period 1-First Treatment Intervention||6
8744643|NCT01134107|9792964|FG001|NOT COMPLETED|Period 1-First Treatment Intervention||5
8744644|NCT01134107|9792963|FG000|STARTED|Period 2-Second Treatment Intervention||61
8744645|NCT01134107|9792964|FG001|STARTED|Period 2-Second Treatment Intervention||61
8744646|NCT01134107|9792963|FG000|COMPLETED|Period 2-Second Treatment Intervention||57
8744647|NCT01134107|9792964|FG001|COMPLETED|Period 2-Second Treatment Intervention||61
8744648|NCT01134107|9792963|FG000|NOT COMPLETED|Period 2-Second Treatment Intervention||4
8744649|NCT01134107|9792964|FG001|NOT COMPLETED|Period 2-Second Treatment Intervention||0
8744650|NCT01134198|9792972|FG000|STARTED|Phase 1||16
8744651|NCT01134198|9792973|FG001|STARTED|Phase 1||13
8744652|NCT01134198|9792972|FG000|COMPLETED|Phase 1||9
8744653|NCT01134198|9792973|FG001|COMPLETED|Phase 1||11
8744654|NCT01134198|9792972|FG000|NOT COMPLETED|Phase 1||7
8744655|NCT01134198|9792973|FG001|NOT COMPLETED|Phase 1||2
8744656|NCT01134198|9792972|FG000|STARTED|Phase 2||9
8744657|NCT01134198|9792973|FG001|STARTED|Phase 2||11
8744658|NCT01134198|9792972|FG000|COMPLETED|Phase 2||9
8744659|NCT01134198|9792973|FG001|COMPLETED|Phase 2||7
8744660|NCT01134198|9792972|FG000|NOT COMPLETED|Phase 2||0
8744661|NCT01134198|9792973|FG001|NOT COMPLETED|Phase 2||4
8744662|NCT01134263|9792984|FG000|STARTED|Overall Study||164
8744663|NCT01134263|9792985|FG001|STARTED|Overall Study||163
8744664|NCT01134263|9792986|FG002|STARTED|Overall Study||163
8744665|NCT01134263|9792987|FG003|STARTED|Overall Study||168
8744666|NCT01134263|9792988|FG004|STARTED|Overall Study||57
8744667|NCT01134263|9792984|FG000|Received Vaccination 1|Overall Study||163
8744668|NCT01134263|9792985|FG001|Received Vaccination 1|Overall Study||162
8744669|NCT01134263|9792986|FG002|Received Vaccination 1|Overall Study||163
8744670|NCT01134263|9792987|FG003|Received Vaccination 1|Overall Study||167
8744671|NCT01134263|9792988|FG004|Received Vaccination 1|Overall Study||57
8744672|NCT01134263|9792984|FG000|Received Vaccination 2|Overall Study||151
8744673|NCT01134263|9792985|FG001|Received Vaccination 2|Overall Study||152
8744674|NCT01134263|9792986|FG002|Received Vaccination 2|Overall Study||139
8744675|NCT01134263|9792987|FG003|Received Vaccination 2|Overall Study||154
8744676|NCT01134263|9792988|FG004|Received Vaccination 2|Overall Study||53
8744677|NCT01134263|9792984|FG000|Received Vaccination 3|Overall Study||140
8744678|NCT01134263|9792985|FG001|Received Vaccination 3|Overall Study||145
8744679|NCT01134263|9792986|FG002|Received Vaccination 3|Overall Study||134
8744680|NCT01134263|9792987|FG003|Received Vaccination 3|Overall Study||151
8744681|NCT01134263|9792988|FG004|Received Vaccination 3|Overall Study||49
8744682|NCT01134263|9792984|FG000|Safety Population|Overall Study||163
8744683|NCT01134263|9792985|FG001|Safety Population|Overall Study||161
8744684|NCT01134263|9792986|FG002|Safety Population|Overall Study|1 participant randomized to the Phase III Lot 2 group, received Phase III Lot 3 vaccination.|164
8744685|NCT01134263|9792987|FG003|Safety Population|Overall Study||167
8744686|NCT01134263|9792988|FG004|Safety Population|Overall Study||57
8744687|NCT01134263|9792984|FG000|COMPLETED|Overall Study||140
8744688|NCT01134263|9792985|FG001|COMPLETED|Overall Study||143
8744689|NCT01134263|9792986|FG002|COMPLETED|Overall Study||134
8744690|NCT01134263|9792987|FG003|COMPLETED|Overall Study||149
8744691|NCT01134263|9792988|FG004|COMPLETED|Overall Study||48
8744692|NCT01134263|9792984|FG000|NOT COMPLETED|Overall Study||24
8744693|NCT01134263|9792985|FG001|NOT COMPLETED|Overall Study||20
8744694|NCT01134263|9792986|FG002|NOT COMPLETED|Overall Study||29
8744695|NCT01134263|9792987|FG003|NOT COMPLETED|Overall Study||19
8744696|NCT01134263|9792988|FG004|NOT COMPLETED|Overall Study||9
8744697|NCT01134276|9793008|FG000|STARTED|Overall Study||104
8744698|NCT01134276|9793009|FG001|STARTED|Overall Study||107
8744699|NCT01134276|9793008|FG000|COMPLETED|Overall Study||104
8744700|NCT01134276|9793009|FG001|COMPLETED|Overall Study||107
8744701|NCT01134276|9793008|FG000|NOT COMPLETED|Overall Study||0
8744702|NCT01134276|9793009|FG001|NOT COMPLETED|Overall Study||0
8744703|NCT01134315|9793020|FG000|STARTED|Overall Study||21
8744704|NCT01134315|9793021|FG001|STARTED|Overall Study||40
8744705|NCT01134315|9793020|FG000|COMPLETED|Overall Study|Completed study drug treatment during the observational study (ie, prior to study termination).|12
8744706|NCT01134315|9793021|FG001|COMPLETED|Overall Study|Completed study drug treatment during the observational study (ie, prior to study termination).|21
8744707|NCT01134315|9793020|FG000|NOT COMPLETED|Overall Study||9
8744708|NCT01134315|9793021|FG001|NOT COMPLETED|Overall Study||19
8744709|NCT01134328|9793031|FG000|STARTED|Overall Study||21
8744710|NCT01134328|9793032|FG001|STARTED|Overall Study||21
8744711|NCT01134328|9793033|FG002|STARTED|Overall Study||20
8744712|NCT01134328|9793034|FG003|STARTED|Overall Study||21
8744713|NCT01134328|9793031|FG000|COMPLETED|Overall Study||19
8744714|NCT01134328|9793032|FG001|COMPLETED|Overall Study||18
8744715|NCT01134328|9793033|FG002|COMPLETED|Overall Study||17
8744716|NCT01134328|9793034|FG003|COMPLETED|Overall Study||17
8744717|NCT01134328|9793031|FG000|NOT COMPLETED|Overall Study||2
8744718|NCT01134328|9793032|FG001|NOT COMPLETED|Overall Study||3
8744719|NCT01134328|9793033|FG002|NOT COMPLETED|Overall Study||3
8744720|NCT01134328|9793034|FG003|NOT COMPLETED|Overall Study||4
8744721|NCT01134393|9793044|FG000|STARTED|Overall Study|Entered and treated.|501
8744722|NCT01134393|9793044|FG000|COMPLETED|Overall Study|Completed trial medication.|449
8744723|NCT01134393|9793044|FG000|NOT COMPLETED|Overall Study||52
8744724|NCT01134510|9793051|FG000|STARTED|Overall Study|Transplant Day; Infusion #1 C1 esterase inhibitor vs Placebo|10
8744725|NCT01134510|9793052|FG001|STARTED|Overall Study|Transplant Day; Infusion #1 C1 esterase inhibitor vs Placebo|10
8744726|NCT01134510|9793051|FG000|Day 2|Overall Study|Infusion #2 C1 esterase inhibitor vs Placebo|10
8744727|NCT01134510|9793052|FG001|Day 2|Overall Study|Infusion #2 C1 esterase inhibitor vs Placebo|10
8744728|NCT01134510|9793051|FG000|Week 2|Overall Study|Infusion #3 C1 esterase inhibitor vs Placebo|10
8744729|NCT01134510|9793052|FG001|Week 2|Overall Study|Infusion #3 C1 esterase inhibitor vs Placebo|10
8744730|NCT01134510|9793051|FG000|Week 2|Overall Study|Infusion #4 C1 esterase inhibitor vs Placebo|10
8744731|NCT01134510|9793052|FG001|Week 2|Overall Study|Infusion #4 C1 esterase inhibitor vs Placebo|10
8744732|NCT01134510|9793051|FG000|Week 3|Overall Study|Infusion #5 C1 esterase inhibitor vs Placebo|10
8744733|NCT01134510|9793052|FG001|Week 3|Overall Study|Infusion #5 C1 esterase inhibitor vs Placebo|10
8744734|NCT01134510|9793051|FG000|Week 3|Overall Study|Infusion #6 C1 esterase inhibitor vs Placebo|10
8744735|NCT01134510|9793052|FG001|Week 3|Overall Study|Infusion #6 C1 esterase inhibitor vs Placebo|10
8744736|NCT01134510|9793051|FG000|Week 4|Overall Study|Infusion #7 C1 esterase inhibitor vs Placebo|10
8744737|NCT01134510|9793052|FG001|Week 4|Overall Study|Infusion #7 C1 esterase inhibitor vs Placebo|10
8744738|NCT01134510|9793051|FG000|Week 4|Overall Study|Infusion #8 C1 esterase inhibitor vs Placebo|10
8744739|NCT01134510|9793052|FG001|Week 4|Overall Study|Infusion #8 C1 esterase inhibitor vs Placebo|10
8744740|NCT01134510|9793051|FG000|Month 1|Overall Study||10
8744741|NCT01134510|9793052|FG001|Month 1|Overall Study||10
8744742|NCT01134510|9793051|FG000|Month 3|Overall Study||10
8744743|NCT01134510|9793052|FG001|Month 3|Overall Study||9
8744744|NCT01134510|9793051|FG000|COMPLETED|Overall Study||10
8744745|NCT01134510|9793052|FG001|COMPLETED|Overall Study||9
8744746|NCT01134510|9793051|FG000|NOT COMPLETED|Overall Study||0
8744747|NCT01134510|9793052|FG001|NOT COMPLETED|Overall Study||1
8807484|NCT01484431|9859795|FG002|COMPLETED|Period 1: High Dose||6
8807485|NCT01484431|9859793|FG000|NOT COMPLETED|Period 1: High Dose||0
8807486|NCT01484431|9859794|FG001|NOT COMPLETED|Period 1: High Dose||1
8807487|NCT01484431|9859795|FG002|NOT COMPLETED|Period 1: High Dose||0
8807488|NCT01484431|9859793|FG000|STARTED|Period 2||6
8807489|NCT01484431|9859794|FG001|STARTED|Period 2||6
8807490|NCT01484431|9859795|FG002|STARTED|Period 2||6
8807491|NCT01484431|9859793|FG000|Received 7 mg|Period 2||1
8807492|NCT01484431|9859794|FG001|Received 7 mg|Period 2||0
8807493|NCT01484431|9859795|FG002|Received 7 mg|Period 2||0
8807494|NCT01484431|9859793|FG000|Received 7.5 mg|Period 2||0
8807495|NCT01484431|9859794|FG001|Received 7.5 mg|Period 2||2
8807496|NCT01484431|9859795|FG002|Received 7.5 mg|Period 2||0
8807497|NCT01484431|9859793|FG000|Received 8 mg|Period 2||1
8807498|NCT01484431|9859794|FG001|Received 8 mg|Period 2||0
8807499|NCT01484431|9859795|FG002|Received 8 mg|Period 2||0
8807500|NCT01484431|9859793|FG000|Received 10 mg|Period 2||0
8807501|NCT01484431|9859794|FG001|Received 10 mg|Period 2||1
8807502|NCT01484431|9859795|FG002|Received 10 mg|Period 2||0
8807503|NCT01484431|9859793|FG000|Received 15 mg|Period 2||1
8807504|NCT01484431|9859794|FG001|Received 15 mg|Period 2||2
8807505|NCT01484431|9859795|FG002|Received 15 mg|Period 2||1
8807506|NCT01484431|9859793|FG000|Received 20 mg|Period 2||3
8807507|NCT01484431|9859794|FG001|Received 20 mg|Period 2||1
8807508|NCT01484431|9859795|FG002|Received 20 mg|Period 2||4
8807509|NCT01484431|9859793|FG000|Received 40 mg|Period 2||0
8807510|NCT01484431|9859794|FG001|Received 40 mg|Period 2||0
8807511|NCT01484431|9859795|FG002|Received 40 mg|Period 2||1
8807512|NCT01484431|9859793|FG000|COMPLETED|Period 2||5
8807513|NCT01484431|9859794|FG001|COMPLETED|Period 2||5
8807514|NCT01484431|9859795|FG002|COMPLETED|Period 2||4
8807515|NCT01484431|9859793|FG000|NOT COMPLETED|Period 2||1
8807516|NCT01484431|9859794|FG001|NOT COMPLETED|Period 2||1
8807517|NCT01484431|9859795|FG002|NOT COMPLETED|Period 2||2
8807518|NCT01484496|9859810|FG000|STARTED|Period 1||280
8807519|NCT01484496|9859811|FG001|STARTED|Period 1||556
8913327|NCT02160626|9972679|FG002|STARTED|Overall Study||57
8913328|NCT02160626|9972677|FG000|COMPLETED|Overall Study||57
8913329|NCT02160626|9972678|FG001|COMPLETED|Overall Study||56
8913330|NCT02160626|9972679|FG002|COMPLETED|Overall Study||56
8913331|NCT02160626|9972677|FG000|NOT COMPLETED|Overall Study||1
8913332|NCT02160626|9972678|FG001|NOT COMPLETED|Overall Study||1
8913333|NCT02160626|9972679|FG002|NOT COMPLETED|Overall Study||1
8913334|NCT02160730|9972689|FG000|STARTED|Overall Study||4
8807520|NCT01484496|9859812|FG002|STARTED|Period 1||0
8807521|NCT01484496|9859813|FG003|STARTED|Period 1||0
8807522|NCT01484496|9859810|FG000|COMPLETED|Period 1||214
8807523|NCT01484496|9859811|FG001|COMPLETED|Period 1||463
8807524|NCT01484496|9859812|FG002|COMPLETED|Period 1||0
8807525|NCT01484496|9859813|FG003|COMPLETED|Period 1||0
8807526|NCT01484496|9859810|FG000|NOT COMPLETED|Period 1||66
8807527|NCT01484496|9859811|FG001|NOT COMPLETED|Period 1||93
8807528|NCT01484496|9859812|FG002|NOT COMPLETED|Period 1||0
8807529|NCT01484496|9859813|FG003|NOT COMPLETED|Period 1||0
8807530|NCT01484496|9859810|FG000|STARTED|Period 2||0
8807531|NCT01484496|9859811|FG001|STARTED|Period 2||0
8807532|NCT01484496|9859812|FG002|STARTED|Period 2||206
8807533|NCT01484496|9859813|FG003|STARTED|Period 2||456
8807534|NCT01484496|9859810|FG000|COMPLETED|Period 2||0
8807535|NCT01484496|9859811|FG001|COMPLETED|Period 2||0
8807536|NCT01484496|9859812|FG002|COMPLETED|Period 2||191
8807537|NCT01484496|9859813|FG003|COMPLETED|Period 2||434
8807538|NCT01484496|9859810|FG000|NOT COMPLETED|Period 2||0
8913335|NCT02160730|9972689|FG000|COMPLETED|Overall Study||4
8913336|NCT02160730|9972689|FG000|NOT COMPLETED|Overall Study||0
8807539|NCT01484496|9859811|FG001|NOT COMPLETED|Period 2||0
8807540|NCT01484496|9859812|FG002|NOT COMPLETED|Period 2||15
8807541|NCT01484496|9859813|FG003|NOT COMPLETED|Period 2||22
8807542|NCT01484561|9859823|FG000|STARTED|Overall Study||97
8744748|NCT01129011|9793063|FG000|STARTED|Overall Study|Safety, Intent-to-Treat population|210
8744749|NCT01129011|9793064|FG001|STARTED|Overall Study|Safety, Intent-to-Treat population|210
8744750|NCT01129011|9793063|FG000|COMPLETED|Overall Study||151
8744751|NCT01129011|9793064|FG001|COMPLETED|Overall Study||153
8744752|NCT01129011|9793063|FG000|NOT COMPLETED|Overall Study||59
8744753|NCT01129011|9793064|FG001|NOT COMPLETED|Overall Study||57
8744754|NCT01134549|9793075|FG000|STARTED|Overall Study||8
8744755|NCT01134549|9793076|FG001|STARTED|Overall Study||6
8744756|NCT01134549|9793077|FG002|STARTED|Overall Study||6
8744757|NCT01134549|9793078|FG003|STARTED|Overall Study||6
8744758|NCT01134549|9793079|FG004|STARTED|Overall Study||6
8744759|NCT01134549|9793075|FG000|COMPLETED|Overall Study||8
8744760|NCT01134549|9793076|FG001|COMPLETED|Overall Study||6
8744761|NCT01134549|9793077|FG002|COMPLETED|Overall Study||6
8744762|NCT01134549|9793078|FG003|COMPLETED|Overall Study||6
8744763|NCT01134549|9793079|FG004|COMPLETED|Overall Study||6
8744764|NCT01134549|9793075|FG000|NOT COMPLETED|Overall Study||0
8744765|NCT01134549|9793076|FG001|NOT COMPLETED|Overall Study||0
8744766|NCT01134549|9793077|FG002|NOT COMPLETED|Overall Study||0
8744767|NCT01134549|9793078|FG003|NOT COMPLETED|Overall Study||0
8744768|NCT01134549|9793079|FG004|NOT COMPLETED|Overall Study||0
8744769|NCT01134562|9793101|FG000|STARTED|Overall Study||4
8744770|NCT01134562|9793102|FG001|STARTED|Overall Study||4
8744771|NCT01134562|9793103|FG002|STARTED|Overall Study||4
8744772|NCT01134562|9793104|FG003|STARTED|Overall Study||8
8744773|NCT01134562|9793105|FG004|STARTED|Overall Study||8
8744774|NCT01134562|9793101|FG000|COMPLETED|Overall Study||4
8744775|NCT01134562|9793102|FG001|COMPLETED|Overall Study||3
8744776|NCT01134562|9793103|FG002|COMPLETED|Overall Study||4
8744777|NCT01134562|9793104|FG003|COMPLETED|Overall Study||8
8744778|NCT01134562|9793105|FG004|COMPLETED|Overall Study||8
8744779|NCT01134562|9793101|FG000|NOT COMPLETED|Overall Study||0
8744780|NCT01134562|9793102|FG001|NOT COMPLETED|Overall Study||1
8744781|NCT01134562|9793103|FG002|NOT COMPLETED|Overall Study||0
8744782|NCT01134562|9793104|FG003|NOT COMPLETED|Overall Study||0
8744783|NCT01134562|9793105|FG004|NOT COMPLETED|Overall Study||0
8744784|NCT01134575|9793128|FG000|STARTED|Overall Study||3
8744785|NCT01134575|9793129|FG001|STARTED|Overall Study||45
8744786|NCT01134575|9793130|FG002|STARTED|Overall Study||42
8744787|NCT01134575|9793128|FG000|COMPLETED|Overall Study||3
8744788|NCT01134575|9793129|FG001|COMPLETED|Overall Study||45
8744789|NCT01134575|9793130|FG002|COMPLETED|Overall Study||42
8744790|NCT01134575|9793128|FG000|NOT COMPLETED|Overall Study||0
8744791|NCT01134575|9793129|FG001|NOT COMPLETED|Overall Study||0
8744792|NCT01134575|9793130|FG002|NOT COMPLETED|Overall Study||0
8744793|NCT01134627|9793140|FG000|STARTED|Overall Study|Number of participants treated.|149
8744794|NCT01134627|9793141|FG001|STARTED|Overall Study|Number of participants treated.|155
8744795|NCT01134627|9793140|FG000|COMPLETED|Overall Study||80
8744796|NCT01134627|9793141|FG001|COMPLETED|Overall Study||88
8744797|NCT01134627|9793140|FG000|NOT COMPLETED|Overall Study||69
8744798|NCT01134627|9793141|FG001|NOT COMPLETED|Overall Study||67
8744799|NCT01134705|9793149|FG000|STARTED|Overall Study||236
8744800|NCT01134705|9793150|FG001|STARTED|Overall Study||238
8744801|NCT01134705|9793149|FG000|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment.|232
8744802|NCT01134705|9793150|FG001|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment.|234
8744803|NCT01134705|9793149|FG000|COMPLETED|Overall Study||221
8744804|NCT01134705|9793150|FG001|COMPLETED|Overall Study||216
8744805|NCT01134705|9793149|FG000|NOT COMPLETED|Overall Study||15
8744806|NCT01134705|9793150|FG001|NOT COMPLETED|Overall Study||22
8744807|NCT01134731|9793159|FG000|STARTED|Overall Study||23
8744808|NCT01134731|9793160|FG001|STARTED|Overall Study||21
8744809|NCT01134731|9793161|FG002|STARTED|Overall Study||10
8744810|NCT01134731|9793159|FG000|COMPLETED|Overall Study||10
8744811|NCT01134731|9793160|FG001|COMPLETED|Overall Study||10
8744812|NCT01134731|9793161|FG002|COMPLETED|Overall Study||2
8744813|NCT01134731|9793159|FG000|NOT COMPLETED|Overall Study||13
8744814|NCT01134731|9793160|FG001|NOT COMPLETED|Overall Study||11
8744815|NCT01134731|9793161|FG002|NOT COMPLETED|Overall Study||8
8744816|NCT01134783|9793172|FG000|STARTED|Overall Study||224
8744817|NCT01134783|9793173|FG001|STARTED|Overall Study||217
8744818|NCT01134783|9793172|FG000|COMPLETED|Overall Study||188
8744819|NCT01134783|9793173|FG001|COMPLETED|Overall Study||180
8744820|NCT01134783|9793172|FG000|NOT COMPLETED|Overall Study||36
8744821|NCT01134783|9793173|FG001|NOT COMPLETED|Overall Study||37
8744822|NCT01134887|9793187|FG000|STARTED|Overall Study||9
8744823|NCT01134887|9793188|FG001|STARTED|Overall Study||11
8744824|NCT01134887|9793189|FG002|STARTED|Overall Study||5
8744825|NCT01134887|9793190|FG003|STARTED|Overall Study||5
8744826|NCT01134887|9793187|FG000|COMPLETED|Overall Study||9
8744827|NCT01134887|9793188|FG001|COMPLETED|Overall Study|Four patients in the Veteran-Control arm did not have two clinic visits videotaped and left study.|7
8744828|NCT01134887|9793189|FG002|COMPLETED|Overall Study||5
8744829|NCT01134887|9793190|FG003|COMPLETED|Overall Study||5
8744830|NCT01134887|9793187|FG000|NOT COMPLETED|Overall Study||0
8744831|NCT01134887|9793188|FG001|NOT COMPLETED|Overall Study||4
8744832|NCT01134887|9793189|FG002|NOT COMPLETED|Overall Study||0
8744833|NCT01134887|9793190|FG003|NOT COMPLETED|Overall Study||0
8744834|NCT01134900|9793200|FG000|STARTED|Overall Study||200
8744835|NCT01134900|9793201|FG001|STARTED|Overall Study||196
8744836|NCT01134900|9793200|FG000|COMPLETED|Overall Study||200
8744837|NCT01134900|9793201|FG001|COMPLETED|Overall Study||196
8744838|NCT01134900|9793200|FG000|NOT COMPLETED|Overall Study||0
8744839|NCT01134900|9793201|FG001|NOT COMPLETED|Overall Study||0
8744840|NCT01134939|9793215|FG000|STARTED|Overall Study||59
8744841|NCT01134939|9793216|FG001|STARTED|Overall Study||42
8744842|NCT01134939|9793217|FG002|STARTED|Overall Study||51
8744843|NCT01134939|9793218|FG003|STARTED|Overall Study||46
8744844|NCT01134939|9793219|FG004|STARTED|Overall Study||33
8744845|NCT01134939|9793220|FG005|STARTED|Overall Study||14
8744846|NCT01134939|9793221|FG006|STARTED|Overall Study||19
8744847|NCT01134939|9793222|FG007|STARTED|Overall Study||1
8744848|NCT01134939|9793215|FG000|COMPLETED|Overall Study||42
8913337|NCT02160782|9972694|FG000|STARTED|Open-label Period: Maralixibat||31
8913338|NCT02160782|9972695|FG001|STARTED|Open-label Period: Maralixibat||0
8913339|NCT02160782|9972696|FG002|STARTED|Open-label Period: Maralixibat||0
8913340|NCT02160782|9972697|FG003|STARTED|Open-label Period: Maralixibat||0
8913341|NCT02160782|9972698|FG004|STARTED|Open-label Period: Maralixibat||0
8913342|NCT02160782|9972694|FG000|COMPLETED|Open-label Period: Maralixibat||29
8744849|NCT01134939|9793216|FG001|COMPLETED|Overall Study||24
8744850|NCT01134939|9793217|FG002|COMPLETED|Overall Study||41
8744851|NCT01134939|9793218|FG003|COMPLETED|Overall Study||32
8744852|NCT01134939|9793219|FG004|COMPLETED|Overall Study||23
8744853|NCT01134939|9793220|FG005|COMPLETED|Overall Study||5
8744854|NCT01134939|9793221|FG006|COMPLETED|Overall Study||10
8744855|NCT01134939|9793222|FG007|COMPLETED|Overall Study||1
8744856|NCT01134939|9793215|FG000|NOT COMPLETED|Overall Study||17
8744857|NCT01134939|9793216|FG001|NOT COMPLETED|Overall Study||18
8744858|NCT01134939|9793217|FG002|NOT COMPLETED|Overall Study||10
8744859|NCT01134939|9793218|FG003|NOT COMPLETED|Overall Study||14
8744860|NCT01134939|9793219|FG004|NOT COMPLETED|Overall Study||10
8744861|NCT01134939|9793220|FG005|NOT COMPLETED|Overall Study||9
8744862|NCT01134939|9793221|FG006|NOT COMPLETED|Overall Study||9
8744863|NCT01134939|9793222|FG007|NOT COMPLETED|Overall Study||0
8744864|NCT01134952|9793236|FG000|STARTED|Overall Study||11
8744865|NCT01134952|9793236|FG000|COMPLETED|Overall Study||11
8744866|NCT01134952|9793236|FG000|NOT COMPLETED|Overall Study||0
8744867|NCT01135017|9793246|FG000|STARTED|Overall Study||55
8744868|NCT01135017|9793247|FG001|STARTED|Overall Study||57
8744869|NCT01135017|9793246|FG000|Treated|Overall Study||55
8744870|NCT01135017|9793247|FG001|Treated|Overall Study||57
8744871|NCT01135017|9793246|FG000|Evaluable for Efficacy|Overall Study||55
8744872|NCT01135017|9793247|FG001|Evaluable for Efficacy|Overall Study|Two participants did not have interrogation of the pacemaker after randomization|55
8744873|NCT01135017|9793246|FG000|COMPLETED|Overall Study|The study was terminated after enrolled participants completed the study period as per protocol|49
8744874|NCT01135017|9793247|FG001|COMPLETED|Overall Study|The study was terminated after enrolled participants completed the study period as per protocol|45
8744875|NCT01135017|9793246|FG000|NOT COMPLETED|Overall Study||6
8744876|NCT01135017|9793247|FG001|NOT COMPLETED|Overall Study||12
8744877|NCT01135069|9793256|FG000|STARTED|Overall Study||205
8744878|NCT01135069|9793257|FG001|STARTED|Overall Study||209
8744879|NCT01135069|9793258|FG002|STARTED|Overall Study||66
8744880|NCT01135069|9793256|FG000|COMPLETED|Overall Study||169
8744881|NCT01135069|9793257|FG001|COMPLETED|Overall Study||177
8744882|NCT01135069|9793258|FG002|COMPLETED|Overall Study||56
8744883|NCT01135069|9793256|FG000|NOT COMPLETED|Overall Study||36
8744884|NCT01135069|9793257|FG001|NOT COMPLETED|Overall Study||32
8744885|NCT01135069|9793258|FG002|NOT COMPLETED|Overall Study||10
8744886|NCT01135095|9793266|FG000|STARTED|Overall Study||101
8744887|NCT01135095|9793266|FG000|COMPLETED|Overall Study||101
8744888|NCT01135095|9793266|FG000|NOT COMPLETED|Overall Study||0
8744889|NCT01135186|9793270|FG000|STARTED|Overall Study||9
8744890|NCT01135186|9793270|FG000|COMPLETED|Overall Study||9
8744891|NCT01135186|9793270|FG000|NOT COMPLETED|Overall Study||0
8744892|NCT01135329|9793276|FG000|STARTED|Overall Study||15
8744893|NCT01135329|9793276|FG000|COMPLETED|Overall Study||15
8744894|NCT01135329|9793276|FG000|NOT COMPLETED|Overall Study||0
8744895|NCT01135368|9793281|FG000|STARTED|Overall Study||506
8744896|NCT01135368|9793281|FG000|COMPLETED|Overall Study||255
8744897|NCT01135368|9793281|FG000|NOT COMPLETED|Overall Study||251
8744898|NCT01135381|9793323|FG000|STARTED|Overall Study||189
8744899|NCT01135381|9793324|FG001|STARTED|Overall Study||185
8744900|NCT01135381|9793325|FG002|STARTED|Overall Study||69
8744901|NCT01135381|9793326|FG003|STARTED|Overall Study||68
8744902|NCT01135381|9793323|FG000|COMPLETED|Overall Study||168
8744903|NCT01135381|9793324|FG001|COMPLETED|Overall Study||178
8744904|NCT01135381|9793325|FG002|COMPLETED|Overall Study||65
8744905|NCT01135381|9793326|FG003|COMPLETED|Overall Study||67
8744906|NCT01135381|9793323|FG000|NOT COMPLETED|Overall Study||21
8744907|NCT01135381|9793324|FG001|NOT COMPLETED|Overall Study||7
8744908|NCT01135381|9793325|FG002|NOT COMPLETED|Overall Study||4
8744909|NCT01135381|9793326|FG003|NOT COMPLETED|Overall Study||1
8913343|NCT02160782|9972695|FG001|COMPLETED|Open-label Period: Maralixibat||0
8913344|NCT02160782|9972696|FG002|COMPLETED|Open-label Period: Maralixibat||0
8913345|NCT02160782|9972697|FG003|COMPLETED|Open-label Period: Maralixibat||0
8913346|NCT02160782|9972698|FG004|COMPLETED|Open-label Period: Maralixibat||0
8913347|NCT02160782|9972694|FG000|NOT COMPLETED|Open-label Period: Maralixibat||2
8744910|NCT01135394|9793336|FG000|STARTED|Screening||114
8744911|NCT01135394|9793336|FG000|COMPLETED|Screening||81
8744912|NCT01135394|9793336|FG000|NOT COMPLETED|Screening||33
8744913|NCT01135394|9793336|FG000|STARTED|Baseline Assessment||81
8744914|NCT01135394|9793336|FG000|COMPLETED|Baseline Assessment||66
8744915|NCT01135394|9793336|FG000|NOT COMPLETED|Baseline Assessment||15
8744916|NCT01135394|9793336|FG000|STARTED|Study Treatment||66
8744917|NCT01135394|9793336|FG000|COMPLETED|Study Treatment||62
8744918|NCT01135394|9793336|FG000|NOT COMPLETED|Study Treatment||4
8744919|NCT01135420|9793342|FG000|STARTED|Overall Study||199
8744920|NCT01135420|9793343|FG001|STARTED|Overall Study||207
8744921|NCT01135420|9793342|FG000|COMPLETED|Overall Study||155
8744922|NCT01135420|9793343|FG001|COMPLETED|Overall Study||175
8744923|NCT01135420|9793342|FG000|NOT COMPLETED|Overall Study||44
8744924|NCT01135420|9793343|FG001|NOT COMPLETED|Overall Study||32
8744925|NCT01135498|9793349|FG000|STARTED|Overall Study||90
8744926|NCT01135498|9793349|FG000|COMPLETED|Overall Study||0
8744927|NCT01135498|9793349|FG000|NOT COMPLETED|Overall Study||90
8744928|NCT01135511|9793363|FG000|STARTED|Overall Study||41
8744929|NCT01135511|9793364|FG001|STARTED|Overall Study||42
8744930|NCT01135511|9793365|FG002|STARTED|Overall Study||41
8744931|NCT01135511|9793366|FG003|STARTED|Overall Study||40
8744932|NCT01135511|9793367|FG004|STARTED|Overall Study||39
8744933|NCT01135511|9793368|FG005|STARTED|Overall Study||21
8744934|NCT01135511|9793369|FG006|STARTED|Overall Study||19
8744935|NCT01135511|9793370|FG007|STARTED|Overall Study||21
8744936|NCT01135511|9793371|FG008|STARTED|Overall Study||21
8744937|NCT01135511|9793363|FG000|COMPLETED|Overall Study||41
8744938|NCT01135511|9793364|FG001|COMPLETED|Overall Study||39
8744939|NCT01135511|9793365|FG002|COMPLETED|Overall Study||33
8744940|NCT01135511|9793366|FG003|COMPLETED|Overall Study||37
8744941|NCT01135511|9793367|FG004|COMPLETED|Overall Study||38
8744942|NCT01135511|9793368|FG005|COMPLETED|Overall Study||20
8744943|NCT01135511|9793369|FG006|COMPLETED|Overall Study||18
8744944|NCT01135511|9793370|FG007|COMPLETED|Overall Study||20
8744945|NCT01135511|9793371|FG008|COMPLETED|Overall Study||20
8744946|NCT01135511|9793363|FG000|NOT COMPLETED|Overall Study||0
8744947|NCT01135511|9793364|FG001|NOT COMPLETED|Overall Study||3
8744948|NCT01135511|9793365|FG002|NOT COMPLETED|Overall Study||8
8744949|NCT01135511|9793366|FG003|NOT COMPLETED|Overall Study||3
8744950|NCT01135511|9793367|FG004|NOT COMPLETED|Overall Study||1
8744951|NCT01135511|9793368|FG005|NOT COMPLETED|Overall Study||1
8744952|NCT01135511|9793369|FG006|NOT COMPLETED|Overall Study||1
8744953|NCT01135511|9793370|FG007|NOT COMPLETED|Overall Study||1
8744954|NCT01135511|9793371|FG008|NOT COMPLETED|Overall Study||1
8744955|NCT01135524|9793391|FG000|STARTED|Overall Study||196
8744956|NCT01135524|9793391|FG000|COMPLETED|Overall Study||0
8744957|NCT01135524|9793391|FG000|NOT COMPLETED|Overall Study||196
8744958|NCT01135537|9793395|FG000|STARTED|Overall Study||30
8744959|NCT01135537|9793395|FG000|COMPLETED|Overall Study||17
8744960|NCT01135537|9793395|FG000|NOT COMPLETED|Overall Study||13
8744961|NCT01135914|9793402|FG000|STARTED|Overall Study||78
8744962|NCT01135914|9793403|FG001|STARTED|Overall Study||80
8744963|NCT01135914|9793404|FG002|STARTED|Overall Study||81
8744964|NCT01135914|9793402|FG000|Intent to Treat (ITT) Population|Overall Study||73
8744965|NCT01135914|9793403|FG001|Intent to Treat (ITT) Population|Overall Study||75
8744966|NCT01135914|9793404|FG002|Intent to Treat (ITT) Population|Overall Study||72
8744967|NCT01135914|9793402|FG000|Safety Population|Overall Study||73
8744968|NCT01135914|9793403|FG001|Safety Population|Overall Study||75
8744969|NCT01135914|9793404|FG002|Safety Population|Overall Study||74
8744970|NCT01135914|9793402|FG000|COMPLETED|Overall Study||74
8744971|NCT01135914|9793403|FG001|COMPLETED|Overall Study||75
8744972|NCT01135914|9793404|FG002|COMPLETED|Overall Study||59
8744973|NCT01135914|9793402|FG000|NOT COMPLETED|Overall Study||4
8744974|NCT01135914|9793403|FG001|NOT COMPLETED|Overall Study||5
8744975|NCT01135914|9793404|FG002|NOT COMPLETED|Overall Study||22
8744976|NCT01135992|9793412|FG000|STARTED|Overall Study||143
8744977|NCT01135992|9793412|FG000|Exposed|Overall Study|One subject was withdrawn before being exposed.|142
8744978|NCT01135992|9793412|FG000|Full Analysis Set|Overall Study||129
8744979|NCT01135992|9793412|FG000|COMPLETED|Overall Study||122
8744980|NCT01135992|9793412|FG000|NOT COMPLETED|Overall Study||21
8744981|NCT01136174|9793420|FG000|STARTED|Overall Study||12
8744982|NCT01136174|9793421|FG001|STARTED|Overall Study||6
8744983|NCT01136174|9793422|FG002|STARTED|Overall Study||8
8744984|NCT01136174|9793423|FG003|STARTED|Overall Study||24
8744985|NCT01136174|9793420|FG000|COMPLETED|Overall Study||12
8744986|NCT01136174|9793421|FG001|COMPLETED|Overall Study||6
8744987|NCT01136174|9793422|FG002|COMPLETED|Overall Study||8
8744988|NCT01136174|9793423|FG003|COMPLETED|Overall Study||20
8744989|NCT01136174|9793420|FG000|NOT COMPLETED|Overall Study||0
8744990|NCT01136174|9793421|FG001|NOT COMPLETED|Overall Study||0
8744991|NCT01136174|9793422|FG002|NOT COMPLETED|Overall Study||0
8744992|NCT01136174|9793423|FG003|NOT COMPLETED|Overall Study||4
8744993|NCT01136226|9793442|FG000|STARTED|Overall Study||42
8744994|NCT01136226|9793442|FG000|COMPLETED|Overall Study||29
8744995|NCT01136226|9793442|FG000|NOT COMPLETED|Overall Study||13
8744996|NCT01136291|9793449|FG000|STARTED|Overall Study||40
8744997|NCT01136291|9793450|FG001|STARTED|Overall Study||42
8744998|NCT01136291|9793449|FG000|Follow|Overall Study||40
8744999|NCT01136291|9793450|FG001|Follow|Overall Study||42
8745000|NCT01136291|9793449|FG000|COMPLETED|Overall Study||39
8745001|NCT01136291|9793450|FG001|COMPLETED|Overall Study||41
8745002|NCT01136291|9793449|FG000|NOT COMPLETED|Overall Study||1
8745003|NCT01136291|9793450|FG001|NOT COMPLETED|Overall Study||1
8745004|NCT01136356|9793456|FG000|STARTED|First Intervention||6
8745005|NCT01136356|9793457|FG001|STARTED|First Intervention||6
8745006|NCT01136356|9793456|FG000|COMPLETED|First Intervention||6
8745007|NCT01136356|9793457|FG001|COMPLETED|First Intervention||6
8745008|NCT01136356|9793456|FG000|NOT COMPLETED|First Intervention||0
8745009|NCT01136356|9793457|FG001|NOT COMPLETED|First Intervention||0
8745010|NCT01136356|9793456|FG000|STARTED|First 18-day Withdrawal||6
8745011|NCT01136356|9793457|FG001|STARTED|First 18-day Withdrawal||6
8745012|NCT01136356|9793456|FG000|COMPLETED|First 18-day Withdrawal||2
8745013|NCT01136356|9793457|FG001|COMPLETED|First 18-day Withdrawal||6
8745014|NCT01136356|9793456|FG000|NOT COMPLETED|First 18-day Withdrawal||4
8745015|NCT01136356|9793457|FG001|NOT COMPLETED|First 18-day Withdrawal||0
8745016|NCT01136356|9793456|FG000|STARTED|Second Intervention||2
8745017|NCT01136356|9793457|FG001|STARTED|Second Intervention||6
8745018|NCT01136356|9793456|FG000|COMPLETED|Second Intervention||2
8745019|NCT01136356|9793457|FG001|COMPLETED|Second Intervention||6
8745020|NCT01136356|9793456|FG000|NOT COMPLETED|Second Intervention||0
8745021|NCT01136356|9793457|FG001|NOT COMPLETED|Second Intervention||0
8745022|NCT01136356|9793456|FG000|STARTED|Second 18-day Withdrawal||2
8745023|NCT01136356|9793457|FG001|STARTED|Second 18-day Withdrawal||6
8745024|NCT01136356|9793456|FG000|COMPLETED|Second 18-day Withdrawal||2
8745025|NCT01136356|9793457|FG001|COMPLETED|Second 18-day Withdrawal||5
8745026|NCT01136356|9793456|FG000|NOT COMPLETED|Second 18-day Withdrawal||0
8745027|NCT01136356|9793457|FG001|NOT COMPLETED|Second 18-day Withdrawal||1
8745028|NCT01136382|9793464|FG000|STARTED|Overall Study||152
8745029|NCT01136382|9793465|FG001|STARTED|Overall Study||152
8745030|NCT01136382|9793464|FG000|COMPLETED|Overall Study||92
8745031|NCT01136382|9793465|FG001|COMPLETED|Overall Study||121
8745032|NCT01136382|9793464|FG000|NOT COMPLETED|Overall Study||60
8745033|NCT01136382|9793465|FG001|NOT COMPLETED|Overall Study||31
8745034|NCT01136408|9793474|FG000|STARTED|Overall Study||46
8745035|NCT01136408|9793475|FG001|STARTED|Overall Study||58
8745036|NCT01136408|9793476|FG002|STARTED|Overall Study||62
8745037|NCT01136408|9793474|FG000|COMPLETED|Overall Study||41
8745038|NCT01136408|9793475|FG001|COMPLETED|Overall Study||49
8745039|NCT01136408|9793476|FG002|COMPLETED|Overall Study||57
8745040|NCT01136408|9793474|FG000|NOT COMPLETED|Overall Study||5
8745041|NCT01136408|9793475|FG001|NOT COMPLETED|Overall Study||9
8745042|NCT01136408|9793476|FG002|NOT COMPLETED|Overall Study||5
8745043|NCT01136486|9793488|FG000|STARTED|Overall Study||56
8745044|NCT01136486|9793488|FG000|COMPLETED|Overall Study||56
8745045|NCT01136486|9793488|FG000|NOT COMPLETED|Overall Study||0
8745046|NCT01136655|9793492|FG000|STARTED|BUD 160/FM 2.25 (1 Dose)||54
8745047|NCT01136655|9793492|FG000|COMPLETED|BUD 160/FM 2.25 (1 Dose)||54
8745048|NCT01136655|9793492|FG000|NOT COMPLETED|BUD 160/FM 2.25 (1 Dose)||0
8745049|NCT01136655|9793492|FG000|STARTED|Washout After BUD 160/FM 2.25 (7 Days)||54
8745050|NCT01136655|9793492|FG000|COMPLETED|Washout After BUD 160/FM 2.25 (7 Days)||53
8745051|NCT01136655|9793492|FG000|NOT COMPLETED|Washout After BUD 160/FM 2.25 (7 Days)||1
8745052|NCT01136655|9793492|FG000|STARTED|BUD 160/FM 4.5 (1 Dose)||53
8745053|NCT01136655|9793492|FG000|COMPLETED|BUD 160/FM 4.5 (1 Dose)||53
8745054|NCT01136655|9793492|FG000|NOT COMPLETED|BUD 160/FM 4.5 (1 Dose)||0
8745055|NCT01136655|9793492|FG000|STARTED|Washout After BUD 160/FM 4.5 (7 Days)||53
8745056|NCT01136655|9793492|FG000|COMPLETED|Washout After BUD 160/FM 4.5 (7 Days)||52
8745057|NCT01136655|9793492|FG000|NOT COMPLETED|Washout After BUD 160/FM 4.5 (7 Days)||1
8745058|NCT01136655|9793492|FG000|STARTED|BUD 160/FM 9.0 (1 Dose)||53
8745059|NCT01136655|9793492|FG000|COMPLETED|BUD 160/FM 9.0 (1 Dose)||53
8745060|NCT01136655|9793492|FG000|NOT COMPLETED|BUD 160/FM 9.0 (1 Dose)||0
8745061|NCT01136655|9793492|FG000|STARTED|Washout After BUD 160/FM 9.0 (7 Days)||53
8745062|NCT01136655|9793492|FG000|COMPLETED|Washout After BUD 160/FM 9.0 (7 Days)||51
8745063|NCT01136655|9793492|FG000|NOT COMPLETED|Washout After BUD 160/FM 9.0 (7 Days)||2
8745064|NCT01136655|9793492|FG000|STARTED|BUD 160 (1 Dose)||51
8745065|NCT01136655|9793492|FG000|COMPLETED|BUD 160 (1 Dose)||51
8745066|NCT01136655|9793492|FG000|NOT COMPLETED|BUD 160 (1 Dose)||0
8745067|NCT01136655|9793492|FG000|STARTED|Washout After BUD 160 (7 Days)||51
8745068|NCT01136655|9793492|FG000|COMPLETED|Washout After BUD 160 (7 Days)||51
8745069|NCT01136655|9793492|FG000|NOT COMPLETED|Washout After BUD 160 (7 Days)||0
8745070|NCT01136655|9793492|FG000|STARTED|BUD 160/ Foradil 12.0 (1 Dose)||50
8745071|NCT01136655|9793492|FG000|COMPLETED|BUD 160/ Foradil 12.0 (1 Dose)||50
8745072|NCT01136655|9793492|FG000|NOT COMPLETED|BUD 160/ Foradil 12.0 (1 Dose)||0
8745073|NCT01136655|9793492|FG000|STARTED|Washout After BUD 160/ Foradil (7 Days)||50
8745074|NCT01136655|9793492|FG000|COMPLETED|Washout After BUD 160/ Foradil (7 Days)||50
8745075|NCT01136655|9793492|FG000|NOT COMPLETED|Washout After BUD 160/ Foradil (7 Days)||0
8745076|NCT01136733|9793512|FG000|STARTED|Phase 1b|Participants in Phase 1b did not advance to Phase 2.|7
8745077|NCT01136733|9793513|FG001|STARTED|Phase 1b|Participants in Phase 1b did not advance to Phase 2.|11
8745078|NCT01136733|9793514|FG002|STARTED|Phase 1b|Participants in Phase 1b did not advance to Phase 2.|2
8745079|NCT01136733|9793515|FG003|STARTED|Phase 1b|Participants in Phase 1b did not advance to Phase 2.|0
8745080|NCT01136733|9793516|FG004|STARTED|Phase 1b||0
8745081|NCT01136733|9793517|FG005|STARTED|Phase 1b||0
8745082|NCT01136733|9793518|FG006|STARTED|Phase 1b||0
8745083|NCT01136733|9793512|FG000|COMPLETED|Phase 1b||6
9022822|NCT03131648|10085669|FG005|COMPLETED|Open-label Treatment||0
9022823|NCT03131648|10085670|FG006|COMPLETED|Open-label Treatment||446
8745084|NCT01136733|9793513|FG001|COMPLETED|Phase 1b||6
8745085|NCT01136733|9793514|FG002|COMPLETED|Phase 1b||0
8745086|NCT01136733|9793515|FG003|COMPLETED|Phase 1b||0
8745087|NCT01136733|9793516|FG004|COMPLETED|Phase 1b||0
8745088|NCT01136733|9793517|FG005|COMPLETED|Phase 1b||0
8745089|NCT01136733|9793518|FG006|COMPLETED|Phase 1b||0
9022824|NCT03131648|10085671|FG007|COMPLETED|Open-label Treatment||0
9022825|NCT03131648|10085664|FG000|NOT COMPLETED|Open-label Treatment||0
9022826|NCT03131648|10085665|FG001|NOT COMPLETED|Open-label Treatment||0
9022827|NCT03131648|10085666|FG002|NOT COMPLETED|Open-label Treatment||0
8913348|NCT02160782|9972695|FG001|NOT COMPLETED|Open-label Period: Maralixibat||0
8913349|NCT02160782|9972696|FG002|NOT COMPLETED|Open-label Period: Maralixibat||0
8913350|NCT02160782|9972697|FG003|NOT COMPLETED|Open-label Period: Maralixibat||0
8913351|NCT02160782|9972698|FG004|NOT COMPLETED|Open-label Period: Maralixibat||0
8913352|NCT02160782|9972694|FG000|STARTED|Randomized Withdrawal Period- Pbo vs MRX||0
8913353|NCT02160782|9972695|FG001|STARTED|Randomized Withdrawal Period- Pbo vs MRX||13
8913354|NCT02160782|9972696|FG002|STARTED|Randomized Withdrawal Period- Pbo vs MRX||16
8913355|NCT02160782|9972697|FG003|STARTED|Randomized Withdrawal Period- Pbo vs MRX||0
8913356|NCT02160782|9972698|FG004|STARTED|Randomized Withdrawal Period- Pbo vs MRX||0
8913357|NCT02160782|9972694|FG000|COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0
8913358|NCT02160782|9972695|FG001|COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||13
8913359|NCT02160782|9972696|FG002|COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||16
8913360|NCT02160782|9972697|FG003|COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0
8913361|NCT02160782|9972698|FG004|COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0
8913362|NCT02160782|9972694|FG000|NOT COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0
8913363|NCT02160782|9972695|FG001|NOT COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0
8913364|NCT02160782|9972696|FG002|NOT COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0
8913365|NCT02160782|9972697|FG003|NOT COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0
8913366|NCT02160782|9972698|FG004|NOT COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0
8913367|NCT02160782|9972694|FG000|STARTED|After Randomized Withdrawal: Maralixibat||0
8913368|NCT02160782|9972695|FG001|STARTED|After Randomized Withdrawal: Maralixibat||0
8913369|NCT02160782|9972696|FG002|STARTED|After Randomized Withdrawal: Maralixibat||0
8913370|NCT02160782|9972697|FG003|STARTED|After Randomized Withdrawal: Maralixibat||29
8913371|NCT02160782|9972698|FG004|STARTED|After Randomized Withdrawal: Maralixibat||0
8913372|NCT02160782|9972694|FG000|COMPLETED|After Randomized Withdrawal: Maralixibat||0
8913373|NCT02160782|9972695|FG001|COMPLETED|After Randomized Withdrawal: Maralixibat||0
8913374|NCT02160782|9972696|FG002|COMPLETED|After Randomized Withdrawal: Maralixibat||0
8913375|NCT02160782|9972697|FG003|COMPLETED|After Randomized Withdrawal: Maralixibat||23
8913376|NCT02160782|9972698|FG004|COMPLETED|After Randomized Withdrawal: Maralixibat||0
8913377|NCT02160782|9972694|FG000|NOT COMPLETED|After Randomized Withdrawal: Maralixibat||0
8913378|NCT02160782|9972695|FG001|NOT COMPLETED|After Randomized Withdrawal: Maralixibat||0
8913379|NCT02160782|9972696|FG002|NOT COMPLETED|After Randomized Withdrawal: Maralixibat||0
8913380|NCT02160782|9972697|FG003|NOT COMPLETED|After Randomized Withdrawal: Maralixibat||6
8913381|NCT02160782|9972698|FG004|NOT COMPLETED|After Randomized Withdrawal: Maralixibat||0
8913382|NCT02160782|9972694|FG000|STARTED|Long-term Extension Period: Maralixibat||0
8913383|NCT02160782|9972695|FG001|STARTED|Long-term Extension Period: Maralixibat||0
8913384|NCT02160782|9972696|FG002|STARTED|Long-term Extension Period: Maralixibat||0
8913385|NCT02160782|9972697|FG003|STARTED|Long-term Extension Period: Maralixibat||0
8913386|NCT02160782|9972698|FG004|STARTED|Long-term Extension Period: Maralixibat||23
8913387|NCT02160782|9972694|FG000|COMPLETED|Long-term Extension Period: Maralixibat||0
8913388|NCT02160782|9972695|FG001|COMPLETED|Long-term Extension Period: Maralixibat||0
8913389|NCT02160782|9972696|FG002|COMPLETED|Long-term Extension Period: Maralixibat||0
8913390|NCT02160782|9972697|FG003|COMPLETED|Long-term Extension Period: Maralixibat||0
8913391|NCT02160782|9972698|FG004|COMPLETED|Long-term Extension Period: Maralixibat||14
8913392|NCT02160782|9972694|FG000|NOT COMPLETED|Long-term Extension Period: Maralixibat||0
8913393|NCT02160782|9972695|FG001|NOT COMPLETED|Long-term Extension Period: Maralixibat||0
8913394|NCT02160782|9972696|FG002|NOT COMPLETED|Long-term Extension Period: Maralixibat||0
8913395|NCT02160782|9972697|FG003|NOT COMPLETED|Long-term Extension Period: Maralixibat||0
8913396|NCT02160782|9972698|FG004|NOT COMPLETED|Long-term Extension Period: Maralixibat||9
8913397|NCT02160808|9972724|FG000|STARTED|Overall Study||87
8913398|NCT02160808|9972725|FG001|STARTED|Overall Study||83
8913399|NCT02160808|9972724|FG000|COMPLETED|Overall Study||87
8913400|NCT02160808|9972725|FG001|COMPLETED|Overall Study||83
8913401|NCT02160808|9972724|FG000|NOT COMPLETED|Overall Study||0
8913402|NCT02160808|9972725|FG001|NOT COMPLETED|Overall Study||0
8913403|NCT02160847|9972733|FG000|STARTED|Overall Study||16
8913404|NCT02160847|9972734|FG001|STARTED|Overall Study||16
8913405|NCT02160847|9972733|FG000|COMPLETED|Overall Study||16
8913406|NCT02160847|9972734|FG001|COMPLETED|Overall Study||16
8913407|NCT02160847|9972733|FG000|NOT COMPLETED|Overall Study||0
8913408|NCT02160847|9972734|FG001|NOT COMPLETED|Overall Study||0
9022828|NCT03131648|10085667|FG003|NOT COMPLETED|Open-label Treatment||0
8745090|NCT01136733|9793512|FG000|NOT COMPLETED|Phase 1b||1
9022829|NCT03131648|10085668|FG004|NOT COMPLETED|Open-label Treatment||0
8745091|NCT01136733|9793513|FG001|NOT COMPLETED|Phase 1b||5
8745092|NCT01136733|9793514|FG002|NOT COMPLETED|Phase 1b||2
8745093|NCT01136733|9793515|FG003|NOT COMPLETED|Phase 1b||0
8745094|NCT01136733|9793516|FG004|NOT COMPLETED|Phase 1b||0
8745095|NCT01136733|9793517|FG005|NOT COMPLETED|Phase 1b||0
8745096|NCT01136733|9793518|FG006|NOT COMPLETED|Phase 1b||0
8745097|NCT01136733|9793512|FG000|STARTED|Phase 2||0
8745098|NCT01136733|9793513|FG001|STARTED|Phase 2||0
8745099|NCT01136733|9793514|FG002|STARTED|Phase 2||0
8745100|NCT01136733|9793515|FG003|STARTED|Phase 2||0
8745101|NCT01136733|9793516|FG004|STARTED|Phase 2|Participants in Phase 2 did not participate in Phase 1b.|51
8745102|NCT01136733|9793517|FG005|STARTED|Phase 2|Participants in Phase 2 did not participate in Phase 1b.|52
8745103|NCT01136733|9793518|FG006|STARTED|Phase 2|Participants in Phase 2 did not participate in Phase 1b.|50
8745104|NCT01136733|9793512|FG000|COMPLETED|Phase 2||0
8745105|NCT01136733|9793513|FG001|COMPLETED|Phase 2||0
8745106|NCT01136733|9793514|FG002|COMPLETED|Phase 2||0
8745107|NCT01136733|9793515|FG003|COMPLETED|Phase 2||0
8745108|NCT01136733|9793516|FG004|COMPLETED|Phase 2||0
8745109|NCT01136733|9793517|FG005|COMPLETED|Phase 2||0
8745110|NCT01136733|9793518|FG006|COMPLETED|Phase 2||0
8745111|NCT01136733|9793512|FG000|NOT COMPLETED|Phase 2||0
8745112|NCT01136733|9793513|FG001|NOT COMPLETED|Phase 2||0
8745113|NCT01136733|9793514|FG002|NOT COMPLETED|Phase 2||0
8745114|NCT01136733|9793515|FG003|NOT COMPLETED|Phase 2||0
8745115|NCT01136733|9793516|FG004|NOT COMPLETED|Phase 2||51
8745116|NCT01136733|9793517|FG005|NOT COMPLETED|Phase 2||52
8745117|NCT01136733|9793518|FG006|NOT COMPLETED|Phase 2||50
8745118|NCT01136746|9793550|FG000|STARTED|Overall Study||9
8745119|NCT01136746|9793551|FG001|STARTED|Overall Study||7
8745120|NCT01136746|9793550|FG000|COMPLETED|Overall Study||6
8745121|NCT01136746|9793551|FG001|COMPLETED|Overall Study||4
8745122|NCT01136746|9793550|FG000|NOT COMPLETED|Overall Study||3
8745123|NCT01136746|9793551|FG001|NOT COMPLETED|Overall Study||3
8745124|NCT01136772|9793559|FG000|STARTED|Overall Study||157
8745125|NCT01136772|9793560|FG001|STARTED|Overall Study||154
8745126|NCT01136772|9793559|FG000|Safety Population|Overall Study|Includes all randomized participants who received at least one dose of the injectable medication|147
8745127|NCT01136772|9793560|FG001|Safety Population|Overall Study|Includes all randomized participants who received at least one dose of the injectable medication|147
8745128|NCT01136772|9793559|FG000|COMPLETED|Overall Study||41
8745129|NCT01136772|9793560|FG001|COMPLETED|Overall Study||44
8745130|NCT01136772|9793559|FG000|NOT COMPLETED|Overall Study||116
8745131|NCT01136772|9793560|FG001|NOT COMPLETED|Overall Study||110
8745132|NCT01136785|9793568|FG000|STARTED|Overall Study||15
8745133|NCT01136785|9793569|FG001|STARTED|Overall Study||7
8745134|NCT01136785|9793568|FG000|COMPLETED|Overall Study||13
8745135|NCT01136785|9793569|FG001|COMPLETED|Overall Study||6
8913409|NCT02160873|9972742|FG000|STARTED|Overall Study||6
8913410|NCT02160873|9972743|FG001|STARTED|Overall Study||6
8913411|NCT02160873|9972742|FG000|COMPLETED|Overall Study||6
8913412|NCT02160873|9972743|FG001|COMPLETED|Overall Study||6
8913413|NCT02160873|9972742|FG000|NOT COMPLETED|Overall Study||0
8913414|NCT02160873|9972743|FG001|NOT COMPLETED|Overall Study||0
8913415|NCT02160899|9972761|FG000|STARTED|Overall Study||26
8913416|NCT02160899|9972762|FG001|STARTED|Overall Study||4
8913417|NCT02160899|9972763|FG002|STARTED|Overall Study||21
8913418|NCT02160899|9972764|FG003|STARTED|Overall Study||3
8913419|NCT02160899|9972765|FG004|STARTED|Overall Study||2
8913420|NCT02160899|9972766|FG005|STARTED|Overall Study||8
8913421|NCT02160899|9972761|FG000|COMPLETED|Overall Study||26
8913422|NCT02160899|9972762|FG001|COMPLETED|Overall Study||3
8913423|NCT02160899|9972763|FG002|COMPLETED|Overall Study||21
8913424|NCT02160899|9972764|FG003|COMPLETED|Overall Study||2
8913425|NCT02160899|9972765|FG004|COMPLETED|Overall Study||0
8913426|NCT02160899|9972766|FG005|COMPLETED|Overall Study||8
8913427|NCT02160899|9972761|FG000|NOT COMPLETED|Overall Study||0
8913428|NCT02160899|9972762|FG001|NOT COMPLETED|Overall Study||1
8913429|NCT02160899|9972763|FG002|NOT COMPLETED|Overall Study||0
8913430|NCT02160899|9972764|FG003|NOT COMPLETED|Overall Study||1
8913431|NCT02160899|9972765|FG004|NOT COMPLETED|Overall Study||2
8913432|NCT02160899|9972766|FG005|NOT COMPLETED|Overall Study||0
8913433|NCT02160977|9972782|FG000|STARTED|One Week After Surgery||45
8913434|NCT02160977|9972783|FG001|STARTED|One Week After Surgery||45
8913435|NCT02160977|9972782|FG000|COMPLETED|One Week After Surgery||45
8913436|NCT02160977|9972783|FG001|COMPLETED|One Week After Surgery||45
9022830|NCT03131648|10085669|FG005|NOT COMPLETED|Open-label Treatment||0
8745136|NCT01136785|9793568|FG000|NOT COMPLETED|Overall Study||2
8745137|NCT01136785|9793569|FG001|NOT COMPLETED|Overall Study||1
8745138|NCT01136798|9793581|FG000|STARTED|Overall Study||10
8745139|NCT01136798|9793582|FG001|STARTED|Overall Study||8
8913437|NCT02160977|9972782|FG000|NOT COMPLETED|One Week After Surgery||0
8913438|NCT02160977|9972783|FG001|NOT COMPLETED|One Week After Surgery||0
8913439|NCT02160977|9972782|FG000|STARTED|Six Weeks After Surgery||45
8913440|NCT02160977|9972783|FG001|STARTED|Six Weeks After Surgery||45
8913441|NCT02160977|9972782|FG000|COMPLETED|Six Weeks After Surgery||44
8913442|NCT02160977|9972783|FG001|COMPLETED|Six Weeks After Surgery||45
8913443|NCT02160977|9972782|FG000|NOT COMPLETED|Six Weeks After Surgery||1
8913444|NCT02160977|9972783|FG001|NOT COMPLETED|Six Weeks After Surgery||0
9022831|NCT03131648|10085670|FG006|NOT COMPLETED|Open-label Treatment||118
8745140|NCT01136798|9793581|FG000|COMPLETED|Overall Study||10
8745141|NCT01136798|9793582|FG001|COMPLETED|Overall Study||8
8913445|NCT02160977|9972782|FG000|STARTED|Three Months After Surgery||44
8913446|NCT02160977|9972783|FG001|STARTED|Three Months After Surgery||45
8913447|NCT02160977|9972782|FG000|COMPLETED|Three Months After Surgery||44
8913448|NCT02160977|9972783|FG001|COMPLETED|Three Months After Surgery||43
8745142|NCT01136798|9793581|FG000|NOT COMPLETED|Overall Study||0
8745143|NCT01136798|9793582|FG001|NOT COMPLETED|Overall Study||0
8745144|NCT01136876|9793590|FG000|STARTED|Overall Study||28
8745145|NCT01136876|9793591|FG001|STARTED|Overall Study||29
8745146|NCT01136876|9793590|FG000|COMPLETED|Overall Study||23
8745147|NCT01136876|9793591|FG001|COMPLETED|Overall Study||18
8745148|NCT01136876|9793590|FG000|NOT COMPLETED|Overall Study||5
8745149|NCT01136876|9793591|FG001|NOT COMPLETED|Overall Study||11
8745150|NCT01136915|9793601|FG000|STARTED|Overall Study||8
8745151|NCT01136915|9793602|FG001|STARTED|Overall Study||7
8745152|NCT01136915|9793601|FG000|COMPLETED|Overall Study||6
8745153|NCT01136915|9793602|FG001|COMPLETED|Overall Study||6
8745154|NCT01136915|9793601|FG000|NOT COMPLETED|Overall Study||2
8745155|NCT01136915|9793602|FG001|NOT COMPLETED|Overall Study||1
8745156|NCT01136954|9793612|FG000|STARTED|Overall Study||72
8745157|NCT01136954|9793613|FG001|STARTED|Overall Study||72
8745158|NCT01136954|9793612|FG000|COMPLETED|Overall Study||48
8745159|NCT01136954|9793613|FG001|COMPLETED|Overall Study||51
8745160|NCT01136954|9793612|FG000|NOT COMPLETED|Overall Study||24
8745161|NCT01136954|9793613|FG001|NOT COMPLETED|Overall Study||21
8745162|NCT01137006|9793627|FG000|STARTED|Overall Study||3
8745163|NCT01137006|9793628|FG001|STARTED|Overall Study||3
8745164|NCT01137006|9793629|FG002|STARTED|Overall Study||8
8745165|NCT01137006|9793630|FG003|STARTED|Overall Study||3
8745166|NCT01137006|9793631|FG004|STARTED|Overall Study||3
8745167|NCT01137006|9793632|FG005|STARTED|Overall Study||4
8745168|NCT01137006|9793633|FG006|STARTED|Overall Study||3
8745169|NCT01137006|9793627|FG000|Completed at Least 1 Treatment Cycle|Overall Study||3
8745170|NCT01137006|9793628|FG001|Completed at Least 1 Treatment Cycle|Overall Study||3
8745171|NCT01137006|9793629|FG002|Completed at Least 1 Treatment Cycle|Overall Study||8
8745172|NCT01137006|9793630|FG003|Completed at Least 1 Treatment Cycle|Overall Study||3
8745173|NCT01137006|9793631|FG004|Completed at Least 1 Treatment Cycle|Overall Study||3
8745174|NCT01137006|9793632|FG005|Completed at Least 1 Treatment Cycle|Overall Study||4
8745175|NCT01137006|9793633|FG006|Completed at Least 1 Treatment Cycle|Overall Study||3
8745176|NCT01137006|9793627|FG000|COMPLETED|Overall Study||3
8745177|NCT01137006|9793628|FG001|COMPLETED|Overall Study||3
8745178|NCT01137006|9793629|FG002|COMPLETED|Overall Study||8
8745179|NCT01137006|9793630|FG003|COMPLETED|Overall Study||3
8745180|NCT01137006|9793631|FG004|COMPLETED|Overall Study||3
8745181|NCT01137006|9793632|FG005|COMPLETED|Overall Study||4
8745182|NCT01137006|9793633|FG006|COMPLETED|Overall Study||3
8745183|NCT01137006|9793627|FG000|NOT COMPLETED|Overall Study||0
8745184|NCT01137006|9793628|FG001|NOT COMPLETED|Overall Study||0
8745185|NCT01137006|9793629|FG002|NOT COMPLETED|Overall Study||0
8745186|NCT01137006|9793630|FG003|NOT COMPLETED|Overall Study||0
8745187|NCT01137006|9793631|FG004|NOT COMPLETED|Overall Study||0
8745188|NCT01137006|9793632|FG005|NOT COMPLETED|Overall Study||0
8745189|NCT01137006|9793633|FG006|NOT COMPLETED|Overall Study||0
8745190|NCT01137032|9793650|FG000|STARTED|Overall Study||19
8745191|NCT01137032|9793650|FG000|COMPLETED|Overall Study||19
8745192|NCT01137032|9793650|FG000|NOT COMPLETED|Overall Study||0
8745193|NCT01137071|9793654|FG000|STARTED|Overall Study|all patients considered eligible were included on the study|29
8745194|NCT01137071|9793654|FG000|COMPLETED|Overall Study|Of the eligible patients|15
8745195|NCT01137071|9793654|FG000|NOT COMPLETED|Overall Study||14
8745196|NCT01137110|9793665|FG000|STARTED|Overall Study||35
8745197|NCT01137110|9793666|FG001|STARTED|Overall Study||49
8745198|NCT01137110|9793665|FG000|COMPLETED|Overall Study||34
8745199|NCT01137110|9793666|FG001|COMPLETED|Overall Study||49
8745200|NCT01137110|9793665|FG000|NOT COMPLETED|Overall Study||1
8913449|NCT02160977|9972782|FG000|NOT COMPLETED|Three Months After Surgery||0
8913450|NCT02160977|9972783|FG001|NOT COMPLETED|Three Months After Surgery||2
8913451|NCT02160977|9972782|FG000|STARTED|Six Months After Surgery||44
8913452|NCT02160977|9972783|FG001|STARTED|Six Months After Surgery||43
9022832|NCT03131648|10085671|FG007|NOT COMPLETED|Open-label Treatment||0
9022833|NCT03131648|10085664|FG000|STARTED|Maintenance Treatment Period||0
9022834|NCT03131648|10085665|FG001|STARTED|Maintenance Treatment Period||0
9022835|NCT03131648|10085666|FG002|STARTED|Maintenance Treatment Period||71
9022836|NCT03131648|10085667|FG003|STARTED|Maintenance Treatment Period||78
9022837|NCT03131648|10085668|FG004|STARTED|Maintenance Treatment Period||36
9022838|NCT03131648|10085669|FG005|STARTED|Maintenance Treatment Period||29
9022839|NCT03131648|10085670|FG006|STARTED|Maintenance Treatment Period||0
9022840|NCT03131648|10085671|FG007|STARTED|Maintenance Treatment Period||0
9022841|NCT03131648|10085664|FG000|COMPLETED|Maintenance Treatment Period||0
9022842|NCT03131648|10085665|FG001|COMPLETED|Maintenance Treatment Period||0
9022843|NCT03131648|10085666|FG002|COMPLETED|Maintenance Treatment Period||44
9022844|NCT03131648|10085667|FG003|COMPLETED|Maintenance Treatment Period||53
9022845|NCT03131648|10085668|FG004|COMPLETED|Maintenance Treatment Period||21
9022846|NCT03131648|10085669|FG005|COMPLETED|Maintenance Treatment Period||15
9022847|NCT03131648|10085670|FG006|COMPLETED|Maintenance Treatment Period||0
9022848|NCT03131648|10085671|FG007|COMPLETED|Maintenance Treatment Period||0
9022849|NCT03131648|10085664|FG000|NOT COMPLETED|Maintenance Treatment Period||0
9022850|NCT03131648|10085665|FG001|NOT COMPLETED|Maintenance Treatment Period||0
9022851|NCT03131648|10085666|FG002|NOT COMPLETED|Maintenance Treatment Period||27
9022852|NCT03131648|10085667|FG003|NOT COMPLETED|Maintenance Treatment Period||25
9022853|NCT03131648|10085668|FG004|NOT COMPLETED|Maintenance Treatment Period||15
8913453|NCT02160977|9972782|FG000|COMPLETED|Six Months After Surgery||42
8913454|NCT02160977|9972783|FG001|COMPLETED|Six Months After Surgery||42
8913455|NCT02160977|9972782|FG000|NOT COMPLETED|Six Months After Surgery||2
8913456|NCT02160977|9972783|FG001|NOT COMPLETED|Six Months After Surgery||1
8913457|NCT02160990|9972791|FG000|STARTED|Overall Study||10
8913458|NCT02160990|9972792|FG001|STARTED|Overall Study||10
8913459|NCT02160990|9972791|FG000|COMPLETED|Overall Study||10
8913460|NCT02160990|9972792|FG001|COMPLETED|Overall Study||10
8913461|NCT02160990|9972791|FG000|NOT COMPLETED|Overall Study||0
8913462|NCT02160990|9972792|FG001|NOT COMPLETED|Overall Study||0
8913463|NCT02161133|9972800|FG000|STARTED|Overall Study||135
8913464|NCT02161133|9972801|FG001|STARTED|Overall Study||133
8913465|NCT02161133|9972800|FG000|COMPLETED|Overall Study||116
8913466|NCT02161133|9972801|FG001|COMPLETED|Overall Study||122
8913467|NCT02161133|9972800|FG000|NOT COMPLETED|Overall Study||19
8913468|NCT02161133|9972801|FG001|NOT COMPLETED|Overall Study||11
8913469|NCT02161146|9972812|FG000|STARTED|Overall Study||47
8913470|NCT02161146|9972813|FG001|STARTED|Overall Study||47
8913471|NCT02161146|9972814|FG002|STARTED|Overall Study||49
8913472|NCT02161146|9972815|FG003|STARTED|Overall Study||48
8913473|NCT02161146|9972816|FG004|STARTED|Overall Study||49
8913474|NCT02161146|9972812|FG000|COMPLETED|Overall Study||46
8913475|NCT02161146|9972813|FG001|COMPLETED|Overall Study||43
8913476|NCT02161146|9972814|FG002|COMPLETED|Overall Study||49
8913477|NCT02161146|9972815|FG003|COMPLETED|Overall Study||45
8913478|NCT02161146|9972816|FG004|COMPLETED|Overall Study||48
8913479|NCT02161146|9972812|FG000|NOT COMPLETED|Overall Study||1
8913480|NCT02161146|9972813|FG001|NOT COMPLETED|Overall Study||4
8913481|NCT02161146|9972814|FG002|NOT COMPLETED|Overall Study||0
8913482|NCT02161146|9972815|FG003|NOT COMPLETED|Overall Study||3
8913483|NCT02161146|9972816|FG004|NOT COMPLETED|Overall Study||1
8913484|NCT02161185|9972826|FG000|STARTED|Test Dose Phase||7
9022854|NCT03131648|10085669|FG005|NOT COMPLETED|Maintenance Treatment Period||14
9022855|NCT03131648|10085670|FG006|NOT COMPLETED|Maintenance Treatment Period||0
9022856|NCT03131648|10085671|FG007|NOT COMPLETED|Maintenance Treatment Period||0
9022857|NCT03131648|10085664|FG000|STARTED|Open-label (Short Term Extension)||0
8913485|NCT02161185|9972826|FG000|COMPLETED|Test Dose Phase||7
8913486|NCT02161185|9972826|FG000|NOT COMPLETED|Test Dose Phase||0
8913487|NCT02161185|9972826|FG000|STARTED|Treatment Phase||7
8913488|NCT02161185|9972826|FG000|COMPLETED|Treatment Phase||0
8913489|NCT02161185|9972826|FG000|NOT COMPLETED|Treatment Phase||7
8913490|NCT02161406|9972832|FG000|STARTED|Overall Study||44
8913491|NCT02161406|9972833|FG001|STARTED|Overall Study||44
8913492|NCT02161406|9972832|FG000|COMPLETED|Overall Study||34
8913493|NCT02161406|9972833|FG001|COMPLETED|Overall Study||35
8913494|NCT02161406|9972832|FG000|NOT COMPLETED|Overall Study||10
8913495|NCT02161406|9972833|FG001|NOT COMPLETED|Overall Study||9
8913496|NCT02161458|9972843|FG000|STARTED|Overall Study||22
8913497|NCT02161458|9972844|FG001|STARTED|Overall Study||35
8913498|NCT02161458|9972845|FG002|STARTED|Overall Study||33
8913499|NCT02161458|9972846|FG003|STARTED|Overall Study||8
8913500|NCT02161458|9972843|FG000|COMPLETED|Overall Study||22
8913501|NCT02161458|9972844|FG001|COMPLETED|Overall Study||29
8913502|NCT02161458|9972845|FG002|COMPLETED|Overall Study||28
8913503|NCT02161458|9972846|FG003|COMPLETED|Overall Study||8
8913504|NCT02161458|9972843|FG000|NOT COMPLETED|Overall Study||0
8913505|NCT02161458|9972844|FG001|NOT COMPLETED|Overall Study||6
8913506|NCT02161458|9972845|FG002|NOT COMPLETED|Overall Study||5
8913507|NCT02161458|9972846|FG003|NOT COMPLETED|Overall Study||0
8913508|NCT02161484|9972858|FG000|STARTED|Overall Study||5
8913509|NCT02161484|9972859|FG001|STARTED|Overall Study||5
8913510|NCT02161484|9972858|FG000|COMPLETED|Overall Study||1
8913511|NCT02161484|9972859|FG001|COMPLETED|Overall Study||2
8913512|NCT02161484|9972858|FG000|NOT COMPLETED|Overall Study||4
8913513|NCT02161484|9972859|FG001|NOT COMPLETED|Overall Study||3
8913514|NCT02161536|9972868|FG000|STARTED|Overall Study||6
8913515|NCT02161536|9972869|FG001|STARTED|Overall Study||21
8913516|NCT02161536|9972870|FG002|STARTED|Overall Study||20
8913517|NCT02161536|9972868|FG000|COMPLETED|Overall Study||6
8913518|NCT02161536|9972869|FG001|COMPLETED|Overall Study||21
8913519|NCT02161536|9972870|FG002|COMPLETED|Overall Study||20
8913520|NCT02161536|9972868|FG000|NOT COMPLETED|Overall Study||0
8913521|NCT02161536|9972869|FG001|NOT COMPLETED|Overall Study||0
8913522|NCT02161536|9972870|FG002|NOT COMPLETED|Overall Study||0
8913523|NCT02161549|9972880|FG000|STARTED|Overall Study||40
8913524|NCT02161549|9972881|FG001|STARTED|Overall Study||31
8913525|NCT02161549|9972880|FG000|COMPLETED|Overall Study||34
8913526|NCT02161549|9972881|FG001|COMPLETED|Overall Study||29
8913527|NCT02161549|9972880|FG000|NOT COMPLETED|Overall Study||6
8913528|NCT02161549|9972881|FG001|NOT COMPLETED|Overall Study||2
8913529|NCT02161562|9972889|FG000|STARTED|Overall Study||178
8913530|NCT02161562|9972890|FG001|STARTED|Overall Study||136
8913531|NCT02161562|9972889|FG000|COMPLETED|Overall Study||152
8913532|NCT02161562|9972890|FG001|COMPLETED|Overall Study||119
8913533|NCT02161562|9972889|FG000|NOT COMPLETED|Overall Study||26
8913534|NCT02161562|9972890|FG001|NOT COMPLETED|Overall Study||17
8913535|NCT02161575|9972909|FG000|STARTED|Overall Study||103
8913536|NCT02161575|9972909|FG000|Full Analysis Set (FAS) Population|Overall Study||100
8913537|NCT02161575|9972909|FG000|Safety (SAF) Population|Overall Study||100
8913538|NCT02161575|9972909|FG000|COMPLETED|Overall Study||92
8913539|NCT02161575|9972909|FG000|NOT COMPLETED|Overall Study||11
9022858|NCT03131648|10085665|FG001|STARTED|Open-label (Short Term Extension)||0
8745201|NCT01137110|9793666|FG001|NOT COMPLETED|Overall Study||0
8745202|NCT01137292|9793672|FG000|STARTED|Overall Study||177
8745203|NCT01137292|9793672|FG000|COMPLETED|Overall Study||123
8745204|NCT01137292|9793672|FG000|NOT COMPLETED|Overall Study||54
8745205|NCT01137370|9793678|FG000|STARTED|Overall Study||116
8745206|NCT01137370|9793679|FG001|STARTED|Overall Study||87
8745207|NCT01137370|9793678|FG000|COMPLETED|Overall Study||116
8745208|NCT01137370|9793679|FG001|COMPLETED|Overall Study||87
8745209|NCT01137370|9793678|FG000|NOT COMPLETED|Overall Study||0
8745210|NCT01137370|9793679|FG001|NOT COMPLETED|Overall Study||0
8745211|NCT01137396|9793687|FG000|STARTED|Overall Study||30
8745212|NCT01137396|9793688|FG001|STARTED|Overall Study||27
8745213|NCT01137396|9793687|FG000|COMPLETED|Overall Study||22
8745214|NCT01137396|9793688|FG001|COMPLETED|Overall Study||25
8745215|NCT01137396|9793687|FG000|NOT COMPLETED|Overall Study||8
8745216|NCT01137396|9793688|FG001|NOT COMPLETED|Overall Study||2
8745217|NCT01137474|9793698|FG000|STARTED|Overall Study||311
8745218|NCT01137474|9793699|FG001|STARTED|Overall Study||166
8745219|NCT01137474|9793700|FG002|STARTED|Overall Study||165
8745220|NCT01137474|9793701|FG003|STARTED|Overall Study||302
8745221|NCT01137474|9793698|FG000|Received Treatment|Overall Study||311
8745222|NCT01137474|9793699|FG001|Received Treatment|Overall Study||166
8745223|NCT01137474|9793700|FG002|Received Treatment|Overall Study||165
8745224|NCT01137474|9793701|FG003|Received Treatment|Overall Study||302
8745225|NCT01137474|9793698|FG000|COMPLETED|Overall Study||287
8745226|NCT01137474|9793699|FG001|COMPLETED|Overall Study||154
8745227|NCT01137474|9793700|FG002|COMPLETED|Overall Study||158
8745228|NCT01137474|9793701|FG003|COMPLETED|Overall Study||281
8745229|NCT01137474|9793698|FG000|NOT COMPLETED|Overall Study||24
8745230|NCT01137474|9793699|FG001|NOT COMPLETED|Overall Study||12
8745231|NCT01137474|9793700|FG002|NOT COMPLETED|Overall Study||7
8745232|NCT01137474|9793701|FG003|NOT COMPLETED|Overall Study||21
8745233|NCT01137539|9793711|FG000|STARTED|Overall Study||50
8745234|NCT01137539|9793711|FG000|COMPLETED|Overall Study||50
8745235|NCT01137539|9793711|FG000|NOT COMPLETED|Overall Study||0
8745236|NCT01137578|9793715|FG000|STARTED|Overall Study||77
8745237|NCT01137578|9793716|FG001|STARTED|Overall Study||14
8745238|NCT01137578|9793717|FG002|STARTED|Overall Study||43
8745239|NCT01137578|9793715|FG000|COMPLETED|Overall Study|Completed defined as having completed all 3 study-related imaging procedures.|61
8745240|NCT01137578|9793716|FG001|COMPLETED|Overall Study|Completed defined as having completed all 3 study-related imaging procedures.|12
8745241|NCT01137578|9793717|FG002|COMPLETED|Overall Study|Completed defined as having completed all 3 study-related imaging procedures.|37
8745242|NCT01137578|9793715|FG000|NOT COMPLETED|Overall Study||16
8745243|NCT01137578|9793716|FG001|NOT COMPLETED|Overall Study||2
8745244|NCT01137578|9793717|FG002|NOT COMPLETED|Overall Study||6
8745245|NCT01137604|9793749|FG000|STARTED|Overall Study|39 participants were randomized but 1 participant died prior to receiving treatment.|38
8745246|NCT01137604|9793750|FG001|STARTED|Overall Study||42
8745247|NCT01137604|9793751|FG002|STARTED|Overall Study||39
8745248|NCT01137604|9793752|FG003|STARTED|Overall Study||32
8745249|NCT01137604|9793749|FG000|Disease Progression|Overall Study||34
8745250|NCT01137604|9793750|FG001|Disease Progression|Overall Study||29
8745251|NCT01137604|9793751|FG002|Disease Progression|Overall Study||25
8745252|NCT01137604|9793752|FG003|Disease Progression|Overall Study||21
8745253|NCT01137604|9793749|FG000|Treatment Ongoing at Data Cutoff|Overall Study||2
8745254|NCT01137604|9793750|FG001|Treatment Ongoing at Data Cutoff|Overall Study||3
8745255|NCT01137604|9793751|FG002|Treatment Ongoing at Data Cutoff|Overall Study||1
8745256|NCT01137604|9793752|FG003|Treatment Ongoing at Data Cutoff|Overall Study||0
8745257|NCT01137604|9793749|FG000|COMPLETED|Overall Study|Participants with disease progression and treatment ongoing at data cutoff (19 Mar 2013)|36
8745258|NCT01137604|9793750|FG001|COMPLETED|Overall Study||32
8745259|NCT01137604|9793751|FG002|COMPLETED|Overall Study||26
8745260|NCT01137604|9793752|FG003|COMPLETED|Overall Study||21
8745261|NCT01137604|9793749|FG000|NOT COMPLETED|Overall Study||2
8745262|NCT01137604|9793750|FG001|NOT COMPLETED|Overall Study||10
8745263|NCT01137604|9793751|FG002|NOT COMPLETED|Overall Study||13
8745264|NCT01137604|9793752|FG003|NOT COMPLETED|Overall Study||11
8745265|NCT01137682|9793765|FG000|STARTED|Overall Study||65
8745266|NCT01137682|9793766|FG001|STARTED|Overall Study||65
8745267|NCT01137682|9793767|FG002|STARTED|Overall Study||68
8745268|NCT01137682|9793765|FG000|Not Treated|Overall Study||2
8745269|NCT01137682|9793766|FG001|Not Treated|Overall Study||2
8745270|NCT01137682|9793767|FG002|Not Treated|Overall Study||1
8745271|NCT01137682|9793765|FG000|Treated|Overall Study||63
8745272|NCT01137682|9793766|FG001|Treated|Overall Study||63
8745273|NCT01137682|9793767|FG002|Treated|Overall Study||67
8745274|NCT01137682|9793765|FG000|Completed 24-Week Core Phase|Overall Study||59
8745275|NCT01137682|9793766|FG001|Completed 24-Week Core Phase|Overall Study||57
8745276|NCT01137682|9793767|FG002|Completed 24-Week Core Phase|Overall Study||65
8745277|NCT01137682|9793765|FG000|Not Continuing Into Extension|Overall Study||2
8745278|NCT01137682|9793766|FG001|Not Continuing Into Extension|Overall Study||3
8745279|NCT01137682|9793767|FG002|Not Continuing Into Extension|Overall Study||2
8745280|NCT01137682|9793765|FG000|Continuing Into Extension|Overall Study||57
8745281|NCT01137682|9793766|FG001|Continuing Into Extension|Overall Study||54
8745282|NCT01137682|9793767|FG002|Continuing Into Extension|Overall Study||63
8745283|NCT01137682|9793765|FG000|Safety Set - CORE|Overall Study|2 patients never received drug.|63
8745284|NCT01137682|9793766|FG001|Safety Set - CORE|Overall Study|2 patients never received drug. 1 patient had no post baseline safety assement.|62
8745285|NCT01137682|9793767|FG002|Safety Set - CORE|Overall Study|2 patients never received drug.|66
8745286|NCT01137682|9793765|FG000|Safety Set - Extension|Overall Study||57
8745287|NCT01137682|9793766|FG001|Safety Set - Extension|Overall Study||54
8745288|NCT01137682|9793767|FG002|Safety Set - Extension|Overall Study|1 patient did not receive study treatment|62
8745289|NCT01137682|9793765|FG000|COMPLETED|Overall Study||28
8745290|NCT01137682|9793766|FG001|COMPLETED|Overall Study||25
8745291|NCT01137682|9793767|FG002|COMPLETED|Overall Study||34
8745292|NCT01137682|9793765|FG000|NOT COMPLETED|Overall Study||37
8745293|NCT01137682|9793766|FG001|NOT COMPLETED|Overall Study||40
8745294|NCT01137682|9793767|FG002|NOT COMPLETED|Overall Study||34
8745295|NCT01137786|9793781|FG000|STARTED|Overall Study||25
8745296|NCT01137786|9793782|FG001|STARTED|Overall Study||24
8745297|NCT01137786|9793781|FG000|COMPLETED|Overall Study||24
8745298|NCT01137786|9793782|FG001|COMPLETED|Overall Study||21
8745299|NCT01137786|9793781|FG000|NOT COMPLETED|Overall Study||1
8745300|NCT01137786|9793782|FG001|NOT COMPLETED|Overall Study||3
8745301|NCT01137812|9793792|FG000|STARTED|Overall Study||377
8745302|NCT01137812|9793793|FG001|STARTED|Overall Study||378
8745303|NCT01137812|9793792|FG000|COMPLETED|Overall Study||254
8745304|NCT01137812|9793793|FG001|COMPLETED|Overall Study||210
8745305|NCT01137812|9793792|FG000|NOT COMPLETED|Overall Study||123
8745306|NCT01137812|9793793|FG001|NOT COMPLETED|Overall Study||168
8745307|NCT01137890|9793801|FG000|STARTED|Overall Study||14
8745308|NCT01137890|9793802|FG001|STARTED|Overall Study||5
8745309|NCT01137890|9793801|FG000|COMPLETED|Overall Study||8
8745310|NCT01137890|9793802|FG001|COMPLETED|Overall Study||2
8745311|NCT01137890|9793801|FG000|NOT COMPLETED|Overall Study||6
8745312|NCT01137890|9793802|FG001|NOT COMPLETED|Overall Study||3
8745313|NCT01138007|9793857|FG000|STARTED|Overall Study||187
8913540|NCT02161705|9972915|FG000|STARTED|Overall Study||9
8913541|NCT02161705|9972916|FG001|STARTED|Overall Study||9
8913542|NCT02161705|9972915|FG000|COMPLETED|Overall Study||9
8913543|NCT02161705|9972916|FG001|COMPLETED|Overall Study||9
8913544|NCT02161705|9972915|FG000|NOT COMPLETED|Overall Study||0
8913545|NCT02161705|9972916|FG001|NOT COMPLETED|Overall Study||0
8745314|NCT01138007|9793858|FG001|STARTED|Overall Study||190
8745315|NCT01138007|9793859|FG002|STARTED|Overall Study||192
8745316|NCT01138007|9793857|FG000|COMPLETED|Overall Study||165
8745317|NCT01138007|9793858|FG001|COMPLETED|Overall Study||160
8745318|NCT01138007|9793859|FG002|COMPLETED|Overall Study||144
8745319|NCT01138007|9793857|FG000|NOT COMPLETED|Overall Study||22
8745320|NCT01138007|9793858|FG001|NOT COMPLETED|Overall Study||30
8745321|NCT01138007|9793859|FG002|NOT COMPLETED|Overall Study||48
8745322|NCT01138046|9793869|FG000|STARTED|Overall Study||12
8745323|NCT01138046|9793869|FG000|COMPLETED|Overall Study||6
8745324|NCT01138046|9793869|FG000|NOT COMPLETED|Overall Study||6
8745325|NCT01138098|9793875|FG000|STARTED|Overall Study||95
8745326|NCT01138098|9793876|FG001|STARTED|Overall Study||90
8745327|NCT01138098|9793875|FG000|COMPLETED|Overall Study||95
8745328|NCT01138098|9793876|FG001|COMPLETED|Overall Study||90
8745329|NCT01138098|9793875|FG000|NOT COMPLETED|Overall Study||0
8745330|NCT01138098|9793876|FG001|NOT COMPLETED|Overall Study||0
8745331|NCT01138111|9793882|FG000|STARTED|Overall Study||45
8745332|NCT01138111|9793882|FG000|COMPLETED|Overall Study||36
8745333|NCT01138111|9793882|FG000|NOT COMPLETED|Overall Study||9
8745334|NCT01138124|9793915|FG000|STARTED|Overall Study||3149
8745335|NCT01138124|9793916|FG001|STARTED|Overall Study||30026
8745336|NCT01138124|9793917|FG002|STARTED|Overall Study||1981
8745337|NCT01138124|9793918|FG003|STARTED|Overall Study||19046
8745338|NCT01138124|9793915|FG000|COMPLETED|Overall Study||3149
8745339|NCT01138124|9793916|FG001|COMPLETED|Overall Study||30026
8745340|NCT01138124|9793917|FG002|COMPLETED|Overall Study||1981
8745341|NCT01138124|9793918|FG003|COMPLETED|Overall Study||19046
8745342|NCT01138124|9793915|FG000|NOT COMPLETED|Overall Study||0
8745343|NCT01138124|9793916|FG001|NOT COMPLETED|Overall Study||0
8745344|NCT01138124|9793917|FG002|NOT COMPLETED|Overall Study||0
8745345|NCT01138124|9793918|FG003|NOT COMPLETED|Overall Study||0
8745346|NCT01138150|9793928|FG000|STARTED|Overall Study||18
8745347|NCT01138150|9793929|FG001|STARTED|Overall Study||18
8745348|NCT01138150|9793928|FG000|COMPLETED|Overall Study||17
8745349|NCT01138150|9793929|FG001|COMPLETED|Overall Study||17
8745350|NCT01138150|9793928|FG000|NOT COMPLETED|Overall Study||1
8745351|NCT01138150|9793929|FG001|NOT COMPLETED|Overall Study||1
8745352|NCT01138475|9793948|FG000|STARTED|Overall Study||16
8745353|NCT01138475|9793949|FG001|STARTED|Overall Study||16
8745354|NCT01138475|9793950|FG002|STARTED|Overall Study||17
8745355|NCT01138475|9793948|FG000|COMPLETED|Overall Study||16
8745356|NCT01138475|9793949|FG001|COMPLETED|Overall Study||16
8745357|NCT01138475|9793950|FG002|COMPLETED|Overall Study||17
8745358|NCT01138475|9793948|FG000|NOT COMPLETED|Overall Study||0
8745359|NCT01138475|9793949|FG001|NOT COMPLETED|Overall Study||0
8745360|NCT01138475|9793950|FG002|NOT COMPLETED|Overall Study||0
8745361|NCT01138501|9793964|FG000|STARTED|Overall Study|Two subjects withdrew consent after being enrolled but before receiving any trial product.|65
8745362|NCT01138501|9793964|FG000|Exposed|Overall Study||63
8745363|NCT01138501|9793964|FG000|COMPLETED|Overall Study||60
8745364|NCT01138501|9793964|FG000|NOT COMPLETED|Overall Study||5
8745365|NCT01138514|9793971|FG000|STARTED|Overall Study||522
8745366|NCT01138514|9793972|FG001|STARTED|Overall Study||516
8745367|NCT01138514|9793973|FG002|STARTED|Overall Study||517
8745368|NCT01138514|9793971|FG000|COMPLETED|Overall Study||474
8745369|NCT01138514|9793972|FG001|COMPLETED|Overall Study||463
8745370|NCT01138514|9793973|FG002|COMPLETED|Overall Study||424
8745371|NCT01138514|9793971|FG000|NOT COMPLETED|Overall Study||48
8745372|NCT01138514|9793972|FG001|NOT COMPLETED|Overall Study||53
8745373|NCT01138514|9793973|FG002|NOT COMPLETED|Overall Study||93
8745374|NCT01138657|9793984|FG000|STARTED|Overall Study||120
8745375|NCT01138657|9793985|FG001|STARTED|Overall Study||119
8745376|NCT01138657|9793984|FG000|Enrolled in Main Study|Overall Study||112
8745377|NCT01138657|9793985|FG001|Enrolled in Main Study|Overall Study||111
8745378|NCT01138657|9793984|FG000|Enrolled in Japan Sub-study|Overall Study||8
8745379|NCT01138657|9793985|FG001|Enrolled in Japan Sub-study|Overall Study||8
8745380|NCT01138657|9793984|FG000|COMPLETED|Overall Study||112
8745381|NCT01138657|9793985|FG001|COMPLETED|Overall Study||101
8745382|NCT01138657|9793984|FG000|NOT COMPLETED|Overall Study||8
8745383|NCT01138657|9793985|FG001|NOT COMPLETED|Overall Study||18
8745384|NCT01138735|9793995|FG000|STARTED|Overall Study||142
8745385|NCT01138735|9793996|FG001|STARTED|Overall Study||143
8745386|NCT01138735|9793995|FG000|COMPLETED|Overall Study||134
8745387|NCT01138735|9793996|FG001|COMPLETED|Overall Study||126
8745388|NCT01138735|9793995|FG000|NOT COMPLETED|Overall Study||8
8745389|NCT01138735|9793996|FG001|NOT COMPLETED|Overall Study||17
8745390|NCT01138826|9794002|FG000|STARTED|First Intervention Period||3
8745391|NCT01138826|9794003|FG001|STARTED|First Intervention Period||3
8745392|NCT01138826|9794004|FG002|STARTED|First Intervention Period||3
8745393|NCT01138826|9794005|FG003|STARTED|First Intervention Period||3
8745394|NCT01138826|9794006|FG004|STARTED|First Intervention Period||3
8745395|NCT01138826|9794007|FG005|STARTED|First Intervention Period||3
8745396|NCT01138826|9794002|FG000|COMPLETED|First Intervention Period||3
8745397|NCT01138826|9794003|FG001|COMPLETED|First Intervention Period||3
8745398|NCT01138826|9794004|FG002|COMPLETED|First Intervention Period||3
8745399|NCT01138826|9794005|FG003|COMPLETED|First Intervention Period||3
8745400|NCT01138826|9794006|FG004|COMPLETED|First Intervention Period||3
8745401|NCT01138826|9794007|FG005|COMPLETED|First Intervention Period||3
8745402|NCT01138826|9794002|FG000|NOT COMPLETED|First Intervention Period||0
8745403|NCT01138826|9794003|FG001|NOT COMPLETED|First Intervention Period||0
8745404|NCT01138826|9794004|FG002|NOT COMPLETED|First Intervention Period||0
8745405|NCT01138826|9794005|FG003|NOT COMPLETED|First Intervention Period||0
8745406|NCT01138826|9794006|FG004|NOT COMPLETED|First Intervention Period||0
8745407|NCT01138826|9794007|FG005|NOT COMPLETED|First Intervention Period||0
8745408|NCT01138826|9794002|FG000|STARTED|Washout Period I (of 16 Days)||3
8745409|NCT01138826|9794003|FG001|STARTED|Washout Period I (of 16 Days)||3
8745410|NCT01138826|9794004|FG002|STARTED|Washout Period I (of 16 Days)||3
8745411|NCT01138826|9794005|FG003|STARTED|Washout Period I (of 16 Days)||3
8745412|NCT01138826|9794006|FG004|STARTED|Washout Period I (of 16 Days)||3
8745413|NCT01138826|9794007|FG005|STARTED|Washout Period I (of 16 Days)||3
8745414|NCT01138826|9794002|FG000|COMPLETED|Washout Period I (of 16 Days)||2
8745415|NCT01138826|9794003|FG001|COMPLETED|Washout Period I (of 16 Days)||2
8745416|NCT01138826|9794004|FG002|COMPLETED|Washout Period I (of 16 Days)||3
8745417|NCT01138826|9794005|FG003|COMPLETED|Washout Period I (of 16 Days)||3
8745418|NCT01138826|9794006|FG004|COMPLETED|Washout Period I (of 16 Days)||2
8745419|NCT01138826|9794007|FG005|COMPLETED|Washout Period I (of 16 Days)||3
8745420|NCT01138826|9794002|FG000|NOT COMPLETED|Washout Period I (of 16 Days)||1
8745421|NCT01138826|9794003|FG001|NOT COMPLETED|Washout Period I (of 16 Days)||1
8745422|NCT01138826|9794004|FG002|NOT COMPLETED|Washout Period I (of 16 Days)||0
8745423|NCT01138826|9794005|FG003|NOT COMPLETED|Washout Period I (of 16 Days)||0
8745424|NCT01138826|9794006|FG004|NOT COMPLETED|Washout Period I (of 16 Days)||1
8745425|NCT01138826|9794007|FG005|NOT COMPLETED|Washout Period I (of 16 Days)||0
8745426|NCT01138826|9794002|FG000|STARTED|Second Intervention Period||2
8745427|NCT01138826|9794003|FG001|STARTED|Second Intervention Period||2
8745428|NCT01138826|9794004|FG002|STARTED|Second Intervention Period||3
8745429|NCT01138826|9794005|FG003|STARTED|Second Intervention Period||3
8745430|NCT01138826|9794006|FG004|STARTED|Second Intervention Period||2
8745431|NCT01138826|9794007|FG005|STARTED|Second Intervention Period||3
8745432|NCT01138826|9794002|FG000|COMPLETED|Second Intervention Period||2
8745433|NCT01138826|9794003|FG001|COMPLETED|Second Intervention Period||2
8745434|NCT01138826|9794004|FG002|COMPLETED|Second Intervention Period||3
8745435|NCT01138826|9794005|FG003|COMPLETED|Second Intervention Period||3
8745436|NCT01138826|9794006|FG004|COMPLETED|Second Intervention Period||2
8745437|NCT01138826|9794007|FG005|COMPLETED|Second Intervention Period||3
8745438|NCT01138826|9794002|FG000|NOT COMPLETED|Second Intervention Period||0
8745439|NCT01138826|9794003|FG001|NOT COMPLETED|Second Intervention Period||0
8745440|NCT01138826|9794004|FG002|NOT COMPLETED|Second Intervention Period||0
8745441|NCT01138826|9794005|FG003|NOT COMPLETED|Second Intervention Period||0
8745442|NCT01138826|9794006|FG004|NOT COMPLETED|Second Intervention Period||0
8745443|NCT01138826|9794007|FG005|NOT COMPLETED|Second Intervention Period||0
8745444|NCT01138826|9794002|FG000|STARTED|Washout Period II (of 16 Days)||2
8745445|NCT01138826|9794003|FG001|STARTED|Washout Period II (of 16 Days)||2
8745446|NCT01138826|9794004|FG002|STARTED|Washout Period II (of 16 Days)||3
8745447|NCT01138826|9794005|FG003|STARTED|Washout Period II (of 16 Days)||3
8745448|NCT01138826|9794006|FG004|STARTED|Washout Period II (of 16 Days)||2
8745449|NCT01138826|9794007|FG005|STARTED|Washout Period II (of 16 Days)||3
8745450|NCT01138826|9794002|FG000|COMPLETED|Washout Period II (of 16 Days)||2
8745451|NCT01138826|9794003|FG001|COMPLETED|Washout Period II (of 16 Days)||2
8745452|NCT01138826|9794004|FG002|COMPLETED|Washout Period II (of 16 Days)||3
8745453|NCT01138826|9794005|FG003|COMPLETED|Washout Period II (of 16 Days)||3
8745454|NCT01138826|9794006|FG004|COMPLETED|Washout Period II (of 16 Days)||2
8745455|NCT01138826|9794007|FG005|COMPLETED|Washout Period II (of 16 Days)||3
8745456|NCT01138826|9794002|FG000|NOT COMPLETED|Washout Period II (of 16 Days)||0
8745457|NCT01138826|9794003|FG001|NOT COMPLETED|Washout Period II (of 16 Days)||0
8745458|NCT01138826|9794004|FG002|NOT COMPLETED|Washout Period II (of 16 Days)||0
8745459|NCT01138826|9794005|FG003|NOT COMPLETED|Washout Period II (of 16 Days)||0
8745460|NCT01138826|9794006|FG004|NOT COMPLETED|Washout Period II (of 16 Days)||0
8745461|NCT01138826|9794007|FG005|NOT COMPLETED|Washout Period II (of 16 Days)||0
8745462|NCT01138826|9794002|FG000|STARTED|Third Intervention Period||2
8745463|NCT01138826|9794003|FG001|STARTED|Third Intervention Period||2
8745464|NCT01138826|9794004|FG002|STARTED|Third Intervention Period||3
8745465|NCT01138826|9794005|FG003|STARTED|Third Intervention Period||3
8745466|NCT01138826|9794006|FG004|STARTED|Third Intervention Period||2
8745467|NCT01138826|9794007|FG005|STARTED|Third Intervention Period||3
8745468|NCT01138826|9794002|FG000|COMPLETED|Third Intervention Period||2
8745469|NCT01138826|9794003|FG001|COMPLETED|Third Intervention Period||2
8745470|NCT01138826|9794004|FG002|COMPLETED|Third Intervention Period||3
8745471|NCT01138826|9794005|FG003|COMPLETED|Third Intervention Period||3
8745472|NCT01138826|9794006|FG004|COMPLETED|Third Intervention Period||2
8745473|NCT01138826|9794007|FG005|COMPLETED|Third Intervention Period||3
8745474|NCT01138826|9794002|FG000|NOT COMPLETED|Third Intervention Period||0
8745475|NCT01138826|9794003|FG001|NOT COMPLETED|Third Intervention Period||0
8745476|NCT01138826|9794004|FG002|NOT COMPLETED|Third Intervention Period||0
8745477|NCT01138826|9794005|FG003|NOT COMPLETED|Third Intervention Period||0
8745478|NCT01138826|9794006|FG004|NOT COMPLETED|Third Intervention Period||0
8745479|NCT01138826|9794007|FG005|NOT COMPLETED|Third Intervention Period||0
8745480|NCT01138917|9794015|FG000|STARTED|Overall Study||101
8745481|NCT01138917|9794015|FG000|COMPLETED|Overall Study||77
8745482|NCT01138917|9794015|FG000|NOT COMPLETED|Overall Study||24
8745483|NCT01138969|9794025|FG000|STARTED|Overall Study||83
8745484|NCT01138969|9794026|FG001|STARTED|Overall Study||82
8745485|NCT01138969|9794025|FG000|COMPLETED|Overall Study||83
8745486|NCT01138969|9794026|FG001|COMPLETED|Overall Study||82
8745487|NCT01138969|9794025|FG000|NOT COMPLETED|Overall Study||0
8745488|NCT01138969|9794026|FG001|NOT COMPLETED|Overall Study||0
8745489|NCT01138995|9794034|FG000|STARTED|Overall Study||98
8745490|NCT01138995|9794035|FG001|STARTED|Overall Study||99
8745491|NCT01138995|9794034|FG000|COMPLETED|Overall Study||88
8745492|NCT01138995|9794035|FG001|COMPLETED|Overall Study||74
8745493|NCT01138995|9794034|FG000|NOT COMPLETED|Overall Study||10
8745494|NCT01138995|9794035|FG001|NOT COMPLETED|Overall Study||25
8745495|NCT01139008|9794042|FG000|STARTED|Overall Study||80
8745496|NCT01139008|9794042|FG000|COMPLETED|Overall Study||74
8745497|NCT01139008|9794042|FG000|NOT COMPLETED|Overall Study||6
8745498|NCT01139021|9794055|FG000|STARTED|Overall Study||152
8745499|NCT01139021|9794056|FG001|STARTED|Overall Study||153
8745500|NCT01139021|9794057|FG002|STARTED|Overall Study||67
8745501|NCT01139021|9794058|FG003|STARTED|Overall Study||19
8745502|NCT01139021|9794059|FG004|STARTED|Overall Study||116
8745503|NCT01139021|9794060|FG005|STARTED|Overall Study||1
8745504|NCT01139021|9794055|FG000|COMPLETED|Overall Study||151
8745505|NCT01139021|9794056|FG001|COMPLETED|Overall Study||153
8745506|NCT01139021|9794057|FG002|COMPLETED|Overall Study||67
8745507|NCT01139021|9794058|FG003|COMPLETED|Overall Study||18
8745508|NCT01139021|9794059|FG004|COMPLETED|Overall Study||107
8745509|NCT01139021|9794060|FG005|COMPLETED|Overall Study||1
8745510|NCT01139021|9794055|FG000|NOT COMPLETED|Overall Study||1
8745511|NCT01139021|9794056|FG001|NOT COMPLETED|Overall Study||0
8745512|NCT01139021|9794057|FG002|NOT COMPLETED|Overall Study||0
8745513|NCT01139021|9794058|FG003|NOT COMPLETED|Overall Study||1
8745514|NCT01139021|9794059|FG004|NOT COMPLETED|Overall Study||9
8670706|NCT00747474|9714091|FG000|STARTED|Cohort 12 (60 mg/m^2) Period||0
8670707|NCT00747474|9714092|FG001|STARTED|Cohort 12 (60 mg/m^2) Period||0
8670708|NCT00747474|9714093|FG002|STARTED|Cohort 12 (60 mg/m^2) Period||0
8670709|NCT00747474|9714094|FG003|STARTED|Cohort 12 (60 mg/m^2) Period||0
8670710|NCT00747474|9714095|FG004|STARTED|Cohort 12 (60 mg/m^2) Period||0
8670711|NCT00747474|9714096|FG005|STARTED|Cohort 12 (60 mg/m^2) Period||0
8670712|NCT00747474|9714097|FG006|STARTED|Cohort 12 (60 mg/m^2) Period||0
8670713|NCT00747474|9714098|FG007|STARTED|Cohort 12 (60 mg/m^2) Period||0
8670714|NCT00747474|9714099|FG008|STARTED|Cohort 12 (60 mg/m^2) Period||0
8670715|NCT00747474|9714100|FG009|STARTED|Cohort 12 (60 mg/m^2) Period||0
8745515|NCT01139021|9794060|FG005|NOT COMPLETED|Overall Study||0
8745516|NCT01139047|9794075|FG000|STARTED|Overall Study||77
8745517|NCT01139047|9794075|FG000|COMPLETED|Overall Study||76
8745518|NCT01139047|9794075|FG000|NOT COMPLETED|Overall Study||1
8745519|NCT01139164|9794085|FG000|STARTED|Overall Study||4
8745520|NCT01139164|9794086|FG001|STARTED|Overall Study||67
8745521|NCT01139164|9794087|FG002|STARTED|Overall Study||7
8745522|NCT01139164|9794085|FG000|COMPLETED|Overall Study||4
8745523|NCT01139164|9794086|FG001|COMPLETED|Overall Study||65
8745524|NCT01139164|9794087|FG002|COMPLETED|Overall Study||7
8745525|NCT01139164|9794085|FG000|NOT COMPLETED|Overall Study||0
8745526|NCT01139164|9794086|FG001|NOT COMPLETED|Overall Study||2
8745527|NCT01139164|9794087|FG002|NOT COMPLETED|Overall Study||0
8670716|NCT00747474|9714101|FG010|STARTED|Cohort 12 (60 mg/m^2) Period||0
8745528|NCT01139190|9794097|FG000|STARTED|Overall Study||38
8745529|NCT01139190|9794098|FG001|STARTED|Overall Study||39
8745530|NCT01139190|9794097|FG000|COMPLETED|Overall Study||38
8745531|NCT01139190|9794098|FG001|COMPLETED|Overall Study||38
8745532|NCT01139190|9794097|FG000|NOT COMPLETED|Overall Study||0
8745533|NCT01139190|9794098|FG001|NOT COMPLETED|Overall Study||1
8745534|NCT01139411|9794106|FG000|STARTED|Overall Study||26
8745535|NCT01139411|9794107|FG001|STARTED|Overall Study||23
8745536|NCT01139411|9794106|FG000|COMPLETED|Overall Study||24
8745537|NCT01139411|9794107|FG001|COMPLETED|Overall Study||19
8745538|NCT01139411|9794106|FG000|NOT COMPLETED|Overall Study||2
8745539|NCT01139411|9794107|FG001|NOT COMPLETED|Overall Study||4
8745540|NCT01139450|9794118|FG000|STARTED|Overall Study||302
8745541|NCT01139450|9794119|FG001|STARTED|Overall Study||297
8745542|NCT01139450|9794120|FG002|STARTED|Overall Study||300
8745543|NCT01139450|9794118|FG000|COMPLETED|Overall Study||275
8745544|NCT01139450|9794119|FG001|COMPLETED|Overall Study||272
8745545|NCT01139450|9794120|FG002|COMPLETED|Overall Study||262
8745546|NCT01139450|9794118|FG000|NOT COMPLETED|Overall Study||27
8745547|NCT01139450|9794119|FG001|NOT COMPLETED|Overall Study||25
8745548|NCT01139450|9794120|FG002|NOT COMPLETED|Overall Study||38
8745549|NCT01139515|9794128|FG000|STARTED|First Intervention Period||4
8670717|NCT00747474|9714102|FG011|STARTED|Cohort 12 (60 mg/m^2) Period||6
8670718|NCT00747474|9714091|FG000|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
8670719|NCT00747474|9714092|FG001|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
8670720|NCT00747474|9714093|FG002|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
8670721|NCT00747474|9714094|FG003|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
8670722|NCT00747474|9714095|FG004|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
8745550|NCT01139515|9794129|FG001|STARTED|First Intervention Period||4
8745551|NCT01139515|9794130|FG002|STARTED|First Intervention Period||4
8745552|NCT01139515|9794131|FG003|STARTED|First Intervention Period||4
8745553|NCT01139515|9794128|FG000|COMPLETED|First Intervention Period||4
8745554|NCT01139515|9794129|FG001|COMPLETED|First Intervention Period||4
8913546|NCT02161718|9972924|FG000|STARTED|Open-Label ALKS 3831 Period||255
8913547|NCT02161718|9972925|FG001|STARTED|Open-Label ALKS 3831 Period||0
8913548|NCT02161718|9972926|FG002|STARTED|Open-Label ALKS 3831 Period||0
8913549|NCT02161718|9972924|FG000|COMPLETED|Open-Label ALKS 3831 Period||234
8913550|NCT02161718|9972925|FG001|COMPLETED|Open-Label ALKS 3831 Period||0
8913551|NCT02161718|9972926|FG002|COMPLETED|Open-Label ALKS 3831 Period||0
8913552|NCT02161718|9972924|FG000|NOT COMPLETED|Open-Label ALKS 3831 Period||21
8913553|NCT02161718|9972925|FG001|NOT COMPLETED|Open-Label ALKS 3831 Period||0
8913554|NCT02161718|9972926|FG002|NOT COMPLETED|Open-Label ALKS 3831 Period||0
8913555|NCT02161718|9972924|FG000|STARTED|Post- Randomization Period||0
8913556|NCT02161718|9972925|FG001|STARTED|Post- Randomization Period||112
8913557|NCT02161718|9972926|FG002|STARTED|Post- Randomization Period||117
8913558|NCT02161718|9972924|FG000|COMPLETED|Post- Randomization Period||0
8913559|NCT02161718|9972925|FG001|COMPLETED|Post- Randomization Period||53
8913560|NCT02161718|9972926|FG002|COMPLETED|Post- Randomization Period||58
8913561|NCT02161718|9972924|FG000|NOT COMPLETED|Post- Randomization Period||0
8913562|NCT02161718|9972925|FG001|NOT COMPLETED|Post- Randomization Period||59
8913563|NCT02161718|9972926|FG002|NOT COMPLETED|Post- Randomization Period||59
8913564|NCT02161731|9972933|FG000|STARTED|Period 1 (Day -1 to Day 7 Predose)||24
8913565|NCT02161731|9972934|FG001|STARTED|Period 1 (Day -1 to Day 7 Predose)||0
8913566|NCT02161731|9972933|FG000|Received 1 Dose of Study Drug|Period 1 (Day -1 to Day 7 Predose)||24
8913567|NCT02161731|9972934|FG001|Received 1 Dose of Study Drug|Period 1 (Day -1 to Day 7 Predose)||0
8913568|NCT02161731|9972933|FG000|COMPLETED|Period 1 (Day -1 to Day 7 Predose)||24
8913569|NCT02161731|9972934|FG001|COMPLETED|Period 1 (Day -1 to Day 7 Predose)||0
8913570|NCT02161731|9972933|FG000|NOT COMPLETED|Period 1 (Day -1 to Day 7 Predose)||0
8913571|NCT02161731|9972934|FG001|NOT COMPLETED|Period 1 (Day -1 to Day 7 Predose)||0
8913572|NCT02161731|9972933|FG000|STARTED|Period 2 (Day 7 Dosing to Day 23)||0
8913573|NCT02161731|9972934|FG001|STARTED|Period 2 (Day 7 Dosing to Day 23)||24
8913574|NCT02161731|9972933|FG000|Received 1 Dose of Study Drug|Period 2 (Day 7 Dosing to Day 23)||0
8913575|NCT02161731|9972934|FG001|Received 1 Dose of Study Drug|Period 2 (Day 7 Dosing to Day 23)||24
9022859|NCT03131648|10085666|FG002|STARTED|Open-label (Short Term Extension)||0
9022860|NCT03131648|10085667|FG003|STARTED|Open-label (Short Term Extension)||0
9022861|NCT03131648|10085668|FG004|STARTED|Open-label (Short Term Extension)||0
9022862|NCT03131648|10085669|FG005|STARTED|Open-label (Short Term Extension)||0
9022863|NCT03131648|10085670|FG006|STARTED|Open-label (Short Term Extension)||0
9022864|NCT03131648|10085671|FG007|STARTED|Open-label (Short Term Extension)||65
9022865|NCT03131648|10085664|FG000|COMPLETED|Open-label (Short Term Extension)||0
9022866|NCT03131648|10085665|FG001|COMPLETED|Open-label (Short Term Extension)||0
9022867|NCT03131648|10085666|FG002|COMPLETED|Open-label (Short Term Extension)||0
8670723|NCT00747474|9714096|FG005|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
8670724|NCT00747474|9714097|FG006|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
8670725|NCT00747474|9714098|FG007|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
8745555|NCT01139515|9794130|FG002|COMPLETED|First Intervention Period||4
8745556|NCT01139515|9794131|FG003|COMPLETED|First Intervention Period||4
8745557|NCT01139515|9794128|FG000|NOT COMPLETED|First Intervention Period||0
8745558|NCT01139515|9794129|FG001|NOT COMPLETED|First Intervention Period||0
8745559|NCT01139515|9794130|FG002|NOT COMPLETED|First Intervention Period||0
8745560|NCT01139515|9794131|FG003|NOT COMPLETED|First Intervention Period||0
8745561|NCT01139515|9794128|FG000|STARTED|Washout Period I (46hrs)||4
8745562|NCT01139515|9794129|FG001|STARTED|Washout Period I (46hrs)||4
8745563|NCT01139515|9794130|FG002|STARTED|Washout Period I (46hrs)||4
8745564|NCT01139515|9794131|FG003|STARTED|Washout Period I (46hrs)||4
8745565|NCT01139515|9794128|FG000|COMPLETED|Washout Period I (46hrs)||4
8745566|NCT01139515|9794129|FG001|COMPLETED|Washout Period I (46hrs)||4
8745567|NCT01139515|9794130|FG002|COMPLETED|Washout Period I (46hrs)||4
8745568|NCT01139515|9794131|FG003|COMPLETED|Washout Period I (46hrs)||4
8745569|NCT01139515|9794128|FG000|NOT COMPLETED|Washout Period I (46hrs)||0
8745570|NCT01139515|9794129|FG001|NOT COMPLETED|Washout Period I (46hrs)||0
8745571|NCT01139515|9794130|FG002|NOT COMPLETED|Washout Period I (46hrs)||0
8745572|NCT01139515|9794131|FG003|NOT COMPLETED|Washout Period I (46hrs)||0
8745573|NCT01139515|9794128|FG000|STARTED|Second Intervention Period||4
8745574|NCT01139515|9794129|FG001|STARTED|Second Intervention Period||4
8745575|NCT01139515|9794130|FG002|STARTED|Second Intervention Period||4
8745576|NCT01139515|9794131|FG003|STARTED|Second Intervention Period||4
8745577|NCT01139515|9794128|FG000|COMPLETED|Second Intervention Period||4
8745578|NCT01139515|9794129|FG001|COMPLETED|Second Intervention Period||4
8745579|NCT01139515|9794130|FG002|COMPLETED|Second Intervention Period||4
8745580|NCT01139515|9794131|FG003|COMPLETED|Second Intervention Period||4
8745581|NCT01139515|9794128|FG000|NOT COMPLETED|Second Intervention Period||0
8745582|NCT01139515|9794129|FG001|NOT COMPLETED|Second Intervention Period||0
8745583|NCT01139515|9794130|FG002|NOT COMPLETED|Second Intervention Period||0
8745584|NCT01139515|9794131|FG003|NOT COMPLETED|Second Intervention Period||0
8745585|NCT01139515|9794128|FG000|STARTED|Washout Period 2 (46 Hrs)||4
8745586|NCT01139515|9794129|FG001|STARTED|Washout Period 2 (46 Hrs)||4
8745587|NCT01139515|9794130|FG002|STARTED|Washout Period 2 (46 Hrs)||4
8745588|NCT01139515|9794131|FG003|STARTED|Washout Period 2 (46 Hrs)||4
8745589|NCT01139515|9794128|FG000|COMPLETED|Washout Period 2 (46 Hrs)||4
8745590|NCT01139515|9794129|FG001|COMPLETED|Washout Period 2 (46 Hrs)||4
8745591|NCT01139515|9794130|FG002|COMPLETED|Washout Period 2 (46 Hrs)||4
8745592|NCT01139515|9794131|FG003|COMPLETED|Washout Period 2 (46 Hrs)||4
8745593|NCT01139515|9794128|FG000|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
8745594|NCT01139515|9794129|FG001|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
8745595|NCT01139515|9794130|FG002|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
8745596|NCT01139515|9794131|FG003|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
8745597|NCT01139515|9794128|FG000|STARTED|Third Intervention Period||4
8745598|NCT01139515|9794129|FG001|STARTED|Third Intervention Period||4
8745599|NCT01139515|9794130|FG002|STARTED|Third Intervention Period||4
8745600|NCT01139515|9794131|FG003|STARTED|Third Intervention Period||4
8745601|NCT01139515|9794128|FG000|COMPLETED|Third Intervention Period||4
8745602|NCT01139515|9794129|FG001|COMPLETED|Third Intervention Period||4
8745603|NCT01139515|9794130|FG002|COMPLETED|Third Intervention Period||4
8745604|NCT01139515|9794131|FG003|COMPLETED|Third Intervention Period||4
8745605|NCT01139515|9794128|FG000|NOT COMPLETED|Third Intervention Period||0
8745606|NCT01139515|9794129|FG001|NOT COMPLETED|Third Intervention Period||0
8745607|NCT01139515|9794130|FG002|NOT COMPLETED|Third Intervention Period||0
8745608|NCT01139515|9794131|FG003|NOT COMPLETED|Third Intervention Period||0
8745609|NCT01139515|9794128|FG000|STARTED|Washout Period 3 (46 Hrs)||4
8745610|NCT01139515|9794129|FG001|STARTED|Washout Period 3 (46 Hrs)||4
8745611|NCT01139515|9794130|FG002|STARTED|Washout Period 3 (46 Hrs)||4
8745612|NCT01139515|9794131|FG003|STARTED|Washout Period 3 (46 Hrs)||4
8745613|NCT01139515|9794128|FG000|COMPLETED|Washout Period 3 (46 Hrs)||4
8745614|NCT01139515|9794129|FG001|COMPLETED|Washout Period 3 (46 Hrs)||4
8745615|NCT01139515|9794130|FG002|COMPLETED|Washout Period 3 (46 Hrs)||4
8745616|NCT01139515|9794131|FG003|COMPLETED|Washout Period 3 (46 Hrs)||4
8745617|NCT01139515|9794128|FG000|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
8745618|NCT01139515|9794129|FG001|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
8745619|NCT01139515|9794130|FG002|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
8913576|NCT02161731|9972933|FG000|COMPLETED|Period 2 (Day 7 Dosing to Day 23)||0
8913577|NCT02161731|9972934|FG001|COMPLETED|Period 2 (Day 7 Dosing to Day 23)||22
8913578|NCT02161731|9972933|FG000|NOT COMPLETED|Period 2 (Day 7 Dosing to Day 23)||0
8913579|NCT02161731|9972934|FG001|NOT COMPLETED|Period 2 (Day 7 Dosing to Day 23)||2
8913580|NCT02161757|9972944|FG000|STARTED|Randomised Through Start Treatment||401
8745620|NCT01139515|9794131|FG003|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
8745621|NCT01139515|9794128|FG000|STARTED|Fourth Intervention Period||4
8745622|NCT01139515|9794129|FG001|STARTED|Fourth Intervention Period||4
8745623|NCT01139515|9794130|FG002|STARTED|Fourth Intervention Period||4
8745624|NCT01139515|9794131|FG003|STARTED|Fourth Intervention Period||4
8745625|NCT01139515|9794128|FG000|COMPLETED|Fourth Intervention Period||4
8745626|NCT01139515|9794129|FG001|COMPLETED|Fourth Intervention Period||4
8745627|NCT01139515|9794130|FG002|COMPLETED|Fourth Intervention Period||4
8745628|NCT01139515|9794131|FG003|COMPLETED|Fourth Intervention Period||4
8745629|NCT01139515|9794128|FG000|NOT COMPLETED|Fourth Intervention Period||0
8745630|NCT01139515|9794129|FG001|NOT COMPLETED|Fourth Intervention Period||0
8745631|NCT01139515|9794130|FG002|NOT COMPLETED|Fourth Intervention Period||0
8745632|NCT01139515|9794131|FG003|NOT COMPLETED|Fourth Intervention Period||0
8745633|NCT01139580|9794143|FG000|STARTED|Overall Study||181
8745634|NCT01139580|9794144|FG001|STARTED|Overall Study||182
8745635|NCT01139580|9794143|FG000|COMPLETED|Overall Study||158
8745636|NCT01139580|9794144|FG001|COMPLETED|Overall Study||164
8745637|NCT01139580|9794143|FG000|NOT COMPLETED|Overall Study||23
8745638|NCT01139580|9794144|FG001|NOT COMPLETED|Overall Study||18
8745639|NCT01139658|9794152|FG000|STARTED|Overall Study||747
8745640|NCT01139658|9794153|FG001|STARTED|Overall Study||929
8745641|NCT01139658|9794152|FG000|COMPLETED|Overall Study||691
8745642|NCT01139658|9794153|FG001|COMPLETED|Overall Study||816
8745643|NCT01139658|9794152|FG000|NOT COMPLETED|Overall Study||56
8745644|NCT01139658|9794153|FG001|NOT COMPLETED|Overall Study||113
8745645|NCT01139762|9794161|FG000|STARTED|Washout and Placebo Lead-In Period||1070
8745646|NCT01139762|9794162|FG001|STARTED|Washout and Placebo Lead-In Period||0
8745647|NCT01139762|9794163|FG002|STARTED|Washout and Placebo Lead-In Period||0
8745648|NCT01139762|9794161|FG000|COMPLETED|Washout and Placebo Lead-In Period||696
8745649|NCT01139762|9794162|FG001|COMPLETED|Washout and Placebo Lead-In Period||0
8745650|NCT01139762|9794163|FG002|COMPLETED|Washout and Placebo Lead-In Period||0
8745651|NCT01139762|9794161|FG000|NOT COMPLETED|Washout and Placebo Lead-In Period||374
8745652|NCT01139762|9794162|FG001|NOT COMPLETED|Washout and Placebo Lead-In Period||0
8745653|NCT01139762|9794163|FG002|NOT COMPLETED|Washout and Placebo Lead-In Period||0
8745654|NCT01139762|9794161|FG000|STARTED|Double-Blind Randomized Active Treatment||0
8745655|NCT01139762|9794162|FG001|STARTED|Double-Blind Randomized Active Treatment||346
8745656|NCT01139762|9794163|FG002|STARTED|Double-Blind Randomized Active Treatment||350
8745657|NCT01139762|9794161|FG000|Received at Least 1 Dose of Study Drug|Double-Blind Randomized Active Treatment||0
8745658|NCT01139762|9794162|FG001|Received at Least 1 Dose of Study Drug|Double-Blind Randomized Active Treatment||345
8745659|NCT01139762|9794163|FG002|Received at Least 1 Dose of Study Drug|Double-Blind Randomized Active Treatment||350
8745660|NCT01139762|9794161|FG000|COMPLETED|Double-Blind Randomized Active Treatment||0
8745661|NCT01139762|9794162|FG001|COMPLETED|Double-Blind Randomized Active Treatment||306
8745662|NCT01139762|9794163|FG002|COMPLETED|Double-Blind Randomized Active Treatment||286
8745663|NCT01139762|9794161|FG000|NOT COMPLETED|Double-Blind Randomized Active Treatment||0
8745664|NCT01139762|9794162|FG001|NOT COMPLETED|Double-Blind Randomized Active Treatment||40
8745665|NCT01139762|9794163|FG002|NOT COMPLETED|Double-Blind Randomized Active Treatment||64
8745666|NCT01139775|9794173|FG000|STARTED|Overall Study||14
8745667|NCT01139775|9794174|FG001|STARTED|Overall Study||39
8745668|NCT01139775|9794175|FG002|STARTED|Overall Study||23
8745669|NCT01139775|9794173|FG000|Received at Least 1 Dose of Study Drug|Overall Study||14
8745670|NCT01139775|9794174|FG001|Received at Least 1 Dose of Study Drug|Overall Study||39
8745671|NCT01139775|9794175|FG002|Received at Least 1 Dose of Study Drug|Overall Study||22
8745672|NCT01139775|9794173|FG000|COMPLETED|Overall Study||13
8745673|NCT01139775|9794174|FG001|COMPLETED|Overall Study||26
8745674|NCT01139775|9794175|FG002|COMPLETED|Overall Study||17
8745675|NCT01139775|9794173|FG000|NOT COMPLETED|Overall Study||1
8745676|NCT01139775|9794174|FG001|NOT COMPLETED|Overall Study||13
8745677|NCT01139775|9794175|FG002|NOT COMPLETED|Overall Study||6
8745678|NCT01139801|9794187|FG000|STARTED|Overall Study||25
8745679|NCT01139801|9794188|FG001|STARTED|Overall Study||25
8745680|NCT01139801|9794187|FG000|COMPLETED|Overall Study||25
8745681|NCT01139801|9794188|FG001|COMPLETED|Overall Study||25
8745682|NCT01139801|9794187|FG000|NOT COMPLETED|Overall Study||0
8745683|NCT01139801|9794188|FG001|NOT COMPLETED|Overall Study||0
8745684|NCT01139814|9794194|FG000|STARTED|Overall Study||181
8745685|NCT01139814|9794194|FG000|COMPLETED|Overall Study||181
8745686|NCT01139814|9794194|FG000|NOT COMPLETED|Overall Study||0
8745687|NCT01139879|9794199|FG000|STARTED|Overall Study||10
8745688|NCT01139879|9794199|FG000|COMPLETED|Overall Study||10
8745689|NCT01139879|9794199|FG000|NOT COMPLETED|Overall Study||0
8745690|NCT01140061|9794215|FG000|STARTED|Part I|Includes 1 replacement participant|7
8745691|NCT01140061|9794216|FG001|STARTED|Part I||2
8745692|NCT01140061|9794217|FG002|STARTED|Part I||0
8745693|NCT01140061|9794218|FG003|STARTED|Part I||0
8745694|NCT01140061|9794219|FG004|STARTED|Part I||0
8745695|NCT01140061|9794220|FG005|STARTED|Part I||0
8745696|NCT01140061|9794221|FG006|STARTED|Part I||0
8745697|NCT01140061|9794222|FG007|STARTED|Part I||0
8745698|NCT01140061|9794223|FG008|STARTED|Part I||0
8745699|NCT01140061|9794224|FG009|STARTED|Part I||0
8745700|NCT01140061|9794215|FG000|COMPLETED|Part I||6
8745701|NCT01140061|9794216|FG001|COMPLETED|Part I||2
8745702|NCT01140061|9794217|FG002|COMPLETED|Part I||0
8745703|NCT01140061|9794218|FG003|COMPLETED|Part I||0
8745704|NCT01140061|9794219|FG004|COMPLETED|Part I||0
8745705|NCT01140061|9794220|FG005|COMPLETED|Part I||0
8745706|NCT01140061|9794221|FG006|COMPLETED|Part I||0
8745707|NCT01140061|9794222|FG007|COMPLETED|Part I||0
8745708|NCT01140061|9794223|FG008|COMPLETED|Part I||0
8745709|NCT01140061|9794224|FG009|COMPLETED|Part I||0
8745710|NCT01140061|9794215|FG000|NOT COMPLETED|Part I||1
8745711|NCT01140061|9794216|FG001|NOT COMPLETED|Part I||0
8745712|NCT01140061|9794217|FG002|NOT COMPLETED|Part I||0
8745713|NCT01140061|9794218|FG003|NOT COMPLETED|Part I||0
8745714|NCT01140061|9794219|FG004|NOT COMPLETED|Part I||0
8745715|NCT01140061|9794220|FG005|NOT COMPLETED|Part I||0
8745716|NCT01140061|9794221|FG006|NOT COMPLETED|Part I||0
8745717|NCT01140061|9794222|FG007|NOT COMPLETED|Part I||0
8745718|NCT01140061|9794223|FG008|NOT COMPLETED|Part I||0
8745719|NCT01140061|9794224|FG009|NOT COMPLETED|Part I||0
8745720|NCT01140061|9794215|FG000|STARTED|Part II||0
8745721|NCT01140061|9794216|FG001|STARTED|Part II||0
8745722|NCT01140061|9794217|FG002|STARTED|Part II||6
8745723|NCT01140061|9794218|FG003|STARTED|Part II||2
8745724|NCT01140061|9794219|FG004|STARTED|Part II||6
8745725|NCT01140061|9794220|FG005|STARTED|Part II||2
8745726|NCT01140061|9794221|FG006|STARTED|Part II||6
8745727|NCT01140061|9794222|FG007|STARTED|Part II||2
8745728|NCT01140061|9794223|FG008|STARTED|Part II||0
8745729|NCT01140061|9794224|FG009|STARTED|Part II||0
8745730|NCT01140061|9794215|FG000|COMPLETED|Part II||0
8745731|NCT01140061|9794216|FG001|COMPLETED|Part II||0
8745732|NCT01140061|9794217|FG002|COMPLETED|Part II||6
8745733|NCT01140061|9794218|FG003|COMPLETED|Part II||2
8745734|NCT01140061|9794219|FG004|COMPLETED|Part II||6
8745735|NCT01140061|9794220|FG005|COMPLETED|Part II||2
8745736|NCT01140061|9794221|FG006|COMPLETED|Part II||6
8745737|NCT01140061|9794222|FG007|COMPLETED|Part II||2
8745738|NCT01140061|9794223|FG008|COMPLETED|Part II||0
8745739|NCT01140061|9794224|FG009|COMPLETED|Part II||0
8745740|NCT01140061|9794215|FG000|NOT COMPLETED|Part II||0
8745741|NCT01140061|9794216|FG001|NOT COMPLETED|Part II||0
8745742|NCT01140061|9794217|FG002|NOT COMPLETED|Part II||0
8745743|NCT01140061|9794218|FG003|NOT COMPLETED|Part II||0
8745744|NCT01140061|9794219|FG004|NOT COMPLETED|Part II||0
8745745|NCT01140061|9794220|FG005|NOT COMPLETED|Part II||0
8745746|NCT01140061|9794221|FG006|NOT COMPLETED|Part II||0
8913581|NCT02161757|9972945|FG001|STARTED|Randomised Through Start Treatment||406
8913582|NCT02161757|9972946|FG002|STARTED|Randomised Through Start Treatment||400
8913583|NCT02161757|9972944|FG000|COMPLETED|Randomised Through Start Treatment||398
8913584|NCT02161757|9972945|FG001|COMPLETED|Randomised Through Start Treatment||404
8913585|NCT02161757|9972946|FG002|COMPLETED|Randomised Through Start Treatment||400
8913586|NCT02161757|9972944|FG000|NOT COMPLETED|Randomised Through Start Treatment||3
8913587|NCT02161757|9972945|FG001|NOT COMPLETED|Randomised Through Start Treatment||2
8913588|NCT02161757|9972946|FG002|NOT COMPLETED|Randomised Through Start Treatment||0
8913589|NCT02161757|9972944|FG000|STARTED|Treatment Through Study Completion||398
8913590|NCT02161757|9972945|FG001|STARTED|Treatment Through Study Completion||404
8913591|NCT02161757|9972946|FG002|STARTED|Treatment Through Study Completion||400
8913592|NCT02161757|9972944|FG000|Completed Treatment for Week 52 Cut-off|Treatment Through Study Completion||332
8913593|NCT02161757|9972945|FG001|Completed Treatment for Week 52 Cut-off|Treatment Through Study Completion||355
8913594|NCT02161757|9972946|FG002|Completed Treatment for Week 52 Cut-off|Treatment Through Study Completion||360
8913595|NCT02161757|9972944|FG000|COMPLETED|Treatment Through Study Completion||341
8913596|NCT02161757|9972945|FG001|COMPLETED|Treatment Through Study Completion||361
8913597|NCT02161757|9972946|FG002|COMPLETED|Treatment Through Study Completion||361
8913598|NCT02161757|9972944|FG000|NOT COMPLETED|Treatment Through Study Completion||57
8913599|NCT02161757|9972945|FG001|NOT COMPLETED|Treatment Through Study Completion||43
8913600|NCT02161757|9972946|FG002|NOT COMPLETED|Treatment Through Study Completion||39
8913601|NCT02162433|9972958|FG000|STARTED|Overall Study||23
8913602|NCT02162433|9972959|FG001|STARTED|Overall Study||23
8913603|NCT02162433|9972960|FG002|STARTED|Overall Study||23
8913604|NCT02162433|9972961|FG003|STARTED|Overall Study||23
8913605|NCT02162433|9972958|FG000|COMPLETED|Overall Study||22
8913606|NCT02162433|9972959|FG001|COMPLETED|Overall Study||21
8913607|NCT02162433|9972960|FG002|COMPLETED|Overall Study||21
8913608|NCT02162433|9972961|FG003|COMPLETED|Overall Study||22
8913609|NCT02162433|9972958|FG000|NOT COMPLETED|Overall Study||1
8913610|NCT02162433|9972959|FG001|NOT COMPLETED|Overall Study||2
8913611|NCT02162433|9972960|FG002|NOT COMPLETED|Overall Study||2
8913612|NCT02162433|9972961|FG003|NOT COMPLETED|Overall Study||1
8913613|NCT02162446|9972971|FG000|STARTED|Overall Study||12
8913614|NCT02162446|9972971|FG000|COMPLETED|Overall Study||12
8913615|NCT02162446|9972971|FG000|NOT COMPLETED|Overall Study||0
8913616|NCT02162576|9972980|FG000|STARTED|Overall Study||95
8913617|NCT02162576|9972980|FG000|COMPLETED|Overall Study||95
8913618|NCT02162576|9972980|FG000|NOT COMPLETED|Overall Study||0
8913619|NCT02162667|9972987|FG000|STARTED|Neoadjuvant Period||278
8913620|NCT02162667|9972988|FG001|STARTED|Neoadjuvant Period||284
8913621|NCT02162667|9972987|FG000|COMPLETED|Neoadjuvant Period||264
8913622|NCT02162667|9972988|FG001|COMPLETED|Neoadjuvant Period||267
8913623|NCT02162667|9972987|FG000|NOT COMPLETED|Neoadjuvant Period||14
8913624|NCT02162667|9972988|FG001|NOT COMPLETED|Neoadjuvant Period||17
8913625|NCT02162667|9972987|FG000|STARTED|Adjuvant Period||260
8913626|NCT02162667|9972988|FG001|STARTED|Adjuvant Period||268
8913627|NCT02162667|9972987|FG000|COMPLETED|Adjuvant Period||248
8913628|NCT02162667|9972988|FG001|COMPLETED|Adjuvant Period||255
8913629|NCT02162667|9972987|FG000|NOT COMPLETED|Adjuvant Period||12
8913630|NCT02162667|9972988|FG001|NOT COMPLETED|Adjuvant Period||13
8913631|NCT02162680|9973001|FG000|STARTED|Overall Study||33
8745747|NCT01140061|9794222|FG007|NOT COMPLETED|Part II||0
8745748|NCT01140061|9794223|FG008|NOT COMPLETED|Part II||0
8745749|NCT01140061|9794224|FG009|NOT COMPLETED|Part II||0
8913632|NCT02162680|9973002|FG001|STARTED|Overall Study||33
8913633|NCT02162680|9973003|FG002|STARTED|Overall Study||32
8913634|NCT02162680|9973001|FG000|COMPLETED|Overall Study||33
8913635|NCT02162680|9973002|FG001|COMPLETED|Overall Study||33
8913636|NCT02162680|9973003|FG002|COMPLETED|Overall Study||32
8913637|NCT02162680|9973001|FG000|NOT COMPLETED|Overall Study||0
8913638|NCT02162680|9973002|FG001|NOT COMPLETED|Overall Study||0
8913639|NCT02162680|9973003|FG002|NOT COMPLETED|Overall Study||0
8913640|NCT02162719|9973013|FG000|STARTED|Overall Study||62
8913641|NCT02162719|9973014|FG001|STARTED|Overall Study||62
8913642|NCT02162719|9973013|FG000|COMPLETED|Overall Study||0
8913643|NCT02162719|9973014|FG001|COMPLETED|Overall Study||0
8913644|NCT02162719|9973013|FG000|NOT COMPLETED|Overall Study||62
8745750|NCT01140061|9794215|FG000|STARTED|Part III||0
8745751|NCT01140061|9794216|FG001|STARTED|Part III||0
8745752|NCT01140061|9794217|FG002|STARTED|Part III||0
8745753|NCT01140061|9794218|FG003|STARTED|Part III||0
8745754|NCT01140061|9794219|FG004|STARTED|Part III||0
8745755|NCT01140061|9794220|FG005|STARTED|Part III||0
8745756|NCT01140061|9794221|FG006|STARTED|Part III||0
8745757|NCT01140061|9794222|FG007|STARTED|Part III||0
8745758|NCT01140061|9794223|FG008|STARTED|Part III||7
8745759|NCT01140061|9794224|FG009|STARTED|Part III|Includes 1 replacement participant|2
8745760|NCT01140061|9794215|FG000|COMPLETED|Part III||0
8745761|NCT01140061|9794216|FG001|COMPLETED|Part III||0
8745762|NCT01140061|9794217|FG002|COMPLETED|Part III||0
8745763|NCT01140061|9794218|FG003|COMPLETED|Part III||0
8745764|NCT01140061|9794219|FG004|COMPLETED|Part III||0
8745765|NCT01140061|9794220|FG005|COMPLETED|Part III||0
8745766|NCT01140061|9794221|FG006|COMPLETED|Part III||0
8745767|NCT01140061|9794222|FG007|COMPLETED|Part III||0
8745768|NCT01140061|9794223|FG008|COMPLETED|Part III||7
8745769|NCT01140061|9794224|FG009|COMPLETED|Part III||2
9022868|NCT03131648|10085667|FG003|COMPLETED|Open-label (Short Term Extension)||0
9022869|NCT03131648|10085668|FG004|COMPLETED|Open-label (Short Term Extension)||0
9022870|NCT03131648|10085669|FG005|COMPLETED|Open-label (Short Term Extension)||0
9022871|NCT03131648|10085670|FG006|COMPLETED|Open-label (Short Term Extension)||0
9022872|NCT03131648|10085671|FG007|COMPLETED|Open-label (Short Term Extension)||62
9022873|NCT03131648|10085664|FG000|NOT COMPLETED|Open-label (Short Term Extension)||0
9022874|NCT03131648|10085665|FG001|NOT COMPLETED|Open-label (Short Term Extension)||0
9022875|NCT03131648|10085666|FG002|NOT COMPLETED|Open-label (Short Term Extension)||0
9039979|NCT03345108|10100889|FG000|STARTED|Period-2||8
8745770|NCT01140061|9794215|FG000|NOT COMPLETED|Part III||0
8745771|NCT01140061|9794216|FG001|NOT COMPLETED|Part III||0
8745772|NCT01140061|9794217|FG002|NOT COMPLETED|Part III||0
8745773|NCT01140061|9794218|FG003|NOT COMPLETED|Part III||0
8745774|NCT01140061|9794219|FG004|NOT COMPLETED|Part III||0
8745775|NCT01140061|9794220|FG005|NOT COMPLETED|Part III||0
8745776|NCT01140061|9794221|FG006|NOT COMPLETED|Part III||0
8745777|NCT01140061|9794222|FG007|NOT COMPLETED|Part III||0
8745778|NCT01140061|9794223|FG008|NOT COMPLETED|Part III||0
8745779|NCT01140061|9794224|FG009|NOT COMPLETED|Part III||0
8745780|NCT01140061|9794215|FG000|STARTED|Extension||0
8745781|NCT01140061|9794216|FG001|STARTED|Extension||0
8745782|NCT01140061|9794217|FG002|STARTED|Extension||0
8745783|NCT01140061|9794218|FG003|STARTED|Extension||0
8745784|NCT01140061|9794219|FG004|STARTED|Extension||0
8745785|NCT01140061|9794220|FG005|STARTED|Extension||0
8745786|NCT01140061|9794221|FG006|STARTED|Extension||0
8745787|NCT01140061|9794222|FG007|STARTED|Extension||0
8745788|NCT01140061|9794223|FG008|STARTED|Extension||7
8745789|NCT01140061|9794224|FG009|STARTED|Extension||2
8745790|NCT01140061|9794215|FG000|COMPLETED|Extension||0
8745791|NCT01140061|9794216|FG001|COMPLETED|Extension||0
8745792|NCT01140061|9794217|FG002|COMPLETED|Extension||0
8745793|NCT01140061|9794218|FG003|COMPLETED|Extension||0
8745794|NCT01140061|9794219|FG004|COMPLETED|Extension||0
8745795|NCT01140061|9794220|FG005|COMPLETED|Extension||0
8745796|NCT01140061|9794221|FG006|COMPLETED|Extension||0
8745797|NCT01140061|9794222|FG007|COMPLETED|Extension||0
8745798|NCT01140061|9794223|FG008|COMPLETED|Extension||7
8745799|NCT01140061|9794224|FG009|COMPLETED|Extension||1
8745800|NCT01140061|9794215|FG000|NOT COMPLETED|Extension||0
8745801|NCT01140061|9794216|FG001|NOT COMPLETED|Extension||0
8745802|NCT01140061|9794217|FG002|NOT COMPLETED|Extension||0
8745803|NCT01140061|9794218|FG003|NOT COMPLETED|Extension||0
8745804|NCT01140061|9794219|FG004|NOT COMPLETED|Extension||0
8745805|NCT01140061|9794220|FG005|NOT COMPLETED|Extension||0
8745806|NCT01140061|9794221|FG006|NOT COMPLETED|Extension||0
8745807|NCT01140061|9794222|FG007|NOT COMPLETED|Extension||0
8745808|NCT01140061|9794223|FG008|NOT COMPLETED|Extension||0
8745809|NCT01140061|9794224|FG009|NOT COMPLETED|Extension||1
8745810|NCT01140191|9794239|FG000|STARTED|Overall Study||1
8745811|NCT01140191|9794239|FG000|COMPLETED|Overall Study||1
8745812|NCT01140191|9794239|FG000|NOT COMPLETED|Overall Study||0
8745813|NCT01140295|9794245|FG000|STARTED|Overall Study||17
8745814|NCT01140295|9794246|FG001|STARTED|Overall Study||16
8745815|NCT01140295|9794245|FG000|COMPLETED|Overall Study||16
8745816|NCT01140295|9794246|FG001|COMPLETED|Overall Study||14
8745817|NCT01140295|9794245|FG000|NOT COMPLETED|Overall Study||1
8745818|NCT01140295|9794246|FG001|NOT COMPLETED|Overall Study||2
8745819|NCT01140347|9794256|FG000|STARTED|Overall Study||283
8745820|NCT01140347|9794257|FG001|STARTED|Overall Study||282
8745821|NCT01140347|9794256|FG000|Received at Least 1 Dose of Study Drug|Overall Study||277
8745822|NCT01140347|9794257|FG001|Received at Least 1 Dose of Study Drug|Overall Study||276
8745823|NCT01140347|9794256|FG000|COMPLETED|Overall Study||265
8745824|NCT01140347|9794257|FG001|COMPLETED|Overall Study||268
8745825|NCT01140347|9794256|FG000|NOT COMPLETED|Overall Study||18
8745826|NCT01140347|9794257|FG001|NOT COMPLETED|Overall Study||14
8745827|NCT01140360|9794263|FG000|STARTED|Overall Study||21
8745828|NCT01140360|9794263|FG000|COMPLETED|Overall Study||15
8745829|NCT01140360|9794263|FG000|NOT COMPLETED|Overall Study||6
8745830|NCT01140477|9794269|FG000|STARTED|Overall Study||153
8745831|NCT01140477|9794270|FG001|STARTED|Overall Study||76
8745832|NCT01140477|9794269|FG000|COMPLETED|Overall Study||145
8745833|NCT01140477|9794270|FG001|COMPLETED|Overall Study||70
8745834|NCT01140477|9794269|FG000|NOT COMPLETED|Overall Study||8
8745835|NCT01140477|9794270|FG001|NOT COMPLETED|Overall Study||6
9039980|NCT03345108|10100890|FG001|STARTED|Period-2||8
8745836|NCT01140503|9794276|FG000|STARTED|Overall Study||5
8745837|NCT01140503|9794276|FG000|COMPLETED|Overall Study||4
8745838|NCT01140503|9794276|FG000|NOT COMPLETED|Overall Study||1
8745839|NCT01140568|9794280|FG000|STARTED|Overall Study||38
8745840|NCT01140568|9794280|FG000|Screen Fail|Overall Study||4
8745841|NCT01140568|9794280|FG000|Treated With Study Drug|Overall Study||34
8745842|NCT01140568|9794280|FG000|COMPLETED|Overall Study||2
8745843|NCT01140568|9794280|FG000|NOT COMPLETED|Overall Study||36
8745844|NCT01140646|9794284|FG000|STARTED|Overall Study||43
8745845|NCT01140646|9794284|FG000|COMPLETED|Overall Study||34
8745846|NCT01140646|9794284|FG000|NOT COMPLETED|Overall Study||9
8745847|NCT01140815|9794290|FG000|STARTED|Overall Study||25
8745848|NCT01140815|9794291|FG001|STARTED|Overall Study||25
8745849|NCT01140815|9794290|FG000|COMPLETED|Overall Study||25
8745850|NCT01140815|9794291|FG001|COMPLETED|Overall Study||25
8745851|NCT01140815|9794290|FG000|NOT COMPLETED|Overall Study||0
8745852|NCT01140815|9794291|FG001|NOT COMPLETED|Overall Study||0
8745853|NCT01140880|9794301|FG000|STARTED|Overall Study||70
8745854|NCT01140880|9794302|FG001|STARTED|Overall Study||100
8745855|NCT01140880|9794301|FG000|COMPLETED|Overall Study||56
8745856|NCT01140880|9794302|FG001|COMPLETED|Overall Study||56
8745857|NCT01140880|9794301|FG000|NOT COMPLETED|Overall Study||14
8745858|NCT01140880|9794302|FG001|NOT COMPLETED|Overall Study||44
8745859|NCT01140906|9794312|FG000|STARTED|Overall Study||158
8745860|NCT01140906|9794313|FG001|STARTED|Overall Study||151
8745861|NCT01140906|9794314|FG002|STARTED|Overall Study||151
8745862|NCT01140906|9794315|FG003|STARTED|Overall Study||147
8745863|NCT01140906|9794312|FG000|COMPLETED|Overall Study||133
8745864|NCT01140906|9794313|FG001|COMPLETED|Overall Study||117
8745865|NCT01140906|9794314|FG002|COMPLETED|Overall Study||125
8745866|NCT01140906|9794315|FG003|COMPLETED|Overall Study||131
8745867|NCT01140906|9794312|FG000|NOT COMPLETED|Overall Study||25
8745868|NCT01140906|9794313|FG001|NOT COMPLETED|Overall Study||34
8745869|NCT01140906|9794314|FG002|NOT COMPLETED|Overall Study||26
8745870|NCT01140906|9794315|FG003|NOT COMPLETED|Overall Study||16
8807543|NCT01484561|9859824|FG001|STARTED|Overall Study||51
8807544|NCT01484561|9859823|FG000|COMPLETED|Overall Study||88
8807545|NCT01484561|9859824|FG001|COMPLETED|Overall Study||45
8807546|NCT01484561|9859823|FG000|NOT COMPLETED|Overall Study||9
8807547|NCT01484561|9859824|FG001|NOT COMPLETED|Overall Study||6
8807548|NCT01484626|9859830|FG000|STARTED|Overall Study||3
8807549|NCT01484626|9859830|FG000|COMPLETED|Overall Study||3
8807550|NCT01484626|9859830|FG000|NOT COMPLETED|Overall Study||0
8807551|NCT01484652|9859836|FG000|STARTED|Overall Study||166
8807552|NCT01484652|9859837|FG001|STARTED|Overall Study||163
8807553|NCT01484652|9859836|FG000|COMPLETED|Overall Study||151
8807554|NCT01484652|9859837|FG001|COMPLETED|Overall Study||142
8807555|NCT01484652|9859836|FG000|NOT COMPLETED|Overall Study||15
8807556|NCT01484652|9859837|FG001|NOT COMPLETED|Overall Study||21
8807557|NCT01484834|9859847|FG000|STARTED|Overall Study||65
8807558|NCT01484834|9859848|FG001|STARTED|Overall Study||62
8807559|NCT01484834|9859849|FG002|STARTED|Overall Study||39
8807560|NCT01484834|9859850|FG003|STARTED|Overall Study||24
8807561|NCT01484834|9859847|FG000|COMPLETED|Overall Study||60
8807562|NCT01484834|9859848|FG001|COMPLETED|Overall Study||54
8807563|NCT01484834|9859849|FG002|COMPLETED|Overall Study||38
8807564|NCT01484834|9859850|FG003|COMPLETED|Overall Study||20
8807565|NCT01484834|9859847|FG000|NOT COMPLETED|Overall Study||5
8807566|NCT01484834|9859848|FG001|NOT COMPLETED|Overall Study||8
8807567|NCT01484834|9859849|FG002|NOT COMPLETED|Overall Study||1
8807568|NCT01484834|9859850|FG003|NOT COMPLETED|Overall Study||4
8807569|NCT01484873|9859860|FG000|STARTED|Overall Study||10
8807570|NCT01484873|9859860|FG000|COMPLETED|Overall Study||8
8807571|NCT01484873|9859860|FG000|NOT COMPLETED|Overall Study||2
8807572|NCT01484912|9859867|FG000|STARTED|Overall Study||39
8807573|NCT01484912|9859868|FG001|STARTED|Overall Study||40
8807574|NCT01484912|9859867|FG000|COMPLETED|Overall Study||38
8807575|NCT01484912|9859868|FG001|COMPLETED|Overall Study||39
8807576|NCT01484912|9859867|FG000|NOT COMPLETED|Overall Study||1
8807577|NCT01484912|9859868|FG001|NOT COMPLETED|Overall Study||1
8807578|NCT01484938|9859874|FG000|STARTED|Overall Study||175
8807579|NCT01484938|9859874|FG000|COMPLETED|Overall Study||171
8807580|NCT01484938|9859874|FG000|NOT COMPLETED|Overall Study||4
8807581|NCT01484951|9859878|FG000|STARTED|Overall Study||74
8807582|NCT01484951|9859878|FG000|COMPLETED|Overall Study||69
8807583|NCT01484951|9859878|FG000|NOT COMPLETED|Overall Study||5
8807584|NCT01484977|9859882|FG000|STARTED|Overall Study||120
8807585|NCT01484977|9859882|FG000|COMPLETED|Overall Study||93
8807586|NCT01484977|9859882|FG000|NOT COMPLETED|Overall Study||27
8807587|NCT01485055|9859886|FG000|STARTED|Overall Study||11
8807588|NCT01485055|9859886|FG000|COMPLETED|Overall Study||11
8807589|NCT01485055|9859886|FG000|NOT COMPLETED|Overall Study||0
8807590|NCT01485094|9859893|FG000|STARTED|Overall Study||20
8807591|NCT01485094|9859894|FG001|STARTED|Overall Study||20
8807592|NCT01485094|9859895|FG002|STARTED|Overall Study||19
8807593|NCT01485094|9859893|FG000|COMPLETED|Overall Study||17
8807594|NCT01485094|9859894|FG001|COMPLETED|Overall Study||18
8807595|NCT01485094|9859895|FG002|COMPLETED|Overall Study||18
8807596|NCT01485094|9859893|FG000|NOT COMPLETED|Overall Study||3
8807597|NCT01485094|9859894|FG001|NOT COMPLETED|Overall Study||2
8807598|NCT01485094|9859895|FG002|NOT COMPLETED|Overall Study||1
8807599|NCT01485120|9859903|FG000|STARTED|Overall Study||34
8807600|NCT01485120|9859903|FG000|COMPLETED|Overall Study||32
8745871|NCT01141049|9794327|FG000|STARTED|Overall Study||19
8745872|NCT01141049|9794328|FG001|STARTED|Overall Study||21
8745873|NCT01141049|9794327|FG000|COMPLETED|Overall Study||14
8745874|NCT01141049|9794328|FG001|COMPLETED|Overall Study||13
8745875|NCT01141049|9794327|FG000|NOT COMPLETED|Overall Study||5
8745876|NCT01141049|9794328|FG001|NOT COMPLETED|Overall Study||8
8745877|NCT01141075|9794334|FG000|STARTED|Cycle 1||11
8745878|NCT01141075|9794334|FG000|Received at Least 1 Dose of Study Drug|Cycle 1||11
8745879|NCT01141075|9794334|FG000|COMPLETED|Cycle 1||11
8745880|NCT01141075|9794334|FG000|NOT COMPLETED|Cycle 1||0
8745881|NCT01141075|9794334|FG000|STARTED|Cycle 2||11
8745882|NCT01141075|9794334|FG000|Received at Least 1 Dose of Study Drug|Cycle 2||11
8745883|NCT01141075|9794334|FG000|COMPLETED|Cycle 2||11
8745884|NCT01141075|9794334|FG000|NOT COMPLETED|Cycle 2||0
8745885|NCT01141205|9794340|FG000|STARTED|Overall Study||18
8745886|NCT01141205|9794341|FG001|STARTED|Overall Study||5
8745887|NCT01141205|9794340|FG000|COMPLETED|Overall Study||15
8745888|NCT01141205|9794341|FG001|COMPLETED|Overall Study||3
8745889|NCT01141205|9794340|FG000|NOT COMPLETED|Overall Study||3
8745890|NCT01141205|9794341|FG001|NOT COMPLETED|Overall Study||2
8745891|NCT01141283|9794351|FG000|STARTED|Overall Study||290
8745892|NCT01141283|9794351|FG000|COMPLETED|Overall Study||202
8745893|NCT01141283|9794351|FG000|NOT COMPLETED|Overall Study||88
8745894|NCT01141374|9794358|FG000|STARTED|Overall Study||26
8745895|NCT01141374|9794359|FG001|STARTED|Overall Study||27
8745896|NCT01141374|9794360|FG002|STARTED|Overall Study||22
8745897|NCT01141374|9794358|FG000|COMPLETED|Overall Study||26
8745898|NCT01141374|9794359|FG001|COMPLETED|Overall Study||27
8745899|NCT01141374|9794360|FG002|COMPLETED|Overall Study||22
8745900|NCT01141374|9794358|FG000|NOT COMPLETED|Overall Study||0
8745901|NCT01141374|9794359|FG001|NOT COMPLETED|Overall Study||0
8745902|NCT01141374|9794360|FG002|NOT COMPLETED|Overall Study||0
8745903|NCT01141478|9794372|FG000|STARTED|Overall Study||4
8745904|NCT01141478|9794373|FG001|STARTED|Overall Study||4
8745905|NCT01141478|9794372|FG000|COMPLETED|Overall Study||3
8745906|NCT01141478|9794373|FG001|COMPLETED|Overall Study||3
8745907|NCT01141478|9794372|FG000|NOT COMPLETED|Overall Study||1
8745908|NCT01141478|9794373|FG001|NOT COMPLETED|Overall Study||1
8745909|NCT01141491|9794381|FG000|STARTED|Overall Study||68
8745910|NCT01141491|9794382|FG001|STARTED|Overall Study||68
8745911|NCT01141491|9794381|FG000|COMPLETED|Overall Study||20
8745912|NCT01141491|9794382|FG001|COMPLETED|Overall Study||21
8745913|NCT01141491|9794381|FG000|NOT COMPLETED|Overall Study||48
8745914|NCT01141491|9794382|FG001|NOT COMPLETED|Overall Study||47
8745915|NCT01141569|9794388|FG000|STARTED|Overall Study||12
8745916|NCT01141569|9794388|FG000|COMPLETED|Overall Study||12
8745917|NCT01141569|9794388|FG000|NOT COMPLETED|Overall Study||0
8745918|NCT01141595|9794392|FG000|STARTED|Overall Study||10
8745919|NCT01141595|9794392|FG000|COMPLETED|Overall Study||8
8745920|NCT01141595|9794392|FG000|NOT COMPLETED|Overall Study||2
8745921|NCT01141608|9794398|FG000|STARTED|Overall Study||152
8745922|NCT01141608|9794399|FG001|STARTED|Overall Study||150
8745923|NCT01141608|9794398|FG000|COMPLETED|Overall Study||152
8745924|NCT01141608|9794399|FG001|COMPLETED|Overall Study||150
8745925|NCT01141608|9794398|FG000|NOT COMPLETED|Overall Study||0
8745926|NCT01141608|9794399|FG001|NOT COMPLETED|Overall Study||0
8745927|NCT01141647|9794405|FG000|STARTED|Overall Study||213
8745928|NCT01141647|9794405|FG000|COMPLETED|Overall Study||167
8745929|NCT01141647|9794405|FG000|NOT COMPLETED|Overall Study||46
8745930|NCT01141660|9794416|FG000|STARTED|Overall Study||71
8745931|NCT01141660|9794417|FG001|STARTED|Overall Study||60
8745932|NCT01141660|9794416|FG000|COMPLETED|Overall Study||71
8745933|NCT01141660|9794417|FG001|COMPLETED|Overall Study||48
8745934|NCT01141660|9794416|FG000|NOT COMPLETED|Overall Study||0
8745935|NCT01141660|9794417|FG001|NOT COMPLETED|Overall Study||12
8745936|NCT01141725|9794423|FG000|STARTED|Overall Study||3
8745937|NCT01141725|9794424|FG001|STARTED|Overall Study||33
8745938|NCT01141725|9794425|FG002|STARTED|Overall Study||3
8745939|NCT01141725|9794423|FG000|COMPLETED|Overall Study||3
8745940|NCT01141725|9794424|FG001|COMPLETED|Overall Study||33
8745941|NCT01141725|9794425|FG002|COMPLETED|Overall Study||3
8745942|NCT01141725|9794423|FG000|NOT COMPLETED|Overall Study||0
8745943|NCT01141725|9794424|FG001|NOT COMPLETED|Overall Study||0
8745944|NCT01141725|9794425|FG002|NOT COMPLETED|Overall Study||0
8745945|NCT01141907|9794434|FG000|STARTED|Overall Study||6
8745946|NCT01141907|9794435|FG001|STARTED|Overall Study||5
8745947|NCT01141907|9794434|FG000|COMPLETED|Overall Study||6
8745948|NCT01141907|9794435|FG001|COMPLETED|Overall Study||5
8745949|NCT01141907|9794434|FG000|NOT COMPLETED|Overall Study||0
8745950|NCT01141907|9794435|FG001|NOT COMPLETED|Overall Study||0
8745951|NCT01142089|9794443|FG000|STARTED|Overall Study||65
8745952|NCT01142089|9794444|FG001|STARTED|Overall Study||199
8745953|NCT01142089|9794443|FG000|COMPLETED|Overall Study||53
8745954|NCT01142089|9794444|FG001|COMPLETED|Overall Study||178
8745955|NCT01142089|9794443|FG000|NOT COMPLETED|Overall Study||12
8745956|NCT01142089|9794444|FG001|NOT COMPLETED|Overall Study||21
8745957|NCT01142115|9794450|FG000|STARTED|First Intervention||21
8745958|NCT01142115|9794451|FG001|STARTED|First Intervention||20
8745959|NCT01142115|9794450|FG000|COMPLETED|First Intervention||19
8745960|NCT01142115|9794451|FG001|COMPLETED|First Intervention||19
8745961|NCT01142115|9794450|FG000|NOT COMPLETED|First Intervention||2
8745962|NCT01142115|9794451|FG001|NOT COMPLETED|First Intervention||1
8745963|NCT01142115|9794450|FG000|STARTED|Second Intervention||19
8745964|NCT01142115|9794451|FG001|STARTED|Second Intervention||19
8745965|NCT01142115|9794450|FG000|COMPLETED|Second Intervention||19
8745966|NCT01142115|9794451|FG001|COMPLETED|Second Intervention||19
8745967|NCT01142115|9794450|FG000|NOT COMPLETED|Second Intervention||0
8745968|NCT01142115|9794451|FG001|NOT COMPLETED|Second Intervention||0
8745969|NCT01142193|9794458|FG000|STARTED|Overall Study||124
8745970|NCT01142193|9794459|FG001|STARTED|Overall Study||125
8745971|NCT01142193|9794458|FG000|COMPLETED|Overall Study||103
8745972|NCT01142193|9794459|FG001|COMPLETED|Overall Study||114
8745973|NCT01142193|9794458|FG000|NOT COMPLETED|Overall Study||21
8745974|NCT01142193|9794459|FG001|NOT COMPLETED|Overall Study||11
8745975|NCT01142232|9794470|FG000|STARTED|Overall Study||3
8745976|NCT01142232|9794471|FG001|STARTED|Overall Study||4
8745977|NCT01142232|9794472|FG002|STARTED|Overall Study||3
8745978|NCT01142232|9794473|FG003|STARTED|Overall Study||6
8913645|NCT02162719|9973014|FG001|NOT COMPLETED|Overall Study||62
8913646|NCT02162758|9973022|FG000|STARTED|Overall Study||3
8913647|NCT02162758|9973023|FG001|STARTED|Overall Study||3
8913648|NCT02162758|9973022|FG000|COMPLETED|Overall Study||3
8913649|NCT02162758|9973023|FG001|COMPLETED|Overall Study||2
8913650|NCT02162758|9973022|FG000|NOT COMPLETED|Overall Study||0
8913651|NCT02162758|9973023|FG001|NOT COMPLETED|Overall Study||1
8913652|NCT02162771|9973031|FG000|STARTED|Core Study Period (Part 2)||70
8913653|NCT02162771|9973032|FG001|STARTED|Core Study Period (Part 2)||70
8913654|NCT02162771|9973031|FG000|COMPLETED|Core Study Period (Part 2)||62
8913655|NCT02162771|9973032|FG001|COMPLETED|Core Study Period (Part 2)||62
8913656|NCT02162771|9973031|FG000|NOT COMPLETED|Core Study Period (Part 2)||8
8913657|NCT02162771|9973032|FG001|NOT COMPLETED|Core Study Period (Part 2)||8
8913658|NCT02162771|9973031|FG000|STARTED|Maintenance Study Period (Part 2)||62
8913659|NCT02162771|9973032|FG001|STARTED|Maintenance Study Period (Part 2)|Two subjects did not enter this period due to Withdrawal by subject and Non-responder, 1 for each.|60
8913660|NCT02162771|9973031|FG000|COMPLETED|Maintenance Study Period (Part 2)||46
8913661|NCT02162771|9973032|FG001|COMPLETED|Maintenance Study Period (Part 2)||38
8913662|NCT02162771|9973031|FG000|NOT COMPLETED|Maintenance Study Period (Part 2)||16
8913663|NCT02162771|9973032|FG001|NOT COMPLETED|Maintenance Study Period (Part 2)||22
8913664|NCT02162862|9973041|FG000|STARTED|Overall Study||31
8913665|NCT02162862|9973042|FG001|STARTED|Overall Study||35
8913666|NCT02162862|9973043|FG002|STARTED|Overall Study||33
8913667|NCT02162862|9973041|FG000|COMPLETED|Overall Study||31
8913668|NCT02162862|9973042|FG001|COMPLETED|Overall Study||24
8913669|NCT02162862|9973043|FG002|COMPLETED|Overall Study||29
8913670|NCT02162862|9973041|FG000|NOT COMPLETED|Overall Study||0
8913671|NCT02162862|9973042|FG001|NOT COMPLETED|Overall Study||11
8913672|NCT02162862|9973043|FG002|NOT COMPLETED|Overall Study||4
8913673|NCT02162992|9973055|FG000|STARTED|Overall Study||51
8913674|NCT02162992|9973056|FG001|STARTED|Overall Study||100
8913675|NCT02162992|9973055|FG000|COMPLETED|Overall Study||46
8913676|NCT02162992|9973056|FG001|COMPLETED|Overall Study||99
8913677|NCT02162992|9973055|FG000|NOT COMPLETED|Overall Study||5
8913678|NCT02162992|9973056|FG001|NOT COMPLETED|Overall Study||1
8913679|NCT02163057|9973064|FG000|STARTED|Overall Study||6
8913680|NCT02163057|9973065|FG001|STARTED|Overall Study||16
8913681|NCT02163057|9973064|FG000|COMPLETED|Overall Study||3
8913682|NCT02163057|9973065|FG001|COMPLETED|Overall Study||11
8913683|NCT02163057|9973064|FG000|NOT COMPLETED|Overall Study||3
8913684|NCT02163057|9973065|FG001|NOT COMPLETED|Overall Study||5
8913685|NCT02163226|9973075|FG000|STARTED|Overall Study||79
8913686|NCT02163226|9973076|FG001|STARTED|Overall Study||81
8913687|NCT02163226|9973075|FG000|COMPLETED|Overall Study||63
8913688|NCT02163226|9973076|FG001|COMPLETED|Overall Study||70
8913689|NCT02163226|9973075|FG000|NOT COMPLETED|Overall Study||16
8913690|NCT02163226|9973076|FG001|NOT COMPLETED|Overall Study||11
8913691|NCT02163395|9973082|FG000|STARTED|Overall Study||44
8913692|NCT02163395|9973082|FG000|COMPLETED|Overall Study||39
8913693|NCT02163395|9973082|FG000|NOT COMPLETED|Overall Study||5
8913694|NCT02163421|9973090|FG000|STARTED|Overall Study||12
8913695|NCT02163421|9973091|FG001|STARTED|Overall Study||12
8913696|NCT02163421|9973092|FG002|STARTED|Overall Study||12
8913697|NCT02163421|9973093|FG003|STARTED|Overall Study||12
8913698|NCT02163421|9973090|FG000|COMPLETED|Overall Study||12
8913699|NCT02163421|9973091|FG001|COMPLETED|Overall Study||12
8913700|NCT02163421|9973092|FG002|COMPLETED|Overall Study||12
8913701|NCT02163421|9973093|FG003|COMPLETED|Overall Study||12
8913702|NCT02163421|9973090|FG000|NOT COMPLETED|Overall Study||0
8913703|NCT02163421|9973091|FG001|NOT COMPLETED|Overall Study||0
8913704|NCT02163421|9973092|FG002|NOT COMPLETED|Overall Study||0
8913705|NCT02163421|9973093|FG003|NOT COMPLETED|Overall Study||0
8913706|NCT02163434|9973102|FG000|STARTED|Overall Study||15
8913707|NCT02163434|9973103|FG001|STARTED|Overall Study||16
8913708|NCT02163434|9973102|FG000|COMPLETED|Overall Study||12
8913709|NCT02163434|9973103|FG001|COMPLETED|Overall Study||9
8913710|NCT02163434|9973102|FG000|NOT COMPLETED|Overall Study||3
8913711|NCT02163434|9973103|FG001|NOT COMPLETED|Overall Study||7
8913712|NCT02163447|9973112|FG000|STARTED|Overall Study||106
8745979|NCT01142232|9794474|FG004|STARTED|Overall Study||44
8745980|NCT01142232|9794470|FG000|COMPLETED|Overall Study||0
8745981|NCT01142232|9794471|FG001|COMPLETED|Overall Study||0
8913713|NCT02163447|9973113|FG001|STARTED|Overall Study||94
8745982|NCT01142232|9794472|FG002|COMPLETED|Overall Study||0
8745983|NCT01142232|9794473|FG003|COMPLETED|Overall Study||1
8745984|NCT01142232|9794474|FG004|COMPLETED|Overall Study||10
8745985|NCT01142232|9794470|FG000|NOT COMPLETED|Overall Study||3
8745986|NCT01142232|9794471|FG001|NOT COMPLETED|Overall Study||4
8745987|NCT01142232|9794472|FG002|NOT COMPLETED|Overall Study||3
8745988|NCT01142232|9794473|FG003|NOT COMPLETED|Overall Study||5
8913714|NCT02163447|9973114|FG002|STARTED|Overall Study||100
8913715|NCT02163447|9973112|FG000|Infants Born|Overall Study||101
8913716|NCT02163447|9973113|FG001|Infants Born|Overall Study||93
8913717|NCT02163447|9973114|FG002|Infants Born|Overall Study||100
8913718|NCT02163447|9973112|FG000|COMPLETED|Overall Study||100
8913719|NCT02163447|9973113|FG001|COMPLETED|Overall Study||88
8913720|NCT02163447|9973114|FG002|COMPLETED|Overall Study||97
8913721|NCT02163447|9973112|FG000|NOT COMPLETED|Overall Study||6
8913722|NCT02163447|9973113|FG001|NOT COMPLETED|Overall Study||6
8913723|NCT02163447|9973114|FG002|NOT COMPLETED|Overall Study||3
8913724|NCT02163486|9973134|FG000|STARTED|Overall Study||51
8913725|NCT02163486|9973135|FG001|STARTED|Overall Study||52
8913726|NCT02163486|9973134|FG000|COMPLETED|Overall Study||50
8913727|NCT02163486|9973135|FG001|COMPLETED|Overall Study||50
8913728|NCT02163486|9973134|FG000|NOT COMPLETED|Overall Study||1
8913729|NCT02163486|9973135|FG001|NOT COMPLETED|Overall Study||2
8913730|NCT02163499|9973141|FG000|STARTED|Acute Phase: ZS 10 g TID||751
8913731|NCT02163499|9973141|FG000|COMPLETED|Acute Phase: ZS 10 g TID||746
8913732|NCT02163499|9973141|FG000|NOT COMPLETED|Acute Phase: ZS 10 g TID||5
8913733|NCT02163499|9973141|FG000|STARTED|Extended Dosing Phase: ZS||746
8913734|NCT02163499|9973141|FG000|COMPLETED|Extended Dosing Phase: ZS||466
8913735|NCT02163499|9973141|FG000|NOT COMPLETED|Extended Dosing Phase: ZS||280
8913736|NCT02163538|9973151|FG000|STARTED|Overall Study||71
8913737|NCT02163538|9973152|FG001|STARTED|Overall Study||71
8913738|NCT02163538|9973151|FG000|COMPLETED|Overall Study||70
8913739|NCT02163538|9973152|FG001|COMPLETED|Overall Study||70
8913740|NCT02163538|9973151|FG000|NOT COMPLETED|Overall Study||1
8913741|NCT02163538|9973152|FG001|NOT COMPLETED|Overall Study||1
8913742|NCT02163577|9973160|FG000|STARTED|Overall Study||26
8913743|NCT02163577|9973161|FG001|STARTED|Overall Study||26
8913744|NCT02163577|9973160|FG000|COMPLETED|Overall Study||26
8913745|NCT02163577|9973161|FG001|COMPLETED|Overall Study||26
8913746|NCT02163577|9973160|FG000|NOT COMPLETED|Overall Study||0
8913747|NCT02163577|9973161|FG001|NOT COMPLETED|Overall Study||0
8913748|NCT02163759|9973170|FG000|STARTED|Overall Study||72
8913749|NCT02163759|9973171|FG001|STARTED|Overall Study||142
8913750|NCT02163759|9973172|FG002|STARTED|Overall Study||144
8913751|NCT02163759|9973170|FG000|Completed Week 10|Overall Study||71
8913752|NCT02163759|9973171|FG001|Completed Week 10|Overall Study||141
8913753|NCT02163759|9973172|FG002|Completed Week 10|Overall Study||143
8913754|NCT02163759|9973170|FG000|COMPLETED|Overall Study||71
8913755|NCT02163759|9973171|FG001|COMPLETED|Overall Study||137
8913756|NCT02163759|9973172|FG002|COMPLETED|Overall Study||141
8913757|NCT02163759|9973170|FG000|NOT COMPLETED|Overall Study||1
8913758|NCT02163759|9973171|FG001|NOT COMPLETED|Overall Study||5
8913759|NCT02163759|9973172|FG002|NOT COMPLETED|Overall Study||3
8913760|NCT02163811|9973185|FG000|STARTED|Overall Study||71
8913761|NCT02163811|9973186|FG001|STARTED|Overall Study||76
8913762|NCT02163811|9973185|FG000|COMPLETED|Overall Study||35
8913763|NCT02163811|9973186|FG001|COMPLETED|Overall Study||60
8913764|NCT02163811|9973185|FG000|NOT COMPLETED|Overall Study||36
8913765|NCT02163811|9973186|FG001|NOT COMPLETED|Overall Study||16
8913766|NCT02163824|9973195|FG000|STARTED|Overall Study||129
8913767|NCT02163824|9973196|FG001|STARTED|Overall Study||125
8913768|NCT02163824|9973197|FG002|STARTED|Overall Study||126
8913769|NCT02163824|9973195|FG000|COMPLETED|Overall Study||127
8913770|NCT02163824|9973196|FG001|COMPLETED|Overall Study||124
8913771|NCT02163824|9973197|FG002|COMPLETED|Overall Study||124
8913772|NCT02163824|9973195|FG000|NOT COMPLETED|Overall Study||2
8913773|NCT02163824|9973196|FG001|NOT COMPLETED|Overall Study||1
8913774|NCT02163824|9973197|FG002|NOT COMPLETED|Overall Study||2
8913775|NCT02163837|9973205|FG000|STARTED|Before Rifaximin||15
8913776|NCT02163837|9973205|FG000|COMPLETED|Before Rifaximin||15
8913777|NCT02163837|9973205|FG000|NOT COMPLETED|Before Rifaximin||0
8913778|NCT02163837|9973205|FG000|STARTED|Day 28 of Rifaximin Treatment||15
8913779|NCT02163837|9973205|FG000|COMPLETED|Day 28 of Rifaximin Treatment||15
8913780|NCT02163837|9973205|FG000|NOT COMPLETED|Day 28 of Rifaximin Treatment||0
8745989|NCT01142232|9794474|FG004|NOT COMPLETED|Overall Study||34
8745990|NCT01142297|9794486|FG000|STARTED|Overall Study||24
8745991|NCT01142297|9794486|FG000|COMPLETED|Overall Study||18
8745992|NCT01142297|9794486|FG000|NOT COMPLETED|Overall Study||6
8745993|NCT01142310|9794495|FG000|STARTED|Overall Study||26
8745994|NCT01142310|9794496|FG001|STARTED|Overall Study||28
8913781|NCT02163902|9973211|FG000|STARTED|Overall Study||113
8913782|NCT02163902|9973212|FG001|STARTED|Overall Study||111
8913783|NCT02163902|9973211|FG000|COMPLETED|Overall Study||102
8913784|NCT02163902|9973212|FG001|COMPLETED|Overall Study||98
8913785|NCT02163902|9973211|FG000|NOT COMPLETED|Overall Study||11
8913786|NCT02163902|9973212|FG001|NOT COMPLETED|Overall Study||13
8913787|NCT02163915|9973223|FG000|STARTED|Overall Study||10
8913788|NCT02163915|9973224|FG001|STARTED|Overall Study||8
8913789|NCT02163915|9973225|FG002|STARTED|Overall Study||10
8913790|NCT02163915|9973226|FG003|STARTED|Overall Study||9
8913791|NCT02163915|9973227|FG004|STARTED|Overall Study||10
8913792|NCT02163915|9973223|FG000|COMPLETED|Overall Study||7
8913793|NCT02163915|9973224|FG001|COMPLETED|Overall Study||8
8913794|NCT02163915|9973225|FG002|COMPLETED|Overall Study||8
8745995|NCT01142310|9794495|FG000|COMPLETED|Overall Study||17
8745996|NCT01142310|9794496|FG001|COMPLETED|Overall Study||16
8745997|NCT01142310|9794495|FG000|NOT COMPLETED|Overall Study||9
8745998|NCT01142310|9794496|FG001|NOT COMPLETED|Overall Study||12
8745999|NCT01142323|9794502|FG000|STARTED|Overall Study||8
8746000|NCT01142323|9794502|FG000|COMPLETED|Overall Study||8
8746001|NCT01142323|9794502|FG000|NOT COMPLETED|Overall Study||0
8746002|NCT01142336|9794510|FG000|STARTED|Overall Study||26
8746003|NCT01142336|9794511|FG001|STARTED|Overall Study||23
8746004|NCT01142336|9794510|FG000|COMPLETED|Overall Study||25
8746005|NCT01142336|9794511|FG001|COMPLETED|Overall Study||21
8746006|NCT01142336|9794510|FG000|NOT COMPLETED|Overall Study||1
8746007|NCT01142336|9794511|FG001|NOT COMPLETED|Overall Study||2
8746008|NCT01142466|9794522|FG000|STARTED|Overall Study||15
8746009|NCT01142466|9794523|FG001|STARTED|Overall Study||15
8746010|NCT01142466|9794522|FG000|COMPLETED|Overall Study||12
8746011|NCT01142466|9794523|FG001|COMPLETED|Overall Study||13
8746012|NCT01142466|9794522|FG000|NOT COMPLETED|Overall Study||3
8746013|NCT01142466|9794523|FG001|NOT COMPLETED|Overall Study||2
8746014|NCT01142661|9794529|FG000|STARTED|Overall Study||9
8746015|NCT01142661|9794529|FG000|COMPLETED|Overall Study||5
8746016|NCT01142661|9794529|FG000|NOT COMPLETED|Overall Study||4
8746017|NCT01142726|9794536|FG000|STARTED|Treatment Phase: Day 1 Through Month 12||119
8746018|NCT01142726|9794537|FG001|STARTED|Treatment Phase: Day 1 Through Month 12||116
8746019|NCT01142726|9794538|FG002|STARTED|Treatment Phase: Day 1 Through Month 12||116
8746020|NCT01142726|9794536|FG000|COMPLETED|Treatment Phase: Day 1 Through Month 12||103
8746021|NCT01142726|9794537|FG001|COMPLETED|Treatment Phase: Day 1 Through Month 12||91
8746022|NCT01142726|9794538|FG002|COMPLETED|Treatment Phase: Day 1 Through Month 12||96
8746023|NCT01142726|9794536|FG000|NOT COMPLETED|Treatment Phase: Day 1 Through Month 12||16
8746024|NCT01142726|9794537|FG001|NOT COMPLETED|Treatment Phase: Day 1 Through Month 12||25
8746025|NCT01142726|9794538|FG002|NOT COMPLETED|Treatment Phase: Day 1 Through Month 12||20
8746026|NCT01142726|9794536|FG000|STARTED|Withdrawal Phase: Months 12 up to 24||84
8746027|NCT01142726|9794537|FG001|STARTED|Withdrawal Phase: Months 12 up to 24||66
8746028|NCT01142726|9794538|FG002|STARTED|Withdrawal Phase: Months 12 up to 24||75
8746029|NCT01142726|9794536|FG000|COMPLETED|Withdrawal Phase: Months 12 up to 24||14
8746030|NCT01142726|9794537|FG001|COMPLETED|Withdrawal Phase: Months 12 up to 24||10
8746031|NCT01142726|9794538|FG002|COMPLETED|Withdrawal Phase: Months 12 up to 24||17
8746032|NCT01142726|9794536|FG000|NOT COMPLETED|Withdrawal Phase: Months 12 up to 24||70
8746033|NCT01142726|9794537|FG001|NOT COMPLETED|Withdrawal Phase: Months 12 up to 24||56
8746034|NCT01142726|9794538|FG002|NOT COMPLETED|Withdrawal Phase: Months 12 up to 24||58
8746035|NCT01142726|9794536|FG000|STARTED|Re-Exposure Phase: Months 24 up to 30||55
8746036|NCT01142726|9794537|FG001|STARTED|Re-Exposure Phase: Months 24 up to 30||48
8746037|NCT01142726|9794538|FG002|STARTED|Re-Exposure Phase: Months 24 up to 30||43
8746038|NCT01142726|9794536|FG000|COMPLETED|Re-Exposure Phase: Months 24 up to 30||54
8746039|NCT01142726|9794537|FG001|COMPLETED|Re-Exposure Phase: Months 24 up to 30||46
8746040|NCT01142726|9794538|FG002|COMPLETED|Re-Exposure Phase: Months 24 up to 30||40
8746041|NCT01142726|9794536|FG000|NOT COMPLETED|Re-Exposure Phase: Months 24 up to 30||1
8746042|NCT01142726|9794537|FG001|NOT COMPLETED|Re-Exposure Phase: Months 24 up to 30||2
8746043|NCT01142726|9794538|FG002|NOT COMPLETED|Re-Exposure Phase: Months 24 up to 30||3
8746044|NCT01142791|9794554|FG000|STARTED|Overall Study||115
8746045|NCT01142791|9794555|FG001|STARTED|Overall Study|6 participants receiving only 1 sonication were included only in adverse events reporting.|6
8746046|NCT01142791|9794554|FG000|Safety|Overall Study||115
8746047|NCT01142791|9794555|FG001|Safety|Overall Study|Safety data only was reported for 6 participants receiving only 1 sonication.|6
8746048|NCT01142791|9794554|FG000|COMPLETED|Overall Study||108
8746049|NCT01142791|9794555|FG001|COMPLETED|Overall Study||0
8746050|NCT01142791|9794554|FG000|NOT COMPLETED|Overall Study||7
8746051|NCT01142791|9794555|FG001|NOT COMPLETED|Overall Study||6
8746052|NCT01142908|9794561|FG000|STARTED|Overall Study||215
8746053|NCT01142908|9794562|FG001|STARTED|Overall Study||213
8746054|NCT01142908|9794561|FG000|6 Month f/u|Overall Study||188
8746055|NCT01142908|9794562|FG001|6 Month f/u|Overall Study||196
8746056|NCT01142908|9794561|FG000|COMPLETED|Overall Study||183
8746057|NCT01142908|9794562|FG001|COMPLETED|Overall Study||191
8746058|NCT01142908|9794561|FG000|NOT COMPLETED|Overall Study||32
8746059|NCT01142908|9794562|FG001|NOT COMPLETED|Overall Study||22
8746060|NCT01142947|9794568|FG000|STARTED|Overall Study||362
8746061|NCT01142947|9794568|FG000|COMPLETED|Overall Study||244
8746062|NCT01142947|9794568|FG000|NOT COMPLETED|Overall Study||118
8746063|NCT01143038|9794572|FG000|STARTED|Overall Study||75
8746064|NCT01143038|9794572|FG000|COMPLETED|Overall Study|Defined as completion of romiplostim treatment|59
8746065|NCT01143038|9794572|FG000|NOT COMPLETED|Overall Study||16
8746066|NCT01143051|9794582|FG000|STARTED|Visit 1||4
8746067|NCT01143051|9794583|FG001|STARTED|Visit 1||4
8746068|NCT01143051|9794584|FG002|STARTED|Visit 1||4
8746069|NCT01143051|9794585|FG003|STARTED|Visit 1||4
8746070|NCT01143051|9794586|FG004|STARTED|Visit 1||4
8746071|NCT01143051|9794587|FG005|STARTED|Visit 1||4
8746072|NCT01143051|9794582|FG000|COMPLETED|Visit 1||4
8746073|NCT01143051|9794583|FG001|COMPLETED|Visit 1||4
8746074|NCT01143051|9794584|FG002|COMPLETED|Visit 1||4
8746075|NCT01143051|9794585|FG003|COMPLETED|Visit 1||4
8746076|NCT01143051|9794586|FG004|COMPLETED|Visit 1||4
8746077|NCT01143051|9794587|FG005|COMPLETED|Visit 1||4
8746078|NCT01143051|9794582|FG000|NOT COMPLETED|Visit 1||0
8746079|NCT01143051|9794583|FG001|NOT COMPLETED|Visit 1||0
8746080|NCT01143051|9794584|FG002|NOT COMPLETED|Visit 1||0
8746081|NCT01143051|9794585|FG003|NOT COMPLETED|Visit 1||0
8746082|NCT01143051|9794586|FG004|NOT COMPLETED|Visit 1||0
8746083|NCT01143051|9794587|FG005|NOT COMPLETED|Visit 1||0
8746084|NCT01143051|9794582|FG000|STARTED|3-14 Day Washout||4
8746085|NCT01143051|9794583|FG001|STARTED|3-14 Day Washout||4
8746086|NCT01143051|9794584|FG002|STARTED|3-14 Day Washout||4
8746087|NCT01143051|9794585|FG003|STARTED|3-14 Day Washout||4
8746088|NCT01143051|9794586|FG004|STARTED|3-14 Day Washout||4
8746089|NCT01143051|9794587|FG005|STARTED|3-14 Day Washout||4
8746090|NCT01143051|9794582|FG000|COMPLETED|3-14 Day Washout||4
8746091|NCT01143051|9794583|FG001|COMPLETED|3-14 Day Washout||4
8746092|NCT01143051|9794584|FG002|COMPLETED|3-14 Day Washout||3
8746093|NCT01143051|9794585|FG003|COMPLETED|3-14 Day Washout||4
8746094|NCT01143051|9794586|FG004|COMPLETED|3-14 Day Washout||4
8746095|NCT01143051|9794587|FG005|COMPLETED|3-14 Day Washout||4
8746096|NCT01143051|9794582|FG000|NOT COMPLETED|3-14 Day Washout||0
8746097|NCT01143051|9794583|FG001|NOT COMPLETED|3-14 Day Washout||0
8746098|NCT01143051|9794584|FG002|NOT COMPLETED|3-14 Day Washout||1
8746099|NCT01143051|9794585|FG003|NOT COMPLETED|3-14 Day Washout||0
8746100|NCT01143051|9794586|FG004|NOT COMPLETED|3-14 Day Washout||0
8746101|NCT01143051|9794587|FG005|NOT COMPLETED|3-14 Day Washout||0
8746102|NCT01143051|9794582|FG000|STARTED|Visit 2||4
8746103|NCT01143051|9794583|FG001|STARTED|Visit 2||4
8746104|NCT01143051|9794584|FG002|STARTED|Visit 2||3
8746105|NCT01143051|9794585|FG003|STARTED|Visit 2||4
8746106|NCT01143051|9794586|FG004|STARTED|Visit 2||4
8746107|NCT01143051|9794587|FG005|STARTED|Visit 2||4
8746108|NCT01143051|9794582|FG000|COMPLETED|Visit 2||4
8746109|NCT01143051|9794583|FG001|COMPLETED|Visit 2||4
8746110|NCT01143051|9794584|FG002|COMPLETED|Visit 2||3
8746111|NCT01143051|9794585|FG003|COMPLETED|Visit 2||4
8746112|NCT01143051|9794586|FG004|COMPLETED|Visit 2||4
8746113|NCT01143051|9794587|FG005|COMPLETED|Visit 2||4
8746114|NCT01143051|9794582|FG000|NOT COMPLETED|Visit 2||0
8746115|NCT01143051|9794583|FG001|NOT COMPLETED|Visit 2||0
8746116|NCT01143051|9794584|FG002|NOT COMPLETED|Visit 2||0
8746117|NCT01143051|9794585|FG003|NOT COMPLETED|Visit 2||0
8746118|NCT01143051|9794586|FG004|NOT COMPLETED|Visit 2||0
8746119|NCT01143051|9794587|FG005|NOT COMPLETED|Visit 2||0
8746120|NCT01143051|9794582|FG000|STARTED|3-14 Day Washout||4
8746121|NCT01143051|9794583|FG001|STARTED|3-14 Day Washout||4
8746122|NCT01143051|9794584|FG002|STARTED|3-14 Day Washout||3
8746123|NCT01143051|9794585|FG003|STARTED|3-14 Day Washout||4
8746124|NCT01143051|9794586|FG004|STARTED|3-14 Day Washout||4
8746125|NCT01143051|9794587|FG005|STARTED|3-14 Day Washout||4
8746126|NCT01143051|9794582|FG000|COMPLETED|3-14 Day Washout||4
8746127|NCT01143051|9794583|FG001|COMPLETED|3-14 Day Washout||4
8746128|NCT01143051|9794584|FG002|COMPLETED|3-14 Day Washout||3
8746129|NCT01143051|9794585|FG003|COMPLETED|3-14 Day Washout||4
8746130|NCT01143051|9794586|FG004|COMPLETED|3-14 Day Washout||4
8746131|NCT01143051|9794587|FG005|COMPLETED|3-14 Day Washout||3
8746132|NCT01143051|9794582|FG000|NOT COMPLETED|3-14 Day Washout||0
8746133|NCT01143051|9794583|FG001|NOT COMPLETED|3-14 Day Washout||0
8746134|NCT01143051|9794584|FG002|NOT COMPLETED|3-14 Day Washout||0
8746135|NCT01143051|9794585|FG003|NOT COMPLETED|3-14 Day Washout||0
8746136|NCT01143051|9794586|FG004|NOT COMPLETED|3-14 Day Washout||0
8746137|NCT01143051|9794587|FG005|NOT COMPLETED|3-14 Day Washout||1
8746138|NCT01143051|9794582|FG000|STARTED|Visit 3||4
8746139|NCT01143051|9794583|FG001|STARTED|Visit 3||4
8746140|NCT01143051|9794584|FG002|STARTED|Visit 3||3
8746141|NCT01143051|9794585|FG003|STARTED|Visit 3||4
8746142|NCT01143051|9794586|FG004|STARTED|Visit 3||4
8746143|NCT01143051|9794587|FG005|STARTED|Visit 3||3
8746144|NCT01143051|9794582|FG000|COMPLETED|Visit 3||4
8746145|NCT01143051|9794583|FG001|COMPLETED|Visit 3||4
8746146|NCT01143051|9794584|FG002|COMPLETED|Visit 3||3
8746147|NCT01143051|9794585|FG003|COMPLETED|Visit 3||4
8746148|NCT01143051|9794586|FG004|COMPLETED|Visit 3||4
8746149|NCT01143051|9794587|FG005|COMPLETED|Visit 3||3
8746150|NCT01143051|9794582|FG000|NOT COMPLETED|Visit 3||0
8746151|NCT01143051|9794583|FG001|NOT COMPLETED|Visit 3||0
8746152|NCT01143051|9794584|FG002|NOT COMPLETED|Visit 3||0
8746153|NCT01143051|9794585|FG003|NOT COMPLETED|Visit 3||0
8746154|NCT01143051|9794586|FG004|NOT COMPLETED|Visit 3||0
8746155|NCT01143051|9794587|FG005|NOT COMPLETED|Visit 3||0
8746156|NCT01143077|9794600|FG000|STARTED|Overall Study||74
8746157|NCT01143077|9794601|FG001|STARTED|Overall Study||88
8746158|NCT01143077|9794602|FG002|STARTED|Overall Study||82
8746159|NCT01143077|9794600|FG000|COMPLETED|Overall Study||58
8746160|NCT01143077|9794601|FG001|COMPLETED|Overall Study||73
8746161|NCT01143077|9794602|FG002|COMPLETED|Overall Study||67
8746162|NCT01143077|9794600|FG000|NOT COMPLETED|Overall Study||16
8746163|NCT01143077|9794601|FG001|NOT COMPLETED|Overall Study||15
8746164|NCT01143077|9794602|FG002|NOT COMPLETED|Overall Study||15
8746165|NCT01143090|9794610|FG000|STARTED|Overall Study||149
8746166|NCT01143090|9794610|FG000|COMPLETED|Overall Study||98
8746167|NCT01143090|9794610|FG000|NOT COMPLETED|Overall Study||51
8746168|NCT01143142|9794616|FG000|STARTED|Overall Study||36
8746169|NCT01143142|9794617|FG001|STARTED|Overall Study||34
8746170|NCT01143142|9794616|FG000|COMPLETED|Overall Study||36
8746171|NCT01143142|9794617|FG001|COMPLETED|Overall Study||34
8746172|NCT01143142|9794616|FG000|NOT COMPLETED|Overall Study||0
8746173|NCT01143142|9794617|FG001|NOT COMPLETED|Overall Study||0
8746174|NCT01143181|9794627|FG000|STARTED|Overall Study||30
8746175|NCT01143181|9794628|FG001|STARTED|Overall Study||38
8746176|NCT01143181|9794629|FG002|STARTED|Overall Study||102
8746177|NCT01143181|9794630|FG003|STARTED|Overall Study||40
8746178|NCT01143181|9794627|FG000|COMPLETED|Overall Study||14
8746179|NCT01143181|9794628|FG001|COMPLETED|Overall Study||22
8746180|NCT01143181|9794629|FG002|COMPLETED|Overall Study||58
8746181|NCT01143181|9794630|FG003|COMPLETED|Overall Study||17
8913795|NCT02163915|9973226|FG003|COMPLETED|Overall Study||6
8913796|NCT02163915|9973227|FG004|COMPLETED|Overall Study||6
8913797|NCT02163915|9973223|FG000|NOT COMPLETED|Overall Study||3
8913798|NCT02163915|9973224|FG001|NOT COMPLETED|Overall Study||0
8913799|NCT02163915|9973225|FG002|NOT COMPLETED|Overall Study||2
8913800|NCT02163915|9973226|FG003|NOT COMPLETED|Overall Study||3
8746182|NCT01143181|9794627|FG000|NOT COMPLETED|Overall Study||16
8746183|NCT01143181|9794628|FG001|NOT COMPLETED|Overall Study||16
8746184|NCT01143181|9794629|FG002|NOT COMPLETED|Overall Study||44
8746185|NCT01143181|9794630|FG003|NOT COMPLETED|Overall Study||23
8746186|NCT01143207|9794640|FG000|STARTED|Overall Study||26
8746187|NCT01143207|9794640|FG000|COMPLETED|Overall Study||24
8746188|NCT01143207|9794640|FG000|NOT COMPLETED|Overall Study||2
8746189|NCT01143259|9794646|FG000|STARTED|Overall Study||136
8746190|NCT01143259|9794647|FG001|STARTED|Overall Study||138
8746191|NCT01143259|9794646|FG000|COMPLETED|Overall Study||113
8746192|NCT01143259|9794647|FG001|COMPLETED|Overall Study||118
8746193|NCT01143259|9794646|FG000|NOT COMPLETED|Overall Study||23
8746194|NCT01143259|9794647|FG001|NOT COMPLETED|Overall Study||20
8746195|NCT01143272|9794655|FG000|STARTED|Overall Study||246
8746196|NCT01143272|9794656|FG001|STARTED|Overall Study||231
8746197|NCT01143272|9794655|FG000|COMPLETED|Overall Study||246
8746198|NCT01143272|9794656|FG001|COMPLETED|Overall Study||231
8746199|NCT01143272|9794655|FG000|NOT COMPLETED|Overall Study||0
8746200|NCT01143272|9794656|FG001|NOT COMPLETED|Overall Study||0
8746201|NCT01143324|9794662|FG000|STARTED|Overall Study||252
8746202|NCT01143324|9794662|FG000|COMPLETED|Overall Study||233
8746203|NCT01143324|9794662|FG000|NOT COMPLETED|Overall Study||19
8746204|NCT01143337|9794668|FG000|STARTED|Overall Study||49
8746205|NCT01143337|9794669|FG001|STARTED|Overall Study||50
8746206|NCT01143337|9794670|FG002|STARTED|Overall Study||13
8746207|NCT01143337|9794668|FG000|COMPLETED|Overall Study||39
8746208|NCT01143337|9794669|FG001|COMPLETED|Overall Study||39
8746209|NCT01143337|9794670|FG002|COMPLETED|Overall Study|Frequency of this arm AE was higher than assumption before study initiation.|1
8746210|NCT01143337|9794668|FG000|NOT COMPLETED|Overall Study||10
8746211|NCT01143337|9794669|FG001|NOT COMPLETED|Overall Study||11
8913801|NCT02163915|9973227|FG004|NOT COMPLETED|Overall Study||4
8913802|NCT02163967|9973243|FG000|STARTED|First Intervention/ Day 1||4
8913803|NCT02163967|9973244|FG001|STARTED|First Intervention/ Day 1||4
8913804|NCT02163967|9973245|FG002|STARTED|First Intervention/ Day 1||3
8913805|NCT02163967|9973246|FG003|STARTED|First Intervention/ Day 1||4
8913806|NCT02163967|9973247|FG004|STARTED|First Intervention/ Day 1||3
8913807|NCT02163967|9973248|FG005|STARTED|First Intervention/ Day 1||3
8913808|NCT02163967|9973243|FG000|COMPLETED|First Intervention/ Day 1||4
8913809|NCT02163967|9973244|FG001|COMPLETED|First Intervention/ Day 1||4
8913810|NCT02163967|9973245|FG002|COMPLETED|First Intervention/ Day 1||3
8913811|NCT02163967|9973246|FG003|COMPLETED|First Intervention/ Day 1||4
8913812|NCT02163967|9973247|FG004|COMPLETED|First Intervention/ Day 1||3
8913813|NCT02163967|9973248|FG005|COMPLETED|First Intervention/ Day 1||3
8913814|NCT02163967|9973243|FG000|NOT COMPLETED|First Intervention/ Day 1||0
8913815|NCT02163967|9973244|FG001|NOT COMPLETED|First Intervention/ Day 1||0
8913816|NCT02163967|9973245|FG002|NOT COMPLETED|First Intervention/ Day 1||0
8913817|NCT02163967|9973246|FG003|NOT COMPLETED|First Intervention/ Day 1||0
8913818|NCT02163967|9973247|FG004|NOT COMPLETED|First Intervention/ Day 1||0
8913819|NCT02163967|9973248|FG005|NOT COMPLETED|First Intervention/ Day 1||0
8913820|NCT02163967|9973243|FG000|STARTED|Second Intevention/Day 2||3
8913821|NCT02163967|9973244|FG001|STARTED|Second Intevention/Day 2||4
8913822|NCT02163967|9973245|FG002|STARTED|Second Intevention/Day 2||2
8913823|NCT02163967|9973246|FG003|STARTED|Second Intevention/Day 2||4
8913824|NCT02163967|9973247|FG004|STARTED|Second Intevention/Day 2||3
8913825|NCT02163967|9973248|FG005|STARTED|Second Intevention/Day 2||3
8913826|NCT02163967|9973243|FG000|COMPLETED|Second Intevention/Day 2||3
8913827|NCT02163967|9973244|FG001|COMPLETED|Second Intevention/Day 2||4
8913828|NCT02163967|9973245|FG002|COMPLETED|Second Intevention/Day 2||2
8913829|NCT02163967|9973246|FG003|COMPLETED|Second Intevention/Day 2||4
8913830|NCT02163967|9973247|FG004|COMPLETED|Second Intevention/Day 2||3
8913831|NCT02163967|9973248|FG005|COMPLETED|Second Intevention/Day 2||3
8913832|NCT02163967|9973243|FG000|NOT COMPLETED|Second Intevention/Day 2||0
8913833|NCT02163967|9973244|FG001|NOT COMPLETED|Second Intevention/Day 2||0
8913834|NCT02163967|9973245|FG002|NOT COMPLETED|Second Intevention/Day 2||0
8913835|NCT02163967|9973246|FG003|NOT COMPLETED|Second Intevention/Day 2||0
8913836|NCT02163967|9973247|FG004|NOT COMPLETED|Second Intevention/Day 2||0
8913837|NCT02163967|9973248|FG005|NOT COMPLETED|Second Intevention/Day 2||0
8913838|NCT02163967|9973243|FG000|STARTED|Third Intervention/Day 3||3
8577608|NCT00159874|9610370|FG003|Treated|Overall Study||13
8746212|NCT01143337|9794670|FG002|NOT COMPLETED|Overall Study||12
8746213|NCT01143389|9794678|FG000|STARTED|Overall Study||253
8746214|NCT01143389|9794679|FG001|STARTED|Overall Study||257
8746215|NCT01143389|9794678|FG000|COMPLETED|Overall Study||227
8746216|NCT01143389|9794679|FG001|COMPLETED|Overall Study||232
8746217|NCT01143389|9794678|FG000|NOT COMPLETED|Overall Study||26
8746218|NCT01143389|9794679|FG001|NOT COMPLETED|Overall Study||25
8746219|NCT01143402|9794688|FG000|STARTED|Overall Study||51
8746220|NCT01143402|9794689|FG001|STARTED|Overall Study||50
8746221|NCT01143402|9794690|FG002|STARTED|Overall Study||19
8746222|NCT01143402|9794688|FG000|COMPLETED|Overall Study||50
8746223|NCT01143402|9794689|FG001|COMPLETED|Overall Study||49
8746224|NCT01143402|9794690|FG002|COMPLETED|Overall Study||18
8746225|NCT01143402|9794688|FG000|NOT COMPLETED|Overall Study||1
8746226|NCT01143402|9794689|FG001|NOT COMPLETED|Overall Study||1
8746227|NCT01143402|9794690|FG002|NOT COMPLETED|Overall Study||1
8746228|NCT01143610|9794699|FG000|STARTED|Overall Study||7
8746229|NCT01143610|9794700|FG001|STARTED|Overall Study||8
8746230|NCT01143610|9794699|FG000|COMPLETED|Overall Study||7
8746231|NCT01143610|9794700|FG001|COMPLETED|Overall Study||8
8746232|NCT01143610|9794699|FG000|NOT COMPLETED|Overall Study||0
8746233|NCT01143610|9794700|FG001|NOT COMPLETED|Overall Study||0
8746234|NCT01143636|9794709|FG000|STARTED|Overall Study||6
8746235|NCT01143636|9794710|FG001|STARTED|Overall Study||5
8746236|NCT01143636|9794711|FG002|STARTED|Overall Study||8
8746237|NCT01143636|9794712|FG003|STARTED|Overall Study||7
8746238|NCT01143636|9794709|FG000|COMPLETED|Overall Study||5
8746239|NCT01143636|9794710|FG001|COMPLETED|Overall Study||4
8746240|NCT01143636|9794711|FG002|COMPLETED|Overall Study||8
8913839|NCT02163967|9973244|FG001|STARTED|Third Intervention/Day 3||3
8913840|NCT02163967|9973245|FG002|STARTED|Third Intervention/Day 3||2
8913841|NCT02163967|9973246|FG003|STARTED|Third Intervention/Day 3||4
8913842|NCT02163967|9973247|FG004|STARTED|Third Intervention/Day 3||3
8913843|NCT02163967|9973248|FG005|STARTED|Third Intervention/Day 3||3
8913844|NCT02163967|9973243|FG000|COMPLETED|Third Intervention/Day 3||3
8913845|NCT02163967|9973244|FG001|COMPLETED|Third Intervention/Day 3||3
8913846|NCT02163967|9973245|FG002|COMPLETED|Third Intervention/Day 3||2
8913847|NCT02163967|9973246|FG003|COMPLETED|Third Intervention/Day 3||4
8913848|NCT02163967|9973247|FG004|COMPLETED|Third Intervention/Day 3||3
8913849|NCT02163967|9973248|FG005|COMPLETED|Third Intervention/Day 3||3
8913850|NCT02163967|9973243|FG000|NOT COMPLETED|Third Intervention/Day 3||0
8913851|NCT02163967|9973244|FG001|NOT COMPLETED|Third Intervention/Day 3||0
8913852|NCT02163967|9973245|FG002|NOT COMPLETED|Third Intervention/Day 3||0
8913853|NCT02163967|9973246|FG003|NOT COMPLETED|Third Intervention/Day 3||0
8913854|NCT02163967|9973247|FG004|NOT COMPLETED|Third Intervention/Day 3||0
8913855|NCT02163967|9973248|FG005|NOT COMPLETED|Third Intervention/Day 3||0
8913856|NCT02163993|9973264|FG000|STARTED|Treatment Period||138
8913857|NCT02163993|9973265|FG001|STARTED|Treatment Period||68
8913858|NCT02163993|9973266|FG002|STARTED|Treatment Period||68
8913859|NCT02163993|9973267|FG003|STARTED|Treatment Period||71
8913860|NCT02163993|9973268|FG004|STARTED|Treatment Period||69
8913861|NCT02163993|9973264|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||137
8913862|NCT02163993|9973265|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||68
8913863|NCT02163993|9973266|FG002|Received at Least 1 Dose of Study Drug|Treatment Period||68
8913864|NCT02163993|9973267|FG003|Received at Least 1 Dose of Study Drug|Treatment Period||70
8913865|NCT02163993|9973268|FG004|Received at Least 1 Dose of Study Drug|Treatment Period||67
8913866|NCT02163993|9973264|FG000|COMPLETED|Treatment Period||126
8913867|NCT02163993|9973265|FG001|COMPLETED|Treatment Period||59
8913868|NCT02163993|9973266|FG002|COMPLETED|Treatment Period||66
8913869|NCT02163993|9973267|FG003|COMPLETED|Treatment Period||62
8913870|NCT02163993|9973268|FG004|COMPLETED|Treatment Period||62
8913871|NCT02163993|9973264|FG000|NOT COMPLETED|Treatment Period||12
8913872|NCT02163993|9973265|FG001|NOT COMPLETED|Treatment Period||9
8913873|NCT02163993|9973266|FG002|NOT COMPLETED|Treatment Period||2
8913874|NCT02163993|9973267|FG003|NOT COMPLETED|Treatment Period||9
8913875|NCT02163993|9973268|FG004|NOT COMPLETED|Treatment Period||7
8913876|NCT02163993|9973264|FG000|STARTED|Post-treatment Period|One participant discontinued after Treatment Period. Did not enter into Post-treatment Period.|125
8913877|NCT02163993|9973265|FG001|STARTED|Post-treatment Period|Participants who discontinued or completed the Treatment Period entered the Post-treatment period.|61
8913878|NCT02163993|9973266|FG002|STARTED|Post-treatment Period||66
8913879|NCT02163993|9973267|FG003|STARTED|Post-treatment Period|Participants who discontinued or completed the Treatment Period entered the Post-treatment period.|63
8913880|NCT02163993|9973268|FG004|STARTED|Post-treatment Period|Participants who discontinued or completed the Treatment Period entered the Post-treatment period.|65
8913881|NCT02163993|9973264|FG000|COMPLETED|Post-treatment Period||121
8913882|NCT02163993|9973265|FG001|COMPLETED|Post-treatment Period||55
8913883|NCT02163993|9973266|FG002|COMPLETED|Post-treatment Period||62
8913884|NCT02163993|9973267|FG003|COMPLETED|Post-treatment Period||61
9022876|NCT03131648|10085667|FG003|NOT COMPLETED|Open-label (Short Term Extension)||0
8746241|NCT01143636|9794712|FG003|COMPLETED|Overall Study||7
8746242|NCT01143636|9794709|FG000|NOT COMPLETED|Overall Study||1
8746243|NCT01143636|9794710|FG001|NOT COMPLETED|Overall Study||1
8746244|NCT01143636|9794711|FG002|NOT COMPLETED|Overall Study||0
8746245|NCT01143636|9794712|FG003|NOT COMPLETED|Overall Study||0
8746246|NCT01143649|9794727|FG000|STARTED|Overall Study||7
8746247|NCT01143649|9794728|FG001|STARTED|Overall Study||7
8746248|NCT01143649|9794729|FG002|STARTED|Overall Study||10
8746249|NCT01143649|9794730|FG003|STARTED|Overall Study||10
8746250|NCT01143649|9794731|FG004|STARTED|Overall Study||5
8746251|NCT01143649|9794732|FG005|STARTED|Overall Study||5
8746252|NCT01143649|9794727|FG000|COMPLETED|Overall Study||7
8746253|NCT01143649|9794728|FG001|COMPLETED|Overall Study||7
8746254|NCT01143649|9794729|FG002|COMPLETED|Overall Study||10
8746255|NCT01143649|9794730|FG003|COMPLETED|Overall Study||10
8746256|NCT01143649|9794731|FG004|COMPLETED|Overall Study||4
8746257|NCT01143649|9794732|FG005|COMPLETED|Overall Study||3
8746258|NCT01143649|9794727|FG000|NOT COMPLETED|Overall Study||0
8746259|NCT01143649|9794728|FG001|NOT COMPLETED|Overall Study||0
8746260|NCT01143649|9794729|FG002|NOT COMPLETED|Overall Study||0
8746261|NCT01143649|9794730|FG003|NOT COMPLETED|Overall Study||0
8746262|NCT01143649|9794731|FG004|NOT COMPLETED|Overall Study||1
8746263|NCT01143649|9794732|FG005|NOT COMPLETED|Overall Study||2
8746264|NCT01143688|9794746|FG000|STARTED|Overall Study||39
8746265|NCT01143688|9794746|FG000|COMPLETED|Overall Study||39
8746266|NCT01143688|9794746|FG000|NOT COMPLETED|Overall Study||0
8746267|NCT01143701|9794758|FG000|STARTED|Overall Study||258
8746268|NCT01143701|9794759|FG001|STARTED|Overall Study||319
8746269|NCT01143701|9794758|FG000|COMPLETED|Overall Study|Number of patients for whom at least one set of post-baseline parent-ratings were collected|235
8746270|NCT01143701|9794759|FG001|COMPLETED|Overall Study|Number of patients for whom at least one set of post-baseline parent-ratings were collected|287
8746271|NCT01143701|9794758|FG000|NOT COMPLETED|Overall Study||23
8746272|NCT01143701|9794759|FG001|NOT COMPLETED|Overall Study||32
8746273|NCT01143714|9794767|FG000|STARTED|Overall Study||29
8746274|NCT01143714|9794768|FG001|STARTED|Overall Study||28
8746275|NCT01143714|9794767|FG000|COMPLETED|Overall Study||22
8746276|NCT01143714|9794768|FG001|COMPLETED|Overall Study||25
8746277|NCT01143714|9794767|FG000|NOT COMPLETED|Overall Study||7
8746278|NCT01143714|9794768|FG001|NOT COMPLETED|Overall Study||3
8746279|NCT01143727|9794776|FG000|STARTED|Overall Study||9
8746280|NCT01143727|9794777|FG001|STARTED|Overall Study||8
8746281|NCT01143727|9794776|FG000|COMPLETED|Overall Study||9
8746282|NCT01143727|9794777|FG001|COMPLETED|Overall Study||8
8746283|NCT01143727|9794776|FG000|NOT COMPLETED|Overall Study||0
8746284|NCT01143727|9794777|FG001|NOT COMPLETED|Overall Study||0
8746285|NCT01143766|9794785|FG000|STARTED|Overall Study||25
8746286|NCT01143766|9794786|FG001|STARTED|Overall Study||31
8746287|NCT01143766|9794785|FG000|COMPLETED|Overall Study||25
8746288|NCT01143766|9794786|FG001|COMPLETED|Overall Study||31
8746289|NCT01143766|9794785|FG000|NOT COMPLETED|Overall Study||0
8746290|NCT01143766|9794786|FG001|NOT COMPLETED|Overall Study||0
8746291|NCT01143792|9794797|FG000|STARTED|Overall Study||93
8746292|NCT01143792|9794798|FG001|STARTED|Overall Study||86
8746293|NCT01143792|9794799|FG002|STARTED|Overall Study||91
8746294|NCT01143792|9794797|FG000|COMPLETED|Overall Study||93
8746295|NCT01143792|9794798|FG001|COMPLETED|Overall Study||86
8746296|NCT01143792|9794799|FG002|COMPLETED|Overall Study||91
8746297|NCT01143792|9794797|FG000|NOT COMPLETED|Overall Study||0
8746298|NCT01143792|9794798|FG001|NOT COMPLETED|Overall Study||0
8746299|NCT01143792|9794799|FG002|NOT COMPLETED|Overall Study||0
8746300|NCT01143818|9794818|FG000|STARTED|Overall Study|A total of 1053 participants were enrolled but only 1049 received study drug.|1049
8746301|NCT01143818|9794818|FG000|COMPLETED|Overall Study||799
8746302|NCT01143818|9794818|FG000|NOT COMPLETED|Overall Study||250
8746303|NCT01143870|9794825|FG000|STARTED|Overall Study||58
8746304|NCT01143870|9794826|FG001|STARTED|Overall Study||58
8746305|NCT01143870|9794827|FG002|STARTED|Overall Study||61
8746306|NCT01143870|9794825|FG000|Post-intervention Survey|Overall Study||53
8746307|NCT01143870|9794826|FG001|Post-intervention Survey|Overall Study||50
8746308|NCT01143870|9794827|FG002|Post-intervention Survey|Overall Study||61
8746309|NCT01143870|9794825|FG000|Had Available 6-month A1C|Overall Study||27
8746310|NCT01143870|9794826|FG001|Had Available 6-month A1C|Overall Study||29
8746311|NCT01143870|9794827|FG002|Had Available 6-month A1C|Overall Study||31
8746312|NCT01143870|9794825|FG000|A1C Imputed|Overall Study||31
8746313|NCT01143870|9794826|FG001|A1C Imputed|Overall Study||29
8746314|NCT01143870|9794827|FG002|A1C Imputed|Overall Study||30
8746315|NCT01143870|9794825|FG000|COMPLETED|Overall Study||58
8746316|NCT01143870|9794826|FG001|COMPLETED|Overall Study||58
8746317|NCT01143870|9794827|FG002|COMPLETED|Overall Study||61
8746318|NCT01143870|9794825|FG000|NOT COMPLETED|Overall Study||0
8746319|NCT01143870|9794826|FG001|NOT COMPLETED|Overall Study||0
8746320|NCT01143870|9794827|FG002|NOT COMPLETED|Overall Study||0
8746321|NCT01143883|9794837|FG000|STARTED|Overall Study||55
8746322|NCT01143883|9794838|FG001|STARTED|Overall Study||55
8746323|NCT01143883|9794837|FG000|COMPLETED|Overall Study||55
8746324|NCT01143883|9794838|FG001|COMPLETED|Overall Study||55
8746325|NCT01143883|9794837|FG000|NOT COMPLETED|Overall Study||0
8746326|NCT01143883|9794838|FG001|NOT COMPLETED|Overall Study||0
8746327|NCT01143896|9794846|FG000|STARTED|Overall Study||156
8746328|NCT01143896|9794847|FG001|STARTED|Overall Study||153
8746329|NCT01143896|9794846|FG000|COMPLETED|Overall Study||114
8746330|NCT01143896|9794847|FG001|COMPLETED|Overall Study||128
8746331|NCT01143896|9794846|FG000|NOT COMPLETED|Overall Study||42
8746332|NCT01143896|9794847|FG001|NOT COMPLETED|Overall Study||25
8746333|NCT01144026|9794856|FG000|STARTED|Overall Study||10
8746334|NCT01144026|9794857|FG001|STARTED|Overall Study||5
8746335|NCT01144026|9794856|FG000|COMPLETED|Overall Study||10
8746336|NCT01144026|9794857|FG001|COMPLETED|Overall Study||5
8746337|NCT01144026|9794856|FG000|NOT COMPLETED|Overall Study||0
8746338|NCT01144026|9794857|FG001|NOT COMPLETED|Overall Study||0
8746339|NCT01144052|9794865|FG000|STARTED|Overall Study||10
8746340|NCT01144052|9794866|FG001|STARTED|Overall Study||9
8746341|NCT01144052|9794865|FG000|COMPLETED|Overall Study||9
8746342|NCT01144052|9794866|FG001|COMPLETED|Overall Study||8
8746343|NCT01144052|9794865|FG000|NOT COMPLETED|Overall Study||1
8746344|NCT01144052|9794866|FG001|NOT COMPLETED|Overall Study||1
8746345|NCT01144143|9794877|FG000|STARTED|Overall Study||8
8746346|NCT01144143|9794878|FG001|STARTED|Overall Study||4
8746347|NCT01144143|9794879|FG002|STARTED|Overall Study||4
8746348|NCT01144143|9794877|FG000|COMPLETED|Overall Study||8
8746349|NCT01144143|9794878|FG001|COMPLETED|Overall Study||4
8746350|NCT01144143|9794879|FG002|COMPLETED|Overall Study||4
8746351|NCT01144143|9794877|FG000|NOT COMPLETED|Overall Study||0
8746352|NCT01144143|9794878|FG001|NOT COMPLETED|Overall Study||0
8746353|NCT01144143|9794879|FG002|NOT COMPLETED|Overall Study||0
8746354|NCT01144182|9794893|FG000|STARTED|Overall Study||68
8746355|NCT01144182|9794894|FG001|STARTED|Overall Study||68
8746356|NCT01144182|9794893|FG000|COMPLETED|Overall Study||51
8746357|NCT01144182|9794894|FG001|COMPLETED|Overall Study||47
8746358|NCT01144182|9794893|FG000|NOT COMPLETED|Overall Study||17
8746359|NCT01144182|9794894|FG001|NOT COMPLETED|Overall Study||21
8746360|NCT01144286|9794905|FG000|STARTED|Overall Study||57
8746361|NCT01144286|9794906|FG001|STARTED|Overall Study||58
8746362|NCT01144286|9794907|FG002|STARTED|Overall Study||58
8746363|NCT01144286|9794908|FG003|STARTED|Overall Study||56
8746364|NCT01144286|9794905|FG000|COMPLETED|Overall Study||57
8746365|NCT01144286|9794906|FG001|COMPLETED|Overall Study||58
8746366|NCT01144286|9794907|FG002|COMPLETED|Overall Study||58
8746367|NCT01144286|9794908|FG003|COMPLETED|Overall Study||56
8746368|NCT01144286|9794905|FG000|NOT COMPLETED|Overall Study||0
8746369|NCT01144286|9794906|FG001|NOT COMPLETED|Overall Study||0
8746370|NCT01144286|9794907|FG002|NOT COMPLETED|Overall Study||0
8746371|NCT01144286|9794908|FG003|NOT COMPLETED|Overall Study||0
8746372|NCT01144299|9794920|FG000|STARTED|Overall Study||60
8746373|NCT01144299|9794921|FG001|STARTED|Overall Study||54
8746374|NCT01144299|9794920|FG000|COMPLETED|Overall Study||58
8746375|NCT01144299|9794921|FG001|COMPLETED|Overall Study||54
8746376|NCT01144299|9794920|FG000|NOT COMPLETED|Overall Study||2
8746377|NCT01144299|9794921|FG001|NOT COMPLETED|Overall Study||0
8746378|NCT01144338|9794929|FG000|STARTED|Overall Study||7396
8746379|NCT01144338|9794930|FG001|STARTED|Overall Study||7356
8746380|NCT01144338|9794929|FG000|COMPLETED|Overall Study||7093
8746381|NCT01144338|9794930|FG001|COMPLETED|Overall Study||7094
8746382|NCT01144338|9794929|FG000|NOT COMPLETED|Overall Study||303
8746383|NCT01144338|9794930|FG001|NOT COMPLETED|Overall Study||262
8746384|NCT01144364|9794938|FG000|STARTED|Induction Phase||234
8746385|NCT01144364|9794939|FG001|STARTED|Induction Phase||0
8746386|NCT01144364|9794940|FG002|STARTED|Induction Phase||0
8746387|NCT01144364|9794938|FG000|COMPLETED|Induction Phase||202
8746388|NCT01144364|9794939|FG001|COMPLETED|Induction Phase||0
8746389|NCT01144364|9794940|FG002|COMPLETED|Induction Phase||0
8746390|NCT01144364|9794938|FG000|NOT COMPLETED|Induction Phase||32
8746391|NCT01144364|9794939|FG001|NOT COMPLETED|Induction Phase||0
8746392|NCT01144364|9794940|FG002|NOT COMPLETED|Induction Phase||0
8746393|NCT01144364|9794938|FG000|STARTED|Follow-Up/Maintenance Phase||0
8746394|NCT01144364|9794939|FG001|STARTED|Follow-Up/Maintenance Phase||101
8746395|NCT01144364|9794940|FG002|STARTED|Follow-Up/Maintenance Phase||101
8746396|NCT01144364|9794938|FG000|COMPLETED|Follow-Up/Maintenance Phase||0
8746397|NCT01144364|9794939|FG001|COMPLETED|Follow-Up/Maintenance Phase||66
8746398|NCT01144364|9794940|FG002|COMPLETED|Follow-Up/Maintenance Phase||60
8746399|NCT01144364|9794938|FG000|NOT COMPLETED|Follow-Up/Maintenance Phase||0
8746400|NCT01144364|9794939|FG001|NOT COMPLETED|Follow-Up/Maintenance Phase||35
8746401|NCT01144364|9794940|FG002|NOT COMPLETED|Follow-Up/Maintenance Phase||41
8746402|NCT01144377|9794955|FG000|STARTED|52 Week Treatment Period||31
8746403|NCT01144377|9794956|FG001|STARTED|52 Week Treatment Period||30
8746404|NCT01144377|9794957|FG002|STARTED|52 Week Treatment Period||30
8746405|NCT01144377|9794958|FG003|STARTED|52 Week Treatment Period||26
8746406|NCT01144377|9794959|FG004|STARTED|52 Week Treatment Period||37
8746407|NCT01144377|9794955|FG000|Received at Least One Dose of Study Drug|52 Week Treatment Period||31
8746408|NCT01144377|9794956|FG001|Received at Least One Dose of Study Drug|52 Week Treatment Period||30
8746409|NCT01144377|9794957|FG002|Received at Least One Dose of Study Drug|52 Week Treatment Period||30
8746410|NCT01144377|9794958|FG003|Received at Least One Dose of Study Drug|52 Week Treatment Period||25
8746411|NCT01144377|9794959|FG004|Received at Least One Dose of Study Drug|52 Week Treatment Period||37
8746412|NCT01144377|9794955|FG000|COMPLETED|52 Week Treatment Period||26
8746413|NCT01144377|9794956|FG001|COMPLETED|52 Week Treatment Period||29
8746414|NCT01144377|9794957|FG002|COMPLETED|52 Week Treatment Period||25
8746415|NCT01144377|9794958|FG003|COMPLETED|52 Week Treatment Period||22
8746416|NCT01144377|9794959|FG004|COMPLETED|52 Week Treatment Period||34
8746417|NCT01144377|9794955|FG000|NOT COMPLETED|52 Week Treatment Period||5
8746418|NCT01144377|9794956|FG001|NOT COMPLETED|52 Week Treatment Period||1
8746419|NCT01144377|9794957|FG002|NOT COMPLETED|52 Week Treatment Period||5
8746420|NCT01144377|9794958|FG003|NOT COMPLETED|52 Week Treatment Period||4
8746421|NCT01144377|9794959|FG004|NOT COMPLETED|52 Week Treatment Period||3
8746422|NCT01144377|9794955|FG000|STARTED|12 Week Safety Follow-up Period||26
8746423|NCT01144377|9794956|FG001|STARTED|12 Week Safety Follow-up Period||29
8746424|NCT01144377|9794957|FG002|STARTED|12 Week Safety Follow-up Period||25
8746425|NCT01144377|9794958|FG003|STARTED|12 Week Safety Follow-up Period||22
8746426|NCT01144377|9794959|FG004|STARTED|12 Week Safety Follow-up Period||34
8746427|NCT01144377|9794955|FG000|COMPLETED|12 Week Safety Follow-up Period|Of the 26 participants who completed this Period, 22 continued to the Optional 40 Week follow-up.|26
8746428|NCT01144377|9794956|FG001|COMPLETED|12 Week Safety Follow-up Period|Of the 29 participants who completed this Period, 25 continued to the Optional 40 Week follow-up.|29
8746429|NCT01144377|9794957|FG002|COMPLETED|12 Week Safety Follow-up Period|Of the 25 participants who completed this Period, 23 continued to the Optional 40 Week follow-up.|25
8746430|NCT01144377|9794958|FG003|COMPLETED|12 Week Safety Follow-up Period|Of the 22 participants who completed this Period, 3 continued to the Optional 40 Week follow-up.|22
8746431|NCT01144377|9794959|FG004|COMPLETED|12 Week Safety Follow-up Period|Of the 34 participants who completed this Period, 23 continued to the Optional 40 Week follow-up.|34
8746432|NCT01144377|9794955|FG000|NOT COMPLETED|12 Week Safety Follow-up Period||0
8746433|NCT01144377|9794956|FG001|NOT COMPLETED|12 Week Safety Follow-up Period||0
8746434|NCT01144377|9794957|FG002|NOT COMPLETED|12 Week Safety Follow-up Period||0
8746435|NCT01144377|9794958|FG003|NOT COMPLETED|12 Week Safety Follow-up Period||0
8746436|NCT01144377|9794959|FG004|NOT COMPLETED|12 Week Safety Follow-up Period||0
8746437|NCT01144377|9794955|FG000|STARTED|Optional 40 Week Safety Follow-up Period||22
8746438|NCT01144377|9794956|FG001|STARTED|Optional 40 Week Safety Follow-up Period||25
8746439|NCT01144377|9794957|FG002|STARTED|Optional 40 Week Safety Follow-up Period||23
8746440|NCT01144377|9794958|FG003|STARTED|Optional 40 Week Safety Follow-up Period||3
8746441|NCT01144377|9794959|FG004|STARTED|Optional 40 Week Safety Follow-up Period||23
8746442|NCT01144377|9794955|FG000|COMPLETED|Optional 40 Week Safety Follow-up Period||21
8746443|NCT01144377|9794956|FG001|COMPLETED|Optional 40 Week Safety Follow-up Period||24
8746444|NCT01144377|9794957|FG002|COMPLETED|Optional 40 Week Safety Follow-up Period||23
8746445|NCT01144377|9794958|FG003|COMPLETED|Optional 40 Week Safety Follow-up Period||3
8746446|NCT01144377|9794959|FG004|COMPLETED|Optional 40 Week Safety Follow-up Period||21
8746447|NCT01144377|9794955|FG000|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||1
8746448|NCT01144377|9794956|FG001|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||1
8746449|NCT01144377|9794957|FG002|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||0
8746450|NCT01144377|9794958|FG003|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||0
8746451|NCT01144377|9794959|FG004|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||2
8746452|NCT01144403|9794973|FG000|STARTED|Overall Study||8
8746453|NCT01144403|9794973|FG000|COMPLETED|Overall Study||3
8746454|NCT01144403|9794973|FG000|NOT COMPLETED|Overall Study||5
8746455|NCT01144442|9794978|FG000|STARTED|Overall Study||10
8746456|NCT01144442|9794978|FG000|COMPLETED|Overall Study||10
8746457|NCT01144442|9794978|FG000|NOT COMPLETED|Overall Study||0
8746458|NCT01144455|9794985|FG000|STARTED|Overall Study||69
8746459|NCT01144455|9794986|FG001|STARTED|Overall Study||71
8746460|NCT01144455|9794987|FG002|STARTED|Overall Study||74
8746461|NCT01144455|9794985|FG000|COMPLETED|Overall Study||19
8746462|NCT01144455|9794986|FG001|COMPLETED|Overall Study||29
8746463|NCT01144455|9794987|FG002|COMPLETED|Overall Study||38
8746464|NCT01144455|9794985|FG000|NOT COMPLETED|Overall Study||50
8746465|NCT01144455|9794986|FG001|NOT COMPLETED|Overall Study||42
8746466|NCT01144455|9794987|FG002|NOT COMPLETED|Overall Study||36
8746467|NCT01144494|9794995|FG000|STARTED|Overall Study||15
8746468|NCT01144494|9794996|FG001|STARTED|Overall Study||18
8746469|NCT01144494|9794995|FG000|COMPLETED|Overall Study||15
8746470|NCT01144494|9794996|FG001|COMPLETED|Overall Study||14
8746471|NCT01144494|9794995|FG000|NOT COMPLETED|Overall Study||0
8746472|NCT01144494|9794996|FG001|NOT COMPLETED|Overall Study||4
8746473|NCT01144598|9795007|FG000|STARTED|Overall Study||356
8746474|NCT01144598|9795007|FG000|Analysis Population|Overall Study||356
8746475|NCT01144598|9795007|FG000|COMPLETED|Overall Study||356
8746476|NCT01144598|9795007|FG000|NOT COMPLETED|Overall Study||0
8746477|NCT01144624|9795014|FG000|STARTED|Overall Study||7
8746478|NCT01144624|9795015|FG001|STARTED|Overall Study||7
8746479|NCT01144624|9795016|FG002|STARTED|Overall Study||6
8746480|NCT01144624|9795014|FG000|Received Treatment|Overall Study||7
8746481|NCT01144624|9795015|FG001|Received Treatment|Overall Study||7
8746482|NCT01144624|9795016|FG002|Received Treatment|Overall Study||6
8746483|NCT01144624|9795014|FG000|Completed Treatment|Overall Study|One patient died after completing the full course of study treatment.|7
8746484|NCT01144624|9795015|FG001|Completed Treatment|Overall Study||7
8746485|NCT01144624|9795016|FG002|Completed Treatment|Overall Study|Two patients died during the dosing period. Death was not a reason for treatment discontinuation.|6
8746486|NCT01144624|9795014|FG000|COMPLETED|Overall Study|One patient died during the study. Death was not a reason for treatment or study discontinuation.|7
8746487|NCT01144624|9795015|FG001|COMPLETED|Overall Study||7
8746488|NCT01144624|9795016|FG002|COMPLETED|Overall Study|Two patients died during the study. Death was not a reason for treatment or study discontinuation.|6
8746489|NCT01144624|9795014|FG000|NOT COMPLETED|Overall Study||0
8746490|NCT01144624|9795015|FG001|NOT COMPLETED|Overall Study||0
8746491|NCT01144624|9795016|FG002|NOT COMPLETED|Overall Study||0
8746492|NCT01144637|9795028|FG000|STARTED|Overall Study||999
8746493|NCT01144637|9795029|FG001|STARTED|Overall Study||1005
8746494|NCT01144637|9795030|FG002|STARTED|Overall Study||999
8746495|NCT01144637|9795031|FG003|STARTED|Overall Study||1002
8746496|NCT01144637|9795028|FG000|COMPLETED|Overall Study||925
8746497|NCT01144637|9795029|FG001|COMPLETED|Overall Study||929
8746498|NCT01144637|9795030|FG002|COMPLETED|Overall Study||939
8746499|NCT01144637|9795031|FG003|COMPLETED|Overall Study||946
8746500|NCT01144637|9795028|FG000|NOT COMPLETED|Overall Study||74
8746501|NCT01144637|9795029|FG001|NOT COMPLETED|Overall Study||76
8746502|NCT01144637|9795030|FG002|NOT COMPLETED|Overall Study||60
8746503|NCT01144637|9795031|FG003|NOT COMPLETED|Overall Study||56
8746504|NCT01144663|9795045|FG000|STARTED|Primary Vaccination Phase||528
8746505|NCT01144663|9795046|FG001|STARTED|Primary Vaccination Phase||524
8746506|NCT01144663|9795047|FG002|STARTED|Primary Vaccination Phase||516
8746507|NCT01144663|9795048|FG003|STARTED|Primary Vaccination Phase||527
8746508|NCT01144663|9795045|FG000|COMPLETED|Primary Vaccination Phase||508
8746509|NCT01144663|9795046|FG001|COMPLETED|Primary Vaccination Phase||517
8746510|NCT01144663|9795047|FG002|COMPLETED|Primary Vaccination Phase||508
8746511|NCT01144663|9795048|FG003|COMPLETED|Primary Vaccination Phase||509
8746512|NCT01144663|9795045|FG000|NOT COMPLETED|Primary Vaccination Phase||20
8913885|NCT02163993|9973268|FG004|COMPLETED|Post-treatment Period||62
8913886|NCT02163993|9973264|FG000|NOT COMPLETED|Post-treatment Period||4
8913887|NCT02163993|9973265|FG001|NOT COMPLETED|Post-treatment Period||6
8913888|NCT02163993|9973266|FG002|NOT COMPLETED|Post-treatment Period||4
8746513|NCT01144663|9795046|FG001|NOT COMPLETED|Primary Vaccination Phase||7
8746514|NCT01144663|9795047|FG002|NOT COMPLETED|Primary Vaccination Phase||8
8746515|NCT01144663|9795048|FG003|NOT COMPLETED|Primary Vaccination Phase||18
8746516|NCT01144663|9795045|FG000|STARTED|Booster Vaccination Phase||497
8746517|NCT01144663|9795046|FG001|STARTED|Booster Vaccination Phase||511
8746518|NCT01144663|9795047|FG002|STARTED|Booster Vaccination Phase||503
8746519|NCT01144663|9795048|FG003|STARTED|Booster Vaccination Phase||506
8746520|NCT01144663|9795045|FG000|COMPLETED|Booster Vaccination Phase||494
8746521|NCT01144663|9795046|FG001|COMPLETED|Booster Vaccination Phase||509
8746522|NCT01144663|9795047|FG002|COMPLETED|Booster Vaccination Phase||498
8746523|NCT01144663|9795048|FG003|COMPLETED|Booster Vaccination Phase||505
8746524|NCT01144663|9795045|FG000|NOT COMPLETED|Booster Vaccination Phase||3
8746525|NCT01144663|9795046|FG001|NOT COMPLETED|Booster Vaccination Phase||2
8746526|NCT01144663|9795047|FG002|NOT COMPLETED|Booster Vaccination Phase||5
8746527|NCT01144663|9795048|FG003|NOT COMPLETED|Booster Vaccination Phase||1
8746528|NCT01144663|9795045|FG000|STARTED|Extended Safety Follow-Up (ESFU)||497
8746529|NCT01144663|9795046|FG001|STARTED|Extended Safety Follow-Up (ESFU)||511
8746530|NCT01144663|9795047|FG002|STARTED|Extended Safety Follow-Up (ESFU)||503
8746531|NCT01144663|9795048|FG003|STARTED|Extended Safety Follow-Up (ESFU)||506
8746532|NCT01144663|9795045|FG000|COMPLETED|Extended Safety Follow-Up (ESFU)||492
8746533|NCT01144663|9795046|FG001|COMPLETED|Extended Safety Follow-Up (ESFU)||502
8746534|NCT01144663|9795047|FG002|COMPLETED|Extended Safety Follow-Up (ESFU)||496
8746535|NCT01144663|9795048|FG003|COMPLETED|Extended Safety Follow-Up (ESFU)||505
8746536|NCT01144663|9795045|FG000|NOT COMPLETED|Extended Safety Follow-Up (ESFU)||5
8746537|NCT01144663|9795046|FG001|NOT COMPLETED|Extended Safety Follow-Up (ESFU)||9
8746538|NCT01144663|9795047|FG002|NOT COMPLETED|Extended Safety Follow-Up (ESFU)||7
8746539|NCT01144663|9795048|FG003|NOT COMPLETED|Extended Safety Follow-Up (ESFU)||1
8746540|NCT01144715|9795060|FG000|STARTED|Overall Study||51
8746541|NCT01144715|9795061|FG001|STARTED|Overall Study||48
8746542|NCT01144715|9795060|FG000|COMPLETED|Overall Study||47
8746543|NCT01144715|9795061|FG001|COMPLETED|Overall Study||45
8746544|NCT01144715|9795060|FG000|NOT COMPLETED|Overall Study||4
8746545|NCT01144715|9795061|FG001|NOT COMPLETED|Overall Study||3
8746546|NCT01144949|9795069|FG000|STARTED|Overall Study||119
8746547|NCT01144949|9795070|FG001|STARTED|Overall Study||120
8746548|NCT01144949|9795069|FG000|COMPLETED|Overall Study||108
8746549|NCT01144949|9795070|FG001|COMPLETED|Overall Study||106
8746550|NCT01144949|9795069|FG000|NOT COMPLETED|Overall Study||11
8746551|NCT01144949|9795070|FG001|NOT COMPLETED|Overall Study||14
8746552|NCT01145001|9795080|FG000|STARTED|Overall Study||36
8746553|NCT01145001|9795081|FG001|STARTED|Overall Study||37
8746554|NCT01145001|9795082|FG002|STARTED|Overall Study||44
8746555|NCT01145001|9795083|FG003|STARTED|Overall Study||37
8746556|NCT01145001|9795080|FG000|COMPLETED|Overall Study||28
8746557|NCT01145001|9795081|FG001|COMPLETED|Overall Study||31
8746558|NCT01145001|9795082|FG002|COMPLETED|Overall Study||39
8746559|NCT01145001|9795083|FG003|COMPLETED|Overall Study||31
8746560|NCT01145001|9795080|FG000|NOT COMPLETED|Overall Study||8
8746561|NCT01145001|9795081|FG001|NOT COMPLETED|Overall Study||6
8746562|NCT01145001|9795082|FG002|NOT COMPLETED|Overall Study||5
8746563|NCT01145001|9795083|FG003|NOT COMPLETED|Overall Study||6
8746564|NCT01145053|9795093|FG000|STARTED|Overall Study||341
8746565|NCT01145053|9795093|FG000|COMPLETED|Overall Study||248
8746566|NCT01145053|9795093|FG000|NOT COMPLETED|Overall Study||93
8746567|NCT01145066|9795100|FG000|STARTED|Overall Study||26
8746568|NCT01145066|9795101|FG001|STARTED|Overall Study||20
8746569|NCT01145066|9795102|FG002|STARTED|Overall Study||25
8746570|NCT01145066|9795100|FG000|COMPLETED|Overall Study||22
8746571|NCT01145066|9795101|FG001|COMPLETED|Overall Study||16
8746572|NCT01145066|9795102|FG002|COMPLETED|Overall Study||21
8746573|NCT01145066|9795100|FG000|NOT COMPLETED|Overall Study||4
8913889|NCT02163993|9973267|FG003|NOT COMPLETED|Post-treatment Period||2
8746574|NCT01145066|9795101|FG001|NOT COMPLETED|Overall Study||4
8746575|NCT01145066|9795102|FG002|NOT COMPLETED|Overall Study||4
8746576|NCT01145183|9795114|FG000|STARTED|Overall Study||21
8746577|NCT01145183|9795115|FG001|STARTED|Overall Study||26
8746578|NCT01145183|9795116|FG002|STARTED|Overall Study||19
8746579|NCT01145183|9795117|FG003|STARTED|Overall Study||10
8746580|NCT01145183|9795114|FG000|COMPLETED|Overall Study||21
8746581|NCT01145183|9795115|FG001|COMPLETED|Overall Study||26
8746582|NCT01145183|9795116|FG002|COMPLETED|Overall Study||19
8746583|NCT01145183|9795117|FG003|COMPLETED|Overall Study||10
8746584|NCT01145183|9795114|FG000|NOT COMPLETED|Overall Study||0
8746585|NCT01145183|9795115|FG001|NOT COMPLETED|Overall Study||0
8746586|NCT01145183|9795116|FG002|NOT COMPLETED|Overall Study||0
8746587|NCT01145183|9795117|FG003|NOT COMPLETED|Overall Study||0
8746588|NCT01145222|9795131|FG000|STARTED|Overall Study||40
8746589|NCT01145222|9795132|FG001|STARTED|Overall Study||40
8746590|NCT01145222|9795133|FG002|STARTED|Overall Study||41
8746591|NCT01145222|9795134|FG003|STARTED|Overall Study||41
8746592|NCT01145222|9795131|FG000|Safety Population|Overall Study||40
8746593|NCT01145222|9795132|FG001|Safety Population|Overall Study||40
8746594|NCT01145222|9795133|FG002|Safety Population|Overall Study||40
8746595|NCT01145222|9795134|FG003|Safety Population|Overall Study||41
8746596|NCT01145222|9795131|FG000|Intention to Treat (ITT) Population|Overall Study||40
8746597|NCT01145222|9795132|FG001|Intention to Treat (ITT) Population|Overall Study||40
8746598|NCT01145222|9795133|FG002|Intention to Treat (ITT) Population|Overall Study||40
8746599|NCT01145222|9795134|FG003|Intention to Treat (ITT) Population|Overall Study||40
8746600|NCT01145222|9795131|FG000|COMPLETED|Overall Study||40
8746601|NCT01145222|9795132|FG001|COMPLETED|Overall Study||40
8746602|NCT01145222|9795133|FG002|COMPLETED|Overall Study||40
8746603|NCT01145222|9795134|FG003|COMPLETED|Overall Study||40
8746604|NCT01145222|9795131|FG000|NOT COMPLETED|Overall Study||0
8746605|NCT01145222|9795132|FG001|NOT COMPLETED|Overall Study||0
8746606|NCT01145222|9795133|FG002|NOT COMPLETED|Overall Study||1
8746607|NCT01145222|9795134|FG003|NOT COMPLETED|Overall Study||1
8746608|NCT01145352|9795144|FG000|STARTED|Overall Study||113
8746609|NCT01145352|9795144|FG000|COMPLETED|Overall Study||102
8746610|NCT01145352|9795144|FG000|NOT COMPLETED|Overall Study||11
8746611|NCT01145391|9795150|FG000|STARTED|Overall Study||293
8746612|NCT01145391|9795151|FG001|STARTED|Overall Study||298
8746613|NCT01145391|9795150|FG000|9 Months Post-randomization|Overall Study||293
8746614|NCT01145391|9795151|FG001|9 Months Post-randomization|Overall Study||298
8746615|NCT01145391|9795150|FG000|COMPLETED|Overall Study||293
8746616|NCT01145391|9795151|FG001|COMPLETED|Overall Study||298
8746617|NCT01145391|9795150|FG000|NOT COMPLETED|Overall Study||0
8746618|NCT01145391|9795151|FG001|NOT COMPLETED|Overall Study||0
8746619|NCT01145417|9795161|FG000|STARTED|Overall Study||108
8746620|NCT01145417|9795162|FG001|STARTED|Overall Study||109
8746621|NCT01145417|9795161|FG000|COMPLETED|Overall Study||67
8746622|NCT01145417|9795162|FG001|COMPLETED|Overall Study||62
8746623|NCT01145417|9795161|FG000|NOT COMPLETED|Overall Study||41
8746624|NCT01145417|9795162|FG001|NOT COMPLETED|Overall Study||47
8746625|NCT01145482|9795170|FG000|STARTED|First Intervention (1 Day)||6
8746626|NCT01145482|9795171|FG001|STARTED|First Intervention (1 Day)||6
8746627|NCT01145482|9795170|FG000|COMPLETED|First Intervention (1 Day)||6
8746628|NCT01145482|9795171|FG001|COMPLETED|First Intervention (1 Day)||5
8746629|NCT01145482|9795170|FG000|NOT COMPLETED|First Intervention (1 Day)||0
8746630|NCT01145482|9795171|FG001|NOT COMPLETED|First Intervention (1 Day)||1
8913890|NCT02163993|9973268|FG004|NOT COMPLETED|Post-treatment Period||3
8913891|NCT02164240|9973289|FG000|STARTED|Overall Study||4
8913892|NCT02164240|9973290|FG001|STARTED|Overall Study||5
8913893|NCT02164240|9973291|FG002|STARTED|Overall Study||4
8913894|NCT02164240|9973289|FG000|COMPLETED|Overall Study||4
8913895|NCT02164240|9973290|FG001|COMPLETED|Overall Study||5
8913896|NCT02164240|9973291|FG002|COMPLETED|Overall Study||4
8913897|NCT02164240|9973289|FG000|NOT COMPLETED|Overall Study||0
8913898|NCT02164240|9973290|FG001|NOT COMPLETED|Overall Study||0
8913899|NCT02164240|9973291|FG002|NOT COMPLETED|Overall Study||0
9022877|NCT03131648|10085668|FG004|NOT COMPLETED|Open-label (Short Term Extension)||0
9022878|NCT03131648|10085669|FG005|NOT COMPLETED|Open-label (Short Term Extension)||0
9022879|NCT03131648|10085670|FG006|NOT COMPLETED|Open-label (Short Term Extension)||0
9022880|NCT03131648|10085671|FG007|NOT COMPLETED|Open-label (Short Term Extension)||3
9022881|NCT03131687|10085694|FG000|STARTED|Overall Study||51
9022882|NCT03131687|10085695|FG001|STARTED|Overall Study||53
9022883|NCT03131687|10085696|FG002|STARTED|Overall Study||55
8913900|NCT02164318|9973304|FG000|STARTED|Overall Study||4
8913901|NCT02164318|9973305|FG001|STARTED|Overall Study||3
8913902|NCT02164318|9973306|FG002|STARTED|Overall Study||1
8913903|NCT02164318|9973307|FG003|STARTED|Overall Study||3
8913904|NCT02164318|9973304|FG000|COMPLETED|Overall Study||4
8913905|NCT02164318|9973305|FG001|COMPLETED|Overall Study||2
8913906|NCT02164318|9973306|FG002|COMPLETED|Overall Study||1
8913907|NCT02164318|9973307|FG003|COMPLETED|Overall Study||2
8913908|NCT02164318|9973304|FG000|NOT COMPLETED|Overall Study||0
8913909|NCT02164318|9973305|FG001|NOT COMPLETED|Overall Study||1
8913910|NCT02164318|9973306|FG002|NOT COMPLETED|Overall Study||0
8913911|NCT02164318|9973307|FG003|NOT COMPLETED|Overall Study||1
8913912|NCT02164383|9973319|FG000|STARTED|Overall Study||16
8913913|NCT02164383|9973320|FG001|STARTED|Overall Study||14
8913914|NCT02164383|9973319|FG000|COMPLETED|Overall Study||15
8913915|NCT02164383|9973320|FG001|COMPLETED|Overall Study||14
8913916|NCT02164383|9973319|FG000|NOT COMPLETED|Overall Study||1
9022884|NCT03131687|10085697|FG003|STARTED|Overall Study||52
9022885|NCT03131687|10085698|FG004|STARTED|Overall Study||53
9022886|NCT03131687|10085699|FG005|STARTED|Overall Study||54
9022887|NCT03131687|10085694|FG000|Received at Least One Dose of Study Drug|Overall Study||51
9022888|NCT03131687|10085695|FG001|Received at Least One Dose of Study Drug|Overall Study||52
8746631|NCT01145482|9795170|FG000|STARTED|Second Intervention (1 Day)||5
8746632|NCT01145482|9795171|FG001|STARTED|Second Intervention (1 Day)||6
8746633|NCT01145482|9795170|FG000|COMPLETED|Second Intervention (1 Day)||5
8746634|NCT01145482|9795171|FG001|COMPLETED|Second Intervention (1 Day)||6
8746635|NCT01145482|9795170|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
8913917|NCT02164383|9973320|FG001|NOT COMPLETED|Overall Study||0
8913918|NCT02164396|9973329|FG000|STARTED|Overall Study||10
8913919|NCT02164396|9973330|FG001|STARTED|Overall Study||10
9022889|NCT03131687|10085696|FG002|Received at Least One Dose of Study Drug|Overall Study||55
9022890|NCT03131687|10085697|FG003|Received at Least One Dose of Study Drug|Overall Study||51
9022891|NCT03131687|10085698|FG004|Received at Least One Dose of Study Drug|Overall Study||53
9022892|NCT03131687|10085699|FG005|Received at Least One Dose of Study Drug|Overall Study||54
9022893|NCT03131687|10085694|FG000|COMPLETED|Overall Study||45
9022894|NCT03131687|10085695|FG001|COMPLETED|Overall Study||44
9022895|NCT03131687|10085696|FG002|COMPLETED|Overall Study||52
9022896|NCT03131687|10085697|FG003|COMPLETED|Overall Study||48
9022897|NCT03131687|10085698|FG004|COMPLETED|Overall Study||45
9022898|NCT03131687|10085699|FG005|COMPLETED|Overall Study||49
9022899|NCT03131687|10085694|FG000|NOT COMPLETED|Overall Study||6
9022900|NCT03131687|10085695|FG001|NOT COMPLETED|Overall Study||9
9022901|NCT03131687|10085696|FG002|NOT COMPLETED|Overall Study||3
9022902|NCT03131687|10085697|FG003|NOT COMPLETED|Overall Study||4
9022903|NCT03131687|10085698|FG004|NOT COMPLETED|Overall Study||8
9022904|NCT03131687|10085699|FG005|NOT COMPLETED|Overall Study||5
9022905|NCT03131713|10085728|FG000|STARTED|Overall Study||50
9022906|NCT03131713|10085729|FG001|STARTED|Overall Study|1 intervention subject was added on after the protocol was initiated.|51
9022907|NCT03131713|10085728|FG000|COMPLETED|Overall Study||45
9022908|NCT03131713|10085729|FG001|COMPLETED|Overall Study||51
9022909|NCT03131713|10085728|FG000|NOT COMPLETED|Overall Study||5
9022910|NCT03131713|10085729|FG001|NOT COMPLETED|Overall Study||0
9022911|NCT03131895|10085739|FG000|STARTED|Intervention Period 1 (2 Days)||28
9022912|NCT03131895|10085740|FG001|STARTED|Intervention Period 1 (2 Days)||28
9022913|NCT03131895|10085741|FG002|STARTED|Intervention Period 1 (2 Days)||30
9022914|NCT03131895|10085742|FG003|STARTED|Intervention Period 1 (2 Days)||30
9022915|NCT03131895|10085739|FG000|COMPLETED|Intervention Period 1 (2 Days)||28
9022916|NCT03131895|10085740|FG001|COMPLETED|Intervention Period 1 (2 Days)||28
9022917|NCT03131895|10085741|FG002|COMPLETED|Intervention Period 1 (2 Days)||30
9022918|NCT03131895|10085742|FG003|COMPLETED|Intervention Period 1 (2 Days)||30
9022919|NCT03131895|10085739|FG000|NOT COMPLETED|Intervention Period 1 (2 Days)||0
9022920|NCT03131895|10085740|FG001|NOT COMPLETED|Intervention Period 1 (2 Days)||0
9022921|NCT03131895|10085741|FG002|NOT COMPLETED|Intervention Period 1 (2 Days)||0
9022922|NCT03131895|10085742|FG003|NOT COMPLETED|Intervention Period 1 (2 Days)||0
8746636|NCT01145482|9795171|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
8746637|NCT01145508|9795179|FG000|STARTED|Overall Study||7
8746638|NCT01145508|9795180|FG001|STARTED|Overall Study||3
8746639|NCT01145508|9795179|FG000|Treated|Overall Study||6
8746640|NCT01145508|9795180|FG001|Treated|Overall Study||2
8746641|NCT01145508|9795179|FG000|COMPLETED|Overall Study||2
8746642|NCT01145508|9795180|FG001|COMPLETED|Overall Study||1
8746643|NCT01145508|9795179|FG000|NOT COMPLETED|Overall Study||5
8746644|NCT01145508|9795180|FG001|NOT COMPLETED|Overall Study||2
8746645|NCT01145547|9795186|FG000|STARTED|Overall Study||4
8746646|NCT01145547|9795187|FG001|STARTED|Overall Study||3
8746647|NCT01145547|9795186|FG000|COMPLETED|Overall Study||4
8746648|NCT01145547|9795187|FG001|COMPLETED|Overall Study||3
8746649|NCT01145547|9795186|FG000|NOT COMPLETED|Overall Study||0
8746650|NCT01145547|9795187|FG001|NOT COMPLETED|Overall Study||0
8746651|NCT01145560|9795196|FG000|STARTED|Overall Study||100
8746652|NCT01145560|9795197|FG001|STARTED|Overall Study||100
8746653|NCT01145560|9795198|FG002|STARTED|Overall Study||100
8913920|NCT02164396|9973331|FG002|STARTED|Overall Study||10
8913921|NCT02164396|9973329|FG000|COMPLETED|Overall Study||10
8913922|NCT02164396|9973330|FG001|COMPLETED|Overall Study||10
8913923|NCT02164396|9973331|FG002|COMPLETED|Overall Study||10
8913924|NCT02164396|9973329|FG000|NOT COMPLETED|Overall Study||0
8913925|NCT02164396|9973330|FG001|NOT COMPLETED|Overall Study||0
8913926|NCT02164396|9973331|FG002|NOT COMPLETED|Overall Study||0
8913927|NCT02164422|9973342|FG000|STARTED|Overall Study||25
8913928|NCT02164422|9973343|FG001|STARTED|Overall Study||22
8913929|NCT02164422|9973344|FG002|STARTED|Overall Study||23
8913930|NCT02164422|9973342|FG000|COMPLETED|Overall Study||24
8913931|NCT02164422|9973343|FG001|COMPLETED|Overall Study||20
8913932|NCT02164422|9973344|FG002|COMPLETED|Overall Study||23
8913933|NCT02164422|9973342|FG000|NOT COMPLETED|Overall Study||1
8913934|NCT02164422|9973343|FG001|NOT COMPLETED|Overall Study||2
8913935|NCT02164422|9973344|FG002|NOT COMPLETED|Overall Study||0
8913936|NCT02164513|9973355|FG000|STARTED|Overall Study||4151
8913937|NCT02164513|9973356|FG001|STARTED|Overall Study||4134
8913938|NCT02164513|9973357|FG002|STARTED|Overall Study||2070
8913939|NCT02164513|9973355|FG000|Completed Investigational Product (IP)|Overall Study||3393
8913940|NCT02164513|9973356|FG001|Completed Investigational Product (IP)|Overall Study||3094
8913941|NCT02164513|9973357|FG002|Completed Investigational Product (IP)|Overall Study||1504
8913942|NCT02164513|9973355|FG000|Not Completed IP|Overall Study||758
8913943|NCT02164513|9973356|FG001|Not Completed IP|Overall Study||1040
8913944|NCT02164513|9973357|FG002|Not Completed IP|Overall Study||566
8913945|NCT02164513|9973355|FG000|Withdrew IP (WIP): Adverse Event|Overall Study||249
8913946|NCT02164513|9973356|FG001|Withdrew IP (WIP): Adverse Event|Overall Study||325
8913947|NCT02164513|9973357|FG002|Withdrew IP (WIP): Adverse Event|Overall Study||186
8913948|NCT02164513|9973355|FG000|WIP: Lack of Efficacy|Overall Study||163
8913949|NCT02164513|9973356|FG001|WIP: Lack of Efficacy|Overall Study||313
8913950|NCT02164513|9973357|FG002|WIP: Lack of Efficacy|Overall Study||172
8913951|NCT02164513|9973355|FG000|Withdrew IP: Protocol Deviation|Overall Study||32
8913952|NCT02164513|9973356|FG001|Withdrew IP: Protocol Deviation|Overall Study||41
8913953|NCT02164513|9973357|FG002|Withdrew IP: Protocol Deviation|Overall Study||19
8913954|NCT02164513|9973355|FG000|WIP (Other): Stopping Criteria Reached|Overall Study||4
8913955|NCT02164513|9973356|FG001|WIP (Other): Stopping Criteria Reached|Overall Study||1
9022923|NCT03131895|10085739|FG000|STARTED|Washout Period (at Least 5 Days)||28
9022924|NCT03131895|10085740|FG001|STARTED|Washout Period (at Least 5 Days)||28
9022925|NCT03131895|10085741|FG002|STARTED|Washout Period (at Least 5 Days)||30
8746654|NCT01145560|9795196|FG000|Received Treatment|Overall Study||99
8746655|NCT01145560|9795197|FG001|Received Treatment|Overall Study||98
8913956|NCT02164513|9973357|FG002|WIP (Other): Stopping Criteria Reached|Overall Study||2
8746656|NCT01145560|9795198|FG002|Received Treatment|Overall Study||99
8746657|NCT01145560|9795196|FG000|Completed Treatment|Overall Study|9 patients died during the treatment period without completing the full course of treatment.|69
8746658|NCT01145560|9795197|FG001|Completed Treatment|Overall Study|8 patients died during the treatment period without completing the full course of treatment.|85
8746659|NCT01145560|9795198|FG002|Completed Treatment|Overall Study|7 patients died during the treatment period without completing the full course of treatment.|78
8746660|NCT01145560|9795196|FG000|COMPLETED|Overall Study|20 patients died during the study. Death was not a reason for treatment or study discontinuation.|96
8746661|NCT01145560|9795197|FG001|COMPLETED|Overall Study|33 patients died during the study. Death was not a reason for treatment or study discontinuation.|96
8746662|NCT01145560|9795198|FG002|COMPLETED|Overall Study|27 patients died during the study. Death was not a reason for treatment or study discontinuation.|98
8746663|NCT01145560|9795196|FG000|NOT COMPLETED|Overall Study||4
8746664|NCT01145560|9795197|FG001|NOT COMPLETED|Overall Study||4
8746665|NCT01145560|9795198|FG002|NOT COMPLETED|Overall Study||2
8746666|NCT01145625|9795208|FG000|STARTED|Overall Study||161
8746667|NCT01145625|9795209|FG001|STARTED|Overall Study||161
8746668|NCT01145625|9795208|FG000|COMPLETED|Overall Study||137
8746669|NCT01145625|9795209|FG001|COMPLETED|Overall Study||130
8746670|NCT01145625|9795208|FG000|NOT COMPLETED|Overall Study||24
8746671|NCT01145625|9795209|FG001|NOT COMPLETED|Overall Study||31
8746672|NCT01145638|9795217|FG000|STARTED|Overall Study||231
8746673|NCT01145638|9795218|FG001|STARTED|Overall Study||119
8746674|NCT01145638|9795217|FG000|COMPLETED|Overall Study||141
8746675|NCT01145638|9795218|FG001|COMPLETED|Overall Study||62
8746676|NCT01145638|9795217|FG000|NOT COMPLETED|Overall Study||90
8746677|NCT01145638|9795218|FG001|NOT COMPLETED|Overall Study||57
8746678|NCT01145755|9795227|FG000|STARTED|Overall Study||40
8746679|NCT01145755|9795228|FG001|STARTED|Overall Study||47
8746680|NCT01145755|9795229|FG002|STARTED|Overall Study||44
8746681|NCT01145755|9795227|FG000|COMPLETED|Overall Study||20
8746682|NCT01145755|9795228|FG001|COMPLETED|Overall Study||19
8746683|NCT01145755|9795229|FG002|COMPLETED|Overall Study||19
8746684|NCT01145755|9795227|FG000|NOT COMPLETED|Overall Study||20
8746685|NCT01145755|9795228|FG001|NOT COMPLETED|Overall Study||28
8746686|NCT01145755|9795229|FG002|NOT COMPLETED|Overall Study||25
8746687|NCT01145833|9795239|FG000|STARTED|Overall Study||25
8746688|NCT01145833|9795240|FG001|STARTED|Overall Study||25
8746689|NCT01145833|9795239|FG000|COMPLETED|Overall Study||22
8746690|NCT01145833|9795240|FG001|COMPLETED|Overall Study||25
8746691|NCT01145833|9795239|FG000|NOT COMPLETED|Overall Study||3
8746692|NCT01145833|9795240|FG001|NOT COMPLETED|Overall Study||0
8746693|NCT01145885|9795246|FG000|STARTED|Overall Study||7
8746694|NCT01145885|9795246|FG000|COMPLETED|Overall Study||0
8746695|NCT01145885|9795246|FG000|NOT COMPLETED|Overall Study||7
8746696|NCT01145898|9795258|FG000|STARTED|6-month Treatment||12
8746697|NCT01145898|9795259|FG001|STARTED|6-month Treatment||44
8746698|NCT01145898|9795258|FG000|COMPLETED|6-month Treatment||12
8746699|NCT01145898|9795259|FG001|COMPLETED|6-month Treatment||44
8746700|NCT01145898|9795258|FG000|NOT COMPLETED|6-month Treatment||0
8746701|NCT01145898|9795259|FG001|NOT COMPLETED|6-month Treatment||0
8746702|NCT01145898|9795258|FG000|STARTED|3-year Treatment||12
8746703|NCT01145898|9795259|FG001|STARTED|3-year Treatment||44
8746704|NCT01145898|9795258|FG000|COMPLETED|3-year Treatment||9
8746705|NCT01145898|9795259|FG001|COMPLETED|3-year Treatment||28
8746706|NCT01145898|9795258|FG000|NOT COMPLETED|3-year Treatment||3
8746707|NCT01145898|9795259|FG001|NOT COMPLETED|3-year Treatment||16
8746708|NCT01146054|9795264|FG000|STARTED|Overall Study||59
8746709|NCT01146054|9795264|FG000|COMPLETED|Overall Study||49
8746710|NCT01146054|9795264|FG000|NOT COMPLETED|Overall Study||10
8746711|NCT01146275|9795268|FG000|STARTED|Overall Study||6
8746712|NCT01146275|9795268|FG000|COMPLETED|Overall Study||6
8746713|NCT01146275|9795268|FG000|NOT COMPLETED|Overall Study||0
8746714|NCT01146288|9795275|FG000|STARTED|First Intervention(1 Day)||7
8746715|NCT01146288|9795276|FG001|STARTED|First Intervention(1 Day)||6
8746716|NCT01146288|9795275|FG000|COMPLETED|First Intervention(1 Day)||7
8746717|NCT01146288|9795276|FG001|COMPLETED|First Intervention(1 Day)||5
8746718|NCT01146288|9795275|FG000|NOT COMPLETED|First Intervention(1 Day)||0
8746719|NCT01146288|9795276|FG001|NOT COMPLETED|First Intervention(1 Day)||1
8746720|NCT01146288|9795275|FG000|STARTED|Second Intervention (1 Day)||7
8746721|NCT01146288|9795276|FG001|STARTED|Second Intervention (1 Day)||5
8746722|NCT01146288|9795275|FG000|COMPLETED|Second Intervention (1 Day)||7
8746723|NCT01146288|9795276|FG001|COMPLETED|Second Intervention (1 Day)||5
8746724|NCT01146288|9795275|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
8746725|NCT01146288|9795276|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
8746726|NCT01146379|9795287|FG000|STARTED|Overall Study||21
8746727|NCT01146379|9795288|FG001|STARTED|Overall Study||22
8746728|NCT01146379|9795289|FG002|STARTED|Overall Study||21
8746729|NCT01146379|9795290|FG003|STARTED|Overall Study||21
8746730|NCT01146379|9795287|FG000|COMPLETED|Overall Study||20
8746731|NCT01146379|9795288|FG001|COMPLETED|Overall Study||21
8746732|NCT01146379|9795289|FG002|COMPLETED|Overall Study||21
8746733|NCT01146379|9795290|FG003|COMPLETED|Overall Study||20
8746734|NCT01146379|9795287|FG000|NOT COMPLETED|Overall Study||1
8746735|NCT01146379|9795288|FG001|NOT COMPLETED|Overall Study||1
8746736|NCT01146379|9795289|FG002|NOT COMPLETED|Overall Study||0
8746737|NCT01146379|9795290|FG003|NOT COMPLETED|Overall Study||1
8746738|NCT01146457|9795305|FG000|STARTED|Overall Study||19
8746739|NCT01146457|9795306|FG001|STARTED|Overall Study||17
8746740|NCT01146457|9795307|FG002|STARTED|Overall Study||21
8746741|NCT01146457|9795308|FG003|STARTED|Overall Study||13
8746742|NCT01146457|9795309|FG004|STARTED|Overall Study||13
8746743|NCT01146457|9795305|FG000|COMPLETED|Overall Study||19
8746744|NCT01146457|9795306|FG001|COMPLETED|Overall Study||17
8746745|NCT01146457|9795307|FG002|COMPLETED|Overall Study||20
8746746|NCT01146457|9795308|FG003|COMPLETED|Overall Study||13
8746747|NCT01146457|9795309|FG004|COMPLETED|Overall Study||13
8746748|NCT01146457|9795305|FG000|NOT COMPLETED|Overall Study||0
8746749|NCT01146457|9795306|FG001|NOT COMPLETED|Overall Study||0
8913957|NCT02164513|9973355|FG000|WIP: Study Closed/Terminated|Overall Study||5
8913958|NCT02164513|9973356|FG001|WIP: Study Closed/Terminated|Overall Study||2
8913959|NCT02164513|9973357|FG002|WIP: Study Closed/Terminated|Overall Study||5
8913960|NCT02164513|9973355|FG000|WIP: Lost to Follow-up|Overall Study||21
8913961|NCT02164513|9973356|FG001|WIP: Lost to Follow-up|Overall Study||25
8913962|NCT02164513|9973357|FG002|WIP: Lost to Follow-up|Overall Study||14
8913963|NCT02164513|9973355|FG000|WIP: Investigator Discretion|Overall Study||33
8913964|NCT02164513|9973356|FG001|WIP: Investigator Discretion|Overall Study||36
8913965|NCT02164513|9973357|FG002|WIP: Investigator Discretion|Overall Study||15
8913966|NCT02164513|9973355|FG000|WIP: Withdrawal by Participant|Overall Study||250
8913967|NCT02164513|9973356|FG001|WIP: Withdrawal by Participant|Overall Study||296
8913968|NCT02164513|9973357|FG002|WIP: Withdrawal by Participant|Overall Study||153
8913969|NCT02164513|9973355|FG000|WIP :Did Not Complete Study Treatment|Overall Study||1
8913970|NCT02164513|9973356|FG001|WIP :Did Not Complete Study Treatment|Overall Study||1
8913971|NCT02164513|9973357|FG002|WIP :Did Not Complete Study Treatment|Overall Study||0
8913972|NCT02164513|9973355|FG000|COMPLETED|Overall Study||3714
8913973|NCT02164513|9973356|FG001|COMPLETED|Overall Study||3598
8913974|NCT02164513|9973357|FG002|COMPLETED|Overall Study||1775
8913975|NCT02164513|9973355|FG000|NOT COMPLETED|Overall Study||437
8913976|NCT02164513|9973356|FG001|NOT COMPLETED|Overall Study||536
8913977|NCT02164513|9973357|FG002|NOT COMPLETED|Overall Study||295
8913978|NCT02164539|9973372|FG000|STARTED|Treatment Phase A (4 Weeks)||41
9022926|NCT03131895|10085742|FG003|STARTED|Washout Period (at Least 5 Days)||30
9022927|NCT03131895|10085739|FG000|COMPLETED|Washout Period (at Least 5 Days)||27
9022928|NCT03131895|10085740|FG001|COMPLETED|Washout Period (at Least 5 Days)||23
8746750|NCT01146457|9795307|FG002|NOT COMPLETED|Overall Study||1
8746751|NCT01146457|9795308|FG003|NOT COMPLETED|Overall Study||0
9022929|NCT03131895|10085741|FG002|COMPLETED|Washout Period (at Least 5 Days)||26
9022930|NCT03131895|10085742|FG003|COMPLETED|Washout Period (at Least 5 Days)||25
9022931|NCT03131895|10085739|FG000|NOT COMPLETED|Washout Period (at Least 5 Days)||1
9022932|NCT03131895|10085740|FG001|NOT COMPLETED|Washout Period (at Least 5 Days)||5
9022933|NCT03131895|10085741|FG002|NOT COMPLETED|Washout Period (at Least 5 Days)||4
9022934|NCT03131895|10085742|FG003|NOT COMPLETED|Washout Period (at Least 5 Days)||5
9022935|NCT03131895|10085739|FG000|STARTED|Intervention Period 2 (2 Days)||27
9022936|NCT03131895|10085740|FG001|STARTED|Intervention Period 2 (2 Days)||23
9022937|NCT03131895|10085741|FG002|STARTED|Intervention Period 2 (2 Days)||26
9022938|NCT03131895|10085742|FG003|STARTED|Intervention Period 2 (2 Days)||25
9022939|NCT03131895|10085739|FG000|COMPLETED|Intervention Period 2 (2 Days)||26
9022940|NCT03131895|10085740|FG001|COMPLETED|Intervention Period 2 (2 Days)||22
9022941|NCT03131895|10085741|FG002|COMPLETED|Intervention Period 2 (2 Days)||26
9022942|NCT03131895|10085742|FG003|COMPLETED|Intervention Period 2 (2 Days)||25
9022943|NCT03131895|10085739|FG000|NOT COMPLETED|Intervention Period 2 (2 Days)||1
9022944|NCT03131895|10085740|FG001|NOT COMPLETED|Intervention Period 2 (2 Days)||1
9022945|NCT03131895|10085741|FG002|NOT COMPLETED|Intervention Period 2 (2 Days)||0
9022946|NCT03131895|10085742|FG003|NOT COMPLETED|Intervention Period 2 (2 Days)||0
9022947|NCT03131999|10085754|FG000|STARTED|Overall Study||8
9022948|NCT03131999|10085755|FG001|STARTED|Overall Study||8
9022949|NCT03131999|10085754|FG000|COMPLETED|Overall Study||8
9022950|NCT03131999|10085755|FG001|COMPLETED|Overall Study||7
9022951|NCT03131999|10085754|FG000|NOT COMPLETED|Overall Study||0
9022952|NCT03131999|10085755|FG001|NOT COMPLETED|Overall Study||1
9022953|NCT03132220|10085763|FG000|STARTED|Overall Study||65
9022954|NCT03132220|10085764|FG001|STARTED|Overall Study||66
9022955|NCT03132220|10085763|FG000|Began Study Sessions|Overall Study|65 participants randomized to intervention arm;17 lost to f/u prior to study start;48 began sessions|48
9022956|NCT03132220|10085764|FG001|Began Study Sessions|Overall Study|66 participants randomized to control arm;8 were lost to f/u prior to study start; 58 began sessions|58
9022957|NCT03132220|10085763|FG000|COMPLETED|Overall Study||47
9022958|NCT03132220|10085764|FG001|COMPLETED|Overall Study||54
9022959|NCT03132220|10085763|FG000|NOT COMPLETED|Overall Study||18
9022960|NCT03132220|10085764|FG001|NOT COMPLETED|Overall Study||12
9022961|NCT03132246|10085772|FG000|STARTED|Overall Study||260
9022962|NCT03132246|10085772|FG000|COMPLETED|Overall Study||156
9022963|NCT03132246|10085772|FG000|NOT COMPLETED|Overall Study||104
9022964|NCT03132298|10085781|FG000|STARTED|Overall Study||48
9022965|NCT03132298|10085782|FG001|STARTED|Overall Study||48
9022966|NCT03132298|10085781|FG000|COMPLETED|Overall Study||36
9022967|NCT03132298|10085782|FG001|COMPLETED|Overall Study||35
9022968|NCT03132298|10085781|FG000|NOT COMPLETED|Overall Study||12
9022969|NCT03132298|10085782|FG001|NOT COMPLETED|Overall Study||13
8746752|NCT01146457|9795309|FG004|NOT COMPLETED|Overall Study||0
8746753|NCT01146496|9795323|FG000|STARTED|Overall Study||114168
8746754|NCT01146496|9795324|FG001|STARTED|Overall Study||109693
8746755|NCT01146496|9795323|FG000|COMPLETED|Overall Study||114168
8746756|NCT01146496|9795324|FG001|COMPLETED|Overall Study||109693
8746757|NCT01146496|9795323|FG000|NOT COMPLETED|Overall Study||0
8746758|NCT01146496|9795324|FG001|NOT COMPLETED|Overall Study||0
8746759|NCT01146561|9795331|FG000|STARTED|Overall Study||2
8746760|NCT01146561|9795331|FG000|COMPLETED|Overall Study||0
8746761|NCT01146561|9795331|FG000|NOT COMPLETED|Overall Study||2
8746762|NCT01146600|9795337|FG000|STARTED|Period 1 (Weeks 1 & 2)||13
8746763|NCT01146600|9795338|FG001|STARTED|Period 1 (Weeks 1 & 2)||10
8746764|NCT01146600|9795337|FG000|COMPLETED|Period 1 (Weeks 1 & 2)||10
8746765|NCT01146600|9795338|FG001|COMPLETED|Period 1 (Weeks 1 & 2)||10
8746766|NCT01146600|9795337|FG000|NOT COMPLETED|Period 1 (Weeks 1 & 2)||3
8746767|NCT01146600|9795338|FG001|NOT COMPLETED|Period 1 (Weeks 1 & 2)||0
8746768|NCT01146600|9795337|FG000|STARTED|Washout (Week 3)||10
8746769|NCT01146600|9795338|FG001|STARTED|Washout (Week 3)||10
8746770|NCT01146600|9795337|FG000|COMPLETED|Washout (Week 3)||10
8746771|NCT01146600|9795338|FG001|COMPLETED|Washout (Week 3)||10
8746772|NCT01146600|9795337|FG000|NOT COMPLETED|Washout (Week 3)||0
8746773|NCT01146600|9795338|FG001|NOT COMPLETED|Washout (Week 3)||0
8746774|NCT01146600|9795337|FG000|STARTED|Period 2 (Weeks 4 & 5)||10
8746775|NCT01146600|9795338|FG001|STARTED|Period 2 (Weeks 4 & 5)||10
8746776|NCT01146600|9795337|FG000|COMPLETED|Period 2 (Weeks 4 & 5)||10
8746777|NCT01146600|9795338|FG001|COMPLETED|Period 2 (Weeks 4 & 5)||10
8746778|NCT01146600|9795337|FG000|NOT COMPLETED|Period 2 (Weeks 4 & 5)||0
8746779|NCT01146600|9795338|FG001|NOT COMPLETED|Period 2 (Weeks 4 & 5)||0
8746780|NCT01146613|9795347|FG000|STARTED|Overall Study||99
8746781|NCT01146613|9795348|FG001|STARTED|Overall Study||101
8746782|NCT01146613|9795347|FG000|COMPLETED|Overall Study||92
8746783|NCT01146613|9795348|FG001|COMPLETED|Overall Study||89
8746784|NCT01146613|9795347|FG000|NOT COMPLETED|Overall Study||7
8746785|NCT01146613|9795348|FG001|NOT COMPLETED|Overall Study||12
8807601|NCT01485120|9859903|FG000|NOT COMPLETED|Overall Study||2
8807602|NCT01485172|9859914|FG000|STARTED|Overall Study||40
8807603|NCT01485172|9859915|FG001|STARTED|Overall Study||13
8807604|NCT01485172|9859916|FG002|STARTED|Overall Study||41
8807605|NCT01485172|9859917|FG003|STARTED|Overall Study||40
8807606|NCT01485172|9859918|FG004|STARTED|Overall Study||39
8807607|NCT01485172|9859919|FG005|STARTED|Overall Study||13
8807608|NCT01485172|9859914|FG000|COMPLETED|Overall Study||33
8807609|NCT01485172|9859915|FG001|COMPLETED|Overall Study||12
8807610|NCT01485172|9859916|FG002|COMPLETED|Overall Study||34
8807611|NCT01485172|9859917|FG003|COMPLETED|Overall Study||32
8807612|NCT01485172|9859918|FG004|COMPLETED|Overall Study||34
8807613|NCT01485172|9859919|FG005|COMPLETED|Overall Study||9
8807614|NCT01485172|9859914|FG000|NOT COMPLETED|Overall Study||7
8807615|NCT01485172|9859915|FG001|NOT COMPLETED|Overall Study||1
8807616|NCT01485172|9859916|FG002|NOT COMPLETED|Overall Study||7
8807617|NCT01485172|9859917|FG003|NOT COMPLETED|Overall Study||8
8807618|NCT01485172|9859918|FG004|NOT COMPLETED|Overall Study||5
8807619|NCT01485172|9859919|FG005|NOT COMPLETED|Overall Study||4
8807620|NCT01485354|9859933|FG000|STARTED|Overall Study||17
8807621|NCT01485354|9859933|FG000|COMPLETED|Overall Study||12
8807622|NCT01485354|9859933|FG000|NOT COMPLETED|Overall Study||5
8807623|NCT01485380|9859937|FG000|STARTED|Overall Study||20
8807624|NCT01485380|9859937|FG000|COMPLETED|Overall Study||17
8807625|NCT01485380|9859937|FG000|NOT COMPLETED|Overall Study||3
8807626|NCT01485393|9859941|FG000|STARTED|Overall Study||5
8807627|NCT01485393|9859942|FG001|STARTED|Overall Study||5
8807628|NCT01485393|9859941|FG000|COMPLETED|Overall Study||5
8807629|NCT01485393|9859942|FG001|COMPLETED|Overall Study||5
8807630|NCT01485393|9859941|FG000|NOT COMPLETED|Overall Study||0
8807631|NCT01485393|9859942|FG001|NOT COMPLETED|Overall Study||0
8807632|NCT01485536|9859949|FG000|STARTED|Overall Study||21
8807633|NCT01485536|9859949|FG000|COMPLETED|Overall Study||17
8807634|NCT01485536|9859949|FG000|NOT COMPLETED|Overall Study||4
8807635|NCT01485588|9859956|FG000|STARTED|Overall Study||6
8807636|NCT01485588|9859957|FG001|STARTED|Overall Study||6
8807637|NCT01485588|9859958|FG002|STARTED|Overall Study||6
8807638|NCT01485588|9859956|FG000|COMPLETED|Overall Study||6
8807639|NCT01485588|9859957|FG001|COMPLETED|Overall Study||6
8807640|NCT01485588|9859958|FG002|COMPLETED|Overall Study||6
8807641|NCT01485588|9859956|FG000|NOT COMPLETED|Overall Study||0
8807642|NCT01485588|9859957|FG001|NOT COMPLETED|Overall Study||0
8807643|NCT01485588|9859958|FG002|NOT COMPLETED|Overall Study||0
8807644|NCT01485614|9859972|FG000|STARTED|Randomization||96
8807645|NCT01485614|9859973|FG001|STARTED|Randomization||90
8807646|NCT01485614|9859974|FG002|STARTED|Randomization||9
8807647|NCT01485614|9859975|FG003|STARTED|Randomization||5
8807648|NCT01485614|9859972|FG000|COMPLETED|Randomization||95
8807649|NCT01485614|9859973|FG001|COMPLETED|Randomization||90
8807650|NCT01485614|9859974|FG002|COMPLETED|Randomization||9
8807651|NCT01485614|9859975|FG003|COMPLETED|Randomization||5
8807652|NCT01485614|9859972|FG000|NOT COMPLETED|Randomization||1
8807653|NCT01485614|9859973|FG001|NOT COMPLETED|Randomization||0
8807654|NCT01485614|9859974|FG002|NOT COMPLETED|Randomization||0
8807655|NCT01485614|9859975|FG003|NOT COMPLETED|Randomization||0
8807656|NCT01485614|9859972|FG000|STARTED|Weeks 0-20||95
8807657|NCT01485614|9859973|FG001|STARTED|Weeks 0-20||90
8807658|NCT01485614|9859974|FG002|STARTED|Weeks 0-20||9
8807659|NCT01485614|9859975|FG003|STARTED|Weeks 0-20||5
8807660|NCT01485614|9859972|FG000|Treated|Weeks 0-20||95
8807661|NCT01485614|9859973|FG001|Treated|Weeks 0-20||90
8746786|NCT01146665|9795356|FG000|STARTED|Overall Study||18
8746787|NCT01146665|9795357|FG001|STARTED|Overall Study||26
8746788|NCT01146665|9795356|FG000|1-month Post-ED Discharge (Follow-up)|Overall Study||9
8746789|NCT01146665|9795357|FG001|1-month Post-ED Discharge (Follow-up)|Overall Study||12
8746790|NCT01146665|9795356|FG000|3-month Post-ED Discharge (Follow-up)|Overall Study||8
8746791|NCT01146665|9795357|FG001|3-month Post-ED Discharge (Follow-up)|Overall Study||10
8746792|NCT01146665|9795356|FG000|COMPLETED|Overall Study||8
8746793|NCT01146665|9795357|FG001|COMPLETED|Overall Study||10
8746794|NCT01146665|9795356|FG000|NOT COMPLETED|Overall Study||10
8746795|NCT01146665|9795357|FG001|NOT COMPLETED|Overall Study||16
8746796|NCT01146704|9795374|FG000|STARTED|Overall Study||16
8746797|NCT01146704|9795375|FG001|STARTED|Overall Study||15
8746798|NCT01146704|9795374|FG000|COMPLETED|Overall Study||16
8746799|NCT01146704|9795375|FG001|COMPLETED|Overall Study||15
8746800|NCT01146704|9795374|FG000|NOT COMPLETED|Overall Study||0
8746801|NCT01146704|9795375|FG001|NOT COMPLETED|Overall Study||0
8746802|NCT01146782|9795381|FG000|STARTED|Screening Cohort||367
8746803|NCT01146782|9795381|FG000|COMPLETED|Screening Cohort||146
8746804|NCT01146782|9795381|FG000|NOT COMPLETED|Screening Cohort||221
8746805|NCT01146782|9795381|FG000|STARTED|Safety Cohort||146
8746806|NCT01146782|9795381|FG000|COMPLETED|Safety Cohort||63
8746807|NCT01146782|9795381|FG000|NOT COMPLETED|Safety Cohort||83
8746808|NCT01146782|9795381|FG000|STARTED|Primary Endpoint Cohort|63 Subjects in the Primary Endpoint Cohort|63
8746809|NCT01146782|9795381|FG000|COMPLETED|Primary Endpoint Cohort|57 Subjects in the Primary Endpoint Cohort completed the 28 day study|57
8746810|NCT01146782|9795381|FG000|NOT COMPLETED|Primary Endpoint Cohort||6
8746811|NCT01146795|9795386|FG000|STARTED|Overall Study||32
8746812|NCT01146795|9795386|FG000|COMPLETED|Overall Study||12
8746813|NCT01146795|9795386|FG000|NOT COMPLETED|Overall Study||20
8746814|NCT01146808|9795390|FG000|STARTED|Overall Study||16
8746815|NCT01146808|9795390|FG000|COMPLETED|Overall Study||16
8746816|NCT01146808|9795390|FG000|NOT COMPLETED|Overall Study||0
8746817|NCT01146834|9795399|FG000|STARTED|Overall Study||20
8746818|NCT01146834|9795400|FG001|STARTED|Overall Study||4
8746819|NCT01146834|9795401|FG002|STARTED|Overall Study||23
8746820|NCT01146834|9795402|FG003|STARTED|Overall Study||0
8746821|NCT01146834|9795403|FG004|STARTED|Overall Study||0
8746822|NCT01146834|9795399|FG000|COMPLETED|Overall Study||17
8746823|NCT01146834|9795400|FG001|COMPLETED|Overall Study||4
8746824|NCT01146834|9795401|FG002|COMPLETED|Overall Study||21
8746825|NCT01146834|9795402|FG003|COMPLETED|Overall Study||0
8746826|NCT01146834|9795403|FG004|COMPLETED|Overall Study||0
8746827|NCT01146834|9795399|FG000|NOT COMPLETED|Overall Study||3
8746828|NCT01146834|9795400|FG001|NOT COMPLETED|Overall Study||0
8746829|NCT01146834|9795401|FG002|NOT COMPLETED|Overall Study||2
8746830|NCT01146834|9795402|FG003|NOT COMPLETED|Overall Study||0
8746831|NCT01146834|9795403|FG004|NOT COMPLETED|Overall Study||0
8746832|NCT01146860|9795417|FG000|STARTED|Overall Study||194
8746833|NCT01146860|9795418|FG001|STARTED|Overall Study||192
8746834|NCT01146860|9795417|FG000|COMPLETED|Overall Study||194
8746835|NCT01146860|9795418|FG001|COMPLETED|Overall Study||191
8746836|NCT01146860|9795417|FG000|NOT COMPLETED|Overall Study||0
8746837|NCT01146860|9795418|FG001|NOT COMPLETED|Overall Study||1
8746838|NCT01146873|9795426|FG000|STARTED|Overall Study||148
8746839|NCT01146873|9795427|FG001|STARTED|Overall Study||150
8913979|NCT02164539|9973373|FG001|STARTED|Treatment Phase A (4 Weeks)||42
8913980|NCT02164539|9973374|FG002|STARTED|Treatment Phase A (4 Weeks)||40
8913981|NCT02164539|9973375|FG003|STARTED|Treatment Phase A (4 Weeks)||46
8913982|NCT02164539|9973376|FG004|STARTED|Treatment Phase A (4 Weeks)||85
8913983|NCT02164539|9973377|FG005|STARTED|Treatment Phase A (4 Weeks)||84
8913984|NCT02164539|9973378|FG006|STARTED|Treatment Phase A (4 Weeks)||0
8913985|NCT02164539|9973372|FG000|COMPLETED|Treatment Phase A (4 Weeks)||39
8913986|NCT02164539|9973373|FG001|COMPLETED|Treatment Phase A (4 Weeks)||42
8913987|NCT02164539|9973374|FG002|COMPLETED|Treatment Phase A (4 Weeks)||39
8913988|NCT02164539|9973375|FG003|COMPLETED|Treatment Phase A (4 Weeks)||44
8913989|NCT02164539|9973376|FG004|COMPLETED|Treatment Phase A (4 Weeks)||82
8913990|NCT02164539|9973377|FG005|COMPLETED|Treatment Phase A (4 Weeks)||83
8746840|NCT01146873|9795426|FG000|COMPLETED|Overall Study||148
8746841|NCT01146873|9795427|FG001|COMPLETED|Overall Study||144
8746842|NCT01146873|9795426|FG000|NOT COMPLETED|Overall Study||0
8746843|NCT01146873|9795427|FG001|NOT COMPLETED|Overall Study||6
8746844|NCT01146912|9795440|FG000|STARTED|Overall Study||4607
8746845|NCT01146912|9795441|FG001|STARTED|Overall Study||4606
8746846|NCT01146912|9795442|FG002|STARTED|Overall Study||593
8746847|NCT01146912|9795443|FG003|STARTED|Overall Study||594
8746848|NCT01146912|9795444|FG004|STARTED|Overall Study||1821
8746849|NCT01146912|9795445|FG005|STARTED|Overall Study||1821
8746850|NCT01146912|9795446|FG006|STARTED|Overall Study||1820
8746851|NCT01146912|9795447|FG007|STARTED|Overall Study||14675
8746852|NCT01146912|9795440|FG000|COMPLETED|Overall Study||3790
8746853|NCT01146912|9795441|FG001|COMPLETED|Overall Study||3784
8746854|NCT01146912|9795442|FG002|COMPLETED|Overall Study||576
8746855|NCT01146912|9795443|FG003|COMPLETED|Overall Study||577
8746856|NCT01146912|9795444|FG004|COMPLETED|Overall Study||1780
8913991|NCT02164539|9973378|FG006|COMPLETED|Treatment Phase A (4 Weeks)||0
8913992|NCT02164539|9973372|FG000|NOT COMPLETED|Treatment Phase A (4 Weeks)||2
8913993|NCT02164539|9973373|FG001|NOT COMPLETED|Treatment Phase A (4 Weeks)||0
8746857|NCT01146912|9795445|FG005|COMPLETED|Overall Study||1760
8746858|NCT01146912|9795446|FG006|COMPLETED|Overall Study||1764
8746859|NCT01146912|9795447|FG007|COMPLETED|Overall Study|Parents are considered subjects but outcomes are on child level|14675
8746860|NCT01146912|9795440|FG000|NOT COMPLETED|Overall Study||817
8746861|NCT01146912|9795441|FG001|NOT COMPLETED|Overall Study||822
8746862|NCT01146912|9795442|FG002|NOT COMPLETED|Overall Study||17
8746863|NCT01146912|9795443|FG003|NOT COMPLETED|Overall Study||17
8746864|NCT01146912|9795444|FG004|NOT COMPLETED|Overall Study||41
8746865|NCT01146912|9795445|FG005|NOT COMPLETED|Overall Study||61
8746866|NCT01146912|9795446|FG006|NOT COMPLETED|Overall Study||56
8746867|NCT01146912|9795447|FG007|NOT COMPLETED|Overall Study||0
8746868|NCT01146951|9795468|FG000|STARTED|Overall Study||29
8746869|NCT01146951|9795469|FG001|STARTED|Overall Study||30
8746870|NCT01146951|9795468|FG000|COMPLETED|Overall Study||25
8746871|NCT01146951|9795469|FG001|COMPLETED|Overall Study||29
8746872|NCT01146951|9795468|FG000|NOT COMPLETED|Overall Study||4
8746873|NCT01146951|9795469|FG001|NOT COMPLETED|Overall Study||1
8746874|NCT01147055|9795475|FG000|STARTED|First Intervention Period||15
8746875|NCT01147055|9795476|FG001|STARTED|First Intervention Period||0
8746876|NCT01147055|9795475|FG000|COMPLETED|First Intervention Period||14
8746877|NCT01147055|9795476|FG001|COMPLETED|First Intervention Period||0
8746878|NCT01147055|9795475|FG000|NOT COMPLETED|First Intervention Period||1
8746879|NCT01147055|9795476|FG001|NOT COMPLETED|First Intervention Period||0
8746880|NCT01147055|9795475|FG000|STARTED|Washout Period (at Least 14 Days)||14
8746881|NCT01147055|9795476|FG001|STARTED|Washout Period (at Least 14 Days)||0
8746882|NCT01147055|9795475|FG000|COMPLETED|Washout Period (at Least 14 Days)||14
8746883|NCT01147055|9795476|FG001|COMPLETED|Washout Period (at Least 14 Days)||0
8913994|NCT02164539|9973374|FG002|NOT COMPLETED|Treatment Phase A (4 Weeks)||1
8913995|NCT02164539|9973375|FG003|NOT COMPLETED|Treatment Phase A (4 Weeks)||2
8913996|NCT02164539|9973376|FG004|NOT COMPLETED|Treatment Phase A (4 Weeks)||3
8913997|NCT02164539|9973377|FG005|NOT COMPLETED|Treatment Phase A (4 Weeks)||1
8913998|NCT02164539|9973378|FG006|NOT COMPLETED|Treatment Phase A (4 Weeks)||0
8913999|NCT02164539|9973372|FG000|STARTED|Treatment Phase B (1 Week)||0
8914000|NCT02164539|9973373|FG001|STARTED|Treatment Phase B (1 Week)||0
8914001|NCT02164539|9973374|FG002|STARTED|Treatment Phase B (1 Week)||0
8914002|NCT02164539|9973375|FG003|STARTED|Treatment Phase B (1 Week)||0
8914003|NCT02164539|9973376|FG004|STARTED|Treatment Phase B (1 Week)||166
8914004|NCT02164539|9973377|FG005|STARTED|Treatment Phase B (1 Week)||0
8914005|NCT02164539|9973378|FG006|STARTED|Treatment Phase B (1 Week)||163
8914006|NCT02164539|9973372|FG000|COMPLETED|Treatment Phase B (1 Week)||0
8914007|NCT02164539|9973373|FG001|COMPLETED|Treatment Phase B (1 Week)||0
8914008|NCT02164539|9973374|FG002|COMPLETED|Treatment Phase B (1 Week)||0
8914009|NCT02164539|9973375|FG003|COMPLETED|Treatment Phase B (1 Week)||0
8914010|NCT02164539|9973376|FG004|COMPLETED|Treatment Phase B (1 Week)||163
8914011|NCT02164539|9973377|FG005|COMPLETED|Treatment Phase B (1 Week)||0
8914012|NCT02164539|9973378|FG006|COMPLETED|Treatment Phase B (1 Week)||162
8914013|NCT02164539|9973372|FG000|NOT COMPLETED|Treatment Phase B (1 Week)||0
8914014|NCT02164539|9973373|FG001|NOT COMPLETED|Treatment Phase B (1 Week)||0
8914015|NCT02164539|9973374|FG002|NOT COMPLETED|Treatment Phase B (1 Week)||0
8914016|NCT02164539|9973375|FG003|NOT COMPLETED|Treatment Phase B (1 Week)||0
8914017|NCT02164539|9973376|FG004|NOT COMPLETED|Treatment Phase B (1 Week)||3
8914018|NCT02164539|9973377|FG005|NOT COMPLETED|Treatment Phase B (1 Week)||0
8914019|NCT02164539|9973378|FG006|NOT COMPLETED|Treatment Phase B (1 Week)||1
8914020|NCT02164539|9973372|FG000|STARTED|Treatment Phase C (1 Week)||79
8914021|NCT02164539|9973373|FG001|STARTED|Treatment Phase C (1 Week)||0
8914022|NCT02164539|9973374|FG002|STARTED|Treatment Phase C (1 Week)||0
8914023|NCT02164539|9973375|FG003|STARTED|Treatment Phase C (1 Week)||0
8914024|NCT02164539|9973376|FG004|STARTED|Treatment Phase C (1 Week)||84
8914025|NCT02164539|9973377|FG005|STARTED|Treatment Phase C (1 Week)||82
8914026|NCT02164539|9973378|FG006|STARTED|Treatment Phase C (1 Week)||80
8914027|NCT02164539|9973372|FG000|COMPLETED|Treatment Phase C (1 Week)||78
8914028|NCT02164539|9973373|FG001|COMPLETED|Treatment Phase C (1 Week)||0
8914029|NCT02164539|9973374|FG002|COMPLETED|Treatment Phase C (1 Week)||0
8914030|NCT02164539|9973375|FG003|COMPLETED|Treatment Phase C (1 Week)||0
8914031|NCT02164539|9973376|FG004|COMPLETED|Treatment Phase C (1 Week)||84
8914032|NCT02164539|9973377|FG005|COMPLETED|Treatment Phase C (1 Week)||82
8746884|NCT01147055|9795475|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8746885|NCT01147055|9795476|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8746886|NCT01147055|9795475|FG000|STARTED|Second Intervention Period||0
8746887|NCT01147055|9795476|FG001|STARTED|Second Intervention Period||14
8746888|NCT01147055|9795475|FG000|COMPLETED|Second Intervention Period||0
8746889|NCT01147055|9795476|FG001|COMPLETED|Second Intervention Period||14
8746890|NCT01147055|9795475|FG000|NOT COMPLETED|Second Intervention Period||0
8746891|NCT01147055|9795476|FG001|NOT COMPLETED|Second Intervention Period||0
8746892|NCT01147068|9795489|FG000|STARTED|Subjects That Received 1st Dose||60
8746893|NCT01147068|9795490|FG001|STARTED|Subjects That Received 1st Dose||57
8746894|NCT01147068|9795491|FG002|STARTED|Subjects That Received 1st Dose||55
8746895|NCT01147068|9795492|FG003|STARTED|Subjects That Received 1st Dose||56
8746896|NCT01147068|9795493|FG004|STARTED|Subjects That Received 1st Dose||56
8914033|NCT02164539|9973378|FG006|COMPLETED|Treatment Phase C (1 Week)||78
8914034|NCT02164539|9973372|FG000|NOT COMPLETED|Treatment Phase C (1 Week)||1
8914035|NCT02164539|9973373|FG001|NOT COMPLETED|Treatment Phase C (1 Week)||0
8914036|NCT02164539|9973374|FG002|NOT COMPLETED|Treatment Phase C (1 Week)||0
8746897|NCT01147068|9795494|FG005|STARTED|Subjects That Received 1st Dose||53
8746898|NCT01147068|9795495|FG006|STARTED|Subjects That Received 1st Dose||55
8746899|NCT01147068|9795489|FG000|COMPLETED|Subjects That Received 1st Dose||60
8746900|NCT01147068|9795490|FG001|COMPLETED|Subjects That Received 1st Dose||57
8746901|NCT01147068|9795491|FG002|COMPLETED|Subjects That Received 1st Dose||55
8746902|NCT01147068|9795492|FG003|COMPLETED|Subjects That Received 1st Dose||56
8746903|NCT01147068|9795493|FG004|COMPLETED|Subjects That Received 1st Dose||56
8746904|NCT01147068|9795494|FG005|COMPLETED|Subjects That Received 1st Dose||53
8746905|NCT01147068|9795495|FG006|COMPLETED|Subjects That Received 1st Dose||55
8746906|NCT01147068|9795489|FG000|NOT COMPLETED|Subjects That Received 1st Dose||0
8746907|NCT01147068|9795490|FG001|NOT COMPLETED|Subjects That Received 1st Dose||0
8746908|NCT01147068|9795491|FG002|NOT COMPLETED|Subjects That Received 1st Dose||0
8746909|NCT01147068|9795492|FG003|NOT COMPLETED|Subjects That Received 1st Dose||0
8746910|NCT01147068|9795493|FG004|NOT COMPLETED|Subjects That Received 1st Dose||0
8746911|NCT01147068|9795494|FG005|NOT COMPLETED|Subjects That Received 1st Dose||0
8746912|NCT01147068|9795495|FG006|NOT COMPLETED|Subjects That Received 1st Dose||0
8746913|NCT01147068|9795489|FG000|STARTED|Subjects That Received 2nd Dose||60
8746914|NCT01147068|9795490|FG001|STARTED|Subjects That Received 2nd Dose||57
8746915|NCT01147068|9795491|FG002|STARTED|Subjects That Received 2nd Dose||55
8746916|NCT01147068|9795492|FG003|STARTED|Subjects That Received 2nd Dose||56
8746917|NCT01147068|9795493|FG004|STARTED|Subjects That Received 2nd Dose||56
8746918|NCT01147068|9795494|FG005|STARTED|Subjects That Received 2nd Dose||53
8746919|NCT01147068|9795495|FG006|STARTED|Subjects That Received 2nd Dose||55
8746920|NCT01147068|9795489|FG000|COMPLETED|Subjects That Received 2nd Dose||59
8746921|NCT01147068|9795490|FG001|COMPLETED|Subjects That Received 2nd Dose||52
8746922|NCT01147068|9795491|FG002|COMPLETED|Subjects That Received 2nd Dose||52
8746923|NCT01147068|9795492|FG003|COMPLETED|Subjects That Received 2nd Dose||56
8746924|NCT01147068|9795493|FG004|COMPLETED|Subjects That Received 2nd Dose||55
8746925|NCT01147068|9795494|FG005|COMPLETED|Subjects That Received 2nd Dose||51
8746926|NCT01147068|9795495|FG006|COMPLETED|Subjects That Received 2nd Dose||55
8746927|NCT01147068|9795489|FG000|NOT COMPLETED|Subjects That Received 2nd Dose||1
8746928|NCT01147068|9795490|FG001|NOT COMPLETED|Subjects That Received 2nd Dose||5
8746929|NCT01147068|9795491|FG002|NOT COMPLETED|Subjects That Received 2nd Dose||3
8746930|NCT01147068|9795492|FG003|NOT COMPLETED|Subjects That Received 2nd Dose||0
8746931|NCT01147068|9795493|FG004|NOT COMPLETED|Subjects That Received 2nd Dose||1
8746932|NCT01147068|9795494|FG005|NOT COMPLETED|Subjects That Received 2nd Dose||2
8746933|NCT01147068|9795495|FG006|NOT COMPLETED|Subjects That Received 2nd Dose||0
8746934|NCT01147068|9795489|FG000|STARTED|Subjects That Completed Safety Follow-up|Participants were eligible for follow-up regardless of number of doses received.|60
8746935|NCT01147068|9795490|FG001|STARTED|Subjects That Completed Safety Follow-up|One subject was ineligible, one subject did not complete the study, and the other data is unknown.|57
8746936|NCT01147068|9795491|FG002|STARTED|Subjects That Completed Safety Follow-up|Data on three subjects is unknown.|55
8746937|NCT01147068|9795492|FG003|STARTED|Subjects That Completed Safety Follow-up||56
8746938|NCT01147068|9795493|FG004|STARTED|Subjects That Completed Safety Follow-up|Data for one subject is unknown.|56
8746939|NCT01147068|9795494|FG005|STARTED|Subjects That Completed Safety Follow-up|One subject was lost to follow up and one subject did not complete the study.|53
8746940|NCT01147068|9795495|FG006|STARTED|Subjects That Completed Safety Follow-up||55
8746941|NCT01147068|9795489|FG000|COMPLETED|Subjects That Completed Safety Follow-up||59
8746942|NCT01147068|9795490|FG001|COMPLETED|Subjects That Completed Safety Follow-up||56
8746943|NCT01147068|9795491|FG002|COMPLETED|Subjects That Completed Safety Follow-up||55
8746944|NCT01147068|9795492|FG003|COMPLETED|Subjects That Completed Safety Follow-up||54
8746945|NCT01147068|9795493|FG004|COMPLETED|Subjects That Completed Safety Follow-up||56
8746946|NCT01147068|9795494|FG005|COMPLETED|Subjects That Completed Safety Follow-up||52
8746947|NCT01147068|9795495|FG006|COMPLETED|Subjects That Completed Safety Follow-up||54
8746948|NCT01147068|9795489|FG000|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
8746949|NCT01147068|9795490|FG001|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
8746950|NCT01147068|9795491|FG002|NOT COMPLETED|Subjects That Completed Safety Follow-up||0
8746951|NCT01147068|9795492|FG003|NOT COMPLETED|Subjects That Completed Safety Follow-up||2
8746952|NCT01147068|9795493|FG004|NOT COMPLETED|Subjects That Completed Safety Follow-up||0
8746953|NCT01147068|9795494|FG005|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
8746954|NCT01147068|9795495|FG006|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
8746955|NCT01147107|9795513|FG000|STARTED|Overall Study||39
8746956|NCT01147107|9795514|FG001|STARTED|Overall Study||41
8746957|NCT01147107|9795513|FG000|COMPLETED|Overall Study||33
8746958|NCT01147107|9795514|FG001|COMPLETED|Overall Study||40
8746959|NCT01147107|9795513|FG000|NOT COMPLETED|Overall Study||6
8746960|NCT01147107|9795514|FG001|NOT COMPLETED|Overall Study||1
8746961|NCT01147172|9795520|FG000|STARTED|Overall Study||100
8746962|NCT01147172|9795520|FG000|COMPLETED|Overall Study||96
8746963|NCT01147172|9795520|FG000|NOT COMPLETED|Overall Study||4
8746964|NCT01147250|9795528|FG000|STARTED|Overall Study||3034
8746965|NCT01147250|9795529|FG001|STARTED|Overall Study||3034
8746966|NCT01147250|9795528|FG000|Treated|Overall Study||3032
8746967|NCT01147250|9795529|FG001|Treated|Overall Study||3031
8746968|NCT01147250|9795528|FG000|COMPLETED|Overall Study||2924
8746969|NCT01147250|9795529|FG001|COMPLETED|Overall Study||2929
8746970|NCT01147250|9795528|FG000|NOT COMPLETED|Overall Study||110
8746971|NCT01147250|9795529|FG001|NOT COMPLETED|Overall Study||105
8746972|NCT01147302|9795537|FG000|STARTED|Overall Study||9
8746973|NCT01147302|9795538|FG001|STARTED|Overall Study||9
8746974|NCT01147302|9795537|FG000|COMPLETED|Overall Study||9
8746975|NCT01147302|9795538|FG001|COMPLETED|Overall Study||9
8746976|NCT01147302|9795537|FG000|NOT COMPLETED|Overall Study||0
8746977|NCT01147302|9795538|FG001|NOT COMPLETED|Overall Study||0
8746978|NCT01147341|9795546|FG000|STARTED|Double Blind Period||27
8746979|NCT01147341|9795547|FG001|STARTED|Double Blind Period||10
8746980|NCT01147341|9795546|FG000|COMPLETED|Double Blind Period||26
8746981|NCT01147341|9795547|FG001|COMPLETED|Double Blind Period||8
8746982|NCT01147341|9795546|FG000|NOT COMPLETED|Double Blind Period||1
8746983|NCT01147341|9795547|FG001|NOT COMPLETED|Double Blind Period||2
8746984|NCT01147341|9795546|FG000|STARTED|Open Label Period||26
8746985|NCT01147341|9795547|FG001|STARTED|Open Label Period||8
8746986|NCT01147341|9795546|FG000|COMPLETED|Open Label Period||22
8746987|NCT01147341|9795547|FG001|COMPLETED|Open Label Period||8
8746988|NCT01147341|9795546|FG000|NOT COMPLETED|Open Label Period||4
8746989|NCT01147341|9795547|FG001|NOT COMPLETED|Open Label Period||0
8746990|NCT01147380|9795555|FG000|STARTED|Overall Study||6
8746991|NCT01147380|9795556|FG001|STARTED|Overall Study||12
8746992|NCT01147380|9795555|FG000|COMPLETED|Overall Study||6
8746993|NCT01147380|9795556|FG001|COMPLETED|Overall Study||12
8746994|NCT01147380|9795555|FG000|NOT COMPLETED|Overall Study||0
8746995|NCT01147380|9795556|FG001|NOT COMPLETED|Overall Study||0
8746996|NCT01147406|9795570|FG000|STARTED|Overall Study||6
8746997|NCT01147406|9795571|FG001|STARTED|Overall Study||12
8746998|NCT01147406|9795572|FG002|STARTED|Overall Study||1
8746999|NCT01147406|9795573|FG003|STARTED|Overall Study||6
8747000|NCT01147406|9795574|FG004|STARTED|Overall Study||6
8747001|NCT01147406|9795575|FG005|STARTED|Overall Study||10
8747002|NCT01147406|9795570|FG000|COMPLETED|Overall Study||6
8747003|NCT01147406|9795571|FG001|COMPLETED|Overall Study||12
8747004|NCT01147406|9795572|FG002|COMPLETED|Overall Study||1
8747005|NCT01147406|9795573|FG003|COMPLETED|Overall Study||6
8747006|NCT01147406|9795574|FG004|COMPLETED|Overall Study||6
8747007|NCT01147406|9795575|FG005|COMPLETED|Overall Study||10
8747008|NCT01147406|9795570|FG000|NOT COMPLETED|Overall Study||0
8747009|NCT01147406|9795571|FG001|NOT COMPLETED|Overall Study||0
8747010|NCT01147406|9795572|FG002|NOT COMPLETED|Overall Study||0
8747011|NCT01147406|9795573|FG003|NOT COMPLETED|Overall Study||0
8747012|NCT01147406|9795574|FG004|NOT COMPLETED|Overall Study||0
8747013|NCT01147406|9795575|FG005|NOT COMPLETED|Overall Study||0
8747014|NCT01147458|9795590|FG000|STARTED|First Intervention||48
8747015|NCT01147458|9795591|FG001|STARTED|First Intervention||47
8747016|NCT01147458|9795592|FG002|STARTED|First Intervention||47
8747017|NCT01147458|9795593|FG003|STARTED|First Intervention||48
8747018|NCT01147458|9795590|FG000|COMPLETED|First Intervention||34
8747019|NCT01147458|9795591|FG001|COMPLETED|First Intervention||31
8747020|NCT01147458|9795592|FG002|COMPLETED|First Intervention||35
8747021|NCT01147458|9795593|FG003|COMPLETED|First Intervention||34
8747022|NCT01147458|9795590|FG000|NOT COMPLETED|First Intervention||14
8747023|NCT01147458|9795591|FG001|NOT COMPLETED|First Intervention||16
8747024|NCT01147458|9795592|FG002|NOT COMPLETED|First Intervention||12
8747025|NCT01147458|9795593|FG003|NOT COMPLETED|First Intervention||14
8747026|NCT01147458|9795590|FG000|STARTED|Washout Period of 2 Weeks||34
8747027|NCT01147458|9795591|FG001|STARTED|Washout Period of 2 Weeks||31
8747028|NCT01147458|9795592|FG002|STARTED|Washout Period of 2 Weeks||35
8747029|NCT01147458|9795593|FG003|STARTED|Washout Period of 2 Weeks||34
8747030|NCT01147458|9795590|FG000|COMPLETED|Washout Period of 2 Weeks||34
8747031|NCT01147458|9795591|FG001|COMPLETED|Washout Period of 2 Weeks||31
8747032|NCT01147458|9795592|FG002|COMPLETED|Washout Period of 2 Weeks||35
8747033|NCT01147458|9795593|FG003|COMPLETED|Washout Period of 2 Weeks||34
8747034|NCT01147458|9795590|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
8747035|NCT01147458|9795591|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
8747036|NCT01147458|9795592|FG002|NOT COMPLETED|Washout Period of 2 Weeks||0
8747037|NCT01147458|9795593|FG003|NOT COMPLETED|Washout Period of 2 Weeks||0
8747038|NCT01147458|9795590|FG000|STARTED|Second Intervention||34
8747039|NCT01147458|9795591|FG001|STARTED|Second Intervention||31
8747040|NCT01147458|9795592|FG002|STARTED|Second Intervention||35
8747041|NCT01147458|9795593|FG003|STARTED|Second Intervention||34
8747042|NCT01147458|9795590|FG000|COMPLETED|Second Intervention||25
8747043|NCT01147458|9795591|FG001|COMPLETED|Second Intervention||24
8914037|NCT02164539|9973375|FG003|NOT COMPLETED|Treatment Phase C (1 Week)||0
9022970|NCT03132571|10085790|FG000|STARTED|Overall Study||3
8747044|NCT01147458|9795592|FG002|COMPLETED|Second Intervention||27
8747045|NCT01147458|9795593|FG003|COMPLETED|Second Intervention||30
8747046|NCT01147458|9795590|FG000|NOT COMPLETED|Second Intervention||9
8747047|NCT01147458|9795591|FG001|NOT COMPLETED|Second Intervention||7
8747048|NCT01147458|9795592|FG002|NOT COMPLETED|Second Intervention||8
8747049|NCT01147458|9795593|FG003|NOT COMPLETED|Second Intervention||4
8747050|NCT01147471|9795607|FG000|STARTED|Through Initial Hospital Discharge||13
8747051|NCT01147471|9795608|FG001|STARTED|Through Initial Hospital Discharge||11
8747052|NCT01147471|9795607|FG000|COMPLETED|Through Initial Hospital Discharge||13
8747053|NCT01147471|9795608|FG001|COMPLETED|Through Initial Hospital Discharge||11
8747054|NCT01147471|9795607|FG000|NOT COMPLETED|Through Initial Hospital Discharge||0
8747055|NCT01147471|9795608|FG001|NOT COMPLETED|Through Initial Hospital Discharge||0
8747056|NCT01147471|9795607|FG000|STARTED|Post-discharge Follow Up (Approx 2 Wks)||13
8747057|NCT01147471|9795608|FG001|STARTED|Post-discharge Follow Up (Approx 2 Wks)||11
8914038|NCT02164539|9973376|FG004|NOT COMPLETED|Treatment Phase C (1 Week)||0
8747058|NCT01147471|9795607|FG000|COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||13
8747059|NCT01147471|9795608|FG001|COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||8
8747060|NCT01147471|9795607|FG000|NOT COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||0
8747061|NCT01147471|9795608|FG001|NOT COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||3
8747062|NCT01147471|9795607|FG000|STARTED|3 Month Follow Up||13
8747063|NCT01147471|9795608|FG001|STARTED|3 Month Follow Up||8
8747064|NCT01147471|9795607|FG000|COMPLETED|3 Month Follow Up||12
8747065|NCT01147471|9795608|FG001|COMPLETED|3 Month Follow Up||6
8747066|NCT01147471|9795607|FG000|NOT COMPLETED|3 Month Follow Up||1
8747067|NCT01147471|9795608|FG001|NOT COMPLETED|3 Month Follow Up||2
8747068|NCT01147471|9795607|FG000|STARTED|6 Month Follow Up||12
8747069|NCT01147471|9795608|FG001|STARTED|6 Month Follow Up||6
8747070|NCT01147471|9795607|FG000|COMPLETED|6 Month Follow Up||8
8747071|NCT01147471|9795608|FG001|COMPLETED|6 Month Follow Up||4
8747072|NCT01147471|9795607|FG000|NOT COMPLETED|6 Month Follow Up||4
8747073|NCT01147471|9795608|FG001|NOT COMPLETED|6 Month Follow Up||2
8747074|NCT01147497|9795616|FG000|STARTED|Overall Study||37
8747075|NCT01147497|9795617|FG001|STARTED|Overall Study||36
8747076|NCT01147497|9795616|FG000|COMPLETED|Overall Study||35
8747077|NCT01147497|9795617|FG001|COMPLETED|Overall Study||36
8747078|NCT01147497|9795616|FG000|NOT COMPLETED|Overall Study||2
8747079|NCT01147497|9795617|FG001|NOT COMPLETED|Overall Study||0
8747080|NCT01147601|9795625|FG000|STARTED|Overall Study||5
8747081|NCT01147601|9795626|FG001|STARTED|Overall Study||1
8747082|NCT01147601|9795625|FG000|COMPLETED|Overall Study||2
8747083|NCT01147601|9795626|FG001|COMPLETED|Overall Study||1
8747084|NCT01147601|9795625|FG000|NOT COMPLETED|Overall Study||3
8747085|NCT01147601|9795626|FG001|NOT COMPLETED|Overall Study||0
8747086|NCT01147627|9795635|FG000|STARTED|Overall Study||142
8747087|NCT01147627|9795636|FG001|STARTED|Overall Study||138
8747088|NCT01147627|9795637|FG002|STARTED|Overall Study||136
8747089|NCT01147627|9795635|FG000|COMPLETED|Overall Study||110
8747090|NCT01147627|9795636|FG001|COMPLETED|Overall Study||114
8747091|NCT01147627|9795637|FG002|COMPLETED|Overall Study||118
8747092|NCT01147627|9795635|FG000|NOT COMPLETED|Overall Study||32
8747093|NCT01147627|9795636|FG001|NOT COMPLETED|Overall Study||24
8747094|NCT01147627|9795637|FG002|NOT COMPLETED|Overall Study||18
8747095|NCT01147640|9795647|FG000|STARTED|Overall Study||83
8747096|NCT01147640|9795648|FG001|STARTED|Overall Study||39
8747097|NCT01147640|9795647|FG000|COMPLETED|Overall Study||78
8747098|NCT01147640|9795648|FG001|COMPLETED|Overall Study||38
8747099|NCT01147640|9795647|FG000|NOT COMPLETED|Overall Study||5
8747100|NCT01147640|9795648|FG001|NOT COMPLETED|Overall Study||1
8747101|NCT01147744|9795661|FG000|STARTED|Overall Study||100
8747102|NCT01147744|9795662|FG001|STARTED|Overall Study||99
8747103|NCT01147744|9795663|FG002|STARTED|Overall Study||100
8747104|NCT01147744|9795664|FG003|STARTED|Overall Study||100
8747105|NCT01147744|9795665|FG004|STARTED|Overall Study||101
8747106|NCT01147744|9795666|FG005|STARTED|Overall Study||103
8747107|NCT01147744|9795667|FG006|STARTED|Overall Study||97
8747108|NCT01147744|9795661|FG000|COMPLETED|Overall Study||71
8747109|NCT01147744|9795662|FG001|COMPLETED|Overall Study||76
8747110|NCT01147744|9795663|FG002|COMPLETED|Overall Study||82
8747111|NCT01147744|9795664|FG003|COMPLETED|Overall Study||82
8747112|NCT01147744|9795665|FG004|COMPLETED|Overall Study||76
8747113|NCT01147744|9795666|FG005|COMPLETED|Overall Study||83
8747114|NCT01147744|9795667|FG006|COMPLETED|Overall Study||78
8747115|NCT01147744|9795661|FG000|NOT COMPLETED|Overall Study||29
8747116|NCT01147744|9795662|FG001|NOT COMPLETED|Overall Study||23
8747117|NCT01147744|9795663|FG002|NOT COMPLETED|Overall Study||18
8747118|NCT01147744|9795664|FG003|NOT COMPLETED|Overall Study||18
8747119|NCT01147744|9795665|FG004|NOT COMPLETED|Overall Study||25
8747120|NCT01147744|9795666|FG005|NOT COMPLETED|Overall Study||20
8747121|NCT01147744|9795667|FG006|NOT COMPLETED|Overall Study||19
8747122|NCT01147809|9795695|FG000|STARTED|Phase I (168 Days)||3
8747123|NCT01147809|9795696|FG001|STARTED|Phase I (168 Days)||9
8747124|NCT01147809|9795697|FG002|STARTED|Phase I (168 Days)||4
8747125|NCT01147809|9795698|FG003|STARTED|Phase I (168 Days)||10
8747126|NCT01147809|9795699|FG004|STARTED|Phase I (168 Days)||0
8747127|NCT01147809|9795700|FG005|STARTED|Phase I (168 Days)||0
8747128|NCT01147809|9795695|FG000|COMPLETED|Phase I (168 Days)||2
8747129|NCT01147809|9795696|FG001|COMPLETED|Phase I (168 Days)||8
8747130|NCT01147809|9795697|FG002|COMPLETED|Phase I (168 Days)||2
8747131|NCT01147809|9795698|FG003|COMPLETED|Phase I (168 Days)||5
8747132|NCT01147809|9795699|FG004|COMPLETED|Phase I (168 Days)||0
8747133|NCT01147809|9795700|FG005|COMPLETED|Phase I (168 Days)||0
8747134|NCT01147809|9795695|FG000|NOT COMPLETED|Phase I (168 Days)||1
8747135|NCT01147809|9795696|FG001|NOT COMPLETED|Phase I (168 Days)||1
8747136|NCT01147809|9795697|FG002|NOT COMPLETED|Phase I (168 Days)||2
8747137|NCT01147809|9795698|FG003|NOT COMPLETED|Phase I (168 Days)||5
8747138|NCT01147809|9795699|FG004|NOT COMPLETED|Phase I (168 Days)||0
8747139|NCT01147809|9795700|FG005|NOT COMPLETED|Phase I (168 Days)||0
8747140|NCT01147809|9795695|FG000|STARTED|Phase II (168 Days)||0
8747141|NCT01147809|9795696|FG001|STARTED|Phase II (168 Days)||0
8747142|NCT01147809|9795697|FG002|STARTED|Phase II (168 Days)||0
8747143|NCT01147809|9795698|FG003|STARTED|Phase II (168 Days)||0
8747144|NCT01147809|9795699|FG004|STARTED|Phase II (168 Days)||23
8747145|NCT01147809|9795700|FG005|STARTED|Phase II (168 Days)||52
8747146|NCT01147809|9795695|FG000|Ongoing|Phase II (168 Days)||0
8747147|NCT01147809|9795696|FG001|Ongoing|Phase II (168 Days)||0
8747148|NCT01147809|9795697|FG002|Ongoing|Phase II (168 Days)||0
8747149|NCT01147809|9795698|FG003|Ongoing|Phase II (168 Days)||0
8747150|NCT01147809|9795699|FG004|Ongoing|Phase II (168 Days)||1
8747151|NCT01147809|9795700|FG005|Ongoing|Phase II (168 Days)||0
8747152|NCT01147809|9795695|FG000|COMPLETED|Phase II (168 Days)||0
8747153|NCT01147809|9795696|FG001|COMPLETED|Phase II (168 Days)||0
8747154|NCT01147809|9795697|FG002|COMPLETED|Phase II (168 Days)||0
8747155|NCT01147809|9795698|FG003|COMPLETED|Phase II (168 Days)||0
8747156|NCT01147809|9795699|FG004|COMPLETED|Phase II (168 Days)||7
8747157|NCT01147809|9795700|FG005|COMPLETED|Phase II (168 Days)||19
8747158|NCT01147809|9795695|FG000|NOT COMPLETED|Phase II (168 Days)||0
8747159|NCT01147809|9795696|FG001|NOT COMPLETED|Phase II (168 Days)||0
8747160|NCT01147809|9795697|FG002|NOT COMPLETED|Phase II (168 Days)||0
8747161|NCT01147809|9795698|FG003|NOT COMPLETED|Phase II (168 Days)||0
8747162|NCT01147809|9795699|FG004|NOT COMPLETED|Phase II (168 Days)||16
8747163|NCT01147809|9795700|FG005|NOT COMPLETED|Phase II (168 Days)||33
8747164|NCT01147848|9795717|FG000|STARTED|Run-in Period||1564
8747165|NCT01147848|9795718|FG001|STARTED|Run-in Period||0
8747166|NCT01147848|9795719|FG002|STARTED|Run-in Period||0
8747167|NCT01147848|9795717|FG000|COMPLETED|Run-in Period||806
8747168|NCT01147848|9795718|FG001|COMPLETED|Run-in Period||0
8747169|NCT01147848|9795719|FG002|COMPLETED|Run-in Period||0
8747170|NCT01147848|9795717|FG000|NOT COMPLETED|Run-in Period||758
8747171|NCT01147848|9795718|FG001|NOT COMPLETED|Run-in Period||0
8747172|NCT01147848|9795719|FG002|NOT COMPLETED|Run-in Period||0
8747173|NCT01147848|9795717|FG000|STARTED|Randomized Phase||0
8747174|NCT01147848|9795718|FG001|STARTED|Randomized Phase||403
8747175|NCT01147848|9795719|FG002|STARTED|Randomized Phase||403
8747176|NCT01147848|9795717|FG000|COMPLETED|Randomized Phase||0
8747177|NCT01147848|9795718|FG001|COMPLETED|Randomized Phase||358
8747178|NCT01147848|9795719|FG002|COMPLETED|Randomized Phase||357
8747179|NCT01147848|9795717|FG000|NOT COMPLETED|Randomized Phase||0
8747180|NCT01147848|9795718|FG001|NOT COMPLETED|Randomized Phase||45
8747181|NCT01147848|9795719|FG002|NOT COMPLETED|Randomized Phase||46
8747182|NCT01147874|9795726|FG000|STARTED|Overall Study||1013
8747183|NCT01147874|9795726|FG000|COMPLETED|Overall Study||946
8747184|NCT01147874|9795726|FG000|NOT COMPLETED|Overall Study||67
8747185|NCT01147900|9795733|FG000|STARTED|At Year 8.5||54
8747186|NCT01147900|9795734|FG001|STARTED|At Year 8.5||60
8747187|NCT01147900|9795735|FG002|STARTED|At Year 8.5||66
8747188|NCT01147900|9795733|FG000|COMPLETED|At Year 8.5||54
8747189|NCT01147900|9795734|FG001|COMPLETED|At Year 8.5||60
8747190|NCT01147900|9795735|FG002|COMPLETED|At Year 8.5||66
8747191|NCT01147900|9795733|FG000|NOT COMPLETED|At Year 8.5||0
8747192|NCT01147900|9795734|FG001|NOT COMPLETED|At Year 8.5||0
8747193|NCT01147900|9795735|FG002|NOT COMPLETED|At Year 8.5||0
8747194|NCT01147900|9795733|FG000|STARTED|At Year 10|At Year 10, a total of 177 subjects (out of the 180 planned) were enrolled|55
8747195|NCT01147900|9795734|FG001|STARTED|At Year 10||60
8747196|NCT01147900|9795735|FG002|STARTED|At Year 10|At Year 10, a total of 177 subjects (out of the 180 planned) were enrolled.|62
8747197|NCT01147900|9795733|FG000|COMPLETED|At Year 10||55
8670726|NCT00747474|9714099|FG008|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
8670727|NCT00747474|9714100|FG009|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
8670728|NCT00747474|9714101|FG010|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
8670729|NCT00747474|9714102|FG011|COMPLETED|Cohort 12 (60 mg/m^2) Period||6
8670730|NCT00747474|9714091|FG000|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
8670731|NCT00747474|9714092|FG001|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
8747198|NCT01147900|9795734|FG001|COMPLETED|At Year 10||59
8747199|NCT01147900|9795735|FG002|COMPLETED|At Year 10||62
8747200|NCT01147900|9795733|FG000|NOT COMPLETED|At Year 10||0
8747201|NCT01147900|9795734|FG001|NOT COMPLETED|At Year 10||1
8747202|NCT01147900|9795735|FG002|NOT COMPLETED|At Year 10||0
8747203|NCT01147926|9795745|FG000|STARTED|Overall Study||187
8747204|NCT01147926|9795746|FG001|STARTED|Overall Study||187
8747205|NCT01147926|9795745|FG000|COMPLETED|Overall Study||160
8747206|NCT01147926|9795746|FG001|COMPLETED|Overall Study||158
8747207|NCT01147926|9795745|FG000|NOT COMPLETED|Overall Study||27
8747208|NCT01147926|9795746|FG001|NOT COMPLETED|Overall Study||29
8747209|NCT01148017|9795756|FG000|STARTED|Overall Study||214
8747210|NCT01148017|9795757|FG001|STARTED|Overall Study||121
8747211|NCT01148017|9795758|FG002|STARTED|Overall Study||53
8747212|NCT01148017|9795759|FG003|STARTED|Overall Study||45
8747213|NCT01148017|9795756|FG000|COMPLETED|Overall Study||134
8747214|NCT01148017|9795757|FG001|COMPLETED|Overall Study||87
8747215|NCT01148017|9795758|FG002|COMPLETED|Overall Study||53
8747216|NCT01148017|9795759|FG003|COMPLETED|Overall Study||45
8747217|NCT01148017|9795756|FG000|NOT COMPLETED|Overall Study||80
8747218|NCT01148017|9795757|FG001|NOT COMPLETED|Overall Study||34
8747219|NCT01148017|9795758|FG002|NOT COMPLETED|Overall Study||0
8747220|NCT01148017|9795759|FG003|NOT COMPLETED|Overall Study||0
8670732|NCT00747474|9714093|FG002|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
8670733|NCT00747474|9714094|FG003|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
8670734|NCT00747474|9714095|FG004|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
8670735|NCT00747474|9714096|FG005|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
8670736|NCT00747474|9714097|FG006|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
8747221|NCT01148225|9795770|FG000|STARTED|Overall Study||424
8747222|NCT01148225|9795770|FG000|COMPLETED|Overall Study||239
8747223|NCT01148225|9795770|FG000|NOT COMPLETED|Overall Study||185
8747224|NCT01148420|9795777|FG000|STARTED|Overall Study||48
8747225|NCT01148420|9795777|FG000|COMPLETED|Overall Study||48
8747226|NCT01148420|9795777|FG000|NOT COMPLETED|Overall Study||0
8747227|NCT01148459|9795784|FG000|STARTED|Overall Study||99
8747228|NCT01148459|9795785|FG001|STARTED|Overall Study||101
8747229|NCT01148459|9795784|FG000|COMPLETED|Overall Study||87
8747230|NCT01148459|9795785|FG001|COMPLETED|Overall Study||90
8747231|NCT01148459|9795784|FG000|NOT COMPLETED|Overall Study||12
8747232|NCT01148459|9795785|FG001|NOT COMPLETED|Overall Study||11
8747233|NCT01148511|9795793|FG000|STARTED|Exposed to Study Drug||99
8747234|NCT01148511|9795794|FG001|STARTED|Exposed to Study Drug|Patients were not randomized to this group until the Randomized Period.|0
8747235|NCT01148511|9795795|FG002|STARTED|Exposed to Study Drug|Patients were not randomized to this group until the Randomized Period.|0
8747236|NCT01148511|9795793|FG000|COMPLETED|Exposed to Study Drug||93
8747237|NCT01148511|9795794|FG001|COMPLETED|Exposed to Study Drug||0
8747238|NCT01148511|9795795|FG002|COMPLETED|Exposed to Study Drug||0
8747239|NCT01148511|9795793|FG000|NOT COMPLETED|Exposed to Study Drug||6
8747240|NCT01148511|9795794|FG001|NOT COMPLETED|Exposed to Study Drug||0
8747241|NCT01148511|9795795|FG002|NOT COMPLETED|Exposed to Study Drug||0
8747242|NCT01148511|9795793|FG000|STARTED|Randomized|All patients were randomized into the Treat and Extend and the Treat and Observe treatment groups.|0
8747243|NCT01148511|9795794|FG001|STARTED|Randomized||48
8747244|NCT01148511|9795795|FG002|STARTED|Randomized||45
8747245|NCT01148511|9795793|FG000|COMPLETED|Randomized||0
8747246|NCT01148511|9795794|FG001|COMPLETED|Randomized||38
8747247|NCT01148511|9795795|FG002|COMPLETED|Randomized||39
8747248|NCT01148511|9795793|FG000|NOT COMPLETED|Randomized||0
8747249|NCT01148511|9795794|FG001|NOT COMPLETED|Randomized||10
8747250|NCT01148511|9795795|FG002|NOT COMPLETED|Randomized||6
8747251|NCT01148524|9795811|FG000|STARTED|Overall Study||49
8747252|NCT01148524|9795812|FG001|STARTED|Overall Study||95
8747253|NCT01148524|9795813|FG002|STARTED|Overall Study||53
8747254|NCT01148524|9795814|FG003|STARTED|Overall Study||102
8747255|NCT01148524|9795815|FG004|STARTED|Overall Study||57
8747256|NCT01148524|9795816|FG005|STARTED|Overall Study||106
8747257|NCT01148524|9795817|FG006|STARTED|Overall Study||153
8747258|NCT01148524|9795818|FG007|STARTED|Overall Study||51
8747259|NCT01148524|9795819|FG008|STARTED|Overall Study||151
8747260|NCT01148524|9795811|FG000|COMPLETED|Overall Study||49
8747261|NCT01148524|9795812|FG001|COMPLETED|Overall Study||95
8747262|NCT01148524|9795813|FG002|COMPLETED|Overall Study||53
8747263|NCT01148524|9795814|FG003|COMPLETED|Overall Study||102
8747264|NCT01148524|9795815|FG004|COMPLETED|Overall Study||57
8747265|NCT01148524|9795816|FG005|COMPLETED|Overall Study||106
8747266|NCT01148524|9795817|FG006|COMPLETED|Overall Study||153
8747267|NCT01148524|9795818|FG007|COMPLETED|Overall Study||51
8747268|NCT01148524|9795819|FG008|COMPLETED|Overall Study||151
8747269|NCT01148524|9795811|FG000|NOT COMPLETED|Overall Study||0
8747270|NCT01148524|9795812|FG001|NOT COMPLETED|Overall Study||0
8747271|NCT01148524|9795813|FG002|NOT COMPLETED|Overall Study||0
8747272|NCT01148524|9795814|FG003|NOT COMPLETED|Overall Study||0
8747273|NCT01148524|9795815|FG004|NOT COMPLETED|Overall Study||0
8747274|NCT01148524|9795816|FG005|NOT COMPLETED|Overall Study||0
8747275|NCT01148524|9795817|FG006|NOT COMPLETED|Overall Study||0
8747276|NCT01148524|9795818|FG007|NOT COMPLETED|Overall Study||0
8747277|NCT01148524|9795819|FG008|NOT COMPLETED|Overall Study||0
8747278|NCT01148537|9795842|FG000|STARTED|Overall Study||44
8747279|NCT01148537|9795843|FG001|STARTED|Overall Study||44
8747280|NCT01148537|9795844|FG002|STARTED|Overall Study||44
8747281|NCT01148537|9795842|FG000|COMPLETED|Overall Study||41
8747282|NCT01148537|9795843|FG001|COMPLETED|Overall Study||44
8747283|NCT01148537|9795844|FG002|COMPLETED|Overall Study||41
8747284|NCT01148537|9795842|FG000|NOT COMPLETED|Overall Study||3
8747285|NCT01148537|9795843|FG001|NOT COMPLETED|Overall Study||0
8747286|NCT01148537|9795844|FG002|NOT COMPLETED|Overall Study||3
8747287|NCT01148563|9795855|FG000|STARTED|Overall Study||69
8747288|NCT01148563|9795856|FG001|STARTED|Overall Study||67
8747289|NCT01148563|9795855|FG000|COMPLETED|Overall Study||40
8747290|NCT01148563|9795856|FG001|COMPLETED|Overall Study||37
8747291|NCT01148563|9795855|FG000|NOT COMPLETED|Overall Study||29
8747292|NCT01148563|9795856|FG001|NOT COMPLETED|Overall Study||30
8747293|NCT01148693|9795865|FG000|STARTED|Overall Study||70
8747294|NCT01148693|9795866|FG001|STARTED|Overall Study||67
8747295|NCT01148693|9795865|FG000|COMPLETED|Overall Study||57
8747296|NCT01148693|9795866|FG001|COMPLETED|Overall Study||57
8747297|NCT01148693|9795865|FG000|NOT COMPLETED|Overall Study||13
8747298|NCT01148693|9795866|FG001|NOT COMPLETED|Overall Study||10
8747299|NCT01148745|9795872|FG000|STARTED|Overall Study||15
8747300|NCT01148745|9795872|FG000|COMPLETED|Overall Study||15
8747301|NCT01148745|9795872|FG000|NOT COMPLETED|Overall Study||0
8747302|NCT01148771|9795880|FG000|STARTED|First Intervention||6
8747303|NCT01148771|9795881|FG001|STARTED|First Intervention||6
8747304|NCT01148771|9795880|FG000|COMPLETED|First Intervention||6
8747305|NCT01148771|9795881|FG001|COMPLETED|First Intervention||6
8747306|NCT01148771|9795880|FG000|NOT COMPLETED|First Intervention||0
8747307|NCT01148771|9795881|FG001|NOT COMPLETED|First Intervention||0
8747308|NCT01148771|9795880|FG000|STARTED|Washout Period||6
8747309|NCT01148771|9795881|FG001|STARTED|Washout Period||6
8747310|NCT01148771|9795880|FG000|COMPLETED|Washout Period||6
8747311|NCT01148771|9795881|FG001|COMPLETED|Washout Period||5
8747312|NCT01148771|9795880|FG000|NOT COMPLETED|Washout Period||0
8747313|NCT01148771|9795881|FG001|NOT COMPLETED|Washout Period||1
8747314|NCT01148771|9795880|FG000|STARTED|Second Intervention||6
8747315|NCT01148771|9795881|FG001|STARTED|Second Intervention||5
8747316|NCT01148771|9795880|FG000|COMPLETED|Second Intervention||6
8747317|NCT01148771|9795881|FG001|COMPLETED|Second Intervention||5
8747318|NCT01148771|9795880|FG000|NOT COMPLETED|Second Intervention||0
8747319|NCT01148771|9795881|FG001|NOT COMPLETED|Second Intervention||0
8747320|NCT01148810|9795893|FG000|STARTED|Overall Study||8
8747321|NCT01148810|9795894|FG001|STARTED|Overall Study||10
8747322|NCT01148810|9795893|FG000|COMPLETED|Overall Study||7
8747323|NCT01148810|9795894|FG001|COMPLETED|Overall Study||5
8747324|NCT01148810|9795893|FG000|NOT COMPLETED|Overall Study||1
8747325|NCT01148810|9795894|FG001|NOT COMPLETED|Overall Study||5
8747326|NCT01148836|9795903|FG000|STARTED|Overall Study|Enrollment completed|8
8747327|NCT01148836|9795904|FG001|STARTED|Overall Study||10
8747328|NCT01148836|9795903|FG000|COMPLETED|Overall Study|Enrollment completed|7
8747329|NCT01148836|9795904|FG001|COMPLETED|Overall Study||8
8747330|NCT01148836|9795903|FG000|NOT COMPLETED|Overall Study||1
8747331|NCT01148836|9795904|FG001|NOT COMPLETED|Overall Study||2
8747332|NCT01148862|9795910|FG000|STARTED|First Intervention||25
8747333|NCT01148862|9795911|FG001|STARTED|First Intervention||25
8747334|NCT01148862|9795910|FG000|COMPLETED|First Intervention||25
8747335|NCT01148862|9795911|FG001|COMPLETED|First Intervention||25
8747336|NCT01148862|9795910|FG000|NOT COMPLETED|First Intervention||0
8747337|NCT01148862|9795911|FG001|NOT COMPLETED|First Intervention||0
8747338|NCT01148862|9795910|FG000|STARTED|Washout Period of 2 Weeks||25
8747339|NCT01148862|9795911|FG001|STARTED|Washout Period of 2 Weeks||25
8747340|NCT01148862|9795910|FG000|COMPLETED|Washout Period of 2 Weeks||25
8747341|NCT01148862|9795911|FG001|COMPLETED|Washout Period of 2 Weeks||25
8747342|NCT01148862|9795910|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
8747343|NCT01148862|9795911|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
8747344|NCT01148862|9795910|FG000|STARTED|Second Intervention||25
8747345|NCT01148862|9795911|FG001|STARTED|Second Intervention||25
8747346|NCT01148862|9795910|FG000|COMPLETED|Second Intervention||25
8747347|NCT01148862|9795911|FG001|COMPLETED|Second Intervention||23
8747348|NCT01148862|9795910|FG000|NOT COMPLETED|Second Intervention||0
8747349|NCT01148862|9795911|FG001|NOT COMPLETED|Second Intervention||2
8747350|NCT01148940|9795919|FG000|STARTED|Overall Study||7
8747351|NCT01148940|9795920|FG001|STARTED|Overall Study||27
8747352|NCT01148940|9795921|FG002|STARTED|Overall Study||0
8747353|NCT01148940|9795919|FG000|COMPLETED|Overall Study||7
8747354|NCT01148940|9795920|FG001|COMPLETED|Overall Study||27
8747355|NCT01148940|9795921|FG002|COMPLETED|Overall Study||0
8747356|NCT01148940|9795919|FG000|NOT COMPLETED|Overall Study||0
8747357|NCT01148940|9795920|FG001|NOT COMPLETED|Overall Study||0
8747358|NCT01148940|9795921|FG002|NOT COMPLETED|Overall Study||0
8747359|NCT01148979|9795931|FG000|STARTED|Overall Study||13
8747360|NCT01148979|9795932|FG001|STARTED|Overall Study||16
8747361|NCT01148979|9795931|FG000|COMPLETED|Overall Study||13
8747362|NCT01148979|9795932|FG001|COMPLETED|Overall Study||15
8747363|NCT01148979|9795931|FG000|NOT COMPLETED|Overall Study||0
8747364|NCT01148979|9795932|FG001|NOT COMPLETED|Overall Study||1
8747365|NCT01149057|9795938|FG000|STARTED|Overall Study||145
8747366|NCT01149057|9795938|FG000|COMPLETED|Overall Study||88
8747367|NCT01149057|9795938|FG000|NOT COMPLETED|Overall Study||57
8747368|NCT01149096|9795944|FG000|STARTED|Overall Study||6
8747369|NCT01149096|9795945|FG001|STARTED|Overall Study||7
8747370|NCT01149096|9795944|FG000|COMPLETED|Overall Study||6
8747371|NCT01149096|9795945|FG001|COMPLETED|Overall Study||6
8747372|NCT01149096|9795944|FG000|NOT COMPLETED|Overall Study||0
8747373|NCT01149096|9795945|FG001|NOT COMPLETED|Overall Study||1
8747374|NCT01149148|9795954|FG000|STARTED|Overall Study||12
8747375|NCT01149148|9795955|FG001|STARTED|Overall Study||13
8747376|NCT01149148|9795954|FG000|COMPLETED|Overall Study||10
8747377|NCT01149148|9795955|FG001|COMPLETED|Overall Study||11
8747378|NCT01149148|9795954|FG000|NOT COMPLETED|Overall Study||2
8747379|NCT01149148|9795955|FG001|NOT COMPLETED|Overall Study||2
8747380|NCT01149343|9795966|FG000|STARTED|Overall Study||20
8747381|NCT01149343|9795967|FG001|STARTED|Overall Study||24
8747382|NCT01149343|9795968|FG002|STARTED|Overall Study||22
8747383|NCT01149343|9795969|FG003|STARTED|Overall Study||40
8747384|NCT01149343|9795966|FG000|COMPLETED|Overall Study||0
8747385|NCT01149343|9795967|FG001|COMPLETED|Overall Study||0
8747386|NCT01149343|9795968|FG002|COMPLETED|Overall Study||0
8747387|NCT01149343|9795969|FG003|COMPLETED|Overall Study||0
8747388|NCT01149343|9795966|FG000|NOT COMPLETED|Overall Study||20
8747389|NCT01149343|9795967|FG001|NOT COMPLETED|Overall Study||24
8747390|NCT01149343|9795968|FG002|NOT COMPLETED|Overall Study||22
8747391|NCT01149343|9795969|FG003|NOT COMPLETED|Overall Study||40
8747392|NCT01149369|9795985|FG000|STARTED|Overall Study||63
8747393|NCT01149369|9795986|FG001|STARTED|Overall Study||63
8747394|NCT01149369|9795985|FG000|COMPLETED|Overall Study||57
8747395|NCT01149369|9795986|FG001|COMPLETED|Overall Study||60
8747396|NCT01149369|9795985|FG000|NOT COMPLETED|Overall Study||6
8747397|NCT01149369|9795986|FG001|NOT COMPLETED|Overall Study||3
8747398|NCT01149421|9795995|FG000|STARTED|Overall Study||251
8747399|NCT01149421|9795996|FG001|STARTED|Overall Study||254
8747400|NCT01149421|9795997|FG002|STARTED|Overall Study||250
8747401|NCT01149421|9795995|FG000|Received at Least One Dose of Study Drug|Overall Study||251
8747402|NCT01149421|9795996|FG001|Received at Least One Dose of Study Drug|Overall Study||254
8747403|NCT01149421|9795997|FG002|Received at Least One Dose of Study Drug|Overall Study||250
8747404|NCT01149421|9795995|FG000|COMPLETED|Overall Study||199
8747405|NCT01149421|9795996|FG001|COMPLETED|Overall Study||225
8747406|NCT01149421|9795997|FG002|COMPLETED|Overall Study||206
8747407|NCT01149421|9795995|FG000|NOT COMPLETED|Overall Study||52
8914039|NCT02164539|9973377|FG005|NOT COMPLETED|Treatment Phase C (1 Week)||0
8914040|NCT02164539|9973378|FG006|NOT COMPLETED|Treatment Phase C (1 Week)||2
8914041|NCT02164721|9973393|FG000|STARTED|Overall Study||30
8914042|NCT02164721|9973393|FG000|COMPLETED|Overall Study||30
8914043|NCT02164721|9973393|FG000|NOT COMPLETED|Overall Study||0
8914044|NCT02164864|9973401|FG000|STARTED|Overall Study|Started are the Randomised/entered patients.|981
8914045|NCT02164864|9973402|FG001|STARTED|Overall Study|Started are the Randomised/entered patients.|763
8914046|NCT02164864|9973403|FG002|STARTED|Overall Study|Started are the Randomised/entered patients.|981
8914047|NCT02164864|9973401|FG000|COMPLETED|Overall Study||886
8914048|NCT02164864|9973402|FG001|COMPLETED|Overall Study||703
8914049|NCT02164864|9973403|FG002|COMPLETED|Overall Study||849
8914050|NCT02164864|9973401|FG000|NOT COMPLETED|Overall Study||95
8914051|NCT02164864|9973402|FG001|NOT COMPLETED|Overall Study||60
8914052|NCT02164864|9973403|FG002|NOT COMPLETED|Overall Study||132
8914053|NCT02164916|9973416|FG000|STARTED|Overall Study||52
8914054|NCT02164916|9973417|FG001|STARTED|Overall Study||54
8914055|NCT02164916|9973416|FG000|Eligible|Overall Study||50
8914056|NCT02164916|9973417|FG001|Eligible|Overall Study||49
8914057|NCT02164916|9973416|FG000|Cross-over to Arm II|Overall Study|Following disease progression on Arm 1. Note: these patients are also counted in 'Not Completed'.|24
8914058|NCT02164916|9973417|FG001|Cross-over to Arm II|Overall Study||0
8914059|NCT02164916|9973416|FG000|COMPLETED|Overall Study||0
8914060|NCT02164916|9973417|FG001|COMPLETED|Overall Study||0
8914061|NCT02164916|9973416|FG000|NOT COMPLETED|Overall Study||52
8914062|NCT02164916|9973417|FG001|NOT COMPLETED|Overall Study||54
8914063|NCT02164929|9973432|FG000|STARTED|Overall Study||4
8914064|NCT02164929|9973433|FG001|STARTED|Overall Study||3
8914065|NCT02164929|9973434|FG002|STARTED|Overall Study||5
8914066|NCT02164929|9973435|FG003|STARTED|Overall Study||4
8914067|NCT02164929|9973432|FG000|COMPLETED|Overall Study||3
8914068|NCT02164929|9973433|FG001|COMPLETED|Overall Study||3
8914069|NCT02164929|9973434|FG002|COMPLETED|Overall Study||4
8914070|NCT02164929|9973435|FG003|COMPLETED|Overall Study||2
8914071|NCT02164929|9973432|FG000|NOT COMPLETED|Overall Study||1
8914072|NCT02164929|9973433|FG001|NOT COMPLETED|Overall Study||0
8914073|NCT02164929|9973434|FG002|NOT COMPLETED|Overall Study||1
8914074|NCT02164929|9973435|FG003|NOT COMPLETED|Overall Study||2
8914075|NCT02164981|9973448|FG000|STARTED|Started||23
8914076|NCT02164981|9973449|FG001|STARTED|Started||19
8914077|NCT02164981|9973450|FG002|STARTED|Started||18
8914078|NCT02164981|9973448|FG000|COMPLETED|Started||18
8914079|NCT02164981|9973449|FG001|COMPLETED|Started||16
8914080|NCT02164981|9973450|FG002|COMPLETED|Started||18
8914081|NCT02164981|9973448|FG000|NOT COMPLETED|Started||5
8914082|NCT02164981|9973449|FG001|NOT COMPLETED|Started||3
8914083|NCT02164981|9973450|FG002|NOT COMPLETED|Started||0
8914084|NCT02164981|9973448|FG000|STARTED|Phase 1 (Day 0 - Day 14)||18
8914085|NCT02164981|9973449|FG001|STARTED|Phase 1 (Day 0 - Day 14)||16
8914086|NCT02164981|9973450|FG002|STARTED|Phase 1 (Day 0 - Day 14)||18
8914087|NCT02164981|9973448|FG000|COMPLETED|Phase 1 (Day 0 - Day 14)||18
8914088|NCT02164981|9973449|FG001|COMPLETED|Phase 1 (Day 0 - Day 14)||14
8914089|NCT02164981|9973450|FG002|COMPLETED|Phase 1 (Day 0 - Day 14)||18
8914090|NCT02164981|9973448|FG000|NOT COMPLETED|Phase 1 (Day 0 - Day 14)||0
8914091|NCT02164981|9973449|FG001|NOT COMPLETED|Phase 1 (Day 0 - Day 14)||2
8914092|NCT02164981|9973450|FG002|NOT COMPLETED|Phase 1 (Day 0 - Day 14)||0
8914093|NCT02164981|9973448|FG000|STARTED|Phase 2 (Day 14 - Day 28)||18
8914094|NCT02164981|9973449|FG001|STARTED|Phase 2 (Day 14 - Day 28)||14
8914095|NCT02164981|9973450|FG002|STARTED|Phase 2 (Day 14 - Day 28)||18
8914096|NCT02164981|9973448|FG000|COMPLETED|Phase 2 (Day 14 - Day 28)||16
8914097|NCT02164981|9973449|FG001|COMPLETED|Phase 2 (Day 14 - Day 28)||12
8914098|NCT02164981|9973450|FG002|COMPLETED|Phase 2 (Day 14 - Day 28)||18
8914099|NCT02164981|9973448|FG000|NOT COMPLETED|Phase 2 (Day 14 - Day 28)||2
8914100|NCT02164981|9973449|FG001|NOT COMPLETED|Phase 2 (Day 14 - Day 28)||2
8914101|NCT02164981|9973450|FG002|NOT COMPLETED|Phase 2 (Day 14 - Day 28)||0
8914102|NCT02165072|9973471|FG000|STARTED|Overall Study||30
8914103|NCT02165072|9973471|FG000|COMPLETED|Overall Study||30
8914104|NCT02165072|9973471|FG000|NOT COMPLETED|Overall Study||0
8914105|NCT02165111|9973477|FG000|STARTED|Overall Study||40
8914106|NCT02165111|9973478|FG001|STARTED|Overall Study||40
8914107|NCT02165111|9973477|FG000|COMPLETED|Overall Study||40
8914108|NCT02165111|9973478|FG001|COMPLETED|Overall Study||40
9022971|NCT03132571|10085791|FG001|STARTED|Overall Study||2
9022972|NCT03132571|10085790|FG000|COMPLETED|Overall Study||3
9022973|NCT03132571|10085791|FG001|COMPLETED|Overall Study||2
9022974|NCT03132571|10085790|FG000|NOT COMPLETED|Overall Study||0
9022975|NCT03132571|10085791|FG001|NOT COMPLETED|Overall Study||0
9022976|NCT03133481|10085799|FG000|STARTED|Overall Study||45
9022977|NCT03133481|10085800|FG001|STARTED|Overall Study||49
9022978|NCT03133481|10085799|FG000|COMPLETED|Overall Study||45
9022979|NCT03133481|10085800|FG001|COMPLETED|Overall Study||45
9022980|NCT03133481|10085799|FG000|NOT COMPLETED|Overall Study||0
9022981|NCT03133481|10085800|FG001|NOT COMPLETED|Overall Study||4
8914109|NCT02165111|9973477|FG000|NOT COMPLETED|Overall Study||0
8914110|NCT02165111|9973478|FG001|NOT COMPLETED|Overall Study||0
8914111|NCT02165124|9973486|FG000|STARTED|Overall Study||20
8914112|NCT02165124|9973486|FG000|COMPLETED|Overall Study||15
8914113|NCT02165124|9973486|FG000|NOT COMPLETED|Overall Study||5
8914114|NCT02165202|9973492|FG000|STARTED|Oral Phase|Participants Enrolled in the study|91
8747408|NCT01149421|9795996|FG001|NOT COMPLETED|Overall Study||29
8747409|NCT01149421|9795997|FG002|NOT COMPLETED|Overall Study||44
8747410|NCT01149434|9796007|FG000|STARTED|Overall Study||4
8747411|NCT01149434|9796008|FG001|STARTED|Overall Study||15
8747412|NCT01149434|9796007|FG000|COMPLETED|Overall Study||4
8747413|NCT01149434|9796008|FG001|COMPLETED|Overall Study||10
8747414|NCT01149434|9796007|FG000|NOT COMPLETED|Overall Study||0
8747415|NCT01149434|9796008|FG001|NOT COMPLETED|Overall Study||5
8747416|NCT01149460|9796017|FG000|STARTED|Overall Study||18
8747417|NCT01149460|9796018|FG001|STARTED|Overall Study||18
8747418|NCT01149460|9796017|FG000|COMPLETED|Overall Study||18
8747419|NCT01149460|9796018|FG001|COMPLETED|Overall Study||16
8747420|NCT01149460|9796017|FG000|NOT COMPLETED|Overall Study||0
8747421|NCT01149460|9796018|FG001|NOT COMPLETED|Overall Study||2
8747422|NCT01149473|9796026|FG000|STARTED|First Intervention||40
8747423|NCT01149473|9796027|FG001|STARTED|First Intervention||40
8747424|NCT01149473|9796026|FG000|COMPLETED|First Intervention||39
8747425|NCT01149473|9796027|FG001|COMPLETED|First Intervention||39
8747426|NCT01149473|9796026|FG000|NOT COMPLETED|First Intervention||1
8747427|NCT01149473|9796027|FG001|NOT COMPLETED|First Intervention||1
8747428|NCT01149473|9796026|FG000|STARTED|Washout of 7 Days||39
8747429|NCT01149473|9796027|FG001|STARTED|Washout of 7 Days||39
8747430|NCT01149473|9796026|FG000|COMPLETED|Washout of 7 Days||38
8747431|NCT01149473|9796027|FG001|COMPLETED|Washout of 7 Days||38
8747432|NCT01149473|9796026|FG000|NOT COMPLETED|Washout of 7 Days||1
8747433|NCT01149473|9796027|FG001|NOT COMPLETED|Washout of 7 Days||1
8747434|NCT01149473|9796026|FG000|STARTED|Second Intervention||38
8747435|NCT01149473|9796027|FG001|STARTED|Second Intervention||38
8747436|NCT01149473|9796026|FG000|COMPLETED|Second Intervention||38
8747437|NCT01149473|9796027|FG001|COMPLETED|Second Intervention||38
8747438|NCT01149473|9796026|FG000|NOT COMPLETED|Second Intervention||0
8747439|NCT01149473|9796027|FG001|NOT COMPLETED|Second Intervention||0
8747440|NCT01149486|9796035|FG000|STARTED|First Intervention||10
8747441|NCT01149486|9796036|FG001|STARTED|First Intervention||10
8747442|NCT01149486|9796035|FG000|COMPLETED|First Intervention||10
8747443|NCT01149486|9796036|FG001|COMPLETED|First Intervention||9
8747444|NCT01149486|9796035|FG000|NOT COMPLETED|First Intervention||0
8747445|NCT01149486|9796036|FG001|NOT COMPLETED|First Intervention||1
8747446|NCT01149486|9796035|FG000|STARTED|Washout of 7 Days||10
8747447|NCT01149486|9796036|FG001|STARTED|Washout of 7 Days||9
8747448|NCT01149486|9796035|FG000|COMPLETED|Washout of 7 Days||10
8747449|NCT01149486|9796036|FG001|COMPLETED|Washout of 7 Days||9
8747450|NCT01149486|9796035|FG000|NOT COMPLETED|Washout of 7 Days||0
8747451|NCT01149486|9796036|FG001|NOT COMPLETED|Washout of 7 Days||0
8747452|NCT01149486|9796035|FG000|STARTED|Second Intervention||10
8747453|NCT01149486|9796036|FG001|STARTED|Second Intervention||9
8747454|NCT01149486|9796035|FG000|COMPLETED|Second Intervention||10
8747455|NCT01149486|9796036|FG001|COMPLETED|Second Intervention||9
8747456|NCT01149486|9796035|FG000|NOT COMPLETED|Second Intervention||0
8747457|NCT01149486|9796036|FG001|NOT COMPLETED|Second Intervention||0
8747458|NCT01149512|9796042|FG000|STARTED|Overall Study||178
8747459|NCT01149512|9796042|FG000|COMPLETED|Overall Study||178
8747460|NCT01149512|9796042|FG000|NOT COMPLETED|Overall Study||0
8747461|NCT01149538|9796048|FG000|STARTED|Overall Study||31
8747462|NCT01149538|9796049|FG001|STARTED|Overall Study||29
8747463|NCT01149538|9796048|FG000|COMPLETED|Overall Study||26
8747464|NCT01149538|9796049|FG001|COMPLETED|Overall Study||25
8747465|NCT01149538|9796048|FG000|NOT COMPLETED|Overall Study||5
8747466|NCT01149538|9796049|FG001|NOT COMPLETED|Overall Study||4
8747467|NCT01149616|9796057|FG000|STARTED|Overall Study||41
8747468|NCT01149616|9796058|FG001|STARTED|Overall Study||41
8747469|NCT01149616|9796057|FG000|COMPLETED|Overall Study||41
8747470|NCT01149616|9796058|FG001|COMPLETED|Overall Study||41
8747471|NCT01149616|9796057|FG000|NOT COMPLETED|Overall Study||0
8747472|NCT01149616|9796058|FG001|NOT COMPLETED|Overall Study||0
8747473|NCT01149655|9796068|FG000|STARTED|Period 1 - Conversion Phase||186
8747474|NCT01149655|9796069|FG001|STARTED|Period 1 - Conversion Phase||0
8747475|NCT01149655|9796070|FG002|STARTED|Period 1 - Conversion Phase||0
8747476|NCT01149655|9796071|FG003|STARTED|Period 1 - Conversion Phase||0
8747477|NCT01149655|9796068|FG000|COMPLETED|Period 1 - Conversion Phase||168
8747478|NCT01149655|9796069|FG001|COMPLETED|Period 1 - Conversion Phase||0
8747479|NCT01149655|9796070|FG002|COMPLETED|Period 1 - Conversion Phase||0
8747480|NCT01149655|9796071|FG003|COMPLETED|Period 1 - Conversion Phase||0
8747481|NCT01149655|9796068|FG000|NOT COMPLETED|Period 1 - Conversion Phase||18
8747482|NCT01149655|9796069|FG001|NOT COMPLETED|Period 1 - Conversion Phase||0
8747483|NCT01149655|9796070|FG002|NOT COMPLETED|Period 1 - Conversion Phase||0
8747484|NCT01149655|9796071|FG003|NOT COMPLETED|Period 1 - Conversion Phase||0
8747485|NCT01149655|9796068|FG000|STARTED|Period 2-Stabilization Phase||0
8747486|NCT01149655|9796069|FG001|STARTED|Period 2-Stabilization Phase||183
8747487|NCT01149655|9796070|FG002|STARTED|Period 2-Stabilization Phase||0
8747488|NCT01149655|9796071|FG003|STARTED|Period 2-Stabilization Phase||0
8747489|NCT01149655|9796068|FG000|COMPLETED|Period 2-Stabilization Phase||0
8747490|NCT01149655|9796069|FG001|COMPLETED|Period 2-Stabilization Phase||146
8747491|NCT01149655|9796070|FG002|COMPLETED|Period 2-Stabilization Phase||0
8747492|NCT01149655|9796071|FG003|COMPLETED|Period 2-Stabilization Phase||0
8747493|NCT01149655|9796068|FG000|NOT COMPLETED|Period 2-Stabilization Phase||0
8747494|NCT01149655|9796069|FG001|NOT COMPLETED|Period 2-Stabilization Phase||37
8747495|NCT01149655|9796070|FG002|NOT COMPLETED|Period 2-Stabilization Phase||0
8747496|NCT01149655|9796071|FG003|NOT COMPLETED|Period 2-Stabilization Phase||0
8747497|NCT01149655|9796068|FG000|STARTED|Period 3-DB Maintenance Phase||0
8747498|NCT01149655|9796069|FG001|STARTED|Period 3-DB Maintenance Phase||0
8747499|NCT01149655|9796070|FG002|STARTED|Period 3-DB Maintenance Phase||98
8747500|NCT01149655|9796071|FG003|STARTED|Period 3-DB Maintenance Phase||48
8747501|NCT01149655|9796068|FG000|COMPLETED|Period 3-DB Maintenance Phase||0
8747502|NCT01149655|9796069|FG001|COMPLETED|Period 3-DB Maintenance Phase||0
8747503|NCT01149655|9796070|FG002|COMPLETED|Period 3-DB Maintenance Phase||15
8747504|NCT01149655|9796071|FG003|COMPLETED|Period 3-DB Maintenance Phase||6
8747505|NCT01149655|9796068|FG000|NOT COMPLETED|Period 3-DB Maintenance Phase||0
8747506|NCT01149655|9796069|FG001|NOT COMPLETED|Period 3-DB Maintenance Phase||0
8747507|NCT01149655|9796070|FG002|NOT COMPLETED|Period 3-DB Maintenance Phase||83
8747508|NCT01149655|9796071|FG003|NOT COMPLETED|Period 3-DB Maintenance Phase||42
8747509|NCT01149681|9796079|FG000|STARTED|Overall Study||12
8747510|NCT01149681|9796079|FG000|COMPLETED|Overall Study||0
8747511|NCT01149681|9796079|FG000|NOT COMPLETED|Overall Study||12
8747512|NCT01149733|9796086|FG000|STARTED|Overall Study||16
8747513|NCT01149733|9796087|FG001|STARTED|Overall Study||16
8747514|NCT01149733|9796086|FG000|COMPLETED|Overall Study||16
8747515|NCT01149733|9796087|FG001|COMPLETED|Overall Study||16
8747516|NCT01149733|9796086|FG000|NOT COMPLETED|Overall Study||0
8747517|NCT01149733|9796087|FG001|NOT COMPLETED|Overall Study||0
8747518|NCT01149759|9796093|FG000|STARTED|Overall Study||9
8747519|NCT01149759|9796093|FG000|COMPLETED|Overall Study||9
8747520|NCT01149759|9796093|FG000|NOT COMPLETED|Overall Study||0
8747521|NCT01149772|9796099|FG000|STARTED|Overall Study||180
8747522|NCT01149772|9796100|FG001|STARTED|Overall Study||122
8747523|NCT01149772|9796099|FG000|COMPLETED|Overall Study||132
8747524|NCT01149772|9796100|FG001|COMPLETED|Overall Study||101
8747525|NCT01149772|9796099|FG000|NOT COMPLETED|Overall Study||48
8747526|NCT01149772|9796100|FG001|NOT COMPLETED|Overall Study||21
8747527|NCT01149785|9796108|FG000|STARTED|First Intervention||15
8747528|NCT01149785|9796109|FG001|STARTED|First Intervention||0
8747529|NCT01149785|9796108|FG000|COMPLETED|First Intervention||15
8747530|NCT01149785|9796109|FG001|COMPLETED|First Intervention||0
8747531|NCT01149785|9796108|FG000|NOT COMPLETED|First Intervention||0
8747532|NCT01149785|9796109|FG001|NOT COMPLETED|First Intervention||0
8747533|NCT01149785|9796108|FG000|STARTED|Washout Period of at Least 14 Days||15
8747534|NCT01149785|9796109|FG001|STARTED|Washout Period of at Least 14 Days||0
8747535|NCT01149785|9796108|FG000|COMPLETED|Washout Period of at Least 14 Days||15
8747536|NCT01149785|9796109|FG001|COMPLETED|Washout Period of at Least 14 Days||0
8747537|NCT01149785|9796108|FG000|NOT COMPLETED|Washout Period of at Least 14 Days||0
8747538|NCT01149785|9796109|FG001|NOT COMPLETED|Washout Period of at Least 14 Days||0
8747539|NCT01149785|9796108|FG000|STARTED|Second Intervention||0
8747540|NCT01149785|9796109|FG001|STARTED|Second Intervention||15
8747541|NCT01149785|9796108|FG000|COMPLETED|Second Intervention||0
8747542|NCT01149785|9796109|FG001|COMPLETED|Second Intervention||15
8747543|NCT01149785|9796108|FG000|NOT COMPLETED|Second Intervention||0
8747544|NCT01149785|9796109|FG001|NOT COMPLETED|Second Intervention||0
8747545|NCT01149863|9796115|FG000|STARTED|Overall Study||34
8747546|NCT01149863|9796115|FG000|COMPLETED|Overall Study||31
8747547|NCT01149863|9796115|FG000|NOT COMPLETED|Overall Study||3
8747548|NCT01149876|9796123|FG000|STARTED|Overall Study||21
8747549|NCT01149876|9796124|FG001|STARTED|Overall Study||20
8747550|NCT01149876|9796125|FG002|STARTED|Overall Study||21
8747551|NCT01149876|9796126|FG003|STARTED|Overall Study||18
8747552|NCT01149876|9796123|FG000|COMPLETED|Overall Study||20
8747553|NCT01149876|9796124|FG001|COMPLETED|Overall Study||20
8747554|NCT01149876|9796125|FG002|COMPLETED|Overall Study||20
8747555|NCT01149876|9796126|FG003|COMPLETED|Overall Study||18
8747556|NCT01149876|9796123|FG000|NOT COMPLETED|Overall Study||1
8747557|NCT01149876|9796124|FG001|NOT COMPLETED|Overall Study||0
8747558|NCT01149876|9796125|FG002|NOT COMPLETED|Overall Study||1
8747559|NCT01149876|9796126|FG003|NOT COMPLETED|Overall Study||0
8914115|NCT02165202|9973493|FG001|STARTED|Oral Phase|Participants Enrolled in the study|45
8914116|NCT02165202|9973492|FG000|COMPLETED|Oral Phase||80
8914117|NCT02165202|9973493|FG001|COMPLETED|Oral Phase||42
8914118|NCT02165202|9973492|FG000|NOT COMPLETED|Oral Phase||11
8914119|NCT02165202|9973493|FG001|NOT COMPLETED|Oral Phase||3
8914120|NCT02165202|9973492|FG000|STARTED|Injection Phase|Participants who received at least one injection.|80
8914121|NCT02165202|9973493|FG001|STARTED|Injection Phase|Participants who received at least one injection.|42
8914122|NCT02165202|9973492|FG000|COMPLETED|Injection Phase||70
8914123|NCT02165202|9973493|FG001|COMPLETED|Injection Phase||36
8914124|NCT02165202|9973492|FG000|NOT COMPLETED|Injection Phase||10
8747560|NCT01150097|9796140|FG000|STARTED|Months 24 to 36 Post-transplantation||106
8747561|NCT01150097|9796141|FG001|STARTED|Months 24 to 36 Post-transplantation||51
8747562|NCT01150097|9796142|FG002|STARTED|Months 24 to 36 Post-transplantation||125
8747563|NCT01150097|9796140|FG000|COMPLETED|Months 24 to 36 Post-transplantation||96
8747564|NCT01150097|9796141|FG001|COMPLETED|Months 24 to 36 Post-transplantation||49
8747565|NCT01150097|9796142|FG002|COMPLETED|Months 24 to 36 Post-transplantation||117
8747566|NCT01150097|9796140|FG000|NOT COMPLETED|Months 24 to 36 Post-transplantation||10
8747567|NCT01150097|9796141|FG001|NOT COMPLETED|Months 24 to 36 Post-transplantation||2
8747568|NCT01150097|9796142|FG002|NOT COMPLETED|Months 24 to 36 Post-transplantation||8
8747569|NCT01150097|9796140|FG000|STARTED|Months 24 to 48 Post-transplantation||106
8747570|NCT01150097|9796141|FG001|STARTED|Months 24 to 48 Post-transplantation||51
8747571|NCT01150097|9796142|FG002|STARTED|Months 24 to 48 Post-transplantation||0
8747572|NCT01150097|9796140|FG000|COMPLETED|Months 24 to 48 Post-transplantation||95
8747573|NCT01150097|9796141|FG001|COMPLETED|Months 24 to 48 Post-transplantation||47
8747574|NCT01150097|9796142|FG002|COMPLETED|Months 24 to 48 Post-transplantation||0
8747575|NCT01150097|9796140|FG000|NOT COMPLETED|Months 24 to 48 Post-transplantation||11
8747576|NCT01150097|9796141|FG001|NOT COMPLETED|Months 24 to 48 Post-transplantation||4
8747577|NCT01150097|9796142|FG002|NOT COMPLETED|Months 24 to 48 Post-transplantation||0
8747578|NCT01150123|9796170|FG000|STARTED|Overall Study||40
8747579|NCT01150123|9796171|FG001|STARTED|Overall Study||40
8747580|NCT01150123|9796172|FG002|STARTED|Overall Study||39
8747581|NCT01150123|9796173|FG003|STARTED|Overall Study||40
8747582|NCT01150123|9796174|FG004|STARTED|Overall Study||40
8747583|NCT01150123|9796175|FG005|STARTED|Overall Study||40
8747584|NCT01150123|9796176|FG006|STARTED|Overall Study||39
8747585|NCT01150123|9796177|FG007|STARTED|Overall Study||40
8747586|NCT01150123|9796178|FG008|STARTED|Overall Study||20
8747587|NCT01150123|9796179|FG009|STARTED|Overall Study||40
8747588|NCT01150123|9796180|FG010|STARTED|Overall Study||40
8747589|NCT01150123|9796181|FG011|STARTED|Overall Study||40
8747590|NCT01150123|9796182|FG012|STARTED|Overall Study||40
8747591|NCT01150123|9796183|FG013|STARTED|Overall Study||40
8747592|NCT01150123|9796184|FG014|STARTED|Overall Study||40
8747593|NCT01150123|9796185|FG015|STARTED|Overall Study||40
8747594|NCT01150123|9796186|FG016|STARTED|Overall Study||40
8747595|NCT01150123|9796187|FG017|STARTED|Overall Study||20
8747596|NCT01150123|9796170|FG000|COMPLETED|Overall Study||37
8747597|NCT01150123|9796171|FG001|COMPLETED|Overall Study||38
8747598|NCT01150123|9796172|FG002|COMPLETED|Overall Study||35
8747599|NCT01150123|9796173|FG003|COMPLETED|Overall Study||37
8747600|NCT01150123|9796174|FG004|COMPLETED|Overall Study||37
8747601|NCT01150123|9796175|FG005|COMPLETED|Overall Study||34
8747602|NCT01150123|9796176|FG006|COMPLETED|Overall Study||39
8747603|NCT01150123|9796177|FG007|COMPLETED|Overall Study||37
8747604|NCT01150123|9796178|FG008|COMPLETED|Overall Study||15
8747605|NCT01150123|9796179|FG009|COMPLETED|Overall Study||39
8747606|NCT01150123|9796180|FG010|COMPLETED|Overall Study||38
8747607|NCT01150123|9796181|FG011|COMPLETED|Overall Study||39
8747608|NCT01150123|9796182|FG012|COMPLETED|Overall Study||37
8747609|NCT01150123|9796183|FG013|COMPLETED|Overall Study||40
8747610|NCT01150123|9796184|FG014|COMPLETED|Overall Study||40
8747611|NCT01150123|9796185|FG015|COMPLETED|Overall Study||39
8747612|NCT01150123|9796186|FG016|COMPLETED|Overall Study||40
8747613|NCT01150123|9796187|FG017|COMPLETED|Overall Study||19
8747614|NCT01150123|9796170|FG000|NOT COMPLETED|Overall Study||3
8747615|NCT01150123|9796171|FG001|NOT COMPLETED|Overall Study||2
8747616|NCT01150123|9796172|FG002|NOT COMPLETED|Overall Study||4
8747617|NCT01150123|9796173|FG003|NOT COMPLETED|Overall Study||3
8747618|NCT01150123|9796174|FG004|NOT COMPLETED|Overall Study||3
8747619|NCT01150123|9796175|FG005|NOT COMPLETED|Overall Study||6
8747620|NCT01150123|9796176|FG006|NOT COMPLETED|Overall Study||0
8747621|NCT01150123|9796177|FG007|NOT COMPLETED|Overall Study||3
8747622|NCT01150123|9796178|FG008|NOT COMPLETED|Overall Study||5
8747623|NCT01150123|9796179|FG009|NOT COMPLETED|Overall Study||1
8747624|NCT01150123|9796180|FG010|NOT COMPLETED|Overall Study||2
8747625|NCT01150123|9796181|FG011|NOT COMPLETED|Overall Study||1
8747626|NCT01150123|9796182|FG012|NOT COMPLETED|Overall Study||3
8747627|NCT01150123|9796183|FG013|NOT COMPLETED|Overall Study||0
8747628|NCT01150123|9796184|FG014|NOT COMPLETED|Overall Study||0
8747629|NCT01150123|9796185|FG015|NOT COMPLETED|Overall Study||1
8747630|NCT01150123|9796186|FG016|NOT COMPLETED|Overall Study||0
8747631|NCT01150123|9796187|FG017|NOT COMPLETED|Overall Study||1
8747632|NCT01150357|9796247|FG000|STARTED|Dose Response Phase (Phase 1)||108
8747633|NCT01150357|9796248|FG001|STARTED|Dose Response Phase (Phase 1)||54
8747634|NCT01150357|9796249|FG002|STARTED|Dose Response Phase (Phase 1)||105
8747635|NCT01150357|9796247|FG000|COMPLETED|Dose Response Phase (Phase 1)||107
8747636|NCT01150357|9796248|FG001|COMPLETED|Dose Response Phase (Phase 1)||51
8747637|NCT01150357|9796249|FG002|COMPLETED|Dose Response Phase (Phase 1)||102
8747638|NCT01150357|9796247|FG000|NOT COMPLETED|Dose Response Phase (Phase 1)||1
8747639|NCT01150357|9796248|FG001|NOT COMPLETED|Dose Response Phase (Phase 1)||3
8747640|NCT01150357|9796249|FG002|NOT COMPLETED|Dose Response Phase (Phase 1)||3
8747641|NCT01150357|9796247|FG000|STARTED|Placebo-controlled Withdrawal (Phase 2)||107
8747642|NCT01150357|9796248|FG001|STARTED|Placebo-controlled Withdrawal (Phase 2)||51
8747643|NCT01150357|9796249|FG002|STARTED|Placebo-controlled Withdrawal (Phase 2)||102
8747644|NCT01150357|9796247|FG000|Started Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||50
8807662|NCT01485614|9859974|FG002|Treated|Weeks 0-20||9
8747645|NCT01150357|9796248|FG001|Started Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||30
8747646|NCT01150357|9796249|FG002|Started Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||50
8747647|NCT01150357|9796247|FG000|Completed Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||50
8747648|NCT01150357|9796248|FG001|Completed Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||30
8747649|NCT01150357|9796249|FG002|Completed Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||49
8747650|NCT01150357|9796247|FG000|Started Placebo Treatment|Placebo-controlled Withdrawal (Phase 2)||57
8747651|NCT01150357|9796248|FG001|Started Placebo Treatment|Placebo-controlled Withdrawal (Phase 2)||21
8747652|NCT01150357|9796249|FG002|Started Placebo Treatment|Placebo-controlled Withdrawal (Phase 2)||52
8747653|NCT01150357|9796247|FG000|Completed Placebo Treament|Placebo-controlled Withdrawal (Phase 2)||54
8747654|NCT01150357|9796248|FG001|Completed Placebo Treament|Placebo-controlled Withdrawal (Phase 2)||21
8747655|NCT01150357|9796249|FG002|Completed Placebo Treament|Placebo-controlled Withdrawal (Phase 2)||51
8747656|NCT01150357|9796247|FG000|COMPLETED|Placebo-controlled Withdrawal (Phase 2)||104
8747657|NCT01150357|9796248|FG001|COMPLETED|Placebo-controlled Withdrawal (Phase 2)||51
8747658|NCT01150357|9796249|FG002|COMPLETED|Placebo-controlled Withdrawal (Phase 2)||100
8747659|NCT01150357|9796247|FG000|NOT COMPLETED|Placebo-controlled Withdrawal (Phase 2)||3
8747660|NCT01150357|9796248|FG001|NOT COMPLETED|Placebo-controlled Withdrawal (Phase 2)||0
8747661|NCT01150357|9796249|FG002|NOT COMPLETED|Placebo-controlled Withdrawal (Phase 2)||2
8747662|NCT01150461|9796271|FG000|STARTED|Overall Study||11
8747663|NCT01150461|9796272|FG001|STARTED|Overall Study||9
8747664|NCT01150461|9796271|FG000|COMPLETED|Overall Study||11
8747665|NCT01150461|9796272|FG001|COMPLETED|Overall Study||9
8747666|NCT01150461|9796271|FG000|NOT COMPLETED|Overall Study||0
8747667|NCT01150461|9796272|FG001|NOT COMPLETED|Overall Study||0
8747668|NCT01150474|9796280|FG000|STARTED|Overall Study||51
8747669|NCT01150474|9796281|FG001|STARTED|Overall Study||52
8747670|NCT01150474|9796280|FG000|COMPLETED|Overall Study||41
8747671|NCT01150474|9796281|FG001|COMPLETED|Overall Study||49
8747672|NCT01150474|9796280|FG000|NOT COMPLETED|Overall Study||10
8747673|NCT01150474|9796281|FG001|NOT COMPLETED|Overall Study||3
8747674|NCT01150500|9796287|FG000|STARTED|Overall Study||65
8747675|NCT01150500|9796287|FG000|COMPLETED|Overall Study||0
8747676|NCT01150500|9796287|FG000|NOT COMPLETED|Overall Study||65
8747677|NCT01150760|9796293|FG000|STARTED|Overall Study||3525
8747678|NCT01150760|9796294|FG001|STARTED|Overall Study||3525
8747679|NCT01150760|9796293|FG000|COMPLETED|Overall Study||3525
8747680|NCT01150760|9796294|FG001|COMPLETED|Overall Study||3525
8747681|NCT01150760|9796293|FG000|NOT COMPLETED|Overall Study||0
8747682|NCT01150760|9796294|FG001|NOT COMPLETED|Overall Study||0
8747683|NCT01150838|9796305|FG000|STARTED|Overall Study||19
8747684|NCT01150838|9796306|FG001|STARTED|Overall Study||26
8747685|NCT01150838|9796307|FG002|STARTED|Overall Study||24
8747686|NCT01150838|9796308|FG003|STARTED|Overall Study||15
8747687|NCT01150838|9796309|FG004|STARTED|Overall Study||16
8747688|NCT01150838|9796310|FG005|STARTED|Overall Study||2
8747689|NCT01150838|9796305|FG000|COMPLETED|Overall Study||19
8747690|NCT01150838|9796306|FG001|COMPLETED|Overall Study||26
8747691|NCT01150838|9796307|FG002|COMPLETED|Overall Study||24
8747692|NCT01150838|9796308|FG003|COMPLETED|Overall Study||15
8747693|NCT01150838|9796309|FG004|COMPLETED|Overall Study||16
8747694|NCT01150838|9796310|FG005|COMPLETED|Overall Study||2
8747695|NCT01150838|9796305|FG000|NOT COMPLETED|Overall Study||0
8747696|NCT01150838|9796306|FG001|NOT COMPLETED|Overall Study||0
8747697|NCT01150838|9796307|FG002|NOT COMPLETED|Overall Study||0
8747698|NCT01150838|9796308|FG003|NOT COMPLETED|Overall Study||0
8747699|NCT01150838|9796309|FG004|NOT COMPLETED|Overall Study||0
8747700|NCT01150838|9796310|FG005|NOT COMPLETED|Overall Study||0
8747701|NCT01150903|9796320|FG000|STARTED|Overall Study||24708
8747702|NCT01150903|9796321|FG001|STARTED|Overall Study||74124
8747703|NCT01150903|9796320|FG000|COMPLETED|Overall Study||24708
8747704|NCT01150903|9796321|FG001|COMPLETED|Overall Study||74124
8747705|NCT01150903|9796320|FG000|NOT COMPLETED|Overall Study||0
8747706|NCT01150903|9796321|FG001|NOT COMPLETED|Overall Study||0
8747707|NCT01150981|9796329|FG000|STARTED|Overall Study||20
8747708|NCT01150981|9796330|FG001|STARTED|Overall Study||15
8747709|NCT01150981|9796329|FG000|COMPLETED|Overall Study||16
8747710|NCT01150981|9796330|FG001|COMPLETED|Overall Study||13
8747711|NCT01150981|9796329|FG000|NOT COMPLETED|Overall Study||4
8747712|NCT01150981|9796330|FG001|NOT COMPLETED|Overall Study||2
8747713|NCT01151020|9796336|FG000|STARTED|Overall Study||110
8747714|NCT01151020|9796336|FG000|30-day|Overall Study||110
8747715|NCT01151020|9796336|FG000|COMPLETED|Overall Study||56
8747716|NCT01151020|9796336|FG000|NOT COMPLETED|Overall Study||54
8747717|NCT01151046|9796342|FG000|STARTED|Overall Study||59
8747718|NCT01151046|9796343|FG001|STARTED|Overall Study||59
8747719|NCT01151046|9796342|FG000|COMPLETED|Overall Study||56
8747720|NCT01151046|9796343|FG001|COMPLETED|Overall Study||59
8747721|NCT01151046|9796342|FG000|NOT COMPLETED|Overall Study||3
8747722|NCT01151046|9796343|FG001|NOT COMPLETED|Overall Study||0
8747723|NCT01151085|9796353|FG000|STARTED|Overall Study||1002
8747724|NCT01151085|9796353|FG000|COMPLETED|Overall Study||946
8747725|NCT01151085|9796353|FG000|NOT COMPLETED|Overall Study||56
8747726|NCT01151098|9796364|FG000|STARTED|Overall Study|Extension Safety Population|189
8747727|NCT01151098|9796364|FG000|COMPLETED|Overall Study||72
8747728|NCT01151098|9796364|FG000|NOT COMPLETED|Overall Study||117
8747729|NCT01151137|9796370|FG000|STARTED|Overall Study||1617
8747730|NCT01151137|9796371|FG001|STARTED|Overall Study||1619
8747731|NCT01151137|9796370|FG000|Treated|Overall Study|One participant randomized to the placebo group received Dronedarone for 7 days by mistake|1610
8747732|NCT01151137|9796371|FG001|Treated|Overall Study||1613
8747733|NCT01151137|9796370|FG000|Discontinued Treatment|Overall Study||171
8747734|NCT01151137|9796371|FG001|Discontinued Treatment|Overall Study||342
8747735|NCT01151137|9796370|FG000|COMPLETED|Overall Study||1601
8747736|NCT01151137|9796371|FG001|COMPLETED|Overall Study||1591
8747737|NCT01151137|9796370|FG000|NOT COMPLETED|Overall Study||16
8747738|NCT01151137|9796371|FG001|NOT COMPLETED|Overall Study||28
8747739|NCT01151189|9796379|FG000|STARTED|Overall Study||326
8747740|NCT01151189|9796380|FG001|STARTED|Overall Study||324
8747741|NCT01151189|9796379|FG000|Received Vaccine|Overall Study||325
8747742|NCT01151189|9796380|FG001|Received Vaccine|Overall Study||324
8747743|NCT01151189|9796379|FG000|COMPLETED|Overall Study||311
8747744|NCT01151189|9796380|FG001|COMPLETED|Overall Study||314
8747745|NCT01151189|9796379|FG000|NOT COMPLETED|Overall Study||15
8747746|NCT01151189|9796380|FG001|NOT COMPLETED|Overall Study||10
8747747|NCT01151215|9796389|FG000|STARTED|Overall Study||120
8747748|NCT01151215|9796390|FG001|STARTED|Overall Study||118
8747749|NCT01151215|9796391|FG002|STARTED|Overall Study||121
8747750|NCT01151215|9796389|FG000|COMPLETED|Overall Study|This is number of patients who were continuing at cut off (ie not withdrawn)|100
8747751|NCT01151215|9796390|FG001|COMPLETED|Overall Study|This is number of patients who were continuing at cut off (ie not withdrawn)|95
8747752|NCT01151215|9796391|FG002|COMPLETED|Overall Study|This is number of patients who were continuing at cut off (ie not withdrawn)|102
8747753|NCT01151215|9796389|FG000|NOT COMPLETED|Overall Study||20
8747754|NCT01151215|9796390|FG001|NOT COMPLETED|Overall Study||23
8747755|NCT01151215|9796391|FG002|NOT COMPLETED|Overall Study||19
8747756|NCT01151280|9796399|FG000|STARTED|Overall Study||10
8914125|NCT02165202|9973493|FG001|NOT COMPLETED|Injection Phase||6
8914126|NCT02165384|9973499|FG000|STARTED|Overall Study||199
8914127|NCT02165384|9973499|FG000|COMPLETED|Overall Study||199
8914128|NCT02165384|9973499|FG000|NOT COMPLETED|Overall Study||0
8914129|NCT02165397|9973506|FG000|STARTED|Overall Study||75
8914130|NCT02165397|9973507|FG001|STARTED|Overall Study||75
8914131|NCT02165397|9973508|FG002|STARTED|Overall Study||31
8914132|NCT02165397|9973506|FG000|COMPLETED|Overall Study||61
8914133|NCT02165397|9973507|FG001|COMPLETED|Overall Study||56
8914134|NCT02165397|9973508|FG002|COMPLETED|Overall Study||21
8914135|NCT02165397|9973506|FG000|NOT COMPLETED|Overall Study||14
8914136|NCT02165397|9973507|FG001|NOT COMPLETED|Overall Study||19
8914137|NCT02165397|9973508|FG002|NOT COMPLETED|Overall Study||10
8914138|NCT02165462|9973518|FG000|STARTED|Overall Study||17
8914139|NCT02165462|9973518|FG000|COMPLETED|Overall Study||17
8914140|NCT02165462|9973518|FG000|NOT COMPLETED|Overall Study||0
8914141|NCT02165605|9973522|FG000|STARTED|Overall Study||28
8914142|NCT02165605|9973522|FG000|COMPLETED|Overall Study||28
8914143|NCT02165605|9973522|FG000|NOT COMPLETED|Overall Study||0
8914144|NCT02165722|9973531|FG000|STARTED|Overall Study||1971
8914145|NCT02165722|9973532|FG001|STARTED|Overall Study||2202
8914146|NCT02165722|9973531|FG000|COMPLETED|Overall Study|Started and completed participants reflect the longitudinal analytic data set of patients used|1971
8914147|NCT02165722|9973532|FG001|COMPLETED|Overall Study|Started and completed participants reflect the longitudinal analytic data set of patients used|2202
8914148|NCT02165722|9973531|FG000|NOT COMPLETED|Overall Study||0
8914149|NCT02165722|9973532|FG001|NOT COMPLETED|Overall Study||0
8914150|NCT02165735|9973546|FG000|STARTED|Overall Study||180
8914151|NCT02165735|9973547|FG001|STARTED|Overall Study||180
8914152|NCT02165735|9973546|FG000|COMPLETED|Overall Study||164
8914153|NCT02165735|9973547|FG001|COMPLETED|Overall Study||166
8914154|NCT02165735|9973546|FG000|NOT COMPLETED|Overall Study||16
9022982|NCT03133676|10085815|FG000|STARTED|Overall Study||6
9022983|NCT03133676|10085816|FG001|STARTED|Overall Study||3
9022984|NCT03133676|10085817|FG002|STARTED|Overall Study||3
9022985|NCT03133676|10085818|FG003|STARTED|Overall Study||6
9022986|NCT03133676|10085819|FG004|STARTED|Overall Study||6
9022987|NCT03133676|10085820|FG005|STARTED|Overall Study||9
9022988|NCT03133676|10085821|FG006|STARTED|Overall Study||9
9022989|NCT03133676|10085822|FG007|STARTED|Overall Study||9
9022990|NCT03133676|10085823|FG008|STARTED|Overall Study||9
9022991|NCT03133676|10085815|FG000|COMPLETED|Overall Study||6
9022992|NCT03133676|10085816|FG001|COMPLETED|Overall Study||3
9022993|NCT03133676|10085817|FG002|COMPLETED|Overall Study||3
9022994|NCT03133676|10085818|FG003|COMPLETED|Overall Study||6
9022995|NCT03133676|10085819|FG004|COMPLETED|Overall Study||6
9022996|NCT03133676|10085820|FG005|COMPLETED|Overall Study||9
9022997|NCT03133676|10085821|FG006|COMPLETED|Overall Study||9
9022998|NCT03133676|10085822|FG007|COMPLETED|Overall Study||9
9022999|NCT03133676|10085823|FG008|COMPLETED|Overall Study||9
9023000|NCT03133676|10085815|FG000|NOT COMPLETED|Overall Study||0
8747757|NCT01151280|9796399|FG000|COMPLETED|Overall Study||6
8747758|NCT01151280|9796399|FG000|NOT COMPLETED|Overall Study||4
8747759|NCT01151345|9796403|FG000|STARTED|First Intervention Period||13
8747760|NCT01151345|9796404|FG001|STARTED|First Intervention Period||13
8914155|NCT02165735|9973547|FG001|NOT COMPLETED|Overall Study||14
8914156|NCT02165761|9973555|FG000|STARTED|Overall Study||23
8914157|NCT02165761|9973556|FG001|STARTED|Overall Study||19
8914158|NCT02165761|9973555|FG000|COMPLETED|Overall Study||4
8914159|NCT02165761|9973556|FG001|COMPLETED|Overall Study||5
8914160|NCT02165761|9973555|FG000|NOT COMPLETED|Overall Study||19
9023001|NCT03133676|10085816|FG001|NOT COMPLETED|Overall Study||0
9023002|NCT03133676|10085817|FG002|NOT COMPLETED|Overall Study||0
8747761|NCT01151345|9796403|FG000|Treated|First Intervention Period||13
8747762|NCT01151345|9796404|FG001|Treated|First Intervention Period||12
8747763|NCT01151345|9796403|FG000|COMPLETED|First Intervention Period||13
8747764|NCT01151345|9796404|FG001|COMPLETED|First Intervention Period||12
8747765|NCT01151345|9796403|FG000|NOT COMPLETED|First Intervention Period||0
8747766|NCT01151345|9796404|FG001|NOT COMPLETED|First Intervention Period||1
8747767|NCT01151345|9796403|FG000|STARTED|Wash-out Period (7 Days)||13
8747768|NCT01151345|9796404|FG001|STARTED|Wash-out Period (7 Days)||12
8747769|NCT01151345|9796403|FG000|COMPLETED|Wash-out Period (7 Days)||13
8747770|NCT01151345|9796404|FG001|COMPLETED|Wash-out Period (7 Days)||12
8747771|NCT01151345|9796403|FG000|NOT COMPLETED|Wash-out Period (7 Days)||0
8747772|NCT01151345|9796404|FG001|NOT COMPLETED|Wash-out Period (7 Days)||0
8747773|NCT01151345|9796403|FG000|STARTED|Second Intervention Period||13
8747774|NCT01151345|9796404|FG001|STARTED|Second Intervention Period||12
8747775|NCT01151345|9796403|FG000|COMPLETED|Second Intervention Period||13
8747776|NCT01151345|9796404|FG001|COMPLETED|Second Intervention Period||12
8747777|NCT01151345|9796403|FG000|NOT COMPLETED|Second Intervention Period||0
8747778|NCT01151345|9796404|FG001|NOT COMPLETED|Second Intervention Period||0
8747779|NCT01151371|9796413|FG000|STARTED|Overall Study||149
8747780|NCT01151371|9796414|FG001|STARTED|Overall Study||150
8747781|NCT01151371|9796415|FG002|STARTED|Overall Study||153
8747782|NCT01151371|9796413|FG000|COMPLETED|Overall Study||144
8747783|NCT01151371|9796414|FG001|COMPLETED|Overall Study||149
8747784|NCT01151371|9796415|FG002|COMPLETED|Overall Study||146
8747785|NCT01151371|9796413|FG000|NOT COMPLETED|Overall Study||5
8747786|NCT01151371|9796414|FG001|NOT COMPLETED|Overall Study||1
8747787|NCT01151371|9796415|FG002|NOT COMPLETED|Overall Study||7
8747788|NCT01151410|9796425|FG000|STARTED|Overall Study||104
8747789|NCT01151410|9796426|FG001|STARTED|Overall Study||104
8747790|NCT01151410|9796425|FG000|Safety Set (SAF)|Overall Study||105
8747791|NCT01151410|9796426|FG001|Safety Set (SAF)|Overall Study|Number of patients in SAF differed due to kit dispensing error in 1 patient at Visit 12|103
8747792|NCT01151410|9796425|FG000|COMPLETED|Overall Study||93
8747793|NCT01151410|9796426|FG001|COMPLETED|Overall Study||89
8747794|NCT01151410|9796425|FG000|NOT COMPLETED|Overall Study||11
8747795|NCT01151410|9796426|FG001|NOT COMPLETED|Overall Study||15
8747796|NCT01151423|9796434|FG000|STARTED|Overall Study||36
8747797|NCT01151423|9796435|FG001|STARTED|Overall Study||39
8747798|NCT01151423|9796434|FG000|Received Study Drug|Overall Study||35
8747799|NCT01151423|9796435|FG001|Received Study Drug|Overall Study||37
8747800|NCT01151423|9796434|FG000|COMPLETED|Overall Study||20
8747801|NCT01151423|9796435|FG001|COMPLETED|Overall Study||21
8747802|NCT01151423|9796434|FG000|NOT COMPLETED|Overall Study||16
8747803|NCT01151423|9796435|FG001|NOT COMPLETED|Overall Study||18
8747804|NCT01151436|9796441|FG000|STARTED|Overall Study||77
8747805|NCT01151436|9796441|FG000|COMPLETED|Overall Study||76
8747806|NCT01151436|9796441|FG000|NOT COMPLETED|Overall Study||1
8747807|NCT01151449|9796445|FG000|STARTED|Overall Study||6
8747808|NCT01151449|9796445|FG000|COMPLETED|Overall Study||6
8747809|NCT01151449|9796445|FG000|NOT COMPLETED|Overall Study||0
8747810|NCT01151540|9796449|FG000|STARTED|Overall Study||54
8747811|NCT01151540|9796449|FG000|COMPLETED|Overall Study||41
8747812|NCT01151540|9796449|FG000|NOT COMPLETED|Overall Study||13
8747813|NCT01151579|9796455|FG000|STARTED|Overall Study||58
8747814|NCT01151579|9796456|FG001|STARTED|Overall Study||31
8747815|NCT01151579|9796455|FG000|COMPLETED|Overall Study||46
8747816|NCT01151579|9796456|FG001|COMPLETED|Overall Study||24
8747817|NCT01151579|9796455|FG000|NOT COMPLETED|Overall Study||12
8747818|NCT01151579|9796456|FG001|NOT COMPLETED|Overall Study||7
8747819|NCT01151618|9796462|FG000|STARTED|Overall Study||22
8747820|NCT01151618|9796462|FG000|COMPLETED|Overall Study||13
8747821|NCT01151618|9796462|FG000|NOT COMPLETED|Overall Study||9
8747822|NCT01151761|9796466|FG000|STARTED|Overall Study||2
8747823|NCT01151761|9796466|FG000|COMPLETED|Overall Study||2
8747824|NCT01151761|9796466|FG000|NOT COMPLETED|Overall Study||0
8747825|NCT01151813|9796470|FG000|STARTED|Period 1||8
8747826|NCT01151813|9796471|FG001|STARTED|Period 1||7
8747827|NCT01151813|9796470|FG000|COMPLETED|Period 1||8
8747828|NCT01151813|9796471|FG001|COMPLETED|Period 1||7
8747829|NCT01151813|9796470|FG000|NOT COMPLETED|Period 1||0
8747830|NCT01151813|9796471|FG001|NOT COMPLETED|Period 1||0
8747831|NCT01151813|9796470|FG000|STARTED|Period 2||8
8747832|NCT01151813|9796471|FG001|STARTED|Period 2||7
8747833|NCT01151813|9796470|FG000|COMPLETED|Period 2||8
8747834|NCT01151813|9796471|FG001|COMPLETED|Period 2||7
8747835|NCT01151813|9796470|FG000|NOT COMPLETED|Period 2||0
8747836|NCT01151813|9796471|FG001|NOT COMPLETED|Period 2||0
8747837|NCT01151852|9796480|FG000|STARTED|Overall Study||41
8747838|NCT01151852|9796481|FG001|STARTED|Overall Study||40
8747839|NCT01151852|9796480|FG000|COMPLETED|Overall Study||41
8747840|NCT01151852|9796481|FG001|COMPLETED|Overall Study||40
8747841|NCT01151852|9796480|FG000|NOT COMPLETED|Overall Study||0
8747842|NCT01151852|9796481|FG001|NOT COMPLETED|Overall Study||0
8914161|NCT02165761|9973556|FG001|NOT COMPLETED|Overall Study||14
8747843|NCT01152021|9796489|FG000|STARTED|Overall Study||8
8747844|NCT01152021|9796490|FG001|STARTED|Overall Study||7
8747845|NCT01152021|9796489|FG000|COMPLETED|Overall Study||2
8747846|NCT01152021|9796490|FG001|COMPLETED|Overall Study||1
8747847|NCT01152021|9796489|FG000|NOT COMPLETED|Overall Study||6
8747848|NCT01152021|9796490|FG001|NOT COMPLETED|Overall Study||6
8747849|NCT01152112|9796500|FG000|STARTED|Overall Study||42
8914162|NCT02165826|9973565|FG000|STARTED|Main Treatment Period||441
8747850|NCT01152112|9796501|FG001|STARTED|Overall Study||32
8747851|NCT01152112|9796500|FG000|COMPLETED|Overall Study||42
8747852|NCT01152112|9796501|FG001|COMPLETED|Overall Study||32
8747853|NCT01152112|9796500|FG000|NOT COMPLETED|Overall Study||0
8747854|NCT01152112|9796501|FG001|NOT COMPLETED|Overall Study||0
8807663|NCT01485614|9859975|FG003|Treated|Weeks 0-20||5
8807664|NCT01485614|9859972|FG000|COMPLETED|Weeks 0-20||85
8807665|NCT01485614|9859973|FG001|COMPLETED|Weeks 0-20||86
8807666|NCT01485614|9859974|FG002|COMPLETED|Weeks 0-20||8
8807667|NCT01485614|9859975|FG003|COMPLETED|Weeks 0-20||5
8807668|NCT01485614|9859972|FG000|NOT COMPLETED|Weeks 0-20||10
8807669|NCT01485614|9859973|FG001|NOT COMPLETED|Weeks 0-20||4
8807670|NCT01485614|9859974|FG002|NOT COMPLETED|Weeks 0-20||1
8807671|NCT01485614|9859975|FG003|NOT COMPLETED|Weeks 0-20||0
8807672|NCT01485614|9859972|FG000|STARTED|Weeks 20-54||85
8807673|NCT01485614|9859973|FG001|STARTED|Weeks 20-54||86
8807674|NCT01485614|9859974|FG002|STARTED|Weeks 20-54||8
8807675|NCT01485614|9859975|FG003|STARTED|Weeks 20-54||5
8807676|NCT01485614|9859972|FG000|COMPLETED|Weeks 20-54||74
8807677|NCT01485614|9859973|FG001|COMPLETED|Weeks 20-54||78
8807678|NCT01485614|9859974|FG002|COMPLETED|Weeks 20-54||6
8807679|NCT01485614|9859975|FG003|COMPLETED|Weeks 20-54||5
8807680|NCT01485614|9859972|FG000|NOT COMPLETED|Weeks 20-54||11
8807681|NCT01485614|9859973|FG001|NOT COMPLETED|Weeks 20-54||8
8807682|NCT01485614|9859974|FG002|NOT COMPLETED|Weeks 20-54||2
8807683|NCT01485614|9859975|FG003|NOT COMPLETED|Weeks 20-54||0
8807684|NCT01485627|9859993|FG000|STARTED|Overall Study|139 patients and 105 caregivers|244
8807685|NCT01485627|9859994|FG001|STARTED|Overall Study|142 patients and 99 caregivers|241
8807686|NCT01485627|9859993|FG000|Allocated Caregivers: Total|Overall Study||105
8807687|NCT01485627|9859994|FG001|Allocated Caregivers: Total|Overall Study||99
8807688|NCT01485627|9859993|FG000|Bereaved Caregivers: Total|Overall Study||63
8807689|NCT01485627|9859994|FG001|Bereaved Caregivers: Total|Overall Study||64
8807690|NCT01485627|9859993|FG000|Bereaved Caregivers: 1 Month|Overall Study||51
8807691|NCT01485627|9859994|FG001|Bereaved Caregivers: 1 Month|Overall Study||51
8807692|NCT01485627|9859993|FG000|Bereaved Caregivers: 2 Month Completed|Overall Study||49
8807693|NCT01485627|9859994|FG001|Bereaved Caregivers: 2 Month Completed|Overall Study||52
8807694|NCT01485627|9859993|FG000|Bereaved Caregivers: 7 Month Completed|Overall Study||48
8807695|NCT01485627|9859994|FG001|Bereaved Caregivers: 7 Month Completed|Overall Study||49
8807696|NCT01485627|9859993|FG000|COMPLETED|Overall Study|130 patients and 48 caregivers|178
8807697|NCT01485627|9859994|FG001|COMPLETED|Overall Study|135 patients and 49 caregivers|184
8807698|NCT01485627|9859993|FG000|NOT COMPLETED|Overall Study||66
8807699|NCT01485627|9859994|FG001|NOT COMPLETED|Overall Study||57
8807700|NCT01485640|9860004|FG000|STARTED|Overall Study||162
8807701|NCT01485640|9860004|FG000|COMPLETED|Overall Study||40
8807702|NCT01485640|9860004|FG000|NOT COMPLETED|Overall Study||122
8807703|NCT01485770|9860010|FG000|STARTED|First Intervention (2 Weeks)||17
8807704|NCT01485770|9860011|FG001|STARTED|First Intervention (2 Weeks)||16
8807705|NCT01485770|9860010|FG000|COMPLETED|First Intervention (2 Weeks)||17
8807706|NCT01485770|9860011|FG001|COMPLETED|First Intervention (2 Weeks)||16
8807707|NCT01485770|9860010|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0
8807708|NCT01485770|9860011|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0
8807709|NCT01485770|9860010|FG000|STARTED|Second Intervention (2 Weeks)||17
8807710|NCT01485770|9860011|FG001|STARTED|Second Intervention (2 Weeks)||16
8807711|NCT01485770|9860010|FG000|COMPLETED|Second Intervention (2 Weeks)||17
8807712|NCT01485770|9860011|FG001|COMPLETED|Second Intervention (2 Weeks)||16
8807713|NCT01485770|9860010|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0
8807714|NCT01485770|9860011|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0
8807715|NCT01485796|9860019|FG000|STARTED|Period 1: Epoch 1 (Ramp-up)||37
8807716|NCT01485796|9860019|FG000|Treated in Epoch 1|Period 1: Epoch 1 (Ramp-up)||37
8807717|NCT01485796|9860019|FG000|COMPLETED|Period 1: Epoch 1 (Ramp-up)||36
8807718|NCT01485796|9860019|FG000|NOT COMPLETED|Period 1: Epoch 1 (Ramp-up)||1
8807719|NCT01485796|9860019|FG000|STARTED|Period 2: Epoch 2||36
8807720|NCT01485796|9860019|FG000|Treated in Epoch 2|Period 2: Epoch 2||36
8807721|NCT01485796|9860019|FG000|COMPLETED|Period 2: Epoch 2||1
8807722|NCT01485796|9860019|FG000|NOT COMPLETED|Period 2: Epoch 2||35
8807723|NCT01485796|9860019|FG000|STARTED|Overall Trial (Incl. Safety Follow-up)||37
8807724|NCT01485796|9860019|FG000|Treated in Epoch 1 (Ramp-up)|Overall Trial (Incl. Safety Follow-up)||37
8807725|NCT01485796|9860019|FG000|Completed Epoch 1 (Ramp-up)|Overall Trial (Incl. Safety Follow-up)||36
8807726|NCT01485796|9860019|FG000|Started Epoch 2|Overall Trial (Incl. Safety Follow-up)||36
8807727|NCT01485796|9860019|FG000|Treated in Epoch 2|Overall Trial (Incl. Safety Follow-up)||36
8807728|NCT01485796|9860019|FG000|Completed Epoch 2|Overall Trial (Incl. Safety Follow-up)||1
8807729|NCT01485796|9860019|FG000|Switch to Safety Follow-up|Overall Trial (Incl. Safety Follow-up)||26
8807730|NCT01485796|9860019|FG000|Completed Safety Follow-up|Overall Trial (Incl. Safety Follow-up)||24
8807731|NCT01485796|9860019|FG000|COMPLETED|Overall Trial (Incl. Safety Follow-up)|1 subject who completed Epoch 2 + 24 subjects who completed the safety follow-up|25
8807732|NCT01485796|9860019|FG000|NOT COMPLETED|Overall Trial (Incl. Safety Follow-up)||12
8807733|NCT01485887|9860027|FG000|STARTED|Overall Study||50
8807734|NCT01485887|9860027|FG000|COMPLETED|Overall Study||38
8807735|NCT01485887|9860027|FG000|NOT COMPLETED|Overall Study||12
8807736|NCT01485991|9860033|FG000|STARTED|Overall Study||385
8807737|NCT01485991|9860034|FG001|STARTED|Overall Study||386
8807738|NCT01485991|9860033|FG000|Treated|Overall Study||379
8807739|NCT01485991|9860034|FG001|Treated|Overall Study||384
8747855|NCT01152190|9796509|FG000|STARTED|Overall Study||50
8747856|NCT01152190|9796510|FG001|STARTED|Overall Study||47
8747857|NCT01152190|9796509|FG000|Received at Least 1 Dose of Study Drug|Overall Study||50
8747858|NCT01152190|9796510|FG001|Received at Least 1 Dose of Study Drug|Overall Study||47
8747859|NCT01152190|9796509|FG000|COMPLETED|Overall Study||45
8747860|NCT01152190|9796510|FG001|COMPLETED|Overall Study||39
8747861|NCT01152190|9796509|FG000|NOT COMPLETED|Overall Study||5
8747862|NCT01152190|9796510|FG001|NOT COMPLETED|Overall Study||8
8747863|NCT01152294|9796518|FG000|STARTED|Overall Study||213
8747864|NCT01152294|9796519|FG001|STARTED|Overall Study||188
8747865|NCT01152294|9796518|FG000|COMPLETED|Overall Study||213
8747866|NCT01152294|9796519|FG001|COMPLETED|Overall Study||188
8747867|NCT01152294|9796518|FG000|NOT COMPLETED|Overall Study||0
8747868|NCT01152294|9796519|FG001|NOT COMPLETED|Overall Study||0
8747869|NCT01152307|9796527|FG000|STARTED|Overall Study||191
8747870|NCT01152307|9796528|FG001|STARTED|Overall Study||214
8747871|NCT01152307|9796527|FG000|COMPLETED|Overall Study||191
8747872|NCT01152307|9796528|FG001|COMPLETED|Overall Study||214
8747873|NCT01152307|9796527|FG000|NOT COMPLETED|Overall Study||0
8747874|NCT01152307|9796528|FG001|NOT COMPLETED|Overall Study||0
8747875|NCT01152359|9796536|FG000|STARTED|Overall Study||105
8747876|NCT01152359|9796537|FG001|STARTED|Overall Study||102
8747877|NCT01152359|9796536|FG000|COMPLETED|Overall Study||81
8747878|NCT01152359|9796537|FG001|COMPLETED|Overall Study||80
8747879|NCT01152359|9796536|FG000|NOT COMPLETED|Overall Study||24
8747880|NCT01152359|9796537|FG001|NOT COMPLETED|Overall Study||22
8747881|NCT01152385|9796547|FG000|STARTED|Overall Study||55
8747882|NCT01152385|9796548|FG001|STARTED|Overall Study||58
8747883|NCT01152385|9796549|FG002|STARTED|Overall Study||56
8747884|NCT01152385|9796550|FG003|STARTED|Overall Study||55
8747885|NCT01152385|9796547|FG000|COMPLETED|Overall Study||46
8747886|NCT01152385|9796548|FG001|COMPLETED|Overall Study||52
8747887|NCT01152385|9796549|FG002|COMPLETED|Overall Study||51
8747888|NCT01152385|9796550|FG003|COMPLETED|Overall Study||50
8747889|NCT01152385|9796547|FG000|NOT COMPLETED|Overall Study||9
8747890|NCT01152385|9796548|FG001|NOT COMPLETED|Overall Study||6
8747891|NCT01152385|9796549|FG002|NOT COMPLETED|Overall Study||5
8747892|NCT01152385|9796550|FG003|NOT COMPLETED|Overall Study||5
8747893|NCT01152437|9796567|FG000|STARTED|Overall Study|randomised|36
8747894|NCT01152437|9796568|FG001|STARTED|Overall Study|randomised|15
8747895|NCT01152437|9796569|FG002|STARTED|Overall Study|entered|43
8747896|NCT01152437|9796567|FG000|COMPLETED|Overall Study||0
8747897|NCT01152437|9796568|FG001|COMPLETED|Overall Study||0
8747898|NCT01152437|9796569|FG002|COMPLETED|Overall Study||0
8747899|NCT01152437|9796567|FG000|NOT COMPLETED|Overall Study||36
8747900|NCT01152437|9796568|FG001|NOT COMPLETED|Overall Study||15
8747901|NCT01152437|9796569|FG002|NOT COMPLETED|Overall Study||43
8747902|NCT01152450|9796579|FG000|STARTED|Period 1 (4 Weeks)||15
8747903|NCT01152450|9796580|FG001|STARTED|Period 1 (4 Weeks)||16
8747904|NCT01152450|9796581|FG002|STARTED|Period 1 (4 Weeks)||17
8747905|NCT01152450|9796582|FG003|STARTED|Period 1 (4 Weeks)||15
8747906|NCT01152450|9796583|FG004|STARTED|Period 1 (4 Weeks)||18
8747907|NCT01152450|9796584|FG005|STARTED|Period 1 (4 Weeks)||13
8747908|NCT01152450|9796579|FG000|COMPLETED|Period 1 (4 Weeks)||15
8747909|NCT01152450|9796580|FG001|COMPLETED|Period 1 (4 Weeks)||15
8747910|NCT01152450|9796581|FG002|COMPLETED|Period 1 (4 Weeks)||16
8747911|NCT01152450|9796582|FG003|COMPLETED|Period 1 (4 Weeks)||15
8747912|NCT01152450|9796583|FG004|COMPLETED|Period 1 (4 Weeks)||16
8747913|NCT01152450|9796584|FG005|COMPLETED|Period 1 (4 Weeks)||12
8747914|NCT01152450|9796579|FG000|NOT COMPLETED|Period 1 (4 Weeks)||0
8747915|NCT01152450|9796580|FG001|NOT COMPLETED|Period 1 (4 Weeks)||1
8747916|NCT01152450|9796581|FG002|NOT COMPLETED|Period 1 (4 Weeks)||1
8747917|NCT01152450|9796582|FG003|NOT COMPLETED|Period 1 (4 Weeks)||0
8747918|NCT01152450|9796583|FG004|NOT COMPLETED|Period 1 (4 Weeks)||2
8747919|NCT01152450|9796584|FG005|NOT COMPLETED|Period 1 (4 Weeks)||1
8747920|NCT01152450|9796579|FG000|STARTED|Period 2 (4 Weeks)||15
8747921|NCT01152450|9796580|FG001|STARTED|Period 2 (4 Weeks)||15
8747922|NCT01152450|9796581|FG002|STARTED|Period 2 (4 Weeks)||16
8747923|NCT01152450|9796582|FG003|STARTED|Period 2 (4 Weeks)||15
8747924|NCT01152450|9796583|FG004|STARTED|Period 2 (4 Weeks)||16
8747925|NCT01152450|9796584|FG005|STARTED|Period 2 (4 Weeks)||12
8747926|NCT01152450|9796579|FG000|COMPLETED|Period 2 (4 Weeks)||15
8747927|NCT01152450|9796580|FG001|COMPLETED|Period 2 (4 Weeks)||15
8747928|NCT01152450|9796581|FG002|COMPLETED|Period 2 (4 Weeks)||16
8747929|NCT01152450|9796582|FG003|COMPLETED|Period 2 (4 Weeks)||15
8747930|NCT01152450|9796583|FG004|COMPLETED|Period 2 (4 Weeks)||16
8747931|NCT01152450|9796584|FG005|COMPLETED|Period 2 (4 Weeks)||12
8747932|NCT01152450|9796579|FG000|NOT COMPLETED|Period 2 (4 Weeks)||0
8747933|NCT01152450|9796580|FG001|NOT COMPLETED|Period 2 (4 Weeks)||0
8747934|NCT01152450|9796581|FG002|NOT COMPLETED|Period 2 (4 Weeks)||0
8747935|NCT01152450|9796582|FG003|NOT COMPLETED|Period 2 (4 Weeks)||0
8747936|NCT01152450|9796583|FG004|NOT COMPLETED|Period 2 (4 Weeks)||0
8747937|NCT01152450|9796584|FG005|NOT COMPLETED|Period 2 (4 Weeks)||0
8747938|NCT01152450|9796579|FG000|STARTED|Period 3 (4 Weeks)||15
8747939|NCT01152450|9796580|FG001|STARTED|Period 3 (4 Weeks)||15
8747940|NCT01152450|9796581|FG002|STARTED|Period 3 (4 Weeks)||16
8747941|NCT01152450|9796582|FG003|STARTED|Period 3 (4 Weeks)||15
8747942|NCT01152450|9796583|FG004|STARTED|Period 3 (4 Weeks)||16
8747943|NCT01152450|9796584|FG005|STARTED|Period 3 (4 Weeks)||12
8747944|NCT01152450|9796579|FG000|COMPLETED|Period 3 (4 Weeks)||15
8747945|NCT01152450|9796580|FG001|COMPLETED|Period 3 (4 Weeks)||15
8747946|NCT01152450|9796581|FG002|COMPLETED|Period 3 (4 Weeks)||16
8747947|NCT01152450|9796582|FG003|COMPLETED|Period 3 (4 Weeks)||15
8747948|NCT01152450|9796583|FG004|COMPLETED|Period 3 (4 Weeks)||16
8747949|NCT01152450|9796584|FG005|COMPLETED|Period 3 (4 Weeks)||12
8747950|NCT01152450|9796579|FG000|NOT COMPLETED|Period 3 (4 Weeks)||0
8747951|NCT01152450|9796580|FG001|NOT COMPLETED|Period 3 (4 Weeks)||0
8747952|NCT01152450|9796581|FG002|NOT COMPLETED|Period 3 (4 Weeks)||0
8747953|NCT01152450|9796582|FG003|NOT COMPLETED|Period 3 (4 Weeks)||0
8747954|NCT01152450|9796583|FG004|NOT COMPLETED|Period 3 (4 Weeks)||0
8747955|NCT01152450|9796584|FG005|NOT COMPLETED|Period 3 (4 Weeks)||0
8747956|NCT01152515|9796594|FG000|STARTED|Overall Study||25
8747957|NCT01152515|9796595|FG001|STARTED|Overall Study||25
8747958|NCT01152515|9796594|FG000|COMPLETED|Overall Study||25
8747959|NCT01152515|9796595|FG001|COMPLETED|Overall Study||25
8747960|NCT01152515|9796594|FG000|NOT COMPLETED|Overall Study||0
8747961|NCT01152515|9796595|FG001|NOT COMPLETED|Overall Study||0
8747962|NCT01152554|9796603|FG000|STARTED|Overall Study||610
8747963|NCT01152554|9796604|FG001|STARTED|Overall Study||203
8747964|NCT01152554|9796603|FG000|Received Treatment|Overall Study||607
8747965|NCT01152554|9796604|FG001|Received Treatment|Overall Study||201
8747966|NCT01152554|9796603|FG000|COMPLETED|Overall Study||276
8747967|NCT01152554|9796604|FG001|COMPLETED|Overall Study||92
8747968|NCT01152554|9796603|FG000|NOT COMPLETED|Overall Study||334
8747969|NCT01152554|9796604|FG001|NOT COMPLETED|Overall Study||111
8747970|NCT01152580|9796612|FG000|STARTED|Overall Study||5
8747971|NCT01152580|9796613|FG001|STARTED|Overall Study||14
8747972|NCT01152580|9796612|FG000|COMPLETED|Overall Study||5
8747973|NCT01152580|9796613|FG001|COMPLETED|Overall Study||13
8747974|NCT01152580|9796612|FG000|NOT COMPLETED|Overall Study||0
8747975|NCT01152580|9796613|FG001|NOT COMPLETED|Overall Study||1
8747976|NCT01152697|9796619|FG000|STARTED|Overall Study||30
8747977|NCT01152697|9796619|FG000|COMPLETED|Overall Study||11
8747978|NCT01152697|9796619|FG000|NOT COMPLETED|Overall Study||19
8747979|NCT01152788|9796625|FG000|STARTED|Overall Study||32
8747980|NCT01152788|9796626|FG001|STARTED|Overall Study||32
8747981|NCT01152788|9796625|FG000|COMPLETED|Overall Study||32
8747982|NCT01152788|9796626|FG001|COMPLETED|Overall Study||28
8747983|NCT01152788|9796625|FG000|NOT COMPLETED|Overall Study||0
8747984|NCT01152788|9796626|FG001|NOT COMPLETED|Overall Study||4
8747985|NCT01152814|9796632|FG000|STARTED|Overall Study||64
8747986|NCT01152814|9796632|FG000|COMPLETED|Overall Study||62
8747987|NCT01152814|9796632|FG000|NOT COMPLETED|Overall Study||2
8747988|NCT01152996|9796636|FG000|STARTED|Overall Study||1075
8747989|NCT01152996|9796636|FG000|Treated|Overall Study||1073
8747990|NCT01152996|9796636|FG000|COMPLETED|Overall Study||538
8747991|NCT01152996|9796636|FG000|NOT COMPLETED|Overall Study||537
8914163|NCT02165826|9973566|FG001|STARTED|Main Treatment Period||439
8914164|NCT02165826|9973567|FG002|STARTED|Main Treatment Period||443
8914165|NCT02165826|9973565|FG000|Safety Analysis Set: Received Study Drug|Main Treatment Period||441
8914166|NCT02165826|9973566|FG001|Safety Analysis Set: Received Study Drug|Main Treatment Period||437
8914167|NCT02165826|9973567|FG002|Safety Analysis Set: Received Study Drug|Main Treatment Period||443
8914168|NCT02165826|9973565|FG000|COMPLETED|Main Treatment Period||360
8914169|NCT02165826|9973566|FG001|COMPLETED|Main Treatment Period||349
8914170|NCT02165826|9973567|FG002|COMPLETED|Main Treatment Period||334
8914171|NCT02165826|9973565|FG000|NOT COMPLETED|Main Treatment Period||81
8914172|NCT02165826|9973566|FG001|NOT COMPLETED|Main Treatment Period||90
8914173|NCT02165826|9973567|FG002|NOT COMPLETED|Main Treatment Period||109
8914174|NCT02165826|9973565|FG000|STARTED|Down-Titration Period||27
8914175|NCT02165826|9973566|FG001|STARTED|Down-Titration Period||39
8914176|NCT02165826|9973567|FG002|STARTED|Down-Titration Period||38
8914177|NCT02165826|9973565|FG000|Safety Analysis Set: Received Study Drug|Down-Titration Period||27
8914178|NCT02165826|9973566|FG001|Safety Analysis Set: Received Study Drug|Down-Titration Period||39
8914179|NCT02165826|9973567|FG002|Safety Analysis Set: Received Study Drug|Down-Titration Period||38
8914180|NCT02165826|9973565|FG000|COMPLETED|Down-Titration Period||20
8914181|NCT02165826|9973566|FG001|COMPLETED|Down-Titration Period||28
8914182|NCT02165826|9973567|FG002|COMPLETED|Down-Titration Period||31
8914183|NCT02165826|9973565|FG000|NOT COMPLETED|Down-Titration Period||7
8914184|NCT02165826|9973566|FG001|NOT COMPLETED|Down-Titration Period||11
8914185|NCT02165826|9973567|FG002|NOT COMPLETED|Down-Titration Period||7
8914186|NCT02165839|9973594|FG000|STARTED|Overall Study||66
8914187|NCT02165839|9973595|FG001|STARTED|Overall Study||73
8914188|NCT02165839|9973594|FG000|COMPLETED|Overall Study||66
8914189|NCT02165839|9973595|FG001|COMPLETED|Overall Study||73
8914190|NCT02165839|9973594|FG000|NOT COMPLETED|Overall Study||0
8914191|NCT02165839|9973595|FG001|NOT COMPLETED|Overall Study||0
8914192|NCT02165904|9973602|FG000|STARTED|Overall Study||10
8914193|NCT02165904|9973602|FG000|COMPLETED|Overall Study||10
8914194|NCT02165904|9973602|FG000|NOT COMPLETED|Overall Study||0
8747992|NCT01153009|9796644|FG000|STARTED|Overall Study||161
8747993|NCT01153009|9796645|FG001|STARTED|Overall Study||147
8747994|NCT01153009|9796646|FG002|STARTED|Overall Study||154
8747995|NCT01153009|9796647|FG003|STARTED|Overall Study||152
8747996|NCT01153009|9796644|FG000|Treated|Overall Study||159
8747997|NCT01153009|9796645|FG001|Treated|Overall Study||147
8747998|NCT01153009|9796646|FG002|Treated|Overall Study||154
8747999|NCT01153009|9796647|FG003|Treated|Overall Study||150
8914195|NCT02166047|9973618|FG000|STARTED|Overall Study||16
8914196|NCT02166047|9973619|FG001|STARTED|Overall Study||15
8748000|NCT01153009|9796644|FG000|COMPLETED|Overall Study||129
8748001|NCT01153009|9796645|FG001|COMPLETED|Overall Study||113
8748002|NCT01153009|9796646|FG002|COMPLETED|Overall Study||113
8748003|NCT01153009|9796647|FG003|COMPLETED|Overall Study||115
8748004|NCT01153009|9796644|FG000|NOT COMPLETED|Overall Study||32
8748005|NCT01153009|9796645|FG001|NOT COMPLETED|Overall Study||34
8748006|NCT01153009|9796646|FG002|NOT COMPLETED|Overall Study||41
8748007|NCT01153009|9796647|FG003|NOT COMPLETED|Overall Study||37
8748008|NCT01153269|9796657|FG000|STARTED|Overall Study||33
8748009|NCT01153269|9796657|FG000|Participants Analyzed|Overall Study||33
8748010|NCT01153269|9796657|FG000|COMPLETED|Overall Study||31
8748011|NCT01153269|9796657|FG000|NOT COMPLETED|Overall Study||2
8748012|NCT01153321|9796666|FG000|STARTED|Overall Study||22
8748013|NCT01153321|9796667|FG001|STARTED|Overall Study||22
8748014|NCT01153321|9796666|FG000|COMPLETED|Overall Study||21
8748015|NCT01153321|9796667|FG001|COMPLETED|Overall Study||19
8748016|NCT01153321|9796666|FG000|NOT COMPLETED|Overall Study||1
8748017|NCT01153321|9796667|FG001|NOT COMPLETED|Overall Study||3
8748018|NCT01153347|9796677|FG000|STARTED|Overall Study||160
8748019|NCT01153347|9796678|FG001|STARTED|Overall Study||160
8748020|NCT01153347|9796679|FG002|STARTED|Overall Study||160
8748021|NCT01153347|9796680|FG003|STARTED|Overall Study||161
8748022|NCT01153347|9796677|FG000|Received Treatment|Overall Study||160
8748023|NCT01153347|9796678|FG001|Received Treatment|Overall Study||158
8748024|NCT01153347|9796679|FG002|Received Treatment|Overall Study||158
8748025|NCT01153347|9796680|FG003|Received Treatment|Overall Study||160
8748026|NCT01153347|9796677|FG000|COMPLETED|Overall Study||127
8748027|NCT01153347|9796678|FG001|COMPLETED|Overall Study||116
8748028|NCT01153347|9796679|FG002|COMPLETED|Overall Study||110
8748029|NCT01153347|9796680|FG003|COMPLETED|Overall Study||129
8748030|NCT01153347|9796677|FG000|NOT COMPLETED|Overall Study||33
8748031|NCT01153347|9796678|FG001|NOT COMPLETED|Overall Study||44
8748032|NCT01153347|9796679|FG002|NOT COMPLETED|Overall Study||50
8748033|NCT01153347|9796680|FG003|NOT COMPLETED|Overall Study||32
8748034|NCT01153425|9796692|FG000|STARTED|Overall Study||16
8748035|NCT01153425|9796693|FG001|STARTED|Overall Study||17
8748036|NCT01153425|9796692|FG000|COMPLETED|Overall Study||13
8748037|NCT01153425|9796693|FG001|COMPLETED|Overall Study||14
8748038|NCT01153425|9796692|FG000|NOT COMPLETED|Overall Study||3
8748039|NCT01153425|9796693|FG001|NOT COMPLETED|Overall Study||3
8748040|NCT01153503|9796703|FG000|STARTED|Overall Study||25
8748041|NCT01153503|9796704|FG001|STARTED|Overall Study||25
8748042|NCT01153503|9796705|FG002|STARTED|Overall Study||25
8748043|NCT01153503|9796703|FG000|COMPLETED|Overall Study||25
8748044|NCT01153503|9796704|FG001|COMPLETED|Overall Study||24
8748045|NCT01153503|9796705|FG002|COMPLETED|Overall Study||25
8748046|NCT01153503|9796703|FG000|NOT COMPLETED|Overall Study||0
8748047|NCT01153503|9796704|FG001|NOT COMPLETED|Overall Study||1
8748048|NCT01153503|9796705|FG002|NOT COMPLETED|Overall Study||0
8748049|NCT01153516|9796715|FG000|STARTED|Overall Study||12
8748050|NCT01153516|9796716|FG001|STARTED|Overall Study||10
8748051|NCT01153516|9796715|FG000|COMPLETED|Overall Study||10
8748052|NCT01153516|9796716|FG001|COMPLETED|Overall Study||10
8748053|NCT01153516|9796715|FG000|NOT COMPLETED|Overall Study||2
8748054|NCT01153516|9796716|FG001|NOT COMPLETED|Overall Study||0
8748055|NCT01153581|9796722|FG000|STARTED|Overall Study||109
8748056|NCT01153581|9796722|FG000|COMPLETED|Overall Study||109
8748057|NCT01153581|9796722|FG000|NOT COMPLETED|Overall Study||0
8748058|NCT01153620|9796734|FG000|STARTED|Overall Study||30
8748059|NCT01153620|9796735|FG001|STARTED|Overall Study|30 patients (31 wounds)|30
8748060|NCT01153620|9796734|FG000|COMPLETED|Overall Study||30
8748061|NCT01153620|9796735|FG001|COMPLETED|Overall Study|30 patients (31 wounds)|30
8748062|NCT01153620|9796734|FG000|NOT COMPLETED|Overall Study||0
8748063|NCT01153620|9796735|FG001|NOT COMPLETED|Overall Study||0
8748064|NCT01153633|9796743|FG000|STARTED|Overall Study||17
8748065|NCT01153633|9796744|FG001|STARTED|Overall Study||17
8748066|NCT01153633|9796743|FG000|COMPLETED|Overall Study||13
8748067|NCT01153633|9796744|FG001|COMPLETED|Overall Study||13
8748068|NCT01153633|9796743|FG000|NOT COMPLETED|Overall Study||4
8748069|NCT01153633|9796744|FG001|NOT COMPLETED|Overall Study||4
8748070|NCT01153672|9796752|FG000|STARTED|Overall Study||8
8748071|NCT01153672|9796752|FG000|COMPLETED|Overall Study||6
8748072|NCT01153672|9796752|FG000|NOT COMPLETED|Overall Study||2
8748073|NCT01153685|9796758|FG000|STARTED|Overall Study||50
8748074|NCT01153685|9796759|FG001|STARTED|Overall Study||70
8748075|NCT01153685|9796758|FG000|COMPLETED|Overall Study||50
8748076|NCT01153685|9796759|FG001|COMPLETED|Overall Study||70
8748077|NCT01153685|9796758|FG000|NOT COMPLETED|Overall Study||0
8748078|NCT01153685|9796759|FG001|NOT COMPLETED|Overall Study||0
8748079|NCT01153698|9796765|FG000|STARTED|Overall Study|Entered and treated.|168
8748080|NCT01153698|9796765|FG000|COMPLETED|Overall Study|Completed Pradaxa treatment.|139
8748081|NCT01153698|9796765|FG000|NOT COMPLETED|Overall Study||29
8748082|NCT01153711|9796770|FG000|STARTED|Overall Study||32
8748083|NCT01153711|9796770|FG000|COMPLETED|Overall Study||32
8748084|NCT01153711|9796770|FG000|NOT COMPLETED|Overall Study||0
8748085|NCT01153724|9796776|FG000|STARTED|Treatment Period 1||35
8748086|NCT01153724|9796776|FG000|COMPLETED|Treatment Period 1||34
8748087|NCT01153724|9796776|FG000|NOT COMPLETED|Treatment Period 1||1
8748088|NCT01153724|9796776|FG000|STARTED|Treatment Period 2||34
8748089|NCT01153724|9796776|FG000|COMPLETED|Treatment Period 2||32
8748090|NCT01153724|9796776|FG000|NOT COMPLETED|Treatment Period 2||2
8748091|NCT01153763|9796782|FG000|STARTED|Overall Study||92
8748092|NCT01153763|9796782|FG000|COMPLETED|Overall Study||71
8748093|NCT01153763|9796782|FG000|NOT COMPLETED|Overall Study||21
8748094|NCT01153815|9796788|FG000|STARTED|Overall Study||83
8748095|NCT01153815|9796789|FG001|STARTED|Overall Study||87
8748096|NCT01153815|9796788|FG000|COMPLETED|Overall Study||74
8748097|NCT01153815|9796789|FG001|COMPLETED|Overall Study||82
8748098|NCT01153815|9796788|FG000|NOT COMPLETED|Overall Study||9
8748099|NCT01153815|9796789|FG001|NOT COMPLETED|Overall Study||5
8748100|NCT01153841|9796797|FG000|STARTED|Overall Study||199
8748101|NCT01153841|9796798|FG001|STARTED|Overall Study||99
8748102|NCT01153841|9796797|FG000|COMPLETED|Overall Study||193
8748103|NCT01153841|9796798|FG001|COMPLETED|Overall Study||99
8748104|NCT01153841|9796797|FG000|NOT COMPLETED|Overall Study||6
8748105|NCT01153841|9796798|FG001|NOT COMPLETED|Overall Study||0
8748106|NCT01153893|9796806|FG000|STARTED|Overall Study|Issues with the informed consent obtained from one child led to related data not used in this report|68
8748107|NCT01153893|9796807|FG001|STARTED|Overall Study||36
8748108|NCT01153893|9796806|FG000|COMPLETED|Overall Study|Number of subjects who completed the follow-up visit at Month 1.|67
8748109|NCT01153893|9796807|FG001|COMPLETED|Overall Study|Number of subjects who completed the follow-up visit at Month 3.|36
8748110|NCT01153893|9796806|FG000|NOT COMPLETED|Overall Study||1
8748111|NCT01153893|9796807|FG001|NOT COMPLETED|Overall Study||0
8748112|NCT01153958|9796815|FG000|STARTED|Overall Study||66
8748113|NCT01153958|9796816|FG001|STARTED|Overall Study||67
8748114|NCT01153958|9796815|FG000|COMPLETED|Overall Study||30
8748115|NCT01153958|9796816|FG001|COMPLETED|Overall Study||35
8748116|NCT01153958|9796815|FG000|NOT COMPLETED|Overall Study||36
8748117|NCT01153958|9796816|FG001|NOT COMPLETED|Overall Study||32
8748118|NCT01153971|9796822|FG000|STARTED|Induction Phase (Months 1 to 7 of Study)||47
8748119|NCT01153971|9796822|FG000|COMPLETED|Induction Phase (Months 1 to 7 of Study)||44
8748120|NCT01153971|9796822|FG000|NOT COMPLETED|Induction Phase (Months 1 to 7 of Study)||3
8748121|NCT01153971|9796822|FG000|STARTED|Maintenance Phase (Months 8-16 of Study)||44
8748122|NCT01153971|9796822|FG000|COMPLETED|Maintenance Phase (Months 8-16 of Study)||41
8748123|NCT01153971|9796822|FG000|NOT COMPLETED|Maintenance Phase (Months 8-16 of Study)||3
8748124|NCT01153971|9796822|FG000|STARTED|Follow-up (Months 17-40 of Study)||41
8748125|NCT01153971|9796822|FG000|COMPLETED|Follow-up (Months 17-40 of Study)||37
8748126|NCT01153971|9796822|FG000|NOT COMPLETED|Follow-up (Months 17-40 of Study)||4
8748127|NCT01153984|9796826|FG000|STARTED|Overall Study||23
8748128|NCT01153984|9796826|FG000|COMPLETED|Overall Study||21
8748129|NCT01153984|9796826|FG000|NOT COMPLETED|Overall Study||2
8748130|NCT01154010|9796832|FG000|STARTED|Overall Study||9
8748131|NCT01154010|9796833|FG001|STARTED|Overall Study||9
8748132|NCT01154010|9796832|FG000|COMPLETED|Overall Study||9
8748133|NCT01154010|9796833|FG001|COMPLETED|Overall Study||8
8748134|NCT01154010|9796832|FG000|NOT COMPLETED|Overall Study||0
8748135|NCT01154010|9796833|FG001|NOT COMPLETED|Overall Study||1
8748136|NCT01154088|9796842|FG000|STARTED|Overall Study||390
8748137|NCT01154088|9796843|FG001|STARTED|Overall Study||390
8748138|NCT01154088|9796844|FG002|STARTED|Overall Study||390
8748139|NCT01154088|9796842|FG000|COMPLETED|Overall Study||386
8748140|NCT01154088|9796843|FG001|COMPLETED|Overall Study||384
8748141|NCT01154088|9796844|FG002|COMPLETED|Overall Study||383
8748142|NCT01154088|9796842|FG000|NOT COMPLETED|Overall Study||4
8748143|NCT01154088|9796843|FG001|NOT COMPLETED|Overall Study||6
8748144|NCT01154088|9796844|FG002|NOT COMPLETED|Overall Study||7
8748145|NCT01154101|9796858|FG000|STARTED|Overall Study||7
8748146|NCT01154101|9796859|FG001|STARTED|Overall Study||9
8748147|NCT01154101|9796860|FG002|STARTED|Overall Study||12
8748148|NCT01154101|9796861|FG003|STARTED|Overall Study||11
8748149|NCT01154101|9796862|FG004|STARTED|Overall Study||1
8748150|NCT01154101|9796858|FG000|COMPLETED|Overall Study||7
8748151|NCT01154101|9796859|FG001|COMPLETED|Overall Study||5
8748152|NCT01154101|9796860|FG002|COMPLETED|Overall Study||9
8748153|NCT01154101|9796861|FG003|COMPLETED|Overall Study||9
8748154|NCT01154101|9796862|FG004|COMPLETED|Overall Study||0
8748155|NCT01154101|9796858|FG000|NOT COMPLETED|Overall Study||0
8748156|NCT01154101|9796859|FG001|NOT COMPLETED|Overall Study||4
8748157|NCT01154101|9796860|FG002|NOT COMPLETED|Overall Study||3
8748158|NCT01154101|9796861|FG003|NOT COMPLETED|Overall Study||2
8748159|NCT01154101|9796862|FG004|NOT COMPLETED|Overall Study||1
8748160|NCT01154127|9796881|FG000|STARTED|Period 1 (21 Days)||55
8748161|NCT01154127|9796882|FG001|STARTED|Period 1 (21 Days)||53
8748162|NCT01154127|9796881|FG000|COMPLETED|Period 1 (21 Days)||52
8748163|NCT01154127|9796882|FG001|COMPLETED|Period 1 (21 Days)||47
8748164|NCT01154127|9796881|FG000|NOT COMPLETED|Period 1 (21 Days)||3
8748165|NCT01154127|9796882|FG001|NOT COMPLETED|Period 1 (21 Days)||6
8748166|NCT01154127|9796881|FG000|STARTED|Washout (14 - 28 Days)||52
8748167|NCT01154127|9796882|FG001|STARTED|Washout (14 - 28 Days)||47
8748168|NCT01154127|9796881|FG000|COMPLETED|Washout (14 - 28 Days)||49
8748169|NCT01154127|9796882|FG001|COMPLETED|Washout (14 - 28 Days)||47
8748170|NCT01154127|9796881|FG000|NOT COMPLETED|Washout (14 - 28 Days)||3
8748171|NCT01154127|9796882|FG001|NOT COMPLETED|Washout (14 - 28 Days)||0
8748172|NCT01154127|9796881|FG000|STARTED|Period 2 (21 Days)||49
8748173|NCT01154127|9796882|FG001|STARTED|Period 2 (21 Days)||47
8748174|NCT01154127|9796881|FG000|COMPLETED|Period 2 (21 Days)||49
8748175|NCT01154127|9796882|FG001|COMPLETED|Period 2 (21 Days)||46
8748176|NCT01154127|9796881|FG000|NOT COMPLETED|Period 2 (21 Days)||0
8748177|NCT01154127|9796882|FG001|NOT COMPLETED|Period 2 (21 Days)||1
8748178|NCT01154140|9796890|FG000|STARTED|Overall Study||172
8748179|NCT01154140|9796891|FG001|STARTED|Overall Study||171
8748180|NCT01154140|9796890|FG000|Treated|Overall Study||171
8748181|NCT01154140|9796891|FG001|Treated|Overall Study||169
8748182|NCT01154140|9796890|FG000|COMPLETED|Overall Study||81
8748183|NCT01154140|9796891|FG001|COMPLETED|Overall Study||69
8748184|NCT01154140|9796890|FG000|NOT COMPLETED|Overall Study||91
8748185|NCT01154140|9796891|FG001|NOT COMPLETED|Overall Study||102
8748186|NCT01154153|9796899|FG000|STARTED|Overall Study||71
8748187|NCT01154153|9796900|FG001|STARTED|Overall Study||69
8748188|NCT01154153|9796899|FG000|COMPLETED|Overall Study||66
8748189|NCT01154153|9796900|FG001|COMPLETED|Overall Study||66
8748190|NCT01154153|9796899|FG000|NOT COMPLETED|Overall Study||5
8748191|NCT01154153|9796900|FG001|NOT COMPLETED|Overall Study||3
8748192|NCT01154166|9796908|FG000|STARTED|Overall Study||169
8748193|NCT01154166|9796909|FG001|STARTED|Overall Study||175
8748194|NCT01154166|9796908|FG000|COMPLETED|Overall Study||135
8748195|NCT01154166|9796909|FG001|COMPLETED|Overall Study||163
8748196|NCT01154166|9796908|FG000|NOT COMPLETED|Overall Study||34
8748197|NCT01154166|9796909|FG001|NOT COMPLETED|Overall Study||12
8748198|NCT01154192|9796918|FG000|STARTED|Overall Study||14
8748199|NCT01154192|9796919|FG001|STARTED|Overall Study||10
8748200|NCT01154192|9796920|FG002|STARTED|Overall Study||0
8748201|NCT01154192|9796918|FG000|COMPLETED|Overall Study||14
8748202|NCT01154192|9796919|FG001|COMPLETED|Overall Study||10
8748203|NCT01154192|9796920|FG002|COMPLETED|Overall Study||0
8748204|NCT01154192|9796918|FG000|NOT COMPLETED|Overall Study||0
8748205|NCT01154192|9796919|FG001|NOT COMPLETED|Overall Study||0
8748206|NCT01154192|9796920|FG002|NOT COMPLETED|Overall Study||0
8748207|NCT01154218|9796929|FG000|STARTED|First Intervention Period||9
8748208|NCT01154218|9796930|FG001|STARTED|First Intervention Period||9
8748209|NCT01154218|9796931|FG002|STARTED|First Intervention Period||9
8748210|NCT01154218|9796932|FG003|STARTED|First Intervention Period||9
8748211|NCT01154218|9796929|FG000|COMPLETED|First Intervention Period||9
8748212|NCT01154218|9796930|FG001|COMPLETED|First Intervention Period||9
8748213|NCT01154218|9796931|FG002|COMPLETED|First Intervention Period||9
8748214|NCT01154218|9796932|FG003|COMPLETED|First Intervention Period||9
8748215|NCT01154218|9796929|FG000|NOT COMPLETED|First Intervention Period||0
8748216|NCT01154218|9796930|FG001|NOT COMPLETED|First Intervention Period||0
8748217|NCT01154218|9796931|FG002|NOT COMPLETED|First Intervention Period||0
8748218|NCT01154218|9796932|FG003|NOT COMPLETED|First Intervention Period||0
8748219|NCT01154218|9796929|FG000|STARTED|Washout Period (at Least 14 Days)||9
8748220|NCT01154218|9796930|FG001|STARTED|Washout Period (at Least 14 Days)||9
8748221|NCT01154218|9796931|FG002|STARTED|Washout Period (at Least 14 Days)||9
8748222|NCT01154218|9796932|FG003|STARTED|Washout Period (at Least 14 Days)||9
8748223|NCT01154218|9796929|FG000|COMPLETED|Washout Period (at Least 14 Days)||9
8748224|NCT01154218|9796930|FG001|COMPLETED|Washout Period (at Least 14 Days)||9
8748225|NCT01154218|9796931|FG002|COMPLETED|Washout Period (at Least 14 Days)||9
8748226|NCT01154218|9796932|FG003|COMPLETED|Washout Period (at Least 14 Days)||9
8748227|NCT01154218|9796929|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8748228|NCT01154218|9796930|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8748229|NCT01154218|9796931|FG002|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8748230|NCT01154218|9796932|FG003|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8748231|NCT01154218|9796929|FG000|STARTED|Second Intervention Period||9
8748232|NCT01154218|9796930|FG001|STARTED|Second Intervention Period||9
8748233|NCT01154218|9796931|FG002|STARTED|Second Intervention Period||9
8748234|NCT01154218|9796932|FG003|STARTED|Second Intervention Period||9
8748235|NCT01154218|9796929|FG000|COMPLETED|Second Intervention Period||9
8748236|NCT01154218|9796930|FG001|COMPLETED|Second Intervention Period||9
8748237|NCT01154218|9796931|FG002|COMPLETED|Second Intervention Period||9
8748238|NCT01154218|9796932|FG003|COMPLETED|Second Intervention Period||9
8748239|NCT01154218|9796929|FG000|NOT COMPLETED|Second Intervention Period||0
8748240|NCT01154218|9796930|FG001|NOT COMPLETED|Second Intervention Period||0
8748241|NCT01154218|9796931|FG002|NOT COMPLETED|Second Intervention Period||0
8748242|NCT01154218|9796932|FG003|NOT COMPLETED|Second Intervention Period||0
8748243|NCT01154218|9796929|FG000|STARTED|Washout Period (at Least 14 Days)||9
8748244|NCT01154218|9796930|FG001|STARTED|Washout Period (at Least 14 Days)||9
8748245|NCT01154218|9796931|FG002|STARTED|Washout Period (at Least 14 Days)||9
8748246|NCT01154218|9796932|FG003|STARTED|Washout Period (at Least 14 Days)||9
8748247|NCT01154218|9796929|FG000|COMPLETED|Washout Period (at Least 14 Days)||9
8748248|NCT01154218|9796930|FG001|COMPLETED|Washout Period (at Least 14 Days)||9
8748249|NCT01154218|9796931|FG002|COMPLETED|Washout Period (at Least 14 Days)||9
8748250|NCT01154218|9796932|FG003|COMPLETED|Washout Period (at Least 14 Days)||9
8748251|NCT01154218|9796929|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8748252|NCT01154218|9796930|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8748253|NCT01154218|9796931|FG002|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8748254|NCT01154218|9796932|FG003|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8748255|NCT01154218|9796929|FG000|STARTED|Third Intervention Period||9
8748256|NCT01154218|9796930|FG001|STARTED|Third Intervention Period||9
8748257|NCT01154218|9796931|FG002|STARTED|Third Intervention Period||9
8748258|NCT01154218|9796932|FG003|STARTED|Third Intervention Period||9
8748259|NCT01154218|9796929|FG000|COMPLETED|Third Intervention Period||9
8748260|NCT01154218|9796930|FG001|COMPLETED|Third Intervention Period||8
8748261|NCT01154218|9796931|FG002|COMPLETED|Third Intervention Period||9
8748262|NCT01154218|9796932|FG003|COMPLETED|Third Intervention Period||9
8748263|NCT01154218|9796929|FG000|NOT COMPLETED|Third Intervention Period||0
8748264|NCT01154218|9796930|FG001|NOT COMPLETED|Third Intervention Period||1
8748265|NCT01154218|9796931|FG002|NOT COMPLETED|Third Intervention Period||0
8748266|NCT01154218|9796932|FG003|NOT COMPLETED|Third Intervention Period||0
8748267|NCT01154218|9796929|FG000|STARTED|Washout Period (at Least 14 Days)||9
8748268|NCT01154218|9796930|FG001|STARTED|Washout Period (at Least 14 Days)||8
8748269|NCT01154218|9796931|FG002|STARTED|Washout Period (at Least 14 Days)||9
8748270|NCT01154218|9796932|FG003|STARTED|Washout Period (at Least 14 Days)||9
8748271|NCT01154218|9796929|FG000|COMPLETED|Washout Period (at Least 14 Days)||9
8748272|NCT01154218|9796930|FG001|COMPLETED|Washout Period (at Least 14 Days)||8
8748273|NCT01154218|9796931|FG002|COMPLETED|Washout Period (at Least 14 Days)||9
8748274|NCT01154218|9796932|FG003|COMPLETED|Washout Period (at Least 14 Days)||8
8748275|NCT01154218|9796929|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8748276|NCT01154218|9796930|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8748277|NCT01154218|9796931|FG002|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8748278|NCT01154218|9796932|FG003|NOT COMPLETED|Washout Period (at Least 14 Days)||1
8748279|NCT01154218|9796929|FG000|STARTED|Fourth Intervention Period||9
8748280|NCT01154218|9796930|FG001|STARTED|Fourth Intervention Period||8
8748281|NCT01154218|9796931|FG002|STARTED|Fourth Intervention Period||9
8748282|NCT01154218|9796932|FG003|STARTED|Fourth Intervention Period||8
8748283|NCT01154218|9796929|FG000|COMPLETED|Fourth Intervention Period||8
8748284|NCT01154218|9796930|FG001|COMPLETED|Fourth Intervention Period||8
8748285|NCT01154218|9796931|FG002|COMPLETED|Fourth Intervention Period||9
8748286|NCT01154218|9796932|FG003|COMPLETED|Fourth Intervention Period||8
8748287|NCT01154218|9796929|FG000|NOT COMPLETED|Fourth Intervention Period||1
8748288|NCT01154218|9796930|FG001|NOT COMPLETED|Fourth Intervention Period||0
8748289|NCT01154218|9796931|FG002|NOT COMPLETED|Fourth Intervention Period||0
8748290|NCT01154218|9796932|FG003|NOT COMPLETED|Fourth Intervention Period||0
8748291|NCT01154231|9796942|FG000|STARTED|Overall Study||314
8748292|NCT01154231|9796942|FG000|COMPLETED|Overall Study||312
8748293|NCT01154231|9796942|FG000|NOT COMPLETED|Overall Study||2
8748294|NCT01154283|9796948|FG000|STARTED|0-6 Weeks||14
8748295|NCT01154283|9796949|FG001|STARTED|0-6 Weeks||14
8748296|NCT01154283|9796948|FG000|COMPLETED|0-6 Weeks||7
8748297|NCT01154283|9796949|FG001|COMPLETED|0-6 Weeks||11
8748298|NCT01154283|9796948|FG000|NOT COMPLETED|0-6 Weeks||7
8748299|NCT01154283|9796949|FG001|NOT COMPLETED|0-6 Weeks||3
8748300|NCT01154283|9796948|FG000|STARTED|7-12 Weeks||7
8748301|NCT01154283|9796949|FG001|STARTED|7-12 Weeks||11
8748302|NCT01154283|9796948|FG000|COMPLETED|7-12 Weeks||6
8748303|NCT01154283|9796949|FG001|COMPLETED|7-12 Weeks||10
8748304|NCT01154283|9796948|FG000|NOT COMPLETED|7-12 Weeks||1
8748305|NCT01154283|9796949|FG001|NOT COMPLETED|7-12 Weeks||1
8748306|NCT01154296|9796957|FG000|STARTED|Randomization and Intervention||2505
8748307|NCT01154296|9796958|FG001|STARTED|Randomization and Intervention||2507
8748308|NCT01154296|9796957|FG000|COMPLETED|Randomization and Intervention||2500
8748309|NCT01154296|9796958|FG001|COMPLETED|Randomization and Intervention||2505
8748310|NCT01154296|9796957|FG000|NOT COMPLETED|Randomization and Intervention||5
8748311|NCT01154296|9796958|FG001|NOT COMPLETED|Randomization and Intervention||2
8748312|NCT01154296|9796957|FG000|STARTED|6-month Follow-up||2505
8748313|NCT01154296|9796958|FG001|STARTED|6-month Follow-up||2507
8748314|NCT01154296|9796957|FG000|COMPLETED|6-month Follow-up||2177
8748315|NCT01154296|9796958|FG001|COMPLETED|6-month Follow-up||2179
8748316|NCT01154296|9796957|FG000|NOT COMPLETED|6-month Follow-up||328
8748317|NCT01154296|9796958|FG001|NOT COMPLETED|6-month Follow-up||328
8748318|NCT01154322|9796964|FG000|STARTED|Overall Study||16
8748319|NCT01154322|9796964|FG000|COMPLETED|Overall Study||14
8748320|NCT01154322|9796964|FG000|NOT COMPLETED|Overall Study||2
8748321|NCT01154452|9796973|FG000|STARTED|Phase Ib||6
8748322|NCT01154452|9796974|FG001|STARTED|Phase Ib||4
8748323|NCT01154452|9796975|FG002|STARTED|Phase Ib||0
8748324|NCT01154452|9796976|FG003|STARTED|Phase Ib||0
8748325|NCT01154452|9796973|FG000|COMPLETED|Phase Ib||3
8748326|NCT01154452|9796974|FG001|COMPLETED|Phase Ib||3
8748327|NCT01154452|9796975|FG002|COMPLETED|Phase Ib||0
8748328|NCT01154452|9796976|FG003|COMPLETED|Phase Ib||0
8748329|NCT01154452|9796973|FG000|NOT COMPLETED|Phase Ib||3
8748330|NCT01154452|9796974|FG001|NOT COMPLETED|Phase Ib||1
8748331|NCT01154452|9796975|FG002|NOT COMPLETED|Phase Ib||0
8748332|NCT01154452|9796976|FG003|NOT COMPLETED|Phase Ib||0
8748333|NCT01154452|9796973|FG000|STARTED|Phase II||0
8748334|NCT01154452|9796974|FG001|STARTED|Phase II||0
8748335|NCT01154452|9796975|FG002|STARTED|Phase II||35
8748336|NCT01154452|9796976|FG003|STARTED|Phase II||33
8748337|NCT01154452|9796973|FG000|COMPLETED|Phase II||0
8748338|NCT01154452|9796974|FG001|COMPLETED|Phase II||0
8748339|NCT01154452|9796975|FG002|COMPLETED|Phase II||30
8748340|NCT01154452|9796976|FG003|COMPLETED|Phase II||27
8748341|NCT01154452|9796973|FG000|NOT COMPLETED|Phase II||0
8748342|NCT01154452|9796974|FG001|NOT COMPLETED|Phase II||0
8748343|NCT01154452|9796975|FG002|NOT COMPLETED|Phase II||5
8748344|NCT01154452|9796976|FG003|NOT COMPLETED|Phase II||6
8748345|NCT01154634|9796993|FG000|STARTED|Period 1 - First Intervention||4
8748346|NCT01154634|9796994|FG001|STARTED|Period 1 - First Intervention||7
8748347|NCT01154634|9796995|FG002|STARTED|Period 1 - First Intervention||4
8748348|NCT01154634|9796996|FG003|STARTED|Period 1 - First Intervention||5
8748349|NCT01154634|9796993|FG000|COMPLETED|Period 1 - First Intervention||4
8748350|NCT01154634|9796994|FG001|COMPLETED|Period 1 - First Intervention||7
8748351|NCT01154634|9796995|FG002|COMPLETED|Period 1 - First Intervention||4
8748352|NCT01154634|9796996|FG003|COMPLETED|Period 1 - First Intervention||5
8748353|NCT01154634|9796993|FG000|NOT COMPLETED|Period 1 - First Intervention||0
8748354|NCT01154634|9796994|FG001|NOT COMPLETED|Period 1 - First Intervention||0
8748355|NCT01154634|9796995|FG002|NOT COMPLETED|Period 1 - First Intervention||0
8748356|NCT01154634|9796996|FG003|NOT COMPLETED|Period 1 - First Intervention||0
8748357|NCT01154634|9796993|FG000|STARTED|Period 2 - Washout||4
8748358|NCT01154634|9796994|FG001|STARTED|Period 2 - Washout||7
8748359|NCT01154634|9796995|FG002|STARTED|Period 2 - Washout||4
8748360|NCT01154634|9796996|FG003|STARTED|Period 2 - Washout||5
8748361|NCT01154634|9796993|FG000|COMPLETED|Period 2 - Washout||4
8748362|NCT01154634|9796994|FG001|COMPLETED|Period 2 - Washout||7
8748363|NCT01154634|9796995|FG002|COMPLETED|Period 2 - Washout||4
8748364|NCT01154634|9796996|FG003|COMPLETED|Period 2 - Washout||5
8748365|NCT01154634|9796993|FG000|NOT COMPLETED|Period 2 - Washout||0
8748366|NCT01154634|9796994|FG001|NOT COMPLETED|Period 2 - Washout||0
8748367|NCT01154634|9796995|FG002|NOT COMPLETED|Period 2 - Washout||0
8748368|NCT01154634|9796996|FG003|NOT COMPLETED|Period 2 - Washout||0
8748369|NCT01154634|9796993|FG000|STARTED|Period 3- Second Intervention||4
8748370|NCT01154634|9796994|FG001|STARTED|Period 3- Second Intervention||7
8748371|NCT01154634|9796995|FG002|STARTED|Period 3- Second Intervention||4
8748372|NCT01154634|9796996|FG003|STARTED|Period 3- Second Intervention||5
8748373|NCT01154634|9796993|FG000|COMPLETED|Period 3- Second Intervention||4
8748374|NCT01154634|9796994|FG001|COMPLETED|Period 3- Second Intervention||7
8748375|NCT01154634|9796995|FG002|COMPLETED|Period 3- Second Intervention||4
8748376|NCT01154634|9796996|FG003|COMPLETED|Period 3- Second Intervention||5
8748377|NCT01154634|9796993|FG000|NOT COMPLETED|Period 3- Second Intervention||0
8748378|NCT01154634|9796994|FG001|NOT COMPLETED|Period 3- Second Intervention||0
8748379|NCT01154634|9796995|FG002|NOT COMPLETED|Period 3- Second Intervention||0
8748380|NCT01154634|9796996|FG003|NOT COMPLETED|Period 3- Second Intervention||0
8748381|NCT01154634|9796993|FG000|STARTED|Period 4 - Washout||4
8748382|NCT01154634|9796994|FG001|STARTED|Period 4 - Washout||7
8748383|NCT01154634|9796995|FG002|STARTED|Period 4 - Washout||4
8748384|NCT01154634|9796996|FG003|STARTED|Period 4 - Washout||5
8748385|NCT01154634|9796993|FG000|COMPLETED|Period 4 - Washout||4
8748386|NCT01154634|9796994|FG001|COMPLETED|Period 4 - Washout||7
8748387|NCT01154634|9796995|FG002|COMPLETED|Period 4 - Washout||4
8748388|NCT01154634|9796996|FG003|COMPLETED|Period 4 - Washout||5
8748389|NCT01154634|9796993|FG000|NOT COMPLETED|Period 4 - Washout||0
8748390|NCT01154634|9796994|FG001|NOT COMPLETED|Period 4 - Washout||0
8748391|NCT01154634|9796995|FG002|NOT COMPLETED|Period 4 - Washout||0
8748392|NCT01154634|9796996|FG003|NOT COMPLETED|Period 4 - Washout||0
8748393|NCT01154634|9796993|FG000|STARTED|Period 5 - Third Intervention||4
8748394|NCT01154634|9796994|FG001|STARTED|Period 5 - Third Intervention||7
8748395|NCT01154634|9796995|FG002|STARTED|Period 5 - Third Intervention||4
8748396|NCT01154634|9796996|FG003|STARTED|Period 5 - Third Intervention||5
8748397|NCT01154634|9796993|FG000|COMPLETED|Period 5 - Third Intervention||4
8748398|NCT01154634|9796994|FG001|COMPLETED|Period 5 - Third Intervention||7
8748399|NCT01154634|9796995|FG002|COMPLETED|Period 5 - Third Intervention||4
8748400|NCT01154634|9796996|FG003|COMPLETED|Period 5 - Third Intervention||5
8748401|NCT01154634|9796993|FG000|NOT COMPLETED|Period 5 - Third Intervention||0
8748402|NCT01154634|9796994|FG001|NOT COMPLETED|Period 5 - Third Intervention||0
8748403|NCT01154634|9796995|FG002|NOT COMPLETED|Period 5 - Third Intervention||0
8748404|NCT01154634|9796996|FG003|NOT COMPLETED|Period 5 - Third Intervention||0
8748405|NCT01154634|9796993|FG000|STARTED|Period 6 - Washout||4
8748406|NCT01154634|9796994|FG001|STARTED|Period 6 - Washout||7
8748407|NCT01154634|9796995|FG002|STARTED|Period 6 - Washout||4
8748408|NCT01154634|9796996|FG003|STARTED|Period 6 - Washout||5
8748409|NCT01154634|9796993|FG000|COMPLETED|Period 6 - Washout||4
8748410|NCT01154634|9796994|FG001|COMPLETED|Period 6 - Washout||7
8748411|NCT01154634|9796995|FG002|COMPLETED|Period 6 - Washout||4
8748412|NCT01154634|9796996|FG003|COMPLETED|Period 6 - Washout||5
8748413|NCT01154634|9796993|FG000|NOT COMPLETED|Period 6 - Washout||0
8748414|NCT01154634|9796994|FG001|NOT COMPLETED|Period 6 - Washout||0
8748415|NCT01154634|9796995|FG002|NOT COMPLETED|Period 6 - Washout||0
8748416|NCT01154634|9796996|FG003|NOT COMPLETED|Period 6 - Washout||0
8748417|NCT01154634|9796993|FG000|STARTED|Period 7 - Fourth Intervention||4
8748418|NCT01154634|9796994|FG001|STARTED|Period 7 - Fourth Intervention||7
8748419|NCT01154634|9796995|FG002|STARTED|Period 7 - Fourth Intervention||4
8748420|NCT01154634|9796996|FG003|STARTED|Period 7 - Fourth Intervention||5
8748421|NCT01154634|9796993|FG000|COMPLETED|Period 7 - Fourth Intervention||4
8748422|NCT01154634|9796994|FG001|COMPLETED|Period 7 - Fourth Intervention||7
8748423|NCT01154634|9796995|FG002|COMPLETED|Period 7 - Fourth Intervention||4
8748424|NCT01154634|9796996|FG003|COMPLETED|Period 7 - Fourth Intervention||5
8748425|NCT01154634|9796993|FG000|NOT COMPLETED|Period 7 - Fourth Intervention||0
8748426|NCT01154634|9796994|FG001|NOT COMPLETED|Period 7 - Fourth Intervention||0
8748427|NCT01154634|9796995|FG002|NOT COMPLETED|Period 7 - Fourth Intervention||0
8748428|NCT01154634|9796996|FG003|NOT COMPLETED|Period 7 - Fourth Intervention||0
8748429|NCT01154673|9797008|FG000|STARTED|Overall Study||16
8748430|NCT01154673|9797009|FG001|STARTED|Overall Study||16
8748431|NCT01154673|9797008|FG000|COMPLETED|Overall Study||14
8748432|NCT01154673|9797009|FG001|COMPLETED|Overall Study||16
8748433|NCT01154673|9797008|FG000|NOT COMPLETED|Overall Study||2
8748434|NCT01154673|9797009|FG001|NOT COMPLETED|Overall Study||0
8748435|NCT01154699|9797017|FG000|STARTED|First Intervention (4 Weeks)||13
8748436|NCT01154699|9797018|FG001|STARTED|First Intervention (4 Weeks)||8
8748437|NCT01154699|9797017|FG000|Subjects With Asthma Only|First Intervention (4 Weeks)||7
8748438|NCT01154699|9797018|FG001|Subjects With Asthma Only|First Intervention (4 Weeks)||6
8748439|NCT01154699|9797017|FG000|Subjects With Asthma + OSA|First Intervention (4 Weeks)||6
8748440|NCT01154699|9797018|FG001|Subjects With Asthma + OSA|First Intervention (4 Weeks)||2
8748441|NCT01154699|9797017|FG000|COMPLETED|First Intervention (4 Weeks)||13
8748442|NCT01154699|9797018|FG001|COMPLETED|First Intervention (4 Weeks)||8
8748443|NCT01154699|9797017|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0
8748444|NCT01154699|9797018|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0
8748445|NCT01154699|9797017|FG000|STARTED|Washout Period (4 Weeks)||13
8748446|NCT01154699|9797018|FG001|STARTED|Washout Period (4 Weeks)||8
8748447|NCT01154699|9797017|FG000|Subjects With Asthma Only|Washout Period (4 Weeks)||7
8748448|NCT01154699|9797018|FG001|Subjects With Asthma Only|Washout Period (4 Weeks)||6
8748449|NCT01154699|9797017|FG000|Subjects With Asthma + OSA|Washout Period (4 Weeks)||6
8748450|NCT01154699|9797018|FG001|Subjects With Asthma + OSA|Washout Period (4 Weeks)||2
8748451|NCT01154699|9797017|FG000|COMPLETED|Washout Period (4 Weeks)||13
8914197|NCT02166047|9973620|FG002|STARTED|Overall Study||16
8914198|NCT02166047|9973621|FG003|STARTED|Overall Study||5
8914199|NCT02166047|9973622|FG004|STARTED|Overall Study||18
8914200|NCT02166047|9973623|FG005|STARTED|Overall Study||17
8914201|NCT02166047|9973624|FG006|STARTED|Overall Study||17
8914202|NCT02166047|9973625|FG007|STARTED|Overall Study||5
8914203|NCT02166047|9973626|FG008|STARTED|Overall Study||16
8914204|NCT02166047|9973627|FG009|STARTED|Overall Study||17
8914205|NCT02166047|9973628|FG010|STARTED|Overall Study||14
8914206|NCT02166047|9973629|FG011|STARTED|Overall Study||6
8914207|NCT02166047|9973618|FG000|COMPLETED|Overall Study||16
8914208|NCT02166047|9973619|FG001|COMPLETED|Overall Study||14
8914209|NCT02166047|9973620|FG002|COMPLETED|Overall Study||14
8914210|NCT02166047|9973621|FG003|COMPLETED|Overall Study||5
8914211|NCT02166047|9973622|FG004|COMPLETED|Overall Study||17
8914212|NCT02166047|9973623|FG005|COMPLETED|Overall Study||17
8914213|NCT02166047|9973624|FG006|COMPLETED|Overall Study||15
8914214|NCT02166047|9973625|FG007|COMPLETED|Overall Study||5
8914215|NCT02166047|9973626|FG008|COMPLETED|Overall Study||16
8914216|NCT02166047|9973627|FG009|COMPLETED|Overall Study||17
8914217|NCT02166047|9973628|FG010|COMPLETED|Overall Study||12
8914218|NCT02166047|9973629|FG011|COMPLETED|Overall Study||6
8914219|NCT02166047|9973618|FG000|NOT COMPLETED|Overall Study||0
8914220|NCT02166047|9973619|FG001|NOT COMPLETED|Overall Study||1
8914221|NCT02166047|9973620|FG002|NOT COMPLETED|Overall Study||2
8914222|NCT02166047|9973621|FG003|NOT COMPLETED|Overall Study||0
8914223|NCT02166047|9973622|FG004|NOT COMPLETED|Overall Study||1
8914224|NCT02166047|9973623|FG005|NOT COMPLETED|Overall Study||0
8914225|NCT02166047|9973624|FG006|NOT COMPLETED|Overall Study||2
8914226|NCT02166047|9973625|FG007|NOT COMPLETED|Overall Study||0
8914227|NCT02166047|9973626|FG008|NOT COMPLETED|Overall Study||0
8914228|NCT02166047|9973627|FG009|NOT COMPLETED|Overall Study||0
8914229|NCT02166047|9973628|FG010|NOT COMPLETED|Overall Study||2
8914230|NCT02166047|9973629|FG011|NOT COMPLETED|Overall Study||0
8914231|NCT02166333|9973659|FG000|STARTED|Stage 1||262
8914232|NCT02166333|9973660|FG001|STARTED|Stage 1||0
8914233|NCT02166333|9973661|FG002|STARTED|Stage 1||130
8914234|NCT02166333|9973662|FG003|STARTED|Stage 1||0
8914235|NCT02166333|9973663|FG004|STARTED|Stage 1|Randomization to 2000 IU/d was stopped in February 2018 as part of planned dose-finding|68
8914236|NCT02166333|9973664|FG005|STARTED|Stage 1|Randomization to 4000 IU/d was stopped in March 2018 as part of planned dose-finding|69
8914237|NCT02166333|9973659|FG000|COMPLETED|Stage 1||242
8914238|NCT02166333|9973660|FG001|COMPLETED|Stage 1||0
8914239|NCT02166333|9973661|FG002|COMPLETED|Stage 1||122
8914240|NCT02166333|9973662|FG003|COMPLETED|Stage 1||0
8914241|NCT02166333|9973663|FG004|COMPLETED|Stage 1||59
8914242|NCT02166333|9973664|FG005|COMPLETED|Stage 1||63
8914243|NCT02166333|9973659|FG000|NOT COMPLETED|Stage 1||20
8914244|NCT02166333|9973660|FG001|NOT COMPLETED|Stage 1||0
8914245|NCT02166333|9973661|FG002|NOT COMPLETED|Stage 1||8
8914246|NCT02166333|9973662|FG003|NOT COMPLETED|Stage 1||0
8914247|NCT02166333|9973663|FG004|NOT COMPLETED|Stage 1||9
8914248|NCT02166333|9973664|FG005|NOT COMPLETED|Stage 1||6
8914249|NCT02166333|9973659|FG000|STARTED|Stage 2||242
8914250|NCT02166333|9973660|FG001|STARTED|Stage 2||77
8914251|NCT02166333|9973661|FG002|STARTED|Stage 2||122
8914252|NCT02166333|9973662|FG003|STARTED|Stage 2||82
8914253|NCT02166333|9973663|FG004|STARTED|Stage 2||59
8914254|NCT02166333|9973664|FG005|STARTED|Stage 2||63
8914255|NCT02166333|9973659|FG000|COMPLETED|Stage 2||35
8914256|NCT02166333|9973660|FG001|COMPLETED|Stage 2||71
8914257|NCT02166333|9973661|FG002|COMPLETED|Stage 2||47
8914258|NCT02166333|9973662|FG003|COMPLETED|Stage 2||73
8914259|NCT02166333|9973663|FG004|COMPLETED|Stage 2||2
8748452|NCT01154699|9797018|FG001|COMPLETED|Washout Period (4 Weeks)||8
8914260|NCT02166333|9973664|FG005|COMPLETED|Stage 2||4
8914261|NCT02166333|9973659|FG000|NOT COMPLETED|Stage 2||207
8914262|NCT02166333|9973660|FG001|NOT COMPLETED|Stage 2||6
8914263|NCT02166333|9973661|FG002|NOT COMPLETED|Stage 2||75
8914264|NCT02166333|9973662|FG003|NOT COMPLETED|Stage 2||9
8914265|NCT02166333|9973663|FG004|NOT COMPLETED|Stage 2||57
8914266|NCT02166333|9973664|FG005|NOT COMPLETED|Stage 2||59
8914267|NCT02166346|9973676|FG000|STARTED|Screening and Randomization||12
8748453|NCT01154699|9797017|FG000|NOT COMPLETED|Washout Period (4 Weeks)||0
8748454|NCT01154699|9797018|FG001|NOT COMPLETED|Washout Period (4 Weeks)||0
8748455|NCT01154699|9797017|FG000|STARTED|Second Intervention||13
8748456|NCT01154699|9797018|FG001|STARTED|Second Intervention||8
8748457|NCT01154699|9797017|FG000|Subjects With Asthma Only|Second Intervention||7
8748458|NCT01154699|9797018|FG001|Subjects With Asthma Only|Second Intervention||6
8748459|NCT01154699|9797017|FG000|Subjects With Asthma + OSA|Second Intervention||6
8748460|NCT01154699|9797018|FG001|Subjects With Asthma + OSA|Second Intervention||2
8748461|NCT01154699|9797017|FG000|COMPLETED|Second Intervention||13
8748462|NCT01154699|9797018|FG001|COMPLETED|Second Intervention||8
8748463|NCT01154699|9797017|FG000|NOT COMPLETED|Second Intervention||0
8748464|NCT01154699|9797018|FG001|NOT COMPLETED|Second Intervention||0
8748465|NCT01154751|9797026|FG000|STARTED|6-month Follow-up||109
8748466|NCT01154751|9797026|FG000|COMPLETED|6-month Follow-up||98
8748467|NCT01154751|9797026|FG000|NOT COMPLETED|6-month Follow-up||11
8748468|NCT01154751|9797026|FG000|STARTED|1-year Follow-up||98
8748469|NCT01154751|9797026|FG000|COMPLETED|1-year Follow-up||93
8748470|NCT01154751|9797026|FG000|NOT COMPLETED|1-year Follow-up||5
8748471|NCT01154751|9797026|FG000|STARTED|2-year Follow-up||93
9023003|NCT03133676|10085818|FG003|NOT COMPLETED|Overall Study||0
8670737|NCT00747474|9714098|FG007|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
8670738|NCT00747474|9714099|FG008|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
8670739|NCT00747474|9714100|FG009|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
8670740|NCT00747474|9714101|FG010|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
8748472|NCT01154751|9797026|FG000|COMPLETED|2-year Follow-up||83
8748473|NCT01154751|9797026|FG000|NOT COMPLETED|2-year Follow-up||10
8748474|NCT01154751|9797026|FG000|STARTED|3-year Follow-up||83
8748475|NCT01154751|9797026|FG000|COMPLETED|3-year Follow-up||34
8748476|NCT01154751|9797026|FG000|NOT COMPLETED|3-year Follow-up||49
8748477|NCT01154816|9797042|FG000|STARTED|Overall Study||20
8748478|NCT01154816|9797043|FG001|STARTED|Overall Study||12
8748479|NCT01154816|9797044|FG002|STARTED|Overall Study||10
8748480|NCT01154816|9797045|FG003|STARTED|Overall Study||10
8748481|NCT01154816|9797046|FG004|STARTED|Overall Study||10
8748482|NCT01154816|9797047|FG005|STARTED|Overall Study||8
8748483|NCT01154816|9797048|FG006|STARTED|Overall Study||6
8748484|NCT01154816|9797049|FG007|STARTED|Overall Study||7
8748485|NCT01154816|9797050|FG008|STARTED|Overall Study||10
8748486|NCT01154816|9797051|FG009|STARTED|Overall Study||10
8748487|NCT01154816|9797052|FG010|STARTED|Overall Study||11
8748488|NCT01154816|9797053|FG011|STARTED|Overall Study||4
8748489|NCT01154816|9797042|FG000|COMPLETED|Overall Study||0
8748490|NCT01154816|9797043|FG001|COMPLETED|Overall Study||2
8748491|NCT01154816|9797044|FG002|COMPLETED|Overall Study||0
8748492|NCT01154816|9797045|FG003|COMPLETED|Overall Study||0
8748493|NCT01154816|9797046|FG004|COMPLETED|Overall Study||0
8748494|NCT01154816|9797047|FG005|COMPLETED|Overall Study||0
8748495|NCT01154816|9797048|FG006|COMPLETED|Overall Study||0
8748496|NCT01154816|9797049|FG007|COMPLETED|Overall Study||0
8748497|NCT01154816|9797050|FG008|COMPLETED|Overall Study||1
8748498|NCT01154816|9797051|FG009|COMPLETED|Overall Study||0
8748499|NCT01154816|9797052|FG010|COMPLETED|Overall Study||0
8748500|NCT01154816|9797053|FG011|COMPLETED|Overall Study||0
8748501|NCT01154816|9797042|FG000|NOT COMPLETED|Overall Study||20
8748502|NCT01154816|9797043|FG001|NOT COMPLETED|Overall Study||10
8748503|NCT01154816|9797044|FG002|NOT COMPLETED|Overall Study||10
8748504|NCT01154816|9797045|FG003|NOT COMPLETED|Overall Study||10
8748505|NCT01154816|9797046|FG004|NOT COMPLETED|Overall Study||10
8748506|NCT01154816|9797047|FG005|NOT COMPLETED|Overall Study||8
8748507|NCT01154816|9797048|FG006|NOT COMPLETED|Overall Study||6
8748508|NCT01154816|9797049|FG007|NOT COMPLETED|Overall Study||7
8748509|NCT01154816|9797050|FG008|NOT COMPLETED|Overall Study||9
8748510|NCT01154816|9797051|FG009|NOT COMPLETED|Overall Study||10
8748511|NCT01154816|9797052|FG010|NOT COMPLETED|Overall Study||11
8748512|NCT01154816|9797053|FG011|NOT COMPLETED|Overall Study||4
8748513|NCT01154985|9797084|FG000|STARTED|Overall Study|Randomized|75
8748514|NCT01154985|9797085|FG001|STARTED|Overall Study|Randomized|82
8748515|NCT01154985|9797086|FG002|STARTED|Overall Study|Randomized|86
8748516|NCT01154985|9797084|FG000|Full Analysis Set|Overall Study|Received at least one dose of study medication|75
8748517|NCT01154985|9797085|FG001|Full Analysis Set|Overall Study|Received at least one dose of study medication|82
8670741|NCT00747474|9714102|FG011|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
8670742|NCT00747552|9714107|FG000|STARTED|Overall Study|This number does not include the 2 who were enrolled but had no data collected on them.|30
8670743|NCT00747552|9714107|FG000|COMPLETED|Overall Study||30
8670744|NCT00747552|9714107|FG000|NOT COMPLETED|Overall Study||0
8692652|NCT00862654|9738217|FG001|NOT COMPLETED|Overall Study||8
8748518|NCT01154985|9797086|FG002|Full Analysis Set|Overall Study|Received at least one dose of study medication|86
8748519|NCT01154985|9797084|FG000|Valid Biopsy -Baseline and Month 12.5|Overall Study||60
8748520|NCT01154985|9797085|FG001|Valid Biopsy -Baseline and Month 12.5|Overall Study||62
8748521|NCT01154985|9797086|FG002|Valid Biopsy -Baseline and Month 12.5|Overall Study||68
8748522|NCT01154985|9797084|FG000|Efficacy Evaluable Analysis Set|Overall Study|12-months histological data, no major protocol violations; after minimum 6 months treatment|55
8748523|NCT01154985|9797085|FG001|Efficacy Evaluable Analysis Set|Overall Study|12-months histological data, no major protocol violations; after minimum 6 months treatment|55
8748524|NCT01154985|9797086|FG002|Efficacy Evaluable Analysis Set|Overall Study|12-months histological data, no major protocol violations; after minimum 6 months treatment|64
8748525|NCT01154985|9797084|FG000|COMPLETED|Overall Study||58
8748526|NCT01154985|9797085|FG001|COMPLETED|Overall Study||55
8748527|NCT01154985|9797086|FG002|COMPLETED|Overall Study||68
8748528|NCT01154985|9797084|FG000|NOT COMPLETED|Overall Study||17
8748529|NCT01154985|9797085|FG001|NOT COMPLETED|Overall Study||27
8748530|NCT01154985|9797086|FG002|NOT COMPLETED|Overall Study||18
8748531|NCT01155011|9797096|FG000|STARTED|Baseline to 6 Months||151
8748532|NCT01155011|9797097|FG001|STARTED|Baseline to 6 Months||156
8748533|NCT01155011|9797096|FG000|COMPLETED|Baseline to 6 Months||129
8748534|NCT01155011|9797097|FG001|COMPLETED|Baseline to 6 Months||131
8748535|NCT01155011|9797096|FG000|NOT COMPLETED|Baseline to 6 Months||22
8748536|NCT01155011|9797097|FG001|NOT COMPLETED|Baseline to 6 Months||25
8748537|NCT01155011|9797096|FG000|STARTED|6 to 12 Months||129
8748538|NCT01155011|9797097|FG001|STARTED|6 to 12 Months||131
8748539|NCT01155011|9797096|FG000|COMPLETED|6 to 12 Months||120
8748540|NCT01155011|9797097|FG001|COMPLETED|6 to 12 Months||121
8748541|NCT01155011|9797096|FG000|NOT COMPLETED|6 to 12 Months||9
8748542|NCT01155011|9797097|FG001|NOT COMPLETED|6 to 12 Months||10
8748543|NCT01155024|9797107|FG000|STARTED|First Socket Intervention Fitting||5
8748544|NCT01155024|9797108|FG001|STARTED|First Socket Intervention Fitting||5
8748545|NCT01155024|9797107|FG000|COMPLETED|First Socket Intervention Fitting||5
8748546|NCT01155024|9797108|FG001|COMPLETED|First Socket Intervention Fitting||5
8748547|NCT01155024|9797107|FG000|NOT COMPLETED|First Socket Intervention Fitting||0
8748548|NCT01155024|9797108|FG001|NOT COMPLETED|First Socket Intervention Fitting||0
8748549|NCT01155024|9797107|FG000|STARTED|Second Socket Intervention Fitting||5
8748550|NCT01155024|9797108|FG001|STARTED|Second Socket Intervention Fitting||5
8748551|NCT01155024|9797107|FG000|COMPLETED|Second Socket Intervention Fitting||5
8748552|NCT01155024|9797108|FG001|COMPLETED|Second Socket Intervention Fitting||5
8748553|NCT01155024|9797107|FG000|NOT COMPLETED|Second Socket Intervention Fitting||0
8748554|NCT01155024|9797108|FG001|NOT COMPLETED|Second Socket Intervention Fitting||0
8748555|NCT01155024|9797107|FG000|STARTED|Direct Manufactured Socket 3 Month Trial||0
8748556|NCT01155024|9797108|FG001|STARTED|Direct Manufactured Socket 3 Month Trial||10
8748557|NCT01155024|9797107|FG000|COMPLETED|Direct Manufactured Socket 3 Month Trial||0
8748558|NCT01155024|9797108|FG001|COMPLETED|Direct Manufactured Socket 3 Month Trial||4
8748559|NCT01155024|9797107|FG000|NOT COMPLETED|Direct Manufactured Socket 3 Month Trial||0
8748560|NCT01155024|9797108|FG001|NOT COMPLETED|Direct Manufactured Socket 3 Month Trial||6
8748561|NCT01155050|9797119|FG000|STARTED|Overall Study||50
8748562|NCT01155050|9797120|FG001|STARTED|Overall Study||51
8748563|NCT01155050|9797121|FG002|STARTED|Overall Study||52
8748564|NCT01155050|9797122|FG003|STARTED|Overall Study||49
8748565|NCT01155050|9797119|FG000|COMPLETED|Overall Study||35
8748566|NCT01155050|9797120|FG001|COMPLETED|Overall Study||31
8748567|NCT01155050|9797121|FG002|COMPLETED|Overall Study||33
8748568|NCT01155050|9797122|FG003|COMPLETED|Overall Study||27
8748569|NCT01155050|9797119|FG000|NOT COMPLETED|Overall Study||15
8748570|NCT01155050|9797120|FG001|NOT COMPLETED|Overall Study||20
8748571|NCT01155050|9797121|FG002|NOT COMPLETED|Overall Study||19
8748572|NCT01155050|9797122|FG003|NOT COMPLETED|Overall Study||22
8748573|NCT01155063|9797132|FG000|STARTED|Overall Study||89
8748574|NCT01155063|9797132|FG000|COMPLETED|Overall Study||0
8748575|NCT01155063|9797132|FG000|NOT COMPLETED|Overall Study||89
8748576|NCT01155141|9797136|FG000|STARTED|Overall Study||16
8748577|NCT01155141|9797136|FG000|COMPLETED|Overall Study||14
8748578|NCT01155141|9797136|FG000|NOT COMPLETED|Overall Study||2
8748579|NCT01155154|9797143|FG000|STARTED|Overall Study||25
8748580|NCT01155154|9797144|FG001|STARTED|Overall Study||24
8748581|NCT01155154|9797145|FG002|STARTED|Overall Study||24
8748582|NCT01155154|9797143|FG000|COMPLETED|Overall Study||25
8748583|NCT01155154|9797144|FG001|COMPLETED|Overall Study||24
8748584|NCT01155154|9797145|FG002|COMPLETED|Overall Study||24
8748585|NCT01155154|9797143|FG000|NOT COMPLETED|Overall Study||0
8748586|NCT01155154|9797144|FG001|NOT COMPLETED|Overall Study||0
8748587|NCT01155154|9797145|FG002|NOT COMPLETED|Overall Study||0
8748588|NCT01155167|9797155|FG000|STARTED|Overall Study||43
8748589|NCT01155167|9797156|FG001|STARTED|Overall Study||43
8748590|NCT01155167|9797155|FG000|COMPLETED|Overall Study||40
8748591|NCT01155167|9797156|FG001|COMPLETED|Overall Study||43
8748592|NCT01155167|9797155|FG000|NOT COMPLETED|Overall Study||3
8748593|NCT01155167|9797156|FG001|NOT COMPLETED|Overall Study||0
8748594|NCT01155180|9797164|FG000|STARTED|Overall Study||18
8748595|NCT01155180|9797165|FG001|STARTED|Overall Study||6
8748596|NCT01155180|9797164|FG000|COMPLETED|Overall Study||18
8748597|NCT01155180|9797165|FG001|COMPLETED|Overall Study||6
8748598|NCT01155180|9797164|FG000|NOT COMPLETED|Overall Study||0
8748599|NCT01155180|9797165|FG001|NOT COMPLETED|Overall Study||0
8748600|NCT01155193|9797175|FG000|STARTED|Overall Study||10924
8748601|NCT01155193|9797176|FG001|STARTED|Overall Study||3818
8748602|NCT01155193|9797177|FG002|STARTED|Overall Study||2260
8748603|NCT01155193|9797178|FG003|STARTED|Overall Study||13802
8748604|NCT01155193|9797175|FG000|COMPLETED|Overall Study|Evaluable population (participants treated between 01 September and 01 May of the following year)|10686
8748605|NCT01155193|9797176|FG001|COMPLETED|Overall Study|Evaluable population (participants treated between 01 September and 01 May of the following year)|3805
8748606|NCT01155193|9797177|FG002|COMPLETED|Overall Study|Evaluable population (participants treated between 01 September and 01 May of the following year)|2248
8748607|NCT01155193|9797178|FG003|COMPLETED|Overall Study|Evaluable population (participants treated between 01 September and 01 May of the following year)|13711
8748608|NCT01155193|9797175|FG000|NOT COMPLETED|Overall Study||238
8748609|NCT01155193|9797176|FG001|NOT COMPLETED|Overall Study||13
8748610|NCT01155193|9797177|FG002|NOT COMPLETED|Overall Study||12
8748611|NCT01155193|9797178|FG003|NOT COMPLETED|Overall Study||91
8748612|NCT01155219|9797195|FG000|STARTED|Overall Study||77
8748613|NCT01155219|9797196|FG001|STARTED|Overall Study||73
8748614|NCT01155219|9797195|FG000|COMPLETED|Overall Study||73
8748615|NCT01155219|9797196|FG001|COMPLETED|Overall Study||70
8748616|NCT01155219|9797195|FG000|NOT COMPLETED|Overall Study||4
8748617|NCT01155219|9797196|FG001|NOT COMPLETED|Overall Study||3
8748618|NCT01155284|9797204|FG000|STARTED|Overall Study||47
8748619|NCT01155284|9797205|FG001|STARTED|Overall Study||23
8748620|NCT01155284|9797204|FG000|COMPLETED|Overall Study||40
8748621|NCT01155284|9797205|FG001|COMPLETED|Overall Study||18
8748622|NCT01155284|9797204|FG000|NOT COMPLETED|Overall Study||7
8748623|NCT01155284|9797205|FG001|NOT COMPLETED|Overall Study||5
8748624|NCT01155323|9797213|FG000|STARTED|First Intervention||60
8748625|NCT01155323|9797214|FG001|STARTED|First Intervention||58
8748626|NCT01155323|9797213|FG000|COMPLETED|First Intervention||59
8748627|NCT01155323|9797214|FG001|COMPLETED|First Intervention||57
8748628|NCT01155323|9797213|FG000|NOT COMPLETED|First Intervention||1
8748629|NCT01155323|9797214|FG001|NOT COMPLETED|First Intervention||1
8748630|NCT01155323|9797213|FG000|STARTED|Second Intervention||59
8748631|NCT01155323|9797214|FG001|STARTED|Second Intervention||57
8748632|NCT01155323|9797213|FG000|COMPLETED|Second Intervention||58
8748633|NCT01155323|9797214|FG001|COMPLETED|Second Intervention||56
8748634|NCT01155323|9797213|FG000|NOT COMPLETED|Second Intervention||1
8748635|NCT01155323|9797214|FG001|NOT COMPLETED|Second Intervention||1
8748636|NCT01155336|9797222|FG000|STARTED|Overall Study|We did not complete the study.|0
8748637|NCT01155336|9797223|FG001|STARTED|Overall Study|We did not complete the study.|4
8748638|NCT01155336|9797222|FG000|COMPLETED|Overall Study|We did not complete the study.|0
8748639|NCT01155336|9797223|FG001|COMPLETED|Overall Study|We did not complete the study.|4
8748640|NCT01155336|9797222|FG000|NOT COMPLETED|Overall Study||0
8748641|NCT01155336|9797223|FG001|NOT COMPLETED|Overall Study||0
8748642|NCT01155466|9797234|FG000|STARTED|Overall Study||156
8748643|NCT01155466|9797235|FG001|STARTED|Overall Study||155
8748644|NCT01155466|9797236|FG002|STARTED|Overall Study||156
8748645|NCT01155466|9797237|FG003|STARTED|Overall Study||155
8748646|NCT01155466|9797238|FG004|STARTED|Overall Study||156
8748647|NCT01155466|9797234|FG000|Treated|Overall Study||154
8748648|NCT01155466|9797235|FG001|Treated|Overall Study||153
8748649|NCT01155466|9797236|FG002|Treated|Overall Study||153
8748650|NCT01155466|9797237|FG003|Treated|Overall Study||155
8748651|NCT01155466|9797238|FG004|Treated|Overall Study||154
8748652|NCT01155466|9797234|FG000|COMPLETED|Overall Study|Completed treatment phase|134
8748653|NCT01155466|9797235|FG001|COMPLETED|Overall Study|Completed treatment phase|130
8748654|NCT01155466|9797236|FG002|COMPLETED|Overall Study|Completed treatment phase|136
8748655|NCT01155466|9797237|FG003|COMPLETED|Overall Study|Completed treatment phase|134
8748656|NCT01155466|9797238|FG004|COMPLETED|Overall Study|Completed treatment phase|129
8748657|NCT01155466|9797234|FG000|NOT COMPLETED|Overall Study||22
8748658|NCT01155466|9797235|FG001|NOT COMPLETED|Overall Study||25
8748659|NCT01155466|9797236|FG002|NOT COMPLETED|Overall Study||20
8748660|NCT01155466|9797237|FG003|NOT COMPLETED|Overall Study||21
8748661|NCT01155466|9797238|FG004|NOT COMPLETED|Overall Study||27
8748662|NCT01155479|9797255|FG000|STARTED|Part I||204
8748663|NCT01155479|9797256|FG001|STARTED|Part I||204
8748664|NCT01155479|9797257|FG002|STARTED|Part I||206
8748665|NCT01155479|9797258|FG003|STARTED|Part I||204
8748666|NCT01155479|9797259|FG004|STARTED|Part I||204
8748667|NCT01155479|9797255|FG000|Treated|Part I||200
8748668|NCT01155479|9797256|FG001|Treated|Part I||202
8748669|NCT01155479|9797257|FG002|Treated|Part I||204
8748670|NCT01155479|9797258|FG003|Treated|Part I||198
8748671|NCT01155479|9797259|FG004|Treated|Part I||203
8748672|NCT01155479|9797255|FG000|COMPLETED|Part I||166
8748673|NCT01155479|9797256|FG001|COMPLETED|Part I||177
8748674|NCT01155479|9797257|FG002|COMPLETED|Part I||167
8748675|NCT01155479|9797258|FG003|COMPLETED|Part I||177
8748676|NCT01155479|9797259|FG004|COMPLETED|Part I||181
8748677|NCT01155479|9797255|FG000|NOT COMPLETED|Part I||38
8748678|NCT01155479|9797256|FG001|NOT COMPLETED|Part I||27
8748679|NCT01155479|9797257|FG002|NOT COMPLETED|Part I||39
8748680|NCT01155479|9797258|FG003|NOT COMPLETED|Part I||27
8748681|NCT01155479|9797259|FG004|NOT COMPLETED|Part I||23
8748682|NCT01155479|9797255|FG000|STARTED|Part II||166
8748683|NCT01155479|9797256|FG001|STARTED|Part II||177
8748684|NCT01155479|9797257|FG002|STARTED|Part II||167
8748685|NCT01155479|9797258|FG003|STARTED|Part II||177
8748686|NCT01155479|9797259|FG004|STARTED|Part II||181
8748687|NCT01155479|9797255|FG000|COMPLETED|Part II||107
8748688|NCT01155479|9797256|FG001|COMPLETED|Part II||116
8748689|NCT01155479|9797257|FG002|COMPLETED|Part II||109
8748690|NCT01155479|9797258|FG003|COMPLETED|Part II||127
8748691|NCT01155479|9797259|FG004|COMPLETED|Part II||126
8748692|NCT01155479|9797255|FG000|NOT COMPLETED|Part II||59
8748693|NCT01155479|9797256|FG001|NOT COMPLETED|Part II||61
8748694|NCT01155479|9797257|FG002|NOT COMPLETED|Part II||58
8748695|NCT01155479|9797258|FG003|NOT COMPLETED|Part II||50
8748696|NCT01155479|9797259|FG004|NOT COMPLETED|Part II||55
8748697|NCT01155531|9797291|FG000|STARTED|Overall Study||10
8748698|NCT01155531|9797292|FG001|STARTED|Overall Study||10
8748699|NCT01155531|9797293|FG002|STARTED|Overall Study||10
8748700|NCT01155531|9797294|FG003|STARTED|Overall Study||10
8748701|NCT01155531|9797291|FG000|COMPLETED|Overall Study||9
8748702|NCT01155531|9797292|FG001|COMPLETED|Overall Study||10
8748703|NCT01155531|9797293|FG002|COMPLETED|Overall Study||8
8748704|NCT01155531|9797294|FG003|COMPLETED|Overall Study||9
8748705|NCT01155531|9797291|FG000|NOT COMPLETED|Overall Study||1
8748706|NCT01155531|9797292|FG001|NOT COMPLETED|Overall Study||0
8748707|NCT01155531|9797293|FG002|NOT COMPLETED|Overall Study||2
8748708|NCT01155531|9797294|FG003|NOT COMPLETED|Overall Study||1
8748709|NCT01155570|9797304|FG000|STARTED|Overall Study|Safety Analysis Population|734
8748710|NCT01155570|9797304|FG000|Efficacy Analysis Population|Overall Study|5 received Humira off-label, 21 did not receive Humira after the first administration|708
8748711|NCT01155570|9797304|FG000|COMPLETED|Overall Study||592
8748712|NCT01155570|9797304|FG000|NOT COMPLETED|Overall Study||142
8748713|NCT01155583|9797319|FG000|STARTED|Phase I||3
8748714|NCT01155583|9797320|FG001|STARTED|Phase I||3
8748715|NCT01155583|9797321|FG002|STARTED|Phase I||4
8748716|NCT01155583|9797322|FG003|STARTED|Phase I||6
8748717|NCT01155583|9797323|FG004|STARTED|Phase I||7
8748718|NCT01155583|9797324|FG005|STARTED|Phase I||0
8748719|NCT01155583|9797325|FG006|STARTED|Phase I||3
8748720|NCT01155583|9797326|FG007|STARTED|Phase I||8
8748721|NCT01155583|9797327|FG008|STARTED|Phase I||0
8748722|NCT01155583|9797319|FG000|COMPLETED|Phase I||3
8748723|NCT01155583|9797320|FG001|COMPLETED|Phase I||3
8748724|NCT01155583|9797321|FG002|COMPLETED|Phase I||4
8748725|NCT01155583|9797322|FG003|COMPLETED|Phase I||6
8748726|NCT01155583|9797323|FG004|COMPLETED|Phase I||6
8748727|NCT01155583|9797324|FG005|COMPLETED|Phase I||0
8748728|NCT01155583|9797325|FG006|COMPLETED|Phase I||3
8748729|NCT01155583|9797326|FG007|COMPLETED|Phase I||5
8748730|NCT01155583|9797327|FG008|COMPLETED|Phase I||0
8748731|NCT01155583|9797319|FG000|NOT COMPLETED|Phase I||0
8748732|NCT01155583|9797320|FG001|NOT COMPLETED|Phase I||0
8748733|NCT01155583|9797321|FG002|NOT COMPLETED|Phase I||0
8748734|NCT01155583|9797322|FG003|NOT COMPLETED|Phase I||0
8748735|NCT01155583|9797323|FG004|NOT COMPLETED|Phase I||1
8748736|NCT01155583|9797324|FG005|NOT COMPLETED|Phase I||0
8748737|NCT01155583|9797325|FG006|NOT COMPLETED|Phase I||0
8748738|NCT01155583|9797326|FG007|NOT COMPLETED|Phase I||3
8748739|NCT01155583|9797327|FG008|NOT COMPLETED|Phase I||0
8748740|NCT01155583|9797319|FG000|STARTED|Phase II - Expansion Phase||0
8748741|NCT01155583|9797320|FG001|STARTED|Phase II - Expansion Phase||0
8748742|NCT01155583|9797321|FG002|STARTED|Phase II - Expansion Phase||0
8748743|NCT01155583|9797322|FG003|STARTED|Phase II - Expansion Phase||0
8748744|NCT01155583|9797323|FG004|STARTED|Phase II - Expansion Phase||0
8748745|NCT01155583|9797324|FG005|STARTED|Phase II - Expansion Phase||0
8748746|NCT01155583|9797325|FG006|STARTED|Phase II - Expansion Phase||0
8748747|NCT01155583|9797326|FG007|STARTED|Phase II - Expansion Phase||0
8748748|NCT01155583|9797327|FG008|STARTED|Phase II - Expansion Phase||11
8748749|NCT01155583|9797319|FG000|COMPLETED|Phase II - Expansion Phase||0
8748750|NCT01155583|9797320|FG001|COMPLETED|Phase II - Expansion Phase||0
8748751|NCT01155583|9797321|FG002|COMPLETED|Phase II - Expansion Phase||0
8748752|NCT01155583|9797322|FG003|COMPLETED|Phase II - Expansion Phase||0
8748753|NCT01155583|9797323|FG004|COMPLETED|Phase II - Expansion Phase||0
8748754|NCT01155583|9797324|FG005|COMPLETED|Phase II - Expansion Phase||0
8748755|NCT01155583|9797325|FG006|COMPLETED|Phase II - Expansion Phase||0
8748756|NCT01155583|9797326|FG007|COMPLETED|Phase II - Expansion Phase||0
8748757|NCT01155583|9797327|FG008|COMPLETED|Phase II - Expansion Phase||11
8748758|NCT01155583|9797319|FG000|NOT COMPLETED|Phase II - Expansion Phase||0
8748759|NCT01155583|9797320|FG001|NOT COMPLETED|Phase II - Expansion Phase||0
8748760|NCT01155583|9797321|FG002|NOT COMPLETED|Phase II - Expansion Phase||0
8748761|NCT01155583|9797322|FG003|NOT COMPLETED|Phase II - Expansion Phase||0
8748762|NCT01155583|9797323|FG004|NOT COMPLETED|Phase II - Expansion Phase||0
8748763|NCT01155583|9797324|FG005|NOT COMPLETED|Phase II - Expansion Phase||0
8748764|NCT01155583|9797325|FG006|NOT COMPLETED|Phase II - Expansion Phase||0
8748765|NCT01155583|9797326|FG007|NOT COMPLETED|Phase II - Expansion Phase||0
8748766|NCT01155583|9797327|FG008|NOT COMPLETED|Phase II - Expansion Phase||0
8748767|NCT01155661|9797343|FG000|STARTED|Overall Study||608
8748768|NCT01155661|9797343|FG000|COMPLETED|Overall Study||328
8748769|NCT01155661|9797343|FG000|NOT COMPLETED|Overall Study||280
8748770|NCT01155726|9797349|FG000|STARTED|Period 1, 3 Days (Masked)||24
8748771|NCT01155726|9797350|FG001|STARTED|Period 1, 3 Days (Masked)||20
8748772|NCT01155726|9797351|FG002|STARTED|Period 1, 3 Days (Masked)||30
8748773|NCT01155726|9797352|FG003|STARTED|Period 1, 3 Days (Masked)||25
8748774|NCT01155726|9797349|FG000|COMPLETED|Period 1, 3 Days (Masked)||23
8748775|NCT01155726|9797350|FG001|COMPLETED|Period 1, 3 Days (Masked)||20
8748776|NCT01155726|9797351|FG002|COMPLETED|Period 1, 3 Days (Masked)||28
8748777|NCT01155726|9797352|FG003|COMPLETED|Period 1, 3 Days (Masked)||25
8748778|NCT01155726|9797349|FG000|NOT COMPLETED|Period 1, 3 Days (Masked)||1
8748779|NCT01155726|9797350|FG001|NOT COMPLETED|Period 1, 3 Days (Masked)||0
8748780|NCT01155726|9797351|FG002|NOT COMPLETED|Period 1, 3 Days (Masked)||2
8748781|NCT01155726|9797352|FG003|NOT COMPLETED|Period 1, 3 Days (Masked)||0
8748782|NCT01155726|9797349|FG000|STARTED|Period 2, 3 Days (Unmask) or (Partial)||23
8748783|NCT01155726|9797350|FG001|STARTED|Period 2, 3 Days (Unmask) or (Partial)||20
8748784|NCT01155726|9797351|FG002|STARTED|Period 2, 3 Days (Unmask) or (Partial)||28
8748785|NCT01155726|9797352|FG003|STARTED|Period 2, 3 Days (Unmask) or (Partial)||25
8748786|NCT01155726|9797349|FG000|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||23
8748787|NCT01155726|9797350|FG001|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||20
8748788|NCT01155726|9797351|FG002|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||28
8748789|NCT01155726|9797352|FG003|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||25
8748790|NCT01155726|9797349|FG000|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
8748791|NCT01155726|9797350|FG001|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
8748792|NCT01155726|9797351|FG002|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
8748793|NCT01155726|9797352|FG003|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
8748794|NCT01155778|9797377|FG000|STARTED|Overall Study||4
8748795|NCT01155778|9797378|FG001|STARTED|Overall Study||4
8748796|NCT01155778|9797379|FG002|STARTED|Overall Study||4
8748797|NCT01155778|9797377|FG000|COMPLETED|Overall Study||4
8748798|NCT01155778|9797378|FG001|COMPLETED|Overall Study||4
8748799|NCT01155778|9797379|FG002|COMPLETED|Overall Study||4
8748800|NCT01155778|9797377|FG000|NOT COMPLETED|Overall Study||0
8748801|NCT01155778|9797378|FG001|NOT COMPLETED|Overall Study||0
8748802|NCT01155778|9797379|FG002|NOT COMPLETED|Overall Study||0
8748803|NCT01155830|9797390|FG000|STARTED|Overall Study||0
8748804|NCT01155830|9797391|FG001|STARTED|Overall Study||0
8748805|NCT01155830|9797392|FG002|STARTED|Overall Study||21
8748806|NCT01155830|9797390|FG000|COMPLETED|Overall Study||0
8748807|NCT01155830|9797391|FG001|COMPLETED|Overall Study||0
8748808|NCT01155830|9797392|FG002|COMPLETED|Overall Study||21
8748809|NCT01155830|9797390|FG000|NOT COMPLETED|Overall Study||0
8748810|NCT01155830|9797391|FG001|NOT COMPLETED|Overall Study||0
8748811|NCT01155830|9797392|FG002|NOT COMPLETED|Overall Study||0
8748812|NCT01155869|9797402|FG000|STARTED|Overall Study||3
8748813|NCT01155869|9797403|FG001|STARTED|Overall Study||4
8748814|NCT01155869|9797402|FG000|COMPLETED|Overall Study||0
8748815|NCT01155869|9797403|FG001|COMPLETED|Overall Study||3
8914268|NCT02166346|9973677|FG001|STARTED|Screening and Randomization||12
8914269|NCT02166346|9973676|FG000|COMPLETED|Screening and Randomization||8
8914270|NCT02166346|9973677|FG001|COMPLETED|Screening and Randomization||8
8914271|NCT02166346|9973676|FG000|NOT COMPLETED|Screening and Randomization||4
8914272|NCT02166346|9973677|FG001|NOT COMPLETED|Screening and Randomization||4
8914273|NCT02166346|9973676|FG000|STARTED|Intervention - Phase 1||8
8914274|NCT02166346|9973677|FG001|STARTED|Intervention - Phase 1||8
8914275|NCT02166346|9973676|FG000|COMPLETED|Intervention - Phase 1||8
8914276|NCT02166346|9973677|FG001|COMPLETED|Intervention - Phase 1||6
8914277|NCT02166346|9973676|FG000|NOT COMPLETED|Intervention - Phase 1||0
8914278|NCT02166346|9973677|FG001|NOT COMPLETED|Intervention - Phase 1||2
8914279|NCT02166346|9973676|FG000|STARTED|Intervention - Phase 2 (After Crossover)||8
8914280|NCT02166346|9973677|FG001|STARTED|Intervention - Phase 2 (After Crossover)||6
8914281|NCT02166346|9973676|FG000|COMPLETED|Intervention - Phase 2 (After Crossover)||7
8914282|NCT02166346|9973677|FG001|COMPLETED|Intervention - Phase 2 (After Crossover)||6
8914283|NCT02166346|9973676|FG000|NOT COMPLETED|Intervention - Phase 2 (After Crossover)||1
8914284|NCT02166346|9973677|FG001|NOT COMPLETED|Intervention - Phase 2 (After Crossover)||0
8914285|NCT02166476|9973685|FG000|STARTED|Overall Study||272
8914286|NCT02166476|9973686|FG001|STARTED|Overall Study||273
8914287|NCT02166476|9973685|FG000|Received at Least 1 Dose of Study Drug|Overall Study||272
8914288|NCT02166476|9973686|FG001|Received at Least 1 Dose of Study Drug|Overall Study||273
8914289|NCT02166476|9973685|FG000|COMPLETED|Overall Study||258
8914290|NCT02166476|9973686|FG001|COMPLETED|Overall Study||250
8914291|NCT02166476|9973685|FG000|NOT COMPLETED|Overall Study||14
8914292|NCT02166476|9973686|FG001|NOT COMPLETED|Overall Study||23
8914293|NCT02166606|9973695|FG000|STARTED|Overall Study||1184
8914294|NCT02166606|9973695|FG000|Actively Enrolled|Overall Study||1180
8914295|NCT02166606|9973695|FG000|Consent Eligible|Overall Study||1174
8914296|NCT02166606|9973695|FG000|COMPLETED|Overall Study||1106
8914297|NCT02166606|9973695|FG000|NOT COMPLETED|Overall Study||78
8914298|NCT02166697|9973699|FG000|STARTED|Overall Study||14151
8914299|NCT02166697|9973699|FG000|COMPLETED|Overall Study||13804
8914300|NCT02166697|9973699|FG000|NOT COMPLETED|Overall Study||347
8914301|NCT02167035|9973705|FG000|STARTED|Overall Study||21
8914302|NCT02167035|9973706|FG001|STARTED|Overall Study||22
8914303|NCT02167035|9973705|FG000|COMPLETED|Overall Study||16
8914304|NCT02167035|9973706|FG001|COMPLETED|Overall Study||16
8914305|NCT02167035|9973705|FG000|NOT COMPLETED|Overall Study||5
8914306|NCT02167035|9973706|FG001|NOT COMPLETED|Overall Study||6
8914307|NCT02167074|9973716|FG000|STARTED|Overall Study||306
8914308|NCT02167074|9973717|FG001|STARTED|Overall Study||302
8914309|NCT02167074|9973716|FG000|COMPLETED|Overall Study||306
8914310|NCT02167074|9973717|FG001|COMPLETED|Overall Study||302
8914311|NCT02167074|9973716|FG000|NOT COMPLETED|Overall Study||0
8914312|NCT02167074|9973717|FG001|NOT COMPLETED|Overall Study||0
8914313|NCT02167139|9973725|FG000|STARTED|Randomised, Double-blind||271
8914314|NCT02167139|9973726|FG001|STARTED|Randomised, Double-blind||273
8914315|NCT02167139|9973727|FG002|STARTED|Randomised, Double-blind||0
8748816|NCT01155869|9797402|FG000|NOT COMPLETED|Overall Study||3
8748817|NCT01155869|9797403|FG001|NOT COMPLETED|Overall Study||1
8748818|NCT01155999|9797411|FG000|STARTED|Overall Study||146
8748819|NCT01155999|9797412|FG001|STARTED|Overall Study||140
8748820|NCT01155999|9797411|FG000|COMPLETED|Overall Study||139
8748821|NCT01155999|9797412|FG001|COMPLETED|Overall Study||136
8748822|NCT01155999|9797411|FG000|NOT COMPLETED|Overall Study||7
8748823|NCT01155999|9797412|FG001|NOT COMPLETED|Overall Study||4
8914316|NCT02167139|9973728|FG003|STARTED|Randomised, Double-blind||0
8914317|NCT02167139|9973725|FG000|COMPLETED|Randomised, Double-blind||254
8914318|NCT02167139|9973726|FG001|COMPLETED|Randomised, Double-blind||254
8914319|NCT02167139|9973727|FG002|COMPLETED|Randomised, Double-blind||0
8748824|NCT01156012|9797420|FG000|STARTED|Overall Study||213
8748825|NCT01156012|9797421|FG001|STARTED|Overall Study||189
8748826|NCT01156012|9797420|FG000|COMPLETED|Overall Study||206
8748827|NCT01156012|9797421|FG001|COMPLETED|Overall Study||186
8748828|NCT01156012|9797420|FG000|NOT COMPLETED|Overall Study||7
8748829|NCT01156012|9797421|FG001|NOT COMPLETED|Overall Study||3
8748830|NCT01156051|9797429|FG000|STARTED|Overall Study||12
8748831|NCT01156051|9797430|FG001|STARTED|Overall Study||17
8748832|NCT01156051|9797429|FG000|COMPLETED|Overall Study||11
8748833|NCT01156051|9797430|FG001|COMPLETED|Overall Study||16
8748834|NCT01156051|9797429|FG000|NOT COMPLETED|Overall Study||1
8748835|NCT01156051|9797430|FG001|NOT COMPLETED|Overall Study||1
8748836|NCT01156116|9797438|FG000|STARTED|Overall Study||26
8748837|NCT01156116|9797439|FG001|STARTED|Overall Study||13
8748838|NCT01156116|9797438|FG000|COMPLETED|Overall Study||21
8748839|NCT01156116|9797439|FG001|COMPLETED|Overall Study||12
8748840|NCT01156116|9797438|FG000|NOT COMPLETED|Overall Study||5
8748841|NCT01156116|9797439|FG001|NOT COMPLETED|Overall Study||1
8748842|NCT01156142|9797447|FG000|STARTED|Overall Study||77
8748843|NCT01156142|9797448|FG001|STARTED|Overall Study||78
8748844|NCT01156142|9797447|FG000|COMPLETED|Overall Study||69
8748845|NCT01156142|9797448|FG001|COMPLETED|Overall Study||71
8748846|NCT01156142|9797447|FG000|NOT COMPLETED|Overall Study||8
8748847|NCT01156142|9797448|FG001|NOT COMPLETED|Overall Study||7
8748848|NCT01156311|9797456|FG000|STARTED|2-Month Monotherapy Period||59
8748849|NCT01156311|9797457|FG001|STARTED|2-Month Monotherapy Period||49
8748850|NCT01156311|9797458|FG002|STARTED|2-Month Monotherapy Period||0
8748851|NCT01156311|9797459|FG003|STARTED|2-Month Monotherapy Period||0
8748852|NCT01156311|9797456|FG000|COMPLETED|2-Month Monotherapy Period||57
8748853|NCT01156311|9797457|FG001|COMPLETED|2-Month Monotherapy Period||47
8748854|NCT01156311|9797458|FG002|COMPLETED|2-Month Monotherapy Period||0
8748855|NCT01156311|9797459|FG003|COMPLETED|2-Month Monotherapy Period||0
8748856|NCT01156311|9797456|FG000|NOT COMPLETED|2-Month Monotherapy Period||2
8748857|NCT01156311|9797457|FG001|NOT COMPLETED|2-Month Monotherapy Period||2
8748858|NCT01156311|9797458|FG002|NOT COMPLETED|2-Month Monotherapy Period||0
8748859|NCT01156311|9797459|FG003|NOT COMPLETED|2-Month Monotherapy Period||0
8748860|NCT01156311|9797456|FG000|STARTED|6-month Add-on Therapy Period||0
8748861|NCT01156311|9797457|FG001|STARTED|6-month Add-on Therapy Period||0
8748862|NCT01156311|9797458|FG002|STARTED|6-month Add-on Therapy Period||57
8748863|NCT01156311|9797459|FG003|STARTED|6-month Add-on Therapy Period||47
8748864|NCT01156311|9797456|FG000|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||0
8748865|NCT01156311|9797457|FG001|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||0
8748866|NCT01156311|9797458|FG002|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||45
8748867|NCT01156311|9797459|FG003|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||38
8748868|NCT01156311|9797456|FG000|COMPLETED|6-month Add-on Therapy Period||0
8748869|NCT01156311|9797457|FG001|COMPLETED|6-month Add-on Therapy Period||0
8748870|NCT01156311|9797458|FG002|COMPLETED|6-month Add-on Therapy Period||45
8748871|NCT01156311|9797459|FG003|COMPLETED|6-month Add-on Therapy Period||37
8748872|NCT01156311|9797456|FG000|NOT COMPLETED|6-month Add-on Therapy Period||0
8748873|NCT01156311|9797457|FG001|NOT COMPLETED|6-month Add-on Therapy Period||0
8748874|NCT01156311|9797458|FG002|NOT COMPLETED|6-month Add-on Therapy Period||12
8748875|NCT01156311|9797459|FG003|NOT COMPLETED|6-month Add-on Therapy Period||10
8748876|NCT01156363|9797470|FG000|STARTED|Overall Study||86
8748877|NCT01156363|9797470|FG000|COMPLETED|Overall Study||64
8748878|NCT01156363|9797470|FG000|NOT COMPLETED|Overall Study||22
8748879|NCT01156376|9797484|FG000|STARTED|Overall Study||27
8748880|NCT01156376|9797485|FG001|STARTED|Overall Study||26
8748881|NCT01156376|9797486|FG002|STARTED|Overall Study||27
8748882|NCT01156376|9797484|FG000|COMPLETED|Overall Study||26
8748883|NCT01156376|9797485|FG001|COMPLETED|Overall Study||26
8748884|NCT01156376|9797486|FG002|COMPLETED|Overall Study||23
8748885|NCT01156376|9797484|FG000|NOT COMPLETED|Overall Study||1
8748886|NCT01156376|9797485|FG001|NOT COMPLETED|Overall Study||0
8748887|NCT01156376|9797486|FG002|NOT COMPLETED|Overall Study||4
8748888|NCT01156480|9797496|FG000|STARTED|Overall Study||0
8748889|NCT01156480|9797497|FG001|STARTED|Overall Study||2
8748890|NCT01156480|9797496|FG000|COMPLETED|Overall Study||0
8748891|NCT01156480|9797497|FG001|COMPLETED|Overall Study||1
8748892|NCT01156480|9797496|FG000|NOT COMPLETED|Overall Study||0
8748893|NCT01156480|9797497|FG001|NOT COMPLETED|Overall Study||1
8748894|NCT01156532|9797505|FG000|STARTED|Overall Study||30
8748895|NCT01156532|9797505|FG000|COMPLETED|Overall Study||28
8748896|NCT01156532|9797505|FG000|NOT COMPLETED|Overall Study||2
8748897|NCT01156571|9797511|FG000|STARTED|Overall Study|ITT: defined as all patients randomized.|5581
8748898|NCT01156571|9797512|FG001|STARTED|Overall Study|ITT: defined as all patients randomized.|5564
8748899|NCT01156571|9797511|FG000|COMPLETED|Overall Study|Completed = ITT patients who completed scheduled visits or developed a primary endpoint event|5564
8748900|NCT01156571|9797512|FG001|COMPLETED|Overall Study|Completed = ITT patients who completed scheduled visits or developed a primary endpoint event|5545
8748901|NCT01156571|9797511|FG000|NOT COMPLETED|Overall Study||17
8748902|NCT01156571|9797512|FG001|NOT COMPLETED|Overall Study||19
8748903|NCT01156597|9797520|FG000|STARTED|Overall Study||16
8748904|NCT01156597|9797521|FG001|STARTED|Overall Study||14
8748905|NCT01156597|9797520|FG000|COMPLETED|Overall Study||13
8748906|NCT01156597|9797521|FG001|COMPLETED|Overall Study||13
8748907|NCT01156597|9797520|FG000|NOT COMPLETED|Overall Study||3
8748908|NCT01156597|9797521|FG001|NOT COMPLETED|Overall Study||1
8748909|NCT01156675|9797531|FG000|STARTED|Overall Study||107
8748910|NCT01156675|9797532|FG001|STARTED|Overall Study||106
8748911|NCT01156675|9797533|FG002|STARTED|Overall Study||2
8748912|NCT01156675|9797531|FG000|COMPLETED|Overall Study||73
8748913|NCT01156675|9797532|FG001|COMPLETED|Overall Study||81
8748914|NCT01156675|9797533|FG002|COMPLETED|Overall Study||0
8748915|NCT01156675|9797531|FG000|NOT COMPLETED|Overall Study||34
8748916|NCT01156675|9797532|FG001|NOT COMPLETED|Overall Study||25
8748917|NCT01156675|9797533|FG002|NOT COMPLETED|Overall Study||2
8748918|NCT01156701|9797542|FG000|STARTED|Overall Study||257
8748919|NCT01156701|9797543|FG001|STARTED|Overall Study||1007
8748920|NCT01156701|9797544|FG002|STARTED|Overall Study||163716
8748921|NCT01156701|9797545|FG003|STARTED|Overall Study||6725
8748922|NCT01156701|9797542|FG000|COMPLETED|Overall Study||257
8748923|NCT01156701|9797543|FG001|COMPLETED|Overall Study||1007
8748924|NCT01156701|9797544|FG002|COMPLETED|Overall Study||163716
8748925|NCT01156701|9797545|FG003|COMPLETED|Overall Study||6725
8748926|NCT01156701|9797542|FG000|NOT COMPLETED|Overall Study||0
8748927|NCT01156701|9797543|FG001|NOT COMPLETED|Overall Study||0
8748928|NCT01156701|9797544|FG002|NOT COMPLETED|Overall Study||0
8748929|NCT01156701|9797545|FG003|NOT COMPLETED|Overall Study||0
8748930|NCT01156714|9797558|FG000|STARTED|Overall Study||20
8748931|NCT01156714|9797559|FG001|STARTED|Overall Study||19
8748932|NCT01156714|9797560|FG002|STARTED|Overall Study||20
8748933|NCT01156714|9797558|FG000|COMPLETED|Overall Study||11
8748934|NCT01156714|9797559|FG001|COMPLETED|Overall Study||15
8748935|NCT01156714|9797560|FG002|COMPLETED|Overall Study||17
8748936|NCT01156714|9797558|FG000|NOT COMPLETED|Overall Study||9
8748937|NCT01156714|9797559|FG001|NOT COMPLETED|Overall Study||4
8748938|NCT01156714|9797560|FG002|NOT COMPLETED|Overall Study||3
8748939|NCT01156792|9797571|FG000|STARTED|Overall Study||162
8748940|NCT01156792|9797571|FG000|COMPLETED|Overall Study||93
8748941|NCT01156792|9797571|FG000|NOT COMPLETED|Overall Study||69
8748942|NCT01156805|9797588|FG000|STARTED|Overall Study||237
8748943|NCT01156805|9797589|FG001|STARTED|Overall Study||272
8748944|NCT01156805|9797588|FG000|COMPLETED|Overall Study||181
8748945|NCT01156805|9797589|FG001|COMPLETED|Overall Study||216
8748946|NCT01156805|9797588|FG000|NOT COMPLETED|Overall Study||56
8748947|NCT01156805|9797589|FG001|NOT COMPLETED|Overall Study||56
8748948|NCT01156844|9797599|FG000|STARTED|Overall Study|Randomized participants.|48
8748949|NCT01156844|9797600|FG001|STARTED|Overall Study||48
8748950|NCT01156844|9797601|FG002|STARTED|Overall Study||48
8748951|NCT01156844|9797602|FG003|STARTED|Overall Study||47
8748952|NCT01156844|9797599|FG000|PD & Safety Sets: Received Study Drug|Overall Study|PD=Pharmacodynamic|48
8748953|NCT01156844|9797600|FG001|PD & Safety Sets: Received Study Drug|Overall Study||47
8748954|NCT01156844|9797601|FG002|PD & Safety Sets: Received Study Drug|Overall Study||48
8748955|NCT01156844|9797602|FG003|PD & Safety Sets: Received Study Drug|Overall Study||46
8748956|NCT01156844|9797599|FG000|COMPLETED|Overall Study||46
8748957|NCT01156844|9797600|FG001|COMPLETED|Overall Study||46
8748958|NCT01156844|9797601|FG002|COMPLETED|Overall Study||42
8748959|NCT01156844|9797602|FG003|COMPLETED|Overall Study||41
8748960|NCT01156844|9797599|FG000|NOT COMPLETED|Overall Study||2
8748961|NCT01156844|9797600|FG001|NOT COMPLETED|Overall Study||2
8748962|NCT01156844|9797601|FG002|NOT COMPLETED|Overall Study||6
8748963|NCT01156844|9797602|FG003|NOT COMPLETED|Overall Study||6
8748964|NCT01156987|9797617|FG000|STARTED|Overall Study||8
8748965|NCT01156987|9797618|FG001|STARTED|Overall Study||23
8748966|NCT01156987|9797617|FG000|COMPLETED|Overall Study||8
8748967|NCT01156987|9797618|FG001|COMPLETED|Overall Study||12
8748968|NCT01156987|9797617|FG000|NOT COMPLETED|Overall Study||0
8748969|NCT01156987|9797618|FG001|NOT COMPLETED|Overall Study||11
8748970|NCT01157065|9797626|FG000|STARTED|Overall Study||38
8748971|NCT01157065|9797627|FG001|STARTED|Overall Study||11
8748972|NCT01157065|9797626|FG000|COMPLETED|Overall Study||38
8748973|NCT01157065|9797627|FG001|COMPLETED|Overall Study||10
8748974|NCT01157065|9797626|FG000|NOT COMPLETED|Overall Study||0
8748975|NCT01157065|9797627|FG001|NOT COMPLETED|Overall Study||1
8748976|NCT01157078|9797635|FG000|STARTED|Overall Study||159
8748977|NCT01157078|9797636|FG001|STARTED|Overall Study||160
8748978|NCT01157078|9797635|FG000|Received Treatment|Overall Study||157
8748979|NCT01157078|9797636|FG001|Received Treatment|Overall Study||159
8748980|NCT01157078|9797635|FG000|COMPLETED|Overall Study||124
8748981|NCT01157078|9797636|FG001|COMPLETED|Overall Study||124
8748982|NCT01157078|9797635|FG000|NOT COMPLETED|Overall Study||35
8914320|NCT02167139|9973728|FG003|COMPLETED|Randomised, Double-blind||0
8748983|NCT01157078|9797636|FG001|NOT COMPLETED|Overall Study||36
8807740|NCT01485991|9860033|FG000|COMPLETED|Overall Study||353
8807741|NCT01485991|9860034|FG001|COMPLETED|Overall Study||350
8807742|NCT01485991|9860033|FG000|NOT COMPLETED|Overall Study||32
8807743|NCT01485991|9860034|FG001|NOT COMPLETED|Overall Study||36
8807744|NCT01486043|9860040|FG000|STARTED|Overall Study||4
8807745|NCT01486043|9860040|FG000|COMPLETED|Overall Study|Study terminated due to insufficient recruitment|2
8807746|NCT01486043|9860040|FG000|NOT COMPLETED|Overall Study||2
8807747|NCT01486199|9860046|FG000|STARTED|Baseline Study Day||10
8807748|NCT01486199|9860047|FG001|STARTED|Baseline Study Day||10
8807749|NCT01486199|9860046|FG000|COMPLETED|Baseline Study Day||10
8807750|NCT01486199|9860047|FG001|COMPLETED|Baseline Study Day||9
8807751|NCT01486199|9860046|FG000|NOT COMPLETED|Baseline Study Day||0
8807752|NCT01486199|9860047|FG001|NOT COMPLETED|Baseline Study Day||1
8748984|NCT01157117|9797645|FG000|STARTED|Overall Study||28
8748985|NCT01157117|9797646|FG001|STARTED|Overall Study||29
8748986|NCT01157117|9797647|FG002|STARTED|Overall Study||20
8748987|NCT01157117|9797645|FG000|Began Omalizumab or Placebo Dosing|Overall Study||27
8748988|NCT01157117|9797646|FG001|Began Omalizumab or Placebo Dosing|Overall Study||28
8748989|NCT01157117|9797647|FG002|Began Omalizumab or Placebo Dosing|Overall Study||0
8748990|NCT01157117|9797645|FG000|Began Milk OIT Dosing at Month 4|Overall Study||27
8748991|NCT01157117|9797646|FG001|Began Milk OIT Dosing at Month 4|Overall Study||28
8748992|NCT01157117|9797647|FG002|Began Milk OIT Dosing at Month 4|Overall Study||0
8748993|NCT01157117|9797645|FG000|Reached Milk OIT Maintenance Dosing|Overall Study||26
8748994|NCT01157117|9797646|FG001|Reached Milk OIT Maintenance Dosing|Overall Study||26
8748995|NCT01157117|9797647|FG002|Reached Milk OIT Maintenance Dosing|Overall Study||0
8748996|NCT01157117|9797645|FG000|Unblinded at Month 16|Overall Study||26
8748997|NCT01157117|9797646|FG001|Unblinded at Month 16|Overall Study||26
8748998|NCT01157117|9797647|FG002|Unblinded at Month 16|Overall Study||0
8748999|NCT01157117|9797645|FG000|Completed Month 28 Desensitization OFC|Overall Study||26
8749000|NCT01157117|9797646|FG001|Completed Month 28 Desensitization OFC|Overall Study||24
8749001|NCT01157117|9797647|FG002|Completed Month 28 Desensitization OFC|Overall Study||0
8749002|NCT01157117|9797645|FG000|Discontinued Milk OIT at Month 30|Overall Study||24
8749003|NCT01157117|9797646|FG001|Discontinued Milk OIT at Month 30|Overall Study||20
8749004|NCT01157117|9797647|FG002|Discontinued Milk OIT at Month 30|Overall Study||0
8749005|NCT01157117|9797645|FG000|Completed Month 32 Tolerance OFC|Overall Study||24
8749006|NCT01157117|9797646|FG001|Completed Month 32 Tolerance OFC|Overall Study||20
8749007|NCT01157117|9797647|FG002|Completed Month 32 Tolerance OFC|Overall Study||0
8749008|NCT01157117|9797645|FG000|Completed Final Month 38 Study Visit|Overall Study||19
8749009|NCT01157117|9797646|FG001|Completed Final Month 38 Study Visit|Overall Study||18
8749010|NCT01157117|9797647|FG002|Completed Final Month 38 Study Visit|Overall Study||3
8914321|NCT02167139|9973725|FG000|NOT COMPLETED|Randomised, Double-blind||17
8914322|NCT02167139|9973726|FG001|NOT COMPLETED|Randomised, Double-blind||19
8914323|NCT02167139|9973727|FG002|NOT COMPLETED|Randomised, Double-blind||0
8914324|NCT02167139|9973728|FG003|NOT COMPLETED|Randomised, Double-blind||0
8914325|NCT02167139|9973725|FG000|STARTED|Transition-extension||254
8914326|NCT02167139|9973726|FG001|STARTED|Transition-extension||0
8914327|NCT02167139|9973727|FG002|STARTED|Transition-extension||125
8914328|NCT02167139|9973728|FG003|STARTED|Transition-extension||129
8914329|NCT02167139|9973725|FG000|COMPLETED|Transition-extension||248
8914330|NCT02167139|9973726|FG001|COMPLETED|Transition-extension||0
8914331|NCT02167139|9973727|FG002|COMPLETED|Transition-extension||117
8914332|NCT02167139|9973728|FG003|COMPLETED|Transition-extension||124
8914333|NCT02167139|9973725|FG000|NOT COMPLETED|Transition-extension||6
8914334|NCT02167139|9973726|FG001|NOT COMPLETED|Transition-extension||0
8914335|NCT02167139|9973727|FG002|NOT COMPLETED|Transition-extension||8
8914336|NCT02167139|9973728|FG003|NOT COMPLETED|Transition-extension||5
8914337|NCT02167204|9973742|FG000|STARTED|Overall Study||9
8914338|NCT02167204|9973742|FG000|COMPLETED|Overall Study||9
8914339|NCT02167204|9973742|FG000|NOT COMPLETED|Overall Study||0
8914340|NCT02167217|9973752|FG000|STARTED|Overall Study||25
8914341|NCT02167217|9973752|FG000|COMPLETED|Overall Study||23
8914342|NCT02167217|9973752|FG000|NOT COMPLETED|Overall Study||2
8914343|NCT02167256|9973758|FG000|STARTED|Overall Study||79
8914344|NCT02167256|9973759|FG001|STARTED|Overall Study||80
8914345|NCT02167256|9973758|FG000|COMPLETED|Overall Study||58
8914346|NCT02167256|9973759|FG001|COMPLETED|Overall Study||70
8914347|NCT02167256|9973758|FG000|NOT COMPLETED|Overall Study||21
8914348|NCT02167256|9973759|FG001|NOT COMPLETED|Overall Study||10
8914349|NCT02167451|9973765|FG000|STARTED|Overall Study||31
8914350|NCT02167451|9973765|FG000|COMPLETED|Overall Study||30
8914351|NCT02167451|9973765|FG000|NOT COMPLETED|Overall Study||1
8914352|NCT02167594|9973772|FG000|STARTED|Overall Study||20
8914353|NCT02167594|9973773|FG001|STARTED|Overall Study||6
8914354|NCT02167594|9973774|FG002|STARTED|Overall Study||3
8914355|NCT02167594|9973772|FG000|COMPLETED|Overall Study||18
8914356|NCT02167594|9973773|FG001|COMPLETED|Overall Study||5
9023004|NCT03133676|10085819|FG004|NOT COMPLETED|Overall Study||0
9023005|NCT03133676|10085820|FG005|NOT COMPLETED|Overall Study||0
9023006|NCT03133676|10085821|FG006|NOT COMPLETED|Overall Study||0
9023007|NCT03133676|10085822|FG007|NOT COMPLETED|Overall Study||0
9023008|NCT03133676|10085823|FG008|NOT COMPLETED|Overall Study||0
9023009|NCT03133767|10085852|FG000|STARTED|Overall Study||79
9023010|NCT03133767|10085853|FG001|STARTED|Overall Study||78
9023011|NCT03133767|10085852|FG000|COMPLETED|Overall Study||41
9023012|NCT03133767|10085853|FG001|COMPLETED|Overall Study||53
8749011|NCT01157117|9797645|FG000|COMPLETED|Overall Study|Completed final study visit at Month 38, 6 months after final Month 32 OFC.|19
8807753|NCT01486199|9860046|FG000|STARTED|Two Year Period Between Study Days||10
8914357|NCT02167594|9973774|FG002|COMPLETED|Overall Study||3
9023013|NCT03133767|10085852|FG000|NOT COMPLETED|Overall Study||38
9023014|NCT03133767|10085853|FG001|NOT COMPLETED|Overall Study||25
9023015|NCT03134092|10085862|FG000|STARTED|Overall Study||434
8914358|NCT02167594|9973772|FG000|NOT COMPLETED|Overall Study||2
8914359|NCT02167594|9973773|FG001|NOT COMPLETED|Overall Study||1
8914360|NCT02167594|9973774|FG002|NOT COMPLETED|Overall Study||0
8914361|NCT02167815|9973785|FG000|STARTED|Overall Study||9
9023016|NCT03134092|10085863|FG001|STARTED|Overall Study||435
9023017|NCT03134092|10085864|FG002|STARTED|Overall Study||433
8749012|NCT01157117|9797646|FG001|COMPLETED|Overall Study|Completed final study visit at Month 38, 6 months after final Month 32 OFC.|18
8749013|NCT01157117|9797647|FG002|COMPLETED|Overall Study|Completed final study visit at Month 38, 6 months after final Month 32 OFC.|5
8749014|NCT01157117|9797645|FG000|NOT COMPLETED|Overall Study||9
8749015|NCT01157117|9797646|FG001|NOT COMPLETED|Overall Study||11
8749016|NCT01157117|9797647|FG002|NOT COMPLETED|Overall Study||15
8749017|NCT01157169|9797657|FG000|STARTED|First Intervention||20
8749018|NCT01157169|9797658|FG001|STARTED|First Intervention||20
8749019|NCT01157169|9797657|FG000|COMPLETED|First Intervention||16
8749020|NCT01157169|9797658|FG001|COMPLETED|First Intervention||18
8749021|NCT01157169|9797657|FG000|NOT COMPLETED|First Intervention||4
8749022|NCT01157169|9797658|FG001|NOT COMPLETED|First Intervention||2
8749023|NCT01157169|9797657|FG000|STARTED|Washout of 10 Days||16
8749024|NCT01157169|9797658|FG001|STARTED|Washout of 10 Days||18
8749025|NCT01157169|9797657|FG000|COMPLETED|Washout of 10 Days||16
8749026|NCT01157169|9797658|FG001|COMPLETED|Washout of 10 Days||18
8749027|NCT01157169|9797657|FG000|NOT COMPLETED|Washout of 10 Days||0
8749028|NCT01157169|9797658|FG001|NOT COMPLETED|Washout of 10 Days||0
8749029|NCT01157169|9797657|FG000|STARTED|Second Intervention||16
8749030|NCT01157169|9797658|FG001|STARTED|Second Intervention||18
8749031|NCT01157169|9797657|FG000|COMPLETED|Second Intervention||16
8749032|NCT01157169|9797658|FG001|COMPLETED|Second Intervention||17
8749033|NCT01157169|9797657|FG000|NOT COMPLETED|Second Intervention||0
8749034|NCT01157169|9797658|FG001|NOT COMPLETED|Second Intervention||1
8749035|NCT01157182|9797666|FG000|STARTED|First Intervention||18
8749036|NCT01157182|9797667|FG001|STARTED|First Intervention||18
8749037|NCT01157182|9797666|FG000|COMPLETED|First Intervention||18
8749038|NCT01157182|9797667|FG001|COMPLETED|First Intervention||18
8749039|NCT01157182|9797666|FG000|NOT COMPLETED|First Intervention||0
8749040|NCT01157182|9797667|FG001|NOT COMPLETED|First Intervention||0
8749041|NCT01157182|9797666|FG000|STARTED|Washout of 28 Days||18
8749042|NCT01157182|9797667|FG001|STARTED|Washout of 28 Days||18
8749043|NCT01157182|9797666|FG000|COMPLETED|Washout of 28 Days||16
8749044|NCT01157182|9797667|FG001|COMPLETED|Washout of 28 Days||18
8749045|NCT01157182|9797666|FG000|NOT COMPLETED|Washout of 28 Days||2
8749046|NCT01157182|9797667|FG001|NOT COMPLETED|Washout of 28 Days||0
8749047|NCT01157182|9797666|FG000|STARTED|Second Intervention||16
8749048|NCT01157182|9797667|FG001|STARTED|Second Intervention||18
8749049|NCT01157182|9797666|FG000|COMPLETED|Second Intervention||16
8749050|NCT01157182|9797667|FG001|COMPLETED|Second Intervention||18
8749051|NCT01157182|9797666|FG000|NOT COMPLETED|Second Intervention||0
8914362|NCT02167815|9973786|FG001|STARTED|Overall Study||21
8914363|NCT02167815|9973785|FG000|COMPLETED|Overall Study||9
8914364|NCT02167815|9973786|FG001|COMPLETED|Overall Study||21
8914365|NCT02167815|9973785|FG000|NOT COMPLETED|Overall Study||0
8914366|NCT02167815|9973786|FG001|NOT COMPLETED|Overall Study||0
8914367|NCT02167867|9973796|FG000|STARTED|Overall Study||22
8914368|NCT02167867|9973797|FG001|STARTED|Overall Study||22
8914369|NCT02167867|9973796|FG000|COMPLETED|Overall Study||22
8914370|NCT02167867|9973797|FG001|COMPLETED|Overall Study||22
8914371|NCT02167867|9973796|FG000|NOT COMPLETED|Overall Study||0
8914372|NCT02167867|9973797|FG001|NOT COMPLETED|Overall Study||0
8914373|NCT02167893|9973802|FG000|STARTED|Overall Study||11288
8914374|NCT02167893|9973802|FG000|COMPLETED|Overall Study||11125
8914375|NCT02167893|9973802|FG000|NOT COMPLETED|Overall Study||163
8914376|NCT02168062|9973809|FG000|STARTED|Overall Study||23
8914377|NCT02168062|9973810|FG001|STARTED|Overall Study||26
8914378|NCT02168062|9973811|FG002|STARTED|Overall Study||8
8914379|NCT02168062|9973809|FG000|COMPLETED|Overall Study||23
8914380|NCT02168062|9973810|FG001|COMPLETED|Overall Study||26
8914381|NCT02168062|9973811|FG002|COMPLETED|Overall Study||8
8914382|NCT02168062|9973809|FG000|NOT COMPLETED|Overall Study||0
8914383|NCT02168062|9973810|FG001|NOT COMPLETED|Overall Study||0
8914384|NCT02168062|9973811|FG002|NOT COMPLETED|Overall Study||0
8914385|NCT02168101|9973824|FG000|STARTED|Overall Study||3
8914386|NCT02168101|9973825|FG001|STARTED|Overall Study||3
8914387|NCT02168101|9973826|FG002|STARTED|Overall Study||3
8914388|NCT02168101|9973824|FG000|COMPLETED|Overall Study||1
8914389|NCT02168101|9973825|FG001|COMPLETED|Overall Study||1
8914390|NCT02168101|9973826|FG002|COMPLETED|Overall Study||2
8914391|NCT02168101|9973824|FG000|NOT COMPLETED|Overall Study||2
8914392|NCT02168101|9973825|FG001|NOT COMPLETED|Overall Study||2
8914393|NCT02168101|9973826|FG002|NOT COMPLETED|Overall Study||1
8914394|NCT02168153|9973837|FG000|STARTED|Overall Study||60
8914395|NCT02168153|9973838|FG001|STARTED|Overall Study||60
8914396|NCT02168153|9973837|FG000|COMPLETED|Overall Study||57
8914397|NCT02168153|9973838|FG001|COMPLETED|Overall Study||60
8914398|NCT02168153|9973837|FG000|NOT COMPLETED|Overall Study||3
8914399|NCT02168153|9973838|FG001|NOT COMPLETED|Overall Study||0
8914400|NCT02168309|9973846|FG000|STARTED|Overall Study||25
8914401|NCT02168309|9973847|FG001|STARTED|Overall Study||25
8914402|NCT02168309|9973846|FG000|COMPLETED|Overall Study||25
8914403|NCT02168309|9973847|FG001|COMPLETED|Overall Study||25
8914404|NCT02168309|9973846|FG000|NOT COMPLETED|Overall Study||0
8914405|NCT02168309|9973847|FG001|NOT COMPLETED|Overall Study||0
8749052|NCT01157182|9797667|FG001|NOT COMPLETED|Second Intervention||0
8749053|NCT01157234|9797675|FG000|STARTED|Overall Study||15
8749054|NCT01157234|9797676|FG001|STARTED|Overall Study||15
8749055|NCT01157234|9797675|FG000|COMPLETED|Overall Study||14
9023018|NCT03134092|10085862|FG000|COMPLETED|Overall Study||434
8749056|NCT01157234|9797676|FG001|COMPLETED|Overall Study||15
8749057|NCT01157234|9797675|FG000|NOT COMPLETED|Overall Study||1
8749058|NCT01157234|9797676|FG001|NOT COMPLETED|Overall Study||0
8749059|NCT01157351|9797691|FG000|STARTED|Overall Study||230
8749060|NCT01157351|9797692|FG001|STARTED|Overall Study||220
8749061|NCT01157351|9797691|FG000|Treated|Overall Study||226
8749062|NCT01157351|9797692|FG001|Treated|Overall Study||218
8749063|NCT01157351|9797691|FG000|COMPLETED|Overall Study||93
8749064|NCT01157351|9797692|FG001|COMPLETED|Overall Study||88
8749065|NCT01157351|9797691|FG000|NOT COMPLETED|Overall Study||137
8749066|NCT01157351|9797692|FG001|NOT COMPLETED|Overall Study||132
8749067|NCT01157364|9797704|FG000|STARTED|Overall Study||15
8749068|NCT01157364|9797705|FG001|STARTED|Overall Study||21
8749069|NCT01157364|9797706|FG002|STARTED|Overall Study||21
8749070|NCT01157364|9797707|FG003|STARTED|Overall Study||18
8749071|NCT01157364|9797708|FG004|STARTED|Overall Study||11
8749072|NCT01157364|9797709|FG005|STARTED|Overall Study||23
8749073|NCT01157364|9797704|FG000|COMPLETED|Overall Study||13
8749074|NCT01157364|9797705|FG001|COMPLETED|Overall Study||17
8749075|NCT01157364|9797706|FG002|COMPLETED|Overall Study||17
8749076|NCT01157364|9797707|FG003|COMPLETED|Overall Study||16
8749077|NCT01157364|9797708|FG004|COMPLETED|Overall Study||9
8749078|NCT01157364|9797709|FG005|COMPLETED|Overall Study||22
8749079|NCT01157364|9797704|FG000|NOT COMPLETED|Overall Study||2
8749080|NCT01157364|9797705|FG001|NOT COMPLETED|Overall Study||4
8749081|NCT01157364|9797706|FG002|NOT COMPLETED|Overall Study||4
8749082|NCT01157364|9797707|FG003|NOT COMPLETED|Overall Study||2
8749083|NCT01157364|9797708|FG004|NOT COMPLETED|Overall Study||2
8749084|NCT01157364|9797709|FG005|NOT COMPLETED|Overall Study||1
8749085|NCT01157377|9797730|FG000|STARTED|Overall Study||23
8749086|NCT01157377|9797731|FG001|STARTED|Overall Study||23
8749087|NCT01157377|9797732|FG002|STARTED|Overall Study||27
8749088|NCT01157377|9797733|FG003|STARTED|Overall Study||15
8749089|NCT01157377|9797734|FG004|STARTED|Overall Study||20
8749090|NCT01157377|9797735|FG005|STARTED|Overall Study||19
8749091|NCT01157377|9797736|FG006|STARTED|Overall Study||29
8749092|NCT01157377|9797730|FG000|COMPLETED|Overall Study||21
8749093|NCT01157377|9797731|FG001|COMPLETED|Overall Study||20
8749094|NCT01157377|9797732|FG002|COMPLETED|Overall Study||26
8749095|NCT01157377|9797733|FG003|COMPLETED|Overall Study||14
8749096|NCT01157377|9797734|FG004|COMPLETED|Overall Study||18
8749097|NCT01157377|9797735|FG005|COMPLETED|Overall Study||16
8749098|NCT01157377|9797736|FG006|COMPLETED|Overall Study||27
8749099|NCT01157377|9797730|FG000|NOT COMPLETED|Overall Study||2
8749100|NCT01157377|9797731|FG001|NOT COMPLETED|Overall Study||3
8749101|NCT01157377|9797732|FG002|NOT COMPLETED|Overall Study||1
8749102|NCT01157377|9797733|FG003|NOT COMPLETED|Overall Study||1
8749103|NCT01157377|9797734|FG004|NOT COMPLETED|Overall Study||2
8749104|NCT01157377|9797735|FG005|NOT COMPLETED|Overall Study||3
8749105|NCT01157377|9797736|FG006|NOT COMPLETED|Overall Study||2
8749106|NCT01157416|9797754|FG000|STARTED|Overall Study||17
8749107|NCT01157416|9797755|FG001|STARTED|Overall Study||16
8749108|NCT01157416|9797754|FG000|COMPLETED|Overall Study||15
8749109|NCT01157416|9797755|FG001|COMPLETED|Overall Study||16
8749110|NCT01157416|9797754|FG000|NOT COMPLETED|Overall Study||2
8749111|NCT01157416|9797755|FG001|NOT COMPLETED|Overall Study||0
8749112|NCT01157429|9797763|FG000|STARTED|Overall Study||12
8749113|NCT01157429|9797764|FG001|STARTED|Overall Study||12
8749114|NCT01157429|9797763|FG000|COMPLETED|Overall Study||8
8749115|NCT01157429|9797764|FG001|COMPLETED|Overall Study||8
8749116|NCT01157429|9797763|FG000|NOT COMPLETED|Overall Study||4
8749117|NCT01157429|9797764|FG001|NOT COMPLETED|Overall Study||4
8749118|NCT01157676|9797772|FG000|STARTED|Enrollment||174
8749119|NCT01157676|9797773|FG001|STARTED|Enrollment||176
8749120|NCT01157676|9797772|FG000|COMPLETED|Enrollment||174
8749121|NCT01157676|9797773|FG001|COMPLETED|Enrollment||176
8749122|NCT01157676|9797772|FG000|NOT COMPLETED|Enrollment||0
8749123|NCT01157676|9797773|FG001|NOT COMPLETED|Enrollment||0
8749124|NCT01157676|9797772|FG000|STARTED|Randomization||174
8749125|NCT01157676|9797773|FG001|STARTED|Randomization||176
8749126|NCT01157676|9797772|FG000|COMPLETED|Randomization||153
8749127|NCT01157676|9797773|FG001|COMPLETED|Randomization||159
8749128|NCT01157676|9797772|FG000|NOT COMPLETED|Randomization||21
8749129|NCT01157676|9797773|FG001|NOT COMPLETED|Randomization||17
8749130|NCT01157676|9797772|FG000|STARTED|Surgery||153
8749131|NCT01157676|9797773|FG001|STARTED|Surgery||159
8749132|NCT01157676|9797772|FG000|COMPLETED|Surgery||152
8749133|NCT01157676|9797773|FG001|COMPLETED|Surgery|advanced disease=2, inadequate visualization=1, inability to tolerate position=1, colonic mass=1.|150
8749134|NCT01157676|9797772|FG000|NOT COMPLETED|Surgery||1
8749135|NCT01157676|9797773|FG001|NOT COMPLETED|Surgery||9
8749136|NCT01157845|9797785|FG000|STARTED|Overall Study||165
8749137|NCT01157845|9797785|FG000|COMPLETED|Overall Study||130
8749138|NCT01157845|9797785|FG000|NOT COMPLETED|Overall Study||35
8749139|NCT01157897|9797793|FG000|STARTED|Overall Study||10
8749140|NCT01157897|9797794|FG001|STARTED|Overall Study||10
8749141|NCT01157897|9797795|FG002|STARTED|Overall Study||10
8749142|NCT01157897|9797796|FG003|STARTED|Overall Study||6
8749143|NCT01157897|9797793|FG000|COMPLETED|Overall Study||8
8749144|NCT01157897|9797794|FG001|COMPLETED|Overall Study||8
8749145|NCT01157897|9797795|FG002|COMPLETED|Overall Study||10
8749146|NCT01157897|9797796|FG003|COMPLETED|Overall Study||5
8749147|NCT01157897|9797793|FG000|NOT COMPLETED|Overall Study||2
8749148|NCT01157897|9797794|FG001|NOT COMPLETED|Overall Study||2
8749149|NCT01157897|9797795|FG002|NOT COMPLETED|Overall Study||0
8749150|NCT01157897|9797796|FG003|NOT COMPLETED|Overall Study||1
8749151|NCT01158118|9797808|FG000|STARTED|Overall Study||24
8749152|NCT01158118|9797809|FG001|STARTED|Overall Study||24
8749153|NCT01158118|9797808|FG000|COMPLETED|Overall Study||23
8749154|NCT01158118|9797809|FG001|COMPLETED|Overall Study||21
8749155|NCT01158118|9797808|FG000|NOT COMPLETED|Overall Study||1
8749156|NCT01158118|9797809|FG001|NOT COMPLETED|Overall Study||3
8749157|NCT01158157|9797815|FG000|STARTED|Overall Study|61 subjects screened; 25 subjects were vaccinated; 36 subjects were not eligible.|25
8749158|NCT01158157|9797815|FG000|COMPLETED|Overall Study||25
8749159|NCT01158157|9797815|FG000|NOT COMPLETED|Overall Study||0
8749160|NCT01158222|9797819|FG000|STARTED|Overall Study||37
8749161|NCT01158222|9797819|FG000|COMPLETED|Overall Study||20
8749162|NCT01158222|9797819|FG000|NOT COMPLETED|Overall Study||17
8749163|NCT01158261|9797823|FG000|STARTED|Overall Study||300
8749164|NCT01158261|9797823|FG000|COMPLETED|Overall Study||283
8749165|NCT01158261|9797823|FG000|NOT COMPLETED|Overall Study||17
8749166|NCT01158378|9797829|FG000|STARTED|Overall Study||124
8749167|NCT01158378|9797830|FG001|STARTED|Overall Study||126
8749168|NCT01158378|9797829|FG000|COMPLETED|Overall Study||114
8749169|NCT01158378|9797830|FG001|COMPLETED|Overall Study||117
8749170|NCT01158378|9797829|FG000|NOT COMPLETED|Overall Study||10
8749171|NCT01158378|9797830|FG001|NOT COMPLETED|Overall Study||9
8749172|NCT01158404|9797845|FG000|STARTED|Overall Study||3
8749173|NCT01158404|9797846|FG001|STARTED|Overall Study||4
8749174|NCT01158404|9797847|FG002|STARTED|Overall Study||3
8749175|NCT01158404|9797848|FG003|STARTED|Overall Study||3
8749176|NCT01158404|9797849|FG004|STARTED|Overall Study||6
8749177|NCT01158404|9797850|FG005|STARTED|Overall Study||5
8749178|NCT01158404|9797851|FG006|STARTED|Overall Study||3
8749179|NCT01158404|9797852|FG007|STARTED|Overall Study||8
8749180|NCT01158404|9797845|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
8749181|NCT01158404|9797846|FG001|Received at Least 1 Dose of Study Drug|Overall Study||4
8749182|NCT01158404|9797847|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
8749183|NCT01158404|9797848|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
8749184|NCT01158404|9797849|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6
8749185|NCT01158404|9797850|FG005|Received at Least 1 Dose of Study Drug|Overall Study||5
8749186|NCT01158404|9797851|FG006|Received at Least 1 Dose of Study Drug|Overall Study||3
8749187|NCT01158404|9797852|FG007|Received at Least 1 Dose of Study Drug|Overall Study||8
8749188|NCT01158404|9797845|FG000|COMPLETED|Overall Study||3
8749189|NCT01158404|9797846|FG001|COMPLETED|Overall Study||3
8749190|NCT01158404|9797847|FG002|COMPLETED|Overall Study||3
8749191|NCT01158404|9797848|FG003|COMPLETED|Overall Study||3
8749192|NCT01158404|9797849|FG004|COMPLETED|Overall Study||3
8749193|NCT01158404|9797850|FG005|COMPLETED|Overall Study||4
8749194|NCT01158404|9797851|FG006|COMPLETED|Overall Study||2
8914406|NCT02168361|9973855|FG000|STARTED|Overall Study||62
8914407|NCT02168361|9973856|FG001|STARTED|Overall Study||31
8914408|NCT02168361|9973855|FG000|COMPLETED|Overall Study||57
8914409|NCT02168361|9973856|FG001|COMPLETED|Overall Study||21
8914410|NCT02168361|9973855|FG000|NOT COMPLETED|Overall Study||5
8914411|NCT02168361|9973856|FG001|NOT COMPLETED|Overall Study||10
8914412|NCT02168387|9973864|FG000|STARTED|Overall Study||20
8914413|NCT02168387|9973865|FG001|STARTED|Overall Study||19
8914414|NCT02168387|9973864|FG000|COMPLETED|Overall Study||13
8914415|NCT02168387|9973865|FG001|COMPLETED|Overall Study||16
8914416|NCT02168387|9973864|FG000|NOT COMPLETED|Overall Study||7
8914417|NCT02168387|9973865|FG001|NOT COMPLETED|Overall Study||3
8914418|NCT02168439|9973873|FG000|STARTED|Overall Study||20
8914419|NCT02168439|9973874|FG001|STARTED|Overall Study||20
8914420|NCT02168439|9973873|FG000|COMPLETED|Overall Study||20
8914421|NCT02168439|9973874|FG001|COMPLETED|Overall Study||18
8914422|NCT02168439|9973873|FG000|NOT COMPLETED|Overall Study||0
8914423|NCT02168439|9973874|FG001|NOT COMPLETED|Overall Study||2
8914424|NCT02168478|9973880|FG000|STARTED|Overall Study||206
8914425|NCT02168478|9973880|FG000|COMPLETED|Overall Study||202
8914426|NCT02168478|9973880|FG000|NOT COMPLETED|Overall Study||4
8914427|NCT02168491|9973884|FG000|STARTED|Overall Study||9
8914428|NCT02168491|9973884|FG000|COMPLETED|Overall Study||8
8914429|NCT02168491|9973884|FG000|NOT COMPLETED|Overall Study||1
8914430|NCT02168660|9973891|FG000|STARTED|Overall Study||38
8914431|NCT02168660|9973892|FG001|STARTED|Overall Study||35
9023019|NCT03134092|10085863|FG001|COMPLETED|Overall Study||435
8749195|NCT01158404|9797852|FG007|COMPLETED|Overall Study||6
8914432|NCT02168660|9973893|FG002|STARTED|Overall Study||36
8914433|NCT02168660|9973891|FG000|COMPLETED|Overall Study||22
8914434|NCT02168660|9973892|FG001|COMPLETED|Overall Study||18
8914435|NCT02168660|9973893|FG002|COMPLETED|Overall Study||21
8914436|NCT02168660|9973891|FG000|NOT COMPLETED|Overall Study||16
8749196|NCT01158404|9797845|FG000|NOT COMPLETED|Overall Study||0
8749197|NCT01158404|9797846|FG001|NOT COMPLETED|Overall Study||1
8749198|NCT01158404|9797847|FG002|NOT COMPLETED|Overall Study||0
8749199|NCT01158404|9797848|FG003|NOT COMPLETED|Overall Study||0
8749200|NCT01158404|9797849|FG004|NOT COMPLETED|Overall Study||3
8749201|NCT01158404|9797850|FG005|NOT COMPLETED|Overall Study||1
8749202|NCT01158404|9797851|FG006|NOT COMPLETED|Overall Study||1
8749203|NCT01158404|9797852|FG007|NOT COMPLETED|Overall Study||2
8914437|NCT02168660|9973892|FG001|NOT COMPLETED|Overall Study||17
9023020|NCT03134092|10085864|FG002|COMPLETED|Overall Study||433
8749204|NCT01158521|9797872|FG000|STARTED|Overall Study||25
8749205|NCT01158521|9797872|FG000|COMPLETED|Overall Study||25
8749206|NCT01158521|9797872|FG000|NOT COMPLETED|Overall Study||0
8749207|NCT01158534|9797878|FG000|STARTED|Overall Study||17
8749208|NCT01158534|9797878|FG000|COMPLETED|Overall Study|All three pts that did not complete study had some treatment|14
8749209|NCT01158534|9797878|FG000|NOT COMPLETED|Overall Study||3
8749210|NCT01158573|9797886|FG000|STARTED|Overall Study|Aimed to recruit 160 from July 2010 to May 2013. Each subject studied on one time point only|30
9023021|NCT03134092|10085862|FG000|NOT COMPLETED|Overall Study||0
9023022|NCT03134092|10085863|FG001|NOT COMPLETED|Overall Study||0
9023023|NCT03134092|10085864|FG002|NOT COMPLETED|Overall Study||0
9023024|NCT03134144|10085878|FG000|STARTED|Overall Study||15
8749211|NCT01158573|9797887|FG001|STARTED|Overall Study||30
8749212|NCT01158573|9797888|FG002|STARTED|Overall Study||29
8749213|NCT01158573|9797889|FG003|STARTED|Overall Study||28
8749214|NCT01158573|9797886|FG000|COMPLETED|Overall Study|Study completed at 117 subjects.|30
8749215|NCT01158573|9797887|FG001|COMPLETED|Overall Study||30
8749216|NCT01158573|9797888|FG002|COMPLETED|Overall Study||29
8749217|NCT01158573|9797889|FG003|COMPLETED|Overall Study||28
8749218|NCT01158573|9797886|FG000|NOT COMPLETED|Overall Study||0
8749219|NCT01158573|9797887|FG001|NOT COMPLETED|Overall Study||0
8749220|NCT01158573|9797888|FG002|NOT COMPLETED|Overall Study||0
8749221|NCT01158573|9797889|FG003|NOT COMPLETED|Overall Study||0
8749222|NCT01158651|9797899|FG000|STARTED|Overall Study||23
8749223|NCT01158651|9797899|FG000|COMPLETED|Overall Study||22
8749224|NCT01158651|9797899|FG000|NOT COMPLETED|Overall Study||1
8749225|NCT01158703|9797905|FG000|STARTED|Overall Study||12
8749226|NCT01158703|9797906|FG001|STARTED|Overall Study||8
8749227|NCT01158703|9797905|FG000|COMPLETED|Overall Study||12
8749228|NCT01158703|9797906|FG001|COMPLETED|Overall Study||8
8749229|NCT01158703|9797905|FG000|NOT COMPLETED|Overall Study||0
8749230|NCT01158703|9797906|FG001|NOT COMPLETED|Overall Study||0
8749231|NCT01158716|9797914|FG000|STARTED|Overall Study||48
8749232|NCT01158716|9797915|FG001|STARTED|Overall Study||48
8749233|NCT01158716|9797914|FG000|COMPLETED|Overall Study||47
8749234|NCT01158716|9797915|FG001|COMPLETED|Overall Study||47
8749235|NCT01158716|9797914|FG000|NOT COMPLETED|Overall Study||1
8749236|NCT01158716|9797915|FG001|NOT COMPLETED|Overall Study||1
8749237|NCT01158820|9797923|FG000|STARTED|Overall Study||25
8749238|NCT01158820|9797924|FG001|STARTED|Overall Study||25
8749239|NCT01158820|9797923|FG000|COMPLETED|Overall Study||25
8749240|NCT01158820|9797924|FG001|COMPLETED|Overall Study||25
8749241|NCT01158820|9797923|FG000|NOT COMPLETED|Overall Study||0
8749242|NCT01158820|9797924|FG001|NOT COMPLETED|Overall Study||0
8749243|NCT01158885|9797931|FG000|STARTED|Treatment Course 1||2
8749244|NCT01158885|9797931|FG000|COMPLETED|Treatment Course 1||2
8749245|NCT01158885|9797931|FG000|NOT COMPLETED|Treatment Course 1||0
8749246|NCT01158885|9797931|FG000|STARTED|Treatment Course 2|Neither of the patients that were treated on Treatment Course 1 were eligible to proceed to Course 2|0
8749247|NCT01158885|9797931|FG000|COMPLETED|Treatment Course 2||0
8749248|NCT01158885|9797931|FG000|NOT COMPLETED|Treatment Course 2||0
8749249|NCT01158924|9797937|FG000|STARTED|Overall Study||14
8749250|NCT01158924|9797938|FG001|STARTED|Overall Study||26
8749251|NCT01158924|9797937|FG000|COMPLETED|Overall Study||13
8749252|NCT01158924|9797938|FG001|COMPLETED|Overall Study||23
8749253|NCT01158924|9797937|FG000|NOT COMPLETED|Overall Study||1
8749254|NCT01158924|9797938|FG001|NOT COMPLETED|Overall Study||3
8749255|NCT01158950|9797944|FG000|STARTED|1st Intervention (1 Day)||13
8749256|NCT01158950|9797945|FG001|STARTED|1st Intervention (1 Day)||13
8749257|NCT01158950|9797944|FG000|Data Collected|1st Intervention (1 Day)||12
8749258|NCT01158950|9797945|FG001|Data Collected|1st Intervention (1 Day)||11
8749259|NCT01158950|9797944|FG000|COMPLETED|1st Intervention (1 Day)||12
8749260|NCT01158950|9797945|FG001|COMPLETED|1st Intervention (1 Day)||11
8749261|NCT01158950|9797944|FG000|NOT COMPLETED|1st Intervention (1 Day)||1
8749262|NCT01158950|9797945|FG001|NOT COMPLETED|1st Intervention (1 Day)||2
8749263|NCT01158950|9797944|FG000|STARTED|Washout (1 Week)||12
8749264|NCT01158950|9797945|FG001|STARTED|Washout (1 Week)||11
8749265|NCT01158950|9797944|FG000|COMPLETED|Washout (1 Week)||12
8749266|NCT01158950|9797945|FG001|COMPLETED|Washout (1 Week)||11
8749267|NCT01158950|9797944|FG000|NOT COMPLETED|Washout (1 Week)||0
8749268|NCT01158950|9797945|FG001|NOT COMPLETED|Washout (1 Week)||0
8749269|NCT01158950|9797944|FG000|STARTED|2nd Intervention (1 Day)||12
8749270|NCT01158950|9797945|FG001|STARTED|2nd Intervention (1 Day)||11
8749271|NCT01158950|9797944|FG000|COMPLETED|2nd Intervention (1 Day)||12
8749272|NCT01158950|9797945|FG001|COMPLETED|2nd Intervention (1 Day)||11
8749273|NCT01158950|9797944|FG000|NOT COMPLETED|2nd Intervention (1 Day)||0
8749274|NCT01158950|9797945|FG001|NOT COMPLETED|2nd Intervention (1 Day)||0
8749275|NCT01158976|9797952|FG000|STARTED|Overall Study||43
8749276|NCT01158976|9797953|FG001|STARTED|Overall Study||21
8749277|NCT01158976|9797952|FG000|COMPLETED|Overall Study||34
8749278|NCT01158976|9797953|FG001|COMPLETED|Overall Study||17
8749279|NCT01158976|9797952|FG000|NOT COMPLETED|Overall Study||9
8749280|NCT01158976|9797953|FG001|NOT COMPLETED|Overall Study||4
8749281|NCT01159015|9797961|FG000|STARTED|Overall Study||357
8749282|NCT01159015|9797962|FG001|STARTED|Overall Study||177
8749283|NCT01159015|9797961|FG000|COMPLETED|Overall Study||339
8749284|NCT01159015|9797962|FG001|COMPLETED|Overall Study||170
8749285|NCT01159015|9797961|FG000|NOT COMPLETED|Overall Study||18
8749286|NCT01159015|9797962|FG001|NOT COMPLETED|Overall Study||7
9023025|NCT03134144|10085879|FG001|STARTED|Overall Study||30
9023026|NCT03134144|10085878|FG000|COMPLETED|Overall Study||15
8749287|NCT01159054|9797968|FG000|STARTED|Overall Study||22
8749288|NCT01159054|9797968|FG000|COMPLETED|Overall Study||2
8749289|NCT01159054|9797968|FG000|NOT COMPLETED|Overall Study||20
8749290|NCT01159067|9797972|FG000|STARTED|Overall Study||1
8749291|NCT01159067|9797972|FG000|COMPLETED|Overall Study||1
8749292|NCT01159067|9797972|FG000|NOT COMPLETED|Overall Study||0
8749293|NCT01159171|9797976|FG000|STARTED|Overall Study||50
8749294|NCT01159171|9797976|FG000|COMPLETED|Overall Study||0
8749295|NCT01159171|9797976|FG000|NOT COMPLETED|Overall Study||50
8749296|NCT01159262|9797984|FG000|STARTED|Overall Study||14
8749297|NCT01159262|9797985|FG001|STARTED|Overall Study||14
8749298|NCT01159262|9797986|FG002|STARTED|Overall Study||8
8749299|NCT01159262|9797984|FG000|COMPLETED|Overall Study||14
8749300|NCT01159262|9797985|FG001|COMPLETED|Overall Study||14
8749301|NCT01159262|9797986|FG002|COMPLETED|Overall Study||8
8749302|NCT01159262|9797984|FG000|NOT COMPLETED|Overall Study||0
8749303|NCT01159262|9797985|FG001|NOT COMPLETED|Overall Study||0
8749304|NCT01159262|9797986|FG002|NOT COMPLETED|Overall Study||0
8749305|NCT01159431|9797996|FG000|STARTED|Overall Study||25
8749306|NCT01159431|9797997|FG001|STARTED|Overall Study||25
8749307|NCT01159431|9797996|FG000|COMPLETED|Overall Study||23
8749308|NCT01159431|9797997|FG001|COMPLETED|Overall Study||19
8749309|NCT01159431|9797996|FG000|NOT COMPLETED|Overall Study||2
8749310|NCT01159431|9797997|FG001|NOT COMPLETED|Overall Study||6
8749311|NCT01159535|9798013|FG000|STARTED|Overall Study||103
8749312|NCT01159535|9798014|FG001|STARTED|Overall Study||88
8749313|NCT01159535|9798015|FG002|STARTED|Overall Study||95
8749314|NCT01159535|9798013|FG000|COMPLETED|Overall Study||79
8749315|NCT01159535|9798014|FG001|COMPLETED|Overall Study||64
8749316|NCT01159535|9798015|FG002|COMPLETED|Overall Study||64
8749317|NCT01159535|9798013|FG000|NOT COMPLETED|Overall Study||24
8749318|NCT01159535|9798014|FG001|NOT COMPLETED|Overall Study||24
8749319|NCT01159535|9798015|FG002|NOT COMPLETED|Overall Study||31
8749320|NCT01159574|9798023|FG000|STARTED|Treatment Phase||121
8749321|NCT01159574|9798023|FG000|COMPLETED|Treatment Phase||100
8749322|NCT01159574|9798023|FG000|NOT COMPLETED|Treatment Phase||21
8749323|NCT01159574|9798023|FG000|STARTED|Follow Up Phase||112
8749324|NCT01159574|9798023|FG000|COMPLETED|Follow Up Phase|Completion defined as those that are no longer in long term follow up due to death.|92
8749325|NCT01159574|9798023|FG000|NOT COMPLETED|Follow Up Phase||20
8749326|NCT01159600|9798035|FG000|STARTED|Overall Study||207
8749327|NCT01159600|9798036|FG001|STARTED|Overall Study||217
8749328|NCT01159600|9798037|FG002|STARTED|Overall Study||214
8749329|NCT01159600|9798038|FG003|STARTED|Overall Study||69
8749330|NCT01159600|9798039|FG004|STARTED|Overall Study||225
8749331|NCT01159600|9798040|FG005|STARTED|Overall Study||226
8749332|NCT01159600|9798041|FG006|STARTED|Overall Study||218
8749333|NCT01159600|9798042|FG007|STARTED|Overall Study||103
8749334|NCT01159600|9798035|FG000|COMPLETED|Overall Study||186
8749335|NCT01159600|9798036|FG001|COMPLETED|Overall Study||209
8749336|NCT01159600|9798037|FG002|COMPLETED|Overall Study||196
8749337|NCT01159600|9798038|FG003|COMPLETED|Overall Study||58
8749338|NCT01159600|9798039|FG004|COMPLETED|Overall Study||201
8749339|NCT01159600|9798040|FG005|COMPLETED|Overall Study||208
8749340|NCT01159600|9798041|FG006|COMPLETED|Overall Study||199
8749341|NCT01159600|9798042|FG007|COMPLETED|Overall Study||85
8749342|NCT01159600|9798035|FG000|NOT COMPLETED|Overall Study||21
8749343|NCT01159600|9798036|FG001|NOT COMPLETED|Overall Study||8
8749344|NCT01159600|9798037|FG002|NOT COMPLETED|Overall Study||18
8749345|NCT01159600|9798038|FG003|NOT COMPLETED|Overall Study||11
8749346|NCT01159600|9798039|FG004|NOT COMPLETED|Overall Study||24
8749347|NCT01159600|9798040|FG005|NOT COMPLETED|Overall Study||18
8749348|NCT01159600|9798041|FG006|NOT COMPLETED|Overall Study||19
8749349|NCT01159600|9798042|FG007|NOT COMPLETED|Overall Study||18
8749350|NCT01159665|9798067|FG000|STARTED|Overall Study||9
8749351|NCT01159665|9798068|FG001|STARTED|Overall Study||9
8749352|NCT01159665|9798069|FG002|STARTED|Overall Study||8
8749353|NCT01159665|9798070|FG003|STARTED|Overall Study||4
8749354|NCT01159665|9798071|FG004|STARTED|Overall Study||4
8749355|NCT01159665|9798072|FG005|STARTED|Overall Study||4
8749356|NCT01159665|9798067|FG000|COMPLETED|Overall Study||9
8749357|NCT01159665|9798068|FG001|COMPLETED|Overall Study||8
8749358|NCT01159665|9798069|FG002|COMPLETED|Overall Study||8
8749359|NCT01159665|9798070|FG003|COMPLETED|Overall Study||4
8749360|NCT01159665|9798071|FG004|COMPLETED|Overall Study||4
8749361|NCT01159665|9798072|FG005|COMPLETED|Overall Study||4
8749362|NCT01159665|9798067|FG000|NOT COMPLETED|Overall Study||0
8749363|NCT01159665|9798068|FG001|NOT COMPLETED|Overall Study||1
8749364|NCT01159665|9798069|FG002|NOT COMPLETED|Overall Study||0
8749365|NCT01159665|9798070|FG003|NOT COMPLETED|Overall Study||0
8749366|NCT01159665|9798071|FG004|NOT COMPLETED|Overall Study||0
8749367|NCT01159665|9798072|FG005|NOT COMPLETED|Overall Study||0
8749368|NCT01159691|9798086|FG000|STARTED|Overall Study||76
8749369|NCT01159691|9798086|FG000|COMPLETED|Overall Study|Multiple discontinuation reasons were possible.|54
8749370|NCT01159691|9798086|FG000|NOT COMPLETED|Overall Study||22
9023027|NCT03134144|10085879|FG001|COMPLETED|Overall Study||30
8749371|NCT01159743|9798092|FG000|STARTED|Overall Study||237
8749372|NCT01159743|9798093|FG001|STARTED|Overall Study||109
8749373|NCT01159743|9798092|FG000|COMPLETED|Overall Study||237
8749374|NCT01159743|9798093|FG001|COMPLETED|Overall Study||109
8749375|NCT01159743|9798092|FG000|NOT COMPLETED|Overall Study||0
8749376|NCT01159743|9798093|FG001|NOT COMPLETED|Overall Study||0
8749377|NCT01159769|9798099|FG000|STARTED|Overall Study||215
8749378|NCT01159769|9798099|FG000|COMPLETED|Overall Study||214
8749379|NCT01159769|9798099|FG000|NOT COMPLETED|Overall Study||1
8749380|NCT01159912|9798106|FG000|STARTED|Overall Study||115
8749381|NCT01159912|9798107|FG001|STARTED|Overall Study||114
8749382|NCT01159912|9798108|FG002|STARTED|Overall Study||114
8749383|NCT01159912|9798106|FG000|COMPLETED|Overall Study||75
8749384|NCT01159912|9798107|FG001|COMPLETED|Overall Study||92
8749385|NCT01159912|9798108|FG002|COMPLETED|Overall Study||88
8749386|NCT01159912|9798106|FG000|NOT COMPLETED|Overall Study||40
8749387|NCT01159912|9798107|FG001|NOT COMPLETED|Overall Study||22
8749388|NCT01159912|9798108|FG002|NOT COMPLETED|Overall Study||26
8749389|NCT01159938|9798119|FG000|STARTED|First Study Period||26
8749390|NCT01159938|9798120|FG001|STARTED|First Study Period||11
8749391|NCT01159938|9798121|FG002|STARTED|First Study Period||11
8749392|NCT01159938|9798122|FG003|STARTED|First Study Period||12
8749393|NCT01159938|9798123|FG004|STARTED|First Study Period||12
8749394|NCT01159938|9798119|FG000|Received at Least 1 Dose of Study Drug|First Study Period||0
8749395|NCT01159938|9798120|FG001|Received at Least 1 Dose of Study Drug|First Study Period||11
8749396|NCT01159938|9798121|FG002|Received at Least 1 Dose of Study Drug|First Study Period||11
8749397|NCT01159938|9798122|FG003|Received at Least 1 Dose of Study Drug|First Study Period||12
8749398|NCT01159938|9798123|FG004|Received at Least 1 Dose of Study Drug|First Study Period||12
8749399|NCT01159938|9798119|FG000|Safety and Efficacy Analysis Population|First Study Period|One healthy participant completed study but was excluded from analyses (major protocol violation).|25
8749400|NCT01159938|9798120|FG001|Safety and Efficacy Analysis Population|First Study Period||11
8749401|NCT01159938|9798121|FG002|Safety and Efficacy Analysis Population|First Study Period|Microalbuminuria relaxed with protocol amendment. T2DM albuminuria participant included in analyses.|11
8749402|NCT01159938|9798122|FG003|Safety and Efficacy Analysis Population|First Study Period||12
8749403|NCT01159938|9798123|FG004|Safety and Efficacy Analysis Population|First Study Period||12
8749404|NCT01159938|9798119|FG000|COMPLETED|First Study Period||26
8749405|NCT01159938|9798120|FG001|COMPLETED|First Study Period||11
8749406|NCT01159938|9798121|FG002|COMPLETED|First Study Period||10
8749407|NCT01159938|9798122|FG003|COMPLETED|First Study Period||12
8749408|NCT01159938|9798123|FG004|COMPLETED|First Study Period||12
8749409|NCT01159938|9798119|FG000|NOT COMPLETED|First Study Period||0
8749410|NCT01159938|9798120|FG001|NOT COMPLETED|First Study Period||0
8749411|NCT01159938|9798121|FG002|NOT COMPLETED|First Study Period||1
8749412|NCT01159938|9798122|FG003|NOT COMPLETED|First Study Period||0
8749413|NCT01159938|9798123|FG004|NOT COMPLETED|First Study Period||0
8749414|NCT01159938|9798119|FG000|STARTED|Second Study Period||0
8749415|NCT01159938|9798120|FG001|STARTED|Second Study Period||11
8749416|NCT01159938|9798121|FG002|STARTED|Second Study Period||10
8749417|NCT01159938|9798122|FG003|STARTED|Second Study Period||12
8749418|NCT01159938|9798123|FG004|STARTED|Second Study Period||12
8749419|NCT01159938|9798119|FG000|COMPLETED|Second Study Period||0
8749420|NCT01159938|9798120|FG001|COMPLETED|Second Study Period||11
8749421|NCT01159938|9798121|FG002|COMPLETED|Second Study Period||10
8749422|NCT01159938|9798122|FG003|COMPLETED|Second Study Period||12
8749423|NCT01159938|9798123|FG004|COMPLETED|Second Study Period||12
8749424|NCT01159938|9798119|FG000|NOT COMPLETED|Second Study Period||0
8749425|NCT01159938|9798120|FG001|NOT COMPLETED|Second Study Period||0
8914438|NCT02168660|9973893|FG002|NOT COMPLETED|Overall Study||15
8914439|NCT02168777|9973907|FG000|STARTED|Overall Study||2
8914440|NCT02168777|9973908|FG001|STARTED|Overall Study||7
8914441|NCT02168777|9973909|FG002|STARTED|Overall Study||11
8914442|NCT02168777|9973907|FG000|COMPLETED|Overall Study||0
8914443|NCT02168777|9973908|FG001|COMPLETED|Overall Study||0
8914444|NCT02168777|9973909|FG002|COMPLETED|Overall Study||0
8914445|NCT02168777|9973907|FG000|NOT COMPLETED|Overall Study||2
8914446|NCT02168777|9973908|FG001|NOT COMPLETED|Overall Study||7
8914447|NCT02168777|9973909|FG002|NOT COMPLETED|Overall Study||11
8914448|NCT02168803|9973923|FG000|STARTED|Overall Study||30
8914449|NCT02168803|9973924|FG001|STARTED|Overall Study||32
8914450|NCT02168803|9973925|FG002|STARTED|Overall Study||39
8914451|NCT02168803|9973923|FG000|Received at Least 1 Dose of Study Drug|Overall Study||30
8914452|NCT02168803|9973924|FG001|Received at Least 1 Dose of Study Drug|Overall Study||32
8914453|NCT02168803|9973925|FG002|Received at Least 1 Dose of Study Drug|Overall Study||39
8914454|NCT02168803|9973923|FG000|COMPLETED|Overall Study||28
8914455|NCT02168803|9973924|FG001|COMPLETED|Overall Study||29
8914456|NCT02168803|9973925|FG002|COMPLETED|Overall Study||33
8914457|NCT02168803|9973923|FG000|NOT COMPLETED|Overall Study||2
8914458|NCT02168803|9973924|FG001|NOT COMPLETED|Overall Study||3
8914459|NCT02168803|9973925|FG002|NOT COMPLETED|Overall Study||6
8914460|NCT02168816|9973942|FG000|STARTED|Overall Study||5
8914461|NCT02168816|9973943|FG001|STARTED|Overall Study||7
8914462|NCT02168816|9973942|FG000|COMPLETED|Overall Study||3
8914463|NCT02168816|9973943|FG001|COMPLETED|Overall Study||5
8914464|NCT02168816|9973942|FG000|NOT COMPLETED|Overall Study||2
8914465|NCT02168816|9973943|FG001|NOT COMPLETED|Overall Study||2
8749426|NCT01159938|9798121|FG002|NOT COMPLETED|Second Study Period||0
8749427|NCT01159938|9798122|FG003|NOT COMPLETED|Second Study Period||0
8749428|NCT01159938|9798123|FG004|NOT COMPLETED|Second Study Period||0
8749429|NCT01160198|9798147|FG000|STARTED|Overall Study||89
8749430|NCT01160198|9798148|FG001|STARTED|Overall Study||91
8749431|NCT01160198|9798149|FG002|STARTED|Overall Study||90
8749432|NCT01160198|9798147|FG000|COMPLETED|Overall Study||87
8914466|NCT02168842|9973951|FG000|STARTED|Overall Study||170
8749433|NCT01160198|9798148|FG001|COMPLETED|Overall Study||88
8749434|NCT01160198|9798149|FG002|COMPLETED|Overall Study||89
8749435|NCT01160198|9798147|FG000|NOT COMPLETED|Overall Study||2
8749436|NCT01160198|9798148|FG001|NOT COMPLETED|Overall Study||3
8749437|NCT01160198|9798149|FG002|NOT COMPLETED|Overall Study||1
8749438|NCT01160211|9798160|FG000|STARTED|Overall Study||120
8749439|NCT01160211|9798161|FG001|STARTED|Overall Study||118
8749440|NCT01160211|9798162|FG002|STARTED|Overall Study||117
8749441|NCT01160211|9798160|FG000|Ongoing|Overall Study||90
8749442|NCT01160211|9798161|FG001|Ongoing|Overall Study||75
8749443|NCT01160211|9798162|FG002|Ongoing|Overall Study||79
8749444|NCT01160211|9798160|FG000|COMPLETED|Overall Study||21
8749445|NCT01160211|9798161|FG001|COMPLETED|Overall Study||31
8749446|NCT01160211|9798162|FG002|COMPLETED|Overall Study||30
8749447|NCT01160211|9798160|FG000|NOT COMPLETED|Overall Study||99
8749448|NCT01160211|9798161|FG001|NOT COMPLETED|Overall Study||87
8749449|NCT01160211|9798162|FG002|NOT COMPLETED|Overall Study||87
8749450|NCT01160237|9798174|FG000|STARTED|Overall Study||4
8749451|NCT01160237|9798175|FG001|STARTED|Overall Study||3
8749452|NCT01160237|9798176|FG002|STARTED|Overall Study||0
8749453|NCT01160237|9798174|FG000|COMPLETED|Overall Study||4
8749454|NCT01160237|9798175|FG001|COMPLETED|Overall Study||3
8749455|NCT01160237|9798176|FG002|COMPLETED|Overall Study||0
8749456|NCT01160237|9798174|FG000|NOT COMPLETED|Overall Study||0
8749457|NCT01160237|9798175|FG001|NOT COMPLETED|Overall Study||0
8749458|NCT01160237|9798176|FG002|NOT COMPLETED|Overall Study||0
8749459|NCT01160289|9798189|FG000|STARTED|Screening, Washout, and Lead-In Period||894
8749460|NCT01160289|9798190|FG001|STARTED|Screening, Washout, and Lead-In Period||0
8749461|NCT01160289|9798191|FG002|STARTED|Screening, Washout, and Lead-In Period||0
8749462|NCT01160289|9798192|FG003|STARTED|Screening, Washout, and Lead-In Period||0
8749463|NCT01160289|9798193|FG004|STARTED|Screening, Washout, and Lead-In Period||0
8749464|NCT01160289|9798194|FG005|STARTED|Screening, Washout, and Lead-In Period||0
8749465|NCT01160289|9798189|FG000|COMPLETED|Screening, Washout, and Lead-In Period||410
8749466|NCT01160289|9798190|FG001|COMPLETED|Screening, Washout, and Lead-In Period||0
8749467|NCT01160289|9798191|FG002|COMPLETED|Screening, Washout, and Lead-In Period||0
8749468|NCT01160289|9798192|FG003|COMPLETED|Screening, Washout, and Lead-In Period||0
8749469|NCT01160289|9798193|FG004|COMPLETED|Screening, Washout, and Lead-In Period||0
8914467|NCT02168842|9973952|FG001|STARTED|Overall Study||166
8914468|NCT02168842|9973951|FG000|COMPLETED|Overall Study||162
8914469|NCT02168842|9973952|FG001|COMPLETED|Overall Study||158
8914470|NCT02168842|9973951|FG000|NOT COMPLETED|Overall Study||8
8914471|NCT02168842|9973952|FG001|NOT COMPLETED|Overall Study||8
8914472|NCT02168855|9973962|FG000|STARTED|Overall Study||181
8914473|NCT02168855|9973963|FG001|STARTED|Overall Study||188
8914474|NCT02168855|9973962|FG000|COMPLETED|Overall Study||169
8914475|NCT02168855|9973963|FG001|COMPLETED|Overall Study||177
8914476|NCT02168855|9973962|FG000|NOT COMPLETED|Overall Study||12
8914477|NCT02168855|9973963|FG001|NOT COMPLETED|Overall Study||11
8914478|NCT02168933|9973971|FG000|STARTED|Overall Study||8
8914479|NCT02168933|9973971|FG000|COMPLETED|Overall Study||7
8914480|NCT02168933|9973971|FG000|NOT COMPLETED|Overall Study||1
8914481|NCT02168946|9973981|FG000|STARTED|Overall Study|2 additional subjects were randomized to Vabomere but did not receive study drug|50
8914482|NCT02168946|9973982|FG001|STARTED|Overall Study||25
8914483|NCT02168946|9973981|FG000|COMPLETED|Overall Study||38
8914484|NCT02168946|9973982|FG001|COMPLETED|Overall Study||20
8914485|NCT02168946|9973981|FG000|NOT COMPLETED|Overall Study||12
8914486|NCT02168946|9973982|FG001|NOT COMPLETED|Overall Study||5
8914487|NCT02169115|9973991|FG000|STARTED|Overall Study||19
8914488|NCT02169115|9973992|FG001|STARTED|Overall Study||21
8914489|NCT02169115|9973993|FG002|STARTED|Overall Study||21
8914490|NCT02169115|9973991|FG000|COMPLETED|Overall Study||19
8914491|NCT02169115|9973992|FG001|COMPLETED|Overall Study||21
8914492|NCT02169115|9973993|FG002|COMPLETED|Overall Study||21
8914493|NCT02169115|9973991|FG000|NOT COMPLETED|Overall Study||0
8914494|NCT02169115|9973992|FG001|NOT COMPLETED|Overall Study||0
8914495|NCT02169115|9973993|FG002|NOT COMPLETED|Overall Study||0
8914496|NCT02169219|9974002|FG000|STARTED|Overall Study||20
8914497|NCT02169219|9974002|FG000|COMPLETED|Overall Study||14
8914498|NCT02169219|9974002|FG000|NOT COMPLETED|Overall Study||6
8914499|NCT02169271|9974013|FG000|STARTED|Overall Study||49
8914500|NCT02169271|9974014|FG001|STARTED|Overall Study||49
8914501|NCT02169271|9974013|FG000|COMPLETED|Overall Study||48
8914502|NCT02169271|9974014|FG001|COMPLETED|Overall Study||47
8914503|NCT02169271|9974013|FG000|NOT COMPLETED|Overall Study||1
8749470|NCT01160289|9798194|FG005|COMPLETED|Screening, Washout, and Lead-In Period||0
8749471|NCT01160289|9798189|FG000|NOT COMPLETED|Screening, Washout, and Lead-In Period||484
8749472|NCT01160289|9798190|FG001|NOT COMPLETED|Screening, Washout, and Lead-In Period||0
8749473|NCT01160289|9798191|FG002|NOT COMPLETED|Screening, Washout, and Lead-In Period||0
8914504|NCT02169271|9974014|FG001|NOT COMPLETED|Overall Study||2
8914505|NCT02169284|9974022|FG000|STARTED|Overall Study||24
8914506|NCT02169284|9974023|FG001|STARTED|Overall Study||13
8914507|NCT02169284|9974022|FG000|COMPLETED|Overall Study||24
8914508|NCT02169284|9974023|FG001|COMPLETED|Overall Study||12
8914509|NCT02169284|9974022|FG000|NOT COMPLETED|Overall Study||0
8914510|NCT02169284|9974023|FG001|NOT COMPLETED|Overall Study||1
8914511|NCT02169336|9974034|FG000|STARTED|Overall Study||31
8914512|NCT02169336|9974035|FG001|STARTED|Overall Study||32
8914513|NCT02169336|9974036|FG002|STARTED|Overall Study||32
8914514|NCT02169336|9974034|FG000|COMPLETED|Overall Study||27
8749474|NCT01160289|9798192|FG003|NOT COMPLETED|Screening, Washout, and Lead-In Period||0
8749475|NCT01160289|9798193|FG004|NOT COMPLETED|Screening, Washout, and Lead-In Period||0
8749476|NCT01160289|9798194|FG005|NOT COMPLETED|Screening, Washout, and Lead-In Period||0
8749477|NCT01160289|9798189|FG000|STARTED|Post-Randomization Period||0
8749478|NCT01160289|9798190|FG001|STARTED|Post-Randomization Period||85
8749479|NCT01160289|9798191|FG002|STARTED|Post-Randomization Period||97
8749480|NCT01160289|9798192|FG003|STARTED|Post-Randomization Period||52
8749481|NCT01160289|9798193|FG004|STARTED|Post-Randomization Period||89
8749482|NCT01160289|9798194|FG005|STARTED|Post-Randomization Period||87
8749483|NCT01160289|9798189|FG000|Received at Least 1 Dose of Study Drug|Post-Randomization Period||0
8749484|NCT01160289|9798190|FG001|Received at Least 1 Dose of Study Drug|Post-Randomization Period||85
8749485|NCT01160289|9798191|FG002|Received at Least 1 Dose of Study Drug|Post-Randomization Period||97
8749486|NCT01160289|9798192|FG003|Received at Least 1 Dose of Study Drug|Post-Randomization Period||52
8749487|NCT01160289|9798193|FG004|Received at Least 1 Dose of Study Drug|Post-Randomization Period||89
8749488|NCT01160289|9798194|FG005|Received at Least 1 Dose of Study Drug|Post-Randomization Period||87
8749489|NCT01160289|9798189|FG000|COMPLETED|Post-Randomization Period||0
8749490|NCT01160289|9798190|FG001|COMPLETED|Post-Randomization Period||65
8749491|NCT01160289|9798191|FG002|COMPLETED|Post-Randomization Period||73
8749492|NCT01160289|9798192|FG003|COMPLETED|Post-Randomization Period||31
8749493|NCT01160289|9798193|FG004|COMPLETED|Post-Randomization Period||80
8749494|NCT01160289|9798194|FG005|COMPLETED|Post-Randomization Period||73
8749495|NCT01160289|9798189|FG000|NOT COMPLETED|Post-Randomization Period||0
8749496|NCT01160289|9798190|FG001|NOT COMPLETED|Post-Randomization Period||20
8749497|NCT01160289|9798191|FG002|NOT COMPLETED|Post-Randomization Period||24
8749498|NCT01160289|9798192|FG003|NOT COMPLETED|Post-Randomization Period||21
8749499|NCT01160289|9798193|FG004|NOT COMPLETED|Post-Randomization Period||9
8749500|NCT01160289|9798194|FG005|NOT COMPLETED|Post-Randomization Period||14
8749501|NCT01160354|9798210|FG000|STARTED|Overall Study||3
8749502|NCT01160354|9798211|FG001|STARTED|Overall Study||4
8749503|NCT01160354|9798212|FG002|STARTED|Overall Study||15
8749504|NCT01160354|9798210|FG000|COMPLETED|Overall Study||3
8749505|NCT01160354|9798211|FG001|COMPLETED|Overall Study||3
8749506|NCT01160354|9798212|FG002|COMPLETED|Overall Study||14
8749507|NCT01160354|9798210|FG000|NOT COMPLETED|Overall Study||0
8749508|NCT01160354|9798211|FG001|NOT COMPLETED|Overall Study||1
8749509|NCT01160354|9798212|FG002|NOT COMPLETED|Overall Study||1
8749510|NCT01160380|9798222|FG000|STARTED|Overall Study||25
8749511|NCT01160380|9798223|FG001|STARTED|Overall Study||25
8749512|NCT01160380|9798222|FG000|COMPLETED|Overall Study||17
8749513|NCT01160380|9798223|FG001|COMPLETED|Overall Study||20
8749514|NCT01160380|9798222|FG000|NOT COMPLETED|Overall Study||8
8749515|NCT01160380|9798223|FG001|NOT COMPLETED|Overall Study||5
8749516|NCT01160445|9798231|FG000|STARTED|Overall Study||7
8749517|NCT01160445|9798232|FG001|STARTED|Overall Study||2
8749518|NCT01160445|9798231|FG000|COMPLETED|Overall Study||7
8749519|NCT01160445|9798232|FG001|COMPLETED|Overall Study||2
8749520|NCT01160445|9798231|FG000|NOT COMPLETED|Overall Study||0
8749521|NCT01160445|9798232|FG001|NOT COMPLETED|Overall Study||0
8749522|NCT01160458|9798238|FG000|STARTED|Overall Study||20
8749523|NCT01160458|9798238|FG000|COMPLETED|Overall Study||20
8749524|NCT01160458|9798238|FG000|NOT COMPLETED|Overall Study||0
8749525|NCT01160484|9798242|FG000|STARTED|Overall Study||40
8749526|NCT01160484|9798242|FG000|COMPLETED|Overall Study||22
8749527|NCT01160484|9798242|FG000|NOT COMPLETED|Overall Study||18
8749528|NCT01160614|9798248|FG000|STARTED|Overall Study||5
8749529|NCT01160614|9798249|FG001|STARTED|Overall Study||25
8749530|NCT01160614|9798248|FG000|COMPLETED|Overall Study||5
8749531|NCT01160614|9798249|FG001|COMPLETED|Overall Study||23
8749532|NCT01160614|9798248|FG000|NOT COMPLETED|Overall Study||0
8749533|NCT01160614|9798249|FG001|NOT COMPLETED|Overall Study||2
8749534|NCT01160640|9798275|FG000|STARTED|Overall Study||117
8749535|NCT01160640|9798276|FG001|STARTED|Overall Study||116
8749536|NCT01160640|9798275|FG000|COMPLETED|Overall Study||113
8749537|NCT01160640|9798276|FG001|COMPLETED|Overall Study||110
8749538|NCT01160640|9798275|FG000|NOT COMPLETED|Overall Study||4
8749539|NCT01160640|9798276|FG001|NOT COMPLETED|Overall Study||6
8749540|NCT01160744|9798288|FG000|STARTED|Overall Study||71
8914515|NCT02169336|9974035|FG001|COMPLETED|Overall Study||28
8749541|NCT01160744|9798289|FG001|STARTED|Overall Study||69
8749542|NCT01160744|9798290|FG002|STARTED|Overall Study||69
8749543|NCT01160744|9798291|FG003|STARTED|Overall Study||71
8749544|NCT01160744|9798288|FG000|Received Study Drug|Overall Study||69
8749545|NCT01160744|9798289|FG001|Received Study Drug|Overall Study||67
8749546|NCT01160744|9798290|FG002|Received Study Drug|Overall Study||63
8749547|NCT01160744|9798291|FG003|Received Study Drug|Overall Study||71
8749548|NCT01160744|9798288|FG000|COMPLETED|Overall Study||60
8749549|NCT01160744|9798289|FG001|COMPLETED|Overall Study||64
8749550|NCT01160744|9798290|FG002|COMPLETED|Overall Study||62
8749551|NCT01160744|9798291|FG003|COMPLETED|Overall Study||67
8749552|NCT01160744|9798288|FG000|NOT COMPLETED|Overall Study||11
8749553|NCT01160744|9798289|FG001|NOT COMPLETED|Overall Study||5
8749554|NCT01160744|9798290|FG002|NOT COMPLETED|Overall Study||7
8749555|NCT01160744|9798291|FG003|NOT COMPLETED|Overall Study||4
8749556|NCT01160770|9798303|FG000|STARTED|Overall Study||267
8749557|NCT01160770|9798303|FG000|COMPLETED|Overall Study||188
8749558|NCT01160770|9798303|FG000|NOT COMPLETED|Overall Study||79
8749559|NCT01160822|9798314|FG000|STARTED|Overall Study||6
8749560|NCT01160822|9798315|FG001|STARTED|Overall Study||7
8749561|NCT01160822|9798316|FG002|STARTED|Overall Study||6
8749562|NCT01160822|9798317|FG003|STARTED|Overall Study||5
8749563|NCT01160822|9798318|FG004|STARTED|Overall Study||45
8749564|NCT01160822|9798319|FG005|STARTED|Overall Study||47
8749565|NCT01160822|9798320|FG006|STARTED|Overall Study||53
8749566|NCT01160822|9798314|FG000|COMPLETED|Overall Study||6
8749567|NCT01160822|9798315|FG001|COMPLETED|Overall Study||7
8749568|NCT01160822|9798316|FG002|COMPLETED|Overall Study||6
8749569|NCT01160822|9798317|FG003|COMPLETED|Overall Study||5
8749570|NCT01160822|9798318|FG004|COMPLETED|Overall Study||36
8749571|NCT01160822|9798319|FG005|COMPLETED|Overall Study||40
8749572|NCT01160822|9798320|FG006|COMPLETED|Overall Study||44
8749573|NCT01160822|9798314|FG000|NOT COMPLETED|Overall Study||0
8749574|NCT01160822|9798315|FG001|NOT COMPLETED|Overall Study||0
8749575|NCT01160822|9798316|FG002|NOT COMPLETED|Overall Study||0
8749576|NCT01160822|9798317|FG003|NOT COMPLETED|Overall Study||0
8749577|NCT01160822|9798318|FG004|NOT COMPLETED|Overall Study||9
8749578|NCT01160822|9798319|FG005|NOT COMPLETED|Overall Study||7
8749579|NCT01160822|9798320|FG006|NOT COMPLETED|Overall Study||9
8749580|NCT01160848|9798339|FG000|STARTED|Overall Study||12
8749581|NCT01160848|9798340|FG001|STARTED|Overall Study||8
8749582|NCT01160848|9798339|FG000|COMPLETED|Overall Study||12
8749583|NCT01160848|9798340|FG001|COMPLETED|Overall Study||8
8749584|NCT01160848|9798339|FG000|NOT COMPLETED|Overall Study||0
8749585|NCT01160848|9798340|FG001|NOT COMPLETED|Overall Study||0
8749586|NCT01161043|9798350|FG000|STARTED|Overall Study||83
8749587|NCT01161043|9798350|FG000|COMPLETED|Overall Study||80
8749588|NCT01161043|9798350|FG000|NOT COMPLETED|Overall Study||3
8749589|NCT01161121|9798354|FG000|STARTED|Overall Study||46
8749590|NCT01161121|9798354|FG000|COMPLETED|Overall Study||46
8749591|NCT01161121|9798354|FG000|NOT COMPLETED|Overall Study||0
8749592|NCT01161160|9798365|FG000|STARTED|Overall Study||76
8749593|NCT01161160|9798366|FG001|STARTED|Overall Study||75
8749594|NCT01161160|9798367|FG002|STARTED|Overall Study||58
8749595|NCT01161160|9798365|FG000|COMPLETED|Overall Study||76
8749596|NCT01161160|9798366|FG001|COMPLETED|Overall Study||75
8749597|NCT01161160|9798367|FG002|COMPLETED|Overall Study||58
8749598|NCT01161160|9798365|FG000|NOT COMPLETED|Overall Study||0
8749599|NCT01161160|9798366|FG001|NOT COMPLETED|Overall Study||0
8749600|NCT01161160|9798367|FG002|NOT COMPLETED|Overall Study||0
8749601|NCT01161173|9798375|FG000|STARTED|Overall Study||347
8749602|NCT01161173|9798375|FG000|COMPLETED|Overall Study||0
8749603|NCT01161173|9798375|FG000|NOT COMPLETED|Overall Study||347
8749604|NCT01161225|9798382|FG000|STARTED|Overall Study||59
8749605|NCT01161225|9798383|FG001|STARTED|Overall Study||53
8749606|NCT01161225|9798384|FG002|STARTED|Overall Study||14
8749607|NCT01161225|9798382|FG000|COMPLETED|Overall Study||45
8749608|NCT01161225|9798383|FG001|COMPLETED|Overall Study||44
8749609|NCT01161225|9798384|FG002|COMPLETED|Overall Study||12
8749610|NCT01161225|9798382|FG000|NOT COMPLETED|Overall Study||14
8749611|NCT01161225|9798383|FG001|NOT COMPLETED|Overall Study||9
8749612|NCT01161225|9798384|FG002|NOT COMPLETED|Overall Study||2
8749613|NCT01161329|9798398|FG000|STARTED|Overall Study||33
8749614|NCT01161329|9798399|FG001|STARTED|Overall Study||34
8749615|NCT01161329|9798398|FG000|COMPLETED|Overall Study||29
8749616|NCT01161329|9798399|FG001|COMPLETED|Overall Study||24
8749617|NCT01161329|9798398|FG000|NOT COMPLETED|Overall Study||4
8749618|NCT01161329|9798399|FG001|NOT COMPLETED|Overall Study||10
8749619|NCT01161407|9798408|FG000|STARTED|Overall Study||6
8749620|NCT01161407|9798409|FG001|STARTED|Overall Study||6
8749621|NCT01161407|9798408|FG000|COMPLETED|Overall Study||3
8749622|NCT01161407|9798409|FG001|COMPLETED|Overall Study||5
8749623|NCT01161407|9798408|FG000|NOT COMPLETED|Overall Study||3
8749624|NCT01161407|9798409|FG001|NOT COMPLETED|Overall Study||1
8749625|NCT01161420|9798415|FG000|STARTED|Inspire Therapy||126
8749626|NCT01161420|9798415|FG000|COMPLETED|Inspire Therapy||124
8749627|NCT01161420|9798415|FG000|NOT COMPLETED|Inspire Therapy||2
8749628|NCT01161420|9798415|FG000|STARTED|Withdrawal Study - Maintenance||23
8749629|NCT01161420|9798415|FG000|COMPLETED|Withdrawal Study - Maintenance||23
8749630|NCT01161420|9798415|FG000|NOT COMPLETED|Withdrawal Study - Maintenance||0
8749631|NCT01161420|9798415|FG000|STARTED|Withdrawal Study - Withdrawal||23
8749632|NCT01161420|9798415|FG000|COMPLETED|Withdrawal Study - Withdrawal||23
8749633|NCT01161420|9798415|FG000|NOT COMPLETED|Withdrawal Study - Withdrawal||0
8749634|NCT01161446|9798427|FG000|STARTED|Overall Study||116
8749635|NCT01161446|9798428|FG001|STARTED|Overall Study||114
8749636|NCT01161446|9798427|FG000|COMPLETED|Overall Study||98
8749637|NCT01161446|9798428|FG001|COMPLETED|Overall Study||99
8749638|NCT01161446|9798427|FG000|NOT COMPLETED|Overall Study||18
8749639|NCT01161446|9798428|FG001|NOT COMPLETED|Overall Study||15
8749640|NCT01161472|9798434|FG000|STARTED|First Intervention Period||5
8749641|NCT01161472|9798435|FG001|STARTED|First Intervention Period||5
8749642|NCT01161472|9798436|FG002|STARTED|First Intervention Period||5
8749643|NCT01161472|9798437|FG003|STARTED|First Intervention Period||5
8749644|NCT01161472|9798434|FG000|Treated|First Intervention Period||5
8749645|NCT01161472|9798435|FG001|Treated|First Intervention Period||5
8749646|NCT01161472|9798436|FG002|Treated|First Intervention Period||5
8749647|NCT01161472|9798437|FG003|Treated|First Intervention Period||5
8749648|NCT01161472|9798434|FG000|COMPLETED|First Intervention Period||5
8749649|NCT01161472|9798435|FG001|COMPLETED|First Intervention Period||5
8749650|NCT01161472|9798436|FG002|COMPLETED|First Intervention Period||5
8749651|NCT01161472|9798437|FG003|COMPLETED|First Intervention Period||5
8749652|NCT01161472|9798434|FG000|NOT COMPLETED|First Intervention Period||0
8749653|NCT01161472|9798435|FG001|NOT COMPLETED|First Intervention Period||0
8749654|NCT01161472|9798436|FG002|NOT COMPLETED|First Intervention Period||0
8749655|NCT01161472|9798437|FG003|NOT COMPLETED|First Intervention Period||0
8749656|NCT01161472|9798434|FG000|STARTED|Washout Period (At Least 3 to 6 Days)||5
8749657|NCT01161472|9798435|FG001|STARTED|Washout Period (At Least 3 to 6 Days)||5
8749658|NCT01161472|9798436|FG002|STARTED|Washout Period (At Least 3 to 6 Days)||5
8749659|NCT01161472|9798437|FG003|STARTED|Washout Period (At Least 3 to 6 Days)||5
8749660|NCT01161472|9798434|FG000|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
8749661|NCT01161472|9798435|FG001|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
8749662|NCT01161472|9798436|FG002|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
8749663|NCT01161472|9798437|FG003|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
8749664|NCT01161472|9798434|FG000|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
8749665|NCT01161472|9798435|FG001|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
8749666|NCT01161472|9798436|FG002|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
8749667|NCT01161472|9798437|FG003|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
8749668|NCT01161472|9798434|FG000|STARTED|Second Intervention Period||5
8749669|NCT01161472|9798435|FG001|STARTED|Second Intervention Period||5
8749670|NCT01161472|9798436|FG002|STARTED|Second Intervention Period||5
8749671|NCT01161472|9798437|FG003|STARTED|Second Intervention Period||5
8749672|NCT01161472|9798434|FG000|COMPLETED|Second Intervention Period||5
8749673|NCT01161472|9798435|FG001|COMPLETED|Second Intervention Period||5
8749674|NCT01161472|9798436|FG002|COMPLETED|Second Intervention Period||5
8749675|NCT01161472|9798437|FG003|COMPLETED|Second Intervention Period||5
8749676|NCT01161472|9798434|FG000|NOT COMPLETED|Second Intervention Period||0
8749677|NCT01161472|9798435|FG001|NOT COMPLETED|Second Intervention Period||0
8749678|NCT01161472|9798436|FG002|NOT COMPLETED|Second Intervention Period||0
8749679|NCT01161472|9798437|FG003|NOT COMPLETED|Second Intervention Period||0
8749680|NCT01161472|9798434|FG000|STARTED|Washout Period (At Least 3 to 6 Days)||5
8749681|NCT01161472|9798435|FG001|STARTED|Washout Period (At Least 3 to 6 Days)||5
8749682|NCT01161472|9798436|FG002|STARTED|Washout Period (At Least 3 to 6 Days)||5
8749683|NCT01161472|9798437|FG003|STARTED|Washout Period (At Least 3 to 6 Days)||5
8749684|NCT01161472|9798434|FG000|COMPLETED|Washout Period (At Least 3 to 6 Days)||4
8749685|NCT01161472|9798435|FG001|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
8749686|NCT01161472|9798436|FG002|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
8749687|NCT01161472|9798437|FG003|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
8749688|NCT01161472|9798434|FG000|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||1
8749689|NCT01161472|9798435|FG001|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
8749690|NCT01161472|9798436|FG002|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
8749691|NCT01161472|9798437|FG003|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
8749692|NCT01161472|9798434|FG000|STARTED|Third Intervention Period||4
8749693|NCT01161472|9798435|FG001|STARTED|Third Intervention Period||5
8749694|NCT01161472|9798436|FG002|STARTED|Third Intervention Period||5
8749695|NCT01161472|9798437|FG003|STARTED|Third Intervention Period||5
8749696|NCT01161472|9798434|FG000|COMPLETED|Third Intervention Period||4
8749697|NCT01161472|9798435|FG001|COMPLETED|Third Intervention Period||5
8749698|NCT01161472|9798436|FG002|COMPLETED|Third Intervention Period||5
8749699|NCT01161472|9798437|FG003|COMPLETED|Third Intervention Period||5
8749700|NCT01161472|9798434|FG000|NOT COMPLETED|Third Intervention Period||0
8749701|NCT01161472|9798435|FG001|NOT COMPLETED|Third Intervention Period||0
8749702|NCT01161472|9798436|FG002|NOT COMPLETED|Third Intervention Period||0
8749703|NCT01161472|9798437|FG003|NOT COMPLETED|Third Intervention Period||0
8749704|NCT01161472|9798434|FG000|STARTED|Washout Period (At Least 3 to 6 Days)||4
8749705|NCT01161472|9798435|FG001|STARTED|Washout Period (At Least 3 to 6 Days)||5
8749706|NCT01161472|9798436|FG002|STARTED|Washout Period (At Least 3 to 6 Days)||5
8749707|NCT01161472|9798437|FG003|STARTED|Washout Period (At Least 3 to 6 Days)||5
8749708|NCT01161472|9798434|FG000|COMPLETED|Washout Period (At Least 3 to 6 Days)||4
8749709|NCT01161472|9798435|FG001|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
8749710|NCT01161472|9798436|FG002|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
8749711|NCT01161472|9798437|FG003|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
8749712|NCT01161472|9798434|FG000|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
8749713|NCT01161472|9798435|FG001|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
8749714|NCT01161472|9798436|FG002|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
8749715|NCT01161472|9798437|FG003|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
8749716|NCT01161472|9798434|FG000|STARTED|Fourth Intervention Period||4
8749717|NCT01161472|9798435|FG001|STARTED|Fourth Intervention Period||5
8749718|NCT01161472|9798436|FG002|STARTED|Fourth Intervention Period||5
8749719|NCT01161472|9798437|FG003|STARTED|Fourth Intervention Period||5
8749720|NCT01161472|9798434|FG000|COMPLETED|Fourth Intervention Period||4
8749721|NCT01161472|9798435|FG001|COMPLETED|Fourth Intervention Period||5
8749722|NCT01161472|9798436|FG002|COMPLETED|Fourth Intervention Period||5
8749723|NCT01161472|9798437|FG003|COMPLETED|Fourth Intervention Period||5
8749724|NCT01161472|9798434|FG000|NOT COMPLETED|Fourth Intervention Period||0
8749725|NCT01161472|9798435|FG001|NOT COMPLETED|Fourth Intervention Period||0
8749726|NCT01161472|9798436|FG002|NOT COMPLETED|Fourth Intervention Period||0
8749727|NCT01161472|9798437|FG003|NOT COMPLETED|Fourth Intervention Period||0
8749728|NCT01161498|9798449|FG000|STARTED|Overall Study||3
8749729|NCT01161498|9798450|FG001|STARTED|Overall Study||2
8749730|NCT01161498|9798449|FG000|COMPLETED|Overall Study||3
8749731|NCT01161498|9798450|FG001|COMPLETED|Overall Study||1
8749732|NCT01161498|9798449|FG000|NOT COMPLETED|Overall Study||0
8749733|NCT01161498|9798450|FG001|NOT COMPLETED|Overall Study||1
8749734|NCT01161524|9798458|FG000|STARTED|Core Study (23 Weeks)||85
8749735|NCT01161524|9798459|FG001|STARTED|Core Study (23 Weeks)||48
8749736|NCT01161524|9798460|FG002|STARTED|Core Study (23 Weeks)||0
8749737|NCT01161524|9798458|FG000|COMPLETED|Core Study (23 Weeks)||76
8749738|NCT01161524|9798459|FG001|COMPLETED|Core Study (23 Weeks)||43
8749739|NCT01161524|9798460|FG002|COMPLETED|Core Study (23 Weeks)||0
8749740|NCT01161524|9798458|FG000|NOT COMPLETED|Core Study (23 Weeks)||9
8749741|NCT01161524|9798459|FG001|NOT COMPLETED|Core Study (23 Weeks)||5
8749742|NCT01161524|9798460|FG002|NOT COMPLETED|Core Study (23 Weeks)||0
8749743|NCT01161524|9798458|FG000|STARTED|Extension Phase (Approximately 83 Weeks)||0
8749744|NCT01161524|9798459|FG001|STARTED|Extension Phase (Approximately 83 Weeks)||0
8749745|NCT01161524|9798460|FG002|STARTED|Extension Phase (Approximately 83 Weeks)||114
8749746|NCT01161524|9798458|FG000|COMPLETED|Extension Phase (Approximately 83 Weeks)||0
8749747|NCT01161524|9798459|FG001|COMPLETED|Extension Phase (Approximately 83 Weeks)||0
8749748|NCT01161524|9798460|FG002|COMPLETED|Extension Phase (Approximately 83 Weeks)||90
8749749|NCT01161524|9798458|FG000|NOT COMPLETED|Extension Phase (Approximately 83 Weeks)||0
8749750|NCT01161524|9798459|FG001|NOT COMPLETED|Extension Phase (Approximately 83 Weeks)||0
8749751|NCT01161524|9798460|FG002|NOT COMPLETED|Extension Phase (Approximately 83 Weeks)||24
8749752|NCT01161537|9798469|FG000|STARTED|Part A||8
8749753|NCT01161537|9798469|FG000|COMPLETED|Part A||8
8749754|NCT01161537|9798469|FG000|NOT COMPLETED|Part A||0
8749755|NCT01161537|9798469|FG000|STARTED|Part B|4 subjects from Part A continued in Part B of the study.|9
8749756|NCT01161537|9798469|FG000|COMPLETED|Part B||7
8749757|NCT01161537|9798469|FG000|NOT COMPLETED|Part B||2
8749758|NCT01161563|9798480|FG000|STARTED|Overall Study||63
8749759|NCT01161563|9798481|FG001|STARTED|Overall Study||55
8749760|NCT01161563|9798480|FG000|COMPLETED|Overall Study||58
8749761|NCT01161563|9798481|FG001|COMPLETED|Overall Study||49
8749762|NCT01161563|9798480|FG000|NOT COMPLETED|Overall Study||5
8749763|NCT01161563|9798481|FG001|NOT COMPLETED|Overall Study||6
8749764|NCT01161628|9798487|FG000|STARTED|Overall Study||25
8749765|NCT01161628|9798487|FG000|COMPLETED|Overall Study||17
8749766|NCT01161628|9798487|FG000|NOT COMPLETED|Overall Study||8
8749767|NCT01161771|9798491|FG000|STARTED|Overall Study||32
8749768|NCT01161771|9798491|FG000|COMPLETED|Overall Study||32
8749769|NCT01161771|9798491|FG000|NOT COMPLETED|Overall Study||0
8749770|NCT01161862|9798497|FG000|STARTED|Overall Study||12
8749771|NCT01161862|9798498|FG001|STARTED|Overall Study||12
8749772|NCT01161862|9798497|FG000|COMPLETED|Overall Study||12
8749773|NCT01161862|9798498|FG001|COMPLETED|Overall Study||12
8749774|NCT01161862|9798497|FG000|NOT COMPLETED|Overall Study||0
8749775|NCT01161862|9798498|FG001|NOT COMPLETED|Overall Study||0
8749776|NCT01162005|9798509|FG000|STARTED|Overall Study||44
8749777|NCT01162005|9798510|FG001|STARTED|Overall Study||33
8749778|NCT01162005|9798509|FG000|COMPLETED|Overall Study||44
8749779|NCT01162005|9798510|FG001|COMPLETED|Overall Study||33
8749780|NCT01162005|9798509|FG000|NOT COMPLETED|Overall Study||0
8749781|NCT01162005|9798510|FG001|NOT COMPLETED|Overall Study||0
8749782|NCT01162096|9798518|FG000|STARTED|Overall Study||34
8749783|NCT01162096|9798518|FG000|COMPLETED|Overall Study||34
8749784|NCT01162096|9798518|FG000|NOT COMPLETED|Overall Study||0
8749785|NCT01162122|9798525|FG000|STARTED|Overall Study||3552
8749786|NCT01162122|9798526|FG001|STARTED|Overall Study||3552
8749787|NCT01162122|9798525|FG000|Vaccinated|Overall Study||3541
8749788|NCT01162122|9798526|FG001|Vaccinated|Overall Study||3541
8749789|NCT01162122|9798525|FG000|COMPLETED|Overall Study||3361
8749790|NCT01162122|9798526|FG001|COMPLETED|Overall Study||3356
8749791|NCT01162122|9798525|FG000|NOT COMPLETED|Overall Study||191
8749792|NCT01162122|9798526|FG001|NOT COMPLETED|Overall Study||196
8749793|NCT01162135|9798535|FG000|STARTED|Overall Study||16
8749794|NCT01162135|9798535|FG000|COMPLETED|Overall Study||13
8749795|NCT01162135|9798535|FG000|NOT COMPLETED|Overall Study||3
8749796|NCT01162239|9798543|FG000|STARTED|Treatment Phase||55
8749797|NCT01162239|9798544|FG001|STARTED|Treatment Phase||54
8749798|NCT01162239|9798545|FG002|STARTED|Treatment Phase||52
8749799|NCT01162239|9798546|FG003|STARTED|Treatment Phase||55
8749800|NCT01162239|9798543|FG000|Week 12|Treatment Phase||50
8749801|NCT01162239|9798544|FG001|Week 12|Treatment Phase||51
8749802|NCT01162239|9798545|FG002|Week 12|Treatment Phase||49
8749803|NCT01162239|9798546|FG003|Week 12|Treatment Phase||53
8749804|NCT01162239|9798543|FG000|Week 24|Treatment Phase||51
8749805|NCT01162239|9798544|FG001|Week 24|Treatment Phase||48
8749806|NCT01162239|9798545|FG002|Week 24|Treatment Phase||48
8749807|NCT01162239|9798546|FG003|Week 24|Treatment Phase||50
8749808|NCT01162239|9798543|FG000|Week 52|Treatment Phase||49
8749809|NCT01162239|9798544|FG001|Week 52|Treatment Phase||47
8749810|NCT01162239|9798545|FG002|Week 52|Treatment Phase||48
8749811|NCT01162239|9798546|FG003|Week 52|Treatment Phase||50
8749812|NCT01162239|9798543|FG000|COMPLETED|Treatment Phase||49
8749813|NCT01162239|9798544|FG001|COMPLETED|Treatment Phase||47
8749814|NCT01162239|9798545|FG002|COMPLETED|Treatment Phase||48
8749815|NCT01162239|9798546|FG003|COMPLETED|Treatment Phase||50
8749816|NCT01162239|9798543|FG000|NOT COMPLETED|Treatment Phase||6
8749817|NCT01162239|9798544|FG001|NOT COMPLETED|Treatment Phase||7
8749818|NCT01162239|9798545|FG002|NOT COMPLETED|Treatment Phase||4
8749819|NCT01162239|9798546|FG003|NOT COMPLETED|Treatment Phase||5
8749820|NCT01162239|9798543|FG000|STARTED|Extended Follow-up||47
8749821|NCT01162239|9798544|FG001|STARTED|Extended Follow-up||45
8749822|NCT01162239|9798545|FG002|STARTED|Extended Follow-up||45
8749823|NCT01162239|9798546|FG003|STARTED|Extended Follow-up||47
8749824|NCT01162239|9798543|FG000|COMPLETED|Extended Follow-up||39
8749825|NCT01162239|9798544|FG001|COMPLETED|Extended Follow-up||32
8749826|NCT01162239|9798545|FG002|COMPLETED|Extended Follow-up||37
8749827|NCT01162239|9798546|FG003|COMPLETED|Extended Follow-up||41
8749828|NCT01162239|9798543|FG000|NOT COMPLETED|Extended Follow-up||8
8749829|NCT01162239|9798544|FG001|NOT COMPLETED|Extended Follow-up||13
8749830|NCT01162239|9798545|FG002|NOT COMPLETED|Extended Follow-up||8
8749831|NCT01162239|9798546|FG003|NOT COMPLETED|Extended Follow-up||6
8749832|NCT01162317|9798559|FG000|STARTED|Overall Study||30
8749833|NCT01162317|9798560|FG001|STARTED|Overall Study||30
8749834|NCT01162317|9798559|FG000|COMPLETED|Overall Study||27
8749835|NCT01162317|9798560|FG001|COMPLETED|Overall Study||28
8749836|NCT01162317|9798559|FG000|NOT COMPLETED|Overall Study||3
8749837|NCT01162317|9798560|FG001|NOT COMPLETED|Overall Study||2
8749838|NCT01162343|9798566|FG000|STARTED|Overall Study||498
8749839|NCT01162343|9798566|FG000|COMPLETED|Overall Study||406
8749840|NCT01162343|9798566|FG000|NOT COMPLETED|Overall Study||92
8749841|NCT01162421|9798572|FG000|STARTED|Overall Study||37
8749842|NCT01162421|9798573|FG001|STARTED|Overall Study||40
8749843|NCT01162421|9798572|FG000|COMPLETED|Overall Study||29
8749844|NCT01162421|9798573|FG001|COMPLETED|Overall Study||27
8749845|NCT01162421|9798572|FG000|NOT COMPLETED|Overall Study||8
8749846|NCT01162421|9798573|FG001|NOT COMPLETED|Overall Study||13
8749847|NCT01162473|9798581|FG000|STARTED|Overall Study||8
8749848|NCT01162473|9798582|FG001|STARTED|Overall Study||17
8749849|NCT01162473|9798581|FG000|COMPLETED|Overall Study||6
8749850|NCT01162473|9798582|FG001|COMPLETED|Overall Study||12
8749851|NCT01162473|9798581|FG000|NOT COMPLETED|Overall Study||2
8749852|NCT01162473|9798582|FG001|NOT COMPLETED|Overall Study||5
8749853|NCT01162486|9798593|FG000|STARTED|Overall Study||8
8749854|NCT01162486|9798594|FG001|STARTED|Overall Study||6
8749855|NCT01162486|9798595|FG002|STARTED|Overall Study||6
8749856|NCT01162486|9798596|FG003|STARTED|Overall Study||7
8749857|NCT01162486|9798597|FG004|STARTED|Overall Study||6
8749858|NCT01162486|9798593|FG000|Took at Least One Dose Study Drug|Overall Study||8
8749859|NCT01162486|9798594|FG001|Took at Least One Dose Study Drug|Overall Study||6
8749860|NCT01162486|9798595|FG002|Took at Least One Dose Study Drug|Overall Study||6
8749861|NCT01162486|9798596|FG003|Took at Least One Dose Study Drug|Overall Study||7
8749862|NCT01162486|9798597|FG004|Took at Least One Dose Study Drug|Overall Study||6
8749863|NCT01162486|9798593|FG000|COMPLETED|Overall Study||6
8749864|NCT01162486|9798594|FG001|COMPLETED|Overall Study||6
8749865|NCT01162486|9798595|FG002|COMPLETED|Overall Study||5
8749866|NCT01162486|9798596|FG003|COMPLETED|Overall Study||6
8749867|NCT01162486|9798597|FG004|COMPLETED|Overall Study||6
8749868|NCT01162486|9798593|FG000|NOT COMPLETED|Overall Study||2
8749869|NCT01162486|9798594|FG001|NOT COMPLETED|Overall Study||0
8749870|NCT01162486|9798595|FG002|NOT COMPLETED|Overall Study||1
8749871|NCT01162486|9798596|FG003|NOT COMPLETED|Overall Study||1
8749872|NCT01162486|9798597|FG004|NOT COMPLETED|Overall Study||0
8749873|NCT01162499|9798613|FG000|STARTED|Intervention 1 (4 Hours)||3
8749874|NCT01162499|9798614|FG001|STARTED|Intervention 1 (4 Hours)||4
8749875|NCT01162499|9798613|FG000|Received Intervention|Intervention 1 (4 Hours)||3
8749876|NCT01162499|9798614|FG001|Received Intervention|Intervention 1 (4 Hours)||3
8749877|NCT01162499|9798613|FG000|COMPLETED|Intervention 1 (4 Hours)||3
8749878|NCT01162499|9798614|FG001|COMPLETED|Intervention 1 (4 Hours)||3
8749879|NCT01162499|9798613|FG000|NOT COMPLETED|Intervention 1 (4 Hours)||0
8749880|NCT01162499|9798614|FG001|NOT COMPLETED|Intervention 1 (4 Hours)||1
8749881|NCT01162499|9798613|FG000|STARTED|Intervention 2 (4 Hours)||3
8749882|NCT01162499|9798614|FG001|STARTED|Intervention 2 (4 Hours)||3
8749883|NCT01162499|9798613|FG000|COMPLETED|Intervention 2 (4 Hours)||3
8749884|NCT01162499|9798614|FG001|COMPLETED|Intervention 2 (4 Hours)||3
8749885|NCT01162499|9798613|FG000|NOT COMPLETED|Intervention 2 (4 Hours)||0
8749886|NCT01162499|9798614|FG001|NOT COMPLETED|Intervention 2 (4 Hours)||0
8749887|NCT01162551|9798622|FG000|STARTED|Overall Study|2 subjects were enrolled but withdrew before receiving any study treatment|3
8749888|NCT01162551|9798622|FG000|COMPLETED|Overall Study||3
8749889|NCT01162551|9798622|FG000|NOT COMPLETED|Overall Study||0
8749890|NCT01162733|9798628|FG000|STARTED|Overall Study||49
8749891|NCT01162733|9798629|FG001|STARTED|Overall Study||50
8749892|NCT01162733|9798628|FG000|COMPLETED|Overall Study||22
8749893|NCT01162733|9798629|FG001|COMPLETED|Overall Study||25
8749894|NCT01162733|9798628|FG000|NOT COMPLETED|Overall Study||27
8749895|NCT01162733|9798629|FG001|NOT COMPLETED|Overall Study||25
8749896|NCT01162863|9798638|FG000|STARTED|Overall Study||18
8749897|NCT01162863|9798639|FG001|STARTED|Overall Study||17
8749898|NCT01162863|9798640|FG002|STARTED|Overall Study||17
8749899|NCT01162863|9798638|FG000|COMPLETED|Overall Study||17
8749900|NCT01162863|9798639|FG001|COMPLETED|Overall Study||16
8749901|NCT01162863|9798640|FG002|COMPLETED|Overall Study||17
8749902|NCT01162863|9798638|FG000|NOT COMPLETED|Overall Study||1
8749903|NCT01162863|9798639|FG001|NOT COMPLETED|Overall Study||1
8749904|NCT01162863|9798640|FG002|NOT COMPLETED|Overall Study||0
8749905|NCT01163032|9798651|FG000|STARTED|Randomization Phase||42
8749906|NCT01163032|9798652|FG001|STARTED|Randomization Phase||42
8749907|NCT01163032|9798653|FG002|STARTED|Randomization Phase|Not applicable for Randomized Phase|0
8749908|NCT01163032|9798651|FG000|COMPLETED|Randomization Phase||32
8749909|NCT01163032|9798652|FG001|COMPLETED|Randomization Phase||30
8749910|NCT01163032|9798653|FG002|COMPLETED|Randomization Phase|Not applicable for Randomized Phase|0
8749911|NCT01163032|9798651|FG000|NOT COMPLETED|Randomization Phase||10
8749912|NCT01163032|9798652|FG001|NOT COMPLETED|Randomization Phase||12
8749913|NCT01163032|9798653|FG002|NOT COMPLETED|Randomization Phase||0
8749914|NCT01163032|9798651|FG000|STARTED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
8749915|NCT01163032|9798652|FG001|STARTED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
8749916|NCT01163032|9798653|FG002|STARTED|Open Label Extension Phase|3 randomized patients rolled into extension (2 randomized to tasimelteon and one to placebo)|55
8749917|NCT01163032|9798651|FG000|COMPLETED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
8749918|NCT01163032|9798652|FG001|COMPLETED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
8749919|NCT01163032|9798653|FG002|COMPLETED|Open Label Extension Phase||39
8749920|NCT01163032|9798651|FG000|NOT COMPLETED|Open Label Extension Phase||0
8749921|NCT01163032|9798652|FG001|NOT COMPLETED|Open Label Extension Phase||0
8749922|NCT01163032|9798653|FG002|NOT COMPLETED|Open Label Extension Phase||16
8749923|NCT01163097|9798664|FG000|STARTED|Overall Study|15 subjects were successfully titrated and entered the palifermin treatment|20
8749924|NCT01163097|9798665|FG001|STARTED|Overall Study||16
8749925|NCT01163097|9798666|FG002|STARTED|Overall Study||8
8749926|NCT01163097|9798664|FG000|COMPLETED|Overall Study||14
8749927|NCT01163097|9798665|FG001|COMPLETED|Overall Study||16
8749928|NCT01163097|9798666|FG002|COMPLETED|Overall Study||8
8749929|NCT01163097|9798664|FG000|NOT COMPLETED|Overall Study||6
8749930|NCT01163097|9798665|FG001|NOT COMPLETED|Overall Study||0
8749931|NCT01163097|9798666|FG002|NOT COMPLETED|Overall Study||0
8749932|NCT01163149|9798679|FG000|STARTED|Primary Treatment Period||7
8749933|NCT01163149|9798680|FG001|STARTED|Primary Treatment Period||6
8749934|NCT01163149|9798681|FG002|STARTED|Primary Treatment Period||6
8749935|NCT01163149|9798679|FG000|COMPLETED|Primary Treatment Period||7
8749936|NCT01163149|9798680|FG001|COMPLETED|Primary Treatment Period||6
8749937|NCT01163149|9798681|FG002|COMPLETED|Primary Treatment Period||6
8749938|NCT01163149|9798679|FG000|NOT COMPLETED|Primary Treatment Period||0
8749939|NCT01163149|9798680|FG001|NOT COMPLETED|Primary Treatment Period||0
8749940|NCT01163149|9798681|FG002|NOT COMPLETED|Primary Treatment Period||0
8749941|NCT01163149|9798679|FG000|STARTED|Extension Treatment Period||7
8749942|NCT01163149|9798680|FG001|STARTED|Extension Treatment Period||6
8749943|NCT01163149|9798681|FG002|STARTED|Extension Treatment Period||6
8749944|NCT01163149|9798679|FG000|COMPLETED|Extension Treatment Period||5
8749945|NCT01163149|9798680|FG001|COMPLETED|Extension Treatment Period||5
8749946|NCT01163149|9798681|FG002|COMPLETED|Extension Treatment Period||4
8749947|NCT01163149|9798679|FG000|NOT COMPLETED|Extension Treatment Period||2
8749948|NCT01163149|9798680|FG001|NOT COMPLETED|Extension Treatment Period||1
8749949|NCT01163149|9798681|FG002|NOT COMPLETED|Extension Treatment Period||2
8749950|NCT01163162|9798703|FG000|STARTED|Overall Study||16
8749951|NCT01163162|9798703|FG000|COMPLETED|Overall Study||16
8749952|NCT01163162|9798703|FG000|NOT COMPLETED|Overall Study||0
8749953|NCT01163214|9798709|FG000|STARTED|Overall Study||79
8749954|NCT01163214|9798710|FG001|STARTED|Overall Study||81
8749955|NCT01163214|9798709|FG000|COMPLETED|Overall Study||79
8749956|NCT01163214|9798710|FG001|COMPLETED|Overall Study||81
8749957|NCT01163214|9798709|FG000|NOT COMPLETED|Overall Study||0
8749958|NCT01163214|9798710|FG001|NOT COMPLETED|Overall Study||0
8749959|NCT01163253|9798718|FG000|STARTED|Overall Study||2281
8749960|NCT01163253|9798719|FG001|STARTED|Overall Study||586
8749961|NCT01163253|9798718|FG000|COMPLETED|Overall Study||0
8749962|NCT01163253|9798719|FG001|COMPLETED|Overall Study||0
8749963|NCT01163253|9798718|FG000|NOT COMPLETED|Overall Study||2281
8749964|NCT01163253|9798719|FG001|NOT COMPLETED|Overall Study||586
8749965|NCT01163266|9798728|FG000|STARTED|Overall Study||157
8749966|NCT01163266|9798729|FG001|STARTED|Overall Study||155
8749967|NCT01163266|9798730|FG002|STARTED|Overall Study||150
8749968|NCT01163266|9798728|FG000|Treated|Overall Study||157
8749969|NCT01163266|9798729|FG001|Treated|Overall Study||155
8749970|NCT01163266|9798730|FG002|Treated|Overall Study||150
8749971|NCT01163266|9798728|FG000|COMPLETED|Overall Study||139
8749972|NCT01163266|9798729|FG001|COMPLETED|Overall Study||124
8749973|NCT01163266|9798730|FG002|COMPLETED|Overall Study||122
8749974|NCT01163266|9798728|FG000|NOT COMPLETED|Overall Study||18
8749975|NCT01163266|9798729|FG001|NOT COMPLETED|Overall Study||31
8749976|NCT01163266|9798730|FG002|NOT COMPLETED|Overall Study||28
8749977|NCT01163279|9798740|FG000|STARTED|Overall Study||10
8749978|NCT01163279|9798741|FG001|STARTED|Overall Study||9
8749979|NCT01163279|9798740|FG000|COMPLETED|Overall Study||8
8749980|NCT01163279|9798741|FG001|COMPLETED|Overall Study||9
8749981|NCT01163279|9798740|FG000|NOT COMPLETED|Overall Study||2
8749982|NCT01163279|9798741|FG001|NOT COMPLETED|Overall Study||0
8749983|NCT01163292|9798750|FG000|STARTED|Overall Study||106
8749984|NCT01163292|9798751|FG001|STARTED|Overall Study||114
8749985|NCT01163292|9798750|FG000|COMPLETED|Overall Study||65
8749986|NCT01163292|9798751|FG001|COMPLETED|Overall Study||92
8749987|NCT01163292|9798750|FG000|NOT COMPLETED|Overall Study||41
8749988|NCT01163292|9798751|FG001|NOT COMPLETED|Overall Study||22
8749989|NCT01163318|9798757|FG000|STARTED|Overall Study||552
8749990|NCT01163318|9798757|FG000|COMPLETED|Overall Study||284
8749991|NCT01163318|9798757|FG000|NOT COMPLETED|Overall Study||268
8807754|NCT01486199|9860047|FG001|STARTED|Two Year Period Between Study Days||0
8807755|NCT01486199|9860046|FG000|COMPLETED|Two Year Period Between Study Days||9
8807756|NCT01486199|9860047|FG001|COMPLETED|Two Year Period Between Study Days||0
8807757|NCT01486199|9860046|FG000|NOT COMPLETED|Two Year Period Between Study Days||1
8807758|NCT01486199|9860047|FG001|NOT COMPLETED|Two Year Period Between Study Days||0
8807759|NCT01486199|9860046|FG000|STARTED|Study Day at t= 2 Years||9
8807760|NCT01486199|9860047|FG001|STARTED|Study Day at t= 2 Years||0
8807761|NCT01486199|9860046|FG000|COMPLETED|Study Day at t= 2 Years||9
8807762|NCT01486199|9860047|FG001|COMPLETED|Study Day at t= 2 Years||0
8807763|NCT01486199|9860046|FG000|NOT COMPLETED|Study Day at t= 2 Years||0
8807764|NCT01486199|9860047|FG001|NOT COMPLETED|Study Day at t= 2 Years||0
8807765|NCT01486238|9860055|FG000|STARTED|Overall Study||23
8807766|NCT01486238|9860056|FG001|STARTED|Overall Study||49
8807767|NCT01486238|9860055|FG000|COMPLETED|Overall Study||21
8807768|NCT01486238|9860056|FG001|COMPLETED|Overall Study||43
8807769|NCT01486238|9860055|FG000|NOT COMPLETED|Overall Study||2
8807770|NCT01486238|9860056|FG001|NOT COMPLETED|Overall Study||6
8807771|NCT01486316|9860065|FG000|STARTED|Overall Study|prior to study closure, 24 subjects were enrolled 7 subjects randomized to Control Arm|7
8807772|NCT01486316|9860066|FG001|STARTED|Overall Study|prior to study closure, 24 subjects were enrolled with 10 being randomized to HFRS Guided Arm|10
8807773|NCT01486316|9860067|FG002|STARTED|Overall Study|Exited prior to implant|5
8807774|NCT01486316|9860068|FG003|STARTED|Overall Study|Exited prior to 6 month visit|2
8807775|NCT01486316|9860065|FG000|COMPLETED|Overall Study||3
8807776|NCT01486316|9860066|FG001|COMPLETED|Overall Study||7
8807777|NCT01486316|9860067|FG002|COMPLETED|Overall Study||0
8807778|NCT01486316|9860068|FG003|COMPLETED|Overall Study||0
8807779|NCT01486316|9860065|FG000|NOT COMPLETED|Overall Study||4
8807780|NCT01486316|9860066|FG001|NOT COMPLETED|Overall Study||3
8807781|NCT01486316|9860067|FG002|NOT COMPLETED|Overall Study||5
8807782|NCT01486316|9860068|FG003|NOT COMPLETED|Overall Study||2
8807783|NCT01486446|9860079|FG000|STARTED|Overall Study||7
8914516|NCT02169336|9974036|FG002|COMPLETED|Overall Study||29
8914517|NCT02169336|9974034|FG000|NOT COMPLETED|Overall Study||4
8914518|NCT02169336|9974035|FG001|NOT COMPLETED|Overall Study||4
8914519|NCT02169336|9974036|FG002|NOT COMPLETED|Overall Study||3
8914520|NCT02169414|9974048|FG000|STARTED|Overall Study||19
8914521|NCT02169414|9974049|FG001|STARTED|Overall Study||19
8914522|NCT02169414|9974050|FG002|STARTED|Overall Study||18
8914523|NCT02169414|9974051|FG003|STARTED|Overall Study||18
8914524|NCT02169414|9974048|FG000|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||18
8914525|NCT02169414|9974049|FG001|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||19
8914526|NCT02169414|9974050|FG002|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||18
8914527|NCT02169414|9974051|FG003|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||18
8914528|NCT02169414|9974048|FG000|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
8914529|NCT02169414|9974049|FG001|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
8914530|NCT02169414|9974050|FG002|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
8914531|NCT02169414|9974051|FG003|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
8914532|NCT02169414|9974048|FG000|COMPLETED|Overall Study||18
8914533|NCT02169414|9974049|FG001|COMPLETED|Overall Study||18
8914534|NCT02169414|9974050|FG002|COMPLETED|Overall Study||18
8914535|NCT02169414|9974051|FG003|COMPLETED|Overall Study||18
8914536|NCT02169414|9974048|FG000|NOT COMPLETED|Overall Study||1
8914537|NCT02169414|9974049|FG001|NOT COMPLETED|Overall Study||1
8914538|NCT02169414|9974050|FG002|NOT COMPLETED|Overall Study||0
8914539|NCT02169414|9974051|FG003|NOT COMPLETED|Overall Study||0
8914540|NCT02169427|9974065|FG000|STARTED|Overall Study||6
8914541|NCT02169427|9974065|FG000|COMPLETED|Overall Study||6
8914542|NCT02169427|9974065|FG000|NOT COMPLETED|Overall Study||0
8914543|NCT02169440|9974071|FG000|STARTED|Overall Study||10
8914544|NCT02169440|9974072|FG001|STARTED|Overall Study||10
8914545|NCT02169440|9974071|FG000|COMPLETED|Overall Study||10
8914546|NCT02169440|9974072|FG001|COMPLETED|Overall Study||10
8807784|NCT01486446|9860080|FG001|STARTED|Overall Study||1
8807785|NCT01486446|9860079|FG000|COMPLETED|Overall Study||6
8807786|NCT01486446|9860080|FG001|COMPLETED|Overall Study||1
8807787|NCT01486446|9860079|FG000|NOT COMPLETED|Overall Study||1
8807788|NCT01486446|9860080|FG001|NOT COMPLETED|Overall Study||0
8807789|NCT01486615|9860090|FG000|STARTED|Overall Study||20
8807790|NCT01486615|9860091|FG001|STARTED|Overall Study||20
8807791|NCT01486615|9860092|FG002|STARTED|Overall Study||20
8807792|NCT01486615|9860093|FG003|STARTED|Overall Study||20
8807793|NCT01486615|9860090|FG000|COMPLETED|Overall Study||20
8807794|NCT01486615|9860091|FG001|COMPLETED|Overall Study|observed till 2 hrs after premedication, not available after 24 hours as surgery was postponed|19
8807795|NCT01486615|9860092|FG002|COMPLETED|Overall Study|observed till 2 hrs after premedication, not available after 24 hours as surgery was postponed|18
8807796|NCT01486615|9860093|FG003|COMPLETED|Overall Study|observed till 2 hrs after premedication, not available after 24 hours as surgery was postponed|18
8807797|NCT01486615|9860090|FG000|NOT COMPLETED|Overall Study||0
8914547|NCT02169440|9974071|FG000|NOT COMPLETED|Overall Study||0
8914548|NCT02169440|9974072|FG001|NOT COMPLETED|Overall Study||0
8914549|NCT02169453|9974083|FG000|STARTED|Overall Study||3
8914550|NCT02169453|9974084|FG001|STARTED|Overall Study||3
8914551|NCT02169453|9974085|FG002|STARTED|Overall Study||3
8914552|NCT02169453|9974086|FG003|STARTED|Overall Study||3
8914553|NCT02169453|9974083|FG000|25 mg BIA 9-1067|Overall Study||3
8749992|NCT01163461|9798761|FG000|STARTED|Overall Study||14
8749993|NCT01163461|9798762|FG001|STARTED|Overall Study||14
8749994|NCT01163461|9798761|FG000|COMPLETED|Overall Study||14
8749995|NCT01163461|9798762|FG001|COMPLETED|Overall Study||14
8749996|NCT01163461|9798761|FG000|NOT COMPLETED|Overall Study||0
8914554|NCT02169453|9974084|FG001|25 mg BIA 9-1067|Overall Study||3
8914555|NCT02169453|9974085|FG002|25 mg BIA 9-1067|Overall Study||3
8914556|NCT02169453|9974086|FG003|25 mg BIA 9-1067|Overall Study||3
8914557|NCT02169453|9974083|FG000|50 mg BIA 9-1067|Overall Study||3
8914558|NCT02169453|9974084|FG001|50 mg BIA 9-1067|Overall Study||3
8914559|NCT02169453|9974085|FG002|50 mg BIA 9-1067|Overall Study||2
8914560|NCT02169453|9974086|FG003|50 mg BIA 9-1067|Overall Study||3
8914561|NCT02169453|9974083|FG000|100 mg BIA 9-1067|Overall Study||3
8914562|NCT02169453|9974084|FG001|100 mg BIA 9-1067|Overall Study||3
8914563|NCT02169453|9974085|FG002|100 mg BIA 9-1067|Overall Study||3
8914564|NCT02169453|9974086|FG003|100 mg BIA 9-1067|Overall Study||3
8914565|NCT02169453|9974083|FG000|Placebo|Overall Study||3
8914566|NCT02169453|9974084|FG001|Placebo|Overall Study||3
8914567|NCT02169453|9974085|FG002|Placebo|Overall Study||3
8914568|NCT02169453|9974086|FG003|Placebo|Overall Study||3
8914569|NCT02169453|9974083|FG000|COMPLETED|Overall Study||3
8914570|NCT02169453|9974084|FG001|COMPLETED|Overall Study||3
8670745|NCT00747565|9714113|FG000|STARTED|Overall Study|125 multifocal subjects in original study plus 222 multifocal subjects in the expansion study.|347
8670746|NCT00747565|9714114|FG001|STARTED|Overall Study||123
8670747|NCT00747565|9714113|FG000|COMPLETED|Overall Study|118 multifocal subjects in the original study plus 215 multifocal subejcts in the expansion study.|333
8670748|NCT00747565|9714114|FG001|COMPLETED|Overall Study||116
8670749|NCT00747565|9714113|FG000|NOT COMPLETED|Overall Study||14
8670750|NCT00747565|9714114|FG001|NOT COMPLETED|Overall Study||7
8670751|NCT00747617|9714122|FG000|STARTED|Overall Study||13
8670752|NCT00747617|9714123|FG001|STARTED|Overall Study||12
8670753|NCT00747617|9714122|FG000|COMPLETED|Overall Study||10
8670754|NCT00747617|9714123|FG001|COMPLETED|Overall Study||11
8670755|NCT00747617|9714122|FG000|NOT COMPLETED|Overall Study||3
8670756|NCT00747617|9714123|FG001|NOT COMPLETED|Overall Study||1
8670757|NCT00747643|9714131|FG000|STARTED|Overall Study||82
8670758|NCT00747643|9714132|FG001|STARTED|Overall Study||81
8670759|NCT00747643|9714131|FG000|COMPLETED|Overall Study||46
8670760|NCT00747643|9714132|FG001|COMPLETED|Overall Study||54
8670761|NCT00747643|9714131|FG000|NOT COMPLETED|Overall Study||36
8670762|NCT00747643|9714132|FG001|NOT COMPLETED|Overall Study||27
8670763|NCT00747747|9714141|FG000|STARTED|Overall Study||14
8670764|NCT00747747|9714142|FG001|STARTED|Overall Study||14
8670765|NCT00747747|9714143|FG002|STARTED|Overall Study||21
8670766|NCT00747747|9714141|FG000|COMPLETED|Overall Study|13 with acute episode + 1 with recurrent episode|14
8670767|NCT00747747|9714142|FG001|COMPLETED|Overall Study|11 with acute episode + 3 with recurrent episode|14
8670768|NCT00747747|9714143|FG002|COMPLETED|Overall Study|17 with acute episode + 4 with recurrent episode|21
8670769|NCT00747747|9714141|FG000|NOT COMPLETED|Overall Study||0
8670770|NCT00747747|9714142|FG001|NOT COMPLETED|Overall Study||0
8670771|NCT00747747|9714143|FG002|NOT COMPLETED|Overall Study||0
8670772|NCT00747812|9714153|FG000|STARTED|Overall Study||5
8670773|NCT00747812|9714154|FG001|STARTED|Overall Study|4 subjects were randomized to the Control Group; 1 was not implanted due to early enrollment closure|3
8670774|NCT00747812|9714153|FG000|COMPLETED|Overall Study||0
8670775|NCT00747812|9714154|FG001|COMPLETED|Overall Study||0
8749997|NCT01163461|9798762|FG001|NOT COMPLETED|Overall Study||0
8749998|NCT01163474|9798766|FG000|STARTED|Overall Study||40
8914571|NCT02169453|9974085|FG002|COMPLETED|Overall Study||2
8914572|NCT02169453|9974086|FG003|COMPLETED|Overall Study||3
8914573|NCT02169453|9974083|FG000|NOT COMPLETED|Overall Study||0
8914574|NCT02169453|9974084|FG001|NOT COMPLETED|Overall Study||0
8914575|NCT02169453|9974085|FG002|NOT COMPLETED|Overall Study||1
8914576|NCT02169453|9974086|FG003|NOT COMPLETED|Overall Study||0
8914577|NCT02169466|9974100|FG000|STARTED|Overall Study||6
8914578|NCT02169466|9974101|FG001|STARTED|Overall Study||6
8914579|NCT02169466|9974102|FG002|STARTED|Overall Study||5
8914580|NCT02169466|9974103|FG003|STARTED|Overall Study||5
8914581|NCT02169466|9974100|FG000|25 mg BIA 9-1067|Overall Study||6
8914582|NCT02169466|9974101|FG001|25 mg BIA 9-1067|Overall Study||5
8914583|NCT02169466|9974102|FG002|25 mg BIA 9-1067|Overall Study||5
8914584|NCT02169466|9974103|FG003|25 mg BIA 9-1067|Overall Study||5
8914585|NCT02169466|9974100|FG000|50 mg BIA 9-1067|Overall Study||6
9023028|NCT03134144|10085878|FG000|NOT COMPLETED|Overall Study||0
9023029|NCT03134144|10085879|FG001|NOT COMPLETED|Overall Study||0
9023030|NCT03134183|10085892|FG000|STARTED|Overall Study||36
9023031|NCT03134183|10085893|FG001|STARTED|Overall Study||34
9023032|NCT03134183|10085892|FG000|COMPLETED|Overall Study||35
9023033|NCT03134183|10085893|FG001|COMPLETED|Overall Study||33
9023034|NCT03134183|10085892|FG000|NOT COMPLETED|Overall Study||1
9023035|NCT03134183|10085893|FG001|NOT COMPLETED|Overall Study||1
9023036|NCT03134209|10085902|FG000|STARTED|Overall Study||53
9023037|NCT03134209|10085903|FG001|STARTED|Overall Study||54
9023038|NCT03134209|10085904|FG002|STARTED|Overall Study||53
9023039|NCT03134209|10085902|FG000|COMPLETED|Overall Study||53
9023040|NCT03134209|10085903|FG001|COMPLETED|Overall Study||54
9023041|NCT03134209|10085904|FG002|COMPLETED|Overall Study||53
9023042|NCT03134209|10085902|FG000|NOT COMPLETED|Overall Study||0
9023043|NCT03134209|10085903|FG001|NOT COMPLETED|Overall Study||0
8749999|NCT01163474|9798766|FG000|COMPLETED|Overall Study||24
8750000|NCT01163474|9798766|FG000|NOT COMPLETED|Overall Study||16
8750001|NCT01163604|9798775|FG000|STARTED|Overall Study|August 2010|58
8750002|NCT01163604|9798776|FG001|STARTED|Overall Study|August 2010|56
8750003|NCT01163604|9798775|FG000|COMPLETED|Overall Study|August 2011|58
8750004|NCT01163604|9798776|FG001|COMPLETED|Overall Study|August 2011|56
8750005|NCT01163604|9798775|FG000|NOT COMPLETED|Overall Study||0
8750006|NCT01163604|9798776|FG001|NOT COMPLETED|Overall Study||0
8914586|NCT02169466|9974101|FG001|50 mg BIA 9-1067|Overall Study||6
8914587|NCT02169466|9974102|FG002|50 mg BIA 9-1067|Overall Study||5
8914588|NCT02169466|9974103|FG003|50 mg BIA 9-1067|Overall Study||5
8914589|NCT02169466|9974100|FG000|100 mg BIA 9-1067|Overall Study||6
8914590|NCT02169466|9974101|FG001|100 mg BIA 9-1067|Overall Study||6
8914591|NCT02169466|9974102|FG002|100 mg BIA 9-1067|Overall Study||5
8914592|NCT02169466|9974103|FG003|100 mg BIA 9-1067|Overall Study||5
8914593|NCT02169466|9974100|FG000|Placebo|Overall Study||5
8914594|NCT02169466|9974101|FG001|Placebo|Overall Study||6
8914595|NCT02169466|9974102|FG002|Placebo|Overall Study||5
8914596|NCT02169466|9974103|FG003|Placebo|Overall Study||5
9023044|NCT03134209|10085904|FG002|NOT COMPLETED|Overall Study||0
9023045|NCT03134222|10085915|FG000|STARTED|Treatment Period (Up to Week 12)||19
9023046|NCT03134222|10085916|FG001|STARTED|Treatment Period (Up to Week 12)||18
9023047|NCT03134222|10085917|FG002|STARTED|Treatment Period (Up to Week 12)||10
9023048|NCT03134222|10085918|FG003|STARTED|Treatment Period (Up to Week 12)||0
9023049|NCT03134222|10085919|FG004|STARTED|Treatment Period (Up to Week 12)||0
9023050|NCT03134222|10085915|FG000|COMPLETED|Treatment Period (Up to Week 12)||14
9023051|NCT03134222|10085916|FG001|COMPLETED|Treatment Period (Up to Week 12)||14
9023052|NCT03134222|10085917|FG002|COMPLETED|Treatment Period (Up to Week 12)||8
9023053|NCT03134222|10085918|FG003|COMPLETED|Treatment Period (Up to Week 12)||0
9023054|NCT03134222|10085919|FG004|COMPLETED|Treatment Period (Up to Week 12)||0
9023055|NCT03134222|10085915|FG000|NOT COMPLETED|Treatment Period (Up to Week 12)||5
9023056|NCT03134222|10085916|FG001|NOT COMPLETED|Treatment Period (Up to Week 12)||4
9023057|NCT03134222|10085917|FG002|NOT COMPLETED|Treatment Period (Up to Week 12)||2
9023058|NCT03134222|10085918|FG003|NOT COMPLETED|Treatment Period (Up to Week 12)||0
9023059|NCT03134222|10085919|FG004|NOT COMPLETED|Treatment Period (Up to Week 12)||0
9023060|NCT03134222|10085915|FG000|STARTED|Treatment Period (Week 12 to 48)||14
9023061|NCT03134222|10085916|FG001|STARTED|Treatment Period (Week 12 to 48)||14
9023062|NCT03134222|10085917|FG002|STARTED|Treatment Period (Week 12 to 48)|Participants were rerandomized 1:1 to either Placebo to Lanraplenib or Placebo to Filgotinib arm.|0
9023063|NCT03134222|10085918|FG003|STARTED|Treatment Period (Week 12 to 48)|Participants were rerandomized from the Placebo arm.|4
9023064|NCT03134222|10085919|FG004|STARTED|Treatment Period (Week 12 to 48)|Participants were rerandomized from the Placebo arm.|4
9023065|NCT03134222|10085915|FG000|COMPLETED|Treatment Period (Week 12 to 48)||12
9023066|NCT03134222|10085916|FG001|COMPLETED|Treatment Period (Week 12 to 48)||11
9023067|NCT03134222|10085917|FG002|COMPLETED|Treatment Period (Week 12 to 48)||0
9023068|NCT03134222|10085918|FG003|COMPLETED|Treatment Period (Week 12 to 48)||3
9023069|NCT03134222|10085919|FG004|COMPLETED|Treatment Period (Week 12 to 48)||3
9023070|NCT03134222|10085915|FG000|NOT COMPLETED|Treatment Period (Week 12 to 48)||2
9023071|NCT03134222|10085916|FG001|NOT COMPLETED|Treatment Period (Week 12 to 48)||3
9023072|NCT03134222|10085917|FG002|NOT COMPLETED|Treatment Period (Week 12 to 48)||0
9023073|NCT03134222|10085918|FG003|NOT COMPLETED|Treatment Period (Week 12 to 48)||1
9023074|NCT03134222|10085919|FG004|NOT COMPLETED|Treatment Period (Week 12 to 48)||1
9023075|NCT03134248|10085929|FG000|STARTED|Week 1||7
9023076|NCT03134248|10085930|FG001|STARTED|Week 1||8
9023077|NCT03134248|10085931|FG002|STARTED|Week 1||9
9023078|NCT03134248|10085932|FG003|STARTED|Week 1||7
9023079|NCT03134248|10085933|FG004|STARTED|Week 1||9
9023080|NCT03134248|10085934|FG005|STARTED|Week 1||9
9023081|NCT03134248|10085929|FG000|COMPLETED|Week 1||7
9023082|NCT03134248|10085930|FG001|COMPLETED|Week 1||8
9023083|NCT03134248|10085931|FG002|COMPLETED|Week 1||9
9023084|NCT03134248|10085932|FG003|COMPLETED|Week 1||7
9023085|NCT03134248|10085933|FG004|COMPLETED|Week 1||9
9023086|NCT03134248|10085934|FG005|COMPLETED|Week 1||9
9023087|NCT03134248|10085929|FG000|NOT COMPLETED|Week 1||0
9023088|NCT03134248|10085930|FG001|NOT COMPLETED|Week 1||0
9023089|NCT03134248|10085931|FG002|NOT COMPLETED|Week 1||0
9023090|NCT03134248|10085932|FG003|NOT COMPLETED|Week 1||0
9023091|NCT03134248|10085933|FG004|NOT COMPLETED|Week 1||0
9023092|NCT03134248|10085934|FG005|NOT COMPLETED|Week 1||0
9023093|NCT03134248|10085929|FG000|STARTED|Week 2||7
9023094|NCT03134248|10085930|FG001|STARTED|Week 2||8
9023095|NCT03134248|10085931|FG002|STARTED|Week 2||9
9023096|NCT03134248|10085932|FG003|STARTED|Week 2||7
8750007|NCT01163617|9798782|FG000|STARTED|Phase A (User Experience), Weeks 0 and 2||19
8914597|NCT02169466|9974100|FG000|COMPLETED|Overall Study||5
8914598|NCT02169466|9974101|FG001|COMPLETED|Overall Study||5
8914599|NCT02169466|9974102|FG002|COMPLETED|Overall Study||5
8914600|NCT02169466|9974103|FG003|COMPLETED|Overall Study||5
9023097|NCT03134248|10085933|FG004|STARTED|Week 2||9
9023098|NCT03134248|10085934|FG005|STARTED|Week 2||9
9023099|NCT03134248|10085929|FG000|COMPLETED|Week 2||7
9023100|NCT03134248|10085930|FG001|COMPLETED|Week 2||8
9023101|NCT03134248|10085931|FG002|COMPLETED|Week 2||9
9023102|NCT03134248|10085932|FG003|COMPLETED|Week 2||7
9023103|NCT03134248|10085933|FG004|COMPLETED|Week 2||9
9023104|NCT03134248|10085934|FG005|COMPLETED|Week 2||9
9023105|NCT03134248|10085929|FG000|NOT COMPLETED|Week 2||0
9023106|NCT03134248|10085930|FG001|NOT COMPLETED|Week 2||0
8750008|NCT01163617|9798783|FG001|STARTED|Phase A (User Experience), Weeks 0 and 2||23
8750009|NCT01163617|9798784|FG002|STARTED|Phase A (User Experience), Weeks 0 and 2||21
8750010|NCT01163617|9798785|FG003|STARTED|Phase A (User Experience), Weeks 0 and 2||21
8750011|NCT01163617|9798786|FG004|STARTED|Phase A (User Experience), Weeks 0 and 2||0
8750012|NCT01163617|9798787|FG005|STARTED|Phase A (User Experience), Weeks 0 and 2||0
8750013|NCT01163617|9798788|FG006|STARTED|Phase A (User Experience), Weeks 0 and 2||0
8750014|NCT01163617|9798789|FG007|STARTED|Phase A (User Experience), Weeks 0 and 2||0
8750015|NCT01163617|9798782|FG000|COMPLETED|Phase A (User Experience), Weeks 0 and 2||19
8750016|NCT01163617|9798783|FG001|COMPLETED|Phase A (User Experience), Weeks 0 and 2||21
8750017|NCT01163617|9798784|FG002|COMPLETED|Phase A (User Experience), Weeks 0 and 2||20
8750018|NCT01163617|9798785|FG003|COMPLETED|Phase A (User Experience), Weeks 0 and 2||21
8750019|NCT01163617|9798786|FG004|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
8750020|NCT01163617|9798787|FG005|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
8750021|NCT01163617|9798788|FG006|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
8750022|NCT01163617|9798789|FG007|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
8750023|NCT01163617|9798782|FG000|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
8750024|NCT01163617|9798783|FG001|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||2
8750025|NCT01163617|9798784|FG002|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||1
8750026|NCT01163617|9798785|FG003|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
8750027|NCT01163617|9798786|FG004|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
8750028|NCT01163617|9798787|FG005|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
8750029|NCT01163617|9798788|FG006|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
8750030|NCT01163617|9798789|FG007|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
8750031|NCT01163617|9798782|FG000|STARTED|Phase B (Injection Time), Week 4||0
8750032|NCT01163617|9798783|FG001|STARTED|Phase B (Injection Time), Week 4||0
8750033|NCT01163617|9798784|FG002|STARTED|Phase B (Injection Time), Week 4||0
8750034|NCT01163617|9798785|FG003|STARTED|Phase B (Injection Time), Week 4||0
8750035|NCT01163617|9798786|FG004|STARTED|Phase B (Injection Time), Week 4||18
8750036|NCT01163617|9798787|FG005|STARTED|Phase B (Injection Time), Week 4||27
8750037|NCT01163617|9798788|FG006|STARTED|Phase B (Injection Time), Week 4||16
8750038|NCT01163617|9798789|FG007|STARTED|Phase B (Injection Time), Week 4||20
8750039|NCT01163617|9798782|FG000|COMPLETED|Phase B (Injection Time), Week 4||0
8750040|NCT01163617|9798783|FG001|COMPLETED|Phase B (Injection Time), Week 4||0
8750041|NCT01163617|9798784|FG002|COMPLETED|Phase B (Injection Time), Week 4||0
8750042|NCT01163617|9798785|FG003|COMPLETED|Phase B (Injection Time), Week 4||0
8750043|NCT01163617|9798786|FG004|COMPLETED|Phase B (Injection Time), Week 4||18
8750044|NCT01163617|9798787|FG005|COMPLETED|Phase B (Injection Time), Week 4||27
8750045|NCT01163617|9798788|FG006|COMPLETED|Phase B (Injection Time), Week 4||16
8750046|NCT01163617|9798789|FG007|COMPLETED|Phase B (Injection Time), Week 4||20
8750047|NCT01163617|9798782|FG000|NOT COMPLETED|Phase B (Injection Time), Week 4||0
8750048|NCT01163617|9798783|FG001|NOT COMPLETED|Phase B (Injection Time), Week 4||0
8750049|NCT01163617|9798784|FG002|NOT COMPLETED|Phase B (Injection Time), Week 4||0
8750050|NCT01163617|9798785|FG003|NOT COMPLETED|Phase B (Injection Time), Week 4||0
8750051|NCT01163617|9798786|FG004|NOT COMPLETED|Phase B (Injection Time), Week 4||0
8750052|NCT01163617|9798787|FG005|NOT COMPLETED|Phase B (Injection Time), Week 4||0
8750053|NCT01163617|9798788|FG006|NOT COMPLETED|Phase B (Injection Time), Week 4||0
8750054|NCT01163617|9798789|FG007|NOT COMPLETED|Phase B (Injection Time), Week 4||0
8750055|NCT01163643|9798815|FG000|STARTED|Overall Study||68
8750056|NCT01163643|9798816|FG001|STARTED|Overall Study||37
8750057|NCT01163643|9798817|FG002|STARTED|Overall Study||35
8750058|NCT01163643|9798818|FG003|STARTED|Overall Study||74
8750059|NCT01163643|9798819|FG004|STARTED|Overall Study||69
8750060|NCT01163643|9798820|FG005|STARTED|Overall Study||73
8750061|NCT01163643|9798815|FG000|COMPLETED|Overall Study||62
8750062|NCT01163643|9798816|FG001|COMPLETED|Overall Study||35
8750063|NCT01163643|9798817|FG002|COMPLETED|Overall Study||33
8750064|NCT01163643|9798818|FG003|COMPLETED|Overall Study||69
8750065|NCT01163643|9798819|FG004|COMPLETED|Overall Study||61
8750066|NCT01163643|9798820|FG005|COMPLETED|Overall Study||66
8750067|NCT01163643|9798815|FG000|NOT COMPLETED|Overall Study||6
8750068|NCT01163643|9798816|FG001|NOT COMPLETED|Overall Study||2
8750069|NCT01163643|9798817|FG002|NOT COMPLETED|Overall Study||2
8750070|NCT01163643|9798818|FG003|NOT COMPLETED|Overall Study||5
8750071|NCT01163643|9798819|FG004|NOT COMPLETED|Overall Study||8
8750072|NCT01163643|9798820|FG005|NOT COMPLETED|Overall Study||7
8750073|NCT01163656|9798836|FG000|STARTED|Overall Study||33
8750074|NCT01163656|9798837|FG001|STARTED|Overall Study||33
8750075|NCT01163656|9798836|FG000|COMPLETED|Overall Study||30
8750076|NCT01163656|9798837|FG001|COMPLETED|Overall Study||30
8750077|NCT01163656|9798836|FG000|NOT COMPLETED|Overall Study||3
8750078|NCT01163656|9798837|FG001|NOT COMPLETED|Overall Study||3
8750079|NCT01163721|9798845|FG000|STARTED|Overall Study||39
8750080|NCT01163721|9798846|FG001|STARTED|Overall Study||41
8750081|NCT01163721|9798845|FG000|COMPLETED|Overall Study||31
8750082|NCT01163721|9798846|FG001|COMPLETED|Overall Study||29
8750083|NCT01163721|9798845|FG000|NOT COMPLETED|Overall Study||8
8750084|NCT01163721|9798846|FG001|NOT COMPLETED|Overall Study||12
8750085|NCT01163747|9798854|FG000|STARTED|Overall Study||31
8750086|NCT01163747|9798855|FG001|STARTED|Overall Study||60
8750087|NCT01163747|9798854|FG000|Per Protocol Population|Overall Study|Participants who received at least 1 dose of study treatment excluding major protocol violators.|27
8750088|NCT01163747|9798855|FG001|Per Protocol Population|Overall Study|Participants who received at least 1 dose of study treatment excluding major protocol violators.|54
8750089|NCT01163747|9798854|FG000|COMPLETED|Overall Study||25
8750090|NCT01163747|9798855|FG001|COMPLETED|Overall Study||49
8750091|NCT01163747|9798854|FG000|NOT COMPLETED|Overall Study||6
8750092|NCT01163747|9798855|FG001|NOT COMPLETED|Overall Study||11
8750093|NCT01163760|9798861|FG000|STARTED|Period 1 (Fit)||12
8750094|NCT01163760|9798862|FG001|STARTED|Period 1 (Fit)||13
8750095|NCT01163760|9798863|FG002|STARTED|Period 1 (Fit)||13
8750096|NCT01163760|9798864|FG003|STARTED|Period 1 (Fit)||12
8750097|NCT01163760|9798861|FG000|COMPLETED|Period 1 (Fit)||12
8750098|NCT01163760|9798862|FG001|COMPLETED|Period 1 (Fit)||13
8750099|NCT01163760|9798863|FG002|COMPLETED|Period 1 (Fit)||13
8750100|NCT01163760|9798864|FG003|COMPLETED|Period 1 (Fit)||12
8750101|NCT01163760|9798861|FG000|NOT COMPLETED|Period 1 (Fit)||0
8750102|NCT01163760|9798862|FG001|NOT COMPLETED|Period 1 (Fit)||0
8750103|NCT01163760|9798863|FG002|NOT COMPLETED|Period 1 (Fit)||0
8750104|NCT01163760|9798864|FG003|NOT COMPLETED|Period 1 (Fit)||0
8750105|NCT01163760|9798861|FG000|STARTED|Period 2 (Follow-up)||12
8750106|NCT01163760|9798862|FG001|STARTED|Period 2 (Follow-up)||13
8750107|NCT01163760|9798863|FG002|STARTED|Period 2 (Follow-up)||13
8750108|NCT01163760|9798864|FG003|STARTED|Period 2 (Follow-up)||12
8750109|NCT01163760|9798861|FG000|COMPLETED|Period 2 (Follow-up)||12
8750110|NCT01163760|9798862|FG001|COMPLETED|Period 2 (Follow-up)||13
8750111|NCT01163760|9798863|FG002|COMPLETED|Period 2 (Follow-up)||13
8750112|NCT01163760|9798864|FG003|COMPLETED|Period 2 (Follow-up)||12
8750113|NCT01163760|9798861|FG000|NOT COMPLETED|Period 2 (Follow-up)||0
8750114|NCT01163760|9798862|FG001|NOT COMPLETED|Period 2 (Follow-up)||0
8750115|NCT01163760|9798863|FG002|NOT COMPLETED|Period 2 (Follow-up)||0
8750116|NCT01163760|9798864|FG003|NOT COMPLETED|Period 2 (Follow-up)||0
8750117|NCT01163760|9798861|FG000|STARTED|Period 3 (Fit)||12
8750118|NCT01163760|9798862|FG001|STARTED|Period 3 (Fit)||13
8750119|NCT01163760|9798863|FG002|STARTED|Period 3 (Fit)||13
8750120|NCT01163760|9798864|FG003|STARTED|Period 3 (Fit)||12
8750121|NCT01163760|9798861|FG000|COMPLETED|Period 3 (Fit)||12
8750122|NCT01163760|9798862|FG001|COMPLETED|Period 3 (Fit)||13
8750123|NCT01163760|9798863|FG002|COMPLETED|Period 3 (Fit)||13
8750124|NCT01163760|9798864|FG003|COMPLETED|Period 3 (Fit)||12
8750125|NCT01163760|9798861|FG000|NOT COMPLETED|Period 3 (Fit)||0
8750126|NCT01163760|9798862|FG001|NOT COMPLETED|Period 3 (Fit)||0
8750127|NCT01163760|9798863|FG002|NOT COMPLETED|Period 3 (Fit)||0
8750128|NCT01163760|9798864|FG003|NOT COMPLETED|Period 3 (Fit)||0
8750129|NCT01163760|9798861|FG000|STARTED|Period 4 (Follow-up)||12
8750130|NCT01163760|9798862|FG001|STARTED|Period 4 (Follow-up)||13
8750131|NCT01163760|9798863|FG002|STARTED|Period 4 (Follow-up)||13
8750132|NCT01163760|9798864|FG003|STARTED|Period 4 (Follow-up)||12
8750133|NCT01163760|9798861|FG000|COMPLETED|Period 4 (Follow-up)||12
8750134|NCT01163760|9798862|FG001|COMPLETED|Period 4 (Follow-up)||13
8750135|NCT01163760|9798863|FG002|COMPLETED|Period 4 (Follow-up)||13
8750136|NCT01163760|9798864|FG003|COMPLETED|Period 4 (Follow-up)||12
8750137|NCT01163760|9798861|FG000|NOT COMPLETED|Period 4 (Follow-up)||0
8750138|NCT01163760|9798862|FG001|NOT COMPLETED|Period 4 (Follow-up)||0
8750139|NCT01163760|9798863|FG002|NOT COMPLETED|Period 4 (Follow-up)||0
8750140|NCT01163760|9798864|FG003|NOT COMPLETED|Period 4 (Follow-up)||0
8750141|NCT01163786|9798872|FG000|STARTED|Treatment With Bortezomib||17
8750142|NCT01163786|9798872|FG000|Completed 1st Cycle|Treatment With Bortezomib||17
8750143|NCT01163786|9798872|FG000|Completed 2nd Cycle|Treatment With Bortezomib|One patient completed cycle 2 but missed one dose of Bortezomib.|14
9023107|NCT03134248|10085931|FG002|NOT COMPLETED|Week 2||0
9023108|NCT03134248|10085932|FG003|NOT COMPLETED|Week 2||0
9023109|NCT03134248|10085933|FG004|NOT COMPLETED|Week 2||0
9023110|NCT03134248|10085934|FG005|NOT COMPLETED|Week 2||0
9023111|NCT03134248|10085929|FG000|STARTED|Week 3||7
9023112|NCT03134248|10085930|FG001|STARTED|Week 3||8
9023113|NCT03134248|10085931|FG002|STARTED|Week 3||9
9023114|NCT03134248|10085932|FG003|STARTED|Week 3||7
9023115|NCT03134248|10085933|FG004|STARTED|Week 3||9
9023116|NCT03134248|10085934|FG005|STARTED|Week 3||9
9023117|NCT03134248|10085929|FG000|COMPLETED|Week 3||7
9023118|NCT03134248|10085930|FG001|COMPLETED|Week 3||8
9023119|NCT03134248|10085931|FG002|COMPLETED|Week 3||9
9023120|NCT03134248|10085932|FG003|COMPLETED|Week 3||7
9023121|NCT03134248|10085933|FG004|COMPLETED|Week 3||9
9023122|NCT03134248|10085934|FG005|COMPLETED|Week 3||9
9023123|NCT03134248|10085929|FG000|NOT COMPLETED|Week 3||0
9023124|NCT03134248|10085930|FG001|NOT COMPLETED|Week 3||0
9023125|NCT03134248|10085931|FG002|NOT COMPLETED|Week 3||0
9023126|NCT03134248|10085932|FG003|NOT COMPLETED|Week 3||0
9023127|NCT03134248|10085933|FG004|NOT COMPLETED|Week 3||0
9023128|NCT03134248|10085934|FG005|NOT COMPLETED|Week 3||0
9023129|NCT03134313|10085944|FG000|STARTED|Overall Study||25
8750144|NCT01163786|9798872|FG000|COMPLETED|Treatment With Bortezomib||14
8750145|NCT01163786|9798872|FG000|NOT COMPLETED|Treatment With Bortezomib||3
8750146|NCT01163786|9798872|FG000|STARTED|Completed Follow up (Visit 9 and 10)||14
8807798|NCT01486615|9860091|FG001|NOT COMPLETED|Overall Study||1
9023130|NCT03134313|10085944|FG000|COMPLETED|Overall Study||25
9023131|NCT03134313|10085944|FG000|NOT COMPLETED|Overall Study||0
9023132|NCT03134326|10085948|FG000|STARTED|Overall Study||21
9023133|NCT03134326|10085948|FG000|COMPLETED|Overall Study||21
9023134|NCT03134326|10085948|FG000|NOT COMPLETED|Overall Study||0
9023135|NCT03134599|10085952|FG000|STARTED|Week 1||10
9023136|NCT03134599|10085953|FG001|STARTED|Week 1||10
8750147|NCT01163786|9798872|FG000|Completed Week 12 Follow up (Visit 9)|Completed Follow up (Visit 9 and 10)||14
8750148|NCT01163786|9798872|FG000|Completed Week 18 Follow up (Visit 10)|Completed Follow up (Visit 9 and 10)||13
8750149|NCT01163786|9798872|FG000|COMPLETED|Completed Follow up (Visit 9 and 10)||13
8750150|NCT01163786|9798872|FG000|NOT COMPLETED|Completed Follow up (Visit 9 and 10)||1
8750151|NCT01163851|9798878|FG000|STARTED|Overall Study||13
8750152|NCT01163851|9798879|FG001|STARTED|Overall Study||12
8750153|NCT01163851|9798878|FG000|Treated|Overall Study||12
8750154|NCT01163851|9798879|FG001|Treated|Overall Study||12
8750155|NCT01163851|9798878|FG000|COMPLETED|Overall Study||12
8750156|NCT01163851|9798879|FG001|COMPLETED|Overall Study||11
8750157|NCT01163851|9798878|FG000|NOT COMPLETED|Overall Study||1
8750158|NCT01163851|9798879|FG001|NOT COMPLETED|Overall Study||1
8750159|NCT01163916|9798888|FG000|STARTED|Overall Study||126
8750160|NCT01163916|9798889|FG001|STARTED|Overall Study||35
8750161|NCT01163916|9798890|FG002|STARTED|Overall Study||91
8750162|NCT01163916|9798888|FG000|Safety Population|Overall Study|One patient discontinued prior to receiving treatment with adalimumab due to absence of medication.|125
8750163|NCT01163916|9798889|FG001|Safety Population|Overall Study||35
8750164|NCT01163916|9798890|FG002|Safety Population|Overall Study||91
8750165|NCT01163916|9798888|FG000|COMPLETED|Overall Study|Completed 12-months treatment with adalimumab|96
8750166|NCT01163916|9798889|FG001|COMPLETED|Overall Study|Completed 12-months treatment with adalimumab|31
8750167|NCT01163916|9798890|FG002|COMPLETED|Overall Study|Completed 12-months treatment with adalimumab|71
8750168|NCT01163916|9798888|FG000|NOT COMPLETED|Overall Study||30
8750169|NCT01163916|9798889|FG001|NOT COMPLETED|Overall Study||4
8750170|NCT01163916|9798890|FG002|NOT COMPLETED|Overall Study||20
8750171|NCT01163955|9798905|FG000|STARTED|Overall Study||26
8750172|NCT01163955|9798906|FG001|STARTED|Overall Study||30
8750173|NCT01163955|9798905|FG000|COMPLETED|Overall Study||26
8750174|NCT01163955|9798906|FG001|COMPLETED|Overall Study||26
8750175|NCT01163955|9798905|FG000|NOT COMPLETED|Overall Study||0
8750176|NCT01163955|9798906|FG001|NOT COMPLETED|Overall Study||4
8750177|NCT01164007|9798912|FG000|STARTED|Overall Study||40
8750178|NCT01164007|9798912|FG000|Treated|Overall Study||37
8750179|NCT01164007|9798912|FG000|COMPLETED|Overall Study||0
8750180|NCT01164007|9798912|FG000|NOT COMPLETED|Overall Study||40
8750181|NCT01164098|9798918|FG000|STARTED|Overall Study||15
8750182|NCT01164098|9798919|FG001|STARTED|Overall Study||15
8750183|NCT01164098|9798918|FG000|COMPLETED|Overall Study||15
8750184|NCT01164098|9798919|FG001|COMPLETED|Overall Study||15
8750185|NCT01164098|9798918|FG000|NOT COMPLETED|Overall Study||0
8750186|NCT01164098|9798919|FG001|NOT COMPLETED|Overall Study||0
8750187|NCT01164137|9798927|FG000|STARTED|Overall Study||80
8750188|NCT01164137|9798928|FG001|STARTED|Overall Study||76
8750189|NCT01164137|9798927|FG000|COMPLETED|Overall Study||77
8750190|NCT01164137|9798928|FG001|COMPLETED|Overall Study||76
8750191|NCT01164137|9798927|FG000|NOT COMPLETED|Overall Study||3
8750192|NCT01164137|9798928|FG001|NOT COMPLETED|Overall Study||0
8750193|NCT01164475|9798936|FG000|STARTED|Overall Study||30
8750194|NCT01164475|9798937|FG001|STARTED|Overall Study||31
8750195|NCT01164475|9798936|FG000|COMPLETED|Overall Study||28
8750196|NCT01164475|9798937|FG001|COMPLETED|Overall Study||29
8750197|NCT01164475|9798936|FG000|NOT COMPLETED|Overall Study||2
8750198|NCT01164475|9798937|FG001|NOT COMPLETED|Overall Study||2
8750199|NCT01164501|9798946|FG000|STARTED|Overall Study||321
8750200|NCT01164501|9798947|FG001|STARTED|Overall Study||98
8750201|NCT01164501|9798948|FG002|STARTED|Overall Study||322
8750202|NCT01164501|9798946|FG000|COMPLETED|Overall Study||278
8750203|NCT01164501|9798947|FG001|COMPLETED|Overall Study||88
8750204|NCT01164501|9798948|FG002|COMPLETED|Overall Study||280
8750205|NCT01164501|9798946|FG000|NOT COMPLETED|Overall Study||43
8750206|NCT01164501|9798947|FG001|NOT COMPLETED|Overall Study||10
8750207|NCT01164501|9798948|FG002|NOT COMPLETED|Overall Study||42
8750208|NCT01164579|9798961|FG000|STARTED|Overall Study||36
8750209|NCT01164579|9798962|FG001|STARTED|Overall Study||36
8750210|NCT01164579|9798963|FG002|STARTED|Overall Study||37
8750211|NCT01164579|9798961|FG000|COMPLETED|Overall Study||28
8750212|NCT01164579|9798962|FG001|COMPLETED|Overall Study||27
8750213|NCT01164579|9798963|FG002|COMPLETED|Overall Study||21
8750214|NCT01164579|9798961|FG000|NOT COMPLETED|Overall Study||8
8750215|NCT01164579|9798962|FG001|NOT COMPLETED|Overall Study||9
8750216|NCT01164579|9798963|FG002|NOT COMPLETED|Overall Study||16
8750217|NCT01164644|9798974|FG000|STARTED|Overall Study||12
8750218|NCT01164644|9798975|FG001|STARTED|Overall Study||14
8750219|NCT01164644|9798974|FG000|COMPLETED|Overall Study||9
8750220|NCT01164644|9798975|FG001|COMPLETED|Overall Study||13
8750221|NCT01164644|9798974|FG000|NOT COMPLETED|Overall Study||3
8750222|NCT01164644|9798975|FG001|NOT COMPLETED|Overall Study||1
8750223|NCT01164722|9798983|FG000|STARTED|Overall Study||60
8750224|NCT01164722|9798984|FG001|STARTED|Overall Study||60
8750225|NCT01164722|9798983|FG000|COMPLETED|Overall Study||42
8750226|NCT01164722|9798984|FG001|COMPLETED|Overall Study||45
8750227|NCT01164722|9798983|FG000|NOT COMPLETED|Overall Study||18
8750228|NCT01164722|9798984|FG001|NOT COMPLETED|Overall Study||15
8750229|NCT01164865|9798992|FG000|STARTED|Overall Study||39
8750230|NCT01164865|9798993|FG001|STARTED|Overall Study||39
8750231|NCT01164865|9798992|FG000|COMPLETED|Overall Study||37
8750232|NCT01164865|9798993|FG001|COMPLETED|Overall Study||38
8750233|NCT01164865|9798992|FG000|NOT COMPLETED|Overall Study||2
8750234|NCT01164865|9798993|FG001|NOT COMPLETED|Overall Study||1
8750235|NCT01164891|9798999|FG000|STARTED|Overall Study||7
8750236|NCT01164891|9798999|FG000|COMPLETED|Overall Study||1
8750237|NCT01164891|9798999|FG000|NOT COMPLETED|Overall Study||6
8750238|NCT01164956|9799004|FG000|STARTED|Overall Study||1
8750239|NCT01164956|9799005|FG001|STARTED|Overall Study||1
8750240|NCT01164956|9799006|FG002|STARTED|Overall Study||1
8750241|NCT01164956|9799004|FG000|Evaluable for pedsFACIT-F Score Change|Overall Study||0
8750242|NCT01164956|9799005|FG001|Evaluable for pedsFACIT-F Score Change|Overall Study||1
8750243|NCT01164956|9799006|FG002|Evaluable for pedsFACIT-F Score Change|Overall Study||0
8750244|NCT01164956|9799004|FG000|COMPLETED|Overall Study||0
8750245|NCT01164956|9799005|FG001|COMPLETED|Overall Study||1
8750246|NCT01164956|9799006|FG002|COMPLETED|Overall Study||0
8750247|NCT01164956|9799004|FG000|NOT COMPLETED|Overall Study||1
8750248|NCT01164956|9799005|FG001|NOT COMPLETED|Overall Study||0
8750249|NCT01164956|9799006|FG002|NOT COMPLETED|Overall Study||1
8750250|NCT01165021|9799014|FG000|STARTED|Overall Study||19
8750251|NCT01165021|9799014|FG000|≥1 Dose Chemo|Overall Study||19
8750252|NCT01165021|9799014|FG000|≥1 Dose Chemo, Baseline, Cy 3 Assessment|Overall Study||17
8750253|NCT01165021|9799014|FG000|3 Cycles of Chemo, Then Surgery|Overall Study||15
8750254|NCT01165021|9799014|FG000|COMPLETED|Overall Study||18
8750255|NCT01165021|9799014|FG000|NOT COMPLETED|Overall Study||1
8750256|NCT01165047|9799018|FG000|STARTED|Overall Study||10
8750257|NCT01165047|9799018|FG000|COMPLETED|Overall Study||10
8750258|NCT01165047|9799018|FG000|NOT COMPLETED|Overall Study||0
8750259|NCT01165112|9799022|FG000|STARTED|Overall Study||48
8750260|NCT01165112|9799022|FG000|COMPLETED|Overall Study||48
8750261|NCT01165112|9799022|FG000|NOT COMPLETED|Overall Study||0
8750262|NCT01165138|9799029|FG000|STARTED|Overall Study||0
8750263|NCT01165138|9799030|FG001|STARTED|Overall Study||203
8750264|NCT01165138|9799031|FG002|STARTED|Overall Study||205
8750265|NCT01165138|9799032|FG003|STARTED|Overall Study||201
8750266|NCT01165138|9799029|FG000|COMPLETED|Overall Study||0
8750267|NCT01165138|9799030|FG001|COMPLETED|Overall Study||151
8750268|NCT01165138|9799031|FG002|COMPLETED|Overall Study||185
8750269|NCT01165138|9799032|FG003|COMPLETED|Overall Study||179
8750270|NCT01165138|9799029|FG000|NOT COMPLETED|Overall Study||0
8750271|NCT01165138|9799030|FG001|NOT COMPLETED|Overall Study||52
8750272|NCT01165138|9799031|FG002|NOT COMPLETED|Overall Study||20
8750273|NCT01165138|9799032|FG003|NOT COMPLETED|Overall Study||22
8750274|NCT01165177|9799042|FG000|STARTED|Overall Study||7695
8750275|NCT01165177|9799043|FG001|STARTED|Overall Study||7710
8750276|NCT01165177|9799042|FG000|COMPLETED|Overall Study||6773
8750277|NCT01165177|9799043|FG001|COMPLETED|Overall Study||6808
8750278|NCT01165177|9799042|FG000|NOT COMPLETED|Overall Study||922
8750279|NCT01165177|9799043|FG001|NOT COMPLETED|Overall Study||902
8750280|NCT01165203|9799059|FG000|STARTED|Active Phase||74
8750281|NCT01165203|9799060|FG001|STARTED|Active Phase||49
8750282|NCT01165203|9799059|FG000|COMPLETED|Active Phase||69
8750283|NCT01165203|9799060|FG001|COMPLETED|Active Phase||47
8750284|NCT01165203|9799059|FG000|NOT COMPLETED|Active Phase||5
8750285|NCT01165203|9799060|FG001|NOT COMPLETED|Active Phase||2
8750286|NCT01165203|9799059|FG000|STARTED|Extended Safety Follow-up Phase||74
8750287|NCT01165203|9799060|FG001|STARTED|Extended Safety Follow-up Phase||49
8750288|NCT01165203|9799059|FG000|COMPLETED|Extended Safety Follow-up Phase||67
8750289|NCT01165203|9799060|FG001|COMPLETED|Extended Safety Follow-up Phase||45
8750290|NCT01165203|9799059|FG000|NOT COMPLETED|Extended Safety Follow-up Phase||7
8750291|NCT01165203|9799060|FG001|NOT COMPLETED|Extended Safety Follow-up Phase||4
8750292|NCT01165216|9799075|FG000|STARTED|Overall Study|Participants who received any study drug|8
8750293|NCT01165216|9799076|FG001|STARTED|Overall Study|Participants who received any study drug|7
8750294|NCT01165216|9799075|FG000|Received at Least 1 Dose of Ipilimumab|Overall Study||6
8750295|NCT01165216|9799076|FG001|Received at Least 1 Dose of Ipilimumab|Overall Study||6
8750296|NCT01165216|9799075|FG000|COMPLETED|Overall Study|Completed=still on study drug|0
8750297|NCT01165216|9799076|FG001|COMPLETED|Overall Study|Completed=still on study drug|0
8750298|NCT01165216|9799075|FG000|NOT COMPLETED|Overall Study||8
8750299|NCT01165216|9799076|FG001|NOT COMPLETED|Overall Study||7
8750300|NCT01165229|9799086|FG000|STARTED|Overall Study||6950
8750301|NCT01165229|9799087|FG001|STARTED|Overall Study||6950
8750302|NCT01165229|9799086|FG000|COMPLETED|Overall Study||5770
8750303|NCT01165229|9799087|FG001|COMPLETED|Overall Study||5760
8750304|NCT01165229|9799086|FG000|NOT COMPLETED|Overall Study||1180
8750305|NCT01165229|9799087|FG001|NOT COMPLETED|Overall Study||1190
8750306|NCT01165242|9799126|FG000|STARTED|Overall Study||337
8750307|NCT01165242|9799127|FG001|STARTED|Overall Study||336
8750308|NCT01165242|9799128|FG002|STARTED|Overall Study||338
8750309|NCT01165242|9799126|FG000|COMPLETED|Overall Study||327
8750310|NCT01165242|9799127|FG001|COMPLETED|Overall Study||326
8750311|NCT01165242|9799128|FG002|COMPLETED|Overall Study||324
8750312|NCT01165242|9799126|FG000|NOT COMPLETED|Overall Study||10
8750313|NCT01165242|9799127|FG001|NOT COMPLETED|Overall Study||10
8750314|NCT01165242|9799128|FG002|NOT COMPLETED|Overall Study||14
8750315|NCT01165281|9799140|FG000|STARTED|Overall Study||168
8750316|NCT01165281|9799141|FG001|STARTED|Overall Study||172
8750317|NCT01165281|9799140|FG000|COMPLETED|Overall Study||110
8750318|NCT01165281|9799141|FG001|COMPLETED|Overall Study||121
8750319|NCT01165281|9799140|FG000|NOT COMPLETED|Overall Study||58
8750320|NCT01165281|9799141|FG001|NOT COMPLETED|Overall Study||51
8750321|NCT01165307|9799149|FG000|STARTED|Overall Study||33
8750322|NCT01165307|9799150|FG001|STARTED|Overall Study||34
8750323|NCT01165307|9799149|FG000|COMPLETED|Overall Study||19
8750324|NCT01165307|9799150|FG001|COMPLETED|Overall Study||31
8750325|NCT01165307|9799149|FG000|NOT COMPLETED|Overall Study||14
8750326|NCT01165307|9799150|FG001|NOT COMPLETED|Overall Study||3
8750327|NCT01165320|9799158|FG000|STARTED|Overall Study||12
8750328|NCT01165320|9799159|FG001|STARTED|Overall Study||8
8750329|NCT01165320|9799160|FG002|STARTED|Overall Study|No participants with esophageal candidiasis were identified for inclusion in the study|0
8750330|NCT01165320|9799158|FG000|COMPLETED|Overall Study||9
8750331|NCT01165320|9799159|FG001|COMPLETED|Overall Study||4
8750332|NCT01165320|9799160|FG002|COMPLETED|Overall Study||0
8750333|NCT01165320|9799158|FG000|NOT COMPLETED|Overall Study||3
8750334|NCT01165320|9799159|FG001|NOT COMPLETED|Overall Study||4
8750335|NCT01165320|9799160|FG002|NOT COMPLETED|Overall Study||0
8750336|NCT01165541|9799166|FG000|STARTED|Quetiapine XR Monotherapy||20
8750337|NCT01165541|9799166|FG000|COMPLETED|Quetiapine XR Monotherapy||16
8750338|NCT01165541|9799166|FG000|NOT COMPLETED|Quetiapine XR Monotherapy||4
8750339|NCT01165541|9799166|FG000|STARTED|Quetiapine XR and Mirtazepine||16
8750340|NCT01165541|9799166|FG000|COMPLETED|Quetiapine XR and Mirtazepine||11
8750341|NCT01165541|9799166|FG000|NOT COMPLETED|Quetiapine XR and Mirtazepine||5
8750342|NCT01165554|9799172|FG000|STARTED|Overall Study|This was the number of subjects that started the study.|203
8750343|NCT01165554|9799172|FG000|COMPLETED|Overall Study||180
8750344|NCT01165554|9799172|FG000|NOT COMPLETED|Overall Study||23
8750345|NCT01165684|9799181|FG000|STARTED|Overall Study||201
8750346|NCT01165684|9799182|FG001|STARTED|Overall Study||200
8750347|NCT01165684|9799181|FG000|Exposed|Overall Study|3 subjects withdrew prior to exposure to trial drug|198
8750348|NCT01165684|9799182|FG001|Exposed|Overall Study|1 subject withdrew prior to exposure to trial drug|199
8750349|NCT01165684|9799181|FG000|COMPLETED|Overall Study||173
8750350|NCT01165684|9799182|FG001|COMPLETED|Overall Study||148
8750351|NCT01165684|9799181|FG000|NOT COMPLETED|Overall Study||28
8750352|NCT01165684|9799182|FG001|NOT COMPLETED|Overall Study||52
8750353|NCT01165775|9799188|FG000|STARTED|Overall Study||17
8750354|NCT01165775|9799188|FG000|COMPLETED|Overall Study||15
8750355|NCT01165775|9799188|FG000|NOT COMPLETED|Overall Study||2
8750356|NCT01165840|9799196|FG000|STARTED|Overall Study||36
8750357|NCT01165840|9799196|FG000|COMPLETED|Overall Study||36
8750358|NCT01165840|9799196|FG000|NOT COMPLETED|Overall Study||0
8750359|NCT01165983|9799202|FG000|STARTED|Overall Study||51
8750360|NCT01165983|9799203|FG001|STARTED|Overall Study||49
8750361|NCT01165983|9799202|FG000|COMPLETED|Overall Study||46
8750362|NCT01165983|9799203|FG001|COMPLETED|Overall Study||42
8750363|NCT01165983|9799202|FG000|NOT COMPLETED|Overall Study||5
8750364|NCT01165983|9799203|FG001|NOT COMPLETED|Overall Study||7
8750365|NCT01165996|9799211|FG000|STARTED|Overall Study||25
8750366|NCT01165996|9799211|FG000|Induction Phase|Overall Study||25
8750367|NCT01165996|9799211|FG000|Maintenance Phase|Overall Study||23
8750368|NCT01165996|9799211|FG000|COMPLETED|Overall Study||23
8750369|NCT01165996|9799211|FG000|NOT COMPLETED|Overall Study||2
8750370|NCT01166126|9799216|FG000|STARTED|Overall Study||4
8750371|NCT01166126|9799216|FG000|COMPLETED|Overall Study||4
8750372|NCT01166126|9799216|FG000|NOT COMPLETED|Overall Study||0
8750373|NCT01166139|9799220|FG000|STARTED|Overall Study||10
8750374|NCT01166139|9799220|FG000|COMPLETED|Overall Study||7
8750375|NCT01166139|9799220|FG000|NOT COMPLETED|Overall Study||3
8750376|NCT01166230|9799226|FG000|STARTED|Overall Study||280
8750377|NCT01166230|9799227|FG001|STARTED|Overall Study||271
8750378|NCT01166230|9799226|FG000|COMPLETED|Overall Study||261
8750379|NCT01166230|9799227|FG001|COMPLETED|Overall Study||255
8750380|NCT01166230|9799226|FG000|NOT COMPLETED|Overall Study||19
8750381|NCT01166230|9799227|FG001|NOT COMPLETED|Overall Study||16
8750382|NCT01166282|9799235|FG000|STARTED|Double-blind Period||15
8750383|NCT01166282|9799236|FG001|STARTED|Double-blind Period||31
8750384|NCT01166282|9799237|FG002|STARTED|Double-blind Period||0
8750385|NCT01166282|9799235|FG000|COMPLETED|Double-blind Period||15
8750386|NCT01166282|9799236|FG001|COMPLETED|Double-blind Period||31
8750387|NCT01166282|9799237|FG002|COMPLETED|Double-blind Period||0
8750388|NCT01166282|9799235|FG000|NOT COMPLETED|Double-blind Period||0
8750389|NCT01166282|9799236|FG001|NOT COMPLETED|Double-blind Period||0
8750390|NCT01166282|9799237|FG002|NOT COMPLETED|Double-blind Period||0
8750391|NCT01166282|9799235|FG000|STARTED|Open-label Period||0
8750392|NCT01166282|9799236|FG001|STARTED|Open-label Period||0
8750393|NCT01166282|9799237|FG002|STARTED|Open-label Period||46
8750394|NCT01166282|9799235|FG000|COMPLETED|Open-label Period||0
8750395|NCT01166282|9799236|FG001|COMPLETED|Open-label Period||0
8750396|NCT01166282|9799237|FG002|COMPLETED|Open-label Period||29
8750397|NCT01166282|9799235|FG000|NOT COMPLETED|Open-label Period||0
8750398|NCT01166282|9799236|FG001|NOT COMPLETED|Open-label Period||0
8750399|NCT01166282|9799237|FG002|NOT COMPLETED|Open-label Period||17
8750400|NCT01166347|9799247|FG000|STARTED|Overall Study||297
8750401|NCT01166347|9799248|FG001|STARTED|Overall Study||149
8750402|NCT01166347|9799247|FG000|COMPLETED|Overall Study||295
8750403|NCT01166347|9799248|FG001|COMPLETED|Overall Study||148
8750404|NCT01166347|9799247|FG000|NOT COMPLETED|Overall Study||2
8750405|NCT01166347|9799248|FG001|NOT COMPLETED|Overall Study||1
8750406|NCT01166373|9799258|FG000|STARTED|Overall Study||95
8750407|NCT01166373|9799259|FG001|STARTED|Overall Study||91
8750408|NCT01166373|9799260|FG002|STARTED|Overall Study||91
8750409|NCT01166373|9799261|FG003|STARTED|Overall Study||97
8750410|NCT01166373|9799258|FG000|Completed OPTIMAL Year 2 Visit|Overall Study||81
8750411|NCT01166373|9799259|FG001|Completed OPTIMAL Year 2 Visit|Overall Study||80
8750412|NCT01166373|9799260|FG002|Completed OPTIMAL Year 2 Visit|Overall Study||79
8750413|NCT01166373|9799261|FG003|Completed OPTIMAL Year 2 Visit|Overall Study||87
8750414|NCT01166373|9799258|FG000|Randomized to Video|Overall Study||32
8750415|NCT01166373|9799259|FG001|Randomized to Video|Overall Study||43
8750416|NCT01166373|9799260|FG002|Randomized to Video|Overall Study||38
8750417|NCT01166373|9799261|FG003|Randomized to Video|Overall Study||40
8750418|NCT01166373|9799258|FG000|Randomized to No Video|Overall Study||45
8750419|NCT01166373|9799259|FG001|Randomized to No Video|Overall Study||30
8750420|NCT01166373|9799260|FG002|Randomized to No Video|Overall Study||34
8750421|NCT01166373|9799261|FG003|Randomized to No Video|Overall Study||42
8750422|NCT01166373|9799258|FG000|Consented to Participate E-OPTIMAL|Overall Study||72
8750423|NCT01166373|9799259|FG001|Consented to Participate E-OPTIMAL|Overall Study||66
8750424|NCT01166373|9799260|FG002|Consented to Participate E-OPTIMAL|Overall Study||69
8750425|NCT01166373|9799261|FG003|Consented to Participate E-OPTIMAL|Overall Study||78
8750426|NCT01166373|9799258|FG000|Completed E-OPTIMAL Year 3 Visit|Overall Study||70
8750427|NCT01166373|9799259|FG001|Completed E-OPTIMAL Year 3 Visit|Overall Study||66
8750428|NCT01166373|9799260|FG002|Completed E-OPTIMAL Year 3 Visit|Overall Study||66
8914601|NCT02169466|9974100|FG000|NOT COMPLETED|Overall Study||1
8914602|NCT02169466|9974101|FG001|NOT COMPLETED|Overall Study||1
8914603|NCT02169466|9974102|FG002|NOT COMPLETED|Overall Study||0
8914604|NCT02169466|9974103|FG003|NOT COMPLETED|Overall Study||0
8914605|NCT02169479|9974121|FG000|STARTED|Overall Study||4
8914606|NCT02169479|9974122|FG001|STARTED|Overall Study||4
8914607|NCT02169479|9974123|FG002|STARTED|Overall Study||4
8914608|NCT02169479|9974124|FG003|STARTED|Overall Study||4
8914609|NCT02169479|9974121|FG000|25 mg BIA 9-1067|Overall Study||4
8914610|NCT02169479|9974122|FG001|25 mg BIA 9-1067|Overall Study||3
8914611|NCT02169479|9974123|FG002|25 mg BIA 9-1067|Overall Study||4
8914612|NCT02169479|9974124|FG003|25 mg BIA 9-1067|Overall Study||4
8914613|NCT02169479|9974121|FG000|50 mg BIA 9-1067|Overall Study||4
8914614|NCT02169479|9974122|FG001|50 mg BIA 9-1067|Overall Study||4
8914615|NCT02169479|9974123|FG002|50 mg BIA 9-1067|Overall Study||4
8914616|NCT02169479|9974124|FG003|50 mg BIA 9-1067|Overall Study||4
8914617|NCT02169479|9974121|FG000|100 mg BIA 9-1067|Overall Study||3
8914618|NCT02169479|9974122|FG001|100 mg BIA 9-1067|Overall Study||4
8914619|NCT02169479|9974123|FG002|100 mg BIA 9-1067|Overall Study||4
8914620|NCT02169479|9974124|FG003|100 mg BIA 9-1067|Overall Study||4
8914621|NCT02169479|9974121|FG000|Placebo|Overall Study||3
8914622|NCT02169479|9974122|FG001|Placebo|Overall Study||3
8914623|NCT02169479|9974123|FG002|Placebo|Overall Study||4
8914624|NCT02169479|9974124|FG003|Placebo|Overall Study||4
8914625|NCT02169479|9974121|FG000|COMPLETED|Overall Study||3
8914626|NCT02169479|9974122|FG001|COMPLETED|Overall Study||3
8914627|NCT02169479|9974123|FG002|COMPLETED|Overall Study||4
8914628|NCT02169479|9974124|FG003|COMPLETED|Overall Study||4
8914629|NCT02169479|9974121|FG000|NOT COMPLETED|Overall Study||1
8914630|NCT02169479|9974122|FG001|NOT COMPLETED|Overall Study||1
8914631|NCT02169479|9974123|FG002|NOT COMPLETED|Overall Study||0
8914632|NCT02169479|9974124|FG003|NOT COMPLETED|Overall Study||0
8914633|NCT02169505|9974134|FG000|STARTED|Overall Study||2
8914634|NCT02169505|9974134|FG000|COMPLETED|Overall Study||1
8914635|NCT02169505|9974134|FG000|NOT COMPLETED|Overall Study||1
8914636|NCT02169674|9974140|FG000|STARTED|Overall Study||137
8914637|NCT02169674|9974141|FG001|STARTED|Overall Study||213
8914638|NCT02169674|9974140|FG000|COMPLETED|Overall Study||105
8914639|NCT02169674|9974141|FG001|COMPLETED|Overall Study||135
8914640|NCT02169674|9974140|FG000|NOT COMPLETED|Overall Study||32
8914641|NCT02169674|9974141|FG001|NOT COMPLETED|Overall Study||78
8914642|NCT02169739|9974149|FG000|STARTED|Overall Study||2
8914643|NCT02169739|9974150|FG001|STARTED|Overall Study||4
8914644|NCT02169739|9974149|FG000|COMPLETED|Overall Study||2
8914645|NCT02169739|9974150|FG001|COMPLETED|Overall Study||0
8914646|NCT02169739|9974149|FG000|NOT COMPLETED|Overall Study||0
8914647|NCT02169739|9974150|FG001|NOT COMPLETED|Overall Study||4
8914648|NCT02169791|9974157|FG000|STARTED|Overall Study||25
8914649|NCT02169791|9974157|FG000|COMPLETED|Overall Study||18
8914650|NCT02169791|9974157|FG000|NOT COMPLETED|Overall Study||7
8914651|NCT02169869|9974163|FG000|STARTED|Overall Study||17
8914652|NCT02169869|9974164|FG001|STARTED|Overall Study||16
8914653|NCT02169869|9974163|FG000|COMPLETED|Overall Study||17
8914654|NCT02169869|9974164|FG001|COMPLETED|Overall Study||16
8914655|NCT02169869|9974163|FG000|NOT COMPLETED|Overall Study||0
8914656|NCT02169869|9974164|FG001|NOT COMPLETED|Overall Study||0
8914657|NCT02169895|9974174|FG000|STARTED|Overall Study||4
8914658|NCT02169895|9974175|FG001|STARTED|Overall Study||4
8914659|NCT02169895|9974176|FG002|STARTED|Overall Study||4
8914660|NCT02169895|9974177|FG003|STARTED|Overall Study||4
8914661|NCT02169895|9974174|FG000|25 mg BIA 9-1067|Overall Study||4
8914662|NCT02169895|9974175|FG001|25 mg BIA 9-1067|Overall Study||4
8914663|NCT02169895|9974176|FG002|25 mg BIA 9-1067|Overall Study||4
8914664|NCT02169895|9974177|FG003|25 mg BIA 9-1067|Overall Study||4
8914665|NCT02169895|9974174|FG000|50 mg BIA 9-1067|Overall Study||4
8914666|NCT02169895|9974175|FG001|50 mg BIA 9-1067|Overall Study||4
8914667|NCT02169895|9974176|FG002|50 mg BIA 9-1067|Overall Study||4
8914668|NCT02169895|9974177|FG003|50 mg BIA 9-1067|Overall Study||4
8914669|NCT02169895|9974174|FG000|100 mg BIA 9-1067|Overall Study||4
8914670|NCT02169895|9974175|FG001|100 mg BIA 9-1067|Overall Study||4
8750429|NCT01166373|9799261|FG003|Completed E-OPTIMAL Year 3 Visit|Overall Study||77
8750430|NCT01166373|9799258|FG000|Completed E-OPTIMAL Year 4 Visit|Overall Study||67
8750431|NCT01166373|9799259|FG001|Completed E-OPTIMAL Year 4 Visit|Overall Study||61
8750432|NCT01166373|9799260|FG002|Completed E-OPTIMAL Year 4 Visit|Overall Study||63
8750433|NCT01166373|9799261|FG003|Completed E-OPTIMAL Year 4 Visit|Overall Study||68
8750434|NCT01166373|9799258|FG000|Completed E-OPTIMAL Year 5 Visit|Overall Study||62
8750435|NCT01166373|9799259|FG001|Completed E-OPTIMAL Year 5 Visit|Overall Study||56
8750436|NCT01166373|9799260|FG002|Completed E-OPTIMAL Year 5 Visit|Overall Study||62
8750437|NCT01166373|9799261|FG003|Completed E-OPTIMAL Year 5 Visit|Overall Study||64
8750438|NCT01166373|9799258|FG000|COMPLETED|Overall Study||90
8750439|NCT01166373|9799259|FG001|COMPLETED|Overall Study||87
8750440|NCT01166373|9799260|FG002|COMPLETED|Overall Study||87
8750441|NCT01166373|9799261|FG003|COMPLETED|Overall Study||92
8750442|NCT01166373|9799258|FG000|NOT COMPLETED|Overall Study||5
8750443|NCT01166373|9799259|FG001|NOT COMPLETED|Overall Study||4
8750444|NCT01166373|9799260|FG002|NOT COMPLETED|Overall Study||4
8750445|NCT01166373|9799261|FG003|NOT COMPLETED|Overall Study||5
8750446|NCT01166438|9799275|FG000|STARTED|Double-blind Phase: 1st 6 Months||122
8750447|NCT01166438|9799276|FG001|STARTED|Double-blind Phase: 1st 6 Months||127
8750448|NCT01166438|9799275|FG000|Treated|Double-blind Phase: 1st 6 Months||121
9023137|NCT03134599|10085954|FG002|STARTED|Week 1||10
9023138|NCT03134599|10085955|FG003|STARTED|Week 1||11
9023139|NCT03134599|10085956|FG004|STARTED|Week 1||10
9023140|NCT03134599|10085957|FG005|STARTED|Week 1||9
9023141|NCT03134599|10085952|FG000|COMPLETED|Week 1||10
9023142|NCT03134599|10085953|FG001|COMPLETED|Week 1||10
9023143|NCT03134599|10085954|FG002|COMPLETED|Week 1||10
9023144|NCT03134599|10085955|FG003|COMPLETED|Week 1||11
9023145|NCT03134599|10085956|FG004|COMPLETED|Week 1||9
9023146|NCT03134599|10085957|FG005|COMPLETED|Week 1||9
9023147|NCT03134599|10085952|FG000|NOT COMPLETED|Week 1||0
9023148|NCT03134599|10085953|FG001|NOT COMPLETED|Week 1||0
9023149|NCT03134599|10085954|FG002|NOT COMPLETED|Week 1||0
9023150|NCT03134599|10085955|FG003|NOT COMPLETED|Week 1||0
9023151|NCT03134599|10085956|FG004|NOT COMPLETED|Week 1||1
9023152|NCT03134599|10085957|FG005|NOT COMPLETED|Week 1||0
9023153|NCT03134599|10085952|FG000|STARTED|Week 2||10
9023154|NCT03134599|10085953|FG001|STARTED|Week 2||10
9023155|NCT03134599|10085954|FG002|STARTED|Week 2||10
9023156|NCT03134599|10085955|FG003|STARTED|Week 2||11
9023157|NCT03134599|10085956|FG004|STARTED|Week 2||9
9023158|NCT03134599|10085957|FG005|STARTED|Week 2||9
9023159|NCT03134599|10085952|FG000|COMPLETED|Week 2||9
9023160|NCT03134599|10085953|FG001|COMPLETED|Week 2||10
9023161|NCT03134599|10085954|FG002|COMPLETED|Week 2||10
9023162|NCT03134599|10085955|FG003|COMPLETED|Week 2||10
9023163|NCT03134599|10085956|FG004|COMPLETED|Week 2||8
9023164|NCT03134599|10085957|FG005|COMPLETED|Week 2||9
9023165|NCT03134599|10085952|FG000|NOT COMPLETED|Week 2||1
9023166|NCT03134599|10085953|FG001|NOT COMPLETED|Week 2||0
9023167|NCT03134599|10085954|FG002|NOT COMPLETED|Week 2||0
9023168|NCT03134599|10085955|FG003|NOT COMPLETED|Week 2||1
9023169|NCT03134599|10085956|FG004|NOT COMPLETED|Week 2||1
9023170|NCT03134599|10085957|FG005|NOT COMPLETED|Week 2||0
9023171|NCT03134599|10085952|FG000|STARTED|Week 3||9
9023172|NCT03134599|10085953|FG001|STARTED|Week 3||10
9023173|NCT03134599|10085954|FG002|STARTED|Week 3||10
9023174|NCT03134599|10085955|FG003|STARTED|Week 3||10
9023175|NCT03134599|10085956|FG004|STARTED|Week 3||8
9023176|NCT03134599|10085957|FG005|STARTED|Week 3||9
9023177|NCT03134599|10085952|FG000|COMPLETED|Week 3||9
9023178|NCT03134599|10085953|FG001|COMPLETED|Week 3||10
9023179|NCT03134599|10085954|FG002|COMPLETED|Week 3||10
9023180|NCT03134599|10085955|FG003|COMPLETED|Week 3||9
9023181|NCT03134599|10085956|FG004|COMPLETED|Week 3||8
9023182|NCT03134599|10085957|FG005|COMPLETED|Week 3||8
9023183|NCT03134599|10085952|FG000|NOT COMPLETED|Week 3||0
9023184|NCT03134599|10085953|FG001|NOT COMPLETED|Week 3||0
9023185|NCT03134599|10085954|FG002|NOT COMPLETED|Week 3||0
9023186|NCT03134599|10085955|FG003|NOT COMPLETED|Week 3||1
9023187|NCT03134599|10085956|FG004|NOT COMPLETED|Week 3||0
8750449|NCT01166438|9799276|FG001|Treated|Double-blind Phase: 1st 6 Months||126
9023188|NCT03134599|10085957|FG005|NOT COMPLETED|Week 3||1
9023189|NCT03134703|10085967|FG000|STARTED|Overall Study||6
9023190|NCT03134703|10085968|FG001|STARTED|Overall Study||5
9023191|NCT03134703|10085967|FG000|COMPLETED|Overall Study||0
9023192|NCT03134703|10085968|FG001|COMPLETED|Overall Study||3
9023193|NCT03134703|10085967|FG000|NOT COMPLETED|Overall Study||6
9023194|NCT03134703|10085968|FG001|NOT COMPLETED|Overall Study||2
9023195|NCT03134768|10085974|FG000|STARTED|Overall Study||50
9023196|NCT03134768|10085974|FG000|COMPLETED|Overall Study||50
9023197|NCT03134768|10085974|FG000|NOT COMPLETED|Overall Study||0
9023198|NCT03134911|10085980|FG000|STARTED|Overall Study||535
9023199|NCT03134911|10085980|FG000|COMPLETED|Overall Study||501
9023200|NCT03134911|10085980|FG000|NOT COMPLETED|Overall Study||34
9023201|NCT03134963|10085992|FG000|STARTED|Overall Study||12
9023202|NCT03134963|10085993|FG001|STARTED|Overall Study||13
9023203|NCT03134963|10085994|FG002|STARTED|Overall Study||3
9023204|NCT03134963|10085995|FG003|STARTED|Overall Study||14
9023205|NCT03134963|10085992|FG000|COMPLETED|Overall Study||12
9023206|NCT03134963|10085993|FG001|COMPLETED|Overall Study||13
9023207|NCT03134963|10085994|FG002|COMPLETED|Overall Study||3
9023208|NCT03134963|10085995|FG003|COMPLETED|Overall Study||14
9023209|NCT03134963|10085992|FG000|NOT COMPLETED|Overall Study||0
9023210|NCT03134963|10085993|FG001|NOT COMPLETED|Overall Study||0
9023211|NCT03134963|10085994|FG002|NOT COMPLETED|Overall Study||0
8750450|NCT01166438|9799275|FG000|COMPLETED|Double-blind Phase: 1st 6 Months|Completion of 12 month follow-up visit|113
8750451|NCT01166438|9799276|FG001|COMPLETED|Double-blind Phase: 1st 6 Months|Completion of 12 month follow-up visit|118
8750452|NCT01166438|9799275|FG000|NOT COMPLETED|Double-blind Phase: 1st 6 Months||9
8750453|NCT01166438|9799276|FG001|NOT COMPLETED|Double-blind Phase: 1st 6 Months||9
8750454|NCT01166438|9799275|FG000|STARTED|Off Treatment Follow-up Phase||85
8750455|NCT01166438|9799276|FG001|STARTED|Off Treatment Follow-up Phase||89
8750456|NCT01166438|9799275|FG000|COMPLETED|Off Treatment Follow-up Phase||51
8750457|NCT01166438|9799276|FG001|COMPLETED|Off Treatment Follow-up Phase||33
8750458|NCT01166438|9799275|FG000|NOT COMPLETED|Off Treatment Follow-up Phase||34
8750459|NCT01166438|9799276|FG001|NOT COMPLETED|Off Treatment Follow-up Phase||56
8750460|NCT01166568|9799286|FG000|STARTED|Deferred Implantation- Randomized||0
8750461|NCT01166568|9799287|FG001|STARTED|Deferred Implantation- Randomized||0
8750462|NCT01166568|9799288|FG002|STARTED|Deferred Implantation- Randomized||16
8750463|NCT01166568|9799286|FG000|COMPLETED|Deferred Implantation- Randomized||0
8750464|NCT01166568|9799287|FG001|COMPLETED|Deferred Implantation- Randomized||0
8750465|NCT01166568|9799288|FG002|COMPLETED|Deferred Implantation- Randomized|From the randomized sub-study control group (n=16), 1 subject withdrew during the observation phase|15
8750466|NCT01166568|9799286|FG000|NOT COMPLETED|Deferred Implantation- Randomized||0
8750467|NCT01166568|9799287|FG001|NOT COMPLETED|Deferred Implantation- Randomized||0
8750468|NCT01166568|9799288|FG002|NOT COMPLETED|Deferred Implantation- Randomized||1
8750469|NCT01166568|9799286|FG000|STARTED|Implantation- Nonrandomized & Randomized||288
8750470|NCT01166568|9799287|FG001|STARTED|Implantation- Nonrandomized & Randomized||33
8750471|NCT01166568|9799288|FG002|STARTED|Implantation- Nonrandomized & Randomized|15 subjects completed the observation phase and 9 subjects (17 eyes) proceeded with implantation.|9
8750472|NCT01166568|9799286|FG000|COMPLETED|Implantation- Nonrandomized & Randomized||274
8750473|NCT01166568|9799287|FG001|COMPLETED|Implantation- Nonrandomized & Randomized||32
8750474|NCT01166568|9799288|FG002|COMPLETED|Implantation- Nonrandomized & Randomized|(1) Primary eye implanted only subject withdrew consent after implantation of the device.|8
8750475|NCT01166568|9799286|FG000|NOT COMPLETED|Implantation- Nonrandomized & Randomized||14
8750476|NCT01166568|9799287|FG001|NOT COMPLETED|Implantation- Nonrandomized & Randomized||1
8750477|NCT01166568|9799288|FG002|NOT COMPLETED|Implantation- Nonrandomized & Randomized||1
8750478|NCT01166646|9799296|FG000|STARTED|Overall Study||21
8750479|NCT01166646|9799297|FG001|STARTED|Overall Study||22
8750480|NCT01166646|9799296|FG000|COMPLETED|Overall Study||20
8750481|NCT01166646|9799297|FG001|COMPLETED|Overall Study||21
8750482|NCT01166646|9799296|FG000|NOT COMPLETED|Overall Study||1
8750483|NCT01166646|9799297|FG001|NOT COMPLETED|Overall Study||1
8750484|NCT01166659|9799303|FG000|STARTED|Overall Study||48
8750485|NCT01166659|9799303|FG000|COMPLETED|Overall Study||35
8750486|NCT01166659|9799303|FG000|NOT COMPLETED|Overall Study||13
8750487|NCT01166750|9799310|FG000|STARTED|Overall Study||10
8750488|NCT01166750|9799311|FG001|STARTED|Overall Study||13
8750489|NCT01166750|9799310|FG000|COMPLETED|Overall Study||9
8750490|NCT01166750|9799311|FG001|COMPLETED|Overall Study||13
8750491|NCT01166750|9799310|FG000|NOT COMPLETED|Overall Study||1
8750492|NCT01166750|9799311|FG001|NOT COMPLETED|Overall Study||0
8750493|NCT01166763|9799317|FG000|STARTED|Overall Study||30
8750494|NCT01166763|9799317|FG000|COMPLETED|Overall Study||27
8750495|NCT01166763|9799317|FG000|NOT COMPLETED|Overall Study||3
8750496|NCT01166945|9799323|FG000|STARTED|Randomized||51
8750497|NCT01166945|9799324|FG001|STARTED|Randomized||47
8750498|NCT01166945|9799323|FG000|COMPLETED|Randomized||47
8750499|NCT01166945|9799324|FG001|COMPLETED|Randomized||43
8750500|NCT01166945|9799323|FG000|NOT COMPLETED|Randomized||4
8750501|NCT01166945|9799324|FG001|NOT COMPLETED|Randomized||4
8750502|NCT01166945|9799323|FG000|STARTED|Day 5||47
8750503|NCT01166945|9799324|FG001|STARTED|Day 5||43
8750504|NCT01166945|9799323|FG000|COMPLETED|Day 5||47
8750505|NCT01166945|9799324|FG001|COMPLETED|Day 5||43
8750506|NCT01166945|9799323|FG000|NOT COMPLETED|Day 5||0
8750507|NCT01166945|9799324|FG001|NOT COMPLETED|Day 5||0
8750508|NCT01166945|9799323|FG000|STARTED|Day 10||47
8750509|NCT01166945|9799324|FG001|STARTED|Day 10||43
8750510|NCT01166945|9799323|FG000|COMPLETED|Day 10||44
8750511|NCT01166945|9799324|FG001|COMPLETED|Day 10||41
8750512|NCT01166945|9799323|FG000|NOT COMPLETED|Day 10||3
8750513|NCT01166945|9799324|FG001|NOT COMPLETED|Day 10||2
8750514|NCT01166945|9799323|FG000|STARTED|Day 15||44
8750515|NCT01166945|9799324|FG001|STARTED|Day 15||41
8750516|NCT01166945|9799323|FG000|COMPLETED|Day 15||42
8750517|NCT01166945|9799324|FG001|COMPLETED|Day 15||40
8750518|NCT01166945|9799323|FG000|NOT COMPLETED|Day 15||2
8750519|NCT01166945|9799324|FG001|NOT COMPLETED|Day 15||1
8750520|NCT01166945|9799323|FG000|STARTED|Day 20||42
8750521|NCT01166945|9799324|FG001|STARTED|Day 20||40
8750522|NCT01166945|9799323|FG000|COMPLETED|Day 20||42
8750523|NCT01166945|9799324|FG001|COMPLETED|Day 20||40
8750524|NCT01166945|9799323|FG000|NOT COMPLETED|Day 20||0
8750525|NCT01166945|9799324|FG001|NOT COMPLETED|Day 20||0
8750526|NCT01166945|9799323|FG000|STARTED|Day 30||42
8750527|NCT01166945|9799324|FG001|STARTED|Day 30||40
8750528|NCT01166945|9799323|FG000|COMPLETED|Day 30||38
8750529|NCT01166945|9799324|FG001|COMPLETED|Day 30||37
8750530|NCT01166945|9799323|FG000|NOT COMPLETED|Day 30||4
8750531|NCT01166945|9799324|FG001|NOT COMPLETED|Day 30||3
8750532|NCT01166958|9799334|FG000|STARTED|Overall Study||13
8750533|NCT01166958|9799335|FG001|STARTED|Overall Study||13
8750534|NCT01166958|9799334|FG000|COMPLETED|Overall Study||12
8750535|NCT01166958|9799335|FG001|COMPLETED|Overall Study||13
8750536|NCT01166958|9799334|FG000|NOT COMPLETED|Overall Study||1
8750537|NCT01166958|9799335|FG001|NOT COMPLETED|Overall Study||0
8750538|NCT01166971|9799343|FG000|STARTED|Overall Study||33
8750539|NCT01166971|9799344|FG001|STARTED|Overall Study||31
8750540|NCT01166971|9799343|FG000|COMPLETED|Overall Study||32
8750541|NCT01166971|9799344|FG001|COMPLETED|Overall Study||30
8750542|NCT01166971|9799343|FG000|NOT COMPLETED|Overall Study||1
8750543|NCT01166971|9799344|FG001|NOT COMPLETED|Overall Study||1
8750544|NCT01166984|9799355|FG000|STARTED|Overall Study||5
8750545|NCT01166984|9799356|FG001|STARTED|Overall Study||5
8750546|NCT01166984|9799357|FG002|STARTED|Overall Study||5
8750547|NCT01166984|9799358|FG003|STARTED|Overall Study||5
8750548|NCT01166984|9799359|FG004|STARTED|Overall Study||5
8750549|NCT01166984|9799355|FG000|COMPLETED|Overall Study||5
8750550|NCT01166984|9799356|FG001|COMPLETED|Overall Study||5
8750551|NCT01166984|9799357|FG002|COMPLETED|Overall Study||5
8750552|NCT01166984|9799358|FG003|COMPLETED|Overall Study||5
8750553|NCT01166984|9799359|FG004|COMPLETED|Overall Study||5
8750554|NCT01166984|9799355|FG000|NOT COMPLETED|Overall Study||0
8750555|NCT01166984|9799356|FG001|NOT COMPLETED|Overall Study||0
8750556|NCT01166984|9799357|FG002|NOT COMPLETED|Overall Study||0
8750557|NCT01166984|9799358|FG003|NOT COMPLETED|Overall Study||0
8750558|NCT01166984|9799359|FG004|NOT COMPLETED|Overall Study||0
8750559|NCT01166997|9799383|FG000|STARTED|Overall Study||29
8750560|NCT01166997|9799384|FG001|STARTED|Overall Study||30
8750561|NCT01166997|9799383|FG000|COMPLETED|Overall Study||27
8750562|NCT01166997|9799384|FG001|COMPLETED|Overall Study||30
8750563|NCT01166997|9799383|FG000|NOT COMPLETED|Overall Study||2
8750564|NCT01166997|9799384|FG001|NOT COMPLETED|Overall Study||0
8750565|NCT01167023|9799394|FG000|STARTED|Overall Study||0
8750566|NCT01167023|9799395|FG001|STARTED|Overall Study||21
8750567|NCT01167023|9799396|FG002|STARTED|Overall Study||41
8750568|NCT01167023|9799394|FG000|Received at Least 1 Dose of Study Drug|Overall Study||0
8750569|NCT01167023|9799395|FG001|Received at Least 1 Dose of Study Drug|Overall Study||19
8750570|NCT01167023|9799396|FG002|Received at Least 1 Dose of Study Drug|Overall Study||41
8750571|NCT01167023|9799394|FG000|COMPLETED|Overall Study||0
8750572|NCT01167023|9799395|FG001|COMPLETED|Overall Study||18
8750573|NCT01167023|9799396|FG002|COMPLETED|Overall Study||39
8750574|NCT01167023|9799394|FG000|NOT COMPLETED|Overall Study||0
8750575|NCT01167023|9799395|FG001|NOT COMPLETED|Overall Study||3
8750576|NCT01167023|9799396|FG002|NOT COMPLETED|Overall Study||2
8750577|NCT01167140|9799402|FG000|STARTED|Overall Study||42
8750578|NCT01167140|9799402|FG000|COMPLETED|Overall Study||41
8750579|NCT01167140|9799402|FG000|NOT COMPLETED|Overall Study||1
8750580|NCT01167153|9799408|FG000|STARTED|Overall Study||282
8750581|NCT01167153|9799409|FG001|STARTED|Overall Study||282
8750582|NCT01167153|9799408|FG000|Intention to Treat (ITT)|Overall Study||272
8750583|NCT01167153|9799409|FG001|Intention to Treat (ITT)|Overall Study||268
8750584|NCT01167153|9799408|FG000|COMPLETED|Overall Study||264
8750585|NCT01167153|9799409|FG001|COMPLETED|Overall Study||249
8750586|NCT01167153|9799408|FG000|NOT COMPLETED|Overall Study||18
8750587|NCT01167153|9799409|FG001|NOT COMPLETED|Overall Study||33
8750588|NCT01167179|9799417|FG000|STARTED|Overall Study||80
8750589|NCT01167179|9799418|FG001|STARTED|Overall Study||80
8750590|NCT01167179|9799417|FG000|COMPLETED|Overall Study||65
8750591|NCT01167179|9799418|FG001|COMPLETED|Overall Study||59
8750592|NCT01167179|9799417|FG000|NOT COMPLETED|Overall Study||15
8750593|NCT01167179|9799418|FG001|NOT COMPLETED|Overall Study||21
8750594|NCT01167192|9799424|FG000|STARTED|Overall Study||10
8750595|NCT01167192|9799424|FG000|COMPLETED|Overall Study||6
8750596|NCT01167192|9799424|FG000|NOT COMPLETED|Overall Study||4
8750597|NCT01167257|9799430|FG000|STARTED|Overall Study||31
8750598|NCT01167257|9799431|FG001|STARTED|Overall Study||31
8750599|NCT01167257|9799430|FG000|COMPLETED|Overall Study||28
8750600|NCT01167257|9799431|FG001|COMPLETED|Overall Study||28
8750601|NCT01167257|9799430|FG000|NOT COMPLETED|Overall Study||3
8750602|NCT01167257|9799431|FG001|NOT COMPLETED|Overall Study||3
8750603|NCT01167426|9799441|FG000|STARTED|Overall Study||148
8750604|NCT01167426|9799441|FG000|COMPLETED|Overall Study||138
8750605|NCT01167426|9799441|FG000|NOT COMPLETED|Overall Study||10
8750606|NCT01167452|9799446|FG000|STARTED|Overall Study||36
8750607|NCT01167452|9799446|FG000|COMPLETED|Overall Study||36
8750608|NCT01167452|9799446|FG000|NOT COMPLETED|Overall Study||0
8750609|NCT01167504|9799451|FG000|STARTED|Overall Study||15
8750610|NCT01167504|9799451|FG000|COMPLETED|Overall Study||12
8750611|NCT01167504|9799451|FG000|NOT COMPLETED|Overall Study||3
8750612|NCT01167569|9799457|FG000|STARTED|Overall Study||28
8750613|NCT01167569|9799458|FG001|STARTED|Overall Study||29
8750614|NCT01167569|9799457|FG000|COMPLETED|Overall Study||27
8750615|NCT01167569|9799458|FG001|COMPLETED|Overall Study||27
8750616|NCT01167569|9799457|FG000|NOT COMPLETED|Overall Study||1
8750617|NCT01167569|9799458|FG001|NOT COMPLETED|Overall Study||2
8750618|NCT01167582|9799468|FG000|STARTED|Overall Study||55
8750619|NCT01167582|9799469|FG001|STARTED|Overall Study||55
8750620|NCT01167582|9799468|FG000|COMPLETED|Overall Study||55
8750621|NCT01167582|9799469|FG001|COMPLETED|Overall Study||54
8750622|NCT01167582|9799468|FG000|NOT COMPLETED|Overall Study||0
8750623|NCT01167582|9799469|FG001|NOT COMPLETED|Overall Study||1
8750624|NCT01167595|9799477|FG000|STARTED|Overall Study||522
8750625|NCT01167595|9799478|FG001|STARTED|Overall Study||537
8750626|NCT01167595|9799477|FG000|COMPLETED|Overall Study||522
8750627|NCT01167595|9799478|FG001|COMPLETED|Overall Study||537
8750628|NCT01167595|9799477|FG000|NOT COMPLETED|Overall Study||0
8750629|NCT01167595|9799478|FG001|NOT COMPLETED|Overall Study||0
8750630|NCT01167608|9799484|FG000|STARTED|Overall Study||883
8750631|NCT01167608|9799484|FG000|COMPLETED|Overall Study||769
8750632|NCT01167608|9799484|FG000|NOT COMPLETED|Overall Study||114
8750633|NCT01167634|9799493|FG000|STARTED|Overall Study||33
8750634|NCT01167634|9799494|FG001|STARTED|Overall Study||33
8750635|NCT01167634|9799495|FG002|STARTED|Overall Study||33
8750636|NCT01167634|9799496|FG003|STARTED|Overall Study||33
8750637|NCT01167634|9799493|FG000|COMPLETED|Overall Study||31
8750638|NCT01167634|9799494|FG001|COMPLETED|Overall Study||29
8750639|NCT01167634|9799495|FG002|COMPLETED|Overall Study||30
8750640|NCT01167634|9799496|FG003|COMPLETED|Overall Study||29
8750641|NCT01167634|9799493|FG000|NOT COMPLETED|Overall Study||2
8750642|NCT01167634|9799494|FG001|NOT COMPLETED|Overall Study||4
8750643|NCT01167634|9799495|FG002|NOT COMPLETED|Overall Study||3
8750644|NCT01167634|9799496|FG003|NOT COMPLETED|Overall Study||4
8750645|NCT01167712|9799508|FG000|STARTED|Overall Study||346
8750646|NCT01167712|9799509|FG001|STARTED|Overall Study||346
8750647|NCT01167712|9799508|FG000|COMPLETED|Overall Study||346
8750648|NCT01167712|9799509|FG001|COMPLETED|Overall Study||346
8750649|NCT01167712|9799508|FG000|NOT COMPLETED|Overall Study||0
8750650|NCT01167712|9799509|FG001|NOT COMPLETED|Overall Study||0
8750651|NCT01167829|9799515|FG000|STARTED|Overall Study||12
8750652|NCT01167829|9799515|FG000|COMPLETED|Overall Study||12
8750653|NCT01167829|9799515|FG000|NOT COMPLETED|Overall Study||0
8750654|NCT01167881|9799523|FG000|STARTED|Overall Study||769
8750655|NCT01167881|9799524|FG001|STARTED|Overall Study||780
8750656|NCT01167881|9799523|FG000|Completed After 2 Years Treatment|Overall Study||95
8750657|NCT01167881|9799524|FG001|Completed After 2 Years Treatment|Overall Study||127
8750658|NCT01167881|9799523|FG000|Completed After 4 Years Treatment|Overall Study||515
8750659|NCT01167881|9799524|FG001|Completed After 4 Years Treatment|Overall Study||462
8750660|NCT01167881|9799523|FG000|COMPLETED|Overall Study||610
8750661|NCT01167881|9799524|FG001|COMPLETED|Overall Study||589
8750662|NCT01167881|9799523|FG000|NOT COMPLETED|Overall Study||159
8750663|NCT01167881|9799524|FG001|NOT COMPLETED|Overall Study||191
8750664|NCT01167907|9799532|FG000|STARTED|Overall Study||17
8750665|NCT01167907|9799533|FG001|STARTED|Overall Study||15
8750666|NCT01167907|9799532|FG000|COMPLETED|Overall Study||15
8750667|NCT01167907|9799533|FG001|COMPLETED|Overall Study||14
8750668|NCT01167907|9799532|FG000|NOT COMPLETED|Overall Study||2
8750669|NCT01167907|9799533|FG001|NOT COMPLETED|Overall Study||1
8750670|NCT01168024|9799541|FG000|STARTED|Overall Study|13 tx/3 controls. Roll-ins occurred for product training, several more treatment cases than control.|13
8750671|NCT01168024|9799542|FG001|STARTED|Overall Study||3
8750672|NCT01168024|9799541|FG000|COMPLETED|Overall Study||13
8914671|NCT02169895|9974176|FG002|100 mg BIA 9-1067|Overall Study||4
8914672|NCT02169895|9974177|FG003|100 mg BIA 9-1067|Overall Study||2
8914673|NCT02169895|9974174|FG000|Placebo|Overall Study||4
8914674|NCT02169895|9974175|FG001|Placebo|Overall Study||4
8914675|NCT02169895|9974176|FG002|Placebo|Overall Study||4
8914676|NCT02169895|9974177|FG003|Placebo|Overall Study||4
8914677|NCT02169895|9974174|FG000|COMPLETED|Overall Study||4
8914678|NCT02169895|9974175|FG001|COMPLETED|Overall Study||4
8914679|NCT02169895|9974176|FG002|COMPLETED|Overall Study||4
8914680|NCT02169895|9974177|FG003|COMPLETED|Overall Study||2
8914681|NCT02169895|9974174|FG000|NOT COMPLETED|Overall Study||0
8750673|NCT01168024|9799542|FG001|COMPLETED|Overall Study||3
8750674|NCT01168024|9799541|FG000|NOT COMPLETED|Overall Study||0
8750675|NCT01168024|9799542|FG001|NOT COMPLETED|Overall Study||0
8750676|NCT01168232|9799548|FG000|STARTED|Overall Study||42
8750677|NCT01168232|9799548|FG000|COMPLETED|Overall Study|Eligible and treated patients|34
8750678|NCT01168232|9799548|FG000|NOT COMPLETED|Overall Study||8
8750679|NCT01168349|9799552|FG000|STARTED|Overall Study||1055
8750680|NCT01168349|9799552|FG000|COMPLETED|Overall Study||754
8750681|NCT01168349|9799552|FG000|NOT COMPLETED|Overall Study||301
8750682|NCT01168401|9799583|FG000|STARTED|Overall Study||10
8750683|NCT01168401|9799584|FG001|STARTED|Overall Study||10
8750684|NCT01168401|9799585|FG002|STARTED|Overall Study||10
8750685|NCT01168401|9799586|FG003|STARTED|Overall Study||9
8750686|NCT01168401|9799587|FG004|STARTED|Overall Study||9
8750687|NCT01168401|9799588|FG005|STARTED|Overall Study||9
8750688|NCT01168401|9799589|FG006|STARTED|Overall Study||10
8750689|NCT01168401|9799590|FG007|STARTED|Overall Study||10
8750690|NCT01168401|9799591|FG008|STARTED|Overall Study||9
8750691|NCT01168401|9799592|FG009|STARTED|Overall Study||8
8750692|NCT01168401|9799593|FG010|STARTED|Overall Study||8
8750693|NCT01168401|9799583|FG000|COMPLETED|Overall Study||9
8750694|NCT01168401|9799584|FG001|COMPLETED|Overall Study||9
8750695|NCT01168401|9799585|FG002|COMPLETED|Overall Study||8
8750696|NCT01168401|9799586|FG003|COMPLETED|Overall Study||7
8750697|NCT01168401|9799587|FG004|COMPLETED|Overall Study||9
8750698|NCT01168401|9799588|FG005|COMPLETED|Overall Study||9
8750699|NCT01168401|9799589|FG006|COMPLETED|Overall Study||10
8750700|NCT01168401|9799590|FG007|COMPLETED|Overall Study||10
8750701|NCT01168401|9799591|FG008|COMPLETED|Overall Study||9
8750702|NCT01168401|9799592|FG009|COMPLETED|Overall Study||8
8750703|NCT01168401|9799593|FG010|COMPLETED|Overall Study||8
8750704|NCT01168401|9799583|FG000|NOT COMPLETED|Overall Study||1
8750705|NCT01168401|9799584|FG001|NOT COMPLETED|Overall Study||1
8750706|NCT01168401|9799585|FG002|NOT COMPLETED|Overall Study||2
8750707|NCT01168401|9799586|FG003|NOT COMPLETED|Overall Study||2
8750708|NCT01168401|9799587|FG004|NOT COMPLETED|Overall Study||0
8750709|NCT01168401|9799588|FG005|NOT COMPLETED|Overall Study||0
8750710|NCT01168401|9799589|FG006|NOT COMPLETED|Overall Study||0
8750711|NCT01168401|9799590|FG007|NOT COMPLETED|Overall Study||0
8750712|NCT01168401|9799591|FG008|NOT COMPLETED|Overall Study||0
8750713|NCT01168401|9799592|FG009|NOT COMPLETED|Overall Study||0
8750714|NCT01168401|9799593|FG010|NOT COMPLETED|Overall Study||0
8750715|NCT01168427|9799617|FG000|STARTED|Overall Study||66
8750716|NCT01168427|9799617|FG000|COMPLETED|Overall Study||65
8750717|NCT01168427|9799617|FG000|NOT COMPLETED|Overall Study||1
8750718|NCT01168596|9799623|FG000|STARTED|Overall Study||16
8750719|NCT01168596|9799624|FG001|STARTED|Overall Study||14
8750720|NCT01168596|9799623|FG000|COMPLETED|Overall Study||13
8750721|NCT01168596|9799624|FG001|COMPLETED|Overall Study||13
8750722|NCT01168596|9799623|FG000|NOT COMPLETED|Overall Study||3
8750723|NCT01168596|9799624|FG001|NOT COMPLETED|Overall Study||1
8750724|NCT01168674|9799630|FG000|STARTED|Overall Study||25
8750725|NCT01168674|9799631|FG001|STARTED|Overall Study||24
8750726|NCT01168674|9799630|FG000|COMPLETED|Overall Study||25
8750727|NCT01168674|9799631|FG001|COMPLETED|Overall Study||24
8750728|NCT01168674|9799630|FG000|NOT COMPLETED|Overall Study||0
8750729|NCT01168674|9799631|FG001|NOT COMPLETED|Overall Study||0
8750730|NCT01168687|9799640|FG000|STARTED|Overall Study||23
8750731|NCT01168687|9799641|FG001|STARTED|Overall Study||23
8750732|NCT01168687|9799640|FG000|COMPLETED|Overall Study||23
8750733|NCT01168687|9799641|FG001|COMPLETED|Overall Study||23
8750734|NCT01168687|9799640|FG000|NOT COMPLETED|Overall Study||0
8750735|NCT01168687|9799641|FG001|NOT COMPLETED|Overall Study||0
8750736|NCT01168726|9799650|FG000|STARTED|Overall Study||111
8750737|NCT01168726|9799651|FG001|STARTED|Overall Study||121
8750738|NCT01168726|9799652|FG002|STARTED|Overall Study||133
8750739|NCT01168726|9799650|FG000|COMPLETED|Overall Study||103
8750740|NCT01168726|9799651|FG001|COMPLETED|Overall Study||112
8750741|NCT01168726|9799652|FG002|COMPLETED|Overall Study||128
8750742|NCT01168726|9799650|FG000|NOT COMPLETED|Overall Study||8
8750743|NCT01168726|9799651|FG001|NOT COMPLETED|Overall Study||9
8750744|NCT01168726|9799652|FG002|NOT COMPLETED|Overall Study||5
8750745|NCT01168856|9799662|FG000|STARTED|Overall Study||176
8750746|NCT01168856|9799663|FG001|STARTED|Overall Study||558
8750747|NCT01168856|9799662|FG000|COMPLETED|Overall Study||158
8750748|NCT01168856|9799663|FG001|COMPLETED|Overall Study||215
8750749|NCT01168856|9799662|FG000|NOT COMPLETED|Overall Study||18
8750750|NCT01168856|9799663|FG001|NOT COMPLETED|Overall Study||343
8750751|NCT01168908|9799676|FG000|STARTED|Double Blind, Placebo Controlled||10
8750752|NCT01168908|9799677|FG001|STARTED|Double Blind, Placebo Controlled||10
8750753|NCT01168908|9799676|FG000|COMPLETED|Double Blind, Placebo Controlled||7
8750754|NCT01168908|9799677|FG001|COMPLETED|Double Blind, Placebo Controlled||8
8750755|NCT01168908|9799676|FG000|NOT COMPLETED|Double Blind, Placebo Controlled||3
8750756|NCT01168908|9799677|FG001|NOT COMPLETED|Double Blind, Placebo Controlled||2
8750757|NCT01168908|9799676|FG000|STARTED|Open Label||7
8750758|NCT01168908|9799677|FG001|STARTED|Open Label||8
8750759|NCT01168908|9799676|FG000|COMPLETED|Open Label||6
8750760|NCT01168908|9799677|FG001|COMPLETED|Open Label||7
8750761|NCT01168908|9799676|FG000|NOT COMPLETED|Open Label||1
8750762|NCT01168908|9799677|FG001|NOT COMPLETED|Open Label||1
8750763|NCT01168934|9799683|FG000|STARTED|First Intervention Period||7
8750764|NCT01168934|9799684|FG001|STARTED|First Intervention Period||7
8750765|NCT01168934|9799683|FG000|COMPLETED|First Intervention Period||7
8750766|NCT01168934|9799684|FG001|COMPLETED|First Intervention Period||7
8750767|NCT01168934|9799683|FG000|NOT COMPLETED|First Intervention Period||0
8750768|NCT01168934|9799684|FG001|NOT COMPLETED|First Intervention Period||0
8750769|NCT01168934|9799683|FG000|STARTED|Washout Period (at Least 14 Days)||7
8750770|NCT01168934|9799684|FG001|STARTED|Washout Period (at Least 14 Days)||7
8750771|NCT01168934|9799683|FG000|COMPLETED|Washout Period (at Least 14 Days)||7
8750772|NCT01168934|9799684|FG001|COMPLETED|Washout Period (at Least 14 Days)||7
8750773|NCT01168934|9799683|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8750774|NCT01168934|9799684|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8750775|NCT01168934|9799683|FG000|STARTED|Second Intervention Period||7
8750776|NCT01168934|9799684|FG001|STARTED|Second Intervention Period||7
8750777|NCT01168934|9799683|FG000|COMPLETED|Second Intervention Period||7
8750778|NCT01168934|9799684|FG001|COMPLETED|Second Intervention Period||7
8750779|NCT01168934|9799683|FG000|NOT COMPLETED|Second Intervention Period||0
8750780|NCT01168934|9799684|FG001|NOT COMPLETED|Second Intervention Period||0
8750781|NCT01168973|9799693|FG000|STARTED|Overall Study||628
8750782|NCT01168973|9799694|FG001|STARTED|Overall Study||625
8750783|NCT01168973|9799693|FG000|Received Any Quantity of Any Study Drug|Overall Study||624
8750784|NCT01168973|9799694|FG001|Received Any Quantity of Any Study Drug|Overall Study|Three participants randomized to placebo and docetaxel received 1 dose of ramucirumab in error.|621
8750785|NCT01168973|9799693|FG000|COMPLETED|Overall Study||15
8750786|NCT01168973|9799694|FG001|COMPLETED|Overall Study||14
8750787|NCT01168973|9799693|FG000|NOT COMPLETED|Overall Study||613
8750788|NCT01168973|9799694|FG001|NOT COMPLETED|Overall Study||611
8750789|NCT01168986|9799703|FG000|STARTED|Overall Study||20
8750790|NCT01168986|9799704|FG001|STARTED|Overall Study||21
8750791|NCT01168986|9799705|FG002|STARTED|Overall Study||21
8750792|NCT01168986|9799703|FG000|COMPLETED|Overall Study||18
8750793|NCT01168986|9799704|FG001|COMPLETED|Overall Study||20
8750794|NCT01168986|9799705|FG002|COMPLETED|Overall Study||21
8750795|NCT01168986|9799703|FG000|NOT COMPLETED|Overall Study||2
8750796|NCT01168986|9799704|FG001|NOT COMPLETED|Overall Study||1
8750797|NCT01168986|9799705|FG002|NOT COMPLETED|Overall Study||0
8750798|NCT01168999|9799717|FG000|STARTED|Overall Study||28
8750799|NCT01168999|9799718|FG001|STARTED|Overall Study||27
8750800|NCT01168999|9799719|FG002|STARTED|Overall Study||27
8750801|NCT01168999|9799720|FG003|STARTED|Overall Study||28
8750802|NCT01168999|9799717|FG000|COMPLETED|Overall Study||26
8750803|NCT01168999|9799718|FG001|COMPLETED|Overall Study||26
8750804|NCT01168999|9799719|FG002|COMPLETED|Overall Study||27
8750805|NCT01168999|9799720|FG003|COMPLETED|Overall Study||28
8750806|NCT01168999|9799717|FG000|NOT COMPLETED|Overall Study||2
8750807|NCT01168999|9799718|FG001|NOT COMPLETED|Overall Study||1
8750808|NCT01168999|9799719|FG002|NOT COMPLETED|Overall Study||0
8750809|NCT01168999|9799720|FG003|NOT COMPLETED|Overall Study||0
8750810|NCT01169038|9799730|FG000|STARTED|Overall Study||15
8750811|NCT01169038|9799730|FG000|COMPLETED|Overall Study||8
8750812|NCT01169038|9799730|FG000|NOT COMPLETED|Overall Study||7
8750813|NCT01169064|9799736|FG000|STARTED|Overall Study||239
8750814|NCT01169064|9799737|FG001|STARTED|Overall Study||236
8750815|NCT01169064|9799736|FG000|COMPLETED|Overall Study||239
8750816|NCT01169064|9799737|FG001|COMPLETED|Overall Study||236
8750817|NCT01169064|9799736|FG000|NOT COMPLETED|Overall Study||0
8750818|NCT01169064|9799737|FG001|NOT COMPLETED|Overall Study||0
8750819|NCT01169103|9799747|FG000|STARTED|Overall Study||11
8750820|NCT01169103|9799748|FG001|STARTED|Overall Study||11
8750821|NCT01169103|9799747|FG000|COMPLETED|Overall Study||5
8750822|NCT01169103|9799748|FG001|COMPLETED|Overall Study||7
8750823|NCT01169103|9799747|FG000|NOT COMPLETED|Overall Study||6
8750824|NCT01169103|9799748|FG001|NOT COMPLETED|Overall Study||4
8750825|NCT01169311|9799754|FG000|STARTED|Overall Study||27
8750826|NCT01169311|9799754|FG000|COMPLETED|Overall Study||27
8750827|NCT01169311|9799754|FG000|NOT COMPLETED|Overall Study||0
8750828|NCT01169337|9799762|FG000|STARTED|Overall Study||44
8750829|NCT01169337|9799763|FG001|STARTED|Overall Study||90
8750830|NCT01169337|9799764|FG002|STARTED|Overall Study||92
8750831|NCT01169337|9799762|FG000|Received Treatment/Observation|Overall Study||44
8750832|NCT01169337|9799763|FG001|Received Treatment/Observation|Overall Study||88
8750833|NCT01169337|9799764|FG002|Received Treatment/Observation|Overall Study||86
8750834|NCT01169337|9799762|FG000|COMPLETED|Overall Study||0
8750835|NCT01169337|9799763|FG001|COMPLETED|Overall Study||0
8750836|NCT01169337|9799764|FG002|COMPLETED|Overall Study||86
8750837|NCT01169337|9799762|FG000|NOT COMPLETED|Overall Study||44
8750838|NCT01169337|9799763|FG001|NOT COMPLETED|Overall Study||90
8750839|NCT01169337|9799764|FG002|NOT COMPLETED|Overall Study||6
8750840|NCT01169350|9799772|FG000|STARTED|Overall Study||8
8750841|NCT01169350|9799772|FG000|COMPLETED|Overall Study||3
8750842|NCT01169350|9799772|FG000|NOT COMPLETED|Overall Study||5
8750843|NCT01169467|9799778|FG000|STARTED|Overall Study||44
8750844|NCT01169467|9799779|FG001|STARTED|Overall Study||40
8750845|NCT01169467|9799778|FG000|COMPLETED|Overall Study||37
8750846|NCT01169467|9799779|FG001|COMPLETED|Overall Study||36
8750847|NCT01169467|9799778|FG000|NOT COMPLETED|Overall Study||7
8750848|NCT01169467|9799779|FG001|NOT COMPLETED|Overall Study||4
8807799|NCT01486615|9860092|FG002|NOT COMPLETED|Overall Study||2
8807800|NCT01486615|9860093|FG003|NOT COMPLETED|Overall Study||2
8807801|NCT01486758|9860105|FG000|STARTED|Overall Study||20
8807802|NCT01486758|9860106|FG001|STARTED|Overall Study||20
8807803|NCT01486758|9860105|FG000|COMPLETED|Overall Study||20
8807804|NCT01486758|9860106|FG001|COMPLETED|Overall Study||19
8807805|NCT01486758|9860105|FG000|NOT COMPLETED|Overall Study||0
8807806|NCT01486758|9860106|FG001|NOT COMPLETED|Overall Study||1
8807807|NCT01486784|9860119|FG000|STARTED|Overall Study||3
8807808|NCT01486784|9860120|FG001|STARTED|Overall Study||7
8807809|NCT01486784|9860121|FG002|STARTED|Overall Study||6
8807810|NCT01486784|9860122|FG003|STARTED|Overall Study||1
8807811|NCT01486784|9860123|FG004|STARTED|Overall Study||5
8807812|NCT01486784|9860124|FG005|STARTED|Overall Study||5
8807813|NCT01486784|9860119|FG000|Completed Cycle 1|Overall Study||2
8807814|NCT01486784|9860120|FG001|Completed Cycle 1|Overall Study||6
8807815|NCT01486784|9860121|FG002|Completed Cycle 1|Overall Study||3
8807816|NCT01486784|9860122|FG003|Completed Cycle 1|Overall Study||1
8807817|NCT01486784|9860123|FG004|Completed Cycle 1|Overall Study||3
8807818|NCT01486784|9860124|FG005|Completed Cycle 1|Overall Study||2
8807819|NCT01486784|9860119|FG000|Received Treatment|Overall Study||3
8807820|NCT01486784|9860120|FG001|Received Treatment|Overall Study||7
8807821|NCT01486784|9860121|FG002|Received Treatment|Overall Study||5
8807822|NCT01486784|9860122|FG003|Received Treatment|Overall Study||1
8807823|NCT01486784|9860123|FG004|Received Treatment|Overall Study||3
8807824|NCT01486784|9860124|FG005|Received Treatment|Overall Study||2
8807825|NCT01486784|9860119|FG000|COMPLETED|Overall Study||3
8807826|NCT01486784|9860120|FG001|COMPLETED|Overall Study||7
8807827|NCT01486784|9860121|FG002|COMPLETED|Overall Study||5
8807828|NCT01486784|9860122|FG003|COMPLETED|Overall Study||1
8807829|NCT01486784|9860123|FG004|COMPLETED|Overall Study||3
8807830|NCT01486784|9860124|FG005|COMPLETED|Overall Study||2
8807831|NCT01486784|9860119|FG000|NOT COMPLETED|Overall Study||0
8807832|NCT01486784|9860120|FG001|NOT COMPLETED|Overall Study||0
8807833|NCT01486784|9860121|FG002|NOT COMPLETED|Overall Study||1
8807834|NCT01486784|9860122|FG003|NOT COMPLETED|Overall Study||0
8807835|NCT01486784|9860123|FG004|NOT COMPLETED|Overall Study||2
8807836|NCT01486784|9860124|FG005|NOT COMPLETED|Overall Study||3
8750849|NCT01169493|9799791|FG000|STARTED|Period 1 (6 Months)||2
8750850|NCT01169493|9799792|FG001|STARTED|Period 1 (6 Months)||4
8750851|NCT01169493|9799793|FG002|STARTED|Period 1 (6 Months)||5
8750852|NCT01169493|9799794|FG003|STARTED|Period 1 (6 Months)||0
8750853|NCT01169493|9799795|FG004|STARTED|Period 1 (6 Months)||0
8750854|NCT01169493|9799796|FG005|STARTED|Period 1 (6 Months)||5
8750855|NCT01169493|9799791|FG000|COMPLETED|Period 1 (6 Months)||2
8750856|NCT01169493|9799792|FG001|COMPLETED|Period 1 (6 Months)||3
8750857|NCT01169493|9799793|FG002|COMPLETED|Period 1 (6 Months)||3
8750858|NCT01169493|9799794|FG003|COMPLETED|Period 1 (6 Months)||0
8750859|NCT01169493|9799795|FG004|COMPLETED|Period 1 (6 Months)||0
8750860|NCT01169493|9799796|FG005|COMPLETED|Period 1 (6 Months)||2
8750861|NCT01169493|9799791|FG000|NOT COMPLETED|Period 1 (6 Months)||0
8750862|NCT01169493|9799792|FG001|NOT COMPLETED|Period 1 (6 Months)||1
8750863|NCT01169493|9799793|FG002|NOT COMPLETED|Period 1 (6 Months)||2
8750864|NCT01169493|9799794|FG003|NOT COMPLETED|Period 1 (6 Months)||0
8750865|NCT01169493|9799795|FG004|NOT COMPLETED|Period 1 (6 Months)||0
8750866|NCT01169493|9799796|FG005|NOT COMPLETED|Period 1 (6 Months)||3
8750867|NCT01169493|9799791|FG000|STARTED|Period 2 (6 Months)||2
8750868|NCT01169493|9799792|FG001|STARTED|Period 2 (6 Months)||3
8750869|NCT01169493|9799793|FG002|STARTED|Period 2 (6 Months)||3
8750870|NCT01169493|9799794|FG003|STARTED|Period 2 (6 Months)||0
8750871|NCT01169493|9799795|FG004|STARTED|Period 2 (6 Months)||0
8750872|NCT01169493|9799796|FG005|STARTED|Period 2 (6 Months)||2
8750873|NCT01169493|9799791|FG000|COMPLETED|Period 2 (6 Months)||2
8750874|NCT01169493|9799792|FG001|COMPLETED|Period 2 (6 Months)||3
8750875|NCT01169493|9799793|FG002|COMPLETED|Period 2 (6 Months)||3
8750876|NCT01169493|9799794|FG003|COMPLETED|Period 2 (6 Months)||0
8750877|NCT01169493|9799795|FG004|COMPLETED|Period 2 (6 Months)||0
8750878|NCT01169493|9799796|FG005|COMPLETED|Period 2 (6 Months)||2
8750879|NCT01169493|9799791|FG000|NOT COMPLETED|Period 2 (6 Months)||0
8750880|NCT01169493|9799792|FG001|NOT COMPLETED|Period 2 (6 Months)||0
8750881|NCT01169493|9799793|FG002|NOT COMPLETED|Period 2 (6 Months)||0
9023212|NCT03134963|10085995|FG003|NOT COMPLETED|Overall Study||0
9023213|NCT03134989|10086005|FG000|STARTED|Overall Study||80
9023214|NCT03134989|10086005|FG000|COMPLETED|Overall Study|Clinical investigation termination date: Last Subject, Final Visit 18-Jun-2020|80
9023215|NCT03134989|10086005|FG000|NOT COMPLETED|Overall Study||0
9023216|NCT03135015|10086012|FG000|STARTED|Overall Study||11
9023217|NCT03135015|10086013|FG001|STARTED|Overall Study||11
9023218|NCT03135015|10086012|FG000|Water Control|Overall Study||9
9023219|NCT03135015|10086013|FG001|Water Control|Overall Study||11
9023220|NCT03135015|10086012|FG000|Placebo Capsules|Overall Study||9
9023221|NCT03135015|10086013|FG001|Placebo Capsules|Overall Study||11
9023222|NCT03135015|10086012|FG000|2g Capsules|Overall Study||9
9023223|NCT03135015|10086013|FG001|2g Capsules|Overall Study||11
9023224|NCT03135015|10086012|FG000|4g Capsules|Overall Study||9
9023225|NCT03135015|10086013|FG001|4g Capsules|Overall Study||11
9023226|NCT03135015|10086012|FG000|2g Tablets|Overall Study||9
9023227|NCT03135015|10086013|FG001|2g Tablets|Overall Study||11
9023228|NCT03135015|10086012|FG000|4g Tablets|Overall Study||9
9023229|NCT03135015|10086013|FG001|4g Tablets|Overall Study||11
9023230|NCT03135015|10086012|FG000|COMPLETED|Overall Study||9
9023231|NCT03135015|10086013|FG001|COMPLETED|Overall Study||11
9023232|NCT03135015|10086012|FG000|NOT COMPLETED|Overall Study||2
9023233|NCT03135015|10086013|FG001|NOT COMPLETED|Overall Study||0
9023234|NCT03135028|10086063|FG000|STARTED|Overall Study||9
9023235|NCT03135028|10086063|FG000|COMPLETED|Overall Study||0
9023236|NCT03135028|10086063|FG000|NOT COMPLETED|Overall Study||9
9023237|NCT03135210|10086069|FG000|STARTED|Overall Study||2
9023238|NCT03135210|10086070|FG001|STARTED|Overall Study||2
9023239|NCT03135210|10086069|FG000|COMPLETED|Overall Study||2
9023240|NCT03135210|10086070|FG001|COMPLETED|Overall Study||1
9023241|NCT03135210|10086069|FG000|NOT COMPLETED|Overall Study||0
9023242|NCT03135210|10086070|FG001|NOT COMPLETED|Overall Study||1
9023243|NCT03135379|10086078|FG000|STARTED|Overall Study||62
9023244|NCT03135379|10086079|FG001|STARTED|Overall Study||62
8750882|NCT01169493|9799794|FG003|NOT COMPLETED|Period 2 (6 Months)||0
8750883|NCT01169493|9799795|FG004|NOT COMPLETED|Period 2 (6 Months)||0
8750884|NCT01169493|9799796|FG005|NOT COMPLETED|Period 2 (6 Months)||0
8750885|NCT01169493|9799791|FG000|STARTED|Period 3 (6 Months)||2
8914682|NCT02169895|9974175|FG001|NOT COMPLETED|Overall Study||0
8914683|NCT02169895|9974176|FG002|NOT COMPLETED|Overall Study||0
8914684|NCT02169895|9974177|FG003|NOT COMPLETED|Overall Study||2
8914685|NCT02170025|9974189|FG000|STARTED|Overall Study||14
8914686|NCT02170025|9974190|FG001|STARTED|Overall Study||7
8914687|NCT02170025|9974189|FG000|COMPLETED|Overall Study||12
8914688|NCT02170025|9974190|FG001|COMPLETED|Overall Study||7
8914689|NCT02170025|9974189|FG000|NOT COMPLETED|Overall Study||2
8914690|NCT02170025|9974190|FG001|NOT COMPLETED|Overall Study||0
8914691|NCT02170051|9974198|FG000|STARTED|Overall Study||26
8914692|NCT02170051|9974199|FG001|STARTED|Overall Study||29
8914693|NCT02170051|9974198|FG000|Tested at Mid-point|Overall Study||13
8914694|NCT02170051|9974199|FG001|Tested at Mid-point|Overall Study||18
8914695|NCT02170051|9974198|FG000|Tested at Post-treatment|Overall Study||15
9023245|NCT03135379|10086078|FG000|COMPLETED|Overall Study||61
9023246|NCT03135379|10086079|FG001|COMPLETED|Overall Study||59
9023247|NCT03135379|10086078|FG000|NOT COMPLETED|Overall Study||1
9023248|NCT03135379|10086079|FG001|NOT COMPLETED|Overall Study||3
9023249|NCT03135431|10086087|FG000|STARTED|Overall Study||20
8750886|NCT01169493|9799792|FG001|STARTED|Period 3 (6 Months)||3
8750887|NCT01169493|9799793|FG002|STARTED|Period 3 (6 Months)||3
8750888|NCT01169493|9799794|FG003|STARTED|Period 3 (6 Months)||0
9023250|NCT03135431|10086088|FG001|STARTED|Overall Study||20
9023251|NCT03135431|10086087|FG000|COMPLETED|Overall Study||18
9023252|NCT03135431|10086088|FG001|COMPLETED|Overall Study||20
9023253|NCT03135431|10086087|FG000|NOT COMPLETED|Overall Study||2
9023254|NCT03135431|10086088|FG001|NOT COMPLETED|Overall Study||0
9023255|NCT03135522|10086096|FG000|STARTED|Overall Study||17
9023256|NCT03135522|10086097|FG001|STARTED|Overall Study||17
9023257|NCT03135522|10086096|FG000|COMPLETED|Overall Study||16
9023258|NCT03135522|10086097|FG001|COMPLETED|Overall Study||17
9023259|NCT03135522|10086096|FG000|NOT COMPLETED|Overall Study||1
9023260|NCT03135522|10086097|FG001|NOT COMPLETED|Overall Study||0
9023261|NCT03135535|10086103|FG000|STARTED|Overall Study||30
9023262|NCT03135535|10086103|FG000|COMPLETED|Overall Study||30
9023263|NCT03135535|10086103|FG000|NOT COMPLETED|Overall Study||0
9023264|NCT03135548|10086110|FG000|STARTED|Overall Study||19
9023265|NCT03135548|10086111|FG001|STARTED|Overall Study||19
9023266|NCT03135548|10086112|FG002|STARTED|Overall Study||21
9023267|NCT03135548|10086110|FG000|COMPLETED|Overall Study||14
9023268|NCT03135548|10086111|FG001|COMPLETED|Overall Study||15
9023269|NCT03135548|10086112|FG002|COMPLETED|Overall Study||18
9023270|NCT03135548|10086110|FG000|NOT COMPLETED|Overall Study||5
9023271|NCT03135548|10086111|FG001|NOT COMPLETED|Overall Study||4
9023272|NCT03135548|10086112|FG002|NOT COMPLETED|Overall Study||3
9023273|NCT03135899|10086128|FG000|STARTED|Overall Study||1
9023274|NCT03135899|10086129|FG001|STARTED|Overall Study||1
9023275|NCT03135899|10086130|FG002|STARTED|Overall Study||1
9023276|NCT03135899|10086131|FG003|STARTED|Overall Study||1
9023277|NCT03135899|10086132|FG004|STARTED|Overall Study||8
9023278|NCT03135899|10086133|FG005|STARTED|Overall Study||9
9023279|NCT03135899|10086134|FG006|STARTED|Overall Study||8
9023280|NCT03135899|10086135|FG007|STARTED|Overall Study||8
9023281|NCT03135899|10086128|FG000|COMPLETED|Overall Study||1
9023282|NCT03135899|10086129|FG001|COMPLETED|Overall Study||1
9023283|NCT03135899|10086130|FG002|COMPLETED|Overall Study||1
9023284|NCT03135899|10086131|FG003|COMPLETED|Overall Study||1
9023285|NCT03135899|10086132|FG004|COMPLETED|Overall Study||8
9023286|NCT03135899|10086133|FG005|COMPLETED|Overall Study||7
9023287|NCT03135899|10086134|FG006|COMPLETED|Overall Study||7
9023288|NCT03135899|10086135|FG007|COMPLETED|Overall Study||8
9023289|NCT03135899|10086128|FG000|NOT COMPLETED|Overall Study||0
9023290|NCT03135899|10086129|FG001|NOT COMPLETED|Overall Study||0
9023291|NCT03135899|10086130|FG002|NOT COMPLETED|Overall Study||0
9023292|NCT03135899|10086131|FG003|NOT COMPLETED|Overall Study||0
9023293|NCT03135899|10086132|FG004|NOT COMPLETED|Overall Study||0
9023294|NCT03135899|10086133|FG005|NOT COMPLETED|Overall Study||2
9023295|NCT03135899|10086134|FG006|NOT COMPLETED|Overall Study||1
9023296|NCT03135899|10086135|FG007|NOT COMPLETED|Overall Study||0
9023297|NCT03136068|10086151|FG000|STARTED|Overall Study||88
9023298|NCT03136068|10086152|FG001|STARTED|Overall Study||90
9023299|NCT03136068|10086151|FG000|COMPLETED|Overall Study||86
9023300|NCT03136068|10086152|FG001|COMPLETED|Overall Study||89
9023301|NCT03136068|10086151|FG000|NOT COMPLETED|Overall Study||2
9023302|NCT03136068|10086152|FG001|NOT COMPLETED|Overall Study||1
9023303|NCT03136107|10086158|FG000|STARTED|Overall Study||26
9023304|NCT03136107|10086158|FG000|Test Product|Overall Study||26
9023305|NCT03136107|10086158|FG000|Reference Product|Overall Study||26
9023306|NCT03136107|10086158|FG000|Negative Control|Overall Study||26
9023307|NCT03136107|10086158|FG000|COMPLETED|Overall Study||25
9023308|NCT03136107|10086158|FG000|NOT COMPLETED|Overall Study||1
9023309|NCT03136159|10086168|FG000|STARTED|Overall Study||190
9023310|NCT03136159|10086169|FG001|STARTED|Overall Study||190
9023311|NCT03136159|10086168|FG000|COMPLETED|Overall Study||185
9023312|NCT03136159|10086169|FG001|COMPLETED|Overall Study||190
9023313|NCT03136159|10086168|FG000|NOT COMPLETED|Overall Study||5
9023314|NCT03136159|10086169|FG001|NOT COMPLETED|Overall Study||0
9023315|NCT03136198|10086177|FG000|STARTED|Overall Study||66
9023316|NCT03136198|10086178|FG001|STARTED|Overall Study||64
9023317|NCT03136198|10086177|FG000|COMPLETED|Overall Study||66
9023318|NCT03136198|10086178|FG001|COMPLETED|Overall Study||63
9023319|NCT03136198|10086177|FG000|NOT COMPLETED|Overall Study||0
9023320|NCT03136198|10086178|FG001|NOT COMPLETED|Overall Study||1
9023321|NCT03136328|10086184|FG000|STARTED|Overall Study||11
9023322|NCT03136328|10086184|FG000|COMPLETED|Overall Study||11
9023323|NCT03136328|10086184|FG000|NOT COMPLETED|Overall Study||0
9023324|NCT03136367|10086192|FG000|STARTED|T1 Consultation||66
9023325|NCT03136367|10086193|FG001|STARTED|T1 Consultation||248
9023326|NCT03136367|10086194|FG002|STARTED|T1 Consultation||257
9023327|NCT03136367|10086192|FG000|COMPLETED|T1 Consultation|received the intervention|64
9023328|NCT03136367|10086193|FG001|COMPLETED|T1 Consultation||241
8750889|NCT01169493|9799795|FG004|STARTED|Period 3 (6 Months)||0
8750890|NCT01169493|9799796|FG005|STARTED|Period 3 (6 Months)||2
8750891|NCT01169493|9799791|FG000|COMPLETED|Period 3 (6 Months)||2
9023329|NCT03136367|10086194|FG002|COMPLETED|T1 Consultation||256
9023330|NCT03136367|10086192|FG000|NOT COMPLETED|T1 Consultation||2
9023331|NCT03136367|10086193|FG001|NOT COMPLETED|T1 Consultation||7
9023332|NCT03136367|10086194|FG002|NOT COMPLETED|T1 Consultation||1
9023333|NCT03136367|10086192|FG000|STARTED|T2 Post-consultation||64
9023334|NCT03136367|10086193|FG001|STARTED|T2 Post-consultation||241
9023335|NCT03136367|10086194|FG002|STARTED|T2 Post-consultation||256
9023336|NCT03136367|10086192|FG000|COMPLETED|T2 Post-consultation||61
8750892|NCT01169493|9799792|FG001|COMPLETED|Period 3 (6 Months)||1
8750893|NCT01169493|9799793|FG002|COMPLETED|Period 3 (6 Months)||2
8750894|NCT01169493|9799794|FG003|COMPLETED|Period 3 (6 Months)||0
8750895|NCT01169493|9799795|FG004|COMPLETED|Period 3 (6 Months)||0
8750896|NCT01169493|9799796|FG005|COMPLETED|Period 3 (6 Months)||2
8750897|NCT01169493|9799791|FG000|NOT COMPLETED|Period 3 (6 Months)||0
8750898|NCT01169493|9799792|FG001|NOT COMPLETED|Period 3 (6 Months)||2
8750899|NCT01169493|9799793|FG002|NOT COMPLETED|Period 3 (6 Months)||1
8750900|NCT01169493|9799794|FG003|NOT COMPLETED|Period 3 (6 Months)||0
8750901|NCT01169493|9799795|FG004|NOT COMPLETED|Period 3 (6 Months)||0
8750902|NCT01169493|9799796|FG005|NOT COMPLETED|Period 3 (6 Months)||0
8750903|NCT01169519|9799804|FG000|STARTED|Overall Study|This was a pre-post study, All patients receiving a baseline assessment, also received sildenafil.|21
8750904|NCT01169519|9799804|FG000|COMPLETED|Overall Study||21
8750905|NCT01169519|9799804|FG000|NOT COMPLETED|Overall Study||0
8750906|NCT01169532|9799816|FG000|STARTED|Overall Study||16
8750907|NCT01169532|9799816|FG000|COMPLETED|Overall Study||15
8750908|NCT01169532|9799816|FG000|NOT COMPLETED|Overall Study||1
8750909|NCT01169558|9799820|FG000|STARTED|Overall Study||162
8750910|NCT01169558|9799820|FG000|COMPLETED|Overall Study||6
8750911|NCT01169558|9799820|FG000|NOT COMPLETED|Overall Study||156
8750912|NCT01169636|9799829|FG000|STARTED|Overall Study||3
8750913|NCT01169636|9799830|FG001|STARTED|Overall Study||6
8750914|NCT01169636|9799831|FG002|STARTED|Overall Study||20
8750915|NCT01169636|9799832|FG003|STARTED|Overall Study||13
8750916|NCT01169636|9799833|FG004|STARTED|Overall Study||14
8750917|NCT01169636|9799829|FG000|COMPLETED|Overall Study||3
8750918|NCT01169636|9799830|FG001|COMPLETED|Overall Study||6
8750919|NCT01169636|9799831|FG002|COMPLETED|Overall Study||17
8750920|NCT01169636|9799832|FG003|COMPLETED|Overall Study||12
8750921|NCT01169636|9799833|FG004|COMPLETED|Overall Study||11
8750922|NCT01169636|9799829|FG000|NOT COMPLETED|Overall Study||0
8750923|NCT01169636|9799830|FG001|NOT COMPLETED|Overall Study||0
8750924|NCT01169636|9799831|FG002|NOT COMPLETED|Overall Study||3
8750925|NCT01169636|9799832|FG003|NOT COMPLETED|Overall Study||1
8750926|NCT01169636|9799833|FG004|NOT COMPLETED|Overall Study||3
8750927|NCT01169649|9799843|FG000|STARTED|Overall Study||11
8750928|NCT01169649|9799843|FG000|COMPLETED|Overall Study||8
8750929|NCT01169649|9799843|FG000|NOT COMPLETED|Overall Study||3
8750930|NCT01169675|9799852|FG000|STARTED|Overall Study||20
8750931|NCT01169675|9799853|FG001|STARTED|Overall Study||3
8750932|NCT01169675|9799854|FG002|STARTED|Overall Study||7
8750933|NCT01169675|9799855|FG003|STARTED|Overall Study||17
8750934|NCT01169675|9799856|FG004|STARTED|Overall Study||6
8750935|NCT01169675|9799852|FG000|COMPLETED|Overall Study||0
8750936|NCT01169675|9799853|FG001|COMPLETED|Overall Study||0
8750937|NCT01169675|9799854|FG002|COMPLETED|Overall Study||0
8750938|NCT01169675|9799855|FG003|COMPLETED|Overall Study||0
8750939|NCT01169675|9799856|FG004|COMPLETED|Overall Study||0
8750940|NCT01169675|9799852|FG000|NOT COMPLETED|Overall Study||20
8750941|NCT01169675|9799853|FG001|NOT COMPLETED|Overall Study||3
8750942|NCT01169675|9799854|FG002|NOT COMPLETED|Overall Study||7
8750943|NCT01169675|9799855|FG003|NOT COMPLETED|Overall Study||17
8750944|NCT01169675|9799856|FG004|NOT COMPLETED|Overall Study||6
8750945|NCT01169701|9799870|FG000|STARTED|Overall Study||36
8750946|NCT01169701|9799871|FG001|STARTED|Overall Study||35
8750947|NCT01169701|9799870|FG000|Safety Set|Overall Study||36
8750948|NCT01169701|9799871|FG001|Safety Set|Overall Study||35
8750949|NCT01169701|9799870|FG000|Intent to Treat (ITT) Set|Overall Study||32
8750950|NCT01169701|9799871|FG001|Intent to Treat (ITT) Set|Overall Study||28
8750951|NCT01169701|9799870|FG000|COMPLETED|Overall Study||31
8750952|NCT01169701|9799871|FG001|COMPLETED|Overall Study||25
8750953|NCT01169701|9799870|FG000|NOT COMPLETED|Overall Study||5
8750954|NCT01169701|9799871|FG001|NOT COMPLETED|Overall Study||10
8750955|NCT01169779|9799879|FG000|STARTED|Overall Study|Randomized.|195
8750956|NCT01169779|9799880|FG001|STARTED|Overall Study||196
8750957|NCT01169779|9799879|FG000|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|194
8750958|NCT01169779|9799880|FG001|Treated/Safety Population|Overall Study||196
8750959|NCT01169779|9799879|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|193
8750960|NCT01169779|9799880|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||195
8750961|NCT01169779|9799879|FG000|Subgroup for Standardized Meal Test|Overall Study|Patients at selected sites where standardized meal test was performed.|130
8750962|NCT01169779|9799880|FG001|Subgroup for Standardized Meal Test|Overall Study||121
8750963|NCT01169779|9799879|FG000|COMPLETED|Overall Study||184
8750964|NCT01169779|9799880|FG001|COMPLETED|Overall Study||179
8750965|NCT01169779|9799879|FG000|NOT COMPLETED|Overall Study||11
8750966|NCT01169779|9799880|FG001|NOT COMPLETED|Overall Study||17
8750967|NCT01169844|9799888|FG000|STARTED|Overall Study||19
8750968|NCT01169844|9799889|FG001|STARTED|Overall Study||9
8750969|NCT01169844|9799888|FG000|COMPLETED|Overall Study||14
8750970|NCT01169844|9799889|FG001|COMPLETED|Overall Study||8
8750971|NCT01169844|9799888|FG000|NOT COMPLETED|Overall Study||5
8750972|NCT01169844|9799889|FG001|NOT COMPLETED|Overall Study||1
8750973|NCT01169987|9799895|FG000|STARTED|Overall Study||191
8750974|NCT01169987|9799895|FG000|COMPLETED|Overall Study||160
8750975|NCT01169987|9799895|FG000|NOT COMPLETED|Overall Study||31
8750976|NCT01170039|9799907|FG000|STARTED|Overall Study||37
8750977|NCT01170039|9799908|FG001|STARTED|Overall Study||39
8750978|NCT01170039|9799907|FG000|COMPLETED|Overall Study||29
8750979|NCT01170039|9799908|FG001|COMPLETED|Overall Study||33
8750980|NCT01170039|9799907|FG000|NOT COMPLETED|Overall Study||8
8750981|NCT01170039|9799908|FG001|NOT COMPLETED|Overall Study||6
8807837|NCT01486810|9860138|FG000|STARTED|Overall Study||17
8807838|NCT01486810|9860138|FG000|COMPLETED|Overall Study||9
8807839|NCT01486810|9860138|FG000|NOT COMPLETED|Overall Study||8
8807840|NCT01486927|9860142|FG000|STARTED|Overall Study||174
8807841|NCT01486927|9860142|FG000|COMPLETED|Overall Study||161
8807842|NCT01486927|9860142|FG000|NOT COMPLETED|Overall Study||13
8807843|NCT01486966|9860155|FG000|STARTED|Overall Study||29
8807844|NCT01486966|9860156|FG001|STARTED|Overall Study||29
8807845|NCT01486966|9860155|FG000|COMPLETED|Overall Study||29
8807846|NCT01486966|9860156|FG001|COMPLETED|Overall Study||27
8807847|NCT01486966|9860155|FG000|NOT COMPLETED|Overall Study||0
8807848|NCT01486966|9860156|FG001|NOT COMPLETED|Overall Study||2
8807849|NCT01487161|9860166|FG000|STARTED|Overall Study||58
8807850|NCT01487161|9860167|FG001|STARTED|Overall Study||59
8807851|NCT01487161|9860168|FG002|STARTED|Overall Study||60
8807852|NCT01487161|9860169|FG003|STARTED|Overall Study||52
8807853|NCT01487161|9860166|FG000|COMPLETED|Overall Study||56
8807854|NCT01487161|9860167|FG001|COMPLETED|Overall Study||57
8807855|NCT01487161|9860168|FG002|COMPLETED|Overall Study||59
8807856|NCT01487161|9860169|FG003|COMPLETED|Overall Study||50
8807857|NCT01487161|9860166|FG000|NOT COMPLETED|Overall Study||2
8807858|NCT01487161|9860167|FG001|NOT COMPLETED|Overall Study||2
8807859|NCT01487161|9860168|FG002|NOT COMPLETED|Overall Study||1
8807860|NCT01487161|9860169|FG003|NOT COMPLETED|Overall Study||2
8807861|NCT01487200|9860188|FG000|STARTED|Overall Study||5
8807862|NCT01487200|9860189|FG001|STARTED|Overall Study||7
8807863|NCT01487200|9860190|FG002|STARTED|Overall Study||7
8807864|NCT01487200|9860191|FG003|STARTED|Overall Study||5
8807865|NCT01487200|9860188|FG000|COMPLETED|Overall Study||5
8807866|NCT01487200|9860189|FG001|COMPLETED|Overall Study||6
8807867|NCT01487200|9860190|FG002|COMPLETED|Overall Study||7
8807868|NCT01487200|9860191|FG003|COMPLETED|Overall Study||5
8807869|NCT01487200|9860188|FG000|NOT COMPLETED|Overall Study||0
8807870|NCT01487200|9860189|FG001|NOT COMPLETED|Overall Study||1
8807871|NCT01487200|9860190|FG002|NOT COMPLETED|Overall Study||0
8807872|NCT01487200|9860191|FG003|NOT COMPLETED|Overall Study||0
8807873|NCT01487265|9860202|FG000|STARTED|Overall Study||37
8807874|NCT01487265|9860202|FG000|COMPLETED|Overall Study||0
8807875|NCT01487265|9860202|FG000|NOT COMPLETED|Overall Study||37
8807876|NCT01487525|9860208|FG000|STARTED|Overall Study||22
8807877|NCT01487525|9860209|FG001|STARTED|Overall Study||20
8807878|NCT01487525|9860208|FG000|COMPLETED|Overall Study||22
8807879|NCT01487525|9860209|FG001|COMPLETED|Overall Study||19
8807880|NCT01487525|9860208|FG000|NOT COMPLETED|Overall Study||0
8807881|NCT01487525|9860209|FG001|NOT COMPLETED|Overall Study||1
8807882|NCT01487577|9860215|FG000|STARTED|Overall Study||19
8807883|NCT01487577|9860215|FG000|COMPLETED|Overall Study|One participant became ineligible after signing consent, but before receiving protocol therapy.|18
8807884|NCT01487577|9860215|FG000|NOT COMPLETED|Overall Study||1
8807885|NCT01487668|9860221|FG000|STARTED|Overall Study||146
8807886|NCT01487668|9860222|FG001|STARTED|Overall Study||141
8807887|NCT01487668|9860221|FG000|COMPLETED|Overall Study||121
8807888|NCT01487668|9860222|FG001|COMPLETED|Overall Study||124
8807889|NCT01487668|9860221|FG000|NOT COMPLETED|Overall Study||25
8807890|NCT01487668|9860222|FG001|NOT COMPLETED|Overall Study||17
8807891|NCT01487863|9860232|FG000|STARTED|Overall Study||35
8807892|NCT01487863|9860233|FG001|STARTED|Overall Study||34
8807893|NCT01487863|9860232|FG000|Subjects Randomized (Efficacy Analysis)|Overall Study||35
8807894|NCT01487863|9860233|FG001|Subjects Randomized (Efficacy Analysis)|Overall Study||34
8807895|NCT01487863|9860232|FG000|Rcvd ≥1 Leukapheresis (Safety Analysis)|Overall Study||35
8807896|NCT01487863|9860233|FG001|Rcvd ≥1 Leukapheresis (Safety Analysis)|Overall Study||34
8807897|NCT01487863|9860232|FG000|COMPLETED|Overall Study||16
8807898|NCT01487863|9860233|FG001|COMPLETED|Overall Study||15
8807899|NCT01487863|9860232|FG000|NOT COMPLETED|Overall Study||19
8807900|NCT01487863|9860233|FG001|NOT COMPLETED|Overall Study||19
8914696|NCT02170051|9974199|FG001|Tested at Post-treatment|Overall Study||16
8914697|NCT02170051|9974198|FG000|COMPLETED|Overall Study||15
8914698|NCT02170051|9974199|FG001|COMPLETED|Overall Study||16
8914699|NCT02170051|9974198|FG000|NOT COMPLETED|Overall Study||11
8914700|NCT02170051|9974199|FG001|NOT COMPLETED|Overall Study||13
8914701|NCT02170064|9974208|FG000|STARTED|Overall Study||15
8914702|NCT02170064|9974209|FG001|STARTED|Overall Study||9
8914703|NCT02170064|9974210|FG002|STARTED|Overall Study||11
8914704|NCT02170064|9974208|FG000|Safety Population (SP)|Overall Study||12
8914705|NCT02170064|9974209|FG001|Safety Population (SP)|Overall Study||8
8914706|NCT02170064|9974210|FG002|Safety Population (SP)|Overall Study||11
8914707|NCT02170064|9974208|FG000|Pharmacokinetic Population (PKP)|Overall Study||11
8914708|NCT02170064|9974209|FG001|Pharmacokinetic Population (PKP)|Overall Study||8
8914709|NCT02170064|9974210|FG002|Pharmacokinetic Population (PKP)|Overall Study||10
8914710|NCT02170064|9974208|FG000|Efficacy Population (EP)|Overall Study||11
8914711|NCT02170064|9974209|FG001|Efficacy Population (EP)|Overall Study||8
8914712|NCT02170064|9974210|FG002|Efficacy Population (EP)|Overall Study||10
8750982|NCT01170065|9799917|FG000|STARTED|Overall Study||37
8750983|NCT01170065|9799918|FG001|STARTED|Overall Study||126
8750984|NCT01170065|9799919|FG002|STARTED|Overall Study||35
8750985|NCT01170065|9799917|FG000|COMPLETED|Overall Study|Planned observation time is from first trial drug intake to follow-up visit|9
8750986|NCT01170065|9799918|FG001|COMPLETED|Overall Study|Planned observation time is from first trial drug intake to follow-up visit|34
8750987|NCT01170065|9799919|FG002|COMPLETED|Overall Study|Planned observation time is from first trial drug intake to follow-up visit|9
8750988|NCT01170065|9799917|FG000|NOT COMPLETED|Overall Study||28
8750989|NCT01170065|9799918|FG001|NOT COMPLETED|Overall Study||92
8750990|NCT01170065|9799919|FG002|NOT COMPLETED|Overall Study||26
8750991|NCT01170091|9799927|FG000|STARTED|Overall Study||651
8750992|NCT01170091|9799927|FG000|COMPLETED|Overall Study||627
8750993|NCT01170091|9799927|FG000|NOT COMPLETED|Overall Study||24
8750994|NCT01170117|9799933|FG000|STARTED|Overall Study||77
8750995|NCT01170117|9799934|FG001|STARTED|Overall Study||75
8750996|NCT01170117|9799933|FG000|COMPLETED|Overall Study||47
8750997|NCT01170117|9799934|FG001|COMPLETED|Overall Study||55
8750998|NCT01170117|9799933|FG000|NOT COMPLETED|Overall Study||30
8750999|NCT01170117|9799934|FG001|NOT COMPLETED|Overall Study||20
8751000|NCT01170208|9799943|FG000|STARTED|Overall Study||20
8751001|NCT01170208|9799944|FG001|STARTED|Overall Study||20
8751002|NCT01170208|9799945|FG002|STARTED|Overall Study||6
8751003|NCT01170208|9799943|FG000|COMPLETED|Overall Study||14
8751004|NCT01170208|9799944|FG001|COMPLETED|Overall Study||20
8751005|NCT01170208|9799945|FG002|COMPLETED|Overall Study||4
8670776|NCT00747812|9714153|FG000|NOT COMPLETED|Overall Study||5
8670777|NCT00747812|9714154|FG001|NOT COMPLETED|Overall Study||3
8670778|NCT00748033|9714162|FG000|STARTED|Overall Study||12
8670779|NCT00748033|9714163|FG001|STARTED|Overall Study||13
8670780|NCT00748033|9714162|FG000|COMPLETED|Overall Study||12
8670781|NCT00748033|9714163|FG001|COMPLETED|Overall Study|One subject participated only in 2 arms due to an adverse event.|12
8670782|NCT00748033|9714162|FG000|NOT COMPLETED|Overall Study||0
8670783|NCT00748033|9714163|FG001|NOT COMPLETED|Overall Study||1
8670784|NCT00748072|9714179|FG000|STARTED|Overall Study||82
8670785|NCT00748072|9714180|FG001|STARTED|Overall Study||80
8670786|NCT00748072|9714179|FG000|COMPLETED|Overall Study||82
8670787|NCT00748072|9714180|FG001|COMPLETED|Overall Study||80
8670788|NCT00748072|9714179|FG000|NOT COMPLETED|Overall Study||0
8670789|NCT00748072|9714180|FG001|NOT COMPLETED|Overall Study||0
8670790|NCT00748098|9714186|FG000|STARTED|First Treatment Intervention Period||69
8670791|NCT00748098|9714187|FG001|STARTED|First Treatment Intervention Period||67
8670792|NCT00748098|9714186|FG000|COMPLETED|First Treatment Intervention Period||64
8670793|NCT00748098|9714187|FG001|COMPLETED|First Treatment Intervention Period||66
8670794|NCT00748098|9714186|FG000|NOT COMPLETED|First Treatment Intervention Period||5
8670795|NCT00748098|9714187|FG001|NOT COMPLETED|First Treatment Intervention Period||1
8670796|NCT00748098|9714186|FG000|STARTED|First Taper Period||64
8670797|NCT00748098|9714187|FG001|STARTED|First Taper Period||66
8670798|NCT00748098|9714186|FG000|COMPLETED|First Taper Period||61
8670799|NCT00748098|9714187|FG001|COMPLETED|First Taper Period||65
8670800|NCT00748098|9714186|FG000|NOT COMPLETED|First Taper Period||3
8670801|NCT00748098|9714187|FG001|NOT COMPLETED|First Taper Period||1
8670802|NCT00748098|9714186|FG000|STARTED|1-Week Washout Period||61
8670803|NCT00748098|9714187|FG001|STARTED|1-Week Washout Period||65
8670804|NCT00748098|9714186|FG000|COMPLETED|1-Week Washout Period||59
8670805|NCT00748098|9714187|FG001|COMPLETED|1-Week Washout Period||64
8670806|NCT00748098|9714186|FG000|NOT COMPLETED|1-Week Washout Period||2
8670807|NCT00748098|9714187|FG001|NOT COMPLETED|1-Week Washout Period||1
8670808|NCT00748098|9714186|FG000|STARTED|Second Treatment Intervention Period||59
8670809|NCT00748098|9714187|FG001|STARTED|Second Treatment Intervention Period||64
8670810|NCT00748098|9714186|FG000|COMPLETED|Second Treatment Intervention Period||53
8670811|NCT00748098|9714187|FG001|COMPLETED|Second Treatment Intervention Period||61
8670812|NCT00748098|9714186|FG000|NOT COMPLETED|Second Treatment Intervention Period||6
8670813|NCT00748098|9714187|FG001|NOT COMPLETED|Second Treatment Intervention Period||3
8670814|NCT00748098|9714186|FG000|STARTED|Second Taper Period||53
8670815|NCT00748098|9714187|FG001|STARTED|Second Taper Period||61
8670816|NCT00748098|9714186|FG000|COMPLETED|Second Taper Period||53
8670817|NCT00748098|9714187|FG001|COMPLETED|Second Taper Period||61
8670818|NCT00748098|9714186|FG000|NOT COMPLETED|Second Taper Period||0
8670819|NCT00748098|9714187|FG001|NOT COMPLETED|Second Taper Period||0
8670820|NCT00748189|9714196|FG000|STARTED|Overall Study||226
8670821|NCT00748189|9714197|FG001|STARTED|Overall Study||221
8670822|NCT00748189|9714196|FG000|COMPLETED|Overall Study||10
8670823|NCT00748189|9714197|FG001|COMPLETED|Overall Study||9
8670824|NCT00748189|9714196|FG000|NOT COMPLETED|Overall Study||216
8670825|NCT00748189|9714197|FG001|NOT COMPLETED|Overall Study||212
8670826|NCT00748215|9714210|FG000|STARTED|Overall Study||50
8670827|NCT00748215|9714211|FG001|STARTED|Overall Study||50
8670828|NCT00748215|9714210|FG000|Open Label CASAD After Initial 6 Weeks Intervention|Overall Study||22
8670829|NCT00748215|9714211|FG001|Open Label CASAD After Initial 6 Weeks Intervention|Overall Study||17
8670830|NCT00748215|9714210|FG000|COMPLETED|Overall Study||41
8670831|NCT00748215|9714211|FG001|COMPLETED|Overall Study||32
8751006|NCT01170208|9799943|FG000|NOT COMPLETED|Overall Study||6
8751007|NCT01170208|9799944|FG001|NOT COMPLETED|Overall Study||0
8751008|NCT01170208|9799945|FG002|NOT COMPLETED|Overall Study||2
8670832|NCT00748215|9714210|FG000|NOT COMPLETED|Overall Study||9
8670833|NCT00748215|9714211|FG001|NOT COMPLETED|Overall Study||18
8670834|NCT00748241|9714217|FG000|STARTED|Overall Study||19
8670835|NCT00748241|9714217|FG000|COMPLETED|Overall Study||11
8670836|NCT00748241|9714217|FG000|NOT COMPLETED|Overall Study||8
8670837|NCT00748410|9714223|FG000|STARTED|Overall Study||1
8670838|NCT00748410|9714224|FG001|STARTED|Overall Study||2
8670839|NCT00748410|9714223|FG000|COMPLETED|Overall Study||1
8670840|NCT00748410|9714224|FG001|COMPLETED|Overall Study||2
8670841|NCT00748410|9714223|FG000|NOT COMPLETED|Overall Study||0
8670842|NCT00748410|9714224|FG001|NOT COMPLETED|Overall Study||0
8751009|NCT01170221|9799958|FG000|STARTED|Overall Study||332
8751010|NCT01170221|9799959|FG001|STARTED|Overall Study||335
8751011|NCT01170221|9799958|FG000|COMPLETED|Overall Study||299
8751012|NCT01170221|9799959|FG001|COMPLETED|Overall Study||307
8751013|NCT01170221|9799958|FG000|NOT COMPLETED|Overall Study||33
8751014|NCT01170221|9799959|FG001|NOT COMPLETED|Overall Study||28
8751015|NCT01170247|9799967|FG000|STARTED|Overall Study||2
8751016|NCT01170247|9799968|FG001|STARTED|Overall Study||1
8751017|NCT01170247|9799967|FG000|COMPLETED|Overall Study||2
8751018|NCT01170247|9799968|FG001|COMPLETED|Overall Study||1
8751019|NCT01170247|9799967|FG000|NOT COMPLETED|Overall Study||0
8751020|NCT01170247|9799968|FG001|NOT COMPLETED|Overall Study||0
8751021|NCT01170273|9799976|FG000|STARTED|Overall Study||64
8751022|NCT01170273|9799977|FG001|STARTED|Overall Study||66
8751023|NCT01170273|9799976|FG000|COMPLETED|Overall Study||56
8751024|NCT01170273|9799977|FG001|COMPLETED|Overall Study||57
8751025|NCT01170273|9799976|FG000|NOT COMPLETED|Overall Study||8
8751026|NCT01170273|9799977|FG001|NOT COMPLETED|Overall Study||9
8751027|NCT01170364|9799985|FG000|STARTED|Overall Study||8
8751028|NCT01170364|9799986|FG001|STARTED|Overall Study||6
8751029|NCT01170364|9799985|FG000|COMPLETED|Overall Study||4
8751030|NCT01170364|9799986|FG001|COMPLETED|Overall Study|One participant was unable to begin the second testing period due to scheduling conflicts.|5
8751031|NCT01170364|9799985|FG000|NOT COMPLETED|Overall Study||4
8751032|NCT01170364|9799986|FG001|NOT COMPLETED|Overall Study||1
8751033|NCT01170390|9799994|FG000|STARTED|Oral Contraceptives||32
8751034|NCT01170390|9799995|FG001|STARTED|Oral Contraceptives||0
8751035|NCT01170390|9799996|FG002|STARTED|Oral Contraceptives||0
8751036|NCT01170390|9799994|FG000|COMPLETED|Oral Contraceptives||31
8751037|NCT01170390|9799995|FG001|COMPLETED|Oral Contraceptives||0
8751038|NCT01170390|9799996|FG002|COMPLETED|Oral Contraceptives||0
8751039|NCT01170390|9799994|FG000|NOT COMPLETED|Oral Contraceptives||1
8751040|NCT01170390|9799995|FG001|NOT COMPLETED|Oral Contraceptives||0
8751041|NCT01170390|9799996|FG002|NOT COMPLETED|Oral Contraceptives||0
8751042|NCT01170390|9799994|FG000|STARTED|Randomized Treatment||0
8751043|NCT01170390|9799995|FG001|STARTED|Randomized Treatment||17
8751044|NCT01170390|9799996|FG002|STARTED|Randomized Treatment||15
8751045|NCT01170390|9799994|FG000|COMPLETED|Randomized Treatment||0
8751046|NCT01170390|9799995|FG001|COMPLETED|Randomized Treatment||16
8751047|NCT01170390|9799996|FG002|COMPLETED|Randomized Treatment||15
8751048|NCT01170390|9799994|FG000|NOT COMPLETED|Randomized Treatment||0
8751049|NCT01170390|9799995|FG001|NOT COMPLETED|Randomized Treatment||1
8751050|NCT01170390|9799996|FG002|NOT COMPLETED|Randomized Treatment||0
8751051|NCT01170533|9800004|FG000|STARTED|Omeprazole Cross-over||20
8751052|NCT01170533|9800005|FG001|STARTED|Omeprazole Cross-over||0
8751053|NCT01170533|9800004|FG000|COMPLETED|Omeprazole Cross-over||20
8751054|NCT01170533|9800005|FG001|COMPLETED|Omeprazole Cross-over||0
8751055|NCT01170533|9800004|FG000|NOT COMPLETED|Omeprazole Cross-over||0
8751056|NCT01170533|9800005|FG001|NOT COMPLETED|Omeprazole Cross-over||0
8751057|NCT01170533|9800004|FG000|STARTED|Pantoprazole Cross-over||0
8751058|NCT01170533|9800005|FG001|STARTED|Pantoprazole Cross-over|15 participants continued from omeprazole cross-over; the remaining 5 were new participants|20
8751059|NCT01170533|9800004|FG000|COMPLETED|Pantoprazole Cross-over||0
8751060|NCT01170533|9800005|FG001|COMPLETED|Pantoprazole Cross-over||20
8751061|NCT01170533|9800004|FG000|NOT COMPLETED|Pantoprazole Cross-over||0
8751062|NCT01170533|9800005|FG001|NOT COMPLETED|Pantoprazole Cross-over||0
8751063|NCT01170546|9800019|FG000|STARTED|Overall Study||7
8751064|NCT01170546|9800020|FG001|STARTED|Overall Study||7
8751065|NCT01170546|9800021|FG002|STARTED|Overall Study||6
8751066|NCT01170546|9800022|FG003|STARTED|Overall Study||8
8751067|NCT01170546|9800019|FG000|COMPLETED|Overall Study||7
8751068|NCT01170546|9800020|FG001|COMPLETED|Overall Study||7
8751069|NCT01170546|9800021|FG002|COMPLETED|Overall Study||6
8751070|NCT01170546|9800022|FG003|COMPLETED|Overall Study||8
8751071|NCT01170546|9800019|FG000|NOT COMPLETED|Overall Study||0
8751072|NCT01170546|9800020|FG001|NOT COMPLETED|Overall Study||0
8751073|NCT01170546|9800021|FG002|NOT COMPLETED|Overall Study||0
8751074|NCT01170546|9800022|FG003|NOT COMPLETED|Overall Study||0
8751075|NCT01170598|9800032|FG000|STARTED|Overall Study||35
8751076|NCT01170598|9800032|FG000|COMPLETED|Overall Study||29
8751077|NCT01170598|9800032|FG000|NOT COMPLETED|Overall Study||6
8751078|NCT01170663|9800038|FG000|STARTED|Overall Study|Participant was included in ramucirumab (IMC-1121B)/paclitaxel treatment arm (safety population).|330
8751079|NCT01170663|9800039|FG001|STARTED|Overall Study|Participant was included in the placebo/paclitaxel treatment arm (intent-to-treat (ITT) population).|335
8670843|NCT00748540|9714230|FG000|STARTED|Overall Study||50
8670844|NCT00748540|9714230|FG000|COMPLETED|Overall Study||49
8751080|NCT01170663|9800038|FG000|Received Any Treatment (Safety Pop)|Overall Study||327
8751081|NCT01170663|9800039|FG001|Received Any Treatment (Safety Pop)|Overall Study||329
8751082|NCT01170663|9800038|FG000|COMPLETED|Overall Study||316
8751083|NCT01170663|9800039|FG001|COMPLETED|Overall Study||315
8751084|NCT01170663|9800038|FG000|NOT COMPLETED|Overall Study||14
8751085|NCT01170663|9800039|FG001|NOT COMPLETED|Overall Study||20
8751086|NCT01170715|9800045|FG000|STARTED|Overall Study||21
8751087|NCT01170715|9800045|FG000|COMPLETED|Overall Study||14
8751088|NCT01170715|9800045|FG000|NOT COMPLETED|Overall Study||7
8751089|NCT01170754|9800051|FG000|STARTED|Overall Study||66
8751090|NCT01170754|9800052|FG001|STARTED|Overall Study||70
8751091|NCT01170754|9800051|FG000|COMPLETED|Overall Study||66
8751092|NCT01170754|9800052|FG001|COMPLETED|Overall Study||70
8751093|NCT01170754|9800051|FG000|NOT COMPLETED|Overall Study||0
8751094|NCT01170754|9800052|FG001|NOT COMPLETED|Overall Study||0
8751095|NCT01170884|9800062|FG000|STARTED|Overall Study||59
8751096|NCT01170884|9800063|FG001|STARTED|Overall Study||62
8751097|NCT01170884|9800062|FG000|COMPLETED|Overall Study||54
8751098|NCT01170884|9800063|FG001|COMPLETED|Overall Study||60
8751099|NCT01170884|9800062|FG000|NOT COMPLETED|Overall Study||5
8751100|NCT01170884|9800063|FG001|NOT COMPLETED|Overall Study||2
8751101|NCT01170949|9800071|FG000|STARTED|Overall Study||50
8751102|NCT01170949|9800072|FG001|STARTED|Overall Study||26
8751103|NCT01170949|9800071|FG000|COMPLETED|Overall Study||43
8751104|NCT01170949|9800072|FG001|COMPLETED|Overall Study||22
8751105|NCT01170949|9800071|FG000|NOT COMPLETED|Overall Study||7
8751106|NCT01170949|9800072|FG001|NOT COMPLETED|Overall Study||4
8751107|NCT01170962|9800081|FG000|STARTED|Treatment Period||203
8751108|NCT01170962|9800082|FG001|STARTED|Treatment Period||199
8751109|NCT01170962|9800083|FG002|STARTED|Treatment Period||17
8751110|NCT01170962|9800081|FG000|No PDR|Treatment Period||145
8751111|NCT01170962|9800082|FG001|No PDR|Treatment Period||127
8751112|NCT01170962|9800083|FG002|No PDR|Treatment Period||17
8751113|NCT01170962|9800081|FG000|PDR -Randomized to 24 Weeks pegIFNα--2a|Treatment Period||30
8751114|NCT01170962|9800082|FG001|PDR -Randomized to 24 Weeks pegIFNα--2a|Treatment Period||36
8751115|NCT01170962|9800083|FG002|PDR -Randomized to 24 Weeks pegIFNα--2a|Treatment Period||0
8751116|NCT01170962|9800081|FG000|PDR -Randomized to 48 Weeks Follow--up|Treatment Period||28
8751117|NCT01170962|9800082|FG001|PDR -Randomized to 48 Weeks Follow--up|Treatment Period||36
8751118|NCT01170962|9800083|FG002|PDR -Randomized to 48 Weeks Follow--up|Treatment Period||0
8751119|NCT01170962|9800081|FG000|COMPLETED|Treatment Period||76
8751120|NCT01170962|9800082|FG001|COMPLETED|Treatment Period||88
8751121|NCT01170962|9800083|FG002|COMPLETED|Treatment Period||5
8751122|NCT01170962|9800081|FG000|NOT COMPLETED|Treatment Period||127
8751123|NCT01170962|9800082|FG001|NOT COMPLETED|Treatment Period||111
8751124|NCT01170962|9800083|FG002|NOT COMPLETED|Treatment Period||12
8751125|NCT01170962|9800081|FG000|STARTED|Follow up Period|Out of 203 participants who entered the treatment period, 198 continued in the follow-up period.|198
8751126|NCT01170962|9800082|FG001|STARTED|Follow up Period|Out of 199 participants who entered the treatment period, 192 continued in the follow-up period.|192
8751127|NCT01170962|9800083|FG002|STARTED|Follow up Period|Out of 17 participants who entered the treatment period, 15 continued in the follow-up period.|15
8751128|NCT01170962|9800081|FG000|COMPLETED|Follow up Period||159
8751129|NCT01170962|9800082|FG001|COMPLETED|Follow up Period||165
8751130|NCT01170962|9800083|FG002|COMPLETED|Follow up Period||9
8751131|NCT01170962|9800081|FG000|NOT COMPLETED|Follow up Period||39
8751132|NCT01170962|9800082|FG001|NOT COMPLETED|Follow up Period||27
8751133|NCT01170962|9800083|FG002|NOT COMPLETED|Follow up Period||6
8751134|NCT01171118|9800100|FG000|STARTED|Overall Study||10
8751135|NCT01171118|9800100|FG000|COMPLETED|Overall Study||10
8751136|NCT01171118|9800100|FG000|NOT COMPLETED|Overall Study||0
8751137|NCT01171183|9800112|FG000|STARTED|Residential Facility (Weeks 1-2)|Those who were admitted to the residential facility and received at least one dose of study med.|15
8751138|NCT01171183|9800113|FG001|STARTED|Residential Facility (Weeks 1-2)|Subjects receiving at least one dose of study med. One did not due to BP outside study parameters.|16
8751139|NCT01171183|9800112|FG000|COMPLETED|Residential Facility (Weeks 1-2)||13
8751140|NCT01171183|9800113|FG001|COMPLETED|Residential Facility (Weeks 1-2)||10
8751141|NCT01171183|9800112|FG000|NOT COMPLETED|Residential Facility (Weeks 1-2)||2
8751142|NCT01171183|9800113|FG001|NOT COMPLETED|Residential Facility (Weeks 1-2)||6
8751143|NCT01171183|9800112|FG000|STARTED|Outpatient Participation (Weeks 3-10)|One subject completed the residential stay but withdrew prior to starting the outpatient phase.|12
8751144|NCT01171183|9800113|FG001|STARTED|Outpatient Participation (Weeks 3-10)|One subject completed the residential stay but was discharged due to protocol noncompliance.|9
8751145|NCT01171183|9800112|FG000|COMPLETED|Outpatient Participation (Weeks 3-10)||2
8751146|NCT01171183|9800113|FG001|COMPLETED|Outpatient Participation (Weeks 3-10)||4
8751147|NCT01171183|9800112|FG000|NOT COMPLETED|Outpatient Participation (Weeks 3-10)||10
8751148|NCT01171183|9800113|FG001|NOT COMPLETED|Outpatient Participation (Weeks 3-10)||5
8751149|NCT01171521|9800119|FG000|STARTED|Overall Study||6
8751150|NCT01171521|9800119|FG000|COMPLETED|Overall Study||0
8751151|NCT01171521|9800119|FG000|NOT COMPLETED|Overall Study||6
8751152|NCT01171612|9800123|FG000|STARTED|Overall Study||483
8751153|NCT01171612|9800123|FG000|COMPLETED|Overall Study||432
8751154|NCT01171612|9800123|FG000|NOT COMPLETED|Overall Study||51
8751155|NCT01171625|9800130|FG000|STARTED|Overall Study||283
8751156|NCT01171625|9800130|FG000|Subjects Implanted With Device|Overall Study||258
8751157|NCT01171625|9800130|FG000|COMPLETED|Overall Study||103
8751158|NCT01171625|9800130|FG000|NOT COMPLETED|Overall Study||180
8751159|NCT01171677|9800144|FG000|STARTED|Overall Study||17
8751160|NCT01171677|9800145|FG001|STARTED|Overall Study||15
8751161|NCT01171677|9800144|FG000|COMPLETED|Overall Study||11
8751162|NCT01171677|9800145|FG001|COMPLETED|Overall Study||12
8751163|NCT01171677|9800144|FG000|NOT COMPLETED|Overall Study||6
8751164|NCT01171677|9800145|FG001|NOT COMPLETED|Overall Study||3
8751165|NCT01171690|9800153|FG000|STARTED|Overall Study||5
8751166|NCT01171690|9800154|FG001|STARTED|Overall Study||5
8751167|NCT01171690|9800153|FG000|COMPLETED|Overall Study||5
8751168|NCT01171690|9800154|FG001|COMPLETED|Overall Study||5
8751169|NCT01171690|9800153|FG000|NOT COMPLETED|Overall Study||0
8751170|NCT01171690|9800154|FG001|NOT COMPLETED|Overall Study||0
8751171|NCT01171794|9800162|FG000|STARTED|Overall Study||47
8751172|NCT01171794|9800163|FG001|STARTED|Overall Study||42
8751173|NCT01171794|9800162|FG000|COMPLETED|Overall Study||44
8751174|NCT01171794|9800163|FG001|COMPLETED|Overall Study||42
8751175|NCT01171794|9800162|FG000|NOT COMPLETED|Overall Study||3
8751176|NCT01171794|9800163|FG001|NOT COMPLETED|Overall Study||0
8751177|NCT01171820|9800171|FG000|STARTED|Overall Study||106
8751178|NCT01171820|9800172|FG001|STARTED|Overall Study||218
8751179|NCT01171820|9800171|FG000|COMPLETED|Overall Study||100
8751180|NCT01171820|9800172|FG001|COMPLETED|Overall Study||212
8751181|NCT01171820|9800171|FG000|NOT COMPLETED|Overall Study||6
8751182|NCT01171820|9800172|FG001|NOT COMPLETED|Overall Study||6
8751183|NCT01171924|9800180|FG000|STARTED|Overall Study||23
8751184|NCT01171924|9800181|FG001|STARTED|Overall Study||23
8751185|NCT01171924|9800180|FG000|COMPLETED|Overall Study||0
8751186|NCT01171924|9800181|FG001|COMPLETED|Overall Study||0
8751187|NCT01171924|9800180|FG000|NOT COMPLETED|Overall Study||23
8751188|NCT01171924|9800181|FG001|NOT COMPLETED|Overall Study||23
8751189|NCT01171963|9800189|FG000|STARTED|Overall Study||1666
8751190|NCT01171963|9800190|FG001|STARTED|Overall Study||1667
8751191|NCT01171963|9800189|FG000|COMPLETED|Overall Study||1518
8751192|NCT01171963|9800190|FG001|COMPLETED|Overall Study||1499
8751193|NCT01171963|9800189|FG000|NOT COMPLETED|Overall Study||148
8751194|NCT01171963|9800190|FG001|NOT COMPLETED|Overall Study||168
8751195|NCT01171976|9800202|FG000|STARTED|Overall Study||121
8751196|NCT01171976|9800203|FG001|STARTED|Overall Study||128
8751197|NCT01171976|9800204|FG002|STARTED|Overall Study||123
8751198|NCT01171976|9800202|FG000|Safety Set|Overall Study|Include 4 from PRN and 3 from TE alone who got laser treatment, exclude 2 with no laser treatment.|126
8751199|NCT01171976|9800203|FG001|Safety Set|Overall Study|Exclude 1 who did not get drug and 3 got laser treatment, include 2 from 1st arm with no laser|126
8751200|NCT01171976|9800204|FG002|Safety Set|Overall Study|Exclude 1 who did not get drug and 4 got laser treatment|118
8751201|NCT01171976|9800202|FG000|COMPLETED|Overall Study||107
8751202|NCT01171976|9800203|FG001|COMPLETED|Overall Study||117
8751203|NCT01171976|9800204|FG002|COMPLETED|Overall Study||108
8751204|NCT01171976|9800202|FG000|NOT COMPLETED|Overall Study||14
8751205|NCT01171976|9800203|FG001|NOT COMPLETED|Overall Study||11
8751206|NCT01171976|9800204|FG002|NOT COMPLETED|Overall Study||15
8751207|NCT01171989|9800215|FG000|STARTED|Overall Study||137
8751208|NCT01171989|9800216|FG001|STARTED|Overall Study||133
8751209|NCT01171989|9800217|FG002|STARTED|Overall Study||121
8751210|NCT01171989|9800215|FG000|COMPLETED|Overall Study||137
8751211|NCT01171989|9800216|FG001|COMPLETED|Overall Study||133
8751212|NCT01171989|9800217|FG002|COMPLETED|Overall Study||120
8751213|NCT01171989|9800215|FG000|NOT COMPLETED|Overall Study||0
8751214|NCT01171989|9800216|FG001|NOT COMPLETED|Overall Study||0
8751215|NCT01171989|9800217|FG002|NOT COMPLETED|Overall Study||1
8751216|NCT01172067|9800227|FG000|STARTED|Overall Study||200
8751217|NCT01172067|9800228|FG001|STARTED|Overall Study||200
8751218|NCT01172067|9800227|FG000|COMPLETED|Overall Study||153
8751219|NCT01172067|9800228|FG001|COMPLETED|Overall Study||163
8751220|NCT01172067|9800227|FG000|NOT COMPLETED|Overall Study||47
8751221|NCT01172067|9800228|FG001|NOT COMPLETED|Overall Study||37
8751222|NCT01172145|9800236|FG000|STARTED|Overall Study||11
8751223|NCT01172145|9800237|FG001|STARTED|Overall Study||11
8751224|NCT01172145|9800236|FG000|COMPLETED|Overall Study||11
8751225|NCT01172145|9800237|FG001|COMPLETED|Overall Study||11
8751226|NCT01172145|9800236|FG000|NOT COMPLETED|Overall Study||0
8751227|NCT01172145|9800237|FG001|NOT COMPLETED|Overall Study||0
8751228|NCT01172184|9800243|FG000|STARTED|Overall Study||111
8751229|NCT01172184|9800243|FG000|COMPLETED|Overall Study||111
8751230|NCT01172184|9800243|FG000|NOT COMPLETED|Overall Study||0
8751231|NCT01172197|9800249|FG000|STARTED|Overall Study||7
8751232|NCT01172197|9800250|FG001|STARTED|Overall Study||7
8751233|NCT01172197|9800249|FG000|COMPLETED|Overall Study||7
8751234|NCT01172197|9800250|FG001|COMPLETED|Overall Study||7
8751235|NCT01172197|9800249|FG000|NOT COMPLETED|Overall Study||0
8751236|NCT01172197|9800250|FG001|NOT COMPLETED|Overall Study||0
8751237|NCT01172275|9800258|FG000|STARTED|Overall Study||5
8751238|NCT01172275|9800259|FG001|STARTED|Overall Study||6
8751239|NCT01172275|9800258|FG000|COMPLETED|Overall Study||3
8751240|NCT01172275|9800259|FG001|COMPLETED|Overall Study||6
8751241|NCT01172275|9800258|FG000|NOT COMPLETED|Overall Study||2
8751242|NCT01172275|9800259|FG001|NOT COMPLETED|Overall Study||0
8751243|NCT01172288|9800267|FG000|STARTED|Overall Study||17
8751244|NCT01172288|9800268|FG001|STARTED|Overall Study||14
8751245|NCT01172288|9800267|FG000|COMPLETED|Overall Study||16
8751246|NCT01172288|9800268|FG001|COMPLETED|Overall Study||13
8751247|NCT01172288|9800267|FG000|NOT COMPLETED|Overall Study||1
8751248|NCT01172288|9800268|FG001|NOT COMPLETED|Overall Study||1
8751249|NCT01172353|9800276|FG000|STARTED|Overall Study||150
8751250|NCT01172353|9800277|FG001|STARTED|Overall Study||151
8751251|NCT01172353|9800276|FG000|COMPLETED|Overall Study||150
8751252|NCT01172353|9800277|FG001|COMPLETED|Overall Study||151
8751253|NCT01172353|9800276|FG000|NOT COMPLETED|Overall Study||0
8751254|NCT01172353|9800277|FG001|NOT COMPLETED|Overall Study||0
8751255|NCT01172418|9800285|FG000|STARTED|Overall Study||100
8751256|NCT01172418|9800286|FG001|STARTED|Overall Study||100
8751257|NCT01172418|9800285|FG000|COMPLETED|Overall Study||100
8914713|NCT02170064|9974208|FG000|COMPLETED|Overall Study||9
8914714|NCT02170064|9974209|FG001|COMPLETED|Overall Study||7
8914715|NCT02170064|9974210|FG002|COMPLETED|Overall Study||10
8914716|NCT02170064|9974208|FG000|NOT COMPLETED|Overall Study||6
8914717|NCT02170064|9974209|FG001|NOT COMPLETED|Overall Study||2
8914718|NCT02170064|9974210|FG002|NOT COMPLETED|Overall Study||1
8914719|NCT02170077|9974221|FG000|STARTED|Overall Study||50
8914720|NCT02170077|9974222|FG001|STARTED|Overall Study||47
8914721|NCT02170077|9974223|FG002|STARTED|Overall Study||47
8914722|NCT02170077|9974221|FG000|Intent to Treat (ITT) Population|Overall Study||50
8914723|NCT02170077|9974222|FG001|Intent to Treat (ITT) Population|Overall Study||46
8914724|NCT02170077|9974223|FG002|Intent to Treat (ITT) Population|Overall Study||47
8914725|NCT02170077|9974221|FG000|COMPLETED|Overall Study||41
8914726|NCT02170077|9974222|FG001|COMPLETED|Overall Study||34
8914727|NCT02170077|9974223|FG002|COMPLETED|Overall Study||35
8914728|NCT02170077|9974221|FG000|NOT COMPLETED|Overall Study||9
8914729|NCT02170077|9974222|FG001|NOT COMPLETED|Overall Study||13
8914730|NCT02170077|9974223|FG002|NOT COMPLETED|Overall Study||12
8914731|NCT02170207|9974231|FG000|STARTED|Overall Study||63
8914732|NCT02170207|9974231|FG000|COMPLETED|Overall Study||58
8914733|NCT02170207|9974231|FG000|NOT COMPLETED|Overall Study||5
8914734|NCT02170220|9974237|FG000|STARTED|Overall Study||6
8914735|NCT02170220|9974238|FG001|STARTED|Overall Study||6
8914736|NCT02170220|9974237|FG000|COMPLETED|Overall Study||6
8914737|NCT02170220|9974238|FG001|COMPLETED|Overall Study||6
8914738|NCT02170220|9974237|FG000|NOT COMPLETED|Overall Study||0
8914739|NCT02170220|9974238|FG001|NOT COMPLETED|Overall Study||0
8914740|NCT02170363|9974244|FG000|STARTED|Overall Study||50
8914741|NCT02170363|9974244|FG000|COMPLETED|Overall Study|Followed to the 6-Month Primary Endpoint|50
8914742|NCT02170363|9974244|FG000|NOT COMPLETED|Overall Study||0
8914743|NCT02170376|9974255|FG000|STARTED|Overall Study||16
8914744|NCT02170376|9974256|FG001|STARTED|Overall Study||16
8914745|NCT02170376|9974257|FG002|STARTED|Overall Study||16
8914746|NCT02170376|9974258|FG003|STARTED|Overall Study||16
8914747|NCT02170376|9974259|FG004|STARTED|Overall Study||16
8914748|NCT02170376|9974255|FG000|Pharmacokinetic Population|Overall Study||16
8914749|NCT02170376|9974256|FG001|Pharmacokinetic Population|Overall Study||15
8914750|NCT02170376|9974257|FG002|Pharmacokinetic Population|Overall Study||16
8914751|NCT02170376|9974258|FG003|Pharmacokinetic Population|Overall Study||16
8914752|NCT02170376|9974259|FG004|Pharmacokinetic Population|Overall Study||16
8914753|NCT02170376|9974255|FG000|COMPLETED|Overall Study||16
8914754|NCT02170376|9974256|FG001|COMPLETED|Overall Study||15
8914755|NCT02170376|9974257|FG002|COMPLETED|Overall Study||16
8914756|NCT02170376|9974258|FG003|COMPLETED|Overall Study||16
8914757|NCT02170376|9974259|FG004|COMPLETED|Overall Study||16
8914758|NCT02170376|9974255|FG000|NOT COMPLETED|Overall Study||0
8914759|NCT02170376|9974256|FG001|NOT COMPLETED|Overall Study||1
8914760|NCT02170376|9974257|FG002|NOT COMPLETED|Overall Study||0
8914761|NCT02170376|9974258|FG003|NOT COMPLETED|Overall Study||0
8914762|NCT02170376|9974259|FG004|NOT COMPLETED|Overall Study||0
8914763|NCT02170389|9974271|FG000|STARTED|Overall Study||5
8914764|NCT02170389|9974271|FG000|COMPLETED|Overall Study||4
8914765|NCT02170389|9974271|FG000|NOT COMPLETED|Overall Study||1
8914766|NCT02170519|9974277|FG000|STARTED|Overall Study||22
8914767|NCT02170519|9974278|FG001|STARTED|Overall Study||5
8914768|NCT02170519|9974277|FG000|COMPLETED|Overall Study||22
8914769|NCT02170519|9974278|FG001|COMPLETED|Overall Study||5
8914770|NCT02170519|9974277|FG000|NOT COMPLETED|Overall Study||0
8914771|NCT02170519|9974278|FG001|NOT COMPLETED|Overall Study||0
8914772|NCT02170532|9974285|FG000|STARTED|Overall Study||10
8914773|NCT02170532|9974285|FG000|COMPLETED|Overall Study||10
8914774|NCT02170532|9974285|FG000|NOT COMPLETED|Overall Study||0
8914775|NCT02170649|9974296|FG000|STARTED|Fasting Period||12
8914776|NCT02170649|9974296|FG000|COMPLETED|Fasting Period||12
8914777|NCT02170649|9974296|FG000|NOT COMPLETED|Fasting Period||0
8914778|NCT02170649|9974296|FG000|STARTED|Fed Period||12
8914779|NCT02170649|9974296|FG000|COMPLETED|Fed Period||12
8914780|NCT02170649|9974296|FG000|NOT COMPLETED|Fed Period||0
8914781|NCT02170662|9974302|FG000|STARTED|Overall Study||3
8914782|NCT02170662|9974303|FG001|STARTED|Overall Study||6
8914783|NCT02170662|9974302|FG000|COMPLETED|Overall Study||3
8914784|NCT02170662|9974303|FG001|COMPLETED|Overall Study||6
8914785|NCT02170662|9974302|FG000|NOT COMPLETED|Overall Study||0
8914786|NCT02170662|9974303|FG001|NOT COMPLETED|Overall Study||0
8751258|NCT01172418|9800286|FG001|COMPLETED|Overall Study||100
8914787|NCT02170688|9974314|FG000|STARTED|Overall Study||29
8914788|NCT02170688|9974315|FG001|STARTED|Overall Study||29
8914789|NCT02170688|9974316|FG002|STARTED|Overall Study||29
8914790|NCT02170688|9974317|FG003|STARTED|Overall Study||27
8914791|NCT02170688|9974318|FG004|STARTED|Overall Study||25
8914792|NCT02170688|9974314|FG000|COMPLETED|Overall Study||25
9023337|NCT03136367|10086193|FG001|COMPLETED|T2 Post-consultation||235
8751259|NCT01172418|9800285|FG000|NOT COMPLETED|Overall Study||0
9023338|NCT03136367|10086194|FG002|COMPLETED|T2 Post-consultation||225
8751260|NCT01172418|9800286|FG001|NOT COMPLETED|Overall Study||0
8914793|NCT02170688|9974315|FG001|COMPLETED|Overall Study||26
9023339|NCT03136367|10086192|FG000|NOT COMPLETED|T2 Post-consultation||3
8751261|NCT01172522|9800296|FG000|STARTED|Overall Study||15
8751262|NCT01172522|9800297|FG001|STARTED|Overall Study||15
8751263|NCT01172522|9800296|FG000|COMPLETED|Overall Study||15
8751264|NCT01172522|9800297|FG001|COMPLETED|Overall Study||15
8751265|NCT01172522|9800296|FG000|NOT COMPLETED|Overall Study||0
8751266|NCT01172522|9800297|FG001|NOT COMPLETED|Overall Study||0
8751267|NCT01172535|9800302|FG000|STARTED|Overall Study||97
8751268|NCT01172535|9800302|FG000|COMPLETED|Overall Study||89
8751269|NCT01172535|9800302|FG000|NOT COMPLETED|Overall Study||8
8751270|NCT01172600|9800311|FG000|STARTED|Overall Study||39
8751271|NCT01172600|9800312|FG001|STARTED|Overall Study||39
8751272|NCT01172600|9800311|FG000|COMPLETED|Overall Study||39
8751273|NCT01172600|9800312|FG001|COMPLETED|Overall Study||39
8751274|NCT01172600|9800311|FG000|NOT COMPLETED|Overall Study||0
8751275|NCT01172600|9800312|FG001|NOT COMPLETED|Overall Study||0
8751276|NCT01172639|9800323|FG000|STARTED|Overall Study||98
8751277|NCT01172639|9800324|FG001|STARTED|Overall Study||98
8751278|NCT01172639|9800325|FG002|STARTED|Overall Study||93
8751279|NCT01172639|9800326|FG003|STARTED|Overall Study||43
8751280|NCT01172639|9800327|FG004|STARTED|Overall Study||47
8751281|NCT01172639|9800323|FG000|Week 16|Overall Study||94
8751282|NCT01172639|9800324|FG001|Week 16|Overall Study||96
8751283|NCT01172639|9800325|FG002|Week 16|Overall Study||91
8751284|NCT01172639|9800326|FG003|Week 16|Overall Study||39
8751285|NCT01172639|9800327|FG004|Week 16|Overall Study||47
8751286|NCT01172639|9800323|FG000|Week 52|Overall Study||89
8751287|NCT01172639|9800324|FG001|Week 52|Overall Study||89
8751288|NCT01172639|9800325|FG002|Week 52|Overall Study||88
8751289|NCT01172639|9800326|FG003|Week 52|Overall Study||38
8751290|NCT01172639|9800327|FG004|Week 52|Overall Study||45
8751291|NCT01172639|9800323|FG000|COMPLETED|Overall Study||85
8751292|NCT01172639|9800324|FG001|COMPLETED|Overall Study||87
8751293|NCT01172639|9800325|FG002|COMPLETED|Overall Study||77
8751294|NCT01172639|9800326|FG003|COMPLETED|Overall Study||32
8751295|NCT01172639|9800327|FG004|COMPLETED|Overall Study||41
8751296|NCT01172639|9800323|FG000|NOT COMPLETED|Overall Study||13
8751297|NCT01172639|9800324|FG001|NOT COMPLETED|Overall Study||11
8751298|NCT01172639|9800325|FG002|NOT COMPLETED|Overall Study||16
8751299|NCT01172639|9800326|FG003|NOT COMPLETED|Overall Study||11
8751300|NCT01172639|9800327|FG004|NOT COMPLETED|Overall Study||6
8751301|NCT01172808|9800343|FG000|STARTED|Overall Study|Entered and Treated|269
8751302|NCT01172808|9800344|FG001|STARTED|Overall Study|Entered and Treated|262
8751303|NCT01172808|9800345|FG002|STARTED|Overall Study|Entered and Treated|264
8751304|NCT01172808|9800346|FG003|STARTED|Overall Study|Entered and Treated|275
8751305|NCT01172808|9800343|FG000|COMPLETED|Overall Study||248
8751306|NCT01172808|9800344|FG001|COMPLETED|Overall Study||249
8751307|NCT01172808|9800345|FG002|COMPLETED|Overall Study||241
8751308|NCT01172808|9800346|FG003|COMPLETED|Overall Study||260
8751309|NCT01172808|9800343|FG000|NOT COMPLETED|Overall Study||21
8751310|NCT01172808|9800344|FG001|NOT COMPLETED|Overall Study||13
8751311|NCT01172808|9800345|FG002|NOT COMPLETED|Overall Study||23
8751312|NCT01172808|9800346|FG003|NOT COMPLETED|Overall Study||15
8751313|NCT01172821|9800360|FG000|STARTED|Overall Study|Entered and Treated|254
8751314|NCT01172821|9800361|FG001|STARTED|Overall Study|Entered and Treated|257
8751315|NCT01172821|9800362|FG002|STARTED|Overall Study|Entered and Treated|253
8751316|NCT01172821|9800363|FG003|STARTED|Overall Study|Entered and Treated|266
8751317|NCT01172821|9800360|FG000|COMPLETED|Overall Study||240
8751318|NCT01172821|9800361|FG001|COMPLETED|Overall Study||245
8751319|NCT01172821|9800362|FG002|COMPLETED|Overall Study||240
8751320|NCT01172821|9800363|FG003|COMPLETED|Overall Study||249
8751321|NCT01172821|9800360|FG000|NOT COMPLETED|Overall Study||14
8751322|NCT01172821|9800361|FG001|NOT COMPLETED|Overall Study||12
8751323|NCT01172821|9800362|FG002|NOT COMPLETED|Overall Study||13
8751324|NCT01172821|9800363|FG003|NOT COMPLETED|Overall Study||17
8751325|NCT01172847|9800373|FG000|STARTED|Overall Study||24
8751326|NCT01172847|9800373|FG000|Oseltamivir|Overall Study||24
8751327|NCT01172847|9800373|FG000|Rimantadine|Overall Study||22
8751328|NCT01172847|9800373|FG000|Oseltamivir + Rimantadine|Overall Study||21
8751329|NCT01172847|9800373|FG000|COMPLETED|Overall Study||21
8751330|NCT01172847|9800373|FG000|NOT COMPLETED|Overall Study||3
8751331|NCT01172873|9800385|FG000|STARTED|Overall Study||11
8751332|NCT01172873|9800386|FG001|STARTED|Overall Study||5
8751333|NCT01172873|9800385|FG000|COMPLETED|Overall Study||8
8751334|NCT01172873|9800386|FG001|COMPLETED|Overall Study||3
8751335|NCT01172873|9800385|FG000|NOT COMPLETED|Overall Study||3
8751336|NCT01172873|9800386|FG001|NOT COMPLETED|Overall Study||2
8751337|NCT01172938|9800395|FG000|STARTED|Placebo-controlled Phase (Week 0-24)||168
8751338|NCT01172938|9800396|FG001|STARTED|Placebo-controlled Phase (Week 0-24)||168
8751339|NCT01172938|9800397|FG002|STARTED|Placebo-controlled Phase (Week 0-24)||168
8751340|NCT01172938|9800398|FG003|STARTED|Placebo-controlled Phase (Week 0-24)||0
8751341|NCT01172938|9800399|FG004|STARTED|Placebo-controlled Phase (Week 0-24)||0
8751342|NCT01172938|9800400|FG005|STARTED|Placebo-controlled Phase (Week 0-24)||0
8751343|NCT01172938|9800401|FG006|STARTED|Placebo-controlled Phase (Week 0-24)||0
8751344|NCT01172938|9800402|FG007|STARTED|Placebo-controlled Phase (Week 0-24)||0
8751345|NCT01172938|9800403|FG008|STARTED|Placebo-controlled Phase (Week 0-24)||0
8751346|NCT01172938|9800395|FG000|Received Treatment|Placebo-controlled Phase (Week 0-24)||168
8751347|NCT01172938|9800396|FG001|Received Treatment|Placebo-controlled Phase (Week 0-24)||168
8751348|NCT01172938|9800397|FG002|Received Treatment|Placebo-controlled Phase (Week 0-24)||168
8807901|NCT01487954|9860241|FG000|STARTED|Overall Study||29
8751349|NCT01172938|9800398|FG003|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
8751350|NCT01172938|9800399|FG004|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
8751351|NCT01172938|9800400|FG005|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
8751352|NCT01172938|9800401|FG006|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
8751353|NCT01172938|9800402|FG007|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
8751354|NCT01172938|9800403|FG008|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
8751355|NCT01172938|9800395|FG000|Completed Week 16|Placebo-controlled Phase (Week 0-24)||158
8751356|NCT01172938|9800396|FG001|Completed Week 16|Placebo-controlled Phase (Week 0-24)||158
8751357|NCT01172938|9800397|FG002|Completed Week 16|Placebo-controlled Phase (Week 0-24)||154
8751358|NCT01172938|9800398|FG003|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
8751359|NCT01172938|9800399|FG004|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
8751360|NCT01172938|9800400|FG005|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
8751361|NCT01172938|9800401|FG006|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
8751362|NCT01172938|9800402|FG007|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
8751363|NCT01172938|9800403|FG008|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
8751364|NCT01172938|9800395|FG000|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)|Five participants who escaped early did not complete Week 24|107
8751365|NCT01172938|9800396|FG001|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)|Six participants who escaped early did not complete Week 24|78
8751366|NCT01172938|9800397|FG002|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||58
8751367|NCT01172938|9800398|FG003|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
8751368|NCT01172938|9800399|FG004|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
8751369|NCT01172938|9800400|FG005|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
8751370|NCT01172938|9800401|FG006|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
8751371|NCT01172938|9800402|FG007|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
8751372|NCT01172938|9800403|FG008|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
8751373|NCT01172938|9800395|FG000|COMPLETED|Placebo-controlled Phase (Week 0-24)|One participant who completed Week 24 did not enter the active treatment phase|150
8751374|NCT01172938|9800396|FG001|COMPLETED|Placebo-controlled Phase (Week 0-24)||146
8751375|NCT01172938|9800397|FG002|COMPLETED|Placebo-controlled Phase (Week 0-24)||148
8751376|NCT01172938|9800398|FG003|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
8751377|NCT01172938|9800399|FG004|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
8751378|NCT01172938|9800400|FG005|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
8751379|NCT01172938|9800401|FG006|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
8751380|NCT01172938|9800402|FG007|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
8751381|NCT01172938|9800403|FG008|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
8751382|NCT01172938|9800395|FG000|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||18
8751383|NCT01172938|9800396|FG001|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||22
8751384|NCT01172938|9800397|FG002|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||20
8751385|NCT01172938|9800398|FG003|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
8751386|NCT01172938|9800399|FG004|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
8751387|NCT01172938|9800400|FG005|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
8751388|NCT01172938|9800401|FG006|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
8751389|NCT01172938|9800402|FG007|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
8751390|NCT01172938|9800403|FG008|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
8751391|NCT01172938|9800395|FG000|STARTED|Active Treatment Phase (Weeks 25-52)||0
8751392|NCT01172938|9800396|FG001|STARTED|Active Treatment Phase (Weeks 25-52)|Ten participants who completed Week 24 did not enter the active treatment phase|136
8751393|NCT01172938|9800397|FG002|STARTED|Active Treatment Phase (Weeks 25-52)|Three participants who completed Week 24 did not enter the active treatment phase|145
8751394|NCT01172938|9800398|FG003|STARTED|Active Treatment Phase (Weeks 25-52)|One participant who escaped early and completed Week 24 did not enter the active treatment phase|51
8751395|NCT01172938|9800399|FG004|STARTED|Active Treatment Phase (Weeks 25-52)||23
8751396|NCT01172938|9800400|FG005|STARTED|Active Treatment Phase (Weeks 25-52)|One participant who escaped early and completed Week 24 did not enter the active treatment phase|49
8751397|NCT01172938|9800401|FG006|STARTED|Active Treatment Phase (Weeks 25-52)||24
8751398|NCT01172938|9800402|FG007|STARTED|Active Treatment Phase (Weeks 25-52)||0
8751399|NCT01172938|9800403|FG008|STARTED|Active Treatment Phase (Weeks 25-52)||0
8751400|NCT01172938|9800395|FG000|COMPLETED|Active Treatment Phase (Weeks 25-52)||0
8751401|NCT01172938|9800396|FG001|COMPLETED|Active Treatment Phase (Weeks 25-52)||124
8751402|NCT01172938|9800397|FG002|COMPLETED|Active Treatment Phase (Weeks 25-52)||130
8751403|NCT01172938|9800398|FG003|COMPLETED|Active Treatment Phase (Weeks 25-52)||44
8751404|NCT01172938|9800399|FG004|COMPLETED|Active Treatment Phase (Weeks 25-52)||19
8751405|NCT01172938|9800400|FG005|COMPLETED|Active Treatment Phase (Weeks 25-52)||34
8751406|NCT01172938|9800401|FG006|COMPLETED|Active Treatment Phase (Weeks 25-52)||22
8751407|NCT01172938|9800402|FG007|COMPLETED|Active Treatment Phase (Weeks 25-52)||0
8751408|NCT01172938|9800403|FG008|COMPLETED|Active Treatment Phase (Weeks 25-52)||0
8751409|NCT01172938|9800395|FG000|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||0
8751410|NCT01172938|9800396|FG001|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||12
8751411|NCT01172938|9800397|FG002|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||15
8751412|NCT01172938|9800398|FG003|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||7
8751413|NCT01172938|9800399|FG004|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||4
8807902|NCT01487954|9860242|FG001|STARTED|Overall Study||16
8751414|NCT01172938|9800400|FG005|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||15
8751415|NCT01172938|9800401|FG006|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||2
8751416|NCT01172938|9800402|FG007|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||0
8751417|NCT01172938|9800403|FG008|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||0
8751418|NCT01172938|9800395|FG000|STARTED|Active-Treatment Phase (Weeks 52-104)||0
8751419|NCT01172938|9800396|FG001|STARTED|Active-Treatment Phase (Weeks 52-104)|Six participants who completed Week 52 did not enter the next year of active treatment phase|118
8751420|NCT01172938|9800397|FG002|STARTED|Active-Treatment Phase (Weeks 52-104)|Nine participants who completed Week 52 did not enter the next year of active treatment phase|121
8751421|NCT01172938|9800398|FG003|STARTED|Active-Treatment Phase (Weeks 52-104)||0
8751422|NCT01172938|9800399|FG004|STARTED|Active-Treatment Phase (Weeks 52-104)||0
8751423|NCT01172938|9800400|FG005|STARTED|Active-Treatment Phase (Weeks 52-104)||0
8751424|NCT01172938|9800401|FG006|STARTED|Active-Treatment Phase (Weeks 52-104)||0
8751425|NCT01172938|9800402|FG007|STARTED|Active-Treatment Phase (Weeks 52-104)||61
8751426|NCT01172938|9800403|FG008|STARTED|Active-Treatment Phase (Weeks 52-104)||49
8751427|NCT01172938|9800395|FG000|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
8751428|NCT01172938|9800396|FG001|COMPLETED|Active-Treatment Phase (Weeks 52-104)||95
9023340|NCT03136367|10086193|FG001|NOT COMPLETED|T2 Post-consultation||6
9023341|NCT03136367|10086194|FG002|NOT COMPLETED|T2 Post-consultation||31
9023342|NCT03136367|10086192|FG000|STARTED|T3 1 Week After Surgery||61
9023343|NCT03136367|10086193|FG001|STARTED|T3 1 Week After Surgery||235
9023344|NCT03136367|10086194|FG002|STARTED|T3 1 Week After Surgery||225
9023345|NCT03136367|10086192|FG000|COMPLETED|T3 1 Week After Surgery||51
9023346|NCT03136367|10086193|FG001|COMPLETED|T3 1 Week After Surgery||203
9023347|NCT03136367|10086194|FG002|COMPLETED|T3 1 Week After Surgery||194
9023348|NCT03136367|10086192|FG000|NOT COMPLETED|T3 1 Week After Surgery||10
9023349|NCT03136367|10086193|FG001|NOT COMPLETED|T3 1 Week After Surgery||32
9023350|NCT03136367|10086194|FG002|NOT COMPLETED|T3 1 Week After Surgery||31
9023351|NCT03136367|10086192|FG000|STARTED|T4 12 Weeks After Surgery||51
9023352|NCT03136367|10086193|FG001|STARTED|T4 12 Weeks After Surgery||203
9023353|NCT03136367|10086194|FG002|STARTED|T4 12 Weeks After Surgery||194
9023354|NCT03136367|10086192|FG000|COMPLETED|T4 12 Weeks After Surgery||49
9023355|NCT03136367|10086193|FG001|COMPLETED|T4 12 Weeks After Surgery||198
9023356|NCT03136367|10086194|FG002|COMPLETED|T4 12 Weeks After Surgery||185
9023357|NCT03136367|10086192|FG000|NOT COMPLETED|T4 12 Weeks After Surgery||2
9023358|NCT03136367|10086193|FG001|NOT COMPLETED|T4 12 Weeks After Surgery||5
9023359|NCT03136367|10086194|FG002|NOT COMPLETED|T4 12 Weeks After Surgery||9
9023360|NCT03136367|10086192|FG000|STARTED|T5 1 Year After Surgery||49
9023361|NCT03136367|10086193|FG001|STARTED|T5 1 Year After Surgery||198
9023362|NCT03136367|10086194|FG002|STARTED|T5 1 Year After Surgery||185
9023363|NCT03136367|10086192|FG000|COMPLETED|T5 1 Year After Surgery||13
9023364|NCT03136367|10086193|FG001|COMPLETED|T5 1 Year After Surgery||62
9023365|NCT03136367|10086194|FG002|COMPLETED|T5 1 Year After Surgery||56
9023366|NCT03136367|10086192|FG000|NOT COMPLETED|T5 1 Year After Surgery||36
9023367|NCT03136367|10086193|FG001|NOT COMPLETED|T5 1 Year After Surgery||136
9023368|NCT03136367|10086194|FG002|NOT COMPLETED|T5 1 Year After Surgery||129
9023369|NCT03136380|10086207|FG000|STARTED|Part 1, Period 1 (3 Days)||6
9023370|NCT03136380|10086208|FG001|STARTED|Part 1, Period 1 (3 Days)||6
9023371|NCT03136380|10086209|FG002|STARTED|Part 1, Period 1 (3 Days)||6
9023372|NCT03136380|10086210|FG003|STARTED|Part 1, Period 1 (3 Days)||0
9023373|NCT03136380|10086211|FG004|STARTED|Part 1, Period 1 (3 Days)||0
9023374|NCT03136380|10086207|FG000|COMPLETED|Part 1, Period 1 (3 Days)||6
9023375|NCT03136380|10086208|FG001|COMPLETED|Part 1, Period 1 (3 Days)||6
9023376|NCT03136380|10086209|FG002|COMPLETED|Part 1, Period 1 (3 Days)||6
9023377|NCT03136380|10086210|FG003|COMPLETED|Part 1, Period 1 (3 Days)||0
9023378|NCT03136380|10086211|FG004|COMPLETED|Part 1, Period 1 (3 Days)||0
9023379|NCT03136380|10086207|FG000|NOT COMPLETED|Part 1, Period 1 (3 Days)||0
9023380|NCT03136380|10086208|FG001|NOT COMPLETED|Part 1, Period 1 (3 Days)||0
9023381|NCT03136380|10086209|FG002|NOT COMPLETED|Part 1, Period 1 (3 Days)||0
9023382|NCT03136380|10086210|FG003|NOT COMPLETED|Part 1, Period 1 (3 Days)||0
9023383|NCT03136380|10086211|FG004|NOT COMPLETED|Part 1, Period 1 (3 Days)||0
9023384|NCT03136380|10086207|FG000|STARTED|Part 1, Washout Period 1 (7 Days)||6
9023385|NCT03136380|10086208|FG001|STARTED|Part 1, Washout Period 1 (7 Days)||6
9023386|NCT03136380|10086209|FG002|STARTED|Part 1, Washout Period 1 (7 Days)||6
9023387|NCT03136380|10086210|FG003|STARTED|Part 1, Washout Period 1 (7 Days)||0
9023388|NCT03136380|10086211|FG004|STARTED|Part 1, Washout Period 1 (7 Days)||0
9023389|NCT03136380|10086207|FG000|COMPLETED|Part 1, Washout Period 1 (7 Days)||6
9023390|NCT03136380|10086208|FG001|COMPLETED|Part 1, Washout Period 1 (7 Days)||6
9023391|NCT03136380|10086209|FG002|COMPLETED|Part 1, Washout Period 1 (7 Days)||6
9023392|NCT03136380|10086210|FG003|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
9023393|NCT03136380|10086211|FG004|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
9023394|NCT03136380|10086207|FG000|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
9023395|NCT03136380|10086208|FG001|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
9023396|NCT03136380|10086209|FG002|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
9023397|NCT03136380|10086210|FG003|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
9023398|NCT03136380|10086211|FG004|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
9023399|NCT03136380|10086207|FG000|STARTED|Part 1, Period 2 (3 Days)||6
8751429|NCT01172938|9800397|FG002|COMPLETED|Active-Treatment Phase (Weeks 52-104)||100
8751430|NCT01172938|9800398|FG003|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
8807903|NCT01487954|9860241|FG000|Safety lead-in|Overall Study||10
8751431|NCT01172938|9800399|FG004|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
8751432|NCT01172938|9800400|FG005|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
8751433|NCT01172938|9800401|FG006|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
8751434|NCT01172938|9800402|FG007|COMPLETED|Active-Treatment Phase (Weeks 52-104)||46
8751435|NCT01172938|9800403|FG008|COMPLETED|Active-Treatment Phase (Weeks 52-104)||45
8751436|NCT01172938|9800395|FG000|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
8751437|NCT01172938|9800396|FG001|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||23
8751438|NCT01172938|9800397|FG002|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||21
8751439|NCT01172938|9800398|FG003|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
8751440|NCT01172938|9800399|FG004|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
8751441|NCT01172938|9800400|FG005|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
8751442|NCT01172938|9800401|FG006|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
8751443|NCT01172938|9800402|FG007|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||15
8751444|NCT01172938|9800403|FG008|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||4
8751445|NCT01172938|9800395|FG000|STARTED|Active-Treatment Phase Weeks (104-156)||0
8751446|NCT01172938|9800396|FG001|STARTED|Active-Treatment Phase Weeks (104-156)||95
8751447|NCT01172938|9800397|FG002|STARTED|Active-Treatment Phase Weeks (104-156)||100
8751448|NCT01172938|9800398|FG003|STARTED|Active-Treatment Phase Weeks (104-156)||0
8751449|NCT01172938|9800399|FG004|STARTED|Active-Treatment Phase Weeks (104-156)||0
8751450|NCT01172938|9800400|FG005|STARTED|Active-Treatment Phase Weeks (104-156)||0
8751451|NCT01172938|9800401|FG006|STARTED|Active-Treatment Phase Weeks (104-156)||0
8751452|NCT01172938|9800402|FG007|STARTED|Active-Treatment Phase Weeks (104-156)||46
8751453|NCT01172938|9800403|FG008|STARTED|Active-Treatment Phase Weeks (104-156)||45
8751454|NCT01172938|9800395|FG000|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
8751455|NCT01172938|9800396|FG001|COMPLETED|Active-Treatment Phase Weeks (104-156)||84
8751456|NCT01172938|9800397|FG002|COMPLETED|Active-Treatment Phase Weeks (104-156)||93
8751457|NCT01172938|9800398|FG003|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
8751458|NCT01172938|9800399|FG004|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
8751459|NCT01172938|9800400|FG005|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
8751460|NCT01172938|9800401|FG006|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
8751461|NCT01172938|9800402|FG007|COMPLETED|Active-Treatment Phase Weeks (104-156)||41
8751462|NCT01172938|9800403|FG008|COMPLETED|Active-Treatment Phase Weeks (104-156)||41
8751463|NCT01172938|9800395|FG000|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
8751464|NCT01172938|9800396|FG001|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||11
8751465|NCT01172938|9800397|FG002|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||7
8751466|NCT01172938|9800398|FG003|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
8751467|NCT01172938|9800399|FG004|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
8751468|NCT01172938|9800400|FG005|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
8751469|NCT01172938|9800401|FG006|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
8751470|NCT01172938|9800402|FG007|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||5
8751471|NCT01172938|9800403|FG008|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||4
8751472|NCT01172938|9800395|FG000|STARTED|Active-Treatment Phase (Weeks 156-208)||0
8751473|NCT01172938|9800396|FG001|STARTED|Active-Treatment Phase (Weeks 156-208)||84
8751474|NCT01172938|9800397|FG002|STARTED|Active-Treatment Phase (Weeks 156-208)||93
8751475|NCT01172938|9800398|FG003|STARTED|Active-Treatment Phase (Weeks 156-208)||0
8751476|NCT01172938|9800399|FG004|STARTED|Active-Treatment Phase (Weeks 156-208)||0
8751477|NCT01172938|9800400|FG005|STARTED|Active-Treatment Phase (Weeks 156-208)||0
8751478|NCT01172938|9800401|FG006|STARTED|Active-Treatment Phase (Weeks 156-208)||0
8751479|NCT01172938|9800402|FG007|STARTED|Active-Treatment Phase (Weeks 156-208)||41
8751480|NCT01172938|9800403|FG008|STARTED|Active-Treatment Phase (Weeks 156-208)||41
8751481|NCT01172938|9800395|FG000|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
8751482|NCT01172938|9800396|FG001|COMPLETED|Active-Treatment Phase (Weeks 156-208)||75
8751483|NCT01172938|9800397|FG002|COMPLETED|Active-Treatment Phase (Weeks 156-208)||88
8751484|NCT01172938|9800398|FG003|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
8751485|NCT01172938|9800399|FG004|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
8751486|NCT01172938|9800400|FG005|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
8751487|NCT01172938|9800401|FG006|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
8751488|NCT01172938|9800402|FG007|COMPLETED|Active-Treatment Phase (Weeks 156-208)||32
8751489|NCT01172938|9800403|FG008|COMPLETED|Active-Treatment Phase (Weeks 156-208)||34
8751490|NCT01172938|9800395|FG000|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
8751491|NCT01172938|9800396|FG001|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||9
8751492|NCT01172938|9800397|FG002|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||5
8751493|NCT01172938|9800398|FG003|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
8751494|NCT01172938|9800399|FG004|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
8751495|NCT01172938|9800400|FG005|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
8751496|NCT01172938|9800401|FG006|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
8751497|NCT01172938|9800402|FG007|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||9
8751498|NCT01172938|9800403|FG008|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||7
8751499|NCT01172938|9800395|FG000|STARTED|Active-Treatment Phase (Weeks 208-260)||0
8751500|NCT01172938|9800396|FG001|STARTED|Active-Treatment Phase (Weeks 208-260)||75
8751501|NCT01172938|9800397|FG002|STARTED|Active-Treatment Phase (Weeks 208-260)||88
8751502|NCT01172938|9800398|FG003|STARTED|Active-Treatment Phase (Weeks 208-260)||0
8751503|NCT01172938|9800399|FG004|STARTED|Active-Treatment Phase (Weeks 208-260)||0
8751504|NCT01172938|9800400|FG005|STARTED|Active-Treatment Phase (Weeks 208-260)||0
8751505|NCT01172938|9800401|FG006|STARTED|Active-Treatment Phase (Weeks 208-260)||0
8751506|NCT01172938|9800402|FG007|STARTED|Active-Treatment Phase (Weeks 208-260)||32
8751507|NCT01172938|9800403|FG008|STARTED|Active-Treatment Phase (Weeks 208-260)||34
8751508|NCT01172938|9800395|FG000|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
8751509|NCT01172938|9800396|FG001|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
8751510|NCT01172938|9800397|FG002|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
8751511|NCT01172938|9800398|FG003|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
8751512|NCT01172938|9800399|FG004|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
8751513|NCT01172938|9800400|FG005|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
8751514|NCT01172938|9800401|FG006|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
8751515|NCT01172938|9800402|FG007|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||25
8751516|NCT01172938|9800403|FG008|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
8751517|NCT01172938|9800395|FG000|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
8751518|NCT01172938|9800396|FG001|COMPLETED|Active-Treatment Phase (Weeks 208-260)||72
8751519|NCT01172938|9800397|FG002|COMPLETED|Active-Treatment Phase (Weeks 208-260)||80
8751520|NCT01172938|9800398|FG003|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
8751521|NCT01172938|9800399|FG004|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
8751522|NCT01172938|9800400|FG005|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
8751523|NCT01172938|9800401|FG006|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
8751524|NCT01172938|9800402|FG007|COMPLETED|Active-Treatment Phase (Weeks 208-260)||29
8751525|NCT01172938|9800403|FG008|COMPLETED|Active-Treatment Phase (Weeks 208-260)||32
8751526|NCT01172938|9800395|FG000|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
8751527|NCT01172938|9800396|FG001|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||3
8751528|NCT01172938|9800397|FG002|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||8
8751529|NCT01172938|9800398|FG003|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
8751530|NCT01172938|9800399|FG004|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
8751531|NCT01172938|9800400|FG005|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
8751532|NCT01172938|9800401|FG006|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
8751533|NCT01172938|9800402|FG007|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||3
8751534|NCT01172938|9800403|FG008|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||2
8751535|NCT01173016|9800421|FG000|STARTED|Overall Study||11
8751536|NCT01173016|9800421|FG000|COMPLETED|Overall Study||10
8751537|NCT01173016|9800421|FG000|NOT COMPLETED|Overall Study||1
8751538|NCT01173029|9800427|FG000|STARTED|Overall Study||61
8751539|NCT01173029|9800428|FG001|STARTED|Overall Study||31
8751540|NCT01173029|9800427|FG000|COMPLETED|Overall Study||61
8751541|NCT01173029|9800428|FG001|COMPLETED|Overall Study||31
8751542|NCT01173029|9800427|FG000|NOT COMPLETED|Overall Study||0
8751543|NCT01173029|9800428|FG001|NOT COMPLETED|Overall Study||0
8751544|NCT01173055|9800445|FG000|STARTED|Period 1 - Day 1 to 49||10
8751545|NCT01173055|9800446|FG001|STARTED|Period 1 - Day 1 to 49||12
8751546|NCT01173055|9800445|FG000|COMPLETED|Period 1 - Day 1 to 49||8
8751547|NCT01173055|9800446|FG001|COMPLETED|Period 1 - Day 1 to 49||10
8751548|NCT01173055|9800445|FG000|NOT COMPLETED|Period 1 - Day 1 to 49||2
8751549|NCT01173055|9800446|FG001|NOT COMPLETED|Period 1 - Day 1 to 49||2
8751550|NCT01173055|9800445|FG000|STARTED|Placebo Washout Period - Day 50 to 63||8
8751551|NCT01173055|9800446|FG001|STARTED|Placebo Washout Period - Day 50 to 63||10
8751552|NCT01173055|9800445|FG000|COMPLETED|Placebo Washout Period - Day 50 to 63||8
8751553|NCT01173055|9800446|FG001|COMPLETED|Placebo Washout Period - Day 50 to 63||10
8751554|NCT01173055|9800445|FG000|NOT COMPLETED|Placebo Washout Period - Day 50 to 63||0
8751555|NCT01173055|9800446|FG001|NOT COMPLETED|Placebo Washout Period - Day 50 to 63||0
8751556|NCT01173055|9800445|FG000|STARTED|Period 2 - Day 64 to 112||8
8751557|NCT01173055|9800446|FG001|STARTED|Period 2 - Day 64 to 112||10
8751558|NCT01173055|9800445|FG000|COMPLETED|Period 2 - Day 64 to 112||8
8751559|NCT01173055|9800446|FG001|COMPLETED|Period 2 - Day 64 to 112||9
8751560|NCT01173055|9800445|FG000|NOT COMPLETED|Period 2 - Day 64 to 112||0
8751561|NCT01173055|9800446|FG001|NOT COMPLETED|Period 2 - Day 64 to 112||1
8751562|NCT01173120|9800452|FG000|STARTED|Overall Study||62
8751563|NCT01173120|9800452|FG000|Switched Back to Main Study|Overall Study||57
8751564|NCT01173120|9800452|FG000|Discontinued ACP Substudy and Main Study|Overall Study||5
8751565|NCT01173120|9800452|FG000|COMPLETED|Overall Study||0
8751566|NCT01173120|9800452|FG000|NOT COMPLETED|Overall Study||62
8751567|NCT01173159|9800458|FG000|STARTED|Overall Study||10
8751568|NCT01173159|9800458|FG000|COMPLETED|Overall Study||10
8751569|NCT01173159|9800458|FG000|NOT COMPLETED|Overall Study||0
8751570|NCT01173211|9800468|FG000|STARTED|Overall Study||48
8751571|NCT01173211|9800469|FG001|STARTED|Overall Study||45
8751572|NCT01173211|9800470|FG002|STARTED|Overall Study||46
8751573|NCT01173211|9800471|FG003|STARTED|Overall Study||15
8751574|NCT01173211|9800472|FG004|STARTED|Overall Study||16
8751575|NCT01173211|9800473|FG005|STARTED|Overall Study||13
8751576|NCT01173211|9800468|FG000|COMPLETED|Overall Study||46
8751577|NCT01173211|9800469|FG001|COMPLETED|Overall Study||44
8751578|NCT01173211|9800470|FG002|COMPLETED|Overall Study||44
8751579|NCT01173211|9800471|FG003|COMPLETED|Overall Study||15
8751580|NCT01173211|9800472|FG004|COMPLETED|Overall Study||16
8751581|NCT01173211|9800473|FG005|COMPLETED|Overall Study||13
8751582|NCT01173211|9800468|FG000|NOT COMPLETED|Overall Study||2
8751583|NCT01173211|9800469|FG001|NOT COMPLETED|Overall Study||1
8751584|NCT01173211|9800470|FG002|NOT COMPLETED|Overall Study||2
8751585|NCT01173211|9800471|FG003|NOT COMPLETED|Overall Study||0
8751586|NCT01173211|9800472|FG004|NOT COMPLETED|Overall Study||0
8751587|NCT01173211|9800473|FG005|NOT COMPLETED|Overall Study||0
8751588|NCT01173471|9800491|FG000|STARTED|Overall Study|Randomized|6
8751589|NCT01173471|9800492|FG001|STARTED|Overall Study|Randomized|7
8751590|NCT01173471|9800493|FG002|STARTED|Overall Study|Randomized|18
8751591|NCT01173471|9800494|FG003|STARTED|Overall Study|Randomized|19
8751592|NCT01173471|9800491|FG000|Received Treatment|Overall Study||6
8751593|NCT01173471|9800492|FG001|Received Treatment|Overall Study||7
8751594|NCT01173471|9800493|FG002|Received Treatment|Overall Study||18
8751595|NCT01173471|9800494|FG003|Received Treatment|Overall Study||19
8751596|NCT01173471|9800491|FG000|Completed Treatment|Overall Study||4
8751597|NCT01173471|9800492|FG001|Completed Treatment|Overall Study||7
8751598|NCT01173471|9800493|FG002|Completed Treatment|Overall Study||15
8751599|NCT01173471|9800494|FG003|Completed Treatment|Overall Study||18
8751600|NCT01173471|9800491|FG000|COMPLETED|Overall Study|Completed study|4
8751601|NCT01173471|9800492|FG001|COMPLETED|Overall Study|Completed study|7
8751602|NCT01173471|9800493|FG002|COMPLETED|Overall Study|Completed study|15
8751603|NCT01173471|9800494|FG003|COMPLETED|Overall Study|Completed study|18
8751604|NCT01173471|9800491|FG000|NOT COMPLETED|Overall Study||2
9023400|NCT03136380|10086208|FG001|STARTED|Part 1, Period 2 (3 Days)||6
9023401|NCT03136380|10086209|FG002|STARTED|Part 1, Period 2 (3 Days)||6
9023402|NCT03136380|10086210|FG003|STARTED|Part 1, Period 2 (3 Days)||0
9023403|NCT03136380|10086211|FG004|STARTED|Part 1, Period 2 (3 Days)||0
9023404|NCT03136380|10086207|FG000|COMPLETED|Part 1, Period 2 (3 Days)||6
9023405|NCT03136380|10086208|FG001|COMPLETED|Part 1, Period 2 (3 Days)||6
9023406|NCT03136380|10086209|FG002|COMPLETED|Part 1, Period 2 (3 Days)||6
9023407|NCT03136380|10086210|FG003|COMPLETED|Part 1, Period 2 (3 Days)||0
9023408|NCT03136380|10086211|FG004|COMPLETED|Part 1, Period 2 (3 Days)||0
9023409|NCT03136380|10086207|FG000|NOT COMPLETED|Part 1, Period 2 (3 Days)||0
9023410|NCT03136380|10086208|FG001|NOT COMPLETED|Part 1, Period 2 (3 Days)||0
9023411|NCT03136380|10086209|FG002|NOT COMPLETED|Part 1, Period 2 (3 Days)||0
9023412|NCT03136380|10086210|FG003|NOT COMPLETED|Part 1, Period 2 (3 Days)||0
9023413|NCT03136380|10086211|FG004|NOT COMPLETED|Part 1, Period 2 (3 Days)||0
9023414|NCT03136380|10086207|FG000|STARTED|Part 1, Washout Period 2 (7 Days)||6
8751605|NCT01173471|9800492|FG001|NOT COMPLETED|Overall Study||0
8751606|NCT01173471|9800493|FG002|NOT COMPLETED|Overall Study||3
8751607|NCT01173471|9800494|FG003|NOT COMPLETED|Overall Study||1
8751608|NCT01173523|9800506|FG000|STARTED|Overall Study||13
8751609|NCT01173523|9800507|FG001|STARTED|Overall Study||12
8914794|NCT02170688|9974316|FG002|COMPLETED|Overall Study||25
8914795|NCT02170688|9974317|FG003|COMPLETED|Overall Study||25
8914796|NCT02170688|9974318|FG004|COMPLETED|Overall Study||25
8914797|NCT02170688|9974314|FG000|NOT COMPLETED|Overall Study||4
8914798|NCT02170688|9974315|FG001|NOT COMPLETED|Overall Study||3
8914799|NCT02170688|9974316|FG002|NOT COMPLETED|Overall Study||4
8914800|NCT02170688|9974317|FG003|NOT COMPLETED|Overall Study||2
8914801|NCT02170688|9974318|FG004|NOT COMPLETED|Overall Study||0
8914802|NCT02170727|9974332|FG000|STARTED|Overall Study||138
8914803|NCT02170727|9974333|FG001|STARTED|Overall Study||31
8914804|NCT02170727|9974332|FG000|COMPLETED|Overall Study||135
8914805|NCT02170727|9974333|FG001|COMPLETED|Overall Study||31
8914806|NCT02170727|9974332|FG000|NOT COMPLETED|Overall Study||3
8914807|NCT02170727|9974333|FG001|NOT COMPLETED|Overall Study||0
8914808|NCT02170779|9974344|FG000|STARTED|Overall Study||20
8914809|NCT02170779|9974345|FG001|STARTED|Overall Study||20
8914810|NCT02170779|9974344|FG000|COMPLETED|Overall Study||19
8914811|NCT02170779|9974345|FG001|COMPLETED|Overall Study||19
8914812|NCT02170779|9974344|FG000|NOT COMPLETED|Overall Study||1
8914813|NCT02170779|9974345|FG001|NOT COMPLETED|Overall Study||1
8914814|NCT02170870|9974357|FG000|STARTED|Overall Study||13
8914815|NCT02170870|9974358|FG001|STARTED|Overall Study||11
8914816|NCT02170870|9974359|FG002|STARTED|Overall Study||20
8914817|NCT02170870|9974360|FG003|STARTED|Overall Study||20
8914818|NCT02170870|9974361|FG004|STARTED|Overall Study||20
8914819|NCT02170870|9974362|FG005|STARTED|Overall Study||20
8914820|NCT02170870|9974357|FG000|COMPLETED|Overall Study||13
8914821|NCT02170870|9974358|FG001|COMPLETED|Overall Study||11
8914822|NCT02170870|9974359|FG002|COMPLETED|Overall Study||20
8914823|NCT02170870|9974360|FG003|COMPLETED|Overall Study||20
8914824|NCT02170870|9974361|FG004|COMPLETED|Overall Study||20
8914825|NCT02170870|9974362|FG005|COMPLETED|Overall Study||20
8914826|NCT02170870|9974357|FG000|NOT COMPLETED|Overall Study||0
8914827|NCT02170870|9974358|FG001|NOT COMPLETED|Overall Study||0
8914828|NCT02170870|9974359|FG002|NOT COMPLETED|Overall Study||0
8914829|NCT02170870|9974360|FG003|NOT COMPLETED|Overall Study||0
8914830|NCT02170870|9974361|FG004|NOT COMPLETED|Overall Study||0
8914831|NCT02170870|9974362|FG005|NOT COMPLETED|Overall Study||0
8914832|NCT02171065|9974382|FG000|STARTED|Overall Study||89
8914833|NCT02171065|9974383|FG001|STARTED|Overall Study||93
8914834|NCT02171065|9974384|FG002|STARTED|Overall Study||716
8914835|NCT02171065|9974382|FG000|COMPLETED|Overall Study||88
8914836|NCT02171065|9974383|FG001|COMPLETED|Overall Study||93
8914837|NCT02171065|9974384|FG002|COMPLETED|Overall Study||715
8914838|NCT02171065|9974382|FG000|NOT COMPLETED|Overall Study||1
8751610|NCT01173523|9800506|FG000|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
8751611|NCT01173523|9800507|FG001|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
8751612|NCT01173523|9800506|FG000|NOT COMPLETED|Overall Study||13
8751613|NCT01173523|9800507|FG001|NOT COMPLETED|Overall Study||12
8751614|NCT01173601|9800517|FG000|STARTED|Confirmation (CF) Phase, 3 Weeks||1416
8751615|NCT01173601|9800518|FG001|STARTED|Confirmation (CF) Phase, 3 Weeks||0
8751616|NCT01173601|9800519|FG002|STARTED|Confirmation (CF) Phase, 3 Weeks||0
8751617|NCT01173601|9800520|FG003|STARTED|Confirmation (CF) Phase, 3 Weeks||0
8751618|NCT01173601|9800521|FG004|STARTED|Confirmation (CF) Phase, 3 Weeks||0
8751619|NCT01173601|9800517|FG000|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks|Participants who discontinued the CF Phase had the option to enter the DC phase.|21
8751620|NCT01173601|9800518|FG001|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0
8751621|NCT01173601|9800519|FG002|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0
8751622|NCT01173601|9800520|FG003|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0
8751623|NCT01173601|9800521|FG004|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0
8751624|NCT01173601|9800517|FG000|COMPLETED|Confirmation (CF) Phase, 3 Weeks|Participants who completed the CF Phase entered the AT Phase.|1328
8751625|NCT01173601|9800518|FG001|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
8751626|NCT01173601|9800519|FG002|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
8751627|NCT01173601|9800520|FG003|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
8751628|NCT01173601|9800521|FG004|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
8751629|NCT01173601|9800517|FG000|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||88
8751630|NCT01173601|9800518|FG001|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
8751631|NCT01173601|9800519|FG002|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
8751632|NCT01173601|9800520|FG003|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
8751633|NCT01173601|9800521|FG004|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
8751634|NCT01173601|9800517|FG000|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
8751635|NCT01173601|9800518|FG001|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||231
8751636|NCT01173601|9800519|FG002|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||230
8751637|NCT01173601|9800520|FG003|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||240
8751638|NCT01173601|9800521|FG004|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||627
8751639|NCT01173601|9800517|FG000|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
8751640|NCT01173601|9800518|FG001|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the taper DC Phase.|100
8751641|NCT01173601|9800519|FG002|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the taper DC Phase.|107
8751642|NCT01173601|9800520|FG003|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
8751643|NCT01173601|9800521|FG004|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
8751644|NCT01173601|9800517|FG000|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
8751645|NCT01173601|9800518|FG001|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the abrupt DC Phase.|100
8751646|NCT01173601|9800519|FG002|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the abrupt DC Phase.|108
8751647|NCT01173601|9800520|FG003|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the abrupt DC Phase.|221
8751648|NCT01173601|9800521|FG004|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the abrupt DC Phase.|586
8751649|NCT01173601|9800517|FG000|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
8751650|NCT01173601|9800518|FG001|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||196
8751651|NCT01173601|9800519|FG002|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||197
8751652|NCT01173601|9800520|FG003|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||210
8751653|NCT01173601|9800521|FG004|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||559
8751654|NCT01173601|9800517|FG000|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
8751655|NCT01173601|9800518|FG001|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||35
8751656|NCT01173601|9800519|FG002|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||33
8751657|NCT01173601|9800520|FG003|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||30
8751658|NCT01173601|9800521|FG004|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||68
8751659|NCT01173653|9800541|FG000|STARTED|Overall Study||109
8751660|NCT01173653|9800542|FG001|STARTED|Overall Study||90
8751661|NCT01173653|9800541|FG000|COMPLETED|Overall Study||56
8751662|NCT01173653|9800542|FG001|COMPLETED|Overall Study||49
8751663|NCT01173653|9800541|FG000|NOT COMPLETED|Overall Study||53
8751664|NCT01173653|9800542|FG001|NOT COMPLETED|Overall Study||41
8751665|NCT01173679|9800548|FG000|STARTED|Overall Study||10
8751666|NCT01173679|9800548|FG000|COMPLETED|Overall Study||9
8751667|NCT01173679|9800548|FG000|NOT COMPLETED|Overall Study||1
8751668|NCT01173692|9800555|FG000|STARTED|Overall Study||22
8751669|NCT01173692|9800556|FG001|STARTED|Overall Study||25
8751670|NCT01173692|9800555|FG000|COMPLETED|Overall Study||20
8751671|NCT01173692|9800556|FG001|COMPLETED|Overall Study||20
8751672|NCT01173692|9800555|FG000|NOT COMPLETED|Overall Study||2
8751673|NCT01173692|9800556|FG001|NOT COMPLETED|Overall Study||5
8751674|NCT01173718|9800562|FG000|STARTED|Overall Study||138
8751675|NCT01173718|9800562|FG000|COMPLETED|Overall Study||94
8751676|NCT01173718|9800562|FG000|NOT COMPLETED|Overall Study||44
8751677|NCT01173848|9800568|FG000|STARTED|Overall Study||8
8751678|NCT01173848|9800569|FG001|STARTED|Overall Study||11
8751679|NCT01173848|9800568|FG000|COMPLETED|Overall Study||4
8751680|NCT01173848|9800569|FG001|COMPLETED|Overall Study||3
8751681|NCT01173848|9800568|FG000|NOT COMPLETED|Overall Study||4
8751682|NCT01173848|9800569|FG001|NOT COMPLETED|Overall Study||8
8751683|NCT01173874|9800576|FG000|STARTED|Overall Study||56
8751684|NCT01173874|9800577|FG001|STARTED|Overall Study||64
8751685|NCT01173874|9800576|FG000|COMPLETED|Overall Study||33
8751686|NCT01173874|9800577|FG001|COMPLETED|Overall Study||41
8751687|NCT01173874|9800576|FG000|NOT COMPLETED|Overall Study||23
8751688|NCT01173874|9800577|FG001|NOT COMPLETED|Overall Study||23
8751689|NCT01174004|9800585|FG000|STARTED|Overall Study||94
8751690|NCT01174004|9800586|FG001|STARTED|Overall Study||105
8751691|NCT01174004|9800585|FG000|COMPLETED|Overall Study||87
8751692|NCT01174004|9800586|FG001|COMPLETED|Overall Study||89
8751693|NCT01174004|9800585|FG000|NOT COMPLETED|Overall Study||7
8751694|NCT01174004|9800586|FG001|NOT COMPLETED|Overall Study||16
8751695|NCT01174030|9800597|FG000|STARTED|Overall Study||53
8751696|NCT01174030|9800598|FG001|STARTED|Overall Study||54
8751697|NCT01174030|9800599|FG002|STARTED|Overall Study||54
8751698|NCT01174030|9800600|FG003|STARTED|Overall Study||55
8751699|NCT01174030|9800601|FG004|STARTED|Overall Study||53
8751700|NCT01174030|9800597|FG000|COMPLETED|Overall Study||51
8751701|NCT01174030|9800598|FG001|COMPLETED|Overall Study||52
8751702|NCT01174030|9800599|FG002|COMPLETED|Overall Study||52
8751703|NCT01174030|9800600|FG003|COMPLETED|Overall Study||53
8751704|NCT01174030|9800601|FG004|COMPLETED|Overall Study||52
8751705|NCT01174030|9800597|FG000|NOT COMPLETED|Overall Study||2
8751706|NCT01174030|9800598|FG001|NOT COMPLETED|Overall Study||2
8751707|NCT01174030|9800599|FG002|NOT COMPLETED|Overall Study||2
8751708|NCT01174030|9800600|FG003|NOT COMPLETED|Overall Study||2
8751709|NCT01174030|9800601|FG004|NOT COMPLETED|Overall Study||1
8751710|NCT01174043|9800613|FG000|STARTED|Overall Study||11
8751711|NCT01174043|9800613|FG000|COMPLETED|Overall Study||0
8751712|NCT01174043|9800613|FG000|NOT COMPLETED|Overall Study||11
8751713|NCT01174082|9800619|FG000|STARTED|Overall Study||1
8751714|NCT01174082|9800620|FG001|STARTED|Overall Study||1
8751715|NCT01174082|9800619|FG000|COMPLETED|Overall Study||1
8751716|NCT01174082|9800620|FG001|COMPLETED|Overall Study||1
8751717|NCT01174082|9800619|FG000|NOT COMPLETED|Overall Study||0
8751718|NCT01174082|9800620|FG001|NOT COMPLETED|Overall Study||0
8751719|NCT01174160|9800628|FG000|STARTED|Overall Study||61
8751720|NCT01174160|9800629|FG001|STARTED|Overall Study||62
8751721|NCT01174160|9800628|FG000|Discontinued Pre Dose|Overall Study||6
8751722|NCT01174160|9800629|FG001|Discontinued Pre Dose|Overall Study||6
8751723|NCT01174160|9800628|FG000|Dosed|Overall Study||55
8751724|NCT01174160|9800629|FG001|Dosed|Overall Study||56
8751725|NCT01174160|9800628|FG000|Discontinued Post Dose|Overall Study||2
8751726|NCT01174160|9800629|FG001|Discontinued Post Dose|Overall Study||0
8751727|NCT01174160|9800628|FG000|COMPLETED|Overall Study||53
8751728|NCT01174160|9800629|FG001|COMPLETED|Overall Study||56
8751729|NCT01174160|9800628|FG000|NOT COMPLETED|Overall Study||8
8751730|NCT01174160|9800629|FG001|NOT COMPLETED|Overall Study||6
8751731|NCT01174173|9800635|FG000|STARTED|Overall Study||11
8751732|NCT01174173|9800635|FG000|COMPLETED|Overall Study||10
8751733|NCT01174173|9800635|FG000|NOT COMPLETED|Overall Study||1
8751734|NCT01174186|9800642|FG000|STARTED|Overall Study|Patients were included over three years|15
8751735|NCT01174186|9800643|FG001|STARTED|Overall Study||15
8751736|NCT01174186|9800642|FG000|COMPLETED|Overall Study||15
8751737|NCT01174186|9800643|FG001|COMPLETED|Overall Study||12
8751738|NCT01174186|9800642|FG000|NOT COMPLETED|Overall Study||0
8751739|NCT01174186|9800643|FG001|NOT COMPLETED|Overall Study||3
8751740|NCT01174238|9800649|FG000|STARTED|Overall Study||38
8751741|NCT01174238|9800649|FG000|Participants That Underwent FLT-PET Scan|Overall Study||6
8751742|NCT01174238|9800649|FG000|COMPLETED|Overall Study||36
8751743|NCT01174238|9800649|FG000|NOT COMPLETED|Overall Study||2
8751744|NCT01174264|9800659|FG000|STARTED|Single Dose Pharmacokinetics||23
8751745|NCT01174264|9800660|FG001|STARTED|Single Dose Pharmacokinetics||20
8751746|NCT01174264|9800661|FG002|STARTED|Single Dose Pharmacokinetics||20
8751747|NCT01174264|9800659|FG000|COMPLETED|Single Dose Pharmacokinetics||22
8751748|NCT01174264|9800660|FG001|COMPLETED|Single Dose Pharmacokinetics||20
8751749|NCT01174264|9800661|FG002|COMPLETED|Single Dose Pharmacokinetics||18
8751750|NCT01174264|9800659|FG000|NOT COMPLETED|Single Dose Pharmacokinetics||1
8751751|NCT01174264|9800660|FG001|NOT COMPLETED|Single Dose Pharmacokinetics||0
8751752|NCT01174264|9800661|FG002|NOT COMPLETED|Single Dose Pharmacokinetics||2
8751753|NCT01174264|9800659|FG000|STARTED|Steady-state Pharmacokinetics|Includes 22 patients from period 1 fasting arm and 9 patients from period 1 high-fat arm|31
8751754|NCT01174264|9800660|FG001|STARTED|Steady-state Pharmacokinetics|Patients in period 2 were randomized to fasting vs. fed state only.|0
8751755|NCT01174264|9800661|FG002|STARTED|Steady-state Pharmacokinetics|Includes 11 patients from period 1 high-fat arm and 18 patients from period 1 low-fat arm|29
8751756|NCT01174264|9800659|FG000|COMPLETED|Steady-state Pharmacokinetics||25
8751757|NCT01174264|9800660|FG001|COMPLETED|Steady-state Pharmacokinetics||0
8751758|NCT01174264|9800661|FG002|COMPLETED|Steady-state Pharmacokinetics||27
8751759|NCT01174264|9800659|FG000|NOT COMPLETED|Steady-state Pharmacokinetics||6
8751760|NCT01174264|9800660|FG001|NOT COMPLETED|Steady-state Pharmacokinetics||0
8751761|NCT01174264|9800661|FG002|NOT COMPLETED|Steady-state Pharmacokinetics||2
8751762|NCT01174342|9800669|FG000|STARTED|Overall Study||30
8751763|NCT01174342|9800669|FG000|COMPLETED|Overall Study||26
8751764|NCT01174342|9800669|FG000|NOT COMPLETED|Overall Study||4
8751765|NCT01174446|9800673|FG000|STARTED|Part 1 -Pharmacokinetic Crossover||14
8751766|NCT01174446|9800674|FG001|STARTED|Part 1 -Pharmacokinetic Crossover||14
8751767|NCT01174446|9800675|FG002|STARTED|Part 1 -Pharmacokinetic Crossover||0
8751768|NCT01174446|9800676|FG003|STARTED|Part 1 -Pharmacokinetic Crossover||0
8751769|NCT01174446|9800673|FG000|COMPLETED|Part 1 -Pharmacokinetic Crossover|BAX326 was mistakenly infused for second PK infusion (ie should have been BeneFIX) for 1 participant|14
8751770|NCT01174446|9800674|FG001|COMPLETED|Part 1 -Pharmacokinetic Crossover||14
8751771|NCT01174446|9800675|FG002|COMPLETED|Part 1 -Pharmacokinetic Crossover||0
9023415|NCT03136380|10086208|FG001|STARTED|Part 1, Washout Period 2 (7 Days)||6
9023416|NCT03136380|10086209|FG002|STARTED|Part 1, Washout Period 2 (7 Days)||6
9023417|NCT03136380|10086210|FG003|STARTED|Part 1, Washout Period 2 (7 Days)||0
9023418|NCT03136380|10086211|FG004|STARTED|Part 1, Washout Period 2 (7 Days)||0
9023419|NCT03136380|10086207|FG000|COMPLETED|Part 1, Washout Period 2 (7 Days)||6
9023420|NCT03136380|10086208|FG001|COMPLETED|Part 1, Washout Period 2 (7 Days)||5
9023421|NCT03136380|10086209|FG002|COMPLETED|Part 1, Washout Period 2 (7 Days)||6
8914839|NCT02171065|9974383|FG001|NOT COMPLETED|Overall Study||0
8914840|NCT02171065|9974384|FG002|NOT COMPLETED|Overall Study||1
8914841|NCT02171130|9974394|FG000|STARTED|Overall Study||129
9023422|NCT03136380|10086210|FG003|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
9023423|NCT03136380|10086211|FG004|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
9023424|NCT03136380|10086207|FG000|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
9023425|NCT03136380|10086208|FG001|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||1
9023426|NCT03136380|10086209|FG002|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
9023427|NCT03136380|10086210|FG003|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
9023428|NCT03136380|10086211|FG004|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
9023429|NCT03136380|10086207|FG000|STARTED|Part 1, Period 3 (4 Days)||6
9023430|NCT03136380|10086208|FG001|STARTED|Part 1, Period 3 (4 Days)||5
9023431|NCT03136380|10086209|FG002|STARTED|Part 1, Period 3 (4 Days)||6
9023432|NCT03136380|10086210|FG003|STARTED|Part 1, Period 3 (4 Days)||0
9023433|NCT03136380|10086211|FG004|STARTED|Part 1, Period 3 (4 Days)||0
9023434|NCT03136380|10086207|FG000|COMPLETED|Part 1, Period 3 (4 Days)||6
9023435|NCT03136380|10086208|FG001|COMPLETED|Part 1, Period 3 (4 Days)||5
9023436|NCT03136380|10086209|FG002|COMPLETED|Part 1, Period 3 (4 Days)||6
9023437|NCT03136380|10086210|FG003|COMPLETED|Part 1, Period 3 (4 Days)||0
9023438|NCT03136380|10086211|FG004|COMPLETED|Part 1, Period 3 (4 Days)||0
9023439|NCT03136380|10086207|FG000|NOT COMPLETED|Part 1, Period 3 (4 Days)||0
9023440|NCT03136380|10086208|FG001|NOT COMPLETED|Part 1, Period 3 (4 Days)||0
9023441|NCT03136380|10086209|FG002|NOT COMPLETED|Part 1, Period 3 (4 Days)||0
9023442|NCT03136380|10086210|FG003|NOT COMPLETED|Part 1, Period 3 (4 Days)||0
9023443|NCT03136380|10086211|FG004|NOT COMPLETED|Part 1, Period 3 (4 Days)||0
9023444|NCT03136380|10086207|FG000|STARTED|Part 2, Period 1 (3 Days)||0
9023445|NCT03136380|10086208|FG001|STARTED|Part 2, Period 1 (3 Days)||0
9023446|NCT03136380|10086209|FG002|STARTED|Part 2, Period 1 (3 Days)||0
9023447|NCT03136380|10086210|FG003|STARTED|Part 2, Period 1 (3 Days)||8
9023448|NCT03136380|10086211|FG004|STARTED|Part 2, Period 1 (3 Days)||8
9023449|NCT03136380|10086207|FG000|COMPLETED|Part 2, Period 1 (3 Days)||0
9023450|NCT03136380|10086208|FG001|COMPLETED|Part 2, Period 1 (3 Days)||0
9023451|NCT03136380|10086209|FG002|COMPLETED|Part 2, Period 1 (3 Days)||0
9023452|NCT03136380|10086210|FG003|COMPLETED|Part 2, Period 1 (3 Days)||8
9023453|NCT03136380|10086211|FG004|COMPLETED|Part 2, Period 1 (3 Days)||8
9023454|NCT03136380|10086207|FG000|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
9023455|NCT03136380|10086208|FG001|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
9023456|NCT03136380|10086209|FG002|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
9023457|NCT03136380|10086210|FG003|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
9023458|NCT03136380|10086211|FG004|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
9023459|NCT03136380|10086207|FG000|STARTED|Part 2, Washout Period 1 (7 Days)||0
9023460|NCT03136380|10086208|FG001|STARTED|Part 2, Washout Period 1 (7 Days)||0
9023461|NCT03136380|10086209|FG002|STARTED|Part 2, Washout Period 1 (7 Days)||0
9023462|NCT03136380|10086210|FG003|STARTED|Part 2, Washout Period 1 (7 Days)||8
9023463|NCT03136380|10086211|FG004|STARTED|Part 2, Washout Period 1 (7 Days)||8
9023464|NCT03136380|10086207|FG000|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
9023465|NCT03136380|10086208|FG001|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
9023466|NCT03136380|10086209|FG002|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
9023467|NCT03136380|10086210|FG003|COMPLETED|Part 2, Washout Period 1 (7 Days)||8
9023468|NCT03136380|10086211|FG004|COMPLETED|Part 2, Washout Period 1 (7 Days)||8
9023469|NCT03136380|10086207|FG000|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
8914842|NCT02171130|9974394|FG000|Received at Least One Dose of Study Drug|Overall Study||87
8914843|NCT02171130|9974394|FG000|Experienced Hypoglycemic Event|Overall Study|Experienced at least one hypoglycemic event and received at least one dose of study drug.|87
8914844|NCT02171130|9974394|FG000|COMPLETED|Overall Study|Including participants who completed the 6-month study but did not experience any hypoglycemia event|101
8914845|NCT02171130|9974394|FG000|NOT COMPLETED|Overall Study||28
8751772|NCT01174446|9800676|FG003|COMPLETED|Part 1 -Pharmacokinetic Crossover||0
8751773|NCT01174446|9800673|FG000|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
8751774|NCT01174446|9800674|FG001|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
8751775|NCT01174446|9800675|FG002|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
8751776|NCT01174446|9800676|FG003|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
8751777|NCT01174446|9800673|FG000|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|In Study Part 2 all 14 participants received Prophylaxis|14
8751778|NCT01174446|9800674|FG001|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|In Study Part 2 all 14 participants received Prophylaxis|14
8751779|NCT01174446|9800675|FG002|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|This group only participated in Study Part 2|31
8751780|NCT01174446|9800676|FG003|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|This group only participated in Study Part 2|14
8751781|NCT01174446|9800673|FG000|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||14
8751782|NCT01174446|9800674|FG001|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||14
8751783|NCT01174446|9800675|FG002|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||29
8751784|NCT01174446|9800676|FG003|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||14
8751785|NCT01174446|9800673|FG000|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||0
8751786|NCT01174446|9800674|FG001|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||0
8751787|NCT01174446|9800675|FG002|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||2
8751788|NCT01174446|9800676|FG003|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||0
8751789|NCT01174446|9800673|FG000|STARTED|Part 3 -Pharmacokinetic BAX326 Only|Includes all participants who completed Part 1|14
8751790|NCT01174446|9800674|FG001|STARTED|Part 3 -Pharmacokinetic BAX326 Only|Includes all participants who completed Part 1|14
8751791|NCT01174446|9800675|FG002|STARTED|Part 3 -Pharmacokinetic BAX326 Only||0
8751792|NCT01174446|9800676|FG003|STARTED|Part 3 -Pharmacokinetic BAX326 Only||0
8751793|NCT01174446|9800673|FG000|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||13
8751794|NCT01174446|9800674|FG001|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||13
8751795|NCT01174446|9800675|FG002|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
8751796|NCT01174446|9800676|FG003|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
8751797|NCT01174446|9800673|FG000|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||1
8751798|NCT01174446|9800674|FG001|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||1
8751799|NCT01174446|9800675|FG002|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
8751800|NCT01174446|9800676|FG003|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
8751801|NCT01174459|9800723|FG000|STARTED|Overall Study|Registered patients|571
8751802|NCT01174459|9800723|FG000|COMPLETED|Overall Study|Case report form (CRF) collected|566
8751803|NCT01174459|9800723|FG000|NOT COMPLETED|Overall Study||5
8751804|NCT01174550|9800729|FG000|STARTED|Overall Study||5007
8751805|NCT01174550|9800730|FG001|STARTED|Overall Study||4996
8751806|NCT01174550|9800729|FG000|COMPLETED|Overall Study||3737
8751807|NCT01174550|9800730|FG001|COMPLETED|Overall Study||4123
8751808|NCT01174550|9800729|FG000|NOT COMPLETED|Overall Study||1270
8751809|NCT01174550|9800730|FG001|NOT COMPLETED|Overall Study||873
8751810|NCT01174576|9800736|FG000|STARTED|Overall Study|All participants received all interventions without exception.|16
8751811|NCT01174576|9800736|FG000|COMPLETED|Overall Study||16
8751812|NCT01174576|9800736|FG000|NOT COMPLETED|Overall Study||0
8751813|NCT01174784|9800749|FG000|STARTED|Overall Study||88
8751814|NCT01174784|9800749|FG000|COMPLETED|Overall Study|While 88 subjects did complete the procedure, 4 were considered screen failures post-procedure.|84
8751815|NCT01174784|9800749|FG000|NOT COMPLETED|Overall Study||4
8751816|NCT01174823|9800756|FG000|STARTED|Overall Study||122
8751817|NCT01174823|9800757|FG001|STARTED|Overall Study||123
8751818|NCT01174823|9800756|FG000|COMPLETED|Overall Study||115
8751819|NCT01174823|9800757|FG001|COMPLETED|Overall Study||119
8751820|NCT01174823|9800756|FG000|NOT COMPLETED|Overall Study||7
8751821|NCT01174823|9800757|FG001|NOT COMPLETED|Overall Study||4
8751822|NCT01175005|9800763|FG000|STARTED|Overall Study||62
8751823|NCT01175005|9800763|FG000|COMPLETED|Overall Study||62
8751824|NCT01175005|9800763|FG000|NOT COMPLETED|Overall Study||0
8751825|NCT01175018|9800770|FG000|STARTED|Overall Study||15
8751826|NCT01175018|9800771|FG001|STARTED|Overall Study||15
8751827|NCT01175018|9800770|FG000|COMPLETED|Overall Study||12
8751828|NCT01175018|9800771|FG001|COMPLETED|Overall Study||14
8751829|NCT01175018|9800770|FG000|NOT COMPLETED|Overall Study||3
8751830|NCT01175018|9800771|FG001|NOT COMPLETED|Overall Study||1
8751831|NCT01175031|9800779|FG000|STARTED|Overall Study||45
8751832|NCT01175031|9800779|FG000|COMPLETED|Overall Study||45
8751833|NCT01175031|9800779|FG000|NOT COMPLETED|Overall Study||0
8751834|NCT01175083|9800793|FG000|STARTED|Primary Epoch||50
8751835|NCT01175083|9800794|FG001|STARTED|Primary Epoch||50
8751836|NCT01175083|9800795|FG002|STARTED|Primary Epoch||50
8751837|NCT01175083|9800796|FG003|STARTED|Primary Epoch||50
8751838|NCT01175083|9800797|FG004|STARTED|Primary Epoch||50
8751839|NCT01175083|9800798|FG005|STARTED|Primary Epoch||50
8751840|NCT01175083|9800793|FG000|COMPLETED|Primary Epoch||50
8751841|NCT01175083|9800794|FG001|COMPLETED|Primary Epoch||50
8751842|NCT01175083|9800795|FG002|COMPLETED|Primary Epoch||50
8751843|NCT01175083|9800796|FG003|COMPLETED|Primary Epoch||50
8751844|NCT01175083|9800797|FG004|COMPLETED|Primary Epoch||50
8751845|NCT01175083|9800798|FG005|COMPLETED|Primary Epoch||47
8751846|NCT01175083|9800793|FG000|NOT COMPLETED|Primary Epoch||0
8751847|NCT01175083|9800794|FG001|NOT COMPLETED|Primary Epoch||0
8751848|NCT01175083|9800795|FG002|NOT COMPLETED|Primary Epoch||0
8751849|NCT01175083|9800796|FG003|NOT COMPLETED|Primary Epoch||0
8751850|NCT01175083|9800797|FG004|NOT COMPLETED|Primary Epoch||0
8751851|NCT01175083|9800798|FG005|NOT COMPLETED|Primary Epoch||3
8751852|NCT01175083|9800793|FG000|STARTED|Booster Epoch|One subject died between both Epochs and hence did not participate in the Booster Epoch.|49
8751853|NCT01175083|9800794|FG001|STARTED|Booster Epoch|One subject died between both Epochs and hence did not participate in the Booster Epoch.|49
8751854|NCT01175083|9800795|FG002|STARTED|Booster Epoch||50
8751855|NCT01175083|9800796|FG003|STARTED|Booster Epoch||50
8751856|NCT01175083|9800797|FG004|STARTED|Booster Epoch|No subjects participated in the Booster Epoch, as no booster dose was planned per protocol.|0
8751857|NCT01175083|9800798|FG005|STARTED|Booster Epoch|No subjects participated in the Booster Epoch, as no booster dose was planned per protocol.|0
8751858|NCT01175083|9800793|FG000|COMPLETED|Booster Epoch||49
8751859|NCT01175083|9800794|FG001|COMPLETED|Booster Epoch||49
8751860|NCT01175083|9800795|FG002|COMPLETED|Booster Epoch||49
8751861|NCT01175083|9800796|FG003|COMPLETED|Booster Epoch||49
8751862|NCT01175083|9800797|FG004|COMPLETED|Booster Epoch||0
8751863|NCT01175083|9800798|FG005|COMPLETED|Booster Epoch||0
8751864|NCT01175083|9800793|FG000|NOT COMPLETED|Booster Epoch||0
8751865|NCT01175083|9800794|FG001|NOT COMPLETED|Booster Epoch||0
8751866|NCT01175083|9800795|FG002|NOT COMPLETED|Booster Epoch||1
8751867|NCT01175083|9800796|FG003|NOT COMPLETED|Booster Epoch||1
8751868|NCT01175083|9800797|FG004|NOT COMPLETED|Booster Epoch||0
8751869|NCT01175083|9800798|FG005|NOT COMPLETED|Booster Epoch||0
8751870|NCT01175135|9800820|FG000|STARTED|Overall Study||74
8751871|NCT01175135|9800821|FG001|STARTED|Overall Study||74
8751872|NCT01175135|9800822|FG002|STARTED|Overall Study||37
8751873|NCT01175135|9800823|FG003|STARTED|Overall Study||74
8751874|NCT01175135|9800820|FG000|Treated|Overall Study||74
8751875|NCT01175135|9800821|FG001|Treated|Overall Study||74
8751876|NCT01175135|9800822|FG002|Treated|Overall Study||36
8751877|NCT01175135|9800823|FG003|Treated|Overall Study||74
8751878|NCT01175135|9800820|FG000|Analyzed for Efficacy|Overall Study||74
8751879|NCT01175135|9800821|FG001|Analyzed for Efficacy|Overall Study||73
8751880|NCT01175135|9800822|FG002|Analyzed for Efficacy|Overall Study||34
8751881|NCT01175135|9800823|FG003|Analyzed for Efficacy|Overall Study||73
8751882|NCT01175135|9800820|FG000|COMPLETED|Overall Study||58
8751883|NCT01175135|9800821|FG001|COMPLETED|Overall Study||52
8751884|NCT01175135|9800822|FG002|COMPLETED|Overall Study||25
8751885|NCT01175135|9800823|FG003|COMPLETED|Overall Study||60
8751886|NCT01175135|9800820|FG000|NOT COMPLETED|Overall Study||16
8751887|NCT01175135|9800821|FG001|NOT COMPLETED|Overall Study||22
8751888|NCT01175135|9800822|FG002|NOT COMPLETED|Overall Study||12
8751889|NCT01175135|9800823|FG003|NOT COMPLETED|Overall Study||14
8751890|NCT01175148|9800835|FG000|STARTED|Overall Study||30
8751891|NCT01175148|9800836|FG001|STARTED|Overall Study||30
8751892|NCT01175148|9800835|FG000|COMPLETED|Overall Study||30
8751893|NCT01175148|9800836|FG001|COMPLETED|Overall Study||30
8751894|NCT01175148|9800835|FG000|NOT COMPLETED|Overall Study||0
8751895|NCT01175148|9800836|FG001|NOT COMPLETED|Overall Study||0
8751896|NCT01175213|9800845|FG000|STARTED|IGSC, 10%/rHuPH20||63
8751897|NCT01175213|9800846|FG001|STARTED|IGSC, 10%/rHuPH20|3 participants treated IV with IGIV,10% without rHuPH20 throughout the study.|3
8751898|NCT01175213|9800845|FG000|COMPLETED|IGSC, 10%/rHuPH20||48
8751899|NCT01175213|9800846|FG001|COMPLETED|IGSC, 10%/rHuPH20||3
8751900|NCT01175213|9800845|FG000|NOT COMPLETED|IGSC, 10%/rHuPH20||15
8751901|NCT01175213|9800846|FG001|NOT COMPLETED|IGSC, 10%/rHuPH20||0
8751902|NCT01175213|9800845|FG000|STARTED|Safety Follow-up||48
8751903|NCT01175213|9800846|FG001|STARTED|Safety Follow-up||3
8751904|NCT01175213|9800845|FG000|COMPLETED|Safety Follow-up||47
8751905|NCT01175213|9800846|FG001|COMPLETED|Safety Follow-up||3
8751906|NCT01175213|9800845|FG000|NOT COMPLETED|Safety Follow-up||1
8751907|NCT01175213|9800846|FG001|NOT COMPLETED|Safety Follow-up||0
8751908|NCT01175226|9800857|FG000|STARTED|Overall Study||155
8751909|NCT01175226|9800858|FG001|STARTED|Overall Study||145
8751910|NCT01175226|9800857|FG000|COMPLETED|Overall Study||144
8751911|NCT01175226|9800858|FG001|COMPLETED|Overall Study||140
8751912|NCT01175226|9800857|FG000|NOT COMPLETED|Overall Study||11
8751913|NCT01175226|9800858|FG001|NOT COMPLETED|Overall Study||5
8751914|NCT01175317|9800866|FG000|STARTED|Overall Study||27
8751915|NCT01175317|9800867|FG001|STARTED|Overall Study||31
8751916|NCT01175317|9800866|FG000|COMPLETED|Overall Study||27
8751917|NCT01175317|9800867|FG001|COMPLETED|Overall Study||31
8751918|NCT01175317|9800866|FG000|NOT COMPLETED|Overall Study||0
8751919|NCT01175317|9800867|FG001|NOT COMPLETED|Overall Study||0
8807904|NCT01487954|9860242|FG001|Safety lead-in|Overall Study|Only the first 10 patients in the alkaline group were analyzed, as that was the experimental group.|0
8807905|NCT01487954|9860241|FG000|COMPLETED|Overall Study||29
8807906|NCT01487954|9860242|FG001|COMPLETED|Overall Study||16
8807907|NCT01487954|9860241|FG000|NOT COMPLETED|Overall Study||0
8807908|NCT01487954|9860242|FG001|NOT COMPLETED|Overall Study||0
8807909|NCT01488019|9860250|FG000|STARTED|Overall Study||541
8807910|NCT01488019|9860251|FG001|STARTED|Overall Study||530
8807911|NCT01488019|9860250|FG000|COMPLETED|Overall Study||294
8807912|NCT01488019|9860251|FG001|COMPLETED|Overall Study||226
8807913|NCT01488019|9860250|FG000|NOT COMPLETED|Overall Study||247
8807914|NCT01488019|9860251|FG001|NOT COMPLETED|Overall Study||304
8914846|NCT02171195|9974407|FG000|STARTED|Overall Study||16
8914847|NCT02171195|9974408|FG001|STARTED|Overall Study||6
8807915|NCT01488071|9860261|FG000|STARTED|Overall Study|all-patients-treated set (APTS)|253
8807916|NCT01488071|9860262|FG001|STARTED|Overall Study|APTS|242
8807917|NCT01488071|9860261|FG000|COMPLETED|Overall Study||200
8807918|NCT01488071|9860262|FG001|COMPLETED|Overall Study||179
8751920|NCT01175343|9800873|FG000|STARTED|Overall Study||44
8751921|NCT01175343|9800873|FG000|COMPLETED|Overall Study||44
8751922|NCT01175343|9800873|FG000|NOT COMPLETED|Overall Study||0
8751923|NCT01175369|9800879|FG000|STARTED|Overall Study||265
8751924|NCT01175369|9800880|FG001|STARTED|Overall Study||265
8751925|NCT01175369|9800879|FG000|COMPLETED|Overall Study||263
8751926|NCT01175369|9800880|FG001|COMPLETED|Overall Study||260
8751927|NCT01175369|9800879|FG000|NOT COMPLETED|Overall Study||2
8751928|NCT01175369|9800880|FG001|NOT COMPLETED|Overall Study||5
8751929|NCT01175382|9800889|FG000|STARTED|Overall Study||71
8751930|NCT01175382|9800890|FG001|STARTED|Overall Study||68
8751931|NCT01175382|9800891|FG002|STARTED|Overall Study||65
8751932|NCT01175382|9800889|FG000|COMPLETED|Overall Study||63
8751933|NCT01175382|9800890|FG001|COMPLETED|Overall Study||61
8751934|NCT01175382|9800891|FG002|COMPLETED|Overall Study||59
8751935|NCT01175382|9800889|FG000|NOT COMPLETED|Overall Study||8
8751936|NCT01175382|9800890|FG001|NOT COMPLETED|Overall Study||7
8751937|NCT01175382|9800891|FG002|NOT COMPLETED|Overall Study||6
8751938|NCT01175395|9800899|FG000|STARTED|Overall Study||10
8751939|NCT01175395|9800899|FG000|COMPLETED|Overall Study||10
8751940|NCT01175395|9800899|FG000|NOT COMPLETED|Overall Study||0
8751941|NCT01175434|9800905|FG000|STARTED|Overall Study||48
8751942|NCT01175434|9800906|FG001|STARTED|Overall Study||51
8751943|NCT01175434|9800905|FG000|COMPLETED|Overall Study||48
8751944|NCT01175434|9800906|FG001|COMPLETED|Overall Study||51
8751945|NCT01175434|9800905|FG000|NOT COMPLETED|Overall Study||0
8751946|NCT01175434|9800906|FG001|NOT COMPLETED|Overall Study||0
8751947|NCT01175473|9800914|FG000|STARTED|Overall Study|Randomized and treated.|77
8751948|NCT01175473|9800915|FG001|STARTED|Overall Study||71
8751949|NCT01175473|9800914|FG000|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|77
8751950|NCT01175473|9800915|FG001|Safety Population|Overall Study||71
8751951|NCT01175473|9800914|FG000|Pharmacodynamic (PD) Population|Overall Study|All patients who received at least 1 dose; had baseline and at least 1 post-baseline PD assessment.|75
8751952|NCT01175473|9800915|FG001|Pharmacodynamic (PD) Population|Overall Study||68
8751953|NCT01175473|9800914|FG000|COMPLETED|Overall Study||75
8751954|NCT01175473|9800915|FG001|COMPLETED|Overall Study||69
8751955|NCT01175473|9800914|FG000|NOT COMPLETED|Overall Study||2
8751956|NCT01175473|9800915|FG001|NOT COMPLETED|Overall Study||2
8751957|NCT01175590|9800923|FG000|STARTED|Overall Study||347
8751958|NCT01175590|9800924|FG001|STARTED|Overall Study||171
8751959|NCT01175590|9800923|FG000|Modified Intent to Treat Population|Overall Study||212
8751960|NCT01175590|9800924|FG001|Modified Intent to Treat Population|Overall Study||87
8751961|NCT01175590|9800923|FG000|Safety Population|Overall Study||344
8751962|NCT01175590|9800924|FG001|Safety Population|Overall Study||170
8751963|NCT01175590|9800923|FG000|COMPLETED|Overall Study||335
8751964|NCT01175590|9800924|FG001|COMPLETED|Overall Study||161
8751965|NCT01175590|9800923|FG000|NOT COMPLETED|Overall Study||12
8751966|NCT01175590|9800924|FG001|NOT COMPLETED|Overall Study||10
8751967|NCT01175668|9800933|FG000|STARTED|Overall Study||34
8751968|NCT01175668|9800934|FG001|STARTED|Overall Study||34
8751969|NCT01175668|9800933|FG000|COMPLETED|Overall Study||32
8751970|NCT01175668|9800934|FG001|COMPLETED|Overall Study||34
8751971|NCT01175668|9800933|FG000|NOT COMPLETED|Overall Study||2
8751972|NCT01175668|9800934|FG001|NOT COMPLETED|Overall Study||0
8751973|NCT01175707|9800942|FG000|STARTED|Overall Study||40
8751974|NCT01175707|9800943|FG001|STARTED|Overall Study||40
8751975|NCT01175707|9800942|FG000|COMPLETED|Overall Study||36
8751976|NCT01175707|9800943|FG001|COMPLETED|Overall Study||34
8751977|NCT01175707|9800942|FG000|NOT COMPLETED|Overall Study||4
8751978|NCT01175707|9800943|FG001|NOT COMPLETED|Overall Study||6
8751979|NCT01175798|9800952|FG000|STARTED|Overall Study||34
8751980|NCT01175798|9800953|FG001|STARTED|Overall Study||62
8751981|NCT01175798|9800952|FG000|COMPLETED|Overall Study||27
8751982|NCT01175798|9800953|FG001|COMPLETED|Overall Study||41
8751983|NCT01175798|9800952|FG000|NOT COMPLETED|Overall Study||7
8751984|NCT01175798|9800953|FG001|NOT COMPLETED|Overall Study||21
8751985|NCT01175811|9800961|FG000|STARTED|Overall Study||199
8751986|NCT01175811|9800962|FG001|STARTED|Overall Study||203
8751987|NCT01175811|9800961|FG000|Received at Least 1 Dose of Study Drug|Overall Study||197
8751988|NCT01175811|9800962|FG001|Received at Least 1 Dose of Study Drug|Overall Study||202
8751989|NCT01175811|9800961|FG000|COMPLETED|Overall Study||183
8751990|NCT01175811|9800962|FG001|COMPLETED|Overall Study||189
8751991|NCT01175811|9800961|FG000|NOT COMPLETED|Overall Study||16
8751992|NCT01175811|9800962|FG001|NOT COMPLETED|Overall Study||14
8751993|NCT01175824|9800970|FG000|STARTED|Overall Study||236
8751994|NCT01175824|9800971|FG001|STARTED|Overall Study||242
8751995|NCT01175824|9800970|FG000|Received at Least 1 Dose of Study Drug|Overall Study||236
8751996|NCT01175824|9800971|FG001|Received at Least 1 Dose of Study Drug|Overall Study||240
8751997|NCT01175824|9800970|FG000|COMPLETED|Overall Study||220
8751998|NCT01175824|9800971|FG001|COMPLETED|Overall Study||220
8751999|NCT01175824|9800970|FG000|NOT COMPLETED|Overall Study||16
8752000|NCT01175824|9800971|FG001|NOT COMPLETED|Overall Study||22
8752001|NCT01175850|9800979|FG000|STARTED|IN.PACT SFA I Phase||99
8752002|NCT01175850|9800980|FG001|STARTED|IN.PACT SFA I Phase||51
8752003|NCT01175850|9800979|FG000|COMPLETED|IN.PACT SFA I Phase||88
8752004|NCT01175850|9800980|FG001|COMPLETED|IN.PACT SFA I Phase||49
8752005|NCT01175850|9800979|FG000|NOT COMPLETED|IN.PACT SFA I Phase||11
8752006|NCT01175850|9800980|FG001|NOT COMPLETED|IN.PACT SFA I Phase||2
8752007|NCT01175850|9800979|FG000|STARTED|IN.PACT SFA II Phase||121
8752008|NCT01175850|9800980|FG001|STARTED|IN.PACT SFA II Phase||60
8752009|NCT01175850|9800979|FG000|COMPLETED|IN.PACT SFA II Phase||109
8752010|NCT01175850|9800980|FG001|COMPLETED|IN.PACT SFA II Phase||55
8752011|NCT01175850|9800979|FG000|NOT COMPLETED|IN.PACT SFA II Phase||12
8752012|NCT01175850|9800980|FG001|NOT COMPLETED|IN.PACT SFA II Phase||5
8752013|NCT01175902|9800989|FG000|STARTED|Overall Study||22
8752014|NCT01175902|9800990|FG001|STARTED|Overall Study||22
8752015|NCT01175902|9800989|FG000|COMPLETED|Overall Study||22
8752016|NCT01175902|9800990|FG001|COMPLETED|Overall Study||22
8752017|NCT01175902|9800989|FG000|NOT COMPLETED|Overall Study||0
8752018|NCT01175902|9800990|FG001|NOT COMPLETED|Overall Study||0
8752019|NCT01175980|9800998|FG000|STARTED|Overall Study||30
8752020|NCT01175980|9800998|FG000|COMPLETED|Overall Study||30
8752021|NCT01175980|9800998|FG000|NOT COMPLETED|Overall Study||0
8752022|NCT01176032|9801004|FG000|STARTED|Overall Study|"Started indicates randomized and safety population"|37
8752023|NCT01176032|9801005|FG001|STARTED|Overall Study||37
8752024|NCT01176032|9801004|FG000|Intention-to-treat (ITT) Population|Overall Study||32
8752025|NCT01176032|9801005|FG001|Intention-to-treat (ITT) Population|Overall Study||37
8752026|NCT01176032|9801004|FG000|COMPLETED|Overall Study||31
8752027|NCT01176032|9801005|FG001|COMPLETED|Overall Study||36
8752028|NCT01176032|9801004|FG000|NOT COMPLETED|Overall Study||6
8752029|NCT01176032|9801005|FG001|NOT COMPLETED|Overall Study||1
8752030|NCT01176058|9801018|FG000|STARTED|Overall Study||9
8752031|NCT01176058|9801019|FG001|STARTED|Overall Study||8
8752032|NCT01176058|9801018|FG000|COMPLETED|Overall Study||5
8752033|NCT01176058|9801019|FG001|COMPLETED|Overall Study||5
8752034|NCT01176058|9801018|FG000|NOT COMPLETED|Overall Study||4
8752035|NCT01176058|9801019|FG001|NOT COMPLETED|Overall Study||3
8752036|NCT01176240|9801029|FG000|STARTED|Study 306A||24
8752037|NCT01176240|9801030|FG001|STARTED|Study 306A||27
8752038|NCT01176240|9801029|FG000|COMPLETED|Study 306A||21
8752039|NCT01176240|9801030|FG001|COMPLETED|Study 306A||24
8752040|NCT01176240|9801029|FG000|NOT COMPLETED|Study 306A||3
8752041|NCT01176240|9801030|FG001|NOT COMPLETED|Study 306A||3
8752042|NCT01176240|9801029|FG000|STARTED|Study 306B||89
8752043|NCT01176240|9801030|FG001|STARTED|Study 306B||85
8752044|NCT01176240|9801029|FG000|Took at Least 1 Dose of Study Drug|Study 306B|Two randomized patients discontinued before receiving study drug.|87
8752045|NCT01176240|9801030|FG001|Took at Least 1 Dose of Study Drug|Study 306B|One randomized patient discontinued before receiving study drug.|84
8752046|NCT01176240|9801029|FG000|1 wk of Stable Dosing and Visit 4|Study 306B||69
8752047|NCT01176240|9801030|FG001|1 wk of Stable Dosing and Visit 4|Study 306B||78
8752048|NCT01176240|9801029|FG000|2 wk of Stable Dosing and Visit 5|Study 306B||68
8752049|NCT01176240|9801030|FG001|2 wk of Stable Dosing and Visit 5|Study 306B||75
8752050|NCT01176240|9801029|FG000|4 wk of Stable Dosing and Visit 6|Study 306B||67
8752051|NCT01176240|9801030|FG001|4 wk of Stable Dosing and Visit 6|Study 306B||73
8752052|NCT01176240|9801029|FG000|COMPLETED|Study 306B||63
8752053|NCT01176240|9801030|FG001|COMPLETED|Study 306B||68
8752054|NCT01176240|9801029|FG000|NOT COMPLETED|Study 306B||26
8752055|NCT01176240|9801030|FG001|NOT COMPLETED|Study 306B||17
8752056|NCT01176266|9801036|FG000|STARTED|Overall Study||69
8752057|NCT01176266|9801036|FG000|COMPLETED|Overall Study||60
8752058|NCT01176266|9801036|FG000|NOT COMPLETED|Overall Study||9
8752059|NCT01176292|9801046|FG000|STARTED|Overall Study||71
8752060|NCT01176292|9801047|FG001|STARTED|Overall Study||71
8752061|NCT01176292|9801046|FG000|COMPLETED|Overall Study||66
8752062|NCT01176292|9801047|FG001|COMPLETED|Overall Study||62
8752063|NCT01176292|9801046|FG000|NOT COMPLETED|Overall Study||5
8752064|NCT01176292|9801047|FG001|NOT COMPLETED|Overall Study||9
8752065|NCT01176435|9801056|FG000|STARTED|Overall Study||15
8752066|NCT01176435|9801057|FG001|STARTED|Overall Study||15
8752067|NCT01176435|9801058|FG002|STARTED|Overall Study||15
8752068|NCT01176435|9801056|FG000|COMPLETED|Overall Study||15
8752069|NCT01176435|9801057|FG001|COMPLETED|Overall Study||15
8752070|NCT01176435|9801058|FG002|COMPLETED|Overall Study||15
8752071|NCT01176435|9801056|FG000|NOT COMPLETED|Overall Study||0
8752072|NCT01176435|9801057|FG001|NOT COMPLETED|Overall Study||0
8752073|NCT01176435|9801058|FG002|NOT COMPLETED|Overall Study||0
8752074|NCT01176448|9801066|FG000|STARTED|Overall Study||6
8752075|NCT01176448|9801066|FG000|COMPLETED|Overall Study||6
8752076|NCT01176448|9801066|FG000|NOT COMPLETED|Overall Study||0
8752077|NCT01176565|9801076|FG000|STARTED|Overall Study||500
8752078|NCT01176565|9801077|FG001|STARTED|Overall Study||500
8752079|NCT01176565|9801076|FG000|COMPLETED|Overall Study||480
8752080|NCT01176565|9801077|FG001|COMPLETED|Overall Study||481
8752081|NCT01176565|9801076|FG000|NOT COMPLETED|Overall Study||20
8752082|NCT01176565|9801077|FG001|NOT COMPLETED|Overall Study||19
8752083|NCT01176591|9801085|FG000|STARTED|Session 1||10
8752084|NCT01176591|9801086|FG001|STARTED|Session 1||3
8752085|NCT01176591|9801085|FG000|COMPLETED|Session 1||10
8752086|NCT01176591|9801086|FG001|COMPLETED|Session 1||3
8752087|NCT01176591|9801085|FG000|NOT COMPLETED|Session 1||0
8752088|NCT01176591|9801086|FG001|NOT COMPLETED|Session 1||0
8752089|NCT01176591|9801085|FG000|STARTED|Session 2||10
8752090|NCT01176591|9801086|FG001|STARTED|Session 2||3
8752091|NCT01176591|9801085|FG000|COMPLETED|Session 2||10
8752092|NCT01176591|9801086|FG001|COMPLETED|Session 2||3
8752093|NCT01176591|9801085|FG000|NOT COMPLETED|Session 2||0
8752094|NCT01176591|9801086|FG001|NOT COMPLETED|Session 2||0
8752095|NCT01176617|9801096|FG000|STARTED|1 - 6 Months (Ron-randomized)||0
8752096|NCT01176617|9801097|FG001|STARTED|1 - 6 Months (Ron-randomized)||0
8752097|NCT01176617|9801098|FG002|STARTED|1 - 6 Months (Ron-randomized)||38
8752098|NCT01176617|9801096|FG000|COMPLETED|1 - 6 Months (Ron-randomized)||0
8752099|NCT01176617|9801097|FG001|COMPLETED|1 - 6 Months (Ron-randomized)||0
8752100|NCT01176617|9801098|FG002|COMPLETED|1 - 6 Months (Ron-randomized)||38
8752101|NCT01176617|9801096|FG000|NOT COMPLETED|1 - 6 Months (Ron-randomized)||0
8752102|NCT01176617|9801097|FG001|NOT COMPLETED|1 - 6 Months (Ron-randomized)||0
8752103|NCT01176617|9801098|FG002|NOT COMPLETED|1 - 6 Months (Ron-randomized)||0
8752104|NCT01176617|9801096|FG000|STARTED|6 - 12 Months (Randomized)||18
8752105|NCT01176617|9801097|FG001|STARTED|6 - 12 Months (Randomized)||20
8752106|NCT01176617|9801098|FG002|STARTED|6 - 12 Months (Randomized)||0
8752107|NCT01176617|9801096|FG000|COMPLETED|6 - 12 Months (Randomized)||13
8752108|NCT01176617|9801097|FG001|COMPLETED|6 - 12 Months (Randomized)||20
8752109|NCT01176617|9801098|FG002|COMPLETED|6 - 12 Months (Randomized)||0
8752110|NCT01176617|9801096|FG000|NOT COMPLETED|6 - 12 Months (Randomized)||5
8752111|NCT01176617|9801097|FG001|NOT COMPLETED|6 - 12 Months (Randomized)||0
8752112|NCT01176617|9801098|FG002|NOT COMPLETED|6 - 12 Months (Randomized)||0
8752113|NCT01176773|9801106|FG000|STARTED|Overall Study||62
8752114|NCT01176773|9801106|FG000|COMPLETED|Overall Study||59
8752115|NCT01176773|9801106|FG000|NOT COMPLETED|Overall Study||3
8752116|NCT01176877|9801111|FG000|STARTED|Overall Study||40
8752117|NCT01176877|9801111|FG000|COMPLETED|Overall Study||31
8752118|NCT01176877|9801111|FG000|NOT COMPLETED|Overall Study||9
8752119|NCT01176916|9801116|FG000|STARTED|Overall Study||564
8752120|NCT01176916|9801116|FG000|Treated|Overall Study||558
8752121|NCT01176916|9801116|FG000|Assigne But Not Treated|Overall Study||6
8752122|NCT01176916|9801116|FG000|COMPLETED|Overall Study||397
8752123|NCT01176916|9801116|FG000|NOT COMPLETED|Overall Study||167
8752124|NCT01176955|9801122|FG000|STARTED|Overall Study||10
8752125|NCT01176955|9801123|FG001|STARTED|Overall Study||10
8752126|NCT01176955|9801122|FG000|COMPLETED|Overall Study||7
8752127|NCT01176955|9801123|FG001|COMPLETED|Overall Study||8
8752128|NCT01176955|9801122|FG000|NOT COMPLETED|Overall Study||3
8752129|NCT01176955|9801123|FG001|NOT COMPLETED|Overall Study||2
8752130|NCT01176968|9801134|FG000|STARTED|Overall Study||506
8752131|NCT01176968|9801135|FG001|STARTED|Overall Study||506
8752132|NCT01176968|9801134|FG000|Treated|Overall Study||505
8752133|NCT01176968|9801135|FG001|Treated|Overall Study||505
8752134|NCT01176968|9801134|FG000|COMPLETED|Overall Study||422
8752135|NCT01176968|9801135|FG001|COMPLETED|Overall Study||424
8752136|NCT01176968|9801134|FG000|NOT COMPLETED|Overall Study||84
8752137|NCT01176968|9801135|FG001|NOT COMPLETED|Overall Study||82
8752138|NCT01176981|9801141|FG000|STARTED|Overall Study||6
8752139|NCT01176981|9801141|FG000|COMPLETED|Overall Study||6
8752140|NCT01176981|9801141|FG000|NOT COMPLETED|Overall Study||0
8752141|NCT01177007|9801145|FG000|STARTED|Overall Study||50
8752142|NCT01177007|9801145|FG000|Completed First Y90 Treatment|Overall Study||50
8752143|NCT01177007|9801145|FG000|Completed First Clinical and Imaging|Overall Study||43
8752144|NCT01177007|9801145|FG000|COMPLETED|Overall Study||12
8752145|NCT01177007|9801145|FG000|NOT COMPLETED|Overall Study||38
8752146|NCT01177059|9801151|FG000|STARTED|Overall Study||68
8752147|NCT01177059|9801151|FG000|COMPLETED|Overall Study||18
8752148|NCT01177059|9801151|FG000|NOT COMPLETED|Overall Study||50
8752149|NCT01177098|9801157|FG000|STARTED|Overall Study||278
8752150|NCT01177098|9801158|FG001|STARTED|Overall Study||283
8752151|NCT01177098|9801157|FG000|COMPLETED|Overall Study||269
8752152|NCT01177098|9801158|FG001|COMPLETED|Overall Study||271
8752153|NCT01177098|9801157|FG000|NOT COMPLETED|Overall Study||9
8752154|NCT01177098|9801158|FG001|NOT COMPLETED|Overall Study||12
8752155|NCT01177137|9801167|FG000|STARTED|Overall Study||51
8752156|NCT01177137|9801168|FG001|STARTED|Overall Study||51
8752157|NCT01177137|9801169|FG002|STARTED|Overall Study||49
8752158|NCT01177137|9801167|FG000|COMPLETED|Overall Study||41
8752159|NCT01177137|9801168|FG001|COMPLETED|Overall Study||41
8752160|NCT01177137|9801169|FG002|COMPLETED|Overall Study||47
8752161|NCT01177137|9801167|FG000|NOT COMPLETED|Overall Study||10
8752162|NCT01177137|9801168|FG001|NOT COMPLETED|Overall Study||10
8752163|NCT01177137|9801169|FG002|NOT COMPLETED|Overall Study||2
8752164|NCT01177189|9801182|FG000|STARTED|Overall Study||42
8752165|NCT01177189|9801183|FG001|STARTED|Overall Study||45
8752166|NCT01177189|9801182|FG000|COMPLETED|Overall Study||42
8752167|NCT01177189|9801183|FG001|COMPLETED|Overall Study||45
8752168|NCT01177189|9801182|FG000|NOT COMPLETED|Overall Study||0
8752169|NCT01177189|9801183|FG001|NOT COMPLETED|Overall Study||0
8752170|NCT01177228|9801193|FG000|STARTED|Overall Study||9
8752171|NCT01177228|9801194|FG001|STARTED|Overall Study||13
8752172|NCT01177228|9801195|FG002|STARTED|Overall Study||14
8752173|NCT01177228|9801196|FG003|STARTED|Overall Study||11
8752174|NCT01177228|9801193|FG000|Received Treatment|Overall Study||9
8752175|NCT01177228|9801194|FG001|Received Treatment|Overall Study||12
8752176|NCT01177228|9801195|FG002|Received Treatment|Overall Study||14
8752177|NCT01177228|9801196|FG003|Received Treatment|Overall Study||11
8752178|NCT01177228|9801193|FG000|COMPLETED|Overall Study||8
8752179|NCT01177228|9801194|FG001|COMPLETED|Overall Study||11
8752180|NCT01177228|9801195|FG002|COMPLETED|Overall Study||14
8752181|NCT01177228|9801196|FG003|COMPLETED|Overall Study||11
8752182|NCT01177228|9801193|FG000|NOT COMPLETED|Overall Study||1
8752183|NCT01177228|9801194|FG001|NOT COMPLETED|Overall Study||2
8752184|NCT01177228|9801195|FG002|NOT COMPLETED|Overall Study||0
8752185|NCT01177228|9801196|FG003|NOT COMPLETED|Overall Study||0
8752186|NCT01177293|9801211|FG000|STARTED|First Intervention Period||7
8752187|NCT01177293|9801212|FG001|STARTED|First Intervention Period||7
8752188|NCT01177293|9801211|FG000|COMPLETED|First Intervention Period||7
8752189|NCT01177293|9801212|FG001|COMPLETED|First Intervention Period||7
8752190|NCT01177293|9801211|FG000|NOT COMPLETED|First Intervention Period||0
8752191|NCT01177293|9801212|FG001|NOT COMPLETED|First Intervention Period||0
8752192|NCT01177293|9801211|FG000|STARTED|Washout Period (of 14 Days)||7
8752193|NCT01177293|9801212|FG001|STARTED|Washout Period (of 14 Days)||7
8752194|NCT01177293|9801211|FG000|COMPLETED|Washout Period (of 14 Days)||7
8752195|NCT01177293|9801212|FG001|COMPLETED|Washout Period (of 14 Days)||6
8752196|NCT01177293|9801211|FG000|NOT COMPLETED|Washout Period (of 14 Days)||0
8752197|NCT01177293|9801212|FG001|NOT COMPLETED|Washout Period (of 14 Days)||1
8752198|NCT01177293|9801211|FG000|STARTED|Second Intervention Period||7
8752199|NCT01177293|9801212|FG001|STARTED|Second Intervention Period||6
8752200|NCT01177293|9801211|FG000|COMPLETED|Second Intervention Period||7
8752201|NCT01177293|9801212|FG001|COMPLETED|Second Intervention Period||6
8752202|NCT01177293|9801211|FG000|NOT COMPLETED|Second Intervention Period||0
8752203|NCT01177293|9801212|FG001|NOT COMPLETED|Second Intervention Period||0
8752204|NCT01177384|9801220|FG000|STARTED|Overall Study||191
8752205|NCT01177384|9801221|FG001|STARTED|Overall Study|Includes the second randomization of a participant|190
8752206|NCT01177384|9801220|FG000|COMPLETED|Overall Study||177
8752207|NCT01177384|9801221|FG001|COMPLETED|Overall Study||164
8752208|NCT01177384|9801220|FG000|NOT COMPLETED|Overall Study||14
8752209|NCT01177384|9801221|FG001|NOT COMPLETED|Overall Study||26
8752210|NCT01177410|9801230|FG000|STARTED|Overall Study||51
8752211|NCT01177410|9801231|FG001|STARTED|Overall Study||47
8752212|NCT01177410|9801232|FG002|STARTED|Overall Study||50
8752213|NCT01177410|9801230|FG000|COMPLETED|Overall Study||50
8752214|NCT01177410|9801231|FG001|COMPLETED|Overall Study||40
8752215|NCT01177410|9801232|FG002|COMPLETED|Overall Study||45
8752216|NCT01177410|9801230|FG000|NOT COMPLETED|Overall Study||1
8914848|NCT02171195|9974409|FG002|STARTED|Overall Study||6
8914849|NCT02171195|9974410|FG003|STARTED|Overall Study||6
8914850|NCT02171195|9974411|FG004|STARTED|Overall Study||6
8914851|NCT02171195|9974412|FG005|STARTED|Overall Study||6
8914852|NCT02171195|9974413|FG006|STARTED|Overall Study||6
8914853|NCT02171195|9974414|FG007|STARTED|Overall Study||6
8914854|NCT02171195|9974415|FG008|STARTED|Overall Study||6
8914855|NCT02171195|9974407|FG000|COMPLETED|Overall Study||16
8914856|NCT02171195|9974408|FG001|COMPLETED|Overall Study||6
8914857|NCT02171195|9974409|FG002|COMPLETED|Overall Study||6
8914858|NCT02171195|9974410|FG003|COMPLETED|Overall Study||6
8914859|NCT02171195|9974411|FG004|COMPLETED|Overall Study||6
8914860|NCT02171195|9974412|FG005|COMPLETED|Overall Study||6
8914861|NCT02171195|9974413|FG006|COMPLETED|Overall Study||6
8914862|NCT02171195|9974414|FG007|COMPLETED|Overall Study||6
8914863|NCT02171195|9974415|FG008|COMPLETED|Overall Study||6
8914864|NCT02171195|9974407|FG000|NOT COMPLETED|Overall Study||0
8914865|NCT02171195|9974408|FG001|NOT COMPLETED|Overall Study||0
8914866|NCT02171195|9974409|FG002|NOT COMPLETED|Overall Study||0
8914867|NCT02171195|9974410|FG003|NOT COMPLETED|Overall Study||0
8914868|NCT02171195|9974411|FG004|NOT COMPLETED|Overall Study||0
8914869|NCT02171195|9974412|FG005|NOT COMPLETED|Overall Study||0
8914870|NCT02171195|9974413|FG006|NOT COMPLETED|Overall Study||0
8914871|NCT02171195|9974414|FG007|NOT COMPLETED|Overall Study||0
8914872|NCT02171195|9974415|FG008|NOT COMPLETED|Overall Study||0
8914873|NCT02171234|9974440|FG000|STARTED|Overall Study||8
8914874|NCT02171234|9974441|FG001|STARTED|Overall Study||6
8914875|NCT02171234|9974442|FG002|STARTED|Overall Study||6
8914876|NCT02171234|9974443|FG003|STARTED|Overall Study||6
8914877|NCT02171234|9974444|FG004|STARTED|Overall Study||6
8914878|NCT02171234|9974440|FG000|COMPLETED|Overall Study||8
8914879|NCT02171234|9974441|FG001|COMPLETED|Overall Study||6
8914880|NCT02171234|9974442|FG002|COMPLETED|Overall Study||6
8914881|NCT02171234|9974443|FG003|COMPLETED|Overall Study||6
8914882|NCT02171234|9974444|FG004|COMPLETED|Overall Study||6
8914883|NCT02171234|9974440|FG000|NOT COMPLETED|Overall Study||0
8914884|NCT02171234|9974441|FG001|NOT COMPLETED|Overall Study||0
8914885|NCT02171234|9974442|FG002|NOT COMPLETED|Overall Study||0
8914886|NCT02171234|9974443|FG003|NOT COMPLETED|Overall Study||0
8914887|NCT02171234|9974444|FG004|NOT COMPLETED|Overall Study||0
8914888|NCT02171247|9974458|FG000|STARTED|Overall Study||16
8914889|NCT02171247|9974459|FG001|STARTED|Overall Study||17
8914890|NCT02171247|9974458|FG000|COMPLETED|Overall Study||16
8914891|NCT02171247|9974459|FG001|COMPLETED|Overall Study||17
9023470|NCT03136380|10086208|FG001|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
9023471|NCT03136380|10086209|FG002|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
8752217|NCT01177410|9801231|FG001|NOT COMPLETED|Overall Study||7
8752218|NCT01177410|9801232|FG002|NOT COMPLETED|Overall Study||5
8752219|NCT01177553|9801242|FG000|STARTED|Overall Study||3
8752220|NCT01177553|9801243|FG001|STARTED|Overall Study||2
8752221|NCT01177553|9801242|FG000|COMPLETED|Overall Study|data as of March 2009|2
8752222|NCT01177553|9801243|FG001|COMPLETED|Overall Study|data as of March 2009|2
8752223|NCT01177553|9801242|FG000|NOT COMPLETED|Overall Study||1
8914892|NCT02171247|9974458|FG000|NOT COMPLETED|Overall Study||0
8914893|NCT02171247|9974459|FG001|NOT COMPLETED|Overall Study||0
8914894|NCT02171260|9974469|FG000|STARTED|Overall Study||6
8914895|NCT02171260|9974470|FG001|STARTED|Overall Study||6
8914896|NCT02171260|9974471|FG002|STARTED|Overall Study||5
8914897|NCT02171260|9974472|FG003|STARTED|Overall Study||5
8752224|NCT01177553|9801243|FG001|NOT COMPLETED|Overall Study||0
8752225|NCT01177670|9801249|FG000|STARTED|Overall Study||169
8752226|NCT01177670|9801249|FG000|COMPLETED|Overall Study||0
8752227|NCT01177670|9801249|FG000|NOT COMPLETED|Overall Study||169
8752228|NCT01177709|9801253|FG000|STARTED|Overall Study||12
8752229|NCT01177709|9801253|FG000|COMPLETED|Overall Study||12
8752230|NCT01177709|9801253|FG000|NOT COMPLETED|Overall Study||0
8752231|NCT01177722|9801261|FG000|STARTED|Overall Study|A Batch B participant got Batch A vaccine data analyses was according to actual vaccine administered|344
8752232|NCT01177722|9801262|FG001|STARTED|Overall Study|A randomized participant got Batch A vaccine, analyses was according to actual vaccine administered.|344
8752233|NCT01177722|9801263|FG002|STARTED|Overall Study||342
8752234|NCT01177722|9801264|FG003|STARTED|Overall Study||345
8752235|NCT01177722|9801261|FG000|COMPLETED|Overall Study||331
8752236|NCT01177722|9801262|FG001|COMPLETED|Overall Study||334
8752237|NCT01177722|9801263|FG002|COMPLETED|Overall Study||333
8752238|NCT01177722|9801264|FG003|COMPLETED|Overall Study||338
8752239|NCT01177722|9801261|FG000|NOT COMPLETED|Overall Study||13
8752240|NCT01177722|9801262|FG001|NOT COMPLETED|Overall Study||10
8752241|NCT01177722|9801263|FG002|NOT COMPLETED|Overall Study||9
8752242|NCT01177722|9801264|FG003|NOT COMPLETED|Overall Study||7
8752243|NCT01177735|9801275|FG000|STARTED|Overall Study||71
8752244|NCT01177735|9801275|FG000|COMPLETED|Overall Study||0
8752245|NCT01177735|9801275|FG000|NOT COMPLETED|Overall Study||71
8752246|NCT01177787|9801279|FG000|STARTED|Clinical Efficacy of Cryolipolysis||28
8752247|NCT01177787|9801279|FG000|COMPLETED|Clinical Efficacy of Cryolipolysis||28
8752248|NCT01177787|9801279|FG000|NOT COMPLETED|Clinical Efficacy of Cryolipolysis||0
8752249|NCT01177787|9801279|FG000|STARTED|Cryolipolysis on Thigh||28
8752250|NCT01177787|9801279|FG000|COMPLETED|Cryolipolysis on Thigh||14
8752251|NCT01177787|9801279|FG000|NOT COMPLETED|Cryolipolysis on Thigh||14
8752252|NCT01177800|9801293|FG000|STARTED|Overall Study||84
8752253|NCT01177800|9801294|FG001|STARTED|Overall Study||45
8752254|NCT01177800|9801293|FG000|COMPLETED|Overall Study||74
8752255|NCT01177800|9801294|FG001|COMPLETED|Overall Study||40
8752256|NCT01177800|9801293|FG000|NOT COMPLETED|Overall Study||10
8752257|NCT01177800|9801294|FG001|NOT COMPLETED|Overall Study||5
8752258|NCT01177813|9801305|FG000|STARTED|Overall Study||228
8752259|NCT01177813|9801306|FG001|STARTED|Overall Study||224
8752260|NCT01177813|9801307|FG002|STARTED|Overall Study||224
8752261|NCT01177813|9801308|FG003|STARTED|Overall Study||223
8752262|NCT01177813|9801309|FG004|STARTED|Overall Study||87
8752263|NCT01177813|9801305|FG000|COMPLETED|Overall Study||187
8752264|NCT01177813|9801306|FG001|COMPLETED|Overall Study||206
8752265|NCT01177813|9801307|FG002|COMPLETED|Overall Study||204
8752266|NCT01177813|9801308|FG003|COMPLETED|Overall Study||206
8752267|NCT01177813|9801309|FG004|COMPLETED|Overall Study||78
8752268|NCT01177813|9801305|FG000|NOT COMPLETED|Overall Study||41
9023472|NCT03136380|10086210|FG003|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
9023473|NCT03136380|10086211|FG004|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
9023474|NCT03136380|10086207|FG000|STARTED|Part 2, Period 2 (3 Days)||0
9023475|NCT03136380|10086208|FG001|STARTED|Part 2, Period 2 (3 Days)||0
9023476|NCT03136380|10086209|FG002|STARTED|Part 2, Period 2 (3 Days)||0
9023477|NCT03136380|10086210|FG003|STARTED|Part 2, Period 2 (3 Days)||8
9023478|NCT03136380|10086211|FG004|STARTED|Part 2, Period 2 (3 Days)||8
9023479|NCT03136380|10086207|FG000|COMPLETED|Part 2, Period 2 (3 Days)||0
9023480|NCT03136380|10086208|FG001|COMPLETED|Part 2, Period 2 (3 Days)||0
9023481|NCT03136380|10086209|FG002|COMPLETED|Part 2, Period 2 (3 Days)||0
9023482|NCT03136380|10086210|FG003|COMPLETED|Part 2, Period 2 (3 Days)||8
9023483|NCT03136380|10086211|FG004|COMPLETED|Part 2, Period 2 (3 Days)||8
9023484|NCT03136380|10086207|FG000|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
9023485|NCT03136380|10086208|FG001|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
9023486|NCT03136380|10086209|FG002|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
9023487|NCT03136380|10086210|FG003|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
9023488|NCT03136380|10086211|FG004|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
9023489|NCT03136484|10086231|FG000|STARTED|Overall Study||394
9023490|NCT03136484|10086232|FG001|STARTED|Overall Study||394
9023491|NCT03136484|10086231|FG000|Exposed|Overall Study||392
9023492|NCT03136484|10086232|FG001|Exposed|Overall Study||394
9023493|NCT03136484|10086231|FG000|COMPLETED|Overall Study||367
9023494|NCT03136484|10086232|FG001|COMPLETED|Overall Study||372
9023495|NCT03136484|10086231|FG000|NOT COMPLETED|Overall Study||27
9023496|NCT03136484|10086232|FG001|NOT COMPLETED|Overall Study||22
9023497|NCT03136861|10086245|FG000|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||285
9023498|NCT03136861|10086246|FG001|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||95
9023499|NCT03136861|10086247|FG002|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
9023500|NCT03136861|10086248|FG003|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
8577609|NCT00159874|9610371|FG004|Treated|Overall Study||19
8752269|NCT01177813|9801306|FG001|NOT COMPLETED|Overall Study||18
8752270|NCT01177813|9801307|FG002|NOT COMPLETED|Overall Study||20
8752271|NCT01177813|9801308|FG003|NOT COMPLETED|Overall Study||17
8752272|NCT01177813|9801309|FG004|NOT COMPLETED|Overall Study||9
8752273|NCT01177943|9801323|FG000|STARTED|First Intervention||21
8752274|NCT01177943|9801324|FG001|STARTED|First Intervention||21
9023501|NCT03136861|10086249|FG004|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
9023502|NCT03136861|10086250|FG005|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
9023503|NCT03136861|10086251|FG006|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
9023504|NCT03136861|10086245|FG000|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||278
9039981|NCT03345108|10100891|FG002|STARTED|Period-2||8
8752275|NCT01177943|9801323|FG000|COMPLETED|First Intervention||19
8752276|NCT01177943|9801324|FG001|COMPLETED|First Intervention||21
8752277|NCT01177943|9801323|FG000|NOT COMPLETED|First Intervention||2
8752278|NCT01177943|9801324|FG001|NOT COMPLETED|First Intervention||0
8752279|NCT01177943|9801323|FG000|STARTED|Second Intervention||19
8752280|NCT01177943|9801324|FG001|STARTED|Second Intervention||21
8752281|NCT01177943|9801323|FG000|COMPLETED|Second Intervention||19
8752282|NCT01177943|9801324|FG001|COMPLETED|Second Intervention||21
8752283|NCT01177943|9801323|FG000|NOT COMPLETED|Second Intervention||0
8752284|NCT01177943|9801324|FG001|NOT COMPLETED|Second Intervention||0
8752285|NCT01177956|9801330|FG000|STARTED|Overall Study||68
8752286|NCT01177956|9801330|FG000|COMPLETED|Overall Study||68
8752287|NCT01177956|9801330|FG000|NOT COMPLETED|Overall Study||0
8752288|NCT01177969|9801337|FG000|STARTED|Overall Study||19
8752289|NCT01177969|9801338|FG001|STARTED|Overall Study||14
8752290|NCT01177969|9801337|FG000|COMPLETED|Overall Study||16
8752291|NCT01177969|9801338|FG001|COMPLETED|Overall Study||11
8752292|NCT01177969|9801337|FG000|NOT COMPLETED|Overall Study||3
8752293|NCT01177969|9801338|FG001|NOT COMPLETED|Overall Study||3
8752294|NCT01178073|9801347|FG000|STARTED|Overall Study||302
8752295|NCT01178073|9801348|FG001|STARTED|Overall Study||152
8752296|NCT01178073|9801349|FG002|STARTED|Overall Study||151
8752297|NCT01178073|9801347|FG000|COMPLETED|Overall Study||240
9023505|NCT03136861|10086246|FG001|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||89
9023506|NCT03136861|10086247|FG002|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
9023507|NCT03136861|10086248|FG003|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
9023508|NCT03136861|10086249|FG004|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
9023509|NCT03136861|10086250|FG005|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
9023510|NCT03136861|10086251|FG006|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
9023511|NCT03136861|10086245|FG000|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||7
9023512|NCT03136861|10086246|FG001|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||6
9023513|NCT03136861|10086247|FG002|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
9023514|NCT03136861|10086248|FG003|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
9023515|NCT03136861|10086249|FG004|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
9023516|NCT03136861|10086250|FG005|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
9023517|NCT03136861|10086251|FG006|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
9023518|NCT03136861|10086245|FG000|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
9023519|NCT03136861|10086246|FG001|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
9023520|NCT03136861|10086247|FG002|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||90
9023521|NCT03136861|10086248|FG003|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||94
9023522|NCT03136861|10086249|FG004|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||94
9023523|NCT03136861|10086250|FG005|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||45
9023524|NCT03136861|10086251|FG006|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||44
9023525|NCT03136861|10086245|FG000|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
9023526|NCT03136861|10086246|FG001|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
9023527|NCT03136861|10086247|FG002|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||88
9023528|NCT03136861|10086248|FG003|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||93
9023529|NCT03136861|10086249|FG004|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||92
9023530|NCT03136861|10086250|FG005|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||45
9023531|NCT03136861|10086251|FG006|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||43
9023532|NCT03136861|10086245|FG000|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
9023533|NCT03136861|10086246|FG001|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
9023534|NCT03136861|10086247|FG002|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||2
9023535|NCT03136861|10086248|FG003|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||1
9023536|NCT03136861|10086249|FG004|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||2
9023537|NCT03136861|10086250|FG005|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
9023538|NCT03136861|10086251|FG006|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||1
9023539|NCT03136913|10086262|FG000|STARTED|Overall Study||13
9023540|NCT03136913|10086262|FG000|Subjects Received Both Intervention|Overall Study|10 subjects with 10 OFT and 10 CFT sites received clinical measurement before implant surgery|10
9023541|NCT03136913|10086262|FG000|COMPLETED|Overall Study|8 subjects with 8 OFT and 8 CFT sites received implant surgery|8
9023542|NCT03136913|10086262|FG000|NOT COMPLETED|Overall Study||5
9023543|NCT03137069|10086275|FG000|STARTED|Overall Study||13
9023544|NCT03137069|10086276|FG001|STARTED|Overall Study||28
9023545|NCT03137069|10086277|FG002|STARTED|Overall Study||23
9023546|NCT03137069|10086278|FG003|STARTED|Overall Study||23
9023547|NCT03137069|10086279|FG004|STARTED|Overall Study||24
9023548|NCT03137069|10086280|FG005|STARTED|Overall Study||23
9023549|NCT03137069|10086275|FG000|COMPLETED|Overall Study||12
9023550|NCT03137069|10086276|FG001|COMPLETED|Overall Study||22
9023551|NCT03137069|10086277|FG002|COMPLETED|Overall Study||20
9023552|NCT03137069|10086278|FG003|COMPLETED|Overall Study||17
9023553|NCT03137069|10086279|FG004|COMPLETED|Overall Study||22
9023554|NCT03137069|10086280|FG005|COMPLETED|Overall Study||21
9023555|NCT03137069|10086275|FG000|NOT COMPLETED|Overall Study||1
9023556|NCT03137069|10086276|FG001|NOT COMPLETED|Overall Study||6
9023557|NCT03137069|10086277|FG002|NOT COMPLETED|Overall Study||3
9023558|NCT03137069|10086278|FG003|NOT COMPLETED|Overall Study||6
9023559|NCT03137069|10086279|FG004|NOT COMPLETED|Overall Study||2
9023560|NCT03137069|10086280|FG005|NOT COMPLETED|Overall Study||2
8752298|NCT01178073|9801348|FG001|COMPLETED|Overall Study||108
8752299|NCT01178073|9801349|FG002|COMPLETED|Overall Study||105
8752300|NCT01178073|9801347|FG000|NOT COMPLETED|Overall Study||62
8752301|NCT01178073|9801348|FG001|NOT COMPLETED|Overall Study||44
8752302|NCT01178073|9801349|FG002|NOT COMPLETED|Overall Study||46
8752303|NCT01178086|9801360|FG000|STARTED|Overall Study|Safety analysis set: participants who received at least one dose of rituximab.|681
8752304|NCT01178086|9801360|FG000|Effectiveness Analysis Set (EAS)|Overall Study|who received at least 1 dose of rituximab and had data from baseline and at least 1 follow-up visit.|661
8752305|NCT01178086|9801360|FG000|COMPLETED|Overall Study||349
8752306|NCT01178086|9801360|FG000|NOT COMPLETED|Overall Study||332
8752307|NCT01178099|9801370|FG000|STARTED|Overall Study||13
8752308|NCT01178099|9801371|FG001|STARTED|Overall Study||13
8752309|NCT01178099|9801370|FG000|COMPLETED|Overall Study||13
8752310|NCT01178099|9801371|FG001|COMPLETED|Overall Study||12
8752311|NCT01178099|9801370|FG000|NOT COMPLETED|Overall Study||0
8752312|NCT01178099|9801371|FG001|NOT COMPLETED|Overall Study||1
8752313|NCT01178125|9801381|FG000|STARTED|Overall Study|Number enrolled.|2858
8752314|NCT01178125|9801381|FG000|Safety Population|Overall Study|Received at least 1 dose of DR-102.|2765
8752315|NCT01178125|9801381|FG000|Intent to Treat (ITT) Population|Overall Study|Completed at least one 28-day cycle of investigational product.|2607
8752316|NCT01178125|9801381|FG000|Pregnancy ITT (PITT) Population|Overall Study|Participants in the ITT population between the ages of 18 and 35, inclusive.|2401
8752317|NCT01178125|9801381|FG000|COMPLETED|Overall Study||1680
8752318|NCT01178125|9801381|FG000|NOT COMPLETED|Overall Study||1178
8752319|NCT01178138|9801390|FG000|STARTED|Overall Study||24
8752320|NCT01178138|9801390|FG000|Completed 6 Sessions|Overall Study||1
8752321|NCT01178138|9801390|FG000|Completed 5 Sessions|Overall Study||1
8752322|NCT01178138|9801390|FG000|Completed 3 Sessions|Overall Study||1
8752323|NCT01178138|9801390|FG000|COMPLETED|Overall Study||1
8752324|NCT01178138|9801390|FG000|NOT COMPLETED|Overall Study||23
8752325|NCT01178216|9801399|FG000|STARTED|Overall Study||41
8752326|NCT01178216|9801399|FG000|COMPLETED|Overall Study||39
8752327|NCT01178216|9801399|FG000|NOT COMPLETED|Overall Study||2
8752328|NCT01178268|9801405|FG000|STARTED|Overall Study||367
8752329|NCT01178268|9801406|FG001|STARTED|Overall Study||121
8752330|NCT01178268|9801405|FG000|COMPLETED|Overall Study||360
9023561|NCT03137121|10086300|FG000|STARTED|Overall Study||15
9023562|NCT03137121|10086301|FG001|STARTED|Overall Study||15
9023563|NCT03137121|10086300|FG000|COMPLETED|Overall Study||15
9023564|NCT03137121|10086301|FG001|COMPLETED|Overall Study||14
9023565|NCT03137121|10086300|FG000|NOT COMPLETED|Overall Study||0
9023566|NCT03137121|10086301|FG001|NOT COMPLETED|Overall Study||1
9023567|NCT03137303|10086309|FG000|STARTED|T0: Time of Enrollment - Baseline Visit||231
9023568|NCT03137303|10086310|FG001|STARTED|T0: Time of Enrollment - Baseline Visit||171
9023569|NCT03137303|10086309|FG000|COMPLETED|T0: Time of Enrollment - Baseline Visit||231
9023570|NCT03137303|10086310|FG001|COMPLETED|T0: Time of Enrollment - Baseline Visit||171
9023571|NCT03137303|10086309|FG000|NOT COMPLETED|T0: Time of Enrollment - Baseline Visit||0
9023572|NCT03137303|10086310|FG001|NOT COMPLETED|T0: Time of Enrollment - Baseline Visit||0
9023573|NCT03137303|10086309|FG000|STARTED|T1: 3-month Follow-up||231
9023574|NCT03137303|10086310|FG001|STARTED|T1: 3-month Follow-up||171
9023575|NCT03137303|10086309|FG000|COMPLETED|T1: 3-month Follow-up||225
9023576|NCT03137303|10086310|FG001|COMPLETED|T1: 3-month Follow-up||161
9023577|NCT03137303|10086309|FG000|NOT COMPLETED|T1: 3-month Follow-up||6
9023578|NCT03137303|10086310|FG001|NOT COMPLETED|T1: 3-month Follow-up||10
9023579|NCT03137303|10086309|FG000|STARTED|T2: 6-month Follow-up||230
9023580|NCT03137303|10086310|FG001|STARTED|T2: 6-month Follow-up||167
9023581|NCT03137303|10086309|FG000|COMPLETED|T2: 6-month Follow-up||225
9023582|NCT03137303|10086310|FG001|COMPLETED|T2: 6-month Follow-up||162
9023583|NCT03137303|10086309|FG000|NOT COMPLETED|T2: 6-month Follow-up||5
9023584|NCT03137303|10086310|FG001|NOT COMPLETED|T2: 6-month Follow-up||5
9023585|NCT03137303|10086309|FG000|STARTED|T3: 9-month Follow-up||230
9023586|NCT03137303|10086310|FG001|STARTED|T3: 9-month Follow-up||167
9023587|NCT03137303|10086309|FG000|COMPLETED|T3: 9-month Follow-up||225
9023588|NCT03137303|10086310|FG001|COMPLETED|T3: 9-month Follow-up||163
9023589|NCT03137303|10086309|FG000|NOT COMPLETED|T3: 9-month Follow-up||5
9023590|NCT03137303|10086310|FG001|NOT COMPLETED|T3: 9-month Follow-up||4
9023591|NCT03137303|10086309|FG000|STARTED|T4: 12-month Follow-up||229
9023592|NCT03137303|10086310|FG001|STARTED|T4: 12-month Follow-up||167
9023593|NCT03137303|10086309|FG000|COMPLETED|T4: 12-month Follow-up||222
9023594|NCT03137303|10086310|FG001|COMPLETED|T4: 12-month Follow-up||162
9023595|NCT03137303|10086309|FG000|NOT COMPLETED|T4: 12-month Follow-up||7
9023596|NCT03137303|10086310|FG001|NOT COMPLETED|T4: 12-month Follow-up||5
9023597|NCT03137459|10086318|FG000|STARTED|2-month Assessment||455
9023598|NCT03137459|10086319|FG001|STARTED|2-month Assessment||454
9023599|NCT03137459|10086318|FG000|COMPLETED|2-month Assessment||387
9023600|NCT03137459|10086319|FG001|COMPLETED|2-month Assessment||412
9023601|NCT03137459|10086318|FG000|NOT COMPLETED|2-month Assessment||68
9023602|NCT03137459|10086319|FG001|NOT COMPLETED|2-month Assessment||42
9023603|NCT03137459|10086318|FG000|STARTED|4-month Assessment||442
9023604|NCT03137459|10086319|FG001|STARTED|4-month Assessment||451
9023605|NCT03137459|10086318|FG000|COMPLETED|4-month Assessment||364
9023606|NCT03137459|10086319|FG001|COMPLETED|4-month Assessment||405
9023607|NCT03137459|10086318|FG000|NOT COMPLETED|4-month Assessment||78
9023608|NCT03137459|10086319|FG001|NOT COMPLETED|4-month Assessment||46
9023609|NCT03137459|10086318|FG000|STARTED|6-months||434
9023610|NCT03137459|10086319|FG001|STARTED|6-months||447
9023611|NCT03137459|10086318|FG000|COMPLETED|6-months||413
9023612|NCT03137459|10086319|FG001|COMPLETED|6-months||430
8752331|NCT01178268|9801406|FG001|COMPLETED|Overall Study||120
8752332|NCT01178268|9801405|FG000|NOT COMPLETED|Overall Study||7
8752333|NCT01178268|9801406|FG001|NOT COMPLETED|Overall Study||1
8752334|NCT01178281|9801415|FG000|STARTED|Overall Study||168
8752335|NCT01178281|9801416|FG001|STARTED|Overall Study||84
8752336|NCT01178281|9801417|FG002|STARTED|Overall Study||15
8752337|NCT01178281|9801415|FG000|Received Study Drug|Overall Study||167
8752338|NCT01178281|9801416|FG001|Received Study Drug|Overall Study||83
8752339|NCT01178281|9801417|FG002|Received Study Drug|Overall Study||15
8752340|NCT01178281|9801415|FG000|COMPLETED|Overall Study||168
8752341|NCT01178281|9801416|FG001|COMPLETED|Overall Study||84
8752342|NCT01178281|9801417|FG002|COMPLETED|Overall Study||15
8752343|NCT01178281|9801415|FG000|NOT COMPLETED|Overall Study||0
8752344|NCT01178281|9801416|FG001|NOT COMPLETED|Overall Study||0
8752345|NCT01178281|9801417|FG002|NOT COMPLETED|Overall Study||0
8752346|NCT01178294|9801427|FG000|STARTED|Overall Study|25 subjects enrolled under OBI-1-301 + 4 subjects enrolled under expanded access OBI-1-301a.|29
8752347|NCT01178294|9801427|FG000|COMPLETED|Overall Study||18
8752348|NCT01178294|9801427|FG000|NOT COMPLETED|Overall Study||11
8752349|NCT01178333|9801434|FG000|STARTED|Overall Study||71
8752350|NCT01178333|9801435|FG001|STARTED|Overall Study||284
8752351|NCT01178333|9801436|FG002|STARTED|Overall Study||87
8752352|NCT01178333|9801434|FG000|COMPLETED|Overall Study||71
8752353|NCT01178333|9801435|FG001|COMPLETED|Overall Study||284
8752354|NCT01178333|9801436|FG002|COMPLETED|Overall Study||87
8752355|NCT01178333|9801434|FG000|NOT COMPLETED|Overall Study||0
8752356|NCT01178333|9801435|FG001|NOT COMPLETED|Overall Study||0
9023613|NCT03137459|10086318|FG000|NOT COMPLETED|6-months||21
9023614|NCT03137459|10086319|FG001|NOT COMPLETED|6-months||17
9023615|NCT03137784|10086326|FG000|STARTED|Overall Study||24
9023616|NCT03137784|10086327|FG001|STARTED|Overall Study||25
9023617|NCT03137784|10086328|FG002|STARTED|Overall Study||25
9023618|NCT03137784|10086329|FG003|STARTED|Overall Study||24
9023619|NCT03137784|10086330|FG004|STARTED|Overall Study||25
9023620|NCT03137784|10086331|FG005|STARTED|Overall Study||25
9023621|NCT03137784|10086326|FG000|COMPLETED|Overall Study||22
9023622|NCT03137784|10086327|FG001|COMPLETED|Overall Study||24
9023623|NCT03137784|10086328|FG002|COMPLETED|Overall Study||25
9023624|NCT03137784|10086329|FG003|COMPLETED|Overall Study||24
9023625|NCT03137784|10086330|FG004|COMPLETED|Overall Study||24
9023626|NCT03137784|10086331|FG005|COMPLETED|Overall Study||25
9023627|NCT03137784|10086326|FG000|NOT COMPLETED|Overall Study||2
9023628|NCT03137784|10086327|FG001|NOT COMPLETED|Overall Study||1
9023629|NCT03137784|10086328|FG002|NOT COMPLETED|Overall Study||0
9023630|NCT03137784|10086329|FG003|NOT COMPLETED|Overall Study||0
9023631|NCT03137784|10086330|FG004|NOT COMPLETED|Overall Study||1
9023632|NCT03137784|10086331|FG005|NOT COMPLETED|Overall Study||0
9023633|NCT03137992|10086339|FG000|STARTED|Period 1 (Visit 2)||62
9023634|NCT03137992|10086340|FG001|STARTED|Period 1 (Visit 2)||63
9023635|NCT03137992|10086341|FG002|STARTED|Period 1 (Visit 2)||63
9023636|NCT03137992|10086342|FG003|STARTED|Period 1 (Visit 2)||63
9023637|NCT03137992|10086343|FG004|STARTED|Period 1 (Visit 2)||62
9023638|NCT03137992|10086344|FG005|STARTED|Period 1 (Visit 2)||61
9023639|NCT03137992|10086339|FG000|COMPLETED|Period 1 (Visit 2)||62
9023640|NCT03137992|10086340|FG001|COMPLETED|Period 1 (Visit 2)||63
9023641|NCT03137992|10086341|FG002|COMPLETED|Period 1 (Visit 2)||63
9023642|NCT03137992|10086342|FG003|COMPLETED|Period 1 (Visit 2)||63
9023643|NCT03137992|10086343|FG004|COMPLETED|Period 1 (Visit 2)||62
9023644|NCT03137992|10086344|FG005|COMPLETED|Period 1 (Visit 2)||61
9023645|NCT03137992|10086339|FG000|NOT COMPLETED|Period 1 (Visit 2)||0
9023646|NCT03137992|10086340|FG001|NOT COMPLETED|Period 1 (Visit 2)||0
9023647|NCT03137992|10086341|FG002|NOT COMPLETED|Period 1 (Visit 2)||0
9023648|NCT03137992|10086342|FG003|NOT COMPLETED|Period 1 (Visit 2)||0
9023649|NCT03137992|10086343|FG004|NOT COMPLETED|Period 1 (Visit 2)||0
9023650|NCT03137992|10086344|FG005|NOT COMPLETED|Period 1 (Visit 2)||0
9023651|NCT03137992|10086339|FG000|STARTED|Washout Period 1||62
9023652|NCT03137992|10086340|FG001|STARTED|Washout Period 1||63
9023653|NCT03137992|10086341|FG002|STARTED|Washout Period 1||63
9023654|NCT03137992|10086342|FG003|STARTED|Washout Period 1||63
9023655|NCT03137992|10086343|FG004|STARTED|Washout Period 1||62
9023656|NCT03137992|10086344|FG005|STARTED|Washout Period 1||61
9023657|NCT03137992|10086339|FG000|COMPLETED|Washout Period 1||59
9023658|NCT03137992|10086340|FG001|COMPLETED|Washout Period 1||59
9023659|NCT03137992|10086341|FG002|COMPLETED|Washout Period 1||61
9023660|NCT03137992|10086342|FG003|COMPLETED|Washout Period 1||63
9023661|NCT03137992|10086343|FG004|COMPLETED|Washout Period 1||60
9023662|NCT03137992|10086344|FG005|COMPLETED|Washout Period 1||59
9023663|NCT03137992|10086339|FG000|NOT COMPLETED|Washout Period 1||3
9023664|NCT03137992|10086340|FG001|NOT COMPLETED|Washout Period 1||4
9023665|NCT03137992|10086341|FG002|NOT COMPLETED|Washout Period 1||2
9023666|NCT03137992|10086342|FG003|NOT COMPLETED|Washout Period 1||0
9023667|NCT03137992|10086343|FG004|NOT COMPLETED|Washout Period 1||2
9023668|NCT03137992|10086344|FG005|NOT COMPLETED|Washout Period 1||2
9023669|NCT03137992|10086339|FG000|STARTED|Period 2 (Visit 3)||59
9023670|NCT03137992|10086340|FG001|STARTED|Period 2 (Visit 3)||59
8752357|NCT01178333|9801436|FG002|NOT COMPLETED|Overall Study||0
8752358|NCT01178385|9801448|FG000|STARTED|Overall Study||24
8752359|NCT01178385|9801449|FG001|STARTED|Overall Study||21
8752360|NCT01178385|9801448|FG000|COMPLETED|Overall Study||22
9023671|NCT03137992|10086341|FG002|STARTED|Period 2 (Visit 3)||61
9023672|NCT03137992|10086342|FG003|STARTED|Period 2 (Visit 3)||63
8752361|NCT01178385|9801449|FG001|COMPLETED|Overall Study||21
8752362|NCT01178385|9801448|FG000|NOT COMPLETED|Overall Study||2
8752363|NCT01178385|9801449|FG001|NOT COMPLETED|Overall Study||0
8752364|NCT01178411|9801455|FG000|STARTED|Overall Study||60
8752365|NCT01178411|9801455|FG000|COMPLETED|Overall Study||0
8752366|NCT01178411|9801455|FG000|NOT COMPLETED|Overall Study||60
8752367|NCT01178528|9801462|FG000|STARTED|Overall Study||41
8752368|NCT01178528|9801463|FG001|STARTED|Overall Study||38
8752369|NCT01178528|9801464|FG002|STARTED|Overall Study||42
8752370|NCT01178528|9801462|FG000|COMPLETED|Overall Study||41
8752371|NCT01178528|9801463|FG001|COMPLETED|Overall Study||38
8752372|NCT01178528|9801464|FG002|COMPLETED|Overall Study||42
8752373|NCT01178528|9801462|FG000|NOT COMPLETED|Overall Study||0
8752374|NCT01178528|9801463|FG001|NOT COMPLETED|Overall Study||0
8752375|NCT01178528|9801464|FG002|NOT COMPLETED|Overall Study||0
8752376|NCT01178671|9801475|FG000|STARTED|Overall Study||18
8752377|NCT01178671|9801476|FG001|STARTED|Overall Study||18
8752378|NCT01178671|9801475|FG000|COMPLETED|Overall Study||6
8752379|NCT01178671|9801476|FG001|COMPLETED|Overall Study||3
8752380|NCT01178671|9801475|FG000|NOT COMPLETED|Overall Study||12
8752381|NCT01178671|9801476|FG001|NOT COMPLETED|Overall Study||15
8752382|NCT01178762|9801482|FG000|STARTED|Overall Study||42
8752383|NCT01178762|9801482|FG000|COMPLETED|Overall Study||27
8752384|NCT01178762|9801482|FG000|NOT COMPLETED|Overall Study||15
8752385|NCT01178827|9801489|FG000|STARTED|Overall Study||6
8752386|NCT01178827|9801490|FG001|STARTED|Overall Study||10
8752387|NCT01178827|9801491|FG002|STARTED|Overall Study||4
8752388|NCT01178827|9801489|FG000|COMPLETED|Overall Study||6
8752389|NCT01178827|9801490|FG001|COMPLETED|Overall Study||10
8752390|NCT01178827|9801491|FG002|COMPLETED|Overall Study||4
8752391|NCT01178827|9801489|FG000|NOT COMPLETED|Overall Study||0
8752392|NCT01178827|9801490|FG001|NOT COMPLETED|Overall Study||0
8752393|NCT01178827|9801491|FG002|NOT COMPLETED|Overall Study||0
8752394|NCT01178853|9801501|FG000|STARTED|Period 1 (Warfarin Titration)||24
8752395|NCT01178853|9801502|FG001|STARTED|Period 1 (Warfarin Titration)||24
8752396|NCT01178853|9801501|FG000|COMPLETED|Period 1 (Warfarin Titration)||23
8752397|NCT01178853|9801502|FG001|COMPLETED|Period 1 (Warfarin Titration)||22
8752398|NCT01178853|9801501|FG000|NOT COMPLETED|Period 1 (Warfarin Titration)||1
8752399|NCT01178853|9801502|FG001|NOT COMPLETED|Period 1 (Warfarin Titration)||2
8752400|NCT01178853|9801501|FG000|STARTED|Period 2 (Warfarin + Study Drug)||23
8752401|NCT01178853|9801502|FG001|STARTED|Period 2 (Warfarin + Study Drug)||22
8752402|NCT01178853|9801501|FG000|COMPLETED|Period 2 (Warfarin + Study Drug)||22
8752403|NCT01178853|9801502|FG001|COMPLETED|Period 2 (Warfarin + Study Drug)||22
8752404|NCT01178853|9801501|FG000|NOT COMPLETED|Period 2 (Warfarin + Study Drug)||1
8752405|NCT01178853|9801502|FG001|NOT COMPLETED|Period 2 (Warfarin + Study Drug)||0
8752406|NCT01178853|9801501|FG000|STARTED|Period 3 (Warfarin Titration)||22
8752407|NCT01178853|9801502|FG001|STARTED|Period 3 (Warfarin Titration)||22
8752408|NCT01178853|9801501|FG000|COMPLETED|Period 3 (Warfarin Titration)||21
8752409|NCT01178853|9801502|FG001|COMPLETED|Period 3 (Warfarin Titration)||22
8752410|NCT01178853|9801501|FG000|NOT COMPLETED|Period 3 (Warfarin Titration)||1
8752411|NCT01178853|9801502|FG001|NOT COMPLETED|Period 3 (Warfarin Titration)||0
8752412|NCT01178853|9801501|FG000|STARTED|Period 4 (Warfarin + Study Drug)||21
8752413|NCT01178853|9801502|FG001|STARTED|Period 4 (Warfarin + Study Drug)||22
8752414|NCT01178853|9801501|FG000|COMPLETED|Period 4 (Warfarin + Study Drug)||21
8752415|NCT01178853|9801502|FG001|COMPLETED|Period 4 (Warfarin + Study Drug)||19
8752416|NCT01178853|9801501|FG000|NOT COMPLETED|Period 4 (Warfarin + Study Drug)||0
8752417|NCT01178853|9801502|FG001|NOT COMPLETED|Period 4 (Warfarin + Study Drug)||3
8752418|NCT01178944|9801508|FG000|STARTED|Overall Study||35
8752419|NCT01178944|9801508|FG000|COMPLETED|Overall Study||35
8752420|NCT01178944|9801508|FG000|NOT COMPLETED|Overall Study||0
8752421|NCT01179048|9801514|FG000|STARTED|Overall Study||4668
8752422|NCT01179048|9801515|FG001|STARTED|Overall Study||4672
8752423|NCT01179048|9801514|FG000|COMPLETED|Overall Study||4529
8752424|NCT01179048|9801515|FG001|COMPLETED|Overall Study||4513
8752425|NCT01179048|9801514|FG000|NOT COMPLETED|Overall Study||139
8752426|NCT01179048|9801515|FG001|NOT COMPLETED|Overall Study||159
8752427|NCT01179113|9801523|FG000|STARTED|Overall Study||17
8752428|NCT01179113|9801524|FG001|STARTED|Overall Study||16
8752429|NCT01179113|9801523|FG000|COMPLETED|Overall Study||17
8752430|NCT01179113|9801524|FG001|COMPLETED|Overall Study||16
8752431|NCT01179113|9801523|FG000|NOT COMPLETED|Overall Study||0
8752432|NCT01179113|9801524|FG001|NOT COMPLETED|Overall Study||0
8752433|NCT01179191|9801530|FG000|STARTED|Titration Phase (up to 6 Weeks)||684
8752434|NCT01179191|9801530|FG000|COMPLETED|Titration Phase (up to 6 Weeks)||351
8752435|NCT01179191|9801530|FG000|NOT COMPLETED|Titration Phase (up to 6 Weeks)||333
8752436|NCT01179191|9801530|FG000|STARTED|Maintenance Phase (8 Weeks)||351
8752437|NCT01179191|9801530|FG000|COMPLETED|Maintenance Phase (8 Weeks)||234
8752438|NCT01179191|9801530|FG000|NOT COMPLETED|Maintenance Phase (8 Weeks)||117
8752439|NCT01179217|9801536|FG000|STARTED|Overall Study||152
8752440|NCT01179217|9801537|FG001|STARTED|Overall Study||78
8752441|NCT01179217|9801536|FG000|COMPLETED|Overall Study||97
8752442|NCT01179217|9801537|FG001|COMPLETED|Overall Study||59
8752443|NCT01179217|9801536|FG000|NOT COMPLETED|Overall Study||55
8752444|NCT01179217|9801537|FG001|NOT COMPLETED|Overall Study||19
8752445|NCT01179334|9801547|FG000|STARTED|Treatment Period||12
8752446|NCT01179334|9801548|FG001|STARTED|Treatment Period||6
8752447|NCT01179334|9801547|FG000|Participants Received Treatment|Treatment Period||12
8752448|NCT01179334|9801548|FG001|Participants Received Treatment|Treatment Period||6
8752449|NCT01179334|9801547|FG000|COMPLETED|Treatment Period||11
8752450|NCT01179334|9801548|FG001|COMPLETED|Treatment Period||6
8752451|NCT01179334|9801547|FG000|NOT COMPLETED|Treatment Period||1
8752452|NCT01179334|9801548|FG001|NOT COMPLETED|Treatment Period||0
8752453|NCT01179334|9801547|FG000|STARTED|Long-term Extension (LTE) Period||11
8752454|NCT01179334|9801548|FG001|STARTED|Long-term Extension (LTE) Period||6
8752455|NCT01179334|9801547|FG000|COMPLETED|Long-term Extension (LTE) Period|LTE phase was terminated by sponsor|0
8752456|NCT01179334|9801548|FG001|COMPLETED|Long-term Extension (LTE) Period|LTE phase was terminated by sponsor|0
8752457|NCT01179334|9801547|FG000|NOT COMPLETED|Long-term Extension (LTE) Period||11
8752458|NCT01179334|9801548|FG001|NOT COMPLETED|Long-term Extension (LTE) Period||6
8752459|NCT01179347|9801556|FG000|STARTED|Double-blind Period (12 Weeks)|Entered and treated in double-blind period.|155
8752460|NCT01179347|9801557|FG001|STARTED|Double-blind Period (12 Weeks)|Entered and treated in double-blind period.|308
8752461|NCT01179347|9801556|FG000|COMPLETED|Double-blind Period (12 Weeks)|Completed double-blind period.|147
8752462|NCT01179347|9801557|FG001|COMPLETED|Double-blind Period (12 Weeks)|Completed double-blind period.|294
8752463|NCT01179347|9801556|FG000|NOT COMPLETED|Double-blind Period (12 Weeks)||8
8752464|NCT01179347|9801557|FG001|NOT COMPLETED|Double-blind Period (12 Weeks)||14
8752465|NCT01179347|9801556|FG000|STARTED|Open-label Period (12 Weeks)|Treated in open-label period.|147
8752466|NCT01179347|9801557|FG001|STARTED|Open-label Period (12 Weeks)|Treated in open-label period.|294
8752467|NCT01179347|9801556|FG000|COMPLETED|Open-label Period (12 Weeks)|Completed open-label period.|132
8752468|NCT01179347|9801557|FG001|COMPLETED|Open-label Period (12 Weeks)|Completed open-label period.|278
8752469|NCT01179347|9801556|FG000|NOT COMPLETED|Open-label Period (12 Weeks)||15
8752470|NCT01179347|9801557|FG001|NOT COMPLETED|Open-label Period (12 Weeks)||16
8752471|NCT01179477|9801565|FG000|STARTED|Overall Study||1930
8752472|NCT01179477|9801565|FG000|COMPLETED|Overall Study||843
8752473|NCT01179477|9801565|FG000|NOT COMPLETED|Overall Study||1087
8752474|NCT01179490|9801569|FG000|STARTED|Overall Study||5
8752475|NCT01179490|9801569|FG000|COMPLETED|Overall Study||5
8752476|NCT01179490|9801569|FG000|NOT COMPLETED|Overall Study||0
8752477|NCT01179516|9801576|FG000|STARTED|Overall Study||160
8752478|NCT01179516|9801577|FG001|STARTED|Overall Study||157
8752479|NCT01179516|9801578|FG002|STARTED|Overall Study||152
8752480|NCT01179516|9801576|FG000|Treated|Overall Study||160
8752481|NCT01179516|9801577|FG001|Treated|Overall Study||154
8752482|NCT01179516|9801578|FG002|Treated|Overall Study||151
8752483|NCT01179516|9801576|FG000|COMPLETED|Overall Study||133
8752484|NCT01179516|9801577|FG001|COMPLETED|Overall Study||131
8752485|NCT01179516|9801578|FG002|COMPLETED|Overall Study||121
8752486|NCT01179516|9801576|FG000|NOT COMPLETED|Overall Study||27
8752487|NCT01179516|9801577|FG001|NOT COMPLETED|Overall Study||26
8752488|NCT01179516|9801578|FG002|NOT COMPLETED|Overall Study||31
8752489|NCT01179568|9801590|FG000|STARTED|Overall Study||101
8752490|NCT01179568|9801591|FG001|STARTED|Overall Study||99
8752491|NCT01179568|9801592|FG002|STARTED|Overall Study||99
8752492|NCT01179568|9801593|FG003|STARTED|Overall Study||96
8752493|NCT01179568|9801590|FG000|Completed Week 12 Assessment|Overall Study||69
8752494|NCT01179568|9801591|FG001|Completed Week 12 Assessment|Overall Study||69
8752495|NCT01179568|9801592|FG002|Completed Week 12 Assessment|Overall Study||76
8752496|NCT01179568|9801593|FG003|Completed Week 12 Assessment|Overall Study||75
8752497|NCT01179568|9801590|FG000|COMPLETED|Overall Study||73
8752498|NCT01179568|9801591|FG001|COMPLETED|Overall Study||61
8752499|NCT01179568|9801592|FG002|COMPLETED|Overall Study||76
8752500|NCT01179568|9801593|FG003|COMPLETED|Overall Study||76
8752501|NCT01179568|9801590|FG000|NOT COMPLETED|Overall Study||28
8752502|NCT01179568|9801591|FG001|NOT COMPLETED|Overall Study||38
8752503|NCT01179568|9801592|FG002|NOT COMPLETED|Overall Study||23
8752504|NCT01179568|9801593|FG003|NOT COMPLETED|Overall Study||20
8752505|NCT01179672|9801608|FG000|STARTED|Overall Study||203
8752506|NCT01179672|9801609|FG001|STARTED|Overall Study||202
8752507|NCT01179672|9801608|FG000|Received at Least 1 Dose of Study Drug|Overall Study||202
8752508|NCT01179672|9801609|FG001|Received at Least 1 Dose of Study Drug|Overall Study||202
8752509|NCT01179672|9801608|FG000|Entered Taper|Overall Study||181
8752510|NCT01179672|9801609|FG001|Entered Taper|Overall Study||177
8752511|NCT01179672|9801608|FG000|COMPLETED|Overall Study||173
8752512|NCT01179672|9801609|FG001|COMPLETED|Overall Study||176
8752513|NCT01179672|9801608|FG000|NOT COMPLETED|Overall Study||30
8752514|NCT01179672|9801609|FG001|NOT COMPLETED|Overall Study||26
8752515|NCT01179919|9801619|FG000|STARTED|Overall Study||21
8752516|NCT01179919|9801619|FG000|COMPLETED|Overall Study||19
8752517|NCT01179919|9801619|FG000|NOT COMPLETED|Overall Study||2
8752518|NCT01179984|9801623|FG000|STARTED|Overall Study||76
8752519|NCT01179984|9801623|FG000|COMPLETED|Overall Study||58
8752520|NCT01179984|9801623|FG000|NOT COMPLETED|Overall Study||18
8752521|NCT01180036|9801630|FG000|STARTED|Overall Study||65
8752522|NCT01180036|9801631|FG001|STARTED|Overall Study||65
8752523|NCT01180036|9801630|FG000|COMPLETED|Overall Study||65
8752524|NCT01180036|9801631|FG001|COMPLETED|Overall Study||65
8752525|NCT01180036|9801630|FG000|NOT COMPLETED|Overall Study||0
8752526|NCT01180036|9801631|FG001|NOT COMPLETED|Overall Study||0
8752527|NCT01180049|9801641|FG000|STARTED|Overall Study||53
8752528|NCT01180049|9801642|FG001|STARTED|Overall Study||48
8752529|NCT01180049|9801641|FG000|COMPLETED|Overall Study||0
8752530|NCT01180049|9801642|FG001|COMPLETED|Overall Study||0
8752531|NCT01180049|9801641|FG000|NOT COMPLETED|Overall Study||53
8752532|NCT01180049|9801642|FG001|NOT COMPLETED|Overall Study||48
8752533|NCT01180127|9801652|FG000|STARTED|Overall Study||10
8752534|NCT01180127|9801653|FG001|STARTED|Overall Study||11
8752535|NCT01180127|9801654|FG002|STARTED|Overall Study||10
8752536|NCT01180127|9801655|FG003|STARTED|Overall Study||10
8752537|NCT01180127|9801652|FG000|COMPLETED|Overall Study||8
8752538|NCT01180127|9801653|FG001|COMPLETED|Overall Study||11
8752539|NCT01180127|9801654|FG002|COMPLETED|Overall Study||9
8752540|NCT01180127|9801655|FG003|COMPLETED|Overall Study||9
8752541|NCT01180127|9801652|FG000|NOT COMPLETED|Overall Study||2
8752542|NCT01180127|9801653|FG001|NOT COMPLETED|Overall Study||0
8752543|NCT01180127|9801654|FG002|NOT COMPLETED|Overall Study||1
8752544|NCT01180127|9801655|FG003|NOT COMPLETED|Overall Study||1
8752545|NCT01180244|9801671|FG000|STARTED|Overall Study|Number of enrolled patients initially randomized to active treatment group|45
8752546|NCT01180244|9801672|FG001|STARTED|Overall Study|Number of enrolled patients initially randomized to placebo group|46
8752547|NCT01180244|9801671|FG000|Received Treatment|Overall Study|Number of patients in the active treatment group that received at least one study treatment|40
8752548|NCT01180244|9801672|FG001|Received Treatment|Overall Study|Number of patients in the placebo group that received at least one sham treatment|45
8752549|NCT01180244|9801671|FG000|COMPLETED|Overall Study|Number of active treatment patients who completed all study visits and are evaluable|39
8752550|NCT01180244|9801672|FG001|COMPLETED|Overall Study|Number of placebo group patients who completed all study visits and are evaluable|38
8752551|NCT01180244|9801671|FG000|NOT COMPLETED|Overall Study||6
8752552|NCT01180244|9801672|FG001|NOT COMPLETED|Overall Study||8
8752553|NCT01180296|9801680|FG000|STARTED|Overall Study||20
8752554|NCT01180296|9801681|FG001|STARTED|Overall Study||16
8752555|NCT01180296|9801680|FG000|COMPLETED|Overall Study||19
8752556|NCT01180296|9801681|FG001|COMPLETED|Overall Study||14
8752557|NCT01180296|9801680|FG000|NOT COMPLETED|Overall Study||1
8752558|NCT01180296|9801681|FG001|NOT COMPLETED|Overall Study||2
8752559|NCT01180400|9801691|FG000|STARTED|Overall Study||147
8752560|NCT01180400|9801692|FG001|STARTED|Overall Study||148
8752561|NCT01180400|9801691|FG000|Received Treatment|Overall Study||147
8752562|NCT01180400|9801692|FG001|Received Treatment|Overall Study||146
8752563|NCT01180400|9801691|FG000|COMPLETED|Overall Study||122
8752564|NCT01180400|9801692|FG001|COMPLETED|Overall Study||121
8752565|NCT01180400|9801691|FG000|NOT COMPLETED|Overall Study||25
8752566|NCT01180400|9801692|FG001|NOT COMPLETED|Overall Study||27
8752567|NCT01180478|9801700|FG000|STARTED|Overall Study||484
8752568|NCT01180478|9801701|FG001|STARTED|Overall Study||481
8752569|NCT01180478|9801700|FG000|COMPLETED|Overall Study||303
8752570|NCT01180478|9801701|FG001|COMPLETED|Overall Study||293
8752571|NCT01180478|9801700|FG000|NOT COMPLETED|Overall Study||181
8752572|NCT01180478|9801701|FG001|NOT COMPLETED|Overall Study||188
8752573|NCT01180647|9801711|FG000|STARTED|Overall Study||17
8752574|NCT01180647|9801712|FG001|STARTED|Overall Study||17
8752575|NCT01180647|9801711|FG000|COMPLETED|Overall Study||12
8752576|NCT01180647|9801712|FG001|COMPLETED|Overall Study||11
8752577|NCT01180647|9801711|FG000|NOT COMPLETED|Overall Study||5
8752578|NCT01180647|9801712|FG001|NOT COMPLETED|Overall Study||6
8752579|NCT01180660|9801720|FG000|STARTED|Overall Study||25
8752580|NCT01180660|9801721|FG001|STARTED|Overall Study||26
8752581|NCT01180660|9801720|FG000|COMPLETED|Overall Study||24
8752582|NCT01180660|9801721|FG001|COMPLETED|Overall Study||26
8752583|NCT01180660|9801720|FG000|NOT COMPLETED|Overall Study||1
8752584|NCT01180660|9801721|FG001|NOT COMPLETED|Overall Study||0
8752585|NCT01180777|9801727|FG000|STARTED|Overall Study||92
8752586|NCT01180777|9801727|FG000|COMPLETED|Overall Study||80
8752587|NCT01180777|9801727|FG000|NOT COMPLETED|Overall Study||12
8752588|NCT01180790|9801740|FG000|STARTED|Overall Study||16
8752589|NCT01180790|9801741|FG001|STARTED|Overall Study||16
8752590|NCT01180790|9801742|FG002|STARTED|Overall Study||17
8752591|NCT01180790|9801743|FG003|STARTED|Overall Study||15
8752592|NCT01180790|9801744|FG004|STARTED|Overall Study||19
8752593|NCT01180790|9801745|FG005|STARTED|Overall Study||20
8752594|NCT01180790|9801746|FG006|STARTED|Overall Study||19
8752595|NCT01180790|9801740|FG000|COMPLETED|Overall Study||7
8752596|NCT01180790|9801741|FG001|COMPLETED|Overall Study||11
8752597|NCT01180790|9801742|FG002|COMPLETED|Overall Study||4
8752598|NCT01180790|9801743|FG003|COMPLETED|Overall Study||6
8752599|NCT01180790|9801744|FG004|COMPLETED|Overall Study||14
8752600|NCT01180790|9801745|FG005|COMPLETED|Overall Study||13
8752601|NCT01180790|9801746|FG006|COMPLETED|Overall Study||18
8752602|NCT01180790|9801740|FG000|NOT COMPLETED|Overall Study||9
8752603|NCT01180790|9801741|FG001|NOT COMPLETED|Overall Study||5
8752604|NCT01180790|9801742|FG002|NOT COMPLETED|Overall Study||13
8752605|NCT01180790|9801743|FG003|NOT COMPLETED|Overall Study||9
8752606|NCT01180790|9801744|FG004|NOT COMPLETED|Overall Study||5
8752607|NCT01180790|9801745|FG005|NOT COMPLETED|Overall Study||7
8752608|NCT01180790|9801746|FG006|NOT COMPLETED|Overall Study||1
8752609|NCT01180894|9801792|FG000|STARTED|Overall Study||75
8752610|NCT01180894|9801793|FG001|STARTED|Overall Study||75
8752611|NCT01180894|9801792|FG000|COMPLETED|Overall Study||75
8752612|NCT01180894|9801793|FG001|COMPLETED|Overall Study||75
8752613|NCT01180894|9801792|FG000|NOT COMPLETED|Overall Study||0
8752614|NCT01180894|9801793|FG001|NOT COMPLETED|Overall Study||0
8752615|NCT01180985|9801801|FG000|STARTED|Period 1 (7 +/- Days)||27
8752616|NCT01180985|9801802|FG001|STARTED|Period 1 (7 +/- Days)||26
8752617|NCT01180985|9801801|FG000|COMPLETED|Period 1 (7 +/- Days)||27
8752618|NCT01180985|9801802|FG001|COMPLETED|Period 1 (7 +/- Days)||26
8752619|NCT01180985|9801801|FG000|NOT COMPLETED|Period 1 (7 +/- Days)||0
8752620|NCT01180985|9801802|FG001|NOT COMPLETED|Period 1 (7 +/- Days)||0
8752621|NCT01180985|9801801|FG000|STARTED|Period 2 (7 +/- 1 Days)||27
8752622|NCT01180985|9801802|FG001|STARTED|Period 2 (7 +/- 1 Days)||26
8752623|NCT01180985|9801801|FG000|COMPLETED|Period 2 (7 +/- 1 Days)||26
8752624|NCT01180985|9801802|FG001|COMPLETED|Period 2 (7 +/- 1 Days)||26
8752625|NCT01180985|9801801|FG000|NOT COMPLETED|Period 2 (7 +/- 1 Days)||1
8752626|NCT01180985|9801802|FG001|NOT COMPLETED|Period 2 (7 +/- 1 Days)||0
8752627|NCT01180998|9801812|FG000|STARTED|Overall Study||67
8752628|NCT01180998|9801813|FG001|STARTED|Overall Study||72
8752629|NCT01180998|9801814|FG002|STARTED|Overall Study||61
8752630|NCT01180998|9801812|FG000|COMPLETED|Overall Study||63
8752631|NCT01180998|9801813|FG001|COMPLETED|Overall Study||68
8752632|NCT01180998|9801814|FG002|COMPLETED|Overall Study||51
8752633|NCT01180998|9801812|FG000|NOT COMPLETED|Overall Study||4
8752634|NCT01180998|9801813|FG001|NOT COMPLETED|Overall Study||4
8752635|NCT01180998|9801814|FG002|NOT COMPLETED|Overall Study||10
8752636|NCT01181011|9801823|FG000|STARTED|Overall Study||28
8752637|NCT01181011|9801823|FG000|Received Telmisartan 80mg|Overall Study||27
8752638|NCT01181011|9801823|FG000|Received Telmisartan 80mg,Amlodipine 5mg|Overall Study||27
8752639|NCT01181011|9801823|FG000|Received Amlodipine 5mg|Overall Study||26
8752640|NCT01181011|9801823|FG000|COMPLETED|Overall Study||25
8752641|NCT01181011|9801823|FG000|NOT COMPLETED|Overall Study||3
8752642|NCT01181050|9801834|FG000|STARTED|Overall Study||41
9023673|NCT03137992|10086343|FG004|STARTED|Period 2 (Visit 3)||60
9023674|NCT03137992|10086344|FG005|STARTED|Period 2 (Visit 3)||59
9023675|NCT03137992|10086339|FG000|COMPLETED|Period 2 (Visit 3)||56
9023676|NCT03137992|10086340|FG001|COMPLETED|Period 2 (Visit 3)||52
9023677|NCT03137992|10086341|FG002|COMPLETED|Period 2 (Visit 3)||58
9023678|NCT03137992|10086342|FG003|COMPLETED|Period 2 (Visit 3)||58
9023679|NCT03137992|10086343|FG004|COMPLETED|Period 2 (Visit 3)||56
9023680|NCT03137992|10086344|FG005|COMPLETED|Period 2 (Visit 3)||51
9023681|NCT03137992|10086339|FG000|NOT COMPLETED|Period 2 (Visit 3)||3
9023682|NCT03137992|10086340|FG001|NOT COMPLETED|Period 2 (Visit 3)||7
9023683|NCT03137992|10086341|FG002|NOT COMPLETED|Period 2 (Visit 3)||3
9023684|NCT03137992|10086342|FG003|NOT COMPLETED|Period 2 (Visit 3)||5
9023685|NCT03137992|10086343|FG004|NOT COMPLETED|Period 2 (Visit 3)||4
9023686|NCT03137992|10086344|FG005|NOT COMPLETED|Period 2 (Visit 3)||8
9023687|NCT03137992|10086339|FG000|STARTED|Washout Period 2||56
9023688|NCT03137992|10086340|FG001|STARTED|Washout Period 2||52
9023689|NCT03137992|10086341|FG002|STARTED|Washout Period 2||58
9023690|NCT03137992|10086342|FG003|STARTED|Washout Period 2||58
9023691|NCT03137992|10086343|FG004|STARTED|Washout Period 2||56
9023692|NCT03137992|10086344|FG005|STARTED|Washout Period 2||51
9023693|NCT03137992|10086339|FG000|COMPLETED|Washout Period 2||54
9023694|NCT03137992|10086340|FG001|COMPLETED|Washout Period 2||50
9023695|NCT03137992|10086341|FG002|COMPLETED|Washout Period 2||58
9023696|NCT03137992|10086342|FG003|COMPLETED|Washout Period 2||57
8752643|NCT01181050|9801835|FG001|STARTED|Overall Study||22
8752644|NCT01181050|9801834|FG000|COMPLETED|Overall Study||41
8752645|NCT01181050|9801835|FG001|COMPLETED|Overall Study||22
8752646|NCT01181050|9801834|FG000|NOT COMPLETED|Overall Study||0
9023697|NCT03137992|10086343|FG004|COMPLETED|Washout Period 2||53
9023698|NCT03137992|10086344|FG005|COMPLETED|Washout Period 2||50
9023699|NCT03137992|10086339|FG000|NOT COMPLETED|Washout Period 2||2
9023700|NCT03137992|10086340|FG001|NOT COMPLETED|Washout Period 2||2
9023701|NCT03137992|10086341|FG002|NOT COMPLETED|Washout Period 2||0
9023702|NCT03137992|10086342|FG003|NOT COMPLETED|Washout Period 2||1
9023703|NCT03137992|10086343|FG004|NOT COMPLETED|Washout Period 2||3
9023704|NCT03137992|10086344|FG005|NOT COMPLETED|Washout Period 2||1
9023705|NCT03137992|10086339|FG000|STARTED|Period 3 (Visit 04)||54
9023706|NCT03137992|10086340|FG001|STARTED|Period 3 (Visit 04)||50
9023707|NCT03137992|10086341|FG002|STARTED|Period 3 (Visit 04)||58
9023708|NCT03137992|10086342|FG003|STARTED|Period 3 (Visit 04)||57
9023709|NCT03137992|10086343|FG004|STARTED|Period 3 (Visit 04)||53
9023710|NCT03137992|10086344|FG005|STARTED|Period 3 (Visit 04)||50
9023711|NCT03137992|10086339|FG000|COMPLETED|Period 3 (Visit 04)||48
9023712|NCT03137992|10086340|FG001|COMPLETED|Period 3 (Visit 04)||48
9023713|NCT03137992|10086341|FG002|COMPLETED|Period 3 (Visit 04)||55
9023714|NCT03137992|10086342|FG003|COMPLETED|Period 3 (Visit 04)||57
9023715|NCT03137992|10086343|FG004|COMPLETED|Period 3 (Visit 04)||50
9023716|NCT03137992|10086344|FG005|COMPLETED|Period 3 (Visit 04)||47
9023717|NCT03137992|10086339|FG000|NOT COMPLETED|Period 3 (Visit 04)||6
9023718|NCT03137992|10086340|FG001|NOT COMPLETED|Period 3 (Visit 04)||2
9023719|NCT03137992|10086341|FG002|NOT COMPLETED|Period 3 (Visit 04)||3
9023720|NCT03137992|10086342|FG003|NOT COMPLETED|Period 3 (Visit 04)||0
9023721|NCT03137992|10086343|FG004|NOT COMPLETED|Period 3 (Visit 04)||3
9023722|NCT03137992|10086344|FG005|NOT COMPLETED|Period 3 (Visit 04)||3
9023723|NCT03137992|10086339|FG000|STARTED|Part 2 (Open-label Extension)||22
9023724|NCT03137992|10086340|FG001|STARTED|Part 2 (Open-label Extension)||17
9023725|NCT03137992|10086341|FG002|STARTED|Part 2 (Open-label Extension)||21
9023726|NCT03137992|10086342|FG003|STARTED|Part 2 (Open-label Extension)||25
8752647|NCT01181050|9801835|FG001|NOT COMPLETED|Overall Study||0
8752648|NCT01181076|9801843|FG000|STARTED|Overall Study||59
8752649|NCT01181076|9801844|FG001|STARTED|Overall Study||60
8752650|NCT01181076|9801843|FG000|COMPLETED|Overall Study||40
8752651|NCT01181076|9801844|FG001|COMPLETED|Overall Study|As determined|48
8752652|NCT01181076|9801843|FG000|NOT COMPLETED|Overall Study||19
8752653|NCT01181076|9801844|FG001|NOT COMPLETED|Overall Study||12
8752654|NCT01181102|9801852|FG000|STARTED|Overall Study||360
8752655|NCT01181102|9801853|FG001|STARTED|Overall Study||356
8752656|NCT01181102|9801852|FG000|Safety Analysis Set|Overall Study||354
8752657|NCT01181102|9801853|FG001|Safety Analysis Set|Overall Study||349
8752658|NCT01181102|9801852|FG000|Efficacy Analysis Population|Overall Study||299
8752659|NCT01181102|9801853|FG001|Efficacy Analysis Population|Overall Study||295
8752660|NCT01181102|9801852|FG000|COMPLETED|Overall Study||309
8752661|NCT01181102|9801853|FG001|COMPLETED|Overall Study||310
8752662|NCT01181102|9801852|FG000|NOT COMPLETED|Overall Study||51
8752663|NCT01181102|9801853|FG001|NOT COMPLETED|Overall Study||46
8807919|NCT01488071|9860261|FG000|NOT COMPLETED|Overall Study||53
8807920|NCT01488071|9860262|FG001|NOT COMPLETED|Overall Study||63
8807921|NCT01488097|9860268|FG000|STARTED|Overall Study||8
8807922|NCT01488097|9860268|FG000|Received Study Drug in Extension Study|Overall Study||8
8807923|NCT01488097|9860268|FG000|COMPLETED|Overall Study||7
8807924|NCT01488097|9860268|FG000|NOT COMPLETED|Overall Study||1
8807925|NCT01488188|9860274|FG000|STARTED|Overall Study||20
8807926|NCT01488188|9860275|FG001|STARTED|Overall Study||20
8807927|NCT01488188|9860274|FG000|COMPLETED|Overall Study||20
8807928|NCT01488188|9860275|FG001|COMPLETED|Overall Study||20
8807929|NCT01488188|9860274|FG000|NOT COMPLETED|Overall Study||0
8807930|NCT01488188|9860275|FG001|NOT COMPLETED|Overall Study||0
8807931|NCT01488279|9860283|FG000|STARTED|Overall Study||5
8807932|NCT01488279|9860284|FG001|STARTED|Overall Study||5
8807933|NCT01488279|9860283|FG000|COMPLETED|Overall Study||5
8807934|NCT01488279|9860284|FG001|COMPLETED|Overall Study||5
8807935|NCT01488279|9860283|FG000|NOT COMPLETED|Overall Study||0
8807936|NCT01488279|9860284|FG001|NOT COMPLETED|Overall Study||0
8807937|NCT01488318|9860293|FG000|STARTED|Overall Study||14
8807938|NCT01488318|9860293|FG000|COMPLETED|Overall Study||14
8807939|NCT01488318|9860293|FG000|NOT COMPLETED|Overall Study||0
8807940|NCT01488370|9860300|FG000|STARTED|Overall Study||22
8807941|NCT01488370|9860301|FG001|STARTED|Overall Study||23
8807942|NCT01488370|9860302|FG002|STARTED|Overall Study||20
8807943|NCT01488370|9860300|FG000|COMPLETED|Overall Study||22
8807944|NCT01488370|9860301|FG001|COMPLETED|Overall Study||22
8807945|NCT01488370|9860302|FG002|COMPLETED|Overall Study||19
8807946|NCT01488370|9860300|FG000|NOT COMPLETED|Overall Study||0
8807947|NCT01488370|9860301|FG001|NOT COMPLETED|Overall Study||1
8807948|NCT01488370|9860302|FG002|NOT COMPLETED|Overall Study||1
8807949|NCT01488409|9860312|FG000|STARTED|Overall Study||20
8807950|NCT01488409|9860313|FG001|STARTED|Overall Study||19
8807951|NCT01488409|9860312|FG000|COMPLETED|Overall Study||16
8807952|NCT01488409|9860313|FG001|COMPLETED|Overall Study||15
8807953|NCT01488409|9860312|FG000|NOT COMPLETED|Overall Study||4
8807954|NCT01488409|9860313|FG001|NOT COMPLETED|Overall Study||4
8807955|NCT01488448|9860321|FG000|STARTED|Overall Study||113
8807956|NCT01488448|9860322|FG001|STARTED|Overall Study||114
8807957|NCT01488448|9860321|FG000|COMPLETED|Overall Study||93
8807958|NCT01488448|9860322|FG001|COMPLETED|Overall Study||97
8807959|NCT01488448|9860321|FG000|NOT COMPLETED|Overall Study||20
8807960|NCT01488448|9860322|FG001|NOT COMPLETED|Overall Study||17
8807961|NCT01488487|9860330|FG000|STARTED|Overall Study||24
8807962|NCT01488487|9860330|FG000|Received Treatment|Overall Study||24
8807963|NCT01488487|9860330|FG000|COMPLETED|Overall Study||15
8807964|NCT01488487|9860330|FG000|NOT COMPLETED|Overall Study||9
8807965|NCT01488578|9860334|FG000|STARTED|Overall Study||11157
8807966|NCT01488578|9860334|FG000|COMPLETED|Overall Study||9321
8807967|NCT01488578|9860334|FG000|NOT COMPLETED|Overall Study||1836
8807968|NCT01488708|9860366|FG000|STARTED|Overall Study||940
8807969|NCT01488708|9860367|FG001|STARTED|Overall Study||578
8807970|NCT01488708|9860366|FG000|Received at Least 1 Dose of Study Drug|Overall Study||937
8807971|NCT01488708|9860367|FG001|Received at Least 1 Dose of Study Drug|Overall Study||578
8807972|NCT01488708|9860366|FG000|Participated in Follow Up|Overall Study||810
8807973|NCT01488708|9860367|FG001|Participated in Follow Up|Overall Study||526
8807974|NCT01488708|9860366|FG000|COMPLETED|Overall Study||0
8807975|NCT01488708|9860367|FG001|COMPLETED|Overall Study||0
8807976|NCT01488708|9860366|FG000|NOT COMPLETED|Overall Study||940
8807977|NCT01488708|9860367|FG001|NOT COMPLETED|Overall Study||578
8807978|NCT01488877|9860375|FG000|STARTED|Initial Randomization||1
8807979|NCT01488877|9860376|FG001|STARTED|Initial Randomization||5
8807980|NCT01488877|9860377|FG002|STARTED|Initial Randomization||0
8807981|NCT01488877|9860375|FG000|COMPLETED|Initial Randomization||1
8807982|NCT01488877|9860376|FG001|COMPLETED|Initial Randomization||5
8807983|NCT01488877|9860377|FG002|COMPLETED|Initial Randomization||0
8807984|NCT01488877|9860375|FG000|NOT COMPLETED|Initial Randomization||0
8807985|NCT01488877|9860376|FG001|NOT COMPLETED|Initial Randomization||0
8807986|NCT01488877|9860377|FG002|NOT COMPLETED|Initial Randomization||0
8807987|NCT01488877|9860375|FG000|STARTED|Re-randomization||0
8807988|NCT01488877|9860376|FG001|STARTED|Re-randomization||0
8807989|NCT01488877|9860377|FG002|STARTED|Re-randomization|Three participants were re-randomized from PF-03882845 3 mg arm.|3
8807990|NCT01488877|9860375|FG000|COMPLETED|Re-randomization||0
8807991|NCT01488877|9860376|FG001|COMPLETED|Re-randomization||0
8807992|NCT01488877|9860377|FG002|COMPLETED|Re-randomization||3
8807993|NCT01488877|9860375|FG000|NOT COMPLETED|Re-randomization||0
8807994|NCT01488877|9860376|FG001|NOT COMPLETED|Re-randomization||0
8807995|NCT01488877|9860377|FG002|NOT COMPLETED|Re-randomization||0
8807996|NCT01488994|9860386|FG000|STARTED|Overall Study||11
8807997|NCT01488994|9860387|FG001|STARTED|Overall Study||12
8752664|NCT01181128|9801862|FG000|STARTED|Overall Study||118
8752665|NCT01181128|9801863|FG001|STARTED|Overall Study||24
8752666|NCT01181128|9801864|FG002|STARTED|Overall Study||23
8752667|NCT01181128|9801862|FG000|Pharmacokinetic (PK) Subgroup|Overall Study||30
8752668|NCT01181128|9801863|FG001|Pharmacokinetic (PK) Subgroup|Overall Study||0
8752669|NCT01181128|9801864|FG002|Pharmacokinetic (PK) Subgroup|Overall Study||0
8752670|NCT01181128|9801862|FG000|Perioperative Management Subgroup|Overall Study|Participants who underwent major surgery.|8
8752671|NCT01181128|9801863|FG001|Perioperative Management Subgroup|Overall Study|Participants who underwent major surgery.|1
8752672|NCT01181128|9801864|FG002|Perioperative Management Subgroup|Overall Study|Participants who underwent major surgery.|0
8752673|NCT01181128|9801862|FG000|COMPLETED|Overall Study||112
8752674|NCT01181128|9801863|FG001|COMPLETED|Overall Study||19
8752675|NCT01181128|9801864|FG002|COMPLETED|Overall Study||22
8752676|NCT01181128|9801862|FG000|NOT COMPLETED|Overall Study||6
9023727|NCT03137992|10086343|FG004|STARTED|Part 2 (Open-label Extension)||18
9023728|NCT03137992|10086344|FG005|STARTED|Part 2 (Open-label Extension)||22
9023729|NCT03137992|10086339|FG000|COMPLETED|Part 2 (Open-label Extension)||20
9023730|NCT03137992|10086340|FG001|COMPLETED|Part 2 (Open-label Extension)||17
9023731|NCT03137992|10086341|FG002|COMPLETED|Part 2 (Open-label Extension)||20
9023732|NCT03137992|10086342|FG003|COMPLETED|Part 2 (Open-label Extension)||24
9023733|NCT03137992|10086343|FG004|COMPLETED|Part 2 (Open-label Extension)||18
9023734|NCT03137992|10086344|FG005|COMPLETED|Part 2 (Open-label Extension)||21
9023735|NCT03137992|10086339|FG000|NOT COMPLETED|Part 2 (Open-label Extension)||2
9023736|NCT03137992|10086340|FG001|NOT COMPLETED|Part 2 (Open-label Extension)||0
9023737|NCT03137992|10086341|FG002|NOT COMPLETED|Part 2 (Open-label Extension)||1
9023738|NCT03137992|10086342|FG003|NOT COMPLETED|Part 2 (Open-label Extension)||1
9023739|NCT03137992|10086343|FG004|NOT COMPLETED|Part 2 (Open-label Extension)||0
9023740|NCT03137992|10086344|FG005|NOT COMPLETED|Part 2 (Open-label Extension)||1
9023741|NCT03138330|10086352|FG000|STARTED|Overall Study||95
9023742|NCT03138330|10086352|FG000|COMPLETED|Overall Study||91
9023743|NCT03138330|10086352|FG000|NOT COMPLETED|Overall Study||4
9023744|NCT03138382|10086358|FG000|STARTED|Overall Study||10
9023745|NCT03138382|10086359|FG001|STARTED|Overall Study||10
9023746|NCT03138382|10086358|FG000|COMPLETED|Overall Study||10
9023747|NCT03138382|10086359|FG001|COMPLETED|Overall Study||10
9023748|NCT03138382|10086358|FG000|NOT COMPLETED|Overall Study||0
9023749|NCT03138382|10086359|FG001|NOT COMPLETED|Overall Study||0
9023750|NCT03138577|10086372|FG000|STARTED|Overall Study||3
9023751|NCT03138577|10086373|FG001|STARTED|Overall Study||3
9023752|NCT03138577|10086374|FG002|STARTED|Overall Study||3
9023753|NCT03138577|10086375|FG003|STARTED|Overall Study||3
9023754|NCT03138577|10086376|FG004|STARTED|Overall Study||3
9023755|NCT03138577|10086377|FG005|STARTED|Overall Study||3
9023756|NCT03138577|10086378|FG006|STARTED|Overall Study||3
9023757|NCT03138577|10086372|FG000|COMPLETED|Overall Study||3
9023758|NCT03138577|10086373|FG001|COMPLETED|Overall Study||3
9023759|NCT03138577|10086374|FG002|COMPLETED|Overall Study||3
9023760|NCT03138577|10086375|FG003|COMPLETED|Overall Study||3
9023761|NCT03138577|10086376|FG004|COMPLETED|Overall Study||3
9023762|NCT03138577|10086377|FG005|COMPLETED|Overall Study||3
9023763|NCT03138577|10086378|FG006|COMPLETED|Overall Study||3
9023764|NCT03138577|10086372|FG000|NOT COMPLETED|Overall Study||0
9023765|NCT03138577|10086373|FG001|NOT COMPLETED|Overall Study||0
9023766|NCT03138577|10086374|FG002|NOT COMPLETED|Overall Study||0
9023767|NCT03138577|10086375|FG003|NOT COMPLETED|Overall Study||0
9023768|NCT03138577|10086376|FG004|NOT COMPLETED|Overall Study||0
9023769|NCT03138577|10086377|FG005|NOT COMPLETED|Overall Study||0
9023770|NCT03138577|10086378|FG006|NOT COMPLETED|Overall Study||0
9023771|NCT03138655|10086404|FG000|STARTED|Overall Study||10
9023772|NCT03138655|10086405|FG001|STARTED|Overall Study||9
9023773|NCT03138655|10086406|FG002|STARTED|Overall Study||11
9023774|NCT03138655|10086407|FG003|STARTED|Overall Study||10
9023775|NCT03138655|10086408|FG004|STARTED|Overall Study||13
9023776|NCT03138655|10086409|FG005|STARTED|Overall Study||12
9023777|NCT03138655|10086410|FG006|STARTED|Overall Study||12
9023778|NCT03138655|10086411|FG007|STARTED|Overall Study||12
9023779|NCT03138655|10086404|FG000|COMPLETED|Overall Study||7
9023780|NCT03138655|10086405|FG001|COMPLETED|Overall Study||7
9023781|NCT03138655|10086406|FG002|COMPLETED|Overall Study||9
9023782|NCT03138655|10086407|FG003|COMPLETED|Overall Study||7
9023783|NCT03138655|10086408|FG004|COMPLETED|Overall Study||11
9023784|NCT03138655|10086409|FG005|COMPLETED|Overall Study||7
9023785|NCT03138655|10086410|FG006|COMPLETED|Overall Study||9
9023786|NCT03138655|10086411|FG007|COMPLETED|Overall Study||10
9023787|NCT03138655|10086404|FG000|NOT COMPLETED|Overall Study||3
9023788|NCT03138655|10086405|FG001|NOT COMPLETED|Overall Study||2
9023789|NCT03138655|10086406|FG002|NOT COMPLETED|Overall Study||2
9023790|NCT03138655|10086407|FG003|NOT COMPLETED|Overall Study||3
9023791|NCT03138655|10086408|FG004|NOT COMPLETED|Overall Study||2
9023792|NCT03138655|10086409|FG005|NOT COMPLETED|Overall Study||5
9023793|NCT03138655|10086410|FG006|NOT COMPLETED|Overall Study||3
9023794|NCT03138655|10086411|FG007|NOT COMPLETED|Overall Study||2
9023795|NCT03138798|10086435|FG000|STARTED|Overall Study||173
9023796|NCT03138798|10086436|FG001|STARTED|Overall Study||175
9023797|NCT03138798|10086435|FG000|Randomized But Did Not Meet Eligibility|Overall Study||6
9023798|NCT03138798|10086436|FG001|Randomized But Did Not Meet Eligibility|Overall Study||4
9023799|NCT03138798|10086435|FG000|COMPLETED|Overall Study||167
9023800|NCT03138798|10086436|FG001|COMPLETED|Overall Study||171
8752677|NCT01181128|9801863|FG001|NOT COMPLETED|Overall Study||5
8752678|NCT01181128|9801864|FG002|NOT COMPLETED|Overall Study||1
8752679|NCT01181141|9801886|FG000|STARTED|Overall Study||62
8752680|NCT01181141|9801887|FG001|STARTED|Overall Study||30
8752681|NCT01181141|9801886|FG000|Safety Analysis Population|Overall Study||59
8752682|NCT01181141|9801887|FG001|Safety Analysis Population|Overall Study||29
8752683|NCT01181141|9801886|FG000|COMPLETED|Overall Study||50
8752684|NCT01181141|9801887|FG001|COMPLETED|Overall Study||26
8752685|NCT01181141|9801886|FG000|NOT COMPLETED|Overall Study||12
8752686|NCT01181141|9801887|FG001|NOT COMPLETED|Overall Study||4
8752687|NCT01181167|9801895|FG000|STARTED|Overall Study||307
8752688|NCT01181167|9801896|FG001|STARTED|Overall Study||303
8752689|NCT01181167|9801895|FG000|Efficacy Analysis Population|Overall Study||255
8752690|NCT01181167|9801896|FG001|Efficacy Analysis Population|Overall Study||248
8752691|NCT01181167|9801895|FG000|COMPLETED|Overall Study||284
8752692|NCT01181167|9801896|FG001|COMPLETED|Overall Study||271
8752693|NCT01181167|9801895|FG000|NOT COMPLETED|Overall Study||23
8752694|NCT01181167|9801896|FG001|NOT COMPLETED|Overall Study||32
8752695|NCT01181258|9801902|FG000|STARTED|Overall Study||16
8752696|NCT01181258|9801902|FG000|COMPLETED|Overall Study||16
8752697|NCT01181258|9801902|FG000|NOT COMPLETED|Overall Study||0
8752698|NCT01181271|9801906|FG000|STARTED|Autologous Transplant||42
8752699|NCT01181271|9801906|FG000|COMPLETED|Autologous Transplant||42
8752700|NCT01181271|9801906|FG000|NOT COMPLETED|Autologous Transplant||0
8752701|NCT01181271|9801906|FG000|STARTED|Evaluation for Allogeneic Transplant||42
8752702|NCT01181271|9801906|FG000|COMPLETED|Evaluation for Allogeneic Transplant||29
8752703|NCT01181271|9801906|FG000|NOT COMPLETED|Evaluation for Allogeneic Transplant||13
8752704|NCT01181271|9801906|FG000|STARTED|Allogeneic Transplant||29
8752705|NCT01181271|9801906|FG000|COMPLETED|Allogeneic Transplant||29
8752706|NCT01181271|9801906|FG000|NOT COMPLETED|Allogeneic Transplant||0
8752707|NCT01181323|9801914|FG000|STARTED|Overall Study||124
8752708|NCT01181323|9801915|FG001|STARTED|Overall Study||124
8752709|NCT01181323|9801916|FG002|STARTED|Overall Study||124
8752710|NCT01181323|9801917|FG003|STARTED|Overall Study||125
8752711|NCT01181323|9801914|FG000|COMPLETED|Overall Study||123
8752712|NCT01181323|9801915|FG001|COMPLETED|Overall Study||121
8752713|NCT01181323|9801916|FG002|COMPLETED|Overall Study||123
8752714|NCT01181323|9801917|FG003|COMPLETED|Overall Study||122
8752715|NCT01181323|9801914|FG000|NOT COMPLETED|Overall Study||1
8752716|NCT01181323|9801915|FG001|NOT COMPLETED|Overall Study||3
8752717|NCT01181323|9801916|FG002|NOT COMPLETED|Overall Study||1
8752718|NCT01181323|9801917|FG003|NOT COMPLETED|Overall Study||3
8752719|NCT01181349|9801939|FG000|STARTED|Overall Study||350
8752720|NCT01181349|9801939|FG000|COMPLETED|Overall Study||350
8752721|NCT01181349|9801939|FG000|NOT COMPLETED|Overall Study||0
8752722|NCT01181479|9801947|FG000|STARTED|Subjects Receive AG200-15 or Lessina||1129
8752723|NCT01181479|9801948|FG001|STARTED|Subjects Receive AG200-15 or Lessina||375
8752724|NCT01181479|9801949|FG002|STARTED|Subjects Receive AG200-15 or Lessina|"This column is a subset of the Lessina completers in the Lessina (Cycles 1-6) column."|0
8752725|NCT01181479|9801947|FG000|COMPLETED|Subjects Receive AG200-15 or Lessina||485
8752726|NCT01181479|9801948|FG001|COMPLETED|Subjects Receive AG200-15 or Lessina||249
8752727|NCT01181479|9801949|FG002|COMPLETED|Subjects Receive AG200-15 or Lessina||0
8752728|NCT01181479|9801947|FG000|NOT COMPLETED|Subjects Receive AG200-15 or Lessina||644
8752729|NCT01181479|9801948|FG001|NOT COMPLETED|Subjects Receive AG200-15 or Lessina||126
8752730|NCT01181479|9801949|FG002|NOT COMPLETED|Subjects Receive AG200-15 or Lessina||0
8752731|NCT01181479|9801947|FG000|STARTED|Crossover Subjects Recieve AG200-15||0
8752732|NCT01181479|9801948|FG001|STARTED|Crossover Subjects Recieve AG200-15||0
8752733|NCT01181479|9801949|FG002|STARTED|Crossover Subjects Recieve AG200-15|"This column is a subset of the Lessina completers in the Lessina (Cycles 1-6) column."|249
8752734|NCT01181479|9801947|FG000|COMPLETED|Crossover Subjects Recieve AG200-15||0
8752735|NCT01181479|9801948|FG001|COMPLETED|Crossover Subjects Recieve AG200-15||0
8752736|NCT01181479|9801949|FG002|COMPLETED|Crossover Subjects Recieve AG200-15||150
8752737|NCT01181479|9801947|FG000|NOT COMPLETED|Crossover Subjects Recieve AG200-15||0
8752738|NCT01181479|9801948|FG001|NOT COMPLETED|Crossover Subjects Recieve AG200-15||0
8752739|NCT01181479|9801949|FG002|NOT COMPLETED|Crossover Subjects Recieve AG200-15||99
8752740|NCT01181492|9801964|FG000|STARTED|Overall Study||103
8752741|NCT01181492|9801965|FG001|STARTED|Overall Study||66
8752742|NCT01181492|9801966|FG002|STARTED|Overall Study||7
8752743|NCT01181492|9801964|FG000|COMPLETED|Overall Study||103
8752744|NCT01181492|9801965|FG001|COMPLETED|Overall Study||66
8752745|NCT01181492|9801966|FG002|COMPLETED|Overall Study||7
8752746|NCT01181492|9801964|FG000|NOT COMPLETED|Overall Study||0
8752747|NCT01181492|9801965|FG001|NOT COMPLETED|Overall Study||0
8752748|NCT01181492|9801966|FG002|NOT COMPLETED|Overall Study||0
8752749|NCT01181531|9801976|FG000|STARTED|Overall Study|Subjects are randomized after washout.|157
8752750|NCT01181531|9801977|FG001|STARTED|Overall Study|Subjects are randomized after washout.|155
8752751|NCT01181531|9801976|FG000|Received Investigational Product|Overall Study||155
8752752|NCT01181531|9801977|FG001|Received Investigational Product|Overall Study||153
8752753|NCT01181531|9801976|FG000|COMPLETED|Overall Study||96
8752754|NCT01181531|9801977|FG001|COMPLETED|Overall Study||102
8752755|NCT01181531|9801976|FG000|NOT COMPLETED|Overall Study||61
8752756|NCT01181531|9801977|FG001|NOT COMPLETED|Overall Study||53
8752757|NCT01181596|9801983|FG000|STARTED|Overall Study||31
8752758|NCT01181596|9801983|FG000|COMPLETED|Overall Study||31
8752759|NCT01181596|9801983|FG000|NOT COMPLETED|Overall Study||0
8670845|NCT00748540|9714230|FG000|NOT COMPLETED|Overall Study||1
8670846|NCT00748553|9714236|FG000|STARTED|Overall Study||16
8670847|NCT00748553|9714237|FG001|STARTED|Overall Study||14
8670848|NCT00748553|9714236|FG000|COMPLETED|Overall Study||13
8670849|NCT00748553|9714237|FG001|COMPLETED|Overall Study||13
8670850|NCT00748553|9714236|FG000|NOT COMPLETED|Overall Study||3
8670851|NCT00748553|9714237|FG001|NOT COMPLETED|Overall Study||1
8670852|NCT00748566|9714242|FG000|STARTED|Overall Study||172
8670853|NCT00748566|9714242|FG000|COMPLETED|Overall Study||60
8670854|NCT00748566|9714242|FG000|NOT COMPLETED|Overall Study||112
8670855|NCT00748657|9714246|FG000|STARTED|Overall Study||36
8670856|NCT00748657|9714246|FG000|COMPLETED|Overall Study||36
8670857|NCT00748657|9714246|FG000|NOT COMPLETED|Overall Study||0
8670858|NCT00748709|9714256|FG000|STARTED|Overall Study|Treated|20
8670859|NCT00748709|9714256|FG000|COMPLETED|Overall Study||0
8670860|NCT00748709|9714256|FG000|NOT COMPLETED|Overall Study||20
8670861|NCT00748826|9714260|FG000|STARTED|Overall Study|Of 576 total enrolled, 68 out of scope participants were not used for analyses|508
8670862|NCT00748826|9714260|FG000|COMPLETED|Overall Study||207
8670863|NCT00748826|9714260|FG000|NOT COMPLETED|Overall Study||301
9023801|NCT03138798|10086435|FG000|NOT COMPLETED|Overall Study||6
9023802|NCT03138798|10086436|FG001|NOT COMPLETED|Overall Study||4
9023803|NCT03138876|10086443|FG000|STARTED|Overall Study||20
9023804|NCT03138876|10086443|FG000|COMPLETED|Overall Study||20
8670864|NCT00748865|9714264|FG000|STARTED|Overall Study||10
8670865|NCT00748865|9714265|FG001|STARTED|Overall Study||10
8670866|NCT00748865|9714264|FG000|COMPLETED|Overall Study||10
8670867|NCT00748865|9714265|FG001|COMPLETED|Overall Study||10
8752760|NCT01181609|9801988|FG000|STARTED|Overall Study||54
8752761|NCT01181609|9801988|FG000|COMPLETED|Overall Study||1
8752762|NCT01181609|9801988|FG000|NOT COMPLETED|Overall Study||53
8752763|NCT01181674|9801995|FG000|STARTED|Overall Study||28
8752764|NCT01181674|9801996|FG001|STARTED|Overall Study||27
8752765|NCT01181674|9801997|FG002|STARTED|Overall Study||28
8752766|NCT01181674|9801995|FG000|COMPLETED|Overall Study||28
8752767|NCT01181674|9801996|FG001|COMPLETED|Overall Study||27
8752768|NCT01181674|9801997|FG002|COMPLETED|Overall Study|28 included in analyses|26
8752769|NCT01181674|9801995|FG000|NOT COMPLETED|Overall Study||0
8752770|NCT01181674|9801996|FG001|NOT COMPLETED|Overall Study||0
8752771|NCT01181674|9801997|FG002|NOT COMPLETED|Overall Study||2
8752772|NCT01181726|9802007|FG000|STARTED|First Intervention||20
8752773|NCT01181726|9802008|FG001|STARTED|First Intervention||20
8752774|NCT01181726|9802007|FG000|COMPLETED|First Intervention||19
8752775|NCT01181726|9802008|FG001|COMPLETED|First Intervention||20
8752776|NCT01181726|9802007|FG000|NOT COMPLETED|First Intervention||1
8752777|NCT01181726|9802008|FG001|NOT COMPLETED|First Intervention||0
8752778|NCT01181726|9802007|FG000|STARTED|Washout of 28 Days||19
8752779|NCT01181726|9802008|FG001|STARTED|Washout of 28 Days||20
8752780|NCT01181726|9802007|FG000|COMPLETED|Washout of 28 Days||19
8752781|NCT01181726|9802008|FG001|COMPLETED|Washout of 28 Days||20
8752782|NCT01181726|9802007|FG000|NOT COMPLETED|Washout of 28 Days||0
8752783|NCT01181726|9802008|FG001|NOT COMPLETED|Washout of 28 Days||0
8752784|NCT01181726|9802007|FG000|STARTED|Second Intervention||19
8752785|NCT01181726|9802008|FG001|STARTED|Second Intervention||20
8752786|NCT01181726|9802007|FG000|COMPLETED|Second Intervention||19
8752787|NCT01181726|9802008|FG001|COMPLETED|Second Intervention||20
8752788|NCT01181726|9802007|FG000|NOT COMPLETED|Second Intervention||0
8752789|NCT01181726|9802008|FG001|NOT COMPLETED|Second Intervention||0
8752790|NCT01181804|9802018|FG000|STARTED|Period 1, Fed (Part 1)||30
8752791|NCT01181804|9802019|FG001|STARTED|Period 1, Fed (Part 1)||30
8752792|NCT01181804|9802020|FG002|STARTED|Period 1, Fed (Part 1)||0
8914898|NCT02171260|9974469|FG000|COMPLETED|Overall Study||0
8752793|NCT01181804|9802021|FG003|STARTED|Period 1, Fed (Part 1)||0
8752794|NCT01181804|9802018|FG000|COMPLETED|Period 1, Fed (Part 1)||30
8752795|NCT01181804|9802019|FG001|COMPLETED|Period 1, Fed (Part 1)||30
8752796|NCT01181804|9802020|FG002|COMPLETED|Period 1, Fed (Part 1)||0
8752797|NCT01181804|9802021|FG003|COMPLETED|Period 1, Fed (Part 1)||0
8752798|NCT01181804|9802018|FG000|NOT COMPLETED|Period 1, Fed (Part 1)||0
8752799|NCT01181804|9802019|FG001|NOT COMPLETED|Period 1, Fed (Part 1)||0
8752800|NCT01181804|9802020|FG002|NOT COMPLETED|Period 1, Fed (Part 1)||0
8752801|NCT01181804|9802021|FG003|NOT COMPLETED|Period 1, Fed (Part 1)||0
8752802|NCT01181804|9802018|FG000|STARTED|Period 2, Fed (Part 1)||30
8752803|NCT01181804|9802019|FG001|STARTED|Period 2, Fed (Part 1)||30
8752804|NCT01181804|9802020|FG002|STARTED|Period 2, Fed (Part 1)||0
8752805|NCT01181804|9802021|FG003|STARTED|Period 2, Fed (Part 1)||0
8752806|NCT01181804|9802018|FG000|COMPLETED|Period 2, Fed (Part 1)||30
8914899|NCT02171260|9974470|FG001|COMPLETED|Overall Study||0
8914900|NCT02171260|9974471|FG002|COMPLETED|Overall Study||0
8914901|NCT02171260|9974472|FG003|COMPLETED|Overall Study||0
8914902|NCT02171260|9974469|FG000|NOT COMPLETED|Overall Study||6
8914903|NCT02171260|9974470|FG001|NOT COMPLETED|Overall Study||6
8914904|NCT02171260|9974471|FG002|NOT COMPLETED|Overall Study||5
8914905|NCT02171260|9974472|FG003|NOT COMPLETED|Overall Study||5
8914906|NCT02171429|9974491|FG000|STARTED|Overall Study||72
8914907|NCT02171429|9974492|FG001|STARTED|Overall Study||143
8914908|NCT02171429|9974493|FG002|STARTED|Overall Study||143
8914909|NCT02171429|9974491|FG000|Completed Week 10 Visit|Overall Study||70
8914910|NCT02171429|9974492|FG001|Completed Week 10 Visit|Overall Study||141
8914911|NCT02171429|9974493|FG002|Completed Week 10 Visit|Overall Study||141
8914912|NCT02171429|9974491|FG000|COMPLETED|Overall Study||71
8752807|NCT01181804|9802019|FG001|COMPLETED|Period 2, Fed (Part 1)||30
8752808|NCT01181804|9802020|FG002|COMPLETED|Period 2, Fed (Part 1)||0
8752809|NCT01181804|9802021|FG003|COMPLETED|Period 2, Fed (Part 1)||0
8752810|NCT01181804|9802018|FG000|NOT COMPLETED|Period 2, Fed (Part 1)||0
8752811|NCT01181804|9802019|FG001|NOT COMPLETED|Period 2, Fed (Part 1)||0
8752812|NCT01181804|9802020|FG002|NOT COMPLETED|Period 2, Fed (Part 1)||0
8752813|NCT01181804|9802021|FG003|NOT COMPLETED|Period 2, Fed (Part 1)||0
8752814|NCT01181804|9802018|FG000|STARTED|Period 3, Fasted (Part 2)||0
8752815|NCT01181804|9802019|FG001|STARTED|Period 3, Fasted (Part 2)||0
8752816|NCT01181804|9802020|FG002|STARTED|Period 3, Fasted (Part 2)||59
8752817|NCT01181804|9802021|FG003|STARTED|Period 3, Fasted (Part 2)||58
8752818|NCT01181804|9802018|FG000|COMPLETED|Period 3, Fasted (Part 2)||0
8752819|NCT01181804|9802019|FG001|COMPLETED|Period 3, Fasted (Part 2)||0
8752820|NCT01181804|9802020|FG002|COMPLETED|Period 3, Fasted (Part 2)||59
8752821|NCT01181804|9802021|FG003|COMPLETED|Period 3, Fasted (Part 2)||58
8752822|NCT01181804|9802018|FG000|NOT COMPLETED|Period 3, Fasted (Part 2)||0
8752823|NCT01181804|9802019|FG001|NOT COMPLETED|Period 3, Fasted (Part 2)||0
8752824|NCT01181804|9802020|FG002|NOT COMPLETED|Period 3, Fasted (Part 2)||0
8752825|NCT01181804|9802021|FG003|NOT COMPLETED|Period 3, Fasted (Part 2)||0
8752826|NCT01181804|9802018|FG000|STARTED|Period 4, Fasted (Part 2)||0
8752827|NCT01181804|9802019|FG001|STARTED|Period 4, Fasted (Part 2)||0
8752828|NCT01181804|9802020|FG002|STARTED|Period 4, Fasted (Part 2)||59
8752829|NCT01181804|9802021|FG003|STARTED|Period 4, Fasted (Part 2)||58
8752830|NCT01181804|9802018|FG000|COMPLETED|Period 4, Fasted (Part 2)||0
8752831|NCT01181804|9802019|FG001|COMPLETED|Period 4, Fasted (Part 2)||0
8752832|NCT01181804|9802020|FG002|COMPLETED|Period 4, Fasted (Part 2)||58
8752833|NCT01181804|9802021|FG003|COMPLETED|Period 4, Fasted (Part 2)||58
8752834|NCT01181804|9802018|FG000|NOT COMPLETED|Period 4, Fasted (Part 2)||0
8752835|NCT01181804|9802019|FG001|NOT COMPLETED|Period 4, Fasted (Part 2)||0
8752836|NCT01181804|9802020|FG002|NOT COMPLETED|Period 4, Fasted (Part 2)||1
8752837|NCT01181804|9802021|FG003|NOT COMPLETED|Period 4, Fasted (Part 2)||0
8752838|NCT01181895|9802034|FG000|STARTED|Overall Study||116
8752839|NCT01181895|9802035|FG001|STARTED|Overall Study||115
8752840|NCT01181895|9802036|FG002|STARTED|Overall Study||116
8752841|NCT01181895|9802034|FG000|COMPLETED|Overall Study||99
8752842|NCT01181895|9802035|FG001|COMPLETED|Overall Study||101
8752843|NCT01181895|9802036|FG002|COMPLETED|Overall Study||98
8752844|NCT01181895|9802034|FG000|NOT COMPLETED|Overall Study||17
8752845|NCT01181895|9802035|FG001|NOT COMPLETED|Overall Study||14
8752846|NCT01181895|9802036|FG002|NOT COMPLETED|Overall Study||18
8752847|NCT01181947|9802044|FG000|STARTED|Overall Study||100
8752848|NCT01181947|9802044|FG000|COMPLETED|Overall Study||100
8752849|NCT01181947|9802044|FG000|NOT COMPLETED|Overall Study||0
8752850|NCT01181986|9802051|FG000|STARTED|Phase 1||19
8752851|NCT01181986|9802052|FG001|STARTED|Phase 1||23
8752852|NCT01181986|9802053|FG002|STARTED|Phase 1||34
8752853|NCT01181986|9802051|FG000|Saline+Exenatide|Phase 1|N/A for this arm|0
8752854|NCT01181986|9802052|FG001|Saline+Exenatide|Phase 1|N/A for this arm|0
8752855|NCT01181986|9802053|FG002|Saline+Exenatide|Phase 1||32
8752856|NCT01181986|9802051|FG000|Saline+Placebo|Phase 1|N/A for this arm|0
8752857|NCT01181986|9802052|FG001|Saline+Placebo|Phase 1|N/A for this arm|0
8752858|NCT01181986|9802053|FG002|Saline+Placebo|Phase 1||33
8752859|NCT01181986|9802051|FG000|Exendin-9+Exenatide|Phase 1|N/A for this arm|0
8752860|NCT01181986|9802052|FG001|Exendin-9+Exenatide|Phase 1|N/A for this arm|0
8752861|NCT01181986|9802053|FG002|Exendin-9+Exenatide|Phase 1||33
8752862|NCT01181986|9802051|FG000|COMPLETED|Phase 1||18
8752863|NCT01181986|9802052|FG001|COMPLETED|Phase 1||22
8752864|NCT01181986|9802053|FG002|COMPLETED|Phase 1||32
8752865|NCT01181986|9802051|FG000|NOT COMPLETED|Phase 1||1
8752866|NCT01181986|9802052|FG001|NOT COMPLETED|Phase 1||1
8752867|NCT01181986|9802053|FG002|NOT COMPLETED|Phase 1||2
8752868|NCT01181986|9802051|FG000|STARTED|Phase 2||18
8752869|NCT01181986|9802052|FG001|STARTED|Phase 2||22
8752870|NCT01181986|9802053|FG002|STARTED|Phase 2|N/A for Sub-study 2|0
8752871|NCT01181986|9802051|FG000|COMPLETED|Phase 2||18
8752872|NCT01181986|9802052|FG001|COMPLETED|Phase 2||18
8752873|NCT01181986|9802053|FG002|COMPLETED|Phase 2||0
8752874|NCT01181986|9802051|FG000|NOT COMPLETED|Phase 2||0
8752875|NCT01181986|9802052|FG001|NOT COMPLETED|Phase 2||4
8752876|NCT01181986|9802053|FG002|NOT COMPLETED|Phase 2||0
8752877|NCT01182103|9802069|FG000|STARTED|Overall Study||48
8752878|NCT01182103|9802070|FG001|STARTED|Overall Study||62
8752879|NCT01182103|9802069|FG000|COMPLETED|Overall Study||48
8752880|NCT01182103|9802070|FG001|COMPLETED|Overall Study||62
8752881|NCT01182103|9802069|FG000|NOT COMPLETED|Overall Study||0
8752882|NCT01182103|9802070|FG001|NOT COMPLETED|Overall Study||0
8752883|NCT01182181|9802081|FG000|STARTED|First Intervention||11
8752884|NCT01182181|9802082|FG001|STARTED|First Intervention||11
8752885|NCT01182181|9802081|FG000|COMPLETED|First Intervention||10
8752886|NCT01182181|9802082|FG001|COMPLETED|First Intervention||11
8752887|NCT01182181|9802081|FG000|NOT COMPLETED|First Intervention||1
8752888|NCT01182181|9802082|FG001|NOT COMPLETED|First Intervention||0
8752889|NCT01182181|9802081|FG000|STARTED|Washout of 21 Days||10
8752890|NCT01182181|9802082|FG001|STARTED|Washout of 21 Days||11
8752891|NCT01182181|9802081|FG000|COMPLETED|Washout of 21 Days||10
8752892|NCT01182181|9802082|FG001|COMPLETED|Washout of 21 Days||10
8752893|NCT01182181|9802081|FG000|NOT COMPLETED|Washout of 21 Days||0
8752894|NCT01182181|9802082|FG001|NOT COMPLETED|Washout of 21 Days||1
8752895|NCT01182181|9802081|FG000|STARTED|Second Intervention||10
8752896|NCT01182181|9802082|FG001|STARTED|Second Intervention||10
8752897|NCT01182181|9802081|FG000|COMPLETED|Second Intervention||10
8752898|NCT01182181|9802082|FG001|COMPLETED|Second Intervention||10
8752899|NCT01182181|9802081|FG000|NOT COMPLETED|Second Intervention||0
8752900|NCT01182181|9802082|FG001|NOT COMPLETED|Second Intervention||0
8752901|NCT01182194|9802090|FG000|STARTED|First Intervention||16
8752902|NCT01182194|9802091|FG001|STARTED|First Intervention||16
8752903|NCT01182194|9802090|FG000|COMPLETED|First Intervention||16
8752904|NCT01182194|9802091|FG001|COMPLETED|First Intervention||16
8752905|NCT01182194|9802090|FG000|NOT COMPLETED|First Intervention||0
8752906|NCT01182194|9802091|FG001|NOT COMPLETED|First Intervention||0
8752907|NCT01182194|9802090|FG000|STARTED|Washout of 28 Days||16
8752908|NCT01182194|9802091|FG001|STARTED|Washout of 28 Days||16
8752909|NCT01182194|9802090|FG000|COMPLETED|Washout of 28 Days||15
8752910|NCT01182194|9802091|FG001|COMPLETED|Washout of 28 Days||16
8752911|NCT01182194|9802090|FG000|NOT COMPLETED|Washout of 28 Days||1
8752912|NCT01182194|9802091|FG001|NOT COMPLETED|Washout of 28 Days||0
8752913|NCT01182194|9802090|FG000|STARTED|Second Intervention||15
8752914|NCT01182194|9802091|FG001|STARTED|Second Intervention||16
8752915|NCT01182194|9802090|FG000|COMPLETED|Second Intervention||15
8752916|NCT01182194|9802091|FG001|COMPLETED|Second Intervention||16
8752917|NCT01182194|9802090|FG000|NOT COMPLETED|Second Intervention||0
8752918|NCT01182194|9802091|FG001|NOT COMPLETED|Second Intervention||0
8752919|NCT01182207|9802099|FG000|STARTED|First Intervention||18
8752920|NCT01182207|9802100|FG001|STARTED|First Intervention||15
8752921|NCT01182207|9802099|FG000|COMPLETED|First Intervention||18
8752922|NCT01182207|9802100|FG001|COMPLETED|First Intervention||14
8752923|NCT01182207|9802099|FG000|NOT COMPLETED|First Intervention||0
8752924|NCT01182207|9802100|FG001|NOT COMPLETED|First Intervention||1
8752925|NCT01182207|9802099|FG000|STARTED|Washout of 28 Days||18
8752926|NCT01182207|9802100|FG001|STARTED|Washout of 28 Days||14
8752927|NCT01182207|9802099|FG000|COMPLETED|Washout of 28 Days||18
8752928|NCT01182207|9802100|FG001|COMPLETED|Washout of 28 Days||14
8752929|NCT01182207|9802099|FG000|NOT COMPLETED|Washout of 28 Days||0
8752930|NCT01182207|9802100|FG001|NOT COMPLETED|Washout of 28 Days||0
8752931|NCT01182207|9802099|FG000|STARTED|Second Intervention||18
8752932|NCT01182207|9802100|FG001|STARTED|Second Intervention||14
8752933|NCT01182207|9802099|FG000|COMPLETED|Second Intervention||17
8752934|NCT01182207|9802100|FG001|COMPLETED|Second Intervention||14
8752935|NCT01182207|9802099|FG000|NOT COMPLETED|Second Intervention||1
8752936|NCT01182207|9802100|FG001|NOT COMPLETED|Second Intervention||0
8752937|NCT01182285|9802106|FG000|STARTED|First Intervention Week 1-10||13
8752938|NCT01182285|9802107|FG001|STARTED|First Intervention Week 1-10||0
8752939|NCT01182285|9802108|FG002|STARTED|First Intervention Week 1-10||0
8752940|NCT01182285|9802106|FG000|COMPLETED|First Intervention Week 1-10||10
8752941|NCT01182285|9802107|FG001|COMPLETED|First Intervention Week 1-10||0
8752942|NCT01182285|9802108|FG002|COMPLETED|First Intervention Week 1-10||0
8752943|NCT01182285|9802106|FG000|NOT COMPLETED|First Intervention Week 1-10||3
8752944|NCT01182285|9802107|FG001|NOT COMPLETED|First Intervention Week 1-10||0
8752945|NCT01182285|9802108|FG002|NOT COMPLETED|First Intervention Week 1-10||0
8752946|NCT01182285|9802106|FG000|STARTED|Second Intervention Week 11-17||0
8752947|NCT01182285|9802107|FG001|STARTED|Second Intervention Week 11-17||0
8752948|NCT01182285|9802108|FG002|STARTED|Second Intervention Week 11-17||0
8752949|NCT01182285|9802106|FG000|COMPLETED|Second Intervention Week 11-17||0
8752950|NCT01182285|9802107|FG001|COMPLETED|Second Intervention Week 11-17||0
8752951|NCT01182285|9802108|FG002|COMPLETED|Second Intervention Week 11-17||0
8752952|NCT01182285|9802106|FG000|NOT COMPLETED|Second Intervention Week 11-17||0
8752953|NCT01182285|9802107|FG001|NOT COMPLETED|Second Intervention Week 11-17||0
8752954|NCT01182285|9802108|FG002|NOT COMPLETED|Second Intervention Week 11-17||0
8752955|NCT01182285|9802106|FG000|STARTED|Third Intervention Week 11-52||0
8752956|NCT01182285|9802107|FG001|STARTED|Third Intervention Week 11-52||0
8752957|NCT01182285|9802108|FG002|STARTED|Third Intervention Week 11-52|2 subj. taken off study after completing ph 1: 1 due to a negative uptake scan & one off due to PD.|8
8752958|NCT01182285|9802106|FG000|COMPLETED|Third Intervention Week 11-52||0
8752959|NCT01182285|9802107|FG001|COMPLETED|Third Intervention Week 11-52||0
8752960|NCT01182285|9802108|FG002|COMPLETED|Third Intervention Week 11-52||0
8752961|NCT01182285|9802106|FG000|NOT COMPLETED|Third Intervention Week 11-52||0
8752962|NCT01182285|9802107|FG001|NOT COMPLETED|Third Intervention Week 11-52||0
8752963|NCT01182285|9802108|FG002|NOT COMPLETED|Third Intervention Week 11-52||8
8752964|NCT01182298|9802115|FG000|STARTED|Overall Study||10
8752965|NCT01182298|9802115|FG000|COMPLETED|Overall Study||4
8752966|NCT01182298|9802115|FG000|NOT COMPLETED|Overall Study||6
8752967|NCT01182337|9802121|FG000|STARTED|Overall Study||22
8752968|NCT01182337|9802122|FG001|STARTED|Overall Study||9
8752969|NCT01182337|9802121|FG000|COMPLETED|Overall Study||19
8752970|NCT01182337|9802122|FG001|COMPLETED|Overall Study||7
8752971|NCT01182337|9802121|FG000|NOT COMPLETED|Overall Study||3
8752972|NCT01182337|9802122|FG001|NOT COMPLETED|Overall Study||2
8752973|NCT01182350|9802129|FG000|STARTED|Overall Study||30
8752974|NCT01182350|9802130|FG001|STARTED|Overall Study||14
8752975|NCT01182350|9802131|FG002|STARTED|Overall Study||3
8752976|NCT01182350|9802132|FG003|STARTED|Overall Study||3
8752977|NCT01182350|9802133|FG004|STARTED|Overall Study||3
8752978|NCT01182350|9802129|FG000|Underwent Stereotactic Biopsy|Overall Study||30
8752979|NCT01182350|9802130|FG001|Underwent Stereotactic Biopsy|Overall Study||14
8752980|NCT01182350|9802131|FG002|Underwent Stereotactic Biopsy|Overall Study||3
8752981|NCT01182350|9802132|FG003|Underwent Stereotactic Biopsy|Overall Study||3
8752982|NCT01182350|9802133|FG004|Underwent Stereotactic Biopsy|Overall Study||0
8752983|NCT01182350|9802129|FG000|Started Assigned Chemoradiation|Overall Study||27
8752984|NCT01182350|9802130|FG001|Started Assigned Chemoradiation|Overall Study||14
8752985|NCT01182350|9802131|FG002|Started Assigned Chemoradiation|Overall Study||2
8752986|NCT01182350|9802132|FG003|Started Assigned Chemoradiation|Overall Study||2
8752987|NCT01182350|9802133|FG004|Started Assigned Chemoradiation|Overall Study||0
8752988|NCT01182350|9802129|FG000|COMPLETED|Overall Study||3
8752989|NCT01182350|9802130|FG001|COMPLETED|Overall Study||0
8752990|NCT01182350|9802131|FG002|COMPLETED|Overall Study||0
8752991|NCT01182350|9802132|FG003|COMPLETED|Overall Study||0
8752992|NCT01182350|9802133|FG004|COMPLETED|Overall Study||0
8752993|NCT01182350|9802129|FG000|NOT COMPLETED|Overall Study||27
8752994|NCT01182350|9802130|FG001|NOT COMPLETED|Overall Study||14
8752995|NCT01182350|9802131|FG002|NOT COMPLETED|Overall Study||3
8752996|NCT01182350|9802132|FG003|NOT COMPLETED|Overall Study||3
8752997|NCT01182350|9802133|FG004|NOT COMPLETED|Overall Study||3
8752998|NCT01182376|9802151|FG000|STARTED|Overall Study||15
8752999|NCT01182376|9802152|FG001|STARTED|Overall Study||18
8753000|NCT01182376|9802151|FG000|COMPLETED|Overall Study||4
8753001|NCT01182376|9802152|FG001|COMPLETED|Overall Study||13
8753002|NCT01182376|9802151|FG000|NOT COMPLETED|Overall Study||11
8753003|NCT01182376|9802152|FG001|NOT COMPLETED|Overall Study||5
8753004|NCT01182415|9802158|FG000|STARTED|Overall Study||30
8753005|NCT01182415|9802158|FG000|COMPLETED|Overall Study||29
8753006|NCT01182415|9802158|FG000|NOT COMPLETED|Overall Study||1
8753007|NCT01182428|9802164|FG000|STARTED|Overall Study||304
8753008|NCT01182428|9802165|FG001|STARTED|Overall Study||151
8753009|NCT01182428|9802164|FG000|COMPLETED|Overall Study||293
8753010|NCT01182428|9802165|FG001|COMPLETED|Overall Study||150
8753011|NCT01182428|9802164|FG000|NOT COMPLETED|Overall Study||11
8753012|NCT01182428|9802165|FG001|NOT COMPLETED|Overall Study||1
8753013|NCT01182441|9802173|FG000|STARTED|Overall Study||269
8753014|NCT01182441|9802174|FG001|STARTED|Overall Study||138
8753015|NCT01182441|9802173|FG000|COMPLETED|Overall Study||49
8753016|NCT01182441|9802174|FG001|COMPLETED|Overall Study||19
8753017|NCT01182441|9802173|FG000|NOT COMPLETED|Overall Study||220
8753018|NCT01182441|9802174|FG001|NOT COMPLETED|Overall Study||119
8753019|NCT01182480|9802180|FG000|STARTED|Overall Study||47
8753020|NCT01182480|9802180|FG000|COMPLETED|Overall Study||47
8753021|NCT01182480|9802180|FG000|NOT COMPLETED|Overall Study||0
8914913|NCT02171429|9974492|FG001|COMPLETED|Overall Study||140
8914914|NCT02171429|9974493|FG002|COMPLETED|Overall Study||138
8914915|NCT02171429|9974491|FG000|NOT COMPLETED|Overall Study||1
8914916|NCT02171429|9974492|FG001|NOT COMPLETED|Overall Study||3
8914917|NCT02171429|9974493|FG002|NOT COMPLETED|Overall Study||5
8914918|NCT02171611|9974504|FG000|STARTED|Overall Study||5
8914919|NCT02171611|9974505|FG001|STARTED|Overall Study||5
8914920|NCT02171611|9974506|FG002|STARTED|Overall Study||5
8914921|NCT02171611|9974507|FG003|STARTED|Overall Study||5
8914922|NCT02171611|9974508|FG004|STARTED|Overall Study||5
8914923|NCT02171611|9974509|FG005|STARTED|Overall Study||5
9023805|NCT03138876|10086443|FG000|NOT COMPLETED|Overall Study||0
9023806|NCT03138967|10086449|FG000|STARTED|Overall Study||26
9023807|NCT03138967|10086450|FG001|STARTED|Overall Study||28
9023808|NCT03138967|10086449|FG000|Post-operative Day(POD) 1 Follow-up|Overall Study||25
9023809|NCT03138967|10086450|FG001|Post-operative Day(POD) 1 Follow-up|Overall Study||25
9023810|NCT03138967|10086449|FG000|Post-operative Day(POD) 7 Follow-up|Overall Study||25
9023811|NCT03138967|10086450|FG001|Post-operative Day(POD) 7 Follow-up|Overall Study||24
9023812|NCT03138967|10086449|FG000|COMPLETED|Overall Study||25
9023813|NCT03138967|10086450|FG001|COMPLETED|Overall Study||24
9023814|NCT03138967|10086449|FG000|NOT COMPLETED|Overall Study||1
9023815|NCT03138967|10086450|FG001|NOT COMPLETED|Overall Study||4
9023816|NCT03139032|10086456|FG000|STARTED|Overall Study||1
9023817|NCT03139032|10086456|FG000|COMPLETED|Overall Study||1
9023818|NCT03139032|10086456|FG000|NOT COMPLETED|Overall Study||0
9023819|NCT03139240|10086465|FG000|STARTED|Overall Study||48
9023820|NCT03139240|10086466|FG001|STARTED|Overall Study||48
9023821|NCT03139240|10086467|FG002|STARTED|Overall Study||38
9023822|NCT03139240|10086468|FG003|STARTED|Overall Study||38
9023823|NCT03139240|10086465|FG000|COMPLETED|Overall Study||48
9023824|NCT03139240|10086466|FG001|COMPLETED|Overall Study||47
9023825|NCT03139240|10086467|FG002|COMPLETED|Overall Study||37
9023826|NCT03139240|10086468|FG003|COMPLETED|Overall Study||38
9023827|NCT03139240|10086465|FG000|NOT COMPLETED|Overall Study||0
9023828|NCT03139240|10086466|FG001|NOT COMPLETED|Overall Study||1
9023829|NCT03139240|10086467|FG002|NOT COMPLETED|Overall Study||1
9023830|NCT03139240|10086468|FG003|NOT COMPLETED|Overall Study||0
8753022|NCT01182493|9802186|FG000|STARTED|Overall Study||168
8753023|NCT01182493|9802187|FG001|STARTED|Overall Study||163
8753024|NCT01182493|9802186|FG000|COMPLETED|Overall Study||152
8753025|NCT01182493|9802187|FG001|COMPLETED|Overall Study||156
8753026|NCT01182493|9802186|FG000|NOT COMPLETED|Overall Study||16
8753027|NCT01182493|9802187|FG001|NOT COMPLETED|Overall Study||7
8753028|NCT01182675|9802195|FG000|STARTED|Overall Study||7
8753029|NCT01182675|9802196|FG001|STARTED|Overall Study||0
8753030|NCT01182675|9802195|FG000|COMPLETED|Overall Study||7
8753031|NCT01182675|9802196|FG001|COMPLETED|Overall Study||0
8914924|NCT02171611|9974504|FG000|COMPLETED|Overall Study||5
9023831|NCT03139279|10086478|FG000|STARTED|Overall Study||58
8753032|NCT01182675|9802195|FG000|NOT COMPLETED|Overall Study||0
8753033|NCT01182675|9802196|FG001|NOT COMPLETED|Overall Study||0
8753034|NCT01182805|9802204|FG000|STARTED|Overall Study||50
8753035|NCT01182805|9802204|FG000|COMPLETED|Overall Study||50
8753036|NCT01182805|9802204|FG000|NOT COMPLETED|Overall Study||0
8753037|NCT01182844|9802212|FG000|STARTED|Overall Study||15
8753038|NCT01182844|9802213|FG001|STARTED|Overall Study||15
8753039|NCT01182844|9802212|FG000|COMPLETED|Overall Study||15
8753040|NCT01182844|9802213|FG001|COMPLETED|Overall Study||13
8753041|NCT01182844|9802212|FG000|NOT COMPLETED|Overall Study||0
8753042|NCT01182844|9802213|FG001|NOT COMPLETED|Overall Study||2
8753043|NCT01183013|9802226|FG000|STARTED|Overall Study||131
8753044|NCT01183013|9802227|FG001|STARTED|Overall Study||140
8753045|NCT01183013|9802228|FG002|STARTED|Overall Study||138
8753046|NCT01183013|9802229|FG003|STARTED|Overall Study||135
8753047|NCT01183013|9802230|FG004|STARTED|Overall Study||126
8753048|NCT01183013|9802231|FG005|STARTED|Overall Study||133
8753049|NCT01183013|9802232|FG006|STARTED|Overall Study||133
8753050|NCT01183013|9802226|FG000|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|86
8753051|NCT01183013|9802227|FG001|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|101
8753052|NCT01183013|9802228|FG002|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|97
8753053|NCT01183013|9802229|FG003|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|105
8753054|NCT01183013|9802230|FG004|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|90
8753055|NCT01183013|9802231|FG005|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|88
8753056|NCT01183013|9802232|FG006|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|96
8753057|NCT01183013|9802226|FG000|NOT COMPLETED|Overall Study||45
8753058|NCT01183013|9802227|FG001|NOT COMPLETED|Overall Study||39
8753059|NCT01183013|9802228|FG002|NOT COMPLETED|Overall Study||41
8753060|NCT01183013|9802229|FG003|NOT COMPLETED|Overall Study||30
8753061|NCT01183013|9802230|FG004|NOT COMPLETED|Overall Study||36
8753062|NCT01183013|9802231|FG005|NOT COMPLETED|Overall Study||45
8753063|NCT01183013|9802232|FG006|NOT COMPLETED|Overall Study||37
8753064|NCT01183065|9802249|FG000|STARTED|Overall Study||13
8753065|NCT01183065|9802249|FG000|COMPLETED|Overall Study||12
8753066|NCT01183065|9802249|FG000|NOT COMPLETED|Overall Study||1
9023832|NCT03139279|10086479|FG001|STARTED|Overall Study||56
9023833|NCT03139279|10086478|FG000|COMPLETED|Overall Study||51
9023834|NCT03139279|10086479|FG001|COMPLETED|Overall Study||50
9023835|NCT03139279|10086478|FG000|NOT COMPLETED|Overall Study||7
9023836|NCT03139279|10086479|FG001|NOT COMPLETED|Overall Study||6
9023837|NCT03139448|10086487|FG000|STARTED|Overall Study||85
9023838|NCT03139448|10086488|FG001|STARTED|Overall Study||89
9023839|NCT03139448|10086487|FG000|Intervention Started|Overall Study||79
9023840|NCT03139448|10086488|FG001|Intervention Started|Overall Study||70
9023841|NCT03139448|10086487|FG000|COMPLETED|Overall Study||73
9023842|NCT03139448|10086488|FG001|COMPLETED|Overall Study||63
9023843|NCT03139448|10086487|FG000|NOT COMPLETED|Overall Study||12
9023844|NCT03139448|10086488|FG001|NOT COMPLETED|Overall Study||26
9023845|NCT03139552|10086494|FG000|STARTED|Overall Study||150
9023846|NCT03139552|10086494|FG000|COMPLETED|Overall Study||147
9023847|NCT03139552|10086494|FG000|NOT COMPLETED|Overall Study||3
9023848|NCT03139578|10086505|FG000|STARTED|Period 1||12
9023849|NCT03139578|10086506|FG001|STARTED|Period 1||13
9023850|NCT03139578|10086507|FG002|STARTED|Period 1||12
9023851|NCT03139578|10086508|FG003|STARTED|Period 1||13
9023852|NCT03139578|10086505|FG000|Discontinued|Period 1||0
9023853|NCT03139578|10086506|FG001|Discontinued|Period 1||0
9023854|NCT03139578|10086507|FG002|Discontinued|Period 1||0
9023855|NCT03139578|10086508|FG003|Discontinued|Period 1||0
9023856|NCT03139578|10086505|FG000|COMPLETED|Period 1||12
9023857|NCT03139578|10086506|FG001|COMPLETED|Period 1||13
9023858|NCT03139578|10086507|FG002|COMPLETED|Period 1||12
9023859|NCT03139578|10086508|FG003|COMPLETED|Period 1||13
9023860|NCT03139578|10086505|FG000|NOT COMPLETED|Period 1||0
9023861|NCT03139578|10086506|FG001|NOT COMPLETED|Period 1||0
9023862|NCT03139578|10086507|FG002|NOT COMPLETED|Period 1||0
9023863|NCT03139578|10086508|FG003|NOT COMPLETED|Period 1||0
9023864|NCT03139578|10086505|FG000|STARTED|Period 2||12
9023865|NCT03139578|10086506|FG001|STARTED|Period 2||13
9023866|NCT03139578|10086507|FG002|STARTED|Period 2||12
9023867|NCT03139578|10086508|FG003|STARTED|Period 2||13
9023868|NCT03139578|10086505|FG000|Discontinued|Period 2||0
9023869|NCT03139578|10086506|FG001|Discontinued|Period 2||0
9023870|NCT03139578|10086507|FG002|Discontinued|Period 2||0
9023871|NCT03139578|10086508|FG003|Discontinued|Period 2||0
9023872|NCT03139578|10086505|FG000|COMPLETED|Period 2||12
9023873|NCT03139578|10086506|FG001|COMPLETED|Period 2||13
9023874|NCT03139578|10086507|FG002|COMPLETED|Period 2||12
8753067|NCT01183104|9802255|FG000|STARTED|Overall Study||153
9023875|NCT03139578|10086508|FG003|COMPLETED|Period 2||13
9023876|NCT03139578|10086505|FG000|NOT COMPLETED|Period 2||0
9023877|NCT03139578|10086506|FG001|NOT COMPLETED|Period 2||0
9023878|NCT03139578|10086507|FG002|NOT COMPLETED|Period 2||0
9023879|NCT03139578|10086508|FG003|NOT COMPLETED|Period 2||0
9023880|NCT03139604|10086520|FG000|STARTED|Overall Study||219
9023881|NCT03139604|10086521|FG001|STARTED|Overall Study||220
9039982|NCT03345108|10100892|FG003|STARTED|Period-2||8
8753068|NCT01183104|9802256|FG001|STARTED|Overall Study||152
8753069|NCT01183104|9802255|FG000|Received Study Drug|Overall Study||148
8753070|NCT01183104|9802256|FG001|Received Study Drug|Overall Study||143
8753071|NCT01183104|9802255|FG000|Continued Treatment for 12 Weeks|Overall Study||143
8753072|NCT01183104|9802256|FG001|Continued Treatment for 12 Weeks|Overall Study||129
8753073|NCT01183104|9802255|FG000|Completed 52-week Treatment|Overall Study||119
8753074|NCT01183104|9802256|FG001|Completed 52-week Treatment|Overall Study||111
8753075|NCT01183104|9802255|FG000|Enrolled in Extension Study|Overall Study||80
8753076|NCT01183104|9802256|FG001|Enrolled in Extension Study|Overall Study||61
8753077|NCT01183104|9802255|FG000|COMPLETED|Overall Study||76
8753078|NCT01183104|9802256|FG001|COMPLETED|Overall Study||60
8753079|NCT01183104|9802255|FG000|NOT COMPLETED|Overall Study||77
8753080|NCT01183104|9802256|FG001|NOT COMPLETED|Overall Study||92
8753081|NCT01183143|9802262|FG000|STARTED|Overall Study||215
8753082|NCT01183143|9802262|FG000|Intention to Treat (ITT) Population|Overall Study|ITT=Subjects who received at least 1 dose of the investigational medicinal product (IMP).|204
8753083|NCT01183143|9802262|FG000|COMPLETED|Overall Study||65
8753084|NCT01183143|9802262|FG000|NOT COMPLETED|Overall Study||150
8753085|NCT01183169|9802270|FG000|STARTED|Main Phase||121
8753086|NCT01183169|9802271|FG001|STARTED|Main Phase||115
8753087|NCT01183169|9802272|FG002|STARTED|Main Phase||59
8753088|NCT01183169|9802273|FG003|STARTED|Main Phase||55
8753089|NCT01183169|9802274|FG004|STARTED|Main Phase||109
8753090|NCT01183169|9802275|FG005|STARTED|Main Phase||0
8753091|NCT01183169|9802276|FG006|STARTED|Main Phase||0
8753092|NCT01183169|9802270|FG000|Completed Treatment|Main Phase||72
8753093|NCT01183169|9802271|FG001|Completed Treatment|Main Phase||78
8753094|NCT01183169|9802272|FG002|Completed Treatment|Main Phase||17
8753095|NCT01183169|9802273|FG003|Completed Treatment|Main Phase||17
8753096|NCT01183169|9802274|FG004|Completed Treatment|Main Phase||77
8753097|NCT01183169|9802275|FG005|Completed Treatment|Main Phase||0
8753098|NCT01183169|9802276|FG006|Completed Treatment|Main Phase||0
8753099|NCT01183169|9802270|FG000|Switched to ALV|Main Phase||0
8753100|NCT01183169|9802271|FG001|Switched to ALV|Main Phase||0
8753101|NCT01183169|9802272|FG002|Switched to ALV|Main Phase||35
8753102|NCT01183169|9802273|FG003|Switched to ALV|Main Phase||30
8753103|NCT01183169|9802274|FG004|Switched to ALV|Main Phase||0
8753104|NCT01183169|9802275|FG005|Switched to ALV|Main Phase||0
8753105|NCT01183169|9802276|FG006|Switched to ALV|Main Phase||0
8753106|NCT01183169|9802270|FG000|COMPLETED|Main Phase||94
8753107|NCT01183169|9802271|FG001|COMPLETED|Main Phase||93
8753108|NCT01183169|9802272|FG002|COMPLETED|Main Phase||18
8753109|NCT01183169|9802273|FG003|COMPLETED|Main Phase||18
8753110|NCT01183169|9802274|FG004|COMPLETED|Main Phase||83
8753111|NCT01183169|9802275|FG005|COMPLETED|Main Phase||0
8753112|NCT01183169|9802276|FG006|COMPLETED|Main Phase||0
8753113|NCT01183169|9802270|FG000|NOT COMPLETED|Main Phase||27
8753114|NCT01183169|9802271|FG001|NOT COMPLETED|Main Phase||22
8753115|NCT01183169|9802272|FG002|NOT COMPLETED|Main Phase||41
8753116|NCT01183169|9802273|FG003|NOT COMPLETED|Main Phase||37
8753117|NCT01183169|9802274|FG004|NOT COMPLETED|Main Phase||26
8753118|NCT01183169|9802275|FG005|NOT COMPLETED|Main Phase||0
8753119|NCT01183169|9802276|FG006|NOT COMPLETED|Main Phase||0
8753120|NCT01183169|9802270|FG000|STARTED|Post-switch Phase|Not a post-switch group|0
8753121|NCT01183169|9802271|FG001|STARTED|Post-switch Phase|Not a post-switch group|0
8753122|NCT01183169|9802272|FG002|STARTED|Post-switch Phase|Not a post-switch group|0
8753123|NCT01183169|9802273|FG003|STARTED|Post-switch Phase|Not a post-switch group|0
8753124|NCT01183169|9802274|FG004|STARTED|Post-switch Phase|Not a post-switch group|0
8753125|NCT01183169|9802275|FG005|STARTED|Post-switch Phase|Participants in Treatment C1 who switched to active ALV|35
8753126|NCT01183169|9802276|FG006|STARTED|Post-switch Phase|Participants in Treatment C2 who switched to active ALV|30
8753127|NCT01183169|9802270|FG000|Completed Treatment|Post-switch Phase||0
8753128|NCT01183169|9802271|FG001|Completed Treatment|Post-switch Phase||0
8753129|NCT01183169|9802272|FG002|Completed Treatment|Post-switch Phase||0
8753130|NCT01183169|9802273|FG003|Completed Treatment|Post-switch Phase||0
8753131|NCT01183169|9802274|FG004|Completed Treatment|Post-switch Phase||0
8753132|NCT01183169|9802275|FG005|Completed Treatment|Post-switch Phase||12
8753133|NCT01183169|9802276|FG006|Completed Treatment|Post-switch Phase||13
8753134|NCT01183169|9802270|FG000|COMPLETED|Post-switch Phase||0
8753135|NCT01183169|9802271|FG001|COMPLETED|Post-switch Phase||0
8753136|NCT01183169|9802272|FG002|COMPLETED|Post-switch Phase||0
8753137|NCT01183169|9802273|FG003|COMPLETED|Post-switch Phase||0
8753138|NCT01183169|9802274|FG004|COMPLETED|Post-switch Phase||0
8753139|NCT01183169|9802275|FG005|COMPLETED|Post-switch Phase||21
8753140|NCT01183169|9802276|FG006|COMPLETED|Post-switch Phase||21
8753141|NCT01183169|9802270|FG000|NOT COMPLETED|Post-switch Phase||0
8753142|NCT01183169|9802271|FG001|NOT COMPLETED|Post-switch Phase||0
8753143|NCT01183169|9802272|FG002|NOT COMPLETED|Post-switch Phase||0
8753144|NCT01183169|9802273|FG003|NOT COMPLETED|Post-switch Phase||0
8914925|NCT02171611|9974505|FG001|COMPLETED|Overall Study||5
8753145|NCT01183169|9802274|FG004|NOT COMPLETED|Post-switch Phase||0
8753146|NCT01183169|9802275|FG005|NOT COMPLETED|Post-switch Phase||14
8753147|NCT01183169|9802276|FG006|NOT COMPLETED|Post-switch Phase||9
8753148|NCT01183234|9802296|FG000|STARTED|First Intervention||14
8753149|NCT01183234|9802297|FG001|STARTED|First Intervention||14
8753150|NCT01183234|9802296|FG000|COMPLETED|First Intervention||13
8753151|NCT01183234|9802297|FG001|COMPLETED|First Intervention||14
8753152|NCT01183234|9802296|FG000|NOT COMPLETED|First Intervention||1
8753153|NCT01183234|9802297|FG001|NOT COMPLETED|First Intervention||0
8753154|NCT01183234|9802296|FG000|STARTED|Washout||13
8753155|NCT01183234|9802297|FG001|STARTED|Washout||14
8753156|NCT01183234|9802296|FG000|COMPLETED|Washout||13
8753157|NCT01183234|9802297|FG001|COMPLETED|Washout||14
8753158|NCT01183234|9802296|FG000|NOT COMPLETED|Washout||0
8753159|NCT01183234|9802297|FG001|NOT COMPLETED|Washout||0
8753160|NCT01183234|9802296|FG000|STARTED|Second Intervention||13
8753161|NCT01183234|9802297|FG001|STARTED|Second Intervention||14
8753162|NCT01183234|9802296|FG000|COMPLETED|Second Intervention||13
8753163|NCT01183234|9802297|FG001|COMPLETED|Second Intervention||14
8753164|NCT01183234|9802296|FG000|NOT COMPLETED|Second Intervention||0
8753165|NCT01183234|9802297|FG001|NOT COMPLETED|Second Intervention||0
8753166|NCT01183260|9802305|FG000|STARTED|Overall Study||14
8753167|NCT01183260|9802306|FG001|STARTED|Overall Study||11
8753168|NCT01183260|9802305|FG000|COMPLETED|Overall Study||10
8753169|NCT01183260|9802306|FG001|COMPLETED|Overall Study||9
8753170|NCT01183260|9802305|FG000|NOT COMPLETED|Overall Study||4
8753171|NCT01183260|9802306|FG001|NOT COMPLETED|Overall Study||2
8753172|NCT01183312|9802314|FG000|STARTED|First Intervention Day||5
8753173|NCT01183312|9802315|FG001|STARTED|First Intervention Day||5
8753174|NCT01183312|9802314|FG000|COMPLETED|First Intervention Day||5
8753175|NCT01183312|9802315|FG001|COMPLETED|First Intervention Day||5
8753176|NCT01183312|9802314|FG000|NOT COMPLETED|First Intervention Day||0
8753177|NCT01183312|9802315|FG001|NOT COMPLETED|First Intervention Day||0
8753178|NCT01183312|9802314|FG000|STARTED|Washout Period of at Least 1 Week||5
9023882|NCT03139604|10086520|FG000|COMPLETED|Overall Study|Participants were considered to have completed the study if they dies or discontinued study treatment for any reason|0
9023883|NCT03139604|10086521|FG001|COMPLETED|Overall Study|Participants were considered to have completed the study if they dies or discontinued study treatment for any reason|0
9023884|NCT03139604|10086520|FG000|NOT COMPLETED|Overall Study||219
9023885|NCT03139604|10086521|FG001|NOT COMPLETED|Overall Study||220
9023886|NCT03140254|10086528|FG000|STARTED|Overall Study||145
9023887|NCT03140254|10086528|FG000|Treatment IP - Groin|Overall Study||51
9023888|NCT03140254|10086528|FG000|Treatment IP - Abdomen|Overall Study||48
9023889|NCT03140254|10086528|FG000|Treatment AC - Groin|Overall Study||51
9023890|NCT03140254|10086528|FG000|Treatment AC - Abdomen|Overall Study||48
9023891|NCT03140254|10086528|FG000|Treatment VC - Groin|Overall Study||18
9023892|NCT03140254|10086528|FG000|Treatment VC - Abdomen|Overall Study||19
9023893|NCT03140254|10086528|FG000|COMPLETED|Overall Study||144
9023894|NCT03140254|10086528|FG000|NOT COMPLETED|Overall Study||1
9039983|NCT03345108|10100893|FG004|STARTED|Period-2||8
9039984|NCT03345108|10100894|FG005|STARTED|Period-2||8
9039985|NCT03345108|10100889|FG000|COMPLETED|Period-2||8
9039986|NCT03345108|10100890|FG001|COMPLETED|Period-2||8
9039987|NCT03345108|10100891|FG002|COMPLETED|Period-2||8
9039988|NCT03345108|10100892|FG003|COMPLETED|Period-2||8
9039989|NCT03345108|10100893|FG004|COMPLETED|Period-2||8
9039990|NCT03345108|10100894|FG005|COMPLETED|Period-2||8
9039991|NCT03345108|10100889|FG000|NOT COMPLETED|Period-2||0
9039992|NCT03345108|10100890|FG001|NOT COMPLETED|Period-2||0
9039993|NCT03345108|10100891|FG002|NOT COMPLETED|Period-2||0
9039994|NCT03345108|10100892|FG003|NOT COMPLETED|Period-2||0
9039995|NCT03345108|10100893|FG004|NOT COMPLETED|Period-2||0
9039996|NCT03345108|10100894|FG005|NOT COMPLETED|Period-2||0
9039997|NCT03345108|10100889|FG000|STARTED|Period-3||7
9039998|NCT03345108|10100890|FG001|STARTED|Period-3||8
9039999|NCT03345108|10100891|FG002|STARTED|Period-3||8
9040000|NCT03345108|10100892|FG003|STARTED|Period-3||8
9040001|NCT03345108|10100893|FG004|STARTED|Period-3||8
9040002|NCT03345108|10100894|FG005|STARTED|Period-3||8
9040003|NCT03345108|10100889|FG000|COMPLETED|Period-3||7
9040004|NCT03345108|10100890|FG001|COMPLETED|Period-3||8
9040005|NCT03345108|10100891|FG002|COMPLETED|Period-3||8
9040006|NCT03345108|10100892|FG003|COMPLETED|Period-3||8
9040007|NCT03345108|10100893|FG004|COMPLETED|Period-3||8
9040008|NCT03345108|10100894|FG005|COMPLETED|Period-3||8
9040009|NCT03345108|10100889|FG000|NOT COMPLETED|Period-3||0
9040010|NCT03345108|10100890|FG001|NOT COMPLETED|Period-3||0
9040011|NCT03345108|10100891|FG002|NOT COMPLETED|Period-3||0
9040012|NCT03345108|10100892|FG003|NOT COMPLETED|Period-3||0
9040013|NCT03345108|10100893|FG004|NOT COMPLETED|Period-3||0
9040014|NCT03345108|10100894|FG005|NOT COMPLETED|Period-3||0
9040015|NCT03345160|10100902|FG000|STARTED|Overall Study||7
9040016|NCT03345160|10100902|FG000|COMPLETED|Overall Study||7
9040017|NCT03345160|10100902|FG000|NOT COMPLETED|Overall Study||0
9040018|NCT03345394|10100908|FG000|STARTED|Overall Study||48
9040019|NCT03345394|10100909|FG001|STARTED|Overall Study||50
9040020|NCT03345394|10100908|FG000|COMPLETED|Overall Study||48
8753179|NCT01183312|9802315|FG001|STARTED|Washout Period of at Least 1 Week||5
8753180|NCT01183312|9802314|FG000|COMPLETED|Washout Period of at Least 1 Week||5
8753181|NCT01183312|9802315|FG001|COMPLETED|Washout Period of at Least 1 Week||5
8753182|NCT01183312|9802314|FG000|NOT COMPLETED|Washout Period of at Least 1 Week||0
8753183|NCT01183312|9802315|FG001|NOT COMPLETED|Washout Period of at Least 1 Week||0
9040021|NCT03345394|10100909|FG001|COMPLETED|Overall Study||50
9040022|NCT03345394|10100908|FG000|NOT COMPLETED|Overall Study||0
9040023|NCT03345394|10100909|FG001|NOT COMPLETED|Overall Study||0
8753184|NCT01183312|9802314|FG000|STARTED|Second Intervention Day||5
8753185|NCT01183312|9802315|FG001|STARTED|Second Intervention Day||5
8753186|NCT01183312|9802314|FG000|COMPLETED|Second Intervention Day||5
8753187|NCT01183312|9802315|FG001|COMPLETED|Second Intervention Day||5
8753188|NCT01183312|9802314|FG000|NOT COMPLETED|Second Intervention Day||0
8753189|NCT01183312|9802315|FG001|NOT COMPLETED|Second Intervention Day||0
8753190|NCT01183390|9802323|FG000|STARTED|First Intervention||11
8753191|NCT01183390|9802324|FG001|STARTED|First Intervention||11
8753192|NCT01183390|9802323|FG000|COMPLETED|First Intervention||11
8753193|NCT01183390|9802324|FG001|COMPLETED|First Intervention||10
8753194|NCT01183390|9802323|FG000|NOT COMPLETED|First Intervention||0
8753195|NCT01183390|9802324|FG001|NOT COMPLETED|First Intervention||1
8753196|NCT01183390|9802323|FG000|STARTED|Washout of 21 Days||11
8753197|NCT01183390|9802324|FG001|STARTED|Washout of 21 Days||10
8753198|NCT01183390|9802323|FG000|COMPLETED|Washout of 21 Days||11
8753199|NCT01183390|9802324|FG001|COMPLETED|Washout of 21 Days||10
8753200|NCT01183390|9802323|FG000|NOT COMPLETED|Washout of 21 Days||0
8753201|NCT01183390|9802324|FG001|NOT COMPLETED|Washout of 21 Days||0
8753202|NCT01183390|9802323|FG000|STARTED|Second Intervention||11
8753203|NCT01183390|9802324|FG001|STARTED|Second Intervention||10
8753204|NCT01183390|9802323|FG000|COMPLETED|Second Intervention||11
8753205|NCT01183390|9802324|FG001|COMPLETED|Second Intervention||10
8753206|NCT01183390|9802323|FG000|NOT COMPLETED|Second Intervention||0
8753207|NCT01183390|9802324|FG001|NOT COMPLETED|Second Intervention||0
8753208|NCT01183481|9802330|FG000|STARTED|Overall Study||19
8753209|NCT01183481|9802330|FG000|COMPLETED|Overall Study||19
8753210|NCT01183481|9802330|FG000|NOT COMPLETED|Overall Study||0
8753211|NCT01183533|9802335|FG000|STARTED|Overall Study|Between Oct 2010 and Oct 2013.|40
8753212|NCT01183533|9802335|FG000|COMPLETED|Overall Study|- all pre-planned 40 patients received the study medication.|40
8753213|NCT01183533|9802335|FG000|NOT COMPLETED|Overall Study||0
8753214|NCT01183546|9802339|FG000|STARTED|Overall Study||53
8753215|NCT01183546|9802339|FG000|COMPLETED|Overall Study||53
8753216|NCT01183546|9802339|FG000|NOT COMPLETED|Overall Study||0
8753217|NCT01183559|9802344|FG000|STARTED|Overall Study||9
8753218|NCT01183559|9802344|FG000|COMPLETED|Overall Study||9
8753219|NCT01183559|9802344|FG000|NOT COMPLETED|Overall Study||0
8753220|NCT01183650|9802351|FG000|STARTED|Overall Study||12
8753221|NCT01183650|9802352|FG001|STARTED|Overall Study||12
8753222|NCT01183650|9802351|FG000|COMPLETED|Overall Study||12
8753223|NCT01183650|9802352|FG001|COMPLETED|Overall Study||12
8753224|NCT01183650|9802351|FG000|NOT COMPLETED|Overall Study||0
8753225|NCT01183650|9802352|FG001|NOT COMPLETED|Overall Study||0
8753226|NCT01183689|9802361|FG000|STARTED|Overall Study||202
8753227|NCT01183689|9802362|FG001|STARTED|Overall Study||200
8753228|NCT01183689|9802363|FG002|STARTED|Overall Study||197
8753229|NCT01183689|9802361|FG000|Month 4 Visit|Overall Study||197
8753230|NCT01183689|9802362|FG001|Month 4 Visit|Overall Study||192
8753231|NCT01183689|9802363|FG002|Month 4 Visit|Overall Study||187
8753232|NCT01183689|9802361|FG000|Year 1 Visit|Overall Study||187
8753233|NCT01183689|9802362|FG001|Year 1 Visit|Overall Study||172
8753234|NCT01183689|9802363|FG002|Year 1 Visit|Overall Study||183
8753235|NCT01183689|9802361|FG000|Year 2 Visit|Overall Study||178
8753236|NCT01183689|9802362|FG001|Year 2 Visit|Overall Study||172
8753237|NCT01183689|9802363|FG002|Year 2 Visit|Overall Study||174
8753238|NCT01183689|9802361|FG000|Year 3 Visit|Overall Study||139
8753239|NCT01183689|9802362|FG001|Year 3 Visit|Overall Study||125
8753240|NCT01183689|9802363|FG002|Year 3 Visit|Overall Study||126
8753241|NCT01183689|9802361|FG000|Year 4 Visit|Overall Study||38
8753242|NCT01183689|9802362|FG001|Year 4 Visit|Overall Study||33
8753243|NCT01183689|9802363|FG002|Year 4 Visit|Overall Study||30
9023895|NCT03140631|10086536|FG000|STARTED|Overall Study||73
9023896|NCT03140631|10086537|FG001|STARTED|Overall Study||77
9023897|NCT03140631|10086536|FG000|COMPLETED|Overall Study||73
9023898|NCT03140631|10086537|FG001|COMPLETED|Overall Study||77
9023899|NCT03140631|10086536|FG000|NOT COMPLETED|Overall Study||0
9023900|NCT03140631|10086537|FG001|NOT COMPLETED|Overall Study||0
9023901|NCT03140722|10086546|FG000|STARTED|Overall Study||0
9023902|NCT03140722|10086547|FG001|STARTED|Overall Study||2
9023903|NCT03140722|10086546|FG000|COMPLETED|Overall Study||0
9023904|NCT03140722|10086547|FG001|COMPLETED|Overall Study||2
9023905|NCT03140722|10086546|FG000|NOT COMPLETED|Overall Study||0
9023906|NCT03140722|10086547|FG001|NOT COMPLETED|Overall Study||0
9023907|NCT03141086|10086555|FG000|STARTED|Overall Study||7
9023908|NCT03141086|10086556|FG001|STARTED|Overall Study||17
9023909|NCT03141086|10086555|FG000|COMPLETED|Overall Study||6
9023910|NCT03141086|10086556|FG001|COMPLETED|Overall Study||12
9023911|NCT03141086|10086555|FG000|NOT COMPLETED|Overall Study||1
9023912|NCT03141086|10086556|FG001|NOT COMPLETED|Overall Study||5
9023913|NCT03141151|10086564|FG000|STARTED|Overall Study||59
8753244|NCT01183689|9802361|FG000|COMPLETED|Overall Study||202
8753245|NCT01183689|9802362|FG001|COMPLETED|Overall Study||200
8753246|NCT01183689|9802363|FG002|COMPLETED|Overall Study||197
8753247|NCT01183689|9802361|FG000|NOT COMPLETED|Overall Study||0
8753248|NCT01183689|9802362|FG001|NOT COMPLETED|Overall Study||0
8753249|NCT01183689|9802363|FG002|NOT COMPLETED|Overall Study||0
8753250|NCT01183728|9802373|FG000|STARTED|Overall Study||12
9023914|NCT03141151|10086565|FG001|STARTED|Overall Study||58
9023915|NCT03141151|10086564|FG000|COMPLETED|Overall Study||53
9023916|NCT03141151|10086565|FG001|COMPLETED|Overall Study||54
9023917|NCT03141151|10086564|FG000|NOT COMPLETED|Overall Study||6
8753251|NCT01183728|9802373|FG000|COMPLETED|Overall Study||12
8753252|NCT01183728|9802373|FG000|NOT COMPLETED|Overall Study||0
8753253|NCT01183780|9802379|FG000|STARTED|Overall Study||536
8753254|NCT01183780|9802380|FG001|STARTED|Overall Study||536
8753255|NCT01183780|9802379|FG000|Received at Least 1 Dose of Study Drug|Overall Study||528
8753256|NCT01183780|9802380|FG001|Received at Least 1 Dose of Study Drug|Overall Study||529
8753257|NCT01183780|9802379|FG000|COMPLETED|Overall Study||505
8753258|NCT01183780|9802380|FG001|COMPLETED|Overall Study||511
8753259|NCT01183780|9802379|FG000|NOT COMPLETED|Overall Study||31
8753260|NCT01183780|9802380|FG001|NOT COMPLETED|Overall Study||25
8753261|NCT01183858|9802388|FG000|STARTED|Overall Study||154
8753262|NCT01183858|9802389|FG001|STARTED|Overall Study||159
8753263|NCT01183858|9802388|FG000|Safety Population|Overall Study||154
8753264|NCT01183858|9802389|FG001|Safety Population|Overall Study||158
8753265|NCT01183858|9802388|FG000|COMPLETED|Overall Study||1
8753266|NCT01183858|9802389|FG001|COMPLETED|Overall Study||3
8753267|NCT01183858|9802388|FG000|NOT COMPLETED|Overall Study||153
8753268|NCT01183858|9802389|FG001|NOT COMPLETED|Overall Study||156
8753269|NCT01183923|9802395|FG000|STARTED|Intervention 1 (7 Days)||1
8753270|NCT01183923|9802396|FG001|STARTED|Intervention 1 (7 Days)||0
8753271|NCT01183923|9802395|FG000|COMPLETED|Intervention 1 (7 Days)||1
8753272|NCT01183923|9802396|FG001|COMPLETED|Intervention 1 (7 Days)||0
8753273|NCT01183923|9802395|FG000|NOT COMPLETED|Intervention 1 (7 Days)||0
8753274|NCT01183923|9802396|FG001|NOT COMPLETED|Intervention 1 (7 Days)||0
8753275|NCT01183923|9802395|FG000|STARTED|Washout (14 Days)||1
8753276|NCT01183923|9802396|FG001|STARTED|Washout (14 Days)||0
8753277|NCT01183923|9802395|FG000|COMPLETED|Washout (14 Days)||1
8753278|NCT01183923|9802396|FG001|COMPLETED|Washout (14 Days)||0
8753279|NCT01183923|9802395|FG000|NOT COMPLETED|Washout (14 Days)||0
8753280|NCT01183923|9802396|FG001|NOT COMPLETED|Washout (14 Days)||0
8753281|NCT01183923|9802395|FG000|STARTED|Intervention 2 (7 Days)||1
8753282|NCT01183923|9802396|FG001|STARTED|Intervention 2 (7 Days)||0
8753283|NCT01183923|9802395|FG000|COMPLETED|Intervention 2 (7 Days)||1
8753284|NCT01183923|9802396|FG001|COMPLETED|Intervention 2 (7 Days)||0
8753285|NCT01183923|9802395|FG000|NOT COMPLETED|Intervention 2 (7 Days)||0
8753286|NCT01183923|9802396|FG001|NOT COMPLETED|Intervention 2 (7 Days)||0
8753287|NCT01183975|9802401|FG000|STARTED|Overall Study||517
8753288|NCT01183975|9802401|FG000|COMPLETED|Overall Study||444
8753289|NCT01183975|9802401|FG000|NOT COMPLETED|Overall Study||73
8753290|NCT01184014|9802407|FG000|STARTED|Overall Study||35
8753291|NCT01184014|9802408|FG001|STARTED|Overall Study||37
8753292|NCT01184014|9802407|FG000|COMPLETED|Overall Study||30
8753293|NCT01184014|9802408|FG001|COMPLETED|Overall Study||31
8753294|NCT01184014|9802407|FG000|NOT COMPLETED|Overall Study||5
8753295|NCT01184014|9802408|FG001|NOT COMPLETED|Overall Study||6
8753296|NCT01184053|9802414|FG000|STARTED|Overall Study||3
8753297|NCT01184053|9802414|FG000|COMPLETED|Overall Study||0
8753298|NCT01184053|9802414|FG000|NOT COMPLETED|Overall Study||3
8753299|NCT01184079|9802421|FG000|STARTED|Overall Study||111
8753300|NCT01184079|9802422|FG001|STARTED|Overall Study||109
8753301|NCT01184079|9802421|FG000|Dose 2|Overall Study||110
8753302|NCT01184079|9802422|FG001|Dose 2|Overall Study||108
8753303|NCT01184079|9802421|FG000|Dose 3|Overall Study||101
8753304|NCT01184079|9802422|FG001|Dose 3|Overall Study||107
8753305|NCT01184079|9802421|FG000|Final Blood Draw|Overall Study||97
8753306|NCT01184079|9802422|FG001|Final Blood Draw|Overall Study||107
8753307|NCT01184079|9802421|FG000|COMPLETED|Overall Study||97
8753308|NCT01184079|9802422|FG001|COMPLETED|Overall Study||107
8753309|NCT01184079|9802421|FG000|NOT COMPLETED|Overall Study||14
8753310|NCT01184079|9802422|FG001|NOT COMPLETED|Overall Study||2
8753311|NCT01184118|9802430|FG000|STARTED|Overall Study||36
8753312|NCT01184118|9802430|FG000|FP MDI 1,760 mcg/Day (16 Weeks)|Overall Study||18
8753313|NCT01184118|9802430|FG000|FP MDI 880 mcg/Day (2 Weeks)|Overall Study||18
8753314|NCT01184118|9802430|FG000|FP MDI as Indicated (2 Weeks)|Overall Study||18
8753315|NCT01184118|9802430|FG000|COMPLETED|Overall Study||18
8753316|NCT01184118|9802430|FG000|NOT COMPLETED|Overall Study||18
8753317|NCT01184326|9802437|FG000|STARTED|Overall Study||3
8753318|NCT01184326|9802438|FG001|STARTED|Overall Study||6
8753319|NCT01184326|9802439|FG002|STARTED|Overall Study||14
8753320|NCT01184326|9802437|FG000|COMPLETED|Overall Study||0
8753321|NCT01184326|9802438|FG001|COMPLETED|Overall Study||0
8753322|NCT01184326|9802439|FG002|COMPLETED|Overall Study||0
8753323|NCT01184326|9802437|FG000|NOT COMPLETED|Overall Study||3
8753324|NCT01184326|9802438|FG001|NOT COMPLETED|Overall Study||6
9023918|NCT03141151|10086565|FG001|NOT COMPLETED|Overall Study||4
8753325|NCT01184326|9802439|FG002|NOT COMPLETED|Overall Study||14
8753326|NCT01184417|9802452|FG000|STARTED|Overall Study||51
8753327|NCT01184417|9802453|FG001|STARTED|Overall Study||51
8753328|NCT01184417|9802452|FG000|COMPLETED|Overall Study||51
8753329|NCT01184417|9802453|FG001|COMPLETED|Overall Study||51
8753330|NCT01184417|9802452|FG000|NOT COMPLETED|Overall Study||0
8753331|NCT01184417|9802453|FG001|NOT COMPLETED|Overall Study||0
8753332|NCT01184508|9802461|FG000|STARTED|Overall Study||45
8753333|NCT01184508|9802462|FG001|STARTED|Overall Study||42
8753334|NCT01184508|9802461|FG000|Received at Least 1 Dose of Study Drug|Overall Study||45
8753335|NCT01184508|9802462|FG001|Received at Least 1 Dose of Study Drug|Overall Study||41
8753336|NCT01184508|9802461|FG000|COMPLETED|Overall Study||29
8753337|NCT01184508|9802462|FG001|COMPLETED|Overall Study||27
8753338|NCT01184508|9802461|FG000|NOT COMPLETED|Overall Study||16
8753339|NCT01184508|9802462|FG001|NOT COMPLETED|Overall Study||15
8753340|NCT01184755|9802472|FG000|STARTED|Overall Study||126
8753341|NCT01184755|9802473|FG001|STARTED|Overall Study||65
8753342|NCT01184755|9802474|FG002|STARTED|Overall Study||62
8753343|NCT01184755|9802472|FG000|COMPLETED|Overall Study||101
8753344|NCT01184755|9802473|FG001|COMPLETED|Overall Study||54
8753345|NCT01184755|9802474|FG002|COMPLETED|Overall Study||56
8753346|NCT01184755|9802472|FG000|NOT COMPLETED|Overall Study||25
8753347|NCT01184755|9802473|FG001|NOT COMPLETED|Overall Study||11
8753348|NCT01184755|9802474|FG002|NOT COMPLETED|Overall Study||6
8753349|NCT01184846|9802482|FG000|STARTED|Overall Study||28
8753350|NCT01184846|9802482|FG000|COMPLETED|Overall Study||25
8753351|NCT01184846|9802482|FG000|NOT COMPLETED|Overall Study||3
8753352|NCT01184859|9802493|FG000|STARTED|Period 1: Single Dose||23
8753353|NCT01184859|9802494|FG001|STARTED|Period 1: Single Dose||25
8753354|NCT01184859|9802495|FG002|STARTED|Period 1: Single Dose||22
8753355|NCT01184859|9802496|FG003|STARTED|Period 1: Single Dose||22
8753356|NCT01184859|9802497|FG004|STARTED|Period 1: Single Dose||24
8753357|NCT01184859|9802493|FG000|Full Analysis Set (FAS)|Period 1: Single Dose||23
8753358|NCT01184859|9802494|FG001|Full Analysis Set (FAS)|Period 1: Single Dose|2 participants disqualified due to no post-baseline primary efficacy data, and/or 'other'.|23
8753359|NCT01184859|9802495|FG002|Full Analysis Set (FAS)|Period 1: Single Dose||22
8753360|NCT01184859|9802496|FG003|Full Analysis Set (FAS)|Period 1: Single Dose|1 participant disqualified due to major entry criteria violation|21
8753361|NCT01184859|9802497|FG004|Full Analysis Set (FAS)|Period 1: Single Dose||24
8753362|NCT01184859|9802493|FG000|Per Protocol (PP)|Period 1: Single Dose||23
8753363|NCT01184859|9802494|FG001|Per Protocol (PP)|Period 1: Single Dose||23
8753364|NCT01184859|9802495|FG002|Per Protocol (PP)|Period 1: Single Dose||22
8753365|NCT01184859|9802496|FG003|Per Protocol (PP)|Period 1: Single Dose||21
8753366|NCT01184859|9802497|FG004|Per Protocol (PP)|Period 1: Single Dose|1 additional participant disqualified due to 'other'.|23
8753367|NCT01184859|9802493|FG000|COMPLETED|Period 1: Single Dose||23
8753368|NCT01184859|9802494|FG001|COMPLETED|Period 1: Single Dose||23
9023919|NCT03141242|10086573|FG000|STARTED|Overall Study||55
9023920|NCT03141242|10086574|FG001|STARTED|Overall Study||55
9023921|NCT03141242|10086573|FG000|Received Allocated Intervenion|Overall Study|11 subjects didn't attend their scheduled group session; all were included in ITT analysis|44
9023922|NCT03141242|10086574|FG001|Received Allocated Intervenion|Overall Study||55
9023923|NCT03141242|10086573|FG000|6 Month Interview|Overall Study||51
9023924|NCT03141242|10086574|FG001|6 Month Interview|Overall Study||49
9023925|NCT03141242|10086573|FG000|COMPLETED|Overall Study||55
9023926|NCT03141242|10086574|FG001|COMPLETED|Overall Study||55
9023927|NCT03141242|10086573|FG000|NOT COMPLETED|Overall Study||0
9023928|NCT03141242|10086574|FG001|NOT COMPLETED|Overall Study||0
9023929|NCT03141281|10086585|FG000|STARTED|Overall Study||57
9023930|NCT03141281|10086586|FG001|STARTED|Overall Study||59
9023931|NCT03141281|10086587|FG002|STARTED|Overall Study||56
9023932|NCT03141281|10086588|FG003|STARTED|Overall Study||58
9023933|NCT03141281|10086585|FG000|Post-Test|Overall Study||50
9023934|NCT03141281|10086586|FG001|Post-Test|Overall Study||47
9023935|NCT03141281|10086587|FG002|Post-Test|Overall Study||50
9023936|NCT03141281|10086588|FG003|Post-Test|Overall Study||56
9023937|NCT03141281|10086585|FG000|COMPLETED|Overall Study||45
9023938|NCT03141281|10086586|FG001|COMPLETED|Overall Study||38
9023939|NCT03141281|10086587|FG002|COMPLETED|Overall Study||42
9023940|NCT03141281|10086588|FG003|COMPLETED|Overall Study||47
9023941|NCT03141281|10086585|FG000|NOT COMPLETED|Overall Study||12
9023942|NCT03141281|10086586|FG001|NOT COMPLETED|Overall Study||21
9023943|NCT03141281|10086587|FG002|NOT COMPLETED|Overall Study||14
9023944|NCT03141281|10086588|FG003|NOT COMPLETED|Overall Study||11
9023945|NCT03141307|10086600|FG000|STARTED|In-Hospital||471
9023946|NCT03141307|10086601|FG001|STARTED|In-Hospital||240
9023947|NCT03141307|10086600|FG000|COMPLETED|In-Hospital||467
9023948|NCT03141307|10086601|FG001|COMPLETED|In-Hospital||238
9023949|NCT03141307|10086600|FG000|NOT COMPLETED|In-Hospital||4
9023950|NCT03141307|10086601|FG001|NOT COMPLETED|In-Hospital||2
9023951|NCT03141307|10086600|FG000|STARTED|Follow-Up||467
9023952|NCT03141307|10086601|FG001|STARTED|Follow-Up||238
9023953|NCT03141307|10086600|FG000|COMPLETED|Follow-Up||370
9023954|NCT03141307|10086601|FG001|COMPLETED|Follow-Up||184
9023955|NCT03141307|10086600|FG000|NOT COMPLETED|Follow-Up||97
9023956|NCT03141307|10086601|FG001|NOT COMPLETED|Follow-Up||54
9023957|NCT03141372|10086609|FG000|STARTED|Overall Study||42
9023958|NCT03141372|10086610|FG001|STARTED|Overall Study||42
9023959|NCT03141372|10086609|FG000|COMPLETED|Overall Study||42
9023960|NCT03141372|10086610|FG001|COMPLETED|Overall Study||40
9023961|NCT03141372|10086609|FG000|NOT COMPLETED|Overall Study||0
8753369|NCT01184859|9802495|FG002|COMPLETED|Period 1: Single Dose||22
8753370|NCT01184859|9802496|FG003|COMPLETED|Period 1: Single Dose||22
8753371|NCT01184859|9802497|FG004|COMPLETED|Period 1: Single Dose||23
8753372|NCT01184859|9802493|FG000|NOT COMPLETED|Period 1: Single Dose||0
8753373|NCT01184859|9802494|FG001|NOT COMPLETED|Period 1: Single Dose||2
8753374|NCT01184859|9802495|FG002|NOT COMPLETED|Period 1: Single Dose||0
8753375|NCT01184859|9802496|FG003|NOT COMPLETED|Period 1: Single Dose||0
8753376|NCT01184859|9802497|FG004|NOT COMPLETED|Period 1: Single Dose||1
9023962|NCT03141372|10086610|FG001|NOT COMPLETED|Overall Study||2
9023963|NCT03141528|10086620|FG000|STARTED|Overall Study||122
9023964|NCT03141528|10086621|FG001|STARTED|Overall Study||118
9023965|NCT03141528|10086620|FG000|COMPLETED|Overall Study||75
9023966|NCT03141528|10086621|FG001|COMPLETED|Overall Study||77
9023967|NCT03141528|10086620|FG000|NOT COMPLETED|Overall Study||47
9023968|NCT03141528|10086621|FG001|NOT COMPLETED|Overall Study||41
8753377|NCT01184859|9802493|FG000|STARTED|Washout Period||23
8753378|NCT01184859|9802494|FG001|STARTED|Washout Period||23
8753379|NCT01184859|9802495|FG002|STARTED|Washout Period||22
8753380|NCT01184859|9802496|FG003|STARTED|Washout Period||22
8753381|NCT01184859|9802497|FG004|STARTED|Washout Period||23
8753382|NCT01184859|9802493|FG000|COMPLETED|Washout Period||23
8753383|NCT01184859|9802494|FG001|COMPLETED|Washout Period||23
8753384|NCT01184859|9802495|FG002|COMPLETED|Washout Period||22
8753385|NCT01184859|9802496|FG003|COMPLETED|Washout Period||22
8753386|NCT01184859|9802497|FG004|COMPLETED|Washout Period||23
8753387|NCT01184859|9802493|FG000|NOT COMPLETED|Washout Period||0
8753388|NCT01184859|9802494|FG001|NOT COMPLETED|Washout Period||0
8753389|NCT01184859|9802495|FG002|NOT COMPLETED|Washout Period||0
8753390|NCT01184859|9802496|FG003|NOT COMPLETED|Washout Period||0
8753391|NCT01184859|9802497|FG004|NOT COMPLETED|Washout Period||0
8753392|NCT01184859|9802493|FG000|STARTED|Period 2: Daily Dose for 28 Days||23
8753393|NCT01184859|9802494|FG001|STARTED|Period 2: Daily Dose for 28 Days||23
8753394|NCT01184859|9802495|FG002|STARTED|Period 2: Daily Dose for 28 Days||22
8753395|NCT01184859|9802496|FG003|STARTED|Period 2: Daily Dose for 28 Days||22
8753396|NCT01184859|9802497|FG004|STARTED|Period 2: Daily Dose for 28 Days||23
8753397|NCT01184859|9802493|FG000|COMPLETED|Period 2: Daily Dose for 28 Days||22
8753398|NCT01184859|9802494|FG001|COMPLETED|Period 2: Daily Dose for 28 Days||23
8753399|NCT01184859|9802495|FG002|COMPLETED|Period 2: Daily Dose for 28 Days||22
8753400|NCT01184859|9802496|FG003|COMPLETED|Period 2: Daily Dose for 28 Days||22
8753401|NCT01184859|9802497|FG004|COMPLETED|Period 2: Daily Dose for 28 Days||22
8753402|NCT01184859|9802493|FG000|NOT COMPLETED|Period 2: Daily Dose for 28 Days||1
8753403|NCT01184859|9802494|FG001|NOT COMPLETED|Period 2: Daily Dose for 28 Days||0
8753404|NCT01184859|9802495|FG002|NOT COMPLETED|Period 2: Daily Dose for 28 Days||0
8753405|NCT01184859|9802496|FG003|NOT COMPLETED|Period 2: Daily Dose for 28 Days||0
8753406|NCT01184859|9802497|FG004|NOT COMPLETED|Period 2: Daily Dose for 28 Days||1
8753407|NCT01184872|9802516|FG000|STARTED|Overall Study|"Started indicates randomized and full analysis set."|81
8753408|NCT01184872|9802517|FG001|STARTED|Overall Study||39
8753409|NCT01184872|9802516|FG000|Safety Set|Overall Study|One patient randomized to Daptomycin received Vancomycin.|80
8753410|NCT01184872|9802517|FG001|Safety Set|Overall Study||40
8753411|NCT01184872|9802516|FG000|Clinical Evaluable Set (CES)|Overall Study||73
8753412|NCT01184872|9802517|FG001|Clinical Evaluable Set (CES)|Overall Study||30
8753413|NCT01184872|9802516|FG000|Microbiologically Evaluable Set (MES)|Overall Study||65
8753414|NCT01184872|9802517|FG001|Microbiologically Evaluable Set (MES)|Overall Study||27
8753415|NCT01184872|9802516|FG000|COMPLETED|Overall Study||71
8753416|NCT01184872|9802517|FG001|COMPLETED|Overall Study||31
8753417|NCT01184872|9802516|FG000|NOT COMPLETED|Overall Study||10
8753418|NCT01184872|9802517|FG001|NOT COMPLETED|Overall Study||8
8753419|NCT01184885|9802523|FG000|STARTED|Overall Study||7
8753420|NCT01184885|9802523|FG000|COMPLETED|Overall Study||7
8753421|NCT01184885|9802523|FG000|NOT COMPLETED|Overall Study||0
8753422|NCT01184898|9802528|FG000|STARTED|Overall Study||36
8753423|NCT01184898|9802528|FG000|COMPLETED|Overall Study||36
8753424|NCT01184898|9802528|FG000|NOT COMPLETED|Overall Study||0
8753425|NCT01184989|9802532|FG000|STARTED|Overall Study|Treated Patients|112
8753426|NCT01184989|9802532|FG000|COMPLETED|Overall Study||100
8753427|NCT01184989|9802532|FG000|NOT COMPLETED|Overall Study||12
8753428|NCT01185028|9802536|FG000|STARTED|Overall Study||8
8753429|NCT01185028|9802536|FG000|COMPLETED|Overall Study||4
8753430|NCT01185028|9802536|FG000|NOT COMPLETED|Overall Study||4
8753431|NCT01185080|9802543|FG000|STARTED|Overall Study||50
8753432|NCT01185080|9802544|FG001|STARTED|Overall Study||16
8753433|NCT01185080|9802545|FG002|STARTED|Overall Study||17
9023969|NCT03141788|10086627|FG000|STARTED|Overall Study||52
9023970|NCT03141788|10086627|FG000|COMPLETED|Overall Study||44
9023971|NCT03141788|10086627|FG000|NOT COMPLETED|Overall Study||8
9023972|NCT03141905|10086636|FG000|STARTED|Overall Study||176
9023973|NCT03141905|10086637|FG001|STARTED|Overall Study||166
9023974|NCT03141905|10086636|FG000|COMPLETED|Overall Study||152
9023975|NCT03141905|10086637|FG001|COMPLETED|Overall Study||147
9023976|NCT03141905|10086636|FG000|NOT COMPLETED|Overall Study||24
9023977|NCT03141905|10086637|FG001|NOT COMPLETED|Overall Study||19
9023978|NCT03141931|10086646|FG000|STARTED|Overall Study||61
9023979|NCT03141931|10086647|FG001|STARTED|Overall Study||58
9023980|NCT03141931|10086646|FG000|COMPLETED|Overall Study||49
9023981|NCT03141931|10086647|FG001|COMPLETED|Overall Study||52
9023982|NCT03141931|10086646|FG000|NOT COMPLETED|Overall Study||12
9023983|NCT03141931|10086647|FG001|NOT COMPLETED|Overall Study||6
9023984|NCT03142438|10086653|FG000|STARTED|Overall Study||57
9023985|NCT03142438|10086653|FG000|COMPLETED|Overall Study||57
9023986|NCT03142438|10086653|FG000|NOT COMPLETED|Overall Study||0
8753434|NCT01185080|9802543|FG000|COMPLETED|Overall Study||49
9023987|NCT03142451|10086659|FG000|STARTED|Overall Study||495
9023988|NCT03142451|10086660|FG001|STARTED|Overall Study||256
9023989|NCT03142451|10086659|FG000|COMPLETED|Overall Study||437
9023990|NCT03142451|10086660|FG001|COMPLETED|Overall Study||232
8753435|NCT01185080|9802544|FG001|COMPLETED|Overall Study||15
8753436|NCT01185080|9802545|FG002|COMPLETED|Overall Study||16
8753437|NCT01185080|9802543|FG000|NOT COMPLETED|Overall Study||1
8753438|NCT01185080|9802544|FG001|NOT COMPLETED|Overall Study||1
8753439|NCT01185080|9802545|FG002|NOT COMPLETED|Overall Study||1
9023991|NCT03142451|10086659|FG000|NOT COMPLETED|Overall Study||58
9023992|NCT03142451|10086660|FG001|NOT COMPLETED|Overall Study||24
9023993|NCT03142750|10086668|FG000|STARTED|Overall Study||14
8753440|NCT01185171|9802553|FG000|STARTED|Induction Chemotherapy||59
8753441|NCT01185171|9802553|FG000|COMPLETED|Induction Chemotherapy||57
8753442|NCT01185171|9802553|FG000|NOT COMPLETED|Induction Chemotherapy||2
8753443|NCT01185171|9802553|FG000|STARTED|Concurrent Chemo and Radiation Treatment||69
8753444|NCT01185171|9802553|FG000|COMPLETED|Concurrent Chemo and Radiation Treatment||66
8753445|NCT01185171|9802553|FG000|NOT COMPLETED|Concurrent Chemo and Radiation Treatment||3
8753446|NCT01185171|9802553|FG000|STARTED|Maintenance||60
8753447|NCT01185171|9802553|FG000|COMPLETED|Maintenance||48
8753448|NCT01185171|9802553|FG000|NOT COMPLETED|Maintenance||12
8753449|NCT01185249|9802557|FG000|STARTED|Overall Study|Total number of patients consented to participate.|66
8753450|NCT01185249|9802557|FG000|COMPLETED|Overall Study|Data was analyzed for patients with three consecutive days of data.|24
8753451|NCT01185249|9802557|FG000|NOT COMPLETED|Overall Study||42
8753452|NCT01185288|9802564|FG000|STARTED|Overall Study||154
8753453|NCT01185288|9802565|FG001|STARTED|Overall Study||155
8753454|NCT01185288|9802564|FG000|COMPLETED|Overall Study||135
8753455|NCT01185288|9802565|FG001|COMPLETED|Overall Study||139
8753456|NCT01185288|9802564|FG000|NOT COMPLETED|Overall Study||19
8753457|NCT01185288|9802565|FG001|NOT COMPLETED|Overall Study||16
8753458|NCT01185301|9802575|FG000|STARTED|Overall Study||98
8753459|NCT01185301|9802576|FG001|STARTED|Overall Study||100
8753460|NCT01185301|9802577|FG002|STARTED|Overall Study||99
8753461|NCT01185301|9802578|FG003|STARTED|Overall Study||98
8753462|NCT01185301|9802575|FG000|COMPLETED|Overall Study||83
8753463|NCT01185301|9802576|FG001|COMPLETED|Overall Study||93
8753464|NCT01185301|9802577|FG002|COMPLETED|Overall Study||93
8753465|NCT01185301|9802578|FG003|COMPLETED|Overall Study||89
8753466|NCT01185301|9802575|FG000|NOT COMPLETED|Overall Study||15
8753467|NCT01185301|9802576|FG001|NOT COMPLETED|Overall Study||7
8753468|NCT01185301|9802577|FG002|NOT COMPLETED|Overall Study||6
8753469|NCT01185301|9802578|FG003|NOT COMPLETED|Overall Study||9
8753470|NCT01185340|9802591|FG000|STARTED|Confirmation (CF) Phase, 3 Weeks||1056
8753471|NCT01185340|9802592|FG001|STARTED|Confirmation (CF) Phase, 3 Weeks||0
8753472|NCT01185340|9802593|FG002|STARTED|Confirmation (CF) Phase, 3 Weeks||0
8753473|NCT01185340|9802594|FG003|STARTED|Confirmation (CF) Phase, 3 Weeks||0
8753474|NCT01185340|9802591|FG000|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks|Participants who discontinued the CF Phase early had the option to enter the DC Phase.|18
8753475|NCT01185340|9802592|FG001|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
8753476|NCT01185340|9802593|FG002|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
8753477|NCT01185340|9802594|FG003|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
8753478|NCT01185340|9802591|FG000|COMPLETED|Confirmation (CF) Phase, 3 Weeks|Participants who completed the CF Phase entered the Adjunctive Treatment (AT) Phase.|968
8753479|NCT01185340|9802592|FG001|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
8753480|NCT01185340|9802593|FG002|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
8753481|NCT01185340|9802594|FG003|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
8753482|NCT01185340|9802591|FG000|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||88
8753483|NCT01185340|9802592|FG001|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
8753484|NCT01185340|9802593|FG002|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
8753485|NCT01185340|9802594|FG003|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
8753486|NCT01185340|9802591|FG000|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
8753487|NCT01185340|9802592|FG001|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||230
8753488|NCT01185340|9802593|FG002|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||219
8753489|NCT01185340|9802594|FG003|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||519
8753490|NCT01185340|9802591|FG000|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
8753491|NCT01185340|9802592|FG001|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|206
8753492|NCT01185340|9802593|FG002|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|204
8753493|NCT01185340|9802594|FG003|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|483
8753494|NCT01185340|9802591|FG000|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
8753495|NCT01185340|9802592|FG001|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||195
8753496|NCT01185340|9802593|FG002|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||186
8753497|NCT01185340|9802594|FG003|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||458
8753498|NCT01185340|9802591|FG000|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
8753499|NCT01185340|9802592|FG001|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||35
8753500|NCT01185340|9802593|FG002|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||33
8753501|NCT01185340|9802594|FG003|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||61
8753502|NCT01185353|9802611|FG000|STARTED|Part A (Weeks 0 Through 12)||49
8753503|NCT01185353|9802612|FG001|STARTED|Part A (Weeks 0 Through 12)||52
8753504|NCT01185353|9802613|FG002|STARTED|Part A (Weeks 0 Through 12)||52
8753505|NCT01185353|9802614|FG003|STARTED|Part A (Weeks 0 Through 12)||50
8753506|NCT01185353|9802615|FG004|STARTED|Part A (Weeks 0 Through 12)||98
8753507|NCT01185353|9802616|FG005|STARTED|Part A (Weeks 0 Through 12)||0
8753508|NCT01185353|9802617|FG006|STARTED|Part A (Weeks 0 Through 12)||0
8753509|NCT01185353|9802618|FG007|STARTED|Part A (Weeks 0 Through 12)||0
8753510|NCT01185353|9802619|FG008|STARTED|Part A (Weeks 0 Through 12)||0
8753511|NCT01185353|9802620|FG009|STARTED|Part A (Weeks 0 Through 12)||0
8807998|NCT01488994|9860386|FG000|COMPLETED|Overall Study||11
8753512|NCT01185353|9802611|FG000|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||49
8753513|NCT01185353|9802612|FG001|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||52
8753514|NCT01185353|9802613|FG002|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||52
8753515|NCT01185353|9802614|FG003|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||50
8753516|NCT01185353|9802615|FG004|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||98
8753517|NCT01185353|9802616|FG005|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
8753518|NCT01185353|9802617|FG006|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
8753519|NCT01185353|9802618|FG007|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
8753520|NCT01185353|9802619|FG008|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
8753521|NCT01185353|9802620|FG009|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
8753522|NCT01185353|9802611|FG000|COMPLETED|Part A (Weeks 0 Through 12)||44
8753523|NCT01185353|9802612|FG001|COMPLETED|Part A (Weeks 0 Through 12)||51
8753524|NCT01185353|9802613|FG002|COMPLETED|Part A (Weeks 0 Through 12)||50
8753525|NCT01185353|9802614|FG003|COMPLETED|Part A (Weeks 0 Through 12)||49
8753526|NCT01185353|9802615|FG004|COMPLETED|Part A (Weeks 0 Through 12)||82
8753527|NCT01185353|9802616|FG005|COMPLETED|Part A (Weeks 0 Through 12)||0
8753528|NCT01185353|9802617|FG006|COMPLETED|Part A (Weeks 0 Through 12)||0
8753529|NCT01185353|9802618|FG007|COMPLETED|Part A (Weeks 0 Through 12)||0
8753530|NCT01185353|9802619|FG008|COMPLETED|Part A (Weeks 0 Through 12)||0
8753531|NCT01185353|9802620|FG009|COMPLETED|Part A (Weeks 0 Through 12)||0
8753532|NCT01185353|9802611|FG000|NOT COMPLETED|Part A (Weeks 0 Through 12)||5
8753533|NCT01185353|9802612|FG001|NOT COMPLETED|Part A (Weeks 0 Through 12)||1
8753534|NCT01185353|9802613|FG002|NOT COMPLETED|Part A (Weeks 0 Through 12)||2
8753535|NCT01185353|9802614|FG003|NOT COMPLETED|Part A (Weeks 0 Through 12)||1
8753536|NCT01185353|9802615|FG004|NOT COMPLETED|Part A (Weeks 0 Through 12)||16
8753537|NCT01185353|9802616|FG005|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
8753538|NCT01185353|9802617|FG006|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
8753539|NCT01185353|9802618|FG007|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
8753540|NCT01185353|9802619|FG008|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
8753541|NCT01185353|9802620|FG009|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
8753542|NCT01185353|9802611|FG000|STARTED|Part B (Weeks 12 Through 24)||0
8753543|NCT01185353|9802612|FG001|STARTED|Part B (Weeks 12 Through 24)||51
8753544|NCT01185353|9802613|FG002|STARTED|Part B (Weeks 12 Through 24)||50
8753545|NCT01185353|9802614|FG003|STARTED|Part B (Weeks 12 Through 24)||49
8753546|NCT01185353|9802615|FG004|STARTED|Part B (Weeks 12 Through 24)||0
8753547|NCT01185353|9802616|FG005|STARTED|Part B (Weeks 12 Through 24)||63
8753548|NCT01185353|9802617|FG006|STARTED|Part B (Weeks 12 Through 24)||63
8753549|NCT01185353|9802618|FG007|STARTED|Part B (Weeks 12 Through 24)||0
8753550|NCT01185353|9802619|FG008|STARTED|Part B (Weeks 12 Through 24)||0
8670868|NCT00748865|9714264|FG000|NOT COMPLETED|Overall Study||0
8670869|NCT00748865|9714265|FG001|NOT COMPLETED|Overall Study||0
8670870|NCT00748956|9714274|FG000|STARTED|Overall Study||0
8670871|NCT00748956|9714275|FG001|STARTED|Overall Study||5
8670872|NCT00748956|9714276|FG002|STARTED|Overall Study||5
8670873|NCT00748956|9714274|FG000|COMPLETED|Overall Study||0
8670874|NCT00748956|9714275|FG001|COMPLETED|Overall Study||5
8670875|NCT00748956|9714276|FG002|COMPLETED|Overall Study||5
8670876|NCT00748956|9714274|FG000|NOT COMPLETED|Overall Study||0
8670877|NCT00748956|9714275|FG001|NOT COMPLETED|Overall Study||0
8670878|NCT00748956|9714276|FG002|NOT COMPLETED|Overall Study||0
8670879|NCT00748969|9714286|FG000|STARTED|Overall Study|Subject withdrew from study due to worsening sleep apnea|1
8670880|NCT00748969|9714287|FG001|STARTED|Overall Study|Subject withdrew from study due to randomization to no treatment|1
8753551|NCT01185353|9802620|FG009|STARTED|Part B (Weeks 12 Through 24)||0
8753552|NCT01185353|9802611|FG000|COMPLETED|Part B (Weeks 12 Through 24)||0
8753553|NCT01185353|9802612|FG001|COMPLETED|Part B (Weeks 12 Through 24)||50
8753554|NCT01185353|9802613|FG002|COMPLETED|Part B (Weeks 12 Through 24)||48
8753555|NCT01185353|9802614|FG003|COMPLETED|Part B (Weeks 12 Through 24)||45
8753556|NCT01185353|9802615|FG004|COMPLETED|Part B (Weeks 12 Through 24)||0
8753557|NCT01185353|9802616|FG005|COMPLETED|Part B (Weeks 12 Through 24)||59
8753558|NCT01185353|9802617|FG006|COMPLETED|Part B (Weeks 12 Through 24)||57
8753559|NCT01185353|9802618|FG007|COMPLETED|Part B (Weeks 12 Through 24)||0
8753560|NCT01185353|9802619|FG008|COMPLETED|Part B (Weeks 12 Through 24)||0
8753561|NCT01185353|9802620|FG009|COMPLETED|Part B (Weeks 12 Through 24)||0
8753562|NCT01185353|9802611|FG000|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
8753563|NCT01185353|9802612|FG001|NOT COMPLETED|Part B (Weeks 12 Through 24)||1
8753564|NCT01185353|9802613|FG002|NOT COMPLETED|Part B (Weeks 12 Through 24)||2
8753565|NCT01185353|9802614|FG003|NOT COMPLETED|Part B (Weeks 12 Through 24)||4
8753566|NCT01185353|9802615|FG004|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
8753567|NCT01185353|9802616|FG005|NOT COMPLETED|Part B (Weeks 12 Through 24)||4
8753568|NCT01185353|9802617|FG006|NOT COMPLETED|Part B (Weeks 12 Through 24)||6
8753569|NCT01185353|9802618|FG007|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
8753570|NCT01185353|9802619|FG008|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
8753571|NCT01185353|9802620|FG009|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
8753572|NCT01185353|9802611|FG000|STARTED|Part C (Weeks 24 Through 76)||0
9023994|NCT03142750|10086669|FG001|STARTED|Overall Study||10
9023995|NCT03142750|10086668|FG000|COMPLETED|Overall Study||10
8753573|NCT01185353|9802612|FG001|STARTED|Part C (Weeks 24 Through 76)||0
9023996|NCT03142750|10086669|FG001|COMPLETED|Overall Study||9
8753574|NCT01185353|9802613|FG002|STARTED|Part C (Weeks 24 Through 76)||0
8753575|NCT01185353|9802614|FG003|STARTED|Part C (Weeks 24 Through 76)||0
8753576|NCT01185353|9802615|FG004|STARTED|Part C (Weeks 24 Through 76)||0
8753577|NCT01185353|9802616|FG005|STARTED|Part C (Weeks 24 Through 76)||0
8753578|NCT01185353|9802617|FG006|STARTED|Part C (Weeks 24 Through 76)||0
8753579|NCT01185353|9802618|FG007|STARTED|Part C (Weeks 24 Through 76)||108
8753580|NCT01185353|9802619|FG008|STARTED|Part C (Weeks 24 Through 76)||61
8753581|NCT01185353|9802620|FG009|STARTED|Part C (Weeks 24 Through 76)||32
8753582|NCT01185353|9802611|FG000|COMPLETED|Part C (Weeks 24 Through 76)||0
8753583|NCT01185353|9802612|FG001|COMPLETED|Part C (Weeks 24 Through 76)||0
8753584|NCT01185353|9802613|FG002|COMPLETED|Part C (Weeks 24 Through 76)||0
8753585|NCT01185353|9802614|FG003|COMPLETED|Part C (Weeks 24 Through 76)||0
8753586|NCT01185353|9802615|FG004|COMPLETED|Part C (Weeks 24 Through 76)||0
8753587|NCT01185353|9802616|FG005|COMPLETED|Part C (Weeks 24 Through 76)||0
8753588|NCT01185353|9802617|FG006|COMPLETED|Part C (Weeks 24 Through 76)||0
8753589|NCT01185353|9802618|FG007|COMPLETED|Part C (Weeks 24 Through 76)||92
8753590|NCT01185353|9802619|FG008|COMPLETED|Part C (Weeks 24 Through 76)||53
8753591|NCT01185353|9802620|FG009|COMPLETED|Part C (Weeks 24 Through 76)||24
8753592|NCT01185353|9802611|FG000|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
8753593|NCT01185353|9802612|FG001|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
8753594|NCT01185353|9802613|FG002|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
8753595|NCT01185353|9802614|FG003|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
8753596|NCT01185353|9802615|FG004|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
8753597|NCT01185353|9802616|FG005|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
8753598|NCT01185353|9802617|FG006|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
8753599|NCT01185353|9802618|FG007|NOT COMPLETED|Part C (Weeks 24 Through 76)||16
8753600|NCT01185353|9802619|FG008|NOT COMPLETED|Part C (Weeks 24 Through 76)||8
8753601|NCT01185353|9802620|FG009|NOT COMPLETED|Part C (Weeks 24 Through 76)||8
8753602|NCT01185353|9802611|FG000|STARTED|Part D (Weeks 76 Through 128)||0
8753603|NCT01185353|9802612|FG001|STARTED|Part D (Weeks 76 Through 128)||0
8753604|NCT01185353|9802613|FG002|STARTED|Part D (Weeks 76 Through 128)||0
8753605|NCT01185353|9802614|FG003|STARTED|Part D (Weeks 76 Through 128)||0
8753606|NCT01185353|9802615|FG004|STARTED|Part D (Weeks 76 Through 128)||0
8753607|NCT01185353|9802616|FG005|STARTED|Part D (Weeks 76 Through 128)||0
8753608|NCT01185353|9802617|FG006|STARTED|Part D (Weeks 76 Through 128)||0
8753609|NCT01185353|9802618|FG007|STARTED|Part D (Weeks 76 Through 128)||79
8753610|NCT01185353|9802619|FG008|STARTED|Part D (Weeks 76 Through 128)||47
8753611|NCT01185353|9802620|FG009|STARTED|Part D (Weeks 76 Through 128)||18
8753612|NCT01185353|9802611|FG000|COMPLETED|Part D (Weeks 76 Through 128)||0
8753613|NCT01185353|9802612|FG001|COMPLETED|Part D (Weeks 76 Through 128)||0
8753614|NCT01185353|9802613|FG002|COMPLETED|Part D (Weeks 76 Through 128)||0
8753615|NCT01185353|9802614|FG003|COMPLETED|Part D (Weeks 76 Through 128)||0
8753616|NCT01185353|9802615|FG004|COMPLETED|Part D (Weeks 76 Through 128)||0
8753617|NCT01185353|9802616|FG005|COMPLETED|Part D (Weeks 76 Through 128)||0
8753618|NCT01185353|9802617|FG006|COMPLETED|Part D (Weeks 76 Through 128)||0
8753619|NCT01185353|9802618|FG007|COMPLETED|Part D (Weeks 76 Through 128)||76
8753620|NCT01185353|9802619|FG008|COMPLETED|Part D (Weeks 76 Through 128)||40
8753621|NCT01185353|9802620|FG009|COMPLETED|Part D (Weeks 76 Through 128)||17
8753622|NCT01185353|9802611|FG000|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
8753623|NCT01185353|9802612|FG001|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
8753624|NCT01185353|9802613|FG002|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
8753625|NCT01185353|9802614|FG003|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
8753626|NCT01185353|9802615|FG004|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
8753627|NCT01185353|9802616|FG005|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
8753628|NCT01185353|9802617|FG006|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
8753629|NCT01185353|9802618|FG007|NOT COMPLETED|Part D (Weeks 76 Through 128)||3
8753630|NCT01185353|9802619|FG008|NOT COMPLETED|Part D (Weeks 76 Through 128)||7
8753631|NCT01185353|9802620|FG009|NOT COMPLETED|Part D (Weeks 76 Through 128)||1
8753632|NCT01185366|9802661|FG000|STARTED|First Line Therapy||38
8753633|NCT01185366|9802662|FG001|STARTED|First Line Therapy||34
8753634|NCT01185366|9802661|FG000|Received 1st Drug|First Line Therapy||36
8753635|NCT01185366|9802662|FG001|Received 1st Drug|First Line Therapy||33
8753636|NCT01185366|9802661|FG000|COMPLETED|First Line Therapy||35
8753637|NCT01185366|9802662|FG001|COMPLETED|First Line Therapy||33
8753638|NCT01185366|9802661|FG000|NOT COMPLETED|First Line Therapy||3
8753639|NCT01185366|9802662|FG001|NOT COMPLETED|First Line Therapy||1
8753640|NCT01185366|9802661|FG000|STARTED|Crossover to Second Line Therapy||35
8753641|NCT01185366|9802662|FG001|STARTED|Crossover to Second Line Therapy||33
9023997|NCT03142750|10086668|FG000|NOT COMPLETED|Overall Study||4
9023998|NCT03142750|10086669|FG001|NOT COMPLETED|Overall Study||1
9023999|NCT03142932|10086681|FG000|STARTED|Overall Study||52
9024000|NCT03142932|10086682|FG001|STARTED|Overall Study||50
9024001|NCT03142932|10086681|FG000|COMPLETED|Overall Study||50
9024002|NCT03142932|10086682|FG001|COMPLETED|Overall Study||39
9024003|NCT03142932|10086681|FG000|NOT COMPLETED|Overall Study||2
9024004|NCT03142932|10086682|FG001|NOT COMPLETED|Overall Study||11
8753642|NCT01185366|9802661|FG000|Received Crossover Drug|Crossover to Second Line Therapy||21
8753643|NCT01185366|9802662|FG001|Received Crossover Drug|Crossover to Second Line Therapy||23
8753644|NCT01185366|9802661|FG000|COMPLETED|Crossover to Second Line Therapy||21
8753645|NCT01185366|9802662|FG001|COMPLETED|Crossover to Second Line Therapy||23
8753646|NCT01185366|9802661|FG000|NOT COMPLETED|Crossover to Second Line Therapy||14
8753647|NCT01185366|9802662|FG001|NOT COMPLETED|Crossover to Second Line Therapy||10
8753648|NCT01185509|9802672|FG000|STARTED|Overall Study||11
8753649|NCT01185509|9802673|FG001|STARTED|Overall Study||20
8753650|NCT01185509|9802672|FG000|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
8753651|NCT01185509|9802673|FG001|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
8753652|NCT01185509|9802672|FG000|NOT COMPLETED|Overall Study||11
8753653|NCT01185509|9802673|FG001|NOT COMPLETED|Overall Study||20
8753654|NCT01185522|9802680|FG000|STARTED|Overall Study||693
8753655|NCT01185522|9802680|FG000|COMPLETED|Overall Study||585
8753656|NCT01185522|9802680|FG000|NOT COMPLETED|Overall Study||108
8753657|NCT01185548|9802685|FG000|STARTED|Period 1 : Tolbutamide||4
8753658|NCT01185548|9802685|FG000|COMPLETED|Period 1 : Tolbutamide||4
8753659|NCT01185548|9802685|FG000|NOT COMPLETED|Period 1 : Tolbutamide||0
8753660|NCT01185548|9802685|FG000|STARTED|Period 2: Tasisulam and Tolbutamide||4
8753661|NCT01185548|9802685|FG000|COMPLETED|Period 2: Tasisulam and Tolbutamide||2
8753662|NCT01185548|9802685|FG000|NOT COMPLETED|Period 2: Tasisulam and Tolbutamide||2
8753663|NCT01185548|9802685|FG000|STARTED|Period 3: Tasisulam and Tolbutamide||2
8753664|NCT01185548|9802685|FG000|COMPLETED|Period 3: Tasisulam and Tolbutamide||2
8753665|NCT01185548|9802685|FG000|NOT COMPLETED|Period 3: Tasisulam and Tolbutamide||0
8753666|NCT01185561|9802700|FG000|STARTED|Overall Study||36
8753667|NCT01185561|9802701|FG001|STARTED|Overall Study||38
8753668|NCT01185561|9802700|FG000|COMPLETED|Overall Study||34
8753669|NCT01185561|9802701|FG001|COMPLETED|Overall Study||26
8753670|NCT01185561|9802700|FG000|NOT COMPLETED|Overall Study||2
8753671|NCT01185561|9802701|FG001|NOT COMPLETED|Overall Study||12
8753672|NCT01185600|9802709|FG000|STARTED|Overall Study||73
8753673|NCT01185600|9802710|FG001|STARTED|Overall Study||104
8753674|NCT01185600|9802709|FG000|COMPLETED|Overall Study||41
8753675|NCT01185600|9802710|FG001|COMPLETED|Overall Study||59
8753676|NCT01185600|9802709|FG000|NOT COMPLETED|Overall Study||32
8753677|NCT01185600|9802710|FG001|NOT COMPLETED|Overall Study||45
8753678|NCT01185639|9802719|FG000|STARTED|Overall Study||29
8753679|NCT01185639|9802719|FG000|COMPLETED|Overall Study||27
8753680|NCT01185639|9802719|FG000|NOT COMPLETED|Overall Study||2
8753681|NCT01185704|9802725|FG000|STARTED|Overall Study||68
8753682|NCT01185704|9802726|FG001|STARTED|Overall Study||68
8753683|NCT01185704|9802725|FG000|Treated|Overall Study||65
8753684|NCT01185704|9802726|FG001|Treated|Overall Study||65
8753685|NCT01185704|9802725|FG000|COMPLETED|Overall Study||55
8753686|NCT01185704|9802726|FG001|COMPLETED|Overall Study||60
8753687|NCT01185704|9802725|FG000|NOT COMPLETED|Overall Study||13
8753688|NCT01185704|9802726|FG001|NOT COMPLETED|Overall Study||8
8753689|NCT01185782|9802734|FG000|STARTED|Overall Study||129
8753690|NCT01185782|9802735|FG001|STARTED|Overall Study||136
8753691|NCT01185782|9802734|FG000|Treated|Overall Study||129
8753692|NCT01185782|9802735|FG001|Treated|Overall Study||132
8753693|NCT01185782|9802734|FG000|COMPLETED|Overall Study||123
8753694|NCT01185782|9802735|FG001|COMPLETED|Overall Study||125
8753695|NCT01185782|9802734|FG000|NOT COMPLETED|Overall Study||6
8753696|NCT01185782|9802735|FG001|NOT COMPLETED|Overall Study||11
8753697|NCT01185821|9802746|FG000|STARTED|Overall Study||33
8753698|NCT01185821|9802747|FG001|STARTED|Overall Study||29
8753699|NCT01185821|9802748|FG002|STARTED|Overall Study||43
8753700|NCT01185821|9802749|FG003|STARTED|Overall Study||29
8753701|NCT01185821|9802750|FG004|STARTED|Overall Study||50
8753702|NCT01185821|9802746|FG000|Patients With Washout|Overall Study||33
8753703|NCT01185821|9802747|FG001|Patients With Washout|Overall Study||29
8753704|NCT01185821|9802748|FG002|Patients With Washout|Overall Study||39
8753705|NCT01185821|9802749|FG003|Patients With Washout|Overall Study||29
8753706|NCT01185821|9802750|FG004|Patients With Washout|Overall Study||33
8753707|NCT01185821|9802746|FG000|Patients Without Washout|Overall Study||0
8753708|NCT01185821|9802747|FG001|Patients Without Washout|Overall Study||0
8753709|NCT01185821|9802748|FG002|Patients Without Washout|Overall Study||4
8753710|NCT01185821|9802749|FG003|Patients Without Washout|Overall Study||0
8753711|NCT01185821|9802750|FG004|Patients Without Washout|Overall Study||17
8753712|NCT01185821|9802746|FG000|Patients on Placebo in Core|Overall Study||8
8753713|NCT01185821|9802747|FG001|Patients on Placebo in Core|Overall Study||7
8753714|NCT01185821|9802748|FG002|Patients on Placebo in Core|Overall Study||9
8753715|NCT01185821|9802749|FG003|Patients on Placebo in Core|Overall Study||8
9024005|NCT03143101|10086691|FG000|STARTED|Overall Study||67
9024006|NCT03143101|10086692|FG001|STARTED|Overall Study||66
9024007|NCT03143101|10086693|FG002|STARTED|Overall Study||67
9024008|NCT03143101|10086691|FG000|COMPLETED|Overall Study||65
9024009|NCT03143101|10086692|FG001|COMPLETED|Overall Study||63
9024010|NCT03143101|10086693|FG002|COMPLETED|Overall Study||67
8753716|NCT01185821|9802750|FG004|Patients on Placebo in Core|Overall Study||2
8753717|NCT01185821|9802746|FG000|COMPLETED|Overall Study||26
8753718|NCT01185821|9802747|FG001|COMPLETED|Overall Study||20
8753719|NCT01185821|9802748|FG002|COMPLETED|Overall Study||33
8753720|NCT01185821|9802749|FG003|COMPLETED|Overall Study||23
8753721|NCT01185821|9802750|FG004|COMPLETED|Overall Study||26
8753722|NCT01185821|9802746|FG000|NOT COMPLETED|Overall Study||7
8753723|NCT01185821|9802747|FG001|NOT COMPLETED|Overall Study||9
8753724|NCT01185821|9802748|FG002|NOT COMPLETED|Overall Study||10
8753725|NCT01185821|9802749|FG003|NOT COMPLETED|Overall Study||6
8753726|NCT01185821|9802750|FG004|NOT COMPLETED|Overall Study||24
8753727|NCT01185834|9802764|FG000|STARTED|Overall Study||118
8753728|NCT01185834|9802764|FG000|COMPLETED|Overall Study||104
8753729|NCT01185834|9802764|FG000|NOT COMPLETED|Overall Study||14
8753730|NCT01185964|9802771|FG000|STARTED|Phase 1b and Phase 2||15
8753731|NCT01185964|9802772|FG001|STARTED|Phase 1b and Phase 2||66
8753732|NCT01185964|9802773|FG002|STARTED|Phase 1b and Phase 2||67
8753733|NCT01185964|9802774|FG003|STARTED|Phase 1b and Phase 2||0
8753734|NCT01185964|9802771|FG000|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||15
8753735|NCT01185964|9802772|FG001|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||64
8753736|NCT01185964|9802773|FG002|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||65
8753737|NCT01185964|9802774|FG003|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||0
8753738|NCT01185964|9802771|FG000|COMPLETED|Phase 1b and Phase 2||13
8753739|NCT01185964|9802772|FG001|COMPLETED|Phase 1b and Phase 2||56
8753740|NCT01185964|9802773|FG002|COMPLETED|Phase 1b and Phase 2||58
8753741|NCT01185964|9802774|FG003|COMPLETED|Phase 1b and Phase 2||0
8753742|NCT01185964|9802771|FG000|NOT COMPLETED|Phase 1b and Phase 2||2
8753743|NCT01185964|9802772|FG001|NOT COMPLETED|Phase 1b and Phase 2||10
8753744|NCT01185964|9802773|FG002|NOT COMPLETED|Phase 1b and Phase 2||9
8753745|NCT01185964|9802774|FG003|NOT COMPLETED|Phase 1b and Phase 2||0
8753746|NCT01185964|9802771|FG000|STARTED|Optional Olaratumab Monotherapy on Dox||0
8753747|NCT01185964|9802772|FG001|STARTED|Optional Olaratumab Monotherapy on Dox||0
8753748|NCT01185964|9802773|FG002|STARTED|Optional Olaratumab Monotherapy on Dox||0
8753749|NCT01185964|9802774|FG003|STARTED|Optional Olaratumab Monotherapy on Dox|Participants with disease progression after treatment received olaratumab.|30
8753750|NCT01185964|9802771|FG000|COMPLETED|Optional Olaratumab Monotherapy on Dox||0
8753751|NCT01185964|9802772|FG001|COMPLETED|Optional Olaratumab Monotherapy on Dox||0
8753752|NCT01185964|9802773|FG002|COMPLETED|Optional Olaratumab Monotherapy on Dox||0
8753753|NCT01185964|9802774|FG003|COMPLETED|Optional Olaratumab Monotherapy on Dox||25
8753754|NCT01185964|9802771|FG000|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||0
8753755|NCT01185964|9802772|FG001|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||0
8753756|NCT01185964|9802773|FG002|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||0
8753757|NCT01185964|9802774|FG003|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||5
8753758|NCT01186250|9802792|FG000|STARTED|Overall Study||9
8753759|NCT01186250|9802793|FG001|STARTED|Overall Study||9
8753760|NCT01186250|9802792|FG000|COMPLETED|Overall Study||8
8753761|NCT01186250|9802793|FG001|COMPLETED|Overall Study||9
8753762|NCT01186250|9802792|FG000|NOT COMPLETED|Overall Study||1
8753763|NCT01186250|9802793|FG001|NOT COMPLETED|Overall Study||0
8753764|NCT01186328|9802799|FG000|STARTED|Overall Study||6
8753765|NCT01186328|9802800|FG001|STARTED|Overall Study||0
8753766|NCT01186328|9802801|FG002|STARTED|Overall Study||0
8753767|NCT01186328|9802799|FG000|COMPLETED|Overall Study||5
8753768|NCT01186328|9802800|FG001|COMPLETED|Overall Study||0
9024011|NCT03143101|10086691|FG000|NOT COMPLETED|Overall Study||2
9024012|NCT03143101|10086692|FG001|NOT COMPLETED|Overall Study||3
9024013|NCT03143101|10086693|FG002|NOT COMPLETED|Overall Study||0
9024014|NCT03143166|10086701|FG000|STARTED|Period 1||36
9024015|NCT03143166|10086701|FG000|COMPLETED|Period 1||36
9024016|NCT03143166|10086701|FG000|NOT COMPLETED|Period 1||0
9024017|NCT03143166|10086701|FG000|STARTED|Period 2 (Washout of at Least 4 Days)||36
9024018|NCT03143166|10086701|FG000|COMPLETED|Period 2 (Washout of at Least 4 Days)||35
9024019|NCT03143166|10086701|FG000|NOT COMPLETED|Period 2 (Washout of at Least 4 Days)||1
9024020|NCT03143569|10086709|FG000|STARTED|Overall Study||10
9024021|NCT03143569|10086710|FG001|STARTED|Overall Study||10
9024022|NCT03143569|10086709|FG000|COMPLETED|Overall Study||10
9024023|NCT03143569|10086710|FG001|COMPLETED|Overall Study||8
9024024|NCT03143569|10086709|FG000|NOT COMPLETED|Overall Study||0
9024025|NCT03143569|10086710|FG001|NOT COMPLETED|Overall Study||2
9024026|NCT03143855|10086720|FG000|STARTED|Overall Study||17
9024027|NCT03143855|10086721|FG001|STARTED|Overall Study||10
9024028|NCT03143855|10086720|FG000|COMPLETED|Overall Study||12
9024029|NCT03143855|10086721|FG001|COMPLETED|Overall Study||6
9024030|NCT03143855|10086720|FG000|NOT COMPLETED|Overall Study||5
9024031|NCT03143855|10086721|FG001|NOT COMPLETED|Overall Study||4
9024032|NCT03143894|10086729|FG000|STARTED|First Intervention (5 Days)||3
9024033|NCT03143894|10086730|FG001|STARTED|First Intervention (5 Days)||4
9024034|NCT03143894|10086729|FG000|COMPLETED|First Intervention (5 Days)||3
8753769|NCT01186328|9802801|FG002|COMPLETED|Overall Study||0
8753770|NCT01186328|9802799|FG000|NOT COMPLETED|Overall Study||1
8753771|NCT01186328|9802800|FG001|NOT COMPLETED|Overall Study||0
8753772|NCT01186328|9802801|FG002|NOT COMPLETED|Overall Study||0
8753773|NCT01186406|9802806|FG000|STARTED|Overall Study||41
8753774|NCT01186406|9802806|FG000|COMPLETED|Overall Study||41
8753775|NCT01186406|9802806|FG000|NOT COMPLETED|Overall Study||0
9024035|NCT03143894|10086730|FG001|COMPLETED|First Intervention (5 Days)||4
9024036|NCT03143894|10086729|FG000|NOT COMPLETED|First Intervention (5 Days)||0
9024037|NCT03143894|10086730|FG001|NOT COMPLETED|First Intervention (5 Days)||0
9024038|NCT03143894|10086729|FG000|STARTED|Washout (4 Weeks)||3
9024039|NCT03143894|10086730|FG001|STARTED|Washout (4 Weeks)||4
8753776|NCT01186419|9802812|FG000|STARTED|Overall Study||24
8753777|NCT01186419|9802813|FG001|STARTED|Overall Study||27
8753778|NCT01186419|9802812|FG000|COMPLETED|Overall Study||17
8753779|NCT01186419|9802813|FG001|COMPLETED|Overall Study||18
8753780|NCT01186419|9802812|FG000|NOT COMPLETED|Overall Study||7
8753781|NCT01186419|9802813|FG001|NOT COMPLETED|Overall Study||9
8753782|NCT01186458|9802818|FG000|STARTED|Overall Study||4
8753783|NCT01186458|9802818|FG000|COMPLETED|Overall Study||3
8753784|NCT01186458|9802818|FG000|NOT COMPLETED|Overall Study||1
8753785|NCT01186562|9802824|FG000|STARTED|Overall Study||54
8753786|NCT01186562|9802825|FG001|STARTED|Overall Study||29
8753787|NCT01186562|9802824|FG000|COMPLETED|Overall Study||50
8753788|NCT01186562|9802825|FG001|COMPLETED|Overall Study||27
8753789|NCT01186562|9802824|FG000|NOT COMPLETED|Overall Study||4
8753790|NCT01186562|9802825|FG001|NOT COMPLETED|Overall Study||2
8753791|NCT01186692|9802831|FG000|STARTED|Overall Study||131
8753792|NCT01186692|9802831|FG000|COMPLETED|Overall Study||99
8753793|NCT01186692|9802831|FG000|NOT COMPLETED|Overall Study||32
8753794|NCT01186705|9802839|FG000|STARTED|Overall Study||1
8753795|NCT01186705|9802839|FG000|COMPLETED|Overall Study||1
9024040|NCT03143894|10086729|FG000|COMPLETED|Washout (4 Weeks)||3
9024041|NCT03143894|10086730|FG001|COMPLETED|Washout (4 Weeks)||4
9024042|NCT03143894|10086729|FG000|NOT COMPLETED|Washout (4 Weeks)||0
9024043|NCT03143894|10086730|FG001|NOT COMPLETED|Washout (4 Weeks)||0
9024044|NCT03143894|10086729|FG000|STARTED|Second Intervention (5 Days)||3
9024045|NCT03143894|10086730|FG001|STARTED|Second Intervention (5 Days)||4
9024046|NCT03143894|10086729|FG000|COMPLETED|Second Intervention (5 Days)||3
9024047|NCT03143894|10086730|FG001|COMPLETED|Second Intervention (5 Days)||3
9024048|NCT03143894|10086729|FG000|NOT COMPLETED|Second Intervention (5 Days)||0
9024049|NCT03143894|10086730|FG001|NOT COMPLETED|Second Intervention (5 Days)||1
9024050|NCT03144089|10086740|FG000|STARTED|Overall Study||28
9024051|NCT03144089|10086741|FG001|STARTED|Overall Study||28
9024052|NCT03144089|10086740|FG000|COMPLETED|Overall Study||28
9024053|NCT03144089|10086741|FG001|COMPLETED|Overall Study||28
9024054|NCT03144089|10086740|FG000|NOT COMPLETED|Overall Study||0
9024055|NCT03144089|10086741|FG001|NOT COMPLETED|Overall Study||0
9024056|NCT03144180|10086751|FG000|STARTED|Overall Study||16
9024057|NCT03144180|10086752|FG001|STARTED|Overall Study||16
9024058|NCT03144180|10086751|FG000|COMPLETED|Overall Study||14
9024059|NCT03144180|10086752|FG001|COMPLETED|Overall Study||10
9024060|NCT03144180|10086751|FG000|NOT COMPLETED|Overall Study||2
9024061|NCT03144180|10086752|FG001|NOT COMPLETED|Overall Study||6
9024062|NCT03144518|10086762|FG000|STARTED|Primary Outcome (Mood)||52
9024063|NCT03144518|10086763|FG001|STARTED|Primary Outcome (Mood)||51
9024064|NCT03144518|10086762|FG000|COMPLETED|Primary Outcome (Mood)||52
9024065|NCT03144518|10086763|FG001|COMPLETED|Primary Outcome (Mood)||51
9024066|NCT03144518|10086762|FG000|NOT COMPLETED|Primary Outcome (Mood)||0
9024067|NCT03144518|10086763|FG001|NOT COMPLETED|Primary Outcome (Mood)||0
9024068|NCT03144518|10086762|FG000|STARTED|4 Weeks Post-Vaccination||52
9024069|NCT03144518|10086763|FG001|STARTED|4 Weeks Post-Vaccination||51
9024070|NCT03144518|10086762|FG000|COMPLETED|4 Weeks Post-Vaccination||51
9024071|NCT03144518|10086763|FG001|COMPLETED|4 Weeks Post-Vaccination||51
9024072|NCT03144518|10086762|FG000|NOT COMPLETED|4 Weeks Post-Vaccination||1
9024073|NCT03144518|10086763|FG001|NOT COMPLETED|4 Weeks Post-Vaccination||0
9024074|NCT03144518|10086762|FG000|STARTED|16 Week Post-Vaccination||52
9024075|NCT03144518|10086763|FG001|STARTED|16 Week Post-Vaccination||51
9024076|NCT03144518|10086762|FG000|COMPLETED|16 Week Post-Vaccination||49
9024077|NCT03144518|10086763|FG001|COMPLETED|16 Week Post-Vaccination||49
9024078|NCT03144518|10086762|FG000|NOT COMPLETED|16 Week Post-Vaccination||3
9024079|NCT03144518|10086763|FG001|NOT COMPLETED|16 Week Post-Vaccination||2
9024080|NCT03144635|10086770|FG000|STARTED|Overall Study||80
9024081|NCT03144635|10086770|FG000|COMPLETED|Overall Study||0
9024082|NCT03144635|10086770|FG000|NOT COMPLETED|Overall Study||80
9024083|NCT03144687|10086778|FG000|STARTED|Overall Study||13
9024084|NCT03144687|10086779|FG001|STARTED|Overall Study||10
9024085|NCT03144687|10086778|FG000|COMPLETED|Overall Study||0
9024086|NCT03144687|10086779|FG001|COMPLETED|Overall Study||0
9024087|NCT03144687|10086778|FG000|NOT COMPLETED|Overall Study||13
9024088|NCT03144687|10086779|FG001|NOT COMPLETED|Overall Study||10
9024089|NCT03144804|10086789|FG000|STARTED|Overall Study||36
9024090|NCT03144804|10086789|FG000|COMPLETED|Overall Study||32
9024091|NCT03144804|10086789|FG000|NOT COMPLETED|Overall Study||4
9024092|NCT03145064|10086793|FG000|STARTED|Overall Study||41
9024093|NCT03145064|10086793|FG000|Received At Least 1 Dose of Study Drug|Overall Study||41
9024094|NCT03145064|10086793|FG000|COMPLETED|Overall Study||0
9024095|NCT03145064|10086793|FG000|NOT COMPLETED|Overall Study||41
9024096|NCT03145207|10086798|FG000|STARTED|Overall Study|The same 12 volunteers completed each of the seven study sessions.|14
9024097|NCT03145207|10086798|FG000|COMPLETED|Overall Study||12
9024098|NCT03145207|10086798|FG000|NOT COMPLETED|Overall Study||2
9024099|NCT03145259|10086813|FG000|STARTED|Overall Study||12
9024100|NCT03145259|10086813|FG000|COMPLETED|Overall Study||12
9024101|NCT03145259|10086813|FG000|NOT COMPLETED|Overall Study||0
9024102|NCT03145818|10086824|FG000|STARTED|Overall Study||99
9024103|NCT03145818|10086825|FG001|STARTED|Overall Study||8
9024104|NCT03145818|10086826|FG002|STARTED|Overall Study||10
9024105|NCT03145818|10086827|FG003|STARTED|Overall Study||9
9024106|NCT03145818|10086824|FG000|COMPLETED|Overall Study||8
9024107|NCT03145818|10086825|FG001|COMPLETED|Overall Study||0
9024108|NCT03145818|10086826|FG002|COMPLETED|Overall Study||10
9024109|NCT03145818|10086827|FG003|COMPLETED|Overall Study||9
9024110|NCT03145818|10086824|FG000|NOT COMPLETED|Overall Study||91
9024111|NCT03145818|10086825|FG001|NOT COMPLETED|Overall Study||8
8753796|NCT01186705|9802839|FG000|NOT COMPLETED|Overall Study||0
8753797|NCT01186744|9802849|FG000|STARTED|Overall Study||218
8753798|NCT01186744|9802850|FG001|STARTED|Overall Study||157
8753799|NCT01186744|9802851|FG002|STARTED|Overall Study||31
8753800|NCT01186744|9802852|FG003|STARTED|Overall Study||82
8753801|NCT01186744|9802853|FG004|STARTED|Overall Study||45
8753802|NCT01186744|9802854|FG005|STARTED|Overall Study||133
8753803|NCT01186744|9802849|FG000|COMPLETED|Overall Study||10
8753804|NCT01186744|9802850|FG001|COMPLETED|Overall Study||5
8753805|NCT01186744|9802851|FG002|COMPLETED|Overall Study||25
8753806|NCT01186744|9802852|FG003|COMPLETED|Overall Study||70
8753807|NCT01186744|9802853|FG004|COMPLETED|Overall Study||39
8753808|NCT01186744|9802854|FG005|COMPLETED|Overall Study||107
8753809|NCT01186744|9802849|FG000|NOT COMPLETED|Overall Study||208
8753810|NCT01186744|9802850|FG001|NOT COMPLETED|Overall Study||152
8753811|NCT01186744|9802851|FG002|NOT COMPLETED|Overall Study||6
8753812|NCT01186744|9802852|FG003|NOT COMPLETED|Overall Study||12
8753813|NCT01186744|9802853|FG004|NOT COMPLETED|Overall Study||6
8753814|NCT01186744|9802854|FG005|NOT COMPLETED|Overall Study||26
8753815|NCT01186770|9802893|FG000|STARTED|Overall Study||201
8753816|NCT01186770|9802894|FG001|STARTED|Overall Study||202
8753817|NCT01186770|9802895|FG002|STARTED|Overall Study||200
8753818|NCT01186770|9802896|FG003|STARTED|Overall Study||201
8753819|NCT01186770|9802893|FG000|Intent-to-treat (ITT Population)|Overall Study||201
8753820|NCT01186770|9802894|FG001|Intent-to-treat (ITT Population)|Overall Study||201
8753821|NCT01186770|9802895|FG002|Intent-to-treat (ITT Population)|Overall Study||200
8753822|NCT01186770|9802896|FG003|Intent-to-treat (ITT Population)|Overall Study||201
9024112|NCT03145818|10086826|FG002|NOT COMPLETED|Overall Study||0
9024113|NCT03145818|10086827|FG003|NOT COMPLETED|Overall Study||0
9024114|NCT03146403|10086837|FG000|STARTED|Overall Study||16
9024115|NCT03146403|10086838|FG001|STARTED|Overall Study||17
9024116|NCT03146403|10086837|FG000|COMPLETED|Overall Study||14
9024117|NCT03146403|10086838|FG001|COMPLETED|Overall Study||14
9024118|NCT03146403|10086837|FG000|NOT COMPLETED|Overall Study||2
9024119|NCT03146403|10086838|FG001|NOT COMPLETED|Overall Study||3
9024120|NCT03146585|10086847|FG000|STARTED|Overall Study||25
9024121|NCT03146585|10086848|FG001|STARTED|Overall Study||10
9024122|NCT03146585|10086849|FG002|STARTED|Overall Study||5
9024123|NCT03146585|10086847|FG000|COMPLETED|Overall Study||25
9024124|NCT03146585|10086848|FG001|COMPLETED|Overall Study||10
9024125|NCT03146585|10086849|FG002|COMPLETED|Overall Study||5
9024126|NCT03146585|10086847|FG000|NOT COMPLETED|Overall Study||0
9024127|NCT03146585|10086848|FG001|NOT COMPLETED|Overall Study||0
9024128|NCT03146585|10086849|FG002|NOT COMPLETED|Overall Study||0
9024129|NCT03146663|10086859|FG000|STARTED|Overall Study||25
9024130|NCT03146663|10086860|FG001|STARTED|Overall Study||28
9024131|NCT03146663|10086859|FG000|COMPLETED|Overall Study||24
9024132|NCT03146663|10086860|FG001|COMPLETED|Overall Study||27
9024133|NCT03146663|10086859|FG000|NOT COMPLETED|Overall Study||1
9024134|NCT03146663|10086860|FG001|NOT COMPLETED|Overall Study||1
9024135|NCT03146741|10086867|FG000|STARTED|Overall Study||20
9024136|NCT03146741|10086867|FG000|COMPLETED|Overall Study||10
9024137|NCT03146741|10086867|FG000|NOT COMPLETED|Overall Study||10
9024138|NCT03146806|10086871|FG000|STARTED|Overall Study||10
9024139|NCT03146806|10086871|FG000|COMPLETED|Overall Study||10
8753823|NCT01186770|9802893|FG000|COMPLETED|Overall Study||160
8753824|NCT01186770|9802894|FG001|COMPLETED|Overall Study||156
9024140|NCT03146806|10086871|FG000|NOT COMPLETED|Overall Study||0
9024141|NCT03147248|10086893|FG000|STARTED|Overall Study|This cohort is only for Part 1.|13
9024142|NCT03147248|10086894|FG001|STARTED|Overall Study|This cohort is only for Part 1.|11
9024143|NCT03147248|10086895|FG002|STARTED|Overall Study|This cohort is only for Part 1.|12
9024144|NCT03147248|10086896|FG003|STARTED|Overall Study|This cohort is only for Part 1.|12
9024145|NCT03147248|10086897|FG004|STARTED|Overall Study|This arm is for Part 2. All of the participants in Part 2 were screened only for Part 2.|167
9024146|NCT03147248|10086898|FG005|STARTED|Overall Study|This arm is for Part 2. All of the participants in Part 2 were screened only for Part 2.|176
9024147|NCT03147248|10086893|FG000|COMPLETED|Overall Study||12
9024148|NCT03147248|10086894|FG001|COMPLETED|Overall Study||9
9024149|NCT03147248|10086895|FG002|COMPLETED|Overall Study||10
9024150|NCT03147248|10086896|FG003|COMPLETED|Overall Study||10
9024151|NCT03147248|10086897|FG004|COMPLETED|Overall Study||141
9024152|NCT03147248|10086898|FG005|COMPLETED|Overall Study||145
9024153|NCT03147248|10086893|FG000|NOT COMPLETED|Overall Study||1
9024154|NCT03147248|10086894|FG001|NOT COMPLETED|Overall Study||2
9024155|NCT03147248|10086895|FG002|NOT COMPLETED|Overall Study||2
9024156|NCT03147248|10086896|FG003|NOT COMPLETED|Overall Study||2
9024157|NCT03147248|10086897|FG004|NOT COMPLETED|Overall Study||26
9024158|NCT03147248|10086898|FG005|NOT COMPLETED|Overall Study||31
9024159|NCT03147495|10086914|FG000|STARTED|Overall Study||40
9024160|NCT03147495|10086915|FG001|STARTED|Overall Study||46
9024161|NCT03147495|10086914|FG000|COMPLETED|Overall Study||40
9024162|NCT03147495|10086915|FG001|COMPLETED|Overall Study||40
9024163|NCT03147495|10086914|FG000|NOT COMPLETED|Overall Study||0
9024164|NCT03147495|10086915|FG001|NOT COMPLETED|Overall Study||6
9024165|NCT03147690|10086921|FG000|STARTED|Overall Study||74
9024166|NCT03147690|10086921|FG000|COMPLETED|Overall Study||71
9024167|NCT03147690|10086921|FG000|NOT COMPLETED|Overall Study||3
9024168|NCT03148067|10086938|FG000|STARTED|Overall Study||225
9024169|NCT03148067|10086938|FG000|COMPLETED|Overall Study||221
8753825|NCT01186770|9802895|FG002|COMPLETED|Overall Study||148
8753826|NCT01186770|9802896|FG003|COMPLETED|Overall Study||143
8753827|NCT01186770|9802893|FG000|NOT COMPLETED|Overall Study||41
8753828|NCT01186770|9802894|FG001|NOT COMPLETED|Overall Study||46
8753829|NCT01186770|9802895|FG002|NOT COMPLETED|Overall Study||52
8753830|NCT01186770|9802896|FG003|NOT COMPLETED|Overall Study||58
8753831|NCT01186796|9802908|FG000|STARTED|Overall Study||14
8753832|NCT01186796|9802909|FG001|STARTED|Overall Study|1 subject was randomized but withdrew before study interventions.|16
8753833|NCT01186796|9802908|FG000|COMPLETED|Overall Study||10
8753834|NCT01186796|9802909|FG001|COMPLETED|Overall Study||14
8753835|NCT01186796|9802908|FG000|NOT COMPLETED|Overall Study||4
8753836|NCT01186796|9802909|FG001|NOT COMPLETED|Overall Study||2
8807999|NCT01488994|9860387|FG001|COMPLETED|Overall Study||11
8808000|NCT01488994|9860386|FG000|NOT COMPLETED|Overall Study||0
8808001|NCT01488994|9860387|FG001|NOT COMPLETED|Overall Study||1
8808002|NCT01489020|9860404|FG000|STARTED|Overall Study||12
8808003|NCT01489020|9860405|FG001|STARTED|Overall Study||4
8808004|NCT01489020|9860406|FG002|STARTED|Overall Study||12
8808005|NCT01489020|9860407|FG003|STARTED|Overall Study||4
8808006|NCT01489020|9860408|FG004|STARTED|Overall Study||12
8808007|NCT01489020|9860409|FG005|STARTED|Overall Study||4
8808008|NCT01489020|9860404|FG000|COMPLETED|Overall Study||11
8808009|NCT01489020|9860405|FG001|COMPLETED|Overall Study||4
8808010|NCT01489020|9860406|FG002|COMPLETED|Overall Study||9
8808011|NCT01489020|9860407|FG003|COMPLETED|Overall Study||4
8808012|NCT01489020|9860408|FG004|COMPLETED|Overall Study||6
8808013|NCT01489020|9860409|FG005|COMPLETED|Overall Study||4
8808014|NCT01489020|9860404|FG000|NOT COMPLETED|Overall Study||1
8808015|NCT01489020|9860405|FG001|NOT COMPLETED|Overall Study||0
8808016|NCT01489020|9860406|FG002|NOT COMPLETED|Overall Study||3
8808017|NCT01489020|9860407|FG003|NOT COMPLETED|Overall Study||0
8808018|NCT01489020|9860408|FG004|NOT COMPLETED|Overall Study||6
8808019|NCT01489020|9860409|FG005|NOT COMPLETED|Overall Study||0
8808020|NCT01489111|9860429|FG000|STARTED|Overall Study||36
8808021|NCT01489111|9860429|FG000|COMPLETED|Overall Study||35
8808022|NCT01489111|9860429|FG000|NOT COMPLETED|Overall Study||1
8808023|NCT01489189|9860435|FG000|STARTED|Overall Study|Number of Eyes|191
8808024|NCT01489189|9860436|FG001|STARTED|Overall Study|Number of Eyes|203
8808025|NCT01489189|9860435|FG000|COMPLETED|Overall Study|Number of Eyes|160
8808026|NCT01489189|9860436|FG001|COMPLETED|Overall Study|Number of Eyes|168
8808027|NCT01489189|9860435|FG000|NOT COMPLETED|Overall Study||31
8808028|NCT01489189|9860436|FG001|NOT COMPLETED|Overall Study||35
8808029|NCT01489254|9860446|FG000|STARTED|Double-blind Part||355
8808030|NCT01489254|9860447|FG001|STARTED|Double-blind Part||357
8808031|NCT01489254|9860448|FG002|STARTED|Double-blind Part||84
8808032|NCT01489254|9860449|FG003|STARTED|Double-blind Part||0
8808033|NCT01489254|9860446|FG000|COMPLETED|Double-blind Part||330
8808034|NCT01489254|9860447|FG001|COMPLETED|Double-blind Part||324
8914926|NCT02171611|9974506|FG002|COMPLETED|Overall Study||5
8914927|NCT02171611|9974507|FG003|COMPLETED|Overall Study||5
8914928|NCT02171611|9974508|FG004|COMPLETED|Overall Study||5
8914929|NCT02171611|9974509|FG005|COMPLETED|Overall Study||5
8914930|NCT02171611|9974504|FG000|NOT COMPLETED|Overall Study||0
8914931|NCT02171611|9974505|FG001|NOT COMPLETED|Overall Study||0
8808035|NCT01489254|9860448|FG002|COMPLETED|Double-blind Part||81
8808036|NCT01489254|9860449|FG003|COMPLETED|Double-blind Part||0
8808037|NCT01489254|9860446|FG000|NOT COMPLETED|Double-blind Part||25
8808038|NCT01489254|9860447|FG001|NOT COMPLETED|Double-blind Part||33
8808039|NCT01489254|9860448|FG002|NOT COMPLETED|Double-blind Part||3
8808040|NCT01489254|9860449|FG003|NOT COMPLETED|Double-blind Part||0
8808041|NCT01489254|9860446|FG000|STARTED|Open-label Extension Part||0
8808042|NCT01489254|9860447|FG001|STARTED|Open-label Extension Part||0
8808043|NCT01489254|9860448|FG002|STARTED|Open-label Extension Part||0
8914932|NCT02171611|9974506|FG002|NOT COMPLETED|Overall Study||0
8914933|NCT02171611|9974507|FG003|NOT COMPLETED|Overall Study||0
8914934|NCT02171611|9974508|FG004|NOT COMPLETED|Overall Study||0
8914935|NCT02171611|9974509|FG005|NOT COMPLETED|Overall Study||0
8914936|NCT02171819|9974520|FG000|STARTED|Overall Study||31
8914937|NCT02171819|9974521|FG001|STARTED|Overall Study||32
8914938|NCT02171819|9974522|FG002|STARTED|Overall Study||12
8914939|NCT02171819|9974520|FG000|COMPLETED|Overall Study||31
8914940|NCT02171819|9974521|FG001|COMPLETED|Overall Study||32
8914941|NCT02171819|9974522|FG002|COMPLETED|Overall Study||12
8914942|NCT02171819|9974520|FG000|NOT COMPLETED|Overall Study||0
8914943|NCT02171819|9974521|FG001|NOT COMPLETED|Overall Study||0
8914944|NCT02171819|9974522|FG002|NOT COMPLETED|Overall Study||0
8914945|NCT02172040|9974538|FG000|STARTED|Overall Study||49
8914946|NCT02172040|9974539|FG001|STARTED|Overall Study||45
8914947|NCT02172040|9974540|FG002|STARTED|Overall Study||31
8914948|NCT02172040|9974541|FG003|STARTED|Overall Study||27
8914949|NCT02172040|9974538|FG000|COMPLETED|Overall Study||49
9024170|NCT03148067|10086938|FG000|NOT COMPLETED|Overall Study||4
8808044|NCT01489254|9860449|FG003|STARTED|Open-label Extension Part|735 completed the DB part, 729 were eligible to continue in the OL part, 1 opted not to continue|728
8808045|NCT01489254|9860446|FG000|COMPLETED|Open-label Extension Part||0
8808046|NCT01489254|9860447|FG001|COMPLETED|Open-label Extension Part||0
8808047|NCT01489254|9860448|FG002|COMPLETED|Open-label Extension Part||0
8808048|NCT01489254|9860449|FG003|COMPLETED|Open-label Extension Part||670
8808049|NCT01489254|9860446|FG000|NOT COMPLETED|Open-label Extension Part||0
8808050|NCT01489254|9860447|FG001|NOT COMPLETED|Open-label Extension Part||0
8914950|NCT02172040|9974539|FG001|COMPLETED|Overall Study||42
8914951|NCT02172040|9974540|FG002|COMPLETED|Overall Study||29
8914952|NCT02172040|9974541|FG003|COMPLETED|Overall Study||26
8914953|NCT02172040|9974538|FG000|NOT COMPLETED|Overall Study||0
8914954|NCT02172040|9974539|FG001|NOT COMPLETED|Overall Study||3
8914955|NCT02172040|9974540|FG002|NOT COMPLETED|Overall Study||2
8753837|NCT01186809|9802915|FG000|STARTED|Overall Study||73
8753838|NCT01186809|9802915|FG000|COMPLETED|Overall Study||43
8753839|NCT01186809|9802915|FG000|NOT COMPLETED|Overall Study||30
8753840|NCT01186939|9802919|FG000|STARTED|Overall Study||40
8753841|NCT01186939|9802919|FG000|COMPLETED|Overall Study||0
8753842|NCT01186939|9802919|FG000|NOT COMPLETED|Overall Study||40
8753843|NCT01186978|9802923|FG000|STARTED|Overall Study||63
8753844|NCT01186978|9802923|FG000|COMPLETED|Overall Study||62
8753845|NCT01186978|9802923|FG000|NOT COMPLETED|Overall Study||1
8753846|NCT01187004|9802929|FG000|STARTED|Overall Study||20
8753847|NCT01187004|9802930|FG001|STARTED|Overall Study||144
8753848|NCT01187004|9802929|FG000|COMPLETED|Overall Study||20
8753849|NCT01187004|9802930|FG001|COMPLETED|Overall Study||144
8753850|NCT01187004|9802929|FG000|NOT COMPLETED|Overall Study||0
8753851|NCT01187004|9802930|FG001|NOT COMPLETED|Overall Study||0
8753852|NCT01187017|9802937|FG000|STARTED|Overall Study||1
8753853|NCT01187017|9802937|FG000|COMPLETED|Overall Study||1
8753854|NCT01187017|9802937|FG000|NOT COMPLETED|Overall Study||0
8753855|NCT01187043|9802948|FG000|STARTED|Overall Study||12
8753856|NCT01187043|9802949|FG001|STARTED|Overall Study||10
8753857|NCT01187043|9802950|FG002|STARTED|Overall Study||12
8753858|NCT01187043|9802951|FG003|STARTED|Overall Study||12
8753859|NCT01187043|9802952|FG004|STARTED|Overall Study||12
8753860|NCT01187043|9802948|FG000|COMPLETED|Overall Study||11
8753861|NCT01187043|9802949|FG001|COMPLETED|Overall Study||10
8753862|NCT01187043|9802950|FG002|COMPLETED|Overall Study||8
8753863|NCT01187043|9802951|FG003|COMPLETED|Overall Study||12
8753864|NCT01187043|9802952|FG004|COMPLETED|Overall Study||10
8753865|NCT01187043|9802948|FG000|NOT COMPLETED|Overall Study||1
8753866|NCT01187043|9802949|FG001|NOT COMPLETED|Overall Study||0
8753867|NCT01187043|9802950|FG002|NOT COMPLETED|Overall Study||4
8753868|NCT01187043|9802951|FG003|NOT COMPLETED|Overall Study||0
8753869|NCT01187043|9802952|FG004|NOT COMPLETED|Overall Study||2
8753870|NCT01187095|9802966|FG000|STARTED|Overall Study||153
8753871|NCT01187095|9802967|FG001|STARTED|Overall Study||142
8753872|NCT01187095|9802966|FG000|COMPLETED|Overall Study||108
8753873|NCT01187095|9802967|FG001|COMPLETED|Overall Study||108
8753874|NCT01187095|9802966|FG000|NOT COMPLETED|Overall Study||45
8753875|NCT01187095|9802967|FG001|NOT COMPLETED|Overall Study||34
8753876|NCT01187329|9802975|FG000|STARTED|Overall Study||50
8753877|NCT01187329|9802976|FG001|STARTED|Overall Study||50
8753878|NCT01187329|9802975|FG000|COMPLETED|Overall Study||49
8753879|NCT01187329|9802976|FG001|COMPLETED|Overall Study||48
8753880|NCT01187329|9802975|FG000|NOT COMPLETED|Overall Study||1
8753881|NCT01187329|9802976|FG001|NOT COMPLETED|Overall Study||2
8753882|NCT01187355|9802984|FG000|STARTED|Overall Study||294
8753883|NCT01187355|9802985|FG001|STARTED|Overall Study||297
8753884|NCT01187355|9802984|FG000|COMPLETED|Overall Study||276
8753885|NCT01187355|9802985|FG001|COMPLETED|Overall Study||277
8753886|NCT01187355|9802984|FG000|NOT COMPLETED|Overall Study||18
8753887|NCT01187355|9802985|FG001|NOT COMPLETED|Overall Study||20
8753888|NCT01187381|9802991|FG000|STARTED|Overall Study||250
8753889|NCT01187381|9802991|FG000|COMPLETED|Overall Study|A participant completed study when the trastuzumab treatment was discontinued.|250
8753890|NCT01187381|9802991|FG000|NOT COMPLETED|Overall Study||0
8753891|NCT01187407|9802999|FG000|STARTED|Confirmation (CF) Phase, 3 Weeks||1480
8753892|NCT01187407|9803000|FG001|STARTED|Confirmation (CF) Phase, 3 Weeks||0
8753893|NCT01187407|9803001|FG002|STARTED|Confirmation (CF) Phase, 3 Weeks||0
8753894|NCT01187407|9803002|FG003|STARTED|Confirmation (CF) Phase, 3 Weeks||0
8753895|NCT01187407|9803003|FG004|STARTED|Confirmation (CF) Phase, 3 Weeks||0
8753896|NCT01187407|9802999|FG000|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks|Participants who discontinued the CF Phase early had the option to enter the DC Phase.|25
8753897|NCT01187407|9803000|FG001|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
8753898|NCT01187407|9803001|FG002|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
8753899|NCT01187407|9803002|FG003|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
8753900|NCT01187407|9803003|FG004|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
8753901|NCT01187407|9802999|FG000|COMPLETED|Confirmation (CF) Phase, 3 Weeks|Participants who completed the CF Phase entered the Adjunctive Treatment (AT) Phase.|1390
8753902|NCT01187407|9803000|FG001|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
8753903|NCT01187407|9803001|FG002|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
8753904|NCT01187407|9803002|FG003|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
8753905|NCT01187407|9803003|FG004|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
8753906|NCT01187407|9802999|FG000|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||90
8753907|NCT01187407|9803000|FG001|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
8753908|NCT01187407|9803001|FG002|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
8753909|NCT01187407|9803002|FG003|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
8753910|NCT01187407|9803003|FG004|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
8753911|NCT01187407|9802999|FG000|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
8753912|NCT01187407|9803000|FG001|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||232
8753913|NCT01187407|9803001|FG002|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||226
8753914|NCT01187407|9803002|FG003|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||231
8753915|NCT01187407|9803003|FG004|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||701
8753916|NCT01187407|9802999|FG000|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
8753917|NCT01187407|9803000|FG001|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|212
8753918|NCT01187407|9803001|FG002|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|215
8753919|NCT01187407|9803002|FG003|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|220
8753920|NCT01187407|9803003|FG004|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|660
8753921|NCT01187407|9802999|FG000|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
8753922|NCT01187407|9803000|FG001|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||196
8753923|NCT01187407|9803001|FG002|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||191
8753924|NCT01187407|9803002|FG003|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||202
8753925|NCT01187407|9803003|FG004|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||626
8753926|NCT01187407|9802999|FG000|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
8753927|NCT01187407|9803000|FG001|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||36
8753928|NCT01187407|9803001|FG002|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||35
8753929|NCT01187407|9803002|FG003|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||29
8753930|NCT01187407|9803003|FG004|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||75
8753931|NCT01187446|9803022|FG000|STARTED|Overall Study||14
8753932|NCT01187446|9803023|FG001|STARTED|Overall Study||14
8753933|NCT01187446|9803022|FG000|COMPLETED|Overall Study||14
8753934|NCT01187446|9803023|FG001|COMPLETED|Overall Study||13
8753935|NCT01187446|9803022|FG000|NOT COMPLETED|Overall Study||0
8753936|NCT01187446|9803023|FG001|NOT COMPLETED|Overall Study||1
8753937|NCT01187498|9803031|FG000|STARTED|Overall Study||73
8753938|NCT01187498|9803032|FG001|STARTED|Overall Study||70
8753939|NCT01187498|9803031|FG000|COMPLETED|Overall Study||64
8753940|NCT01187498|9803032|FG001|COMPLETED|Overall Study||60
8753941|NCT01187498|9803031|FG000|NOT COMPLETED|Overall Study||9
8753942|NCT01187498|9803032|FG001|NOT COMPLETED|Overall Study||10
8753943|NCT01187511|9803040|FG000|STARTED|Overall Study||22
8753944|NCT01187511|9803041|FG001|STARTED|Overall Study||22
8753945|NCT01187511|9803040|FG000|COMPLETED|Overall Study||14
8753946|NCT01187511|9803041|FG001|COMPLETED|Overall Study||21
8753947|NCT01187511|9803040|FG000|NOT COMPLETED|Overall Study||8
8753948|NCT01187511|9803041|FG001|NOT COMPLETED|Overall Study||1
8753949|NCT01187550|9803049|FG000|STARTED|Overall Study||183
8753950|NCT01187550|9803050|FG001|STARTED|Overall Study||30
8753951|NCT01187550|9803049|FG000|Treated|Overall Study||175
8753952|NCT01187550|9803050|FG001|Treated|Overall Study||30
8753953|NCT01187550|9803049|FG000|COMPLETED|Overall Study||169
8753954|NCT01187550|9803050|FG001|COMPLETED|Overall Study||29
8753955|NCT01187550|9803049|FG000|NOT COMPLETED|Overall Study||14
8753956|NCT01187550|9803050|FG001|NOT COMPLETED|Overall Study||1
8753957|NCT01187771|9803058|FG000|STARTED|Overall Study||28
8753958|NCT01187771|9803059|FG001|STARTED|Overall Study||21
8753959|NCT01187771|9803058|FG000|COMPLETED|Overall Study||25
8753960|NCT01187771|9803059|FG001|COMPLETED|Overall Study||18
8753961|NCT01187771|9803058|FG000|NOT COMPLETED|Overall Study||3
8753962|NCT01187771|9803059|FG001|NOT COMPLETED|Overall Study||3
8753963|NCT01187901|9803069|FG000|STARTED|Overall Study||46
8753964|NCT01187901|9803070|FG001|STARTED|Overall Study||46
8753965|NCT01187901|9803069|FG000|COMPLETED|Overall Study||37
8753966|NCT01187901|9803070|FG001|COMPLETED|Overall Study||36
8753967|NCT01187901|9803069|FG000|NOT COMPLETED|Overall Study||9
8753968|NCT01187901|9803070|FG001|NOT COMPLETED|Overall Study||10
8753969|NCT01187914|9803076|FG000|STARTED|Overall Study||40
8753970|NCT01187914|9803076|FG000|COMPLETED|Overall Study||40
8753971|NCT01187914|9803076|FG000|NOT COMPLETED|Overall Study||0
8753972|NCT01187953|9803082|FG000|STARTED|Overall Study||268
8753973|NCT01187953|9803083|FG001|STARTED|Overall Study||275
8753974|NCT01187953|9803082|FG000|Dosed|Overall Study||266
8753975|NCT01187953|9803083|FG001|Dosed|Overall Study||271
8753976|NCT01187953|9803082|FG000|COMPLETED|Overall Study||253
8753977|NCT01187953|9803083|FG001|COMPLETED|Overall Study||254
8753978|NCT01187953|9803082|FG000|NOT COMPLETED|Overall Study||15
8753979|NCT01187953|9803083|FG001|NOT COMPLETED|Overall Study||21
8753980|NCT01188109|9803089|FG000|STARTED|Overall Study||22
8753981|NCT01188109|9803089|FG000|COMPLETED|Overall Study||22
8753982|NCT01188109|9803089|FG000|NOT COMPLETED|Overall Study||0
8753983|NCT01188226|9803093|FG000|STARTED|Overall Study||10
8753984|NCT01188226|9803093|FG000|COMPLETED|Overall Study||6
8753985|NCT01188226|9803093|FG000|NOT COMPLETED|Overall Study||4
8753986|NCT01188343|9803110|FG000|STARTED|Overall Study||102
8753987|NCT01188343|9803111|FG001|STARTED|Overall Study||219
8753988|NCT01188343|9803112|FG002|STARTED|Overall Study||221
8753989|NCT01188343|9803110|FG000|COMPLETED|Overall Study||101
8753990|NCT01188343|9803111|FG001|COMPLETED|Overall Study||193
8753991|NCT01188343|9803112|FG002|COMPLETED|Overall Study||220
8753992|NCT01188343|9803110|FG000|NOT COMPLETED|Overall Study||1
8753993|NCT01188343|9803111|FG001|NOT COMPLETED|Overall Study||26
8753994|NCT01188343|9803112|FG002|NOT COMPLETED|Overall Study||1
8753995|NCT01188369|9803125|FG000|STARTED|Overall Study||10
8753996|NCT01188369|9803126|FG001|STARTED|Overall Study||10
8753997|NCT01188369|9803125|FG000|COMPLETED|Overall Study||10
8753998|NCT01188369|9803126|FG001|COMPLETED|Overall Study||10
8753999|NCT01188369|9803125|FG000|NOT COMPLETED|Overall Study||0
8754000|NCT01188369|9803126|FG001|NOT COMPLETED|Overall Study||0
8754001|NCT01188421|9803135|FG000|STARTED|Overall Study||31
8754002|NCT01188421|9803136|FG001|STARTED|Overall Study||36
8754003|NCT01188421|9803137|FG002|STARTED|Overall Study||36
8754004|NCT01188421|9803135|FG000|COMPLETED|Overall Study||28
8754005|NCT01188421|9803136|FG001|COMPLETED|Overall Study||26
8754006|NCT01188421|9803137|FG002|COMPLETED|Overall Study||22
8754007|NCT01188421|9803135|FG000|NOT COMPLETED|Overall Study||3
8754008|NCT01188421|9803136|FG001|NOT COMPLETED|Overall Study||10
8754009|NCT01188421|9803137|FG002|NOT COMPLETED|Overall Study||14
8754010|NCT01188447|9803145|FG000|STARTED|Overall Study||4034
8754011|NCT01188447|9803145|FG000|COMPLETED|Overall Study||4034
8754012|NCT01188447|9803145|FG000|NOT COMPLETED|Overall Study||0
8754013|NCT01188460|9803152|FG000|STARTED|Overall Study||25
8754014|NCT01188460|9803153|FG001|STARTED|Overall Study||23
8754015|NCT01188460|9803152|FG000|COMPLETED|Overall Study||25
8754016|NCT01188460|9803153|FG001|COMPLETED|Overall Study||23
8754017|NCT01188460|9803152|FG000|NOT COMPLETED|Overall Study||0
8754018|NCT01188460|9803153|FG001|NOT COMPLETED|Overall Study||0
8754019|NCT01188499|9803164|FG000|STARTED|Overall Study||24
8754020|NCT01188499|9803165|FG001|STARTED|Overall Study||83
8754021|NCT01188499|9803166|FG002|STARTED|Overall Study||33
8754022|NCT01188499|9803167|FG003|STARTED|Overall Study||18
8754023|NCT01188499|9803168|FG004|STARTED|Overall Study||18
8754024|NCT01188499|9803164|FG000|COMPLETED|Overall Study||24
8754025|NCT01188499|9803165|FG001|COMPLETED|Overall Study||83
8754026|NCT01188499|9803166|FG002|COMPLETED|Overall Study||33
8754027|NCT01188499|9803167|FG003|COMPLETED|Overall Study||18
8754028|NCT01188499|9803168|FG004|COMPLETED|Overall Study||18
8754029|NCT01188499|9803164|FG000|NOT COMPLETED|Overall Study||0
8754030|NCT01188499|9803165|FG001|NOT COMPLETED|Overall Study||0
8754031|NCT01188499|9803166|FG002|NOT COMPLETED|Overall Study||0
8754032|NCT01188499|9803167|FG003|NOT COMPLETED|Overall Study||0
8754033|NCT01188499|9803168|FG004|NOT COMPLETED|Overall Study||0
8754034|NCT01188538|9803182|FG000|STARTED|Overall Study||20
8754035|NCT01188538|9803183|FG001|STARTED|Overall Study||20
8754036|NCT01188538|9803182|FG000|COMPLETED|Overall Study||20
8754037|NCT01188538|9803183|FG001|COMPLETED|Overall Study||19
8754038|NCT01188538|9803182|FG000|NOT COMPLETED|Overall Study||0
8754039|NCT01188538|9803183|FG001|NOT COMPLETED|Overall Study||1
8754040|NCT01188551|9803195|FG000|STARTED|Overall Study||25
8754041|NCT01188551|9803196|FG001|STARTED|Overall Study||25
8754042|NCT01188551|9803197|FG002|STARTED|Overall Study||25
8754043|NCT01188551|9803198|FG003|STARTED|Overall Study||25
8754044|NCT01188551|9803195|FG000|COMPLETED|Overall Study||24
8754045|NCT01188551|9803196|FG001|COMPLETED|Overall Study||25
8754046|NCT01188551|9803197|FG002|COMPLETED|Overall Study||25
8754047|NCT01188551|9803198|FG003|COMPLETED|Overall Study||25
8754048|NCT01188551|9803195|FG000|NOT COMPLETED|Overall Study||1
8754049|NCT01188551|9803196|FG001|NOT COMPLETED|Overall Study||0
8754050|NCT01188551|9803197|FG002|NOT COMPLETED|Overall Study||0
8754051|NCT01188551|9803198|FG003|NOT COMPLETED|Overall Study||0
8754052|NCT01188564|9803210|FG000|STARTED|Double-blind Phase||44
8754053|NCT01188564|9803211|FG001|STARTED|Double-blind Phase||31
8754054|NCT01188564|9803210|FG000|COMPLETED|Double-blind Phase||43
8754055|NCT01188564|9803211|FG001|COMPLETED|Double-blind Phase||31
8754056|NCT01188564|9803210|FG000|NOT COMPLETED|Double-blind Phase||1
8754057|NCT01188564|9803211|FG001|NOT COMPLETED|Double-blind Phase||0
8754058|NCT01188564|9803210|FG000|STARTED|Open Label Phase|Not all Double-Blind Phase participants went on to Open Label Phase|24
8754059|NCT01188564|9803211|FG001|STARTED|Open Label Phase|Not all Double Blind Phase participants went on to Open Label Phase|20
8754060|NCT01188564|9803210|FG000|COMPLETED|Open Label Phase||24
8754061|NCT01188564|9803211|FG001|COMPLETED|Open Label Phase||20
8754062|NCT01188564|9803210|FG000|NOT COMPLETED|Open Label Phase||0
8754063|NCT01188564|9803211|FG001|NOT COMPLETED|Open Label Phase||0
8754064|NCT01188577|9803219|FG000|STARTED|Visit 1||11
8754065|NCT01188577|9803220|FG001|STARTED|Visit 1||12
8754066|NCT01188577|9803219|FG000|COMPLETED|Visit 1||11
8754067|NCT01188577|9803220|FG001|COMPLETED|Visit 1||12
8754068|NCT01188577|9803219|FG000|NOT COMPLETED|Visit 1||0
8754069|NCT01188577|9803220|FG001|NOT COMPLETED|Visit 1||0
8754070|NCT01188577|9803219|FG000|STARTED|3-14 Day Washout||11
8754071|NCT01188577|9803220|FG001|STARTED|3-14 Day Washout||12
8754072|NCT01188577|9803219|FG000|COMPLETED|3-14 Day Washout||11
8754073|NCT01188577|9803220|FG001|COMPLETED|3-14 Day Washout||12
8754074|NCT01188577|9803219|FG000|NOT COMPLETED|3-14 Day Washout||0
8754075|NCT01188577|9803220|FG001|NOT COMPLETED|3-14 Day Washout||0
8754076|NCT01188577|9803219|FG000|STARTED|Visit 2||11
8754077|NCT01188577|9803220|FG001|STARTED|Visit 2||12
9024171|NCT03148236|10086945|FG000|STARTED|Overall Study||10
8754078|NCT01188577|9803219|FG000|COMPLETED|Visit 2||11
8754079|NCT01188577|9803220|FG001|COMPLETED|Visit 2||12
8754080|NCT01188577|9803219|FG000|NOT COMPLETED|Visit 2||0
8754081|NCT01188577|9803220|FG001|NOT COMPLETED|Visit 2||0
8754082|NCT01188603|9803226|FG000|STARTED|Overall Study||24
8754083|NCT01188603|9803226|FG000|COMPLETED|Overall Study||24
9024172|NCT03148236|10086946|FG001|STARTED|Overall Study||10
8754084|NCT01188603|9803226|FG000|NOT COMPLETED|Overall Study||0
8754085|NCT01188655|9803230|FG000|STARTED|Overall Study||89
8754086|NCT01188655|9803230|FG000|COMPLETED|Overall Study||76
8754087|NCT01188655|9803230|FG000|NOT COMPLETED|Overall Study||13
8754088|NCT01188668|9803234|FG000|STARTED|Period 1: ARIP Alone||38
8754089|NCT01188668|9803234|FG000|COMPLETED|Period 1: ARIP Alone||36
8754090|NCT01188668|9803234|FG000|NOT COMPLETED|Period 1: ARIP Alone||2
8754091|NCT01188668|9803234|FG000|STARTED|Period 2: Coadministration ARIP + DVS SR||36
8808051|NCT01489254|9860448|FG002|NOT COMPLETED|Open-label Extension Part||0
8754092|NCT01188668|9803234|FG000|COMPLETED|Period 2: Coadministration ARIP + DVS SR||33
8754093|NCT01188668|9803234|FG000|NOT COMPLETED|Period 2: Coadministration ARIP + DVS SR||3
8754094|NCT01188681|9803245|FG000|STARTED|Overall Study||6
8754095|NCT01188681|9803246|FG001|STARTED|Overall Study||6
8754096|NCT01188681|9803247|FG002|STARTED|Overall Study|33 patients enrolled, 32 patients treated. One patient had bladder cancer and was not treated.|33
8754097|NCT01188681|9803248|FG003|STARTED|Overall Study|34 patients enrolled, 33 patients treated. One patient withdrew consent and was not treated.|34
8754098|NCT01188681|9803245|FG000|COMPLETED|Overall Study||6
8754099|NCT01188681|9803246|FG001|COMPLETED|Overall Study||6
8754100|NCT01188681|9803247|FG002|COMPLETED|Overall Study||32
8754101|NCT01188681|9803248|FG003|COMPLETED|Overall Study||33
8754102|NCT01188681|9803245|FG000|NOT COMPLETED|Overall Study||0
8754103|NCT01188681|9803246|FG001|NOT COMPLETED|Overall Study||0
8754104|NCT01188681|9803247|FG002|NOT COMPLETED|Overall Study||1
8754105|NCT01188681|9803248|FG003|NOT COMPLETED|Overall Study||1
8754106|NCT01188694|9803265|FG000|STARTED|Overall Study||15
8754107|NCT01188694|9803266|FG001|STARTED|Overall Study||16
8754108|NCT01188694|9803267|FG002|STARTED|Overall Study||11
8754109|NCT01188694|9803265|FG000|COMPLETED|Overall Study||10
8754110|NCT01188694|9803266|FG001|COMPLETED|Overall Study||15
8754111|NCT01188694|9803267|FG002|COMPLETED|Overall Study||10
8754112|NCT01188694|9803265|FG000|NOT COMPLETED|Overall Study||5
8754113|NCT01188694|9803266|FG001|NOT COMPLETED|Overall Study||1
8754114|NCT01188694|9803267|FG002|NOT COMPLETED|Overall Study||1
8754115|NCT01188772|9803279|FG000|STARTED|Overall Study||48
8754116|NCT01188772|9803280|FG001|STARTED|Overall Study||48
8754117|NCT01188772|9803281|FG002|STARTED|Overall Study||26
8754118|NCT01188772|9803282|FG003|STARTED|Overall Study||25
8754119|NCT01188772|9803279|FG000|Randomized and Treated|Overall Study||48
8754120|NCT01188772|9803280|FG001|Randomized and Treated|Overall Study||47
8754121|NCT01188772|9803281|FG002|Randomized and Treated|Overall Study||26
8754122|NCT01188772|9803282|FG003|Randomized and Treated|Overall Study||25
8754123|NCT01188772|9803279|FG000|COMPLETED|Overall Study||43
8754124|NCT01188772|9803280|FG001|COMPLETED|Overall Study||45
8754125|NCT01188772|9803281|FG002|COMPLETED|Overall Study||15
8754126|NCT01188772|9803282|FG003|COMPLETED|Overall Study||24
8754127|NCT01188772|9803279|FG000|NOT COMPLETED|Overall Study||5
8754128|NCT01188772|9803280|FG001|NOT COMPLETED|Overall Study||3
8754129|NCT01188772|9803281|FG002|NOT COMPLETED|Overall Study||11
8754130|NCT01188772|9803282|FG003|NOT COMPLETED|Overall Study||1
8754131|NCT01188811|9803297|FG000|STARTED|Overall Study||28
8754132|NCT01188811|9803298|FG001|STARTED|Overall Study||26
8754133|NCT01188811|9803297|FG000|COMPLETED|Overall Study||22
8754134|NCT01188811|9803298|FG001|COMPLETED|Overall Study||24
8754135|NCT01188811|9803297|FG000|NOT COMPLETED|Overall Study||6
8754136|NCT01188811|9803298|FG001|NOT COMPLETED|Overall Study||2
8754137|NCT01188876|9803304|FG000|STARTED|Overall Study||50
8754138|NCT01188876|9803304|FG000|COMPLETED|Overall Study||50
8754139|NCT01188876|9803304|FG000|NOT COMPLETED|Overall Study||0
8754140|NCT01188928|9803312|FG000|STARTED|Overall Study||482
8754141|NCT01188928|9803313|FG001|STARTED|Overall Study||479
8754142|NCT01188928|9803314|FG002|STARTED|Overall Study||96
8754143|NCT01188928|9803315|FG003|STARTED|Overall Study||95
8754144|NCT01188928|9803312|FG000|COMPLETED|Overall Study||444
8754145|NCT01188928|9803313|FG001|COMPLETED|Overall Study||417
8754146|NCT01188928|9803314|FG002|COMPLETED|Overall Study||82
8754147|NCT01188928|9803315|FG003|COMPLETED|Overall Study||77
8754148|NCT01188928|9803312|FG000|NOT COMPLETED|Overall Study||38
8754149|NCT01188928|9803313|FG001|NOT COMPLETED|Overall Study||62
8754150|NCT01188928|9803314|FG002|NOT COMPLETED|Overall Study||14
8754151|NCT01188928|9803315|FG003|NOT COMPLETED|Overall Study||18
8754152|NCT01188967|9803327|FG000|STARTED|Overall Study||10
8754153|NCT01188967|9803328|FG001|STARTED|Overall Study||8
8754154|NCT01188967|9803327|FG000|COMPLETED|Overall Study||5
8754155|NCT01188967|9803328|FG001|COMPLETED|Overall Study||4
8754156|NCT01188967|9803327|FG000|NOT COMPLETED|Overall Study||5
8754157|NCT01188967|9803328|FG001|NOT COMPLETED|Overall Study||4
8754158|NCT01189032|9803339|FG000|STARTED|Overall Study||94
8754159|NCT01189032|9803340|FG001|STARTED|Overall Study||96
8754160|NCT01189032|9803341|FG002|STARTED|Overall Study||96
8754161|NCT01189032|9803339|FG000|COMPLETED|Overall Study||89
8754162|NCT01189032|9803340|FG001|COMPLETED|Overall Study||89
8754163|NCT01189032|9803341|FG002|COMPLETED|Overall Study||90
8754164|NCT01189032|9803339|FG000|NOT COMPLETED|Overall Study||5
8754165|NCT01189032|9803340|FG001|NOT COMPLETED|Overall Study||7
8754166|NCT01189032|9803341|FG002|NOT COMPLETED|Overall Study||6
8754167|NCT01189110|9803351|FG000|STARTED|Overall Study|September, 2010|64
8754168|NCT01189110|9803352|FG001|STARTED|Overall Study||61
8754169|NCT01189110|9803351|FG000|COMPLETED|Overall Study|February, 2011|64
8754170|NCT01189110|9803352|FG001|COMPLETED|Overall Study||61
8754171|NCT01189110|9803351|FG000|NOT COMPLETED|Overall Study||0
8754172|NCT01189110|9803352|FG001|NOT COMPLETED|Overall Study||0
8754173|NCT01189123|9803360|FG000|STARTED|Overall Study||52
8754174|NCT01189123|9803361|FG001|STARTED|Overall Study||53
8754175|NCT01189123|9803360|FG000|COMPLETED|Overall Study||50
8754176|NCT01189123|9803361|FG001|COMPLETED|Overall Study||47
8754177|NCT01189123|9803360|FG000|NOT COMPLETED|Overall Study||2
8754178|NCT01189123|9803361|FG001|NOT COMPLETED|Overall Study||6
8754179|NCT01189136|9803369|FG000|STARTED|Overall Study||42
8754180|NCT01189136|9803370|FG001|STARTED|Overall Study||42
8754181|NCT01189136|9803369|FG000|COMPLETED|Overall Study||42
8754182|NCT01189136|9803370|FG001|COMPLETED|Overall Study||42
8754183|NCT01189136|9803369|FG000|NOT COMPLETED|Overall Study||0
8754184|NCT01189136|9803370|FG001|NOT COMPLETED|Overall Study||0
8754185|NCT01189201|9803376|FG000|STARTED|Overall Study||42
8754186|NCT01189201|9803376|FG000|Received Empa/Linagliptin FDC A1(Fasted)|Overall Study||42
8754187|NCT01189201|9803376|FG000|Rec. Empa/Linagliptin Ind.Tablet(Fasted)|Overall Study||41
8754188|NCT01189201|9803376|FG000|Received Empa/Linagliptin FDC A1 (Fed)|Overall Study||18
8754189|NCT01189201|9803376|FG000|Received Empa/Linagliptin FDC A3(Fasted)|Overall Study||24
8754190|NCT01189201|9803376|FG000|COMPLETED|Overall Study||41
8754191|NCT01189201|9803376|FG000|NOT COMPLETED|Overall Study||1
8754192|NCT01189240|9803391|FG000|STARTED|Overall Study||4
9024173|NCT03148236|10086945|FG000|COMPLETED|Overall Study||10
9024174|NCT03148236|10086946|FG001|COMPLETED|Overall Study||10
9024175|NCT03148236|10086945|FG000|NOT COMPLETED|Overall Study||0
9024176|NCT03148236|10086946|FG001|NOT COMPLETED|Overall Study||0
9024177|NCT03148262|10086954|FG000|STARTED|Overall Study||31
9024178|NCT03148262|10086955|FG001|STARTED|Overall Study||32
9024179|NCT03148262|10086954|FG000|COMPLETED|Overall Study||28
9024180|NCT03148262|10086955|FG001|COMPLETED|Overall Study||31
9024181|NCT03148262|10086954|FG000|NOT COMPLETED|Overall Study||3
9024182|NCT03148262|10086955|FG001|NOT COMPLETED|Overall Study||1
9024183|NCT03148470|10086963|FG000|STARTED|Overall Study|21 Participants completed the Tasks following Sham-stimulation|21
9024184|NCT03148470|10086964|FG001|STARTED|Overall Study|20 Participants completed the Tasks following Sham-stimulation|20
9024185|NCT03148470|10086963|FG000|COMPLETED|Overall Study|20 Participants completed the Tasks following iTBS-stimulation|20
9024186|NCT03148470|10086964|FG001|COMPLETED|Overall Study|20 Participants completed the Tasks following cTBS-stimulation|20
9024187|NCT03148470|10086963|FG000|NOT COMPLETED|Overall Study||1
9024188|NCT03148470|10086964|FG001|NOT COMPLETED|Overall Study||0
9024189|NCT03148691|10086981|FG000|STARTED|Overall Study||50
9024190|NCT03148691|10086982|FG001|STARTED|Overall Study||103
9024191|NCT03148691|10086983|FG002|STARTED|Overall Study||100
9024192|NCT03148691|10086981|FG000|COMPLETED|Overall Study||47
9024193|NCT03148691|10086982|FG001|COMPLETED|Overall Study||101
9024194|NCT03148691|10086983|FG002|COMPLETED|Overall Study||92
9024195|NCT03148691|10086981|FG000|NOT COMPLETED|Overall Study||3
9024196|NCT03148691|10086982|FG001|NOT COMPLETED|Overall Study||2
9024197|NCT03148691|10086983|FG002|NOT COMPLETED|Overall Study||8
9024198|NCT03149042|10086991|FG000|STARTED|Overall Study||75
9024199|NCT03149042|10086991|FG000|COMPLETED|Overall Study||52
9024200|NCT03149042|10086991|FG000|NOT COMPLETED|Overall Study||23
9024201|NCT03149055|10086996|FG000|STARTED|Overall Study||99
9024202|NCT03149055|10086996|FG000|COMPLETED|Overall Study||95
9024203|NCT03149055|10086996|FG000|NOT COMPLETED|Overall Study||4
9024204|NCT03149172|10087003|FG000|STARTED|Overall Study||8
9024205|NCT03149172|10087004|FG001|STARTED|Overall Study||6
9024206|NCT03149172|10087005|FG002|STARTED|Overall Study||7
9024207|NCT03149172|10087003|FG000|COMPLETED|Overall Study||6
9024208|NCT03149172|10087004|FG001|COMPLETED|Overall Study||5
9024209|NCT03149172|10087005|FG002|COMPLETED|Overall Study||5
9024210|NCT03149172|10087003|FG000|NOT COMPLETED|Overall Study||2
9024211|NCT03149172|10087004|FG001|NOT COMPLETED|Overall Study||1
9024212|NCT03149172|10087005|FG002|NOT COMPLETED|Overall Study||2
9024213|NCT03149328|10087015|FG000|STARTED|Overall Study||284
9024214|NCT03149328|10087016|FG001|STARTED|Overall Study||259
9024215|NCT03149328|10087015|FG000|COMPLETED|Overall Study||200
9024216|NCT03149328|10087016|FG001|COMPLETED|Overall Study||213
9024217|NCT03149328|10087015|FG000|NOT COMPLETED|Overall Study||84
9024218|NCT03149328|10087016|FG001|NOT COMPLETED|Overall Study||46
9024219|NCT03149848|10087022|FG000|STARTED|Period 1 (Day 1 to Day 14)||15
9024220|NCT03149848|10087022|FG000|COMPLETED|Period 1 (Day 1 to Day 14)||14
9024221|NCT03149848|10087022|FG000|NOT COMPLETED|Period 1 (Day 1 to Day 14)||1
9024222|NCT03149848|10087022|FG000|STARTED|Period 2 (Day 15 to Day 28)||14
9024223|NCT03149848|10087022|FG000|COMPLETED|Period 2 (Day 15 to Day 28)||12
9024224|NCT03149848|10087022|FG000|NOT COMPLETED|Period 2 (Day 15 to Day 28)||2
9024225|NCT03149887|10087031|FG000|STARTED|Overall Study||27
9024226|NCT03149887|10087032|FG001|STARTED|Overall Study||27
9024227|NCT03149887|10087031|FG000|COMPLETED|Overall Study||27
9024228|NCT03149887|10087032|FG001|COMPLETED|Overall Study||27
9024229|NCT03149887|10087031|FG000|NOT COMPLETED|Overall Study||0
9024230|NCT03149887|10087032|FG001|NOT COMPLETED|Overall Study||0
9024231|NCT03149991|10087040|FG000|STARTED|Overall Study||25
9024232|NCT03149991|10087041|FG001|STARTED|Overall Study||26
9024233|NCT03149991|10087040|FG000|Completed Primary Endpoint (Day 14)|Overall Study||25
9024234|NCT03149991|10087041|FG001|Completed Primary Endpoint (Day 14)|Overall Study||24
9024235|NCT03149991|10087040|FG000|Exited|Overall Study||4
9024236|NCT03149991|10087041|FG001|Exited|Overall Study||2
9024237|NCT03149991|10087040|FG000|COMPLETED|Overall Study||21
9024238|NCT03149991|10087041|FG001|COMPLETED|Overall Study||24
9024239|NCT03149991|10087040|FG000|NOT COMPLETED|Overall Study||4
9024240|NCT03149991|10087041|FG001|NOT COMPLETED|Overall Study||2
9024241|NCT03150043|10087047|FG000|STARTED|Overall Study||65
9024242|NCT03150043|10087047|FG000|COMPLETED|Overall Study||65
9024243|NCT03150043|10087047|FG000|NOT COMPLETED|Overall Study||0
9024244|NCT03150056|10087058|FG000|STARTED|Overall Study||10
8754193|NCT01189240|9803392|FG001|STARTED|Overall Study||6
9024245|NCT03150056|10087059|FG001|STARTED|Overall Study||6
9024246|NCT03150056|10087060|FG002|STARTED|Overall Study||4
9024247|NCT03150056|10087061|FG003|STARTED|Overall Study||10
9024248|NCT03150056|10087062|FG004|STARTED|Overall Study||22
8754194|NCT01189240|9803393|FG002|STARTED|Overall Study||3
8754195|NCT01189240|9803391|FG000|COMPLETED|Overall Study||4
8754196|NCT01189240|9803392|FG001|COMPLETED|Overall Study||6
8754197|NCT01189240|9803393|FG002|COMPLETED|Overall Study||3
8754198|NCT01189240|9803391|FG000|NOT COMPLETED|Overall Study||0
8754199|NCT01189240|9803392|FG001|NOT COMPLETED|Overall Study||0
8754200|NCT01189240|9803393|FG002|NOT COMPLETED|Overall Study||0
8754201|NCT01189266|9803406|FG000|STARTED|Overall Study||6
8754202|NCT01189266|9803407|FG001|STARTED|Overall Study||6
8754203|NCT01189266|9803408|FG002|STARTED|Overall Study||67
8754204|NCT01189266|9803406|FG000|COMPLETED|Overall Study||0
8754205|NCT01189266|9803407|FG001|COMPLETED|Overall Study||0
8754206|NCT01189266|9803408|FG002|COMPLETED|Overall Study||2
8754207|NCT01189266|9803406|FG000|NOT COMPLETED|Overall Study||6
8754208|NCT01189266|9803407|FG001|NOT COMPLETED|Overall Study||6
8754209|NCT01189266|9803408|FG002|NOT COMPLETED|Overall Study||65
8754210|NCT01189279|9803420|FG000|STARTED|Overall Study||14
8754211|NCT01189279|9803421|FG001|STARTED|Overall Study||14
8754212|NCT01189279|9803422|FG002|STARTED|Overall Study||14
8754213|NCT01189279|9803420|FG000|COMPLETED|Overall Study||13
8754214|NCT01189279|9803421|FG001|COMPLETED|Overall Study||14
8754215|NCT01189279|9803422|FG002|COMPLETED|Overall Study||13
8754216|NCT01189279|9803420|FG000|NOT COMPLETED|Overall Study||1
8754217|NCT01189279|9803421|FG001|NOT COMPLETED|Overall Study||0
8754218|NCT01189279|9803422|FG002|NOT COMPLETED|Overall Study||1
8754219|NCT01189292|9803432|FG000|STARTED|Intention to Treat Analysis||76
8754220|NCT01189292|9803433|FG001|STARTED|Intention to Treat Analysis||76
8754221|NCT01189292|9803432|FG000|COMPLETED|Intention to Treat Analysis||76
8754222|NCT01189292|9803433|FG001|COMPLETED|Intention to Treat Analysis||76
8754223|NCT01189292|9803432|FG000|NOT COMPLETED|Intention to Treat Analysis||0
8754224|NCT01189292|9803433|FG001|NOT COMPLETED|Intention to Treat Analysis||0
8754225|NCT01189292|9803432|FG000|STARTED|Per Protocol Analysis||76
8754226|NCT01189292|9803433|FG001|STARTED|Per Protocol Analysis||76
8754227|NCT01189292|9803432|FG000|COMPLETED|Per Protocol Analysis||65
8754228|NCT01189292|9803433|FG001|COMPLETED|Per Protocol Analysis||60
8754229|NCT01189292|9803432|FG000|NOT COMPLETED|Per Protocol Analysis||11
8754230|NCT01189292|9803433|FG001|NOT COMPLETED|Per Protocol Analysis||16
8754231|NCT01189370|9803439|FG000|STARTED|Dose Level 1||25
8754232|NCT01189370|9803440|FG001|STARTED|Dose Level 1||0
8754233|NCT01189370|9803441|FG002|STARTED|Dose Level 1||0
8754234|NCT01189370|9803439|FG000|COMPLETED|Dose Level 1||16
8754235|NCT01189370|9803440|FG001|COMPLETED|Dose Level 1||0
8754236|NCT01189370|9803441|FG002|COMPLETED|Dose Level 1||0
8754237|NCT01189370|9803439|FG000|NOT COMPLETED|Dose Level 1||9
8754238|NCT01189370|9803440|FG001|NOT COMPLETED|Dose Level 1||0
8754239|NCT01189370|9803441|FG002|NOT COMPLETED|Dose Level 1||0
8754240|NCT01189370|9803439|FG000|STARTED|Dose Level 2||0
8754241|NCT01189370|9803440|FG001|STARTED|Dose Level 2||16
8754242|NCT01189370|9803441|FG002|STARTED|Dose Level 2||0
8754243|NCT01189370|9803439|FG000|COMPLETED|Dose Level 2||0
8754244|NCT01189370|9803440|FG001|COMPLETED|Dose Level 2||12
8754245|NCT01189370|9803441|FG002|COMPLETED|Dose Level 2||0
8754246|NCT01189370|9803439|FG000|NOT COMPLETED|Dose Level 2||0
8754247|NCT01189370|9803440|FG001|NOT COMPLETED|Dose Level 2||4
8754248|NCT01189370|9803441|FG002|NOT COMPLETED|Dose Level 2||0
8754249|NCT01189370|9803439|FG000|STARTED|Dose Level 3||0
8754250|NCT01189370|9803440|FG001|STARTED|Dose Level 3||0
8754251|NCT01189370|9803441|FG002|STARTED|Dose Level 3||12
8754252|NCT01189370|9803439|FG000|COMPLETED|Dose Level 3||0
8754253|NCT01189370|9803440|FG001|COMPLETED|Dose Level 3||0
8754254|NCT01189370|9803441|FG002|COMPLETED|Dose Level 3||6
8754255|NCT01189370|9803439|FG000|NOT COMPLETED|Dose Level 3||0
8754256|NCT01189370|9803440|FG001|NOT COMPLETED|Dose Level 3||0
8754257|NCT01189370|9803441|FG002|NOT COMPLETED|Dose Level 3||6
8754258|NCT01189409|9803450|FG000|STARTED|First 3 Weeks||37
8754259|NCT01189409|9803451|FG001|STARTED|First 3 Weeks||33
8754260|NCT01189409|9803450|FG000|COMPLETED|First 3 Weeks||19
8754261|NCT01189409|9803451|FG001|COMPLETED|First 3 Weeks||23
8754262|NCT01189409|9803450|FG000|NOT COMPLETED|First 3 Weeks||18
8754263|NCT01189409|9803451|FG001|NOT COMPLETED|First 3 Weeks||10
8754264|NCT01189409|9803450|FG000|STARTED|Second 3 Weeks (Switch to 2nd Treatment)||19
8754265|NCT01189409|9803451|FG001|STARTED|Second 3 Weeks (Switch to 2nd Treatment)||23
8754266|NCT01189409|9803450|FG000|COMPLETED|Second 3 Weeks (Switch to 2nd Treatment)||13
8754267|NCT01189409|9803451|FG001|COMPLETED|Second 3 Weeks (Switch to 2nd Treatment)||15
8754268|NCT01189409|9803450|FG000|NOT COMPLETED|Second 3 Weeks (Switch to 2nd Treatment)||6
8754269|NCT01189409|9803451|FG001|NOT COMPLETED|Second 3 Weeks (Switch to 2nd Treatment)||8
8754270|NCT01189461|9803464|FG000|STARTED|Overall Study||46
8754271|NCT01189461|9803464|FG000|COMPLETED|Overall Study||12
8754272|NCT01189461|9803464|FG000|NOT COMPLETED|Overall Study||34
8754273|NCT01189487|9803468|FG000|STARTED|Overall Study|Treated participants|47
8754274|NCT01189487|9803468|FG000|COMPLETED|Overall Study||44
8754275|NCT01189487|9803468|FG000|NOT COMPLETED|Overall Study||3
8754276|NCT01189500|9803472|FG000|STARTED|Period 1: TAMOX Alone||30
8754277|NCT01189500|9803472|FG000|COMPLETED|Period 1: TAMOX Alone||29
8754278|NCT01189500|9803472|FG000|NOT COMPLETED|Period 1: TAMOX Alone||1
8754279|NCT01189500|9803472|FG000|STARTED|Period 2: Coadministration TAMOX+DVS SR||29
8754280|NCT01189500|9803472|FG000|COMPLETED|Period 2: Coadministration TAMOX+DVS SR||28
8754281|NCT01189500|9803472|FG000|NOT COMPLETED|Period 2: Coadministration TAMOX+DVS SR||1
8754282|NCT01189604|9803486|FG000|STARTED|Overall Study||21
8754283|NCT01189604|9803487|FG001|STARTED|Overall Study||21
8754284|NCT01189604|9803488|FG002|STARTED|Overall Study||20
8754285|NCT01189604|9803489|FG003|STARTED|Overall Study||20
8754286|NCT01189604|9803490|FG004|STARTED|Overall Study||20
8754287|NCT01189604|9803491|FG005|STARTED|Overall Study||11
8754288|NCT01189604|9803492|FG006|STARTED|Overall Study||10
8754289|NCT01189604|9803486|FG000|Administered Study Drug|Overall Study||20
8754290|NCT01189604|9803487|FG001|Administered Study Drug|Overall Study||20
8754291|NCT01189604|9803488|FG002|Administered Study Drug|Overall Study||20
8754292|NCT01189604|9803489|FG003|Administered Study Drug|Overall Study||20
8754293|NCT01189604|9803490|FG004|Administered Study Drug|Overall Study||20
8754294|NCT01189604|9803491|FG005|Administered Study Drug|Overall Study||10
8754295|NCT01189604|9803492|FG006|Administered Study Drug|Overall Study||10
8754296|NCT01189604|9803486|FG000|COMPLETED|Overall Study||20
8754297|NCT01189604|9803487|FG001|COMPLETED|Overall Study||20
8754298|NCT01189604|9803488|FG002|COMPLETED|Overall Study||20
8754299|NCT01189604|9803489|FG003|COMPLETED|Overall Study||20
8754300|NCT01189604|9803490|FG004|COMPLETED|Overall Study||18
8754301|NCT01189604|9803491|FG005|COMPLETED|Overall Study||10
8754302|NCT01189604|9803492|FG006|COMPLETED|Overall Study||9
8754303|NCT01189604|9803486|FG000|NOT COMPLETED|Overall Study||1
8754304|NCT01189604|9803487|FG001|NOT COMPLETED|Overall Study||1
8754305|NCT01189604|9803488|FG002|NOT COMPLETED|Overall Study||0
8754306|NCT01189604|9803489|FG003|NOT COMPLETED|Overall Study||0
8754307|NCT01189604|9803490|FG004|NOT COMPLETED|Overall Study||2
8754308|NCT01189604|9803491|FG005|NOT COMPLETED|Overall Study||1
8754309|NCT01189604|9803492|FG006|NOT COMPLETED|Overall Study||1
8754310|NCT01189617|9803510|FG000|STARTED|Overall Study||35
8754311|NCT01189617|9803511|FG001|STARTED|Overall Study||35
8754312|NCT01189617|9803510|FG000|COMPLETED|Overall Study||35
8754313|NCT01189617|9803511|FG001|COMPLETED|Overall Study||35
8754314|NCT01189617|9803510|FG000|NOT COMPLETED|Overall Study||0
8754315|NCT01189617|9803511|FG001|NOT COMPLETED|Overall Study||0
8754316|NCT01189747|9803519|FG000|STARTED|Overall Study||222
8754317|NCT01189747|9803520|FG001|STARTED|Overall Study||224
8754318|NCT01189747|9803519|FG000|COMPLETED|Overall Study||210
8754319|NCT01189747|9803520|FG001|COMPLETED|Overall Study||206
8754320|NCT01189747|9803519|FG000|NOT COMPLETED|Overall Study||12
8754321|NCT01189747|9803520|FG001|NOT COMPLETED|Overall Study||18
8754322|NCT01189760|9803529|FG000|STARTED|Overall Study||305
8754323|NCT01189760|9803530|FG001|STARTED|Overall Study||306
8754324|NCT01189760|9803531|FG002|STARTED|Overall Study||306
8754325|NCT01189760|9803529|FG000|COMPLETED|Overall Study||291
8754326|NCT01189760|9803530|FG001|COMPLETED|Overall Study||283
8754327|NCT01189760|9803531|FG002|COMPLETED|Overall Study||255
8754328|NCT01189760|9803529|FG000|NOT COMPLETED|Overall Study||14
8754329|NCT01189760|9803530|FG001|NOT COMPLETED|Overall Study||23
8754330|NCT01189760|9803531|FG002|NOT COMPLETED|Overall Study||51
8754331|NCT01189812|9803541|FG000|STARTED|Overall Study||40
8754332|NCT01189812|9803542|FG001|STARTED|Overall Study||40
8754333|NCT01189812|9803541|FG000|COMPLETED|Overall Study||32
8754334|NCT01189812|9803542|FG001|COMPLETED|Overall Study||32
8754335|NCT01189812|9803541|FG000|NOT COMPLETED|Overall Study||8
8754336|NCT01189812|9803542|FG001|NOT COMPLETED|Overall Study||8
8754337|NCT01189890|9803550|FG000|STARTED|Overall Study||241
8754338|NCT01189890|9803551|FG001|STARTED|Overall Study|3 randomized glimepiride participants did not receive study drug.|239
8754339|NCT01189890|9803550|FG000|COMPLETED|Overall Study||204
8754340|NCT01189890|9803551|FG001|COMPLETED|Overall Study||200
8754341|NCT01189890|9803550|FG000|NOT COMPLETED|Overall Study||37
8754342|NCT01189890|9803551|FG001|NOT COMPLETED|Overall Study||39
8754343|NCT01190007|9803557|FG000|STARTED|Overall Study|Treated|159
8754344|NCT01190007|9803557|FG000|COMPLETED|Overall Study||145
8754345|NCT01190007|9803557|FG000|NOT COMPLETED|Overall Study||14
8754346|NCT01190020|9803563|FG000|STARTED|Overall Study||29
8754347|NCT01190020|9803564|FG001|STARTED|Overall Study||12
8754348|NCT01190020|9803563|FG000|COMPLETED|Overall Study||22
8754349|NCT01190020|9803564|FG001|COMPLETED|Overall Study||12
8754350|NCT01190020|9803563|FG000|NOT COMPLETED|Overall Study||7
8754351|NCT01190020|9803564|FG001|NOT COMPLETED|Overall Study||0
8754352|NCT01190085|9803573|FG000|STARTED|Overall Study||13
8754353|NCT01190085|9803574|FG001|STARTED|Overall Study||14
8754354|NCT01190085|9803575|FG002|STARTED|Overall Study||18
8754355|NCT01190085|9803573|FG000|COMPLETED|Overall Study||13
8754356|NCT01190085|9803574|FG001|COMPLETED|Overall Study||14
8754357|NCT01190085|9803575|FG002|COMPLETED|Overall Study||18
8754358|NCT01190085|9803573|FG000|NOT COMPLETED|Overall Study||0
8754359|NCT01190085|9803574|FG001|NOT COMPLETED|Overall Study||0
8754360|NCT01190085|9803575|FG002|NOT COMPLETED|Overall Study||0
8754361|NCT01190098|9803585|FG000|STARTED|Overall Study||42
8754362|NCT01190098|9803586|FG001|STARTED|Overall Study||10
8754363|NCT01190098|9803585|FG000|COMPLETED|Overall Study||39
8754364|NCT01190098|9803586|FG001|COMPLETED|Overall Study||8
8754365|NCT01190098|9803585|FG000|NOT COMPLETED|Overall Study||3
8754366|NCT01190098|9803586|FG001|NOT COMPLETED|Overall Study||2
8754367|NCT01190124|9803595|FG000|STARTED|Overall Study||107
8754368|NCT01190124|9803596|FG001|STARTED|Overall Study||24
8754369|NCT01190124|9803597|FG002|STARTED|Overall Study||20
8754370|NCT01190124|9803595|FG000|COMPLETED|Overall Study||90
8754371|NCT01190124|9803596|FG001|COMPLETED|Overall Study||24
8754372|NCT01190124|9803597|FG002|COMPLETED|Overall Study||19
8754373|NCT01190124|9803595|FG000|NOT COMPLETED|Overall Study||17
8754374|NCT01190124|9803596|FG001|NOT COMPLETED|Overall Study||0
8754375|NCT01190124|9803597|FG002|NOT COMPLETED|Overall Study||1
8754376|NCT01190150|9803610|FG000|STARTED|First Treatment|Randomized, as well as Safety and PK populations|11
8754377|NCT01190150|9803611|FG001|STARTED|First Treatment|Randomized, as well as Safety and PK populations|9
8754378|NCT01190150|9803610|FG000|COMPLETED|First Treatment||10
8754379|NCT01190150|9803611|FG001|COMPLETED|First Treatment||9
8754380|NCT01190150|9803610|FG000|NOT COMPLETED|First Treatment||1
8754381|NCT01190150|9803611|FG001|NOT COMPLETED|First Treatment||0
8754382|NCT01190150|9803610|FG000|STARTED|Washout||10
8754383|NCT01190150|9803611|FG001|STARTED|Washout||9
8754384|NCT01190150|9803610|FG000|COMPLETED|Washout||10
8754385|NCT01190150|9803611|FG001|COMPLETED|Washout||7
8754386|NCT01190150|9803610|FG000|NOT COMPLETED|Washout||0
8754387|NCT01190150|9803611|FG001|NOT COMPLETED|Washout||2
8754388|NCT01190150|9803610|FG000|STARTED|Second Treatment||10
8754389|NCT01190150|9803611|FG001|STARTED|Second Treatment||7
8754390|NCT01190150|9803610|FG000|COMPLETED|Second Treatment||10
8754391|NCT01190150|9803611|FG001|COMPLETED|Second Treatment||7
8754392|NCT01190150|9803610|FG000|NOT COMPLETED|Second Treatment||0
8754393|NCT01190150|9803611|FG001|NOT COMPLETED|Second Treatment||0
8754394|NCT01190176|9803617|FG000|STARTED|Overall Study||32
8754395|NCT01190176|9803617|FG000|COMPLETED|Overall Study||30
8754396|NCT01190176|9803617|FG000|NOT COMPLETED|Overall Study||2
8754397|NCT01190189|9803621|FG000|STARTED|Overall Study||137
8754398|NCT01190189|9803621|FG000|COMPLETED|Overall Study||131
8754399|NCT01190189|9803621|FG000|NOT COMPLETED|Overall Study||6
8754400|NCT01190215|9803627|FG000|STARTED|Up to Day 28||38
8754401|NCT01190215|9803628|FG001|STARTED|Up to Day 28||39
8754402|NCT01190215|9803627|FG000|COMPLETED|Up to Day 28||38
8754403|NCT01190215|9803628|FG001|COMPLETED|Up to Day 28||39
8754404|NCT01190215|9803627|FG000|NOT COMPLETED|Up to Day 28||0
8754405|NCT01190215|9803628|FG001|NOT COMPLETED|Up to Day 28||0
8754406|NCT01190215|9803627|FG000|STARTED|Up to Month 6||38
8754407|NCT01190215|9803628|FG001|STARTED|Up to Month 6||39
8754408|NCT01190215|9803627|FG000|COMPLETED|Up to Month 6||36
8754409|NCT01190215|9803628|FG001|COMPLETED|Up to Month 6||39
8754410|NCT01190215|9803627|FG000|NOT COMPLETED|Up to Month 6||2
8754411|NCT01190215|9803628|FG001|NOT COMPLETED|Up to Month 6||0
8754412|NCT01190410|9803636|FG000|STARTED|Overall Study||4
8754413|NCT01190410|9803637|FG001|STARTED|Overall Study||12
8754414|NCT01190410|9803636|FG000|Re-Induction|Overall Study||0
8754415|NCT01190410|9803637|FG001|Re-Induction|Overall Study||2
8754416|NCT01190410|9803636|FG000|COMPLETED|Overall Study||3
8754417|NCT01190410|9803637|FG001|COMPLETED|Overall Study||3
8754418|NCT01190410|9803636|FG000|NOT COMPLETED|Overall Study||1
8754419|NCT01190410|9803637|FG001|NOT COMPLETED|Overall Study||9
8754420|NCT01190436|9803649|FG000|STARTED|Overall Study||125
8754421|NCT01190436|9803649|FG000|COMPLETED|Overall Study||86
8754422|NCT01190436|9803649|FG000|NOT COMPLETED|Overall Study||39
8754423|NCT01190449|9803656|FG000|STARTED|Overall Study||15
8754424|NCT01190449|9803657|FG001|STARTED|Overall Study||36
8754425|NCT01190449|9803656|FG000|COMPLETED|Overall Study||15
8754426|NCT01190449|9803657|FG001|COMPLETED|Overall Study||32
8754427|NCT01190449|9803656|FG000|NOT COMPLETED|Overall Study||0
8754428|NCT01190449|9803657|FG001|NOT COMPLETED|Overall Study||4
8754429|NCT01190475|9803666|FG000|STARTED|Overall Study||2
8754430|NCT01190475|9803667|FG001|STARTED|Overall Study||2
8754431|NCT01190475|9803668|FG002|STARTED|Overall Study||2
8754432|NCT01190475|9803666|FG000|COMPLETED|Overall Study||2
8754433|NCT01190475|9803667|FG001|COMPLETED|Overall Study||2
8754434|NCT01190475|9803668|FG002|COMPLETED|Overall Study||1
8754435|NCT01190475|9803666|FG000|NOT COMPLETED|Overall Study||0
8754436|NCT01190475|9803667|FG001|NOT COMPLETED|Overall Study||0
8754437|NCT01190475|9803668|FG002|NOT COMPLETED|Overall Study||1
8754438|NCT01190514|9803678|FG000|STARTED|First Intervention (Period 1)||11
8754439|NCT01190514|9803679|FG001|STARTED|First Intervention (Period 1)||10
8754440|NCT01190514|9803680|FG002|STARTED|First Intervention (Period 1)||10
8754441|NCT01190514|9803681|FG003|STARTED|First Intervention (Period 1)||10
8754442|NCT01190514|9803678|FG000|COMPLETED|First Intervention (Period 1)|Discontinued participant received treatment A of sequence ABCD.|10
8754443|NCT01190514|9803679|FG001|COMPLETED|First Intervention (Period 1)||10
8754444|NCT01190514|9803680|FG002|COMPLETED|First Intervention (Period 1)||10
8754445|NCT01190514|9803681|FG003|COMPLETED|First Intervention (Period 1)||10
8754446|NCT01190514|9803678|FG000|NOT COMPLETED|First Intervention (Period 1)||1
8754447|NCT01190514|9803679|FG001|NOT COMPLETED|First Intervention (Period 1)||0
8754448|NCT01190514|9803680|FG002|NOT COMPLETED|First Intervention (Period 1)||0
8754449|NCT01190514|9803681|FG003|NOT COMPLETED|First Intervention (Period 1)||0
8754450|NCT01190514|9803678|FG000|STARTED|Second Intervention (Period 2)|Period 2 received treatment B|10
8754451|NCT01190514|9803679|FG001|STARTED|Second Intervention (Period 2)|Period 2 received treatment A|10
8754452|NCT01190514|9803680|FG002|STARTED|Second Intervention (Period 2)|Period 2 received treatment D|10
8754453|NCT01190514|9803681|FG003|STARTED|Second Intervention (Period 2)|Period 2 received treatment C|10
8754454|NCT01190514|9803678|FG000|COMPLETED|Second Intervention (Period 2)||10
8754455|NCT01190514|9803679|FG001|COMPLETED|Second Intervention (Period 2)||10
8754456|NCT01190514|9803680|FG002|COMPLETED|Second Intervention (Period 2)||10
8754457|NCT01190514|9803681|FG003|COMPLETED|Second Intervention (Period 2)||10
8754458|NCT01190514|9803678|FG000|NOT COMPLETED|Second Intervention (Period 2)||0
8754459|NCT01190514|9803679|FG001|NOT COMPLETED|Second Intervention (Period 2)||0
8754460|NCT01190514|9803680|FG002|NOT COMPLETED|Second Intervention (Period 2)||0
8754461|NCT01190514|9803681|FG003|NOT COMPLETED|Second Intervention (Period 2)||0
8754462|NCT01190514|9803678|FG000|STARTED|Third Intervention (Period 3)|Period 3 received treatment C|10
8754463|NCT01190514|9803679|FG001|STARTED|Third Intervention (Period 3)|Period 3 received treatment D|10
8754464|NCT01190514|9803680|FG002|STARTED|Third Intervention (Period 3)|Period 3 received treatment A|10
8754465|NCT01190514|9803681|FG003|STARTED|Third Intervention (Period 3)|Period 3 received treatment B|10
8754466|NCT01190514|9803678|FG000|COMPLETED|Third Intervention (Period 3)|Discontinued participant received treatments ABC of sequence ABCD.|9
8754467|NCT01190514|9803679|FG001|COMPLETED|Third Intervention (Period 3)||10
8754468|NCT01190514|9803680|FG002|COMPLETED|Third Intervention (Period 3)||10
8754469|NCT01190514|9803681|FG003|COMPLETED|Third Intervention (Period 3)||10
8754470|NCT01190514|9803678|FG000|NOT COMPLETED|Third Intervention (Period 3)||1
8754471|NCT01190514|9803679|FG001|NOT COMPLETED|Third Intervention (Period 3)||0
8754472|NCT01190514|9803680|FG002|NOT COMPLETED|Third Intervention (Period 3)||0
8754473|NCT01190514|9803681|FG003|NOT COMPLETED|Third Intervention (Period 3)||0
8754474|NCT01190514|9803678|FG000|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment D|9
8754475|NCT01190514|9803679|FG001|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment C|10
8754476|NCT01190514|9803680|FG002|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment B|10
8754477|NCT01190514|9803681|FG003|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment A|10
8754478|NCT01190514|9803678|FG000|COMPLETED|Fourth Intervention (Period 4)||9
8754479|NCT01190514|9803679|FG001|COMPLETED|Fourth Intervention (Period 4)||10
8754480|NCT01190514|9803680|FG002|COMPLETED|Fourth Intervention (Period 4)||10
8754481|NCT01190514|9803681|FG003|COMPLETED|Fourth Intervention (Period 4)||10
8754482|NCT01190514|9803678|FG000|NOT COMPLETED|Fourth Intervention (Period 4)||0
8754483|NCT01190514|9803679|FG001|NOT COMPLETED|Fourth Intervention (Period 4)||0
8754484|NCT01190514|9803680|FG002|NOT COMPLETED|Fourth Intervention (Period 4)||0
8754485|NCT01190514|9803681|FG003|NOT COMPLETED|Fourth Intervention (Period 4)||0
8754486|NCT01190527|9803691|FG000|STARTED|Overall Study||42
8754487|NCT01190527|9803691|FG000|COMPLETED|Overall Study||42
8754488|NCT01190527|9803691|FG000|NOT COMPLETED|Overall Study||0
8754489|NCT01190566|9803697|FG000|STARTED|Overall Study||6
8754490|NCT01190566|9803698|FG001|STARTED|Overall Study||42
8754491|NCT01190566|9803697|FG000|COMPLETED|Overall Study||6
8754492|NCT01190566|9803698|FG001|COMPLETED|Overall Study||42
8754493|NCT01190566|9803697|FG000|NOT COMPLETED|Overall Study||0
8754494|NCT01190566|9803698|FG001|NOT COMPLETED|Overall Study||0
8754495|NCT01190813|9803707|FG000|STARTED|Overall Study||90
8754496|NCT01190813|9803708|FG001|STARTED|Overall Study||49
8754497|NCT01190813|9803707|FG000|2-week Phone Call|Overall Study|2 missed, 1 dropped|87
8754498|NCT01190813|9803708|FG001|2-week Phone Call|Overall Study|1 missed, 0 dropped|48
8754499|NCT01190813|9803707|FG000|4-week Visit|Overall Study|0 missed, 1 dropped|88
8754500|NCT01190813|9803708|FG001|4-week Visit|Overall Study|1 missed, 1 dropped|47
8754501|NCT01190813|9803707|FG000|7-week Phone Call|Overall Study|3 missed, 0 dropped|85
8754502|NCT01190813|9803708|FG001|7-week Phone Call|Overall Study|2 missed, 0 dropped|46
8754503|NCT01190813|9803707|FG000|10-week Visit|Overall Study|0 missed, 0 dropped|88
8754504|NCT01190813|9803708|FG001|10-week Visit|Overall Study|0 dropped, 0 missed|48
8754505|NCT01190813|9803707|FG000|13-week Phone Call|Overall Study|6 missed, 0 dropped|82
8754506|NCT01190813|9803708|FG001|13-week Phone Call|Overall Study|0 dropped, 0 missed|48
8754507|NCT01190813|9803707|FG000|16-week Visit|Overall Study|1 dropped|87
8754508|NCT01190813|9803708|FG001|16-week Visit|Overall Study|2 dropped|46
8754509|NCT01190813|9803707|FG000|18-week Visit (Masked Primary)|Overall Study|0 dropped|87
8754510|NCT01190813|9803708|FG001|18-week Visit (Masked Primary)|Overall Study|1 dropped|45
8754511|NCT01190813|9803707|FG000|23-week Phone Call|Overall Study|4 missed, 1 dropped|82
8754512|NCT01190813|9803708|FG001|23-week Phone Call|Overall Study|4 missed, 0 dropped|41
8754513|NCT01190813|9803707|FG000|26-week Visit|Overall Study|0 missed, 0 dropped|86
8754514|NCT01190813|9803708|FG001|26-week Visit|Overall Study|0 missed, 0 dropped|45
8754515|NCT01190813|9803707|FG000|COMPLETED|Overall Study||86
8754516|NCT01190813|9803708|FG001|COMPLETED|Overall Study||45
8754517|NCT01190813|9803707|FG000|NOT COMPLETED|Overall Study||4
8754518|NCT01190813|9803708|FG001|NOT COMPLETED|Overall Study||4
8754519|NCT01190839|9803716|FG000|STARTED|Overall Study||150
8754520|NCT01190839|9803717|FG001|STARTED|Overall Study||147
8754521|NCT01190839|9803716|FG000|Treated|Overall Study||148
8754522|NCT01190839|9803717|FG001|Treated|Overall Study||143
8754523|NCT01190839|9803716|FG000|COMPLETED|Overall Study||0
8754524|NCT01190839|9803717|FG001|COMPLETED|Overall Study||0
8754525|NCT01190839|9803716|FG000|NOT COMPLETED|Overall Study||150
8754526|NCT01190839|9803717|FG001|NOT COMPLETED|Overall Study||147
8754527|NCT01190865|9803725|FG000|STARTED|Overall Study||28
8754528|NCT01190865|9803725|FG000|COMPLETED|Overall Study||25
8754529|NCT01190865|9803725|FG000|NOT COMPLETED|Overall Study||3
8754530|NCT01190878|9803733|FG000|STARTED|Overall Study||40
8754531|NCT01190878|9803734|FG001|STARTED|Overall Study||45
8754532|NCT01190878|9803735|FG002|STARTED|Overall Study||42
8754533|NCT01190878|9803736|FG003|STARTED|Overall Study||42
8754534|NCT01190878|9803733|FG000|COMPLETED|Overall Study||37
8754535|NCT01190878|9803734|FG001|COMPLETED|Overall Study||42
8754536|NCT01190878|9803735|FG002|COMPLETED|Overall Study||37
8754537|NCT01190878|9803736|FG003|COMPLETED|Overall Study||22
8754538|NCT01190878|9803733|FG000|NOT COMPLETED|Overall Study||3
8754539|NCT01190878|9803734|FG001|NOT COMPLETED|Overall Study||3
8754540|NCT01190878|9803735|FG002|NOT COMPLETED|Overall Study||5
8754541|NCT01190878|9803736|FG003|NOT COMPLETED|Overall Study||20
8754542|NCT01190891|9803748|FG000|STARTED|Overall Study||52
8754543|NCT01190891|9803749|FG001|STARTED|Overall Study||52
8754544|NCT01190891|9803748|FG000|COMPLETED|Overall Study||46
8754545|NCT01190891|9803749|FG001|COMPLETED|Overall Study||52
8754546|NCT01190891|9803748|FG000|NOT COMPLETED|Overall Study||6
8754547|NCT01190891|9803749|FG001|NOT COMPLETED|Overall Study||0
8754548|NCT01190930|9803757|FG000|STARTED|Induction||9298
8754549|NCT01190930|9803758|FG001|STARTED|Induction||52
8754550|NCT01190930|9803759|FG002|STARTED|Induction||0
8754551|NCT01190930|9803760|FG003|STARTED|Induction||0
8754552|NCT01190930|9803761|FG004|STARTED|Induction||0
8754553|NCT01190930|9803762|FG005|STARTED|Induction||0
8754554|NCT01190930|9803763|FG006|STARTED|Induction||0
8754555|NCT01190930|9803764|FG007|STARTED|Induction||0
8754556|NCT01190930|9803765|FG008|STARTED|Induction||0
8754557|NCT01190930|9803766|FG009|STARTED|Induction||0
8754558|NCT01190930|9803757|FG000|COMPLETED|Induction||3949
8754559|NCT01190930|9803758|FG001|COMPLETED|Induction||43
8754560|NCT01190930|9803759|FG002|COMPLETED|Induction||0
8754561|NCT01190930|9803760|FG003|COMPLETED|Induction||0
8754562|NCT01190930|9803761|FG004|COMPLETED|Induction||0
8754563|NCT01190930|9803762|FG005|COMPLETED|Induction||0
8754564|NCT01190930|9803763|FG006|COMPLETED|Induction||0
8754565|NCT01190930|9803764|FG007|COMPLETED|Induction||0
8754566|NCT01190930|9803765|FG008|COMPLETED|Induction||0
8754567|NCT01190930|9803766|FG009|COMPLETED|Induction||0
8754568|NCT01190930|9803757|FG000|NOT COMPLETED|Induction||5349
8754569|NCT01190930|9803758|FG001|NOT COMPLETED|Induction||9
8754570|NCT01190930|9803759|FG002|NOT COMPLETED|Induction||0
8754571|NCT01190930|9803760|FG003|NOT COMPLETED|Induction||0
8754572|NCT01190930|9803761|FG004|NOT COMPLETED|Induction||0
8754573|NCT01190930|9803762|FG005|NOT COMPLETED|Induction||0
8754574|NCT01190930|9803763|FG006|NOT COMPLETED|Induction||0
8754575|NCT01190930|9803764|FG007|NOT COMPLETED|Induction||0
8754576|NCT01190930|9803765|FG008|NOT COMPLETED|Induction||0
8754577|NCT01190930|9803766|FG009|NOT COMPLETED|Induction||0
8754578|NCT01190930|9803757|FG000|STARTED|Post Induction Pre-Maintenance||0
8754579|NCT01190930|9803758|FG001|STARTED|Post Induction Pre-Maintenance||43
8754580|NCT01190930|9803759|FG002|STARTED|Post Induction Pre-Maintenance||3122
8754581|NCT01190930|9803760|FG003|STARTED|Post Induction Pre-Maintenance||224
8754582|NCT01190930|9803761|FG004|STARTED|Post Induction Pre-Maintenance||301
8754583|NCT01190930|9803762|FG005|STARTED|Post Induction Pre-Maintenance||302
8754584|NCT01190930|9803763|FG006|STARTED|Post Induction Pre-Maintenance||0
8754585|NCT01190930|9803764|FG007|STARTED|Post Induction Pre-Maintenance||0
8754586|NCT01190930|9803765|FG008|STARTED|Post Induction Pre-Maintenance||0
8754587|NCT01190930|9803766|FG009|STARTED|Post Induction Pre-Maintenance||0
8754588|NCT01190930|9803757|FG000|COMPLETED|Post Induction Pre-Maintenance||0
8754589|NCT01190930|9803758|FG001|COMPLETED|Post Induction Pre-Maintenance||37
8754590|NCT01190930|9803759|FG002|COMPLETED|Post Induction Pre-Maintenance||2364
8754591|NCT01190930|9803760|FG003|COMPLETED|Post Induction Pre-Maintenance||207
8754592|NCT01190930|9803761|FG004|COMPLETED|Post Induction Pre-Maintenance||296
8754593|NCT01190930|9803762|FG005|COMPLETED|Post Induction Pre-Maintenance||296
8754594|NCT01190930|9803763|FG006|COMPLETED|Post Induction Pre-Maintenance||0
8754595|NCT01190930|9803764|FG007|COMPLETED|Post Induction Pre-Maintenance||0
8754596|NCT01190930|9803765|FG008|COMPLETED|Post Induction Pre-Maintenance||0
8754597|NCT01190930|9803766|FG009|COMPLETED|Post Induction Pre-Maintenance||0
8754598|NCT01190930|9803757|FG000|NOT COMPLETED|Post Induction Pre-Maintenance||0
8754599|NCT01190930|9803758|FG001|NOT COMPLETED|Post Induction Pre-Maintenance||6
8754600|NCT01190930|9803759|FG002|NOT COMPLETED|Post Induction Pre-Maintenance||758
8754601|NCT01190930|9803760|FG003|NOT COMPLETED|Post Induction Pre-Maintenance||17
8754602|NCT01190930|9803761|FG004|NOT COMPLETED|Post Induction Pre-Maintenance||5
8754603|NCT01190930|9803762|FG005|NOT COMPLETED|Post Induction Pre-Maintenance||6
8754604|NCT01190930|9803763|FG006|NOT COMPLETED|Post Induction Pre-Maintenance||0
8754605|NCT01190930|9803764|FG007|NOT COMPLETED|Post Induction Pre-Maintenance||0
8754606|NCT01190930|9803765|FG008|NOT COMPLETED|Post Induction Pre-Maintenance||0
8754607|NCT01190930|9803766|FG009|NOT COMPLETED|Post Induction Pre-Maintenance||0
8754608|NCT01190930|9803757|FG000|STARTED|Maintenance||0
8754609|NCT01190930|9803758|FG001|STARTED|Maintenance||37
8754610|NCT01190930|9803759|FG002|STARTED|Maintenance||0
8754611|NCT01190930|9803760|FG003|STARTED|Maintenance||207
8754612|NCT01190930|9803761|FG004|STARTED|Maintenance||296
8754613|NCT01190930|9803762|FG005|STARTED|Maintenance||296
8754614|NCT01190930|9803763|FG006|STARTED|Maintenance||600
8754615|NCT01190930|9803764|FG007|STARTED|Maintenance||586
8754616|NCT01190930|9803765|FG008|STARTED|Maintenance||586
8754617|NCT01190930|9803766|FG009|STARTED|Maintenance||592
8754618|NCT01190930|9803757|FG000|COMPLETED|Maintenance||0
8754619|NCT01190930|9803758|FG001|COMPLETED|Maintenance||27
8754620|NCT01190930|9803759|FG002|COMPLETED|Maintenance||0
8754621|NCT01190930|9803760|FG003|COMPLETED|Maintenance||167
8754622|NCT01190930|9803761|FG004|COMPLETED|Maintenance||287
8754623|NCT01190930|9803762|FG005|COMPLETED|Maintenance||284
8754624|NCT01190930|9803763|FG006|COMPLETED|Maintenance||574
8754625|NCT01190930|9803764|FG007|COMPLETED|Maintenance||540
8754626|NCT01190930|9803765|FG008|COMPLETED|Maintenance||540
8754627|NCT01190930|9803766|FG009|COMPLETED|Maintenance||555
8754628|NCT01190930|9803757|FG000|NOT COMPLETED|Maintenance||0
8754629|NCT01190930|9803758|FG001|NOT COMPLETED|Maintenance||10
8754630|NCT01190930|9803759|FG002|NOT COMPLETED|Maintenance||0
8754631|NCT01190930|9803760|FG003|NOT COMPLETED|Maintenance||40
8754632|NCT01190930|9803761|FG004|NOT COMPLETED|Maintenance||9
8754633|NCT01190930|9803762|FG005|NOT COMPLETED|Maintenance||12
8754634|NCT01190930|9803763|FG006|NOT COMPLETED|Maintenance||26
8754635|NCT01190930|9803764|FG007|NOT COMPLETED|Maintenance||46
8754636|NCT01190930|9803765|FG008|NOT COMPLETED|Maintenance||46
8754637|NCT01190930|9803766|FG009|NOT COMPLETED|Maintenance||37
8754638|NCT01191008|9803790|FG000|STARTED|Overall Study||633
8754639|NCT01191008|9803790|FG000|COMPLETED|Overall Study||618
8754640|NCT01191008|9803790|FG000|NOT COMPLETED|Overall Study||15
8754641|NCT01191086|9803794|FG000|STARTED|Overall Study||210
8754642|NCT01191086|9803794|FG000|COMPLETED|Overall Study||148
8754643|NCT01191086|9803794|FG000|NOT COMPLETED|Overall Study||62
8754644|NCT01191190|9803798|FG000|STARTED|Overall Study||21
8754645|NCT01191190|9803798|FG000|COMPLETED|Overall Study||20
8754646|NCT01191190|9803798|FG000|NOT COMPLETED|Overall Study||1
8754647|NCT01191242|9803802|FG000|STARTED|Overall Study||31
8754648|NCT01191242|9803802|FG000|COMPLETED|Overall Study||31
8754649|NCT01191242|9803802|FG000|NOT COMPLETED|Overall Study||0
8754650|NCT01191255|9803810|FG000|STARTED|Safety Assessment Period|3 subjects were assigned to receive KRX-0502 but didn't receive a single dose|149
8754651|NCT01191255|9803811|FG001|STARTED|Safety Assessment Period||292
8754652|NCT01191255|9803812|FG002|STARTED|Safety Assessment Period||0
9024249|NCT03150056|10087063|FG005|STARTED|Overall Study||21
9024250|NCT03150056|10087058|FG000|COMPLETED|Overall Study||0
9024251|NCT03150056|10087059|FG001|COMPLETED|Overall Study||1
9024252|NCT03150056|10087060|FG002|COMPLETED|Overall Study||0
9024253|NCT03150056|10087061|FG003|COMPLETED|Overall Study||1
9024254|NCT03150056|10087062|FG004|COMPLETED|Overall Study||6
9024255|NCT03150056|10087063|FG005|COMPLETED|Overall Study||3
9024256|NCT03150056|10087058|FG000|NOT COMPLETED|Overall Study||10
9024257|NCT03150056|10087059|FG001|NOT COMPLETED|Overall Study||5
9024258|NCT03150056|10087060|FG002|NOT COMPLETED|Overall Study||4
9024259|NCT03150056|10087061|FG003|NOT COMPLETED|Overall Study||9
9024260|NCT03150056|10087062|FG004|NOT COMPLETED|Overall Study||16
9024261|NCT03150056|10087063|FG005|NOT COMPLETED|Overall Study||18
9024262|NCT03150082|10087080|FG000|STARTED|Treatment Period 1 (Up to 4 Weeks)||13
9024263|NCT03150082|10087081|FG001|STARTED|Treatment Period 1 (Up to 4 Weeks)||13
9024264|NCT03150082|10087080|FG000|COMPLETED|Treatment Period 1 (Up to 4 Weeks)||12
9024265|NCT03150082|10087081|FG001|COMPLETED|Treatment Period 1 (Up to 4 Weeks)||13
9024266|NCT03150082|10087080|FG000|NOT COMPLETED|Treatment Period 1 (Up to 4 Weeks)||1
9024267|NCT03150082|10087081|FG001|NOT COMPLETED|Treatment Period 1 (Up to 4 Weeks)||0
9024268|NCT03150082|10087080|FG000|STARTED|Washout Period (Up to 4 Weeks)||12
9024269|NCT03150082|10087081|FG001|STARTED|Washout Period (Up to 4 Weeks)||13
9024270|NCT03150082|10087080|FG000|COMPLETED|Washout Period (Up to 4 Weeks)||12
9024271|NCT03150082|10087081|FG001|COMPLETED|Washout Period (Up to 4 Weeks)||13
9024272|NCT03150082|10087080|FG000|NOT COMPLETED|Washout Period (Up to 4 Weeks)||0
9024273|NCT03150082|10087081|FG001|NOT COMPLETED|Washout Period (Up to 4 Weeks)||0
9024274|NCT03150082|10087080|FG000|STARTED|Treatment Period 2 (Up to 4 Weeks)||12
9024275|NCT03150082|10087081|FG001|STARTED|Treatment Period 2 (Up to 4 Weeks)||13
9024276|NCT03150082|10087080|FG000|COMPLETED|Treatment Period 2 (Up to 4 Weeks)||12
9024277|NCT03150082|10087081|FG001|COMPLETED|Treatment Period 2 (Up to 4 Weeks)||13
9024278|NCT03150082|10087080|FG000|NOT COMPLETED|Treatment Period 2 (Up to 4 Weeks)||0
9024279|NCT03150082|10087081|FG001|NOT COMPLETED|Treatment Period 2 (Up to 4 Weeks)||0
9024280|NCT03150108|10087091|FG000|STARTED|Overall Study||12
9024281|NCT03150108|10087092|FG001|STARTED|Overall Study||12
9024282|NCT03150108|10087091|FG000|COMPLETED|Overall Study||12
9024283|NCT03150108|10087092|FG001|COMPLETED|Overall Study||12
9024284|NCT03150108|10087091|FG000|NOT COMPLETED|Overall Study||0
9024285|NCT03150108|10087092|FG001|NOT COMPLETED|Overall Study||0
9024286|NCT03150199|10087109|FG000|STARTED|Overall Study||30
9024287|NCT03150199|10087110|FG001|STARTED|Overall Study||30
9024288|NCT03150199|10087109|FG000|COMPLETED|Overall Study||30
9024289|NCT03150199|10087110|FG001|COMPLETED|Overall Study||30
9024290|NCT03150199|10087109|FG000|NOT COMPLETED|Overall Study||0
9024291|NCT03150199|10087110|FG001|NOT COMPLETED|Overall Study||0
9024292|NCT03150485|10087117|FG000|STARTED|Overall Study||2
9024293|NCT03150485|10087118|FG001|STARTED|Overall Study||9
9024294|NCT03150485|10087119|FG002|STARTED|Overall Study||4
9024295|NCT03150485|10087120|FG003|STARTED|Overall Study||5
9024296|NCT03150485|10087121|FG004|STARTED|Overall Study||2
9024297|NCT03150485|10087122|FG005|STARTED|Overall Study||1
9024298|NCT03150485|10087117|FG000|COMPLETED|Overall Study||2
9024299|NCT03150485|10087118|FG001|COMPLETED|Overall Study||8
8754653|NCT01191255|9803813|FG003|STARTED|Safety Assessment Period||0
8754654|NCT01191255|9803810|FG000|Safety Population|Safety Assessment Period||149
8754655|NCT01191255|9803811|FG001|Safety Population|Safety Assessment Period||289
8754656|NCT01191255|9803812|FG002|Safety Population|Safety Assessment Period||0
8754657|NCT01191255|9803813|FG003|Safety Population|Safety Assessment Period||0
8754658|NCT01191255|9803810|FG000|COMPLETED|Safety Assessment Period||111
8754659|NCT01191255|9803811|FG001|COMPLETED|Safety Assessment Period||193
8754660|NCT01191255|9803812|FG002|COMPLETED|Safety Assessment Period||0
8754661|NCT01191255|9803813|FG003|COMPLETED|Safety Assessment Period||0
8754662|NCT01191255|9803810|FG000|NOT COMPLETED|Safety Assessment Period||38
8754663|NCT01191255|9803811|FG001|NOT COMPLETED|Safety Assessment Period||99
8754664|NCT01191255|9803812|FG002|NOT COMPLETED|Safety Assessment Period||0
8754665|NCT01191255|9803813|FG003|NOT COMPLETED|Safety Assessment Period||0
8754666|NCT01191255|9803810|FG000|STARTED|Efficacy Assessment Period||0
8754667|NCT01191255|9803811|FG001|STARTED|Efficacy Assessment Period||0
8754668|NCT01191255|9803812|FG002|STARTED|Efficacy Assessment Period||96
8754669|NCT01191255|9803813|FG003|STARTED|Efficacy Assessment Period||96
8754670|NCT01191255|9803810|FG000|COMPLETED|Efficacy Assessment Period||0
8754671|NCT01191255|9803811|FG001|COMPLETED|Efficacy Assessment Period||0
8754672|NCT01191255|9803812|FG002|COMPLETED|Efficacy Assessment Period||70
8754673|NCT01191255|9803813|FG003|COMPLETED|Efficacy Assessment Period||90
8754674|NCT01191255|9803810|FG000|NOT COMPLETED|Efficacy Assessment Period||0
8754675|NCT01191255|9803811|FG001|NOT COMPLETED|Efficacy Assessment Period||0
8754676|NCT01191255|9803812|FG002|NOT COMPLETED|Efficacy Assessment Period||26
8754677|NCT01191255|9803813|FG003|NOT COMPLETED|Efficacy Assessment Period||6
8754678|NCT01191268|9803826|FG000|STARTED|Overall Study||295
8754679|NCT01191268|9803827|FG001|STARTED|Overall Study||293
8754680|NCT01191268|9803828|FG002|STARTED|Overall Study||296
8754681|NCT01191268|9803826|FG000|Received at Least One Dose of Study Drug|Overall Study||295
8754682|NCT01191268|9803827|FG001|Received at Least One Dose of Study Drug|Overall Study||293
8754683|NCT01191268|9803828|FG002|Received at Least One Dose of Study Drug|Overall Study||296
8754684|NCT01191268|9803826|FG000|COMPLETED|Overall Study||237
8754685|NCT01191268|9803827|FG001|COMPLETED|Overall Study||238
8754686|NCT01191268|9803828|FG002|COMPLETED|Overall Study||244
8754687|NCT01191268|9803826|FG000|NOT COMPLETED|Overall Study||58
8754688|NCT01191268|9803827|FG001|NOT COMPLETED|Overall Study||55
8754689|NCT01191268|9803828|FG002|NOT COMPLETED|Overall Study||52
8754690|NCT01191320|9803840|FG000|STARTED|Overall Study||43
8754691|NCT01191320|9803841|FG001|STARTED|Overall Study||38
8754692|NCT01191320|9803842|FG002|STARTED|Overall Study||38
8754693|NCT01191320|9803840|FG000|COMPLETED|Overall Study||36
8754694|NCT01191320|9803841|FG001|COMPLETED|Overall Study||32
8754695|NCT01191320|9803842|FG002|COMPLETED|Overall Study||31
9024300|NCT03150485|10087119|FG002|COMPLETED|Overall Study||4
9024301|NCT03150485|10087120|FG003|COMPLETED|Overall Study||5
9024302|NCT03150485|10087121|FG004|COMPLETED|Overall Study||2
9024303|NCT03150485|10087122|FG005|COMPLETED|Overall Study||1
9024304|NCT03150485|10087117|FG000|NOT COMPLETED|Overall Study||0
9024305|NCT03150485|10087118|FG001|NOT COMPLETED|Overall Study||1
9024306|NCT03150485|10087119|FG002|NOT COMPLETED|Overall Study||0
9024307|NCT03150485|10087120|FG003|NOT COMPLETED|Overall Study||0
9024308|NCT03150485|10087121|FG004|NOT COMPLETED|Overall Study||0
8670881|NCT00748969|9714286|FG000|COMPLETED|Overall Study||0
8670882|NCT00748969|9714287|FG001|COMPLETED|Overall Study||0
8670883|NCT00748969|9714286|FG000|NOT COMPLETED|Overall Study||1
8670884|NCT00748969|9714287|FG001|NOT COMPLETED|Overall Study||1
8670885|NCT00748982|9714295|FG000|STARTED|Overall Study||12
8670886|NCT00748982|9714296|FG001|STARTED|Overall Study||4
9024309|NCT03150485|10087122|FG005|NOT COMPLETED|Overall Study||0
9024310|NCT03150589|10087129|FG000|STARTED|Overall Study||351
9024311|NCT03150589|10087130|FG001|STARTED|Overall Study||354
9024312|NCT03150589|10087129|FG000|COMPLETED|Overall Study||307
9024313|NCT03150589|10087130|FG001|COMPLETED|Overall Study||327
9024314|NCT03150589|10087129|FG000|NOT COMPLETED|Overall Study||44
9024315|NCT03150589|10087130|FG001|NOT COMPLETED|Overall Study||27
9024316|NCT03150719|10087138|FG000|STARTED|Overall Study||47
9024317|NCT03150719|10087139|FG001|STARTED|Overall Study||50
9024318|NCT03150719|10087138|FG000|COMPLETED|Overall Study||46
8754696|NCT01191320|9803840|FG000|NOT COMPLETED|Overall Study||7
8754697|NCT01191320|9803841|FG001|NOT COMPLETED|Overall Study||6
8754698|NCT01191320|9803842|FG002|NOT COMPLETED|Overall Study||7
8754699|NCT01191333|9803852|FG000|STARTED|Overall Study||81
8754700|NCT01191333|9803853|FG001|STARTED|Overall Study||83
8754701|NCT01191333|9803852|FG000|COMPLETED|Overall Study||60
8754702|NCT01191333|9803853|FG001|COMPLETED|Overall Study||65
8754703|NCT01191333|9803852|FG000|NOT COMPLETED|Overall Study||21
8754704|NCT01191333|9803853|FG001|NOT COMPLETED|Overall Study||18
8754705|NCT01191398|9803862|FG000|STARTED|Overall Study||17
8754706|NCT01191398|9803863|FG001|STARTED|Overall Study||17
8754707|NCT01191398|9803864|FG002|STARTED|Overall Study||18
8754708|NCT01191398|9803862|FG000|COMPLETED|Overall Study||17
8754709|NCT01191398|9803863|FG001|COMPLETED|Overall Study||17
8754710|NCT01191398|9803864|FG002|COMPLETED|Overall Study||18
9024319|NCT03150719|10087139|FG001|COMPLETED|Overall Study||48
9024320|NCT03150719|10087138|FG000|NOT COMPLETED|Overall Study||1
9024321|NCT03150719|10087139|FG001|NOT COMPLETED|Overall Study||2
9024322|NCT03150758|10087145|FG000|STARTED|Overall Study||6
9024323|NCT03150758|10087145|FG000|COMPLETED|Overall Study||6
9024324|NCT03150758|10087145|FG000|NOT COMPLETED|Overall Study||0
9024325|NCT03150875|10087151|FG000|STARTED|Overall Study||145
8670887|NCT00748982|9714295|FG000|COMPLETED|Overall Study||12
8670888|NCT00748982|9714296|FG001|COMPLETED|Overall Study||4
8670889|NCT00748982|9714295|FG000|NOT COMPLETED|Overall Study||0
8754711|NCT01191398|9803862|FG000|NOT COMPLETED|Overall Study||0
8754712|NCT01191398|9803863|FG001|NOT COMPLETED|Overall Study||0
8754713|NCT01191398|9803864|FG002|NOT COMPLETED|Overall Study||0
8754714|NCT01191411|9803875|FG000|STARTED|Overall Study||1593
8754715|NCT01191411|9803876|FG001|STARTED|Overall Study||479
8754716|NCT01191411|9803877|FG002|STARTED|Overall Study||3898
8754717|NCT01191411|9803875|FG000|COMPLETED|Overall Study||648
8754718|NCT01191411|9803876|FG001|COMPLETED|Overall Study||118
8754719|NCT01191411|9803877|FG002|COMPLETED|Overall Study||471
8754720|NCT01191411|9803875|FG000|NOT COMPLETED|Overall Study||945
8754721|NCT01191411|9803876|FG001|NOT COMPLETED|Overall Study||361
8670890|NCT00748982|9714296|FG001|NOT COMPLETED|Overall Study||0
8670891|NCT00749073|9714302|FG000|STARTED|Overall Study||10
8670892|NCT00749073|9714302|FG000|COMPLETED|Overall Study||10
8670893|NCT00749073|9714302|FG000|NOT COMPLETED|Overall Study||0
8670894|NCT00749125|9714309|FG000|STARTED|Overall Study||47
8670895|NCT00749125|9714310|FG001|STARTED|Overall Study||52
8670896|NCT00749125|9714309|FG000|COMPLETED|Overall Study||36
8670897|NCT00749125|9714310|FG001|COMPLETED|Overall Study||34
8670898|NCT00749125|9714309|FG000|NOT COMPLETED|Overall Study||11
8670899|NCT00749125|9714310|FG001|NOT COMPLETED|Overall Study||18
8670900|NCT00749190|9714323|FG000|STARTED|Overall Study||71
8670901|NCT00749190|9714324|FG001|STARTED|Overall Study||71
8670902|NCT00749190|9714325|FG002|STARTED|Overall Study||71
8670903|NCT00749190|9714326|FG003|STARTED|Overall Study||71
8670904|NCT00749190|9714327|FG004|STARTED|Overall Study||70
8670905|NCT00749190|9714328|FG005|STARTED|Overall Study||70
8670906|NCT00749190|9714329|FG006|STARTED|Overall Study||71
8670907|NCT00749190|9714323|FG000|COMPLETED|Overall Study||66
8670908|NCT00749190|9714324|FG001|COMPLETED|Overall Study||66
8670909|NCT00749190|9714325|FG002|COMPLETED|Overall Study||70
8670910|NCT00749190|9714326|FG003|COMPLETED|Overall Study||66
8670911|NCT00749190|9714327|FG004|COMPLETED|Overall Study||70
8670912|NCT00749190|9714328|FG005|COMPLETED|Overall Study||65
8670913|NCT00749190|9714329|FG006|COMPLETED|Overall Study||70
8670914|NCT00749190|9714323|FG000|NOT COMPLETED|Overall Study||5
8670915|NCT00749190|9714324|FG001|NOT COMPLETED|Overall Study||5
8670916|NCT00749190|9714325|FG002|NOT COMPLETED|Overall Study||1
8670917|NCT00749190|9714326|FG003|NOT COMPLETED|Overall Study||5
8670918|NCT00749190|9714327|FG004|NOT COMPLETED|Overall Study||0
8670919|NCT00749190|9714328|FG005|NOT COMPLETED|Overall Study||5
8670920|NCT00749190|9714329|FG006|NOT COMPLETED|Overall Study||1
8670921|NCT00749203|9714352|FG000|STARTED|First Infusion Day 1||22
8670922|NCT00749203|9714353|FG001|STARTED|First Infusion Day 1||19
8670923|NCT00749203|9714352|FG000|COMPLETED|First Infusion Day 1||22
8670924|NCT00749203|9714353|FG001|COMPLETED|First Infusion Day 1||19
8670925|NCT00749203|9714352|FG000|NOT COMPLETED|First Infusion Day 1||0
8670926|NCT00749203|9714353|FG001|NOT COMPLETED|First Infusion Day 1||0
8670927|NCT00749203|9714352|FG000|STARTED|no Infusion at Week 1||22
8670928|NCT00749203|9714353|FG001|STARTED|no Infusion at Week 1||19
8670929|NCT00749203|9714352|FG000|COMPLETED|no Infusion at Week 1||22
8670930|NCT00749203|9714353|FG001|COMPLETED|no Infusion at Week 1||15
8670931|NCT00749203|9714352|FG000|NOT COMPLETED|no Infusion at Week 1||0
8670932|NCT00749203|9714353|FG001|NOT COMPLETED|no Infusion at Week 1||4
8670933|NCT00749203|9714352|FG000|STARTED|Second Infusion at 2 Weeks|N=6 completed the study at 2 wks due to CAPS scores < 50, precluding 2nd infusion.|16
8670934|NCT00749203|9714353|FG001|STARTED|Second Infusion at 2 Weeks||15
8670935|NCT00749203|9714352|FG000|COMPLETED|Second Infusion at 2 Weeks||16
8670936|NCT00749203|9714353|FG001|COMPLETED|Second Infusion at 2 Weeks||13
8670937|NCT00749203|9714352|FG000|NOT COMPLETED|Second Infusion at 2 Weeks||0
8670938|NCT00749203|9714353|FG001|NOT COMPLETED|Second Infusion at 2 Weeks||2
8670939|NCT00749268|9714363|FG000|STARTED|Overall Study||106
8670940|NCT00749268|9714364|FG001|STARTED|Overall Study||110
8670941|NCT00749268|9714363|FG000|COMPLETED|Overall Study||72
8670942|NCT00749268|9714364|FG001|COMPLETED|Overall Study||74
8670943|NCT00749268|9714363|FG000|NOT COMPLETED|Overall Study||34
8670944|NCT00749268|9714364|FG001|NOT COMPLETED|Overall Study||36
8670945|NCT00749398|9714374|FG000|STARTED|Overall Study|Nine participants were excluded because they did not fulfill the inclusion criteria.|124
8670946|NCT00749398|9714374|FG000|COMPLETED|Overall Study||71
8670947|NCT00749398|9714374|FG000|NOT COMPLETED|Overall Study||53
8670948|NCT00749411|9714380|FG000|STARTED|Overall Study||21
8670949|NCT00749411|9714381|FG001|STARTED|Overall Study||40
8670950|NCT00749411|9714380|FG000|COMPLETED|Overall Study||20
8670951|NCT00749411|9714381|FG001|COMPLETED|Overall Study||35
8670952|NCT00749411|9714380|FG000|NOT COMPLETED|Overall Study||1
8670953|NCT00749411|9714381|FG001|NOT COMPLETED|Overall Study||5
8670954|NCT00749463|9714390|FG000|STARTED|Overall Study||86
8670955|NCT00749463|9714391|FG001|STARTED|Overall Study||64
8670956|NCT00749463|9714392|FG002|STARTED|Overall Study||150
8670957|NCT00749463|9714390|FG000|COMPLETED|Overall Study||85
8670958|NCT00749463|9714391|FG001|COMPLETED|Overall Study||60
8670959|NCT00749463|9714392|FG002|COMPLETED|Overall Study||149
8670960|NCT00749463|9714390|FG000|NOT COMPLETED|Overall Study||1
8670961|NCT00749463|9714391|FG001|NOT COMPLETED|Overall Study||4
8670962|NCT00749463|9714392|FG002|NOT COMPLETED|Overall Study||1
8670963|NCT00749515|9714402|FG000|STARTED|Overall Study||10
8670964|NCT00749515|9714403|FG001|STARTED|Overall Study||5
8670965|NCT00749515|9714402|FG000|COMPLETED|Overall Study||10
8754722|NCT01191411|9803877|FG002|NOT COMPLETED|Overall Study||3427
8754723|NCT01191476|9803888|FG000|STARTED|Overall Study||112
8754724|NCT01191476|9803889|FG001|STARTED|Overall Study|Data was not collected for 1 subject for baseline characteristics or the full analysis set.|111
8754725|NCT01191476|9803890|FG002|STARTED|Overall Study|Data was not collected for 1 subject for baseline characteristics or the full analysis set.|111
8754726|NCT01191476|9803888|FG000|COMPLETED|Overall Study||109
8754727|NCT01191476|9803889|FG001|COMPLETED|Overall Study||107
8754728|NCT01191476|9803890|FG002|COMPLETED|Overall Study||111
8754729|NCT01191476|9803888|FG000|NOT COMPLETED|Overall Study||3
8754730|NCT01191476|9803889|FG001|NOT COMPLETED|Overall Study||4
8754731|NCT01191476|9803890|FG002|NOT COMPLETED|Overall Study||0
8754732|NCT01191541|9803902|FG000|STARTED|All the Patients||30
8754733|NCT01191541|9803903|FG001|STARTED|All the Patients||35
8754734|NCT01191541|9803902|FG000|COMPLETED|All the Patients||30
8754735|NCT01191541|9803903|FG001|COMPLETED|All the Patients||35
8754736|NCT01191541|9803902|FG000|NOT COMPLETED|All the Patients||0
8754737|NCT01191541|9803903|FG001|NOT COMPLETED|All the Patients||0
8754738|NCT01191541|9803902|FG000|STARTED|the Randomized Patients||30
8754739|NCT01191541|9803903|FG001|STARTED|the Randomized Patients||35
8754740|NCT01191541|9803902|FG000|COMPLETED|the Randomized Patients||30
8754741|NCT01191541|9803903|FG001|COMPLETED|the Randomized Patients||35
8754742|NCT01191541|9803902|FG000|NOT COMPLETED|the Randomized Patients||0
8754743|NCT01191541|9803903|FG001|NOT COMPLETED|the Randomized Patients||0
8754744|NCT01191723|9803919|FG000|STARTED|Overall Study||9
8754745|NCT01191723|9803920|FG001|STARTED|Overall Study||9
8754746|NCT01191723|9803921|FG002|STARTED|Overall Study||9
8754747|NCT01191723|9803922|FG003|STARTED|Overall Study||9
8754748|NCT01191723|9803923|FG004|STARTED|Overall Study||9
8754749|NCT01191723|9803924|FG005|STARTED|Overall Study||9
8754750|NCT01191723|9803919|FG000|COMPLETED|Overall Study||9
8754751|NCT01191723|9803920|FG001|COMPLETED|Overall Study||9
8754752|NCT01191723|9803921|FG002|COMPLETED|Overall Study||9
8754753|NCT01191723|9803922|FG003|COMPLETED|Overall Study||9
8754754|NCT01191723|9803923|FG004|COMPLETED|Overall Study||9
8754755|NCT01191723|9803924|FG005|COMPLETED|Overall Study||9
8754756|NCT01191723|9803919|FG000|NOT COMPLETED|Overall Study||0
8754757|NCT01191723|9803920|FG001|NOT COMPLETED|Overall Study||0
8754758|NCT01191723|9803921|FG002|NOT COMPLETED|Overall Study||0
8754759|NCT01191723|9803922|FG003|NOT COMPLETED|Overall Study||0
8754760|NCT01191723|9803923|FG004|NOT COMPLETED|Overall Study||0
8754761|NCT01191723|9803924|FG005|NOT COMPLETED|Overall Study||0
8754762|NCT01191736|9803940|FG000|STARTED|Overall Study||51
8754763|NCT01191736|9803941|FG001|STARTED|Overall Study||47
8754764|NCT01191736|9803942|FG002|STARTED|Overall Study||49
8754765|NCT01191736|9803943|FG003|STARTED|Overall Study||46
8754766|NCT01191736|9803944|FG004|STARTED|Overall Study||48
8754767|NCT01191736|9803945|FG005|STARTED|Overall Study||50
8754768|NCT01191736|9803946|FG006|STARTED|Overall Study||45
8754769|NCT01191736|9803940|FG000|COMPLETED|Overall Study||51
8754770|NCT01191736|9803941|FG001|COMPLETED|Overall Study||47
8754771|NCT01191736|9803942|FG002|COMPLETED|Overall Study||49
8754772|NCT01191736|9803943|FG003|COMPLETED|Overall Study||46
8754773|NCT01191736|9803944|FG004|COMPLETED|Overall Study||48
8754774|NCT01191736|9803945|FG005|COMPLETED|Overall Study||50
8754775|NCT01191736|9803946|FG006|COMPLETED|Overall Study||45
8754776|NCT01191736|9803940|FG000|NOT COMPLETED|Overall Study||0
8754777|NCT01191736|9803941|FG001|NOT COMPLETED|Overall Study||0
8754778|NCT01191736|9803942|FG002|NOT COMPLETED|Overall Study||0
8754779|NCT01191736|9803943|FG003|NOT COMPLETED|Overall Study||0
8754780|NCT01191736|9803944|FG004|NOT COMPLETED|Overall Study||0
8754781|NCT01191736|9803945|FG005|NOT COMPLETED|Overall Study||0
8754782|NCT01191736|9803946|FG006|NOT COMPLETED|Overall Study||0
8754783|NCT01191749|9803962|FG000|STARTED|Overall Study||7
8754784|NCT01191749|9803962|FG000|COMPLETED|Overall Study||7
8754785|NCT01191749|9803962|FG000|NOT COMPLETED|Overall Study||0
8754786|NCT01191762|9803968|FG000|STARTED|Overall Study||15
8754787|NCT01191762|9803969|FG001|STARTED|Overall Study||15
8754788|NCT01191762|9803968|FG000|COMPLETED|Overall Study|One subject dropped out on the 3rd treatment day because of gastrointestinal complaints.|14
8754789|NCT01191762|9803969|FG001|COMPLETED|Overall Study||15
8754790|NCT01191762|9803968|FG000|NOT COMPLETED|Overall Study||1
8754791|NCT01191762|9803969|FG001|NOT COMPLETED|Overall Study||0
8754792|NCT01191788|9803977|FG000|STARTED|Overall Study||140
8754793|NCT01191788|9803978|FG001|STARTED|Overall Study||159
8754794|NCT01191788|9803977|FG000|COMPLETED|Overall Study|Completed 3-month followup|119
8754795|NCT01191788|9803978|FG001|COMPLETED|Overall Study|Completed 3-month followup|137
8754796|NCT01191788|9803977|FG000|NOT COMPLETED|Overall Study||21
8754797|NCT01191788|9803978|FG001|NOT COMPLETED|Overall Study||22
8808052|NCT01489254|9860449|FG003|NOT COMPLETED|Open-label Extension Part||58
8808053|NCT01489358|9860461|FG000|STARTED|Overall Study||5
8808054|NCT01489358|9860462|FG001|STARTED|Overall Study||10
8808055|NCT01489358|9860463|FG002|STARTED|Overall Study||10
8808056|NCT01489358|9860461|FG000|COMPLETED|Overall Study||5
8808057|NCT01489358|9860462|FG001|COMPLETED|Overall Study||10
8808058|NCT01489358|9860463|FG002|COMPLETED|Overall Study||8
8808059|NCT01489358|9860461|FG000|NOT COMPLETED|Overall Study||0
8808060|NCT01489358|9860462|FG001|NOT COMPLETED|Overall Study||0
8808061|NCT01489358|9860463|FG002|NOT COMPLETED|Overall Study||2
8808062|NCT01489527|9860473|FG000|STARTED|Overall Study||205
8808063|NCT01489527|9860474|FG001|STARTED|Overall Study||201
8808064|NCT01489527|9860473|FG000|COMPLETED|Overall Study||183
8754798|NCT01191801|9803987|FG000|STARTED|Overall Study||356
8754799|NCT01191801|9803988|FG001|STARTED|Overall Study||355
8754800|NCT01191801|9803987|FG000|COMPLETED|Overall Study||40
8754801|NCT01191801|9803988|FG001|COMPLETED|Overall Study||18
8754802|NCT01191801|9803987|FG000|NOT COMPLETED|Overall Study||316
8754803|NCT01191801|9803988|FG001|NOT COMPLETED|Overall Study||337
8754804|NCT01191827|9803996|FG000|STARTED|Overall Study||20
8754805|NCT01191827|9803997|FG001|STARTED|Overall Study||20
8754806|NCT01191827|9803996|FG000|COMPLETED|Overall Study||20
8754807|NCT01191827|9803997|FG001|COMPLETED|Overall Study||20
8754808|NCT01191827|9803996|FG000|NOT COMPLETED|Overall Study||0
8754809|NCT01191827|9803997|FG001|NOT COMPLETED|Overall Study||0
8754810|NCT01191840|9804005|FG000|STARTED|Overall Study||254
8754811|NCT01191840|9804006|FG001|STARTED|Overall Study||255
8754812|NCT01191840|9804005|FG000|COMPLETED|Overall Study||240
8754813|NCT01191840|9804006|FG001|COMPLETED|Overall Study||240
8754814|NCT01191840|9804005|FG000|NOT COMPLETED|Overall Study||14
8754815|NCT01191840|9804006|FG001|NOT COMPLETED|Overall Study||15
8754816|NCT01191944|9804014|FG000|STARTED|Overall Study|Treated titration/maintenance|234
8754817|NCT01191944|9804015|FG001|STARTED|Overall Study|Treated titration/maintenance|239
8754818|NCT01191944|9804014|FG000|COMPLETED|Overall Study|Completed titration/maintenance|217
8754819|NCT01191944|9804015|FG001|COMPLETED|Overall Study|Completed titration/maintenance|220
8754820|NCT01191944|9804014|FG000|NOT COMPLETED|Overall Study||17
8754821|NCT01191944|9804015|FG001|NOT COMPLETED|Overall Study||19
8754822|NCT01192022|9804025|FG000|STARTED|Overall Study||114
8754823|NCT01192022|9804026|FG001|STARTED|Overall Study||110
8754824|NCT01192022|9804027|FG002|STARTED|Overall Study||8
8754825|NCT01192022|9804028|FG003|STARTED|Overall Study||9
8754826|NCT01192022|9804029|FG004|STARTED|Overall Study||12
8754827|NCT01192022|9804025|FG000|Safety Population-Received Treatment|Overall Study||114
8754828|NCT01192022|9804026|FG001|Safety Population-Received Treatment|Overall Study||109
8754829|NCT01192022|9804027|FG002|Safety Population-Received Treatment|Overall Study||8
8754830|NCT01192022|9804028|FG003|Safety Population-Received Treatment|Overall Study||9
8754831|NCT01192022|9804029|FG004|Safety Population-Received Treatment|Overall Study||12
8754832|NCT01192022|9804025|FG000|COMPLETED|Overall Study||101
8754833|NCT01192022|9804026|FG001|COMPLETED|Overall Study||99
8754834|NCT01192022|9804027|FG002|COMPLETED|Overall Study||7
8754835|NCT01192022|9804028|FG003|COMPLETED|Overall Study||7
8754836|NCT01192022|9804029|FG004|COMPLETED|Overall Study||11
8754837|NCT01192022|9804025|FG000|NOT COMPLETED|Overall Study||13
8754838|NCT01192022|9804026|FG001|NOT COMPLETED|Overall Study||11
8754839|NCT01192022|9804027|FG002|NOT COMPLETED|Overall Study||1
8754840|NCT01192022|9804028|FG003|NOT COMPLETED|Overall Study||2
8754841|NCT01192022|9804029|FG004|NOT COMPLETED|Overall Study||1
8754842|NCT01192100|9804040|FG000|STARTED|Overall Study||6
8754843|NCT01192100|9804041|FG001|STARTED|Overall Study||4
8754844|NCT01192100|9804042|FG002|STARTED|Overall Study||3
8754845|NCT01192100|9804043|FG003|STARTED|Overall Study||4
8754846|NCT01192100|9804044|FG004|STARTED|Overall Study||3
8754847|NCT01192100|9804045|FG005|STARTED|Overall Study||2
8754848|NCT01192100|9804040|FG000|Began 1st Intervention Week|Overall Study||6
8754849|NCT01192100|9804041|FG001|Began 1st Intervention Week|Overall Study||4
8754850|NCT01192100|9804042|FG002|Began 1st Intervention Week|Overall Study||3
8754851|NCT01192100|9804043|FG003|Began 1st Intervention Week|Overall Study||4
8754852|NCT01192100|9804044|FG004|Began 1st Intervention Week|Overall Study||3
8754853|NCT01192100|9804045|FG005|Began 1st Intervention Week|Overall Study||2
8754854|NCT01192100|9804040|FG000|Began 2nd Intervention Week|Overall Study||6
8754855|NCT01192100|9804041|FG001|Began 2nd Intervention Week|Overall Study||4
8754856|NCT01192100|9804042|FG002|Began 2nd Intervention Week|Overall Study||3
8754857|NCT01192100|9804043|FG003|Began 2nd Intervention Week|Overall Study||3
8754858|NCT01192100|9804044|FG004|Began 2nd Intervention Week|Overall Study||2
8754859|NCT01192100|9804045|FG005|Began 2nd Intervention Week|Overall Study||2
8754860|NCT01192100|9804040|FG000|Began 3rd Intervention Week|Overall Study||6
8754861|NCT01192100|9804041|FG001|Began 3rd Intervention Week|Overall Study||4
8754862|NCT01192100|9804042|FG002|Began 3rd Intervention Week|Overall Study||3
8754863|NCT01192100|9804043|FG003|Began 3rd Intervention Week|Overall Study||3
8754864|NCT01192100|9804044|FG004|Began 3rd Intervention Week|Overall Study||2
8754865|NCT01192100|9804045|FG005|Began 3rd Intervention Week|Overall Study||2
8754866|NCT01192100|9804040|FG000|COMPLETED|Overall Study||6
8754867|NCT01192100|9804041|FG001|COMPLETED|Overall Study||4
8754868|NCT01192100|9804042|FG002|COMPLETED|Overall Study||3
8754869|NCT01192100|9804043|FG003|COMPLETED|Overall Study||3
8754870|NCT01192100|9804044|FG004|COMPLETED|Overall Study||2
8754871|NCT01192100|9804045|FG005|COMPLETED|Overall Study||2
8754872|NCT01192100|9804040|FG000|NOT COMPLETED|Overall Study||0
8754873|NCT01192100|9804041|FG001|NOT COMPLETED|Overall Study||0
8754874|NCT01192100|9804042|FG002|NOT COMPLETED|Overall Study||0
8754875|NCT01192100|9804043|FG003|NOT COMPLETED|Overall Study||1
8754876|NCT01192100|9804044|FG004|NOT COMPLETED|Overall Study||1
8754877|NCT01192100|9804045|FG005|NOT COMPLETED|Overall Study||0
8754878|NCT01192126|9804055|FG000|STARTED|First Intervention (1 Week)||51
8754879|NCT01192126|9804056|FG001|STARTED|First Intervention (1 Week)||51
8754880|NCT01192126|9804055|FG000|COMPLETED|First Intervention (1 Week)||49
8754881|NCT01192126|9804056|FG001|COMPLETED|First Intervention (1 Week)||50
8754882|NCT01192126|9804055|FG000|NOT COMPLETED|First Intervention (1 Week)||2
8754883|NCT01192126|9804056|FG001|NOT COMPLETED|First Intervention (1 Week)||1
8754884|NCT01192126|9804055|FG000|STARTED|Second Intervention (1 Week)||49
8754885|NCT01192126|9804056|FG001|STARTED|Second Intervention (1 Week)||50
8754886|NCT01192126|9804055|FG000|COMPLETED|Second Intervention (1 Week)||49
8754887|NCT01192126|9804056|FG001|COMPLETED|Second Intervention (1 Week)||50
8754888|NCT01192126|9804055|FG000|NOT COMPLETED|Second Intervention (1 Week)||0
8754889|NCT01192126|9804056|FG001|NOT COMPLETED|Second Intervention (1 Week)||0
8754890|NCT01192139|9804062|FG000|STARTED|Period 1||5
8754891|NCT01192139|9804063|FG001|STARTED|Period 1||5
8754892|NCT01192139|9804064|FG002|STARTED|Period 1||5
8754893|NCT01192139|9804065|FG003|STARTED|Period 1||5
8754894|NCT01192139|9804066|FG004|STARTED|Period 1||5
8754895|NCT01192139|9804067|FG005|STARTED|Period 1||5
8754896|NCT01192139|9804062|FG000|COMPLETED|Period 1||5
8754897|NCT01192139|9804063|FG001|COMPLETED|Period 1||5
8754898|NCT01192139|9804064|FG002|COMPLETED|Period 1||5
8754899|NCT01192139|9804065|FG003|COMPLETED|Period 1||5
8754900|NCT01192139|9804066|FG004|COMPLETED|Period 1||5
8754901|NCT01192139|9804067|FG005|COMPLETED|Period 1||5
8754902|NCT01192139|9804062|FG000|NOT COMPLETED|Period 1||0
8754903|NCT01192139|9804063|FG001|NOT COMPLETED|Period 1||0
8754904|NCT01192139|9804064|FG002|NOT COMPLETED|Period 1||0
8754905|NCT01192139|9804065|FG003|NOT COMPLETED|Period 1||0
8754906|NCT01192139|9804066|FG004|NOT COMPLETED|Period 1||0
8754907|NCT01192139|9804067|FG005|NOT COMPLETED|Period 1||0
8754908|NCT01192139|9804062|FG000|STARTED|Period 2||5
8754909|NCT01192139|9804063|FG001|STARTED|Period 2||5
8754910|NCT01192139|9804064|FG002|STARTED|Period 2||5
8754911|NCT01192139|9804065|FG003|STARTED|Period 2||5
8754912|NCT01192139|9804066|FG004|STARTED|Period 2||5
8754913|NCT01192139|9804067|FG005|STARTED|Period 2||5
8754914|NCT01192139|9804062|FG000|COMPLETED|Period 2||5
8754915|NCT01192139|9804063|FG001|COMPLETED|Period 2||5
8754916|NCT01192139|9804064|FG002|COMPLETED|Period 2||5
8754917|NCT01192139|9804065|FG003|COMPLETED|Period 2||5
8754918|NCT01192139|9804066|FG004|COMPLETED|Period 2||5
8754919|NCT01192139|9804067|FG005|COMPLETED|Period 2||5
8754920|NCT01192139|9804062|FG000|NOT COMPLETED|Period 2||0
8754921|NCT01192139|9804063|FG001|NOT COMPLETED|Period 2||0
8754922|NCT01192139|9804064|FG002|NOT COMPLETED|Period 2||0
8754923|NCT01192139|9804065|FG003|NOT COMPLETED|Period 2||0
8754924|NCT01192139|9804066|FG004|NOT COMPLETED|Period 2||0
8754925|NCT01192139|9804067|FG005|NOT COMPLETED|Period 2||0
8754926|NCT01192139|9804062|FG000|STARTED|Period 3||5
8754927|NCT01192139|9804063|FG001|STARTED|Period 3||5
8754928|NCT01192139|9804064|FG002|STARTED|Period 3||5
8754929|NCT01192139|9804065|FG003|STARTED|Period 3||5
8754930|NCT01192139|9804066|FG004|STARTED|Period 3||5
8754931|NCT01192139|9804067|FG005|STARTED|Period 3||5
8754932|NCT01192139|9804062|FG000|COMPLETED|Period 3||5
8754933|NCT01192139|9804063|FG001|COMPLETED|Period 3||5
8754934|NCT01192139|9804064|FG002|COMPLETED|Period 3||5
8754935|NCT01192139|9804065|FG003|COMPLETED|Period 3||5
8754936|NCT01192139|9804066|FG004|COMPLETED|Period 3||5
8754937|NCT01192139|9804067|FG005|COMPLETED|Period 3||5
8754938|NCT01192139|9804062|FG000|NOT COMPLETED|Period 3||0
8754939|NCT01192139|9804063|FG001|NOT COMPLETED|Period 3||0
8754940|NCT01192139|9804064|FG002|NOT COMPLETED|Period 3||0
8754941|NCT01192139|9804065|FG003|NOT COMPLETED|Period 3||0
8754942|NCT01192139|9804066|FG004|NOT COMPLETED|Period 3||0
8754943|NCT01192139|9804067|FG005|NOT COMPLETED|Period 3||0
8754944|NCT01192152|9804075|FG000|STARTED|Period 1||15
8754945|NCT01192152|9804076|FG001|STARTED|Period 1||15
8754946|NCT01192152|9804075|FG000|COMPLETED|Period 1||15
8754947|NCT01192152|9804076|FG001|COMPLETED|Period 1||14
8754948|NCT01192152|9804075|FG000|NOT COMPLETED|Period 1||0
8754949|NCT01192152|9804076|FG001|NOT COMPLETED|Period 1||1
8754950|NCT01192152|9804075|FG000|STARTED|Period 2||15
8754951|NCT01192152|9804076|FG001|STARTED|Period 2||14
8754952|NCT01192152|9804075|FG000|COMPLETED|Period 2||15
8754953|NCT01192152|9804076|FG001|COMPLETED|Period 2||14
8754954|NCT01192152|9804075|FG000|NOT COMPLETED|Period 2||0
8754955|NCT01192152|9804076|FG001|NOT COMPLETED|Period 2||0
8754956|NCT01192152|9804075|FG000|STARTED|Period 3||15
8754957|NCT01192152|9804076|FG001|STARTED|Period 3||0
8754958|NCT01192152|9804075|FG000|COMPLETED|Period 3||14
8754959|NCT01192152|9804076|FG001|COMPLETED|Period 3||0
8754960|NCT01192152|9804075|FG000|NOT COMPLETED|Period 3||1
8754961|NCT01192152|9804076|FG001|NOT COMPLETED|Period 3||0
8754962|NCT01192178|9804086|FG000|STARTED|Overall Study||171
8754963|NCT01192178|9804087|FG001|STARTED|Overall Study||168
8754964|NCT01192178|9804086|FG000|COMPLETED|Overall Study||147
8754965|NCT01192178|9804087|FG001|COMPLETED|Overall Study||145
8754966|NCT01192178|9804086|FG000|NOT COMPLETED|Overall Study||24
8754967|NCT01192178|9804087|FG001|NOT COMPLETED|Overall Study||23
8754968|NCT01192191|9804097|FG000|STARTED|Overall Study||60
8754969|NCT01192191|9804098|FG001|STARTED|Overall Study||127
8754970|NCT01192191|9804097|FG000|COMPLETED|Overall Study||49
8754971|NCT01192191|9804098|FG001|COMPLETED|Overall Study||106
8754972|NCT01192191|9804097|FG000|NOT COMPLETED|Overall Study||11
8754973|NCT01192191|9804098|FG001|NOT COMPLETED|Overall Study||21
8754974|NCT01192204|9804106|FG000|STARTED|Overall Study||23
8754975|NCT01192204|9804107|FG001|STARTED|Overall Study||18
8754976|NCT01192204|9804106|FG000|COMPLETED|Overall Study||22
8754977|NCT01192204|9804107|FG001|COMPLETED|Overall Study||18
8754978|NCT01192204|9804106|FG000|NOT COMPLETED|Overall Study||1
8754979|NCT01192204|9804107|FG001|NOT COMPLETED|Overall Study||0
8754980|NCT01192282|9804117|FG000|STARTED|Overall Study||156
8754981|NCT01192282|9804117|FG000|COMPLETED|Overall Study||156
8754982|NCT01192282|9804117|FG000|NOT COMPLETED|Overall Study||0
8754983|NCT01192295|9804132|FG000|STARTED|Overall Study||27
8754984|NCT01192295|9804133|FG001|STARTED|Overall Study||128
8754985|NCT01192295|9804132|FG000|COMPLETED|Overall Study||17
8754986|NCT01192295|9804133|FG001|COMPLETED|Overall Study||105
8914956|NCT02172040|9974541|FG003|NOT COMPLETED|Overall Study||1
8914957|NCT02172625|9974554|FG000|STARTED|Overall Study||19
8914958|NCT02172625|9974555|FG001|STARTED|Overall Study||19
8914959|NCT02172625|9974554|FG000|COMPLETED|Overall Study||19
8914960|NCT02172625|9974555|FG001|COMPLETED|Overall Study||16
8914961|NCT02172625|9974554|FG000|NOT COMPLETED|Overall Study||0
8914962|NCT02172625|9974555|FG001|NOT COMPLETED|Overall Study||3
8914963|NCT02172664|9974565|FG000|STARTED|Overall Study||33
8914964|NCT02172664|9974566|FG001|STARTED|Overall Study||33
8914965|NCT02172664|9974565|FG000|COMPLETED|Overall Study||27
8914966|NCT02172664|9974566|FG001|COMPLETED|Overall Study||27
8914967|NCT02172664|9974565|FG000|NOT COMPLETED|Overall Study||6
8914968|NCT02172664|9974566|FG001|NOT COMPLETED|Overall Study||6
8914969|NCT02172742|9974573|FG000|STARTED|Overall Study||7
8914970|NCT02172742|9974574|FG001|STARTED|Overall Study||6
8914971|NCT02172742|9974573|FG000|COMPLETED|Overall Study||6
8914972|NCT02172742|9974574|FG001|COMPLETED|Overall Study||6
8914973|NCT02172742|9974573|FG000|NOT COMPLETED|Overall Study||1
8914974|NCT02172742|9974574|FG001|NOT COMPLETED|Overall Study||0
8914975|NCT02172755|9974581|FG000|STARTED|Overall Study||14
8914976|NCT02172755|9974582|FG001|STARTED|Overall Study||16
8914977|NCT02172755|9974581|FG000|COMPLETED|Overall Study||12
8914978|NCT02172755|9974582|FG001|COMPLETED|Overall Study||12
8914979|NCT02172755|9974581|FG000|NOT COMPLETED|Overall Study||2
8914980|NCT02172755|9974582|FG001|NOT COMPLETED|Overall Study||4
8914981|NCT02172820|9974590|FG000|STARTED|Overall Study||65
8914982|NCT02172820|9974591|FG001|STARTED|Overall Study||65
8914983|NCT02172820|9974590|FG000|COMPLETED|Overall Study||65
8914984|NCT02172820|9974591|FG001|COMPLETED|Overall Study||65
8914985|NCT02172820|9974590|FG000|NOT COMPLETED|Overall Study||0
8914986|NCT02172820|9974591|FG001|NOT COMPLETED|Overall Study||0
8914987|NCT02172911|9974599|FG000|STARTED|Overall Study||7
8914988|NCT02172911|9974600|FG001|STARTED|Overall Study||3
8914989|NCT02172911|9974599|FG000|COMPLETED|Overall Study||6
8914990|NCT02172911|9974600|FG001|COMPLETED|Overall Study||1
8914991|NCT02172911|9974599|FG000|NOT COMPLETED|Overall Study||1
8914992|NCT02172911|9974600|FG001|NOT COMPLETED|Overall Study||2
8914993|NCT02172950|9974608|FG000|STARTED|Overall Study||222
8914994|NCT02172950|9974609|FG001|STARTED|Overall Study||24
8914995|NCT02172950|9974608|FG000|COMPLETED|Overall Study||197
8914996|NCT02172950|9974609|FG001|COMPLETED|Overall Study||19
8914997|NCT02172950|9974608|FG000|NOT COMPLETED|Overall Study||25
8914998|NCT02172950|9974609|FG001|NOT COMPLETED|Overall Study||5
8914999|NCT02173054|9974619|FG000|STARTED|Overall Study||40
8915000|NCT02173054|9974620|FG001|STARTED|Overall Study||40
8915001|NCT02173054|9974621|FG002|STARTED|Overall Study||40
8915002|NCT02173054|9974619|FG000|COMPLETED|Overall Study||39
9024326|NCT03150875|10087152|FG001|STARTED|Overall Study||145
9024327|NCT03150875|10087151|FG000|Treated|Overall Study||144
9024328|NCT03150875|10087152|FG001|Treated|Overall Study||130
9024329|NCT03150875|10087151|FG000|Crossover to Certain Treatment|Overall Study||0
9024330|NCT03150875|10087152|FG001|Crossover to Certain Treatment|Overall Study||0
9024331|NCT03150875|10087151|FG000|COMPLETED|Overall Study||0
9024332|NCT03150875|10087152|FG001|COMPLETED|Overall Study||0
9024333|NCT03150875|10087151|FG000|NOT COMPLETED|Overall Study||145
9024334|NCT03150875|10087152|FG001|NOT COMPLETED|Overall Study||145
9024335|NCT03151148|10087160|FG000|STARTED|Overall Study||36
9024336|NCT03151148|10087161|FG001|STARTED|Overall Study||18
9024337|NCT03151148|10087160|FG000|COMPLETED|Overall Study||34
9024338|NCT03151148|10087161|FG001|COMPLETED|Overall Study||18
9024339|NCT03151148|10087160|FG000|NOT COMPLETED|Overall Study||2
9024340|NCT03151148|10087161|FG001|NOT COMPLETED|Overall Study||0
9024341|NCT03151265|10087170|FG000|STARTED|Overall Study||20
9024342|NCT03151265|10087171|FG001|STARTED|Overall Study||20
9024343|NCT03151265|10087170|FG000|COMPLETED|Overall Study||20
9024344|NCT03151265|10087171|FG001|COMPLETED|Overall Study||20
9024345|NCT03151265|10087170|FG000|NOT COMPLETED|Overall Study||0
9024346|NCT03151265|10087171|FG001|NOT COMPLETED|Overall Study||0
9024347|NCT03151395|10087177|FG000|STARTED|Overall Study||197
9024348|NCT03151395|10087177|FG000|COMPLETED|Overall Study||182
9024349|NCT03151395|10087177|FG000|NOT COMPLETED|Overall Study||15
9024350|NCT03151434|10087184|FG000|STARTED|Overall Study||53
9024351|NCT03151434|10087185|FG001|STARTED|Overall Study||47
9024352|NCT03151434|10087186|FG002|STARTED|Overall Study||47
8754987|NCT01192295|9804132|FG000|NOT COMPLETED|Overall Study||10
8915003|NCT02173054|9974620|FG001|COMPLETED|Overall Study||40
8915004|NCT02173054|9974621|FG002|COMPLETED|Overall Study||39
8915005|NCT02173054|9974619|FG000|NOT COMPLETED|Overall Study||1
8915006|NCT02173054|9974620|FG001|NOT COMPLETED|Overall Study||0
8915007|NCT02173054|9974621|FG002|NOT COMPLETED|Overall Study||1
8915008|NCT02173158|9974629|FG000|STARTED|Efficacy Phase||9
8915009|NCT02173158|9974629|FG000|COMPLETED|Efficacy Phase||8
8915010|NCT02173158|9974629|FG000|NOT COMPLETED|Efficacy Phase||1
8915011|NCT02173158|9974629|FG000|STARTED|Safety Phase||8
8915012|NCT02173158|9974629|FG000|COMPLETED|Safety Phase||8
9024353|NCT03151434|10087184|FG000|COMPLETED|Overall Study||40
9024354|NCT03151434|10087185|FG001|COMPLETED|Overall Study||40
9024355|NCT03151434|10087186|FG002|COMPLETED|Overall Study||40
8754988|NCT01192295|9804133|FG001|NOT COMPLETED|Overall Study||23
8754989|NCT01192347|9804141|FG000|STARTED|Overall Study||175
8754990|NCT01192347|9804141|FG000|COMPLETED|Overall Study||163
8754991|NCT01192347|9804141|FG000|NOT COMPLETED|Overall Study||12
8754992|NCT01192399|9804145|FG000|STARTED|Overall Study||29
8754993|NCT01192399|9804145|FG000|COMPLETED|Overall Study||27
8754994|NCT01192399|9804145|FG000|NOT COMPLETED|Overall Study||2
8754995|NCT01192412|9804151|FG000|STARTED|Overall Study||497
8754996|NCT01192412|9804152|FG001|STARTED|Overall Study||490
8754997|NCT01192412|9804151|FG000|COMPLETED|Overall Study||493
8754998|NCT01192412|9804152|FG001|COMPLETED|Overall Study||488
8754999|NCT01192412|9804151|FG000|NOT COMPLETED|Overall Study||4
8755000|NCT01192412|9804152|FG001|NOT COMPLETED|Overall Study||2
8755001|NCT01192516|9804161|FG000|STARTED|Overall Study|Indicates number of people initially randomized to group|66
8755002|NCT01192516|9804162|FG001|STARTED|Overall Study|Indicates number of people initially randomized to group|66
8755003|NCT01192516|9804163|FG002|STARTED|Overall Study|Indicates number of people initially randomized to group|63
8755004|NCT01192516|9804161|FG000|COMPLETED|Overall Study||46
8755005|NCT01192516|9804162|FG001|COMPLETED|Overall Study||49
8755006|NCT01192516|9804163|FG002|COMPLETED|Overall Study||55
8755007|NCT01192516|9804161|FG000|NOT COMPLETED|Overall Study||20
8755008|NCT01192516|9804162|FG001|NOT COMPLETED|Overall Study||17
8755009|NCT01192516|9804163|FG002|NOT COMPLETED|Overall Study||8
8755010|NCT01192542|9804175|FG000|STARTED|Period 1||18
8755011|NCT01192542|9804176|FG001|STARTED|Period 1||20
8755012|NCT01192542|9804175|FG000|COMPLETED|Period 1||18
8755013|NCT01192542|9804176|FG001|COMPLETED|Period 1||20
9024356|NCT03151434|10087184|FG000|NOT COMPLETED|Overall Study||13
9024357|NCT03151434|10087185|FG001|NOT COMPLETED|Overall Study||7
9024358|NCT03151434|10087186|FG002|NOT COMPLETED|Overall Study||7
9024359|NCT03151551|10087199|FG000|STARTED|Open-Label Treatment Period||283
9024360|NCT03151551|10087200|FG001|STARTED|Open-Label Treatment Period||283
9024361|NCT03151551|10087199|FG000|Received at Least One Dose of Study Drug|Open-Label Treatment Period||283
9024362|NCT03151551|10087200|FG001|Received at Least One Dose of Study Drug|Open-Label Treatment Period||283
9024363|NCT03151551|10087199|FG000|IXE 160 mg at Baseline, 80 mg Q2W/Q4W|Open-Label Treatment Period||49
9024364|NCT03151551|10087200|FG001|IXE 160 mg at Baseline, 80 mg Q2W/Q4W|Open-Label Treatment Period|Row represents Ixekizumab data only.|0
9024365|NCT03151551|10087199|FG000|IXE 160 mg at Baseline, 80 mg Q4W|Open-Label Treatment Period||218
9024366|NCT03151551|10087200|FG001|IXE 160 mg at Baseline, 80 mg Q4W|Open-Label Treatment Period|Row represents Ixekizumab data only.|0
8755014|NCT01192542|9804175|FG000|NOT COMPLETED|Period 1||0
8755015|NCT01192542|9804176|FG001|NOT COMPLETED|Period 1||0
8755016|NCT01192542|9804175|FG000|STARTED|Period 2||18
8755017|NCT01192542|9804176|FG001|STARTED|Period 2||20
8755018|NCT01192542|9804175|FG000|COMPLETED|Period 2||18
8755019|NCT01192542|9804176|FG001|COMPLETED|Period 2||20
8755020|NCT01192542|9804175|FG000|NOT COMPLETED|Period 2||0
8755021|NCT01192542|9804176|FG001|NOT COMPLETED|Period 2||0
8755022|NCT01192815|9804184|FG000|STARTED|Overall Study||2
8755023|NCT01192815|9804184|FG000|COMPLETED|Overall Study||0
8755024|NCT01192815|9804184|FG000|NOT COMPLETED|Overall Study||2
8755025|NCT01192828|9804188|FG000|STARTED|Overall Study||14
8755026|NCT01192828|9804188|FG000|COMPLETED|Overall Study||14
8755027|NCT01192828|9804188|FG000|NOT COMPLETED|Overall Study||0
8755028|NCT01193010|9804196|FG000|STARTED|Overall Study||20
8755029|NCT01193010|9804197|FG001|STARTED|Overall Study||20
8755030|NCT01193010|9804196|FG000|COMPLETED|Overall Study||17
8755031|NCT01193010|9804197|FG001|COMPLETED|Overall Study||20
8755032|NCT01193010|9804196|FG000|NOT COMPLETED|Overall Study||3
8755033|NCT01193010|9804197|FG001|NOT COMPLETED|Overall Study||0
8755034|NCT01193049|9804203|FG000|STARTED|Period 1: Placebo Run-In||5
8755035|NCT01193049|9804204|FG001|STARTED|Period 1: Placebo Run-In||6
8755036|NCT01193049|9804203|FG000|COMPLETED|Period 1: Placebo Run-In||5
8755037|NCT01193049|9804204|FG001|COMPLETED|Period 1: Placebo Run-In||6
8755038|NCT01193049|9804203|FG000|NOT COMPLETED|Period 1: Placebo Run-In||0
8755039|NCT01193049|9804204|FG001|NOT COMPLETED|Period 1: Placebo Run-In||0
8755040|NCT01193049|9804203|FG000|STARTED|Washout 1 : 21 Day Washout||5
8755041|NCT01193049|9804204|FG001|STARTED|Washout 1 : 21 Day Washout||6
8755042|NCT01193049|9804203|FG000|COMPLETED|Washout 1 : 21 Day Washout||5
8755043|NCT01193049|9804204|FG001|COMPLETED|Washout 1 : 21 Day Washout||6
8755044|NCT01193049|9804203|FG000|NOT COMPLETED|Washout 1 : 21 Day Washout||0
8755045|NCT01193049|9804204|FG001|NOT COMPLETED|Washout 1 : 21 Day Washout||0
8755046|NCT01193049|9804203|FG000|STARTED|Period 2 : Double Blind Crossover||5
8755047|NCT01193049|9804204|FG001|STARTED|Period 2 : Double Blind Crossover||6
8755048|NCT01193049|9804203|FG000|COMPLETED|Period 2 : Double Blind Crossover||5
8755049|NCT01193049|9804204|FG001|COMPLETED|Period 2 : Double Blind Crossover||6
8755050|NCT01193049|9804203|FG000|NOT COMPLETED|Period 2 : Double Blind Crossover||0
8755051|NCT01193049|9804204|FG001|NOT COMPLETED|Period 2 : Double Blind Crossover||0
8755052|NCT01193049|9804203|FG000|STARTED|Washout 2 : 21 Day Washout||5
8755053|NCT01193049|9804204|FG001|STARTED|Washout 2 : 21 Day Washout||6
8755054|NCT01193049|9804203|FG000|COMPLETED|Washout 2 : 21 Day Washout||5
8755055|NCT01193049|9804204|FG001|COMPLETED|Washout 2 : 21 Day Washout||6
8755056|NCT01193049|9804203|FG000|NOT COMPLETED|Washout 2 : 21 Day Washout||0
8755057|NCT01193049|9804204|FG001|NOT COMPLETED|Washout 2 : 21 Day Washout||0
8755058|NCT01193049|9804203|FG000|STARTED|Period 3 : Double Blind Crossover||5
9024367|NCT03151551|10087199|FG000|ADA 80 mg at Baseline, 40 mg Q2W|Open-Label Treatment Period|Row represents adalimumab data only.|0
8755059|NCT01193049|9804204|FG001|STARTED|Period 3 : Double Blind Crossover||6
8755060|NCT01193049|9804203|FG000|COMPLETED|Period 3 : Double Blind Crossover||5
8755061|NCT01193049|9804204|FG001|COMPLETED|Period 3 : Double Blind Crossover||6
8755062|NCT01193049|9804203|FG000|NOT COMPLETED|Period 3 : Double Blind Crossover||0
8755063|NCT01193049|9804204|FG001|NOT COMPLETED|Period 3 : Double Blind Crossover||0
8755064|NCT01193101|9804214|FG000|STARTED|Overall Study||100
8755065|NCT01193101|9804215|FG001|STARTED|Overall Study||101
8755066|NCT01193101|9804216|FG002|STARTED|Overall Study||96
8755067|NCT01193101|9804217|FG003|STARTED|Overall Study||92
8755068|NCT01193101|9804214|FG000|Full Analysis Set|Overall Study||100
8755069|NCT01193101|9804215|FG001|Full Analysis Set|Overall Study||101
8755070|NCT01193101|9804216|FG002|Full Analysis Set|Overall Study||96
8755071|NCT01193101|9804217|FG003|Full Analysis Set|Overall Study||92
8755072|NCT01193101|9804214|FG000|Placebo Withdrawal Set|Overall Study||95
8755073|NCT01193101|9804215|FG001|Placebo Withdrawal Set|Overall Study||94
8755074|NCT01193101|9804216|FG002|Placebo Withdrawal Set|Overall Study||93
8755075|NCT01193101|9804217|FG003|Placebo Withdrawal Set|Overall Study||80
8755076|NCT01193101|9804214|FG000|COMPLETED|Overall Study||95
8755077|NCT01193101|9804215|FG001|COMPLETED|Overall Study||94
8755078|NCT01193101|9804216|FG002|COMPLETED|Overall Study||93
8755079|NCT01193101|9804217|FG003|COMPLETED|Overall Study||80
8755080|NCT01193101|9804214|FG000|NOT COMPLETED|Overall Study||5
8755081|NCT01193101|9804215|FG001|NOT COMPLETED|Overall Study||7
8755082|NCT01193101|9804216|FG002|NOT COMPLETED|Overall Study||3
8755083|NCT01193101|9804217|FG003|NOT COMPLETED|Overall Study||12
8755084|NCT01193114|9804229|FG000|STARTED|Overall Study||30
8755085|NCT01193114|9804230|FG001|STARTED|Overall Study||30
8755086|NCT01193114|9804229|FG000|COMPLETED|Overall Study||30
8755087|NCT01193114|9804230|FG001|COMPLETED|Overall Study||30
8755088|NCT01193114|9804229|FG000|NOT COMPLETED|Overall Study||0
8755089|NCT01193114|9804230|FG001|NOT COMPLETED|Overall Study||0
8755090|NCT01193127|9804240|FG000|STARTED|Randomized||57
8755091|NCT01193127|9804241|FG001|STARTED|Randomized||54
8755092|NCT01193127|9804242|FG002|STARTED|Randomized||55
8755093|NCT01193127|9804243|FG003|STARTED|Randomized||57
8755094|NCT01193127|9804240|FG000|COMPLETED|Randomized||57
8755095|NCT01193127|9804241|FG001|COMPLETED|Randomized||54
8755096|NCT01193127|9804242|FG002|COMPLETED|Randomized||55
8755097|NCT01193127|9804243|FG003|COMPLETED|Randomized||56
8755098|NCT01193127|9804240|FG000|NOT COMPLETED|Randomized||0
8755099|NCT01193127|9804241|FG001|NOT COMPLETED|Randomized||0
8755100|NCT01193127|9804242|FG002|NOT COMPLETED|Randomized||0
8755101|NCT01193127|9804243|FG003|NOT COMPLETED|Randomized||1
8755102|NCT01193127|9804240|FG000|STARTED|Treated||57
8755103|NCT01193127|9804241|FG001|STARTED|Treated||54
8755104|NCT01193127|9804242|FG002|STARTED|Treated||55
8755105|NCT01193127|9804243|FG003|STARTED|Treated||56
8755106|NCT01193127|9804240|FG000|COMPLETED|Treated||57
8755107|NCT01193127|9804241|FG001|COMPLETED|Treated||54
8755108|NCT01193127|9804242|FG002|COMPLETED|Treated||55
8755109|NCT01193127|9804243|FG003|COMPLETED|Treated||55
8755110|NCT01193127|9804240|FG000|NOT COMPLETED|Treated||0
8755111|NCT01193127|9804241|FG001|NOT COMPLETED|Treated||0
8755112|NCT01193127|9804242|FG002|NOT COMPLETED|Treated||0
8755113|NCT01193127|9804243|FG003|NOT COMPLETED|Treated||1
8755114|NCT01193153|9804255|FG000|STARTED|Open-label Lead in Period||667
8755115|NCT01193153|9804256|FG001|STARTED|Open-label Lead in Period||0
8755116|NCT01193153|9804255|FG000|COMPLETED|Open-label Lead in Period||432
8755117|NCT01193153|9804256|FG001|COMPLETED|Open-label Lead in Period||0
8755118|NCT01193153|9804255|FG000|NOT COMPLETED|Open-label Lead in Period||235
8755119|NCT01193153|9804256|FG001|NOT COMPLETED|Open-label Lead in Period||0
8755120|NCT01193153|9804255|FG000|STARTED|Open-label Stabilization Period||432
8755121|NCT01193153|9804256|FG001|STARTED|Open-label Stabilization Period||0
8755122|NCT01193153|9804255|FG000|COMPLETED|Open-label Stabilization Period||334
8755123|NCT01193153|9804256|FG001|COMPLETED|Open-label Stabilization Period||0
8755124|NCT01193153|9804255|FG000|NOT COMPLETED|Open-label Stabilization Period||98
8755125|NCT01193153|9804256|FG001|NOT COMPLETED|Open-label Stabilization Period||0
8755126|NCT01193153|9804255|FG000|STARTED|Double Blind Relapse Prevention Period||164
8755127|NCT01193153|9804256|FG001|STARTED|Double Blind Relapse Prevention Period||170
8755128|NCT01193153|9804255|FG000|COMPLETED|Double Blind Relapse Prevention Period||100
8755129|NCT01193153|9804256|FG001|COMPLETED|Double Blind Relapse Prevention Period||65
8755130|NCT01193153|9804255|FG000|NOT COMPLETED|Double Blind Relapse Prevention Period||64
8755131|NCT01193153|9804256|FG001|NOT COMPLETED|Double Blind Relapse Prevention Period||105
8755132|NCT01193218|9804270|FG000|STARTED|0-12 Weeks|It is actually placebo group|109
8755133|NCT01193218|9804271|FG001|STARTED|0-12 Weeks|It is actually N/A|0
8755134|NCT01193218|9804272|FG002|STARTED|0-12 Weeks|It is actually empa 5mg group|110
8755135|NCT01193218|9804273|FG003|STARTED|0-12 Weeks|It is actually N/A|0
8755136|NCT01193218|9804274|FG004|STARTED|0-12 Weeks||109
8755137|NCT01193218|9804275|FG005|STARTED|0-12 Weeks||109
8755138|NCT01193218|9804276|FG006|STARTED|0-12 Weeks|It is actually empa 50mg group|110
8755139|NCT01193218|9804277|FG007|STARTED|0-12 Weeks|It is actually N/A|0
8755140|NCT01193218|9804270|FG000|COMPLETED|0-12 Weeks||100
8755141|NCT01193218|9804271|FG001|COMPLETED|0-12 Weeks||0
8755142|NCT01193218|9804272|FG002|COMPLETED|0-12 Weeks||107
8755143|NCT01193218|9804273|FG003|COMPLETED|0-12 Weeks||0
8755144|NCT01193218|9804274|FG004|COMPLETED|0-12 Weeks||108
8755145|NCT01193218|9804275|FG005|COMPLETED|0-12 Weeks||106
8755146|NCT01193218|9804276|FG006|COMPLETED|0-12 Weeks||107
8755147|NCT01193218|9804277|FG007|COMPLETED|0-12 Weeks||0
8755148|NCT01193218|9804270|FG000|NOT COMPLETED|0-12 Weeks||9
8755149|NCT01193218|9804271|FG001|NOT COMPLETED|0-12 Weeks||0
8755150|NCT01193218|9804272|FG002|NOT COMPLETED|0-12 Weeks||3
8755151|NCT01193218|9804273|FG003|NOT COMPLETED|0-12 Weeks||0
8755152|NCT01193218|9804274|FG004|NOT COMPLETED|0-12 Weeks||1
8755153|NCT01193218|9804275|FG005|NOT COMPLETED|0-12 Weeks||3
8755154|NCT01193218|9804276|FG006|NOT COMPLETED|0-12 Weeks||3
8755155|NCT01193218|9804277|FG007|NOT COMPLETED|0-12 Weeks||0
8755156|NCT01193218|9804270|FG000|STARTED|12-52 Weeks||50
8755157|NCT01193218|9804271|FG001|STARTED|12-52 Weeks||50
8755158|NCT01193218|9804272|FG002|STARTED|12-52 Weeks||54
8755159|NCT01193218|9804273|FG003|STARTED|12-52 Weeks||53
8755160|NCT01193218|9804274|FG004|STARTED|12-52 Weeks||108
8755161|NCT01193218|9804275|FG005|STARTED|12-52 Weeks||106
8755162|NCT01193218|9804276|FG006|STARTED|12-52 Weeks||54
8755163|NCT01193218|9804277|FG007|STARTED|12-52 Weeks||53
8755164|NCT01193218|9804270|FG000|COMPLETED|12-52 Weeks||45
8755165|NCT01193218|9804271|FG001|COMPLETED|12-52 Weeks||50
8755166|NCT01193218|9804272|FG002|COMPLETED|12-52 Weeks||50
8755167|NCT01193218|9804273|FG003|COMPLETED|12-52 Weeks||50
8755168|NCT01193218|9804274|FG004|COMPLETED|12-52 Weeks||104
8755169|NCT01193218|9804275|FG005|COMPLETED|12-52 Weeks||101
8755170|NCT01193218|9804276|FG006|COMPLETED|12-52 Weeks||51
8755171|NCT01193218|9804277|FG007|COMPLETED|12-52 Weeks||49
8755172|NCT01193218|9804270|FG000|NOT COMPLETED|12-52 Weeks||5
8755173|NCT01193218|9804271|FG001|NOT COMPLETED|12-52 Weeks||0
8755174|NCT01193218|9804272|FG002|NOT COMPLETED|12-52 Weeks||4
8755175|NCT01193218|9804273|FG003|NOT COMPLETED|12-52 Weeks||3
8755176|NCT01193218|9804274|FG004|NOT COMPLETED|12-52 Weeks||4
8755177|NCT01193218|9804275|FG005|NOT COMPLETED|12-52 Weeks||5
8755178|NCT01193218|9804276|FG006|NOT COMPLETED|12-52 Weeks||3
8755179|NCT01193218|9804277|FG007|NOT COMPLETED|12-52 Weeks||4
8755180|NCT01193244|9804295|FG000|STARTED|Overall Study||779
8755181|NCT01193244|9804296|FG001|STARTED|Overall Study||781
8755182|NCT01193244|9804295|FG000|Treated|Overall Study|Participants who continued to receive Placebo after unblinding.|770
8755183|NCT01193244|9804296|FG001|Treated|Overall Study|Participants randomized to receive Placebo but crossed-over to receive Orteronel after unblinding.|784
8755184|NCT01193244|9804295|FG000|COMPLETED|Overall Study||391
8755185|NCT01193244|9804296|FG001|COMPLETED|Overall Study||391
8755186|NCT01193244|9804295|FG000|NOT COMPLETED|Overall Study||388
8755187|NCT01193244|9804296|FG001|NOT COMPLETED|Overall Study||390
8755188|NCT01193257|9804304|FG000|STARTED|Overall Study||365
9024368|NCT03151551|10087200|FG001|ADA 80 mg at Baseline, 40 mg Q2W|Open-Label Treatment Period||51
9024369|NCT03151551|10087199|FG000|ADA 40 mg at Baseline, 40 mg Q2W|Open-Label Treatment Period|Row represents adalimumab data only.|0
9024370|NCT03151551|10087200|FG001|ADA 40 mg at Baseline, 40 mg Q2W|Open-Label Treatment Period||219
9024371|NCT03151551|10087199|FG000|COMPLETED|Open-Label Treatment Period||265
9024372|NCT03151551|10087200|FG001|COMPLETED|Open-Label Treatment Period||259
9024373|NCT03151551|10087199|FG000|NOT COMPLETED|Open-Label Treatment Period||18
9024374|NCT03151551|10087200|FG001|NOT COMPLETED|Open-Label Treatment Period||24
9024375|NCT03151551|10087199|FG000|STARTED|Post-Treatment Follow-Up Period|All participants who received at least one dose of study drug could enter the follow-up period.|265
9024376|NCT03151551|10087200|FG001|STARTED|Post-Treatment Follow-Up Period|All participants who received at least one dose of study drug could enter the follow-up period.|258
9024377|NCT03151551|10087199|FG000|COMPLETED|Post-Treatment Follow-Up Period||240
9024378|NCT03151551|10087200|FG001|COMPLETED|Post-Treatment Follow-Up Period||230
9024379|NCT03151551|10087199|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||25
9024380|NCT03151551|10087200|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||28
9024381|NCT03152019|10087210|FG000|STARTED|Overall Study||25
9024382|NCT03152019|10087211|FG001|STARTED|Overall Study||25
9024383|NCT03152019|10087210|FG000|COMPLETED|Overall Study||25
9024384|NCT03152019|10087211|FG001|COMPLETED|Overall Study||24
9024385|NCT03152019|10087210|FG000|NOT COMPLETED|Overall Study||0
9024386|NCT03152019|10087211|FG001|NOT COMPLETED|Overall Study||1
9024387|NCT03152084|10087219|FG000|STARTED|Overall Study||17
9024388|NCT03152084|10087220|FG001|STARTED|Overall Study||7
9024389|NCT03152084|10087219|FG000|COMPLETED|Overall Study||17
9024390|NCT03152084|10087220|FG001|COMPLETED|Overall Study||7
9024391|NCT03152084|10087219|FG000|NOT COMPLETED|Overall Study||0
9024392|NCT03152084|10087220|FG001|NOT COMPLETED|Overall Study||0
9024393|NCT03152110|10087226|FG000|STARTED|Overall Study||10
9024394|NCT03152110|10087226|FG000|COMPLETED|Overall Study||7
9024395|NCT03152110|10087226|FG000|NOT COMPLETED|Overall Study||3
9024396|NCT03152136|10087234|FG000|STARTED|Overall Study||32
8755189|NCT01193257|9804305|FG001|STARTED|Overall Study||734
8755190|NCT01193257|9804304|FG000|Treated|Overall Study||363
8755191|NCT01193257|9804305|FG001|Treated|Overall Study||732
8755192|NCT01193257|9804304|FG000|COMPLETED|Overall Study||0
8755193|NCT01193257|9804305|FG001|COMPLETED|Overall Study||0
8755194|NCT01193257|9804304|FG000|NOT COMPLETED|Overall Study||365
8755195|NCT01193257|9804305|FG001|NOT COMPLETED|Overall Study||734
8755196|NCT01193283|9804311|FG000|STARTED|Overall Study||22
8755197|NCT01193283|9804311|FG000|COMPLETED|Overall Study||21
8755198|NCT01193283|9804311|FG000|NOT COMPLETED|Overall Study||1
8755199|NCT01193335|9804317|FG000|STARTED|Infant Series||100
8755200|NCT01193335|9804318|FG001|STARTED|Infant Series||100
8755201|NCT01193335|9804317|FG000|COMPLETED|Infant Series||100
8755202|NCT01193335|9804318|FG001|COMPLETED|Infant Series||100
8755203|NCT01193335|9804317|FG000|NOT COMPLETED|Infant Series||0
8755204|NCT01193335|9804318|FG001|NOT COMPLETED|Infant Series||0
8755205|NCT01193335|9804317|FG000|STARTED|After Infant Series||100
8755206|NCT01193335|9804318|FG001|STARTED|After Infant Series||100
8755207|NCT01193335|9804317|FG000|COMPLETED|After Infant Series||99
8755208|NCT01193335|9804318|FG001|COMPLETED|After Infant Series||97
8755209|NCT01193335|9804317|FG000|NOT COMPLETED|After Infant Series||1
8755210|NCT01193335|9804318|FG001|NOT COMPLETED|After Infant Series||3
8755211|NCT01193335|9804317|FG000|STARTED|Toddler Dose||99
8755212|NCT01193335|9804318|FG001|STARTED|Toddler Dose||97
8755213|NCT01193335|9804317|FG000|COMPLETED|Toddler Dose||99
8755214|NCT01193335|9804318|FG001|COMPLETED|Toddler Dose||97
8755215|NCT01193335|9804317|FG000|NOT COMPLETED|Toddler Dose||0
8755216|NCT01193335|9804318|FG001|NOT COMPLETED|Toddler Dose||0
8755217|NCT01193335|9804317|FG000|STARTED|1-Year Follow-up||99
8755218|NCT01193335|9804318|FG001|STARTED|1-Year Follow-up||97
8755219|NCT01193335|9804317|FG000|COMPLETED|1-Year Follow-up||88
8755220|NCT01193335|9804318|FG001|COMPLETED|1-Year Follow-up||88
8755221|NCT01193335|9804317|FG000|NOT COMPLETED|1-Year Follow-up||11
8755222|NCT01193335|9804318|FG001|NOT COMPLETED|1-Year Follow-up||9
8755223|NCT01193335|9804317|FG000|STARTED|2-Year Follow-up||88
8755224|NCT01193335|9804318|FG001|STARTED|2-Year Follow-up||88
8755225|NCT01193335|9804317|FG000|COMPLETED|2-Year Follow-up||81
8755226|NCT01193335|9804318|FG001|COMPLETED|2-Year Follow-up||80
8755227|NCT01193335|9804317|FG000|NOT COMPLETED|2-Year Follow-up||7
8755228|NCT01193335|9804318|FG001|NOT COMPLETED|2-Year Follow-up||8
8755229|NCT01193348|9804340|FG000|STARTED|Screening Period||27
8755230|NCT01193348|9804340|FG000|COMPLETED|Screening Period||22
8755231|NCT01193348|9804340|FG000|NOT COMPLETED|Screening Period||5
8755232|NCT01193348|9804340|FG000|STARTED|Treatment Period (26 Weeks)||22
8755233|NCT01193348|9804340|FG000|COMPLETED|Treatment Period (26 Weeks)||19
8755234|NCT01193348|9804340|FG000|NOT COMPLETED|Treatment Period (26 Weeks)||3
8755235|NCT01193348|9804340|FG000|STARTED|Extension Treatment Period||17
8755236|NCT01193348|9804340|FG000|COMPLETED|Extension Treatment Period||16
8755237|NCT01193348|9804340|FG000|NOT COMPLETED|Extension Treatment Period||1
8755238|NCT01193348|9804340|FG000|STARTED|Post Treatment Period (Patients Who Disc||10
8755239|NCT01193348|9804340|FG000|COMPLETED|Post Treatment Period (Patients Who Disc||8
8755240|NCT01193348|9804340|FG000|NOT COMPLETED|Post Treatment Period (Patients Who Disc||2
8755241|NCT01193517|9804352|FG000|STARTED|Overall Study||3
8755242|NCT01193517|9804353|FG001|STARTED|Overall Study||12
8755243|NCT01193517|9804354|FG002|STARTED|Overall Study||11
8755244|NCT01193517|9804352|FG000|COMPLETED|Overall Study||2
8755245|NCT01193517|9804353|FG001|COMPLETED|Overall Study||12
8755246|NCT01193517|9804354|FG002|COMPLETED|Overall Study||11
8755247|NCT01193517|9804352|FG000|NOT COMPLETED|Overall Study||1
8755248|NCT01193517|9804353|FG001|NOT COMPLETED|Overall Study||0
8755249|NCT01193517|9804354|FG002|NOT COMPLETED|Overall Study||0
8755250|NCT01193582|9804367|FG000|STARTED|Vaccination Series||100
8755251|NCT01193582|9804368|FG001|STARTED|Vaccination Series||101
8755252|NCT01193582|9804369|FG002|STARTED|Vaccination Series||125
8755253|NCT01193582|9804370|FG003|STARTED|Vaccination Series||180
8755254|NCT01193582|9804367|FG000|Vaccinated Dose 1|Vaccination Series||100
8755255|NCT01193582|9804368|FG001|Vaccinated Dose 1|Vaccination Series||100
8755256|NCT01193582|9804369|FG002|Vaccinated Dose 1|Vaccination Series||125
8755257|NCT01193582|9804370|FG003|Vaccinated Dose 1|Vaccination Series||180
8755258|NCT01193582|9804367|FG000|Vaccinated Dose 2|Vaccination Series||92
8755259|NCT01193582|9804368|FG001|Vaccinated Dose 2|Vaccination Series||91
8755260|NCT01193582|9804369|FG002|Vaccinated Dose 2|Vaccination Series||118
8755261|NCT01193582|9804370|FG003|Vaccinated Dose 2|Vaccination Series||0
8755262|NCT01193582|9804367|FG000|Vaccinated Dose 3|Vaccination Series||90
8755263|NCT01193582|9804368|FG001|Vaccinated Dose 3|Vaccination Series||89
8755264|NCT01193582|9804369|FG002|Vaccinated Dose 3|Vaccination Series||0
8755265|NCT01193582|9804370|FG003|Vaccinated Dose 3|Vaccination Series||0
8755266|NCT01193582|9804367|FG000|Vaccinated Dose 4|Vaccination Series||90
8755267|NCT01193582|9804368|FG001|Vaccinated Dose 4|Vaccination Series||0
8755268|NCT01193582|9804369|FG002|Vaccinated Dose 4|Vaccination Series||0
8755269|NCT01193582|9804370|FG003|Vaccinated Dose 4|Vaccination Series||0
8755270|NCT01193582|9804367|FG000|COMPLETED|Vaccination Series||89
8755271|NCT01193582|9804368|FG001|COMPLETED|Vaccination Series||88
8755272|NCT01193582|9804369|FG002|COMPLETED|Vaccination Series||117
8755273|NCT01193582|9804370|FG003|COMPLETED|Vaccination Series||177
8755274|NCT01193582|9804367|FG000|NOT COMPLETED|Vaccination Series||11
8755275|NCT01193582|9804368|FG001|NOT COMPLETED|Vaccination Series||13
8755276|NCT01193582|9804369|FG002|NOT COMPLETED|Vaccination Series||8
8755277|NCT01193582|9804370|FG003|NOT COMPLETED|Vaccination Series||3
8755278|NCT01193582|9804367|FG000|STARTED|12 Month Follow-up||89
8755279|NCT01193582|9804368|FG001|STARTED|12 Month Follow-up||88
8755280|NCT01193582|9804369|FG002|STARTED|12 Month Follow-up||117
8755281|NCT01193582|9804370|FG003|STARTED|12 Month Follow-up||177
8755282|NCT01193582|9804367|FG000|COMPLETED|12 Month Follow-up||83
8755283|NCT01193582|9804368|FG001|COMPLETED|12 Month Follow-up||88
8755284|NCT01193582|9804369|FG002|COMPLETED|12 Month Follow-up||113
8755285|NCT01193582|9804370|FG003|COMPLETED|12 Month Follow-up||166
8755286|NCT01193582|9804367|FG000|NOT COMPLETED|12 Month Follow-up||6
8755287|NCT01193582|9804368|FG001|NOT COMPLETED|12 Month Follow-up||0
8755288|NCT01193582|9804369|FG002|NOT COMPLETED|12 Month Follow-up||4
8755289|NCT01193582|9804370|FG003|NOT COMPLETED|12 Month Follow-up||11
8755290|NCT01193608|9804388|FG000|STARTED|Overall Study||6
8755291|NCT01193608|9804389|FG001|STARTED|Overall Study||6
8755292|NCT01193608|9804390|FG002|STARTED|Overall Study||16
8755293|NCT01193608|9804391|FG003|STARTED|Overall Study||17
8755294|NCT01193608|9804392|FG004|STARTED|Overall Study||24
8755295|NCT01193608|9804393|FG005|STARTED|Overall Study||19
8755296|NCT01193608|9804388|FG000|COMPLETED|Overall Study||6
8755297|NCT01193608|9804389|FG001|COMPLETED|Overall Study||4
8755298|NCT01193608|9804390|FG002|COMPLETED|Overall Study||14
8755299|NCT01193608|9804391|FG003|COMPLETED|Overall Study||14
8755300|NCT01193608|9804392|FG004|COMPLETED|Overall Study||19
8755301|NCT01193608|9804393|FG005|COMPLETED|Overall Study||17
8755302|NCT01193608|9804388|FG000|NOT COMPLETED|Overall Study||0
8755303|NCT01193608|9804389|FG001|NOT COMPLETED|Overall Study||2
8755304|NCT01193608|9804390|FG002|NOT COMPLETED|Overall Study||2
8755305|NCT01193608|9804391|FG003|NOT COMPLETED|Overall Study||3
8755306|NCT01193608|9804392|FG004|NOT COMPLETED|Overall Study||5
8755307|NCT01193608|9804393|FG005|NOT COMPLETED|Overall Study||2
8755308|NCT01193660|9804415|FG000|STARTED|Overall Study||35
8755309|NCT01193660|9804416|FG001|STARTED|Overall Study||36
8755310|NCT01193660|9804417|FG002|STARTED|Overall Study||34
8755311|NCT01193660|9804415|FG000|COMPLETED|Overall Study||31
8755312|NCT01193660|9804416|FG001|COMPLETED|Overall Study||33
8755313|NCT01193660|9804417|FG002|COMPLETED|Overall Study||32
8755314|NCT01193660|9804415|FG000|NOT COMPLETED|Overall Study||4
8755315|NCT01193660|9804416|FG001|NOT COMPLETED|Overall Study||3
8755316|NCT01193660|9804417|FG002|NOT COMPLETED|Overall Study||2
8755317|NCT01193686|9804427|FG000|STARTED|Overall Study||15
8755318|NCT01193686|9804428|FG001|STARTED|Overall Study||9
8755319|NCT01193686|9804427|FG000|Completed Baseline Assessment|Overall Study||15
8755320|NCT01193686|9804428|FG001|Completed Baseline Assessment|Overall Study||9
8755321|NCT01193686|9804427|FG000|Completed Mentor Training|Overall Study||9
8755322|NCT01193686|9804428|FG001|Completed Mentor Training|Overall Study|Not applicable. Recipients were not required to complete training.|0
8755323|NCT01193686|9804427|FG000|Completed Visits and Final Assessment|Overall Study||8
8755324|NCT01193686|9804428|FG001|Completed Visits and Final Assessment|Overall Study||8
8755325|NCT01193686|9804427|FG000|COMPLETED|Overall Study||8
8755326|NCT01193686|9804428|FG001|COMPLETED|Overall Study||8
8755327|NCT01193686|9804427|FG000|NOT COMPLETED|Overall Study||7
8755328|NCT01193686|9804428|FG001|NOT COMPLETED|Overall Study||1
8755329|NCT01193868|9804435|FG000|STARTED|Overall Study||6
8755330|NCT01193868|9804435|FG000|COMPLETED|Overall Study||6
8755331|NCT01193868|9804435|FG000|NOT COMPLETED|Overall Study||0
8755332|NCT01193907|9804443|FG000|STARTED|Overall Study||22
8755333|NCT01193907|9804444|FG001|STARTED|Overall Study||22
8755334|NCT01193907|9804445|FG002|STARTED|Overall Study||22
8755335|NCT01193907|9804446|FG003|STARTED|Overall Study||22
8755336|NCT01193907|9804443|FG000|COMPLETED|Overall Study||21
8755337|NCT01193907|9804444|FG001|COMPLETED|Overall Study||22
8755338|NCT01193907|9804445|FG002|COMPLETED|Overall Study||22
9024397|NCT03152136|10087235|FG001|STARTED|Overall Study||15
9024398|NCT03152136|10087236|FG002|STARTED|Overall Study||15
9024399|NCT03152136|10087234|FG000|COMPLETED|Overall Study||29
9024400|NCT03152136|10087235|FG001|COMPLETED|Overall Study||15
9024401|NCT03152136|10087236|FG002|COMPLETED|Overall Study||14
9024402|NCT03152136|10087234|FG000|NOT COMPLETED|Overall Study||3
9024403|NCT03152136|10087235|FG001|NOT COMPLETED|Overall Study||0
9024404|NCT03152136|10087236|FG002|NOT COMPLETED|Overall Study||1
9024405|NCT03152552|10087248|FG000|STARTED|Treatment Period 1 (12 Weeks)||15
9024406|NCT03152552|10087249|FG001|STARTED|Treatment Period 1 (12 Weeks)||16
9024407|NCT03152552|10087250|FG002|STARTED|Treatment Period 1 (12 Weeks)||31
9024408|NCT03152552|10087251|FG003|STARTED|Treatment Period 1 (12 Weeks)||30
9024409|NCT03152552|10087252|FG004|STARTED|Treatment Period 1 (12 Weeks)||33
9024410|NCT03152552|10087248|FG000|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||15
9024411|NCT03152552|10087249|FG001|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||16
9024412|NCT03152552|10087250|FG002|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||30
9024413|NCT03152552|10087251|FG003|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||30
9024414|NCT03152552|10087252|FG004|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||33
9024415|NCT03152552|10087248|FG000|COMPLETED|Treatment Period 1 (12 Weeks)||7
9024416|NCT03152552|10087249|FG001|COMPLETED|Treatment Period 1 (12 Weeks)||5
9024417|NCT03152552|10087250|FG002|COMPLETED|Treatment Period 1 (12 Weeks)||10
9024418|NCT03152552|10087251|FG003|COMPLETED|Treatment Period 1 (12 Weeks)||10
9024419|NCT03152552|10087252|FG004|COMPLETED|Treatment Period 1 (12 Weeks)||12
9024420|NCT03152552|10087248|FG000|NOT COMPLETED|Treatment Period 1 (12 Weeks)||8
8755339|NCT01193907|9804446|FG003|COMPLETED|Overall Study||21
8755340|NCT01193907|9804443|FG000|NOT COMPLETED|Overall Study||1
8755341|NCT01193907|9804444|FG001|NOT COMPLETED|Overall Study||0
8755342|NCT01193907|9804445|FG002|NOT COMPLETED|Overall Study||0
8755343|NCT01193907|9804446|FG003|NOT COMPLETED|Overall Study||1
9024421|NCT03152552|10087249|FG001|NOT COMPLETED|Treatment Period 1 (12 Weeks)||11
9024422|NCT03152552|10087250|FG002|NOT COMPLETED|Treatment Period 1 (12 Weeks)||21
9024423|NCT03152552|10087251|FG003|NOT COMPLETED|Treatment Period 1 (12 Weeks)||20
8755344|NCT01193920|9804466|FG000|STARTED|Overall Study||40
8755345|NCT01193920|9804467|FG001|STARTED|Overall Study||20
8755346|NCT01193920|9804468|FG002|STARTED|Overall Study||80
8755347|NCT01193920|9804469|FG003|STARTED|Overall Study||80
8755348|NCT01193920|9804470|FG004|STARTED|Overall Study||80
8755349|NCT01193920|9804471|FG005|STARTED|Overall Study||80
8755350|NCT01193920|9804472|FG006|STARTED|Overall Study||80
8755351|NCT01193920|9804473|FG007|STARTED|Overall Study||80
8755352|NCT01193920|9804474|FG008|STARTED|Overall Study||76
8755353|NCT01193920|9804475|FG009|STARTED|Overall Study||81
8755354|NCT01193920|9804466|FG000|COMPLETED|Overall Study||37
8755355|NCT01193920|9804467|FG001|COMPLETED|Overall Study||20
8755356|NCT01193920|9804468|FG002|COMPLETED|Overall Study||74
8755357|NCT01193920|9804469|FG003|COMPLETED|Overall Study||76
8755358|NCT01193920|9804470|FG004|COMPLETED|Overall Study||74
8755359|NCT01193920|9804471|FG005|COMPLETED|Overall Study||76
8755360|NCT01193920|9804472|FG006|COMPLETED|Overall Study||74
8755361|NCT01193920|9804473|FG007|COMPLETED|Overall Study||76
8755362|NCT01193920|9804474|FG008|COMPLETED|Overall Study||71
8755363|NCT01193920|9804475|FG009|COMPLETED|Overall Study||74
8755364|NCT01193920|9804466|FG000|NOT COMPLETED|Overall Study||3
8755365|NCT01193920|9804467|FG001|NOT COMPLETED|Overall Study||0
8755366|NCT01193920|9804468|FG002|NOT COMPLETED|Overall Study||6
8755367|NCT01193920|9804469|FG003|NOT COMPLETED|Overall Study||4
8755368|NCT01193920|9804470|FG004|NOT COMPLETED|Overall Study||6
8755369|NCT01193920|9804471|FG005|NOT COMPLETED|Overall Study||4
8755370|NCT01193920|9804472|FG006|NOT COMPLETED|Overall Study||6
8755371|NCT01193920|9804473|FG007|NOT COMPLETED|Overall Study||4
8755372|NCT01193920|9804474|FG008|NOT COMPLETED|Overall Study||5
8755373|NCT01193920|9804475|FG009|NOT COMPLETED|Overall Study||7
8755374|NCT01194089|9804500|FG000|STARTED|Overall Study||42
8755375|NCT01194089|9804501|FG001|STARTED|Overall Study||47
8755376|NCT01194089|9804500|FG000|COMPLETED|Overall Study||42
8755377|NCT01194089|9804501|FG001|COMPLETED|Overall Study||47
8755378|NCT01194089|9804500|FG000|NOT COMPLETED|Overall Study||0
8755379|NCT01194089|9804501|FG001|NOT COMPLETED|Overall Study||0
8755380|NCT01194154|9804509|FG000|STARTED|Overall Study||117
8755381|NCT01194154|9804510|FG001|STARTED|Overall Study||124
8755382|NCT01194154|9804509|FG000|Full Analysis Set|Overall Study||115
8755383|NCT01194154|9804510|FG001|Full Analysis Set|Overall Study||120
8755384|NCT01194154|9804509|FG000|Safety Analysis Set|Overall Study|3 participants randomized to placebo but received MIRCERA and included in MIRCERA arm (as treated).|118
8755385|NCT01194154|9804510|FG001|Safety Analysis Set|Overall Study|3 participants randomized to placebo but received MIRCERA and included in MIRCERA arm (as treated).|117
8755386|NCT01194154|9804509|FG000|COMPLETED|Overall Study||68
8755387|NCT01194154|9804510|FG001|COMPLETED|Overall Study||91
8755388|NCT01194154|9804509|FG000|NOT COMPLETED|Overall Study||49
8755389|NCT01194154|9804510|FG001|NOT COMPLETED|Overall Study||33
8755390|NCT01194245|9804523|FG000|STARTED|Titration Period (4 to 6 Weeks)||135
8755391|NCT01194245|9804524|FG001|STARTED|Titration Period (4 to 6 Weeks)||0
8755392|NCT01194245|9804525|FG002|STARTED|Titration Period (4 to 6 Weeks)||0
8755393|NCT01194245|9804526|FG003|STARTED|Titration Period (4 to 6 Weeks)||0
8755394|NCT01194245|9804527|FG004|STARTED|Titration Period (4 to 6 Weeks)||0
8755395|NCT01194245|9804523|FG000|COMPLETED|Titration Period (4 to 6 Weeks)|Participants that completed the Titration Period were randomized to Treatment Period 1.|117
8755396|NCT01194245|9804524|FG001|COMPLETED|Titration Period (4 to 6 Weeks)||0
8755397|NCT01194245|9804525|FG002|COMPLETED|Titration Period (4 to 6 Weeks)||0
8755398|NCT01194245|9804526|FG003|COMPLETED|Titration Period (4 to 6 Weeks)||0
8755399|NCT01194245|9804527|FG004|COMPLETED|Titration Period (4 to 6 Weeks)||0
8755400|NCT01194245|9804523|FG000|NOT COMPLETED|Titration Period (4 to 6 Weeks)||18
8755401|NCT01194245|9804524|FG001|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
8755402|NCT01194245|9804525|FG002|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
8755403|NCT01194245|9804526|FG003|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
8755404|NCT01194245|9804527|FG004|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
8755405|NCT01194245|9804523|FG000|STARTED|Treatment Period 1 (Weeks 0 to 12)||0
8755406|NCT01194245|9804524|FG001|STARTED|Treatment Period 1 (Weeks 0 to 12)||29
8755407|NCT01194245|9804525|FG002|STARTED|Treatment Period 1 (Weeks 0 to 12)||28
8755408|NCT01194245|9804526|FG003|STARTED|Treatment Period 1 (Weeks 0 to 12)||30
8755409|NCT01194245|9804527|FG004|STARTED|Treatment Period 1 (Weeks 0 to 12)||30
8755410|NCT01194245|9804523|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||0
8755411|NCT01194245|9804524|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||29
8755412|NCT01194245|9804525|FG002|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||28
8755413|NCT01194245|9804526|FG003|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||30
8755414|NCT01194245|9804527|FG004|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||30
8755415|NCT01194245|9804523|FG000|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||0
8755416|NCT01194245|9804524|FG001|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||29
8755417|NCT01194245|9804525|FG002|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||27
8755418|NCT01194245|9804526|FG003|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||29
8755419|NCT01194245|9804527|FG004|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||28
8755420|NCT01194245|9804523|FG000|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||0
8755421|NCT01194245|9804524|FG001|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||0
8755422|NCT01194245|9804525|FG002|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||1
8755423|NCT01194245|9804526|FG003|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||1
8755424|NCT01194245|9804527|FG004|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||2
8755425|NCT01194245|9804523|FG000|STARTED|Treatment Period 2 (Weeks 12 to 24)||0
8755426|NCT01194245|9804524|FG001|STARTED|Treatment Period 2 (Weeks 12 to 24)||29
8755427|NCT01194245|9804525|FG002|STARTED|Treatment Period 2 (Weeks 12 to 24)||27
8755428|NCT01194245|9804526|FG003|STARTED|Treatment Period 2 (Weeks 12 to 24)||29
8755429|NCT01194245|9804527|FG004|STARTED|Treatment Period 2 (Weeks 12 to 24)||28
8755430|NCT01194245|9804523|FG000|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
8755431|NCT01194245|9804524|FG001|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||29
8755432|NCT01194245|9804525|FG002|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||27
8755433|NCT01194245|9804526|FG003|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||29
8755434|NCT01194245|9804527|FG004|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||28
8755435|NCT01194245|9804523|FG000|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
8755436|NCT01194245|9804524|FG001|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
8755437|NCT01194245|9804525|FG002|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
8755438|NCT01194245|9804526|FG003|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
8755439|NCT01194245|9804527|FG004|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
8755440|NCT01194258|9804536|FG000|STARTED|Titration Period||132
8755441|NCT01194258|9804537|FG001|STARTED|Titration Period||0
8755442|NCT01194258|9804538|FG002|STARTED|Titration Period||0
8755443|NCT01194258|9804539|FG003|STARTED|Titration Period||0
8755444|NCT01194258|9804540|FG004|STARTED|Titration Period||0
8755445|NCT01194258|9804536|FG000|COMPLETED|Titration Period||121
8755446|NCT01194258|9804537|FG001|COMPLETED|Titration Period||0
8755447|NCT01194258|9804538|FG002|COMPLETED|Titration Period||0
8755448|NCT01194258|9804539|FG003|COMPLETED|Titration Period||0
8755449|NCT01194258|9804540|FG004|COMPLETED|Titration Period||0
8755450|NCT01194258|9804536|FG000|NOT COMPLETED|Titration Period||11
8755451|NCT01194258|9804537|FG001|NOT COMPLETED|Titration Period||0
8755452|NCT01194258|9804538|FG002|NOT COMPLETED|Titration Period||0
8755453|NCT01194258|9804539|FG003|NOT COMPLETED|Titration Period||0
8755454|NCT01194258|9804540|FG004|NOT COMPLETED|Titration Period||0
8755455|NCT01194258|9804536|FG000|STARTED|Period 1 (12 Weeks)|Participants were randomized to the Insulin lispro or an Analog-PH20 group after titration.|0
8755456|NCT01194258|9804537|FG001|STARTED|Period 1 (12 Weeks)|After the titration phase, 29 participants were randomized to the Insulin lispro/Lispro-PH20 group.|29
8755457|NCT01194258|9804538|FG002|STARTED|Period 1 (12 Weeks)|After the titration phase, 30 participants were randomized to the Lispro-PH20/Insulin lispro group.|30
8755458|NCT01194258|9804539|FG003|STARTED|Period 1 (12 Weeks)|After the titration phase, 29 participants were randomized to the Insulin lispro/Aspart-PH20 group.|29
8755459|NCT01194258|9804540|FG004|STARTED|Period 1 (12 Weeks)|After the titration phase, 33 participants were randomized to the Aspart-PH20/Insulin lispro group.|33
8755460|NCT01194258|9804536|FG000|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||0
8755461|NCT01194258|9804537|FG001|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||29
8755462|NCT01194258|9804538|FG002|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||30
8755463|NCT01194258|9804539|FG003|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||29
8755464|NCT01194258|9804540|FG004|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||33
8755465|NCT01194258|9804536|FG000|COMPLETED|Period 1 (12 Weeks)||0
8755466|NCT01194258|9804537|FG001|COMPLETED|Period 1 (12 Weeks)||29
8755467|NCT01194258|9804538|FG002|COMPLETED|Period 1 (12 Weeks)||30
8755468|NCT01194258|9804539|FG003|COMPLETED|Period 1 (12 Weeks)||29
8755469|NCT01194258|9804540|FG004|COMPLETED|Period 1 (12 Weeks)||32
8755470|NCT01194258|9804536|FG000|NOT COMPLETED|Period 1 (12 Weeks)||0
8755471|NCT01194258|9804537|FG001|NOT COMPLETED|Period 1 (12 Weeks)||0
8755472|NCT01194258|9804538|FG002|NOT COMPLETED|Period 1 (12 Weeks)||0
8755473|NCT01194258|9804539|FG003|NOT COMPLETED|Period 1 (12 Weeks)||0
8755474|NCT01194258|9804540|FG004|NOT COMPLETED|Period 1 (12 Weeks)||1
8755475|NCT01194258|9804536|FG000|STARTED|Period 2 (12 Weeks)||0
8755476|NCT01194258|9804537|FG001|STARTED|Period 2 (12 Weeks)||29
8755477|NCT01194258|9804538|FG002|STARTED|Period 2 (12 Weeks)||30
8755478|NCT01194258|9804539|FG003|STARTED|Period 2 (12 Weeks)||29
8755479|NCT01194258|9804540|FG004|STARTED|Period 2 (12 Weeks)||32
8755480|NCT01194258|9804536|FG000|COMPLETED|Period 2 (12 Weeks)||0
8755481|NCT01194258|9804537|FG001|COMPLETED|Period 2 (12 Weeks)||27
8755482|NCT01194258|9804538|FG002|COMPLETED|Period 2 (12 Weeks)||29
8755483|NCT01194258|9804539|FG003|COMPLETED|Period 2 (12 Weeks)||29
8755484|NCT01194258|9804540|FG004|COMPLETED|Period 2 (12 Weeks)||30
8755485|NCT01194258|9804536|FG000|NOT COMPLETED|Period 2 (12 Weeks)||0
8755486|NCT01194258|9804537|FG001|NOT COMPLETED|Period 2 (12 Weeks)||2
8755487|NCT01194258|9804538|FG002|NOT COMPLETED|Period 2 (12 Weeks)||1
8755488|NCT01194258|9804539|FG003|NOT COMPLETED|Period 2 (12 Weeks)||0
8755489|NCT01194258|9804540|FG004|NOT COMPLETED|Period 2 (12 Weeks)||2
8755490|NCT01194271|9804551|FG000|STARTED|Overall Study||19
8755491|NCT01194271|9804551|FG000|COMPLETED|Overall Study||16
8755492|NCT01194271|9804551|FG000|NOT COMPLETED|Overall Study||3
8755493|NCT01194297|9804557|FG000|STARTED|Overall Study||2
8755494|NCT01194297|9804558|FG001|STARTED|Overall Study||1
8755495|NCT01194297|9804557|FG000|COMPLETED|Overall Study||2
8755496|NCT01194297|9804558|FG001|COMPLETED|Overall Study||1
8755497|NCT01194297|9804557|FG000|NOT COMPLETED|Overall Study||0
8755498|NCT01194297|9804558|FG001|NOT COMPLETED|Overall Study||0
8755499|NCT01194414|9804566|FG000|STARTED|24 Weeks Double Blind Period||631
8755500|NCT01194414|9804567|FG001|STARTED|24 Weeks Double Blind Period||631
8755501|NCT01194414|9804568|FG002|STARTED|24 Weeks Double Blind Period||0
8755502|NCT01194414|9804569|FG003|STARTED|24 Weeks Double Blind Period||0
8755503|NCT01194414|9804566|FG000|Per Protocol Population|24 Weeks Double Blind Period||558
8755504|NCT01194414|9804567|FG001|Per Protocol Population|24 Weeks Double Blind Period||537
8755505|NCT01194414|9804568|FG002|Per Protocol Population|24 Weeks Double Blind Period||0
8808065|NCT01489527|9860474|FG001|COMPLETED|Overall Study||175
8755506|NCT01194414|9804569|FG003|Per Protocol Population|24 Weeks Double Blind Period||0
8755507|NCT01194414|9804566|FG000|COMPLETED|24 Weeks Double Blind Period||572
8755508|NCT01194414|9804567|FG001|COMPLETED|24 Weeks Double Blind Period||564
8755509|NCT01194414|9804568|FG002|COMPLETED|24 Weeks Double Blind Period||0
8755510|NCT01194414|9804569|FG003|COMPLETED|24 Weeks Double Blind Period||0
8755511|NCT01194414|9804566|FG000|NOT COMPLETED|24 Weeks Double Blind Period||59
8755512|NCT01194414|9804567|FG001|NOT COMPLETED|24 Weeks Double Blind Period||67
8755513|NCT01194414|9804568|FG002|NOT COMPLETED|24 Weeks Double Blind Period||0
8755514|NCT01194414|9804569|FG003|NOT COMPLETED|24 Weeks Double Blind Period||0
8755515|NCT01194414|9804566|FG000|STARTED|72 Weeks Open Label Extension||524
8755516|NCT01194414|9804567|FG001|STARTED|72 Weeks Open Label Extension||377
8755517|NCT01194414|9804568|FG002|STARTED|72 Weeks Open Label Extension||48
8755518|NCT01194414|9804569|FG003|STARTED|72 Weeks Open Label Extension||186
8755519|NCT01194414|9804566|FG000|COMPLETED|72 Weeks Open Label Extension||445
8755520|NCT01194414|9804567|FG001|COMPLETED|72 Weeks Open Label Extension||311
8755521|NCT01194414|9804568|FG002|COMPLETED|72 Weeks Open Label Extension||40
8755522|NCT01194414|9804569|FG003|COMPLETED|72 Weeks Open Label Extension||160
8755523|NCT01194414|9804566|FG000|NOT COMPLETED|72 Weeks Open Label Extension||79
8755524|NCT01194414|9804567|FG001|NOT COMPLETED|72 Weeks Open Label Extension||66
8755525|NCT01194414|9804568|FG002|NOT COMPLETED|72 Weeks Open Label Extension||8
8755526|NCT01194414|9804569|FG003|NOT COMPLETED|72 Weeks Open Label Extension||26
8755527|NCT01194440|9804581|FG000|STARTED|Baseline (First Dose)||59
8755528|NCT01194440|9804581|FG000|COMPLETED|Baseline (First Dose)||52
8755529|NCT01194440|9804581|FG000|NOT COMPLETED|Baseline (First Dose)||7
8755530|NCT01194440|9804581|FG000|STARTED|6-months (2nd Dose)||52
8755531|NCT01194440|9804581|FG000|COMPLETED|6-months (2nd Dose)||48
8755532|NCT01194440|9804581|FG000|NOT COMPLETED|6-months (2nd Dose)||4
8755533|NCT01194453|9804588|FG000|STARTED|Overall Study||144
8755534|NCT01194453|9804589|FG001|STARTED|Overall Study||144
8755535|NCT01194453|9804588|FG000|COMPLETED|Overall Study||127
8755536|NCT01194453|9804589|FG001|COMPLETED|Overall Study||127
8755537|NCT01194453|9804588|FG000|NOT COMPLETED|Overall Study||17
8755538|NCT01194453|9804589|FG001|NOT COMPLETED|Overall Study||17
8755539|NCT01194466|9804595|FG000|STARTED|Overall Study||14
8755540|NCT01194466|9804596|FG001|STARTED|Overall Study||14
8755541|NCT01194466|9804597|FG002|STARTED|Overall Study||13
8755542|NCT01194466|9804595|FG000|COMPLETED|Overall Study||14
8755543|NCT01194466|9804596|FG001|COMPLETED|Overall Study||14
8755544|NCT01194466|9804597|FG002|COMPLETED|Overall Study||13
8755545|NCT01194466|9804595|FG000|NOT COMPLETED|Overall Study||0
8755546|NCT01194466|9804596|FG001|NOT COMPLETED|Overall Study||0
8755547|NCT01194466|9804597|FG002|NOT COMPLETED|Overall Study||0
8755548|NCT01194479|9804607|FG000|STARTED|Overall Study||3
8755549|NCT01194479|9804608|FG001|STARTED|Overall Study||4
8755550|NCT01194479|9804609|FG002|STARTED|Overall Study||2
8755551|NCT01194479|9804610|FG003|STARTED|Overall Study||5
8755552|NCT01194479|9804607|FG000|Cross-over at Second Visit|Overall Study||3
8755553|NCT01194479|9804608|FG001|Cross-over at Second Visit|Overall Study||4
8755554|NCT01194479|9804609|FG002|Cross-over at Second Visit|Overall Study||2
8755555|NCT01194479|9804610|FG003|Cross-over at Second Visit|Overall Study||5
8755556|NCT01194479|9804607|FG000|COMPLETED|Overall Study||3
8755557|NCT01194479|9804608|FG001|COMPLETED|Overall Study||4
8755558|NCT01194479|9804609|FG002|COMPLETED|Overall Study||2
8755559|NCT01194479|9804610|FG003|COMPLETED|Overall Study||5
8755560|NCT01194479|9804607|FG000|NOT COMPLETED|Overall Study||0
8755561|NCT01194479|9804608|FG001|NOT COMPLETED|Overall Study||0
8755562|NCT01194479|9804609|FG002|NOT COMPLETED|Overall Study||0
8755563|NCT01194479|9804610|FG003|NOT COMPLETED|Overall Study||0
8755564|NCT01194531|9804622|FG000|STARTED|Overall Study||29
8755565|NCT01194531|9804623|FG001|STARTED|Overall Study||30
8755566|NCT01194531|9804622|FG000|COMPLETED|Overall Study||24
8755567|NCT01194531|9804623|FG001|COMPLETED|Overall Study||27
8755568|NCT01194531|9804622|FG000|NOT COMPLETED|Overall Study||5
8755569|NCT01194531|9804623|FG001|NOT COMPLETED|Overall Study||3
8755570|NCT01194674|9804629|FG000|STARTED|Overall Study||2
8755571|NCT01194674|9804629|FG000|COMPLETED|Overall Study||2
8755572|NCT01194674|9804629|FG000|NOT COMPLETED|Overall Study||0
8755573|NCT01194804|9804634|FG000|STARTED|Overall Study||27
8755574|NCT01194804|9804634|FG000|COMPLETED|Overall Study||26
8755575|NCT01194804|9804634|FG000|NOT COMPLETED|Overall Study||1
8755576|NCT01194830|9804640|FG000|STARTED|Overall Study||124
8755577|NCT01194830|9804641|FG001|STARTED|Overall Study||110
8755578|NCT01194830|9804640|FG000|COMPLETED|Overall Study||88
8755579|NCT01194830|9804641|FG001|COMPLETED|Overall Study||83
8755580|NCT01194830|9804640|FG000|NOT COMPLETED|Overall Study||36
8755581|NCT01194830|9804641|FG001|NOT COMPLETED|Overall Study||27
8755582|NCT01194869|9804647|FG000|STARTED|Overall Study||25
8755583|NCT01194869|9804647|FG000|COMPLETED|Overall Study||21
8755584|NCT01194869|9804647|FG000|NOT COMPLETED|Overall Study||4
8755585|NCT01194973|9804651|FG000|STARTED|Screening Period||44
8755586|NCT01194973|9804651|FG000|COMPLETED|Screening Period||41
8755587|NCT01194973|9804651|FG000|NOT COMPLETED|Screening Period||3
8755588|NCT01194973|9804651|FG000|STARTED|26 Week Treatment Period||41
8755589|NCT01194973|9804651|FG000|COMPLETED|26 Week Treatment Period||38
8755590|NCT01194973|9804651|FG000|NOT COMPLETED|26 Week Treatment Period||3
8755591|NCT01194999|9804655|FG000|STARTED|Overall Study||132
8755592|NCT01194999|9804655|FG000|COMPLETED|Overall Study||115
8755593|NCT01194999|9804655|FG000|NOT COMPLETED|Overall Study||17
8755594|NCT01195025|9804659|FG000|STARTED|First Intervention A||2
8755595|NCT01195025|9804660|FG001|STARTED|First Intervention A||3
8755596|NCT01195025|9804661|FG002|STARTED|First Intervention A||2
8755597|NCT01195025|9804662|FG003|STARTED|First Intervention A||2
8755598|NCT01195025|9804663|FG004|STARTED|First Intervention A||1
8755599|NCT01195025|9804659|FG000|COMPLETED|First Intervention A||2
8755600|NCT01195025|9804660|FG001|COMPLETED|First Intervention A||3
8755601|NCT01195025|9804661|FG002|COMPLETED|First Intervention A||2
8755602|NCT01195025|9804662|FG003|COMPLETED|First Intervention A||2
8755603|NCT01195025|9804663|FG004|COMPLETED|First Intervention A||1
8755604|NCT01195025|9804659|FG000|NOT COMPLETED|First Intervention A||0
8755605|NCT01195025|9804660|FG001|NOT COMPLETED|First Intervention A||0
8755606|NCT01195025|9804661|FG002|NOT COMPLETED|First Intervention A||0
8755607|NCT01195025|9804662|FG003|NOT COMPLETED|First Intervention A||0
8755608|NCT01195025|9804663|FG004|NOT COMPLETED|First Intervention A||0
8755609|NCT01195025|9804659|FG000|STARTED|Second Intervention B||2
9024424|NCT03152552|10087252|FG004|NOT COMPLETED|Treatment Period 1 (12 Weeks)||21
9024425|NCT03152552|10087248|FG000|STARTED|Treatment Period 2 (24 Weeks)||7
9024426|NCT03152552|10087249|FG001|STARTED|Treatment Period 2 (24 Weeks)||5
9024427|NCT03152552|10087250|FG002|STARTED|Treatment Period 2 (24 Weeks)|All patients who entered Treatment Period 2 (EPOCH 4)|9
9024428|NCT03152552|10087251|FG003|STARTED|Treatment Period 2 (24 Weeks)|All patients who entered Treatment Period 2 (EPOCH 4)|9
9024429|NCT03152552|10087252|FG004|STARTED|Treatment Period 2 (24 Weeks)|All patients who entered Treatment Period 2 (EPOCH 4)|11
9024430|NCT03152552|10087248|FG000|COMPLETED|Treatment Period 2 (24 Weeks)||1
9024431|NCT03152552|10087249|FG001|COMPLETED|Treatment Period 2 (24 Weeks)||0
9024432|NCT03152552|10087250|FG002|COMPLETED|Treatment Period 2 (24 Weeks)||0
9024433|NCT03152552|10087251|FG003|COMPLETED|Treatment Period 2 (24 Weeks)||0
9024434|NCT03152552|10087252|FG004|COMPLETED|Treatment Period 2 (24 Weeks)||0
9024435|NCT03152552|10087248|FG000|NOT COMPLETED|Treatment Period 2 (24 Weeks)||6
9024436|NCT03152552|10087249|FG001|NOT COMPLETED|Treatment Period 2 (24 Weeks)||5
9024437|NCT03152552|10087250|FG002|NOT COMPLETED|Treatment Period 2 (24 Weeks)||9
9024438|NCT03152552|10087251|FG003|NOT COMPLETED|Treatment Period 2 (24 Weeks)||9
9024439|NCT03152552|10087252|FG004|NOT COMPLETED|Treatment Period 2 (24 Weeks)||11
9024440|NCT03152591|10087267|FG000|STARTED|Overall Study||15
9024441|NCT03152591|10087268|FG001|STARTED|Overall Study||14
9024442|NCT03152591|10087267|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||14
9024443|NCT03152591|10087268|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||0
9024444|NCT03152591|10087267|FG000|Pharmacodynamic (PD) Analysis Set|Overall Study||15
9024445|NCT03152591|10087268|FG001|Pharmacodynamic (PD) Analysis Set|Overall Study||14
9024446|NCT03152591|10087267|FG000|COMPLETED|Overall Study||15
9024447|NCT03152591|10087268|FG001|COMPLETED|Overall Study||14
9024448|NCT03152591|10087267|FG000|NOT COMPLETED|Overall Study||0
9024449|NCT03152591|10087268|FG001|NOT COMPLETED|Overall Study||0
9024450|NCT03153956|10087276|FG000|STARTED|Overall Study||39
9024451|NCT03153956|10087277|FG001|STARTED|Overall Study||38
9024452|NCT03153956|10087276|FG000|COMPLETED|Overall Study||39
9024453|NCT03153956|10087277|FG001|COMPLETED|Overall Study||38
9024454|NCT03153956|10087276|FG000|NOT COMPLETED|Overall Study||0
9024455|NCT03153956|10087277|FG001|NOT COMPLETED|Overall Study||0
9024456|NCT03154047|10087283|FG000|STARTED|Overall Study||80
9024457|NCT03154047|10087283|FG000|Number of Patients Dosed|Overall Study||80
9024458|NCT03154047|10087283|FG000|COMPLETED|Overall Study||0
9024459|NCT03154047|10087283|FG000|NOT COMPLETED|Overall Study||80
9024460|NCT03154086|10087302|FG000|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||2
9024461|NCT03154086|10087303|FG001|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||2
9024462|NCT03154086|10087304|FG002|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||2
9024463|NCT03154086|10087305|FG003|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||2
9024464|NCT03154086|10087306|FG004|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
9024465|NCT03154086|10087307|FG005|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
9024466|NCT03154086|10087308|FG006|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
9024467|NCT03154086|10087309|FG007|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
9024468|NCT03154086|10087310|FG008|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
9024469|NCT03154086|10087311|FG009|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
9024470|NCT03154086|10087312|FG010|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
9024471|NCT03154086|10087313|FG011|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
9024472|NCT03154086|10087314|FG012|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
9024473|NCT03154086|10087315|FG013|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
9024474|NCT03154086|10087316|FG014|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
9024475|NCT03154086|10087302|FG000|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||2
9024476|NCT03154086|10087303|FG001|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||2
9024477|NCT03154086|10087304|FG002|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||2
9024478|NCT03154086|10087305|FG003|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||2
9024479|NCT03154086|10087306|FG004|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
9024480|NCT03154086|10087307|FG005|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8755610|NCT01195025|9804660|FG001|STARTED|Second Intervention B||3
8755611|NCT01195025|9804661|FG002|STARTED|Second Intervention B||2
8755612|NCT01195025|9804662|FG003|STARTED|Second Intervention B||2
8755613|NCT01195025|9804663|FG004|STARTED|Second Intervention B||1
8755614|NCT01195025|9804659|FG000|COMPLETED|Second Intervention B||2
8755615|NCT01195025|9804660|FG001|COMPLETED|Second Intervention B||3
8755616|NCT01195025|9804661|FG002|COMPLETED|Second Intervention B||2
8755617|NCT01195025|9804662|FG003|COMPLETED|Second Intervention B||2
8755618|NCT01195025|9804663|FG004|COMPLETED|Second Intervention B||1
8755619|NCT01195025|9804659|FG000|NOT COMPLETED|Second Intervention B||0
8755620|NCT01195025|9804660|FG001|NOT COMPLETED|Second Intervention B||0
8755621|NCT01195025|9804661|FG002|NOT COMPLETED|Second Intervention B||0
8755622|NCT01195025|9804662|FG003|NOT COMPLETED|Second Intervention B||0
8755623|NCT01195025|9804663|FG004|NOT COMPLETED|Second Intervention B||0
8755624|NCT01195025|9804659|FG000|STARTED|Third Intervention C||2
8755625|NCT01195025|9804660|FG001|STARTED|Third Intervention C||3
8755626|NCT01195025|9804661|FG002|STARTED|Third Intervention C||2
8755627|NCT01195025|9804662|FG003|STARTED|Third Intervention C||2
8755628|NCT01195025|9804663|FG004|STARTED|Third Intervention C||1
8755629|NCT01195025|9804659|FG000|COMPLETED|Third Intervention C||2
8755630|NCT01195025|9804660|FG001|COMPLETED|Third Intervention C||3
8755631|NCT01195025|9804661|FG002|COMPLETED|Third Intervention C||2
8755632|NCT01195025|9804662|FG003|COMPLETED|Third Intervention C||2
8755633|NCT01195025|9804663|FG004|COMPLETED|Third Intervention C||1
8755634|NCT01195025|9804659|FG000|NOT COMPLETED|Third Intervention C||0
8755635|NCT01195025|9804660|FG001|NOT COMPLETED|Third Intervention C||0
8755636|NCT01195025|9804661|FG002|NOT COMPLETED|Third Intervention C||0
8755637|NCT01195025|9804662|FG003|NOT COMPLETED|Third Intervention C||0
8755638|NCT01195025|9804663|FG004|NOT COMPLETED|Third Intervention C||0
8755639|NCT01195090|9804671|FG000|STARTED|Overall Study||60
9024481|NCT03154086|10087308|FG006|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
9024482|NCT03154086|10087309|FG007|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
9024483|NCT03154086|10087310|FG008|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
9024484|NCT03154086|10087311|FG009|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
9024485|NCT03154086|10087312|FG010|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
9024486|NCT03154086|10087313|FG011|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
9024487|NCT03154086|10087314|FG012|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
9024488|NCT03154086|10087315|FG013|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
9024489|NCT03154086|10087316|FG014|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
9024490|NCT03154086|10087302|FG000|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8670966|NCT00749515|9714403|FG001|COMPLETED|Overall Study||5
8670967|NCT00749515|9714402|FG000|NOT COMPLETED|Overall Study||0
8670968|NCT00749515|9714403|FG001|NOT COMPLETED|Overall Study||0
8670969|NCT00749580|9714411|FG000|STARTED|Overall Study|September 2008|21
8670970|NCT00749580|9714412|FG001|STARTED|Overall Study||25
8670971|NCT00749580|9714411|FG000|COMPLETED|Overall Study|December 2010|17
8670972|NCT00749580|9714412|FG001|COMPLETED|Overall Study||16
8670973|NCT00749580|9714411|FG000|NOT COMPLETED|Overall Study||4
8670974|NCT00749580|9714412|FG001|NOT COMPLETED|Overall Study||9
8670975|NCT00749606|9714420|FG000|STARTED|Year 1||129
8670976|NCT00749606|9714421|FG001|STARTED|Year 1||128
8670977|NCT00749606|9714420|FG000|COMPLETED|Year 1||74
8670978|NCT00749606|9714421|FG001|COMPLETED|Year 1||80
8670979|NCT00749606|9714420|FG000|NOT COMPLETED|Year 1||55
8670980|NCT00749606|9714421|FG001|NOT COMPLETED|Year 1||48
8670981|NCT00749606|9714420|FG000|STARTED|Year 2||74
8670982|NCT00749606|9714421|FG001|STARTED|Year 2||80
8670983|NCT00749606|9714420|FG000|COMPLETED|Year 2||63
8670984|NCT00749606|9714421|FG001|COMPLETED|Year 2||72
8670985|NCT00749606|9714420|FG000|NOT COMPLETED|Year 2||11
8670986|NCT00749606|9714421|FG001|NOT COMPLETED|Year 2||8
8670987|NCT00749606|9714420|FG000|STARTED|Year 3 (Observation)||63
8670988|NCT00749606|9714421|FG001|STARTED|Year 3 (Observation)||72
8670989|NCT00749606|9714420|FG000|COMPLETED|Year 3 (Observation)||63
8670990|NCT00749606|9714421|FG001|COMPLETED|Year 3 (Observation)||69
8670991|NCT00749606|9714420|FG000|NOT COMPLETED|Year 3 (Observation)||0
8670992|NCT00749606|9714421|FG001|NOT COMPLETED|Year 3 (Observation)||3
8670993|NCT00749671|9714431|FG000|STARTED|Overall Study||11
8670994|NCT00749671|9714432|FG001|STARTED|Overall Study||9
8670995|NCT00749671|9714431|FG000|COMPLETED|Overall Study||11
8670996|NCT00749671|9714432|FG001|COMPLETED|Overall Study||9
8670997|NCT00749671|9714431|FG000|NOT COMPLETED|Overall Study||0
8670998|NCT00749671|9714432|FG001|NOT COMPLETED|Overall Study||0
8670999|NCT00749684|9714440|FG000|STARTED|Overall Study||138
8671000|NCT00749684|9714440|FG000|COMPLETED|Overall Study||56
8671001|NCT00749684|9714440|FG000|NOT COMPLETED|Overall Study||82
8671002|NCT00749749|9714446|FG000|STARTED|Overall Study||14
8671003|NCT00749749|9714447|FG001|STARTED|Overall Study||13
8671004|NCT00749749|9714446|FG000|COMPLETED|Overall Study||14
8671005|NCT00749749|9714447|FG001|COMPLETED|Overall Study||13
8671006|NCT00749749|9714446|FG000|NOT COMPLETED|Overall Study||0
8671007|NCT00749749|9714447|FG001|NOT COMPLETED|Overall Study||0
8671008|NCT00749775|9714453|FG000|STARTED|Overall Study||3317
8671009|NCT00749775|9714453|FG000|COMPLETED|Overall Study||3210
8671010|NCT00749775|9714453|FG000|NOT COMPLETED|Overall Study||107
8671011|NCT00749879|9714467|FG000|STARTED|Overall Study||12
8671012|NCT00749879|9714467|FG000|COMPLETED|Overall Study||12
8671013|NCT00749879|9714467|FG000|NOT COMPLETED|Overall Study||0
8671014|NCT00749892|9714479|FG000|STARTED|Overall Study||34
8671015|NCT00749892|9714479|FG000|COMPLETED|Overall Study||31
8671016|NCT00749892|9714479|FG000|NOT COMPLETED|Overall Study||3
8671017|NCT00749931|9714485|FG000|STARTED|Overall Study||298
8671018|NCT00749931|9714486|FG001|STARTED|Overall Study||298
8671019|NCT00749931|9714487|FG002|STARTED|Overall Study||68
8671020|NCT00749931|9714485|FG000|COMPLETED|Overall Study||298
8755640|NCT01195090|9804672|FG001|STARTED|Overall Study||60
8755641|NCT01195090|9804671|FG000|COMPLETED|Overall Study||54
8755642|NCT01195090|9804672|FG001|COMPLETED|Overall Study||52
8755643|NCT01195090|9804671|FG000|NOT COMPLETED|Overall Study||6
8755644|NCT01195090|9804672|FG001|NOT COMPLETED|Overall Study||8
8755645|NCT01195103|9804681|FG000|STARTED|Overall Study||6
8755646|NCT01195103|9804682|FG001|STARTED|Overall Study||2
8755647|NCT01195103|9804683|FG002|STARTED|Overall Study||5
8755648|NCT01195103|9804681|FG000|COMPLETED|Overall Study|One patient withdrew after randomization but before received study drug.|5
8755649|NCT01195103|9804682|FG001|COMPLETED|Overall Study||2
8755650|NCT01195103|9804683|FG002|COMPLETED|Overall Study||5
8755651|NCT01195103|9804681|FG000|NOT COMPLETED|Overall Study||1
8755652|NCT01195103|9804682|FG001|NOT COMPLETED|Overall Study||0
8755653|NCT01195103|9804683|FG002|NOT COMPLETED|Overall Study||0
8755654|NCT01195116|9804693|FG000|STARTED|Overall Study||21
8755655|NCT01195116|9804694|FG001|STARTED|Overall Study||20
8755656|NCT01195116|9804693|FG000|COMPLETED|Overall Study||21
8755657|NCT01195116|9804694|FG001|COMPLETED|Overall Study||20
8755658|NCT01195116|9804693|FG000|NOT COMPLETED|Overall Study||0
8755659|NCT01195116|9804694|FG001|NOT COMPLETED|Overall Study||0
8755660|NCT01195272|9804700|FG000|STARTED|Overall Study||21
8755661|NCT01195272|9804700|FG000|COMPLETED|Overall Study||17
8755662|NCT01195272|9804700|FG000|NOT COMPLETED|Overall Study||4
8755663|NCT01195363|9804706|FG000|STARTED|Overall Study||15
8755664|NCT01195363|9804707|FG001|STARTED|Overall Study||13
8755665|NCT01195363|9804706|FG000|COMPLETED|Overall Study||4
8755666|NCT01195363|9804707|FG001|COMPLETED|Overall Study||4
8755667|NCT01195363|9804706|FG000|NOT COMPLETED|Overall Study||11
8755668|NCT01195363|9804707|FG001|NOT COMPLETED|Overall Study||9
8755669|NCT01195415|9804713|FG000|STARTED|Overall Study||25
8755670|NCT01195415|9804713|FG000|COMPLETED|Overall Study||23
8755671|NCT01195415|9804713|FG000|NOT COMPLETED|Overall Study||2
8755672|NCT01195467|9804717|FG000|STARTED|Overall Study||40
8755673|NCT01195467|9804717|FG000|COMPLETED|Overall Study||30
8755674|NCT01195467|9804717|FG000|NOT COMPLETED|Overall Study||10
8755675|NCT01195545|9804721|FG000|STARTED|Overall Study||20
8755676|NCT01195545|9804721|FG000|COMPLETED|Overall Study||16
8755677|NCT01195545|9804721|FG000|NOT COMPLETED|Overall Study||4
8755678|NCT01195584|9804728|FG000|STARTED|Overall Study||20
8755679|NCT01195584|9804729|FG001|STARTED|Overall Study||25
8755680|NCT01195584|9804730|FG002|STARTED|Overall Study||27
8755681|NCT01195584|9804728|FG000|COMPLETED|Overall Study||20
8755682|NCT01195584|9804729|FG001|COMPLETED|Overall Study||25
8755683|NCT01195584|9804730|FG002|COMPLETED|Overall Study||27
8755684|NCT01195584|9804728|FG000|NOT COMPLETED|Overall Study||0
8755685|NCT01195584|9804729|FG001|NOT COMPLETED|Overall Study||0
8755686|NCT01195584|9804730|FG002|NOT COMPLETED|Overall Study||0
8755687|NCT01195597|9804740|FG000|STARTED|Overall Study||40
8755688|NCT01195597|9804740|FG000|COMPLETED|Overall Study||27
8755689|NCT01195597|9804740|FG000|NOT COMPLETED|Overall Study||13
8755690|NCT01195623|9804746|FG000|STARTED|Overall Study|166 legs total operated|148
8755691|NCT01195623|9804747|FG001|STARTED|Overall Study|177 legs total operated|145
8755692|NCT01195623|9804746|FG000|COMPLETED|Overall Study|127 legs|113
8755693|NCT01195623|9804747|FG001|COMPLETED|Overall Study|129 legs|108
8755694|NCT01195623|9804746|FG000|NOT COMPLETED|Overall Study||35
8755695|NCT01195623|9804747|FG001|NOT COMPLETED|Overall Study||37
8755696|NCT01195636|9804755|FG000|STARTED|First Intervention (3 Weeks)||35
8755697|NCT01195636|9804756|FG001|STARTED|First Intervention (3 Weeks)||35
8755698|NCT01195636|9804755|FG000|Received at Least 1 Dose of Drug|First Intervention (3 Weeks)||33
8755699|NCT01195636|9804756|FG001|Received at Least 1 Dose of Drug|First Intervention (3 Weeks)||35
8755700|NCT01195636|9804755|FG000|COMPLETED|First Intervention (3 Weeks)||30
8755701|NCT01195636|9804756|FG001|COMPLETED|First Intervention (3 Weeks)||32
8755702|NCT01195636|9804755|FG000|NOT COMPLETED|First Intervention (3 Weeks)||5
8755703|NCT01195636|9804756|FG001|NOT COMPLETED|First Intervention (3 Weeks)||3
8755704|NCT01195636|9804755|FG000|STARTED|Washout Period (2 Weeks)||30
8755705|NCT01195636|9804756|FG001|STARTED|Washout Period (2 Weeks)||32
8755706|NCT01195636|9804755|FG000|COMPLETED|Washout Period (2 Weeks)||28
8755707|NCT01195636|9804756|FG001|COMPLETED|Washout Period (2 Weeks)||29
8755708|NCT01195636|9804755|FG000|NOT COMPLETED|Washout Period (2 Weeks)||2
8755709|NCT01195636|9804756|FG001|NOT COMPLETED|Washout Period (2 Weeks)||3
8755710|NCT01195636|9804755|FG000|STARTED|Second Intervention (3 Weeks)||28
8755711|NCT01195636|9804756|FG001|STARTED|Second Intervention (3 Weeks)||29
8755712|NCT01195636|9804755|FG000|COMPLETED|Second Intervention (3 Weeks)||27
8755713|NCT01195636|9804756|FG001|COMPLETED|Second Intervention (3 Weeks)||27
8755714|NCT01195636|9804755|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||1
8755715|NCT01195636|9804756|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||2
8755716|NCT01195662|9804765|FG000|STARTED|Double Blind Treatment Period||224
8755717|NCT01195662|9804766|FG001|STARTED|Double Blind Treatment Period||225
8755718|NCT01195662|9804767|FG002|STARTED|Double Blind Treatment Period||133
8755719|NCT01195662|9804765|FG000|COMPLETED|Double Blind Treatment Period||202
8755720|NCT01195662|9804766|FG001|COMPLETED|Double Blind Treatment Period||211
8755721|NCT01195662|9804767|FG002|COMPLETED|Double Blind Treatment Period||119
8755722|NCT01195662|9804765|FG000|NOT COMPLETED|Double Blind Treatment Period||22
8755723|NCT01195662|9804766|FG001|NOT COMPLETED|Double Blind Treatment Period||14
8755724|NCT01195662|9804767|FG002|NOT COMPLETED|Double Blind Treatment Period||14
8808066|NCT01489527|9860473|FG000|NOT COMPLETED|Overall Study||22
8755725|NCT01195662|9804765|FG000|STARTED|Follow-Up(Week 13/1 Week Post Last Dose)|1 participant discontinued drug but remained in study and entered Follow-Up.|203
8755726|NCT01195662|9804766|FG001|STARTED|Follow-Up(Week 13/1 Week Post Last Dose)|2 participants completed treatment period but chose not to enter follow up period.|209
8755727|NCT01195662|9804767|FG002|STARTED|Follow-Up(Week 13/1 Week Post Last Dose)|1 participant discontinued drug but remained in the study and entered the follow up period.|120
8755728|NCT01195662|9804765|FG000|COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||200
8755729|NCT01195662|9804766|FG001|COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||209
8755730|NCT01195662|9804767|FG002|COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||119
8755731|NCT01195662|9804765|FG000|NOT COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||3
8755732|NCT01195662|9804766|FG001|NOT COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||0
8755733|NCT01195662|9804767|FG002|NOT COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||1
8755734|NCT01195675|9804776|FG000|STARTED|Overall Study||30
8755735|NCT01195675|9804776|FG000|Received Empa 25mg|Overall Study||28
8755736|NCT01195675|9804776|FG000|Received Empa 200mg|Overall Study||30
8755737|NCT01195675|9804776|FG000|Received Moxifloxacin|Overall Study||29
8755738|NCT01195675|9804776|FG000|Received Placebo 1|Overall Study||29
8755739|NCT01195675|9804776|FG000|Received Placebo 2|Overall Study||28
8755740|NCT01195675|9804776|FG000|COMPLETED|Overall Study||27
8755741|NCT01195675|9804776|FG000|NOT COMPLETED|Overall Study||3
8755742|NCT01195701|9804793|FG000|STARTED|Overall Study||10
8755743|NCT01195701|9804794|FG001|STARTED|Overall Study||25
8755744|NCT01195701|9804793|FG000|COMPLETED|Overall Study||10
8755745|NCT01195701|9804794|FG001|COMPLETED|Overall Study||20
8755746|NCT01195701|9804793|FG000|NOT COMPLETED|Overall Study||0
8755747|NCT01195701|9804794|FG001|NOT COMPLETED|Overall Study||5
8755748|NCT01195779|9804814|FG000|STARTED|Overall Study||0
8755749|NCT01195779|9804815|FG001|STARTED|Overall Study||0
8755750|NCT01195779|9804816|FG002|STARTED|Overall Study||0
8755751|NCT01195779|9804817|FG003|STARTED|Overall Study||0
8755752|NCT01195779|9804818|FG004|STARTED|Overall Study||1
8755753|NCT01195779|9804819|FG005|STARTED|Overall Study||0
8755754|NCT01195779|9804820|FG006|STARTED|Overall Study||0
8755755|NCT01195779|9804821|FG007|STARTED|Overall Study||1
8755756|NCT01195779|9804822|FG008|STARTED|Overall Study||0
8755757|NCT01195779|9804823|FG009|STARTED|Overall Study||0
8755758|NCT01195779|9804824|FG010|STARTED|Overall Study||0
8755759|NCT01195779|9804825|FG011|STARTED|Overall Study||1
8755760|NCT01195779|9804826|FG012|STARTED|Overall Study||0
8755761|NCT01195779|9804827|FG013|STARTED|Overall Study||1
8755762|NCT01195779|9804814|FG000|COMPLETED|Overall Study||0
8755763|NCT01195779|9804815|FG001|COMPLETED|Overall Study||0
8755764|NCT01195779|9804816|FG002|COMPLETED|Overall Study||0
8755765|NCT01195779|9804817|FG003|COMPLETED|Overall Study||0
8755766|NCT01195779|9804818|FG004|COMPLETED|Overall Study||1
8755767|NCT01195779|9804819|FG005|COMPLETED|Overall Study||0
8755768|NCT01195779|9804820|FG006|COMPLETED|Overall Study||0
8755769|NCT01195779|9804821|FG007|COMPLETED|Overall Study||1
8755770|NCT01195779|9804822|FG008|COMPLETED|Overall Study||0
8755771|NCT01195779|9804823|FG009|COMPLETED|Overall Study||0
8755772|NCT01195779|9804824|FG010|COMPLETED|Overall Study||0
8755773|NCT01195779|9804825|FG011|COMPLETED|Overall Study||1
8755774|NCT01195779|9804826|FG012|COMPLETED|Overall Study||0
8755775|NCT01195779|9804827|FG013|COMPLETED|Overall Study||1
8755776|NCT01195779|9804814|FG000|NOT COMPLETED|Overall Study||0
8755777|NCT01195779|9804815|FG001|NOT COMPLETED|Overall Study||0
8755778|NCT01195779|9804816|FG002|NOT COMPLETED|Overall Study||0
8755779|NCT01195779|9804817|FG003|NOT COMPLETED|Overall Study||0
8755780|NCT01195779|9804818|FG004|NOT COMPLETED|Overall Study||0
8755781|NCT01195779|9804819|FG005|NOT COMPLETED|Overall Study||0
8755782|NCT01195779|9804820|FG006|NOT COMPLETED|Overall Study||0
8755783|NCT01195779|9804821|FG007|NOT COMPLETED|Overall Study||0
8755784|NCT01195779|9804822|FG008|NOT COMPLETED|Overall Study||0
8755785|NCT01195779|9804823|FG009|NOT COMPLETED|Overall Study||0
8755786|NCT01195779|9804824|FG010|NOT COMPLETED|Overall Study||0
8755787|NCT01195779|9804825|FG011|NOT COMPLETED|Overall Study||0
8755788|NCT01195779|9804826|FG012|NOT COMPLETED|Overall Study||0
8755789|NCT01195779|9804827|FG013|NOT COMPLETED|Overall Study||0
8755790|NCT01195831|9804859|FG000|STARTED|Overall Study||120
8755791|NCT01195831|9804860|FG001|STARTED|Overall Study||124
8755792|NCT01195831|9804859|FG000|COMPLETED|Overall Study||112
8755793|NCT01195831|9804860|FG001|COMPLETED|Overall Study||114
8755794|NCT01195831|9804859|FG000|NOT COMPLETED|Overall Study||8
8755795|NCT01195831|9804860|FG001|NOT COMPLETED|Overall Study||10
8755796|NCT01195844|9804866|FG000|STARTED|Overall Study||230
8755797|NCT01195844|9804866|FG000|COMPLETED|Overall Study||190
8755798|NCT01195844|9804866|FG000|NOT COMPLETED|Overall Study||40
8755799|NCT01195883|9804882|FG000|STARTED|Overall Study||553
8755800|NCT01195883|9804883|FG001|STARTED|Overall Study||549
8755801|NCT01195883|9804882|FG000|COMPLETED|Overall Study||534
8755802|NCT01195883|9804883|FG001|COMPLETED|Overall Study||523
8755803|NCT01195883|9804882|FG000|NOT COMPLETED|Overall Study||19
8755804|NCT01195883|9804883|FG001|NOT COMPLETED|Overall Study||26
8755805|NCT01195922|9804889|FG000|STARTED|Overall Study||16
8755806|NCT01195922|9804889|FG000|COMPLETED|Overall Study||16
8755807|NCT01195922|9804889|FG000|NOT COMPLETED|Overall Study||0
8755808|NCT01195948|9804896|FG000|STARTED|Overall Study||10
8755809|NCT01195948|9804897|FG001|STARTED|Overall Study||10
8755810|NCT01195948|9804898|FG002|STARTED|Overall Study||11
8755811|NCT01195948|9804896|FG000|Week 24|Overall Study||10
8755812|NCT01195948|9804897|FG001|Week 24|Overall Study||10
8755813|NCT01195948|9804898|FG002|Week 24|Overall Study||10
8755814|NCT01195948|9804896|FG000|COMPLETED|Overall Study||10
8755815|NCT01195948|9804897|FG001|COMPLETED|Overall Study||9
8755816|NCT01195948|9804898|FG002|COMPLETED|Overall Study||9
8755817|NCT01195948|9804896|FG000|NOT COMPLETED|Overall Study||0
8755818|NCT01195948|9804897|FG001|NOT COMPLETED|Overall Study||1
8755819|NCT01195948|9804898|FG002|NOT COMPLETED|Overall Study||2
8755820|NCT01196026|9804915|FG000|STARTED|Overall Study||10
8755821|NCT01196026|9804916|FG001|STARTED|Overall Study||44
8755822|NCT01196026|9804917|FG002|STARTED|Overall Study||23
8755823|NCT01196026|9804918|FG003|STARTED|Overall Study||10
8755824|NCT01196026|9804919|FG004|STARTED|Overall Study||43
8755825|NCT01196026|9804920|FG005|STARTED|Overall Study||24
8755826|NCT01196026|9804915|FG000|Completed at Day 28|Overall Study||9
8755827|NCT01196026|9804916|FG001|Completed at Day 28|Overall Study||41
8755828|NCT01196026|9804917|FG002|Completed at Day 28|Overall Study||23
8755829|NCT01196026|9804918|FG003|Completed at Day 28|Overall Study||10
8755830|NCT01196026|9804919|FG004|Completed at Day 28|Overall Study||42
8755831|NCT01196026|9804920|FG005|Completed at Day 28|Overall Study||24
8755832|NCT01196026|9804915|FG000|COMPLETED|Overall Study||9
8755833|NCT01196026|9804916|FG001|COMPLETED|Overall Study||36
8755834|NCT01196026|9804917|FG002|COMPLETED|Overall Study||23
8755835|NCT01196026|9804918|FG003|COMPLETED|Overall Study||10
8755836|NCT01196026|9804919|FG004|COMPLETED|Overall Study||42
8755837|NCT01196026|9804920|FG005|COMPLETED|Overall Study||24
8755838|NCT01196026|9804915|FG000|NOT COMPLETED|Overall Study||1
8755839|NCT01196026|9804916|FG001|NOT COMPLETED|Overall Study||8
8755840|NCT01196026|9804917|FG002|NOT COMPLETED|Overall Study||0
8755841|NCT01196026|9804918|FG003|NOT COMPLETED|Overall Study||0
8755842|NCT01196026|9804919|FG004|NOT COMPLETED|Overall Study||1
8755843|NCT01196026|9804920|FG005|NOT COMPLETED|Overall Study||0
8755844|NCT01196052|9804936|FG000|STARTED|Overall Study||153
8755845|NCT01196052|9804936|FG000|Received Trastuzumab Emtansine|Overall Study||148
8755846|NCT01196052|9804936|FG000|COMPLETED|Overall Study||130
8755847|NCT01196052|9804936|FG000|NOT COMPLETED|Overall Study||23
8755848|NCT01196078|9804942|FG000|STARTED|Overall Study||57
8755849|NCT01196078|9804943|FG001|STARTED|Overall Study||57
8755850|NCT01196078|9804942|FG000|COMPLETED|Overall Study||24
8755851|NCT01196078|9804943|FG001|COMPLETED|Overall Study||20
8755852|NCT01196078|9804942|FG000|NOT COMPLETED|Overall Study||33
8755853|NCT01196078|9804943|FG001|NOT COMPLETED|Overall Study||37
8755854|NCT01196091|9804952|FG000|STARTED|Overall Study||387
8755855|NCT01196091|9804953|FG001|STARTED|Overall Study||389
8755856|NCT01196091|9804954|FG002|STARTED|Overall Study||388
8755857|NCT01196091|9804952|FG000|Received at Least 1 Dose of Study Drug|Overall Study||386
8755858|NCT01196091|9804953|FG001|Received at Least 1 Dose of Study Drug|Overall Study||389
8755859|NCT01196091|9804954|FG002|Received at Least 1 Dose of Study Drug|Overall Study||387
8755860|NCT01196091|9804952|FG000|ITT-Received Drug and Excluded Sites|Overall Study||381
8755861|NCT01196091|9804953|FG001|ITT-Received Drug and Excluded Sites|Overall Study||378
8755862|NCT01196091|9804954|FG002|ITT-Received Drug and Excluded Sites|Overall Study||379
8755863|NCT01196091|9804952|FG000|Follow-Up|Overall Study||103
8755864|NCT01196091|9804953|FG001|Follow-Up|Overall Study||105
8755865|NCT01196091|9804954|FG002|Follow-Up|Overall Study||128
8755866|NCT01196091|9804952|FG000|COMPLETED|Overall Study||299
8755867|NCT01196091|9804953|FG001|COMPLETED|Overall Study||291
8755868|NCT01196091|9804954|FG002|COMPLETED|Overall Study||284
8755869|NCT01196091|9804952|FG000|NOT COMPLETED|Overall Study||88
8755870|NCT01196091|9804953|FG001|NOT COMPLETED|Overall Study||98
8755871|NCT01196091|9804954|FG002|NOT COMPLETED|Overall Study||104
8755872|NCT01196104|9804969|FG000|STARTED|Overall Study||19
8755873|NCT01196104|9804970|FG001|STARTED|Overall Study||20
8755874|NCT01196104|9804969|FG000|COMPLETED|Overall Study||15
8755875|NCT01196104|9804970|FG001|COMPLETED|Overall Study||15
8755876|NCT01196104|9804969|FG000|NOT COMPLETED|Overall Study||4
8755877|NCT01196104|9804970|FG001|NOT COMPLETED|Overall Study||5
8755878|NCT01196117|9804978|FG000|STARTED|Placebo, Then CPAP||18
8755879|NCT01196117|9804979|FG001|STARTED|Placebo, Then CPAP||0
8755880|NCT01196117|9804978|FG000|COMPLETED|Placebo, Then CPAP||18
8755881|NCT01196117|9804979|FG001|COMPLETED|Placebo, Then CPAP||0
8755882|NCT01196117|9804978|FG000|NOT COMPLETED|Placebo, Then CPAP||0
8755883|NCT01196117|9804979|FG001|NOT COMPLETED|Placebo, Then CPAP||0
8755884|NCT01196117|9804978|FG000|STARTED|CPAP||0
8755885|NCT01196117|9804979|FG001|STARTED|CPAP||18
8755886|NCT01196117|9804978|FG000|COMPLETED|CPAP||0
8755887|NCT01196117|9804979|FG001|COMPLETED|CPAP||18
8755888|NCT01196117|9804978|FG000|NOT COMPLETED|CPAP||0
8755889|NCT01196117|9804979|FG001|NOT COMPLETED|CPAP||0
8755890|NCT01196377|9804993|FG000|STARTED|Overall Study||4
8755891|NCT01196377|9804994|FG001|STARTED|Overall Study||4
8755892|NCT01196377|9804995|FG002|STARTED|Overall Study||4
8755893|NCT01196377|9804996|FG003|STARTED|Overall Study||4
8755894|NCT01196377|9804993|FG000|COMPLETED|Overall Study||4
8755895|NCT01196377|9804994|FG001|COMPLETED|Overall Study||4
8755896|NCT01196377|9804995|FG002|COMPLETED|Overall Study||4
8755897|NCT01196377|9804996|FG003|COMPLETED|Overall Study||4
8755898|NCT01196377|9804993|FG000|NOT COMPLETED|Overall Study||0
8755899|NCT01196377|9804994|FG001|NOT COMPLETED|Overall Study||0
8755900|NCT01196377|9804995|FG002|NOT COMPLETED|Overall Study||0
8755901|NCT01196377|9804996|FG003|NOT COMPLETED|Overall Study||0
8755902|NCT01196416|9805006|FG000|STARTED|Overall Study||14
8755903|NCT01196416|9805006|FG000|COMPLETED|Overall Study||12
8755904|NCT01196416|9805006|FG000|NOT COMPLETED|Overall Study||2
8755905|NCT01196429|9805012|FG000|STARTED|Overall Study||45
8755906|NCT01196429|9805013|FG001|STARTED|Overall Study||45
8755907|NCT01196429|9805012|FG000|COMPLETED|Overall Study||42
8755908|NCT01196429|9805013|FG001|COMPLETED|Overall Study||45
8755909|NCT01196429|9805012|FG000|NOT COMPLETED|Overall Study||3
8755910|NCT01196429|9805013|FG001|NOT COMPLETED|Overall Study||0
8755911|NCT01196442|9805021|FG000|STARTED|Overall Study||39
8755912|NCT01196442|9805021|FG000|COMPLETED|Overall Study||39
8755913|NCT01196442|9805021|FG000|NOT COMPLETED|Overall Study||0
8755914|NCT01196533|9805026|FG000|STARTED|Overall Study||94
8755915|NCT01196533|9805026|FG000|COMPLETED|Overall Study||94
8755916|NCT01196533|9805026|FG000|NOT COMPLETED|Overall Study||0
8755917|NCT01196741|9805032|FG000|STARTED|Overall Study||71
8755918|NCT01196741|9805033|FG001|STARTED|Overall Study||36
8755919|NCT01196741|9805032|FG000|COMPLETED|Overall Study||11
8755920|NCT01196741|9805033|FG001|COMPLETED|Overall Study||8
8755921|NCT01196741|9805032|FG000|NOT COMPLETED|Overall Study||60
8755922|NCT01196741|9805033|FG001|NOT COMPLETED|Overall Study||28
8755923|NCT01196793|9805039|FG000|STARTED|Overall Study||108
8755924|NCT01196793|9805039|FG000|COMPLETED|Overall Study||108
8755925|NCT01196793|9805039|FG000|NOT COMPLETED|Overall Study||0
8755926|NCT01196819|9805045|FG000|STARTED|Overall Study||231
8755927|NCT01196819|9805046|FG001|STARTED|Overall Study||227
8755928|NCT01196819|9805045|FG000|COMPLETED|Overall Study||225
8755929|NCT01196819|9805046|FG001|COMPLETED|Overall Study||227
8915013|NCT02173158|9974629|FG000|NOT COMPLETED|Safety Phase||0
8915014|NCT02173392|9974636|FG000|STARTED|Overall Study||73
8915015|NCT02173392|9974637|FG001|STARTED|Overall Study||72
8915016|NCT02173392|9974636|FG000|COMPLETED|Overall Study||59
8915017|NCT02173392|9974637|FG001|COMPLETED|Overall Study||68
8915018|NCT02173392|9974636|FG000|NOT COMPLETED|Overall Study||14
8915019|NCT02173392|9974637|FG001|NOT COMPLETED|Overall Study||4
8915020|NCT02173522|9974647|FG000|STARTED|Overall Study||4
8915021|NCT02173522|9974648|FG001|STARTED|Overall Study||0
8915022|NCT02173522|9974647|FG000|COMPLETED|Overall Study||4
8915023|NCT02173522|9974648|FG001|COMPLETED|Overall Study||0
8915024|NCT02173522|9974647|FG000|NOT COMPLETED|Overall Study||0
8915025|NCT02173522|9974648|FG001|NOT COMPLETED|Overall Study||0
8915026|NCT02173535|9974672|FG000|STARTED|Period 1||12
8915027|NCT02173535|9974673|FG001|STARTED|Period 1||12
8915028|NCT02173535|9974674|FG002|STARTED|Period 1||12
8915029|NCT02173535|9974675|FG003|STARTED|Period 1||12
8915030|NCT02173535|9974676|FG004|STARTED|Period 1||12
8915031|NCT02173535|9974677|FG005|STARTED|Period 1||12
8915032|NCT02173535|9974678|FG006|STARTED|Period 1||12
8915033|NCT02173535|9974679|FG007|STARTED|Period 1||12
8915034|NCT02173535|9974680|FG008|STARTED|Period 1||12
8915035|NCT02173535|9974681|FG009|STARTED|Period 1||12
8915036|NCT02173535|9974682|FG010|STARTED|Period 1||12
8915037|NCT02173535|9974683|FG011|STARTED|Period 1||12
8915038|NCT02173535|9974684|FG012|STARTED|Period 1||12
8915039|NCT02173535|9974685|FG013|STARTED|Period 1||12
8915040|NCT02173535|9974686|FG014|STARTED|Period 1||12
8915041|NCT02173535|9974687|FG015|STARTED|Period 1||12
8915042|NCT02173535|9974688|FG016|STARTED|Period 1||12
8915043|NCT02173535|9974689|FG017|STARTED|Period 1||12
8915044|NCT02173535|9974690|FG018|STARTED|Period 1||12
8915045|NCT02173535|9974691|FG019|STARTED|Period 1||12
8915046|NCT02173535|9974672|FG000|COMPLETED|Period 1||12
8915047|NCT02173535|9974673|FG001|COMPLETED|Period 1||12
8915048|NCT02173535|9974674|FG002|COMPLETED|Period 1||12
8915049|NCT02173535|9974675|FG003|COMPLETED|Period 1||12
8915050|NCT02173535|9974676|FG004|COMPLETED|Period 1||12
8915051|NCT02173535|9974677|FG005|COMPLETED|Period 1||12
8915052|NCT02173535|9974678|FG006|COMPLETED|Period 1||12
8915053|NCT02173535|9974679|FG007|COMPLETED|Period 1||12
8915054|NCT02173535|9974680|FG008|COMPLETED|Period 1||12
8915055|NCT02173535|9974681|FG009|COMPLETED|Period 1||12
8915056|NCT02173535|9974682|FG010|COMPLETED|Period 1||12
8915057|NCT02173535|9974683|FG011|COMPLETED|Period 1||12
8915058|NCT02173535|9974684|FG012|COMPLETED|Period 1||12
8915059|NCT02173535|9974685|FG013|COMPLETED|Period 1||12
8915060|NCT02173535|9974686|FG014|COMPLETED|Period 1||12
8915061|NCT02173535|9974687|FG015|COMPLETED|Period 1||12
8915062|NCT02173535|9974688|FG016|COMPLETED|Period 1||12
8915063|NCT02173535|9974689|FG017|COMPLETED|Period 1||12
8915064|NCT02173535|9974690|FG018|COMPLETED|Period 1||12
8915065|NCT02173535|9974691|FG019|COMPLETED|Period 1||12
8755930|NCT01196819|9805045|FG000|NOT COMPLETED|Overall Study||6
8755931|NCT01196819|9805046|FG001|NOT COMPLETED|Overall Study||0
8755932|NCT01196871|9805058|FG000|STARTED|Stage 1: Period 1||5
8755933|NCT01196871|9805059|FG001|STARTED|Stage 1: Period 1||3
8915066|NCT02173535|9974672|FG000|NOT COMPLETED|Period 1||0
8915067|NCT02173535|9974673|FG001|NOT COMPLETED|Period 1||0
8915068|NCT02173535|9974674|FG002|NOT COMPLETED|Period 1||0
8915069|NCT02173535|9974675|FG003|NOT COMPLETED|Period 1||0
8915070|NCT02173535|9974676|FG004|NOT COMPLETED|Period 1||0
8915071|NCT02173535|9974677|FG005|NOT COMPLETED|Period 1||0
8915072|NCT02173535|9974678|FG006|NOT COMPLETED|Period 1||0
8915073|NCT02173535|9974679|FG007|NOT COMPLETED|Period 1||0
8915074|NCT02173535|9974680|FG008|NOT COMPLETED|Period 1||0
8915075|NCT02173535|9974681|FG009|NOT COMPLETED|Period 1||0
8915076|NCT02173535|9974682|FG010|NOT COMPLETED|Period 1||0
8915077|NCT02173535|9974683|FG011|NOT COMPLETED|Period 1||0
8915078|NCT02173535|9974684|FG012|NOT COMPLETED|Period 1||0
8755934|NCT01196871|9805060|FG002|STARTED|Stage 1: Period 1||4
8755935|NCT01196871|9805061|FG003|STARTED|Stage 1: Period 1|Zero participants noted since these participants started in Stage 2|0
8755936|NCT01196871|9805062|FG004|STARTED|Stage 1: Period 1|Zero participants noted since these participants started in Stage 2|0
8755937|NCT01196871|9805063|FG005|STARTED|Stage 1: Period 1|Zero participants noted since these participants started in Stage 2|0
8755938|NCT01196871|9805058|FG000|PK Population|Stage 1: Period 1||5
8755939|NCT01196871|9805059|FG001|PK Population|Stage 1: Period 1||3
8755940|NCT01196871|9805060|FG002|PK Population|Stage 1: Period 1||4
8755941|NCT01196871|9805061|FG003|PK Population|Stage 1: Period 1||0
8755942|NCT01196871|9805062|FG004|PK Population|Stage 1: Period 1||0
8755943|NCT01196871|9805063|FG005|PK Population|Stage 1: Period 1||0
8755944|NCT01196871|9805058|FG000|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||5
8755945|NCT01196871|9805059|FG001|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||3
8755946|NCT01196871|9805060|FG002|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||4
8755947|NCT01196871|9805061|FG003|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||0
8755948|NCT01196871|9805062|FG004|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||0
8755949|NCT01196871|9805063|FG005|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||0
8755950|NCT01196871|9805058|FG000|COMPLETED|Stage 1: Period 1||5
8755951|NCT01196871|9805059|FG001|COMPLETED|Stage 1: Period 1||3
8755952|NCT01196871|9805060|FG002|COMPLETED|Stage 1: Period 1||4
8755953|NCT01196871|9805061|FG003|COMPLETED|Stage 1: Period 1||0
8755954|NCT01196871|9805062|FG004|COMPLETED|Stage 1: Period 1||0
8755955|NCT01196871|9805063|FG005|COMPLETED|Stage 1: Period 1||0
8755956|NCT01196871|9805058|FG000|NOT COMPLETED|Stage 1: Period 1||0
8755957|NCT01196871|9805059|FG001|NOT COMPLETED|Stage 1: Period 1||0
8755958|NCT01196871|9805060|FG002|NOT COMPLETED|Stage 1: Period 1||0
8755959|NCT01196871|9805061|FG003|NOT COMPLETED|Stage 1: Period 1||0
8755960|NCT01196871|9805062|FG004|NOT COMPLETED|Stage 1: Period 1||0
8755961|NCT01196871|9805063|FG005|NOT COMPLETED|Stage 1: Period 1||0
8755962|NCT01196871|9805058|FG000|STARTED|Stage 1: Period 2||5
8755963|NCT01196871|9805059|FG001|STARTED|Stage 1: Period 2||3
8755964|NCT01196871|9805060|FG002|STARTED|Stage 1: Period 2||4
8755965|NCT01196871|9805061|FG003|STARTED|Stage 1: Period 2|Zero participants noted since these participants started in Stage 2|0
8755966|NCT01196871|9805062|FG004|STARTED|Stage 1: Period 2|Zero participants noted since these participants started in Stage 2|0
8755967|NCT01196871|9805063|FG005|STARTED|Stage 1: Period 2|Zero participants noted since these participants started in Stage 2|0
8755968|NCT01196871|9805058|FG000|PK Population|Stage 1: Period 2||5
8755969|NCT01196871|9805059|FG001|PK Population|Stage 1: Period 2||3
8755970|NCT01196871|9805060|FG002|PK Population|Stage 1: Period 2||4
8755971|NCT01196871|9805061|FG003|PK Population|Stage 1: Period 2||0
8755972|NCT01196871|9805062|FG004|PK Population|Stage 1: Period 2||0
8755973|NCT01196871|9805063|FG005|PK Population|Stage 1: Period 2||0
8755974|NCT01196871|9805058|FG000|COMPLETED|Stage 1: Period 2||5
8755975|NCT01196871|9805059|FG001|COMPLETED|Stage 1: Period 2||3
8755976|NCT01196871|9805060|FG002|COMPLETED|Stage 1: Period 2||4
8755977|NCT01196871|9805061|FG003|COMPLETED|Stage 1: Period 2||0
8755978|NCT01196871|9805062|FG004|COMPLETED|Stage 1: Period 2||0
8755979|NCT01196871|9805063|FG005|COMPLETED|Stage 1: Period 2||0
8755980|NCT01196871|9805058|FG000|NOT COMPLETED|Stage 1: Period 2||0
8755981|NCT01196871|9805059|FG001|NOT COMPLETED|Stage 1: Period 2||0
8755982|NCT01196871|9805060|FG002|NOT COMPLETED|Stage 1: Period 2||0
8755983|NCT01196871|9805061|FG003|NOT COMPLETED|Stage 1: Period 2||0
8755984|NCT01196871|9805062|FG004|NOT COMPLETED|Stage 1: Period 2||0
8755985|NCT01196871|9805063|FG005|NOT COMPLETED|Stage 1: Period 2||0
8755986|NCT01196871|9805058|FG000|STARTED|Stage 1: Period 3||5
8755987|NCT01196871|9805059|FG001|STARTED|Stage 1: Period 3||3
8755988|NCT01196871|9805060|FG002|STARTED|Stage 1: Period 3||4
8755989|NCT01196871|9805061|FG003|STARTED|Stage 1: Period 3|Zero participants noted since these participants started in Stage 2|0
8755990|NCT01196871|9805062|FG004|STARTED|Stage 1: Period 3|Zero participants noted since these participants started in Stage 2|0
8755991|NCT01196871|9805063|FG005|STARTED|Stage 1: Period 3|Zero participants noted since these participants started in Stage 2|0
8755992|NCT01196871|9805058|FG000|COMPLETED|Stage 1: Period 3||5
8755993|NCT01196871|9805059|FG001|COMPLETED|Stage 1: Period 3||3
8755994|NCT01196871|9805060|FG002|COMPLETED|Stage 1: Period 3||4
8755995|NCT01196871|9805061|FG003|COMPLETED|Stage 1: Period 3||0
8755996|NCT01196871|9805062|FG004|COMPLETED|Stage 1: Period 3||0
8755997|NCT01196871|9805063|FG005|COMPLETED|Stage 1: Period 3||0
8755998|NCT01196871|9805058|FG000|NOT COMPLETED|Stage 1: Period 3||0
8755999|NCT01196871|9805059|FG001|NOT COMPLETED|Stage 1: Period 3||0
8756000|NCT01196871|9805060|FG002|NOT COMPLETED|Stage 1: Period 3||0
8756001|NCT01196871|9805061|FG003|NOT COMPLETED|Stage 1: Period 3||0
8756002|NCT01196871|9805062|FG004|NOT COMPLETED|Stage 1: Period 3||0
8756003|NCT01196871|9805063|FG005|NOT COMPLETED|Stage 1: Period 3||0
8756004|NCT01196871|9805058|FG000|STARTED|Stage 2: Period 1|Zero participants noted because participants had completed Stage 1|0
8756005|NCT01196871|9805059|FG001|STARTED|Stage 2: Period 1|Zero participants noted because participants had completed Stage 1|0
8756006|NCT01196871|9805060|FG002|STARTED|Stage 2: Period 1|Zero participants noted because participants had completed Stage 1|0
8756007|NCT01196871|9805061|FG003|STARTED|Stage 2: Period 1|Both participants re-enrolled into Stage 2 after completing Stage 1|2
8756008|NCT01196871|9805062|FG004|STARTED|Stage 2: Period 1|One participant re-enrolled into Stage 2 after completing Stage 1|5
8756009|NCT01196871|9805063|FG005|STARTED|Stage 2: Period 1||4
8756010|NCT01196871|9805058|FG000|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||0
8756011|NCT01196871|9805059|FG001|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||0
8756012|NCT01196871|9805060|FG002|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||0
8756013|NCT01196871|9805061|FG003|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||2
8756014|NCT01196871|9805062|FG004|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||5
8756015|NCT01196871|9805063|FG005|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||4
8756016|NCT01196871|9805058|FG000|PK Population|Stage 2: Period 1||0
8756017|NCT01196871|9805059|FG001|PK Population|Stage 2: Period 1||0
8756018|NCT01196871|9805060|FG002|PK Population|Stage 2: Period 1||0
8756019|NCT01196871|9805061|FG003|PK Population|Stage 2: Period 1||1
8756020|NCT01196871|9805062|FG004|PK Population|Stage 2: Period 1||5
8756021|NCT01196871|9805063|FG005|PK Population|Stage 2: Period 1||4
8756022|NCT01196871|9805058|FG000|COMPLETED|Stage 2: Period 1||0
8756023|NCT01196871|9805059|FG001|COMPLETED|Stage 2: Period 1||0
8756024|NCT01196871|9805060|FG002|COMPLETED|Stage 2: Period 1||0
8756025|NCT01196871|9805061|FG003|COMPLETED|Stage 2: Period 1||2
8756026|NCT01196871|9805062|FG004|COMPLETED|Stage 2: Period 1||5
8756027|NCT01196871|9805063|FG005|COMPLETED|Stage 2: Period 1||4
8756028|NCT01196871|9805058|FG000|NOT COMPLETED|Stage 2: Period 1||0
8756029|NCT01196871|9805059|FG001|NOT COMPLETED|Stage 2: Period 1||0
8756030|NCT01196871|9805060|FG002|NOT COMPLETED|Stage 2: Period 1||0
8756031|NCT01196871|9805061|FG003|NOT COMPLETED|Stage 2: Period 1||0
8756032|NCT01196871|9805062|FG004|NOT COMPLETED|Stage 2: Period 1||0
8756033|NCT01196871|9805063|FG005|NOT COMPLETED|Stage 2: Period 1||0
8756034|NCT01196871|9805058|FG000|STARTED|Stage 2: Period 2|Zero participants noted because participants had completed Stage 1|0
8756035|NCT01196871|9805059|FG001|STARTED|Stage 2: Period 2|Zero participants noted because participants had completed Stage 1|0
8756036|NCT01196871|9805060|FG002|STARTED|Stage 2: Period 2|Zero participants noted because participants had completed Stage 1|0
8756037|NCT01196871|9805061|FG003|STARTED|Stage 2: Period 2|One participant switched agalsidase dose from 0.5 mg/kg in Period 1 to 1.0 mg/kg in Period 2|1
8756038|NCT01196871|9805062|FG004|STARTED|Stage 2: Period 2|One participant switched agalsidase dose from 0.5 mg/kg in Period 1 to 1.0 mg/kg in Period 2|6
8756039|NCT01196871|9805063|FG005|STARTED|Stage 2: Period 2||4
8756040|NCT01196871|9805058|FG000|PK Population|Stage 2: Period 2||0
8756041|NCT01196871|9805059|FG001|PK Population|Stage 2: Period 2||0
8756042|NCT01196871|9805060|FG002|PK Population|Stage 2: Period 2||0
8756043|NCT01196871|9805061|FG003|PK Population|Stage 2: Period 2||1
8756044|NCT01196871|9805062|FG004|PK Population|Stage 2: Period 2||6
8756045|NCT01196871|9805063|FG005|PK Population|Stage 2: Period 2||4
8756046|NCT01196871|9805058|FG000|COMPLETED|Stage 2: Period 2||0
8756047|NCT01196871|9805059|FG001|COMPLETED|Stage 2: Period 2||0
8756048|NCT01196871|9805060|FG002|COMPLETED|Stage 2: Period 2||0
8756049|NCT01196871|9805061|FG003|COMPLETED|Stage 2: Period 2||1
8756050|NCT01196871|9805062|FG004|COMPLETED|Stage 2: Period 2||6
9024491|NCT03154086|10087303|FG001|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
9024492|NCT03154086|10087304|FG002|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
9024493|NCT03154086|10087305|FG003|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
9024494|NCT03154086|10087306|FG004|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
9024495|NCT03154086|10087307|FG005|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
9024496|NCT03154086|10087308|FG006|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
9024497|NCT03154086|10087309|FG007|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
9024498|NCT03154086|10087310|FG008|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
9024499|NCT03154086|10087311|FG009|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
9024500|NCT03154086|10087312|FG010|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
9024501|NCT03154086|10087313|FG011|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
9024502|NCT03154086|10087314|FG012|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
9024503|NCT03154086|10087315|FG013|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
9024504|NCT03154086|10087316|FG014|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
9024505|NCT03154086|10087302|FG000|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
9024506|NCT03154086|10087303|FG001|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
9024507|NCT03154086|10087304|FG002|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
9024508|NCT03154086|10087305|FG003|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
9024509|NCT03154086|10087306|FG004|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
9024510|NCT03154086|10087307|FG005|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
9024511|NCT03154086|10087308|FG006|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
9024512|NCT03154086|10087309|FG007|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
9024513|NCT03154086|10087310|FG008|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
9024514|NCT03154086|10087311|FG009|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
9024515|NCT03154086|10087312|FG010|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
9024516|NCT03154086|10087313|FG011|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
9024517|NCT03154086|10087314|FG012|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
9024518|NCT03154086|10087315|FG013|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
9024519|NCT03154086|10087316|FG014|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
9024520|NCT03154086|10087302|FG000|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
9024521|NCT03154086|10087303|FG001|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
9024522|NCT03154086|10087304|FG002|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
9024523|NCT03154086|10087305|FG003|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||1
9024524|NCT03154086|10087306|FG004|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
8756051|NCT01196871|9805063|FG005|COMPLETED|Stage 2: Period 2||4
8756052|NCT01196871|9805058|FG000|NOT COMPLETED|Stage 2: Period 2||0
8756053|NCT01196871|9805059|FG001|NOT COMPLETED|Stage 2: Period 2||0
8756054|NCT01196871|9805060|FG002|NOT COMPLETED|Stage 2: Period 2||0
8756055|NCT01196871|9805061|FG003|NOT COMPLETED|Stage 2: Period 2||0
8756056|NCT01196871|9805062|FG004|NOT COMPLETED|Stage 2: Period 2||0
8756057|NCT01196871|9805063|FG005|NOT COMPLETED|Stage 2: Period 2||0
8756058|NCT01196923|9805086|FG000|STARTED|Overall Study||20
8756059|NCT01196923|9805086|FG000|COMPLETED|Overall Study||20
8756060|NCT01196923|9805086|FG000|NOT COMPLETED|Overall Study||0
8756061|NCT01196975|9805095|FG000|STARTED|Overall Study||423
8756062|NCT01196975|9805096|FG001|STARTED|Overall Study||424
8756063|NCT01196975|9805097|FG002|STARTED|Overall Study||425
8756064|NCT01196975|9805098|FG003|STARTED|Overall Study||213
8756065|NCT01196975|9805099|FG004|STARTED|Overall Study||218
8756066|NCT01196975|9805095|FG000|COMPLETED|Overall Study||408
8756067|NCT01196975|9805096|FG001|COMPLETED|Overall Study||415
8756068|NCT01196975|9805097|FG002|COMPLETED|Overall Study||420
8756069|NCT01196975|9805098|FG003|COMPLETED|Overall Study||207
8756070|NCT01196975|9805099|FG004|COMPLETED|Overall Study||205
8756071|NCT01196975|9805095|FG000|NOT COMPLETED|Overall Study||15
8756072|NCT01196975|9805096|FG001|NOT COMPLETED|Overall Study||9
8756073|NCT01196975|9805097|FG002|NOT COMPLETED|Overall Study||5
8756074|NCT01196975|9805098|FG003|NOT COMPLETED|Overall Study||6
8756075|NCT01196975|9805099|FG004|NOT COMPLETED|Overall Study||13
8756076|NCT01196988|9805138|FG000|STARTED|Overall Study||915
8756077|NCT01196988|9805139|FG001|STARTED|Overall Study||912
8756078|NCT01196988|9805140|FG002|STARTED|Overall Study||911
8756079|NCT01196988|9805141|FG003|STARTED|Overall Study||277
8756080|NCT01196988|9805138|FG000|COMPLETED|Overall Study||891
8756081|NCT01196988|9805139|FG001|COMPLETED|Overall Study||880
8756082|NCT01196988|9805140|FG002|COMPLETED|Overall Study||886
8756083|NCT01196988|9805141|FG003|COMPLETED|Overall Study||276
8756084|NCT01196988|9805138|FG000|NOT COMPLETED|Overall Study||24
8756085|NCT01196988|9805139|FG001|NOT COMPLETED|Overall Study||32
8756086|NCT01196988|9805140|FG002|NOT COMPLETED|Overall Study||25
8756087|NCT01196988|9805141|FG003|NOT COMPLETED|Overall Study||1
8756088|NCT01197300|9805154|FG000|STARTED|Overall Study||10
8756089|NCT01197300|9805155|FG001|STARTED|Overall Study||15
8756090|NCT01197300|9805154|FG000|COMPLETED|Overall Study||10
8756091|NCT01197300|9805155|FG001|COMPLETED|Overall Study||13
8756092|NCT01197300|9805154|FG000|NOT COMPLETED|Overall Study||0
8756093|NCT01197300|9805155|FG001|NOT COMPLETED|Overall Study||2
8808067|NCT01489527|9860474|FG001|NOT COMPLETED|Overall Study||26
8808068|NCT01489579|9860482|FG000|STARTED|Overall Study||56
8808069|NCT01489579|9860483|FG001|STARTED|Overall Study||64
8808070|NCT01489579|9860482|FG000|COMPLETED|Overall Study||47
8808071|NCT01489579|9860483|FG001|COMPLETED|Overall Study||57
8808072|NCT01489579|9860482|FG000|NOT COMPLETED|Overall Study||9
8808073|NCT01489579|9860483|FG001|NOT COMPLETED|Overall Study||7
8808074|NCT01489670|9860491|FG000|STARTED|Overall Study||387
8808075|NCT01489670|9860491|FG000|COMPLETED|Overall Study||334
8808076|NCT01489670|9860491|FG000|NOT COMPLETED|Overall Study||53
8808077|NCT01489826|9860504|FG000|STARTED|Overall Study||3
8808078|NCT01489826|9860505|FG001|STARTED|Overall Study||3
8808079|NCT01489826|9860506|FG002|STARTED|Overall Study||3
8808080|NCT01489826|9860507|FG003|STARTED|Overall Study||7
8808081|NCT01489826|9860508|FG004|STARTED|Overall Study||3
8808082|NCT01489826|9860509|FG005|STARTED|Overall Study||3
8808083|NCT01489826|9860510|FG006|STARTED|Overall Study||9
8808084|NCT01489826|9860511|FG007|STARTED|Overall Study||3
8808085|NCT01489826|9860512|FG008|STARTED|Overall Study||6
8808086|NCT01489826|9860504|FG000|COMPLETED|Overall Study||3
8808087|NCT01489826|9860505|FG001|COMPLETED|Overall Study||3
8808088|NCT01489826|9860506|FG002|COMPLETED|Overall Study||3
8808089|NCT01489826|9860507|FG003|COMPLETED|Overall Study||7
8808090|NCT01489826|9860508|FG004|COMPLETED|Overall Study||3
8808091|NCT01489826|9860509|FG005|COMPLETED|Overall Study||3
8808092|NCT01489826|9860510|FG006|COMPLETED|Overall Study||9
8808093|NCT01489826|9860511|FG007|COMPLETED|Overall Study||3
8808094|NCT01489826|9860512|FG008|COMPLETED|Overall Study||6
8808095|NCT01489826|9860504|FG000|NOT COMPLETED|Overall Study||0
8808096|NCT01489826|9860505|FG001|NOT COMPLETED|Overall Study||0
8808097|NCT01489826|9860506|FG002|NOT COMPLETED|Overall Study||0
8808098|NCT01489826|9860507|FG003|NOT COMPLETED|Overall Study||0
8808099|NCT01489826|9860508|FG004|NOT COMPLETED|Overall Study||0
8808100|NCT01489826|9860509|FG005|NOT COMPLETED|Overall Study||0
8808101|NCT01489826|9860510|FG006|NOT COMPLETED|Overall Study||0
8808102|NCT01489826|9860511|FG007|NOT COMPLETED|Overall Study||0
8808103|NCT01489826|9860512|FG008|NOT COMPLETED|Overall Study||0
8808104|NCT01489891|9860542|FG000|STARTED|Overall Study||60
8808105|NCT01489891|9860543|FG001|STARTED|Overall Study||60
8808106|NCT01489891|9860542|FG000|COMPLETED|Overall Study||59
8808107|NCT01489891|9860543|FG001|COMPLETED|Overall Study||60
8808108|NCT01489891|9860542|FG000|NOT COMPLETED|Overall Study||1
8808109|NCT01489891|9860543|FG001|NOT COMPLETED|Overall Study||0
8808110|NCT01489956|9860551|FG000|STARTED|Overall Study|Ten of the 13 participants were considered evaluable.|13
8808111|NCT01489956|9860552|FG001|STARTED|Overall Study|Nine of the 10 participants receiving Immucothel alone had a response, so Montanide was not used.|0
8808112|NCT01489956|9860553|FG002|STARTED|Overall Study|These 6 subjects had Immucothel alone since Montanide was not needed for the 10 participants dosed.|6
8808113|NCT01489956|9860551|FG000|COMPLETED|Overall Study||12
8808114|NCT01489956|9860552|FG001|COMPLETED|Overall Study||0
8756094|NCT01197326|9805163|FG000|STARTED|Overall Study||205
8756095|NCT01197326|9805164|FG001|STARTED|Overall Study||209
8756096|NCT01197326|9805163|FG000|COMPLETED|Overall Study||205
8756097|NCT01197326|9805164|FG001|COMPLETED|Overall Study||209
8756098|NCT01197326|9805163|FG000|NOT COMPLETED|Overall Study||0
8756099|NCT01197326|9805164|FG001|NOT COMPLETED|Overall Study||0
8756100|NCT01197378|9805172|FG000|STARTED|Overall Study||60
8756101|NCT01197378|9805172|FG000|Received Treatment|Overall Study||59
8756102|NCT01197378|9805172|FG000|COMPLETED|Overall Study||53
8756103|NCT01197378|9805172|FG000|NOT COMPLETED|Overall Study||7
8756104|NCT01197417|9805178|FG000|STARTED|Overall Study||104
8756105|NCT01197417|9805179|FG001|STARTED|Overall Study||104
8756106|NCT01197417|9805178|FG000|Received Study Drug|Overall Study||101
8756107|NCT01197417|9805179|FG001|Received Study Drug|Overall Study||103
8756108|NCT01197417|9805178|FG000|COMPLETED|Overall Study||96
9024525|NCT03154086|10087307|FG005|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
9024526|NCT03154086|10087308|FG006|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
9024527|NCT03154086|10087309|FG007|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
9024528|NCT03154086|10087310|FG008|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
9024529|NCT03154086|10087311|FG009|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
9024530|NCT03154086|10087312|FG010|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
9024531|NCT03154086|10087313|FG011|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
9024532|NCT03154086|10087314|FG012|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
9024533|NCT03154086|10087315|FG013|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
9024534|NCT03154086|10087316|FG014|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
9024535|NCT03154086|10087302|FG000|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
9024536|NCT03154086|10087303|FG001|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
9024537|NCT03154086|10087304|FG002|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
9024538|NCT03154086|10087305|FG003|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||1
9024539|NCT03154086|10087306|FG004|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
9024540|NCT03154086|10087307|FG005|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
9024541|NCT03154086|10087308|FG006|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
9024542|NCT03154086|10087309|FG007|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
9024543|NCT03154086|10087310|FG008|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
9024544|NCT03154086|10087311|FG009|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
9024545|NCT03154086|10087312|FG010|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
9024546|NCT03154086|10087313|FG011|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
9024547|NCT03154086|10087314|FG012|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
9024548|NCT03154086|10087315|FG013|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
9024549|NCT03154086|10087316|FG014|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
9024550|NCT03154086|10087302|FG000|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||2
9024551|NCT03154086|10087303|FG001|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||2
9024552|NCT03154086|10087304|FG002|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||2
9024553|NCT03154086|10087305|FG003|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)|One replacement participant (par) was enrolled and dosed|2
9024554|NCT03154086|10087306|FG004|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
9024555|NCT03154086|10087307|FG005|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
9024556|NCT03154086|10087308|FG006|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
9024557|NCT03154086|10087309|FG007|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
9024558|NCT03154086|10087310|FG008|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
9024559|NCT03154086|10087311|FG009|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
9024560|NCT03154086|10087312|FG010|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
9024561|NCT03154086|10087313|FG011|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
9024562|NCT03154086|10087314|FG012|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
9024563|NCT03154086|10087315|FG013|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
9024564|NCT03154086|10087316|FG014|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
9024565|NCT03154086|10087302|FG000|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||2
9024566|NCT03154086|10087303|FG001|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||2
9024567|NCT03154086|10087304|FG002|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||2
9024568|NCT03154086|10087305|FG003|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||2
9024569|NCT03154086|10087306|FG004|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
9024570|NCT03154086|10087307|FG005|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
9024571|NCT03154086|10087308|FG006|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
9024572|NCT03154086|10087309|FG007|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
9024573|NCT03154086|10087310|FG008|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
9024574|NCT03154086|10087311|FG009|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
9024575|NCT03154086|10087312|FG010|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
9024576|NCT03154086|10087313|FG011|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
9024577|NCT03154086|10087314|FG012|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
9024578|NCT03154086|10087315|FG013|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
9024579|NCT03154086|10087316|FG014|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
9024580|NCT03154086|10087302|FG000|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
9024581|NCT03154086|10087303|FG001|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8577610|NCT00159874|9610372|FG005|Treated|Overall Study||23
8756109|NCT01197417|9805179|FG001|COMPLETED|Overall Study||86
8756110|NCT01197417|9805178|FG000|NOT COMPLETED|Overall Study||8
8756111|NCT01197417|9805179|FG001|NOT COMPLETED|Overall Study||18
8756112|NCT01197456|9805187|FG000|STARTED|Overall Study||171
8756113|NCT01197456|9805188|FG001|STARTED|Overall Study||61
8756114|NCT01197456|9805187|FG000|COMPLETED|Overall Study||171
8756115|NCT01197456|9805188|FG001|COMPLETED|Overall Study||61
8756116|NCT01197456|9805187|FG000|NOT COMPLETED|Overall Study||0
8756117|NCT01197456|9805188|FG001|NOT COMPLETED|Overall Study||0
8756118|NCT01197495|9805196|FG000|STARTED|Overall Study||157
8756119|NCT01197495|9805197|FG001|STARTED|Overall Study||56
8756120|NCT01197495|9805196|FG000|COMPLETED|Overall Study||144
8756121|NCT01197495|9805197|FG001|COMPLETED|Overall Study||49
8756122|NCT01197495|9805196|FG000|NOT COMPLETED|Overall Study||13
8756123|NCT01197495|9805197|FG001|NOT COMPLETED|Overall Study||7
8756124|NCT01197508|9805207|FG000|STARTED|Overall Study||174
8756125|NCT01197508|9805208|FG001|STARTED|Overall Study||174
8756126|NCT01197508|9805209|FG002|STARTED|Overall Study||174
8756127|NCT01197508|9805210|FG003|STARTED|Overall Study||174
8756128|NCT01197508|9805207|FG000|Received Treatment|Overall Study||174
8756129|NCT01197508|9805208|FG001|Received Treatment|Overall Study||174
8756130|NCT01197508|9805209|FG002|Received Treatment|Overall Study||171
8756131|NCT01197508|9805210|FG003|Received Treatment|Overall Study||174
8756132|NCT01197508|9805207|FG000|COMPLETED|Overall Study||151
8756133|NCT01197508|9805208|FG001|COMPLETED|Overall Study||144
8756134|NCT01197508|9805209|FG002|COMPLETED|Overall Study||125
8756135|NCT01197508|9805210|FG003|COMPLETED|Overall Study||158
8756136|NCT01197508|9805207|FG000|NOT COMPLETED|Overall Study||23
8756137|NCT01197508|9805208|FG001|NOT COMPLETED|Overall Study||30
8756138|NCT01197508|9805209|FG002|NOT COMPLETED|Overall Study||49
8756139|NCT01197508|9805210|FG003|NOT COMPLETED|Overall Study||16
8756140|NCT01197521|9805223|FG000|STARTED|Overall Study|Patients who received treatment|310
8756141|NCT01197521|9805224|FG001|STARTED|Overall Study|Patients who received treatment|304
8756142|NCT01197521|9805225|FG002|STARTED|Overall Study|Patients who received treatment|304
8756143|NCT01197521|9805223|FG000|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled|1
8756144|NCT01197521|9805224|FG001|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/other|2
8756145|NCT01197521|9805225|FG002|Randomised But Did Not Receive Treatment|Overall Study|Adverse event/eligibility criteria not fulfilled|2
8756146|NCT01197521|9805223|FG000|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|207
8756147|NCT01197521|9805224|FG001|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|191
8756148|NCT01197521|9805225|FG002|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|161
8756149|NCT01197521|9805223|FG000|NOT COMPLETED|Overall Study||103
8756150|NCT01197521|9805224|FG001|NOT COMPLETED|Overall Study||113
8756151|NCT01197521|9805225|FG002|NOT COMPLETED|Overall Study||143
8756152|NCT01197534|9805239|FG000|STARTED|Overall Study|Patients who received treatment|308
8756153|NCT01197534|9805240|FG001|STARTED|Overall Study|Patients who received treatment|298
8756154|NCT01197534|9805241|FG002|STARTED|Overall Study|Patients who received treatment|302
8756155|NCT01197534|9805239|FG000|Randomised But Did Not Receive Treatment|Overall Study||0
8756156|NCT01197534|9805240|FG001|Randomised But Did Not Receive Treatment|Overall Study|Adverse event / Other|2
8756157|NCT01197534|9805241|FG002|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled / Severe non-compliance to protocol|3
8756158|NCT01197534|9805239|FG000|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|174
8756159|NCT01197534|9805240|FG001|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|168
8756160|NCT01197534|9805241|FG002|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|129
8756161|NCT01197534|9805239|FG000|NOT COMPLETED|Overall Study||134
8756162|NCT01197534|9805240|FG001|NOT COMPLETED|Overall Study||130
8756163|NCT01197534|9805241|FG002|NOT COMPLETED|Overall Study||173
8756164|NCT01197547|9805252|FG000|STARTED|Overall Study||1014
8756165|NCT01197547|9805252|FG000|COMPLETED|Overall Study|992 Intent-To-Treat (ITT) 931 evaluable subjects|992
8756166|NCT01197547|9805252|FG000|NOT COMPLETED|Overall Study||22
8756167|NCT01197560|9805258|FG000|STARTED|Overall Study|This is the intent to treat population|54
8756168|NCT01197560|9805259|FG001|STARTED|Overall Study|This is the intent to treat population|57
8756169|NCT01197560|9805258|FG000|Received ≥ One Dose Study Drug|Overall Study||54
8756170|NCT01197560|9805259|FG001|Received ≥ One Dose Study Drug|Overall Study||55
8756171|NCT01197560|9805258|FG000|Lenalidomide Crossover|Overall Study||0
8756172|NCT01197560|9805259|FG001|Lenalidomide Crossover|Overall Study||29
8756173|NCT01197560|9805258|FG000|Discontinued Treatment After ≥ 6 Cycles|Overall Study||14
8756174|NCT01197560|9805259|FG001|Discontinued Treatment After ≥ 6 Cycles|Overall Study||0
8756175|NCT01197560|9805258|FG000|COMPLETED|Overall Study||0
8756176|NCT01197560|9805259|FG001|COMPLETED|Overall Study||4
8756177|NCT01197560|9805258|FG000|NOT COMPLETED|Overall Study||54
8756178|NCT01197560|9805259|FG001|NOT COMPLETED|Overall Study||53
8756179|NCT01197573|9805270|FG000|STARTED|Overall Study||33
8756180|NCT01197573|9805271|FG001|STARTED|Overall Study||46
8756181|NCT01197573|9805272|FG002|STARTED|Overall Study||12
8756182|NCT01197573|9805273|FG003|STARTED|Overall Study||12
8756183|NCT01197573|9805270|FG000|COMPLETED|Overall Study||33
8756184|NCT01197573|9805271|FG001|COMPLETED|Overall Study||46
8756185|NCT01197573|9805272|FG002|COMPLETED|Overall Study||12
8756186|NCT01197573|9805273|FG003|COMPLETED|Overall Study||12
8756187|NCT01197573|9805270|FG000|NOT COMPLETED|Overall Study||0
8756188|NCT01197573|9805271|FG001|NOT COMPLETED|Overall Study||0
8756189|NCT01197573|9805272|FG002|NOT COMPLETED|Overall Study||0
8756190|NCT01197573|9805273|FG003|NOT COMPLETED|Overall Study||0
8756191|NCT01197612|9805283|FG000|STARTED|Overall Study||18
8756192|NCT01197612|9805283|FG000|Week 3|Overall Study||16
8756193|NCT01197612|9805283|FG000|Returned for Week 24|Overall Study||6
8756194|NCT01197612|9805283|FG000|COMPLETED|Overall Study||6
8756195|NCT01197612|9805283|FG000|NOT COMPLETED|Overall Study||12
8756196|NCT01197755|9805293|FG000|STARTED|Overall Study|Patients who received treatment|105
8756197|NCT01197755|9805294|FG001|STARTED|Overall Study|Patients who received treatment|108
8756198|NCT01197755|9805295|FG002|STARTED|Overall Study|Patients who received treatment|109
8756199|NCT01197755|9805293|FG000|Randomised But Did Not Receive Treatment|Overall Study||0
8756200|NCT01197755|9805294|FG001|Randomised But Did Not Receive Treatment|Overall Study||0
8756201|NCT01197755|9805295|FG002|Randomised But Did Not Receive Treatment|Overall Study|Severe non-compliance to the protocol|1
8756202|NCT01197755|9805293|FG000|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|67
8756203|NCT01197755|9805294|FG001|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|65
8756204|NCT01197755|9805295|FG002|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|55
8756205|NCT01197755|9805293|FG000|NOT COMPLETED|Overall Study||38
8756206|NCT01197755|9805294|FG001|NOT COMPLETED|Overall Study||43
8756207|NCT01197755|9805295|FG002|NOT COMPLETED|Overall Study||54
8756208|NCT01197794|9805312|FG000|STARTED|Overall Study||164
8756209|NCT01197794|9805313|FG001|STARTED|Overall Study|Two participants did not receive study treatment|161
8756210|NCT01197794|9805314|FG002|STARTED|Overall Study|Two participants did not receive study treatment|166
8756211|NCT01197794|9805315|FG003|STARTED|Overall Study||164
8756212|NCT01197794|9805316|FG004|STARTED|Overall Study|One participant excluded due to Good Clinical Practice (GCP) violation at centre 4323|163
8756213|NCT01197794|9805317|FG005|STARTED|Overall Study||163
8756214|NCT01197794|9805318|FG006|STARTED|Overall Study|Two participants excluded due to Good Clinical Practice (GCP) violation at centre 4323|163
8756215|NCT01197794|9805312|FG000|COMPLETED|Overall Study||148
8756216|NCT01197794|9805313|FG001|COMPLETED|Overall Study||146
8756217|NCT01197794|9805314|FG002|COMPLETED|Overall Study||153
8756218|NCT01197794|9805315|FG003|COMPLETED|Overall Study||152
8756219|NCT01197794|9805316|FG004|COMPLETED|Overall Study||149
8756220|NCT01197794|9805317|FG005|COMPLETED|Overall Study||144
8756221|NCT01197794|9805318|FG006|COMPLETED|Overall Study||142
8756222|NCT01197794|9805312|FG000|NOT COMPLETED|Overall Study||16
8756223|NCT01197794|9805313|FG001|NOT COMPLETED|Overall Study||15
8756224|NCT01197794|9805314|FG002|NOT COMPLETED|Overall Study||13
8756225|NCT01197794|9805315|FG003|NOT COMPLETED|Overall Study||12
8756226|NCT01197794|9805316|FG004|NOT COMPLETED|Overall Study||14
8756227|NCT01197794|9805317|FG005|NOT COMPLETED|Overall Study||19
8756228|NCT01197794|9805318|FG006|NOT COMPLETED|Overall Study||21
8756229|NCT01197833|9805338|FG000|STARTED|Overall Study||38
8756230|NCT01197833|9805339|FG001|STARTED|Overall Study||39
8756231|NCT01197833|9805340|FG002|STARTED|Overall Study||40
8756232|NCT01197833|9805338|FG000|COMPLETED|Overall Study||38
8756233|NCT01197833|9805339|FG001|COMPLETED|Overall Study||39
8756234|NCT01197833|9805340|FG002|COMPLETED|Overall Study||40
8756235|NCT01197833|9805338|FG000|NOT COMPLETED|Overall Study||0
8756236|NCT01197833|9805339|FG001|NOT COMPLETED|Overall Study||0
8756237|NCT01197833|9805340|FG002|NOT COMPLETED|Overall Study||0
8756238|NCT01197898|9805350|FG000|STARTED|Overall Study||5
8756239|NCT01197898|9805351|FG001|STARTED|Overall Study||5
8756240|NCT01197898|9805350|FG000|COMPLETED|Overall Study||5
8756241|NCT01197898|9805351|FG001|COMPLETED|Overall Study||5
8756242|NCT01197898|9805350|FG000|NOT COMPLETED|Overall Study||0
8756243|NCT01197898|9805351|FG001|NOT COMPLETED|Overall Study||0
8756244|NCT01197911|9805360|FG000|STARTED|Overall Study||18
8756245|NCT01197911|9805361|FG001|STARTED|Overall Study||10
8756246|NCT01197911|9805362|FG002|STARTED|Overall Study||10
8756247|NCT01197911|9805360|FG000|COMPLETED|Overall Study||18
8756248|NCT01197911|9805361|FG001|COMPLETED|Overall Study||10
8756249|NCT01197911|9805362|FG002|COMPLETED|Overall Study||9
8756250|NCT01197911|9805360|FG000|NOT COMPLETED|Overall Study||0
8756251|NCT01197911|9805361|FG001|NOT COMPLETED|Overall Study||0
8756252|NCT01197911|9805362|FG002|NOT COMPLETED|Overall Study||1
8756253|NCT01198002|9805374|FG000|STARTED|Treatment Period 1 (Weeks 0-52)||345
8756254|NCT01198002|9805375|FG001|STARTED|Treatment Period 1 (Weeks 0-52)||347
8756255|NCT01198002|9805376|FG002|STARTED|Treatment Period 1 (Weeks 0-52)||349
8756256|NCT01198002|9805374|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0-52)||345
8756257|NCT01198002|9805375|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0-52)||345
8756258|NCT01198002|9805376|FG002|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0-52)||348
8756259|NCT01198002|9805374|FG000|Week 16 NR|Treatment Period 1 (Weeks 0-52)||58
8756260|NCT01198002|9805375|FG001|Week 16 NR|Treatment Period 1 (Weeks 0-52)||62
8756261|NCT01198002|9805376|FG002|Week 16 NR|Treatment Period 1 (Weeks 0-52)||90
8756262|NCT01198002|9805374|FG000|Post-Treatment Follow-Up Population|Treatment Period 1 (Weeks 0-52)||293
8756263|NCT01198002|9805375|FG001|Post-Treatment Follow-Up Population|Treatment Period 1 (Weeks 0-52)||303
8756264|NCT01198002|9805376|FG002|Post-Treatment Follow-Up Population|Treatment Period 1 (Weeks 0-52)||307
8756265|NCT01198002|9805374|FG000|COMPLETED|Treatment Period 1 (Weeks 0-52)|Those who completed 52-week Treatment Period 1 including both Week 16 responders and NR.|70
8756266|NCT01198002|9805375|FG001|COMPLETED|Treatment Period 1 (Weeks 0-52)|Those who completed 52-week Treatment Period 1 including both Week 16 responders and NR.|73
8756267|NCT01198002|9805376|FG002|COMPLETED|Treatment Period 1 (Weeks 0-52)|Those who completed 52-week Treatment Period 1 including both Week 16 responders and NR.|80
8756268|NCT01198002|9805374|FG000|NOT COMPLETED|Treatment Period 1 (Weeks 0-52)||275
8756269|NCT01198002|9805375|FG001|NOT COMPLETED|Treatment Period 1 (Weeks 0-52)||274
8756270|NCT01198002|9805376|FG002|NOT COMPLETED|Treatment Period 1 (Weeks 0-52)||269
8756271|NCT01198002|9805374|FG000|STARTED|Treatment Period 2 (Weeks 52-100)||70
8756272|NCT01198002|9805375|FG001|STARTED|Treatment Period 2 (Weeks 52-100)||73
8756273|NCT01198002|9805376|FG002|STARTED|Treatment Period 2 (Weeks 52-100)||80
8756274|NCT01198002|9805374|FG000|COMPLETED|Treatment Period 2 (Weeks 52-100)||1
8756275|NCT01198002|9805375|FG001|COMPLETED|Treatment Period 2 (Weeks 52-100)||0
9024582|NCT03154086|10087304|FG002|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
9024583|NCT03154086|10087305|FG003|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
9024584|NCT03154086|10087306|FG004|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
9024585|NCT03154086|10087307|FG005|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
9024586|NCT03154086|10087308|FG006|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
9024587|NCT03154086|10087309|FG007|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
9024588|NCT03154086|10087310|FG008|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
9024589|NCT03154086|10087311|FG009|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
9024590|NCT03154086|10087312|FG010|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
9024591|NCT03154086|10087313|FG011|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
9024592|NCT03154086|10087314|FG012|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
9024593|NCT03154086|10087315|FG013|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
9024594|NCT03154086|10087316|FG014|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
9024595|NCT03154086|10087302|FG000|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
9024596|NCT03154086|10087303|FG001|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
9024597|NCT03154086|10087304|FG002|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
9024598|NCT03154086|10087305|FG003|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
9024599|NCT03154086|10087306|FG004|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
9024600|NCT03154086|10087307|FG005|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
9024601|NCT03154086|10087308|FG006|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
9024602|NCT03154086|10087309|FG007|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
9024603|NCT03154086|10087310|FG008|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
9024604|NCT03154086|10087311|FG009|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
9024605|NCT03154086|10087312|FG010|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
9024606|NCT03154086|10087313|FG011|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
9024607|NCT03154086|10087314|FG012|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
9024608|NCT03154086|10087315|FG013|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
9024609|NCT03154086|10087316|FG014|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
9024610|NCT03154086|10087302|FG000|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
9024611|NCT03154086|10087303|FG001|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||1
9024612|NCT03154086|10087304|FG002|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
9024613|NCT03154086|10087305|FG003|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
9024614|NCT03154086|10087306|FG004|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
9024615|NCT03154086|10087307|FG005|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
9024616|NCT03154086|10087308|FG006|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
9024617|NCT03154086|10087309|FG007|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
9024618|NCT03154086|10087310|FG008|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
9024619|NCT03154086|10087311|FG009|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
9024620|NCT03154086|10087312|FG010|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
9024621|NCT03154086|10087313|FG011|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
9024622|NCT03154086|10087314|FG012|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
9024623|NCT03154086|10087315|FG013|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
9024624|NCT03154086|10087316|FG014|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
9024625|NCT03154086|10087302|FG000|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
9024626|NCT03154086|10087303|FG001|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||1
9024627|NCT03154086|10087304|FG002|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
9024628|NCT03154086|10087305|FG003|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
9024629|NCT03154086|10087306|FG004|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
9024630|NCT03154086|10087307|FG005|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
9024631|NCT03154086|10087308|FG006|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
9024632|NCT03154086|10087309|FG007|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
9024633|NCT03154086|10087310|FG008|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
9024634|NCT03154086|10087311|FG009|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
9024635|NCT03154086|10087312|FG010|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
9024636|NCT03154086|10087313|FG011|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
9024637|NCT03154086|10087314|FG012|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
9024638|NCT03154086|10087315|FG013|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
9024639|NCT03154086|10087316|FG014|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
9024640|NCT03154086|10087302|FG000|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||2
9024641|NCT03154086|10087303|FG001|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)|One replacement par was enrolled and dosed|2
8756276|NCT01198002|9805376|FG002|COMPLETED|Treatment Period 2 (Weeks 52-100)||2
8756277|NCT01198002|9805374|FG000|NOT COMPLETED|Treatment Period 2 (Weeks 52-100)||69
8756278|NCT01198002|9805375|FG001|NOT COMPLETED|Treatment Period 2 (Weeks 52-100)||73
8756279|NCT01198002|9805376|FG002|NOT COMPLETED|Treatment Period 2 (Weeks 52-100)||78
8756280|NCT01198028|9805406|FG000|STARTED|Overall Study||39
8756281|NCT01198028|9805406|FG000|COMPLETED|Overall Study||29
8756282|NCT01198028|9805406|FG000|NOT COMPLETED|Overall Study||10
8756283|NCT01198132|9805412|FG000|STARTED|Overall Study||63
8756284|NCT01198132|9805413|FG001|STARTED|Overall Study||66
8756285|NCT01198132|9805412|FG000|COMPLETED|Overall Study||45
8756286|NCT01198132|9805413|FG001|COMPLETED|Overall Study||45
8756287|NCT01198132|9805412|FG000|NOT COMPLETED|Overall Study||18
8756288|NCT01198132|9805413|FG001|NOT COMPLETED|Overall Study||21
8756289|NCT01198145|9805423|FG000|STARTED|Overall Study||44
8756290|NCT01198145|9805424|FG001|STARTED|Overall Study||43
8756291|NCT01198145|9805423|FG000|COMPLETED|Overall Study||43
8756292|NCT01198145|9805424|FG001|COMPLETED|Overall Study||42
8756293|NCT01198145|9805423|FG000|NOT COMPLETED|Overall Study||1
8756294|NCT01198145|9805424|FG001|NOT COMPLETED|Overall Study||1
8756295|NCT01198158|9805433|FG000|STARTED|Overall Study||41
8756296|NCT01198158|9805434|FG001|STARTED|Overall Study||36
8756297|NCT01198158|9805433|FG000|COMPLETED|Overall Study||41
8756298|NCT01198158|9805434|FG001|COMPLETED|Overall Study||36
8756299|NCT01198158|9805433|FG000|NOT COMPLETED|Overall Study||0
8756300|NCT01198158|9805434|FG001|NOT COMPLETED|Overall Study||0
8756301|NCT01198275|9805442|FG000|STARTED|Overall Study||100
8756302|NCT01198275|9805443|FG001|STARTED|Overall Study||99
8756303|NCT01198275|9805442|FG000|COMPLETED|Overall Study||94
8756304|NCT01198275|9805443|FG001|COMPLETED|Overall Study||94
8756305|NCT01198275|9805442|FG000|NOT COMPLETED|Overall Study||6
8756306|NCT01198275|9805443|FG001|NOT COMPLETED|Overall Study||5
8756307|NCT01198327|9805449|FG000|STARTED|Overall Study||66
8756308|NCT01198327|9805449|FG000|COMPLETED|Overall Study||56
8756309|NCT01198327|9805449|FG000|NOT COMPLETED|Overall Study||10
8756310|NCT01198366|9805462|FG000|STARTED|Overall Study||52
8756311|NCT01198366|9805463|FG001|STARTED|Overall Study||51
8756312|NCT01198366|9805464|FG002|STARTED|Overall Study||51
8756313|NCT01198366|9805465|FG003|STARTED|Overall Study||52
8756314|NCT01198366|9805466|FG004|STARTED|Overall Study||140
8756315|NCT01198366|9805467|FG005|STARTED|Overall Study||141
8756316|NCT01198366|9805462|FG000|COMPLETED|Overall Study||40
8756317|NCT01198366|9805463|FG001|COMPLETED|Overall Study||44
8756318|NCT01198366|9805464|FG002|COMPLETED|Overall Study||43
8756319|NCT01198366|9805465|FG003|COMPLETED|Overall Study||47
8756320|NCT01198366|9805466|FG004|COMPLETED|Overall Study||125
8756321|NCT01198366|9805467|FG005|COMPLETED|Overall Study||128
8756322|NCT01198366|9805462|FG000|NOT COMPLETED|Overall Study||12
8756323|NCT01198366|9805463|FG001|NOT COMPLETED|Overall Study||7
8756324|NCT01198366|9805464|FG002|NOT COMPLETED|Overall Study||8
8756325|NCT01198366|9805465|FG003|NOT COMPLETED|Overall Study||5
8756326|NCT01198366|9805466|FG004|NOT COMPLETED|Overall Study||15
8756327|NCT01198366|9805467|FG005|NOT COMPLETED|Overall Study||13
8756328|NCT01198470|9805481|FG000|STARTED|Overall Study||20
8756329|NCT01198470|9805481|FG000|COMPLETED|Overall Study||18
8756330|NCT01198470|9805481|FG000|NOT COMPLETED|Overall Study||2
8756331|NCT01198509|9805491|FG000|STARTED|Overall Study||5
8756332|NCT01198509|9805492|FG001|STARTED|Overall Study||10
8756333|NCT01198509|9805493|FG002|STARTED|Overall Study||19
8756334|NCT01198509|9805494|FG003|STARTED|Overall Study||66
8756335|NCT01198509|9805495|FG004|STARTED|Overall Study||20
8756336|NCT01198509|9805496|FG005|STARTED|Overall Study||58
8756337|NCT01198509|9805491|FG000|COMPLETED|Overall Study|Patient declined further participation after enrollment and allocation to treatment group|4
8756338|NCT01198509|9805492|FG001|COMPLETED|Overall Study||10
8756339|NCT01198509|9805493|FG002|COMPLETED|Overall Study||19
8756340|NCT01198509|9805494|FG003|COMPLETED|Overall Study||66
8756341|NCT01198509|9805495|FG004|COMPLETED|Overall Study||20
8756342|NCT01198509|9805496|FG005|COMPLETED|Overall Study||58
8756343|NCT01198509|9805491|FG000|NOT COMPLETED|Overall Study||1
9024642|NCT03154086|10087304|FG002|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||2
9024643|NCT03154086|10087305|FG003|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||2
9024644|NCT03154086|10087306|FG004|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
9024645|NCT03154086|10087307|FG005|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
9024646|NCT03154086|10087308|FG006|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
9024647|NCT03154086|10087309|FG007|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
9024648|NCT03154086|10087310|FG008|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
9024649|NCT03154086|10087311|FG009|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
9024650|NCT03154086|10087312|FG010|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
9024651|NCT03154086|10087313|FG011|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8756344|NCT01198509|9805492|FG001|NOT COMPLETED|Overall Study||0
8577611|NCT00159874|9610373|FG006|Treated|Overall Study||5
8756345|NCT01198509|9805493|FG002|NOT COMPLETED|Overall Study||0
8756346|NCT01198509|9805494|FG003|NOT COMPLETED|Overall Study||0
8756347|NCT01198509|9805495|FG004|NOT COMPLETED|Overall Study||0
8756348|NCT01198509|9805496|FG005|NOT COMPLETED|Overall Study||0
8756349|NCT01198574|9805512|FG000|STARTED|Overall Study||98
8756350|NCT01198574|9805513|FG001|STARTED|Overall Study||102
8756351|NCT01198574|9805514|FG002|STARTED|Overall Study||100
8756352|NCT01198574|9805515|FG003|STARTED|Overall Study||102
9024652|NCT03154086|10087314|FG012|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8756353|NCT01198574|9805512|FG000|COMPLETED|Overall Study||94
8756354|NCT01198574|9805513|FG001|COMPLETED|Overall Study||101
8756355|NCT01198574|9805514|FG002|COMPLETED|Overall Study||99
8756356|NCT01198574|9805515|FG003|COMPLETED|Overall Study||98
8756357|NCT01198574|9805512|FG000|NOT COMPLETED|Overall Study||4
8756358|NCT01198574|9805513|FG001|NOT COMPLETED|Overall Study||1
8756359|NCT01198574|9805514|FG002|NOT COMPLETED|Overall Study||1
8756360|NCT01198574|9805515|FG003|NOT COMPLETED|Overall Study||4
8756361|NCT01198587|9805529|FG000|STARTED|Overall Study||31
8756362|NCT01198587|9805530|FG001|STARTED|Overall Study||5
8756363|NCT01198587|9805531|FG002|STARTED|Overall Study||30
8756364|NCT01198587|9805532|FG003|STARTED|Overall Study||5
8756365|NCT01198587|9805529|FG000|COMPLETED|Overall Study||23
8756366|NCT01198587|9805530|FG001|COMPLETED|Overall Study||5
8756367|NCT01198587|9805531|FG002|COMPLETED|Overall Study||21
8756368|NCT01198587|9805532|FG003|COMPLETED|Overall Study||5
8756369|NCT01198587|9805529|FG000|NOT COMPLETED|Overall Study||8
8756370|NCT01198587|9805530|FG001|NOT COMPLETED|Overall Study||0
8756371|NCT01198587|9805531|FG002|NOT COMPLETED|Overall Study||9
8756372|NCT01198587|9805532|FG003|NOT COMPLETED|Overall Study||0
8756373|NCT01198600|9805547|FG000|STARTED|Phase 1: Period One, 30 Days of Wear||35
8756374|NCT01198600|9805548|FG001|STARTED|Phase 1: Period One, 30 Days of Wear||37
8756375|NCT01198600|9805549|FG002|STARTED|Phase 1: Period One, 30 Days of Wear||0
8756376|NCT01198600|9805550|FG003|STARTED|Phase 1: Period One, 30 Days of Wear||0
8756377|NCT01198600|9805547|FG000|COMPLETED|Phase 1: Period One, 30 Days of Wear||33
8756378|NCT01198600|9805548|FG001|COMPLETED|Phase 1: Period One, 30 Days of Wear||36
8756379|NCT01198600|9805549|FG002|COMPLETED|Phase 1: Period One, 30 Days of Wear||0
8756380|NCT01198600|9805550|FG003|COMPLETED|Phase 1: Period One, 30 Days of Wear||0
8756381|NCT01198600|9805547|FG000|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||2
8756382|NCT01198600|9805548|FG001|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||1
8756383|NCT01198600|9805549|FG002|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||0
8756384|NCT01198600|9805550|FG003|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||0
8756385|NCT01198600|9805547|FG000|STARTED|Phase 1: Period Two, 30 Days of Wear|One participant discontinued between Period One and Period Two due to unconvenience.|32
8756386|NCT01198600|9805548|FG001|STARTED|Phase 1: Period Two, 30 Days of Wear||36
8756387|NCT01198600|9805549|FG002|STARTED|Phase 1: Period Two, 30 Days of Wear||0
8756388|NCT01198600|9805550|FG003|STARTED|Phase 1: Period Two, 30 Days of Wear||0
8756389|NCT01198600|9805547|FG000|COMPLETED|Phase 1: Period Two, 30 Days of Wear||32
8756390|NCT01198600|9805548|FG001|COMPLETED|Phase 1: Period Two, 30 Days of Wear||35
8756391|NCT01198600|9805549|FG002|COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
8756392|NCT01198600|9805550|FG003|COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
8756393|NCT01198600|9805547|FG000|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
8756394|NCT01198600|9805548|FG001|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||1
8756395|NCT01198600|9805549|FG002|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
8756396|NCT01198600|9805550|FG003|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
8756397|NCT01198600|9805547|FG000|STARTED|Phase 2: 56 Days of Wear||0
8756398|NCT01198600|9805548|FG001|STARTED|Phase 2: 56 Days of Wear||0
8756399|NCT01198600|9805549|FG002|STARTED|Phase 2: 56 Days of Wear||67
8756400|NCT01198600|9805550|FG003|STARTED|Phase 2: 56 Days of Wear||0
8756401|NCT01198600|9805547|FG000|COMPLETED|Phase 2: 56 Days of Wear||0
8756402|NCT01198600|9805548|FG001|COMPLETED|Phase 2: 56 Days of Wear||0
8756403|NCT01198600|9805549|FG002|COMPLETED|Phase 2: 56 Days of Wear||62
8756404|NCT01198600|9805550|FG003|COMPLETED|Phase 2: 56 Days of Wear||0
8756405|NCT01198600|9805547|FG000|NOT COMPLETED|Phase 2: 56 Days of Wear||0
8915079|NCT02173535|9974685|FG013|NOT COMPLETED|Period 1||0
8915080|NCT02173535|9974686|FG014|NOT COMPLETED|Period 1||0
8915081|NCT02173535|9974687|FG015|NOT COMPLETED|Period 1||0
8915082|NCT02173535|9974688|FG016|NOT COMPLETED|Period 1||0
8915083|NCT02173535|9974689|FG017|NOT COMPLETED|Period 1||0
8915084|NCT02173535|9974690|FG018|NOT COMPLETED|Period 1||0
8915085|NCT02173535|9974691|FG019|NOT COMPLETED|Period 1||0
8915086|NCT02173535|9974672|FG000|STARTED|Period 2||12
8756406|NCT01198600|9805548|FG001|NOT COMPLETED|Phase 2: 56 Days of Wear||0
8756407|NCT01198600|9805549|FG002|NOT COMPLETED|Phase 2: 56 Days of Wear||5
8756408|NCT01198600|9805550|FG003|NOT COMPLETED|Phase 2: 56 Days of Wear||0
8756409|NCT01198600|9805547|FG000|STARTED|Phase 3: 43 Days of Wear||0
8756410|NCT01198600|9805548|FG001|STARTED|Phase 3: 43 Days of Wear||0
8756411|NCT01198600|9805549|FG002|STARTED|Phase 3: 43 Days of Wear||0
8756412|NCT01198600|9805550|FG003|STARTED|Phase 3: 43 Days of Wear||38
8756413|NCT01198600|9805547|FG000|COMPLETED|Phase 3: 43 Days of Wear||0
8756414|NCT01198600|9805548|FG001|COMPLETED|Phase 3: 43 Days of Wear||0
8756415|NCT01198600|9805549|FG002|COMPLETED|Phase 3: 43 Days of Wear||0
8756416|NCT01198600|9805550|FG003|COMPLETED|Phase 3: 43 Days of Wear||38
8756417|NCT01198600|9805547|FG000|NOT COMPLETED|Phase 3: 43 Days of Wear||0
8756418|NCT01198600|9805548|FG001|NOT COMPLETED|Phase 3: 43 Days of Wear||0
8756419|NCT01198600|9805549|FG002|NOT COMPLETED|Phase 3: 43 Days of Wear||0
8756420|NCT01198600|9805550|FG003|NOT COMPLETED|Phase 3: 43 Days of Wear||0
8808115|NCT01489956|9860553|FG002|COMPLETED|Overall Study||5
8808116|NCT01489956|9860551|FG000|NOT COMPLETED|Overall Study||1
8808117|NCT01489956|9860552|FG001|NOT COMPLETED|Overall Study||0
8808118|NCT01489956|9860553|FG002|NOT COMPLETED|Overall Study||1
8808119|NCT01489969|9860564|FG000|STARTED|Overall Study||45
8808120|NCT01489969|9860565|FG001|STARTED|Overall Study||47
8808121|NCT01489969|9860566|FG002|STARTED|Overall Study||45
8915087|NCT02173535|9974673|FG001|STARTED|Period 2||12
8915088|NCT02173535|9974674|FG002|STARTED|Period 2||12
8915089|NCT02173535|9974675|FG003|STARTED|Period 2||12
8915090|NCT02173535|9974676|FG004|STARTED|Period 2||12
8915091|NCT02173535|9974677|FG005|STARTED|Period 2||12
8915092|NCT02173535|9974678|FG006|STARTED|Period 2||12
8915093|NCT02173535|9974679|FG007|STARTED|Period 2||12
8756421|NCT01198691|9805560|FG000|STARTED|Completed Surgery -Received Intervention||50
8756422|NCT01198691|9805561|FG001|STARTED|Completed Surgery -Received Intervention||50
8756423|NCT01198691|9805560|FG000|COMPLETED|Completed Surgery -Received Intervention||50
8756424|NCT01198691|9805561|FG001|COMPLETED|Completed Surgery -Received Intervention||50
8756425|NCT01198691|9805560|FG000|NOT COMPLETED|Completed Surgery -Received Intervention||0
8756426|NCT01198691|9805561|FG001|NOT COMPLETED|Completed Surgery -Received Intervention||0
8756427|NCT01198691|9805560|FG000|STARTED|Completed VAS Score Postop Day 1||50
8756428|NCT01198691|9805561|FG001|STARTED|Completed VAS Score Postop Day 1||50
8756429|NCT01198691|9805560|FG000|COMPLETED|Completed VAS Score Postop Day 1||47
8756430|NCT01198691|9805561|FG001|COMPLETED|Completed VAS Score Postop Day 1||46
8756431|NCT01198691|9805560|FG000|NOT COMPLETED|Completed VAS Score Postop Day 1||3
8756432|NCT01198691|9805561|FG001|NOT COMPLETED|Completed VAS Score Postop Day 1||4
8756433|NCT01198691|9805560|FG000|STARTED|Completed VAS Score at Discharge|Missing a VAS score on postop day one did not exclude participants from having a score at discharge.|50
8756434|NCT01198691|9805561|FG001|STARTED|Completed VAS Score at Discharge|Missing a VAS score on postop day one did not exclude participants from having a score at discharge.|50
8756435|NCT01198691|9805560|FG000|COMPLETED|Completed VAS Score at Discharge||45
8756436|NCT01198691|9805561|FG001|COMPLETED|Completed VAS Score at Discharge||44
8756437|NCT01198691|9805560|FG000|NOT COMPLETED|Completed VAS Score at Discharge||5
8756438|NCT01198691|9805561|FG001|NOT COMPLETED|Completed VAS Score at Discharge||6
8756439|NCT01198691|9805560|FG000|STARTED|Survey Prior to Discharge|Survey was given to all participants even if they were missing data from previous periods.|50
8756440|NCT01198691|9805561|FG001|STARTED|Survey Prior to Discharge|Survey was given to all participants even if they were missing data from previous periods.|50
8756441|NCT01198691|9805560|FG000|COMPLETED|Survey Prior to Discharge||18
8756442|NCT01198691|9805561|FG001|COMPLETED|Survey Prior to Discharge||17
8756443|NCT01198691|9805560|FG000|NOT COMPLETED|Survey Prior to Discharge||32
8756444|NCT01198691|9805561|FG001|NOT COMPLETED|Survey Prior to Discharge||33
8756445|NCT01198691|9805560|FG000|STARTED|6 Week Post-partum Survey|Survey was sent to all participants even if they were missing data from the previous two periods.|50
8756446|NCT01198691|9805561|FG001|STARTED|6 Week Post-partum Survey|Survey was sent to all participants even if they were missing data from the previous two periods.|50
8756447|NCT01198691|9805560|FG000|COMPLETED|6 Week Post-partum Survey||21
8756448|NCT01198691|9805561|FG001|COMPLETED|6 Week Post-partum Survey||26
8756449|NCT01198691|9805560|FG000|NOT COMPLETED|6 Week Post-partum Survey||29
8756450|NCT01198691|9805561|FG001|NOT COMPLETED|6 Week Post-partum Survey||24
8756451|NCT01198756|9805571|FG000|STARTED|Overall Study||932
8756452|NCT01198756|9805572|FG001|STARTED|Overall Study||929
8756453|NCT01198756|9805573|FG002|STARTED|Overall Study||932
8756454|NCT01198756|9805574|FG003|STARTED|Overall Study||301
8756455|NCT01198756|9805571|FG000|COMPLETED|Overall Study||894
8756456|NCT01198756|9805572|FG001|COMPLETED|Overall Study||889
8756457|NCT01198756|9805573|FG002|COMPLETED|Overall Study||902
8756458|NCT01198756|9805574|FG003|COMPLETED|Overall Study||275
8756459|NCT01198756|9805571|FG000|NOT COMPLETED|Overall Study||38
8756460|NCT01198756|9805572|FG001|NOT COMPLETED|Overall Study||40
8756461|NCT01198756|9805573|FG002|NOT COMPLETED|Overall Study||30
8756462|NCT01198756|9805574|FG003|NOT COMPLETED|Overall Study||26
8756463|NCT01198769|9805591|FG000|STARTED|Overall Study||15
8756464|NCT01198769|9805591|FG000|COMPLETED|Overall Study||15
8756465|NCT01198769|9805591|FG000|NOT COMPLETED|Overall Study||0
8756466|NCT01198795|9805595|FG000|STARTED|Overall Study||162
8756467|NCT01198795|9805595|FG000|COMPLETED|Overall Study||80
8756468|NCT01198795|9805595|FG000|NOT COMPLETED|Overall Study||82
8756469|NCT01198873|9805601|FG000|STARTED|Overall Study||41
8756470|NCT01198873|9805602|FG001|STARTED|Overall Study||35
8756471|NCT01198873|9805601|FG000|Treated|Overall Study||41
8756472|NCT01198873|9805602|FG001|Treated|Overall Study||35
8756473|NCT01198873|9805601|FG000|Evaluable for Efficacy|Overall Study|8 participants discontinued before completing 3-month treatment and were not assessed post-baseline|33
8756474|NCT01198873|9805602|FG001|Evaluable for Efficacy|Overall Study|9 participants discontinued before completing 3-month treatment and were not assessed post-baseline|26
8756475|NCT01198873|9805601|FG000|COMPLETED|Overall Study||4
8756476|NCT01198873|9805602|FG001|COMPLETED|Overall Study||3
8756477|NCT01198873|9805601|FG000|NOT COMPLETED|Overall Study||37
8756478|NCT01198873|9805602|FG001|NOT COMPLETED|Overall Study||32
8756479|NCT01198977|9805610|FG000|STARTED|Overall Study||31
8756480|NCT01198977|9805611|FG001|STARTED|Overall Study||33
8756481|NCT01198977|9805610|FG000|COMPLETED|Overall Study||30
8756482|NCT01198977|9805611|FG001|COMPLETED|Overall Study||33
8756483|NCT01198977|9805610|FG000|NOT COMPLETED|Overall Study||1
8756484|NCT01198977|9805611|FG001|NOT COMPLETED|Overall Study||0
8756485|NCT01199016|9805619|FG000|STARTED|Overall Study||239
8756486|NCT01199016|9805619|FG000|Treated|Overall Study||236
8756487|NCT01199016|9805619|FG000|COMPLETED|Overall Study||162
8756488|NCT01199016|9805619|FG000|NOT COMPLETED|Overall Study||77
8756489|NCT01199042|9805623|FG000|STARTED|Sleep Laboratory (3 Nights)||29
8915094|NCT02173535|9974680|FG008|STARTED|Period 2||12
8915095|NCT02173535|9974681|FG009|STARTED|Period 2||12
8915096|NCT02173535|9974682|FG010|STARTED|Period 2||12
8756490|NCT01199042|9805623|FG000|COMPLETED|Sleep Laboratory (3 Nights)||27
8756491|NCT01199042|9805623|FG000|NOT COMPLETED|Sleep Laboratory (3 Nights)||2
8756492|NCT01199042|9805623|FG000|STARTED|At Home (3 Months)||27
8756493|NCT01199042|9805623|FG000|COMPLETED|At Home (3 Months)||26
8756494|NCT01199042|9805623|FG000|NOT COMPLETED|At Home (3 Months)||1
8756495|NCT01199055|9805635|FG000|STARTED|Overall Study||3
8756496|NCT01199055|9805636|FG001|STARTED|Overall Study||4
8756497|NCT01199055|9805637|FG002|STARTED|Overall Study||9
8756498|NCT01199055|9805635|FG000|COMPLETED|Overall Study||1
8756499|NCT01199055|9805636|FG001|COMPLETED|Overall Study||1
8756500|NCT01199055|9805637|FG002|COMPLETED|Overall Study||5
8756501|NCT01199055|9805635|FG000|NOT COMPLETED|Overall Study||2
8756502|NCT01199055|9805636|FG001|NOT COMPLETED|Overall Study||3
8756503|NCT01199055|9805637|FG002|NOT COMPLETED|Overall Study||4
8756504|NCT01199068|9805650|FG000|STARTED|Overall Study||3
8756505|NCT01199068|9805651|FG001|STARTED|Overall Study||3
8756506|NCT01199068|9805652|FG002|STARTED|Overall Study||9
8756507|NCT01199068|9805650|FG000|Received Treatment|Overall Study||3
8756508|NCT01199068|9805651|FG001|Received Treatment|Overall Study||3
8756509|NCT01199068|9805652|FG002|Received Treatment|Overall Study||8
8756510|NCT01199068|9805650|FG000|COMPLETED|Overall Study||0
8756511|NCT01199068|9805651|FG001|COMPLETED|Overall Study||0
8756512|NCT01199068|9805652|FG002|COMPLETED|Overall Study||0
8756513|NCT01199068|9805650|FG000|NOT COMPLETED|Overall Study||3
8756514|NCT01199068|9805651|FG001|NOT COMPLETED|Overall Study||3
8756515|NCT01199068|9805652|FG002|NOT COMPLETED|Overall Study||9
8756516|NCT01199146|9805667|FG000|STARTED|Overall Study||42
8756517|NCT01199146|9805667|FG000|COMPLETED|Overall Study||39
8756518|NCT01199146|9805667|FG000|NOT COMPLETED|Overall Study||3
8756519|NCT01199198|9805673|FG000|STARTED|Overall Study||24
8756520|NCT01199198|9805674|FG001|STARTED|Overall Study||24
8756521|NCT01199198|9805673|FG000|COMPLETED|Overall Study||17
8756522|NCT01199198|9805674|FG001|COMPLETED|Overall Study||13
8756523|NCT01199198|9805673|FG000|NOT COMPLETED|Overall Study||7
8756524|NCT01199198|9805674|FG001|NOT COMPLETED|Overall Study||11
8756525|NCT01199237|9805682|FG000|STARTED|Overall Study||41
8756526|NCT01199237|9805683|FG001|STARTED|Overall Study||40
8756527|NCT01199237|9805682|FG000|COMPLETED|Overall Study||41
8756528|NCT01199237|9805683|FG001|COMPLETED|Overall Study||40
8756529|NCT01199237|9805682|FG000|NOT COMPLETED|Overall Study||0
8756530|NCT01199237|9805683|FG001|NOT COMPLETED|Overall Study||0
8756531|NCT01199263|9805693|FG000|STARTED|Overall Study||54
8756532|NCT01199263|9805694|FG001|STARTED|Overall Study||54
8756533|NCT01199263|9805693|FG000|COMPLETED|Overall Study||48
8756534|NCT01199263|9805694|FG001|COMPLETED|Overall Study||52
8756535|NCT01199263|9805693|FG000|NOT COMPLETED|Overall Study||6
8756536|NCT01199263|9805694|FG001|NOT COMPLETED|Overall Study||2
8756537|NCT01199289|9805706|FG000|STARTED|Overall Study||77
8756538|NCT01199289|9805707|FG001|STARTED|Overall Study||75
8756539|NCT01199289|9805708|FG002|STARTED|Overall Study||76
8756540|NCT01199289|9805709|FG003|STARTED|Overall Study||77
8756541|NCT01199289|9805706|FG000|Participants Who Received Study Treatment|Overall Study||76
8756542|NCT01199289|9805707|FG001|Participants Who Received Study Treatment|Overall Study||74
8756543|NCT01199289|9805708|FG002|Participants Who Received Study Treatment|Overall Study||76
8756544|NCT01199289|9805709|FG003|Participants Who Received Study Treatment|Overall Study||76
8756545|NCT01199289|9805706|FG000|COMPLETED|Overall Study||68
8756546|NCT01199289|9805707|FG001|COMPLETED|Overall Study||68
8756547|NCT01199289|9805708|FG002|COMPLETED|Overall Study||71
8756548|NCT01199289|9805709|FG003|COMPLETED|Overall Study||65
8756549|NCT01199289|9805706|FG000|NOT COMPLETED|Overall Study||9
8756550|NCT01199289|9805707|FG001|NOT COMPLETED|Overall Study||7
8756551|NCT01199289|9805708|FG002|NOT COMPLETED|Overall Study||5
8756552|NCT01199289|9805709|FG003|NOT COMPLETED|Overall Study||12
8756553|NCT01199471|9805722|FG000|STARTED|Overall Study|3 patients who did not meet ASA Physical Status Class 1 - 3 were excluded from all analyses.|4000
8756554|NCT01199471|9805722|FG000|COMPLETED|Overall Study||3994
8756555|NCT01199471|9805722|FG000|NOT COMPLETED|Overall Study||6
8756556|NCT01199575|9805727|FG000|STARTED|Overall Study||30
8756557|NCT01199575|9805727|FG000|COMPLETED|Overall Study||25
8756558|NCT01199575|9805727|FG000|NOT COMPLETED|Overall Study||5
8756559|NCT01199601|9805734|FG000|STARTED|Overall Study|Control Group|422
8756560|NCT01199601|9805735|FG001|STARTED|Overall Study|Intervention Group|422
8756561|NCT01199601|9805734|FG000|COMPLETED|Overall Study||353
8756562|NCT01199601|9805735|FG001|COMPLETED|Overall Study||344
8756563|NCT01199601|9805734|FG000|NOT COMPLETED|Overall Study||69
8756564|NCT01199601|9805735|FG001|NOT COMPLETED|Overall Study||78
8756565|NCT01199705|9805741|FG000|STARTED|IVIG Treatment||25
8756566|NCT01199705|9805741|FG000|COMPLETED|IVIG Treatment||25
8756567|NCT01199705|9805741|FG000|NOT COMPLETED|IVIG Treatment||0
8756568|NCT01199705|9805741|FG000|STARTED|SCIG Treatment (Wash-in/Wash-out)||25
8756569|NCT01199705|9805741|FG000|COMPLETED|SCIG Treatment (Wash-in/Wash-out)||24
8756570|NCT01199705|9805741|FG000|NOT COMPLETED|SCIG Treatment (Wash-in/Wash-out)||1
8756571|NCT01199705|9805741|FG000|STARTED|SCIG Treatment (Efficacy)||24
8756572|NCT01199705|9805741|FG000|COMPLETED|SCIG Treatment (Efficacy)||24
8756573|NCT01199705|9805741|FG000|NOT COMPLETED|SCIG Treatment (Efficacy)||0
8756574|NCT01199731|9805759|FG000|STARTED|Overall Study||9
8756575|NCT01199731|9805760|FG001|STARTED|Overall Study||11
8756576|NCT01199731|9805761|FG002|STARTED|Overall Study||10
8756577|NCT01199731|9805759|FG000|COMPLETED|Overall Study||0
8756578|NCT01199731|9805760|FG001|COMPLETED|Overall Study||0
8756579|NCT01199731|9805761|FG002|COMPLETED|Overall Study||0
8756580|NCT01199731|9805759|FG000|NOT COMPLETED|Overall Study||9
8756581|NCT01199731|9805760|FG001|NOT COMPLETED|Overall Study||11
8756582|NCT01199731|9805761|FG002|NOT COMPLETED|Overall Study||10
8756583|NCT01199744|9805769|FG000|STARTED|Overall Study||1575
8756584|NCT01199744|9805769|FG000|COMPLETED|Overall Study||1575
8756585|NCT01199744|9805769|FG000|NOT COMPLETED|Overall Study||0
8756586|NCT01199822|9805776|FG000|STARTED|Overall Study||3
8756587|NCT01199822|9805777|FG001|STARTED|Overall Study||7
8756588|NCT01199822|9805778|FG002|STARTED|Overall Study||6
8756589|NCT01199822|9805776|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
8756590|NCT01199822|9805777|FG001|Received at Least 1 Dose of Study Drug|Overall Study||7
8756591|NCT01199822|9805778|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
8756592|NCT01199822|9805776|FG000|COMPLETED|Overall Study||3
8756593|NCT01199822|9805777|FG001|COMPLETED|Overall Study||6
8756594|NCT01199822|9805778|FG002|COMPLETED|Overall Study||6
8756595|NCT01199822|9805776|FG000|NOT COMPLETED|Overall Study||0
8756596|NCT01199822|9805777|FG001|NOT COMPLETED|Overall Study||1
8756597|NCT01199822|9805778|FG002|NOT COMPLETED|Overall Study||0
8756598|NCT01199848|9805793|FG000|STARTED|Placebo Arm||29
8756599|NCT01199848|9805793|FG000|COMPLETED|Placebo Arm||21
8756600|NCT01199848|9805793|FG000|NOT COMPLETED|Placebo Arm||8
8756601|NCT01199848|9805793|FG000|STARTED|10g STR Arm||21
8756602|NCT01199848|9805793|FG000|COMPLETED|10g STR Arm||21
8756603|NCT01199848|9805793|FG000|NOT COMPLETED|10g STR Arm||0
8756604|NCT01199848|9805793|FG000|STARTED|20G STRB Arm||21
8756605|NCT01199848|9805793|FG000|COMPLETED|20G STRB Arm||21
8756606|NCT01199848|9805793|FG000|NOT COMPLETED|20G STRB Arm||0
8756607|NCT01199848|9805793|FG000|STARTED|40G STRB Arm||21
8756608|NCT01199848|9805793|FG000|COMPLETED|40G STRB Arm||21
8756609|NCT01199848|9805793|FG000|NOT COMPLETED|40G STRB Arm||0
8756610|NCT01199861|9805805|FG000|STARTED|Overall Study||95
8756611|NCT01199861|9805806|FG001|STARTED|Overall Study||43
8756612|NCT01199861|9805805|FG000|COMPLETED|Overall Study||93
8756613|NCT01199861|9805806|FG001|COMPLETED|Overall Study||43
8756614|NCT01199861|9805805|FG000|NOT COMPLETED|Overall Study||2
8756615|NCT01199861|9805806|FG001|NOT COMPLETED|Overall Study||0
8756616|NCT01199926|9805814|FG000|STARTED|Overall Study||17
8756617|NCT01199926|9805815|FG001|STARTED|Overall Study||17
8756618|NCT01199926|9805814|FG000|COMPLETED|Overall Study||10
8756619|NCT01199926|9805815|FG001|COMPLETED|Overall Study||13
8756620|NCT01199926|9805814|FG000|NOT COMPLETED|Overall Study||7
8756621|NCT01199926|9805815|FG001|NOT COMPLETED|Overall Study||4
8756622|NCT01199939|9805821|FG000|STARTED|Overall Study|Number of enrolled participants|54
8756623|NCT01199939|9805821|FG000|COMPLETED|Overall Study||41
8756624|NCT01199939|9805821|FG000|NOT COMPLETED|Overall Study||13
8756625|NCT01199952|9805827|FG000|STARTED|Overall Study||103
8756626|NCT01199952|9805828|FG001|STARTED|Overall Study||104
8756627|NCT01199952|9805827|FG000|COMPLETED|Overall Study||51
8756628|NCT01199952|9805828|FG001|COMPLETED|Overall Study||59
8756629|NCT01199952|9805827|FG000|NOT COMPLETED|Overall Study||52
8756630|NCT01199952|9805828|FG001|NOT COMPLETED|Overall Study||45
8756631|NCT01199965|9805837|FG000|STARTED|Overall Study||23
8756632|NCT01199965|9805838|FG001|STARTED|Overall Study||24
8756633|NCT01199965|9805837|FG000|COMPLETED|Overall Study||22
8756634|NCT01199965|9805838|FG001|COMPLETED|Overall Study||24
8756635|NCT01199965|9805837|FG000|NOT COMPLETED|Overall Study||1
8756636|NCT01199965|9805838|FG001|NOT COMPLETED|Overall Study||0
8756637|NCT01200030|9805855|FG000|STARTED|Overall Study||12
8756638|NCT01200030|9805856|FG001|STARTED|Overall Study||13
8756639|NCT01200030|9805857|FG002|STARTED|Overall Study||12
8756640|NCT01200030|9805855|FG000|COMPLETED|Overall Study||12
8756641|NCT01200030|9805856|FG001|COMPLETED|Overall Study||13
8756642|NCT01200030|9805857|FG002|COMPLETED|Overall Study||12
8756643|NCT01200030|9805855|FG000|NOT COMPLETED|Overall Study||0
8756644|NCT01200030|9805856|FG001|NOT COMPLETED|Overall Study||0
8756645|NCT01200030|9805857|FG002|NOT COMPLETED|Overall Study||0
8756646|NCT01200069|9805867|FG000|STARTED|Overall Study||8
8756647|NCT01200069|9805868|FG001|STARTED|Overall Study||6
8756648|NCT01200069|9805867|FG000|COMPLETED|Overall Study||8
8756649|NCT01200069|9805868|FG001|COMPLETED|Overall Study||5
8756650|NCT01200069|9805867|FG000|NOT COMPLETED|Overall Study||0
8756651|NCT01200069|9805868|FG001|NOT COMPLETED|Overall Study||1
8756652|NCT01200160|9805917|FG000|STARTED|Overall Study||128
8756653|NCT01200160|9805917|FG000|COMPLETED|Overall Study||66
8756654|NCT01200160|9805917|FG000|NOT COMPLETED|Overall Study||62
8756655|NCT01200238|9805923|FG000|STARTED|Overall Study||7
8756656|NCT01200238|9805924|FG001|STARTED|Overall Study||10
8756657|NCT01200238|9805923|FG000|COMPLETED|Overall Study||0
8756658|NCT01200238|9805924|FG001|COMPLETED|Overall Study||0
8756659|NCT01200238|9805923|FG000|NOT COMPLETED|Overall Study||7
8756660|NCT01200238|9805924|FG001|NOT COMPLETED|Overall Study||10
8756661|NCT01200290|9805930|FG000|STARTED|Treatment Period||18
8756662|NCT01200290|9805930|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||18
8756663|NCT01200290|9805930|FG000|COMPLETED|Treatment Period||17
8756664|NCT01200290|9805930|FG000|NOT COMPLETED|Treatment Period||1
8756665|NCT01200290|9805930|FG000|STARTED|Post-Treatment Follow-Up Period|Participant who discontinued treatment was included in the post-treatment follow-up period.|18
8756666|NCT01200290|9805930|FG000|COMPLETED|Post-Treatment Follow-Up Period||16
8756667|NCT01200290|9805930|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||2
8756668|NCT01200329|9805934|FG000|STARTED|Overall Study||81
8756669|NCT01200329|9805934|FG000|COMPLETED|Overall Study||78
8756670|NCT01200329|9805934|FG000|NOT COMPLETED|Overall Study||3
8756671|NCT01200342|9805938|FG000|STARTED|Overall Study||7
8756672|NCT01200342|9805938|FG000|COMPLETED|Overall Study||6
8756673|NCT01200342|9805938|FG000|NOT COMPLETED|Overall Study||1
8756674|NCT01200355|9805944|FG000|STARTED|Overall Study||58
8756675|NCT01200355|9805945|FG001|STARTED|Overall Study||55
8756676|NCT01200355|9805944|FG000|COMPLETED|Overall Study||51
8756677|NCT01200355|9805945|FG001|COMPLETED|Overall Study||53
8756678|NCT01200355|9805944|FG000|NOT COMPLETED|Overall Study||7
8756679|NCT01200355|9805945|FG001|NOT COMPLETED|Overall Study||2
8756680|NCT01200368|9805954|FG000|STARTED|Infant Series||183
8756681|NCT01200368|9805955|FG001|STARTED|Infant Series||184
8756682|NCT01200368|9805956|FG002|STARTED|Infant Series||184
8756683|NCT01200368|9805954|FG000|Vaccinated Dose 1|Infant Series||183
8756684|NCT01200368|9805955|FG001|Vaccinated Dose 1|Infant Series||183
8756685|NCT01200368|9805956|FG002|Vaccinated Dose 1|Infant Series||183
8756686|NCT01200368|9805954|FG000|Vaccinated Dose 2|Infant Series||183
8756687|NCT01200368|9805955|FG001|Vaccinated Dose 2|Infant Series||182
8756688|NCT01200368|9805956|FG002|Vaccinated Dose 2|Infant Series||183
8756689|NCT01200368|9805954|FG000|Vaccinated Dose 3|Infant Series||181
8756690|NCT01200368|9805955|FG001|Vaccinated Dose 3|Infant Series||178
8756691|NCT01200368|9805956|FG002|Vaccinated Dose 3|Infant Series||182
8756692|NCT01200368|9805954|FG000|COMPLETED|Infant Series||180
8756693|NCT01200368|9805955|FG001|COMPLETED|Infant Series||178
8915097|NCT02173535|9974683|FG011|STARTED|Period 2||12
8915098|NCT02173535|9974684|FG012|STARTED|Period 2||12
8915099|NCT02173535|9974685|FG013|STARTED|Period 2||12
8915100|NCT02173535|9974686|FG014|STARTED|Period 2||12
8915101|NCT02173535|9974687|FG015|STARTED|Period 2||12
8915102|NCT02173535|9974688|FG016|STARTED|Period 2||12
8915103|NCT02173535|9974689|FG017|STARTED|Period 2||12
8915104|NCT02173535|9974690|FG018|STARTED|Period 2||12
8915105|NCT02173535|9974691|FG019|STARTED|Period 2||12
8915106|NCT02173535|9974672|FG000|COMPLETED|Period 2||12
8915107|NCT02173535|9974673|FG001|COMPLETED|Period 2||12
8915108|NCT02173535|9974674|FG002|COMPLETED|Period 2||12
8915109|NCT02173535|9974675|FG003|COMPLETED|Period 2||12
8915110|NCT02173535|9974676|FG004|COMPLETED|Period 2||12
8915111|NCT02173535|9974677|FG005|COMPLETED|Period 2||12
8915112|NCT02173535|9974678|FG006|COMPLETED|Period 2||12
8915113|NCT02173535|9974679|FG007|COMPLETED|Period 2||12
8915114|NCT02173535|9974680|FG008|COMPLETED|Period 2||12
8915115|NCT02173535|9974681|FG009|COMPLETED|Period 2||12
8915116|NCT02173535|9974682|FG010|COMPLETED|Period 2||12
8915117|NCT02173535|9974683|FG011|COMPLETED|Period 2||12
8915118|NCT02173535|9974684|FG012|COMPLETED|Period 2||12
8915119|NCT02173535|9974685|FG013|COMPLETED|Period 2||12
8915120|NCT02173535|9974686|FG014|COMPLETED|Period 2||12
8915121|NCT02173535|9974687|FG015|COMPLETED|Period 2||12
8915122|NCT02173535|9974688|FG016|COMPLETED|Period 2||12
8915123|NCT02173535|9974689|FG017|COMPLETED|Period 2||12
8915124|NCT02173535|9974690|FG018|COMPLETED|Period 2||12
8915125|NCT02173535|9974691|FG019|COMPLETED|Period 2||12
8915126|NCT02173535|9974672|FG000|NOT COMPLETED|Period 2||0
8915127|NCT02173535|9974673|FG001|NOT COMPLETED|Period 2||0
8915128|NCT02173535|9974674|FG002|NOT COMPLETED|Period 2||0
8915129|NCT02173535|9974675|FG003|NOT COMPLETED|Period 2||0
8915130|NCT02173535|9974676|FG004|NOT COMPLETED|Period 2||0
8756694|NCT01200368|9805956|FG002|COMPLETED|Infant Series||178
8756695|NCT01200368|9805954|FG000|NOT COMPLETED|Infant Series||3
8756696|NCT01200368|9805955|FG001|NOT COMPLETED|Infant Series||6
8756697|NCT01200368|9805956|FG002|NOT COMPLETED|Infant Series||6
8756698|NCT01200368|9805954|FG000|STARTED|After Infant Series||180
8756699|NCT01200368|9805955|FG001|STARTED|After Infant Series||178
8756700|NCT01200368|9805956|FG002|STARTED|After Infant Series||178
8756701|NCT01200368|9805954|FG000|COMPLETED|After Infant Series||162
8756702|NCT01200368|9805955|FG001|COMPLETED|After Infant Series||162
8756703|NCT01200368|9805956|FG002|COMPLETED|After Infant Series||169
8756704|NCT01200368|9805954|FG000|NOT COMPLETED|After Infant Series||18
8756705|NCT01200368|9805955|FG001|NOT COMPLETED|After Infant Series||16
8756706|NCT01200368|9805956|FG002|NOT COMPLETED|After Infant Series||9
8756707|NCT01200368|9805954|FG000|STARTED|Toddler Dose||162
8756708|NCT01200368|9805955|FG001|STARTED|Toddler Dose||162
8756709|NCT01200368|9805956|FG002|STARTED|Toddler Dose||169
8756710|NCT01200368|9805954|FG000|COMPLETED|Toddler Dose||162
8756711|NCT01200368|9805955|FG001|COMPLETED|Toddler Dose||159
8756712|NCT01200368|9805956|FG002|COMPLETED|Toddler Dose||168
8756713|NCT01200368|9805954|FG000|NOT COMPLETED|Toddler Dose||0
8756714|NCT01200368|9805955|FG001|NOT COMPLETED|Toddler Dose||3
8756715|NCT01200368|9805956|FG002|NOT COMPLETED|Toddler Dose||1
8756716|NCT01200394|9805973|FG000|STARTED|Overall Study||64
8756717|NCT01200394|9805974|FG001|STARTED|Overall Study||192
8756718|NCT01200394|9805973|FG000|COMPLETED|Overall Study||62
8756719|NCT01200394|9805974|FG001|COMPLETED|Overall Study||164
8756720|NCT01200394|9805973|FG000|NOT COMPLETED|Overall Study||2
8915131|NCT02173535|9974677|FG005|NOT COMPLETED|Period 2||0
8915132|NCT02173535|9974678|FG006|NOT COMPLETED|Period 2||0
8915133|NCT02173535|9974679|FG007|NOT COMPLETED|Period 2||0
8915134|NCT02173535|9974680|FG008|NOT COMPLETED|Period 2||0
8915135|NCT02173535|9974681|FG009|NOT COMPLETED|Period 2||0
8915136|NCT02173535|9974682|FG010|NOT COMPLETED|Period 2||0
8915137|NCT02173535|9974683|FG011|NOT COMPLETED|Period 2||0
8915138|NCT02173535|9974684|FG012|NOT COMPLETED|Period 2||0
8915139|NCT02173535|9974685|FG013|NOT COMPLETED|Period 2||0
8756721|NCT01200394|9805974|FG001|NOT COMPLETED|Overall Study||28
8756722|NCT01200407|9805981|FG000|STARTED|Overall Study||615
8756723|NCT01200407|9805981|FG000|COMPLETED|Overall Study||533
8756724|NCT01200407|9805981|FG000|NOT COMPLETED|Overall Study||82
8756725|NCT01200433|9805987|FG000|STARTED|Overall Study||21
8756726|NCT01200433|9805988|FG001|STARTED|Overall Study||23
8756727|NCT01200433|9805987|FG000|COMPLETED|Overall Study||21
8756728|NCT01200433|9805988|FG001|COMPLETED|Overall Study||23
8756729|NCT01200433|9805987|FG000|NOT COMPLETED|Overall Study||0
8756730|NCT01200433|9805988|FG001|NOT COMPLETED|Overall Study||0
8756731|NCT01200485|9805994|FG000|STARTED|Cycle 1: Rasburicase Alone Delivery|Of 55 participants screened, only 52 treated.|55
8756732|NCT01200485|9805995|FG001|STARTED|Cycle 1: Rasburicase Alone Delivery||0
8756733|NCT01200485|9805996|FG002|STARTED|Cycle 1: Rasburicase Alone Delivery||0
8756734|NCT01200485|9805994|FG000|COMPLETED|Cycle 1: Rasburicase Alone Delivery||52
8756735|NCT01200485|9805995|FG001|COMPLETED|Cycle 1: Rasburicase Alone Delivery||0
8756736|NCT01200485|9805996|FG002|COMPLETED|Cycle 1: Rasburicase Alone Delivery||0
8756737|NCT01200485|9805994|FG000|NOT COMPLETED|Cycle 1: Rasburicase Alone Delivery||3
8756738|NCT01200485|9805995|FG001|NOT COMPLETED|Cycle 1: Rasburicase Alone Delivery||0
8756739|NCT01200485|9805996|FG002|NOT COMPLETED|Cycle 1: Rasburicase Alone Delivery||0
8756740|NCT01200485|9805994|FG000|STARTED|Cycle 2: Randomization|Of 55 enrolled on study, 52 participants were treated in Cycle 1, only 46 randomized to Cycle 2|0
8756741|NCT01200485|9805995|FG001|STARTED|Cycle 2: Randomization|Six not randomized: Methemoglobinemia-1, Kidney failure-2, Chemotherapy changed-2, Not evaluable-1|21
8756742|NCT01200485|9805996|FG002|STARTED|Cycle 2: Randomization||25
8756743|NCT01200485|9805994|FG000|COMPLETED|Cycle 2: Randomization||0
8756744|NCT01200485|9805995|FG001|COMPLETED|Cycle 2: Randomization||21
8756745|NCT01200485|9805996|FG002|COMPLETED|Cycle 2: Randomization||25
8756746|NCT01200485|9805994|FG000|NOT COMPLETED|Cycle 2: Randomization||0
8756747|NCT01200485|9805995|FG001|NOT COMPLETED|Cycle 2: Randomization||0
8756748|NCT01200485|9805996|FG002|NOT COMPLETED|Cycle 2: Randomization||0
8756749|NCT01200498|9806003|FG000|STARTED|Overall Study||22
8756750|NCT01200498|9806003|FG000|COMPLETED|Overall Study||22
8756751|NCT01200498|9806003|FG000|NOT COMPLETED|Overall Study||0
8756752|NCT01200511|9806007|FG000|STARTED|Overall Study||49
8756753|NCT01200511|9806007|FG000|COMPLETED|Overall Study||44
8756754|NCT01200511|9806007|FG000|NOT COMPLETED|Overall Study||5
8756755|NCT01200524|9806016|FG000|STARTED|Overall Study||41
8756756|NCT01200524|9806017|FG001|STARTED|Overall Study||48
8756757|NCT01200524|9806018|FG002|STARTED|Overall Study||44
8756758|NCT01200524|9806016|FG000|COMPLETED|Overall Study||39
8756759|NCT01200524|9806017|FG001|COMPLETED|Overall Study||47
8756760|NCT01200524|9806018|FG002|COMPLETED|Overall Study||40
8756761|NCT01200524|9806016|FG000|NOT COMPLETED|Overall Study||2
8756762|NCT01200524|9806017|FG001|NOT COMPLETED|Overall Study||1
8756763|NCT01200524|9806018|FG002|NOT COMPLETED|Overall Study||4
8756764|NCT01200589|9806028|FG000|STARTED|Overall Study||219
8756765|NCT01200589|9806029|FG001|STARTED|Overall Study||219
8756766|NCT01200589|9806028|FG000|Intent-to-treat (ITT) Analysis Set|Overall Study||219
8756767|NCT01200589|9806029|FG001|Intent-to-treat (ITT) Analysis Set|Overall Study||219
8756768|NCT01200589|9806028|FG000|Safety Set|Overall Study||217
8756769|NCT01200589|9806029|FG001|Safety Set|Overall Study||218
8756770|NCT01200589|9806028|FG000|COMPLETED|Overall Study||29
8756771|NCT01200589|9806029|FG001|COMPLETED|Overall Study||30
8756772|NCT01200589|9806028|FG000|NOT COMPLETED|Overall Study||190
8756773|NCT01200589|9806029|FG001|NOT COMPLETED|Overall Study||189
8756774|NCT01200758|9806037|FG000|STARTED|Stage I||64
8756775|NCT01200758|9806038|FG001|STARTED|Stage I||63
8756776|NCT01200758|9806039|FG002|STARTED|Stage I|Different participants were randomized into different stages of the study.|0
8756777|NCT01200758|9806040|FG003|STARTED|Stage I|Different participants were randomized into different stages of the study.|0
8756778|NCT01200758|9806037|FG000|COMPLETED|Stage I|Participants completed treatment period.|46
8756779|NCT01200758|9806038|FG001|COMPLETED|Stage I|Participants completed treatment period.|46
8756780|NCT01200758|9806039|FG002|COMPLETED|Stage I||0
8756781|NCT01200758|9806040|FG003|COMPLETED|Stage I||0
8756782|NCT01200758|9806037|FG000|NOT COMPLETED|Stage I||18
8756783|NCT01200758|9806038|FG001|NOT COMPLETED|Stage I||17
8756784|NCT01200758|9806039|FG002|NOT COMPLETED|Stage I||0
8756785|NCT01200758|9806040|FG003|NOT COMPLETED|Stage I||0
8756786|NCT01200758|9806037|FG000|STARTED|Stage 2|Different participants were randomized into different stages of the study.|0
8756787|NCT01200758|9806038|FG001|STARTED|Stage 2|Different participants were randomized into different stages of the study.|0
8756788|NCT01200758|9806039|FG002|STARTED|Stage 2||141
8756789|NCT01200758|9806040|FG003|STARTED|Stage 2||142
8756790|NCT01200758|9806037|FG000|COMPLETED|Stage 2||0
8756791|NCT01200758|9806038|FG001|COMPLETED|Stage 2||0
8756792|NCT01200758|9806039|FG002|COMPLETED|Stage 2|Participants completed treatment period.|100
8756793|NCT01200758|9806040|FG003|COMPLETED|Stage 2|Participants completed treatment period.|92
8756794|NCT01200758|9806037|FG000|NOT COMPLETED|Stage 2||0
8756795|NCT01200758|9806038|FG001|NOT COMPLETED|Stage 2||0
8756796|NCT01200758|9806039|FG002|NOT COMPLETED|Stage 2||41
8756797|NCT01200758|9806040|FG003|NOT COMPLETED|Stage 2||50
8756798|NCT01200797|9806052|FG000|STARTED|Overall Study||19
8756799|NCT01200797|9806052|FG000|COMPLETED|Overall Study||0
8756800|NCT01200797|9806052|FG000|NOT COMPLETED|Overall Study||19
8756801|NCT01200810|9806059|FG000|STARTED|Overall Study||5
8756802|NCT01200810|9806060|FG001|STARTED|Overall Study||5
8756803|NCT01200810|9806059|FG000|COMPLETED|Overall Study||0
8756804|NCT01200810|9806060|FG001|COMPLETED|Overall Study||0
8756805|NCT01200810|9806059|FG000|NOT COMPLETED|Overall Study||5
8756806|NCT01200810|9806060|FG001|NOT COMPLETED|Overall Study||5
8756807|NCT01200875|9806066|FG000|STARTED|Overall Study||25
8756808|NCT01200875|9806066|FG000|COMPLETED|Overall Study||25
8756809|NCT01200875|9806066|FG000|NOT COMPLETED|Overall Study||0
8756810|NCT01200992|9806072|FG000|STARTED|Overall Study||39
8756811|NCT01200992|9806073|FG001|STARTED|Overall Study||45
8756812|NCT01200992|9806072|FG000|COMPLETED|Overall Study||2
8756813|NCT01200992|9806073|FG001|COMPLETED|Overall Study||4
8756814|NCT01200992|9806072|FG000|NOT COMPLETED|Overall Study||37
8756815|NCT01200992|9806073|FG001|NOT COMPLETED|Overall Study||41
8756816|NCT01201057|9806085|FG000|STARTED|Overall Study||34
8756817|NCT01201057|9806086|FG001|STARTED|Overall Study||33
8756818|NCT01201057|9806087|FG002|STARTED|Overall Study||32
8756819|NCT01201057|9806088|FG003|STARTED|Overall Study||33
8756820|NCT01201057|9806085|FG000|COMPLETED|Overall Study||32
8756821|NCT01201057|9806086|FG001|COMPLETED|Overall Study||29
8756822|NCT01201057|9806087|FG002|COMPLETED|Overall Study||27
8756823|NCT01201057|9806088|FG003|COMPLETED|Overall Study||29
8756824|NCT01201057|9806085|FG000|NOT COMPLETED|Overall Study||2
8756825|NCT01201057|9806086|FG001|NOT COMPLETED|Overall Study||4
8756826|NCT01201057|9806087|FG002|NOT COMPLETED|Overall Study||5
8756827|NCT01201057|9806088|FG003|NOT COMPLETED|Overall Study||4
8756828|NCT01201265|9806098|FG000|STARTED|Overall Study||40
8756829|NCT01201265|9806098|FG000|COMPLETED|Overall Study||2
8756830|NCT01201265|9806098|FG000|NOT COMPLETED|Overall Study||38
8756831|NCT01201317|9806105|FG000|STARTED|Overall Study||48
8756832|NCT01201317|9806106|FG001|STARTED|Overall Study||45
8756833|NCT01201317|9806107|FG002|STARTED|Overall Study||41
8756834|NCT01201317|9806105|FG000|COMPLETED|Overall Study||39
8756835|NCT01201317|9806106|FG001|COMPLETED|Overall Study||38
8756836|NCT01201317|9806107|FG002|COMPLETED|Overall Study||33
8756837|NCT01201317|9806105|FG000|NOT COMPLETED|Overall Study||9
8756838|NCT01201317|9806106|FG001|NOT COMPLETED|Overall Study||7
8756839|NCT01201317|9806107|FG002|NOT COMPLETED|Overall Study||8
8756840|NCT01201343|9806115|FG000|STARTED|Overall Study||79
8756841|NCT01201343|9806115|FG000|Treated|Overall Study||76
8756842|NCT01201343|9806115|FG000|COMPLETED|Overall Study||60
8756843|NCT01201343|9806115|FG000|NOT COMPLETED|Overall Study||19
8756844|NCT01201356|9806119|FG000|STARTED|Overall Study||4125
8756845|NCT01201356|9806119|FG000|Safety Set|Overall Study||4083
8756846|NCT01201356|9806119|FG000|Fingolimod Full Analysis Set|Overall Study||4046
8756847|NCT01201356|9806119|FG000|COMPLETED|Overall Study||3481
8756848|NCT01201356|9806119|FG000|NOT COMPLETED|Overall Study||644
8756849|NCT01201486|9806123|FG000|STARTED|Overall Study||6781
8756850|NCT01201486|9806123|FG000|COMPLETED|Overall Study||6781
8756851|NCT01201486|9806123|FG000|NOT COMPLETED|Overall Study||0
8756852|NCT01201629|9806129|FG000|STARTED|Overall Study||8
8756853|NCT01201629|9806130|FG001|STARTED|Overall Study||8
8756854|NCT01201629|9806129|FG000|COMPLETED|Overall Study||8
8756855|NCT01201629|9806130|FG001|COMPLETED|Overall Study||8
8756856|NCT01201629|9806129|FG000|NOT COMPLETED|Overall Study||0
8756857|NCT01201629|9806130|FG001|NOT COMPLETED|Overall Study||0
8756858|NCT01201759|9806138|FG000|STARTED|Visit 1 Wash-in ( Untreated)||10
8756859|NCT01201759|9806139|FG001|STARTED|Visit 1 Wash-in ( Untreated)||8
8756860|NCT01201759|9806138|FG000|COMPLETED|Visit 1 Wash-in ( Untreated)||8
8756861|NCT01201759|9806139|FG001|COMPLETED|Visit 1 Wash-in ( Untreated)||7
8756862|NCT01201759|9806138|FG000|NOT COMPLETED|Visit 1 Wash-in ( Untreated)||2
8756863|NCT01201759|9806139|FG001|NOT COMPLETED|Visit 1 Wash-in ( Untreated)||1
8756864|NCT01201759|9806138|FG000|STARTED|Visit 2||8
8756865|NCT01201759|9806139|FG001|STARTED|Visit 2||7
8756866|NCT01201759|9806138|FG000|COMPLETED|Visit 2||8
8756867|NCT01201759|9806139|FG001|COMPLETED|Visit 2||7
8756868|NCT01201759|9806138|FG000|NOT COMPLETED|Visit 2||0
8756869|NCT01201759|9806139|FG001|NOT COMPLETED|Visit 2||0
8756870|NCT01201759|9806138|FG000|STARTED|Visit 3 - Washout||8
8756871|NCT01201759|9806139|FG001|STARTED|Visit 3 - Washout||7
8756872|NCT01201759|9806138|FG000|COMPLETED|Visit 3 - Washout||7
8756873|NCT01201759|9806139|FG001|COMPLETED|Visit 3 - Washout||4
8756874|NCT01201759|9806138|FG000|NOT COMPLETED|Visit 3 - Washout||1
8756875|NCT01201759|9806139|FG001|NOT COMPLETED|Visit 3 - Washout||3
8756876|NCT01201759|9806138|FG000|STARTED|Visit 4 Crossover||7
8756877|NCT01201759|9806139|FG001|STARTED|Visit 4 Crossover||4
8756878|NCT01201759|9806138|FG000|COMPLETED|Visit 4 Crossover||7
8756879|NCT01201759|9806139|FG001|COMPLETED|Visit 4 Crossover||3
8756880|NCT01201759|9806138|FG000|NOT COMPLETED|Visit 4 Crossover||0
8756881|NCT01201759|9806139|FG001|NOT COMPLETED|Visit 4 Crossover||1
8756882|NCT01201759|9806138|FG000|STARTED|Visit 5||7
8756883|NCT01201759|9806139|FG001|STARTED|Visit 5||3
8756884|NCT01201759|9806138|FG000|COMPLETED|Visit 5||7
8756885|NCT01201759|9806139|FG001|COMPLETED|Visit 5||3
8756886|NCT01201759|9806138|FG000|NOT COMPLETED|Visit 5||0
8756887|NCT01201759|9806139|FG001|NOT COMPLETED|Visit 5||0
8756888|NCT01201772|9806150|FG000|STARTED|Overall Study||23
8756889|NCT01201772|9806151|FG001|STARTED|Overall Study||21
8756890|NCT01201772|9806152|FG002|STARTED|Overall Study||21
8756891|NCT01201772|9806150|FG000|COMPLETED|Overall Study||22
8756892|NCT01201772|9806151|FG001|COMPLETED|Overall Study||21
8756893|NCT01201772|9806152|FG002|COMPLETED|Overall Study||21
8756894|NCT01201772|9806150|FG000|NOT COMPLETED|Overall Study||1
8756895|NCT01201772|9806151|FG001|NOT COMPLETED|Overall Study||0
8756896|NCT01201772|9806152|FG002|NOT COMPLETED|Overall Study||0
8756897|NCT01201785|9806158|FG000|STARTED|Overall Study||36
8756898|NCT01201785|9806158|FG000|COMPLETED|Overall Study||20
8756899|NCT01201785|9806158|FG000|NOT COMPLETED|Overall Study||16
8756900|NCT01201798|9806164|FG000|STARTED|Overall Study||56
8756901|NCT01201798|9806165|FG001|STARTED|Overall Study||54
8756902|NCT01201798|9806164|FG000|COMPLETED|Overall Study||47
8756903|NCT01201798|9806165|FG001|COMPLETED|Overall Study||39
8756904|NCT01201798|9806164|FG000|NOT COMPLETED|Overall Study||9
8756905|NCT01201798|9806165|FG001|NOT COMPLETED|Overall Study||15
8756906|NCT01201811|9806171|FG000|STARTED|Overall Study||44
8756907|NCT01201811|9806171|FG000|COMPLETED|Overall Study||25
8756908|NCT01201811|9806171|FG000|NOT COMPLETED|Overall Study||19
8756909|NCT01201850|9806175|FG000|STARTED|Overall Study||7
8756910|NCT01201850|9806175|FG000|COMPLETED|Overall Study||3
8756911|NCT01201850|9806175|FG000|NOT COMPLETED|Overall Study||4
8756912|NCT01201863|9806182|FG000|STARTED|Overall Study||12
8756913|NCT01201863|9806183|FG001|STARTED|Overall Study||10
8756914|NCT01201863|9806184|FG002|STARTED|Overall Study||24
8756915|NCT01201863|9806182|FG000|COMPLETED|Overall Study||11
8756916|NCT01201863|9806183|FG001|COMPLETED|Overall Study||6
8756917|NCT01201863|9806184|FG002|COMPLETED|Overall Study||18
8756918|NCT01201863|9806182|FG000|NOT COMPLETED|Overall Study||1
8756919|NCT01201863|9806183|FG001|NOT COMPLETED|Overall Study||4
8756920|NCT01201863|9806184|FG002|NOT COMPLETED|Overall Study||6
8756921|NCT01201915|9806195|FG000|STARTED|Overall Study||24
8915140|NCT02173535|9974686|FG014|NOT COMPLETED|Period 2||0
8915141|NCT02173535|9974687|FG015|NOT COMPLETED|Period 2||0
8915142|NCT02173535|9974688|FG016|NOT COMPLETED|Period 2||0
8915143|NCT02173535|9974689|FG017|NOT COMPLETED|Period 2||0
8915144|NCT02173535|9974690|FG018|NOT COMPLETED|Period 2||0
8915145|NCT02173535|9974691|FG019|NOT COMPLETED|Period 2||0
8915146|NCT02173535|9974672|FG000|STARTED|Period 3||12
8915147|NCT02173535|9974673|FG001|STARTED|Period 3||12
8915148|NCT02173535|9974674|FG002|STARTED|Period 3||12
8915149|NCT02173535|9974675|FG003|STARTED|Period 3||12
8915150|NCT02173535|9974676|FG004|STARTED|Period 3||12
9024653|NCT03154086|10087315|FG013|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8756922|NCT01201915|9806196|FG001|STARTED|Overall Study||25
8756923|NCT01201915|9806197|FG002|STARTED|Overall Study||25
8756924|NCT01201915|9806195|FG000|COMPLETED|Overall Study||16
8756925|NCT01201915|9806196|FG001|COMPLETED|Overall Study||14
8756926|NCT01201915|9806197|FG002|COMPLETED|Overall Study||19
8756927|NCT01201915|9806195|FG000|NOT COMPLETED|Overall Study||8
8756928|NCT01201915|9806196|FG001|NOT COMPLETED|Overall Study||11
8756929|NCT01201915|9806197|FG002|NOT COMPLETED|Overall Study||6
8756930|NCT01201967|9806207|FG000|STARTED|Overall Study||92
8756931|NCT01201967|9806208|FG001|STARTED|Overall Study||91
8756932|NCT01201967|9806207|FG000|COMPLETED|Overall Study||86
8756933|NCT01201967|9806208|FG001|COMPLETED|Overall Study||86
8756934|NCT01201967|9806207|FG000|NOT COMPLETED|Overall Study||6
8756935|NCT01201967|9806208|FG001|NOT COMPLETED|Overall Study||5
8756936|NCT01202071|9806215|FG000|STARTED|Overall Study||6
8756937|NCT01202071|9806216|FG001|STARTED|Overall Study||6
8756938|NCT01202071|9806217|FG002|STARTED|Overall Study||6
8756939|NCT01202071|9806218|FG003|STARTED|Overall Study||6
8756940|NCT01202071|9806215|FG000|COMPLETED|Overall Study||6
8756941|NCT01202071|9806216|FG001|COMPLETED|Overall Study||6
8756942|NCT01202071|9806217|FG002|COMPLETED|Overall Study||6
8756943|NCT01202071|9806218|FG003|COMPLETED|Overall Study||6
8756944|NCT01202071|9806215|FG000|NOT COMPLETED|Overall Study||0
8756945|NCT01202071|9806216|FG001|NOT COMPLETED|Overall Study||0
8756946|NCT01202071|9806217|FG002|NOT COMPLETED|Overall Study||0
8756947|NCT01202071|9806218|FG003|NOT COMPLETED|Overall Study||0
8756948|NCT01202162|9806230|FG000|STARTED|Overall Study||43
8756949|NCT01202162|9806231|FG001|STARTED|Overall Study||42
8756950|NCT01202162|9806230|FG000|COMPLETED|Overall Study|40 completed the intraoperative through discharge phase of the study.|40
8756951|NCT01202162|9806231|FG001|COMPLETED|Overall Study|40 completed the intraoperative through discharge phase of the study.|40
8756952|NCT01202162|9806230|FG000|NOT COMPLETED|Overall Study||3
8756953|NCT01202162|9806231|FG001|NOT COMPLETED|Overall Study||2
8756954|NCT01202175|9806239|FG000|STARTED|Overall Study||50
9024654|NCT03154086|10087316|FG014|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
9024655|NCT03154086|10087302|FG000|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||2
9024656|NCT03154086|10087303|FG001|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||2
9024657|NCT03154086|10087304|FG002|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||2
9024658|NCT03154086|10087305|FG003|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||2
8756955|NCT01202175|9806239|FG000|Nebivolol|Overall Study||25
8756956|NCT01202175|9806239|FG000|Pacebo|Overall Study||25
8756957|NCT01202175|9806239|FG000|COMPLETED|Overall Study||45
8756958|NCT01202175|9806239|FG000|NOT COMPLETED|Overall Study||5
8756959|NCT01202188|9806249|FG000|STARTED|Overall Study||475
8756960|NCT01202188|9806250|FG001|STARTED|Overall Study||477
8756961|NCT01202188|9806251|FG002|STARTED|Overall Study||475
8756962|NCT01202188|9806252|FG003|STARTED|Overall Study||483
8756963|NCT01202188|9806253|FG004|STARTED|Overall Study||234
8756964|NCT01202188|9806249|FG000|Safety Set; Received Study Drug|Overall Study||474
8756965|NCT01202188|9806250|FG001|Safety Set; Received Study Drug|Overall Study||476
8756966|NCT01202188|9806251|FG002|Safety Set; Received Study Drug|Overall Study||473
8756967|NCT01202188|9806252|FG003|Safety Set; Received Study Drug|Overall Study||480
8915151|NCT02173535|9974677|FG005|STARTED|Period 3||12
8915152|NCT02173535|9974678|FG006|STARTED|Period 3||12
8915153|NCT02173535|9974679|FG007|STARTED|Period 3||12
9024659|NCT03154086|10087306|FG004|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
9024660|NCT03154086|10087307|FG005|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
9024661|NCT03154086|10087308|FG006|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
9024662|NCT03154086|10087309|FG007|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
9024663|NCT03154086|10087310|FG008|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
9024664|NCT03154086|10087311|FG009|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
9024665|NCT03154086|10087312|FG010|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
9024666|NCT03154086|10087313|FG011|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
9024667|NCT03154086|10087314|FG012|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
9024668|NCT03154086|10087315|FG013|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
9024669|NCT03154086|10087316|FG014|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
9024670|NCT03154086|10087302|FG000|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
9024671|NCT03154086|10087303|FG001|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8671021|NCT00749931|9714486|FG001|COMPLETED|Overall Study||298
8671022|NCT00749931|9714487|FG002|COMPLETED|Overall Study||68
9024672|NCT03154086|10087304|FG002|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
9024673|NCT03154086|10087305|FG003|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
9024674|NCT03154086|10087306|FG004|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
9024675|NCT03154086|10087307|FG005|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
9024676|NCT03154086|10087308|FG006|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
9024677|NCT03154086|10087309|FG007|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
9024678|NCT03154086|10087310|FG008|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
9024679|NCT03154086|10087311|FG009|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
9024680|NCT03154086|10087312|FG010|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
9024681|NCT03154086|10087313|FG011|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
9024682|NCT03154086|10087314|FG012|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
9024683|NCT03154086|10087315|FG013|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
9024684|NCT03154086|10087316|FG014|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
9024685|NCT03154086|10087302|FG000|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
9024686|NCT03154086|10087303|FG001|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
9024687|NCT03154086|10087304|FG002|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
9024688|NCT03154086|10087305|FG003|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
9024689|NCT03154086|10087306|FG004|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
9024690|NCT03154086|10087307|FG005|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
9024691|NCT03154086|10087308|FG006|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
9024692|NCT03154086|10087309|FG007|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
9024693|NCT03154086|10087310|FG008|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
9024694|NCT03154086|10087311|FG009|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
9024695|NCT03154086|10087312|FG010|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
9024696|NCT03154086|10087313|FG011|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
9024697|NCT03154086|10087314|FG012|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
9024698|NCT03154086|10087315|FG013|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
9024699|NCT03154086|10087316|FG014|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
9024700|NCT03154086|10087302|FG000|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
9024701|NCT03154086|10087303|FG001|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
9024702|NCT03154086|10087304|FG002|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||1
9024703|NCT03154086|10087305|FG003|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
9024704|NCT03154086|10087306|FG004|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
9024705|NCT03154086|10087307|FG005|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
9024706|NCT03154086|10087308|FG006|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
9024707|NCT03154086|10087309|FG007|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
9024708|NCT03154086|10087310|FG008|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
9024709|NCT03154086|10087311|FG009|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
9024710|NCT03154086|10087312|FG010|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
9024711|NCT03154086|10087313|FG011|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
9024712|NCT03154086|10087314|FG012|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
9024713|NCT03154086|10087315|FG013|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
9024714|NCT03154086|10087316|FG014|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
9024715|NCT03154086|10087302|FG000|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
9024716|NCT03154086|10087303|FG001|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
9024717|NCT03154086|10087304|FG002|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||1
9024718|NCT03154086|10087305|FG003|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
8671023|NCT00749931|9714485|FG000|NOT COMPLETED|Overall Study||0
8671024|NCT00749931|9714486|FG001|NOT COMPLETED|Overall Study||0
8671025|NCT00749931|9714487|FG002|NOT COMPLETED|Overall Study||0
8671026|NCT00749944|9714496|FG000|STARTED|Overall Study||55
8671027|NCT00749944|9714497|FG001|STARTED|Overall Study||55
8671028|NCT00749944|9714496|FG000|COMPLETED|Overall Study||50
8671029|NCT00749944|9714497|FG001|COMPLETED|Overall Study||54
8671030|NCT00749944|9714496|FG000|NOT COMPLETED|Overall Study||5
8671031|NCT00749944|9714497|FG001|NOT COMPLETED|Overall Study||1
8671032|NCT00749957|9714505|FG000|STARTED|Overall Study||6
8671033|NCT00749957|9714506|FG001|STARTED|Overall Study||6
8671034|NCT00749957|9714505|FG000|COMPLETED|Overall Study||6
8756968|NCT01202188|9806253|FG004|Safety Set; Received Study Drug|Overall Study||232
8756969|NCT01202188|9806249|FG000|COMPLETED|Overall Study||437
8756970|NCT01202188|9806250|FG001|COMPLETED|Overall Study||421
8756971|NCT01202188|9806251|FG002|COMPLETED|Overall Study||422
8756972|NCT01202188|9806252|FG003|COMPLETED|Overall Study||441
8756973|NCT01202188|9806253|FG004|COMPLETED|Overall Study||189
8756974|NCT01202188|9806249|FG000|NOT COMPLETED|Overall Study||38
8756975|NCT01202188|9806250|FG001|NOT COMPLETED|Overall Study||56
8756976|NCT01202188|9806251|FG002|NOT COMPLETED|Overall Study||53
8756977|NCT01202188|9806252|FG003|NOT COMPLETED|Overall Study||42
8756978|NCT01202188|9806253|FG004|NOT COMPLETED|Overall Study||45
8808122|NCT01489969|9860564|FG000|COMPLETED|Overall Study||40
8808123|NCT01489969|9860565|FG001|COMPLETED|Overall Study||43
8808124|NCT01489969|9860566|FG002|COMPLETED|Overall Study||44
8808125|NCT01489969|9860564|FG000|NOT COMPLETED|Overall Study||5
8808126|NCT01489969|9860565|FG001|NOT COMPLETED|Overall Study||4
8808127|NCT01489969|9860566|FG002|NOT COMPLETED|Overall Study||1
8808128|NCT01490060|9860576|FG000|STARTED|Cycle 1||11
8808129|NCT01490060|9860577|FG001|STARTED|Cycle 1||13
8808130|NCT01490060|9860578|FG002|STARTED|Cycle 1||12
8808131|NCT01490060|9860579|FG003|STARTED|Cycle 1||11
8808132|NCT01490060|9860576|FG000|COMPLETED|Cycle 1||11
8808133|NCT01490060|9860577|FG001|COMPLETED|Cycle 1||12
8808134|NCT01490060|9860578|FG002|COMPLETED|Cycle 1||9
8808135|NCT01490060|9860579|FG003|COMPLETED|Cycle 1||8
8808136|NCT01490060|9860576|FG000|NOT COMPLETED|Cycle 1||0
8808137|NCT01490060|9860577|FG001|NOT COMPLETED|Cycle 1||1
8808138|NCT01490060|9860578|FG002|NOT COMPLETED|Cycle 1||3
8808139|NCT01490060|9860579|FG003|NOT COMPLETED|Cycle 1||3
8808140|NCT01490060|9860576|FG000|STARTED|Cycle 2||11
8808141|NCT01490060|9860577|FG001|STARTED|Cycle 2||12
8808142|NCT01490060|9860578|FG002|STARTED|Cycle 2||9
8808143|NCT01490060|9860579|FG003|STARTED|Cycle 2||8
8808144|NCT01490060|9860576|FG000|COMPLETED|Cycle 2||9
8808145|NCT01490060|9860577|FG001|COMPLETED|Cycle 2||11
8808146|NCT01490060|9860578|FG002|COMPLETED|Cycle 2||8
8808147|NCT01490060|9860579|FG003|COMPLETED|Cycle 2||8
8808148|NCT01490060|9860576|FG000|NOT COMPLETED|Cycle 2||2
8808149|NCT01490060|9860577|FG001|NOT COMPLETED|Cycle 2||1
8808150|NCT01490060|9860578|FG002|NOT COMPLETED|Cycle 2||1
8808151|NCT01490060|9860579|FG003|NOT COMPLETED|Cycle 2||0
8808152|NCT01490073|9860589|FG000|STARTED|Overall Study||12
8808153|NCT01490073|9860590|FG001|STARTED|Overall Study||12
8808154|NCT01490073|9860589|FG000|COMPLETED|Overall Study||12
8808155|NCT01490073|9860590|FG001|COMPLETED|Overall Study||12
8808156|NCT01490073|9860589|FG000|NOT COMPLETED|Overall Study||0
8808157|NCT01490073|9860590|FG001|NOT COMPLETED|Overall Study||0
8808158|NCT01490086|9860601|FG000|STARTED|Overall Study||58
8808159|NCT01490086|9860602|FG001|STARTED|Overall Study||59
8808160|NCT01490086|9860603|FG002|STARTED|Overall Study||58
9024719|NCT03154086|10087306|FG004|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
9024720|NCT03154086|10087307|FG005|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
9024721|NCT03154086|10087308|FG006|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
9024722|NCT03154086|10087309|FG007|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
9024723|NCT03154086|10087310|FG008|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
8671035|NCT00749957|9714506|FG001|COMPLETED|Overall Study||6
8671036|NCT00749957|9714505|FG000|NOT COMPLETED|Overall Study||0
8671037|NCT00749957|9714506|FG001|NOT COMPLETED|Overall Study||0
9024724|NCT03154086|10087311|FG009|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
9024725|NCT03154086|10087312|FG010|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
9024726|NCT03154086|10087313|FG011|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
9024727|NCT03154086|10087314|FG012|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
9024728|NCT03154086|10087315|FG013|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
9024729|NCT03154086|10087316|FG014|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
9024730|NCT03154086|10087302|FG000|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)|1 par was not dosed on day of dosing due to elevated lab; hence 1 replacement was enrolled and dosed|3
9024731|NCT03154086|10087303|FG001|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||2
9024732|NCT03154086|10087304|FG002|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||1
9024733|NCT03154086|10087305|FG003|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||2
9024734|NCT03154086|10087306|FG004|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
9024735|NCT03154086|10087307|FG005|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
8671038|NCT00749996|9714516|FG000|STARTED|Overall Study|4 pts were removed due to compliance issue. 2 pts were randomized but not treated (non-eligible)|75
8671039|NCT00749996|9714517|FG001|STARTED|Overall Study|5 pts were removed due to compliance issue. 1 pt was randomized but not treated (Non-eligible)|71
8671040|NCT00749996|9714516|FG000|6 Weeks Follow-up|Overall Study|Withdrawn (n=1). Visit not done (n=2)|72
8671041|NCT00749996|9714517|FG001|6 Weeks Follow-up|Overall Study|Withdrawn (n=2). Visit not done (n=2)|67
8671042|NCT00749996|9714516|FG000|3 Months Follow-up|Overall Study|Visit not done (n=2)|72
8671043|NCT00749996|9714517|FG001|3 Months Follow-up|Overall Study|Visit not done (n=1)|68
8808161|NCT01490086|9860604|FG003|STARTED|Overall Study||20
8808162|NCT01490086|9860605|FG004|STARTED|Overall Study||39
8808163|NCT01490086|9860601|FG000|COMPLETED|Overall Study||50
8808164|NCT01490086|9860602|FG001|COMPLETED|Overall Study||44
8808165|NCT01490086|9860603|FG002|COMPLETED|Overall Study||51
8808166|NCT01490086|9860604|FG003|COMPLETED|Overall Study||13
8808167|NCT01490086|9860605|FG004|COMPLETED|Overall Study||28
8808168|NCT01490086|9860601|FG000|NOT COMPLETED|Overall Study||8
8808169|NCT01490086|9860602|FG001|NOT COMPLETED|Overall Study||15
8756979|NCT01202227|9806271|FG000|STARTED|Overall Study|Treated|103
8756980|NCT01202227|9806271|FG000|COMPLETED|Overall Study||84
8756981|NCT01202227|9806271|FG000|NOT COMPLETED|Overall Study||19
8756982|NCT01202253|9806275|FG000|STARTED|Overall Study||50
8756983|NCT01202253|9806275|FG000|COMPLETED|Overall Study||50
8756984|NCT01202253|9806275|FG000|NOT COMPLETED|Overall Study||0
8756985|NCT01202279|9806281|FG000|STARTED|Overall Study||591
8756986|NCT01202279|9806282|FG001|STARTED|Overall Study||588
8756987|NCT01202279|9806281|FG000|COMPLETED|Overall Study||554
8756988|NCT01202279|9806282|FG001|COMPLETED|Overall Study||561
8756989|NCT01202279|9806281|FG000|NOT COMPLETED|Overall Study||37
8756990|NCT01202279|9806282|FG001|NOT COMPLETED|Overall Study||27
8756991|NCT01202409|9806288|FG000|STARTED|Overall Study||19
8756992|NCT01202409|9806288|FG000|COMPLETED|Overall Study||11
8756993|NCT01202409|9806288|FG000|NOT COMPLETED|Overall Study||8
8756994|NCT01202565|9806292|FG000|STARTED|Overall Study||506
8756995|NCT01202565|9806292|FG000|Full Analysis Set|Overall Study|Participants with a signed informed consent and any available data regarding adalimumab treatment.|501
8756996|NCT01202565|9806292|FG000|COMPLETED|Overall Study|Indicates participants who completed the Month 12 visit|439
8756997|NCT01202565|9806292|FG000|NOT COMPLETED|Overall Study||67
8756998|NCT01202578|9806296|FG000|STARTED|Overall Study||53
8756999|NCT01202578|9806296|FG000|COMPLETED|Overall Study||53
8757000|NCT01202578|9806296|FG000|NOT COMPLETED|Overall Study||0
8757001|NCT01202591|9806306|FG000|STARTED|Overall Study||5
8757002|NCT01202591|9806307|FG001|STARTED|Overall Study||5
8757003|NCT01202591|9806308|FG002|STARTED|Overall Study||12
8757004|NCT01202591|9806309|FG003|STARTED|Overall Study||9
8757005|NCT01202591|9806310|FG004|STARTED|Overall Study||5
8757006|NCT01202591|9806311|FG005|STARTED|Overall Study||4
8757007|NCT01202591|9806306|FG000|COMPLETED|Overall Study||0
8757008|NCT01202591|9806307|FG001|COMPLETED|Overall Study||0
8757009|NCT01202591|9806308|FG002|COMPLETED|Overall Study||1
8757010|NCT01202591|9806309|FG003|COMPLETED|Overall Study||2
8757011|NCT01202591|9806310|FG004|COMPLETED|Overall Study||0
8757012|NCT01202591|9806311|FG005|COMPLETED|Overall Study||0
8757013|NCT01202591|9806306|FG000|NOT COMPLETED|Overall Study||5
8757014|NCT01202591|9806307|FG001|NOT COMPLETED|Overall Study||5
8757015|NCT01202591|9806308|FG002|NOT COMPLETED|Overall Study||11
8757016|NCT01202591|9806309|FG003|NOT COMPLETED|Overall Study||7
8757017|NCT01202591|9806310|FG004|NOT COMPLETED|Overall Study||5
8757018|NCT01202591|9806311|FG005|NOT COMPLETED|Overall Study||4
8757019|NCT01202643|9806327|FG000|STARTED|Period 1||6
8757020|NCT01202643|9806328|FG001|STARTED|Period 1||6
8757021|NCT01202643|9806327|FG000|COMPLETED|Period 1||6
8757022|NCT01202643|9806328|FG001|COMPLETED|Period 1||6
8757023|NCT01202643|9806327|FG000|NOT COMPLETED|Period 1||0
8757024|NCT01202643|9806328|FG001|NOT COMPLETED|Period 1||0
8757025|NCT01202643|9806327|FG000|STARTED|Crossover Cycle|One patient became pregnant following Period 1, Only one non-pregnant chose to cycle again|1
8757026|NCT01202643|9806328|FG001|STARTED|Crossover Cycle|Three patients became pregnant after Period 1, 1 patient chose not to cycle again|2
8757027|NCT01202643|9806327|FG000|COMPLETED|Crossover Cycle||1
8757028|NCT01202643|9806328|FG001|COMPLETED|Crossover Cycle||2
8757029|NCT01202643|9806327|FG000|NOT COMPLETED|Crossover Cycle||0
8757030|NCT01202643|9806328|FG001|NOT COMPLETED|Crossover Cycle||0
8757031|NCT01202656|9806336|FG000|STARTED|Cycle 1|Results reported In Barad et al 2014 are combined from both G-CSF studies|67
8757032|NCT01202656|9806337|FG001|STARTED|Cycle 1|Results reported In Barad et al 2014 are combined from both G-CSF studies|62
8757033|NCT01202656|9806336|FG000|COMPLETED|Cycle 1||67
8757034|NCT01202656|9806337|FG001|COMPLETED|Cycle 1||62
8757035|NCT01202656|9806336|FG000|NOT COMPLETED|Cycle 1||0
8757036|NCT01202656|9806337|FG001|NOT COMPLETED|Cycle 1||0
8757037|NCT01202656|9806336|FG000|STARTED|CrossoverCycle|16 ongoing pregnancies were not eligible for crossover, others chose to not have another IVF cycle|18
8757038|NCT01202656|9806337|FG001|STARTED|CrossoverCycle|14 ongoing pregnancies were not eligible for crossover, others chose to not have another IVF cycle|14
8757039|NCT01202656|9806336|FG000|COMPLETED|CrossoverCycle||18
8757040|NCT01202656|9806337|FG001|COMPLETED|CrossoverCycle||14
8757041|NCT01202656|9806336|FG000|NOT COMPLETED|CrossoverCycle||0
8757042|NCT01202656|9806337|FG001|NOT COMPLETED|CrossoverCycle||0
8757043|NCT01202721|9806347|FG000|STARTED|Overall Study||18
8757044|NCT01202721|9806348|FG001|STARTED|Overall Study||26
8757045|NCT01202721|9806349|FG002|STARTED|Overall Study||14
8757046|NCT01202721|9806350|FG003|STARTED|Overall Study||27
8757047|NCT01202721|9806347|FG000|COMPLETED|Overall Study||18
8757048|NCT01202721|9806348|FG001|COMPLETED|Overall Study||26
8757049|NCT01202721|9806349|FG002|COMPLETED|Overall Study||14
8757050|NCT01202721|9806350|FG003|COMPLETED|Overall Study||27
8757051|NCT01202721|9806347|FG000|NOT COMPLETED|Overall Study||0
8757052|NCT01202721|9806348|FG001|NOT COMPLETED|Overall Study||0
8757053|NCT01202721|9806349|FG002|NOT COMPLETED|Overall Study||0
8757054|NCT01202721|9806350|FG003|NOT COMPLETED|Overall Study||0
8757055|NCT01202747|9806362|FG000|STARTED|Overall Study||50
8757056|NCT01202747|9806362|FG000|COMPLETED|Overall Study|One subject did not return for the 4 Week visit due to inconvenience.|49
8757057|NCT01202747|9806362|FG000|NOT COMPLETED|Overall Study||1
8757058|NCT01202760|9806369|FG000|STARTED|Overall Study||379
8757059|NCT01202760|9806370|FG001|STARTED|Overall Study||374
8757060|NCT01202760|9806371|FG002|STARTED|Overall Study||251
8757061|NCT01202760|9806369|FG000|Received at Least One Dose of Study Drug|Overall Study||379
8757062|NCT01202760|9806370|FG001|Received at Least One Dose of Study Drug|Overall Study||371
8757063|NCT01202760|9806371|FG002|Received at Least One Dose of Study Drug|Overall Study||250
8757064|NCT01202760|9806369|FG000|COMPLETED|Overall Study||332
8757065|NCT01202760|9806370|FG001|COMPLETED|Overall Study||322
8757066|NCT01202760|9806371|FG002|COMPLETED|Overall Study||216
8757067|NCT01202760|9806369|FG000|NOT COMPLETED|Overall Study||47
8757068|NCT01202760|9806370|FG001|NOT COMPLETED|Overall Study||52
8757069|NCT01202760|9806371|FG002|NOT COMPLETED|Overall Study||35
8757070|NCT01202773|9806394|FG000|STARTED|Overall Study||153
8757071|NCT01202773|9806395|FG001|STARTED|Overall Study||148
8757072|NCT01202773|9806396|FG002|STARTED|Overall Study||155
9024736|NCT03154086|10087308|FG006|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
9024737|NCT03154086|10087309|FG007|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
9024738|NCT03154086|10087310|FG008|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
9024739|NCT03154086|10087311|FG009|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
9024740|NCT03154086|10087312|FG010|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
9024741|NCT03154086|10087313|FG011|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
9024742|NCT03154086|10087314|FG012|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
9024743|NCT03154086|10087315|FG013|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
9024744|NCT03154086|10087316|FG014|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
9024745|NCT03154086|10087302|FG000|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||2
9024746|NCT03154086|10087303|FG001|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||2
9024747|NCT03154086|10087304|FG002|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||1
9024748|NCT03154086|10087305|FG003|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||2
9024749|NCT03154086|10087306|FG004|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
9024750|NCT03154086|10087307|FG005|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
9024751|NCT03154086|10087308|FG006|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
9024752|NCT03154086|10087309|FG007|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
9024753|NCT03154086|10087310|FG008|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
9024754|NCT03154086|10087311|FG009|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
9024755|NCT03154086|10087312|FG010|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
9024756|NCT03154086|10087313|FG011|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
9024757|NCT03154086|10087314|FG012|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
9024758|NCT03154086|10087315|FG013|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
9024759|NCT03154086|10087316|FG014|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
9024760|NCT03154086|10087302|FG000|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||1
9024761|NCT03154086|10087303|FG001|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
9024762|NCT03154086|10087304|FG002|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
9024763|NCT03154086|10087305|FG003|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
9024764|NCT03154086|10087306|FG004|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
9024765|NCT03154086|10087307|FG005|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
9024766|NCT03154086|10087308|FG006|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
9024767|NCT03154086|10087309|FG007|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
9024768|NCT03154086|10087310|FG008|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
9024769|NCT03154086|10087311|FG009|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
9024770|NCT03154086|10087312|FG010|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
9024771|NCT03154086|10087313|FG011|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
9024772|NCT03154086|10087314|FG012|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
9024773|NCT03154086|10087315|FG013|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
9024774|NCT03154086|10087316|FG014|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
9024775|NCT03154086|10087302|FG000|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
9024776|NCT03154086|10087303|FG001|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
9024777|NCT03154086|10087304|FG002|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
9024778|NCT03154086|10087305|FG003|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
9024779|NCT03154086|10087306|FG004|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||6
9024780|NCT03154086|10087307|FG005|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||2
9024781|NCT03154086|10087308|FG006|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
9024782|NCT03154086|10087309|FG007|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
9024783|NCT03154086|10087310|FG008|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
9024784|NCT03154086|10087311|FG009|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
9024785|NCT03154086|10087312|FG010|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
9024786|NCT03154086|10087313|FG011|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
9024787|NCT03154086|10087314|FG012|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
9024788|NCT03154086|10087315|FG013|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
9024789|NCT03154086|10087316|FG014|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
9024790|NCT03154086|10087302|FG000|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
9024791|NCT03154086|10087303|FG001|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
9024792|NCT03154086|10087304|FG002|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
9024793|NCT03154086|10087305|FG003|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
9024794|NCT03154086|10087306|FG004|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||6
9024795|NCT03154086|10087307|FG005|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||2
9024796|NCT03154086|10087308|FG006|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
9024797|NCT03154086|10087309|FG007|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
9024798|NCT03154086|10087310|FG008|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8757073|NCT01202773|9806394|FG000|Received at Least 1 Dose of Study Drug|Overall Study||153
8757074|NCT01202773|9806395|FG001|Received at Least 1 Dose of Study Drug|Overall Study||147
8757075|NCT01202773|9806396|FG002|Received at Least 1 Dose of Study Drug|Overall Study||154
8757076|NCT01202773|9806394|FG000|Week 16 NR|Overall Study||23
8757077|NCT01202773|9806395|FG001|Week 16 NR|Overall Study||33
8757078|NCT01202773|9806396|FG002|Week 16 NR|Overall Study||37
8757079|NCT01202773|9806394|FG000|Post-Treatment Follow-Up Population|Overall Study||46
8757080|NCT01202773|9806395|FG001|Post-Treatment Follow-Up Population|Overall Study||36
8757081|NCT01202773|9806396|FG002|Post-Treatment Follow-Up Population|Overall Study||51
8757082|NCT01202773|9806394|FG000|COMPLETED|Overall Study|Those who completed 24-week treatment period including both Week 16 responders and NR.|96
8757083|NCT01202773|9806395|FG001|COMPLETED|Overall Study|Those who completed 24-week treatment period including both Week 16 responders and NR.|105
8757084|NCT01202773|9806396|FG002|COMPLETED|Overall Study|Those who completed 24-week treatment period including both Week 16 responders and NR.|100
8757085|NCT01202773|9806394|FG000|NOT COMPLETED|Overall Study||57
8757086|NCT01202773|9806395|FG001|NOT COMPLETED|Overall Study||43
8757087|NCT01202773|9806396|FG002|NOT COMPLETED|Overall Study||55
8757088|NCT01202877|9806417|FG000|STARTED|Overall Study||6
8757089|NCT01202877|9806418|FG001|STARTED|Overall Study||8
8757090|NCT01202877|9806419|FG002|STARTED|Overall Study||40
8757091|NCT01202877|9806417|FG000|COMPLETED|Overall Study||6
8757092|NCT01202877|9806418|FG001|COMPLETED|Overall Study||7
8757093|NCT01202877|9806419|FG002|COMPLETED|Overall Study||34
8757094|NCT01202877|9806417|FG000|NOT COMPLETED|Overall Study||0
8757095|NCT01202877|9806418|FG001|NOT COMPLETED|Overall Study||1
8757096|NCT01202877|9806419|FG002|NOT COMPLETED|Overall Study||6
8757097|NCT01202903|9806429|FG000|STARTED|Overall Study||308
8757098|NCT01202903|9806430|FG001|STARTED|Overall Study||308
8757099|NCT01202903|9806429|FG000|Full Analysis Set|Overall Study||306
8757100|NCT01202903|9806430|FG001|Full Analysis Set|Overall Study||302
8757101|NCT01202903|9806429|FG000|Safety Set*|Overall Study||310
8757102|NCT01202903|9806430|FG001|Safety Set*|Overall Study||299
8757103|NCT01202903|9806429|FG000|COMPLETED|Overall Study||297
8757104|NCT01202903|9806430|FG001|COMPLETED|Overall Study||292
8757105|NCT01202903|9806429|FG000|NOT COMPLETED|Overall Study||11
8757106|NCT01202903|9806430|FG001|NOT COMPLETED|Overall Study||16
8757107|NCT01202955|9806438|FG000|STARTED|Period 1: 10 Days||9
8757108|NCT01202955|9806439|FG001|STARTED|Period 1: 10 Days||10
8757109|NCT01202955|9806438|FG000|COMPLETED|Period 1: 10 Days||9
8757110|NCT01202955|9806439|FG001|COMPLETED|Period 1: 10 Days||8
8757111|NCT01202955|9806438|FG000|NOT COMPLETED|Period 1: 10 Days||0
8757112|NCT01202955|9806439|FG001|NOT COMPLETED|Period 1: 10 Days||2
8757113|NCT01202955|9806438|FG000|STARTED|Period 2: 7 Days (Wash-Out)||9
8757114|NCT01202955|9806439|FG001|STARTED|Period 2: 7 Days (Wash-Out)||8
8757115|NCT01202955|9806438|FG000|COMPLETED|Period 2: 7 Days (Wash-Out)||9
8757116|NCT01202955|9806439|FG001|COMPLETED|Period 2: 7 Days (Wash-Out)||8
8757117|NCT01202955|9806438|FG000|NOT COMPLETED|Period 2: 7 Days (Wash-Out)||0
8757118|NCT01202955|9806439|FG001|NOT COMPLETED|Period 2: 7 Days (Wash-Out)||0
8757119|NCT01202955|9806438|FG000|STARTED|Period 3: 10 Days||9
8757120|NCT01202955|9806439|FG001|STARTED|Period 3: 10 Days||8
8757121|NCT01202955|9806438|FG000|COMPLETED|Period 3: 10 Days||9
8757122|NCT01202955|9806439|FG001|COMPLETED|Period 3: 10 Days||8
8757123|NCT01202955|9806438|FG000|NOT COMPLETED|Period 3: 10 Days||0
8757124|NCT01202955|9806439|FG001|NOT COMPLETED|Period 3: 10 Days||0
8757125|NCT01202994|9806445|FG000|STARTED|Overall Study||27
8757126|NCT01202994|9806445|FG000|COMPLETED|Overall Study||27
8757127|NCT01202994|9806445|FG000|NOT COMPLETED|Overall Study||0
8757128|NCT01203046|9806452|FG000|STARTED|Overall Study||28
8757129|NCT01203046|9806453|FG001|STARTED|Overall Study||28
8757130|NCT01203046|9806452|FG000|COMPLETED|Overall Study||28
9024799|NCT03154086|10087311|FG009|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
9024800|NCT03154086|10087312|FG010|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
9024801|NCT03154086|10087313|FG011|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
9024802|NCT03154086|10087314|FG012|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
9024803|NCT03154086|10087315|FG013|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
9024804|NCT03154086|10087316|FG014|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
9024805|NCT03154086|10087302|FG000|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
9024806|NCT03154086|10087303|FG001|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
9024807|NCT03154086|10087304|FG002|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
9024808|NCT03154086|10087305|FG003|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
9024809|NCT03154086|10087306|FG004|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
9024810|NCT03154086|10087307|FG005|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
9024811|NCT03154086|10087308|FG006|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
9024812|NCT03154086|10087309|FG007|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
9024813|NCT03154086|10087310|FG008|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8757131|NCT01203046|9806453|FG001|COMPLETED|Overall Study||28
8757132|NCT01203046|9806452|FG000|NOT COMPLETED|Overall Study||0
8757133|NCT01203046|9806453|FG001|NOT COMPLETED|Overall Study||0
8757134|NCT01203072|9806466|FG000|STARTED|Overall Study||105
8757135|NCT01203072|9806467|FG001|STARTED|Overall Study||106
8757136|NCT01203072|9806468|FG002|STARTED|Overall Study||104
8757137|NCT01203072|9806469|FG003|STARTED|Overall Study||106
8757138|NCT01203072|9806470|FG004|STARTED|Overall Study||102
8757139|NCT01203072|9806466|FG000|COMPLETED|Overall Study||95
8757140|NCT01203072|9806467|FG001|COMPLETED|Overall Study||100
8757141|NCT01203072|9806468|FG002|COMPLETED|Overall Study||101
9024814|NCT03154086|10087311|FG009|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
9024815|NCT03154086|10087312|FG010|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8757142|NCT01203072|9806469|FG003|COMPLETED|Overall Study||100
8757143|NCT01203072|9806470|FG004|COMPLETED|Overall Study||96
8757144|NCT01203072|9806466|FG000|NOT COMPLETED|Overall Study||10
8757145|NCT01203072|9806467|FG001|NOT COMPLETED|Overall Study||6
8757146|NCT01203072|9806468|FG002|NOT COMPLETED|Overall Study||3
8757147|NCT01203072|9806469|FG003|NOT COMPLETED|Overall Study||6
8757148|NCT01203072|9806470|FG004|NOT COMPLETED|Overall Study||6
8757149|NCT01203098|9806485|FG000|STARTED|Overall Study||89
8757150|NCT01203098|9806486|FG001|STARTED|Overall Study||86
8757151|NCT01203098|9806487|FG002|STARTED|Overall Study||89
8757152|NCT01203098|9806485|FG000|Safety Analysis Dataset|Overall Study||89
8757153|NCT01203098|9806486|FG001|Safety Analysis Dataset|Overall Study||85
8757154|NCT01203098|9806487|FG002|Safety Analysis Dataset|Overall Study||87
8757155|NCT01203098|9806485|FG000|COMPLETED|Overall Study||83
8757156|NCT01203098|9806486|FG001|COMPLETED|Overall Study||82
8757157|NCT01203098|9806487|FG002|COMPLETED|Overall Study||78
8757158|NCT01203098|9806485|FG000|NOT COMPLETED|Overall Study||6
8757159|NCT01203098|9806486|FG001|NOT COMPLETED|Overall Study||4
8757160|NCT01203098|9806487|FG002|NOT COMPLETED|Overall Study||11
8757161|NCT01203189|9806498|FG000|STARTED|First 4 Weeks Treatment||10
8757162|NCT01203189|9806499|FG001|STARTED|First 4 Weeks Treatment||10
8757163|NCT01203189|9806500|FG002|STARTED|First 4 Weeks Treatment||3
8757164|NCT01203189|9806498|FG000|COMPLETED|First 4 Weeks Treatment||8
8757165|NCT01203189|9806499|FG001|COMPLETED|First 4 Weeks Treatment||8
8757166|NCT01203189|9806500|FG002|COMPLETED|First 4 Weeks Treatment||3
8757167|NCT01203189|9806498|FG000|NOT COMPLETED|First 4 Weeks Treatment||2
8757168|NCT01203189|9806499|FG001|NOT COMPLETED|First 4 Weeks Treatment||2
8757169|NCT01203189|9806500|FG002|NOT COMPLETED|First 4 Weeks Treatment||0
8757170|NCT01203189|9806498|FG000|STARTED|Cross Over Period 4 Weeks Treatment||0
8757171|NCT01203189|9806499|FG001|STARTED|Cross Over Period 4 Weeks Treatment||0
8757172|NCT01203189|9806500|FG002|STARTED|Cross Over Period 4 Weeks Treatment||3
8757173|NCT01203189|9806498|FG000|COMPLETED|Cross Over Period 4 Weeks Treatment||0
8757174|NCT01203189|9806499|FG001|COMPLETED|Cross Over Period 4 Weeks Treatment||0
8757175|NCT01203189|9806500|FG002|COMPLETED|Cross Over Period 4 Weeks Treatment||3
8757176|NCT01203189|9806498|FG000|NOT COMPLETED|Cross Over Period 4 Weeks Treatment||0
8757177|NCT01203189|9806499|FG001|NOT COMPLETED|Cross Over Period 4 Weeks Treatment||0
8757178|NCT01203189|9806500|FG002|NOT COMPLETED|Cross Over Period 4 Weeks Treatment||0
8757179|NCT01203319|9806511|FG000|STARTED|Overall Study||434
8757180|NCT01203319|9806512|FG001|STARTED|Overall Study||435
8757181|NCT01203319|9806513|FG002|STARTED|Overall Study||222
8757182|NCT01203319|9806511|FG000|COMPLETED|Overall Study||428
8757183|NCT01203319|9806512|FG001|COMPLETED|Overall Study||426
8757184|NCT01203319|9806513|FG002|COMPLETED|Overall Study||217
8757185|NCT01203319|9806511|FG000|NOT COMPLETED|Overall Study||6
8757186|NCT01203319|9806512|FG001|NOT COMPLETED|Overall Study||9
8757187|NCT01203319|9806513|FG002|NOT COMPLETED|Overall Study||5
8757188|NCT01203644|9806523|FG000|STARTED|Overall Study||26
8757189|NCT01203644|9806524|FG001|STARTED|Overall Study||50
8757190|NCT01203644|9806523|FG000|COMPLETED|Overall Study||26
8757191|NCT01203644|9806524|FG001|COMPLETED|Overall Study||50
8757192|NCT01203644|9806523|FG000|NOT COMPLETED|Overall Study||0
8757193|NCT01203644|9806524|FG001|NOT COMPLETED|Overall Study||0
8757194|NCT01203774|9806533|FG000|STARTED|Overall Study||21
8757195|NCT01203774|9806534|FG001|STARTED|Overall Study||10
8757196|NCT01203774|9806533|FG000|COMPLETED|Overall Study||21
8757197|NCT01203774|9806534|FG001|COMPLETED|Overall Study||10
8757198|NCT01203774|9806533|FG000|NOT COMPLETED|Overall Study||0
8757199|NCT01203774|9806534|FG001|NOT COMPLETED|Overall Study||0
8757200|NCT01203787|9806542|FG000|STARTED|Overall Study||63
8757201|NCT01203787|9806543|FG001|STARTED|Overall Study||57
8757202|NCT01203787|9806542|FG000|COMPLETED|Overall Study||32
8757203|NCT01203787|9806543|FG001|COMPLETED|Overall Study||30
8757204|NCT01203787|9806542|FG000|NOT COMPLETED|Overall Study||31
8757205|NCT01203787|9806543|FG001|NOT COMPLETED|Overall Study||27
8757206|NCT01203826|9806553|FG000|STARTED|Overall Study|Dose cohorts are per assigned dose in ENB-006-09. Results presented are for Study ENB-008-10 only.|6
8757207|NCT01203826|9806554|FG001|STARTED|Overall Study|Dose cohorts are per assigned dose in ENB-006-09. Results presented are for Study ENB-008-10 only.|6
8757208|NCT01203826|9806553|FG000|COMPLETED|Overall Study||6
8757209|NCT01203826|9806554|FG001|COMPLETED|Overall Study||6
8757210|NCT01203826|9806553|FG000|NOT COMPLETED|Overall Study||0
8757211|NCT01203826|9806554|FG001|NOT COMPLETED|Overall Study||0
8757212|NCT01203852|9806560|FG000|STARTED|Metoprolol 8 Weeks|This is the total number of subjects for both groups.|839
8757213|NCT01203852|9806560|FG000|COMPLETED|Metoprolol 8 Weeks||369
8757214|NCT01203852|9806560|FG000|NOT COMPLETED|Metoprolol 8 Weeks||470
8757215|NCT01203852|9806560|FG000|STARTED|Washout 2 Weeks|Some study subjects did not proceed to the washout phase after the first intervention.|328
8757216|NCT01203852|9806560|FG000|COMPLETED|Washout 2 Weeks||282
8757217|NCT01203852|9806560|FG000|NOT COMPLETED|Washout 2 Weeks||46
8757218|NCT01203852|9806560|FG000|STARTED|Chlorthalidone 8 Weeks|Subjects were allowed to enter the study at Chlorthalidone without completing Metoprolol.|328
8757219|NCT01203852|9806560|FG000|Continued From Metoprolol|Chlorthalidone 8 Weeks||282
8757220|NCT01203852|9806560|FG000|COMPLETED|Chlorthalidone 8 Weeks||328
8757221|NCT01203852|9806560|FG000|NOT COMPLETED|Chlorthalidone 8 Weeks||0
8757222|NCT01203878|9806570|FG000|STARTED|Overall Study||9
8757223|NCT01203878|9806571|FG001|STARTED|Overall Study||9
8757224|NCT01203878|9806572|FG002|STARTED|Overall Study||3
8757225|NCT01203878|9806570|FG000|COMPLETED|Overall Study||9
8757226|NCT01203878|9806571|FG001|COMPLETED|Overall Study||9
8757227|NCT01203878|9806572|FG002|COMPLETED|Overall Study||0
8757228|NCT01203878|9806570|FG000|NOT COMPLETED|Overall Study||0
8757229|NCT01203878|9806571|FG001|NOT COMPLETED|Overall Study||0
8757230|NCT01203878|9806572|FG002|NOT COMPLETED|Overall Study||3
8757231|NCT01203917|9806579|FG000|STARTED|Overall Study|106 patients were EGFR M+ patients and 1 patient was EGFR M+I|107
8757232|NCT01203917|9806579|FG000|COMPLETED|Overall Study|Patients on-going study at data cut-off(of which 49 were still on study treatment).|71
8757233|NCT01203917|9806579|FG000|NOT COMPLETED|Overall Study||36
8757234|NCT01203930|9806585|FG000|STARTED|Overall Study||64
8757235|NCT01203930|9806586|FG001|STARTED|Overall Study||41
8757236|NCT01203930|9806585|FG000|COMPLETED|Overall Study|43 participants completed 12 cycles and were then eligible to enroll in the extension study (101-99)|43
8757237|NCT01203930|9806586|FG001|COMPLETED|Overall Study||0
8757238|NCT01203930|9806585|FG000|NOT COMPLETED|Overall Study||21
8757239|NCT01203930|9806586|FG001|NOT COMPLETED|Overall Study||41
8757240|NCT01203956|9806594|FG000|STARTED|First Two-week Period||15
8757241|NCT01203956|9806595|FG001|STARTED|First Two-week Period||13
8757242|NCT01203956|9806594|FG000|COMPLETED|First Two-week Period|All participants continued to the second two-week period, whether or not they had evaluable results.|15
8757243|NCT01203956|9806595|FG001|COMPLETED|First Two-week Period|All participants continued to the second two-week period, whether or not they had evaluable results.|13
8757244|NCT01203956|9806594|FG000|NOT COMPLETED|First Two-week Period||0
8757245|NCT01203956|9806595|FG001|NOT COMPLETED|First Two-week Period||0
8757246|NCT01203956|9806594|FG000|STARTED|Second Two-week Period||15
8757247|NCT01203956|9806595|FG001|STARTED|Second Two-week Period||13
8757248|NCT01203956|9806594|FG000|Attended Sleep Studies for 14 Nights|Second Two-week Period||15
8757249|NCT01203956|9806595|FG001|Attended Sleep Studies for 14 Nights|Second Two-week Period||13
8757250|NCT01203956|9806594|FG000|COMPLETED|Second Two-week Period|Completed with evaluable results, as assessed over both two-week study periods.|10
8757251|NCT01203956|9806595|FG001|COMPLETED|Second Two-week Period|Completed with evaluable results, as assessed over both two-week study periods.|7
8757252|NCT01203956|9806594|FG000|NOT COMPLETED|Second Two-week Period||5
8757253|NCT01203956|9806595|FG001|NOT COMPLETED|Second Two-week Period||6
8757254|NCT01204203|9806602|FG000|STARTED|Overall Study||8
8757255|NCT01204203|9806602|FG000|COMPLETED|Overall Study||8
8757256|NCT01204203|9806602|FG000|NOT COMPLETED|Overall Study||0
8757257|NCT01204255|9806606|FG000|STARTED|Overall Study||11
8757258|NCT01204255|9806606|FG000|COMPLETED|Overall Study||10
8757259|NCT01204255|9806606|FG000|NOT COMPLETED|Overall Study||1
8757260|NCT01204294|9806617|FG000|STARTED|Overall Study||82
8757261|NCT01204294|9806618|FG001|STARTED|Overall Study||66
8757262|NCT01204294|9806619|FG002|STARTED|Overall Study||74
8757263|NCT01204294|9806620|FG003|STARTED|Overall Study||143
8757264|NCT01204294|9806621|FG004|STARTED|Overall Study||85
8757265|NCT01204294|9806622|FG005|STARTED|Overall Study||63
8757266|NCT01204294|9806623|FG006|STARTED|Overall Study||61
8757267|NCT01204294|9806617|FG000|COMPLETED|Overall Study||79
8757268|NCT01204294|9806618|FG001|COMPLETED|Overall Study||58
8757269|NCT01204294|9806619|FG002|COMPLETED|Overall Study||69
8757270|NCT01204294|9806620|FG003|COMPLETED|Overall Study||132
8757271|NCT01204294|9806621|FG004|COMPLETED|Overall Study||83
8757272|NCT01204294|9806622|FG005|COMPLETED|Overall Study||58
8757273|NCT01204294|9806623|FG006|COMPLETED|Overall Study||59
8757274|NCT01204294|9806617|FG000|NOT COMPLETED|Overall Study||3
8757275|NCT01204294|9806618|FG001|NOT COMPLETED|Overall Study||8
8757276|NCT01204294|9806619|FG002|NOT COMPLETED|Overall Study||5
8757277|NCT01204294|9806620|FG003|NOT COMPLETED|Overall Study||11
8757278|NCT01204294|9806621|FG004|NOT COMPLETED|Overall Study||2
8757279|NCT01204294|9806622|FG005|NOT COMPLETED|Overall Study||5
8757280|NCT01204294|9806623|FG006|NOT COMPLETED|Overall Study||2
8757281|NCT01204398|9806639|FG000|STARTED|Overall Study|Entered and treated.|27
8757282|NCT01204398|9806639|FG000|COMPLETED|Overall Study|Completed trial medication.|26
8757283|NCT01204398|9806639|FG000|NOT COMPLETED|Overall Study||1
8757284|NCT01204658|9806647|FG000|STARTED|Primary Phase||146
8757285|NCT01204658|9806648|FG001|STARTED|Primary Phase||142
8757286|NCT01204658|9806649|FG002|STARTED|Primary Phase||145
8757287|NCT01204658|9806650|FG003|STARTED|Primary Phase||142
8757288|NCT01204658|9806647|FG000|COMPLETED|Primary Phase||146
8757289|NCT01204658|9806648|FG001|COMPLETED|Primary Phase||142
8757290|NCT01204658|9806649|FG002|COMPLETED|Primary Phase||144
8757291|NCT01204658|9806650|FG003|COMPLETED|Primary Phase||142
8757292|NCT01204658|9806647|FG000|NOT COMPLETED|Primary Phase||0
8757293|NCT01204658|9806648|FG001|NOT COMPLETED|Primary Phase||0
8757294|NCT01204658|9806649|FG002|NOT COMPLETED|Primary Phase||1
8757295|NCT01204658|9806650|FG003|NOT COMPLETED|Primary Phase||0
8757296|NCT01204658|9806647|FG000|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|144
8757297|NCT01204658|9806648|FG001|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|140
8757298|NCT01204658|9806649|FG002|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|140
8757299|NCT01204658|9806650|FG003|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|140
8757300|NCT01204658|9806647|FG000|COMPLETED|Booster Phase||144
8757301|NCT01204658|9806648|FG001|COMPLETED|Booster Phase||140
8757302|NCT01204658|9806649|FG002|COMPLETED|Booster Phase||140
8757303|NCT01204658|9806650|FG003|COMPLETED|Booster Phase||140
8757304|NCT01204658|9806647|FG000|NOT COMPLETED|Booster Phase||0
8757305|NCT01204658|9806648|FG001|NOT COMPLETED|Booster Phase||0
8757306|NCT01204658|9806649|FG002|NOT COMPLETED|Booster Phase||0
8757307|NCT01204658|9806650|FG003|NOT COMPLETED|Booster Phase||0
8757308|NCT01204671|9806668|FG000|STARTED|Overall Study||1012
8757309|NCT01204671|9806669|FG001|STARTED|Overall Study||1013
8757310|NCT01204671|9806670|FG002|STARTED|Overall Study||1011
8757311|NCT01204671|9806671|FG003|STARTED|Overall Study||1010
8757312|NCT01204671|9806672|FG004|STARTED|Overall Study||610
8757313|NCT01204671|9806668|FG000|COMPLETED|Overall Study||998
8757314|NCT01204671|9806669|FG001|COMPLETED|Overall Study||998
8757315|NCT01204671|9806670|FG002|COMPLETED|Overall Study||998
8757316|NCT01204671|9806671|FG003|COMPLETED|Overall Study||997
8757317|NCT01204671|9806672|FG004|COMPLETED|Overall Study||606
8757318|NCT01204671|9806668|FG000|NOT COMPLETED|Overall Study||14
8915154|NCT02173535|9974680|FG008|STARTED|Period 3||12
8915155|NCT02173535|9974681|FG009|STARTED|Period 3||12
8915156|NCT02173535|9974682|FG010|STARTED|Period 3||12
8915157|NCT02173535|9974683|FG011|STARTED|Period 3||12
8915158|NCT02173535|9974684|FG012|STARTED|Period 3||12
8915159|NCT02173535|9974685|FG013|STARTED|Period 3||12
8915160|NCT02173535|9974686|FG014|STARTED|Period 3||12
8915161|NCT02173535|9974687|FG015|STARTED|Period 3||12
8915162|NCT02173535|9974688|FG016|STARTED|Period 3||12
8915163|NCT02173535|9974689|FG017|STARTED|Period 3||12
8915164|NCT02173535|9974690|FG018|STARTED|Period 3||12
8915165|NCT02173535|9974691|FG019|STARTED|Period 3||12
8915166|NCT02173535|9974672|FG000|COMPLETED|Period 3||12
8915167|NCT02173535|9974673|FG001|COMPLETED|Period 3||12
8915168|NCT02173535|9974674|FG002|COMPLETED|Period 3||12
8915169|NCT02173535|9974675|FG003|COMPLETED|Period 3||12
8915170|NCT02173535|9974676|FG004|COMPLETED|Period 3||12
8915171|NCT02173535|9974677|FG005|COMPLETED|Period 3||12
8915172|NCT02173535|9974678|FG006|COMPLETED|Period 3||12
8915173|NCT02173535|9974679|FG007|COMPLETED|Period 3||12
8915174|NCT02173535|9974680|FG008|COMPLETED|Period 3||12
8915175|NCT02173535|9974681|FG009|COMPLETED|Period 3||12
8915176|NCT02173535|9974682|FG010|COMPLETED|Period 3||12
8915177|NCT02173535|9974683|FG011|COMPLETED|Period 3||12
8915178|NCT02173535|9974684|FG012|COMPLETED|Period 3||12
8915179|NCT02173535|9974685|FG013|COMPLETED|Period 3||12
8915180|NCT02173535|9974686|FG014|COMPLETED|Period 3||12
8915181|NCT02173535|9974687|FG015|COMPLETED|Period 3||12
8915182|NCT02173535|9974688|FG016|COMPLETED|Period 3||12
8915183|NCT02173535|9974689|FG017|COMPLETED|Period 3||12
8915184|NCT02173535|9974690|FG018|COMPLETED|Period 3||12
8915185|NCT02173535|9974691|FG019|COMPLETED|Period 3||12
8915186|NCT02173535|9974672|FG000|NOT COMPLETED|Period 3||0
8915187|NCT02173535|9974673|FG001|NOT COMPLETED|Period 3||0
8915188|NCT02173535|9974674|FG002|NOT COMPLETED|Period 3||0
8915189|NCT02173535|9974675|FG003|NOT COMPLETED|Period 3||0
8915190|NCT02173535|9974676|FG004|NOT COMPLETED|Period 3||0
8915191|NCT02173535|9974677|FG005|NOT COMPLETED|Period 3||0
8915192|NCT02173535|9974678|FG006|NOT COMPLETED|Period 3||0
8915193|NCT02173535|9974679|FG007|NOT COMPLETED|Period 3||0
8915194|NCT02173535|9974680|FG008|NOT COMPLETED|Period 3||0
8915195|NCT02173535|9974681|FG009|NOT COMPLETED|Period 3||0
8915196|NCT02173535|9974682|FG010|NOT COMPLETED|Period 3||0
8915197|NCT02173535|9974683|FG011|NOT COMPLETED|Period 3||0
8915198|NCT02173535|9974684|FG012|NOT COMPLETED|Period 3||0
8915199|NCT02173535|9974685|FG013|NOT COMPLETED|Period 3||0
8915200|NCT02173535|9974686|FG014|NOT COMPLETED|Period 3||0
8915201|NCT02173535|9974687|FG015|NOT COMPLETED|Period 3||0
8915202|NCT02173535|9974688|FG016|NOT COMPLETED|Period 3||0
8915203|NCT02173535|9974689|FG017|NOT COMPLETED|Period 3||0
8915204|NCT02173535|9974690|FG018|NOT COMPLETED|Period 3||0
8915205|NCT02173535|9974691|FG019|NOT COMPLETED|Period 3||0
8915206|NCT02173535|9974672|FG000|STARTED|Period 4||12
8915207|NCT02173535|9974673|FG001|STARTED|Period 4||12
8915208|NCT02173535|9974674|FG002|STARTED|Period 4||12
8915209|NCT02173535|9974675|FG003|STARTED|Period 4||12
8915210|NCT02173535|9974676|FG004|STARTED|Period 4||12
8915211|NCT02173535|9974677|FG005|STARTED|Period 4||12
8915212|NCT02173535|9974678|FG006|STARTED|Period 4||12
8915213|NCT02173535|9974679|FG007|STARTED|Period 4||12
8915214|NCT02173535|9974680|FG008|STARTED|Period 4||12
8915215|NCT02173535|9974681|FG009|STARTED|Period 4||12
8915216|NCT02173535|9974682|FG010|STARTED|Period 4||12
8915217|NCT02173535|9974683|FG011|STARTED|Period 4||12
8915218|NCT02173535|9974684|FG012|STARTED|Period 4||12
8915219|NCT02173535|9974685|FG013|STARTED|Period 4||12
8915220|NCT02173535|9974686|FG014|STARTED|Period 4||12
8915221|NCT02173535|9974687|FG015|STARTED|Period 4||12
8915222|NCT02173535|9974688|FG016|STARTED|Period 4||12
8915223|NCT02173535|9974689|FG017|STARTED|Period 4||12
8915224|NCT02173535|9974690|FG018|STARTED|Period 4||12
8915225|NCT02173535|9974691|FG019|STARTED|Period 4||12
8915226|NCT02173535|9974672|FG000|COMPLETED|Period 4||12
8915227|NCT02173535|9974673|FG001|COMPLETED|Period 4||12
8915228|NCT02173535|9974674|FG002|COMPLETED|Period 4||12
8915229|NCT02173535|9974675|FG003|COMPLETED|Period 4||12
8915230|NCT02173535|9974676|FG004|COMPLETED|Period 4||12
8915231|NCT02173535|9974677|FG005|COMPLETED|Period 4||12
8915232|NCT02173535|9974678|FG006|COMPLETED|Period 4||12
8915233|NCT02173535|9974679|FG007|COMPLETED|Period 4||12
8915234|NCT02173535|9974680|FG008|COMPLETED|Period 4||12
8915235|NCT02173535|9974681|FG009|COMPLETED|Period 4||12
8915236|NCT02173535|9974682|FG010|COMPLETED|Period 4||12
8915237|NCT02173535|9974683|FG011|COMPLETED|Period 4||12
8915238|NCT02173535|9974684|FG012|COMPLETED|Period 4||12
8757319|NCT01204671|9806669|FG001|NOT COMPLETED|Overall Study||15
8757320|NCT01204671|9806670|FG002|NOT COMPLETED|Overall Study||13
8757321|NCT01204671|9806671|FG003|NOT COMPLETED|Overall Study||13
8757322|NCT01204671|9806672|FG004|NOT COMPLETED|Overall Study||4
8757323|NCT01204697|9806690|FG000|STARTED|Overall Study||36
8757324|NCT01204697|9806691|FG001|STARTED|Overall Study||38
8757325|NCT01204697|9806690|FG000|Treated|Overall Study||36
8757326|NCT01204697|9806691|FG001|Treated|Overall Study||37
8757327|NCT01204697|9806690|FG000|COMPLETED|Overall Study||5
8757328|NCT01204697|9806691|FG001|COMPLETED|Overall Study||2
8757329|NCT01204697|9806690|FG000|NOT COMPLETED|Overall Study||31
8757330|NCT01204697|9806691|FG001|NOT COMPLETED|Overall Study||36
8757331|NCT01204710|9806699|FG000|STARTED|Randomization Treatment||63
8757332|NCT01204710|9806700|FG001|STARTED|Randomization Treatment||60
8757333|NCT01204710|9806699|FG000|Received ≥1 Dose of Study Drug|Randomization Treatment||62
8757334|NCT01204710|9806700|FG001|Received ≥1 Dose of Study Drug|Randomization Treatment||59
8757335|NCT01204710|9806699|FG000|COMPLETED|Randomization Treatment||49
8757336|NCT01204710|9806700|FG001|COMPLETED|Randomization Treatment||47
8757337|NCT01204710|9806699|FG000|NOT COMPLETED|Randomization Treatment||14
8757338|NCT01204710|9806700|FG001|NOT COMPLETED|Randomization Treatment||13
8757339|NCT01204710|9806699|FG000|STARTED|Optional Olaratumab Monotherapy|Olaratumab follow-on treatment was optional for participants in mitoxantrone group only who had PD.|0
8757340|NCT01204710|9806700|FG001|STARTED|Optional Olaratumab Monotherapy|Among 43 participants who experienced PD, 19 received olaratumab monotherapy.|19
8757341|NCT01204710|9806699|FG000|COMPLETED|Optional Olaratumab Monotherapy||0
8757342|NCT01204710|9806700|FG001|COMPLETED|Optional Olaratumab Monotherapy||16
8757343|NCT01204710|9806699|FG000|NOT COMPLETED|Optional Olaratumab Monotherapy||0
8757344|NCT01204710|9806700|FG001|NOT COMPLETED|Optional Olaratumab Monotherapy||3
8757345|NCT01204736|9806717|FG000|STARTED|Overall Study||4
8757346|NCT01204736|9806718|FG001|STARTED|Overall Study||5
8757347|NCT01204736|9806719|FG002|STARTED|Overall Study||3
8757348|NCT01204736|9806720|FG003|STARTED|Overall Study||2
8757349|NCT01204736|9806717|FG000|COMPLETED|Overall Study||4
8757350|NCT01204736|9806718|FG001|COMPLETED|Overall Study||5
8757351|NCT01204736|9806719|FG002|COMPLETED|Overall Study||3
8757352|NCT01204736|9806720|FG003|COMPLETED|Overall Study||2
8757353|NCT01204736|9806717|FG000|NOT COMPLETED|Overall Study||0
8757354|NCT01204736|9806718|FG001|NOT COMPLETED|Overall Study||0
8757355|NCT01204736|9806719|FG002|NOT COMPLETED|Overall Study||0
8757356|NCT01204736|9806720|FG003|NOT COMPLETED|Overall Study||0
8757357|NCT01204775|9806732|FG000|STARTED|Overall Study||4
8757358|NCT01204775|9806733|FG001|STARTED|Overall Study||4
8757359|NCT01204775|9806732|FG000|Double-blind Treatment Period|Overall Study||4
8757360|NCT01204775|9806733|FG001|Double-blind Treatment Period|Overall Study||4
8757361|NCT01204775|9806732|FG000|COMPLETED|Overall Study||3
8757362|NCT01204775|9806733|FG001|COMPLETED|Overall Study||3
8757363|NCT01204775|9806732|FG000|NOT COMPLETED|Overall Study||1
8757364|NCT01204775|9806733|FG001|NOT COMPLETED|Overall Study||1
8757365|NCT01204853|9806739|FG000|STARTED|Overall Study||2
8757366|NCT01204853|9806739|FG000|COMPLETED|Overall Study||2
8757367|NCT01204853|9806739|FG000|NOT COMPLETED|Overall Study||0
8757368|NCT01204905|9806743|FG000|STARTED|Overall Study||7
8757369|NCT01204905|9806743|FG000|COMPLETED|Overall Study||5
8757370|NCT01204905|9806743|FG000|NOT COMPLETED|Overall Study||2
8757371|NCT01204918|9806750|FG000|STARTED|Overall Study||25
8757372|NCT01204918|9806751|FG001|STARTED|Overall Study||39
8757373|NCT01204918|9806752|FG002|STARTED|Overall Study||40
8757374|NCT01204918|9806750|FG000|Stage 1 Begin|Overall Study||25
8757375|NCT01204918|9806751|FG001|Stage 1 Begin|Overall Study||39
8757376|NCT01204918|9806752|FG002|Stage 1 Begin|Overall Study||40
8757377|NCT01204918|9806750|FG000|Stage 1 End|Overall Study||22
8757378|NCT01204918|9806751|FG001|Stage 1 End|Overall Study||35
8757379|NCT01204918|9806752|FG002|Stage 1 End|Overall Study||36
8757380|NCT01204918|9806750|FG000|Stage 2 Begin|Overall Study||22
8757381|NCT01204918|9806751|FG001|Stage 2 Begin|Overall Study||35
8757382|NCT01204918|9806752|FG002|Stage 2 Begin|Overall Study||36
8757383|NCT01204918|9806750|FG000|Stage 2 End|Overall Study||21
8757384|NCT01204918|9806751|FG001|Stage 2 End|Overall Study||29
8757385|NCT01204918|9806752|FG002|Stage 2 End|Overall Study||35
8757386|NCT01204918|9806750|FG000|COMPLETED|Overall Study||21
8757387|NCT01204918|9806751|FG001|COMPLETED|Overall Study||29
8757388|NCT01204918|9806752|FG002|COMPLETED|Overall Study||35
8757389|NCT01204918|9806750|FG000|NOT COMPLETED|Overall Study||4
8757390|NCT01204918|9806751|FG001|NOT COMPLETED|Overall Study||10
8757391|NCT01204918|9806752|FG002|NOT COMPLETED|Overall Study||5
8757392|NCT01205035|9806762|FG000|STARTED|Overall Study||3
8757393|NCT01205035|9806763|FG001|STARTED|Overall Study||3
8757394|NCT01205035|9806762|FG000|COMPLETED|Overall Study||1
8757395|NCT01205035|9806763|FG001|COMPLETED|Overall Study||3
8757396|NCT01205035|9806762|FG000|NOT COMPLETED|Overall Study||2
8757397|NCT01205035|9806763|FG001|NOT COMPLETED|Overall Study||0
8757398|NCT01205126|9806771|FG000|STARTED|Titration Phase||130
8757399|NCT01205126|9806772|FG001|STARTED|Titration Phase||130
8757400|NCT01205126|9806771|FG000|COMPLETED|Titration Phase||107
8757401|NCT01205126|9806772|FG001|COMPLETED|Titration Phase||111
8757402|NCT01205126|9806771|FG000|NOT COMPLETED|Titration Phase||23
8757403|NCT01205126|9806772|FG001|NOT COMPLETED|Titration Phase||19
8757404|NCT01205126|9806771|FG000|STARTED|Between Titration & Maintenance Phase||107
8757405|NCT01205126|9806772|FG001|STARTED|Between Titration & Maintenance Phase||111
8757406|NCT01205126|9806771|FG000|COMPLETED|Between Titration & Maintenance Phase||107
8757407|NCT01205126|9806772|FG001|COMPLETED|Between Titration & Maintenance Phase||107
8757408|NCT01205126|9806771|FG000|NOT COMPLETED|Between Titration & Maintenance Phase||0
8757409|NCT01205126|9806772|FG001|NOT COMPLETED|Between Titration & Maintenance Phase||4
8757410|NCT01205126|9806771|FG000|STARTED|Maintenance Phase||107
8757411|NCT01205126|9806772|FG001|STARTED|Maintenance Phase||107
8757412|NCT01205126|9806771|FG000|COMPLETED|Maintenance Phase||70
8757413|NCT01205126|9806772|FG001|COMPLETED|Maintenance Phase||67
8757414|NCT01205126|9806771|FG000|NOT COMPLETED|Maintenance Phase||37
8757415|NCT01205126|9806772|FG001|NOT COMPLETED|Maintenance Phase||40
8757416|NCT01205152|9806778|FG000|STARTED|Overall Study||10
8757417|NCT01205152|9806778|FG000|COMPLETED|Overall Study||9
8757418|NCT01205152|9806778|FG000|NOT COMPLETED|Overall Study||1
8757419|NCT01205165|9806784|FG000|STARTED|Overall Study||104
8757420|NCT01205165|9806784|FG000|COMPLETED|Overall Study||102
8757421|NCT01205165|9806784|FG000|NOT COMPLETED|Overall Study||2
8757422|NCT01205230|9806791|FG000|STARTED|Overall Study||21
8757423|NCT01205230|9806792|FG001|STARTED|Overall Study||13
8757424|NCT01205230|9806791|FG000|Combination Therapy|Overall Study||21
8757425|NCT01205230|9806792|FG001|Combination Therapy|Overall Study||13
8757426|NCT01205230|9806791|FG000|COMPLETED|Overall Study||16
8757427|NCT01205230|9806792|FG001|COMPLETED|Overall Study||13
8757428|NCT01205230|9806791|FG000|NOT COMPLETED|Overall Study||5
8757429|NCT01205230|9806792|FG001|NOT COMPLETED|Overall Study||0
8757430|NCT01205269|9806803|FG000|STARTED|Period 1 - First Intervention||4
8757431|NCT01205269|9806804|FG001|STARTED|Period 1 - First Intervention||4
8757432|NCT01205269|9806805|FG002|STARTED|Period 1 - First Intervention||4
8757433|NCT01205269|9806806|FG003|STARTED|Period 1 - First Intervention||6
8757434|NCT01205269|9806807|FG004|STARTED|Period 1 - First Intervention||5
8757435|NCT01205269|9806808|FG005|STARTED|Period 1 - First Intervention||5
8757436|NCT01205269|9806803|FG000|COMPLETED|Period 1 - First Intervention||4
8757437|NCT01205269|9806804|FG001|COMPLETED|Period 1 - First Intervention||4
8757438|NCT01205269|9806805|FG002|COMPLETED|Period 1 - First Intervention||4
8757439|NCT01205269|9806806|FG003|COMPLETED|Period 1 - First Intervention||6
8757440|NCT01205269|9806807|FG004|COMPLETED|Period 1 - First Intervention||5
8757441|NCT01205269|9806808|FG005|COMPLETED|Period 1 - First Intervention||5
8757442|NCT01205269|9806803|FG000|NOT COMPLETED|Period 1 - First Intervention||0
8757443|NCT01205269|9806804|FG001|NOT COMPLETED|Period 1 - First Intervention||0
8757444|NCT01205269|9806805|FG002|NOT COMPLETED|Period 1 - First Intervention||0
8757445|NCT01205269|9806806|FG003|NOT COMPLETED|Period 1 - First Intervention||0
8757446|NCT01205269|9806807|FG004|NOT COMPLETED|Period 1 - First Intervention||0
8757447|NCT01205269|9806808|FG005|NOT COMPLETED|Period 1 - First Intervention||0
8757448|NCT01205269|9806803|FG000|STARTED|Period 2 - Washout||4
8757449|NCT01205269|9806804|FG001|STARTED|Period 2 - Washout||4
8757450|NCT01205269|9806805|FG002|STARTED|Period 2 - Washout||4
8757451|NCT01205269|9806806|FG003|STARTED|Period 2 - Washout||6
8757452|NCT01205269|9806807|FG004|STARTED|Period 2 - Washout||5
8757453|NCT01205269|9806808|FG005|STARTED|Period 2 - Washout||5
8757454|NCT01205269|9806803|FG000|COMPLETED|Period 2 - Washout||4
8757455|NCT01205269|9806804|FG001|COMPLETED|Period 2 - Washout||4
8757456|NCT01205269|9806805|FG002|COMPLETED|Period 2 - Washout||4
8757457|NCT01205269|9806806|FG003|COMPLETED|Period 2 - Washout||6
8757458|NCT01205269|9806807|FG004|COMPLETED|Period 2 - Washout||5
8757459|NCT01205269|9806808|FG005|COMPLETED|Period 2 - Washout||5
8757460|NCT01205269|9806803|FG000|NOT COMPLETED|Period 2 - Washout||0
8757461|NCT01205269|9806804|FG001|NOT COMPLETED|Period 2 - Washout||0
8757462|NCT01205269|9806805|FG002|NOT COMPLETED|Period 2 - Washout||0
8757463|NCT01205269|9806806|FG003|NOT COMPLETED|Period 2 - Washout||0
8757464|NCT01205269|9806807|FG004|NOT COMPLETED|Period 2 - Washout||0
8757465|NCT01205269|9806808|FG005|NOT COMPLETED|Period 2 - Washout||0
8757466|NCT01205269|9806803|FG000|STARTED|Period 3 - Second Intervention||4
8915239|NCT02173535|9974685|FG013|COMPLETED|Period 4||12
8915240|NCT02173535|9974686|FG014|COMPLETED|Period 4||12
8915241|NCT02173535|9974687|FG015|COMPLETED|Period 4||12
8915242|NCT02173535|9974688|FG016|COMPLETED|Period 4||12
8915243|NCT02173535|9974689|FG017|COMPLETED|Period 4||12
8915244|NCT02173535|9974690|FG018|COMPLETED|Period 4||12
8915245|NCT02173535|9974691|FG019|COMPLETED|Period 4||12
8915246|NCT02173535|9974672|FG000|NOT COMPLETED|Period 4||0
8915247|NCT02173535|9974673|FG001|NOT COMPLETED|Period 4||0
8915248|NCT02173535|9974674|FG002|NOT COMPLETED|Period 4||0
8915249|NCT02173535|9974675|FG003|NOT COMPLETED|Period 4||0
8915250|NCT02173535|9974676|FG004|NOT COMPLETED|Period 4||0
8915251|NCT02173535|9974677|FG005|NOT COMPLETED|Period 4||0
8915252|NCT02173535|9974678|FG006|NOT COMPLETED|Period 4||0
8915253|NCT02173535|9974679|FG007|NOT COMPLETED|Period 4||0
8915254|NCT02173535|9974680|FG008|NOT COMPLETED|Period 4||0
8915255|NCT02173535|9974681|FG009|NOT COMPLETED|Period 4||0
8915256|NCT02173535|9974682|FG010|NOT COMPLETED|Period 4||0
8915257|NCT02173535|9974683|FG011|NOT COMPLETED|Period 4||0
8915258|NCT02173535|9974684|FG012|NOT COMPLETED|Period 4||0
8757467|NCT01205269|9806804|FG001|STARTED|Period 3 - Second Intervention||4
8757468|NCT01205269|9806805|FG002|STARTED|Period 3 - Second Intervention||4
8757469|NCT01205269|9806806|FG003|STARTED|Period 3 - Second Intervention||6
8915259|NCT02173535|9974685|FG013|NOT COMPLETED|Period 4||0
8915260|NCT02173535|9974686|FG014|NOT COMPLETED|Period 4||0
8915261|NCT02173535|9974687|FG015|NOT COMPLETED|Period 4||0
8915262|NCT02173535|9974688|FG016|NOT COMPLETED|Period 4||0
8757470|NCT01205269|9806807|FG004|STARTED|Period 3 - Second Intervention||5
8757471|NCT01205269|9806808|FG005|STARTED|Period 3 - Second Intervention||5
8757472|NCT01205269|9806803|FG000|COMPLETED|Period 3 - Second Intervention||4
8757473|NCT01205269|9806804|FG001|COMPLETED|Period 3 - Second Intervention||4
8757474|NCT01205269|9806805|FG002|COMPLETED|Period 3 - Second Intervention||4
8757475|NCT01205269|9806806|FG003|COMPLETED|Period 3 - Second Intervention||6
8757476|NCT01205269|9806807|FG004|COMPLETED|Period 3 - Second Intervention||5
8757477|NCT01205269|9806808|FG005|COMPLETED|Period 3 - Second Intervention||5
8757478|NCT01205269|9806803|FG000|NOT COMPLETED|Period 3 - Second Intervention||0
8757479|NCT01205269|9806804|FG001|NOT COMPLETED|Period 3 - Second Intervention||0
8757480|NCT01205269|9806805|FG002|NOT COMPLETED|Period 3 - Second Intervention||0
8757481|NCT01205269|9806806|FG003|NOT COMPLETED|Period 3 - Second Intervention||0
8757482|NCT01205269|9806807|FG004|NOT COMPLETED|Period 3 - Second Intervention||0
8757483|NCT01205269|9806808|FG005|NOT COMPLETED|Period 3 - Second Intervention||0
8757484|NCT01205269|9806803|FG000|STARTED|Period 4 - Washout||4
8757485|NCT01205269|9806804|FG001|STARTED|Period 4 - Washout||4
8757486|NCT01205269|9806805|FG002|STARTED|Period 4 - Washout||4
8757487|NCT01205269|9806806|FG003|STARTED|Period 4 - Washout||6
8757488|NCT01205269|9806807|FG004|STARTED|Period 4 - Washout||5
8757489|NCT01205269|9806808|FG005|STARTED|Period 4 - Washout||5
8757490|NCT01205269|9806803|FG000|COMPLETED|Period 4 - Washout||4
8757491|NCT01205269|9806804|FG001|COMPLETED|Period 4 - Washout||4
8757492|NCT01205269|9806805|FG002|COMPLETED|Period 4 - Washout||4
8757493|NCT01205269|9806806|FG003|COMPLETED|Period 4 - Washout||5
8757494|NCT01205269|9806807|FG004|COMPLETED|Period 4 - Washout||5
8757495|NCT01205269|9806808|FG005|COMPLETED|Period 4 - Washout||5
8757496|NCT01205269|9806803|FG000|NOT COMPLETED|Period 4 - Washout||0
8757497|NCT01205269|9806804|FG001|NOT COMPLETED|Period 4 - Washout||0
8757498|NCT01205269|9806805|FG002|NOT COMPLETED|Period 4 - Washout||0
8757499|NCT01205269|9806806|FG003|NOT COMPLETED|Period 4 - Washout||1
8757500|NCT01205269|9806807|FG004|NOT COMPLETED|Period 4 - Washout||0
8757501|NCT01205269|9806808|FG005|NOT COMPLETED|Period 4 - Washout||0
8757502|NCT01205269|9806803|FG000|STARTED|Period 5 - Third Intervention||4
8757503|NCT01205269|9806804|FG001|STARTED|Period 5 - Third Intervention||4
8757504|NCT01205269|9806805|FG002|STARTED|Period 5 - Third Intervention||4
8757505|NCT01205269|9806806|FG003|STARTED|Period 5 - Third Intervention||5
8757506|NCT01205269|9806807|FG004|STARTED|Period 5 - Third Intervention||5
8757507|NCT01205269|9806808|FG005|STARTED|Period 5 - Third Intervention||5
8757508|NCT01205269|9806803|FG000|COMPLETED|Period 5 - Third Intervention||4
8757509|NCT01205269|9806804|FG001|COMPLETED|Period 5 - Third Intervention||4
8757510|NCT01205269|9806805|FG002|COMPLETED|Period 5 - Third Intervention||4
8757511|NCT01205269|9806806|FG003|COMPLETED|Period 5 - Third Intervention||5
8757512|NCT01205269|9806807|FG004|COMPLETED|Period 5 - Third Intervention||5
8757513|NCT01205269|9806808|FG005|COMPLETED|Period 5 - Third Intervention||5
8757514|NCT01205269|9806803|FG000|NOT COMPLETED|Period 5 - Third Intervention||0
8757515|NCT01205269|9806804|FG001|NOT COMPLETED|Period 5 - Third Intervention||0
8757516|NCT01205269|9806805|FG002|NOT COMPLETED|Period 5 - Third Intervention||0
8757517|NCT01205269|9806806|FG003|NOT COMPLETED|Period 5 - Third Intervention||0
8757518|NCT01205269|9806807|FG004|NOT COMPLETED|Period 5 - Third Intervention||0
8757519|NCT01205269|9806808|FG005|NOT COMPLETED|Period 5 - Third Intervention||0
8757520|NCT01205399|9806816|FG000|STARTED|Overall Study||78
8757521|NCT01205399|9806816|FG000|COMPLETED|Overall Study||78
8757522|NCT01205399|9806816|FG000|NOT COMPLETED|Overall Study||0
8757523|NCT01205438|9806823|FG000|STARTED|Overall Study||372
8757524|NCT01205438|9806824|FG001|STARTED|Overall Study||376
8757525|NCT01205438|9806825|FG002|STARTED|Overall Study||376
8757526|NCT01205438|9806823|FG000|Received At Least One Dose of Study Drug|Overall Study||371
8757527|NCT01205438|9806824|FG001|Received At Least One Dose of Study Drug|Overall Study||374
8757528|NCT01205438|9806825|FG002|Received At Least One Dose of Study Drug|Overall Study||376
8757529|NCT01205438|9806823|FG000|Participated in Follow Up|Overall Study||72
8757530|NCT01205438|9806824|FG001|Participated in Follow Up|Overall Study||78
8757531|NCT01205438|9806825|FG002|Participated in Follow Up|Overall Study||66
8757532|NCT01205438|9806823|FG000|COMPLETED|Overall Study||295
8757533|NCT01205438|9806824|FG001|COMPLETED|Overall Study||289
8757534|NCT01205438|9806825|FG002|COMPLETED|Overall Study||288
8757535|NCT01205438|9806823|FG000|NOT COMPLETED|Overall Study||77
8757536|NCT01205438|9806824|FG001|NOT COMPLETED|Overall Study||87
8757537|NCT01205438|9806825|FG002|NOT COMPLETED|Overall Study||88
8757538|NCT01205451|9806838|FG000|STARTED|Overall Study||53
8757539|NCT01205451|9806839|FG001|STARTED|Overall Study||56
8757540|NCT01205451|9806838|FG000|COMPLETED|Overall Study||47
8757541|NCT01205451|9806839|FG001|COMPLETED|Overall Study||46
8757542|NCT01205451|9806838|FG000|NOT COMPLETED|Overall Study||6
8757543|NCT01205451|9806839|FG001|NOT COMPLETED|Overall Study||10
8757544|NCT01205503|9806847|FG000|STARTED|First Intervention (1st Cycle)||16
8757545|NCT01205503|9806848|FG001|STARTED|First Intervention (1st Cycle)||16
8757546|NCT01205503|9806847|FG000|COMPLETED|First Intervention (1st Cycle)||16
8757547|NCT01205503|9806848|FG001|COMPLETED|First Intervention (1st Cycle)||16
8757548|NCT01205503|9806847|FG000|NOT COMPLETED|First Intervention (1st Cycle)||0
8757549|NCT01205503|9806848|FG001|NOT COMPLETED|First Intervention (1st Cycle)||0
8757550|NCT01205503|9806847|FG000|STARTED|Second Intervention (2nd Cycle)||16
8757551|NCT01205503|9806848|FG001|STARTED|Second Intervention (2nd Cycle)||16
8757552|NCT01205503|9806847|FG000|COMPLETED|Second Intervention (2nd Cycle)||16
8757553|NCT01205503|9806848|FG001|COMPLETED|Second Intervention (2nd Cycle)||16
8757554|NCT01205503|9806847|FG000|NOT COMPLETED|Second Intervention (2nd Cycle)||0
8757555|NCT01205503|9806848|FG001|NOT COMPLETED|Second Intervention (2nd Cycle)||0
8757556|NCT01205529|9806854|FG000|STARTED|Overall Study||161
8757557|NCT01205529|9806854|FG000|COMPLETED|Overall Study||106
8757558|NCT01205529|9806854|FG000|NOT COMPLETED|Overall Study||55
8757559|NCT01205568|9806858|FG000|STARTED|Overall Study|26 patients received only CB therapy, 39 patients received both CB and HPB therapy.|65
8757560|NCT01205568|9806859|FG001|STARTED|Overall Study|8 patients received only HPB therapy, 39 patients received both CB and HPB therapy.|47
8757561|NCT01205568|9806858|FG000|COMPLETED|Overall Study||65
8757562|NCT01205568|9806859|FG001|COMPLETED|Overall Study||47
8757563|NCT01205568|9806858|FG000|NOT COMPLETED|Overall Study||0
8757564|NCT01205568|9806859|FG001|NOT COMPLETED|Overall Study||0
8757565|NCT01205581|9806869|FG000|STARTED|Overall Study||14
8757566|NCT01205581|9806870|FG001|STARTED|Overall Study||13
8757567|NCT01205581|9806871|FG002|STARTED|Overall Study||8
8757568|NCT01205581|9806872|FG003|STARTED|Overall Study||9
8757569|NCT01205581|9806873|FG004|STARTED|Overall Study||20
8757570|NCT01205581|9806874|FG005|STARTED|Overall Study||20
8757571|NCT01205581|9806869|FG000|COMPLETED|Overall Study||13
8757572|NCT01205581|9806870|FG001|COMPLETED|Overall Study||13
8757573|NCT01205581|9806871|FG002|COMPLETED|Overall Study||8
8757574|NCT01205581|9806872|FG003|COMPLETED|Overall Study||9
8757575|NCT01205581|9806873|FG004|COMPLETED|Overall Study||20
8757576|NCT01205581|9806874|FG005|COMPLETED|Overall Study||20
8757577|NCT01205581|9806869|FG000|NOT COMPLETED|Overall Study||1
8757578|NCT01205581|9806870|FG001|NOT COMPLETED|Overall Study||0
8757579|NCT01205581|9806871|FG002|NOT COMPLETED|Overall Study||0
8757580|NCT01205581|9806872|FG003|NOT COMPLETED|Overall Study||0
8757581|NCT01205581|9806873|FG004|NOT COMPLETED|Overall Study||0
8757582|NCT01205581|9806874|FG005|NOT COMPLETED|Overall Study||0
8757583|NCT01205646|9806905|FG000|STARTED|Overall Study||11
8757584|NCT01205646|9806905|FG000|COMPLETED|Overall Study||11
8757585|NCT01205646|9806905|FG000|NOT COMPLETED|Overall Study||0
8757586|NCT01205685|9806909|FG000|STARTED|Overall Study||11
8757587|NCT01205685|9806909|FG000|COMPLETED|Overall Study||0
8757588|NCT01205685|9806909|FG000|NOT COMPLETED|Overall Study||11
8757589|NCT01205776|9806915|FG000|STARTED|Overall Study||948
8757590|NCT01205776|9806916|FG001|STARTED|Overall Study||957
8757591|NCT01205776|9806915|FG000|COMPLETED|Overall Study||884
8757592|NCT01205776|9806916|FG001|COMPLETED|Overall Study||862
8757593|NCT01205776|9806915|FG000|NOT COMPLETED|Overall Study||64
8757594|NCT01205776|9806916|FG001|NOT COMPLETED|Overall Study||95
8757595|NCT01205828|9806922|FG000|STARTED|Overall Study||16
8757596|NCT01205828|9806922|FG000|COMPLETED|Overall Study|Completed the first stage of the study, terminated as pre-planned due to lack of efficacy|16
8757597|NCT01205828|9806922|FG000|NOT COMPLETED|Overall Study||0
8757598|NCT01206062|9806929|FG000|STARTED|Overall Study||4678
8757599|NCT01206062|9806930|FG001|STARTED|Overall Study||4683
8757600|NCT01206062|9806929|FG000|COMPLETED|Overall Study||4678
8757601|NCT01206062|9806930|FG001|COMPLETED|Overall Study||4683
8757602|NCT01206062|9806929|FG000|NOT COMPLETED|Overall Study||0
8757603|NCT01206062|9806930|FG001|NOT COMPLETED|Overall Study||0
8757604|NCT01206140|9806940|FG000|STARTED|Overall Study||35
8757605|NCT01206140|9806941|FG001|STARTED|Overall Study||35
8757606|NCT01206140|9806940|FG000|COMPLETED|Overall Study||34
8757607|NCT01206140|9806941|FG001|COMPLETED|Overall Study||35
8757608|NCT01206140|9806940|FG000|NOT COMPLETED|Overall Study||1
8757609|NCT01206140|9806941|FG001|NOT COMPLETED|Overall Study||0
8757610|NCT01206166|9806949|FG000|STARTED|Overall Study||73
8757611|NCT01206166|9806950|FG001|STARTED|Overall Study||52
8757612|NCT01206166|9806949|FG000|COMPLETED|Overall Study||71
8757613|NCT01206166|9806950|FG001|COMPLETED|Overall Study||49
8757614|NCT01206166|9806949|FG000|NOT COMPLETED|Overall Study||2
9024816|NCT03154086|10087313|FG011|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
9024817|NCT03154086|10087314|FG012|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
9024818|NCT03154086|10087315|FG013|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
9024819|NCT03154086|10087316|FG014|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
9024820|NCT03154086|10087302|FG000|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
9024821|NCT03154086|10087303|FG001|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
9024822|NCT03154086|10087304|FG002|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
9024823|NCT03154086|10087305|FG003|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8757615|NCT01206166|9806950|FG001|NOT COMPLETED|Overall Study||3
8757616|NCT01206322|9806961|FG000|STARTED|Overall Study||4
8757617|NCT01206322|9806962|FG001|STARTED|Overall Study||11
8757618|NCT01206322|9806963|FG002|STARTED|Overall Study||9
8757619|NCT01206322|9806964|FG003|STARTED|Overall Study||6
8757620|NCT01206322|9806961|FG000|COMPLETED|Overall Study||4
8757621|NCT01206322|9806962|FG001|COMPLETED|Overall Study||11
8757622|NCT01206322|9806963|FG002|COMPLETED|Overall Study||9
8757623|NCT01206322|9806964|FG003|COMPLETED|Overall Study||5
8757624|NCT01206322|9806961|FG000|NOT COMPLETED|Overall Study||0
8757625|NCT01206322|9806962|FG001|NOT COMPLETED|Overall Study||0
8757626|NCT01206322|9806963|FG002|NOT COMPLETED|Overall Study||0
9024824|NCT03154086|10087306|FG004|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||6
8757627|NCT01206322|9806964|FG003|NOT COMPLETED|Overall Study||1
8757628|NCT01206387|9806976|FG000|STARTED|Overall Study||60
8757629|NCT01206387|9806977|FG001|STARTED|Overall Study||60
8757630|NCT01206387|9806976|FG000|COMPLETED|Overall Study||59
8757631|NCT01206387|9806977|FG001|COMPLETED|Overall Study||60
8757632|NCT01206387|9806976|FG000|NOT COMPLETED|Overall Study||1
8757633|NCT01206387|9806977|FG001|NOT COMPLETED|Overall Study||0
8757634|NCT01206452|9806985|FG000|STARTED|Overall Study||30
8757635|NCT01206452|9806986|FG001|STARTED|Overall Study||30
8757636|NCT01206452|9806985|FG000|COMPLETED|Overall Study||30
8757637|NCT01206452|9806986|FG001|COMPLETED|Overall Study||30
8757638|NCT01206452|9806985|FG000|NOT COMPLETED|Overall Study||0
8757639|NCT01206452|9806986|FG001|NOT COMPLETED|Overall Study||0
8757640|NCT01206465|9806992|FG000|STARTED|Overall Study||3
8757641|NCT01206465|9806993|FG001|STARTED|Overall Study||6
8757642|NCT01206465|9806994|FG002|STARTED|Overall Study||6
8757643|NCT01206465|9806995|FG003|STARTED|Overall Study||6
8757644|NCT01206465|9806996|FG004|STARTED|Overall Study||6
8757645|NCT01206465|9806992|FG000|COMPLETED|Overall Study||3
8757646|NCT01206465|9806993|FG001|COMPLETED|Overall Study||6
8757647|NCT01206465|9806994|FG002|COMPLETED|Overall Study||6
8757648|NCT01206465|9806995|FG003|COMPLETED|Overall Study||6
8757649|NCT01206465|9806996|FG004|COMPLETED|Overall Study||6
8757650|NCT01206465|9806992|FG000|NOT COMPLETED|Overall Study||0
8757651|NCT01206465|9806993|FG001|NOT COMPLETED|Overall Study||0
8757652|NCT01206465|9806994|FG002|NOT COMPLETED|Overall Study||0
8757653|NCT01206465|9806995|FG003|NOT COMPLETED|Overall Study||0
9024825|NCT03154086|10087307|FG005|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||2
9024826|NCT03154086|10087308|FG006|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
9024827|NCT03154086|10087309|FG007|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
9024828|NCT03154086|10087310|FG008|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
9024829|NCT03154086|10087311|FG009|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
9024830|NCT03154086|10087312|FG010|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
9024831|NCT03154086|10087313|FG011|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
9024832|NCT03154086|10087314|FG012|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
9024833|NCT03154086|10087315|FG013|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
9024834|NCT03154086|10087316|FG014|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
9024835|NCT03154086|10087302|FG000|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
9024836|NCT03154086|10087303|FG001|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
9024837|NCT03154086|10087304|FG002|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
9024838|NCT03154086|10087305|FG003|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
9024839|NCT03154086|10087306|FG004|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||6
9024840|NCT03154086|10087307|FG005|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||2
9024841|NCT03154086|10087308|FG006|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
9024842|NCT03154086|10087309|FG007|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
9024843|NCT03154086|10087310|FG008|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
9024844|NCT03154086|10087311|FG009|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
9024845|NCT03154086|10087312|FG010|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
9024846|NCT03154086|10087313|FG011|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
9024847|NCT03154086|10087314|FG012|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
9024848|NCT03154086|10087315|FG013|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
9024849|NCT03154086|10087316|FG014|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
9024850|NCT03154086|10087302|FG000|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
9024851|NCT03154086|10087303|FG001|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
9024852|NCT03154086|10087304|FG002|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
9024853|NCT03154086|10087305|FG003|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
9024854|NCT03154086|10087306|FG004|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
9024855|NCT03154086|10087307|FG005|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
9024856|NCT03154086|10087308|FG006|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
9024857|NCT03154086|10087309|FG007|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
9024858|NCT03154086|10087310|FG008|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
9024859|NCT03154086|10087311|FG009|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
9024860|NCT03154086|10087312|FG010|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
9024861|NCT03154086|10087313|FG011|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
9024862|NCT03154086|10087314|FG012|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
9024863|NCT03154086|10087315|FG013|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
9024864|NCT03154086|10087316|FG014|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
9024865|NCT03154086|10087302|FG000|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
9024866|NCT03154086|10087303|FG001|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
9024867|NCT03154086|10087304|FG002|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
9024868|NCT03154086|10087305|FG003|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
9024869|NCT03154086|10087306|FG004|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||6
9024870|NCT03154086|10087307|FG005|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||2
9024871|NCT03154086|10087308|FG006|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
9024872|NCT03154086|10087309|FG007|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
9024873|NCT03154086|10087310|FG008|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
9024874|NCT03154086|10087311|FG009|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8757654|NCT01206465|9806996|FG004|NOT COMPLETED|Overall Study||0
8757655|NCT01206478|9807014|FG000|STARTED|Overall Study||9
8757656|NCT01206478|9807015|FG001|STARTED|Overall Study||12
8757657|NCT01206478|9807014|FG000|COMPLETED|Overall Study||7
8757658|NCT01206478|9807015|FG001|COMPLETED|Overall Study||7
8757659|NCT01206478|9807014|FG000|NOT COMPLETED|Overall Study||2
8757660|NCT01206478|9807015|FG001|NOT COMPLETED|Overall Study||5
8757661|NCT01206582|9807023|FG000|STARTED|Overall Study||11
8757662|NCT01206582|9807024|FG001|STARTED|Overall Study||9
8757663|NCT01206582|9807023|FG000|COMPLETED|Overall Study||9
8757664|NCT01206582|9807024|FG001|COMPLETED|Overall Study||7
8757665|NCT01206582|9807023|FG000|NOT COMPLETED|Overall Study||2
8757666|NCT01206582|9807024|FG001|NOT COMPLETED|Overall Study||2
8757667|NCT01206595|9807032|FG000|STARTED|Overall Study||38
8757668|NCT01206595|9807033|FG001|STARTED|Overall Study||20
8757669|NCT01206595|9807032|FG000|COMPLETED|Overall Study||38
8757670|NCT01206595|9807033|FG001|COMPLETED|Overall Study||20
8757671|NCT01206595|9807032|FG000|NOT COMPLETED|Overall Study||0
8757672|NCT01206595|9807033|FG001|NOT COMPLETED|Overall Study||0
8757673|NCT01206608|9807043|FG000|STARTED|Overall Study||20
8757674|NCT01206608|9807044|FG001|STARTED|Overall Study||20
8757675|NCT01206608|9807043|FG000|COMPLETED|Overall Study||20
8757676|NCT01206608|9807044|FG001|COMPLETED|Overall Study||20
8757677|NCT01206608|9807043|FG000|NOT COMPLETED|Overall Study||0
8757678|NCT01206608|9807044|FG001|NOT COMPLETED|Overall Study||0
8671044|NCT00749996|9714516|FG000|6 Months Follow-up|Overall Study|Visit not done (n=3)|71
8671045|NCT00749996|9714517|FG001|6 Months Follow-up|Overall Study|Withdrawn (n=3). Visit not done (n=3)|63
8671046|NCT00749996|9714516|FG000|12 Months Follow-up|Overall Study|Withdrawn(n=4). Visit not done (n=2)|68
8671047|NCT00749996|9714517|FG001|12 Months Follow-up|Overall Study|Withdrawn (n=1). Visit not done (n=4). Lost to follow-up (n=1)|60
8671048|NCT00749996|9714516|FG000|24 Months Follow up|Overall Study|Withdrawn (n=5) Accidental death (n=1) Lost to follow up (n=7)|57
8671049|NCT00749996|9714517|FG001|24 Months Follow up|Overall Study|Withdrawn (n=3). Lost to follow-up (n=3)|58
8757679|NCT01206660|9807052|FG000|STARTED|Overall Study||60
8757680|NCT01206660|9807053|FG001|STARTED|Overall Study||60
8757681|NCT01206660|9807052|FG000|COMPLETED|Overall Study||60
8757682|NCT01206660|9807053|FG001|COMPLETED|Overall Study||60
8757683|NCT01206660|9807052|FG000|NOT COMPLETED|Overall Study||0
8757684|NCT01206660|9807053|FG001|NOT COMPLETED|Overall Study||0
8757685|NCT01206738|9807062|FG000|STARTED|Overall Study||63
8757686|NCT01206738|9807063|FG001|STARTED|Overall Study||74
8757687|NCT01206738|9807064|FG002|STARTED|Overall Study||61
8757688|NCT01206738|9807062|FG000|COMPLETED|Overall Study||40
8757689|NCT01206738|9807063|FG001|COMPLETED|Overall Study||49
8757690|NCT01206738|9807064|FG002|COMPLETED|Overall Study||42
8757691|NCT01206738|9807062|FG000|NOT COMPLETED|Overall Study||23
8757692|NCT01206738|9807063|FG001|NOT COMPLETED|Overall Study||25
8757693|NCT01206738|9807064|FG002|NOT COMPLETED|Overall Study||19
8757694|NCT01206764|9807074|FG000|STARTED|Overall Study||142
8757695|NCT01206764|9807074|FG000|COMPLETED|Overall Study||4
8757696|NCT01206764|9807074|FG000|NOT COMPLETED|Overall Study||138
8757697|NCT01206777|9807078|FG000|STARTED|Overall Study||52
8757698|NCT01206777|9807078|FG000|Discontinued Trial and Deemed Ineligible|Overall Study||2
8757699|NCT01206777|9807078|FG000|COMPLETED|Overall Study||50
8757700|NCT01206777|9807078|FG000|NOT COMPLETED|Overall Study||2
8757701|NCT01206816|9807089|FG000|STARTED|Overall Study|Started=Treated|3
8757702|NCT01206816|9807090|FG001|STARTED|Overall Study|Started=Treated|3
8757703|NCT01206816|9807091|FG002|STARTED|Overall Study|Started=Treated|20
8757704|NCT01206816|9807092|FG003|STARTED|Overall Study|Started=Treated|3
8757705|NCT01206816|9807093|FG004|STARTED|Overall Study|Started=Treated|3
8757706|NCT01206816|9807094|FG005|STARTED|Overall Study|Started=Treated|19
8757707|NCT01206816|9807095|FG006|STARTED|Overall Study|Started=Treated|6
8757708|NCT01206816|9807089|FG000|COMPLETED|Overall Study||0
8757709|NCT01206816|9807090|FG001|COMPLETED|Overall Study||0
8757710|NCT01206816|9807091|FG002|COMPLETED|Overall Study|1pt dist.due to 'Other AE' for vol& since 'other' from aftb.1pt 'PD' for vol& since,'DLT' from aftb|0
8757711|NCT01206816|9807092|FG003|COMPLETED|Overall Study|1pt discontinue (dist.)due to 'PD' for vol.& since, 'Other AE' from aftb|0
8757712|NCT01206816|9807093|FG004|COMPLETED|Overall Study||0
8757713|NCT01206816|9807094|FG005|COMPLETED|Overall Study|1pt dist. due to 'PD' for vol & since, 'Other AE' from aftb|0
8757714|NCT01206816|9807095|FG006|COMPLETED|Overall Study|1pt dist. due to 'other AE' & 1pt 'other' for vol & since,'PD' from aftb.|0
8757715|NCT01206816|9807089|FG000|NOT COMPLETED|Overall Study||3
8757716|NCT01206816|9807090|FG001|NOT COMPLETED|Overall Study||3
8757717|NCT01206816|9807091|FG002|NOT COMPLETED|Overall Study||20
8757718|NCT01206816|9807092|FG003|NOT COMPLETED|Overall Study||3
8757719|NCT01206816|9807093|FG004|NOT COMPLETED|Overall Study||3
8757720|NCT01206816|9807094|FG005|NOT COMPLETED|Overall Study||19
8757721|NCT01206816|9807095|FG006|NOT COMPLETED|Overall Study||6
8757722|NCT01207219|9807118|FG000|STARTED|Overall Study||45
8757723|NCT01207219|9807119|FG001|STARTED|Overall Study||40
8757724|NCT01207219|9807120|FG002|STARTED|Overall Study||39
8757725|NCT01207219|9807118|FG000|Included in ITT Analysis|Overall Study||40
8757726|NCT01207219|9807119|FG001|Included in ITT Analysis|Overall Study||37
8757727|NCT01207219|9807120|FG002|Included in ITT Analysis|Overall Study||38
8757728|NCT01207219|9807118|FG000|COMPLETED|Overall Study||34
8757729|NCT01207219|9807119|FG001|COMPLETED|Overall Study||29
8757730|NCT01207219|9807120|FG002|COMPLETED|Overall Study||32
8757731|NCT01207219|9807118|FG000|NOT COMPLETED|Overall Study||11
8671050|NCT00749996|9714516|FG000|COMPLETED|Overall Study||57
8671051|NCT00749996|9714517|FG001|COMPLETED|Overall Study||58
8671052|NCT00749996|9714516|FG000|NOT COMPLETED|Overall Study||18
8671053|NCT00749996|9714517|FG001|NOT COMPLETED|Overall Study||13
8671054|NCT00750061|9714525|FG000|STARTED|Overall Study||20
8671055|NCT00750061|9714526|FG001|STARTED|Overall Study||20
9024875|NCT03154086|10087312|FG010|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
9024876|NCT03154086|10087313|FG011|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
9024877|NCT03154086|10087314|FG012|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
9024878|NCT03154086|10087315|FG013|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
9024879|NCT03154086|10087316|FG014|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
9024880|NCT03154086|10087302|FG000|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
9024881|NCT03154086|10087303|FG001|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
9024882|NCT03154086|10087304|FG002|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
9024883|NCT03154086|10087305|FG003|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
9024884|NCT03154086|10087306|FG004|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||6
9024885|NCT03154086|10087307|FG005|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||2
9024886|NCT03154086|10087308|FG006|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
9024887|NCT03154086|10087309|FG007|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8671056|NCT00750061|9714525|FG000|COMPLETED|Overall Study||18
8671057|NCT00750061|9714526|FG001|COMPLETED|Overall Study||18
8671058|NCT00750061|9714525|FG000|NOT COMPLETED|Overall Study||2
8671059|NCT00750061|9714526|FG001|NOT COMPLETED|Overall Study||2
8671060|NCT00750139|9714536|FG000|STARTED|Overall Study||234
8671061|NCT00750139|9714537|FG001|STARTED|Overall Study||118
8671062|NCT00750139|9714538|FG002|STARTED|Overall Study||236
8671063|NCT00750139|9714539|FG003|STARTED|Overall Study||119
8671064|NCT00750139|9714536|FG000|COMPLETED|Overall Study||145
8671065|NCT00750139|9714537|FG001|COMPLETED|Overall Study||59
8671066|NCT00750139|9714538|FG002|COMPLETED|Overall Study||135
8671067|NCT00750139|9714539|FG003|COMPLETED|Overall Study||73
8671068|NCT00750139|9714536|FG000|NOT COMPLETED|Overall Study||89
8671069|NCT00750139|9714537|FG001|NOT COMPLETED|Overall Study||59
8671070|NCT00750139|9714538|FG002|NOT COMPLETED|Overall Study||101
8671071|NCT00750139|9714539|FG003|NOT COMPLETED|Overall Study||46
8671072|NCT00750152|9714553|FG000|STARTED|Overall Study||166
8671073|NCT00750152|9714554|FG001|STARTED|Overall Study||168
8671074|NCT00750152|9714553|FG000|COMPLETED|Overall Study||144
8671075|NCT00750152|9714554|FG001|COMPLETED|Overall Study||141
8671076|NCT00750152|9714553|FG000|NOT COMPLETED|Overall Study||22
8671077|NCT00750152|9714554|FG001|NOT COMPLETED|Overall Study||27
8671078|NCT00750165|9714560|FG000|STARTED|Overall Study||32
8671079|NCT00750165|9714560|FG000|COMPLETED|Overall Study||21
8671080|NCT00750165|9714560|FG000|NOT COMPLETED|Overall Study||11
8671081|NCT00750191|9714566|FG000|STARTED|Overall Study||27
8671082|NCT00750191|9714567|FG001|STARTED|Overall Study||30
8671083|NCT00750191|9714566|FG000|COMPLETED|Overall Study||22
8671084|NCT00750191|9714567|FG001|COMPLETED|Overall Study||20
8671085|NCT00750191|9714566|FG000|NOT COMPLETED|Overall Study||5
8671086|NCT00750191|9714567|FG001|NOT COMPLETED|Overall Study||10
8671087|NCT00750269|9714578|FG000|STARTED|Overall Study||8
8671088|NCT00750269|9714579|FG001|STARTED|Overall Study||8
8671089|NCT00750269|9714580|FG002|STARTED|Overall Study||18
8671090|NCT00750269|9714581|FG003|STARTED|Overall Study||43
8671091|NCT00750269|9714582|FG004|STARTED|Overall Study||43
8671092|NCT00750269|9714578|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study|8
8671093|NCT00750269|9714579|FG001|COMPLETED|Overall Study||7
8671094|NCT00750269|9714580|FG002|COMPLETED|Overall Study||14
8671095|NCT00750269|9714581|FG003|COMPLETED|Overall Study||38
8671096|NCT00750269|9714582|FG004|COMPLETED|Overall Study||33
8671097|NCT00750269|9714578|FG000|NOT COMPLETED|Overall Study||0
8671098|NCT00750269|9714579|FG001|NOT COMPLETED|Overall Study||1
8671099|NCT00750269|9714580|FG002|NOT COMPLETED|Overall Study||4
8671100|NCT00750269|9714581|FG003|NOT COMPLETED|Overall Study||5
8671101|NCT00750269|9714582|FG004|NOT COMPLETED|Overall Study||10
8671102|NCT00750282|9714605|FG000|STARTED|Overall Study||69
8671103|NCT00750282|9714606|FG001|STARTED|Overall Study||82
8671104|NCT00750282|9714607|FG002|STARTED|Overall Study||126
8671105|NCT00750282|9714608|FG003|STARTED|Overall Study||148
8671106|NCT00750282|9714605|FG000|COMPLETED|Overall Study||69
8671107|NCT00750282|9714606|FG001|COMPLETED|Overall Study||81
8671108|NCT00750282|9714607|FG002|COMPLETED|Overall Study||125
8671109|NCT00750282|9714608|FG003|COMPLETED|Overall Study||147
8671110|NCT00750282|9714605|FG000|NOT COMPLETED|Overall Study||0
8671111|NCT00750282|9714606|FG001|NOT COMPLETED|Overall Study||1
8671112|NCT00750282|9714607|FG002|NOT COMPLETED|Overall Study||1
8671113|NCT00750282|9714608|FG003|NOT COMPLETED|Overall Study||1
8671114|NCT00750308|9714632|FG000|STARTED|First Treatment|One female withdrew due to muscle pain|2
8671115|NCT00750308|9714633|FG001|STARTED|First Treatment||3
8671116|NCT00750308|9714634|FG002|STARTED|First Treatment||2
8671117|NCT00750308|9714635|FG003|STARTED|First Treatment||2
8671118|NCT00750308|9714636|FG004|STARTED|First Treatment||2
8671119|NCT00750308|9714637|FG005|STARTED|First Treatment||3
8671120|NCT00750308|9714638|FG006|STARTED|First Treatment||2
8671121|NCT00750308|9714639|FG007|STARTED|First Treatment||3
8671122|NCT00750308|9714640|FG008|STARTED|First Treatment||2
8671123|NCT00750308|9714641|FG009|STARTED|First Treatment||2
8671124|NCT00750308|9714642|FG010|STARTED|First Treatment||2
8671125|NCT00750308|9714643|FG011|STARTED|First Treatment||2
8671126|NCT00750308|9714632|FG000|COMPLETED|First Treatment||2
8671127|NCT00750308|9714633|FG001|COMPLETED|First Treatment||2
8671128|NCT00750308|9714634|FG002|COMPLETED|First Treatment||2
9024888|NCT03154086|10087310|FG008|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
9024889|NCT03154086|10087311|FG009|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
9024890|NCT03154086|10087312|FG010|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
9024891|NCT03154086|10087313|FG011|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
9024892|NCT03154086|10087314|FG012|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
9024893|NCT03154086|10087315|FG013|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
9024894|NCT03154086|10087316|FG014|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
9024895|NCT03154086|10087302|FG000|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8575113|NCT00132730|9607609|FG003|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
8575114|NCT00132730|9607610|FG004|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||179
8575115|NCT00132730|9607611|FG005|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||68
8575116|NCT00132730|9607606|FG000|STARTED|Period V - Open-label Extension (EXT2)||0
8575117|NCT00132730|9607607|FG001|STARTED|Period V - Open-label Extension (EXT2)||0
8575118|NCT00132730|9607608|FG002|STARTED|Period V - Open-label Extension (EXT2)||0
8575119|NCT00132730|9607609|FG003|STARTED|Period V - Open-label Extension (EXT2)||0
8575120|NCT00132730|9607610|FG004|STARTED|Period V - Open-label Extension (EXT2)|Not all participants who completed Period IV entered Period V|7
8575121|NCT00132730|9607611|FG005|STARTED|Period V - Open-label Extension (EXT2)|Not all participants who completed Period IV entered Period V|2
8575122|NCT00132730|9607606|FG000|COMPLETED|Period V - Open-label Extension (EXT2)||0
8575123|NCT00132730|9607607|FG001|COMPLETED|Period V - Open-label Extension (EXT2)||0
8575124|NCT00132730|9607608|FG002|COMPLETED|Period V - Open-label Extension (EXT2)||0
8575125|NCT00132730|9607609|FG003|COMPLETED|Period V - Open-label Extension (EXT2)||0
8575126|NCT00132730|9607610|FG004|COMPLETED|Period V - Open-label Extension (EXT2)||0
8575127|NCT00132730|9607611|FG005|COMPLETED|Period V - Open-label Extension (EXT2)||0
8575128|NCT00132730|9607606|FG000|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
8575129|NCT00132730|9607607|FG001|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
8575130|NCT00132730|9607608|FG002|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
8575131|NCT00132730|9607609|FG003|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
8575132|NCT00132730|9607610|FG004|NOT COMPLETED|Period V - Open-label Extension (EXT2)||7
8575133|NCT00132730|9607611|FG005|NOT COMPLETED|Period V - Open-label Extension (EXT2)||2
8575134|NCT00132769|9607627|FG000|STARTED|Overall Study||53
8575135|NCT00132769|9607628|FG001|STARTED|Overall Study||53
8575136|NCT00132769|9607627|FG000|COMPLETED|Overall Study||42
8575137|NCT00132769|9607628|FG001|COMPLETED|Overall Study||42
8575138|NCT00132769|9607627|FG000|NOT COMPLETED|Overall Study||11
8575139|NCT00132769|9607628|FG001|NOT COMPLETED|Overall Study||11
8575140|NCT00132808|9607637|FG000|STARTED|Stratum I||77
8575141|NCT00132808|9607638|FG001|STARTED|Stratum I||70
8575142|NCT00132808|9607639|FG002|STARTED|Stratum I||77
8575143|NCT00132808|9607637|FG000|COMPLETED|Stratum I||68
8575144|NCT00132808|9607638|FG001|COMPLETED|Stratum I||58
8575145|NCT00132808|9607639|FG002|COMPLETED|Stratum I||72
8575146|NCT00132808|9607637|FG000|NOT COMPLETED|Stratum I||9
8575147|NCT00132808|9607638|FG001|NOT COMPLETED|Stratum I||12
8575148|NCT00132808|9607639|FG002|NOT COMPLETED|Stratum I||5
8575149|NCT00132808|9607637|FG000|STARTED|Stratum II||121
8575150|NCT00132808|9607638|FG001|STARTED|Stratum II||111
8575151|NCT00132808|9607639|FG002|STARTED|Stratum II||125
8575152|NCT00132808|9607637|FG000|COMPLETED|Stratum II||113
8575153|NCT00132808|9607638|FG001|COMPLETED|Stratum II||96
8575154|NCT00132808|9607639|FG002|COMPLETED|Stratum II||116
8575155|NCT00132808|9607637|FG000|NOT COMPLETED|Stratum II||8
8575156|NCT00132808|9607638|FG001|NOT COMPLETED|Stratum II||15
8575157|NCT00132808|9607639|FG002|NOT COMPLETED|Stratum II||9
8575158|NCT00132873|9607647|FG000|STARTED|Overall Study||59
8575159|NCT00132873|9607647|FG000|COMPLETED|Overall Study||50
8575160|NCT00132873|9607647|FG000|NOT COMPLETED|Overall Study||9
8575161|NCT00132964|9607653|FG000|STARTED|Overall Study||54
8575162|NCT00132964|9607654|FG001|STARTED|Overall Study||57
8575163|NCT00132964|9607653|FG000|COMPLETED|Overall Study||50
8575164|NCT00132964|9607654|FG001|COMPLETED|Overall Study||54
9024896|NCT03154086|10087303|FG001|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
9024897|NCT03154086|10087304|FG002|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
9024898|NCT03154086|10087305|FG003|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
9024899|NCT03154086|10087306|FG004|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
9024900|NCT03154086|10087307|FG005|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
9024901|NCT03154086|10087308|FG006|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
9024902|NCT03154086|10087309|FG007|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
9024903|NCT03154086|10087310|FG008|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
9024904|NCT03154086|10087311|FG009|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
9024905|NCT03154086|10087312|FG010|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
9024906|NCT03154086|10087313|FG011|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
9024907|NCT03154086|10087314|FG012|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
9024908|NCT03154086|10087315|FG013|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
9024909|NCT03154086|10087316|FG014|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
9024910|NCT03154086|10087302|FG000|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
9024911|NCT03154086|10087303|FG001|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
9024912|NCT03154086|10087304|FG002|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
9024913|NCT03154086|10087305|FG003|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
9024914|NCT03154086|10087306|FG004|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
9024915|NCT03154086|10087307|FG005|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
9024916|NCT03154086|10087308|FG006|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||2
9024917|NCT03154086|10087309|FG007|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||2
9024918|NCT03154086|10087310|FG008|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||4
9024919|NCT03154086|10087311|FG009|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
9024920|NCT03154086|10087312|FG010|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
9024921|NCT03154086|10087313|FG011|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
9024922|NCT03154086|10087314|FG012|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
9024923|NCT03154086|10087315|FG013|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
9024924|NCT03154086|10087316|FG014|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
9024925|NCT03154086|10087302|FG000|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
9024926|NCT03154086|10087303|FG001|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
9024927|NCT03154086|10087304|FG002|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
9024928|NCT03154086|10087305|FG003|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
9024929|NCT03154086|10087306|FG004|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
9024930|NCT03154086|10087307|FG005|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
9024931|NCT03154086|10087308|FG006|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||2
9024932|NCT03154086|10087309|FG007|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||2
9024933|NCT03154086|10087310|FG008|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||4
9024934|NCT03154086|10087311|FG009|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
9024935|NCT03154086|10087312|FG010|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
9024936|NCT03154086|10087313|FG011|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
9024937|NCT03154086|10087314|FG012|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
9024938|NCT03154086|10087315|FG013|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
9024939|NCT03154086|10087316|FG014|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
9024940|NCT03154086|10087302|FG000|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
9024941|NCT03154086|10087303|FG001|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
9024942|NCT03154086|10087304|FG002|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
9024943|NCT03154086|10087305|FG003|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8671129|NCT00750308|9714635|FG003|COMPLETED|First Treatment||1
8671130|NCT00750308|9714636|FG004|COMPLETED|First Treatment||2
8671131|NCT00750308|9714637|FG005|COMPLETED|First Treatment||3
8671132|NCT00750308|9714638|FG006|COMPLETED|First Treatment||2
8671133|NCT00750308|9714639|FG007|COMPLETED|First Treatment||2
8671134|NCT00750308|9714640|FG008|COMPLETED|First Treatment||2
8671135|NCT00750308|9714641|FG009|COMPLETED|First Treatment||2
8671136|NCT00750308|9714642|FG010|COMPLETED|First Treatment||1
8671137|NCT00750308|9714643|FG011|COMPLETED|First Treatment||1
8671138|NCT00750308|9714632|FG000|NOT COMPLETED|First Treatment||0
8671139|NCT00750308|9714633|FG001|NOT COMPLETED|First Treatment||1
8671140|NCT00750308|9714634|FG002|NOT COMPLETED|First Treatment||0
8671141|NCT00750308|9714635|FG003|NOT COMPLETED|First Treatment||1
8671142|NCT00750308|9714636|FG004|NOT COMPLETED|First Treatment||0
8671143|NCT00750308|9714637|FG005|NOT COMPLETED|First Treatment||0
8671144|NCT00750308|9714638|FG006|NOT COMPLETED|First Treatment||0
8671145|NCT00750308|9714639|FG007|NOT COMPLETED|First Treatment||1
8671146|NCT00750308|9714640|FG008|NOT COMPLETED|First Treatment||0
8671147|NCT00750308|9714641|FG009|NOT COMPLETED|First Treatment||0
8671148|NCT00750308|9714642|FG010|NOT COMPLETED|First Treatment||1
8671149|NCT00750308|9714643|FG011|NOT COMPLETED|First Treatment||1
8671150|NCT00750308|9714632|FG000|STARTED|Washout||2
8671151|NCT00750308|9714633|FG001|STARTED|Washout||2
8671152|NCT00750308|9714634|FG002|STARTED|Washout||2
9024944|NCT03154086|10087306|FG004|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
9024945|NCT03154086|10087307|FG005|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
9024946|NCT03154086|10087308|FG006|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
9024947|NCT03154086|10087309|FG007|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8671153|NCT00750308|9714635|FG003|STARTED|Washout||1
8671154|NCT00750308|9714636|FG004|STARTED|Washout||2
8671155|NCT00750308|9714637|FG005|STARTED|Washout||3
8671156|NCT00750308|9714638|FG006|STARTED|Washout||2
8671157|NCT00750308|9714639|FG007|STARTED|Washout||2
9024948|NCT03154086|10087310|FG008|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
9024949|NCT03154086|10087311|FG009|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
9024950|NCT03154086|10087312|FG010|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
9024951|NCT03154086|10087313|FG011|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
9024952|NCT03154086|10087314|FG012|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
9024953|NCT03154086|10087315|FG013|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
9024954|NCT03154086|10087316|FG014|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
9024955|NCT03154086|10087302|FG000|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
9024956|NCT03154086|10087303|FG001|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
9024957|NCT03154086|10087304|FG002|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
9024958|NCT03154086|10087305|FG003|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
9024959|NCT03154086|10087306|FG004|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
9024960|NCT03154086|10087307|FG005|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
9024961|NCT03154086|10087308|FG006|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||2
9024962|NCT03154086|10087309|FG007|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||2
9024963|NCT03154086|10087310|FG008|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||4
9024964|NCT03154086|10087311|FG009|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
9024965|NCT03154086|10087312|FG010|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
9024966|NCT03154086|10087313|FG011|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
9024967|NCT03154086|10087314|FG012|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
9024968|NCT03154086|10087315|FG013|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
9024969|NCT03154086|10087316|FG014|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
9024970|NCT03154086|10087302|FG000|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
9024971|NCT03154086|10087303|FG001|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
9024972|NCT03154086|10087304|FG002|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
9024973|NCT03154086|10087305|FG003|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
9024974|NCT03154086|10087306|FG004|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
9024975|NCT03154086|10087307|FG005|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
9024976|NCT03154086|10087308|FG006|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||2
9024977|NCT03154086|10087309|FG007|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||2
9024978|NCT03154086|10087310|FG008|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||4
9024979|NCT03154086|10087311|FG009|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
9024980|NCT03154086|10087312|FG010|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
9024981|NCT03154086|10087313|FG011|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
9024982|NCT03154086|10087314|FG012|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
9024983|NCT03154086|10087315|FG013|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
9024984|NCT03154086|10087316|FG014|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
9024985|NCT03154086|10087302|FG000|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
9024986|NCT03154086|10087303|FG001|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
9024987|NCT03154086|10087304|FG002|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
9024988|NCT03154086|10087305|FG003|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
9024989|NCT03154086|10087306|FG004|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
9024990|NCT03154086|10087307|FG005|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
9024991|NCT03154086|10087308|FG006|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
9024992|NCT03154086|10087309|FG007|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
9024993|NCT03154086|10087310|FG008|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
9024994|NCT03154086|10087311|FG009|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
9024995|NCT03154086|10087312|FG010|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
9024996|NCT03154086|10087313|FG011|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
9024997|NCT03154086|10087314|FG012|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
9024998|NCT03154086|10087315|FG013|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
9024999|NCT03154086|10087316|FG014|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
9025000|NCT03154086|10087302|FG000|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
9025001|NCT03154086|10087303|FG001|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
9025002|NCT03154086|10087304|FG002|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
9025003|NCT03154086|10087305|FG003|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
9025004|NCT03154086|10087306|FG004|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
9025005|NCT03154086|10087307|FG005|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
9025006|NCT03154086|10087308|FG006|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||2
9025007|NCT03154086|10087309|FG007|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||2
9025008|NCT03154086|10087310|FG008|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)|1 par was unwell on Day-1 of Period 2 and discontinued; hence,1 replacement was enrolled and dosed|5
9025009|NCT03154086|10087311|FG009|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
9025010|NCT03154086|10087312|FG010|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
9025011|NCT03154086|10087313|FG011|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
9025012|NCT03154086|10087314|FG012|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
9025013|NCT03154086|10087315|FG013|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
9025014|NCT03154086|10087316|FG014|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
9025015|NCT03154086|10087302|FG000|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
9025016|NCT03154086|10087303|FG001|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
9025017|NCT03154086|10087304|FG002|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
9025018|NCT03154086|10087305|FG003|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
9025019|NCT03154086|10087306|FG004|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
9025020|NCT03154086|10087307|FG005|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
9025021|NCT03154086|10087308|FG006|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||2
9025022|NCT03154086|10087309|FG007|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||1
9025023|NCT03154086|10087310|FG008|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||4
9025024|NCT03154086|10087311|FG009|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
9025025|NCT03154086|10087312|FG010|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
9025026|NCT03154086|10087313|FG011|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
9025027|NCT03154086|10087314|FG012|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
9025028|NCT03154086|10087315|FG013|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
9025029|NCT03154086|10087316|FG014|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
9025030|NCT03154086|10087302|FG000|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
9025031|NCT03154086|10087303|FG001|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
9025032|NCT03154086|10087304|FG002|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
9025033|NCT03154086|10087305|FG003|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
9025034|NCT03154086|10087306|FG004|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
9025035|NCT03154086|10087307|FG005|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
9025036|NCT03154086|10087308|FG006|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
9025037|NCT03154086|10087309|FG007|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||1
9025038|NCT03154086|10087310|FG008|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||1
9025039|NCT03154086|10087311|FG009|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
9025040|NCT03154086|10087312|FG010|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
9025041|NCT03154086|10087313|FG011|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
9025042|NCT03154086|10087314|FG012|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
9025043|NCT03154086|10087315|FG013|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
9025044|NCT03154086|10087316|FG014|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
9025045|NCT03154086|10087302|FG000|STARTED|Part B (Up to 25 Days)||0
9025046|NCT03154086|10087303|FG001|STARTED|Part B (Up to 25 Days)||0
9025047|NCT03154086|10087304|FG002|STARTED|Part B (Up to 25 Days)||0
9025048|NCT03154086|10087305|FG003|STARTED|Part B (Up to 25 Days)||0
9025049|NCT03154086|10087306|FG004|STARTED|Part B (Up to 25 Days)||0
9025050|NCT03154086|10087307|FG005|STARTED|Part B (Up to 25 Days)||0
9025051|NCT03154086|10087308|FG006|STARTED|Part B (Up to 25 Days)||0
9025052|NCT03154086|10087309|FG007|STARTED|Part B (Up to 25 Days)||0
9025053|NCT03154086|10087310|FG008|STARTED|Part B (Up to 25 Days)||0
9025054|NCT03154086|10087311|FG009|STARTED|Part B (Up to 25 Days)||10
9025055|NCT03154086|10087312|FG010|STARTED|Part B (Up to 25 Days)||6
9025056|NCT03154086|10087313|FG011|STARTED|Part B (Up to 25 Days)||6
9025057|NCT03154086|10087314|FG012|STARTED|Part B (Up to 25 Days)||6
9025058|NCT03154086|10087315|FG013|STARTED|Part B (Up to 25 Days)||6
9025059|NCT03154086|10087316|FG014|STARTED|Part B (Up to 25 Days)||6
9025060|NCT03154086|10087302|FG000|COMPLETED|Part B (Up to 25 Days)||0
9025061|NCT03154086|10087303|FG001|COMPLETED|Part B (Up to 25 Days)||0
9025062|NCT03154086|10087304|FG002|COMPLETED|Part B (Up to 25 Days)||0
8757732|NCT01207219|9807119|FG001|NOT COMPLETED|Overall Study||11
8757733|NCT01207219|9807120|FG002|NOT COMPLETED|Overall Study||7
8757734|NCT01207388|9807128|FG000|STARTED|Overall Study||116
8757735|NCT01207388|9807128|FG000|COMPLETED|Overall Study||48
8757736|NCT01207388|9807128|FG000|NOT COMPLETED|Overall Study||68
8757737|NCT01207401|9807142|FG000|STARTED|Overall Study||26
8757738|NCT01207401|9807143|FG001|STARTED|Overall Study||24
8757739|NCT01207401|9807142|FG000|COMPLETED|Overall Study||26
8757740|NCT01207401|9807143|FG001|COMPLETED|Overall Study||24
8757741|NCT01207401|9807142|FG000|NOT COMPLETED|Overall Study||0
8757742|NCT01207401|9807143|FG001|NOT COMPLETED|Overall Study||0
8757743|NCT01207414|9807151|FG000|STARTED|Overall Study|Includes 1 patient randomized in error.|241
8757744|NCT01207414|9807152|FG001|STARTED|Overall Study||260
8757745|NCT01207414|9807151|FG000|Safety Population: Received Study Drug|Overall Study||240
8757746|NCT01207414|9807152|FG001|Safety Population: Received Study Drug|Overall Study||260
8757747|NCT01207414|9807151|FG000|COMPLETED|Overall Study||168
8757748|NCT01207414|9807152|FG001|COMPLETED|Overall Study||178
8757749|NCT01207414|9807151|FG000|NOT COMPLETED|Overall Study||73
8757750|NCT01207414|9807152|FG001|NOT COMPLETED|Overall Study||82
8757751|NCT01207427|9807161|FG000|STARTED|Run-in Placebo Period||43
8757752|NCT01207427|9807162|FG001|STARTED|Run-in Placebo Period||45
8757753|NCT01207427|9807163|FG002|STARTED|Run-in Placebo Period||43
8757754|NCT01207427|9807161|FG000|COMPLETED|Run-in Placebo Period||43
8757755|NCT01207427|9807162|FG001|COMPLETED|Run-in Placebo Period||45
8757756|NCT01207427|9807163|FG002|COMPLETED|Run-in Placebo Period||43
8757757|NCT01207427|9807161|FG000|NOT COMPLETED|Run-in Placebo Period||0
8757758|NCT01207427|9807162|FG001|NOT COMPLETED|Run-in Placebo Period||0
8757759|NCT01207427|9807163|FG002|NOT COMPLETED|Run-in Placebo Period||0
8757760|NCT01207427|9807161|FG000|STARTED|Double-blind Treatment Period||43
8757761|NCT01207427|9807162|FG001|STARTED|Double-blind Treatment Period||45
8757762|NCT01207427|9807163|FG002|STARTED|Double-blind Treatment Period||43
8757763|NCT01207427|9807161|FG000|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||43
8757764|NCT01207427|9807162|FG001|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||45
8757765|NCT01207427|9807163|FG002|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||43
8757766|NCT01207427|9807161|FG000|COMPLETED|Double-blind Treatment Period||40
8757767|NCT01207427|9807162|FG001|COMPLETED|Double-blind Treatment Period||43
8757768|NCT01207427|9807163|FG002|COMPLETED|Double-blind Treatment Period||41
8757769|NCT01207427|9807161|FG000|NOT COMPLETED|Double-blind Treatment Period||3
8757770|NCT01207427|9807162|FG001|NOT COMPLETED|Double-blind Treatment Period||2
8757771|NCT01207427|9807163|FG002|NOT COMPLETED|Double-blind Treatment Period||2
8757772|NCT01207427|9807161|FG000|STARTED|Run-out Placebo Period||40
8757773|NCT01207427|9807162|FG001|STARTED|Run-out Placebo Period||43
8757774|NCT01207427|9807163|FG002|STARTED|Run-out Placebo Period||41
8757775|NCT01207427|9807161|FG000|COMPLETED|Run-out Placebo Period||40
8757776|NCT01207427|9807162|FG001|COMPLETED|Run-out Placebo Period||43
8757777|NCT01207427|9807163|FG002|COMPLETED|Run-out Placebo Period||41
8757778|NCT01207427|9807161|FG000|NOT COMPLETED|Run-out Placebo Period||0
8757779|NCT01207427|9807162|FG001|NOT COMPLETED|Run-out Placebo Period||0
9025063|NCT03154086|10087305|FG003|COMPLETED|Part B (Up to 25 Days)||0
9025064|NCT03154086|10087306|FG004|COMPLETED|Part B (Up to 25 Days)||0
9025065|NCT03154086|10087307|FG005|COMPLETED|Part B (Up to 25 Days)||0
9025066|NCT03154086|10087308|FG006|COMPLETED|Part B (Up to 25 Days)||0
9025067|NCT03154086|10087309|FG007|COMPLETED|Part B (Up to 25 Days)||0
9025068|NCT03154086|10087310|FG008|COMPLETED|Part B (Up to 25 Days)||0
9025069|NCT03154086|10087311|FG009|COMPLETED|Part B (Up to 25 Days)||10
9025070|NCT03154086|10087312|FG010|COMPLETED|Part B (Up to 25 Days)||5
9025071|NCT03154086|10087313|FG011|COMPLETED|Part B (Up to 25 Days)||6
9025072|NCT03154086|10087314|FG012|COMPLETED|Part B (Up to 25 Days)||6
9025073|NCT03154086|10087315|FG013|COMPLETED|Part B (Up to 25 Days)||6
9025074|NCT03154086|10087316|FG014|COMPLETED|Part B (Up to 25 Days)||6
9025075|NCT03154086|10087302|FG000|NOT COMPLETED|Part B (Up to 25 Days)||0
9025076|NCT03154086|10087303|FG001|NOT COMPLETED|Part B (Up to 25 Days)||0
9025077|NCT03154086|10087304|FG002|NOT COMPLETED|Part B (Up to 25 Days)||0
9025078|NCT03154086|10087305|FG003|NOT COMPLETED|Part B (Up to 25 Days)||0
9025079|NCT03154086|10087306|FG004|NOT COMPLETED|Part B (Up to 25 Days)||0
9025080|NCT03154086|10087307|FG005|NOT COMPLETED|Part B (Up to 25 Days)||0
9025081|NCT03154086|10087308|FG006|NOT COMPLETED|Part B (Up to 25 Days)||0
9025082|NCT03154086|10087309|FG007|NOT COMPLETED|Part B (Up to 25 Days)||0
9025083|NCT03154086|10087310|FG008|NOT COMPLETED|Part B (Up to 25 Days)||0
9025084|NCT03154086|10087311|FG009|NOT COMPLETED|Part B (Up to 25 Days)||0
9025085|NCT03154086|10087312|FG010|NOT COMPLETED|Part B (Up to 25 Days)||1
9025086|NCT03154086|10087313|FG011|NOT COMPLETED|Part B (Up to 25 Days)||0
9025087|NCT03154086|10087314|FG012|NOT COMPLETED|Part B (Up to 25 Days)||0
9025088|NCT03154086|10087315|FG013|NOT COMPLETED|Part B (Up to 25 Days)||0
9025089|NCT03154086|10087316|FG014|NOT COMPLETED|Part B (Up to 25 Days)||0
9025090|NCT03154333|10087374|FG000|STARTED|Overall Study||28
9025091|NCT03154333|10087375|FG001|STARTED|Overall Study||26
9025092|NCT03154333|10087374|FG000|COMPLETED|Overall Study||21
9025093|NCT03154333|10087375|FG001|COMPLETED|Overall Study||21
9025094|NCT03154333|10087374|FG000|NOT COMPLETED|Overall Study||7
9025095|NCT03154333|10087375|FG001|NOT COMPLETED|Overall Study||5
9025096|NCT03154476|10087384|FG000|STARTED|Overall Study||10
9025097|NCT03154476|10087385|FG001|STARTED|Overall Study||10
9025098|NCT03154476|10087384|FG000|COMPLETED|Overall Study||6
9025099|NCT03154476|10087385|FG001|COMPLETED|Overall Study||6
9025100|NCT03154476|10087384|FG000|NOT COMPLETED|Overall Study||4
9025101|NCT03154476|10087385|FG001|NOT COMPLETED|Overall Study||4
9025102|NCT03154658|10087393|FG000|STARTED|Overall Study||33
9025103|NCT03154658|10087394|FG001|STARTED|Overall Study||33
9025104|NCT03154658|10087393|FG000|COMPLETED|Overall Study||32
9025105|NCT03154658|10087394|FG001|COMPLETED|Overall Study||32
9025106|NCT03154658|10087393|FG000|NOT COMPLETED|Overall Study||1
9025107|NCT03154658|10087394|FG001|NOT COMPLETED|Overall Study||1
9025108|NCT03154710|10087402|FG000|STARTED|Overall Study||27
9025109|NCT03154710|10087403|FG001|STARTED|Overall Study||25
9025110|NCT03154710|10087402|FG000|COMPLETED|Overall Study||20
9025111|NCT03154710|10087403|FG001|COMPLETED|Overall Study||20
9025112|NCT03154710|10087402|FG000|NOT COMPLETED|Overall Study||7
9025113|NCT03154710|10087403|FG001|NOT COMPLETED|Overall Study||5
8757780|NCT01207427|9807163|FG002|NOT COMPLETED|Run-out Placebo Period||0
8757781|NCT01207440|9807178|FG000|STARTED|Overall Study||203
8757782|NCT01207440|9807179|FG001|STARTED|Overall Study||64
8757783|NCT01207440|9807180|FG002|STARTED|Overall Study||65
8757784|NCT01207440|9807181|FG003|STARTED|Overall Study||18
8757785|NCT01207440|9807182|FG004|STARTED|Overall Study||48
8757786|NCT01207440|9807183|FG005|STARTED|Overall Study||46
8757787|NCT01207440|9807184|FG006|STARTED|Overall Study||5
8757788|NCT01207440|9807178|FG000|COMPLETED|Overall Study||0
8757789|NCT01207440|9807179|FG001|COMPLETED|Overall Study||0
8757790|NCT01207440|9807180|FG002|COMPLETED|Overall Study||0
8757791|NCT01207440|9807181|FG003|COMPLETED|Overall Study||0
8757792|NCT01207440|9807182|FG004|COMPLETED|Overall Study||0
8757793|NCT01207440|9807183|FG005|COMPLETED|Overall Study||0
8757794|NCT01207440|9807184|FG006|COMPLETED|Overall Study||0
8757795|NCT01207440|9807178|FG000|NOT COMPLETED|Overall Study||203
8757796|NCT01207440|9807179|FG001|NOT COMPLETED|Overall Study||64
8757797|NCT01207440|9807180|FG002|NOT COMPLETED|Overall Study||65
8757798|NCT01207440|9807181|FG003|NOT COMPLETED|Overall Study||18
8757799|NCT01207440|9807182|FG004|NOT COMPLETED|Overall Study||48
8757800|NCT01207440|9807183|FG005|NOT COMPLETED|Overall Study||46
8757801|NCT01207440|9807184|FG006|NOT COMPLETED|Overall Study||5
8757802|NCT01207453|9807208|FG000|STARTED|First Intervention||23
8757803|NCT01207453|9807209|FG001|STARTED|First Intervention||18
8757804|NCT01207453|9807208|FG000|COMPLETED|First Intervention||21
8757805|NCT01207453|9807209|FG001|COMPLETED|First Intervention||17
8757806|NCT01207453|9807208|FG000|NOT COMPLETED|First Intervention||2
8757807|NCT01207453|9807209|FG001|NOT COMPLETED|First Intervention||1
8757808|NCT01207453|9807208|FG000|STARTED|Washout||21
8757809|NCT01207453|9807209|FG001|STARTED|Washout||17
8757810|NCT01207453|9807208|FG000|COMPLETED|Washout||19
8757811|NCT01207453|9807209|FG001|COMPLETED|Washout||17
8757812|NCT01207453|9807208|FG000|NOT COMPLETED|Washout||2
8757813|NCT01207453|9807209|FG001|NOT COMPLETED|Washout||0
8757814|NCT01207453|9807208|FG000|STARTED|2nd Intervention||19
8757815|NCT01207453|9807209|FG001|STARTED|2nd Intervention||17
8757816|NCT01207453|9807208|FG000|COMPLETED|2nd Intervention||17
8757817|NCT01207453|9807209|FG001|COMPLETED|2nd Intervention||15
8757818|NCT01207453|9807208|FG000|NOT COMPLETED|2nd Intervention||2
8757819|NCT01207453|9807209|FG001|NOT COMPLETED|2nd Intervention||2
8757820|NCT01207466|9807218|FG000|STARTED|Period 1, One Week of Wear||46
8757821|NCT01207466|9807219|FG001|STARTED|Period 1, One Week of Wear||48
8757822|NCT01207466|9807218|FG000|COMPLETED|Period 1, One Week of Wear|One participant discontinued between Period 1 and Period 2 due to inclusion/exclusion criteria.|46
8757823|NCT01207466|9807219|FG001|COMPLETED|Period 1, One Week of Wear||48
8757824|NCT01207466|9807218|FG000|NOT COMPLETED|Period 1, One Week of Wear||0
8757825|NCT01207466|9807219|FG001|NOT COMPLETED|Period 1, One Week of Wear||0
8757826|NCT01207466|9807218|FG000|STARTED|Period 2, One Week of Wear||45
8757827|NCT01207466|9807219|FG001|STARTED|Period 2, One Week of Wear||48
8757828|NCT01207466|9807218|FG000|COMPLETED|Period 2, One Week of Wear||45
8757829|NCT01207466|9807219|FG001|COMPLETED|Period 2, One Week of Wear||48
8757830|NCT01207466|9807218|FG000|NOT COMPLETED|Period 2, One Week of Wear||0
8757831|NCT01207466|9807219|FG001|NOT COMPLETED|Period 2, One Week of Wear||0
8757832|NCT01207570|9807227|FG000|STARTED|The First Stage (Before Crossover)||23
8757833|NCT01207570|9807228|FG001|STARTED|The First Stage (Before Crossover)||31
8757834|NCT01207570|9807227|FG000|COMPLETED|The First Stage (Before Crossover)||23
8757835|NCT01207570|9807228|FG001|COMPLETED|The First Stage (Before Crossover)||31
8757836|NCT01207570|9807227|FG000|NOT COMPLETED|The First Stage (Before Crossover)||0
8757837|NCT01207570|9807228|FG001|NOT COMPLETED|The First Stage (Before Crossover)||0
8757838|NCT01207570|9807227|FG000|STARTED|The Second Stage (After Crossover)||31
8757839|NCT01207570|9807228|FG001|STARTED|The Second Stage (After Crossover)||23
8757840|NCT01207570|9807227|FG000|COMPLETED|The Second Stage (After Crossover)||31
8757841|NCT01207570|9807228|FG001|COMPLETED|The Second Stage (After Crossover)||23
8757842|NCT01207570|9807227|FG000|NOT COMPLETED|The Second Stage (After Crossover)||0
8757843|NCT01207570|9807228|FG001|NOT COMPLETED|The Second Stage (After Crossover)||0
8757844|NCT01207583|9807239|FG000|STARTED|Overall Study||14
8757845|NCT01207583|9807240|FG001|STARTED|Overall Study||31
8757846|NCT01207583|9807241|FG002|STARTED|Overall Study||55
8757847|NCT01207583|9807239|FG000|Dose 1|Overall Study||14
8757848|NCT01207583|9807240|FG001|Dose 1|Overall Study||31
8757849|NCT01207583|9807241|FG002|Dose 1|Overall Study||55
8757850|NCT01207583|9807239|FG000|Dose 2|Overall Study||13
8757851|NCT01207583|9807240|FG001|Dose 2|Overall Study||29
8757852|NCT01207583|9807241|FG002|Dose 2|Overall Study||54
8757853|NCT01207583|9807239|FG000|Dose 3|Overall Study||13
8757854|NCT01207583|9807240|FG001|Dose 3|Overall Study||27
8757855|NCT01207583|9807241|FG002|Dose 3|Overall Study||0
8757856|NCT01207583|9807239|FG000|Dose 4|Overall Study||7
8757857|NCT01207583|9807240|FG001|Dose 4|Overall Study||0
8757858|NCT01207583|9807241|FG002|Dose 4|Overall Study||0
8757859|NCT01207583|9807239|FG000|COMPLETED|Overall Study||13
8757860|NCT01207583|9807240|FG001|COMPLETED|Overall Study||26
8757861|NCT01207583|9807241|FG002|COMPLETED|Overall Study||54
8757862|NCT01207583|9807239|FG000|NOT COMPLETED|Overall Study||1
8757863|NCT01207583|9807240|FG001|NOT COMPLETED|Overall Study||5
8757864|NCT01207583|9807241|FG002|NOT COMPLETED|Overall Study||1
8757865|NCT01207596|9807262|FG000|STARTED|Overall Study||30
8757866|NCT01207596|9807262|FG000|COMPLETED|Overall Study||21
8757867|NCT01207596|9807262|FG000|NOT COMPLETED|Overall Study||9
8757868|NCT01207648|9807266|FG000|STARTED|Overall Study||307
8757869|NCT01207648|9807266|FG000|COMPLETED|Overall Study||307
8757870|NCT01207648|9807266|FG000|NOT COMPLETED|Overall Study||0
8757871|NCT01207687|9807270|FG000|STARTED|Overall Study||14
8757872|NCT01207687|9807270|FG000|COMPLETED|Overall Study||12
8757873|NCT01207687|9807270|FG000|NOT COMPLETED|Overall Study||2
8757874|NCT01207752|9807282|FG000|STARTED|Overall Study||35
8757875|NCT01207752|9807283|FG001|STARTED|Overall Study||34
8757876|NCT01207752|9807282|FG000|COMPLETED|Overall Study||33
8757877|NCT01207752|9807283|FG001|COMPLETED|Overall Study||27
8757878|NCT01207752|9807282|FG000|NOT COMPLETED|Overall Study||2
8757879|NCT01207752|9807283|FG001|NOT COMPLETED|Overall Study||7
8757880|NCT01207765|9807289|FG000|STARTED|Overall Study||8
8757881|NCT01207765|9807289|FG000|COMPLETED|Overall Study||8
8757882|NCT01207765|9807289|FG000|NOT COMPLETED|Overall Study||0
8757883|NCT01207908|9807295|FG000|STARTED|Overall Study||22
8757884|NCT01207908|9807296|FG001|STARTED|Overall Study||22
8757885|NCT01207908|9807295|FG000|COMPLETED|Overall Study||17
8757886|NCT01207908|9807296|FG001|COMPLETED|Overall Study||21
8757887|NCT01207908|9807295|FG000|NOT COMPLETED|Overall Study||5
8757888|NCT01207908|9807296|FG001|NOT COMPLETED|Overall Study||1
8757889|NCT01207934|9807305|FG000|STARTED|Overall Study||6
8757890|NCT01207934|9807306|FG001|STARTED|Overall Study||6
8757891|NCT01207934|9807307|FG002|STARTED|Overall Study||6
8757892|NCT01207934|9807305|FG000|COMPLETED|Overall Study||6
8757893|NCT01207934|9807306|FG001|COMPLETED|Overall Study||6
8757894|NCT01207934|9807307|FG002|COMPLETED|Overall Study||6
8757895|NCT01207934|9807305|FG000|NOT COMPLETED|Overall Study||0
8757896|NCT01207934|9807306|FG001|NOT COMPLETED|Overall Study||0
8757897|NCT01207934|9807307|FG002|NOT COMPLETED|Overall Study||0
8757898|NCT01208038|9807315|FG000|STARTED|Overall Study||22
8757899|NCT01208038|9807315|FG000|COMPLETED|Overall Study|Patient withdrew before commencing study drug|21
8757900|NCT01208038|9807315|FG000|NOT COMPLETED|Overall Study||1
8757901|NCT01208051|9807324|FG000|STARTED|Total Enrollment||4
8757902|NCT01208051|9807325|FG001|STARTED|Total Enrollment||7
8757903|NCT01208051|9807326|FG002|STARTED|Total Enrollment||6
8757904|NCT01208051|9807327|FG003|STARTED|Total Enrollment||39
8757905|NCT01208051|9807328|FG004|STARTED|Total Enrollment||71
8757906|NCT01208051|9807324|FG000|COMPLETED|Total Enrollment||4
8757907|NCT01208051|9807325|FG001|COMPLETED|Total Enrollment||6
8757908|NCT01208051|9807326|FG002|COMPLETED|Total Enrollment||5
8757909|NCT01208051|9807327|FG003|COMPLETED|Total Enrollment||39
8757910|NCT01208051|9807328|FG004|COMPLETED|Total Enrollment||69
8757911|NCT01208051|9807324|FG000|NOT COMPLETED|Total Enrollment||0
8757912|NCT01208051|9807325|FG001|NOT COMPLETED|Total Enrollment||1
8757913|NCT01208051|9807326|FG002|NOT COMPLETED|Total Enrollment||1
8757914|NCT01208051|9807327|FG003|NOT COMPLETED|Total Enrollment||0
8757915|NCT01208051|9807328|FG004|NOT COMPLETED|Total Enrollment||2
8757916|NCT01208051|9807324|FG000|STARTED|Interim Futility Analysis||0
8757917|NCT01208051|9807325|FG001|STARTED|Interim Futility Analysis||0
8757918|NCT01208051|9807326|FG002|STARTED|Interim Futility Analysis||0
8757919|NCT01208051|9807327|FG003|STARTED|Interim Futility Analysis||39
8757920|NCT01208051|9807328|FG004|STARTED|Interim Futility Analysis||68
8757921|NCT01208051|9807324|FG000|COMPLETED|Interim Futility Analysis||0
8757922|NCT01208051|9807325|FG001|COMPLETED|Interim Futility Analysis||0
8757923|NCT01208051|9807326|FG002|COMPLETED|Interim Futility Analysis||0
8757924|NCT01208051|9807327|FG003|COMPLETED|Interim Futility Analysis||39
8757925|NCT01208051|9807328|FG004|COMPLETED|Interim Futility Analysis||68
8757926|NCT01208051|9807324|FG000|NOT COMPLETED|Interim Futility Analysis||0
8757927|NCT01208051|9807325|FG001|NOT COMPLETED|Interim Futility Analysis||0
8757928|NCT01208051|9807326|FG002|NOT COMPLETED|Interim Futility Analysis||0
8757929|NCT01208051|9807327|FG003|NOT COMPLETED|Interim Futility Analysis||0
8757930|NCT01208051|9807328|FG004|NOT COMPLETED|Interim Futility Analysis||0
8757931|NCT01208051|9807324|FG000|STARTED|After Crossover to Cediranib Only||0
8757932|NCT01208051|9807325|FG001|STARTED|After Crossover to Cediranib Only||0
8757933|NCT01208051|9807326|FG002|STARTED|After Crossover to Cediranib Only||0
8757934|NCT01208051|9807327|FG003|STARTED|After Crossover to Cediranib Only||39
8757935|NCT01208051|9807328|FG004|STARTED|After Crossover to Cediranib Only|One patient entered while futility analysis was ongoing.|69
8757936|NCT01208051|9807324|FG000|COMPLETED|After Crossover to Cediranib Only||0
8757937|NCT01208051|9807325|FG001|COMPLETED|After Crossover to Cediranib Only||0
8757938|NCT01208051|9807326|FG002|COMPLETED|After Crossover to Cediranib Only||0
8757939|NCT01208051|9807327|FG003|COMPLETED|After Crossover to Cediranib Only||39
8757940|NCT01208051|9807328|FG004|COMPLETED|After Crossover to Cediranib Only||69
8757941|NCT01208051|9807324|FG000|NOT COMPLETED|After Crossover to Cediranib Only||0
8757942|NCT01208051|9807325|FG001|NOT COMPLETED|After Crossover to Cediranib Only||0
8757943|NCT01208051|9807326|FG002|NOT COMPLETED|After Crossover to Cediranib Only||0
8757944|NCT01208051|9807327|FG003|NOT COMPLETED|After Crossover to Cediranib Only||0
8757945|NCT01208051|9807328|FG004|NOT COMPLETED|After Crossover to Cediranib Only||0
8757946|NCT01208103|9807344|FG000|STARTED|Overall Study||30
8757947|NCT01208103|9807344|FG000|COMPLETED|Overall Study||28
8757948|NCT01208103|9807344|FG000|NOT COMPLETED|Overall Study||2
8757949|NCT01208220|9807351|FG000|STARTED|Overall Study||1
8757950|NCT01208220|9807352|FG001|STARTED|Overall Study||1
8757951|NCT01208220|9807351|FG000|COMPLETED|Overall Study||1
8757952|NCT01208220|9807352|FG001|COMPLETED|Overall Study||1
8757953|NCT01208220|9807351|FG000|NOT COMPLETED|Overall Study||0
8757954|NCT01208220|9807352|FG001|NOT COMPLETED|Overall Study||0
8757955|NCT01208233|9807364|FG000|STARTED|Overall Study||11
9025114|NCT03155178|10087413|FG000|STARTED|Overall Study||69
9025115|NCT03155178|10087414|FG001|STARTED|Overall Study||69
9025116|NCT03155178|10087415|FG002|STARTED|Overall Study||69
9025117|NCT03155178|10087416|FG003|STARTED|Overall Study||69
9025118|NCT03155178|10087413|FG000|COMPLETED|Overall Study||62
9025119|NCT03155178|10087414|FG001|COMPLETED|Overall Study||62
9025120|NCT03155178|10087415|FG002|COMPLETED|Overall Study||62
9025121|NCT03155178|10087416|FG003|COMPLETED|Overall Study||62
9025122|NCT03155178|10087413|FG000|NOT COMPLETED|Overall Study||7
9025123|NCT03155178|10087414|FG001|NOT COMPLETED|Overall Study||7
9025124|NCT03155178|10087415|FG002|NOT COMPLETED|Overall Study||7
9025125|NCT03155178|10087416|FG003|NOT COMPLETED|Overall Study||7
9025126|NCT03155269|10087432|FG000|STARTED|Overall Study||57
9025127|NCT03155269|10087433|FG001|STARTED|Overall Study||57
9025128|NCT03155269|10087432|FG000|COMPLETED|Overall Study||52
9025129|NCT03155269|10087433|FG001|COMPLETED|Overall Study||50
9025130|NCT03155269|10087432|FG000|NOT COMPLETED|Overall Study||5
9025131|NCT03155269|10087433|FG001|NOT COMPLETED|Overall Study||7
9025132|NCT03155724|10087439|FG000|STARTED|Overall Study||53
9025133|NCT03155724|10087439|FG000|COMPLETED|Overall Study||42
9025134|NCT03155724|10087439|FG000|NOT COMPLETED|Overall Study||11
9025135|NCT03155945|10087445|FG000|STARTED|Overall Study||6
9025136|NCT03155945|10087446|FG001|STARTED|Overall Study||8
9025137|NCT03155945|10087445|FG000|COMPLETED|Overall Study||6
9025138|NCT03155945|10087446|FG001|COMPLETED|Overall Study||5
9025139|NCT03155945|10087445|FG000|NOT COMPLETED|Overall Study||0
9025140|NCT03155945|10087446|FG001|NOT COMPLETED|Overall Study||3
9025141|NCT03156270|10087452|FG000|STARTED|Overall Study||20
9025142|NCT03156270|10087452|FG000|COMPLETED|Overall Study||18
9025143|NCT03156270|10087452|FG000|NOT COMPLETED|Overall Study||2
9025144|NCT03156543|10087460|FG000|STARTED|Overall Study||9
9025145|NCT03156543|10087461|FG001|STARTED|Overall Study||23
9025146|NCT03156543|10087460|FG000|COMPLETED|Overall Study||8
9025147|NCT03156543|10087461|FG001|COMPLETED|Overall Study||23
9025148|NCT03156543|10087460|FG000|NOT COMPLETED|Overall Study||1
9025149|NCT03156543|10087461|FG001|NOT COMPLETED|Overall Study||0
9025150|NCT03156621|10087469|FG000|STARTED|Double-Blind Treatment Period (DBTP)||24
9025151|NCT03156621|10087470|FG001|STARTED|Double-Blind Treatment Period (DBTP)||45
9025152|NCT03156621|10087469|FG000|COMPLETED|Double-Blind Treatment Period (DBTP)||24
9025153|NCT03156621|10087470|FG001|COMPLETED|Double-Blind Treatment Period (DBTP)||45
9025154|NCT03156621|10087469|FG000|NOT COMPLETED|Double-Blind Treatment Period (DBTP)||0
9025155|NCT03156621|10087470|FG001|NOT COMPLETED|Double-Blind Treatment Period (DBTP)||0
9025156|NCT03156621|10087469|FG000|STARTED|Open-Label Treatment Period (OLTP)||24
9025157|NCT03156621|10087470|FG001|STARTED|Open-Label Treatment Period (OLTP)||45
9025158|NCT03156621|10087469|FG000|COMPLETED|Open-Label Treatment Period (OLTP)||24
9025159|NCT03156621|10087470|FG001|COMPLETED|Open-Label Treatment Period (OLTP)||42
9025160|NCT03156621|10087469|FG000|NOT COMPLETED|Open-Label Treatment Period (OLTP)||0
9025161|NCT03156621|10087470|FG001|NOT COMPLETED|Open-Label Treatment Period (OLTP)||3
9025162|NCT03157089|10087481|FG000|STARTED|Overall Study||12
9025163|NCT03157089|10087482|FG001|STARTED|Overall Study||12
9025164|NCT03157089|10087481|FG000|Treated|Overall Study||12
9025165|NCT03157089|10087482|FG001|Treated|Overall Study||12
9025166|NCT03157089|10087481|FG000|COMPLETED|Overall Study||0
9025167|NCT03157089|10087482|FG001|COMPLETED|Overall Study||0
9025168|NCT03157089|10087481|FG000|NOT COMPLETED|Overall Study||12
9025169|NCT03157089|10087482|FG001|NOT COMPLETED|Overall Study||12
9025170|NCT03157232|10087489|FG000|STARTED|Overall Study||18
9025171|NCT03157232|10087489|FG000|COMPLETED|Overall Study||18
9025172|NCT03157232|10087489|FG000|NOT COMPLETED|Overall Study||0
9025173|NCT03157531|10087493|FG000|STARTED|Overall Study||97
9025174|NCT03157531|10087493|FG000|Analyzed at 30 Days For MAEs|Overall Study||93
9025175|NCT03157531|10087493|FG000|COMPLETED|Overall Study||91
9025176|NCT03157531|10087493|FG000|NOT COMPLETED|Overall Study||6
9025177|NCT03157583|10087497|FG000|STARTED|Overall Study||8
9025178|NCT03157583|10087497|FG000|COMPLETED|Overall Study||7
9025179|NCT03157583|10087497|FG000|NOT COMPLETED|Overall Study||1
9025180|NCT03158012|10087517|FG000|STARTED|Overall Study||8
9025181|NCT03158012|10087518|FG001|STARTED|Overall Study||7
9025182|NCT03158012|10087517|FG000|COMPLETED|Overall Study||8
9025183|NCT03158012|10087518|FG001|COMPLETED|Overall Study||6
9025184|NCT03158012|10087517|FG000|NOT COMPLETED|Overall Study||0
9025185|NCT03158012|10087518|FG001|NOT COMPLETED|Overall Study||1
9025186|NCT03158038|10087526|FG000|STARTED|Overall Study||240
9025187|NCT03158038|10087527|FG001|STARTED|Overall Study||60
9025188|NCT03158038|10087526|FG000|COMPLETED|Overall Study||240
9025189|NCT03158038|10087527|FG001|COMPLETED|Overall Study||60
9025190|NCT03158038|10087526|FG000|NOT COMPLETED|Overall Study||0
9025191|NCT03158038|10087527|FG001|NOT COMPLETED|Overall Study||0
8757956|NCT01208233|9807365|FG001|STARTED|Overall Study||9
8757957|NCT01208233|9807366|FG002|STARTED|Overall Study||11
9025192|NCT03158116|10087533|FG000|STARTED|Overall Study||5
9025193|NCT03158116|10087533|FG000|COMPLETED|Overall Study||5
9025194|NCT03158116|10087533|FG000|NOT COMPLETED|Overall Study||0
9025195|NCT03158220|10087539|FG000|STARTED|Overall Study||570
9025196|NCT03158220|10087540|FG001|STARTED|Overall Study||642
9025197|NCT03158220|10087539|FG000|Vaccination 1|Overall Study||570
9025198|NCT03158220|10087540|FG001|Vaccination 1|Overall Study||640
9025199|NCT03158220|10087539|FG000|Vaccination 2|Overall Study||563
8757958|NCT01208233|9807367|FG003|STARTED|Overall Study||10
8757959|NCT01208233|9807368|FG004|STARTED|Overall Study||70
8757960|NCT01208233|9807369|FG005|STARTED|Overall Study||67
8757961|NCT01208233|9807364|FG000|COMPLETED|Overall Study||6
8757962|NCT01208233|9807365|FG001|COMPLETED|Overall Study||6
8757963|NCT01208233|9807366|FG002|COMPLETED|Overall Study||7
8757964|NCT01208233|9807367|FG003|COMPLETED|Overall Study||9
8757965|NCT01208233|9807368|FG004|COMPLETED|Overall Study||46
8757966|NCT01208233|9807369|FG005|COMPLETED|Overall Study||46
8757967|NCT01208233|9807364|FG000|NOT COMPLETED|Overall Study||5
8757968|NCT01208233|9807365|FG001|NOT COMPLETED|Overall Study||3
8757969|NCT01208233|9807366|FG002|NOT COMPLETED|Overall Study||4
8757970|NCT01208233|9807367|FG003|NOT COMPLETED|Overall Study||1
8757971|NCT01208233|9807368|FG004|NOT COMPLETED|Overall Study||24
8757972|NCT01208233|9807369|FG005|NOT COMPLETED|Overall Study||21
8757973|NCT01208324|9807393|FG000|STARTED|Pre-randomization of Patch||14
8757974|NCT01208324|9807394|FG001|STARTED|Pre-randomization of Patch||15
8757975|NCT01208324|9807395|FG002|STARTED|Pre-randomization of Patch||10
8757976|NCT01208324|9807396|FG003|STARTED|Pre-randomization of Patch||8
8757977|NCT01208324|9807393|FG000|Test Day 1|Pre-randomization of Patch||14
8757978|NCT01208324|9807394|FG001|Test Day 1|Pre-randomization of Patch||15
8757979|NCT01208324|9807395|FG002|Test Day 1|Pre-randomization of Patch||10
8757980|NCT01208324|9807396|FG003|Test Day 1|Pre-randomization of Patch||8
8757981|NCT01208324|9807393|FG000|Test Day 2|Pre-randomization of Patch||14
8757982|NCT01208324|9807394|FG001|Test Day 2|Pre-randomization of Patch||15
8757983|NCT01208324|9807395|FG002|Test Day 2|Pre-randomization of Patch||8
8757984|NCT01208324|9807396|FG003|Test Day 2|Pre-randomization of Patch||5
8757985|NCT01208324|9807393|FG000|COMPLETED|Pre-randomization of Patch||14
8757986|NCT01208324|9807394|FG001|COMPLETED|Pre-randomization of Patch||15
8757987|NCT01208324|9807395|FG002|COMPLETED|Pre-randomization of Patch||8
8757988|NCT01208324|9807396|FG003|COMPLETED|Pre-randomization of Patch||5
8757989|NCT01208324|9807393|FG000|NOT COMPLETED|Pre-randomization of Patch||0
8757990|NCT01208324|9807394|FG001|NOT COMPLETED|Pre-randomization of Patch||0
8757991|NCT01208324|9807395|FG002|NOT COMPLETED|Pre-randomization of Patch||2
8757992|NCT01208324|9807396|FG003|NOT COMPLETED|Pre-randomization of Patch||3
8757993|NCT01208324|9807393|FG000|STARTED|Post-randomization of Patch||14
8757994|NCT01208324|9807394|FG001|STARTED|Post-randomization of Patch||15
8757995|NCT01208324|9807395|FG002|STARTED|Post-randomization of Patch||8
8757996|NCT01208324|9807396|FG003|STARTED|Post-randomization of Patch||5
8757997|NCT01208324|9807393|FG000|Test Day 3|Post-randomization of Patch||13
8757998|NCT01208324|9807394|FG001|Test Day 3|Post-randomization of Patch||15
8757999|NCT01208324|9807395|FG002|Test Day 3|Post-randomization of Patch||8
8758000|NCT01208324|9807396|FG003|Test Day 3|Post-randomization of Patch||5
8758001|NCT01208324|9807393|FG000|Test Day 4|Post-randomization of Patch||13
8758002|NCT01208324|9807394|FG001|Test Day 4|Post-randomization of Patch||15
8758003|NCT01208324|9807395|FG002|Test Day 4|Post-randomization of Patch||8
8758004|NCT01208324|9807396|FG003|Test Day 4|Post-randomization of Patch||5
8758005|NCT01208324|9807393|FG000|COMPLETED|Post-randomization of Patch||13
8758006|NCT01208324|9807394|FG001|COMPLETED|Post-randomization of Patch||15
8758007|NCT01208324|9807395|FG002|COMPLETED|Post-randomization of Patch||8
8758008|NCT01208324|9807396|FG003|COMPLETED|Post-randomization of Patch||5
8758009|NCT01208324|9807393|FG000|NOT COMPLETED|Post-randomization of Patch||1
8758010|NCT01208324|9807394|FG001|NOT COMPLETED|Post-randomization of Patch||0
8758011|NCT01208324|9807395|FG002|NOT COMPLETED|Post-randomization of Patch||0
8758012|NCT01208324|9807396|FG003|NOT COMPLETED|Post-randomization of Patch||0
8808170|NCT01490086|9860603|FG002|NOT COMPLETED|Overall Study||7
8808171|NCT01490086|9860604|FG003|NOT COMPLETED|Overall Study||7
8808172|NCT01490086|9860605|FG004|NOT COMPLETED|Overall Study||11
8808173|NCT01490125|9860617|FG000|STARTED|Period I||43
8808174|NCT01490125|9860618|FG001|STARTED|Period I||42
8808175|NCT01490125|9860619|FG002|STARTED|Period I||41
8808176|NCT01490125|9860620|FG003|STARTED|Period I||38
8808177|NCT01490125|9860621|FG004|STARTED|Period I||40
8808178|NCT01490125|9860622|FG005|STARTED|Period I||42
8808179|NCT01490125|9860617|FG000|COMPLETED|Period I||37
8808180|NCT01490125|9860618|FG001|COMPLETED|Period I||37
8808181|NCT01490125|9860619|FG002|COMPLETED|Period I||37
8808182|NCT01490125|9860620|FG003|COMPLETED|Period I||33
8808183|NCT01490125|9860621|FG004|COMPLETED|Period I||36
8808184|NCT01490125|9860622|FG005|COMPLETED|Period I||37
8808185|NCT01490125|9860617|FG000|NOT COMPLETED|Period I||6
8808186|NCT01490125|9860618|FG001|NOT COMPLETED|Period I||5
8808187|NCT01490125|9860619|FG002|NOT COMPLETED|Period I||4
8808188|NCT01490125|9860620|FG003|NOT COMPLETED|Period I||5
8808189|NCT01490125|9860621|FG004|NOT COMPLETED|Period I||4
8808190|NCT01490125|9860622|FG005|NOT COMPLETED|Period I||5
8808191|NCT01490125|9860617|FG000|STARTED|Period II||37
8808192|NCT01490125|9860618|FG001|STARTED|Period II||37
8808193|NCT01490125|9860619|FG002|STARTED|Period II||37
8808194|NCT01490125|9860620|FG003|STARTED|Period II||33
8808195|NCT01490125|9860621|FG004|STARTED|Period II||36
8808196|NCT01490125|9860622|FG005|STARTED|Period II||37
8808197|NCT01490125|9860617|FG000|COMPLETED|Period II||34
8808198|NCT01490125|9860618|FG001|COMPLETED|Period II||33
8808199|NCT01490125|9860619|FG002|COMPLETED|Period II||34
8808200|NCT01490125|9860620|FG003|COMPLETED|Period II||30
8808201|NCT01490125|9860621|FG004|COMPLETED|Period II||32
8808202|NCT01490125|9860622|FG005|COMPLETED|Period II||35
8808203|NCT01490125|9860617|FG000|NOT COMPLETED|Period II||3
8758013|NCT01208337|9807406|FG000|STARTED|Overall Study||23
8758014|NCT01208337|9807406|FG000|One-year Follow-up|Overall Study||23
8758015|NCT01208337|9807406|FG000|Five-year Follow-up|Overall Study||20
8758016|NCT01208337|9807406|FG000|COMPLETED|Overall Study||20
8758017|NCT01208337|9807406|FG000|NOT COMPLETED|Overall Study||3
8758018|NCT01208402|9807412|FG000|STARTED|Overall Study||31
8758019|NCT01208402|9807413|FG001|STARTED|Overall Study||28
8758020|NCT01208402|9807412|FG000|COMPLETED|Overall Study||30
8758021|NCT01208402|9807413|FG001|COMPLETED|Overall Study||28
8758022|NCT01208402|9807412|FG000|NOT COMPLETED|Overall Study||1
8758023|NCT01208402|9807413|FG001|NOT COMPLETED|Overall Study||0
8758024|NCT01208415|9807419|FG000|STARTED|Overall Study||40
8758025|NCT01208415|9807419|FG000|6 Months|Overall Study||37
8758026|NCT01208415|9807419|FG000|COMPLETED|Overall Study||0
8758027|NCT01208415|9807419|FG000|NOT COMPLETED|Overall Study||40
8758028|NCT01208870|9807425|FG000|STARTED|Overall Study|The same group was run as Pilot 1 Spring 2012 and Pilot 2 Summer 2013|46
8758029|NCT01208870|9807426|FG001|STARTED|Overall Study|The same group was run as Pilot 1 Spring 2012 and Pilot 2 Summer 2013.|44
8758030|NCT01208870|9807425|FG000|Pilot 1|Overall Study||20
8758031|NCT01208870|9807426|FG001|Pilot 1|Overall Study||22
8758032|NCT01208870|9807425|FG000|Pilot 2|Overall Study||26
8758033|NCT01208870|9807426|FG001|Pilot 2|Overall Study||22
8758034|NCT01208870|9807425|FG000|COMPLETED|Overall Study||44
8758035|NCT01208870|9807426|FG001|COMPLETED|Overall Study||36
8758036|NCT01208870|9807425|FG000|NOT COMPLETED|Overall Study||2
8758037|NCT01208870|9807426|FG001|NOT COMPLETED|Overall Study||8
8758038|NCT01208922|9807436|FG000|STARTED|Overall Study||420
8758039|NCT01208922|9807437|FG001|STARTED|Overall Study||415
8758040|NCT01208922|9807436|FG000|COMPLETED|Overall Study||409
8758041|NCT01208922|9807437|FG001|COMPLETED|Overall Study||405
8758042|NCT01208922|9807436|FG000|NOT COMPLETED|Overall Study||11
8758043|NCT01208922|9807437|FG001|NOT COMPLETED|Overall Study||10
8758044|NCT01208961|9807443|FG000|STARTED|Low-Fat Period I||27
8758045|NCT01208961|9807444|FG001|STARTED|Low-Fat Period I||27
8758046|NCT01208961|9807443|FG000|COMPLETED|Low-Fat Period I||27
8758047|NCT01208961|9807444|FG001|COMPLETED|Low-Fat Period I||27
8758048|NCT01208961|9807443|FG000|NOT COMPLETED|Low-Fat Period I||0
8758049|NCT01208961|9807444|FG001|NOT COMPLETED|Low-Fat Period I||0
9025200|NCT03158220|10087540|FG001|Vaccination 2|Overall Study||635
9025201|NCT03158220|10087539|FG000|Vaccination 3|Overall Study||556
9025202|NCT03158220|10087540|FG001|Vaccination 3|Overall Study||629
9025203|NCT03158220|10087539|FG000|COMPLETED|Overall Study||553
9025204|NCT03158220|10087540|FG001|COMPLETED|Overall Study||626
9025205|NCT03158220|10087539|FG000|NOT COMPLETED|Overall Study||17
9025206|NCT03158220|10087540|FG001|NOT COMPLETED|Overall Study||16
9025207|NCT03158272|10087550|FG000|STARTED|Overall Study||3
9025208|NCT03158272|10087551|FG001|STARTED|Overall Study||4
9025209|NCT03158272|10087552|FG002|STARTED|Overall Study||6
9025210|NCT03158272|10087553|FG003|STARTED|Overall Study||6
9025211|NCT03158272|10087550|FG000|COMPLETED|Overall Study||0
9025212|NCT03158272|10087551|FG001|COMPLETED|Overall Study||0
9025213|NCT03158272|10087552|FG002|COMPLETED|Overall Study||0
9025214|NCT03158272|10087553|FG003|COMPLETED|Overall Study||0
9025215|NCT03158272|10087550|FG000|NOT COMPLETED|Overall Study||3
9025216|NCT03158272|10087551|FG001|NOT COMPLETED|Overall Study||4
9025217|NCT03158272|10087552|FG002|NOT COMPLETED|Overall Study||6
9025218|NCT03158272|10087553|FG003|NOT COMPLETED|Overall Study||6
9025219|NCT03158311|10087568|FG000|STARTED|Overall Study||474
9025220|NCT03158311|10087569|FG001|STARTED|Overall Study||476
9025221|NCT03158311|10087570|FG002|STARTED|Overall Study||476
9025222|NCT03158311|10087568|FG000|Full Analysis Set (FAS)|Overall Study||474
9025223|NCT03158311|10087569|FG001|Full Analysis Set (FAS)|Overall Study||476
9025224|NCT03158311|10087570|FG002|Full Analysis Set (FAS)|Overall Study||475
9025225|NCT03158311|10087568|FG000|Safety Set (SAF)|Overall Study||474
9025226|NCT03158311|10087569|FG001|Safety Set (SAF)|Overall Study||476
9025227|NCT03158311|10087570|FG002|Safety Set (SAF)|Overall Study||475
9025228|NCT03158311|10087568|FG000|COMPLETED|Overall Study||452
9025229|NCT03158311|10087569|FG001|COMPLETED|Overall Study||460
9025230|NCT03158311|10087570|FG002|COMPLETED|Overall Study||448
9025231|NCT03158311|10087568|FG000|NOT COMPLETED|Overall Study||22
9025232|NCT03158311|10087569|FG001|NOT COMPLETED|Overall Study||16
9025233|NCT03158311|10087570|FG002|NOT COMPLETED|Overall Study||28
9025234|NCT03158714|10087581|FG000|STARTED|Overall Study|Number of participants enrolled and Started represents number of individual participants rather than couples|626
8758050|NCT01208961|9807443|FG000|STARTED|Low-Fat Period II||26
8758051|NCT01208961|9807444|FG001|STARTED|Low-Fat Period II||27
8758052|NCT01208961|9807443|FG000|COMPLETED|Low-Fat Period II||26
8758053|NCT01208961|9807444|FG001|COMPLETED|Low-Fat Period II||27
8758054|NCT01208961|9807443|FG000|NOT COMPLETED|Low-Fat Period II||0
8758055|NCT01208961|9807444|FG001|NOT COMPLETED|Low-Fat Period II||0
8758056|NCT01208961|9807443|FG000|STARTED|High-Fat Period III||26
8758057|NCT01208961|9807444|FG001|STARTED|High-Fat Period III||26
8758058|NCT01208961|9807443|FG000|COMPLETED|High-Fat Period III||25
8758059|NCT01208961|9807444|FG001|COMPLETED|High-Fat Period III||26
8758060|NCT01208961|9807443|FG000|NOT COMPLETED|High-Fat Period III||1
8758061|NCT01208961|9807444|FG001|NOT COMPLETED|High-Fat Period III||0
8758062|NCT01208961|9807443|FG000|STARTED|High-Fat Period IV||25
8758063|NCT01208961|9807444|FG001|STARTED|High-Fat Period IV||26
8758064|NCT01208961|9807443|FG000|COMPLETED|High-Fat Period IV||25
9025235|NCT03158714|10087582|FG001|STARTED|Overall Study|Number of participants enrolled and Started represents number of individual participants rather than couples|626
8758065|NCT01208961|9807444|FG001|COMPLETED|High-Fat Period IV||26
8758066|NCT01208961|9807443|FG000|NOT COMPLETED|High-Fat Period IV||0
8758067|NCT01208961|9807444|FG001|NOT COMPLETED|High-Fat Period IV||0
8758068|NCT01209078|9807451|FG000|STARTED|Overall Study||57
8758069|NCT01209078|9807452|FG001|STARTED|Overall Study||27
8758070|NCT01209078|9807451|FG000|COMPLETED|Overall Study||41
8758071|NCT01209078|9807452|FG001|COMPLETED|Overall Study||24
8758072|NCT01209078|9807451|FG000|NOT COMPLETED|Overall Study||16
8758073|NCT01209078|9807452|FG001|NOT COMPLETED|Overall Study||3
8758074|NCT01209143|9807462|FG000|STARTED|Overall Study||24
8758075|NCT01209143|9807463|FG001|STARTED|Overall Study||28
8758076|NCT01209143|9807462|FG000|COMPLETED|Overall Study||5
8758077|NCT01209143|9807463|FG001|COMPLETED|Overall Study||8
8758078|NCT01209143|9807462|FG000|NOT COMPLETED|Overall Study||19
8758079|NCT01209143|9807463|FG001|NOT COMPLETED|Overall Study||20
8758080|NCT01209195|9807471|FG000|STARTED|Overall Study||7
8758081|NCT01209195|9807472|FG001|STARTED|Overall Study||3
8758082|NCT01209195|9807473|FG002|STARTED|Overall Study||6
8758083|NCT01209195|9807474|FG003|STARTED|Overall Study||6
8758084|NCT01209195|9807475|FG004|STARTED|Overall Study||6
8758085|NCT01209195|9807476|FG005|STARTED|Overall Study||13
8758086|NCT01209195|9807471|FG000|COMPLETED|Overall Study||7
8758087|NCT01209195|9807472|FG001|COMPLETED|Overall Study||3
8758088|NCT01209195|9807473|FG002|COMPLETED|Overall Study||6
8758089|NCT01209195|9807474|FG003|COMPLETED|Overall Study||6
8758090|NCT01209195|9807475|FG004|COMPLETED|Overall Study||6
8758091|NCT01209195|9807476|FG005|COMPLETED|Overall Study||13
8758092|NCT01209195|9807471|FG000|NOT COMPLETED|Overall Study||0
8758093|NCT01209195|9807472|FG001|NOT COMPLETED|Overall Study||0
8758094|NCT01209195|9807473|FG002|NOT COMPLETED|Overall Study||0
8758095|NCT01209195|9807474|FG003|NOT COMPLETED|Overall Study||0
8758096|NCT01209195|9807475|FG004|NOT COMPLETED|Overall Study||0
8758097|NCT01209195|9807476|FG005|NOT COMPLETED|Overall Study||0
8758098|NCT01209234|9807494|FG000|STARTED|Overall Study||1070
8758099|NCT01209234|9807495|FG001|STARTED|Overall Study||1070
8758100|NCT01209234|9807494|FG000|COMPLETED|Overall Study||1058
8758101|NCT01209234|9807495|FG001|COMPLETED|Overall Study||1063
8758102|NCT01209234|9807494|FG000|NOT COMPLETED|Overall Study||12
8758103|NCT01209234|9807495|FG001|NOT COMPLETED|Overall Study||7
8758104|NCT01209260|9807503|FG000|STARTED|Overall Study||36
8758105|NCT01209260|9807504|FG001|STARTED|Overall Study||36
8758106|NCT01209260|9807503|FG000|COMPLETED|Overall Study||36
8758107|NCT01209260|9807504|FG001|COMPLETED|Overall Study||36
8758108|NCT01209260|9807503|FG000|NOT COMPLETED|Overall Study||0
8758109|NCT01209260|9807504|FG001|NOT COMPLETED|Overall Study||0
8758110|NCT01209286|9807515|FG000|STARTED|Overall Study||7
8758111|NCT01209286|9807516|FG001|STARTED|Overall Study||23
8758112|NCT01209286|9807517|FG002|STARTED|Overall Study||6
8758113|NCT01209286|9807515|FG000|COMPLETED|Overall Study||2
8758114|NCT01209286|9807516|FG001|COMPLETED|Overall Study||13
8758115|NCT01209286|9807517|FG002|COMPLETED|Overall Study||3
8758116|NCT01209286|9807515|FG000|NOT COMPLETED|Overall Study||5
8758117|NCT01209286|9807516|FG001|NOT COMPLETED|Overall Study||10
8758118|NCT01209286|9807517|FG002|NOT COMPLETED|Overall Study||3
8758119|NCT01209325|9807534|FG000|STARTED|Overall Study||149
8758120|NCT01209325|9807534|FG000|Eligible|Overall Study||145
8758121|NCT01209325|9807534|FG000|Received First Vaccine Injection|Overall Study||144
8758122|NCT01209325|9807534|FG000|Received Second Vaccine Injection|Overall Study||141
8758123|NCT01209325|9807534|FG000|Received Third Vaccine Infjection|Overall Study||138
8758124|NCT01209325|9807534|FG000|Returned After Week 28|Overall Study||124
8758125|NCT01209325|9807534|FG000|COMPLETED|Overall Study||106
8758126|NCT01209325|9807534|FG000|NOT COMPLETED|Overall Study||43
8758127|NCT01209442|9807560|FG000|STARTED|Overall Study||30
8758128|NCT01209442|9807560|FG000|COMPLETED|Overall Study||30
8758129|NCT01209442|9807560|FG000|NOT COMPLETED|Overall Study||0
8758130|NCT01209598|9807566|FG000|STARTED|Overall Study||30
8758131|NCT01209598|9807567|FG001|STARTED|Overall Study||60
8758132|NCT01209598|9807566|FG000|COMPLETED|Overall Study||29
8758133|NCT01209598|9807567|FG001|COMPLETED|Overall Study||60
8758134|NCT01209598|9807566|FG000|NOT COMPLETED|Overall Study||1
8758135|NCT01209598|9807567|FG001|NOT COMPLETED|Overall Study||0
8758136|NCT01209624|9807574|FG000|STARTED|Overall Study||902
8758137|NCT01209624|9807574|FG000|Per Protocol Population|Overall Study||469
8758138|NCT01209624|9807574|FG000|COMPLETED|Overall Study||576
8758139|NCT01209624|9807574|FG000|NOT COMPLETED|Overall Study||326
8758140|NCT01209689|9807580|FG000|STARTED|Overall Study||91
8758141|NCT01209689|9807581|FG001|STARTED|Overall Study||22
8758142|NCT01209689|9807580|FG000|COMPLETED|Overall Study||0
8758143|NCT01209689|9807581|FG001|COMPLETED|Overall Study||0
8758144|NCT01209689|9807580|FG000|NOT COMPLETED|Overall Study||91
8758145|NCT01209689|9807581|FG001|NOT COMPLETED|Overall Study||22
8758146|NCT01209702|9807589|FG000|STARTED|Overall Study||51
8758147|NCT01209702|9807590|FG001|STARTED|Overall Study||51
8758148|NCT01209702|9807591|FG002|STARTED|Overall Study||51
8758149|NCT01209702|9807592|FG003|STARTED|Overall Study||153
8758150|NCT01209702|9807589|FG000|Treated|Overall Study||51
8758151|NCT01209702|9807590|FG001|Treated|Overall Study||51
8758152|NCT01209702|9807591|FG002|Treated|Overall Study||51
8758153|NCT01209702|9807592|FG003|Treated|Overall Study||152
8758154|NCT01209702|9807589|FG000|Escape or Switched to Tocilizumab|Overall Study||51
8758155|NCT01209702|9807590|FG001|Escape or Switched to Tocilizumab|Overall Study||0
8758156|NCT01209702|9807591|FG002|Escape or Switched to Tocilizumab|Overall Study||6
8758157|NCT01209702|9807592|FG003|Escape or Switched to Tocilizumab|Overall Study||0
8758158|NCT01209702|9807589|FG000|Completed 12 Weeks Treatment|Overall Study||50
8758159|NCT01209702|9807590|FG001|Completed 12 Weeks Treatment|Overall Study||48
8758160|NCT01209702|9807591|FG002|Completed 12 Weeks Treatment|Overall Study||12
8758161|NCT01209702|9807592|FG003|Completed 12 Weeks Treatment|Overall Study||59
8758162|NCT01209702|9807589|FG000|Completed 24 Weeks Treatment|Overall Study||19
8758163|NCT01209702|9807590|FG001|Completed 24 Weeks Treatment|Overall Study||28
8758164|NCT01209702|9807591|FG002|Completed 24 Weeks Treatment|Overall Study||3
8758165|NCT01209702|9807592|FG003|Completed 24 Weeks Treatment|Overall Study||10
8758166|NCT01209702|9807589|FG000|COMPLETED|Overall Study||0
8758167|NCT01209702|9807590|FG001|COMPLETED|Overall Study||0
8758168|NCT01209702|9807591|FG002|COMPLETED|Overall Study||0
8758169|NCT01209702|9807592|FG003|COMPLETED|Overall Study||0
8758170|NCT01209702|9807589|FG000|NOT COMPLETED|Overall Study||51
8758171|NCT01209702|9807590|FG001|NOT COMPLETED|Overall Study||51
8758172|NCT01209702|9807591|FG002|NOT COMPLETED|Overall Study||51
8758173|NCT01209702|9807592|FG003|NOT COMPLETED|Overall Study||153
8758174|NCT01209780|9807615|FG000|STARTED|Overall Study||1042
8758175|NCT01209780|9807616|FG001|STARTED|Overall Study||485
8758176|NCT01209780|9807617|FG002|STARTED|Overall Study||48
8758177|NCT01209780|9807618|FG003|STARTED|Overall Study||817
8758178|NCT01209780|9807619|FG004|STARTED|Overall Study||412
8758179|NCT01209780|9807615|FG000|COMPLETED|Overall Study||1016
8758180|NCT01209780|9807616|FG001|COMPLETED|Overall Study||467
8758181|NCT01209780|9807617|FG002|COMPLETED|Overall Study||44
8758182|NCT01209780|9807618|FG003|COMPLETED|Overall Study||807
8758183|NCT01209780|9807619|FG004|COMPLETED|Overall Study||407
8758184|NCT01209780|9807615|FG000|NOT COMPLETED|Overall Study||26
8758185|NCT01209780|9807616|FG001|NOT COMPLETED|Overall Study||18
8758186|NCT01209780|9807617|FG002|NOT COMPLETED|Overall Study||4
8758187|NCT01209780|9807618|FG003|NOT COMPLETED|Overall Study||10
8758188|NCT01209780|9807619|FG004|NOT COMPLETED|Overall Study||5
8758189|NCT01209832|9807632|FG000|STARTED|Period 1||11
8758190|NCT01209832|9807632|FG000|Received At Least 1 Dose of Study Drug|Period 1||10
8758191|NCT01209832|9807632|FG000|COMPLETED|Period 1||10
8758192|NCT01209832|9807632|FG000|NOT COMPLETED|Period 1||1
8758193|NCT01209832|9807632|FG000|STARTED|Period 2||10
8758194|NCT01209832|9807632|FG000|COMPLETED|Period 2||9
8758195|NCT01209832|9807632|FG000|NOT COMPLETED|Period 2||1
8758196|NCT01209832|9807632|FG000|STARTED|Maintenance Period 1 (M1)|Five participants who completed Period 2 did not enroll into Maintenance Period.|4
8758197|NCT01209832|9807632|FG000|COMPLETED|Maintenance Period 1 (M1)||4
8758198|NCT01209832|9807632|FG000|NOT COMPLETED|Maintenance Period 1 (M1)||0
8758199|NCT01209832|9807632|FG000|STARTED|Maintenance Period 2 (M1)|One participant who completed maintenance period 1 did not enter maintenance period 2.|3
8758200|NCT01209832|9807632|FG000|COMPLETED|Maintenance Period 2 (M1)||3
8758201|NCT01209832|9807632|FG000|NOT COMPLETED|Maintenance Period 2 (M1)||0
8758202|NCT01209949|9807643|FG000|STARTED|Overall Study||30
8758203|NCT01209949|9807643|FG000|COMPLETED|Overall Study||27
8758204|NCT01209949|9807643|FG000|NOT COMPLETED|Overall Study||3
8758205|NCT01210001|9807650|FG000|STARTED|Overall Study||166
8758206|NCT01210001|9807651|FG001|STARTED|Overall Study||165
8758207|NCT01210001|9807652|FG002|STARTED|Overall Study||168
8758208|NCT01210001|9807650|FG000|COMPLETED|Overall Study||147
8758209|NCT01210001|9807651|FG001|COMPLETED|Overall Study||154
8758210|NCT01210001|9807652|FG002|COMPLETED|Overall Study||156
8758211|NCT01210001|9807650|FG000|NOT COMPLETED|Overall Study||19
8758212|NCT01210001|9807651|FG001|NOT COMPLETED|Overall Study||11
8758213|NCT01210001|9807652|FG002|NOT COMPLETED|Overall Study||12
8758214|NCT01210079|9807662|FG000|STARTED|Overall Study||10
8758215|NCT01210079|9807663|FG001|STARTED|Overall Study||16
8758216|NCT01210079|9807662|FG000|COMPLETED|Overall Study||10
8758217|NCT01210079|9807663|FG001|COMPLETED|Overall Study||16
8758218|NCT01210079|9807662|FG000|NOT COMPLETED|Overall Study||0
8758219|NCT01210079|9807663|FG001|NOT COMPLETED|Overall Study||0
8758220|NCT01210118|9807671|FG000|STARTED|Overall Study||45
8758221|NCT01210118|9807672|FG001|STARTED|Overall Study||47
8758222|NCT01210118|9807671|FG000|COMPLETED|Overall Study||42
8758223|NCT01210118|9807672|FG001|COMPLETED|Overall Study||42
8758224|NCT01210118|9807671|FG000|NOT COMPLETED|Overall Study||3
8758225|NCT01210118|9807672|FG001|NOT COMPLETED|Overall Study||5
8758226|NCT01210144|9807683|FG000|STARTED|Overall Study||13
8758227|NCT01210144|9807684|FG001|STARTED|Overall Study||11
8758228|NCT01210144|9807683|FG000|COMPLETED|Overall Study||10
8758229|NCT01210144|9807684|FG001|COMPLETED|Overall Study||11
8758230|NCT01210144|9807683|FG000|NOT COMPLETED|Overall Study||3
8758231|NCT01210144|9807684|FG001|NOT COMPLETED|Overall Study||0
8758232|NCT01210170|9807691|FG000|STARTED|Overall Study||22
8758233|NCT01210170|9807691|FG000|COMPLETED|Overall Study||15
8758234|NCT01210170|9807691|FG000|NOT COMPLETED|Overall Study||7
8758235|NCT01210222|9807712|FG000|STARTED|Overall Study||35
8758236|NCT01210222|9807712|FG000|COMPLETED|Overall Study||32
8758237|NCT01210222|9807712|FG000|NOT COMPLETED|Overall Study||3
8758238|NCT01210352|9807731|FG000|STARTED|Overall Study||6
8758239|NCT01210352|9807732|FG001|STARTED|Overall Study||6
8758240|NCT01210352|9807733|FG002|STARTED|Overall Study||7
8758241|NCT01210352|9807734|FG003|STARTED|Overall Study||7
8758242|NCT01210352|9807735|FG004|STARTED|Overall Study||6
8758243|NCT01210352|9807736|FG005|STARTED|Overall Study||6
8758244|NCT01210352|9807737|FG006|STARTED|Overall Study||7
8758245|NCT01210352|9807738|FG007|STARTED|Overall Study||10
8758246|NCT01210352|9807739|FG008|STARTED|Overall Study||6
8758247|NCT01210352|9807731|FG000|COMPLETED|Overall Study||6
8758248|NCT01210352|9807732|FG001|COMPLETED|Overall Study||6
8758249|NCT01210352|9807733|FG002|COMPLETED|Overall Study||5
8758250|NCT01210352|9807734|FG003|COMPLETED|Overall Study||7
8758251|NCT01210352|9807735|FG004|COMPLETED|Overall Study||6
8758252|NCT01210352|9807736|FG005|COMPLETED|Overall Study||6
8758253|NCT01210352|9807737|FG006|COMPLETED|Overall Study||5
8758254|NCT01210352|9807738|FG007|COMPLETED|Overall Study||7
8758255|NCT01210352|9807739|FG008|COMPLETED|Overall Study||2
8758256|NCT01210352|9807731|FG000|NOT COMPLETED|Overall Study||0
8758257|NCT01210352|9807732|FG001|NOT COMPLETED|Overall Study||0
8758258|NCT01210352|9807733|FG002|NOT COMPLETED|Overall Study||2
8758259|NCT01210352|9807734|FG003|NOT COMPLETED|Overall Study||0
8758260|NCT01210352|9807735|FG004|NOT COMPLETED|Overall Study||0
8758261|NCT01210352|9807736|FG005|NOT COMPLETED|Overall Study||0
8758262|NCT01210352|9807737|FG006|NOT COMPLETED|Overall Study||2
8758263|NCT01210352|9807738|FG007|NOT COMPLETED|Overall Study||3
8758264|NCT01210352|9807739|FG008|NOT COMPLETED|Overall Study||4
8758265|NCT01210443|9807844|FG000|STARTED|Overall Study||2
8758266|NCT01210443|9807844|FG000|COMPLETED|Overall Study||0
8758267|NCT01210443|9807844|FG000|NOT COMPLETED|Overall Study||2
8758268|NCT01210495|9807852|FG000|STARTED|Overall Study||15
8758269|NCT01210495|9807853|FG001|STARTED|Overall Study||7
8758270|NCT01210495|9807854|FG002|STARTED|Overall Study||134
8758271|NCT01210495|9807855|FG003|STARTED|Overall Study||68
8758272|NCT01210495|9807852|FG000|COMPLETED|Overall Study||0
8758273|NCT01210495|9807853|FG001|COMPLETED|Overall Study||0
8758274|NCT01210495|9807854|FG002|COMPLETED|Overall Study||0
8758275|NCT01210495|9807855|FG003|COMPLETED|Overall Study||0
8758276|NCT01210495|9807852|FG000|NOT COMPLETED|Overall Study||15
8758277|NCT01210495|9807853|FG001|NOT COMPLETED|Overall Study||7
8758278|NCT01210495|9807854|FG002|NOT COMPLETED|Overall Study||134
8758279|NCT01210495|9807855|FG003|NOT COMPLETED|Overall Study||68
8758280|NCT01210560|9807867|FG000|STARTED|Intervention 1 (7 Days)||2
8758281|NCT01210560|9807868|FG001|STARTED|Intervention 1 (7 Days)||2
8758282|NCT01210560|9807869|FG002|STARTED|Intervention 1 (7 Days)||2
8758283|NCT01210560|9807870|FG003|STARTED|Intervention 1 (7 Days)||2
8758284|NCT01210560|9807871|FG004|STARTED|Intervention 1 (7 Days)||2
8758285|NCT01210560|9807872|FG005|STARTED|Intervention 1 (7 Days)||2
8758286|NCT01210560|9807873|FG006|STARTED|Intervention 1 (7 Days)||4
8758287|NCT01210560|9807874|FG007|STARTED|Intervention 1 (7 Days)||4
8758288|NCT01210560|9807875|FG008|STARTED|Intervention 1 (7 Days)||5
8758289|NCT01210560|9807867|FG000|COMPLETED|Intervention 1 (7 Days)||2
8758290|NCT01210560|9807868|FG001|COMPLETED|Intervention 1 (7 Days)||2
8758291|NCT01210560|9807869|FG002|COMPLETED|Intervention 1 (7 Days)||2
8758292|NCT01210560|9807870|FG003|COMPLETED|Intervention 1 (7 Days)||2
8758293|NCT01210560|9807871|FG004|COMPLETED|Intervention 1 (7 Days)||2
8758294|NCT01210560|9807872|FG005|COMPLETED|Intervention 1 (7 Days)||2
8758295|NCT01210560|9807873|FG006|COMPLETED|Intervention 1 (7 Days)||4
8758296|NCT01210560|9807874|FG007|COMPLETED|Intervention 1 (7 Days)||4
8758297|NCT01210560|9807875|FG008|COMPLETED|Intervention 1 (7 Days)||5
8758298|NCT01210560|9807867|FG000|NOT COMPLETED|Intervention 1 (7 Days)||0
8758299|NCT01210560|9807868|FG001|NOT COMPLETED|Intervention 1 (7 Days)||0
8758300|NCT01210560|9807869|FG002|NOT COMPLETED|Intervention 1 (7 Days)||0
8758301|NCT01210560|9807870|FG003|NOT COMPLETED|Intervention 1 (7 Days)||0
8758302|NCT01210560|9807871|FG004|NOT COMPLETED|Intervention 1 (7 Days)||0
8758303|NCT01210560|9807872|FG005|NOT COMPLETED|Intervention 1 (7 Days)||0
8758304|NCT01210560|9807873|FG006|NOT COMPLETED|Intervention 1 (7 Days)||0
8758305|NCT01210560|9807874|FG007|NOT COMPLETED|Intervention 1 (7 Days)||0
8758306|NCT01210560|9807875|FG008|NOT COMPLETED|Intervention 1 (7 Days)||0
8758307|NCT01210560|9807867|FG000|STARTED|Intervention 2 (7 Days)||2
8758308|NCT01210560|9807868|FG001|STARTED|Intervention 2 (7 Days)||2
8758309|NCT01210560|9807869|FG002|STARTED|Intervention 2 (7 Days)||2
8758310|NCT01210560|9807870|FG003|STARTED|Intervention 2 (7 Days)||2
8758311|NCT01210560|9807871|FG004|STARTED|Intervention 2 (7 Days)||2
8758312|NCT01210560|9807872|FG005|STARTED|Intervention 2 (7 Days)||2
8758313|NCT01210560|9807873|FG006|STARTED|Intervention 2 (7 Days)||4
8758314|NCT01210560|9807874|FG007|STARTED|Intervention 2 (7 Days)||4
8758315|NCT01210560|9807875|FG008|STARTED|Intervention 2 (7 Days)||5
8758316|NCT01210560|9807867|FG000|COMPLETED|Intervention 2 (7 Days)||2
8758317|NCT01210560|9807868|FG001|COMPLETED|Intervention 2 (7 Days)||2
8758318|NCT01210560|9807869|FG002|COMPLETED|Intervention 2 (7 Days)||2
8758319|NCT01210560|9807870|FG003|COMPLETED|Intervention 2 (7 Days)||2
8758320|NCT01210560|9807871|FG004|COMPLETED|Intervention 2 (7 Days)||2
8758321|NCT01210560|9807872|FG005|COMPLETED|Intervention 2 (7 Days)||2
8758322|NCT01210560|9807873|FG006|COMPLETED|Intervention 2 (7 Days)||4
8758323|NCT01210560|9807874|FG007|COMPLETED|Intervention 2 (7 Days)||4
8758324|NCT01210560|9807875|FG008|COMPLETED|Intervention 2 (7 Days)||5
8758325|NCT01210560|9807867|FG000|NOT COMPLETED|Intervention 2 (7 Days)||0
8758326|NCT01210560|9807868|FG001|NOT COMPLETED|Intervention 2 (7 Days)||0
8758327|NCT01210560|9807869|FG002|NOT COMPLETED|Intervention 2 (7 Days)||0
8758328|NCT01210560|9807870|FG003|NOT COMPLETED|Intervention 2 (7 Days)||0
8758329|NCT01210560|9807871|FG004|NOT COMPLETED|Intervention 2 (7 Days)||0
8758330|NCT01210560|9807872|FG005|NOT COMPLETED|Intervention 2 (7 Days)||0
8758331|NCT01210560|9807873|FG006|NOT COMPLETED|Intervention 2 (7 Days)||0
8758332|NCT01210560|9807874|FG007|NOT COMPLETED|Intervention 2 (7 Days)||0
8758333|NCT01210560|9807875|FG008|NOT COMPLETED|Intervention 2 (7 Days)||0
8758334|NCT01210560|9807867|FG000|STARTED|Intervention 3 (7 Days)||2
8758335|NCT01210560|9807868|FG001|STARTED|Intervention 3 (7 Days)||2
8758336|NCT01210560|9807869|FG002|STARTED|Intervention 3 (7 Days)||2
8758337|NCT01210560|9807870|FG003|STARTED|Intervention 3 (7 Days)||2
8758338|NCT01210560|9807871|FG004|STARTED|Intervention 3 (7 Days)||2
8758339|NCT01210560|9807872|FG005|STARTED|Intervention 3 (7 Days)||2
8758340|NCT01210560|9807873|FG006|STARTED|Intervention 3 (7 Days)||4
8758341|NCT01210560|9807874|FG007|STARTED|Intervention 3 (7 Days)||4
8758342|NCT01210560|9807875|FG008|STARTED|Intervention 3 (7 Days)||5
8758343|NCT01210560|9807867|FG000|COMPLETED|Intervention 3 (7 Days)||2
8758344|NCT01210560|9807868|FG001|COMPLETED|Intervention 3 (7 Days)||2
8758345|NCT01210560|9807869|FG002|COMPLETED|Intervention 3 (7 Days)||2
8758346|NCT01210560|9807870|FG003|COMPLETED|Intervention 3 (7 Days)||2
8758347|NCT01210560|9807871|FG004|COMPLETED|Intervention 3 (7 Days)||2
8758348|NCT01210560|9807872|FG005|COMPLETED|Intervention 3 (7 Days)||2
8758349|NCT01210560|9807873|FG006|COMPLETED|Intervention 3 (7 Days)||4
8758350|NCT01210560|9807874|FG007|COMPLETED|Intervention 3 (7 Days)||4
8758351|NCT01210560|9807875|FG008|COMPLETED|Intervention 3 (7 Days)||5
8758352|NCT01210560|9807867|FG000|NOT COMPLETED|Intervention 3 (7 Days)||0
8758353|NCT01210560|9807868|FG001|NOT COMPLETED|Intervention 3 (7 Days)||0
8758354|NCT01210560|9807869|FG002|NOT COMPLETED|Intervention 3 (7 Days)||0
8758355|NCT01210560|9807870|FG003|NOT COMPLETED|Intervention 3 (7 Days)||0
8758356|NCT01210560|9807871|FG004|NOT COMPLETED|Intervention 3 (7 Days)||0
8758357|NCT01210560|9807872|FG005|NOT COMPLETED|Intervention 3 (7 Days)||0
8758358|NCT01210560|9807873|FG006|NOT COMPLETED|Intervention 3 (7 Days)||0
8758359|NCT01210560|9807874|FG007|NOT COMPLETED|Intervention 3 (7 Days)||0
8758360|NCT01210560|9807875|FG008|NOT COMPLETED|Intervention 3 (7 Days)||0
8758361|NCT01210651|9807890|FG000|STARTED|Overall Study|Number randomized to intervention, but not number who started intervention by attending 1st session.|20
8758362|NCT01210651|9807891|FG001|STARTED|Overall Study|Number randomized to intervention, but not number who started intervention by attending 1st session.|18
8758363|NCT01210651|9807890|FG000|Number Attending 1st Assigned Session|Overall Study||18
8758364|NCT01210651|9807891|FG001|Number Attending 1st Assigned Session|Overall Study||12
8758365|NCT01210651|9807890|FG000|COMPLETED|Overall Study||15
8758366|NCT01210651|9807891|FG001|COMPLETED|Overall Study||10
8758367|NCT01210651|9807890|FG000|NOT COMPLETED|Overall Study||5
8758368|NCT01210651|9807891|FG001|NOT COMPLETED|Overall Study||8
8758369|NCT01210664|9807901|FG000|STARTED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||3
8758370|NCT01210664|9807902|FG001|STARTED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
8758371|NCT01210664|9807903|FG002|STARTED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
8758372|NCT01210664|9807904|FG003|STARTED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
8758373|NCT01210664|9807901|FG000|Received Study Treatment|Cohort 1: PolyTregs 0.05 x 10^8 Cells||3
8758374|NCT01210664|9807902|FG001|Received Study Treatment|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
8758375|NCT01210664|9807903|FG002|Received Study Treatment|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
8758376|NCT01210664|9807904|FG003|Received Study Treatment|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
8758377|NCT01210664|9807901|FG000|COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||3
8758378|NCT01210664|9807902|FG001|COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
8758379|NCT01210664|9807903|FG002|COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
8758380|NCT01210664|9807904|FG003|COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
8758381|NCT01210664|9807901|FG000|NOT COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
8758382|NCT01210664|9807902|FG001|NOT COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
8758383|NCT01210664|9807903|FG002|NOT COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
8758384|NCT01210664|9807904|FG003|NOT COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
8758385|NCT01210664|9807901|FG000|STARTED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
8758386|NCT01210664|9807902|FG001|STARTED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||3
8758387|NCT01210664|9807903|FG002|STARTED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
8758388|NCT01210664|9807904|FG003|STARTED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
8758389|NCT01210664|9807901|FG000|Received Study Treatment|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
8758390|NCT01210664|9807902|FG001|Received Study Treatment|Cohort 2: PolyTregs 0.4 x 10^8 Cells||3
8758391|NCT01210664|9807903|FG002|Received Study Treatment|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
8758392|NCT01210664|9807904|FG003|Received Study Treatment|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
8758393|NCT01210664|9807901|FG000|COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
8758394|NCT01210664|9807902|FG001|COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||3
8758395|NCT01210664|9807903|FG002|COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
8758396|NCT01210664|9807904|FG003|COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
8758397|NCT01210664|9807901|FG000|NOT COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
8758398|NCT01210664|9807902|FG001|NOT COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
8758399|NCT01210664|9807903|FG002|NOT COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
8758400|NCT01210664|9807904|FG003|NOT COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
8758401|NCT01210664|9807901|FG000|STARTED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
8758402|NCT01210664|9807902|FG001|STARTED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
8758403|NCT01210664|9807903|FG002|STARTED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||5
8758404|NCT01210664|9807904|FG003|STARTED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
8758405|NCT01210664|9807901|FG000|Received Study Treatment|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
8758406|NCT01210664|9807902|FG001|Received Study Treatment|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
8758407|NCT01210664|9807903|FG002|Received Study Treatment|Cohort 3: PolyTregs 3.2 x 10^8 Cells||4
8758408|NCT01210664|9807904|FG003|Received Study Treatment|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
8758409|NCT01210664|9807901|FG000|COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
8758410|NCT01210664|9807902|FG001|COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
8758411|NCT01210664|9807903|FG002|COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||3
8758412|NCT01210664|9807904|FG003|COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
8758413|NCT01210664|9807901|FG000|NOT COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
8758414|NCT01210664|9807902|FG001|NOT COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
8758415|NCT01210664|9807903|FG002|NOT COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||2
8758416|NCT01210664|9807904|FG003|NOT COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
8758417|NCT01210664|9807901|FG000|STARTED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
8758418|NCT01210664|9807902|FG001|STARTED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
8758419|NCT01210664|9807903|FG002|STARTED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
8758420|NCT01210664|9807904|FG003|STARTED|Cohort 4: PolyTregs 26 x 10^8 Cells||5
8758421|NCT01210664|9807901|FG000|Received Study Treatment|Cohort 4: PolyTregs 26 x 10^8 Cells||0
8758422|NCT01210664|9807902|FG001|Received Study Treatment|Cohort 4: PolyTregs 26 x 10^8 Cells||0
8758423|NCT01210664|9807903|FG002|Received Study Treatment|Cohort 4: PolyTregs 26 x 10^8 Cells||0
8758424|NCT01210664|9807904|FG003|Received Study Treatment|Cohort 4: PolyTregs 26 x 10^8 Cells||4
8758425|NCT01210664|9807901|FG000|COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
8758426|NCT01210664|9807902|FG001|COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
8758427|NCT01210664|9807903|FG002|COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
8758428|NCT01210664|9807904|FG003|COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||4
8758429|NCT01210664|9807901|FG000|NOT COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
8758430|NCT01210664|9807902|FG001|NOT COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
8758431|NCT01210664|9807903|FG002|NOT COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
9025236|NCT03158714|10087583|FG002|STARTED|Overall Study|Number of participants enrolled and Started represents number of individual participants rather than couples|606
9025237|NCT03158714|10087581|FG000|COMPLETED|Overall Study|Participated in half or more of program.|445
9025238|NCT03158714|10087582|FG001|COMPLETED|Overall Study|Participated in half or more of program.|398
9025239|NCT03158714|10087583|FG002|COMPLETED|Overall Study|All control group participants completed the control protocol (no program).|606
9025240|NCT03158714|10087581|FG000|NOT COMPLETED|Overall Study||181
9025241|NCT03158714|10087582|FG001|NOT COMPLETED|Overall Study||228
8758432|NCT01210664|9807904|FG003|NOT COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||1
8758433|NCT01210690|9807914|FG000|STARTED|Overall Study||101
8758434|NCT01210690|9807914|FG000|COMPLETED|Overall Study||75
8758435|NCT01210690|9807914|FG000|NOT COMPLETED|Overall Study||26
8758436|NCT01210716|9807919|FG000|STARTED|First TPE Procedure||20
8758437|NCT01210716|9807920|FG001|STARTED|First TPE Procedure||17
8758438|NCT01210716|9807919|FG000|COMPLETED|First TPE Procedure||18
8758439|NCT01210716|9807920|FG001|COMPLETED|First TPE Procedure||15
8758440|NCT01210716|9807919|FG000|NOT COMPLETED|First TPE Procedure||2
8758441|NCT01210716|9807920|FG001|NOT COMPLETED|First TPE Procedure||2
8758442|NCT01210716|9807919|FG000|STARTED|Second TPE Procedure||18
8758443|NCT01210716|9807920|FG001|STARTED|Second TPE Procedure||15
8758444|NCT01210716|9807919|FG000|COMPLETED|Second TPE Procedure||15
8758445|NCT01210716|9807920|FG001|COMPLETED|Second TPE Procedure||15
8758446|NCT01210716|9807919|FG000|NOT COMPLETED|Second TPE Procedure||3
8758447|NCT01210716|9807920|FG001|NOT COMPLETED|Second TPE Procedure||0
8758448|NCT01210807|9807928|FG000|STARTED|Overall Study||36
8758449|NCT01210807|9807929|FG001|STARTED|Overall Study||34
9025242|NCT03158714|10087583|FG002|NOT COMPLETED|Overall Study||0
9025243|NCT03159091|10087593|FG000|STARTED|Overall Study||121
9025244|NCT03159091|10087594|FG001|STARTED|Overall Study||117
9025245|NCT03159091|10087593|FG000|COMPLETED|Overall Study||116
9025246|NCT03159091|10087594|FG001|COMPLETED|Overall Study||113
9025247|NCT03159091|10087593|FG000|NOT COMPLETED|Overall Study||5
9025248|NCT03159091|10087594|FG001|NOT COMPLETED|Overall Study||4
9025249|NCT03159143|10087600|FG000|STARTED|Overall Study||22
9025250|NCT03159143|10087600|FG000|COMPLETED|Overall Study||22
9025251|NCT03159143|10087600|FG000|NOT COMPLETED|Overall Study||0
9025252|NCT03159195|10087606|FG000|STARTED|Overall Study||360
9025253|NCT03159195|10087607|FG001|STARTED|Overall Study||292
9025254|NCT03159195|10087606|FG000|COMPLETED|Overall Study||360
9025255|NCT03159195|10087607|FG001|COMPLETED|Overall Study||292
9025256|NCT03159195|10087606|FG000|NOT COMPLETED|Overall Study||0
9025257|NCT03159195|10087607|FG001|NOT COMPLETED|Overall Study||0
8758450|NCT01210807|9807928|FG000|COMPLETED|Overall Study||33
8758451|NCT01210807|9807929|FG001|COMPLETED|Overall Study||31
8758452|NCT01210807|9807928|FG000|NOT COMPLETED|Overall Study||3
8758453|NCT01210807|9807929|FG001|NOT COMPLETED|Overall Study||3
8758454|NCT01210820|9807937|FG000|STARTED|Overall Study||17
8758455|NCT01210820|9807938|FG001|STARTED|Overall Study||4
8758456|NCT01210820|9807937|FG000|COMPLETED|Overall Study||17
8758457|NCT01210820|9807938|FG001|COMPLETED|Overall Study||4
8758458|NCT01210820|9807937|FG000|NOT COMPLETED|Overall Study||0
8758459|NCT01210820|9807938|FG001|NOT COMPLETED|Overall Study||0
8758460|NCT01211106|9807946|FG000|STARTED|Overall Study||95
8758461|NCT01211106|9807947|FG001|STARTED|Overall Study||88
8915263|NCT02173535|9974689|FG017|NOT COMPLETED|Period 4||0
8915264|NCT02173535|9974690|FG018|NOT COMPLETED|Period 4||0
8915265|NCT02173535|9974691|FG019|NOT COMPLETED|Period 4||0
8915266|NCT02173535|9974672|FG000|STARTED|Period 5||12
8915267|NCT02173535|9974673|FG001|STARTED|Period 5||12
8915268|NCT02173535|9974674|FG002|STARTED|Period 5||12
8915269|NCT02173535|9974675|FG003|STARTED|Period 5||12
8915270|NCT02173535|9974676|FG004|STARTED|Period 5||12
8915271|NCT02173535|9974677|FG005|STARTED|Period 5||12
8915272|NCT02173535|9974678|FG006|STARTED|Period 5||12
8915273|NCT02173535|9974679|FG007|STARTED|Period 5||12
8915274|NCT02173535|9974680|FG008|STARTED|Period 5||12
8915275|NCT02173535|9974681|FG009|STARTED|Period 5||12
8915276|NCT02173535|9974682|FG010|STARTED|Period 5||12
8915277|NCT02173535|9974683|FG011|STARTED|Period 5||12
8915278|NCT02173535|9974684|FG012|STARTED|Period 5||12
8915279|NCT02173535|9974685|FG013|STARTED|Period 5||12
8915280|NCT02173535|9974686|FG014|STARTED|Period 5||12
8915281|NCT02173535|9974687|FG015|STARTED|Period 5||12
8915282|NCT02173535|9974688|FG016|STARTED|Period 5||12
8915283|NCT02173535|9974689|FG017|STARTED|Period 5||12
8915284|NCT02173535|9974690|FG018|STARTED|Period 5||12
8915285|NCT02173535|9974691|FG019|STARTED|Period 5||12
8915286|NCT02173535|9974672|FG000|COMPLETED|Period 5||12
8915287|NCT02173535|9974673|FG001|COMPLETED|Period 5||12
8915288|NCT02173535|9974674|FG002|COMPLETED|Period 5||12
8915289|NCT02173535|9974675|FG003|COMPLETED|Period 5||12
8915290|NCT02173535|9974676|FG004|COMPLETED|Period 5||12
8915291|NCT02173535|9974677|FG005|COMPLETED|Period 5||12
8915292|NCT02173535|9974678|FG006|COMPLETED|Period 5||12
8915293|NCT02173535|9974679|FG007|COMPLETED|Period 5||12
8915294|NCT02173535|9974680|FG008|COMPLETED|Period 5||12
8915295|NCT02173535|9974681|FG009|COMPLETED|Period 5||12
8915296|NCT02173535|9974682|FG010|COMPLETED|Period 5||12
8915297|NCT02173535|9974683|FG011|COMPLETED|Period 5||12
8915298|NCT02173535|9974684|FG012|COMPLETED|Period 5||12
8915299|NCT02173535|9974685|FG013|COMPLETED|Period 5||12
8915300|NCT02173535|9974686|FG014|COMPLETED|Period 5||12
8915301|NCT02173535|9974687|FG015|COMPLETED|Period 5||12
8915302|NCT02173535|9974688|FG016|COMPLETED|Period 5||12
9025258|NCT03159260|10087615|FG000|STARTED|Overall Study||28
9025259|NCT03159260|10087616|FG001|STARTED|Overall Study||29
9025260|NCT03159260|10087615|FG000|COMPLETED|Overall Study||25
9025261|NCT03159260|10087616|FG001|COMPLETED|Overall Study||25
9025262|NCT03159260|10087615|FG000|NOT COMPLETED|Overall Study||3
9025263|NCT03159260|10087616|FG001|NOT COMPLETED|Overall Study||4
9025264|NCT03159299|10087624|FG000|STARTED|Overall Study||26
9025265|NCT03159299|10087625|FG001|STARTED|Overall Study||21
9025266|NCT03159299|10087624|FG000|COMPLETED|Overall Study||24
9025267|NCT03159299|10087625|FG001|COMPLETED|Overall Study||20
9025268|NCT03159299|10087624|FG000|NOT COMPLETED|Overall Study||2
9025269|NCT03159299|10087625|FG001|NOT COMPLETED|Overall Study||1
9025270|NCT03159455|10087637|FG000|STARTED|Overall Study||9
9025271|NCT03159455|10087638|FG001|STARTED|Overall Study||9
9025272|NCT03159455|10087639|FG002|STARTED|Overall Study||9
9025273|NCT03159455|10087640|FG003|STARTED|Overall Study||9
9025274|NCT03159455|10087641|FG004|STARTED|Overall Study||3
9025275|NCT03159455|10087642|FG005|STARTED|Overall Study||9
9025276|NCT03159455|10087637|FG000|COMPLETED|Overall Study||9
9025277|NCT03159455|10087638|FG001|COMPLETED|Overall Study||9
9025278|NCT03159455|10087639|FG002|COMPLETED|Overall Study||9
9025279|NCT03159455|10087640|FG003|COMPLETED|Overall Study||9
9025280|NCT03159455|10087641|FG004|COMPLETED|Overall Study||3
8758462|NCT01211106|9807946|FG000|COMPLETED|Overall Study||82
8758463|NCT01211106|9807947|FG001|COMPLETED|Overall Study||77
8758464|NCT01211106|9807946|FG000|NOT COMPLETED|Overall Study||13
8915303|NCT02173535|9974689|FG017|COMPLETED|Period 5||12
8915304|NCT02173535|9974690|FG018|COMPLETED|Period 5||12
8915305|NCT02173535|9974691|FG019|COMPLETED|Period 5||12
8915306|NCT02173535|9974672|FG000|NOT COMPLETED|Period 5||0
8915307|NCT02173535|9974673|FG001|NOT COMPLETED|Period 5||0
8915308|NCT02173535|9974674|FG002|NOT COMPLETED|Period 5||0
8915309|NCT02173535|9974675|FG003|NOT COMPLETED|Period 5||0
8915310|NCT02173535|9974676|FG004|NOT COMPLETED|Period 5||0
8915311|NCT02173535|9974677|FG005|NOT COMPLETED|Period 5||0
8915312|NCT02173535|9974678|FG006|NOT COMPLETED|Period 5||0
9025281|NCT03159455|10087642|FG005|COMPLETED|Overall Study||8
9025282|NCT03159455|10087637|FG000|NOT COMPLETED|Overall Study||0
9025283|NCT03159455|10087638|FG001|NOT COMPLETED|Overall Study||0
9025284|NCT03159455|10087639|FG002|NOT COMPLETED|Overall Study||0
9025285|NCT03159455|10087640|FG003|NOT COMPLETED|Overall Study||0
9025286|NCT03159455|10087641|FG004|NOT COMPLETED|Overall Study||0
9025287|NCT03159455|10087642|FG005|NOT COMPLETED|Overall Study||1
9025288|NCT03159468|10087666|FG000|STARTED|Overall Study||35
9025289|NCT03159468|10087667|FG001|STARTED|Overall Study||35
8758465|NCT01211106|9807947|FG001|NOT COMPLETED|Overall Study||11
8758466|NCT01211145|9807959|FG000|STARTED|Overall Study||296
8758467|NCT01211145|9807960|FG001|STARTED|Overall Study||115
8758468|NCT01211145|9807961|FG002|STARTED|Overall Study||99
8758469|NCT01211145|9807962|FG003|STARTED|Overall Study||288
8758470|NCT01211145|9807959|FG000|COMPLETED|Overall Study|1 patient was not counted as completed or discontinued due to incomplete information (N=270-1=269).|270
8758471|NCT01211145|9807960|FG001|COMPLETED|Overall Study||98
8758472|NCT01211145|9807961|FG002|COMPLETED|Overall Study||86
8758473|NCT01211145|9807962|FG003|COMPLETED|Overall Study||268
8758474|NCT01211145|9807959|FG000|NOT COMPLETED|Overall Study||26
8758475|NCT01211145|9807960|FG001|NOT COMPLETED|Overall Study||17
8758476|NCT01211145|9807961|FG002|NOT COMPLETED|Overall Study||13
8758477|NCT01211145|9807962|FG003|NOT COMPLETED|Overall Study||20
8758478|NCT01211184|9807975|FG000|STARTED|Overall Study||20
8758479|NCT01211184|9807976|FG001|STARTED|Overall Study||20
8758480|NCT01211184|9807977|FG002|STARTED|Overall Study||20
8758481|NCT01211184|9807975|FG000|COMPLETED|Overall Study||20
8758482|NCT01211184|9807976|FG001|COMPLETED|Overall Study||18
8758483|NCT01211184|9807977|FG002|COMPLETED|Overall Study||19
8758484|NCT01211184|9807975|FG000|NOT COMPLETED|Overall Study||0
8758485|NCT01211184|9807976|FG001|NOT COMPLETED|Overall Study||2
8758486|NCT01211184|9807977|FG002|NOT COMPLETED|Overall Study||1
8758487|NCT01211197|9807988|FG000|STARTED|Treatment Period 1 (1 Day)||3
8758488|NCT01211197|9807989|FG001|STARTED|Treatment Period 1 (1 Day)||3
8758489|NCT01211197|9807990|FG002|STARTED|Treatment Period 1 (1 Day)||3
8758490|NCT01211197|9807991|FG003|STARTED|Treatment Period 1 (1 Day)||3
8758491|NCT01211197|9807992|FG004|STARTED|Treatment Period 1 (1 Day)||2
8758492|NCT01211197|9807993|FG005|STARTED|Treatment Period 1 (1 Day)||2
8758493|NCT01211197|9807988|FG000|COMPLETED|Treatment Period 1 (1 Day)||3
8758494|NCT01211197|9807989|FG001|COMPLETED|Treatment Period 1 (1 Day)||3
8758495|NCT01211197|9807990|FG002|COMPLETED|Treatment Period 1 (1 Day)||3
8758496|NCT01211197|9807991|FG003|COMPLETED|Treatment Period 1 (1 Day)||3
8758497|NCT01211197|9807992|FG004|COMPLETED|Treatment Period 1 (1 Day)||2
8758498|NCT01211197|9807993|FG005|COMPLETED|Treatment Period 1 (1 Day)||2
8758499|NCT01211197|9807988|FG000|NOT COMPLETED|Treatment Period 1 (1 Day)||0
8758500|NCT01211197|9807989|FG001|NOT COMPLETED|Treatment Period 1 (1 Day)||0
8758501|NCT01211197|9807990|FG002|NOT COMPLETED|Treatment Period 1 (1 Day)||0
8758502|NCT01211197|9807991|FG003|NOT COMPLETED|Treatment Period 1 (1 Day)||0
8758503|NCT01211197|9807992|FG004|NOT COMPLETED|Treatment Period 1 (1 Day)||0
8758504|NCT01211197|9807993|FG005|NOT COMPLETED|Treatment Period 1 (1 Day)||0
8758505|NCT01211197|9807988|FG000|STARTED|Washout Period 1 (7 Days)||3
8758506|NCT01211197|9807989|FG001|STARTED|Washout Period 1 (7 Days)||3
8758507|NCT01211197|9807990|FG002|STARTED|Washout Period 1 (7 Days)||3
8758508|NCT01211197|9807991|FG003|STARTED|Washout Period 1 (7 Days)||3
8758509|NCT01211197|9807992|FG004|STARTED|Washout Period 1 (7 Days)||2
8758510|NCT01211197|9807993|FG005|STARTED|Washout Period 1 (7 Days)||2
8758511|NCT01211197|9807988|FG000|COMPLETED|Washout Period 1 (7 Days)||3
8758512|NCT01211197|9807989|FG001|COMPLETED|Washout Period 1 (7 Days)||3
8758513|NCT01211197|9807990|FG002|COMPLETED|Washout Period 1 (7 Days)||2
8758514|NCT01211197|9807991|FG003|COMPLETED|Washout Period 1 (7 Days)||3
8758515|NCT01211197|9807992|FG004|COMPLETED|Washout Period 1 (7 Days)||2
8758516|NCT01211197|9807993|FG005|COMPLETED|Washout Period 1 (7 Days)||2
8758517|NCT01211197|9807988|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
8758518|NCT01211197|9807989|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
8758519|NCT01211197|9807990|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||1
8758520|NCT01211197|9807991|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
8758521|NCT01211197|9807992|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||0
8758522|NCT01211197|9807993|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||0
9025290|NCT03159468|10087668|FG002|STARTED|Overall Study||37
9025291|NCT03159468|10087669|FG003|STARTED|Overall Study||34
9025292|NCT03159468|10087670|FG004|STARTED|Overall Study||34
8758523|NCT01211197|9807988|FG000|STARTED|Treatment Period 2 (1 Day)||3
8758524|NCT01211197|9807989|FG001|STARTED|Treatment Period 2 (1 Day)||3
8758525|NCT01211197|9807990|FG002|STARTED|Treatment Period 2 (1 Day)||2
8758526|NCT01211197|9807991|FG003|STARTED|Treatment Period 2 (1 Day)||3
8758527|NCT01211197|9807992|FG004|STARTED|Treatment Period 2 (1 Day)||2
8758528|NCT01211197|9807993|FG005|STARTED|Treatment Period 2 (1 Day)||2
8758529|NCT01211197|9807988|FG000|COMPLETED|Treatment Period 2 (1 Day)||3
8758530|NCT01211197|9807989|FG001|COMPLETED|Treatment Period 2 (1 Day)||3
8758531|NCT01211197|9807990|FG002|COMPLETED|Treatment Period 2 (1 Day)||2
8758532|NCT01211197|9807991|FG003|COMPLETED|Treatment Period 2 (1 Day)||3
8758533|NCT01211197|9807992|FG004|COMPLETED|Treatment Period 2 (1 Day)||2
8758534|NCT01211197|9807993|FG005|COMPLETED|Treatment Period 2 (1 Day)||2
8758535|NCT01211197|9807988|FG000|NOT COMPLETED|Treatment Period 2 (1 Day)||0
8758536|NCT01211197|9807989|FG001|NOT COMPLETED|Treatment Period 2 (1 Day)||0
8758537|NCT01211197|9807990|FG002|NOT COMPLETED|Treatment Period 2 (1 Day)||0
9025293|NCT03159468|10087671|FG005|STARTED|Overall Study||34
9025294|NCT03159468|10087666|FG000|COMPLETED|Overall Study||35
9025295|NCT03159468|10087667|FG001|COMPLETED|Overall Study||35
9025296|NCT03159468|10087668|FG002|COMPLETED|Overall Study||34
8758538|NCT01211197|9807991|FG003|NOT COMPLETED|Treatment Period 2 (1 Day)||0
9025297|NCT03159468|10087669|FG003|COMPLETED|Overall Study||34
9025298|NCT03159468|10087670|FG004|COMPLETED|Overall Study||34
9025299|NCT03159468|10087671|FG005|COMPLETED|Overall Study||34
9025300|NCT03159468|10087666|FG000|NOT COMPLETED|Overall Study||0
8758539|NCT01211197|9807992|FG004|NOT COMPLETED|Treatment Period 2 (1 Day)||0
8758540|NCT01211197|9807993|FG005|NOT COMPLETED|Treatment Period 2 (1 Day)||0
8758541|NCT01211197|9807988|FG000|STARTED|Washout Period 2 (7 Days)||3
8758542|NCT01211197|9807989|FG001|STARTED|Washout Period 2 (7 Days)||3
8758543|NCT01211197|9807990|FG002|STARTED|Washout Period 2 (7 Days)||2
8758544|NCT01211197|9807991|FG003|STARTED|Washout Period 2 (7 Days)||3
8758545|NCT01211197|9807992|FG004|STARTED|Washout Period 2 (7 Days)||2
8758546|NCT01211197|9807993|FG005|STARTED|Washout Period 2 (7 Days)||2
8758547|NCT01211197|9807988|FG000|COMPLETED|Washout Period 2 (7 Days)||2
8758548|NCT01211197|9807989|FG001|COMPLETED|Washout Period 2 (7 Days)||3
8758549|NCT01211197|9807990|FG002|COMPLETED|Washout Period 2 (7 Days)||2
8758550|NCT01211197|9807991|FG003|COMPLETED|Washout Period 2 (7 Days)||3
8758551|NCT01211197|9807992|FG004|COMPLETED|Washout Period 2 (7 Days)||2
8758552|NCT01211197|9807993|FG005|COMPLETED|Washout Period 2 (7 Days)||2
8758553|NCT01211197|9807988|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||1
8758554|NCT01211197|9807989|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
8758555|NCT01211197|9807990|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
8758556|NCT01211197|9807991|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
8758557|NCT01211197|9807992|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0
8758558|NCT01211197|9807993|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0
8758559|NCT01211197|9807988|FG000|STARTED|Treatment Period 3 (1 Day)||2
8758560|NCT01211197|9807989|FG001|STARTED|Treatment Period 3 (1 Day)||3
8758561|NCT01211197|9807990|FG002|STARTED|Treatment Period 3 (1 Day)||2
8758562|NCT01211197|9807991|FG003|STARTED|Treatment Period 3 (1 Day)||3
8758563|NCT01211197|9807992|FG004|STARTED|Treatment Period 3 (1 Day)||2
8758564|NCT01211197|9807993|FG005|STARTED|Treatment Period 3 (1 Day)||2
8758565|NCT01211197|9807988|FG000|COMPLETED|Treatment Period 3 (1 Day)||2
8758566|NCT01211197|9807989|FG001|COMPLETED|Treatment Period 3 (1 Day)||3
8758567|NCT01211197|9807990|FG002|COMPLETED|Treatment Period 3 (1 Day)||2
8758568|NCT01211197|9807991|FG003|COMPLETED|Treatment Period 3 (1 Day)||3
8758569|NCT01211197|9807992|FG004|COMPLETED|Treatment Period 3 (1 Day)||2
8758570|NCT01211197|9807993|FG005|COMPLETED|Treatment Period 3 (1 Day)||2
8758571|NCT01211197|9807988|FG000|NOT COMPLETED|Treatment Period 3 (1 Day)||0
8758572|NCT01211197|9807989|FG001|NOT COMPLETED|Treatment Period 3 (1 Day)||0
8758573|NCT01211197|9807990|FG002|NOT COMPLETED|Treatment Period 3 (1 Day)||0
8758574|NCT01211197|9807991|FG003|NOT COMPLETED|Treatment Period 3 (1 Day)||0
8758575|NCT01211197|9807992|FG004|NOT COMPLETED|Treatment Period 3 (1 Day)||0
8758576|NCT01211197|9807993|FG005|NOT COMPLETED|Treatment Period 3 (1 Day)||0
8758577|NCT01211262|9808003|FG000|STARTED|Overall Study||66
8758578|NCT01211262|9808004|FG001|STARTED|Overall Study||18
8758579|NCT01211262|9808003|FG000|COMPLETED|Overall Study||43
8758580|NCT01211262|9808004|FG001|COMPLETED|Overall Study||8
8758581|NCT01211262|9808003|FG000|NOT COMPLETED|Overall Study||23
8758582|NCT01211262|9808004|FG001|NOT COMPLETED|Overall Study||10
8758583|NCT01211288|9808015|FG000|STARTED|Overall Study||21
8758584|NCT01211288|9808016|FG001|STARTED|Overall Study||20
8758585|NCT01211288|9808015|FG000|COMPLETED|Overall Study||20
8758586|NCT01211288|9808016|FG001|COMPLETED|Overall Study||19
8758587|NCT01211288|9808015|FG000|NOT COMPLETED|Overall Study||1
8758588|NCT01211288|9808016|FG001|NOT COMPLETED|Overall Study||1
8758589|NCT01211340|9808026|FG000|STARTED|Overall Study||223
8758590|NCT01211340|9808027|FG001|STARTED|Overall Study||223
8758591|NCT01211340|9808026|FG000|COMPLETED|Overall Study||223
8758592|NCT01211340|9808027|FG001|COMPLETED|Overall Study||223
8758593|NCT01211340|9808026|FG000|NOT COMPLETED|Overall Study||0
8758594|NCT01211340|9808027|FG001|NOT COMPLETED|Overall Study||0
8758595|NCT01211483|9808037|FG000|STARTED|Phase 1b||7
8758596|NCT01211483|9808038|FG001|STARTED|Phase 1b||0
8758597|NCT01211483|9808039|FG002|STARTED|Phase 1b||0
8758598|NCT01211483|9808040|FG003|STARTED|Phase 1b||0
8758599|NCT01211483|9808037|FG000|COMPLETED|Phase 1b||0
8758600|NCT01211483|9808038|FG001|COMPLETED|Phase 1b||0
8758601|NCT01211483|9808039|FG002|COMPLETED|Phase 1b||0
8758602|NCT01211483|9808040|FG003|COMPLETED|Phase 1b||0
8758603|NCT01211483|9808037|FG000|NOT COMPLETED|Phase 1b||7
8758604|NCT01211483|9808038|FG001|NOT COMPLETED|Phase 1b||0
8758605|NCT01211483|9808039|FG002|NOT COMPLETED|Phase 1b||0
8758606|NCT01211483|9808040|FG003|NOT COMPLETED|Phase 1b||0
8758607|NCT01211483|9808037|FG000|STARTED|Phase 2||0
8758608|NCT01211483|9808038|FG001|STARTED|Phase 2|Participants entered only at Period 2.|72
8758609|NCT01211483|9808039|FG002|STARTED|Phase 2|Participants entered only at Period 2.|72
8758610|NCT01211483|9808040|FG003|STARTED|Phase 2|Participants entered only at Period 2.|71
8758611|NCT01211483|9808037|FG000|COMPLETED|Phase 2||0
8758612|NCT01211483|9808038|FG001|COMPLETED|Phase 2||0
8758613|NCT01211483|9808039|FG002|COMPLETED|Phase 2||0
8758614|NCT01211483|9808040|FG003|COMPLETED|Phase 2||0
8758615|NCT01211483|9808037|FG000|NOT COMPLETED|Phase 2||0
8758616|NCT01211483|9808038|FG001|NOT COMPLETED|Phase 2||72
8758617|NCT01211483|9808039|FG002|NOT COMPLETED|Phase 2||72
8758618|NCT01211483|9808040|FG003|NOT COMPLETED|Phase 2||71
8758619|NCT01211522|9808057|FG000|STARTED|Overall Study||192
8758620|NCT01211522|9808058|FG001|STARTED|Overall Study||190
8758621|NCT01211522|9808059|FG002|STARTED|Overall Study||184
8758622|NCT01211522|9808057|FG000|COMPLETED|Overall Study||189
8758623|NCT01211522|9808058|FG001|COMPLETED|Overall Study||183
8758624|NCT01211522|9808059|FG002|COMPLETED|Overall Study||179
8758625|NCT01211522|9808057|FG000|NOT COMPLETED|Overall Study||3
8758626|NCT01211522|9808058|FG001|NOT COMPLETED|Overall Study||7
8758627|NCT01211522|9808059|FG002|NOT COMPLETED|Overall Study||5
8758628|NCT01211535|9808069|FG000|STARTED|Overall Study||52
8758629|NCT01211535|9808070|FG001|STARTED|Overall Study||52
8758630|NCT01211535|9808069|FG000|COMPLETED|Overall Study||52
8758631|NCT01211535|9808070|FG001|COMPLETED|Overall Study||51
8758632|NCT01211535|9808069|FG000|NOT COMPLETED|Overall Study||0
8758633|NCT01211535|9808070|FG001|NOT COMPLETED|Overall Study||1
8758634|NCT01211600|9808078|FG000|STARTED|Overall Study||370
8758635|NCT01211600|9808079|FG001|STARTED|Overall Study||376
8758636|NCT01211600|9808078|FG000|COMPLETED|Overall Study||370
8758637|NCT01211600|9808079|FG001|COMPLETED|Overall Study||376
8758638|NCT01211600|9808078|FG000|NOT COMPLETED|Overall Study||0
8758639|NCT01211600|9808079|FG001|NOT COMPLETED|Overall Study||0
8758640|NCT01211613|9808090|FG000|STARTED|Overall Study||37
8758641|NCT01211613|9808091|FG001|STARTED|Overall Study||35
8758642|NCT01211613|9808092|FG002|STARTED|Overall Study||35
8758643|NCT01211613|9808090|FG000|COMPLETED|Overall Study||34
8758644|NCT01211613|9808091|FG001|COMPLETED|Overall Study||33
8758645|NCT01211613|9808092|FG002|COMPLETED|Overall Study||33
8758646|NCT01211613|9808090|FG000|NOT COMPLETED|Overall Study||3
8758647|NCT01211613|9808091|FG001|NOT COMPLETED|Overall Study||2
8758648|NCT01211613|9808092|FG002|NOT COMPLETED|Overall Study||2
8758649|NCT01211665|9808102|FG000|STARTED|Overall Study||2
8758650|NCT01211665|9808103|FG001|STARTED|Overall Study||1
8758651|NCT01211665|9808102|FG000|COMPLETED|Overall Study||0
8758652|NCT01211665|9808103|FG001|COMPLETED|Overall Study|completed treatment with study drug|1
8758653|NCT01211665|9808102|FG000|NOT COMPLETED|Overall Study||2
8758654|NCT01211665|9808103|FG001|NOT COMPLETED|Overall Study||0
8758655|NCT01211730|9808111|FG000|STARTED|Overall Study||82
8758656|NCT01211730|9808112|FG001|STARTED|Overall Study||82
8758657|NCT01211730|9808111|FG000|COMPLETED|Overall Study||82
8758658|NCT01211730|9808112|FG001|COMPLETED|Overall Study||82
8758659|NCT01211730|9808111|FG000|NOT COMPLETED|Overall Study||0
8758660|NCT01211730|9808112|FG001|NOT COMPLETED|Overall Study||0
8758661|NCT01211769|9808122|FG000|STARTED|Overall Study||20
8758662|NCT01211769|9808123|FG001|STARTED|Overall Study||20
8758663|NCT01211769|9808124|FG002|STARTED|Overall Study||20
8758664|NCT01211769|9808125|FG003|STARTED|Overall Study||20
8758665|NCT01211769|9808122|FG000|Participants/Group|Overall Study||20
8758666|NCT01211769|9808123|FG001|Participants/Group|Overall Study||20
9025301|NCT03159468|10087667|FG001|NOT COMPLETED|Overall Study||0
8758667|NCT01211769|9808124|FG002|Participants/Group|Overall Study||20
8758668|NCT01211769|9808125|FG003|Participants/Group|Overall Study||20
8758669|NCT01211769|9808122|FG000|COMPLETED|Overall Study||11
8758670|NCT01211769|9808123|FG001|COMPLETED|Overall Study||10
8758671|NCT01211769|9808124|FG002|COMPLETED|Overall Study||12
8758672|NCT01211769|9808125|FG003|COMPLETED|Overall Study||9
8758673|NCT01211769|9808122|FG000|NOT COMPLETED|Overall Study||9
8758674|NCT01211769|9808123|FG001|NOT COMPLETED|Overall Study||10
8758675|NCT01211769|9808124|FG002|NOT COMPLETED|Overall Study||8
8758676|NCT01211769|9808125|FG003|NOT COMPLETED|Overall Study||11
8758677|NCT01211873|9808138|FG000|STARTED|Overall Study||245
8758678|NCT01211873|9808139|FG001|STARTED|Overall Study||119
8758679|NCT01211873|9808140|FG002|STARTED|Overall Study||38
8758680|NCT01211873|9808138|FG000|COMPLETED|Overall Study||240
8758681|NCT01211873|9808139|FG001|COMPLETED|Overall Study||117
8758682|NCT01211873|9808140|FG002|COMPLETED|Overall Study||36
8758683|NCT01211873|9808138|FG000|NOT COMPLETED|Overall Study||5
8758684|NCT01211873|9808139|FG001|NOT COMPLETED|Overall Study||2
8758685|NCT01211873|9808140|FG002|NOT COMPLETED|Overall Study||2
8758686|NCT01212094|9808152|FG000|STARTED|Year 1: Baseline Monitoring||43
8758687|NCT01212094|9808153|FG001|STARTED|Year 1: Baseline Monitoring||0
8758688|NCT01212094|9808154|FG002|STARTED|Year 1: Baseline Monitoring||0
8758689|NCT01212094|9808152|FG000|COMPLETED|Year 1: Baseline Monitoring||27
8758690|NCT01212094|9808153|FG001|COMPLETED|Year 1: Baseline Monitoring||0
8758691|NCT01212094|9808154|FG002|COMPLETED|Year 1: Baseline Monitoring||0
8758692|NCT01212094|9808152|FG000|NOT COMPLETED|Year 1: Baseline Monitoring||16
8758693|NCT01212094|9808153|FG001|NOT COMPLETED|Year 1: Baseline Monitoring||0
8758694|NCT01212094|9808154|FG002|NOT COMPLETED|Year 1: Baseline Monitoring||0
8758695|NCT01212094|9808152|FG000|STARTED|Years 2 & 3: Treatment Randomization||0
8758696|NCT01212094|9808153|FG001|STARTED|Years 2 & 3: Treatment Randomization||9
8758697|NCT01212094|9808154|FG002|STARTED|Years 2 & 3: Treatment Randomization||18
8758698|NCT01212094|9808152|FG000|COMPLETED|Years 2 & 3: Treatment Randomization||0
9025302|NCT03159468|10087668|FG002|NOT COMPLETED|Overall Study||3
8758699|NCT01212094|9808153|FG001|COMPLETED|Years 2 & 3: Treatment Randomization||5
8758700|NCT01212094|9808154|FG002|COMPLETED|Years 2 & 3: Treatment Randomization||7
8758701|NCT01212094|9808152|FG000|NOT COMPLETED|Years 2 & 3: Treatment Randomization||0
8758702|NCT01212094|9808153|FG001|NOT COMPLETED|Years 2 & 3: Treatment Randomization||4
8758703|NCT01212094|9808154|FG002|NOT COMPLETED|Years 2 & 3: Treatment Randomization||11
8758704|NCT01212107|9808173|FG000|STARTED|Overall Study||3
8758705|NCT01212107|9808174|FG001|STARTED|Overall Study||3
8758706|NCT01212107|9808175|FG002|STARTED|Overall Study||6
8758707|NCT01212107|9808176|FG003|STARTED|Overall Study||3
8758708|NCT01212107|9808177|FG004|STARTED|Overall Study||3
8758709|NCT01212107|9808178|FG005|STARTED|Overall Study||3
8758710|NCT01212107|9808179|FG006|STARTED|Overall Study||3
8758711|NCT01212107|9808180|FG007|STARTED|Overall Study||3
8758712|NCT01212107|9808181|FG008|STARTED|Overall Study||3
8758713|NCT01212107|9808182|FG009|STARTED|Overall Study||3
8758714|NCT01212107|9808183|FG010|STARTED|Overall Study||3
8758715|NCT01212107|9808184|FG011|STARTED|Overall Study||58
8758716|NCT01212107|9808173|FG000|COMPLETED|Overall Study||2
8758717|NCT01212107|9808174|FG001|COMPLETED|Overall Study||2
8758718|NCT01212107|9808175|FG002|COMPLETED|Overall Study||3
8758719|NCT01212107|9808176|FG003|COMPLETED|Overall Study||3
8758720|NCT01212107|9808177|FG004|COMPLETED|Overall Study||2
8758721|NCT01212107|9808178|FG005|COMPLETED|Overall Study||2
8758722|NCT01212107|9808179|FG006|COMPLETED|Overall Study||3
8758723|NCT01212107|9808180|FG007|COMPLETED|Overall Study||2
8758724|NCT01212107|9808181|FG008|COMPLETED|Overall Study||1
8758725|NCT01212107|9808182|FG009|COMPLETED|Overall Study||1
8758726|NCT01212107|9808183|FG010|COMPLETED|Overall Study||2
8758727|NCT01212107|9808184|FG011|COMPLETED|Overall Study||26
8758728|NCT01212107|9808173|FG000|NOT COMPLETED|Overall Study||1
8915313|NCT02173535|9974679|FG007|NOT COMPLETED|Period 5||0
8915314|NCT02173535|9974680|FG008|NOT COMPLETED|Period 5||0
8915315|NCT02173535|9974681|FG009|NOT COMPLETED|Period 5||0
8915316|NCT02173535|9974682|FG010|NOT COMPLETED|Period 5||0
8915317|NCT02173535|9974683|FG011|NOT COMPLETED|Period 5||0
8915318|NCT02173535|9974684|FG012|NOT COMPLETED|Period 5||0
8915319|NCT02173535|9974685|FG013|NOT COMPLETED|Period 5||0
8915320|NCT02173535|9974686|FG014|NOT COMPLETED|Period 5||0
8915321|NCT02173535|9974687|FG015|NOT COMPLETED|Period 5||0
8915322|NCT02173535|9974688|FG016|NOT COMPLETED|Period 5||0
8915323|NCT02173535|9974689|FG017|NOT COMPLETED|Period 5||0
8915324|NCT02173535|9974690|FG018|NOT COMPLETED|Period 5||0
8915325|NCT02173535|9974691|FG019|NOT COMPLETED|Period 5||0
8915326|NCT02173548|9974720|FG000|STARTED|Overall Study||21
8915327|NCT02173548|9974721|FG001|STARTED|Overall Study||10
8915328|NCT02173548|9974720|FG000|COMPLETED|Overall Study||20
8915329|NCT02173548|9974721|FG001|COMPLETED|Overall Study||8
8915330|NCT02173548|9974720|FG000|NOT COMPLETED|Overall Study||1
8915331|NCT02173548|9974721|FG001|NOT COMPLETED|Overall Study||2
8915332|NCT02173704|9974729|FG000|STARTED|Overall Study||150
8915333|NCT02173704|9974730|FG001|STARTED|Overall Study||75
8915334|NCT02173704|9974729|FG000|COMPLETED|Overall Study||137
8915335|NCT02173704|9974730|FG001|COMPLETED|Overall Study||71
8915336|NCT02173704|9974729|FG000|NOT COMPLETED|Overall Study||13
8915337|NCT02173704|9974730|FG001|NOT COMPLETED|Overall Study||4
8915338|NCT02173769|9974736|FG000|STARTED|Overall Study||1858
8915339|NCT02173769|9974736|FG000|COMPLETED|Overall Study||1854
8915340|NCT02173769|9974736|FG000|NOT COMPLETED|Overall Study||4
8915341|NCT02174198|9974743|FG000|STARTED|Overall Study||16
8915342|NCT02174198|9974744|FG001|STARTED|Overall Study||16
8915343|NCT02174198|9974743|FG000|COMPLETED|Overall Study||16
8915344|NCT02174198|9974744|FG001|COMPLETED|Overall Study||16
8915345|NCT02174198|9974743|FG000|NOT COMPLETED|Overall Study||0
8915346|NCT02174198|9974744|FG001|NOT COMPLETED|Overall Study||0
8915347|NCT02174276|9974754|FG000|STARTED|Study Treatment Phase (Weeks 1 to 48)||27
8915348|NCT02174276|9974755|FG001|STARTED|Study Treatment Phase (Weeks 1 to 48)||57
8915349|NCT02174276|9974756|FG002|STARTED|Study Treatment Phase (Weeks 1 to 48)||56
8915350|NCT02174276|9974757|FG003|STARTED|Study Treatment Phase (Weeks 1 to 48)||55
8915351|NCT02174276|9974754|FG000|COMPLETED|Study Treatment Phase (Weeks 1 to 48)||26
8915352|NCT02174276|9974755|FG001|COMPLETED|Study Treatment Phase (Weeks 1 to 48)||56
8915353|NCT02174276|9974756|FG002|COMPLETED|Study Treatment Phase (Weeks 1 to 48)||53
8915354|NCT02174276|9974757|FG003|COMPLETED|Study Treatment Phase (Weeks 1 to 48)||55
8915355|NCT02174276|9974754|FG000|NOT COMPLETED|Study Treatment Phase (Weeks 1 to 48)||1
8915356|NCT02174276|9974755|FG001|NOT COMPLETED|Study Treatment Phase (Weeks 1 to 48)||1
8915357|NCT02174276|9974756|FG002|NOT COMPLETED|Study Treatment Phase (Weeks 1 to 48)||3
8915358|NCT02174276|9974757|FG003|NOT COMPLETED|Study Treatment Phase (Weeks 1 to 48)||0
8915359|NCT02174276|9974754|FG000|STARTED|OTEP (Weeks 48 to 144)||26
8915360|NCT02174276|9974755|FG001|STARTED|OTEP (Weeks 48 to 144)|2 Participants completed the study treatment phase but did not continue in OTEP.|54
8915361|NCT02174276|9974756|FG002|STARTED|OTEP (Weeks 48 to 144)|2 Participants completed the study treatment phase but did not continue in OTEP.|51
8915362|NCT02174276|9974757|FG003|STARTED|OTEP (Weeks 48 to 144)|3 Participants completed the study treatment phase but did not continue in OTEP.|52
8915363|NCT02174276|9974754|FG000|COMPLETED|OTEP (Weeks 48 to 144)||25
8915364|NCT02174276|9974755|FG001|COMPLETED|OTEP (Weeks 48 to 144)||54
8915365|NCT02174276|9974756|FG002|COMPLETED|OTEP (Weeks 48 to 144)||48
8915366|NCT02174276|9974757|FG003|COMPLETED|OTEP (Weeks 48 to 144)||50
8915367|NCT02174276|9974754|FG000|NOT COMPLETED|OTEP (Weeks 48 to 144)||1
8915368|NCT02174276|9974755|FG001|NOT COMPLETED|OTEP (Weeks 48 to 144)||0
8915369|NCT02174276|9974756|FG002|NOT COMPLETED|OTEP (Weeks 48 to 144)||3
8915370|NCT02174276|9974757|FG003|NOT COMPLETED|OTEP (Weeks 48 to 144)||2
8915371|NCT02174419|9974770|FG000|STARTED|Overall Study||22
8915372|NCT02174419|9974771|FG001|STARTED|Overall Study||18
8915373|NCT02174419|9974772|FG002|STARTED|Overall Study||22
8915374|NCT02174419|9974770|FG000|COMPLETED|Overall Study||18
8758729|NCT01212107|9808174|FG001|NOT COMPLETED|Overall Study||1
8915375|NCT02174419|9974771|FG001|COMPLETED|Overall Study||12
8915376|NCT02174419|9974772|FG002|COMPLETED|Overall Study||20
8915377|NCT02174419|9974770|FG000|NOT COMPLETED|Overall Study||4
8915378|NCT02174419|9974771|FG001|NOT COMPLETED|Overall Study||6
8915379|NCT02174419|9974772|FG002|NOT COMPLETED|Overall Study||2
8915380|NCT02174432|9974780|FG000|STARTED|Overall Study||36
8915381|NCT02174432|9974780|FG000|COMPLETED|Overall Study||16
8758730|NCT01212107|9808175|FG002|NOT COMPLETED|Overall Study||3
8758731|NCT01212107|9808176|FG003|NOT COMPLETED|Overall Study||0
8758732|NCT01212107|9808177|FG004|NOT COMPLETED|Overall Study||1
8758733|NCT01212107|9808178|FG005|NOT COMPLETED|Overall Study||1
8758734|NCT01212107|9808179|FG006|NOT COMPLETED|Overall Study||0
8758735|NCT01212107|9808180|FG007|NOT COMPLETED|Overall Study||1
8758736|NCT01212107|9808181|FG008|NOT COMPLETED|Overall Study||2
8758737|NCT01212107|9808182|FG009|NOT COMPLETED|Overall Study||2
8758738|NCT01212107|9808183|FG010|NOT COMPLETED|Overall Study||1
8758739|NCT01212107|9808184|FG011|NOT COMPLETED|Overall Study||32
8758740|NCT01212159|9808228|FG000|STARTED|Overall Study||26
8758741|NCT01212159|9808229|FG001|STARTED|Overall Study||44
8758742|NCT01212159|9808228|FG000|COMPLETED|Overall Study||14
8758743|NCT01212159|9808229|FG001|COMPLETED|Overall Study||32
8758744|NCT01212159|9808228|FG000|NOT COMPLETED|Overall Study||12
8758745|NCT01212159|9808229|FG001|NOT COMPLETED|Overall Study||12
8758746|NCT01212172|9808235|FG000|STARTED|Overall Study||10
8758747|NCT01212172|9808236|FG001|STARTED|Overall Study||10
8758748|NCT01212172|9808235|FG000|COMPLETED|Overall Study||9
8758749|NCT01212172|9808236|FG001|COMPLETED|Overall Study||9
8758750|NCT01212172|9808235|FG000|NOT COMPLETED|Overall Study||1
8758751|NCT01212172|9808236|FG001|NOT COMPLETED|Overall Study||1
8758752|NCT01212185|9808246|FG000|STARTED|Overall Study||6
8758753|NCT01212185|9808247|FG001|STARTED|Overall Study||8
8758754|NCT01212185|9808246|FG000|COMPLETED|Overall Study||4
8758755|NCT01212185|9808247|FG001|COMPLETED|Overall Study||7
8758756|NCT01212185|9808246|FG000|NOT COMPLETED|Overall Study||2
8758757|NCT01212185|9808247|FG001|NOT COMPLETED|Overall Study||1
8758758|NCT01212302|9808253|FG000|STARTED|Overall Study||504
8758759|NCT01212302|9808253|FG000|COMPLETED|Overall Study||504
8758760|NCT01212302|9808253|FG000|NOT COMPLETED|Overall Study||0
8758761|NCT01212445|9808260|FG000|STARTED|Overall Study||52
8758762|NCT01212445|9808261|FG001|STARTED|Overall Study||51
8758763|NCT01212445|9808262|FG002|STARTED|Overall Study||51
8758764|NCT01212445|9808260|FG000|COMPLETED|Overall Study||52
8758765|NCT01212445|9808261|FG001|COMPLETED|Overall Study||51
8758766|NCT01212445|9808262|FG002|COMPLETED|Overall Study||51
8758767|NCT01212445|9808260|FG000|NOT COMPLETED|Overall Study||0
8758768|NCT01212445|9808261|FG001|NOT COMPLETED|Overall Study||0
8758769|NCT01212445|9808262|FG002|NOT COMPLETED|Overall Study||0
8758770|NCT01212471|9808274|FG000|STARTED|Overall Study||141
8758771|NCT01212471|9808275|FG001|STARTED|Overall Study||140
8758772|NCT01212471|9808276|FG002|STARTED|Overall Study||139
8758773|NCT01212471|9808274|FG000|COMPLETED|Overall Study||139
8758774|NCT01212471|9808275|FG001|COMPLETED|Overall Study||137
8758775|NCT01212471|9808276|FG002|COMPLETED|Overall Study||132
8758776|NCT01212471|9808274|FG000|NOT COMPLETED|Overall Study||2
8758777|NCT01212471|9808275|FG001|NOT COMPLETED|Overall Study||3
8758778|NCT01212471|9808276|FG002|NOT COMPLETED|Overall Study||7
8758779|NCT01212484|9808284|FG000|STARTED|Carbidopa Titration Period (4 Weeks)||6
8758780|NCT01212484|9808285|FG001|STARTED|Carbidopa Titration Period (4 Weeks)||6
8758781|NCT01212484|9808284|FG000|COMPLETED|Carbidopa Titration Period (4 Weeks)||5
8758782|NCT01212484|9808285|FG001|COMPLETED|Carbidopa Titration Period (4 Weeks)||6
8758783|NCT01212484|9808284|FG000|NOT COMPLETED|Carbidopa Titration Period (4 Weeks)||1
8758784|NCT01212484|9808285|FG001|NOT COMPLETED|Carbidopa Titration Period (4 Weeks)||0
8758785|NCT01212484|9808284|FG000|STARTED|First Intervention (4 Weeks)||5
8758786|NCT01212484|9808285|FG001|STARTED|First Intervention (4 Weeks)||6
8758787|NCT01212484|9808284|FG000|COMPLETED|First Intervention (4 Weeks)||5
8758788|NCT01212484|9808285|FG001|COMPLETED|First Intervention (4 Weeks)||4
8758789|NCT01212484|9808284|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0
8758790|NCT01212484|9808285|FG001|NOT COMPLETED|First Intervention (4 Weeks)||2
8758791|NCT01212484|9808284|FG000|STARTED|Second Intervention (4 Weeks)||5
8758792|NCT01212484|9808285|FG001|STARTED|Second Intervention (4 Weeks)||4
8758793|NCT01212484|9808284|FG000|COMPLETED|Second Intervention (4 Weeks)||5
8758794|NCT01212484|9808285|FG001|COMPLETED|Second Intervention (4 Weeks)||3
8758795|NCT01212484|9808284|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0
8758796|NCT01212484|9808285|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||1
8758797|NCT01212588|9808293|FG000|STARTED|Overall Study||10
8758798|NCT01212588|9808294|FG001|STARTED|Overall Study||12
8758799|NCT01212588|9808293|FG000|COMPLETED|Overall Study||9
8758800|NCT01212588|9808294|FG001|COMPLETED|Overall Study||10
8758801|NCT01212588|9808293|FG000|NOT COMPLETED|Overall Study||1
8758802|NCT01212588|9808294|FG001|NOT COMPLETED|Overall Study||2
8758803|NCT01212627|9808300|FG000|STARTED|Overall Study||12
8758804|NCT01212627|9808300|FG000|COMPLETED|Overall Study||12
8758805|NCT01212627|9808300|FG000|NOT COMPLETED|Overall Study||0
8758806|NCT01212744|9808304|FG000|STARTED|Overall Study||16
8758807|NCT01212744|9808304|FG000|COMPLETED|Overall Study||15
8758808|NCT01212744|9808304|FG000|NOT COMPLETED|Overall Study||1
8758809|NCT01212757|9808313|FG000|STARTED|Placebo-controlled Phase (Week 0 - 24)||162
8758810|NCT01212757|9808314|FG001|STARTED|Placebo-controlled Phase (Week 0 - 24)||163
8758811|NCT01212757|9808315|FG002|STARTED|Placebo-controlled Phase (Week 0 - 24)||163
8758812|NCT01212757|9808316|FG003|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
8758813|NCT01212757|9808317|FG004|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
8758814|NCT01212757|9808318|FG005|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
8758815|NCT01212757|9808319|FG006|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
8758816|NCT01212757|9808320|FG007|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
8758817|NCT01212757|9808321|FG008|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
8758818|NCT01212757|9808313|FG000|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||159
8758819|NCT01212757|9808314|FG001|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||163
8758820|NCT01212757|9808315|FG002|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||162
8758821|NCT01212757|9808316|FG003|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
8758822|NCT01212757|9808317|FG004|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
8758823|NCT01212757|9808318|FG005|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
8758824|NCT01212757|9808319|FG006|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
8758825|NCT01212757|9808320|FG007|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
8758826|NCT01212757|9808321|FG008|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
8758827|NCT01212757|9808313|FG000|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||148
8758828|NCT01212757|9808314|FG001|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||151
8758829|NCT01212757|9808315|FG002|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||149
8758830|NCT01212757|9808316|FG003|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8758831|NCT01212757|9808317|FG004|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8758832|NCT01212757|9808318|FG005|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8758833|NCT01212757|9808319|FG006|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8758834|NCT01212757|9808320|FG007|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8758835|NCT01212757|9808321|FG008|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8758836|NCT01212757|9808313|FG000|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|Two participants who escaped early did not complete Week 24|88
8758837|NCT01212757|9808314|FG001|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|Three participants who escaped early did not complete Week 24|59
8758838|NCT01212757|9808315|FG002|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||64
8758839|NCT01212757|9808316|FG003|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8758840|NCT01212757|9808317|FG004|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8758841|NCT01212757|9808318|FG005|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8758842|NCT01212757|9808319|FG006|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8758843|NCT01212757|9808320|FG007|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8758844|NCT01212757|9808321|FG008|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8758845|NCT01212757|9808313|FG000|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|Two participants who completed Week 24 did not enter the active treatment phase|143
8758846|NCT01212757|9808314|FG001|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||143
8758847|NCT01212757|9808315|FG002|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||142
8758848|NCT01212757|9808316|FG003|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8758849|NCT01212757|9808317|FG004|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8758850|NCT01212757|9808318|FG005|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8758851|NCT01212757|9808319|FG006|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8758852|NCT01212757|9808320|FG007|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8758853|NCT01212757|9808321|FG008|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8758854|NCT01212757|9808313|FG000|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||19
8758855|NCT01212757|9808314|FG001|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||20
8758856|NCT01212757|9808315|FG002|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||21
8758857|NCT01212757|9808316|FG003|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8758858|NCT01212757|9808317|FG004|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8758859|NCT01212757|9808318|FG005|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8758860|NCT01212757|9808319|FG006|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8758861|NCT01212757|9808320|FG007|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8758862|NCT01212757|9808321|FG008|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8758863|NCT01212757|9808313|FG000|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
8758864|NCT01212757|9808314|FG001|STARTED|Active Treatment Phase (Weeks 24 - 52)|6 participants who completed Week 24 did not enter the Week 24-52 active treatment phase|137
8758865|NCT01212757|9808315|FG002|STARTED|Active Treatment Phase (Weeks 24 - 52)|8 participants who completed Week 24 did not enter the Week 24-52 active treatment phase|134
8758866|NCT01212757|9808316|FG003|STARTED|Active Treatment Phase (Weeks 24 - 52)||43
8758867|NCT01212757|9808317|FG004|STARTED|Active Treatment Phase (Weeks 24 - 52)||27
8758868|NCT01212757|9808318|FG005|STARTED|Active Treatment Phase (Weeks 24 - 52)|2 participants who EE and completed Week 24 did not enter the Week 24-52 active treatment phase|41
8758869|NCT01212757|9808319|FG006|STARTED|Active Treatment Phase (Weeks 24 - 52)||28
8758870|NCT01212757|9808320|FG007|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
8758871|NCT01212757|9808321|FG008|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
8758872|NCT01212757|9808313|FG000|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
8758873|NCT01212757|9808314|FG001|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||125
8758874|NCT01212757|9808315|FG002|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||114
9025303|NCT03159468|10087669|FG003|NOT COMPLETED|Overall Study||0
9025304|NCT03159468|10087670|FG004|NOT COMPLETED|Overall Study||0
9025305|NCT03159468|10087671|FG005|NOT COMPLETED|Overall Study||0
9025306|NCT03159611|10087687|FG000|STARTED|Overall Study||95
9025307|NCT03159611|10087688|FG001|STARTED|Overall Study||87
9025308|NCT03159611|10087687|FG000|COMPLETED|Overall Study||72
9025309|NCT03159611|10087688|FG001|COMPLETED|Overall Study||72
9025310|NCT03159611|10087687|FG000|NOT COMPLETED|Overall Study||23
9025311|NCT03159611|10087688|FG001|NOT COMPLETED|Overall Study||15
9025312|NCT03159624|10087696|FG000|STARTED|Overall Study||21
9025313|NCT03159624|10087697|FG001|STARTED|Overall Study||26
9025314|NCT03159624|10087696|FG000|COMPLETED|Overall Study||21
9025315|NCT03159624|10087697|FG001|COMPLETED|Overall Study||25
9025316|NCT03159624|10087696|FG000|NOT COMPLETED|Overall Study||0
9025317|NCT03159624|10087697|FG001|NOT COMPLETED|Overall Study||1
9025318|NCT03160027|10087707|FG000|STARTED|Overall Study||6
9025319|NCT03160027|10087708|FG001|STARTED|Overall Study||4
9025320|NCT03160027|10087709|FG002|STARTED|Overall Study||6
8758875|NCT01212757|9808316|FG003|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||35
8758876|NCT01212757|9808317|FG004|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||25
8758877|NCT01212757|9808318|FG005|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||34
8758878|NCT01212757|9808319|FG006|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||28
8758879|NCT01212757|9808320|FG007|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
8758880|NCT01212757|9808321|FG008|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
8758881|NCT01212757|9808313|FG000|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
8758882|NCT01212757|9808314|FG001|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||12
8758883|NCT01212757|9808315|FG002|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||20
8758884|NCT01212757|9808316|FG003|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||8
8758885|NCT01212757|9808317|FG004|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||2
8758886|NCT01212757|9808318|FG005|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||7
8758887|NCT01212757|9808319|FG006|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
8758888|NCT01212757|9808320|FG007|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
8758889|NCT01212757|9808321|FG008|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
8758890|NCT01212757|9808313|FG000|STARTED|Long-Term Safety Phase (Year 2)||0
8758891|NCT01212757|9808314|FG001|STARTED|Long-Term Safety Phase (Year 2)|6 participants who completed Week 52 did not enter the long-term safety phase|119
8758892|NCT01212757|9808315|FG002|STARTED|Long-Term Safety Phase (Year 2)|5 participants who completed Week 52 did not enter the long-term safety phase|109
8758893|NCT01212757|9808316|FG003|STARTED|Long-Term Safety Phase (Year 2)||0
8758894|NCT01212757|9808317|FG004|STARTED|Long-Term Safety Phase (Year 2)||0
8758895|NCT01212757|9808318|FG005|STARTED|Long-Term Safety Phase (Year 2)||0
8758896|NCT01212757|9808319|FG006|STARTED|Long-Term Safety Phase (Year 2)||0
8758897|NCT01212757|9808320|FG007|STARTED|Long-Term Safety Phase (Year 2)|Combined PBO-APR 20EE+XO;2 participants who completed Week 52 did not enter long-term safety phase|58
8758898|NCT01212757|9808321|FG008|STARTED|Long-Term Safety Phase (Year 2)|Combined PBO-APR 30EE+XO;2 participants who completed Week 52 did not enter long-term safety phase|60
8758899|NCT01212757|9808313|FG000|COMPLETED|Long-Term Safety Phase (Year 2)||0
8758900|NCT01212757|9808314|FG001|COMPLETED|Long-Term Safety Phase (Year 2)||107
8758901|NCT01212757|9808315|FG002|COMPLETED|Long-Term Safety Phase (Year 2)||95
8758902|NCT01212757|9808316|FG003|COMPLETED|Long-Term Safety Phase (Year 2)||0
8758903|NCT01212757|9808317|FG004|COMPLETED|Long-Term Safety Phase (Year 2)||0
8758904|NCT01212757|9808318|FG005|COMPLETED|Long-Term Safety Phase (Year 2)||0
8758905|NCT01212757|9808319|FG006|COMPLETED|Long-Term Safety Phase (Year 2)||0
8758906|NCT01212757|9808320|FG007|COMPLETED|Long-Term Safety Phase (Year 2)||48
8758907|NCT01212757|9808321|FG008|COMPLETED|Long-Term Safety Phase (Year 2)||51
8758908|NCT01212757|9808313|FG000|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
8758909|NCT01212757|9808314|FG001|NOT COMPLETED|Long-Term Safety Phase (Year 2)||12
8758910|NCT01212757|9808315|FG002|NOT COMPLETED|Long-Term Safety Phase (Year 2)||14
8758911|NCT01212757|9808316|FG003|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
8758912|NCT01212757|9808317|FG004|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
8758913|NCT01212757|9808318|FG005|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
8758914|NCT01212757|9808319|FG006|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
8758915|NCT01212757|9808320|FG007|NOT COMPLETED|Long-Term Safety Phase (Year 2)||10
8758916|NCT01212757|9808321|FG008|NOT COMPLETED|Long-Term Safety Phase (Year 2)||9
8758917|NCT01212757|9808313|FG000|STARTED|Long-Term Safety Phase (Year 3)||0
8758918|NCT01212757|9808314|FG001|STARTED|Long-Term Safety Phase (Year 3)||107
8758919|NCT01212757|9808315|FG002|STARTED|Long-Term Safety Phase (Year 3)||95
8758920|NCT01212757|9808316|FG003|STARTED|Long-Term Safety Phase (Year 3)||0
8758921|NCT01212757|9808317|FG004|STARTED|Long-Term Safety Phase (Year 3)||0
8758922|NCT01212757|9808318|FG005|STARTED|Long-Term Safety Phase (Year 3)||0
8758923|NCT01212757|9808319|FG006|STARTED|Long-Term Safety Phase (Year 3)||0
8758924|NCT01212757|9808320|FG007|STARTED|Long-Term Safety Phase (Year 3)||48
8758925|NCT01212757|9808321|FG008|STARTED|Long-Term Safety Phase (Year 3)||51
8758926|NCT01212757|9808313|FG000|COMPLETED|Long-Term Safety Phase (Year 3)||0
8758927|NCT01212757|9808314|FG001|COMPLETED|Long-Term Safety Phase (Year 3)||89
8758928|NCT01212757|9808315|FG002|COMPLETED|Long-Term Safety Phase (Year 3)||84
8758929|NCT01212757|9808316|FG003|COMPLETED|Long-Term Safety Phase (Year 3)||0
8758930|NCT01212757|9808317|FG004|COMPLETED|Long-Term Safety Phase (Year 3)||0
8758931|NCT01212757|9808318|FG005|COMPLETED|Long-Term Safety Phase (Year 3)||0
8758932|NCT01212757|9808319|FG006|COMPLETED|Long-Term Safety Phase (Year 3)||0
8758933|NCT01212757|9808320|FG007|COMPLETED|Long-Term Safety Phase (Year 3)||42
8758934|NCT01212757|9808321|FG008|COMPLETED|Long-Term Safety Phase (Year 3)||46
8758935|NCT01212757|9808313|FG000|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
8758936|NCT01212757|9808314|FG001|NOT COMPLETED|Long-Term Safety Phase (Year 3)||18
8758937|NCT01212757|9808315|FG002|NOT COMPLETED|Long-Term Safety Phase (Year 3)||11
8758938|NCT01212757|9808316|FG003|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
8758939|NCT01212757|9808317|FG004|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
8758940|NCT01212757|9808318|FG005|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
8758941|NCT01212757|9808319|FG006|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
8758942|NCT01212757|9808320|FG007|NOT COMPLETED|Long-Term Safety Phase (Year 3)||6
8758943|NCT01212757|9808321|FG008|NOT COMPLETED|Long-Term Safety Phase (Year 3)||5
8758944|NCT01212757|9808313|FG000|STARTED|Long-Term Safety Phase (Year 4)||0
8758945|NCT01212757|9808314|FG001|STARTED|Long-Term Safety Phase (Year 4)||89
8758946|NCT01212757|9808315|FG002|STARTED|Long-Term Safety Phase (Year 4)||84
8758947|NCT01212757|9808316|FG003|STARTED|Long-Term Safety Phase (Year 4)||0
8758948|NCT01212757|9808317|FG004|STARTED|Long-Term Safety Phase (Year 4)||0
8758949|NCT01212757|9808318|FG005|STARTED|Long-Term Safety Phase (Year 4)||0
8758950|NCT01212757|9808319|FG006|STARTED|Long-Term Safety Phase (Year 4)||0
8758951|NCT01212757|9808320|FG007|STARTED|Long-Term Safety Phase (Year 4)|1 participant who completed Year 3 did not continue treatment in Year 4|41
8758952|NCT01212757|9808321|FG008|STARTED|Long-Term Safety Phase (Year 4)||46
8758953|NCT01212757|9808313|FG000|COMPLETED|Long-Term Safety Phase (Year 4)||0
8758954|NCT01212757|9808314|FG001|COMPLETED|Long-Term Safety Phase (Year 4)||80
8758955|NCT01212757|9808315|FG002|COMPLETED|Long-Term Safety Phase (Year 4)||77
8758956|NCT01212757|9808316|FG003|COMPLETED|Long-Term Safety Phase (Year 4)||0
8758957|NCT01212757|9808317|FG004|COMPLETED|Long-Term Safety Phase (Year 4)||0
8758958|NCT01212757|9808318|FG005|COMPLETED|Long-Term Safety Phase (Year 4)||0
8758959|NCT01212757|9808319|FG006|COMPLETED|Long-Term Safety Phase (Year 4)||0
8758960|NCT01212757|9808320|FG007|COMPLETED|Long-Term Safety Phase (Year 4)||37
8758961|NCT01212757|9808321|FG008|COMPLETED|Long-Term Safety Phase (Year 4)||39
8758962|NCT01212757|9808313|FG000|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
8758963|NCT01212757|9808314|FG001|NOT COMPLETED|Long-Term Safety Phase (Year 4)||9
8758964|NCT01212757|9808315|FG002|NOT COMPLETED|Long-Term Safety Phase (Year 4)||7
8758965|NCT01212757|9808316|FG003|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
8758966|NCT01212757|9808317|FG004|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
8758967|NCT01212757|9808318|FG005|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
8758968|NCT01212757|9808319|FG006|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
8758969|NCT01212757|9808320|FG007|NOT COMPLETED|Long-Term Safety Phase (Year 4)||4
8758970|NCT01212757|9808321|FG008|NOT COMPLETED|Long-Term Safety Phase (Year 4)||7
8758971|NCT01212757|9808313|FG000|STARTED|Long-Term Safety Phase (Year 5)||0
8758972|NCT01212757|9808314|FG001|STARTED|Long-Term Safety Phase (Year 5)||80
8758973|NCT01212757|9808315|FG002|STARTED|Long-Term Safety Phase (Year 5)||77
8758974|NCT01212757|9808316|FG003|STARTED|Long-Term Safety Phase (Year 5)||0
8758975|NCT01212757|9808317|FG004|STARTED|Long-Term Safety Phase (Year 5)||0
8758976|NCT01212757|9808318|FG005|STARTED|Long-Term Safety Phase (Year 5)||0
8758977|NCT01212757|9808319|FG006|STARTED|Long-Term Safety Phase (Year 5)||0
8758978|NCT01212757|9808320|FG007|STARTED|Long-Term Safety Phase (Year 5)|1 participant was only counted in year 5 but not in 4 year due to late APR dispensing|38
8758979|NCT01212757|9808321|FG008|STARTED|Long-Term Safety Phase (Year 5)||39
8758980|NCT01212757|9808313|FG000|COMPLETED|Long-Term Safety Phase (Year 5)||0
8758981|NCT01212757|9808314|FG001|COMPLETED|Long-Term Safety Phase (Year 5)||72
8758982|NCT01212757|9808315|FG002|COMPLETED|Long-Term Safety Phase (Year 5)||69
8758983|NCT01212757|9808316|FG003|COMPLETED|Long-Term Safety Phase (Year 5)||0
8758984|NCT01212757|9808317|FG004|COMPLETED|Long-Term Safety Phase (Year 5)||0
8758985|NCT01212757|9808318|FG005|COMPLETED|Long-Term Safety Phase (Year 5)||0
8758986|NCT01212757|9808319|FG006|COMPLETED|Long-Term Safety Phase (Year 5)||0
8758987|NCT01212757|9808320|FG007|COMPLETED|Long-Term Safety Phase (Year 5)||33
8758988|NCT01212757|9808321|FG008|COMPLETED|Long-Term Safety Phase (Year 5)||37
8758989|NCT01212757|9808313|FG000|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
8758990|NCT01212757|9808314|FG001|NOT COMPLETED|Long-Term Safety Phase (Year 5)||8
8758991|NCT01212757|9808315|FG002|NOT COMPLETED|Long-Term Safety Phase (Year 5)||8
8758992|NCT01212757|9808316|FG003|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
8758993|NCT01212757|9808317|FG004|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
8758994|NCT01212757|9808318|FG005|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
8758995|NCT01212757|9808319|FG006|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
8758996|NCT01212757|9808320|FG007|NOT COMPLETED|Long-Term Safety Phase (Year 5)||5
8758997|NCT01212757|9808321|FG008|NOT COMPLETED|Long-Term Safety Phase (Year 5)||2
8758998|NCT01212770|9808342|FG000|STARTED|Placebo-controlled Phase (Week 0 - 24)||169
8758999|NCT01212770|9808343|FG001|STARTED|Placebo-controlled Phase (Week 0 - 24)||169
8759000|NCT01212770|9808344|FG002|STARTED|Placebo-controlled Phase (Week 0 - 24)||167
8759001|NCT01212770|9808345|FG003|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
8759002|NCT01212770|9808346|FG004|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
8759003|NCT01212770|9808347|FG005|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
8759004|NCT01212770|9808348|FG006|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
8759005|NCT01212770|9808349|FG007|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
8759006|NCT01212770|9808350|FG008|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
8759007|NCT01212770|9808342|FG000|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||169
8759008|NCT01212770|9808343|FG001|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||169
8759009|NCT01212770|9808344|FG002|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||167
8759010|NCT01212770|9808345|FG003|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
8759011|NCT01212770|9808346|FG004|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
8759012|NCT01212770|9808347|FG005|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
8759013|NCT01212770|9808348|FG006|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
8759014|NCT01212770|9808349|FG007|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
8759015|NCT01212770|9808350|FG008|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
8759016|NCT01212770|9808342|FG000|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||156
8759017|NCT01212770|9808343|FG001|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||157
8759018|NCT01212770|9808344|FG002|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||156
8759019|NCT01212770|9808345|FG003|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8759020|NCT01212770|9808346|FG004|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8759021|NCT01212770|9808347|FG005|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8759022|NCT01212770|9808348|FG006|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8759023|NCT01212770|9808349|FG007|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8759024|NCT01212770|9808350|FG008|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8759025|NCT01212770|9808342|FG000|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|1 participant who escaped early did not complete Week (Wk) 24|97
8759026|NCT01212770|9808343|FG001|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||76
8759027|NCT01212770|9808344|FG002|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|1 participant who escaped early did not complete Week 24|53
8759028|NCT01212770|9808345|FG003|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8759029|NCT01212770|9808346|FG004|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8759030|NCT01212770|9808347|FG005|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8759031|NCT01212770|9808348|FG006|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8759032|NCT01212770|9808349|FG007|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8759033|NCT01212770|9808350|FG008|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8759034|NCT01212770|9808342|FG000|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||146
8759035|NCT01212770|9808343|FG001|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||147
8759036|NCT01212770|9808344|FG002|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||145
8759037|NCT01212770|9808345|FG003|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8759038|NCT01212770|9808346|FG004|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8759039|NCT01212770|9808347|FG005|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8759040|NCT01212770|9808348|FG006|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8759041|NCT01212770|9808349|FG007|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8759042|NCT01212770|9808350|FG008|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8759043|NCT01212770|9808342|FG000|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||23
8759044|NCT01212770|9808343|FG001|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||22
8759045|NCT01212770|9808344|FG002|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||22
8759046|NCT01212770|9808345|FG003|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8759047|NCT01212770|9808346|FG004|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8759048|NCT01212770|9808347|FG005|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8759049|NCT01212770|9808348|FG006|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8759050|NCT01212770|9808349|FG007|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8759051|NCT01212770|9808350|FG008|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8759052|NCT01212770|9808342|FG000|STARTED|Active Treatment Phase (Weeks 25 - 52)||0
8759053|NCT01212770|9808343|FG001|STARTED|Active Treatment Phase (Weeks 25 - 52)|8 participants who completed Week 24 did not enter the Week 24-52 active treatment phase|139
8759054|NCT01212770|9808344|FG002|STARTED|Active Treatment Phase (Weeks 25 - 52)|7 participants who completed Week 24 did not enter the Week 24-52 active treatment phase|138
8759055|NCT01212770|9808345|FG003|STARTED|Active Treatment Phase (Weeks 25 - 52)|3 participants who EE completed Week 24 did not enter the Week 24-52 active treatment phase|43
8759056|NCT01212770|9808346|FG004|STARTED|Active Treatment Phase (Weeks 25 - 52)||25
8759057|NCT01212770|9808347|FG005|STARTED|Active Treatment Phase (Weeks 25 - 52)|3 participants who EE completed Week 24 did not enter the Week 24-52 active treatment phase|47
8759058|NCT01212770|9808348|FG006|STARTED|Active Treatment Phase (Weeks 25 - 52)||25
8759059|NCT01212770|9808349|FG007|STARTED|Active Treatment Phase (Weeks 25 - 52)||0
8759060|NCT01212770|9808350|FG008|STARTED|Active Treatment Phase (Weeks 25 - 52)||0
8759061|NCT01212770|9808342|FG000|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
8759062|NCT01212770|9808343|FG001|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||120
8759063|NCT01212770|9808344|FG002|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||126
8759064|NCT01212770|9808345|FG003|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||32
8759065|NCT01212770|9808346|FG004|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||23
8759066|NCT01212770|9808347|FG005|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||44
8759067|NCT01212770|9808348|FG006|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||23
8759068|NCT01212770|9808349|FG007|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
8759069|NCT01212770|9808350|FG008|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
8759070|NCT01212770|9808342|FG000|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
8759071|NCT01212770|9808343|FG001|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||19
8759072|NCT01212770|9808344|FG002|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||12
8759073|NCT01212770|9808345|FG003|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||11
8759074|NCT01212770|9808346|FG004|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||2
8759075|NCT01212770|9808347|FG005|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||3
8759076|NCT01212770|9808348|FG006|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||2
8759077|NCT01212770|9808349|FG007|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
8759078|NCT01212770|9808350|FG008|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
8759079|NCT01212770|9808342|FG000|STARTED|Long-term Safety Phase (Year 2)||0
8759080|NCT01212770|9808343|FG001|STARTED|Long-term Safety Phase (Year 2)|9 participants who completed Week 52 did not enter the long-term safety phase (LTSP)|111
8759081|NCT01212770|9808344|FG002|STARTED|Long-term Safety Phase (Year 2)|5 participants who completed Week 52 did not enter the long-term safety phase|121
8759082|NCT01212770|9808345|FG003|STARTED|Long-term Safety Phase (Year 2)||0
8759083|NCT01212770|9808346|FG004|STARTED|Long-term Safety Phase (Year 2)||0
8759084|NCT01212770|9808347|FG005|STARTED|Long-term Safety Phase (Year 2)||0
8759085|NCT01212770|9808348|FG006|STARTED|Long-term Safety Phase (Year 2)||0
8759086|NCT01212770|9808349|FG007|STARTED|Long-term Safety Phase (Year 2)|Patients from the PBO/APR 20 mg EE and XO are combined;5 patients finished Wk 52;no entry into LTSP|51
8759087|NCT01212770|9808350|FG008|STARTED|Long-term Safety Phase (Year 2)|Patients from the PBO/APR 30 mg EE and XO are combined;3 patients finished Wk 52;no entry into LTSP|64
8759088|NCT01212770|9808342|FG000|COMPLETED|Long-term Safety Phase (Year 2)||0
8759089|NCT01212770|9808343|FG001|COMPLETED|Long-term Safety Phase (Year 2)||88
8759090|NCT01212770|9808344|FG002|COMPLETED|Long-term Safety Phase (Year 2)||106
8759091|NCT01212770|9808345|FG003|COMPLETED|Long-term Safety Phase (Year 2)||0
8759092|NCT01212770|9808346|FG004|COMPLETED|Long-term Safety Phase (Year 2)||0
8759093|NCT01212770|9808347|FG005|COMPLETED|Long-term Safety Phase (Year 2)||0
8759094|NCT01212770|9808348|FG006|COMPLETED|Long-term Safety Phase (Year 2)||0
8759095|NCT01212770|9808349|FG007|COMPLETED|Long-term Safety Phase (Year 2)||42
8759096|NCT01212770|9808350|FG008|COMPLETED|Long-term Safety Phase (Year 2)||50
8759097|NCT01212770|9808342|FG000|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
8759098|NCT01212770|9808343|FG001|NOT COMPLETED|Long-term Safety Phase (Year 2)||23
8759099|NCT01212770|9808344|FG002|NOT COMPLETED|Long-term Safety Phase (Year 2)||15
8759100|NCT01212770|9808345|FG003|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
8759101|NCT01212770|9808346|FG004|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
8759102|NCT01212770|9808347|FG005|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
8759103|NCT01212770|9808348|FG006|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
8759104|NCT01212770|9808349|FG007|NOT COMPLETED|Long-term Safety Phase (Year 2)||9
8759105|NCT01212770|9808350|FG008|NOT COMPLETED|Long-term Safety Phase (Year 2)||14
8759106|NCT01212770|9808342|FG000|STARTED|Long-term Safety Phase (Year 3)||0
8759107|NCT01212770|9808343|FG001|STARTED|Long-term Safety Phase (Year 3)|1 participant who completed Year 2 did not continue treatment in Year 3|87
8759108|NCT01212770|9808344|FG002|STARTED|Long-term Safety Phase (Year 3)|1 participant who completed Year 2 did not continue treatment in Year 3|105
8759109|NCT01212770|9808345|FG003|STARTED|Long-term Safety Phase (Year 3)||0
8759110|NCT01212770|9808346|FG004|STARTED|Long-term Safety Phase (Year 3)||0
8759111|NCT01212770|9808347|FG005|STARTED|Long-term Safety Phase (Year 3)||0
8759112|NCT01212770|9808348|FG006|STARTED|Long-term Safety Phase (Year 3)||0
8759113|NCT01212770|9808349|FG007|STARTED|Long-term Safety Phase (Year 3)|The PBO/APR 20 mg EE and XO participants from week 24-52 are combined within the LTSP.|42
8759114|NCT01212770|9808350|FG008|STARTED|Long-term Safety Phase (Year 3)|Patients from the PBO/APR 30 mg EE and XO are combined;1 patient finished Wk 52;no entry into LTSP|49
8759115|NCT01212770|9808342|FG000|COMPLETED|Long-term Safety Phase (Year 3)||0
8759116|NCT01212770|9808343|FG001|COMPLETED|Long-term Safety Phase (Year 3)|1 participant missed due to APR dispensed late|76
8759117|NCT01212770|9808344|FG002|COMPLETED|Long-term Safety Phase (Year 3)||94
8759118|NCT01212770|9808345|FG003|COMPLETED|Long-term Safety Phase (Year 3)||0
8759119|NCT01212770|9808346|FG004|COMPLETED|Long-term Safety Phase (Year 3)||0
8759120|NCT01212770|9808347|FG005|COMPLETED|Long-term Safety Phase (Year 3)||0
8759121|NCT01212770|9808348|FG006|COMPLETED|Long-term Safety Phase (Year 3)||0
8759122|NCT01212770|9808349|FG007|COMPLETED|Long-term Safety Phase (Year 3)||35
8759123|NCT01212770|9808350|FG008|COMPLETED|Long-term Safety Phase (Year 3)||44
8759124|NCT01212770|9808342|FG000|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
8759125|NCT01212770|9808343|FG001|NOT COMPLETED|Long-term Safety Phase (Year 3)||11
9025321|NCT03160027|10087710|FG003|STARTED|Overall Study||4
9025322|NCT03160027|10087707|FG000|COMPLETED|Overall Study||6
9025323|NCT03160027|10087708|FG001|COMPLETED|Overall Study||4
9025324|NCT03160027|10087709|FG002|COMPLETED|Overall Study||6
9025325|NCT03160027|10087710|FG003|COMPLETED|Overall Study||4
9025326|NCT03160027|10087707|FG000|NOT COMPLETED|Overall Study||0
9025327|NCT03160027|10087708|FG001|NOT COMPLETED|Overall Study||0
9025328|NCT03160027|10087709|FG002|NOT COMPLETED|Overall Study||0
9025329|NCT03160027|10087710|FG003|NOT COMPLETED|Overall Study||0
9025330|NCT03160170|10087723|FG000|STARTED|Overall Study||10
9025331|NCT03160170|10087724|FG001|STARTED|Overall Study||10
9025332|NCT03160170|10087723|FG000|COMPLETED|Overall Study||10
9025333|NCT03160170|10087724|FG001|COMPLETED|Overall Study||10
9025334|NCT03160170|10087723|FG000|NOT COMPLETED|Overall Study||0
9025335|NCT03160170|10087724|FG001|NOT COMPLETED|Overall Study||0
9025336|NCT03160287|10087730|FG000|STARTED|Overall Study||24
9025337|NCT03160287|10087730|FG000|COMPLETED|Overall Study||22
9025338|NCT03160287|10087730|FG000|NOT COMPLETED|Overall Study||2
9025339|NCT03160560|10087738|FG000|STARTED|First Intervention (3 Weeks)||25
9025340|NCT03160560|10087739|FG001|STARTED|First Intervention (3 Weeks)||25
9025341|NCT03160560|10087740|FG002|STARTED|First Intervention (3 Weeks)||25
9025342|NCT03160560|10087741|FG003|STARTED|First Intervention (3 Weeks)||25
9025343|NCT03160560|10087738|FG000|COMPLETED|First Intervention (3 Weeks)||23
9025344|NCT03160560|10087739|FG001|COMPLETED|First Intervention (3 Weeks)||24
9025345|NCT03160560|10087740|FG002|COMPLETED|First Intervention (3 Weeks)||24
9025346|NCT03160560|10087741|FG003|COMPLETED|First Intervention (3 Weeks)||25
9025347|NCT03160560|10087738|FG000|NOT COMPLETED|First Intervention (3 Weeks)||2
9025348|NCT03160560|10087739|FG001|NOT COMPLETED|First Intervention (3 Weeks)||1
9025349|NCT03160560|10087740|FG002|NOT COMPLETED|First Intervention (3 Weeks)||1
9025350|NCT03160560|10087741|FG003|NOT COMPLETED|First Intervention (3 Weeks)||0
9025351|NCT03160560|10087738|FG000|STARTED|Washout (2 Weeks)||23
9025352|NCT03160560|10087739|FG001|STARTED|Washout (2 Weeks)||24
9025353|NCT03160560|10087740|FG002|STARTED|Washout (2 Weeks)||24
8759126|NCT01212770|9808344|FG002|NOT COMPLETED|Long-term Safety Phase (Year 3)||11
8759127|NCT01212770|9808345|FG003|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
8759128|NCT01212770|9808346|FG004|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
8759129|NCT01212770|9808347|FG005|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
8759130|NCT01212770|9808348|FG006|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
8759131|NCT01212770|9808349|FG007|NOT COMPLETED|Long-term Safety Phase (Year 3)||7
8759132|NCT01212770|9808350|FG008|NOT COMPLETED|Long-term Safety Phase (Year 3)||5
8759133|NCT01212770|9808342|FG000|STARTED|Long-term Safety Phase (Year 4)||0
8759134|NCT01212770|9808343|FG001|STARTED|Long-term Safety Phase (Year 4)|1 participant was counted in Year 4 but not in year 3 due to late APR dispensing|77
8759135|NCT01212770|9808344|FG002|STARTED|Long-term Safety Phase (Year 4)||94
8759136|NCT01212770|9808345|FG003|STARTED|Long-term Safety Phase (Year 4)||0
8759137|NCT01212770|9808346|FG004|STARTED|Long-term Safety Phase (Year 4)||0
8759138|NCT01212770|9808347|FG005|STARTED|Long-term Safety Phase (Year 4)||0
8759139|NCT01212770|9808348|FG006|STARTED|Long-term Safety Phase (Year 4)||0
8759140|NCT01212770|9808349|FG007|STARTED|Long-term Safety Phase (Year 4)||35
8759141|NCT01212770|9808350|FG008|STARTED|Long-term Safety Phase (Year 4)||44
8759142|NCT01212770|9808342|FG000|COMPLETED|Long-term Safety Phase (Year 4)||0
8759143|NCT01212770|9808343|FG001|COMPLETED|Long-term Safety Phase (Year 4)||71
8759144|NCT01212770|9808344|FG002|COMPLETED|Long-term Safety Phase (Year 4)||83
8759145|NCT01212770|9808345|FG003|COMPLETED|Long-term Safety Phase (Year 4)||0
8759146|NCT01212770|9808346|FG004|COMPLETED|Long-term Safety Phase (Year 4)||0
8759147|NCT01212770|9808347|FG005|COMPLETED|Long-term Safety Phase (Year 4)||0
8759148|NCT01212770|9808348|FG006|COMPLETED|Long-term Safety Phase (Year 4)||0
8759149|NCT01212770|9808349|FG007|COMPLETED|Long-term Safety Phase (Year 4)||32
8759150|NCT01212770|9808350|FG008|COMPLETED|Long-term Safety Phase (Year 4)||42
8759151|NCT01212770|9808342|FG000|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
8759152|NCT01212770|9808343|FG001|NOT COMPLETED|Long-term Safety Phase (Year 4)||6
8759153|NCT01212770|9808344|FG002|NOT COMPLETED|Long-term Safety Phase (Year 4)||11
8759154|NCT01212770|9808345|FG003|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
8759155|NCT01212770|9808346|FG004|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
8759156|NCT01212770|9808347|FG005|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
8759157|NCT01212770|9808348|FG006|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
8759158|NCT01212770|9808349|FG007|NOT COMPLETED|Long-term Safety Phase (Year 4)||3
8759159|NCT01212770|9808350|FG008|NOT COMPLETED|Long-term Safety Phase (Year 4)||2
8759160|NCT01212770|9808342|FG000|STARTED|Long-term Safety Phase (Year 5)||0
8759161|NCT01212770|9808343|FG001|STARTED|Long-term Safety Phase (Year 5)|1 participant who completed Year 4 did not continue treatment in Year 5|70
8759162|NCT01212770|9808344|FG002|STARTED|Long-term Safety Phase (Year 5)||83
8759163|NCT01212770|9808345|FG003|STARTED|Long-term Safety Phase (Year 5)||0
8759164|NCT01212770|9808346|FG004|STARTED|Long-term Safety Phase (Year 5)||0
8759165|NCT01212770|9808347|FG005|STARTED|Long-term Safety Phase (Year 5)||0
8759166|NCT01212770|9808348|FG006|STARTED|Long-term Safety Phase (Year 5)||0
8759167|NCT01212770|9808349|FG007|STARTED|Long-term Safety Phase (Year 5)||32
8759168|NCT01212770|9808350|FG008|STARTED|Long-term Safety Phase (Year 5)||42
8759169|NCT01212770|9808342|FG000|COMPLETED|Long-term Safety Phase (Year 5)||0
8759170|NCT01212770|9808343|FG001|COMPLETED|Long-term Safety Phase (Year 5)||68
8759171|NCT01212770|9808344|FG002|COMPLETED|Long-term Safety Phase (Year 5)||72
9025354|NCT03160560|10087741|FG003|STARTED|Washout (2 Weeks)||25
9025355|NCT03160560|10087738|FG000|COMPLETED|Washout (2 Weeks)||23
9025356|NCT03160560|10087739|FG001|COMPLETED|Washout (2 Weeks)||24
9025357|NCT03160560|10087740|FG002|COMPLETED|Washout (2 Weeks)||24
9025358|NCT03160560|10087741|FG003|COMPLETED|Washout (2 Weeks)||25
9025359|NCT03160560|10087738|FG000|NOT COMPLETED|Washout (2 Weeks)||0
9025360|NCT03160560|10087739|FG001|NOT COMPLETED|Washout (2 Weeks)||0
9025361|NCT03160560|10087740|FG002|NOT COMPLETED|Washout (2 Weeks)||0
9025362|NCT03160560|10087741|FG003|NOT COMPLETED|Washout (2 Weeks)||0
9025363|NCT03160560|10087738|FG000|STARTED|Second Intervention (3 Weeks)||23
9025364|NCT03160560|10087739|FG001|STARTED|Second Intervention (3 Weeks)||24
9025365|NCT03160560|10087740|FG002|STARTED|Second Intervention (3 Weeks)||24
9025366|NCT03160560|10087741|FG003|STARTED|Second Intervention (3 Weeks)||25
9025367|NCT03160560|10087738|FG000|COMPLETED|Second Intervention (3 Weeks)||22
9025368|NCT03160560|10087739|FG001|COMPLETED|Second Intervention (3 Weeks)||24
9025369|NCT03160560|10087740|FG002|COMPLETED|Second Intervention (3 Weeks)||24
9025370|NCT03160560|10087741|FG003|COMPLETED|Second Intervention (3 Weeks)||25
8759172|NCT01212770|9808345|FG003|COMPLETED|Long-term Safety Phase (Year 5)||0
8759173|NCT01212770|9808346|FG004|COMPLETED|Long-term Safety Phase (Year 5)||0
8759174|NCT01212770|9808347|FG005|COMPLETED|Long-term Safety Phase (Year 5)||0
8759175|NCT01212770|9808348|FG006|COMPLETED|Long-term Safety Phase (Year 5)||0
8759176|NCT01212770|9808349|FG007|COMPLETED|Long-term Safety Phase (Year 5)||30
8759177|NCT01212770|9808350|FG008|COMPLETED|Long-term Safety Phase (Year 5)||41
8759178|NCT01212770|9808342|FG000|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
8759179|NCT01212770|9808343|FG001|NOT COMPLETED|Long-term Safety Phase (Year 5)||2
8759180|NCT01212770|9808344|FG002|NOT COMPLETED|Long-term Safety Phase (Year 5)||11
9025371|NCT03160560|10087738|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||1
9025372|NCT03160560|10087739|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
9025373|NCT03160560|10087740|FG002|NOT COMPLETED|Second Intervention (3 Weeks)||0
9025374|NCT03160560|10087741|FG003|NOT COMPLETED|Second Intervention (3 Weeks)||0
9025375|NCT03160573|10087755|FG000|STARTED|First Sequence (3 Weeks)||23
9025376|NCT03160573|10087756|FG001|STARTED|First Sequence (3 Weeks)||26
8759181|NCT01212770|9808345|FG003|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
8759182|NCT01212770|9808346|FG004|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
8759183|NCT01212770|9808347|FG005|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
8759184|NCT01212770|9808348|FG006|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
8759185|NCT01212770|9808349|FG007|NOT COMPLETED|Long-term Safety Phase (Year 5)||2
8759186|NCT01212770|9808350|FG008|NOT COMPLETED|Long-term Safety Phase (Year 5)||1
8759187|NCT01212874|9808374|FG000|STARTED|Overall Study||35
8759188|NCT01212874|9808375|FG001|STARTED|Overall Study||35
8759189|NCT01212874|9808374|FG000|Received Allocated Intervention|Overall Study||13
8759190|NCT01212874|9808375|FG001|Received Allocated Intervention|Overall Study||12
8759191|NCT01212874|9808374|FG000|COMPLETED|Overall Study||13
8759192|NCT01212874|9808375|FG001|COMPLETED|Overall Study||12
8759193|NCT01212874|9808374|FG000|NOT COMPLETED|Overall Study||22
8759194|NCT01212874|9808375|FG001|NOT COMPLETED|Overall Study||23
8759195|NCT01212900|9808383|FG000|STARTED|Overall Study||116
8759196|NCT01212900|9808384|FG001|STARTED|Overall Study||114
8759197|NCT01212900|9808383|FG000|COMPLETED|Overall Study||104
8759198|NCT01212900|9808384|FG001|COMPLETED|Overall Study||107
8759199|NCT01212900|9808383|FG000|NOT COMPLETED|Overall Study||12
8759200|NCT01212900|9808384|FG001|NOT COMPLETED|Overall Study||7
8759201|NCT01212952|9808393|FG000|STARTED|Overall Study||3
8759202|NCT01212952|9808394|FG001|STARTED|Overall Study||6
8759203|NCT01212952|9808395|FG002|STARTED|Overall Study||41
8759204|NCT01212952|9808393|FG000|COMPLETED|Overall Study||3
8759205|NCT01212952|9808394|FG001|COMPLETED|Overall Study||6
8759206|NCT01212952|9808395|FG002|COMPLETED|Overall Study||41
8759207|NCT01212952|9808393|FG000|NOT COMPLETED|Overall Study||0
8759208|NCT01212952|9808394|FG001|NOT COMPLETED|Overall Study||0
8759209|NCT01212952|9808395|FG002|NOT COMPLETED|Overall Study||0
8759210|NCT01212991|9808407|FG000|STARTED|Double-blind||872
8759211|NCT01212991|9808408|FG001|STARTED|Double-blind||845
8759212|NCT01212991|9808409|FG002|STARTED|Double-blind||0
8759213|NCT01212991|9808407|FG000|Safety Population|Double-blind||871
8759214|NCT01212991|9808408|FG001|Safety Population|Double-blind||844
8759215|NCT01212991|9808409|FG002|Safety Population|Double-blind||0
8759216|NCT01212991|9808407|FG000|COMPLETED|Double-blind||0
8759217|NCT01212991|9808408|FG001|COMPLETED|Double-blind||234
8759218|NCT01212991|9808409|FG002|COMPLETED|Double-blind||0
8759219|NCT01212991|9808407|FG000|NOT COMPLETED|Double-blind||872
8759220|NCT01212991|9808408|FG001|NOT COMPLETED|Double-blind||611
8759221|NCT01212991|9808409|FG002|NOT COMPLETED|Double-blind||0
8759222|NCT01212991|9808407|FG000|STARTED|Open-label||0
8759223|NCT01212991|9808408|FG001|STARTED|Open-label|participants were given the opportunity to receive open-label access to enzalutamide|0
8759224|NCT01212991|9808409|FG002|STARTED|Open-label|previous placebo treated participants were given the opportunity to receive enzalutamide|234
8759225|NCT01212991|9808407|FG000|COMPLETED|Open-label||0
8759226|NCT01212991|9808408|FG001|COMPLETED|Open-label||0
8759227|NCT01212991|9808409|FG002|COMPLETED|Open-label||0
8759228|NCT01212991|9808407|FG000|NOT COMPLETED|Open-label||0
8759229|NCT01212991|9808408|FG001|NOT COMPLETED|Open-label||0
8759230|NCT01212991|9808409|FG002|NOT COMPLETED|Open-label||234
8759231|NCT01213043|9808419|FG000|STARTED|Treatment Period 1||15
8759232|NCT01213043|9808420|FG001|STARTED|Treatment Period 1||15
8759233|NCT01213043|9808419|FG000|COMPLETED|Treatment Period 1||15
8759234|NCT01213043|9808420|FG001|COMPLETED|Treatment Period 1||15
8759235|NCT01213043|9808419|FG000|NOT COMPLETED|Treatment Period 1||0
8759236|NCT01213043|9808420|FG001|NOT COMPLETED|Treatment Period 1||0
8759237|NCT01213043|9808419|FG000|STARTED|Washout Period||15
8759238|NCT01213043|9808420|FG001|STARTED|Washout Period||15
8759239|NCT01213043|9808419|FG000|COMPLETED|Washout Period||15
8759240|NCT01213043|9808420|FG001|COMPLETED|Washout Period||15
8759241|NCT01213043|9808419|FG000|NOT COMPLETED|Washout Period||0
8759242|NCT01213043|9808420|FG001|NOT COMPLETED|Washout Period||0
9025377|NCT03160573|10087757|FG002|STARTED|First Sequence (3 Weeks)||25
9025378|NCT03160573|10087758|FG003|STARTED|First Sequence (3 Weeks)||25
9025379|NCT03160573|10087755|FG000|COMPLETED|First Sequence (3 Weeks)||22
9025380|NCT03160573|10087756|FG001|COMPLETED|First Sequence (3 Weeks)||23
9025381|NCT03160573|10087757|FG002|COMPLETED|First Sequence (3 Weeks)||23
9025382|NCT03160573|10087758|FG003|COMPLETED|First Sequence (3 Weeks)||23
9025383|NCT03160573|10087755|FG000|NOT COMPLETED|First Sequence (3 Weeks)||1
9025384|NCT03160573|10087756|FG001|NOT COMPLETED|First Sequence (3 Weeks)||3
9025385|NCT03160573|10087757|FG002|NOT COMPLETED|First Sequence (3 Weeks)||2
9025386|NCT03160573|10087758|FG003|NOT COMPLETED|First Sequence (3 Weeks)||2
9025387|NCT03160573|10087755|FG000|STARTED|Washout (2 Weeks)||22
9025388|NCT03160573|10087756|FG001|STARTED|Washout (2 Weeks)||23
9025389|NCT03160573|10087757|FG002|STARTED|Washout (2 Weeks)||23
9025390|NCT03160573|10087758|FG003|STARTED|Washout (2 Weeks)||23
8759243|NCT01213043|9808419|FG000|STARTED|Treatment Period 2||15
8759244|NCT01213043|9808420|FG001|STARTED|Treatment Period 2||15
8759245|NCT01213043|9808419|FG000|COMPLETED|Treatment Period 2||15
8759246|NCT01213043|9808420|FG001|COMPLETED|Treatment Period 2||15
8759247|NCT01213043|9808419|FG000|NOT COMPLETED|Treatment Period 2||0
8759248|NCT01213043|9808420|FG001|NOT COMPLETED|Treatment Period 2||0
8759249|NCT01213043|9808419|FG000|STARTED|Follow-up||15
8759250|NCT01213043|9808420|FG001|STARTED|Follow-up||15
8759251|NCT01213043|9808419|FG000|COMPLETED|Follow-up||15
8759252|NCT01213043|9808420|FG001|COMPLETED|Follow-up||15
8759253|NCT01213043|9808419|FG000|NOT COMPLETED|Follow-up||0
9025391|NCT03160573|10087755|FG000|COMPLETED|Washout (2 Weeks)||22
8759254|NCT01213043|9808420|FG001|NOT COMPLETED|Follow-up||0
8759255|NCT01213082|9808429|FG000|STARTED|Overall Study||12
8759256|NCT01213082|9808430|FG001|STARTED|Overall Study||11
8759257|NCT01213082|9808431|FG002|STARTED|Overall Study||11
8759258|NCT01213082|9808429|FG000|COMPLETED|Overall Study||6
8759259|NCT01213082|9808430|FG001|COMPLETED|Overall Study||4
8759260|NCT01213082|9808431|FG002|COMPLETED|Overall Study||6
8759261|NCT01213082|9808429|FG000|NOT COMPLETED|Overall Study||6
8759262|NCT01213082|9808430|FG001|NOT COMPLETED|Overall Study||7
8759263|NCT01213082|9808431|FG002|NOT COMPLETED|Overall Study||5
8759264|NCT01213173|9808441|FG000|STARTED|Overall Study|Patients who were randomized and received treatment|125
8759265|NCT01213173|9808442|FG001|STARTED|Overall Study|Patients who were randomized and received treatment|126
8759266|NCT01213173|9808441|FG000|Patients Included in Safety Population|Overall Study||139
8759267|NCT01213173|9808442|FG001|Patients Included in Safety Population|Overall Study||112
8759268|NCT01213173|9808441|FG000|Patients Included in ITT Population|Overall Study||116
8759269|NCT01213173|9808442|FG001|Patients Included in ITT Population|Overall Study||115
8759270|NCT01213173|9808441|FG000|Patients Included in PP Population|Overall Study||102
8759271|NCT01213173|9808442|FG001|Patients Included in PP Population|Overall Study||89
8759272|NCT01213173|9808441|FG000|COMPLETED|Overall Study|Patients who completed the study|113
8759273|NCT01213173|9808442|FG001|COMPLETED|Overall Study|Patients who completed the study|110
8759274|NCT01213173|9808441|FG000|NOT COMPLETED|Overall Study||12
8759275|NCT01213173|9808442|FG001|NOT COMPLETED|Overall Study||16
8759276|NCT01213199|9808448|FG000|STARTED|Overall Study||20
8759277|NCT01213199|9808448|FG000|COMPLETED|Overall Study||16
8759278|NCT01213199|9808448|FG000|NOT COMPLETED|Overall Study||4
8759279|NCT01213251|9808455|FG000|STARTED|Overall Study||40
8759280|NCT01213251|9808456|FG001|STARTED|Overall Study||41
8759281|NCT01213251|9808457|FG002|STARTED|Overall Study||45
8759282|NCT01213251|9808455|FG000|COMPLETED|Overall Study|Patients that had the 18-Month follow-up visit|34
8759283|NCT01213251|9808456|FG001|COMPLETED|Overall Study|Patients that had the 18-Month follow-up visit|37
8759284|NCT01213251|9808457|FG002|COMPLETED|Overall Study|Patients that had the 18-Month follow-up visit|34
8759285|NCT01213251|9808455|FG000|NOT COMPLETED|Overall Study||6
8759286|NCT01213251|9808456|FG001|NOT COMPLETED|Overall Study||4
8759287|NCT01213251|9808457|FG002|NOT COMPLETED|Overall Study||11
8759288|NCT01213264|9808473|FG000|STARTED|Overall Study||155
8759289|NCT01213264|9808474|FG001|STARTED|Overall Study||177
8759290|NCT01213264|9808475|FG002|STARTED|Overall Study||327
8759291|NCT01213264|9808473|FG000|COMPLETED|Overall Study||153
8759292|NCT01213264|9808474|FG001|COMPLETED|Overall Study||175
8759293|NCT01213264|9808475|FG002|COMPLETED|Overall Study||321
8759294|NCT01213264|9808473|FG000|NOT COMPLETED|Overall Study||2
8759295|NCT01213264|9808474|FG001|NOT COMPLETED|Overall Study||2
8759296|NCT01213264|9808475|FG002|NOT COMPLETED|Overall Study||6
8759297|NCT01213316|9808486|FG000|STARTED|Overall Study|Participants in the initial and amendment cohorts|451
8759298|NCT01213316|9808486|FG000|Amendment Cohort: Prolonged Participants|Overall Study|Participants >=50 years of age in the initial cohort who accept an additional 48-week observation|48
8759299|NCT01213316|9808486|FG000|Amendment Cohort: Newly Enrolled|Overall Study|Participants >=50 years of age newly enrolled|179
8759300|NCT01213316|9808486|FG000|Discontinued Treatment Before 48 Weeks|Overall Study||67
8759301|NCT01213316|9808486|FG000|Initial Cohort|Overall Study|Participants >=18 years of age in the initial cohort|272
8759302|NCT01213316|9808486|FG000|COMPLETED|Overall Study||451
8759303|NCT01213316|9808486|FG000|NOT COMPLETED|Overall Study||0
8759304|NCT01213472|9808494|FG000|STARTED|Overall Study||33
8759305|NCT01213472|9808494|FG000|COMPLETED|Overall Study||6
8759306|NCT01213472|9808494|FG000|NOT COMPLETED|Overall Study||27
8759307|NCT01213524|9808500|FG000|STARTED|Baseline|Total number who signed informed consent.|75
8759308|NCT01213524|9808500|FG000|COMPLETED|Baseline|Number of participants who continued in the study past baseline|68
8759309|NCT01213524|9808500|FG000|NOT COMPLETED|Baseline||7
8759310|NCT01213524|9808500|FG000|STARTED|Session 2||68
8759311|NCT01213524|9808500|FG000|COMPLETED|Session 2|Number who continued in the study to the next session|63
8759312|NCT01213524|9808500|FG000|NOT COMPLETED|Session 2||5
8759313|NCT01213524|9808500|FG000|STARTED|Session 3||63
8759314|NCT01213524|9808500|FG000|COMPLETED|Session 3|Number who continued in study to next session|59
8759315|NCT01213524|9808500|FG000|NOT COMPLETED|Session 3||4
8759316|NCT01213524|9808500|FG000|STARTED|Session 4||59
8759317|NCT01213524|9808500|FG000|COMPLETED|Session 4|Number who continued in the study to the next session|56
8759318|NCT01213524|9808500|FG000|NOT COMPLETED|Session 4||3
8759319|NCT01213524|9808500|FG000|STARTED|Session 5||56
8759320|NCT01213524|9808500|FG000|COMPLETED|Session 5|Number who continued in the study to the next session|56
8759321|NCT01213524|9808500|FG000|NOT COMPLETED|Session 5||0
8759322|NCT01213524|9808500|FG000|STARTED|Session 6||56
8759323|NCT01213524|9808500|FG000|COMPLETED|Session 6|Number who continued in the study to the next session|56
8759324|NCT01213524|9808500|FG000|NOT COMPLETED|Session 6||0
8759325|NCT01213524|9808500|FG000|STARTED|Session 7||56
8759326|NCT01213524|9808500|FG000|COMPLETED|Session 7||56
8759327|NCT01213524|9808500|FG000|NOT COMPLETED|Session 7||0
8759328|NCT01213576|9808515|FG000|STARTED|Overall Study||18
8759329|NCT01213576|9808516|FG001|STARTED|Overall Study||17
8759330|NCT01213576|9808517|FG002|STARTED|Overall Study||18
8759331|NCT01213576|9808518|FG003|STARTED|Overall Study||17
8759332|NCT01213576|9808515|FG000|COMPLETED|Overall Study||15
8759333|NCT01213576|9808516|FG001|COMPLETED|Overall Study||13
8759334|NCT01213576|9808517|FG002|COMPLETED|Overall Study||13
8759335|NCT01213576|9808518|FG003|COMPLETED|Overall Study||13
8759336|NCT01213576|9808515|FG000|NOT COMPLETED|Overall Study||3
8759337|NCT01213576|9808516|FG001|NOT COMPLETED|Overall Study||4
8759338|NCT01213576|9808517|FG002|NOT COMPLETED|Overall Study||5
8759339|NCT01213576|9808518|FG003|NOT COMPLETED|Overall Study||4
8759340|NCT01213589|9808531|FG000|STARTED|Overall Study||50
8759341|NCT01213589|9808532|FG001|STARTED|Overall Study||24
8759342|NCT01213589|9808533|FG002|STARTED|Overall Study||26
8759343|NCT01213589|9808531|FG000|COMPLETED|Overall Study||37
8759344|NCT01213589|9808532|FG001|COMPLETED|Overall Study||19
8759345|NCT01213589|9808533|FG002|COMPLETED|Overall Study||18
8759346|NCT01213589|9808531|FG000|NOT COMPLETED|Overall Study||13
8759347|NCT01213589|9808532|FG001|NOT COMPLETED|Overall Study||5
8759348|NCT01213589|9808533|FG002|NOT COMPLETED|Overall Study||8
8759349|NCT01213706|9808541|FG000|STARTED|Sham WBPA||45
8759350|NCT01213706|9808541|FG000|COMPLETED|Sham WBPA||45
8759351|NCT01213706|9808541|FG000|NOT COMPLETED|Sham WBPA||0
8759352|NCT01213706|9808541|FG000|STARTED|Washout (1 Hour)||45
8759353|NCT01213706|9808541|FG000|COMPLETED|Washout (1 Hour)||45
8759354|NCT01213706|9808541|FG000|NOT COMPLETED|Washout (1 Hour)||0
8759355|NCT01213706|9808541|FG000|STARTED|WBPA||45
8759356|NCT01213706|9808541|FG000|COMPLETED|WBPA||45
8759357|NCT01213706|9808541|FG000|NOT COMPLETED|WBPA||0
8759358|NCT01213823|9808549|FG000|STARTED|Overall Study||69
8759359|NCT01213823|9808550|FG001|STARTED|Overall Study||467
8759360|NCT01213823|9808549|FG000|COMPLETED|Overall Study||69
8759361|NCT01213823|9808550|FG001|COMPLETED|Overall Study||467
8759362|NCT01213823|9808549|FG000|NOT COMPLETED|Overall Study||0
8759363|NCT01213823|9808550|FG001|NOT COMPLETED|Overall Study||0
8759364|NCT01213836|9808558|FG000|STARTED|Period 1, First Intervention||34
8759365|NCT01213836|9808559|FG001|STARTED|Period 1, First Intervention||32
8759366|NCT01213836|9808558|FG000|COMPLETED|Period 1, First Intervention||31
8759367|NCT01213836|9808559|FG001|COMPLETED|Period 1, First Intervention||29
8759368|NCT01213836|9808558|FG000|NOT COMPLETED|Period 1, First Intervention||3
8759369|NCT01213836|9808559|FG001|NOT COMPLETED|Period 1, First Intervention||3
8759370|NCT01213836|9808558|FG000|STARTED|Period 2, Second Intervention||31
8759371|NCT01213836|9808559|FG001|STARTED|Period 2, Second Intervention||29
8759372|NCT01213836|9808558|FG000|COMPLETED|Period 2, Second Intervention||31
8759373|NCT01213836|9808559|FG001|COMPLETED|Period 2, Second Intervention||29
8759374|NCT01213836|9808558|FG000|NOT COMPLETED|Period 2, Second Intervention||0
8759375|NCT01213836|9808559|FG001|NOT COMPLETED|Period 2, Second Intervention||0
8759376|NCT01213940|9808570|FG000|STARTED|Overall Study||14
8759377|NCT01213940|9808571|FG001|STARTED|Overall Study||6
8759378|NCT01213940|9808570|FG000|COMPLETED|Overall Study||14
8759379|NCT01213940|9808571|FG001|COMPLETED|Overall Study||6
8759380|NCT01213940|9808570|FG000|NOT COMPLETED|Overall Study||0
8759381|NCT01213940|9808571|FG001|NOT COMPLETED|Overall Study||0
8759382|NCT01213966|9808581|FG000|STARTED|Overall Study||20
8759383|NCT01213966|9808582|FG001|STARTED|Overall Study||20
8759384|NCT01213966|9808583|FG002|STARTED|Overall Study||20
8759385|NCT01213966|9808584|FG003|STARTED|Overall Study||21
8759386|NCT01213966|9808581|FG000|COMPLETED|Overall Study||19
8759387|NCT01213966|9808582|FG001|COMPLETED|Overall Study||20
8759388|NCT01213966|9808583|FG002|COMPLETED|Overall Study||17
8759389|NCT01213966|9808584|FG003|COMPLETED|Overall Study||20
8759390|NCT01213966|9808581|FG000|NOT COMPLETED|Overall Study||1
8759391|NCT01213966|9808582|FG001|NOT COMPLETED|Overall Study||0
8759392|NCT01213966|9808583|FG002|NOT COMPLETED|Overall Study||3
8759393|NCT01213966|9808584|FG003|NOT COMPLETED|Overall Study||1
8759394|NCT01214044|9808594|FG000|STARTED|Visit 1: Screening and Consent, Washout||31
8759395|NCT01214044|9808594|FG000|COMPLETED|Visit 1: Screening and Consent, Washout||19
8759396|NCT01214044|9808594|FG000|NOT COMPLETED|Visit 1: Screening and Consent, Washout||12
8759397|NCT01214044|9808594|FG000|STARTED|Visit 2: End Washout & Start Placebo||19
8759398|NCT01214044|9808594|FG000|COMPLETED|Visit 2: End Washout & Start Placebo|2 subjects dropped out during the placebo week (between study visits 2 & 3)|17
8759399|NCT01214044|9808594|FG000|NOT COMPLETED|Visit 2: End Washout & Start Placebo||2
8759400|NCT01214044|9808594|FG000|STARTED|Visits 3-5: Escitalopram 10 mg Daily||17
8759401|NCT01214044|9808594|FG000|COMPLETED|Visits 3-5: Escitalopram 10 mg Daily||14
8759402|NCT01214044|9808594|FG000|NOT COMPLETED|Visits 3-5: Escitalopram 10 mg Daily||3
8759403|NCT01214044|9808594|FG000|STARTED|Visits 6-11: Escitalopram 20 mg Daily||14
8759404|NCT01214044|9808594|FG000|COMPLETED|Visits 6-11: Escitalopram 20 mg Daily||10
8759405|NCT01214044|9808594|FG000|NOT COMPLETED|Visits 6-11: Escitalopram 20 mg Daily||4
8759406|NCT01214057|9808604|FG000|STARTED|Overall Study||12
8759407|NCT01214057|9808605|FG001|STARTED|Overall Study||11
8759408|NCT01214057|9808604|FG000|COMPLETED|Overall Study||12
8759409|NCT01214057|9808605|FG001|COMPLETED|Overall Study||11
8759410|NCT01214057|9808604|FG000|NOT COMPLETED|Overall Study||0
8759411|NCT01214057|9808605|FG001|NOT COMPLETED|Overall Study||0
8759412|NCT01214083|9808614|FG000|STARTED|Overall Study||31
8759413|NCT01214083|9808615|FG001|STARTED|Overall Study||33
8759414|NCT01214083|9808616|FG002|STARTED|Overall Study||31
8759415|NCT01214083|9808614|FG000|COMPLETED|Overall Study||19
8759416|NCT01214083|9808615|FG001|COMPLETED|Overall Study||23
8759417|NCT01214083|9808616|FG002|COMPLETED|Overall Study||21
8759418|NCT01214083|9808614|FG000|NOT COMPLETED|Overall Study||12
8759419|NCT01214083|9808615|FG001|NOT COMPLETED|Overall Study||10
8759420|NCT01214083|9808616|FG002|NOT COMPLETED|Overall Study||10
8759421|NCT01214109|9808624|FG000|STARTED|Overall Study||24
8759422|NCT01214109|9808625|FG001|STARTED|Overall Study||24
8759423|NCT01214109|9808626|FG002|STARTED|Overall Study||24
8759424|NCT01214109|9808627|FG003|STARTED|Overall Study||24
8759425|NCT01214109|9808624|FG000|COMPLETED|Overall Study||24
8759426|NCT01214109|9808625|FG001|COMPLETED|Overall Study||24
8759427|NCT01214109|9808626|FG002|COMPLETED|Overall Study||24
8759428|NCT01214109|9808627|FG003|COMPLETED|Overall Study||24
8759429|NCT01214109|9808624|FG000|NOT COMPLETED|Overall Study||0
8759430|NCT01214109|9808625|FG001|NOT COMPLETED|Overall Study||0
9025392|NCT03160573|10087756|FG001|COMPLETED|Washout (2 Weeks)||23
9025393|NCT03160573|10087757|FG002|COMPLETED|Washout (2 Weeks)||23
9025394|NCT03160573|10087758|FG003|COMPLETED|Washout (2 Weeks)||23
9025395|NCT03160573|10087755|FG000|NOT COMPLETED|Washout (2 Weeks)||0
9025396|NCT03160573|10087756|FG001|NOT COMPLETED|Washout (2 Weeks)||0
9025397|NCT03160573|10087757|FG002|NOT COMPLETED|Washout (2 Weeks)||0
9025398|NCT03160573|10087758|FG003|NOT COMPLETED|Washout (2 Weeks)||0
9025399|NCT03160573|10087755|FG000|STARTED|Second Sequence (3 Weeks)||22
9025400|NCT03160573|10087756|FG001|STARTED|Second Sequence (3 Weeks)||23
9025401|NCT03160573|10087757|FG002|STARTED|Second Sequence (3 Weeks)||23
9025402|NCT03160573|10087758|FG003|STARTED|Second Sequence (3 Weeks)||23
9025403|NCT03160573|10087755|FG000|COMPLETED|Second Sequence (3 Weeks)||22
9025404|NCT03160573|10087756|FG001|COMPLETED|Second Sequence (3 Weeks)||23
9025405|NCT03160573|10087757|FG002|COMPLETED|Second Sequence (3 Weeks)||23
9025406|NCT03160573|10087758|FG003|COMPLETED|Second Sequence (3 Weeks)||23
9025407|NCT03160573|10087755|FG000|NOT COMPLETED|Second Sequence (3 Weeks)||0
9025408|NCT03160573|10087756|FG001|NOT COMPLETED|Second Sequence (3 Weeks)||0
9025409|NCT03160573|10087757|FG002|NOT COMPLETED|Second Sequence (3 Weeks)||0
9025410|NCT03160573|10087758|FG003|NOT COMPLETED|Second Sequence (3 Weeks)||0
9025411|NCT03160703|10087772|FG000|STARTED|Overall Study||55
9025412|NCT03160703|10087773|FG001|STARTED|Overall Study||55
9025413|NCT03160703|10087774|FG002|STARTED|Overall Study||55
9025414|NCT03160703|10087775|FG003|STARTED|Overall Study||55
9025415|NCT03160703|10087772|FG000|COMPLETED|Overall Study||55
9025416|NCT03160703|10087773|FG001|COMPLETED|Overall Study||55
9025417|NCT03160703|10087774|FG002|COMPLETED|Overall Study||55
9025418|NCT03160703|10087775|FG003|COMPLETED|Overall Study||54
9025419|NCT03160703|10087772|FG000|NOT COMPLETED|Overall Study||0
9025420|NCT03160703|10087773|FG001|NOT COMPLETED|Overall Study||0
9025421|NCT03160703|10087774|FG002|NOT COMPLETED|Overall Study||0
9025422|NCT03160703|10087775|FG003|NOT COMPLETED|Overall Study||1
9025423|NCT03160716|10087785|FG000|STARTED|Overall Study||60
9025424|NCT03160716|10087785|FG000|COMPLETED|Overall Study||59
9025425|NCT03160716|10087785|FG000|NOT COMPLETED|Overall Study||1
9025426|NCT03160885|10087791|FG000|STARTED|Initial Treatment Period||593
9025427|NCT03160885|10087792|FG001|STARTED|Initial Treatment Period||201
9025428|NCT03160885|10087793|FG002|STARTED|Initial Treatment Period||0
9025429|NCT03160885|10087794|FG003|STARTED|Initial Treatment Period||0
9025430|NCT03160885|10087795|FG004|STARTED|Initial Treatment Period||0
9025431|NCT03160885|10087796|FG005|STARTED|Initial Treatment Period||0
9025432|NCT03160885|10087797|FG006|STARTED|Initial Treatment Period||0
9025433|NCT03160885|10087791|FG000|COMPLETED|Initial Treatment Period||558
9025434|NCT03160885|10087792|FG001|COMPLETED|Initial Treatment Period||179
9025435|NCT03160885|10087793|FG002|COMPLETED|Initial Treatment Period||0
9025436|NCT03160885|10087794|FG003|COMPLETED|Initial Treatment Period||0
9025437|NCT03160885|10087795|FG004|COMPLETED|Initial Treatment Period||0
9025438|NCT03160885|10087796|FG005|COMPLETED|Initial Treatment Period||0
9025439|NCT03160885|10087797|FG006|COMPLETED|Initial Treatment Period||0
9025440|NCT03160885|10087791|FG000|NOT COMPLETED|Initial Treatment Period||35
9025441|NCT03160885|10087792|FG001|NOT COMPLETED|Initial Treatment Period||22
9025442|NCT03160885|10087793|FG002|NOT COMPLETED|Initial Treatment Period||0
9025443|NCT03160885|10087794|FG003|NOT COMPLETED|Initial Treatment Period||0
9025444|NCT03160885|10087795|FG004|NOT COMPLETED|Initial Treatment Period||0
9025445|NCT03160885|10087796|FG005|NOT COMPLETED|Initial Treatment Period||0
9025446|NCT03160885|10087797|FG006|NOT COMPLETED|Initial Treatment Period||0
9025447|NCT03160885|10087791|FG000|STARTED|Open-label Treatment||0
9025448|NCT03160885|10087792|FG001|STARTED|Open-label Treatment||0
9025449|NCT03160885|10087793|FG002|STARTED|Open-label Treatment||0
9025450|NCT03160885|10087794|FG003|STARTED|Open-label Treatment||0
9025451|NCT03160885|10087795|FG004|STARTED|Open-label Treatment||0
9025452|NCT03160885|10087796|FG005|STARTED|Open-label Treatment||0
9025453|NCT03160885|10087797|FG006|STARTED|Open-label Treatment||560
9025454|NCT03160885|10087791|FG000|COMPLETED|Open-label Treatment||0
9025455|NCT03160885|10087792|FG001|COMPLETED|Open-label Treatment||0
9025456|NCT03160885|10087793|FG002|COMPLETED|Open-label Treatment||0
9025457|NCT03160885|10087794|FG003|COMPLETED|Open-label Treatment||0
9025458|NCT03160885|10087795|FG004|COMPLETED|Open-label Treatment||0
9025459|NCT03160885|10087796|FG005|COMPLETED|Open-label Treatment||0
9025460|NCT03160885|10087797|FG006|COMPLETED|Open-label Treatment||423
9025461|NCT03160885|10087791|FG000|NOT COMPLETED|Open-label Treatment||0
9025462|NCT03160885|10087792|FG001|NOT COMPLETED|Open-label Treatment||0
8759431|NCT01214109|9808626|FG002|NOT COMPLETED|Overall Study||0
8759432|NCT01214109|9808627|FG003|NOT COMPLETED|Overall Study||0
9025463|NCT03160885|10087793|FG002|NOT COMPLETED|Open-label Treatment||0
9025464|NCT03160885|10087794|FG003|NOT COMPLETED|Open-label Treatment||0
9025465|NCT03160885|10087795|FG004|NOT COMPLETED|Open-label Treatment||0
9025466|NCT03160885|10087796|FG005|NOT COMPLETED|Open-label Treatment||0
9025467|NCT03160885|10087797|FG006|NOT COMPLETED|Open-label Treatment||137
8759433|NCT01214161|9808642|FG000|STARTED|Overall Study||100
8759434|NCT01214161|9808643|FG001|STARTED|Overall Study||100
8759435|NCT01214161|9808642|FG000|COMPLETED|Overall Study||100
8759436|NCT01214161|9808643|FG001|COMPLETED|Overall Study||100
8759437|NCT01214161|9808642|FG000|NOT COMPLETED|Overall Study||0
8759438|NCT01214161|9808643|FG001|NOT COMPLETED|Overall Study||0
8759439|NCT01214174|9808654|FG000|STARTED|Overall Study||13
8759440|NCT01214174|9808655|FG001|STARTED|Overall Study||16
8759441|NCT01214174|9808656|FG002|STARTED|Overall Study||14
8759442|NCT01214174|9808654|FG000|COMPLETED|Overall Study||13
8759443|NCT01214174|9808655|FG001|COMPLETED|Overall Study||16
8759444|NCT01214174|9808656|FG002|COMPLETED|Overall Study||13
8759445|NCT01214174|9808654|FG000|NOT COMPLETED|Overall Study||0
8759446|NCT01214174|9808655|FG001|NOT COMPLETED|Overall Study||0
8759447|NCT01214174|9808656|FG002|NOT COMPLETED|Overall Study||1
8759448|NCT01214187|9808666|FG000|STARTED|Overall Study||29
8759449|NCT01214187|9808667|FG001|STARTED|Overall Study||29
8759450|NCT01214187|9808666|FG000|COMPLETED|Overall Study||22
8759451|NCT01214187|9808667|FG001|COMPLETED|Overall Study||23
8759452|NCT01214187|9808666|FG000|NOT COMPLETED|Overall Study||7
8759453|NCT01214187|9808667|FG001|NOT COMPLETED|Overall Study||6
8759454|NCT01214200|9808673|FG000|STARTED|Overall Study||20
8759455|NCT01214200|9808673|FG000|COMPLETED|Overall Study||9
8759456|NCT01214200|9808673|FG000|NOT COMPLETED|Overall Study||11
8759457|NCT01214239|9808681|FG000|STARTED|Overall Study|patients who were randomised and treated with placebo|99
8759458|NCT01214239|9808682|FG001|STARTED|Overall Study|patients who were randomised and treated with placebo. 1 patient was not treated then not included|200
8759459|NCT01214239|9808681|FG000|COMPLETED|Overall Study||87
8759460|NCT01214239|9808682|FG001|COMPLETED|Overall Study||182
8759461|NCT01214239|9808681|FG000|NOT COMPLETED|Overall Study||12
8759462|NCT01214239|9808682|FG001|NOT COMPLETED|Overall Study||18
8915382|NCT02174432|9974780|FG000|NOT COMPLETED|Overall Study||20
8915383|NCT02174510|9974788|FG000|STARTED|Overall Study||8
8915384|NCT02174510|9974789|FG001|STARTED|Overall Study||8
8915385|NCT02174510|9974790|FG002|STARTED|Overall Study||12
9025468|NCT03160885|10087791|FG000|STARTED|Maintenance Treatment Period||0
9025469|NCT03160885|10087792|FG001|STARTED|Maintenance Treatment Period||0
9025470|NCT03160885|10087793|FG002|STARTED|Maintenance Treatment Period||91
9025471|NCT03160885|10087794|FG003|STARTED|Maintenance Treatment Period||90
9025472|NCT03160885|10087795|FG004|STARTED|Maintenance Treatment Period||46
9025473|NCT03160885|10087796|FG005|STARTED|Maintenance Treatment Period||31
9025474|NCT03160885|10087797|FG006|STARTED|Maintenance Treatment Period||0
9025475|NCT03160885|10087791|FG000|COMPLETED|Maintenance Treatment Period||0
9025476|NCT03160885|10087792|FG001|COMPLETED|Maintenance Treatment Period||0
9025477|NCT03160885|10087793|FG002|COMPLETED|Maintenance Treatment Period||52
9025478|NCT03160885|10087794|FG003|COMPLETED|Maintenance Treatment Period||50
9025479|NCT03160885|10087795|FG004|COMPLETED|Maintenance Treatment Period||15
9025480|NCT03160885|10087796|FG005|COMPLETED|Maintenance Treatment Period||16
9025481|NCT03160885|10087797|FG006|COMPLETED|Maintenance Treatment Period||0
9025482|NCT03160885|10087791|FG000|NOT COMPLETED|Maintenance Treatment Period||0
9025483|NCT03160885|10087792|FG001|NOT COMPLETED|Maintenance Treatment Period||0
9025484|NCT03160885|10087793|FG002|NOT COMPLETED|Maintenance Treatment Period||39
8759463|NCT01214252|9808688|FG000|STARTED|Overall Study||425
8759464|NCT01214252|9808688|FG000|COMPLETED|Overall Study||343
8759465|NCT01214252|9808688|FG000|NOT COMPLETED|Overall Study||82
8759466|NCT01214317|9808695|FG000|STARTED|Overall Study||18
8759467|NCT01214317|9808696|FG001|STARTED|Overall Study||22
8759468|NCT01214317|9808695|FG000|COMPLETED|Overall Study||18
8759469|NCT01214317|9808696|FG001|COMPLETED|Overall Study||22
8759470|NCT01214317|9808695|FG000|NOT COMPLETED|Overall Study||0
8915386|NCT02174510|9974791|FG003|STARTED|Overall Study||9
8915387|NCT02174510|9974788|FG000|COMPLETED|Overall Study||8
8915388|NCT02174510|9974789|FG001|COMPLETED|Overall Study||8
8915389|NCT02174510|9974790|FG002|COMPLETED|Overall Study||12
8915390|NCT02174510|9974791|FG003|COMPLETED|Overall Study||9
8915391|NCT02174510|9974788|FG000|NOT COMPLETED|Overall Study||0
8915392|NCT02174510|9974789|FG001|NOT COMPLETED|Overall Study||0
8915393|NCT02174510|9974790|FG002|NOT COMPLETED|Overall Study||0
8915394|NCT02174510|9974791|FG003|NOT COMPLETED|Overall Study||0
8915395|NCT02174523|9974802|FG000|STARTED|Overall Study||10
8915396|NCT02174523|9974803|FG001|STARTED|Overall Study||4
8915397|NCT02174523|9974802|FG000|COMPLETED|Overall Study||9
8915398|NCT02174523|9974803|FG001|COMPLETED|Overall Study||4
8915399|NCT02174523|9974802|FG000|NOT COMPLETED|Overall Study||1
8915400|NCT02174523|9974803|FG001|NOT COMPLETED|Overall Study||0
8759471|NCT01214317|9808696|FG001|NOT COMPLETED|Overall Study||0
8759472|NCT01214330|9808704|FG000|STARTED|Overall Study||150
8759473|NCT01214330|9808704|FG000|COMPLETED|Overall Study||102
8759474|NCT01214330|9808704|FG000|NOT COMPLETED|Overall Study||48
8759475|NCT01214356|9808710|FG000|STARTED|Overall Study||27
8759476|NCT01214356|9808711|FG001|STARTED|Overall Study||27
8759477|NCT01214356|9808710|FG000|COMPLETED|Overall Study||10
8759478|NCT01214356|9808711|FG001|COMPLETED|Overall Study||13
8759479|NCT01214356|9808710|FG000|NOT COMPLETED|Overall Study||17
8759480|NCT01214356|9808711|FG001|NOT COMPLETED|Overall Study||14
8808204|NCT01490125|9860618|FG001|NOT COMPLETED|Period II||4
8808205|NCT01490125|9860619|FG002|NOT COMPLETED|Period II||3
8808206|NCT01490125|9860620|FG003|NOT COMPLETED|Period II||3
8808207|NCT01490125|9860621|FG004|NOT COMPLETED|Period II||4
8808208|NCT01490125|9860622|FG005|NOT COMPLETED|Period II||2
8808209|NCT01490125|9860617|FG000|STARTED|Period III||34
8808210|NCT01490125|9860618|FG001|STARTED|Period III||33
8808211|NCT01490125|9860619|FG002|STARTED|Period III||34
8808212|NCT01490125|9860620|FG003|STARTED|Period III||30
8808213|NCT01490125|9860621|FG004|STARTED|Period III||32
8808214|NCT01490125|9860622|FG005|STARTED|Period III||35
8808215|NCT01490125|9860617|FG000|COMPLETED|Period III||31
8808216|NCT01490125|9860618|FG001|COMPLETED|Period III||32
8808217|NCT01490125|9860619|FG002|COMPLETED|Period III||34
8808218|NCT01490125|9860620|FG003|COMPLETED|Period III||28
8808219|NCT01490125|9860621|FG004|COMPLETED|Period III||31
8808220|NCT01490125|9860622|FG005|COMPLETED|Period III||35
8808221|NCT01490125|9860617|FG000|NOT COMPLETED|Period III||3
8808222|NCT01490125|9860618|FG001|NOT COMPLETED|Period III||1
8808223|NCT01490125|9860619|FG002|NOT COMPLETED|Period III||0
8808224|NCT01490125|9860620|FG003|NOT COMPLETED|Period III||2
8808225|NCT01490125|9860621|FG004|NOT COMPLETED|Period III||1
8808226|NCT01490125|9860622|FG005|NOT COMPLETED|Period III||0
8808227|NCT01490151|9860630|FG000|STARTED|Overall Study||22
8808228|NCT01490151|9860630|FG000|COMPLETED|Overall Study||22
8808229|NCT01490151|9860630|FG000|NOT COMPLETED|Overall Study||0
8808230|NCT01490294|9860640|FG000|STARTED|Overall Study||58
8808231|NCT01490294|9860641|FG001|STARTED|Overall Study||60
8808232|NCT01490294|9860642|FG002|STARTED|Overall Study||59
8808233|NCT01490294|9860643|FG003|STARTED|Overall Study||55
8808234|NCT01490294|9860640|FG000|Participant Received Treatment|Overall Study||54
8808235|NCT01490294|9860641|FG001|Participant Received Treatment|Overall Study||60
8808236|NCT01490294|9860642|FG002|Participant Received Treatment|Overall Study||58
8808237|NCT01490294|9860643|FG003|Participant Received Treatment|Overall Study||54
8808238|NCT01490294|9860640|FG000|COMPLETED|Overall Study||53
8808239|NCT01490294|9860641|FG001|COMPLETED|Overall Study||60
8808240|NCT01490294|9860642|FG002|COMPLETED|Overall Study||58
8808241|NCT01490294|9860643|FG003|COMPLETED|Overall Study||54
8808242|NCT01490294|9860640|FG000|NOT COMPLETED|Overall Study||5
8808243|NCT01490294|9860641|FG001|NOT COMPLETED|Overall Study||0
8808244|NCT01490294|9860642|FG002|NOT COMPLETED|Overall Study||1
8808245|NCT01490294|9860643|FG003|NOT COMPLETED|Overall Study||1
8808246|NCT01490359|9860655|FG000|STARTED|Overall Study||609
8808247|NCT01490359|9860656|FG001|STARTED|Overall Study||572
8808248|NCT01490359|9860655|FG000|Followed-up at 6 mo|Overall Study||558
8808249|NCT01490359|9860656|FG001|Followed-up at 6 mo|Overall Study||535
8808250|NCT01490359|9860655|FG000|Followed-up at 12 mo|Overall Study||569
8808251|NCT01490359|9860656|FG001|Followed-up at 12 mo|Overall Study||537
8808252|NCT01490359|9860655|FG000|COMPLETED|Overall Study||585
8808253|NCT01490359|9860656|FG001|COMPLETED|Overall Study||555
8808254|NCT01490359|9860655|FG000|NOT COMPLETED|Overall Study||24
8808255|NCT01490359|9860656|FG001|NOT COMPLETED|Overall Study||17
9025485|NCT03160885|10087794|FG003|NOT COMPLETED|Maintenance Treatment Period||40
9025486|NCT03160885|10087795|FG004|NOT COMPLETED|Maintenance Treatment Period||31
9025487|NCT03160885|10087796|FG005|NOT COMPLETED|Maintenance Treatment Period||15
9025488|NCT03160885|10087797|FG006|NOT COMPLETED|Maintenance Treatment Period||0
9025489|NCT03160898|10087818|FG000|STARTED|Overall Study||115
9025490|NCT03160898|10087819|FG001|STARTED|Overall Study|1 patient withdrew consent before study drug dosing and was therefore excluded from safety analysis|113
9025491|NCT03160898|10087820|FG002|STARTED|Overall Study||113
9025492|NCT03160898|10087821|FG003|STARTED|Overall Study||117
9025493|NCT03160898|10087818|FG000|COMPLETED|Overall Study||95
9025494|NCT03160898|10087819|FG001|COMPLETED|Overall Study||100
9025495|NCT03160898|10087820|FG002|COMPLETED|Overall Study||97
9025496|NCT03160898|10087821|FG003|COMPLETED|Overall Study||98
9025497|NCT03160898|10087818|FG000|NOT COMPLETED|Overall Study||20
9025498|NCT03160898|10087819|FG001|NOT COMPLETED|Overall Study||13
8808256|NCT01490450|9860667|FG000|STARTED|Period 1||41
8808257|NCT01490450|9860668|FG001|STARTED|Period 1||41
9025499|NCT03160898|10087820|FG002|NOT COMPLETED|Overall Study||16
8808258|NCT01490450|9860669|FG002|STARTED|Period 1||42
8808259|NCT01490450|9860670|FG003|STARTED|Period 1||41
8808260|NCT01490450|9860667|FG000|COMPLETED|Period 1||38
8808261|NCT01490450|9860668|FG001|COMPLETED|Period 1||40
8808262|NCT01490450|9860669|FG002|COMPLETED|Period 1||38
8808263|NCT01490450|9860670|FG003|COMPLETED|Period 1||33
8808264|NCT01490450|9860667|FG000|NOT COMPLETED|Period 1||3
9025500|NCT03160898|10087821|FG003|NOT COMPLETED|Overall Study||19
8808265|NCT01490450|9860668|FG001|NOT COMPLETED|Period 1||1
8808266|NCT01490450|9860669|FG002|NOT COMPLETED|Period 1||4
8808267|NCT01490450|9860670|FG003|NOT COMPLETED|Period 1||8
8808268|NCT01490450|9860667|FG000|STARTED|Period 2||38
8808269|NCT01490450|9860668|FG001|STARTED|Period 2||40
8759481|NCT01214395|9808717|FG000|STARTED|Overall Study||5
8759482|NCT01214395|9808717|FG000|COMPLETED|Overall Study||0
8759483|NCT01214395|9808717|FG000|NOT COMPLETED|Overall Study||5
8759484|NCT01214421|9808726|FG000|STARTED|Overall Study||557
8759485|NCT01214421|9808727|FG001|STARTED|Overall Study||314
8759486|NCT01214421|9808728|FG002|STARTED|Overall Study||181
8759487|NCT01214421|9808729|FG003|STARTED|Overall Study||31
8759488|NCT01214421|9808726|FG000|COMPLETED|Overall Study||507
8759489|NCT01214421|9808727|FG001|COMPLETED|Overall Study||256
8759490|NCT01214421|9808728|FG002|COMPLETED|Overall Study||143
8759491|NCT01214421|9808729|FG003|COMPLETED|Overall Study||22
8759492|NCT01214421|9808726|FG000|NOT COMPLETED|Overall Study||50
8759493|NCT01214421|9808727|FG001|NOT COMPLETED|Overall Study||58
8759494|NCT01214421|9808728|FG002|NOT COMPLETED|Overall Study||38
8759495|NCT01214421|9808729|FG003|NOT COMPLETED|Overall Study||9
8759496|NCT01214434|9808741|FG000|STARTED|Overall Study||15
8759497|NCT01214434|9808742|FG001|STARTED|Overall Study||27
8759498|NCT01214434|9808741|FG000|COMPLETED|Overall Study||11
8759499|NCT01214434|9808742|FG001|COMPLETED|Overall Study||25
8759500|NCT01214434|9808741|FG000|NOT COMPLETED|Overall Study||4
8759501|NCT01214434|9808742|FG001|NOT COMPLETED|Overall Study||2
8759502|NCT01214603|9808751|FG000|STARTED|Overall Study||7
8759503|NCT01214603|9808752|FG001|STARTED|Overall Study||6
8759504|NCT01214603|9808753|FG002|STARTED|Overall Study||7
8759505|NCT01214603|9808751|FG000|Received at Least 1 Dose of LY2090314|Overall Study||7
8759506|NCT01214603|9808752|FG001|Received at Least 1 Dose of LY2090314|Overall Study||6
8759507|NCT01214603|9808753|FG002|Received at Least 1 Dose of LY2090314|Overall Study||7
8759508|NCT01214603|9808751|FG000|COMPLETED|Overall Study||2
8759509|NCT01214603|9808752|FG001|COMPLETED|Overall Study||5
8759510|NCT01214603|9808753|FG002|COMPLETED|Overall Study||3
8759511|NCT01214603|9808751|FG000|NOT COMPLETED|Overall Study||5
8759512|NCT01214603|9808752|FG001|NOT COMPLETED|Overall Study||1
8759513|NCT01214603|9808753|FG002|NOT COMPLETED|Overall Study||4
8759514|NCT01214616|9808766|FG000|STARTED|Overall Study||3
8759515|NCT01214616|9808767|FG001|STARTED|Overall Study||5
8759516|NCT01214616|9808768|FG002|STARTED|Overall Study||3
8759517|NCT01214616|9808769|FG003|STARTED|Overall Study|Cohort 3 with afatinib/vinorelbine modification. Skipping vinorelbine allowed and not considered DLT|6
8759518|NCT01214616|9808766|FG000|COMPLETED|Overall Study||0
8759519|NCT01214616|9808767|FG001|COMPLETED|Overall Study||0
8759520|NCT01214616|9808768|FG002|COMPLETED|Overall Study||0
8759521|NCT01214616|9808769|FG003|COMPLETED|Overall Study||0
8759522|NCT01214616|9808766|FG000|NOT COMPLETED|Overall Study||3
8759523|NCT01214616|9808767|FG001|NOT COMPLETED|Overall Study||5
8759524|NCT01214616|9808768|FG002|NOT COMPLETED|Overall Study||3
8759525|NCT01214616|9808769|FG003|NOT COMPLETED|Overall Study||6
8759526|NCT01214629|9808798|FG000|STARTED|Overall Study||1
8759527|NCT01214629|9808799|FG001|STARTED|Overall Study||1
8759528|NCT01214629|9808800|FG002|STARTED|Overall Study||1
8759529|NCT01214629|9808801|FG003|STARTED|Overall Study||3
8759530|NCT01214629|9808802|FG004|STARTED|Overall Study||3
8759531|NCT01214629|9808803|FG005|STARTED|Overall Study||13
8759532|NCT01214629|9808804|FG006|STARTED|Overall Study||5
8759533|NCT01214629|9808805|FG007|STARTED|Overall Study||3
8759534|NCT01214629|9808806|FG008|STARTED|Overall Study||3
8759535|NCT01214629|9808807|FG009|STARTED|Overall Study||18
8759536|NCT01214629|9808808|FG010|STARTED|Overall Study||3
8759537|NCT01214629|9808798|FG000|Received at Least 1 Dose of Study Drug|Overall Study||1
8759538|NCT01214629|9808799|FG001|Received at Least 1 Dose of Study Drug|Overall Study||1
8759539|NCT01214629|9808800|FG002|Received at Least 1 Dose of Study Drug|Overall Study||1
8759540|NCT01214629|9808801|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
8759541|NCT01214629|9808802|FG004|Received at Least 1 Dose of Study Drug|Overall Study||3
8759542|NCT01214629|9808803|FG005|Received at Least 1 Dose of Study Drug|Overall Study||13
8759543|NCT01214629|9808804|FG006|Received at Least 1 Dose of Study Drug|Overall Study||5
8759544|NCT01214629|9808805|FG007|Received at Least 1 Dose of Study Drug|Overall Study||3
8759545|NCT01214629|9808806|FG008|Received at Least 1 Dose of Study Drug|Overall Study||3
8759546|NCT01214629|9808807|FG009|Received at Least 1 Dose of Study Drug|Overall Study||18
8759547|NCT01214629|9808808|FG010|Received at Least 1 Dose of Study Drug|Overall Study||3
8759548|NCT01214629|9808798|FG000|COMPLETED|Overall Study||0
8759549|NCT01214629|9808799|FG001|COMPLETED|Overall Study||0
8759550|NCT01214629|9808800|FG002|COMPLETED|Overall Study||1
8759551|NCT01214629|9808801|FG003|COMPLETED|Overall Study||1
8759552|NCT01214629|9808802|FG004|COMPLETED|Overall Study||1
8759553|NCT01214629|9808803|FG005|COMPLETED|Overall Study||9
8759554|NCT01214629|9808804|FG006|COMPLETED|Overall Study||4
8759555|NCT01214629|9808805|FG007|COMPLETED|Overall Study||2
8759556|NCT01214629|9808806|FG008|COMPLETED|Overall Study||2
8759557|NCT01214629|9808807|FG009|COMPLETED|Overall Study||11
8759558|NCT01214629|9808808|FG010|COMPLETED|Overall Study||1
8759559|NCT01214629|9808798|FG000|NOT COMPLETED|Overall Study||1
8759560|NCT01214629|9808799|FG001|NOT COMPLETED|Overall Study||1
8759561|NCT01214629|9808800|FG002|NOT COMPLETED|Overall Study||0
8759562|NCT01214629|9808801|FG003|NOT COMPLETED|Overall Study||2
8759563|NCT01214629|9808802|FG004|NOT COMPLETED|Overall Study||2
8759564|NCT01214629|9808803|FG005|NOT COMPLETED|Overall Study||4
8759565|NCT01214629|9808804|FG006|NOT COMPLETED|Overall Study||1
8759566|NCT01214629|9808805|FG007|NOT COMPLETED|Overall Study||1
8759567|NCT01214629|9808806|FG008|NOT COMPLETED|Overall Study||1
8759568|NCT01214629|9808807|FG009|NOT COMPLETED|Overall Study||7
8759569|NCT01214629|9808808|FG010|NOT COMPLETED|Overall Study||2
8759570|NCT01214642|9808858|FG000|STARTED|Overall Study||3
8759571|NCT01214642|9808859|FG001|STARTED|Overall Study||3
8759572|NCT01214642|9808860|FG002|STARTED|Overall Study||6
8759573|NCT01214642|9808861|FG003|STARTED|Overall Study||6
8759574|NCT01214642|9808862|FG004|STARTED|Overall Study||6
8759575|NCT01214642|9808863|FG005|STARTED|Overall Study||3
8759576|NCT01214642|9808864|FG006|STARTED|Overall Study||6
8759577|NCT01214642|9808865|FG007|STARTED|Overall Study||3
8759578|NCT01214642|9808866|FG008|STARTED|Overall Study|All participants who received 12 mg/m2/day on Days 1 and 5 plus PEG in Part A and Part B.|13
8759579|NCT01214642|9808867|FG009|STARTED|Overall Study||4
8759580|NCT01214642|9808868|FG010|STARTED|Overall Study||4
8759581|NCT01214642|9808869|FG011|STARTED|Overall Study||6
8759582|NCT01214642|9808858|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
8759583|NCT01214642|9808859|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
8759584|NCT01214642|9808860|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
8759585|NCT01214642|9808861|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
8759586|NCT01214642|9808862|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6
8759587|NCT01214642|9808863|FG005|Received at Least 1 Dose of Study Drug|Overall Study||3
8759588|NCT01214642|9808864|FG006|Received at Least 1 Dose of Study Drug|Overall Study||6
8759589|NCT01214642|9808865|FG007|Received at Least 1 Dose of Study Drug|Overall Study||3
8759590|NCT01214642|9808866|FG008|Received at Least 1 Dose of Study Drug|Overall Study||13
8759591|NCT01214642|9808867|FG009|Received at Least 1 Dose of Study Drug|Overall Study||4
8759592|NCT01214642|9808868|FG010|Received at Least 1 Dose of Study Drug|Overall Study||4
8759593|NCT01214642|9808869|FG011|Received at Least 1 Dose of Study Drug|Overall Study||6
8759594|NCT01214642|9808858|FG000|Complete at Least 2 Cycles of Study Drug|Overall Study||3
8759595|NCT01214642|9808859|FG001|Complete at Least 2 Cycles of Study Drug|Overall Study||1
8759596|NCT01214642|9808860|FG002|Complete at Least 2 Cycles of Study Drug|Overall Study||5
8759597|NCT01214642|9808861|FG003|Complete at Least 2 Cycles of Study Drug|Overall Study||4
8759598|NCT01214642|9808862|FG004|Complete at Least 2 Cycles of Study Drug|Overall Study||6
8759599|NCT01214642|9808863|FG005|Complete at Least 2 Cycles of Study Drug|Overall Study||1
8759600|NCT01214642|9808864|FG006|Complete at Least 2 Cycles of Study Drug|Overall Study||6
8759601|NCT01214642|9808865|FG007|Complete at Least 2 Cycles of Study Drug|Overall Study||3
8759602|NCT01214642|9808866|FG008|Complete at Least 2 Cycles of Study Drug|Overall Study||12
8759603|NCT01214642|9808867|FG009|Complete at Least 2 Cycles of Study Drug|Overall Study||2
8759604|NCT01214642|9808868|FG010|Complete at Least 2 Cycles of Study Drug|Overall Study||2
8759605|NCT01214642|9808869|FG011|Complete at Least 2 Cycles of Study Drug|Overall Study||5
8759606|NCT01214642|9808858|FG000|COMPLETED|Overall Study||0
8759607|NCT01214642|9808859|FG001|COMPLETED|Overall Study||0
8759608|NCT01214642|9808860|FG002|COMPLETED|Overall Study||0
8759609|NCT01214642|9808861|FG003|COMPLETED|Overall Study||0
8759610|NCT01214642|9808862|FG004|COMPLETED|Overall Study||0
8759611|NCT01214642|9808863|FG005|COMPLETED|Overall Study||0
8759612|NCT01214642|9808864|FG006|COMPLETED|Overall Study||0
8759613|NCT01214642|9808865|FG007|COMPLETED|Overall Study||0
8759614|NCT01214642|9808866|FG008|COMPLETED|Overall Study||0
8759615|NCT01214642|9808867|FG009|COMPLETED|Overall Study||0
8759616|NCT01214642|9808868|FG010|COMPLETED|Overall Study||0
8759617|NCT01214642|9808869|FG011|COMPLETED|Overall Study||0
8759618|NCT01214642|9808858|FG000|NOT COMPLETED|Overall Study||3
8759619|NCT01214642|9808859|FG001|NOT COMPLETED|Overall Study||3
8759620|NCT01214642|9808860|FG002|NOT COMPLETED|Overall Study||6
8759621|NCT01214642|9808861|FG003|NOT COMPLETED|Overall Study||6
8759622|NCT01214642|9808862|FG004|NOT COMPLETED|Overall Study||6
8759623|NCT01214642|9808863|FG005|NOT COMPLETED|Overall Study||3
8759624|NCT01214642|9808864|FG006|NOT COMPLETED|Overall Study||6
8759625|NCT01214642|9808865|FG007|NOT COMPLETED|Overall Study||3
8759626|NCT01214642|9808866|FG008|NOT COMPLETED|Overall Study||13
8759627|NCT01214642|9808867|FG009|NOT COMPLETED|Overall Study||4
8759628|NCT01214642|9808868|FG010|NOT COMPLETED|Overall Study||4
8759629|NCT01214642|9808869|FG011|NOT COMPLETED|Overall Study||6
8759630|NCT01214655|9808915|FG000|STARTED|Part A|Total on Schedule A, dose days 1,2,3|10
8759631|NCT01214655|9808916|FG001|STARTED|Part A||0
8759632|NCT01214655|9808917|FG002|STARTED|Part A||0
8759633|NCT01214655|9808915|FG000|Received 2 mg Study Drug|Part A||3
8759634|NCT01214655|9808916|FG001|Received 2 mg Study Drug|Part A||0
8759635|NCT01214655|9808917|FG002|Received 2 mg Study Drug|Part A||0
8759636|NCT01214655|9808915|FG000|Escalated From 2 to 4 mg/m²/Day|Part A||3
8759637|NCT01214655|9808916|FG001|Escalated From 2 to 4 mg/m²/Day|Part A||0
8759638|NCT01214655|9808917|FG002|Escalated From 2 to 4 mg/m²/Day|Part A||0
8759639|NCT01214655|9808915|FG000|Joined 4 mg Group|Part A||1
8759640|NCT01214655|9808916|FG001|Joined 4 mg Group|Part A||0
8759641|NCT01214655|9808917|FG002|Joined 4 mg Group|Part A||0
8759642|NCT01214655|9808915|FG000|Escalated From 4 mg Study Drug|Part A||0
8759643|NCT01214655|9808916|FG001|Escalated From 4 mg Study Drug|Part A||0
8759644|NCT01214655|9808917|FG002|Escalated From 4 mg Study Drug|Part A||0
8759645|NCT01214655|9808915|FG000|Joined 5 mg Study Drug|Part A||2
8759646|NCT01214655|9808916|FG001|Joined 5 mg Study Drug|Part A||0
8759647|NCT01214655|9808917|FG002|Joined 5 mg Study Drug|Part A||0
8759648|NCT01214655|9808915|FG000|Escalated From 5 mg Study Drug|Part A||1
8759649|NCT01214655|9808916|FG001|Escalated From 5 mg Study Drug|Part A||0
8759650|NCT01214655|9808917|FG002|Escalated From 5 mg Study Drug|Part A||0
8759651|NCT01214655|9808915|FG000|Joined 6 mg Group|Part A||4
8759652|NCT01214655|9808916|FG001|Joined 6 mg Group|Part A||0
8759653|NCT01214655|9808917|FG002|Joined 6 mg Group|Part A||0
8759654|NCT01214655|9808915|FG000|Received 6 mg Study Drug|Part A||5
8759655|NCT01214655|9808916|FG001|Received 6 mg Study Drug|Part A||0
8759656|NCT01214655|9808917|FG002|Received 6 mg Study Drug|Part A||0
8759657|NCT01214655|9808915|FG000|COMPLETED|Part A||2
8759658|NCT01214655|9808916|FG001|COMPLETED|Part A||0
8759659|NCT01214655|9808917|FG002|COMPLETED|Part A||0
8759660|NCT01214655|9808915|FG000|NOT COMPLETED|Part A||8
8759661|NCT01214655|9808916|FG001|NOT COMPLETED|Part A||0
8759662|NCT01214655|9808917|FG002|NOT COMPLETED|Part A||0
8759663|NCT01214655|9808915|FG000|STARTED|Part B|Part A participants did not enroll in Part B. Participants in A, B, C are considered Cohorts.|0
8759664|NCT01214655|9808916|FG001|STARTED|Part B|Total on Schedule B, dose days 1,5,9|15
8759665|NCT01214655|9808917|FG002|STARTED|Part B||0
8759666|NCT01214655|9808915|FG000|Received at Least 1 Dose of Study Drug|Part B||0
8759667|NCT01214655|9808916|FG001|Received at Least 1 Dose of Study Drug|Part B||15
8759668|NCT01214655|9808917|FG002|Received at Least 1 Dose of Study Drug|Part B||0
8759669|NCT01214655|9808915|FG000|Recieved 8 mg/m²/Day Study Drug|Part B||0
8759670|NCT01214655|9808916|FG001|Recieved 8 mg/m²/Day Study Drug|Part B||4
8759671|NCT01214655|9808917|FG002|Recieved 8 mg/m²/Day Study Drug|Part B||0
8759672|NCT01214655|9808915|FG000|Escalated From 8 to 10 mg/m²/Day|Part B||0
8759673|NCT01214655|9808916|FG001|Escalated From 8 to 10 mg/m²/Day|Part B||2
8759674|NCT01214655|9808917|FG002|Escalated From 8 to 10 mg/m²/Day|Part B||0
8759675|NCT01214655|9808915|FG000|Joined 10 mg/m²/Day Study D|Part B||0
8759676|NCT01214655|9808916|FG001|Joined 10 mg/m²/Day Study D|Part B||3
8759677|NCT01214655|9808917|FG002|Joined 10 mg/m²/Day Study D|Part B||0
8759678|NCT01214655|9808915|FG000|Escalated to 12 mg/m²/Day|Part B||0
8759679|NCT01214655|9808916|FG001|Escalated to 12 mg/m²/Day|Part B||2
8759680|NCT01214655|9808917|FG002|Escalated to 12 mg/m²/Day|Part B||0
8759681|NCT01214655|9808915|FG000|Joined 12 mg/m²/Day|Part B||0
8759682|NCT01214655|9808916|FG001|Joined 12 mg/m²/Day|Part B||5
8759683|NCT01214655|9808917|FG002|Joined 12 mg/m²/Day|Part B||0
8759684|NCT01214655|9808915|FG000|Escalated From 12 to 14 mg/m²/Day|Part B||0
8759685|NCT01214655|9808916|FG001|Escalated From 12 to 14 mg/m²/Day|Part B||1
8759686|NCT01214655|9808917|FG002|Escalated From 12 to 14 mg/m²/Day|Part B||0
8759687|NCT01214655|9808915|FG000|Joined 14 mg/m²/Day|Part B||0
8759688|NCT01214655|9808916|FG001|Joined 14 mg/m²/Day|Part B||3
8759689|NCT01214655|9808917|FG002|Joined 14 mg/m²/Day|Part B||0
8759690|NCT01214655|9808915|FG000|COMPLETED|Part B||0
8759691|NCT01214655|9808916|FG001|COMPLETED|Part B||2
8759692|NCT01214655|9808917|FG002|COMPLETED|Part B||0
8759693|NCT01214655|9808915|FG000|NOT COMPLETED|Part B||0
8759694|NCT01214655|9808916|FG001|NOT COMPLETED|Part B||13
8759695|NCT01214655|9808917|FG002|NOT COMPLETED|Part B||0
8759696|NCT01214655|9808915|FG000|STARTED|Part C||0
8759697|NCT01214655|9808916|FG001|STARTED|Part C||0
8759698|NCT01214655|9808917|FG002|STARTED|Part C|Total on Schedule C, dose days 1,2,3|8
8759699|NCT01214655|9808915|FG000|Received at Least 1 Dose of 5 mg/m²/Day|Part C||0
8759700|NCT01214655|9808916|FG001|Received at Least 1 Dose of 5 mg/m²/Day|Part C||0
8759701|NCT01214655|9808917|FG002|Received at Least 1 Dose of 5 mg/m²/Day|Part C||8
8759702|NCT01214655|9808915|FG000|COMPLETED|Part C||0
8759703|NCT01214655|9808916|FG001|COMPLETED|Part C||0
8759704|NCT01214655|9808917|FG002|COMPLETED|Part C||1
8759705|NCT01214655|9808915|FG000|NOT COMPLETED|Part C||0
8759706|NCT01214655|9808916|FG001|NOT COMPLETED|Part C||0
8759707|NCT01214655|9808917|FG002|NOT COMPLETED|Part C||7
8759708|NCT01214668|9808969|FG000|STARTED|Overall Study||4
8759709|NCT01214668|9808970|FG001|STARTED|Overall Study||3
8759710|NCT01214668|9808971|FG002|STARTED|Overall Study||6
8759711|NCT01214668|9808972|FG003|STARTED|Overall Study||6
8759712|NCT01214668|9808973|FG004|STARTED|Overall Study||6
8759713|NCT01214668|9808974|FG005|STARTED|Overall Study||6
8759714|NCT01214668|9808969|FG000|Received at Least One Dose of Study Drug|Overall Study||4
8759715|NCT01214668|9808970|FG001|Received at Least One Dose of Study Drug|Overall Study||3
8759716|NCT01214668|9808971|FG002|Received at Least One Dose of Study Drug|Overall Study||6
8759717|NCT01214668|9808972|FG003|Received at Least One Dose of Study Drug|Overall Study||6
8759718|NCT01214668|9808973|FG004|Received at Least One Dose of Study Drug|Overall Study||6
8759719|NCT01214668|9808974|FG005|Received at Least One Dose of Study Drug|Overall Study||6
8759720|NCT01214668|9808969|FG000|COMPLETED|Overall Study||0
8759721|NCT01214668|9808970|FG001|COMPLETED|Overall Study||0
8759722|NCT01214668|9808971|FG002|COMPLETED|Overall Study||0
8759723|NCT01214668|9808972|FG003|COMPLETED|Overall Study||0
8759724|NCT01214668|9808973|FG004|COMPLETED|Overall Study||0
8759725|NCT01214668|9808974|FG005|COMPLETED|Overall Study||0
8759726|NCT01214668|9808969|FG000|NOT COMPLETED|Overall Study||4
8759727|NCT01214668|9808970|FG001|NOT COMPLETED|Overall Study||3
8759728|NCT01214668|9808971|FG002|NOT COMPLETED|Overall Study||6
8759729|NCT01214668|9808972|FG003|NOT COMPLETED|Overall Study||6
8759730|NCT01214668|9808973|FG004|NOT COMPLETED|Overall Study||6
8759731|NCT01214668|9808974|FG005|NOT COMPLETED|Overall Study||6
8759732|NCT01214720|9808991|FG000|STARTED|Overall Study||306
8759733|NCT01214720|9808992|FG001|STARTED|Overall Study||301
8759734|NCT01214720|9808991|FG000|COMPLETED|Overall Study|Indicates patients who had died at the time of the data cut-off|221
8759735|NCT01214720|9808992|FG001|COMPLETED|Overall Study|Indicates patients who had died at the time of the data cut-off|233
8759736|NCT01214720|9808991|FG000|NOT COMPLETED|Overall Study||85
8759737|NCT01214720|9808992|FG001|NOT COMPLETED|Overall Study||68
8759738|NCT01214759|9808998|FG000|STARTED|Overall Study||103
8759739|NCT01214759|9808998|FG000|28 Days nPEP Completion|Overall Study||85
8759740|NCT01214759|9808998|FG000|COMPLETED|Overall Study||55
8759741|NCT01214759|9808998|FG000|NOT COMPLETED|Overall Study||48
8759742|NCT01214811|9809002|FG000|STARTED|Overall Study||27
8759743|NCT01214811|9809002|FG000|COMPLETED|Overall Study||24
8759744|NCT01214811|9809002|FG000|NOT COMPLETED|Overall Study||3
8759745|NCT01214824|9809006|FG000|STARTED|Overall Study||32
8759746|NCT01214824|9809006|FG000|COMPLETED|Overall Study||29
8759747|NCT01214824|9809006|FG000|NOT COMPLETED|Overall Study||3
8759748|NCT01214837|9809014|FG000|STARTED|Overall Study||249
8759749|NCT01214837|9809015|FG001|STARTED|Overall Study||256
8759750|NCT01214837|9809016|FG002|STARTED|Overall Study||246
8759751|NCT01214837|9809014|FG000|COMPLETED|Overall Study||195
8759752|NCT01214837|9809015|FG001|COMPLETED|Overall Study||192
8759753|NCT01214837|9809016|FG002|COMPLETED|Overall Study||184
8759754|NCT01214837|9809014|FG000|NOT COMPLETED|Overall Study||54
8759755|NCT01214837|9809015|FG001|NOT COMPLETED|Overall Study||64
8759756|NCT01214837|9809016|FG002|NOT COMPLETED|Overall Study||62
8759757|NCT01214850|9809028|FG000|STARTED|Overall Study||979
8759758|NCT01214850|9809029|FG001|STARTED|Overall Study||988
8759759|NCT01214850|9809030|FG002|STARTED|Overall Study||987
8759760|NCT01214850|9809028|FG000|COMPLETED|Overall Study||796
8759761|NCT01214850|9809029|FG001|COMPLETED|Overall Study||844
8759762|NCT01214850|9809030|FG002|COMPLETED|Overall Study||826
8759763|NCT01214850|9809028|FG000|NOT COMPLETED|Overall Study||183
8759764|NCT01214850|9809029|FG001|NOT COMPLETED|Overall Study||144
8759765|NCT01214850|9809030|FG002|NOT COMPLETED|Overall Study||161
8759766|NCT01214915|9809041|FG000|STARTED|Overall Study||53
8759767|NCT01214915|9809041|FG000|COMPLETED|Overall Study||42
8759768|NCT01214915|9809041|FG000|NOT COMPLETED|Overall Study||11
8759769|NCT01214980|9809047|FG000|STARTED|Overall Study||16
8759770|NCT01214980|9809048|FG001|STARTED|Overall Study||16
8759771|NCT01214980|9809047|FG000|COMPLETED|Overall Study||13
8759772|NCT01214980|9809048|FG001|COMPLETED|Overall Study||14
8759773|NCT01214980|9809047|FG000|NOT COMPLETED|Overall Study||3
8759774|NCT01214980|9809048|FG001|NOT COMPLETED|Overall Study||2
8759775|NCT01215032|9809054|FG000|STARTED|Overall Study||21
8759776|NCT01215032|9809054|FG000|COMPLETED|Overall Study||1
8759777|NCT01215032|9809054|FG000|NOT COMPLETED|Overall Study||20
8759778|NCT01215097|9809062|FG000|STARTED|Overall Study|Patients who are randomised and treated with placebo. 1 patient was not treated then not included.|100
8759779|NCT01215097|9809063|FG001|STARTED|Overall Study|Patients who are randomised and treated with linagliptin.|205
8759780|NCT01215097|9809062|FG000|COMPLETED|Overall Study||88
8759781|NCT01215097|9809063|FG001|COMPLETED|Overall Study||191
8759782|NCT01215097|9809062|FG000|NOT COMPLETED|Overall Study||12
8759783|NCT01215097|9809063|FG001|NOT COMPLETED|Overall Study||14
8759784|NCT01215110|9809074|FG000|STARTED|Overall Study||15
8759785|NCT01215110|9809075|FG001|STARTED|Overall Study||15
8759786|NCT01215110|9809076|FG002|STARTED|Overall Study||15
8759787|NCT01215110|9809077|FG003|STARTED|Overall Study||15
8759788|NCT01215110|9809078|FG004|STARTED|Overall Study||8
8759789|NCT01215110|9809074|FG000|COMPLETED|Overall Study||15
8759790|NCT01215110|9809075|FG001|COMPLETED|Overall Study||15
8759791|NCT01215110|9809076|FG002|COMPLETED|Overall Study||13
8759792|NCT01215110|9809077|FG003|COMPLETED|Overall Study||14
8759793|NCT01215110|9809078|FG004|COMPLETED|Overall Study||8
8759794|NCT01215110|9809074|FG000|NOT COMPLETED|Overall Study||0
8759795|NCT01215110|9809075|FG001|NOT COMPLETED|Overall Study||0
8759796|NCT01215110|9809076|FG002|NOT COMPLETED|Overall Study||2
8759797|NCT01215110|9809077|FG003|NOT COMPLETED|Overall Study||1
8759798|NCT01215110|9809078|FG004|NOT COMPLETED|Overall Study||0
8759799|NCT01215123|9809094|FG000|STARTED|Overall Study||28
8759800|NCT01215123|9809094|FG000|COMPLETED|Overall Study||28
8759801|NCT01215123|9809094|FG000|NOT COMPLETED|Overall Study||0
8759802|NCT01215175|9809103|FG000|STARTED|Overall Study||30
8759803|NCT01215175|9809104|FG001|STARTED|Overall Study||30
8759804|NCT01215175|9809105|FG002|STARTED|Overall Study||33
8759805|NCT01215175|9809106|FG003|STARTED|Overall Study||29
8759806|NCT01215175|9809107|FG004|STARTED|Overall Study||28
8759807|NCT01215175|9809103|FG000|Treated|Overall Study||30
8759808|NCT01215175|9809104|FG001|Treated|Overall Study||30
8759809|NCT01215175|9809105|FG002|Treated|Overall Study||33
8759810|NCT01215175|9809106|FG003|Treated|Overall Study||29
8759811|NCT01215175|9809107|FG004|Treated|Overall Study||28
8915401|NCT02174562|9974810|FG000|STARTED|Overall Study||50
8759812|NCT01215175|9809103|FG000|COMPLETED|Overall Study||30
8759813|NCT01215175|9809104|FG001|COMPLETED|Overall Study||29
8759814|NCT01215175|9809105|FG002|COMPLETED|Overall Study||33
8759815|NCT01215175|9809106|FG003|COMPLETED|Overall Study||28
8759816|NCT01215175|9809107|FG004|COMPLETED|Overall Study||28
8759817|NCT01215175|9809103|FG000|NOT COMPLETED|Overall Study||0
8759818|NCT01215175|9809104|FG001|NOT COMPLETED|Overall Study||1
8759819|NCT01215175|9809105|FG002|NOT COMPLETED|Overall Study||0
8759820|NCT01215175|9809106|FG003|NOT COMPLETED|Overall Study||1
8759821|NCT01215175|9809107|FG004|NOT COMPLETED|Overall Study||0
8759822|NCT01215188|9809122|FG000|STARTED|Overall Study||378
8759823|NCT01215188|9809123|FG001|STARTED|Overall Study||386
8759824|NCT01215188|9809124|FG002|STARTED|Overall Study||378
8759825|NCT01215188|9809122|FG000|COMPLETED|Overall Study||320
8759826|NCT01215188|9809123|FG001|COMPLETED|Overall Study||327
8759827|NCT01215188|9809124|FG002|COMPLETED|Overall Study||326
8759828|NCT01215188|9809122|FG000|NOT COMPLETED|Overall Study||58
8759829|NCT01215188|9809123|FG001|NOT COMPLETED|Overall Study||59
8759830|NCT01215188|9809124|FG002|NOT COMPLETED|Overall Study||52
8759831|NCT01215227|9809138|FG000|STARTED|Overall Study||218
8759832|NCT01215227|9809139|FG001|STARTED|Overall Study||215
8759833|NCT01215227|9809140|FG002|STARTED|Overall Study||107
8759834|NCT01215227|9809141|FG003|STARTED|Overall Study||97
8759835|NCT01215227|9809142|FG004|STARTED|Overall Study||93
8759836|NCT01215227|9809143|FG005|STARTED|Overall Study||109
8759837|NCT01215227|9809138|FG000|Treated|Overall Study||218
8759838|NCT01215227|9809139|FG001|Treated|Overall Study||215
8759839|NCT01215227|9809140|FG002|Treated|Overall Study||106
8759840|NCT01215227|9809141|FG003|Treated|Overall Study||96
8759841|NCT01215227|9809142|FG004|Treated|Overall Study||93
8759842|NCT01215227|9809143|FG005|Treated|Overall Study||108
8759843|NCT01215227|9809138|FG000|COMPLETED|Overall Study||97
8759844|NCT01215227|9809139|FG001|COMPLETED|Overall Study||96
8759845|NCT01215227|9809140|FG002|COMPLETED|Overall Study||50
8759846|NCT01215227|9809141|FG003|COMPLETED|Overall Study||48
8759847|NCT01215227|9809142|FG004|COMPLETED|Overall Study||45
8759848|NCT01215227|9809143|FG005|COMPLETED|Overall Study||51
8759849|NCT01215227|9809138|FG000|NOT COMPLETED|Overall Study||121
8759850|NCT01215227|9809139|FG001|NOT COMPLETED|Overall Study||119
8759851|NCT01215227|9809140|FG002|NOT COMPLETED|Overall Study||57
8759852|NCT01215227|9809141|FG003|NOT COMPLETED|Overall Study||49
8759853|NCT01215227|9809142|FG004|NOT COMPLETED|Overall Study||48
8759854|NCT01215227|9809143|FG005|NOT COMPLETED|Overall Study||58
8759855|NCT01215240|9809159|FG000|STARTED|Overall Study||10
8759856|NCT01215240|9809160|FG001|STARTED|Overall Study||12
8759857|NCT01215240|9809159|FG000|COMPLETED|Overall Study||10
8759858|NCT01215240|9809160|FG001|COMPLETED|Overall Study||12
8759859|NCT01215240|9809159|FG000|NOT COMPLETED|Overall Study||0
8759860|NCT01215240|9809160|FG001|NOT COMPLETED|Overall Study||0
8759861|NCT01215253|9809168|FG000|STARTED|Overall Study||510
8759862|NCT01215253|9809169|FG001|STARTED|Overall Study||502
8759863|NCT01215253|9809168|FG000|COMPLETED|Overall Study||424
8759864|NCT01215253|9809169|FG001|COMPLETED|Overall Study||439
8759865|NCT01215253|9809168|FG000|NOT COMPLETED|Overall Study||86
8759866|NCT01215253|9809169|FG001|NOT COMPLETED|Overall Study||63
8759867|NCT01215279|9809178|FG000|STARTED|Overall Study||31
8759868|NCT01215279|9809179|FG001|STARTED|Overall Study||32
8759869|NCT01215279|9809178|FG000|COMPLETED|Overall Study||31
8759870|NCT01215279|9809179|FG001|COMPLETED|Overall Study||32
8759871|NCT01215279|9809178|FG000|NOT COMPLETED|Overall Study||0
8759872|NCT01215279|9809179|FG001|NOT COMPLETED|Overall Study||0
8759873|NCT01215292|9809190|FG000|STARTED|Overall Study||8
8759874|NCT01215292|9809191|FG001|STARTED|Overall Study||8
8759875|NCT01215292|9809192|FG002|STARTED|Overall Study||8
8759876|NCT01215292|9809193|FG003|STARTED|Overall Study||8
8759877|NCT01215292|9809194|FG004|STARTED|Overall Study||8
8759878|NCT01215292|9809190|FG000|COMPLETED|Overall Study||8
8759879|NCT01215292|9809191|FG001|COMPLETED|Overall Study||8
8759880|NCT01215292|9809192|FG002|COMPLETED|Overall Study||8
8759881|NCT01215292|9809193|FG003|COMPLETED|Overall Study||8
8759882|NCT01215292|9809194|FG004|COMPLETED|Overall Study||8
8759883|NCT01215292|9809190|FG000|NOT COMPLETED|Overall Study||0
8759884|NCT01215292|9809191|FG001|NOT COMPLETED|Overall Study||0
8759885|NCT01215292|9809192|FG002|NOT COMPLETED|Overall Study||0
8759886|NCT01215292|9809193|FG003|NOT COMPLETED|Overall Study||0
8759887|NCT01215292|9809194|FG004|NOT COMPLETED|Overall Study||0
8759888|NCT01215318|9809216|FG000|STARTED|Overall Study||20
8759889|NCT01215318|9809217|FG001|STARTED|Overall Study||24
8759890|NCT01215318|9809216|FG000|COMPLETED|Overall Study||20
8759891|NCT01215318|9809217|FG001|COMPLETED|Overall Study||24
8759892|NCT01215318|9809216|FG000|NOT COMPLETED|Overall Study||0
8759893|NCT01215318|9809217|FG001|NOT COMPLETED|Overall Study||0
8759894|NCT01215344|9809227|FG000|STARTED|Overall Study||33
8759895|NCT01215344|9809228|FG001|STARTED|Overall Study||3
8759896|NCT01215344|9809227|FG000|COMPLETED|Overall Study||23
8759897|NCT01215344|9809228|FG001|COMPLETED|Overall Study||3
8759898|NCT01215344|9809227|FG000|NOT COMPLETED|Overall Study||10
8759899|NCT01215344|9809228|FG001|NOT COMPLETED|Overall Study||0
8759900|NCT01215357|9809236|FG000|STARTED|Overall Study||34
8759901|NCT01215357|9809236|FG000|COMPLETED|Overall Study||22
8759902|NCT01215357|9809236|FG000|NOT COMPLETED|Overall Study||12
8759903|NCT01215422|9809244|FG000|STARTED|Overall Study||14
8759904|NCT01215422|9809245|FG001|STARTED|Overall Study||249
8759905|NCT01215422|9809246|FG002|STARTED|Overall Study||196
8759906|NCT01215422|9809247|FG003|STARTED|Overall Study||201
8759907|NCT01215422|9809244|FG000|COMPLETED|Overall Study||6
8759908|NCT01215422|9809245|FG001|COMPLETED|Overall Study||249
8759909|NCT01215422|9809246|FG002|COMPLETED|Overall Study||193
8759910|NCT01215422|9809247|FG003|COMPLETED|Overall Study||193
8759911|NCT01215422|9809244|FG000|NOT COMPLETED|Overall Study||8
8759912|NCT01215422|9809245|FG001|NOT COMPLETED|Overall Study||0
8759913|NCT01215422|9809246|FG002|NOT COMPLETED|Overall Study||3
8759914|NCT01215422|9809247|FG003|NOT COMPLETED|Overall Study||8
8915402|NCT02174562|9974811|FG001|STARTED|Overall Study||51
8759915|NCT01215435|9809271|FG000|STARTED|Overall Study||122
8759916|NCT01215435|9809272|FG001|STARTED|Overall Study||123
8759917|NCT01215435|9809271|FG000|COMPLETED|Overall Study||103
8759918|NCT01215435|9809272|FG001|COMPLETED|Overall Study||107
8759919|NCT01215435|9809271|FG000|NOT COMPLETED|Overall Study||19
8759920|NCT01215435|9809272|FG001|NOT COMPLETED|Overall Study||16
8759921|NCT01215513|9809278|FG000|STARTED|Overall Study|157 participants were allocated to treatment in CS42 main study (Intent-to-treat analysis set)|157
8759922|NCT01215513|9809278|FG000|CS42 and CS42A Safety Analysis Set|Overall Study|156 participants received at least 1 dose of degarelix|156
8759923|NCT01215513|9809278|FG000|CS42 and CS42A Full Analysis Set|Overall Study|155 participants received at least 1 dose of degarelix and had at least 1 efficacy assessment|155
8759924|NCT01215513|9809278|FG000|CS42A Safety Analysis Set|Overall Study|127 participants were enrolled in the extension study CS42A|127
8759925|NCT01215513|9809278|FG000|COMPLETED|Overall Study||112
8759926|NCT01215513|9809278|FG000|NOT COMPLETED|Overall Study||45
8759927|NCT01215643|9809288|FG000|STARTED|Overall Study||83
8759928|NCT01215643|9809289|FG001|STARTED|Overall Study||84
8759929|NCT01215643|9809290|FG002|STARTED|Overall Study||94
8759930|NCT01215643|9809291|FG003|STARTED|Overall Study||39
8759931|NCT01215643|9809292|FG004|STARTED|Overall Study||40
8759932|NCT01215643|9809288|FG000|COMPLETED|Overall Study||74
8759933|NCT01215643|9809289|FG001|COMPLETED|Overall Study||80
8759934|NCT01215643|9809290|FG002|COMPLETED|Overall Study||82
8759935|NCT01215643|9809291|FG003|COMPLETED|Overall Study||35
8759936|NCT01215643|9809292|FG004|COMPLETED|Overall Study||29
8759937|NCT01215643|9809288|FG000|NOT COMPLETED|Overall Study||9
8759938|NCT01215643|9809289|FG001|NOT COMPLETED|Overall Study||4
8759939|NCT01215643|9809290|FG002|NOT COMPLETED|Overall Study||12
8759940|NCT01215643|9809291|FG003|NOT COMPLETED|Overall Study||4
8759941|NCT01215643|9809292|FG004|NOT COMPLETED|Overall Study||11
8759942|NCT01215695|9809311|FG000|STARTED|Overall Study||70
8759943|NCT01215695|9809312|FG001|STARTED|Overall Study||70
8759944|NCT01215695|9809311|FG000|COMPLETED|Overall Study||70
8759945|NCT01215695|9809312|FG001|COMPLETED|Overall Study||70
8759946|NCT01215695|9809311|FG000|NOT COMPLETED|Overall Study||0
8759947|NCT01215695|9809312|FG001|NOT COMPLETED|Overall Study||0
8759948|NCT01215721|9809318|FG000|STARTED|Overall Study||40
8759949|NCT01215721|9809318|FG000|COMPLETED|Overall Study||38
8759950|NCT01215721|9809318|FG000|NOT COMPLETED|Overall Study||2
8759951|NCT01215734|9809324|FG000|STARTED|Overall Study||29
8759952|NCT01215734|9809325|FG001|STARTED|Overall Study||15
8759953|NCT01215734|9809324|FG000|COMPLETED|Overall Study||29
8759954|NCT01215734|9809325|FG001|COMPLETED|Overall Study||14
8759955|NCT01215734|9809324|FG000|NOT COMPLETED|Overall Study||0
8759956|NCT01215734|9809325|FG001|NOT COMPLETED|Overall Study||1
8759957|NCT01215786|9809334|FG000|STARTED|Overall Study||21
8759958|NCT01215786|9809335|FG001|STARTED|Overall Study||19
8759959|NCT01215786|9809336|FG002|STARTED|Overall Study||10
8759960|NCT01215786|9809334|FG000|COMPLETED|Overall Study||21
8759961|NCT01215786|9809335|FG001|COMPLETED|Overall Study||19
8759962|NCT01215786|9809336|FG002|COMPLETED|Overall Study||10
8759963|NCT01215786|9809334|FG000|NOT COMPLETED|Overall Study||0
8759964|NCT01215786|9809335|FG001|NOT COMPLETED|Overall Study||0
8759965|NCT01215786|9809336|FG002|NOT COMPLETED|Overall Study||0
8759966|NCT01215851|9809350|FG000|STARTED|Treatment Period||15
8759967|NCT01215851|9809351|FG001|STARTED|Treatment Period||15
8759968|NCT01215851|9809352|FG002|STARTED|Treatment Period||15
8759969|NCT01215851|9809353|FG003|STARTED|Treatment Period||15
8759970|NCT01215851|9809354|FG004|STARTED|Treatment Period||10
8759971|NCT01215851|9809355|FG005|STARTED|Treatment Period||15
8759972|NCT01215851|9809350|FG000|COMPLETED|Treatment Period||14
8759973|NCT01215851|9809351|FG001|COMPLETED|Treatment Period||14
8759974|NCT01215851|9809352|FG002|COMPLETED|Treatment Period||14
8759975|NCT01215851|9809353|FG003|COMPLETED|Treatment Period||12
8759976|NCT01215851|9809354|FG004|COMPLETED|Treatment Period||10
8759977|NCT01215851|9809355|FG005|COMPLETED|Treatment Period||14
8759978|NCT01215851|9809350|FG000|NOT COMPLETED|Treatment Period||1
8759979|NCT01215851|9809351|FG001|NOT COMPLETED|Treatment Period||1
8759980|NCT01215851|9809352|FG002|NOT COMPLETED|Treatment Period||1
8759981|NCT01215851|9809353|FG003|NOT COMPLETED|Treatment Period||3
8759982|NCT01215851|9809354|FG004|NOT COMPLETED|Treatment Period||0
8759983|NCT01215851|9809355|FG005|NOT COMPLETED|Treatment Period||1
8759984|NCT01215851|9809350|FG000|STARTED|Follow up Period||14
8759985|NCT01215851|9809351|FG001|STARTED|Follow up Period||14
8759986|NCT01215851|9809352|FG002|STARTED|Follow up Period||14
8759987|NCT01215851|9809353|FG003|STARTED|Follow up Period||12
8759988|NCT01215851|9809354|FG004|STARTED|Follow up Period||10
8759989|NCT01215851|9809355|FG005|STARTED|Follow up Period||14
8759990|NCT01215851|9809350|FG000|COMPLETED|Follow up Period||14
8759991|NCT01215851|9809351|FG001|COMPLETED|Follow up Period||14
8759992|NCT01215851|9809352|FG002|COMPLETED|Follow up Period||14
8759993|NCT01215851|9809353|FG003|COMPLETED|Follow up Period||12
8759994|NCT01215851|9809354|FG004|COMPLETED|Follow up Period||10
8759995|NCT01215851|9809355|FG005|COMPLETED|Follow up Period||13
8759996|NCT01215851|9809350|FG000|NOT COMPLETED|Follow up Period||0
8759997|NCT01215851|9809351|FG001|NOT COMPLETED|Follow up Period||0
8759998|NCT01215851|9809352|FG002|NOT COMPLETED|Follow up Period||0
8759999|NCT01215851|9809353|FG003|NOT COMPLETED|Follow up Period||0
8760000|NCT01215851|9809354|FG004|NOT COMPLETED|Follow up Period||0
8760001|NCT01215851|9809355|FG005|NOT COMPLETED|Follow up Period||1
8760002|NCT01215916|9809379|FG000|STARTED|Overall Study||1
8760003|NCT01215916|9809380|FG001|STARTED|Overall Study||5
8760004|NCT01215916|9809381|FG002|STARTED|Overall Study||3
8760005|NCT01215916|9809382|FG003|STARTED|Overall Study||6
8760006|NCT01215916|9809383|FG004|STARTED|Overall Study||6
8760007|NCT01215916|9809384|FG005|STARTED|Overall Study||4
8760008|NCT01215916|9809385|FG006|STARTED|Overall Study||9
8760009|NCT01215916|9809386|FG007|STARTED|Overall Study||3
8760010|NCT01215916|9809387|FG008|STARTED|Overall Study||2
8760011|NCT01215916|9809379|FG000|Received at Least 1 Dose of Either Drug|Overall Study||1
8760012|NCT01215916|9809380|FG001|Received at Least 1 Dose of Either Drug|Overall Study||5
8760013|NCT01215916|9809381|FG002|Received at Least 1 Dose of Either Drug|Overall Study||3
8760014|NCT01215916|9809382|FG003|Received at Least 1 Dose of Either Drug|Overall Study||6
8760015|NCT01215916|9809383|FG004|Received at Least 1 Dose of Either Drug|Overall Study||6
8760016|NCT01215916|9809384|FG005|Received at Least 1 Dose of Either Drug|Overall Study||4
8760017|NCT01215916|9809385|FG006|Received at Least 1 Dose of Either Drug|Overall Study||9
8760018|NCT01215916|9809386|FG007|Received at Least 1 Dose of Either Drug|Overall Study||3
8760019|NCT01215916|9809387|FG008|Received at Least 1 Dose of Either Drug|Overall Study||2
8760020|NCT01215916|9809379|FG000|COMPLETED|Overall Study||0
8760021|NCT01215916|9809380|FG001|COMPLETED|Overall Study||0
8760022|NCT01215916|9809381|FG002|COMPLETED|Overall Study||0
8760023|NCT01215916|9809382|FG003|COMPLETED|Overall Study||0
8760024|NCT01215916|9809383|FG004|COMPLETED|Overall Study||0
8760025|NCT01215916|9809384|FG005|COMPLETED|Overall Study||0
8760026|NCT01215916|9809385|FG006|COMPLETED|Overall Study||0
8760027|NCT01215916|9809386|FG007|COMPLETED|Overall Study||0
8760028|NCT01215916|9809387|FG008|COMPLETED|Overall Study||0
8760029|NCT01215916|9809379|FG000|NOT COMPLETED|Overall Study||1
8760030|NCT01215916|9809380|FG001|NOT COMPLETED|Overall Study||5
8760031|NCT01215916|9809381|FG002|NOT COMPLETED|Overall Study||3
8760032|NCT01215916|9809382|FG003|NOT COMPLETED|Overall Study||6
8760033|NCT01215916|9809383|FG004|NOT COMPLETED|Overall Study||6
9025501|NCT03161158|10087834|FG000|STARTED|Overall Study||18
9025502|NCT03161158|10087835|FG001|STARTED|Overall Study||19
9025503|NCT03161158|10087834|FG000|COMPLETED|Overall Study||9
9025504|NCT03161158|10087835|FG001|COMPLETED|Overall Study||13
9025505|NCT03161158|10087834|FG000|NOT COMPLETED|Overall Study||9
9025506|NCT03161158|10087835|FG001|NOT COMPLETED|Overall Study||6
9025507|NCT03161327|10087841|FG000|STARTED|Overall Study||238
9025508|NCT03161327|10087841|FG000|COMPLETED|Overall Study||238
9025509|NCT03161327|10087841|FG000|NOT COMPLETED|Overall Study||0
9025510|NCT03161405|10087846|FG000|STARTED|First Intervention Period (3 Days)||12
9025511|NCT03161405|10087846|FG000|COMPLETED|First Intervention Period (3 Days)||12
9025512|NCT03161405|10087846|FG000|NOT COMPLETED|First Intervention Period (3 Days)||0
9025513|NCT03161405|10087846|FG000|STARTED|Washout Period (at Least 4 Days)||12
9025514|NCT03161405|10087846|FG000|COMPLETED|Washout Period (at Least 4 Days)||12
9025515|NCT03161405|10087846|FG000|NOT COMPLETED|Washout Period (at Least 4 Days)||0
9025516|NCT03161405|10087846|FG000|STARTED|Second Intervention Period (6 Days)||12
9025517|NCT03161405|10087846|FG000|COMPLETED|Second Intervention Period (6 Days)||11
9025518|NCT03161405|10087846|FG000|NOT COMPLETED|Second Intervention Period (6 Days)||1
9025519|NCT03161483|10087857|FG000|STARTED|Overall Study||83
9025520|NCT03161483|10087858|FG001|STARTED|Overall Study||42
9025521|NCT03161483|10087859|FG002|STARTED|Overall Study||82
9025522|NCT03161483|10087860|FG003|STARTED|Overall Study||81
9025523|NCT03161483|10087857|FG000|COMPLETED|Overall Study||73
9025524|NCT03161483|10087858|FG001|COMPLETED|Overall Study||39
9025525|NCT03161483|10087859|FG002|COMPLETED|Overall Study||62
9025526|NCT03161483|10087860|FG003|COMPLETED|Overall Study||73
9025527|NCT03161483|10087857|FG000|NOT COMPLETED|Overall Study||10
9025528|NCT03161483|10087858|FG001|NOT COMPLETED|Overall Study||3
9025529|NCT03161483|10087859|FG002|NOT COMPLETED|Overall Study||20
9025530|NCT03161483|10087860|FG003|NOT COMPLETED|Overall Study||8
9025531|NCT03161938|10087872|FG000|STARTED|Overall Study||32
9025532|NCT03161938|10087873|FG001|STARTED|Overall Study||32
9025533|NCT03161938|10087872|FG000|COMPLETED|Overall Study||32
9025534|NCT03161938|10087873|FG001|COMPLETED|Overall Study||32
9025535|NCT03161938|10087872|FG000|NOT COMPLETED|Overall Study||0
9025536|NCT03161938|10087873|FG001|NOT COMPLETED|Overall Study||0
9025537|NCT03162055|10087881|FG000|STARTED|Overall Study||559
9025538|NCT03162055|10087882|FG001|STARTED|Overall Study||560
9025539|NCT03162055|10087881|FG000|Received Treatment|Overall Study||557
9025540|NCT03162055|10087882|FG001|Received Treatment|Overall Study||560
9025541|NCT03162055|10087881|FG000|Safety Analysis Set|Overall Study||552
9025542|NCT03162055|10087882|FG001|Safety Analysis Set|Overall Study||552
9025543|NCT03162055|10087881|FG000|Full Analysis Set (FAS)|Overall Study||552
9025544|NCT03162055|10087882|FG001|Full Analysis Set (FAS)|Overall Study||552
8760034|NCT01215916|9809384|FG005|NOT COMPLETED|Overall Study||4
8760035|NCT01215916|9809385|FG006|NOT COMPLETED|Overall Study||9
9025545|NCT03162055|10087881|FG000|Per Protocol (PP) Analysis Set|Overall Study||506
8760036|NCT01215916|9809386|FG007|NOT COMPLETED|Overall Study||3
8760037|NCT01215916|9809387|FG008|NOT COMPLETED|Overall Study||2
8760038|NCT01215929|9809413|FG000|STARTED|Overall Study||18
8760039|NCT01215929|9809414|FG001|STARTED|Overall Study||17
8760040|NCT01215929|9809413|FG000|COMPLETED|Overall Study||12
9025546|NCT03162055|10087882|FG001|Per Protocol (PP) Analysis Set|Overall Study||510
8760041|NCT01215929|9809414|FG001|COMPLETED|Overall Study||12
8760042|NCT01215929|9809413|FG000|NOT COMPLETED|Overall Study||6
8760043|NCT01215929|9809414|FG001|NOT COMPLETED|Overall Study||5
8760044|NCT01215942|9809422|FG000|STARTED|Treatment Period|Participants who discontinued treatment were followed in post-treatment follow-up.|414
8760045|NCT01215942|9809423|FG001|STARTED|Treatment Period|Participants who discontinued treatment were followed in post-treatment follow-up.|672
8760046|NCT01215942|9809422|FG000|COMPLETED|Treatment Period||0
8760047|NCT01215942|9809423|FG001|COMPLETED|Treatment Period||0
8760048|NCT01215942|9809422|FG000|NOT COMPLETED|Treatment Period||414
8760049|NCT01215942|9809423|FG001|NOT COMPLETED|Treatment Period||672
8760050|NCT01215942|9809422|FG000|STARTED|Post-Treatment Follow-Up Period|Not all participants who discontinued treatment entered post-treatment follow-up period.|368
8760051|NCT01215942|9809423|FG001|STARTED|Post-Treatment Follow-Up Period|Not all participants who discontinued treatment entered post-treatment follow-up period.|591
8760052|NCT01215942|9809422|FG000|COMPLETED|Post-Treatment Follow-Up Period||283
8760053|NCT01215942|9809423|FG001|COMPLETED|Post-Treatment Follow-Up Period||445
8760054|NCT01215942|9809422|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||85
8760055|NCT01215942|9809423|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||146
8760056|NCT01215955|9809444|FG000|STARTED|Overall Study||268
8760057|NCT01215955|9809445|FG001|STARTED|Overall Study||263
8760058|NCT01215955|9809446|FG002|STARTED|Overall Study|Three (3) participants from 1 site were excluded due to quality issues and validity of data.|292
8760059|NCT01215955|9809447|FG003|STARTED|Overall Study|Two (2) participants from 1 site were excluded due to quality issues and validity of the data.|294
8760060|NCT01215955|9809444|FG000|Received at Least 1 Dose of Study Drug|Overall Study||267
8760061|NCT01215955|9809445|FG001|Received at Least 1 Dose of Study Drug|Overall Study||261
8760062|NCT01215955|9809446|FG002|Received at Least 1 Dose of Study Drug|Overall Study||288
8760063|NCT01215955|9809447|FG003|Received at Least 1 Dose of Study Drug|Overall Study||290
8760064|NCT01215955|9809444|FG000|COMPLETED|Overall Study||223
8760065|NCT01215955|9809445|FG001|COMPLETED|Overall Study||210
8760066|NCT01215955|9809446|FG002|COMPLETED|Overall Study||244
8760067|NCT01215955|9809447|FG003|COMPLETED|Overall Study||241
8760068|NCT01215955|9809444|FG000|NOT COMPLETED|Overall Study||45
8760069|NCT01215955|9809445|FG001|NOT COMPLETED|Overall Study||53
8760070|NCT01215955|9809446|FG002|NOT COMPLETED|Overall Study||48
8760071|NCT01215955|9809447|FG003|NOT COMPLETED|Overall Study||53
8760072|NCT01215968|9809462|FG000|STARTED|Overall Study||13
8760073|NCT01215968|9809463|FG001|STARTED|Overall Study||25
8760074|NCT01215968|9809462|FG000|Received at Least 1 Dose of Study Drug|Overall Study||13
8760075|NCT01215968|9809463|FG001|Received at Least 1 Dose of Study Drug|Overall Study|25 participants received placebo during Week 1.|24
8760076|NCT01215968|9809462|FG000|COMPLETED|Overall Study||11
8760077|NCT01215968|9809463|FG001|COMPLETED|Overall Study||18
8760078|NCT01215968|9809462|FG000|NOT COMPLETED|Overall Study||2
8760079|NCT01215968|9809463|FG001|NOT COMPLETED|Overall Study||7
8760080|NCT01215981|9809474|FG000|STARTED|Overall Study||35
8760081|NCT01215981|9809475|FG001|STARTED|Overall Study||33
8760082|NCT01215981|9809474|FG000|COMPLETED|Overall Study||33
8760083|NCT01215981|9809475|FG001|COMPLETED|Overall Study||32
8760084|NCT01215981|9809474|FG000|NOT COMPLETED|Overall Study||2
8760085|NCT01215981|9809475|FG001|NOT COMPLETED|Overall Study||1
8760086|NCT01216072|9809483|FG000|STARTED|Open-Label Core Period ( 6 Months)||790
8760087|NCT01216072|9809484|FG001|STARTED|Open-Label Core Period ( 6 Months)||263
8760088|NCT01216072|9809483|FG000|Full Analysis Set|Open-Label Core Period ( 6 Months)|One patient was randomized in error and was not included in FAS.|789
8760089|NCT01216072|9809484|FG001|Full Analysis Set|Open-Label Core Period ( 6 Months)||263
8760090|NCT01216072|9809483|FG000|Safety Set|Open-Label Core Period ( 6 Months)||783
8760091|NCT01216072|9809484|FG001|Safety Set|Open-Label Core Period ( 6 Months)||245
8760092|NCT01216072|9809483|FG000|COMPLETED|Open-Label Core Period ( 6 Months)||714
8760093|NCT01216072|9809484|FG001|COMPLETED|Open-Label Core Period ( 6 Months)||229
8760094|NCT01216072|9809483|FG000|NOT COMPLETED|Open-Label Core Period ( 6 Months)||76
8760095|NCT01216072|9809484|FG001|NOT COMPLETED|Open-Label Core Period ( 6 Months)||34
8760096|NCT01216072|9809483|FG000|STARTED|Open-Label Extension Period (3 Months)||0
8760097|NCT01216072|9809484|FG001|STARTED|Open-Label Extension Period (3 Months)|Only DMT patients, who completed the core study, were eligible for fingolimod.|195
8760098|NCT01216072|9809483|FG000|Safety Set|Open-Label Extension Period (3 Months)||0
8760099|NCT01216072|9809484|FG001|Safety Set|Open-Label Extension Period (3 Months)||193
8760100|NCT01216072|9809483|FG000|COMPLETED|Open-Label Extension Period (3 Months)||0
8760101|NCT01216072|9809484|FG001|COMPLETED|Open-Label Extension Period (3 Months)||181
8760102|NCT01216072|9809483|FG000|NOT COMPLETED|Open-Label Extension Period (3 Months)||0
8760103|NCT01216072|9809484|FG001|NOT COMPLETED|Open-Label Extension Period (3 Months)||14
8760104|NCT01216163|9809496|FG000|STARTED|Overall Study||45
8760105|NCT01216163|9809497|FG001|STARTED|Overall Study||88
8760106|NCT01216163|9809498|FG002|STARTED|Overall Study||85
8760107|NCT01216163|9809496|FG000|COMPLETED|Overall Study||44
8760108|NCT01216163|9809497|FG001|COMPLETED|Overall Study||87
8760109|NCT01216163|9809498|FG002|COMPLETED|Overall Study||85
8760110|NCT01216163|9809496|FG000|NOT COMPLETED|Overall Study||1
8760111|NCT01216163|9809497|FG001|NOT COMPLETED|Overall Study||1
8760112|NCT01216163|9809498|FG002|NOT COMPLETED|Overall Study||0
8760113|NCT01216176|9809509|FG000|STARTED|Overall Study||12
8760114|NCT01216176|9809510|FG001|STARTED|Overall Study||39
8760115|NCT01216176|9809511|FG002|STARTED|Overall Study||20
8760116|NCT01216176|9809509|FG000|COMPLETED|Overall Study||12
8760117|NCT01216176|9809510|FG001|COMPLETED|Overall Study||31
8760118|NCT01216176|9809511|FG002|COMPLETED|Overall Study||19
8760119|NCT01216176|9809509|FG000|NOT COMPLETED|Overall Study||0
8760120|NCT01216176|9809510|FG001|NOT COMPLETED|Overall Study||8
8760121|NCT01216176|9809511|FG002|NOT COMPLETED|Overall Study||1
8760122|NCT01216189|9809522|FG000|STARTED|Overall Study||110
8760123|NCT01216189|9809523|FG001|STARTED|Overall Study||32
8760124|NCT01216189|9809522|FG000|COMPLETED|Overall Study||85
8760125|NCT01216189|9809523|FG001|COMPLETED|Overall Study||27
8760126|NCT01216189|9809522|FG000|NOT COMPLETED|Overall Study||25
8760127|NCT01216189|9809523|FG001|NOT COMPLETED|Overall Study||5
8760128|NCT01216202|9809531|FG000|STARTED|Overall Study||101
8760129|NCT01216202|9809532|FG001|STARTED|Overall Study||77
8760130|NCT01216202|9809531|FG000|Analysed at Baseline|Overall Study||93
8760131|NCT01216202|9809532|FG001|Analysed at Baseline|Overall Study||75
8760132|NCT01216202|9809531|FG000|Analysed After RT|Overall Study||79
8760133|NCT01216202|9809532|FG001|Analysed After RT|Overall Study||0
8760134|NCT01216202|9809531|FG000|COMPLETED|Overall Study||79
8760135|NCT01216202|9809532|FG001|COMPLETED|Overall Study||75
8760136|NCT01216202|9809531|FG000|NOT COMPLETED|Overall Study||22
8760137|NCT01216202|9809532|FG001|NOT COMPLETED|Overall Study||2
8760138|NCT01216241|9809542|FG000|STARTED|Overall Study|18 subjects randomized. All didn't receive study drug/placebo if they didn't have neutropenic fever|18
8760139|NCT01216241|9809543|FG001|STARTED|Overall Study|18 subjects randomized. All didn't receive study drug/placebo if they didn't have neutropenic fever|18
8760140|NCT01216241|9809542|FG000|COMPLETED|Overall Study|Reporter remains blinded so the 4 completed could have been either study drug or placebo.|18
8760141|NCT01216241|9809543|FG001|COMPLETED|Overall Study|Reporter remains blinded so the 4 completed could have been either study drug or placebo.|18
8760142|NCT01216241|9809542|FG000|NOT COMPLETED|Overall Study||0
8760143|NCT01216241|9809543|FG001|NOT COMPLETED|Overall Study||0
8760144|NCT01216319|9809549|FG000|STARTED|Overall Study||50
8760145|NCT01216319|9809549|FG000|COMPLETED|Overall Study||46
8760146|NCT01216319|9809549|FG000|NOT COMPLETED|Overall Study||4
8760147|NCT01216332|9809555|FG000|STARTED|Overall Study||34
8760148|NCT01216332|9809556|FG001|STARTED|Overall Study||16
8760149|NCT01216332|9809555|FG000|COMPLETED|Overall Study||30
8760150|NCT01216332|9809556|FG001|COMPLETED|Overall Study||16
8760151|NCT01216332|9809555|FG000|NOT COMPLETED|Overall Study||4
8760152|NCT01216332|9809556|FG001|NOT COMPLETED|Overall Study||0
8760153|NCT01216397|9809562|FG000|STARTED|Period 1||20
8760154|NCT01216397|9809563|FG001|STARTED|Period 1||20
8760155|NCT01216397|9809562|FG000|COMPLETED|Period 1||20
8760156|NCT01216397|9809563|FG001|COMPLETED|Period 1||20
8760157|NCT01216397|9809562|FG000|NOT COMPLETED|Period 1||0
8760158|NCT01216397|9809563|FG001|NOT COMPLETED|Period 1||0
8760159|NCT01216397|9809562|FG000|STARTED|Washout (35 Days)||20
8760160|NCT01216397|9809563|FG001|STARTED|Washout (35 Days)||20
8760161|NCT01216397|9809562|FG000|COMPLETED|Washout (35 Days)||20
8760162|NCT01216397|9809563|FG001|COMPLETED|Washout (35 Days)||20
8760163|NCT01216397|9809562|FG000|NOT COMPLETED|Washout (35 Days)||0
8760164|NCT01216397|9809563|FG001|NOT COMPLETED|Washout (35 Days)||0
8760165|NCT01216397|9809562|FG000|STARTED|Period 2||20
8760166|NCT01216397|9809563|FG001|STARTED|Period 2||20
8760167|NCT01216397|9809562|FG000|COMPLETED|Period 2||20
8760168|NCT01216397|9809563|FG001|COMPLETED|Period 2||20
8760169|NCT01216397|9809562|FG000|NOT COMPLETED|Period 2||0
8760170|NCT01216397|9809563|FG001|NOT COMPLETED|Period 2||0
8760171|NCT01216410|9809572|FG000|STARTED|Overall Study||103
8760172|NCT01216410|9809573|FG001|STARTED|Overall Study||100
8760173|NCT01216410|9809574|FG002|STARTED|Overall Study||103
8760174|NCT01216410|9809572|FG000|COMPLETED|Overall Study||101
8760175|NCT01216410|9809573|FG001|COMPLETED|Overall Study||99
8760176|NCT01216410|9809574|FG002|COMPLETED|Overall Study||100
8760177|NCT01216410|9809572|FG000|NOT COMPLETED|Overall Study||2
8760178|NCT01216410|9809573|FG001|NOT COMPLETED|Overall Study||1
8760179|NCT01216410|9809574|FG002|NOT COMPLETED|Overall Study||3
8760180|NCT01216735|9809584|FG000|STARTED|First Intervention (3 Weeks)||8
8760181|NCT01216735|9809585|FG001|STARTED|First Intervention (3 Weeks)||7
8760182|NCT01216735|9809584|FG000|COMPLETED|First Intervention (3 Weeks)||8
8760183|NCT01216735|9809585|FG001|COMPLETED|First Intervention (3 Weeks)||7
8760184|NCT01216735|9809584|FG000|NOT COMPLETED|First Intervention (3 Weeks)||0
8760185|NCT01216735|9809585|FG001|NOT COMPLETED|First Intervention (3 Weeks)||0
8760186|NCT01216735|9809584|FG000|STARTED|Washout (3 Weeks)||8
8760187|NCT01216735|9809585|FG001|STARTED|Washout (3 Weeks)||7
8760188|NCT01216735|9809584|FG000|COMPLETED|Washout (3 Weeks)||8
8760189|NCT01216735|9809585|FG001|COMPLETED|Washout (3 Weeks)||7
8760190|NCT01216735|9809584|FG000|NOT COMPLETED|Washout (3 Weeks)||0
8760191|NCT01216735|9809585|FG001|NOT COMPLETED|Washout (3 Weeks)||0
8760192|NCT01216735|9809584|FG000|STARTED|Second Intervention (3 Weeks)||8
8760193|NCT01216735|9809585|FG001|STARTED|Second Intervention (3 Weeks)||7
8760194|NCT01216735|9809584|FG000|COMPLETED|Second Intervention (3 Weeks)||8
8760195|NCT01216735|9809585|FG001|COMPLETED|Second Intervention (3 Weeks)||7
8760196|NCT01216735|9809584|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0
8760197|NCT01216735|9809585|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
8760198|NCT01216748|9809591|FG000|STARTED|Overall Study||10
8760199|NCT01216748|9809591|FG000|Quiet Breathing|Overall Study||10
8760200|NCT01216748|9809591|FG000|Hypocapnic Hyperventilation|Overall Study||10
8760201|NCT01216748|9809591|FG000|Hypercapnic Hyperventilation|Overall Study||10
8760202|NCT01216748|9809591|FG000|Eucapnic Hyperventilation|Overall Study||10
8760203|NCT01216748|9809591|FG000|COMPLETED|Overall Study||10
8760204|NCT01216748|9809591|FG000|NOT COMPLETED|Overall Study||0
8760205|NCT01216761|9809595|FG000|STARTED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1421
8760206|NCT01216761|9809596|FG001|STARTED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1410
8760207|NCT01216761|9809597|FG002|STARTED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1379
8760208|NCT01216761|9809595|FG000|COMPLETED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1421
8760209|NCT01216761|9809596|FG001|COMPLETED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1410
8760210|NCT01216761|9809597|FG002|COMPLETED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1379
8760211|NCT01216761|9809595|FG000|NOT COMPLETED|Overall Study||0
8760212|NCT01216761|9809596|FG001|NOT COMPLETED|Overall Study||0
8760213|NCT01216761|9809597|FG002|NOT COMPLETED|Overall Study||0
8760214|NCT01216943|9809605|FG000|STARTED|Overall Study||126
8760215|NCT01216943|9809605|FG000|COMPLETED|Overall Study||113
9025547|NCT03162055|10087881|FG000|COMPLETED|Overall Study||497
9025548|NCT03162055|10087882|FG001|COMPLETED|Overall Study||517
9025549|NCT03162055|10087881|FG000|NOT COMPLETED|Overall Study||62
9025550|NCT03162055|10087882|FG001|NOT COMPLETED|Overall Study||43
9025551|NCT03162328|10087888|FG000|STARTED|Screening Period||84
9025552|NCT03162328|10087889|FG001|STARTED|Screening Period||0
9025553|NCT03162328|10087890|FG002|STARTED|Screening Period||0
9025554|NCT03162328|10087888|FG000|COMPLETED|Screening Period||62
9025555|NCT03162328|10087889|FG001|COMPLETED|Screening Period||0
9025556|NCT03162328|10087890|FG002|COMPLETED|Screening Period||0
9025557|NCT03162328|10087888|FG000|NOT COMPLETED|Screening Period||22
9025558|NCT03162328|10087889|FG001|NOT COMPLETED|Screening Period||0
9025559|NCT03162328|10087890|FG002|NOT COMPLETED|Screening Period||0
9025560|NCT03162328|10087888|FG000|STARTED|Study Period||0
9025561|NCT03162328|10087889|FG001|STARTED|Study Period||30
9025562|NCT03162328|10087890|FG002|STARTED|Study Period||32
9025563|NCT03162328|10087888|FG000|COMPLETED|Study Period||0
9025564|NCT03162328|10087889|FG001|COMPLETED|Study Period||30
9025565|NCT03162328|10087890|FG002|COMPLETED|Study Period||31
9025566|NCT03162328|10087888|FG000|NOT COMPLETED|Study Period||0
9025567|NCT03162328|10087889|FG001|NOT COMPLETED|Study Period||0
9025568|NCT03162328|10087890|FG002|NOT COMPLETED|Study Period||1
9025569|NCT03162354|10087903|FG000|STARTED|Overall Study||183
9025570|NCT03162354|10087904|FG001|STARTED|Overall Study||237
9025571|NCT03162354|10087903|FG000|COMPLETED|Overall Study||183
9025572|NCT03162354|10087904|FG001|COMPLETED|Overall Study||237
9025573|NCT03162354|10087903|FG000|NOT COMPLETED|Overall Study||0
9025574|NCT03162354|10087904|FG001|NOT COMPLETED|Overall Study||0
9025575|NCT03162458|10087917|FG000|STARTED|Overall Study||71
9025576|NCT03162458|10087918|FG001|STARTED|Overall Study||71
9025577|NCT03162458|10087917|FG000|COMPLETED|Overall Study||71
9025578|NCT03162458|10087918|FG001|COMPLETED|Overall Study||71
9025579|NCT03162458|10087917|FG000|NOT COMPLETED|Overall Study||0
9025580|NCT03162458|10087918|FG001|NOT COMPLETED|Overall Study||0
9025581|NCT03162614|10087930|FG000|STARTED|Overall Study||26
9025582|NCT03162614|10087931|FG001|STARTED|Overall Study||26
9025583|NCT03162614|10087932|FG002|STARTED|Overall Study||26
9025584|NCT03162614|10087933|FG003|STARTED|Overall Study||26
9025585|NCT03162614|10087934|FG004|STARTED|Overall Study||26
9025586|NCT03162614|10087935|FG005|STARTED|Overall Study||24
9025587|NCT03162614|10087930|FG000|COMPLETED|Overall Study||20
9025588|NCT03162614|10087931|FG001|COMPLETED|Overall Study||21
9025589|NCT03162614|10087932|FG002|COMPLETED|Overall Study||22
9025590|NCT03162614|10087933|FG003|COMPLETED|Overall Study||19
9025591|NCT03162614|10087934|FG004|COMPLETED|Overall Study||21
9025592|NCT03162614|10087935|FG005|COMPLETED|Overall Study||24
9025593|NCT03162614|10087930|FG000|NOT COMPLETED|Overall Study||6
9025594|NCT03162614|10087931|FG001|NOT COMPLETED|Overall Study||5
9025595|NCT03162614|10087932|FG002|NOT COMPLETED|Overall Study||4
9025596|NCT03162614|10087933|FG003|NOT COMPLETED|Overall Study||7
9025597|NCT03162614|10087934|FG004|NOT COMPLETED|Overall Study||5
9025598|NCT03162614|10087935|FG005|NOT COMPLETED|Overall Study||0
9025599|NCT03162796|10087952|FG000|STARTED|Placebo Controlled Period: Week 0 - 24||126
9025600|NCT03162796|10087953|FG001|STARTED|Placebo Controlled Period: Week 0 - 24||127
9025601|NCT03162796|10087954|FG002|STARTED|Placebo Controlled Period: Week 0 - 24||128
9025602|NCT03162796|10087952|FG000|COMPLETED|Placebo Controlled Period: Week 0 - 24||114
9025603|NCT03162796|10087953|FG001|COMPLETED|Placebo Controlled Period: Week 0 - 24||123
9025604|NCT03162796|10087954|FG002|COMPLETED|Placebo Controlled Period: Week 0 - 24||125
9025605|NCT03162796|10087952|FG000|NOT COMPLETED|Placebo Controlled Period: Week 0 - 24||12
9025606|NCT03162796|10087953|FG001|NOT COMPLETED|Placebo Controlled Period: Week 0 - 24||4
9025607|NCT03162796|10087954|FG002|NOT COMPLETED|Placebo Controlled Period: Week 0 - 24||3
9025608|NCT03162796|10087952|FG000|STARTED|Active Treatment Period: Week 24 - 52||114
9025609|NCT03162796|10087953|FG001|STARTED|Active Treatment Period: Week 24 - 52||123
9025610|NCT03162796|10087954|FG002|STARTED|Active Treatment Period: Week 24 - 52||125
9025611|NCT03162796|10087952|FG000|COMPLETED|Active Treatment Period: Week 24 - 52||107
9025612|NCT03162796|10087953|FG001|COMPLETED|Active Treatment Period: Week 24 - 52||116
9025613|NCT03162796|10087954|FG002|COMPLETED|Active Treatment Period: Week 24 - 52||124
9025614|NCT03162796|10087952|FG000|NOT COMPLETED|Active Treatment Period: Week 24 - 52||7
9025615|NCT03162796|10087953|FG001|NOT COMPLETED|Active Treatment Period: Week 24 - 52||7
8760216|NCT01216943|9809605|FG000|NOT COMPLETED|Overall Study||13
8760217|NCT01217073|9809615|FG000|STARTED|Base Period||113
8760218|NCT01217073|9809616|FG001|STARTED|Base Period||115
8760219|NCT01217073|9809617|FG002|STARTED|Base Period||114
8760220|NCT01217073|9809618|FG003|STARTED|Base Period||115
8760221|NCT01217073|9809619|FG004|STARTED|Base Period||114
8760222|NCT01217073|9809620|FG005|STARTED|Base Period||114
8760223|NCT01217073|9809621|FG006|STARTED|Base Period||0
8760224|NCT01217073|9809622|FG007|STARTED|Base Period||0
8760225|NCT01217073|9809615|FG000|COMPLETED|Base Period||106
8760226|NCT01217073|9809616|FG001|COMPLETED|Base Period||110
8760227|NCT01217073|9809617|FG002|COMPLETED|Base Period||107
8760228|NCT01217073|9809618|FG003|COMPLETED|Base Period||113
8760229|NCT01217073|9809619|FG004|COMPLETED|Base Period||99
8760230|NCT01217073|9809620|FG005|COMPLETED|Base Period||105
8760231|NCT01217073|9809621|FG006|COMPLETED|Base Period||0
8760232|NCT01217073|9809622|FG007|COMPLETED|Base Period||0
8760233|NCT01217073|9809615|FG000|NOT COMPLETED|Base Period||7
8760234|NCT01217073|9809616|FG001|NOT COMPLETED|Base Period||5
8760235|NCT01217073|9809617|FG002|NOT COMPLETED|Base Period||7
8760236|NCT01217073|9809618|FG003|NOT COMPLETED|Base Period||2
8760237|NCT01217073|9809619|FG004|NOT COMPLETED|Base Period||15
8760238|NCT01217073|9809620|FG005|NOT COMPLETED|Base Period||9
8760239|NCT01217073|9809621|FG006|NOT COMPLETED|Base Period||0
8760240|NCT01217073|9809622|FG007|NOT COMPLETED|Base Period||0
8760241|NCT01217073|9809615|FG000|STARTED|Extension Period||0
8760242|NCT01217073|9809616|FG001|STARTED|Extension Period||0
8760243|NCT01217073|9809617|FG002|STARTED|Extension Period||0
8760244|NCT01217073|9809618|FG003|STARTED|Extension Period||0
8760245|NCT01217073|9809619|FG004|STARTED|Extension Period||0
8760246|NCT01217073|9809620|FG005|STARTED|Extension Period||0
8760247|NCT01217073|9809621|FG006|STARTED|Extension Period||405
8760248|NCT01217073|9809622|FG007|STARTED|Extension Period||80
8760249|NCT01217073|9809615|FG000|COMPLETED|Extension Period||0
8760250|NCT01217073|9809616|FG001|COMPLETED|Extension Period||0
8760251|NCT01217073|9809617|FG002|COMPLETED|Extension Period||0
8760252|NCT01217073|9809618|FG003|COMPLETED|Extension Period||0
8760253|NCT01217073|9809619|FG004|COMPLETED|Extension Period||0
8760254|NCT01217073|9809620|FG005|COMPLETED|Extension Period||0
8760255|NCT01217073|9809621|FG006|COMPLETED|Extension Period||314
8760256|NCT01217073|9809622|FG007|COMPLETED|Extension Period||60
8760257|NCT01217073|9809615|FG000|NOT COMPLETED|Extension Period||0
8760258|NCT01217073|9809616|FG001|NOT COMPLETED|Extension Period||0
8760259|NCT01217073|9809617|FG002|NOT COMPLETED|Extension Period||0
8760260|NCT01217073|9809618|FG003|NOT COMPLETED|Extension Period||0
8760261|NCT01217073|9809619|FG004|NOT COMPLETED|Extension Period||0
8760262|NCT01217073|9809620|FG005|NOT COMPLETED|Extension Period||0
8760263|NCT01217073|9809621|FG006|NOT COMPLETED|Extension Period||91
8760264|NCT01217073|9809622|FG007|NOT COMPLETED|Extension Period||20
8760265|NCT01217112|9809651|FG000|STARTED|Overall Study||11
8760266|NCT01217112|9809652|FG001|STARTED|Overall Study||12
8760267|NCT01217112|9809653|FG002|STARTED|Overall Study||13
8760268|NCT01217112|9809654|FG003|STARTED|Overall Study||12
8760269|NCT01217112|9809655|FG004|STARTED|Overall Study||14
8760270|NCT01217112|9809651|FG000|COMPLETED|Overall Study||11
8760271|NCT01217112|9809652|FG001|COMPLETED|Overall Study||10
8760272|NCT01217112|9809653|FG002|COMPLETED|Overall Study||12
8760273|NCT01217112|9809654|FG003|COMPLETED|Overall Study||10
8760274|NCT01217112|9809655|FG004|COMPLETED|Overall Study||13
8760275|NCT01217112|9809651|FG000|NOT COMPLETED|Overall Study||0
8760276|NCT01217112|9809652|FG001|NOT COMPLETED|Overall Study||2
8760277|NCT01217112|9809653|FG002|NOT COMPLETED|Overall Study||1
8760278|NCT01217112|9809654|FG003|NOT COMPLETED|Overall Study||2
8760279|NCT01217112|9809655|FG004|NOT COMPLETED|Overall Study||1
8760280|NCT01217190|9809669|FG000|STARTED|First Dosing||24
8760281|NCT01217190|9809670|FG001|STARTED|First Dosing||24
8760282|NCT01217190|9809669|FG000|COMPLETED|First Dosing||24
8760283|NCT01217190|9809670|FG001|COMPLETED|First Dosing||24
8760284|NCT01217190|9809669|FG000|NOT COMPLETED|First Dosing||0
8760285|NCT01217190|9809670|FG001|NOT COMPLETED|First Dosing||0
8760286|NCT01217190|9809669|FG000|STARTED|Second Dosing||24
8760287|NCT01217190|9809670|FG001|STARTED|Second Dosing||24
8760288|NCT01217190|9809669|FG000|COMPLETED|Second Dosing||24
8760289|NCT01217190|9809670|FG001|COMPLETED|Second Dosing|Two subjects withdrew for personal reasons (other than adverse event).|22
8760290|NCT01217190|9809669|FG000|NOT COMPLETED|Second Dosing||0
8760291|NCT01217190|9809670|FG001|NOT COMPLETED|Second Dosing||2
8760292|NCT01217229|9809679|FG000|STARTED|Overall Study||20
8760293|NCT01217229|9809679|FG000|COMPLETED|Overall Study||0
8760294|NCT01217229|9809679|FG000|NOT COMPLETED|Overall Study||20
8760295|NCT01217307|9809685|FG000|STARTED|Overall Study||191
8760296|NCT01217307|9809686|FG001|STARTED|Overall Study||189
8760297|NCT01217307|9809685|FG000|COMPLETED|Overall Study||191
8760298|NCT01217307|9809686|FG001|COMPLETED|Overall Study||188
8760299|NCT01217307|9809685|FG000|NOT COMPLETED|Overall Study||0
8760300|NCT01217307|9809686|FG001|NOT COMPLETED|Overall Study||1
8760301|NCT01217385|9809692|FG000|STARTED|Overall Study||60
8760302|NCT01217385|9809692|FG000|COMPLETED|Overall Study||34
8760303|NCT01217385|9809692|FG000|NOT COMPLETED|Overall Study||26
8760304|NCT01217411|9809704|FG000|STARTED|Overall Study||3
8760305|NCT01217411|9809705|FG001|STARTED|Overall Study||2
8760306|NCT01217411|9809704|FG000|5mg|Overall Study||3
8760307|NCT01217411|9809705|FG001|5mg|Overall Study||2
8760308|NCT01217411|9809704|FG000|10mg|Overall Study||0
8760309|NCT01217411|9809705|FG001|10mg|Overall Study||0
8760310|NCT01217411|9809704|FG000|20mg|Overall Study||0
8760311|NCT01217411|9809705|FG001|20mg|Overall Study||0
8760312|NCT01217411|9809704|FG000|COMPLETED|Overall Study||0
8760313|NCT01217411|9809705|FG001|COMPLETED|Overall Study||0
8760314|NCT01217411|9809704|FG000|NOT COMPLETED|Overall Study||3
8760315|NCT01217411|9809705|FG001|NOT COMPLETED|Overall Study||2
8760316|NCT01217437|9809715|FG000|STARTED|Overall Study||55
8760317|NCT01217437|9809716|FG001|STARTED|Overall Study||53
8760318|NCT01217437|9809715|FG000|COMPLETED|Overall Study||12
8760319|NCT01217437|9809716|FG001|COMPLETED|Overall Study||12
8760320|NCT01217437|9809715|FG000|NOT COMPLETED|Overall Study||43
8760321|NCT01217437|9809716|FG001|NOT COMPLETED|Overall Study||41
8760322|NCT01217463|9809724|FG000|STARTED|Overall Study||99
8760323|NCT01217463|9809725|FG001|STARTED|Overall Study||102
8760324|NCT01217463|9809724|FG000|COMPLETED|Overall Study||86
8760325|NCT01217463|9809725|FG001|COMPLETED|Overall Study||94
8760326|NCT01217463|9809724|FG000|NOT COMPLETED|Overall Study||13
8760327|NCT01217463|9809725|FG001|NOT COMPLETED|Overall Study||8
8760328|NCT01217476|9809735|FG000|STARTED|Overall Study||105
8760329|NCT01217476|9809736|FG001|STARTED|Overall Study||102
8760330|NCT01217476|9809735|FG000|COMPLETED|Overall Study||93
8760331|NCT01217476|9809736|FG001|COMPLETED|Overall Study||95
9025616|NCT03162796|10087954|FG002|NOT COMPLETED|Active Treatment Period: Week 24 - 52||1
9025617|NCT03162796|10087952|FG000|STARTED|Safety Follow-up: Week 52 - 60||107
9025618|NCT03162796|10087953|FG001|STARTED|Safety Follow-up: Week 52 - 60||116
9025619|NCT03162796|10087954|FG002|STARTED|Safety Follow-up: Week 52 - 60||124
9025620|NCT03162796|10087952|FG000|COMPLETED|Safety Follow-up: Week 52 - 60||106
9025621|NCT03162796|10087953|FG001|COMPLETED|Safety Follow-up: Week 52 - 60||114
9025622|NCT03162796|10087954|FG002|COMPLETED|Safety Follow-up: Week 52 - 60||123
9025623|NCT03162796|10087952|FG000|NOT COMPLETED|Safety Follow-up: Week 52 - 60||1
9025624|NCT03162796|10087953|FG001|NOT COMPLETED|Safety Follow-up: Week 52 - 60||2
9025625|NCT03162796|10087954|FG002|NOT COMPLETED|Safety Follow-up: Week 52 - 60||1
9025626|NCT03163017|10087967|FG000|STARTED|Overall Study||30
9025627|NCT03163017|10087967|FG000|COMPLETED|Overall Study||30
9025628|NCT03163017|10087967|FG000|NOT COMPLETED|Overall Study||0
9025629|NCT03163134|10087973|FG000|STARTED|Overall Study||85
9025630|NCT03163134|10087974|FG001|STARTED|Overall Study||85
9025631|NCT03163134|10087973|FG000|COMPLETED|Overall Study||85
9025632|NCT03163134|10087974|FG001|COMPLETED|Overall Study||85
9025633|NCT03163134|10087973|FG000|NOT COMPLETED|Overall Study||0
9025634|NCT03163134|10087974|FG001|NOT COMPLETED|Overall Study||0
9025635|NCT03163303|10087982|FG000|STARTED|Overall Study||85
9025636|NCT03163303|10087983|FG001|STARTED|Overall Study||94
9025637|NCT03163303|10087982|FG000|COMPLETED|Overall Study||85
9025638|NCT03163303|10087983|FG001|COMPLETED|Overall Study||94
9025639|NCT03163303|10087982|FG000|NOT COMPLETED|Overall Study||0
9025640|NCT03163303|10087983|FG001|NOT COMPLETED|Overall Study||0
9025641|NCT03163342|10087989|FG000|STARTED|Overall Study||20
9025642|NCT03163342|10087989|FG000|COMPLETED|Overall Study||20
9025643|NCT03163342|10087989|FG000|NOT COMPLETED|Overall Study||0
9025644|NCT03163446|10087995|FG000|STARTED|Overall Study||73
9025645|NCT03163446|10087996|FG001|STARTED|Overall Study||48
9025646|NCT03163446|10087995|FG000|COMPLETED|Overall Study||45
9025647|NCT03163446|10087996|FG001|COMPLETED|Overall Study||31
9025648|NCT03163446|10087995|FG000|NOT COMPLETED|Overall Study||28
9025649|NCT03163446|10087996|FG001|NOT COMPLETED|Overall Study||17
9025650|NCT03163472|10088010|FG000|STARTED|Overall Study||15
9025651|NCT03163472|10088011|FG001|STARTED|Overall Study||15
9025652|NCT03163472|10088010|FG000|COMPLETED|Overall Study||15
9025653|NCT03163472|10088011|FG001|COMPLETED|Overall Study||15
9025654|NCT03163472|10088010|FG000|NOT COMPLETED|Overall Study||0
9025655|NCT03163472|10088011|FG001|NOT COMPLETED|Overall Study||0
9025656|NCT03163758|10088021|FG000|STARTED|Overall Study||21
9025657|NCT03163758|10088022|FG001|STARTED|Overall Study||21
9025658|NCT03163758|10088021|FG000|COMPLETED|Overall Study||13
9025659|NCT03163758|10088022|FG001|COMPLETED|Overall Study||14
9025660|NCT03163758|10088021|FG000|NOT COMPLETED|Overall Study||8
9025661|NCT03163758|10088022|FG001|NOT COMPLETED|Overall Study||7
8760332|NCT01217476|9809735|FG000|NOT COMPLETED|Overall Study||12
8760333|NCT01217476|9809736|FG001|NOT COMPLETED|Overall Study||7
8760334|NCT01217515|9809745|FG000|STARTED|Overall Study||154
8760335|NCT01217515|9809746|FG001|STARTED|Overall Study||156
8760336|NCT01217515|9809747|FG002|STARTED|Overall Study||155
8760337|NCT01217515|9809745|FG000|COMPLETED|Overall Study||147
8760338|NCT01217515|9809746|FG001|COMPLETED|Overall Study||148
8760339|NCT01217515|9809747|FG002|COMPLETED|Overall Study||145
9025662|NCT03164538|10088030|FG000|STARTED|Overall Study||35
9025663|NCT03164538|10088031|FG001|STARTED|Overall Study||35
9025664|NCT03164538|10088030|FG000|COMPLETED|Overall Study||28
9025665|NCT03164538|10088031|FG001|COMPLETED|Overall Study||29
9025666|NCT03164538|10088030|FG000|NOT COMPLETED|Overall Study||7
8760340|NCT01217515|9809745|FG000|NOT COMPLETED|Overall Study||7
8760341|NCT01217515|9809746|FG001|NOT COMPLETED|Overall Study||8
8760342|NCT01217515|9809747|FG002|NOT COMPLETED|Overall Study||10
8760343|NCT01217606|9809757|FG000|STARTED|Initial Treatment Phase||90
8760344|NCT01217606|9809758|FG001|STARTED|Initial Treatment Phase||95
9025667|NCT03164538|10088031|FG001|NOT COMPLETED|Overall Study||6
9025668|NCT03164551|10088039|FG000|STARTED|Overall Study||200
9025669|NCT03164551|10088040|FG001|STARTED|Overall Study||208
9025670|NCT03164551|10088039|FG000|COMPLETED|Overall Study||171
8760345|NCT01217606|9809757|FG000|COMPLETED|Initial Treatment Phase||76
8760346|NCT01217606|9809758|FG001|COMPLETED|Initial Treatment Phase||83
8760347|NCT01217606|9809757|FG000|NOT COMPLETED|Initial Treatment Phase||14
8760348|NCT01217606|9809758|FG001|NOT COMPLETED|Initial Treatment Phase||12
8760349|NCT01217606|9809757|FG000|STARTED|9-Month Masked Extension||67
8760350|NCT01217606|9809758|FG001|STARTED|9-Month Masked Extension||73
8760351|NCT01217606|9809757|FG000|Not Enrolled in Masked Extension|9-Month Masked Extension||9
8760352|NCT01217606|9809758|FG001|Not Enrolled in Masked Extension|9-Month Masked Extension||10
8760353|NCT01217606|9809757|FG000|COMPLETED|9-Month Masked Extension||54
8760354|NCT01217606|9809758|FG001|COMPLETED|9-Month Masked Extension||62
8760355|NCT01217606|9809757|FG000|NOT COMPLETED|9-Month Masked Extension||13
8760356|NCT01217606|9809758|FG001|NOT COMPLETED|9-Month Masked Extension||11
8760357|NCT01217749|9809767|FG000|STARTED|Overall Study||27
8760358|NCT01217749|9809768|FG001|STARTED|Overall Study||20
8760359|NCT01217749|9809769|FG002|STARTED|Overall Study||24
8760360|NCT01217749|9809767|FG000|COMPLETED|Overall Study||24
8760361|NCT01217749|9809768|FG001|COMPLETED|Overall Study||17
8760362|NCT01217749|9809769|FG002|COMPLETED|Overall Study||22
8760363|NCT01217749|9809767|FG000|NOT COMPLETED|Overall Study||3
8760364|NCT01217749|9809768|FG001|NOT COMPLETED|Overall Study||3
8760365|NCT01217749|9809769|FG002|NOT COMPLETED|Overall Study||2
8760366|NCT01217801|9809781|FG000|STARTED|Period 1||24
8760367|NCT01217801|9809782|FG001|STARTED|Period 1||24
8760368|NCT01217801|9809781|FG000|COMPLETED|Period 1||23
8760369|NCT01217801|9809782|FG001|COMPLETED|Period 1||22
8760370|NCT01217801|9809781|FG000|NOT COMPLETED|Period 1||1
8760371|NCT01217801|9809782|FG001|NOT COMPLETED|Period 1||2
8760372|NCT01217801|9809781|FG000|STARTED|Period 2||23
8760373|NCT01217801|9809782|FG001|STARTED|Period 2||22
8760374|NCT01217801|9809781|FG000|COMPLETED|Period 2||23
8760375|NCT01217801|9809782|FG001|COMPLETED|Period 2||22
8760376|NCT01217801|9809781|FG000|NOT COMPLETED|Period 2||0
8760377|NCT01217801|9809782|FG001|NOT COMPLETED|Period 2||0
8760378|NCT01217814|9809791|FG000|STARTED|Overall Study||4
8760379|NCT01217814|9809792|FG001|STARTED|Overall Study||5
8760380|NCT01217814|9809793|FG002|STARTED|Overall Study||7
8760381|NCT01217814|9809791|FG000|COMPLETED|Overall Study||3
8760382|NCT01217814|9809792|FG001|COMPLETED|Overall Study||4
8760383|NCT01217814|9809793|FG002|COMPLETED|Overall Study||6
8760384|NCT01217814|9809791|FG000|NOT COMPLETED|Overall Study||1
8760385|NCT01217814|9809792|FG001|NOT COMPLETED|Overall Study||1
8760386|NCT01217814|9809793|FG002|NOT COMPLETED|Overall Study||1
8760387|NCT01217827|9809804|FG000|STARTED|Overall Study||46
8760388|NCT01217827|9809805|FG001|STARTED|Overall Study||43
8760389|NCT01217827|9809804|FG000|COMPLETED|Overall Study||46
8760390|NCT01217827|9809805|FG001|COMPLETED|Overall Study||43
8760391|NCT01217827|9809804|FG000|NOT COMPLETED|Overall Study||0
8760392|NCT01217827|9809805|FG001|NOT COMPLETED|Overall Study||0
8760393|NCT01217840|9809813|FG000|STARTED|Overall Study||20
8760394|NCT01217840|9809814|FG001|STARTED|Overall Study||20
8760395|NCT01217840|9809813|FG000|COMPLETED|Overall Study||14
8760396|NCT01217840|9809814|FG001|COMPLETED|Overall Study||17
8760397|NCT01217840|9809813|FG000|NOT COMPLETED|Overall Study||6
8760398|NCT01217840|9809814|FG001|NOT COMPLETED|Overall Study||3
8760399|NCT01217892|9809825|FG000|STARTED|Overall Study||100
8760400|NCT01217892|9809826|FG001|STARTED|Overall Study||100
8760401|NCT01217892|9809827|FG002|STARTED|Overall Study||99
8760402|NCT01217892|9809828|FG003|STARTED|Overall Study||101
8760403|NCT01217892|9809825|FG000|COMPLETED|Overall Study||93
8760404|NCT01217892|9809826|FG001|COMPLETED|Overall Study||94
8760405|NCT01217892|9809827|FG002|COMPLETED|Overall Study||90
8760406|NCT01217892|9809828|FG003|COMPLETED|Overall Study||93
8760407|NCT01217892|9809825|FG000|NOT COMPLETED|Overall Study||7
8760408|NCT01217892|9809826|FG001|NOT COMPLETED|Overall Study||6
8760409|NCT01217892|9809827|FG002|NOT COMPLETED|Overall Study||9
8760410|NCT01217892|9809828|FG003|NOT COMPLETED|Overall Study||8
8760411|NCT01217944|9809841|FG000|STARTED|Overall Study||106
8760412|NCT01217944|9809842|FG001|STARTED|Overall Study||116
8760413|NCT01217944|9809843|FG002|STARTED|Overall Study||55
8760414|NCT01217944|9809841|FG000|Completed 3 Months|Overall Study||105
8760415|NCT01217944|9809842|FG001|Completed 3 Months|Overall Study||116
8760416|NCT01217944|9809843|FG002|Completed 3 Months|Overall Study||55
8760417|NCT01217944|9809841|FG000|Completed 6 Months|Overall Study||103
8760418|NCT01217944|9809842|FG001|Completed 6 Months|Overall Study||116
8760419|NCT01217944|9809843|FG002|Completed 6 Months|Overall Study||55
8760420|NCT01217944|9809841|FG000|COMPLETED|Overall Study||100
8760421|NCT01217944|9809842|FG001|COMPLETED|Overall Study||112
8760422|NCT01217944|9809843|FG002|COMPLETED|Overall Study||55
8760423|NCT01217944|9809841|FG000|NOT COMPLETED|Overall Study||6
8760424|NCT01217944|9809842|FG001|NOT COMPLETED|Overall Study||4
8760425|NCT01217944|9809843|FG002|NOT COMPLETED|Overall Study||0
8760426|NCT01217957|9809858|FG000|STARTED|Phase 1||3
8760427|NCT01217957|9809859|FG001|STARTED|Phase 1||3
8760428|NCT01217957|9809860|FG002|STARTED|Phase 1||6
8760429|NCT01217957|9809861|FG003|STARTED|Phase 1||3
8760430|NCT01217957|9809862|FG004|STARTED|Phase 1||0
8760431|NCT01217957|9809858|FG000|COMPLETED|Phase 1||2
8760432|NCT01217957|9809859|FG001|COMPLETED|Phase 1||3
8760433|NCT01217957|9809860|FG002|COMPLETED|Phase 1||5
8760434|NCT01217957|9809861|FG003|COMPLETED|Phase 1||2
8760435|NCT01217957|9809862|FG004|COMPLETED|Phase 1||0
8760436|NCT01217957|9809858|FG000|NOT COMPLETED|Phase 1||1
8760437|NCT01217957|9809859|FG001|NOT COMPLETED|Phase 1||0
8760438|NCT01217957|9809860|FG002|NOT COMPLETED|Phase 1||1
8760439|NCT01217957|9809861|FG003|NOT COMPLETED|Phase 1||1
8760440|NCT01217957|9809862|FG004|NOT COMPLETED|Phase 1||0
8760441|NCT01217957|9809858|FG000|STARTED|Phase 2||0
8760442|NCT01217957|9809859|FG001|STARTED|Phase 2||0
8760443|NCT01217957|9809860|FG002|STARTED|Phase 2||0
8760444|NCT01217957|9809861|FG003|STARTED|Phase 2||0
8760445|NCT01217957|9809862|FG004|STARTED|Phase 2||50
8760446|NCT01217957|9809858|FG000|COMPLETED|Phase 2||0
8760447|NCT01217957|9809859|FG001|COMPLETED|Phase 2||0
8760448|NCT01217957|9809860|FG002|COMPLETED|Phase 2||0
8760449|NCT01217957|9809861|FG003|COMPLETED|Phase 2||0
8760450|NCT01217957|9809862|FG004|COMPLETED|Phase 2|Completed=Participants who are ongoing or who have died on study.|49
8760451|NCT01217957|9809858|FG000|NOT COMPLETED|Phase 2||0
8760452|NCT01217957|9809859|FG001|NOT COMPLETED|Phase 2||0
8760453|NCT01217957|9809860|FG002|NOT COMPLETED|Phase 2||0
8760454|NCT01217957|9809861|FG003|NOT COMPLETED|Phase 2||0
8760455|NCT01217957|9809862|FG004|NOT COMPLETED|Phase 2||1
8760456|NCT01218009|9809885|FG000|STARTED|Overall Study||166
8760457|NCT01218009|9809886|FG001|STARTED|Overall Study||165
8760458|NCT01218009|9809885|FG000|COMPLETED|Overall Study||0
8760459|NCT01218009|9809886|FG001|COMPLETED|Overall Study||0
9025671|NCT03164551|10088040|FG001|COMPLETED|Overall Study||192
9025672|NCT03164551|10088039|FG000|NOT COMPLETED|Overall Study||29
9025673|NCT03164551|10088040|FG001|NOT COMPLETED|Overall Study||16
9025674|NCT03164629|10088048|FG000|STARTED|Overall Study||25
9025675|NCT03164629|10088049|FG001|STARTED|Overall Study||25
9025676|NCT03164629|10088048|FG000|COMPLETED|Overall Study||25
9025677|NCT03164629|10088049|FG001|COMPLETED|Overall Study||25
9025678|NCT03164629|10088048|FG000|NOT COMPLETED|Overall Study||0
9025679|NCT03164629|10088049|FG001|NOT COMPLETED|Overall Study||0
9025680|NCT03165045|10088055|FG000|STARTED|Visit 1||1351
9025681|NCT03165045|10088055|FG000|COMPLETED|Visit 1||1322
9025682|NCT03165045|10088055|FG000|NOT COMPLETED|Visit 1||29
9025683|NCT03165045|10088055|FG000|STARTED|Visit 2||1322
9025684|NCT03165045|10088055|FG000|COMPLETED|Visit 2||1140
9025685|NCT03165045|10088055|FG000|NOT COMPLETED|Visit 2||182
9025686|NCT03165058|10088063|FG000|STARTED|Overall Study||21
9025687|NCT03165058|10088064|FG001|STARTED|Overall Study||11
9025688|NCT03165058|10088063|FG000|COMPLETED|Overall Study||21
9025689|NCT03165058|10088064|FG001|COMPLETED|Overall Study||11
9025690|NCT03165058|10088063|FG000|NOT COMPLETED|Overall Study||0
9025691|NCT03165058|10088064|FG001|NOT COMPLETED|Overall Study||0
9025692|NCT03165110|10088070|FG000|STARTED|Overall Study||47
9025693|NCT03165110|10088070|FG000|COMPLETED|Overall Study||46
9025694|NCT03165110|10088070|FG000|NOT COMPLETED|Overall Study||1
9025695|NCT03165175|10088076|FG000|STARTED|1-month to 3-month||41
9025696|NCT03165175|10088077|FG001|STARTED|1-month to 3-month||39
9025697|NCT03165175|10088076|FG000|COMPLETED|1-month to 3-month||35
9025698|NCT03165175|10088077|FG001|COMPLETED|1-month to 3-month||39
9025699|NCT03165175|10088076|FG000|NOT COMPLETED|1-month to 3-month||6
9025700|NCT03165175|10088077|FG001|NOT COMPLETED|1-month to 3-month||0
9025701|NCT03165175|10088076|FG000|STARTED|Baseline to 3-month||35
9025702|NCT03165175|10088077|FG001|STARTED|Baseline to 3-month||39
9025703|NCT03165175|10088076|FG000|COMPLETED|Baseline to 3-month||31
9025704|NCT03165175|10088077|FG001|COMPLETED|Baseline to 3-month||39
9025705|NCT03165175|10088076|FG000|NOT COMPLETED|Baseline to 3-month||4
9025706|NCT03165175|10088077|FG001|NOT COMPLETED|Baseline to 3-month||0
9025707|NCT03165617|10088085|FG000|STARTED|Overall Study||2258
9025708|NCT03165617|10088086|FG001|STARTED|Overall Study||2256
9025709|NCT03165617|10088085|FG000|COMPLETED|Overall Study||2249
9025710|NCT03165617|10088086|FG001|COMPLETED|Overall Study||2247
9025711|NCT03165617|10088085|FG000|NOT COMPLETED|Overall Study||9
9025712|NCT03165617|10088086|FG001|NOT COMPLETED|Overall Study||9
9025713|NCT03165981|10088112|FG000|STARTED|Overall Study||110
9025714|NCT03165981|10088113|FG001|STARTED|Overall Study||111
9025715|NCT03165981|10088112|FG000|Per Protocol Population|Overall Study||99
9025716|NCT03165981|10088113|FG001|Per Protocol Population|Overall Study||107
9025717|NCT03165981|10088112|FG000|COMPLETED|Overall Study||99
9025718|NCT03165981|10088113|FG001|COMPLETED|Overall Study||107
9025719|NCT03165981|10088112|FG000|NOT COMPLETED|Overall Study||11
9025720|NCT03165981|10088113|FG001|NOT COMPLETED|Overall Study||4
9025721|NCT03166124|10088121|FG000|STARTED|Treatment Period 1||20
9025722|NCT03166124|10088122|FG001|STARTED|Treatment Period 1||20
9025723|NCT03166124|10088123|FG002|STARTED|Treatment Period 1||19
9025724|NCT03166124|10088124|FG003|STARTED|Treatment Period 1||21
9025725|NCT03166124|10088121|FG000|Received at Least One Dose of Study Drug|Treatment Period 1||20
9025726|NCT03166124|10088122|FG001|Received at Least One Dose of Study Drug|Treatment Period 1||20
9025727|NCT03166124|10088123|FG002|Received at Least One Dose of Study Drug|Treatment Period 1||18
9025728|NCT03166124|10088124|FG003|Received at Least One Dose of Study Drug|Treatment Period 1||21
9025729|NCT03166124|10088121|FG000|COMPLETED|Treatment Period 1||20
9025730|NCT03166124|10088122|FG001|COMPLETED|Treatment Period 1||20
9025731|NCT03166124|10088123|FG002|COMPLETED|Treatment Period 1||18
8760460|NCT01218009|9809885|FG000|NOT COMPLETED|Overall Study||166
8760461|NCT01218009|9809886|FG001|NOT COMPLETED|Overall Study||165
8760462|NCT01218048|9809892|FG000|STARTED|Overall Study||40
8760463|NCT01218048|9809892|FG000|COMPLETED|Overall Study||40
8760464|NCT01218048|9809892|FG000|NOT COMPLETED|Overall Study||0
8760465|NCT01218087|9809899|FG000|STARTED|Overall Study||42
8760466|NCT01218087|9809900|FG001|STARTED|Overall Study||41
8760467|NCT01218087|9809899|FG000|COMPLETED|Overall Study||27
8760468|NCT01218087|9809900|FG001|COMPLETED|Overall Study||35
8760469|NCT01218087|9809899|FG000|NOT COMPLETED|Overall Study||15
8760470|NCT01218087|9809900|FG001|NOT COMPLETED|Overall Study||6
8760471|NCT01218100|9809910|FG000|STARTED|Overall Study||95
8760472|NCT01218100|9809911|FG001|STARTED|Overall Study||190
8760473|NCT01218100|9809912|FG002|STARTED|Overall Study||189
8760474|NCT01218100|9809913|FG003|STARTED|Overall Study||190
8760475|NCT01218100|9809910|FG000|COMPLETED|Overall Study||71
8760476|NCT01218100|9809911|FG001|COMPLETED|Overall Study||165
8760477|NCT01218100|9809912|FG002|COMPLETED|Overall Study||162
8760478|NCT01218100|9809913|FG003|COMPLETED|Overall Study||156
8760479|NCT01218100|9809910|FG000|NOT COMPLETED|Overall Study||24
8760480|NCT01218100|9809911|FG001|NOT COMPLETED|Overall Study||25
8760481|NCT01218100|9809912|FG002|NOT COMPLETED|Overall Study||27
8760482|NCT01218100|9809913|FG003|NOT COMPLETED|Overall Study||34
8760483|NCT01218113|9809926|FG000|STARTED|Overall Study||62
8760484|NCT01218113|9809927|FG001|STARTED|Overall Study||64
8760485|NCT01218113|9809928|FG002|STARTED|Overall Study||64
8760486|NCT01218113|9809926|FG000|COMPLETED|Overall Study||57
8760487|NCT01218113|9809927|FG001|COMPLETED|Overall Study||63
8760488|NCT01218113|9809928|FG002|COMPLETED|Overall Study||58
8760489|NCT01218113|9809926|FG000|NOT COMPLETED|Overall Study||5
8760490|NCT01218113|9809927|FG001|NOT COMPLETED|Overall Study||1
8760491|NCT01218113|9809928|FG002|NOT COMPLETED|Overall Study||6
8760492|NCT01218126|9809947|FG000|STARTED|Overall Study||153
8760493|NCT01218126|9809948|FG001|STARTED|Overall Study||149
8760494|NCT01218126|9809949|FG002|STARTED|Overall Study||151
8760495|NCT01218126|9809950|FG003|STARTED|Overall Study||149
8760496|NCT01218126|9809947|FG000|COMPLETED|Overall Study||129
8760497|NCT01218126|9809948|FG001|COMPLETED|Overall Study||127
8760498|NCT01218126|9809949|FG002|COMPLETED|Overall Study||127
8760499|NCT01218126|9809950|FG003|COMPLETED|Overall Study||114
8760500|NCT01218126|9809947|FG000|NOT COMPLETED|Overall Study||24
8760501|NCT01218126|9809948|FG001|NOT COMPLETED|Overall Study||22
8760502|NCT01218126|9809949|FG002|NOT COMPLETED|Overall Study||24
8760503|NCT01218126|9809950|FG003|NOT COMPLETED|Overall Study||35
8760504|NCT01218204|9809962|FG000|STARTED|Part A||6
8760505|NCT01218204|9809963|FG001|STARTED|Part A||0
8760506|NCT01218204|9809964|FG002|STARTED|Part A||0
8760507|NCT01218204|9809965|FG003|STARTED|Part A||0
8760508|NCT01218204|9809962|FG000|COMPLETED|Part A||6
8760509|NCT01218204|9809963|FG001|COMPLETED|Part A||0
8760510|NCT01218204|9809964|FG002|COMPLETED|Part A||0
8760511|NCT01218204|9809965|FG003|COMPLETED|Part A||0
8760512|NCT01218204|9809962|FG000|NOT COMPLETED|Part A||0
8760513|NCT01218204|9809963|FG001|NOT COMPLETED|Part A||0
8760514|NCT01218204|9809964|FG002|NOT COMPLETED|Part A||0
8760515|NCT01218204|9809965|FG003|NOT COMPLETED|Part A||0
8760516|NCT01218204|9809962|FG000|STARTED|Part B Washout||0
8760517|NCT01218204|9809963|FG001|STARTED|Part B Washout||281
8760518|NCT01218204|9809964|FG002|STARTED|Part B Washout||0
8760519|NCT01218204|9809965|FG003|STARTED|Part B Washout||0
8760520|NCT01218204|9809962|FG000|COMPLETED|Part B Washout||0
8760521|NCT01218204|9809963|FG001|COMPLETED|Part B Washout||136
8760522|NCT01218204|9809964|FG002|COMPLETED|Part B Washout||0
8760523|NCT01218204|9809965|FG003|COMPLETED|Part B Washout||0
8760524|NCT01218204|9809962|FG000|NOT COMPLETED|Part B Washout||0
8760525|NCT01218204|9809963|FG001|NOT COMPLETED|Part B Washout||145
8760526|NCT01218204|9809964|FG002|NOT COMPLETED|Part B Washout||0
8760527|NCT01218204|9809965|FG003|NOT COMPLETED|Part B Washout||0
8760528|NCT01218204|9809962|FG000|STARTED|Part B Run-in||0
8760529|NCT01218204|9809963|FG001|STARTED|Part B Run-in||0
8760530|NCT01218204|9809964|FG002|STARTED|Part B Run-in||89
8760531|NCT01218204|9809965|FG003|STARTED|Part B Run-in||0
8760532|NCT01218204|9809962|FG000|COMPLETED|Part B Run-in||0
8760533|NCT01218204|9809963|FG001|COMPLETED|Part B Run-in||0
8760534|NCT01218204|9809964|FG002|COMPLETED|Part B Run-in||83
8760535|NCT01218204|9809965|FG003|COMPLETED|Part B Run-in||0
8760536|NCT01218204|9809962|FG000|NOT COMPLETED|Part B Run-in||0
8760537|NCT01218204|9809963|FG001|NOT COMPLETED|Part B Run-in||0
8760538|NCT01218204|9809964|FG002|NOT COMPLETED|Part B Run-in||6
8760539|NCT01218204|9809965|FG003|NOT COMPLETED|Part B Run-in||0
8760540|NCT01218204|9809962|FG000|STARTED|Part B Pooled Treatment Arm||0
8760541|NCT01218204|9809963|FG001|STARTED|Part B Pooled Treatment Arm||0
8760542|NCT01218204|9809964|FG002|STARTED|Part B Pooled Treatment Arm||0
8760543|NCT01218204|9809965|FG003|STARTED|Part B Pooled Treatment Arm||130
8760544|NCT01218204|9809962|FG000|COMPLETED|Part B Pooled Treatment Arm||0
8760545|NCT01218204|9809963|FG001|COMPLETED|Part B Pooled Treatment Arm||0
8760546|NCT01218204|9809964|FG002|COMPLETED|Part B Pooled Treatment Arm||0
8760547|NCT01218204|9809965|FG003|COMPLETED|Part B Pooled Treatment Arm||127
8760548|NCT01218204|9809962|FG000|NOT COMPLETED|Part B Pooled Treatment Arm||0
8760549|NCT01218204|9809963|FG001|NOT COMPLETED|Part B Pooled Treatment Arm||0
8760550|NCT01218204|9809964|FG002|NOT COMPLETED|Part B Pooled Treatment Arm||0
8760551|NCT01218204|9809965|FG003|NOT COMPLETED|Part B Pooled Treatment Arm||3
8760552|NCT01218243|9810014|FG000|STARTED|Overall Study||50
8760553|NCT01218243|9810015|FG001|STARTED|Overall Study||50
8760554|NCT01218243|9810014|FG000|Treatment Completed|Overall Study||45
8760555|NCT01218243|9810015|FG001|Treatment Completed|Overall Study||42
8760556|NCT01218243|9810014|FG000|COMPLETED|Overall Study||41
8760557|NCT01218243|9810015|FG001|COMPLETED|Overall Study||36
8760558|NCT01218243|9810014|FG000|NOT COMPLETED|Overall Study||9
8760559|NCT01218243|9810015|FG001|NOT COMPLETED|Overall Study||14
8760560|NCT01218308|9810023|FG000|STARTED|Overall Study||2584
8760561|NCT01218308|9810024|FG001|STARTED|Overall Study||2584
8760562|NCT01218308|9810023|FG000|COMPLETED|Overall Study||2481
8760563|NCT01218308|9810024|FG001|COMPLETED|Overall Study||2464
8760564|NCT01218308|9810023|FG000|NOT COMPLETED|Overall Study||103
8760565|NCT01218308|9810024|FG001|NOT COMPLETED|Overall Study||120
8760566|NCT01218399|9810032|FG000|STARTED|Overall Study||5
8760567|NCT01218399|9810033|FG001|STARTED|Overall Study||5
8760568|NCT01218399|9810032|FG000|COMPLETED|Overall Study||5
8760569|NCT01218399|9810033|FG001|COMPLETED|Overall Study||5
8760570|NCT01218399|9810032|FG000|NOT COMPLETED|Overall Study||0
8760571|NCT01218399|9810033|FG001|NOT COMPLETED|Overall Study||0
8760572|NCT01218438|9810039|FG000|STARTED|Epoch 1||77
8760573|NCT01218438|9810039|FG000|COMPLETED|Epoch 1||74
8760574|NCT01218438|9810039|FG000|NOT COMPLETED|Epoch 1||3
8760575|NCT01218438|9810039|FG000|STARTED|Epoch 2||45
8760576|NCT01218438|9810039|FG000|COMPLETED|Epoch 2||45
8760577|NCT01218438|9810039|FG000|NOT COMPLETED|Epoch 2||0
8760578|NCT01218438|9810039|FG000|STARTED|Epoch 3||74
8760579|NCT01218438|9810039|FG000|COMPLETED|Epoch 3||70
8760580|NCT01218438|9810039|FG000|NOT COMPLETED|Epoch 3||4
8760581|NCT01218438|9810039|FG000|STARTED|Epoch 4||70
8760582|NCT01218438|9810039|FG000|COMPLETED|Epoch 4||67
8760583|NCT01218438|9810039|FG000|NOT COMPLETED|Epoch 4||3
8760584|NCT01218477|9810117|FG000|STARTED|Overall Study|Participants who received treatment|3
8760585|NCT01218477|9810118|FG001|STARTED|Overall Study|Participants who received treatment|8
8760586|NCT01218477|9810119|FG002|STARTED|Overall Study|Participants who received treatment|14
8760587|NCT01218477|9810120|FG003|STARTED|Overall Study|Participants who received treatment|2
8760588|NCT01218477|9810117|FG000|COMPLETED|Overall Study|Still receiving study drug|0
8760589|NCT01218477|9810118|FG001|COMPLETED|Overall Study|Still receiving study drug|0
8760590|NCT01218477|9810119|FG002|COMPLETED|Overall Study|Still receiving study drug|0
8760591|NCT01218477|9810120|FG003|COMPLETED|Overall Study|Still receiving study drug|0
8760592|NCT01218477|9810117|FG000|NOT COMPLETED|Overall Study||3
8760593|NCT01218477|9810118|FG001|NOT COMPLETED|Overall Study||8
8760594|NCT01218477|9810119|FG002|NOT COMPLETED|Overall Study||14
8760595|NCT01218477|9810120|FG003|NOT COMPLETED|Overall Study||2
8760596|NCT01218516|9810136|FG000|STARTED|Combination Therapy (up to 4.5 Months)||67
8760597|NCT01218516|9810137|FG001|STARTED|Combination Therapy (up to 4.5 Months)||63
8760598|NCT01218516|9810138|FG002|STARTED|Combination Therapy (up to 4.5 Months)||0
8760599|NCT01218516|9810139|FG003|STARTED|Combination Therapy (up to 4.5 Months)||0
8760600|NCT01218516|9810136|FG000|COMPLETED|Combination Therapy (up to 4.5 Months)||38
8760601|NCT01218516|9810137|FG001|COMPLETED|Combination Therapy (up to 4.5 Months)||28
8760602|NCT01218516|9810138|FG002|COMPLETED|Combination Therapy (up to 4.5 Months)||0
8760603|NCT01218516|9810139|FG003|COMPLETED|Combination Therapy (up to 4.5 Months)||0
8760604|NCT01218516|9810136|FG000|NOT COMPLETED|Combination Therapy (up to 4.5 Months)||29
8760605|NCT01218516|9810137|FG001|NOT COMPLETED|Combination Therapy (up to 4.5 Months)||35
8760606|NCT01218516|9810138|FG002|NOT COMPLETED|Combination Therapy (up to 4.5 Months)||0
8760607|NCT01218516|9810139|FG003|NOT COMPLETED|Combination Therapy (up to 4.5 Months)||0
8760608|NCT01218516|9810136|FG000|STARTED|Monotherapy (up to 23.5 Months)|This phase ended once all participants finished.|0
8760609|NCT01218516|9810137|FG001|STARTED|Monotherapy (up to 23.5 Months)|This phase ended once all participants finished.|0
8760610|NCT01218516|9810138|FG002|STARTED|Monotherapy (up to 23.5 Months)|Only eligible participants entered this phase of the study.|38
8760611|NCT01218516|9810139|FG003|STARTED|Monotherapy (up to 23.5 Months)|Only eligible participants entered this phase of the study.|28
8760612|NCT01218516|9810136|FG000|Safety Analysis Set|Monotherapy (up to 23.5 Months)||0
8760613|NCT01218516|9810137|FG001|Safety Analysis Set|Monotherapy (up to 23.5 Months)||0
8760614|NCT01218516|9810138|FG002|Safety Analysis Set|Monotherapy (up to 23.5 Months)||35
8760615|NCT01218516|9810139|FG003|Safety Analysis Set|Monotherapy (up to 23.5 Months)|Three participants were randomized to placebo but actually received Farletuzumab.|31
8760616|NCT01218516|9810136|FG000|COMPLETED|Monotherapy (up to 23.5 Months)||0
8760617|NCT01218516|9810137|FG001|COMPLETED|Monotherapy (up to 23.5 Months)||0
8760618|NCT01218516|9810138|FG002|COMPLETED|Monotherapy (up to 23.5 Months)||38
8760619|NCT01218516|9810139|FG003|COMPLETED|Monotherapy (up to 23.5 Months)||28
8760620|NCT01218516|9810136|FG000|NOT COMPLETED|Monotherapy (up to 23.5 Months)||0
8760621|NCT01218516|9810137|FG001|NOT COMPLETED|Monotherapy (up to 23.5 Months)||0
8760622|NCT01218516|9810138|FG002|NOT COMPLETED|Monotherapy (up to 23.5 Months)||0
8760623|NCT01218516|9810139|FG003|NOT COMPLETED|Monotherapy (up to 23.5 Months)||0
8760624|NCT01218542|9810149|FG000|STARTED|Overall Study||22
8760625|NCT01218542|9810149|FG000|COMPLETED|Overall Study||13
8760626|NCT01218542|9810149|FG000|NOT COMPLETED|Overall Study||9
8760627|NCT01218594|9810154|FG000|STARTED|Overall Study||48
8760628|NCT01218594|9810154|FG000|COMPLETED|Overall Study||36
8760629|NCT01218594|9810154|FG000|NOT COMPLETED|Overall Study||12
8760630|NCT01218646|9810162|FG000|STARTED|Overall Study||225
8760631|NCT01218646|9810163|FG001|STARTED|Overall Study||225
8760632|NCT01218646|9810164|FG002|STARTED|Overall Study||225
8760633|NCT01218646|9810165|FG003|STARTED|Overall Study||64
8760634|NCT01218646|9810162|FG000|COMPLETED|Overall Study||224
8760635|NCT01218646|9810163|FG001|COMPLETED|Overall Study||225
8760636|NCT01218646|9810164|FG002|COMPLETED|Overall Study||223
8760637|NCT01218646|9810165|FG003|COMPLETED|Overall Study||63
8760638|NCT01218646|9810162|FG000|NOT COMPLETED|Overall Study||1
8760639|NCT01218646|9810163|FG001|NOT COMPLETED|Overall Study||0
8760640|NCT01218646|9810164|FG002|NOT COMPLETED|Overall Study||2
8760641|NCT01218646|9810165|FG003|NOT COMPLETED|Overall Study||1
8760642|NCT01218659|9810177|FG000|STARTED|18-Month Randomized Period||36
8760643|NCT01218659|9810178|FG001|STARTED|18-Month Randomized Period||24
8760644|NCT01218659|9810179|FG002|STARTED|18-Month Randomized Period|Zero participants are noted here because participants started in this group during the 12-month OLE.|0
8760645|NCT01218659|9810177|FG000|Safety Population|18-Month Randomized Period||36
8760646|NCT01218659|9810178|FG001|Safety Population|18-Month Randomized Period||21
8760647|NCT01218659|9810179|FG002|Safety Population|18-Month Randomized Period|Zero participants are noted here because participants started in this group during the 12-month OLE.|0
8760648|NCT01218659|9810177|FG000|COMPLETED|18-Month Randomized Period||34
8760649|NCT01218659|9810178|FG001|COMPLETED|18-Month Randomized Period||18
8760650|NCT01218659|9810179|FG002|COMPLETED|18-Month Randomized Period|Zero participants are noted here because participants started in this group during the 12-month OLE.|0
8760651|NCT01218659|9810177|FG000|NOT COMPLETED|18-Month Randomized Period||2
8760652|NCT01218659|9810178|FG001|NOT COMPLETED|18-Month Randomized Period||6
8760653|NCT01218659|9810179|FG002|NOT COMPLETED|18-Month Randomized Period||0
8760654|NCT01218659|9810177|FG000|STARTED|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
8915403|NCT02174562|9974810|FG000|COMPLETED|Overall Study||41
8915404|NCT02174562|9974811|FG001|COMPLETED|Overall Study||46
8915405|NCT02174562|9974810|FG000|NOT COMPLETED|Overall Study||9
8915406|NCT02174562|9974811|FG001|NOT COMPLETED|Overall Study||5
8915407|NCT02174627|9974819|FG000|STARTED|Overall Study||1384
8915408|NCT02174627|9974820|FG001|STARTED|Overall Study||1377
8915409|NCT02174627|9974819|FG000|Received Treatment|Overall Study||1384
8915410|NCT02174627|9974820|FG001|Received Treatment|Overall Study||1376
8915411|NCT02174627|9974819|FG000|Discontinued Treatment|Overall Study||499
8915412|NCT02174627|9974820|FG001|Discontinued Treatment|Overall Study||801
8915413|NCT02174627|9974819|FG000|COMPLETED|Overall Study||1300
8915414|NCT02174627|9974820|FG001|COMPLETED|Overall Study||1247
8915415|NCT02174627|9974819|FG000|NOT COMPLETED|Overall Study||84
8915416|NCT02174627|9974820|FG001|NOT COMPLETED|Overall Study||130
8915417|NCT02174731|9974828|FG000|STARTED|Overall Study||1051
8915418|NCT02174731|9974829|FG001|STARTED|Overall Study||1055
8915419|NCT02174731|9974828|FG000|Received Treatment|Overall Study||1048
8915420|NCT02174731|9974829|FG001|Received Treatment|Overall Study||1053
8915421|NCT02174731|9974828|FG000|COMPLETED|Overall Study||982
8915422|NCT02174731|9974829|FG001|COMPLETED|Overall Study||990
8915423|NCT02174731|9974828|FG000|NOT COMPLETED|Overall Study||69
8915424|NCT02174731|9974829|FG001|NOT COMPLETED|Overall Study||65
8915425|NCT02174848|9974837|FG000|STARTED|Overall Study||24
8915426|NCT02174848|9974838|FG001|STARTED|Overall Study||44
8915427|NCT02174848|9974837|FG000|Provided Post-baseline Efficacy Data|Overall Study||19
8915428|NCT02174848|9974838|FG001|Provided Post-baseline Efficacy Data|Overall Study||43
8915429|NCT02174848|9974837|FG000|COMPLETED|Overall Study||17
8915430|NCT02174848|9974838|FG001|COMPLETED|Overall Study||38
8915431|NCT02174848|9974837|FG000|NOT COMPLETED|Overall Study||7
8915432|NCT02174848|9974838|FG001|NOT COMPLETED|Overall Study||6
8915433|NCT02174913|9974851|FG000|STARTED|Overall Study||17
8915434|NCT02174913|9974852|FG001|STARTED|Overall Study||17
8915435|NCT02174913|9974851|FG000|COMPLETED|Overall Study||17
8915436|NCT02174913|9974852|FG001|COMPLETED|Overall Study||17
8915437|NCT02174913|9974851|FG000|NOT COMPLETED|Overall Study||0
8915438|NCT02174913|9974852|FG001|NOT COMPLETED|Overall Study||0
8915439|NCT02175121|9974863|FG000|STARTED|Overall Study||34
8915440|NCT02175121|9974864|FG001|STARTED|Overall Study||35
8915441|NCT02175121|9974865|FG002|STARTED|Overall Study||34
8915442|NCT02175121|9974866|FG003|STARTED|Overall Study||35
8915443|NCT02175121|9974867|FG004|STARTED|Overall Study||34
8915444|NCT02175121|9974863|FG000|COMPLETED|Overall Study||33
8915445|NCT02175121|9974864|FG001|COMPLETED|Overall Study||34
8915446|NCT02175121|9974865|FG002|COMPLETED|Overall Study||32
8915447|NCT02175121|9974866|FG003|COMPLETED|Overall Study||34
8915448|NCT02175121|9974867|FG004|COMPLETED|Overall Study||33
8915449|NCT02175121|9974863|FG000|NOT COMPLETED|Overall Study||1
8915450|NCT02175121|9974864|FG001|NOT COMPLETED|Overall Study||1
8915451|NCT02175121|9974865|FG002|NOT COMPLETED|Overall Study||2
8915452|NCT02175121|9974866|FG003|NOT COMPLETED|Overall Study||1
8915453|NCT02175121|9974867|FG004|NOT COMPLETED|Overall Study||1
8915454|NCT02175199|9974885|FG000|STARTED|Overall Study||74
8915455|NCT02175199|9974886|FG001|STARTED|Overall Study||76
8915456|NCT02175199|9974885|FG000|Dispensed|Overall Study|Two subjects were randomized but never dispensed study lenses.|72
8915457|NCT02175199|9974886|FG001|Dispensed|Overall Study|Two subjects were randomized but never dispensed study lenses.|74
8915458|NCT02175199|9974885|FG000|COMPLETED|Overall Study||71
8915459|NCT02175199|9974886|FG001|COMPLETED|Overall Study||71
8915460|NCT02175199|9974885|FG000|NOT COMPLETED|Overall Study||3
8915461|NCT02175199|9974886|FG001|NOT COMPLETED|Overall Study||5
8915462|NCT02175212|9974895|FG000|STARTED|Overall Study||177
9025732|NCT03166124|10088124|FG003|COMPLETED|Treatment Period 1||21
9025733|NCT03166124|10088121|FG000|NOT COMPLETED|Treatment Period 1||0
9025734|NCT03166124|10088122|FG001|NOT COMPLETED|Treatment Period 1||0
9025735|NCT03166124|10088123|FG002|NOT COMPLETED|Treatment Period 1||1
9025736|NCT03166124|10088124|FG003|NOT COMPLETED|Treatment Period 1||0
9025737|NCT03166124|10088121|FG000|STARTED|Wash-out Period||20
9025738|NCT03166124|10088122|FG001|STARTED|Wash-out Period||20
9025739|NCT03166124|10088123|FG002|STARTED|Wash-out Period||18
8915463|NCT02175212|9974896|FG001|STARTED|Overall Study||178
8915464|NCT02175212|9974895|FG000|COMPLETED|Overall Study||14
8915465|NCT02175212|9974896|FG001|COMPLETED|Overall Study||31
9025740|NCT03166124|10088124|FG003|STARTED|Wash-out Period||21
8760655|NCT01218659|9810178|FG001|STARTED|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
8760656|NCT01218659|9810179|FG002|STARTED|12-Month OLE|Fifty-two participants completed the 18-mo. randomized treatment period.|52
8760657|NCT01218659|9810177|FG000|Safety Population|12-Month OLE||0
8760658|NCT01218659|9810178|FG001|Safety Population|12-Month OLE||0
8760659|NCT01218659|9810179|FG002|Safety Population|12-Month OLE||51
8760660|NCT01218659|9810177|FG000|Modified Intent-to-Treat (mITT)|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
8760661|NCT01218659|9810178|FG001|Modified Intent-to-Treat (mITT)|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
8760662|NCT01218659|9810179|FG002|Modified Intent-to-Treat (mITT)|12-Month OLE||46
8760663|NCT01218659|9810177|FG000|COMPLETED|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
8760664|NCT01218659|9810178|FG001|COMPLETED|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
8760665|NCT01218659|9810179|FG002|COMPLETED|12-Month OLE||42
8760666|NCT01218659|9810177|FG000|NOT COMPLETED|12-Month OLE||0
8760667|NCT01218659|9810178|FG001|NOT COMPLETED|12-Month OLE||0
8760668|NCT01218659|9810179|FG002|NOT COMPLETED|12-Month OLE||10
8760669|NCT01218672|9810188|FG000|STARTED|Overall Study||139
8760670|NCT01218672|9810189|FG001|STARTED|Overall Study||142
8760671|NCT01218672|9810188|FG000|Treated|Overall Study||136
8760672|NCT01218672|9810189|FG001|Treated|Overall Study||133
8760673|NCT01218672|9810188|FG000|COMPLETED|Overall Study||128
8760674|NCT01218672|9810189|FG001|COMPLETED|Overall Study||121
8760675|NCT01218672|9810188|FG000|NOT COMPLETED|Overall Study||11
8760676|NCT01218672|9810189|FG001|NOT COMPLETED|Overall Study||21
8760677|NCT01218802|9810199|FG000|STARTED|Overall Study||72
8760678|NCT01218802|9810200|FG001|STARTED|Overall Study||75
8760679|NCT01218802|9810199|FG000|COMPLETED|Overall Study||62
8760680|NCT01218802|9810200|FG001|COMPLETED|Overall Study||57
8760681|NCT01218802|9810199|FG000|NOT COMPLETED|Overall Study||10
8760682|NCT01218802|9810200|FG001|NOT COMPLETED|Overall Study||18
8760683|NCT01218867|9810217|FG000|STARTED|Overall Study||1
8760684|NCT01218867|9810218|FG001|STARTED|Overall Study||1
8760685|NCT01218867|9810219|FG002|STARTED|Overall Study||3
8760686|NCT01218867|9810220|FG003|STARTED|Overall Study||1
8760687|NCT01218867|9810221|FG004|STARTED|Overall Study||1
8760688|NCT01218867|9810222|FG005|STARTED|Overall Study||1
8760689|NCT01218867|9810223|FG006|STARTED|Overall Study||4
8760690|NCT01218867|9810224|FG007|STARTED|Overall Study||3
8760691|NCT01218867|9810225|FG008|STARTED|Overall Study||3
8760692|NCT01218867|9810226|FG009|STARTED|Overall Study||4
8760693|NCT01218867|9810227|FG010|STARTED|Overall Study||2
8760694|NCT01218867|9810217|FG000|COMPLETED|Overall Study||1
8760695|NCT01218867|9810218|FG001|COMPLETED|Overall Study||1
8760696|NCT01218867|9810219|FG002|COMPLETED|Overall Study||3
8760697|NCT01218867|9810220|FG003|COMPLETED|Overall Study||1
8760698|NCT01218867|9810221|FG004|COMPLETED|Overall Study||1
8760699|NCT01218867|9810222|FG005|COMPLETED|Overall Study||1
8760700|NCT01218867|9810223|FG006|COMPLETED|Overall Study||3
8760701|NCT01218867|9810224|FG007|COMPLETED|Overall Study||3
8760702|NCT01218867|9810225|FG008|COMPLETED|Overall Study||3
8760703|NCT01218867|9810226|FG009|COMPLETED|Overall Study||4
8760704|NCT01218867|9810227|FG010|COMPLETED|Overall Study||2
8760705|NCT01218867|9810217|FG000|NOT COMPLETED|Overall Study||0
8760706|NCT01218867|9810218|FG001|NOT COMPLETED|Overall Study||0
8760707|NCT01218867|9810219|FG002|NOT COMPLETED|Overall Study||0
8760708|NCT01218867|9810220|FG003|NOT COMPLETED|Overall Study||0
8760709|NCT01218867|9810221|FG004|NOT COMPLETED|Overall Study||0
8760710|NCT01218867|9810222|FG005|NOT COMPLETED|Overall Study||0
8760711|NCT01218867|9810223|FG006|NOT COMPLETED|Overall Study||1
8760712|NCT01218867|9810224|FG007|NOT COMPLETED|Overall Study||0
8760713|NCT01218867|9810225|FG008|NOT COMPLETED|Overall Study||0
8760714|NCT01218867|9810226|FG009|NOT COMPLETED|Overall Study||0
8760715|NCT01218867|9810227|FG010|NOT COMPLETED|Overall Study||0
8808270|NCT01490450|9860669|FG002|STARTED|Period 2||37
8808271|NCT01490450|9860670|FG003|STARTED|Period 2||32
8808272|NCT01490450|9860667|FG000|COMPLETED|Period 2||36
8808273|NCT01490450|9860668|FG001|COMPLETED|Period 2||39
8808274|NCT01490450|9860669|FG002|COMPLETED|Period 2||37
8808275|NCT01490450|9860670|FG003|COMPLETED|Period 2||28
8808276|NCT01490450|9860667|FG000|NOT COMPLETED|Period 2||2
8808277|NCT01490450|9860668|FG001|NOT COMPLETED|Period 2||1
8808278|NCT01490450|9860669|FG002|NOT COMPLETED|Period 2||0
8808279|NCT01490450|9860670|FG003|NOT COMPLETED|Period 2||4
8808280|NCT01490580|9860685|FG000|STARTED|Overall Study||82
8808281|NCT01490580|9860686|FG001|STARTED|Overall Study||91
8808282|NCT01490580|9860685|FG000|COMPLETED|Overall Study||82
8808283|NCT01490580|9860686|FG001|COMPLETED|Overall Study||89
8808284|NCT01490580|9860685|FG000|NOT COMPLETED|Overall Study||0
8808285|NCT01490580|9860686|FG001|NOT COMPLETED|Overall Study||2
8808286|NCT01490632|9860701|FG000|STARTED|Part A: Initial Treatment Period||34
8808287|NCT01490632|9860702|FG001|STARTED|Part A: Initial Treatment Period||32
8808288|NCT01490632|9860703|FG002|STARTED|Part A: Initial Treatment Period||72
8808289|NCT01490632|9860704|FG003|STARTED|Part A: Initial Treatment Period||64
8808290|NCT01490632|9860705|FG004|STARTED|Part A: Initial Treatment Period||69
8808291|NCT01490632|9860706|FG005|STARTED|Part A: Initial Treatment Period||0
8808292|NCT01490632|9860707|FG006|STARTED|Part A: Initial Treatment Period||0
8808293|NCT01490632|9860708|FG007|STARTED|Part A: Initial Treatment Period||0
8760716|NCT01218958|9810265|FG000|STARTED|Overall Study||210
8760717|NCT01218958|9810266|FG001|STARTED|Overall Study||205
8760718|NCT01218958|9810267|FG002|STARTED|Overall Study||209
8760719|NCT01218958|9810265|FG000|COMPLETED|Overall Study||126
8760720|NCT01218958|9810266|FG001|COMPLETED|Overall Study||124
8760721|NCT01218958|9810267|FG002|COMPLETED|Overall Study||128
8760722|NCT01218958|9810265|FG000|NOT COMPLETED|Overall Study||84
8760723|NCT01218958|9810266|FG001|NOT COMPLETED|Overall Study||81
8760724|NCT01218958|9810267|FG002|NOT COMPLETED|Overall Study||81
8760725|NCT01218971|9810277|FG000|STARTED|Overall Study||175
9025741|NCT03166124|10088121|FG000|COMPLETED|Wash-out Period||20
9025742|NCT03166124|10088122|FG001|COMPLETED|Wash-out Period||18
9025743|NCT03166124|10088123|FG002|COMPLETED|Wash-out Period||17
9025744|NCT03166124|10088124|FG003|COMPLETED|Wash-out Period||20
9025745|NCT03166124|10088121|FG000|NOT COMPLETED|Wash-out Period||0
9025746|NCT03166124|10088122|FG001|NOT COMPLETED|Wash-out Period||2
9025747|NCT03166124|10088123|FG002|NOT COMPLETED|Wash-out Period||1
9025748|NCT03166124|10088124|FG003|NOT COMPLETED|Wash-out Period||1
9025749|NCT03166124|10088121|FG000|STARTED|Treatment Period 2||20
9025750|NCT03166124|10088122|FG001|STARTED|Treatment Period 2||18
9025751|NCT03166124|10088123|FG002|STARTED|Treatment Period 2||17
9025752|NCT03166124|10088124|FG003|STARTED|Treatment Period 2||20
9025753|NCT03166124|10088121|FG000|COMPLETED|Treatment Period 2||20
9025754|NCT03166124|10088122|FG001|COMPLETED|Treatment Period 2||18
9025755|NCT03166124|10088123|FG002|COMPLETED|Treatment Period 2||17
9025756|NCT03166124|10088124|FG003|COMPLETED|Treatment Period 2||20
9025757|NCT03166124|10088121|FG000|NOT COMPLETED|Treatment Period 2||0
9025758|NCT03166124|10088122|FG001|NOT COMPLETED|Treatment Period 2||0
9025759|NCT03166124|10088123|FG002|NOT COMPLETED|Treatment Period 2||0
9025760|NCT03166124|10088124|FG003|NOT COMPLETED|Treatment Period 2||0
9025761|NCT03166215|10088137|FG000|STARTED|Part 1 (Double-blind TP: Days 1 - 30)||4
9025762|NCT03166215|10088138|FG001|STARTED|Part 1 (Double-blind TP: Days 1 - 30)||14
9025763|NCT03166215|10088139|FG002|STARTED|Part 1 (Double-blind TP: Days 1 - 30)||0
9025764|NCT03166215|10088137|FG000|COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||4
9025765|NCT03166215|10088138|FG001|COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||12
9025766|NCT03166215|10088139|FG002|COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||0
9025767|NCT03166215|10088137|FG000|NOT COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||0
9025768|NCT03166215|10088138|FG001|NOT COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||2
9025769|NCT03166215|10088139|FG002|NOT COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||0
9025770|NCT03166215|10088137|FG000|STARTED|Part 2 (Open-Label TP: Days 31 - 85)||0
9025771|NCT03166215|10088138|FG001|STARTED|Part 2 (Open-Label TP: Days 31 - 85)||0
9025772|NCT03166215|10088139|FG002|STARTED|Part 2 (Open-Label TP: Days 31 - 85)||16
9025773|NCT03166215|10088137|FG000|COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||0
9025774|NCT03166215|10088138|FG001|COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||0
9025775|NCT03166215|10088139|FG002|COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||14
9025776|NCT03166215|10088137|FG000|NOT COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||0
9025777|NCT03166215|10088138|FG001|NOT COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||0
9025778|NCT03166215|10088139|FG002|NOT COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||2
9025779|NCT03166735|10088155|FG000|STARTED|Overall Study||33
9025780|NCT03166735|10088156|FG001|STARTED|Overall Study||16
9025781|NCT03166735|10088157|FG002|STARTED|Overall Study||16
9025782|NCT03166735|10088158|FG003|STARTED|Overall Study||17
9025783|NCT03166735|10088159|FG004|STARTED|Overall Study||32
9025784|NCT03166735|10088155|FG000|Treated|Overall Study||32
9025785|NCT03166735|10088156|FG001|Treated|Overall Study||16
9025786|NCT03166735|10088157|FG002|Treated|Overall Study||16
9025787|NCT03166735|10088158|FG003|Treated|Overall Study||17
9025788|NCT03166735|10088159|FG004|Treated|Overall Study||32
9025789|NCT03166735|10088155|FG000|COMPLETED|Overall Study||32
9025790|NCT03166735|10088156|FG001|COMPLETED|Overall Study||13
9025791|NCT03166735|10088157|FG002|COMPLETED|Overall Study||13
9025792|NCT03166735|10088158|FG003|COMPLETED|Overall Study||16
9025793|NCT03166735|10088159|FG004|COMPLETED|Overall Study||28
9025794|NCT03166735|10088155|FG000|NOT COMPLETED|Overall Study||1
9025795|NCT03166735|10088156|FG001|NOT COMPLETED|Overall Study||3
9025796|NCT03166735|10088157|FG002|NOT COMPLETED|Overall Study||3
9025797|NCT03166735|10088158|FG003|NOT COMPLETED|Overall Study||1
9025798|NCT03166735|10088159|FG004|NOT COMPLETED|Overall Study||4
9025799|NCT03167073|10088174|FG000|STARTED|Overall Study||85
9025800|NCT03167073|10088175|FG001|STARTED|Overall Study||85
9025801|NCT03167073|10088174|FG000|COMPLETED|Overall Study||84
8760726|NCT01218971|9810278|FG001|STARTED|Overall Study||157
8760727|NCT01218971|9810277|FG000|COMPLETED|Overall Study||71
9025802|NCT03167073|10088175|FG001|COMPLETED|Overall Study||85
9025803|NCT03167073|10088174|FG000|NOT COMPLETED|Overall Study||1
9025804|NCT03167073|10088175|FG001|NOT COMPLETED|Overall Study||0
9025805|NCT03167151|10088184|FG000|STARTED|Overall Study||3
9025806|NCT03167151|10088185|FG001|STARTED|Overall Study||3
9025807|NCT03167151|10088186|FG002|STARTED|Overall Study||3
9025808|NCT03167151|10088184|FG000|COMPLETED|Overall Study||2
9025809|NCT03167151|10088185|FG001|COMPLETED|Overall Study||2
9025810|NCT03167151|10088186|FG002|COMPLETED|Overall Study||2
8760728|NCT01218971|9810278|FG001|COMPLETED|Overall Study||77
9025811|NCT03167151|10088184|FG000|NOT COMPLETED|Overall Study||1
9025812|NCT03167151|10088185|FG001|NOT COMPLETED|Overall Study||1
8760729|NCT01218971|9810277|FG000|NOT COMPLETED|Overall Study||104
9025813|NCT03167151|10088186|FG002|NOT COMPLETED|Overall Study||1
9025814|NCT03167359|10088194|FG000|STARTED|Overall Study||74
8760730|NCT01218971|9810278|FG001|NOT COMPLETED|Overall Study||80
8760731|NCT01218984|9810291|FG000|STARTED|Overall Study||9
8760732|NCT01218984|9810292|FG001|STARTED|Overall Study||8
8760733|NCT01218984|9810293|FG002|STARTED|Overall Study||10
8760734|NCT01218984|9810291|FG000|COMPLETED|Overall Study||8
8760735|NCT01218984|9810292|FG001|COMPLETED|Overall Study||6
8760736|NCT01218984|9810293|FG002|COMPLETED|Overall Study||7
8760737|NCT01218984|9810291|FG000|NOT COMPLETED|Overall Study||1
8760738|NCT01218984|9810292|FG001|NOT COMPLETED|Overall Study||2
8760739|NCT01218984|9810293|FG002|NOT COMPLETED|Overall Study||3
8760740|NCT01218997|9810303|FG000|STARTED|Overall Study||371
8760741|NCT01218997|9810304|FG001|STARTED|Overall Study||65
8760742|NCT01218997|9810303|FG000|COMPLETED|Overall Study||126
8760743|NCT01218997|9810304|FG001|COMPLETED|Overall Study||24
8760744|NCT01218997|9810303|FG000|NOT COMPLETED|Overall Study||245
8760745|NCT01218997|9810304|FG001|NOT COMPLETED|Overall Study||41
8760746|NCT01219738|9810310|FG000|STARTED|Overall Study||20
8760747|NCT01219738|9810310|FG000|Budesonide 360|Overall Study||20
8760748|NCT01219738|9810310|FG000|Budesonide 720|Overall Study||20
8760749|NCT01219738|9810310|FG000|Budesonide 1440|Overall Study||20
8760750|NCT01219738|9810310|FG000|Budesonide 720- 4 Times|Overall Study||20
8760751|NCT01219738|9810310|FG000|COMPLETED|Overall Study||20
8760752|NCT01219738|9810310|FG000|NOT COMPLETED|Overall Study||0
8760753|NCT01219777|9810323|FG000|STARTED|Overall Study||9
8760754|NCT01219777|9810323|FG000|COMPLETED|Overall Study||9
8760755|NCT01219777|9810323|FG000|NOT COMPLETED|Overall Study||0
8760756|NCT01219855|9810333|FG000|STARTED|Overall Study||17
8760757|NCT01219855|9810334|FG001|STARTED|Overall Study||17
8760758|NCT01219855|9810335|FG002|STARTED|Overall Study||17
8760759|NCT01219855|9810336|FG003|STARTED|Overall Study||13
8760760|NCT01219855|9810337|FG004|STARTED|Overall Study||14
8760761|NCT01219855|9810333|FG000|COMPLETED|Overall Study||16
8760762|NCT01219855|9810334|FG001|COMPLETED|Overall Study||12
8760763|NCT01219855|9810335|FG002|COMPLETED|Overall Study||16
8760764|NCT01219855|9810336|FG003|COMPLETED|Overall Study||12
8760765|NCT01219855|9810337|FG004|COMPLETED|Overall Study||13
8760766|NCT01219855|9810333|FG000|NOT COMPLETED|Overall Study||1
8760767|NCT01219855|9810334|FG001|NOT COMPLETED|Overall Study||5
8760768|NCT01219855|9810335|FG002|NOT COMPLETED|Overall Study||1
8760769|NCT01219855|9810336|FG003|NOT COMPLETED|Overall Study||1
8760770|NCT01219855|9810337|FG004|NOT COMPLETED|Overall Study||1
8760771|NCT01219881|9810350|FG000|STARTED|Overall Study||38
8760772|NCT01219881|9810351|FG001|STARTED|Overall Study||37
8760773|NCT01219881|9810350|FG000|COMPLETED|Overall Study||34
8760774|NCT01219881|9810351|FG001|COMPLETED|Overall Study||32
8760775|NCT01219881|9810350|FG000|NOT COMPLETED|Overall Study||4
8760776|NCT01219881|9810351|FG001|NOT COMPLETED|Overall Study||5
8760777|NCT01219933|9810357|FG000|STARTED|Overall Study||68
8760778|NCT01219933|9810357|FG000|COMPLETED|Overall Study||30
8760779|NCT01219933|9810357|FG000|NOT COMPLETED|Overall Study||38
8760780|NCT01219959|9810364|FG000|STARTED|Overall Study||127
8760781|NCT01219959|9810365|FG001|STARTED|Overall Study||124
8760782|NCT01219959|9810364|FG000|COMPLETED|Overall Study||120
8760783|NCT01219959|9810365|FG001|COMPLETED|Overall Study||101
8760784|NCT01219959|9810364|FG000|NOT COMPLETED|Overall Study||7
8760785|NCT01219959|9810365|FG001|NOT COMPLETED|Overall Study||23
8760786|NCT01219985|9810371|FG000|STARTED|Overall Study||50
9025815|NCT03167359|10088194|FG000|COMPLETED|Overall Study||72
9025816|NCT03167359|10088194|FG000|NOT COMPLETED|Overall Study||2
9025817|NCT03167411|10088200|FG000|STARTED|Overall Study||10
9025818|NCT03167411|10088201|FG001|STARTED|Overall Study||10
9025819|NCT03167411|10088200|FG000|COMPLETED|Overall Study||10
9025820|NCT03167411|10088201|FG001|COMPLETED|Overall Study||9
9025821|NCT03167411|10088200|FG000|NOT COMPLETED|Overall Study||0
9025822|NCT03167411|10088201|FG001|NOT COMPLETED|Overall Study||1
9025823|NCT03167541|10088207|FG000|STARTED|First Intervention||9
9025824|NCT03167541|10088208|FG001|STARTED|First Intervention||9
9025825|NCT03167541|10088207|FG000|COMPLETED|First Intervention||9
9025826|NCT03167541|10088208|FG001|COMPLETED|First Intervention||9
9025827|NCT03167541|10088207|FG000|NOT COMPLETED|First Intervention||0
9025828|NCT03167541|10088208|FG001|NOT COMPLETED|First Intervention||0
9025829|NCT03167541|10088207|FG000|STARTED|Washout: 5-8 Days||9
9025830|NCT03167541|10088208|FG001|STARTED|Washout: 5-8 Days||9
8760787|NCT01219985|9810371|FG000|COMPLETED|Overall Study||30
8760788|NCT01219985|9810371|FG000|NOT COMPLETED|Overall Study||20
8760789|NCT01220024|9810379|FG000|STARTED|Overall Study||25
9025831|NCT03167541|10088207|FG000|COMPLETED|Washout: 5-8 Days||9
9025832|NCT03167541|10088208|FG001|COMPLETED|Washout: 5-8 Days||9
9025833|NCT03167541|10088207|FG000|NOT COMPLETED|Washout: 5-8 Days||0
9025834|NCT03167541|10088208|FG001|NOT COMPLETED|Washout: 5-8 Days||0
8760790|NCT01220024|9810380|FG001|STARTED|Overall Study||25
8760791|NCT01220024|9810379|FG000|COMPLETED|Overall Study||24
8760792|NCT01220024|9810380|FG001|COMPLETED|Overall Study||24
8760793|NCT01220024|9810379|FG000|NOT COMPLETED|Overall Study||1
8760794|NCT01220024|9810380|FG001|NOT COMPLETED|Overall Study||1
8760795|NCT01220128|9810393|FG000|STARTED|Overall Study||15
8760796|NCT01220128|9810394|FG001|STARTED|Overall Study||7
8760797|NCT01220128|9810395|FG002|STARTED|Overall Study||9
8760798|NCT01220128|9810396|FG003|STARTED|Overall Study||6
8760799|NCT01220128|9810397|FG004|STARTED|Overall Study||11
9025835|NCT03167541|10088207|FG000|STARTED|Second Intervention||9
9025836|NCT03167541|10088208|FG001|STARTED|Second Intervention||9
8760800|NCT01220128|9810398|FG005|STARTED|Overall Study||4
8760801|NCT01220128|9810399|FG006|STARTED|Overall Study||8
8760802|NCT01220128|9810393|FG000|COMPLETED|Overall Study||11
8760803|NCT01220128|9810394|FG001|COMPLETED|Overall Study||6
8760804|NCT01220128|9810395|FG002|COMPLETED|Overall Study||6
8760805|NCT01220128|9810396|FG003|COMPLETED|Overall Study||6
8760806|NCT01220128|9810397|FG004|COMPLETED|Overall Study||11
8760807|NCT01220128|9810398|FG005|COMPLETED|Overall Study||4
8760808|NCT01220128|9810399|FG006|COMPLETED|Overall Study||3
8760809|NCT01220128|9810393|FG000|NOT COMPLETED|Overall Study||4
8760810|NCT01220128|9810394|FG001|NOT COMPLETED|Overall Study||1
8760811|NCT01220128|9810395|FG002|NOT COMPLETED|Overall Study||3
8760812|NCT01220128|9810396|FG003|NOT COMPLETED|Overall Study||0
8760813|NCT01220128|9810397|FG004|NOT COMPLETED|Overall Study||0
8760814|NCT01220128|9810398|FG005|NOT COMPLETED|Overall Study||0
8760815|NCT01220128|9810399|FG006|NOT COMPLETED|Overall Study||5
8760816|NCT01220167|9810419|FG000|STARTED|Period 1||6
8760817|NCT01220167|9810420|FG001|STARTED|Period 1||6
8760818|NCT01220167|9810421|FG002|STARTED|Period 1||6
8760819|NCT01220167|9810419|FG000|COMPLETED|Period 1||6
8760820|NCT01220167|9810420|FG001|COMPLETED|Period 1||6
8760821|NCT01220167|9810421|FG002|COMPLETED|Period 1||6
8760822|NCT01220167|9810419|FG000|NOT COMPLETED|Period 1||0
8760823|NCT01220167|9810420|FG001|NOT COMPLETED|Period 1||0
8760824|NCT01220167|9810421|FG002|NOT COMPLETED|Period 1||0
8760825|NCT01220167|9810419|FG000|STARTED|Period 2||6
8760826|NCT01220167|9810420|FG001|STARTED|Period 2||6
8760827|NCT01220167|9810421|FG002|STARTED|Period 2||6
8760828|NCT01220167|9810419|FG000|COMPLETED|Period 2||6
8760829|NCT01220167|9810420|FG001|COMPLETED|Period 2||6
8760830|NCT01220167|9810421|FG002|COMPLETED|Period 2||6
8760831|NCT01220167|9810419|FG000|NOT COMPLETED|Period 2||0
8760832|NCT01220167|9810420|FG001|NOT COMPLETED|Period 2||0
8760833|NCT01220167|9810421|FG002|NOT COMPLETED|Period 2||0
8760834|NCT01220167|9810419|FG000|STARTED|Period 3||6
8760835|NCT01220167|9810420|FG001|STARTED|Period 3||6
8760836|NCT01220167|9810421|FG002|STARTED|Period 3||6
8760837|NCT01220167|9810419|FG000|COMPLETED|Period 3||6
8760838|NCT01220167|9810420|FG001|COMPLETED|Period 3||5
8760839|NCT01220167|9810421|FG002|COMPLETED|Period 3||6
8760840|NCT01220167|9810419|FG000|NOT COMPLETED|Period 3||0
8760841|NCT01220167|9810420|FG001|NOT COMPLETED|Period 3||1
8760842|NCT01220167|9810421|FG002|NOT COMPLETED|Period 3||0
8760843|NCT01220180|9810430|FG000|STARTED|Overall Study||4175
8760844|NCT01220180|9810430|FG000|Treated|Overall Study||4174
8760845|NCT01220180|9810430|FG000|COMPLETED|Overall Study||3968
8760846|NCT01220180|9810430|FG000|NOT COMPLETED|Overall Study||207
8760847|NCT01220297|9810436|FG000|STARTED|Overall Study||3
8760848|NCT01220297|9810436|FG000|COMPLETED|Overall Study||0
8760849|NCT01220297|9810436|FG000|NOT COMPLETED|Overall Study||3
8760850|NCT01220401|9810442|FG000|STARTED|Overall Study||21
8760851|NCT01220401|9810442|FG000|COMPLETED|Overall Study||18
8760852|NCT01220401|9810442|FG000|NOT COMPLETED|Overall Study||3
8760853|NCT01220414|9810448|FG000|STARTED|Overall Study||15
8760854|NCT01220414|9810449|FG001|STARTED|Overall Study||14
8760855|NCT01220414|9810450|FG002|STARTED|Overall Study||14
8760856|NCT01220414|9810451|FG003|STARTED|Overall Study||15
8760857|NCT01220414|9810448|FG000|COMPLETED|Overall Study||14
8760858|NCT01220414|9810449|FG001|COMPLETED|Overall Study||14
8760859|NCT01220414|9810450|FG002|COMPLETED|Overall Study||14
8760860|NCT01220414|9810451|FG003|COMPLETED|Overall Study||14
8760861|NCT01220414|9810448|FG000|NOT COMPLETED|Overall Study||1
8760862|NCT01220414|9810449|FG001|NOT COMPLETED|Overall Study||0
8760863|NCT01220414|9810450|FG002|NOT COMPLETED|Overall Study||0
8760864|NCT01220414|9810451|FG003|NOT COMPLETED|Overall Study||1
8760865|NCT01220466|9810461|FG000|STARTED|Overall Study|19 eyes|11
8760866|NCT01220466|9810462|FG001|STARTED|Overall Study|108 eyes|56
8760867|NCT01220466|9810463|FG002|STARTED|Overall Study|16 eyes|10
8760868|NCT01220466|9810461|FG000|COMPLETED|Overall Study|19 eyes|11
8760869|NCT01220466|9810462|FG001|COMPLETED|Overall Study|108 eyes|56
8760870|NCT01220466|9810463|FG002|COMPLETED|Overall Study|16 eyes|10
8760871|NCT01220466|9810461|FG000|NOT COMPLETED|Overall Study||0
8760872|NCT01220466|9810462|FG001|NOT COMPLETED|Overall Study||0
8760873|NCT01220466|9810463|FG002|NOT COMPLETED|Overall Study||0
8760874|NCT01220557|9810473|FG000|STARTED|Overall Study||81
8760875|NCT01220557|9810474|FG001|STARTED|Overall Study||79
8760876|NCT01220557|9810473|FG000|COMPLETED|Overall Study|per protocol analysis including patients which participated in at least 6 out of 12 lessons.|75
8760877|NCT01220557|9810474|FG001|COMPLETED|Overall Study|per protocol analysis including patients which participated in at least 6 out of 12 lessons.|74
8760878|NCT01220557|9810473|FG000|NOT COMPLETED|Overall Study||6
8760879|NCT01220557|9810474|FG001|NOT COMPLETED|Overall Study||5
8760880|NCT01220609|9810480|FG000|STARTED|Overall Study||26
8760881|NCT01220609|9810480|FG000|COMPLETED|Overall Study|Eligible and treated patients|23
8760882|NCT01220609|9810480|FG000|NOT COMPLETED|Overall Study||3
8760883|NCT01220687|9810492|FG000|STARTED|Overall Study||16
8760884|NCT01220687|9810493|FG001|STARTED|Overall Study||15
8760885|NCT01220687|9810492|FG000|COMPLETED|Overall Study||14
8760886|NCT01220687|9810493|FG001|COMPLETED|Overall Study||14
8760887|NCT01220687|9810492|FG000|NOT COMPLETED|Overall Study||2
8760888|NCT01220687|9810493|FG001|NOT COMPLETED|Overall Study||1
8760889|NCT01220726|9810501|FG000|STARTED|Overall Study||15
8760890|NCT01220726|9810502|FG001|STARTED|Overall Study||15
8760891|NCT01220726|9810501|FG000|COMPLETED|Overall Study||15
8760892|NCT01220726|9810502|FG001|COMPLETED|Overall Study||13
8760893|NCT01220726|9810501|FG000|NOT COMPLETED|Overall Study||0
8760894|NCT01220726|9810502|FG001|NOT COMPLETED|Overall Study||2
8760895|NCT01220739|9810510|FG000|STARTED|Overall Study||7
8760896|NCT01220739|9810511|FG001|STARTED|Overall Study||5
8760897|NCT01220739|9810510|FG000|COMPLETED|Overall Study||7
8760898|NCT01220739|9810511|FG001|COMPLETED|Overall Study||5
8760899|NCT01220739|9810510|FG000|NOT COMPLETED|Overall Study||0
8760900|NCT01220739|9810511|FG001|NOT COMPLETED|Overall Study||0
8760901|NCT01220856|9810519|FG000|STARTED|Overall Study||6
8760902|NCT01220856|9810520|FG001|STARTED|Overall Study||3
8760903|NCT01220856|9810519|FG000|COMPLETED|Overall Study||2
8760904|NCT01220856|9810520|FG001|COMPLETED|Overall Study||0
8760905|NCT01220856|9810519|FG000|NOT COMPLETED|Overall Study||4
8760906|NCT01220856|9810520|FG001|NOT COMPLETED|Overall Study||3
8760907|NCT01220869|9810529|FG000|STARTED|Overall Study||110
8760908|NCT01220869|9810529|FG000|COMPLETED|Overall Study||104
8760909|NCT01220869|9810529|FG000|NOT COMPLETED|Overall Study||6
8760910|NCT01220973|9810533|FG000|STARTED|Overall Study||27
8760911|NCT01220973|9810533|FG000|COMPLETED|Overall Study||23
8760912|NCT01220973|9810533|FG000|NOT COMPLETED|Overall Study||4
8760913|NCT01220999|9810542|FG000|STARTED|Overall Study||2
8760914|NCT01220999|9810543|FG001|STARTED|Overall Study||4
8760915|NCT01220999|9810544|FG002|STARTED|Overall Study||5
8760916|NCT01220999|9810545|FG003|STARTED|Overall Study||3
8760917|NCT01220999|9810546|FG004|STARTED|Overall Study||5
8760918|NCT01220999|9810542|FG000|COMPLETED|Overall Study||2
8760919|NCT01220999|9810543|FG001|COMPLETED|Overall Study||4
8760920|NCT01220999|9810544|FG002|COMPLETED|Overall Study||4
8760921|NCT01220999|9810545|FG003|COMPLETED|Overall Study||3
8760922|NCT01220999|9810546|FG004|COMPLETED|Overall Study||5
8760923|NCT01220999|9810542|FG000|NOT COMPLETED|Overall Study||0
8760924|NCT01220999|9810543|FG001|NOT COMPLETED|Overall Study||0
8760925|NCT01220999|9810544|FG002|NOT COMPLETED|Overall Study||1
8760926|NCT01220999|9810545|FG003|NOT COMPLETED|Overall Study||0
8760927|NCT01220999|9810546|FG004|NOT COMPLETED|Overall Study||0
8760928|NCT01221090|9810562|FG000|STARTED|Overall Study||101
8760929|NCT01221090|9810563|FG001|STARTED|Overall Study||81
8760930|NCT01221090|9810564|FG002|STARTED|Overall Study||99
8760931|NCT01221090|9810565|FG003|STARTED|Overall Study||95
8760932|NCT01221090|9810562|FG000|COMPLETED|Overall Study||86
8760933|NCT01221090|9810563|FG001|COMPLETED|Overall Study||47
8760934|NCT01221090|9810564|FG002|COMPLETED|Overall Study||57
8760935|NCT01221090|9810565|FG003|COMPLETED|Overall Study||73
8760936|NCT01221090|9810562|FG000|NOT COMPLETED|Overall Study||15
8760937|NCT01221090|9810563|FG001|NOT COMPLETED|Overall Study||34
8760938|NCT01221090|9810564|FG002|NOT COMPLETED|Overall Study||42
8760939|NCT01221090|9810565|FG003|NOT COMPLETED|Overall Study||22
8760940|NCT01221181|9810575|FG000|STARTED|Overall Study||6
8760941|NCT01221181|9810575|FG000|COMPLETED|Overall Study||5
8760942|NCT01221181|9810575|FG000|NOT COMPLETED|Overall Study||1
8760943|NCT01221194|9810581|FG000|STARTED|Overall Study||195
8760944|NCT01221194|9810582|FG001|STARTED|Overall Study||186
8760945|NCT01221194|9810581|FG000|COMPLETED|Overall Study||195
8760946|NCT01221194|9810582|FG001|COMPLETED|Overall Study||186
8760947|NCT01221194|9810581|FG000|NOT COMPLETED|Overall Study||0
8760948|NCT01221194|9810582|FG001|NOT COMPLETED|Overall Study||0
8760949|NCT01221207|9810591|FG000|STARTED|Overall Study||75
8760950|NCT01221207|9810592|FG001|STARTED|Overall Study||75
8760951|NCT01221207|9810593|FG002|STARTED|Overall Study||75
8760952|NCT01221207|9810591|FG000|COMPLETED|Overall Study||43
8760953|NCT01221207|9810592|FG001|COMPLETED|Overall Study||66
8760954|NCT01221207|9810593|FG002|COMPLETED|Overall Study||54
8760955|NCT01221207|9810591|FG000|NOT COMPLETED|Overall Study||32
8760956|NCT01221207|9810592|FG001|NOT COMPLETED|Overall Study||9
8760957|NCT01221207|9810593|FG002|NOT COMPLETED|Overall Study||21
8760958|NCT01221233|9810603|FG000|STARTED|Overall Study||18
8760959|NCT01221233|9810604|FG001|STARTED|Overall Study||20
8760960|NCT01221233|9810603|FG000|COMPLETED|Overall Study||15
8760961|NCT01221233|9810604|FG001|COMPLETED|Overall Study||19
8760962|NCT01221233|9810603|FG000|NOT COMPLETED|Overall Study||3
8760963|NCT01221233|9810604|FG001|NOT COMPLETED|Overall Study||1
8760964|NCT01221272|9810610|FG000|STARTED|Period 1||41
8760965|NCT01221272|9810611|FG001|STARTED|Period 1||40
8760966|NCT01221272|9810610|FG000|COMPLETED|Period 1||39
8760967|NCT01221272|9810611|FG001|COMPLETED|Period 1||38
8760968|NCT01221272|9810610|FG000|NOT COMPLETED|Period 1||2
8760969|NCT01221272|9810611|FG001|NOT COMPLETED|Period 1||2
8760970|NCT01221272|9810610|FG000|STARTED|Period 2||39
8760971|NCT01221272|9810611|FG001|STARTED|Period 2|1 participant did not complete Period 1, but started and completed Period 2.|39
8760972|NCT01221272|9810610|FG000|COMPLETED|Period 2||39
8760973|NCT01221272|9810611|FG001|COMPLETED|Period 2||37
8760974|NCT01221272|9810610|FG000|NOT COMPLETED|Period 2||0
8760975|NCT01221272|9810611|FG001|NOT COMPLETED|Period 2||2
8760976|NCT01221285|9810620|FG000|STARTED|Overall Study||11
8760977|NCT01221285|9810620|FG000|COMPLETED|Overall Study||10
8760978|NCT01221285|9810620|FG000|NOT COMPLETED|Overall Study||1
8760979|NCT01221298|9810624|FG000|STARTED|Overall Study||11
8760980|NCT01221298|9810624|FG000|COMPLETED|Overall Study|The number of participants who completed study drug|11
8760981|NCT01221298|9810624|FG000|NOT COMPLETED|Overall Study||0
8760982|NCT01221311|9810630|FG000|STARTED|Overall Study||57
8760983|NCT01221311|9810631|FG001|STARTED|Overall Study||55
8760984|NCT01221311|9810630|FG000|COMPLETED|Overall Study||57
8760985|NCT01221311|9810631|FG001|COMPLETED|Overall Study||55
8760986|NCT01221311|9810630|FG000|NOT COMPLETED|Overall Study||0
8760987|NCT01221311|9810631|FG001|NOT COMPLETED|Overall Study||0
8760988|NCT01221350|9810639|FG000|STARTED|Overall Study||28
8760989|NCT01221350|9810640|FG001|STARTED|Overall Study||27
8760990|NCT01221350|9810639|FG000|Received Intervention|Overall Study||28
8760991|NCT01221350|9810640|FG001|Received Intervention|Overall Study||27
8760992|NCT01221350|9810639|FG000|Analysis Population|Overall Study||23
8760993|NCT01221350|9810640|FG001|Analysis Population|Overall Study||24
8760994|NCT01221350|9810639|FG000|COMPLETED|Overall Study||23
8760995|NCT01221350|9810640|FG001|COMPLETED|Overall Study||24
8760996|NCT01221350|9810639|FG000|NOT COMPLETED|Overall Study||5
8760997|NCT01221350|9810640|FG001|NOT COMPLETED|Overall Study||3
8760998|NCT01221363|9810650|FG000|STARTED|Overall Study||93
8760999|NCT01221363|9810651|FG001|STARTED|Overall Study||73
8761000|NCT01221363|9810650|FG000|COMPLETED|Overall Study||81
8761001|NCT01221363|9810651|FG001|COMPLETED|Overall Study||68
8761002|NCT01221363|9810650|FG000|NOT COMPLETED|Overall Study||12
8761003|NCT01221363|9810651|FG001|NOT COMPLETED|Overall Study||5
8761004|NCT01221441|9810659|FG000|STARTED|Overall Study||67
8761005|NCT01221441|9810660|FG001|STARTED|Overall Study||35
8761006|NCT01221441|9810659|FG000|COMPLETED|Overall Study||45
8761007|NCT01221441|9810660|FG001|COMPLETED|Overall Study||23
8761008|NCT01221441|9810659|FG000|NOT COMPLETED|Overall Study||22
8761009|NCT01221441|9810660|FG001|NOT COMPLETED|Overall Study||12
8761010|NCT01221597|9810668|FG000|STARTED|Overall Study||277
8761011|NCT01221597|9810669|FG001|STARTED|Overall Study||140
8761012|NCT01221597|9810668|FG000|COMPLETED|Overall Study||241
8761013|NCT01221597|9810669|FG001|COMPLETED|Overall Study||124
8761014|NCT01221597|9810668|FG000|NOT COMPLETED|Overall Study||36
8761015|NCT01221597|9810669|FG001|NOT COMPLETED|Overall Study||16
8761016|NCT01221623|9810678|FG000|STARTED|Overall Study||274
8761017|NCT01221623|9810679|FG001|STARTED|Overall Study||141
8761018|NCT01221623|9810678|FG000|COMPLETED|Overall Study||236
8761019|NCT01221623|9810679|FG001|COMPLETED|Overall Study||127
8761020|NCT01221623|9810678|FG000|NOT COMPLETED|Overall Study||38
8761021|NCT01221623|9810679|FG001|NOT COMPLETED|Overall Study||14
8761022|NCT01221727|9810687|FG000|STARTED|Overall Study|Number of subjects randomized into the study|21
8761023|NCT01221727|9810688|FG001|STARTED|Overall Study|Number of subjects randomized into the study|9
8761024|NCT01221727|9810687|FG000|Treated|Overall Study|Number of subjects received investigational product|19
8761025|NCT01221727|9810688|FG001|Treated|Overall Study|Number of subjects received investigational product|8
8761026|NCT01221727|9810687|FG000|COMPLETED|Overall Study||18
8761027|NCT01221727|9810688|FG001|COMPLETED|Overall Study||8
8761028|NCT01221727|9810687|FG000|NOT COMPLETED|Overall Study||3
8761029|NCT01221727|9810688|FG001|NOT COMPLETED|Overall Study||1
8761030|NCT01221753|9810700|FG000|STARTED|Overall Study||7
8761031|NCT01221753|9810700|FG000|COMPLETED|Overall Study||6
8761032|NCT01221753|9810700|FG000|NOT COMPLETED|Overall Study||1
8761033|NCT01221857|9810704|FG000|STARTED|Overall Study||12
8761034|NCT01221857|9810704|FG000|COMPLETED|Overall Study||12
8761035|NCT01221857|9810704|FG000|NOT COMPLETED|Overall Study||0
8761036|NCT01221948|9810712|FG000|STARTED|Overall Study||53
8761037|NCT01221948|9810712|FG000|COMPLETED|Overall Study||39
8761038|NCT01221948|9810712|FG000|NOT COMPLETED|Overall Study||14
8761039|NCT01222078|9810716|FG000|STARTED|Overall Study||1
8761040|NCT01222078|9810716|FG000|COMPLETED|Overall Study||0
8761041|NCT01222078|9810716|FG000|NOT COMPLETED|Overall Study||1
8761042|NCT01222091|9810721|FG000|STARTED|Overall Study||5
8761043|NCT01222091|9810722|FG001|STARTED|Overall Study||5
8761044|NCT01222091|9810721|FG000|COMPLETED|Overall Study||5
8761045|NCT01222091|9810722|FG001|COMPLETED|Overall Study||5
8761046|NCT01222091|9810721|FG000|NOT COMPLETED|Overall Study||0
8761047|NCT01222091|9810722|FG001|NOT COMPLETED|Overall Study||0
8761048|NCT01222104|9810728|FG000|STARTED|Overall Study||634
8761049|NCT01222104|9810728|FG000|Angio-Seal Deployment Attempted|Overall Study||534
8761050|NCT01222104|9810728|FG000|Successful Deployment|Overall Study||529
8761051|NCT01222104|9810728|FG000|Successful Deployment and Hemostasis|Overall Study||524
8761052|NCT01222104|9810728|FG000|Completed 30-day Visit-Angio-Seal|Overall Study||497
8761053|NCT01222104|9810728|FG000|Completed 30-day Visit-No Angio-Seal|Overall Study||90
8761054|NCT01222104|9810728|FG000|COMPLETED|Overall Study||587
8761055|NCT01222104|9810728|FG000|NOT COMPLETED|Overall Study||47
8761056|NCT01222117|9810749|FG000|STARTED|Overall Study||20
8761057|NCT01222117|9810750|FG001|STARTED|Overall Study||20
8761058|NCT01222117|9810751|FG002|STARTED|Overall Study||22
8761059|NCT01222117|9810752|FG003|STARTED|Overall Study||20
8761060|NCT01222117|9810753|FG004|STARTED|Overall Study||9
8761061|NCT01222117|9810754|FG005|STARTED|Overall Study||10
8761062|NCT01222117|9810755|FG006|STARTED|Overall Study||13
8761063|NCT01222117|9810756|FG007|STARTED|Overall Study||12
8761064|NCT01222117|9810757|FG008|STARTED|Overall Study||23
8761065|NCT01222117|9810758|FG009|STARTED|Overall Study||19
8761066|NCT01222117|9810759|FG010|STARTED|Overall Study||6
8761067|NCT01222117|9810749|FG000|COMPLETED|Overall Study||17
8761068|NCT01222117|9810750|FG001|COMPLETED|Overall Study||19
8761069|NCT01222117|9810751|FG002|COMPLETED|Overall Study||22
8761070|NCT01222117|9810752|FG003|COMPLETED|Overall Study||19
8761071|NCT01222117|9810753|FG004|COMPLETED|Overall Study||8
8761072|NCT01222117|9810754|FG005|COMPLETED|Overall Study||9
8761073|NCT01222117|9810755|FG006|COMPLETED|Overall Study||13
8761074|NCT01222117|9810756|FG007|COMPLETED|Overall Study||12
8761075|NCT01222117|9810757|FG008|COMPLETED|Overall Study||20
8761076|NCT01222117|9810758|FG009|COMPLETED|Overall Study||17
8761077|NCT01222117|9810759|FG010|COMPLETED|Overall Study||6
8761078|NCT01222117|9810749|FG000|NOT COMPLETED|Overall Study||3
8761079|NCT01222117|9810750|FG001|NOT COMPLETED|Overall Study||1
8761080|NCT01222117|9810751|FG002|NOT COMPLETED|Overall Study||0
8761081|NCT01222117|9810752|FG003|NOT COMPLETED|Overall Study||1
8761082|NCT01222117|9810753|FG004|NOT COMPLETED|Overall Study||1
8761083|NCT01222117|9810754|FG005|NOT COMPLETED|Overall Study||1
8761084|NCT01222117|9810755|FG006|NOT COMPLETED|Overall Study||0
8761085|NCT01222117|9810756|FG007|NOT COMPLETED|Overall Study||0
8761086|NCT01222117|9810757|FG008|NOT COMPLETED|Overall Study||3
8761087|NCT01222117|9810758|FG009|NOT COMPLETED|Overall Study||2
8761088|NCT01222117|9810759|FG010|NOT COMPLETED|Overall Study||0
8761089|NCT01222195|9810783|FG000|STARTED|Overall Study||1
8761090|NCT01222195|9810783|FG000|COMPLETED|Overall Study||1
8761091|NCT01222195|9810783|FG000|NOT COMPLETED|Overall Study||0
8761092|NCT01222234|9810790|FG000|STARTED|Overall Study||15
8761093|NCT01222234|9810791|FG001|STARTED|Overall Study||17
8761094|NCT01222234|9810792|FG002|STARTED|Overall Study||24
8761095|NCT01222234|9810790|FG000|COMPLETED|Overall Study||15
8761096|NCT01222234|9810791|FG001|COMPLETED|Overall Study||15
8761097|NCT01222234|9810792|FG002|COMPLETED|Overall Study||22
8761098|NCT01222234|9810790|FG000|NOT COMPLETED|Overall Study||0
9025837|NCT03167541|10088207|FG000|COMPLETED|Second Intervention||9
9025838|NCT03167541|10088208|FG001|COMPLETED|Second Intervention||9
9025839|NCT03167541|10088207|FG000|NOT COMPLETED|Second Intervention||0
9025840|NCT03167541|10088208|FG001|NOT COMPLETED|Second Intervention||0
9025841|NCT03168022|10088215|FG000|STARTED|Overall Study||21
9025842|NCT03168022|10088216|FG001|STARTED|Overall Study||22
9025843|NCT03168022|10088215|FG000|COMPLETED|Overall Study||21
9025844|NCT03168022|10088216|FG001|COMPLETED|Overall Study||21
9025845|NCT03168022|10088215|FG000|NOT COMPLETED|Overall Study||0
9025846|NCT03168022|10088216|FG001|NOT COMPLETED|Overall Study||1
9025847|NCT03168295|10088227|FG000|STARTED|Overall Study||3
9025848|NCT03168295|10088228|FG001|STARTED|Overall Study||3
9025849|NCT03168295|10088229|FG002|STARTED|Overall Study||4
9025850|NCT03168295|10088230|FG003|STARTED|Overall Study||4
9025851|NCT03168295|10088231|FG004|STARTED|Overall Study||20
9025852|NCT03168295|10088227|FG000|COMPLETED|Overall Study||3
9025853|NCT03168295|10088228|FG001|COMPLETED|Overall Study||3
9025854|NCT03168295|10088229|FG002|COMPLETED|Overall Study||4
9025855|NCT03168295|10088230|FG003|COMPLETED|Overall Study||4
9025856|NCT03168295|10088231|FG004|COMPLETED|Overall Study||20
9025857|NCT03168295|10088227|FG000|NOT COMPLETED|Overall Study||0
9025858|NCT03168295|10088228|FG001|NOT COMPLETED|Overall Study||0
9025859|NCT03168295|10088229|FG002|NOT COMPLETED|Overall Study||0
9025860|NCT03168295|10088230|FG003|NOT COMPLETED|Overall Study||0
9025861|NCT03168295|10088231|FG004|NOT COMPLETED|Overall Study||0
9025862|NCT03168308|10088244|FG000|STARTED|Overall Study||48
9025863|NCT03168308|10088245|FG001|STARTED|Overall Study||44
9025864|NCT03168308|10088244|FG000|COMPLETED|Overall Study||48
9025865|NCT03168308|10088245|FG001|COMPLETED|Overall Study||44
9025866|NCT03168308|10088244|FG000|NOT COMPLETED|Overall Study||0
9025867|NCT03168308|10088245|FG001|NOT COMPLETED|Overall Study||0
9025868|NCT03168321|10088253|FG000|STARTED|Overall Study||402
9025869|NCT03168321|10088254|FG001|STARTED|Overall Study||411
9025870|NCT03168321|10088253|FG000|COMPLETED|Overall Study||347
9025871|NCT03168321|10088254|FG001|COMPLETED|Overall Study||356
9025872|NCT03168321|10088253|FG000|NOT COMPLETED|Overall Study||55
9025873|NCT03168321|10088254|FG001|NOT COMPLETED|Overall Study||55
9025874|NCT03168334|10088262|FG000|STARTED|Overall Study||397
9025875|NCT03168334|10088263|FG001|STARTED|Overall Study||404
9025876|NCT03168334|10088262|FG000|COMPLETED|Overall Study||345
9025877|NCT03168334|10088263|FG001|COMPLETED|Overall Study||366
9025878|NCT03168334|10088262|FG000|NOT COMPLETED|Overall Study||52
9025879|NCT03168334|10088263|FG001|NOT COMPLETED|Overall Study||38
9025880|NCT03168425|10088271|FG000|STARTED|Overall Study||94
9025881|NCT03168425|10088272|FG001|STARTED|Overall Study||96
9025882|NCT03168425|10088271|FG000|COMPLETED|Overall Study||87
9025883|NCT03168425|10088272|FG001|COMPLETED|Overall Study||85
9025884|NCT03168425|10088271|FG000|NOT COMPLETED|Overall Study||7
9025885|NCT03168425|10088272|FG001|NOT COMPLETED|Overall Study||11
8761099|NCT01222234|9810791|FG001|NOT COMPLETED|Overall Study||2
8761100|NCT01222234|9810792|FG002|NOT COMPLETED|Overall Study||2
8761101|NCT01222260|9810801|FG000|STARTED|Overall Study||31
8761102|NCT01222260|9810801|FG000|COMPLETED|Overall Study||29
8761103|NCT01222260|9810801|FG000|NOT COMPLETED|Overall Study||2
9025886|NCT03168542|10088279|FG000|STARTED|Overall Study||7
9025887|NCT03168542|10088280|FG001|STARTED|Overall Study||5
9025888|NCT03168542|10088281|FG002|STARTED|Overall Study||9
9025889|NCT03168542|10088279|FG000|COMPLETED|Overall Study||7
9025890|NCT03168542|10088280|FG001|COMPLETED|Overall Study||5
9025891|NCT03168542|10088281|FG002|COMPLETED|Overall Study||9
9025892|NCT03168542|10088279|FG000|NOT COMPLETED|Overall Study||0
9025893|NCT03168542|10088280|FG001|NOT COMPLETED|Overall Study||0
9025894|NCT03168542|10088281|FG002|NOT COMPLETED|Overall Study||0
9025895|NCT03168711|10088288|FG000|STARTED|Overall Study||14
9025896|NCT03168711|10088289|FG001|STARTED|Overall Study||9
8761104|NCT01222273|9810805|FG000|STARTED|Overall Study||7
8761105|NCT01222273|9810805|FG000|COMPLETED|Overall Study||7
9025897|NCT03168711|10088288|FG000|COMPLETED|Overall Study||12
9025898|NCT03168711|10088289|FG001|COMPLETED|Overall Study||7
8761106|NCT01222273|9810805|FG000|NOT COMPLETED|Overall Study||0
8761107|NCT01222286|9810811|FG000|STARTED|Overall Study||16
8761108|NCT01222286|9810812|FG001|STARTED|Overall Study||14
8761109|NCT01222286|9810811|FG000|COMPLETED|Overall Study||16
8761110|NCT01222286|9810812|FG001|COMPLETED|Overall Study||14
8761111|NCT01222286|9810811|FG000|NOT COMPLETED|Overall Study||0
8761112|NCT01222286|9810812|FG001|NOT COMPLETED|Overall Study||0
8761113|NCT01222299|9810822|FG000|STARTED|Overall Study||21
8761114|NCT01222299|9810823|FG001|STARTED|Overall Study||23
8761115|NCT01222299|9810824|FG002|STARTED|Overall Study||22
8761116|NCT01222299|9810825|FG003|STARTED|Overall Study||23
8761117|NCT01222299|9810822|FG000|COMPLETED|Overall Study||21
8761118|NCT01222299|9810823|FG001|COMPLETED|Overall Study||21
8761119|NCT01222299|9810824|FG002|COMPLETED|Overall Study||20
8761120|NCT01222299|9810825|FG003|COMPLETED|Overall Study||18
8761121|NCT01222299|9810822|FG000|NOT COMPLETED|Overall Study||0
8761122|NCT01222299|9810823|FG001|NOT COMPLETED|Overall Study||2
8761123|NCT01222299|9810824|FG002|NOT COMPLETED|Overall Study||2
8761124|NCT01222299|9810825|FG003|NOT COMPLETED|Overall Study||5
8761125|NCT01222390|9810835|FG000|STARTED|Overall Study||12
8761126|NCT01222390|9810835|FG000|COMPLETED|Overall Study||12
8761127|NCT01222390|9810835|FG000|NOT COMPLETED|Overall Study||0
8761128|NCT01222403|9810841|FG000|STARTED|Overall Study||386
8761129|NCT01222403|9810842|FG001|STARTED|Overall Study||381
8761130|NCT01222403|9810841|FG000|COMPLETED|Overall Study||386
8761131|NCT01222403|9810842|FG001|COMPLETED|Overall Study||379
8761132|NCT01222403|9810841|FG000|NOT COMPLETED|Overall Study||0
8761133|NCT01222403|9810842|FG001|NOT COMPLETED|Overall Study||2
8761134|NCT01222416|9810850|FG000|STARTED|Overall Study||50
8761135|NCT01222416|9810851|FG001|STARTED|Overall Study||0
8761136|NCT01222416|9810850|FG000|COMPLETED|Overall Study||30
8761137|NCT01222416|9810851|FG001|COMPLETED|Overall Study||0
8761138|NCT01222416|9810850|FG000|NOT COMPLETED|Overall Study||20
8761139|NCT01222416|9810851|FG001|NOT COMPLETED|Overall Study||0
8761140|NCT01222494|9810860|FG000|STARTED|Overall Study||7
8761141|NCT01222494|9810861|FG001|STARTED|Overall Study||19
8761142|NCT01222494|9810862|FG002|STARTED|Overall Study||21
8761143|NCT01222494|9810860|FG000|COMPLETED|Overall Study||6
8761144|NCT01222494|9810861|FG001|COMPLETED|Overall Study||15
8761145|NCT01222494|9810862|FG002|COMPLETED|Overall Study||17
8761146|NCT01222494|9810860|FG000|NOT COMPLETED|Overall Study||1
8761147|NCT01222494|9810861|FG001|NOT COMPLETED|Overall Study||4
8761148|NCT01222494|9810862|FG002|NOT COMPLETED|Overall Study||4
8761149|NCT01222507|9810870|FG000|STARTED|Overall Study||62
8761150|NCT01222507|9810870|FG000|COMPLETED|Overall Study||60
8761151|NCT01222507|9810870|FG000|NOT COMPLETED|Overall Study||2
8761152|NCT01222520|9810876|FG000|STARTED|Open-label run-in Period||0
8761153|NCT01222520|9810877|FG001|STARTED|Open-label run-in Period||197
8761154|NCT01222520|9810876|FG000|COMPLETED|Open-label run-in Period||0
8761155|NCT01222520|9810877|FG001|COMPLETED|Open-label run-in Period||174
8761156|NCT01222520|9810876|FG000|NOT COMPLETED|Open-label run-in Period||0
9025899|NCT03168711|10088288|FG000|NOT COMPLETED|Overall Study||2
9025900|NCT03168711|10088289|FG001|NOT COMPLETED|Overall Study||2
9025901|NCT03168841|10088295|FG000|STARTED|Overall Study||40
9025902|NCT03168841|10088295|FG000|COMPLETED|Overall Study||36
9025903|NCT03168841|10088295|FG000|NOT COMPLETED|Overall Study||4
9025904|NCT03168919|10088299|FG000|STARTED|Overall Study||5
9025905|NCT03168919|10088299|FG000|COMPLETED|Overall Study||3
9025906|NCT03168919|10088299|FG000|NOT COMPLETED|Overall Study||2
9025907|NCT03169062|10088307|FG000|STARTED|Overall Study||10
9025908|NCT03169062|10088307|FG000|COMPLETED|Overall Study||10
9025909|NCT03169062|10088307|FG000|NOT COMPLETED|Overall Study||0
9025910|NCT03169153|10088311|FG000|STARTED|Period 1, First 30 Days of Wear||42
9025911|NCT03169153|10088312|FG001|STARTED|Period 1, First 30 Days of Wear||39
9025912|NCT03169153|10088311|FG000|COMPLETED|Period 1, First 30 Days of Wear||39
9025913|NCT03169153|10088312|FG001|COMPLETED|Period 1, First 30 Days of Wear||35
9025914|NCT03169153|10088311|FG000|NOT COMPLETED|Period 1, First 30 Days of Wear||3
9025915|NCT03169153|10088312|FG001|NOT COMPLETED|Period 1, First 30 Days of Wear||4
9025916|NCT03169153|10088311|FG000|STARTED|Period 2, Second 30 Days of Wear||39
9025917|NCT03169153|10088312|FG001|STARTED|Period 2, Second 30 Days of Wear|One subject discontinued after completing Period 1 and was not exposed in Period 2.|34
9025918|NCT03169153|10088311|FG000|COMPLETED|Period 2, Second 30 Days of Wear||37
9025919|NCT03169153|10088312|FG001|COMPLETED|Period 2, Second 30 Days of Wear||32
9025920|NCT03169153|10088311|FG000|NOT COMPLETED|Period 2, Second 30 Days of Wear||2
9025921|NCT03169153|10088312|FG001|NOT COMPLETED|Period 2, Second 30 Days of Wear||2
8761157|NCT01222520|9810877|FG001|NOT COMPLETED|Open-label run-in Period||23
8761158|NCT01222520|9810876|FG000|STARTED|Double-blind Period||87
8761159|NCT01222520|9810877|FG001|STARTED|Double-blind Period||87
8761160|NCT01222520|9810876|FG000|COMPLETED|Double-blind Period||86
8761161|NCT01222520|9810877|FG001|COMPLETED|Double-blind Period||85
8761162|NCT01222520|9810876|FG000|NOT COMPLETED|Double-blind Period||1
9025922|NCT03169244|10088320|FG000|STARTED|Overall Study||22
8761163|NCT01222520|9810877|FG001|NOT COMPLETED|Double-blind Period||2
8761164|NCT01222533|9810883|FG000|STARTED|Overall Study|Entered and treated.|154
8761165|NCT01222533|9810883|FG000|Received Placebo|Overall Study||147
8761166|NCT01222533|9810883|FG000|Received Tio R1.25|Overall Study||147
8761167|NCT01222533|9810883|FG000|Received Tio R2.5|Overall Study||145
8761168|NCT01222533|9810883|FG000|Received Tio R5|Overall Study||150
8761169|NCT01222533|9810883|FG000|Received Tio HH18|Overall Study||146
8761170|NCT01222533|9810883|FG000|COMPLETED|Overall Study|Completed planned observation time (week 21)|140
8761171|NCT01222533|9810883|FG000|NOT COMPLETED|Overall Study||14
8761172|NCT01222572|9810895|FG000|STARTED|Overall Study||1
8761173|NCT01222572|9810896|FG001|STARTED|Overall Study||0
8761174|NCT01222572|9810897|FG002|STARTED|Overall Study||0
8761175|NCT01222572|9810895|FG000|COMPLETED|Overall Study||1
8761176|NCT01222572|9810896|FG001|COMPLETED|Overall Study||0
8761177|NCT01222572|9810897|FG002|COMPLETED|Overall Study||0
8761178|NCT01222572|9810895|FG000|NOT COMPLETED|Overall Study||0
8761179|NCT01222572|9810896|FG001|NOT COMPLETED|Overall Study||0
8761180|NCT01222572|9810897|FG002|NOT COMPLETED|Overall Study||0
8761181|NCT01222585|9810901|FG000|STARTED|Overall Study||24
8761182|NCT01222585|9810901|FG000|COMPLETED|Overall Study||24
8761183|NCT01222585|9810901|FG000|NOT COMPLETED|Overall Study||0
8761184|NCT01222689|9810905|FG000|STARTED|Overall Study||46
9025923|NCT03169244|10088321|FG001|STARTED|Overall Study||20
9025924|NCT03169244|10088320|FG000|Randomly Assigned|Overall Study||22
9025925|NCT03169244|10088321|FG001|Randomly Assigned|Overall Study||20
9025926|NCT03169244|10088320|FG000|Received Intervention|Overall Study||22
9025927|NCT03169244|10088321|FG001|Received Intervention|Overall Study||18
9025928|NCT03169244|10088320|FG000|COMPLETED|Overall Study||17
9025929|NCT03169244|10088321|FG001|COMPLETED|Overall Study||16
9025930|NCT03169244|10088320|FG000|NOT COMPLETED|Overall Study||5
9025931|NCT03169244|10088321|FG001|NOT COMPLETED|Overall Study||4
9025932|NCT03169816|10088329|FG000|STARTED|Overall Study||33
9025933|NCT03169816|10088330|FG001|STARTED|Overall Study||16
9025934|NCT03169816|10088329|FG000|COMPLETED|Overall Study||6
9025935|NCT03169816|10088330|FG001|COMPLETED|Overall Study||3
9025936|NCT03169816|10088329|FG000|NOT COMPLETED|Overall Study||27
9025937|NCT03169816|10088330|FG001|NOT COMPLETED|Overall Study||13
9025938|NCT03170154|10088336|FG000|STARTED|Overall Study||350
9025939|NCT03170154|10088336|FG000|Rotational Stability Sub-study|Overall Study||141
9025940|NCT03170154|10088336|FG000|COMPLETED|Overall Study||342
9025941|NCT03170154|10088336|FG000|NOT COMPLETED|Overall Study||8
9025942|NCT03170193|10088352|FG000|STARTED|Overall Study||12
9025943|NCT03170193|10088353|FG001|STARTED|Overall Study||6
9025944|NCT03170193|10088354|FG002|STARTED|Overall Study||6
9025945|NCT03170193|10088355|FG003|STARTED|Overall Study||6
9025946|NCT03170193|10088356|FG004|STARTED|Overall Study||6
9025947|NCT03170193|10088357|FG005|STARTED|Overall Study||6
9025948|NCT03170193|10088358|FG006|STARTED|Overall Study||6
9025949|NCT03170193|10088352|FG000|COMPLETED|Overall Study||11
9025950|NCT03170193|10088353|FG001|COMPLETED|Overall Study||5
9025951|NCT03170193|10088354|FG002|COMPLETED|Overall Study||6
9025952|NCT03170193|10088355|FG003|COMPLETED|Overall Study||5
9025953|NCT03170193|10088356|FG004|COMPLETED|Overall Study||6
9025954|NCT03170193|10088357|FG005|COMPLETED|Overall Study||6
9025955|NCT03170193|10088358|FG006|COMPLETED|Overall Study||6
9025956|NCT03170193|10088352|FG000|NOT COMPLETED|Overall Study||1
9025957|NCT03170193|10088353|FG001|NOT COMPLETED|Overall Study||1
9025958|NCT03170193|10088354|FG002|NOT COMPLETED|Overall Study||0
9025959|NCT03170193|10088355|FG003|NOT COMPLETED|Overall Study||1
9025960|NCT03170193|10088356|FG004|NOT COMPLETED|Overall Study||0
9025961|NCT03170193|10088357|FG005|NOT COMPLETED|Overall Study||0
9025962|NCT03170193|10088358|FG006|NOT COMPLETED|Overall Study||0
9025963|NCT03170219|10088382|FG000|STARTED|Overall Study||7
9025964|NCT03170219|10088383|FG001|STARTED|Overall Study||4
9025965|NCT03170219|10088382|FG000|COMPLETED|Overall Study||7
9025966|NCT03170219|10088383|FG001|COMPLETED|Overall Study||4
9025967|NCT03170219|10088382|FG000|NOT COMPLETED|Overall Study||0
9025968|NCT03170219|10088383|FG001|NOT COMPLETED|Overall Study||0
9025969|NCT03170232|10088391|FG000|STARTED|Overall Study||27
9025970|NCT03170232|10088392|FG001|STARTED|Overall Study||27
9025971|NCT03170232|10088391|FG000|COMPLETED|Overall Study||0
9025972|NCT03170232|10088392|FG001|COMPLETED|Overall Study||0
9025973|NCT03170232|10088391|FG000|NOT COMPLETED|Overall Study||27
9025974|NCT03170232|10088392|FG001|NOT COMPLETED|Overall Study||27
9025975|NCT03170271|10088400|FG000|STARTED|Overall Study||431
9025976|NCT03170271|10088401|FG001|STARTED|Overall Study||229
9025977|NCT03170271|10088400|FG000|Received Treatment|Overall Study||427
9025978|NCT03170271|10088401|FG001|Received Treatment|Overall Study||229
9025979|NCT03170271|10088400|FG000|COMPLETED|Overall Study||398
9025980|NCT03170271|10088401|FG001|COMPLETED|Overall Study||218
9025981|NCT03170271|10088400|FG000|NOT COMPLETED|Overall Study||33
9025982|NCT03170271|10088401|FG001|NOT COMPLETED|Overall Study||11
9025983|NCT03170388|10088412|FG000|STARTED|Overall Study||147
9025984|NCT03170388|10088413|FG001|STARTED|Overall Study||150
9025985|NCT03170388|10088414|FG002|STARTED|Overall Study||146
9025986|NCT03170388|10088415|FG003|STARTED|Overall Study||150
9025987|NCT03170388|10088416|FG004|STARTED|Overall Study||148
9025988|NCT03170388|10088412|FG000|COMPLETED|Overall Study||125
9025989|NCT03170388|10088413|FG001|COMPLETED|Overall Study||132
9025990|NCT03170388|10088414|FG002|COMPLETED|Overall Study||133
9025991|NCT03170388|10088415|FG003|COMPLETED|Overall Study||132
9025992|NCT03170388|10088416|FG004|COMPLETED|Overall Study||127
8761185|NCT01222689|9810905|FG000|COMPLETED|Overall Study||46
9025993|NCT03170388|10088412|FG000|NOT COMPLETED|Overall Study||22
9025994|NCT03170388|10088413|FG001|NOT COMPLETED|Overall Study||18
8761186|NCT01222689|9810905|FG000|NOT COMPLETED|Overall Study||0
8761187|NCT01222715|9810911|FG000|STARTED|Overall Study||44
9025995|NCT03170388|10088414|FG002|NOT COMPLETED|Overall Study||13
9025996|NCT03170388|10088415|FG003|NOT COMPLETED|Overall Study||18
8761188|NCT01222715|9810912|FG001|STARTED|Overall Study||43
8761189|NCT01222715|9810911|FG000|COMPLETED|Overall Study||8
8761190|NCT01222715|9810912|FG001|COMPLETED|Overall Study||16
8761191|NCT01222715|9810911|FG000|NOT COMPLETED|Overall Study||36
8761192|NCT01222715|9810912|FG001|NOT COMPLETED|Overall Study||27
8761193|NCT01222767|9810918|FG000|STARTED|Overall Study||17
8761194|NCT01222767|9810918|FG000|Received Treatment|Overall Study||16
8761195|NCT01222767|9810918|FG000|COMPLETED|Overall Study||0
8761196|NCT01222767|9810918|FG000|NOT COMPLETED|Overall Study||17
8761197|NCT01222832|9810924|FG000|STARTED|Overall Study||113
8761198|NCT01222832|9810925|FG001|STARTED|Overall Study||113
8761199|NCT01222832|9810924|FG000|COMPLETED|Overall Study||113
8761200|NCT01222832|9810925|FG001|COMPLETED|Overall Study||112
8761201|NCT01222832|9810924|FG000|NOT COMPLETED|Overall Study||0
8761202|NCT01222832|9810925|FG001|NOT COMPLETED|Overall Study||1
8761203|NCT01222884|9810933|FG000|STARTED|Overall Study||234
8761204|NCT01222884|9810934|FG001|STARTED|Overall Study||117
8761205|NCT01222884|9810933|FG000|COMPLETED|Overall Study||210
8761206|NCT01222884|9810934|FG001|COMPLETED|Overall Study||113
8761207|NCT01222884|9810933|FG000|NOT COMPLETED|Overall Study||24
8761208|NCT01222884|9810934|FG001|NOT COMPLETED|Overall Study||4
8761209|NCT01223027|9810942|FG000|STARTED|Overall Study||284
8761210|NCT01223027|9810943|FG001|STARTED|Overall Study||286
8761211|NCT01223027|9810942|FG000|COMPLETED|Overall Study|Completed = Ongoing at data cut-off of 25-Jan-2013|10
8761212|NCT01223027|9810943|FG001|COMPLETED|Overall Study|Completed = Ongoing at data cut-off of 25-Jan-2013|9
8761213|NCT01223027|9810942|FG000|NOT COMPLETED|Overall Study||274
8761214|NCT01223027|9810943|FG001|NOT COMPLETED|Overall Study||277
8761215|NCT01223183|9810951|FG000|STARTED|Imaging Day 1||10
8761216|NCT01223183|9810952|FG001|STARTED|Imaging Day 1||10
8761217|NCT01223183|9810951|FG000|COMPLETED|Imaging Day 1||10
8761218|NCT01223183|9810952|FG001|COMPLETED|Imaging Day 1||9
8761219|NCT01223183|9810951|FG000|NOT COMPLETED|Imaging Day 1||0
8761220|NCT01223183|9810952|FG001|NOT COMPLETED|Imaging Day 1||1
8761221|NCT01223183|9810951|FG000|STARTED|Washout Period (5-24 Days)||10
8761222|NCT01223183|9810952|FG001|STARTED|Washout Period (5-24 Days)||9
8761223|NCT01223183|9810951|FG000|COMPLETED|Washout Period (5-24 Days)||8
8761224|NCT01223183|9810952|FG001|COMPLETED|Washout Period (5-24 Days)||9
8761225|NCT01223183|9810951|FG000|NOT COMPLETED|Washout Period (5-24 Days)||2
8761226|NCT01223183|9810952|FG001|NOT COMPLETED|Washout Period (5-24 Days)||0
8761227|NCT01223183|9810951|FG000|STARTED|Imaging Day 2||8
8761228|NCT01223183|9810952|FG001|STARTED|Imaging Day 2||9
8761229|NCT01223183|9810951|FG000|COMPLETED|Imaging Day 2||8
8761230|NCT01223183|9810952|FG001|COMPLETED|Imaging Day 2||9
8761231|NCT01223183|9810951|FG000|NOT COMPLETED|Imaging Day 2||0
8915466|NCT02175212|9974895|FG000|NOT COMPLETED|Overall Study||163
8915467|NCT02175212|9974896|FG001|NOT COMPLETED|Overall Study||147
8915468|NCT02175225|9974904|FG000|STARTED|Overall Study||145
8915469|NCT02175225|9974905|FG001|STARTED|Overall Study||149
8915470|NCT02175225|9974904|FG000|Initiated Study Drug|Overall Study|Subjects in whom study drug was not initiated are not subsequently followed per the protocol.|144
8915471|NCT02175225|9974905|FG001|Initiated Study Drug|Overall Study|Subjects in whom study drug was not initiated are not subsequently followed per the protocol.|147
8915472|NCT02175225|9974904|FG000|90 Day Outcome Obtained|Overall Study||140
8915473|NCT02175225|9974905|FG001|90 Day Outcome Obtained|Overall Study||143
8915474|NCT02175225|9974904|FG000|180 Day Outcome Obtained|Overall Study||135
8761232|NCT01223183|9810952|FG001|NOT COMPLETED|Imaging Day 2||0
8761233|NCT01223196|9810961|FG000|STARTED|Overall Study||13
8761234|NCT01223196|9810962|FG001|STARTED|Overall Study||11
8761235|NCT01223196|9810961|FG000|COMPLETED|Overall Study||9
8761236|NCT01223196|9810962|FG001|COMPLETED|Overall Study||11
8761237|NCT01223196|9810961|FG000|NOT COMPLETED|Overall Study||4
8761238|NCT01223196|9810962|FG001|NOT COMPLETED|Overall Study||0
8761239|NCT01223235|9810970|FG000|STARTED|Overall Study||22
8761240|NCT01223235|9810970|FG000|COMPLETED|Overall Study||21
8761241|NCT01223235|9810970|FG000|NOT COMPLETED|Overall Study||1
8761242|NCT01223352|9810976|FG000|STARTED|Overall Study||31
8761243|NCT01223352|9810977|FG001|STARTED|Overall Study||33
8761244|NCT01223352|9810976|FG000|COMPLETED|Overall Study||31
8761245|NCT01223352|9810977|FG001|COMPLETED|Overall Study||33
8761246|NCT01223352|9810976|FG000|NOT COMPLETED|Overall Study||0
8761247|NCT01223352|9810977|FG001|NOT COMPLETED|Overall Study||0
8761248|NCT01223365|9810989|FG000|STARTED|Open-label Titration Period||330
8761249|NCT01223365|9810989|FG000|Safety Analysis Set|Open-label Titration Period||329
8761250|NCT01223365|9810989|FG000|Achieved Stable Pain Relief|Open-label Titration Period||294
8761251|NCT01223365|9810989|FG000|COMPLETED|Open-label Titration Period||291
8761252|NCT01223365|9810989|FG000|NOT COMPLETED|Open-label Titration Period||39
8761253|NCT01223365|9810989|FG000|STARTED|Open-label Treatment Period||291
8761254|NCT01223365|9810989|FG000|COMPLETED|Open-label Treatment Period||189
8761255|NCT01223365|9810989|FG000|NOT COMPLETED|Open-label Treatment Period||102
8761256|NCT01223378|9811003|FG000|STARTED|Overall Study||82
8761257|NCT01223378|9811004|FG001|STARTED|Overall Study||85
8761258|NCT01223378|9811005|FG002|STARTED|Overall Study||83
8761259|NCT01223378|9811006|FG003|STARTED|Overall Study||81
8761260|NCT01223378|9811007|FG004|STARTED|Overall Study||82
8761261|NCT01223378|9811003|FG000|COMPLETED|Overall Study||76
8761262|NCT01223378|9811004|FG001|COMPLETED|Overall Study||81
8761263|NCT01223378|9811005|FG002|COMPLETED|Overall Study||80
8761264|NCT01223378|9811006|FG003|COMPLETED|Overall Study||80
8761265|NCT01223378|9811007|FG004|COMPLETED|Overall Study||79
8761266|NCT01223378|9811003|FG000|NOT COMPLETED|Overall Study||6
8761267|NCT01223378|9811004|FG001|NOT COMPLETED|Overall Study||4
8761268|NCT01223378|9811005|FG002|NOT COMPLETED|Overall Study||3
8761269|NCT01223378|9811006|FG003|NOT COMPLETED|Overall Study||1
8761270|NCT01223378|9811007|FG004|NOT COMPLETED|Overall Study||3
8761271|NCT01223404|9811019|FG000|STARTED|First Intervention (1 Day)||4
8761272|NCT01223404|9811020|FG001|STARTED|First Intervention (1 Day)||3
8761273|NCT01223404|9811021|FG002|STARTED|First Intervention (1 Day)||4
8761274|NCT01223404|9811022|FG003|STARTED|First Intervention (1 Day)||5
8761275|NCT01223404|9811023|FG004|STARTED|First Intervention (1 Day)||2
8761276|NCT01223404|9811024|FG005|STARTED|First Intervention (1 Day)||3
8761277|NCT01223404|9811019|FG000|COMPLETED|First Intervention (1 Day)||4
8761278|NCT01223404|9811020|FG001|COMPLETED|First Intervention (1 Day)||3
8761279|NCT01223404|9811021|FG002|COMPLETED|First Intervention (1 Day)||4
8761280|NCT01223404|9811022|FG003|COMPLETED|First Intervention (1 Day)||4
8761281|NCT01223404|9811023|FG004|COMPLETED|First Intervention (1 Day)||2
8761282|NCT01223404|9811024|FG005|COMPLETED|First Intervention (1 Day)||3
8761283|NCT01223404|9811019|FG000|NOT COMPLETED|First Intervention (1 Day)||0
8761284|NCT01223404|9811020|FG001|NOT COMPLETED|First Intervention (1 Day)||0
8761285|NCT01223404|9811021|FG002|NOT COMPLETED|First Intervention (1 Day)||0
8761286|NCT01223404|9811022|FG003|NOT COMPLETED|First Intervention (1 Day)||1
8761287|NCT01223404|9811023|FG004|NOT COMPLETED|First Intervention (1 Day)||0
8761288|NCT01223404|9811024|FG005|NOT COMPLETED|First Intervention (1 Day)||0
8761289|NCT01223404|9811019|FG000|STARTED|Second Intervention (1 Day)||4
8761290|NCT01223404|9811020|FG001|STARTED|Second Intervention (1 Day)||3
8761291|NCT01223404|9811021|FG002|STARTED|Second Intervention (1 Day)||4
8761292|NCT01223404|9811022|FG003|STARTED|Second Intervention (1 Day)||4
8761293|NCT01223404|9811023|FG004|STARTED|Second Intervention (1 Day)||2
8761294|NCT01223404|9811024|FG005|STARTED|Second Intervention (1 Day)||3
8761295|NCT01223404|9811019|FG000|COMPLETED|Second Intervention (1 Day)||3
8761296|NCT01223404|9811020|FG001|COMPLETED|Second Intervention (1 Day)||3
8761297|NCT01223404|9811021|FG002|COMPLETED|Second Intervention (1 Day)||4
8761298|NCT01223404|9811022|FG003|COMPLETED|Second Intervention (1 Day)||4
8761299|NCT01223404|9811023|FG004|COMPLETED|Second Intervention (1 Day)||2
8761300|NCT01223404|9811024|FG005|COMPLETED|Second Intervention (1 Day)||3
8761301|NCT01223404|9811019|FG000|NOT COMPLETED|Second Intervention (1 Day)||1
8761302|NCT01223404|9811020|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
8761303|NCT01223404|9811021|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
8761304|NCT01223404|9811022|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
8761305|NCT01223404|9811023|FG004|NOT COMPLETED|Second Intervention (1 Day)||0
8761306|NCT01223404|9811024|FG005|NOT COMPLETED|Second Intervention (1 Day)||0
8761307|NCT01223404|9811019|FG000|STARTED|Third Intervention (1 Day)||3
8761308|NCT01223404|9811020|FG001|STARTED|Third Intervention (1 Day)||3
8761309|NCT01223404|9811021|FG002|STARTED|Third Intervention (1 Day)||4
8761310|NCT01223404|9811022|FG003|STARTED|Third Intervention (1 Day)||4
8761311|NCT01223404|9811023|FG004|STARTED|Third Intervention (1 Day)||2
8761312|NCT01223404|9811024|FG005|STARTED|Third Intervention (1 Day)||3
8761313|NCT01223404|9811019|FG000|COMPLETED|Third Intervention (1 Day)||3
8761314|NCT01223404|9811020|FG001|COMPLETED|Third Intervention (1 Day)||3
8761315|NCT01223404|9811021|FG002|COMPLETED|Third Intervention (1 Day)||4
8761316|NCT01223404|9811022|FG003|COMPLETED|Third Intervention (1 Day)||3
8761317|NCT01223404|9811023|FG004|COMPLETED|Third Intervention (1 Day)||2
8761318|NCT01223404|9811024|FG005|COMPLETED|Third Intervention (1 Day)||3
8761319|NCT01223404|9811019|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
8761320|NCT01223404|9811020|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
8761321|NCT01223404|9811021|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
8761322|NCT01223404|9811022|FG003|NOT COMPLETED|Third Intervention (1 Day)||1
8761323|NCT01223404|9811023|FG004|NOT COMPLETED|Third Intervention (1 Day)||0
8761324|NCT01223404|9811024|FG005|NOT COMPLETED|Third Intervention (1 Day)||0
8761325|NCT01223469|9811042|FG000|STARTED|Overall Study||34
8761326|NCT01223469|9811043|FG001|STARTED|Overall Study||43
8761327|NCT01223469|9811042|FG000|COMPLETED|Overall Study||34
8761328|NCT01223469|9811043|FG001|COMPLETED|Overall Study||43
8761329|NCT01223469|9811042|FG000|NOT COMPLETED|Overall Study||0
8761330|NCT01223469|9811043|FG001|NOT COMPLETED|Overall Study||0
8761331|NCT01223703|9811051|FG000|STARTED|Overall Study||67
8761332|NCT01223703|9811052|FG001|STARTED|Overall Study||66
8761333|NCT01223703|9811051|FG000|COMPLETED|Overall Study||67
8761334|NCT01223703|9811052|FG001|COMPLETED|Overall Study||66
8761335|NCT01223703|9811051|FG000|NOT COMPLETED|Overall Study||0
8761336|NCT01223703|9811052|FG001|NOT COMPLETED|Overall Study||0
8761337|NCT01223937|9811060|FG000|STARTED|Overall Study|Intent to treat population: randomized participants regardless if they were exposed to treatment.|131
8761338|NCT01223937|9811061|FG001|STARTED|Overall Study|Intent to treat population: randomized participants regardless if they were exposed to treatment.|137
8761339|NCT01223937|9811060|FG000|Full Analysis Set (FAS)|Overall Study|FAS: participants with at least one post-treatment efficacy assessment|128
8761340|NCT01223937|9811061|FG001|Full Analysis Set (FAS)|Overall Study|FAS: participants with at least one post-treatment efficacy assessment|133
8761341|NCT01223937|9811060|FG000|Safety Analysis Set (SAS)|Overall Study|SAS: participants with at least one post-treatment safety assessment|126
8761342|NCT01223937|9811061|FG001|Safety Analysis Set (SAS)|Overall Study|SAS: participants with at least one post-treatment safety assessment|135
8761343|NCT01223937|9811060|FG000|COMPLETED|Overall Study||114
8761344|NCT01223937|9811061|FG001|COMPLETED|Overall Study||119
8761345|NCT01223937|9811060|FG000|NOT COMPLETED|Overall Study||17
8761346|NCT01223937|9811061|FG001|NOT COMPLETED|Overall Study||18
8761347|NCT01223963|9811067|FG000|STARTED|Overall Study|All subjects treated between May 1 2008 and Dec 31 2009 in selected clinics were to be asked.|93
8761348|NCT01223963|9811067|FG000|COMPLETED|Overall Study||93
8761349|NCT01223963|9811067|FG000|NOT COMPLETED|Overall Study||0
8761350|NCT01224015|9811075|FG000|STARTED|Overall Study||361
8761351|NCT01224015|9811076|FG001|STARTED|Overall Study||227
8761352|NCT01224015|9811077|FG002|STARTED|Overall Study||96
8761353|NCT01224015|9811075|FG000|COMPLETED|Overall Study||347
8761354|NCT01224015|9811076|FG001|COMPLETED|Overall Study||211
8761355|NCT01224015|9811077|FG002|COMPLETED|Overall Study||83
8761356|NCT01224015|9811075|FG000|NOT COMPLETED|Overall Study||14
8761357|NCT01224015|9811076|FG001|NOT COMPLETED|Overall Study||16
8761358|NCT01224015|9811077|FG002|NOT COMPLETED|Overall Study||13
8761359|NCT01224145|9811085|FG000|STARTED|Overall Study||10
8761360|NCT01224145|9811085|FG000|COMPLETED|Overall Study||10
8761361|NCT01224145|9811085|FG000|NOT COMPLETED|Overall Study||0
8761362|NCT01224158|9811092|FG000|STARTED|Overall Study||76
8761363|NCT01224158|9811093|FG001|STARTED|Overall Study||77
8761364|NCT01224158|9811092|FG000|COMPLETED|Overall Study||75
8761365|NCT01224158|9811093|FG001|COMPLETED|Overall Study||77
8761366|NCT01224158|9811092|FG000|NOT COMPLETED|Overall Study||1
8761367|NCT01224158|9811093|FG001|NOT COMPLETED|Overall Study||0
8761368|NCT01224171|9811101|FG000|STARTED|Overall Study||207
8761369|NCT01224171|9811102|FG001|STARTED|Overall Study||209
8761370|NCT01224171|9811101|FG000|TNFα Antagonist Failure Population|Overall Study|Previously failed (inadequate response, loss of response, or intolerance) TNFα antagonist therapy|157
8761371|NCT01224171|9811102|FG001|TNFα Antagonist Failure Population|Overall Study|Previously failed (inadequate response, loss of response, or intolerance) TNFα antagonist therapy|158
8761372|NCT01224171|9811101|FG000|COMPLETED|Overall Study|Completed study is defined as patients who completed the Week 10 assessments.|192
8761373|NCT01224171|9811102|FG001|COMPLETED|Overall Study|Completed study is defined as patients who completed the Week 10 assessments.|196
8761374|NCT01224171|9811101|FG000|NOT COMPLETED|Overall Study||15
8761375|NCT01224171|9811102|FG001|NOT COMPLETED|Overall Study||13
8761376|NCT01224210|9811108|FG000|STARTED|Overall Study||30
8761377|NCT01224210|9811108|FG000|COMPLETED|Overall Study||23
8761378|NCT01224210|9811108|FG000|NOT COMPLETED|Overall Study||7
8761379|NCT01224236|9811115|FG000|STARTED|Overall Study||76
8761380|NCT01224236|9811116|FG001|STARTED|Overall Study||74
9025997|NCT03170388|10088416|FG004|NOT COMPLETED|Overall Study||21
9025998|NCT03170544|10088440|FG000|STARTED|Part 1||10
9025999|NCT03170544|10088441|FG001|STARTED|Part 1||6
9026000|NCT03170544|10088442|FG002|STARTED|Part 1||6
9026001|NCT03170544|10088443|FG003|STARTED|Part 1||7
9026002|NCT03170544|10088444|FG004|STARTED|Part 1||6
9026003|NCT03170544|10088445|FG005|STARTED|Part 1||6
9026004|NCT03170544|10088446|FG006|STARTED|Part 1||0
9026005|NCT03170544|10088447|FG007|STARTED|Part 1||0
8671158|NCT00750308|9714640|FG008|STARTED|Washout||2
8671159|NCT00750308|9714641|FG009|STARTED|Washout||2
8671160|NCT00750308|9714642|FG010|STARTED|Washout||1
8671161|NCT00750308|9714643|FG011|STARTED|Washout||1
8671162|NCT00750308|9714632|FG000|COMPLETED|Washout||2
8671163|NCT00750308|9714633|FG001|COMPLETED|Washout||2
8671164|NCT00750308|9714634|FG002|COMPLETED|Washout||2
8671165|NCT00750308|9714635|FG003|COMPLETED|Washout||1
8671166|NCT00750308|9714636|FG004|COMPLETED|Washout||2
8671167|NCT00750308|9714637|FG005|COMPLETED|Washout||3
8671168|NCT00750308|9714638|FG006|COMPLETED|Washout||2
8671169|NCT00750308|9714639|FG007|COMPLETED|Washout||2
8671170|NCT00750308|9714640|FG008|COMPLETED|Washout||2
8671171|NCT00750308|9714641|FG009|COMPLETED|Washout||2
8671172|NCT00750308|9714642|FG010|COMPLETED|Washout||1
8671173|NCT00750308|9714643|FG011|COMPLETED|Washout||1
8671174|NCT00750308|9714632|FG000|NOT COMPLETED|Washout||0
8671175|NCT00750308|9714633|FG001|NOT COMPLETED|Washout||0
8671176|NCT00750308|9714634|FG002|NOT COMPLETED|Washout||0
8671177|NCT00750308|9714635|FG003|NOT COMPLETED|Washout||0
8671178|NCT00750308|9714636|FG004|NOT COMPLETED|Washout||0
8671179|NCT00750308|9714637|FG005|NOT COMPLETED|Washout||0
8671180|NCT00750308|9714638|FG006|NOT COMPLETED|Washout||0
8671181|NCT00750308|9714639|FG007|NOT COMPLETED|Washout||0
8671182|NCT00750308|9714640|FG008|NOT COMPLETED|Washout||0
8671183|NCT00750308|9714641|FG009|NOT COMPLETED|Washout||0
8671184|NCT00750308|9714642|FG010|NOT COMPLETED|Washout||0
8671185|NCT00750308|9714643|FG011|NOT COMPLETED|Washout||0
8671186|NCT00750308|9714632|FG000|STARTED|Second Treatment||2
8671187|NCT00750308|9714633|FG001|STARTED|Second Treatment||2
8671188|NCT00750308|9714634|FG002|STARTED|Second Treatment||2
8671189|NCT00750308|9714635|FG003|STARTED|Second Treatment||1
8671190|NCT00750308|9714636|FG004|STARTED|Second Treatment||2
8671191|NCT00750308|9714637|FG005|STARTED|Second Treatment||3
8761381|NCT01224236|9811115|FG000|COMPLETED|Overall Study||75
9026006|NCT03170544|10088448|FG008|STARTED|Part 1||0
8671192|NCT00750308|9714638|FG006|STARTED|Second Treatment||2
8671193|NCT00750308|9714639|FG007|STARTED|Second Treatment||2
8671194|NCT00750308|9714640|FG008|STARTED|Second Treatment||2
8671195|NCT00750308|9714641|FG009|STARTED|Second Treatment||2
8671196|NCT00750308|9714642|FG010|STARTED|Second Treatment||1
8671197|NCT00750308|9714643|FG011|STARTED|Second Treatment||1
8671198|NCT00750308|9714632|FG000|COMPLETED|Second Treatment||2
8671199|NCT00750308|9714633|FG001|COMPLETED|Second Treatment||2
8671200|NCT00750308|9714634|FG002|COMPLETED|Second Treatment||2
8761382|NCT01224236|9811116|FG001|COMPLETED|Overall Study||73
8761383|NCT01224236|9811115|FG000|NOT COMPLETED|Overall Study||1
8761384|NCT01224236|9811116|FG001|NOT COMPLETED|Overall Study||1
8761385|NCT01224431|9811124|FG000|STARTED|Overall Study||30
8761386|NCT01224431|9811125|FG001|STARTED|Overall Study||30
8761387|NCT01224431|9811124|FG000|COMPLETED|Overall Study||30
8761388|NCT01224431|9811125|FG001|COMPLETED|Overall Study||25
8761389|NCT01224431|9811124|FG000|NOT COMPLETED|Overall Study||0
8761390|NCT01224431|9811125|FG001|NOT COMPLETED|Overall Study||5
8761391|NCT01224444|9811133|FG000|STARTED|Overall Study||269
8761392|NCT01224444|9811133|FG000|COMPLETED|Overall Study||269
8761393|NCT01224444|9811133|FG000|NOT COMPLETED|Overall Study||0
8761394|NCT01224626|9811137|FG000|STARTED|Overall Study||42
8761395|NCT01224626|9811137|FG000|COMPLETED|Overall Study||41
8761396|NCT01224626|9811137|FG000|NOT COMPLETED|Overall Study||1
8761397|NCT01224639|9811149|FG000|STARTED|Overall Study||19
8761398|NCT01224639|9811150|FG001|STARTED|Overall Study||5
8761399|NCT01224639|9811151|FG002|STARTED|Overall Study||21
8761400|NCT01224639|9811152|FG003|STARTED|Overall Study||3
8761401|NCT01224639|9811153|FG004|STARTED|Overall Study||21
8761402|NCT01224639|9811154|FG005|STARTED|Overall Study||4
8761403|NCT01224639|9811155|FG006|STARTED|Overall Study||18
8761404|NCT01224639|9811156|FG007|STARTED|Overall Study||5
8761405|NCT01224639|9811149|FG000|COMPLETED|Overall Study||19
8761406|NCT01224639|9811150|FG001|COMPLETED|Overall Study||5
8761407|NCT01224639|9811151|FG002|COMPLETED|Overall Study||21
8761408|NCT01224639|9811152|FG003|COMPLETED|Overall Study||3
8761409|NCT01224639|9811153|FG004|COMPLETED|Overall Study||19
8761410|NCT01224639|9811154|FG005|COMPLETED|Overall Study||4
8761411|NCT01224639|9811155|FG006|COMPLETED|Overall Study||17
8761412|NCT01224639|9811156|FG007|COMPLETED|Overall Study||3
8761413|NCT01224639|9811149|FG000|NOT COMPLETED|Overall Study||0
8761414|NCT01224639|9811150|FG001|NOT COMPLETED|Overall Study||0
8761415|NCT01224639|9811151|FG002|NOT COMPLETED|Overall Study||0
8761416|NCT01224639|9811152|FG003|NOT COMPLETED|Overall Study||0
8761417|NCT01224639|9811153|FG004|NOT COMPLETED|Overall Study||2
8761418|NCT01224639|9811154|FG005|NOT COMPLETED|Overall Study||0
8761419|NCT01224639|9811155|FG006|NOT COMPLETED|Overall Study||1
8761420|NCT01224639|9811156|FG007|NOT COMPLETED|Overall Study||2
8761421|NCT01224678|9811176|FG000|STARTED|Overall Study||150
8761422|NCT01224678|9811177|FG001|STARTED|Overall Study||150
8761423|NCT01224678|9811176|FG000|COMPLETED|Overall Study||150
8761424|NCT01224678|9811177|FG001|COMPLETED|Overall Study||150
8761425|NCT01224678|9811176|FG000|NOT COMPLETED|Overall Study||0
8761426|NCT01224678|9811177|FG001|NOT COMPLETED|Overall Study||0
8761427|NCT01224782|9811183|FG000|STARTED|Overall Study||994
8761428|NCT01224782|9811183|FG000|COMPLETED|Overall Study||730
8761429|NCT01224782|9811183|FG000|NOT COMPLETED|Overall Study||264
8761430|NCT01224821|9811187|FG000|STARTED|Dosimetric and Therapeutic Treatment||47
8761431|NCT01224821|9811187|FG000|COMPLETED|Dosimetric and Therapeutic Treatment|This participant completed the study per Protocol Amendment 2.|1
8761432|NCT01224821|9811187|FG000|NOT COMPLETED|Dosimetric and Therapeutic Treatment||46
8761433|NCT01224821|9811187|FG000|STARTED|Long-Term Follow-Up|11/47 participants withdrawing from this study enrolled in the LTFU study for continued evaluation.|11
8761434|NCT01224821|9811187|FG000|COMPLETED|Long-Term Follow-Up||0
8761435|NCT01224821|9811187|FG000|NOT COMPLETED|Long-Term Follow-Up||11
8761436|NCT01224925|9811193|FG000|STARTED|Overall Study||37
8761437|NCT01224925|9811194|FG001|STARTED|Overall Study||33
8761438|NCT01224925|9811193|FG000|COMPLETED|Overall Study||34
8761439|NCT01224925|9811194|FG001|COMPLETED|Overall Study||31
8761440|NCT01224925|9811193|FG000|NOT COMPLETED|Overall Study||3
8761441|NCT01224925|9811194|FG001|NOT COMPLETED|Overall Study||2
8761442|NCT01225029|9811204|FG000|STARTED|Overall Study||32
8761443|NCT01225029|9811205|FG001|STARTED|Overall Study||32
8761444|NCT01225029|9811204|FG000|COMPLETED|Overall Study||32
8761445|NCT01225029|9811205|FG001|COMPLETED|Overall Study||32
8761446|NCT01225029|9811204|FG000|NOT COMPLETED|Overall Study||0
8761447|NCT01225029|9811205|FG001|NOT COMPLETED|Overall Study||0
8761448|NCT01225055|9811214|FG000|STARTED|Overall Study||20
8761449|NCT01225055|9811215|FG001|STARTED|Overall Study||20
8761450|NCT01225055|9811216|FG002|STARTED|Overall Study||21
8761451|NCT01225055|9811214|FG000|COMPLETED|Overall Study||20
8761452|NCT01225055|9811215|FG001|COMPLETED|Overall Study||18
8761453|NCT01225055|9811216|FG002|COMPLETED|Overall Study||18
8761454|NCT01225055|9811214|FG000|NOT COMPLETED|Overall Study||0
8761455|NCT01225055|9811215|FG001|NOT COMPLETED|Overall Study||2
8761456|NCT01225055|9811216|FG002|NOT COMPLETED|Overall Study||3
8761457|NCT01225068|9811226|FG000|STARTED|Overall Study||20
8761458|NCT01225068|9811227|FG001|STARTED|Overall Study||20
8761459|NCT01225068|9811226|FG000|COMPLETED|Overall Study||16
8761460|NCT01225068|9811227|FG001|COMPLETED|Overall Study||19
8761461|NCT01225068|9811226|FG000|NOT COMPLETED|Overall Study||4
8761462|NCT01225068|9811227|FG001|NOT COMPLETED|Overall Study||1
8761463|NCT01225146|9811235|FG000|STARTED|Overall Study||6
8761464|NCT01225146|9811236|FG001|STARTED|Overall Study||2
8761465|NCT01225146|9811235|FG000|COMPLETED|Overall Study||6
8761466|NCT01225146|9811236|FG001|COMPLETED|Overall Study||0
8761467|NCT01225146|9811235|FG000|NOT COMPLETED|Overall Study||0
8761468|NCT01225146|9811236|FG001|NOT COMPLETED|Overall Study||2
8808294|NCT01490632|9860709|FG008|STARTED|Part A: Initial Treatment Period||0
8808295|NCT01490632|9860710|FG009|STARTED|Part A: Initial Treatment Period||0
8808296|NCT01490632|9860711|FG010|STARTED|Part A: Initial Treatment Period||0
8761469|NCT01225159|9811246|FG000|STARTED|Overall Study||100
8761470|NCT01225159|9811247|FG001|STARTED|Overall Study||100
8761471|NCT01225159|9811246|FG000|COMPLETED|Overall Study||99
8761472|NCT01225159|9811247|FG001|COMPLETED|Overall Study||100
8761473|NCT01225159|9811246|FG000|NOT COMPLETED|Overall Study||1
8761474|NCT01225159|9811247|FG001|NOT COMPLETED|Overall Study||0
8761475|NCT01225172|9811255|FG000|STARTED|Overall Study||52
8761476|NCT01225172|9811256|FG001|STARTED|Overall Study||7
8761477|NCT01225172|9811255|FG000|COMPLETED|Overall Study||46
8761478|NCT01225172|9811256|FG001|COMPLETED|Overall Study||6
8761479|NCT01225172|9811255|FG000|NOT COMPLETED|Overall Study||6
8761480|NCT01225172|9811256|FG001|NOT COMPLETED|Overall Study||1
8761481|NCT01225211|9811272|FG000|STARTED|Overall Study||21
8761482|NCT01225211|9811273|FG001|STARTED|Overall Study||20
8761483|NCT01225211|9811274|FG002|STARTED|Overall Study||21
8761484|NCT01225211|9811275|FG003|STARTED|Overall Study||27
8761485|NCT01225211|9811276|FG004|STARTED|Overall Study||23
8761486|NCT01225211|9811277|FG005|STARTED|Overall Study||21
8761487|NCT01225211|9811278|FG006|STARTED|Overall Study||42
8761488|NCT01225211|9811279|FG007|STARTED|Overall Study||11
8761489|NCT01225211|9811280|FG008|STARTED|Overall Study||63
8761490|NCT01225211|9811281|FG009|STARTED|Overall Study||62
8761491|NCT01225211|9811272|FG000|COMPLETED|Overall Study||21
8761492|NCT01225211|9811273|FG001|COMPLETED|Overall Study||20
8761493|NCT01225211|9811274|FG002|COMPLETED|Overall Study||20
8761494|NCT01225211|9811275|FG003|COMPLETED|Overall Study||27
8761495|NCT01225211|9811276|FG004|COMPLETED|Overall Study||23
8761496|NCT01225211|9811277|FG005|COMPLETED|Overall Study||21
8761497|NCT01225211|9811278|FG006|COMPLETED|Overall Study||41
8761498|NCT01225211|9811279|FG007|COMPLETED|Overall Study||11
8761499|NCT01225211|9811280|FG008|COMPLETED|Overall Study||62
8761500|NCT01225211|9811281|FG009|COMPLETED|Overall Study||57
8761501|NCT01225211|9811272|FG000|NOT COMPLETED|Overall Study||0
8761502|NCT01225211|9811273|FG001|NOT COMPLETED|Overall Study||0
8761503|NCT01225211|9811274|FG002|NOT COMPLETED|Overall Study||1
8761504|NCT01225211|9811275|FG003|NOT COMPLETED|Overall Study||0
8761505|NCT01225211|9811276|FG004|NOT COMPLETED|Overall Study||0
8761506|NCT01225211|9811277|FG005|NOT COMPLETED|Overall Study||0
8761507|NCT01225211|9811278|FG006|NOT COMPLETED|Overall Study||1
8761508|NCT01225211|9811279|FG007|NOT COMPLETED|Overall Study||0
8761509|NCT01225211|9811280|FG008|NOT COMPLETED|Overall Study||1
8761510|NCT01225211|9811281|FG009|NOT COMPLETED|Overall Study||5
8761511|NCT01225250|9811340|FG000|STARTED|Overall Study||15
8761512|NCT01225250|9811341|FG001|STARTED|Overall Study||15
8761513|NCT01225250|9811340|FG000|COMPLETED|Overall Study||10
8761514|NCT01225250|9811341|FG001|COMPLETED|Overall Study||10
8761515|NCT01225250|9811340|FG000|NOT COMPLETED|Overall Study||5
8761516|NCT01225250|9811341|FG001|NOT COMPLETED|Overall Study||5
8761517|NCT01225263|9811349|FG000|STARTED|Weeks 1 to 12||28
8761518|NCT01225263|9811350|FG001|STARTED|Weeks 1 to 12||29
8761519|NCT01225263|9811349|FG000|COMPLETED|Weeks 1 to 12||28
8761520|NCT01225263|9811350|FG001|COMPLETED|Weeks 1 to 12||29
8761521|NCT01225263|9811349|FG000|NOT COMPLETED|Weeks 1 to 12||0
8761522|NCT01225263|9811350|FG001|NOT COMPLETED|Weeks 1 to 12||0
8761523|NCT01225263|9811349|FG000|STARTED|Weeks 13 to 24||28
8761524|NCT01225263|9811350|FG001|STARTED|Weeks 13 to 24||29
8761525|NCT01225263|9811349|FG000|COMPLETED|Weeks 13 to 24||24
8761526|NCT01225263|9811350|FG001|COMPLETED|Weeks 13 to 24||28
8761527|NCT01225263|9811349|FG000|NOT COMPLETED|Weeks 13 to 24||4
8761528|NCT01225263|9811350|FG001|NOT COMPLETED|Weeks 13 to 24||1
8761529|NCT01225289|9811359|FG000|STARTED|Overall Study||18
8761530|NCT01225289|9811360|FG001|STARTED|Overall Study||18
8761531|NCT01225289|9811359|FG000|COMPLETED|Overall Study||18
8761532|NCT01225289|9811360|FG001|COMPLETED|Overall Study||17
8761533|NCT01225289|9811359|FG000|NOT COMPLETED|Overall Study||0
8761534|NCT01225289|9811360|FG001|NOT COMPLETED|Overall Study||1
8761535|NCT01225354|9811366|FG000|STARTED|Overall Study||20
8761536|NCT01225354|9811366|FG000|COMPLETED|Overall Study||19
8761537|NCT01225354|9811366|FG000|NOT COMPLETED|Overall Study||1
8761538|NCT01225549|9811371|FG000|STARTED|Period 1 - First Treatment Period||1
8761539|NCT01225549|9811372|FG001|STARTED|Period 1 - First Treatment Period||4
8761540|NCT01225549|9811373|FG002|STARTED|Period 1 - First Treatment Period||3
8761541|NCT01225549|9811374|FG003|STARTED|Period 1 - First Treatment Period||1
8761542|NCT01225549|9811375|FG004|STARTED|Period 1 - First Treatment Period||1
8761543|NCT01225549|9811376|FG005|STARTED|Period 1 - First Treatment Period||1
8761544|NCT01225549|9811377|FG006|STARTED|Period 1 - First Treatment Period||3
8761545|NCT01225549|9811378|FG007|STARTED|Period 1 - First Treatment Period||1
8761546|NCT01225549|9811379|FG008|STARTED|Period 1 - First Treatment Period||4
8761547|NCT01225549|9811380|FG009|STARTED|Period 1 - First Treatment Period||1
8761548|NCT01225549|9811371|FG000|COMPLETED|Period 1 - First Treatment Period||1
8761549|NCT01225549|9811372|FG001|COMPLETED|Period 1 - First Treatment Period||4
8761550|NCT01225549|9811373|FG002|COMPLETED|Period 1 - First Treatment Period||3
8761551|NCT01225549|9811374|FG003|COMPLETED|Period 1 - First Treatment Period||1
8761552|NCT01225549|9811375|FG004|COMPLETED|Period 1 - First Treatment Period||1
8761553|NCT01225549|9811376|FG005|COMPLETED|Period 1 - First Treatment Period||1
8761554|NCT01225549|9811377|FG006|COMPLETED|Period 1 - First Treatment Period||3
8761555|NCT01225549|9811378|FG007|COMPLETED|Period 1 - First Treatment Period||1
8761556|NCT01225549|9811379|FG008|COMPLETED|Period 1 - First Treatment Period||4
8761557|NCT01225549|9811380|FG009|COMPLETED|Period 1 - First Treatment Period||1
8761558|NCT01225549|9811371|FG000|NOT COMPLETED|Period 1 - First Treatment Period||0
8761559|NCT01225549|9811372|FG001|NOT COMPLETED|Period 1 - First Treatment Period||0
8761560|NCT01225549|9811373|FG002|NOT COMPLETED|Period 1 - First Treatment Period||0
8761561|NCT01225549|9811374|FG003|NOT COMPLETED|Period 1 - First Treatment Period||0
8761562|NCT01225549|9811375|FG004|NOT COMPLETED|Period 1 - First Treatment Period||0
8761563|NCT01225549|9811376|FG005|NOT COMPLETED|Period 1 - First Treatment Period||0
8761564|NCT01225549|9811377|FG006|NOT COMPLETED|Period 1 - First Treatment Period||0
8761565|NCT01225549|9811378|FG007|NOT COMPLETED|Period 1 - First Treatment Period||0
8761566|NCT01225549|9811379|FG008|NOT COMPLETED|Period 1 - First Treatment Period||0
8761567|NCT01225549|9811380|FG009|NOT COMPLETED|Period 1 - First Treatment Period||0
8761568|NCT01225549|9811371|FG000|STARTED|Period 2 - Washout||1
8761569|NCT01225549|9811372|FG001|STARTED|Period 2 - Washout||4
8761570|NCT01225549|9811373|FG002|STARTED|Period 2 - Washout||3
8761571|NCT01225549|9811374|FG003|STARTED|Period 2 - Washout||1
8761572|NCT01225549|9811375|FG004|STARTED|Period 2 - Washout||1
8761573|NCT01225549|9811376|FG005|STARTED|Period 2 - Washout||1
8761574|NCT01225549|9811377|FG006|STARTED|Period 2 - Washout||3
8761575|NCT01225549|9811378|FG007|STARTED|Period 2 - Washout||1
8761576|NCT01225549|9811379|FG008|STARTED|Period 2 - Washout||4
8761577|NCT01225549|9811380|FG009|STARTED|Period 2 - Washout||1
8761578|NCT01225549|9811371|FG000|COMPLETED|Period 2 - Washout||1
8761579|NCT01225549|9811372|FG001|COMPLETED|Period 2 - Washout||4
8761580|NCT01225549|9811373|FG002|COMPLETED|Period 2 - Washout||3
8761581|NCT01225549|9811374|FG003|COMPLETED|Period 2 - Washout||1
8761582|NCT01225549|9811375|FG004|COMPLETED|Period 2 - Washout||1
8761583|NCT01225549|9811376|FG005|COMPLETED|Period 2 - Washout||1
8761584|NCT01225549|9811377|FG006|COMPLETED|Period 2 - Washout||3
8761585|NCT01225549|9811378|FG007|COMPLETED|Period 2 - Washout||1
8761586|NCT01225549|9811379|FG008|COMPLETED|Period 2 - Washout||4
8761587|NCT01225549|9811380|FG009|COMPLETED|Period 2 - Washout||1
8761588|NCT01225549|9811371|FG000|NOT COMPLETED|Period 2 - Washout||0
8761589|NCT01225549|9811372|FG001|NOT COMPLETED|Period 2 - Washout||0
8761590|NCT01225549|9811373|FG002|NOT COMPLETED|Period 2 - Washout||0
8761591|NCT01225549|9811374|FG003|NOT COMPLETED|Period 2 - Washout||0
8761592|NCT01225549|9811375|FG004|NOT COMPLETED|Period 2 - Washout||0
8761593|NCT01225549|9811376|FG005|NOT COMPLETED|Period 2 - Washout||0
8761594|NCT01225549|9811377|FG006|NOT COMPLETED|Period 2 - Washout||0
8761595|NCT01225549|9811378|FG007|NOT COMPLETED|Period 2 - Washout||0
8761596|NCT01225549|9811379|FG008|NOT COMPLETED|Period 2 - Washout||0
8761597|NCT01225549|9811380|FG009|NOT COMPLETED|Period 2 - Washout||0
8761598|NCT01225549|9811371|FG000|STARTED|Period 3 - Second Treatment Period||1
8761599|NCT01225549|9811372|FG001|STARTED|Period 3 - Second Treatment Period||4
8761600|NCT01225549|9811373|FG002|STARTED|Period 3 - Second Treatment Period||3
8761601|NCT01225549|9811374|FG003|STARTED|Period 3 - Second Treatment Period||1
8761602|NCT01225549|9811375|FG004|STARTED|Period 3 - Second Treatment Period||1
8761603|NCT01225549|9811376|FG005|STARTED|Period 3 - Second Treatment Period||1
8761604|NCT01225549|9811377|FG006|STARTED|Period 3 - Second Treatment Period||3
8761605|NCT01225549|9811378|FG007|STARTED|Period 3 - Second Treatment Period||1
8761606|NCT01225549|9811379|FG008|STARTED|Period 3 - Second Treatment Period||4
8761607|NCT01225549|9811380|FG009|STARTED|Period 3 - Second Treatment Period||1
8761608|NCT01225549|9811371|FG000|COMPLETED|Period 3 - Second Treatment Period||1
8761609|NCT01225549|9811372|FG001|COMPLETED|Period 3 - Second Treatment Period||4
8761610|NCT01225549|9811373|FG002|COMPLETED|Period 3 - Second Treatment Period||3
8761611|NCT01225549|9811374|FG003|COMPLETED|Period 3 - Second Treatment Period||1
8761612|NCT01225549|9811375|FG004|COMPLETED|Period 3 - Second Treatment Period||1
8761613|NCT01225549|9811376|FG005|COMPLETED|Period 3 - Second Treatment Period||1
8761614|NCT01225549|9811377|FG006|COMPLETED|Period 3 - Second Treatment Period||3
8761615|NCT01225549|9811378|FG007|COMPLETED|Period 3 - Second Treatment Period||1
8761616|NCT01225549|9811379|FG008|COMPLETED|Period 3 - Second Treatment Period||4
8761617|NCT01225549|9811380|FG009|COMPLETED|Period 3 - Second Treatment Period||1
8761618|NCT01225549|9811371|FG000|NOT COMPLETED|Period 3 - Second Treatment Period||0
8761619|NCT01225549|9811372|FG001|NOT COMPLETED|Period 3 - Second Treatment Period||0
8761620|NCT01225549|9811373|FG002|NOT COMPLETED|Period 3 - Second Treatment Period||0
8761621|NCT01225549|9811374|FG003|NOT COMPLETED|Period 3 - Second Treatment Period||0
8761622|NCT01225549|9811375|FG004|NOT COMPLETED|Period 3 - Second Treatment Period||0
8915475|NCT02175225|9974905|FG001|180 Day Outcome Obtained|Overall Study||135
8915476|NCT02175225|9974904|FG000|COMPLETED|Overall Study||137
8915477|NCT02175225|9974905|FG001|COMPLETED|Overall Study||138
8915478|NCT02175225|9974904|FG000|NOT COMPLETED|Overall Study||8
8915479|NCT02175225|9974905|FG001|NOT COMPLETED|Overall Study||11
8915480|NCT02175277|9974911|FG000|STARTED|Overall Study||9
8915481|NCT02175277|9974911|FG000|COMPLETED|Overall Study||8
8915482|NCT02175277|9974911|FG000|NOT COMPLETED|Overall Study||1
8915483|NCT02175368|9974915|FG000|STARTED|Overall Study||28
8915484|NCT02175368|9974915|FG000|COMPLETED|Overall Study||27
8915485|NCT02175368|9974915|FG000|NOT COMPLETED|Overall Study||1
8915486|NCT02175472|9974921|FG000|STARTED|Overall Study||45
8915487|NCT02175472|9974922|FG001|STARTED|Overall Study||47
8915488|NCT02175472|9974921|FG000|COMPLETED|Overall Study||38
8915489|NCT02175472|9974922|FG001|COMPLETED|Overall Study||45
8915490|NCT02175472|9974921|FG000|NOT COMPLETED|Overall Study||7
8915491|NCT02175472|9974922|FG001|NOT COMPLETED|Overall Study||2
8915492|NCT02175641|9974930|FG000|STARTED|Overall Study||157
8761623|NCT01225549|9811376|FG005|NOT COMPLETED|Period 3 - Second Treatment Period||0
8761624|NCT01225549|9811377|FG006|NOT COMPLETED|Period 3 - Second Treatment Period||0
8761625|NCT01225549|9811378|FG007|NOT COMPLETED|Period 3 - Second Treatment Period||0
8761626|NCT01225549|9811379|FG008|NOT COMPLETED|Period 3 - Second Treatment Period||0
8761627|NCT01225549|9811380|FG009|NOT COMPLETED|Period 3 - Second Treatment Period||0
8761628|NCT01225549|9811371|FG000|STARTED|Period 4 - Washout||1
8761629|NCT01225549|9811372|FG001|STARTED|Period 4 - Washout||4
8761630|NCT01225549|9811373|FG002|STARTED|Period 4 - Washout||3
8761631|NCT01225549|9811374|FG003|STARTED|Period 4 - Washout||1
8761632|NCT01225549|9811375|FG004|STARTED|Period 4 - Washout||1
8761633|NCT01225549|9811376|FG005|STARTED|Period 4 - Washout||1
8761634|NCT01225549|9811377|FG006|STARTED|Period 4 - Washout||3
8761635|NCT01225549|9811378|FG007|STARTED|Period 4 - Washout||1
8761636|NCT01225549|9811379|FG008|STARTED|Period 4 - Washout||4
8761637|NCT01225549|9811380|FG009|STARTED|Period 4 - Washout||1
8761638|NCT01225549|9811371|FG000|COMPLETED|Period 4 - Washout||1
8761639|NCT01225549|9811372|FG001|COMPLETED|Period 4 - Washout||3
8761640|NCT01225549|9811373|FG002|COMPLETED|Period 4 - Washout||3
8761641|NCT01225549|9811374|FG003|COMPLETED|Period 4 - Washout||1
8761642|NCT01225549|9811375|FG004|COMPLETED|Period 4 - Washout||1
8761643|NCT01225549|9811376|FG005|COMPLETED|Period 4 - Washout||1
8761644|NCT01225549|9811377|FG006|COMPLETED|Period 4 - Washout||3
8761645|NCT01225549|9811378|FG007|COMPLETED|Period 4 - Washout||1
8761646|NCT01225549|9811379|FG008|COMPLETED|Period 4 - Washout||4
8761647|NCT01225549|9811380|FG009|COMPLETED|Period 4 - Washout||1
8761648|NCT01225549|9811371|FG000|NOT COMPLETED|Period 4 - Washout||0
8761649|NCT01225549|9811372|FG001|NOT COMPLETED|Period 4 - Washout||1
8761650|NCT01225549|9811373|FG002|NOT COMPLETED|Period 4 - Washout||0
8761651|NCT01225549|9811374|FG003|NOT COMPLETED|Period 4 - Washout||0
8761652|NCT01225549|9811375|FG004|NOT COMPLETED|Period 4 - Washout||0
8761653|NCT01225549|9811376|FG005|NOT COMPLETED|Period 4 - Washout||0
8761654|NCT01225549|9811377|FG006|NOT COMPLETED|Period 4 - Washout||0
8761655|NCT01225549|9811378|FG007|NOT COMPLETED|Period 4 - Washout||0
8761656|NCT01225549|9811379|FG008|NOT COMPLETED|Period 4 - Washout||0
8761657|NCT01225549|9811380|FG009|NOT COMPLETED|Period 4 - Washout||0
8761658|NCT01225549|9811371|FG000|STARTED|Period 5 - Third Treatment Period||1
8761659|NCT01225549|9811372|FG001|STARTED|Period 5 - Third Treatment Period||3
8761660|NCT01225549|9811373|FG002|STARTED|Period 5 - Third Treatment Period||3
8761661|NCT01225549|9811374|FG003|STARTED|Period 5 - Third Treatment Period||1
8761662|NCT01225549|9811375|FG004|STARTED|Period 5 - Third Treatment Period||1
8761663|NCT01225549|9811376|FG005|STARTED|Period 5 - Third Treatment Period||1
8761664|NCT01225549|9811377|FG006|STARTED|Period 5 - Third Treatment Period||3
8761665|NCT01225549|9811378|FG007|STARTED|Period 5 - Third Treatment Period||1
8761666|NCT01225549|9811379|FG008|STARTED|Period 5 - Third Treatment Period||4
8761667|NCT01225549|9811380|FG009|STARTED|Period 5 - Third Treatment Period||1
8761668|NCT01225549|9811371|FG000|COMPLETED|Period 5 - Third Treatment Period||1
8761669|NCT01225549|9811372|FG001|COMPLETED|Period 5 - Third Treatment Period||3
8761670|NCT01225549|9811373|FG002|COMPLETED|Period 5 - Third Treatment Period||3
8761671|NCT01225549|9811374|FG003|COMPLETED|Period 5 - Third Treatment Period||1
8761672|NCT01225549|9811375|FG004|COMPLETED|Period 5 - Third Treatment Period||1
8761673|NCT01225549|9811376|FG005|COMPLETED|Period 5 - Third Treatment Period||1
8761674|NCT01225549|9811377|FG006|COMPLETED|Period 5 - Third Treatment Period||3
8761675|NCT01225549|9811378|FG007|COMPLETED|Period 5 - Third Treatment Period||1
8761676|NCT01225549|9811379|FG008|COMPLETED|Period 5 - Third Treatment Period||4
8761677|NCT01225549|9811380|FG009|COMPLETED|Period 5 - Third Treatment Period||1
8761678|NCT01225549|9811371|FG000|NOT COMPLETED|Period 5 - Third Treatment Period||0
8761679|NCT01225549|9811372|FG001|NOT COMPLETED|Period 5 - Third Treatment Period||0
8761680|NCT01225549|9811373|FG002|NOT COMPLETED|Period 5 - Third Treatment Period||0
8761681|NCT01225549|9811374|FG003|NOT COMPLETED|Period 5 - Third Treatment Period||0
8761682|NCT01225549|9811375|FG004|NOT COMPLETED|Period 5 - Third Treatment Period||0
8761683|NCT01225549|9811376|FG005|NOT COMPLETED|Period 5 - Third Treatment Period||0
8761684|NCT01225549|9811377|FG006|NOT COMPLETED|Period 5 - Third Treatment Period||0
8761685|NCT01225549|9811378|FG007|NOT COMPLETED|Period 5 - Third Treatment Period||0
8761686|NCT01225549|9811379|FG008|NOT COMPLETED|Period 5 - Third Treatment Period||0
8761687|NCT01225549|9811380|FG009|NOT COMPLETED|Period 5 - Third Treatment Period||0
8761688|NCT01225549|9811371|FG000|STARTED|Period 6 - Washout||1
8761689|NCT01225549|9811372|FG001|STARTED|Period 6 - Washout||3
8761690|NCT01225549|9811373|FG002|STARTED|Period 6 - Washout||3
8761691|NCT01225549|9811374|FG003|STARTED|Period 6 - Washout||1
8761692|NCT01225549|9811375|FG004|STARTED|Period 6 - Washout||1
8761693|NCT01225549|9811376|FG005|STARTED|Period 6 - Washout||1
8761694|NCT01225549|9811377|FG006|STARTED|Period 6 - Washout||3
8761695|NCT01225549|9811378|FG007|STARTED|Period 6 - Washout||1
8761696|NCT01225549|9811379|FG008|STARTED|Period 6 - Washout||4
8761697|NCT01225549|9811380|FG009|STARTED|Period 6 - Washout||1
8761698|NCT01225549|9811371|FG000|COMPLETED|Period 6 - Washout||1
8761699|NCT01225549|9811372|FG001|COMPLETED|Period 6 - Washout||3
8761700|NCT01225549|9811373|FG002|COMPLETED|Period 6 - Washout||3
8761701|NCT01225549|9811374|FG003|COMPLETED|Period 6 - Washout||0
8761702|NCT01225549|9811375|FG004|COMPLETED|Period 6 - Washout||1
8761703|NCT01225549|9811376|FG005|COMPLETED|Period 6 - Washout||1
8761704|NCT01225549|9811377|FG006|COMPLETED|Period 6 - Washout||3
8761705|NCT01225549|9811378|FG007|COMPLETED|Period 6 - Washout||1
8761706|NCT01225549|9811379|FG008|COMPLETED|Period 6 - Washout||4
8761707|NCT01225549|9811380|FG009|COMPLETED|Period 6 - Washout||1
8761708|NCT01225549|9811371|FG000|NOT COMPLETED|Period 6 - Washout||0
8761709|NCT01225549|9811372|FG001|NOT COMPLETED|Period 6 - Washout||0
8761710|NCT01225549|9811373|FG002|NOT COMPLETED|Period 6 - Washout||0
8761711|NCT01225549|9811374|FG003|NOT COMPLETED|Period 6 - Washout||1
8761712|NCT01225549|9811375|FG004|NOT COMPLETED|Period 6 - Washout||0
8761713|NCT01225549|9811376|FG005|NOT COMPLETED|Period 6 - Washout||0
8761714|NCT01225549|9811377|FG006|NOT COMPLETED|Period 6 - Washout||0
8761715|NCT01225549|9811378|FG007|NOT COMPLETED|Period 6 - Washout||0
8761716|NCT01225549|9811379|FG008|NOT COMPLETED|Period 6 - Washout||0
8761717|NCT01225549|9811380|FG009|NOT COMPLETED|Period 6 - Washout||0
8761718|NCT01225549|9811371|FG000|STARTED|Period 7 - Fourth Treatment Period||1
8761719|NCT01225549|9811372|FG001|STARTED|Period 7 - Fourth Treatment Period||3
8761720|NCT01225549|9811373|FG002|STARTED|Period 7 - Fourth Treatment Period||3
8761721|NCT01225549|9811374|FG003|STARTED|Period 7 - Fourth Treatment Period||0
8761722|NCT01225549|9811375|FG004|STARTED|Period 7 - Fourth Treatment Period||1
8761723|NCT01225549|9811376|FG005|STARTED|Period 7 - Fourth Treatment Period||1
8761724|NCT01225549|9811377|FG006|STARTED|Period 7 - Fourth Treatment Period||3
8761725|NCT01225549|9811378|FG007|STARTED|Period 7 - Fourth Treatment Period||1
8761726|NCT01225549|9811379|FG008|STARTED|Period 7 - Fourth Treatment Period||4
8761727|NCT01225549|9811380|FG009|STARTED|Period 7 - Fourth Treatment Period||1
8761728|NCT01225549|9811371|FG000|COMPLETED|Period 7 - Fourth Treatment Period||1
8761729|NCT01225549|9811372|FG001|COMPLETED|Period 7 - Fourth Treatment Period||3
8761730|NCT01225549|9811373|FG002|COMPLETED|Period 7 - Fourth Treatment Period||3
8761731|NCT01225549|9811374|FG003|COMPLETED|Period 7 - Fourth Treatment Period||0
8761732|NCT01225549|9811375|FG004|COMPLETED|Period 7 - Fourth Treatment Period||1
8761733|NCT01225549|9811376|FG005|COMPLETED|Period 7 - Fourth Treatment Period||1
8761734|NCT01225549|9811377|FG006|COMPLETED|Period 7 - Fourth Treatment Period||3
8761735|NCT01225549|9811378|FG007|COMPLETED|Period 7 - Fourth Treatment Period||1
8761736|NCT01225549|9811379|FG008|COMPLETED|Period 7 - Fourth Treatment Period||4
8761737|NCT01225549|9811380|FG009|COMPLETED|Period 7 - Fourth Treatment Period||1
8761738|NCT01225549|9811371|FG000|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
8761739|NCT01225549|9811372|FG001|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
8761740|NCT01225549|9811373|FG002|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
8761741|NCT01225549|9811374|FG003|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
8761742|NCT01225549|9811375|FG004|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
8761743|NCT01225549|9811376|FG005|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
8761744|NCT01225549|9811377|FG006|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
8761745|NCT01225549|9811378|FG007|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
8761746|NCT01225549|9811379|FG008|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
8761747|NCT01225549|9811380|FG009|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
8761748|NCT01225562|9811393|FG000|STARTED|Overall Study||7050
8761749|NCT01225562|9811394|FG001|STARTED|Overall Study||7045
8761750|NCT01225562|9811395|FG002|STARTED|Overall Study||7067
8761751|NCT01225562|9811393|FG000|COMPLETED|Overall Study||6995
8761752|NCT01225562|9811394|FG001|COMPLETED|Overall Study||6989
8761753|NCT01225562|9811395|FG002|COMPLETED|Overall Study||7014
8761754|NCT01225562|9811393|FG000|NOT COMPLETED|Overall Study||55
8761755|NCT01225562|9811394|FG001|NOT COMPLETED|Overall Study||56
8761756|NCT01225562|9811395|FG002|NOT COMPLETED|Overall Study||53
8761757|NCT01225731|9811408|FG000|STARTED|Part 1||42
8761758|NCT01225731|9811409|FG001|STARTED|Part 1||92
8761759|NCT01225731|9811410|FG002|STARTED|Part 1||89
8761760|NCT01225731|9811411|FG003|STARTED|Part 1||86
8761761|NCT01225731|9811412|FG004|STARTED|Part 1||46
8761762|NCT01225731|9811413|FG005|STARTED|Part 1||0
8761763|NCT01225731|9811414|FG006|STARTED|Part 1||0
8761764|NCT01225731|9811415|FG007|STARTED|Part 1||0
8761765|NCT01225731|9811416|FG008|STARTED|Part 1||0
8761766|NCT01225731|9811417|FG009|STARTED|Part 1||0
8761767|NCT01225731|9811418|FG010|STARTED|Part 1||0
8761768|NCT01225731|9811419|FG011|STARTED|Part 1||0
8761769|NCT01225731|9811420|FG012|STARTED|Part 1||0
8761770|NCT01225731|9811408|FG000|COMPLETED|Part 1||40
8761771|NCT01225731|9811409|FG001|COMPLETED|Part 1||87
8761772|NCT01225731|9811410|FG002|COMPLETED|Part 1||88
8761773|NCT01225731|9811411|FG003|COMPLETED|Part 1||84
8761774|NCT01225731|9811412|FG004|COMPLETED|Part 1||40
8761775|NCT01225731|9811413|FG005|COMPLETED|Part 1||0
8761776|NCT01225731|9811414|FG006|COMPLETED|Part 1||0
8761777|NCT01225731|9811415|FG007|COMPLETED|Part 1||0
8761778|NCT01225731|9811416|FG008|COMPLETED|Part 1||0
8761779|NCT01225731|9811417|FG009|COMPLETED|Part 1||0
8761780|NCT01225731|9811418|FG010|COMPLETED|Part 1||0
8761781|NCT01225731|9811419|FG011|COMPLETED|Part 1||0
8761782|NCT01225731|9811420|FG012|COMPLETED|Part 1||0
8761783|NCT01225731|9811408|FG000|NOT COMPLETED|Part 1||2
8761784|NCT01225731|9811409|FG001|NOT COMPLETED|Part 1||5
8761785|NCT01225731|9811410|FG002|NOT COMPLETED|Part 1||1
8761786|NCT01225731|9811411|FG003|NOT COMPLETED|Part 1||2
8761787|NCT01225731|9811412|FG004|NOT COMPLETED|Part 1||6
8761788|NCT01225731|9811413|FG005|NOT COMPLETED|Part 1||0
8761789|NCT01225731|9811414|FG006|NOT COMPLETED|Part 1||0
8761790|NCT01225731|9811415|FG007|NOT COMPLETED|Part 1||0
8761791|NCT01225731|9811416|FG008|NOT COMPLETED|Part 1||0
8761792|NCT01225731|9811417|FG009|NOT COMPLETED|Part 1||0
8761793|NCT01225731|9811418|FG010|NOT COMPLETED|Part 1||0
8761794|NCT01225731|9811419|FG011|NOT COMPLETED|Part 1||0
8761795|NCT01225731|9811420|FG012|NOT COMPLETED|Part 1||0
8761796|NCT01225731|9811408|FG000|STARTED|Part 2|Participants could progress into Part 2|0
8761797|NCT01225731|9811409|FG001|STARTED|Part 2|Participants could progress into Part 2|0
8761798|NCT01225731|9811410|FG002|STARTED|Part 2|Participants could progress into Part 2|0
8761799|NCT01225731|9811411|FG003|STARTED|Part 2|Participants could progress into Part 2|0
8761800|NCT01225731|9811412|FG004|STARTED|Part 2|Participants could progress into Part 2; no placebo was given in Part 2|0
8761801|NCT01225731|9811413|FG005|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|13
8761802|NCT01225731|9811414|FG006|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|94
8761803|NCT01225731|9811415|FG007|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|153
8761804|NCT01225731|9811416|FG008|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|79
8761805|NCT01225731|9811417|FG009|STARTED|Part 2||0
8761806|NCT01225731|9811418|FG010|STARTED|Part 2||0
8761807|NCT01225731|9811419|FG011|STARTED|Part 2||0
8761808|NCT01225731|9811420|FG012|STARTED|Part 2||0
8761809|NCT01225731|9811408|FG000|COMPLETED|Part 2||0
8761810|NCT01225731|9811409|FG001|COMPLETED|Part 2||0
8761811|NCT01225731|9811410|FG002|COMPLETED|Part 2||0
8761812|NCT01225731|9811411|FG003|COMPLETED|Part 2||0
8761813|NCT01225731|9811412|FG004|COMPLETED|Part 2||0
8761814|NCT01225731|9811413|FG005|COMPLETED|Part 2||10
8761815|NCT01225731|9811414|FG006|COMPLETED|Part 2||86
8761816|NCT01225731|9811415|FG007|COMPLETED|Part 2||128
8761817|NCT01225731|9811416|FG008|COMPLETED|Part 2||68
8761818|NCT01225731|9811417|FG009|COMPLETED|Part 2||0
8761819|NCT01225731|9811418|FG010|COMPLETED|Part 2||0
8761820|NCT01225731|9811419|FG011|COMPLETED|Part 2||0
8761821|NCT01225731|9811420|FG012|COMPLETED|Part 2||0
8761822|NCT01225731|9811408|FG000|NOT COMPLETED|Part 2||0
8761823|NCT01225731|9811409|FG001|NOT COMPLETED|Part 2||0
8761824|NCT01225731|9811410|FG002|NOT COMPLETED|Part 2||0
8761825|NCT01225731|9811411|FG003|NOT COMPLETED|Part 2||0
8761826|NCT01225731|9811412|FG004|NOT COMPLETED|Part 2||0
8761827|NCT01225731|9811413|FG005|NOT COMPLETED|Part 2||3
8761828|NCT01225731|9811414|FG006|NOT COMPLETED|Part 2||8
8761829|NCT01225731|9811415|FG007|NOT COMPLETED|Part 2||25
8761830|NCT01225731|9811416|FG008|NOT COMPLETED|Part 2||11
8761831|NCT01225731|9811417|FG009|NOT COMPLETED|Part 2||0
8761832|NCT01225731|9811418|FG010|NOT COMPLETED|Part 2||0
8761833|NCT01225731|9811419|FG011|NOT COMPLETED|Part 2||0
9026007|NCT03170544|10088449|FG009|STARTED|Part 1||0
9026008|NCT03170544|10088450|FG010|STARTED|Part 1||0
9026009|NCT03170544|10088451|FG011|STARTED|Part 1||0
9026010|NCT03170544|10088440|FG000|COMPLETED|Part 1||9
9026011|NCT03170544|10088441|FG001|COMPLETED|Part 1||6
9026012|NCT03170544|10088442|FG002|COMPLETED|Part 1||6
9026013|NCT03170544|10088443|FG003|COMPLETED|Part 1||6
9026014|NCT03170544|10088444|FG004|COMPLETED|Part 1||6
9026015|NCT03170544|10088445|FG005|COMPLETED|Part 1||6
9026016|NCT03170544|10088446|FG006|COMPLETED|Part 1||0
9026017|NCT03170544|10088447|FG007|COMPLETED|Part 1||0
9026018|NCT03170544|10088448|FG008|COMPLETED|Part 1||0
9026019|NCT03170544|10088449|FG009|COMPLETED|Part 1||0
9026020|NCT03170544|10088450|FG010|COMPLETED|Part 1||0
9026021|NCT03170544|10088451|FG011|COMPLETED|Part 1||0
9026022|NCT03170544|10088440|FG000|NOT COMPLETED|Part 1||1
9026023|NCT03170544|10088441|FG001|NOT COMPLETED|Part 1||0
9026024|NCT03170544|10088442|FG002|NOT COMPLETED|Part 1||0
9026025|NCT03170544|10088443|FG003|NOT COMPLETED|Part 1||1
9026026|NCT03170544|10088444|FG004|NOT COMPLETED|Part 1||0
9026027|NCT03170544|10088445|FG005|NOT COMPLETED|Part 1||0
9026028|NCT03170544|10088446|FG006|NOT COMPLETED|Part 1||0
9026029|NCT03170544|10088447|FG007|NOT COMPLETED|Part 1||0
9026030|NCT03170544|10088448|FG008|NOT COMPLETED|Part 1||0
9026031|NCT03170544|10088449|FG009|NOT COMPLETED|Part 1||0
9026032|NCT03170544|10088450|FG010|NOT COMPLETED|Part 1||0
9026033|NCT03170544|10088451|FG011|NOT COMPLETED|Part 1||0
9026034|NCT03170544|10088440|FG000|STARTED|Part 2||0
9026035|NCT03170544|10088441|FG001|STARTED|Part 2||0
9026036|NCT03170544|10088442|FG002|STARTED|Part 2||0
9026037|NCT03170544|10088443|FG003|STARTED|Part 2||0
9026038|NCT03170544|10088444|FG004|STARTED|Part 2||0
9026039|NCT03170544|10088445|FG005|STARTED|Part 2||0
9026040|NCT03170544|10088446|FG006|STARTED|Part 2||4
9026041|NCT03170544|10088447|FG007|STARTED|Part 2||0
9026042|NCT03170544|10088448|FG008|STARTED|Part 2||0
9026043|NCT03170544|10088449|FG009|STARTED|Part 2||0
9026044|NCT03170544|10088450|FG010|STARTED|Part 2||0
8761834|NCT01225731|9811420|FG012|NOT COMPLETED|Part 2||0
9026045|NCT03170544|10088451|FG011|STARTED|Part 2||0
9026046|NCT03170544|10088440|FG000|COMPLETED|Part 2||0
8761835|NCT01225731|9811408|FG000|STARTED|Part 3||0
8761836|NCT01225731|9811409|FG001|STARTED|Part 3||0
8761837|NCT01225731|9811410|FG002|STARTED|Part 3||0
8761838|NCT01225731|9811411|FG003|STARTED|Part 3||0
8761839|NCT01225731|9811412|FG004|STARTED|Part 3||0
8761840|NCT01225731|9811413|FG005|STARTED|Part 3|Participants could enter the follow-up period|0
8761841|NCT01225731|9811414|FG006|STARTED|Part 3|Participants could enter the follow-up period|0
9026047|NCT03170544|10088441|FG001|COMPLETED|Part 2||0
9026048|NCT03170544|10088442|FG002|COMPLETED|Part 2||0
9026049|NCT03170544|10088443|FG003|COMPLETED|Part 2||0
9026050|NCT03170544|10088444|FG004|COMPLETED|Part 2||0
9026051|NCT03170544|10088445|FG005|COMPLETED|Part 2||0
9026052|NCT03170544|10088446|FG006|COMPLETED|Part 2||4
9026053|NCT03170544|10088447|FG007|COMPLETED|Part 2||0
9026054|NCT03170544|10088448|FG008|COMPLETED|Part 2||0
8761842|NCT01225731|9811415|FG007|STARTED|Part 3|Participants could enter the follow-up period|0
8761843|NCT01225731|9811416|FG008|STARTED|Part 3|Participants could enter the follow-up period|0
8761844|NCT01225731|9811417|FG009|STARTED|Part 3|Not all participants entered follow-up|10
8761845|NCT01225731|9811418|FG010|STARTED|Part 3|Not all participants entered follow-up|86
8761846|NCT01225731|9811419|FG011|STARTED|Part 3|Not all participants entered follow-up|126
8761847|NCT01225731|9811420|FG012|STARTED|Part 3|Not all participants entered follow-up|67
8761848|NCT01225731|9811408|FG000|COMPLETED|Part 3||0
8761849|NCT01225731|9811409|FG001|COMPLETED|Part 3||0
8761850|NCT01225731|9811410|FG002|COMPLETED|Part 3||0
8761851|NCT01225731|9811411|FG003|COMPLETED|Part 3||0
8761852|NCT01225731|9811412|FG004|COMPLETED|Part 3||0
8761853|NCT01225731|9811413|FG005|COMPLETED|Part 3||0
8761854|NCT01225731|9811414|FG006|COMPLETED|Part 3||0
8761855|NCT01225731|9811415|FG007|COMPLETED|Part 3||0
8761856|NCT01225731|9811416|FG008|COMPLETED|Part 3||0
8761857|NCT01225731|9811417|FG009|COMPLETED|Part 3||10
8761858|NCT01225731|9811418|FG010|COMPLETED|Part 3||80
8761859|NCT01225731|9811419|FG011|COMPLETED|Part 3||116
8761860|NCT01225731|9811420|FG012|COMPLETED|Part 3||60
8761861|NCT01225731|9811408|FG000|NOT COMPLETED|Part 3||0
8761862|NCT01225731|9811409|FG001|NOT COMPLETED|Part 3||0
8761863|NCT01225731|9811410|FG002|NOT COMPLETED|Part 3||0
8761864|NCT01225731|9811411|FG003|NOT COMPLETED|Part 3||0
8761865|NCT01225731|9811412|FG004|NOT COMPLETED|Part 3||0
8761866|NCT01225731|9811413|FG005|NOT COMPLETED|Part 3||0
8761867|NCT01225731|9811414|FG006|NOT COMPLETED|Part 3||0
8761868|NCT01225731|9811415|FG007|NOT COMPLETED|Part 3||0
8761869|NCT01225731|9811416|FG008|NOT COMPLETED|Part 3||0
8761870|NCT01225731|9811417|FG009|NOT COMPLETED|Part 3||0
8761871|NCT01225731|9811418|FG010|NOT COMPLETED|Part 3||6
8761872|NCT01225731|9811419|FG011|NOT COMPLETED|Part 3||10
8761873|NCT01225731|9811420|FG012|NOT COMPLETED|Part 3||7
8761874|NCT01225822|9811454|FG000|STARTED|Overall Study||389
8761875|NCT01225822|9811455|FG001|STARTED|Overall Study||390
8761876|NCT01225822|9811456|FG002|STARTED|Overall Study||393
8761877|NCT01225822|9811457|FG003|STARTED|Overall Study||385
8761878|NCT01225822|9811458|FG004|STARTED|Overall Study||392
8761879|NCT01225822|9811454|FG000|COMPLETED|Overall Study||351
8761880|NCT01225822|9811455|FG001|COMPLETED|Overall Study||334
8761881|NCT01225822|9811456|FG002|COMPLETED|Overall Study||355
8761882|NCT01225822|9811457|FG003|COMPLETED|Overall Study||333
8761883|NCT01225822|9811458|FG004|COMPLETED|Overall Study||361
8761884|NCT01225822|9811454|FG000|NOT COMPLETED|Overall Study||38
8761885|NCT01225822|9811455|FG001|NOT COMPLETED|Overall Study||56
8761886|NCT01225822|9811456|FG002|NOT COMPLETED|Overall Study||38
8761887|NCT01225822|9811457|FG003|NOT COMPLETED|Overall Study||52
8761888|NCT01225822|9811458|FG004|NOT COMPLETED|Overall Study||31
8761889|NCT01225835|9811475|FG000|STARTED|Overall Study||62
8761890|NCT01225835|9811476|FG001|STARTED|Overall Study||62
8761891|NCT01225835|9811475|FG000|Per Protocol Population|Overall Study||48
8761892|NCT01225835|9811476|FG001|Per Protocol Population|Overall Study||58
8761893|NCT01225835|9811475|FG000|COMPLETED|Overall Study|hCG criterion met|55
8761894|NCT01225835|9811476|FG001|COMPLETED|Overall Study|hCG criterion met|59
8761895|NCT01225835|9811475|FG000|NOT COMPLETED|Overall Study||7
8761896|NCT01225835|9811476|FG001|NOT COMPLETED|Overall Study||3
8761897|NCT01225887|9811488|FG000|STARTED|Overall Study||37
8761898|NCT01225887|9811488|FG000|COMPLETED|Overall Study||32
8761899|NCT01225887|9811488|FG000|NOT COMPLETED|Overall Study||5
8761900|NCT01225926|9811494|FG000|STARTED|Overall Study||12
8761901|NCT01225926|9811495|FG001|STARTED|Overall Study||12
8761902|NCT01225926|9811494|FG000|COMPLETED|Overall Study||12
8761903|NCT01225926|9811495|FG001|COMPLETED|Overall Study||12
8761904|NCT01225926|9811494|FG000|NOT COMPLETED|Overall Study||0
8761905|NCT01225926|9811495|FG001|NOT COMPLETED|Overall Study||0
8761906|NCT01225952|9811504|FG000|STARTED|Overall Study||31
8761907|NCT01225952|9811505|FG001|STARTED|Overall Study||31
8761908|NCT01225952|9811506|FG002|STARTED|Overall Study||31
8761909|NCT01225952|9811504|FG000|COMPLETED|Overall Study||25
8761910|NCT01225952|9811505|FG001|COMPLETED|Overall Study||27
8761911|NCT01225952|9811506|FG002|COMPLETED|Overall Study||25
8761912|NCT01225952|9811504|FG000|NOT COMPLETED|Overall Study||6
8761913|NCT01225952|9811505|FG001|NOT COMPLETED|Overall Study||4
8761914|NCT01225952|9811506|FG002|NOT COMPLETED|Overall Study||6
8761915|NCT01225991|9811514|FG000|STARTED|Overall Study||18
8761916|NCT01225991|9811514|FG000|COMPLETED|Overall Study||12
8761917|NCT01225991|9811514|FG000|NOT COMPLETED|Overall Study||6
8761918|NCT01226043|9811520|FG000|STARTED|4-week Crossover Phase - Period 1||202
8761919|NCT01226043|9811521|FG001|STARTED|4-week Crossover Phase - Period 1||203
8761920|NCT01226043|9811522|FG002|STARTED|4-week Crossover Phase - Period 1||0
8761921|NCT01226043|9811523|FG003|STARTED|4-week Crossover Phase - Period 1||0
8761922|NCT01226043|9811520|FG000|TREATED|4-week Crossover Phase - Period 1||202
8761923|NCT01226043|9811521|FG001|TREATED|4-week Crossover Phase - Period 1||200
8761924|NCT01226043|9811522|FG002|TREATED|4-week Crossover Phase - Period 1||0
8761925|NCT01226043|9811523|FG003|TREATED|4-week Crossover Phase - Period 1||0
8761926|NCT01226043|9811520|FG000|COMPLETED|4-week Crossover Phase - Period 1||199
8761927|NCT01226043|9811521|FG001|COMPLETED|4-week Crossover Phase - Period 1||194
8761928|NCT01226043|9811522|FG002|COMPLETED|4-week Crossover Phase - Period 1||0
8761929|NCT01226043|9811523|FG003|COMPLETED|4-week Crossover Phase - Period 1||0
8761930|NCT01226043|9811520|FG000|NOT COMPLETED|4-week Crossover Phase - Period 1||3
8761931|NCT01226043|9811521|FG001|NOT COMPLETED|4-week Crossover Phase - Period 1||9
8761932|NCT01226043|9811522|FG002|NOT COMPLETED|4-week Crossover Phase - Period 1||0
8761933|NCT01226043|9811523|FG003|NOT COMPLETED|4-week Crossover Phase - Period 1||0
8761934|NCT01226043|9811520|FG000|STARTED|4-week Crossover Phase - Period 2||199
8761935|NCT01226043|9811521|FG001|STARTED|4-week Crossover Phase - Period 2||194
8761936|NCT01226043|9811522|FG002|STARTED|4-week Crossover Phase - Period 2||0
8761937|NCT01226043|9811523|FG003|STARTED|4-week Crossover Phase - Period 2||0
8761938|NCT01226043|9811520|FG000|TREATED|4-week Crossover Phase - Period 2||199
8761939|NCT01226043|9811521|FG001|TREATED|4-week Crossover Phase - Period 2||194
8761940|NCT01226043|9811522|FG002|TREATED|4-week Crossover Phase - Period 2||0
8761941|NCT01226043|9811523|FG003|TREATED|4-week Crossover Phase - Period 2||0
8761942|NCT01226043|9811520|FG000|COMPLETED|4-week Crossover Phase - Period 2|28 patients were not re-randomized to the second phase of the study|195
8761943|NCT01226043|9811521|FG001|COMPLETED|4-week Crossover Phase - Period 2|22 patients were not re-randomized to the second phase of the study|188
8761944|NCT01226043|9811522|FG002|COMPLETED|4-week Crossover Phase - Period 2||0
8761945|NCT01226043|9811523|FG003|COMPLETED|4-week Crossover Phase - Period 2||0
8761946|NCT01226043|9811520|FG000|NOT COMPLETED|4-week Crossover Phase - Period 2||4
8761947|NCT01226043|9811521|FG001|NOT COMPLETED|4-week Crossover Phase - Period 2||6
8761948|NCT01226043|9811522|FG002|NOT COMPLETED|4-week Crossover Phase - Period 2||0
8761949|NCT01226043|9811523|FG003|NOT COMPLETED|4-week Crossover Phase - Period 2||0
8761950|NCT01226043|9811520|FG000|STARTED|6-week Re-randomization Phase||0
8761951|NCT01226043|9811521|FG001|STARTED|6-week Re-randomization Phase||0
8761952|NCT01226043|9811522|FG002|STARTED|6-week Re-randomization Phase||166
8761953|NCT01226043|9811523|FG003|STARTED|6-week Re-randomization Phase||167
8761954|NCT01226043|9811520|FG000|TREATED|6-week Re-randomization Phase||0
8761955|NCT01226043|9811521|FG001|TREATED|6-week Re-randomization Phase||0
8761956|NCT01226043|9811522|FG002|TREATED|6-week Re-randomization Phase||165
8761957|NCT01226043|9811523|FG003|TREATED|6-week Re-randomization Phase||165
8761958|NCT01226043|9811520|FG000|COMPLETED|6-week Re-randomization Phase||0
8761959|NCT01226043|9811521|FG001|COMPLETED|6-week Re-randomization Phase||0
8761960|NCT01226043|9811522|FG002|COMPLETED|6-week Re-randomization Phase||159
8761961|NCT01226043|9811523|FG003|COMPLETED|6-week Re-randomization Phase|3 patients did not enter the observational phase of the study|156
8761962|NCT01226043|9811520|FG000|NOT COMPLETED|6-week Re-randomization Phase||0
8761963|NCT01226043|9811521|FG001|NOT COMPLETED|6-week Re-randomization Phase||0
9026055|NCT03170544|10088449|FG009|COMPLETED|Part 2||0
9026056|NCT03170544|10088450|FG010|COMPLETED|Part 2||0
9026057|NCT03170544|10088451|FG011|COMPLETED|Part 2||0
9026058|NCT03170544|10088440|FG000|NOT COMPLETED|Part 2||0
9026059|NCT03170544|10088441|FG001|NOT COMPLETED|Part 2||0
9026060|NCT03170544|10088442|FG002|NOT COMPLETED|Part 2||0
9026061|NCT03170544|10088443|FG003|NOT COMPLETED|Part 2||0
9026062|NCT03170544|10088444|FG004|NOT COMPLETED|Part 2||0
9026063|NCT03170544|10088445|FG005|NOT COMPLETED|Part 2||0
9026064|NCT03170544|10088446|FG006|NOT COMPLETED|Part 2||0
9026065|NCT03170544|10088447|FG007|NOT COMPLETED|Part 2||0
9026066|NCT03170544|10088448|FG008|NOT COMPLETED|Part 2||0
9026067|NCT03170544|10088449|FG009|NOT COMPLETED|Part 2||0
9026068|NCT03170544|10088450|FG010|NOT COMPLETED|Part 2||0
9026069|NCT03170544|10088451|FG011|NOT COMPLETED|Part 2||0
9026070|NCT03170544|10088440|FG000|STARTED|Part 3||0
9026071|NCT03170544|10088441|FG001|STARTED|Part 3||0
9026072|NCT03170544|10088442|FG002|STARTED|Part 3||0
9026073|NCT03170544|10088443|FG003|STARTED|Part 3||0
9026074|NCT03170544|10088444|FG004|STARTED|Part 3||0
9026075|NCT03170544|10088445|FG005|STARTED|Part 3||0
9026076|NCT03170544|10088446|FG006|STARTED|Part 3||0
9026077|NCT03170544|10088447|FG007|STARTED|Part 3||4
9026078|NCT03170544|10088448|FG008|STARTED|Part 3||6
9026079|NCT03170544|10088449|FG009|STARTED|Part 3||6
9026080|NCT03170544|10088450|FG010|STARTED|Part 3||0
9026081|NCT03170544|10088451|FG011|STARTED|Part 3||0
9026082|NCT03170544|10088440|FG000|COMPLETED|Part 3||0
9026083|NCT03170544|10088441|FG001|COMPLETED|Part 3||0
9026084|NCT03170544|10088442|FG002|COMPLETED|Part 3||0
9026085|NCT03170544|10088443|FG003|COMPLETED|Part 3||0
9026086|NCT03170544|10088444|FG004|COMPLETED|Part 3||0
9026087|NCT03170544|10088445|FG005|COMPLETED|Part 3||0
9026088|NCT03170544|10088446|FG006|COMPLETED|Part 3||0
9026089|NCT03170544|10088447|FG007|COMPLETED|Part 3||4
9026090|NCT03170544|10088448|FG008|COMPLETED|Part 3||6
9026091|NCT03170544|10088449|FG009|COMPLETED|Part 3||6
9026092|NCT03170544|10088450|FG010|COMPLETED|Part 3||0
9026093|NCT03170544|10088451|FG011|COMPLETED|Part 3||0
9026094|NCT03170544|10088440|FG000|NOT COMPLETED|Part 3||0
9026095|NCT03170544|10088441|FG001|NOT COMPLETED|Part 3||0
9026096|NCT03170544|10088442|FG002|NOT COMPLETED|Part 3||0
9026097|NCT03170544|10088443|FG003|NOT COMPLETED|Part 3||0
9026098|NCT03170544|10088444|FG004|NOT COMPLETED|Part 3||0
9026099|NCT03170544|10088445|FG005|NOT COMPLETED|Part 3||0
9026100|NCT03170544|10088446|FG006|NOT COMPLETED|Part 3||0
9026101|NCT03170544|10088447|FG007|NOT COMPLETED|Part 3||0
9026102|NCT03170544|10088448|FG008|NOT COMPLETED|Part 3||0
9026103|NCT03170544|10088449|FG009|NOT COMPLETED|Part 3||0
9026104|NCT03170544|10088450|FG010|NOT COMPLETED|Part 3||0
9026105|NCT03170544|10088451|FG011|NOT COMPLETED|Part 3||0
9026106|NCT03170544|10088440|FG000|STARTED|Part 4||0
9026107|NCT03170544|10088441|FG001|STARTED|Part 4||0
9026108|NCT03170544|10088442|FG002|STARTED|Part 4||0
9026109|NCT03170544|10088443|FG003|STARTED|Part 4||0
9026110|NCT03170544|10088444|FG004|STARTED|Part 4||0
9026111|NCT03170544|10088445|FG005|STARTED|Part 4||0
9026112|NCT03170544|10088446|FG006|STARTED|Part 4||0
8761964|NCT01226043|9811522|FG002|NOT COMPLETED|6-week Re-randomization Phase||7
8761965|NCT01226043|9811523|FG003|NOT COMPLETED|6-week Re-randomization Phase||11
8761966|NCT01226043|9811520|FG000|STARTED|30-week Observational Phase||0
8761967|NCT01226043|9811521|FG001|STARTED|30-week Observational Phase||0
8761968|NCT01226043|9811522|FG002|STARTED|30-week Observational Phase||159
8761969|NCT01226043|9811523|FG003|STARTED|30-week Observational Phase||153
8761970|NCT01226043|9811520|FG000|TREATED|30-week Observational Phase||0
8761971|NCT01226043|9811521|FG001|TREATED|30-week Observational Phase||0
8761972|NCT01226043|9811522|FG002|TREATED|30-week Observational Phase||159
8761973|NCT01226043|9811523|FG003|TREATED|30-week Observational Phase||153
8761974|NCT01226043|9811520|FG000|COMPLETED|30-week Observational Phase||0
8761975|NCT01226043|9811521|FG001|COMPLETED|30-week Observational Phase||0
8761976|NCT01226043|9811522|FG002|COMPLETED|30-week Observational Phase||153
8761977|NCT01226043|9811523|FG003|COMPLETED|30-week Observational Phase||140
8761978|NCT01226043|9811520|FG000|NOT COMPLETED|30-week Observational Phase||0
8761979|NCT01226043|9811521|FG001|NOT COMPLETED|30-week Observational Phase||0
8761980|NCT01226043|9811522|FG002|NOT COMPLETED|30-week Observational Phase||6
8761981|NCT01226043|9811523|FG003|NOT COMPLETED|30-week Observational Phase||13
8761982|NCT01226095|9811553|FG000|STARTED|Overall Study||519
8761983|NCT01226095|9811553|FG000|COMPLETED|Overall Study||518
8761984|NCT01226095|9811553|FG000|NOT COMPLETED|Overall Study||1
8761985|NCT01226121|9811567|FG000|STARTED|Overall Study||13
8761986|NCT01226121|9811568|FG001|STARTED|Overall Study||11
8761987|NCT01226121|9811569|FG002|STARTED|Overall Study||13
8761988|NCT01226121|9811567|FG000|30 Day Evaluation|Overall Study||12
8761989|NCT01226121|9811568|FG001|30 Day Evaluation|Overall Study||11
8761990|NCT01226121|9811569|FG002|30 Day Evaluation|Overall Study||13
8761991|NCT01226121|9811567|FG000|COMPLETED|Overall Study||11
8761992|NCT01226121|9811568|FG001|COMPLETED|Overall Study||11
8761993|NCT01226121|9811569|FG002|COMPLETED|Overall Study||12
8761994|NCT01226121|9811567|FG000|NOT COMPLETED|Overall Study||2
8761995|NCT01226121|9811568|FG001|NOT COMPLETED|Overall Study||0
8761996|NCT01226121|9811569|FG002|NOT COMPLETED|Overall Study||1
8761997|NCT01226420|9811577|FG000|STARTED|Overall Study||6
8761998|NCT01226420|9811577|FG000|COMPLETED|Overall Study||6
8761999|NCT01226420|9811577|FG000|NOT COMPLETED|Overall Study||0
8762000|NCT01226459|9811583|FG000|STARTED|Overall Study||201
8762001|NCT01226459|9811584|FG001|STARTED|Overall Study||203
8762002|NCT01226459|9811583|FG000|COMPLETED|Overall Study||180
8762003|NCT01226459|9811584|FG001|COMPLETED|Overall Study||171
8762004|NCT01226459|9811583|FG000|NOT COMPLETED|Overall Study||21
8762005|NCT01226459|9811584|FG001|NOT COMPLETED|Overall Study||32
8762006|NCT01226472|9811590|FG000|STARTED|Overall Study||1
8762007|NCT01226472|9811590|FG000|COMPLETED|Overall Study||0
8762008|NCT01226472|9811590|FG000|NOT COMPLETED|Overall Study||1
8762009|NCT01226485|9811601|FG000|STARTED|Overall Study||3
8762010|NCT01226485|9811602|FG001|STARTED|Overall Study||6
8762011|NCT01226485|9811603|FG002|STARTED|Overall Study||3
8762012|NCT01226485|9811604|FG003|STARTED|Overall Study||6
8762013|NCT01226485|9811605|FG004|STARTED|Overall Study||7
8762014|NCT01226485|9811606|FG005|STARTED|Overall Study||19
8762015|NCT01226485|9811607|FG006|STARTED|Overall Study||40
8762016|NCT01226485|9811601|FG000|Received at Least One Dose of Drug|Overall Study||3
8762017|NCT01226485|9811602|FG001|Received at Least One Dose of Drug|Overall Study||6
8762018|NCT01226485|9811603|FG002|Received at Least One Dose of Drug|Overall Study||3
8762019|NCT01226485|9811604|FG003|Received at Least One Dose of Drug|Overall Study||6
8762020|NCT01226485|9811605|FG004|Received at Least One Dose of Drug|Overall Study||7
8762021|NCT01226485|9811606|FG005|Received at Least One Dose of Drug|Overall Study||19
8762022|NCT01226485|9811607|FG006|Received at Least One Dose of Drug|Overall Study||40
8762023|NCT01226485|9811601|FG000|COMPLETED|Overall Study||3
8762024|NCT01226485|9811602|FG001|COMPLETED|Overall Study||6
8762025|NCT01226485|9811603|FG002|COMPLETED|Overall Study||3
8762026|NCT01226485|9811604|FG003|COMPLETED|Overall Study||6
8762027|NCT01226485|9811605|FG004|COMPLETED|Overall Study||7
8762028|NCT01226485|9811606|FG005|COMPLETED|Overall Study||19
8762029|NCT01226485|9811607|FG006|COMPLETED|Overall Study||40
8762030|NCT01226485|9811601|FG000|NOT COMPLETED|Overall Study||0
8762031|NCT01226485|9811602|FG001|NOT COMPLETED|Overall Study||0
8762032|NCT01226485|9811603|FG002|NOT COMPLETED|Overall Study||0
8762033|NCT01226485|9811604|FG003|NOT COMPLETED|Overall Study||0
8762034|NCT01226485|9811605|FG004|NOT COMPLETED|Overall Study||0
8762035|NCT01226485|9811606|FG005|NOT COMPLETED|Overall Study||0
8762036|NCT01226485|9811607|FG006|NOT COMPLETED|Overall Study||0
8762037|NCT01226511|9811633|FG000|STARTED|Acute Treatment Period|Thirty-one (31) participants who discontinued acute treatment did not enter the taper period.|140
8762038|NCT01226511|9811634|FG001|STARTED|Acute Treatment Period|Twenty-six (26) participants who discontinued acute treatment did not enter the taper period.|141
8762039|NCT01226511|9811633|FG000|COMPLETED|Acute Treatment Period||108
8762040|NCT01226511|9811634|FG001|COMPLETED|Acute Treatment Period||110
8762041|NCT01226511|9811633|FG000|NOT COMPLETED|Acute Treatment Period||32
8762042|NCT01226511|9811634|FG001|NOT COMPLETED|Acute Treatment Period||31
8762043|NCT01226511|9811633|FG000|STARTED|Extension Treatment Period|Nineteen (19) participants who discontinued extension treatment did not enter the taper period.|108
8762044|NCT01226511|9811634|FG001|STARTED|Extension Treatment Period|Twenty-three (23) participants who discontinued extension treatment did not enter the taper period.|110
8762045|NCT01226511|9811633|FG000|COMPLETED|Extension Treatment Period|Thirty-nine (39) participants who completed extension treatment did not enter the taper period.|81
8762046|NCT01226511|9811634|FG001|COMPLETED|Extension Treatment Period|Thirty-five (35) participants who completed extension treatment did not enter the taper period.|83
8762047|NCT01226511|9811633|FG000|NOT COMPLETED|Extension Treatment Period||27
8762048|NCT01226511|9811634|FG001|NOT COMPLETED|Extension Treatment Period||27
8762049|NCT01226511|9811633|FG000|STARTED|Taper Period||51
8762050|NCT01226511|9811634|FG001|STARTED|Taper Period||57
8762051|NCT01226511|9811633|FG000|COMPLETED|Taper Period||46
9026113|NCT03170544|10088447|FG007|STARTED|Part 4||0
9026114|NCT03170544|10088448|FG008|STARTED|Part 4||0
9026115|NCT03170544|10088449|FG009|STARTED|Part 4||0
9026116|NCT03170544|10088450|FG010|STARTED|Part 4||3
9026117|NCT03170544|10088451|FG011|STARTED|Part 4||6
9026118|NCT03170544|10088440|FG000|COMPLETED|Part 4||0
9026119|NCT03170544|10088441|FG001|COMPLETED|Part 4||0
9026120|NCT03170544|10088442|FG002|COMPLETED|Part 4||0
9026121|NCT03170544|10088443|FG003|COMPLETED|Part 4||0
9026122|NCT03170544|10088444|FG004|COMPLETED|Part 4||0
9026123|NCT03170544|10088445|FG005|COMPLETED|Part 4||0
9026124|NCT03170544|10088446|FG006|COMPLETED|Part 4||0
9026125|NCT03170544|10088447|FG007|COMPLETED|Part 4||0
9026126|NCT03170544|10088448|FG008|COMPLETED|Part 4||0
9026127|NCT03170544|10088449|FG009|COMPLETED|Part 4||0
9026128|NCT03170544|10088450|FG010|COMPLETED|Part 4||3
9026129|NCT03170544|10088451|FG011|COMPLETED|Part 4||6
9026130|NCT03170544|10088440|FG000|NOT COMPLETED|Part 4||0
9026131|NCT03170544|10088441|FG001|NOT COMPLETED|Part 4||0
9026132|NCT03170544|10088442|FG002|NOT COMPLETED|Part 4||0
9026133|NCT03170544|10088443|FG003|NOT COMPLETED|Part 4||0
9026134|NCT03170544|10088444|FG004|NOT COMPLETED|Part 4||0
9026135|NCT03170544|10088445|FG005|NOT COMPLETED|Part 4||0
8762052|NCT01226511|9811634|FG001|COMPLETED|Taper Period||54
8762053|NCT01226511|9811633|FG000|NOT COMPLETED|Taper Period||5
9026136|NCT03170544|10088446|FG006|NOT COMPLETED|Part 4||0
9026137|NCT03170544|10088447|FG007|NOT COMPLETED|Part 4||0
9026138|NCT03170544|10088448|FG008|NOT COMPLETED|Part 4||0
8762054|NCT01226511|9811634|FG001|NOT COMPLETED|Taper Period||3
8762055|NCT01226706|9811648|FG000|STARTED|Overall Study||10
8762056|NCT01226706|9811649|FG001|STARTED|Overall Study||11
8762057|NCT01226706|9811648|FG000|COMPLETED|Overall Study||10
8762058|NCT01226706|9811649|FG001|COMPLETED|Overall Study||11
8762059|NCT01226706|9811648|FG000|NOT COMPLETED|Overall Study||0
8762060|NCT01226706|9811649|FG001|NOT COMPLETED|Overall Study||0
8762061|NCT01226719|9811657|FG000|STARTED|Overall Study||15
8762062|NCT01226719|9811657|FG000|COMPLETED|Overall Study|Completed = patient is surgical candidate, underwent resection, received treatment to week 24.|2
8762063|NCT01226719|9811657|FG000|NOT COMPLETED|Overall Study||13
8762064|NCT01226745|9811667|FG000|STARTED|Overall Study||80
8762065|NCT01226745|9811668|FG001|STARTED|Overall Study||87
8762066|NCT01226745|9811669|FG002|STARTED|Overall Study||89
8762067|NCT01226745|9811670|FG003|STARTED|Overall Study||29
8762068|NCT01226745|9811671|FG004|STARTED|Overall Study||26
8762069|NCT01226745|9811672|FG005|STARTED|Overall Study||29
8762070|NCT01226745|9811667|FG000|COMPLETED|Overall Study||63
8762071|NCT01226745|9811668|FG001|COMPLETED|Overall Study||71
8762072|NCT01226745|9811669|FG002|COMPLETED|Overall Study||69
8762073|NCT01226745|9811670|FG003|COMPLETED|Overall Study||24
8762074|NCT01226745|9811671|FG004|COMPLETED|Overall Study||22
8762075|NCT01226745|9811672|FG005|COMPLETED|Overall Study||24
8762076|NCT01226745|9811667|FG000|NOT COMPLETED|Overall Study||17
8762077|NCT01226745|9811668|FG001|NOT COMPLETED|Overall Study||16
8762078|NCT01226745|9811669|FG002|NOT COMPLETED|Overall Study||20
8762079|NCT01226745|9811670|FG003|NOT COMPLETED|Overall Study||5
8762080|NCT01226745|9811671|FG004|NOT COMPLETED|Overall Study||4
8762081|NCT01226745|9811672|FG005|NOT COMPLETED|Overall Study||5
8762082|NCT01226914|9811689|FG000|STARTED|Overall Study||28
8762083|NCT01226914|9811690|FG001|STARTED|Overall Study||27
8762084|NCT01226914|9811689|FG000|COMPLETED|Overall Study||28
8762085|NCT01226914|9811690|FG001|COMPLETED|Overall Study||27
8762086|NCT01226914|9811689|FG000|NOT COMPLETED|Overall Study||0
8762087|NCT01226914|9811690|FG001|NOT COMPLETED|Overall Study||0
8762088|NCT01226979|9811696|FG000|STARTED|Overall Study||16
8762089|NCT01226979|9811696|FG000|COMPLETED|Overall Study||16
8762090|NCT01226979|9811696|FG000|NOT COMPLETED|Overall Study||0
9026139|NCT03170544|10088449|FG009|NOT COMPLETED|Part 4||0
9026140|NCT03170544|10088450|FG010|NOT COMPLETED|Part 4||0
9026141|NCT03170544|10088451|FG011|NOT COMPLETED|Part 4||0
9026142|NCT03170609|10088541|FG000|STARTED|Overall Study||53
9026143|NCT03170609|10088542|FG001|STARTED|Overall Study||52
9026144|NCT03170609|10088543|FG002|STARTED|Overall Study||52
9026145|NCT03170609|10088544|FG003|STARTED|Overall Study||52
9026146|NCT03170609|10088545|FG004|STARTED|Overall Study||52
9026147|NCT03170609|10088546|FG005|STARTED|Overall Study||52
9026148|NCT03170609|10088547|FG006|STARTED|Overall Study||52
9026149|NCT03170609|10088541|FG000|Vaccinated|Overall Study||52
9026150|NCT03170609|10088542|FG001|Vaccinated|Overall Study||52
9026151|NCT03170609|10088543|FG002|Vaccinated|Overall Study||52
9026152|NCT03170609|10088544|FG003|Vaccinated|Overall Study||52
9026153|NCT03170609|10088545|FG004|Vaccinated|Overall Study||52
9026154|NCT03170609|10088546|FG005|Vaccinated|Overall Study||52
9026155|NCT03170609|10088547|FG006|Vaccinated|Overall Study||52
9026156|NCT03170609|10088541|FG000|COMPLETED|Overall Study||50
9026157|NCT03170609|10088542|FG001|COMPLETED|Overall Study||50
9026158|NCT03170609|10088543|FG002|COMPLETED|Overall Study||46
9026159|NCT03170609|10088544|FG003|COMPLETED|Overall Study||50
9026160|NCT03170609|10088545|FG004|COMPLETED|Overall Study||51
9026161|NCT03170609|10088546|FG005|COMPLETED|Overall Study||50
9026162|NCT03170609|10088547|FG006|COMPLETED|Overall Study||51
9026163|NCT03170609|10088541|FG000|NOT COMPLETED|Overall Study||3
9026164|NCT03170609|10088542|FG001|NOT COMPLETED|Overall Study||2
9026165|NCT03170609|10088543|FG002|NOT COMPLETED|Overall Study||6
9026166|NCT03170609|10088544|FG003|NOT COMPLETED|Overall Study||2
9026167|NCT03170609|10088545|FG004|NOT COMPLETED|Overall Study||1
9026168|NCT03170609|10088546|FG005|NOT COMPLETED|Overall Study||2
9026169|NCT03170609|10088547|FG006|NOT COMPLETED|Overall Study||1
9026170|NCT03170661|10088565|FG000|STARTED|Overall Study||49
9026171|NCT03170661|10088566|FG001|STARTED|Overall Study||49
9026172|NCT03170661|10088565|FG000|COMPLETED|Overall Study||49
9026173|NCT03170661|10088566|FG001|COMPLETED|Overall Study||49
9026174|NCT03170661|10088565|FG000|NOT COMPLETED|Overall Study||0
9026175|NCT03170661|10088566|FG001|NOT COMPLETED|Overall Study||0
9026176|NCT03171051|10088574|FG000|STARTED|Overall Study||10
9026177|NCT03171051|10088574|FG000|COMPLETED|Overall Study||10
9026178|NCT03171051|10088574|FG000|NOT COMPLETED|Overall Study||0
9026179|NCT03171415|10088584|FG000|STARTED|Overall Study||6
9026180|NCT03171415|10088585|FG001|STARTED|Overall Study||6
9026181|NCT03171415|10088586|FG002|STARTED|Overall Study||6
9026182|NCT03171415|10088587|FG003|STARTED|Overall Study||6
8762091|NCT01227005|9811703|FG000|STARTED|Overall Study||55
8762092|NCT01227005|9811704|FG001|STARTED|Overall Study||52
8762093|NCT01227005|9811703|FG000|COMPLETED|Overall Study||50
9026183|NCT03171415|10088588|FG004|STARTED|Overall Study||9
9026184|NCT03171415|10088584|FG000|COMPLETED|Overall Study||6
9026185|NCT03171415|10088585|FG001|COMPLETED|Overall Study||6
9026186|NCT03171415|10088586|FG002|COMPLETED|Overall Study||6
9026187|NCT03171415|10088587|FG003|COMPLETED|Overall Study||6
9026188|NCT03171415|10088588|FG004|COMPLETED|Overall Study||7
9026189|NCT03171415|10088584|FG000|NOT COMPLETED|Overall Study||0
9026190|NCT03171415|10088585|FG001|NOT COMPLETED|Overall Study||0
9026191|NCT03171415|10088586|FG002|NOT COMPLETED|Overall Study||0
8762094|NCT01227005|9811704|FG001|COMPLETED|Overall Study||51
8762095|NCT01227005|9811703|FG000|NOT COMPLETED|Overall Study||5
8762096|NCT01227005|9811704|FG001|NOT COMPLETED|Overall Study||1
8762097|NCT01227018|9811710|FG000|STARTED|Overall Study||15
8762098|NCT01227018|9811710|FG000|COMPLETED|Overall Study||0
8762099|NCT01227018|9811710|FG000|NOT COMPLETED|Overall Study||15
8762100|NCT01227044|9811716|FG000|STARTED|Overall Study||25
8762101|NCT01227044|9811717|FG001|STARTED|Overall Study||26
8762102|NCT01227044|9811716|FG000|COMPLETED|Overall Study||19
8762103|NCT01227044|9811717|FG001|COMPLETED|Overall Study||17
8762104|NCT01227044|9811716|FG000|NOT COMPLETED|Overall Study||6
8762105|NCT01227044|9811717|FG001|NOT COMPLETED|Overall Study||9
8762106|NCT01227057|9811725|FG000|STARTED|Overall Study||31
8762107|NCT01227057|9811726|FG001|STARTED|Overall Study||27
8762108|NCT01227057|9811725|FG000|COMPLETED|Overall Study||25
8762109|NCT01227057|9811726|FG001|COMPLETED|Overall Study||19
8762110|NCT01227057|9811725|FG000|NOT COMPLETED|Overall Study||6
8762111|NCT01227057|9811726|FG001|NOT COMPLETED|Overall Study||8
8762112|NCT01227252|9811737|FG000|STARTED|Overall Study||12
8762113|NCT01227252|9811738|FG001|STARTED|Overall Study||10
8762114|NCT01227252|9811739|FG002|STARTED|Overall Study||10
8762115|NCT01227252|9811740|FG003|STARTED|Overall Study||10
8762116|NCT01227252|9811737|FG000|Received at Least 1 Dose of Study Drug|Overall Study||12
8762117|NCT01227252|9811738|FG001|Received at Least 1 Dose of Study Drug|Overall Study||10
8762118|NCT01227252|9811739|FG002|Received at Least 1 Dose of Study Drug|Overall Study||10
8762119|NCT01227252|9811740|FG003|Received at Least 1 Dose of Study Drug|Overall Study||10
8762120|NCT01227252|9811737|FG000|COMPLETED|Overall Study||12
8762121|NCT01227252|9811738|FG001|COMPLETED|Overall Study||7
8762122|NCT01227252|9811739|FG002|COMPLETED|Overall Study||10
8762123|NCT01227252|9811740|FG003|COMPLETED|Overall Study||10
8762124|NCT01227252|9811737|FG000|NOT COMPLETED|Overall Study||0
8762125|NCT01227252|9811738|FG001|NOT COMPLETED|Overall Study||3
8762126|NCT01227252|9811739|FG002|NOT COMPLETED|Overall Study||0
8762127|NCT01227252|9811740|FG003|NOT COMPLETED|Overall Study||0
8762128|NCT01227265|9811756|FG000|STARTED|Overall Study||158
8762129|NCT01227265|9811757|FG001|STARTED|Overall Study||159
8762130|NCT01227265|9811758|FG002|STARTED|Overall Study||159
9026192|NCT03171415|10088587|FG003|NOT COMPLETED|Overall Study||0
9026193|NCT03171415|10088588|FG004|NOT COMPLETED|Overall Study||2
9026194|NCT03172130|10088613|FG000|STARTED|Overall Study||12
9026195|NCT03172130|10088614|FG001|STARTED|Overall Study||10
9026196|NCT03172130|10088613|FG000|COMPLETED|Overall Study||9
9026197|NCT03172130|10088614|FG001|COMPLETED|Overall Study||9
9026198|NCT03172130|10088613|FG000|NOT COMPLETED|Overall Study||3
9026199|NCT03172130|10088614|FG001|NOT COMPLETED|Overall Study||1
9026200|NCT03172325|10088622|FG000|STARTED|Overall Study||68
9026201|NCT03172325|10088623|FG001|STARTED|Overall Study||68
9026202|NCT03172325|10088622|FG000|COMPLETED|Overall Study||64
9026203|NCT03172325|10088623|FG001|COMPLETED|Overall Study||64
9026204|NCT03172325|10088622|FG000|NOT COMPLETED|Overall Study||4
9026205|NCT03172325|10088623|FG001|NOT COMPLETED|Overall Study||4
9026206|NCT03172364|10088631|FG000|STARTED|Overall Study||55
9026207|NCT03172364|10088632|FG001|STARTED|Overall Study||58
9026208|NCT03172364|10088631|FG000|COMPLETED|Overall Study||53
9026209|NCT03172364|10088632|FG001|COMPLETED|Overall Study||57
9026210|NCT03172364|10088631|FG000|NOT COMPLETED|Overall Study||2
9026211|NCT03172364|10088632|FG001|NOT COMPLETED|Overall Study||1
9026212|NCT03172481|10088640|FG000|STARTED|Open-label||156
9026213|NCT03172481|10088641|FG001|STARTED|Open-label||0
9026214|NCT03172481|10088640|FG000|COMPLETED|Open-label||148
9026215|NCT03172481|10088641|FG001|COMPLETED|Open-label||0
9026216|NCT03172481|10088640|FG000|NOT COMPLETED|Open-label||8
9026217|NCT03172481|10088641|FG001|NOT COMPLETED|Open-label||0
9026218|NCT03172481|10088640|FG000|STARTED|Double-blind||75
9026219|NCT03172481|10088641|FG001|STARTED|Double-blind|From 148 subjects who completed the Open-label period, 73 randomly received Placebo|73
9026220|NCT03172481|10088640|FG000|COMPLETED|Double-blind||74
9026221|NCT03172481|10088641|FG001|COMPLETED|Double-blind||73
9026222|NCT03172481|10088640|FG000|NOT COMPLETED|Double-blind||1
9026223|NCT03172481|10088641|FG001|NOT COMPLETED|Double-blind||0
9026224|NCT03172494|10088650|FG000|STARTED|Overall Study||361
9026225|NCT03172494|10088651|FG001|STARTED|Overall Study||179
9026226|NCT03172494|10088652|FG002|STARTED|Overall Study||180
9026227|NCT03172494|10088650|FG000|Full Analysis Set (FAS)|Overall Study||361
9026228|NCT03172494|10088651|FG001|Full Analysis Set (FAS)|Overall Study||179
8762131|NCT01227265|9811756|FG000|Treated|Overall Study||157
8762132|NCT01227265|9811757|FG001|Treated|Overall Study||157
8762133|NCT01227265|9811758|FG002|Treated|Overall Study||159
8762134|NCT01227265|9811756|FG000|COMPLETED|Overall Study||139
8762135|NCT01227265|9811757|FG001|COMPLETED|Overall Study||139
8762136|NCT01227265|9811758|FG002|COMPLETED|Overall Study||145
8762137|NCT01227265|9811756|FG000|NOT COMPLETED|Overall Study||19
8762138|NCT01227265|9811757|FG001|NOT COMPLETED|Overall Study||20
8762139|NCT01227265|9811758|FG002|NOT COMPLETED|Overall Study||14
8762140|NCT01227278|9811768|FG000|STARTED|Overall Study||50
8762141|NCT01227278|9811769|FG001|STARTED|Overall Study||51
8762142|NCT01227278|9811768|FG000|COMPLETED|Overall Study||45
9026229|NCT03172494|10088652|FG002|Full Analysis Set (FAS)|Overall Study||180
9026230|NCT03172494|10088650|FG000|Safety Analysis Set (SAS)|Overall Study||358
9026231|NCT03172494|10088651|FG001|Safety Analysis Set (SAS)|Overall Study||175
9026232|NCT03172494|10088652|FG002|Safety Analysis Set (SAS)|Overall Study||180
9026233|NCT03172494|10088650|FG000|Exposed|Overall Study||358
8762143|NCT01227278|9811769|FG001|COMPLETED|Overall Study||43
8762144|NCT01227278|9811768|FG000|NOT COMPLETED|Overall Study||5
8762145|NCT01227278|9811769|FG001|NOT COMPLETED|Overall Study||8
8762146|NCT01227382|9811775|FG000|STARTED|Overall Study||26
8762147|NCT01227382|9811775|FG000|COMPLETED|Overall Study||26
8762148|NCT01227382|9811775|FG000|NOT COMPLETED|Overall Study||0
8762149|NCT01227395|9811783|FG000|STARTED|Overall Study||391
8762150|NCT01227395|9811784|FG001|STARTED|Overall Study||85
8762151|NCT01227395|9811783|FG000|COMPLETED|Overall Study||391
8762152|NCT01227395|9811784|FG001|COMPLETED|Overall Study||84
8762153|NCT01227395|9811783|FG000|NOT COMPLETED|Overall Study||0
8762154|NCT01227395|9811784|FG001|NOT COMPLETED|Overall Study||1
8762155|NCT01227421|9811812|FG000|STARTED|Overall Study||201
8762156|NCT01227421|9811813|FG001|STARTED|Overall Study||212
8762157|NCT01227421|9811814|FG002|STARTED|Overall Study||211
8762158|NCT01227421|9811812|FG000|COMPLETED|Overall Study||190
8762159|NCT01227421|9811813|FG001|COMPLETED|Overall Study||194
8762160|NCT01227421|9811814|FG002|COMPLETED|Overall Study||201
8762161|NCT01227421|9811812|FG000|NOT COMPLETED|Overall Study||11
8762162|NCT01227421|9811813|FG001|NOT COMPLETED|Overall Study||18
8762163|NCT01227421|9811814|FG002|NOT COMPLETED|Overall Study||10
8762164|NCT01227434|9811824|FG000|STARTED|Overall Study||6
8762165|NCT01227434|9811825|FG001|STARTED|Overall Study||16
8762166|NCT01227434|9811824|FG000|COMPLETED|Overall Study||6
8762167|NCT01227434|9811825|FG001|COMPLETED|Overall Study||16
8762168|NCT01227434|9811824|FG000|NOT COMPLETED|Overall Study||0
8762169|NCT01227434|9811825|FG001|NOT COMPLETED|Overall Study||0
8762170|NCT01227512|9811834|FG000|STARTED|Overall Study||66
8762171|NCT01227512|9811835|FG001|STARTED|Overall Study||58
8762172|NCT01227512|9811834|FG000|COMPLETED|Overall Study||53
8762173|NCT01227512|9811835|FG001|COMPLETED|Overall Study||48
8762174|NCT01227512|9811834|FG000|NOT COMPLETED|Overall Study||13
8762175|NCT01227512|9811835|FG001|NOT COMPLETED|Overall Study||10
8762176|NCT01227551|9811843|FG000|STARTED|Overall Study||57
8762177|NCT01227551|9811843|FG000|COMPLETED|Overall Study||23
8762178|NCT01227551|9811843|FG000|NOT COMPLETED|Overall Study||34
8762179|NCT01227564|9811850|FG000|STARTED|Overall Study||22
8762180|NCT01227564|9811851|FG001|STARTED|Overall Study||20
8762181|NCT01227564|9811852|FG002|STARTED|Overall Study||21
8762182|NCT01227564|9811850|FG000|Treated|Overall Study||22
8762183|NCT01227564|9811851|FG001|Treated|Overall Study||20
8762184|NCT01227564|9811852|FG002|Treated|Overall Study||21
8762185|NCT01227564|9811850|FG000|Completed Treatment|Overall Study|1 participant discontinued treatment due to an adverse event (AE).|21
8762186|NCT01227564|9811851|FG001|Completed Treatment|Overall Study|2 participants discontinued treatment due to no longer willing to participate in study.|18
8762187|NCT01227564|9811852|FG002|Completed Treatment|Overall Study|1 participant stopped treatment due to lack of efficacy, 3 due to no longer willing to participate.|17
8762188|NCT01227564|9811850|FG000|COMPLETED|Overall Study|Completed study|18
8762189|NCT01227564|9811851|FG001|COMPLETED|Overall Study|Completed study|18
8762190|NCT01227564|9811852|FG002|COMPLETED|Overall Study|Completed study|15
8762191|NCT01227564|9811850|FG000|NOT COMPLETED|Overall Study||4
8762192|NCT01227564|9811851|FG001|NOT COMPLETED|Overall Study||2
8762193|NCT01227564|9811852|FG002|NOT COMPLETED|Overall Study||6
8762194|NCT01227577|9811862|FG000|STARTED|Overall Study||128
8762195|NCT01227577|9811862|FG000|COMPLETED|Overall Study||93
8762196|NCT01227577|9811862|FG000|NOT COMPLETED|Overall Study||35
8762197|NCT01227629|9811876|FG000|STARTED|Overall Study|Started: Participant was randomised and took at least one dose of randomised study medication|58
8762198|NCT01227629|9811877|FG001|STARTED|Overall Study||20
8762199|NCT01227629|9811878|FG002|STARTED|Overall Study||27
8762200|NCT01227629|9811879|FG003|STARTED|Overall Study||99
8762201|NCT01227629|9811880|FG004|STARTED|Overall Study||34
8762202|NCT01227629|9811881|FG005|STARTED|Overall Study||33
8762203|NCT01227629|9811882|FG006|STARTED|Overall Study||98
8762204|NCT01227629|9811883|FG007|STARTED|Overall Study||33
8762205|NCT01227629|9811884|FG008|STARTED|Overall Study||30
8762206|NCT01227629|9811885|FG009|STARTED|Overall Study||70
8762207|NCT01227629|9811876|FG000|COMPLETED|Overall Study|Completed: Participant without premature discontinuation in the randomised treatment period|56
8762208|NCT01227629|9811877|FG001|COMPLETED|Overall Study||18
8762209|NCT01227629|9811878|FG002|COMPLETED|Overall Study||26
8762210|NCT01227629|9811879|FG003|COMPLETED|Overall Study||91
8762211|NCT01227629|9811880|FG004|COMPLETED|Overall Study||32
8762212|NCT01227629|9811881|FG005|COMPLETED|Overall Study||32
8762213|NCT01227629|9811882|FG006|COMPLETED|Overall Study||90
8762214|NCT01227629|9811883|FG007|COMPLETED|Overall Study||27
8762215|NCT01227629|9811884|FG008|COMPLETED|Overall Study||24
8762216|NCT01227629|9811885|FG009|COMPLETED|Overall Study||68
8762217|NCT01227629|9811876|FG000|NOT COMPLETED|Overall Study||2
8762218|NCT01227629|9811877|FG001|NOT COMPLETED|Overall Study||2
8762219|NCT01227629|9811878|FG002|NOT COMPLETED|Overall Study||1
8762220|NCT01227629|9811879|FG003|NOT COMPLETED|Overall Study||8
8762221|NCT01227629|9811880|FG004|NOT COMPLETED|Overall Study||2
8762222|NCT01227629|9811881|FG005|NOT COMPLETED|Overall Study||1
8762223|NCT01227629|9811882|FG006|NOT COMPLETED|Overall Study||8
8762224|NCT01227629|9811883|FG007|NOT COMPLETED|Overall Study||6
8762225|NCT01227629|9811884|FG008|NOT COMPLETED|Overall Study||6
8762226|NCT01227629|9811885|FG009|NOT COMPLETED|Overall Study||2
8762227|NCT01227655|9811934|FG000|STARTED|Overall Study||129
8762228|NCT01227655|9811935|FG001|STARTED|Overall Study||154
8762229|NCT01227655|9811936|FG002|STARTED|Overall Study||144
8762230|NCT01227655|9811934|FG000|Safety Set|Overall Study||125
8762231|NCT01227655|9811935|FG001|Safety Set|Overall Study||150
8762232|NCT01227655|9811936|FG002|Safety Set|Overall Study||136
8762233|NCT01227655|9811934|FG000|Full Analysis Set|Overall Study||125
8762234|NCT01227655|9811935|FG001|Full Analysis Set|Overall Study||147
8762235|NCT01227655|9811936|FG002|Full Analysis Set|Overall Study||135
8762236|NCT01227655|9811934|FG000|COMPLETED|Overall Study||118
8762237|NCT01227655|9811935|FG001|COMPLETED|Overall Study||128
8762238|NCT01227655|9811936|FG002|COMPLETED|Overall Study||130
8762239|NCT01227655|9811934|FG000|NOT COMPLETED|Overall Study||11
8762240|NCT01227655|9811935|FG001|NOT COMPLETED|Overall Study||26
8762241|NCT01227655|9811936|FG002|NOT COMPLETED|Overall Study||14
8762242|NCT01227668|9811946|FG000|STARTED|Phase 1 (Stabilization Phase)|Randomized|157
8762243|NCT01227668|9811947|FG001|STARTED|Phase 1 (Stabilization Phase)||0
8762244|NCT01227668|9811946|FG000|Received Treatment|Phase 1 (Stabilization Phase)||155
8762245|NCT01227668|9811947|FG001|Received Treatment|Phase 1 (Stabilization Phase)||0
8762246|NCT01227668|9811946|FG000|COMPLETED|Phase 1 (Stabilization Phase)||85
8762247|NCT01227668|9811947|FG001|COMPLETED|Phase 1 (Stabilization Phase)||0
8762248|NCT01227668|9811946|FG000|NOT COMPLETED|Phase 1 (Stabilization Phase)||72
8762249|NCT01227668|9811947|FG001|NOT COMPLETED|Phase 1 (Stabilization Phase)||0
8762250|NCT01227668|9811946|FG000|STARTED|Phase 2 (Randomization Phase)|Randomized|41
8762251|NCT01227668|9811947|FG001|STARTED|Phase 2 (Randomization Phase)|Randomized|44
8762252|NCT01227668|9811946|FG000|Received Treatment|Phase 2 (Randomization Phase)||39
8762253|NCT01227668|9811947|FG001|Received Treatment|Phase 2 (Randomization Phase)||43
8762254|NCT01227668|9811946|FG000|COMPLETED|Phase 2 (Randomization Phase)||22
8762255|NCT01227668|9811947|FG001|COMPLETED|Phase 2 (Randomization Phase)||19
8762256|NCT01227668|9811946|FG000|NOT COMPLETED|Phase 2 (Randomization Phase)||19
8762257|NCT01227668|9811947|FG001|NOT COMPLETED|Phase 2 (Randomization Phase)||25
8762258|NCT01227681|9811960|FG000|STARTED|Overall Study||4
8762259|NCT01227681|9811961|FG001|STARTED|Overall Study||0
8762260|NCT01227681|9811962|FG002|STARTED|Overall Study||0
8762261|NCT01227681|9811960|FG000|COMPLETED|Overall Study||4
8762262|NCT01227681|9811961|FG001|COMPLETED|Overall Study||0
8762263|NCT01227681|9811962|FG002|COMPLETED|Overall Study||0
8762264|NCT01227681|9811960|FG000|NOT COMPLETED|Overall Study||0
8762265|NCT01227681|9811961|FG001|NOT COMPLETED|Overall Study||0
8762266|NCT01227681|9811962|FG002|NOT COMPLETED|Overall Study||0
8762267|NCT01227707|9811966|FG000|STARTED|Overall Study||43
8762268|NCT01227707|9811966|FG000|COMPLETED|Overall Study||19
8762269|NCT01227707|9811966|FG000|NOT COMPLETED|Overall Study||24
8762270|NCT01227785|9811970|FG000|STARTED|Overall Study||120
8762271|NCT01227785|9811970|FG000|COMPLETED|Overall Study||108
8762272|NCT01227785|9811970|FG000|NOT COMPLETED|Overall Study||12
8762273|NCT01227824|9811983|FG000|STARTED|Double-blind Phase: 96 Weeks Duration||411
8762274|NCT01227824|9811984|FG001|STARTED|Double-blind Phase: 96 Weeks Duration||411
8762275|NCT01227824|9811985|FG002|STARTED|Double-blind Phase: 96 Weeks Duration||0
8762276|NCT01227824|9811983|FG000|COMPLETED|Double-blind Phase: 96 Weeks Duration||304
8762277|NCT01227824|9811984|FG001|COMPLETED|Double-blind Phase: 96 Weeks Duration||332
8762278|NCT01227824|9811985|FG002|COMPLETED|Double-blind Phase: 96 Weeks Duration||0
8762279|NCT01227824|9811983|FG000|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||107
8762280|NCT01227824|9811984|FG001|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||79
8762281|NCT01227824|9811985|FG002|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||0
8762282|NCT01227824|9811983|FG000|STARTED|Open-label Phase: Median of 1267 Days||0
8762283|NCT01227824|9811984|FG001|STARTED|Open-label Phase: Median of 1267 Days||0
8762284|NCT01227824|9811985|FG002|STARTED|Open-label Phase: Median of 1267 Days|338 participants continued into the Open-label phase on completing the Double-blind Phase|338
8762285|NCT01227824|9811983|FG000|COMPLETED|Open-label Phase: Median of 1267 Days||0
8762286|NCT01227824|9811984|FG001|COMPLETED|Open-label Phase: Median of 1267 Days||0
8762287|NCT01227824|9811985|FG002|COMPLETED|Open-label Phase: Median of 1267 Days||294
8762288|NCT01227824|9811983|FG000|NOT COMPLETED|Open-label Phase: Median of 1267 Days||0
8762289|NCT01227824|9811984|FG001|NOT COMPLETED|Open-label Phase: Median of 1267 Days||0
8762290|NCT01227824|9811985|FG002|NOT COMPLETED|Open-label Phase: Median of 1267 Days||44
8762291|NCT01227889|9811994|FG000|STARTED|Randomized Phase (RP)||187
8762292|NCT01227889|9811995|FG001|STARTED|Randomized Phase (RP)||63
8762293|NCT01227889|9811994|FG000|COMPLETED|Randomized Phase (RP)||0
8762294|NCT01227889|9811995|FG001|COMPLETED|Randomized Phase (RP)||0
8762295|NCT01227889|9811994|FG000|NOT COMPLETED|Randomized Phase (RP)||187
8762296|NCT01227889|9811995|FG001|NOT COMPLETED|Randomized Phase (RP)||63
8762297|NCT01227889|9811994|FG000|STARTED|Crossover Phase||0
8762298|NCT01227889|9811995|FG001|STARTED|Crossover Phase|As of the data cut on December 18, 2012, 36 of 63 participants crossed over from DTIC to GSK2118436.|37
8762299|NCT01227889|9811994|FG000|COMPLETED|Crossover Phase||0
8762300|NCT01227889|9811995|FG001|COMPLETED|Crossover Phase||0
8762301|NCT01227889|9811994|FG000|NOT COMPLETED|Crossover Phase||0
8762302|NCT01227889|9811995|FG001|NOT COMPLETED|Crossover Phase||37
8762303|NCT01227902|9812013|FG000|STARTED|Overall Study||56
8762304|NCT01227902|9812014|FG001|STARTED|Overall Study||51
8762305|NCT01227902|9812015|FG002|STARTED|Overall Study||44
8762306|NCT01227902|9812016|FG003|STARTED|Overall Study||52
8762307|NCT01227902|9812013|FG000|COMPLETED|Overall Study||38
8762308|NCT01227902|9812014|FG001|COMPLETED|Overall Study||38
8762309|NCT01227902|9812015|FG002|COMPLETED|Overall Study||25
8762310|NCT01227902|9812016|FG003|COMPLETED|Overall Study||42
8762311|NCT01227902|9812013|FG000|NOT COMPLETED|Overall Study||18
8762312|NCT01227902|9812014|FG001|NOT COMPLETED|Overall Study||13
8762313|NCT01227902|9812015|FG002|NOT COMPLETED|Overall Study||19
8762314|NCT01227902|9812016|FG003|NOT COMPLETED|Overall Study||10
8762315|NCT01227928|9812029|FG000|STARTED|Overall Study||72
8762316|NCT01227928|9812030|FG001|STARTED|Overall Study||73
8762317|NCT01227928|9812029|FG000|COMPLETED|Overall Study||50
8762318|NCT01227928|9812030|FG001|COMPLETED|Overall Study||56
8762319|NCT01227928|9812029|FG000|NOT COMPLETED|Overall Study||22
8762320|NCT01227928|9812030|FG001|NOT COMPLETED|Overall Study||17
8762321|NCT01227954|9812036|FG000|STARTED|Overall Study||113
8762322|NCT01227954|9812036|FG000|COMPLETED|Overall Study|Eligible subjects available for analysis|100
8762323|NCT01227954|9812036|FG000|NOT COMPLETED|Overall Study||13
8762324|NCT01227967|9812042|FG000|STARTED|Overall Study||314
8762325|NCT01227967|9812043|FG001|STARTED|Overall Study||316
8762326|NCT01227967|9812042|FG000|COMPLETED|Overall Study||298
8762327|NCT01227967|9812043|FG001|COMPLETED|Overall Study||303
8762328|NCT01227967|9812042|FG000|NOT COMPLETED|Overall Study||16
8762329|NCT01227967|9812043|FG001|NOT COMPLETED|Overall Study||13
8762330|NCT01227980|9812051|FG000|STARTED|Overall Study||40
8762331|NCT01227980|9812052|FG001|STARTED|Overall Study||30
8762332|NCT01227980|9812051|FG000|Scripts Challenge Sessions|Overall Study||26
8762333|NCT01227980|9812052|FG001|Scripts Challenge Sessions|Overall Study||25
8762334|NCT01227980|9812051|FG000|Measure Drug Level Concentration|Overall Study||10
8762335|NCT01227980|9812052|FG001|Measure Drug Level Concentration|Overall Study|No placebo subjects completed this milestone which measured active drug levels|0
8762336|NCT01227980|9812051|FG000|COMPLETED|Overall Study|Two subjects did not complete the scripts sessions but completed the remainder of the protocol|38
8762337|NCT01227980|9812052|FG001|COMPLETED|Overall Study||25
8762338|NCT01227980|9812051|FG000|NOT COMPLETED|Overall Study||2
8762339|NCT01227980|9812052|FG001|NOT COMPLETED|Overall Study||5
8762340|NCT01227993|9812058|FG000|STARTED|Overall Study||3
8762341|NCT01227993|9812058|FG000|COMPLETED|Overall Study||3
8762342|NCT01227993|9812058|FG000|NOT COMPLETED|Overall Study||0
8762343|NCT01228019|9812062|FG000|STARTED|Overall Study||1166
8762344|NCT01228019|9812062|FG000|COMPLETED|Overall Study||862
8762345|NCT01228019|9812062|FG000|NOT COMPLETED|Overall Study||304
8762346|NCT01228071|9812066|FG000|STARTED|Overall Study||34
8762347|NCT01228071|9812066|FG000|COMPLETED|Overall Study||32
8762348|NCT01228071|9812066|FG000|NOT COMPLETED|Overall Study||2
8762349|NCT01228084|9812070|FG000|STARTED|Overall Study||20
8762350|NCT01228084|9812070|FG000|COMPLETED|Overall Study||16
8762351|NCT01228084|9812070|FG000|NOT COMPLETED|Overall Study||4
8762352|NCT01228149|9812076|FG000|STARTED|Overall Study||32
8762353|NCT01228149|9812077|FG001|STARTED|Overall Study||30
8762354|NCT01228149|9812076|FG000|COMPLETED|Overall Study||27
8762355|NCT01228149|9812077|FG001|COMPLETED|Overall Study||26
8762356|NCT01228149|9812076|FG000|NOT COMPLETED|Overall Study||5
8762357|NCT01228149|9812077|FG001|NOT COMPLETED|Overall Study||4
8762358|NCT01228175|9812088|FG000|STARTED|Overall Study||119
8762359|NCT01228175|9812089|FG001|STARTED|Overall Study||99
8762360|NCT01228175|9812088|FG000|COMPLETED|Overall Study||53
8762361|NCT01228175|9812089|FG001|COMPLETED|Overall Study||46
8762362|NCT01228175|9812088|FG000|NOT COMPLETED|Overall Study||66
8762363|NCT01228175|9812089|FG001|NOT COMPLETED|Overall Study||53
8762364|NCT01228318|9812097|FG000|STARTED|Overall Study||34
8762365|NCT01228318|9812098|FG001|STARTED|Overall Study||29
8762366|NCT01228318|9812097|FG000|COMPLETED|Overall Study||30
8762367|NCT01228318|9812098|FG001|COMPLETED|Overall Study||22
8762368|NCT01228318|9812097|FG000|NOT COMPLETED|Overall Study||4
8762369|NCT01228318|9812098|FG001|NOT COMPLETED|Overall Study||7
8762370|NCT01228435|9812106|FG000|STARTED|Overall Study||1
8762371|NCT01228435|9812107|FG001|STARTED|Overall Study||2
8762372|NCT01228435|9812106|FG000|COMPLETED|Overall Study||1
8762373|NCT01228435|9812107|FG001|COMPLETED|Overall Study||2
8762374|NCT01228435|9812106|FG000|NOT COMPLETED|Overall Study||0
8762375|NCT01228435|9812107|FG001|NOT COMPLETED|Overall Study||0
8762376|NCT01228591|9812113|FG000|STARTED|Baseline||18
8762377|NCT01228591|9812114|FG001|STARTED|Baseline||18
8762378|NCT01228591|9812113|FG000|COMPLETED|Baseline||17
8762379|NCT01228591|9812114|FG001|COMPLETED|Baseline||16
8762380|NCT01228591|9812113|FG000|NOT COMPLETED|Baseline||1
8762381|NCT01228591|9812114|FG001|NOT COMPLETED|Baseline||2
8762382|NCT01228591|9812113|FG000|STARTED|1-Week Follow-Up||17
8762383|NCT01228591|9812114|FG001|STARTED|1-Week Follow-Up||16
8762384|NCT01228591|9812113|FG000|COMPLETED|1-Week Follow-Up||17
8762385|NCT01228591|9812114|FG001|COMPLETED|1-Week Follow-Up||16
8762386|NCT01228591|9812113|FG000|NOT COMPLETED|1-Week Follow-Up||0
9026234|NCT03172494|10088651|FG001|Exposed|Overall Study||175
8762387|NCT01228591|9812114|FG001|NOT COMPLETED|1-Week Follow-Up||0
8762388|NCT01228591|9812113|FG000|STARTED|Final Visit||17
8762389|NCT01228591|9812114|FG001|STARTED|Final Visit||16
8762390|NCT01228591|9812113|FG000|COMPLETED|Final Visit||17
8762391|NCT01228591|9812114|FG001|COMPLETED|Final Visit||16
8762392|NCT01228591|9812113|FG000|NOT COMPLETED|Final Visit||0
8762393|NCT01228591|9812114|FG001|NOT COMPLETED|Final Visit||0
8762394|NCT01228734|9812126|FG000|STARTED|Overall Study||193
8762395|NCT01228734|9812127|FG001|STARTED|Overall Study||204
9026235|NCT03172494|10088652|FG002|Exposed|Overall Study||180
8762396|NCT01228734|9812126|FG000|Modified Intent-to-treat Population|Overall Study||193
8762397|NCT01228734|9812127|FG001|Modified Intent-to-treat Population|Overall Study||200
8762398|NCT01228734|9812126|FG000|Modified Safety Population|Overall Study|One subject was randomized to FOLFOX-4 group but received cetuximab + FOLFOX-4 treatment instead|194
8762399|NCT01228734|9812127|FG001|Modified Safety Population|Overall Study||199
8762400|NCT01228734|9812126|FG000|COMPLETED|Overall Study||193
8762401|NCT01228734|9812127|FG001|COMPLETED|Overall Study||200
8762402|NCT01228734|9812126|FG000|NOT COMPLETED|Overall Study||0
8762403|NCT01228734|9812127|FG001|NOT COMPLETED|Overall Study||4
8762404|NCT01228747|9812135|FG000|STARTED|Overall Study||125
8762405|NCT01228747|9812136|FG001|STARTED|Overall Study||126
8762406|NCT01228747|9812135|FG000|COMPLETED|Overall Study||60
8762407|NCT01228747|9812136|FG001|COMPLETED|Overall Study||81
8762408|NCT01228747|9812135|FG000|NOT COMPLETED|Overall Study||65
8762409|NCT01228747|9812136|FG001|NOT COMPLETED|Overall Study||45
8762410|NCT01228903|9812144|FG000|STARTED|Overall Study||41
8762411|NCT01228903|9812145|FG001|STARTED|Overall Study||39
8762412|NCT01228903|9812144|FG000|COMPLETED|Overall Study||36
8762413|NCT01228903|9812145|FG001|COMPLETED|Overall Study||34
8762414|NCT01228903|9812144|FG000|NOT COMPLETED|Overall Study||5
8762415|NCT01228903|9812145|FG001|NOT COMPLETED|Overall Study||5
8762416|NCT01228929|9812154|FG000|STARTED|Nominal Condition||6
8762417|NCT01228929|9812155|FG001|STARTED|Nominal Condition||6
8762418|NCT01228929|9812156|FG002|STARTED|Nominal Condition||6
8762419|NCT01228929|9812154|FG000|COMPLETED|Nominal Condition||6
8762420|NCT01228929|9812155|FG001|COMPLETED|Nominal Condition||6
8762421|NCT01228929|9812156|FG002|COMPLETED|Nominal Condition||6
8762422|NCT01228929|9812154|FG000|NOT COMPLETED|Nominal Condition||0
8762423|NCT01228929|9812155|FG001|NOT COMPLETED|Nominal Condition||0
8762424|NCT01228929|9812156|FG002|NOT COMPLETED|Nominal Condition||0
8762425|NCT01228929|9812154|FG000|STARTED|Low Humidity Condition||6
8762426|NCT01228929|9812155|FG001|STARTED|Low Humidity Condition||6
8762427|NCT01228929|9812156|FG002|STARTED|Low Humidity Condition||6
8762428|NCT01228929|9812154|FG000|COMPLETED|Low Humidity Condition||6
8762429|NCT01228929|9812155|FG001|COMPLETED|Low Humidity Condition||6
8762430|NCT01228929|9812156|FG002|COMPLETED|Low Humidity Condition||6
8762431|NCT01228929|9812154|FG000|NOT COMPLETED|Low Humidity Condition||0
8762432|NCT01228929|9812155|FG001|NOT COMPLETED|Low Humidity Condition||0
8762433|NCT01228929|9812156|FG002|NOT COMPLETED|Low Humidity Condition||0
8762434|NCT01228929|9812154|FG000|STARTED|High Temperature Condition||6
8762435|NCT01228929|9812155|FG001|STARTED|High Temperature Condition||6
8762436|NCT01228929|9812156|FG002|STARTED|High Temperature Condition||6
8762437|NCT01228929|9812154|FG000|COMPLETED|High Temperature Condition||6
8762438|NCT01228929|9812155|FG001|COMPLETED|High Temperature Condition||6
8762439|NCT01228929|9812156|FG002|COMPLETED|High Temperature Condition||6
8762440|NCT01228929|9812154|FG000|NOT COMPLETED|High Temperature Condition||0
8762441|NCT01228929|9812155|FG001|NOT COMPLETED|High Temperature Condition||0
8762442|NCT01228929|9812156|FG002|NOT COMPLETED|High Temperature Condition||0
8762443|NCT01228968|9812164|FG000|STARTED|Overall Study||9
8762444|NCT01228968|9812164|FG000|COMPLETED|Overall Study||9
8762445|NCT01228968|9812164|FG000|NOT COMPLETED|Overall Study||0
8762446|NCT01229111|9812168|FG000|STARTED|Overall Study||14
8762447|NCT01229111|9812168|FG000|COMPLETED|Overall Study||13
8762448|NCT01229111|9812168|FG000|NOT COMPLETED|Overall Study||1
8762449|NCT01229150|9812176|FG000|STARTED|Overall Study||30
8762450|NCT01229150|9812177|FG001|STARTED|Overall Study||11
8762451|NCT01229150|9812178|FG002|STARTED|Overall Study||19
8762452|NCT01229150|9812179|FG003|STARTED|Overall Study||19
8762453|NCT01229150|9812176|FG000|COMPLETED|Overall Study||28
8762454|NCT01229150|9812177|FG001|COMPLETED|Overall Study||9
8762455|NCT01229150|9812178|FG002|COMPLETED|Overall Study||19
8762456|NCT01229150|9812179|FG003|COMPLETED|Overall Study||19
8762457|NCT01229150|9812176|FG000|NOT COMPLETED|Overall Study||2
8762458|NCT01229150|9812177|FG001|NOT COMPLETED|Overall Study||2
8762459|NCT01229150|9812178|FG002|NOT COMPLETED|Overall Study||0
8762460|NCT01229150|9812179|FG003|NOT COMPLETED|Overall Study||0
8762461|NCT01229176|9812201|FG000|STARTED|Overall Study||40
8762462|NCT01229176|9812202|FG001|STARTED|Overall Study||40
8762463|NCT01229176|9812203|FG002|STARTED|Overall Study||20
8762464|NCT01229176|9812204|FG003|STARTED|Overall Study||20
8762465|NCT01229176|9812205|FG004|STARTED|Overall Study||20
8762466|NCT01229176|9812206|FG005|STARTED|Overall Study||20
8762467|NCT01229176|9812207|FG006|STARTED|Overall Study||20
8762468|NCT01229176|9812208|FG007|STARTED|Overall Study||20
8762469|NCT01229176|9812201|FG000|COMPLETED|Overall Study||40
8762470|NCT01229176|9812202|FG001|COMPLETED|Overall Study||37
8762471|NCT01229176|9812203|FG002|COMPLETED|Overall Study||20
8762472|NCT01229176|9812204|FG003|COMPLETED|Overall Study||19
8762473|NCT01229176|9812205|FG004|COMPLETED|Overall Study||18
8762474|NCT01229176|9812206|FG005|COMPLETED|Overall Study||18
8762475|NCT01229176|9812207|FG006|COMPLETED|Overall Study||20
8762476|NCT01229176|9812208|FG007|COMPLETED|Overall Study||17
8762477|NCT01229176|9812201|FG000|NOT COMPLETED|Overall Study||0
8762478|NCT01229176|9812202|FG001|NOT COMPLETED|Overall Study||3
8762479|NCT01229176|9812203|FG002|NOT COMPLETED|Overall Study||0
8762480|NCT01229176|9812204|FG003|NOT COMPLETED|Overall Study||1
8762481|NCT01229176|9812205|FG004|NOT COMPLETED|Overall Study||2
8762482|NCT01229176|9812206|FG005|NOT COMPLETED|Overall Study||2
8762483|NCT01229176|9812207|FG006|NOT COMPLETED|Overall Study||0
8762484|NCT01229176|9812208|FG007|NOT COMPLETED|Overall Study||3
8762485|NCT01229228|9812231|FG000|STARTED|Overall Study||51
8762486|NCT01229228|9812232|FG001|STARTED|Overall Study||51
8762487|NCT01229228|9812233|FG002|STARTED|Overall Study||50
8762488|NCT01229228|9812234|FG003|STARTED|Overall Study||51
8762489|NCT01229228|9812235|FG004|STARTED|Overall Study||51
8762490|NCT01229228|9812231|FG000|COMPLETED|Overall Study||50
8762491|NCT01229228|9812232|FG001|COMPLETED|Overall Study||51
8762492|NCT01229228|9812233|FG002|COMPLETED|Overall Study||49
8762493|NCT01229228|9812234|FG003|COMPLETED|Overall Study||51
8762494|NCT01229228|9812235|FG004|COMPLETED|Overall Study||50
9026236|NCT03172494|10088650|FG000|COMPLETED|Overall Study||341
9026237|NCT03172494|10088651|FG001|COMPLETED|Overall Study||167
9026238|NCT03172494|10088652|FG002|COMPLETED|Overall Study||151
9026239|NCT03172494|10088650|FG000|NOT COMPLETED|Overall Study||20
9026240|NCT03172494|10088651|FG001|NOT COMPLETED|Overall Study||12
9026241|NCT03172494|10088652|FG002|NOT COMPLETED|Overall Study||29
9026242|NCT03172702|10088661|FG000|STARTED|Overall Study||150
9026243|NCT03172702|10088661|FG000|Received Treatment in CP|Overall Study||150
9026244|NCT03172702|10088661|FG000|Received Treatment in MP|Overall Study||150
9026245|NCT03172702|10088661|FG000|COMPLETED|Overall Study||122
9026246|NCT03172702|10088661|FG000|NOT COMPLETED|Overall Study||28
9026247|NCT03172884|10088670|FG000|STARTED|Overall Study||8
9026248|NCT03172884|10088671|FG001|STARTED|Overall Study||6
9026249|NCT03172884|10088672|FG002|STARTED|Overall Study||8
9026250|NCT03172884|10088673|FG003|STARTED|Overall Study||8
9026251|NCT03172884|10088670|FG000|COMPLETED|Overall Study||8
9026252|NCT03172884|10088671|FG001|COMPLETED|Overall Study||6
9026253|NCT03172884|10088672|FG002|COMPLETED|Overall Study||8
9026254|NCT03172884|10088673|FG003|COMPLETED|Overall Study||8
9026255|NCT03172884|10088670|FG000|NOT COMPLETED|Overall Study||0
9026256|NCT03172884|10088671|FG001|NOT COMPLETED|Overall Study||0
9026257|NCT03172884|10088672|FG002|NOT COMPLETED|Overall Study||0
9026258|NCT03172884|10088673|FG003|NOT COMPLETED|Overall Study||0
9026259|NCT03173170|10088683|FG000|STARTED|First Intervention Period (6 Days)||10
9026260|NCT03173170|10088683|FG000|COMPLETED|First Intervention Period (6 Days)||10
9026261|NCT03173170|10088683|FG000|NOT COMPLETED|First Intervention Period (6 Days)||0
9026262|NCT03173170|10088683|FG000|STARTED|Washout Period (at Least 7 Days)||10
9026263|NCT03173170|10088683|FG000|COMPLETED|Washout Period (at Least 7 Days)||10
9026264|NCT03173170|10088683|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0
9026265|NCT03173170|10088683|FG000|STARTED|Intervention Period 2 (9 Days)||10
9026266|NCT03173170|10088683|FG000|COMPLETED|Intervention Period 2 (9 Days)||10
9026267|NCT03173170|10088683|FG000|NOT COMPLETED|Intervention Period 2 (9 Days)||0
9026268|NCT03173313|10088693|FG000|STARTED|Overall Study||58
9026269|NCT03173313|10088694|FG001|STARTED|Overall Study||53
9026270|NCT03173313|10088693|FG000|Informed Consent Signed|Overall Study||58
9026271|NCT03173313|10088694|FG001|Informed Consent Signed|Overall Study||53
9026272|NCT03173313|10088693|FG000|Randomized|Overall Study||58
9026273|NCT03173313|10088694|FG001|Randomized|Overall Study||53
9026274|NCT03173313|10088693|FG000|Cooled|Overall Study||54
9026275|NCT03173313|10088694|FG001|Cooled|Overall Study||0
9026276|NCT03173313|10088693|FG000|4-6 Day Follow-up|Overall Study||57
9026277|NCT03173313|10088694|FG001|4-6 Day Follow-up|Overall Study||53
9026278|NCT03173313|10088693|FG000|30-day Follow-up|Overall Study||52
9026279|NCT03173313|10088694|FG001|30-day Follow-up|Overall Study||51
9026280|NCT03173313|10088693|FG000|12-month Follow-up|Overall Study||49
9026281|NCT03173313|10088694|FG001|12-month Follow-up|Overall Study||48
9026282|NCT03173313|10088693|FG000|COMPLETED|Overall Study||49
9026283|NCT03173313|10088694|FG001|COMPLETED|Overall Study||48
9026284|NCT03173313|10088693|FG000|NOT COMPLETED|Overall Study||9
9026285|NCT03173313|10088694|FG001|NOT COMPLETED|Overall Study||5
9026286|NCT03173547|10088702|FG000|STARTED|Overall Study||40
9026287|NCT03173547|10088703|FG001|STARTED|Overall Study||40
9026288|NCT03173547|10088702|FG000|COMPLETED|Overall Study||36
9026289|NCT03173547|10088703|FG001|COMPLETED|Overall Study||38
8671201|NCT00750308|9714635|FG003|COMPLETED|Second Treatment||1
8671202|NCT00750308|9714636|FG004|COMPLETED|Second Treatment||1
8671203|NCT00750308|9714637|FG005|COMPLETED|Second Treatment||2
8671204|NCT00750308|9714638|FG006|COMPLETED|Second Treatment||2
8671205|NCT00750308|9714639|FG007|COMPLETED|Second Treatment||2
8671206|NCT00750308|9714640|FG008|COMPLETED|Second Treatment||1
8671207|NCT00750308|9714641|FG009|COMPLETED|Second Treatment||2
8671208|NCT00750308|9714642|FG010|COMPLETED|Second Treatment||1
8671209|NCT00750308|9714643|FG011|COMPLETED|Second Treatment||1
8671210|NCT00750308|9714632|FG000|NOT COMPLETED|Second Treatment||0
8671211|NCT00750308|9714633|FG001|NOT COMPLETED|Second Treatment||0
8671212|NCT00750308|9714634|FG002|NOT COMPLETED|Second Treatment||0
8671213|NCT00750308|9714635|FG003|NOT COMPLETED|Second Treatment||0
8671214|NCT00750308|9714636|FG004|NOT COMPLETED|Second Treatment||1
8671215|NCT00750308|9714637|FG005|NOT COMPLETED|Second Treatment||1
8671216|NCT00750308|9714638|FG006|NOT COMPLETED|Second Treatment||0
8671217|NCT00750308|9714639|FG007|NOT COMPLETED|Second Treatment||0
8762495|NCT01229228|9812231|FG000|NOT COMPLETED|Overall Study||1
9026290|NCT03173547|10088702|FG000|NOT COMPLETED|Overall Study||4
9026291|NCT03173547|10088703|FG001|NOT COMPLETED|Overall Study||2
9026292|NCT03173560|10088711|FG000|STARTED|Overall Study||172
9026293|NCT03173560|10088712|FG001|STARTED|Overall Study||171
9026294|NCT03173560|10088711|FG000|Treated Participants|Overall Study||172
9026295|NCT03173560|10088712|FG001|Treated Participants|Overall Study||169
9026296|NCT03173560|10088711|FG000|Safety Set|Overall Study||173
9026297|NCT03173560|10088712|FG001|Safety Set|Overall Study||168
9026298|NCT03173560|10088711|FG000|COMPLETED|Overall Study||67
9026299|NCT03173560|10088712|FG001|COMPLETED|Overall Study||54
9026300|NCT03173560|10088711|FG000|NOT COMPLETED|Overall Study||105
8671218|NCT00750308|9714640|FG008|NOT COMPLETED|Second Treatment||1
8762496|NCT01229228|9812232|FG001|NOT COMPLETED|Overall Study||0
8762497|NCT01229228|9812233|FG002|NOT COMPLETED|Overall Study||1
8762498|NCT01229228|9812234|FG003|NOT COMPLETED|Overall Study||0
8762499|NCT01229228|9812235|FG004|NOT COMPLETED|Overall Study||1
8762500|NCT01229254|9812250|FG000|STARTED|Overall Study||42
8762501|NCT01229254|9812251|FG001|STARTED|Overall Study||74
8762502|NCT01229254|9812252|FG002|STARTED|Overall Study||73
8762503|NCT01229254|9812250|FG000|COMPLETED|Overall Study||27
8762504|NCT01229254|9812251|FG001|COMPLETED|Overall Study||58
8762505|NCT01229254|9812252|FG002|COMPLETED|Overall Study||61
8762506|NCT01229254|9812250|FG000|NOT COMPLETED|Overall Study||15
8762507|NCT01229254|9812251|FG001|NOT COMPLETED|Overall Study||16
8762508|NCT01229254|9812252|FG002|NOT COMPLETED|Overall Study||12
8762509|NCT01229267|9812266|FG000|STARTED|Overall Study||189
8762510|NCT01229267|9812267|FG001|STARTED|Overall Study||184
8762511|NCT01229267|9812268|FG002|STARTED|Overall Study||187
8762512|NCT01229267|9812269|FG003|STARTED|Overall Study||106
8762513|NCT01229267|9812270|FG004|STARTED|Overall Study||564
8762514|NCT01229267|9812266|FG000|Received Vaccination 1|Overall Study||188
8762515|NCT01229267|9812267|FG001|Received Vaccination 1|Overall Study||180
8762516|NCT01229267|9812268|FG002|Received Vaccination 1|Overall Study||186
8762517|NCT01229267|9812269|FG003|Received Vaccination 1|Overall Study||104
8762518|NCT01229267|9812270|FG004|Received Vaccination 1|Overall Study||556
8762519|NCT01229267|9812266|FG000|Received Vaccination 2|Overall Study||171
8762520|NCT01229267|9812267|FG001|Received Vaccination 2|Overall Study||163
8762521|NCT01229267|9812268|FG002|Received Vaccination 2|Overall Study||168
8762522|NCT01229267|9812269|FG003|Received Vaccination 2|Overall Study||94
8762523|NCT01229267|9812270|FG004|Received Vaccination 2|Overall Study||511
8762524|NCT01229267|9812266|FG000|Received Vaccination 3|Overall Study||163
8762525|NCT01229267|9812267|FG001|Received Vaccination 3|Overall Study||155
8762526|NCT01229267|9812268|FG002|Received Vaccination 3|Overall Study||160
8762527|NCT01229267|9812269|FG003|Received Vaccination 3|Overall Study||89
8762528|NCT01229267|9812270|FG004|Received Vaccination 3|Overall Study||491
8762529|NCT01229267|9812266|FG000|Received Vaccination 4|Overall Study||155
8762530|NCT01229267|9812267|FG001|Received Vaccination 4|Overall Study||149
8762531|NCT01229267|9812268|FG002|Received Vaccination 4|Overall Study||149
8762532|NCT01229267|9812269|FG003|Received Vaccination 4|Overall Study||87
8762533|NCT01229267|9812270|FG004|Received Vaccination 4|Overall Study||477
8762534|NCT01229267|9812266|FG000|COMPLETED|Overall Study||108
8762535|NCT01229267|9812267|FG001|COMPLETED|Overall Study||102
8762536|NCT01229267|9812268|FG002|COMPLETED|Overall Study||101
8762537|NCT01229267|9812269|FG003|COMPLETED|Overall Study||71
8762538|NCT01229267|9812270|FG004|COMPLETED|Overall Study||344
8762539|NCT01229267|9812266|FG000|NOT COMPLETED|Overall Study||81
8762540|NCT01229267|9812267|FG001|NOT COMPLETED|Overall Study||82
8762541|NCT01229267|9812268|FG002|NOT COMPLETED|Overall Study||86
8762542|NCT01229267|9812269|FG003|NOT COMPLETED|Overall Study||35
8762543|NCT01229267|9812270|FG004|NOT COMPLETED|Overall Study||220
8762544|NCT01229371|9812281|FG000|STARTED|Overall Study||109
8762545|NCT01229371|9812282|FG001|STARTED|Overall Study||111
8762546|NCT01229371|9812283|FG002|STARTED|Overall Study||110
8762547|NCT01229371|9812284|FG003|STARTED|Overall Study||110
8762548|NCT01229371|9812281|FG000|COMPLETED|Overall Study||109
8762549|NCT01229371|9812282|FG001|COMPLETED|Overall Study||110
8762550|NCT01229371|9812283|FG002|COMPLETED|Overall Study||110
8762551|NCT01229371|9812284|FG003|COMPLETED|Overall Study||110
8762552|NCT01229371|9812281|FG000|NOT COMPLETED|Overall Study||0
8762553|NCT01229371|9812282|FG001|NOT COMPLETED|Overall Study||1
8762554|NCT01229371|9812283|FG002|NOT COMPLETED|Overall Study||0
8762555|NCT01229371|9812284|FG003|NOT COMPLETED|Overall Study||0
8762556|NCT01229397|9812296|FG000|STARTED|Overall Study||103
8762557|NCT01229397|9812297|FG001|STARTED|Overall Study||102
8762558|NCT01229397|9812296|FG000|COMPLETED|Overall Study||92
8762559|NCT01229397|9812297|FG001|COMPLETED|Overall Study||93
8762560|NCT01229397|9812296|FG000|NOT COMPLETED|Overall Study||11
8762561|NCT01229397|9812297|FG001|NOT COMPLETED|Overall Study||9
8762562|NCT01229410|9812309|FG000|STARTED|Overall Study||12
8762563|NCT01229410|9812310|FG001|STARTED|Overall Study||12
8762564|NCT01229410|9812309|FG000|COMPLETED|Overall Study||7
8762565|NCT01229410|9812310|FG001|COMPLETED|Overall Study||9
8762566|NCT01229410|9812309|FG000|NOT COMPLETED|Overall Study||5
8762567|NCT01229410|9812310|FG001|NOT COMPLETED|Overall Study||3
8762568|NCT01229423|9812316|FG000|STARTED|Overall Study||62
8762569|NCT01229423|9812316|FG000|COMPLETED|Overall Study||47
8762570|NCT01229423|9812316|FG000|NOT COMPLETED|Overall Study||15
8762571|NCT01229436|9812320|FG000|STARTED|Overall Study||254
8762572|NCT01229436|9812320|FG000|COMPLETED|Overall Study||249
8762573|NCT01229436|9812320|FG000|NOT COMPLETED|Overall Study||5
8762574|NCT01229449|9812329|FG000|STARTED|Overall Study||173
8762575|NCT01229449|9812330|FG001|STARTED|Overall Study||168
8762576|NCT01229449|9812331|FG002|STARTED|Overall Study||169
8762577|NCT01229449|9812332|FG003|STARTED|Overall Study||113
8762578|NCT01229449|9812333|FG004|STARTED|Overall Study||55
8762579|NCT01229449|9812329|FG000|COMPLETED|Overall Study||172
8762580|NCT01229449|9812330|FG001|COMPLETED|Overall Study||164
8762581|NCT01229449|9812331|FG002|COMPLETED|Overall Study||167
8762582|NCT01229449|9812332|FG003|COMPLETED|Overall Study||112
8762583|NCT01229449|9812333|FG004|COMPLETED|Overall Study||54
8762584|NCT01229449|9812329|FG000|NOT COMPLETED|Overall Study||1
8762585|NCT01229449|9812330|FG001|NOT COMPLETED|Overall Study||4
8762586|NCT01229449|9812331|FG002|NOT COMPLETED|Overall Study||2
8762587|NCT01229449|9812332|FG003|NOT COMPLETED|Overall Study||1
8762588|NCT01229449|9812333|FG004|NOT COMPLETED|Overall Study||1
8762589|NCT01229462|9812347|FG000|STARTED|Overall Study||120
8762590|NCT01229462|9812348|FG001|STARTED|Overall Study||118
8762591|NCT01229462|9812347|FG000|COMPLETED|Overall Study||115
8762592|NCT01229462|9812348|FG001|COMPLETED|Overall Study||109
8762593|NCT01229462|9812347|FG000|NOT COMPLETED|Overall Study||5
8762594|NCT01229462|9812348|FG001|NOT COMPLETED|Overall Study||9
8762595|NCT01229527|9812357|FG000|STARTED|Overall Study||30
8762596|NCT01229527|9812358|FG001|STARTED|Overall Study||30
8762597|NCT01229527|9812359|FG002|STARTED|Overall Study||30
8762598|NCT01229527|9812357|FG000|COMPLETED|Overall Study||30
8762599|NCT01229527|9812358|FG001|COMPLETED|Overall Study||30
8762600|NCT01229527|9812359|FG002|COMPLETED|Overall Study||30
8762601|NCT01229527|9812357|FG000|NOT COMPLETED|Overall Study||0
8762602|NCT01229527|9812358|FG001|NOT COMPLETED|Overall Study||0
8762603|NCT01229527|9812359|FG002|NOT COMPLETED|Overall Study||0
8762604|NCT01229722|9812369|FG000|STARTED|Overall Study||36
8762605|NCT01229722|9812370|FG001|STARTED|Overall Study||34
8762606|NCT01229722|9812369|FG000|COMPLETED|Overall Study||36
8762607|NCT01229722|9812370|FG001|COMPLETED|Overall Study||30
8762608|NCT01229722|9812369|FG000|NOT COMPLETED|Overall Study||0
8762609|NCT01229722|9812370|FG001|NOT COMPLETED|Overall Study||4
8762610|NCT01229735|9812382|FG000|STARTED|Overall Study||177
8762611|NCT01229735|9812383|FG001|STARTED|Overall Study||166
8762612|NCT01229735|9812382|FG000|COMPLETED|Overall Study||111
8762613|NCT01229735|9812383|FG001|COMPLETED|Overall Study||100
8762614|NCT01229735|9812382|FG000|NOT COMPLETED|Overall Study||66
8762615|NCT01229735|9812383|FG001|NOT COMPLETED|Overall Study||66
8762616|NCT01229891|9812394|FG000|STARTED|Overall Study||30
8762617|NCT01229891|9812395|FG001|STARTED|Overall Study||30
8762618|NCT01229891|9812396|FG002|STARTED|Overall Study||30
8762619|NCT01229891|9812394|FG000|COMPLETED|Overall Study||30
8762620|NCT01229891|9812395|FG001|COMPLETED|Overall Study||30
8762621|NCT01229891|9812396|FG002|COMPLETED|Overall Study||30
8762622|NCT01229891|9812394|FG000|NOT COMPLETED|Overall Study||0
8762623|NCT01229891|9812395|FG001|NOT COMPLETED|Overall Study||0
8762624|NCT01229891|9812396|FG002|NOT COMPLETED|Overall Study||0
8762625|NCT01230021|9812404|FG000|STARTED|Overall Study||6
8762626|NCT01230021|9812404|FG000|COMPLETED|Overall Study||6
8762627|NCT01230021|9812404|FG000|NOT COMPLETED|Overall Study||0
8762628|NCT01230060|9812408|FG000|STARTED|Overall Study||122
8762629|NCT01230060|9812408|FG000|COMPLETED|Overall Study||121
8762630|NCT01230060|9812408|FG000|NOT COMPLETED|Overall Study||1
8762631|NCT01230125|9812414|FG000|STARTED|Overall Study||207
8762632|NCT01230125|9812415|FG001|STARTED|Overall Study||104
8762633|NCT01230125|9812414|FG000|COMPLETED|Overall Study||134
8762634|NCT01230125|9812415|FG001|COMPLETED|Overall Study||54
8762635|NCT01230125|9812414|FG000|NOT COMPLETED|Overall Study||73
8762636|NCT01230125|9812415|FG001|NOT COMPLETED|Overall Study||50
8762637|NCT01230177|9812421|FG000|STARTED|Overall Study||3
8762638|NCT01230177|9812421|FG000|COMPLETED|Overall Study||3
8762639|NCT01230177|9812421|FG000|NOT COMPLETED|Overall Study||0
8762640|NCT01230424|9812427|FG000|STARTED|Overall Study||70
8762641|NCT01230424|9812428|FG001|STARTED|Overall Study||70
8762642|NCT01230424|9812427|FG000|COMPLETED|Overall Study||70
8762643|NCT01230424|9812428|FG001|COMPLETED|Overall Study||70
8762644|NCT01230424|9812427|FG000|NOT COMPLETED|Overall Study||0
8762645|NCT01230424|9812428|FG001|NOT COMPLETED|Overall Study||0
8762646|NCT01230502|9812440|FG000|STARTED|Overall Study||9
8762647|NCT01230502|9812441|FG001|STARTED|Overall Study||0
8762648|NCT01230502|9812442|FG002|STARTED|Overall Study||0
8762649|NCT01230502|9812440|FG000|COMPLETED|Overall Study||9
8762650|NCT01230502|9812441|FG001|COMPLETED|Overall Study||0
8762651|NCT01230502|9812442|FG002|COMPLETED|Overall Study||0
8762652|NCT01230502|9812440|FG000|NOT COMPLETED|Overall Study||0
8762653|NCT01230502|9812441|FG001|NOT COMPLETED|Overall Study||0
8762654|NCT01230502|9812442|FG002|NOT COMPLETED|Overall Study||0
8762655|NCT01230554|9812453|FG000|STARTED|Overall Study||212
8762656|NCT01230554|9812453|FG000|COMPLETED|Overall Study||209
8762657|NCT01230554|9812453|FG000|NOT COMPLETED|Overall Study||3
8762658|NCT01230593|9812460|FG000|STARTED|Overall Study||50
8762659|NCT01230593|9812461|FG001|STARTED|Overall Study||50
8762660|NCT01230593|9812462|FG002|STARTED|Overall Study||50
8762661|NCT01230593|9812460|FG000|COMPLETED|Overall Study||35
8762662|NCT01230593|9812461|FG001|COMPLETED|Overall Study||32
8762663|NCT01230593|9812462|FG002|COMPLETED|Overall Study||38
8762664|NCT01230593|9812460|FG000|NOT COMPLETED|Overall Study||15
8762665|NCT01230593|9812461|FG001|NOT COMPLETED|Overall Study||18
8762666|NCT01230593|9812462|FG002|NOT COMPLETED|Overall Study||12
8762667|NCT01230710|9812470|FG000|STARTED|Overall Study||51
8762668|NCT01230710|9812470|FG000|COMPLETED|Overall Study||2
8762669|NCT01230710|9812470|FG000|NOT COMPLETED|Overall Study||49
8762670|NCT01230749|9812478|FG000|STARTED|Overall Study||22
8762671|NCT01230749|9812479|FG001|STARTED|Overall Study||22
8762672|NCT01230749|9812480|FG002|STARTED|Overall Study||23
8762673|NCT01230749|9812481|FG003|STARTED|Overall Study||22
8762674|NCT01230749|9812478|FG000|COMPLETED|Overall Study||22
8762675|NCT01230749|9812479|FG001|COMPLETED|Overall Study||20
8762676|NCT01230749|9812480|FG002|COMPLETED|Overall Study||21
8762677|NCT01230749|9812481|FG003|COMPLETED|Overall Study||20
8762678|NCT01230749|9812478|FG000|NOT COMPLETED|Overall Study||0
8762679|NCT01230749|9812479|FG001|NOT COMPLETED|Overall Study||2
8762680|NCT01230749|9812480|FG002|NOT COMPLETED|Overall Study||2
8762681|NCT01230749|9812481|FG003|NOT COMPLETED|Overall Study||2
8762682|NCT01230801|9812497|FG000|STARTED|Overall Study||3
8762683|NCT01230801|9812498|FG001|STARTED|Overall Study||3
8762684|NCT01230801|9812499|FG002|STARTED|Overall Study||16
8762685|NCT01230801|9812497|FG000|COMPLETED|Overall Study||3
8762686|NCT01230801|9812498|FG001|COMPLETED|Overall Study||3
8762687|NCT01230801|9812499|FG002|COMPLETED|Overall Study||15
8762688|NCT01230801|9812497|FG000|NOT COMPLETED|Overall Study||0
8762689|NCT01230801|9812498|FG001|NOT COMPLETED|Overall Study||0
8762690|NCT01230801|9812499|FG002|NOT COMPLETED|Overall Study||1
8762691|NCT01230814|9812512|FG000|STARTED|Overall Study||118
8762692|NCT01230814|9812513|FG001|STARTED|Overall Study||116
8762693|NCT01230814|9812512|FG000|COMPLETED|Overall Study||105
8762694|NCT01230814|9812513|FG001|COMPLETED|Overall Study||112
8762695|NCT01230814|9812512|FG000|NOT COMPLETED|Overall Study||13
8762696|NCT01230814|9812513|FG001|NOT COMPLETED|Overall Study||4
8808297|NCT01490632|9860712|FG011|STARTED|Part A: Initial Treatment Period||0
8808298|NCT01490632|9860713|FG012|STARTED|Part A: Initial Treatment Period||0
8808299|NCT01490632|9860714|FG013|STARTED|Part A: Initial Treatment Period||0
8808300|NCT01490632|9860715|FG014|STARTED|Part A: Initial Treatment Period||0
8808301|NCT01490632|9860716|FG015|STARTED|Part A: Initial Treatment Period||0
8808302|NCT01490632|9860717|FG016|STARTED|Part A: Initial Treatment Period||0
8808303|NCT01490632|9860718|FG017|STARTED|Part A: Initial Treatment Period||0
8808304|NCT01490632|9860719|FG018|STARTED|Part A: Initial Treatment Period||0
8808305|NCT01490632|9860720|FG019|STARTED|Part A: Initial Treatment Period||0
8808306|NCT01490632|9860701|FG000|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||34
8808307|NCT01490632|9860702|FG001|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||32
8808308|NCT01490632|9860703|FG002|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||72
8808309|NCT01490632|9860704|FG003|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||64
8808310|NCT01490632|9860705|FG004|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||69
8808311|NCT01490632|9860706|FG005|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
8808312|NCT01490632|9860707|FG006|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
8808313|NCT01490632|9860708|FG007|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
8808314|NCT01490632|9860709|FG008|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
8808315|NCT01490632|9860710|FG009|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
8808316|NCT01490632|9860711|FG010|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
8808317|NCT01490632|9860712|FG011|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
8808318|NCT01490632|9860713|FG012|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
8808319|NCT01490632|9860714|FG013|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
8808320|NCT01490632|9860715|FG014|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
8808321|NCT01490632|9860716|FG015|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
8808322|NCT01490632|9860717|FG016|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
8808323|NCT01490632|9860718|FG017|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
8808324|NCT01490632|9860719|FG018|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
8808325|NCT01490632|9860720|FG019|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
8808326|NCT01490632|9860701|FG000|COMPLETED|Part A: Initial Treatment Period||27
8808327|NCT01490632|9860702|FG001|COMPLETED|Part A: Initial Treatment Period||28
8808328|NCT01490632|9860703|FG002|COMPLETED|Part A: Initial Treatment Period||67
8808329|NCT01490632|9860704|FG003|COMPLETED|Part A: Initial Treatment Period||55
8808330|NCT01490632|9860705|FG004|COMPLETED|Part A: Initial Treatment Period|Includes participants who completed Part A, but discontinued per protocol using Part A PASI score.|52
8808331|NCT01490632|9860706|FG005|COMPLETED|Part A: Initial Treatment Period||0
8808332|NCT01490632|9860707|FG006|COMPLETED|Part A: Initial Treatment Period||0
8808333|NCT01490632|9860708|FG007|COMPLETED|Part A: Initial Treatment Period||0
8808334|NCT01490632|9860709|FG008|COMPLETED|Part A: Initial Treatment Period||0
8808335|NCT01490632|9860710|FG009|COMPLETED|Part A: Initial Treatment Period||0
8808336|NCT01490632|9860711|FG010|COMPLETED|Part A: Initial Treatment Period||0
8808337|NCT01490632|9860712|FG011|COMPLETED|Part A: Initial Treatment Period||0
8808338|NCT01490632|9860713|FG012|COMPLETED|Part A: Initial Treatment Period||0
8808339|NCT01490632|9860714|FG013|COMPLETED|Part A: Initial Treatment Period||0
8808340|NCT01490632|9860715|FG014|COMPLETED|Part A: Initial Treatment Period||0
8808341|NCT01490632|9860716|FG015|COMPLETED|Part A: Initial Treatment Period||0
8808342|NCT01490632|9860717|FG016|COMPLETED|Part A: Initial Treatment Period||0
8808343|NCT01490632|9860718|FG017|COMPLETED|Part A: Initial Treatment Period||0
8808344|NCT01490632|9860719|FG018|COMPLETED|Part A: Initial Treatment Period||0
8808345|NCT01490632|9860720|FG019|COMPLETED|Part A: Initial Treatment Period||0
8808346|NCT01490632|9860701|FG000|NOT COMPLETED|Part A: Initial Treatment Period||7
8808347|NCT01490632|9860702|FG001|NOT COMPLETED|Part A: Initial Treatment Period||4
8808348|NCT01490632|9860703|FG002|NOT COMPLETED|Part A: Initial Treatment Period||5
8808349|NCT01490632|9860704|FG003|NOT COMPLETED|Part A: Initial Treatment Period||9
8808350|NCT01490632|9860705|FG004|NOT COMPLETED|Part A: Initial Treatment Period||17
8808351|NCT01490632|9860706|FG005|NOT COMPLETED|Part A: Initial Treatment Period||0
8808352|NCT01490632|9860707|FG006|NOT COMPLETED|Part A: Initial Treatment Period||0
8808353|NCT01490632|9860708|FG007|NOT COMPLETED|Part A: Initial Treatment Period||0
8762697|NCT01230827|9812523|FG000|STARTED|Overall Study||19
8762698|NCT01230827|9812524|FG001|STARTED|Overall Study||11
8762699|NCT01230827|9812525|FG002|STARTED|Overall Study||65
8762700|NCT01230827|9812526|FG003|STARTED|Overall Study||78
8762701|NCT01230827|9812523|FG000|COMPLETED|Overall Study||0
8762702|NCT01230827|9812524|FG001|COMPLETED|Overall Study||0
8762703|NCT01230827|9812525|FG002|COMPLETED|Overall Study||0
8762704|NCT01230827|9812526|FG003|COMPLETED|Overall Study||0
8762705|NCT01230827|9812523|FG000|NOT COMPLETED|Overall Study||19
8762706|NCT01230827|9812524|FG001|NOT COMPLETED|Overall Study||11
8762707|NCT01230827|9812525|FG002|NOT COMPLETED|Overall Study||65
8762708|NCT01230827|9812526|FG003|NOT COMPLETED|Overall Study||78
8762709|NCT01230892|9812536|FG000|STARTED|Overall Study||15
8762710|NCT01230892|9812537|FG001|STARTED|Overall Study||14
8762711|NCT01230892|9812536|FG000|COMPLETED|Overall Study||12
8762712|NCT01230892|9812537|FG001|COMPLETED|Overall Study||13
8762713|NCT01230892|9812536|FG000|NOT COMPLETED|Overall Study||3
8762714|NCT01230892|9812537|FG001|NOT COMPLETED|Overall Study||1
8762715|NCT01230931|9812545|FG000|STARTED|Overall Study||10
8762716|NCT01230931|9812546|FG001|STARTED|Overall Study||10
8762717|NCT01230931|9812545|FG000|COMPLETED|Overall Study||10
8762718|NCT01230931|9812546|FG001|COMPLETED|Overall Study||10
8762719|NCT01230931|9812545|FG000|NOT COMPLETED|Overall Study||0
8762720|NCT01230931|9812546|FG001|NOT COMPLETED|Overall Study||0
8762721|NCT01231230|9812553|FG000|STARTED|Overall Study||14
8762722|NCT01231230|9812553|FG000|Fluticasone|Overall Study||14
8762723|NCT01231230|9812553|FG000|Salmeterol|Overall Study||14
8762724|NCT01231230|9812553|FG000|Fluticasone/Salmeterol|Overall Study||14
8762725|NCT01231230|9812553|FG000|Placebo|Overall Study||14
8762726|NCT01231230|9812553|FG000|COMPLETED|Overall Study||14
8762727|NCT01231230|9812553|FG000|NOT COMPLETED|Overall Study||0
8762728|NCT01231321|9812563|FG000|STARTED|Overall Study||100
8762729|NCT01231321|9812563|FG000|COMPLETED|Overall Study||95
8762730|NCT01231321|9812563|FG000|NOT COMPLETED|Overall Study||5
8762731|NCT01231334|9812575|FG000|STARTED|Overall Study||145
8762732|NCT01231334|9812576|FG001|STARTED|Overall Study||141
8762733|NCT01231334|9812575|FG000|COMPLETED|Overall Study||126
8762734|NCT01231334|9812576|FG001|COMPLETED|Overall Study||120
8762735|NCT01231334|9812575|FG000|NOT COMPLETED|Overall Study||19
8762736|NCT01231334|9812576|FG001|NOT COMPLETED|Overall Study||21
8762737|NCT01231373|9812586|FG000|STARTED|Overall Study||59
8762738|NCT01231373|9812587|FG001|STARTED|Overall Study||58
8762739|NCT01231373|9812588|FG002|STARTED|Overall Study||60
8762740|NCT01231373|9812589|FG003|STARTED|Overall Study||58
9026301|NCT03173560|10088712|FG001|NOT COMPLETED|Overall Study||117
9026302|NCT03174132|10088718|FG000|STARTED|Overall Study||70
9026303|NCT03174132|10088718|FG000|COMPLETED|Overall Study||70
9026304|NCT03174132|10088718|FG000|NOT COMPLETED|Overall Study||0
9026305|NCT03174158|10088726|FG000|STARTED|Overall Study||39
9026306|NCT03174158|10088727|FG001|STARTED|Overall Study||39
9026307|NCT03174158|10088728|FG002|STARTED|Overall Study||36
9026308|NCT03174158|10088729|FG003|STARTED|Overall Study||39
9026309|NCT03174158|10088726|FG000|COMPLETED|Overall Study||35
9026310|NCT03174158|10088727|FG001|COMPLETED|Overall Study||37
9026311|NCT03174158|10088728|FG002|COMPLETED|Overall Study||34
9026312|NCT03174158|10088729|FG003|COMPLETED|Overall Study||38
9026313|NCT03174158|10088726|FG000|NOT COMPLETED|Overall Study||4
9026314|NCT03174158|10088727|FG001|NOT COMPLETED|Overall Study||2
9026315|NCT03174158|10088728|FG002|NOT COMPLETED|Overall Study||2
9026316|NCT03174158|10088729|FG003|NOT COMPLETED|Overall Study||1
9026317|NCT03174366|10088747|FG000|STARTED|Overall Study||7
9026318|NCT03174366|10088747|FG000|COMPLETED|Overall Study||7
9026319|NCT03174366|10088747|FG000|NOT COMPLETED|Overall Study||0
9026320|NCT03174925|10088751|FG000|STARTED|Overall Study||55
9026321|NCT03174925|10088751|FG000|COMPLETED|Overall Study||52
9026322|NCT03174925|10088751|FG000|NOT COMPLETED|Overall Study||3
9026323|NCT03175120|10088757|FG000|STARTED|Overall Study||302
9026324|NCT03175120|10088758|FG001|STARTED|Overall Study||151
9026325|NCT03175120|10088757|FG000|Treated|Overall Study||301
8762741|NCT01231373|9812586|FG000|Patients Receiving Blinded Treatment|Overall Study||57
8762742|NCT01231373|9812587|FG001|Patients Receiving Blinded Treatment|Overall Study||57
8762743|NCT01231373|9812588|FG002|Patients Receiving Blinded Treatment|Overall Study||60
8762744|NCT01231373|9812589|FG003|Patients Receiving Blinded Treatment|Overall Study||58
8762745|NCT01231373|9812586|FG000|COMPLETED|Overall Study||56
8762746|NCT01231373|9812587|FG001|COMPLETED|Overall Study||57
8762747|NCT01231373|9812588|FG002|COMPLETED|Overall Study||60
8762748|NCT01231373|9812589|FG003|COMPLETED|Overall Study||57
9026326|NCT03175120|10088758|FG001|Treated|Overall Study||151
8762749|NCT01231373|9812586|FG000|NOT COMPLETED|Overall Study||3
8762750|NCT01231373|9812587|FG001|NOT COMPLETED|Overall Study||1
8762751|NCT01231373|9812588|FG002|NOT COMPLETED|Overall Study||0
8762752|NCT01231373|9812589|FG003|NOT COMPLETED|Overall Study||1
8762753|NCT01231399|9812601|FG000|STARTED|Overall Study||6
8762754|NCT01231399|9812601|FG000|COMPLETED|Overall Study||6
8762755|NCT01231399|9812601|FG000|NOT COMPLETED|Overall Study||0
8762756|NCT01231412|9812609|FG000|STARTED|Overall Study||77
8762757|NCT01231412|9812610|FG001|STARTED|Overall Study||91
8762758|NCT01231412|9812611|FG002|STARTED|Overall Study||6
8762759|NCT01231412|9812609|FG000|COMPLETED|Overall Study||77
8762760|NCT01231412|9812610|FG001|COMPLETED|Overall Study||90
8762761|NCT01231412|9812611|FG002|COMPLETED|Overall Study||6
9026327|NCT03175120|10088757|FG000|Full Analysis Set (FAS)|Overall Study||302
8762762|NCT01231412|9812609|FG000|NOT COMPLETED|Overall Study||0
8762763|NCT01231412|9812610|FG001|NOT COMPLETED|Overall Study||1
8762764|NCT01231412|9812611|FG002|NOT COMPLETED|Overall Study||0
8762765|NCT01231464|9812621|FG000|STARTED|Overall Study||182
8762766|NCT01231464|9812622|FG001|STARTED|Overall Study||183
8762767|NCT01231464|9812621|FG000|COMPLETED|Overall Study||177
8762768|NCT01231464|9812622|FG001|COMPLETED|Overall Study||176
8762769|NCT01231464|9812621|FG000|NOT COMPLETED|Overall Study||5
8762770|NCT01231464|9812622|FG001|NOT COMPLETED|Overall Study||7
8762771|NCT01231503|9812638|FG000|STARTED|Overall Study||60
8762772|NCT01231503|9812639|FG001|STARTED|Overall Study||59
8762773|NCT01231503|9812640|FG002|STARTED|Overall Study||60
8762774|NCT01231503|9812641|FG003|STARTED|Overall Study||60
8762775|NCT01231503|9812642|FG004|STARTED|Overall Study||60
8762776|NCT01231503|9812643|FG005|STARTED|Overall Study||60
8762777|NCT01231503|9812644|FG006|STARTED|Overall Study||60
8762778|NCT01231503|9812645|FG007|STARTED|Overall Study||60
8762779|NCT01231503|9812638|FG000|COMPLETED|Overall Study||46
8762780|NCT01231503|9812639|FG001|COMPLETED|Overall Study||46
9026328|NCT03175120|10088758|FG001|Full Analysis Set (FAS)|Overall Study||151
9026329|NCT03175120|10088757|FG000|Safety Analysis Set (SAS)|Overall Study||301
9026330|NCT03175120|10088758|FG001|Safety Analysis Set (SAS)|Overall Study||151
8762781|NCT01231503|9812640|FG002|COMPLETED|Overall Study||48
8762782|NCT01231503|9812641|FG003|COMPLETED|Overall Study||52
8762783|NCT01231503|9812642|FG004|COMPLETED|Overall Study||50
8762784|NCT01231503|9812643|FG005|COMPLETED|Overall Study||44
8762785|NCT01231503|9812644|FG006|COMPLETED|Overall Study||53
8762786|NCT01231503|9812645|FG007|COMPLETED|Overall Study||52
8762787|NCT01231503|9812638|FG000|NOT COMPLETED|Overall Study||14
8762788|NCT01231503|9812639|FG001|NOT COMPLETED|Overall Study||13
8762789|NCT01231503|9812640|FG002|NOT COMPLETED|Overall Study||12
8762790|NCT01231503|9812641|FG003|NOT COMPLETED|Overall Study||8
8762791|NCT01231503|9812642|FG004|NOT COMPLETED|Overall Study||10
8762792|NCT01231503|9812643|FG005|NOT COMPLETED|Overall Study||16
8762793|NCT01231503|9812644|FG006|NOT COMPLETED|Overall Study||7
8762794|NCT01231503|9812645|FG007|NOT COMPLETED|Overall Study||8
8762795|NCT01231555|9812676|FG000|STARTED|Overall Study||8
8762796|NCT01231555|9812677|FG001|STARTED|Overall Study||7
8762797|NCT01231555|9812678|FG002|STARTED|Overall Study||8
8762798|NCT01231555|9812676|FG000|COMPLETED|Overall Study||0
8762799|NCT01231555|9812677|FG001|COMPLETED|Overall Study||0
8762800|NCT01231555|9812678|FG002|COMPLETED|Overall Study||0
8762801|NCT01231555|9812676|FG000|NOT COMPLETED|Overall Study||8
8762802|NCT01231555|9812677|FG001|NOT COMPLETED|Overall Study||7
8762803|NCT01231555|9812678|FG002|NOT COMPLETED|Overall Study||8
8762804|NCT01231581|9812688|FG000|STARTED|Overall Study||80
8762805|NCT01231581|9812689|FG001|STARTED|Overall Study||80
8762806|NCT01231581|9812688|FG000|Ongoing|Overall Study|Participant is continuing treatment with trametinib and gemcitabine under roll over study MEK114375.|1
8762807|NCT01231581|9812689|FG001|Ongoing|Overall Study||0
8762808|NCT01231581|9812688|FG000|COMPLETED|Overall Study||0
8762809|NCT01231581|9812689|FG001|COMPLETED|Overall Study||0
8762810|NCT01231581|9812688|FG000|NOT COMPLETED|Overall Study||80
8762811|NCT01231581|9812689|FG001|NOT COMPLETED|Overall Study||80
8762812|NCT01231607|9812700|FG000|STARTED|Overall Study||185
8762813|NCT01231607|9812701|FG001|STARTED|Overall Study||188
8762814|NCT01231607|9812702|FG002|STARTED|Overall Study||184
8762815|NCT01231607|9812703|FG003|STARTED|Overall Study||179
8762816|NCT01231607|9812704|FG004|STARTED|Overall Study||181
8762817|NCT01231607|9812700|FG000|COMPLETED|Overall Study||156
8762818|NCT01231607|9812701|FG001|COMPLETED|Overall Study||154
8762819|NCT01231607|9812702|FG002|COMPLETED|Overall Study||153
8762820|NCT01231607|9812703|FG003|COMPLETED|Overall Study||141
8762821|NCT01231607|9812704|FG004|COMPLETED|Overall Study||157
8762822|NCT01231607|9812700|FG000|NOT COMPLETED|Overall Study||29
8762823|NCT01231607|9812701|FG001|NOT COMPLETED|Overall Study||34
8762824|NCT01231607|9812702|FG002|NOT COMPLETED|Overall Study||31
8762825|NCT01231607|9812703|FG003|NOT COMPLETED|Overall Study||38
8762826|NCT01231607|9812704|FG004|NOT COMPLETED|Overall Study||24
8762827|NCT01231620|9812722|FG000|STARTED|Overall Study||201
8762828|NCT01231620|9812723|FG001|STARTED|Overall Study||209
8762829|NCT01231620|9812724|FG002|STARTED|Overall Study||205
8762830|NCT01231620|9812722|FG000|COMPLETED|Overall Study||175
8762831|NCT01231620|9812723|FG001|COMPLETED|Overall Study||178
8762832|NCT01231620|9812724|FG002|COMPLETED|Overall Study||166
8762833|NCT01231620|9812722|FG000|NOT COMPLETED|Overall Study||26
8762834|NCT01231620|9812723|FG001|NOT COMPLETED|Overall Study||31
8762835|NCT01231620|9812724|FG002|NOT COMPLETED|Overall Study||39
8762836|NCT01231633|9812734|FG000|STARTED|Overall Study||14
8762837|NCT01231633|9812735|FG001|STARTED|Overall Study||13
8762838|NCT01231633|9812734|FG000|COMPLETED|Overall Study||14
8762839|NCT01231633|9812735|FG001|COMPLETED|Overall Study||13
8762840|NCT01231633|9812734|FG000|NOT COMPLETED|Overall Study||0
8762841|NCT01231633|9812735|FG001|NOT COMPLETED|Overall Study||0
8762842|NCT01231646|9812745|FG000|STARTED|Overall Study||28
8762843|NCT01231646|9812746|FG001|STARTED|Overall Study||10
8762844|NCT01231646|9812745|FG000|COMPLETED|Overall Study||28
8762845|NCT01231646|9812746|FG001|COMPLETED|Overall Study||10
8762846|NCT01231646|9812745|FG000|NOT COMPLETED|Overall Study||0
8762847|NCT01231646|9812746|FG001|NOT COMPLETED|Overall Study||0
8762848|NCT01231659|9812752|FG000|STARTED|Overall Study||72
8762849|NCT01231659|9812752|FG000|Per Protocol (PP) Set|Overall Study||72
8762850|NCT01231659|9812752|FG000|Safety Set|Overall Study||72
8762851|NCT01231659|9812752|FG000|COMPLETED|Overall Study||0
9026331|NCT03175120|10088757|FG000|COMPLETED|Overall Study||290
9026332|NCT03175120|10088758|FG001|COMPLETED|Overall Study||139
9026333|NCT03175120|10088757|FG000|NOT COMPLETED|Overall Study||12
9026334|NCT03175120|10088758|FG001|NOT COMPLETED|Overall Study||12
9026335|NCT03175172|10088764|FG000|STARTED|Overall Study||10
9026336|NCT03175172|10088764|FG000|COMPLETED|Overall Study||0
9026337|NCT03175172|10088764|FG000|NOT COMPLETED|Overall Study||10
9026338|NCT03175562|10088768|FG000|STARTED|Overall Study||240
9026339|NCT03175562|10088768|FG000|Test Product|Overall Study||240
9026340|NCT03175562|10088768|FG000|Negative Control|Overall Study||240
9026341|NCT03175562|10088768|FG000|COMPLETED|Overall Study||224
9026342|NCT03175562|10088768|FG000|NOT COMPLETED|Overall Study||16
9026343|NCT03175731|10088777|FG000|STARTED|Overall Study||53
9026344|NCT03175731|10088778|FG001|STARTED|Overall Study||53
9026345|NCT03175731|10088777|FG000|COMPLETED|Overall Study||46
9026346|NCT03175731|10088778|FG001|COMPLETED|Overall Study||48
9026347|NCT03175731|10088777|FG000|NOT COMPLETED|Overall Study||7
9026348|NCT03175731|10088778|FG001|NOT COMPLETED|Overall Study||5
9026349|NCT03176238|10088786|FG000|STARTED|Overall Study||199
9026350|NCT03176238|10088787|FG001|STARTED|Overall Study||36
9026351|NCT03176238|10088786|FG000|COMPLETED|Overall Study||0
9026352|NCT03176238|10088787|FG001|COMPLETED|Overall Study||0
9026353|NCT03176238|10088786|FG000|NOT COMPLETED|Overall Study||199
9026354|NCT03176238|10088787|FG001|NOT COMPLETED|Overall Study||36
9026355|NCT03176407|10088797|FG000|STARTED|Overall Study||30
9026356|NCT03176407|10088797|FG000|COMPLETED|Overall Study||27
9026357|NCT03176407|10088797|FG000|NOT COMPLETED|Overall Study||3
9026358|NCT03176459|10088805|FG000|STARTED|Overall Study||96
9026359|NCT03176459|10088806|FG001|STARTED|Overall Study||90
9026360|NCT03176459|10088805|FG000|COMPLETED|Overall Study||91
9026361|NCT03176459|10088806|FG001|COMPLETED|Overall Study||83
9026362|NCT03176459|10088805|FG000|NOT COMPLETED|Overall Study||5
9026363|NCT03176459|10088806|FG001|NOT COMPLETED|Overall Study||7
9026364|NCT03176654|10088814|FG000|STARTED|Overall Study||13
9026365|NCT03176654|10088815|FG001|STARTED|Overall Study||15
9026366|NCT03176654|10088814|FG000|COMPLETED|Overall Study||13
9026367|NCT03176654|10088815|FG001|COMPLETED|Overall Study||15
9026368|NCT03176654|10088814|FG000|NOT COMPLETED|Overall Study||0
9026369|NCT03176654|10088815|FG001|NOT COMPLETED|Overall Study||0
9026370|NCT03176784|10088825|FG000|STARTED|Overall Study||314
9026371|NCT03176784|10088826|FG001|STARTED|Overall Study||315
9026372|NCT03176784|10088827|FG002|STARTED|Overall Study||311
9026373|NCT03176784|10088828|FG003|STARTED|Overall Study||311
9026374|NCT03176784|10088825|FG000|COMPLETED|Overall Study||209
9026375|NCT03176784|10088826|FG001|COMPLETED|Overall Study||202
9026376|NCT03176784|10088827|FG002|COMPLETED|Overall Study||198
9026377|NCT03176784|10088828|FG003|COMPLETED|Overall Study||241
9026378|NCT03176784|10088825|FG000|NOT COMPLETED|Overall Study||105
9026379|NCT03176784|10088826|FG001|NOT COMPLETED|Overall Study||113
9026380|NCT03176784|10088827|FG002|NOT COMPLETED|Overall Study||113
9026381|NCT03176784|10088828|FG003|NOT COMPLETED|Overall Study||70
9026382|NCT03177395|10088842|FG000|STARTED|Overall Study||6
9026383|NCT03177395|10088843|FG001|STARTED|Overall Study||6
9026384|NCT03177395|10088844|FG002|STARTED|Overall Study||6
9026385|NCT03177395|10088845|FG003|STARTED|Overall Study||6
9026386|NCT03177395|10088842|FG000|COMPLETED|Overall Study||6
9026387|NCT03177395|10088843|FG001|COMPLETED|Overall Study||6
9026388|NCT03177395|10088844|FG002|COMPLETED|Overall Study||6
9026389|NCT03177395|10088845|FG003|COMPLETED|Overall Study||6
9026390|NCT03177395|10088842|FG000|NOT COMPLETED|Overall Study||0
9026391|NCT03177395|10088843|FG001|NOT COMPLETED|Overall Study||0
9026392|NCT03177395|10088844|FG002|NOT COMPLETED|Overall Study||0
9026393|NCT03177395|10088845|FG003|NOT COMPLETED|Overall Study||0
8762852|NCT01231659|9812752|FG000|NOT COMPLETED|Overall Study||72
8762853|NCT01231841|9812756|FG000|STARTED|Overall Study||20
8762854|NCT01231841|9812756|FG000|COMPLETED|Overall Study||20
8762855|NCT01231841|9812756|FG000|NOT COMPLETED|Overall Study||0
8762856|NCT01231984|9812762|FG000|STARTED|Study Period 1||69
8762857|NCT01231984|9812763|FG001|STARTED|Study Period 1||70
8762858|NCT01231984|9812764|FG002|STARTED|Study Period 1||66
8762859|NCT01231984|9812765|FG003|STARTED|Study Period 1||69
8762860|NCT01231984|9812762|FG000|COMPLETED|Study Period 1||57
8762861|NCT01231984|9812763|FG001|COMPLETED|Study Period 1||63
8762862|NCT01231984|9812764|FG002|COMPLETED|Study Period 1||59
8762863|NCT01231984|9812765|FG003|COMPLETED|Study Period 1||60
9026394|NCT03177512|10088859|FG000|STARTED|Overall Study||40
9026395|NCT03177512|10088860|FG001|STARTED|Overall Study||21
9026396|NCT03177512|10088859|FG000|COMPLETED|Overall Study||31
9026397|NCT03177512|10088860|FG001|COMPLETED|Overall Study||18
9026398|NCT03177512|10088859|FG000|NOT COMPLETED|Overall Study||9
9026399|NCT03177512|10088860|FG001|NOT COMPLETED|Overall Study||3
8762864|NCT01231984|9812762|FG000|NOT COMPLETED|Study Period 1||12
8762865|NCT01231984|9812763|FG001|NOT COMPLETED|Study Period 1||7
8762866|NCT01231984|9812764|FG002|NOT COMPLETED|Study Period 1||7
8762867|NCT01231984|9812765|FG003|NOT COMPLETED|Study Period 1||9
8762868|NCT01231984|9812762|FG000|STARTED|Study Period 2||57
8762869|NCT01231984|9812763|FG001|STARTED|Study Period 2||63
8762870|NCT01231984|9812764|FG002|STARTED|Study Period 2||59
8762871|NCT01231984|9812765|FG003|STARTED|Study Period 2||60
8762872|NCT01231984|9812762|FG000|COMPLETED|Study Period 2||54
8762873|NCT01231984|9812763|FG001|COMPLETED|Study Period 2||61
8762874|NCT01231984|9812764|FG002|COMPLETED|Study Period 2||59
8762875|NCT01231984|9812765|FG003|COMPLETED|Study Period 2||56
8762876|NCT01231984|9812762|FG000|NOT COMPLETED|Study Period 2||3
8762877|NCT01231984|9812763|FG001|NOT COMPLETED|Study Period 2||2
8762878|NCT01231984|9812764|FG002|NOT COMPLETED|Study Period 2||0
8762879|NCT01231984|9812765|FG003|NOT COMPLETED|Study Period 2||4
8762880|NCT01232127|9812783|FG000|STARTED|Period 1: Days 1-10|Participants who received treatment.|25
8762881|NCT01232127|9812784|FG001|STARTED|Period 1: Days 1-10||0
8762882|NCT01232127|9812785|FG002|STARTED|Period 1: Days 1-10||0
8762883|NCT01232127|9812783|FG000|COMPLETED|Period 1: Days 1-10||24
8762884|NCT01232127|9812784|FG001|COMPLETED|Period 1: Days 1-10||0
8762885|NCT01232127|9812785|FG002|COMPLETED|Period 1: Days 1-10||0
8762886|NCT01232127|9812783|FG000|NOT COMPLETED|Period 1: Days 1-10||1
8762887|NCT01232127|9812784|FG001|NOT COMPLETED|Period 1: Days 1-10||0
8762888|NCT01232127|9812785|FG002|NOT COMPLETED|Period 1: Days 1-10||0
8762889|NCT01232127|9812783|FG000|STARTED|Period 2: Days 11-17||0
8762890|NCT01232127|9812784|FG001|STARTED|Period 2: Days 11-17|Participants who received treatment.|24
8762891|NCT01232127|9812785|FG002|STARTED|Period 2: Days 11-17||0
8762892|NCT01232127|9812783|FG000|COMPLETED|Period 2: Days 11-17||0
8762893|NCT01232127|9812784|FG001|COMPLETED|Period 2: Days 11-17||24
8762894|NCT01232127|9812785|FG002|COMPLETED|Period 2: Days 11-17||0
8762895|NCT01232127|9812783|FG000|NOT COMPLETED|Period 2: Days 11-17||0
9026400|NCT03177603|10088870|FG000|STARTED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||4
9026401|NCT03177603|10088871|FG001|STARTED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
9026402|NCT03177603|10088872|FG002|STARTED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
9026403|NCT03177603|10088873|FG003|STARTED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
9026404|NCT03177603|10088870|FG000|COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||4
9026405|NCT03177603|10088871|FG001|COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
9026406|NCT03177603|10088872|FG002|COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
9026407|NCT03177603|10088873|FG003|COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
9026408|NCT03177603|10088870|FG000|NOT COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
9026409|NCT03177603|10088871|FG001|NOT COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
9026410|NCT03177603|10088872|FG002|NOT COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
9026411|NCT03177603|10088873|FG003|NOT COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
9026412|NCT03177603|10088870|FG000|STARTED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
9026413|NCT03177603|10088871|FG001|STARTED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||5
9026414|NCT03177603|10088872|FG002|STARTED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
9026415|NCT03177603|10088873|FG003|STARTED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
9026416|NCT03177603|10088870|FG000|COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
9026417|NCT03177603|10088871|FG001|COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||5
9026418|NCT03177603|10088872|FG002|COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
9026419|NCT03177603|10088873|FG003|COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
9026420|NCT03177603|10088870|FG000|NOT COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
9026421|NCT03177603|10088871|FG001|NOT COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
9026422|NCT03177603|10088872|FG002|NOT COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
9026423|NCT03177603|10088873|FG003|NOT COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
8762896|NCT01232127|9812784|FG001|NOT COMPLETED|Period 2: Days 11-17||0
8762897|NCT01232127|9812785|FG002|NOT COMPLETED|Period 2: Days 11-17||0
8762898|NCT01232127|9812783|FG000|STARTED|Period 3: Days 18-24||0
8762899|NCT01232127|9812784|FG001|STARTED|Period 3: Days 18-24||0
8762900|NCT01232127|9812785|FG002|STARTED|Period 3: Days 18-24|Participants who received treatment.|24
8762901|NCT01232127|9812783|FG000|COMPLETED|Period 3: Days 18-24||0
8762902|NCT01232127|9812784|FG001|COMPLETED|Period 3: Days 18-24||0
8762903|NCT01232127|9812785|FG002|COMPLETED|Period 3: Days 18-24||24
8762904|NCT01232127|9812783|FG000|NOT COMPLETED|Period 3: Days 18-24||0
8762905|NCT01232127|9812784|FG001|NOT COMPLETED|Period 3: Days 18-24||0
8762906|NCT01232127|9812785|FG002|NOT COMPLETED|Period 3: Days 18-24||0
8762907|NCT01232205|9812799|FG000|STARTED|Overall Study||52
8762908|NCT01232205|9812800|FG001|STARTED|Overall Study||58
8762909|NCT01232205|9812799|FG000|COMPLETED|Overall Study||49
8762910|NCT01232205|9812800|FG001|COMPLETED|Overall Study||55
8762911|NCT01232205|9812799|FG000|NOT COMPLETED|Overall Study||3
8762912|NCT01232205|9812800|FG001|NOT COMPLETED|Overall Study||3
8762913|NCT01232296|9812808|FG000|STARTED|Overall Study||82
8762914|NCT01232296|9812809|FG001|STARTED|Overall Study||83
8762915|NCT01232296|9812808|FG000|Full Analysis Set|Overall Study||82
8762916|NCT01232296|9812809|FG001|Full Analysis Set|Overall Study||83
8762917|NCT01232296|9812808|FG000|Safety Set|Overall Study|The Safety Set includes all patients who received at least one dose of study medication|79
8762918|NCT01232296|9812809|FG001|Safety Set|Overall Study||83
8762919|NCT01232296|9812808|FG000|COMPLETED|Overall Study||0
8762920|NCT01232296|9812809|FG001|COMPLETED|Overall Study||0
8762921|NCT01232296|9812808|FG000|NOT COMPLETED|Overall Study||82
8762922|NCT01232296|9812809|FG001|NOT COMPLETED|Overall Study||83
8762923|NCT01232452|9812817|FG000|STARTED|Overall Study||87
8762924|NCT01232452|9812818|FG001|STARTED|Overall Study||85
8762925|NCT01232452|9812817|FG000|Received at Least One Dose of Study Drug|Overall Study||85
8762926|NCT01232452|9812818|FG001|Received at Least One Dose of Study Drug|Overall Study||81
8762927|NCT01232452|9812817|FG000|COMPLETED|Overall Study||48
8762928|NCT01232452|9812818|FG001|COMPLETED|Overall Study||46
8762929|NCT01232452|9812817|FG000|NOT COMPLETED|Overall Study||39
8762930|NCT01232452|9812818|FG001|NOT COMPLETED|Overall Study||39
8762931|NCT01232465|9812826|FG000|STARTED|Overall Study||337
8762932|NCT01232465|9812827|FG001|STARTED|Overall Study||402
8762933|NCT01232465|9812826|FG000|COMPLETED|Overall Study||337
8762934|NCT01232465|9812827|FG001|COMPLETED|Overall Study||402
8762935|NCT01232465|9812826|FG000|NOT COMPLETED|Overall Study||0
8762936|NCT01232465|9812827|FG001|NOT COMPLETED|Overall Study||0
8762937|NCT01232491|9812835|FG000|STARTED|Overall Study||306
8762938|NCT01232491|9812836|FG001|STARTED|Overall Study||305
8762939|NCT01232491|9812835|FG000|Exposed (Safety Analysis Set)|Overall Study|One subject withdrew prior to exposure to trial drug.|305
8762940|NCT01232491|9812836|FG001|Exposed (Safety Analysis Set)|Overall Study|Four subjects withdrew prior to exposure to trial drug.|301
8762941|NCT01232491|9812835|FG000|COMPLETED|Overall Study||246
8762942|NCT01232491|9812836|FG001|COMPLETED|Overall Study||242
8762943|NCT01232491|9812835|FG000|NOT COMPLETED|Overall Study||60
8762944|NCT01232491|9812836|FG001|NOT COMPLETED|Overall Study||63
8762945|NCT01232504|9812845|FG000|STARTED|Overall Study||68
8762946|NCT01232504|9812846|FG001|STARTED|Overall Study||69
8762947|NCT01232504|9812847|FG002|STARTED|Overall Study||69
8762948|NCT01232504|9812845|FG000|COMPLETED|Overall Study||59
8762949|NCT01232504|9812846|FG001|COMPLETED|Overall Study||67
8762950|NCT01232504|9812847|FG002|COMPLETED|Overall Study||61
8762951|NCT01232504|9812845|FG000|NOT COMPLETED|Overall Study||9
8762952|NCT01232504|9812846|FG001|NOT COMPLETED|Overall Study||2
8762953|NCT01232504|9812847|FG002|NOT COMPLETED|Overall Study||8
8762954|NCT01232556|9812865|FG000|STARTED|Overall Study||166
8762955|NCT01232556|9812866|FG001|STARTED|Overall Study||172
8762956|NCT01232556|9812865|FG000|Treated|Overall Study|One subject in this arm received rituximab only and was excluded from the safety population.|165
8762957|NCT01232556|9812866|FG001|Treated|Overall Study||167
8762958|NCT01232556|9812865|FG000|COMPLETED|Overall Study||7
8762959|NCT01232556|9812866|FG001|COMPLETED|Overall Study||1
8762960|NCT01232556|9812865|FG000|NOT COMPLETED|Overall Study||159
8762961|NCT01232556|9812866|FG001|NOT COMPLETED|Overall Study||171
8762962|NCT01232569|9812874|FG000|STARTED|Double-blind Treatment Period||438
8762963|NCT01232569|9812875|FG001|STARTED|Double-blind Treatment Period||218
8762964|NCT01232569|9812876|FG002|STARTED|Double-blind Treatment Period|There were no participants in this reporting group in this period.|0
8762965|NCT01232569|9812877|FG003|STARTED|Double-blind Treatment Period|There were no participants in this reporting group in this period.|0
8762966|NCT01232569|9812874|FG000|COMPLETED|Double-blind Treatment Period||410
8762967|NCT01232569|9812875|FG001|COMPLETED|Double-blind Treatment Period||209
8762968|NCT01232569|9812876|FG002|COMPLETED|Double-blind Treatment Period||0
8762969|NCT01232569|9812877|FG003|COMPLETED|Double-blind Treatment Period||0
8762970|NCT01232569|9812874|FG000|NOT COMPLETED|Double-blind Treatment Period||28
8762971|NCT01232569|9812875|FG001|NOT COMPLETED|Double-blind Treatment Period||9
8762972|NCT01232569|9812876|FG002|NOT COMPLETED|Double-blind Treatment Period||0
8762973|NCT01232569|9812877|FG003|NOT COMPLETED|Double-blind Treatment Period||0
8762974|NCT01232569|9812874|FG000|STARTED|Open-label Extension Period|There were no participants in this reporting group in this period.|0
8762975|NCT01232569|9812875|FG001|STARTED|Open-label Extension Period|There were no participants in this reporting group in this period.|0
8762976|NCT01232569|9812876|FG002|STARTED|Open-label Extension Period|Some participants who completed the double-blind period did not enter the open-label period.|230
8762977|NCT01232569|9812877|FG003|STARTED|Open-label Extension Period|Some participants who completed the double-blind period did not enter the open-label period.|227
8762978|NCT01232569|9812874|FG000|COMPLETED|Open-label Extension Period||0
8762979|NCT01232569|9812875|FG001|COMPLETED|Open-label Extension Period||0
8762980|NCT01232569|9812876|FG002|COMPLETED|Open-label Extension Period||203
8762981|NCT01232569|9812877|FG003|COMPLETED|Open-label Extension Period||200
8762982|NCT01232569|9812874|FG000|NOT COMPLETED|Open-label Extension Period||0
8762983|NCT01232569|9812875|FG001|NOT COMPLETED|Open-label Extension Period||0
8762984|NCT01232569|9812876|FG002|NOT COMPLETED|Open-label Extension Period||27
8915493|NCT02175641|9974931|FG001|STARTED|Overall Study||157
8915494|NCT02175641|9974930|FG000|6-month Follow up|Overall Study||144
8915495|NCT02175641|9974931|FG001|6-month Follow up|Overall Study||149
8915496|NCT02175641|9974930|FG000|12-month Follow up|Overall Study||129
8915497|NCT02175641|9974931|FG001|12-month Follow up|Overall Study||136
8915498|NCT02175641|9974930|FG000|18-month Follow up|Overall Study||122
8915499|NCT02175641|9974931|FG001|18-month Follow up|Overall Study||130
8915500|NCT02175641|9974930|FG000|COMPLETED|Overall Study||122
8915501|NCT02175641|9974931|FG001|COMPLETED|Overall Study||130
8915502|NCT02175641|9974930|FG000|NOT COMPLETED|Overall Study||35
8915503|NCT02175641|9974931|FG001|NOT COMPLETED|Overall Study||27
8915504|NCT02175745|9974937|FG000|STARTED|Overall Study||2
8915505|NCT02175745|9974937|FG000|COMPLETED|Overall Study||1
8915506|NCT02175745|9974937|FG000|NOT COMPLETED|Overall Study||1
8915507|NCT02175758|9974947|FG000|STARTED|PK Lead-in Phase||4
8915508|NCT02175758|9974948|FG001|STARTED|PK Lead-in Phase||6
8915509|NCT02175758|9974949|FG002|STARTED|PK Lead-in Phase||2
8915510|NCT02175758|9974950|FG003|STARTED|PK Lead-in Phase||10
8915511|NCT02175758|9974951|FG004|STARTED|PK Lead-in Phase||4
8915512|NCT02175758|9974952|FG005|STARTED|PK Lead-in Phase||8
8915513|NCT02175758|9974947|FG000|COMPLETED|PK Lead-in Phase||4
8915514|NCT02175758|9974948|FG001|COMPLETED|PK Lead-in Phase||6
8915515|NCT02175758|9974949|FG002|COMPLETED|PK Lead-in Phase||2
8915516|NCT02175758|9974950|FG003|COMPLETED|PK Lead-in Phase||10
8915517|NCT02175758|9974951|FG004|COMPLETED|PK Lead-in Phase||4
8915518|NCT02175758|9974952|FG005|COMPLETED|PK Lead-in Phase||8
8915519|NCT02175758|9974947|FG000|NOT COMPLETED|PK Lead-in Phase||0
8915520|NCT02175758|9974948|FG001|NOT COMPLETED|PK Lead-in Phase||0
8915521|NCT02175758|9974949|FG002|NOT COMPLETED|PK Lead-in Phase||0
8915522|NCT02175758|9974950|FG003|NOT COMPLETED|PK Lead-in Phase||0
8915523|NCT02175758|9974951|FG004|NOT COMPLETED|PK Lead-in Phase||0
8915524|NCT02175758|9974952|FG005|NOT COMPLETED|PK Lead-in Phase||0
8915525|NCT02175758|9974947|FG000|STARTED|Treatment Phase|9 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|13
8915526|NCT02175758|9974948|FG001|STARTED|Treatment Phase|33 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|39
8915527|NCT02175758|9974949|FG002|STARTED|Treatment Phase|11 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|13
8915528|NCT02175758|9974950|FG003|STARTED|Treatment Phase|18 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|28
8915529|NCT02175758|9974951|FG004|STARTED|Treatment Phase|1 participant enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|5
8915530|NCT02175758|9974952|FG005|STARTED|Treatment Phase||8
8915531|NCT02175758|9974947|FG000|COMPLETED|Treatment Phase||13
8915532|NCT02175758|9974948|FG001|COMPLETED|Treatment Phase||38
8915533|NCT02175758|9974949|FG002|COMPLETED|Treatment Phase||13
8915534|NCT02175758|9974950|FG003|COMPLETED|Treatment Phase||28
8915535|NCT02175758|9974951|FG004|COMPLETED|Treatment Phase||4
8915536|NCT02175758|9974952|FG005|COMPLETED|Treatment Phase||8
8915537|NCT02175758|9974947|FG000|NOT COMPLETED|Treatment Phase||0
8915538|NCT02175758|9974948|FG001|NOT COMPLETED|Treatment Phase||1
8915539|NCT02175758|9974949|FG002|NOT COMPLETED|Treatment Phase||0
8915540|NCT02175758|9974950|FG003|NOT COMPLETED|Treatment Phase||0
8915541|NCT02175758|9974951|FG004|NOT COMPLETED|Treatment Phase||1
8915542|NCT02175758|9974952|FG005|NOT COMPLETED|Treatment Phase||0
8915543|NCT02175771|9975000|FG000|STARTED|Run-In Period (Pre-assignment)|Enrolled; two participants were enrolled but had no enrollment date in their records.|758
8915544|NCT02175771|9975001|FG001|STARTED|Run-In Period (Pre-assignment)||0
8915545|NCT02175771|9975002|FG002|STARTED|Run-In Period (Pre-assignment)||0
8915546|NCT02175771|9975003|FG003|STARTED|Run-In Period (Pre-assignment)||0
8915547|NCT02175771|9975004|FG004|STARTED|Run-In Period (Pre-assignment)||0
8915548|NCT02175771|9975005|FG005|STARTED|Run-In Period (Pre-assignment)||0
8915549|NCT02175771|9975006|FG006|STARTED|Run-In Period (Pre-assignment)||0
8915550|NCT02175771|9975007|FG007|STARTED|Run-In Period (Pre-assignment)||0
8915551|NCT02175771|9975008|FG008|STARTED|Run-In Period (Pre-assignment)||0
8915552|NCT02175771|9975000|FG000|COMPLETED|Run-In Period (Pre-assignment)||674
8915553|NCT02175771|9975001|FG001|COMPLETED|Run-In Period (Pre-assignment)||0
8915554|NCT02175771|9975002|FG002|COMPLETED|Run-In Period (Pre-assignment)||0
8915555|NCT02175771|9975003|FG003|COMPLETED|Run-In Period (Pre-assignment)||0
8915556|NCT02175771|9975004|FG004|COMPLETED|Run-In Period (Pre-assignment)||0
8915557|NCT02175771|9975005|FG005|COMPLETED|Run-In Period (Pre-assignment)||0
8915558|NCT02175771|9975006|FG006|COMPLETED|Run-In Period (Pre-assignment)||0
8915559|NCT02175771|9975007|FG007|COMPLETED|Run-In Period (Pre-assignment)||0
8915560|NCT02175771|9975008|FG008|COMPLETED|Run-In Period (Pre-assignment)||0
8915561|NCT02175771|9975000|FG000|NOT COMPLETED|Run-In Period (Pre-assignment)||84
8915562|NCT02175771|9975001|FG001|NOT COMPLETED|Run-In Period (Pre-assignment)||0
8915563|NCT02175771|9975002|FG002|NOT COMPLETED|Run-In Period (Pre-assignment)||0
8915564|NCT02175771|9975003|FG003|NOT COMPLETED|Run-In Period (Pre-assignment)||0
8915565|NCT02175771|9975004|FG004|NOT COMPLETED|Run-In Period (Pre-assignment)||0
8915566|NCT02175771|9975005|FG005|NOT COMPLETED|Run-In Period (Pre-assignment)||0
8915567|NCT02175771|9975006|FG006|NOT COMPLETED|Run-In Period (Pre-assignment)||0
8915568|NCT02175771|9975007|FG007|NOT COMPLETED|Run-In Period (Pre-assignment)||0
8915569|NCT02175771|9975008|FG008|NOT COMPLETED|Run-In Period (Pre-assignment)||0
8915570|NCT02175771|9975000|FG000|STARTED|Treatment Period||0
8915571|NCT02175771|9975001|FG001|STARTED|Treatment Period||127
8762985|NCT01232569|9812877|FG003|NOT COMPLETED|Open-label Extension Period||27
8762986|NCT01232738|9812886|FG000|STARTED|Overall Study||36
8762987|NCT01232738|9812886|FG000|COMPLETED|Overall Study||23
8762988|NCT01232738|9812886|FG000|NOT COMPLETED|Overall Study||13
8762989|NCT01232790|9812894|FG000|STARTED|Randomization||14
8762990|NCT01232790|9812895|FG001|STARTED|Randomization||14
8762991|NCT01232790|9812894|FG000|COMPLETED|Randomization||12
8762992|NCT01232790|9812895|FG001|COMPLETED|Randomization||12
8762993|NCT01232790|9812894|FG000|NOT COMPLETED|Randomization||2
8762994|NCT01232790|9812895|FG001|NOT COMPLETED|Randomization||2
8762995|NCT01232790|9812894|FG000|STARTED|Initial Assessment||12
8762996|NCT01232790|9812895|FG001|STARTED|Initial Assessment||12
8762997|NCT01232790|9812894|FG000|COMPLETED|Initial Assessment||12
8762998|NCT01232790|9812895|FG001|COMPLETED|Initial Assessment||11
8762999|NCT01232790|9812894|FG000|NOT COMPLETED|Initial Assessment||0
8763000|NCT01232790|9812895|FG001|NOT COMPLETED|Initial Assessment||1
8763001|NCT01232790|9812894|FG000|STARTED|First Crossover||12
8763002|NCT01232790|9812895|FG001|STARTED|First Crossover||11
8763003|NCT01232790|9812894|FG000|COMPLETED|First Crossover||11
8915572|NCT02175771|9975002|FG002|STARTED|Treatment Period||42
8915573|NCT02175771|9975003|FG003|STARTED|Treatment Period||126
8915574|NCT02175771|9975004|FG004|STARTED|Treatment Period||41
8915575|NCT02175771|9975005|FG005|STARTED|Treatment Period||120
8915576|NCT02175771|9975006|FG006|STARTED|Treatment Period||41
8915577|NCT02175771|9975007|FG007|STARTED|Treatment Period||133
8915578|NCT02175771|9975008|FG008|STARTED|Treatment Period||44
8915579|NCT02175771|9975000|FG000|COMPLETED|Treatment Period||0
8915580|NCT02175771|9975001|FG001|COMPLETED|Treatment Period||111
8915581|NCT02175771|9975002|FG002|COMPLETED|Treatment Period||35
8915582|NCT02175771|9975003|FG003|COMPLETED|Treatment Period||113
8915583|NCT02175771|9975004|FG004|COMPLETED|Treatment Period||36
8915584|NCT02175771|9975005|FG005|COMPLETED|Treatment Period||110
8915585|NCT02175771|9975006|FG006|COMPLETED|Treatment Period||36
8915586|NCT02175771|9975007|FG007|COMPLETED|Treatment Period||116
8915587|NCT02175771|9975008|FG008|COMPLETED|Treatment Period||38
8915588|NCT02175771|9975000|FG000|NOT COMPLETED|Treatment Period||0
8915589|NCT02175771|9975001|FG001|NOT COMPLETED|Treatment Period||16
8915590|NCT02175771|9975002|FG002|NOT COMPLETED|Treatment Period||7
8915591|NCT02175771|9975003|FG003|NOT COMPLETED|Treatment Period||13
8915592|NCT02175771|9975004|FG004|NOT COMPLETED|Treatment Period||5
8915593|NCT02175771|9975005|FG005|NOT COMPLETED|Treatment Period||10
8915594|NCT02175771|9975006|FG006|NOT COMPLETED|Treatment Period||5
8915595|NCT02175771|9975007|FG007|NOT COMPLETED|Treatment Period||17
8915596|NCT02175771|9975008|FG008|NOT COMPLETED|Treatment Period||6
8915597|NCT02175966|9975028|FG000|STARTED|Treatment Period||14
8915598|NCT02175966|9975029|FG001|STARTED|Treatment Period||14
8915599|NCT02175966|9975028|FG000|COMPLETED|Treatment Period||14
8915600|NCT02175966|9975029|FG001|COMPLETED|Treatment Period||14
8915601|NCT02175966|9975028|FG000|NOT COMPLETED|Treatment Period||0
8915602|NCT02175966|9975029|FG001|NOT COMPLETED|Treatment Period||0
8915603|NCT02175966|9975028|FG000|STARTED|Follow-up Period||14
8915604|NCT02175966|9975029|FG001|STARTED|Follow-up Period||14
8915605|NCT02175966|9975028|FG000|COMPLETED|Follow-up Period||4
8915606|NCT02175966|9975029|FG001|COMPLETED|Follow-up Period||8
8915607|NCT02175966|9975028|FG000|NOT COMPLETED|Follow-up Period||10
8915608|NCT02175966|9975029|FG001|NOT COMPLETED|Follow-up Period||6
8915609|NCT02175979|9975037|FG000|STARTED|Overall Study||140
8915610|NCT02175979|9975038|FG001|STARTED|Overall Study||140
8915611|NCT02175979|9975037|FG000|COMPLETED|Overall Study||133
8915612|NCT02175979|9975038|FG001|COMPLETED|Overall Study||132
8915613|NCT02175979|9975037|FG000|NOT COMPLETED|Overall Study||7
8915614|NCT02175979|9975038|FG001|NOT COMPLETED|Overall Study||8
8915615|NCT02176005|9975048|FG000|STARTED|Overall Study||14
8915616|NCT02176005|9975049|FG001|STARTED|Overall Study||14
8915617|NCT02176005|9975050|FG002|STARTED|Overall Study||8
8915618|NCT02176005|9975051|FG003|STARTED|Overall Study||8
8915619|NCT02176005|9975048|FG000|COMPLETED|Overall Study||14
8915620|NCT02176005|9975049|FG001|COMPLETED|Overall Study||14
8915621|NCT02176005|9975050|FG002|COMPLETED|Overall Study||8
8915622|NCT02176005|9975051|FG003|COMPLETED|Overall Study||8
8915623|NCT02176005|9975048|FG000|NOT COMPLETED|Overall Study||0
8915624|NCT02176005|9975049|FG001|NOT COMPLETED|Overall Study||0
8915625|NCT02176005|9975050|FG002|NOT COMPLETED|Overall Study||0
8915626|NCT02176005|9975051|FG003|NOT COMPLETED|Overall Study||0
8915627|NCT02176018|9975063|FG000|STARTED|Overall Study||22
8915628|NCT02176018|9975064|FG001|STARTED|Overall Study||23
8915629|NCT02176018|9975063|FG000|COMPLETED|Overall Study||17
8915630|NCT02176018|9975064|FG001|COMPLETED|Overall Study||17
8915631|NCT02176018|9975063|FG000|NOT COMPLETED|Overall Study||5
8763004|NCT01232790|9812895|FG001|COMPLETED|First Crossover||11
8763005|NCT01232790|9812894|FG000|NOT COMPLETED|First Crossover||1
8763006|NCT01232790|9812895|FG001|NOT COMPLETED|First Crossover||0
8763007|NCT01232790|9812894|FG000|STARTED|Second Crossover||11
8763008|NCT01232790|9812895|FG001|STARTED|Second Crossover||11
8915632|NCT02176018|9975064|FG001|NOT COMPLETED|Overall Study||6
8915633|NCT02176031|9975070|FG000|STARTED|Overall Study||21
8915634|NCT02176031|9975070|FG000|COMPLETED|Overall Study||9
8915635|NCT02176031|9975070|FG000|NOT COMPLETED|Overall Study||12
8915636|NCT02176083|9975077|FG000|STARTED|Overall Study||11
8915637|NCT02176083|9975078|FG001|STARTED|Overall Study||27
8915638|NCT02176083|9975077|FG000|COMPLETED|Overall Study||11
8915639|NCT02176083|9975078|FG001|COMPLETED|Overall Study||27
8763009|NCT01232790|9812894|FG000|COMPLETED|Second Crossover||10
8763010|NCT01232790|9812895|FG001|COMPLETED|Second Crossover||9
8763011|NCT01232790|9812894|FG000|NOT COMPLETED|Second Crossover||1
8763012|NCT01232790|9812895|FG001|NOT COMPLETED|Second Crossover||2
8763013|NCT01232829|9812911|FG000|STARTED|Overall Study||18
8763014|NCT01232829|9812911|FG000|COMPLETED|Overall Study||18
8763015|NCT01232829|9812911|FG000|NOT COMPLETED|Overall Study||0
8763016|NCT01232868|9812917|FG000|STARTED|Overall Study||22
8763017|NCT01232868|9812918|FG001|STARTED|Overall Study||44
8763018|NCT01232868|9812917|FG000|COMPLETED|Overall Study||20
8763019|NCT01232868|9812918|FG001|COMPLETED|Overall Study||40
8763020|NCT01232868|9812917|FG000|NOT COMPLETED|Overall Study||2
8763021|NCT01232868|9812918|FG001|NOT COMPLETED|Overall Study||4
8763022|NCT01232894|9812926|FG000|STARTED|Overall Study||60
8763023|NCT01232894|9812927|FG001|STARTED|Overall Study||30
8763024|NCT01232894|9812926|FG000|Received Study Drug|Overall Study||59
8763025|NCT01232894|9812927|FG001|Received Study Drug|Overall Study||28
8763026|NCT01232894|9812926|FG000|COMPLETED|Overall Study||48
8763027|NCT01232894|9812927|FG001|COMPLETED|Overall Study||22
8763028|NCT01232894|9812926|FG000|NOT COMPLETED|Overall Study||12
8763029|NCT01232894|9812927|FG001|NOT COMPLETED|Overall Study||8
8763030|NCT01232920|9812935|FG000|STARTED|Overall Study||41
8763031|NCT01232920|9812936|FG001|STARTED|Overall Study||39
8763032|NCT01232920|9812935|FG000|COMPLETED|Overall Study||35
8763033|NCT01232920|9812936|FG001|COMPLETED|Overall Study||32
8763034|NCT01232920|9812935|FG000|NOT COMPLETED|Overall Study||6
8763035|NCT01232920|9812936|FG001|NOT COMPLETED|Overall Study||7
8763036|NCT01232946|9812945|FG000|STARTED|Overall Study||9
8763037|NCT01232946|9812946|FG001|STARTED|Overall Study||10
8763038|NCT01232946|9812947|FG002|STARTED|Overall Study||11
8763039|NCT01232946|9812945|FG000|COMPLETED|Overall Study||9
8763040|NCT01232946|9812946|FG001|COMPLETED|Overall Study|1 participant died unrelated to study|9
8763041|NCT01232946|9812947|FG002|COMPLETED|Overall Study|2 withdrew after baseline measurements|9
8763042|NCT01232946|9812945|FG000|NOT COMPLETED|Overall Study||0
8763043|NCT01232946|9812946|FG001|NOT COMPLETED|Overall Study||1
8763044|NCT01232946|9812947|FG002|NOT COMPLETED|Overall Study||2
8763045|NCT01233050|9812957|FG000|STARTED|Overall Study||400
8763046|NCT01233050|9812958|FG001|STARTED|Overall Study||402
8763047|NCT01233050|9812957|FG000|COMPLETED|Overall Study|8 participants were excluded after treatment administered due to inclusion/exclusion criteria|392
9026424|NCT03177603|10088870|FG000|STARTED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
9026425|NCT03177603|10088871|FG001|STARTED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
9026426|NCT03177603|10088872|FG002|STARTED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||6
9026427|NCT03177603|10088873|FG003|STARTED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
9026428|NCT03177603|10088870|FG000|COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
9026429|NCT03177603|10088871|FG001|COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
9026430|NCT03177603|10088872|FG002|COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||6
9026431|NCT03177603|10088873|FG003|COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
9026432|NCT03177603|10088870|FG000|NOT COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
9026433|NCT03177603|10088871|FG001|NOT COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
9026434|NCT03177603|10088872|FG002|NOT COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
9026435|NCT03177603|10088873|FG003|NOT COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
9026436|NCT03177603|10088870|FG000|STARTED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
9026437|NCT03177603|10088871|FG001|STARTED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
9026438|NCT03177603|10088872|FG002|STARTED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
9026439|NCT03177603|10088873|FG003|STARTED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||8
9026440|NCT03177603|10088870|FG000|COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
9026441|NCT03177603|10088871|FG001|COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
9026442|NCT03177603|10088872|FG002|COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
9026443|NCT03177603|10088873|FG003|COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||8
9026444|NCT03177603|10088870|FG000|NOT COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
9026445|NCT03177603|10088871|FG001|NOT COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
9026446|NCT03177603|10088872|FG002|NOT COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
8763048|NCT01233050|9812958|FG001|COMPLETED|Overall Study|6 participants were excluded after treatment administered due to inclusion/exclusion criteria|396
8763049|NCT01233050|9812957|FG000|NOT COMPLETED|Overall Study||8
8763050|NCT01233050|9812958|FG001|NOT COMPLETED|Overall Study||6
8763051|NCT01233076|9812964|FG000|STARTED|Period 1, One Week||30
8763052|NCT01233076|9812965|FG001|STARTED|Period 1, One Week||30
8763053|NCT01233076|9812964|FG000|COMPLETED|Period 1, One Week||30
8763054|NCT01233076|9812965|FG001|COMPLETED|Period 1, One Week||30
8763055|NCT01233076|9812964|FG000|NOT COMPLETED|Period 1, One Week||0
8763056|NCT01233076|9812965|FG001|NOT COMPLETED|Period 1, One Week||0
8763057|NCT01233076|9812964|FG000|STARTED|Period 2, One Week||30
8763058|NCT01233076|9812965|FG001|STARTED|Period 2, One Week||30
8763059|NCT01233076|9812964|FG000|COMPLETED|Period 2, One Week||29
8763060|NCT01233076|9812965|FG001|COMPLETED|Period 2, One Week||30
8763061|NCT01233076|9812964|FG000|NOT COMPLETED|Period 2, One Week||1
8763062|NCT01233076|9812965|FG001|NOT COMPLETED|Period 2, One Week||0
8763063|NCT01233232|9812974|FG000|STARTED|Overall Study||29
8763064|NCT01233232|9812975|FG001|STARTED|Overall Study||30
8763065|NCT01233232|9812976|FG002|STARTED|Overall Study||28
8763066|NCT01233232|9812974|FG000|COMPLETED|Overall Study||28
8763067|NCT01233232|9812975|FG001|COMPLETED|Overall Study||30
8763068|NCT01233232|9812976|FG002|COMPLETED|Overall Study||28
8763069|NCT01233232|9812974|FG000|NOT COMPLETED|Overall Study||1
8763070|NCT01233232|9812975|FG001|NOT COMPLETED|Overall Study||0
8763071|NCT01233232|9812976|FG002|NOT COMPLETED|Overall Study||0
8763072|NCT01233258|9812989|FG000|STARTED|First Intervention (6 Months)||11
8763073|NCT01233258|9812990|FG001|STARTED|First Intervention (6 Months)||10
8763074|NCT01233258|9812991|FG002|STARTED|First Intervention (6 Months)||14
8763075|NCT01233258|9812992|FG003|STARTED|First Intervention (6 Months)||16
8763076|NCT01233258|9812993|FG004|STARTED|First Intervention (6 Months)||16
8763077|NCT01233258|9812994|FG005|STARTED|First Intervention (6 Months)||16
8763078|NCT01233258|9812989|FG000|Participants Received Treatment|First Intervention (6 Months)||11
8763079|NCT01233258|9812990|FG001|Participants Received Treatment|First Intervention (6 Months)||10
8763080|NCT01233258|9812991|FG002|Participants Received Treatment|First Intervention (6 Months)||13
8763081|NCT01233258|9812992|FG003|Participants Received Treatment|First Intervention (6 Months)||15
8763082|NCT01233258|9812993|FG004|Participants Received Treatment|First Intervention (6 Months)||16
8763083|NCT01233258|9812994|FG005|Participants Received Treatment|First Intervention (6 Months)||15
8763084|NCT01233258|9812989|FG000|COMPLETED|First Intervention (6 Months)||10
8763085|NCT01233258|9812990|FG001|COMPLETED|First Intervention (6 Months)||10
8763086|NCT01233258|9812991|FG002|COMPLETED|First Intervention (6 Months)||13
8763087|NCT01233258|9812992|FG003|COMPLETED|First Intervention (6 Months)||15
8763088|NCT01233258|9812993|FG004|COMPLETED|First Intervention (6 Months)||16
8763089|NCT01233258|9812994|FG005|COMPLETED|First Intervention (6 Months)||15
8763090|NCT01233258|9812989|FG000|NOT COMPLETED|First Intervention (6 Months)||1
8763091|NCT01233258|9812990|FG001|NOT COMPLETED|First Intervention (6 Months)||0
8763092|NCT01233258|9812991|FG002|NOT COMPLETED|First Intervention (6 Months)||1
8763093|NCT01233258|9812992|FG003|NOT COMPLETED|First Intervention (6 Months)||1
8763094|NCT01233258|9812993|FG004|NOT COMPLETED|First Intervention (6 Months)||0
8763095|NCT01233258|9812994|FG005|NOT COMPLETED|First Intervention (6 Months)||1
8763096|NCT01233258|9812989|FG000|STARTED|Washout (2-3 Days)||10
8763097|NCT01233258|9812990|FG001|STARTED|Washout (2-3 Days)||10
8763098|NCT01233258|9812991|FG002|STARTED|Washout (2-3 Days)||13
8763099|NCT01233258|9812992|FG003|STARTED|Washout (2-3 Days)||15
8763100|NCT01233258|9812993|FG004|STARTED|Washout (2-3 Days)||16
8763101|NCT01233258|9812994|FG005|STARTED|Washout (2-3 Days)||15
8763102|NCT01233258|9812989|FG000|COMPLETED|Washout (2-3 Days)||10
8763103|NCT01233258|9812990|FG001|COMPLETED|Washout (2-3 Days)||10
8763104|NCT01233258|9812991|FG002|COMPLETED|Washout (2-3 Days)||13
8763105|NCT01233258|9812992|FG003|COMPLETED|Washout (2-3 Days)||15
8763106|NCT01233258|9812993|FG004|COMPLETED|Washout (2-3 Days)||16
8763107|NCT01233258|9812994|FG005|COMPLETED|Washout (2-3 Days)||15
8763108|NCT01233258|9812989|FG000|NOT COMPLETED|Washout (2-3 Days)||0
8763109|NCT01233258|9812990|FG001|NOT COMPLETED|Washout (2-3 Days)||0
8763110|NCT01233258|9812991|FG002|NOT COMPLETED|Washout (2-3 Days)||0
8763111|NCT01233258|9812992|FG003|NOT COMPLETED|Washout (2-3 Days)||0
8763112|NCT01233258|9812993|FG004|NOT COMPLETED|Washout (2-3 Days)||0
8763113|NCT01233258|9812994|FG005|NOT COMPLETED|Washout (2-3 Days)||0
8763114|NCT01233258|9812989|FG000|STARTED|Second Intervention (6 Months)||10
9026447|NCT03177603|10088873|FG003|NOT COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
9026448|NCT03177798|10088885|FG000|STARTED|Overall Study||5
9026449|NCT03177798|10088886|FG001|STARTED|Overall Study||6
9026450|NCT03177798|10088885|FG000|Intervention 1|Overall Study||5
9026451|NCT03177798|10088886|FG001|Intervention 1|Overall Study||6
9026452|NCT03177798|10088885|FG000|Washout|Overall Study||5
9026453|NCT03177798|10088886|FG001|Washout|Overall Study||6
9026454|NCT03177798|10088885|FG000|Intervention 2|Overall Study||5
9026455|NCT03177798|10088886|FG001|Intervention 2|Overall Study||6
9026456|NCT03177798|10088885|FG000|COMPLETED|Overall Study||5
9026457|NCT03177798|10088886|FG001|COMPLETED|Overall Study||6
9026458|NCT03177798|10088885|FG000|NOT COMPLETED|Overall Study||0
9026459|NCT03177798|10088886|FG001|NOT COMPLETED|Overall Study||0
9026460|NCT03178266|10088896|FG000|STARTED|Overall Study||21
9026461|NCT03178266|10088897|FG001|STARTED|Overall Study||20
9026462|NCT03178266|10088896|FG000|COMPLETED|Overall Study||21
9026463|NCT03178266|10088897|FG001|COMPLETED|Overall Study||16
9026464|NCT03178266|10088896|FG000|NOT COMPLETED|Overall Study||0
9026465|NCT03178266|10088897|FG001|NOT COMPLETED|Overall Study||4
9026466|NCT03178344|10088903|FG000|STARTED|First Session||10
9026467|NCT03178344|10088904|FG001|STARTED|First Session||10
9026468|NCT03178344|10088903|FG000|COMPLETED|First Session||10
9026469|NCT03178344|10088904|FG001|COMPLETED|First Session||10
9026470|NCT03178344|10088903|FG000|NOT COMPLETED|First Session||0
9026471|NCT03178344|10088904|FG001|NOT COMPLETED|First Session||0
9026472|NCT03178344|10088903|FG000|STARTED|Washout Period (5-9 Days)||10
9026473|NCT03178344|10088904|FG001|STARTED|Washout Period (5-9 Days)||10
9026474|NCT03178344|10088903|FG000|COMPLETED|Washout Period (5-9 Days)||10
9026475|NCT03178344|10088904|FG001|COMPLETED|Washout Period (5-9 Days)||10
9026476|NCT03178344|10088903|FG000|NOT COMPLETED|Washout Period (5-9 Days)||0
9026477|NCT03178344|10088904|FG001|NOT COMPLETED|Washout Period (5-9 Days)||0
9026478|NCT03178344|10088903|FG000|STARTED|Second Session||10
9026479|NCT03178344|10088904|FG001|STARTED|Second Session||10
9026480|NCT03178344|10088903|FG000|COMPLETED|Second Session||10
9026481|NCT03178344|10088904|FG001|COMPLETED|Second Session||10
9026482|NCT03178344|10088903|FG000|NOT COMPLETED|Second Session||0
9026483|NCT03178344|10088904|FG001|NOT COMPLETED|Second Session||0
8763115|NCT01233258|9812990|FG001|STARTED|Second Intervention (6 Months)||10
8763116|NCT01233258|9812991|FG002|STARTED|Second Intervention (6 Months)||13
8763117|NCT01233258|9812992|FG003|STARTED|Second Intervention (6 Months)||15
8763118|NCT01233258|9812993|FG004|STARTED|Second Intervention (6 Months)||16
8763119|NCT01233258|9812994|FG005|STARTED|Second Intervention (6 Months)||15
8763120|NCT01233258|9812989|FG000|COMPLETED|Second Intervention (6 Months)||10
8763121|NCT01233258|9812990|FG001|COMPLETED|Second Intervention (6 Months)||10
8763122|NCT01233258|9812991|FG002|COMPLETED|Second Intervention (6 Months)||13
8763123|NCT01233258|9812992|FG003|COMPLETED|Second Intervention (6 Months)||15
8763124|NCT01233258|9812993|FG004|COMPLETED|Second Intervention (6 Months)||16
8763125|NCT01233258|9812994|FG005|COMPLETED|Second Intervention (6 Months)||15
8763126|NCT01233258|9812989|FG000|NOT COMPLETED|Second Intervention (6 Months)||0
8763127|NCT01233258|9812990|FG001|NOT COMPLETED|Second Intervention (6 Months)||0
8763128|NCT01233258|9812991|FG002|NOT COMPLETED|Second Intervention (6 Months)||0
8763129|NCT01233258|9812992|FG003|NOT COMPLETED|Second Intervention (6 Months)||0
8763130|NCT01233258|9812993|FG004|NOT COMPLETED|Second Intervention (6 Months)||0
8763131|NCT01233258|9812994|FG005|NOT COMPLETED|Second Intervention (6 Months)||0
8763132|NCT01233284|9813009|FG000|STARTED|Period 1 (4 Weeks)||37
8763133|NCT01233284|9813010|FG001|STARTED|Period 1 (4 Weeks)||38
8763134|NCT01233284|9813011|FG002|STARTED|Period 1 (4 Weeks)||38
8763135|NCT01233284|9813012|FG003|STARTED|Period 1 (4 Weeks)||35
8763136|NCT01233284|9813013|FG004|STARTED|Period 1 (4 Weeks)||1
8763137|NCT01233284|9813009|FG000|COMPLETED|Period 1 (4 Weeks)||36
8763138|NCT01233284|9813010|FG001|COMPLETED|Period 1 (4 Weeks)||37
8763139|NCT01233284|9813011|FG002|COMPLETED|Period 1 (4 Weeks)||37
8763140|NCT01233284|9813012|FG003|COMPLETED|Period 1 (4 Weeks)||35
8763141|NCT01233284|9813013|FG004|COMPLETED|Period 1 (4 Weeks)||1
8763142|NCT01233284|9813009|FG000|NOT COMPLETED|Period 1 (4 Weeks)||1
8763143|NCT01233284|9813010|FG001|NOT COMPLETED|Period 1 (4 Weeks)||1
8763144|NCT01233284|9813011|FG002|NOT COMPLETED|Period 1 (4 Weeks)||1
8763145|NCT01233284|9813012|FG003|NOT COMPLETED|Period 1 (4 Weeks)||0
8763146|NCT01233284|9813013|FG004|NOT COMPLETED|Period 1 (4 Weeks)||0
8763147|NCT01233284|9813009|FG000|STARTED|Period 2 (4 Weeks)||36
8763148|NCT01233284|9813010|FG001|STARTED|Period 2 (4 Weeks)||37
8763149|NCT01233284|9813011|FG002|STARTED|Period 2 (4 Weeks)||37
8763150|NCT01233284|9813012|FG003|STARTED|Period 2 (4 Weeks)||35
8763151|NCT01233284|9813013|FG004|STARTED|Period 2 (4 Weeks)||1
8763152|NCT01233284|9813009|FG000|COMPLETED|Period 2 (4 Weeks)||36
8763153|NCT01233284|9813010|FG001|COMPLETED|Period 2 (4 Weeks)||37
8763154|NCT01233284|9813011|FG002|COMPLETED|Period 2 (4 Weeks)||36
8763155|NCT01233284|9813012|FG003|COMPLETED|Period 2 (4 Weeks)||35
8763156|NCT01233284|9813013|FG004|COMPLETED|Period 2 (4 Weeks)||1
8763157|NCT01233284|9813009|FG000|NOT COMPLETED|Period 2 (4 Weeks)||0
8763158|NCT01233284|9813010|FG001|NOT COMPLETED|Period 2 (4 Weeks)||0
8763159|NCT01233284|9813011|FG002|NOT COMPLETED|Period 2 (4 Weeks)||1
8763160|NCT01233284|9813012|FG003|NOT COMPLETED|Period 2 (4 Weeks)||0
8763161|NCT01233284|9813013|FG004|NOT COMPLETED|Period 2 (4 Weeks)||0
8763162|NCT01233284|9813009|FG000|STARTED|Period 3 (4 Weeks)||36
8763163|NCT01233284|9813010|FG001|STARTED|Period 3 (4 Weeks)||37
8763164|NCT01233284|9813011|FG002|STARTED|Period 3 (4 Weeks)||36
8763165|NCT01233284|9813012|FG003|STARTED|Period 3 (4 Weeks)||35
8763166|NCT01233284|9813013|FG004|STARTED|Period 3 (4 Weeks)||1
8763167|NCT01233284|9813009|FG000|COMPLETED|Period 3 (4 Weeks)||36
8763168|NCT01233284|9813010|FG001|COMPLETED|Period 3 (4 Weeks)||37
8763169|NCT01233284|9813011|FG002|COMPLETED|Period 3 (4 Weeks)||35
8763170|NCT01233284|9813012|FG003|COMPLETED|Period 3 (4 Weeks)||34
8763171|NCT01233284|9813013|FG004|COMPLETED|Period 3 (4 Weeks)||1
8763172|NCT01233284|9813009|FG000|NOT COMPLETED|Period 3 (4 Weeks)||0
8763173|NCT01233284|9813010|FG001|NOT COMPLETED|Period 3 (4 Weeks)||0
8763174|NCT01233284|9813011|FG002|NOT COMPLETED|Period 3 (4 Weeks)||1
8763175|NCT01233284|9813012|FG003|NOT COMPLETED|Period 3 (4 Weeks)||1
8763176|NCT01233284|9813013|FG004|NOT COMPLETED|Period 3 (4 Weeks)||0
8763177|NCT01233284|9813009|FG000|STARTED|Period 4 (4 Weeks)||36
8763178|NCT01233284|9813010|FG001|STARTED|Period 4 (4 Weeks)||37
8763179|NCT01233284|9813011|FG002|STARTED|Period 4 (4 Weeks)||35
8763180|NCT01233284|9813012|FG003|STARTED|Period 4 (4 Weeks)||34
8763181|NCT01233284|9813013|FG004|STARTED|Period 4 (4 Weeks)||1
8763182|NCT01233284|9813009|FG000|COMPLETED|Period 4 (4 Weeks)||36
8763183|NCT01233284|9813010|FG001|COMPLETED|Period 4 (4 Weeks)||36
8763184|NCT01233284|9813011|FG002|COMPLETED|Period 4 (4 Weeks)||35
8763185|NCT01233284|9813012|FG003|COMPLETED|Period 4 (4 Weeks)||33
8763186|NCT01233284|9813013|FG004|COMPLETED|Period 4 (4 Weeks)||1
8763187|NCT01233284|9813009|FG000|NOT COMPLETED|Period 4 (4 Weeks)||0
8763188|NCT01233284|9813010|FG001|NOT COMPLETED|Period 4 (4 Weeks)||1
8763189|NCT01233284|9813011|FG002|NOT COMPLETED|Period 4 (4 Weeks)||0
8763190|NCT01233284|9813012|FG003|NOT COMPLETED|Period 4 (4 Weeks)||1
8763191|NCT01233284|9813013|FG004|NOT COMPLETED|Period 4 (4 Weeks)||0
8763192|NCT01233518|9813023|FG000|STARTED|Overall Study||285
8763193|NCT01233518|9813023|FG000|COMPLETED|Overall Study||252
8763194|NCT01233518|9813023|FG000|NOT COMPLETED|Overall Study||33
8763195|NCT01233609|9813030|FG000|STARTED|Overall Study||46
8763196|NCT01233609|9813031|FG001|STARTED|Overall Study||44
8763197|NCT01233609|9813030|FG000|COMPLETED|Overall Study||37
8763198|NCT01233609|9813031|FG001|COMPLETED|Overall Study||42
8763199|NCT01233609|9813030|FG000|NOT COMPLETED|Overall Study||9
8763200|NCT01233609|9813031|FG001|NOT COMPLETED|Overall Study||2
8763201|NCT01233687|9813045|FG000|STARTED|Phase I RP2D AMG 102 + Erlotinib||7
8763202|NCT01233687|9813045|FG000|COMPLETED|Phase I RP2D AMG 102 + Erlotinib||7
8763203|NCT01233687|9813045|FG000|NOT COMPLETED|Phase I RP2D AMG 102 + Erlotinib||0
8763204|NCT01233687|9813045|FG000|STARTED|Phase II AMG 102 + Erlotinib|Includes 7 participants from Phase 1 part of study.|49
8763205|NCT01233687|9813045|FG000|Response-Evaluable|Phase II AMG 102 + Erlotinib||45
8763206|NCT01233687|9813045|FG000|COMPLETED|Phase II AMG 102 + Erlotinib||45
8763207|NCT01233687|9813045|FG000|NOT COMPLETED|Phase II AMG 102 + Erlotinib||4
8763208|NCT01233726|9813052|FG000|STARTED|Overall Study||53
8763209|NCT01233726|9813053|FG001|STARTED|Overall Study||53
8763210|NCT01233726|9813054|FG002|STARTED|Overall Study||53
8763211|NCT01233726|9813052|FG000|COMPLETED|Overall Study||52
8763212|NCT01233726|9813053|FG001|COMPLETED|Overall Study||53
8763213|NCT01233726|9813054|FG002|COMPLETED|Overall Study||52
8763214|NCT01233726|9813052|FG000|NOT COMPLETED|Overall Study||1
8763215|NCT01233726|9813053|FG001|NOT COMPLETED|Overall Study||0
8763216|NCT01233726|9813054|FG002|NOT COMPLETED|Overall Study||1
8763217|NCT01233817|9813065|FG000|STARTED|Overall Study||12
8763218|NCT01233817|9813065|FG000|COMPLETED|Overall Study||9
8763219|NCT01233817|9813065|FG000|NOT COMPLETED|Overall Study||3
8763220|NCT01233869|9813073|FG000|STARTED|Initial Treatment Period (24 Months)||58
8763221|NCT01233869|9813074|FG001|STARTED|Initial Treatment Period (24 Months)||31
8763222|NCT01233869|9813075|FG002|STARTED|Initial Treatment Period (24 Months)||24
8763223|NCT01233869|9813076|FG003|STARTED|Initial Treatment Period (24 Months)||56
8763224|NCT01233869|9813073|FG000|COMPLETED|Initial Treatment Period (24 Months)||34
8763225|NCT01233869|9813074|FG001|COMPLETED|Initial Treatment Period (24 Months)||3
8763226|NCT01233869|9813075|FG002|COMPLETED|Initial Treatment Period (24 Months)||22
8763227|NCT01233869|9813076|FG003|COMPLETED|Initial Treatment Period (24 Months)||34
8763228|NCT01233869|9813073|FG000|NOT COMPLETED|Initial Treatment Period (24 Months)||24
8763229|NCT01233869|9813074|FG001|NOT COMPLETED|Initial Treatment Period (24 Months)||28
8763230|NCT01233869|9813075|FG002|NOT COMPLETED|Initial Treatment Period (24 Months)||2
8763231|NCT01233869|9813076|FG003|NOT COMPLETED|Initial Treatment Period (24 Months)||22
8763232|NCT01233869|9813073|FG000|STARTED|Washout Period 30 Days||34
8763233|NCT01233869|9813074|FG001|STARTED|Washout Period 30 Days||3
8763234|NCT01233869|9813075|FG002|STARTED|Washout Period 30 Days||22
8763235|NCT01233869|9813076|FG003|STARTED|Washout Period 30 Days||34
8763236|NCT01233869|9813073|FG000|COMPLETED|Washout Period 30 Days||34
8763237|NCT01233869|9813074|FG001|COMPLETED|Washout Period 30 Days||3
8763238|NCT01233869|9813075|FG002|COMPLETED|Washout Period 30 Days||22
8763239|NCT01233869|9813076|FG003|COMPLETED|Washout Period 30 Days||34
8763240|NCT01233869|9813073|FG000|NOT COMPLETED|Washout Period 30 Days||0
8763241|NCT01233869|9813074|FG001|NOT COMPLETED|Washout Period 30 Days||0
8763242|NCT01233869|9813075|FG002|NOT COMPLETED|Washout Period 30 Days||0
8763243|NCT01233869|9813076|FG003|NOT COMPLETED|Washout Period 30 Days||0
8763244|NCT01233869|9813073|FG000|STARTED|Extended Treatment Period (46 Months)||34
8763245|NCT01233869|9813074|FG001|STARTED|Extended Treatment Period (46 Months)||3
8763246|NCT01233869|9813075|FG002|STARTED|Extended Treatment Period (46 Months)||22
8763247|NCT01233869|9813076|FG003|STARTED|Extended Treatment Period (46 Months)||34
8763248|NCT01233869|9813073|FG000|COMPLETED|Extended Treatment Period (46 Months)||20
8763249|NCT01233869|9813074|FG001|COMPLETED|Extended Treatment Period (46 Months)||0
8763250|NCT01233869|9813075|FG002|COMPLETED|Extended Treatment Period (46 Months)||17
8763251|NCT01233869|9813076|FG003|COMPLETED|Extended Treatment Period (46 Months)||18
8763252|NCT01233869|9813073|FG000|NOT COMPLETED|Extended Treatment Period (46 Months)||14
8763253|NCT01233869|9813074|FG001|NOT COMPLETED|Extended Treatment Period (46 Months)||3
8763254|NCT01233869|9813075|FG002|NOT COMPLETED|Extended Treatment Period (46 Months)||5
8763255|NCT01233869|9813076|FG003|NOT COMPLETED|Extended Treatment Period (46 Months)||16
8763256|NCT01233921|9813088|FG000|STARTED|Overall Study||3
8763257|NCT01233921|9813089|FG001|STARTED|Overall Study||3
8763258|NCT01233921|9813088|FG000|COMPLETED|Overall Study||3
8763259|NCT01233921|9813089|FG001|COMPLETED|Overall Study||3
8763260|NCT01233921|9813088|FG000|NOT COMPLETED|Overall Study||0
8763261|NCT01233921|9813089|FG001|NOT COMPLETED|Overall Study||0
8763262|NCT01233999|9813095|FG000|STARTED|Overall Study||10
8763263|NCT01233999|9813095|FG000|COMPLETED|Overall Study||8
8763264|NCT01233999|9813095|FG000|NOT COMPLETED|Overall Study||2
8763265|NCT01234207|9813099|FG000|STARTED|First Intervention||47
8763266|NCT01234207|9813100|FG001|STARTED|First Intervention||48
8763267|NCT01234207|9813099|FG000|COMPLETED|First Intervention||47
8763268|NCT01234207|9813100|FG001|COMPLETED|First Intervention||48
8763269|NCT01234207|9813099|FG000|NOT COMPLETED|First Intervention||0
8763270|NCT01234207|9813100|FG001|NOT COMPLETED|First Intervention||0
8763271|NCT01234207|9813099|FG000|STARTED|1-Week Washout Period||47
8763272|NCT01234207|9813100|FG001|STARTED|1-Week Washout Period||48
8763273|NCT01234207|9813099|FG000|COMPLETED|1-Week Washout Period||47
8763274|NCT01234207|9813100|FG001|COMPLETED|1-Week Washout Period||48
8763275|NCT01234207|9813099|FG000|NOT COMPLETED|1-Week Washout Period||0
8763276|NCT01234207|9813100|FG001|NOT COMPLETED|1-Week Washout Period||0
8763277|NCT01234207|9813099|FG000|STARTED|Second Intervention||47
8763278|NCT01234207|9813100|FG001|STARTED|Second Intervention||48
8763279|NCT01234207|9813099|FG000|COMPLETED|Second Intervention||47
8763280|NCT01234207|9813100|FG001|COMPLETED|Second Intervention||48
8763281|NCT01234207|9813099|FG000|NOT COMPLETED|Second Intervention||0
8763282|NCT01234207|9813100|FG001|NOT COMPLETED|Second Intervention||0
8763283|NCT01234337|9813110|FG000|STARTED|Overall Study||266
8763284|NCT01234337|9813111|FG001|STARTED|Overall Study||271
8763285|NCT01234337|9813110|FG000|Participants Received Treatment|Overall Study||260
8763286|NCT01234337|9813111|FG001|Participants Received Treatment|Overall Study||267
8763287|NCT01234337|9813110|FG000|COMPLETED|Overall Study||0
8763288|NCT01234337|9813111|FG001|COMPLETED|Overall Study||0
8763289|NCT01234337|9813110|FG000|NOT COMPLETED|Overall Study||266
8763290|NCT01234337|9813111|FG001|NOT COMPLETED|Overall Study||271
8763291|NCT01234350|9813119|FG000|STARTED|Overall Study||1000
8763292|NCT01234350|9813120|FG001|STARTED|Overall Study||493
8763293|NCT01234350|9813119|FG000|COMPLETED|Overall Study||313
8763294|NCT01234350|9813120|FG001|COMPLETED|Overall Study||226
8763295|NCT01234350|9813119|FG000|NOT COMPLETED|Overall Study||687
8763296|NCT01234350|9813120|FG001|NOT COMPLETED|Overall Study||267
8763297|NCT01234402|9813131|FG000|STARTED|Overall Study||52
8763298|NCT01234402|9813132|FG001|STARTED|Overall Study||51
8763299|NCT01234402|9813133|FG002|STARTED|Overall Study||50
8763300|NCT01234402|9813131|FG000|Received at Least One Dose of Study Drug|Overall Study||52
8763301|NCT01234402|9813132|FG001|Received at Least One Dose of Study Drug|Overall Study||49
8763302|NCT01234402|9813133|FG002|Received at Least One Dose of Study Drug|Overall Study||49
9026484|NCT03178669|10088915|FG000|STARTED|Overall Study||40
9026485|NCT03178669|10088916|FG001|STARTED|Overall Study||43
9026486|NCT03178669|10088917|FG002|STARTED|Overall Study||42
9026487|NCT03178669|10088918|FG003|STARTED|Overall Study||42
9026488|NCT03178669|10088919|FG004|STARTED|Overall Study||44
9026489|NCT03178669|10088915|FG000|Completed Week 6|Overall Study||35
9026490|NCT03178669|10088916|FG001|Completed Week 6|Overall Study||42
9026491|NCT03178669|10088917|FG002|Completed Week 6|Overall Study||36
9026492|NCT03178669|10088918|FG003|Completed Week 6|Overall Study||38
9026493|NCT03178669|10088919|FG004|Completed Week 6|Overall Study||42
9026494|NCT03178669|10088915|FG000|COMPLETED|Overall Study||35
9026495|NCT03178669|10088916|FG001|COMPLETED|Overall Study||42
9026496|NCT03178669|10088917|FG002|COMPLETED|Overall Study||35
9026497|NCT03178669|10088918|FG003|COMPLETED|Overall Study||38
9026498|NCT03178669|10088919|FG004|COMPLETED|Overall Study||40
9026499|NCT03178669|10088915|FG000|NOT COMPLETED|Overall Study||5
9026500|NCT03178669|10088916|FG001|NOT COMPLETED|Overall Study||1
9026501|NCT03178669|10088917|FG002|NOT COMPLETED|Overall Study||7
9026502|NCT03178669|10088918|FG003|NOT COMPLETED|Overall Study||4
9026503|NCT03178669|10088919|FG004|NOT COMPLETED|Overall Study||4
9026504|NCT03178773|10088933|FG000|STARTED|Overall Study||86
9026505|NCT03178773|10088934|FG001|STARTED|Overall Study||80
9026506|NCT03178773|10088933|FG000|3month Phone Follow up|Overall Study||49
9026507|NCT03178773|10088934|FG001|3month Phone Follow up|Overall Study||51
9026508|NCT03178773|10088933|FG000|6month in Person Follow up|Overall Study||54
9026509|NCT03178773|10088934|FG001|6month in Person Follow up|Overall Study||46
9026510|NCT03178773|10088933|FG000|9month Follow up Phone|Overall Study||36
9026511|NCT03178773|10088934|FG001|9month Follow up Phone|Overall Study||51
9026512|NCT03178773|10088933|FG000|COMPLETED|Overall Study||47
9026513|NCT03178773|10088934|FG001|COMPLETED|Overall Study||40
9026514|NCT03178773|10088933|FG000|NOT COMPLETED|Overall Study||39
9026515|NCT03178773|10088934|FG001|NOT COMPLETED|Overall Study||40
9026516|NCT03178851|10088944|FG000|STARTED|Overall Study||92
9026517|NCT03178851|10088945|FG001|STARTED|Overall Study||11
9026518|NCT03178851|10088946|FG002|STARTED|Overall Study||52
9026519|NCT03178851|10088944|FG000|COMPLETED|Overall Study||0
9026520|NCT03178851|10088945|FG001|COMPLETED|Overall Study||0
9026521|NCT03178851|10088946|FG002|COMPLETED|Overall Study||0
9026522|NCT03178851|10088944|FG000|NOT COMPLETED|Overall Study||92
9026523|NCT03178851|10088945|FG001|NOT COMPLETED|Overall Study||11
9026524|NCT03178851|10088946|FG002|NOT COMPLETED|Overall Study||52
9026525|NCT03178942|10088957|FG000|STARTED|Overall Study||129
9026526|NCT03178942|10088958|FG001|STARTED|Overall Study||125
9026527|NCT03178942|10088957|FG000|COMPLETED|Overall Study||126
9026528|NCT03178942|10088958|FG001|COMPLETED|Overall Study||123
9026529|NCT03178942|10088957|FG000|NOT COMPLETED|Overall Study||3
9026530|NCT03178942|10088958|FG001|NOT COMPLETED|Overall Study||2
9026531|NCT03179319|10088966|FG000|STARTED|Overall Study||40
9026532|NCT03179319|10088967|FG001|STARTED|Overall Study||20
9026533|NCT03179319|10088966|FG000|3 Month Visit|Overall Study||37
9026534|NCT03179319|10088967|FG001|3 Month Visit|Overall Study||20
9026535|NCT03179319|10088966|FG000|COMPLETED|Overall Study||34
9026536|NCT03179319|10088967|FG001|COMPLETED|Overall Study||20
9026537|NCT03179319|10088966|FG000|NOT COMPLETED|Overall Study||6
9026538|NCT03179319|10088967|FG001|NOT COMPLETED|Overall Study||0
9026539|NCT03179345|10088977|FG000|STARTED|Overall Study||8
9026540|NCT03179345|10088978|FG001|STARTED|Overall Study||8
9026541|NCT03179345|10088979|FG002|STARTED|Overall Study||8
9026542|NCT03179345|10088980|FG003|STARTED|Overall Study||8
9026543|NCT03179345|10088977|FG000|Received Gralise®|Overall Study||8
9026544|NCT03179345|10088978|FG001|Received Gralise®|Overall Study||7
9026545|NCT03179345|10088979|FG002|Received Gralise®|Overall Study||7
8763303|NCT01234402|9813131|FG000|Capecitabine Crossover to Ramucirumab|Overall Study||0
9026546|NCT03179345|10088980|FG003|Received Gralise®|Overall Study||6
9026547|NCT03179345|10088977|FG000|Received Neurontin®|Overall Study||8
9026548|NCT03179345|10088978|FG001|Received Neurontin®|Overall Study||8
9026549|NCT03179345|10088979|FG002|Received Neurontin®|Overall Study||7
9026550|NCT03179345|10088980|FG003|Received Neurontin®|Overall Study||8
8763304|NCT01234402|9813132|FG001|Capecitabine Crossover to Ramucirumab|Overall Study||0
8763305|NCT01234402|9813133|FG002|Capecitabine Crossover to Ramucirumab|Overall Study||29
8763306|NCT01234402|9813131|FG000|Capecitabine Crossover to Icrucumab|Overall Study||0
8763307|NCT01234402|9813132|FG001|Capecitabine Crossover to Icrucumab|Overall Study||0
8763308|NCT01234402|9813133|FG002|Capecitabine Crossover to Icrucumab|Overall Study||1
8763309|NCT01234402|9813131|FG000|COMPLETED|Overall Study||51
8763310|NCT01234402|9813132|FG001|COMPLETED|Overall Study||45
8763311|NCT01234402|9813133|FG002|COMPLETED|Overall Study||42
8763312|NCT01234402|9813131|FG000|NOT COMPLETED|Overall Study||1
8763313|NCT01234402|9813132|FG001|NOT COMPLETED|Overall Study||6
8763314|NCT01234402|9813133|FG002|NOT COMPLETED|Overall Study||8
8763315|NCT01234467|9813143|FG000|STARTED|Overall Study||23
8763316|NCT01234467|9813143|FG000|COMPLETED|Overall Study||11
8763317|NCT01234467|9813143|FG000|NOT COMPLETED|Overall Study||12
8763318|NCT01234480|9813147|FG000|STARTED|Overall Study||5859
8763319|NCT01234480|9813147|FG000|COMPLETED|Overall Study||5416
8763320|NCT01234480|9813147|FG000|NOT COMPLETED|Overall Study||443
8763321|NCT01234649|9813156|FG000|STARTED|Overall Study||78
8763322|NCT01234649|9813157|FG001|STARTED|Overall Study||75
8763323|NCT01234649|9813156|FG000|COMPLETED|Overall Study||35
8763324|NCT01234649|9813157|FG001|COMPLETED|Overall Study||37
8763325|NCT01234649|9813156|FG000|NOT COMPLETED|Overall Study||43
8763326|NCT01234649|9813157|FG001|NOT COMPLETED|Overall Study||38
8763327|NCT01234675|9813163|FG000|STARTED|First Intervention (6 Weeks)||10
8763328|NCT01234675|9813164|FG001|STARTED|First Intervention (6 Weeks)||9
8763329|NCT01234675|9813163|FG000|COMPLETED|First Intervention (6 Weeks)||9
8763330|NCT01234675|9813164|FG001|COMPLETED|First Intervention (6 Weeks)||8
8763331|NCT01234675|9813163|FG000|NOT COMPLETED|First Intervention (6 Weeks)||1
8763332|NCT01234675|9813164|FG001|NOT COMPLETED|First Intervention (6 Weeks)||1
8763333|NCT01234675|9813163|FG000|STARTED|Second Intervention (6 Weeks)||9
8763334|NCT01234675|9813164|FG001|STARTED|Second Intervention (6 Weeks)||8
8763335|NCT01234675|9813163|FG000|COMPLETED|Second Intervention (6 Weeks)||7
8763336|NCT01234675|9813164|FG001|COMPLETED|Second Intervention (6 Weeks)||8
8763337|NCT01234675|9813163|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||2
8763338|NCT01234675|9813164|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0
8763339|NCT01234714|9813170|FG000|STARTED|Overall Study||84
8763340|NCT01234714|9813170|FG000|COMPLETED|Overall Study||84
8763341|NCT01234714|9813170|FG000|NOT COMPLETED|Overall Study||0
8763342|NCT01234766|9813177|FG000|STARTED|Overall Study||39
8763343|NCT01234766|9813177|FG000|COMPLETED|Overall Study||35
8763344|NCT01234766|9813177|FG000|NOT COMPLETED|Overall Study||4
8763345|NCT01234831|9813183|FG000|STARTED|Overall Study||261
8763346|NCT01234831|9813184|FG001|STARTED|Overall Study||202
8763347|NCT01234831|9813183|FG000|COMPLETED|Overall Study||259
8763348|NCT01234831|9813184|FG001|COMPLETED|Overall Study||198
8763349|NCT01234831|9813183|FG000|NOT COMPLETED|Overall Study||2
8763350|NCT01234831|9813184|FG001|NOT COMPLETED|Overall Study||4
8763351|NCT01234870|9813191|FG000|STARTED|Overall Study||40
8763352|NCT01234870|9813191|FG000|COMPLETED|Overall Study||40
8763353|NCT01234870|9813191|FG000|NOT COMPLETED|Overall Study||0
8763354|NCT01234883|9813198|FG000|STARTED|Overall Study||51
8763355|NCT01234883|9813199|FG001|STARTED|Overall Study||49
8763356|NCT01234883|9813198|FG000|COMPLETED|Overall Study||41
8763357|NCT01234883|9813199|FG001|COMPLETED|Overall Study||36
8763358|NCT01234883|9813198|FG000|NOT COMPLETED|Overall Study||10
8763359|NCT01234883|9813199|FG001|NOT COMPLETED|Overall Study||13
8763360|NCT01234922|9813209|FG000|STARTED|Overall Study||1
8763361|NCT01234922|9813210|FG001|STARTED|Overall Study||1
8763362|NCT01234922|9813211|FG002|STARTED|Overall Study||2
8763363|NCT01234922|9813212|FG003|STARTED|Overall Study||2
8763364|NCT01234922|9813209|FG000|COMPLETED|Overall Study||1
8763365|NCT01234922|9813210|FG001|COMPLETED|Overall Study||1
8763366|NCT01234922|9813211|FG002|COMPLETED|Overall Study||2
8763367|NCT01234922|9813212|FG003|COMPLETED|Overall Study||2
8763368|NCT01234922|9813209|FG000|NOT COMPLETED|Overall Study||0
8763369|NCT01234922|9813210|FG001|NOT COMPLETED|Overall Study||0
8763370|NCT01234922|9813211|FG002|NOT COMPLETED|Overall Study||0
8763371|NCT01234922|9813212|FG003|NOT COMPLETED|Overall Study||0
8763372|NCT01235195|9813222|FG000|STARTED|First Intervention||15
8763373|NCT01235195|9813223|FG001|STARTED|First Intervention||15
8763374|NCT01235195|9813222|FG000|COMPLETED|First Intervention||15
8763375|NCT01235195|9813223|FG001|COMPLETED|First Intervention||15
8763376|NCT01235195|9813222|FG000|NOT COMPLETED|First Intervention||0
8763377|NCT01235195|9813223|FG001|NOT COMPLETED|First Intervention||0
8763378|NCT01235195|9813222|FG000|STARTED|Washout Period of At Least 8 Days||15
8763379|NCT01235195|9813223|FG001|STARTED|Washout Period of At Least 8 Days||15
8763380|NCT01235195|9813222|FG000|COMPLETED|Washout Period of At Least 8 Days||15
8763381|NCT01235195|9813223|FG001|COMPLETED|Washout Period of At Least 8 Days||15
8763382|NCT01235195|9813222|FG000|NOT COMPLETED|Washout Period of At Least 8 Days||0
8763383|NCT01235195|9813223|FG001|NOT COMPLETED|Washout Period of At Least 8 Days||0
8763384|NCT01235195|9813222|FG000|STARTED|Second Intervention||15
8763385|NCT01235195|9813223|FG001|STARTED|Second Intervention||15
8763386|NCT01235195|9813222|FG000|COMPLETED|Second Intervention||15
8763387|NCT01235195|9813223|FG001|COMPLETED|Second Intervention||15
8763388|NCT01235195|9813222|FG000|NOT COMPLETED|Second Intervention||0
8763389|NCT01235195|9813223|FG001|NOT COMPLETED|Second Intervention||0
8763390|NCT01235234|9813232|FG000|STARTED|Overall Study||77
8763391|NCT01235234|9813233|FG001|STARTED|Overall Study||78
8763392|NCT01235234|9813234|FG002|STARTED|Overall Study||81
8763393|NCT01235234|9813232|FG000|COMPLETED|Overall Study||75
8763394|NCT01235234|9813233|FG001|COMPLETED|Overall Study||76
8763395|NCT01235234|9813234|FG002|COMPLETED|Overall Study||80
8763396|NCT01235234|9813232|FG000|NOT COMPLETED|Overall Study||2
8763397|NCT01235234|9813233|FG001|NOT COMPLETED|Overall Study||2
8763398|NCT01235234|9813234|FG002|NOT COMPLETED|Overall Study||1
8763399|NCT01235338|9813244|FG000|STARTED|Overall Study||42
8763400|NCT01235338|9813245|FG001|STARTED|Overall Study||38
8763401|NCT01235338|9813244|FG000|COMPLETED|Overall Study||31
8763402|NCT01235338|9813245|FG001|COMPLETED|Overall Study||33
8763403|NCT01235338|9813244|FG000|NOT COMPLETED|Overall Study||11
8763404|NCT01235338|9813245|FG001|NOT COMPLETED|Overall Study||5
8763405|NCT01235351|9813255|FG000|STARTED|Initial Treatment With 75 mg and 150 mg||247
8763406|NCT01235351|9813256|FG001|STARTED|Initial Treatment With 75 mg and 150 mg||86
8763407|NCT01235351|9813255|FG000|COMPLETED|Initial Treatment With 75 mg and 150 mg|4 allocated to initial treatment included in primary analysis|237
8763408|NCT01235351|9813256|FG001|COMPLETED|Initial Treatment With 75 mg and 150 mg||82
8763409|NCT01235351|9813255|FG000|NOT COMPLETED|Initial Treatment With 75 mg and 150 mg||10
8763410|NCT01235351|9813256|FG001|NOT COMPLETED|Initial Treatment With 75 mg and 150 mg||4
8763411|NCT01235351|9813255|FG000|STARTED|Treatment With Different Dose Sequences||233
8763412|NCT01235351|9813256|FG001|STARTED|Treatment With Different Dose Sequences||82
8763413|NCT01235351|9813255|FG000|75 mg First and Then 150 mg|Treatment With Different Dose Sequences||116
8763414|NCT01235351|9813256|FG001|75 mg First and Then 150 mg|Treatment With Different Dose Sequences||0
8763415|NCT01235351|9813255|FG000|150 mg First Then 75 mg|Treatment With Different Dose Sequences||117
8763416|NCT01235351|9813256|FG001|150 mg First Then 75 mg|Treatment With Different Dose Sequences||0
8763417|NCT01235351|9813255|FG000|225 mg First Then 300 mg|Treatment With Different Dose Sequences||0
8763418|NCT01235351|9813256|FG001|225 mg First Then 300 mg|Treatment With Different Dose Sequences||41
8763419|NCT01235351|9813255|FG000|300 mg First Then 225 mg|Treatment With Different Dose Sequences||0
8763420|NCT01235351|9813256|FG001|300 mg First Then 225 mg|Treatment With Different Dose Sequences||41
8763421|NCT01235351|9813255|FG000|COMPLETED|Treatment With Different Dose Sequences||233
8763422|NCT01235351|9813256|FG001|COMPLETED|Treatment With Different Dose Sequences||82
8763423|NCT01235351|9813255|FG000|NOT COMPLETED|Treatment With Different Dose Sequences||0
8763424|NCT01235351|9813256|FG001|NOT COMPLETED|Treatment With Different Dose Sequences||0
8763425|NCT01235377|9813268|FG000|STARTED|Overall Study||11
8763426|NCT01235377|9813269|FG001|STARTED|Overall Study||9
8763427|NCT01235377|9813268|FG000|COMPLETED|Overall Study||10
8763428|NCT01235377|9813269|FG001|COMPLETED|Overall Study||8
8763429|NCT01235377|9813268|FG000|NOT COMPLETED|Overall Study||1
8763430|NCT01235377|9813269|FG001|NOT COMPLETED|Overall Study||1
8763431|NCT01235403|9813275|FG000|STARTED|Overall Study||100
8763432|NCT01235403|9813275|FG000|COMPLETED|Overall Study||74
8763433|NCT01235403|9813275|FG000|NOT COMPLETED|Overall Study||26
8763434|NCT01235442|9813281|FG000|STARTED|Overall Study||297
8763435|NCT01235442|9813282|FG001|STARTED|Overall Study||295
8763436|NCT01235442|9813281|FG000|COMPLETED|Overall Study||253
8763437|NCT01235442|9813282|FG001|COMPLETED|Overall Study||251
8763438|NCT01235442|9813281|FG000|NOT COMPLETED|Overall Study||44
8763439|NCT01235442|9813282|FG001|NOT COMPLETED|Overall Study||44
8763440|NCT01235507|9813288|FG000|STARTED|Overall Study||71
8763441|NCT01235507|9813288|FG000|COMPLETED|Overall Study||69
8763442|NCT01235507|9813288|FG000|NOT COMPLETED|Overall Study||2
8763443|NCT01235546|9813294|FG000|STARTED|Overall Study||994
8763444|NCT01235546|9813295|FG001|STARTED|Overall Study||1019
8763445|NCT01235546|9813294|FG000|COMPLETED|Overall Study||992
8763446|NCT01235546|9813295|FG001|COMPLETED|Overall Study||1018
8763447|NCT01235546|9813294|FG000|NOT COMPLETED|Overall Study||2
8763448|NCT01235546|9813295|FG001|NOT COMPLETED|Overall Study||1
8763449|NCT01235598|9813312|FG000|STARTED|Overall Study||13
8763450|NCT01235598|9813313|FG001|STARTED|Overall Study|One subject was randomized to the CZP Arm but never received an injection (due to pre-treatment AE)|28
8763451|NCT01235598|9813312|FG000|COMPLETED|Overall Study||12
8763452|NCT01235598|9813313|FG001|COMPLETED|Overall Study||24
8763453|NCT01235598|9813312|FG000|NOT COMPLETED|Overall Study||1
8763454|NCT01235598|9813313|FG001|NOT COMPLETED|Overall Study||4
8763455|NCT01235689|9813322|FG000|STARTED|Overall Study|Total randomized includes participants who randomized at Week 9 and earlier.|122
8763456|NCT01235689|9813323|FG001|STARTED|Overall Study|Total randomized includes participants who randomized at Week 9 and earlier.|122
8763457|NCT01235689|9813322|FG000|Early Randomized (Baseline to Week 9)|Overall Study||63
8763458|NCT01235689|9813323|FG001|Early Randomized (Baseline to Week 9)|Overall Study||69
8763459|NCT01235689|9813322|FG000|Randomized at Week 9|Overall Study||59
8763460|NCT01235689|9813323|FG001|Randomized at Week 9|Overall Study||53
8763461|NCT01235689|9813322|FG000|COMPLETED|Overall Study||93
8763462|NCT01235689|9813323|FG001|COMPLETED|Overall Study||90
8763463|NCT01235689|9813322|FG000|NOT COMPLETED|Overall Study||29
8763464|NCT01235689|9813323|FG001|NOT COMPLETED|Overall Study||32
8763465|NCT01235715|9813331|FG000|STARTED|Overall Study||98
8763466|NCT01235715|9813332|FG001|STARTED|Overall Study||102
8763467|NCT01235715|9813331|FG000|COMPLETED|Overall Study||98
8763468|NCT01235715|9813332|FG001|COMPLETED|Overall Study||100
8763469|NCT01235715|9813331|FG000|NOT COMPLETED|Overall Study||0
8763470|NCT01235715|9813332|FG001|NOT COMPLETED|Overall Study||2
8763471|NCT01235728|9813339|FG000|STARTED|Overall Study||3
8763472|NCT01235728|9813340|FG001|STARTED|Overall Study||3
8915640|NCT02176083|9975077|FG000|NOT COMPLETED|Overall Study||0
8763473|NCT01235728|9813341|FG002|STARTED|Overall Study||3
8763474|NCT01235728|9813342|FG003|STARTED|Overall Study||3
8763475|NCT01235728|9813343|FG004|STARTED|Overall Study||3
8763476|NCT01235728|9813344|FG005|STARTED|Overall Study||3
9026551|NCT03179345|10088977|FG000|Received Lyrica®|Overall Study||8
9026552|NCT03179345|10088978|FG001|Received Lyrica®|Overall Study||7
9026553|NCT03179345|10088979|FG002|Received Lyrica®|Overall Study||8
9026554|NCT03179345|10088980|FG003|Received Lyrica®|Overall Study||8
9026555|NCT03179345|10088977|FG000|Received Placebo|Overall Study||8
9026556|NCT03179345|10088978|FG001|Received Placebo|Overall Study||7
9026557|NCT03179345|10088979|FG002|Received Placebo|Overall Study||7
9026558|NCT03179345|10088980|FG003|Received Placebo|Overall Study||8
9026559|NCT03179345|10088977|FG000|COMPLETED|Overall Study||8
9026560|NCT03179345|10088978|FG001|COMPLETED|Overall Study||7
9026561|NCT03179345|10088979|FG002|COMPLETED|Overall Study||7
9026562|NCT03179345|10088980|FG003|COMPLETED|Overall Study||6
9026563|NCT03179345|10088977|FG000|NOT COMPLETED|Overall Study||0
9026564|NCT03179345|10088978|FG001|NOT COMPLETED|Overall Study||1
9026565|NCT03179345|10088979|FG002|NOT COMPLETED|Overall Study||1
9026566|NCT03179345|10088980|FG003|NOT COMPLETED|Overall Study||2
9026567|NCT03179410|10088996|FG000|STARTED|Overall Study||15
9026568|NCT03179410|10088996|FG000|COMPLETED|Overall Study||15
9026569|NCT03179410|10088996|FG000|NOT COMPLETED|Overall Study||0
9026570|NCT03179787|10089000|FG000|STARTED|Overall Study||528
9026571|NCT03179787|10089000|FG000|COMPLETED|Overall Study||510
9026572|NCT03179787|10089000|FG000|NOT COMPLETED|Overall Study||18
9026573|NCT03179891|10089004|FG000|STARTED|First Intervention||13
9026574|NCT03179891|10089005|FG001|STARTED|First Intervention||22
9026575|NCT03179891|10089004|FG000|COMPLETED|First Intervention||11
9026576|NCT03179891|10089005|FG001|COMPLETED|First Intervention||20
9026577|NCT03179891|10089004|FG000|NOT COMPLETED|First Intervention||2
9026578|NCT03179891|10089005|FG001|NOT COMPLETED|First Intervention||2
9026579|NCT03179891|10089004|FG000|STARTED|Second Intervention (After 14 Days)||11
9026580|NCT03179891|10089005|FG001|STARTED|Second Intervention (After 14 Days)||20
9026581|NCT03179891|10089004|FG000|COMPLETED|Second Intervention (After 14 Days)||11
9026582|NCT03179891|10089005|FG001|COMPLETED|Second Intervention (After 14 Days)||20
9026583|NCT03179891|10089004|FG000|NOT COMPLETED|Second Intervention (After 14 Days)||0
9026584|NCT03179891|10089005|FG001|NOT COMPLETED|Second Intervention (After 14 Days)||0
9026585|NCT03180138|10089017|FG000|STARTED|Overall Study||204
9026586|NCT03180138|10089018|FG001|STARTED|Overall Study||201
9026587|NCT03180138|10089019|FG002|STARTED|Overall Study||203
9026588|NCT03180138|10089017|FG000|COMPLETED|Overall Study||182
9026589|NCT03180138|10089018|FG001|COMPLETED|Overall Study||188
9026590|NCT03180138|10089019|FG002|COMPLETED|Overall Study||179
9026591|NCT03180138|10089017|FG000|NOT COMPLETED|Overall Study||22
9026592|NCT03180138|10089018|FG001|NOT COMPLETED|Overall Study||13
9026593|NCT03180138|10089019|FG002|NOT COMPLETED|Overall Study||24
9026594|NCT03180385|10089029|FG000|STARTED|Overall Study||0
9026595|NCT03180385|10089030|FG001|STARTED|Overall Study||2
9026596|NCT03180385|10089029|FG000|COMPLETED|Overall Study||0
9026597|NCT03180385|10089030|FG001|COMPLETED|Overall Study||2
9026598|NCT03180385|10089029|FG000|NOT COMPLETED|Overall Study||0
9026599|NCT03180385|10089030|FG001|NOT COMPLETED|Overall Study||0
9026600|NCT03180489|10089038|FG000|STARTED|Overall Study||33
9026601|NCT03180489|10089039|FG001|STARTED|Overall Study||29
9026602|NCT03180489|10089038|FG000|COMPLETED|Overall Study||25
9026603|NCT03180489|10089039|FG001|COMPLETED|Overall Study||25
9026604|NCT03180489|10089038|FG000|NOT COMPLETED|Overall Study||8
9026605|NCT03180489|10089039|FG001|NOT COMPLETED|Overall Study||4
9026606|NCT03180515|10089045|FG000|STARTED|Aim 1||12
9026607|NCT03180515|10089045|FG000|COMPLETED|Aim 1||12
9026608|NCT03180515|10089045|FG000|NOT COMPLETED|Aim 1||0
9026609|NCT03180515|10089045|FG000|STARTED|Aim 2||12
9026610|NCT03180515|10089045|FG000|COMPLETED|Aim 2||12
9026611|NCT03180515|10089045|FG000|NOT COMPLETED|Aim 2||0
9026612|NCT03180515|10089045|FG000|STARTED|Aim 3||1
9026613|NCT03180515|10089045|FG000|COMPLETED|Aim 3||1
9026614|NCT03180515|10089045|FG000|NOT COMPLETED|Aim 3||0
9026615|NCT03180528|10089061|FG000|STARTED|Overall Study||30
9026616|NCT03180528|10089061|FG000|COMPLETED|Overall Study||27
9026617|NCT03180528|10089061|FG000|NOT COMPLETED|Overall Study||3
9026618|NCT03180619|10089068|FG000|STARTED|Overall Study||78
9026619|NCT03180619|10089069|FG001|STARTED|Overall Study||15
9026620|NCT03180619|10089070|FG002|STARTED|Overall Study||31
9026621|NCT03180619|10089068|FG000|COMPLETED|Overall Study||67
9026622|NCT03180619|10089069|FG001|COMPLETED|Overall Study||14
9026623|NCT03180619|10089070|FG002|COMPLETED|Overall Study||25
9026624|NCT03180619|10089068|FG000|NOT COMPLETED|Overall Study||11
9026625|NCT03180619|10089069|FG001|NOT COMPLETED|Overall Study||1
9026626|NCT03180619|10089070|FG002|NOT COMPLETED|Overall Study||6
8763477|NCT01235728|9813345|FG006|STARTED|Overall Study||3
8763478|NCT01235728|9813346|FG007|STARTED|Overall Study||3
8763479|NCT01235728|9813339|FG000|COMPLETED|Overall Study||3
8763480|NCT01235728|9813340|FG001|COMPLETED|Overall Study||3
8763481|NCT01235728|9813341|FG002|COMPLETED|Overall Study||3
8763482|NCT01235728|9813342|FG003|COMPLETED|Overall Study||2
8763483|NCT01235728|9813343|FG004|COMPLETED|Overall Study||3
8763484|NCT01235728|9813344|FG005|COMPLETED|Overall Study||3
8763485|NCT01235728|9813345|FG006|COMPLETED|Overall Study||3
8763486|NCT01235728|9813346|FG007|COMPLETED|Overall Study||3
8763487|NCT01235728|9813339|FG000|NOT COMPLETED|Overall Study||0
8763488|NCT01235728|9813340|FG001|NOT COMPLETED|Overall Study||0
8763489|NCT01235728|9813341|FG002|NOT COMPLETED|Overall Study||0
8763490|NCT01235728|9813342|FG003|NOT COMPLETED|Overall Study||1
8763491|NCT01235728|9813343|FG004|NOT COMPLETED|Overall Study||0
8763492|NCT01235728|9813344|FG005|NOT COMPLETED|Overall Study||0
8763493|NCT01235728|9813345|FG006|NOT COMPLETED|Overall Study||0
8763494|NCT01235728|9813346|FG007|NOT COMPLETED|Overall Study||0
8763495|NCT01235741|9813357|FG000|STARTED|Non-Randomized Low Calorie Diet Lead-In|6 Week LCD period. Those who lost >=2% of body weight were randomized to treatment.|213
8763496|NCT01235741|9813358|FG001|STARTED|Non-Randomized Low Calorie Diet Lead-In||0
8763497|NCT01235741|9813359|FG002|STARTED|Non-Randomized Low Calorie Diet Lead-In||0
8763498|NCT01235741|9813357|FG000|COMPLETED|Non-Randomized Low Calorie Diet Lead-In|Study terminated by Sponsor. 72 randomized to treatment at time study halted.|72
8763499|NCT01235741|9813358|FG001|COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
8763500|NCT01235741|9813359|FG002|COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
8763501|NCT01235741|9813357|FG000|NOT COMPLETED|Non-Randomized Low Calorie Diet Lead-In||141
8763502|NCT01235741|9813358|FG001|NOT COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
8763503|NCT01235741|9813359|FG002|NOT COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
8763504|NCT01235741|9813357|FG000|STARTED|Randomized to Treatment||0
8763505|NCT01235741|9813358|FG001|STARTED|Randomized to Treatment||36
8763506|NCT01235741|9813359|FG002|STARTED|Randomized to Treatment||36
8763507|NCT01235741|9813357|FG000|COMPLETED|Randomized to Treatment||0
8763508|NCT01235741|9813358|FG001|COMPLETED|Randomized to Treatment|Study terminated by Sponsor. Maximum exposure to study drug was 30 days.|0
8763509|NCT01235741|9813359|FG002|COMPLETED|Randomized to Treatment|Study terminated by Sponsor. Maximum exposure to study drug was 30 days.|0
8763510|NCT01235741|9813357|FG000|NOT COMPLETED|Randomized to Treatment||0
8763511|NCT01235741|9813358|FG001|NOT COMPLETED|Randomized to Treatment||36
8763512|NCT01235741|9813359|FG002|NOT COMPLETED|Randomized to Treatment||36
8763513|NCT01235741|9813357|FG000|STARTED|Follow-Up Post Treatment up to Month 6||0
8763514|NCT01235741|9813358|FG001|STARTED|Follow-Up Post Treatment up to Month 6|No treatment; those who had been treated with placebo (36) were followed up 6 Months post treatment.|36
8763515|NCT01235741|9813359|FG002|STARTED|Follow-Up Post Treatment up to Month 6|No treatment; those who had been treated with drug (36) were followed up 6 months post treatment.|36
8763516|NCT01235741|9813357|FG000|COMPLETED|Follow-Up Post Treatment up to Month 6||0
8763517|NCT01235741|9813358|FG001|COMPLETED|Follow-Up Post Treatment up to Month 6|9 participants did not complete the 6 month follow up period|27
8763518|NCT01235741|9813359|FG002|COMPLETED|Follow-Up Post Treatment up to Month 6|7 participants did not complete the 6 month follow up period|29
8763519|NCT01235741|9813357|FG000|NOT COMPLETED|Follow-Up Post Treatment up to Month 6||0
8763520|NCT01235741|9813358|FG001|NOT COMPLETED|Follow-Up Post Treatment up to Month 6||9
8763521|NCT01235741|9813359|FG002|NOT COMPLETED|Follow-Up Post Treatment up to Month 6||7
8763522|NCT01235793|9813371|FG000|STARTED|Overall Study||11
8763523|NCT01235793|9813371|FG000|COMPLETED|Overall Study||5
8763524|NCT01235793|9813371|FG000|NOT COMPLETED|Overall Study||6
8763525|NCT01235897|9813376|FG000|STARTED|Overall Study||16
8763526|NCT01235897|9813376|FG000|COMPLETED|Overall Study||16
8763527|NCT01235897|9813376|FG000|NOT COMPLETED|Overall Study||0
8763528|NCT01235910|9813381|FG000|STARTED|Overall Study||1
8763529|NCT01235910|9813381|FG000|COMPLETED|Overall Study||1
8763530|NCT01235910|9813381|FG000|NOT COMPLETED|Overall Study||0
8763531|NCT01235923|9813387|FG000|STARTED|Overall Study||10
8763532|NCT01235923|9813388|FG001|STARTED|Overall Study||10
8763533|NCT01235923|9813387|FG000|COMPLETED|Overall Study||10
8763534|NCT01235923|9813388|FG001|COMPLETED|Overall Study||10
8763535|NCT01235923|9813387|FG000|NOT COMPLETED|Overall Study||0
8763536|NCT01235923|9813388|FG001|NOT COMPLETED|Overall Study||0
8763537|NCT01235949|9813412|FG000|STARTED|Primary Phase||198
8763538|NCT01235949|9813413|FG001|STARTED|Primary Phase||198
8763539|NCT01235949|9813414|FG002|STARTED|Primary Phase||199
8763540|NCT01235949|9813415|FG003|STARTED|Primary Phase||71
8763541|NCT01235949|9813416|FG004|STARTED|Primary Phase||72
8763542|NCT01235949|9813417|FG005|STARTED|Primary Phase||74
8763543|NCT01235949|9813418|FG006|STARTED|Primary Phase||0
8763544|NCT01235949|9813419|FG007|STARTED|Primary Phase||0
8763545|NCT01235949|9813420|FG008|STARTED|Primary Phase||0
8763546|NCT01235949|9813421|FG009|STARTED|Primary Phase||0
8763547|NCT01235949|9813422|FG010|STARTED|Primary Phase||0
8763548|NCT01235949|9813423|FG011|STARTED|Primary Phase||0
8763549|NCT01235949|9813424|FG012|STARTED|Primary Phase||0
8763550|NCT01235949|9813425|FG013|STARTED|Primary Phase||0
8763551|NCT01235949|9813426|FG014|STARTED|Primary Phase||0
8763552|NCT01235949|9813427|FG015|STARTED|Primary Phase||0
8763553|NCT01235949|9813428|FG016|STARTED|Primary Phase||0
8763554|NCT01235949|9813429|FG017|STARTED|Primary Phase||0
8763555|NCT01235949|9813412|FG000|COMPLETED|Primary Phase|After Primary Phase completion, 7 subjects were not willing to participate in the Booster Phase|194
8915641|NCT02176083|9975078|FG001|NOT COMPLETED|Overall Study||0
8763556|NCT01235949|9813413|FG001|COMPLETED|Primary Phase|After Primary Phase completion, 6 subjects were not willing to participate in the Booster Phase|195
8763557|NCT01235949|9813414|FG002|COMPLETED|Primary Phase|After Primary Phase completion, 6 subjects were not willing to participate in the Booster Phase|196
8763558|NCT01235949|9813415|FG003|COMPLETED|Primary Phase|After Primary Phase completion, 2 subjects were not willing to participate in the Booster Phase|69
8763559|NCT01235949|9813416|FG004|COMPLETED|Primary Phase|After Primary Phase completion, 3 subjects were not willing to participate in the Booster Phase|71
8763560|NCT01235949|9813417|FG005|COMPLETED|Primary Phase|After Primary Phase completion, all subjects were willing to participate in the Booster Phase|67
8763561|NCT01235949|9813418|FG006|COMPLETED|Primary Phase||0
8763562|NCT01235949|9813419|FG007|COMPLETED|Primary Phase||0
8763563|NCT01235949|9813420|FG008|COMPLETED|Primary Phase||0
8763564|NCT01235949|9813421|FG009|COMPLETED|Primary Phase||0
8763565|NCT01235949|9813422|FG010|COMPLETED|Primary Phase||0
8763566|NCT01235949|9813423|FG011|COMPLETED|Primary Phase||0
8763567|NCT01235949|9813424|FG012|COMPLETED|Primary Phase||0
8763568|NCT01235949|9813425|FG013|COMPLETED|Primary Phase||0
8763569|NCT01235949|9813426|FG014|COMPLETED|Primary Phase||0
8763570|NCT01235949|9813427|FG015|COMPLETED|Primary Phase||0
8763571|NCT01235949|9813428|FG016|COMPLETED|Primary Phase||0
8763572|NCT01235949|9813429|FG017|COMPLETED|Primary Phase||0
8763573|NCT01235949|9813412|FG000|NOT COMPLETED|Primary Phase||4
8763574|NCT01235949|9813413|FG001|NOT COMPLETED|Primary Phase||3
8763575|NCT01235949|9813414|FG002|NOT COMPLETED|Primary Phase||3
8763576|NCT01235949|9813415|FG003|NOT COMPLETED|Primary Phase||2
8763577|NCT01235949|9813416|FG004|NOT COMPLETED|Primary Phase||1
8763578|NCT01235949|9813417|FG005|NOT COMPLETED|Primary Phase||7
8763579|NCT01235949|9813418|FG006|NOT COMPLETED|Primary Phase||0
8763580|NCT01235949|9813419|FG007|NOT COMPLETED|Primary Phase||0
8763581|NCT01235949|9813420|FG008|NOT COMPLETED|Primary Phase||0
8763582|NCT01235949|9813421|FG009|NOT COMPLETED|Primary Phase||0
8763583|NCT01235949|9813422|FG010|NOT COMPLETED|Primary Phase||0
8763584|NCT01235949|9813423|FG011|NOT COMPLETED|Primary Phase||0
8763585|NCT01235949|9813424|FG012|NOT COMPLETED|Primary Phase||0
8763586|NCT01235949|9813425|FG013|NOT COMPLETED|Primary Phase||0
8763587|NCT01235949|9813426|FG014|NOT COMPLETED|Primary Phase||0
8763588|NCT01235949|9813427|FG015|NOT COMPLETED|Primary Phase||0
8763589|NCT01235949|9813428|FG016|NOT COMPLETED|Primary Phase||0
8763590|NCT01235949|9813429|FG017|NOT COMPLETED|Primary Phase||0
8763591|NCT01235949|9813412|FG000|STARTED|Booster Phase|re-randomized to diverse treatments (IIBU-IIBU, IIBU-DIBU and IIBU-NIBU Groups) in booster phase|0
8763592|NCT01235949|9813413|FG001|STARTED|Booster Phase|re-randomized to diverse treatments (DIBU-IIBU, DIBU-DIBU and DIBU-NIBU Groups) in booster phase|0
8763593|NCT01235949|9813414|FG002|STARTED|Booster Phase|re-randomized to diverse treatments (NIBU-IIBU, NIBU-DIBU and NIBU-NIBU Groups) in booster phase|0
8763594|NCT01235949|9813415|FG003|STARTED|Booster Phase|subjects re-randomized to IPARA-NPARA Group in booster phase|0
8763595|NCT01235949|9813416|FG004|STARTED|Booster Phase|subjects re-randomized to DPARA-IPARA Group in booster phase|0
8763596|NCT01235949|9813417|FG005|STARTED|Booster Phase|subjects re-randomized to NPARA-IPARA Group in booster phase|0
8763597|NCT01235949|9813418|FG006|STARTED|Booster Phase|1/3 of subjects from primary IIBU group re-randomized to receive diverse booster phase treatments|64
8763598|NCT01235949|9813419|FG007|STARTED|Booster Phase|1/3 of subjects from primary IIBU group re-randomized to receive diverse booster phase treatments|60
8763599|NCT01235949|9813420|FG008|STARTED|Booster Phase|1/3 of subjects from primary IIBU group re-randomized to receive diverse booster phase treatments|63
8763600|NCT01235949|9813421|FG009|STARTED|Booster Phase|1/3 of subjects from primary DIBU group re-randomized to receive diverse booster phase treatments|63
8763601|NCT01235949|9813422|FG010|STARTED|Booster Phase|1/3 of subjects from primary DIBU group re-randomized to receive diverse booster phase treatments|63
8763602|NCT01235949|9813423|FG011|STARTED|Booster Phase|1/3 of subjects from primary DIBU group re-randomized to receive diverse booster phase treatments|63
8763603|NCT01235949|9813424|FG012|STARTED|Booster Phase|1/3 of subjects from primary NIBU group re-randomized to receive diverse booster phase treatments|63
8763604|NCT01235949|9813425|FG013|STARTED|Booster Phase|1/3 of subjects from primary NIBU group re-randomized to receive diverse booster phase treatments|65
8763605|NCT01235949|9813426|FG014|STARTED|Booster Phase|1/3 of subjects from primary NIBU group re-randomized to receive diverse booster phase treatments|62
8763606|NCT01235949|9813427|FG015|STARTED|Booster Phase|subjects from the primary IPARA group continuing in booster phase with different treatment|67
8763607|NCT01235949|9813428|FG016|STARTED|Booster Phase|subjects from the primary DPARA group continuing in booster phase with different treatment|68
8763608|NCT01235949|9813429|FG017|STARTED|Booster Phase|subjects from the primary NPARA group continuing in booster phase with different treatment|67
8763609|NCT01235949|9813412|FG000|COMPLETED|Booster Phase||0
8763610|NCT01235949|9813413|FG001|COMPLETED|Booster Phase||0
8763611|NCT01235949|9813414|FG002|COMPLETED|Booster Phase||0
8763612|NCT01235949|9813415|FG003|COMPLETED|Booster Phase||0
8763613|NCT01235949|9813416|FG004|COMPLETED|Booster Phase||0
8763614|NCT01235949|9813417|FG005|COMPLETED|Booster Phase||0
8763615|NCT01235949|9813418|FG006|COMPLETED|Booster Phase||64
8763616|NCT01235949|9813419|FG007|COMPLETED|Booster Phase||59
8763617|NCT01235949|9813420|FG008|COMPLETED|Booster Phase||61
8763618|NCT01235949|9813421|FG009|COMPLETED|Booster Phase||62
8763619|NCT01235949|9813422|FG010|COMPLETED|Booster Phase||61
8763620|NCT01235949|9813423|FG011|COMPLETED|Booster Phase||60
8763621|NCT01235949|9813424|FG012|COMPLETED|Booster Phase||60
8763622|NCT01235949|9813425|FG013|COMPLETED|Booster Phase||65
8763623|NCT01235949|9813426|FG014|COMPLETED|Booster Phase||60
8763624|NCT01235949|9813427|FG015|COMPLETED|Booster Phase||66
8763625|NCT01235949|9813428|FG016|COMPLETED|Booster Phase||68
8763626|NCT01235949|9813429|FG017|COMPLETED|Booster Phase||65
8763627|NCT01235949|9813412|FG000|NOT COMPLETED|Booster Phase||0
8763628|NCT01235949|9813413|FG001|NOT COMPLETED|Booster Phase||0
8763629|NCT01235949|9813414|FG002|NOT COMPLETED|Booster Phase||0
8763630|NCT01235949|9813415|FG003|NOT COMPLETED|Booster Phase||0
8763631|NCT01235949|9813416|FG004|NOT COMPLETED|Booster Phase||0
8763632|NCT01235949|9813417|FG005|NOT COMPLETED|Booster Phase||0
8763633|NCT01235949|9813418|FG006|NOT COMPLETED|Booster Phase||0
8763634|NCT01235949|9813419|FG007|NOT COMPLETED|Booster Phase||1
8763635|NCT01235949|9813420|FG008|NOT COMPLETED|Booster Phase||2
8763636|NCT01235949|9813421|FG009|NOT COMPLETED|Booster Phase||1
8763637|NCT01235949|9813422|FG010|NOT COMPLETED|Booster Phase||2
8763638|NCT01235949|9813423|FG011|NOT COMPLETED|Booster Phase||3
8763639|NCT01235949|9813424|FG012|NOT COMPLETED|Booster Phase||3
8763640|NCT01235949|9813425|FG013|NOT COMPLETED|Booster Phase||0
8763641|NCT01235949|9813426|FG014|NOT COMPLETED|Booster Phase||2
8763642|NCT01235949|9813427|FG015|NOT COMPLETED|Booster Phase||1
8763643|NCT01235949|9813428|FG016|NOT COMPLETED|Booster Phase||0
8763644|NCT01235949|9813429|FG017|NOT COMPLETED|Booster Phase||2
8763645|NCT01235975|9813469|FG000|STARTED|Overall Study||274
8763646|NCT01235975|9813470|FG001|STARTED|Overall Study||95
8763647|NCT01235975|9813469|FG000|COMPLETED|Overall Study||257
8763648|NCT01235975|9813470|FG001|COMPLETED|Overall Study||88
8763649|NCT01235975|9813469|FG000|NOT COMPLETED|Overall Study||17
8763650|NCT01235975|9813470|FG001|NOT COMPLETED|Overall Study||7
8763651|NCT01236001|9813478|FG000|STARTED|Overall Study||105
8763652|NCT01236001|9813479|FG001|STARTED|Overall Study||87
8763653|NCT01236001|9813478|FG000|COMPLETED|Overall Study||87
8763654|NCT01236001|9813479|FG001|COMPLETED|Overall Study||65
8763655|NCT01236001|9813478|FG000|NOT COMPLETED|Overall Study||18
8763656|NCT01236001|9813479|FG001|NOT COMPLETED|Overall Study||22
8763657|NCT01236053|9813508|FG000|STARTED|Overall Study||179138
8763658|NCT01236053|9813509|FG001|STARTED|Overall Study||1710950
8763659|NCT01236053|9813510|FG002|STARTED|Overall Study||1877
8763660|NCT01236053|9813511|FG003|STARTED|Overall Study||17853
8763661|NCT01236053|9813512|FG004|STARTED|Overall Study||212
8763662|NCT01236053|9813513|FG005|STARTED|Overall Study||2067
8763663|NCT01236053|9813514|FG006|STARTED|Overall Study||10855
8763664|NCT01236053|9813515|FG007|STARTED|Overall Study||102836
8763665|NCT01236053|9813516|FG008|STARTED|Overall Study||300
8763666|NCT01236053|9813517|FG009|STARTED|Overall Study||2935
8763667|NCT01236053|9813518|FG010|STARTED|Overall Study||19564
8763668|NCT01236053|9813519|FG011|STARTED|Overall Study||188924
8763669|NCT01236053|9813520|FG012|STARTED|Overall Study||148
8763670|NCT01236053|9813521|FG013|STARTED|Overall Study||1396
8763671|NCT01236053|9813522|FG014|STARTED|Overall Study||4600
8763672|NCT01236053|9813523|FG015|STARTED|Overall Study||43559
9026627|NCT04426500|10089088|FG000|STARTED|Overall Study||28
9026628|NCT04426500|10089089|FG001|STARTED|Overall Study||64
9026629|NCT04426500|10089090|FG002|STARTED|Overall Study||56
9026630|NCT04426500|10089088|FG000|COMPLETED|Overall Study||28
9026631|NCT04426500|10089089|FG001|COMPLETED|Overall Study||64
9026632|NCT04426500|10089090|FG002|COMPLETED|Overall Study||56
9026633|NCT04426500|10089088|FG000|NOT COMPLETED|Overall Study||0
9026634|NCT04426500|10089089|FG001|NOT COMPLETED|Overall Study||0
9026635|NCT04426500|10089090|FG002|NOT COMPLETED|Overall Study||0
9026636|NCT04042103|10089098|FG000|STARTED|Overall Study||21
9026637|NCT04042103|10089098|FG000|COMPLETED|Overall Study||19
9026638|NCT04042103|10089098|FG000|NOT COMPLETED|Overall Study||2
9026639|NCT04004208|10089104|FG000|STARTED|Overall Study||75
9026640|NCT04004208|10089105|FG001|STARTED|Overall Study||38
9026641|NCT04004208|10089104|FG000|SAF|Overall Study||75
9026642|NCT04004208|10089105|FG001|SAF|Overall Study||38
9026643|NCT04004208|10089104|FG000|PKS|Overall Study||75
9026644|NCT04004208|10089105|FG001|PKS|Overall Study||0
9026645|NCT04004208|10089104|FG000|AAS|Overall Study||75
9026646|NCT04004208|10089105|FG001|AAS|Overall Study||0
9026647|NCT04004208|10089104|FG000|COMPLETED|Overall Study||68
9026648|NCT04004208|10089105|FG001|COMPLETED|Overall Study||36
9026649|NCT04004208|10089104|FG000|NOT COMPLETED|Overall Study||7
9026650|NCT04004208|10089105|FG001|NOT COMPLETED|Overall Study||2
8763673|NCT01236053|9813524|FG016|STARTED|Overall Study||38
8763674|NCT01236053|9813525|FG017|STARTED|Overall Study||380
8763675|NCT01236053|9813526|FG018|STARTED|Overall Study||2155
8763676|NCT01236053|9813527|FG019|STARTED|Overall Study||20382
8763677|NCT01236053|9813528|FG020|STARTED|Overall Study||1272
8763678|NCT01236053|9813529|FG021|STARTED|Overall Study||12167
8763679|NCT01236053|9813508|FG000|COMPLETED|Overall Study||179138
8763680|NCT01236053|9813509|FG001|COMPLETED|Overall Study||1710950
8763681|NCT01236053|9813510|FG002|COMPLETED|Overall Study||1877
8763682|NCT01236053|9813511|FG003|COMPLETED|Overall Study||17853
8763683|NCT01236053|9813512|FG004|COMPLETED|Overall Study||212
8763684|NCT01236053|9813513|FG005|COMPLETED|Overall Study||2067
8763685|NCT01236053|9813514|FG006|COMPLETED|Overall Study||10855
8763686|NCT01236053|9813515|FG007|COMPLETED|Overall Study||102836
8763687|NCT01236053|9813516|FG008|COMPLETED|Overall Study||300
8763688|NCT01236053|9813517|FG009|COMPLETED|Overall Study||2935
8763689|NCT01236053|9813518|FG010|COMPLETED|Overall Study||19564
8763690|NCT01236053|9813519|FG011|COMPLETED|Overall Study||188924
8763691|NCT01236053|9813520|FG012|COMPLETED|Overall Study||148
8763692|NCT01236053|9813521|FG013|COMPLETED|Overall Study||1396
8763693|NCT01236053|9813522|FG014|COMPLETED|Overall Study||4600
8763694|NCT01236053|9813523|FG015|COMPLETED|Overall Study||43559
8763695|NCT01236053|9813524|FG016|COMPLETED|Overall Study||38
8763696|NCT01236053|9813525|FG017|COMPLETED|Overall Study||380
8763697|NCT01236053|9813526|FG018|COMPLETED|Overall Study||2155
8763698|NCT01236053|9813527|FG019|COMPLETED|Overall Study||20382
8763699|NCT01236053|9813528|FG020|COMPLETED|Overall Study||1272
8763700|NCT01236053|9813529|FG021|COMPLETED|Overall Study||12167
8763701|NCT01236053|9813508|FG000|NOT COMPLETED|Overall Study||0
8763702|NCT01236053|9813509|FG001|NOT COMPLETED|Overall Study||0
8763703|NCT01236053|9813510|FG002|NOT COMPLETED|Overall Study||0
8763704|NCT01236053|9813511|FG003|NOT COMPLETED|Overall Study||0
8763705|NCT01236053|9813512|FG004|NOT COMPLETED|Overall Study||0
8763706|NCT01236053|9813513|FG005|NOT COMPLETED|Overall Study||0
8763707|NCT01236053|9813514|FG006|NOT COMPLETED|Overall Study||0
8763708|NCT01236053|9813515|FG007|NOT COMPLETED|Overall Study||0
8763709|NCT01236053|9813516|FG008|NOT COMPLETED|Overall Study||0
8763710|NCT01236053|9813517|FG009|NOT COMPLETED|Overall Study||0
8763711|NCT01236053|9813518|FG010|NOT COMPLETED|Overall Study||0
8763712|NCT01236053|9813519|FG011|NOT COMPLETED|Overall Study||0
8763713|NCT01236053|9813520|FG012|NOT COMPLETED|Overall Study||0
8763714|NCT01236053|9813521|FG013|NOT COMPLETED|Overall Study||0
8763715|NCT01236053|9813522|FG014|NOT COMPLETED|Overall Study||0
8763716|NCT01236053|9813523|FG015|NOT COMPLETED|Overall Study||0
8763717|NCT01236053|9813524|FG016|NOT COMPLETED|Overall Study||0
8763718|NCT01236053|9813525|FG017|NOT COMPLETED|Overall Study||0
8763719|NCT01236053|9813526|FG018|NOT COMPLETED|Overall Study||0
8763720|NCT01236053|9813527|FG019|NOT COMPLETED|Overall Study||0
8763721|NCT01236053|9813528|FG020|NOT COMPLETED|Overall Study||0
8763722|NCT01236053|9813529|FG021|NOT COMPLETED|Overall Study||0
8763723|NCT01236105|9813578|FG000|STARTED|Overall Study||21
8763724|NCT01236105|9813578|FG000|COMPLETED|Overall Study||21
8763725|NCT01236105|9813578|FG000|NOT COMPLETED|Overall Study||0
8763726|NCT01236118|9813589|FG000|STARTED|Overall Study||6
8763727|NCT01236118|9813590|FG001|STARTED|Overall Study||5
8763728|NCT01236118|9813591|FG002|STARTED|Overall Study||17
8763729|NCT01236118|9813589|FG000|COMPLETED|Overall Study||4
8763730|NCT01236118|9813590|FG001|COMPLETED|Overall Study||4
8763731|NCT01236118|9813591|FG002|COMPLETED|Overall Study||14
8763732|NCT01236118|9813589|FG000|NOT COMPLETED|Overall Study||2
8763733|NCT01236118|9813590|FG001|NOT COMPLETED|Overall Study||1
8763734|NCT01236118|9813591|FG002|NOT COMPLETED|Overall Study||3
8763735|NCT01236170|9813599|FG000|STARTED|Overall Study||497
8763736|NCT01236170|9813599|FG000|COMPLETED|Overall Study||482
8763737|NCT01236170|9813599|FG000|NOT COMPLETED|Overall Study||15
8763738|NCT01236196|9813605|FG000|STARTED|Overall Study||18
8763739|NCT01236196|9813606|FG001|STARTED|Overall Study||21
8763740|NCT01236196|9813605|FG000|COMPLETED|Overall Study||17
8763741|NCT01236196|9813606|FG001|COMPLETED|Overall Study||13
8763742|NCT01236196|9813605|FG000|NOT COMPLETED|Overall Study||1
8763743|NCT01236196|9813606|FG001|NOT COMPLETED|Overall Study||8
8763744|NCT01236300|9813612|FG000|STARTED|Overall Study||66
8763745|NCT01236300|9813612|FG000|COMPLETED|Overall Study||66
8763746|NCT01236300|9813612|FG000|NOT COMPLETED|Overall Study||0
8763747|NCT01236326|9813619|FG000|STARTED|Overall Study||50
8763748|NCT01236326|9813620|FG001|STARTED|Overall Study||55
8763749|NCT01236326|9813619|FG000|COMPLETED|Overall Study||49
8763750|NCT01236326|9813620|FG001|COMPLETED|Overall Study||51
8763751|NCT01236326|9813619|FG000|NOT COMPLETED|Overall Study||1
8763752|NCT01236326|9813620|FG001|NOT COMPLETED|Overall Study||4
8763753|NCT01236339|9813628|FG000|STARTED|Overall Study||13
8763754|NCT01236339|9813629|FG001|STARTED|Overall Study||13
8763755|NCT01236339|9813628|FG000|LVP Crossover to TIPS|Overall Study||0
8763756|NCT01236339|9813629|FG001|LVP Crossover to TIPS|Overall Study|ONLY patients failing LVP and meeting crossover according to protocol definition|4
8763757|NCT01236339|9813628|FG000|COMPLETED|Overall Study||2
8763758|NCT01236339|9813629|FG001|COMPLETED|Overall Study||0
8763759|NCT01236339|9813628|FG000|NOT COMPLETED|Overall Study||11
8763760|NCT01236339|9813629|FG001|NOT COMPLETED|Overall Study||13
8763761|NCT01236352|9813647|FG000|STARTED|Overall Study||4
8763762|NCT01236352|9813648|FG001|STARTED|Overall Study||4
8763763|NCT01236352|9813649|FG002|STARTED|Overall Study||4
8763764|NCT01236352|9813650|FG003|STARTED|Overall Study||4
8763765|NCT01236352|9813651|FG004|STARTED|Overall Study||4
8763766|NCT01236352|9813652|FG005|STARTED|Overall Study||4
8763767|NCT01236352|9813653|FG006|STARTED|Overall Study||8
8763768|NCT01236352|9813654|FG007|STARTED|Overall Study||7
8763769|NCT01236352|9813655|FG008|STARTED|Overall Study||3
8763770|NCT01236352|9813656|FG009|STARTED|Overall Study||22
8763771|NCT01236352|9813657|FG010|STARTED|Overall Study||20
8763772|NCT01236352|9813647|FG000|COMPLETED|Overall Study||0
8763773|NCT01236352|9813648|FG001|COMPLETED|Overall Study||0
8763774|NCT01236352|9813649|FG002|COMPLETED|Overall Study||0
8763775|NCT01236352|9813650|FG003|COMPLETED|Overall Study||1
8763776|NCT01236352|9813651|FG004|COMPLETED|Overall Study||0
8763777|NCT01236352|9813652|FG005|COMPLETED|Overall Study||0
8763778|NCT01236352|9813653|FG006|COMPLETED|Overall Study||0
8763779|NCT01236352|9813654|FG007|COMPLETED|Overall Study||0
8763780|NCT01236352|9813655|FG008|COMPLETED|Overall Study||0
8763781|NCT01236352|9813656|FG009|COMPLETED|Overall Study||0
8763782|NCT01236352|9813657|FG010|COMPLETED|Overall Study||0
8763783|NCT01236352|9813647|FG000|NOT COMPLETED|Overall Study||4
8763784|NCT01236352|9813648|FG001|NOT COMPLETED|Overall Study||4
8763785|NCT01236352|9813649|FG002|NOT COMPLETED|Overall Study||4
8763786|NCT01236352|9813650|FG003|NOT COMPLETED|Overall Study||3
8763787|NCT01236352|9813651|FG004|NOT COMPLETED|Overall Study||4
8763788|NCT01236352|9813652|FG005|NOT COMPLETED|Overall Study||4
8763789|NCT01236352|9813653|FG006|NOT COMPLETED|Overall Study||8
8763790|NCT01236352|9813654|FG007|NOT COMPLETED|Overall Study||7
8763791|NCT01236352|9813655|FG008|NOT COMPLETED|Overall Study||3
8763792|NCT01236352|9813656|FG009|NOT COMPLETED|Overall Study||22
8763793|NCT01236352|9813657|FG010|NOT COMPLETED|Overall Study||20
8763794|NCT01236365|9813683|FG000|STARTED|Overall Study||21
8763795|NCT01236365|9813684|FG001|STARTED|Overall Study||21
8763796|NCT01236365|9813683|FG000|COMPLETED|Overall Study||19
8763797|NCT01236365|9813684|FG001|COMPLETED|Overall Study||19
8763798|NCT01236365|9813683|FG000|NOT COMPLETED|Overall Study||2
8763799|NCT01236365|9813684|FG001|NOT COMPLETED|Overall Study||2
8763800|NCT01236378|9813702|FG000|STARTED|Overall Study||24
8763801|NCT01236378|9813702|FG000|COMPLETED|Overall Study||24
8763802|NCT01236378|9813702|FG000|NOT COMPLETED|Overall Study||0
8763803|NCT01236391|9813706|FG000|STARTED|Overall Study|Participants who received study treatment|111
8763804|NCT01236391|9813706|FG000|COMPLETED|Overall Study|Participants who were on treatment or discontinued treatment due to disease progression or death|95
8763805|NCT01236391|9813706|FG000|NOT COMPLETED|Overall Study||16
8763806|NCT01236521|9813715|FG000|STARTED|Overall Study||131
8763807|NCT01236521|9813716|FG001|STARTED|Overall Study||130
8763808|NCT01236521|9813715|FG000|3-month Completed|Overall Study||122
8763809|NCT01236521|9813716|FG001|3-month Completed|Overall Study||119
8763810|NCT01236521|9813715|FG000|6-month Completed|Overall Study||122
8763811|NCT01236521|9813716|FG001|6-month Completed|Overall Study||116
8763812|NCT01236521|9813715|FG000|9-month Completed|Overall Study||115
8763813|NCT01236521|9813716|FG001|9-month Completed|Overall Study||101
8763814|NCT01236521|9813715|FG000|12-moth Completed|Overall Study||110
8763815|NCT01236521|9813716|FG001|12-moth Completed|Overall Study||105
8763816|NCT01236521|9813715|FG000|COMPLETED|Overall Study||110
8763817|NCT01236521|9813716|FG001|COMPLETED|Overall Study||105
8763818|NCT01236521|9813715|FG000|NOT COMPLETED|Overall Study||21
8763819|NCT01236521|9813716|FG001|NOT COMPLETED|Overall Study||25
8763820|NCT01236534|9813724|FG000|STARTED|Overall Study||11
8763821|NCT01236534|9813725|FG001|STARTED|Overall Study||10
8915642|NCT02176226|9975084|FG000|STARTED|Overall Study||105
8915643|NCT02176226|9975084|FG000|COMPLETED|Overall Study||96
8915644|NCT02176226|9975084|FG000|NOT COMPLETED|Overall Study||9
8915645|NCT02176291|9975090|FG000|STARTED|Overall Study||20
8915646|NCT02176291|9975091|FG001|STARTED|Overall Study||11
8915647|NCT02176291|9975090|FG000|COMPLETED|Overall Study||15
8915648|NCT02176291|9975091|FG001|COMPLETED|Overall Study||11
8915649|NCT02176291|9975090|FG000|NOT COMPLETED|Overall Study||5
8915650|NCT02176291|9975091|FG001|NOT COMPLETED|Overall Study||0
8915651|NCT02176343|9975097|FG000|STARTED|Overall Study||31
8915652|NCT02176343|9975097|FG000|COMPLETED|Overall Study||31
8915653|NCT02176343|9975097|FG000|NOT COMPLETED|Overall Study||0
8915654|NCT02176356|9975101|FG000|STARTED|Overall Study||116
8915655|NCT02176356|9975101|FG000|Eligible and Received Treatment|Overall Study||100
8915656|NCT02176356|9975101|FG000|COMPLETED|Overall Study||93
8915657|NCT02176356|9975101|FG000|NOT COMPLETED|Overall Study||23
8915658|NCT02176382|9975107|FG000|STARTED|DATA-HD Study||39
8915659|NCT02176382|9975108|FG001|STARTED|DATA-HD Study||37
8915660|NCT02176382|9975107|FG000|COMPLETED|DATA-HD Study||31
8915661|NCT02176382|9975108|FG001|COMPLETED|DATA-HD Study||29
8915662|NCT02176382|9975107|FG000|NOT COMPLETED|DATA-HD Study||8
8915663|NCT02176382|9975108|FG001|NOT COMPLETED|DATA-HD Study||8
8915664|NCT02176382|9975107|FG000|STARTED|DATA-HD Extension||27
8915665|NCT02176382|9975108|FG001|STARTED|DATA-HD Extension||26
8915666|NCT02176382|9975107|FG000|COMPLETED|DATA-HD Extension||26
8915667|NCT02176382|9975108|FG001|COMPLETED|DATA-HD Extension||26
8915668|NCT02176382|9975107|FG000|NOT COMPLETED|DATA-HD Extension||1
8915669|NCT02176382|9975108|FG001|NOT COMPLETED|DATA-HD Extension||0
8915670|NCT02176408|9975116|FG000|STARTED|Overall Study||15
8915671|NCT02176408|9975117|FG001|STARTED|Overall Study||16
8915672|NCT02176408|9975116|FG000|COMPLETED|Overall Study||9
9026651|NCT03817190|10089113|FG000|STARTED|Overall Study||110
8763822|NCT01236534|9813724|FG000|COMPLETED|Overall Study|2 subjects stopped treatment due to diarrhea, and 1 stopped treatment due to constipation.|8
8763823|NCT01236534|9813725|FG001|COMPLETED|Overall Study||10
8763824|NCT01236534|9813724|FG000|NOT COMPLETED|Overall Study||3
8763825|NCT01236534|9813725|FG001|NOT COMPLETED|Overall Study||0
8763826|NCT01236573|9813742|FG000|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||1
8915673|NCT02176408|9975117|FG001|COMPLETED|Overall Study||12
8915674|NCT02176408|9975116|FG000|NOT COMPLETED|Overall Study||6
8915675|NCT02176408|9975117|FG001|NOT COMPLETED|Overall Study||4
8763827|NCT01236573|9813743|FG001|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||1
8763828|NCT01236573|9813744|FG002|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||6
8763829|NCT01236573|9813745|FG003|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||1
8763830|NCT01236573|9813746|FG004|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
8763831|NCT01236573|9813747|FG005|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
8763832|NCT01236573|9813748|FG006|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
8763833|NCT01236573|9813749|FG007|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
8763834|NCT01236573|9813750|FG008|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
8763835|NCT01236573|9813751|FG009|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
8763836|NCT01236573|9813752|FG010|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
8763837|NCT01236573|9813742|FG000|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||1
8763838|NCT01236573|9813743|FG001|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||1
8763839|NCT01236573|9813744|FG002|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||6
8763840|NCT01236573|9813745|FG003|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||1
8763841|NCT01236573|9813746|FG004|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
8763842|NCT01236573|9813747|FG005|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
8763843|NCT01236573|9813748|FG006|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
8763844|NCT01236573|9813749|FG007|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
8763845|NCT01236573|9813750|FG008|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
8763846|NCT01236573|9813751|FG009|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
8763847|NCT01236573|9813752|FG010|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
8763848|NCT01236573|9813742|FG000|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
8763849|NCT01236573|9813743|FG001|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
8763850|NCT01236573|9813744|FG002|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
8763851|NCT01236573|9813745|FG003|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
8763852|NCT01236573|9813746|FG004|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
8763853|NCT01236573|9813747|FG005|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
8763854|NCT01236573|9813748|FG006|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
8763855|NCT01236573|9813749|FG007|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
8763856|NCT01236573|9813750|FG008|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
8763857|NCT01236573|9813751|FG009|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
8763858|NCT01236573|9813752|FG010|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
8763859|NCT01236573|9813742|FG000|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
8763860|NCT01236573|9813743|FG001|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
8763861|NCT01236573|9813744|FG002|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
8763862|NCT01236573|9813745|FG003|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
8763863|NCT01236573|9813746|FG004|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||1
8763864|NCT01236573|9813747|FG005|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||4
8763865|NCT01236573|9813748|FG006|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||3
8763866|NCT01236573|9813749|FG007|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||3
8763867|NCT01236573|9813750|FG008|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||4
8763868|NCT01236573|9813751|FG009|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||4
8763869|NCT01236573|9813752|FG010|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
9026652|NCT03817190|10089114|FG001|STARTED|Overall Study||109
9026653|NCT03817190|10089113|FG000|COMPLETED|Overall Study||50
9026654|NCT03817190|10089114|FG001|COMPLETED|Overall Study||50
9026655|NCT03817190|10089113|FG000|NOT COMPLETED|Overall Study||60
9026656|NCT03817190|10089114|FG001|NOT COMPLETED|Overall Study||59
9026657|NCT03447782|10089120|FG000|STARTED|Overall Study||45
9026658|NCT03447782|10089120|FG000|COMPLETED|Overall Study||25
9026659|NCT03447782|10089120|FG000|NOT COMPLETED|Overall Study||20
8763870|NCT01236573|9813742|FG000|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
8763871|NCT01236573|9813743|FG001|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
8763872|NCT01236573|9813744|FG002|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
8763873|NCT01236573|9813745|FG003|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
8763874|NCT01236573|9813746|FG004|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||1
8763875|NCT01236573|9813747|FG005|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||4
8763876|NCT01236573|9813748|FG006|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||2
8763877|NCT01236573|9813749|FG007|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||3
8763878|NCT01236573|9813750|FG008|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||2
8763879|NCT01236573|9813751|FG009|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||3
8763880|NCT01236573|9813752|FG010|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
8763881|NCT01236573|9813742|FG000|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
8763882|NCT01236573|9813743|FG001|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
8763883|NCT01236573|9813744|FG002|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
8763884|NCT01236573|9813745|FG003|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
8763885|NCT01236573|9813746|FG004|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
8763886|NCT01236573|9813747|FG005|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
8763887|NCT01236573|9813748|FG006|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||1
8763888|NCT01236573|9813749|FG007|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
8763889|NCT01236573|9813750|FG008|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||2
8763890|NCT01236573|9813751|FG009|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||1
8763891|NCT01236573|9813752|FG010|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
8763892|NCT01236573|9813742|FG000|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8763893|NCT01236573|9813743|FG001|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8763894|NCT01236573|9813744|FG002|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8763895|NCT01236573|9813745|FG003|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8763896|NCT01236573|9813746|FG004|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8763897|NCT01236573|9813747|FG005|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8763898|NCT01236573|9813748|FG006|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8763899|NCT01236573|9813749|FG007|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8763900|NCT01236573|9813750|FG008|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8763901|NCT01236573|9813751|FG009|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8763902|NCT01236573|9813752|FG010|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||6
8763903|NCT01236573|9813742|FG000|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8763904|NCT01236573|9813743|FG001|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8763905|NCT01236573|9813744|FG002|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8763906|NCT01236573|9813745|FG003|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8763907|NCT01236573|9813746|FG004|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8763908|NCT01236573|9813747|FG005|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8763909|NCT01236573|9813748|FG006|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8763910|NCT01236573|9813749|FG007|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8763911|NCT01236573|9813750|FG008|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8763912|NCT01236573|9813751|FG009|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8763913|NCT01236573|9813752|FG010|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||5
8763914|NCT01236573|9813742|FG000|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8763915|NCT01236573|9813743|FG001|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8763916|NCT01236573|9813744|FG002|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8763917|NCT01236573|9813745|FG003|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8763918|NCT01236573|9813746|FG004|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8763919|NCT01236573|9813747|FG005|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8763920|NCT01236573|9813748|FG006|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8763921|NCT01236573|9813749|FG007|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8763922|NCT01236573|9813750|FG008|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8763923|NCT01236573|9813751|FG009|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8763924|NCT01236573|9813752|FG010|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||1
8763925|NCT01236742|9813780|FG000|STARTED|Overall Study||18
8763926|NCT01236742|9813781|FG001|STARTED|Overall Study||19
8763927|NCT01236742|9813782|FG002|STARTED|Overall Study||16
8763928|NCT01236742|9813780|FG000|COMPLETED|Overall Study||15
8763929|NCT01236742|9813781|FG001|COMPLETED|Overall Study||16
8763930|NCT01236742|9813782|FG002|COMPLETED|Overall Study||13
8763931|NCT01236742|9813780|FG000|NOT COMPLETED|Overall Study||3
8763932|NCT01236742|9813781|FG001|NOT COMPLETED|Overall Study||3
8763933|NCT01236742|9813782|FG002|NOT COMPLETED|Overall Study||3
8808354|NCT01490632|9860709|FG008|NOT COMPLETED|Part A: Initial Treatment Period||0
8808355|NCT01490632|9860710|FG009|NOT COMPLETED|Part A: Initial Treatment Period||0
8808356|NCT01490632|9860711|FG010|NOT COMPLETED|Part A: Initial Treatment Period||0
8808357|NCT01490632|9860712|FG011|NOT COMPLETED|Part A: Initial Treatment Period||0
8808358|NCT01490632|9860713|FG012|NOT COMPLETED|Part A: Initial Treatment Period||0
8808359|NCT01490632|9860714|FG013|NOT COMPLETED|Part A: Initial Treatment Period||0
8808360|NCT01490632|9860715|FG014|NOT COMPLETED|Part A: Initial Treatment Period||0
8808361|NCT01490632|9860716|FG015|NOT COMPLETED|Part A: Initial Treatment Period||0
8808362|NCT01490632|9860717|FG016|NOT COMPLETED|Part A: Initial Treatment Period||0
8808363|NCT01490632|9860718|FG017|NOT COMPLETED|Part A: Initial Treatment Period||0
8808364|NCT01490632|9860719|FG018|NOT COMPLETED|Part A: Initial Treatment Period||0
8808365|NCT01490632|9860720|FG019|NOT COMPLETED|Part A: Initial Treatment Period||0
8808366|NCT01490632|9860701|FG000|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
8808367|NCT01490632|9860702|FG001|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
8915676|NCT02176421|9975123|FG000|STARTED|Overall Study||80
9026660|NCT03041311|10089126|FG000|STARTED|Overall Study||54
9026661|NCT03041311|10089127|FG001|STARTED|Overall Study||53
8763934|NCT01236755|9813790|FG000|STARTED|Spectacles Wearing Phase||91
8763935|NCT01236755|9813790|FG000|COMPLETED|Spectacles Wearing Phase||74
8763936|NCT01236755|9813790|FG000|NOT COMPLETED|Spectacles Wearing Phase||17
8763937|NCT01236755|9813790|FG000|STARTED|Orthokeratology Wearing Phase||74
8763938|NCT01236755|9813790|FG000|COMPLETED|Orthokeratology Wearing Phase||66
8763939|NCT01236755|9813790|FG000|NOT COMPLETED|Orthokeratology Wearing Phase||8
8763940|NCT01236768|9813797|FG000|STARTED|Overall Study||201
8763941|NCT01236768|9813798|FG001|STARTED|Overall Study||206
8763942|NCT01236768|9813797|FG000|COMPLETED|Overall Study||112
8763943|NCT01236768|9813798|FG001|COMPLETED|Overall Study||145
8763944|NCT01236768|9813797|FG000|NOT COMPLETED|Overall Study||89
8763945|NCT01236768|9813798|FG001|NOT COMPLETED|Overall Study||61
8763946|NCT01237041|9813810|FG000|STARTED|Overall Study||2
8763947|NCT01237041|9813811|FG001|STARTED|Overall Study||3
8763948|NCT01237041|9813812|FG002|STARTED|Overall Study||2
8763949|NCT01237041|9813813|FG003|STARTED|Overall Study||5
8763950|NCT01237041|9813814|FG004|STARTED|Overall Study||5
8763951|NCT01237041|9813810|FG000|COMPLETED|Overall Study||2
8763952|NCT01237041|9813811|FG001|COMPLETED|Overall Study||3
8763953|NCT01237041|9813812|FG002|COMPLETED|Overall Study||2
8763954|NCT01237041|9813813|FG003|COMPLETED|Overall Study||5
8763955|NCT01237041|9813814|FG004|COMPLETED|Overall Study||5
8763956|NCT01237041|9813810|FG000|NOT COMPLETED|Overall Study||0
8763957|NCT01237041|9813811|FG001|NOT COMPLETED|Overall Study||0
8763958|NCT01237041|9813812|FG002|NOT COMPLETED|Overall Study||0
8763959|NCT01237041|9813813|FG003|NOT COMPLETED|Overall Study||0
8763960|NCT01237041|9813814|FG004|NOT COMPLETED|Overall Study||0
8763961|NCT01237054|9813824|FG000|STARTED|Overall Study||31
8763962|NCT01237054|9813824|FG000|COMPLETED|Overall Study||30
8763963|NCT01237054|9813824|FG000|NOT COMPLETED|Overall Study||1
8763964|NCT01237080|9813833|FG000|STARTED|Overall Study||50
8763965|NCT01237080|9813834|FG001|STARTED|Overall Study||50
8763966|NCT01237080|9813833|FG000|COMPLETED|Overall Study||50
8763967|NCT01237080|9813834|FG001|COMPLETED|Overall Study||50
8763968|NCT01237080|9813833|FG000|NOT COMPLETED|Overall Study||0
8763969|NCT01237080|9813834|FG001|NOT COMPLETED|Overall Study||0
8763970|NCT01237197|9813842|FG000|STARTED|Randomization Period||13
8763971|NCT01237197|9813843|FG001|STARTED|Randomization Period||13
8763972|NCT01237197|9813842|FG000|COMPLETED|Randomization Period||12
8763973|NCT01237197|9813843|FG001|COMPLETED|Randomization Period||10
8763974|NCT01237197|9813842|FG000|NOT COMPLETED|Randomization Period||1
8763975|NCT01237197|9813843|FG001|NOT COMPLETED|Randomization Period||3
8763976|NCT01237197|9813842|FG000|STARTED|Open Label Period||12
8763977|NCT01237197|9813843|FG001|STARTED|Open Label Period||10
8763978|NCT01237197|9813842|FG000|COMPLETED|Open Label Period||12
8763979|NCT01237197|9813843|FG001|COMPLETED|Open Label Period||10
8763980|NCT01237197|9813842|FG000|NOT COMPLETED|Open Label Period||0
8763981|NCT01237197|9813843|FG001|NOT COMPLETED|Open Label Period||0
8763982|NCT01237223|9813855|FG000|STARTED|Single Blind(Run-in Period, 4 Weeks)|All the patients enrolled to single blind period received only placebo treatment.|1342
8763983|NCT01237223|9813856|FG001|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
8763984|NCT01237223|9813857|FG002|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
8763985|NCT01237223|9813858|FG003|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
8763986|NCT01237223|9813859|FG004|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
8763987|NCT01237223|9813860|FG005|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
8763988|NCT01237223|9813855|FG000|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||944
8763989|NCT01237223|9813856|FG001|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
8763990|NCT01237223|9813857|FG002|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
8763991|NCT01237223|9813858|FG003|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
8763992|NCT01237223|9813859|FG004|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
8763993|NCT01237223|9813860|FG005|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
8763994|NCT01237223|9813855|FG000|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||398
8763995|NCT01237223|9813856|FG001|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
9026662|NCT03041311|10089126|FG000|COMPLETED|Overall Study||0
9026663|NCT03041311|10089127|FG001|COMPLETED|Overall Study||0
9026664|NCT03041311|10089126|FG000|NOT COMPLETED|Overall Study||54
9026665|NCT03041311|10089127|FG001|NOT COMPLETED|Overall Study||53
9026666|NCT03020914|10089143|FG000|STARTED|Overall Study||10
9026667|NCT03020914|10089144|FG001|STARTED|Overall Study||9
9026668|NCT03020914|10089143|FG000|COMPLETED|Overall Study||9
9026669|NCT03020914|10089144|FG001|COMPLETED|Overall Study||9
9026670|NCT03020914|10089143|FG000|NOT COMPLETED|Overall Study||1
9026671|NCT03020914|10089144|FG001|NOT COMPLETED|Overall Study||0
9026672|NCT02803307|10089152|FG000|STARTED|Overall Study||20
9026673|NCT02803307|10089153|FG001|STARTED|Overall Study||20
9026674|NCT02803307|10089152|FG000|COMPLETED|Overall Study||20
9026675|NCT02803307|10089153|FG001|COMPLETED|Overall Study||20
9026676|NCT02803307|10089152|FG000|NOT COMPLETED|Overall Study||0
9026677|NCT02803307|10089153|FG001|NOT COMPLETED|Overall Study||0
9026678|NCT02698891|10089159|FG000|STARTED|Overall Study||127
9026679|NCT02698891|10089159|FG000|Treated|Overall Study||125
9026680|NCT02698891|10089159|FG000|COMPLETED|Overall Study||115
9026681|NCT02698891|10089159|FG000|NOT COMPLETED|Overall Study||12
8763996|NCT01237223|9813857|FG002|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
8763997|NCT01237223|9813858|FG003|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
8763998|NCT01237223|9813859|FG004|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
8763999|NCT01237223|9813860|FG005|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
8764000|NCT01237223|9813855|FG000|STARTED|Double Blind (Treatment Period, 8 Weeks)||153
8764001|NCT01237223|9813856|FG001|STARTED|Double Blind (Treatment Period, 8 Weeks)||157
8764002|NCT01237223|9813857|FG002|STARTED|Double Blind (Treatment Period, 8 Weeks)||158
8764003|NCT01237223|9813858|FG003|STARTED|Double Blind (Treatment Period, 8 Weeks)||158
8764004|NCT01237223|9813859|FG004|STARTED|Double Blind (Treatment Period, 8 Weeks)||159
8764005|NCT01237223|9813860|FG005|STARTED|Double Blind (Treatment Period, 8 Weeks)||159
8764006|NCT01237223|9813855|FG000|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||120
8764007|NCT01237223|9813856|FG001|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||142
8764008|NCT01237223|9813857|FG002|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||143
8764009|NCT01237223|9813858|FG003|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||153
8764010|NCT01237223|9813859|FG004|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||155
8764011|NCT01237223|9813860|FG005|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||154
8764012|NCT01237223|9813855|FG000|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||33
8764013|NCT01237223|9813856|FG001|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||15
8764014|NCT01237223|9813857|FG002|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||15
8764015|NCT01237223|9813858|FG003|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||5
8764016|NCT01237223|9813859|FG004|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||4
8764017|NCT01237223|9813860|FG005|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||5
8764018|NCT01237301|9813878|FG000|STARTED|Overall Study||65
8764019|NCT01237301|9813879|FG001|STARTED|Overall Study||59
8764020|NCT01237301|9813878|FG000|COMPLETED|Overall Study||60
8764021|NCT01237301|9813879|FG001|COMPLETED|Overall Study||55
8764022|NCT01237301|9813878|FG000|NOT COMPLETED|Overall Study||5
8764023|NCT01237301|9813879|FG001|NOT COMPLETED|Overall Study||4
8764024|NCT01237327|9813889|FG000|STARTED|Overall Study||43
8764025|NCT01237327|9813890|FG001|STARTED|Overall Study||41
8764026|NCT01237327|9813889|FG000|Stopped Treatment in Core Study (D/C)|Overall Study|Continued in Extension Study for follow-up only; not treated with study medication.|22
8764027|NCT01237327|9813890|FG001|Stopped Treatment in Core Study (D/C)|Overall Study|Continued in Extension Study for follow-up only; not treated with study medication.|24
8764028|NCT01237327|9813889|FG000|Completed Treatment in Core Study|Overall Study|Completed 26 weeks of treatment in Core Study; continued in Extension Study for follow-up only.|3
8764029|NCT01237327|9813890|FG001|Completed Treatment in Core Study|Overall Study|Completed 26 weeks of treatment in Core Study; continued in Extension Study for follow-up only.|2
8764030|NCT01237327|9813889|FG000|Continued Treatment in Extension Study|Overall Study||21
8764031|NCT01237327|9813890|FG001|Continued Treatment in Extension Study|Overall Study||17
8764032|NCT01237327|9813889|FG000|COMPLETED|Overall Study|On treatment at Extension Study cut-off date.|1
8764033|NCT01237327|9813890|FG001|COMPLETED|Overall Study|On treatment at Extension Study cut-off date.|1
8764034|NCT01237327|9813889|FG000|NOT COMPLETED|Overall Study||42
8764035|NCT01237327|9813890|FG001|NOT COMPLETED|Overall Study||40
8764036|NCT01237340|9813896|FG000|STARTED|Overall Study||59
8764037|NCT01237340|9813896|FG000|COMPLETED|Overall Study||19
8764038|NCT01237340|9813896|FG000|NOT COMPLETED|Overall Study||40
8764039|NCT01237353|9813903|FG000|STARTED|Overall Study||6
8764040|NCT01237353|9813903|FG000|COMPLETED|Overall Study||6
8764041|NCT01237353|9813903|FG000|NOT COMPLETED|Overall Study||0
8764042|NCT01237587|9813909|FG000|STARTED|Double Blind Treatment (Acute Phase)||91
8764043|NCT01237587|9813910|FG001|STARTED|Double Blind Treatment (Acute Phase)||93
8764044|NCT01237587|9813909|FG000|Received at Least One Dose of Study Drug|Double Blind Treatment (Acute Phase)||91
8764045|NCT01237587|9813910|FG001|Received at Least One Dose of Study Drug|Double Blind Treatment (Acute Phase)||93
8764046|NCT01237587|9813909|FG000|COMPLETED|Double Blind Treatment (Acute Phase)||74
8764047|NCT01237587|9813910|FG001|COMPLETED|Double Blind Treatment (Acute Phase)||75
8764048|NCT01237587|9813909|FG000|NOT COMPLETED|Double Blind Treatment (Acute Phase)||17
8764049|NCT01237587|9813910|FG001|NOT COMPLETED|Double Blind Treatment (Acute Phase)||18
8764050|NCT01237587|9813909|FG000|STARTED|Open Label Treatment (Extension Phase)||74
8764051|NCT01237587|9813910|FG001|STARTED|Open Label Treatment (Extension Phase)||75
8764052|NCT01237587|9813909|FG000|Received at Least One Dose of Study Drug|Open Label Treatment (Extension Phase)||74
8764053|NCT01237587|9813910|FG001|Received at Least One Dose of Study Drug|Open Label Treatment (Extension Phase)||75
8764054|NCT01237587|9813909|FG000|COMPLETED|Open Label Treatment (Extension Phase)||56
8764055|NCT01237587|9813910|FG001|COMPLETED|Open Label Treatment (Extension Phase)||50
8764056|NCT01237587|9813909|FG000|NOT COMPLETED|Open Label Treatment (Extension Phase)||18
8764057|NCT01237587|9813910|FG001|NOT COMPLETED|Open Label Treatment (Extension Phase)||25
8764058|NCT01237587|9813909|FG000|STARTED|Taper Phase|Participants who discontinued Acute or Extension phase had an option to enter tapering phase.|36
8764059|NCT01237587|9813910|FG001|STARTED|Taper Phase|Participants who discontinued Acute or Extension phase had an option to enter tapering phase.|44
8764060|NCT01237587|9813909|FG000|COMPLETED|Taper Phase||31
8764061|NCT01237587|9813910|FG001|COMPLETED|Taper Phase||34
8764062|NCT01237587|9813909|FG000|NOT COMPLETED|Taper Phase||5
8764063|NCT01237587|9813910|FG001|NOT COMPLETED|Taper Phase||10
8764064|NCT01237678|9813926|FG000|STARTED|Phase I - IMGN901+Carboplatin+Etoposide||33
8764065|NCT01237678|9813927|FG001|STARTED|Phase I - IMGN901+Carboplatin+Etoposide||0
8764066|NCT01237678|9813928|FG002|STARTED|Phase I - IMGN901+Carboplatin+Etoposide||0
8764067|NCT01237678|9813926|FG000|Received Intervention|Phase I - IMGN901+Carboplatin+Etoposide||33
8764068|NCT01237678|9813927|FG001|Received Intervention|Phase I - IMGN901+Carboplatin+Etoposide||0
8764069|NCT01237678|9813928|FG002|Received Intervention|Phase I - IMGN901+Carboplatin+Etoposide||0
8764070|NCT01237678|9813926|FG000|COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
8764071|NCT01237678|9813927|FG001|COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
8764072|NCT01237678|9813928|FG002|COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
8764073|NCT01237678|9813926|FG000|NOT COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||33
8764074|NCT01237678|9813927|FG001|NOT COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
8764075|NCT01237678|9813928|FG002|NOT COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
8764076|NCT01237678|9813926|FG000|STARTED|Phase II||0
8764077|NCT01237678|9813927|FG001|STARTED|Phase II|98 subjects were randomized, 94 subjects treated|98
8764078|NCT01237678|9813928|FG002|STARTED|Phase II|50 subjects were randomized, 47 subjects treated|50
8764079|NCT01237678|9813926|FG000|Received Intervention|Phase II||0
8764080|NCT01237678|9813927|FG001|Received Intervention|Phase II||94
8764081|NCT01237678|9813928|FG002|Received Intervention|Phase II||47
8764082|NCT01237678|9813926|FG000|COMPLETED|Phase II||0
8764083|NCT01237678|9813927|FG001|COMPLETED|Phase II||0
8764084|NCT01237678|9813928|FG002|COMPLETED|Phase II||0
8764085|NCT01237678|9813926|FG000|NOT COMPLETED|Phase II||0
8764086|NCT01237678|9813927|FG001|NOT COMPLETED|Phase II||98
8764087|NCT01237678|9813928|FG002|NOT COMPLETED|Phase II||50
8764088|NCT01237821|9813945|FG000|STARTED|Overall Study||32
8764089|NCT01237821|9813946|FG001|STARTED|Overall Study||34
8764090|NCT01237821|9813945|FG000|COMPLETED|Overall Study||26
8764091|NCT01237821|9813946|FG001|COMPLETED|Overall Study||34
8764092|NCT01237821|9813945|FG000|NOT COMPLETED|Overall Study||6
8764093|NCT01237821|9813946|FG001|NOT COMPLETED|Overall Study||0
8764094|NCT01237899|9813963|FG000|STARTED|First Dosing Period||1
8764095|NCT01237899|9813964|FG001|STARTED|First Dosing Period||3
8764096|NCT01237899|9813965|FG002|STARTED|First Dosing Period||4
8764097|NCT01237899|9813966|FG003|STARTED|First Dosing Period||3
8764098|NCT01237899|9813967|FG004|STARTED|First Dosing Period||2
8764099|NCT01237899|9813968|FG005|STARTED|First Dosing Period||4
8764100|NCT01237899|9813969|FG006|STARTED|First Dosing Period||1
8764101|NCT01237899|9813970|FG007|STARTED|First Dosing Period||3
8764102|NCT01237899|9813971|FG008|STARTED|First Dosing Period||4
8764103|NCT01237899|9813972|FG009|STARTED|First Dosing Period||3
8764104|NCT01237899|9813973|FG010|STARTED|First Dosing Period||4
8764105|NCT01237899|9813963|FG000|COMPLETED|First Dosing Period||1
8764106|NCT01237899|9813964|FG001|COMPLETED|First Dosing Period||3
8764107|NCT01237899|9813965|FG002|COMPLETED|First Dosing Period||4
8764108|NCT01237899|9813966|FG003|COMPLETED|First Dosing Period||3
8764109|NCT01237899|9813967|FG004|COMPLETED|First Dosing Period||2
8764110|NCT01237899|9813968|FG005|COMPLETED|First Dosing Period||4
8764111|NCT01237899|9813969|FG006|COMPLETED|First Dosing Period||1
8764112|NCT01237899|9813970|FG007|COMPLETED|First Dosing Period||3
8764113|NCT01237899|9813971|FG008|COMPLETED|First Dosing Period||4
8764114|NCT01237899|9813972|FG009|COMPLETED|First Dosing Period||3
8764115|NCT01237899|9813973|FG010|COMPLETED|First Dosing Period||4
8764116|NCT01237899|9813963|FG000|NOT COMPLETED|First Dosing Period||0
8764117|NCT01237899|9813964|FG001|NOT COMPLETED|First Dosing Period||0
8764118|NCT01237899|9813965|FG002|NOT COMPLETED|First Dosing Period||0
8764119|NCT01237899|9813966|FG003|NOT COMPLETED|First Dosing Period||0
8764120|NCT01237899|9813967|FG004|NOT COMPLETED|First Dosing Period||0
8764121|NCT01237899|9813968|FG005|NOT COMPLETED|First Dosing Period||0
8764122|NCT01237899|9813969|FG006|NOT COMPLETED|First Dosing Period||0
8764123|NCT01237899|9813970|FG007|NOT COMPLETED|First Dosing Period||0
8764124|NCT01237899|9813971|FG008|NOT COMPLETED|First Dosing Period||0
8764125|NCT01237899|9813972|FG009|NOT COMPLETED|First Dosing Period||0
8764126|NCT01237899|9813973|FG010|NOT COMPLETED|First Dosing Period||0
8764127|NCT01237899|9813963|FG000|STARTED|Washout Period of at Least 7 Days||1
8764128|NCT01237899|9813964|FG001|STARTED|Washout Period of at Least 7 Days||3
8764129|NCT01237899|9813965|FG002|STARTED|Washout Period of at Least 7 Days||4
8764130|NCT01237899|9813966|FG003|STARTED|Washout Period of at Least 7 Days||3
8764131|NCT01237899|9813967|FG004|STARTED|Washout Period of at Least 7 Days||2
8764132|NCT01237899|9813968|FG005|STARTED|Washout Period of at Least 7 Days||4
8764133|NCT01237899|9813969|FG006|STARTED|Washout Period of at Least 7 Days||1
8764134|NCT01237899|9813970|FG007|STARTED|Washout Period of at Least 7 Days||3
8764135|NCT01237899|9813971|FG008|STARTED|Washout Period of at Least 7 Days||4
8764136|NCT01237899|9813972|FG009|STARTED|Washout Period of at Least 7 Days||3
8764137|NCT01237899|9813973|FG010|STARTED|Washout Period of at Least 7 Days||4
8764138|NCT01237899|9813963|FG000|COMPLETED|Washout Period of at Least 7 Days||1
8764139|NCT01237899|9813964|FG001|COMPLETED|Washout Period of at Least 7 Days||3
8764140|NCT01237899|9813965|FG002|COMPLETED|Washout Period of at Least 7 Days||3
8764141|NCT01237899|9813966|FG003|COMPLETED|Washout Period of at Least 7 Days||3
8764142|NCT01237899|9813967|FG004|COMPLETED|Washout Period of at Least 7 Days||2
8764143|NCT01237899|9813968|FG005|COMPLETED|Washout Period of at Least 7 Days||4
8764144|NCT01237899|9813969|FG006|COMPLETED|Washout Period of at Least 7 Days||1
8764145|NCT01237899|9813970|FG007|COMPLETED|Washout Period of at Least 7 Days||3
8764146|NCT01237899|9813971|FG008|COMPLETED|Washout Period of at Least 7 Days||4
8764147|NCT01237899|9813972|FG009|COMPLETED|Washout Period of at Least 7 Days||3
8764148|NCT01237899|9813973|FG010|COMPLETED|Washout Period of at Least 7 Days||4
8764149|NCT01237899|9813963|FG000|NOT COMPLETED|Washout Period of at Least 7 Days||0
8764150|NCT01237899|9813964|FG001|NOT COMPLETED|Washout Period of at Least 7 Days||0
8764151|NCT01237899|9813965|FG002|NOT COMPLETED|Washout Period of at Least 7 Days||1
9026682|NCT02537678|10089165|FG000|STARTED|Baseline to Post-treatment|91 parents/guardians and 91 children started.|91
8764152|NCT01237899|9813966|FG003|NOT COMPLETED|Washout Period of at Least 7 Days||0
8764153|NCT01237899|9813967|FG004|NOT COMPLETED|Washout Period of at Least 7 Days||0
8764154|NCT01237899|9813968|FG005|NOT COMPLETED|Washout Period of at Least 7 Days||0
8764155|NCT01237899|9813969|FG006|NOT COMPLETED|Washout Period of at Least 7 Days||0
8764156|NCT01237899|9813970|FG007|NOT COMPLETED|Washout Period of at Least 7 Days||0
8764157|NCT01237899|9813971|FG008|NOT COMPLETED|Washout Period of at Least 7 Days||0
8764158|NCT01237899|9813972|FG009|NOT COMPLETED|Washout Period of at Least 7 Days||0
8764159|NCT01237899|9813973|FG010|NOT COMPLETED|Washout Period of at Least 7 Days||0
8764160|NCT01237899|9813963|FG000|STARTED|Second Dosing Period||1
8764161|NCT01237899|9813964|FG001|STARTED|Second Dosing Period||3
8764162|NCT01237899|9813965|FG002|STARTED|Second Dosing Period||3
8764163|NCT01237899|9813966|FG003|STARTED|Second Dosing Period||3
8764164|NCT01237899|9813967|FG004|STARTED|Second Dosing Period||2
8764165|NCT01237899|9813968|FG005|STARTED|Second Dosing Period||4
8764166|NCT01237899|9813969|FG006|STARTED|Second Dosing Period||1
8764167|NCT01237899|9813970|FG007|STARTED|Second Dosing Period||3
8764168|NCT01237899|9813971|FG008|STARTED|Second Dosing Period||4
8764169|NCT01237899|9813972|FG009|STARTED|Second Dosing Period||3
8764170|NCT01237899|9813973|FG010|STARTED|Second Dosing Period||4
8764171|NCT01237899|9813963|FG000|COMPLETED|Second Dosing Period||1
8764172|NCT01237899|9813964|FG001|COMPLETED|Second Dosing Period||3
8764173|NCT01237899|9813965|FG002|COMPLETED|Second Dosing Period||3
8764174|NCT01237899|9813966|FG003|COMPLETED|Second Dosing Period||3
8764175|NCT01237899|9813967|FG004|COMPLETED|Second Dosing Period||2
8764176|NCT01237899|9813968|FG005|COMPLETED|Second Dosing Period||4
8764177|NCT01237899|9813969|FG006|COMPLETED|Second Dosing Period||1
8764178|NCT01237899|9813970|FG007|COMPLETED|Second Dosing Period||3
8764179|NCT01237899|9813971|FG008|COMPLETED|Second Dosing Period||4
8764180|NCT01237899|9813972|FG009|COMPLETED|Second Dosing Period||3
8764181|NCT01237899|9813973|FG010|COMPLETED|Second Dosing Period||4
8764182|NCT01237899|9813963|FG000|NOT COMPLETED|Second Dosing Period||0
8764183|NCT01237899|9813964|FG001|NOT COMPLETED|Second Dosing Period||0
8764184|NCT01237899|9813965|FG002|NOT COMPLETED|Second Dosing Period||0
8764185|NCT01237899|9813966|FG003|NOT COMPLETED|Second Dosing Period||0
8764186|NCT01237899|9813967|FG004|NOT COMPLETED|Second Dosing Period||0
8764187|NCT01237899|9813968|FG005|NOT COMPLETED|Second Dosing Period||0
8764188|NCT01237899|9813969|FG006|NOT COMPLETED|Second Dosing Period||0
8764189|NCT01237899|9813970|FG007|NOT COMPLETED|Second Dosing Period||0
8764190|NCT01237899|9813971|FG008|NOT COMPLETED|Second Dosing Period||0
8764191|NCT01237899|9813972|FG009|NOT COMPLETED|Second Dosing Period||0
8764192|NCT01237899|9813973|FG010|NOT COMPLETED|Second Dosing Period||0
8764193|NCT01237951|9813991|FG000|STARTED|Overall Study||75
8764194|NCT01237951|9813991|FG000|COMPLETED|Overall Study||74
8764195|NCT01237951|9813991|FG000|NOT COMPLETED|Overall Study||1
8764196|NCT01238120|9813999|FG000|STARTED|Overall Study||25
8764197|NCT01238120|9814000|FG001|STARTED|Overall Study||23
8764198|NCT01238120|9814001|FG002|STARTED|Overall Study||25
8764199|NCT01238120|9814002|FG003|STARTED|Overall Study||24
8764200|NCT01238120|9813999|FG000|Received Intervention and Completed Baseline Assessments|Overall Study||21
8764201|NCT01238120|9814000|FG001|Received Intervention and Completed Baseline Assessments|Overall Study||22
8764202|NCT01238120|9814001|FG002|Received Intervention and Completed Baseline Assessments|Overall Study||22
8764203|NCT01238120|9814002|FG003|Received Intervention and Completed Baseline Assessments|Overall Study||21
8764204|NCT01238120|9813999|FG000|COMPLETED|Overall Study||17
8764205|NCT01238120|9814000|FG001|COMPLETED|Overall Study||22
8764206|NCT01238120|9814001|FG002|COMPLETED|Overall Study||21
8764207|NCT01238120|9814002|FG003|COMPLETED|Overall Study||18
8764208|NCT01238120|9813999|FG000|NOT COMPLETED|Overall Study||8
8764209|NCT01238120|9814000|FG001|NOT COMPLETED|Overall Study||1
8764210|NCT01238120|9814001|FG002|NOT COMPLETED|Overall Study||4
8764211|NCT01238120|9814002|FG003|NOT COMPLETED|Overall Study||6
8764212|NCT01238172|9814014|FG000|STARTED|Overall Study||237
8764213|NCT01238172|9814015|FG001|STARTED|Overall Study||241
8764214|NCT01238172|9814014|FG000|COMPLETED|Overall Study||226
8764215|NCT01238172|9814015|FG001|COMPLETED|Overall Study||217
8764216|NCT01238172|9814014|FG000|NOT COMPLETED|Overall Study||11
8764217|NCT01238172|9814015|FG001|NOT COMPLETED|Overall Study||24
8764218|NCT01238341|9814021|FG000|STARTED|Overall Study||7
8764219|NCT01238341|9814021|FG000|COMPLETED|Overall Study||7
8764220|NCT01238341|9814021|FG000|NOT COMPLETED|Overall Study||0
8764221|NCT01238471|9814027|FG000|STARTED|Overall Study||10
8764222|NCT01238471|9814028|FG001|STARTED|Overall Study||10
8764223|NCT01238471|9814027|FG000|COMPLETED|Overall Study||10
8764224|NCT01238471|9814028|FG001|COMPLETED|Overall Study||10
8764225|NCT01238471|9814027|FG000|NOT COMPLETED|Overall Study||0
8764226|NCT01238471|9814028|FG001|NOT COMPLETED|Overall Study||0
8764227|NCT01238536|9814036|FG000|STARTED|Overall Study||200
8764228|NCT01238536|9814037|FG001|STARTED|Overall Study||200
8764229|NCT01238536|9814036|FG000|COMPLETED|Overall Study||153
8764230|NCT01238536|9814037|FG001|COMPLETED|Overall Study||150
8764231|NCT01238536|9814036|FG000|NOT COMPLETED|Overall Study||47
8764232|NCT01238536|9814037|FG001|NOT COMPLETED|Overall Study||50
8764233|NCT01238549|9814045|FG000|STARTED|Overall Study||284
8764234|NCT01238549|9814045|FG000|COMPLETED|Overall Study||248
8764235|NCT01238549|9814045|FG000|NOT COMPLETED|Overall Study||36
8764236|NCT01238575|9814051|FG000|STARTED|Overall Study||30
8764237|NCT01238575|9814052|FG001|STARTED|Overall Study||32
8764238|NCT01238575|9814051|FG000|COMPLETED|Overall Study||26
8764239|NCT01238575|9814052|FG001|COMPLETED|Overall Study||28
8764240|NCT01238575|9814051|FG000|NOT COMPLETED|Overall Study||4
8764241|NCT01238575|9814052|FG001|NOT COMPLETED|Overall Study||4
8764242|NCT01238588|9814058|FG000|STARTED|Overall Study||12
8764243|NCT01238588|9814058|FG000|COMPLETED|Overall Study||9
8764244|NCT01238588|9814058|FG000|NOT COMPLETED|Overall Study||3
8764245|NCT01238640|9814062|FG000|STARTED|Overall Study||84
8764246|NCT01238640|9814062|FG000|COMPLETED|Overall Study||84
8764247|NCT01238640|9814062|FG000|NOT COMPLETED|Overall Study||0
8764248|NCT01238822|9814070|FG000|STARTED|Overall Study||96
8764249|NCT01238822|9814070|FG000|Received Placebo|Overall Study||93
8764250|NCT01238822|9814070|FG000|Received Low Dosage|Overall Study||93
8764251|NCT01238822|9814070|FG000|Received Medium Dosage|Overall Study||93
8764252|NCT01238822|9814070|FG000|Received High Dosage|Overall Study||93
8764253|NCT01238822|9814070|FG000|COMPLETED|Overall Study||93
8764254|NCT01238822|9814070|FG000|NOT COMPLETED|Overall Study||3
8764255|NCT01238835|9814080|FG000|STARTED|Overall Study||218
8764256|NCT01238835|9814080|FG000|COMPLETED|Overall Study||82
8764257|NCT01238835|9814080|FG000|NOT COMPLETED|Overall Study||136
8764258|NCT01238848|9814086|FG000|STARTED|Overall Study||50
8764259|NCT01238848|9814087|FG001|STARTED|Overall Study||50
8764260|NCT01238848|9814086|FG000|COMPLETED|Overall Study||37
8764261|NCT01238848|9814087|FG001|COMPLETED|Overall Study||45
8764262|NCT01238848|9814086|FG000|NOT COMPLETED|Overall Study||13
8764263|NCT01238848|9814087|FG001|NOT COMPLETED|Overall Study||5
8764264|NCT01238861|9814099|FG000|STARTED|Overall Study||80
8764265|NCT01238861|9814100|FG001|STARTED|Overall Study||81
8764266|NCT01238861|9814101|FG002|STARTED|Overall Study||81
8764267|NCT01238861|9814102|FG003|STARTED|Overall Study||82
8764268|NCT01238861|9814103|FG004|STARTED|Overall Study||142
9026683|NCT02537678|10089166|FG001|STARTED|Baseline to Post-treatment|92 parents/guardians and 92 children started.|92
9026684|NCT02537678|10089165|FG000|Completed Post-treatment|Baseline to Post-treatment|61 parents/guardians and 61 children completed post-treatment.|61
9026685|NCT02537678|10089166|FG001|Completed Post-treatment|Baseline to Post-treatment|71 parents/guardians and 71 children completed post-treatment.|71
9026686|NCT02537678|10089165|FG000|COMPLETED|Baseline to Post-treatment|61 parent/guardian-child dyads completed.|61
9026687|NCT02537678|10089166|FG001|COMPLETED|Baseline to Post-treatment|71 parent/guardian-child dyads completed.|71
9026688|NCT02537678|10089165|FG000|NOT COMPLETED|Baseline to Post-treatment||30
9026689|NCT02537678|10089166|FG001|NOT COMPLETED|Baseline to Post-treatment||21
9026690|NCT02537678|10089165|FG000|STARTED|Post-treatment to 6 Month Assessment|61 parents/guardians and 61 children started.|61
9026691|NCT02537678|10089166|FG001|STARTED|Post-treatment to 6 Month Assessment|71 parents/guardians and 71 children started.|71
9026692|NCT02537678|10089165|FG000|COMPLETED|Post-treatment to 6 Month Assessment|53 parents/guardians and 53 children completed.|53
9026693|NCT02537678|10089166|FG001|COMPLETED|Post-treatment to 6 Month Assessment|64 parents/guardians and 64 children completed.|64
9026694|NCT02537678|10089165|FG000|NOT COMPLETED|Post-treatment to 6 Month Assessment||8
9026695|NCT02537678|10089166|FG001|NOT COMPLETED|Post-treatment to 6 Month Assessment||7
9026696|NCT02537678|10089165|FG000|STARTED|6 Month to 12 Month Assessment|53 parent/guardians and 53 children started.|53
9026697|NCT02537678|10089166|FG001|STARTED|6 Month to 12 Month Assessment|64 parent/guardians and 64 children started.|64
9026698|NCT02537678|10089165|FG000|COMPLETED|6 Month to 12 Month Assessment|53 parent/guardians and 53 children completed.|53
9026699|NCT02537678|10089166|FG001|COMPLETED|6 Month to 12 Month Assessment|63 parent/guardians and 63 children completed.|63
9026700|NCT02537678|10089165|FG000|NOT COMPLETED|6 Month to 12 Month Assessment||0
9026701|NCT02537678|10089166|FG001|NOT COMPLETED|6 Month to 12 Month Assessment||1
9026702|NCT02400476|10089182|FG000|STARTED|Overall Study||137
9026703|NCT02400476|10089183|FG001|STARTED|Overall Study||64
9026704|NCT02400476|10089184|FG002|STARTED|Overall Study||136
9026705|NCT02400476|10089185|FG003|STARTED|Overall Study||104
9026706|NCT02400476|10089186|FG004|STARTED|Overall Study||60
9026707|NCT02400476|10089187|FG005|STARTED|Overall Study||62
9026708|NCT02400476|10089182|FG000|COMPLETED|Overall Study||76
9026709|NCT02400476|10089183|FG001|COMPLETED|Overall Study||52
9026710|NCT02400476|10089184|FG002|COMPLETED|Overall Study||95
9026711|NCT02400476|10089185|FG003|COMPLETED|Overall Study||74
9026712|NCT02400476|10089186|FG004|COMPLETED|Overall Study||45
9026713|NCT02400476|10089187|FG005|COMPLETED|Overall Study||46
9026714|NCT02400476|10089182|FG000|NOT COMPLETED|Overall Study||61
9026715|NCT02400476|10089183|FG001|NOT COMPLETED|Overall Study||12
9026716|NCT02400476|10089184|FG002|NOT COMPLETED|Overall Study||41
9026717|NCT02400476|10089185|FG003|NOT COMPLETED|Overall Study||30
9026718|NCT02400476|10089186|FG004|NOT COMPLETED|Overall Study||15
9026719|NCT02400476|10089187|FG005|NOT COMPLETED|Overall Study||16
9026720|NCT02362035|10089201|FG000|STARTED|Overall Study||161
9026721|NCT02362035|10089201|FG000|COMPLETED|Overall Study||0
9026722|NCT02362035|10089201|FG000|NOT COMPLETED|Overall Study||161
9026723|NCT02231749|10089207|FG000|STARTED|Overall Study||550
8764269|NCT01238861|9814104|FG005|STARTED|Overall Study||140
8764270|NCT01238861|9814099|FG000|COMPLETED|Overall Study||69
8764271|NCT01238861|9814100|FG001|COMPLETED|Overall Study||73
8764272|NCT01238861|9814101|FG002|COMPLETED|Overall Study||70
8764273|NCT01238861|9814102|FG003|COMPLETED|Overall Study||69
8764274|NCT01238861|9814103|FG004|COMPLETED|Overall Study||129
8764275|NCT01238861|9814104|FG005|COMPLETED|Overall Study||125
8764276|NCT01238861|9814099|FG000|NOT COMPLETED|Overall Study||11
8764277|NCT01238861|9814100|FG001|NOT COMPLETED|Overall Study||8
8764278|NCT01238861|9814101|FG002|NOT COMPLETED|Overall Study||11
8764279|NCT01238861|9814102|FG003|NOT COMPLETED|Overall Study||13
8764280|NCT01238861|9814103|FG004|NOT COMPLETED|Overall Study||13
8764281|NCT01238861|9814104|FG005|NOT COMPLETED|Overall Study||15
8764282|NCT01238900|9814125|FG000|STARTED|6 Months Post Stent Placement||23
8764283|NCT01238900|9814125|FG000|COMPLETED|6 Months Post Stent Placement||23
8764284|NCT01238900|9814125|FG000|NOT COMPLETED|6 Months Post Stent Placement||0
8764285|NCT01238900|9814125|FG000|STARTED|<12 Months Post Stent Removal||23
8764286|NCT01238900|9814125|FG000|COMPLETED|<12 Months Post Stent Removal||18
8764287|NCT01238900|9814125|FG000|NOT COMPLETED|<12 Months Post Stent Removal||5
8764288|NCT01238991|9814140|FG000|STARTED|Overall Study||7
8764289|NCT01238991|9814141|FG001|STARTED|Overall Study||3
8764290|NCT01238991|9814142|FG002|STARTED|Overall Study||11
8764291|NCT01238991|9814143|FG003|STARTED|Overall Study||6
8764292|NCT01238991|9814144|FG004|STARTED|Overall Study||5
8764293|NCT01238991|9814145|FG005|STARTED|Overall Study||2
8764294|NCT01238991|9814146|FG006|STARTED|Overall Study||8
8764295|NCT01238991|9814147|FG007|STARTED|Overall Study||5
8764296|NCT01238991|9814148|FG008|STARTED|Overall Study||4
8764297|NCT01238991|9814149|FG009|STARTED|Overall Study||2
8764298|NCT01238991|9814140|FG000|Received Treatment|Overall Study||7
8764299|NCT01238991|9814141|FG001|Received Treatment|Overall Study||3
8764300|NCT01238991|9814142|FG002|Received Treatment|Overall Study||11
8764301|NCT01238991|9814143|FG003|Received Treatment|Overall Study||6
8764302|NCT01238991|9814144|FG004|Received Treatment|Overall Study||5
8764303|NCT01238991|9814145|FG005|Received Treatment|Overall Study||2
8764304|NCT01238991|9814146|FG006|Received Treatment|Overall Study||8
8764305|NCT01238991|9814147|FG007|Received Treatment|Overall Study||5
8764306|NCT01238991|9814148|FG008|Received Treatment|Overall Study||4
8764307|NCT01238991|9814149|FG009|Received Treatment|Overall Study||2
8764308|NCT01238991|9814140|FG000|COMPLETED|Overall Study||5
8764309|NCT01238991|9814141|FG001|COMPLETED|Overall Study||3
8764310|NCT01238991|9814142|FG002|COMPLETED|Overall Study||5
8764311|NCT01238991|9814143|FG003|COMPLETED|Overall Study||4
8764312|NCT01238991|9814144|FG004|COMPLETED|Overall Study||3
8764313|NCT01238991|9814145|FG005|COMPLETED|Overall Study||2
8764314|NCT01238991|9814146|FG006|COMPLETED|Overall Study||0
8764315|NCT01238991|9814147|FG007|COMPLETED|Overall Study||0
8764316|NCT01238991|9814148|FG008|COMPLETED|Overall Study||0
8764317|NCT01238991|9814149|FG009|COMPLETED|Overall Study||0
8764318|NCT01238991|9814140|FG000|NOT COMPLETED|Overall Study||2
8764319|NCT01238991|9814141|FG001|NOT COMPLETED|Overall Study||0
8764320|NCT01238991|9814142|FG002|NOT COMPLETED|Overall Study||6
8764321|NCT01238991|9814143|FG003|NOT COMPLETED|Overall Study||2
8764322|NCT01238991|9814144|FG004|NOT COMPLETED|Overall Study||2
8764323|NCT01238991|9814145|FG005|NOT COMPLETED|Overall Study||0
8764324|NCT01238991|9814146|FG006|NOT COMPLETED|Overall Study||8
8764325|NCT01238991|9814147|FG007|NOT COMPLETED|Overall Study||5
8764326|NCT01238991|9814148|FG008|NOT COMPLETED|Overall Study||4
9026724|NCT02231749|10089208|FG001|STARTED|Overall Study||546
9026725|NCT02231749|10089207|FG000|Received Treatment|Overall Study||547
9026726|NCT02231749|10089208|FG001|Received Treatment|Overall Study||535
9026727|NCT02231749|10089207|FG000|COMPLETED|Overall Study||128
9026728|NCT02231749|10089208|FG001|COMPLETED|Overall Study||97
9026729|NCT02231749|10089207|FG000|NOT COMPLETED|Overall Study||422
9026730|NCT02231749|10089208|FG001|NOT COMPLETED|Overall Study||449
9026731|NCT01818986|10089214|FG000|STARTED|Overall Study||20
9026732|NCT01818986|10089214|FG000|COMPLETED|Overall Study||20
9026733|NCT01818986|10089214|FG000|NOT COMPLETED|Overall Study||0
9026734|NCT01660451|10089221|FG000|STARTED|Overall Study||33
9026735|NCT01660451|10089222|FG001|STARTED|Overall Study||51
9026736|NCT01660451|10089223|FG002|STARTED|Overall Study||142
9026737|NCT01660451|10089221|FG000|COMPLETED|Overall Study||16
9026738|NCT01660451|10089222|FG001|COMPLETED|Overall Study||34
9026739|NCT01660451|10089223|FG002|COMPLETED|Overall Study||37
9026740|NCT01660451|10089221|FG000|NOT COMPLETED|Overall Study||17
9026741|NCT01660451|10089222|FG001|NOT COMPLETED|Overall Study||17
9026742|NCT01660451|10089223|FG002|NOT COMPLETED|Overall Study||105
8764327|NCT01238991|9814149|FG009|NOT COMPLETED|Overall Study||2
8764328|NCT01239043|9814176|FG000|STARTED|Overall Study|For safety analysis number includes 1 participant randomized to Menactra who received Menomune.|36
8764329|NCT01239043|9814177|FG001|STARTED|Overall Study||103
8764330|NCT01239043|9814176|FG000|COMPLETED|Overall Study||34
8764331|NCT01239043|9814177|FG001|COMPLETED|Overall Study||102
8764332|NCT01239043|9814176|FG000|NOT COMPLETED|Overall Study||2
8764333|NCT01239043|9814177|FG001|NOT COMPLETED|Overall Study||1
9026743|NCT01507545|10089234|FG000|STARTED|Overall Study||84
9026744|NCT01507545|10089235|FG001|STARTED|Overall Study||42
9026745|NCT01507545|10089234|FG000|Treated/Safety Set|Overall Study||82
9026746|NCT01507545|10089235|FG001|Treated/Safety Set|Overall Study||40
9026747|NCT01507545|10089234|FG000|COMPLETED|Overall Study||0
9026748|NCT01507545|10089235|FG001|COMPLETED|Overall Study||0
9026749|NCT01507545|10089234|FG000|NOT COMPLETED|Overall Study||84
9026750|NCT01507545|10089235|FG001|NOT COMPLETED|Overall Study||42
9026751|NCT01463670|10089241|FG000|STARTED|Overall Study||11
8764334|NCT01239056|9814183|FG000|STARTED|Overall Study||20
8764335|NCT01239056|9814183|FG000|COMPLETED|Overall Study||20
8764336|NCT01239056|9814183|FG000|NOT COMPLETED|Overall Study||0
8764337|NCT01239121|9814191|FG000|STARTED|Overall Study||188
8764338|NCT01239121|9814192|FG001|STARTED|Overall Study||199
8764339|NCT01239121|9814193|FG002|STARTED|Overall Study||15
8764340|NCT01239121|9814191|FG000|COMPLETED|Overall Study||186
8764341|NCT01239121|9814192|FG001|COMPLETED|Overall Study||195
8764342|NCT01239121|9814193|FG002|COMPLETED|Overall Study||15
8764343|NCT01239121|9814191|FG000|NOT COMPLETED|Overall Study||2
8764344|NCT01239121|9814192|FG001|NOT COMPLETED|Overall Study||4
8764345|NCT01239121|9814193|FG002|NOT COMPLETED|Overall Study||0
8764346|NCT01239160|9814203|FG000|STARTED|Overall Study||114
8764347|NCT01239160|9814204|FG001|STARTED|Overall Study||114
8764348|NCT01239160|9814205|FG002|STARTED|Overall Study||10
8764349|NCT01239160|9814203|FG000|COMPLETED|Overall Study||89
8764350|NCT01239160|9814204|FG001|COMPLETED|Overall Study||95
8764351|NCT01239160|9814205|FG002|COMPLETED|Overall Study||0
8764352|NCT01239160|9814203|FG000|NOT COMPLETED|Overall Study||25
8764353|NCT01239160|9814204|FG001|NOT COMPLETED|Overall Study||19
8764354|NCT01239160|9814205|FG002|NOT COMPLETED|Overall Study||10
8764355|NCT01239212|9814211|FG000|STARTED|Overall Study||7
8764356|NCT01239212|9814211|FG000|COMPLETED|Overall Study||7
8764357|NCT01239212|9814211|FG000|NOT COMPLETED|Overall Study||0
8764358|NCT01239316|9814215|FG000|STARTED|Overall Study||12
8764359|NCT01239316|9814215|FG000|COMPLETED|Overall Study||0
8764360|NCT01239316|9814215|FG000|NOT COMPLETED|Overall Study||12
8764361|NCT01239342|9814221|FG000|STARTED|Overall Study||29
8764362|NCT01239342|9814222|FG001|STARTED|Overall Study||14
8764363|NCT01239342|9814221|FG000|COMPLETED|Overall Study||26
8764364|NCT01239342|9814222|FG001|COMPLETED|Overall Study||8
8764365|NCT01239342|9814221|FG000|NOT COMPLETED|Overall Study||3
8764366|NCT01239342|9814222|FG001|NOT COMPLETED|Overall Study||6
8764367|NCT01239355|9814228|FG000|STARTED|Overall Study||15
8764368|NCT01239355|9814228|FG000|COMPLETED|Overall Study||15
8764369|NCT01239355|9814228|FG000|NOT COMPLETED|Overall Study||0
8764370|NCT01239381|9814232|FG000|STARTED|Overall Study||92
8764371|NCT01239381|9814232|FG000|COMPLETED|Overall Study||90
8764372|NCT01239381|9814232|FG000|NOT COMPLETED|Overall Study||2
8764373|NCT01239394|9814237|FG000|STARTED|Overall Study||42
8764374|NCT01239394|9814237|FG000|COMPLETED|Overall Study||41
8764375|NCT01239394|9814237|FG000|NOT COMPLETED|Overall Study||1
8764376|NCT01239472|9814243|FG000|STARTED|Overall Study||15
8764377|NCT01239472|9814244|FG001|STARTED|Overall Study||15
8764378|NCT01239472|9814243|FG000|COMPLETED|Overall Study||10
8764379|NCT01239472|9814244|FG001|COMPLETED|Overall Study||12
8764380|NCT01239472|9814243|FG000|NOT COMPLETED|Overall Study||5
8764381|NCT01239472|9814244|FG001|NOT COMPLETED|Overall Study||3
8764382|NCT01239511|9814256|FG000|STARTED|Overall Study||47
8764383|NCT01239511|9814257|FG001|STARTED|Overall Study||45
8764384|NCT01239511|9814258|FG002|STARTED|Overall Study||47
8764385|NCT01239511|9814259|FG003|STARTED|Overall Study||47
8764386|NCT01239511|9814256|FG000|COMPLETED|Overall Study||46
8764387|NCT01239511|9814257|FG001|COMPLETED|Overall Study||40
8764388|NCT01239511|9814258|FG002|COMPLETED|Overall Study||43
8764389|NCT01239511|9814259|FG003|COMPLETED|Overall Study||38
8764390|NCT01239511|9814256|FG000|NOT COMPLETED|Overall Study||1
8764391|NCT01239511|9814257|FG001|NOT COMPLETED|Overall Study||5
8764392|NCT01239511|9814258|FG002|NOT COMPLETED|Overall Study||4
8764393|NCT01239511|9814259|FG003|NOT COMPLETED|Overall Study||9
8764394|NCT01239732|9814269|FG000|STARTED|Overall Study||1021
8764395|NCT01239732|9814269|FG000|COMPLETED|Overall Study||0
8764396|NCT01239732|9814269|FG000|NOT COMPLETED|Overall Study||1021
8764397|NCT01239745|9814273|FG000|STARTED|Overall Study||46
8764398|NCT01239745|9814273|FG000|COMPLETED|Overall Study||0
8764399|NCT01239745|9814273|FG000|NOT COMPLETED|Overall Study||46
8764400|NCT01239797|9814279|FG000|STARTED|Randomized Participants||321
8764401|NCT01239797|9814280|FG001|STARTED|Randomized Participants||325
8764402|NCT01239797|9814279|FG000|COMPLETED|Randomized Participants||319
8764403|NCT01239797|9814280|FG001|COMPLETED|Randomized Participants||316
8764404|NCT01239797|9814279|FG000|NOT COMPLETED|Randomized Participants||2
8764405|NCT01239797|9814280|FG001|NOT COMPLETED|Randomized Participants||9
8764406|NCT01239797|9814279|FG000|STARTED|Treated Participants|1 participant was randomized to treatment E-Ld but received treatment Ld|318
8764407|NCT01239797|9814280|FG001|STARTED|Treated Participants|1 participant was randomized to treatment E-Ld but received treatment Ld|317
8764408|NCT01239797|9814279|FG000|COMPLETED|Treated Participants|Completed = Still on Treatment|83
8764409|NCT01239797|9814280|FG001|COMPLETED|Treated Participants|Completed = Still on Treatment|43
8764410|NCT01239797|9814279|FG000|NOT COMPLETED|Treated Participants||235
8764411|NCT01239797|9814280|FG001|NOT COMPLETED|Treated Participants||274
8764412|NCT01239992|9814286|FG000|STARTED|Overall Study||12
8764413|NCT01239992|9814286|FG000|COMPLETED|Overall Study||10
8764414|NCT01239992|9814286|FG000|NOT COMPLETED|Overall Study||2
8764415|NCT01240122|9814290|FG000|STARTED|Overall Study||29
8764416|NCT01240122|9814290|FG000|COMPLETED|Overall Study||29
8764417|NCT01240122|9814290|FG000|NOT COMPLETED|Overall Study||0
8764418|NCT01240135|9814301|FG000|STARTED|Period One, 14 Days of Wear||44
8764419|NCT01240135|9814302|FG001|STARTED|Period One, 14 Days of Wear||45
8764420|NCT01240135|9814301|FG000|COMPLETED|Period One, 14 Days of Wear||44
8764421|NCT01240135|9814302|FG001|COMPLETED|Period One, 14 Days of Wear||45
8764422|NCT01240135|9814301|FG000|NOT COMPLETED|Period One, 14 Days of Wear||0
8764423|NCT01240135|9814302|FG001|NOT COMPLETED|Period One, 14 Days of Wear||0
8764424|NCT01240135|9814301|FG000|STARTED|Period Two, 14 Days of Wear||44
8764425|NCT01240135|9814302|FG001|STARTED|Period Two, 14 Days of Wear||45
8764426|NCT01240135|9814301|FG000|COMPLETED|Period Two, 14 Days of Wear||43
8764427|NCT01240135|9814302|FG001|COMPLETED|Period Two, 14 Days of Wear||43
8764428|NCT01240135|9814301|FG000|NOT COMPLETED|Period Two, 14 Days of Wear||1
8764429|NCT01240135|9814302|FG001|NOT COMPLETED|Period Two, 14 Days of Wear||2
8764430|NCT01240200|9814310|FG000|STARTED|12-week Crossover Phase - Period 1||25
8764431|NCT01240200|9814311|FG001|STARTED|12-week Crossover Phase - Period 1||24
8764432|NCT01240200|9814310|FG000|COMPLETED|12-week Crossover Phase - Period 1||23
8764433|NCT01240200|9814311|FG001|COMPLETED|12-week Crossover Phase - Period 1||23
8764434|NCT01240200|9814310|FG000|NOT COMPLETED|12-week Crossover Phase - Period 1||2
8764435|NCT01240200|9814311|FG001|NOT COMPLETED|12-week Crossover Phase - Period 1||1
8764436|NCT01240200|9814310|FG000|STARTED|12-week Crossover Phase - Period 2||23
8764437|NCT01240200|9814311|FG001|STARTED|12-week Crossover Phase - Period 2||23
8764438|NCT01240200|9814310|FG000|COMPLETED|12-week Crossover Phase - Period 2||23
8764439|NCT01240200|9814311|FG001|COMPLETED|12-week Crossover Phase - Period 2||23
8764440|NCT01240200|9814310|FG000|NOT COMPLETED|12-week Crossover Phase - Period 2||0
8764441|NCT01240200|9814311|FG001|NOT COMPLETED|12-week Crossover Phase - Period 2||0
8764442|NCT01240330|9814320|FG000|STARTED|Overall Study||33
8764443|NCT01240330|9814320|FG000|COMPLETED|Overall Study||33
8764444|NCT01240330|9814320|FG000|NOT COMPLETED|Overall Study||0
8764445|NCT01240356|9814326|FG000|STARTED|Overall Study||18
8764446|NCT01240356|9814327|FG001|STARTED|Overall Study||20
8764447|NCT01240356|9814326|FG000|COMPLETED|Overall Study||15
8764448|NCT01240356|9814327|FG001|COMPLETED|Overall Study||20
8764449|NCT01240356|9814326|FG000|NOT COMPLETED|Overall Study||3
8764450|NCT01240356|9814327|FG001|NOT COMPLETED|Overall Study||0
8764451|NCT01240382|9814338|FG000|STARTED|Overall Study||144
8764452|NCT01240382|9814339|FG001|STARTED|Overall Study||143
8764453|NCT01240382|9814338|FG000|COMPLETED|Overall Study||142
8764454|NCT01240382|9814339|FG001|COMPLETED|Overall Study||139
8764455|NCT01240382|9814338|FG000|NOT COMPLETED|Overall Study||2
8764456|NCT01240382|9814339|FG001|NOT COMPLETED|Overall Study||4
8764457|NCT01240551|9814347|FG000|STARTED|Overall Study||30
8764458|NCT01240551|9814348|FG001|STARTED|Overall Study||30
8764459|NCT01240551|9814347|FG000|COMPLETED|Overall Study||26
8764460|NCT01240551|9814348|FG001|COMPLETED|Overall Study||27
8764461|NCT01240551|9814347|FG000|NOT COMPLETED|Overall Study||4
8764462|NCT01240551|9814348|FG001|NOT COMPLETED|Overall Study||3
9026752|NCT01463670|10089241|FG000|COMPLETED|Overall Study||11
9026753|NCT01463670|10089241|FG000|NOT COMPLETED|Overall Study||0
9026754|NCT00920816|10089249|FG000|STARTED|Overall Study||192
9026755|NCT00920816|10089250|FG001|STARTED|Overall Study||96
9026756|NCT00920816|10089251|FG002|STARTED|Overall Study||135
9026757|NCT00920816|10089252|FG003|STARTED|Overall Study||69
9026758|NCT00920816|10089249|FG000|Treated|Overall Study||189
9026759|NCT00920816|10089250|FG001|Treated|Overall Study||96
9026760|NCT00920816|10089251|FG002|Treated|Overall Study||135
9026761|NCT00920816|10089252|FG003|Treated|Overall Study||69
9026762|NCT00920816|10089249|FG000|Participants From China (Excluded From Safety Analysis)|Overall Study||16
9026763|NCT00920816|10089250|FG001|Participants From China (Excluded From Safety Analysis)|Overall Study||8
9026764|NCT00920816|10089251|FG002|Participants From China (Excluded From Safety Analysis)|Overall Study||124
9026765|NCT00920816|10089252|FG003|Participants From China (Excluded From Safety Analysis)|Overall Study||64
9026766|NCT00920816|10089249|FG000|COMPLETED|Overall Study||0
9026767|NCT00920816|10089250|FG001|COMPLETED|Overall Study||0
9026768|NCT00920816|10089251|FG002|COMPLETED|Overall Study||0
9026769|NCT00920816|10089252|FG003|COMPLETED|Overall Study||0
9026770|NCT00920816|10089249|FG000|NOT COMPLETED|Overall Study||192
9026771|NCT00920816|10089250|FG001|NOT COMPLETED|Overall Study||96
9026772|NCT00920816|10089251|FG002|NOT COMPLETED|Overall Study||135
9026773|NCT00920816|10089252|FG003|NOT COMPLETED|Overall Study||69
8764463|NCT01240590|9814359|FG000|STARTED|Phase I||0
8764464|NCT01240590|9814360|FG001|STARTED|Phase I||6
8764465|NCT01240590|9814361|FG002|STARTED|Phase I||3
8764466|NCT01240590|9814362|FG003|STARTED|Phase I||0
8764467|NCT01240590|9814363|FG004|STARTED|Phase I||0
8764468|NCT01240590|9814359|FG000|COMPLETED|Phase I||0
8764469|NCT01240590|9814360|FG001|COMPLETED|Phase I||6
8764470|NCT01240590|9814361|FG002|COMPLETED|Phase I||0
8764471|NCT01240590|9814362|FG003|COMPLETED|Phase I||0
8764472|NCT01240590|9814363|FG004|COMPLETED|Phase I||0
8764473|NCT01240590|9814359|FG000|NOT COMPLETED|Phase I||0
8764474|NCT01240590|9814360|FG001|NOT COMPLETED|Phase I||0
8764475|NCT01240590|9814361|FG002|NOT COMPLETED|Phase I||3
8764476|NCT01240590|9814362|FG003|NOT COMPLETED|Phase I||0
8764477|NCT01240590|9814363|FG004|NOT COMPLETED|Phase I||0
8764478|NCT01240590|9814359|FG000|STARTED|Phase II||0
8764479|NCT01240590|9814360|FG001|STARTED|Phase II||0
8764480|NCT01240590|9814361|FG002|STARTED|Phase II||0
8764481|NCT01240590|9814362|FG003|STARTED|Phase II||17
8764482|NCT01240590|9814363|FG004|STARTED|Phase II||1
8764483|NCT01240590|9814359|FG000|COMPLETED|Phase II||0
8764484|NCT01240590|9814360|FG001|COMPLETED|Phase II||0
8764485|NCT01240590|9814361|FG002|COMPLETED|Phase II||0
8764486|NCT01240590|9814362|FG003|COMPLETED|Phase II||15
8764487|NCT01240590|9814363|FG004|COMPLETED|Phase II||0
8764488|NCT01240590|9814359|FG000|NOT COMPLETED|Phase II||0
8764489|NCT01240590|9814360|FG001|NOT COMPLETED|Phase II||0
8764490|NCT01240590|9814361|FG002|NOT COMPLETED|Phase II||0
8764491|NCT01240590|9814362|FG003|NOT COMPLETED|Phase II||2
8764492|NCT01240590|9814363|FG004|NOT COMPLETED|Phase II||1
8764493|NCT01240746|9814392|FG000|STARTED|Overall Study||736
8764494|NCT01240746|9814393|FG001|STARTED|Overall Study||725
8764495|NCT01240746|9814394|FG002|STARTED|Overall Study||2902
8764496|NCT01240746|9814392|FG000|COMPLETED|Overall Study||677
8764497|NCT01240746|9814393|FG001|COMPLETED|Overall Study||677
8764498|NCT01240746|9814394|FG002|COMPLETED|Overall Study||2659
8764499|NCT01240746|9814392|FG000|NOT COMPLETED|Overall Study||59
8764500|NCT01240746|9814393|FG001|NOT COMPLETED|Overall Study||48
8764501|NCT01240746|9814394|FG002|NOT COMPLETED|Overall Study||243
8764502|NCT01240785|9814404|FG000|STARTED|Overall Study||111
8764503|NCT01240785|9814405|FG001|STARTED|Overall Study||110
8764504|NCT01240785|9814404|FG000|COMPLETED|Overall Study|110 women completed in the metformin arm and 107 women completed in the insulin arm.|110
8764505|NCT01240785|9814405|FG001|COMPLETED|Overall Study||107
8764506|NCT01240785|9814404|FG000|NOT COMPLETED|Overall Study||1
8764507|NCT01240785|9814405|FG001|NOT COMPLETED|Overall Study||3
8764508|NCT01240811|9814414|FG000|STARTED|Overall Study||8
8764509|NCT01240811|9814415|FG001|STARTED|Overall Study||17
8764510|NCT01240811|9814416|FG002|STARTED|Overall Study||17
8764511|NCT01240811|9814414|FG000|COMPLETED|Overall Study||8
8764512|NCT01240811|9814415|FG001|COMPLETED|Overall Study||16
8764513|NCT01240811|9814416|FG002|COMPLETED|Overall Study||16
8764514|NCT01240811|9814414|FG000|NOT COMPLETED|Overall Study||0
8764515|NCT01240811|9814415|FG001|NOT COMPLETED|Overall Study||1
8764516|NCT01240811|9814416|FG002|NOT COMPLETED|Overall Study||1
8764517|NCT01240863|9814428|FG000|STARTED|Open-label Titration Period||391
8764518|NCT01240863|9814429|FG001|STARTED|Open-label Titration Period||0
8764519|NCT01240863|9814430|FG002|STARTED|Open-label Titration Period||0
8764520|NCT01240863|9814428|FG000|Safety Analysis Set|Open-label Titration Period||389
8764521|NCT01240863|9814429|FG001|Safety Analysis Set|Open-label Titration Period||0
8764522|NCT01240863|9814430|FG002|Safety Analysis Set|Open-label Titration Period||0
8764523|NCT01240863|9814428|FG000|COMPLETED|Open-label Titration Period||294
8764524|NCT01240863|9814429|FG001|COMPLETED|Open-label Titration Period||0
8764525|NCT01240863|9814430|FG002|COMPLETED|Open-label Titration Period||0
8764526|NCT01240863|9814428|FG000|NOT COMPLETED|Open-label Titration Period||97
8764527|NCT01240863|9814429|FG001|NOT COMPLETED|Open-label Titration Period||0
8764528|NCT01240863|9814430|FG002|NOT COMPLETED|Open-label Titration Period||0
8764529|NCT01240863|9814428|FG000|STARTED|Double-blind Treatment Period (12 Weeks)||0
8764530|NCT01240863|9814429|FG001|STARTED|Double-blind Treatment Period (12 Weeks)||148
8764531|NCT01240863|9814430|FG002|STARTED|Double-blind Treatment Period (12 Weeks)||146
8764532|NCT01240863|9814428|FG000|Full Analysis and Safety Analysis Sets|Double-blind Treatment Period (12 Weeks)||0
8764533|NCT01240863|9814429|FG001|Full Analysis and Safety Analysis Sets|Double-blind Treatment Period (12 Weeks)||147
8764534|NCT01240863|9814430|FG002|Full Analysis and Safety Analysis Sets|Double-blind Treatment Period (12 Weeks)||146
8764535|NCT01240863|9814428|FG000|COMPLETED|Double-blind Treatment Period (12 Weeks)||0
8764536|NCT01240863|9814429|FG001|COMPLETED|Double-blind Treatment Period (12 Weeks)||102
8764537|NCT01240863|9814430|FG002|COMPLETED|Double-blind Treatment Period (12 Weeks)||94
8764538|NCT01240863|9814428|FG000|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||0
8764539|NCT01240863|9814429|FG001|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||46
8764540|NCT01240863|9814430|FG002|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||52
8764541|NCT01240915|9814450|FG000|STARTED|Overall Study||2
8764542|NCT01240915|9814451|FG001|STARTED|Overall Study||3
8764543|NCT01240915|9814452|FG002|STARTED|Overall Study||2
8764544|NCT01240915|9814453|FG003|STARTED|Overall Study||4
8764545|NCT01240915|9814454|FG004|STARTED|Overall Study||6
8764546|NCT01240915|9814455|FG005|STARTED|Overall Study||23
8764547|NCT01240915|9814456|FG006|STARTED|Overall Study||25
8764548|NCT01240915|9814457|FG007|STARTED|Overall Study||19
8764549|NCT01240915|9814458|FG008|STARTED|Overall Study||21
8764550|NCT01240915|9814450|FG000|COMPLETED|Overall Study||0
8764551|NCT01240915|9814451|FG001|COMPLETED|Overall Study||2
8764552|NCT01240915|9814452|FG002|COMPLETED|Overall Study||2
8764553|NCT01240915|9814453|FG003|COMPLETED|Overall Study||1
8764554|NCT01240915|9814454|FG004|COMPLETED|Overall Study||2
8764555|NCT01240915|9814455|FG005|COMPLETED|Overall Study||13
8764556|NCT01240915|9814456|FG006|COMPLETED|Overall Study||17
8764557|NCT01240915|9814457|FG007|COMPLETED|Overall Study||15
8764558|NCT01240915|9814458|FG008|COMPLETED|Overall Study||13
8764559|NCT01240915|9814450|FG000|NOT COMPLETED|Overall Study||2
8764560|NCT01240915|9814451|FG001|NOT COMPLETED|Overall Study||1
8764561|NCT01240915|9814452|FG002|NOT COMPLETED|Overall Study||0
8764562|NCT01240915|9814453|FG003|NOT COMPLETED|Overall Study||3
8764563|NCT01240915|9814454|FG004|NOT COMPLETED|Overall Study||4
8764564|NCT01240915|9814455|FG005|NOT COMPLETED|Overall Study||10
8764565|NCT01240915|9814456|FG006|NOT COMPLETED|Overall Study||8
8764566|NCT01240915|9814457|FG007|NOT COMPLETED|Overall Study||4
8764567|NCT01240915|9814458|FG008|NOT COMPLETED|Overall Study||8
8764568|NCT01241240|9814482|FG000|STARTED|Overall Study||94
8764569|NCT01241240|9814483|FG001|STARTED|Overall Study||98
8764570|NCT01241240|9814482|FG000|COMPLETED|Overall Study||86
8764571|NCT01241240|9814483|FG001|COMPLETED|Overall Study||89
8764572|NCT01241240|9814482|FG000|NOT COMPLETED|Overall Study||8
8764573|NCT01241240|9814483|FG001|NOT COMPLETED|Overall Study||9
8764574|NCT01241292|9814491|FG000|STARTED|Overall Study||3
8764575|NCT01241292|9814492|FG001|STARTED|Overall Study||3
8764576|NCT01241292|9814491|FG000|Entered Treatment Period|Overall Study||3
8764577|NCT01241292|9814492|FG001|Entered Treatment Period|Overall Study||3
8764578|NCT01241292|9814491|FG000|COMPLETED|Overall Study|completed=treatment on-going|0
8764579|NCT01241292|9814492|FG001|COMPLETED|Overall Study|completed=treatment on-going|0
8764580|NCT01241292|9814491|FG000|NOT COMPLETED|Overall Study||3
8764581|NCT01241292|9814492|FG001|NOT COMPLETED|Overall Study||3
8764582|NCT01241318|9814504|FG000|STARTED|Overall Study|Women enrolled|19629
8764583|NCT01241318|9814505|FG001|STARTED|Overall Study|Women enrolled|20050
8764584|NCT01241318|9814504|FG000|Liveborn Infant|Overall Study|Infants|18510
8764585|NCT01241318|9814505|FG001|Liveborn Infant|Overall Study|Infants|19346
8764586|NCT01241318|9814504|FG000|COMPLETED|Overall Study|Infants|18450
8764587|NCT01241318|9814505|FG001|COMPLETED|Overall Study|Infants|19308
8764588|NCT01241318|9814504|FG000|NOT COMPLETED|Overall Study||1179
8764589|NCT01241318|9814505|FG001|NOT COMPLETED|Overall Study||742
8764590|NCT01241344|9814518|FG000|STARTED|Overall Study||14
8764591|NCT01241344|9814519|FG001|STARTED|Overall Study||16
8764592|NCT01241344|9814520|FG002|STARTED|Overall Study||18
8764593|NCT01241344|9814521|FG003|STARTED|Overall Study||4
8764594|NCT01241344|9814518|FG000|Randomized to Open-label|Overall Study||3
8764595|NCT01241344|9814519|FG001|Randomized to Open-label|Overall Study||4
8764596|NCT01241344|9814520|FG002|Randomized to Open-label|Overall Study||5
8764597|NCT01241344|9814521|FG003|Randomized to Open-label|Overall Study||0
8764598|NCT01241344|9814518|FG000|COMPLETED|Overall Study||9
8764599|NCT01241344|9814519|FG001|COMPLETED|Overall Study||7
8764600|NCT01241344|9814520|FG002|COMPLETED|Overall Study||9
8764601|NCT01241344|9814521|FG003|COMPLETED|Overall Study||2
8764602|NCT01241344|9814518|FG000|NOT COMPLETED|Overall Study||5
8764603|NCT01241344|9814519|FG001|NOT COMPLETED|Overall Study||9
8764604|NCT01241344|9814520|FG002|NOT COMPLETED|Overall Study||9
8764605|NCT01241344|9814521|FG003|NOT COMPLETED|Overall Study||2
8764606|NCT01241435|9814534|FG000|STARTED|Overall Study||12
8764607|NCT01241435|9814535|FG001|STARTED|Overall Study||8
8764608|NCT01241435|9814536|FG002|STARTED|Overall Study||8
8764609|NCT01241435|9814537|FG003|STARTED|Overall Study||8
8764610|NCT01241435|9814534|FG000|Received at Least 1 Dose of Study Drug|Overall Study||12
8764611|NCT01241435|9814535|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8
8764612|NCT01241435|9814536|FG002|Received at Least 1 Dose of Study Drug|Overall Study||8
8764613|NCT01241435|9814537|FG003|Received at Least 1 Dose of Study Drug|Overall Study||8
8764614|NCT01241435|9814534|FG000|COMPLETED|Overall Study||12
8764615|NCT01241435|9814535|FG001|COMPLETED|Overall Study||8
8764616|NCT01241435|9814536|FG002|COMPLETED|Overall Study||8
8764617|NCT01241435|9814537|FG003|COMPLETED|Overall Study||8
8764618|NCT01241435|9814534|FG000|NOT COMPLETED|Overall Study||0
8764619|NCT01241435|9814535|FG001|NOT COMPLETED|Overall Study||0
8764620|NCT01241435|9814536|FG002|NOT COMPLETED|Overall Study||0
8764621|NCT01241435|9814537|FG003|NOT COMPLETED|Overall Study||0
8764622|NCT01241448|9814551|FG000|STARTED|Overall Study||66
8764623|NCT01241448|9814552|FG001|STARTED|Overall Study||65
8764624|NCT01241448|9814553|FG002|STARTED|Overall Study||66
8764625|NCT01241448|9814554|FG003|STARTED|Overall Study||66
8764626|NCT01241448|9814551|FG000|Intent-to-Treat Population (ITT)|Overall Study||63
8764627|NCT01241448|9814552|FG001|Intent-to-Treat Population (ITT)|Overall Study||63
8764628|NCT01241448|9814553|FG002|Intent-to-Treat Population (ITT)|Overall Study||64
8764629|NCT01241448|9814554|FG003|Intent-to-Treat Population (ITT)|Overall Study||64
8764630|NCT01241448|9814551|FG000|ITT With ≥1 Post-Baseline Measure|Overall Study||61
8764631|NCT01241448|9814552|FG001|ITT With ≥1 Post-Baseline Measure|Overall Study||61
8764632|NCT01241448|9814553|FG002|ITT With ≥1 Post-Baseline Measure|Overall Study||64
8764633|NCT01241448|9814554|FG003|ITT With ≥1 Post-Baseline Measure|Overall Study||62
8764634|NCT01241448|9814551|FG000|COMPLETED|Overall Study||29
8764635|NCT01241448|9814552|FG001|COMPLETED|Overall Study||36
8764636|NCT01241448|9814553|FG002|COMPLETED|Overall Study||43
8764637|NCT01241448|9814554|FG003|COMPLETED|Overall Study||43
8764638|NCT01241448|9814551|FG000|NOT COMPLETED|Overall Study||37
8764639|NCT01241448|9814552|FG001|NOT COMPLETED|Overall Study||29
8764640|NCT01241448|9814553|FG002|NOT COMPLETED|Overall Study||23
8764641|NCT01241448|9814554|FG003|NOT COMPLETED|Overall Study||23
8764642|NCT01241461|9814567|FG000|STARTED|Overall Study||3
8764643|NCT01241461|9814568|FG001|STARTED|Overall Study||6
8764644|NCT01241461|9814567|FG000|COMPLETED|Overall Study||0
8764645|NCT01241461|9814568|FG001|COMPLETED|Overall Study||0
8764646|NCT01241461|9814567|FG000|NOT COMPLETED|Overall Study||3
8764647|NCT01241461|9814568|FG001|NOT COMPLETED|Overall Study||6
8764648|NCT01241513|9814580|FG000|STARTED|Overall Study||10
8764649|NCT01241513|9814581|FG001|STARTED|Overall Study||9
8764650|NCT01241513|9814580|FG000|COMPLETED|Overall Study|Study has been completed|10
8764651|NCT01241513|9814581|FG001|COMPLETED|Overall Study||9
8764652|NCT01241513|9814580|FG000|NOT COMPLETED|Overall Study||0
8764653|NCT01241513|9814581|FG001|NOT COMPLETED|Overall Study||0
8764654|NCT01241539|9814586|FG000|STARTED|Period 1||7
8764655|NCT01241539|9814586|FG000|COMPLETED|Period 1||7
8764656|NCT01241539|9814586|FG000|NOT COMPLETED|Period 1||0
8764657|NCT01241539|9814586|FG000|STARTED|Period 2|After a wash-out phase of at least 6 weeks.|7
8764658|NCT01241539|9814586|FG000|COMPLETED|Period 2||7
8764659|NCT01241539|9814586|FG000|NOT COMPLETED|Period 2||0
8764660|NCT01241552|9814596|FG000|STARTED|Overall Study||242
8764661|NCT01241552|9814597|FG001|STARTED|Overall Study||403
8764662|NCT01241552|9814598|FG002|STARTED|Overall Study||403
8764663|NCT01241552|9814599|FG003|STARTED|Overall Study||404
8764664|NCT01241552|9814596|FG000|Treated|Overall Study||235
8764665|NCT01241552|9814597|FG001|Treated|Overall Study||392
8764666|NCT01241552|9814598|FG002|Treated|Overall Study||388
8764667|NCT01241552|9814599|FG003|Treated|Overall Study||397
8764668|NCT01241552|9814596|FG000|COMPLETED|Overall Study||201
8764669|NCT01241552|9814597|FG001|COMPLETED|Overall Study||340
8764670|NCT01241552|9814598|FG002|COMPLETED|Overall Study||343
8764671|NCT01241552|9814599|FG003|COMPLETED|Overall Study||340
8764672|NCT01241552|9814596|FG000|NOT COMPLETED|Overall Study||41
8764673|NCT01241552|9814597|FG001|NOT COMPLETED|Overall Study||63
8764674|NCT01241552|9814598|FG002|NOT COMPLETED|Overall Study||60
8764675|NCT01241552|9814599|FG003|NOT COMPLETED|Overall Study||64
8764676|NCT01241565|9814609|FG000|STARTED|Overall Study||50
8764677|NCT01241565|9814609|FG000|COMPLETED|Overall Study||50
8764678|NCT01241565|9814609|FG000|NOT COMPLETED|Overall Study||0
8764679|NCT01241591|9814618|FG000|STARTED|Overall Study||329
8764680|NCT01241591|9814619|FG001|STARTED|Overall Study||330
8764681|NCT01241591|9814620|FG002|STARTED|Overall Study||335
8764682|NCT01241591|9814621|FG003|STARTED|Overall Study||107
8764683|NCT01241591|9814618|FG000|COMPLETED|Overall Study||306
8764684|NCT01241591|9814619|FG001|COMPLETED|Overall Study||306
8764685|NCT01241591|9814620|FG002|COMPLETED|Overall Study||313
8764686|NCT01241591|9814621|FG003|COMPLETED|Overall Study||95
8764687|NCT01241591|9814618|FG000|NOT COMPLETED|Overall Study||23
8764688|NCT01241591|9814619|FG001|NOT COMPLETED|Overall Study||24
8764689|NCT01241591|9814620|FG002|NOT COMPLETED|Overall Study||22
8764690|NCT01241591|9814621|FG003|NOT COMPLETED|Overall Study||12
8764691|NCT01241604|9814631|FG000|STARTED|Screening Period||11
8764692|NCT01241604|9814632|FG001|STARTED|Screening Period||0
8764693|NCT01241604|9814633|FG002|STARTED|Screening Period||0
8764694|NCT01241604|9814631|FG000|COMPLETED|Screening Period||8
8764695|NCT01241604|9814632|FG001|COMPLETED|Screening Period||0
8764696|NCT01241604|9814633|FG002|COMPLETED|Screening Period||0
8764697|NCT01241604|9814631|FG000|NOT COMPLETED|Screening Period||3
8764698|NCT01241604|9814632|FG001|NOT COMPLETED|Screening Period||0
8764699|NCT01241604|9814633|FG002|NOT COMPLETED|Screening Period||0
8764700|NCT01241604|9814631|FG000|STARTED|Study Period||0
8764701|NCT01241604|9814632|FG001|STARTED|Study Period||5
8764702|NCT01241604|9814633|FG002|STARTED|Study Period||3
8764703|NCT01241604|9814631|FG000|COMPLETED|Study Period||0
8764704|NCT01241604|9814632|FG001|COMPLETED|Study Period||5
8764705|NCT01241604|9814633|FG002|COMPLETED|Study Period||3
8764706|NCT01241604|9814631|FG000|NOT COMPLETED|Study Period||0
8764707|NCT01241604|9814632|FG001|NOT COMPLETED|Study Period||0
8764708|NCT01241604|9814633|FG002|NOT COMPLETED|Study Period||0
8764709|NCT01241760|9814642|FG000|STARTED|Overall Study||371
8764710|NCT01241760|9814643|FG001|STARTED|Overall Study||369
8764711|NCT01241760|9814642|FG000|COMPLETED|Overall Study||337
8764712|NCT01241760|9814643|FG001|COMPLETED|Overall Study||329
8764713|NCT01241760|9814642|FG000|NOT COMPLETED|Overall Study||34
8764714|NCT01241760|9814643|FG001|NOT COMPLETED|Overall Study||40
8764715|NCT01241903|9814652|FG000|STARTED|Overall Study||27
8764716|NCT01241903|9814653|FG001|STARTED|Overall Study||27
8764717|NCT01241903|9814652|FG000|COMPLETED|Overall Study||26
8764718|NCT01241903|9814653|FG001|COMPLETED|Overall Study||27
8764719|NCT01241903|9814652|FG000|NOT COMPLETED|Overall Study||1
8764720|NCT01241903|9814653|FG001|NOT COMPLETED|Overall Study||0
8764721|NCT01241916|9814661|FG000|STARTED|Overall Study||35
8764722|NCT01241916|9814662|FG001|STARTED|Overall Study||31
8764723|NCT01241916|9814661|FG000|COMPLETED|Overall Study||28
8764724|NCT01241916|9814662|FG001|COMPLETED|Overall Study||21
8764725|NCT01241916|9814661|FG000|NOT COMPLETED|Overall Study||7
8764726|NCT01241916|9814662|FG001|NOT COMPLETED|Overall Study||10
8764727|NCT01242085|9814671|FG000|STARTED|Overall Study||30
8764728|NCT01242085|9814672|FG001|STARTED|Overall Study||33
8764729|NCT01242085|9814673|FG002|STARTED|Overall Study||1
8764730|NCT01242085|9814671|FG000|COMPLETED|Overall Study|8 patients did not undergo intervention since 4 had medical problems and 4 withdrew|22
8764731|NCT01242085|9814672|FG001|COMPLETED|Overall Study|7 patients did not receive allocated intervention since 5 had medical problems and 2 withdrew|26
8764732|NCT01242085|9814673|FG002|COMPLETED|Overall Study||1
8764733|NCT01242085|9814671|FG000|NOT COMPLETED|Overall Study||8
8764734|NCT01242085|9814672|FG001|NOT COMPLETED|Overall Study||7
8764735|NCT01242085|9814673|FG002|NOT COMPLETED|Overall Study||0
8764736|NCT01242111|9814679|FG000|STARTED|Overall Study||20
8764737|NCT01242111|9814679|FG000|COMPLETED|Overall Study||17
8764738|NCT01242111|9814679|FG000|NOT COMPLETED|Overall Study||3
8764739|NCT01242176|9814683|FG000|STARTED|First Intervention||12
8764740|NCT01242176|9814684|FG001|STARTED|First Intervention||12
8764741|NCT01242176|9814683|FG000|COMPLETED|First Intervention||12
8764742|NCT01242176|9814684|FG001|COMPLETED|First Intervention||12
8764743|NCT01242176|9814683|FG000|NOT COMPLETED|First Intervention||0
8764744|NCT01242176|9814684|FG001|NOT COMPLETED|First Intervention||0
8764745|NCT01242176|9814683|FG000|STARTED|Washout Period of 7 Days||12
8764746|NCT01242176|9814684|FG001|STARTED|Washout Period of 7 Days||12
8764747|NCT01242176|9814683|FG000|COMPLETED|Washout Period of 7 Days||11
8764748|NCT01242176|9814684|FG001|COMPLETED|Washout Period of 7 Days||10
8764749|NCT01242176|9814683|FG000|NOT COMPLETED|Washout Period of 7 Days||1
8764750|NCT01242176|9814684|FG001|NOT COMPLETED|Washout Period of 7 Days||2
8764751|NCT01242176|9814683|FG000|STARTED|Second Intervention||11
8764752|NCT01242176|9814684|FG001|STARTED|Second Intervention||10
8764753|NCT01242176|9814683|FG000|COMPLETED|Second Intervention||11
8764754|NCT01242176|9814684|FG001|COMPLETED|Second Intervention||10
8764755|NCT01242176|9814683|FG000|NOT COMPLETED|Second Intervention||0
8764756|NCT01242176|9814684|FG001|NOT COMPLETED|Second Intervention||0
8764757|NCT01242241|9814692|FG000|STARTED|Overall Study||40
8764758|NCT01242241|9814693|FG001|STARTED|Overall Study||40
8764759|NCT01242241|9814692|FG000|COMPLETED|Overall Study||40
8764760|NCT01242241|9814693|FG001|COMPLETED|Overall Study||40
8764761|NCT01242241|9814692|FG000|NOT COMPLETED|Overall Study||0
8764762|NCT01242241|9814693|FG001|NOT COMPLETED|Overall Study||0
8764763|NCT01242371|9814701|FG000|STARTED|Overall Study||33
8764764|NCT01242371|9814702|FG001|STARTED|Overall Study||32
8764765|NCT01242371|9814701|FG000|COMPLETED|Overall Study||31
8764766|NCT01242371|9814702|FG001|COMPLETED|Overall Study||27
8764767|NCT01242371|9814701|FG000|NOT COMPLETED|Overall Study||2
8764768|NCT01242371|9814702|FG001|NOT COMPLETED|Overall Study||5
8764769|NCT01242514|9814711|FG000|STARTED|Overall Study|Patients who received treatment|1343
8764770|NCT01242514|9814712|FG001|STARTED|Overall Study|Patients who received treatment|357
8764771|NCT01242514|9814713|FG002|STARTED|Overall Study|Patients who received treatment|212
8764772|NCT01242514|9814711|FG000|Enrolled But Did Not Receive Treatment|Overall Study|Other|3
8764773|NCT01242514|9814712|FG001|Enrolled But Did Not Receive Treatment|Overall Study||0
8764774|NCT01242514|9814713|FG002|Enrolled But Did Not Receive Treatment|Overall Study|Adverse event/other|2
8764775|NCT01242514|9814711|FG000|COMPLETED|Overall Study|Due to project closure.|0
8764776|NCT01242514|9814712|FG001|COMPLETED|Overall Study|Due to project closure.|0
8764777|NCT01242514|9814713|FG002|COMPLETED|Overall Study|Due to project closure.|0
8764778|NCT01242514|9814711|FG000|NOT COMPLETED|Overall Study||1343
8764779|NCT01242514|9814712|FG001|NOT COMPLETED|Overall Study||357
8764780|NCT01242514|9814713|FG002|NOT COMPLETED|Overall Study||212
8764781|NCT01242527|9814725|FG000|STARTED|Overall Study||99
8764782|NCT01242527|9814726|FG001|STARTED|Overall Study||100
8764783|NCT01242527|9814727|FG002|STARTED|Overall Study||101
8764784|NCT01242527|9814728|FG003|STARTED|Overall Study||99
8764785|NCT01242527|9814725|FG000|COMPLETED|Overall Study||94
8764786|NCT01242527|9814726|FG001|COMPLETED|Overall Study||93
8764787|NCT01242527|9814727|FG002|COMPLETED|Overall Study||87
8764788|NCT01242527|9814728|FG003|COMPLETED|Overall Study||90
8764789|NCT01242527|9814725|FG000|NOT COMPLETED|Overall Study||5
8764790|NCT01242527|9814726|FG001|NOT COMPLETED|Overall Study||7
8764791|NCT01242527|9814727|FG002|NOT COMPLETED|Overall Study||14
8764792|NCT01242527|9814728|FG003|NOT COMPLETED|Overall Study||9
8764793|NCT01242644|9814741|FG000|STARTED|Overall Study||16
8764794|NCT01242644|9814742|FG001|STARTED|Overall Study||17
8764795|NCT01242644|9814743|FG002|STARTED|Overall Study||15
8764796|NCT01242644|9814741|FG000|COMPLETED|Overall Study||16
8764797|NCT01242644|9814742|FG001|COMPLETED|Overall Study||17
8764798|NCT01242644|9814743|FG002|COMPLETED|Overall Study||15
8764799|NCT01242644|9814741|FG000|NOT COMPLETED|Overall Study||0
8764800|NCT01242644|9814742|FG001|NOT COMPLETED|Overall Study||0
8764801|NCT01242644|9814743|FG002|NOT COMPLETED|Overall Study||0
8764802|NCT01242748|9814753|FG000|STARTED|Overall Study|Enrolled in CS35A, CS35A Full Analysis Set.|194
8764803|NCT01242748|9814754|FG001|STARTED|Overall Study||94
8764804|NCT01242748|9814753|FG000|CS35/CS35A Safety Analysis Set|Overall Study|Received at least 1 dose of trial drug during the main CS35 trial.|565
8764805|NCT01242748|9814754|FG001|CS35/CS35A Safety Analysis Set|Overall Study||283
8764806|NCT01242748|9814753|FG000|CS35/CS35A Full Analysis Set (FAS)|Overall Study|Received at least 1 dose of trial drug during CS35+had at least 1 efficacy assessment after dosing.|565
8764807|NCT01242748|9814754|FG001|CS35/CS35A Full Analysis Set (FAS)|Overall Study||282
8764808|NCT01242748|9814753|FG000|COMPLETED|Overall Study|These participants were ongoing when the trial was closed by the Sponsor.|156
8764809|NCT01242748|9814754|FG001|COMPLETED|Overall Study||80
8764810|NCT01242748|9814753|FG000|NOT COMPLETED|Overall Study||38
8764811|NCT01242748|9814754|FG001|NOT COMPLETED|Overall Study||14
8764812|NCT01242813|9814760|FG000|STARTED|Overall Study||20
8764813|NCT01242813|9814760|FG000|COMPLETED|Overall Study||18
8764814|NCT01242813|9814760|FG000|NOT COMPLETED|Overall Study||2
8764815|NCT01243112|9814764|FG000|STARTED|Overall Study||25
8764816|NCT01243112|9814764|FG000|COMPLETED|Overall Study||25
8764817|NCT01243112|9814764|FG000|NOT COMPLETED|Overall Study||0
8764818|NCT01243151|9814773|FG000|STARTED|Overall Study||12
8764819|NCT01243151|9814774|FG001|STARTED|Overall Study||14
9026774|NCT00565851|10089270|FG000|STARTED|Surgical Assignment||316
9026775|NCT00565851|10089271|FG001|STARTED|Surgical Assignment||456
8764820|NCT01243151|9814775|FG002|STARTED|Overall Study||14
8764821|NCT01243151|9814776|FG003|STARTED|Overall Study||14
8764822|NCT01243151|9814777|FG004|STARTED|Overall Study||14
8764823|NCT01243151|9814773|FG000|Treated|Overall Study||12
8764824|NCT01243151|9814774|FG001|Treated|Overall Study||14
8764825|NCT01243151|9814775|FG002|Treated|Overall Study||14
8764826|NCT01243151|9814776|FG003|Treated|Overall Study||13
8764827|NCT01243151|9814777|FG004|Treated|Overall Study||14
8764828|NCT01243151|9814773|FG000|COMPLETED|Overall Study||12
8764829|NCT01243151|9814774|FG001|COMPLETED|Overall Study||13
8764830|NCT01243151|9814775|FG002|COMPLETED|Overall Study||13
8764831|NCT01243151|9814776|FG003|COMPLETED|Overall Study||12
8764832|NCT01243151|9814777|FG004|COMPLETED|Overall Study||14
8764833|NCT01243151|9814773|FG000|NOT COMPLETED|Overall Study||0
8764834|NCT01243151|9814774|FG001|NOT COMPLETED|Overall Study||1
8764835|NCT01243151|9814775|FG002|NOT COMPLETED|Overall Study||1
8764836|NCT01243151|9814776|FG003|NOT COMPLETED|Overall Study||2
8764837|NCT01243151|9814777|FG004|NOT COMPLETED|Overall Study||0
8764838|NCT01243177|9814795|FG000|STARTED|Overall Study||444
8764839|NCT01243177|9814796|FG001|STARTED|Overall Study||442
8764840|NCT01243177|9814795|FG000|COMPLETED|Overall Study||266
8764841|NCT01243177|9814796|FG001|COMPLETED|Overall Study||264
8764842|NCT01243177|9814795|FG000|NOT COMPLETED|Overall Study||178
8764843|NCT01243177|9814796|FG001|NOT COMPLETED|Overall Study||178
8764844|NCT01243242|9814804|FG000|STARTED|Overall Study||60
8764845|NCT01243242|9814805|FG001|STARTED|Overall Study||60
8764846|NCT01243242|9814804|FG000|COMPLETED|Overall Study||57
8764847|NCT01243242|9814805|FG001|COMPLETED|Overall Study||56
8764848|NCT01243242|9814804|FG000|NOT COMPLETED|Overall Study||3
8764849|NCT01243242|9814805|FG001|NOT COMPLETED|Overall Study||4
8764850|NCT01243268|9814811|FG000|STARTED|Overall Study||674
8764851|NCT01243268|9814811|FG000|COMPLETED|Overall Study||610
8764852|NCT01243268|9814811|FG000|NOT COMPLETED|Overall Study||64
8764853|NCT01243294|9814815|FG000|STARTED|First Intervention (10 Days +/- 2 Days)||28
8764854|NCT01243294|9814816|FG001|STARTED|First Intervention (10 Days +/- 2 Days)||26
8764855|NCT01243294|9814815|FG000|COMPLETED|First Intervention (10 Days +/- 2 Days)||28
8764856|NCT01243294|9814816|FG001|COMPLETED|First Intervention (10 Days +/- 2 Days)||26
8764857|NCT01243294|9814815|FG000|NOT COMPLETED|First Intervention (10 Days +/- 2 Days)||0
8764858|NCT01243294|9814816|FG001|NOT COMPLETED|First Intervention (10 Days +/- 2 Days)||0
8764859|NCT01243294|9814815|FG000|STARTED|Second Intervention (10 Days +/- 2 Days)||28
8764860|NCT01243294|9814816|FG001|STARTED|Second Intervention (10 Days +/- 2 Days)||26
8764861|NCT01243294|9814815|FG000|COMPLETED|Second Intervention (10 Days +/- 2 Days)||28
8764862|NCT01243294|9814816|FG001|COMPLETED|Second Intervention (10 Days +/- 2 Days)||26
8915677|NCT02176421|9975123|FG000|COMPLETED|Overall Study||75
8915678|NCT02176421|9975123|FG000|NOT COMPLETED|Overall Study||5
8915679|NCT02176486|9975130|FG000|STARTED|Overall Study||3
8915680|NCT02176486|9975131|FG001|STARTED|Overall Study||5
8915681|NCT02176486|9975132|FG002|STARTED|Overall Study||4
8915682|NCT02176486|9975130|FG000|COMPLETED|Overall Study||3
8915683|NCT02176486|9975131|FG001|COMPLETED|Overall Study||5
8915684|NCT02176486|9975132|FG002|COMPLETED|Overall Study||4
8915685|NCT02176486|9975130|FG000|NOT COMPLETED|Overall Study||0
8915686|NCT02176486|9975131|FG001|NOT COMPLETED|Overall Study||0
8915687|NCT02176486|9975132|FG002|NOT COMPLETED|Overall Study||0
8915688|NCT02176525|9975150|FG000|STARTED|Overall Study|15 subjects randomized, 14 subjects treated with at least one dose, 1 subject was not treated|15
8915689|NCT02176525|9975151|FG001|STARTED|Overall Study||9
8915690|NCT02176525|9975152|FG002|STARTED|Overall Study||9
8915691|NCT02176525|9975153|FG003|STARTED|Overall Study||9
8915692|NCT02176525|9975154|FG004|STARTED|Overall Study||8
8915693|NCT02176525|9975155|FG005|STARTED|Overall Study|6 subjects randomized, 5 subjects treated with at least one dose, 1 subject was not treated|6
8915694|NCT02176525|9975156|FG006|STARTED|Overall Study||9
8915695|NCT02176525|9975157|FG007|STARTED|Overall Study||10
8915696|NCT02176525|9975150|FG000|COMPLETED|Overall Study||14
8915697|NCT02176525|9975151|FG001|COMPLETED|Overall Study||9
8915698|NCT02176525|9975152|FG002|COMPLETED|Overall Study||9
8915699|NCT02176525|9975153|FG003|COMPLETED|Overall Study||8
8915700|NCT02176525|9975154|FG004|COMPLETED|Overall Study||7
8915701|NCT02176525|9975155|FG005|COMPLETED|Overall Study||5
8915702|NCT02176525|9975156|FG006|COMPLETED|Overall Study||8
8915703|NCT02176525|9975157|FG007|COMPLETED|Overall Study||10
8915704|NCT02176525|9975150|FG000|NOT COMPLETED|Overall Study||1
8915705|NCT02176525|9975151|FG001|NOT COMPLETED|Overall Study||0
8915706|NCT02176525|9975152|FG002|NOT COMPLETED|Overall Study||0
8915707|NCT02176525|9975153|FG003|NOT COMPLETED|Overall Study||1
8915708|NCT02176525|9975154|FG004|NOT COMPLETED|Overall Study||1
8915709|NCT02176525|9975155|FG005|NOT COMPLETED|Overall Study||1
8915710|NCT02176525|9975156|FG006|NOT COMPLETED|Overall Study||1
8915711|NCT02176525|9975157|FG007|NOT COMPLETED|Overall Study||0
8915712|NCT02176642|9975185|FG000|STARTED|Overall Study||18
8915713|NCT02176642|9975186|FG001|STARTED|Overall Study||17
8915714|NCT02176642|9975185|FG000|COMPLETED|Overall Study||18
8915715|NCT02176642|9975186|FG001|COMPLETED|Overall Study||16
8915716|NCT02176642|9975185|FG000|NOT COMPLETED|Overall Study||0
8915717|NCT02176642|9975186|FG001|NOT COMPLETED|Overall Study||1
8915718|NCT02176655|9975192|FG000|STARTED|Overall Study||31
8915719|NCT02176655|9975192|FG000|COMPLETED|Overall Study||25
8915720|NCT02176655|9975192|FG000|NOT COMPLETED|Overall Study||6
8915721|NCT02176837|9975197|FG000|STARTED|Overall Study||6
8915722|NCT02176837|9975197|FG000|COMPLETED|Overall Study||0
8915723|NCT02176837|9975197|FG000|NOT COMPLETED|Overall Study||6
8915724|NCT02176928|9975203|FG000|STARTED|Overall Study||21
8915725|NCT02176928|9975204|FG001|STARTED|Overall Study||21
8915726|NCT02176928|9975203|FG000|COMPLETED|Overall Study||19
8915727|NCT02176928|9975204|FG001|COMPLETED|Overall Study||17
8915728|NCT02176928|9975203|FG000|NOT COMPLETED|Overall Study||2
8764863|NCT01243294|9814815|FG000|NOT COMPLETED|Second Intervention (10 Days +/- 2 Days)||0
8764864|NCT01243294|9814816|FG001|NOT COMPLETED|Second Intervention (10 Days +/- 2 Days)||0
8764865|NCT01243320|9814822|FG000|STARTED|10ppm Oral Silver (3 Days)||36
8764866|NCT01243320|9814822|FG000|COMPLETED|10ppm Oral Silver (3 Days)||36
8764867|NCT01243320|9814822|FG000|NOT COMPLETED|10ppm Oral Silver (3 Days)||0
8764868|NCT01243320|9814822|FG000|STARTED|10ppm Oral Silver (7 Days)||36
8764869|NCT01243320|9814822|FG000|COMPLETED|10ppm Oral Silver (7 Days)||36
8764870|NCT01243320|9814822|FG000|NOT COMPLETED|10ppm Oral Silver (7 Days)||0
8764871|NCT01243320|9814822|FG000|STARTED|10ppm Oral Silver (14 Days)||36
8764872|NCT01243320|9814822|FG000|COMPLETED|10ppm Oral Silver (14 Days)||36
8764873|NCT01243320|9814822|FG000|NOT COMPLETED|10ppm Oral Silver (14 Days)||0
8764874|NCT01243320|9814822|FG000|STARTED|Washout (3 Days)||36
8764875|NCT01243320|9814822|FG000|COMPLETED|Washout (3 Days)||36
8764876|NCT01243320|9814822|FG000|NOT COMPLETED|Washout (3 Days)||0
8764877|NCT01243320|9814822|FG000|STARTED|32ppm Oral Silver (14 Days)||24
8764878|NCT01243320|9814822|FG000|COMPLETED|32ppm Oral Silver (14 Days)||24
8764879|NCT01243320|9814822|FG000|NOT COMPLETED|32ppm Oral Silver (14 Days)||0
8764880|NCT01243333|9814828|FG000|STARTED|Overall Study||26
8764881|NCT01243333|9814828|FG000|COMPLETED|Overall Study||18
8764882|NCT01243333|9814828|FG000|NOT COMPLETED|Overall Study||8
8764883|NCT01243411|9814832|FG000|STARTED|Overall Study||347
8764884|NCT01243411|9814832|FG000|COMPLETED|Overall Study||306
8764885|NCT01243411|9814832|FG000|NOT COMPLETED|Overall Study||41
8764886|NCT01243424|9814838|FG000|STARTED|Discontinuation From Study (Treated Set)||3028
8764887|NCT01243424|9814839|FG001|STARTED|Discontinuation From Study (Treated Set)||3014
8764888|NCT01243424|9814838|FG000|Patient Died (Other Cause Than CV Death)|Discontinuation From Study (Treated Set)||123
8764889|NCT01243424|9814839|FG001|Patient Died (Other Cause Than CV Death)|Discontinuation From Study (Treated Set)||146
8764890|NCT01243424|9814838|FG000|Treated|Discontinuation From Study (Treated Set)||3023
8764891|NCT01243424|9814839|FG001|Treated|Discontinuation From Study (Treated Set)||3010
8764892|NCT01243424|9814838|FG000|COMPLETED|Discontinuation From Study (Treated Set)||2899
8764893|NCT01243424|9814839|FG001|COMPLETED|Discontinuation From Study (Treated Set)||2895
8764894|NCT01243424|9814838|FG000|NOT COMPLETED|Discontinuation From Study (Treated Set)||129
8764895|NCT01243424|9814839|FG001|NOT COMPLETED|Discontinuation From Study (Treated Set)||119
8764896|NCT01243424|9814838|FG000|STARTED|Discontinuation From Treatment||3028
8764897|NCT01243424|9814839|FG001|STARTED|Discontinuation From Treatment||3014
8764898|NCT01243424|9814838|FG000|Treated|Discontinuation From Treatment||3023
8764899|NCT01243424|9814839|FG001|Treated|Discontinuation From Treatment||3010
8764900|NCT01243424|9814838|FG000|COMPLETED|Discontinuation From Treatment||1896
8764901|NCT01243424|9814839|FG001|COMPLETED|Discontinuation From Treatment||1832
8764902|NCT01243424|9814838|FG000|NOT COMPLETED|Discontinuation From Treatment||1132
8764903|NCT01243424|9814839|FG001|NOT COMPLETED|Discontinuation From Treatment||1182
8764904|NCT01243450|9814849|FG000|STARTED|Overall Study||401
8764905|NCT01243450|9814850|FG001|STARTED|Overall Study||135
8764906|NCT01243450|9814851|FG002|STARTED|Overall Study||404
8764907|NCT01243450|9814849|FG000|COMPLETED|Overall Study||318
8764908|NCT01243450|9814850|FG001|COMPLETED|Overall Study||110
8764909|NCT01243450|9814851|FG002|COMPLETED|Overall Study||337
9026776|NCT00565851|10089272|FG002|STARTED|Surgical Assignment||33
9026777|NCT00565851|10089273|FG003|STARTED|Surgical Assignment||165
9026778|NCT00565851|10089274|FG004|STARTED|Surgical Assignment||6
9026779|NCT00565851|10089275|FG005|STARTED|Surgical Assignment||34
9026780|NCT00565851|10089276|FG006|STARTED|Surgical Assignment||5
9026781|NCT00565851|10089277|FG007|STARTED|Surgical Assignment||37
9026782|NCT00565851|10089270|FG000|Randomized - Yes Surgery|Surgical Assignment||0
9026783|NCT00565851|10089271|FG001|Randomized - Yes Surgery|Surgical Assignment||0
9026784|NCT00565851|10089272|FG002|Randomized - Yes Surgery|Surgical Assignment||33
9026785|NCT00565851|10089273|FG003|Randomized - Yes Surgery|Surgical Assignment||165
9026786|NCT00565851|10089274|FG004|Randomized - Yes Surgery|Surgical Assignment||0
9026787|NCT00565851|10089275|FG005|Randomized - Yes Surgery|Surgical Assignment||0
9026788|NCT00565851|10089276|FG006|Randomized - Yes Surgery|Surgical Assignment||5
9026789|NCT00565851|10089277|FG007|Randomized - Yes Surgery|Surgical Assignment||37
9026790|NCT00565851|10089270|FG000|Randomized - no Surgery|Surgical Assignment||33
9026791|NCT00565851|10089271|FG001|Randomized - no Surgery|Surgical Assignment||172
9026792|NCT00565851|10089272|FG002|Randomized - no Surgery|Surgical Assignment||0
9026793|NCT00565851|10089273|FG003|Randomized - no Surgery|Surgical Assignment||0
9026794|NCT00565851|10089274|FG004|Randomized - no Surgery|Surgical Assignment||6
9026795|NCT00565851|10089275|FG005|Randomized - no Surgery|Surgical Assignment||34
9026796|NCT00565851|10089276|FG006|Randomized - no Surgery|Surgical Assignment||0
9026797|NCT00565851|10089277|FG007|Randomized - no Surgery|Surgical Assignment||0
9026798|NCT00565851|10089270|FG000|Not Surgical Candidate|Surgical Assignment||283
9026799|NCT00565851|10089271|FG001|Not Surgical Candidate|Surgical Assignment||284
9026800|NCT00565851|10089272|FG002|Not Surgical Candidate|Surgical Assignment||0
9026801|NCT00565851|10089273|FG003|Not Surgical Candidate|Surgical Assignment||0
9026802|NCT00565851|10089274|FG004|Not Surgical Candidate|Surgical Assignment||0
9026803|NCT00565851|10089275|FG005|Not Surgical Candidate|Surgical Assignment||0
9026804|NCT00565851|10089276|FG006|Not Surgical Candidate|Surgical Assignment||0
8764910|NCT01243450|9814849|FG000|NOT COMPLETED|Overall Study||83
8764911|NCT01243450|9814850|FG001|NOT COMPLETED|Overall Study||25
8764912|NCT01243450|9814851|FG002|NOT COMPLETED|Overall Study||67
8764913|NCT01243567|9814861|FG000|STARTED|Overall Study||43
8764914|NCT01243567|9814862|FG001|STARTED|Overall Study||38
8764915|NCT01243567|9814861|FG000|COMPLETED|Overall Study||42
8764916|NCT01243567|9814862|FG001|COMPLETED|Overall Study||38
8764917|NCT01243567|9814861|FG000|NOT COMPLETED|Overall Study||1
8764918|NCT01243567|9814862|FG001|NOT COMPLETED|Overall Study||0
8764919|NCT01243580|9814870|FG000|STARTED|Overall Study||18
8764920|NCT01243580|9814871|FG001|STARTED|Overall Study||18
8764921|NCT01243580|9814870|FG000|COMPLETED|Overall Study||18
8764922|NCT01243580|9814871|FG001|COMPLETED|Overall Study||16
8764923|NCT01243580|9814870|FG000|NOT COMPLETED|Overall Study||0
8764924|NCT01243580|9814871|FG001|NOT COMPLETED|Overall Study||2
8764925|NCT01243593|9814881|FG000|STARTED|Overall Study||16
8764926|NCT01243593|9814882|FG001|STARTED|Overall Study||16
8764927|NCT01243593|9814881|FG000|COMPLETED|Overall Study||16
8764928|NCT01243593|9814882|FG001|COMPLETED|Overall Study||16
8764929|NCT01243593|9814881|FG000|NOT COMPLETED|Overall Study||0
8764930|NCT01243593|9814882|FG001|NOT COMPLETED|Overall Study||0
8808368|NCT01490632|9860703|FG002|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
8808369|NCT01490632|9860704|FG003|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
8808370|NCT01490632|9860705|FG004|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
8808371|NCT01490632|9860706|FG005|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥75 remained on 2 mg or 4 mg.|29
8808372|NCT01490632|9860707|FG006|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 8 mg or 10 mg with a PASI ≥75 remained on 8 mg or 10 mg.|64
8808373|NCT01490632|9860708|FG007|STARTED|Part B: Extension or Step-Up Period|Placebo participants in Part A with a PASI <75 were re-randomized to 8 mg or 10 mg.|19
8808374|NCT01490632|9860709|FG008|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥50 to <75 remained on 2 mg or 4 mg.|16
8808375|NCT01490632|9860710|FG009|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 2 mg or 4 mg with a PASI <50 were re-randomized to 8 mg or 10 mg.|50
8808376|NCT01490632|9860711|FG010|STARTED|Part B: Extension or Step-Up Period|Part A 10 mg non-responders were discontinued from the study.|43
8808377|NCT01490632|9860712|FG011|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to Placebo remained on Placebo.|8
8808378|NCT01490632|9860713|FG012|STARTED|Part B: Extension or Step-Up Period||0
8808379|NCT01490632|9860714|FG013|STARTED|Part B: Extension or Step-Up Period||0
8808380|NCT01490632|9860715|FG014|STARTED|Part B: Extension or Step-Up Period||0
8808381|NCT01490632|9860716|FG015|STARTED|Part B: Extension or Step-Up Period||0
8808382|NCT01490632|9860717|FG016|STARTED|Part B: Extension or Step-Up Period||0
8808383|NCT01490632|9860718|FG017|STARTED|Part B: Extension or Step-Up Period||0
8808384|NCT01490632|9860719|FG018|STARTED|Part B: Extension or Step-Up Period||0
8808385|NCT01490632|9860720|FG019|STARTED|Part B: Extension or Step-Up Period||0
8808386|NCT01490632|9860701|FG000|COMPLETED|Part B: Extension or Step-Up Period||0
8808387|NCT01490632|9860702|FG001|COMPLETED|Part B: Extension or Step-Up Period||0
8808388|NCT01490632|9860703|FG002|COMPLETED|Part B: Extension or Step-Up Period||0
8808389|NCT01490632|9860704|FG003|COMPLETED|Part B: Extension or Step-Up Period||0
8808390|NCT01490632|9860705|FG004|COMPLETED|Part B: Extension or Step-Up Period||0
8808391|NCT01490632|9860706|FG005|COMPLETED|Part B: Extension or Step-Up Period||25
8808392|NCT01490632|9860707|FG006|COMPLETED|Part B: Extension or Step-Up Period||51
8808393|NCT01490632|9860708|FG007|COMPLETED|Part B: Extension or Step-Up Period||13
8808394|NCT01490632|9860709|FG008|COMPLETED|Part B: Extension or Step-Up Period||6
8808395|NCT01490632|9860710|FG009|COMPLETED|Part B: Extension or Step-Up Period||25
8808396|NCT01490632|9860711|FG010|COMPLETED|Part B: Extension or Step-Up Period||22
8808397|NCT01490632|9860712|FG011|COMPLETED|Part B: Extension or Step-Up Period||0
8808398|NCT01490632|9860713|FG012|COMPLETED|Part B: Extension or Step-Up Period||0
8808399|NCT01490632|9860714|FG013|COMPLETED|Part B: Extension or Step-Up Period||0
8808400|NCT01490632|9860715|FG014|COMPLETED|Part B: Extension or Step-Up Period||0
8808401|NCT01490632|9860716|FG015|COMPLETED|Part B: Extension or Step-Up Period||0
8808402|NCT01490632|9860717|FG016|COMPLETED|Part B: Extension or Step-Up Period||0
8808403|NCT01490632|9860718|FG017|COMPLETED|Part B: Extension or Step-Up Period||0
8808404|NCT01490632|9860719|FG018|COMPLETED|Part B: Extension or Step-Up Period||0
8808405|NCT01490632|9860720|FG019|COMPLETED|Part B: Extension or Step-Up Period||0
8808406|NCT01490632|9860701|FG000|NOT COMPLETED|Part B: Extension or Step-Up Period||0
8808407|NCT01490632|9860702|FG001|NOT COMPLETED|Part B: Extension or Step-Up Period||0
8808408|NCT01490632|9860703|FG002|NOT COMPLETED|Part B: Extension or Step-Up Period||0
8808409|NCT01490632|9860704|FG003|NOT COMPLETED|Part B: Extension or Step-Up Period||0
8808410|NCT01490632|9860705|FG004|NOT COMPLETED|Part B: Extension or Step-Up Period||0
8808411|NCT01490632|9860706|FG005|NOT COMPLETED|Part B: Extension or Step-Up Period||4
8808412|NCT01490632|9860707|FG006|NOT COMPLETED|Part B: Extension or Step-Up Period||13
8808413|NCT01490632|9860708|FG007|NOT COMPLETED|Part B: Extension or Step-Up Period||6
8808414|NCT01490632|9860709|FG008|NOT COMPLETED|Part B: Extension or Step-Up Period||10
8808415|NCT01490632|9860710|FG009|NOT COMPLETED|Part B: Extension or Step-Up Period||25
8808416|NCT01490632|9860711|FG010|NOT COMPLETED|Part B: Extension or Step-Up Period||21
8808417|NCT01490632|9860712|FG011|NOT COMPLETED|Part B: Extension or Step-Up Period||8
8808418|NCT01490632|9860713|FG012|NOT COMPLETED|Part B: Extension or Step-Up Period||0
8808419|NCT01490632|9860714|FG013|NOT COMPLETED|Part B: Extension or Step-Up Period||0
8808420|NCT01490632|9860715|FG014|NOT COMPLETED|Part B: Extension or Step-Up Period||0
8764931|NCT01243619|9814888|FG000|STARTED|Overall Study||5
8764932|NCT01243619|9814888|FG000|COMPLETED|Overall Study|Patient enrollment is complete, data analysis is ongoing|5
8764933|NCT01243619|9814888|FG000|NOT COMPLETED|Overall Study||0
8764934|NCT01243671|9814892|FG000|STARTED|Overall Study||20
8764935|NCT01243671|9814892|FG000|Completed 24 Weeks of Treatment|Overall Study||18
8764936|NCT01243671|9814892|FG000|Completed 52 Weeks of Treatment|Overall Study||17
8764937|NCT01243671|9814892|FG000|COMPLETED|Overall Study|Completed 136 weeks of treatment.|15
8764938|NCT01243671|9814892|FG000|NOT COMPLETED|Overall Study||5
8764939|NCT01243762|9814903|FG000|STARTED|Part 1 (Dose Escalation/MTD)||4
8764940|NCT01243762|9814904|FG001|STARTED|Part 1 (Dose Escalation/MTD)||13
8764941|NCT01243762|9814905|FG002|STARTED|Part 1 (Dose Escalation/MTD)||3
8764942|NCT01243762|9814906|FG003|STARTED|Part 1 (Dose Escalation/MTD)||8
8764943|NCT01243762|9814907|FG004|STARTED|Part 1 (Dose Escalation/MTD)||10
8764944|NCT01243762|9814908|FG005|STARTED|Part 1 (Dose Escalation/MTD)||3
8671219|NCT00750308|9714641|FG009|NOT COMPLETED|Second Treatment||0
8671220|NCT00750308|9714642|FG010|NOT COMPLETED|Second Treatment||0
8671221|NCT00750308|9714643|FG011|NOT COMPLETED|Second Treatment||0
8671222|NCT00750308|9714632|FG000|STARTED|Washout||2
8671223|NCT00750308|9714633|FG001|STARTED|Washout||2
8671224|NCT00750308|9714634|FG002|STARTED|Washout||2
8671225|NCT00750308|9714635|FG003|STARTED|Washout||1
8671226|NCT00750308|9714636|FG004|STARTED|Washout||1
8671227|NCT00750308|9714637|FG005|STARTED|Washout||2
8671228|NCT00750308|9714638|FG006|STARTED|Washout||2
8671229|NCT00750308|9714639|FG007|STARTED|Washout||2
8671230|NCT00750308|9714640|FG008|STARTED|Washout||1
8671231|NCT00750308|9714641|FG009|STARTED|Washout||2
8671232|NCT00750308|9714642|FG010|STARTED|Washout||1
8671233|NCT00750308|9714643|FG011|STARTED|Washout||1
8671234|NCT00750308|9714632|FG000|COMPLETED|Washout||2
8671235|NCT00750308|9714633|FG001|COMPLETED|Washout||2
8671236|NCT00750308|9714634|FG002|COMPLETED|Washout||2
8764945|NCT01243762|9814909|FG006|STARTED|Part 1 (Dose Escalation/MTD)||0
8764946|NCT01243762|9814903|FG000|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|1
8764947|NCT01243762|9814904|FG001|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|5
8764948|NCT01243762|9814905|FG002|COMPLETED|Part 1 (Dose Escalation/MTD)||0
8764949|NCT01243762|9814906|FG003|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|2
8764950|NCT01243762|9814907|FG004|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|4
8764951|NCT01243762|9814908|FG005|COMPLETED|Part 1 (Dose Escalation/MTD)||0
8764952|NCT01243762|9814909|FG006|COMPLETED|Part 1 (Dose Escalation/MTD)||0
8764953|NCT01243762|9814903|FG000|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||3
8764954|NCT01243762|9814904|FG001|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||8
8764955|NCT01243762|9814905|FG002|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||3
8764956|NCT01243762|9814906|FG003|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||6
8764957|NCT01243762|9814907|FG004|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||6
8764958|NCT01243762|9814908|FG005|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||3
8764959|NCT01243762|9814909|FG006|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||0
8764960|NCT01243762|9814903|FG000|STARTED|Part 2 (Dose Confirmation/Efficacy)||1
8764961|NCT01243762|9814904|FG001|STARTED|Part 2 (Dose Confirmation/Efficacy)||5
8764962|NCT01243762|9814905|FG002|STARTED|Part 2 (Dose Confirmation/Efficacy)||0
8764963|NCT01243762|9814906|FG003|STARTED|Part 2 (Dose Confirmation/Efficacy)||2
8764964|NCT01243762|9814907|FG004|STARTED|Part 2 (Dose Confirmation/Efficacy)||4
8764965|NCT01243762|9814908|FG005|STARTED|Part 2 (Dose Confirmation/Efficacy)||0
8764966|NCT01243762|9814909|FG006|STARTED|Part 2 (Dose Confirmation/Efficacy)|New participants were enrolled in Part 2 of the study that did not participate in Part 1|6
8764967|NCT01243762|9814903|FG000|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
8764968|NCT01243762|9814904|FG001|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
8764969|NCT01243762|9814905|FG002|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
8764970|NCT01243762|9814906|FG003|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
8764971|NCT01243762|9814907|FG004|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
8764972|NCT01243762|9814908|FG005|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
8764973|NCT01243762|9814909|FG006|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
8764974|NCT01243762|9814903|FG000|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||1
8764975|NCT01243762|9814904|FG001|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||5
8764976|NCT01243762|9814905|FG002|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
8764977|NCT01243762|9814906|FG003|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||2
8764978|NCT01243762|9814907|FG004|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||4
8764979|NCT01243762|9814908|FG005|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
8764980|NCT01243762|9814909|FG006|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||6
8764981|NCT01243775|9814928|FG000|STARTED|Overall Study||33
8764982|NCT01243775|9814928|FG000|COMPLETED|Overall Study||31
8764983|NCT01243775|9814928|FG000|NOT COMPLETED|Overall Study||2
8764984|NCT01243944|9814934|FG000|STARTED|Overall Study||110
8764985|NCT01243944|9814935|FG001|STARTED|Overall Study|One participant withdrew consent 5 days after randomization to BAT & wasn't treated while on study.|112
9026805|NCT00565851|10089277|FG007|Not Surgical Candidate|Surgical Assignment||0
9026806|NCT00565851|10089270|FG000|COMPLETED|Surgical Assignment||313
9026807|NCT00565851|10089271|FG001|COMPLETED|Surgical Assignment||454
8671237|NCT00750308|9714635|FG003|COMPLETED|Washout||1
8671238|NCT00750308|9714636|FG004|COMPLETED|Washout||1
8764986|NCT01243944|9814934|FG000|Treated|Overall Study||110
9026808|NCT00565851|10089272|FG002|COMPLETED|Surgical Assignment||31
9026809|NCT00565851|10089273|FG003|COMPLETED|Surgical Assignment||154
8764987|NCT01243944|9814935|FG001|Treated|Overall Study||111
8764988|NCT01243944|9814934|FG000|Followed for Survival|Overall Study||22
8764989|NCT01243944|9814935|FG001|Followed for Survival|Overall Study||21
8764990|NCT01243944|9814934|FG000|COMPLETED|Overall Study||65
8764991|NCT01243944|9814935|FG001|COMPLETED|Overall Study|Study evaluation completion is reported for participants that were treated & those never treatment.|61
8764992|NCT01243944|9814934|FG000|NOT COMPLETED|Overall Study||45
8764993|NCT01243944|9814935|FG001|NOT COMPLETED|Overall Study||51
8764994|NCT01243957|9814942|FG000|STARTED|Overall Study||20
9026810|NCT00565851|10089274|FG004|COMPLETED|Surgical Assignment||6
9026811|NCT00565851|10089275|FG005|COMPLETED|Surgical Assignment||34
9026812|NCT00565851|10089276|FG006|COMPLETED|Surgical Assignment||5
9026813|NCT00565851|10089277|FG007|COMPLETED|Surgical Assignment||35
9026814|NCT00565851|10089270|FG000|NOT COMPLETED|Surgical Assignment||3
9026815|NCT00565851|10089271|FG001|NOT COMPLETED|Surgical Assignment||2
9026816|NCT00565851|10089272|FG002|NOT COMPLETED|Surgical Assignment||2
9026817|NCT00565851|10089273|FG003|NOT COMPLETED|Surgical Assignment||11
9026818|NCT00565851|10089274|FG004|NOT COMPLETED|Surgical Assignment||0
9026819|NCT00565851|10089275|FG005|NOT COMPLETED|Surgical Assignment||0
9026820|NCT00565851|10089276|FG006|NOT COMPLETED|Surgical Assignment||0
9026821|NCT00565851|10089277|FG007|NOT COMPLETED|Surgical Assignment||2
9026822|NCT00565851|10089270|FG000|STARTED|Chemotherapy Assignment||316
9026823|NCT00565851|10089271|FG001|STARTED|Chemotherapy Assignment||456
9026824|NCT00565851|10089272|FG002|STARTED|Chemotherapy Assignment||33
9026825|NCT00565851|10089273|FG003|STARTED|Chemotherapy Assignment||165
9026826|NCT00565851|10089274|FG004|STARTED|Chemotherapy Assignment||6
9026827|NCT00565851|10089275|FG005|STARTED|Chemotherapy Assignment||34
9026828|NCT00565851|10089276|FG006|STARTED|Chemotherapy Assignment||5
9026829|NCT00565851|10089277|FG007|STARTED|Chemotherapy Assignment||37
9026830|NCT00565851|10089270|FG000|Randomized to Chemo|Chemotherapy Assignment||310
9026831|NCT00565851|10089271|FG001|Randomized to Chemo|Chemotherapy Assignment||311
9026832|NCT00565851|10089272|FG002|Randomized to Chemo|Chemotherapy Assignment||27
9026833|NCT00565851|10089273|FG003|Randomized to Chemo|Chemotherapy Assignment||26
9026834|NCT00565851|10089274|FG004|Randomized to Chemo|Chemotherapy Assignment||0
9026835|NCT00565851|10089275|FG005|Randomized to Chemo|Chemotherapy Assignment||0
9026836|NCT00565851|10089276|FG006|Randomized to Chemo|Chemotherapy Assignment||0
9026837|NCT00565851|10089277|FG007|Randomized to Chemo|Chemotherapy Assignment||0
9026838|NCT00565851|10089270|FG000|Pre-specified Chemo|Chemotherapy Assignment||6
9026839|NCT00565851|10089271|FG001|Pre-specified Chemo|Chemotherapy Assignment||145
9026840|NCT00565851|10089272|FG002|Pre-specified Chemo|Chemotherapy Assignment||6
9026841|NCT00565851|10089273|FG003|Pre-specified Chemo|Chemotherapy Assignment||139
9026842|NCT00565851|10089274|FG004|Pre-specified Chemo|Chemotherapy Assignment||6
9026843|NCT00565851|10089275|FG005|Pre-specified Chemo|Chemotherapy Assignment||34
9026844|NCT00565851|10089276|FG006|Pre-specified Chemo|Chemotherapy Assignment||5
9026845|NCT00565851|10089277|FG007|Pre-specified Chemo|Chemotherapy Assignment||37
9026846|NCT00565851|10089270|FG000|COMPLETED|Chemotherapy Assignment||307
9026847|NCT00565851|10089271|FG001|COMPLETED|Chemotherapy Assignment||433
9026848|NCT00565851|10089272|FG002|COMPLETED|Chemotherapy Assignment||30
9026849|NCT00565851|10089273|FG003|COMPLETED|Chemotherapy Assignment||129
9026850|NCT00565851|10089274|FG004|COMPLETED|Chemotherapy Assignment||6
9026851|NCT00565851|10089275|FG005|COMPLETED|Chemotherapy Assignment||31
9026852|NCT00565851|10089276|FG006|COMPLETED|Chemotherapy Assignment||5
9026853|NCT00565851|10089277|FG007|COMPLETED|Chemotherapy Assignment||34
9026854|NCT00565851|10089270|FG000|NOT COMPLETED|Chemotherapy Assignment||9
9026855|NCT00565851|10089271|FG001|NOT COMPLETED|Chemotherapy Assignment||23
9026856|NCT00565851|10089272|FG002|NOT COMPLETED|Chemotherapy Assignment||3
9026857|NCT00565851|10089273|FG003|NOT COMPLETED|Chemotherapy Assignment||36
9026858|NCT00565851|10089274|FG004|NOT COMPLETED|Chemotherapy Assignment||0
9026859|NCT00565851|10089275|FG005|NOT COMPLETED|Chemotherapy Assignment||3
9026860|NCT00565851|10089276|FG006|NOT COMPLETED|Chemotherapy Assignment||0
9026861|NCT00565851|10089277|FG007|NOT COMPLETED|Chemotherapy Assignment||3
9026862|NCT00376623|10089302|FG000|STARTED|Overall Study||49
9026863|NCT00376623|10089303|FG001|STARTED|Overall Study||26
9026864|NCT00376623|10089304|FG002|STARTED|Overall Study||21
9026865|NCT00376623|10089302|FG000|Treated With BI 2536|Overall Study||48
9026866|NCT00376623|10089303|FG001|Treated With BI 2536|Overall Study||26
9026867|NCT00376623|10089304|FG002|Treated With BI 2536|Overall Study||21
9026868|NCT00376623|10089302|FG000|COMPLETED|Overall Study||0
9026869|NCT00376623|10089303|FG001|COMPLETED|Overall Study||0
9026870|NCT00376623|10089304|FG002|COMPLETED|Overall Study||0
9026871|NCT00376623|10089302|FG000|NOT COMPLETED|Overall Study||49
9026872|NCT00376623|10089303|FG001|NOT COMPLETED|Overall Study||26
9026873|NCT00376623|10089304|FG002|NOT COMPLETED|Overall Study||21
9026874|NCT03180645|10089321|FG000|STARTED|Overall Study||24
9026875|NCT03180645|10089322|FG001|STARTED|Overall Study||24
9026876|NCT03180645|10089323|FG002|STARTED|Overall Study||24
9026877|NCT03180645|10089321|FG000|COMPLETED|Overall Study||24
9026878|NCT03180645|10089322|FG001|COMPLETED|Overall Study||23
9026879|NCT03180645|10089323|FG002|COMPLETED|Overall Study||22
9026880|NCT03180645|10089321|FG000|NOT COMPLETED|Overall Study||0
9026881|NCT03180645|10089322|FG001|NOT COMPLETED|Overall Study||1
9026882|NCT03180645|10089323|FG002|NOT COMPLETED|Overall Study||2
9026883|NCT03180801|10089338|FG000|STARTED|Overall Study||50
9026884|NCT03180801|10089339|FG001|STARTED|Overall Study||52
8764995|NCT01243957|9814942|FG000|COMPLETED|Overall Study||20
8764996|NCT01243957|9814942|FG000|NOT COMPLETED|Overall Study||0
8764997|NCT01244035|9814948|FG000|STARTED|Part 1: Period 1||5
8764998|NCT01244035|9814949|FG001|STARTED|Part 1: Period 1||5
8764999|NCT01244035|9814950|FG002|STARTED|Part 1: Period 1||6
8765000|NCT01244035|9814951|FG003|STARTED|Part 1: Period 1||5
8765001|NCT01244035|9814952|FG004|STARTED|Part 1: Period 1||5
8765002|NCT01244035|9814953|FG005|STARTED|Part 1: Period 1||5
8765003|NCT01244035|9814948|FG000|COMPLETED|Part 1: Period 1||4
8765004|NCT01244035|9814949|FG001|COMPLETED|Part 1: Period 1||3
8765005|NCT01244035|9814950|FG002|COMPLETED|Part 1: Period 1||4
8765006|NCT01244035|9814951|FG003|COMPLETED|Part 1: Period 1||5
8765007|NCT01244035|9814952|FG004|COMPLETED|Part 1: Period 1||4
8765008|NCT01244035|9814953|FG005|COMPLETED|Part 1: Period 1||3
8765009|NCT01244035|9814948|FG000|NOT COMPLETED|Part 1: Period 1||1
8765010|NCT01244035|9814949|FG001|NOT COMPLETED|Part 1: Period 1||2
8765011|NCT01244035|9814950|FG002|NOT COMPLETED|Part 1: Period 1||2
8765012|NCT01244035|9814951|FG003|NOT COMPLETED|Part 1: Period 1||0
8765013|NCT01244035|9814952|FG004|NOT COMPLETED|Part 1: Period 1||1
8765014|NCT01244035|9814953|FG005|NOT COMPLETED|Part 1: Period 1||2
8765015|NCT01244035|9814948|FG000|STARTED|Part 1: Period 2||4
8765016|NCT01244035|9814949|FG001|STARTED|Part 1: Period 2||3
8765017|NCT01244035|9814950|FG002|STARTED|Part 1: Period 2||4
8765018|NCT01244035|9814951|FG003|STARTED|Part 1: Period 2||5
8765019|NCT01244035|9814952|FG004|STARTED|Part 1: Period 2||4
8765020|NCT01244035|9814953|FG005|STARTED|Part 1: Period 2||3
8765021|NCT01244035|9814948|FG000|COMPLETED|Part 1: Period 2||4
8765022|NCT01244035|9814949|FG001|COMPLETED|Part 1: Period 2||3
8765023|NCT01244035|9814950|FG002|COMPLETED|Part 1: Period 2||3
8765024|NCT01244035|9814951|FG003|COMPLETED|Part 1: Period 2||5
8765025|NCT01244035|9814952|FG004|COMPLETED|Part 1: Period 2||4
8765026|NCT01244035|9814953|FG005|COMPLETED|Part 1: Period 2||3
8765027|NCT01244035|9814948|FG000|NOT COMPLETED|Part 1: Period 2||0
8765028|NCT01244035|9814949|FG001|NOT COMPLETED|Part 1: Period 2||0
8765029|NCT01244035|9814950|FG002|NOT COMPLETED|Part 1: Period 2||1
8765030|NCT01244035|9814951|FG003|NOT COMPLETED|Part 1: Period 2||0
8765031|NCT01244035|9814952|FG004|NOT COMPLETED|Part 1: Period 2||0
8765032|NCT01244035|9814953|FG005|NOT COMPLETED|Part 1: Period 2||0
8765033|NCT01244035|9814948|FG000|STARTED|Part 1: Period 3||4
8765034|NCT01244035|9814949|FG001|STARTED|Part 1: Period 3||3
8765035|NCT01244035|9814950|FG002|STARTED|Part 1: Period 3||3
8765036|NCT01244035|9814951|FG003|STARTED|Part 1: Period 3||5
8765037|NCT01244035|9814952|FG004|STARTED|Part 1: Period 3||4
8765038|NCT01244035|9814953|FG005|STARTED|Part 1: Period 3||3
8765039|NCT01244035|9814948|FG000|COMPLETED|Part 1: Period 3||4
8765040|NCT01244035|9814949|FG001|COMPLETED|Part 1: Period 3||2
8765041|NCT01244035|9814950|FG002|COMPLETED|Part 1: Period 3||3
8765042|NCT01244035|9814951|FG003|COMPLETED|Part 1: Period 3||5
8765043|NCT01244035|9814952|FG004|COMPLETED|Part 1: Period 3||3
8765044|NCT01244035|9814953|FG005|COMPLETED|Part 1: Period 3||2
8765045|NCT01244035|9814948|FG000|NOT COMPLETED|Part 1: Period 3||0
8765046|NCT01244035|9814949|FG001|NOT COMPLETED|Part 1: Period 3||1
8765047|NCT01244035|9814950|FG002|NOT COMPLETED|Part 1: Period 3||0
8765048|NCT01244035|9814951|FG003|NOT COMPLETED|Part 1: Period 3||0
8765049|NCT01244035|9814952|FG004|NOT COMPLETED|Part 1: Period 3||1
8765050|NCT01244035|9814953|FG005|NOT COMPLETED|Part 1: Period 3||1
8765051|NCT01244061|9814975|FG000|STARTED|Overall Study||251
8765052|NCT01244061|9814976|FG001|STARTED|Overall Study||247
8765053|NCT01244061|9814975|FG000|COMPLETED|Overall Study||169
8765054|NCT01244061|9814976|FG001|COMPLETED|Overall Study||144
8765055|NCT01244061|9814975|FG000|NOT COMPLETED|Overall Study||82
8765056|NCT01244061|9814976|FG001|NOT COMPLETED|Overall Study||103
8765057|NCT01244126|9814985|FG000|STARTED|Overall Study||59
8765058|NCT01244126|9814986|FG001|STARTED|Overall Study||55
8765059|NCT01244126|9814987|FG002|STARTED|Overall Study||57
8765060|NCT01244126|9814985|FG000|COMPLETED|Overall Study||56
8765061|NCT01244126|9814986|FG001|COMPLETED|Overall Study||52
8765062|NCT01244126|9814987|FG002|COMPLETED|Overall Study||48
8765063|NCT01244126|9814985|FG000|NOT COMPLETED|Overall Study||3
8765064|NCT01244126|9814986|FG001|NOT COMPLETED|Overall Study||3
8765065|NCT01244126|9814987|FG002|NOT COMPLETED|Overall Study||9
8765066|NCT01244191|9814997|FG000|STARTED|Overall Study||526
8765067|NCT01244191|9814998|FG001|STARTED|Overall Study||522
8765068|NCT01244191|9814997|FG000|Did Not Receive Treatment|Overall Study||6
8765069|NCT01244191|9814998|FG001|Did Not Receive Treatment|Overall Study||5
8765070|NCT01244191|9814997|FG000|COMPLETED|Overall Study||46
8765071|NCT01244191|9814998|FG001|COMPLETED|Overall Study||24
8765072|NCT01244191|9814997|FG000|NOT COMPLETED|Overall Study||480
8765073|NCT01244191|9814998|FG001|NOT COMPLETED|Overall Study||498
8765074|NCT01244243|9815004|FG000|STARTED|Overall Study||41
8765075|NCT01244243|9815004|FG000|COMPLETED|Overall Study||41
8765076|NCT01244243|9815004|FG000|NOT COMPLETED|Overall Study||0
8765077|NCT01244412|9815008|FG000|STARTED|Overall Study||1
8765078|NCT01244412|9815008|FG000|COMPLETED|Overall Study||1
8765079|NCT01244412|9815008|FG000|NOT COMPLETED|Overall Study||0
8765080|NCT01244425|9815014|FG000|STARTED|Overall Study||35
8765081|NCT01244425|9815015|FG001|STARTED|Overall Study||35
8765082|NCT01244425|9815014|FG000|COMPLETED|Overall Study|Adverse Event: multi-organ failure (death)|32
8765083|NCT01244425|9815015|FG001|COMPLETED|Overall Study|Adverse Event: septic shock with multi-organ failure due to liver abscess (death)|32
8765084|NCT01244425|9815014|FG000|NOT COMPLETED|Overall Study||3
8765085|NCT01244425|9815015|FG001|NOT COMPLETED|Overall Study||3
8765086|NCT01244451|9815029|FG000|STARTED|Overall Study||49
8765087|NCT01244451|9815029|FG000|COMPLETED|Overall Study||36
8765088|NCT01244451|9815029|FG000|NOT COMPLETED|Overall Study||13
8765089|NCT01244477|9815036|FG000|STARTED|Overall Study||38
8765090|NCT01244477|9815037|FG001|STARTED|Overall Study||23
8765091|NCT01244477|9815036|FG000|COMPLETED|Overall Study||18
8765092|NCT01244477|9815037|FG001|COMPLETED|Overall Study||20
8765093|NCT01244477|9815036|FG000|NOT COMPLETED|Overall Study||20
8765094|NCT01244477|9815037|FG001|NOT COMPLETED|Overall Study||3
8765095|NCT01244490|9815048|FG000|STARTED|Overall Study||111
8765096|NCT01244490|9815049|FG001|STARTED|Overall Study||115
8765097|NCT01244490|9815050|FG002|STARTED|Overall Study||112
8765098|NCT01244490|9815048|FG000|COMPLETED|Overall Study||92
8765099|NCT01244490|9815049|FG001|COMPLETED|Overall Study||91
8765100|NCT01244490|9815050|FG002|COMPLETED|Overall Study||89
8765101|NCT01244490|9815048|FG000|NOT COMPLETED|Overall Study||19
8765102|NCT01244490|9815049|FG001|NOT COMPLETED|Overall Study||24
8765103|NCT01244490|9815050|FG002|NOT COMPLETED|Overall Study||23
8765104|NCT01244503|9815058|FG000|STARTED|Overall Study||61
8765105|NCT01244503|9815058|FG000|COMPLETED|Overall Study||61
8765106|NCT01244503|9815058|FG000|NOT COMPLETED|Overall Study||0
8765107|NCT01244516|9815065|FG000|STARTED|Period 1 (Baseline to 1-week Visit)||170
8765108|NCT01244516|9815066|FG001|STARTED|Period 1 (Baseline to 1-week Visit)||177
8765109|NCT01244516|9815067|FG002|STARTED|Period 1 (Baseline to 1-week Visit)||173
8765110|NCT01244516|9815065|FG000|COMPLETED|Period 1 (Baseline to 1-week Visit)||166
8765111|NCT01244516|9815066|FG001|COMPLETED|Period 1 (Baseline to 1-week Visit)||171
8765112|NCT01244516|9815067|FG002|COMPLETED|Period 1 (Baseline to 1-week Visit)||170
8765113|NCT01244516|9815065|FG000|NOT COMPLETED|Period 1 (Baseline to 1-week Visit)||4
8765114|NCT01244516|9815066|FG001|NOT COMPLETED|Period 1 (Baseline to 1-week Visit)||6
8765115|NCT01244516|9815067|FG002|NOT COMPLETED|Period 1 (Baseline to 1-week Visit)||3
8765116|NCT01244516|9815065|FG000|STARTED|Period 2 (1-week to 2-week Visit)||166
8765117|NCT01244516|9815066|FG001|STARTED|Period 2 (1-week to 2-week Visit)||171
8765118|NCT01244516|9815067|FG002|STARTED|Period 2 (1-week to 2-week Visit)||170
8765119|NCT01244516|9815065|FG000|COMPLETED|Period 2 (1-week to 2-week Visit)||163
8765120|NCT01244516|9815066|FG001|COMPLETED|Period 2 (1-week to 2-week Visit)||170
8765121|NCT01244516|9815067|FG002|COMPLETED|Period 2 (1-week to 2-week Visit)||168
8765122|NCT01244516|9815065|FG000|NOT COMPLETED|Period 2 (1-week to 2-week Visit)||3
8765123|NCT01244516|9815066|FG001|NOT COMPLETED|Period 2 (1-week to 2-week Visit)||1
8765124|NCT01244516|9815067|FG002|NOT COMPLETED|Period 2 (1-week to 2-week Visit)||2
8765125|NCT01244529|9815076|FG000|STARTED|Overall Study||41
8765126|NCT01244529|9815076|FG000|COMPLETED|Overall Study||41
8765127|NCT01244529|9815076|FG000|NOT COMPLETED|Overall Study||0
8765128|NCT01244633|9815092|FG000|STARTED|Overall Study||18
8765129|NCT01244633|9815092|FG000|COMPLETED|Overall Study||15
8765130|NCT01244633|9815092|FG000|NOT COMPLETED|Overall Study||3
8765131|NCT01244711|9815096|FG000|STARTED|Overall Study||1
8765132|NCT01244711|9815096|FG000|COMPLETED|Overall Study||1
8765133|NCT01244711|9815096|FG000|NOT COMPLETED|Overall Study||0
8765134|NCT01244724|9815100|FG000|STARTED|Overall Study|Of these 15 returned for a week 2 visit and are included in the efficacy analysis.|17
8765135|NCT01244724|9815100|FG000|Week 2 Visit|Overall Study||15
8765136|NCT01244724|9815100|FG000|COMPLETED|Overall Study||9
8765137|NCT01244724|9815100|FG000|NOT COMPLETED|Overall Study||8
8765138|NCT01244893|9815104|FG000|STARTED|Baseline||22
8765139|NCT01244893|9815105|FG001|STARTED|Baseline||22
8765140|NCT01244893|9815104|FG000|COMPLETED|Baseline||22
8765141|NCT01244893|9815105|FG001|COMPLETED|Baseline||21
8765142|NCT01244893|9815104|FG000|NOT COMPLETED|Baseline||0
8765143|NCT01244893|9815105|FG001|NOT COMPLETED|Baseline||1
8765144|NCT01244893|9815104|FG000|STARTED|1-Week Follow Up||22
8765145|NCT01244893|9815105|FG001|STARTED|1-Week Follow Up||21
8765146|NCT01244893|9815104|FG000|COMPLETED|1-Week Follow Up||21
8765147|NCT01244893|9815105|FG001|COMPLETED|1-Week Follow Up||21
8765148|NCT01244893|9815104|FG000|NOT COMPLETED|1-Week Follow Up||1
8765149|NCT01244893|9815105|FG001|NOT COMPLETED|1-Week Follow Up||0
8765150|NCT01244893|9815104|FG000|STARTED|Final Visit||21
8765151|NCT01244893|9815105|FG001|STARTED|Final Visit||21
8915729|NCT02176928|9975204|FG001|NOT COMPLETED|Overall Study||4
8915730|NCT02177032|9975214|FG000|STARTED|Overall Study||355
8915731|NCT02177032|9975215|FG001|STARTED|Overall Study||88
8915732|NCT02177032|9975216|FG002|STARTED|Overall Study||354
8915733|NCT02177032|9975217|FG003|STARTED|Overall Study||88
8915734|NCT02177032|9975214|FG000|COMPLETED|Overall Study||350
8915735|NCT02177032|9975215|FG001|COMPLETED|Overall Study||86
8915736|NCT02177032|9975216|FG002|COMPLETED|Overall Study||351
8915737|NCT02177032|9975217|FG003|COMPLETED|Overall Study||88
8915738|NCT02177032|9975214|FG000|NOT COMPLETED|Overall Study||5
8915739|NCT02177032|9975215|FG001|NOT COMPLETED|Overall Study||2
8915740|NCT02177032|9975216|FG002|NOT COMPLETED|Overall Study||3
8915741|NCT02177032|9975217|FG003|NOT COMPLETED|Overall Study||0
8765152|NCT01244893|9815104|FG000|COMPLETED|Final Visit||21
8765153|NCT01244893|9815105|FG001|COMPLETED|Final Visit||21
8765154|NCT01244893|9815104|FG000|NOT COMPLETED|Final Visit||0
8765155|NCT01244893|9815105|FG001|NOT COMPLETED|Final Visit||0
8765156|NCT01244906|9815116|FG000|STARTED|Overall Study||26
8765157|NCT01244906|9815116|FG000|COMPLETED|Overall Study||18
8915742|NCT02177123|9975238|FG000|STARTED|Overall Study||107
8915743|NCT02177123|9975238|FG000|COMPLETED|Overall Study||83
8765158|NCT01244906|9815116|FG000|NOT COMPLETED|Overall Study||8
8765159|NCT01244984|9815123|FG000|STARTED|Overall Study||60
8765160|NCT01244984|9815124|FG001|STARTED|Overall Study||93
8765161|NCT01244984|9815125|FG002|STARTED|Overall Study||90
8765162|NCT01244984|9815123|FG000|COMPLETED|Overall Study||55
8765163|NCT01244984|9815124|FG001|COMPLETED|Overall Study||79
8765164|NCT01244984|9815125|FG002|COMPLETED|Overall Study||86
8765165|NCT01244984|9815123|FG000|NOT COMPLETED|Overall Study||5
8765166|NCT01244984|9815124|FG001|NOT COMPLETED|Overall Study||14
8765167|NCT01244984|9815125|FG002|NOT COMPLETED|Overall Study||4
8765168|NCT01245049|9815136|FG000|STARTED|Overall Study||255
8765169|NCT01245049|9815137|FG001|STARTED|Overall Study||130
8765170|NCT01245049|9815136|FG000|COMPLETED|Overall Study||254
8765171|NCT01245049|9815137|FG001|COMPLETED|Overall Study||126
8765172|NCT01245049|9815136|FG000|NOT COMPLETED|Overall Study||1
8765173|NCT01245049|9815137|FG001|NOT COMPLETED|Overall Study||4
8765174|NCT01245062|9815145|FG000|STARTED|Randomization and Crossover Phase||214
8765175|NCT01245062|9815146|FG001|STARTED|Randomization and Crossover Phase||108
8765176|NCT01245062|9815147|FG002|STARTED|Randomization and Crossover Phase||0
8765177|NCT01245062|9815145|FG000|COMPLETED|Randomization and Crossover Phase||173
8765178|NCT01245062|9815146|FG001|COMPLETED|Randomization and Crossover Phase||77
8765179|NCT01245062|9815147|FG002|COMPLETED|Randomization and Crossover Phase||0
8765180|NCT01245062|9815145|FG000|NOT COMPLETED|Randomization and Crossover Phase||41
8765181|NCT01245062|9815146|FG001|NOT COMPLETED|Randomization and Crossover Phase||31
8765182|NCT01245062|9815147|FG002|NOT COMPLETED|Randomization and Crossover Phase||0
8765183|NCT01245062|9815145|FG000|STARTED|Cross-over Phase||0
8765184|NCT01245062|9815146|FG001|STARTED|Cross-over Phase||0
8765185|NCT01245062|9815147|FG002|STARTED|Cross-over Phase|As of the data cut on December 16, 2016, 70 of 108 participants crossed over from CT to trametinib.|70
8765186|NCT01245062|9815145|FG000|COMPLETED|Cross-over Phase||0
8765187|NCT01245062|9815146|FG001|COMPLETED|Cross-over Phase||0
8765188|NCT01245062|9815147|FG002|COMPLETED|Cross-over Phase||53
8765189|NCT01245062|9815145|FG000|NOT COMPLETED|Cross-over Phase||0
8765190|NCT01245062|9815146|FG001|NOT COMPLETED|Cross-over Phase||0
8765191|NCT01245062|9815147|FG002|NOT COMPLETED|Cross-over Phase||17
8765192|NCT01245101|9815157|FG000|STARTED|Period 1 (Treatment)||15
8765193|NCT01245101|9815158|FG001|STARTED|Period 1 (Treatment)||0
8765194|NCT01245101|9815157|FG000|COMPLETED|Period 1 (Treatment)||13
8765195|NCT01245101|9815158|FG001|COMPLETED|Period 1 (Treatment)||0
8765196|NCT01245101|9815157|FG000|NOT COMPLETED|Period 1 (Treatment)||2
8765197|NCT01245101|9815158|FG001|NOT COMPLETED|Period 1 (Treatment)||0
8765198|NCT01245101|9815157|FG000|STARTED|Period 2 (Washout)||13
8765199|NCT01245101|9815158|FG001|STARTED|Period 2 (Washout)||0
8765200|NCT01245101|9815157|FG000|COMPLETED|Period 2 (Washout)||12
8765201|NCT01245101|9815158|FG001|COMPLETED|Period 2 (Washout)||0
8765202|NCT01245101|9815157|FG000|NOT COMPLETED|Period 2 (Washout)||1
8765203|NCT01245101|9815158|FG001|NOT COMPLETED|Period 2 (Washout)||0
8765204|NCT01245101|9815157|FG000|STARTED|Period 3 (Treatment)||12
8765205|NCT01245101|9815158|FG001|STARTED|Period 3 (Treatment)||0
8765206|NCT01245101|9815157|FG000|COMPLETED|Period 3 (Treatment)||11
8765207|NCT01245101|9815158|FG001|COMPLETED|Period 3 (Treatment)||0
8765208|NCT01245101|9815157|FG000|NOT COMPLETED|Period 3 (Treatment)||1
8765209|NCT01245101|9815158|FG001|NOT COMPLETED|Period 3 (Treatment)||0
8765210|NCT01245140|9815166|FG000|STARTED|Overall Study||9
8765211|NCT01245140|9815167|FG001|STARTED|Overall Study||24
8765212|NCT01245140|9815166|FG000|COMPLETED|Overall Study||6
8765213|NCT01245140|9815167|FG001|COMPLETED|Overall Study||14
8765214|NCT01245140|9815166|FG000|NOT COMPLETED|Overall Study||3
8765215|NCT01245140|9815167|FG001|NOT COMPLETED|Overall Study||10
8765216|NCT01245270|9815175|FG000|STARTED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
8765217|NCT01245270|9815176|FG001|STARTED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
8765218|NCT01245270|9815175|FG000|COMPLETED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
8765219|NCT01245270|9815176|FG001|COMPLETED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
8765220|NCT01245270|9815175|FG000|NOT COMPLETED|Overall Study||0
8765221|NCT01245270|9815176|FG001|NOT COMPLETED|Overall Study||0
8765222|NCT01245283|9815187|FG000|STARTED|Overall Study||32
8765223|NCT01245283|9815188|FG001|STARTED|Overall Study||28
8765224|NCT01245283|9815189|FG002|STARTED|Overall Study||30
8765225|NCT01245283|9815187|FG000|COMPLETED|Overall Study||18
8765226|NCT01245283|9815188|FG001|COMPLETED|Overall Study||17
8765227|NCT01245283|9815189|FG002|COMPLETED|Overall Study||19
8765228|NCT01245283|9815187|FG000|NOT COMPLETED|Overall Study||14
8765229|NCT01245283|9815188|FG001|NOT COMPLETED|Overall Study||11
8765230|NCT01245283|9815189|FG002|NOT COMPLETED|Overall Study||11
8765231|NCT01245374|9815200|FG000|STARTED|Overall Study||103
8765232|NCT01245374|9815200|FG000|COMPLETED|Overall Study||99
8765233|NCT01245374|9815200|FG000|NOT COMPLETED|Overall Study||4
8765234|NCT01245387|9815205|FG000|STARTED|Overall Study||1001
8765235|NCT01245387|9815205|FG000|COMPLETED|Overall Study||188
8765236|NCT01245387|9815205|FG000|NOT COMPLETED|Overall Study||813
8765237|NCT01245413|9815209|FG000|STARTED|Sensura First,||16
8765238|NCT01245413|9815210|FG001|STARTED|Sensura First,||16
8765239|NCT01245413|9815209|FG000|COMPLETED|Sensura First,||16
8765240|NCT01245413|9815210|FG001|COMPLETED|Sensura First,||16
8765241|NCT01245413|9815209|FG000|NOT COMPLETED|Sensura First,||0
8765242|NCT01245413|9815210|FG001|NOT COMPLETED|Sensura First,||0
8765243|NCT01245413|9815209|FG000|STARTED|Athena First,||16
8765244|NCT01245413|9815210|FG001|STARTED|Athena First,||16
8765245|NCT01245413|9815209|FG000|COMPLETED|Athena First,||16
8765246|NCT01245413|9815210|FG001|COMPLETED|Athena First,||16
8765247|NCT01245413|9815209|FG000|NOT COMPLETED|Athena First,||0
8765248|NCT01245413|9815210|FG001|NOT COMPLETED|Athena First,||0
8765249|NCT01245439|9815216|FG000|STARTED|Overall Study||65
8765250|NCT01245439|9815216|FG000|COMPLETED|Overall Study||65
8765251|NCT01245439|9815216|FG000|NOT COMPLETED|Overall Study||0
8765252|NCT01245595|9815224|FG000|STARTED|Overall Study||72
8765253|NCT01245595|9815225|FG001|STARTED|Overall Study||72
8765254|NCT01245595|9815224|FG000|Completed Full Course of Study Drug|Overall Study||57
8765255|NCT01245595|9815225|FG001|Completed Full Course of Study Drug|Overall Study||61
8765256|NCT01245595|9815224|FG000|COMPLETED|Overall Study||72
8765257|NCT01245595|9815225|FG001|COMPLETED|Overall Study||72
8765258|NCT01245595|9815224|FG000|NOT COMPLETED|Overall Study||0
8765259|NCT01245595|9815225|FG001|NOT COMPLETED|Overall Study||0
8765260|NCT01245647|9815233|FG000|STARTED|Overall Study||7
8765261|NCT01245647|9815234|FG001|STARTED|Overall Study||12
8765262|NCT01245647|9815233|FG000|COMPLETED|Overall Study||7
8765263|NCT01245647|9815234|FG001|COMPLETED|Overall Study||8
8765264|NCT01245647|9815233|FG000|NOT COMPLETED|Overall Study||0
8765265|NCT01245647|9815234|FG001|NOT COMPLETED|Overall Study||4
8765266|NCT01245673|9815240|FG000|STARTED|Enrollment||28
8765267|NCT01245673|9815240|FG000|COMPLETED|Enrollment|One subject failed to meet screening criteria for the trial.|27
8765268|NCT01245673|9815240|FG000|NOT COMPLETED|Enrollment||1
8765269|NCT01245673|9815240|FG000|STARTED|Pre Transplant Vaccinations||27
8765270|NCT01245673|9815240|FG000|Pre Transplant Vaccinations 1-3|Pre Transplant Vaccinations||27
8765271|NCT01245673|9815240|FG000|COMPLETED|Pre Transplant Vaccinations||27
8765272|NCT01245673|9815240|FG000|NOT COMPLETED|Pre Transplant Vaccinations||0
8765273|NCT01245673|9815240|FG000|STARTED|Activated/Costimulated Autologous T Cell||27
8765274|NCT01245673|9815240|FG000|COMPLETED|Activated/Costimulated Autologous T Cell||27
8765275|NCT01245673|9815240|FG000|NOT COMPLETED|Activated/Costimulated Autologous T Cell||0
8765276|NCT01245673|9815240|FG000|STARTED|MAGE-A3, Hiltonol®, PVC After T Cells||27
8765277|NCT01245673|9815240|FG000|COMPLETED|MAGE-A3, Hiltonol®, PVC After T Cells||26
8671239|NCT00750308|9714637|FG005|COMPLETED|Washout||2
8671240|NCT00750308|9714638|FG006|COMPLETED|Washout||2
8671241|NCT00750308|9714639|FG007|COMPLETED|Washout||2
8671242|NCT00750308|9714640|FG008|COMPLETED|Washout||1
8671243|NCT00750308|9714641|FG009|COMPLETED|Washout||2
8671244|NCT00750308|9714642|FG010|COMPLETED|Washout||1
8671245|NCT00750308|9714643|FG011|COMPLETED|Washout||1
8671246|NCT00750308|9714632|FG000|NOT COMPLETED|Washout||0
8671247|NCT00750308|9714633|FG001|NOT COMPLETED|Washout||0
8765278|NCT01245673|9815240|FG000|NOT COMPLETED|MAGE-A3, Hiltonol®, PVC After T Cells||1
8765279|NCT01245673|9815240|FG000|STARTED|Start Lenalidomide||26
8765280|NCT01245673|9815240|FG000|COMPLETED|Start Lenalidomide||26
8765281|NCT01245673|9815240|FG000|NOT COMPLETED|Start Lenalidomide||0
8765282|NCT01245673|9815240|FG000|STARTED|Maintenance: MAGE-A3, PVC After T Cells||26
8765283|NCT01245673|9815240|FG000|COMPLETED|Maintenance: MAGE-A3, PVC After T Cells||26
8765284|NCT01245673|9815240|FG000|NOT COMPLETED|Maintenance: MAGE-A3, PVC After T Cells||0
8765285|NCT01245699|9815246|FG000|STARTED|Overall Study||61
8765286|NCT01245699|9815247|FG001|STARTED|Overall Study||54
8765287|NCT01245699|9815246|FG000|COMPLETED|Overall Study||52
8765288|NCT01245699|9815247|FG001|COMPLETED|Overall Study||49
8765289|NCT01245699|9815246|FG000|NOT COMPLETED|Overall Study||9
8765290|NCT01245699|9815247|FG001|NOT COMPLETED|Overall Study||5
8765291|NCT01245738|9815254|FG000|STARTED|Overall Study||514
8765292|NCT01245738|9815254|FG000|COMPLETED|Overall Study||474
8765293|NCT01245738|9815254|FG000|NOT COMPLETED|Overall Study||40
9026885|NCT03180801|10089340|FG002|STARTED|Overall Study||51
9026886|NCT03180801|10089338|FG000|Safety Population|Overall Study||50
9026887|NCT03180801|10089339|FG001|Safety Population|Overall Study||52
9026888|NCT03180801|10089340|FG002|Safety Population|Overall Study||51
9026889|NCT03180801|10089338|FG000|Intention to Treat|Overall Study||42
9026890|NCT03180801|10089339|FG001|Intention to Treat|Overall Study||40
9026891|NCT03180801|10089340|FG002|Intention to Treat|Overall Study||41
9026892|NCT03180801|10089338|FG000|COMPLETED|Overall Study||42
9026893|NCT03180801|10089339|FG001|COMPLETED|Overall Study||40
8765294|NCT01245751|9815262|FG000|STARTED|Part 1: Day 1 to Week 52 (1 Year)||201
9026894|NCT03180801|10089340|FG002|COMPLETED|Overall Study||41
9026895|NCT03180801|10089338|FG000|NOT COMPLETED|Overall Study||8
9026896|NCT03180801|10089339|FG001|NOT COMPLETED|Overall Study||12
9026897|NCT03180801|10089340|FG002|NOT COMPLETED|Overall Study||10
8671248|NCT00750308|9714634|FG002|NOT COMPLETED|Washout||0
9026898|NCT03181009|10089353|FG000|STARTED|Overall Study||30
9026899|NCT03181009|10089354|FG001|STARTED|Overall Study||30
9026900|NCT03181009|10089353|FG000|COMPLETED|Overall Study||30
9026901|NCT03181009|10089354|FG001|COMPLETED|Overall Study||28
9026902|NCT03181009|10089353|FG000|NOT COMPLETED|Overall Study||0
8671249|NCT00750308|9714635|FG003|NOT COMPLETED|Washout||0
8671250|NCT00750308|9714636|FG004|NOT COMPLETED|Washout||0
8671251|NCT00750308|9714637|FG005|NOT COMPLETED|Washout||0
8671252|NCT00750308|9714638|FG006|NOT COMPLETED|Washout||0
8671253|NCT00750308|9714639|FG007|NOT COMPLETED|Washout||0
8671254|NCT00750308|9714640|FG008|NOT COMPLETED|Washout||0
8765295|NCT01245751|9815263|FG001|STARTED|Part 1: Day 1 to Week 52 (1 Year)||199
8765296|NCT01245751|9815264|FG002|STARTED|Part 1: Day 1 to Week 52 (1 Year)||100
8765297|NCT01245751|9815265|FG003|STARTED|Part 1: Day 1 to Week 52 (1 Year)||100
8765298|NCT01245751|9815262|FG000|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||201
8765299|NCT01245751|9815263|FG001|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||199
8765300|NCT01245751|9815264|FG002|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||100
8765301|NCT01245751|9815265|FG003|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||100
8765302|NCT01245751|9815262|FG000|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||199
8765303|NCT01245751|9815263|FG001|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||194
8765304|NCT01245751|9815264|FG002|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||100
8765305|NCT01245751|9815265|FG003|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||98
8765306|NCT01245751|9815262|FG000|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||2
8765307|NCT01245751|9815263|FG001|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||5
8765308|NCT01245751|9815264|FG002|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||0
8765309|NCT01245751|9815265|FG003|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||2
8765310|NCT01245751|9815262|FG000|STARTED|Part 2: Week 156 (3 Year) Visit|Enrollment in Part 2 was voluntary|161
8765311|NCT01245751|9815263|FG001|STARTED|Part 2: Week 156 (3 Year) Visit|Enrollment in Part 2 was voluntary|139
8765312|NCT01245751|9815264|FG002|STARTED|Part 2: Week 156 (3 Year) Visit|Part 2 was planned for Groups 1 and 2 only|0
8765313|NCT01245751|9815265|FG003|STARTED|Part 2: Week 156 (3 Year) Visit|Part 2 was planned for Groups 1 and 2 only|0
8765314|NCT01245751|9815262|FG000|COMPLETED|Part 2: Week 156 (3 Year) Visit||161
8765315|NCT01245751|9815263|FG001|COMPLETED|Part 2: Week 156 (3 Year) Visit||139
8765316|NCT01245751|9815264|FG002|COMPLETED|Part 2: Week 156 (3 Year) Visit||0
8765317|NCT01245751|9815265|FG003|COMPLETED|Part 2: Week 156 (3 Year) Visit||0
8765318|NCT01245751|9815262|FG000|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
8765319|NCT01245751|9815263|FG001|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
8765320|NCT01245751|9815264|FG002|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
8765321|NCT01245751|9815265|FG003|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
8765322|NCT01245764|9815280|FG000|STARTED|Study Phase A||80
8765323|NCT01245764|9815281|FG001|STARTED|Study Phase A||30
8765324|NCT01245764|9815282|FG002|STARTED|Study Phase A||120
8765325|NCT01245764|9815283|FG003|STARTED|Study Phase A||20
8765326|NCT01245764|9815280|FG000|Completed Vaccinations in Study Phase A|Study Phase A||77
8765327|NCT01245764|9815281|FG001|Completed Vaccinations in Study Phase A|Study Phase A||28
8765328|NCT01245764|9815282|FG002|Completed Vaccinations in Study Phase A|Study Phase A||117
8765329|NCT01245764|9815283|FG003|Completed Vaccinations in Study Phase A|Study Phase A||19
8765330|NCT01245764|9815280|FG000|COMPLETED|Study Phase A||71
8765331|NCT01245764|9815281|FG001|COMPLETED|Study Phase A||25
8765332|NCT01245764|9815282|FG002|COMPLETED|Study Phase A||110
8765333|NCT01245764|9815283|FG003|COMPLETED|Study Phase A||17
8765334|NCT01245764|9815280|FG000|NOT COMPLETED|Study Phase A||9
8765335|NCT01245764|9815281|FG001|NOT COMPLETED|Study Phase A||5
8765336|NCT01245764|9815282|FG002|NOT COMPLETED|Study Phase A||10
8765337|NCT01245764|9815283|FG003|NOT COMPLETED|Study Phase A||3
8765338|NCT01245764|9815280|FG000|STARTED|Study Phase B||0
8765339|NCT01245764|9815281|FG001|STARTED|Study Phase B||0
8765340|NCT01245764|9815282|FG002|STARTED|Study Phase B||0
8765341|NCT01245764|9815283|FG003|STARTED|Study Phase B||17
8765342|NCT01245764|9815280|FG000|Completed Vaccinations in Study Phase B|Study Phase B||0
8765343|NCT01245764|9815281|FG001|Completed Vaccinations in Study Phase B|Study Phase B||0
8765344|NCT01245764|9815282|FG002|Completed Vaccinations in Study Phase B|Study Phase B||0
8765345|NCT01245764|9815283|FG003|Completed Vaccinations in Study Phase B|Study Phase B||17
8765346|NCT01245764|9815280|FG000|COMPLETED|Study Phase B||0
8765347|NCT01245764|9815281|FG001|COMPLETED|Study Phase B||0
8765348|NCT01245764|9815282|FG002|COMPLETED|Study Phase B||0
8765349|NCT01245764|9815283|FG003|COMPLETED|Study Phase B||17
8765350|NCT01245764|9815280|FG000|NOT COMPLETED|Study Phase B||0
8765351|NCT01245764|9815281|FG001|NOT COMPLETED|Study Phase B||0
8765352|NCT01245764|9815282|FG002|NOT COMPLETED|Study Phase B||0
8765353|NCT01245764|9815283|FG003|NOT COMPLETED|Study Phase B||0
8765354|NCT01245972|9815304|FG000|STARTED|Overall Study||7
8765355|NCT01245972|9815305|FG001|STARTED|Overall Study||8
8765356|NCT01245972|9815306|FG002|STARTED|Overall Study||8
8765357|NCT01245972|9815304|FG000|COMPLETED|Overall Study||7
8765358|NCT01245972|9815305|FG001|COMPLETED|Overall Study||8
8765359|NCT01245972|9815306|FG002|COMPLETED|Overall Study||8
8765360|NCT01245972|9815304|FG000|NOT COMPLETED|Overall Study||0
8765361|NCT01245972|9815305|FG001|NOT COMPLETED|Overall Study||0
8765362|NCT01245972|9815306|FG002|NOT COMPLETED|Overall Study||0
8765363|NCT01246050|9815316|FG000|STARTED|Overall Study||6
8765364|NCT01246050|9815317|FG001|STARTED|Overall Study|Control providers were other providers in the same Primary Care Clinic, not enrolled in the study|6
8765365|NCT01246050|9815316|FG000|COMPLETED|Overall Study||6
8765366|NCT01246050|9815317|FG001|COMPLETED|Overall Study|Control providers were other providers in the same Primary Care Clinic, not enrolled in the study|6
8765367|NCT01246050|9815316|FG000|NOT COMPLETED|Overall Study||0
8765368|NCT01246050|9815317|FG001|NOT COMPLETED|Overall Study||0
8765369|NCT01246063|9815329|FG000|STARTED|Overall Study||3
8765370|NCT01246063|9815330|FG001|STARTED|Overall Study||4
8765371|NCT01246063|9815331|FG002|STARTED|Overall Study||4
8765372|NCT01246063|9815332|FG003|STARTED|Overall Study||5
8765373|NCT01246063|9815333|FG004|STARTED|Overall Study||7
8765374|NCT01246063|9815334|FG005|STARTED|Overall Study||17
8671255|NCT00750308|9714641|FG009|NOT COMPLETED|Washout||0
8671256|NCT00750308|9714642|FG010|NOT COMPLETED|Washout||0
8671257|NCT00750308|9714643|FG011|NOT COMPLETED|Washout||0
8671258|NCT00750308|9714632|FG000|STARTED|Third Treatment||2
8671259|NCT00750308|9714633|FG001|STARTED|Third Treatment||2
8671260|NCT00750308|9714634|FG002|STARTED|Third Treatment||2
8671261|NCT00750308|9714635|FG003|STARTED|Third Treatment||1
8671262|NCT00750308|9714636|FG004|STARTED|Third Treatment||1
8671263|NCT00750308|9714637|FG005|STARTED|Third Treatment||2
8671264|NCT00750308|9714638|FG006|STARTED|Third Treatment||2
8671265|NCT00750308|9714639|FG007|STARTED|Third Treatment||2
8671266|NCT00750308|9714640|FG008|STARTED|Third Treatment||1
8671267|NCT00750308|9714641|FG009|STARTED|Third Treatment||2
8671268|NCT00750308|9714642|FG010|STARTED|Third Treatment||1
8671269|NCT00750308|9714643|FG011|STARTED|Third Treatment||1
8671270|NCT00750308|9714632|FG000|COMPLETED|Third Treatment||2
8671271|NCT00750308|9714633|FG001|COMPLETED|Third Treatment||1
8671272|NCT00750308|9714634|FG002|COMPLETED|Third Treatment||2
8671273|NCT00750308|9714635|FG003|COMPLETED|Third Treatment||1
8671274|NCT00750308|9714636|FG004|COMPLETED|Third Treatment||1
8671275|NCT00750308|9714637|FG005|COMPLETED|Third Treatment||2
8671276|NCT00750308|9714638|FG006|COMPLETED|Third Treatment||2
8671277|NCT00750308|9714639|FG007|COMPLETED|Third Treatment||2
8671278|NCT00750308|9714640|FG008|COMPLETED|Third Treatment||1
8671279|NCT00750308|9714641|FG009|COMPLETED|Third Treatment||2
8671280|NCT00750308|9714642|FG010|COMPLETED|Third Treatment||1
8671281|NCT00750308|9714643|FG011|COMPLETED|Third Treatment||1
8671282|NCT00750308|9714632|FG000|NOT COMPLETED|Third Treatment||0
8671283|NCT00750308|9714633|FG001|NOT COMPLETED|Third Treatment||1
8671284|NCT00750308|9714634|FG002|NOT COMPLETED|Third Treatment||0
8671285|NCT00750308|9714635|FG003|NOT COMPLETED|Third Treatment||0
8671286|NCT00750308|9714636|FG004|NOT COMPLETED|Third Treatment||0
8671287|NCT00750308|9714637|FG005|NOT COMPLETED|Third Treatment||0
8671288|NCT00750308|9714638|FG006|NOT COMPLETED|Third Treatment||0
8671289|NCT00750308|9714639|FG007|NOT COMPLETED|Third Treatment||0
8671290|NCT00750308|9714640|FG008|NOT COMPLETED|Third Treatment||0
8671291|NCT00750308|9714641|FG009|NOT COMPLETED|Third Treatment||0
8671292|NCT00750308|9714642|FG010|NOT COMPLETED|Third Treatment||0
8671293|NCT00750308|9714643|FG011|NOT COMPLETED|Third Treatment||0
8671294|NCT00750308|9714632|FG000|STARTED|Washout||2
8671295|NCT00750308|9714633|FG001|STARTED|Washout||1
8671296|NCT00750308|9714634|FG002|STARTED|Washout||2
8671297|NCT00750308|9714635|FG003|STARTED|Washout||1
8671298|NCT00750308|9714636|FG004|STARTED|Washout||1
8671299|NCT00750308|9714637|FG005|STARTED|Washout||2
8671300|NCT00750308|9714638|FG006|STARTED|Washout||2
8671301|NCT00750308|9714639|FG007|STARTED|Washout||2
8671302|NCT00750308|9714640|FG008|STARTED|Washout||1
8671303|NCT00750308|9714641|FG009|STARTED|Washout||2
8671304|NCT00750308|9714642|FG010|STARTED|Washout||1
8671305|NCT00750308|9714643|FG011|STARTED|Washout||1
8671306|NCT00750308|9714632|FG000|COMPLETED|Washout||2
8575165|NCT00132964|9607653|FG000|NOT COMPLETED|Overall Study||4
8575166|NCT00132964|9607654|FG001|NOT COMPLETED|Overall Study||3
8575167|NCT00133575|9607667|FG000|STARTED|Overall Study||10
8575168|NCT00133575|9607668|FG001|STARTED|Overall Study||10
8575169|NCT00133575|9607669|FG002|STARTED|Overall Study||10
8575170|NCT00133575|9607670|FG003|STARTED|Overall Study||10
8575171|NCT00133575|9607671|FG004|STARTED|Overall Study||10
8575172|NCT00133575|9607672|FG005|STARTED|Overall Study||10
8765375|NCT01246063|9815329|FG000|COMPLETED|Overall Study||3
8765376|NCT01246063|9815330|FG001|COMPLETED|Overall Study||4
8765377|NCT01246063|9815331|FG002|COMPLETED|Overall Study||4
8765378|NCT01246063|9815332|FG003|COMPLETED|Overall Study||5
8765379|NCT01246063|9815333|FG004|COMPLETED|Overall Study||7
8765380|NCT01246063|9815334|FG005|COMPLETED|Overall Study||17
8765381|NCT01246063|9815329|FG000|NOT COMPLETED|Overall Study||0
8765382|NCT01246063|9815330|FG001|NOT COMPLETED|Overall Study||0
8765383|NCT01246063|9815331|FG002|NOT COMPLETED|Overall Study||0
8765384|NCT01246063|9815332|FG003|NOT COMPLETED|Overall Study||0
8765385|NCT01246063|9815333|FG004|NOT COMPLETED|Overall Study||0
8765386|NCT01246063|9815334|FG005|NOT COMPLETED|Overall Study||0
8765387|NCT01246076|9815352|FG000|STARTED|Overall Study||24
8765388|NCT01246076|9815352|FG000|COMPLETED|Overall Study||24
8765389|NCT01246076|9815352|FG000|NOT COMPLETED|Overall Study||0
8765390|NCT01246206|9815356|FG000|STARTED|Overall Study||21
8765391|NCT01246206|9815356|FG000|COMPLETED|Overall Study||20
8765392|NCT01246206|9815356|FG000|NOT COMPLETED|Overall Study||1
8765393|NCT01246258|9815360|FG000|STARTED|Overall Study||5
8765394|NCT01246258|9815360|FG000|COMPLETED|Overall Study||5
8765395|NCT01246258|9815360|FG000|NOT COMPLETED|Overall Study||0
8765396|NCT01246349|9815367|FG000|STARTED|Overall Study||20
8765397|NCT01246349|9815368|FG001|STARTED|Overall Study||20
8765398|NCT01246349|9815367|FG000|COMPLETED|Overall Study||20
8765399|NCT01246349|9815368|FG001|COMPLETED|Overall Study||20
8765400|NCT01246349|9815367|FG000|NOT COMPLETED|Overall Study||0
8765401|NCT01246349|9815368|FG001|NOT COMPLETED|Overall Study||0
8765402|NCT01246401|9815376|FG000|STARTED|Overall Study||66
8765403|NCT01246401|9815377|FG001|STARTED|Overall Study||27
8765404|NCT01246401|9815376|FG000|COMPLETED|Overall Study||66
8765405|NCT01246401|9815377|FG001|COMPLETED|Overall Study||27
8765406|NCT01246401|9815376|FG000|NOT COMPLETED|Overall Study||0
8765407|NCT01246401|9815377|FG001|NOT COMPLETED|Overall Study||0
8765408|NCT01246466|9815385|FG000|STARTED|Overall Study||24
8765409|NCT01246466|9815385|FG000|COMPLETED|Overall Study||22
8765410|NCT01246466|9815385|FG000|NOT COMPLETED|Overall Study||2
8765411|NCT01246479|9815390|FG000|STARTED|Overall Study||23
8765412|NCT01246479|9815390|FG000|COMPLETED|Overall Study|primary endpoint at Month 12|18
8765413|NCT01246479|9815390|FG000|NOT COMPLETED|Overall Study||5
8765414|NCT01246583|9815398|FG000|STARTED|Overall Study||23
8765415|NCT01246583|9815399|FG001|STARTED|Overall Study||13
8765416|NCT01246583|9815400|FG002|STARTED|Overall Study||25
8765417|NCT01246583|9815401|FG003|STARTED|Overall Study||10
8765418|NCT01246583|9815398|FG000|COMPLETED|Overall Study||22
8765419|NCT01246583|9815399|FG001|COMPLETED|Overall Study||13
8765420|NCT01246583|9815400|FG002|COMPLETED|Overall Study||24
8765421|NCT01246583|9815401|FG003|COMPLETED|Overall Study||9
8765422|NCT01246583|9815398|FG000|NOT COMPLETED|Overall Study||1
8765423|NCT01246583|9815399|FG001|NOT COMPLETED|Overall Study||0
8765424|NCT01246583|9815400|FG002|NOT COMPLETED|Overall Study||1
8765425|NCT01246583|9815401|FG003|NOT COMPLETED|Overall Study||1
8765426|NCT01246713|9815412|FG000|STARTED|First Acetaminophen Dosing (1 Day)||6
8765427|NCT01246713|9815413|FG001|STARTED|First Acetaminophen Dosing (1 Day)||9
8765428|NCT01246713|9815412|FG000|COMPLETED|First Acetaminophen Dosing (1 Day)||6
8765429|NCT01246713|9815413|FG001|COMPLETED|First Acetaminophen Dosing (1 Day)||9
8765430|NCT01246713|9815412|FG000|NOT COMPLETED|First Acetaminophen Dosing (1 Day)||0
8765431|NCT01246713|9815413|FG001|NOT COMPLETED|First Acetaminophen Dosing (1 Day)||0
8765432|NCT01246713|9815412|FG000|STARTED|Washout (at Least 14 Days)||6
8765433|NCT01246713|9815413|FG001|STARTED|Washout (at Least 14 Days)||9
8765434|NCT01246713|9815412|FG000|COMPLETED|Washout (at Least 14 Days)||6
8765435|NCT01246713|9815413|FG001|COMPLETED|Washout (at Least 14 Days)||9
8765436|NCT01246713|9815412|FG000|NOT COMPLETED|Washout (at Least 14 Days)||0
8765437|NCT01246713|9815413|FG001|NOT COMPLETED|Washout (at Least 14 Days)||0
8765438|NCT01246713|9815412|FG000|STARTED|Second Acetaminophen Dosing (1 Day)||6
8765439|NCT01246713|9815413|FG001|STARTED|Second Acetaminophen Dosing (1 Day)||9
8765440|NCT01246713|9815412|FG000|COMPLETED|Second Acetaminophen Dosing (1 Day)||6
8765441|NCT01246713|9815413|FG001|COMPLETED|Second Acetaminophen Dosing (1 Day)||9
8765442|NCT01246713|9815412|FG000|NOT COMPLETED|Second Acetaminophen Dosing (1 Day)||0
8765443|NCT01246713|9815413|FG001|NOT COMPLETED|Second Acetaminophen Dosing (1 Day)||0
8765444|NCT01246791|9815419|FG000|STARTED|Overall Study||12
8765445|NCT01246791|9815419|FG000|COMPLETED|Overall Study||12
8765446|NCT01246791|9815419|FG000|NOT COMPLETED|Overall Study||0
8765447|NCT01246895|9815425|FG000|STARTED|Overall Study||37
8765448|NCT01246895|9815426|FG001|STARTED|Overall Study||30
8765449|NCT01246895|9815425|FG000|COMPLETED|Overall Study||34
8765450|NCT01246895|9815426|FG001|COMPLETED|Overall Study||26
8765451|NCT01246895|9815425|FG000|NOT COMPLETED|Overall Study||3
8765452|NCT01246895|9815426|FG001|NOT COMPLETED|Overall Study||4
8765453|NCT01246960|9815436|FG000|STARTED|Overall Study||84
8765454|NCT01246960|9815437|FG001|STARTED|Overall Study||84
8765455|NCT01246960|9815436|FG000|Received Any Quantity of Study Drug|Overall Study||82
8765456|NCT01246960|9815437|FG001|Received Any Quantity of Study Drug|Overall Study||80
8765457|NCT01246960|9815436|FG000|COMPLETED|Overall Study||78
8765458|NCT01246960|9815437|FG001|COMPLETED|Overall Study||80
8765459|NCT01246960|9815436|FG000|NOT COMPLETED|Overall Study||6
8765460|NCT01246960|9815437|FG001|NOT COMPLETED|Overall Study||4
8765461|NCT01246973|9815445|FG000|STARTED|Overall Study||344
8765462|NCT01246973|9815446|FG001|STARTED|Overall Study||342
8765463|NCT01246973|9815445|FG000|COMPLETED|Overall Study||283
8765464|NCT01246973|9815446|FG001|COMPLETED|Overall Study||295
8765465|NCT01246973|9815445|FG000|NOT COMPLETED|Overall Study||61
8765466|NCT01246973|9815446|FG001|NOT COMPLETED|Overall Study||47
8765467|NCT01246986|9815459|FG000|STARTED|Overall Study||37
8765468|NCT01246986|9815460|FG001|STARTED|Overall Study||72
8765469|NCT01246986|9815461|FG002|STARTED|Overall Study||40
8765470|NCT01246986|9815462|FG003|STARTED|Overall Study||3
8765471|NCT01246986|9815463|FG004|STARTED|Overall Study||44
8765472|NCT01246986|9815464|FG005|STARTED|Overall Study||3
8765473|NCT01246986|9815465|FG006|STARTED|Overall Study||5
8765474|NCT01246986|9815459|FG000|Received at Least 1 Dose of Study Drug|Overall Study||37
8765475|NCT01246986|9815460|FG001|Received at Least 1 Dose of Study Drug|Overall Study||72
8765476|NCT01246986|9815461|FG002|Received at Least 1 Dose of Study Drug|Overall Study||40
8765477|NCT01246986|9815462|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
8765478|NCT01246986|9815463|FG004|Received at Least 1 Dose of Study Drug|Overall Study||44
8765479|NCT01246986|9815464|FG005|Received at Least 1 Dose of Study Drug|Overall Study||3
8765480|NCT01246986|9815465|FG006|Received at Least 1 Dose of Study Drug|Overall Study||5
8765481|NCT01246986|9815459|FG000|COMPLETED|Overall Study||34
8765482|NCT01246986|9815460|FG001|COMPLETED|Overall Study||67
8765483|NCT01246986|9815461|FG002|COMPLETED|Overall Study||34
8765484|NCT01246986|9815462|FG003|COMPLETED|Overall Study||3
8765485|NCT01246986|9815463|FG004|COMPLETED|Overall Study||40
8765486|NCT01246986|9815464|FG005|COMPLETED|Overall Study||2
8765487|NCT01246986|9815465|FG006|COMPLETED|Overall Study||5
8765488|NCT01246986|9815459|FG000|NOT COMPLETED|Overall Study||3
8765489|NCT01246986|9815460|FG001|NOT COMPLETED|Overall Study||5
8765490|NCT01246986|9815461|FG002|NOT COMPLETED|Overall Study||6
8765491|NCT01246986|9815462|FG003|NOT COMPLETED|Overall Study||0
8765492|NCT01246986|9815463|FG004|NOT COMPLETED|Overall Study||4
8765493|NCT01246986|9815464|FG005|NOT COMPLETED|Overall Study||1
8765494|NCT01246986|9815465|FG006|NOT COMPLETED|Overall Study||0
9026903|NCT03181009|10089354|FG001|NOT COMPLETED|Overall Study||2
9026904|NCT03181308|10089362|FG000|STARTED|Overall Study||3
9026905|NCT03181308|10089363|FG001|STARTED|Overall Study||8
9026906|NCT03181308|10089362|FG000|COMPLETED|Overall Study||3
9026907|NCT03181308|10089363|FG001|COMPLETED|Overall Study||8
9026908|NCT03181308|10089362|FG000|NOT COMPLETED|Overall Study||0
9026909|NCT03181308|10089363|FG001|NOT COMPLETED|Overall Study||0
9026910|NCT03181451|10089372|FG000|STARTED|Overall Study||12
9026911|NCT03181451|10089373|FG001|STARTED|Overall Study||13
9026912|NCT03181451|10089374|FG002|STARTED|Overall Study||12
9026913|NCT03181451|10089372|FG000|COMPLETED|Overall Study||12
9026914|NCT03181451|10089373|FG001|COMPLETED|Overall Study||11
9026915|NCT03181451|10089374|FG002|COMPLETED|Overall Study||12
9026916|NCT03181451|10089372|FG000|NOT COMPLETED|Overall Study||0
9026917|NCT03181451|10089373|FG001|NOT COMPLETED|Overall Study||2
9026918|NCT03181451|10089374|FG002|NOT COMPLETED|Overall Study||0
9026919|NCT03181503|10089386|FG000|STARTED|Overall Study||36
9026920|NCT03181503|10089387|FG001|STARTED|Overall Study||34
9026921|NCT03181503|10089386|FG000|Treated|Overall Study||36
9026922|NCT03181503|10089387|FG001|Treated|Overall Study||34
9026923|NCT03181503|10089386|FG000|COMPLETED|Overall Study||29
9026924|NCT03181503|10089387|FG001|COMPLETED|Overall Study||31
9026925|NCT03181503|10089386|FG000|NOT COMPLETED|Overall Study||7
9026926|NCT03181503|10089387|FG001|NOT COMPLETED|Overall Study||3
9026927|NCT03181594|10089396|FG000|STARTED|Initial Study Protocol (12-month FU)||100
9026928|NCT03181594|10089396|FG000|30-day Follow-up|Initial Study Protocol (12-month FU)||99
9026929|NCT03181594|10089396|FG000|90-day Follow-up|Initial Study Protocol (12-month FU)||98
8765495|NCT01246999|9815500|FG000|STARTED|Overall Study||11
8765496|NCT01246999|9815501|FG001|STARTED|Overall Study||4
8765497|NCT01246999|9815502|FG002|STARTED|Overall Study||2
8765498|NCT01246999|9815503|FG003|STARTED|Overall Study||17
8765499|NCT01246999|9815500|FG000|COMPLETED|Overall Study||11
8765500|NCT01246999|9815501|FG001|COMPLETED|Overall Study||3
8765501|NCT01246999|9815502|FG002|COMPLETED|Overall Study||2
8765502|NCT01246999|9815503|FG003|COMPLETED|Overall Study||15
8765503|NCT01246999|9815500|FG000|NOT COMPLETED|Overall Study||0
8765504|NCT01246999|9815501|FG001|NOT COMPLETED|Overall Study||1
8765505|NCT01246999|9815502|FG002|NOT COMPLETED|Overall Study||0
9026930|NCT03181594|10089396|FG000|6-month Follow-up|Initial Study Protocol (12-month FU)||98
9026931|NCT03181594|10089396|FG000|9-month Follow-up|Initial Study Protocol (12-month FU)||95
9026932|NCT03181594|10089396|FG000|12-month Follow-up|Initial Study Protocol (12-month FU)||91
8765506|NCT01246999|9815503|FG003|NOT COMPLETED|Overall Study||2
8765507|NCT01247064|9815518|FG000|STARTED|Overall Study||31
8765508|NCT01247064|9815519|FG001|STARTED|Overall Study||31
8765509|NCT01247064|9815518|FG000|COMPLETED|Overall Study||31
8765510|NCT01247064|9815519|FG001|COMPLETED|Overall Study||31
8765511|NCT01247064|9815518|FG000|NOT COMPLETED|Overall Study||0
8765512|NCT01247064|9815519|FG001|NOT COMPLETED|Overall Study||0
8765513|NCT01247090|9815528|FG000|STARTED|Overall Study||4
8765514|NCT01247090|9815529|FG001|STARTED|Overall Study||4
8765515|NCT01247090|9815530|FG002|STARTED|Overall Study||4
8765516|NCT01247090|9815528|FG000|COMPLETED|Overall Study||3
8765517|NCT01247090|9815529|FG001|COMPLETED|Overall Study||3
8765518|NCT01247090|9815530|FG002|COMPLETED|Overall Study||4
8765519|NCT01247090|9815528|FG000|NOT COMPLETED|Overall Study||1
8765520|NCT01247090|9815529|FG001|NOT COMPLETED|Overall Study||1
8765521|NCT01247090|9815530|FG002|NOT COMPLETED|Overall Study||0
8765522|NCT01247220|9815540|FG000|STARTED|Overall Study||6
8765523|NCT01247220|9815541|FG001|STARTED|Overall Study||6
8765524|NCT01247220|9815540|FG000|COMPLETED|Overall Study||6
8765525|NCT01247220|9815541|FG001|COMPLETED|Overall Study||6
8765526|NCT01247220|9815540|FG000|NOT COMPLETED|Overall Study||0
8765527|NCT01247220|9815541|FG001|NOT COMPLETED|Overall Study||0
8765528|NCT01247272|9815549|FG000|STARTED|First Intervention||13
8765529|NCT01247272|9815550|FG001|STARTED|First Intervention||13
8765530|NCT01247272|9815549|FG000|COMPLETED|First Intervention||13
8765531|NCT01247272|9815550|FG001|COMPLETED|First Intervention||13
9026933|NCT03181594|10089396|FG000|COMPLETED|Initial Study Protocol (12-month FU)||91
9026934|NCT03181594|10089396|FG000|NOT COMPLETED|Initial Study Protocol (12-month FU)||9
9026935|NCT03181594|10089396|FG000|STARTED|Long-term Extension (15-24 Month FU)||62
9026936|NCT03181594|10089396|FG000|15-month Follow-up|Long-term Extension (15-24 Month FU)||56
9026937|NCT03181594|10089396|FG000|18-month Follow-up|Long-term Extension (15-24 Month FU)||57
9026938|NCT03181594|10089396|FG000|21-month Follow-up|Long-term Extension (15-24 Month FU)||55
9026939|NCT03181594|10089396|FG000|24-month Follow-up|Long-term Extension (15-24 Month FU)||57
9026940|NCT03181594|10089396|FG000|COMPLETED|Long-term Extension (15-24 Month FU)||57
9026941|NCT03181594|10089396|FG000|NOT COMPLETED|Long-term Extension (15-24 Month FU)||5
9026942|NCT03181724|10089402|FG000|STARTED|Overall Study||45
9026943|NCT03181724|10089403|FG001|STARTED|Overall Study||45
9026944|NCT03181724|10089402|FG000|COMPLETED|Overall Study||45
9026945|NCT03181724|10089403|FG001|COMPLETED|Overall Study||45
9026946|NCT03181724|10089402|FG000|NOT COMPLETED|Overall Study||0
9026947|NCT03181724|10089403|FG001|NOT COMPLETED|Overall Study||0
9026948|NCT03181932|10089411|FG000|STARTED|Period 1 (Double-blind Period)||90
9026949|NCT03181932|10089412|FG001|STARTED|Period 1 (Double-blind Period)||98
9026950|NCT03181932|10089411|FG000|COMPLETED|Period 1 (Double-blind Period)||79
9026951|NCT03181932|10089412|FG001|COMPLETED|Period 1 (Double-blind Period)||85
9026952|NCT03181932|10089411|FG000|NOT COMPLETED|Period 1 (Double-blind Period)||11
9026953|NCT03181932|10089412|FG001|NOT COMPLETED|Period 1 (Double-blind Period)||13
9026954|NCT03181932|10089411|FG000|STARTED|Period 2 (Open-label Period)||75
9026955|NCT03181932|10089412|FG001|STARTED|Period 2 (Open-label Period)||83
9026956|NCT03181932|10089411|FG000|COMPLETED|Period 2 (Open-label Period)||67
9026957|NCT03181932|10089412|FG001|COMPLETED|Period 2 (Open-label Period)||70
9026958|NCT03181932|10089411|FG000|NOT COMPLETED|Period 2 (Open-label Period)||8
9026959|NCT03181932|10089412|FG001|NOT COMPLETED|Period 2 (Open-label Period)||13
9026960|NCT03181958|10089422|FG000|STARTED|Overall Study||497
9026961|NCT03181958|10089423|FG001|STARTED|Overall Study||501
9026962|NCT03181958|10089424|FG002|STARTED|Overall Study||495
9026963|NCT03181958|10089422|FG000|COMPLETED|Overall Study||480
9026964|NCT03181958|10089423|FG001|COMPLETED|Overall Study||480
9026965|NCT03181958|10089424|FG002|COMPLETED|Overall Study||480
9026966|NCT03181958|10089422|FG000|NOT COMPLETED|Overall Study||17
9026967|NCT03181958|10089423|FG001|NOT COMPLETED|Overall Study||21
9026968|NCT03181958|10089424|FG002|NOT COMPLETED|Overall Study||15
9026969|NCT03182582|10089432|FG000|STARTED|Treatment 1||12
9026970|NCT03182582|10089433|FG001|STARTED|Treatment 1||10
9026971|NCT03182582|10089432|FG000|COMPLETED|Treatment 1||12
9026972|NCT03182582|10089433|FG001|COMPLETED|Treatment 1||10
9026973|NCT03182582|10089432|FG000|NOT COMPLETED|Treatment 1||0
9026974|NCT03182582|10089433|FG001|NOT COMPLETED|Treatment 1||0
9026975|NCT03182582|10089432|FG000|STARTED|Treatment 2||12
9026976|NCT03182582|10089433|FG001|STARTED|Treatment 2||10
9026977|NCT03182582|10089432|FG000|COMPLETED|Treatment 2||12
9026978|NCT03182582|10089433|FG001|COMPLETED|Treatment 2||10
9026979|NCT03182582|10089432|FG000|NOT COMPLETED|Treatment 2||0
9026980|NCT03182582|10089433|FG001|NOT COMPLETED|Treatment 2||0
9026981|NCT03182725|10089446|FG000|STARTED|Treatment Arm 1 (First Half of Study)||16
8765532|NCT01247272|9815549|FG000|NOT COMPLETED|First Intervention||0
9026982|NCT03182725|10089447|FG001|STARTED|Treatment Arm 1 (First Half of Study)||10
9026983|NCT03182725|10089446|FG000|COMPLETED|Treatment Arm 1 (First Half of Study)||16
9026984|NCT03182725|10089447|FG001|COMPLETED|Treatment Arm 1 (First Half of Study)||7
9026985|NCT03182725|10089446|FG000|NOT COMPLETED|Treatment Arm 1 (First Half of Study)||0
9026986|NCT03182725|10089447|FG001|NOT COMPLETED|Treatment Arm 1 (First Half of Study)||3
9026987|NCT03182725|10089446|FG000|STARTED|Treatment Arm 2 (Second Half of Study)||16
8765533|NCT01247272|9815550|FG001|NOT COMPLETED|First Intervention||0
8765534|NCT01247272|9815549|FG000|STARTED|Washout of 28 Days||13
8765535|NCT01247272|9815550|FG001|STARTED|Washout of 28 Days||13
8765536|NCT01247272|9815549|FG000|COMPLETED|Washout of 28 Days||13
8765537|NCT01247272|9815550|FG001|COMPLETED|Washout of 28 Days||13
8765538|NCT01247272|9815549|FG000|NOT COMPLETED|Washout of 28 Days||0
8765539|NCT01247272|9815550|FG001|NOT COMPLETED|Washout of 28 Days||0
8765540|NCT01247272|9815549|FG000|STARTED|Second Intervention||13
8765541|NCT01247272|9815550|FG001|STARTED|Second Intervention||13
8765542|NCT01247272|9815549|FG000|COMPLETED|Second Intervention||13
8765543|NCT01247272|9815550|FG001|COMPLETED|Second Intervention||13
8765544|NCT01247272|9815549|FG000|NOT COMPLETED|Second Intervention||0
8765545|NCT01247272|9815550|FG001|NOT COMPLETED|Second Intervention||0
8765546|NCT01247285|9815558|FG000|STARTED|First Intervention||13
8765547|NCT01247285|9815559|FG001|STARTED|First Intervention||13
8765548|NCT01247285|9815558|FG000|COMPLETED|First Intervention||13
8765549|NCT01247285|9815559|FG001|COMPLETED|First Intervention||13
8765550|NCT01247285|9815558|FG000|NOT COMPLETED|First Intervention||0
8765551|NCT01247285|9815559|FG001|NOT COMPLETED|First Intervention||0
8765552|NCT01247285|9815558|FG000|STARTED|Washout of 28 Days||13
8765553|NCT01247285|9815559|FG001|STARTED|Washout of 28 Days||13
8765554|NCT01247285|9815558|FG000|COMPLETED|Washout of 28 Days||13
8765555|NCT01247285|9815559|FG001|COMPLETED|Washout of 28 Days||13
8765556|NCT01247285|9815558|FG000|NOT COMPLETED|Washout of 28 Days||0
8765557|NCT01247285|9815559|FG001|NOT COMPLETED|Washout of 28 Days||0
8765558|NCT01247285|9815558|FG000|STARTED|Second Intervention||13
8765559|NCT01247285|9815559|FG001|STARTED|Second Intervention||13
8765560|NCT01247285|9815558|FG000|COMPLETED|Second Intervention||13
8765561|NCT01247285|9815559|FG001|COMPLETED|Second Intervention||13
8765562|NCT01247285|9815558|FG000|NOT COMPLETED|Second Intervention||0
8765563|NCT01247285|9815559|FG001|NOT COMPLETED|Second Intervention||0
8765564|NCT01247298|9815565|FG000|STARTED|Overall Study||17
8765565|NCT01247298|9815565|FG000|COMPLETED|Overall Study||17
8765566|NCT01247298|9815565|FG000|NOT COMPLETED|Overall Study||0
8765567|NCT01247350|9815575|FG000|STARTED|Overall Study||6
8765568|NCT01247350|9815576|FG001|STARTED|Overall Study||6
8765569|NCT01247350|9815577|FG002|STARTED|Overall Study||6
8765570|NCT01247350|9815578|FG003|STARTED|Overall Study||7
8765571|NCT01247350|9815579|FG004|STARTED|Overall Study||9
8765572|NCT01247350|9815575|FG000|Received Multiple Doses of Study Drug|Overall Study||0
8765573|NCT01247350|9815576|FG001|Received Multiple Doses of Study Drug|Overall Study||0
8765574|NCT01247350|9815577|FG002|Received Multiple Doses of Study Drug|Overall Study||6
8765575|NCT01247350|9815578|FG003|Received Multiple Doses of Study Drug|Overall Study||6
8765576|NCT01247350|9815579|FG004|Received Multiple Doses of Study Drug|Overall Study||5
8765577|NCT01247350|9815575|FG000|COMPLETED|Overall Study||6
8765578|NCT01247350|9815576|FG001|COMPLETED|Overall Study||6
8765579|NCT01247350|9815577|FG002|COMPLETED|Overall Study||5
8765580|NCT01247350|9815578|FG003|COMPLETED|Overall Study||6
8765581|NCT01247350|9815579|FG004|COMPLETED|Overall Study||8
8765582|NCT01247350|9815575|FG000|NOT COMPLETED|Overall Study||0
8765583|NCT01247350|9815576|FG001|NOT COMPLETED|Overall Study||0
8765584|NCT01247350|9815577|FG002|NOT COMPLETED|Overall Study||1
8765585|NCT01247350|9815578|FG003|NOT COMPLETED|Overall Study||1
8765586|NCT01247350|9815579|FG004|NOT COMPLETED|Overall Study||1
8765587|NCT01247363|9815605|FG000|STARTED|Overall Study||20
8765588|NCT01247363|9815605|FG000|COMPLETED|Overall Study||20
8765589|NCT01247363|9815605|FG000|NOT COMPLETED|Overall Study||0
8765590|NCT01247428|9815620|FG000|STARTED|Overall Study||30
8765591|NCT01247428|9815620|FG000|COMPLETED|Overall Study||30
8765592|NCT01247428|9815620|FG000|NOT COMPLETED|Overall Study||0
8765593|NCT01247571|9815624|FG000|STARTED|Overall Study||22
8765594|NCT01247571|9815624|FG000|COMPLETED|Overall Study||19
8765595|NCT01247571|9815624|FG000|NOT COMPLETED|Overall Study||3
8765596|NCT01247675|9815632|FG000|STARTED|Overall Study||10
8765597|NCT01247675|9815633|FG001|STARTED|Overall Study||10
8765598|NCT01247675|9815634|FG002|STARTED|Overall Study||9
8765599|NCT01247675|9815635|FG003|STARTED|Overall Study||8
8765600|NCT01247675|9815632|FG000|COMPLETED|Overall Study||8
8765601|NCT01247675|9815633|FG001|COMPLETED|Overall Study||8
8765602|NCT01247675|9815634|FG002|COMPLETED|Overall Study||9
8765603|NCT01247675|9815635|FG003|COMPLETED|Overall Study||8
8765604|NCT01247675|9815632|FG000|NOT COMPLETED|Overall Study||2
8765605|NCT01247675|9815633|FG001|NOT COMPLETED|Overall Study||2
8765606|NCT01247675|9815634|FG002|NOT COMPLETED|Overall Study||0
8765607|NCT01247675|9815635|FG003|NOT COMPLETED|Overall Study||0
8765608|NCT01247922|9815647|FG000|STARTED|Overall Study||4
8765609|NCT01247922|9815647|FG000|Treated|Overall Study||4
8765610|NCT01247922|9815647|FG000|COMPLETED|Overall Study||0
8765611|NCT01247922|9815647|FG000|NOT COMPLETED|Overall Study||4
8765612|NCT01247974|9815653|FG000|STARTED|Overall Study||217
8765613|NCT01247974|9815654|FG001|STARTED|Overall Study||222
8765614|NCT01247974|9815653|FG000|COMPLETED|Overall Study||191
8765615|NCT01247974|9815654|FG001|COMPLETED|Overall Study||203
8765616|NCT01247974|9815653|FG000|NOT COMPLETED|Overall Study||26
8765617|NCT01247974|9815654|FG001|NOT COMPLETED|Overall Study||19
8765618|NCT01248013|9815660|FG000|STARTED|Overall Study||89
8765619|NCT01248013|9815660|FG000|Irritable Bowel Syndrome Hypnotherapy|Overall Study||75
8765620|NCT01248013|9815660|FG000|COMPLETED|Overall Study||75
8765621|NCT01248013|9815660|FG000|NOT COMPLETED|Overall Study||14
8765622|NCT01248065|9815666|FG000|STARTED|Overall Study||207
8765623|NCT01248065|9815667|FG001|STARTED|Overall Study||201
8765624|NCT01248065|9815666|FG000|COMPLETED|Overall Study|All 207 participants were included in the primary time-to-event analysis.|181
8765625|NCT01248065|9815667|FG001|COMPLETED|Overall Study|All 201 participants were included in the primary time-to-event analysis.|179
8765626|NCT01248065|9815666|FG000|NOT COMPLETED|Overall Study||26
8765627|NCT01248065|9815667|FG001|NOT COMPLETED|Overall Study||22
8765628|NCT01248104|9815675|FG000|STARTED|Overall Study||50
8765629|NCT01248104|9815676|FG001|STARTED|Overall Study||50
8765630|NCT01248104|9815675|FG000|COMPLETED|Overall Study||40
8765631|NCT01248104|9815676|FG001|COMPLETED|Overall Study||42
8765632|NCT01248104|9815675|FG000|NOT COMPLETED|Overall Study||10
8765633|NCT01248104|9815676|FG001|NOT COMPLETED|Overall Study||8
8765634|NCT01248221|9815684|FG000|STARTED|Overall Study||15
8765635|NCT01248221|9815685|FG001|STARTED|Overall Study||15
8765636|NCT01248221|9815684|FG000|COMPLETED|Overall Study||15
8765637|NCT01248221|9815685|FG001|COMPLETED|Overall Study||15
8765638|NCT01248221|9815684|FG000|NOT COMPLETED|Overall Study||0
8765639|NCT01248221|9815685|FG001|NOT COMPLETED|Overall Study||0
8765640|NCT01248364|9815697|FG000|STARTED|Overall Study||32
8765641|NCT01248364|9815698|FG001|STARTED|Overall Study||34
8765642|NCT01248364|9815699|FG002|STARTED|Overall Study||13
8765643|NCT01248364|9815700|FG003|STARTED|Overall Study||12
8765644|NCT01248364|9815697|FG000|Completed Acute Phase:Single Dose, Day 1|Overall Study||32
8765645|NCT01248364|9815698|FG001|Completed Acute Phase:Single Dose, Day 1|Overall Study||34
8765646|NCT01248364|9815699|FG002|Completed Acute Phase:Single Dose, Day 1|Overall Study||13
8765647|NCT01248364|9815700|FG003|Completed Acute Phase:Single Dose, Day 1|Overall Study||12
8765648|NCT01248364|9815697|FG000|Completed Chronic Phase:28-day Treatment|Overall Study||32
8765649|NCT01248364|9815698|FG001|Completed Chronic Phase:28-day Treatment|Overall Study||33
8765650|NCT01248364|9815699|FG002|Completed Chronic Phase:28-day Treatment|Overall Study||13
8765651|NCT01248364|9815700|FG003|Completed Chronic Phase:28-day Treatment|Overall Study||0
8765652|NCT01248364|9815697|FG000|COMPLETED|Overall Study||32
8765653|NCT01248364|9815698|FG001|COMPLETED|Overall Study||33
8765654|NCT01248364|9815699|FG002|COMPLETED|Overall Study||13
8765655|NCT01248364|9815700|FG003|COMPLETED|Overall Study||12
8765656|NCT01248364|9815697|FG000|NOT COMPLETED|Overall Study||0
8765657|NCT01248364|9815698|FG001|NOT COMPLETED|Overall Study||1
8765658|NCT01248364|9815699|FG002|NOT COMPLETED|Overall Study||0
8765659|NCT01248364|9815700|FG003|NOT COMPLETED|Overall Study||0
8765660|NCT01248416|9815713|FG000|STARTED|Overall Study||25
8765661|NCT01248416|9815714|FG001|STARTED|Overall Study||25
8765662|NCT01248416|9815715|FG002|STARTED|Overall Study||26
8765663|NCT01248416|9815713|FG000|COMPLETED|Overall Study||21
8765664|NCT01248416|9815714|FG001|COMPLETED|Overall Study||25
8765665|NCT01248416|9815715|FG002|COMPLETED|Overall Study||25
8765666|NCT01248416|9815713|FG000|NOT COMPLETED|Overall Study||4
8765667|NCT01248416|9815714|FG001|NOT COMPLETED|Overall Study||0
8765668|NCT01248416|9815715|FG002|NOT COMPLETED|Overall Study||1
8765669|NCT01248455|9815725|FG000|STARTED|Overall Study||9
8765670|NCT01248455|9815725|FG000|COMPLETED|Overall Study||8
8765671|NCT01248455|9815725|FG000|NOT COMPLETED|Overall Study||1
8765672|NCT01248468|9815732|FG000|STARTED|Overall Study||299
9026988|NCT03182725|10089447|FG001|STARTED|Treatment Arm 2 (Second Half of Study)|One participant withdrew during crossover and therefore did not start Treatment Arm 2.|6
9026989|NCT03182725|10089446|FG000|COMPLETED|Treatment Arm 2 (Second Half of Study)||16
9026990|NCT03182725|10089447|FG001|COMPLETED|Treatment Arm 2 (Second Half of Study)||6
9026991|NCT03182725|10089446|FG000|NOT COMPLETED|Treatment Arm 2 (Second Half of Study)||0
9026992|NCT03182725|10089447|FG001|NOT COMPLETED|Treatment Arm 2 (Second Half of Study)||0
9026993|NCT03182738|10089455|FG000|STARTED|Overall Study||50
9026994|NCT03182738|10089456|FG001|STARTED|Overall Study||50
9026995|NCT03182738|10089455|FG000|COMPLETED|Overall Study||41
9026996|NCT03182738|10089456|FG001|COMPLETED|Overall Study||45
9026997|NCT03182738|10089455|FG000|NOT COMPLETED|Overall Study||9
9026998|NCT03182738|10089456|FG001|NOT COMPLETED|Overall Study||5
9026999|NCT03182920|10089464|FG000|STARTED|Period 1||9
9027000|NCT03182920|10089465|FG001|STARTED|Period 1||9
9027001|NCT03182920|10089466|FG002|STARTED|Period 1||17
9027002|NCT03182920|10089464|FG000|COMPLETED|Period 1||9
9027003|NCT03182920|10089465|FG001|COMPLETED|Period 1||9
9027004|NCT03182920|10089466|FG002|COMPLETED|Period 1||17
9027005|NCT03182920|10089464|FG000|NOT COMPLETED|Period 1||0
9027006|NCT03182920|10089465|FG001|NOT COMPLETED|Period 1||0
9027007|NCT03182920|10089466|FG002|NOT COMPLETED|Period 1||0
9027008|NCT03182920|10089464|FG000|STARTED|Washout Period||9
9027009|NCT03182920|10089465|FG001|STARTED|Washout Period||9
9027010|NCT03182920|10089466|FG002|STARTED|Washout Period||0
9027011|NCT03182920|10089464|FG000|COMPLETED|Washout Period||9
9027012|NCT03182920|10089465|FG001|COMPLETED|Washout Period||9
9027013|NCT03182920|10089466|FG002|COMPLETED|Washout Period||0
9027014|NCT03182920|10089464|FG000|NOT COMPLETED|Washout Period||0
9027015|NCT03182920|10089465|FG001|NOT COMPLETED|Washout Period||0
9027016|NCT03182920|10089466|FG002|NOT COMPLETED|Washout Period||0
9027017|NCT03182920|10089464|FG000|STARTED|Period 2||9
9027018|NCT03182920|10089465|FG001|STARTED|Period 2||9
9027019|NCT03182920|10089466|FG002|STARTED|Period 2|Young participants on Lasmiditan did not move to study period 2.|0
9027020|NCT03182920|10089464|FG000|COMPLETED|Period 2||9
9027021|NCT03182920|10089465|FG001|COMPLETED|Period 2||9
9027022|NCT03182920|10089466|FG002|COMPLETED|Period 2||0
8765673|NCT01248468|9815733|FG001|STARTED|Overall Study||304
8765674|NCT01248468|9815734|FG002|STARTED|Overall Study||149
8765675|NCT01248468|9815732|FG000|Safety Population|Overall Study||266
8765676|NCT01248468|9815733|FG001|Safety Population|Overall Study||271
8765677|NCT01248468|9815734|FG002|Safety Population|Overall Study||133
8765678|NCT01248468|9815732|FG000|ITT Population|Overall Study||256
8765679|NCT01248468|9815733|FG001|ITT Population|Overall Study||261
8765680|NCT01248468|9815734|FG002|ITT Population|Overall Study||125
8765681|NCT01248468|9815732|FG000|COMPLETED|Overall Study||284
8765682|NCT01248468|9815733|FG001|COMPLETED|Overall Study||290
8765683|NCT01248468|9815734|FG002|COMPLETED|Overall Study||145
8765684|NCT01248468|9815732|FG000|NOT COMPLETED|Overall Study||15
8765685|NCT01248468|9815733|FG001|NOT COMPLETED|Overall Study||14
8765686|NCT01248468|9815734|FG002|NOT COMPLETED|Overall Study||4
8765687|NCT01248585|9815744|FG000|STARTED|Overall Study||148
8765688|NCT01248585|9815745|FG001|STARTED|Overall Study||150
8765689|NCT01248585|9815744|FG000|COMPLETED|Overall Study||148
8765690|NCT01248585|9815745|FG001|COMPLETED|Overall Study||150
8765691|NCT01248585|9815744|FG000|NOT COMPLETED|Overall Study||0
8765692|NCT01248585|9815745|FG001|NOT COMPLETED|Overall Study||0
8765693|NCT01248715|9815753|FG000|STARTED|Overall Study||556
8765694|NCT01248715|9815754|FG001|STARTED|Overall Study||551
8765695|NCT01248715|9815753|FG000|COMPLETED|Overall Study||55
8765696|NCT01248715|9815754|FG001|COMPLETED|Overall Study||41
8765697|NCT01248715|9815753|FG000|NOT COMPLETED|Overall Study||501
8765698|NCT01248715|9815754|FG001|NOT COMPLETED|Overall Study||510
8765699|NCT01248728|9815762|FG000|STARTED|Overall Study||19
8765700|NCT01248728|9815763|FG001|STARTED|Overall Study||19
8765701|NCT01248728|9815762|FG000|COMPLETED|Overall Study||15
8765702|NCT01248728|9815763|FG001|COMPLETED|Overall Study||17
8765703|NCT01248728|9815762|FG000|NOT COMPLETED|Overall Study||4
8765704|NCT01248728|9815763|FG001|NOT COMPLETED|Overall Study||2
8765705|NCT01248741|9815771|FG000|STARTED|Overall Study||20
8765706|NCT01248741|9815771|FG000|COMPLETED|Overall Study||20
8765707|NCT01248741|9815771|FG000|NOT COMPLETED|Overall Study||0
8765708|NCT01248780|9815777|FG000|STARTED|Overall Study||132
9027023|NCT03182920|10089464|FG000|NOT COMPLETED|Period 2||0
9027024|NCT03182920|10089465|FG001|NOT COMPLETED|Period 2||0
9027025|NCT03182920|10089466|FG002|NOT COMPLETED|Period 2||0
9027026|NCT03182933|10089475|FG000|STARTED|Overall Study||32
9027027|NCT03182933|10089476|FG001|STARTED|Overall Study||32
9027028|NCT03182933|10089475|FG000|COMPLETED|Overall Study||31
9027029|NCT03182933|10089476|FG001|COMPLETED|Overall Study||32
9027030|NCT03182933|10089475|FG000|NOT COMPLETED|Overall Study||1
9027031|NCT03182933|10089476|FG001|NOT COMPLETED|Overall Study||0
9027032|NCT03183063|10089485|FG000|STARTED|Overall Study||20
9027033|NCT03183063|10089486|FG001|STARTED|Overall Study||4
9027034|NCT03183063|10089487|FG002|STARTED|Overall Study||115
9027035|NCT03183063|10089485|FG000|COMPLETED|Overall Study||15
9027036|NCT03183063|10089486|FG001|COMPLETED|Overall Study||0
9027037|NCT03183063|10089487|FG002|COMPLETED|Overall Study||111
9027038|NCT03183063|10089485|FG000|NOT COMPLETED|Overall Study||5
9027039|NCT03183063|10089486|FG001|NOT COMPLETED|Overall Study||4
9027040|NCT03183063|10089487|FG002|NOT COMPLETED|Overall Study||4
9027041|NCT03183518|10089501|FG000|STARTED|Overall Study||36
9027042|NCT03183518|10089501|FG000|Test Product|Overall Study||36
9027043|NCT03183518|10089501|FG000|Negative Control|Overall Study||36
9027044|NCT03183518|10089501|FG000|COMPLETED|Overall Study||33
9027045|NCT03183518|10089501|FG000|NOT COMPLETED|Overall Study||3
9027046|NCT03183869|10089508|FG000|STARTED|Overall Study||4
9027047|NCT03183869|10089509|FG001|STARTED|Overall Study||7
9027048|NCT03183869|10089508|FG000|COMPLETED|Overall Study||0
9027049|NCT03183869|10089509|FG001|COMPLETED|Overall Study||2
9027050|NCT03183869|10089508|FG000|NOT COMPLETED|Overall Study||4
9027051|NCT03183869|10089509|FG001|NOT COMPLETED|Overall Study||5
9027052|NCT03183908|10089517|FG000|STARTED|Overall Study||378
9027053|NCT03183908|10089518|FG001|STARTED|Overall Study||379
9027054|NCT03183908|10089517|FG000|COMPLETED|Overall Study||378
9027055|NCT03183908|10089518|FG001|COMPLETED|Overall Study||377
9027056|NCT03183908|10089517|FG000|NOT COMPLETED|Overall Study||0
9027057|NCT03183908|10089518|FG001|NOT COMPLETED|Overall Study||2
9027058|NCT03184077|10089530|FG000|STARTED|Overall Study||166
9027059|NCT03184077|10089531|FG001|STARTED|Overall Study||152
9027060|NCT03184077|10089530|FG000|COMPLETED|Overall Study||145
9027061|NCT03184077|10089531|FG001|COMPLETED|Overall Study||131
9027062|NCT03184077|10089530|FG000|NOT COMPLETED|Overall Study||21
9027063|NCT03184077|10089531|FG001|NOT COMPLETED|Overall Study||21
8765709|NCT01248780|9815778|FG001|STARTED|Overall Study||132
8765710|NCT01248780|9815777|FG000|COMPLETED|Overall Study||123
8765711|NCT01248780|9815778|FG001|COMPLETED|Overall Study||117
9027064|NCT03184428|10089537|FG000|STARTED|Overall Study||3785
9027065|NCT03184428|10089537|FG000|COMPLETED|Overall Study||2963
9027066|NCT03184428|10089537|FG000|NOT COMPLETED|Overall Study||822
9027067|NCT03184441|10089553|FG000|STARTED|Overall Study||11
9027068|NCT03184441|10089553|FG000|COMPLETED|Overall Study|Last subject completed study|10
9027069|NCT03184441|10089553|FG000|NOT COMPLETED|Overall Study||1
8765712|NCT01248780|9815777|FG000|NOT COMPLETED|Overall Study||9
8765713|NCT01248780|9815778|FG001|NOT COMPLETED|Overall Study||15
8765714|NCT01248793|9815786|FG000|STARTED|Overall Study||105
8765715|NCT01248793|9815787|FG001|STARTED|Overall Study||108
8765716|NCT01248793|9815786|FG000|COMPLETED|Overall Study||101
8765717|NCT01248793|9815787|FG001|COMPLETED|Overall Study||102
8765718|NCT01248793|9815786|FG000|NOT COMPLETED|Overall Study||4
9027070|NCT03184519|10089560|FG000|STARTED|Overall Study||156
9027071|NCT03184519|10089560|FG000|COMPLETED|Overall Study||129
9027072|NCT03184519|10089560|FG000|NOT COMPLETED|Overall Study||27
9027073|NCT03184558|10089564|FG000|STARTED|Overall Study||29
8765719|NCT01248793|9815787|FG001|NOT COMPLETED|Overall Study||6
8765720|NCT01248884|9815796|FG000|STARTED|Overall Study||240
8765721|NCT01248884|9815797|FG001|STARTED|Overall Study||242
8765722|NCT01248884|9815798|FG002|STARTED|Overall Study||239
8765723|NCT01248884|9815796|FG000|COMPLETED|Overall Study||238
8765724|NCT01248884|9815797|FG001|COMPLETED|Overall Study||239
8765725|NCT01248884|9815798|FG002|COMPLETED|Overall Study||238
8765726|NCT01248884|9815796|FG000|NOT COMPLETED|Overall Study||2
8765727|NCT01248884|9815797|FG001|NOT COMPLETED|Overall Study||3
8765728|NCT01248884|9815798|FG002|NOT COMPLETED|Overall Study||1
8765729|NCT01248936|9815808|FG000|STARTED|Overall Study||374
8765730|NCT01248936|9815808|FG000|COMPLETED|Overall Study||0
8765731|NCT01248936|9815808|FG000|NOT COMPLETED|Overall Study||374
8765732|NCT01248949|9815818|FG000|STARTED|Overall Study||42
8765733|NCT01248949|9815819|FG001|STARTED|Overall Study||16
8765734|NCT01248949|9815820|FG002|STARTED|Overall Study||38
8765735|NCT01248949|9815821|FG003|STARTED|Overall Study||13
8765736|NCT01248949|9815822|FG004|STARTED|Overall Study||7
8765737|NCT01248949|9815818|FG000|COMPLETED|Overall Study||9
8765738|NCT01248949|9815819|FG001|COMPLETED|Overall Study||3
8765739|NCT01248949|9815820|FG002|COMPLETED|Overall Study||1
8765740|NCT01248949|9815821|FG003|COMPLETED|Overall Study||3
8765741|NCT01248949|9815822|FG004|COMPLETED|Overall Study||3
8765742|NCT01248949|9815818|FG000|NOT COMPLETED|Overall Study||33
8765743|NCT01248949|9815819|FG001|NOT COMPLETED|Overall Study||13
8765744|NCT01248949|9815820|FG002|NOT COMPLETED|Overall Study||37
8765745|NCT01248949|9815821|FG003|NOT COMPLETED|Overall Study||10
8765746|NCT01248949|9815822|FG004|NOT COMPLETED|Overall Study||4
8765747|NCT01248962|9815836|FG000|STARTED|Overall Study||74
8765748|NCT01248962|9815837|FG001|STARTED|Overall Study||72
8765749|NCT01248962|9815836|FG000|COMPLETED|Overall Study||58
8765750|NCT01248962|9815837|FG001|COMPLETED|Overall Study||56
8765751|NCT01248962|9815836|FG000|NOT COMPLETED|Overall Study||16
8765752|NCT01248962|9815837|FG001|NOT COMPLETED|Overall Study||16
8765753|NCT01249027|9815844|FG000|STARTED|1 Year Clinical Follow up||2482
8765754|NCT01249027|9815844|FG000|COMPLETED|1 Year Clinical Follow up||2391
8765755|NCT01249027|9815844|FG000|NOT COMPLETED|1 Year Clinical Follow up||91
8765756|NCT01249027|9815844|FG000|STARTED|2 Years Clinical Follow up||2391
8765757|NCT01249027|9815844|FG000|COMPLETED|2 Years Clinical Follow up||2254
8765758|NCT01249027|9815844|FG000|NOT COMPLETED|2 Years Clinical Follow up||137
8765759|NCT01249027|9815844|FG000|STARTED|3 Years Clinical Follow up||2254
8765760|NCT01249027|9815844|FG000|COMPLETED|3 Years Clinical Follow up||2223
8765761|NCT01249027|9815844|FG000|NOT COMPLETED|3 Years Clinical Follow up||31
8765762|NCT01249027|9815844|FG000|STARTED|4 Years Clinical Follow up||2223
8765763|NCT01249027|9815844|FG000|COMPLETED|4 Years Clinical Follow up||2210
8765764|NCT01249027|9815844|FG000|NOT COMPLETED|4 Years Clinical Follow up||13
8765765|NCT01249027|9815844|FG000|STARTED|5 Years Clinical Follow up||2210
8765766|NCT01249027|9815844|FG000|COMPLETED|5 Years Clinical Follow up||2142
8765767|NCT01249027|9815844|FG000|NOT COMPLETED|5 Years Clinical Follow up||68
8765768|NCT01249092|9815848|FG000|STARTED|Overall Study||20
8765769|NCT01249092|9815848|FG000|COMPLETED|Overall Study||18
8765770|NCT01249092|9815848|FG000|NOT COMPLETED|Overall Study||2
8765771|NCT01249118|9815854|FG000|STARTED|First Intervention Period||2
8765772|NCT01249118|9815855|FG001|STARTED|First Intervention Period||6
8765773|NCT01249118|9815856|FG002|STARTED|First Intervention Period||5
8765774|NCT01249118|9815854|FG000|COMPLETED|First Intervention Period||2
8765775|NCT01249118|9815855|FG001|COMPLETED|First Intervention Period||6
8765776|NCT01249118|9815856|FG002|COMPLETED|First Intervention Period||5
8765777|NCT01249118|9815854|FG000|NOT COMPLETED|First Intervention Period||0
8765778|NCT01249118|9815855|FG001|NOT COMPLETED|First Intervention Period||0
8765779|NCT01249118|9815856|FG002|NOT COMPLETED|First Intervention Period||0
8765780|NCT01249118|9815854|FG000|STARTED|First Washout Period||2
8765781|NCT01249118|9815855|FG001|STARTED|First Washout Period||6
8765782|NCT01249118|9815856|FG002|STARTED|First Washout Period||5
8765783|NCT01249118|9815854|FG000|COMPLETED|First Washout Period||2
8765784|NCT01249118|9815855|FG001|COMPLETED|First Washout Period||5
8765785|NCT01249118|9815856|FG002|COMPLETED|First Washout Period||5
8765786|NCT01249118|9815854|FG000|NOT COMPLETED|First Washout Period||0
8765787|NCT01249118|9815855|FG001|NOT COMPLETED|First Washout Period||1
8765788|NCT01249118|9815856|FG002|NOT COMPLETED|First Washout Period||0
8765789|NCT01249118|9815854|FG000|STARTED|Second Intervention Period||2
8765790|NCT01249118|9815855|FG001|STARTED|Second Intervention Period||5
8765791|NCT01249118|9815856|FG002|STARTED|Second Intervention Period||5
8765792|NCT01249118|9815854|FG000|COMPLETED|Second Intervention Period||2
8765793|NCT01249118|9815855|FG001|COMPLETED|Second Intervention Period||5
8765794|NCT01249118|9815856|FG002|COMPLETED|Second Intervention Period||5
8765795|NCT01249118|9815854|FG000|NOT COMPLETED|Second Intervention Period||0
8765796|NCT01249118|9815855|FG001|NOT COMPLETED|Second Intervention Period||0
8765797|NCT01249118|9815856|FG002|NOT COMPLETED|Second Intervention Period||0
8765798|NCT01249118|9815854|FG000|STARTED|Second Washout Period||2
8765799|NCT01249118|9815855|FG001|STARTED|Second Washout Period||5
8765800|NCT01249118|9815856|FG002|STARTED|Second Washout Period||5
8765801|NCT01249118|9815854|FG000|COMPLETED|Second Washout Period||2
8765802|NCT01249118|9815855|FG001|COMPLETED|Second Washout Period||5
8765803|NCT01249118|9815856|FG002|COMPLETED|Second Washout Period||5
8765804|NCT01249118|9815854|FG000|NOT COMPLETED|Second Washout Period||0
8765805|NCT01249118|9815855|FG001|NOT COMPLETED|Second Washout Period||0
8765806|NCT01249118|9815856|FG002|NOT COMPLETED|Second Washout Period||0
8765807|NCT01249131|9815863|FG000|STARTED|First Intervention||3
8765808|NCT01249131|9815864|FG001|STARTED|First Intervention||3
8765809|NCT01249131|9815865|FG002|STARTED|First Intervention||4
8765810|NCT01249131|9815866|FG003|STARTED|First Intervention||3
8765811|NCT01249131|9815867|FG004|STARTED|First Intervention||3
8765812|NCT01249131|9815868|FG005|STARTED|First Intervention||4
8765813|NCT01249131|9815863|FG000|COMPLETED|First Intervention||3
8765814|NCT01249131|9815864|FG001|COMPLETED|First Intervention||3
8765815|NCT01249131|9815865|FG002|COMPLETED|First Intervention||4
8765816|NCT01249131|9815866|FG003|COMPLETED|First Intervention||3
8765817|NCT01249131|9815867|FG004|COMPLETED|First Intervention||3
8765818|NCT01249131|9815868|FG005|COMPLETED|First Intervention||4
8765819|NCT01249131|9815863|FG000|NOT COMPLETED|First Intervention||0
8765820|NCT01249131|9815864|FG001|NOT COMPLETED|First Intervention||0
8765821|NCT01249131|9815865|FG002|NOT COMPLETED|First Intervention||0
8765822|NCT01249131|9815866|FG003|NOT COMPLETED|First Intervention||0
8765823|NCT01249131|9815867|FG004|NOT COMPLETED|First Intervention||0
8765824|NCT01249131|9815868|FG005|NOT COMPLETED|First Intervention||0
8765825|NCT01249131|9815863|FG000|STARTED|Washout Period of 10 Days||3
8765826|NCT01249131|9815864|FG001|STARTED|Washout Period of 10 Days||3
8765827|NCT01249131|9815865|FG002|STARTED|Washout Period of 10 Days||4
8765828|NCT01249131|9815866|FG003|STARTED|Washout Period of 10 Days||3
8765829|NCT01249131|9815867|FG004|STARTED|Washout Period of 10 Days||3
8765830|NCT01249131|9815868|FG005|STARTED|Washout Period of 10 Days||4
8765831|NCT01249131|9815863|FG000|COMPLETED|Washout Period of 10 Days||3
8765832|NCT01249131|9815864|FG001|COMPLETED|Washout Period of 10 Days||3
8765833|NCT01249131|9815865|FG002|COMPLETED|Washout Period of 10 Days||4
8765834|NCT01249131|9815866|FG003|COMPLETED|Washout Period of 10 Days||3
8765835|NCT01249131|9815867|FG004|COMPLETED|Washout Period of 10 Days||2
8765836|NCT01249131|9815868|FG005|COMPLETED|Washout Period of 10 Days||4
8765837|NCT01249131|9815863|FG000|NOT COMPLETED|Washout Period of 10 Days||0
8765838|NCT01249131|9815864|FG001|NOT COMPLETED|Washout Period of 10 Days||0
8765839|NCT01249131|9815865|FG002|NOT COMPLETED|Washout Period of 10 Days||0
8765840|NCT01249131|9815866|FG003|NOT COMPLETED|Washout Period of 10 Days||0
8765841|NCT01249131|9815867|FG004|NOT COMPLETED|Washout Period of 10 Days||1
8765842|NCT01249131|9815868|FG005|NOT COMPLETED|Washout Period of 10 Days||0
8765843|NCT01249131|9815863|FG000|STARTED|Second Intervention||3
8765844|NCT01249131|9815864|FG001|STARTED|Second Intervention||3
8765845|NCT01249131|9815865|FG002|STARTED|Second Intervention||4
8765846|NCT01249131|9815866|FG003|STARTED|Second Intervention||3
8765847|NCT01249131|9815867|FG004|STARTED|Second Intervention||2
8765848|NCT01249131|9815868|FG005|STARTED|Second Intervention||4
8765849|NCT01249131|9815863|FG000|COMPLETED|Second Intervention||3
8765850|NCT01249131|9815864|FG001|COMPLETED|Second Intervention||3
8765851|NCT01249131|9815865|FG002|COMPLETED|Second Intervention||4
8765852|NCT01249131|9815866|FG003|COMPLETED|Second Intervention||3
8765853|NCT01249131|9815867|FG004|COMPLETED|Second Intervention||2
8765854|NCT01249131|9815868|FG005|COMPLETED|Second Intervention||4
8765855|NCT01249131|9815863|FG000|NOT COMPLETED|Second Intervention||0
8765856|NCT01249131|9815864|FG001|NOT COMPLETED|Second Intervention||0
8765857|NCT01249131|9815865|FG002|NOT COMPLETED|Second Intervention||0
8765858|NCT01249131|9815866|FG003|NOT COMPLETED|Second Intervention||0
8765859|NCT01249131|9815867|FG004|NOT COMPLETED|Second Intervention||0
8765860|NCT01249131|9815868|FG005|NOT COMPLETED|Second Intervention||0
8765861|NCT01249131|9815863|FG000|STARTED|Washout Period of 10 Days||3
8765862|NCT01249131|9815864|FG001|STARTED|Washout Period of 10 Days||3
8765863|NCT01249131|9815865|FG002|STARTED|Washout Period of 10 Days||4
8765864|NCT01249131|9815866|FG003|STARTED|Washout Period of 10 Days||3
8765865|NCT01249131|9815867|FG004|STARTED|Washout Period of 10 Days||2
8765866|NCT01249131|9815868|FG005|STARTED|Washout Period of 10 Days||4
8765867|NCT01249131|9815863|FG000|COMPLETED|Washout Period of 10 Days||3
8765868|NCT01249131|9815864|FG001|COMPLETED|Washout Period of 10 Days||3
8765869|NCT01249131|9815865|FG002|COMPLETED|Washout Period of 10 Days||4
8765870|NCT01249131|9815866|FG003|COMPLETED|Washout Period of 10 Days||3
8765871|NCT01249131|9815867|FG004|COMPLETED|Washout Period of 10 Days||2
8765872|NCT01249131|9815868|FG005|COMPLETED|Washout Period of 10 Days||4
8765873|NCT01249131|9815863|FG000|NOT COMPLETED|Washout Period of 10 Days||0
8765874|NCT01249131|9815864|FG001|NOT COMPLETED|Washout Period of 10 Days||0
8765875|NCT01249131|9815865|FG002|NOT COMPLETED|Washout Period of 10 Days||0
8765876|NCT01249131|9815866|FG003|NOT COMPLETED|Washout Period of 10 Days||0
8765877|NCT01249131|9815867|FG004|NOT COMPLETED|Washout Period of 10 Days||0
8765878|NCT01249131|9815868|FG005|NOT COMPLETED|Washout Period of 10 Days||0
8765879|NCT01249131|9815863|FG000|STARTED|Third Intervention||3
8765880|NCT01249131|9815864|FG001|STARTED|Third Intervention||3
8765881|NCT01249131|9815865|FG002|STARTED|Third Intervention||4
8765882|NCT01249131|9815866|FG003|STARTED|Third Intervention||3
8765883|NCT01249131|9815867|FG004|STARTED|Third Intervention||2
8765884|NCT01249131|9815868|FG005|STARTED|Third Intervention||4
8765885|NCT01249131|9815863|FG000|COMPLETED|Third Intervention||3
8765886|NCT01249131|9815864|FG001|COMPLETED|Third Intervention||3
8765887|NCT01249131|9815865|FG002|COMPLETED|Third Intervention||4
8765888|NCT01249131|9815866|FG003|COMPLETED|Third Intervention||3
8765889|NCT01249131|9815867|FG004|COMPLETED|Third Intervention||2
8765890|NCT01249131|9815868|FG005|COMPLETED|Third Intervention||4
8765891|NCT01249131|9815863|FG000|NOT COMPLETED|Third Intervention||0
8765892|NCT01249131|9815864|FG001|NOT COMPLETED|Third Intervention||0
8765893|NCT01249131|9815865|FG002|NOT COMPLETED|Third Intervention||0
8765894|NCT01249131|9815866|FG003|NOT COMPLETED|Third Intervention||0
8765895|NCT01249131|9815867|FG004|NOT COMPLETED|Third Intervention||0
8765896|NCT01249131|9815868|FG005|NOT COMPLETED|Third Intervention||0
8765897|NCT01249261|9815878|FG000|STARTED|Overall Study||30
8765898|NCT01249261|9815879|FG001|STARTED|Overall Study||31
8765899|NCT01249261|9815878|FG000|COMPLETED|Overall Study||29
8765900|NCT01249261|9815879|FG001|COMPLETED|Overall Study||31
8765901|NCT01249261|9815878|FG000|NOT COMPLETED|Overall Study||1
8765902|NCT01249261|9815879|FG001|NOT COMPLETED|Overall Study||0
8765903|NCT01249274|9815887|FG000|STARTED|Overall Study|all 25 were included in intention-to-treat and safety analyses|25
8765904|NCT01249274|9815888|FG001|STARTED|Overall Study|all 25 were included in intention-to-treat and safety analyses|25
8765905|NCT01249274|9815887|FG000|Completed Treatment|Overall Study||21
8765906|NCT01249274|9815888|FG001|Completed Treatment|Overall Study||19
8765907|NCT01249274|9815887|FG000|Completed Treatment & Post Trial Visit|Overall Study||20
8765908|NCT01249274|9815888|FG001|Completed Treatment & Post Trial Visit|Overall Study||17
8765909|NCT01249274|9815887|FG000|Completed Post Trial Visit But Not tx|Overall Study||1
8765910|NCT01249274|9815888|FG001|Completed Post Trial Visit But Not tx|Overall Study||2
8765911|NCT01249274|9815887|FG000|COMPLETED|Overall Study||21
8765912|NCT01249274|9815888|FG001|COMPLETED|Overall Study||19
8765913|NCT01249274|9815887|FG000|NOT COMPLETED|Overall Study||4
8765914|NCT01249274|9815888|FG001|NOT COMPLETED|Overall Study||6
8765915|NCT01249365|9815896|FG000|STARTED|Overall Study||199
8765916|NCT01249365|9815896|FG000|COMPLETED|Overall Study||198
8765917|NCT01249365|9815896|FG000|NOT COMPLETED|Overall Study||1
8765918|NCT01249404|9815903|FG000|STARTED|Overall Study||127
8765919|NCT01249404|9815904|FG001|STARTED|Overall Study||129
8765920|NCT01249404|9815905|FG002|STARTED|Overall Study||132
8765921|NCT01249404|9815903|FG000|COMPLETED|Overall Study||120
8765922|NCT01249404|9815904|FG001|COMPLETED|Overall Study||121
8765923|NCT01249404|9815905|FG002|COMPLETED|Overall Study||125
8765924|NCT01249404|9815903|FG000|NOT COMPLETED|Overall Study||7
8765925|NCT01249404|9815904|FG001|NOT COMPLETED|Overall Study||8
8765926|NCT01249404|9815905|FG002|NOT COMPLETED|Overall Study||7
8765927|NCT01249417|9815916|FG000|STARTED|Randomised Population||80
8765928|NCT01249417|9815917|FG001|STARTED|Randomised Population||80
8765929|NCT01249417|9815918|FG002|STARTED|Randomised Population||81
8765930|NCT01249417|9815916|FG000|Treated|Randomised Population||80
8765931|NCT01249417|9815917|FG001|Treated|Randomised Population||80
8765932|NCT01249417|9815918|FG002|Treated|Randomised Population||79
8765933|NCT01249417|9815916|FG000|COMPLETED|Randomised Population||79
8765934|NCT01249417|9815917|FG001|COMPLETED|Randomised Population||79
8765935|NCT01249417|9815918|FG002|COMPLETED|Randomised Population||77
8765936|NCT01249417|9815916|FG000|NOT COMPLETED|Randomised Population||1
9027074|NCT03184558|10089564|FG000|COMPLETED|Overall Study||0
9027075|NCT03184558|10089564|FG000|NOT COMPLETED|Overall Study||29
9027076|NCT03184701|10089568|FG000|STARTED|Overall Study||45
9027077|NCT03184701|10089568|FG000|COMPLETED|Overall Study||28
9027078|NCT03184701|10089568|FG000|NOT COMPLETED|Overall Study||17
9027079|NCT03184987|10089575|FG000|STARTED|Overall Study||47
9027080|NCT03184987|10089576|FG001|STARTED|Overall Study||9
9027081|NCT03184987|10089577|FG002|STARTED|Overall Study||55
9027082|NCT03184987|10089575|FG000|COMPLETED|Overall Study||46
9027083|NCT03184987|10089576|FG001|COMPLETED|Overall Study||8
9027084|NCT03184987|10089577|FG002|COMPLETED|Overall Study||51
9027085|NCT03184987|10089575|FG000|NOT COMPLETED|Overall Study||1
9027086|NCT03184987|10089576|FG001|NOT COMPLETED|Overall Study||1
9027087|NCT03184987|10089577|FG002|NOT COMPLETED|Overall Study||4
9027088|NCT03185065|10089589|FG000|STARTED|Period 1 (6 Weeks)||35
9027089|NCT03185065|10089590|FG001|STARTED|Period 1 (6 Weeks)||34
9027090|NCT03185065|10089591|FG002|STARTED|Period 1 (6 Weeks)||35
9027091|NCT03185065|10089592|FG003|STARTED|Period 1 (6 Weeks)||37
9027092|NCT03185065|10089589|FG000|COMPLETED|Period 1 (6 Weeks)||32
9027093|NCT03185065|10089590|FG001|COMPLETED|Period 1 (6 Weeks)||33
9027094|NCT03185065|10089591|FG002|COMPLETED|Period 1 (6 Weeks)||32
9027095|NCT03185065|10089592|FG003|COMPLETED|Period 1 (6 Weeks)||36
9027096|NCT03185065|10089589|FG000|NOT COMPLETED|Period 1 (6 Weeks)||3
9027097|NCT03185065|10089590|FG001|NOT COMPLETED|Period 1 (6 Weeks)||1
9027098|NCT03185065|10089591|FG002|NOT COMPLETED|Period 1 (6 Weeks)||3
9027099|NCT03185065|10089592|FG003|NOT COMPLETED|Period 1 (6 Weeks)||1
9027100|NCT03185065|10089589|FG000|STARTED|Washout (2 Weeks)||32
9027101|NCT03185065|10089590|FG001|STARTED|Washout (2 Weeks)||33
9027102|NCT03185065|10089591|FG002|STARTED|Washout (2 Weeks)||32
9027103|NCT03185065|10089592|FG003|STARTED|Washout (2 Weeks)||36
9027104|NCT03185065|10089589|FG000|COMPLETED|Washout (2 Weeks)||32
9027105|NCT03185065|10089590|FG001|COMPLETED|Washout (2 Weeks)||31
9027106|NCT03185065|10089591|FG002|COMPLETED|Washout (2 Weeks)||32
9027107|NCT03185065|10089592|FG003|COMPLETED|Washout (2 Weeks)||35
8765937|NCT01249417|9815917|FG001|NOT COMPLETED|Randomised Population||1
8765938|NCT01249417|9815918|FG002|NOT COMPLETED|Randomised Population||4
8765939|NCT01249417|9815916|FG000|STARTED|Treatment Phase - ITT Population||79
8765940|NCT01249417|9815917|FG001|STARTED|Treatment Phase - ITT Population||79
8765941|NCT01249417|9815918|FG002|STARTED|Treatment Phase - ITT Population||77
9027108|NCT03185065|10089589|FG000|NOT COMPLETED|Washout (2 Weeks)||0
9027109|NCT03185065|10089590|FG001|NOT COMPLETED|Washout (2 Weeks)||2
9027110|NCT03185065|10089591|FG002|NOT COMPLETED|Washout (2 Weeks)||0
8765942|NCT01249417|9815916|FG000|COMPLETED|Treatment Phase - ITT Population||78
8765943|NCT01249417|9815917|FG001|COMPLETED|Treatment Phase - ITT Population||75
8765944|NCT01249417|9815918|FG002|COMPLETED|Treatment Phase - ITT Population||73
8765945|NCT01249417|9815916|FG000|NOT COMPLETED|Treatment Phase - ITT Population||1
8765946|NCT01249417|9815917|FG001|NOT COMPLETED|Treatment Phase - ITT Population||4
8765947|NCT01249417|9815918|FG002|NOT COMPLETED|Treatment Phase - ITT Population||4
8808421|NCT01490632|9860716|FG015|NOT COMPLETED|Part B: Extension or Step-Up Period||0
8808422|NCT01490632|9860717|FG016|NOT COMPLETED|Part B: Extension or Step-Up Period||0
8808423|NCT01490632|9860718|FG017|NOT COMPLETED|Part B: Extension or Step-Up Period||0
8808424|NCT01490632|9860719|FG018|NOT COMPLETED|Part B: Extension or Step-Up Period||0
8808425|NCT01490632|9860720|FG019|NOT COMPLETED|Part B: Extension or Step-Up Period||0
8808426|NCT01490632|9860701|FG000|STARTED|Part C: Washout or Step-Down Period||0
8808427|NCT01490632|9860702|FG001|STARTED|Part C: Washout or Step-Down Period||0
8808428|NCT01490632|9860703|FG002|STARTED|Part C: Washout or Step-Down Period||0
8808429|NCT01490632|9860704|FG003|STARTED|Part C: Washout or Step-Down Period||0
8808430|NCT01490632|9860705|FG004|STARTED|Part C: Washout or Step-Down Period|One participant completed Part B but discontinued without receiving a Part C treatment assignment.|0
8808431|NCT01490632|9860706|FG005|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥75 remained on 2 mg or 4 mg.|0
8808432|NCT01490632|9860707|FG006|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 8 mg or 10 mg with a PASI ≥75 remained on 8 mg or 10 mg.|0
8808433|NCT01490632|9860708|FG007|STARTED|Part C: Washout or Step-Down Period|Placebo participants in Part A with a PASI <75 were re-randomized to 8 mg or 10 mg.|0
8808434|NCT01490632|9860709|FG008|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥50 to <75 remained on 2 mg or 4 mg.|0
8808435|NCT01490632|9860710|FG009|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 2 mg or 4 mg with a PASI <50 were re-randomized to 8 mg or 10 mg.|0
8808436|NCT01490632|9860711|FG010|STARTED|Part C: Washout or Step-Down Period|Part A 10 mg non-responders were discontinued from the study.|0
8808437|NCT01490632|9860712|FG011|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to Placebo remained on Placebo.|0
8808438|NCT01490632|9860713|FG012|STARTED|Part C: Washout or Step-Down Period|Responders receiving 2 or 4 mg were re-randomized to receive placebo.|15
8808439|NCT01490632|9860714|FG013|STARTED|Part C: Washout or Step-Down Period|Responders receiving 2 or 4 mg were re-randomized to receive half of the dose from Part B.|16
8808440|NCT01490632|9860715|FG014|STARTED|Part C: Washout or Step-Down Period|Responders receiving 8 or 10 mg were re-randomized to receive placebo.|55
8808441|NCT01490632|9860716|FG015|STARTED|Part C: Washout or Step-Down Period|Responders receiving 8 or 10 mg were re-randomized to receive 4 mg.|55
8808442|NCT01490632|9860717|FG016|STARTED|Part C: Washout or Step-Down Period||0
8808443|NCT01490632|9860718|FG017|STARTED|Part C: Washout or Step-Down Period||0
8808444|NCT01490632|9860719|FG018|STARTED|Part C: Washout or Step-Down Period||0
8808445|NCT01490632|9860720|FG019|STARTED|Part C: Washout or Step-Down Period||0
8808446|NCT01490632|9860701|FG000|COMPLETED|Part C: Washout or Step-Down Period||0
8808447|NCT01490632|9860702|FG001|COMPLETED|Part C: Washout or Step-Down Period||0
8808448|NCT01490632|9860703|FG002|COMPLETED|Part C: Washout or Step-Down Period||0
8808449|NCT01490632|9860704|FG003|COMPLETED|Part C: Washout or Step-Down Period||0
8808450|NCT01490632|9860705|FG004|COMPLETED|Part C: Washout or Step-Down Period||0
8808451|NCT01490632|9860706|FG005|COMPLETED|Part C: Washout or Step-Down Period||0
8808452|NCT01490632|9860707|FG006|COMPLETED|Part C: Washout or Step-Down Period||0
8808453|NCT01490632|9860708|FG007|COMPLETED|Part C: Washout or Step-Down Period||0
8808454|NCT01490632|9860709|FG008|COMPLETED|Part C: Washout or Step-Down Period||0
8808455|NCT01490632|9860710|FG009|COMPLETED|Part C: Washout or Step-Down Period||0
8808456|NCT01490632|9860711|FG010|COMPLETED|Part C: Washout or Step-Down Period||0
8808457|NCT01490632|9860712|FG011|COMPLETED|Part C: Washout or Step-Down Period||0
8808458|NCT01490632|9860713|FG012|COMPLETED|Part C: Washout or Step-Down Period||10
8808459|NCT01490632|9860714|FG013|COMPLETED|Part C: Washout or Step-Down Period||6
8808460|NCT01490632|9860715|FG014|COMPLETED|Part C: Washout or Step-Down Period||37
8808461|NCT01490632|9860716|FG015|COMPLETED|Part C: Washout or Step-Down Period||18
8808462|NCT01490632|9860717|FG016|COMPLETED|Part C: Washout or Step-Down Period||0
8808463|NCT01490632|9860718|FG017|COMPLETED|Part C: Washout or Step-Down Period||0
8808464|NCT01490632|9860719|FG018|COMPLETED|Part C: Washout or Step-Down Period||0
8808465|NCT01490632|9860720|FG019|COMPLETED|Part C: Washout or Step-Down Period||0
8808466|NCT01490632|9860701|FG000|NOT COMPLETED|Part C: Washout or Step-Down Period||0
8808467|NCT01490632|9860702|FG001|NOT COMPLETED|Part C: Washout or Step-Down Period||0
8808468|NCT01490632|9860703|FG002|NOT COMPLETED|Part C: Washout or Step-Down Period||0
8808469|NCT01490632|9860704|FG003|NOT COMPLETED|Part C: Washout or Step-Down Period||0
8808470|NCT01490632|9860705|FG004|NOT COMPLETED|Part C: Washout or Step-Down Period||0
8808471|NCT01490632|9860706|FG005|NOT COMPLETED|Part C: Washout or Step-Down Period||0
8808472|NCT01490632|9860707|FG006|NOT COMPLETED|Part C: Washout or Step-Down Period||0
8808473|NCT01490632|9860708|FG007|NOT COMPLETED|Part C: Washout or Step-Down Period||0
8915744|NCT02177123|9975238|FG000|NOT COMPLETED|Overall Study||24
8915745|NCT02177136|9975248|FG000|STARTED|DB Phase||26
8915746|NCT02177136|9975249|FG001|STARTED|DB Phase||26
8915747|NCT02177136|9975250|FG002|STARTED|DB Phase||25
8915748|NCT02177136|9975251|FG003|STARTED|DB Phase||0
8915749|NCT02177136|9975248|FG000|Received At Least 1 Dose Of Study Drug|DB Phase|One participant randomized to receive 1.5 mg OCA titrating to 3 mg OCA withdrew prior to dosing.|25
8915750|NCT02177136|9975249|FG001|Received At Least 1 Dose Of Study Drug|DB Phase||26
8765948|NCT01249625|9815928|FG000|STARTED|Overall Study||1374
8765949|NCT01249625|9815929|FG001|STARTED|Overall Study||1488
8765950|NCT01249625|9815928|FG000|COMPLETED|Overall Study||1374
8765951|NCT01249625|9815929|FG001|COMPLETED|Overall Study||1488
8765952|NCT01249625|9815928|FG000|NOT COMPLETED|Overall Study||0
8765953|NCT01249625|9815929|FG001|NOT COMPLETED|Overall Study||0
8765954|NCT01249651|9815935|FG000|STARTED|Overall Study|Enrolled|101
8765955|NCT01249651|9815935|FG000|COMPLETED|Overall Study|Completed the 8-week treatment period|94
8765956|NCT01249651|9815935|FG000|NOT COMPLETED|Overall Study||7
8765957|NCT01249664|9815941|FG000|STARTED|Overall Study||91
8765958|NCT01249664|9815942|FG001|STARTED|Overall Study||31
8765959|NCT01249664|9815941|FG000|Participants Received Treatment|Overall Study|Safety population|91
8765960|NCT01249664|9815942|FG001|Participants Received Treatment|Overall Study|Safety population|31
8765961|NCT01249664|9815941|FG000|Fulfilled Requirements of FAS Population|Overall Study|Full Analysis Set (FAS) population: Basis of efficacy evaluation|90
8765962|NCT01249664|9815942|FG001|Fulfilled Requirements of FAS Population|Overall Study|FAS population: Basis of efficacy evaluation|31
8765963|NCT01249664|9815941|FG000|Completed 24 Weeks Treatment|Overall Study|Withdrawal from treatment does not equal to withdrawal from study.|83
8765964|NCT01249664|9815942|FG001|Completed 24 Weeks Treatment|Overall Study|Withdrawal from treatment does not equal to withdrawal from study.|25
8765965|NCT01249664|9815941|FG000|Completed 48 Weeks Treatment|Overall Study||78
8765966|NCT01249664|9815942|FG001|Completed 48 Weeks Treatment|Overall Study||24
8765967|NCT01249664|9815941|FG000|COMPLETED|Overall Study|Completers of study visits up to week 48|85
8765968|NCT01249664|9815942|FG001|COMPLETED|Overall Study|Completers of study visits up to week 48|31
8765969|NCT01249664|9815941|FG000|NOT COMPLETED|Overall Study||6
8765970|NCT01249664|9815942|FG001|NOT COMPLETED|Overall Study||0
8765971|NCT01249833|9815952|FG000|STARTED|Overall Study||59
8765972|NCT01249833|9815953|FG001|STARTED|Overall Study||63
8765973|NCT01249833|9815952|FG000|COMPLETED|Overall Study||59
8765974|NCT01249833|9815953|FG001|COMPLETED|Overall Study||62
8765975|NCT01249833|9815952|FG000|NOT COMPLETED|Overall Study||0
8765976|NCT01249833|9815953|FG001|NOT COMPLETED|Overall Study||1
8765977|NCT01249872|9815965|FG000|STARTED|Overall Study||16
8765978|NCT01249872|9815966|FG001|STARTED|Overall Study||16
8765979|NCT01249872|9815967|FG002|STARTED|Overall Study||16
8765980|NCT01249872|9815968|FG003|STARTED|Overall Study||16
8765981|NCT01249872|9815969|FG004|STARTED|Overall Study||16
8765982|NCT01249872|9815970|FG005|STARTED|Overall Study||16
8765983|NCT01249872|9815965|FG000|COMPLETED|Overall Study||16
8765984|NCT01249872|9815966|FG001|COMPLETED|Overall Study||16
8765985|NCT01249872|9815967|FG002|COMPLETED|Overall Study||16
8765986|NCT01249872|9815968|FG003|COMPLETED|Overall Study||16
8765987|NCT01249872|9815969|FG004|COMPLETED|Overall Study||16
8765988|NCT01249872|9815970|FG005|COMPLETED|Overall Study||16
8765989|NCT01249872|9815965|FG000|NOT COMPLETED|Overall Study||0
8765990|NCT01249872|9815966|FG001|NOT COMPLETED|Overall Study||0
8765991|NCT01249872|9815967|FG002|NOT COMPLETED|Overall Study||0
8765992|NCT01249872|9815968|FG003|NOT COMPLETED|Overall Study||0
8765993|NCT01249872|9815969|FG004|NOT COMPLETED|Overall Study||0
8765994|NCT01249872|9815970|FG005|NOT COMPLETED|Overall Study||0
8765995|NCT01250002|9815994|FG000|STARTED|Overall Study||35
8765996|NCT01250002|9815995|FG001|STARTED|Overall Study||35
8765997|NCT01250002|9815994|FG000|COMPLETED|Overall Study||31
8765998|NCT01250002|9815995|FG001|COMPLETED|Overall Study||32
8765999|NCT01250002|9815994|FG000|NOT COMPLETED|Overall Study||4
8766000|NCT01250002|9815995|FG001|NOT COMPLETED|Overall Study||3
8766001|NCT01250054|9816001|FG000|STARTED|Period 1, One Week of Wear||8
8766002|NCT01250054|9816002|FG001|STARTED|Period 1, One Week of Wear|One subject did not wear Period 1 lenses due to power availability and proceeded to Period 2 lenses.|8
8766003|NCT01250054|9816001|FG000|COMPLETED|Period 1, One Week of Wear|One subject discontinued between Period 1 and Period 2 due to power availability.|8
8766004|NCT01250054|9816002|FG001|COMPLETED|Period 1, One Week of Wear|One subject discontinued between Period 1 and Period 2 due to noncompliance.|8
8766005|NCT01250054|9816001|FG000|NOT COMPLETED|Period 1, One Week of Wear||0
8766006|NCT01250054|9816002|FG001|NOT COMPLETED|Period 1, One Week of Wear||0
8766007|NCT01250054|9816001|FG000|STARTED|Period 2, One Week of Wear||7
8766008|NCT01250054|9816002|FG001|STARTED|Period 2, One Week of Wear||8
8766009|NCT01250054|9816001|FG000|COMPLETED|Period 2, One Week of Wear||6
8766010|NCT01250054|9816002|FG001|COMPLETED|Period 2, One Week of Wear||8
8766011|NCT01250054|9816001|FG000|NOT COMPLETED|Period 2, One Week of Wear||1
8766012|NCT01250054|9816002|FG001|NOT COMPLETED|Period 2, One Week of Wear||0
8766013|NCT01250119|9816008|FG000|STARTED|Diagnostic Phase||688
8766014|NCT01250119|9816009|FG001|STARTED|Diagnostic Phase||0
8766015|NCT01250119|9816008|FG000|COMPLETED|Diagnostic Phase|Completed refers to participants with both positive and negative EGFR mutation test result.|575
8766016|NCT01250119|9816009|FG001|COMPLETED|Diagnostic Phase||0
8766017|NCT01250119|9816008|FG000|NOT COMPLETED|Diagnostic Phase||113
8766018|NCT01250119|9816009|FG001|NOT COMPLETED|Diagnostic Phase||0
8766019|NCT01250119|9816008|FG000|STARTED|Treatment Phase||0
8766020|NCT01250119|9816009|FG001|STARTED|Treatment Phase|Out of 52 participants with positive EGFR mutation test result, only 41 participants were treated.|41
8766021|NCT01250119|9816008|FG000|COMPLETED|Treatment Phase||0
8766022|NCT01250119|9816009|FG001|COMPLETED|Treatment Phase||0
8766023|NCT01250119|9816008|FG000|NOT COMPLETED|Treatment Phase||0
8766024|NCT01250119|9816009|FG001|NOT COMPLETED|Treatment Phase||41
8766025|NCT01250145|9816018|FG000|STARTED|Overall Study||41
9027111|NCT03185065|10089592|FG003|NOT COMPLETED|Washout (2 Weeks)||1
8766026|NCT01250145|9816019|FG001|STARTED|Overall Study||210
8766027|NCT01250145|9816018|FG000|COMPLETED|Overall Study||39
8766028|NCT01250145|9816019|FG001|COMPLETED|Overall Study||205
8766029|NCT01250145|9816018|FG000|NOT COMPLETED|Overall Study||2
8766030|NCT01250145|9816019|FG001|NOT COMPLETED|Overall Study||5
8766031|NCT01250171|9816042|FG000|STARTED|Overall Study||26
8766032|NCT01250171|9816043|FG001|STARTED|Overall Study||22
8766033|NCT01250171|9816044|FG002|STARTED|Overall Study||24
8766034|NCT01250171|9816042|FG000|COMPLETED|Overall Study||25
8766035|NCT01250171|9816043|FG001|COMPLETED|Overall Study||22
8766036|NCT01250171|9816044|FG002|COMPLETED|Overall Study||24
8766037|NCT01250171|9816042|FG000|NOT COMPLETED|Overall Study||1
8766038|NCT01250171|9816043|FG001|NOT COMPLETED|Overall Study||0
8766039|NCT01250171|9816044|FG002|NOT COMPLETED|Overall Study||0
8766040|NCT01250184|9816055|FG000|STARTED|Overall Study||43
8766041|NCT01250184|9816056|FG001|STARTED|Overall Study||41
8766042|NCT01250184|9816057|FG002|STARTED|Overall Study||43
8766043|NCT01250184|9816055|FG000|COMPLETED|Overall Study||43
8766044|NCT01250184|9816056|FG001|COMPLETED|Overall Study||41
8766045|NCT01250184|9816057|FG002|COMPLETED|Overall Study||43
8766046|NCT01250184|9816055|FG000|NOT COMPLETED|Overall Study||0
8766047|NCT01250184|9816056|FG001|NOT COMPLETED|Overall Study||0
8766048|NCT01250184|9816057|FG002|NOT COMPLETED|Overall Study||0
8766049|NCT01250210|9816068|FG000|STARTED|Overall Study||45
8766050|NCT01250210|9816069|FG001|STARTED|Overall Study||45
8766051|NCT01250210|9816070|FG002|STARTED|Overall Study||33
8766052|NCT01250210|9816068|FG000|COMPLETED|Overall Study||41
8766053|NCT01250210|9816069|FG001|COMPLETED|Overall Study||41
8766054|NCT01250210|9816070|FG002|COMPLETED|Overall Study||25
8766055|NCT01250210|9816068|FG000|NOT COMPLETED|Overall Study||4
8766056|NCT01250210|9816069|FG001|NOT COMPLETED|Overall Study||4
8766057|NCT01250210|9816070|FG002|NOT COMPLETED|Overall Study||8
8766058|NCT01250379|9816080|FG000|STARTED|Overall Study||247
8766059|NCT01250379|9816081|FG001|STARTED|Overall Study||247
8766060|NCT01250379|9816080|FG000|COMPLETED|Overall Study|Participants under study follow-up as of Data Cutoff 30 April 2015 were considered as completers.|45
8766061|NCT01250379|9816081|FG001|COMPLETED|Overall Study|Participants under study follow-up as of Data Cutoff 30 April 2015 were considered as completers.|54
8766062|NCT01250379|9816080|FG000|NOT COMPLETED|Overall Study||202
8766063|NCT01250379|9816081|FG001|NOT COMPLETED|Overall Study||193
8766064|NCT01250418|9816089|FG000|STARTED|Overall Study||9
8766065|NCT01250418|9816090|FG001|STARTED|Overall Study||16
8766066|NCT01250418|9816089|FG000|COMPLETED|Overall Study||8
8766067|NCT01250418|9816090|FG001|COMPLETED|Overall Study||15
8766068|NCT01250418|9816089|FG000|NOT COMPLETED|Overall Study||1
8766069|NCT01250418|9816090|FG001|NOT COMPLETED|Overall Study||1
8766070|NCT01250509|9816098|FG000|STARTED|Overall Study||24
8766071|NCT01250509|9816099|FG001|STARTED|Overall Study||23
8766072|NCT01250509|9816098|FG000|COMPLETED|Overall Study||19
8766073|NCT01250509|9816099|FG001|COMPLETED|Overall Study||21
8766074|NCT01250509|9816098|FG000|NOT COMPLETED|Overall Study||5
8766075|NCT01250509|9816099|FG001|NOT COMPLETED|Overall Study||2
8766076|NCT01250717|9816107|FG000|STARTED|Overall Study||28
8766077|NCT01250717|9816107|FG000|COMPLETED|Overall Study||28
8766078|NCT01250717|9816107|FG000|NOT COMPLETED|Overall Study||0
8766079|NCT01250730|9816114|FG000|STARTED|Overall Study||6
8766080|NCT01250730|9816115|FG001|STARTED|Overall Study||6
8766081|NCT01250730|9816116|FG002|STARTED|Overall Study||6
8766082|NCT01250730|9816114|FG000|COMPLETED|Overall Study||6
8766083|NCT01250730|9816115|FG001|COMPLETED|Overall Study||6
8766084|NCT01250730|9816116|FG002|COMPLETED|Overall Study||6
8766085|NCT01250730|9816114|FG000|NOT COMPLETED|Overall Study||0
8766086|NCT01250730|9816115|FG001|NOT COMPLETED|Overall Study||0
8766087|NCT01250730|9816116|FG002|NOT COMPLETED|Overall Study||0
8766088|NCT01250756|9816126|FG000|STARTED|Infant Series||161
8766089|NCT01250756|9816127|FG001|STARTED|Infant Series||160
8766090|NCT01250756|9816126|FG000|Vaccinated Dose 1|Infant Series||159
8766091|NCT01250756|9816127|FG001|Vaccinated Dose 1|Infant Series||158
8766092|NCT01250756|9816126|FG000|Vaccinated Dose 2|Infant Series||147
8766093|NCT01250756|9816127|FG001|Vaccinated Dose 2|Infant Series||157
8766094|NCT01250756|9816126|FG000|Vaccinated Dose 3|Infant Series||133
8766095|NCT01250756|9816127|FG001|Vaccinated Dose 3|Infant Series||155
8766096|NCT01250756|9816126|FG000|COMPLETED|Infant Series||133
8766097|NCT01250756|9816127|FG001|COMPLETED|Infant Series||153
8766098|NCT01250756|9816126|FG000|NOT COMPLETED|Infant Series||28
8766099|NCT01250756|9816127|FG001|NOT COMPLETED|Infant Series||7
8766100|NCT01250756|9816126|FG000|STARTED|After Infant Series||133
8766101|NCT01250756|9816127|FG001|STARTED|After Infant Series||153
8766102|NCT01250756|9816126|FG000|COMPLETED|After Infant Series||122
8766103|NCT01250756|9816127|FG001|COMPLETED|After Infant Series||149
8766104|NCT01250756|9816126|FG000|NOT COMPLETED|After Infant Series||11
8766105|NCT01250756|9816127|FG001|NOT COMPLETED|After Infant Series||4
8766106|NCT01250756|9816126|FG000|STARTED|Toddler Dose||122
8766107|NCT01250756|9816127|FG001|STARTED|Toddler Dose||149
8766108|NCT01250756|9816126|FG000|COMPLETED|Toddler Dose||122
8766109|NCT01250756|9816127|FG001|COMPLETED|Toddler Dose||148
8766110|NCT01250756|9816126|FG000|NOT COMPLETED|Toddler Dose||0
8766111|NCT01250756|9816127|FG001|NOT COMPLETED|Toddler Dose||1
8766112|NCT01250756|9816126|FG000|STARTED|After Toddler Dose||0
8766113|NCT01250756|9816127|FG001|STARTED|After Toddler Dose||148
8766114|NCT01250756|9816126|FG000|COMPLETED|After Toddler Dose||0
8766115|NCT01250756|9816127|FG001|COMPLETED|After Toddler Dose||147
8766116|NCT01250756|9816126|FG000|NOT COMPLETED|After Toddler Dose||0
8766117|NCT01250756|9816127|FG001|NOT COMPLETED|After Toddler Dose||1
8766118|NCT01250769|9816143|FG000|STARTED|Overall Study||11
8766119|NCT01250769|9816144|FG001|STARTED|Overall Study||73
8766120|NCT01250769|9816145|FG002|STARTED|Overall Study||75
8766121|NCT01250769|9816146|FG003|STARTED|Overall Study||11
8766122|NCT01250769|9816143|FG000|Day 14|Overall Study||11
8766123|NCT01250769|9816144|FG001|Day 14|Overall Study||72
8766124|NCT01250769|9816145|FG002|Day 14|Overall Study||74
8766125|NCT01250769|9816146|FG003|Day 14|Overall Study||11
8766126|NCT01250769|9816143|FG000|COMPLETED|Overall Study||11
8766127|NCT01250769|9816144|FG001|COMPLETED|Overall Study||72
8766128|NCT01250769|9816145|FG002|COMPLETED|Overall Study||73
8766129|NCT01250769|9816146|FG003|COMPLETED|Overall Study||11
8766130|NCT01250769|9816143|FG000|NOT COMPLETED|Overall Study||0
8766131|NCT01250769|9816144|FG001|NOT COMPLETED|Overall Study||1
8766132|NCT01250769|9816145|FG002|NOT COMPLETED|Overall Study||2
8766133|NCT01250769|9816146|FG003|NOT COMPLETED|Overall Study||0
8766134|NCT01250834|9816156|FG000|STARTED|Overall Study||27
8766135|NCT01250834|9816156|FG000|COMPLETED|Overall Study||27
8766136|NCT01250834|9816156|FG000|NOT COMPLETED|Overall Study||0
8766137|NCT01250873|9816163|FG000|STARTED|Period 1: LY2216684 (Days 1-3)||20
8766138|NCT01250873|9816163|FG000|COMPLETED|Period 1: LY2216684 (Days 1-3)||18
8766139|NCT01250873|9816163|FG000|NOT COMPLETED|Period 1: LY2216684 (Days 1-3)||2
8766140|NCT01250873|9816163|FG000|STARTED|Period 2: Sertraline (Day 4, 5-10)||18
8766141|NCT01250873|9816163|FG000|COMPLETED|Period 2: Sertraline (Day 4, 5-10)||18
8766142|NCT01250873|9816163|FG000|NOT COMPLETED|Period 2: Sertraline (Day 4, 5-10)||0
8766143|NCT01250873|9816163|FG000|STARTED|Period 3:LY2216684+Sertraline(Days11-13)||18
9027112|NCT03185065|10089589|FG000|STARTED|Period 2 (6 Weeks)||32
8766144|NCT01250873|9816163|FG000|COMPLETED|Period 3:LY2216684+Sertraline(Days11-13)||17
8766145|NCT01250873|9816163|FG000|NOT COMPLETED|Period 3:LY2216684+Sertraline(Days11-13)||1
8766146|NCT01250899|9816171|FG000|STARTED|Overall Study||40
8766147|NCT01250899|9816172|FG001|STARTED|Overall Study||82
8766148|NCT01250899|9816171|FG000|COMPLETED|Overall Study||40
8766149|NCT01250899|9816172|FG001|COMPLETED|Overall Study||82
8766150|NCT01250899|9816171|FG000|NOT COMPLETED|Overall Study||0
8766151|NCT01250899|9816172|FG001|NOT COMPLETED|Overall Study||0
8766152|NCT01250925|9816179|FG000|STARTED|Overall Study||31
8766153|NCT01250925|9816180|FG001|STARTED|Overall Study||31
8766154|NCT01250925|9816181|FG002|STARTED|Overall Study||32
8766155|NCT01250925|9816179|FG000|COMPLETED|Overall Study||26
8766156|NCT01250925|9816180|FG001|COMPLETED|Overall Study||28
8766157|NCT01250925|9816181|FG002|COMPLETED|Overall Study||30
8766158|NCT01250925|9816179|FG000|NOT COMPLETED|Overall Study||5
8766159|NCT01250925|9816180|FG001|NOT COMPLETED|Overall Study||3
8766160|NCT01250925|9816181|FG002|NOT COMPLETED|Overall Study||2
8766161|NCT01250977|9816191|FG000|STARTED|Overall Study||6
8766162|NCT01250977|9816192|FG001|STARTED|Overall Study||14
8766163|NCT01250977|9816191|FG000|COMPLETED|Overall Study||6
8766164|NCT01250977|9816192|FG001|COMPLETED|Overall Study||12
8766165|NCT01250977|9816191|FG000|NOT COMPLETED|Overall Study||0
8766166|NCT01250977|9816192|FG001|NOT COMPLETED|Overall Study||2
8766167|NCT01250990|9816200|FG000|STARTED|Overall Study||11
8766168|NCT01250990|9816201|FG001|STARTED|Overall Study||11
8766169|NCT01250990|9816200|FG000|COMPLETED|Overall Study||7
8766170|NCT01250990|9816201|FG001|COMPLETED|Overall Study||9
8766171|NCT01250990|9816200|FG000|NOT COMPLETED|Overall Study||4
8766172|NCT01250990|9816201|FG001|NOT COMPLETED|Overall Study||2
8766173|NCT01251042|9816209|FG000|STARTED|Overall Study||26
8766174|NCT01251042|9816210|FG001|STARTED|Overall Study||23
8766175|NCT01251042|9816209|FG000|COMPLETED|Overall Study||26
8766176|NCT01251042|9816210|FG001|COMPLETED|Overall Study||23
8766177|NCT01251042|9816209|FG000|NOT COMPLETED|Overall Study||0
8766178|NCT01251042|9816210|FG001|NOT COMPLETED|Overall Study||0
8766179|NCT01251146|9816218|FG000|STARTED|Overall Study||86
8766180|NCT01251146|9816219|FG001|STARTED|Overall Study||91
8766181|NCT01251146|9816218|FG000|COMPLETED|Overall Study||83
8766182|NCT01251146|9816219|FG001|COMPLETED|Overall Study||81
8766183|NCT01251146|9816218|FG000|NOT COMPLETED|Overall Study||3
8766184|NCT01251146|9816219|FG001|NOT COMPLETED|Overall Study||10
8766185|NCT01251276|9816227|FG000|STARTED|Overall Study|Not all Base Study completers enrolled in the Challenge Dose Study|96
8766186|NCT01251276|9816228|FG001|STARTED|Overall Study|Not all Base Study completers enrolled in the Challenge Dose Study|108
8766187|NCT01251276|9816227|FG000|Vaccinated|Overall Study||96
8766188|NCT01251276|9816228|FG001|Vaccinated|Overall Study||108
8766189|NCT01251276|9816227|FG000|COMPLETED|Overall Study||95
8766190|NCT01251276|9816228|FG001|COMPLETED|Overall Study||107
8766191|NCT01251276|9816227|FG000|NOT COMPLETED|Overall Study||1
8766192|NCT01251276|9816228|FG001|NOT COMPLETED|Overall Study||1
8766193|NCT01251315|9816240|FG000|STARTED|Overall Study||4
8766194|NCT01251315|9816241|FG001|STARTED|Overall Study||4
8766195|NCT01251315|9816242|FG002|STARTED|Overall Study||4
8766196|NCT01251315|9816243|FG003|STARTED|Overall Study||4
8766197|NCT01251315|9816244|FG004|STARTED|Overall Study||4
8766198|NCT01251315|9816245|FG005|STARTED|Overall Study||4
8766199|NCT01251315|9816240|FG000|COMPLETED|Overall Study||4
8766200|NCT01251315|9816241|FG001|COMPLETED|Overall Study||4
8766201|NCT01251315|9816242|FG002|COMPLETED|Overall Study||4
8766202|NCT01251315|9816243|FG003|COMPLETED|Overall Study||4
8766203|NCT01251315|9816244|FG004|COMPLETED|Overall Study||4
8766204|NCT01251315|9816245|FG005|COMPLETED|Overall Study||4
8766205|NCT01251315|9816240|FG000|NOT COMPLETED|Overall Study||0
8766206|NCT01251315|9816241|FG001|NOT COMPLETED|Overall Study||0
8766207|NCT01251315|9816242|FG002|NOT COMPLETED|Overall Study||0
8766208|NCT01251315|9816243|FG003|NOT COMPLETED|Overall Study||0
8766209|NCT01251315|9816244|FG004|NOT COMPLETED|Overall Study||0
8766210|NCT01251315|9816245|FG005|NOT COMPLETED|Overall Study||0
8766211|NCT01251354|9816263|FG000|STARTED|Overall Study||6
8766212|NCT01251354|9816263|FG000|COMPLETED|Overall Study||0
8766213|NCT01251354|9816263|FG000|NOT COMPLETED|Overall Study||6
8766214|NCT01251367|9816267|FG000|STARTED|Overall Study||345
8766215|NCT01251367|9816267|FG000|Cycle 1|Overall Study||345
8766216|NCT01251367|9816267|FG000|Cycle 2|Overall Study||297
8766217|NCT01251367|9816267|FG000|Cycle 3|Overall Study||224
8766218|NCT01251367|9816267|FG000|Cycle 4|Overall Study||139
8766219|NCT01251367|9816267|FG000|COMPLETED|Overall Study||269
8766220|NCT01251367|9816267|FG000|NOT COMPLETED|Overall Study||76
8766221|NCT01251380|9816271|FG000|STARTED|Overall Study|Safety population.|216
8766222|NCT01251380|9816271|FG000|Cycle 1|Overall Study||207
8766223|NCT01251380|9816271|FG000|Cycle 2|Overall Study||175
8766224|NCT01251380|9816271|FG000|Cycle 3|Overall Study||86
8766225|NCT01251380|9816271|FG000|Cycle 4|Overall Study||11
8766226|NCT01251380|9816271|FG000|COMPLETED|Overall Study||194
8766227|NCT01251380|9816271|FG000|NOT COMPLETED|Overall Study||22
8766228|NCT01251393|9816282|FG000|STARTED|Overall Study||56
8766229|NCT01251393|9816283|FG001|STARTED|Overall Study||55
8766230|NCT01251393|9816282|FG000|COMPLETED|Overall Study||24
8766231|NCT01251393|9816283|FG001|COMPLETED|Overall Study||11
8766232|NCT01251393|9816282|FG000|NOT COMPLETED|Overall Study||32
8766233|NCT01251393|9816283|FG001|NOT COMPLETED|Overall Study||44
8766234|NCT01251536|9816292|FG000|STARTED|Overall Study||8
8766235|NCT01251536|9816293|FG001|STARTED|Overall Study||93
8766236|NCT01251536|9816294|FG002|STARTED|Overall Study||7
8766237|NCT01251536|9816292|FG000|COMPLETED|Overall Study||8
8766238|NCT01251536|9816293|FG001|COMPLETED|Overall Study||93
8766239|NCT01251536|9816294|FG002|COMPLETED|Overall Study||7
8766240|NCT01251536|9816292|FG000|NOT COMPLETED|Overall Study||0
8766241|NCT01251536|9816293|FG001|NOT COMPLETED|Overall Study||0
8766242|NCT01251536|9816294|FG002|NOT COMPLETED|Overall Study||0
8766243|NCT01251575|9816304|FG000|STARTED|Overall Study||77
8766244|NCT01251575|9816304|FG000|COMPLETED|Overall Study||76
8766245|NCT01251575|9816304|FG000|NOT COMPLETED|Overall Study||1
8766246|NCT01251588|9816312|FG000|STARTED|Overall Study||65
8766247|NCT01251588|9816313|FG001|STARTED|Overall Study||63
8766248|NCT01251588|9816312|FG000|COMPLETED|Overall Study||65
8766249|NCT01251588|9816313|FG001|COMPLETED|Overall Study||59
8766250|NCT01251588|9816312|FG000|NOT COMPLETED|Overall Study||0
8766251|NCT01251588|9816313|FG001|NOT COMPLETED|Overall Study||4
8766252|NCT01251614|9816324|FG000|STARTED|Overall Study||37
8766253|NCT01251614|9816325|FG001|STARTED|Overall Study||39
8766254|NCT01251614|9816326|FG002|STARTED|Overall Study||38
8766255|NCT01251614|9816324|FG000|Entered Period B|Overall Study|Only participants who were responders at Week 16 (Period A) entered the Treatment Withdrawal Phase|13
8766256|NCT01251614|9816325|FG001|Entered Period B|Overall Study|Only participants who were responders at Week 16 (Period A) entered the Treatment Withdrawal Phase|18
8766257|NCT01251614|9816326|FG002|Entered Period B|Overall Study|Only participants who were responders at Week 16 (Period A) entered the Treatment Withdrawal Phase|23
8766258|NCT01251614|9816324|FG000|Entered Period C|Overall Study|Only participants who experienced loss of disease control in Period B entered the Re-Treatment Phase|8
8766259|NCT01251614|9816325|FG001|Entered Period C|Overall Study|Only participants who experienced loss of disease control in Period B entered the Re-Treatment Phase|11
8766260|NCT01251614|9816326|FG002|Entered Period C|Overall Study|Only participants who experienced loss of disease control in Period B entered the Re-Treatment Phase|19
8766261|NCT01251614|9816324|FG000|Entered Period D|Overall Study|Long-Term Follow-Up Phase (52 Weeks)|36
8766262|NCT01251614|9816325|FG001|Entered Period D|Overall Study|Long-Term Follow-Up Phase (52 Weeks)|36
8766263|NCT01251614|9816326|FG002|Entered Period D|Overall Study|Long-Term Follow-Up Phase (52 Weeks)|36
8766264|NCT01251614|9816324|FG000|COMPLETED|Overall Study||34
8766265|NCT01251614|9816325|FG001|COMPLETED|Overall Study||26
8766266|NCT01251614|9816326|FG002|COMPLETED|Overall Study||30
8766267|NCT01251614|9816324|FG000|NOT COMPLETED|Overall Study||3
8766268|NCT01251614|9816325|FG001|NOT COMPLETED|Overall Study||13
8766269|NCT01251614|9816326|FG002|NOT COMPLETED|Overall Study||8
8766270|NCT01251653|9816353|FG000|STARTED|Overall Study||3
8766271|NCT01251653|9816354|FG001|STARTED|Overall Study||8
8766272|NCT01251653|9816355|FG002|STARTED|Overall Study||20
8766273|NCT01251653|9816356|FG003|STARTED|Overall Study||6
8766274|NCT01251653|9816357|FG004|STARTED|Overall Study||2
8766275|NCT01251653|9816358|FG005|STARTED|Overall Study||18
8766276|NCT01251653|9816359|FG006|STARTED|Overall Study||18
8766277|NCT01251653|9816360|FG007|STARTED|Overall Study||12
8766278|NCT01251653|9816361|FG008|STARTED|Overall Study||6
8766279|NCT01251653|9816353|FG000|COMPLETED|Overall Study||0
8766280|NCT01251653|9816354|FG001|COMPLETED|Overall Study||0
8766281|NCT01251653|9816355|FG002|COMPLETED|Overall Study||0
8766282|NCT01251653|9816356|FG003|COMPLETED|Overall Study||0
8766283|NCT01251653|9816357|FG004|COMPLETED|Overall Study||0
8766284|NCT01251653|9816358|FG005|COMPLETED|Overall Study||0
8766285|NCT01251653|9816359|FG006|COMPLETED|Overall Study||0
8766286|NCT01251653|9816360|FG007|COMPLETED|Overall Study||0
8766287|NCT01251653|9816361|FG008|COMPLETED|Overall Study||0
8766288|NCT01251653|9816353|FG000|NOT COMPLETED|Overall Study||3
8766289|NCT01251653|9816354|FG001|NOT COMPLETED|Overall Study||8
8766290|NCT01251653|9816355|FG002|NOT COMPLETED|Overall Study||20
8766291|NCT01251653|9816356|FG003|NOT COMPLETED|Overall Study||6
8766292|NCT01251653|9816357|FG004|NOT COMPLETED|Overall Study||2
8766293|NCT01251653|9816358|FG005|NOT COMPLETED|Overall Study||18
8766294|NCT01251653|9816359|FG006|NOT COMPLETED|Overall Study||18
8766295|NCT01251653|9816360|FG007|NOT COMPLETED|Overall Study||12
8766296|NCT01251653|9816361|FG008|NOT COMPLETED|Overall Study||6
8766297|NCT01251744|9816399|FG000|STARTED|Overall Study||77
8766298|NCT01251744|9816400|FG001|STARTED|Overall Study||78
8766299|NCT01251744|9816399|FG000|COMPLETED|Overall Study||76
8766300|NCT01251744|9816400|FG001|COMPLETED|Overall Study||78
8766301|NCT01251744|9816399|FG000|NOT COMPLETED|Overall Study||1
8766302|NCT01251744|9816400|FG001|NOT COMPLETED|Overall Study||0
8766303|NCT01251757|9816416|FG000|STARTED|Overall Study|Separate analyses were done for statin users and ACEI/ARB users. This is the combined N.|7255
8766304|NCT01251757|9816417|FG001|STARTED|Overall Study|Separate analyses were done for statin users and ACEI/ARB users. This is the combined N.|7247
8766305|NCT01251757|9816418|FG002|STARTED|Overall Study|Separate analyses were done for statin users and ACEI/ARB users. This is the combined N.|7250
8766306|NCT01251757|9816416|FG000|COMPLETED|Overall Study|mean (SD) duration of follow-up was 9.7 (2.3) mos, but we computed an adherence score for everyone.|7255
8766307|NCT01251757|9816417|FG001|COMPLETED|Overall Study|mean (SD) duration of follow-up was 9.6 (2.4) mos, but we computed an adherence score for everyone.|7247
8766308|NCT01251757|9816418|FG002|COMPLETED|Overall Study|mean (SD) duration of follow-up was 9.6 (2.5) mos, but we computed an adherence score for everyone.|7250
8766309|NCT01251757|9816416|FG000|NOT COMPLETED|Overall Study||0
8766310|NCT01251757|9816417|FG001|NOT COMPLETED|Overall Study||0
8766311|NCT01251757|9816418|FG002|NOT COMPLETED|Overall Study||0
8766312|NCT01251770|9816432|FG000|STARTED|Overall Study||42
8766313|NCT01251770|9816433|FG001|STARTED|Overall Study||36
8766314|NCT01251770|9816432|FG000|COMPLETED|Overall Study||29
8766315|NCT01251770|9816433|FG001|COMPLETED|Overall Study||29
8766316|NCT01251770|9816432|FG000|NOT COMPLETED|Overall Study||13
8766317|NCT01251770|9816433|FG001|NOT COMPLETED|Overall Study||7
8766318|NCT01251887|9816442|FG000|STARTED|Overall Study||18
8766319|NCT01251887|9816443|FG001|STARTED|Overall Study||29
8766320|NCT01251887|9816444|FG002|STARTED|Overall Study||18
8766321|NCT01251887|9816442|FG000|COMPLETED|Overall Study||17
8766322|NCT01251887|9816443|FG001|COMPLETED|Overall Study||26
8766323|NCT01251887|9816444|FG002|COMPLETED|Overall Study||16
8766324|NCT01251887|9816442|FG000|NOT COMPLETED|Overall Study||1
8766325|NCT01251887|9816443|FG001|NOT COMPLETED|Overall Study||3
8766326|NCT01251887|9816444|FG002|NOT COMPLETED|Overall Study||2
8766327|NCT01251965|9816455|FG000|STARTED|Overall Study||4
8766328|NCT01251965|9816456|FG001|STARTED|Overall Study||5
8766329|NCT01251965|9816457|FG002|STARTED|Overall Study||18
8766330|NCT01251965|9816455|FG000|COMPLETED|Overall Study||3
8766331|NCT01251965|9816456|FG001|COMPLETED|Overall Study||3
8766332|NCT01251965|9816457|FG002|COMPLETED|Overall Study||7
8766333|NCT01251965|9816455|FG000|NOT COMPLETED|Overall Study||1
8766334|NCT01251965|9816456|FG001|NOT COMPLETED|Overall Study||2
8766335|NCT01251965|9816457|FG002|NOT COMPLETED|Overall Study||11
8766336|NCT01251978|9816468|FG000|STARTED|Overall Study||5
8766337|NCT01251978|9816469|FG001|STARTED|Overall Study||3
8766338|NCT01251978|9816468|FG000|COMPLETED|Overall Study||5
8766339|NCT01251978|9816469|FG001|COMPLETED|Overall Study||3
8766340|NCT01251978|9816468|FG000|NOT COMPLETED|Overall Study||0
8766341|NCT01251978|9816469|FG001|NOT COMPLETED|Overall Study||0
8766342|NCT01252095|9816477|FG000|STARTED|Overall Study||3
8766343|NCT01252095|9816478|FG001|STARTED|Overall Study||1
8766344|NCT01252095|9816477|FG000|COMPLETED|Overall Study||2
8766345|NCT01252095|9816478|FG001|COMPLETED|Overall Study||1
8766346|NCT01252095|9816477|FG000|NOT COMPLETED|Overall Study||1
8766347|NCT01252095|9816478|FG001|NOT COMPLETED|Overall Study||0
8766348|NCT01252134|9816484|FG000|STARTED|Period 1, 8 Hours||3
8766349|NCT01252134|9816485|FG001|STARTED|Period 1, 8 Hours||4
8766350|NCT01252134|9816486|FG002|STARTED|Period 1, 8 Hours||3
8766351|NCT01252134|9816487|FG003|STARTED|Period 1, 8 Hours||5
8766352|NCT01252134|9816488|FG004|STARTED|Period 1, 8 Hours||3
8766353|NCT01252134|9816489|FG005|STARTED|Period 1, 8 Hours||4
8766354|NCT01252134|9816484|FG000|COMPLETED|Period 1, 8 Hours||3
8766355|NCT01252134|9816485|FG001|COMPLETED|Period 1, 8 Hours||3
8766356|NCT01252134|9816486|FG002|COMPLETED|Period 1, 8 Hours||2
8766357|NCT01252134|9816487|FG003|COMPLETED|Period 1, 8 Hours||5
8766358|NCT01252134|9816488|FG004|COMPLETED|Period 1, 8 Hours||3
8766359|NCT01252134|9816489|FG005|COMPLETED|Period 1, 8 Hours||4
8766360|NCT01252134|9816484|FG000|NOT COMPLETED|Period 1, 8 Hours||0
8766361|NCT01252134|9816485|FG001|NOT COMPLETED|Period 1, 8 Hours||1
8766362|NCT01252134|9816486|FG002|NOT COMPLETED|Period 1, 8 Hours||1
8766363|NCT01252134|9816487|FG003|NOT COMPLETED|Period 1, 8 Hours||0
8766364|NCT01252134|9816488|FG004|NOT COMPLETED|Period 1, 8 Hours||0
8766365|NCT01252134|9816489|FG005|NOT COMPLETED|Period 1, 8 Hours||0
8766366|NCT01252134|9816484|FG000|STARTED|Period 2, 8 Hours||3
8766367|NCT01252134|9816485|FG001|STARTED|Period 2, 8 Hours||3
8766368|NCT01252134|9816486|FG002|STARTED|Period 2, 8 Hours||2
8766369|NCT01252134|9816487|FG003|STARTED|Period 2, 8 Hours||5
8766370|NCT01252134|9816488|FG004|STARTED|Period 2, 8 Hours||3
8766371|NCT01252134|9816489|FG005|STARTED|Period 2, 8 Hours||4
8766372|NCT01252134|9816484|FG000|COMPLETED|Period 2, 8 Hours||3
8766373|NCT01252134|9816485|FG001|COMPLETED|Period 2, 8 Hours||3
8766374|NCT01252134|9816486|FG002|COMPLETED|Period 2, 8 Hours||2
8766375|NCT01252134|9816487|FG003|COMPLETED|Period 2, 8 Hours||5
8766376|NCT01252134|9816488|FG004|COMPLETED|Period 2, 8 Hours||3
8766377|NCT01252134|9816489|FG005|COMPLETED|Period 2, 8 Hours||4
8766378|NCT01252134|9816484|FG000|NOT COMPLETED|Period 2, 8 Hours||0
8766379|NCT01252134|9816485|FG001|NOT COMPLETED|Period 2, 8 Hours||0
8766380|NCT01252134|9816486|FG002|NOT COMPLETED|Period 2, 8 Hours||0
8766381|NCT01252134|9816487|FG003|NOT COMPLETED|Period 2, 8 Hours||0
8766382|NCT01252134|9816488|FG004|NOT COMPLETED|Period 2, 8 Hours||0
8766383|NCT01252134|9816489|FG005|NOT COMPLETED|Period 2, 8 Hours||0
8766384|NCT01252134|9816484|FG000|STARTED|Period 3, 8 Hours||3
8766385|NCT01252134|9816485|FG001|STARTED|Period 3, 8 Hours||3
8766386|NCT01252134|9816486|FG002|STARTED|Period 3, 8 Hours||2
8766387|NCT01252134|9816487|FG003|STARTED|Period 3, 8 Hours||5
8766388|NCT01252134|9816488|FG004|STARTED|Period 3, 8 Hours||3
8766389|NCT01252134|9816489|FG005|STARTED|Period 3, 8 Hours||4
8766390|NCT01252134|9816484|FG000|COMPLETED|Period 3, 8 Hours||3
8766391|NCT01252134|9816485|FG001|COMPLETED|Period 3, 8 Hours||3
8766392|NCT01252134|9816486|FG002|COMPLETED|Period 3, 8 Hours||2
8766393|NCT01252134|9816487|FG003|COMPLETED|Period 3, 8 Hours||5
8766394|NCT01252134|9816488|FG004|COMPLETED|Period 3, 8 Hours||3
8766395|NCT01252134|9816489|FG005|COMPLETED|Period 3, 8 Hours||4
8766396|NCT01252134|9816484|FG000|NOT COMPLETED|Period 3, 8 Hours||0
8766397|NCT01252134|9816485|FG001|NOT COMPLETED|Period 3, 8 Hours||0
8766398|NCT01252134|9816486|FG002|NOT COMPLETED|Period 3, 8 Hours||0
8766399|NCT01252134|9816487|FG003|NOT COMPLETED|Period 3, 8 Hours||0
8766400|NCT01252134|9816488|FG004|NOT COMPLETED|Period 3, 8 Hours||0
8766401|NCT01252134|9816489|FG005|NOT COMPLETED|Period 3, 8 Hours||0
8766402|NCT01252147|9816497|FG000|STARTED|Overall Study||68
8766403|NCT01252147|9816497|FG000|COMPLETED|Overall Study||68
8766404|NCT01252147|9816497|FG000|NOT COMPLETED|Overall Study||0
8766405|NCT01252186|9816504|FG000|STARTED|Overall Study||87
8766406|NCT01252186|9816505|FG001|STARTED|Overall Study||91
8766407|NCT01252186|9816506|FG002|STARTED|Overall Study||87
8766408|NCT01252186|9816504|FG000|Received Study Drug|Overall Study||83
8766409|NCT01252186|9816505|FG001|Received Study Drug|Overall Study||89
8766410|NCT01252186|9816506|FG002|Received Study Drug|Overall Study||80
8766411|NCT01252186|9816504|FG000|COMPLETED|Overall Study||57
8766412|NCT01252186|9816505|FG001|COMPLETED|Overall Study||59
8766413|NCT01252186|9816506|FG002|COMPLETED|Overall Study||53
8766414|NCT01252186|9816504|FG000|NOT COMPLETED|Overall Study||30
8766415|NCT01252186|9816505|FG001|NOT COMPLETED|Overall Study||32
8766416|NCT01252186|9816506|FG002|NOT COMPLETED|Overall Study||34
8766417|NCT01252238|9816517|FG000|STARTED|Overall Study||8
8766418|NCT01252238|9816518|FG001|STARTED|Overall Study||8
8766419|NCT01252238|9816519|FG002|STARTED|Overall Study||8
8766420|NCT01252238|9816517|FG000|COMPLETED|Overall Study|sponsor terminated study|4
8766421|NCT01252238|9816518|FG001|COMPLETED|Overall Study|sponsor terminated study|4
8766422|NCT01252238|9816519|FG002|COMPLETED|Overall Study|sponsor terminated study|4
8766423|NCT01252238|9816517|FG000|NOT COMPLETED|Overall Study||4
8766424|NCT01252238|9816518|FG001|NOT COMPLETED|Overall Study||4
8766425|NCT01252238|9816519|FG002|NOT COMPLETED|Overall Study||4
8766426|NCT01252251|9816530|FG000|STARTED|Overall Study||14
8766427|NCT01252251|9816530|FG000|COMPLETED|Overall Study||13
8766428|NCT01252251|9816530|FG000|NOT COMPLETED|Overall Study||1
8766429|NCT01252277|9816534|FG000|STARTED|Overall Study||36
8766430|NCT01252277|9816534|FG000|COMPLETED|Overall Study||34
8766431|NCT01252277|9816534|FG000|NOT COMPLETED|Overall Study||2
8766432|NCT01252290|9816539|FG000|STARTED|Overall Study||35
8766433|NCT01252290|9816539|FG000|COMPLETED|Overall Study||34
8766434|NCT01252290|9816539|FG000|NOT COMPLETED|Overall Study||1
8766435|NCT01252355|9816546|FG000|STARTED|Overall Study|Randomized.|177
8766436|NCT01252355|9816547|FG001|STARTED|Overall Study|Randomized.|178
8766437|NCT01252355|9816548|FG002|STARTED|Overall Study|Randomized.|179
8766438|NCT01252355|9816546|FG000|Treated|Overall Study||175
8766439|NCT01252355|9816547|FG001|Treated|Overall Study||178
8766440|NCT01252355|9816548|FG002|Treated|Overall Study|One participant received teriflunomide 7 mg.|179
8766441|NCT01252355|9816546|FG000|COMPLETED|Overall Study||0
8766442|NCT01252355|9816547|FG001|COMPLETED|Overall Study||0
8766443|NCT01252355|9816548|FG002|COMPLETED|Overall Study||0
8766444|NCT01252355|9816546|FG000|NOT COMPLETED|Overall Study||177
8766445|NCT01252355|9816547|FG001|NOT COMPLETED|Overall Study||178
8766446|NCT01252355|9816548|FG002|NOT COMPLETED|Overall Study||179
8766447|NCT01252563|9816556|FG000|STARTED|Overall Study||13775
8766448|NCT01252563|9816556|FG000|COMPLETED|Overall Study||13343
8766449|NCT01252563|9816556|FG000|NOT COMPLETED|Overall Study||432
8766450|NCT01252667|9816597|FG000|STARTED|Overall Study||3
8766451|NCT01252667|9816598|FG001|STARTED|Overall Study||3
8766452|NCT01252667|9816599|FG002|STARTED|Overall Study||3
8766453|NCT01252667|9816600|FG003|STARTED|Overall Study||0
8766454|NCT01252667|9816601|FG004|STARTED|Overall Study||0
8766455|NCT01252667|9816602|FG005|STARTED|Overall Study||35
8766456|NCT01252667|9816597|FG000|COMPLETED|Overall Study||3
8766457|NCT01252667|9816598|FG001|COMPLETED|Overall Study||3
8766458|NCT01252667|9816599|FG002|COMPLETED|Overall Study||3
8766459|NCT01252667|9816600|FG003|COMPLETED|Overall Study||0
8766460|NCT01252667|9816601|FG004|COMPLETED|Overall Study||0
8766461|NCT01252667|9816602|FG005|COMPLETED|Overall Study||34
8766462|NCT01252667|9816597|FG000|NOT COMPLETED|Overall Study||0
8766463|NCT01252667|9816598|FG001|NOT COMPLETED|Overall Study||0
8766464|NCT01252667|9816599|FG002|NOT COMPLETED|Overall Study||0
8766465|NCT01252667|9816600|FG003|NOT COMPLETED|Overall Study||0
8766466|NCT01252667|9816601|FG004|NOT COMPLETED|Overall Study||0
8766467|NCT01252667|9816602|FG005|NOT COMPLETED|Overall Study||1
8766468|NCT01252732|9816618|FG000|STARTED|Overall Study|Randomized|509
8766469|NCT01252732|9816619|FG001|STARTED|Overall Study|Randomized|510
8766470|NCT01252732|9816618|FG000|Modified Intent to Treat Population|Overall Study||503
8766471|NCT01252732|9816619|FG001|Modified Intent to Treat Population|Overall Study||502
8766472|NCT01252732|9816618|FG000|COMPLETED|Overall Study||455
8766473|NCT01252732|9816619|FG001|COMPLETED|Overall Study||446
8766474|NCT01252732|9816618|FG000|NOT COMPLETED|Overall Study||54
8766475|NCT01252732|9816619|FG001|NOT COMPLETED|Overall Study||64
8766476|NCT01252745|9816628|FG000|STARTED|Overall Study||8
8766477|NCT01252745|9816629|FG001|STARTED|Overall Study||7
8766478|NCT01252745|9816630|FG002|STARTED|Overall Study||7
8766479|NCT01252745|9816628|FG000|COMPLETED|Overall Study||8
8766480|NCT01252745|9816629|FG001|COMPLETED|Overall Study||7
8766481|NCT01252745|9816630|FG002|COMPLETED|Overall Study||7
8766482|NCT01252745|9816628|FG000|NOT COMPLETED|Overall Study||0
8766483|NCT01252745|9816629|FG001|NOT COMPLETED|Overall Study||0
8766484|NCT01252745|9816630|FG002|NOT COMPLETED|Overall Study||0
8766485|NCT01252810|9816643|FG000|STARTED|Overall Study||142
8766486|NCT01252810|9816644|FG001|STARTED|Overall Study||142
8766487|NCT01252810|9816643|FG000|COMPLETED|Overall Study||128
8766488|NCT01252810|9816644|FG001|COMPLETED|Overall Study||139
8766489|NCT01252810|9816643|FG000|NOT COMPLETED|Overall Study||14
8766490|NCT01252810|9816644|FG001|NOT COMPLETED|Overall Study||3
8766491|NCT01252940|9816652|FG000|STARTED|Main Study Phase||321
8766492|NCT01252940|9816653|FG001|STARTED|Main Study Phase||161
8766493|NCT01252940|9816652|FG000|Completed 24 Weeks|Main Study Phase||0
8766494|NCT01252940|9816653|FG001|Completed 24 Weeks|Main Study Phase|152 participants switched regimens at Week 24.|153
8766495|NCT01252940|9816652|FG000|COMPLETED|Main Study Phase||295
8766496|NCT01252940|9816653|FG001|COMPLETED|Main Study Phase|Discontinuations after switch: withdrawal by subject, 2; adverse event, 1; protocol violation, 1.|149
8766497|NCT01252940|9816652|FG000|NOT COMPLETED|Main Study Phase||26
8766498|NCT01252940|9816653|FG001|NOT COMPLETED|Main Study Phase||12
8808474|NCT01490632|9860709|FG008|NOT COMPLETED|Part C: Washout or Step-Down Period||0
8766499|NCT01252940|9816652|FG000|STARTED|Extension Phase|FTC/RPV/TDF group: 110 participants completing the main study continued in extension phase.|110
8766500|NCT01252940|9816653|FG001|STARTED|Extension Phase|SBR/Delayed Switch Group: 49 participants completing the main study continued in extension phase.|49
8766501|NCT01252940|9816652|FG000|COMPLETED|Extension Phase||100
8766502|NCT01252940|9816653|FG001|COMPLETED|Extension Phase||46
8766503|NCT01252940|9816652|FG000|NOT COMPLETED|Extension Phase||10
8766504|NCT01252940|9816653|FG001|NOT COMPLETED|Extension Phase||3
8766505|NCT01252966|9816662|FG000|STARTED|Overall Study||108
8766506|NCT01252966|9816663|FG001|STARTED|Overall Study||105
8766507|NCT01252966|9816662|FG000|COMPLETED|Overall Study||85
8766508|NCT01252966|9816663|FG001|COMPLETED|Overall Study||92
8766509|NCT01252966|9816662|FG000|NOT COMPLETED|Overall Study||23
8766510|NCT01252966|9816663|FG001|NOT COMPLETED|Overall Study||13
8766511|NCT01253018|9816673|FG000|STARTED|Overall Study||22
8766512|NCT01253018|9816674|FG001|STARTED|Overall Study||23
9027113|NCT03185065|10089590|FG001|STARTED|Period 2 (6 Weeks)||31
9027114|NCT03185065|10089591|FG002|STARTED|Period 2 (6 Weeks)||32
9027115|NCT03185065|10089592|FG003|STARTED|Period 2 (6 Weeks)||35
9027116|NCT03185065|10089589|FG000|COMPLETED|Period 2 (6 Weeks)||32
9027117|NCT03185065|10089590|FG001|COMPLETED|Period 2 (6 Weeks)||31
9027118|NCT03185065|10089591|FG002|COMPLETED|Period 2 (6 Weeks)||32
9027119|NCT03185065|10089592|FG003|COMPLETED|Period 2 (6 Weeks)||34
9027120|NCT03185065|10089589|FG000|NOT COMPLETED|Period 2 (6 Weeks)||0
9027121|NCT03185065|10089590|FG001|NOT COMPLETED|Period 2 (6 Weeks)||0
9027122|NCT03185065|10089591|FG002|NOT COMPLETED|Period 2 (6 Weeks)||0
9027123|NCT03185065|10089592|FG003|NOT COMPLETED|Period 2 (6 Weeks)||1
9027124|NCT03185065|10089589|FG000|STARTED|Washout (2 Weeks)||32
9027125|NCT03185065|10089590|FG001|STARTED|Washout (2 Weeks)||31
9027126|NCT03185065|10089591|FG002|STARTED|Washout (2 Weeks)||32
9027127|NCT03185065|10089592|FG003|STARTED|Washout (2 Weeks)||34
9027128|NCT03185065|10089589|FG000|COMPLETED|Washout (2 Weeks)||31
9027129|NCT03185065|10089590|FG001|COMPLETED|Washout (2 Weeks)||29
9027130|NCT03185065|10089591|FG002|COMPLETED|Washout (2 Weeks)||31
9027131|NCT03185065|10089592|FG003|COMPLETED|Washout (2 Weeks)||32
9027132|NCT03185065|10089589|FG000|NOT COMPLETED|Washout (2 Weeks)||1
9027133|NCT03185065|10089590|FG001|NOT COMPLETED|Washout (2 Weeks)||2
9027134|NCT03185065|10089591|FG002|NOT COMPLETED|Washout (2 Weeks)||1
9027135|NCT03185065|10089592|FG003|NOT COMPLETED|Washout (2 Weeks)||2
9027136|NCT03185065|10089589|FG000|STARTED|Period 3 (6 Weeks)||31
9027137|NCT03185065|10089590|FG001|STARTED|Period 3 (6 Weeks)||29
9027138|NCT03185065|10089591|FG002|STARTED|Period 3 (6 Weeks)||31
9027139|NCT03185065|10089592|FG003|STARTED|Period 3 (6 Weeks)||32
9027140|NCT03185065|10089589|FG000|COMPLETED|Period 3 (6 Weeks)||31
9027141|NCT03185065|10089590|FG001|COMPLETED|Period 3 (6 Weeks)||29
9027142|NCT03185065|10089591|FG002|COMPLETED|Period 3 (6 Weeks)||29
9027143|NCT03185065|10089592|FG003|COMPLETED|Period 3 (6 Weeks)||32
9027144|NCT03185065|10089589|FG000|NOT COMPLETED|Period 3 (6 Weeks)||0
9027145|NCT03185065|10089590|FG001|NOT COMPLETED|Period 3 (6 Weeks)||0
9027146|NCT03185065|10089591|FG002|NOT COMPLETED|Period 3 (6 Weeks)||2
9027147|NCT03185065|10089592|FG003|NOT COMPLETED|Period 3 (6 Weeks)||0
9027148|NCT03185065|10089589|FG000|STARTED|Washout (2 Weeks)||31
9027149|NCT03185065|10089590|FG001|STARTED|Washout (2 Weeks)||29
9027150|NCT03185065|10089591|FG002|STARTED|Washout (2 Weeks)||29
9027151|NCT03185065|10089592|FG003|STARTED|Washout (2 Weeks)||32
9027152|NCT03185065|10089589|FG000|COMPLETED|Washout (2 Weeks)||31
9027153|NCT03185065|10089590|FG001|COMPLETED|Washout (2 Weeks)||28
9027154|NCT03185065|10089591|FG002|COMPLETED|Washout (2 Weeks)||27
9027155|NCT03185065|10089592|FG003|COMPLETED|Washout (2 Weeks)||32
9027156|NCT03185065|10089589|FG000|NOT COMPLETED|Washout (2 Weeks)||0
9027157|NCT03185065|10089590|FG001|NOT COMPLETED|Washout (2 Weeks)||1
9027158|NCT03185065|10089591|FG002|NOT COMPLETED|Washout (2 Weeks)||2
9027159|NCT03185065|10089592|FG003|NOT COMPLETED|Washout (2 Weeks)||0
9027160|NCT03185065|10089589|FG000|STARTED|Period 4 (6 Weeks)||31
9027161|NCT03185065|10089590|FG001|STARTED|Period 4 (6 Weeks)||28
9027162|NCT03185065|10089591|FG002|STARTED|Period 4 (6 Weeks)||27
9027163|NCT03185065|10089592|FG003|STARTED|Period 4 (6 Weeks)||32
9027164|NCT03185065|10089589|FG000|COMPLETED|Period 4 (6 Weeks)||31
9027165|NCT03185065|10089590|FG001|COMPLETED|Period 4 (6 Weeks)||27
9027166|NCT03185065|10089591|FG002|COMPLETED|Period 4 (6 Weeks)||26
9027167|NCT03185065|10089592|FG003|COMPLETED|Period 4 (6 Weeks)||31
9027168|NCT03185065|10089589|FG000|NOT COMPLETED|Period 4 (6 Weeks)||0
9027169|NCT03185065|10089590|FG001|NOT COMPLETED|Period 4 (6 Weeks)||1
9027170|NCT03185065|10089591|FG002|NOT COMPLETED|Period 4 (6 Weeks)||1
9027171|NCT03185065|10089592|FG003|NOT COMPLETED|Period 4 (6 Weeks)||1
9027172|NCT03185182|10089603|FG000|STARTED|Overall Study||5
9027173|NCT03185182|10089603|FG000|COMPLETED|Overall Study||5
9027174|NCT03185182|10089603|FG000|NOT COMPLETED|Overall Study||0
9027175|NCT03185455|10089610|FG000|STARTED|Overall Study||103
9027176|NCT03185455|10089611|FG001|STARTED|Overall Study||103
9027177|NCT03185455|10089610|FG000|COMPLETED|Overall Study||103
9027178|NCT03185455|10089611|FG001|COMPLETED|Overall Study||103
9027179|NCT03185455|10089610|FG000|NOT COMPLETED|Overall Study||0
9027180|NCT03185455|10089611|FG001|NOT COMPLETED|Overall Study||0
9027181|NCT03185481|10089617|FG000|STARTED|Overall Study||5
9027182|NCT03185481|10089617|FG000|COMPLETED|Overall Study||0
9027183|NCT03185481|10089617|FG000|NOT COMPLETED|Overall Study||5
9027184|NCT03185546|10089629|FG000|STARTED|Baseline Through Week 12||6
9027185|NCT03185546|10089630|FG001|STARTED|Baseline Through Week 12||10
9027186|NCT03185546|10089631|FG002|STARTED|Baseline Through Week 12||5
8766513|NCT01253018|9816673|FG000|COMPLETED|Overall Study||18
8766514|NCT01253018|9816674|FG001|COMPLETED|Overall Study||21
8766515|NCT01253018|9816673|FG000|NOT COMPLETED|Overall Study||4
8766516|NCT01253018|9816674|FG001|NOT COMPLETED|Overall Study||2
8766517|NCT01253044|9816683|FG000|STARTED|Overall Study||80
8766518|NCT01253044|9816684|FG001|STARTED|Overall Study||80
8766519|NCT01253044|9816683|FG000|COMPLETED|Overall Study||42
8766520|NCT01253044|9816684|FG001|COMPLETED|Overall Study||51
8766521|NCT01253044|9816683|FG000|NOT COMPLETED|Overall Study||38
8766522|NCT01253044|9816684|FG001|NOT COMPLETED|Overall Study||29
8766523|NCT01253135|9816690|FG000|STARTED|Original Protocol||15
8766524|NCT01253135|9816690|FG000|COMPLETED|Original Protocol||0
8766525|NCT01253135|9816690|FG000|NOT COMPLETED|Original Protocol||15
8766526|NCT01253135|9816690|FG000|STARTED|Amended Protocol||25
8766527|NCT01253135|9816690|FG000|COMPLETED|Amended Protocol||24
8766528|NCT01253135|9816690|FG000|NOT COMPLETED|Amended Protocol||1
8766529|NCT01253148|9816698|FG000|STARTED|Overall Study||25
8766530|NCT01253148|9816698|FG000|COMPLETED|Overall Study||25
8766531|NCT01253148|9816698|FG000|NOT COMPLETED|Overall Study||0
8766532|NCT01253174|9816702|FG000|STARTED|Period 1||6
8766533|NCT01253174|9816703|FG001|STARTED|Period 1||10
8766534|NCT01253174|9816704|FG002|STARTED|Period 1||9
8766535|NCT01253174|9816705|FG003|STARTED|Period 1||7
8766536|NCT01253174|9816706|FG004|STARTED|Period 1||9
8766537|NCT01253174|9816707|FG005|STARTED|Period 1||7
8766538|NCT01253174|9816702|FG000|COMPLETED|Period 1||6
8766539|NCT01253174|9816703|FG001|COMPLETED|Period 1||9
8766540|NCT01253174|9816704|FG002|COMPLETED|Period 1||8
8766541|NCT01253174|9816705|FG003|COMPLETED|Period 1||7
8766542|NCT01253174|9816706|FG004|COMPLETED|Period 1||8
8766543|NCT01253174|9816707|FG005|COMPLETED|Period 1||7
8766544|NCT01253174|9816702|FG000|NOT COMPLETED|Period 1||0
8766545|NCT01253174|9816703|FG001|NOT COMPLETED|Period 1||1
8766546|NCT01253174|9816704|FG002|NOT COMPLETED|Period 1||1
8766547|NCT01253174|9816705|FG003|NOT COMPLETED|Period 1||0
8766548|NCT01253174|9816706|FG004|NOT COMPLETED|Period 1||1
8766549|NCT01253174|9816707|FG005|NOT COMPLETED|Period 1||0
8766550|NCT01253174|9816702|FG000|STARTED|Period 2||6
8766551|NCT01253174|9816703|FG001|STARTED|Period 2||9
8766552|NCT01253174|9816704|FG002|STARTED|Period 2||8
8766553|NCT01253174|9816705|FG003|STARTED|Period 2||7
8766554|NCT01253174|9816706|FG004|STARTED|Period 2||8
8766555|NCT01253174|9816707|FG005|STARTED|Period 2||7
8766556|NCT01253174|9816702|FG000|COMPLETED|Period 2||6
8766557|NCT01253174|9816703|FG001|COMPLETED|Period 2||9
8766558|NCT01253174|9816704|FG002|COMPLETED|Period 2||7
8766559|NCT01253174|9816705|FG003|COMPLETED|Period 2||7
8766560|NCT01253174|9816706|FG004|COMPLETED|Period 2||8
8766561|NCT01253174|9816707|FG005|COMPLETED|Period 2||7
8766562|NCT01253174|9816702|FG000|NOT COMPLETED|Period 2||0
8766563|NCT01253174|9816703|FG001|NOT COMPLETED|Period 2||0
8766564|NCT01253174|9816704|FG002|NOT COMPLETED|Period 2||1
8766565|NCT01253174|9816705|FG003|NOT COMPLETED|Period 2||0
8766566|NCT01253174|9816706|FG004|NOT COMPLETED|Period 2||0
8766567|NCT01253174|9816707|FG005|NOT COMPLETED|Period 2||0
8766568|NCT01253174|9816702|FG000|STARTED|Period 3||6
8766569|NCT01253174|9816703|FG001|STARTED|Period 3||9
8766570|NCT01253174|9816704|FG002|STARTED|Period 3||7
8766571|NCT01253174|9816705|FG003|STARTED|Period 3||7
8766572|NCT01253174|9816706|FG004|STARTED|Period 3||8
8766573|NCT01253174|9816707|FG005|STARTED|Period 3||7
8766574|NCT01253174|9816702|FG000|COMPLETED|Period 3||6
8766575|NCT01253174|9816703|FG001|COMPLETED|Period 3||8
8766576|NCT01253174|9816704|FG002|COMPLETED|Period 3||6
8766577|NCT01253174|9816705|FG003|COMPLETED|Period 3||7
8766578|NCT01253174|9816706|FG004|COMPLETED|Period 3||7
8766579|NCT01253174|9816707|FG005|COMPLETED|Period 3||7
8766580|NCT01253174|9816702|FG000|NOT COMPLETED|Period 3||0
8766581|NCT01253174|9816703|FG001|NOT COMPLETED|Period 3||1
8766582|NCT01253174|9816704|FG002|NOT COMPLETED|Period 3||1
8766583|NCT01253174|9816705|FG003|NOT COMPLETED|Period 3||0
8766584|NCT01253174|9816706|FG004|NOT COMPLETED|Period 3||1
8766585|NCT01253174|9816707|FG005|NOT COMPLETED|Period 3||0
8766586|NCT01253187|9816716|FG000|STARTED|Period 1||7
8766587|NCT01253187|9816717|FG001|STARTED|Period 1||8
8766588|NCT01253187|9816718|FG002|STARTED|Period 1||7
8766589|NCT01253187|9816719|FG003|STARTED|Period 1||7
8766590|NCT01253187|9816720|FG004|STARTED|Period 1||9
8766591|NCT01253187|9816721|FG005|STARTED|Period 1||6
8766592|NCT01253187|9816716|FG000|COMPLETED|Period 1||7
8766593|NCT01253187|9816717|FG001|COMPLETED|Period 1||8
8766594|NCT01253187|9816718|FG002|COMPLETED|Period 1||7
8766595|NCT01253187|9816719|FG003|COMPLETED|Period 1||7
8766596|NCT01253187|9816720|FG004|COMPLETED|Period 1||9
8766597|NCT01253187|9816721|FG005|COMPLETED|Period 1||6
8766598|NCT01253187|9816716|FG000|NOT COMPLETED|Period 1||0
8766599|NCT01253187|9816717|FG001|NOT COMPLETED|Period 1||0
8766600|NCT01253187|9816718|FG002|NOT COMPLETED|Period 1||0
8766601|NCT01253187|9816719|FG003|NOT COMPLETED|Period 1||0
8766602|NCT01253187|9816720|FG004|NOT COMPLETED|Period 1||0
8766603|NCT01253187|9816721|FG005|NOT COMPLETED|Period 1||0
8766604|NCT01253187|9816716|FG000|STARTED|Period 2||7
8766605|NCT01253187|9816717|FG001|STARTED|Period 2||8
8766606|NCT01253187|9816718|FG002|STARTED|Period 2||7
8766607|NCT01253187|9816719|FG003|STARTED|Period 2||7
8766608|NCT01253187|9816720|FG004|STARTED|Period 2||9
8766609|NCT01253187|9816721|FG005|STARTED|Period 2||6
8766610|NCT01253187|9816716|FG000|COMPLETED|Period 2||7
8766611|NCT01253187|9816717|FG001|COMPLETED|Period 2||8
8766612|NCT01253187|9816718|FG002|COMPLETED|Period 2||7
8766613|NCT01253187|9816719|FG003|COMPLETED|Period 2||7
8766614|NCT01253187|9816720|FG004|COMPLETED|Period 2||8
8766615|NCT01253187|9816721|FG005|COMPLETED|Period 2||6
8766616|NCT01253187|9816716|FG000|NOT COMPLETED|Period 2||0
8766617|NCT01253187|9816717|FG001|NOT COMPLETED|Period 2||0
8766618|NCT01253187|9816718|FG002|NOT COMPLETED|Period 2||0
8766619|NCT01253187|9816719|FG003|NOT COMPLETED|Period 2||0
8766620|NCT01253187|9816720|FG004|NOT COMPLETED|Period 2||1
8766621|NCT01253187|9816721|FG005|NOT COMPLETED|Period 2||0
8766622|NCT01253187|9816716|FG000|STARTED|Period 3||7
8766623|NCT01253187|9816717|FG001|STARTED|Period 3||8
8766624|NCT01253187|9816718|FG002|STARTED|Period 3||7
8766625|NCT01253187|9816719|FG003|STARTED|Period 3||7
8766626|NCT01253187|9816720|FG004|STARTED|Period 3||8
8766627|NCT01253187|9816721|FG005|STARTED|Period 3||6
8766628|NCT01253187|9816716|FG000|COMPLETED|Period 3||6
8766629|NCT01253187|9816717|FG001|COMPLETED|Period 3||7
8766630|NCT01253187|9816718|FG002|COMPLETED|Period 3||7
8766631|NCT01253187|9816719|FG003|COMPLETED|Period 3||7
8766632|NCT01253187|9816720|FG004|COMPLETED|Period 3||7
8766633|NCT01253187|9816721|FG005|COMPLETED|Period 3||6
8766634|NCT01253187|9816716|FG000|NOT COMPLETED|Period 3||1
8766635|NCT01253187|9816717|FG001|NOT COMPLETED|Period 3||1
8766636|NCT01253187|9816718|FG002|NOT COMPLETED|Period 3||0
8766637|NCT01253187|9816719|FG003|NOT COMPLETED|Period 3||0
8766638|NCT01253187|9816720|FG004|NOT COMPLETED|Period 3||1
8766639|NCT01253187|9816721|FG005|NOT COMPLETED|Period 3||0
9027187|NCT03185546|10089632|FG003|STARTED|Baseline Through Week 12||5
9027188|NCT03185546|10089633|FG004|STARTED|Baseline Through Week 12||6
9027189|NCT03185546|10089634|FG005|STARTED|Baseline Through Week 12||6
9027190|NCT03185546|10089635|FG006|STARTED|Baseline Through Week 12||7
9027191|NCT03185546|10089636|FG007|STARTED|Baseline Through Week 12||5
9027192|NCT03185546|10089629|FG000|COMPLETED|Baseline Through Week 12||2
9027193|NCT03185546|10089630|FG001|COMPLETED|Baseline Through Week 12||7
9027194|NCT03185546|10089631|FG002|COMPLETED|Baseline Through Week 12||4
9027195|NCT03185546|10089632|FG003|COMPLETED|Baseline Through Week 12||4
9027196|NCT03185546|10089633|FG004|COMPLETED|Baseline Through Week 12||5
9027197|NCT03185546|10089634|FG005|COMPLETED|Baseline Through Week 12||4
9027198|NCT03185546|10089635|FG006|COMPLETED|Baseline Through Week 12||4
9027199|NCT03185546|10089636|FG007|COMPLETED|Baseline Through Week 12||2
9027200|NCT03185546|10089629|FG000|NOT COMPLETED|Baseline Through Week 12||4
9027201|NCT03185546|10089630|FG001|NOT COMPLETED|Baseline Through Week 12||3
9027202|NCT03185546|10089631|FG002|NOT COMPLETED|Baseline Through Week 12||1
9027203|NCT03185546|10089632|FG003|NOT COMPLETED|Baseline Through Week 12||1
9027204|NCT03185546|10089633|FG004|NOT COMPLETED|Baseline Through Week 12||1
9027205|NCT03185546|10089634|FG005|NOT COMPLETED|Baseline Through Week 12||2
9027206|NCT03185546|10089635|FG006|NOT COMPLETED|Baseline Through Week 12||3
9027207|NCT03185546|10089636|FG007|NOT COMPLETED|Baseline Through Week 12||3
9027208|NCT03185546|10089629|FG000|STARTED|Week 12 Through Day 30 Follow up||2
9027209|NCT03185546|10089630|FG001|STARTED|Week 12 Through Day 30 Follow up||7
9027210|NCT03185546|10089631|FG002|STARTED|Week 12 Through Day 30 Follow up||4
9027211|NCT03185546|10089632|FG003|STARTED|Week 12 Through Day 30 Follow up||4
9027212|NCT03185546|10089633|FG004|STARTED|Week 12 Through Day 30 Follow up||5
9027213|NCT03185546|10089634|FG005|STARTED|Week 12 Through Day 30 Follow up||4
9027214|NCT03185546|10089635|FG006|STARTED|Week 12 Through Day 30 Follow up||4
9027215|NCT03185546|10089636|FG007|STARTED|Week 12 Through Day 30 Follow up||2
9027216|NCT03185546|10089629|FG000|COMPLETED|Week 12 Through Day 30 Follow up||2
9027217|NCT03185546|10089630|FG001|COMPLETED|Week 12 Through Day 30 Follow up||7
9027218|NCT03185546|10089631|FG002|COMPLETED|Week 12 Through Day 30 Follow up||4
9027219|NCT03185546|10089632|FG003|COMPLETED|Week 12 Through Day 30 Follow up||3
9027220|NCT03185546|10089633|FG004|COMPLETED|Week 12 Through Day 30 Follow up||5
9027221|NCT03185546|10089634|FG005|COMPLETED|Week 12 Through Day 30 Follow up||4
9027222|NCT03185546|10089635|FG006|COMPLETED|Week 12 Through Day 30 Follow up||3
9027223|NCT03185546|10089636|FG007|COMPLETED|Week 12 Through Day 30 Follow up||2
9027224|NCT03185546|10089629|FG000|NOT COMPLETED|Week 12 Through Day 30 Follow up||0
9027225|NCT03185546|10089630|FG001|NOT COMPLETED|Week 12 Through Day 30 Follow up||0
9027226|NCT03185546|10089631|FG002|NOT COMPLETED|Week 12 Through Day 30 Follow up||0
9027227|NCT03185546|10089632|FG003|NOT COMPLETED|Week 12 Through Day 30 Follow up||1
9027228|NCT03185546|10089633|FG004|NOT COMPLETED|Week 12 Through Day 30 Follow up||0
9027229|NCT03185546|10089634|FG005|NOT COMPLETED|Week 12 Through Day 30 Follow up||0
9027230|NCT03185546|10089635|FG006|NOT COMPLETED|Week 12 Through Day 30 Follow up||1
9027231|NCT03185546|10089636|FG007|NOT COMPLETED|Week 12 Through Day 30 Follow up||0
9027232|NCT03186261|10089657|FG000|STARTED|Overall Study||22
9027233|NCT03186261|10089658|FG001|STARTED|Overall Study||22
9027234|NCT03186261|10089657|FG000|COMPLETED|Overall Study||22
8766640|NCT01253200|9816737|FG000|STARTED|Overall Study||125
8766641|NCT01253200|9816738|FG001|STARTED|Overall Study||125
8766642|NCT01253200|9816739|FG002|STARTED|Overall Study||30
8766643|NCT01253200|9816740|FG003|STARTED|Overall Study||17
8766644|NCT01253200|9816741|FG004|STARTED|Overall Study||5
8766645|NCT01253200|9816737|FG000|Procedure|Overall Study||109
9027235|NCT03186261|10089658|FG001|COMPLETED|Overall Study||22
8766646|NCT01253200|9816738|FG001|Procedure|Overall Study||111
8766647|NCT01253200|9816739|FG002|Procedure|Overall Study||28
8766648|NCT01253200|9816740|FG003|Procedure|Overall Study||12
8766649|NCT01253200|9816741|FG004|Procedure|Overall Study||0
8766650|NCT01253200|9816737|FG000|10 Day Follow-up|Overall Study||106
8766651|NCT01253200|9816738|FG001|10 Day Follow-up|Overall Study||111
8766652|NCT01253200|9816739|FG002|10 Day Follow-up|Overall Study||28
8766653|NCT01253200|9816740|FG003|10 Day Follow-up|Overall Study||12
8766654|NCT01253200|9816741|FG004|10 Day Follow-up|Overall Study||0
8766655|NCT01253200|9816737|FG000|3 Month Follow-up|Overall Study||104
8766656|NCT01253200|9816738|FG001|3 Month Follow-up|Overall Study||106
8766657|NCT01253200|9816739|FG002|3 Month Follow-up|Overall Study||28
8766658|NCT01253200|9816740|FG003|3 Month Follow-up|Overall Study||12
8766659|NCT01253200|9816741|FG004|3 Month Follow-up|Overall Study||0
8766660|NCT01253200|9816737|FG000|COMPLETED|Overall Study||104
8766661|NCT01253200|9816738|FG001|COMPLETED|Overall Study||106
8766662|NCT01253200|9816739|FG002|COMPLETED|Overall Study||28
8766663|NCT01253200|9816740|FG003|COMPLETED|Overall Study||12
8766664|NCT01253200|9816741|FG004|COMPLETED|Overall Study||0
8766665|NCT01253200|9816737|FG000|NOT COMPLETED|Overall Study||21
8766666|NCT01253200|9816738|FG001|NOT COMPLETED|Overall Study||19
8766667|NCT01253200|9816739|FG002|NOT COMPLETED|Overall Study||2
8766668|NCT01253200|9816740|FG003|NOT COMPLETED|Overall Study||5
8766669|NCT01253200|9816741|FG004|NOT COMPLETED|Overall Study||5
8766670|NCT01253226|9816755|FG000|STARTED|Overall Study||6
8766671|NCT01253226|9816756|FG001|STARTED|Overall Study||6
8766672|NCT01253226|9816757|FG002|STARTED|Overall Study||6
8766673|NCT01253226|9816758|FG003|STARTED|Overall Study||6
9027236|NCT03186261|10089657|FG000|NOT COMPLETED|Overall Study||0
9027237|NCT03186261|10089658|FG001|NOT COMPLETED|Overall Study||0
9027238|NCT03186378|10089666|FG000|STARTED|Overall Study||17
9027239|NCT03186378|10089667|FG001|STARTED|Overall Study||16
9027240|NCT03186378|10089666|FG000|COMPLETED|Overall Study||16
9027241|NCT03186378|10089667|FG001|COMPLETED|Overall Study||16
9027242|NCT03186378|10089666|FG000|NOT COMPLETED|Overall Study||1
9027243|NCT03186378|10089667|FG001|NOT COMPLETED|Overall Study||0
9027244|NCT03186677|10089678|FG000|STARTED|Period 1||3
9027245|NCT03186677|10089679|FG001|STARTED|Period 1||3
9027246|NCT03186677|10089680|FG002|STARTED|Period 1||3
9027247|NCT03186677|10089681|FG003|STARTED|Period 1||0
9027248|NCT03186677|10089682|FG004|STARTED|Period 1||0
9027249|NCT03186677|10089678|FG000|COMPLETED|Period 1||3
9027250|NCT03186677|10089679|FG001|COMPLETED|Period 1||3
9027251|NCT03186677|10089680|FG002|COMPLETED|Period 1||3
9027252|NCT03186677|10089681|FG003|COMPLETED|Period 1||0
9027253|NCT03186677|10089682|FG004|COMPLETED|Period 1||0
9027254|NCT03186677|10089678|FG000|NOT COMPLETED|Period 1||0
9027255|NCT03186677|10089679|FG001|NOT COMPLETED|Period 1||0
9027256|NCT03186677|10089680|FG002|NOT COMPLETED|Period 1||0
9027257|NCT03186677|10089681|FG003|NOT COMPLETED|Period 1||0
9027258|NCT03186677|10089682|FG004|NOT COMPLETED|Period 1||0
9027259|NCT03186677|10089678|FG000|STARTED|Period 2||0
9027260|NCT03186677|10089679|FG001|STARTED|Period 2||0
9027261|NCT03186677|10089680|FG002|STARTED|Period 2||0
9027262|NCT03186677|10089681|FG003|STARTED|Period 2||5
9027263|NCT03186677|10089682|FG004|STARTED|Period 2||2
9027264|NCT03186677|10089678|FG000|COMPLETED|Period 2||0
9027265|NCT03186677|10089679|FG001|COMPLETED|Period 2||0
9027266|NCT03186677|10089680|FG002|COMPLETED|Period 2||0
9027267|NCT03186677|10089681|FG003|COMPLETED|Period 2||5
9027268|NCT03186677|10089682|FG004|COMPLETED|Period 2||2
9027269|NCT03186677|10089678|FG000|NOT COMPLETED|Period 2||0
9027270|NCT03186677|10089679|FG001|NOT COMPLETED|Period 2||0
9027271|NCT03186677|10089680|FG002|NOT COMPLETED|Period 2||0
9027272|NCT03186677|10089681|FG003|NOT COMPLETED|Period 2||0
9027273|NCT03186677|10089682|FG004|NOT COMPLETED|Period 2||0
9027274|NCT03186781|10089700|FG000|STARTED|Overall Study||5
9027275|NCT03186781|10089701|FG001|STARTED|Overall Study||5
9027276|NCT03186781|10089702|FG002|STARTED|Overall Study||10
9027277|NCT03186781|10089703|FG003|STARTED|Overall Study||10
9027278|NCT03186781|10089704|FG004|STARTED|Overall Study||10
8766674|NCT01253226|9816759|FG004|STARTED|Overall Study||8
8766675|NCT01253226|9816755|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
8766676|NCT01253226|9816756|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
8766677|NCT01253226|9816757|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
8766678|NCT01253226|9816758|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
8766679|NCT01253226|9816759|FG004|Received at Least 1 Dose of Study Drug|Overall Study||8
8766680|NCT01253226|9816755|FG000|COMPLETED|Overall Study||6
8766681|NCT01253226|9816756|FG001|COMPLETED|Overall Study||5
8766682|NCT01253226|9816757|FG002|COMPLETED|Overall Study||5
8766683|NCT01253226|9816758|FG003|COMPLETED|Overall Study||5
9027279|NCT03186781|10089705|FG005|STARTED|Overall Study||10
9027280|NCT03186781|10089700|FG000|Received First Product Administration|Overall Study||5
9027281|NCT03186781|10089701|FG001|Received First Product Administration|Overall Study||5
9027282|NCT03186781|10089702|FG002|Received First Product Administration|Overall Study||10
9027283|NCT03186781|10089703|FG003|Received First Product Administration|Overall Study||10
9027284|NCT03186781|10089704|FG004|Received First Product Administration|Overall Study||10
9027285|NCT03186781|10089705|FG005|Received First Product Administration|Overall Study||10
9027286|NCT03186781|10089700|FG000|Received All Product Administrations|Overall Study||5
8766684|NCT01253226|9816759|FG004|COMPLETED|Overall Study||6
8766685|NCT01253226|9816755|FG000|NOT COMPLETED|Overall Study||0
9027287|NCT03186781|10089701|FG001|Received All Product Administrations|Overall Study||5
9027288|NCT03186781|10089702|FG002|Received All Product Administrations|Overall Study|2nd dose not given due to unrelated intercurrent illness (n=1) and lost to follow up (n=1)|8
8766686|NCT01253226|9816756|FG001|NOT COMPLETED|Overall Study||1
8766687|NCT01253226|9816757|FG002|NOT COMPLETED|Overall Study||1
8766688|NCT01253226|9816758|FG003|NOT COMPLETED|Overall Study||1
8766689|NCT01253226|9816759|FG004|NOT COMPLETED|Overall Study||2
8766690|NCT01253265|9816776|FG000|STARTED|Overall Study||6
8766691|NCT01253265|9816777|FG001|STARTED|Overall Study||6
8766692|NCT01253265|9816778|FG002|STARTED|Overall Study||6
8766693|NCT01253265|9816779|FG003|STARTED|Overall Study||6
8766694|NCT01253265|9816780|FG004|STARTED|Overall Study||8
8766695|NCT01253265|9816776|FG000|COMPLETED|Overall Study||5
8766696|NCT01253265|9816777|FG001|COMPLETED|Overall Study||6
8766697|NCT01253265|9816778|FG002|COMPLETED|Overall Study||6
8766698|NCT01253265|9816779|FG003|COMPLETED|Overall Study||6
8766699|NCT01253265|9816780|FG004|COMPLETED|Overall Study||7
8766700|NCT01253265|9816776|FG000|NOT COMPLETED|Overall Study||1
8766701|NCT01253265|9816777|FG001|NOT COMPLETED|Overall Study||0
8766702|NCT01253265|9816778|FG002|NOT COMPLETED|Overall Study||0
8766703|NCT01253265|9816779|FG003|NOT COMPLETED|Overall Study||0
8766704|NCT01253265|9816780|FG004|NOT COMPLETED|Overall Study||1
8766705|NCT01253291|9816797|FG000|STARTED|Overall Study||6
8766706|NCT01253291|9816798|FG001|STARTED|Overall Study||6
8766707|NCT01253291|9816799|FG002|STARTED|Overall Study||4
8766708|NCT01253291|9816800|FG003|STARTED|Overall Study||5
8766709|NCT01253291|9816801|FG004|STARTED|Overall Study||5
8766710|NCT01253291|9816797|FG000|Received Study Drug During BCDL|Overall Study||6
8766711|NCT01253291|9816798|FG001|Received Study Drug During BCDL|Overall Study||6
8766712|NCT01253291|9816799|FG002|Received Study Drug During BCDL|Overall Study||4
8766713|NCT01253291|9816800|FG003|Received Study Drug During BCDL|Overall Study||5
8766714|NCT01253291|9816801|FG004|Received Study Drug During BCDL|Overall Study||5
8766715|NCT01253291|9816797|FG000|COMPLETED|Overall Study||2
8766716|NCT01253291|9816798|FG001|COMPLETED|Overall Study||4
8766717|NCT01253291|9816799|FG002|COMPLETED|Overall Study||4
8766718|NCT01253291|9816800|FG003|COMPLETED|Overall Study||5
8766719|NCT01253291|9816801|FG004|COMPLETED|Overall Study||3
8766720|NCT01253291|9816797|FG000|NOT COMPLETED|Overall Study||4
8766721|NCT01253291|9816798|FG001|NOT COMPLETED|Overall Study||2
8766722|NCT01253291|9816799|FG002|NOT COMPLETED|Overall Study||0
8766723|NCT01253291|9816800|FG003|NOT COMPLETED|Overall Study||0
8766724|NCT01253291|9816801|FG004|NOT COMPLETED|Overall Study||2
8766725|NCT01253304|9816818|FG000|STARTED|Overall Study||11
8766726|NCT01253304|9816819|FG001|STARTED|Overall Study||6
8766727|NCT01253304|9816820|FG002|STARTED|Overall Study||6
8766728|NCT01253304|9816821|FG003|STARTED|Overall Study||3
8766729|NCT01253304|9816818|FG000|Received at Least 1 Dose of Study Drug|Overall Study||11
8766730|NCT01253304|9816819|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
8766731|NCT01253304|9816820|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
8766732|NCT01253304|9816821|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
8766733|NCT01253304|9816818|FG000|COMPLETED|Overall Study||11
8766734|NCT01253304|9816819|FG001|COMPLETED|Overall Study||6
8766735|NCT01253304|9816820|FG002|COMPLETED|Overall Study||6
8766736|NCT01253304|9816821|FG003|COMPLETED|Overall Study||2
8766737|NCT01253304|9816818|FG000|NOT COMPLETED|Overall Study||0
8766738|NCT01253304|9816819|FG001|NOT COMPLETED|Overall Study||0
8766739|NCT01253304|9816820|FG002|NOT COMPLETED|Overall Study||0
8766740|NCT01253304|9816821|FG003|NOT COMPLETED|Overall Study||1
8766741|NCT01253317|9816831|FG000|STARTED|Overall Study||12
8766742|NCT01253317|9816831|FG000|COMPLETED|Overall Study||10
8766743|NCT01253317|9816831|FG000|NOT COMPLETED|Overall Study||2
8766744|NCT01253343|9816841|FG000|STARTED|Overall Study||9
8766745|NCT01253343|9816842|FG001|STARTED|Overall Study||8
8766746|NCT01253343|9816841|FG000|COMPLETED|Overall Study||9
8766747|NCT01253343|9816842|FG001|COMPLETED|Overall Study||8
8766748|NCT01253343|9816841|FG000|NOT COMPLETED|Overall Study||0
8766749|NCT01253343|9816842|FG001|NOT COMPLETED|Overall Study||0
8766750|NCT01253369|9816864|FG000|STARTED|Overall Study||33
8766751|NCT01253369|9816864|FG000|Evaluable|Overall Study|Evaluable pts were w/ measurable disease, min 1 cycle of trt rcvd and 1 on-trt disease assessment.|30
8766752|NCT01253369|9816864|FG000|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
8766753|NCT01253369|9816864|FG000|NOT COMPLETED|Overall Study||33
8766754|NCT01253408|9816871|FG000|STARTED|Overall Study||10
8766755|NCT01253408|9816872|FG001|STARTED|Overall Study||13
8766756|NCT01253408|9816873|FG002|STARTED|Overall Study||13
8766757|NCT01253408|9816871|FG000|COMPLETED|Overall Study||10
8766758|NCT01253408|9816872|FG001|COMPLETED|Overall Study||12
8766759|NCT01253408|9816873|FG002|COMPLETED|Overall Study||13
8766760|NCT01253408|9816871|FG000|NOT COMPLETED|Overall Study||0
8766761|NCT01253408|9816872|FG001|NOT COMPLETED|Overall Study||1
8766762|NCT01253408|9816873|FG002|NOT COMPLETED|Overall Study||0
8766763|NCT01253421|9816885|FG000|STARTED|Assessment and Scheduling||159
8766764|NCT01253421|9816886|FG001|STARTED|Assessment and Scheduling|Arm has no participants until randomization.|0
8766765|NCT01253421|9816887|FG002|STARTED|Assessment and Scheduling|Arm has no participants until randomization.|0
8766766|NCT01253421|9816888|FG003|STARTED|Assessment and Scheduling|Arm has no participants until randomization.|0
8766767|NCT01253421|9816889|FG004|STARTED|Assessment and Scheduling|Arm has no participants until randomization.|0
8766768|NCT01253421|9816885|FG000|Eligible After Screening Visit|Assessment and Scheduling||85
8766769|NCT01253421|9816886|FG001|Eligible After Screening Visit|Assessment and Scheduling||0
8766770|NCT01253421|9816887|FG002|Eligible After Screening Visit|Assessment and Scheduling||0
8766771|NCT01253421|9816888|FG003|Eligible After Screening Visit|Assessment and Scheduling||0
8766772|NCT01253421|9816889|FG004|Eligible After Screening Visit|Assessment and Scheduling||0
8766773|NCT01253421|9816885|FG000|Returned for Drug+Scanning Visit|Assessment and Scheduling||60
8766774|NCT01253421|9816886|FG001|Returned for Drug+Scanning Visit|Assessment and Scheduling||0
8766775|NCT01253421|9816887|FG002|Returned for Drug+Scanning Visit|Assessment and Scheduling||0
8766776|NCT01253421|9816888|FG003|Returned for Drug+Scanning Visit|Assessment and Scheduling||0
8766777|NCT01253421|9816889|FG004|Returned for Drug+Scanning Visit|Assessment and Scheduling||0
8766778|NCT01253421|9816885|FG000|COMPLETED|Assessment and Scheduling||60
8766779|NCT01253421|9816886|FG001|COMPLETED|Assessment and Scheduling||0
8766780|NCT01253421|9816887|FG002|COMPLETED|Assessment and Scheduling||0
8766781|NCT01253421|9816888|FG003|COMPLETED|Assessment and Scheduling||0
8766782|NCT01253421|9816889|FG004|COMPLETED|Assessment and Scheduling||0
8766783|NCT01253421|9816885|FG000|NOT COMPLETED|Assessment and Scheduling||99
8766784|NCT01253421|9816886|FG001|NOT COMPLETED|Assessment and Scheduling||0
8766785|NCT01253421|9816887|FG002|NOT COMPLETED|Assessment and Scheduling||0
8766786|NCT01253421|9816888|FG003|NOT COMPLETED|Assessment and Scheduling||0
8766787|NCT01253421|9816889|FG004|NOT COMPLETED|Assessment and Scheduling||0
8766788|NCT01253421|9816885|FG000|STARTED|Drug+Scanning Visit|Arm has no participants once randomization has occurred.|0
8766789|NCT01253421|9816886|FG001|STARTED|Drug+Scanning Visit||15
8766790|NCT01253421|9816887|FG002|STARTED|Drug+Scanning Visit||14
8766791|NCT01253421|9816888|FG003|STARTED|Drug+Scanning Visit||16
8766792|NCT01253421|9816889|FG004|STARTED|Drug+Scanning Visit||15
8766793|NCT01253421|9816885|FG000|Received Drug Challenge|Drug+Scanning Visit||0
8766794|NCT01253421|9816886|FG001|Received Drug Challenge|Drug+Scanning Visit||15
8766795|NCT01253421|9816887|FG002|Received Drug Challenge|Drug+Scanning Visit||14
8766796|NCT01253421|9816888|FG003|Received Drug Challenge|Drug+Scanning Visit||16
8766797|NCT01253421|9816889|FG004|Received Drug Challenge|Drug+Scanning Visit||15
8766798|NCT01253421|9816885|FG000|COMPLETED|Drug+Scanning Visit||0
8766799|NCT01253421|9816886|FG001|COMPLETED|Drug+Scanning Visit||15
8766800|NCT01253421|9816887|FG002|COMPLETED|Drug+Scanning Visit||14
8766801|NCT01253421|9816888|FG003|COMPLETED|Drug+Scanning Visit||16
8766802|NCT01253421|9816889|FG004|COMPLETED|Drug+Scanning Visit||14
8766803|NCT01253421|9816885|FG000|NOT COMPLETED|Drug+Scanning Visit||0
8766804|NCT01253421|9816886|FG001|NOT COMPLETED|Drug+Scanning Visit||0
8766805|NCT01253421|9816887|FG002|NOT COMPLETED|Drug+Scanning Visit||0
8766806|NCT01253421|9816888|FG003|NOT COMPLETED|Drug+Scanning Visit||0
8766807|NCT01253421|9816889|FG004|NOT COMPLETED|Drug+Scanning Visit||1
8766808|NCT01253447|9816899|FG000|STARTED|Overall Study||19
8766809|NCT01253447|9816899|FG000|COMPLETED|Overall Study||17
8766810|NCT01253447|9816899|FG000|NOT COMPLETED|Overall Study||2
8766811|NCT01253460|9816904|FG000|STARTED|Overall Study||18
8766812|NCT01253460|9816904|FG000|COMPLETED|Overall Study||18
8766813|NCT01253460|9816904|FG000|NOT COMPLETED|Overall Study||0
9027289|NCT03186781|10089703|FG003|Received All Product Administrations|Overall Study|PI decided not to give 2nd dose to limit variation in environmental exposure to flu between subjects|9
9027290|NCT03186781|10089704|FG004|Received All Product Administrations|Overall Study|2nd dose not given due to subject decision to withdraw (n=2)|8
9027291|NCT03186781|10089705|FG005|Received All Product Administrations|Overall Study|PI decided not to give 2nd dose to limit variation in environmental exposure to flu between subjects|9
9027292|NCT03186781|10089700|FG000|COMPLETED|Overall Study||5
9027293|NCT03186781|10089701|FG001|COMPLETED|Overall Study||5
9027294|NCT03186781|10089702|FG002|COMPLETED|Overall Study||9
9027295|NCT03186781|10089703|FG003|COMPLETED|Overall Study||10
9027296|NCT03186781|10089704|FG004|COMPLETED|Overall Study||7
9027297|NCT03186781|10089705|FG005|COMPLETED|Overall Study||10
9027298|NCT03186781|10089700|FG000|NOT COMPLETED|Overall Study||0
9027299|NCT03186781|10089701|FG001|NOT COMPLETED|Overall Study||0
9027300|NCT03186781|10089702|FG002|NOT COMPLETED|Overall Study||1
9027301|NCT03186781|10089703|FG003|NOT COMPLETED|Overall Study||0
9027302|NCT03186781|10089704|FG004|NOT COMPLETED|Overall Study||3
9027303|NCT03186781|10089705|FG005|NOT COMPLETED|Overall Study||0
9027304|NCT03187002|10089725|FG000|STARTED|Overall Study||55
9027305|NCT03187002|10089726|FG001|STARTED|Overall Study||54
9027306|NCT03187002|10089725|FG000|COMPLETED|Overall Study||55
9027307|NCT03187002|10089726|FG001|COMPLETED|Overall Study||54
9027308|NCT03187002|10089725|FG000|NOT COMPLETED|Overall Study||0
9027309|NCT03187002|10089726|FG001|NOT COMPLETED|Overall Study||0
9027310|NCT03187119|10089734|FG000|STARTED|Overall Study||22
9027311|NCT03187119|10089735|FG001|STARTED|Overall Study||23
9027312|NCT03187119|10089734|FG000|COMPLETED|Overall Study||20
9027313|NCT03187119|10089735|FG001|COMPLETED|Overall Study||18
9027314|NCT03187119|10089734|FG000|NOT COMPLETED|Overall Study||2
9027315|NCT03187119|10089735|FG001|NOT COMPLETED|Overall Study||5
9027316|NCT03187132|10089743|FG000|STARTED|Inpatient Trauma Only||12
9027317|NCT03187132|10089744|FG001|STARTED|Inpatient Trauma Only||12
9027318|NCT03187132|10089743|FG000|COMPLETED|Inpatient Trauma Only||8
8766814|NCT01253525|9816908|FG000|STARTED|Overall Study||6
8766815|NCT01253525|9816908|FG000|Received Any Quantity of Study Drug|Overall Study||6
8766816|NCT01253525|9816908|FG000|COMPLETED|Overall Study||6
8766817|NCT01253525|9816908|FG000|NOT COMPLETED|Overall Study||0
8766818|NCT01253564|9816912|FG000|STARTED|Overall Study||24
9027319|NCT03187132|10089744|FG001|COMPLETED|Inpatient Trauma Only||0
9027320|NCT03187132|10089743|FG000|NOT COMPLETED|Inpatient Trauma Only||4
9027321|NCT03187132|10089744|FG001|NOT COMPLETED|Inpatient Trauma Only||12
8766819|NCT01253564|9816912|FG000|COMPLETED|Overall Study||0
8766820|NCT01253564|9816912|FG000|NOT COMPLETED|Overall Study||24
8766821|NCT01253577|9816916|FG000|STARTED|Overall Study||105
8766822|NCT01253577|9816916|FG000|COMPLETED|Overall Study||102
8766823|NCT01253577|9816916|FG000|NOT COMPLETED|Overall Study||3
8766824|NCT01253642|9816922|FG000|STARTED|Overall Study||11
8766825|NCT01253642|9816922|FG000|COMPLETED|Overall Study||6
8766826|NCT01253642|9816922|FG000|NOT COMPLETED|Overall Study||5
8766827|NCT01253811|9816927|FG000|STARTED|Overall Study||6
8766828|NCT01253811|9816927|FG000|Exposed|Overall Study||6
8766829|NCT01253811|9816927|FG000|COMPLETED|Overall Study||5
8766830|NCT01253811|9816927|FG000|NOT COMPLETED|Overall Study||1
8766831|NCT01253824|9816933|FG000|STARTED|Overall Study||7
8766832|NCT01253824|9816934|FG001|STARTED|Overall Study||7
8766833|NCT01253824|9816933|FG000|COMPLETED|Overall Study||7
8766834|NCT01253824|9816934|FG001|COMPLETED|Overall Study||7
8766835|NCT01253824|9816933|FG000|NOT COMPLETED|Overall Study||0
8766836|NCT01253824|9816934|FG001|NOT COMPLETED|Overall Study||0
8766837|NCT01253902|9816943|FG000|STARTED|Overall Study||56
8766838|NCT01253902|9816944|FG001|STARTED|Overall Study||53
8766839|NCT01253902|9816945|FG002|STARTED|Overall Study||55
8766840|NCT01253902|9816943|FG000|COMPLETED|Overall Study||51
8766841|NCT01253902|9816944|FG001|COMPLETED|Overall Study||51
8766842|NCT01253902|9816945|FG002|COMPLETED|Overall Study||51
8766843|NCT01253902|9816943|FG000|NOT COMPLETED|Overall Study||5
8766844|NCT01253902|9816944|FG001|NOT COMPLETED|Overall Study||2
8766845|NCT01253902|9816945|FG002|NOT COMPLETED|Overall Study||4
8766846|NCT01253980|9816955|FG000|STARTED|Overall Study||35
8766847|NCT01253980|9816956|FG001|STARTED|Overall Study||39
8766848|NCT01253980|9816955|FG000|COMPLETED|Overall Study||35
8766849|NCT01253980|9816956|FG001|COMPLETED|Overall Study||39
8766850|NCT01253980|9816955|FG000|NOT COMPLETED|Overall Study||0
8766851|NCT01253980|9816956|FG001|NOT COMPLETED|Overall Study||0
8766852|NCT01254019|9816964|FG000|STARTED|Overall Study||61
8766853|NCT01254019|9816965|FG001|STARTED|Overall Study||125
8766854|NCT01254019|9816964|FG000|COMPLETED|Overall Study||60
8766855|NCT01254019|9816965|FG001|COMPLETED|Overall Study||121
8766856|NCT01254019|9816964|FG000|NOT COMPLETED|Overall Study||1
8766857|NCT01254019|9816965|FG001|NOT COMPLETED|Overall Study||4
8766858|NCT01254045|9816974|FG000|STARTED|First/Baseline (1 Day at Week 1 )|One completed all baseline measures including administration of placebo, but then lost to follow-up.|2
8766859|NCT01254045|9816975|FG001|STARTED|First/Baseline (1 Day at Week 1 )||2
8766860|NCT01254045|9816976|FG002|STARTED|First/Baseline (1 Day at Week 1 )||2
8766861|NCT01254045|9816977|FG003|STARTED|First/Baseline (1 Day at Week 1 )||1
8766862|NCT01254045|9816978|FG004|STARTED|First/Baseline (1 Day at Week 1 )||1
8766863|NCT01254045|9816979|FG005|STARTED|First/Baseline (1 Day at Week 1 )||1
8766864|NCT01254045|9816974|FG000|COMPLETED|First/Baseline (1 Day at Week 1 )||1
8766865|NCT01254045|9816975|FG001|COMPLETED|First/Baseline (1 Day at Week 1 )||2
8766866|NCT01254045|9816976|FG002|COMPLETED|First/Baseline (1 Day at Week 1 )||2
8766867|NCT01254045|9816977|FG003|COMPLETED|First/Baseline (1 Day at Week 1 )||1
8766868|NCT01254045|9816978|FG004|COMPLETED|First/Baseline (1 Day at Week 1 )||1
8766869|NCT01254045|9816979|FG005|COMPLETED|First/Baseline (1 Day at Week 1 )||1
8766870|NCT01254045|9816974|FG000|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||1
8766871|NCT01254045|9816975|FG001|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
8766872|NCT01254045|9816976|FG002|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
8766873|NCT01254045|9816977|FG003|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
8766874|NCT01254045|9816978|FG004|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
8766875|NCT01254045|9816979|FG005|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
8766876|NCT01254045|9816974|FG000|STARTED|Second/Time 2 (1 Day at Week 2)||1
8766877|NCT01254045|9816975|FG001|STARTED|Second/Time 2 (1 Day at Week 2)||2
8766878|NCT01254045|9816976|FG002|STARTED|Second/Time 2 (1 Day at Week 2)||2
8766879|NCT01254045|9816977|FG003|STARTED|Second/Time 2 (1 Day at Week 2)||1
8766880|NCT01254045|9816978|FG004|STARTED|Second/Time 2 (1 Day at Week 2)||1
8766881|NCT01254045|9816979|FG005|STARTED|Second/Time 2 (1 Day at Week 2)||1
8766882|NCT01254045|9816974|FG000|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
8766883|NCT01254045|9816975|FG001|COMPLETED|Second/Time 2 (1 Day at Week 2)||2
8766884|NCT01254045|9816976|FG002|COMPLETED|Second/Time 2 (1 Day at Week 2)||2
8766885|NCT01254045|9816977|FG003|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
8766886|NCT01254045|9816978|FG004|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
8766887|NCT01254045|9816979|FG005|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
8766888|NCT01254045|9816974|FG000|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
8766889|NCT01254045|9816975|FG001|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
8766890|NCT01254045|9816976|FG002|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
8766891|NCT01254045|9816977|FG003|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
8766892|NCT01254045|9816978|FG004|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
8766893|NCT01254045|9816979|FG005|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
8766894|NCT01254045|9816974|FG000|STARTED|Third/Time 3 (1 Day at Week 3)||1
8766895|NCT01254045|9816975|FG001|STARTED|Third/Time 3 (1 Day at Week 3)||2
8766896|NCT01254045|9816976|FG002|STARTED|Third/Time 3 (1 Day at Week 3)||2
8766897|NCT01254045|9816977|FG003|STARTED|Third/Time 3 (1 Day at Week 3)||1
8766898|NCT01254045|9816978|FG004|STARTED|Third/Time 3 (1 Day at Week 3)||1
8766899|NCT01254045|9816979|FG005|STARTED|Third/Time 3 (1 Day at Week 3)||1
8766900|NCT01254045|9816974|FG000|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
8766901|NCT01254045|9816975|FG001|COMPLETED|Third/Time 3 (1 Day at Week 3)||2
8766902|NCT01254045|9816976|FG002|COMPLETED|Third/Time 3 (1 Day at Week 3)||2
8766903|NCT01254045|9816977|FG003|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
8766904|NCT01254045|9816978|FG004|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
8766905|NCT01254045|9816979|FG005|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
8766906|NCT01254045|9816974|FG000|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
8766907|NCT01254045|9816975|FG001|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
8766908|NCT01254045|9816976|FG002|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
8766909|NCT01254045|9816977|FG003|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
8766910|NCT01254045|9816978|FG004|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
8766911|NCT01254045|9816979|FG005|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
8766912|NCT01254188|9816989|FG000|STARTED|Overall Study||421
8766913|NCT01254188|9816989|FG000|COMPLETED|Overall Study||328
8766914|NCT01254188|9816989|FG000|NOT COMPLETED|Overall Study||93
8766915|NCT01254214|9816995|FG000|STARTED|Overall Study||27
8766916|NCT01254214|9816996|FG001|STARTED|Overall Study||28
8766917|NCT01254214|9816995|FG000|COMPLETED|Overall Study||24
8766918|NCT01254214|9816996|FG001|COMPLETED|Overall Study||27
8766919|NCT01254214|9816995|FG000|NOT COMPLETED|Overall Study||3
8766920|NCT01254214|9816996|FG001|NOT COMPLETED|Overall Study||1
8766921|NCT01254227|9817002|FG000|STARTED|Overall Study||60
8766922|NCT01254227|9817002|FG000|Completion of 12 Months|Overall Study||39
8766923|NCT01254227|9817002|FG000|Completion of 24 Months|Overall Study||34
8766924|NCT01254227|9817002|FG000|COMPLETED|Overall Study||34
8766925|NCT01254227|9817002|FG000|NOT COMPLETED|Overall Study||26
8766926|NCT01254292|9817008|FG000|STARTED|Comparative Phase||282
8766927|NCT01254292|9817009|FG001|STARTED|Comparative Phase||285
8766928|NCT01254292|9817008|FG000|Participants Received Treatment|Comparative Phase|safety population|279
8766929|NCT01254292|9817009|FG001|Participants Received Treatment|Comparative Phase|safety population|281
8766930|NCT01254292|9817008|FG000|COMPLETED|Comparative Phase||227
8766931|NCT01254292|9817009|FG001|COMPLETED|Comparative Phase||204
8766932|NCT01254292|9817008|FG000|NOT COMPLETED|Comparative Phase||55
8766933|NCT01254292|9817009|FG001|NOT COMPLETED|Comparative Phase||81
8766934|NCT01254292|9817008|FG000|STARTED|LCS12 Extension Phase|A total of 200 participants elected to enter this optional Extension Phase.|200
8766935|NCT01254292|9817009|FG001|STARTED|LCS12 Extension Phase|Optional Extension Phase was for LCS12 group only.|0
8766936|NCT01254292|9817008|FG000|COMPLETED|LCS12 Extension Phase||163
8766937|NCT01254292|9817009|FG001|COMPLETED|LCS12 Extension Phase||0
8766938|NCT01254292|9817008|FG000|NOT COMPLETED|LCS12 Extension Phase||37
8766939|NCT01254292|9817009|FG001|NOT COMPLETED|LCS12 Extension Phase||0
8766940|NCT01254305|9817019|FG000|STARTED|Overall Study||93
8766941|NCT01254305|9817020|FG001|STARTED|Overall Study||90
8766942|NCT01254305|9817021|FG002|STARTED|Overall Study||79
8766943|NCT01254305|9817019|FG000|Safety Population|Overall Study||89
8766944|NCT01254305|9817020|FG001|Safety Population|Overall Study||85
8766945|NCT01254305|9817021|FG002|Safety Population|Overall Study||77
8766946|NCT01254305|9817019|FG000|COMPLETED|Overall Study||71
8766947|NCT01254305|9817020|FG001|COMPLETED|Overall Study||72
8766948|NCT01254305|9817021|FG002|COMPLETED|Overall Study||62
8766949|NCT01254305|9817019|FG000|NOT COMPLETED|Overall Study||22
8766950|NCT01254305|9817020|FG001|NOT COMPLETED|Overall Study||18
8766951|NCT01254305|9817021|FG002|NOT COMPLETED|Overall Study||17
8766952|NCT01254318|9817032|FG000|STARTED|Overall Study|Alive at start of study|130
8766953|NCT01254318|9817032|FG000|COMPLETED|Overall Study|Alive at end of study|78
8766954|NCT01254318|9817032|FG000|NOT COMPLETED|Overall Study||52
8766955|NCT01254331|9817036|FG000|STARTED|Initial Phase||51
8766956|NCT01254331|9817036|FG000|COMPLETED|Initial Phase||46
8766957|NCT01254331|9817036|FG000|NOT COMPLETED|Initial Phase||5
8766958|NCT01254331|9817036|FG000|STARTED|Extension Phase|1 participant withdrew consent after completing initial phase and did not enter the extension phase|45
8766959|NCT01254331|9817036|FG000|COMPLETED|Extension Phase||41
8766960|NCT01254331|9817036|FG000|NOT COMPLETED|Extension Phase||4
8766961|NCT01254344|9817042|FG000|STARTED|Overall Study||299
8766962|NCT01254344|9817043|FG001|STARTED|Overall Study||300
8766963|NCT01254344|9817042|FG000|Treated|Overall Study||290
8766964|NCT01254344|9817043|FG001|Treated|Overall Study||297
8766965|NCT01254344|9817042|FG000|COMPLETED|Overall Study||286
8766966|NCT01254344|9817043|FG001|COMPLETED|Overall Study||281
8766967|NCT01254344|9817042|FG000|NOT COMPLETED|Overall Study||13
8766968|NCT01254344|9817043|FG001|NOT COMPLETED|Overall Study||19
8766969|NCT01254396|9817049|FG000|STARTED|First Intervention Period||6
8766970|NCT01254396|9817050|FG001|STARTED|First Intervention Period||6
8766971|NCT01254396|9817049|FG000|COMPLETED|First Intervention Period||6
8766972|NCT01254396|9817050|FG001|COMPLETED|First Intervention Period||6
8766973|NCT01254396|9817049|FG000|NOT COMPLETED|First Intervention Period||0
8766974|NCT01254396|9817050|FG001|NOT COMPLETED|First Intervention Period||0
8766975|NCT01254396|9817049|FG000|STARTED|Washout Period (at Least 1 Day)||6
8766976|NCT01254396|9817050|FG001|STARTED|Washout Period (at Least 1 Day)||6
8766977|NCT01254396|9817049|FG000|COMPLETED|Washout Period (at Least 1 Day)||6
8766978|NCT01254396|9817050|FG001|COMPLETED|Washout Period (at Least 1 Day)||6
8766979|NCT01254396|9817049|FG000|NOT COMPLETED|Washout Period (at Least 1 Day)||0
8766980|NCT01254396|9817050|FG001|NOT COMPLETED|Washout Period (at Least 1 Day)||0
8766981|NCT01254396|9817049|FG000|STARTED|Second Intervention Period||6
8766982|NCT01254396|9817050|FG001|STARTED|Second Intervention Period||6
8766983|NCT01254396|9817049|FG000|COMPLETED|Second Intervention Period||6
8766984|NCT01254396|9817050|FG001|COMPLETED|Second Intervention Period||6
8766985|NCT01254396|9817049|FG000|NOT COMPLETED|Second Intervention Period||0
8766986|NCT01254396|9817050|FG001|NOT COMPLETED|Second Intervention Period||0
8766987|NCT01254552|9817056|FG000|STARTED|Screening Visit||351
8766988|NCT01254552|9817056|FG000|COMPLETED|Screening Visit||348
8766989|NCT01254552|9817056|FG000|NOT COMPLETED|Screening Visit||3
8766990|NCT01254552|9817056|FG000|STARTED|Delayed-enhanced MRI With Dotarem||348
8766991|NCT01254552|9817056|FG000|COMPLETED|Delayed-enhanced MRI With Dotarem||328
8766992|NCT01254552|9817056|FG000|NOT COMPLETED|Delayed-enhanced MRI With Dotarem||20
8766993|NCT01254552|9817056|FG000|STARTED|CCTA With Xenetix 350||328
8766994|NCT01254552|9817056|FG000|COMPLETED|CCTA With Xenetix 350||322
8766995|NCT01254552|9817056|FG000|NOT COMPLETED|CCTA With Xenetix 350||6
8766996|NCT01254565|9817070|FG000|STARTED|Overall Study||5
8766997|NCT01254565|9817071|FG001|STARTED|Overall Study||7
8766998|NCT01254565|9817072|FG002|STARTED|Overall Study||21
8766999|NCT01254565|9817073|FG003|STARTED|Overall Study||21
8767000|NCT01254565|9817074|FG004|STARTED|Overall Study||16
8767001|NCT01254565|9817075|FG005|STARTED|Overall Study||17
8767002|NCT01254565|9817070|FG000|Received Treatment|Overall Study||4
8767003|NCT01254565|9817071|FG001|Received Treatment|Overall Study||6
8767004|NCT01254565|9817072|FG002|Received Treatment|Overall Study||21
8767005|NCT01254565|9817073|FG003|Received Treatment|Overall Study||21
8767006|NCT01254565|9817074|FG004|Received Treatment|Overall Study||13
8767007|NCT01254565|9817075|FG005|Received Treatment|Overall Study||13
8767008|NCT01254565|9817070|FG000|COMPLETED|Overall Study||4
8767009|NCT01254565|9817071|FG001|COMPLETED|Overall Study||6
8767010|NCT01254565|9817072|FG002|COMPLETED|Overall Study||21
8767011|NCT01254565|9817073|FG003|COMPLETED|Overall Study||20
8767012|NCT01254565|9817074|FG004|COMPLETED|Overall Study||12
8767013|NCT01254565|9817075|FG005|COMPLETED|Overall Study||13
8767014|NCT01254565|9817070|FG000|NOT COMPLETED|Overall Study||1
8767015|NCT01254565|9817071|FG001|NOT COMPLETED|Overall Study||1
8767016|NCT01254565|9817072|FG002|NOT COMPLETED|Overall Study||0
8767017|NCT01254565|9817073|FG003|NOT COMPLETED|Overall Study||1
8767018|NCT01254565|9817074|FG004|NOT COMPLETED|Overall Study||4
8767019|NCT01254565|9817075|FG005|NOT COMPLETED|Overall Study||4
8767020|NCT01254604|9817091|FG000|STARTED|Overall Study||95
8767021|NCT01254604|9817092|FG001|STARTED|Overall Study||95
8767022|NCT01254604|9817091|FG000|Treated|Overall Study|"The 2 out of 95 started who did not take study drug discontinued due to Withdrawal by Subject"|93
8767023|NCT01254604|9817092|FG001|Treated|Overall Study|"The 1 out of 95 started who did not take study drug discontinued due to Withdrawal by Subject"|94
8767024|NCT01254604|9817091|FG000|COMPLETED|Overall Study||87
8767025|NCT01254604|9817092|FG001|COMPLETED|Overall Study||86
8767026|NCT01254604|9817091|FG000|NOT COMPLETED|Overall Study||8
8767027|NCT01254604|9817092|FG001|NOT COMPLETED|Overall Study||9
8808475|NCT01490632|9860710|FG009|NOT COMPLETED|Part C: Washout or Step-Down Period||0
8808476|NCT01490632|9860711|FG010|NOT COMPLETED|Part C: Washout or Step-Down Period||0
8808477|NCT01490632|9860712|FG011|NOT COMPLETED|Part C: Washout or Step-Down Period||0
8808478|NCT01490632|9860713|FG012|NOT COMPLETED|Part C: Washout or Step-Down Period||5
8808479|NCT01490632|9860714|FG013|NOT COMPLETED|Part C: Washout or Step-Down Period||10
8808480|NCT01490632|9860715|FG014|NOT COMPLETED|Part C: Washout or Step-Down Period||18
8808481|NCT01490632|9860716|FG015|NOT COMPLETED|Part C: Washout or Step-Down Period||37
8808482|NCT01490632|9860717|FG016|NOT COMPLETED|Part C: Washout or Step-Down Period||0
8808483|NCT01490632|9860718|FG017|NOT COMPLETED|Part C: Washout or Step-Down Period||0
8808484|NCT01490632|9860719|FG018|NOT COMPLETED|Part C: Washout or Step-Down Period||0
8808485|NCT01490632|9860720|FG019|NOT COMPLETED|Part C: Washout or Step-Down Period||0
8808486|NCT01490632|9860701|FG000|STARTED|Part D: Re-Treatment Period||0
8808487|NCT01490632|9860702|FG001|STARTED|Part D: Re-Treatment Period||0
8808488|NCT01490632|9860703|FG002|STARTED|Part D: Re-Treatment Period||0
8808489|NCT01490632|9860704|FG003|STARTED|Part D: Re-Treatment Period||0
8808490|NCT01490632|9860705|FG004|STARTED|Part D: Re-Treatment Period||0
8808491|NCT01490632|9860706|FG005|STARTED|Part D: Re-Treatment Period||0
8808492|NCT01490632|9860707|FG006|STARTED|Part D: Re-Treatment Period||0
8808493|NCT01490632|9860708|FG007|STARTED|Part D: Re-Treatment Period||0
8808494|NCT01490632|9860709|FG008|STARTED|Part D: Re-Treatment Period||0
8808495|NCT01490632|9860710|FG009|STARTED|Part D: Re-Treatment Period||0
8808496|NCT01490632|9860711|FG010|STARTED|Part D: Re-Treatment Period||0
8808497|NCT01490632|9860712|FG011|STARTED|Part D: Re-Treatment Period||0
8808498|NCT01490632|9860713|FG012|STARTED|Part D: Re-Treatment Period|Responders receiving 2 or 4 mg were re-randomized to receive placebo.|0
8808499|NCT01490632|9860714|FG013|STARTED|Part D: Re-Treatment Period|Responders receiving 2 or 4 mg were re-randomized to receive half of the dose from Part B.|0
8808500|NCT01490632|9860715|FG014|STARTED|Part D: Re-Treatment Period|Responders receiving 8 or 10 mg were re-randomized to receive placebo.|0
8808501|NCT01490632|9860716|FG015|STARTED|Part D: Re-Treatment Period|Responders receiving 8 or 10 mg were re-randomized to receive 4 mg.|0
8808502|NCT01490632|9860717|FG016|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 2 mg.|3
8808503|NCT01490632|9860718|FG017|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 4 mg.|13
8808504|NCT01490632|9860719|FG018|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 8 mg.|19
8808505|NCT01490632|9860720|FG019|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 10 mg.|37
8808506|NCT01490632|9860701|FG000|COMPLETED|Part D: Re-Treatment Period||0
8808507|NCT01490632|9860702|FG001|COMPLETED|Part D: Re-Treatment Period||0
8767028|NCT01254630|9817102|FG000|STARTED|Overall Study||1348
8767029|NCT01254630|9817103|FG001|STARTED|Overall Study||1288
8767030|NCT01254630|9817104|FG002|STARTED|Overall Study||1364
8767031|NCT01254630|9817105|FG003|STARTED|Overall Study||1285
8767032|NCT01254630|9817102|FG000|Received Vaccination 1|Overall Study||1328
8767033|NCT01254630|9817103|FG001|Received Vaccination 1|Overall Study||1277
8767034|NCT01254630|9817104|FG002|Received Vaccination 1|Overall Study||1350
8767035|NCT01254630|9817105|FG003|Received Vaccination 1|Overall Study||1275
8767036|NCT01254630|9817102|FG000|Received Vaccination 2|Overall Study||1255
8767037|NCT01254630|9817103|FG001|Received Vaccination 2|Overall Study||1217
8767038|NCT01254630|9817104|FG002|Received Vaccination 2|Overall Study||1286
8767039|NCT01254630|9817105|FG003|Received Vaccination 2|Overall Study||1226
8767040|NCT01254630|9817102|FG000|Received Vaccination 3|Overall Study||1198
8767041|NCT01254630|9817103|FG001|Received Vaccination 3|Overall Study||1178
8767042|NCT01254630|9817104|FG002|Received Vaccination 3|Overall Study||1247
8767043|NCT01254630|9817105|FG003|Received Vaccination 3|Overall Study||1194
8767044|NCT01254630|9817102|FG000|Received Vaccination 4|Overall Study||1155
8767045|NCT01254630|9817103|FG001|Received Vaccination 4|Overall Study||1145
8767046|NCT01254630|9817104|FG002|Received Vaccination 4|Overall Study||1212
8767047|NCT01254630|9817105|FG003|Received Vaccination 4|Overall Study||1160
8767048|NCT01254630|9817102|FG000|COMPLETED|Overall Study||546
8767049|NCT01254630|9817103|FG001|COMPLETED|Overall Study||0
8767050|NCT01254630|9817104|FG002|COMPLETED|Overall Study||552
8767051|NCT01254630|9817105|FG003|COMPLETED|Overall Study||0
8767052|NCT01254630|9817102|FG000|NOT COMPLETED|Overall Study||802
8767053|NCT01254630|9817103|FG001|NOT COMPLETED|Overall Study||1288
8767054|NCT01254630|9817104|FG002|NOT COMPLETED|Overall Study||812
8767055|NCT01254630|9817105|FG003|NOT COMPLETED|Overall Study||1285
8767056|NCT01254643|9817113|FG000|STARTED|Overall Study||100
8767057|NCT01254643|9817113|FG000|Vaccination 1|Overall Study||100
8767058|NCT01254643|9817113|FG000|Vaccination 2|Overall Study||99
8767059|NCT01254643|9817113|FG000|Vaccination 3|Overall Study||99
8767060|NCT01254643|9817113|FG000|COMPLETED|Overall Study||99
8767061|NCT01254643|9817113|FG000|NOT COMPLETED|Overall Study||1
8767062|NCT01254656|9817120|FG000|STARTED|Overall Study||47
8767063|NCT01254656|9817121|FG001|STARTED|Overall Study||43
8915751|NCT02177136|9975250|FG002|Received At Least 1 Dose Of Study Drug|DB Phase||25
8915752|NCT02177136|9975251|FG003|Received At Least 1 Dose Of Study Drug|DB Phase||0
8915753|NCT02177136|9975248|FG000|COMPLETED|DB Phase||19
8915754|NCT02177136|9975249|FG001|COMPLETED|DB Phase||21
8915755|NCT02177136|9975250|FG002|COMPLETED|DB Phase||21
8915756|NCT02177136|9975251|FG003|COMPLETED|DB Phase||0
8915757|NCT02177136|9975248|FG000|NOT COMPLETED|DB Phase||7
8915758|NCT02177136|9975249|FG001|NOT COMPLETED|DB Phase||5
8915759|NCT02177136|9975250|FG002|NOT COMPLETED|DB Phase||4
8915760|NCT02177136|9975251|FG003|NOT COMPLETED|DB Phase||0
8915761|NCT02177136|9975248|FG000|STARTED|LTSE Phase|Eligible participants who completed the DB phase could enroll in the LTSE phase.|0
8915762|NCT02177136|9975249|FG001|STARTED|LTSE Phase|Eligible participants who completed the DB phase could enroll in the LTSE phase.|0
8915763|NCT02177136|9975250|FG002|STARTED|LTSE Phase|Eligible participants who completed the DB phase could enroll in the LTSE phase.|0
8915764|NCT02177136|9975251|FG003|STARTED|LTSE Phase|Eligible participants who completed the DB phase could enroll in the LTSE phase.|59
8915765|NCT02177136|9975248|FG000|Received At Least 1 Dose Of Study Drug|LTSE Phase||0
8915766|NCT02177136|9975249|FG001|Received At Least 1 Dose Of Study Drug|LTSE Phase||0
8915767|NCT02177136|9975250|FG002|Received At Least 1 Dose Of Study Drug|LTSE Phase||0
8915768|NCT02177136|9975251|FG003|Received At Least 1 Dose Of Study Drug|LTSE Phase||59
8915769|NCT02177136|9975248|FG000|COMPLETED|LTSE Phase||0
8915770|NCT02177136|9975249|FG001|COMPLETED|LTSE Phase||0
8915771|NCT02177136|9975250|FG002|COMPLETED|LTSE Phase||0
8915772|NCT02177136|9975251|FG003|COMPLETED|LTSE Phase||35
8915773|NCT02177136|9975248|FG000|NOT COMPLETED|LTSE Phase||0
8915774|NCT02177136|9975249|FG001|NOT COMPLETED|LTSE Phase||0
8915775|NCT02177136|9975250|FG002|NOT COMPLETED|LTSE Phase||0
8915776|NCT02177136|9975251|FG003|NOT COMPLETED|LTSE Phase||24
8915777|NCT02177201|9975264|FG000|STARTED|Overall Study||80
8915778|NCT02177201|9975265|FG001|STARTED|Overall Study||80
8915779|NCT02177201|9975264|FG000|COMPLETED|Overall Study||77
8915780|NCT02177201|9975265|FG001|COMPLETED|Overall Study||77
8915781|NCT02177201|9975264|FG000|NOT COMPLETED|Overall Study||3
8915782|NCT02177201|9975265|FG001|NOT COMPLETED|Overall Study||3
8915783|NCT02177786|9975275|FG000|STARTED|Overall Study||81
8915784|NCT02177786|9975276|FG001|STARTED|Overall Study||84
8915785|NCT02177786|9975277|FG002|STARTED|Overall Study||84
8915786|NCT02177786|9975278|FG003|STARTED|Overall Study||85
8915787|NCT02177786|9975275|FG000|Randomized and Treated|Overall Study||81
8915788|NCT02177786|9975276|FG001|Randomized and Treated|Overall Study||84
8915789|NCT02177786|9975277|FG002|Randomized and Treated|Overall Study||83
8915790|NCT02177786|9975278|FG003|Randomized and Treated|Overall Study||85
8915791|NCT02177786|9975275|FG000|COMPLETED|Overall Study||75
8915792|NCT02177786|9975276|FG001|COMPLETED|Overall Study||70
8915793|NCT02177786|9975277|FG002|COMPLETED|Overall Study||66
8915794|NCT02177786|9975278|FG003|COMPLETED|Overall Study||72
8915795|NCT02177786|9975275|FG000|NOT COMPLETED|Overall Study||6
8915796|NCT02177786|9975276|FG001|NOT COMPLETED|Overall Study||14
8915797|NCT02177786|9975277|FG002|NOT COMPLETED|Overall Study||18
8767064|NCT01254656|9817122|FG002|STARTED|Overall Study||18
8767065|NCT01254656|9817120|FG000|Treated|Overall Study||47
8915798|NCT02177786|9975278|FG003|NOT COMPLETED|Overall Study||13
8915799|NCT02177812|9975297|FG000|STARTED|Part 1 (Median of 4 Weeks)||1
8915800|NCT02177812|9975298|FG001|STARTED|Part 1 (Median of 4 Weeks)||2
8915801|NCT02177812|9975299|FG002|STARTED|Part 1 (Median of 4 Weeks)||7
8915802|NCT02177812|9975300|FG003|STARTED|Part 1 (Median of 4 Weeks)||5
8915803|NCT02177812|9975301|FG004|STARTED|Part 1 (Median of 4 Weeks)||6
8915804|NCT02177812|9975302|FG005|STARTED|Part 1 (Median of 4 Weeks)||4
8915805|NCT02177812|9975303|FG006|STARTED|Part 1 (Median of 4 Weeks)||10
8915806|NCT02177812|9975304|FG007|STARTED|Part 1 (Median of 4 Weeks)||6
8915807|NCT02177812|9975305|FG008|STARTED|Part 1 (Median of 4 Weeks)||0
8915808|NCT02177812|9975297|FG000|COMPLETED|Part 1 (Median of 4 Weeks)||1
8915809|NCT02177812|9975298|FG001|COMPLETED|Part 1 (Median of 4 Weeks)||2
8915810|NCT02177812|9975299|FG002|COMPLETED|Part 1 (Median of 4 Weeks)||7
8915811|NCT02177812|9975300|FG003|COMPLETED|Part 1 (Median of 4 Weeks)||4
8915812|NCT02177812|9975301|FG004|COMPLETED|Part 1 (Median of 4 Weeks)||5
9027322|NCT03187132|10089743|FG000|STARTED|Inpatient Trauma+Pain Clinic, no Opioid||4
8767066|NCT01254656|9817121|FG001|Treated|Overall Study||43
8767067|NCT01254656|9817122|FG002|Treated|Overall Study||18
8767068|NCT01254656|9817120|FG000|COMPLETED|Overall Study||0
8767069|NCT01254656|9817121|FG001|COMPLETED|Overall Study||0
8767070|NCT01254656|9817122|FG002|COMPLETED|Overall Study||0
8767071|NCT01254656|9817120|FG000|NOT COMPLETED|Overall Study||47
8767072|NCT01254656|9817121|FG001|NOT COMPLETED|Overall Study||43
8767073|NCT01254656|9817122|FG002|NOT COMPLETED|Overall Study||18
8767074|NCT01254669|9817132|FG000|STARTED|Overall Study||100
8767075|NCT01254669|9817133|FG001|STARTED|Overall Study||100
8767076|NCT01254669|9817132|FG000|COMPLETED|Overall Study||97
8767077|NCT01254669|9817133|FG001|COMPLETED|Overall Study||96
8767078|NCT01254669|9817132|FG000|NOT COMPLETED|Overall Study||3
8767079|NCT01254669|9817133|FG001|NOT COMPLETED|Overall Study||4
8767080|NCT01254721|9817143|FG000|STARTED|Overall Study|Seroquel XR: 300mg|67
8767081|NCT01254721|9817144|FG001|STARTED|Overall Study|Seroquel XR: 300mg Lithium: 900mg|64
8767082|NCT01254721|9817143|FG000|COMPLETED|Overall Study||52
8767083|NCT01254721|9817144|FG001|COMPLETED|Overall Study||42
8767084|NCT01254721|9817143|FG000|NOT COMPLETED|Overall Study||15
8767085|NCT01254721|9817144|FG001|NOT COMPLETED|Overall Study||22
8767086|NCT01254747|9817154|FG000|STARTED|Overall Study||40
8767087|NCT01254747|9817155|FG001|STARTED|Overall Study||29
8767088|NCT01254747|9817156|FG002|STARTED|Overall Study||30
8767089|NCT01254747|9817157|FG003|STARTED|Overall Study||30
8767090|NCT01254747|9817154|FG000|COMPLETED|Overall Study||40
8767091|NCT01254747|9817155|FG001|COMPLETED|Overall Study||23
8767092|NCT01254747|9817156|FG002|COMPLETED|Overall Study||26
8767093|NCT01254747|9817157|FG003|COMPLETED|Overall Study||28
8767094|NCT01254747|9817154|FG000|NOT COMPLETED|Overall Study||0
8767095|NCT01254747|9817155|FG001|NOT COMPLETED|Overall Study||6
8767096|NCT01254747|9817156|FG002|NOT COMPLETED|Overall Study||4
8767097|NCT01254747|9817157|FG003|NOT COMPLETED|Overall Study||2
8767098|NCT01254760|9817167|FG000|STARTED|First Period, 5 Days of Wear||34
8767099|NCT01254760|9817168|FG001|STARTED|First Period, 5 Days of Wear||38
8767100|NCT01254760|9817167|FG000|COMPLETED|First Period, 5 Days of Wear||34
8767101|NCT01254760|9817168|FG001|COMPLETED|First Period, 5 Days of Wear||38
8767102|NCT01254760|9817167|FG000|NOT COMPLETED|First Period, 5 Days of Wear||0
8767103|NCT01254760|9817168|FG001|NOT COMPLETED|First Period, 5 Days of Wear||0
8767104|NCT01254760|9817167|FG000|STARTED|Second Period, 5 Days of Wear||34
8767105|NCT01254760|9817168|FG001|STARTED|Second Period, 5 Days of Wear||38
8767106|NCT01254760|9817167|FG000|COMPLETED|Second Period, 5 Days of Wear||34
8767107|NCT01254760|9817168|FG001|COMPLETED|Second Period, 5 Days of Wear||38
8767108|NCT01254760|9817167|FG000|NOT COMPLETED|Second Period, 5 Days of Wear||0
8767109|NCT01254760|9817168|FG001|NOT COMPLETED|Second Period, 5 Days of Wear||0
8767110|NCT01254851|9817177|FG000|STARTED|Overall Study||69
8767111|NCT01254851|9817178|FG001|STARTED|Overall Study||77
8767112|NCT01254851|9817177|FG000|COMPLETED|Overall Study||61
8767113|NCT01254851|9817178|FG001|COMPLETED|Overall Study||68
8767114|NCT01254851|9817177|FG000|NOT COMPLETED|Overall Study||8
8767115|NCT01254851|9817178|FG001|NOT COMPLETED|Overall Study||9
8767116|NCT01254877|9817187|FG000|STARTED|Overall Study||67
8767117|NCT01254877|9817188|FG001|STARTED|Overall Study||69
8767118|NCT01254877|9817189|FG002|STARTED|Overall Study||69
8767119|NCT01254877|9817187|FG000|COMPLETED|Overall Study||57
8767120|NCT01254877|9817188|FG001|COMPLETED|Overall Study||58
8767121|NCT01254877|9817189|FG002|COMPLETED|Overall Study||64
8767122|NCT01254877|9817187|FG000|NOT COMPLETED|Overall Study||10
8767123|NCT01254877|9817188|FG001|NOT COMPLETED|Overall Study||11
8767124|NCT01254877|9817189|FG002|NOT COMPLETED|Overall Study||5
8767125|NCT01254890|9817199|FG000|STARTED|Overall Study||3
8767126|NCT01254890|9817200|FG001|STARTED|Overall Study||57
8767127|NCT01254890|9817199|FG000|COMPLETED|Overall Study||2
8767128|NCT01254890|9817200|FG001|COMPLETED|Overall Study||47
8767129|NCT01254890|9817199|FG000|NOT COMPLETED|Overall Study||1
8767130|NCT01254890|9817200|FG001|NOT COMPLETED|Overall Study||10
8767131|NCT01255137|9817205|FG000|STARTED|Overall Study||13
8767132|NCT01255137|9817205|FG000|COMPLETED|Overall Study||13
8767133|NCT01255137|9817205|FG000|NOT COMPLETED|Overall Study||0
8767134|NCT01255163|9817211|FG000|STARTED|Overall Study||13
8767135|NCT01255163|9817212|FG001|STARTED|Overall Study||14
8767136|NCT01255163|9817211|FG000|COMPLETED|Overall Study||9
8767137|NCT01255163|9817212|FG001|COMPLETED|Overall Study||9
8767138|NCT01255163|9817211|FG000|NOT COMPLETED|Overall Study||4
8767139|NCT01255163|9817212|FG001|NOT COMPLETED|Overall Study||5
8767140|NCT01255306|9817222|FG000|STARTED|Overall Study||26
8767141|NCT01255306|9817223|FG001|STARTED|Overall Study||33
8767142|NCT01255306|9817222|FG000|COMPLETED|Overall Study||25
8767143|NCT01255306|9817223|FG001|COMPLETED|Overall Study||32
8767144|NCT01255306|9817222|FG000|NOT COMPLETED|Overall Study||1
8767145|NCT01255306|9817223|FG001|NOT COMPLETED|Overall Study||1
8767146|NCT01255423|9817234|FG000|STARTED|Overall Study||104
8767147|NCT01255423|9817235|FG001|STARTED|Overall Study||102
8767148|NCT01255423|9817234|FG000|COMPLETED|Overall Study||101
8767149|NCT01255423|9817235|FG001|COMPLETED|Overall Study||99
8767150|NCT01255423|9817234|FG000|NOT COMPLETED|Overall Study||3
8767151|NCT01255423|9817235|FG001|NOT COMPLETED|Overall Study||3
8767152|NCT01255436|9817243|FG000|STARTED|Overall Study|350 patients enrolled but 17 excluded because of missing baseline data.|333
8767153|NCT01255436|9817244|FG001|STARTED|Overall Study|350 patients enrolled but 21 excluded because of missing baseline data|329
8767154|NCT01255436|9817243|FG000|COMPLETED|Overall Study||151
8767155|NCT01255436|9817244|FG001|COMPLETED|Overall Study||135
8767156|NCT01255436|9817243|FG000|NOT COMPLETED|Overall Study||182
8767157|NCT01255436|9817244|FG001|NOT COMPLETED|Overall Study||194
8767158|NCT01255449|9817250|FG000|STARTED|Overall Study||26
8767159|NCT01255449|9817250|FG000|COMPLETED|Overall Study||26
8767160|NCT01255449|9817250|FG000|NOT COMPLETED|Overall Study||0
8767161|NCT01255592|9817257|FG000|STARTED|Overall Study||26
8767162|NCT01255592|9817258|FG001|STARTED|Overall Study||26
8767163|NCT01255592|9817257|FG000|COMPLETED|Overall Study||20
8767164|NCT01255592|9817258|FG001|COMPLETED|Overall Study||25
8767165|NCT01255592|9817257|FG000|NOT COMPLETED|Overall Study||6
8767166|NCT01255592|9817258|FG001|NOT COMPLETED|Overall Study||1
8767167|NCT01255631|9817267|FG000|STARTED|Overall Study||13
8767168|NCT01255631|9817268|FG001|STARTED|Overall Study||9
8767169|NCT01255631|9817267|FG000|COMPLETED|Overall Study|study terminated due to poor enrollment|4
8767170|NCT01255631|9817268|FG001|COMPLETED|Overall Study|study terminated due to poor enrollment|3
8767171|NCT01255631|9817267|FG000|NOT COMPLETED|Overall Study||9
8767172|NCT01255631|9817268|FG001|NOT COMPLETED|Overall Study||6
8767173|NCT01255670|9817276|FG000|STARTED|Overall Study||100
8767174|NCT01255670|9817277|FG001|STARTED|Overall Study||100
8767175|NCT01255670|9817276|FG000|COMPLETED|Overall Study||74
8767176|NCT01255670|9817277|FG001|COMPLETED|Overall Study||80
8767177|NCT01255670|9817276|FG000|NOT COMPLETED|Overall Study||26
8767178|NCT01255670|9817277|FG001|NOT COMPLETED|Overall Study||20
8767179|NCT01255722|9817286|FG000|STARTED|Overall Study||155
8767180|NCT01255722|9817287|FG001|STARTED|Overall Study||160
8767181|NCT01255722|9817288|FG002|STARTED|Overall Study||153
8767182|NCT01255722|9817286|FG000|COMPLETED|Overall Study||152
8767183|NCT01255722|9817287|FG001|COMPLETED|Overall Study||159
8767184|NCT01255722|9817288|FG002|COMPLETED|Overall Study||152
8767185|NCT01255722|9817286|FG000|NOT COMPLETED|Overall Study||3
8767186|NCT01255722|9817287|FG001|NOT COMPLETED|Overall Study||1
8767187|NCT01255722|9817288|FG002|NOT COMPLETED|Overall Study||1
8767188|NCT01255761|9817299|FG000|STARTED|Overall Study||369
8767189|NCT01255761|9817300|FG001|STARTED|Overall Study||367
8767190|NCT01255761|9817299|FG000|COMPLETED|Overall Study||187
8767191|NCT01255761|9817300|FG001|COMPLETED|Overall Study||192
8767192|NCT01255761|9817299|FG000|NOT COMPLETED|Overall Study||182
8767193|NCT01255761|9817300|FG001|NOT COMPLETED|Overall Study||175
8767194|NCT01255787|9817310|FG000|STARTED|Overall Study||152
8767195|NCT01255787|9817311|FG001|STARTED|Overall Study||144
8767196|NCT01255787|9817312|FG002|STARTED|Overall Study||150
8767197|NCT01255787|9817313|FG003|STARTED|Overall Study||154
8767198|NCT01255787|9817310|FG000|Treated|Overall Study||152
8767199|NCT01255787|9817311|FG001|Treated|Overall Study||144
8767200|NCT01255787|9817312|FG002|Treated|Overall Study||148
8767201|NCT01255787|9817313|FG003|Treated|Overall Study||150
8767202|NCT01255787|9817310|FG000|COMPLETED|Overall Study||136
8767203|NCT01255787|9817311|FG001|COMPLETED|Overall Study||127
8915813|NCT02177812|9975302|FG005|COMPLETED|Part 1 (Median of 4 Weeks)||1
9027323|NCT03187132|10089744|FG001|STARTED|Inpatient Trauma+Pain Clinic, no Opioid||5
9027324|NCT03187132|10089743|FG000|COMPLETED|Inpatient Trauma+Pain Clinic, no Opioid||3
8767204|NCT01255787|9817312|FG002|COMPLETED|Overall Study||132
8767205|NCT01255787|9817313|FG003|COMPLETED|Overall Study||132
8767206|NCT01255787|9817310|FG000|NOT COMPLETED|Overall Study||16
8767207|NCT01255787|9817311|FG001|NOT COMPLETED|Overall Study||17
8767208|NCT01255787|9817312|FG002|NOT COMPLETED|Overall Study||18
8767209|NCT01255787|9817313|FG003|NOT COMPLETED|Overall Study||22
8767210|NCT01255865|9817330|FG000|STARTED|Overall Study||1
8767211|NCT01255865|9817331|FG001|STARTED|Overall Study||10
8767212|NCT01255865|9817332|FG002|STARTED|Overall Study||10
8767213|NCT01255865|9817333|FG003|STARTED|Overall Study||30
8767214|NCT01255865|9817334|FG004|STARTED|Overall Study||20
8767215|NCT01255865|9817335|FG005|STARTED|Overall Study||20
8915814|NCT02177812|9975303|FG006|COMPLETED|Part 1 (Median of 4 Weeks)||1
8915815|NCT02177812|9975304|FG007|COMPLETED|Part 1 (Median of 4 Weeks)||4
8915816|NCT02177812|9975305|FG008|COMPLETED|Part 1 (Median of 4 Weeks)||0
8915817|NCT02177812|9975297|FG000|NOT COMPLETED|Part 1 (Median of 4 Weeks)||0
8915818|NCT02177812|9975298|FG001|NOT COMPLETED|Part 1 (Median of 4 Weeks)||0
8915819|NCT02177812|9975299|FG002|NOT COMPLETED|Part 1 (Median of 4 Weeks)||0
8915820|NCT02177812|9975300|FG003|NOT COMPLETED|Part 1 (Median of 4 Weeks)||1
8915821|NCT02177812|9975301|FG004|NOT COMPLETED|Part 1 (Median of 4 Weeks)||1
8767216|NCT01255865|9817336|FG006|STARTED|Overall Study||20
8767217|NCT01255865|9817330|FG000|COMPLETED|Overall Study||1
8767218|NCT01255865|9817331|FG001|COMPLETED|Overall Study||10
8767219|NCT01255865|9817332|FG002|COMPLETED|Overall Study||10
8767220|NCT01255865|9817333|FG003|COMPLETED|Overall Study||30
8767221|NCT01255865|9817334|FG004|COMPLETED|Overall Study||20
8767222|NCT01255865|9817335|FG005|COMPLETED|Overall Study||20
8767223|NCT01255865|9817336|FG006|COMPLETED|Overall Study||20
8767224|NCT01255865|9817330|FG000|NOT COMPLETED|Overall Study||0
8767225|NCT01255865|9817331|FG001|NOT COMPLETED|Overall Study||0
8767226|NCT01255865|9817332|FG002|NOT COMPLETED|Overall Study||0
8767227|NCT01255865|9817333|FG003|NOT COMPLETED|Overall Study||0
8767228|NCT01255865|9817334|FG004|NOT COMPLETED|Overall Study||0
8767229|NCT01255865|9817335|FG005|NOT COMPLETED|Overall Study||0
8767230|NCT01255865|9817336|FG006|NOT COMPLETED|Overall Study||0
8767231|NCT01255904|9817354|FG000|STARTED|Overall Study||45
8767232|NCT01255904|9817355|FG001|STARTED|Overall Study||45
8767233|NCT01255904|9817354|FG000|COMPLETED|Overall Study||44
8767234|NCT01255904|9817355|FG001|COMPLETED|Overall Study||41
8767235|NCT01255904|9817354|FG000|NOT COMPLETED|Overall Study||1
8767236|NCT01255904|9817355|FG001|NOT COMPLETED|Overall Study||4
8767237|NCT01256008|9817364|FG000|STARTED|Overall Study||98
8767238|NCT01256008|9817365|FG001|STARTED|Overall Study||98
8767239|NCT01256008|9817366|FG002|STARTED|Overall Study||196
8767240|NCT01256008|9817364|FG000|COMPLETED|Overall Study||90
8767241|NCT01256008|9817365|FG001|COMPLETED|Overall Study||91
8767242|NCT01256008|9817366|FG002|COMPLETED|Overall Study||175
8767243|NCT01256008|9817364|FG000|NOT COMPLETED|Overall Study||8
8767244|NCT01256008|9817365|FG001|NOT COMPLETED|Overall Study||7
8767245|NCT01256008|9817366|FG002|NOT COMPLETED|Overall Study||21
8767246|NCT01256034|9817378|FG000|STARTED|Overall Study||25
8767247|NCT01256034|9817379|FG001|STARTED|Overall Study||25
8767248|NCT01256034|9817378|FG000|COMPLETED|Overall Study||0
8767249|NCT01256034|9817379|FG001|COMPLETED|Overall Study||0
8767250|NCT01256034|9817378|FG000|NOT COMPLETED|Overall Study||25
8767251|NCT01256034|9817379|FG001|NOT COMPLETED|Overall Study||25
8767252|NCT01256060|9817385|FG000|STARTED|Overall Study||3
8767253|NCT01256060|9817386|FG001|STARTED|Overall Study||3
8767254|NCT01256060|9817387|FG002|STARTED|Overall Study||3
8767255|NCT01256060|9817388|FG003|STARTED|Overall Study||6
8767256|NCT01256060|9817385|FG000|COMPLETED|Overall Study||3
8767257|NCT01256060|9817386|FG001|COMPLETED|Overall Study||2
8767258|NCT01256060|9817387|FG002|COMPLETED|Overall Study||3
8767259|NCT01256060|9817388|FG003|COMPLETED|Overall Study||6
8767260|NCT01256060|9817385|FG000|NOT COMPLETED|Overall Study||0
8767261|NCT01256060|9817386|FG001|NOT COMPLETED|Overall Study||1
8767262|NCT01256060|9817387|FG002|NOT COMPLETED|Overall Study||0
8767263|NCT01256060|9817388|FG003|NOT COMPLETED|Overall Study||0
8767264|NCT01256164|9817396|FG000|STARTED|Overall Study||47
8767265|NCT01256164|9817397|FG001|STARTED|Overall Study||23
8767266|NCT01256164|9817396|FG000|COMPLETED|Overall Study||47
8767267|NCT01256164|9817397|FG001|COMPLETED|Overall Study||23
8767268|NCT01256164|9817396|FG000|NOT COMPLETED|Overall Study||0
8767269|NCT01256164|9817397|FG001|NOT COMPLETED|Overall Study||0
8767270|NCT01256177|9817405|FG000|STARTED|Overall Study||148
8767271|NCT01256177|9817406|FG001|STARTED|Overall Study||148
8767272|NCT01256177|9817405|FG000|COMPLETED|Overall Study||98
8767273|NCT01256177|9817406|FG001|COMPLETED|Overall Study||111
8767274|NCT01256177|9817405|FG000|NOT COMPLETED|Overall Study||50
8767275|NCT01256177|9817406|FG001|NOT COMPLETED|Overall Study||37
8767276|NCT01256190|9817414|FG000|STARTED|Overall Study||39
8767277|NCT01256190|9817415|FG001|STARTED|Overall Study||17
8767278|NCT01256190|9817414|FG000|COMPLETED|Overall Study||37
8767279|NCT01256190|9817415|FG001|COMPLETED|Overall Study||17
8767280|NCT01256190|9817414|FG000|NOT COMPLETED|Overall Study||2
8767281|NCT01256190|9817415|FG001|NOT COMPLETED|Overall Study||0
8767282|NCT01256294|9817421|FG000|STARTED|Overall Study||36
8767283|NCT01256294|9817422|FG001|STARTED|Overall Study||35
8767284|NCT01256294|9817421|FG000|COMPLETED|Overall Study||32
8767285|NCT01256294|9817422|FG001|COMPLETED|Overall Study||33
8767286|NCT01256294|9817421|FG000|NOT COMPLETED|Overall Study||4
8767287|NCT01256294|9817422|FG001|NOT COMPLETED|Overall Study||2
8671307|NCT00750308|9714633|FG001|COMPLETED|Washout||1
8671308|NCT00750308|9714634|FG002|COMPLETED|Washout||2
8671309|NCT00750308|9714635|FG003|COMPLETED|Washout||1
8671310|NCT00750308|9714636|FG004|COMPLETED|Washout||1
8671311|NCT00750308|9714637|FG005|COMPLETED|Washout||2
8671312|NCT00750308|9714638|FG006|COMPLETED|Washout||2
8671313|NCT00750308|9714639|FG007|COMPLETED|Washout||2
8671314|NCT00750308|9714640|FG008|COMPLETED|Washout||1
8671315|NCT00750308|9714641|FG009|COMPLETED|Washout||2
8671316|NCT00750308|9714642|FG010|COMPLETED|Washout||1
8671317|NCT00750308|9714643|FG011|COMPLETED|Washout||1
8671318|NCT00750308|9714632|FG000|NOT COMPLETED|Washout||0
8671319|NCT00750308|9714633|FG001|NOT COMPLETED|Washout||0
8767288|NCT01256385|9817430|FG000|STARTED|Overall Study||43
8767289|NCT01256385|9817431|FG001|STARTED|Overall Study||43
8767290|NCT01256385|9817430|FG000|Crossover From Arm B to Arm A|Overall Study||0
8767291|NCT01256385|9817431|FG001|Crossover From Arm B to Arm A|Overall Study||15
8767292|NCT01256385|9817430|FG000|COMPLETED|Overall Study||40
8671320|NCT00750308|9714634|FG002|NOT COMPLETED|Washout||0
8767293|NCT01256385|9817431|FG001|COMPLETED|Overall Study||40
8767294|NCT01256385|9817430|FG000|NOT COMPLETED|Overall Study||3
8767295|NCT01256385|9817431|FG001|NOT COMPLETED|Overall Study||3
8767296|NCT01256411|9817441|FG000|STARTED|Extension by Maximum Treatment||139
8767297|NCT01256411|9817442|FG001|STARTED|Extension by Maximum Treatment||89
8767298|NCT01256411|9817443|FG002|STARTED|Extension by Maximum Treatment||109
8767299|NCT01256411|9817444|FG003|STARTED|Extension by Maximum Treatment||4
8767300|NCT01256411|9817445|FG004|STARTED|Extension by Maximum Treatment||0
8767301|NCT01256411|9817446|FG005|STARTED|Extension by Maximum Treatment||0
8767302|NCT01256411|9817441|FG000|Down Titrated to 100 mg|Extension by Maximum Treatment||12
8767303|NCT01256411|9817442|FG001|Down Titrated to 100 mg|Extension by Maximum Treatment||0
8767304|NCT01256411|9817443|FG002|Down Titrated to 100 mg|Extension by Maximum Treatment||0
8767305|NCT01256411|9817444|FG003|Down Titrated to 100 mg|Extension by Maximum Treatment||0
8767306|NCT01256411|9817445|FG004|Down Titrated to 100 mg|Extension by Maximum Treatment||0
8767307|NCT01256411|9817446|FG005|Down Titrated to 100 mg|Extension by Maximum Treatment||0
8767308|NCT01256411|9817441|FG000|COMPLETED|Extension by Maximum Treatment||132
8767309|NCT01256411|9817442|FG001|COMPLETED|Extension by Maximum Treatment||79
8767310|NCT01256411|9817443|FG002|COMPLETED|Extension by Maximum Treatment||105
8767311|NCT01256411|9817444|FG003|COMPLETED|Extension by Maximum Treatment||4
8767312|NCT01256411|9817445|FG004|COMPLETED|Extension by Maximum Treatment||0
8767313|NCT01256411|9817446|FG005|COMPLETED|Extension by Maximum Treatment||0
8767314|NCT01256411|9817441|FG000|NOT COMPLETED|Extension by Maximum Treatment||7
8767315|NCT01256411|9817442|FG001|NOT COMPLETED|Extension by Maximum Treatment||10
8767316|NCT01256411|9817443|FG002|NOT COMPLETED|Extension by Maximum Treatment||4
8767317|NCT01256411|9817444|FG003|NOT COMPLETED|Extension by Maximum Treatment||0
8767318|NCT01256411|9817445|FG004|NOT COMPLETED|Extension by Maximum Treatment||0
8767319|NCT01256411|9817446|FG005|NOT COMPLETED|Extension by Maximum Treatment||0
8767320|NCT01256411|9817441|FG000|STARTED|Extension by Mono or Combination Therapy||0
8767321|NCT01256411|9817442|FG001|STARTED|Extension by Mono or Combination Therapy||0
8767322|NCT01256411|9817443|FG002|STARTED|Extension by Mono or Combination Therapy||0
8767323|NCT01256411|9817444|FG003|STARTED|Extension by Mono or Combination Therapy||0
8767324|NCT01256411|9817445|FG004|STARTED|Extension by Mono or Combination Therapy||228
8767325|NCT01256411|9817446|FG005|STARTED|Extension by Mono or Combination Therapy||113
8767326|NCT01256411|9817441|FG000|COMPLETED|Extension by Mono or Combination Therapy||0
8767327|NCT01256411|9817442|FG001|COMPLETED|Extension by Mono or Combination Therapy||0
8767328|NCT01256411|9817443|FG002|COMPLETED|Extension by Mono or Combination Therapy||0
8767329|NCT01256411|9817444|FG003|COMPLETED|Extension by Mono or Combination Therapy||0
8767330|NCT01256411|9817445|FG004|COMPLETED|Extension by Mono or Combination Therapy||211
8767331|NCT01256411|9817446|FG005|COMPLETED|Extension by Mono or Combination Therapy||109
8767332|NCT01256411|9817441|FG000|NOT COMPLETED|Extension by Mono or Combination Therapy||0
8767333|NCT01256411|9817442|FG001|NOT COMPLETED|Extension by Mono or Combination Therapy||0
8767334|NCT01256411|9817443|FG002|NOT COMPLETED|Extension by Mono or Combination Therapy||0
8767335|NCT01256411|9817444|FG003|NOT COMPLETED|Extension by Mono or Combination Therapy||0
8767336|NCT01256411|9817445|FG004|NOT COMPLETED|Extension by Mono or Combination Therapy||17
8767337|NCT01256411|9817446|FG005|NOT COMPLETED|Extension by Mono or Combination Therapy||4
8767338|NCT01256424|9817464|FG000|STARTED|Overall Study||65
8767339|NCT01256424|9817465|FG001|STARTED|Overall Study||67
8767340|NCT01256424|9817466|FG002|STARTED|Overall Study||62
8767341|NCT01256424|9817467|FG003|STARTED|Overall Study||68
8767342|NCT01256424|9817464|FG000|COMPLETED|Overall Study||56
8767343|NCT01256424|9817465|FG001|COMPLETED|Overall Study||59
8767344|NCT01256424|9817466|FG002|COMPLETED|Overall Study||55
8767345|NCT01256424|9817467|FG003|COMPLETED|Overall Study||61
8767346|NCT01256424|9817464|FG000|NOT COMPLETED|Overall Study||9
8767347|NCT01256424|9817465|FG001|NOT COMPLETED|Overall Study||8
8767348|NCT01256424|9817466|FG002|NOT COMPLETED|Overall Study||7
8767349|NCT01256424|9817467|FG003|NOT COMPLETED|Overall Study||7
8767350|NCT01256450|9817480|FG000|STARTED|Open-label Titration||334
8767351|NCT01256450|9817481|FG001|STARTED|Open-label Titration||0
8767352|NCT01256450|9817482|FG002|STARTED|Open-label Titration||0
8767353|NCT01256450|9817480|FG000|COMPLETED|Open-label Titration||235
8767354|NCT01256450|9817481|FG001|COMPLETED|Open-label Titration||0
8767355|NCT01256450|9817482|FG002|COMPLETED|Open-label Titration||0
8767356|NCT01256450|9817480|FG000|NOT COMPLETED|Open-label Titration||99
8767357|NCT01256450|9817481|FG001|NOT COMPLETED|Open-label Titration||0
8767358|NCT01256450|9817482|FG002|NOT COMPLETED|Open-label Titration||0
8767359|NCT01256450|9817480|FG000|STARTED|Double-blind Treatment|All subjects completing OL titration in the previous period were randomized to a DB treatment.|0
8767360|NCT01256450|9817481|FG001|STARTED|Double-blind Treatment|Subjects were randomized to DB treatment after completing OL titration in the previous period.|117
8767361|NCT01256450|9817482|FG002|STARTED|Double-blind Treatment|Subjects were randomized to DB treatment after completing OL titration in the previous period.|118
8767362|NCT01256450|9817480|FG000|COMPLETED|Double-blind Treatment||0
8767363|NCT01256450|9817481|FG001|COMPLETED|Double-blind Treatment||89
8767364|NCT01256450|9817482|FG002|COMPLETED|Double-blind Treatment||81
8767365|NCT01256450|9817480|FG000|NOT COMPLETED|Double-blind Treatment||0
8767366|NCT01256450|9817481|FG001|NOT COMPLETED|Double-blind Treatment||28
8767367|NCT01256450|9817482|FG002|NOT COMPLETED|Double-blind Treatment||37
8767368|NCT01256476|9817491|FG000|STARTED|Overall Study||164
8767369|NCT01256476|9817492|FG001|STARTED|Overall Study||164
8767370|NCT01256476|9817491|FG000|COMPLETED|Overall Study||158
8767371|NCT01256476|9817492|FG001|COMPLETED|Overall Study||157
8767372|NCT01256476|9817491|FG000|NOT COMPLETED|Overall Study||6
8767373|NCT01256476|9817492|FG001|NOT COMPLETED|Overall Study||7
8767374|NCT01256502|9817498|FG000|STARTED|Overall Study|Implanted with SERI during Stage I breast reconstruction surgery|139
8767375|NCT01256502|9817498|FG000|COMPLETED|Overall Study||129
8767376|NCT01256502|9817498|FG000|NOT COMPLETED|Overall Study||10
8767377|NCT01256567|9817507|FG000|STARTED|Overall Study||7
8767378|NCT01256567|9817507|FG000|Received at Least 1 Dose of Study Drug|Overall Study||7
8767379|NCT01256567|9817507|FG000|COMPLETED|Overall Study||6
8767380|NCT01256567|9817507|FG000|NOT COMPLETED|Overall Study||1
8767381|NCT01256593|9817512|FG000|STARTED|Overall Study||3827
8767382|NCT01256593|9817512|FG000|COMPLETED|Overall Study|Number of participants whose survey form were collected and included in analyses is shown.|3613
8767383|NCT01256593|9817512|FG000|NOT COMPLETED|Overall Study||214
8767384|NCT01256658|9817518|FG000|STARTED|Period 1||6817
8767385|NCT01256658|9817519|FG001|STARTED|Period 1||7258
8767386|NCT01256658|9817518|FG000|COMPLETED|Period 1||5897
8767387|NCT01256658|9817519|FG001|COMPLETED|Period 1||6510
8767388|NCT01256658|9817518|FG000|NOT COMPLETED|Period 1||920
8767389|NCT01256658|9817519|FG001|NOT COMPLETED|Period 1||748
8767390|NCT01256658|9817518|FG000|STARTED|Period 2 - Follow up Only - No Treatment|43 participants who completed period 1 did not enroll to continue on period 2|5854
8767391|NCT01256658|9817519|FG001|STARTED|Period 2 - Follow up Only - No Treatment|138 participants who completed period 1 did not enroll to continue on period 2|6372
8767392|NCT01256658|9817518|FG000|Lost to Follow up|Period 2 - Follow up Only - No Treatment||71
8767393|NCT01256658|9817519|FG001|Lost to Follow up|Period 2 - Follow up Only - No Treatment||77
8767394|NCT01256658|9817518|FG000|Death|Period 2 - Follow up Only - No Treatment||6
8767395|NCT01256658|9817519|FG001|Death|Period 2 - Follow up Only - No Treatment||8
8767396|NCT01256658|9817518|FG000|Study Termination|Period 2 - Follow up Only - No Treatment|43 participants who completed period 1 did not enroll to continue on period 2|5777
8767397|NCT01256658|9817519|FG001|Study Termination|Period 2 - Follow up Only - No Treatment|138 participants who completed period 1 did not enroll to continue on period 2|6287
8767398|NCT01256658|9817518|FG000|COMPLETED|Period 2 - Follow up Only - No Treatment||0
8767399|NCT01256658|9817519|FG001|COMPLETED|Period 2 - Follow up Only - No Treatment||0
8767400|NCT01256658|9817518|FG000|NOT COMPLETED|Period 2 - Follow up Only - No Treatment||5854
8767401|NCT01256658|9817519|FG001|NOT COMPLETED|Period 2 - Follow up Only - No Treatment||6372
8767402|NCT01256671|9817528|FG000|STARTED|Overall Study||530
8767403|NCT01256671|9817528|FG000|Safety Population|Overall Study||521
8767404|NCT01256671|9817528|FG000|COMPLETED|Overall Study||435
9027325|NCT03187132|10089744|FG001|COMPLETED|Inpatient Trauma+Pain Clinic, no Opioid||0
9027326|NCT03187132|10089743|FG000|NOT COMPLETED|Inpatient Trauma+Pain Clinic, no Opioid||1
9027327|NCT03187132|10089744|FG001|NOT COMPLETED|Inpatient Trauma+Pain Clinic, no Opioid||5
9027328|NCT03187132|10089743|FG000|STARTED|Inpatient Trauma+Pain Clinic||11
9027329|NCT03187132|10089744|FG001|STARTED|Inpatient Trauma+Pain Clinic||7
9027330|NCT03187132|10089743|FG000|COMPLETED|Inpatient Trauma+Pain Clinic||8
9027331|NCT03187132|10089744|FG001|COMPLETED|Inpatient Trauma+Pain Clinic||0
9027332|NCT03187132|10089743|FG000|NOT COMPLETED|Inpatient Trauma+Pain Clinic||3
9027333|NCT03187132|10089744|FG001|NOT COMPLETED|Inpatient Trauma+Pain Clinic||7
9027334|NCT03187132|10089743|FG000|STARTED|Pain Clinic Only, Fully Remote||76
9027335|NCT03187132|10089744|FG001|STARTED|Pain Clinic Only, Fully Remote||118
9027336|NCT03187132|10089743|FG000|COMPLETED|Pain Clinic Only, Fully Remote||43
9027337|NCT03187132|10089744|FG001|COMPLETED|Pain Clinic Only, Fully Remote||64
9027338|NCT03187132|10089743|FG000|NOT COMPLETED|Pain Clinic Only, Fully Remote||33
9027339|NCT03187132|10089744|FG001|NOT COMPLETED|Pain Clinic Only, Fully Remote||54
9027340|NCT03187197|10089753|FG000|STARTED|Overall Study||153
9027341|NCT03187197|10089754|FG001|STARTED|Overall Study||1097
9027342|NCT03187197|10089755|FG002|STARTED|Overall Study||55
9027343|NCT03187197|10089753|FG000|Started (Eligible Participants as FAS)|Overall Study||139
9027344|NCT03187197|10089754|FG001|Started (Eligible Participants as FAS)|Overall Study||1052
9027345|NCT03187197|10089755|FG002|Started (Eligible Participants as FAS)|Overall Study||54
9027346|NCT03187197|10089753|FG000|COMPLETED|Overall Study||107
9027347|NCT03187197|10089754|FG001|COMPLETED|Overall Study||704
9027348|NCT03187197|10089755|FG002|COMPLETED|Overall Study||32
9027349|NCT03187197|10089753|FG000|NOT COMPLETED|Overall Study||46
9027350|NCT03187197|10089754|FG001|NOT COMPLETED|Overall Study||393
9027351|NCT03187197|10089755|FG002|NOT COMPLETED|Overall Study||23
9027352|NCT03187301|10089763|FG000|STARTED|Titration Period||7
9027353|NCT03187301|10089764|FG001|STARTED|Titration Period||7
9027354|NCT03187301|10089765|FG002|STARTED|Titration Period||7
9027355|NCT03187301|10089766|FG003|STARTED|Titration Period||6
9027356|NCT03187301|10089767|FG004|STARTED|Titration Period||7
9027357|NCT03187301|10089768|FG005|STARTED|Titration Period||7
9027358|NCT03187301|10089769|FG006|STARTED|Titration Period||7
9027359|NCT03187301|10089763|FG000|COMPLETED|Titration Period||7
9027360|NCT03187301|10089764|FG001|COMPLETED|Titration Period||7
9027361|NCT03187301|10089765|FG002|COMPLETED|Titration Period||7
9027362|NCT03187301|10089766|FG003|COMPLETED|Titration Period||6
9027363|NCT03187301|10089767|FG004|COMPLETED|Titration Period||7
9027364|NCT03187301|10089768|FG005|COMPLETED|Titration Period||7
9027365|NCT03187301|10089769|FG006|COMPLETED|Titration Period||0
9027366|NCT03187301|10089763|FG000|NOT COMPLETED|Titration Period||0
9027367|NCT03187301|10089764|FG001|NOT COMPLETED|Titration Period||0
9027368|NCT03187301|10089765|FG002|NOT COMPLETED|Titration Period||0
9027369|NCT03187301|10089766|FG003|NOT COMPLETED|Titration Period||0
9027370|NCT03187301|10089767|FG004|NOT COMPLETED|Titration Period||0
9027371|NCT03187301|10089768|FG005|NOT COMPLETED|Titration Period||0
8767405|NCT01256671|9817528|FG000|NOT COMPLETED|Overall Study||95
8767406|NCT01256684|9817535|FG000|STARTED|Overall Study||81
8767407|NCT01256684|9817536|FG001|STARTED|Overall Study||87
8767408|NCT01256684|9817537|FG002|STARTED|Overall Study||87
8767409|NCT01256684|9817535|FG000|Safety Population|Overall Study||80
8767410|NCT01256684|9817536|FG001|Safety Population|Overall Study||86
8767411|NCT01256684|9817537|FG002|Safety Population|Overall Study||87
8767412|NCT01256684|9817535|FG000|ITT Population|Overall Study||77
8767413|NCT01256684|9817536|FG001|ITT Population|Overall Study||79
8767414|NCT01256684|9817537|FG002|ITT Population|Overall Study||81
8767415|NCT01256684|9817535|FG000|COMPLETED|Overall Study||72
8767416|NCT01256684|9817536|FG001|COMPLETED|Overall Study||74
8767417|NCT01256684|9817537|FG002|COMPLETED|Overall Study||76
8767418|NCT01256684|9817535|FG000|NOT COMPLETED|Overall Study||9
8767419|NCT01256684|9817536|FG001|NOT COMPLETED|Overall Study||13
8767420|NCT01256684|9817537|FG002|NOT COMPLETED|Overall Study||11
8767421|NCT01256788|9817548|FG000|STARTED|Overall Study||12
8767422|NCT01256788|9817549|FG001|STARTED|Overall Study||14
8767423|NCT01256788|9817550|FG002|STARTED|Overall Study||8
8767424|NCT01256788|9817548|FG000|COMPLETED|Overall Study||7
8767425|NCT01256788|9817549|FG001|COMPLETED|Overall Study||6
8767426|NCT01256788|9817550|FG002|COMPLETED|Overall Study||5
8767427|NCT01256788|9817548|FG000|NOT COMPLETED|Overall Study||5
8767428|NCT01256788|9817549|FG001|NOT COMPLETED|Overall Study||8
8767429|NCT01256788|9817550|FG002|NOT COMPLETED|Overall Study||3
8767430|NCT01256840|9817561|FG000|STARTED|Overall Study||30
8767431|NCT01256840|9817562|FG001|STARTED|Overall Study||16
8767432|NCT01256840|9817563|FG002|STARTED|Overall Study||25
8767433|NCT01256840|9817561|FG000|COMPLETED|Overall Study||30
8767434|NCT01256840|9817562|FG001|COMPLETED|Overall Study||16
8767435|NCT01256840|9817563|FG002|COMPLETED|Overall Study||25
8767436|NCT01256840|9817561|FG000|NOT COMPLETED|Overall Study||0
8767437|NCT01256840|9817562|FG001|NOT COMPLETED|Overall Study||0
8767438|NCT01256840|9817563|FG002|NOT COMPLETED|Overall Study||0
8767439|NCT01256879|9817571|FG000|STARTED|Overall Study|25 started in this cross-over study but only 24 completed|25
8767440|NCT01256879|9817571|FG000|CimTest-A|Overall Study|25 started this intervention but only 24 completed|25
8767441|NCT01256879|9817571|FG000|CimTest-B|Overall Study|24 started this intervention and 24 completed|24
8767442|NCT01256879|9817571|FG000|Sorbitol-free Cimetidine Solution|Overall Study|24 started this intervention and 24 completed|24
8767443|NCT01256879|9817571|FG000|Commercial Cimetidine Solution|Overall Study|24 started this intervention and 24 completed|24
8767444|NCT01256879|9817571|FG000|COMPLETED|Overall Study||24
8767445|NCT01256879|9817571|FG000|NOT COMPLETED|Overall Study||1
8767446|NCT01256918|9817581|FG000|STARTED|Overall Study||200
8767447|NCT01256918|9817581|FG000|Full Thickness Nuclear Crack Achieved|Overall Study||200
8767448|NCT01256918|9817581|FG000|COMPLETED|Overall Study||200
8767449|NCT01256918|9817581|FG000|NOT COMPLETED|Overall Study||0
8767450|NCT01256944|9817594|FG000|STARTED|Overall Study||70
8767451|NCT01256944|9817595|FG001|STARTED|Overall Study||220
8767452|NCT01256944|9817594|FG000|COMPLETED|Overall Study||70
8767453|NCT01256944|9817595|FG001|COMPLETED|Overall Study||220
8767454|NCT01256944|9817594|FG000|NOT COMPLETED|Overall Study||0
8767455|NCT01256944|9817595|FG001|NOT COMPLETED|Overall Study||0
8767456|NCT01256983|9817607|FG000|STARTED|Overall Study||15
8767457|NCT01256983|9817608|FG001|STARTED|Overall Study||15
8767458|NCT01256983|9817607|FG000|COMPLETED|Overall Study||14
8767459|NCT01256983|9817608|FG001|COMPLETED|Overall Study||12
8767460|NCT01256983|9817607|FG000|NOT COMPLETED|Overall Study||1
8767461|NCT01256983|9817608|FG001|NOT COMPLETED|Overall Study||3
8767462|NCT01257087|9817616|FG000|STARTED|Overall Study||18
8767463|NCT01257087|9817617|FG001|STARTED|Overall Study||17
8767464|NCT01257087|9817616|FG000|COMPLETED|Overall Study||18
8767465|NCT01257087|9817617|FG001|COMPLETED|Overall Study||17
8767466|NCT01257087|9817616|FG000|NOT COMPLETED|Overall Study||0
8767467|NCT01257087|9817617|FG001|NOT COMPLETED|Overall Study||0
8767468|NCT01257204|9817626|FG000|STARTED|Treatment Period (up to Week 24)||50
8767469|NCT01257204|9817627|FG001|STARTED|Treatment Period (up to Week 24)||50
8767470|NCT01257204|9817628|FG002|STARTED|Treatment Period (up to Week 24)||51
8767471|NCT01257204|9817626|FG000|COMPLETED|Treatment Period (up to Week 24)||45
8767472|NCT01257204|9817627|FG001|COMPLETED|Treatment Period (up to Week 24)||44
8767473|NCT01257204|9817628|FG002|COMPLETED|Treatment Period (up to Week 24)||42
8767474|NCT01257204|9817626|FG000|NOT COMPLETED|Treatment Period (up to Week 24)||5
8767475|NCT01257204|9817627|FG001|NOT COMPLETED|Treatment Period (up to Week 24)||6
8767476|NCT01257204|9817628|FG002|NOT COMPLETED|Treatment Period (up to Week 24)||9
8767477|NCT01257204|9817626|FG000|STARTED|Follow-up Period (up to Week 48)|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment.|49
8767478|NCT01257204|9817627|FG001|STARTED|Follow-up Period (up to Week 48)|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment.|47
8767479|NCT01257204|9817628|FG002|STARTED|Follow-up Period (up to Week 48)|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment.|49
8767480|NCT01257204|9817626|FG000|COMPLETED|Follow-up Period (up to Week 48)||48
8767481|NCT01257204|9817627|FG001|COMPLETED|Follow-up Period (up to Week 48)||41
8767482|NCT01257204|9817628|FG002|COMPLETED|Follow-up Period (up to Week 48)||39
8767483|NCT01257204|9817626|FG000|NOT COMPLETED|Follow-up Period (up to Week 48)||1
8767484|NCT01257204|9817627|FG001|NOT COMPLETED|Follow-up Period (up to Week 48)||6
8767485|NCT01257204|9817628|FG002|NOT COMPLETED|Follow-up Period (up to Week 48)||10
8767486|NCT01257217|9817650|FG000|STARTED|Overall Study||15
8767487|NCT01257217|9817651|FG001|STARTED|Overall Study||10
8767488|NCT01257217|9817650|FG000|COMPLETED|Overall Study||13
8767489|NCT01257217|9817651|FG001|COMPLETED|Overall Study||10
8767490|NCT01257217|9817650|FG000|NOT COMPLETED|Overall Study||2
8767491|NCT01257217|9817651|FG001|NOT COMPLETED|Overall Study||0
8767492|NCT01257230|9817664|FG000|STARTED|Overall Study||138
8767493|NCT01257230|9817665|FG001|STARTED|Overall Study||125
8767494|NCT01257230|9817666|FG002|STARTED|Overall Study||135
8767495|NCT01257230|9817664|FG000|COMPLETED|Overall Study||132
8767496|NCT01257230|9817665|FG001|COMPLETED|Overall Study||115
8767497|NCT01257230|9817666|FG002|COMPLETED|Overall Study||129
8767498|NCT01257230|9817664|FG000|NOT COMPLETED|Overall Study||6
8767499|NCT01257230|9817665|FG001|NOT COMPLETED|Overall Study||10
8767500|NCT01257230|9817666|FG002|NOT COMPLETED|Overall Study||6
8767501|NCT01257347|9817679|FG000|STARTED|Overall Study|Median patients per provider = 3; range 1-10 (35 patients)|12
8767502|NCT01257347|9817680|FG001|STARTED|Overall Study|Median patients per provider = 4; range 1-13 (65 patients)|12
8767503|NCT01257347|9817681|FG002|STARTED|Overall Study||35
8767504|NCT01257347|9817682|FG003|STARTED|Overall Study||65
8767505|NCT01257347|9817679|FG000|COMPLETED|Overall Study||12
8767506|NCT01257347|9817680|FG001|COMPLETED|Overall Study||12
8767507|NCT01257347|9817681|FG002|COMPLETED|Overall Study||35
8767508|NCT01257347|9817682|FG003|COMPLETED|Overall Study||65
8767509|NCT01257347|9817679|FG000|NOT COMPLETED|Overall Study||0
8767510|NCT01257347|9817680|FG001|NOT COMPLETED|Overall Study||0
8767511|NCT01257347|9817681|FG002|NOT COMPLETED|Overall Study||0
8767512|NCT01257347|9817682|FG003|NOT COMPLETED|Overall Study||0
8767513|NCT01257425|9817697|FG000|STARTED|Overall Study||52
8767514|NCT01257425|9817698|FG001|STARTED|Overall Study||51
8767515|NCT01257425|9817697|FG000|COMPLETED|Overall Study||46
8767516|NCT01257425|9817698|FG001|COMPLETED|Overall Study||45
8767517|NCT01257425|9817697|FG000|NOT COMPLETED|Overall Study||6
8767518|NCT01257425|9817698|FG001|NOT COMPLETED|Overall Study||6
8767519|NCT01257438|9817706|FG000|STARTED|Overall Study||132
8767520|NCT01257438|9817707|FG001|STARTED|Overall Study||143
8767521|NCT01257438|9817706|FG000|COMPLETED|Overall Study||102
8767522|NCT01257438|9817707|FG001|COMPLETED|Overall Study||97
8767523|NCT01257438|9817706|FG000|NOT COMPLETED|Overall Study||30
8767524|NCT01257438|9817707|FG001|NOT COMPLETED|Overall Study||46
8767525|NCT01257503|9817715|FG000|STARTED|Overall Study||133
8767526|NCT01257503|9817716|FG001|STARTED|Overall Study||130
8767527|NCT01257503|9817715|FG000|Returned Symptom Diaries|Overall Study||80
8767528|NCT01257503|9817716|FG001|Returned Symptom Diaries|Overall Study||83
8767529|NCT01257503|9817715|FG000|Returned Dosage Logbooks|Overall Study||75
8767530|NCT01257503|9817716|FG001|Returned Dosage Logbooks|Overall Study||80
8767531|NCT01257503|9817715|FG000|COMPLETED|Overall Study|Completed defined as participants who completed telephone follow-up at end of study period|125
8767532|NCT01257503|9817716|FG001|COMPLETED|Overall Study|Completed defined as participants who completed telephone follow-up at end of study period|119
8767533|NCT01257503|9817715|FG000|NOT COMPLETED|Overall Study||8
8767534|NCT01257503|9817716|FG001|NOT COMPLETED|Overall Study||11
8767535|NCT01257542|9817724|FG000|STARTED|Overall Study||55
8767536|NCT01257542|9817725|FG001|STARTED|Overall Study||52
8767537|NCT01257542|9817724|FG000|COMPLETED|Overall Study||52
8767538|NCT01257542|9817725|FG001|COMPLETED|Overall Study||45
8767539|NCT01257542|9817724|FG000|NOT COMPLETED|Overall Study||3
8767540|NCT01257542|9817725|FG001|NOT COMPLETED|Overall Study||7
8767541|NCT01257581|9817734|FG000|STARTED|Overall Study||22
8767542|NCT01257581|9817735|FG001|STARTED|Overall Study||21
8767543|NCT01257581|9817736|FG002|STARTED|Overall Study||17
8767544|NCT01257581|9817734|FG000|COMPLETED|Overall Study||17
8767545|NCT01257581|9817735|FG001|COMPLETED|Overall Study||18
8767546|NCT01257581|9817736|FG002|COMPLETED|Overall Study||11
8767547|NCT01257581|9817734|FG000|NOT COMPLETED|Overall Study||5
8767548|NCT01257581|9817735|FG001|NOT COMPLETED|Overall Study||3
8767549|NCT01257581|9817736|FG002|NOT COMPLETED|Overall Study||6
8767550|NCT01257698|9817746|FG000|STARTED|Overall Study||12
8767551|NCT01257698|9817747|FG001|STARTED|Overall Study||9
8767552|NCT01257698|9817746|FG000|COMPLETED|Overall Study||8
8767553|NCT01257698|9817747|FG001|COMPLETED|Overall Study||9
8767554|NCT01257698|9817746|FG000|NOT COMPLETED|Overall Study||4
8767555|NCT01257698|9817747|FG001|NOT COMPLETED|Overall Study||0
8767556|NCT01257737|9817755|FG000|STARTED|Overall Study||45
8767557|NCT01257737|9817756|FG001|STARTED|Overall Study||43
8767558|NCT01257737|9817755|FG000|COMPLETED|Overall Study||43
8767559|NCT01257737|9817756|FG001|COMPLETED|Overall Study||39
8767560|NCT01257737|9817755|FG000|NOT COMPLETED|Overall Study||2
8767561|NCT01257737|9817756|FG001|NOT COMPLETED|Overall Study||4
8767562|NCT01257750|9817763|FG000|STARTED|Overall Study||20
8767563|NCT01257750|9817763|FG000|COMPLETED|Overall Study||20
8767564|NCT01257750|9817763|FG000|NOT COMPLETED|Overall Study||0
8767565|NCT01257802|9817770|FG000|STARTED|Overall Study||6
8767566|NCT01257802|9817771|FG001|STARTED|Overall Study||8
8767567|NCT01257802|9817770|FG000|6 Month / 24 Week Visit|Overall Study||5
8767568|NCT01257802|9817771|FG001|6 Month / 24 Week Visit|Overall Study||2
8767569|NCT01257802|9817770|FG000|COMPLETED|Overall Study||5
8767570|NCT01257802|9817771|FG001|COMPLETED|Overall Study||2
8767571|NCT01257802|9817770|FG000|NOT COMPLETED|Overall Study||1
8767572|NCT01257802|9817771|FG001|NOT COMPLETED|Overall Study||6
8767573|NCT01257880|9817780|FG000|STARTED|Overall Study||12
8767574|NCT01257880|9817781|FG001|STARTED|Overall Study||19
8767575|NCT01257880|9817780|FG000|COMPLETED|Overall Study||12
8767576|NCT01257880|9817781|FG001|COMPLETED|Overall Study||19
8767577|NCT01257880|9817780|FG000|NOT COMPLETED|Overall Study||0
8767578|NCT01257880|9817781|FG001|NOT COMPLETED|Overall Study||0
8767579|NCT01258049|9817789|FG000|STARTED|Overall Study||77
8767580|NCT01258049|9817790|FG001|STARTED|Overall Study||74
8767581|NCT01258049|9817789|FG000|COMPLETED|Overall Study||75
8767582|NCT01258049|9817790|FG001|COMPLETED|Overall Study||72
8767583|NCT01258049|9817789|FG000|NOT COMPLETED|Overall Study||2
8767584|NCT01258049|9817790|FG001|NOT COMPLETED|Overall Study||2
8767585|NCT01258075|9817798|FG000|STARTED|Overall Study||141
8767586|NCT01258075|9817799|FG001|STARTED|Overall Study||95
8767587|NCT01258075|9817798|FG000|COMPLETED|Overall Study||99
8767588|NCT01258075|9817799|FG001|COMPLETED|Overall Study||72
8767589|NCT01258075|9817798|FG000|NOT COMPLETED|Overall Study||42
8767590|NCT01258075|9817799|FG001|NOT COMPLETED|Overall Study||23
8767591|NCT01258101|9817809|FG000|STARTED|Overall Study||151
8767592|NCT01258101|9817810|FG001|STARTED|Overall Study||144
8767593|NCT01258101|9817811|FG002|STARTED|Overall Study||33
8767594|NCT01258101|9817812|FG003|STARTED|Overall Study||52
8767595|NCT01258101|9817809|FG000|Safety Analysis Population|Overall Study||144
8767596|NCT01258101|9817810|FG001|Safety Analysis Population|Overall Study||141
8767597|NCT01258101|9817811|FG002|Safety Analysis Population|Overall Study||30
8767598|NCT01258101|9817812|FG003|Safety Analysis Population|Overall Study||48
8767599|NCT01258101|9817809|FG000|Standard Analysis Population|Overall Study||115
8767600|NCT01258101|9817810|FG001|Standard Analysis Population|Overall Study||110
8767601|NCT01258101|9817811|FG002|Standard Analysis Population|Overall Study||21
8767602|NCT01258101|9817812|FG003|Standard Analysis Population|Overall Study||26
8767603|NCT01258101|9817809|FG000|COMPLETED|Overall Study||118
9027372|NCT03187301|10089769|FG006|NOT COMPLETED|Titration Period||7
9027373|NCT03187301|10089763|FG000|STARTED|Pre-Intervention||7
9027374|NCT03187301|10089764|FG001|STARTED|Pre-Intervention||7
9027375|NCT03187301|10089765|FG002|STARTED|Pre-Intervention||7
9027376|NCT03187301|10089766|FG003|STARTED|Pre-Intervention||6
9027377|NCT03187301|10089767|FG004|STARTED|Pre-Intervention||7
9027378|NCT03187301|10089768|FG005|STARTED|Pre-Intervention||7
9027379|NCT03187301|10089769|FG006|STARTED|Pre-Intervention||0
9027380|NCT03187301|10089763|FG000|COMPLETED|Pre-Intervention||6
9027381|NCT03187301|10089764|FG001|COMPLETED|Pre-Intervention||7
9027382|NCT03187301|10089765|FG002|COMPLETED|Pre-Intervention||7
9027383|NCT03187301|10089766|FG003|COMPLETED|Pre-Intervention||6
9027384|NCT03187301|10089767|FG004|COMPLETED|Pre-Intervention||7
9027385|NCT03187301|10089768|FG005|COMPLETED|Pre-Intervention||7
9027386|NCT03187301|10089769|FG006|COMPLETED|Pre-Intervention||0
9027387|NCT03187301|10089763|FG000|NOT COMPLETED|Pre-Intervention||1
9027388|NCT03187301|10089764|FG001|NOT COMPLETED|Pre-Intervention||0
9027389|NCT03187301|10089765|FG002|NOT COMPLETED|Pre-Intervention||0
9027390|NCT03187301|10089766|FG003|NOT COMPLETED|Pre-Intervention||0
9027391|NCT03187301|10089767|FG004|NOT COMPLETED|Pre-Intervention||0
9027392|NCT03187301|10089768|FG005|NOT COMPLETED|Pre-Intervention||0
9027393|NCT03187301|10089769|FG006|NOT COMPLETED|Pre-Intervention||0
9027394|NCT03187301|10089763|FG000|STARTED|First Intervention||6
9027395|NCT03187301|10089764|FG001|STARTED|First Intervention||7
9027396|NCT03187301|10089765|FG002|STARTED|First Intervention||7
9027397|NCT03187301|10089766|FG003|STARTED|First Intervention||6
9027398|NCT03187301|10089767|FG004|STARTED|First Intervention||7
9027399|NCT03187301|10089768|FG005|STARTED|First Intervention||7
9027400|NCT03187301|10089769|FG006|STARTED|First Intervention||0
9027401|NCT03187301|10089763|FG000|COMPLETED|First Intervention||6
9027402|NCT03187301|10089764|FG001|COMPLETED|First Intervention||7
9027403|NCT03187301|10089765|FG002|COMPLETED|First Intervention||7
9027404|NCT03187301|10089766|FG003|COMPLETED|First Intervention||6
9027405|NCT03187301|10089767|FG004|COMPLETED|First Intervention||7
9027406|NCT03187301|10089768|FG005|COMPLETED|First Intervention||7
9027407|NCT03187301|10089769|FG006|COMPLETED|First Intervention||0
9027408|NCT03187301|10089763|FG000|NOT COMPLETED|First Intervention||0
9027409|NCT03187301|10089764|FG001|NOT COMPLETED|First Intervention||0
9027410|NCT03187301|10089765|FG002|NOT COMPLETED|First Intervention||0
9027411|NCT03187301|10089766|FG003|NOT COMPLETED|First Intervention||0
9027412|NCT03187301|10089767|FG004|NOT COMPLETED|First Intervention||0
9027413|NCT03187301|10089768|FG005|NOT COMPLETED|First Intervention||0
9027414|NCT03187301|10089769|FG006|NOT COMPLETED|First Intervention||0
9027415|NCT03187301|10089763|FG000|STARTED|First Washout||6
9027416|NCT03187301|10089764|FG001|STARTED|First Washout||7
9027417|NCT03187301|10089765|FG002|STARTED|First Washout||7
9027418|NCT03187301|10089766|FG003|STARTED|First Washout||6
9027419|NCT03187301|10089767|FG004|STARTED|First Washout||7
9027420|NCT03187301|10089768|FG005|STARTED|First Washout||7
9027421|NCT03187301|10089769|FG006|STARTED|First Washout||0
9027422|NCT03187301|10089763|FG000|COMPLETED|First Washout||6
9027423|NCT03187301|10089764|FG001|COMPLETED|First Washout||7
9027424|NCT03187301|10089765|FG002|COMPLETED|First Washout||7
8767604|NCT01258101|9817810|FG001|COMPLETED|Overall Study||110
8767605|NCT01258101|9817811|FG002|COMPLETED|Overall Study||22
9027425|NCT03187301|10089766|FG003|COMPLETED|First Washout||6
9027426|NCT03187301|10089767|FG004|COMPLETED|First Washout||7
9027427|NCT03187301|10089768|FG005|COMPLETED|First Washout||7
9027428|NCT03187301|10089769|FG006|COMPLETED|First Washout||0
9027429|NCT03187301|10089763|FG000|NOT COMPLETED|First Washout||0
9027430|NCT03187301|10089764|FG001|NOT COMPLETED|First Washout||0
9027431|NCT03187301|10089765|FG002|NOT COMPLETED|First Washout||0
8767606|NCT01258101|9817812|FG003|COMPLETED|Overall Study||27
8767607|NCT01258101|9817809|FG000|NOT COMPLETED|Overall Study||33
8767608|NCT01258101|9817810|FG001|NOT COMPLETED|Overall Study||34
8767609|NCT01258101|9817811|FG002|NOT COMPLETED|Overall Study||11
8767610|NCT01258101|9817812|FG003|NOT COMPLETED|Overall Study||25
8767611|NCT01258153|9817825|FG000|STARTED|Overall Study||40
8767612|NCT01258153|9817826|FG001|STARTED|Overall Study||38
8767613|NCT01258153|9817827|FG002|STARTED|Overall Study||37
8767614|NCT01258153|9817825|FG000|COMPLETED|Overall Study||39
8767615|NCT01258153|9817826|FG001|COMPLETED|Overall Study||37
8767616|NCT01258153|9817827|FG002|COMPLETED|Overall Study||36
8767617|NCT01258153|9817825|FG000|NOT COMPLETED|Overall Study||1
8767618|NCT01258153|9817826|FG001|NOT COMPLETED|Overall Study||1
8767619|NCT01258153|9817827|FG002|NOT COMPLETED|Overall Study||1
8767620|NCT01258348|9817837|FG000|STARTED|Overall Study||1
8767621|NCT01258348|9817838|FG001|STARTED|Overall Study||5
8767622|NCT01258348|9817839|FG002|STARTED|Overall Study||3
8767623|NCT01258348|9817840|FG003|STARTED|Overall Study||6
8767624|NCT01258348|9817841|FG004|STARTED|Overall Study||6
8767625|NCT01258348|9817837|FG000|Received at Least 1 Dose of Study Drug|Overall Study||1
8767626|NCT01258348|9817838|FG001|Received at Least 1 Dose of Study Drug|Overall Study||5
8767627|NCT01258348|9817839|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
8767628|NCT01258348|9817840|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
8767629|NCT01258348|9817841|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6
8767630|NCT01258348|9817837|FG000|COMPLETED|Overall Study||0
8767631|NCT01258348|9817838|FG001|COMPLETED|Overall Study||0
8767632|NCT01258348|9817839|FG002|COMPLETED|Overall Study||0
8767633|NCT01258348|9817840|FG003|COMPLETED|Overall Study||0
8767634|NCT01258348|9817841|FG004|COMPLETED|Overall Study||0
8767635|NCT01258348|9817837|FG000|NOT COMPLETED|Overall Study||1
8767636|NCT01258348|9817838|FG001|NOT COMPLETED|Overall Study||5
8767637|NCT01258348|9817839|FG002|NOT COMPLETED|Overall Study||3
8767638|NCT01258348|9817840|FG003|NOT COMPLETED|Overall Study||6
8767639|NCT01258348|9817841|FG004|NOT COMPLETED|Overall Study||6
8767640|NCT01258374|9817855|FG000|STARTED|Overall Study||15
9027432|NCT03187301|10089766|FG003|NOT COMPLETED|First Washout||0
9027433|NCT03187301|10089767|FG004|NOT COMPLETED|First Washout||0
9027434|NCT03187301|10089768|FG005|NOT COMPLETED|First Washout||0
9027435|NCT03187301|10089769|FG006|NOT COMPLETED|First Washout||0
9027436|NCT03187301|10089763|FG000|STARTED|Second Intervention||6
9027437|NCT03187301|10089764|FG001|STARTED|Second Intervention||7
9027438|NCT03187301|10089765|FG002|STARTED|Second Intervention||7
9027439|NCT03187301|10089766|FG003|STARTED|Second Intervention||6
9027440|NCT03187301|10089767|FG004|STARTED|Second Intervention||7
9027441|NCT03187301|10089768|FG005|STARTED|Second Intervention||7
9027442|NCT03187301|10089769|FG006|STARTED|Second Intervention||0
9027443|NCT03187301|10089763|FG000|COMPLETED|Second Intervention||6
9027444|NCT03187301|10089764|FG001|COMPLETED|Second Intervention||7
9027445|NCT03187301|10089765|FG002|COMPLETED|Second Intervention||7
9027446|NCT03187301|10089766|FG003|COMPLETED|Second Intervention||6
9027447|NCT03187301|10089767|FG004|COMPLETED|Second Intervention||7
9027448|NCT03187301|10089768|FG005|COMPLETED|Second Intervention||7
9027449|NCT03187301|10089769|FG006|COMPLETED|Second Intervention||0
9027450|NCT03187301|10089763|FG000|NOT COMPLETED|Second Intervention||0
9027451|NCT03187301|10089764|FG001|NOT COMPLETED|Second Intervention||0
9027452|NCT03187301|10089765|FG002|NOT COMPLETED|Second Intervention||0
9027453|NCT03187301|10089766|FG003|NOT COMPLETED|Second Intervention||0
9027454|NCT03187301|10089767|FG004|NOT COMPLETED|Second Intervention||0
9027455|NCT03187301|10089768|FG005|NOT COMPLETED|Second Intervention||0
9027456|NCT03187301|10089769|FG006|NOT COMPLETED|Second Intervention||0
9027457|NCT03187301|10089763|FG000|STARTED|Second Washout||6
9027458|NCT03187301|10089764|FG001|STARTED|Second Washout||7
9027459|NCT03187301|10089765|FG002|STARTED|Second Washout||7
9027460|NCT03187301|10089766|FG003|STARTED|Second Washout||6
9027461|NCT03187301|10089767|FG004|STARTED|Second Washout||7
9027462|NCT03187301|10089768|FG005|STARTED|Second Washout||7
9027463|NCT03187301|10089769|FG006|STARTED|Second Washout||0
9027464|NCT03187301|10089763|FG000|COMPLETED|Second Washout||6
9027465|NCT03187301|10089764|FG001|COMPLETED|Second Washout||7
9027466|NCT03187301|10089765|FG002|COMPLETED|Second Washout||7
9027467|NCT03187301|10089766|FG003|COMPLETED|Second Washout||6
9027468|NCT03187301|10089767|FG004|COMPLETED|Second Washout||7
8767641|NCT01258374|9817855|FG000|COMPLETED|Overall Study||15
8767642|NCT01258374|9817855|FG000|NOT COMPLETED|Overall Study||0
8767643|NCT01258387|9817868|FG000|STARTED|Overall Study||6
8767644|NCT01258387|9817869|FG001|STARTED|Overall Study||6
8767645|NCT01258387|9817870|FG002|STARTED|Overall Study||6
8767646|NCT01258387|9817871|FG003|STARTED|Overall Study||6
9027469|NCT03187301|10089768|FG005|COMPLETED|Second Washout||7
9027470|NCT03187301|10089769|FG006|COMPLETED|Second Washout||0
9027471|NCT03187301|10089763|FG000|NOT COMPLETED|Second Washout||0
9027472|NCT03187301|10089764|FG001|NOT COMPLETED|Second Washout||0
9027473|NCT03187301|10089765|FG002|NOT COMPLETED|Second Washout||0
9027474|NCT03187301|10089766|FG003|NOT COMPLETED|Second Washout||0
9027475|NCT03187301|10089767|FG004|NOT COMPLETED|Second Washout||0
9027476|NCT03187301|10089768|FG005|NOT COMPLETED|Second Washout||0
9027477|NCT03187301|10089769|FG006|NOT COMPLETED|Second Washout||0
9027478|NCT03187301|10089763|FG000|STARTED|Third Intervention||6
9027479|NCT03187301|10089764|FG001|STARTED|Third Intervention||7
9027480|NCT03187301|10089765|FG002|STARTED|Third Intervention||7
8767647|NCT01258387|9817872|FG004|STARTED|Overall Study||6
8767648|NCT01258387|9817873|FG005|STARTED|Overall Study||6
8767649|NCT01258387|9817874|FG006|STARTED|Overall Study||4
8767650|NCT01258387|9817868|FG000|Patients Randomized to GGF2|Overall Study||4
8767651|NCT01258387|9817869|FG001|Patients Randomized to GGF2|Overall Study||4
8767652|NCT01258387|9817870|FG002|Patients Randomized to GGF2|Overall Study||4
8767653|NCT01258387|9817871|FG003|Patients Randomized to GGF2|Overall Study||4
8767654|NCT01258387|9817872|FG004|Patients Randomized to GGF2|Overall Study||4
8767655|NCT01258387|9817873|FG005|Patients Randomized to GGF2|Overall Study||4
8767656|NCT01258387|9817874|FG006|Patients Randomized to GGF2|Overall Study||3
8767657|NCT01258387|9817868|FG000|Patients Randomized to Placebo|Overall Study||2
8767658|NCT01258387|9817869|FG001|Patients Randomized to Placebo|Overall Study||2
8767659|NCT01258387|9817870|FG002|Patients Randomized to Placebo|Overall Study||2
8767660|NCT01258387|9817871|FG003|Patients Randomized to Placebo|Overall Study||2
8767661|NCT01258387|9817872|FG004|Patients Randomized to Placebo|Overall Study||2
8767662|NCT01258387|9817873|FG005|Patients Randomized to Placebo|Overall Study||2
8767663|NCT01258387|9817874|FG006|Patients Randomized to Placebo|Overall Study||1
8767664|NCT01258387|9817868|FG000|COMPLETED|Overall Study||6
8767665|NCT01258387|9817869|FG001|COMPLETED|Overall Study||6
8767666|NCT01258387|9817870|FG002|COMPLETED|Overall Study||6
8767667|NCT01258387|9817871|FG003|COMPLETED|Overall Study||6
8767668|NCT01258387|9817872|FG004|COMPLETED|Overall Study||6
8767669|NCT01258387|9817873|FG005|COMPLETED|Overall Study||6
8767670|NCT01258387|9817874|FG006|COMPLETED|Overall Study||4
8767671|NCT01258387|9817868|FG000|NOT COMPLETED|Overall Study||0
8767672|NCT01258387|9817869|FG001|NOT COMPLETED|Overall Study||0
8767673|NCT01258387|9817870|FG002|NOT COMPLETED|Overall Study||0
8767674|NCT01258387|9817871|FG003|NOT COMPLETED|Overall Study||0
8767675|NCT01258387|9817872|FG004|NOT COMPLETED|Overall Study||0
8767676|NCT01258387|9817873|FG005|NOT COMPLETED|Overall Study||0
8767677|NCT01258387|9817874|FG006|NOT COMPLETED|Overall Study||0
8767678|NCT01258504|9817892|FG000|STARTED|Bosentan Single Dose||13
8767679|NCT01258504|9817892|FG000|COMPLETED|Bosentan Single Dose||13
8767680|NCT01258504|9817892|FG000|NOT COMPLETED|Bosentan Single Dose||0
8767681|NCT01258504|9817892|FG000|STARTED|Bosentan Steady-state||13
8767682|NCT01258504|9817892|FG000|COMPLETED|Bosentan Steady-state||13
8767683|NCT01258504|9817892|FG000|NOT COMPLETED|Bosentan Steady-state||0
8767684|NCT01258504|9817892|FG000|STARTED|Bosentan and SJW||13
8767685|NCT01258504|9817892|FG000|COMPLETED|Bosentan and SJW||13
8767686|NCT01258504|9817892|FG000|NOT COMPLETED|Bosentan and SJW||0
8767687|NCT01258582|9817903|FG000|STARTED|Overall Study||830
8767688|NCT01258582|9817904|FG001|STARTED|Overall Study||821
8767689|NCT01258582|9817903|FG000|COMPLETED|Overall Study||548
8767690|NCT01258582|9817904|FG001|COMPLETED|Overall Study||563
8767691|NCT01258582|9817903|FG000|NOT COMPLETED|Overall Study||282
8767692|NCT01258582|9817904|FG001|NOT COMPLETED|Overall Study||258
8767693|NCT01258595|9817912|FG000|STARTED|Overall Study||148
8767694|NCT01258595|9817913|FG001|STARTED|Overall Study||152
8767695|NCT01258595|9817912|FG000|COMPLETED|Overall Study||147
8767696|NCT01258595|9817913|FG001|COMPLETED|Overall Study||151
8767697|NCT01258595|9817912|FG000|NOT COMPLETED|Overall Study||1
8767698|NCT01258595|9817913|FG001|NOT COMPLETED|Overall Study||1
8767699|NCT01258608|9817921|FG000|STARTED|Overall Study||51
8767700|NCT01258608|9817922|FG001|STARTED|Overall Study||50
8767701|NCT01258608|9817921|FG000|COMPLETED|Overall Study||30
8767702|NCT01258608|9817922|FG001|COMPLETED|Overall Study||31
8767703|NCT01258608|9817921|FG000|NOT COMPLETED|Overall Study||21
8767704|NCT01258608|9817922|FG001|NOT COMPLETED|Overall Study||19
8767705|NCT01258660|9817931|FG000|STARTED|Overall Study|randomized and received at least one dose of treatment|86
8767706|NCT01258660|9817932|FG001|STARTED|Overall Study|randomized and received at least one dose of treatment|86
8767707|NCT01258660|9817931|FG000|Received Treatment|Overall Study||79
8767708|NCT01258660|9817932|FG001|Received Treatment|Overall Study||82
8767709|NCT01258660|9817931|FG000|Completed Treatment|Overall Study||79
8767710|NCT01258660|9817932|FG001|Completed Treatment|Overall Study||81
8767711|NCT01258660|9817931|FG000|COMPLETED|Overall Study|completed and valid for primary analysis data set|75
8767712|NCT01258660|9817932|FG001|COMPLETED|Overall Study|completed and valid for primary analysis data set|75
8767713|NCT01258660|9817931|FG000|NOT COMPLETED|Overall Study||11
8767714|NCT01258660|9817932|FG001|NOT COMPLETED|Overall Study||11
8767715|NCT01258738|9817941|FG000|STARTED|Double-blind Period||111
8767716|NCT01258738|9817942|FG001|STARTED|Double-blind Period||114
8767717|NCT01258738|9817941|FG000|Treated|Double-blind Period||111
8767718|NCT01258738|9817942|FG001|Treated|Double-blind Period||113
8767719|NCT01258738|9817941|FG000|COMPLETED|Double-blind Period||102
8767720|NCT01258738|9817942|FG001|COMPLETED|Double-blind Period|Only 106 participants entered the open label period.|107
8767721|NCT01258738|9817941|FG000|NOT COMPLETED|Double-blind Period||9
8767722|NCT01258738|9817942|FG001|NOT COMPLETED|Double-blind Period||7
8767723|NCT01258738|9817941|FG000|STARTED|Open-label Period||102
8767724|NCT01258738|9817942|FG001|STARTED|Open-label Period||106
8767725|NCT01258738|9817941|FG000|COMPLETED|Open-label Period||85
8767726|NCT01258738|9817942|FG001|COMPLETED|Open-label Period||85
8767727|NCT01258738|9817941|FG000|NOT COMPLETED|Open-label Period||17
8767728|NCT01258738|9817942|FG001|NOT COMPLETED|Open-label Period||21
8767729|NCT01258790|9817950|FG000|STARTED|Overall Study||6
8767730|NCT01258790|9817951|FG001|STARTED|Overall Study||6
8767731|NCT01258790|9817950|FG000|COMPLETED|Overall Study||6
8767732|NCT01258790|9817951|FG001|COMPLETED|Overall Study||6
8767733|NCT01258790|9817950|FG000|NOT COMPLETED|Overall Study||0
8767734|NCT01258790|9817951|FG001|NOT COMPLETED|Overall Study||0
8767735|NCT01258855|9817959|FG000|STARTED|Overall Study||55
8767736|NCT01258855|9817960|FG001|STARTED|Overall Study||29
8767737|NCT01258855|9817959|FG000|COMPLETED|Overall Study||55
8767738|NCT01258855|9817960|FG001|COMPLETED|Overall Study||29
8767739|NCT01258855|9817959|FG000|NOT COMPLETED|Overall Study||0
8767740|NCT01258855|9817960|FG001|NOT COMPLETED|Overall Study||0
8767741|NCT01258985|9817968|FG000|STARTED|Overall Study||106
8767742|NCT01258985|9817969|FG001|STARTED|Overall Study||98
8767743|NCT01258985|9817968|FG000|COMPLETED|Overall Study||106
8767744|NCT01258985|9817969|FG001|COMPLETED|Overall Study||98
8767745|NCT01258985|9817968|FG000|NOT COMPLETED|Overall Study||0
8767746|NCT01258985|9817969|FG001|NOT COMPLETED|Overall Study||0
8767747|NCT01258998|9817975|FG000|STARTED|Overall Study||60
8767748|NCT01258998|9817975|FG000|COMPLETED|Overall Study||59
8767749|NCT01258998|9817975|FG000|NOT COMPLETED|Overall Study||1
8767750|NCT01259011|9817981|FG000|STARTED|Main Study Period|101 dyads (=202 individuals)|101
8767751|NCT01259011|9817982|FG001|STARTED|Main Study Period|109 dyads (=218 individuals)|109
8767752|NCT01259011|9817981|FG000|COMPLETED|Main Study Period||101
8767753|NCT01259011|9817982|FG001|COMPLETED|Main Study Period||109
8767754|NCT01259011|9817981|FG000|NOT COMPLETED|Main Study Period||0
8767755|NCT01259011|9817982|FG001|NOT COMPLETED|Main Study Period||0
8767756|NCT01259011|9817981|FG000|STARTED|After Patient Death|of 101 patient-surrogate dyads/pairs randomized, 17 surrogates of patients who died|17
8767757|NCT01259011|9817982|FG001|STARTED|After Patient Death|of 109 patient-surrogate dyads/pairs randomized, 28 surrogates of patients who died|28
8767758|NCT01259011|9817981|FG000|COMPLETED|After Patient Death||17
8767759|NCT01259011|9817982|FG001|COMPLETED|After Patient Death||28
8767760|NCT01259011|9817981|FG000|NOT COMPLETED|After Patient Death||0
8767761|NCT01259011|9817982|FG001|NOT COMPLETED|After Patient Death||0
8767762|NCT01259063|9817990|FG000|STARTED|Overall Study||33
8767763|NCT01259063|9817990|FG000|COMPLETED|Overall Study||33
8767764|NCT01259063|9817990|FG000|NOT COMPLETED|Overall Study||0
8767765|NCT01259089|9817994|FG000|STARTED|Reached First Response at 4 Weeks||3
8767766|NCT01259089|9817995|FG001|STARTED|Reached First Response at 4 Weeks||3
8767767|NCT01259089|9817996|FG002|STARTED|Reached First Response at 4 Weeks||3
8767768|NCT01259089|9817997|FG003|STARTED|Reached First Response at 4 Weeks||3
8767769|NCT01259089|9817998|FG004|STARTED|Reached First Response at 4 Weeks||6
8767770|NCT01259089|9817999|FG005|STARTED|Reached First Response at 4 Weeks||20
8767771|NCT01259089|9817994|FG000|Started Treatment on Study|Reached First Response at 4 Weeks||3
8767772|NCT01259089|9817995|FG001|Started Treatment on Study|Reached First Response at 4 Weeks||3
8767773|NCT01259089|9817996|FG002|Started Treatment on Study|Reached First Response at 4 Weeks||3
8767774|NCT01259089|9817997|FG003|Started Treatment on Study|Reached First Response at 4 Weeks||3
8767775|NCT01259089|9817998|FG004|Started Treatment on Study|Reached First Response at 4 Weeks||6
8767776|NCT01259089|9817999|FG005|Started Treatment on Study|Reached First Response at 4 Weeks||19
8767777|NCT01259089|9817994|FG000|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||3
8767778|NCT01259089|9817995|FG001|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||3
8767779|NCT01259089|9817996|FG002|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||3
8767780|NCT01259089|9817997|FG003|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||3
8767781|NCT01259089|9817998|FG004|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||6
8767782|NCT01259089|9817999|FG005|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||18
8767783|NCT01259089|9817994|FG000|COMPLETED|Reached First Response at 4 Weeks||3
8767784|NCT01259089|9817995|FG001|COMPLETED|Reached First Response at 4 Weeks||3
8767785|NCT01259089|9817996|FG002|COMPLETED|Reached First Response at 4 Weeks||3
8767786|NCT01259089|9817997|FG003|COMPLETED|Reached First Response at 4 Weeks||3
8767787|NCT01259089|9817998|FG004|COMPLETED|Reached First Response at 4 Weeks||6
8767788|NCT01259089|9817999|FG005|COMPLETED|Reached First Response at 4 Weeks||18
8767789|NCT01259089|9817994|FG000|NOT COMPLETED|Reached First Response at 4 Weeks||0
8767790|NCT01259089|9817995|FG001|NOT COMPLETED|Reached First Response at 4 Weeks||0
8767791|NCT01259089|9817996|FG002|NOT COMPLETED|Reached First Response at 4 Weeks||0
8767792|NCT01259089|9817997|FG003|NOT COMPLETED|Reached First Response at 4 Weeks||0
8767793|NCT01259089|9817998|FG004|NOT COMPLETED|Reached First Response at 4 Weeks||0
8767794|NCT01259089|9817999|FG005|NOT COMPLETED|Reached First Response at 4 Weeks||2
8767795|NCT01259089|9817994|FG000|STARTED|Confirmed Response at 8 Weeks||3
8767796|NCT01259089|9817995|FG001|STARTED|Confirmed Response at 8 Weeks||3
8767797|NCT01259089|9817996|FG002|STARTED|Confirmed Response at 8 Weeks||3
8767798|NCT01259089|9817997|FG003|STARTED|Confirmed Response at 8 Weeks||3
8767799|NCT01259089|9817998|FG004|STARTED|Confirmed Response at 8 Weeks||6
8767800|NCT01259089|9817999|FG005|STARTED|Confirmed Response at 8 Weeks||18
8767801|NCT01259089|9817994|FG000|COMPLETED|Confirmed Response at 8 Weeks||3
8767802|NCT01259089|9817995|FG001|COMPLETED|Confirmed Response at 8 Weeks||3
8767803|NCT01259089|9817996|FG002|COMPLETED|Confirmed Response at 8 Weeks||2
8767804|NCT01259089|9817997|FG003|COMPLETED|Confirmed Response at 8 Weeks||2
8767805|NCT01259089|9817998|FG004|COMPLETED|Confirmed Response at 8 Weeks||2
8767806|NCT01259089|9817999|FG005|COMPLETED|Confirmed Response at 8 Weeks||8
8767807|NCT01259089|9817994|FG000|NOT COMPLETED|Confirmed Response at 8 Weeks||0
8767808|NCT01259089|9817995|FG001|NOT COMPLETED|Confirmed Response at 8 Weeks||0
8767809|NCT01259089|9817996|FG002|NOT COMPLETED|Confirmed Response at 8 Weeks||1
8767810|NCT01259089|9817997|FG003|NOT COMPLETED|Confirmed Response at 8 Weeks||1
8767811|NCT01259089|9817998|FG004|NOT COMPLETED|Confirmed Response at 8 Weeks||4
8767812|NCT01259089|9817999|FG005|NOT COMPLETED|Confirmed Response at 8 Weeks||10
8767813|NCT01259089|9817994|FG000|STARTED|Continued Treatment After 8 Weeks||3
8767814|NCT01259089|9817995|FG001|STARTED|Continued Treatment After 8 Weeks||3
8767815|NCT01259089|9817996|FG002|STARTED|Continued Treatment After 8 Weeks||2
8767816|NCT01259089|9817997|FG003|STARTED|Continued Treatment After 8 Weeks||2
8767817|NCT01259089|9817998|FG004|STARTED|Continued Treatment After 8 Weeks||2
8767818|NCT01259089|9817999|FG005|STARTED|Continued Treatment After 8 Weeks||8
8767819|NCT01259089|9817994|FG000|COMPLETED|Continued Treatment After 8 Weeks||1
8767820|NCT01259089|9817995|FG001|COMPLETED|Continued Treatment After 8 Weeks||2
8767821|NCT01259089|9817996|FG002|COMPLETED|Continued Treatment After 8 Weeks||1
8767822|NCT01259089|9817997|FG003|COMPLETED|Continued Treatment After 8 Weeks||1
8767823|NCT01259089|9817998|FG004|COMPLETED|Continued Treatment After 8 Weeks||0
8767824|NCT01259089|9817999|FG005|COMPLETED|Continued Treatment After 8 Weeks||7
8767825|NCT01259089|9817994|FG000|NOT COMPLETED|Continued Treatment After 8 Weeks||2
8767826|NCT01259089|9817995|FG001|NOT COMPLETED|Continued Treatment After 8 Weeks||1
8767827|NCT01259089|9817996|FG002|NOT COMPLETED|Continued Treatment After 8 Weeks||1
8767828|NCT01259089|9817997|FG003|NOT COMPLETED|Continued Treatment After 8 Weeks||1
8767829|NCT01259089|9817998|FG004|NOT COMPLETED|Continued Treatment After 8 Weeks||2
8767830|NCT01259089|9817999|FG005|NOT COMPLETED|Continued Treatment After 8 Weeks||1
8767831|NCT01259089|9817994|FG000|STARTED|Survival Follow up for Two Years||3
8767832|NCT01259089|9817995|FG001|STARTED|Survival Follow up for Two Years||3
8767833|NCT01259089|9817996|FG002|STARTED|Survival Follow up for Two Years||3
8767834|NCT01259089|9817997|FG003|STARTED|Survival Follow up for Two Years||3
8767835|NCT01259089|9817998|FG004|STARTED|Survival Follow up for Two Years||6
8767836|NCT01259089|9817999|FG005|STARTED|Survival Follow up for Two Years||19
8767837|NCT01259089|9817994|FG000|COMPLETED|Survival Follow up for Two Years||0
8767838|NCT01259089|9817995|FG001|COMPLETED|Survival Follow up for Two Years||1
8767839|NCT01259089|9817996|FG002|COMPLETED|Survival Follow up for Two Years||1
8767840|NCT01259089|9817997|FG003|COMPLETED|Survival Follow up for Two Years||0
8767841|NCT01259089|9817998|FG004|COMPLETED|Survival Follow up for Two Years||0
8767842|NCT01259089|9817999|FG005|COMPLETED|Survival Follow up for Two Years||0
8767843|NCT01259089|9817994|FG000|NOT COMPLETED|Survival Follow up for Two Years||3
8767844|NCT01259089|9817995|FG001|NOT COMPLETED|Survival Follow up for Two Years||2
8767845|NCT01259089|9817996|FG002|NOT COMPLETED|Survival Follow up for Two Years||2
8767846|NCT01259089|9817997|FG003|NOT COMPLETED|Survival Follow up for Two Years||3
8767847|NCT01259089|9817998|FG004|NOT COMPLETED|Survival Follow up for Two Years||6
8767848|NCT01259089|9817999|FG005|NOT COMPLETED|Survival Follow up for Two Years||19
8767849|NCT01259102|9818018|FG000|STARTED|Overall Study||13
8767850|NCT01259102|9818019|FG001|STARTED|Overall Study||14
8767851|NCT01259102|9818020|FG002|STARTED|Overall Study||15
8767852|NCT01259102|9818021|FG003|STARTED|Overall Study||14
8767853|NCT01259102|9818022|FG004|STARTED|Overall Study||14
8767854|NCT01259102|9818018|FG000|COMPLETED|Overall Study||12
8767855|NCT01259102|9818019|FG001|COMPLETED|Overall Study||14
8767856|NCT01259102|9818020|FG002|COMPLETED|Overall Study||13
8767857|NCT01259102|9818021|FG003|COMPLETED|Overall Study||12
8767858|NCT01259102|9818022|FG004|COMPLETED|Overall Study||13
8767859|NCT01259102|9818018|FG000|NOT COMPLETED|Overall Study||1
8767860|NCT01259102|9818019|FG001|NOT COMPLETED|Overall Study||0
8767861|NCT01259102|9818020|FG002|NOT COMPLETED|Overall Study||2
8767862|NCT01259102|9818021|FG003|NOT COMPLETED|Overall Study||2
8767863|NCT01259102|9818022|FG004|NOT COMPLETED|Overall Study||1
8767864|NCT01259115|9818034|FG000|STARTED|Period 1||10
8767865|NCT01259115|9818035|FG001|STARTED|Period 1||10
8767866|NCT01259115|9818034|FG000|COMPLETED|Period 1||7
8767867|NCT01259115|9818035|FG001|COMPLETED|Period 1||9
8767868|NCT01259115|9818034|FG000|NOT COMPLETED|Period 1||3
8767869|NCT01259115|9818035|FG001|NOT COMPLETED|Period 1||1
8767870|NCT01259115|9818034|FG000|STARTED|Period: Washout Period of 4 to 18 Days||7
8767871|NCT01259115|9818035|FG001|STARTED|Period: Washout Period of 4 to 18 Days||9
8767872|NCT01259115|9818034|FG000|COMPLETED|Period: Washout Period of 4 to 18 Days||7
8767873|NCT01259115|9818035|FG001|COMPLETED|Period: Washout Period of 4 to 18 Days||9
8767874|NCT01259115|9818034|FG000|NOT COMPLETED|Period: Washout Period of 4 to 18 Days||0
8767875|NCT01259115|9818035|FG001|NOT COMPLETED|Period: Washout Period of 4 to 18 Days||0
8767876|NCT01259115|9818034|FG000|STARTED|Period 2||7
8767877|NCT01259115|9818035|FG001|STARTED|Period 2||9
8767878|NCT01259115|9818034|FG000|COMPLETED|Period 2||6
8767879|NCT01259115|9818035|FG001|COMPLETED|Period 2||9
8767880|NCT01259115|9818034|FG000|NOT COMPLETED|Period 2||1
8767881|NCT01259115|9818035|FG001|NOT COMPLETED|Period 2||0
8767882|NCT01259128|9818048|FG000|STARTED|Overall Study||15
8767883|NCT01259128|9818049|FG001|STARTED|Overall Study||17
8767884|NCT01259128|9818048|FG000|COMPLETED|Overall Study||15
8767885|NCT01259128|9818049|FG001|COMPLETED|Overall Study||15
8767886|NCT01259128|9818048|FG000|NOT COMPLETED|Overall Study||0
8767887|NCT01259128|9818049|FG001|NOT COMPLETED|Overall Study||2
8767888|NCT01259245|9818057|FG000|STARTED|Overall Study||98
8767889|NCT01259245|9818058|FG001|STARTED|Overall Study||94
8767890|NCT01259245|9818057|FG000|COMPLETED|Overall Study|27 were lost to follow-up and 1 deceased|70
8767891|NCT01259245|9818058|FG001|COMPLETED|Overall Study|24 discontinued intervention and 2 deceased|68
8767892|NCT01259245|9818057|FG000|NOT COMPLETED|Overall Study||28
8767893|NCT01259245|9818058|FG001|NOT COMPLETED|Overall Study||26
8767894|NCT01259297|9818074|FG000|STARTED|Run-in Open Label Period (4-5 Weeks)||1335
8767895|NCT01259297|9818075|FG001|STARTED|Run-in Open Label Period (4-5 Weeks)||0
8767896|NCT01259297|9818076|FG002|STARTED|Run-in Open Label Period (4-5 Weeks)||1001
8767897|NCT01259297|9818077|FG003|STARTED|Run-in Open Label Period (4-5 Weeks)||0
8767898|NCT01259297|9818078|FG004|STARTED|Run-in Open Label Period (4-5 Weeks)||0
8767899|NCT01259297|9818079|FG005|STARTED|Run-in Open Label Period (4-5 Weeks)||0
8767900|NCT01259297|9818080|FG006|STARTED|Run-in Open Label Period (4-5 Weeks)||0
8767901|NCT01259297|9818081|FG007|STARTED|Run-in Open Label Period (4-5 Weeks)||0
8767902|NCT01259297|9818074|FG000|COMPLETED|Run-in Open Label Period (4-5 Weeks)||980
8767903|NCT01259297|9818075|FG001|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
8767904|NCT01259297|9818076|FG002|COMPLETED|Run-in Open Label Period (4-5 Weeks)||779
8767905|NCT01259297|9818077|FG003|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
8767906|NCT01259297|9818078|FG004|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
8767907|NCT01259297|9818079|FG005|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
8767908|NCT01259297|9818080|FG006|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
8767909|NCT01259297|9818081|FG007|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
9027481|NCT03187301|10089766|FG003|STARTED|Third Intervention||6
9027482|NCT03187301|10089767|FG004|STARTED|Third Intervention||7
9027483|NCT03187301|10089768|FG005|STARTED|Third Intervention||7
9027484|NCT03187301|10089769|FG006|STARTED|Third Intervention||0
9027485|NCT03187301|10089763|FG000|COMPLETED|Third Intervention||6
9027486|NCT03187301|10089764|FG001|COMPLETED|Third Intervention||7
9027487|NCT03187301|10089765|FG002|COMPLETED|Third Intervention||7
9027488|NCT03187301|10089766|FG003|COMPLETED|Third Intervention||6
9027489|NCT03187301|10089767|FG004|COMPLETED|Third Intervention||7
9027490|NCT03187301|10089768|FG005|COMPLETED|Third Intervention||7
9027491|NCT03187301|10089769|FG006|COMPLETED|Third Intervention||0
9027492|NCT03187301|10089763|FG000|NOT COMPLETED|Third Intervention||0
9027493|NCT03187301|10089764|FG001|NOT COMPLETED|Third Intervention||0
9027494|NCT03187301|10089765|FG002|NOT COMPLETED|Third Intervention||0
9027495|NCT03187301|10089766|FG003|NOT COMPLETED|Third Intervention||0
9027496|NCT03187301|10089767|FG004|NOT COMPLETED|Third Intervention||0
9027497|NCT03187301|10089768|FG005|NOT COMPLETED|Third Intervention||0
9027498|NCT03187301|10089769|FG006|NOT COMPLETED|Third Intervention||0
9027499|NCT03187418|10089790|FG000|STARTED|Overall Study||52
9027500|NCT03187418|10089790|FG000|COMPLETED|Overall Study||52
9027501|NCT03187418|10089790|FG000|NOT COMPLETED|Overall Study||0
9027502|NCT03187678|10089794|FG000|STARTED|Period 1 (Oral Selexipag)||20
9027503|NCT03187678|10089794|FG000|COMPLETED|Period 1 (Oral Selexipag)||20
9027504|NCT03187678|10089794|FG000|NOT COMPLETED|Period 1 (Oral Selexipag)||0
9027505|NCT03187678|10089794|FG000|STARTED|Period 2 (Intravenous Selexipag)||20
9027506|NCT03187678|10089794|FG000|COMPLETED|Period 2 (Intravenous Selexipag)||20
9027507|NCT03187678|10089794|FG000|NOT COMPLETED|Period 2 (Intravenous Selexipag)||0
9027508|NCT03187678|10089794|FG000|STARTED|Period 3 (Oral Selexipag)||20
9027509|NCT03187678|10089794|FG000|COMPLETED|Period 3 (Oral Selexipag)||20
9027510|NCT03187678|10089794|FG000|NOT COMPLETED|Period 3 (Oral Selexipag)||0
9027511|NCT03187730|10089800|FG000|STARTED|Overall Study||208
9027512|NCT03187730|10089801|FG001|STARTED|Overall Study||202
9027513|NCT03187730|10089800|FG000|COMPLETED|Overall Study||129
9027514|NCT03187730|10089801|FG001|COMPLETED|Overall Study||154
9027515|NCT03187730|10089800|FG000|NOT COMPLETED|Overall Study||79
9027516|NCT03187730|10089801|FG001|NOT COMPLETED|Overall Study||48
9027517|NCT03187756|10089807|FG000|STARTED|Overall Study||6
8671321|NCT00750308|9714635|FG003|NOT COMPLETED|Washout||0
8671322|NCT00750308|9714636|FG004|NOT COMPLETED|Washout||0
8671323|NCT00750308|9714637|FG005|NOT COMPLETED|Washout||0
8671324|NCT00750308|9714638|FG006|NOT COMPLETED|Washout||0
8671325|NCT00750308|9714639|FG007|NOT COMPLETED|Washout||0
8671326|NCT00750308|9714640|FG008|NOT COMPLETED|Washout||0
8671327|NCT00750308|9714641|FG009|NOT COMPLETED|Washout||0
8671328|NCT00750308|9714642|FG010|NOT COMPLETED|Washout||0
8671329|NCT00750308|9714643|FG011|NOT COMPLETED|Washout||0
8671330|NCT00750308|9714632|FG000|STARTED|Fourth Treatment||2
8671331|NCT00750308|9714633|FG001|STARTED|Fourth Treatment||1
8671332|NCT00750308|9714634|FG002|STARTED|Fourth Treatment||2
8671333|NCT00750308|9714635|FG003|STARTED|Fourth Treatment||1
8671334|NCT00750308|9714636|FG004|STARTED|Fourth Treatment||1
8671335|NCT00750308|9714637|FG005|STARTED|Fourth Treatment||2
8671336|NCT00750308|9714638|FG006|STARTED|Fourth Treatment||2
8671337|NCT00750308|9714639|FG007|STARTED|Fourth Treatment||2
8671338|NCT00750308|9714640|FG008|STARTED|Fourth Treatment||1
8671339|NCT00750308|9714641|FG009|STARTED|Fourth Treatment||2
8671340|NCT00750308|9714642|FG010|STARTED|Fourth Treatment||1
8671341|NCT00750308|9714643|FG011|STARTED|Fourth Treatment||1
8671342|NCT00750308|9714632|FG000|COMPLETED|Fourth Treatment||2
8671343|NCT00750308|9714633|FG001|COMPLETED|Fourth Treatment||1
8671344|NCT00750308|9714634|FG002|COMPLETED|Fourth Treatment||2
8671345|NCT00750308|9714635|FG003|COMPLETED|Fourth Treatment||1
8671346|NCT00750308|9714636|FG004|COMPLETED|Fourth Treatment||1
8671347|NCT00750308|9714637|FG005|COMPLETED|Fourth Treatment||2
9027518|NCT03187756|10089807|FG000|COMPLETED|Overall Study||2
9027519|NCT03187756|10089807|FG000|NOT COMPLETED|Overall Study||4
9027520|NCT03188055|10089813|FG000|STARTED|Overall Study||48
8671348|NCT00750308|9714638|FG006|COMPLETED|Fourth Treatment||2
8671349|NCT00750308|9714639|FG007|COMPLETED|Fourth Treatment||2
8671350|NCT00750308|9714640|FG008|COMPLETED|Fourth Treatment||1
8671351|NCT00750308|9714641|FG009|COMPLETED|Fourth Treatment||2
8767910|NCT01259297|9818074|FG000|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||355
8767911|NCT01259297|9818075|FG001|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
8767912|NCT01259297|9818076|FG002|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||222
8767913|NCT01259297|9818077|FG003|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
8915822|NCT02177812|9975302|FG005|NOT COMPLETED|Part 1 (Median of 4 Weeks)||3
8915823|NCT02177812|9975303|FG006|NOT COMPLETED|Part 1 (Median of 4 Weeks)||9
8915824|NCT02177812|9975304|FG007|NOT COMPLETED|Part 1 (Median of 4 Weeks)||2
8915825|NCT02177812|9975305|FG008|NOT COMPLETED|Part 1 (Median of 4 Weeks)||0
8915826|NCT02177812|9975297|FG000|STARTED|Part 2 (Up to 14 Months)||0
8915827|NCT02177812|9975298|FG001|STARTED|Part 2 (Up to 14 Months)||0
8915828|NCT02177812|9975299|FG002|STARTED|Part 2 (Up to 14 Months)||0
8915829|NCT02177812|9975300|FG003|STARTED|Part 2 (Up to 14 Months)||0
8915830|NCT02177812|9975301|FG004|STARTED|Part 2 (Up to 14 Months)||0
8915831|NCT02177812|9975302|FG005|STARTED|Part 2 (Up to 14 Months)||0
8915832|NCT02177812|9975303|FG006|STARTED|Part 2 (Up to 14 Months)||0
8915833|NCT02177812|9975304|FG007|STARTED|Part 2 (Up to 14 Months)||0
8915834|NCT02177812|9975305|FG008|STARTED|Part 2 (Up to 14 Months)||0
8915835|NCT02177812|9975297|FG000|COMPLETED|Part 2 (Up to 14 Months)||0
8915836|NCT02177812|9975298|FG001|COMPLETED|Part 2 (Up to 14 Months)||0
8915837|NCT02177812|9975299|FG002|COMPLETED|Part 2 (Up to 14 Months)||0
8915838|NCT02177812|9975300|FG003|COMPLETED|Part 2 (Up to 14 Months)||0
8915839|NCT02177812|9975301|FG004|COMPLETED|Part 2 (Up to 14 Months)||0
8915840|NCT02177812|9975302|FG005|COMPLETED|Part 2 (Up to 14 Months)||0
8915841|NCT02177812|9975303|FG006|COMPLETED|Part 2 (Up to 14 Months)||0
8915842|NCT02177812|9975304|FG007|COMPLETED|Part 2 (Up to 14 Months)||0
8915843|NCT02177812|9975305|FG008|COMPLETED|Part 2 (Up to 14 Months)||0
8915844|NCT02177812|9975297|FG000|NOT COMPLETED|Part 2 (Up to 14 Months)||0
8915845|NCT02177812|9975298|FG001|NOT COMPLETED|Part 2 (Up to 14 Months)||0
8915846|NCT02177812|9975299|FG002|NOT COMPLETED|Part 2 (Up to 14 Months)||0
8915847|NCT02177812|9975300|FG003|NOT COMPLETED|Part 2 (Up to 14 Months)||0
8915848|NCT02177812|9975301|FG004|NOT COMPLETED|Part 2 (Up to 14 Months)||0
8915849|NCT02177812|9975302|FG005|NOT COMPLETED|Part 2 (Up to 14 Months)||0
8915850|NCT02177812|9975303|FG006|NOT COMPLETED|Part 2 (Up to 14 Months)||0
8915851|NCT02177812|9975304|FG007|NOT COMPLETED|Part 2 (Up to 14 Months)||0
8915852|NCT02177812|9975305|FG008|NOT COMPLETED|Part 2 (Up to 14 Months)||0
8915853|NCT02177838|9975334|FG000|STARTED|Overall Study||8
8915854|NCT02177838|9975334|FG000|COMPLETED|Overall Study||5
8915855|NCT02177838|9975334|FG000|NOT COMPLETED|Overall Study||3
8915856|NCT02177942|9975340|FG000|STARTED|Overall Study||262
8915857|NCT02177942|9975341|FG001|STARTED|Overall Study||266
8915858|NCT02177942|9975340|FG000|COMPLETED|Overall Study||185
8915859|NCT02177942|9975341|FG001|COMPLETED|Overall Study||178
8915860|NCT02177942|9975340|FG000|NOT COMPLETED|Overall Study||77
8915861|NCT02177942|9975341|FG001|NOT COMPLETED|Overall Study||88
8915862|NCT02178059|9975351|FG000|STARTED|First Intervention||17
8915863|NCT02178059|9975352|FG001|STARTED|First Intervention||17
8915864|NCT02178059|9975351|FG000|COMPLETED|First Intervention||17
8915865|NCT02178059|9975352|FG001|COMPLETED|First Intervention||17
8915866|NCT02178059|9975351|FG000|NOT COMPLETED|First Intervention||0
8915867|NCT02178059|9975352|FG001|NOT COMPLETED|First Intervention||0
8915868|NCT02178059|9975351|FG000|STARTED|Washout||17
8915869|NCT02178059|9975352|FG001|STARTED|Washout||17
8915870|NCT02178059|9975351|FG000|COMPLETED|Washout||16
8915871|NCT02178059|9975352|FG001|COMPLETED|Washout||17
8915872|NCT02178059|9975351|FG000|NOT COMPLETED|Washout||1
8915873|NCT02178059|9975352|FG001|NOT COMPLETED|Washout||0
8915874|NCT02178059|9975351|FG000|STARTED|Second Intervention||16
8915875|NCT02178059|9975352|FG001|STARTED|Second Intervention||17
8915876|NCT02178059|9975351|FG000|COMPLETED|Second Intervention||16
8915877|NCT02178059|9975352|FG001|COMPLETED|Second Intervention||17
8915878|NCT02178059|9975351|FG000|NOT COMPLETED|Second Intervention||0
8915879|NCT02178059|9975352|FG001|NOT COMPLETED|Second Intervention||0
8915880|NCT02178241|9975358|FG000|STARTED|Overall Study||24
8915881|NCT02178241|9975358|FG000|COMPLETED|Overall Study||24
8915882|NCT02178241|9975358|FG000|NOT COMPLETED|Overall Study||0
8915883|NCT02178475|9975362|FG000|STARTED|Overall Study||943
8915884|NCT02178475|9975362|FG000|Primary Analysis Set|Overall Study|All enrolled participants who met eligibility criteria|844
8915885|NCT02178475|9975362|FG000|COMPLETED|Overall Study||814
8915886|NCT02178475|9975362|FG000|NOT COMPLETED|Overall Study||129
8915887|NCT02178540|9975366|FG000|STARTED|Overall Study||45
8915888|NCT02178540|9975366|FG000|COMPLETED|Overall Study||45
8915889|NCT02178540|9975366|FG000|NOT COMPLETED|Overall Study||0
8915890|NCT02178553|9975375|FG000|STARTED|Overall Study||53
8915891|NCT02178553|9975376|FG001|STARTED|Overall Study||49
8915892|NCT02178553|9975375|FG000|COMPLETED|Overall Study||45
8915893|NCT02178553|9975376|FG001|COMPLETED|Overall Study||39
8915894|NCT02178553|9975375|FG000|NOT COMPLETED|Overall Study||8
8915895|NCT02178553|9975376|FG001|NOT COMPLETED|Overall Study||10
8915896|NCT02178592|9975384|FG000|STARTED|Randomized Phase (Up to Week 52)||69
8915897|NCT02178592|9975385|FG001|STARTED|Randomized Phase (Up to Week 52)||44
8915898|NCT02178592|9975384|FG000|COMPLETED|Randomized Phase (Up to Week 52)||50
8767914|NCT01259297|9818078|FG004|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
8767915|NCT01259297|9818079|FG005|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
8767916|NCT01259297|9818080|FG006|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
8767917|NCT01259297|9818081|FG007|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
8767918|NCT01259297|9818074|FG000|STARTED|Double Blind Randomized Period||244
8767919|NCT01259297|9818075|FG001|STARTED|Double Blind Randomized Period||232
8767920|NCT01259297|9818076|FG002|STARTED|Double Blind Randomized Period||189
8767921|NCT01259297|9818077|FG003|STARTED|Double Blind Randomized Period||195
8767922|NCT01259297|9818078|FG004|STARTED|Double Blind Randomized Period||251
8767923|NCT01259297|9818079|FG005|STARTED|Double Blind Randomized Period||253
8767924|NCT01259297|9818080|FG006|STARTED|Double Blind Randomized Period||196
8767925|NCT01259297|9818081|FG007|STARTED|Double Blind Randomized Period||199
8767926|NCT01259297|9818074|FG000|COMPLETED|Double Blind Randomized Period||242
8767927|NCT01259297|9818075|FG001|COMPLETED|Double Blind Randomized Period||229
8767928|NCT01259297|9818076|FG002|COMPLETED|Double Blind Randomized Period||188
8767929|NCT01259297|9818077|FG003|COMPLETED|Double Blind Randomized Period||191
8767930|NCT01259297|9818078|FG004|COMPLETED|Double Blind Randomized Period||247
8767931|NCT01259297|9818079|FG005|COMPLETED|Double Blind Randomized Period||245
8767932|NCT01259297|9818080|FG006|COMPLETED|Double Blind Randomized Period||190
8767933|NCT01259297|9818081|FG007|COMPLETED|Double Blind Randomized Period||196
8767934|NCT01259297|9818074|FG000|NOT COMPLETED|Double Blind Randomized Period||2
8767935|NCT01259297|9818075|FG001|NOT COMPLETED|Double Blind Randomized Period||3
8767936|NCT01259297|9818076|FG002|NOT COMPLETED|Double Blind Randomized Period||1
8767937|NCT01259297|9818077|FG003|NOT COMPLETED|Double Blind Randomized Period||4
8767938|NCT01259297|9818078|FG004|NOT COMPLETED|Double Blind Randomized Period||4
8767939|NCT01259297|9818079|FG005|NOT COMPLETED|Double Blind Randomized Period||8
8767940|NCT01259297|9818080|FG006|NOT COMPLETED|Double Blind Randomized Period||6
8767941|NCT01259297|9818081|FG007|NOT COMPLETED|Double Blind Randomized Period||3
8767942|NCT01259375|9818098|FG000|STARTED|Overall Study||24
8767943|NCT01259375|9818098|FG000|COMPLETED|Overall Study||23
8767944|NCT01259375|9818098|FG000|NOT COMPLETED|Overall Study||1
8767945|NCT01259388|9818106|FG000|STARTED|Overall Study||11
8767946|NCT01259388|9818107|FG001|STARTED|Overall Study||12
8767947|NCT01259388|9818106|FG000|COMPLETED|Overall Study||6
8767948|NCT01259388|9818107|FG001|COMPLETED|Overall Study||11
8767949|NCT01259388|9818106|FG000|NOT COMPLETED|Overall Study||5
8767950|NCT01259388|9818107|FG001|NOT COMPLETED|Overall Study||1
8767951|NCT01259401|9818115|FG000|STARTED|End of 4-week Intervention||21
8767952|NCT01259401|9818116|FG001|STARTED|End of 4-week Intervention||21
8767953|NCT01259401|9818115|FG000|COMPLETED|End of 4-week Intervention||21
8767954|NCT01259401|9818116|FG001|COMPLETED|End of 4-week Intervention||21
8767955|NCT01259401|9818115|FG000|NOT COMPLETED|End of 4-week Intervention||0
8767956|NCT01259401|9818116|FG001|NOT COMPLETED|End of 4-week Intervention||0
8767957|NCT01259401|9818115|FG000|STARTED|4-month Follow-up||21
8767958|NCT01259401|9818116|FG001|STARTED|4-month Follow-up||21
8767959|NCT01259401|9818115|FG000|COMPLETED|4-month Follow-up||21
8767960|NCT01259401|9818116|FG001|COMPLETED|4-month Follow-up||19
8767961|NCT01259401|9818115|FG000|NOT COMPLETED|4-month Follow-up||0
8767962|NCT01259401|9818116|FG001|NOT COMPLETED|4-month Follow-up||2
8767963|NCT01259427|9818124|FG000|STARTED|Overall Study||124
8767964|NCT01259427|9818125|FG001|STARTED|Overall Study||124
8767965|NCT01259427|9818124|FG000|COMPLETED|Overall Study||106
8767966|NCT01259427|9818125|FG001|COMPLETED|Overall Study||110
8767967|NCT01259427|9818124|FG000|NOT COMPLETED|Overall Study||18
8767968|NCT01259427|9818125|FG001|NOT COMPLETED|Overall Study||14
8767969|NCT01259440|9818134|FG000|STARTED|Overall Study||13
8767970|NCT01259440|9818135|FG001|STARTED|Overall Study||10
8767971|NCT01259440|9818134|FG000|COMPLETED|Overall Study||13
8767972|NCT01259440|9818135|FG001|COMPLETED|Overall Study||10
8767973|NCT01259440|9818134|FG000|NOT COMPLETED|Overall Study||0
8767974|NCT01259440|9818135|FG001|NOT COMPLETED|Overall Study||0
8767975|NCT01259466|9818143|FG000|STARTED|Overall Study||27
8767976|NCT01259466|9818144|FG001|STARTED|Overall Study||27
8767977|NCT01259466|9818143|FG000|COMPLETED|Overall Study||26
8767978|NCT01259466|9818144|FG001|COMPLETED|Overall Study||18
8767979|NCT01259466|9818143|FG000|NOT COMPLETED|Overall Study||1
8767980|NCT01259466|9818144|FG001|NOT COMPLETED|Overall Study||9
8767981|NCT01259492|9818154|FG000|STARTED|Period 1 (9 Weeks)||181
8767982|NCT01259492|9818155|FG001|STARTED|Period 1 (9 Weeks)||182
8767983|NCT01259492|9818156|FG002|STARTED|Period 1 (9 Weeks)||181
8767984|NCT01259492|9818157|FG003|STARTED|Period 1 (9 Weeks)||181
8767985|NCT01259492|9818154|FG000|Full Analysis Set|Period 1 (9 Weeks)||174
8767986|NCT01259492|9818155|FG001|Full Analysis Set|Period 1 (9 Weeks)||175
8767987|NCT01259492|9818156|FG002|Full Analysis Set|Period 1 (9 Weeks)||179
8767988|NCT01259492|9818157|FG003|Full Analysis Set|Period 1 (9 Weeks)||172
8767989|NCT01259492|9818154|FG000|COMPLETED|Period 1 (9 Weeks)|"Completed indicates patients entered Period 2."|152
8767990|NCT01259492|9818155|FG001|COMPLETED|Period 1 (9 Weeks)|Completed = entered Period 2|141
8767991|NCT01259492|9818156|FG002|COMPLETED|Period 1 (9 Weeks)|Completed = entered Period 2|138
8767992|NCT01259492|9818157|FG003|COMPLETED|Period 1 (9 Weeks)|Completed = entered Period 2|153
8767993|NCT01259492|9818154|FG000|NOT COMPLETED|Period 1 (9 Weeks)||29
8767994|NCT01259492|9818155|FG001|NOT COMPLETED|Period 1 (9 Weeks)||41
8767995|NCT01259492|9818156|FG002|NOT COMPLETED|Period 1 (9 Weeks)||43
8767996|NCT01259492|9818157|FG003|NOT COMPLETED|Period 1 (9 Weeks)||28
8767997|NCT01259492|9818154|FG000|STARTED|Period 2 (Week 10 to Week 14)|Treatment arms including Placebo indicate patients belong to respective treatment arms in Period 1|152
8767998|NCT01259492|9818155|FG001|STARTED|Period 2 (Week 10 to Week 14)||141
8767999|NCT01259492|9818156|FG002|STARTED|Period 2 (Week 10 to Week 14)||138
8768000|NCT01259492|9818157|FG003|STARTED|Period 2 (Week 10 to Week 14)||153
8768001|NCT01259492|9818154|FG000|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|127
8768002|NCT01259492|9818155|FG001|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|123
8768003|NCT01259492|9818156|FG002|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|114
8768004|NCT01259492|9818157|FG003|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|125
8768005|NCT01259492|9818154|FG000|NOT COMPLETED|Period 2 (Week 10 to Week 14)||25
8768006|NCT01259492|9818155|FG001|NOT COMPLETED|Period 2 (Week 10 to Week 14)||18
8768007|NCT01259492|9818156|FG002|NOT COMPLETED|Period 2 (Week 10 to Week 14)||24
8768008|NCT01259492|9818157|FG003|NOT COMPLETED|Period 2 (Week 10 to Week 14)||28
8768009|NCT01259492|9818154|FG000|STARTED|Period 3 (Week 15 to End of Week 40)|In period 3, all 489 patients who completed period 2 were re-randomized to 4 arms.|114
9027521|NCT03188055|10089814|FG001|STARTED|Overall Study|Family members consented (24/48 had patient enroll along with them as patient had DMC).|48
8768010|NCT01259492|9818155|FG001|STARTED|Period 3 (Week 15 to End of Week 40)||132
8768011|NCT01259492|9818156|FG002|STARTED|Period 3 (Week 15 to End of Week 40)||120
8768012|NCT01259492|9818157|FG003|STARTED|Period 3 (Week 15 to End of Week 40)||123
8768013|NCT01259492|9818154|FG000|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||110
8768014|NCT01259492|9818155|FG001|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||128
8768015|NCT01259492|9818156|FG002|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||114
8768016|NCT01259492|9818157|FG003|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||115
8768017|NCT01259492|9818154|FG000|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|60
8768018|NCT01259492|9818155|FG001|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|63
8768019|NCT01259492|9818156|FG002|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|70
8768020|NCT01259492|9818157|FG003|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|42
8768021|NCT01259492|9818154|FG000|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||54
8768022|NCT01259492|9818155|FG001|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||69
8768023|NCT01259492|9818156|FG002|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||50
8768024|NCT01259492|9818157|FG003|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||81
8768025|NCT01259596|9818168|FG000|STARTED|Overall Study||70
8768026|NCT01259596|9818169|FG001|STARTED|Overall Study||71
8768027|NCT01259596|9818168|FG000|COMPLETED|Overall Study||66
8768028|NCT01259596|9818169|FG001|COMPLETED|Overall Study||65
8768029|NCT01259596|9818168|FG000|NOT COMPLETED|Overall Study||4
8768030|NCT01259596|9818169|FG001|NOT COMPLETED|Overall Study||6
8768031|NCT01259713|9818179|FG000|STARTED|Overall Study||237
8768032|NCT01259713|9818180|FG001|STARTED|Overall Study||118
8768033|NCT01259713|9818179|FG000|COMPLETED|Overall Study||142
8768034|NCT01259713|9818180|FG001|COMPLETED|Overall Study||77
8768035|NCT01259713|9818179|FG000|NOT COMPLETED|Overall Study||95
8768036|NCT01259713|9818180|FG001|NOT COMPLETED|Overall Study||41
8768037|NCT01259726|9818190|FG000|STARTED|Overall Study||43
8768038|NCT01259726|9818191|FG001|STARTED|Overall Study||41
8768039|NCT01259726|9818192|FG002|STARTED|Overall Study||43
8768040|NCT01259726|9818193|FG003|STARTED|Overall Study||41
8768041|NCT01259726|9818190|FG000|Treated|Overall Study||40
8768042|NCT01259726|9818191|FG001|Treated|Overall Study||37
8768043|NCT01259726|9818192|FG002|Treated|Overall Study||41
8768044|NCT01259726|9818193|FG003|Treated|Overall Study||39
8768045|NCT01259726|9818190|FG000|COMPLETED|Overall Study||38
8768046|NCT01259726|9818191|FG001|COMPLETED|Overall Study||37
8768047|NCT01259726|9818192|FG002|COMPLETED|Overall Study||39
8768048|NCT01259726|9818193|FG003|COMPLETED|Overall Study||36
8768049|NCT01259726|9818190|FG000|NOT COMPLETED|Overall Study||5
8768050|NCT01259726|9818191|FG001|NOT COMPLETED|Overall Study||4
8768051|NCT01259726|9818192|FG002|NOT COMPLETED|Overall Study||4
8768052|NCT01259726|9818193|FG003|NOT COMPLETED|Overall Study||5
8768053|NCT01259856|9818205|FG000|STARTED|Overall Study||82
8768054|NCT01259856|9818206|FG001|STARTED|Overall Study||86
8768055|NCT01259856|9818205|FG000|COMPLETED|Overall Study||13
8768056|NCT01259856|9818206|FG001|COMPLETED|Overall Study||12
8768057|NCT01259856|9818205|FG000|NOT COMPLETED|Overall Study||69
8768058|NCT01259856|9818206|FG001|NOT COMPLETED|Overall Study||74
8768059|NCT01259869|9818212|FG000|STARTED|Overall Study||34
8768060|NCT01259869|9818212|FG000|COMPLETED|Overall Study||33
8768061|NCT01259869|9818212|FG000|NOT COMPLETED|Overall Study||1
8808508|NCT01490632|9860703|FG002|COMPLETED|Part D: Re-Treatment Period||0
8808509|NCT01490632|9860704|FG003|COMPLETED|Part D: Re-Treatment Period||0
8808510|NCT01490632|9860705|FG004|COMPLETED|Part D: Re-Treatment Period||0
8808511|NCT01490632|9860706|FG005|COMPLETED|Part D: Re-Treatment Period||0
8808512|NCT01490632|9860707|FG006|COMPLETED|Part D: Re-Treatment Period||0
8808513|NCT01490632|9860708|FG007|COMPLETED|Part D: Re-Treatment Period||0
8808514|NCT01490632|9860709|FG008|COMPLETED|Part D: Re-Treatment Period||0
8808515|NCT01490632|9860710|FG009|COMPLETED|Part D: Re-Treatment Period||0
8808516|NCT01490632|9860711|FG010|COMPLETED|Part D: Re-Treatment Period||0
8808517|NCT01490632|9860712|FG011|COMPLETED|Part D: Re-Treatment Period||0
8808518|NCT01490632|9860713|FG012|COMPLETED|Part D: Re-Treatment Period||0
8808519|NCT01490632|9860714|FG013|COMPLETED|Part D: Re-Treatment Period||0
8808520|NCT01490632|9860715|FG014|COMPLETED|Part D: Re-Treatment Period||0
8808521|NCT01490632|9860716|FG015|COMPLETED|Part D: Re-Treatment Period||0
8808522|NCT01490632|9860717|FG016|COMPLETED|Part D: Re-Treatment Period||3
8808523|NCT01490632|9860718|FG017|COMPLETED|Part D: Re-Treatment Period||8
8808524|NCT01490632|9860719|FG018|COMPLETED|Part D: Re-Treatment Period||12
8808525|NCT01490632|9860720|FG019|COMPLETED|Part D: Re-Treatment Period||30
8768062|NCT01260142|9818222|FG000|STARTED|Treatment Period 1||6
8768063|NCT01260142|9818223|FG001|STARTED|Treatment Period 1||6
8768064|NCT01260142|9818224|FG002|STARTED|Treatment Period 1||6
8768065|NCT01260142|9818225|FG003|STARTED|Treatment Period 1||6
8768066|NCT01260142|9818226|FG004|STARTED|Treatment Period 1||6
8768067|NCT01260142|9818227|FG005|STARTED|Treatment Period 1||6
8768068|NCT01260142|9818222|FG000|COMPLETED|Treatment Period 1||5
8768069|NCT01260142|9818223|FG001|COMPLETED|Treatment Period 1||5
8768070|NCT01260142|9818224|FG002|COMPLETED|Treatment Period 1||6
8768071|NCT01260142|9818225|FG003|COMPLETED|Treatment Period 1||6
8768072|NCT01260142|9818226|FG004|COMPLETED|Treatment Period 1||4
8768073|NCT01260142|9818227|FG005|COMPLETED|Treatment Period 1||3
8768074|NCT01260142|9818222|FG000|NOT COMPLETED|Treatment Period 1||1
8768075|NCT01260142|9818223|FG001|NOT COMPLETED|Treatment Period 1||1
8768076|NCT01260142|9818224|FG002|NOT COMPLETED|Treatment Period 1||0
8768077|NCT01260142|9818225|FG003|NOT COMPLETED|Treatment Period 1||0
8768078|NCT01260142|9818226|FG004|NOT COMPLETED|Treatment Period 1||2
8768079|NCT01260142|9818227|FG005|NOT COMPLETED|Treatment Period 1||3
8768080|NCT01260142|9818222|FG000|STARTED|Treatment Period 2||5
8768081|NCT01260142|9818223|FG001|STARTED|Treatment Period 2||5
8768082|NCT01260142|9818224|FG002|STARTED|Treatment Period 2||6
8768083|NCT01260142|9818225|FG003|STARTED|Treatment Period 2||6
8768084|NCT01260142|9818226|FG004|STARTED|Treatment Period 2||4
8768085|NCT01260142|9818227|FG005|STARTED|Treatment Period 2||3
8768086|NCT01260142|9818222|FG000|COMPLETED|Treatment Period 2||5
8768087|NCT01260142|9818223|FG001|COMPLETED|Treatment Period 2||5
8768088|NCT01260142|9818224|FG002|COMPLETED|Treatment Period 2||6
8768089|NCT01260142|9818225|FG003|COMPLETED|Treatment Period 2||6
8768090|NCT01260142|9818226|FG004|COMPLETED|Treatment Period 2||4
8768091|NCT01260142|9818227|FG005|COMPLETED|Treatment Period 2||3
8768092|NCT01260142|9818222|FG000|NOT COMPLETED|Treatment Period 2||0
8768093|NCT01260142|9818223|FG001|NOT COMPLETED|Treatment Period 2||0
8768094|NCT01260142|9818224|FG002|NOT COMPLETED|Treatment Period 2||0
8768095|NCT01260142|9818225|FG003|NOT COMPLETED|Treatment Period 2||0
8768096|NCT01260142|9818226|FG004|NOT COMPLETED|Treatment Period 2||0
8768097|NCT01260142|9818227|FG005|NOT COMPLETED|Treatment Period 2||0
8768098|NCT01260181|9818247|FG000|STARTED|Overall Study||30
8768099|NCT01260181|9818247|FG000|COMPLETED|Overall Study||29
8768100|NCT01260181|9818247|FG000|NOT COMPLETED|Overall Study||1
8768101|NCT01260194|9818251|FG000|STARTED|Overall Study||4
8768102|NCT01260194|9818251|FG000|COMPLETED|Overall Study||3
8768103|NCT01260194|9818251|FG000|NOT COMPLETED|Overall Study||1
8768104|NCT01260272|9818257|FG000|STARTED|Overall Study||17
8768105|NCT01260272|9818258|FG001|STARTED|Overall Study||32
8768106|NCT01260272|9818257|FG000|COMPLETED|Overall Study||15
8768107|NCT01260272|9818258|FG001|COMPLETED|Overall Study||30
8768108|NCT01260272|9818257|FG000|NOT COMPLETED|Overall Study||2
8768109|NCT01260272|9818258|FG001|NOT COMPLETED|Overall Study||2
8768110|NCT01260311|9818266|FG000|STARTED|Overall Study||508
8768111|NCT01260311|9818266|FG000|COMPLETED|Overall Study||381
8768112|NCT01260311|9818266|FG000|NOT COMPLETED|Overall Study||127
8768113|NCT01260324|9818272|FG000|STARTED|Overall Study||1283
8768114|NCT01260324|9818273|FG001|STARTED|Overall Study||20000
8768115|NCT01260324|9818272|FG000|COMPLETED|Overall Study||1283
8768116|NCT01260324|9818273|FG001|COMPLETED|Overall Study||20000
8768117|NCT01260324|9818272|FG000|NOT COMPLETED|Overall Study||0
8768118|NCT01260324|9818273|FG001|NOT COMPLETED|Overall Study||0
8768119|NCT01260350|9818299|FG000|STARTED|Overall Study||10
8768120|NCT01260350|9818300|FG001|STARTED|Overall Study||9
8768121|NCT01260350|9818301|FG002|STARTED|Overall Study||10
8768122|NCT01260350|9818302|FG003|STARTED|Overall Study||11
8768123|NCT01260350|9818303|FG004|STARTED|Overall Study||10
8768124|NCT01260350|9818304|FG005|STARTED|Overall Study||10
8768125|NCT01260350|9818305|FG006|STARTED|Overall Study||10
8768126|NCT01260350|9818306|FG007|STARTED|Overall Study||25
8768127|NCT01260350|9818307|FG008|STARTED|Overall Study||25
8768128|NCT01260350|9818308|FG009|STARTED|Overall Study||25
8768129|NCT01260350|9818309|FG010|STARTED|Overall Study||10
8768130|NCT01260350|9818310|FG011|STARTED|Overall Study||9
8768131|NCT01260350|9818311|FG012|STARTED|Overall Study||25
8768132|NCT01260350|9818312|FG013|STARTED|Overall Study||10
8768133|NCT01260350|9818313|FG014|STARTED|Overall Study||25
8768134|NCT01260350|9818314|FG015|STARTED|Overall Study||10
8768135|NCT01260350|9818315|FG016|STARTED|Overall Study||9
8768136|NCT01260350|9818316|FG017|STARTED|Overall Study||10
8768137|NCT01260350|9818317|FG018|STARTED|Overall Study||0
8768138|NCT01260350|9818318|FG019|STARTED|Overall Study||14
8768139|NCT01260350|9818319|FG020|STARTED|Overall Study||25
8768140|NCT01260350|9818320|FG021|STARTED|Overall Study||0
8768141|NCT01260350|9818299|FG000|COMPLETED|Overall Study||10
8768142|NCT01260350|9818300|FG001|COMPLETED|Overall Study||9
8768143|NCT01260350|9818301|FG002|COMPLETED|Overall Study||10
8768144|NCT01260350|9818302|FG003|COMPLETED|Overall Study||11
8768145|NCT01260350|9818303|FG004|COMPLETED|Overall Study||10
8768146|NCT01260350|9818304|FG005|COMPLETED|Overall Study||10
8768147|NCT01260350|9818305|FG006|COMPLETED|Overall Study||10
8768148|NCT01260350|9818306|FG007|COMPLETED|Overall Study||25
8768149|NCT01260350|9818307|FG008|COMPLETED|Overall Study||24
8768150|NCT01260350|9818308|FG009|COMPLETED|Overall Study||25
8768151|NCT01260350|9818309|FG010|COMPLETED|Overall Study||10
8768152|NCT01260350|9818310|FG011|COMPLETED|Overall Study||9
8768153|NCT01260350|9818311|FG012|COMPLETED|Overall Study||25
8768154|NCT01260350|9818312|FG013|COMPLETED|Overall Study||10
8768155|NCT01260350|9818313|FG014|COMPLETED|Overall Study||25
8768156|NCT01260350|9818314|FG015|COMPLETED|Overall Study||10
8768157|NCT01260350|9818315|FG016|COMPLETED|Overall Study||9
8768158|NCT01260350|9818316|FG017|COMPLETED|Overall Study||9
8768159|NCT01260350|9818317|FG018|COMPLETED|Overall Study||0
8768160|NCT01260350|9818318|FG019|COMPLETED|Overall Study||14
8768161|NCT01260350|9818319|FG020|COMPLETED|Overall Study||22
8768162|NCT01260350|9818320|FG021|COMPLETED|Overall Study||0
8768163|NCT01260350|9818299|FG000|NOT COMPLETED|Overall Study||0
8768164|NCT01260350|9818300|FG001|NOT COMPLETED|Overall Study||0
8768165|NCT01260350|9818301|FG002|NOT COMPLETED|Overall Study||0
8768166|NCT01260350|9818302|FG003|NOT COMPLETED|Overall Study||0
8768167|NCT01260350|9818303|FG004|NOT COMPLETED|Overall Study||0
8768168|NCT01260350|9818304|FG005|NOT COMPLETED|Overall Study||0
8768169|NCT01260350|9818305|FG006|NOT COMPLETED|Overall Study||0
8768170|NCT01260350|9818306|FG007|NOT COMPLETED|Overall Study||0
8768171|NCT01260350|9818307|FG008|NOT COMPLETED|Overall Study||1
8768172|NCT01260350|9818308|FG009|NOT COMPLETED|Overall Study||0
8768173|NCT01260350|9818309|FG010|NOT COMPLETED|Overall Study||0
8768174|NCT01260350|9818310|FG011|NOT COMPLETED|Overall Study||0
8768175|NCT01260350|9818311|FG012|NOT COMPLETED|Overall Study||0
8768176|NCT01260350|9818312|FG013|NOT COMPLETED|Overall Study||0
8768177|NCT01260350|9818313|FG014|NOT COMPLETED|Overall Study||0
8768178|NCT01260350|9818314|FG015|NOT COMPLETED|Overall Study||0
8768179|NCT01260350|9818315|FG016|NOT COMPLETED|Overall Study||0
8768180|NCT01260350|9818316|FG017|NOT COMPLETED|Overall Study||1
8768181|NCT01260350|9818317|FG018|NOT COMPLETED|Overall Study||0
8768182|NCT01260350|9818318|FG019|NOT COMPLETED|Overall Study||0
8768183|NCT01260350|9818319|FG020|NOT COMPLETED|Overall Study||3
8768184|NCT01260350|9818320|FG021|NOT COMPLETED|Overall Study||0
8768185|NCT01260454|9818374|FG000|STARTED|Overall Study||6
8768186|NCT01260454|9818374|FG000|COMPLETED|Overall Study||6
8768187|NCT01260454|9818374|FG000|NOT COMPLETED|Overall Study||0
8768188|NCT01260467|9818378|FG000|STARTED|Overall Study||4
8768189|NCT01260467|9818378|FG000|COMPLETED|Overall Study||2
8768190|NCT01260467|9818378|FG000|NOT COMPLETED|Overall Study||2
8768191|NCT01260493|9818386|FG000|STARTED|Overall Study||92
8768192|NCT01260493|9818387|FG001|STARTED|Overall Study||89
8768193|NCT01260493|9818386|FG000|COMPLETED|Overall Study||76
8768194|NCT01260493|9818387|FG001|COMPLETED|Overall Study||85
8768195|NCT01260493|9818386|FG000|NOT COMPLETED|Overall Study||16
8768196|NCT01260493|9818387|FG001|NOT COMPLETED|Overall Study||4
8768197|NCT01260584|9818397|FG000|STARTED|Period 1||27
8768198|NCT01260584|9818398|FG001|STARTED|Period 1||28
8768199|NCT01260584|9818399|FG002|STARTED|Period 1||27
8768200|NCT01260584|9818400|FG003|STARTED|Period 1||28
8768201|NCT01260584|9818397|FG000|COMPLETED|Period 1||27
8768202|NCT01260584|9818398|FG001|COMPLETED|Period 1||28
8768203|NCT01260584|9818399|FG002|COMPLETED|Period 1||25
8768204|NCT01260584|9818400|FG003|COMPLETED|Period 1||27
8768205|NCT01260584|9818397|FG000|NOT COMPLETED|Period 1||0
8768206|NCT01260584|9818398|FG001|NOT COMPLETED|Period 1||0
8768207|NCT01260584|9818399|FG002|NOT COMPLETED|Period 1||2
8768208|NCT01260584|9818400|FG003|NOT COMPLETED|Period 1||1
8768209|NCT01260584|9818397|FG000|STARTED|Period 2||27
8768210|NCT01260584|9818398|FG001|STARTED|Period 2||28
8768211|NCT01260584|9818399|FG002|STARTED|Period 2||25
8768212|NCT01260584|9818400|FG003|STARTED|Period 2||27
8768213|NCT01260584|9818397|FG000|COMPLETED|Period 2||26
8768214|NCT01260584|9818398|FG001|COMPLETED|Period 2||25
8768215|NCT01260584|9818399|FG002|COMPLETED|Period 2||20
8768216|NCT01260584|9818400|FG003|COMPLETED|Period 2||26
8768217|NCT01260584|9818397|FG000|NOT COMPLETED|Period 2||1
8768218|NCT01260584|9818398|FG001|NOT COMPLETED|Period 2||3
8768219|NCT01260584|9818399|FG002|NOT COMPLETED|Period 2||5
8768220|NCT01260584|9818400|FG003|NOT COMPLETED|Period 2||1
8768221|NCT01260649|9818412|FG000|STARTED|Overall Study||8
8768222|NCT01260649|9818413|FG001|STARTED|Overall Study||9
8768223|NCT01260649|9818412|FG000|COMPLETED|Overall Study||6
8768224|NCT01260649|9818413|FG001|COMPLETED|Overall Study||8
8768225|NCT01260649|9818412|FG000|NOT COMPLETED|Overall Study||2
8768226|NCT01260649|9818413|FG001|NOT COMPLETED|Overall Study||1
8768227|NCT01260662|9818422|FG000|STARTED|Overall Study||90
8768228|NCT01260662|9818423|FG001|STARTED|Overall Study||85
8768229|NCT01260662|9818424|FG002|STARTED|Overall Study||96
8768230|NCT01260662|9818422|FG000|COMPLETED|Overall Study||90
8768231|NCT01260662|9818423|FG001|COMPLETED|Overall Study||85
8768232|NCT01260662|9818424|FG002|COMPLETED|Overall Study||96
8768233|NCT01260662|9818422|FG000|NOT COMPLETED|Overall Study||0
8768234|NCT01260662|9818423|FG001|NOT COMPLETED|Overall Study||0
8768235|NCT01260662|9818424|FG002|NOT COMPLETED|Overall Study||0
8768236|NCT01260688|9818434|FG000|STARTED|Overall Study||11
8768237|NCT01260688|9818435|FG001|STARTED|Overall Study||11
8768238|NCT01260688|9818434|FG000|COMPLETED|Overall Study||11
8768239|NCT01260688|9818435|FG001|COMPLETED|Overall Study||11
8768240|NCT01260688|9818434|FG000|NOT COMPLETED|Overall Study||0
8768241|NCT01260688|9818435|FG001|NOT COMPLETED|Overall Study||0
8768242|NCT01260701|9818444|FG000|STARTED|Overall Study||75
8768243|NCT01260701|9818444|FG000|Eligible|Overall Study||71
8768244|NCT01260701|9818444|FG000|Eligible and Began Protocol Therapy|Overall Study||70
8768245|NCT01260701|9818444|FG000|COMPLETED|Overall Study||0
8768246|NCT01260701|9818444|FG000|NOT COMPLETED|Overall Study||75
8768247|NCT01260883|9818451|FG000|STARTED|Overall Study||22
8768248|NCT01260883|9818452|FG001|STARTED|Overall Study||11
8768249|NCT01260883|9818453|FG002|STARTED|Overall Study||18
8768250|NCT01260883|9818451|FG000|COMPLETED|Overall Study||22
8768251|NCT01260883|9818452|FG001|COMPLETED|Overall Study||11
8768252|NCT01260883|9818453|FG002|COMPLETED|Overall Study||18
8768253|NCT01260883|9818451|FG000|NOT COMPLETED|Overall Study||0
8768254|NCT01260883|9818452|FG001|NOT COMPLETED|Overall Study||0
8768255|NCT01260883|9818453|FG002|NOT COMPLETED|Overall Study||0
8768256|NCT01260896|9818484|FG000|STARTED|First Intervention||12
8768257|NCT01260896|9818485|FG001|STARTED|First Intervention||12
8768258|NCT01260896|9818484|FG000|COMPLETED|First Intervention||10
8768259|NCT01260896|9818485|FG001|COMPLETED|First Intervention||12
8768260|NCT01260896|9818484|FG000|NOT COMPLETED|First Intervention||2
8768261|NCT01260896|9818485|FG001|NOT COMPLETED|First Intervention||0
8768262|NCT01260896|9818484|FG000|STARTED|Washout of 7 Days||10
8768263|NCT01260896|9818485|FG001|STARTED|Washout of 7 Days||12
8768264|NCT01260896|9818484|FG000|COMPLETED|Washout of 7 Days||10
8768265|NCT01260896|9818485|FG001|COMPLETED|Washout of 7 Days||12
8768266|NCT01260896|9818484|FG000|NOT COMPLETED|Washout of 7 Days||0
8768267|NCT01260896|9818485|FG001|NOT COMPLETED|Washout of 7 Days||0
8768268|NCT01260896|9818484|FG000|STARTED|Second Intervention||10
8768269|NCT01260896|9818485|FG001|STARTED|Second Intervention||12
8768270|NCT01260896|9818484|FG000|COMPLETED|Second Intervention||10
8768271|NCT01260896|9818485|FG001|COMPLETED|Second Intervention||12
8768272|NCT01260896|9818484|FG000|NOT COMPLETED|Second Intervention||0
8768273|NCT01260896|9818485|FG001|NOT COMPLETED|Second Intervention||0
8768274|NCT01260922|9818493|FG000|STARTED|First Intervention||13
8768275|NCT01260922|9818494|FG001|STARTED|First Intervention||13
8768276|NCT01260922|9818493|FG000|COMPLETED|First Intervention||13
8768277|NCT01260922|9818494|FG001|COMPLETED|First Intervention||12
8768278|NCT01260922|9818493|FG000|NOT COMPLETED|First Intervention||0
8768279|NCT01260922|9818494|FG001|NOT COMPLETED|First Intervention||1
8768280|NCT01260922|9818493|FG000|STARTED|Washout of 28 Days||13
8768281|NCT01260922|9818494|FG001|STARTED|Washout of 28 Days||12
8768282|NCT01260922|9818493|FG000|COMPLETED|Washout of 28 Days||9
8768283|NCT01260922|9818494|FG001|COMPLETED|Washout of 28 Days||10
8768284|NCT01260922|9818493|FG000|NOT COMPLETED|Washout of 28 Days||4
8768285|NCT01260922|9818494|FG001|NOT COMPLETED|Washout of 28 Days||2
8768286|NCT01260922|9818493|FG000|STARTED|Second Intervention||9
8768287|NCT01260922|9818494|FG001|STARTED|Second Intervention||10
8768288|NCT01260922|9818493|FG000|COMPLETED|Second Intervention||9
8768289|NCT01260922|9818494|FG001|COMPLETED|Second Intervention||8
8768290|NCT01260922|9818493|FG000|NOT COMPLETED|Second Intervention||0
8768291|NCT01260922|9818494|FG001|NOT COMPLETED|Second Intervention||2
8768292|NCT01260948|9818502|FG000|STARTED|First Intervention||13
8768293|NCT01260948|9818503|FG001|STARTED|First Intervention||13
8768294|NCT01260948|9818502|FG000|COMPLETED|First Intervention||13
8768295|NCT01260948|9818503|FG001|COMPLETED|First Intervention||13
8768296|NCT01260948|9818502|FG000|NOT COMPLETED|First Intervention||0
8768297|NCT01260948|9818503|FG001|NOT COMPLETED|First Intervention||0
8768298|NCT01260948|9818502|FG000|STARTED|Washout of 28 Days||13
8768299|NCT01260948|9818503|FG001|STARTED|Washout of 28 Days||13
8768300|NCT01260948|9818502|FG000|COMPLETED|Washout of 28 Days||12
8768301|NCT01260948|9818503|FG001|COMPLETED|Washout of 28 Days||10
8768302|NCT01260948|9818502|FG000|NOT COMPLETED|Washout of 28 Days||1
8768303|NCT01260948|9818503|FG001|NOT COMPLETED|Washout of 28 Days||3
8768304|NCT01260948|9818502|FG000|STARTED|Second Intervention||12
8768305|NCT01260948|9818503|FG001|STARTED|Second Intervention||10
8768306|NCT01260948|9818502|FG000|COMPLETED|Second Intervention||12
8768307|NCT01260948|9818503|FG001|COMPLETED|Second Intervention||9
8768308|NCT01260948|9818502|FG000|NOT COMPLETED|Second Intervention||0
8768309|NCT01260948|9818503|FG001|NOT COMPLETED|Second Intervention||1
8768310|NCT01261000|9818509|FG000|STARTED|Overall Study||8
8768311|NCT01261000|9818509|FG000|COMPLETED|Overall Study||7
8768312|NCT01261000|9818509|FG000|NOT COMPLETED|Overall Study||1
8768313|NCT01261052|9818513|FG000|STARTED|FMPD/APD Intervention (33 Hours)||14
8768314|NCT01261052|9818513|FG000|COMPLETED|FMPD/APD Intervention (33 Hours)||14
8768315|NCT01261052|9818513|FG000|NOT COMPLETED|FMPD/APD Intervention (33 Hours)||0
8768316|NCT01261052|9818513|FG000|STARTED|APD Only Intervention (33 Hours)||14
8768317|NCT01261052|9818513|FG000|COMPLETED|APD Only Intervention (33 Hours)||14
8768318|NCT01261052|9818513|FG000|NOT COMPLETED|APD Only Intervention (33 Hours)||0
8768319|NCT01261325|9818521|FG000|STARTED|Overall Study||263
8768320|NCT01261325|9818522|FG001|STARTED|Overall Study||254
8768321|NCT01261325|9818523|FG002|STARTED|Overall Study||251
8768322|NCT01261325|9818521|FG000|COMPLETED|Overall Study||246
8768323|NCT01261325|9818522|FG001|COMPLETED|Overall Study||225
8768324|NCT01261325|9818523|FG002|COMPLETED|Overall Study||225
8768325|NCT01261325|9818521|FG000|NOT COMPLETED|Overall Study||17
8768326|NCT01261325|9818522|FG001|NOT COMPLETED|Overall Study||29
8768327|NCT01261325|9818523|FG002|NOT COMPLETED|Overall Study||26
8768328|NCT01261338|9818536|FG000|STARTED|Overall Study|One person in the olestra group started 4 months after the trial began.|14
8768329|NCT01261338|9818537|FG001|STARTED|Overall Study||14
8768330|NCT01261338|9818536|FG000|COMPLETED|Overall Study||11
8768331|NCT01261338|9818537|FG001|COMPLETED|Overall Study||12
8768332|NCT01261338|9818536|FG000|NOT COMPLETED|Overall Study||3
8768333|NCT01261338|9818537|FG001|NOT COMPLETED|Overall Study||2
8768334|NCT01261390|9818547|FG000|STARTED|Overall Study|15 of the 44 participants only had to complete a 6-month follow-up assessment.|44
8768335|NCT01261390|9818548|FG001|STARTED|Overall Study|15 of the 42 participants only had to complete a 6-month follow-up assessment.|42
8768336|NCT01261390|9818549|FG002|STARTED|Overall Study|16 of the 42 participants only had to complete a 6-month follow-up assessment.|42
8768337|NCT01261390|9818550|FG003|STARTED|Overall Study|15 of the 41 participants only had to complete a 6-month follow-up assessment.|41
8768338|NCT01261390|9818547|FG000|6-Month Visit|Overall Study|For 14 of the 30 participants in this arm, this was their final visit.|37
8768339|NCT01261390|9818548|FG001|6-Month Visit|Overall Study|For 12 of the 34 participants in this arm, this was their final visit.|34
8768340|NCT01261390|9818549|FG002|6-Month Visit|Overall Study|For 16 of the 34 participants in this arm, this was their final visit.|34
8768341|NCT01261390|9818550|FG003|6-Month Visit|Overall Study|For 14 of the 32 participants in this arm, this was their final visit.|32
8768342|NCT01261390|9818547|FG000|12-Month Visit|Overall Study||23
8768343|NCT01261390|9818548|FG001|12-Month Visit|Overall Study||21
8768344|NCT01261390|9818549|FG002|12-Month Visit|Overall Study||19
8768345|NCT01261390|9818550|FG003|12-Month Visit|Overall Study||19
8768346|NCT01261390|9818547|FG000|COMPLETED|Overall Study|14 of the 37 participants that completed the study in this arm were under the 6-Month protocol.|37
8768347|NCT01261390|9818548|FG001|COMPLETED|Overall Study|12 of the 33 participants that completed the study in this arm were under the 6-Month protocol.|33
8768348|NCT01261390|9818549|FG002|COMPLETED|Overall Study|16 of the 35 participants that completed the study in this arm were under the 6-Month protocol.|35
8768349|NCT01261390|9818550|FG003|COMPLETED|Overall Study|14 of the 33 participants that completed the study in this arm were under the 6-Month protocol.|33
8768350|NCT01261390|9818547|FG000|NOT COMPLETED|Overall Study||7
8768351|NCT01261390|9818548|FG001|NOT COMPLETED|Overall Study||9
8768352|NCT01261390|9818549|FG002|NOT COMPLETED|Overall Study||7
8768353|NCT01261390|9818550|FG003|NOT COMPLETED|Overall Study||8
8768354|NCT01261507|9818565|FG000|STARTED|Overall Study||15
8768355|NCT01261507|9818565|FG000|COMPLETED|Overall Study||15
8768356|NCT01261507|9818565|FG000|NOT COMPLETED|Overall Study||0
8768357|NCT01261559|9818574|FG000|STARTED|Overall Study||36
8768358|NCT01261559|9818575|FG001|STARTED|Overall Study||36
8768359|NCT01261559|9818574|FG000|COMPLETED|Overall Study||36
8768360|NCT01261559|9818575|FG001|COMPLETED|Overall Study||36
8768361|NCT01261559|9818574|FG000|NOT COMPLETED|Overall Study||0
8768362|NCT01261559|9818575|FG001|NOT COMPLETED|Overall Study||0
8768363|NCT01261611|9818585|FG000|STARTED|Treatment Cycle 1||156
8768364|NCT01261611|9818586|FG001|STARTED|Treatment Cycle 1||159
8768365|NCT01261611|9818587|FG002|STARTED|Treatment Cycle 1||54
8768366|NCT01261611|9818585|FG000|COMPLETED|Treatment Cycle 1||152
8768367|NCT01261611|9818586|FG001|COMPLETED|Treatment Cycle 1||156
8768368|NCT01261611|9818587|FG002|COMPLETED|Treatment Cycle 1||52
8768369|NCT01261611|9818585|FG000|NOT COMPLETED|Treatment Cycle 1||4
8768370|NCT01261611|9818586|FG001|NOT COMPLETED|Treatment Cycle 1||3
8768371|NCT01261611|9818587|FG002|NOT COMPLETED|Treatment Cycle 1||2
8768372|NCT01261611|9818585|FG000|STARTED|Treatment Cycle 2|All but 1 who completed DB period entered the open label period. This subject remained at Cycle 1.|359
8768373|NCT01261611|9818586|FG001|STARTED|Treatment Cycle 2||0
8768374|NCT01261611|9818587|FG002|STARTED|Treatment Cycle 2||0
8768375|NCT01261611|9818585|FG000|COMPLETED|Treatment Cycle 2||346
8768376|NCT01261611|9818586|FG001|COMPLETED|Treatment Cycle 2||0
8768377|NCT01261611|9818587|FG002|COMPLETED|Treatment Cycle 2||0
8768378|NCT01261611|9818585|FG000|NOT COMPLETED|Treatment Cycle 2||13
8768379|NCT01261611|9818586|FG001|NOT COMPLETED|Treatment Cycle 2||0
8768380|NCT01261611|9818587|FG002|NOT COMPLETED|Treatment Cycle 2||0
8768381|NCT01261611|9818585|FG000|STARTED|Treatment Cycle 3||346
8768382|NCT01261611|9818586|FG001|STARTED|Treatment Cycle 3||0
8768383|NCT01261611|9818587|FG002|STARTED|Treatment Cycle 3||0
8768384|NCT01261611|9818585|FG000|COMPLETED|Treatment Cycle 3||316
8768385|NCT01261611|9818586|FG001|COMPLETED|Treatment Cycle 3||0
8768386|NCT01261611|9818587|FG002|COMPLETED|Treatment Cycle 3||0
8768387|NCT01261611|9818585|FG000|NOT COMPLETED|Treatment Cycle 3||30
8768388|NCT01261611|9818586|FG001|NOT COMPLETED|Treatment Cycle 3||0
8768389|NCT01261611|9818587|FG002|NOT COMPLETED|Treatment Cycle 3||0
8768390|NCT01261611|9818585|FG000|STARTED|Treatment Cycle 4||316
8768391|NCT01261611|9818586|FG001|STARTED|Treatment Cycle 4||0
8768392|NCT01261611|9818587|FG002|STARTED|Treatment Cycle 4||0
8768393|NCT01261611|9818585|FG000|COMPLETED|Treatment Cycle 4||220
8768394|NCT01261611|9818586|FG001|COMPLETED|Treatment Cycle 4||0
8768395|NCT01261611|9818587|FG002|COMPLETED|Treatment Cycle 4||0
8768396|NCT01261611|9818585|FG000|NOT COMPLETED|Treatment Cycle 4||96
8768397|NCT01261611|9818586|FG001|NOT COMPLETED|Treatment Cycle 4||0
8768398|NCT01261611|9818587|FG002|NOT COMPLETED|Treatment Cycle 4||0
8768399|NCT01261611|9818585|FG000|STARTED|Treatment Cycle 5||220
8768400|NCT01261611|9818586|FG001|STARTED|Treatment Cycle 5||0
8768401|NCT01261611|9818587|FG002|STARTED|Treatment Cycle 5||0
8768402|NCT01261611|9818585|FG000|COMPLETED|Treatment Cycle 5||217
8768403|NCT01261611|9818586|FG001|COMPLETED|Treatment Cycle 5||0
8768404|NCT01261611|9818587|FG002|COMPLETED|Treatment Cycle 5||0
8768405|NCT01261611|9818585|FG000|NOT COMPLETED|Treatment Cycle 5||3
8768406|NCT01261611|9818586|FG001|NOT COMPLETED|Treatment Cycle 5||0
8768407|NCT01261611|9818587|FG002|NOT COMPLETED|Treatment Cycle 5||0
8768408|NCT01261624|9818601|FG000|STARTED|Week 0 to Week 12||10
8768409|NCT01261624|9818602|FG001|STARTED|Week 0 to Week 12||6
8768410|NCT01261624|9818601|FG000|COMPLETED|Week 0 to Week 12||9
8768411|NCT01261624|9818602|FG001|COMPLETED|Week 0 to Week 12||3
8768412|NCT01261624|9818601|FG000|NOT COMPLETED|Week 0 to Week 12||1
8768413|NCT01261624|9818602|FG001|NOT COMPLETED|Week 0 to Week 12||3
8768414|NCT01261624|9818601|FG000|STARTED|Week 13 to Week 24|Of 9 pts from LDTC: 5 non-responders switched to HDTC; 4 pts responded, but 3 switched to HDTC|1
8768415|NCT01261624|9818602|FG001|STARTED|Week 13 to Week 24|Of 6 pts of HDTC: 3 non-responders went out of study, 3 continued. 8 swithched from LDTC to HDTC|11
8768416|NCT01261624|9818601|FG000|COMPLETED|Week 13 to Week 24||1
8768417|NCT01261624|9818602|FG001|COMPLETED|Week 13 to Week 24||10
8768418|NCT01261624|9818601|FG000|NOT COMPLETED|Week 13 to Week 24||0
8768419|NCT01261624|9818602|FG001|NOT COMPLETED|Week 13 to Week 24||1
8768420|NCT01261780|9818616|FG000|STARTED|Overall Study||7
8768421|NCT01261780|9818617|FG001|STARTED|Overall Study||7
8768422|NCT01261780|9818616|FG000|COMPLETED|Overall Study||5
8768423|NCT01261780|9818617|FG001|COMPLETED|Overall Study||5
8768424|NCT01261780|9818616|FG000|NOT COMPLETED|Overall Study||2
8768425|NCT01261780|9818617|FG001|NOT COMPLETED|Overall Study||2
8768426|NCT01261793|9818626|FG000|STARTED|Overall Study||263
8768427|NCT01261793|9818627|FG001|STARTED|Overall Study||262
8768428|NCT01261793|9818628|FG002|STARTED|Overall Study||266
8768429|NCT01261793|9818626|FG000|COMPLETED|Overall Study||178
8768430|NCT01261793|9818627|FG001|COMPLETED|Overall Study||171
8768431|NCT01261793|9818628|FG002|COMPLETED|Overall Study||184
8768432|NCT01261793|9818626|FG000|NOT COMPLETED|Overall Study||85
8768433|NCT01261793|9818627|FG001|NOT COMPLETED|Overall Study||91
8768434|NCT01261793|9818628|FG002|NOT COMPLETED|Overall Study||82
8768435|NCT01261819|9818638|FG000|STARTED|Overall Study||33
8768436|NCT01261819|9818639|FG001|STARTED|Overall Study||33
8768437|NCT01261819|9818638|FG000|COMPLETED|Overall Study||33
8768438|NCT01261819|9818639|FG001|COMPLETED|Overall Study||33
8768439|NCT01261819|9818638|FG000|NOT COMPLETED|Overall Study||0
8768440|NCT01261819|9818639|FG001|NOT COMPLETED|Overall Study||0
8768441|NCT01261975|9818645|FG000|STARTED|Overall Study|36 Participants 72 eyes started|36
8768442|NCT01261975|9818645|FG000|COMPLETED|Overall Study|35 Participants 70 eyes completed|35
8768443|NCT01261975|9818645|FG000|NOT COMPLETED|Overall Study||1
8768444|NCT01262027|9818652|FG000|STARTED|Overall Study||22
9027522|NCT03188055|10089815|FG002|STARTED|Overall Study||62
9027523|NCT03188055|10089816|FG003|STARTED|Overall Study|Family members consented (19/38 had patient enroll along with them as patient had DMC).|38
9027524|NCT03188055|10089817|FG004|STARTED|Overall Study||59
9027525|NCT03188055|10089818|FG005|STARTED|Overall Study|Anonymous survey, cannot ascertain if same participant completed it for both pre- and post-intervention.|
9027526|NCT03188055|10089813|FG000|Patients Who Provided Self-Consent|Overall Study||0
9027527|NCT03188055|10089814|FG001|Patients Who Provided Self-Consent|Overall Study||24
9027528|NCT03188055|10089815|FG002|Patients Who Provided Self-Consent|Overall Study||0
9027529|NCT03188055|10089816|FG003|Patients Who Provided Self-Consent|Overall Study||19
9027530|NCT03188055|10089817|FG004|Patients Who Provided Self-Consent|Overall Study||0
9027531|NCT03188055|10089818|FG005|Patients Who Provided Self-Consent|Overall Study||0
9027532|NCT03188055|10089813|FG000|MDS Pre-Intervention Survey Responses|Overall Study||0
9027533|NCT03188055|10089814|FG001|MDS Pre-Intervention Survey Responses|Overall Study||0
9027534|NCT03188055|10089815|FG002|MDS Pre-Intervention Survey Responses|Overall Study||0
9027535|NCT03188055|10089816|FG003|MDS Pre-Intervention Survey Responses|Overall Study||0
9027536|NCT03188055|10089817|FG004|MDS Pre-Intervention Survey Responses|Overall Study||0
9027537|NCT03188055|10089818|FG005|MDS Pre-Intervention Survey Responses|Overall Study||99
9027538|NCT03188055|10089813|FG000|MDS Post-Intervention Survey Responses|Overall Study||0
9027539|NCT03188055|10089814|FG001|MDS Post-Intervention Survey Responses|Overall Study||0
9027540|NCT03188055|10089815|FG002|MDS Post-Intervention Survey Responses|Overall Study||0
9027541|NCT03188055|10089816|FG003|MDS Post-Intervention Survey Responses|Overall Study||0
9027542|NCT03188055|10089817|FG004|MDS Post-Intervention Survey Responses|Overall Study||0
9027543|NCT03188055|10089818|FG005|MDS Post-Intervention Survey Responses|Overall Study||134
9027544|NCT03188055|10089813|FG000|Patient Survey 1|Overall Study||0
9027545|NCT03188055|10089814|FG001|Patient Survey 1|Overall Study||16
9027546|NCT03188055|10089815|FG002|Patient Survey 1|Overall Study||0
9027547|NCT03188055|10089816|FG003|Patient Survey 1|Overall Study||13
9027548|NCT03188055|10089817|FG004|Patient Survey 1|Overall Study||0
9027549|NCT03188055|10089818|FG005|Patient Survey 1|Overall Study||0
9027550|NCT03188055|10089813|FG000|Nurse Survey 1|Overall Study||0
9027551|NCT03188055|10089814|FG001|Nurse Survey 1|Overall Study||32
9027552|NCT03188055|10089815|FG002|Nurse Survey 1|Overall Study||0
9027553|NCT03188055|10089816|FG003|Nurse Survey 1|Overall Study||27
9027554|NCT03188055|10089817|FG004|Nurse Survey 1|Overall Study||0
8768445|NCT01262027|9818652|FG000|COMPLETED|Overall Study||17
8768446|NCT01262027|9818652|FG000|NOT COMPLETED|Overall Study||5
8768447|NCT01262092|9818658|FG000|STARTED|Buprenorphine+Gabapentin/Plac Induction||16
8768448|NCT01262092|9818659|FG001|STARTED|Buprenorphine+Gabapentin/Plac Induction||14
8768449|NCT01262092|9818658|FG000|COMPLETED|Buprenorphine+Gabapentin/Plac Induction||13
8768450|NCT01262092|9818659|FG001|COMPLETED|Buprenorphine+Gabapentin/Plac Induction||13
9027555|NCT03188055|10089818|FG005|Nurse Survey 1|Overall Study||0
9027556|NCT03188055|10089813|FG000|Family Survey 1|Overall Study||0
9027557|NCT03188055|10089814|FG001|Family Survey 1|Overall Study||37
9027558|NCT03188055|10089815|FG002|Family Survey 1|Overall Study||0
9027559|NCT03188055|10089816|FG003|Family Survey 1|Overall Study||38
8768451|NCT01262092|9818658|FG000|NOT COMPLETED|Buprenorphine+Gabapentin/Plac Induction||3
8768452|NCT01262092|9818659|FG001|NOT COMPLETED|Buprenorphine+Gabapentin/Plac Induction||1
8768453|NCT01262092|9818658|FG000|STARTED|Buprenorphine Taper|One left the study prior to starting the taper due to pharmacy error (started taper in wk 2)|12
8768454|NCT01262092|9818659|FG001|STARTED|Buprenorphine Taper||13
8768455|NCT01262092|9818658|FG000|COMPLETED|Buprenorphine Taper||11
8768456|NCT01262092|9818659|FG001|COMPLETED|Buprenorphine Taper||12
8768457|NCT01262092|9818658|FG000|NOT COMPLETED|Buprenorphine Taper||1
8768458|NCT01262092|9818659|FG001|NOT COMPLETED|Buprenorphine Taper||1
8768459|NCT01262092|9818658|FG000|STARTED|Gabapentin Taper|One participant dropped out after the buprenorphine taper but prior to the gabapentin taper|10
8768460|NCT01262092|9818659|FG001|STARTED|Gabapentin Taper|One participant dropped out after the buprenorphine taper but prior to the gabapentin taper|11
8768461|NCT01262092|9818658|FG000|COMPLETED|Gabapentin Taper||9
8768462|NCT01262092|9818659|FG001|COMPLETED|Gabapentin Taper||11
8768463|NCT01262092|9818658|FG000|NOT COMPLETED|Gabapentin Taper||1
8768464|NCT01262092|9818659|FG001|NOT COMPLETED|Gabapentin Taper||0
8768465|NCT01262105|9818667|FG000|STARTED|Overall Study||13
8768466|NCT01262105|9818668|FG001|STARTED|Overall Study||10
8768467|NCT01262105|9818667|FG000|COMPLETED|Overall Study||13
8768468|NCT01262105|9818668|FG001|COMPLETED|Overall Study||10
8768469|NCT01262105|9818667|FG000|NOT COMPLETED|Overall Study||0
8768470|NCT01262105|9818668|FG001|NOT COMPLETED|Overall Study||0
8768471|NCT01262118|9818676|FG000|STARTED|Baseline Assessment Period (3 Days)||36
8768472|NCT01262118|9818677|FG001|STARTED|Baseline Assessment Period (3 Days)||33
8768473|NCT01262118|9818676|FG000|COMPLETED|Baseline Assessment Period (3 Days)||36
8768474|NCT01262118|9818677|FG001|COMPLETED|Baseline Assessment Period (3 Days)||33
8768475|NCT01262118|9818676|FG000|NOT COMPLETED|Baseline Assessment Period (3 Days)||0
8768476|NCT01262118|9818677|FG001|NOT COMPLETED|Baseline Assessment Period (3 Days)||0
8768477|NCT01262118|9818676|FG000|STARTED|Treatment Period (6 Weeks)||36
8768478|NCT01262118|9818677|FG001|STARTED|Treatment Period (6 Weeks)||0
8768479|NCT01262118|9818676|FG000|COMPLETED|Treatment Period (6 Weeks)||36
8768480|NCT01262118|9818677|FG001|COMPLETED|Treatment Period (6 Weeks)||0
8768481|NCT01262118|9818676|FG000|NOT COMPLETED|Treatment Period (6 Weeks)||0
8768482|NCT01262118|9818677|FG001|NOT COMPLETED|Treatment Period (6 Weeks)||0
8768483|NCT01262131|9818686|FG000|STARTED|Overall Study||5
8768484|NCT01262131|9818687|FG001|STARTED|Overall Study||4
8768485|NCT01262131|9818688|FG002|STARTED|Overall Study||4
8768486|NCT01262131|9818686|FG000|COMPLETED|Overall Study||5
8768487|NCT01262131|9818687|FG001|COMPLETED|Overall Study||4
8768488|NCT01262131|9818688|FG002|COMPLETED|Overall Study||4
8768489|NCT01262131|9818686|FG000|NOT COMPLETED|Overall Study||0
8768490|NCT01262131|9818687|FG001|NOT COMPLETED|Overall Study||0
8768491|NCT01262131|9818688|FG002|NOT COMPLETED|Overall Study||0
8768492|NCT01262287|9818698|FG000|STARTED|Overall Study||20
8768493|NCT01262287|9818699|FG001|STARTED|Overall Study||19
8768494|NCT01262287|9818698|FG000|COMPLETED|Overall Study||18
8768495|NCT01262287|9818699|FG001|COMPLETED|Overall Study||18
8768496|NCT01262287|9818698|FG000|NOT COMPLETED|Overall Study||2
8768497|NCT01262287|9818699|FG001|NOT COMPLETED|Overall Study||1
8768498|NCT01262352|9818711|FG000|STARTED|Period 1||11
8768499|NCT01262352|9818712|FG001|STARTED|Period 1||10
8768500|NCT01262352|9818711|FG000|Dosed|Period 1||10
8768501|NCT01262352|9818712|FG001|Dosed|Period 1||10
8768502|NCT01262352|9818711|FG000|COMPLETED|Period 1||10
8768503|NCT01262352|9818712|FG001|COMPLETED|Period 1||10
8768504|NCT01262352|9818711|FG000|NOT COMPLETED|Period 1||1
8768505|NCT01262352|9818712|FG001|NOT COMPLETED|Period 1||0
8768506|NCT01262352|9818711|FG000|STARTED|Washout||10
8768507|NCT01262352|9818712|FG001|STARTED|Washout||10
8768508|NCT01262352|9818711|FG000|COMPLETED|Washout||9
8768509|NCT01262352|9818712|FG001|COMPLETED|Washout||8
8768510|NCT01262352|9818711|FG000|NOT COMPLETED|Washout||1
8768511|NCT01262352|9818712|FG001|NOT COMPLETED|Washout||2
8768512|NCT01262352|9818711|FG000|STARTED|Period 2||9
8768513|NCT01262352|9818712|FG001|STARTED|Period 2||8
8768514|NCT01262352|9818711|FG000|Dosed|Period 2||9
8768515|NCT01262352|9818712|FG001|Dosed|Period 2||8
8768516|NCT01262352|9818711|FG000|COMPLETED|Period 2||9
8768517|NCT01262352|9818712|FG001|COMPLETED|Period 2||8
8768518|NCT01262352|9818711|FG000|NOT COMPLETED|Period 2||0
8768519|NCT01262352|9818712|FG001|NOT COMPLETED|Period 2||0
8768520|NCT01262365|9818721|FG000|STARTED|Overall Study||266
8768521|NCT01262365|9818722|FG001|STARTED|Overall Study||262
8768522|NCT01262365|9818723|FG002|STARTED|Overall Study||265
8768523|NCT01262365|9818721|FG000|COMPLETED|Overall Study||176
8768524|NCT01262365|9818722|FG001|COMPLETED|Overall Study||181
8768525|NCT01262365|9818723|FG002|COMPLETED|Overall Study||171
8768526|NCT01262365|9818721|FG000|NOT COMPLETED|Overall Study||90
8768527|NCT01262365|9818722|FG001|NOT COMPLETED|Overall Study||81
8768528|NCT01262365|9818723|FG002|NOT COMPLETED|Overall Study||94
8768529|NCT01262456|9818734|FG000|STARTED|3-Month Double-Blind Period|Intent-to-Treat (ITT) population: randomized participants regardless of exposure to treatment|143
8768530|NCT01262456|9818735|FG001|STARTED|3-Month Double-Blind Period|ITT population: randomized participants regardless of exposure to treatment|123
8768531|NCT01262456|9818736|FG002|STARTED|3-Month Double-Blind Period|ITT population: randomized participants regardless of exposure to treatment|129
8768532|NCT01262456|9818734|FG000|Full Analysis Set (FAS)|3-Month Double-Blind Period|FAS: ITT with at least 1 post-treatment efficacy assessment. Analysis as randomized.|142
8768533|NCT01262456|9818735|FG001|Full Analysis Set (FAS)|3-Month Double-Blind Period|FAS: ITT with at least 1 post-treatment efficacy assessment. Analysis as randomized.|119
8768534|NCT01262456|9818736|FG002|Full Analysis Set (FAS)|3-Month Double-Blind Period|FAS: ITT with at least 1 post-treatment efficacy assessment. Analysis as randomized.|124
8768535|NCT01262456|9818734|FG000|Safety Analysis Set (SAS)|3-Month Double-Blind Period|SAS: received at least 1 dose and had at least 1 safety assessment. Analysis on actual treatment.|143
8768536|NCT01262456|9818735|FG001|Safety Analysis Set (SAS)|3-Month Double-Blind Period|SAS: received at least 1 dose and had at least 1 safety assessment. Analysis on actual treatment.|119
8768537|NCT01262456|9818736|FG002|Safety Analysis Set (SAS)|3-Month Double-Blind Period|SAS: received at least 1 dose and had at least 1 safety assessment. Analysis on actual treatment.|122
8768538|NCT01262456|9818734|FG000|COMPLETED|3-Month Double-Blind Period||124
8768539|NCT01262456|9818735|FG001|COMPLETED|3-Month Double-Blind Period||100
8768540|NCT01262456|9818736|FG002|COMPLETED|3-Month Double-Blind Period||103
8768541|NCT01262456|9818734|FG000|NOT COMPLETED|3-Month Double-Blind Period||19
8768542|NCT01262456|9818735|FG001|NOT COMPLETED|3-Month Double-Blind Period||23
8768543|NCT01262456|9818736|FG002|NOT COMPLETED|3-Month Double-Blind Period||26
8768544|NCT01262456|9818734|FG000|STARTED|1-Month Open-Label Extension Period||124
8768545|NCT01262456|9818735|FG001|STARTED|1-Month Open-Label Extension Period||100
8768546|NCT01262456|9818736|FG002|STARTED|1-Month Open-Label Extension Period||103
8768547|NCT01262456|9818734|FG000|Safety Analysis Set (SAS)|1-Month Open-Label Extension Period||124
8768548|NCT01262456|9818735|FG001|Safety Analysis Set (SAS)|1-Month Open-Label Extension Period||101
8768549|NCT01262456|9818736|FG002|Safety Analysis Set (SAS)|1-Month Open-Label Extension Period|1 subject was randomized to Desmopressin 75 μg but received 50 μg. Also true in Double-Blind Period|102
8768550|NCT01262456|9818734|FG000|COMPLETED|1-Month Open-Label Extension Period||120
8768551|NCT01262456|9818735|FG001|COMPLETED|1-Month Open-Label Extension Period||97
8768552|NCT01262456|9818736|FG002|COMPLETED|1-Month Open-Label Extension Period||98
8768553|NCT01262456|9818734|FG000|NOT COMPLETED|1-Month Open-Label Extension Period||4
8768554|NCT01262456|9818735|FG001|NOT COMPLETED|1-Month Open-Label Extension Period||3
8768555|NCT01262456|9818736|FG002|NOT COMPLETED|1-Month Open-Label Extension Period||5
8768556|NCT01262547|9818752|FG000|STARTED|Overall Study||3
8768557|NCT01262547|9818752|FG000|COMPLETED|Overall Study||3
8768558|NCT01262547|9818752|FG000|NOT COMPLETED|Overall Study||0
8768559|NCT01262560|9818764|FG000|STARTED|Overall Study||53
8768560|NCT01262560|9818765|FG001|STARTED|Overall Study||54
8768561|NCT01262560|9818766|FG002|STARTED|Overall Study||56
8768562|NCT01262560|9818764|FG000|COMPLETED|Overall Study|Randomized eligible patients who received protocol treatment.|53
8768563|NCT01262560|9818765|FG001|COMPLETED|Overall Study|Randomized eligible patients who received protocol treatment.|53
8768564|NCT01262560|9818766|FG002|COMPLETED|Overall Study|Randomized eligible patients who received protocol treatment.|54
8768565|NCT01262560|9818764|FG000|NOT COMPLETED|Overall Study||0
8768566|NCT01262560|9818765|FG001|NOT COMPLETED|Overall Study||1
8768567|NCT01262560|9818766|FG002|NOT COMPLETED|Overall Study||2
8768568|NCT01262573|9818776|FG000|STARTED|Overall Study||32
8768569|NCT01262573|9818777|FG001|STARTED|Overall Study||32
8768570|NCT01262573|9818776|FG000|COMPLETED|Overall Study||32
8768571|NCT01262573|9818777|FG001|COMPLETED|Overall Study||31
8768572|NCT01262573|9818776|FG000|NOT COMPLETED|Overall Study||0
8768573|NCT01262573|9818777|FG001|NOT COMPLETED|Overall Study||1
8768574|NCT01262599|9818785|FG000|STARTED|Overall Study||16
8768575|NCT01262599|9818786|FG001|STARTED|Overall Study||16
8768576|NCT01262599|9818785|FG000|COMPLETED|Overall Study||16
8768577|NCT01262599|9818786|FG001|COMPLETED|Overall Study||16
8768578|NCT01262599|9818785|FG000|NOT COMPLETED|Overall Study||0
8768579|NCT01262599|9818786|FG001|NOT COMPLETED|Overall Study||0
8768580|NCT01262638|9818798|FG000|STARTED|Overall Study||45
8768581|NCT01262638|9818799|FG001|STARTED|Overall Study||44
8768582|NCT01262638|9818800|FG002|STARTED|Overall Study||44
8768583|NCT01262638|9818801|FG003|STARTED|Overall Study||44
8768584|NCT01262638|9818798|FG000|COMPLETED|Overall Study||38
8768585|NCT01262638|9818799|FG001|COMPLETED|Overall Study||38
8768586|NCT01262638|9818800|FG002|COMPLETED|Overall Study||38
8768587|NCT01262638|9818801|FG003|COMPLETED|Overall Study||37
8768588|NCT01262638|9818798|FG000|NOT COMPLETED|Overall Study||7
8768589|NCT01262638|9818799|FG001|NOT COMPLETED|Overall Study||6
8768590|NCT01262638|9818800|FG002|NOT COMPLETED|Overall Study||6
8768591|NCT01262638|9818801|FG003|NOT COMPLETED|Overall Study||7
8768592|NCT01262651|9818816|FG000|STARTED|Overall Study||199
8768593|NCT01262651|9818817|FG001|STARTED|Overall Study||198
8768594|NCT01262651|9818816|FG000|Received at Least 1 Dose of Study Drug|Overall Study||199
8768595|NCT01262651|9818817|FG001|Received at Least 1 Dose of Study Drug|Overall Study||198
8768596|NCT01262651|9818816|FG000|Safety Population|Overall Study||199
8768597|NCT01262651|9818817|FG001|Safety Population|Overall Study||198
8768598|NCT01262651|9818816|FG000|ITT Population|Overall Study||199
8768599|NCT01262651|9818817|FG001|ITT Population|Overall Study||198
8768600|NCT01262651|9818816|FG000|COMPLETED|Overall Study||141
8768601|NCT01262651|9818817|FG001|COMPLETED|Overall Study||150
8768602|NCT01262651|9818816|FG000|NOT COMPLETED|Overall Study||58
8768603|NCT01262651|9818817|FG001|NOT COMPLETED|Overall Study||48
8768604|NCT01262677|9818826|FG000|STARTED|Overall Study||100
8768605|NCT01262677|9818827|FG001|STARTED|Overall Study||113
8768606|NCT01262677|9818828|FG002|STARTED|Overall Study||110
8768607|NCT01262677|9818826|FG000|COMPLETED|Overall Study||91
8768608|NCT01262677|9818827|FG001|COMPLETED|Overall Study||98
8768609|NCT01262677|9818828|FG002|COMPLETED|Overall Study||98
8768610|NCT01262677|9818826|FG000|NOT COMPLETED|Overall Study||9
8768611|NCT01262677|9818827|FG001|NOT COMPLETED|Overall Study||15
8768612|NCT01262677|9818828|FG002|NOT COMPLETED|Overall Study||12
8768613|NCT01262755|9818836|FG000|STARTED|Overall Study||450
8768614|NCT01262755|9818836|FG000|COMPLETED|Overall Study||450
8768615|NCT01262755|9818836|FG000|NOT COMPLETED|Overall Study||0
8768616|NCT01262820|9818840|FG000|STARTED|Overall Study||15
8768617|NCT01262820|9818840|FG000|COMPLETED|Overall Study||0
8768618|NCT01262820|9818840|FG000|NOT COMPLETED|Overall Study||15
8768619|NCT01262846|9818846|FG000|STARTED|Overall Study||95
8768620|NCT01262846|9818847|FG001|STARTED|Overall Study||100
8768621|NCT01262846|9818846|FG000|COMPLETED|Overall Study||93
8768622|NCT01262846|9818847|FG001|COMPLETED|Overall Study||97
8768623|NCT01262846|9818846|FG000|NOT COMPLETED|Overall Study||2
8768624|NCT01262846|9818847|FG001|NOT COMPLETED|Overall Study||3
8768625|NCT01262872|9818861|FG000|STARTED|Step 1||60
8768626|NCT01262872|9818862|FG001|STARTED|Step 1||60
8768627|NCT01262872|9818863|FG002|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
8768628|NCT01262872|9818864|FG003|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
8768629|NCT01262872|9818865|FG004|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
8768630|NCT01262872|9818866|FG005|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
8768631|NCT01262872|9818867|FG006|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
8768632|NCT01262872|9818868|FG007|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
8768633|NCT01262872|9818861|FG000|COMPLETED|Step 1||60
8768634|NCT01262872|9818862|FG001|COMPLETED|Step 1||60
8768635|NCT01262872|9818863|FG002|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
8768636|NCT01262872|9818864|FG003|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone|0
8768637|NCT01262872|9818865|FG004|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
8768638|NCT01262872|9818866|FG005|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
8768639|NCT01262872|9818867|FG006|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
8768640|NCT01262872|9818868|FG007|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
8768641|NCT01262872|9818861|FG000|NOT COMPLETED|Step 1||0
8768642|NCT01262872|9818862|FG001|NOT COMPLETED|Step 1||0
8768643|NCT01262872|9818863|FG002|NOT COMPLETED|Step 1||0
8768644|NCT01262872|9818864|FG003|NOT COMPLETED|Step 1||0
8768645|NCT01262872|9818865|FG004|NOT COMPLETED|Step 1||0
8768646|NCT01262872|9818866|FG005|NOT COMPLETED|Step 1||0
8768647|NCT01262872|9818867|FG006|NOT COMPLETED|Step 1||0
8768648|NCT01262872|9818868|FG007|NOT COMPLETED|Step 1||0
8768649|NCT01262872|9818861|FG000|STARTED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
8768650|NCT01262872|9818862|FG001|STARTED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
8768651|NCT01262872|9818863|FG002|STARTED|Step 2||200
8768652|NCT01262872|9818864|FG003|STARTED|Step 2||200
8768653|NCT01262872|9818865|FG004|STARTED|Step 2||200
8768654|NCT01262872|9818866|FG005|STARTED|Step 2||200
8768655|NCT01262872|9818867|FG006|STARTED|Step 2||200
8768656|NCT01262872|9818868|FG007|STARTED|Step 2||200
8768657|NCT01262872|9818861|FG000|COMPLETED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
8768658|NCT01262872|9818862|FG001|COMPLETED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
8768659|NCT01262872|9818863|FG002|COMPLETED|Step 2||191
8768660|NCT01262872|9818864|FG003|COMPLETED|Step 2||190
8768661|NCT01262872|9818865|FG004|COMPLETED|Step 2||195
8768662|NCT01262872|9818866|FG005|COMPLETED|Step 2||191
8768663|NCT01262872|9818867|FG006|COMPLETED|Step 2||191
8768664|NCT01262872|9818868|FG007|COMPLETED|Step 2||194
8768665|NCT01262872|9818861|FG000|NOT COMPLETED|Step 2||0
8768666|NCT01262872|9818862|FG001|NOT COMPLETED|Step 2||0
8768667|NCT01262872|9818863|FG002|NOT COMPLETED|Step 2||9
8768668|NCT01262872|9818864|FG003|NOT COMPLETED|Step 2||10
8768669|NCT01262872|9818865|FG004|NOT COMPLETED|Step 2||5
8768670|NCT01262872|9818866|FG005|NOT COMPLETED|Step 2||9
8768671|NCT01262872|9818867|FG006|NOT COMPLETED|Step 2||9
8768672|NCT01262872|9818868|FG007|NOT COMPLETED|Step 2||6
8768673|NCT01262898|9818906|FG000|STARTED|Overall Study||21
8768674|NCT01262898|9818907|FG001|STARTED|Overall Study||18
8768675|NCT01262898|9818908|FG002|STARTED|Overall Study||18
8768676|NCT01262898|9818909|FG003|STARTED|Overall Study||22
8768677|NCT01262898|9818906|FG000|COMPLETED|Overall Study||18
8768678|NCT01262898|9818907|FG001|COMPLETED|Overall Study||16
8768679|NCT01262898|9818908|FG002|COMPLETED|Overall Study||18
8768680|NCT01262898|9818909|FG003|COMPLETED|Overall Study||22
8768681|NCT01262898|9818906|FG000|NOT COMPLETED|Overall Study||3
8768682|NCT01262898|9818907|FG001|NOT COMPLETED|Overall Study||2
8768683|NCT01262898|9818908|FG002|NOT COMPLETED|Overall Study||0
8768684|NCT01262898|9818909|FG003|NOT COMPLETED|Overall Study||0
8768685|NCT01262976|9818928|FG000|STARTED|Up to Month 2||40
8768686|NCT01262976|9818929|FG001|STARTED|Up to Month 2||40
8768687|NCT01262976|9818930|FG002|STARTED|Up to Month 2||40
8768688|NCT01262976|9818931|FG003|STARTED|Up to Month 2||40
8768689|NCT01262976|9818932|FG004|STARTED|Up to Month 2||40
8768690|NCT01262976|9818933|FG005|STARTED|Up to Month 2||40
8768691|NCT01262976|9818928|FG000|COMPLETED|Up to Month 2||37
8768692|NCT01262976|9818929|FG001|COMPLETED|Up to Month 2||39
8768693|NCT01262976|9818930|FG002|COMPLETED|Up to Month 2||39
8768694|NCT01262976|9818931|FG003|COMPLETED|Up to Month 2||38
8768695|NCT01262976|9818932|FG004|COMPLETED|Up to Month 2||38
8768696|NCT01262976|9818933|FG005|COMPLETED|Up to Month 2||36
8768697|NCT01262976|9818928|FG000|NOT COMPLETED|Up to Month 2||3
8768698|NCT01262976|9818929|FG001|NOT COMPLETED|Up to Month 2||1
8768699|NCT01262976|9818930|FG002|NOT COMPLETED|Up to Month 2||1
8768700|NCT01262976|9818931|FG003|NOT COMPLETED|Up to Month 2||2
8768701|NCT01262976|9818932|FG004|NOT COMPLETED|Up to Month 2||2
8768702|NCT01262976|9818933|FG005|NOT COMPLETED|Up to Month 2||4
8768703|NCT01262976|9818928|FG000|STARTED|Up to Month 7||40
8768704|NCT01262976|9818929|FG001|STARTED|Up to Month 7||40
8768705|NCT01262976|9818930|FG002|STARTED|Up to Month 7||40
8768706|NCT01262976|9818931|FG003|STARTED|Up to Month 7||40
8768707|NCT01262976|9818932|FG004|STARTED|Up to Month 7||40
8768708|NCT01262976|9818933|FG005|STARTED|Up to Month 7||40
8768709|NCT01262976|9818928|FG000|COMPLETED|Up to Month 7||35
8768710|NCT01262976|9818929|FG001|COMPLETED|Up to Month 7||40
8768711|NCT01262976|9818930|FG002|COMPLETED|Up to Month 7||34
8768712|NCT01262976|9818931|FG003|COMPLETED|Up to Month 7||34
8768713|NCT01262976|9818932|FG004|COMPLETED|Up to Month 7||38
8768714|NCT01262976|9818933|FG005|COMPLETED|Up to Month 7||36
8768715|NCT01262976|9818928|FG000|NOT COMPLETED|Up to Month 7||5
8768716|NCT01262976|9818929|FG001|NOT COMPLETED|Up to Month 7||0
8768717|NCT01262976|9818930|FG002|NOT COMPLETED|Up to Month 7||6
9027560|NCT03188055|10089817|FG004|Family Survey 1|Overall Study||0
9027561|NCT03188055|10089818|FG005|Family Survey 1|Overall Study||0
9027562|NCT03188055|10089813|FG000|Family Survey 2|Overall Study||0
9027563|NCT03188055|10089814|FG001|Family Survey 2|Overall Study||34
9027564|NCT03188055|10089815|FG002|Family Survey 2|Overall Study||0
9027565|NCT03188055|10089816|FG003|Family Survey 2|Overall Study||35
9027566|NCT03188055|10089817|FG004|Family Survey 2|Overall Study||0
9027567|NCT03188055|10089818|FG005|Family Survey 2|Overall Study||0
9027568|NCT03188055|10089813|FG000|Family Survey 3|Overall Study||0
9027569|NCT03188055|10089814|FG001|Family Survey 3|Overall Study||29
9027570|NCT03188055|10089815|FG002|Family Survey 3|Overall Study||0
9027571|NCT03188055|10089816|FG003|Family Survey 3|Overall Study||26
9027572|NCT03188055|10089817|FG004|Family Survey 3|Overall Study||0
9027573|NCT03188055|10089818|FG005|Family Survey 3|Overall Study||0
9027574|NCT03188055|10089813|FG000|COMPLETED|Overall Study||48
9027575|NCT03188055|10089814|FG001|COMPLETED|Overall Study||29
9027576|NCT03188055|10089815|FG002|COMPLETED|Overall Study||43
9027577|NCT03188055|10089816|FG003|COMPLETED|Overall Study||26
9027578|NCT03188055|10089817|FG004|COMPLETED|Overall Study||59
9027579|NCT03188055|10089818|FG005|COMPLETED|Overall Study|Anonymous survey, cannot ascertain if same participant completed it for both pre- and post-intervention.|
9027580|NCT03188055|10089813|FG000|NOT COMPLETED|Overall Study||0
9027581|NCT03188055|10089814|FG001|NOT COMPLETED|Overall Study||19
9027582|NCT03188055|10089815|FG002|NOT COMPLETED|Overall Study||19
9027583|NCT03188055|10089816|FG003|NOT COMPLETED|Overall Study||12
9027584|NCT03188055|10089817|FG004|NOT COMPLETED|Overall Study||0
9027585|NCT03188055|10089818|FG005|NOT COMPLETED|Overall Study||
9027586|NCT03188120|10089829|FG000|STARTED|Overall Study||193
9027587|NCT03188120|10089829|FG000|COMPLETED|Overall Study||146
9027588|NCT03188120|10089829|FG000|NOT COMPLETED|Overall Study||47
9027589|NCT03188185|10089835|FG000|STARTED|Stage 1||198
9027590|NCT03188185|10089836|FG001|STARTED|Stage 1||80
9027591|NCT03188185|10089837|FG002|STARTED|Stage 1||0
9027592|NCT03188185|10089838|FG003|STARTED|Stage 1||0
9027593|NCT03188185|10089835|FG000|COMPLETED|Stage 1||179
9027594|NCT03188185|10089836|FG001|COMPLETED|Stage 1||64
9027595|NCT03188185|10089837|FG002|COMPLETED|Stage 1||0
9027596|NCT03188185|10089838|FG003|COMPLETED|Stage 1||0
9027597|NCT03188185|10089835|FG000|NOT COMPLETED|Stage 1||19
9027598|NCT03188185|10089836|FG001|NOT COMPLETED|Stage 1||16
9027599|NCT03188185|10089837|FG002|NOT COMPLETED|Stage 1||0
9027600|NCT03188185|10089838|FG003|NOT COMPLETED|Stage 1||0
9027601|NCT03188185|10089835|FG000|STARTED|Stage 2||0
9027602|NCT03188185|10089836|FG001|STARTED|Stage 2||0
9027603|NCT03188185|10089837|FG002|STARTED|Stage 2||64
9027604|NCT03188185|10089838|FG003|STARTED|Stage 2||63
8768718|NCT01262976|9818931|FG003|NOT COMPLETED|Up to Month 7||6
8768719|NCT01262976|9818932|FG004|NOT COMPLETED|Up to Month 7||2
8768720|NCT01262976|9818933|FG005|NOT COMPLETED|Up to Month 7||4
8768721|NCT01262976|9818928|FG000|STARTED|Up to Year 1||40
8768722|NCT01262976|9818929|FG001|STARTED|Up to Year 1||40
8768723|NCT01262976|9818930|FG002|STARTED|Up to Year 1||40
8768724|NCT01262976|9818931|FG003|STARTED|Up to Year 1||40
8768725|NCT01262976|9818932|FG004|STARTED|Up to Year 1||40
8768726|NCT01262976|9818933|FG005|STARTED|Up to Year 1||40
8768727|NCT01262976|9818928|FG000|COMPLETED|Up to Year 1||31
9027605|NCT03188185|10089835|FG000|COMPLETED|Stage 2||0
9027606|NCT03188185|10089836|FG001|COMPLETED|Stage 2||0
9027607|NCT03188185|10089837|FG002|COMPLETED|Stage 2||55
9027608|NCT03188185|10089838|FG003|COMPLETED|Stage 2||57
9027609|NCT03188185|10089835|FG000|NOT COMPLETED|Stage 2||0
9027610|NCT03188185|10089836|FG001|NOT COMPLETED|Stage 2||0
9027611|NCT03188185|10089837|FG002|NOT COMPLETED|Stage 2||9
9027612|NCT03188185|10089838|FG003|NOT COMPLETED|Stage 2||6
9027613|NCT03188263|10089850|FG000|STARTED|Overall Study||10
9027614|NCT03188263|10089851|FG001|STARTED|Overall Study||0
9027615|NCT03188263|10089850|FG000|COMPLETED|Overall Study||6
9027616|NCT03188263|10089851|FG001|COMPLETED|Overall Study||0
9027617|NCT03188263|10089850|FG000|NOT COMPLETED|Overall Study||4
9027618|NCT03188263|10089851|FG001|NOT COMPLETED|Overall Study||0
8768728|NCT01262976|9818929|FG001|COMPLETED|Up to Year 1||39
9027619|NCT03188523|10089859|FG000|STARTED|Overall Study||6
9027620|NCT03188523|10089860|FG001|STARTED|Overall Study||6
8768729|NCT01262976|9818930|FG002|COMPLETED|Up to Year 1||37
8768730|NCT01262976|9818931|FG003|COMPLETED|Up to Year 1||36
8768731|NCT01262976|9818932|FG004|COMPLETED|Up to Year 1||29
8768732|NCT01262976|9818933|FG005|COMPLETED|Up to Year 1||31
8768733|NCT01262976|9818928|FG000|NOT COMPLETED|Up to Year 1||9
8768734|NCT01262976|9818929|FG001|NOT COMPLETED|Up to Year 1||1
8768735|NCT01262976|9818930|FG002|NOT COMPLETED|Up to Year 1||3
8768736|NCT01262976|9818931|FG003|NOT COMPLETED|Up to Year 1||4
8768737|NCT01262976|9818932|FG004|NOT COMPLETED|Up to Year 1||11
8768738|NCT01262976|9818933|FG005|NOT COMPLETED|Up to Year 1||9
8768739|NCT01262976|9818928|FG000|STARTED|Up to Year 2||40
8768740|NCT01262976|9818929|FG001|STARTED|Up to Year 2||40
8768741|NCT01262976|9818930|FG002|STARTED|Up to Year 2||40
8768742|NCT01262976|9818931|FG003|STARTED|Up to Year 2||40
8768743|NCT01262976|9818932|FG004|STARTED|Up to Year 2||40
8768744|NCT01262976|9818933|FG005|STARTED|Up to Year 2||40
8768745|NCT01262976|9818928|FG000|COMPLETED|Up to Year 2||35
8768746|NCT01262976|9818929|FG001|COMPLETED|Up to Year 2||39
8768747|NCT01262976|9818930|FG002|COMPLETED|Up to Year 2||35
8768748|NCT01262976|9818931|FG003|COMPLETED|Up to Year 2||36
8768749|NCT01262976|9818932|FG004|COMPLETED|Up to Year 2||36
8768750|NCT01262976|9818933|FG005|COMPLETED|Up to Year 2||35
8768751|NCT01262976|9818928|FG000|NOT COMPLETED|Up to Year 2||5
8768752|NCT01262976|9818929|FG001|NOT COMPLETED|Up to Year 2||1
8768753|NCT01262976|9818930|FG002|NOT COMPLETED|Up to Year 2||5
8768754|NCT01262976|9818931|FG003|NOT COMPLETED|Up to Year 2||4
8768755|NCT01262976|9818932|FG004|NOT COMPLETED|Up to Year 2||4
8768756|NCT01262976|9818933|FG005|NOT COMPLETED|Up to Year 2||5
8768757|NCT01262976|9818928|FG000|STARTED|Up to Year 3||40
8768758|NCT01262976|9818929|FG001|STARTED|Up to Year 3||40
8768759|NCT01262976|9818930|FG002|STARTED|Up to Year 3||40
8768760|NCT01262976|9818931|FG003|STARTED|Up to Year 3||40
8768761|NCT01262976|9818932|FG004|STARTED|Up to Year 3||40
8768762|NCT01262976|9818933|FG005|STARTED|Up to Year 3||40
8768763|NCT01262976|9818928|FG000|COMPLETED|Up to Year 3||34
8768764|NCT01262976|9818929|FG001|COMPLETED|Up to Year 3||38
8768765|NCT01262976|9818930|FG002|COMPLETED|Up to Year 3||33
8768766|NCT01262976|9818931|FG003|COMPLETED|Up to Year 3||35
8768767|NCT01262976|9818932|FG004|COMPLETED|Up to Year 3||38
8768768|NCT01262976|9818933|FG005|COMPLETED|Up to Year 3||36
8768769|NCT01262976|9818928|FG000|NOT COMPLETED|Up to Year 3||6
8768770|NCT01262976|9818929|FG001|NOT COMPLETED|Up to Year 3||2
8768771|NCT01262976|9818930|FG002|NOT COMPLETED|Up to Year 3||7
8768772|NCT01262976|9818931|FG003|NOT COMPLETED|Up to Year 3||5
8768773|NCT01262976|9818932|FG004|NOT COMPLETED|Up to Year 3||2
8768774|NCT01262976|9818933|FG005|NOT COMPLETED|Up to Year 3||4
8768775|NCT01262989|9818948|FG000|STARTED|Period 1||20
8768776|NCT01262989|9818949|FG001|STARTED|Period 1||20
8768777|NCT01262989|9818948|FG000|COMPLETED|Period 1||19
8768778|NCT01262989|9818949|FG001|COMPLETED|Period 1||17
8768779|NCT01262989|9818948|FG000|NOT COMPLETED|Period 1||1
9027621|NCT03188523|10089861|FG002|STARTED|Overall Study||0
9027622|NCT03188523|10089862|FG003|STARTED|Overall Study||0
9027623|NCT03188523|10089859|FG000|COMPLETED|Overall Study||6
9027624|NCT03188523|10089860|FG001|COMPLETED|Overall Study||6
9027625|NCT03188523|10089861|FG002|COMPLETED|Overall Study||0
9027626|NCT03188523|10089862|FG003|COMPLETED|Overall Study||0
9027627|NCT03188523|10089859|FG000|NOT COMPLETED|Overall Study||0
9027628|NCT03188523|10089860|FG001|NOT COMPLETED|Overall Study||0
9027629|NCT03188523|10089861|FG002|NOT COMPLETED|Overall Study||0
9027630|NCT03188523|10089862|FG003|NOT COMPLETED|Overall Study||0
9027631|NCT03188536|10089868|FG000|STARTED|Overall Study||282
9027632|NCT03188536|10089868|FG000|COMPLETED|Overall Study||276
9027633|NCT03188536|10089868|FG000|NOT COMPLETED|Overall Study||6
9027634|NCT03188718|10089872|FG000|STARTED|Overall Study||45
9027635|NCT03188718|10089872|FG000|COMPLETED|Overall Study||37
9027636|NCT03188718|10089872|FG000|NOT COMPLETED|Overall Study||8
9027637|NCT03188991|10089880|FG000|STARTED|Overall Study||3
9027638|NCT03188991|10089881|FG001|STARTED|Overall Study||3
9027639|NCT03188991|10089882|FG002|STARTED|Overall Study||3
9027640|NCT03188991|10089883|FG003|STARTED|Overall Study||11
9027641|NCT03188991|10089880|FG000|COMPLETED|Overall Study||3
9027642|NCT03188991|10089881|FG001|COMPLETED|Overall Study||3
9027643|NCT03188991|10089882|FG002|COMPLETED|Overall Study||3
9027644|NCT03188991|10089883|FG003|COMPLETED|Overall Study||10
9027645|NCT03188991|10089880|FG000|NOT COMPLETED|Overall Study||0
9027646|NCT03188991|10089881|FG001|NOT COMPLETED|Overall Study||0
9027647|NCT03188991|10089882|FG002|NOT COMPLETED|Overall Study||0
9027648|NCT03188991|10089883|FG003|NOT COMPLETED|Overall Study||1
9027649|NCT03189134|10089893|FG000|STARTED|Overall Study||6
9027650|NCT03189134|10089893|FG000|COMPLETED|Overall Study||6
9027651|NCT03189134|10089893|FG000|NOT COMPLETED|Overall Study||0
9027652|NCT03189446|10089897|FG000|STARTED|Overall Study||32
9027653|NCT03189446|10089897|FG000|COMPLETED|Overall Study||27
9027654|NCT03189446|10089897|FG000|NOT COMPLETED|Overall Study||5
9027655|NCT03189524|10089904|FG000|STARTED|Overall Study||11
8768780|NCT01262989|9818949|FG001|NOT COMPLETED|Period 1||3
8768781|NCT01262989|9818948|FG000|STARTED|7-Day Washout Period||19
8768782|NCT01262989|9818949|FG001|STARTED|7-Day Washout Period||17
8768783|NCT01262989|9818948|FG000|COMPLETED|7-Day Washout Period||19
8768784|NCT01262989|9818949|FG001|COMPLETED|7-Day Washout Period||17
8768785|NCT01262989|9818948|FG000|NOT COMPLETED|7-Day Washout Period||0
8768786|NCT01262989|9818949|FG001|NOT COMPLETED|7-Day Washout Period||0
8768787|NCT01262989|9818948|FG000|STARTED|Period 2||19
8768788|NCT01262989|9818949|FG001|STARTED|Period 2||17
8768789|NCT01262989|9818948|FG000|COMPLETED|Period 2||19
8768790|NCT01262989|9818949|FG001|COMPLETED|Period 2||16
8768791|NCT01262989|9818948|FG000|NOT COMPLETED|Period 2||0
8768792|NCT01262989|9818949|FG001|NOT COMPLETED|Period 2||1
8768793|NCT01263015|9818957|FG000|STARTED|Double-blind Phase: 96 Weeks Duration||414
8915899|NCT02178592|9975385|FG001|COMPLETED|Randomized Phase (Up to Week 52)||35
8915900|NCT02178592|9975384|FG000|NOT COMPLETED|Randomized Phase (Up to Week 52)||19
8915901|NCT02178592|9975385|FG001|NOT COMPLETED|Randomized Phase (Up to Week 52)||9
8915902|NCT02178592|9975384|FG000|STARTED|OLE Phase (Week 52 to Week 252)|As OLE phase was optional, 3 participants from DTG arm did not enter OLE from Randomized Phase.|47
8915903|NCT02178592|9975385|FG001|STARTED|OLE Phase (Week 52 to Week 252)|As OLE phase was optional, 16 participants from EFV arm did not enter OLE from Randomized Phase.|19
8915904|NCT02178592|9975384|FG000|COMPLETED|OLE Phase (Week 52 to Week 252)||35
8915905|NCT02178592|9975385|FG001|COMPLETED|OLE Phase (Week 52 to Week 252)||16
8915906|NCT02178592|9975384|FG000|NOT COMPLETED|OLE Phase (Week 52 to Week 252)||12
8915907|NCT02178592|9975385|FG001|NOT COMPLETED|OLE Phase (Week 52 to Week 252)||3
8915908|NCT02178696|9975394|FG000|STARTED|First Assignment and Washout||20
8915909|NCT02178696|9975395|FG001|STARTED|First Assignment and Washout||20
8915910|NCT02178696|9975394|FG000|COMPLETED|First Assignment and Washout||20
8915911|NCT02178696|9975395|FG001|COMPLETED|First Assignment and Washout||20
8915912|NCT02178696|9975394|FG000|NOT COMPLETED|First Assignment and Washout||0
8915913|NCT02178696|9975395|FG001|NOT COMPLETED|First Assignment and Washout||0
8915914|NCT02178696|9975394|FG000|STARTED|Second Assignment After Crossover||20
8915915|NCT02178696|9975395|FG001|STARTED|Second Assignment After Crossover||20
8915916|NCT02178696|9975394|FG000|COMPLETED|Second Assignment After Crossover||20
8915917|NCT02178696|9975395|FG001|COMPLETED|Second Assignment After Crossover||20
8915918|NCT02178696|9975394|FG000|NOT COMPLETED|Second Assignment After Crossover||0
8915919|NCT02178696|9975395|FG001|NOT COMPLETED|Second Assignment After Crossover||0
9027656|NCT03189524|10089905|FG001|STARTED|Overall Study||10
9027657|NCT03189524|10089906|FG002|STARTED|Overall Study||23
9027658|NCT03189524|10089904|FG000|Received at Least 1 Dose of Study Drug|Overall Study||11
9027659|NCT03189524|10089905|FG001|Received at Least 1 Dose of Study Drug|Overall Study||10
9027660|NCT03189524|10089906|FG002|Received at Least 1 Dose of Study Drug|Overall Study||23
9027661|NCT03189524|10089904|FG000|COMPLETED|Overall Study||0
9027662|NCT03189524|10089905|FG001|COMPLETED|Overall Study||0
9027663|NCT03189524|10089906|FG002|COMPLETED|Overall Study||0
9027664|NCT03189524|10089904|FG000|NOT COMPLETED|Overall Study||11
9027665|NCT03189524|10089905|FG001|NOT COMPLETED|Overall Study||10
9027666|NCT03189524|10089906|FG002|NOT COMPLETED|Overall Study||23
9027667|NCT03189589|10089920|FG000|STARTED|Overall Study||6
9027668|NCT03189589|10089921|FG001|STARTED|Overall Study||6
9027669|NCT03189589|10089920|FG000|COMPLETED|Overall Study||6
9027670|NCT03189589|10089921|FG001|COMPLETED|Overall Study||6
9027671|NCT03189589|10089920|FG000|NOT COMPLETED|Overall Study||0
9027672|NCT03189589|10089921|FG001|NOT COMPLETED|Overall Study||0
9027673|NCT03189745|10089929|FG000|STARTED|Overall Study||170
9027674|NCT03189745|10089930|FG001|STARTED|Overall Study||59
9027675|NCT03189745|10089929|FG000|COMPLETED|Overall Study||169
9027676|NCT03189745|10089930|FG001|COMPLETED|Overall Study||58
9027677|NCT03189745|10089929|FG000|NOT COMPLETED|Overall Study||1
9027678|NCT03189745|10089930|FG001|NOT COMPLETED|Overall Study||1
9027679|NCT03190005|10089943|FG000|STARTED|Overall Study||5
9027680|NCT03190005|10089944|FG001|STARTED|Overall Study||5
9027681|NCT03190005|10089945|FG002|STARTED|Overall Study||5
9027682|NCT03190005|10089946|FG003|STARTED|Overall Study||5
9027683|NCT03190005|10089947|FG004|STARTED|Overall Study||5
9027684|NCT03190005|10089948|FG005|STARTED|Overall Study||5
9027685|NCT03190005|10089949|FG006|STARTED|Overall Study||5
9027686|NCT03190005|10089943|FG000|COMPLETED|Overall Study||5
9027687|NCT03190005|10089944|FG001|COMPLETED|Overall Study||5
9027688|NCT03190005|10089945|FG002|COMPLETED|Overall Study||5
9027689|NCT03190005|10089946|FG003|COMPLETED|Overall Study||5
9027690|NCT03190005|10089947|FG004|COMPLETED|Overall Study||5
9027691|NCT03190005|10089948|FG005|COMPLETED|Overall Study||5
9027692|NCT03190005|10089949|FG006|COMPLETED|Overall Study||5
9027693|NCT03190005|10089943|FG000|NOT COMPLETED|Overall Study||0
9027694|NCT03190005|10089944|FG001|NOT COMPLETED|Overall Study||0
9027695|NCT03190005|10089945|FG002|NOT COMPLETED|Overall Study||0
9027696|NCT03190005|10089946|FG003|NOT COMPLETED|Overall Study||0
9027697|NCT03190005|10089947|FG004|NOT COMPLETED|Overall Study||0
9027698|NCT03190005|10089948|FG005|NOT COMPLETED|Overall Study||0
9027699|NCT03190005|10089949|FG006|NOT COMPLETED|Overall Study||0
9027700|NCT03190083|10089965|FG000|STARTED|Overall Study||16
9027701|NCT03190083|10089965|FG000|COMPLETED|Overall Study||16
9027702|NCT03190083|10089965|FG000|NOT COMPLETED|Overall Study||0
9027703|NCT03190213|10089969|FG000|STARTED|Overall Study||6
9027704|NCT03190213|10089969|FG000|COMPLETED|Overall Study||6
9027705|NCT03190213|10089969|FG000|NOT COMPLETED|Overall Study||0
9027706|NCT03190460|10089975|FG000|STARTED|Overall Study||40
9027707|NCT03190460|10089976|FG001|STARTED|Overall Study||20
9027708|NCT03190460|10089975|FG000|COMPLETED|Overall Study||3
9027709|NCT03190460|10089976|FG001|COMPLETED|Overall Study||2
9027710|NCT03190460|10089975|FG000|NOT COMPLETED|Overall Study||37
8768794|NCT01263015|9818958|FG001|STARTED|Double-blind Phase: 96 Weeks Duration||419
9027711|NCT03190460|10089976|FG001|NOT COMPLETED|Overall Study||18
9027712|NCT03190993|10089984|FG000|STARTED|Overall Study||10
8768795|NCT01263015|9818957|FG000|COMPLETED|Double-blind Phase: 96 Weeks Duration||342
8768796|NCT01263015|9818958|FG001|COMPLETED|Double-blind Phase: 96 Weeks Duration||310
8768797|NCT01263015|9818957|FG000|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||72
8768798|NCT01263015|9818958|FG001|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||109
8768799|NCT01263015|9818957|FG000|STARTED|Open-label Phase: 48 Weeks Duration||341
8768800|NCT01263015|9818958|FG001|STARTED|Open-label Phase: 48 Weeks Duration||309
8768801|NCT01263015|9818957|FG000|COMPLETED|Open-label Phase: 48 Weeks Duration||317
8768802|NCT01263015|9818958|FG001|COMPLETED|Open-label Phase: 48 Weeks Duration||278
8768803|NCT01263015|9818957|FG000|NOT COMPLETED|Open-label Phase: 48 Weeks Duration||24
8768804|NCT01263015|9818958|FG001|NOT COMPLETED|Open-label Phase: 48 Weeks Duration||31
8768805|NCT01263054|9818966|FG000|STARTED|Overall Study||29
8768806|NCT01263054|9818967|FG001|STARTED|Overall Study||34
8768807|NCT01263054|9818966|FG000|COMPLETED|Overall Study||24
8768808|NCT01263054|9818967|FG001|COMPLETED|Overall Study||28
8768809|NCT01263054|9818966|FG000|NOT COMPLETED|Overall Study||5
8768810|NCT01263054|9818967|FG001|NOT COMPLETED|Overall Study||6
8768811|NCT01263093|9818975|FG000|STARTED|Period 1||24
8768812|NCT01263093|9818976|FG001|STARTED|Period 1||23
8768813|NCT01263093|9818975|FG000|COMPLETED|Period 1||24
8768814|NCT01263093|9818976|FG001|COMPLETED|Period 1||23
8768815|NCT01263093|9818975|FG000|NOT COMPLETED|Period 1||0
8768816|NCT01263093|9818976|FG001|NOT COMPLETED|Period 1||0
8768817|NCT01263093|9818975|FG000|STARTED|Washout||24
8768818|NCT01263093|9818976|FG001|STARTED|Washout||23
8768819|NCT01263093|9818975|FG000|COMPLETED|Washout||23
8768820|NCT01263093|9818976|FG001|COMPLETED|Washout||23
8768821|NCT01263093|9818975|FG000|NOT COMPLETED|Washout||1
8768822|NCT01263093|9818976|FG001|NOT COMPLETED|Washout||0
8768823|NCT01263093|9818975|FG000|STARTED|Period 2||23
8768824|NCT01263093|9818976|FG001|STARTED|Period 2||23
8768825|NCT01263093|9818975|FG000|COMPLETED|Period 2||22
8768826|NCT01263093|9818976|FG001|COMPLETED|Period 2||23
8768827|NCT01263093|9818975|FG000|NOT COMPLETED|Period 2||1
8768828|NCT01263093|9818976|FG001|NOT COMPLETED|Period 2||0
8768829|NCT01263106|9818983|FG000|STARTED|Period 1 (7 Days)||11
8768830|NCT01263106|9818984|FG001|STARTED|Period 1 (7 Days)||10
8768831|NCT01263106|9818983|FG000|COMPLETED|Period 1 (7 Days)|Period 1: 1 participant took theophylline alone but was not given LY + theophylline.|11
8768832|NCT01263106|9818984|FG001|COMPLETED|Period 1 (7 Days)|Period 1: 1 participant took LY + theophylline but was not given theophylline alone.|10
8768833|NCT01263106|9818983|FG000|NOT COMPLETED|Period 1 (7 Days)||0
8768834|NCT01263106|9818984|FG001|NOT COMPLETED|Period 1 (7 Days)||0
8768835|NCT01263106|9818983|FG000|STARTED|Washout (at Least 7 Days)||11
8768836|NCT01263106|9818984|FG001|STARTED|Washout (at Least 7 Days)||10
8768837|NCT01263106|9818983|FG000|COMPLETED|Washout (at Least 7 Days)||10
8768838|NCT01263106|9818984|FG001|COMPLETED|Washout (at Least 7 Days)||9
8768839|NCT01263106|9818983|FG000|NOT COMPLETED|Washout (at Least 7 Days)||1
8768840|NCT01263106|9818984|FG001|NOT COMPLETED|Washout (at Least 7 Days)||1
8768841|NCT01263106|9818983|FG000|STARTED|Period 2 (7 Days)||10
8768842|NCT01263106|9818984|FG001|STARTED|Period 2 (7 Days)||9
8768843|NCT01263106|9818983|FG000|COMPLETED|Period 2 (7 Days)||10
8768844|NCT01263106|9818984|FG001|COMPLETED|Period 2 (7 Days)||9
8768845|NCT01263106|9818983|FG000|NOT COMPLETED|Period 2 (7 Days)||0
8768846|NCT01263106|9818984|FG001|NOT COMPLETED|Period 2 (7 Days)||0
8768847|NCT01263119|9818993|FG000|STARTED|Period 1||18
8768848|NCT01263119|9818993|FG000|COMPLETED|Period 1||16
8768849|NCT01263119|9818993|FG000|NOT COMPLETED|Period 1||2
8768850|NCT01263119|9818993|FG000|STARTED|Period 2||16
8768851|NCT01263119|9818993|FG000|COMPLETED|Period 2||14
8768852|NCT01263119|9818993|FG000|NOT COMPLETED|Period 2||2
8768853|NCT01263132|9819003|FG000|STARTED|Overall Study||38
8768854|NCT01263132|9819004|FG001|STARTED|Overall Study||37
8768855|NCT01263132|9819003|FG000|COMPLETED|Overall Study||38
8768856|NCT01263132|9819004|FG001|COMPLETED|Overall Study||37
8768857|NCT01263132|9819003|FG000|NOT COMPLETED|Overall Study||0
8768858|NCT01263132|9819004|FG001|NOT COMPLETED|Overall Study||0
8768859|NCT01263197|9819012|FG000|STARTED|First Intervention (Period 1)||8
8768860|NCT01263197|9819013|FG001|STARTED|First Intervention (Period 1)||8
8768861|NCT01263197|9819014|FG002|STARTED|First Intervention (Period 1)||8
8768862|NCT01263197|9819015|FG003|STARTED|First Intervention (Period 1)||8
8768863|NCT01263197|9819016|FG004|STARTED|First Intervention (Period 1)||8
8768864|NCT01263197|9819017|FG005|STARTED|First Intervention (Period 1)||8
8768865|NCT01263197|9819012|FG000|COMPLETED|First Intervention (Period 1)||8
8768866|NCT01263197|9819013|FG001|COMPLETED|First Intervention (Period 1)||8
8768867|NCT01263197|9819014|FG002|COMPLETED|First Intervention (Period 1)||8
8768868|NCT01263197|9819015|FG003|COMPLETED|First Intervention (Period 1)||8
8768869|NCT01263197|9819016|FG004|COMPLETED|First Intervention (Period 1)||8
8768870|NCT01263197|9819017|FG005|COMPLETED|First Intervention (Period 1)||7
8768871|NCT01263197|9819012|FG000|NOT COMPLETED|First Intervention (Period 1)||0
8768872|NCT01263197|9819013|FG001|NOT COMPLETED|First Intervention (Period 1)||0
8768873|NCT01263197|9819014|FG002|NOT COMPLETED|First Intervention (Period 1)||0
8768874|NCT01263197|9819015|FG003|NOT COMPLETED|First Intervention (Period 1)||0
8768875|NCT01263197|9819016|FG004|NOT COMPLETED|First Intervention (Period 1)||0
8768876|NCT01263197|9819017|FG005|NOT COMPLETED|First Intervention (Period 1)||1
8768877|NCT01263197|9819012|FG000|STARTED|Washout Period 1||8
8768878|NCT01263197|9819013|FG001|STARTED|Washout Period 1||8
8768879|NCT01263197|9819014|FG002|STARTED|Washout Period 1||8
8768880|NCT01263197|9819015|FG003|STARTED|Washout Period 1||8
8768881|NCT01263197|9819016|FG004|STARTED|Washout Period 1||8
8768882|NCT01263197|9819017|FG005|STARTED|Washout Period 1||7
8768883|NCT01263197|9819012|FG000|COMPLETED|Washout Period 1||8
8768884|NCT01263197|9819013|FG001|COMPLETED|Washout Period 1||8
8768885|NCT01263197|9819014|FG002|COMPLETED|Washout Period 1||8
8768886|NCT01263197|9819015|FG003|COMPLETED|Washout Period 1||8
8768887|NCT01263197|9819016|FG004|COMPLETED|Washout Period 1||7
8768888|NCT01263197|9819017|FG005|COMPLETED|Washout Period 1||7
8768889|NCT01263197|9819012|FG000|NOT COMPLETED|Washout Period 1||0
8768890|NCT01263197|9819013|FG001|NOT COMPLETED|Washout Period 1||0
8768891|NCT01263197|9819014|FG002|NOT COMPLETED|Washout Period 1||0
8768892|NCT01263197|9819015|FG003|NOT COMPLETED|Washout Period 1||0
8768893|NCT01263197|9819016|FG004|NOT COMPLETED|Washout Period 1||1
8768894|NCT01263197|9819017|FG005|NOT COMPLETED|Washout Period 1||0
8768895|NCT01263197|9819012|FG000|STARTED|Second Intervention (Period 2)||8
8768896|NCT01263197|9819013|FG001|STARTED|Second Intervention (Period 2)||8
8768897|NCT01263197|9819014|FG002|STARTED|Second Intervention (Period 2)||8
8768898|NCT01263197|9819015|FG003|STARTED|Second Intervention (Period 2)||8
8768899|NCT01263197|9819016|FG004|STARTED|Second Intervention (Period 2)||7
8768900|NCT01263197|9819017|FG005|STARTED|Second Intervention (Period 2)||7
8768901|NCT01263197|9819012|FG000|COMPLETED|Second Intervention (Period 2)||8
8768902|NCT01263197|9819013|FG001|COMPLETED|Second Intervention (Period 2)||8
8768903|NCT01263197|9819014|FG002|COMPLETED|Second Intervention (Period 2)||8
8768904|NCT01263197|9819015|FG003|COMPLETED|Second Intervention (Period 2)||8
8768905|NCT01263197|9819016|FG004|COMPLETED|Second Intervention (Period 2)||7
8768906|NCT01263197|9819017|FG005|COMPLETED|Second Intervention (Period 2)||7
8768907|NCT01263197|9819012|FG000|NOT COMPLETED|Second Intervention (Period 2)||0
8768908|NCT01263197|9819013|FG001|NOT COMPLETED|Second Intervention (Period 2)||0
8768909|NCT01263197|9819014|FG002|NOT COMPLETED|Second Intervention (Period 2)||0
8768910|NCT01263197|9819015|FG003|NOT COMPLETED|Second Intervention (Period 2)||0
8768911|NCT01263197|9819016|FG004|NOT COMPLETED|Second Intervention (Period 2)||0
8768912|NCT01263197|9819017|FG005|NOT COMPLETED|Second Intervention (Period 2)||0
8768913|NCT01263197|9819012|FG000|STARTED|Washout Period 2||8
8768914|NCT01263197|9819013|FG001|STARTED|Washout Period 2||8
8768915|NCT01263197|9819014|FG002|STARTED|Washout Period 2||8
8768916|NCT01263197|9819015|FG003|STARTED|Washout Period 2||8
8768917|NCT01263197|9819016|FG004|STARTED|Washout Period 2||7
8768918|NCT01263197|9819017|FG005|STARTED|Washout Period 2||7
8768919|NCT01263197|9819012|FG000|COMPLETED|Washout Period 2||8
8768920|NCT01263197|9819013|FG001|COMPLETED|Washout Period 2||8
8768921|NCT01263197|9819014|FG002|COMPLETED|Washout Period 2||8
8768922|NCT01263197|9819015|FG003|COMPLETED|Washout Period 2||7
8768923|NCT01263197|9819016|FG004|COMPLETED|Washout Period 2||7
8768924|NCT01263197|9819017|FG005|COMPLETED|Washout Period 2||6
8768925|NCT01263197|9819012|FG000|NOT COMPLETED|Washout Period 2||0
8768926|NCT01263197|9819013|FG001|NOT COMPLETED|Washout Period 2||0
8768927|NCT01263197|9819014|FG002|NOT COMPLETED|Washout Period 2||0
8768928|NCT01263197|9819015|FG003|NOT COMPLETED|Washout Period 2||1
8768929|NCT01263197|9819016|FG004|NOT COMPLETED|Washout Period 2||0
8768930|NCT01263197|9819017|FG005|NOT COMPLETED|Washout Period 2||1
8768931|NCT01263197|9819012|FG000|STARTED|Third Intervention (Period 3)||8
8768932|NCT01263197|9819013|FG001|STARTED|Third Intervention (Period 3)||8
8768933|NCT01263197|9819014|FG002|STARTED|Third Intervention (Period 3)||8
8768934|NCT01263197|9819015|FG003|STARTED|Third Intervention (Period 3)||7
8768935|NCT01263197|9819016|FG004|STARTED|Third Intervention (Period 3)||7
8768936|NCT01263197|9819017|FG005|STARTED|Third Intervention (Period 3)||6
8768937|NCT01263197|9819012|FG000|COMPLETED|Third Intervention (Period 3)||8
8768938|NCT01263197|9819013|FG001|COMPLETED|Third Intervention (Period 3)||7
8768939|NCT01263197|9819014|FG002|COMPLETED|Third Intervention (Period 3)||8
8768940|NCT01263197|9819015|FG003|COMPLETED|Third Intervention (Period 3)||7
8768941|NCT01263197|9819016|FG004|COMPLETED|Third Intervention (Period 3)||7
8768942|NCT01263197|9819017|FG005|COMPLETED|Third Intervention (Period 3)||6
8768943|NCT01263197|9819012|FG000|NOT COMPLETED|Third Intervention (Period 3)||0
8768944|NCT01263197|9819013|FG001|NOT COMPLETED|Third Intervention (Period 3)||1
8768945|NCT01263197|9819014|FG002|NOT COMPLETED|Third Intervention (Period 3)||0
8768946|NCT01263197|9819015|FG003|NOT COMPLETED|Third Intervention (Period 3)||0
8768947|NCT01263197|9819016|FG004|NOT COMPLETED|Third Intervention (Period 3)||0
8768948|NCT01263197|9819017|FG005|NOT COMPLETED|Third Intervention (Period 3)||0
8768949|NCT01263223|9819031|FG000|STARTED|Period 1||12
8768950|NCT01263223|9819032|FG001|STARTED|Period 1||12
8768951|NCT01263223|9819031|FG000|COMPLETED|Period 1||12
8768952|NCT01263223|9819032|FG001|COMPLETED|Period 1||12
8768953|NCT01263223|9819031|FG000|NOT COMPLETED|Period 1||0
8768954|NCT01263223|9819032|FG001|NOT COMPLETED|Period 1||0
8768955|NCT01263223|9819031|FG000|STARTED|3-Day Washout||12
8768956|NCT01263223|9819032|FG001|STARTED|3-Day Washout||12
8768957|NCT01263223|9819031|FG000|COMPLETED|3-Day Washout||12
8768958|NCT01263223|9819032|FG001|COMPLETED|3-Day Washout||12
8768959|NCT01263223|9819031|FG000|NOT COMPLETED|3-Day Washout||0
8768960|NCT01263223|9819032|FG001|NOT COMPLETED|3-Day Washout||0
8768961|NCT01263223|9819031|FG000|STARTED|Period 2||12
8768962|NCT01263223|9819032|FG001|STARTED|Period 2||12
8768963|NCT01263223|9819031|FG000|COMPLETED|Period 2||12
8768964|NCT01263223|9819032|FG001|COMPLETED|Period 2||11
8768965|NCT01263223|9819031|FG000|NOT COMPLETED|Period 2||0
8768966|NCT01263223|9819032|FG001|NOT COMPLETED|Period 2||1
8768967|NCT01263223|9819031|FG000|STARTED|Period 3||12
8768968|NCT01263223|9819032|FG001|STARTED|Period 3||11
8768969|NCT01263223|9819031|FG000|COMPLETED|Period 3||12
8768970|NCT01263223|9819032|FG001|COMPLETED|Period 3||11
8768971|NCT01263223|9819031|FG000|NOT COMPLETED|Period 3||0
8768972|NCT01263223|9819032|FG001|NOT COMPLETED|Period 3||0
8768973|NCT01263223|9819031|FG000|STARTED|7-day Follow-up||12
8768974|NCT01263223|9819032|FG001|STARTED|7-day Follow-up||11
8768975|NCT01263223|9819031|FG000|COMPLETED|7-day Follow-up|One participant who did not complete received Placebo in Period 3.|11
8768976|NCT01263223|9819032|FG001|COMPLETED|7-day Follow-up|One participant who did not complete received 36-mg LY2216684 in Period 3.|10
8768977|NCT01263223|9819031|FG000|NOT COMPLETED|7-day Follow-up||1
8768978|NCT01263223|9819032|FG001|NOT COMPLETED|7-day Follow-up||1
8768979|NCT01263301|9819043|FG000|STARTED|Overall Study||5
8768980|NCT01263301|9819044|FG001|STARTED|Overall Study||11
8768981|NCT01263301|9819043|FG000|COMPLETED|Overall Study||5
8768982|NCT01263301|9819044|FG001|COMPLETED|Overall Study||11
8768983|NCT01263301|9819043|FG000|NOT COMPLETED|Overall Study||0
8768984|NCT01263301|9819044|FG001|NOT COMPLETED|Overall Study||0
8768985|NCT01263314|9819058|FG000|STARTED|Period 1||2
8768986|NCT01263314|9819059|FG001|STARTED|Period 1||2
8768987|NCT01263314|9819060|FG002|STARTED|Period 1||2
8768988|NCT01263314|9819061|FG003|STARTED|Period 1||2
8768989|NCT01263314|9819062|FG004|STARTED|Period 1||2
8768990|NCT01263314|9819063|FG005|STARTED|Period 1||2
8768991|NCT01263314|9819064|FG006|STARTED|Period 1||2
8768992|NCT01263314|9819065|FG007|STARTED|Period 1||2
8768993|NCT01263314|9819058|FG000|COMPLETED|Period 1||2
8768994|NCT01263314|9819059|FG001|COMPLETED|Period 1||2
8768995|NCT01263314|9819060|FG002|COMPLETED|Period 1||2
8768996|NCT01263314|9819061|FG003|COMPLETED|Period 1||2
8768997|NCT01263314|9819062|FG004|COMPLETED|Period 1||2
8768998|NCT01263314|9819063|FG005|COMPLETED|Period 1||2
8768999|NCT01263314|9819064|FG006|COMPLETED|Period 1||2
8769000|NCT01263314|9819065|FG007|COMPLETED|Period 1||2
8769001|NCT01263314|9819058|FG000|NOT COMPLETED|Period 1||0
8769002|NCT01263314|9819059|FG001|NOT COMPLETED|Period 1||0
8769003|NCT01263314|9819060|FG002|NOT COMPLETED|Period 1||0
8769004|NCT01263314|9819061|FG003|NOT COMPLETED|Period 1||0
8769005|NCT01263314|9819062|FG004|NOT COMPLETED|Period 1||0
8769006|NCT01263314|9819063|FG005|NOT COMPLETED|Period 1||0
8769007|NCT01263314|9819064|FG006|NOT COMPLETED|Period 1||0
8769008|NCT01263314|9819065|FG007|NOT COMPLETED|Period 1||0
8769009|NCT01263314|9819058|FG000|STARTED|Period 2||2
8769010|NCT01263314|9819059|FG001|STARTED|Period 2||2
8769011|NCT01263314|9819060|FG002|STARTED|Period 2||2
8769012|NCT01263314|9819061|FG003|STARTED|Period 2||2
8769013|NCT01263314|9819062|FG004|STARTED|Period 2||2
8769014|NCT01263314|9819063|FG005|STARTED|Period 2||2
8769015|NCT01263314|9819064|FG006|STARTED|Period 2||2
8769016|NCT01263314|9819065|FG007|STARTED|Period 2||2
8769017|NCT01263314|9819058|FG000|COMPLETED|Period 2||2
8769018|NCT01263314|9819059|FG001|COMPLETED|Period 2||2
8769019|NCT01263314|9819060|FG002|COMPLETED|Period 2||2
8769020|NCT01263314|9819061|FG003|COMPLETED|Period 2||2
8769021|NCT01263314|9819062|FG004|COMPLETED|Period 2||2
8769022|NCT01263314|9819063|FG005|COMPLETED|Period 2||2
8769023|NCT01263314|9819064|FG006|COMPLETED|Period 2||2
8769024|NCT01263314|9819065|FG007|COMPLETED|Period 2||2
8769025|NCT01263314|9819058|FG000|NOT COMPLETED|Period 2||0
8769026|NCT01263314|9819059|FG001|NOT COMPLETED|Period 2||0
8769027|NCT01263314|9819060|FG002|NOT COMPLETED|Period 2||0
8769028|NCT01263314|9819061|FG003|NOT COMPLETED|Period 2||0
8769029|NCT01263314|9819062|FG004|NOT COMPLETED|Period 2||0
8769030|NCT01263314|9819063|FG005|NOT COMPLETED|Period 2||0
8769031|NCT01263314|9819064|FG006|NOT COMPLETED|Period 2||0
8769032|NCT01263314|9819065|FG007|NOT COMPLETED|Period 2||0
8769033|NCT01263314|9819058|FG000|STARTED|Period 3||2
8769034|NCT01263314|9819059|FG001|STARTED|Period 3||2
8769035|NCT01263314|9819060|FG002|STARTED|Period 3||2
8769036|NCT01263314|9819061|FG003|STARTED|Period 3||2
8769037|NCT01263314|9819062|FG004|STARTED|Period 3||2
8769038|NCT01263314|9819063|FG005|STARTED|Period 3||2
8769039|NCT01263314|9819064|FG006|STARTED|Period 3||2
8769040|NCT01263314|9819065|FG007|STARTED|Period 3||2
8769041|NCT01263314|9819058|FG000|COMPLETED|Period 3||2
8769042|NCT01263314|9819059|FG001|COMPLETED|Period 3||2
8769043|NCT01263314|9819060|FG002|COMPLETED|Period 3||2
8769044|NCT01263314|9819061|FG003|COMPLETED|Period 3||2
8769045|NCT01263314|9819062|FG004|COMPLETED|Period 3||2
8769046|NCT01263314|9819063|FG005|COMPLETED|Period 3||2
8769047|NCT01263314|9819064|FG006|COMPLETED|Period 3||2
8769048|NCT01263314|9819065|FG007|COMPLETED|Period 3||2
8769049|NCT01263314|9819058|FG000|NOT COMPLETED|Period 3||0
8769050|NCT01263314|9819059|FG001|NOT COMPLETED|Period 3||0
8769051|NCT01263314|9819060|FG002|NOT COMPLETED|Period 3||0
8769052|NCT01263314|9819061|FG003|NOT COMPLETED|Period 3||0
8769053|NCT01263314|9819062|FG004|NOT COMPLETED|Period 3||0
8769054|NCT01263314|9819063|FG005|NOT COMPLETED|Period 3||0
8769055|NCT01263314|9819064|FG006|NOT COMPLETED|Period 3||0
8769056|NCT01263314|9819065|FG007|NOT COMPLETED|Period 3||0
8769057|NCT01263444|9819089|FG000|STARTED|Overall Study||47
8769058|NCT01263444|9819089|FG000|COMPLETED|Overall Study||37
8769059|NCT01263444|9819089|FG000|NOT COMPLETED|Overall Study||10
8769060|NCT01263470|9819099|FG000|STARTED|Overall Study||75
8769061|NCT01263470|9819100|FG001|STARTED|Overall Study||79
8769062|NCT01263470|9819101|FG002|STARTED|Overall Study||84
8769063|NCT01263470|9819102|FG003|STARTED|Overall Study||80
8769064|NCT01263470|9819103|FG004|STARTED|Overall Study||79
8769065|NCT01263470|9819104|FG005|STARTED|Overall Study||83
8769066|NCT01263470|9819099|FG000|COMPLETED|Overall Study||73
8769067|NCT01263470|9819100|FG001|COMPLETED|Overall Study||74
8769068|NCT01263470|9819101|FG002|COMPLETED|Overall Study||80
8769069|NCT01263470|9819102|FG003|COMPLETED|Overall Study||77
8769070|NCT01263470|9819103|FG004|COMPLETED|Overall Study||76
8769071|NCT01263470|9819104|FG005|COMPLETED|Overall Study||78
8769072|NCT01263470|9819099|FG000|NOT COMPLETED|Overall Study||2
8769073|NCT01263470|9819100|FG001|NOT COMPLETED|Overall Study||5
8769074|NCT01263470|9819101|FG002|NOT COMPLETED|Overall Study||4
8769075|NCT01263470|9819102|FG003|NOT COMPLETED|Overall Study||3
8769076|NCT01263470|9819103|FG004|NOT COMPLETED|Overall Study||3
8769077|NCT01263470|9819104|FG005|NOT COMPLETED|Overall Study||5
8769078|NCT01263483|9819121|FG000|STARTED|Overall Study||75
8769079|NCT01263483|9819122|FG001|STARTED|Overall Study||76
8769080|NCT01263483|9819123|FG002|STARTED|Overall Study||79
8769081|NCT01263483|9819121|FG000|COMPLETED|Overall Study||68
8769082|NCT01263483|9819122|FG001|COMPLETED|Overall Study||74
8769083|NCT01263483|9819123|FG002|COMPLETED|Overall Study||74
8769084|NCT01263483|9819121|FG000|NOT COMPLETED|Overall Study||7
8769085|NCT01263483|9819122|FG001|NOT COMPLETED|Overall Study||2
8769086|NCT01263483|9819123|FG002|NOT COMPLETED|Overall Study||5
8769087|NCT01263496|9819136|FG000|STARTED|Enrolled - Long-Term Extension Study||72
8769088|NCT01263496|9819137|FG001|STARTED|Enrolled - Long-Term Extension Study||75
8769089|NCT01263496|9819138|FG002|STARTED|Enrolled - Long-Term Extension Study||72
8769090|NCT01263496|9819139|FG003|STARTED|Enrolled - Long-Term Extension Study||75
8769091|NCT01263496|9819140|FG004|STARTED|Enrolled - Long-Term Extension Study||74
8769092|NCT01263496|9819141|FG005|STARTED|Enrolled - Long-Term Extension Study||17
8769093|NCT01263496|9819142|FG006|STARTED|Enrolled - Long-Term Extension Study||17
8769094|NCT01263496|9819143|FG007|STARTED|Enrolled - Long-Term Extension Study||18
8769095|NCT01263496|9819144|FG008|STARTED|Enrolled - Long-Term Extension Study||18
8769096|NCT01263496|9819136|FG000|COMPLETED|Enrolled - Long-Term Extension Study||71
8769097|NCT01263496|9819137|FG001|COMPLETED|Enrolled - Long-Term Extension Study||75
8769098|NCT01263496|9819138|FG002|COMPLETED|Enrolled - Long-Term Extension Study||72
8769099|NCT01263496|9819139|FG003|COMPLETED|Enrolled - Long-Term Extension Study||74
8769100|NCT01263496|9819140|FG004|COMPLETED|Enrolled - Long-Term Extension Study||72
8769101|NCT01263496|9819141|FG005|COMPLETED|Enrolled - Long-Term Extension Study||17
8769102|NCT01263496|9819142|FG006|COMPLETED|Enrolled - Long-Term Extension Study||17
8769103|NCT01263496|9819143|FG007|COMPLETED|Enrolled - Long-Term Extension Study||18
8769104|NCT01263496|9819144|FG008|COMPLETED|Enrolled - Long-Term Extension Study||18
8769105|NCT01263496|9819136|FG000|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
8769106|NCT01263496|9819137|FG001|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
8769107|NCT01263496|9819138|FG002|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
8769108|NCT01263496|9819139|FG003|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
8769109|NCT01263496|9819140|FG004|NOT COMPLETED|Enrolled - Long-Term Extension Study||2
8769110|NCT01263496|9819141|FG005|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
8769111|NCT01263496|9819142|FG006|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
8769112|NCT01263496|9819143|FG007|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
8769113|NCT01263496|9819144|FG008|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
8769114|NCT01263496|9819136|FG000|STARTED|Entered - Long-Term Extension Study||71
8769115|NCT01263496|9819137|FG001|STARTED|Entered - Long-Term Extension Study|3 participants did not enter from previous period (1 voluntary withdraw; 2 did not meet criteria).|72
8769116|NCT01263496|9819138|FG002|STARTED|Entered - Long-Term Extension Study||72
8769117|NCT01263496|9819139|FG003|STARTED|Entered - Long-Term Extension Study||74
8769118|NCT01263496|9819140|FG004|STARTED|Entered - Long-Term Extension Study|1 participant did not enter from previous period (voluntary withdraw).|71
8769119|NCT01263496|9819141|FG005|STARTED|Entered - Long-Term Extension Study||17
8769120|NCT01263496|9819142|FG006|STARTED|Entered - Long-Term Extension Study||17
8769121|NCT01263496|9819143|FG007|STARTED|Entered - Long-Term Extension Study|1 participant did not enter from previous period (voluntary withdraw).|17
8769122|NCT01263496|9819144|FG008|STARTED|Entered - Long-Term Extension Study||18
8769123|NCT01263496|9819136|FG000|COMPLETED|Entered - Long-Term Extension Study||62
8769124|NCT01263496|9819137|FG001|COMPLETED|Entered - Long-Term Extension Study||59
8769125|NCT01263496|9819138|FG002|COMPLETED|Entered - Long-Term Extension Study||62
8769126|NCT01263496|9819139|FG003|COMPLETED|Entered - Long-Term Extension Study||68
8769127|NCT01263496|9819140|FG004|COMPLETED|Entered - Long-Term Extension Study||61
8769128|NCT01263496|9819141|FG005|COMPLETED|Entered - Long-Term Extension Study||16
8769129|NCT01263496|9819142|FG006|COMPLETED|Entered - Long-Term Extension Study||16
8769130|NCT01263496|9819143|FG007|COMPLETED|Entered - Long-Term Extension Study||16
8769131|NCT01263496|9819144|FG008|COMPLETED|Entered - Long-Term Extension Study||15
8769132|NCT01263496|9819136|FG000|NOT COMPLETED|Entered - Long-Term Extension Study||9
8769133|NCT01263496|9819137|FG001|NOT COMPLETED|Entered - Long-Term Extension Study||13
8769134|NCT01263496|9819138|FG002|NOT COMPLETED|Entered - Long-Term Extension Study||10
8769135|NCT01263496|9819139|FG003|NOT COMPLETED|Entered - Long-Term Extension Study||6
8769136|NCT01263496|9819140|FG004|NOT COMPLETED|Entered - Long-Term Extension Study||10
8769137|NCT01263496|9819141|FG005|NOT COMPLETED|Entered - Long-Term Extension Study||1
8808526|NCT01490632|9860701|FG000|NOT COMPLETED|Part D: Re-Treatment Period||0
8769138|NCT01263496|9819142|FG006|NOT COMPLETED|Entered - Long-Term Extension Study||1
8769139|NCT01263496|9819143|FG007|NOT COMPLETED|Entered - Long-Term Extension Study||1
8769140|NCT01263496|9819144|FG008|NOT COMPLETED|Entered - Long-Term Extension Study||3
8769141|NCT01263509|9819158|FG000|STARTED|Enrolled - Long-Term Extension Study||61
8769142|NCT01263509|9819159|FG001|STARTED|Enrolled - Long-Term Extension Study||60
8769143|NCT01263509|9819160|FG002|STARTED|Enrolled - Long-Term Extension Study||32
8769144|NCT01263509|9819161|FG003|STARTED|Enrolled - Long-Term Extension Study||26
8769145|NCT01263509|9819158|FG000|COMPLETED|Enrolled - Long-Term Extension Study||61
8769146|NCT01263509|9819159|FG001|COMPLETED|Enrolled - Long-Term Extension Study||60
8769147|NCT01263509|9819160|FG002|COMPLETED|Enrolled - Long-Term Extension Study||32
8769148|NCT01263509|9819161|FG003|COMPLETED|Enrolled - Long-Term Extension Study||26
8769149|NCT01263509|9819158|FG000|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
8769150|NCT01263509|9819159|FG001|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
8769151|NCT01263509|9819160|FG002|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
8769152|NCT01263509|9819161|FG003|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
8769153|NCT01263509|9819158|FG000|STARTED|Entered - Long-Term Extension Study||61
8769154|NCT01263509|9819159|FG001|STARTED|Entered - Long-Term Extension Study||60
8769155|NCT01263509|9819160|FG002|STARTED|Entered - Long-Term Extension Study||32
8769156|NCT01263509|9819161|FG003|STARTED|Entered - Long-Term Extension Study||26
8769157|NCT01263509|9819158|FG000|COMPLETED|Entered - Long-Term Extension Study||53
8769158|NCT01263509|9819159|FG001|COMPLETED|Entered - Long-Term Extension Study||48
8769159|NCT01263509|9819160|FG002|COMPLETED|Entered - Long-Term Extension Study||27
8769160|NCT01263509|9819161|FG003|COMPLETED|Entered - Long-Term Extension Study||24
8769161|NCT01263509|9819158|FG000|NOT COMPLETED|Entered - Long-Term Extension Study||8
8769162|NCT01263509|9819159|FG001|NOT COMPLETED|Entered - Long-Term Extension Study||12
8769163|NCT01263509|9819160|FG002|NOT COMPLETED|Entered - Long-Term Extension Study||5
8769164|NCT01263509|9819161|FG003|NOT COMPLETED|Entered - Long-Term Extension Study||2
8769165|NCT01263561|9819169|FG000|STARTED|Overall Study||31
8769166|NCT01263561|9819170|FG001|STARTED|Overall Study||33
8769167|NCT01263561|9819169|FG000|COMPLETED|Overall Study||30
8769168|NCT01263561|9819170|FG001|COMPLETED|Overall Study||31
8769169|NCT01263561|9819169|FG000|NOT COMPLETED|Overall Study||1
8769170|NCT01263561|9819170|FG001|NOT COMPLETED|Overall Study||2
8769171|NCT01263639|9819178|FG000|STARTED|Overall Study||107
8769172|NCT01263639|9819179|FG001|STARTED|Overall Study||121
8769173|NCT01263639|9819178|FG000|COMPLETED|Overall Study||34
8769174|NCT01263639|9819179|FG001|COMPLETED|Overall Study||42
8769175|NCT01263639|9819178|FG000|NOT COMPLETED|Overall Study||73
8769176|NCT01263639|9819179|FG001|NOT COMPLETED|Overall Study||79
8769177|NCT01263665|9819185|FG000|STARTED|Overall Study||71
8769178|NCT01263665|9819185|FG000|COMPLETED|Overall Study||62
8769179|NCT01263665|9819185|FG000|NOT COMPLETED|Overall Study||9
8769180|NCT01263691|9819195|FG000|STARTED|Overall Study||18
8769181|NCT01263691|9819196|FG001|STARTED|Overall Study||18
8769182|NCT01263691|9819197|FG002|STARTED|Overall Study||17
8769183|NCT01263691|9819198|FG003|STARTED|Overall Study||19
8769184|NCT01263691|9819199|FG004|STARTED|Overall Study||18
8769185|NCT01263691|9819200|FG005|STARTED|Overall Study||15
8769186|NCT01263691|9819195|FG000|COMPLETED|Overall Study||15
8769187|NCT01263691|9819196|FG001|COMPLETED|Overall Study||18
8769188|NCT01263691|9819197|FG002|COMPLETED|Overall Study||16
8769189|NCT01263691|9819198|FG003|COMPLETED|Overall Study||18
8769190|NCT01263691|9819199|FG004|COMPLETED|Overall Study||18
8769191|NCT01263691|9819200|FG005|COMPLETED|Overall Study||15
8769192|NCT01263691|9819195|FG000|NOT COMPLETED|Overall Study||3
8769193|NCT01263691|9819196|FG001|NOT COMPLETED|Overall Study||0
8769194|NCT01263691|9819197|FG002|NOT COMPLETED|Overall Study||1
8769195|NCT01263691|9819198|FG003|NOT COMPLETED|Overall Study||1
8769196|NCT01263691|9819199|FG004|NOT COMPLETED|Overall Study||0
8769197|NCT01263691|9819200|FG005|NOT COMPLETED|Overall Study||0
8769198|NCT01263704|9819235|FG000|STARTED|Overall Study||42
8769199|NCT01263704|9819235|FG000|COMPLETED|Overall Study||13
8769200|NCT01263704|9819235|FG000|NOT COMPLETED|Overall Study||29
8769201|NCT01263717|9819241|FG000|STARTED|Overall Study||28
8769202|NCT01263717|9819242|FG001|STARTED|Overall Study||26
8769203|NCT01263717|9819241|FG000|Baseline Visit|Overall Study||28
8769204|NCT01263717|9819242|FG001|Baseline Visit|Overall Study||22
8769205|NCT01263717|9819241|FG000|COMPLETED|Overall Study||23
8769206|NCT01263717|9819242|FG001|COMPLETED|Overall Study||20
8769207|NCT01263717|9819241|FG000|NOT COMPLETED|Overall Study||5
8769208|NCT01263717|9819242|FG001|NOT COMPLETED|Overall Study||6
8769209|NCT01263782|9819252|FG000|STARTED|Overall Study||6
8769210|NCT01263782|9819253|FG001|STARTED|Overall Study||6
8769211|NCT01263782|9819254|FG002|STARTED|Overall Study||6
8769212|NCT01263782|9819255|FG003|STARTED|Overall Study||6
8769213|NCT01263782|9819252|FG000|COMPLETED|Overall Study||6
8769214|NCT01263782|9819253|FG001|COMPLETED|Overall Study||6
8769215|NCT01263782|9819254|FG002|COMPLETED|Overall Study||3
8769216|NCT01263782|9819255|FG003|COMPLETED|Overall Study||5
8769217|NCT01263782|9819252|FG000|NOT COMPLETED|Overall Study||0
8769218|NCT01263782|9819253|FG001|NOT COMPLETED|Overall Study||0
8769219|NCT01263782|9819254|FG002|NOT COMPLETED|Overall Study||3
8769220|NCT01263782|9819255|FG003|NOT COMPLETED|Overall Study||1
8769221|NCT01263873|9819267|FG000|STARTED|Overall Study||30
8769222|NCT01263873|9819268|FG001|STARTED|Overall Study||30
8769223|NCT01263873|9819267|FG000|COMPLETED|Overall Study||29
8769224|NCT01263873|9819268|FG001|COMPLETED|Overall Study||29
8769225|NCT01263873|9819267|FG000|NOT COMPLETED|Overall Study||1
8769226|NCT01263873|9819268|FG001|NOT COMPLETED|Overall Study||1
8769227|NCT01263925|9819276|FG000|STARTED|Overall Study||276
8769228|NCT01263925|9819277|FG001|STARTED|Overall Study||285
8769229|NCT01263925|9819276|FG000|Full Analysis Set|Overall Study||269
8769230|NCT01263925|9819277|FG001|Full Analysis Set|Overall Study||272
8769231|NCT01263925|9819276|FG000|COMPLETED|Overall Study||225
8769232|NCT01263925|9819277|FG001|COMPLETED|Overall Study||233
8769233|NCT01263925|9819276|FG000|NOT COMPLETED|Overall Study||51
8769234|NCT01263925|9819277|FG001|NOT COMPLETED|Overall Study||52
8769235|NCT01263938|9819283|FG000|STARTED|Overall Study||5
8769236|NCT01263938|9819283|FG000|COMPLETED|Overall Study||5
8769237|NCT01263938|9819283|FG000|NOT COMPLETED|Overall Study||0
8769238|NCT01264016|9819288|FG000|STARTED|Overall Study||96
8769239|NCT01264016|9819288|FG000|COMPLETED|Overall Study||94
8769240|NCT01264016|9819288|FG000|NOT COMPLETED|Overall Study||2
8769241|NCT01264081|9819293|FG000|STARTED|Participants Screened||34
8769242|NCT01264081|9819293|FG000|COMPLETED|Participants Screened||4
8769243|NCT01264081|9819293|FG000|NOT COMPLETED|Participants Screened||30
8769244|NCT01264081|9819293|FG000|STARTED|Started Treatment||4
8769245|NCT01264081|9819293|FG000|COMPLETED|Started Treatment||2
8769246|NCT01264081|9819293|FG000|NOT COMPLETED|Started Treatment||2
8769247|NCT01264081|9819293|FG000|STARTED|Analysis||2
8769248|NCT01264081|9819293|FG000|COMPLETED|Analysis||2
8769249|NCT01264081|9819293|FG000|NOT COMPLETED|Analysis||0
8769250|NCT01264380|9819297|FG000|STARTED|Period A||8
8769251|NCT01264380|9819298|FG001|STARTED|Period A||8
8769252|NCT01264380|9819299|FG002|STARTED|Period A||0
8769253|NCT01264380|9819297|FG000|COMPLETED|Period A||8
8769254|NCT01264380|9819298|FG001|COMPLETED|Period A||8
8769255|NCT01264380|9819299|FG002|COMPLETED|Period A||0
8769256|NCT01264380|9819297|FG000|NOT COMPLETED|Period A||0
8769257|NCT01264380|9819298|FG001|NOT COMPLETED|Period A||0
8769258|NCT01264380|9819299|FG002|NOT COMPLETED|Period A||0
8769259|NCT01264380|9819297|FG000|STARTED|Period B||8
8769260|NCT01264380|9819298|FG001|STARTED|Period B||8
8769261|NCT01264380|9819299|FG002|STARTED|Period B||0
8769262|NCT01264380|9819297|FG000|COMPLETED|Period B||8
8769263|NCT01264380|9819298|FG001|COMPLETED|Period B||8
8769264|NCT01264380|9819299|FG002|COMPLETED|Period B||0
8769265|NCT01264380|9819297|FG000|NOT COMPLETED|Period B||0
8769266|NCT01264380|9819298|FG001|NOT COMPLETED|Period B||0
8769267|NCT01264380|9819299|FG002|NOT COMPLETED|Period B||0
8769268|NCT01264380|9819297|FG000|STARTED|Period C||0
8769269|NCT01264380|9819298|FG001|STARTED|Period C||0
8769270|NCT01264380|9819299|FG002|STARTED|Period C||16
8769271|NCT01264380|9819297|FG000|COMPLETED|Period C||0
8769272|NCT01264380|9819298|FG001|COMPLETED|Period C||0
8769273|NCT01264380|9819299|FG002|COMPLETED|Period C||2
8769274|NCT01264380|9819297|FG000|NOT COMPLETED|Period C||0
8769275|NCT01264380|9819298|FG001|NOT COMPLETED|Period C||0
8769276|NCT01264380|9819299|FG002|NOT COMPLETED|Period C||14
8769277|NCT01264419|9819307|FG000|STARTED|Overall Study||75
8769278|NCT01264419|9819307|FG000|COMPLETED|Overall Study||72
9027713|NCT03190993|10089985|FG001|STARTED|Overall Study||10
9027714|NCT03190993|10089984|FG000|COMPLETED|Overall Study||10
9027715|NCT03190993|10089985|FG001|COMPLETED|Overall Study||10
9027716|NCT03190993|10089984|FG000|NOT COMPLETED|Overall Study||0
9027717|NCT03190993|10089985|FG001|NOT COMPLETED|Overall Study||0
9027718|NCT03191396|10089993|FG000|STARTED|Overall Study||290
9027719|NCT03191396|10089994|FG001|STARTED|Overall Study||287
9027720|NCT03191396|10089993|FG000|COMPLETED|Overall Study||287
9027721|NCT03191396|10089994|FG001|COMPLETED|Overall Study||282
9027722|NCT03191396|10089993|FG000|NOT COMPLETED|Overall Study||3
9027723|NCT03191396|10089994|FG001|NOT COMPLETED|Overall Study||5
9027724|NCT03191552|10090003|FG000|STARTED|Overall Study||9
9027725|NCT03191552|10090004|FG001|STARTED|Overall Study||9
9027726|NCT03191552|10090005|FG002|STARTED|Overall Study||8
9027727|NCT03191552|10090003|FG000|COMPLETED|Overall Study||8
9027728|NCT03191552|10090004|FG001|COMPLETED|Overall Study||8
9027729|NCT03191552|10090005|FG002|COMPLETED|Overall Study||8
9027730|NCT03191552|10090003|FG000|NOT COMPLETED|Overall Study||1
9027731|NCT03191552|10090004|FG001|NOT COMPLETED|Overall Study||1
9027732|NCT03191552|10090005|FG002|NOT COMPLETED|Overall Study||0
9027733|NCT03191630|10090019|FG000|STARTED|Overall Study||30
9027734|NCT03191630|10090020|FG001|STARTED|Overall Study||30
8769279|NCT01264419|9819307|FG000|NOT COMPLETED|Overall Study||3
8769280|NCT01264601|9819313|FG000|STARTED|Overall Study||17
8769281|NCT01264601|9819314|FG001|STARTED|Overall Study||14
8769282|NCT01264601|9819313|FG000|COMPLETED|Overall Study||17
8769283|NCT01264601|9819314|FG001|COMPLETED|Overall Study||14
8769284|NCT01264601|9819313|FG000|NOT COMPLETED|Overall Study||0
8769285|NCT01264601|9819314|FG001|NOT COMPLETED|Overall Study||0
9027735|NCT03191630|10090019|FG000|COMPLETED|Overall Study||23
9027736|NCT03191630|10090020|FG001|COMPLETED|Overall Study||23
9027737|NCT03191630|10090019|FG000|NOT COMPLETED|Overall Study||7
8769286|NCT01264614|9819322|FG000|STARTED|Overall Study||13
8769287|NCT01264614|9819323|FG001|STARTED|Overall Study||9
8769288|NCT01264614|9819322|FG000|COMPLETED|Overall Study||12
8769289|NCT01264614|9819323|FG001|COMPLETED|Overall Study||7
8769290|NCT01264614|9819322|FG000|NOT COMPLETED|Overall Study||1
9027738|NCT03191630|10090020|FG001|NOT COMPLETED|Overall Study||7
9027739|NCT03191799|10090028|FG000|STARTED|Overall Study||195
9027740|NCT03191799|10090028|FG000|Received at Least One Dose of Emicizumab|Overall Study||193
8769291|NCT01264614|9819323|FG001|NOT COMPLETED|Overall Study||2
8769292|NCT01264705|9819332|FG000|STARTED|Overall Study||3
8769293|NCT01264705|9819333|FG001|STARTED|Overall Study||3
8769294|NCT01264705|9819334|FG002|STARTED|Overall Study||41
8769295|NCT01264705|9819332|FG000|COMPLETED|Overall Study||3
8769296|NCT01264705|9819333|FG001|COMPLETED|Overall Study||3
8769297|NCT01264705|9819334|FG002|COMPLETED|Overall Study||41
8769298|NCT01264705|9819332|FG000|NOT COMPLETED|Overall Study||0
8769299|NCT01264705|9819333|FG001|NOT COMPLETED|Overall Study||0
8769300|NCT01264705|9819334|FG002|NOT COMPLETED|Overall Study||0
8769301|NCT01264718|9819347|FG000|STARTED|Overall Study||172
8769302|NCT01264718|9819348|FG001|STARTED|Overall Study||157
8769303|NCT01264718|9819347|FG000|COMPLETED|Overall Study||123
8769304|NCT01264718|9819348|FG001|COMPLETED|Overall Study||114
8769305|NCT01264718|9819347|FG000|NOT COMPLETED|Overall Study||49
8769306|NCT01264718|9819348|FG001|NOT COMPLETED|Overall Study||43
8769307|NCT01264770|9819360|FG000|STARTED|Overall Study|Patients who received treatment|54
8769308|NCT01264770|9819361|FG001|STARTED|Overall Study|Patients who received treatment|48
8769309|NCT01264770|9819362|FG002|STARTED|Overall Study|Patients who received treatment|57
8769310|NCT01264770|9819363|FG003|STARTED|Overall Study|Patients who received treatment|54
8769311|NCT01264770|9819364|FG004|STARTED|Overall Study|Patients who received treatment|27
8769312|NCT01264770|9819365|FG005|STARTED|Overall Study|Patients who received treatment|25
8769313|NCT01264770|9819360|FG000|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|2
8769314|NCT01264770|9819361|FG001|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|5
8769315|NCT01264770|9819362|FG002|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|2
8769316|NCT01264770|9819363|FG003|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|3
8769317|NCT01264770|9819364|FG004|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|2
8769318|NCT01264770|9819365|FG005|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|0
8769319|NCT01264770|9819360|FG000|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|36
8769320|NCT01264770|9819361|FG001|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|38
8769321|NCT01264770|9819362|FG002|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|41
8769322|NCT01264770|9819363|FG003|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|48
8769323|NCT01264770|9819364|FG004|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|19
8769324|NCT01264770|9819365|FG005|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|19
8769325|NCT01264770|9819360|FG000|NOT COMPLETED|Overall Study||18
8769326|NCT01264770|9819361|FG001|NOT COMPLETED|Overall Study||10
8769327|NCT01264770|9819362|FG002|NOT COMPLETED|Overall Study||16
8769328|NCT01264770|9819363|FG003|NOT COMPLETED|Overall Study||6
8769329|NCT01264770|9819364|FG004|NOT COMPLETED|Overall Study||8
8769330|NCT01264770|9819365|FG005|NOT COMPLETED|Overall Study||6
8769331|NCT01264887|9819385|FG000|STARTED|Overall Study||31
8769332|NCT01264887|9819385|FG000|COMPLETED|Overall Study||0
8769333|NCT01264887|9819385|FG000|NOT COMPLETED|Overall Study||31
8769334|NCT01264939|9819393|FG000|STARTED|Overall Study||84
8769335|NCT01264939|9819394|FG001|STARTED|Overall Study||252
8769336|NCT01264939|9819393|FG000|COMPLETED|Overall Study||66
8769337|NCT01264939|9819394|FG001|COMPLETED|Overall Study||224
8769338|NCT01264939|9819393|FG000|NOT COMPLETED|Overall Study||18
8769339|NCT01264939|9819394|FG001|NOT COMPLETED|Overall Study||28
8769340|NCT01264952|9819403|FG000|STARTED|Overall Study||6
8769341|NCT01264952|9819404|FG001|STARTED|Overall Study||2
8769342|NCT01264952|9819405|FG002|STARTED|Overall Study||8
8769343|NCT01264952|9819403|FG000|COMPLETED|Overall Study||6
8769344|NCT01264952|9819404|FG001|COMPLETED|Overall Study||2
8769345|NCT01264952|9819405|FG002|COMPLETED|Overall Study||8
8769346|NCT01264952|9819403|FG000|NOT COMPLETED|Overall Study||0
8769347|NCT01264952|9819404|FG001|NOT COMPLETED|Overall Study||0
8769348|NCT01264952|9819405|FG002|NOT COMPLETED|Overall Study||0
8769349|NCT01265056|9819415|FG000|STARTED|Initial Study Period||26
8769350|NCT01265056|9819416|FG001|STARTED|Initial Study Period||27
8769351|NCT01265056|9819415|FG000|COMPLETED|Initial Study Period||24
8769352|NCT01265056|9819416|FG001|COMPLETED|Initial Study Period||25
8769353|NCT01265056|9819415|FG000|NOT COMPLETED|Initial Study Period||2
8769354|NCT01265056|9819416|FG001|NOT COMPLETED|Initial Study Period||2
8769355|NCT01265056|9819415|FG000|STARTED|Follow up||26
8769356|NCT01265056|9819416|FG001|STARTED|Follow up||27
8769357|NCT01265056|9819415|FG000|COMPLETED|Follow up||19
8769358|NCT01265056|9819416|FG001|COMPLETED|Follow up||24
8769359|NCT01265056|9819415|FG000|NOT COMPLETED|Follow up||7
8769360|NCT01265056|9819416|FG001|NOT COMPLETED|Follow up||3
8769361|NCT01265394|9819422|FG000|STARTED|Overall Study||218
8769362|NCT01265394|9819422|FG000|COMPLETED|Overall Study||181
8769363|NCT01265394|9819422|FG000|NOT COMPLETED|Overall Study||37
8769364|NCT01265420|9819427|FG000|STARTED|Overall Study||7
8769365|NCT01265420|9819427|FG000|COMPLETED|Overall Study|One patient was seen at Day 10 but did not return for Day 30 evaluation|6
8769366|NCT01265420|9819427|FG000|NOT COMPLETED|Overall Study||1
8769367|NCT01265446|9819433|FG000|STARTED|Overall Study||125
8769368|NCT01265446|9819434|FG001|STARTED|Overall Study||125
8769369|NCT01265446|9819433|FG000|COMPLETED|Overall Study||124
8769370|NCT01265446|9819434|FG001|COMPLETED|Overall Study||125
8769371|NCT01265446|9819433|FG000|NOT COMPLETED|Overall Study||1
8769372|NCT01265446|9819434|FG001|NOT COMPLETED|Overall Study||0
8769373|NCT01265459|9819443|FG000|STARTED|Overall Study||23
8769374|NCT01265459|9819444|FG001|STARTED|Overall Study||23
8769375|NCT01265459|9819445|FG002|STARTED|Overall Study||22
8769376|NCT01265459|9819443|FG000|COMPLETED|Overall Study||23
8769377|NCT01265459|9819444|FG001|COMPLETED|Overall Study||23
8769378|NCT01265459|9819445|FG002|COMPLETED|Overall Study||20
8769379|NCT01265459|9819443|FG000|NOT COMPLETED|Overall Study||0
8769380|NCT01265459|9819444|FG001|NOT COMPLETED|Overall Study||0
8769381|NCT01265459|9819445|FG002|NOT COMPLETED|Overall Study||2
8769382|NCT01265498|9819467|FG000|STARTED|Overall Study||141
8769383|NCT01265498|9819468|FG001|STARTED|Overall Study||142
8769384|NCT01265498|9819467|FG000|Both Baseline and Week 72 Biopsy|Overall Study||102
8769385|NCT01265498|9819468|FG001|Both Baseline and Week 72 Biopsy|Overall Study||98
8769386|NCT01265498|9819467|FG000|COMPLETED|Overall Study||110
8769387|NCT01265498|9819468|FG001|COMPLETED|Overall Study||109
8769388|NCT01265498|9819467|FG000|NOT COMPLETED|Overall Study||31
8769389|NCT01265498|9819468|FG001|NOT COMPLETED|Overall Study||33
8769390|NCT01265511|9819476|FG000|STARTED|Overall Study||2
8769391|NCT01265511|9819477|FG001|STARTED|Overall Study||8
8769392|NCT01265511|9819476|FG000|COMPLETED|Overall Study||0
8769393|NCT01265511|9819477|FG001|COMPLETED|Overall Study||5
8769394|NCT01265511|9819476|FG000|NOT COMPLETED|Overall Study||2
8769395|NCT01265511|9819477|FG001|NOT COMPLETED|Overall Study||3
8769396|NCT01265524|9819485|FG000|STARTED|Overall Study||59
8769397|NCT01265524|9819486|FG001|STARTED|Overall Study||52
8769398|NCT01265524|9819485|FG000|COMPLETED|Overall Study||41
8769399|NCT01265524|9819486|FG001|COMPLETED|Overall Study||46
8769400|NCT01265524|9819485|FG000|NOT COMPLETED|Overall Study||18
8769401|NCT01265524|9819486|FG001|NOT COMPLETED|Overall Study||6
8808527|NCT01490632|9860702|FG001|NOT COMPLETED|Part D: Re-Treatment Period||0
8808528|NCT01490632|9860703|FG002|NOT COMPLETED|Part D: Re-Treatment Period||0
8808529|NCT01490632|9860704|FG003|NOT COMPLETED|Part D: Re-Treatment Period||0
8808530|NCT01490632|9860705|FG004|NOT COMPLETED|Part D: Re-Treatment Period||0
9027741|NCT03191799|10090028|FG000|Dose Up-Titrated to 3 mg/kg QW|Overall Study||2
9027742|NCT03191799|10090028|FG000|COMPLETED|Overall Study||186
9027743|NCT03191799|10090028|FG000|NOT COMPLETED|Overall Study||9
9027744|NCT03192137|10090034|FG000|STARTED|Overall Study||173
9027745|NCT03192137|10090035|FG001|STARTED|Overall Study||87
8808531|NCT01490632|9860706|FG005|NOT COMPLETED|Part D: Re-Treatment Period||0
8808532|NCT01490632|9860707|FG006|NOT COMPLETED|Part D: Re-Treatment Period||0
8808533|NCT01490632|9860708|FG007|NOT COMPLETED|Part D: Re-Treatment Period||0
8808534|NCT01490632|9860709|FG008|NOT COMPLETED|Part D: Re-Treatment Period||0
8808535|NCT01490632|9860710|FG009|NOT COMPLETED|Part D: Re-Treatment Period||0
8808536|NCT01490632|9860711|FG010|NOT COMPLETED|Part D: Re-Treatment Period||0
8808537|NCT01490632|9860712|FG011|NOT COMPLETED|Part D: Re-Treatment Period||0
8808538|NCT01490632|9860713|FG012|NOT COMPLETED|Part D: Re-Treatment Period||0
8808539|NCT01490632|9860714|FG013|NOT COMPLETED|Part D: Re-Treatment Period||0
8808540|NCT01490632|9860715|FG014|NOT COMPLETED|Part D: Re-Treatment Period||0
8808541|NCT01490632|9860716|FG015|NOT COMPLETED|Part D: Re-Treatment Period||0
8808542|NCT01490632|9860717|FG016|NOT COMPLETED|Part D: Re-Treatment Period||0
8808543|NCT01490632|9860718|FG017|NOT COMPLETED|Part D: Re-Treatment Period||5
8808544|NCT01490632|9860719|FG018|NOT COMPLETED|Part D: Re-Treatment Period||7
8808545|NCT01490632|9860720|FG019|NOT COMPLETED|Part D: Re-Treatment Period||7
8808546|NCT01490684|9860763|FG000|STARTED|Overall Study||162
8808547|NCT01490684|9860763|FG000|COMPLETED|Overall Study||162
8808548|NCT01490684|9860763|FG000|NOT COMPLETED|Overall Study||0
8808549|NCT01490697|9860769|FG000|STARTED|Overall Study||16
8808550|NCT01490697|9860770|FG001|STARTED|Overall Study||18
8808551|NCT01490697|9860769|FG000|COMPLETED|Overall Study||15
8808552|NCT01490697|9860770|FG001|COMPLETED|Overall Study||16
8915920|NCT02178696|9975394|FG000|STARTED|Open-label Antidepressant||20
8915921|NCT02178696|9975395|FG001|STARTED|Open-label Antidepressant||20
8915922|NCT02178696|9975394|FG000|COMPLETED|Open-label Antidepressant||14
8915923|NCT02178696|9975395|FG001|COMPLETED|Open-label Antidepressant||13
8915924|NCT02178696|9975394|FG000|NOT COMPLETED|Open-label Antidepressant||6
8915925|NCT02178696|9975395|FG001|NOT COMPLETED|Open-label Antidepressant||7
8915926|NCT02178787|9975408|FG000|STARTED|Overall Study||35
8915927|NCT02178787|9975409|FG001|STARTED|Overall Study||39
8915928|NCT02178787|9975408|FG000|COMPLETED|Overall Study||30
8915929|NCT02178787|9975409|FG001|COMPLETED|Overall Study||30
8915930|NCT02178787|9975408|FG000|NOT COMPLETED|Overall Study||5
8915931|NCT02178787|9975409|FG001|NOT COMPLETED|Overall Study||9
8915932|NCT02178800|9975419|FG000|STARTED|Overall Study||151
8915933|NCT02178800|9975420|FG001|STARTED|Overall Study||48
8915934|NCT02178800|9975419|FG000|COMPLETED|Overall Study|Number of participants who weren't terminated at week 41|131
8915935|NCT02178800|9975420|FG001|COMPLETED|Overall Study|Number of participants who weren't terminated at week 41|42
8915936|NCT02178800|9975419|FG000|NOT COMPLETED|Overall Study||20
8915937|NCT02178800|9975420|FG001|NOT COMPLETED|Overall Study||6
8915938|NCT02178995|9975436|FG000|STARTED|Double Blind||0
8915939|NCT02178995|9975437|FG001|STARTED|Double Blind||16
8915940|NCT02178995|9975438|FG002|STARTED|Double Blind||5
9027746|NCT03192137|10090034|FG000|COMPLETED|Overall Study||123
8808553|NCT01490697|9860769|FG000|NOT COMPLETED|Overall Study||1
8808554|NCT01490697|9860770|FG001|NOT COMPLETED|Overall Study||2
8769402|NCT01265537|9819494|FG000|STARTED|Overall Study||15
8769403|NCT01265537|9819495|FG001|STARTED|Overall Study||15
8769404|NCT01265537|9819494|FG000|COMPLETED|Overall Study||13
8769405|NCT01265537|9819495|FG001|COMPLETED|Overall Study||13
8769406|NCT01265537|9819494|FG000|NOT COMPLETED|Overall Study||2
8769407|NCT01265537|9819495|FG001|NOT COMPLETED|Overall Study||2
8769408|NCT01265550|9819505|FG000|STARTED|Pre Randomization||0
8769409|NCT01265550|9819506|FG001|STARTED|Pre Randomization||0
8769410|NCT01265550|9819507|FG002|STARTED|Pre Randomization||0
8769411|NCT01265550|9819508|FG003|STARTED|Pre Randomization||366
8769412|NCT01265550|9819505|FG000|COMPLETED|Pre Randomization||0
8769413|NCT01265550|9819506|FG001|COMPLETED|Pre Randomization||0
8769414|NCT01265550|9819507|FG002|COMPLETED|Pre Randomization||0
8769415|NCT01265550|9819508|FG003|COMPLETED|Pre Randomization||78
8769416|NCT01265550|9819505|FG000|NOT COMPLETED|Pre Randomization||0
8769417|NCT01265550|9819506|FG001|NOT COMPLETED|Pre Randomization||0
8769418|NCT01265550|9819507|FG002|NOT COMPLETED|Pre Randomization||0
8769419|NCT01265550|9819508|FG003|NOT COMPLETED|Pre Randomization||288
8769420|NCT01265550|9819505|FG000|STARTED|Post Randomization||25
8769421|NCT01265550|9819506|FG001|STARTED|Post Randomization||27
8769422|NCT01265550|9819507|FG002|STARTED|Post Randomization||26
8769423|NCT01265550|9819508|FG003|STARTED|Post Randomization||0
8769424|NCT01265550|9819505|FG000|COMPLETED|Post Randomization||10
8769425|NCT01265550|9819506|FG001|COMPLETED|Post Randomization||19
8769426|NCT01265550|9819507|FG002|COMPLETED|Post Randomization||6
8769427|NCT01265550|9819508|FG003|COMPLETED|Post Randomization||0
8769428|NCT01265550|9819505|FG000|NOT COMPLETED|Post Randomization||15
8769429|NCT01265550|9819506|FG001|NOT COMPLETED|Post Randomization||8
8769430|NCT01265550|9819507|FG002|NOT COMPLETED|Post Randomization||20
8769431|NCT01265550|9819508|FG003|NOT COMPLETED|Post Randomization||0
8769432|NCT01265563|9819527|FG000|STARTED|Overall Study||16
8769433|NCT01265563|9819528|FG001|STARTED|Overall Study||13
8769434|NCT01265563|9819529|FG002|STARTED|Overall Study||17
8769435|NCT01265563|9819530|FG003|STARTED|Overall Study||16
8769436|NCT01265563|9819531|FG004|STARTED|Overall Study||16
8769437|NCT01265563|9819527|FG000|COMPLETED|Overall Study||16
8769438|NCT01265563|9819528|FG001|COMPLETED|Overall Study||12
8769439|NCT01265563|9819529|FG002|COMPLETED|Overall Study||16
8769440|NCT01265563|9819530|FG003|COMPLETED|Overall Study||16
8769441|NCT01265563|9819531|FG004|COMPLETED|Overall Study||14
8769442|NCT01265563|9819527|FG000|NOT COMPLETED|Overall Study||0
8769443|NCT01265563|9819528|FG001|NOT COMPLETED|Overall Study||1
8769444|NCT01265563|9819529|FG002|NOT COMPLETED|Overall Study||1
8769445|NCT01265563|9819530|FG003|NOT COMPLETED|Overall Study||0
8769446|NCT01265563|9819531|FG004|NOT COMPLETED|Overall Study||2
8769447|NCT01265615|9819552|FG000|STARTED|Overall Study||30
8769448|NCT01265615|9819553|FG001|STARTED|Overall Study||30
8769449|NCT01265615|9819554|FG002|STARTED|Overall Study||30
8769450|NCT01265615|9819555|FG003|STARTED|Overall Study||30
8769451|NCT01265615|9819552|FG000|COMPLETED|Overall Study||28
8769452|NCT01265615|9819553|FG001|COMPLETED|Overall Study||28
8769453|NCT01265615|9819554|FG002|COMPLETED|Overall Study||26
8769454|NCT01265615|9819555|FG003|COMPLETED|Overall Study||27
8769455|NCT01265615|9819552|FG000|NOT COMPLETED|Overall Study||2
8769456|NCT01265615|9819553|FG001|NOT COMPLETED|Overall Study||2
8769457|NCT01265615|9819554|FG002|NOT COMPLETED|Overall Study||4
8769458|NCT01265615|9819555|FG003|NOT COMPLETED|Overall Study||3
8769459|NCT01265667|9819567|FG000|STARTED|Overall Study||145
8769460|NCT01265667|9819568|FG001|STARTED|Overall Study||148
8769461|NCT01265667|9819567|FG000|COMPLETED|Overall Study||125
8769462|NCT01265667|9819568|FG001|COMPLETED|Overall Study||135
8769463|NCT01265667|9819567|FG000|NOT COMPLETED|Overall Study||20
8769464|NCT01265667|9819568|FG001|NOT COMPLETED|Overall Study||13
8769465|NCT01265719|9819576|FG000|STARTED|Overall Study||102
8769466|NCT01265719|9819577|FG001|STARTED|Overall Study||73
8769467|NCT01265719|9819576|FG000|COMPLETED|Overall Study||88
9027747|NCT03192137|10090035|FG001|COMPLETED|Overall Study||29
9027748|NCT03192137|10090034|FG000|NOT COMPLETED|Overall Study||50
9027749|NCT03192137|10090035|FG001|NOT COMPLETED|Overall Study||58
9027750|NCT03192150|10090043|FG000|STARTED|Overall Study||163
9027751|NCT03192150|10090044|FG001|STARTED|Overall Study||83
9027752|NCT03192150|10090043|FG000|COMPLETED|Overall Study||108
9027753|NCT03192150|10090044|FG001|COMPLETED|Overall Study||29
9027754|NCT03192150|10090043|FG000|NOT COMPLETED|Overall Study||55
9027755|NCT03192150|10090044|FG001|NOT COMPLETED|Overall Study||54
9027756|NCT03192176|10090058|FG000|STARTED|Overall Study||44
9027757|NCT03192176|10090059|FG001|STARTED|Overall Study||45
9027758|NCT03192176|10090060|FG002|STARTED|Overall Study||44
9027759|NCT03192176|10090061|FG003|STARTED|Overall Study||45
9027760|NCT03192176|10090062|FG004|STARTED|Overall Study||44
9027761|NCT03192176|10090063|FG005|STARTED|Overall Study||45
8769468|NCT01265719|9819577|FG001|COMPLETED|Overall Study||60
8769469|NCT01265719|9819576|FG000|NOT COMPLETED|Overall Study||14
8769470|NCT01265719|9819577|FG001|NOT COMPLETED|Overall Study||13
8769471|NCT01265797|9819585|FG000|STARTED|Run-in Month||34
8769472|NCT01265797|9819586|FG001|STARTED|Run-in Month||34
8769473|NCT01265797|9819585|FG000|COMPLETED|Run-in Month||34
8769474|NCT01265797|9819586|FG001|COMPLETED|Run-in Month||29
8769475|NCT01265797|9819585|FG000|NOT COMPLETED|Run-in Month||0
8769476|NCT01265797|9819586|FG001|NOT COMPLETED|Run-in Month||5
9027762|NCT03192176|10090064|FG006|STARTED|Overall Study||45
9027763|NCT03192176|10090065|FG007|STARTED|Overall Study||44
9027764|NCT03192176|10090058|FG000|Treated|Overall Study||43
8769477|NCT01265797|9819585|FG000|STARTED|Blinded Month||34
8769478|NCT01265797|9819586|FG001|STARTED|Blinded Month||29
8769479|NCT01265797|9819585|FG000|COMPLETED|Blinded Month||24
8769480|NCT01265797|9819586|FG001|COMPLETED|Blinded Month||27
8769481|NCT01265797|9819585|FG000|NOT COMPLETED|Blinded Month||10
8769482|NCT01265797|9819586|FG001|NOT COMPLETED|Blinded Month||2
8769483|NCT01265797|9819585|FG000|STARTED|Open Label Month||24
8769484|NCT01265797|9819586|FG001|STARTED|Open Label Month||27
8769485|NCT01265797|9819585|FG000|COMPLETED|Open Label Month||24
8769486|NCT01265797|9819586|FG001|COMPLETED|Open Label Month||26
8769487|NCT01265797|9819585|FG000|NOT COMPLETED|Open Label Month||0
8769488|NCT01265797|9819586|FG001|NOT COMPLETED|Open Label Month||1
8769489|NCT01265823|9819594|FG000|STARTED|Overall Study||150
8769490|NCT01265823|9819594|FG000|COMPLETED|Overall Study||143
8769491|NCT01265823|9819594|FG000|NOT COMPLETED|Overall Study||7
8769492|NCT01265875|9819602|FG000|STARTED|Overall Study||12
8769493|NCT01265875|9819602|FG000|COMPLETED|Overall Study||11
8769494|NCT01265875|9819602|FG000|NOT COMPLETED|Overall Study||1
8769495|NCT01265953|9819609|FG000|STARTED|Overall Study||50
8769496|NCT01265953|9819610|FG001|STARTED|Overall Study||48
8769497|NCT01265953|9819609|FG000|COMPLETED|Overall Study||45
8769498|NCT01265953|9819610|FG001|COMPLETED|Overall Study||45
8769499|NCT01265953|9819609|FG000|NOT COMPLETED|Overall Study||5
8769500|NCT01265953|9819610|FG001|NOT COMPLETED|Overall Study||3
8769501|NCT01265966|9819619|FG000|STARTED|Overall Study||47
8769502|NCT01265966|9819620|FG001|STARTED|Overall Study||41
8769503|NCT01265966|9819621|FG002|STARTED|Overall Study||29
8769504|NCT01265966|9819619|FG000|Analyzed Separately|Overall Study|Patients taking inhaled or intranasal corticosteroids were analyzed separately.|3
8769505|NCT01265966|9819620|FG001|Analyzed Separately|Overall Study|Patients taking inhaled or intranasal corticosteroids were analyzed separately.|2
8769506|NCT01265966|9819621|FG002|Analyzed Separately|Overall Study|Patients taking inhaled or intranasal corticosteroids were analyzed separately.|2
8769507|NCT01265966|9819619|FG000|COMPLETED|Overall Study||44
8769508|NCT01265966|9819620|FG001|COMPLETED|Overall Study||39
8769509|NCT01265966|9819621|FG002|COMPLETED|Overall Study||27
8769510|NCT01265966|9819619|FG000|NOT COMPLETED|Overall Study||3
8769511|NCT01265966|9819620|FG001|NOT COMPLETED|Overall Study||2
8769512|NCT01265966|9819621|FG002|NOT COMPLETED|Overall Study||2
8769513|NCT01265992|9819629|FG000|STARTED|Overall Study||50
8769514|NCT01265992|9819629|FG000|Received Treatment|Overall Study||49
8769515|NCT01265992|9819629|FG000|COMPLETED|Overall Study||41
8769516|NCT01265992|9819629|FG000|NOT COMPLETED|Overall Study||9
8769517|NCT01266018|9819633|FG000|STARTED|Overall Study||9
8769518|NCT01266018|9819634|FG001|STARTED|Overall Study||13
8769519|NCT01266018|9819633|FG000|COMPLETED|Overall Study|Defined as evaluable for the primary endpoint|8
8769520|NCT01266018|9819634|FG001|COMPLETED|Overall Study||12
8769521|NCT01266018|9819633|FG000|NOT COMPLETED|Overall Study||1
8769522|NCT01266018|9819634|FG001|NOT COMPLETED|Overall Study||1
8769523|NCT01266070|9819640|FG000|STARTED|Overall Study||6
8769524|NCT01266070|9819640|FG000|COMPLETED|Overall Study||2
8769525|NCT01266070|9819640|FG000|NOT COMPLETED|Overall Study||4
8769526|NCT01266122|9819646|FG000|STARTED|Overall Study||48
8769527|NCT01266122|9819647|FG001|STARTED|Overall Study||48
8769528|NCT01266122|9819646|FG000|COMPLETED|Overall Study||42
8769529|NCT01266122|9819647|FG001|COMPLETED|Overall Study||42
8769530|NCT01266122|9819646|FG000|NOT COMPLETED|Overall Study||6
8769531|NCT01266122|9819647|FG001|NOT COMPLETED|Overall Study||6
8769532|NCT01266148|9819655|FG000|STARTED|Overall Study||56
8769533|NCT01266148|9819656|FG001|STARTED|Overall Study||59
8769534|NCT01266148|9819655|FG000|COMPLETED|Overall Study||49
8769535|NCT01266148|9819656|FG001|COMPLETED|Overall Study||56
8769536|NCT01266148|9819655|FG000|NOT COMPLETED|Overall Study||7
8769537|NCT01266148|9819656|FG001|NOT COMPLETED|Overall Study||3
8769538|NCT01266161|9819664|FG000|STARTED|Overall Study||52
8769539|NCT01266161|9819665|FG001|STARTED|Overall Study||54
8769540|NCT01266161|9819664|FG000|COMPLETED|Overall Study||48
8769541|NCT01266161|9819665|FG001|COMPLETED|Overall Study||53
8769542|NCT01266161|9819664|FG000|NOT COMPLETED|Overall Study||4
8769543|NCT01266161|9819665|FG001|NOT COMPLETED|Overall Study||1
8769544|NCT01266265|9819673|FG000|STARTED|Overall Study||666
8769545|NCT01266265|9819674|FG001|STARTED|Overall Study||667
8769546|NCT01266265|9819673|FG000|COMPLETED|Overall Study||461
8769547|NCT01266265|9819674|FG001|COMPLETED|Overall Study||477
8769548|NCT01266265|9819673|FG000|NOT COMPLETED|Overall Study||205
8769549|NCT01266265|9819674|FG001|NOT COMPLETED|Overall Study||190
8769550|NCT01266291|9819680|FG000|STARTED|Overall Study||1
8769551|NCT01266291|9819680|FG000|COMPLETED|Overall Study||0
8769552|NCT01266291|9819680|FG000|NOT COMPLETED|Overall Study||1
8769553|NCT01266317|9819684|FG000|STARTED|Overall Study|One additional patient was a protocol violation post consent when autoantibodies returned positive|9
8769554|NCT01266317|9819684|FG000|COMPLETED|Overall Study||7
8769555|NCT01266317|9819684|FG000|NOT COMPLETED|Overall Study||2
8769556|NCT01266447|9819688|FG000|STARTED|Overall Study||27
8769557|NCT01266447|9819688|FG000|COMPLETED|Overall Study|Eligible and treated patients|27
8769558|NCT01266447|9819688|FG000|NOT COMPLETED|Overall Study||0
8769559|NCT01266460|9819692|FG000|STARTED|Overall Study||50
8769560|NCT01266460|9819692|FG000|COMPLETED|Overall Study||16
8769561|NCT01266460|9819692|FG000|NOT COMPLETED|Overall Study||34
8769562|NCT01266590|9819696|FG000|STARTED|Overall Study||30
8769563|NCT01266590|9819696|FG000|COMPLETED|Overall Study||24
8769564|NCT01266590|9819696|FG000|NOT COMPLETED|Overall Study||6
8769565|NCT01266603|9819703|FG000|STARTED|Overall Study||44
8769566|NCT01266603|9819703|FG000|MAGE-A3 Positive Tumor|Overall Study||18
8769567|NCT01266603|9819703|FG000|Patients Evaluable for Safety|Overall Study||17
8769568|NCT01266603|9819703|FG000|Patients Evaluable for Response|Overall Study||16
8769569|NCT01266603|9819703|FG000|Continued to Maintenance- MAGE-A3|Overall Study||4
8769570|NCT01266603|9819703|FG000|Maintenance Completion|Overall Study||2
8769571|NCT01266603|9819703|FG000|COMPLETED|Overall Study||2
8769572|NCT01266603|9819703|FG000|NOT COMPLETED|Overall Study||42
8769573|NCT01266642|9819709|FG000|STARTED|Overall Study||149
8769574|NCT01266642|9819710|FG001|STARTED|Overall Study||138
8769575|NCT01266642|9819709|FG000|COMPLETED|Overall Study||149
8769576|NCT01266642|9819710|FG001|COMPLETED|Overall Study||137
8769577|NCT01266642|9819709|FG000|NOT COMPLETED|Overall Study||0
8769578|NCT01266642|9819710|FG001|NOT COMPLETED|Overall Study||1
8769579|NCT01266850|9819721|FG000|STARTED|Overall Study||242
8769580|NCT01266850|9819722|FG001|STARTED|Overall Study||248
8769581|NCT01266850|9819723|FG002|STARTED|Overall Study||238
8769582|NCT01266850|9819724|FG003|STARTED|Overall Study||329
9027765|NCT03192176|10090059|FG001|Treated|Overall Study||45
9027766|NCT03192176|10090060|FG002|Treated|Overall Study||43
9027767|NCT03192176|10090061|FG003|Treated|Overall Study||45
9027768|NCT03192176|10090062|FG004|Treated|Overall Study||44
9027769|NCT03192176|10090063|FG005|Treated|Overall Study||43
9027770|NCT03192176|10090064|FG006|Treated|Overall Study||45
9027771|NCT03192176|10090065|FG007|Treated|Overall Study||44
9027772|NCT03192176|10090058|FG000|COMPLETED|Overall Study||37
9027773|NCT03192176|10090059|FG001|COMPLETED|Overall Study||40
8769583|NCT01266850|9819725|FG004|STARTED|Overall Study||327
8769584|NCT01266850|9819721|FG000|Received Second Vaccine|Overall Study||231
8769585|NCT01266850|9819722|FG001|Received Second Vaccine|Overall Study||233
8769586|NCT01266850|9819723|FG002|Received Second Vaccine|Overall Study||227
8769587|NCT01266850|9819724|FG003|Received Second Vaccine|Overall Study||311
8769588|NCT01266850|9819725|FG004|Received Second Vaccine|Overall Study||307
8769589|NCT01266850|9819721|FG000|Received Third Vaccine|Overall Study||221
8769590|NCT01266850|9819722|FG001|Received Third Vaccine|Overall Study||221
8769591|NCT01266850|9819723|FG002|Received Third Vaccine|Overall Study||217
8769592|NCT01266850|9819724|FG003|Received Third Vaccine|Overall Study||0
8769593|NCT01266850|9819725|FG004|Received Third Vaccine|Overall Study||299
8769594|NCT01266850|9819721|FG000|COMPLETED|Overall Study||212
8769595|NCT01266850|9819722|FG001|COMPLETED|Overall Study||212
8769596|NCT01266850|9819723|FG002|COMPLETED|Overall Study||214
8769597|NCT01266850|9819724|FG003|COMPLETED|Overall Study||301
8769598|NCT01266850|9819725|FG004|COMPLETED|Overall Study||297
8769599|NCT01266850|9819721|FG000|NOT COMPLETED|Overall Study||30
8769600|NCT01266850|9819722|FG001|NOT COMPLETED|Overall Study||36
8769601|NCT01266850|9819723|FG002|NOT COMPLETED|Overall Study||24
8769602|NCT01266850|9819724|FG003|NOT COMPLETED|Overall Study||28
8769603|NCT01266850|9819725|FG004|NOT COMPLETED|Overall Study||30
8769604|NCT01266876|9819742|FG000|STARTED|Overall Study||15
8769605|NCT01266876|9819743|FG001|STARTED|Overall Study||15
8769606|NCT01266876|9819744|FG002|STARTED|Overall Study||16
8769607|NCT01266876|9819745|FG003|STARTED|Overall Study||15
8769608|NCT01266876|9819746|FG004|STARTED|Overall Study||16
8769609|NCT01266876|9819742|FG000|COMPLETED|Overall Study||15
8769610|NCT01266876|9819743|FG001|COMPLETED|Overall Study||15
8769611|NCT01266876|9819744|FG002|COMPLETED|Overall Study||16
8769612|NCT01266876|9819745|FG003|COMPLETED|Overall Study||14
8769613|NCT01266876|9819746|FG004|COMPLETED|Overall Study||16
8769614|NCT01266876|9819742|FG000|NOT COMPLETED|Overall Study||0
8769615|NCT01266876|9819743|FG001|NOT COMPLETED|Overall Study||0
8769616|NCT01266876|9819744|FG002|NOT COMPLETED|Overall Study||0
8769617|NCT01266876|9819745|FG003|NOT COMPLETED|Overall Study||1
8769618|NCT01266876|9819746|FG004|NOT COMPLETED|Overall Study||0
8769619|NCT01266902|9819760|FG000|STARTED|Period 1 (Main Study)||119
8769620|NCT01266902|9819761|FG001|STARTED|Period 1 (Main Study)||363
8769621|NCT01266902|9819762|FG002|STARTED|Period 1 (Main Study)||0
8769622|NCT01266902|9819760|FG000|COMPLETED|Period 1 (Main Study)||89
8769623|NCT01266902|9819761|FG001|COMPLETED|Period 1 (Main Study)||282
8769624|NCT01266902|9819762|FG002|COMPLETED|Period 1 (Main Study)||0
8769625|NCT01266902|9819760|FG000|NOT COMPLETED|Period 1 (Main Study)||30
8769626|NCT01266902|9819761|FG001|NOT COMPLETED|Period 1 (Main Study)||81
8769627|NCT01266902|9819762|FG002|NOT COMPLETED|Period 1 (Main Study)||0
8769628|NCT01266902|9819760|FG000|STARTED|Period 2 (After Protocol Amendment 3)||0
8769629|NCT01266902|9819761|FG001|STARTED|Period 2 (After Protocol Amendment 3)||0
8769630|NCT01266902|9819762|FG002|STARTED|Period 2 (After Protocol Amendment 3)||45
8769631|NCT01266902|9819760|FG000|COMPLETED|Period 2 (After Protocol Amendment 3)||0
8769632|NCT01266902|9819761|FG001|COMPLETED|Period 2 (After Protocol Amendment 3)||0
8769633|NCT01266902|9819762|FG002|COMPLETED|Period 2 (After Protocol Amendment 3)||37
8769634|NCT01266902|9819760|FG000|NOT COMPLETED|Period 2 (After Protocol Amendment 3)||0
8769635|NCT01266902|9819761|FG001|NOT COMPLETED|Period 2 (After Protocol Amendment 3)||0
8769636|NCT01266902|9819762|FG002|NOT COMPLETED|Period 2 (After Protocol Amendment 3)||8
9027774|NCT03192176|10090060|FG002|COMPLETED|Overall Study||38
9027775|NCT03192176|10090061|FG003|COMPLETED|Overall Study||33
9027776|NCT03192176|10090062|FG004|COMPLETED|Overall Study||32
9027777|NCT03192176|10090063|FG005|COMPLETED|Overall Study||34
9027778|NCT03192176|10090064|FG006|COMPLETED|Overall Study||36
8769637|NCT01266967|9819772|FG000|STARTED|Overall Study||89
8769638|NCT01266967|9819773|FG001|STARTED|Overall Study||83
8769639|NCT01266967|9819772|FG000|COMPLETED|Overall Study||0
8769640|NCT01266967|9819773|FG001|COMPLETED|Overall Study||0
8769641|NCT01266967|9819772|FG000|NOT COMPLETED|Overall Study||89
8769642|NCT01266967|9819773|FG001|NOT COMPLETED|Overall Study||83
8769643|NCT01266993|9819784|FG000|STARTED|Persistence Phase (Month 32-44)||199
8769644|NCT01266993|9819785|FG001|STARTED|Persistence Phase (Month 32-44)||72
8769645|NCT01266993|9819784|FG000|COMPLETED|Persistence Phase (Month 32-44)||199
8769646|NCT01266993|9819785|FG001|COMPLETED|Persistence Phase (Month 32-44)||72
8769647|NCT01266993|9819784|FG000|NOT COMPLETED|Persistence Phase (Month 32-44)||0
8769648|NCT01266993|9819785|FG001|NOT COMPLETED|Persistence Phase (Month 32-44)||0
8769649|NCT01266993|9819784|FG000|STARTED|Persistence Phase (Month 44-56)||193
8769650|NCT01266993|9819785|FG001|STARTED|Persistence Phase (Month 44-56)||68
8769651|NCT01266993|9819784|FG000|COMPLETED|Persistence Phase (Month 44-56)||193
8769652|NCT01266993|9819785|FG001|COMPLETED|Persistence Phase (Month 44-56)||68
8769653|NCT01266993|9819784|FG000|NOT COMPLETED|Persistence Phase (Month 44-56)||0
8769654|NCT01266993|9819785|FG001|NOT COMPLETED|Persistence Phase (Month 44-56)||0
8769655|NCT01266993|9819784|FG000|STARTED|Persistence Phase (Month 56-68)||193
8769656|NCT01266993|9819785|FG001|STARTED|Persistence Phase (Month 56-68)||67
8769657|NCT01266993|9819784|FG000|COMPLETED|Persistence Phase (Month 56-68)||193
8769658|NCT01266993|9819785|FG001|COMPLETED|Persistence Phase (Month 56-68)||67
8769659|NCT01266993|9819784|FG000|NOT COMPLETED|Persistence Phase (Month 56-68)||0
8769660|NCT01266993|9819785|FG001|NOT COMPLETED|Persistence Phase (Month 56-68)||0
8769661|NCT01266993|9819784|FG000|STARTED|Booster Phase (Month 68-69)||179
8769662|NCT01266993|9819785|FG001|STARTED|Booster Phase (Month 68-69)||62
8769663|NCT01266993|9819784|FG000|COMPLETED|Booster Phase (Month 68-69)||174
8769664|NCT01266993|9819785|FG001|COMPLETED|Booster Phase (Month 68-69)||60
8769665|NCT01266993|9819784|FG000|NOT COMPLETED|Booster Phase (Month 68-69)||5
8769666|NCT01266993|9819785|FG001|NOT COMPLETED|Booster Phase (Month 68-69)||2
8769667|NCT01267019|9819794|FG000|STARTED|Overall Study||47
8769668|NCT01267019|9819795|FG001|STARTED|Overall Study||53
8769669|NCT01267019|9819796|FG002|STARTED|Overall Study||53
8769670|NCT01267019|9819794|FG000|COMPLETED|Overall Study||41
8769671|NCT01267019|9819795|FG001|COMPLETED|Overall Study||47
8769672|NCT01267019|9819796|FG002|COMPLETED|Overall Study||47
8769673|NCT01267019|9819794|FG000|NOT COMPLETED|Overall Study||6
8769674|NCT01267019|9819795|FG001|NOT COMPLETED|Overall Study||6
8769675|NCT01267019|9819796|FG002|NOT COMPLETED|Overall Study||6
8769676|NCT01267045|9819806|FG000|STARTED|2-month Outcomes||26
8769677|NCT01267045|9819807|FG001|STARTED|2-month Outcomes||29
8769678|NCT01267045|9819806|FG000|COMPLETED|2-month Outcomes||22
8769679|NCT01267045|9819807|FG001|COMPLETED|2-month Outcomes||26
8769680|NCT01267045|9819806|FG000|NOT COMPLETED|2-month Outcomes||4
8769681|NCT01267045|9819807|FG001|NOT COMPLETED|2-month Outcomes||3
8769682|NCT01267045|9819806|FG000|STARTED|6-month Outcome||22
8769683|NCT01267045|9819807|FG001|STARTED|6-month Outcome||26
8769684|NCT01267045|9819806|FG000|COMPLETED|6-month Outcome||22
8769685|NCT01267045|9819807|FG001|COMPLETED|6-month Outcome||23
8769686|NCT01267045|9819806|FG000|NOT COMPLETED|6-month Outcome||0
8769687|NCT01267045|9819807|FG001|NOT COMPLETED|6-month Outcome||3
8769688|NCT01267136|9819816|FG000|STARTED|Overall Study||42
9027779|NCT03192176|10090065|FG007|COMPLETED|Overall Study||37
9027780|NCT03192176|10090058|FG000|NOT COMPLETED|Overall Study||7
9027781|NCT03192176|10090059|FG001|NOT COMPLETED|Overall Study||5
9027782|NCT03192176|10090060|FG002|NOT COMPLETED|Overall Study||6
9027783|NCT03192176|10090061|FG003|NOT COMPLETED|Overall Study||12
9027784|NCT03192176|10090062|FG004|NOT COMPLETED|Overall Study||12
9027785|NCT03192176|10090063|FG005|NOT COMPLETED|Overall Study||11
9027786|NCT03192176|10090064|FG006|NOT COMPLETED|Overall Study||9
9027787|NCT03192176|10090065|FG007|NOT COMPLETED|Overall Study||7
9027788|NCT03192306|10090086|FG000|STARTED|Overall Study||227
9027789|NCT03192306|10090087|FG001|STARTED|Overall Study||224
9027790|NCT03192306|10090086|FG000|Modified Intent to Treat (MITT)|Overall Study||76
9027791|NCT03192306|10090087|FG001|Modified Intent to Treat (MITT)|Overall Study||80
9027792|NCT03192306|10090086|FG000|COMPLETED|Overall Study||75
9027793|NCT03192306|10090087|FG001|COMPLETED|Overall Study||79
9027794|NCT03192306|10090086|FG000|NOT COMPLETED|Overall Study||152
9027795|NCT03192306|10090087|FG001|NOT COMPLETED|Overall Study||145
9027796|NCT03192475|10090095|FG000|STARTED|Overall Study||162
9027797|NCT03192475|10090096|FG001|STARTED|Overall Study||160
8769689|NCT01267136|9819817|FG001|STARTED|Overall Study||42
8769690|NCT01267136|9819816|FG000|COMPLETED|Overall Study||38
8769691|NCT01267136|9819817|FG001|COMPLETED|Overall Study||36
8769692|NCT01267136|9819816|FG000|NOT COMPLETED|Overall Study||4
8769693|NCT01267136|9819817|FG001|NOT COMPLETED|Overall Study||6
9027798|NCT03192475|10090095|FG000|COMPLETED|Overall Study||149
9027799|NCT03192475|10090096|FG001|COMPLETED|Overall Study||151
9027800|NCT03192475|10090095|FG000|NOT COMPLETED|Overall Study||13
9027801|NCT03192475|10090096|FG001|NOT COMPLETED|Overall Study||9
9027802|NCT03192488|10090103|FG000|STARTED|First Intervention (d1)||1
9027803|NCT03192488|10090104|FG001|STARTED|First Intervention (d1)||5
9027804|NCT03192488|10090105|FG002|STARTED|First Intervention (d1)||2
9027805|NCT03192488|10090106|FG003|STARTED|First Intervention (d1)||1
9027806|NCT03192488|10090107|FG004|STARTED|First Intervention (d1)||1
9027807|NCT03192488|10090108|FG005|STARTED|First Intervention (d1)||1
9027808|NCT03192488|10090103|FG000|COMPLETED|First Intervention (d1)||1
8769694|NCT01267175|9819825|FG000|STARTED|Overall Study||31
8915941|NCT02178995|9975439|FG003|STARTED|Double Blind||6
8915942|NCT02178995|9975440|FG004|STARTED|Double Blind||6
8915943|NCT02178995|9975441|FG005|STARTED|Double Blind||6
8769695|NCT01267175|9819825|FG000|COMPLETED|Overall Study||29
8769696|NCT01267175|9819825|FG000|NOT COMPLETED|Overall Study||2
8769697|NCT01267201|9819829|FG000|STARTED|First Intervention Period||4
8769698|NCT01267201|9819830|FG001|STARTED|First Intervention Period||4
8769699|NCT01267201|9819831|FG002|STARTED|First Intervention Period||4
8769700|NCT01267201|9819832|FG003|STARTED|First Intervention Period||4
8769701|NCT01267201|9819833|FG004|STARTED|First Intervention Period||4
8769702|NCT01267201|9819834|FG005|STARTED|First Intervention Period||4
8769703|NCT01267201|9819829|FG000|COMPLETED|First Intervention Period||3
8769704|NCT01267201|9819830|FG001|COMPLETED|First Intervention Period||4
8769705|NCT01267201|9819831|FG002|COMPLETED|First Intervention Period||4
8769706|NCT01267201|9819832|FG003|COMPLETED|First Intervention Period||4
8769707|NCT01267201|9819833|FG004|COMPLETED|First Intervention Period||4
8769708|NCT01267201|9819834|FG005|COMPLETED|First Intervention Period||4
8769709|NCT01267201|9819829|FG000|NOT COMPLETED|First Intervention Period||1
8769710|NCT01267201|9819830|FG001|NOT COMPLETED|First Intervention Period||0
8769711|NCT01267201|9819831|FG002|NOT COMPLETED|First Intervention Period||0
8769712|NCT01267201|9819832|FG003|NOT COMPLETED|First Intervention Period||0
8769713|NCT01267201|9819833|FG004|NOT COMPLETED|First Intervention Period||0
8769714|NCT01267201|9819834|FG005|NOT COMPLETED|First Intervention Period||0
8769715|NCT01267201|9819829|FG000|STARTED|Washout Period (At Least 2 Days)||3
8769716|NCT01267201|9819830|FG001|STARTED|Washout Period (At Least 2 Days)||4
8769717|NCT01267201|9819831|FG002|STARTED|Washout Period (At Least 2 Days)||4
8769718|NCT01267201|9819832|FG003|STARTED|Washout Period (At Least 2 Days)||4
8769719|NCT01267201|9819833|FG004|STARTED|Washout Period (At Least 2 Days)||4
8769720|NCT01267201|9819834|FG005|STARTED|Washout Period (At Least 2 Days)||4
9027809|NCT03192488|10090104|FG001|COMPLETED|First Intervention (d1)||5
9027810|NCT03192488|10090105|FG002|COMPLETED|First Intervention (d1)||2
9027811|NCT03192488|10090106|FG003|COMPLETED|First Intervention (d1)||1
9027812|NCT03192488|10090107|FG004|COMPLETED|First Intervention (d1)||1
9027813|NCT03192488|10090108|FG005|COMPLETED|First Intervention (d1)||1
9027814|NCT03192488|10090103|FG000|NOT COMPLETED|First Intervention (d1)||0
9027815|NCT03192488|10090104|FG001|NOT COMPLETED|First Intervention (d1)||0
9027816|NCT03192488|10090105|FG002|NOT COMPLETED|First Intervention (d1)||0
9027817|NCT03192488|10090106|FG003|NOT COMPLETED|First Intervention (d1)||0
9027818|NCT03192488|10090107|FG004|NOT COMPLETED|First Intervention (d1)||0
9027819|NCT03192488|10090108|FG005|NOT COMPLETED|First Intervention (d1)||0
9027820|NCT03192488|10090103|FG000|STARTED|First Washout (>6d)||1
9027821|NCT03192488|10090104|FG001|STARTED|First Washout (>6d)||5
8808555|NCT01490723|9860776|FG000|STARTED|Overall Study||20
8808556|NCT01490723|9860776|FG000|COMPLETED|Overall Study||20
8808557|NCT01490723|9860776|FG000|NOT COMPLETED|Overall Study||0
8808558|NCT01490788|9860780|FG000|STARTED|Overall Study||5
8915944|NCT02178995|9975442|FG006|STARTED|Double Blind||5
8915945|NCT02178995|9975443|FG007|STARTED|Double Blind||6
8915946|NCT02178995|9975444|FG008|STARTED|Double Blind||1
8915947|NCT02178995|9975436|FG000|COMPLETED|Double Blind||0
8915948|NCT02178995|9975437|FG001|COMPLETED|Double Blind||15
8915949|NCT02178995|9975438|FG002|COMPLETED|Double Blind||5
8915950|NCT02178995|9975439|FG003|COMPLETED|Double Blind||6
8915951|NCT02178995|9975440|FG004|COMPLETED|Double Blind||6
8915952|NCT02178995|9975441|FG005|COMPLETED|Double Blind||5
8915953|NCT02178995|9975442|FG006|COMPLETED|Double Blind||5
8915954|NCT02178995|9975443|FG007|COMPLETED|Double Blind||4
8915955|NCT02178995|9975444|FG008|COMPLETED|Double Blind||0
8915956|NCT02178995|9975436|FG000|NOT COMPLETED|Double Blind||0
8915957|NCT02178995|9975437|FG001|NOT COMPLETED|Double Blind||1
8915958|NCT02178995|9975438|FG002|NOT COMPLETED|Double Blind||0
8915959|NCT02178995|9975439|FG003|NOT COMPLETED|Double Blind||0
8915960|NCT02178995|9975440|FG004|NOT COMPLETED|Double Blind||0
8915961|NCT02178995|9975441|FG005|NOT COMPLETED|Double Blind||1
8915962|NCT02178995|9975442|FG006|NOT COMPLETED|Double Blind||0
8915963|NCT02178995|9975443|FG007|NOT COMPLETED|Double Blind||2
8915964|NCT02178995|9975444|FG008|NOT COMPLETED|Double Blind||1
8915965|NCT02178995|9975436|FG000|STARTED|Open Label|2 declined to join open-label. 1 withdrew from double-blind but rejoined open-label due to benefit.|30
8915966|NCT02178995|9975437|FG001|STARTED|Open Label|One was lost to follow-up after completion of visit 4.|14
8915967|NCT02178995|9975438|FG002|STARTED|Open Label||0
8915968|NCT02178995|9975439|FG003|STARTED|Open Label||0
8915969|NCT02178995|9975440|FG004|STARTED|Open Label||0
8808559|NCT01490788|9860781|FG001|STARTED|Overall Study||5
8808560|NCT01490788|9860782|FG002|STARTED|Overall Study||5
8808561|NCT01490788|9860783|FG003|STARTED|Overall Study||5
8808562|NCT01490788|9860784|FG004|STARTED|Overall Study||5
8808563|NCT01490788|9860785|FG005|STARTED|Overall Study||5
8808564|NCT01490788|9860780|FG000|COMPLETED|Overall Study||4
8808565|NCT01490788|9860781|FG001|COMPLETED|Overall Study||5
8808566|NCT01490788|9860782|FG002|COMPLETED|Overall Study||5
8808567|NCT01490788|9860783|FG003|COMPLETED|Overall Study||5
8808568|NCT01490788|9860784|FG004|COMPLETED|Overall Study||5
8808569|NCT01490788|9860785|FG005|COMPLETED|Overall Study||5
8808570|NCT01490788|9860780|FG000|NOT COMPLETED|Overall Study||1
8808571|NCT01490788|9860781|FG001|NOT COMPLETED|Overall Study||0
8769721|NCT01267201|9819829|FG000|COMPLETED|Washout Period (At Least 2 Days)||3
8769722|NCT01267201|9819830|FG001|COMPLETED|Washout Period (At Least 2 Days)||4
8769723|NCT01267201|9819831|FG002|COMPLETED|Washout Period (At Least 2 Days)||4
8769724|NCT01267201|9819832|FG003|COMPLETED|Washout Period (At Least 2 Days)||4
8769725|NCT01267201|9819833|FG004|COMPLETED|Washout Period (At Least 2 Days)||4
8769726|NCT01267201|9819834|FG005|COMPLETED|Washout Period (At Least 2 Days)||4
8769727|NCT01267201|9819829|FG000|NOT COMPLETED|Washout Period (At Least 2 Days)||0
8769728|NCT01267201|9819830|FG001|NOT COMPLETED|Washout Period (At Least 2 Days)||0
8769729|NCT01267201|9819831|FG002|NOT COMPLETED|Washout Period (At Least 2 Days)||0
8769730|NCT01267201|9819832|FG003|NOT COMPLETED|Washout Period (At Least 2 Days)||0
8769731|NCT01267201|9819833|FG004|NOT COMPLETED|Washout Period (At Least 2 Days)||0
8769732|NCT01267201|9819834|FG005|NOT COMPLETED|Washout Period (At Least 2 Days)||0
8769733|NCT01267201|9819829|FG000|STARTED|Second Intervention Period||3
8769734|NCT01267201|9819830|FG001|STARTED|Second Intervention Period||4
8769735|NCT01267201|9819831|FG002|STARTED|Second Intervention Period||4
8769736|NCT01267201|9819832|FG003|STARTED|Second Intervention Period||4
8769737|NCT01267201|9819833|FG004|STARTED|Second Intervention Period||4
8769738|NCT01267201|9819834|FG005|STARTED|Second Intervention Period||4
8769739|NCT01267201|9819829|FG000|COMPLETED|Second Intervention Period||3
8769740|NCT01267201|9819830|FG001|COMPLETED|Second Intervention Period||3
8769741|NCT01267201|9819831|FG002|COMPLETED|Second Intervention Period||4
8769742|NCT01267201|9819832|FG003|COMPLETED|Second Intervention Period||4
8769743|NCT01267201|9819833|FG004|COMPLETED|Second Intervention Period||4
8769744|NCT01267201|9819834|FG005|COMPLETED|Second Intervention Period||4
8769745|NCT01267201|9819829|FG000|NOT COMPLETED|Second Intervention Period||0
8769746|NCT01267201|9819830|FG001|NOT COMPLETED|Second Intervention Period||1
8769747|NCT01267201|9819831|FG002|NOT COMPLETED|Second Intervention Period||0
8769748|NCT01267201|9819832|FG003|NOT COMPLETED|Second Intervention Period||0
8769749|NCT01267201|9819833|FG004|NOT COMPLETED|Second Intervention Period||0
8769750|NCT01267201|9819834|FG005|NOT COMPLETED|Second Intervention Period||0
8769751|NCT01267201|9819829|FG000|STARTED|Washout Period (At Least 2 Days)||3
8769752|NCT01267201|9819830|FG001|STARTED|Washout Period (At Least 2 Days)||3
8769753|NCT01267201|9819831|FG002|STARTED|Washout Period (At Least 2 Days)||4
8769754|NCT01267201|9819832|FG003|STARTED|Washout Period (At Least 2 Days)||4
8769755|NCT01267201|9819833|FG004|STARTED|Washout Period (At Least 2 Days)||4
8769756|NCT01267201|9819834|FG005|STARTED|Washout Period (At Least 2 Days)||4
8769757|NCT01267201|9819829|FG000|COMPLETED|Washout Period (At Least 2 Days)||3
8769758|NCT01267201|9819830|FG001|COMPLETED|Washout Period (At Least 2 Days)||3
8769759|NCT01267201|9819831|FG002|COMPLETED|Washout Period (At Least 2 Days)||4
8769760|NCT01267201|9819832|FG003|COMPLETED|Washout Period (At Least 2 Days)||4
8769761|NCT01267201|9819833|FG004|COMPLETED|Washout Period (At Least 2 Days)||4
8769762|NCT01267201|9819834|FG005|COMPLETED|Washout Period (At Least 2 Days)||4
8769763|NCT01267201|9819829|FG000|NOT COMPLETED|Washout Period (At Least 2 Days)||0
8769764|NCT01267201|9819830|FG001|NOT COMPLETED|Washout Period (At Least 2 Days)||0
8769765|NCT01267201|9819831|FG002|NOT COMPLETED|Washout Period (At Least 2 Days)||0
8769766|NCT01267201|9819832|FG003|NOT COMPLETED|Washout Period (At Least 2 Days)||0
8769767|NCT01267201|9819833|FG004|NOT COMPLETED|Washout Period (At Least 2 Days)||0
8769768|NCT01267201|9819834|FG005|NOT COMPLETED|Washout Period (At Least 2 Days)||0
8769769|NCT01267201|9819829|FG000|STARTED|Third Intervention Period||3
8769770|NCT01267201|9819830|FG001|STARTED|Third Intervention Period||3
8769771|NCT01267201|9819831|FG002|STARTED|Third Intervention Period||4
8769772|NCT01267201|9819832|FG003|STARTED|Third Intervention Period||4
8769773|NCT01267201|9819833|FG004|STARTED|Third Intervention Period||4
8769774|NCT01267201|9819834|FG005|STARTED|Third Intervention Period||4
8769775|NCT01267201|9819829|FG000|COMPLETED|Third Intervention Period||3
8769776|NCT01267201|9819830|FG001|COMPLETED|Third Intervention Period||3
8769777|NCT01267201|9819831|FG002|COMPLETED|Third Intervention Period||4
8769778|NCT01267201|9819832|FG003|COMPLETED|Third Intervention Period||4
8769779|NCT01267201|9819833|FG004|COMPLETED|Third Intervention Period||4
8769780|NCT01267201|9819834|FG005|COMPLETED|Third Intervention Period||4
8769781|NCT01267201|9819829|FG000|NOT COMPLETED|Third Intervention Period||0
8769782|NCT01267201|9819830|FG001|NOT COMPLETED|Third Intervention Period||0
8769783|NCT01267201|9819831|FG002|NOT COMPLETED|Third Intervention Period||0
8769784|NCT01267201|9819832|FG003|NOT COMPLETED|Third Intervention Period||0
8769785|NCT01267201|9819833|FG004|NOT COMPLETED|Third Intervention Period||0
8769786|NCT01267201|9819834|FG005|NOT COMPLETED|Third Intervention Period||0
8769787|NCT01267227|9819846|FG000|STARTED|Overall Study||20
8769788|NCT01267227|9819847|FG001|STARTED|Overall Study||20
8769789|NCT01267227|9819848|FG002|STARTED|Overall Study||20
8769790|NCT01267227|9819849|FG003|STARTED|Overall Study||20
8769791|NCT01267227|9819846|FG000|COMPLETED|Overall Study||19
8769792|NCT01267227|9819847|FG001|COMPLETED|Overall Study||19
8769793|NCT01267227|9819848|FG002|COMPLETED|Overall Study||18
8769794|NCT01267227|9819849|FG003|COMPLETED|Overall Study||17
8769795|NCT01267227|9819846|FG000|NOT COMPLETED|Overall Study||1
8769796|NCT01267227|9819847|FG001|NOT COMPLETED|Overall Study||1
8769797|NCT01267227|9819848|FG002|NOT COMPLETED|Overall Study||2
8769798|NCT01267227|9819849|FG003|NOT COMPLETED|Overall Study||3
8769799|NCT01267240|9819863|FG000|STARTED|Overall Study||25
8769800|NCT01267240|9819863|FG000|COMPLETED|Overall Study||25
8769801|NCT01267240|9819863|FG000|NOT COMPLETED|Overall Study||0
8769802|NCT01267253|9819867|FG000|STARTED|Overall Study||31
8769803|NCT01267253|9819867|FG000|COMPLETED|Overall Study|Eligible and treated patients|28
8769804|NCT01267253|9819867|FG000|NOT COMPLETED|Overall Study||3
8769805|NCT01267266|9819871|FG000|STARTED|Enrollment Phase||33
8769806|NCT01267266|9819872|FG001|STARTED|Enrollment Phase||0
8769807|NCT01267266|9819871|FG000|COMPLETED|Enrollment Phase|Two patients signed consent but did not proceed to treatment.|31
8769808|NCT01267266|9819872|FG001|COMPLETED|Enrollment Phase||0
8769809|NCT01267266|9819871|FG000|NOT COMPLETED|Enrollment Phase||2
8769810|NCT01267266|9819872|FG001|NOT COMPLETED|Enrollment Phase||0
8769811|NCT01267266|9819871|FG000|STARTED|Lead-in Phase||31
8769812|NCT01267266|9819872|FG001|STARTED|Lead-in Phase||0
8769813|NCT01267266|9819871|FG000|COMPLETED|Lead-in Phase|12 patients had radiographic progression, 8 clinical progression, 2 toxicity, 1 withdrawal.|8
8769814|NCT01267266|9819872|FG001|COMPLETED|Lead-in Phase||0
8769815|NCT01267266|9819871|FG000|NOT COMPLETED|Lead-in Phase||23
8769816|NCT01267266|9819872|FG001|NOT COMPLETED|Lead-in Phase||0
8769817|NCT01267266|9819871|FG000|STARTED|Randomized Phase|3 of 8 patients randomized to saracatinib.|3
8769818|NCT01267266|9819872|FG001|STARTED|Randomized Phase|5 of 8 patients randomized to placebo.|5
8769819|NCT01267266|9819871|FG000|COMPLETED|Randomized Phase||3
8769820|NCT01267266|9819872|FG001|COMPLETED|Randomized Phase||5
8769821|NCT01267266|9819871|FG000|NOT COMPLETED|Randomized Phase||0
8769822|NCT01267266|9819872|FG001|NOT COMPLETED|Randomized Phase||0
8769823|NCT01267279|9819883|FG000|STARTED|Overall Study||24
8769824|NCT01267279|9819884|FG001|STARTED|Overall Study||27
8769825|NCT01267279|9819883|FG000|COMPLETED|Overall Study||22
8769826|NCT01267279|9819884|FG001|COMPLETED|Overall Study||21
8769827|NCT01267279|9819883|FG000|NOT COMPLETED|Overall Study||2
8769828|NCT01267279|9819884|FG001|NOT COMPLETED|Overall Study||6
8769829|NCT01267292|9819892|FG000|STARTED|Overall Study||24
8769830|NCT01267292|9819893|FG001|STARTED|Overall Study||26
8769831|NCT01267292|9819892|FG000|COMPLETED|Overall Study||20
8769832|NCT01267292|9819893|FG001|COMPLETED|Overall Study||20
8769833|NCT01267292|9819892|FG000|NOT COMPLETED|Overall Study||4
8769834|NCT01267292|9819893|FG001|NOT COMPLETED|Overall Study||6
8769835|NCT01267422|9819899|FG000|STARTED|Intravitreal rAAV2-ND4 Injection||5
8769836|NCT01267422|9819900|FG001|STARTED|Intravitreal rAAV2-ND4 Injection||4
8769837|NCT01267422|9819899|FG000|COMPLETED|Intravitreal rAAV2-ND4 Injection||5
8769838|NCT01267422|9819900|FG001|COMPLETED|Intravitreal rAAV2-ND4 Injection||4
8769839|NCT01267422|9819899|FG000|NOT COMPLETED|Intravitreal rAAV2-ND4 Injection||0
8769840|NCT01267422|9819900|FG001|NOT COMPLETED|Intravitreal rAAV2-ND4 Injection||0
8769841|NCT01267422|9819899|FG000|STARTED|Safety and Efficacy Study||5
8769842|NCT01267422|9819900|FG001|STARTED|Safety and Efficacy Study||4
8769843|NCT01267422|9819899|FG000|COMPLETED|Safety and Efficacy Study||5
8769844|NCT01267422|9819900|FG001|COMPLETED|Safety and Efficacy Study||4
8769845|NCT01267422|9819899|FG000|NOT COMPLETED|Safety and Efficacy Study||0
8769846|NCT01267422|9819900|FG001|NOT COMPLETED|Safety and Efficacy Study||0
8769847|NCT01267656|9819918|FG000|STARTED|Overall Study||83
8769848|NCT01267656|9819919|FG001|STARTED|Overall Study||83
8769849|NCT01267656|9819918|FG000|COMPLETED|Overall Study||82
8769850|NCT01267656|9819919|FG001|COMPLETED|Overall Study||82
8769851|NCT01267656|9819918|FG000|NOT COMPLETED|Overall Study||1
8769852|NCT01267656|9819919|FG001|NOT COMPLETED|Overall Study||1
8769853|NCT01267864|9819928|FG000|STARTED|Overall Study||110
8769854|NCT01267864|9819929|FG001|STARTED|Overall Study||110
8769855|NCT01267864|9819930|FG002|STARTED|Overall Study||110
8769856|NCT01267864|9819928|FG000|COMPLETED|Overall Study||110
8769857|NCT01267864|9819929|FG001|COMPLETED|Overall Study||110
8769858|NCT01267864|9819930|FG002|COMPLETED|Overall Study||110
8769859|NCT01267864|9819928|FG000|NOT COMPLETED|Overall Study||0
8769860|NCT01267864|9819929|FG001|NOT COMPLETED|Overall Study||0
8769861|NCT01267864|9819930|FG002|NOT COMPLETED|Overall Study||0
8769862|NCT01267929|9819940|FG000|STARTED|Overall Study||15
8769863|NCT01267929|9819941|FG001|STARTED|Overall Study||15
8769864|NCT01267929|9819940|FG000|COMPLETED|Overall Study||15
8769865|NCT01267929|9819941|FG001|COMPLETED|Overall Study||15
8769866|NCT01267929|9819940|FG000|NOT COMPLETED|Overall Study||0
8769867|NCT01267929|9819941|FG001|NOT COMPLETED|Overall Study||0
8769868|NCT01267994|9819947|FG000|STARTED|Overall Study|Declined to participate. n=1 Did not receive intervention due to infeciton, n=1|12
8769869|NCT01267994|9819947|FG000|COMPLETED|Overall Study|Excluded from analysis, could not reach first milestone (day 28) for efficacy assessment, n=2|10
8769870|NCT01267994|9819947|FG000|NOT COMPLETED|Overall Study||2
8769871|NCT01268046|9819956|FG000|STARTED|Overall Study||13
8769872|NCT01268046|9819957|FG001|STARTED|Overall Study||9
8769873|NCT01268046|9819958|FG002|STARTED|Overall Study||8
8769874|NCT01268046|9819959|FG003|STARTED|Overall Study||8
8769875|NCT01268046|9819956|FG000|COMPLETED|Overall Study||12
8769876|NCT01268046|9819957|FG001|COMPLETED|Overall Study||9
8769877|NCT01268046|9819958|FG002|COMPLETED|Overall Study||7
8769878|NCT01268046|9819959|FG003|COMPLETED|Overall Study||7
8769879|NCT01268046|9819956|FG000|NOT COMPLETED|Overall Study||1
8769880|NCT01268046|9819957|FG001|NOT COMPLETED|Overall Study||0
8769881|NCT01268046|9819958|FG002|NOT COMPLETED|Overall Study||1
8769882|NCT01268046|9819959|FG003|NOT COMPLETED|Overall Study||1
8769883|NCT01268059|9819973|FG000|STARTED|Overall Study||40
8769884|NCT01268059|9819974|FG001|STARTED|Overall Study|Arm applicable for both dose-determination (Phase 1b) and randomization phase (Phase 2) of study.|45
8769885|NCT01268059|9819975|FG002|STARTED|Overall Study||6
8769886|NCT01268059|9819976|FG003|STARTED|Overall Study||8
8769887|NCT01268059|9819973|FG000|COMPLETED|Overall Study|End of study defined as 14 months from the last participant enrolled, or sponsor stopped the study.|12
8769888|NCT01268059|9819974|FG001|COMPLETED|Overall Study|End of study defined as 14 months from the last participant enrolled, or sponsor stopped the study.|10
8769889|NCT01268059|9819975|FG002|COMPLETED|Overall Study|End of study defined as 14 months from the last participant enrolled, or sponsor stopped the study.|3
8769890|NCT01268059|9819976|FG003|COMPLETED|Overall Study|End of study defined as 14 months from the last participant enrolled, or sponsor stopped the study.|3
8769891|NCT01268059|9819973|FG000|NOT COMPLETED|Overall Study||28
8769892|NCT01268059|9819974|FG001|NOT COMPLETED|Overall Study||35
8769893|NCT01268059|9819975|FG002|NOT COMPLETED|Overall Study||3
8769894|NCT01268059|9819976|FG003|NOT COMPLETED|Overall Study||5
8769895|NCT01268098|9819991|FG000|STARTED|Overall Study||19
8769896|NCT01268098|9819992|FG001|STARTED|Overall Study||23
8769897|NCT01268098|9819991|FG000|COMPLETED|Overall Study||18
8769898|NCT01268098|9819992|FG001|COMPLETED|Overall Study||23
8769899|NCT01268098|9819991|FG000|NOT COMPLETED|Overall Study||1
8769900|NCT01268098|9819992|FG001|NOT COMPLETED|Overall Study||0
9027822|NCT03192488|10090105|FG002|STARTED|First Washout (>6d)||2
9027823|NCT03192488|10090106|FG003|STARTED|First Washout (>6d)||1
9027824|NCT03192488|10090107|FG004|STARTED|First Washout (>6d)||1
9027825|NCT03192488|10090108|FG005|STARTED|First Washout (>6d)||1
9027826|NCT03192488|10090103|FG000|COMPLETED|First Washout (>6d)||1
9027827|NCT03192488|10090104|FG001|COMPLETED|First Washout (>6d)||5
9027828|NCT03192488|10090105|FG002|COMPLETED|First Washout (>6d)||1
9027829|NCT03192488|10090106|FG003|COMPLETED|First Washout (>6d)||1
9027830|NCT03192488|10090107|FG004|COMPLETED|First Washout (>6d)||1
9027831|NCT03192488|10090108|FG005|COMPLETED|First Washout (>6d)||0
9027832|NCT03192488|10090103|FG000|NOT COMPLETED|First Washout (>6d)||0
9027833|NCT03192488|10090104|FG001|NOT COMPLETED|First Washout (>6d)||0
9027834|NCT03192488|10090105|FG002|NOT COMPLETED|First Washout (>6d)||1
9027835|NCT03192488|10090106|FG003|NOT COMPLETED|First Washout (>6d)||0
9027836|NCT03192488|10090107|FG004|NOT COMPLETED|First Washout (>6d)||0
9027837|NCT03192488|10090108|FG005|NOT COMPLETED|First Washout (>6d)||1
9027838|NCT03192488|10090103|FG000|STARTED|Second Intervention (d1)||1
9027839|NCT03192488|10090104|FG001|STARTED|Second Intervention (d1)||5
9027840|NCT03192488|10090105|FG002|STARTED|Second Intervention (d1)||1
9027841|NCT03192488|10090106|FG003|STARTED|Second Intervention (d1)||1
9027842|NCT03192488|10090107|FG004|STARTED|Second Intervention (d1)||1
9027843|NCT03192488|10090108|FG005|STARTED|Second Intervention (d1)||0
9027844|NCT03192488|10090103|FG000|COMPLETED|Second Intervention (d1)||1
9027845|NCT03192488|10090104|FG001|COMPLETED|Second Intervention (d1)||5
9027846|NCT03192488|10090105|FG002|COMPLETED|Second Intervention (d1)||1
9027847|NCT03192488|10090106|FG003|COMPLETED|Second Intervention (d1)||1
9027848|NCT03192488|10090107|FG004|COMPLETED|Second Intervention (d1)||1
9027849|NCT03192488|10090108|FG005|COMPLETED|Second Intervention (d1)||0
9027850|NCT03192488|10090103|FG000|NOT COMPLETED|Second Intervention (d1)||0
9027851|NCT03192488|10090104|FG001|NOT COMPLETED|Second Intervention (d1)||0
9027852|NCT03192488|10090105|FG002|NOT COMPLETED|Second Intervention (d1)||0
9027853|NCT03192488|10090106|FG003|NOT COMPLETED|Second Intervention (d1)||0
9027854|NCT03192488|10090107|FG004|NOT COMPLETED|Second Intervention (d1)||0
9027855|NCT03192488|10090108|FG005|NOT COMPLETED|Second Intervention (d1)||0
9027856|NCT03192488|10090103|FG000|STARTED|Second Washout (>6d)||1
9027857|NCT03192488|10090104|FG001|STARTED|Second Washout (>6d)||5
9027858|NCT03192488|10090105|FG002|STARTED|Second Washout (>6d)||1
9027859|NCT03192488|10090106|FG003|STARTED|Second Washout (>6d)||1
9027860|NCT03192488|10090107|FG004|STARTED|Second Washout (>6d)||1
9027861|NCT03192488|10090108|FG005|STARTED|Second Washout (>6d)||0
9027862|NCT03192488|10090103|FG000|COMPLETED|Second Washout (>6d)||1
9027863|NCT03192488|10090104|FG001|COMPLETED|Second Washout (>6d)||5
9027864|NCT03192488|10090105|FG002|COMPLETED|Second Washout (>6d)||1
9027865|NCT03192488|10090106|FG003|COMPLETED|Second Washout (>6d)||1
9027866|NCT03192488|10090107|FG004|COMPLETED|Second Washout (>6d)||1
9027867|NCT03192488|10090108|FG005|COMPLETED|Second Washout (>6d)||0
9027868|NCT03192488|10090103|FG000|NOT COMPLETED|Second Washout (>6d)||0
9027869|NCT03192488|10090104|FG001|NOT COMPLETED|Second Washout (>6d)||0
9027870|NCT03192488|10090105|FG002|NOT COMPLETED|Second Washout (>6d)||0
9027871|NCT03192488|10090106|FG003|NOT COMPLETED|Second Washout (>6d)||0
9027872|NCT03192488|10090107|FG004|NOT COMPLETED|Second Washout (>6d)||0
9027873|NCT03192488|10090108|FG005|NOT COMPLETED|Second Washout (>6d)||0
9027874|NCT03192488|10090103|FG000|STARTED|Third Intervention (d1)||1
9027875|NCT03192488|10090104|FG001|STARTED|Third Intervention (d1)||5
9027876|NCT03192488|10090105|FG002|STARTED|Third Intervention (d1)||1
9027877|NCT03192488|10090106|FG003|STARTED|Third Intervention (d1)||1
8769901|NCT01268111|9820000|FG000|STARTED|Overall Study||6
9027878|NCT03192488|10090107|FG004|STARTED|Third Intervention (d1)||1
9027879|NCT03192488|10090108|FG005|STARTED|Third Intervention (d1)||0
9027880|NCT03192488|10090103|FG000|COMPLETED|Third Intervention (d1)||1
9027881|NCT03192488|10090104|FG001|COMPLETED|Third Intervention (d1)||5
9027882|NCT03192488|10090105|FG002|COMPLETED|Third Intervention (d1)||1
9027883|NCT03192488|10090106|FG003|COMPLETED|Third Intervention (d1)||1
9027884|NCT03192488|10090107|FG004|COMPLETED|Third Intervention (d1)||0
9027885|NCT03192488|10090108|FG005|COMPLETED|Third Intervention (d1)||0
9027886|NCT03192488|10090103|FG000|NOT COMPLETED|Third Intervention (d1)||0
9027887|NCT03192488|10090104|FG001|NOT COMPLETED|Third Intervention (d1)||0
9027888|NCT03192488|10090105|FG002|NOT COMPLETED|Third Intervention (d1)||0
8769902|NCT01268111|9820001|FG001|STARTED|Overall Study||6
8769903|NCT01268111|9820000|FG000|COMPLETED|Overall Study||6
8769904|NCT01268111|9820001|FG001|COMPLETED|Overall Study||6
8769905|NCT01268111|9820000|FG000|NOT COMPLETED|Overall Study||0
8769906|NCT01268111|9820001|FG001|NOT COMPLETED|Overall Study||0
8769907|NCT01268150|9820007|FG000|STARTED|Treatment Phase||56
8769908|NCT01268150|9820007|FG000|COMPLETED|Treatment Phase||28
8769909|NCT01268150|9820007|FG000|NOT COMPLETED|Treatment Phase||28
8769910|NCT01268150|9820007|FG000|STARTED|Extension Phase|28 participants discontinued study drug in Treatment Phase so did not enter the Extension Phase|28
8769911|NCT01268150|9820007|FG000|Treatment Ongoing at Data Cutoff Date|Extension Phase||1
8769912|NCT01268150|9820007|FG000|COMPLETED|Extension Phase||1
8769913|NCT01268150|9820007|FG000|NOT COMPLETED|Extension Phase||27
8769914|NCT01268189|9820011|FG000|STARTED|Overall Study||20
8769915|NCT01268189|9820011|FG000|COMPLETED|Overall Study||17
8769916|NCT01268189|9820011|FG000|NOT COMPLETED|Overall Study||3
8769917|NCT01268267|9820017|FG000|STARTED|Overall Study||94
8769918|NCT01268267|9820017|FG000|COMPLETED|Overall Study||93
8769919|NCT01268267|9820017|FG000|NOT COMPLETED|Overall Study||1
8769920|NCT01268293|9820022|FG000|STARTED|Overall Study||9
8769921|NCT01268293|9820022|FG000|Completed Cycle 1|Overall Study||9
8769922|NCT01268293|9820022|FG000|COMPLETED|Overall Study||0
8769923|NCT01268293|9820022|FG000|NOT COMPLETED|Overall Study||9
8769924|NCT01268306|9820026|FG000|STARTED|Overall Study||8
8769925|NCT01268306|9820026|FG000|COMPLETED|Overall Study||7
8769926|NCT01268306|9820026|FG000|NOT COMPLETED|Overall Study||1
8769927|NCT01268488|9820030|FG000|STARTED|Overall Study||98
8769928|NCT01268488|9820030|FG000|COMPLETED|Overall Study||93
8769929|NCT01268488|9820030|FG000|NOT COMPLETED|Overall Study||5
8769930|NCT01268501|9820035|FG000|STARTED|Overall Study||96
8769931|NCT01268501|9820035|FG000|COMPLETED|Overall Study||87
8769932|NCT01268501|9820035|FG000|NOT COMPLETED|Overall Study||9
8769933|NCT01268514|9820039|FG000|STARTED|Overall Study||115
8769934|NCT01268514|9820039|FG000|Participants Who Received the Device|Overall Study||114
8769935|NCT01268514|9820039|FG000|COMPLETED|Overall Study||74
8769936|NCT01268514|9820039|FG000|NOT COMPLETED|Overall Study||41
8769937|NCT01268527|9820047|FG000|STARTED|Overall Study||15
8769938|NCT01268527|9820048|FG001|STARTED|Overall Study||15
8769939|NCT01268527|9820047|FG000|COMPLETED|Overall Study||15
8769940|NCT01268527|9820048|FG001|COMPLETED|Overall Study||15
8769941|NCT01268527|9820047|FG000|NOT COMPLETED|Overall Study||0
8769942|NCT01268527|9820048|FG001|NOT COMPLETED|Overall Study||0
8769943|NCT01268553|9820067|FG000|STARTED|Overall Study||6
8769944|NCT01268553|9820067|FG000|COMPLETED|Overall Study||6
8769945|NCT01268553|9820067|FG000|NOT COMPLETED|Overall Study||0
8769946|NCT01268566|9820071|FG000|STARTED|Overall Study||56
8769947|NCT01268566|9820071|FG000|COMPLETED|Overall Study||13
8769948|NCT01268566|9820071|FG000|NOT COMPLETED|Overall Study||43
8769949|NCT01268644|9820075|FG000|STARTED|Baseline Period (Week 0)||8
8769950|NCT01268644|9820075|FG000|COMPLETED|Baseline Period (Week 0)||8
8769951|NCT01268644|9820075|FG000|NOT COMPLETED|Baseline Period (Week 0)||0
8769952|NCT01268644|9820075|FG000|STARTED|Phase A (Weeks 0-12) Leptin Therapy||8
8769953|NCT01268644|9820075|FG000|COMPLETED|Phase A (Weeks 0-12) Leptin Therapy||8
8769954|NCT01268644|9820075|FG000|NOT COMPLETED|Phase A (Weeks 0-12) Leptin Therapy||0
8769955|NCT01268644|9820075|FG000|STARTED|Phase B (Weeks 12-20) Leptin Therapy|One subject withdrew after 12 weeks .|7
8769956|NCT01268644|9820075|FG000|COMPLETED|Phase B (Weeks 12-20) Leptin Therapy||7
8769957|NCT01268644|9820075|FG000|NOT COMPLETED|Phase B (Weeks 12-20) Leptin Therapy||0
8769958|NCT01268644|9820075|FG000|STARTED|Phase C (Weeks 20-24) Off Leptin Therapy||7
8769959|NCT01268644|9820075|FG000|COMPLETED|Phase C (Weeks 20-24) Off Leptin Therapy||7
8769960|NCT01268644|9820075|FG000|NOT COMPLETED|Phase C (Weeks 20-24) Off Leptin Therapy||0
8769961|NCT01268683|9820082|FG000|STARTED|Overall Study||10
8769962|NCT01268683|9820082|FG000|COMPLETED|Overall Study||8
8769963|NCT01268683|9820082|FG000|NOT COMPLETED|Overall Study||2
8769964|NCT01268891|9820088|FG000|STARTED|Overall Study||66
8769965|NCT01268891|9820089|FG001|STARTED|Overall Study||66
8769966|NCT01268891|9820088|FG000|COMPLETED|Overall Study||58
8769967|NCT01268891|9820089|FG001|COMPLETED|Overall Study||58
8769968|NCT01268891|9820088|FG000|NOT COMPLETED|Overall Study||8
8769969|NCT01268891|9820089|FG001|NOT COMPLETED|Overall Study||8
8769970|NCT01268943|9820099|FG000|STARTED|Overall Study||6
8769971|NCT01268943|9820100|FG001|STARTED|Overall Study||3
8769972|NCT01268943|9820101|FG002|STARTED|Overall Study||3
8769973|NCT01268943|9820102|FG003|STARTED|Overall Study||6
8769974|NCT01268943|9820099|FG000|COMPLETED|Overall Study||6
8769975|NCT01268943|9820100|FG001|COMPLETED|Overall Study||3
8769976|NCT01268943|9820101|FG002|COMPLETED|Overall Study||3
8769977|NCT01268943|9820102|FG003|COMPLETED|Overall Study||6
8769978|NCT01268943|9820099|FG000|NOT COMPLETED|Overall Study||0
8769979|NCT01268943|9820100|FG001|NOT COMPLETED|Overall Study||0
8769980|NCT01268943|9820101|FG002|NOT COMPLETED|Overall Study||0
8769981|NCT01268943|9820102|FG003|NOT COMPLETED|Overall Study||0
8769982|NCT01269047|9820115|FG000|STARTED|Overall Study||13
8769983|NCT01269047|9820116|FG001|STARTED|Overall Study||13
8769984|NCT01269047|9820117|FG002|STARTED|Overall Study||11
8769985|NCT01269047|9820115|FG000|COMPLETED|Overall Study||12
8769986|NCT01269047|9820116|FG001|COMPLETED|Overall Study||11
8769987|NCT01269047|9820117|FG002|COMPLETED|Overall Study||10
8769988|NCT01269047|9820115|FG000|NOT COMPLETED|Overall Study||1
8769989|NCT01269047|9820116|FG001|NOT COMPLETED|Overall Study||2
8769990|NCT01269047|9820117|FG002|NOT COMPLETED|Overall Study||1
8769991|NCT01269125|9820130|FG000|STARTED|Overall Study||60
8769992|NCT01269125|9820131|FG001|STARTED|Overall Study||60
8769993|NCT01269125|9820132|FG002|STARTED|Overall Study||60
8769994|NCT01269125|9820130|FG000|COMPLETED|Overall Study|lost to follow up:4; OHSS: 2; premature luteinization: 1|53
8769995|NCT01269125|9820131|FG001|COMPLETED|Overall Study|OHSS:4; premature luteinization: 1|55
8769996|NCT01269125|9820132|FG002|COMPLETED|Overall Study||60
8769997|NCT01269125|9820130|FG000|NOT COMPLETED|Overall Study||7
8769998|NCT01269125|9820131|FG001|NOT COMPLETED|Overall Study||5
8769999|NCT01269125|9820132|FG002|NOT COMPLETED|Overall Study||0
8770000|NCT01269346|9820140|FG000|STARTED|Treatment Phase||52
8770001|NCT01269346|9820140|FG000|Completed 6 Cycles|Treatment Phase||45
8770002|NCT01269346|9820140|FG000|COMPLETED|Treatment Phase||43
8770003|NCT01269346|9820140|FG000|NOT COMPLETED|Treatment Phase||9
8770004|NCT01269346|9820140|FG000|STARTED|Extension Phase|Out of 52 participants randomized, only 43 continued into the Extension Phase of the study.|43
8770005|NCT01269346|9820140|FG000|COMPLETED|Extension Phase||0
8770006|NCT01269346|9820140|FG000|NOT COMPLETED|Extension Phase||43
8770007|NCT01269372|9820145|FG000|STARTED|Overall Study||30
8770008|NCT01269372|9820145|FG000|COMPLETED|Overall Study||30
8770009|NCT01269372|9820145|FG000|NOT COMPLETED|Overall Study||0
8770010|NCT01269385|9820154|FG000|STARTED|Overall Study||4
8770011|NCT01269385|9820155|FG001|STARTED|Overall Study||4
8770012|NCT01269385|9820156|FG002|STARTED|Overall Study||6
8770013|NCT01269385|9820157|FG003|STARTED|Overall Study||8
8770014|NCT01269385|9820154|FG000|COMPLETED|Overall Study||3
8770015|NCT01269385|9820155|FG001|COMPLETED|Overall Study||3
8770016|NCT01269385|9820156|FG002|COMPLETED|Overall Study||6
8770017|NCT01269385|9820157|FG003|COMPLETED|Overall Study||8
8770018|NCT01269385|9820154|FG000|NOT COMPLETED|Overall Study||1
8770019|NCT01269385|9820155|FG001|NOT COMPLETED|Overall Study||1
8770020|NCT01269385|9820156|FG002|NOT COMPLETED|Overall Study||0
8770021|NCT01269385|9820157|FG003|NOT COMPLETED|Overall Study||0
8770022|NCT01269710|9820167|FG000|STARTED|Overall Study||4
8770023|NCT01269710|9820167|FG000|Week 12|Overall Study||3
8770024|NCT01269710|9820167|FG000|Week 36|Overall Study||2
8770025|NCT01269710|9820167|FG000|COMPLETED|Overall Study|This refers to Week 52.|1
8770026|NCT01269710|9820167|FG000|NOT COMPLETED|Overall Study||3
8770027|NCT01269736|9820173|FG000|STARTED|Nurses' Knowledge Assessments|873 unique nurses were assessed at 9 hospitals at the initiation of the study.|1585
8770028|NCT01269736|9820174|FG001|STARTED|Nurses' Knowledge Assessments|866 unique nurses were assessed at 8 hospitals at the initiation of the study.|1428
8770029|NCT01269736|9820173|FG000|Baseline Assessment|Nurses' Knowledge Assessments|873 unique nurses, assessed at 9 hospitals.|873
8770030|NCT01269736|9820174|FG001|Baseline Assessment|Nurses' Knowledge Assessments|866 unique nurses, assessed at 8 hospitals.|866
8770031|NCT01269736|9820173|FG000|15 Months Assessment|Nurses' Knowledge Assessments|1108 unique nurses, assessed at 9 hospitals.|1108
8770032|NCT01269736|9820174|FG001|15 Months Assessment|Nurses' Knowledge Assessments|866 unique nurses, assessed at 8 hospitals.|782
8770033|NCT01269736|9820173|FG000|30 Months Assessment|Nurses' Knowledge Assessments|741 unique nurses, assessed at 8 hospitals.|741
8770034|NCT01269736|9820174|FG001|30 Months Assessment|Nurses' Knowledge Assessments|926 unique nurses, assessed at 8 hospitals.|926
8770035|NCT01269736|9820173|FG000|COMPLETED|Nurses' Knowledge Assessments|1585 unique nurses assessed overall (at any time point) by end of study.|1585
8770036|NCT01269736|9820174|FG001|COMPLETED|Nurses' Knowledge Assessments|1428 unique nurses assessed overall (at any time point) by end of study.|1428
8770037|NCT01269736|9820173|FG000|NOT COMPLETED|Nurses' Knowledge Assessments||0
8770038|NCT01269736|9820174|FG001|NOT COMPLETED|Nurses' Knowledge Assessments||0
8770039|NCT01269736|9820173|FG000|STARTED|Patient Quality of Care Assessments|915 unique patients were assessed at 9 hospitals at the initiation of the study.|2299
8770040|NCT01269736|9820174|FG001|STARTED|Patient Quality of Care Assessments|889 unique patients were assessed at 8 hospitals at the initiation of the study.|2288
8770041|NCT01269736|9820173|FG000|Baseline Assessment|Patient Quality of Care Assessments|915 unique patients, assessed at 9 hospitals.|915
8770042|NCT01269736|9820174|FG001|Baseline Assessment|Patient Quality of Care Assessments|889 unique patients, assessed at 8 hospitals.|889
8770043|NCT01269736|9820173|FG000|15 Months Assessment|Patient Quality of Care Assessments|687 unique patients, assessed at 8 hospitals.|687
8770044|NCT01269736|9820174|FG001|15 Months Assessment|Patient Quality of Care Assessments|773 unique patients, assessed at 8 hospitals.|773
8770045|NCT01269736|9820173|FG000|30 Months Assessment|Patient Quality of Care Assessments|697 unique patients, assessed at 8 hospitals.|697
8770046|NCT01269736|9820174|FG001|30 Months Assessment|Patient Quality of Care Assessments|626 unique patients, assessed at 7 hospitals.|626
8770047|NCT01269736|9820173|FG000|COMPLETED|Patient Quality of Care Assessments|2299 unique patients assessed overall (at any time point) by end of study.|2299
8770048|NCT01269736|9820174|FG001|COMPLETED|Patient Quality of Care Assessments|2288 unique patients assessed overall (at any time point) by end of study.|2288
8770049|NCT01269736|9820173|FG000|NOT COMPLETED|Patient Quality of Care Assessments||0
8770050|NCT01269736|9820174|FG001|NOT COMPLETED|Patient Quality of Care Assessments||0
8770051|NCT01269736|9820173|FG000|STARTED|Patient Outcomes (Hospital Admissions)|17352 unique patients were assessed at 7 hospitals at the initiation of the study.|52085
8770052|NCT01269736|9820174|FG001|STARTED|Patient Outcomes (Hospital Admissions)|16459 unique patients were assessed at 6 hospitals at the initiation of the study.|43799
8770053|NCT01269736|9820173|FG000|Baseline Assessment|Patient Outcomes (Hospital Admissions)|17352 unique patients, assessed at 7 hospitals.|17352
8770054|NCT01269736|9820174|FG001|Baseline Assessment|Patient Outcomes (Hospital Admissions)|16549 unique patients, assessed at 6 hospitals.|16549
8808572|NCT01490788|9860782|FG002|NOT COMPLETED|Overall Study||0
8770055|NCT01269736|9820173|FG000|15 Months Assessment|Patient Outcomes (Hospital Admissions)|18031 unique patients, assessed at 7 hospitals.|18031
8770056|NCT01269736|9820174|FG001|15 Months Assessment|Patient Outcomes (Hospital Admissions)|14075 unique patients, assessed at 6 hospitals.|14075
8770057|NCT01269736|9820173|FG000|30 Months Assessment|Patient Outcomes (Hospital Admissions)|16702 unique patients, assessed at 7 hospitals.|16702
8770058|NCT01269736|9820174|FG001|30 Months Assessment|Patient Outcomes (Hospital Admissions)|13265 unique patients, assessed at 6 hospitals.|13265
8770059|NCT01269736|9820173|FG000|COMPLETED|Patient Outcomes (Hospital Admissions)|52085 unique patients assessed overall (at any time point) by end of study.|52085
8770060|NCT01269736|9820174|FG001|COMPLETED|Patient Outcomes (Hospital Admissions)|43799 unique patients assessed overall (at any time point) by end of study.|43799
8770061|NCT01269736|9820173|FG000|NOT COMPLETED|Patient Outcomes (Hospital Admissions)||0
8770062|NCT01269736|9820174|FG001|NOT COMPLETED|Patient Outcomes (Hospital Admissions)||0
8770063|NCT01269801|9820184|FG000|STARTED|Overall Study||74
8915970|NCT02178995|9975441|FG005|STARTED|Open Label||0
8915971|NCT02178995|9975442|FG006|STARTED|Open Label||0
8915972|NCT02178995|9975443|FG007|STARTED|Open Label||0
8915973|NCT02178995|9975444|FG008|STARTED|Open Label||0
8915974|NCT02178995|9975436|FG000|COMPLETED|Open Label||28
8915975|NCT02178995|9975437|FG001|COMPLETED|Open Label||14
8915976|NCT02178995|9975438|FG002|COMPLETED|Open Label||0
8915977|NCT02178995|9975439|FG003|COMPLETED|Open Label||0
8915978|NCT02178995|9975440|FG004|COMPLETED|Open Label||0
8915979|NCT02178995|9975441|FG005|COMPLETED|Open Label||0
8915980|NCT02178995|9975442|FG006|COMPLETED|Open Label||0
8915981|NCT02178995|9975443|FG007|COMPLETED|Open Label||0
8915982|NCT02178995|9975444|FG008|COMPLETED|Open Label||0
8915983|NCT02178995|9975436|FG000|NOT COMPLETED|Open Label||2
8915984|NCT02178995|9975437|FG001|NOT COMPLETED|Open Label||0
8915985|NCT02178995|9975438|FG002|NOT COMPLETED|Open Label||0
8915986|NCT02178995|9975439|FG003|NOT COMPLETED|Open Label||0
8915987|NCT02178995|9975440|FG004|NOT COMPLETED|Open Label||0
8915988|NCT02178995|9975441|FG005|NOT COMPLETED|Open Label||0
8915989|NCT02178995|9975442|FG006|NOT COMPLETED|Open Label||0
8915990|NCT02178995|9975443|FG007|NOT COMPLETED|Open Label||0
8915991|NCT02178995|9975444|FG008|NOT COMPLETED|Open Label||0
8915992|NCT02179047|9975470|FG000|STARTED|Overall Study||194
8915993|NCT02179047|9975471|FG001|STARTED|Overall Study||20
8915994|NCT02179047|9975470|FG000|COMPLETED|Overall Study||187
8915995|NCT02179047|9975471|FG001|COMPLETED|Overall Study||20
8915996|NCT02179047|9975470|FG000|NOT COMPLETED|Overall Study||7
8915997|NCT02179047|9975471|FG001|NOT COMPLETED|Overall Study||0
8915998|NCT02179177|9975490|FG000|STARTED|Overall Study||8
8915999|NCT02179177|9975491|FG001|STARTED|Overall Study||8
8916000|NCT02179177|9975490|FG000|COMPLETED|Overall Study||6
8916001|NCT02179177|9975491|FG001|COMPLETED|Overall Study||6
8916002|NCT02179177|9975490|FG000|NOT COMPLETED|Overall Study||2
8916003|NCT02179177|9975491|FG001|NOT COMPLETED|Overall Study||2
8916004|NCT02179190|9975497|FG000|STARTED|Enrollment||138
8916005|NCT02179190|9975497|FG000|COMPLETED|Enrollment||127
8916006|NCT02179190|9975497|FG000|NOT COMPLETED|Enrollment||11
8916007|NCT02179190|9975497|FG000|STARTED|Index Procedure With Barrel VRD Attempt||127
8916008|NCT02179190|9975497|FG000|COMPLETED|Index Procedure With Barrel VRD Attempt||120
8916009|NCT02179190|9975497|FG000|NOT COMPLETED|Index Procedure With Barrel VRD Attempt||7
8916010|NCT02179190|9975497|FG000|STARTED|Follow-Up Post Barrel VRD Implanted||120
8916011|NCT02179190|9975497|FG000|COMPLETED|Follow-Up Post Barrel VRD Implanted||111
8916012|NCT02179190|9975497|FG000|NOT COMPLETED|Follow-Up Post Barrel VRD Implanted||9
8916013|NCT02179398|9975503|FG000|STARTED|Overall Study||134
8916014|NCT02179398|9975504|FG001|STARTED|Overall Study||144
8916015|NCT02179398|9975503|FG000|COMPLETED|Overall Study||131
8916016|NCT02179398|9975504|FG001|COMPLETED|Overall Study||140
8916017|NCT02179398|9975503|FG000|NOT COMPLETED|Overall Study||3
8916018|NCT02179398|9975504|FG001|NOT COMPLETED|Overall Study||4
8916019|NCT02179424|9975518|FG000|STARTED|Overall Study||76
8916020|NCT02179424|9975519|FG001|STARTED|Overall Study||11
8916021|NCT02179424|9975520|FG002|STARTED|Overall Study||516
8916022|NCT02179424|9975521|FG003|STARTED|Overall Study||39
8916023|NCT02179424|9975518|FG000|COMPLETED|Overall Study||76
8916024|NCT02179424|9975519|FG001|COMPLETED|Overall Study||11
8916025|NCT02179424|9975520|FG002|COMPLETED|Overall Study||516
8916026|NCT02179424|9975521|FG003|COMPLETED|Overall Study||39
8916027|NCT02179424|9975518|FG000|NOT COMPLETED|Overall Study||0
8916028|NCT02179424|9975519|FG001|NOT COMPLETED|Overall Study||0
8916029|NCT02179424|9975520|FG002|NOT COMPLETED|Overall Study||0
8916030|NCT02179424|9975521|FG003|NOT COMPLETED|Overall Study||0
8916031|NCT02179515|9975535|FG000|STARTED|Overall Study||3
8916032|NCT02179515|9975536|FG001|STARTED|Overall Study||17
8916033|NCT02179515|9975537|FG002|STARTED|Overall Study||18
8916034|NCT02179515|9975535|FG000|COMPLETED|Overall Study||1
8916035|NCT02179515|9975536|FG001|COMPLETED|Overall Study||1
8916036|NCT02179515|9975537|FG002|COMPLETED|Overall Study||4
8916037|NCT02179515|9975535|FG000|NOT COMPLETED|Overall Study||2
8916038|NCT02179515|9975536|FG001|NOT COMPLETED|Overall Study||16
8916039|NCT02179515|9975537|FG002|NOT COMPLETED|Overall Study||14
8916040|NCT02179671|9975554|FG000|STARTED|Overall Study||1
8916041|NCT02179671|9975555|FG001|STARTED|Overall Study||1
8916042|NCT02179671|9975556|FG002|STARTED|Overall Study||2
8916043|NCT02179671|9975557|FG003|STARTED|Overall Study||14
8916044|NCT02179671|9975558|FG004|STARTED|Overall Study||14
8916045|NCT02179671|9975554|FG000|COMPLETED|Overall Study||0
8916046|NCT02179671|9975555|FG001|COMPLETED|Overall Study||0
8770064|NCT01269801|9820185|FG001|STARTED|Overall Study||80
8770065|NCT01269801|9820184|FG000|COMPLETED|Overall Study||74
8770066|NCT01269801|9820185|FG001|COMPLETED|Overall Study||77
8770067|NCT01269801|9820184|FG000|NOT COMPLETED|Overall Study||0
8770068|NCT01269801|9820185|FG001|NOT COMPLETED|Overall Study||3
8770069|NCT01269918|9820193|FG000|STARTED|Overall Study||71
8770070|NCT01269918|9820194|FG001|STARTED|Overall Study||71
8770071|NCT01269918|9820193|FG000|COMPLETED|Overall Study||71
8770072|NCT01269918|9820194|FG001|COMPLETED|Overall Study||68
8770073|NCT01269918|9820193|FG000|NOT COMPLETED|Overall Study||0
8770074|NCT01269918|9820194|FG001|NOT COMPLETED|Overall Study||3
8770075|NCT01270126|9820202|FG000|STARTED|Overall Study||12
8770076|NCT01270126|9820203|FG001|STARTED|Overall Study||10
8770077|NCT01270126|9820202|FG000|COMPLETED|Overall Study||12
8770078|NCT01270126|9820203|FG001|COMPLETED|Overall Study||10
8770079|NCT01270126|9820202|FG000|NOT COMPLETED|Overall Study||0
8770080|NCT01270126|9820203|FG001|NOT COMPLETED|Overall Study||0
8770081|NCT01270139|9820212|FG000|STARTED|Overall Study|Intention-to-treat population|60
8770082|NCT01270139|9820213|FG001|STARTED|Overall Study|Intention-to-treat population|60
8770083|NCT01270139|9820214|FG002|STARTED|Overall Study|Intention-to-treat population|60
8770084|NCT01270139|9820212|FG000|COMPLETED|Overall Study|Pre-treatment evaluable population|42
8770085|NCT01270139|9820213|FG001|COMPLETED|Overall Study|Pre-treatment evaluable population|34
8770086|NCT01270139|9820214|FG002|COMPLETED|Overall Study|Pre-treatment evaluable population|40
8770087|NCT01270139|9820212|FG000|NOT COMPLETED|Overall Study||18
8770088|NCT01270139|9820213|FG001|NOT COMPLETED|Overall Study||26
8770089|NCT01270139|9820214|FG002|NOT COMPLETED|Overall Study||20
8770090|NCT01270256|9820231|FG000|STARTED|Overall Study||21
8770091|NCT01270256|9820232|FG001|STARTED|Overall Study||20
8770092|NCT01270256|9820231|FG000|COMPLETED|Overall Study||20
8770093|NCT01270256|9820232|FG001|COMPLETED|Overall Study||20
8770094|NCT01270256|9820231|FG000|NOT COMPLETED|Overall Study||1
8770095|NCT01270256|9820232|FG001|NOT COMPLETED|Overall Study||0
8770096|NCT01270321|9820241|FG000|STARTED|Overall Study||19
8770097|NCT01270321|9820242|FG001|STARTED|Overall Study||11
8770098|NCT01270321|9820243|FG002|STARTED|Overall Study||12
8770099|NCT01270321|9820241|FG000|COMPLETED|Overall Study||9
8770100|NCT01270321|9820242|FG001|COMPLETED|Overall Study||1
8770101|NCT01270321|9820243|FG002|COMPLETED|Overall Study||3
8770102|NCT01270321|9820241|FG000|NOT COMPLETED|Overall Study||10
8770103|NCT01270321|9820242|FG001|NOT COMPLETED|Overall Study||10
8770104|NCT01270321|9820243|FG002|NOT COMPLETED|Overall Study||9
8770105|NCT01270464|9820254|FG000|STARTED|Overall Study||105
8770106|NCT01270464|9820255|FG001|STARTED|Overall Study||104
8770107|NCT01270464|9820256|FG002|STARTED|Overall Study||106
8770108|NCT01270464|9820254|FG000|Safety Analysis Set|Overall Study||105
8770109|NCT01270464|9820255|FG001|Safety Analysis Set|Overall Study||103
8770110|NCT01270464|9820256|FG002|Safety Analysis Set|Overall Study||103
8770111|NCT01270464|9820254|FG000|Full Analysis Set|Overall Study||105
8770112|NCT01270464|9820255|FG001|Full Analysis Set|Overall Study||103
8770113|NCT01270464|9820256|FG002|Full Analysis Set|Overall Study||103
8770114|NCT01270464|9820254|FG000|Pharmacokinetic Analysis Set|Overall Study||105
8770115|NCT01270464|9820255|FG001|Pharmacokinetic Analysis Set|Overall Study||103
8770116|NCT01270464|9820256|FG002|Pharmacokinetic Analysis Set|Overall Study||103
8770117|NCT01270464|9820254|FG000|COMPLETED|Overall Study||85
8770118|NCT01270464|9820255|FG001|COMPLETED|Overall Study||92
8770119|NCT01270464|9820256|FG002|COMPLETED|Overall Study||88
8770120|NCT01270464|9820254|FG000|NOT COMPLETED|Overall Study||20
8770121|NCT01270464|9820255|FG001|NOT COMPLETED|Overall Study||12
8770122|NCT01270464|9820256|FG002|NOT COMPLETED|Overall Study||18
8770123|NCT01270503|9820264|FG000|STARTED|Overall Study||538
8770124|NCT01270503|9820264|FG000|COMPLETED|Overall Study||537
8770125|NCT01270503|9820264|FG000|NOT COMPLETED|Overall Study||1
8770126|NCT01270516|9820273|FG000|STARTED|Overall Study||20
8770127|NCT01270516|9820274|FG001|STARTED|Overall Study||17
8770128|NCT01270516|9820275|FG002|STARTED|Overall Study||18
8770129|NCT01270516|9820276|FG003|STARTED|Overall Study||18
8770130|NCT01270516|9820273|FG000|COMPLETED|Overall Study||17
8770131|NCT01270516|9820274|FG001|COMPLETED|Overall Study||13
8770132|NCT01270516|9820275|FG002|COMPLETED|Overall Study||13
8770133|NCT01270516|9820276|FG003|COMPLETED|Overall Study||13
8770134|NCT01270516|9820273|FG000|NOT COMPLETED|Overall Study||3
8770135|NCT01270516|9820274|FG001|NOT COMPLETED|Overall Study||4
8770136|NCT01270516|9820275|FG002|NOT COMPLETED|Overall Study||5
8770137|NCT01270516|9820276|FG003|NOT COMPLETED|Overall Study||5
8770138|NCT01270529|9820289|FG000|STARTED|Overall Study||12
8770139|NCT01270529|9820290|FG001|STARTED|Overall Study||7
8770140|NCT01270529|9820291|FG002|STARTED|Overall Study||25
8770141|NCT01270529|9820289|FG000|COMPLETED|Overall Study||12
8770142|NCT01270529|9820290|FG001|COMPLETED|Overall Study||7
8770143|NCT01270529|9820291|FG002|COMPLETED|Overall Study||25
8770144|NCT01270529|9820289|FG000|NOT COMPLETED|Overall Study||0
8770145|NCT01270529|9820290|FG001|NOT COMPLETED|Overall Study||0
8770146|NCT01270529|9820291|FG002|NOT COMPLETED|Overall Study||0
8770147|NCT01270542|9820301|FG000|STARTED|Overall Study||10
8770148|NCT01270542|9820302|FG001|STARTED|Overall Study||9
8770149|NCT01270542|9820301|FG000|COMPLETED|Overall Study||9
8770150|NCT01270542|9820302|FG001|COMPLETED|Overall Study||8
8770151|NCT01270542|9820301|FG000|NOT COMPLETED|Overall Study||1
8770152|NCT01270542|9820302|FG001|NOT COMPLETED|Overall Study||1
8770153|NCT01270555|9820308|FG000|STARTED|Overall Study||32
8770154|NCT01270555|9820308|FG000|COMPLETED|Overall Study||19
8770155|NCT01270555|9820308|FG000|NOT COMPLETED|Overall Study||13
8770156|NCT01270620|9820314|FG000|STARTED|Overall Study||50
8770157|NCT01270620|9820315|FG001|STARTED|Overall Study||50
8770158|NCT01270620|9820314|FG000|COMPLETED|Overall Study||49
8770159|NCT01270620|9820315|FG001|COMPLETED|Overall Study||47
8770160|NCT01270620|9820314|FG000|NOT COMPLETED|Overall Study||1
8770161|NCT01270620|9820315|FG001|NOT COMPLETED|Overall Study||3
8770162|NCT01270659|9820331|FG000|STARTED|Overall Study||6
8770163|NCT01270659|9820332|FG001|STARTED|Overall Study||25
8770164|NCT01270659|9820333|FG002|STARTED|Overall Study||4
8770165|NCT01270659|9820334|FG003|STARTED|Overall Study||25
8770166|NCT01270659|9820331|FG000|COMPLETED|Overall Study||6
8770167|NCT01270659|9820332|FG001|COMPLETED|Overall Study||25
8770168|NCT01270659|9820333|FG002|COMPLETED|Overall Study||4
8770169|NCT01270659|9820334|FG003|COMPLETED|Overall Study||25
8770170|NCT01270659|9820331|FG000|NOT COMPLETED|Overall Study||0
8770171|NCT01270659|9820332|FG001|NOT COMPLETED|Overall Study||0
8770172|NCT01270659|9820333|FG002|NOT COMPLETED|Overall Study||0
8770173|NCT01270659|9820334|FG003|NOT COMPLETED|Overall Study||0
8770174|NCT01270711|9820352|FG000|STARTED|Part 1: Compliance||7537
8770175|NCT01270711|9820353|FG001|STARTED|Part 1: Compliance||6580
8770176|NCT01270711|9820354|FG002|STARTED|Part 1: Compliance||326
8770177|NCT01270711|9820355|FG003|STARTED|Part 1: Compliance||5486
8770178|NCT01270711|9820356|FG004|STARTED|Part 1: Compliance||2024
8770179|NCT01270711|9820357|FG005|STARTED|Part 1: Compliance||0
8770180|NCT01270711|9820358|FG006|STARTED|Part 1: Compliance||0
8770181|NCT01270711|9820359|FG007|STARTED|Part 1: Compliance||0
8770182|NCT01270711|9820352|FG000|COMPLETED|Part 1: Compliance||7537
8770183|NCT01270711|9820353|FG001|COMPLETED|Part 1: Compliance||6580
8770184|NCT01270711|9820354|FG002|COMPLETED|Part 1: Compliance||326
8770185|NCT01270711|9820355|FG003|COMPLETED|Part 1: Compliance||5486
8770186|NCT01270711|9820356|FG004|COMPLETED|Part 1: Compliance||2024
8770187|NCT01270711|9820357|FG005|COMPLETED|Part 1: Compliance||0
8770188|NCT01270711|9820358|FG006|COMPLETED|Part 1: Compliance||0
8770189|NCT01270711|9820359|FG007|COMPLETED|Part 1: Compliance||0
8770190|NCT01270711|9820352|FG000|NOT COMPLETED|Part 1: Compliance||0
8770191|NCT01270711|9820353|FG001|NOT COMPLETED|Part 1: Compliance||0
8770192|NCT01270711|9820354|FG002|NOT COMPLETED|Part 1: Compliance||0
8770193|NCT01270711|9820355|FG003|NOT COMPLETED|Part 1: Compliance||0
8770194|NCT01270711|9820356|FG004|NOT COMPLETED|Part 1: Compliance||0
8770195|NCT01270711|9820357|FG005|NOT COMPLETED|Part 1: Compliance||0
8770196|NCT01270711|9820358|FG006|NOT COMPLETED|Part 1: Compliance||0
8770197|NCT01270711|9820359|FG007|NOT COMPLETED|Part 1: Compliance||0
8770198|NCT01270711|9820352|FG000|STARTED|Part 2: Effectiveness||0
8770199|NCT01270711|9820353|FG001|STARTED|Part 2: Effectiveness||0
8770200|NCT01270711|9820354|FG002|STARTED|Part 2: Effectiveness||0
8770201|NCT01270711|9820355|FG003|STARTED|Part 2: Effectiveness||0
8770202|NCT01270711|9820356|FG004|STARTED|Part 2: Effectiveness||0
8770203|NCT01270711|9820357|FG005|STARTED|Part 2: Effectiveness||11
8770204|NCT01270711|9820358|FG006|STARTED|Part 2: Effectiveness||2
8770205|NCT01270711|9820359|FG007|STARTED|Part 2: Effectiveness||48
8770206|NCT01270711|9820352|FG000|COMPLETED|Part 2: Effectiveness||0
8770207|NCT01270711|9820353|FG001|COMPLETED|Part 2: Effectiveness||0
8770208|NCT01270711|9820354|FG002|COMPLETED|Part 2: Effectiveness||0
8770209|NCT01270711|9820355|FG003|COMPLETED|Part 2: Effectiveness||0
8770210|NCT01270711|9820356|FG004|COMPLETED|Part 2: Effectiveness||0
8770211|NCT01270711|9820357|FG005|COMPLETED|Part 2: Effectiveness||11
8770212|NCT01270711|9820358|FG006|COMPLETED|Part 2: Effectiveness||2
8770213|NCT01270711|9820359|FG007|COMPLETED|Part 2: Effectiveness||48
8770214|NCT01270711|9820352|FG000|NOT COMPLETED|Part 2: Effectiveness||0
8770215|NCT01270711|9820353|FG001|NOT COMPLETED|Part 2: Effectiveness||0
8770216|NCT01270711|9820354|FG002|NOT COMPLETED|Part 2: Effectiveness||0
8770217|NCT01270711|9820355|FG003|NOT COMPLETED|Part 2: Effectiveness||0
8770218|NCT01270711|9820356|FG004|NOT COMPLETED|Part 2: Effectiveness||0
8770219|NCT01270711|9820357|FG005|NOT COMPLETED|Part 2: Effectiveness||0
8770220|NCT01270711|9820358|FG006|NOT COMPLETED|Part 2: Effectiveness||0
8770221|NCT01270711|9820359|FG007|NOT COMPLETED|Part 2: Effectiveness||0
8770222|NCT01270802|9820380|FG000|STARTED|Overall Study||15
8770223|NCT01270802|9820381|FG001|STARTED|Overall Study||15
8770224|NCT01270802|9820380|FG000|COMPLETED|Overall Study||13
8770225|NCT01270802|9820381|FG001|COMPLETED|Overall Study||14
8770226|NCT01270802|9820380|FG000|NOT COMPLETED|Overall Study||2
8770227|NCT01270802|9820381|FG001|NOT COMPLETED|Overall Study||1
8770228|NCT01270828|9820390|FG000|STARTED|Pregabalin CR SB||0
8770229|NCT01270828|9820391|FG001|STARTED|Pregabalin CR SB||0
8770230|NCT01270828|9820392|FG002|STARTED|Pregabalin CR SB||806
8770231|NCT01270828|9820390|FG000|COMPLETED|Pregabalin CR SB||0
8770232|NCT01270828|9820391|FG001|COMPLETED|Pregabalin CR SB||0
8770233|NCT01270828|9820392|FG002|COMPLETED|Pregabalin CR SB||660
8770234|NCT01270828|9820390|FG000|NOT COMPLETED|Pregabalin CR SB||0
8770235|NCT01270828|9820391|FG001|NOT COMPLETED|Pregabalin CR SB||0
8770236|NCT01270828|9820392|FG002|NOT COMPLETED|Pregabalin CR SB||146
8770237|NCT01270828|9820390|FG000|STARTED|Double Blind Phase||208
8770238|NCT01270828|9820391|FG001|STARTED|Double Blind Phase||205
8770239|NCT01270828|9820392|FG002|STARTED|Double Blind Phase||0
8770240|NCT01270828|9820390|FG000|COMPLETED|Double Blind Phase||182
8770241|NCT01270828|9820391|FG001|COMPLETED|Double Blind Phase||160
8770242|NCT01270828|9820392|FG002|COMPLETED|Double Blind Phase||0
8770243|NCT01270828|9820390|FG000|NOT COMPLETED|Double Blind Phase||26
8770244|NCT01270828|9820391|FG001|NOT COMPLETED|Double Blind Phase||45
8770245|NCT01270828|9820392|FG002|NOT COMPLETED|Double Blind Phase||0
8770246|NCT01270841|9820404|FG000|STARTED|Overall Study||29
8770247|NCT01270841|9820405|FG001|STARTED|Overall Study||33
8770248|NCT01270841|9820406|FG002|STARTED|Overall Study||29
8770249|NCT01270841|9820407|FG003|STARTED|Overall Study||33
8770250|NCT01270841|9820404|FG000|COMPLETED|Overall Study||16
8770251|NCT01270841|9820405|FG001|COMPLETED|Overall Study||19
8770252|NCT01270841|9820406|FG002|COMPLETED|Overall Study||18
8770253|NCT01270841|9820407|FG003|COMPLETED|Overall Study||20
8770254|NCT01270841|9820404|FG000|NOT COMPLETED|Overall Study||13
8770255|NCT01270841|9820405|FG001|NOT COMPLETED|Overall Study||14
8770256|NCT01270841|9820406|FG002|NOT COMPLETED|Overall Study||11
8770257|NCT01270841|9820407|FG003|NOT COMPLETED|Overall Study||13
8770258|NCT01270867|9820419|FG000|STARTED|Overall Study||90
8770259|NCT01270867|9820420|FG001|STARTED|Overall Study||88
8770260|NCT01270867|9820419|FG000|COMPLETED|Overall Study||89
8770261|NCT01270867|9820420|FG001|COMPLETED|Overall Study||88
8770262|NCT01270867|9820419|FG000|NOT COMPLETED|Overall Study||1
8770263|NCT01270867|9820420|FG001|NOT COMPLETED|Overall Study||0
8770264|NCT01270880|9820426|FG000|STARTED|Overall Study||18
8770265|NCT01270880|9820426|FG000|COMPLETED|Overall Study||17
8770266|NCT01270880|9820426|FG000|NOT COMPLETED|Overall Study||1
8770267|NCT01270958|9820430|FG000|STARTED|Overall Study||60
8770268|NCT01270958|9820430|FG000|COMPLETED|Overall Study||56
8770269|NCT01270958|9820430|FG000|NOT COMPLETED|Overall Study||4
8770270|NCT01270971|9820436|FG000|STARTED|Overall Study||400
8770271|NCT01270971|9820437|FG001|STARTED|Overall Study||194
8770272|NCT01270971|9820436|FG000|COMPLETED|Overall Study||348
8770273|NCT01270971|9820437|FG001|COMPLETED|Overall Study||171
8770274|NCT01270971|9820436|FG000|NOT COMPLETED|Overall Study||52
8770275|NCT01270971|9820437|FG001|NOT COMPLETED|Overall Study||23
8770276|NCT01271010|9820443|FG000|STARTED|Overall Study||89
8770277|NCT01271010|9820443|FG000|COMPLETED|Overall Study||28
8770278|NCT01271010|9820443|FG000|NOT COMPLETED|Overall Study||61
8770279|NCT01271036|9820449|FG000|STARTED|Overall Study||62
8770280|NCT01271036|9820450|FG001|STARTED|Overall Study||62
8770281|NCT01271036|9820449|FG000|COMPLETED|Overall Study||62
8770282|NCT01271036|9820450|FG001|COMPLETED|Overall Study||62
8770283|NCT01271036|9820449|FG000|NOT COMPLETED|Overall Study||0
8770284|NCT01271036|9820450|FG001|NOT COMPLETED|Overall Study||0
8770285|NCT01271244|9820458|FG000|STARTED|Overall Study||18
8770286|NCT01271244|9820459|FG001|STARTED|Overall Study||8
8770287|NCT01271244|9820458|FG000|COMPLETED|Overall Study||11
8770288|NCT01271244|9820459|FG001|COMPLETED|Overall Study||5
8770289|NCT01271244|9820458|FG000|NOT COMPLETED|Overall Study||7
8770290|NCT01271244|9820459|FG001|NOT COMPLETED|Overall Study||3
8770291|NCT01271413|9820467|FG000|STARTED|Overall Study||37
8770292|NCT01271413|9820468|FG001|STARTED|Overall Study||36
8770293|NCT01271413|9820467|FG000|COMPLETED|Overall Study||28
8770294|NCT01271413|9820468|FG001|COMPLETED|Overall Study||28
8770295|NCT01271413|9820467|FG000|NOT COMPLETED|Overall Study||9
8770296|NCT01271413|9820468|FG001|NOT COMPLETED|Overall Study||8
8770297|NCT01271452|9820476|FG000|STARTED|Overall Study||112
8770298|NCT01271452|9820477|FG001|STARTED|Overall Study||112
8770299|NCT01271452|9820476|FG000|COMPLETED|Overall Study||105
8770300|NCT01271452|9820477|FG001|COMPLETED|Overall Study||104
8770301|NCT01271452|9820476|FG000|NOT COMPLETED|Overall Study||7
8770302|NCT01271452|9820477|FG001|NOT COMPLETED|Overall Study||8
8770303|NCT01271504|9820487|FG000|STARTED|Overall Study||7
8770304|NCT01271504|9820488|FG001|STARTED|Overall Study||8
8770305|NCT01271504|9820489|FG002|STARTED|Overall Study||44
8770306|NCT01271504|9820490|FG003|STARTED|Overall Study||43
8770307|NCT01271504|9820487|FG000|Treated|Overall Study||7
8770308|NCT01271504|9820488|FG001|Treated|Overall Study||7
8770309|NCT01271504|9820489|FG002|Treated|Overall Study||42
8770310|NCT01271504|9820490|FG003|Treated|Overall Study||42
8770311|NCT01271504|9820487|FG000|COMPLETED|Overall Study||0
8770312|NCT01271504|9820488|FG001|COMPLETED|Overall Study||0
8770313|NCT01271504|9820489|FG002|COMPLETED|Overall Study||0
8770314|NCT01271504|9820490|FG003|COMPLETED|Overall Study||0
8770315|NCT01271504|9820487|FG000|NOT COMPLETED|Overall Study||7
8770316|NCT01271504|9820488|FG001|NOT COMPLETED|Overall Study||8
8770317|NCT01271504|9820489|FG002|NOT COMPLETED|Overall Study||44
8770318|NCT01271504|9820490|FG003|NOT COMPLETED|Overall Study||43
8808573|NCT01490788|9860783|FG003|NOT COMPLETED|Overall Study||0
8808574|NCT01490788|9860784|FG004|NOT COMPLETED|Overall Study||0
8808575|NCT01490788|9860785|FG005|NOT COMPLETED|Overall Study||0
8808576|NCT01490814|9860795|FG000|STARTED|Overall Study|378 subjects randomized to Cryoballoon arm|378
8808577|NCT01490814|9860796|FG001|STARTED|Overall Study|384 subjects randomized to radiofrequency arm|384
8808578|NCT01490814|9860795|FG000|COMPLETED|Overall Study|374 received ablation|374
8808579|NCT01490814|9860796|FG001|COMPLETED|Overall Study|376 received ablation|376
8808580|NCT01490814|9860795|FG000|NOT COMPLETED|Overall Study||4
8808581|NCT01490814|9860796|FG001|NOT COMPLETED|Overall Study||8
8808582|NCT01490840|9860804|FG000|STARTED|Phase 1||94
8808583|NCT01490840|9860805|FG001|STARTED|Phase 1||84
8770319|NCT01271543|9820512|FG000|STARTED|Overall Study||30
8770320|NCT01271543|9820513|FG001|STARTED|Overall Study||30
8770321|NCT01271543|9820512|FG000|COMPLETED|Overall Study||29
8770322|NCT01271543|9820513|FG001|COMPLETED|Overall Study||29
8770323|NCT01271543|9820512|FG000|NOT COMPLETED|Overall Study||1
8770324|NCT01271543|9820513|FG001|NOT COMPLETED|Overall Study||1
8770325|NCT01271686|9820520|FG000|STARTED|Overall Study||16
8770326|NCT01271686|9820520|FG000|COMPLETED|Overall Study||16
8770327|NCT01271686|9820520|FG000|NOT COMPLETED|Overall Study||0
8770328|NCT01271712|9820526|FG000|STARTED|Double Blind Treatment||133
8770329|NCT01271712|9820527|FG001|STARTED|Double Blind Treatment||66
8770330|NCT01271712|9820526|FG000|Participants Received Treatment|Double Blind Treatment||132
8770331|NCT01271712|9820527|FG001|Participants Received Treatment|Double Blind Treatment||66
8770332|NCT01271712|9820526|FG000|COMPLETED|Double Blind Treatment|91 participants started open-label treatment with regorafenib|91
8770333|NCT01271712|9820527|FG001|COMPLETED|Double Blind Treatment|58 participants started open-label treatment with regorafenib|58
8770334|NCT01271712|9820526|FG000|NOT COMPLETED|Double Blind Treatment||42
8770335|NCT01271712|9820527|FG001|NOT COMPLETED|Double Blind Treatment||8
8770336|NCT01271712|9820526|FG000|STARTED|Open Label Treatment||91
8770337|NCT01271712|9820527|FG001|STARTED|Open Label Treatment||58
8770338|NCT01271712|9820526|FG000|COMPLETED|Open Label Treatment||0
8770339|NCT01271712|9820527|FG001|COMPLETED|Open Label Treatment||0
8770340|NCT01271712|9820526|FG000|NOT COMPLETED|Open Label Treatment||91
8770341|NCT01271712|9820527|FG001|NOT COMPLETED|Open Label Treatment||58
8770342|NCT01271712|9820526|FG000|STARTED|Safety Follow-up|All participants who discontinued study drug entered 30-day Safety Follow-up|118
8770343|NCT01271712|9820527|FG001|STARTED|Safety Follow-up|All participants who discontinued study drug entered 30-day Safety Follow-up|52
8770344|NCT01271712|9820526|FG000|COMPLETED|Safety Follow-up||97
8770345|NCT01271712|9820527|FG001|COMPLETED|Safety Follow-up||37
8770346|NCT01271712|9820526|FG000|NOT COMPLETED|Safety Follow-up||21
8770347|NCT01271712|9820527|FG001|NOT COMPLETED|Safety Follow-up||15
8770348|NCT01271712|9820526|FG000|STARTED|Survival Follow-up|All participants entered Survival Follow-up immediately after safety follow-up|100
8770349|NCT01271712|9820527|FG001|STARTED|Survival Follow-up|All participants entered Survival Follow-up immediately after safety follow-up|39
8770350|NCT01271712|9820526|FG000|COMPLETED|Survival Follow-up|85 participants died and completed survival follow-up.|85
8770351|NCT01271712|9820527|FG001|COMPLETED|Survival Follow-up|33 participants died and completed survival follow-up.|33
8770352|NCT01271712|9820526|FG000|NOT COMPLETED|Survival Follow-up||15
8770353|NCT01271712|9820527|FG001|NOT COMPLETED|Survival Follow-up||6
8770354|NCT01271725|9820536|FG000|STARTED|Part A|Started are the treated patients|74
8770355|NCT01271725|9820537|FG001|STARTED|Part A||0
8770356|NCT01271725|9820536|FG000|COMPLETED|Part A||39
8770357|NCT01271725|9820537|FG001|COMPLETED|Part A||0
8770358|NCT01271725|9820536|FG000|NOT COMPLETED|Part A||35
8770359|NCT01271725|9820537|FG001|NOT COMPLETED|Part A||0
8770360|NCT01271725|9820536|FG000|STARTED|Part B||0
8770361|NCT01271725|9820537|FG001|STARTED|Part B||39
8770362|NCT01271725|9820536|FG000|COMPLETED|Part B||0
8770363|NCT01271725|9820537|FG001|COMPLETED|Part B|Patient deemed to have completed the trial once they showed progressive disease according to RECIST|27
8770364|NCT01271725|9820536|FG000|NOT COMPLETED|Part B||0
8770365|NCT01271725|9820537|FG001|NOT COMPLETED|Part B||12
8770366|NCT01271803|9820549|FG000|STARTED|Overall Study||66
8770367|NCT01271803|9820550|FG001|STARTED|Overall Study||63
8770368|NCT01271803|9820551|FG002|STARTED|Overall Study||2
8770369|NCT01271803|9820549|FG000|COMPLETED|Overall Study||11
8770370|NCT01271803|9820550|FG001|COMPLETED|Overall Study||24
8770371|NCT01271803|9820551|FG002|COMPLETED|Overall Study||0
8770372|NCT01271803|9820549|FG000|NOT COMPLETED|Overall Study||55
8770373|NCT01271803|9820550|FG001|NOT COMPLETED|Overall Study||39
8770374|NCT01271803|9820551|FG002|NOT COMPLETED|Overall Study||2
8770375|NCT01271855|9820598|FG000|STARTED|Overall Study||48
8770376|NCT01271855|9820599|FG001|STARTED|Overall Study||52
9027889|NCT03192488|10090106|FG003|NOT COMPLETED|Third Intervention (d1)||0
9027890|NCT03192488|10090107|FG004|NOT COMPLETED|Third Intervention (d1)||1
9027891|NCT03192488|10090108|FG005|NOT COMPLETED|Third Intervention (d1)||0
9027892|NCT03192826|10090125|FG000|STARTED|Overall Study||27
9027893|NCT03192826|10090126|FG001|STARTED|Overall Study||27
9027894|NCT03192826|10090127|FG002|STARTED|Overall Study||25
9027895|NCT03192826|10090125|FG000|COMPLETED|Overall Study||27
9027896|NCT03192826|10090126|FG001|COMPLETED|Overall Study||27
9027897|NCT03192826|10090127|FG002|COMPLETED|Overall Study||25
9027898|NCT03192826|10090125|FG000|NOT COMPLETED|Overall Study||0
9027899|NCT03192826|10090126|FG001|NOT COMPLETED|Overall Study||0
9027900|NCT03192826|10090127|FG002|NOT COMPLETED|Overall Study||0
8770377|NCT01271855|9820598|FG000|COMPLETED|Overall Study||48
8770378|NCT01271855|9820599|FG001|COMPLETED|Overall Study||52
8770379|NCT01271855|9820598|FG000|NOT COMPLETED|Overall Study||0
8770380|NCT01271855|9820599|FG001|NOT COMPLETED|Overall Study||0
8770381|NCT01271868|9820605|FG000|STARTED|Pharmacokinetic Study||9
8770382|NCT01271868|9820605|FG000|COMPLETED|Pharmacokinetic Study||9
8770383|NCT01271868|9820605|FG000|NOT COMPLETED|Pharmacokinetic Study||0
8770384|NCT01271868|9820605|FG000|STARTED|Treatment Study||9
8770385|NCT01271868|9820605|FG000|COMPLETED|Treatment Study||9
8770386|NCT01271868|9820605|FG000|NOT COMPLETED|Treatment Study||0
8770387|NCT01271907|9820614|FG000|STARTED|Overall Study||3
9027901|NCT03192904|10090137|FG000|STARTED|Overall Study||35
9027902|NCT03192904|10090138|FG001|STARTED|Overall Study||35
9027903|NCT03192904|10090137|FG000|COMPLETED|Overall Study||32
8770388|NCT01271907|9820615|FG001|STARTED|Overall Study||0
8770389|NCT01271907|9820616|FG002|STARTED|Overall Study||0
8770390|NCT01271907|9820614|FG000|COMPLETED|Overall Study||3
8770391|NCT01271907|9820615|FG001|COMPLETED|Overall Study||0
8770392|NCT01271907|9820616|FG002|COMPLETED|Overall Study||0
8770393|NCT01271907|9820614|FG000|NOT COMPLETED|Overall Study||0
8770394|NCT01271907|9820615|FG001|NOT COMPLETED|Overall Study||0
8770395|NCT01271907|9820616|FG002|NOT COMPLETED|Overall Study||0
8770396|NCT01271933|9820624|FG000|STARTED|Single-Blind Phase||441
8770397|NCT01271933|9820625|FG001|STARTED|Single-Blind Phase||0
8770398|NCT01271933|9820626|FG002|STARTED|Single-Blind Phase||0
8770399|NCT01271933|9820624|FG000|COMPLETED|Single-Blind Phase||320
8770400|NCT01271933|9820625|FG001|COMPLETED|Single-Blind Phase||0
8770401|NCT01271933|9820626|FG002|COMPLETED|Single-Blind Phase||0
8770402|NCT01271933|9820624|FG000|NOT COMPLETED|Single-Blind Phase||121
8770403|NCT01271933|9820625|FG001|NOT COMPLETED|Single-Blind Phase||0
8770404|NCT01271933|9820626|FG002|NOT COMPLETED|Single-Blind Phase||0
8770405|NCT01271933|9820624|FG000|STARTED|Double-Blind Phase||0
8770406|NCT01271933|9820625|FG001|STARTED|Double-Blind Phase||63
8770407|NCT01271933|9820626|FG002|STARTED|Double-Blind Phase||59
8770408|NCT01271933|9820624|FG000|Treated|Double-Blind Phase||0
8770409|NCT01271933|9820625|FG001|Treated|Double-Blind Phase||63
8770410|NCT01271933|9820626|FG002|Treated|Double-Blind Phase||58
8770411|NCT01271933|9820624|FG000|COMPLETED|Double-Blind Phase||0
8770412|NCT01271933|9820625|FG001|COMPLETED|Double-Blind Phase||46
8770413|NCT01271933|9820626|FG002|COMPLETED|Double-Blind Phase||47
8770414|NCT01271933|9820624|FG000|NOT COMPLETED|Double-Blind Phase||0
8770415|NCT01271933|9820625|FG001|NOT COMPLETED|Double-Blind Phase||17
8770416|NCT01271933|9820626|FG002|NOT COMPLETED|Double-Blind Phase||12
8770417|NCT01271946|9820638|FG000|STARTED|Overall Study||346
8770418|NCT01271946|9820639|FG001|STARTED|Overall Study||5
8770419|NCT01271946|9820638|FG000|COMPLETED|Overall Study||346
8770420|NCT01271946|9820639|FG001|COMPLETED|Overall Study||5
8770421|NCT01271946|9820638|FG000|NOT COMPLETED|Overall Study||0
8770422|NCT01271946|9820639|FG001|NOT COMPLETED|Overall Study||0
8770423|NCT01272011|9820662|FG000|STARTED|Overall Study||3
8770424|NCT01272011|9820663|FG001|STARTED|Overall Study||10
8770425|NCT01272011|9820664|FG002|STARTED|Overall Study||3
8770426|NCT01272011|9820662|FG000|COMPLETED|Overall Study||3
8770427|NCT01272011|9820663|FG001|COMPLETED|Overall Study||8
8770428|NCT01272011|9820664|FG002|COMPLETED|Overall Study||3
8770429|NCT01272011|9820662|FG000|NOT COMPLETED|Overall Study||0
8770430|NCT01272011|9820663|FG001|NOT COMPLETED|Overall Study||2
8770431|NCT01272011|9820664|FG002|NOT COMPLETED|Overall Study||0
8770432|NCT01272076|9820672|FG000|STARTED|Overall Study||52
8770433|NCT01272076|9820672|FG000|COMPLETED|Overall Study||52
8770434|NCT01272076|9820672|FG000|NOT COMPLETED|Overall Study||0
8770435|NCT01272180|9820680|FG000|STARTED|Overall Study||120
8770436|NCT01272180|9820681|FG001|STARTED|Overall Study||121
8770437|NCT01272180|9820682|FG002|STARTED|Overall Study||122
8770438|NCT01272180|9820683|FG003|STARTED|Overall Study||121
8770439|NCT01272180|9820680|FG000|COMPLETED|Overall Study||103
8770440|NCT01272180|9820681|FG001|COMPLETED|Overall Study||100
8770441|NCT01272180|9820682|FG002|COMPLETED|Overall Study||109
8770442|NCT01272180|9820683|FG003|COMPLETED|Overall Study||107
8770443|NCT01272180|9820680|FG000|NOT COMPLETED|Overall Study||17
8770444|NCT01272180|9820681|FG001|NOT COMPLETED|Overall Study||21
8770445|NCT01272180|9820682|FG002|NOT COMPLETED|Overall Study||13
8770446|NCT01272180|9820683|FG003|NOT COMPLETED|Overall Study||14
8770447|NCT01272193|9820699|FG000|STARTED|Overall Study||147
8770448|NCT01272193|9820700|FG001|STARTED|Overall Study||149
8770449|NCT01272193|9820699|FG000|COMPLETED|Overall Study||137
8770450|NCT01272193|9820700|FG001|COMPLETED|Overall Study||137
8770451|NCT01272193|9820699|FG000|NOT COMPLETED|Overall Study||10
8770452|NCT01272193|9820700|FG001|NOT COMPLETED|Overall Study||12
8770453|NCT01272219|9820710|FG000|STARTED|Main Period: Week 0 to Week 56||959
8770454|NCT01272219|9820711|FG001|STARTED|Main Period: Week 0 to Week 56|This arm is not considered for main period as these subjects belong to re-randomised period|0
8770455|NCT01272219|9820712|FG002|STARTED|Main Period: Week 0 to Week 56|This arm is not considered for main period as these subjects belong to re-randomised period|0
8770456|NCT01272219|9820713|FG003|STARTED|Main Period: Week 0 to Week 56||487
8770457|NCT01272219|9820714|FG004|STARTED|Main Period: Week 0 to Week 56||1528
8770458|NCT01272219|9820715|FG005|STARTED|Main Period: Week 0 to Week 56||757
8770459|NCT01272219|9820710|FG000|Exposed|Main Period: Week 0 to Week 56||957
8770460|NCT01272219|9820711|FG001|Exposed|Main Period: Week 0 to Week 56||0
8770461|NCT01272219|9820712|FG002|Exposed|Main Period: Week 0 to Week 56||0
8770462|NCT01272219|9820713|FG003|Exposed|Main Period: Week 0 to Week 56||487
8770463|NCT01272219|9820714|FG004|Exposed|Main Period: Week 0 to Week 56||1524
8770464|NCT01272219|9820715|FG005|Exposed|Main Period: Week 0 to Week 56||755
8770465|NCT01272219|9820710|FG000|COMPLETED|Main Period: Week 0 to Week 56||679
8770466|NCT01272219|9820711|FG001|COMPLETED|Main Period: Week 0 to Week 56||0
8770467|NCT01272219|9820712|FG002|COMPLETED|Main Period: Week 0 to Week 56||0
8770468|NCT01272219|9820713|FG003|COMPLETED|Main Period: Week 0 to Week 56||296
8770469|NCT01272219|9820714|FG004|COMPLETED|Main Period: Week 0 to Week 56||1110
8770470|NCT01272219|9820715|FG005|COMPLETED|Main Period: Week 0 to Week 56||505
8770471|NCT01272219|9820710|FG000|NOT COMPLETED|Main Period: Week 0 to Week 56||280
8770472|NCT01272219|9820711|FG001|NOT COMPLETED|Main Period: Week 0 to Week 56||0
8770473|NCT01272219|9820712|FG002|NOT COMPLETED|Main Period: Week 0 to Week 56||0
8770474|NCT01272219|9820713|FG003|NOT COMPLETED|Main Period: Week 0 to Week 56||191
8770475|NCT01272219|9820714|FG004|NOT COMPLETED|Main Period: Week 0 to Week 56||418
8770476|NCT01272219|9820715|FG005|NOT COMPLETED|Main Period: Week 0 to Week 56||252
8770477|NCT01272219|9820710|FG000|STARTED|Re-randomised Period: Week 56 to Week 68|This arm is not considered for re-randomised period as these subjects belong to main period|0
8770478|NCT01272219|9820711|FG001|STARTED|Re-randomised Period: Week 56 to Week 68|Incorrect stratification: In this period, overall 37 pre-diabetic subjects were included by error.|351
8770479|NCT01272219|9820712|FG002|STARTED|Re-randomised Period: Week 56 to Week 68|Incorrect stratification: In this period, overall 37 pre-diabetic subjects were included by error.|350
8770480|NCT01272219|9820713|FG003|STARTED|Re-randomised Period: Week 56 to Week 68|Incorrect stratification: In this period, overall 37 pre-diabetic subjects were included by error.|304
8770481|NCT01272219|9820714|FG004|STARTED|Re-randomised Period: Week 56 to Week 68|This arm is not considered for re-randomised period as these subjects belong to main period|0
8770482|NCT01272219|9820715|FG005|STARTED|Re-randomised Period: Week 56 to Week 68|This arm is not considered for re-randomised period as these subjects belong to main period|0
8770483|NCT01272219|9820710|FG000|COMPLETED|Re-randomised Period: Week 56 to Week 68||0
8770484|NCT01272219|9820711|FG001|COMPLETED|Re-randomised Period: Week 56 to Week 68||342
8770485|NCT01272219|9820712|FG002|COMPLETED|Re-randomised Period: Week 56 to Week 68||343
8770486|NCT01272219|9820713|FG003|COMPLETED|Re-randomised Period: Week 56 to Week 68||289
8770487|NCT01272219|9820714|FG004|COMPLETED|Re-randomised Period: Week 56 to Week 68||0
8770488|NCT01272219|9820715|FG005|COMPLETED|Re-randomised Period: Week 56 to Week 68||0
8770489|NCT01272219|9820710|FG000|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||0
8770490|NCT01272219|9820711|FG001|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||9
8770491|NCT01272219|9820712|FG002|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||7
8770492|NCT01272219|9820713|FG003|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||15
8770493|NCT01272219|9820714|FG004|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||0
8770494|NCT01272219|9820715|FG005|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||0
8770495|NCT01272219|9820710|FG000|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to main period|0
8808584|NCT01490840|9860804|FG000|Modified Full Analysis Set|Phase 1||56
9027904|NCT03192904|10090138|FG001|COMPLETED|Overall Study||33
9027905|NCT03192904|10090137|FG000|NOT COMPLETED|Overall Study||3
9027906|NCT03192904|10090138|FG001|NOT COMPLETED|Overall Study||2
9027907|NCT03193021|10090146|FG000|STARTED|Overall Study||100
9027908|NCT03193021|10090147|FG001|STARTED|Overall Study||104
9027909|NCT03193021|10090146|FG000|COMPLETED|Overall Study||99
9027910|NCT03193021|10090147|FG001|COMPLETED|Overall Study||103
9027911|NCT03193021|10090146|FG000|NOT COMPLETED|Overall Study||1
9027912|NCT03193021|10090147|FG001|NOT COMPLETED|Overall Study||1
9027913|NCT03193047|10090155|FG000|STARTED|Overall Study||31
9027914|NCT03193047|10090156|FG001|STARTED|Overall Study||28
9027915|NCT03193047|10090155|FG000|COMPLETED|Overall Study||29
9027916|NCT03193047|10090156|FG001|COMPLETED|Overall Study||28
9027917|NCT03193047|10090155|FG000|NOT COMPLETED|Overall Study||2
9027918|NCT03193047|10090156|FG001|NOT COMPLETED|Overall Study||0
9027919|NCT03193398|10090166|FG000|STARTED|Overall Study||53
9027920|NCT03193398|10090167|FG001|STARTED|Overall Study||51
9027921|NCT03193398|10090166|FG000|COMPLETED|Overall Study||38
9027922|NCT03193398|10090167|FG001|COMPLETED|Overall Study||35
9027923|NCT03193398|10090166|FG000|NOT COMPLETED|Overall Study||15
9027924|NCT03193398|10090167|FG001|NOT COMPLETED|Overall Study||16
9027925|NCT03193593|10090180|FG000|STARTED|Overall Study||18
9027926|NCT03193593|10090181|FG001|STARTED|Overall Study||4
9027927|NCT03193593|10090182|FG002|STARTED|Overall Study||4
9027928|NCT03193593|10090183|FG003|STARTED|Overall Study||4
9027929|NCT03193593|10090184|FG004|STARTED|Overall Study||8
9027930|NCT03193593|10090185|FG005|STARTED|Overall Study||16
9027931|NCT03193593|10090186|FG006|STARTED|Overall Study||12
9027932|NCT03193593|10090180|FG000|COMPLETED|Overall Study||14
8671352|NCT00750308|9714642|FG010|COMPLETED|Fourth Treatment||1
8671353|NCT00750308|9714643|FG011|COMPLETED|Fourth Treatment||1
8671354|NCT00750308|9714632|FG000|NOT COMPLETED|Fourth Treatment||0
8671355|NCT00750308|9714633|FG001|NOT COMPLETED|Fourth Treatment||0
8671356|NCT00750308|9714634|FG002|NOT COMPLETED|Fourth Treatment||0
8671357|NCT00750308|9714635|FG003|NOT COMPLETED|Fourth Treatment||0
8671358|NCT00750308|9714636|FG004|NOT COMPLETED|Fourth Treatment||0
8671359|NCT00750308|9714637|FG005|NOT COMPLETED|Fourth Treatment||0
8671360|NCT00750308|9714638|FG006|NOT COMPLETED|Fourth Treatment||0
8671361|NCT00750308|9714639|FG007|NOT COMPLETED|Fourth Treatment||0
8671362|NCT00750308|9714640|FG008|NOT COMPLETED|Fourth Treatment||0
8671363|NCT00750308|9714641|FG009|NOT COMPLETED|Fourth Treatment||0
8671364|NCT00750308|9714642|FG010|NOT COMPLETED|Fourth Treatment||0
8671365|NCT00750308|9714643|FG011|NOT COMPLETED|Fourth Treatment||0
8671366|NCT00750360|9714663|FG000|STARTED|Overall Study|"Seven subjects enrolled in this group were not vaccinated and as such not included as STARTED."|294
8671367|NCT00750360|9714664|FG001|STARTED|Overall Study|"One subject enrolled in this group was not vaccinated and as such not included as STARTED."|1
8671368|NCT00750360|9714665|FG002|STARTED|Overall Study||384
8671369|NCT00750360|9714666|FG003|STARTED|Overall Study||79
8671370|NCT00750360|9714667|FG004|STARTED|Overall Study||46
8671371|NCT00750360|9714668|FG005|STARTED|Overall Study||71
8671372|NCT00750360|9714663|FG000|COMPLETED|Overall Study||294
8770496|NCT01272219|9820711|FG001|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to re-randomised period|0
8770497|NCT01272219|9820712|FG002|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to re-randomised period|0
8770498|NCT01272219|9820713|FG003|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to main and re-randomised period|0
8770499|NCT01272219|9820714|FG004|STARTED|Main + Extension Period: Week 0-172|Incorrect stratification: In this period, overall 6 subjects with no pre-diabetes included by error.|1505
8770500|NCT01272219|9820715|FG005|STARTED|Main + Extension Period: Week 0-172|Incorrect stratification: In this period, overall 6 subjects with no pre-diabetes included by error.|749
8770501|NCT01272219|9820710|FG000|Exposed|Main + Extension Period: Week 0-172||0
8770502|NCT01272219|9820711|FG001|Exposed|Main + Extension Period: Week 0-172||0
8770503|NCT01272219|9820712|FG002|Exposed|Main + Extension Period: Week 0-172||0
8770504|NCT01272219|9820713|FG003|Exposed|Main + Extension Period: Week 0-172||0
8770505|NCT01272219|9820714|FG004|Exposed|Main + Extension Period: Week 0-172||1501
8770506|NCT01272219|9820715|FG005|Exposed|Main + Extension Period: Week 0-172||747
8770507|NCT01272219|9820710|FG000|COMPLETED|Main + Extension Period: Week 0-172||0
8770508|NCT01272219|9820711|FG001|COMPLETED|Main + Extension Period: Week 0-172||0
8770509|NCT01272219|9820712|FG002|COMPLETED|Main + Extension Period: Week 0-172||0
8770510|NCT01272219|9820713|FG003|COMPLETED|Main + Extension Period: Week 0-172||0
8770511|NCT01272219|9820714|FG004|COMPLETED|Main + Extension Period: Week 0-172||783
8770512|NCT01272219|9820715|FG005|COMPLETED|Main + Extension Period: Week 0-172||327
8770513|NCT01272219|9820710|FG000|NOT COMPLETED|Main + Extension Period: Week 0-172||0
8770514|NCT01272219|9820711|FG001|NOT COMPLETED|Main + Extension Period: Week 0-172||0
8770515|NCT01272219|9820712|FG002|NOT COMPLETED|Main + Extension Period: Week 0-172||0
8770516|NCT01272219|9820713|FG003|NOT COMPLETED|Main + Extension Period: Week 0-172||0
8770517|NCT01272219|9820714|FG004|NOT COMPLETED|Main + Extension Period: Week 0-172||722
8770518|NCT01272219|9820715|FG005|NOT COMPLETED|Main + Extension Period: Week 0-172||422
8770519|NCT01272232|9820731|FG000|STARTED|Weeks 0-56||423
8770520|NCT01272232|9820732|FG001|STARTED|Weeks 0-56||211
8770521|NCT01272232|9820733|FG002|STARTED|Weeks 0-56||212
8770522|NCT01272232|9820731|FG000|Exposed|Weeks 0-56|1 subject dropped out after randomisation and before exposure to trial drug.|422
8770523|NCT01272232|9820732|FG001|Exposed|Weeks 0-56|1 subject dropped out after randomisation and before exposure to trial drug.|210
8770524|NCT01272232|9820733|FG002|Exposed|Weeks 0-56||212
8770525|NCT01272232|9820731|FG000|COMPLETED|Weeks 0-56||324
8770526|NCT01272232|9820732|FG001|COMPLETED|Weeks 0-56||164
8770527|NCT01272232|9820733|FG002|COMPLETED|Weeks 0-56||140
8770528|NCT01272232|9820731|FG000|NOT COMPLETED|Weeks 0-56||99
8770529|NCT01272232|9820732|FG001|NOT COMPLETED|Weeks 0-56||47
8770530|NCT01272232|9820733|FG002|NOT COMPLETED|Weeks 0-56||72
8770531|NCT01272232|9820731|FG000|STARTED|Off Drug Follow-up Period (Weeks 56-68)||324
8770532|NCT01272232|9820732|FG001|STARTED|Off Drug Follow-up Period (Weeks 56-68)||164
8770533|NCT01272232|9820733|FG002|STARTED|Off Drug Follow-up Period (Weeks 56-68)||140
8770534|NCT01272232|9820731|FG000|COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||310
8770535|NCT01272232|9820732|FG001|COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||154
8770536|NCT01272232|9820733|FG002|COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||135
8770537|NCT01272232|9820731|FG000|NOT COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||14
8770538|NCT01272232|9820732|FG001|NOT COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||10
8770539|NCT01272232|9820733|FG002|NOT COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||5
8770540|NCT01272245|9820741|FG000|STARTED|Overall Study||36
8770541|NCT01272245|9820741|FG000|COMPLETED|Overall Study||36
8770542|NCT01272245|9820741|FG000|NOT COMPLETED|Overall Study||0
8770543|NCT01272284|9820745|FG000|STARTED|3-month Follow-up Visit||113
8770544|NCT01272284|9820745|FG000|COMPLETED|3-month Follow-up Visit||112
8770545|NCT01272284|9820745|FG000|NOT COMPLETED|3-month Follow-up Visit||1
8770546|NCT01272284|9820745|FG000|STARTED|6-month Follow-up Visit||112
8770547|NCT01272284|9820745|FG000|COMPLETED|6-month Follow-up Visit||109
8770548|NCT01272284|9820745|FG000|NOT COMPLETED|6-month Follow-up Visit||3
8770549|NCT01272284|9820745|FG000|STARTED|12-month Follow-up Visit||109
8770550|NCT01272284|9820745|FG000|COMPLETED|12-month Follow-up Visit||105
8770551|NCT01272284|9820745|FG000|NOT COMPLETED|12-month Follow-up Visit||4
8770552|NCT01272388|9820752|FG000|STARTED|Overall Study||1
8770553|NCT01272388|9820753|FG001|STARTED|Overall Study||0
8770554|NCT01272388|9820752|FG000|COMPLETED|Overall Study||1
8770555|NCT01272388|9820753|FG001|COMPLETED|Overall Study||0
8770556|NCT01272388|9820752|FG000|NOT COMPLETED|Overall Study||0
8770557|NCT01272388|9820753|FG001|NOT COMPLETED|Overall Study||0
8770558|NCT01272583|9820761|FG000|STARTED|Overall Study||8
8770559|NCT01272583|9820762|FG001|STARTED|Overall Study||8
8770560|NCT01272583|9820761|FG000|COMPLETED|Overall Study||8
8770561|NCT01272583|9820762|FG001|COMPLETED|Overall Study||8
8770562|NCT01272583|9820761|FG000|NOT COMPLETED|Overall Study||0
8770563|NCT01272583|9820762|FG001|NOT COMPLETED|Overall Study||0
8770564|NCT01272635|9820772|FG000|STARTED|Overall Study||153
8770565|NCT01272635|9820773|FG001|STARTED|Overall Study||154
8770566|NCT01272635|9820774|FG002|STARTED|Overall Study||148
8770567|NCT01272635|9820775|FG003|STARTED|Overall Study||152
8770568|NCT01272635|9820772|FG000|COMPLETED|Overall Study||122
8770569|NCT01272635|9820773|FG001|COMPLETED|Overall Study||134
8770570|NCT01272635|9820774|FG002|COMPLETED|Overall Study||117
8770571|NCT01272635|9820775|FG003|COMPLETED|Overall Study||129
8770572|NCT01272635|9820772|FG000|NOT COMPLETED|Overall Study||31
8770573|NCT01272635|9820773|FG001|NOT COMPLETED|Overall Study||20
8770574|NCT01272635|9820774|FG002|NOT COMPLETED|Overall Study||31
8770575|NCT01272635|9820775|FG003|NOT COMPLETED|Overall Study||23
8770576|NCT01272661|9820786|FG000|STARTED|Overall Study||413
8770577|NCT01272661|9820787|FG001|STARTED|Overall Study||497
8770578|NCT01272661|9820788|FG002|STARTED|Overall Study||386
8770579|NCT01272661|9820786|FG000|COMPLETED|Overall Study||287
8770580|NCT01272661|9820787|FG001|COMPLETED|Overall Study||288
8770581|NCT01272661|9820788|FG002|COMPLETED|Overall Study||314
8770582|NCT01272661|9820786|FG000|NOT COMPLETED|Overall Study||126
8770583|NCT01272661|9820787|FG001|NOT COMPLETED|Overall Study||209
8770584|NCT01272661|9820788|FG002|NOT COMPLETED|Overall Study||72
8770585|NCT01272804|9820802|FG000|STARTED|Overall Study||9
8770586|NCT01272804|9820803|FG001|STARTED|Overall Study||9
8770587|NCT01272804|9820804|FG002|STARTED|Overall Study||9
8770588|NCT01272804|9820805|FG003|STARTED|Overall Study||9
8770589|NCT01272804|9820806|FG004|STARTED|Overall Study||9
8770590|NCT01272804|9820807|FG005|STARTED|Overall Study||16
8770591|NCT01272804|9820802|FG000|COMPLETED|Overall Study||8
8770592|NCT01272804|9820803|FG001|COMPLETED|Overall Study||9
8770593|NCT01272804|9820804|FG002|COMPLETED|Overall Study||9
8770594|NCT01272804|9820805|FG003|COMPLETED|Overall Study||9
8770595|NCT01272804|9820806|FG004|COMPLETED|Overall Study||7
8770596|NCT01272804|9820807|FG005|COMPLETED|Overall Study||15
8770597|NCT01272804|9820802|FG000|NOT COMPLETED|Overall Study||1
8770598|NCT01272804|9820803|FG001|NOT COMPLETED|Overall Study||0
8770599|NCT01272804|9820804|FG002|NOT COMPLETED|Overall Study||0
8770600|NCT01272804|9820805|FG003|NOT COMPLETED|Overall Study||0
8770601|NCT01272804|9820806|FG004|NOT COMPLETED|Overall Study||2
8770602|NCT01272804|9820807|FG005|NOT COMPLETED|Overall Study||1
8770603|NCT01272830|9820823|FG000|STARTED|Overall Study||25
8770604|NCT01272830|9820824|FG001|STARTED|Overall Study||26
8770605|NCT01272830|9820823|FG000|COMPLETED|Overall Study||17
8770606|NCT01272830|9820824|FG001|COMPLETED|Overall Study||21
8770607|NCT01272830|9820823|FG000|NOT COMPLETED|Overall Study||8
8770608|NCT01272830|9820824|FG001|NOT COMPLETED|Overall Study||5
8770609|NCT01272869|9820832|FG000|STARTED|Period 1 (14 Days)||10
8770610|NCT01272869|9820833|FG001|STARTED|Period 1 (14 Days)||10
8770611|NCT01272869|9820832|FG000|COMPLETED|Period 1 (14 Days)||10
8770612|NCT01272869|9820833|FG001|COMPLETED|Period 1 (14 Days)||10
8770613|NCT01272869|9820832|FG000|NOT COMPLETED|Period 1 (14 Days)||0
8770614|NCT01272869|9820833|FG001|NOT COMPLETED|Period 1 (14 Days)||0
8770615|NCT01272869|9820832|FG000|STARTED|Period 2 (14 Days)||10
8770616|NCT01272869|9820833|FG001|STARTED|Period 2 (14 Days)||10
8770617|NCT01272869|9820832|FG000|COMPLETED|Period 2 (14 Days)||9
8770618|NCT01272869|9820833|FG001|COMPLETED|Period 2 (14 Days)||10
8770619|NCT01272869|9820832|FG000|NOT COMPLETED|Period 2 (14 Days)||1
8770620|NCT01272869|9820833|FG001|NOT COMPLETED|Period 2 (14 Days)||0
8770621|NCT01272882|9820839|FG000|STARTED|Overall Study||13
8770622|NCT01272882|9820839|FG000|COMPLETED|Overall Study||13
8770623|NCT01272882|9820839|FG000|NOT COMPLETED|Overall Study||0
8770624|NCT01272908|9820843|FG000|STARTED|Initial Treatment Period||120
8770625|NCT01272908|9820843|FG000|COMPLETED|Initial Treatment Period||112
8770626|NCT01272908|9820843|FG000|NOT COMPLETED|Initial Treatment Period||8
8770627|NCT01272908|9820843|FG000|STARTED|Re-Treatment Period|Only participants with active disease as characterized by DAS-28 score ≥2.6 were included.|77
8770628|NCT01272908|9820843|FG000|COMPLETED|Re-Treatment Period||71
8770629|NCT01272908|9820843|FG000|NOT COMPLETED|Re-Treatment Period||6
8770630|NCT01272921|9820851|FG000|STARTED|Overall Study||71
8770631|NCT01272921|9820852|FG001|STARTED|Overall Study||71
8770632|NCT01272921|9820851|FG000|COMPLETED|Overall Study||69
8770633|NCT01272921|9820852|FG001|COMPLETED|Overall Study||70
8770634|NCT01272921|9820851|FG000|NOT COMPLETED|Overall Study||2
8770635|NCT01272921|9820852|FG001|NOT COMPLETED|Overall Study||1
8770636|NCT01272934|9820862|FG000|STARTED|Overall Study||102
8770637|NCT01272934|9820863|FG001|STARTED|Overall Study||103
8770638|NCT01272934|9820862|FG000|COMPLETED|Overall Study||102
8770639|NCT01272934|9820863|FG001|COMPLETED|Overall Study||101
8770640|NCT01272934|9820862|FG000|NOT COMPLETED|Overall Study||0
8770641|NCT01272934|9820863|FG001|NOT COMPLETED|Overall Study||2
8770642|NCT01272947|9820872|FG000|STARTED|Overall Study||104
8770643|NCT01272947|9820873|FG001|STARTED|Overall Study||100
8770644|NCT01272947|9820872|FG000|COMPLETED|Overall Study||102
8770645|NCT01272947|9820873|FG001|COMPLETED|Overall Study||98
8770646|NCT01272947|9820872|FG000|NOT COMPLETED|Overall Study||2
8770647|NCT01272947|9820873|FG001|NOT COMPLETED|Overall Study||2
8770648|NCT01272960|9820881|FG000|STARTED|Overall Study||14
8770649|NCT01272960|9820882|FG001|STARTED|Overall Study||15
8770650|NCT01272960|9820881|FG000|COMPLETED|Overall Study||14
8770651|NCT01272960|9820882|FG001|COMPLETED|Overall Study||15
8770652|NCT01272960|9820881|FG000|NOT COMPLETED|Overall Study||0
8770653|NCT01272960|9820882|FG001|NOT COMPLETED|Overall Study||0
8770654|NCT01272999|9820893|FG000|STARTED|Overall Study||357
8770655|NCT01272999|9820894|FG001|STARTED|Overall Study||34
8770656|NCT01272999|9820893|FG000|COMPLETED|Overall Study||357
8770657|NCT01272999|9820894|FG001|COMPLETED|Overall Study||34
8770658|NCT01272999|9820893|FG000|NOT COMPLETED|Overall Study||0
8770659|NCT01272999|9820894|FG001|NOT COMPLETED|Overall Study||0
8770660|NCT01273038|9820902|FG000|STARTED|First Intervention (14 Days)||10
8770661|NCT01273038|9820903|FG001|STARTED|First Intervention (14 Days)||10
8770662|NCT01273038|9820902|FG000|COMPLETED|First Intervention (14 Days)||10
8770663|NCT01273038|9820903|FG001|COMPLETED|First Intervention (14 Days)||10
8770664|NCT01273038|9820902|FG000|NOT COMPLETED|First Intervention (14 Days)||0
8770665|NCT01273038|9820903|FG001|NOT COMPLETED|First Intervention (14 Days)||0
8770666|NCT01273038|9820902|FG000|STARTED|Second Intervention (14 Days)||10
8770667|NCT01273038|9820903|FG001|STARTED|Second Intervention (14 Days)||10
8770668|NCT01273038|9820902|FG000|COMPLETED|Second Intervention (14 Days)||10
8770669|NCT01273038|9820903|FG001|COMPLETED|Second Intervention (14 Days)||8
8770670|NCT01273038|9820902|FG000|NOT COMPLETED|Second Intervention (14 Days)||0
8770671|NCT01273038|9820903|FG001|NOT COMPLETED|Second Intervention (14 Days)||2
8770672|NCT01273155|9820913|FG000|STARTED|Overall Study||14
8770673|NCT01273155|9820914|FG001|STARTED|Overall Study||12
8770674|NCT01273155|9820915|FG002|STARTED|Overall Study||18
8770675|NCT01273155|9820916|FG003|STARTED|Overall Study||5
8770676|NCT01273155|9820917|FG004|STARTED|Overall Study||5
8770677|NCT01273155|9820918|FG005|STARTED|Overall Study||10
8770678|NCT01273155|9820919|FG006|STARTED|Overall Study||8
8770679|NCT01273155|9820913|FG000|COMPLETED|Overall Study||12
8770680|NCT01273155|9820914|FG001|COMPLETED|Overall Study||8
8770681|NCT01273155|9820915|FG002|COMPLETED|Overall Study||6
8770682|NCT01273155|9820916|FG003|COMPLETED|Overall Study||4
8770683|NCT01273155|9820917|FG004|COMPLETED|Overall Study||3
8770684|NCT01273155|9820918|FG005|COMPLETED|Overall Study||5
8770685|NCT01273155|9820919|FG006|COMPLETED|Overall Study||2
8770686|NCT01273155|9820913|FG000|NOT COMPLETED|Overall Study||2
8770687|NCT01273155|9820914|FG001|NOT COMPLETED|Overall Study||4
8770688|NCT01273155|9820915|FG002|NOT COMPLETED|Overall Study||12
8770689|NCT01273155|9820916|FG003|NOT COMPLETED|Overall Study||1
8770690|NCT01273155|9820917|FG004|NOT COMPLETED|Overall Study||2
8770691|NCT01273155|9820918|FG005|NOT COMPLETED|Overall Study||5
8770692|NCT01273155|9820919|FG006|NOT COMPLETED|Overall Study||6
8770693|NCT01273181|9820946|FG000|STARTED|Phase I, Dose 1||3
8770694|NCT01273181|9820947|FG001|STARTED|Phase I, Dose 1||0
8770695|NCT01273181|9820948|FG002|STARTED|Phase I, Dose 1||0
8770696|NCT01273181|9820949|FG003|STARTED|Phase I, Dose 1||0
8770697|NCT01273181|9820946|FG000|COMPLETED|Phase I, Dose 1||2
8770698|NCT01273181|9820947|FG001|COMPLETED|Phase I, Dose 1||0
8770699|NCT01273181|9820948|FG002|COMPLETED|Phase I, Dose 1||0
8770700|NCT01273181|9820949|FG003|COMPLETED|Phase I, Dose 1||0
8770701|NCT01273181|9820946|FG000|NOT COMPLETED|Phase I, Dose 1||1
8770702|NCT01273181|9820947|FG001|NOT COMPLETED|Phase I, Dose 1||0
8770703|NCT01273181|9820948|FG002|NOT COMPLETED|Phase I, Dose 1||0
8770704|NCT01273181|9820949|FG003|NOT COMPLETED|Phase I, Dose 1||0
8770705|NCT01273181|9820946|FG000|STARTED|Phase I, Dose 2||0
8770706|NCT01273181|9820947|FG001|STARTED|Phase I, Dose 2||3
8770707|NCT01273181|9820948|FG002|STARTED|Phase I, Dose 2||0
8770708|NCT01273181|9820949|FG003|STARTED|Phase I, Dose 2||0
8770709|NCT01273181|9820946|FG000|COMPLETED|Phase I, Dose 2||0
8770710|NCT01273181|9820947|FG001|COMPLETED|Phase I, Dose 2||2
8770711|NCT01273181|9820948|FG002|COMPLETED|Phase I, Dose 2||0
8770712|NCT01273181|9820949|FG003|COMPLETED|Phase I, Dose 2||0
8770713|NCT01273181|9820946|FG000|NOT COMPLETED|Phase I, Dose 2||0
8770714|NCT01273181|9820947|FG001|NOT COMPLETED|Phase I, Dose 2||1
8770715|NCT01273181|9820948|FG002|NOT COMPLETED|Phase I, Dose 2||0
8770716|NCT01273181|9820949|FG003|NOT COMPLETED|Phase I, Dose 2||0
8770717|NCT01273181|9820946|FG000|STARTED|Phase 2, Dose 1||0
8770718|NCT01273181|9820947|FG001|STARTED|Phase 2, Dose 1||0
8770719|NCT01273181|9820948|FG002|STARTED|Phase 2, Dose 1||2
8770720|NCT01273181|9820949|FG003|STARTED|Phase 2, Dose 1||0
8770721|NCT01273181|9820946|FG000|COMPLETED|Phase 2, Dose 1||0
8770722|NCT01273181|9820947|FG001|COMPLETED|Phase 2, Dose 1||0
8770723|NCT01273181|9820948|FG002|COMPLETED|Phase 2, Dose 1||1
8770724|NCT01273181|9820949|FG003|COMPLETED|Phase 2, Dose 1||0
8770725|NCT01273181|9820946|FG000|NOT COMPLETED|Phase 2, Dose 1||0
8770726|NCT01273181|9820947|FG001|NOT COMPLETED|Phase 2, Dose 1||0
8770727|NCT01273181|9820948|FG002|NOT COMPLETED|Phase 2, Dose 1||1
8770728|NCT01273181|9820949|FG003|NOT COMPLETED|Phase 2, Dose 1||0
8770729|NCT01273181|9820946|FG000|STARTED|Phase 2, Dose 2||0
8770730|NCT01273181|9820947|FG001|STARTED|Phase 2, Dose 2||0
8770731|NCT01273181|9820948|FG002|STARTED|Phase 2, Dose 2||0
8770732|NCT01273181|9820949|FG003|STARTED|Phase 2, Dose 2||1
8770733|NCT01273181|9820946|FG000|COMPLETED|Phase 2, Dose 2||0
8770734|NCT01273181|9820947|FG001|COMPLETED|Phase 2, Dose 2||0
8770735|NCT01273181|9820948|FG002|COMPLETED|Phase 2, Dose 2||0
8770736|NCT01273181|9820949|FG003|COMPLETED|Phase 2, Dose 2||0
8770737|NCT01273181|9820946|FG000|NOT COMPLETED|Phase 2, Dose 2||0
8770738|NCT01273181|9820947|FG001|NOT COMPLETED|Phase 2, Dose 2||0
8770739|NCT01273181|9820948|FG002|NOT COMPLETED|Phase 2, Dose 2||0
8770740|NCT01273181|9820949|FG003|NOT COMPLETED|Phase 2, Dose 2||1
8770741|NCT01273207|9820963|FG000|STARTED|Overall Study||7
8770742|NCT01273207|9820963|FG000|COMPLETED|Overall Study||2
8770743|NCT01273207|9820963|FG000|NOT COMPLETED|Overall Study||5
8770744|NCT01273519|9820970|FG000|STARTED|Overall Study||78
8770745|NCT01273519|9820971|FG001|STARTED|Overall Study||30
8770746|NCT01273519|9820972|FG002|STARTED|Overall Study||47
8770747|NCT01273519|9820970|FG000|COMPLETED|Overall Study||59
8770748|NCT01273519|9820971|FG001|COMPLETED|Overall Study||25
8770749|NCT01273519|9820972|FG002|COMPLETED|Overall Study||39
8770750|NCT01273519|9820970|FG000|NOT COMPLETED|Overall Study||19
8770751|NCT01273519|9820971|FG001|NOT COMPLETED|Overall Study||5
8770752|NCT01273519|9820972|FG002|NOT COMPLETED|Overall Study||8
8770753|NCT01273597|9820983|FG000|STARTED|Overall Study||60
8770754|NCT01273597|9820983|FG000|COMPLETED|Overall Study||52
8770755|NCT01273597|9820983|FG000|NOT COMPLETED|Overall Study||8
8770756|NCT01273623|9820987|FG000|STARTED|Overall Study|met angiographic criteria|55
8770757|NCT01273623|9820987|FG000|COMPLETED|Overall Study|met IVUS criteria|26
8770758|NCT01273623|9820987|FG000|NOT COMPLETED|Overall Study||29
8770759|NCT01273766|9820996|FG000|STARTED|Overall Study||4
8770760|NCT01273766|9820997|FG001|STARTED|Overall Study||7
8770761|NCT01273766|9820998|FG002|STARTED|Overall Study||5
8770762|NCT01273766|9820996|FG000|COMPLETED|Overall Study||4
8770763|NCT01273766|9820997|FG001|COMPLETED|Overall Study||7
8770764|NCT01273766|9820998|FG002|COMPLETED|Overall Study||5
8770765|NCT01273766|9820996|FG000|NOT COMPLETED|Overall Study||0
8770766|NCT01273766|9820997|FG001|NOT COMPLETED|Overall Study||0
8770767|NCT01273766|9820998|FG002|NOT COMPLETED|Overall Study||0
8770768|NCT01273805|9821007|FG000|STARTED|Overall Study||10
8770769|NCT01273805|9821008|FG001|STARTED|Overall Study||10
8770770|NCT01273805|9821007|FG000|COMPLETED|Overall Study||0
8770771|NCT01273805|9821008|FG001|COMPLETED|Overall Study||0
8770772|NCT01273805|9821007|FG000|NOT COMPLETED|Overall Study||10
8770773|NCT01273805|9821008|FG001|NOT COMPLETED|Overall Study||10
8770774|NCT01273818|9821017|FG000|STARTED|Overall Study||100
8770775|NCT01273818|9821018|FG001|STARTED|Overall Study||100
8770776|NCT01273818|9821019|FG002|STARTED|Overall Study||100
8770777|NCT01273818|9821017|FG000|COMPLETED|Overall Study||87
8770778|NCT01273818|9821018|FG001|COMPLETED|Overall Study||98
8770779|NCT01273818|9821019|FG002|COMPLETED|Overall Study||91
8770780|NCT01273818|9821017|FG000|NOT COMPLETED|Overall Study||13
8770781|NCT01273818|9821018|FG001|NOT COMPLETED|Overall Study||2
8770782|NCT01273818|9821019|FG002|NOT COMPLETED|Overall Study||9
8770783|NCT01273857|9821029|FG000|STARTED|Overall Study||7
8770784|NCT01273857|9821030|FG001|STARTED|Overall Study||7
8770785|NCT01273857|9821029|FG000|COMPLETED|Overall Study||7
8770786|NCT01273857|9821030|FG001|COMPLETED|Overall Study||7
8770787|NCT01273857|9821029|FG000|NOT COMPLETED|Overall Study||0
8770788|NCT01273857|9821030|FG001|NOT COMPLETED|Overall Study||0
8770789|NCT01273883|9821036|FG000|STARTED|First Intervention|Received at least 1 dose of study drug.|19
8770790|NCT01273883|9821037|FG001|STARTED|First Intervention|Received at least 1 dose of study drug.|19
8770791|NCT01273883|9821036|FG000|COMPLETED|First Intervention||17
8770792|NCT01273883|9821037|FG001|COMPLETED|First Intervention||18
8770793|NCT01273883|9821036|FG000|NOT COMPLETED|First Intervention||2
8770794|NCT01273883|9821037|FG001|NOT COMPLETED|First Intervention||1
8770795|NCT01273883|9821036|FG000|STARTED|Washout Period of 2 Weeks||17
8770796|NCT01273883|9821037|FG001|STARTED|Washout Period of 2 Weeks||18
8770797|NCT01273883|9821036|FG000|COMPLETED|Washout Period of 2 Weeks||17
8770798|NCT01273883|9821037|FG001|COMPLETED|Washout Period of 2 Weeks||18
8770799|NCT01273883|9821036|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
8770800|NCT01273883|9821037|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
8770801|NCT01273883|9821036|FG000|STARTED|Second Intervention||17
8770802|NCT01273883|9821037|FG001|STARTED|Second Intervention||18
8770803|NCT01273883|9821036|FG000|COMPLETED|Second Intervention||15
8770804|NCT01273883|9821037|FG001|COMPLETED|Second Intervention||17
8770805|NCT01273883|9821036|FG000|NOT COMPLETED|Second Intervention||2
8770806|NCT01273883|9821037|FG001|NOT COMPLETED|Second Intervention||1
8770807|NCT01273896|9821043|FG000|STARTED|Overall Study||22
8770808|NCT01273896|9821043|FG000|COMPLETED|Overall Study||22
8770809|NCT01273896|9821043|FG000|NOT COMPLETED|Overall Study||0
8770810|NCT01274182|9821050|FG000|STARTED|Overall Study||133
8770811|NCT01274182|9821051|FG001|STARTED|Overall Study||87
8770812|NCT01274182|9821052|FG002|STARTED|Overall Study||92
8770813|NCT01274182|9821050|FG000|24 Weeks|Overall Study||123
8770814|NCT01274182|9821051|FG001|24 Weeks|Overall Study||83
8770815|NCT01274182|9821052|FG002|24 Weeks|Overall Study||84
8770816|NCT01274182|9821050|FG000|COMPLETED|Overall Study||112
8770817|NCT01274182|9821051|FG001|COMPLETED|Overall Study||69
8770818|NCT01274182|9821052|FG002|COMPLETED|Overall Study||80
8770819|NCT01274182|9821050|FG000|NOT COMPLETED|Overall Study||21
8770820|NCT01274182|9821051|FG001|NOT COMPLETED|Overall Study||18
8770821|NCT01274182|9821052|FG002|NOT COMPLETED|Overall Study||12
8770822|NCT01274338|9821070|FG000|STARTED|Overall Study||511
8770823|NCT01274338|9821071|FG001|STARTED|Overall Study||636
8770824|NCT01274338|9821072|FG002|STARTED|Overall Study||523
8770825|NCT01274338|9821073|FG003|STARTED|Overall Study||1
8770826|NCT01274338|9821074|FG004|STARTED|Overall Study||1
8770827|NCT01274338|9821075|FG005|STARTED|Overall Study||1
8770828|NCT01274338|9821070|FG000|Received Treatment|Overall Study||503
8770829|NCT01274338|9821071|FG001|Received Treatment|Overall Study||520
8770830|NCT01274338|9821072|FG002|Received Treatment|Overall Study||516
8770831|NCT01274338|9821073|FG003|Received Treatment|Overall Study||1
8770832|NCT01274338|9821074|FG004|Received Treatment|Overall Study||1
8770833|NCT01274338|9821075|FG005|Received Treatment|Overall Study||1
8770834|NCT01274338|9821070|FG000|Data Available for the FACT-G and FACT-BRM Analyses|Overall Study||110
8770835|NCT01274338|9821071|FG001|Data Available for the FACT-G and FACT-BRM Analyses|Overall Study||114
8770836|NCT01274338|9821072|FG002|Data Available for the FACT-G and FACT-BRM Analyses|Overall Study||97
8770837|NCT01274338|9821073|FG003|Data Available for the FACT-G and FACT-BRM Analyses|Overall Study||0
8770838|NCT01274338|9821074|FG004|Data Available for the FACT-G and FACT-BRM Analyses|Overall Study||0
8770839|NCT01274338|9821075|FG005|Data Available for the FACT-G and FACT-BRM Analyses|Overall Study||0
8770840|NCT01274338|9821070|FG000|Data Available for FACIT-D Analysis|Overall Study||109
8770841|NCT01274338|9821071|FG001|Data Available for FACIT-D Analysis|Overall Study||114
8770842|NCT01274338|9821072|FG002|Data Available for FACIT-D Analysis|Overall Study||97
8770843|NCT01274338|9821073|FG003|Data Available for FACIT-D Analysis|Overall Study||0
8770844|NCT01274338|9821074|FG004|Data Available for FACIT-D Analysis|Overall Study||0
8770845|NCT01274338|9821075|FG005|Data Available for FACIT-D Analysis|Overall Study||0
8770846|NCT01274338|9821070|FG000|COMPLETED|Overall Study||108
8770847|NCT01274338|9821071|FG001|COMPLETED|Overall Study||182
8770848|NCT01274338|9821072|FG002|COMPLETED|Overall Study||198
8770849|NCT01274338|9821073|FG003|COMPLETED|Overall Study||0
8770850|NCT01274338|9821074|FG004|COMPLETED|Overall Study||0
8770851|NCT01274338|9821075|FG005|COMPLETED|Overall Study||1
8770852|NCT01274338|9821070|FG000|NOT COMPLETED|Overall Study||403
8770853|NCT01274338|9821071|FG001|NOT COMPLETED|Overall Study||454
8770854|NCT01274338|9821072|FG002|NOT COMPLETED|Overall Study||325
8770855|NCT01274338|9821073|FG003|NOT COMPLETED|Overall Study||1
8770856|NCT01274338|9821074|FG004|NOT COMPLETED|Overall Study||1
8770857|NCT01274338|9821075|FG005|NOT COMPLETED|Overall Study||0
8770858|NCT01274351|9821088|FG000|STARTED|Overall Study||112
8770859|NCT01274351|9821088|FG000|COMPLETED|Overall Study||92
8770860|NCT01274351|9821088|FG000|NOT COMPLETED|Overall Study||20
8770861|NCT01274520|9821094|FG000|STARTED|Overall Study||25
8770862|NCT01274520|9821095|FG001|STARTED|Overall Study||24
8770863|NCT01274520|9821094|FG000|COMPLETED|Overall Study||25
8770864|NCT01274520|9821095|FG001|COMPLETED|Overall Study||24
8770865|NCT01274520|9821094|FG000|NOT COMPLETED|Overall Study||0
8770866|NCT01274520|9821095|FG001|NOT COMPLETED|Overall Study||0
8770867|NCT01274585|9821106|FG000|STARTED|Overall Study||2
8770868|NCT01274585|9821107|FG001|STARTED|Overall Study||3
8770869|NCT01274585|9821106|FG000|COMPLETED|Overall Study||2
8770870|NCT01274585|9821107|FG001|COMPLETED|Overall Study||3
8770871|NCT01274585|9821106|FG000|NOT COMPLETED|Overall Study||0
8770872|NCT01274585|9821107|FG001|NOT COMPLETED|Overall Study||0
8770873|NCT01274637|9821115|FG000|STARTED|Overall Study||30
8770874|NCT01274637|9821116|FG001|STARTED|Overall Study||32
8770875|NCT01274637|9821115|FG000|COMPLETED|Overall Study||30
8770876|NCT01274637|9821116|FG001|COMPLETED|Overall Study||30
8770877|NCT01274637|9821115|FG000|NOT COMPLETED|Overall Study||0
8770878|NCT01274637|9821116|FG001|NOT COMPLETED|Overall Study||2
8770879|NCT01274715|9821122|FG000|STARTED|Overall Study||12
8770880|NCT01274715|9821122|FG000|Screened Out at Baseline|Overall Study||3
8770881|NCT01274715|9821122|FG000|COMPLETED|Overall Study||8
9027933|NCT03193593|10090181|FG001|COMPLETED|Overall Study||3
9027934|NCT03193593|10090182|FG002|COMPLETED|Overall Study||3
9027935|NCT03193593|10090183|FG003|COMPLETED|Overall Study||4
9027936|NCT03193593|10090184|FG004|COMPLETED|Overall Study||7
9027937|NCT03193593|10090185|FG005|COMPLETED|Overall Study||13
9027938|NCT03193593|10090186|FG006|COMPLETED|Overall Study||8
9027939|NCT03193593|10090180|FG000|NOT COMPLETED|Overall Study||4
9027940|NCT03193593|10090181|FG001|NOT COMPLETED|Overall Study||1
9027941|NCT03193593|10090182|FG002|NOT COMPLETED|Overall Study||1
9027942|NCT03193593|10090183|FG003|NOT COMPLETED|Overall Study||0
9027943|NCT03193593|10090184|FG004|NOT COMPLETED|Overall Study||1
9027944|NCT03193593|10090185|FG005|NOT COMPLETED|Overall Study||3
9027945|NCT03193593|10090186|FG006|NOT COMPLETED|Overall Study||4
9027946|NCT03193736|10090202|FG000|STARTED|Overall Study||26
9027947|NCT03193736|10090202|FG000|Received Implant|Overall Study||25
9027948|NCT03193736|10090202|FG000|COMPLETED|Overall Study||21
9027949|NCT03193736|10090202|FG000|NOT COMPLETED|Overall Study||5
9027950|NCT03194217|10090210|FG000|STARTED|Overall Study||60
9027951|NCT03194217|10090211|FG001|STARTED|Overall Study||60
9027952|NCT03194217|10090212|FG002|STARTED|Overall Study||60
9027953|NCT03194217|10090213|FG003|STARTED|Overall Study||64
9027954|NCT03194217|10090210|FG000|COMPLETED|Overall Study||60
9027955|NCT03194217|10090211|FG001|COMPLETED|Overall Study||57
9027956|NCT03194217|10090212|FG002|COMPLETED|Overall Study||56
9027957|NCT03194217|10090213|FG003|COMPLETED|Overall Study||60
9027958|NCT03194217|10090210|FG000|NOT COMPLETED|Overall Study||0
9027959|NCT03194217|10090211|FG001|NOT COMPLETED|Overall Study||3
9027960|NCT03194217|10090212|FG002|NOT COMPLETED|Overall Study||4
9027961|NCT03194217|10090213|FG003|NOT COMPLETED|Overall Study||4
9027962|NCT03194334|10090226|FG000|STARTED|0-3 Months||10
9027963|NCT03194334|10090227|FG001|STARTED|0-3 Months||15
9027964|NCT03194334|10090228|FG002|STARTED|0-3 Months||15
9027965|NCT03194334|10090226|FG000|COMPLETED|0-3 Months||10
9027966|NCT03194334|10090227|FG001|COMPLETED|0-3 Months||15
9027967|NCT03194334|10090228|FG002|COMPLETED|0-3 Months||14
9027968|NCT03194334|10090226|FG000|NOT COMPLETED|0-3 Months||0
8770882|NCT01274715|9821122|FG000|NOT COMPLETED|Overall Study||4
8770883|NCT01274897|9821128|FG000|STARTED|Overall Study||297
8770884|NCT01274897|9821129|FG001|STARTED|Overall Study||153
8770885|NCT01274897|9821128|FG000|COMPLETED|Overall Study||297
8770886|NCT01274897|9821129|FG001|COMPLETED|Overall Study||153
8770887|NCT01274897|9821128|FG000|NOT COMPLETED|Overall Study||0
8770888|NCT01274897|9821129|FG001|NOT COMPLETED|Overall Study||0
8770889|NCT01275053|9821135|FG000|STARTED|Overall Study||12
8770890|NCT01275053|9821135|FG000|COMPLETED|Overall Study||12
8770891|NCT01275053|9821135|FG000|NOT COMPLETED|Overall Study||0
8770892|NCT01275066|9821142|FG000|STARTED|Overall Study||60
9027969|NCT03194334|10090227|FG001|NOT COMPLETED|0-3 Months||0
9027970|NCT03194334|10090228|FG002|NOT COMPLETED|0-3 Months||1
9027971|NCT03194334|10090226|FG000|STARTED|3-6 Months||10
9027972|NCT03194334|10090227|FG001|STARTED|3-6 Months||15
9027973|NCT03194334|10090228|FG002|STARTED|3-6 Months||14
9027974|NCT03194334|10090226|FG000|COMPLETED|3-6 Months||10
9027975|NCT03194334|10090227|FG001|COMPLETED|3-6 Months||15
8770893|NCT01275066|9821143|FG001|STARTED|Overall Study||59
8770894|NCT01275066|9821144|FG002|STARTED|Overall Study||58
8770895|NCT01275066|9821142|FG000|Treated|Overall Study||59
8770896|NCT01275066|9821143|FG001|Treated|Overall Study||59
8770897|NCT01275066|9821144|FG002|Treated|Overall Study||58
8770898|NCT01275066|9821142|FG000|COMPLETED|Overall Study||59
8770899|NCT01275066|9821143|FG001|COMPLETED|Overall Study||59
8770900|NCT01275066|9821144|FG002|COMPLETED|Overall Study||57
8770901|NCT01275066|9821142|FG000|NOT COMPLETED|Overall Study||1
8770902|NCT01275066|9821143|FG001|NOT COMPLETED|Overall Study||0
8770903|NCT01275066|9821144|FG002|NOT COMPLETED|Overall Study||1
8770904|NCT01275092|9821152|FG000|STARTED|Overall Study||164
8770905|NCT01275092|9821152|FG000|COMPLETED|Overall Study||164
8770906|NCT01275092|9821152|FG000|NOT COMPLETED|Overall Study||0
8770907|NCT01275131|9821160|FG000|STARTED|Period 1||11
8770908|NCT01275131|9821161|FG001|STARTED|Period 1||9
8770909|NCT01275131|9821162|FG002|STARTED|Period 1||13
8770910|NCT01275131|9821163|FG003|STARTED|Period 1||12
8770911|NCT01275131|9821160|FG000|Received at Least One Dose of Study Drug|Period 1||11
8770912|NCT01275131|9821161|FG001|Received at Least One Dose of Study Drug|Period 1||9
8770913|NCT01275131|9821162|FG002|Received at Least One Dose of Study Drug|Period 1||13
8770914|NCT01275131|9821163|FG003|Received at Least One Dose of Study Drug|Period 1||12
8770915|NCT01275131|9821160|FG000|COMPLETED|Period 1||9
8770916|NCT01275131|9821161|FG001|COMPLETED|Period 1||9
8770917|NCT01275131|9821162|FG002|COMPLETED|Period 1||10
8770918|NCT01275131|9821163|FG003|COMPLETED|Period 1||10
8770919|NCT01275131|9821160|FG000|NOT COMPLETED|Period 1||2
8770920|NCT01275131|9821161|FG001|NOT COMPLETED|Period 1||0
8770921|NCT01275131|9821162|FG002|NOT COMPLETED|Period 1||3
8770922|NCT01275131|9821163|FG003|NOT COMPLETED|Period 1||2
8770923|NCT01275131|9821160|FG000|STARTED|5- to 14-Day Washout Period||9
8770924|NCT01275131|9821161|FG001|STARTED|5- to 14-Day Washout Period||9
8770925|NCT01275131|9821162|FG002|STARTED|5- to 14-Day Washout Period||10
8770926|NCT01275131|9821163|FG003|STARTED|5- to 14-Day Washout Period||10
8770927|NCT01275131|9821160|FG000|COMPLETED|5- to 14-Day Washout Period||9
8770928|NCT01275131|9821161|FG001|COMPLETED|5- to 14-Day Washout Period||9
8770929|NCT01275131|9821162|FG002|COMPLETED|5- to 14-Day Washout Period||10
8770930|NCT01275131|9821163|FG003|COMPLETED|5- to 14-Day Washout Period||10
8770931|NCT01275131|9821160|FG000|NOT COMPLETED|5- to 14-Day Washout Period||0
8770932|NCT01275131|9821161|FG001|NOT COMPLETED|5- to 14-Day Washout Period||0
8770933|NCT01275131|9821162|FG002|NOT COMPLETED|5- to 14-Day Washout Period||0
8770934|NCT01275131|9821163|FG003|NOT COMPLETED|5- to 14-Day Washout Period||0
8770935|NCT01275131|9821160|FG000|STARTED|Period 2 (Crossover)||9
8770936|NCT01275131|9821161|FG001|STARTED|Period 2 (Crossover)||9
8770937|NCT01275131|9821162|FG002|STARTED|Period 2 (Crossover)||10
8770938|NCT01275131|9821163|FG003|STARTED|Period 2 (Crossover)||10
8770939|NCT01275131|9821160|FG000|COMPLETED|Period 2 (Crossover)||8
8770940|NCT01275131|9821161|FG001|COMPLETED|Period 2 (Crossover)||8
8770941|NCT01275131|9821162|FG002|COMPLETED|Period 2 (Crossover)||9
8770942|NCT01275131|9821163|FG003|COMPLETED|Period 2 (Crossover)||8
8770943|NCT01275131|9821160|FG000|NOT COMPLETED|Period 2 (Crossover)||1
8770944|NCT01275131|9821161|FG001|NOT COMPLETED|Period 2 (Crossover)||1
8770945|NCT01275131|9821162|FG002|NOT COMPLETED|Period 2 (Crossover)||1
8770946|NCT01275131|9821163|FG003|NOT COMPLETED|Period 2 (Crossover)||2
8770947|NCT01275144|9821181|FG000|STARTED|First Intervention (6 Days)||14
8770948|NCT01275144|9821182|FG001|STARTED|First Intervention (6 Days)||14
8770949|NCT01275144|9821181|FG000|Received at Least 1 Dose of Study Drug|First Intervention (6 Days)||14
8770950|NCT01275144|9821182|FG001|Received at Least 1 Dose of Study Drug|First Intervention (6 Days)||14
8770951|NCT01275144|9821181|FG000|COMPLETED|First Intervention (6 Days)||14
8770952|NCT01275144|9821182|FG001|COMPLETED|First Intervention (6 Days)||14
8770953|NCT01275144|9821181|FG000|NOT COMPLETED|First Intervention (6 Days)||0
8770954|NCT01275144|9821182|FG001|NOT COMPLETED|First Intervention (6 Days)||0
8770955|NCT01275144|9821181|FG000|STARTED|Washout (7 Days)||14
8770956|NCT01275144|9821182|FG001|STARTED|Washout (7 Days)||14
8770957|NCT01275144|9821181|FG000|COMPLETED|Washout (7 Days)||14
8770958|NCT01275144|9821182|FG001|COMPLETED|Washout (7 Days)||14
8770959|NCT01275144|9821181|FG000|NOT COMPLETED|Washout (7 Days)||0
8770960|NCT01275144|9821182|FG001|NOT COMPLETED|Washout (7 Days)||0
8770961|NCT01275144|9821181|FG000|STARTED|Second Intervention (6 Days)||14
8770962|NCT01275144|9821182|FG001|STARTED|Second Intervention (6 Days)||14
8770963|NCT01275144|9821181|FG000|COMPLETED|Second Intervention (6 Days)||13
8770964|NCT01275144|9821182|FG001|COMPLETED|Second Intervention (6 Days)||14
8770965|NCT01275144|9821181|FG000|NOT COMPLETED|Second Intervention (6 Days)||1
8770966|NCT01275144|9821182|FG001|NOT COMPLETED|Second Intervention (6 Days)||0
8770967|NCT01275170|9821198|FG000|STARTED|Part 1: Period 1||7
8770968|NCT01275170|9821199|FG001|STARTED|Part 1: Period 1||6
8916047|NCT02179671|9975556|FG002|COMPLETED|Overall Study||1
8916048|NCT02179671|9975557|FG003|COMPLETED|Overall Study||1
8916049|NCT02179671|9975558|FG004|COMPLETED|Overall Study||1
8916050|NCT02179671|9975554|FG000|NOT COMPLETED|Overall Study||1
8916051|NCT02179671|9975555|FG001|NOT COMPLETED|Overall Study||1
8916052|NCT02179671|9975556|FG002|NOT COMPLETED|Overall Study||1
8916053|NCT02179671|9975557|FG003|NOT COMPLETED|Overall Study||13
8770969|NCT01275170|9821200|FG002|STARTED|Part 1: Period 1||6
8770970|NCT01275170|9821201|FG003|STARTED|Part 1: Period 1||6
8770971|NCT01275170|9821202|FG004|STARTED|Part 1: Period 1||6
8770972|NCT01275170|9821203|FG005|STARTED|Part 1: Period 1||6
8770973|NCT01275170|9821204|FG006|STARTED|Part 1: Period 1||6
8770974|NCT01275170|9821205|FG007|STARTED|Part 1: Period 1||6
8770975|NCT01275170|9821198|FG000|Treated|Part 1: Period 1||6
8770976|NCT01275170|9821199|FG001|Treated|Part 1: Period 1||6
8770977|NCT01275170|9821200|FG002|Treated|Part 1: Period 1||6
9027976|NCT03194334|10090228|FG002|COMPLETED|3-6 Months||14
9027977|NCT03194334|10090226|FG000|NOT COMPLETED|3-6 Months||0
9027978|NCT03194334|10090227|FG001|NOT COMPLETED|3-6 Months||0
9027979|NCT03194334|10090228|FG002|NOT COMPLETED|3-6 Months||0
9027980|NCT03194373|10090237|FG000|STARTED|Overall Study||20
9027981|NCT03194373|10090237|FG000|Received Palbociclib and Carboplatin|Overall Study||19
9027982|NCT03194373|10090237|FG000|COMPLETED|Overall Study||18
9027983|NCT03194373|10090237|FG000|NOT COMPLETED|Overall Study||2
9027984|NCT03194464|10090241|FG000|STARTED|Overall Study||15
9027985|NCT03194464|10090241|FG000|COMPLETED|Overall Study||13
9027986|NCT03194464|10090241|FG000|NOT COMPLETED|Overall Study||2
9027987|NCT03194490|10090249|FG000|STARTED|Overall Study||20
9027988|NCT03194490|10090250|FG001|STARTED|Overall Study||23
9027989|NCT03194490|10090249|FG000|COMPLETED|Overall Study||18
9027990|NCT03194490|10090250|FG001|COMPLETED|Overall Study||20
9027991|NCT03194490|10090249|FG000|NOT COMPLETED|Overall Study||2
9027992|NCT03194490|10090250|FG001|NOT COMPLETED|Overall Study||3
9027993|NCT03194503|10090259|FG000|STARTED|Overall Study||458
9027994|NCT03194503|10090260|FG001|STARTED|Overall Study||1054
9027995|NCT03194503|10090259|FG000|COMPLETED|Overall Study||458
9027996|NCT03194503|10090260|FG001|COMPLETED|Overall Study||1054
9027997|NCT03194503|10090259|FG000|NOT COMPLETED|Overall Study||0
9027998|NCT03194503|10090260|FG001|NOT COMPLETED|Overall Study||0
9027999|NCT03194698|10090270|FG000|STARTED|Overall Study||10
9028000|NCT03194698|10090271|FG001|STARTED|Overall Study||10
9028001|NCT03194698|10090270|FG000|COMPLETED|Overall Study||10
9028002|NCT03194698|10090271|FG001|COMPLETED|Overall Study||10
9028003|NCT03194698|10090270|FG000|NOT COMPLETED|Overall Study||0
9028004|NCT03194698|10090271|FG001|NOT COMPLETED|Overall Study||0
9028005|NCT03194737|10090279|FG000|STARTED|Overall Study||52
9028006|NCT03194737|10090280|FG001|STARTED|Overall Study||49
9028007|NCT03194737|10090279|FG000|COMPLETED|Overall Study||47
9028008|NCT03194737|10090280|FG001|COMPLETED|Overall Study||49
9028009|NCT03194737|10090279|FG000|NOT COMPLETED|Overall Study||5
9028010|NCT03194737|10090280|FG001|NOT COMPLETED|Overall Study||0
9028011|NCT03194776|10090288|FG000|STARTED|Overall Study||23
9028012|NCT03194776|10090289|FG001|STARTED|Overall Study||23
9028013|NCT03194776|10090288|FG000|COMPLETED|Overall Study||23
9028014|NCT03194776|10090289|FG001|COMPLETED|Overall Study||23
9028015|NCT03194776|10090288|FG000|NOT COMPLETED|Overall Study||0
9028016|NCT03194776|10090289|FG001|NOT COMPLETED|Overall Study||0
9028017|NCT03195010|10090298|FG000|STARTED|Overall Study||2
9028018|NCT03195010|10090299|FG001|STARTED|Overall Study||2
9028019|NCT03195010|10090298|FG000|COMPLETED|Overall Study||2
9028020|NCT03195010|10090299|FG001|COMPLETED|Overall Study||2
9028021|NCT03195010|10090298|FG000|NOT COMPLETED|Overall Study||0
9028022|NCT03195010|10090299|FG001|NOT COMPLETED|Overall Study||0
9028023|NCT03195517|10090307|FG000|STARTED|Overall Study||33
9028024|NCT03195517|10090307|FG000|COMPLETED|Overall Study||33
9028025|NCT03195517|10090307|FG000|NOT COMPLETED|Overall Study||0
9028026|NCT03196076|10090318|FG000|STARTED|Overall Study||5
9028027|NCT03196076|10090319|FG001|STARTED|Overall Study||20
9028028|NCT03196076|10090320|FG002|STARTED|Overall Study||0
9028029|NCT03196076|10090318|FG000|COMPLETED|Overall Study||5
9028030|NCT03196076|10090319|FG001|COMPLETED|Overall Study||20
9028031|NCT03196076|10090320|FG002|COMPLETED|Overall Study||0
9028032|NCT03196076|10090318|FG000|NOT COMPLETED|Overall Study||0
9028033|NCT03196076|10090319|FG001|NOT COMPLETED|Overall Study||0
9028034|NCT03196076|10090320|FG002|NOT COMPLETED|Overall Study||0
9028035|NCT03196193|10090330|FG000|STARTED|Overall Study||121
9028036|NCT03196193|10090331|FG001|STARTED|Overall Study||119
9028037|NCT03196193|10090330|FG000|COMPLETED|Overall Study||118
9028038|NCT03196193|10090331|FG001|COMPLETED|Overall Study||119
9028039|NCT03196193|10090330|FG000|NOT COMPLETED|Overall Study||3
9028040|NCT03196193|10090331|FG001|NOT COMPLETED|Overall Study||0
9028041|NCT03196232|10090337|FG000|STARTED|Overall Study||3
9028042|NCT03196232|10090337|FG000|COMPLETED|Overall Study||3
9028043|NCT03196232|10090337|FG000|NOT COMPLETED|Overall Study||0
9028044|NCT03196284|10090343|FG000|STARTED|Main Part||17
9028045|NCT03196284|10090344|FG001|STARTED|Main Part||9
9028046|NCT03196284|10090345|FG002|STARTED|Main Part||0
8770978|NCT01275170|9821201|FG003|Treated|Part 1: Period 1||6
9028047|NCT03196284|10090343|FG000|Concizumab 0.15 mg/kg|Main Part||15
9028048|NCT03196284|10090344|FG001|Concizumab 0.15 mg/kg|Main Part||0
9028049|NCT03196284|10090345|FG002|Concizumab 0.15 mg/kg|Main Part||0
9028050|NCT03196284|10090343|FG000|Concizumab 0.20 mg/kg|Main Part||2
9028051|NCT03196284|10090344|FG001|Concizumab 0.20 mg/kg|Main Part||0
9028052|NCT03196284|10090345|FG002|Concizumab 0.20 mg/kg|Main Part||0
9028053|NCT03196284|10090343|FG000|Concizumab 0.25 mg/kg|Main Part||0
9028054|NCT03196284|10090344|FG001|Concizumab 0.25 mg/kg|Main Part||0
9028055|NCT03196284|10090345|FG002|Concizumab 0.25 mg/kg|Main Part||0
9028056|NCT03196284|10090343|FG000|COMPLETED|Main Part||17
9028057|NCT03196284|10090344|FG001|COMPLETED|Main Part||8
9028058|NCT03196284|10090345|FG002|COMPLETED|Main Part||0
8770979|NCT01275170|9821202|FG004|Treated|Part 1: Period 1||6
9028059|NCT03196284|10090343|FG000|NOT COMPLETED|Main Part||0
9028060|NCT03196284|10090344|FG001|NOT COMPLETED|Main Part||1
9028061|NCT03196284|10090345|FG002|NOT COMPLETED|Main Part||0
8770980|NCT01275170|9821203|FG005|Treated|Part 1: Period 1||6
8770981|NCT01275170|9821204|FG006|Treated|Part 1: Period 1||6
8770982|NCT01275170|9821205|FG007|Treated|Part 1: Period 1||6
8770983|NCT01275170|9821198|FG000|COMPLETED|Part 1: Period 1||6
8770984|NCT01275170|9821199|FG001|COMPLETED|Part 1: Period 1||6
8770985|NCT01275170|9821200|FG002|COMPLETED|Part 1: Period 1||6
8770986|NCT01275170|9821201|FG003|COMPLETED|Part 1: Period 1||6
8770987|NCT01275170|9821202|FG004|COMPLETED|Part 1: Period 1||6
8770988|NCT01275170|9821203|FG005|COMPLETED|Part 1: Period 1||6
8770989|NCT01275170|9821204|FG006|COMPLETED|Part 1: Period 1||6
8770990|NCT01275170|9821205|FG007|COMPLETED|Part 1: Period 1||6
8770991|NCT01275170|9821198|FG000|NOT COMPLETED|Part 1: Period 1||1
8770992|NCT01275170|9821199|FG001|NOT COMPLETED|Part 1: Period 1||0
8770993|NCT01275170|9821200|FG002|NOT COMPLETED|Part 1: Period 1||0
8770994|NCT01275170|9821201|FG003|NOT COMPLETED|Part 1: Period 1||0
8770995|NCT01275170|9821202|FG004|NOT COMPLETED|Part 1: Period 1||0
8770996|NCT01275170|9821203|FG005|NOT COMPLETED|Part 1: Period 1||0
8770997|NCT01275170|9821204|FG006|NOT COMPLETED|Part 1: Period 1||0
8770998|NCT01275170|9821205|FG007|NOT COMPLETED|Part 1: Period 1||0
8770999|NCT01275170|9821198|FG000|STARTED|Part 1: Period 2|Panel A participated in Part 1, Period 1 only.|0
8771000|NCT01275170|9821199|FG001|STARTED|Part 1: Period 2|Panel B participated in Part 1, Period 1 only.|0
8771001|NCT01275170|9821200|FG002|STARTED|Part 1: Period 2|Panel C participated in Part 1, Period 1 only.|0
8771002|NCT01275170|9821201|FG003|STARTED|Part 1: Period 2|Panel D participated in Part 1, Period 1 only.|0
8771003|NCT01275170|9821202|FG004|STARTED|Part 1: Period 2|Panel E participated in Part 1, Period 1 and Part 2, Period 1.|0
8771004|NCT01275170|9821203|FG005|STARTED|Part 1: Period 2|Panel E participated in Part 1, Period 1 and Part 2, Period 1.|0
8771005|NCT01275170|9821204|FG006|STARTED|Part 1: Period 2||6
8771006|NCT01275170|9821205|FG007|STARTED|Part 1: Period 2||6
8771007|NCT01275170|9821198|FG000|COMPLETED|Part 1: Period 2||0
8771008|NCT01275170|9821199|FG001|COMPLETED|Part 1: Period 2||0
8771009|NCT01275170|9821200|FG002|COMPLETED|Part 1: Period 2||0
8771010|NCT01275170|9821201|FG003|COMPLETED|Part 1: Period 2||0
8771011|NCT01275170|9821202|FG004|COMPLETED|Part 1: Period 2||0
8771012|NCT01275170|9821203|FG005|COMPLETED|Part 1: Period 2||0
8771013|NCT01275170|9821204|FG006|COMPLETED|Part 1: Period 2||6
8771014|NCT01275170|9821205|FG007|COMPLETED|Part 1: Period 2||6
8771015|NCT01275170|9821198|FG000|NOT COMPLETED|Part 1: Period 2||0
8771016|NCT01275170|9821199|FG001|NOT COMPLETED|Part 1: Period 2||0
8771017|NCT01275170|9821200|FG002|NOT COMPLETED|Part 1: Period 2||0
8771018|NCT01275170|9821201|FG003|NOT COMPLETED|Part 1: Period 2||0
8771019|NCT01275170|9821202|FG004|NOT COMPLETED|Part 1: Period 2||0
8771020|NCT01275170|9821203|FG005|NOT COMPLETED|Part 1: Period 2||0
8771021|NCT01275170|9821204|FG006|NOT COMPLETED|Part 1: Period 2||0
8771022|NCT01275170|9821205|FG007|NOT COMPLETED|Part 1: Period 2||0
8771023|NCT01275170|9821198|FG000|STARTED|Part 2: Period 1||0
8771024|NCT01275170|9821199|FG001|STARTED|Part 2: Period 1||0
8771025|NCT01275170|9821200|FG002|STARTED|Part 2: Period 1||0
8771026|NCT01275170|9821201|FG003|STARTED|Part 2: Period 1||0
8771027|NCT01275170|9821202|FG004|STARTED|Part 2: Period 1||6
8771028|NCT01275170|9821203|FG005|STARTED|Part 2: Period 1||6
8771029|NCT01275170|9821204|FG006|STARTED|Part 2: Period 1||6
8771030|NCT01275170|9821205|FG007|STARTED|Part 2: Period 1||6
8771031|NCT01275170|9821198|FG000|COMPLETED|Part 2: Period 1||0
8771032|NCT01275170|9821199|FG001|COMPLETED|Part 2: Period 1||0
8771033|NCT01275170|9821200|FG002|COMPLETED|Part 2: Period 1||0
8771034|NCT01275170|9821201|FG003|COMPLETED|Part 2: Period 1||0
8771035|NCT01275170|9821202|FG004|COMPLETED|Part 2: Period 1||6
8771036|NCT01275170|9821203|FG005|COMPLETED|Part 2: Period 1||6
8771037|NCT01275170|9821204|FG006|COMPLETED|Part 2: Period 1||6
8771038|NCT01275170|9821205|FG007|COMPLETED|Part 2: Period 1||6
8771039|NCT01275170|9821198|FG000|NOT COMPLETED|Part 2: Period 1||0
8771040|NCT01275170|9821199|FG001|NOT COMPLETED|Part 2: Period 1||0
8771041|NCT01275170|9821200|FG002|NOT COMPLETED|Part 2: Period 1||0
8771042|NCT01275170|9821201|FG003|NOT COMPLETED|Part 2: Period 1||0
8771043|NCT01275170|9821202|FG004|NOT COMPLETED|Part 2: Period 1||0
8771044|NCT01275170|9821203|FG005|NOT COMPLETED|Part 2: Period 1||0
8771045|NCT01275170|9821204|FG006|NOT COMPLETED|Part 2: Period 1||0
8771046|NCT01275170|9821205|FG007|NOT COMPLETED|Part 2: Period 1||0
8771047|NCT01275170|9821198|FG000|STARTED|Part 2: Period 2||0
8771048|NCT01275170|9821199|FG001|STARTED|Part 2: Period 2||0
8771049|NCT01275170|9821200|FG002|STARTED|Part 2: Period 2||0
8771050|NCT01275170|9821201|FG003|STARTED|Part 2: Period 2||0
8771051|NCT01275170|9821202|FG004|STARTED|Part 2: Period 2|Panel E participated in Part 1, Period 1 and Part 2, Period 1.|0
8771052|NCT01275170|9821203|FG005|STARTED|Part 2: Period 2|Panel F participated in Part 1, Period 1 and Part 2, Period 1.|0
8771053|NCT01275170|9821204|FG006|STARTED|Part 2: Period 2||6
8771054|NCT01275170|9821205|FG007|STARTED|Part 2: Period 2||6
8771055|NCT01275170|9821198|FG000|COMPLETED|Part 2: Period 2||0
8771056|NCT01275170|9821199|FG001|COMPLETED|Part 2: Period 2||0
8771057|NCT01275170|9821200|FG002|COMPLETED|Part 2: Period 2||0
8771058|NCT01275170|9821201|FG003|COMPLETED|Part 2: Period 2||0
8771059|NCT01275170|9821202|FG004|COMPLETED|Part 2: Period 2||0
8771060|NCT01275170|9821203|FG005|COMPLETED|Part 2: Period 2||0
8771061|NCT01275170|9821204|FG006|COMPLETED|Part 2: Period 2||6
8771062|NCT01275170|9821205|FG007|COMPLETED|Part 2: Period 2||6
8771063|NCT01275170|9821198|FG000|NOT COMPLETED|Part 2: Period 2||0
8771064|NCT01275170|9821199|FG001|NOT COMPLETED|Part 2: Period 2||0
8771065|NCT01275170|9821200|FG002|NOT COMPLETED|Part 2: Period 2||0
8771066|NCT01275170|9821201|FG003|NOT COMPLETED|Part 2: Period 2||0
8771067|NCT01275170|9821202|FG004|NOT COMPLETED|Part 2: Period 2||0
8771068|NCT01275170|9821203|FG005|NOT COMPLETED|Part 2: Period 2||0
8771069|NCT01275170|9821204|FG006|NOT COMPLETED|Part 2: Period 2||0
8771070|NCT01275170|9821205|FG007|NOT COMPLETED|Part 2: Period 2||0
8771071|NCT01275196|9821240|FG000|STARTED|Overall Study||133
8771072|NCT01275196|9821241|FG001|STARTED|Overall Study||134
8771073|NCT01275196|9821240|FG000|Intended to Continue Into Extension|Overall Study||112
8771074|NCT01275196|9821241|FG001|Intended to Continue Into Extension|Overall Study||113
8771075|NCT01275196|9821240|FG000|COMPLETED|Overall Study||113
8771076|NCT01275196|9821241|FG001|COMPLETED|Overall Study||113
8771077|NCT01275196|9821240|FG000|NOT COMPLETED|Overall Study||20
8771078|NCT01275196|9821241|FG001|NOT COMPLETED|Overall Study||21
8771079|NCT01275222|9821255|FG000|STARTED|Phase l by Treatment||13
8771080|NCT01275222|9821256|FG001|STARTED|Phase l by Treatment||13
8771081|NCT01275222|9821257|FG002|STARTED|Phase l by Treatment||5
8771082|NCT01275222|9821258|FG003|STARTED|Phase l by Treatment||11
8771083|NCT01275222|9821259|FG004|STARTED|Phase l by Treatment||0
8771084|NCT01275222|9821260|FG005|STARTED|Phase l by Treatment||0
8771085|NCT01275222|9821255|FG000|COMPLETED|Phase l by Treatment||0
8771086|NCT01275222|9821256|FG001|COMPLETED|Phase l by Treatment||0
8771087|NCT01275222|9821257|FG002|COMPLETED|Phase l by Treatment||0
8771088|NCT01275222|9821258|FG003|COMPLETED|Phase l by Treatment||0
8771089|NCT01275222|9821259|FG004|COMPLETED|Phase l by Treatment||0
8771090|NCT01275222|9821260|FG005|COMPLETED|Phase l by Treatment||0
8771091|NCT01275222|9821255|FG000|NOT COMPLETED|Phase l by Treatment||13
8771092|NCT01275222|9821256|FG001|NOT COMPLETED|Phase l by Treatment||13
8771093|NCT01275222|9821257|FG002|NOT COMPLETED|Phase l by Treatment||5
8771094|NCT01275222|9821258|FG003|NOT COMPLETED|Phase l by Treatment||11
8771095|NCT01275222|9821259|FG004|NOT COMPLETED|Phase l by Treatment||0
8771096|NCT01275222|9821260|FG005|NOT COMPLETED|Phase l by Treatment||0
8771097|NCT01275222|9821255|FG000|STARTED|Phase ll by Stratum||0
8771098|NCT01275222|9821256|FG001|STARTED|Phase ll by Stratum||0
8771099|NCT01275222|9821257|FG002|STARTED|Phase ll by Stratum||0
8771100|NCT01275222|9821258|FG003|STARTED|Phase ll by Stratum||0
8771101|NCT01275222|9821259|FG004|STARTED|Phase ll by Stratum||28
8771102|NCT01275222|9821260|FG005|STARTED|Phase ll by Stratum||47
8771103|NCT01275222|9821255|FG000|COMPLETED|Phase ll by Stratum||0
8771104|NCT01275222|9821256|FG001|COMPLETED|Phase ll by Stratum||0
8771105|NCT01275222|9821257|FG002|COMPLETED|Phase ll by Stratum||0
8771106|NCT01275222|9821258|FG003|COMPLETED|Phase ll by Stratum||0
8771107|NCT01275222|9821259|FG004|COMPLETED|Phase ll by Stratum||0
8771108|NCT01275222|9821260|FG005|COMPLETED|Phase ll by Stratum||1
8771109|NCT01275222|9821255|FG000|NOT COMPLETED|Phase ll by Stratum||0
8771110|NCT01275222|9821256|FG001|NOT COMPLETED|Phase ll by Stratum||0
8771111|NCT01275222|9821257|FG002|NOT COMPLETED|Phase ll by Stratum||0
8771112|NCT01275222|9821258|FG003|NOT COMPLETED|Phase ll by Stratum||0
8771113|NCT01275222|9821259|FG004|NOT COMPLETED|Phase ll by Stratum||28
8771114|NCT01275222|9821260|FG005|NOT COMPLETED|Phase ll by Stratum||46
8771115|NCT01275300|9821278|FG000|STARTED|1st Intervention (5 Days)||5
8771116|NCT01275300|9821279|FG001|STARTED|1st Intervention (5 Days)||4
8771117|NCT01275300|9821278|FG000|COMPLETED|1st Intervention (5 Days)||5
8771118|NCT01275300|9821279|FG001|COMPLETED|1st Intervention (5 Days)||4
8771119|NCT01275300|9821278|FG000|NOT COMPLETED|1st Intervention (5 Days)||0
8771120|NCT01275300|9821279|FG001|NOT COMPLETED|1st Intervention (5 Days)||0
8771121|NCT01275300|9821278|FG000|STARTED|Washout (14 Days)||5
8771122|NCT01275300|9821279|FG001|STARTED|Washout (14 Days)||4
8771123|NCT01275300|9821278|FG000|COMPLETED|Washout (14 Days)||5
8771124|NCT01275300|9821279|FG001|COMPLETED|Washout (14 Days)||4
8771125|NCT01275300|9821278|FG000|NOT COMPLETED|Washout (14 Days)||0
8771126|NCT01275300|9821279|FG001|NOT COMPLETED|Washout (14 Days)||0
8771127|NCT01275300|9821278|FG000|STARTED|2nd Intervention(5 Days)||5
8771128|NCT01275300|9821279|FG001|STARTED|2nd Intervention(5 Days)||4
8771129|NCT01275300|9821278|FG000|COMPLETED|2nd Intervention(5 Days)||5
8771130|NCT01275300|9821279|FG001|COMPLETED|2nd Intervention(5 Days)||4
8771131|NCT01275300|9821278|FG000|NOT COMPLETED|2nd Intervention(5 Days)||0
8771132|NCT01275300|9821279|FG001|NOT COMPLETED|2nd Intervention(5 Days)||0
8771133|NCT01275300|9821278|FG000|STARTED|Washout (14 Days)||5
8771134|NCT01275300|9821279|FG001|STARTED|Washout (14 Days)||4
8771135|NCT01275300|9821278|FG000|COMPLETED|Washout (14 Days)||5
8771136|NCT01275300|9821279|FG001|COMPLETED|Washout (14 Days)||4
8771137|NCT01275300|9821278|FG000|NOT COMPLETED|Washout (14 Days)||0
8771138|NCT01275300|9821279|FG001|NOT COMPLETED|Washout (14 Days)||0
8771139|NCT01275300|9821278|FG000|STARTED|Phase 2: Open-label 6days)||5
8771140|NCT01275300|9821279|FG001|STARTED|Phase 2: Open-label 6days)||4
8771141|NCT01275300|9821278|FG000|COMPLETED|Phase 2: Open-label 6days)||5
8771142|NCT01275300|9821279|FG001|COMPLETED|Phase 2: Open-label 6days)||4
8771143|NCT01275300|9821278|FG000|NOT COMPLETED|Phase 2: Open-label 6days)||0
8771144|NCT01275300|9821279|FG001|NOT COMPLETED|Phase 2: Open-label 6days)||0
8771145|NCT01275313|9821287|FG000|STARTED|Overall Study||127
8771146|NCT01275313|9821288|FG001|STARTED|Overall Study||131
8771147|NCT01275313|9821287|FG000|COMPLETED|Overall Study||102
8771148|NCT01275313|9821288|FG001|COMPLETED|Overall Study||79
8771149|NCT01275313|9821287|FG000|NOT COMPLETED|Overall Study||25
8771150|NCT01275313|9821288|FG001|NOT COMPLETED|Overall Study||52
8771151|NCT01275339|9821298|FG000|STARTED|Overall Study||2
8771152|NCT01275339|9821299|FG001|STARTED|Overall Study||0
8771153|NCT01275339|9821300|FG002|STARTED|Overall Study||4
8771154|NCT01275339|9821301|FG003|STARTED|Overall Study||4
8771155|NCT01275339|9821298|FG000|COMPLETED|Overall Study||1
8771156|NCT01275339|9821299|FG001|COMPLETED|Overall Study||0
8771157|NCT01275339|9821300|FG002|COMPLETED|Overall Study||3
8771158|NCT01275339|9821301|FG003|COMPLETED|Overall Study||4
8771159|NCT01275339|9821298|FG000|NOT COMPLETED|Overall Study||1
8771160|NCT01275339|9821299|FG001|NOT COMPLETED|Overall Study||0
8771161|NCT01275339|9821300|FG002|NOT COMPLETED|Overall Study||1
8771162|NCT01275339|9821301|FG003|NOT COMPLETED|Overall Study||0
8771163|NCT01275365|9821315|FG000|STARTED|Overall Study||24
9028062|NCT03196284|10090343|FG000|STARTED|Extension Part|Participants who completed main part are presented in separate treatment arm.|0
9028063|NCT03196284|10090344|FG001|STARTED|Extension Part|Participants switched to treatment with concizumab in the extension part of the study.|0
9028064|NCT03196284|10090345|FG002|STARTED|Extension Part|Participants who completed the main part entered the extension part of the study.|25
9028065|NCT03196284|10090343|FG000|Concizumab 0.15 mg/kg|Extension Part||0
9028066|NCT03196284|10090344|FG001|Concizumab 0.15 mg/kg|Extension Part||0
9028067|NCT03196284|10090345|FG002|Concizumab 0.15 mg/kg|Extension Part||12
9028068|NCT03196284|10090343|FG000|Concizumab 0.20 mg/kg|Extension Part||0
9028069|NCT03196284|10090344|FG001|Concizumab 0.20 mg/kg|Extension Part||0
9028070|NCT03196284|10090345|FG002|Concizumab 0.20 mg/kg|Extension Part||9
9028071|NCT03196284|10090343|FG000|Concizumab 0.25 mg/kg|Extension Part||0
9028072|NCT03196284|10090344|FG001|Concizumab 0.25 mg/kg|Extension Part||0
9028073|NCT03196284|10090345|FG002|Concizumab 0.25 mg/kg|Extension Part||4
9028074|NCT03196284|10090343|FG000|COMPLETED|Extension Part||0
9028075|NCT03196284|10090344|FG001|COMPLETED|Extension Part||0
9028076|NCT03196284|10090345|FG002|COMPLETED|Extension Part||22
9028077|NCT03196284|10090343|FG000|NOT COMPLETED|Extension Part||0
9028078|NCT03196284|10090344|FG001|NOT COMPLETED|Extension Part||0
9028079|NCT03196284|10090345|FG002|NOT COMPLETED|Extension Part||3
8771164|NCT01275365|9821316|FG001|STARTED|Overall Study||24
8771165|NCT01275365|9821317|FG002|STARTED|Overall Study||22
9028080|NCT03196297|10090365|FG000|STARTED|Main Period||36
8771166|NCT01275365|9821318|FG003|STARTED|Overall Study||22
8771167|NCT01275365|9821315|FG000|COMPLETED|Overall Study||21
8771168|NCT01275365|9821316|FG001|COMPLETED|Overall Study||21
8771169|NCT01275365|9821317|FG002|COMPLETED|Overall Study||17
8771170|NCT01275365|9821318|FG003|COMPLETED|Overall Study||19
8771171|NCT01275365|9821315|FG000|NOT COMPLETED|Overall Study||3
8771172|NCT01275365|9821316|FG001|NOT COMPLETED|Overall Study||3
8771173|NCT01275365|9821317|FG002|NOT COMPLETED|Overall Study||5
8771174|NCT01275365|9821318|FG003|NOT COMPLETED|Overall Study||3
8771175|NCT01275430|9821328|FG000|STARTED|Overall Study||27
8771176|NCT01275430|9821328|FG000|COMPLETED|Overall Study||18
8771177|NCT01275430|9821328|FG000|NOT COMPLETED|Overall Study||9
8771178|NCT01275586|9821333|FG000|STARTED|Overall Study||6
8771179|NCT01275586|9821333|FG000|COMPLETED|Overall Study||3
8771180|NCT01275586|9821333|FG000|NOT COMPLETED|Overall Study||3
8771181|NCT01275625|9821337|FG000|STARTED|Overall Study||77
8771182|NCT01275625|9821337|FG000|Treated|Overall Study||77
8771183|NCT01275625|9821337|FG000|COMPLETED|Overall Study||64
8771184|NCT01275625|9821337|FG000|NOT COMPLETED|Overall Study||13
8771185|NCT01275664|9821341|FG000|STARTED|Overall Study||4
8771186|NCT01275664|9821341|FG000|COMPLETED|Overall Study||4
8771187|NCT01275664|9821341|FG000|NOT COMPLETED|Overall Study||0
8771188|NCT01275755|9821347|FG000|STARTED|Run-in Placebo Period||41
8771189|NCT01275755|9821348|FG001|STARTED|Run-in Placebo Period||40
8771190|NCT01275755|9821347|FG000|COMPLETED|Run-in Placebo Period||41
8771191|NCT01275755|9821348|FG001|COMPLETED|Run-in Placebo Period||40
8771192|NCT01275755|9821347|FG000|NOT COMPLETED|Run-in Placebo Period||0
8771193|NCT01275755|9821348|FG001|NOT COMPLETED|Run-in Placebo Period||0
8771194|NCT01275755|9821347|FG000|STARTED|Double-blind Treatment Period||41
8771195|NCT01275755|9821348|FG001|STARTED|Double-blind Treatment Period||40
8771196|NCT01275755|9821347|FG000|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||41
8771197|NCT01275755|9821348|FG001|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||40
8771198|NCT01275755|9821347|FG000|COMPLETED|Double-blind Treatment Period||39
8771199|NCT01275755|9821348|FG001|COMPLETED|Double-blind Treatment Period||37
8771200|NCT01275755|9821347|FG000|NOT COMPLETED|Double-blind Treatment Period||2
8771201|NCT01275755|9821348|FG001|NOT COMPLETED|Double-blind Treatment Period||3
8771202|NCT01275755|9821347|FG000|STARTED|Run-out Placebo Period||39
8771203|NCT01275755|9821348|FG001|STARTED|Run-out Placebo Period||37
8771204|NCT01275755|9821347|FG000|COMPLETED|Run-out Placebo Period||38
8771205|NCT01275755|9821348|FG001|COMPLETED|Run-out Placebo Period||37
8771206|NCT01275755|9821347|FG000|NOT COMPLETED|Run-out Placebo Period||1
8771207|NCT01275755|9821348|FG001|NOT COMPLETED|Run-out Placebo Period||0
8771208|NCT01275833|9821356|FG000|STARTED|Overall Study||1
8771209|NCT01275833|9821357|FG001|STARTED|Overall Study||1
8771210|NCT01275833|9821356|FG000|COMPLETED|Overall Study||0
8771211|NCT01275833|9821357|FG001|COMPLETED|Overall Study||0
8771212|NCT01275833|9821356|FG000|NOT COMPLETED|Overall Study||1
8771213|NCT01275833|9821357|FG001|NOT COMPLETED|Overall Study||1
8771214|NCT01276041|9821363|FG000|STARTED|Overall Study||70
8771215|NCT01276041|9821363|FG000|COMPLETED|Overall Study||67
8771216|NCT01276041|9821363|FG000|NOT COMPLETED|Overall Study||3
8771217|NCT01276106|9821371|FG000|STARTED|Overall Study||65
8771218|NCT01276106|9821372|FG001|STARTED|Overall Study||64
8771219|NCT01276106|9821373|FG002|STARTED|Overall Study||65
8771220|NCT01276106|9821374|FG003|STARTED|Overall Study||65
8771221|NCT01276106|9821371|FG000|COMPLETED|Overall Study||53
8771222|NCT01276106|9821372|FG001|COMPLETED|Overall Study||55
8771223|NCT01276106|9821373|FG002|COMPLETED|Overall Study||49
8771224|NCT01276106|9821374|FG003|COMPLETED|Overall Study||52
8771225|NCT01276106|9821371|FG000|NOT COMPLETED|Overall Study||12
8771226|NCT01276106|9821372|FG001|NOT COMPLETED|Overall Study||9
8771227|NCT01276106|9821373|FG002|NOT COMPLETED|Overall Study||16
8771228|NCT01276106|9821374|FG003|NOT COMPLETED|Overall Study||13
8771229|NCT01276171|9821387|FG000|STARTED|Overall Study||249
8771230|NCT01276171|9821388|FG001|STARTED|Overall Study||244
8771231|NCT01276171|9821389|FG002|STARTED|Overall Study||256
8771232|NCT01276171|9821387|FG000|COMPLETED|Overall Study||249
8771233|NCT01276171|9821388|FG001|COMPLETED|Overall Study||244
8771234|NCT01276171|9821389|FG002|COMPLETED|Overall Study||256
8771235|NCT01276171|9821387|FG000|NOT COMPLETED|Overall Study||0
8771236|NCT01276171|9821388|FG001|NOT COMPLETED|Overall Study||0
8771237|NCT01276171|9821389|FG002|NOT COMPLETED|Overall Study||0
8771238|NCT01276184|9821399|FG000|STARTED|Overall Study||13
8771239|NCT01276184|9821400|FG001|STARTED|Overall Study||9
8771240|NCT01276184|9821399|FG000|COMPLETED|Overall Study||13
8771241|NCT01276184|9821400|FG001|COMPLETED|Overall Study||9
8771242|NCT01276184|9821399|FG000|NOT COMPLETED|Overall Study||0
8771243|NCT01276184|9821400|FG001|NOT COMPLETED|Overall Study||0
8771244|NCT01276197|9821408|FG000|STARTED|Overall Study||308
8771245|NCT01276197|9821409|FG001|STARTED|Overall Study||310
8771246|NCT01276197|9821408|FG000|COMPLETED|Overall Study||200
8771247|NCT01276197|9821409|FG001|COMPLETED|Overall Study||200
8771248|NCT01276197|9821408|FG000|NOT COMPLETED|Overall Study||108
8771249|NCT01276197|9821409|FG001|NOT COMPLETED|Overall Study||110
8771250|NCT01276223|9821418|FG000|STARTED|Overall Study||78
8771251|NCT01276223|9821419|FG001|STARTED|Overall Study||107
8771252|NCT01276223|9821420|FG002|STARTED|Overall Study||104
8771253|NCT01276223|9821418|FG000|COMPLETED|Overall Study||67
8771254|NCT01276223|9821419|FG001|COMPLETED|Overall Study||103
8771255|NCT01276223|9821420|FG002|COMPLETED|Overall Study||101
8771256|NCT01276223|9821418|FG000|NOT COMPLETED|Overall Study||11
8771257|NCT01276223|9821419|FG001|NOT COMPLETED|Overall Study||4
8771258|NCT01276223|9821420|FG002|NOT COMPLETED|Overall Study||3
8771259|NCT01276236|9821427|FG000|STARTED|Overall Study||13
8771260|NCT01276236|9821427|FG000|Week 36 Visit|Overall Study||13
8771261|NCT01276236|9821427|FG000|Week 56 Visit|Overall Study||9
8771262|NCT01276236|9821427|FG000|Week 76 Visit|Overall Study||8
8771263|NCT01276236|9821427|FG000|COMPLETED|Overall Study||7
8771264|NCT01276236|9821427|FG000|NOT COMPLETED|Overall Study||6
8771265|NCT01276288|9821431|FG000|STARTED|Overall Study||7
8771266|NCT01276288|9821432|FG001|STARTED|Overall Study||6
8771267|NCT01276288|9821433|FG002|STARTED|Overall Study||5
8771268|NCT01276288|9821434|FG003|STARTED|Overall Study||5
8771269|NCT01276288|9821431|FG000|Received EMPA|Overall Study||6
8771270|NCT01276288|9821432|FG001|Received EMPA|Overall Study||5
8771271|NCT01276288|9821433|FG002|Received EMPA|Overall Study||5
8771272|NCT01276288|9821434|FG003|Received EMPA|Overall Study||5
8771273|NCT01276288|9821431|FG000|Received EMPA+HCT|Overall Study||5
8771274|NCT01276288|9821432|FG001|Received EMPA+HCT|Overall Study||5
8771275|NCT01276288|9821433|FG002|Received EMPA+HCT|Overall Study||0
8771276|NCT01276288|9821434|FG003|Received EMPA+HCT|Overall Study||0
8771277|NCT01276288|9821431|FG000|Received EMPA+TOR|Overall Study||0
8771278|NCT01276288|9821432|FG001|Received EMPA+TOR|Overall Study||0
8771279|NCT01276288|9821433|FG002|Received EMPA+TOR|Overall Study||5
8771280|NCT01276288|9821434|FG003|Received EMPA+TOR|Overall Study||5
8771281|NCT01276288|9821431|FG000|COMPLETED|Overall Study||5
8771282|NCT01276288|9821432|FG001|COMPLETED|Overall Study||5
8771283|NCT01276288|9821433|FG002|COMPLETED|Overall Study||5
8771284|NCT01276288|9821434|FG003|COMPLETED|Overall Study||5
8771285|NCT01276288|9821431|FG000|NOT COMPLETED|Overall Study||2
8771286|NCT01276288|9821432|FG001|NOT COMPLETED|Overall Study||1
8771287|NCT01276288|9821433|FG002|NOT COMPLETED|Overall Study||0
8771288|NCT01276288|9821434|FG003|NOT COMPLETED|Overall Study||0
8771289|NCT01276301|9821456|FG000|STARTED|First Intervention||8
8771290|NCT01276301|9821457|FG001|STARTED|First Intervention||8
8771291|NCT01276301|9821456|FG000|COMPLETED|First Intervention||8
8771292|NCT01276301|9821457|FG001|COMPLETED|First Intervention||8
8771293|NCT01276301|9821456|FG000|NOT COMPLETED|First Intervention||0
8771294|NCT01276301|9821457|FG001|NOT COMPLETED|First Intervention||0
8771295|NCT01276301|9821456|FG000|STARTED|Washout Period of 7 Days||8
8771296|NCT01276301|9821457|FG001|STARTED|Washout Period of 7 Days||8
8771297|NCT01276301|9821456|FG000|COMPLETED|Washout Period of 7 Days||8
8771298|NCT01276301|9821457|FG001|COMPLETED|Washout Period of 7 Days||8
8771299|NCT01276301|9821456|FG000|NOT COMPLETED|Washout Period of 7 Days||0
8771300|NCT01276301|9821457|FG001|NOT COMPLETED|Washout Period of 7 Days||0
8771301|NCT01276301|9821456|FG000|STARTED|Second Intervention||8
8771302|NCT01276301|9821457|FG001|STARTED|Second Intervention||8
8771303|NCT01276301|9821456|FG000|COMPLETED|Second Intervention||8
8771304|NCT01276301|9821457|FG001|COMPLETED|Second Intervention||8
8771305|NCT01276301|9821456|FG000|NOT COMPLETED|Second Intervention||0
8771306|NCT01276301|9821457|FG001|NOT COMPLETED|Second Intervention||0
8771307|NCT01276314|9821468|FG000|STARTED|Overall Study||48
8771308|NCT01276314|9821469|FG001|STARTED|Overall Study||43
8771309|NCT01276314|9821470|FG002|STARTED|Overall Study||22
8771310|NCT01276314|9821471|FG003|STARTED|Overall Study||22
8771311|NCT01276314|9821468|FG000|COMPLETED|Overall Study||38
8771312|NCT01276314|9821469|FG001|COMPLETED|Overall Study||33
8771313|NCT01276314|9821470|FG002|COMPLETED|Overall Study||18
8771314|NCT01276314|9821471|FG003|COMPLETED|Overall Study||17
8771315|NCT01276314|9821468|FG000|NOT COMPLETED|Overall Study||10
8771316|NCT01276314|9821469|FG001|NOT COMPLETED|Overall Study||10
8771317|NCT01276314|9821470|FG002|NOT COMPLETED|Overall Study||4
8771318|NCT01276314|9821471|FG003|NOT COMPLETED|Overall Study||5
8771319|NCT01276327|9821483|FG000|STARTED|Overall Study||32
8771320|NCT01276327|9821484|FG001|STARTED|Overall Study||32
8771321|NCT01276327|9821483|FG000|COMPLETED|Overall Study||30
8771322|NCT01276327|9821484|FG001|COMPLETED|Overall Study||29
8771323|NCT01276327|9821483|FG000|NOT COMPLETED|Overall Study||2
8771324|NCT01276327|9821484|FG001|NOT COMPLETED|Overall Study||3
8771325|NCT01276353|9821492|FG000|STARTED|Double-blind||22
8771326|NCT01276353|9821493|FG001|STARTED|Double-blind||23
8771327|NCT01276353|9821492|FG000|COMPLETED|Double-blind||19
8771328|NCT01276353|9821493|FG001|COMPLETED|Double-blind||23
8771329|NCT01276353|9821492|FG000|NOT COMPLETED|Double-blind||3
8771330|NCT01276353|9821493|FG001|NOT COMPLETED|Double-blind||0
8771331|NCT01276353|9821492|FG000|STARTED|Extension||19
8771332|NCT01276353|9821493|FG001|STARTED|Extension||23
8771333|NCT01276353|9821492|FG000|COMPLETED|Extension||12
8771334|NCT01276353|9821493|FG001|COMPLETED|Extension||14
8771335|NCT01276353|9821492|FG000|NOT COMPLETED|Extension||7
8771336|NCT01276353|9821493|FG001|NOT COMPLETED|Extension||9
8771337|NCT01276379|9821505|FG000|STARTED|Overall Study||221
8771338|NCT01276379|9821505|FG000|COMPLETED|Overall Study||181
8771339|NCT01276379|9821505|FG000|NOT COMPLETED|Overall Study||40
8771340|NCT01276457|9821513|FG000|STARTED|Core Study||142
8771341|NCT01276457|9821514|FG001|STARTED|Core Study||143
8771342|NCT01276457|9821513|FG000|COMPLETED|Core Study||129
8771343|NCT01276457|9821514|FG001|COMPLETED|Core Study||123
8771344|NCT01276457|9821513|FG000|NOT COMPLETED|Core Study||13
8771345|NCT01276457|9821514|FG001|NOT COMPLETED|Core Study||20
8771346|NCT01276457|9821513|FG000|STARTED|Extension Study||111
8771347|NCT01276457|9821514|FG001|STARTED|Extension Study||112
8771348|NCT01276457|9821513|FG000|COMPLETED|Extension Study||105
8771349|NCT01276457|9821514|FG001|COMPLETED|Extension Study||110
8771350|NCT01276457|9821513|FG000|NOT COMPLETED|Extension Study||6
8771351|NCT01276457|9821514|FG001|NOT COMPLETED|Extension Study||2
8771352|NCT01276509|9821524|FG000|STARTED|Overall Study||66
8771353|NCT01276509|9821525|FG001|STARTED|Overall Study||65
8771354|NCT01276509|9821526|FG002|STARTED|Overall Study||68
8771355|NCT01276509|9821527|FG003|STARTED|Overall Study||63
8771356|NCT01276509|9821524|FG000|COMPLETED|Overall Study||53
8771357|NCT01276509|9821525|FG001|COMPLETED|Overall Study||53
8771358|NCT01276509|9821526|FG002|COMPLETED|Overall Study||63
8771359|NCT01276509|9821527|FG003|COMPLETED|Overall Study||58
8771360|NCT01276509|9821524|FG000|NOT COMPLETED|Overall Study||13
8771361|NCT01276509|9821525|FG001|NOT COMPLETED|Overall Study||12
8771362|NCT01276509|9821526|FG002|NOT COMPLETED|Overall Study||5
8771363|NCT01276509|9821527|FG003|NOT COMPLETED|Overall Study||5
8771364|NCT01276535|9821537|FG000|STARTED|Overall Study||12
8771365|NCT01276535|9821537|FG000|COMPLETED|Overall Study||12
8771366|NCT01276535|9821537|FG000|NOT COMPLETED|Overall Study||0
8771367|NCT01276639|9821544|FG000|STARTED|Week 0 to 16||363
8771368|NCT01276639|9821545|FG001|STARTED|Week 0 to 16||361
8771369|NCT01276639|9821546|FG002|STARTED|Week 0 to 16||177
8771370|NCT01276639|9821547|FG003|STARTED|Week 0 to 16||0
8771371|NCT01276639|9821548|FG004|STARTED|Week 0 to 16||0
8771372|NCT01276639|9821544|FG000|Treated|Week 0 to 16||363
8771373|NCT01276639|9821545|FG001|Treated|Week 0 to 16||360
8771374|NCT01276639|9821546|FG002|Treated|Week 0 to 16||177
8771375|NCT01276639|9821547|FG003|Treated|Week 0 to 16||0
9028081|NCT03196297|10090365|FG000|Full Analysis Set (FAS)|Main Period||36
9028082|NCT03196297|10090365|FG000|Subject Analysis Set (SAS)|Main Period||36
9028083|NCT03196297|10090365|FG000|COMPLETED|Main Period||32
9028084|NCT03196297|10090365|FG000|NOT COMPLETED|Main Period||4
9028085|NCT03196297|10090365|FG000|STARTED|Extension Period||32
9028086|NCT03196297|10090365|FG000|FAS|Extension Period||32
9028087|NCT03196297|10090365|FG000|SAS|Extension Period||32
9028088|NCT03196297|10090365|FG000|COMPLETED|Extension Period||29
9028089|NCT03196297|10090365|FG000|NOT COMPLETED|Extension Period||3
8771376|NCT01276639|9821548|FG004|Treated|Week 0 to 16||0
8771377|NCT01276639|9821544|FG000|COMPLETED|Week 0 to 16||313
8771378|NCT01276639|9821545|FG001|COMPLETED|Week 0 to 16||320
8771379|NCT01276639|9821546|FG002|COMPLETED|Week 0 to 16||132
8771380|NCT01276639|9821547|FG003|COMPLETED|Week 0 to 16||0
8771381|NCT01276639|9821548|FG004|COMPLETED|Week 0 to 16||0
8771382|NCT01276639|9821544|FG000|NOT COMPLETED|Week 0 to 16||50
8771383|NCT01276639|9821545|FG001|NOT COMPLETED|Week 0 to 16||41
8771384|NCT01276639|9821546|FG002|NOT COMPLETED|Week 0 to 16||45
8771385|NCT01276639|9821547|FG003|NOT COMPLETED|Week 0 to 16||0
8771386|NCT01276639|9821548|FG004|NOT COMPLETED|Week 0 to 16||0
8771387|NCT01276639|9821544|FG000|STARTED|Week 16 to 52||313
8771388|NCT01276639|9821545|FG001|STARTED|Week 16 to 52||320
8771389|NCT01276639|9821546|FG002|STARTED|Week 16 to 52||0
8771390|NCT01276639|9821547|FG003|STARTED|Week 16 to 52||66
8771391|NCT01276639|9821548|FG004|STARTED|Week 16 to 52||66
8771392|NCT01276639|9821544|FG000|COMPLETED|Week 16 to 52||186
8771393|NCT01276639|9821545|FG001|COMPLETED|Week 16 to 52||219
8771394|NCT01276639|9821546|FG002|COMPLETED|Week 16 to 52||0
8771395|NCT01276639|9821547|FG003|COMPLETED|Week 16 to 52||50
9028090|NCT03196349|10090384|FG000|STARTED|Overall Study||17
9028091|NCT03196349|10090385|FG001|STARTED|Overall Study||14
9028092|NCT03196349|10090386|FG002|STARTED|Overall Study||13
9028093|NCT03196349|10090384|FG000|COMPLETED|Overall Study||0
9028094|NCT03196349|10090385|FG001|COMPLETED|Overall Study||0
9028095|NCT03196349|10090386|FG002|COMPLETED|Overall Study||0
9028096|NCT03196349|10090384|FG000|NOT COMPLETED|Overall Study||17
9028097|NCT03196349|10090385|FG001|NOT COMPLETED|Overall Study||14
9028098|NCT03196349|10090386|FG002|NOT COMPLETED|Overall Study||13
9028099|NCT03196505|10090396|FG000|STARTED|Overall Study||115
9028100|NCT03196505|10090397|FG001|STARTED|Overall Study||116
9028101|NCT03196505|10090396|FG000|COMPLETED|Overall Study||89
9028102|NCT03196505|10090397|FG001|COMPLETED|Overall Study||90
9028103|NCT03196505|10090396|FG000|NOT COMPLETED|Overall Study||26
9028104|NCT03196505|10090397|FG001|NOT COMPLETED|Overall Study||26
9028105|NCT03196635|10090403|FG000|STARTED|Overall Study||31
9028106|NCT03196635|10090403|FG000|COMPLETED|Overall Study||30
9028107|NCT03196635|10090403|FG000|NOT COMPLETED|Overall Study||1
9028108|NCT03196791|10090423|FG000|STARTED|Overall Study||98
9028109|NCT03196791|10090424|FG001|STARTED|Overall Study||98
9028110|NCT03196791|10090423|FG000|COMPLETED|Overall Study||88
9028111|NCT03196791|10090424|FG001|COMPLETED|Overall Study||93
9028112|NCT03196791|10090423|FG000|NOT COMPLETED|Overall Study||10
9028113|NCT03196791|10090424|FG001|NOT COMPLETED|Overall Study||5
9028114|NCT03196973|10090433|FG000|STARTED|Overall Study||197
9028115|NCT03196973|10090434|FG001|STARTED|Overall Study||196
9028116|NCT03196973|10090435|FG002|STARTED|Overall Study||100
9028117|NCT03196973|10090433|FG000|COMPLETED|Overall Study||188
9028118|NCT03196973|10090434|FG001|COMPLETED|Overall Study||184
9028119|NCT03196973|10090435|FG002|COMPLETED|Overall Study||95
9028120|NCT03196973|10090433|FG000|NOT COMPLETED|Overall Study||9
9028121|NCT03196973|10090434|FG001|NOT COMPLETED|Overall Study||12
9028122|NCT03196973|10090435|FG002|NOT COMPLETED|Overall Study||5
9028123|NCT03197025|10090443|FG000|STARTED|Overall Study||1
9028124|NCT03197025|10090443|FG000|COMPLETED|Overall Study||1
9028125|NCT03197025|10090443|FG000|NOT COMPLETED|Overall Study||0
9028126|NCT03197038|10090449|FG000|STARTED|Overall Study||22
9028127|NCT03197038|10090450|FG001|STARTED|Overall Study||17
9028128|NCT03197038|10090449|FG000|COMPLETED|Overall Study||18
9028129|NCT03197038|10090450|FG001|COMPLETED|Overall Study||17
9028130|NCT03197038|10090449|FG000|NOT COMPLETED|Overall Study||4
9028131|NCT03197038|10090450|FG001|NOT COMPLETED|Overall Study||0
9028132|NCT03197129|10090458|FG000|STARTED|Overall Study||60
9028133|NCT03197129|10090459|FG001|STARTED|Overall Study||62
9028134|NCT03197129|10090458|FG000|COMPLETED|Overall Study||56
9028135|NCT03197129|10090459|FG001|COMPLETED|Overall Study||57
9028136|NCT03197129|10090458|FG000|NOT COMPLETED|Overall Study||4
9028137|NCT03197129|10090459|FG001|NOT COMPLETED|Overall Study||5
9028138|NCT03197324|10090467|FG000|STARTED|Overall Study||10
9028139|NCT03197324|10090468|FG001|STARTED|Overall Study||10
9028140|NCT03197324|10090467|FG000|COMPLETED|Overall Study||10
9028141|NCT03197324|10090468|FG001|COMPLETED|Overall Study||9
9028142|NCT03197324|10090467|FG000|NOT COMPLETED|Overall Study||0
9028143|NCT03197324|10090468|FG001|NOT COMPLETED|Overall Study||1
9028144|NCT03197376|10090478|FG000|STARTED|Primary and Booster Phase||502
9028145|NCT03197376|10090479|FG001|STARTED|Primary and Booster Phase||501
9028146|NCT03197376|10090480|FG002|STARTED|Primary and Booster Phase||500
9028147|NCT03197376|10090481|FG003|STARTED|Primary and Booster Phase||747
9028148|NCT03197376|10090478|FG000|Vaccinated-Dose 1|Primary and Booster Phase||502
9028149|NCT03197376|10090479|FG001|Vaccinated-Dose 1|Primary and Booster Phase||501
9028150|NCT03197376|10090480|FG002|Vaccinated-Dose 1|Primary and Booster Phase||500
9028151|NCT03197376|10090481|FG003|Vaccinated-Dose 1|Primary and Booster Phase||747
9028152|NCT03197376|10090478|FG000|Vaccinated-Dose 2|Primary and Booster Phase||495
9028153|NCT03197376|10090479|FG001|Vaccinated-Dose 2|Primary and Booster Phase||495
9028154|NCT03197376|10090480|FG002|Vaccinated-Dose 2|Primary and Booster Phase||491
9028155|NCT03197376|10090481|FG003|Vaccinated-Dose 2|Primary and Booster Phase||738
9028156|NCT03197376|10090478|FG000|Vaccinated-Dose 3|Primary and Booster Phase||492
9028157|NCT03197376|10090479|FG001|Vaccinated-Dose 3|Primary and Booster Phase||493
9028158|NCT03197376|10090480|FG002|Vaccinated-Dose 3|Primary and Booster Phase||490
9028159|NCT03197376|10090481|FG003|Vaccinated-Dose 3|Primary and Booster Phase||731
9028160|NCT03197376|10090478|FG000|Primary Reactogenicity Cohort|Primary and Booster Phase||251
9028161|NCT03197376|10090479|FG001|Primary Reactogenicity Cohort|Primary and Booster Phase||243
9028162|NCT03197376|10090480|FG002|Primary Reactogenicity Cohort|Primary and Booster Phase||257
9028163|NCT03197376|10090481|FG003|Primary Reactogenicity Cohort|Primary and Booster Phase||364
9028164|NCT03197376|10090478|FG000|Booster Cohort|Primary and Booster Phase||150
9028165|NCT03197376|10090479|FG001|Booster Cohort|Primary and Booster Phase||151
9028166|NCT03197376|10090480|FG002|Booster Cohort|Primary and Booster Phase||150
9028167|NCT03197376|10090481|FG003|Booster Cohort|Primary and Booster Phase||224
9028168|NCT03197376|10090478|FG000|Received Booster Vaccine|Primary and Booster Phase||145
8771396|NCT01276639|9821548|FG004|COMPLETED|Week 16 to 52||45
8771397|NCT01276639|9821544|FG000|NOT COMPLETED|Week 16 to 52||127
8771398|NCT01276639|9821545|FG001|NOT COMPLETED|Week 16 to 52||101
8771399|NCT01276639|9821546|FG002|NOT COMPLETED|Week 16 to 52||0
8771400|NCT01276639|9821547|FG003|NOT COMPLETED|Week 16 to 52||16
8771401|NCT01276639|9821548|FG004|NOT COMPLETED|Week 16 to 52||21
8771402|NCT01276652|9821566|FG000|STARTED|Period 1: Randomization||9
8771403|NCT01276652|9821567|FG001|STARTED|Period 1: Randomization||8
8771404|NCT01276652|9821568|FG002|STARTED|Period 1: Randomization|No subjects were enrolled in this arm during Period 1.|0
8771405|NCT01276652|9821566|FG000|COMPLETED|Period 1: Randomization||9
8771406|NCT01276652|9821567|FG001|COMPLETED|Period 1: Randomization||8
8771407|NCT01276652|9821568|FG002|COMPLETED|Period 1: Randomization||0
8771408|NCT01276652|9821566|FG000|NOT COMPLETED|Period 1: Randomization||0
8771409|NCT01276652|9821567|FG001|NOT COMPLETED|Period 1: Randomization||0
8771410|NCT01276652|9821568|FG002|NOT COMPLETED|Period 1: Randomization||0
8771411|NCT01276652|9821566|FG000|STARTED|Period 2: Observational||9
8771412|NCT01276652|9821567|FG001|STARTED|Period 2: Observational||8
8771413|NCT01276652|9821568|FG002|STARTED|Period 2: Observational|Subjects were only enrolled in the Observational arm during Period 2.|5
8771414|NCT01276652|9821566|FG000|COMPLETED|Period 2: Observational||9
8771415|NCT01276652|9821567|FG001|COMPLETED|Period 2: Observational||8
8771416|NCT01276652|9821568|FG002|COMPLETED|Period 2: Observational||5
8771417|NCT01276652|9821566|FG000|NOT COMPLETED|Period 2: Observational||0
8771418|NCT01276652|9821567|FG001|NOT COMPLETED|Period 2: Observational||0
8771419|NCT01276652|9821568|FG002|NOT COMPLETED|Period 2: Observational||0
8771420|NCT01276756|9821583|FG000|STARTED|Overall Study||50
8771421|NCT01276756|9821584|FG001|STARTED|Overall Study||50
8771422|NCT01276756|9821583|FG000|COMPLETED|Overall Study||45
8771423|NCT01276756|9821584|FG001|COMPLETED|Overall Study||48
8771424|NCT01276756|9821583|FG000|NOT COMPLETED|Overall Study||5
8771425|NCT01276756|9821584|FG001|NOT COMPLETED|Overall Study||2
8771426|NCT01276821|9821592|FG000|STARTED|Overall Study||50
8771427|NCT01276821|9821593|FG001|STARTED|Overall Study||50
8771428|NCT01276821|9821592|FG000|COMPLETED|Overall Study||50
8771429|NCT01276821|9821593|FG001|COMPLETED|Overall Study||49
8771430|NCT01276821|9821592|FG000|NOT COMPLETED|Overall Study||0
8771431|NCT01276821|9821593|FG001|NOT COMPLETED|Overall Study||1
8771432|NCT01276847|9821602|FG000|STARTED|Overall Study||10
8771433|NCT01276847|9821603|FG001|STARTED|Overall Study||10
8771434|NCT01276847|9821604|FG002|STARTED|Overall Study||20
8771435|NCT01276847|9821602|FG000|COMPLETED|Overall Study||9
8771436|NCT01276847|9821603|FG001|COMPLETED|Overall Study||10
8771437|NCT01276847|9821604|FG002|COMPLETED|Overall Study||20
8771438|NCT01276847|9821602|FG000|NOT COMPLETED|Overall Study||1
8771439|NCT01276847|9821603|FG001|NOT COMPLETED|Overall Study||0
8771440|NCT01276847|9821604|FG002|NOT COMPLETED|Overall Study||0
8771441|NCT01276860|9821613|FG000|STARTED|Overall Study||5
8771442|NCT01276860|9821614|FG001|STARTED|Overall Study||2
8771443|NCT01276860|9821613|FG000|COMPLETED|Overall Study||5
8771444|NCT01276860|9821614|FG001|COMPLETED|Overall Study||2
8771445|NCT01276860|9821613|FG000|NOT COMPLETED|Overall Study||0
8771446|NCT01276860|9821614|FG001|NOT COMPLETED|Overall Study||0
8771447|NCT01277042|9821622|FG000|STARTED|Overall Study||606
8771448|NCT01277042|9821623|FG001|STARTED|Overall Study||606
8771449|NCT01277042|9821622|FG000|COMPLETED|Overall Study||598
8771450|NCT01277042|9821623|FG001|COMPLETED|Overall Study||601
8771451|NCT01277042|9821622|FG000|NOT COMPLETED|Overall Study||8
8771452|NCT01277042|9821623|FG001|NOT COMPLETED|Overall Study||5
8771453|NCT01277081|9821632|FG000|STARTED|Overall Study||100
8771454|NCT01277081|9821633|FG001|STARTED|Overall Study||100
8771455|NCT01277081|9821632|FG000|COMPLETED|Overall Study||100
8771456|NCT01277081|9821633|FG001|COMPLETED|Overall Study||100
8771457|NCT01277081|9821632|FG000|NOT COMPLETED|Overall Study||0
8771458|NCT01277081|9821633|FG001|NOT COMPLETED|Overall Study||0
8771459|NCT01277159|9821644|FG000|STARTED|Overall Study||21
8771460|NCT01277159|9821645|FG001|STARTED|Overall Study||22
8771461|NCT01277159|9821646|FG002|STARTED|Overall Study||22
8771462|NCT01277159|9821647|FG003|STARTED|Overall Study||22
8771463|NCT01277159|9821648|FG004|STARTED|Overall Study||21
8771464|NCT01277159|9821644|FG000|COMPLETED|Overall Study||17
8771465|NCT01277159|9821645|FG001|COMPLETED|Overall Study||21
8771466|NCT01277159|9821646|FG002|COMPLETED|Overall Study||19
8771467|NCT01277159|9821647|FG003|COMPLETED|Overall Study||19
8771468|NCT01277159|9821648|FG004|COMPLETED|Overall Study||16
8771469|NCT01277159|9821644|FG000|NOT COMPLETED|Overall Study||4
8771470|NCT01277159|9821645|FG001|NOT COMPLETED|Overall Study||1
8771471|NCT01277159|9821646|FG002|NOT COMPLETED|Overall Study||3
8771472|NCT01277159|9821647|FG003|NOT COMPLETED|Overall Study||3
8771473|NCT01277159|9821648|FG004|NOT COMPLETED|Overall Study||5
8771474|NCT01277302|9821663|FG000|STARTED|7-Month Fixed Treatment Period||85
8771475|NCT01277302|9821664|FG001|STARTED|7-Month Fixed Treatment Period||86
8771476|NCT01277302|9821665|FG002|STARTED|7-Month Fixed Treatment Period||31
8771477|NCT01277302|9821663|FG000|COMPLETED|7-Month Fixed Treatment Period||85
8771478|NCT01277302|9821664|FG001|COMPLETED|7-Month Fixed Treatment Period||86
8771479|NCT01277302|9821665|FG002|COMPLETED|7-Month Fixed Treatment Period||19
8771480|NCT01277302|9821663|FG000|NOT COMPLETED|7-Month Fixed Treatment Period||0
8771481|NCT01277302|9821664|FG001|NOT COMPLETED|7-Month Fixed Treatment Period||0
8771482|NCT01277302|9821665|FG002|NOT COMPLETED|7-Month Fixed Treatment Period||12
8771483|NCT01277302|9821663|FG000|STARTED|8-Month Alternate Dose Regimen Period||85
8771484|NCT01277302|9821664|FG001|STARTED|8-Month Alternate Dose Regimen Period||86
8771485|NCT01277302|9821665|FG002|STARTED|8-Month Alternate Dose Regimen Period||19
8771486|NCT01277302|9821663|FG000|COMPLETED|8-Month Alternate Dose Regimen Period||80
8771487|NCT01277302|9821664|FG001|COMPLETED|8-Month Alternate Dose Regimen Period||82
8771488|NCT01277302|9821665|FG002|COMPLETED|8-Month Alternate Dose Regimen Period||13
8771489|NCT01277302|9821663|FG000|NOT COMPLETED|8-Month Alternate Dose Regimen Period||5
8771490|NCT01277302|9821664|FG001|NOT COMPLETED|8-Month Alternate Dose Regimen Period||4
8771491|NCT01277302|9821665|FG002|NOT COMPLETED|8-Month Alternate Dose Regimen Period||6
8771492|NCT01277341|9821677|FG000|STARTED|Overall Study||150
8771493|NCT01277341|9821678|FG001|STARTED|Overall Study||150
8771494|NCT01277341|9821679|FG002|STARTED|Overall Study||149
8771495|NCT01277341|9821680|FG003|STARTED|Overall Study||152
8771496|NCT01277341|9821677|FG000|COMPLETED|Overall Study||146
8771497|NCT01277341|9821678|FG001|COMPLETED|Overall Study||145
8771498|NCT01277341|9821679|FG002|COMPLETED|Overall Study||145
8771499|NCT01277341|9821680|FG003|COMPLETED|Overall Study||146
8771500|NCT01277341|9821677|FG000|NOT COMPLETED|Overall Study||4
8771501|NCT01277341|9821678|FG001|NOT COMPLETED|Overall Study||5
8771502|NCT01277341|9821679|FG002|NOT COMPLETED|Overall Study||4
8771503|NCT01277341|9821680|FG003|NOT COMPLETED|Overall Study||6
8771504|NCT01277354|9821692|FG000|STARTED|Overall Study||1
8771505|NCT01277354|9821693|FG001|STARTED|Overall Study||1
8771506|NCT01277354|9821692|FG000|COMPLETED|Overall Study||1
8771507|NCT01277354|9821693|FG001|COMPLETED|Overall Study||1
8771508|NCT01277354|9821692|FG000|NOT COMPLETED|Overall Study||0
8771509|NCT01277354|9821693|FG001|NOT COMPLETED|Overall Study||0
8771510|NCT01277510|9821701|FG000|STARTED|Double-blind Phase||21
8771511|NCT01277510|9821702|FG001|STARTED|Double-blind Phase||22
8771512|NCT01277510|9821701|FG000|Received Investigational Product|Double-blind Phase||21
8771513|NCT01277510|9821702|FG001|Received Investigational Product|Double-blind Phase||22
8771514|NCT01277510|9821701|FG000|COMPLETED|Double-blind Phase|Completed investigational product|8
8771515|NCT01277510|9821702|FG001|COMPLETED|Double-blind Phase|Completed investigational product|4
8771516|NCT01277510|9821701|FG000|NOT COMPLETED|Double-blind Phase||13
8771517|NCT01277510|9821702|FG001|NOT COMPLETED|Double-blind Phase||18
8771518|NCT01277510|9821701|FG000|STARTED|Open-label Phase||8
8771519|NCT01277510|9821702|FG001|STARTED|Open-label Phase||4
8771520|NCT01277510|9821701|FG000|Received Investigational Product|Open-label Phase||6
8771521|NCT01277510|9821702|FG001|Received Investigational Product|Open-label Phase||4
8771522|NCT01277510|9821701|FG000|COMPLETED|Open-label Phase|Completed investigational product|1
8771523|NCT01277510|9821702|FG001|COMPLETED|Open-label Phase|Completed investigational product|1
8771524|NCT01277510|9821701|FG000|NOT COMPLETED|Open-label Phase||7
8771525|NCT01277510|9821702|FG001|NOT COMPLETED|Open-label Phase||3
8808585|NCT01490840|9860805|FG001|Modified Full Analysis Set|Phase 1||83
8808586|NCT01490840|9860804|FG000|COMPLETED|Phase 1||84
8808587|NCT01490840|9860805|FG001|COMPLETED|Phase 1||78
8808588|NCT01490840|9860804|FG000|NOT COMPLETED|Phase 1||10
8808589|NCT01490840|9860805|FG001|NOT COMPLETED|Phase 1||6
8808590|NCT01490840|9860804|FG000|STARTED|Phase 2|3 participants discontinued between phase 1 and phase 2|81
8808591|NCT01490840|9860805|FG001|STARTED|Phase 2|4 participants discontinued between phase 1 and phase 2|74
8808592|NCT01490840|9860804|FG000|COMPLETED|Phase 2||75
8808593|NCT01490840|9860805|FG001|COMPLETED|Phase 2||68
8808594|NCT01490840|9860804|FG000|NOT COMPLETED|Phase 2||6
8808595|NCT01490840|9860805|FG001|NOT COMPLETED|Phase 2||6
8808596|NCT01490866|9860811|FG000|STARTED|FOLFOX/Bevacizumab Treatment||70
8808597|NCT01490866|9860811|FG000|COMPLETED|FOLFOX/Bevacizumab Treatment||49
8808598|NCT01490866|9860811|FG000|NOT COMPLETED|FOLFOX/Bevacizumab Treatment||21
8808599|NCT01490866|9860811|FG000|STARTED|Axitinib Maintenance Therapy||49
8808600|NCT01490866|9860811|FG000|COMPLETED|Axitinib Maintenance Therapy|No protocol defined endpoint to Axitinib maintenance treatment.|0
8808601|NCT01490866|9860811|FG000|NOT COMPLETED|Axitinib Maintenance Therapy||49
8808602|NCT01490892|9860818|FG000|STARTED|Overall Study||219
8808603|NCT01490892|9860818|FG000|COMPLETED|Overall Study||219
8808604|NCT01490892|9860818|FG000|NOT COMPLETED|Overall Study||0
8808605|NCT01490918|9860825|FG000|STARTED|Overall Study||65
8808606|NCT01490918|9860826|FG001|STARTED|Overall Study||66
8808607|NCT01490918|9860827|FG002|STARTED|Overall Study||34
8808608|NCT01490918|9860825|FG000|COMPLETED|Overall Study||52
8808609|NCT01490918|9860826|FG001|COMPLETED|Overall Study||52
8808610|NCT01490918|9860827|FG002|COMPLETED|Overall Study||22
8808611|NCT01490918|9860825|FG000|NOT COMPLETED|Overall Study||13
8808612|NCT01490918|9860826|FG001|NOT COMPLETED|Overall Study||14
8808613|NCT01490918|9860827|FG002|NOT COMPLETED|Overall Study||12
8808614|NCT01490931|9860839|FG000|STARTED|Overall Study||25
8808615|NCT01490931|9860839|FG000|COMPLETED|Overall Study||25
8808616|NCT01490931|9860839|FG000|NOT COMPLETED|Overall Study||0
8808617|NCT01491022|9860845|FG000|STARTED|Intervention 1||10
8808618|NCT01491022|9860846|FG001|STARTED|Intervention 1||12
8808619|NCT01491022|9860845|FG000|COMPLETED|Intervention 1||9
8808620|NCT01491022|9860846|FG001|COMPLETED|Intervention 1||11
8808621|NCT01491022|9860845|FG000|NOT COMPLETED|Intervention 1||1
8808622|NCT01491022|9860846|FG001|NOT COMPLETED|Intervention 1||1
8808623|NCT01491022|9860845|FG000|STARTED|2 Week Washout||9
8808624|NCT01491022|9860846|FG001|STARTED|2 Week Washout||11
8808625|NCT01491022|9860845|FG000|COMPLETED|2 Week Washout||9
8808626|NCT01491022|9860846|FG001|COMPLETED|2 Week Washout||11
8808627|NCT01491022|9860845|FG000|NOT COMPLETED|2 Week Washout||0
8808628|NCT01491022|9860846|FG001|NOT COMPLETED|2 Week Washout||0
8808629|NCT01491022|9860845|FG000|STARTED|Intervention 2||9
8808630|NCT01491022|9860846|FG001|STARTED|Intervention 2||11
8771526|NCT01277523|9821713|FG000|STARTED|Overall Study||135
8771527|NCT01277523|9821714|FG001|STARTED|Overall Study||127
8771528|NCT01277523|9821715|FG002|STARTED|Overall Study||130
8771529|NCT01277523|9821713|FG000|COMPLETED|Overall Study||132
8771530|NCT01277523|9821714|FG001|COMPLETED|Overall Study||126
8771531|NCT01277523|9821715|FG002|COMPLETED|Overall Study||130
8771532|NCT01277523|9821713|FG000|NOT COMPLETED|Overall Study||3
8771533|NCT01277523|9821714|FG001|NOT COMPLETED|Overall Study||1
8771534|NCT01277523|9821715|FG002|NOT COMPLETED|Overall Study||0
8771535|NCT01277549|9821725|FG000|STARTED|Overall Study||41
8771536|NCT01277549|9821726|FG001|STARTED|Overall Study||29
8771537|NCT01277549|9821725|FG000|COMPLETED|Overall Study||15
8771538|NCT01277549|9821726|FG001|COMPLETED|Overall Study||15
8771539|NCT01277549|9821725|FG000|NOT COMPLETED|Overall Study||26
8771540|NCT01277549|9821726|FG001|NOT COMPLETED|Overall Study||14
8771541|NCT01277601|9821739|FG000|STARTED|Overall Study||188
9028169|NCT03197376|10090479|FG001|Received Booster Vaccine|Primary and Booster Phase||144
9028170|NCT03197376|10090480|FG002|Received Booster Vaccine|Primary and Booster Phase||139
9028171|NCT03197376|10090481|FG003|Received Booster Vaccine|Primary and Booster Phase||213
9028172|NCT03197376|10090478|FG000|COMPLETED|Primary and Booster Phase||487
9028173|NCT03197376|10090479|FG001|COMPLETED|Primary and Booster Phase||488
9028174|NCT03197376|10090480|FG002|COMPLETED|Primary and Booster Phase||480
9028175|NCT03197376|10090481|FG003|COMPLETED|Primary and Booster Phase||722
9028176|NCT03197376|10090478|FG000|NOT COMPLETED|Primary and Booster Phase||15
9028177|NCT03197376|10090479|FG001|NOT COMPLETED|Primary and Booster Phase||13
9028178|NCT03197376|10090480|FG002|NOT COMPLETED|Primary and Booster Phase||20
9028179|NCT03197376|10090481|FG003|NOT COMPLETED|Primary and Booster Phase||25
9028180|NCT03197376|10090478|FG000|STARTED|Immune Persistence Phase||132
9028181|NCT03197376|10090479|FG001|STARTED|Immune Persistence Phase||133
9028182|NCT03197376|10090480|FG002|STARTED|Immune Persistence Phase||128
9028183|NCT03197376|10090481|FG003|STARTED|Immune Persistence Phase||195
9028184|NCT03197376|10090478|FG000|COMPLETED|Immune Persistence Phase||127
9028185|NCT03197376|10090479|FG001|COMPLETED|Immune Persistence Phase||129
9028186|NCT03197376|10090480|FG002|COMPLETED|Immune Persistence Phase||123
9028187|NCT03197376|10090481|FG003|COMPLETED|Immune Persistence Phase||190
9028188|NCT03197376|10090478|FG000|NOT COMPLETED|Immune Persistence Phase||5
9028189|NCT03197376|10090479|FG001|NOT COMPLETED|Immune Persistence Phase||4
9028190|NCT03197376|10090480|FG002|NOT COMPLETED|Immune Persistence Phase||5
9028191|NCT03197376|10090481|FG003|NOT COMPLETED|Immune Persistence Phase||5
9028192|NCT03197389|10090520|FG000|STARTED|Overall Study||16
9028193|NCT03197389|10090521|FG001|STARTED|Overall Study||5
9028194|NCT03197389|10090522|FG002|STARTED|Overall Study||18
9028195|NCT03197389|10090523|FG003|STARTED|Overall Study||9
9028196|NCT03197389|10090524|FG004|STARTED|Overall Study||1
9028197|NCT03197389|10090525|FG005|STARTED|Overall Study||5
9028198|NCT03197389|10090520|FG000|COMPLETED|Overall Study||16
9028199|NCT03197389|10090521|FG001|COMPLETED|Overall Study||5
9028200|NCT03197389|10090522|FG002|COMPLETED|Overall Study||18
9028201|NCT03197389|10090523|FG003|COMPLETED|Overall Study||9
9028202|NCT03197389|10090524|FG004|COMPLETED|Overall Study||1
9028203|NCT03197389|10090525|FG005|COMPLETED|Overall Study||5
9028204|NCT03197389|10090520|FG000|NOT COMPLETED|Overall Study||0
9028205|NCT03197389|10090521|FG001|NOT COMPLETED|Overall Study||0
9028206|NCT03197389|10090522|FG002|NOT COMPLETED|Overall Study||0
9028207|NCT03197389|10090523|FG003|NOT COMPLETED|Overall Study||0
9028208|NCT03197389|10090524|FG004|NOT COMPLETED|Overall Study||0
9028209|NCT03197389|10090525|FG005|NOT COMPLETED|Overall Study||0
9028210|NCT03197558|10090539|FG000|STARTED|Overall Study||30
9028211|NCT03197558|10090539|FG000|COMPLETED|Overall Study||29
9028212|NCT03197558|10090539|FG000|NOT COMPLETED|Overall Study||1
9028213|NCT03197883|10090545|FG000|STARTED|Overall Study||50
9028214|NCT03197883|10090546|FG001|STARTED|Overall Study||50
9028215|NCT03197883|10090545|FG000|COMPLETED|Overall Study||47
9028216|NCT03197883|10090546|FG001|COMPLETED|Overall Study||44
9028217|NCT03197883|10090545|FG000|NOT COMPLETED|Overall Study||3
9028218|NCT03197883|10090546|FG001|NOT COMPLETED|Overall Study||6
9028219|NCT03198000|10090555|FG000|STARTED|Overall Study||41
9028220|NCT03198000|10090556|FG001|STARTED|Overall Study||38
9028221|NCT03198000|10090557|FG002|STARTED|Overall Study||41
9028222|NCT03198000|10090555|FG000|COMPLETED|Overall Study||41
9028223|NCT03198000|10090556|FG001|COMPLETED|Overall Study||38
9028224|NCT03198000|10090557|FG002|COMPLETED|Overall Study||41
9028225|NCT03198000|10090555|FG000|NOT COMPLETED|Overall Study||0
9028226|NCT03198000|10090556|FG001|NOT COMPLETED|Overall Study||0
9028227|NCT03198000|10090557|FG002|NOT COMPLETED|Overall Study||0
9028228|NCT03198221|10090569|FG000|STARTED|Overall Study||3
9028229|NCT03198221|10090570|FG001|STARTED|Overall Study||2
9028230|NCT03198221|10090571|FG002|STARTED|Overall Study||7
9028231|NCT03198221|10090572|FG003|STARTED|Overall Study||2
9028232|NCT03198221|10090569|FG000|COMPLETED|Overall Study||3
9028233|NCT03198221|10090570|FG001|COMPLETED|Overall Study||2
9028234|NCT03198221|10090571|FG002|COMPLETED|Overall Study||7
9028235|NCT03198221|10090572|FG003|COMPLETED|Overall Study||2
9028236|NCT03198221|10090569|FG000|NOT COMPLETED|Overall Study||0
9028237|NCT03198221|10090570|FG001|NOT COMPLETED|Overall Study||0
9028238|NCT03198221|10090571|FG002|NOT COMPLETED|Overall Study||0
9028239|NCT03198221|10090572|FG003|NOT COMPLETED|Overall Study||0
9028240|NCT03198507|10090584|FG000|STARTED|Overall Study||228
8771542|NCT01277601|9821740|FG001|STARTED|Overall Study||187
8771543|NCT01277601|9821741|FG002|STARTED|Overall Study||190
8771544|NCT01277601|9821742|FG003|STARTED|Overall Study||186
8771545|NCT01277601|9821739|FG000|COMPLETED|Overall Study||151
8771546|NCT01277601|9821740|FG001|COMPLETED|Overall Study||139
8771547|NCT01277601|9821741|FG002|COMPLETED|Overall Study||163
8771548|NCT01277601|9821742|FG003|COMPLETED|Overall Study||150
8771549|NCT01277601|9821739|FG000|NOT COMPLETED|Overall Study||37
8771550|NCT01277601|9821740|FG001|NOT COMPLETED|Overall Study||48
8771551|NCT01277601|9821741|FG002|NOT COMPLETED|Overall Study||27
8771552|NCT01277601|9821742|FG003|NOT COMPLETED|Overall Study||36
8771553|NCT01277666|9821772|FG000|STARTED|Overall Study||203
8771554|NCT01277666|9821773|FG001|STARTED|Overall Study||203
8771555|NCT01277666|9821774|FG002|STARTED|Overall Study||202
8771556|NCT01277666|9821772|FG000|COMPLETED|Overall Study||158
8771557|NCT01277666|9821773|FG001|COMPLETED|Overall Study||144
8771558|NCT01277666|9821774|FG002|COMPLETED|Overall Study||153
8771559|NCT01277666|9821772|FG000|NOT COMPLETED|Overall Study||45
8771560|NCT01277666|9821773|FG001|NOT COMPLETED|Overall Study||59
8771561|NCT01277666|9821774|FG002|NOT COMPLETED|Overall Study||49
8771562|NCT01277718|9821782|FG000|STARTED|Period 1 - First Intervention||10
8771563|NCT01277718|9821783|FG001|STARTED|Period 1 - First Intervention||10
8771564|NCT01277718|9821782|FG000|COMPLETED|Period 1 - First Intervention||10
8771565|NCT01277718|9821783|FG001|COMPLETED|Period 1 - First Intervention||10
8771566|NCT01277718|9821782|FG000|NOT COMPLETED|Period 1 - First Intervention||0
8771567|NCT01277718|9821783|FG001|NOT COMPLETED|Period 1 - First Intervention||0
8771568|NCT01277718|9821782|FG000|STARTED|Washout Period of 13 Days||10
8771569|NCT01277718|9821783|FG001|STARTED|Washout Period of 13 Days||10
8771570|NCT01277718|9821782|FG000|COMPLETED|Washout Period of 13 Days||10
8771571|NCT01277718|9821783|FG001|COMPLETED|Washout Period of 13 Days||10
8771572|NCT01277718|9821782|FG000|NOT COMPLETED|Washout Period of 13 Days||0
8771573|NCT01277718|9821783|FG001|NOT COMPLETED|Washout Period of 13 Days||0
8771574|NCT01277718|9821782|FG000|STARTED|Period 2 - Second Intervention||10
8771575|NCT01277718|9821783|FG001|STARTED|Period 2 - Second Intervention||10
8771576|NCT01277718|9821782|FG000|COMPLETED|Period 2 - Second Intervention||10
8771577|NCT01277718|9821783|FG001|COMPLETED|Period 2 - Second Intervention||7
8771578|NCT01277718|9821782|FG000|NOT COMPLETED|Period 2 - Second Intervention||0
8771579|NCT01277718|9821783|FG001|NOT COMPLETED|Period 2 - Second Intervention||3
8771580|NCT01277718|9821782|FG000|STARTED|Washout Period of 13 Days||10
8771581|NCT01277718|9821783|FG001|STARTED|Washout Period of 13 Days||7
8771582|NCT01277718|9821782|FG000|COMPLETED|Washout Period of 13 Days||10
8771583|NCT01277718|9821783|FG001|COMPLETED|Washout Period of 13 Days||7
8771584|NCT01277718|9821782|FG000|NOT COMPLETED|Washout Period of 13 Days||0
8771585|NCT01277718|9821783|FG001|NOT COMPLETED|Washout Period of 13 Days||0
8771586|NCT01277718|9821782|FG000|STARTED|Period 3 - Third Intervention||10
8771587|NCT01277718|9821783|FG001|STARTED|Period 3 - Third Intervention||7
8771588|NCT01277718|9821782|FG000|COMPLETED|Period 3 - Third Intervention||10
8771589|NCT01277718|9821783|FG001|COMPLETED|Period 3 - Third Intervention||7
8771590|NCT01277718|9821782|FG000|NOT COMPLETED|Period 3 - Third Intervention||0
8771591|NCT01277718|9821783|FG001|NOT COMPLETED|Period 3 - Third Intervention||0
8771592|NCT01277744|9821791|FG000|STARTED|Overall Study||22
8771593|NCT01277744|9821791|FG000|COMPLETED|Overall Study||20
8771594|NCT01277744|9821791|FG000|NOT COMPLETED|Overall Study||2
8771595|NCT01277757|9821795|FG000|STARTED|Overall Study||30
8771596|NCT01277757|9821795|FG000|COMPLETED|Overall Study||28
8771597|NCT01277757|9821795|FG000|NOT COMPLETED|Overall Study||2
8771598|NCT01277783|9821799|FG000|STARTED|Overall Study||138
8771599|NCT01277783|9821799|FG000|COMPLETED|Overall Study||138
8771600|NCT01277783|9821799|FG000|NOT COMPLETED|Overall Study||0
8771601|NCT01277861|9821806|FG000|STARTED|Overall Study||51
8771602|NCT01277861|9821807|FG001|STARTED|Overall Study||49
8771603|NCT01277861|9821806|FG000|COMPLETED|Overall Study||49
8771604|NCT01277861|9821807|FG001|COMPLETED|Overall Study||47
8771605|NCT01277861|9821806|FG000|NOT COMPLETED|Overall Study||2
8771606|NCT01277861|9821807|FG001|NOT COMPLETED|Overall Study||2
8771607|NCT01277887|9821817|FG000|STARTED|Pre-Quit Treatment Phase||9
8771608|NCT01277887|9821818|FG001|STARTED|Pre-Quit Treatment Phase||10
8771609|NCT01277887|9821817|FG000|Entered Study|Pre-Quit Treatment Phase||7
8771610|NCT01277887|9821818|FG001|Entered Study|Pre-Quit Treatment Phase||10
8771611|NCT01277887|9821817|FG000|COMPLETED|Pre-Quit Treatment Phase||6
8771612|NCT01277887|9821818|FG001|COMPLETED|Pre-Quit Treatment Phase||10
8771613|NCT01277887|9821817|FG000|NOT COMPLETED|Pre-Quit Treatment Phase||3
8771614|NCT01277887|9821818|FG001|NOT COMPLETED|Pre-Quit Treatment Phase||0
8771615|NCT01277887|9821817|FG000|STARTED|Post-Quit Treatment Phase||6
8771616|NCT01277887|9821818|FG001|STARTED|Post-Quit Treatment Phase||10
8771617|NCT01277887|9821817|FG000|COMPLETED|Post-Quit Treatment Phase||3
8771618|NCT01277887|9821818|FG001|COMPLETED|Post-Quit Treatment Phase||5
8771619|NCT01277887|9821817|FG000|NOT COMPLETED|Post-Quit Treatment Phase||3
8771620|NCT01277887|9821818|FG001|NOT COMPLETED|Post-Quit Treatment Phase||5
8771621|NCT01278030|9821826|FG000|STARTED|Overall Study||43
8771622|NCT01278030|9821827|FG001|STARTED|Overall Study||35
8771623|NCT01278030|9821826|FG000|COMPLETED|Overall Study||35
8771624|NCT01278030|9821827|FG001|COMPLETED|Overall Study||31
8771625|NCT01278030|9821826|FG000|NOT COMPLETED|Overall Study||8
8771626|NCT01278030|9821827|FG001|NOT COMPLETED|Overall Study||4
8771627|NCT01278160|9821835|FG000|STARTED|Overall Study||89
8771628|NCT01278160|9821836|FG001|STARTED|Overall Study||90
8771629|NCT01278160|9821835|FG000|COMPLETED|Overall Study||84
8771630|NCT01278160|9821836|FG001|COMPLETED|Overall Study||84
8771631|NCT01278160|9821835|FG000|NOT COMPLETED|Overall Study||5
8771632|NCT01278160|9821836|FG001|NOT COMPLETED|Overall Study||6
8771633|NCT01278173|9821842|FG000|STARTED|Overall Study||65
8771634|NCT01278173|9821842|FG000|COMPLETED|Overall Study||38
8771635|NCT01278173|9821842|FG000|NOT COMPLETED|Overall Study||27
8771636|NCT01278303|9821846|FG000|STARTED|Overall Study||82
8771637|NCT01278303|9821846|FG000|COMPLETED|Overall Study||82
8771638|NCT01278303|9821846|FG000|NOT COMPLETED|Overall Study||0
8771639|NCT01278342|9821853|FG000|STARTED|Overall Study||7
8771640|NCT01278342|9821854|FG001|STARTED|Overall Study||31
8771641|NCT01278342|9821855|FG002|STARTED|Overall Study||32
8771642|NCT01278342|9821853|FG000|COMPLETED|Overall Study||3
8771643|NCT01278342|9821854|FG001|COMPLETED|Overall Study||30
8771644|NCT01278342|9821855|FG002|COMPLETED|Overall Study||32
8771645|NCT01278342|9821853|FG000|NOT COMPLETED|Overall Study||4
8916054|NCT02179671|9975558|FG004|NOT COMPLETED|Overall Study||13
8916055|NCT02179788|9975572|FG000|STARTED|Overall Study||10
8916056|NCT02179788|9975573|FG001|STARTED|Overall Study||5
8916057|NCT02179788|9975572|FG000|COMPLETED|Overall Study||10
8916058|NCT02179788|9975573|FG001|COMPLETED|Overall Study||5
8916059|NCT02179788|9975572|FG000|NOT COMPLETED|Overall Study||0
8916060|NCT02179788|9975573|FG001|NOT COMPLETED|Overall Study||0
8916061|NCT02179892|9975581|FG000|STARTED|Overall Study||5
8916062|NCT02179892|9975582|FG001|STARTED|Overall Study||4
8916063|NCT02179892|9975581|FG000|COMPLETED|Overall Study||5
8916064|NCT02179892|9975582|FG001|COMPLETED|Overall Study||4
8916065|NCT02179892|9975581|FG000|NOT COMPLETED|Overall Study||0
8916066|NCT02179892|9975582|FG001|NOT COMPLETED|Overall Study||0
8916067|NCT02179918|9975593|FG000|STARTED|Overall Study||5
8916068|NCT02179918|9975594|FG001|STARTED|Overall Study||3
8916069|NCT02179918|9975595|FG002|STARTED|Overall Study||3
8916070|NCT02179918|9975596|FG003|STARTED|Overall Study||3
8916071|NCT02179918|9975597|FG004|STARTED|Overall Study||9
8916072|NCT02179918|9975593|FG000|COMPLETED|Overall Study||1
8916073|NCT02179918|9975594|FG001|COMPLETED|Overall Study||0
8916074|NCT02179918|9975595|FG002|COMPLETED|Overall Study||1
8916075|NCT02179918|9975596|FG003|COMPLETED|Overall Study||0
8916076|NCT02179918|9975597|FG004|COMPLETED|Overall Study||1
8916077|NCT02179918|9975593|FG000|NOT COMPLETED|Overall Study||4
8916078|NCT02179918|9975594|FG001|NOT COMPLETED|Overall Study||3
8916079|NCT02179918|9975595|FG002|NOT COMPLETED|Overall Study||2
8916080|NCT02179918|9975596|FG003|NOT COMPLETED|Overall Study||3
8771646|NCT01278342|9821854|FG001|NOT COMPLETED|Overall Study||1
8771647|NCT01278342|9821855|FG002|NOT COMPLETED|Overall Study||0
8771648|NCT01278394|9821863|FG000|STARTED|Overall Study||29
8771649|NCT01278394|9821863|FG000|COMPLETED|Overall Study||28
8771650|NCT01278394|9821863|FG000|NOT COMPLETED|Overall Study||1
8771651|NCT01278407|9821870|FG000|STARTED|Confirmatory Phase||46
8771652|NCT01278407|9821871|FG001|STARTED|Confirmatory Phase||47
8771653|NCT01278407|9821872|FG002|STARTED|Confirmatory Phase||49
8771654|NCT01278407|9821873|FG003|STARTED|Confirmatory Phase||0
8771655|NCT01278407|9821874|FG004|STARTED|Confirmatory Phase||0
8771656|NCT01278407|9821870|FG000|COMPLETED|Confirmatory Phase||37
8771657|NCT01278407|9821871|FG001|COMPLETED|Confirmatory Phase||31
8771658|NCT01278407|9821872|FG002|COMPLETED|Confirmatory Phase||43
8771659|NCT01278407|9821873|FG003|COMPLETED|Confirmatory Phase||0
8771660|NCT01278407|9821874|FG004|COMPLETED|Confirmatory Phase||0
8771661|NCT01278407|9821870|FG000|NOT COMPLETED|Confirmatory Phase||9
8771662|NCT01278407|9821871|FG001|NOT COMPLETED|Confirmatory Phase||16
8771663|NCT01278407|9821872|FG002|NOT COMPLETED|Confirmatory Phase||6
8771664|NCT01278407|9821873|FG003|NOT COMPLETED|Confirmatory Phase||0
8771665|NCT01278407|9821874|FG004|NOT COMPLETED|Confirmatory Phase||0
8771666|NCT01278407|9821870|FG000|STARTED|Extension Phase||0
8771667|NCT01278407|9821871|FG001|STARTED|Extension Phase||0
8771668|NCT01278407|9821872|FG002|STARTED|Extension Phase||0
8771669|NCT01278407|9821873|FG003|STARTED|Extension Phase||46
8771670|NCT01278407|9821874|FG004|STARTED|Extension Phase||96
8771671|NCT01278407|9821870|FG000|COMPLETED|Extension Phase||0
8771672|NCT01278407|9821871|FG001|COMPLETED|Extension Phase||0
8771673|NCT01278407|9821872|FG002|COMPLETED|Extension Phase||0
8771674|NCT01278407|9821873|FG003|COMPLETED|Extension Phase||34
8771675|NCT01278407|9821874|FG004|COMPLETED|Extension Phase||66
8771676|NCT01278407|9821870|FG000|NOT COMPLETED|Extension Phase||0
8771677|NCT01278407|9821871|FG001|NOT COMPLETED|Extension Phase||0
8771678|NCT01278407|9821872|FG002|NOT COMPLETED|Extension Phase||0
8771679|NCT01278407|9821873|FG003|NOT COMPLETED|Extension Phase||12
8771680|NCT01278407|9821874|FG004|NOT COMPLETED|Extension Phase||30
8771681|NCT01278485|9821884|FG000|STARTED|Overall Study||719
8771682|NCT01278485|9821884|FG000|COMPLETED|Overall Study||719
8771683|NCT01278485|9821884|FG000|NOT COMPLETED|Overall Study||0
8771684|NCT01278615|9821888|FG000|STARTED|Overall Study||16
8771685|NCT01278615|9821888|FG000|COMPLETED|Overall Study||14
8771686|NCT01278615|9821888|FG000|NOT COMPLETED|Overall Study||2
8771687|NCT01278745|9821894|FG000|STARTED|Overall Study||89
8771688|NCT01278745|9821895|FG001|STARTED|Overall Study||74
8771689|NCT01278745|9821896|FG002|STARTED|Overall Study||121
8771690|NCT01278745|9821897|FG003|STARTED|Overall Study||78
8916081|NCT02179918|9975597|FG004|NOT COMPLETED|Overall Study||8
8916082|NCT02180061|9975612|FG000|STARTED|Overall Study||34
8916083|NCT02180061|9975613|FG001|STARTED|Overall Study||8
8771691|NCT01278745|9821894|FG000|COMPLETED|Overall Study||84
8771692|NCT01278745|9821895|FG001|COMPLETED|Overall Study||68
8916084|NCT02180061|9975612|FG000|COMPLETED|Overall Study||9
8771693|NCT01278745|9821896|FG002|COMPLETED|Overall Study||0
8771694|NCT01278745|9821897|FG003|COMPLETED|Overall Study||0
8771695|NCT01278745|9821894|FG000|NOT COMPLETED|Overall Study||5
8771696|NCT01278745|9821895|FG001|NOT COMPLETED|Overall Study||6
8771697|NCT01278745|9821896|FG002|NOT COMPLETED|Overall Study||121
8771698|NCT01278745|9821897|FG003|NOT COMPLETED|Overall Study||78
8771699|NCT01278797|9821905|FG000|STARTED|Period 1||14
8771700|NCT01278797|9821906|FG001|STARTED|Period 1||14
8771701|NCT01278797|9821905|FG000|COMPLETED|Period 1||13
8771702|NCT01278797|9821906|FG001|COMPLETED|Period 1||13
8771703|NCT01278797|9821905|FG000|NOT COMPLETED|Period 1||1
8771704|NCT01278797|9821906|FG001|NOT COMPLETED|Period 1||1
8771705|NCT01278797|9821905|FG000|STARTED|Washout Period of 21 Days||13
8771706|NCT01278797|9821906|FG001|STARTED|Washout Period of 21 Days||13
8771707|NCT01278797|9821905|FG000|COMPLETED|Washout Period of 21 Days||13
8771708|NCT01278797|9821906|FG001|COMPLETED|Washout Period of 21 Days||13
8771709|NCT01278797|9821905|FG000|NOT COMPLETED|Washout Period of 21 Days||0
8771710|NCT01278797|9821906|FG001|NOT COMPLETED|Washout Period of 21 Days||0
8771711|NCT01278797|9821905|FG000|STARTED|Period 2||13
8771712|NCT01278797|9821906|FG001|STARTED|Period 2||13
8771713|NCT01278797|9821905|FG000|COMPLETED|Period 2||13
8771714|NCT01278797|9821906|FG001|COMPLETED|Period 2||13
8771715|NCT01278797|9821905|FG000|NOT COMPLETED|Period 2||0
8771716|NCT01278797|9821906|FG001|NOT COMPLETED|Period 2||0
8771717|NCT01278862|9821914|FG000|STARTED|Overall Study||45
8771718|NCT01278862|9821915|FG001|STARTED|Overall Study||43
8771719|NCT01278862|9821914|FG000|COMPLETED|Overall Study||44
8771720|NCT01278862|9821915|FG001|COMPLETED|Overall Study||42
8771721|NCT01278862|9821914|FG000|NOT COMPLETED|Overall Study||1
8771722|NCT01278862|9821915|FG001|NOT COMPLETED|Overall Study||1
8771723|NCT01278927|9821925|FG000|STARTED|Overall Study||180
8771724|NCT01278927|9821926|FG001|STARTED|Overall Study||178
8771725|NCT01278927|9821927|FG002|STARTED|Overall Study||178
8771726|NCT01278927|9821928|FG003|STARTED|Overall Study||175
8771727|NCT01278927|9821925|FG000|COMPLETED|Overall Study||180
8771728|NCT01278927|9821926|FG001|COMPLETED|Overall Study||178
8771729|NCT01278927|9821927|FG002|COMPLETED|Overall Study||178
8771730|NCT01278927|9821928|FG003|COMPLETED|Overall Study||175
8771731|NCT01278927|9821925|FG000|NOT COMPLETED|Overall Study||0
8771732|NCT01278927|9821926|FG001|NOT COMPLETED|Overall Study||0
8771733|NCT01278927|9821927|FG002|NOT COMPLETED|Overall Study||0
8771734|NCT01278927|9821928|FG003|NOT COMPLETED|Overall Study||0
8771735|NCT01278953|9821941|FG000|STARTED|Overall Study||155
8771736|NCT01278953|9821942|FG001|STARTED|Overall Study||145
8771737|NCT01278953|9821941|FG000|COMPLETED|Overall Study||146
8771738|NCT01278953|9821942|FG001|COMPLETED|Overall Study||134
8771739|NCT01278953|9821941|FG000|NOT COMPLETED|Overall Study||9
8771740|NCT01278953|9821942|FG001|NOT COMPLETED|Overall Study||11
8771741|NCT01279044|9821951|FG000|STARTED|PHASE 1 - Formative||59
8771742|NCT01279044|9821952|FG001|STARTED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
8771743|NCT01279044|9821953|FG002|STARTED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
8771744|NCT01279044|9821951|FG000|COMPLETED|PHASE 1 - Formative||59
8771745|NCT01279044|9821952|FG001|COMPLETED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
8771746|NCT01279044|9821953|FG002|COMPLETED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
8771747|NCT01279044|9821951|FG000|NOT COMPLETED|PHASE 1 - Formative||0
8771748|NCT01279044|9821952|FG001|NOT COMPLETED|PHASE 1 - Formative||0
8771749|NCT01279044|9821953|FG002|NOT COMPLETED|PHASE 1 - Formative||0
8771750|NCT01279044|9821951|FG000|STARTED|PHASE 2 - Randmonized Controlled Trial|Participants who participated in the RCT did not participate in the formative phase.|0
8771751|NCT01279044|9821952|FG001|STARTED|PHASE 2 - Randmonized Controlled Trial||162
8771752|NCT01279044|9821953|FG002|STARTED|PHASE 2 - Randmonized Controlled Trial||164
8771753|NCT01279044|9821951|FG000|COMPLETED|PHASE 2 - Randmonized Controlled Trial|Participants who participated in the RCT did not participate in the formative phase.|0
8771754|NCT01279044|9821952|FG001|COMPLETED|PHASE 2 - Randmonized Controlled Trial||151
8771755|NCT01279044|9821953|FG002|COMPLETED|PHASE 2 - Randmonized Controlled Trial||161
8771756|NCT01279044|9821951|FG000|NOT COMPLETED|PHASE 2 - Randmonized Controlled Trial||0
8771757|NCT01279044|9821952|FG001|NOT COMPLETED|PHASE 2 - Randmonized Controlled Trial||11
8771758|NCT01279044|9821953|FG002|NOT COMPLETED|PHASE 2 - Randmonized Controlled Trial||3
8771759|NCT01279057|9821962|FG000|STARTED|Overall Study||288
8771760|NCT01279057|9821963|FG001|STARTED|Overall Study||292
8771761|NCT01279057|9821964|FG002|STARTED|Overall Study||147
8771762|NCT01279057|9821962|FG000|Per-Protocol (PPP) Population|Overall Study||257
8771763|NCT01279057|9821963|FG001|Per-Protocol (PPP) Population|Overall Study||245
8771764|NCT01279057|9821964|FG002|Per-Protocol (PPP) Population|Overall Study||126
8771765|NCT01279057|9821962|FG000|Intent-to-Treat (ITT) Population|Overall Study||284
8771766|NCT01279057|9821963|FG001|Intent-to-Treat (ITT) Population|Overall Study||285
8771767|NCT01279057|9821964|FG002|Intent-to-Treat (ITT) Population|Overall Study||144
8771768|NCT01279057|9821962|FG000|COMPLETED|Overall Study||282
8771769|NCT01279057|9821963|FG001|COMPLETED|Overall Study||287
8771770|NCT01279057|9821964|FG002|COMPLETED|Overall Study||144
8771771|NCT01279057|9821962|FG000|NOT COMPLETED|Overall Study||6
8771772|NCT01279057|9821963|FG001|NOT COMPLETED|Overall Study||5
8771773|NCT01279057|9821964|FG002|NOT COMPLETED|Overall Study||3
8771774|NCT01279070|9821974|FG000|STARTED|Overall Study|34 outpatients were randomly assigned to 32 sessions of REPYFLEC.|34
8771775|NCT01279070|9821975|FG001|STARTED|Overall Study|28 outpatients were randomly assigned to 32 sessions of leisure group.|28
8771776|NCT01279070|9821974|FG000|COMPLETED|Overall Study|5 outpatients left the treatment up to 2 months after starting REPYFLEC.|29
8771777|NCT01279070|9821975|FG001|COMPLETED|Overall Study|4 outpatients left the leisure group up to 2 months after starting Leisure group.|24
8771778|NCT01279070|9821974|FG000|NOT COMPLETED|Overall Study||5
8771779|NCT01279070|9821975|FG001|NOT COMPLETED|Overall Study||4
8771780|NCT01279109|9821987|FG000|STARTED|Overall Study||68
8771781|NCT01279109|9821988|FG001|STARTED|Overall Study||67
8771782|NCT01279109|9821987|FG000|COMPLETED|Overall Study||55
8771783|NCT01279109|9821988|FG001|COMPLETED|Overall Study||55
8771784|NCT01279109|9821987|FG000|NOT COMPLETED|Overall Study||13
8771785|NCT01279109|9821988|FG001|NOT COMPLETED|Overall Study||12
8771786|NCT01279187|9821996|FG000|STARTED|Overall Study||14
8771787|NCT01279187|9821997|FG001|STARTED|Overall Study||13
8771788|NCT01279187|9821996|FG000|COMPLETED|Overall Study||14
8771789|NCT01279187|9821997|FG001|COMPLETED|Overall Study||13
8771790|NCT01279187|9821996|FG000|NOT COMPLETED|Overall Study||0
8771791|NCT01279187|9821997|FG001|NOT COMPLETED|Overall Study||0
8771792|NCT01279200|9822005|FG000|STARTED|Overall Study||10
8771793|NCT01279200|9822006|FG001|STARTED|Overall Study||11
8771794|NCT01279200|9822005|FG000|COMPLETED|Overall Study||8
8771795|NCT01279200|9822006|FG001|COMPLETED|Overall Study||4
8771796|NCT01279200|9822005|FG000|NOT COMPLETED|Overall Study||2
8771797|NCT01279200|9822006|FG001|NOT COMPLETED|Overall Study||7
8771798|NCT01279265|9822014|FG000|STARTED|Overall Study||13
8771799|NCT01279265|9822015|FG001|STARTED|Overall Study||17
8771800|NCT01279265|9822014|FG000|COMPLETED|Overall Study||9
8771801|NCT01279265|9822015|FG001|COMPLETED|Overall Study||11
8771802|NCT01279265|9822014|FG000|NOT COMPLETED|Overall Study||4
8771803|NCT01279265|9822015|FG001|NOT COMPLETED|Overall Study||6
8771804|NCT01279317|9822023|FG000|STARTED|Period 1||6
8771805|NCT01279317|9822024|FG001|STARTED|Period 1||6
8771806|NCT01279317|9822023|FG000|COMPLETED|Period 1||6
8771807|NCT01279317|9822024|FG001|COMPLETED|Period 1||6
8771808|NCT01279317|9822023|FG000|NOT COMPLETED|Period 1||0
8771809|NCT01279317|9822024|FG001|NOT COMPLETED|Period 1||0
8771810|NCT01279317|9822023|FG000|STARTED|Washout||6
8771811|NCT01279317|9822024|FG001|STARTED|Washout||6
8771812|NCT01279317|9822023|FG000|COMPLETED|Washout||6
8771813|NCT01279317|9822024|FG001|COMPLETED|Washout||6
8771814|NCT01279317|9822023|FG000|NOT COMPLETED|Washout||0
8771815|NCT01279317|9822024|FG001|NOT COMPLETED|Washout||0
8771816|NCT01279317|9822023|FG000|STARTED|Period 2||6
8771817|NCT01279317|9822024|FG001|STARTED|Period 2||6
8771818|NCT01279317|9822023|FG000|COMPLETED|Period 2||6
8771819|NCT01279317|9822024|FG001|COMPLETED|Period 2||6
8771820|NCT01279317|9822023|FG000|NOT COMPLETED|Period 2||0
8771821|NCT01279317|9822024|FG001|NOT COMPLETED|Period 2||0
8771822|NCT01279343|9822031|FG000|STARTED|Overall Study||59
8771823|NCT01279343|9822032|FG001|STARTED|Overall Study||64
8771824|NCT01279343|9822031|FG000|COMPLETED|Overall Study||57
8771825|NCT01279343|9822032|FG001|COMPLETED|Overall Study||58
8771826|NCT01279343|9822031|FG000|NOT COMPLETED|Overall Study||2
8771827|NCT01279343|9822032|FG001|NOT COMPLETED|Overall Study||6
8771828|NCT01279447|9822040|FG000|STARTED|Overall Study||34
8771829|NCT01279447|9822041|FG001|STARTED|Overall Study||34
8771830|NCT01279447|9822040|FG000|COMPLETED|Overall Study||31
8771831|NCT01279447|9822041|FG001|COMPLETED|Overall Study||33
8771832|NCT01279447|9822040|FG000|NOT COMPLETED|Overall Study||3
8771833|NCT01279447|9822041|FG001|NOT COMPLETED|Overall Study||1
8771834|NCT01279486|9822047|FG000|STARTED|Overall Study||120
8771835|NCT01279486|9822047|FG000|COMPLETED|Overall Study|1 result questionnaire was not returned so 119 volunteers results were used for consumer accuracy.|119
8771836|NCT01279486|9822047|FG000|NOT COMPLETED|Overall Study||1
8771837|NCT01279564|9822053|FG000|STARTED|Overall Study||40
8771838|NCT01279564|9822054|FG001|STARTED|Overall Study||32
8771839|NCT01279564|9822053|FG000|COMPLETED|Overall Study||40
8771840|NCT01279564|9822054|FG001|COMPLETED|Overall Study||32
8771841|NCT01279564|9822053|FG000|NOT COMPLETED|Overall Study||0
8771842|NCT01279564|9822054|FG001|NOT COMPLETED|Overall Study||0
8771843|NCT01279681|9822062|FG000|STARTED|Overall Study||15
8771844|NCT01279681|9822063|FG001|STARTED|Overall Study||17
8771845|NCT01279681|9822062|FG000|COMPLETED|Overall Study||0
8771846|NCT01279681|9822063|FG001|COMPLETED|Overall Study||0
8771847|NCT01279681|9822062|FG000|NOT COMPLETED|Overall Study||15
8771848|NCT01279681|9822063|FG001|NOT COMPLETED|Overall Study||17
8771849|NCT01279850|9822069|FG000|STARTED|Overall Study||891
8771850|NCT01279850|9822069|FG000|COMPLETED|Overall Study|Number of participants whose survey form were collected and included in analyses is shown.|800
8771851|NCT01279850|9822069|FG000|NOT COMPLETED|Overall Study||91
8771852|NCT01279954|9822075|FG000|STARTED|Overall Study||5
8771853|NCT01279954|9822076|FG001|STARTED|Overall Study||5
8771854|NCT01279954|9822075|FG000|COMPLETED|Overall Study||2
8771855|NCT01279954|9822076|FG001|COMPLETED|Overall Study||1
8771856|NCT01279954|9822075|FG000|NOT COMPLETED|Overall Study||3
8771857|NCT01279954|9822076|FG001|NOT COMPLETED|Overall Study||4
8771858|NCT01280058|9822087|FG000|STARTED|Overall Study||36
8771859|NCT01280058|9822088|FG001|STARTED|Overall Study||37
8771860|NCT01280058|9822087|FG000|COMPLETED|Overall Study||36
8771861|NCT01280058|9822088|FG001|COMPLETED|Overall Study||37
8771862|NCT01280058|9822087|FG000|NOT COMPLETED|Overall Study||0
8771863|NCT01280058|9822088|FG001|NOT COMPLETED|Overall Study||0
8771864|NCT01280110|9822098|FG000|STARTED|Overall Study||22
8771865|NCT01280110|9822099|FG001|STARTED|Overall Study||22
8771866|NCT01280110|9822098|FG000|COMPLETED|Overall Study||22
8771867|NCT01280110|9822099|FG001|COMPLETED|Overall Study||22
8771868|NCT01280110|9822098|FG000|NOT COMPLETED|Overall Study||0
8771869|NCT01280110|9822099|FG001|NOT COMPLETED|Overall Study||0
8771870|NCT01280123|9822110|FG000|STARTED|Overall Study||72
8771871|NCT01280123|9822111|FG001|STARTED|Overall Study||67
8771872|NCT01280123|9822112|FG002|STARTED|Overall Study||71
8771873|NCT01280123|9822110|FG000|COMPLETED|Overall Study||71
8771874|NCT01280123|9822111|FG001|COMPLETED|Overall Study||63
8771875|NCT01280123|9822112|FG002|COMPLETED|Overall Study||70
8771876|NCT01280123|9822110|FG000|NOT COMPLETED|Overall Study||1
8771877|NCT01280123|9822111|FG001|NOT COMPLETED|Overall Study||4
8771878|NCT01280123|9822112|FG002|NOT COMPLETED|Overall Study||1
8771879|NCT01280201|9822120|FG000|STARTED|Overall Study||44
8771880|NCT01280201|9822120|FG000|COMPLETED|Overall Study||44
8771881|NCT01280201|9822120|FG000|NOT COMPLETED|Overall Study||0
8771882|NCT01280266|9822126|FG000|STARTED|First Intervention (Week 1-4)||15
8771883|NCT01280266|9822127|FG001|STARTED|First Intervention (Week 1-4)||14
8771884|NCT01280266|9822126|FG000|COMPLETED|First Intervention (Week 1-4)||14
8771885|NCT01280266|9822127|FG001|COMPLETED|First Intervention (Week 1-4)||12
8771886|NCT01280266|9822126|FG000|NOT COMPLETED|First Intervention (Week 1-4)||1
8771887|NCT01280266|9822127|FG001|NOT COMPLETED|First Intervention (Week 1-4)||2
8771888|NCT01280266|9822126|FG000|STARTED|Washout Period (Week 4-5)||14
8771889|NCT01280266|9822127|FG001|STARTED|Washout Period (Week 4-5)||12
8771890|NCT01280266|9822126|FG000|COMPLETED|Washout Period (Week 4-5)||14
8771891|NCT01280266|9822127|FG001|COMPLETED|Washout Period (Week 4-5)||12
8771892|NCT01280266|9822126|FG000|NOT COMPLETED|Washout Period (Week 4-5)||0
8771893|NCT01280266|9822127|FG001|NOT COMPLETED|Washout Period (Week 4-5)||0
8771894|NCT01280266|9822126|FG000|STARTED|Second Intervention (Week 5-9)||14
8771895|NCT01280266|9822127|FG001|STARTED|Second Intervention (Week 5-9)||12
8771896|NCT01280266|9822126|FG000|COMPLETED|Second Intervention (Week 5-9)||14
8771897|NCT01280266|9822127|FG001|COMPLETED|Second Intervention (Week 5-9)||12
8771898|NCT01280266|9822126|FG000|NOT COMPLETED|Second Intervention (Week 5-9)||0
8771899|NCT01280266|9822127|FG001|NOT COMPLETED|Second Intervention (Week 5-9)||0
8771900|NCT01280357|9822137|FG000|STARTED|Overall Study||60
8771901|NCT01280357|9822137|FG000|COMPLETED|Overall Study||34
8771902|NCT01280357|9822137|FG000|NOT COMPLETED|Overall Study||26
8771903|NCT01280409|9822146|FG000|STARTED|Overall Study||59
8771904|NCT01280409|9822147|FG001|STARTED|Overall Study||55
8771905|NCT01280409|9822146|FG000|COMPLETED|Overall Study||43
8771906|NCT01280409|9822147|FG001|COMPLETED|Overall Study||36
8771907|NCT01280409|9822146|FG000|NOT COMPLETED|Overall Study||16
8771908|NCT01280409|9822147|FG001|NOT COMPLETED|Overall Study||19
8771909|NCT01280552|9822155|FG000|STARTED|Overall Study||81
8771910|NCT01280552|9822156|FG001|STARTED|Overall Study||43
8771911|NCT01280552|9822155|FG000|COMPLETED|Overall Study|Survival is still being assessed|75
8771912|NCT01280552|9822156|FG001|COMPLETED|Overall Study||42
8771913|NCT01280552|9822155|FG000|NOT COMPLETED|Overall Study||6
8771914|NCT01280552|9822156|FG001|NOT COMPLETED|Overall Study||1
8771915|NCT01280591|9822169|FG000|STARTED|Overall Study||203
8771916|NCT01280591|9822170|FG001|STARTED|Overall Study||204
8771917|NCT01280591|9822171|FG002|STARTED|Overall Study||203
8771918|NCT01280591|9822172|FG003|STARTED|Overall Study||102
8771919|NCT01280591|9822169|FG000|COMPLETED|Overall Study||203
8771920|NCT01280591|9822170|FG001|COMPLETED|Overall Study||204
8771921|NCT01280591|9822171|FG002|COMPLETED|Overall Study||203
8771922|NCT01280591|9822172|FG003|COMPLETED|Overall Study||99
8771923|NCT01280591|9822169|FG000|NOT COMPLETED|Overall Study||0
8771924|NCT01280591|9822170|FG001|NOT COMPLETED|Overall Study||0
8771925|NCT01280591|9822171|FG002|NOT COMPLETED|Overall Study||0
8771926|NCT01280591|9822172|FG003|NOT COMPLETED|Overall Study||3
8771927|NCT01280604|9822184|FG000|STARTED|Overall Study||33
8771928|NCT01280604|9822185|FG001|STARTED|Overall Study||33
8771929|NCT01280604|9822184|FG000|Subjects Meeting All Inclusion Criteria|Overall Study||25
8771930|NCT01280604|9822185|FG001|Subjects Meeting All Inclusion Criteria|Overall Study||29
8771931|NCT01280604|9822184|FG000|COMPLETED|Overall Study||24
8771932|NCT01280604|9822185|FG001|COMPLETED|Overall Study||28
8771933|NCT01280604|9822184|FG000|NOT COMPLETED|Overall Study||9
8771934|NCT01280604|9822185|FG001|NOT COMPLETED|Overall Study||5
8771935|NCT01280617|9822193|FG000|STARTED|Overall Study||23
8771936|NCT01280617|9822194|FG001|STARTED|Overall Study||21
8771937|NCT01280617|9822193|FG000|COMPLETED|Overall Study||23
8771938|NCT01280617|9822194|FG001|COMPLETED|Overall Study||20
8771939|NCT01280617|9822193|FG000|NOT COMPLETED|Overall Study||0
8771940|NCT01280617|9822194|FG001|NOT COMPLETED|Overall Study||1
8771941|NCT01280656|9822203|FG000|STARTED|Overall Study||62
8771942|NCT01280656|9822204|FG001|STARTED|Overall Study||312
8771943|NCT01280656|9822205|FG002|STARTED|Overall Study||286
8771944|NCT01280656|9822203|FG000|COMPLETED|Overall Study||59
8771945|NCT01280656|9822204|FG001|COMPLETED|Overall Study||265
8771946|NCT01280656|9822205|FG002|COMPLETED|Overall Study||223
8771947|NCT01280656|9822203|FG000|NOT COMPLETED|Overall Study||3
8771948|NCT01280656|9822204|FG001|NOT COMPLETED|Overall Study||47
8771949|NCT01280656|9822205|FG002|NOT COMPLETED|Overall Study||63
8771950|NCT01280695|9822218|FG000|STARTED|Overall Study||26
8771951|NCT01280695|9822219|FG001|STARTED|Overall Study||25
8771952|NCT01280695|9822220|FG002|STARTED|Overall Study||26
8771953|NCT01280695|9822221|FG003|STARTED|Overall Study||26
8771954|NCT01280695|9822222|FG004|STARTED|Overall Study||26
8771955|NCT01280695|9822218|FG000|COMPLETED|Overall Study||26
8771956|NCT01280695|9822219|FG001|COMPLETED|Overall Study||24
8771957|NCT01280695|9822220|FG002|COMPLETED|Overall Study||21
8771958|NCT01280695|9822221|FG003|COMPLETED|Overall Study||22
8771959|NCT01280695|9822222|FG004|COMPLETED|Overall Study||24
8771960|NCT01280695|9822218|FG000|NOT COMPLETED|Overall Study||0
8771961|NCT01280695|9822219|FG001|NOT COMPLETED|Overall Study||1
8771962|NCT01280695|9822220|FG002|NOT COMPLETED|Overall Study||5
8771963|NCT01280695|9822221|FG003|NOT COMPLETED|Overall Study||4
8771964|NCT01280695|9822222|FG004|NOT COMPLETED|Overall Study||2
8771965|NCT01280721|9822234|FG000|STARTED|Overall Study||135
8771966|NCT01280721|9822234|FG000|COMPLETED|Overall Study||113
8771967|NCT01280721|9822234|FG000|NOT COMPLETED|Overall Study||22
8771968|NCT01280812|9822252|FG000|STARTED|Overall Study||70
8771969|NCT01280812|9822253|FG001|STARTED|Overall Study||71
8771970|NCT01280812|9822254|FG002|STARTED|Overall Study||69
8771971|NCT01280812|9822252|FG000|COMPLETED|Overall Study||67
8771972|NCT01280812|9822253|FG001|COMPLETED|Overall Study||69
8771973|NCT01280812|9822254|FG002|COMPLETED|Overall Study||68
8771974|NCT01280812|9822252|FG000|NOT COMPLETED|Overall Study||3
8771975|NCT01280812|9822253|FG001|NOT COMPLETED|Overall Study||2
8771976|NCT01280812|9822254|FG002|NOT COMPLETED|Overall Study||1
8771977|NCT01280903|9822265|FG000|STARTED|Overall Study||91
8771978|NCT01280903|9822266|FG001|STARTED|Overall Study||91
8771979|NCT01280903|9822265|FG000|COMPLETED|Overall Study|91 participants analyzed per intention-to-treat|68
8771980|NCT01280903|9822266|FG001|COMPLETED|Overall Study|91 participants analyzed per intention-to-treat|75
8771981|NCT01280903|9822265|FG000|NOT COMPLETED|Overall Study||23
8771982|NCT01280903|9822266|FG001|NOT COMPLETED|Overall Study||16
8771983|NCT01280942|9822274|FG000|STARTED|Overall Study||10120
8771984|NCT01280942|9822275|FG001|STARTED|Overall Study||9911
8771985|NCT01280942|9822274|FG000|COMPLETED|Overall Study||10120
8771986|NCT01280942|9822275|FG001|COMPLETED|Overall Study||9911
8771987|NCT01280942|9822274|FG000|NOT COMPLETED|Overall Study||0
8771988|NCT01280942|9822275|FG001|NOT COMPLETED|Overall Study||0
8771989|NCT01280955|9822281|FG000|STARTED|Overall Study||30
8771990|NCT01280955|9822281|FG000|COMPLETED|Overall Study||27
8771991|NCT01280955|9822281|FG000|NOT COMPLETED|Overall Study||3
8771992|NCT01280968|9822289|FG000|STARTED|Overall Study||45
8771993|NCT01280968|9822290|FG001|STARTED|Overall Study||7
8771994|NCT01280968|9822289|FG000|COMPLETED|Overall Study||27
8771995|NCT01280968|9822290|FG001|COMPLETED|Overall Study||4
8771996|NCT01280968|9822289|FG000|NOT COMPLETED|Overall Study||18
8771997|NCT01280968|9822290|FG001|NOT COMPLETED|Overall Study||3
8771998|NCT01280981|9822297|FG000|STARTED|Overall Study||288
8771999|NCT01280981|9822297|FG000|Intent to Treat (ITT) Population|Overall Study|Participants who took drug during at least one menstrual cycle|260
8772000|NCT01280981|9822297|FG000|COMPLETED|Overall Study||196
8772001|NCT01280981|9822297|FG000|NOT COMPLETED|Overall Study||92
8772002|NCT01281007|9822303|FG000|STARTED|Overall Study||75
8772003|NCT01281007|9822304|FG001|STARTED|Overall Study||75
8772004|NCT01281007|9822303|FG000|COMPLETED|Overall Study||71
8772005|NCT01281007|9822304|FG001|COMPLETED|Overall Study||67
8772006|NCT01281007|9822303|FG000|NOT COMPLETED|Overall Study||4
8772007|NCT01281007|9822304|FG001|NOT COMPLETED|Overall Study||8
8772008|NCT01281137|9822312|FG000|STARTED|Baseline Population||25
8772009|NCT01281137|9822313|FG001|STARTED|Baseline Population||79
8772010|NCT01281137|9822312|FG000|COMPLETED|Baseline Population||25
8772011|NCT01281137|9822313|FG001|COMPLETED|Baseline Population||78
8772012|NCT01281137|9822312|FG000|NOT COMPLETED|Baseline Population||0
8772013|NCT01281137|9822313|FG001|NOT COMPLETED|Baseline Population||1
8772014|NCT01281137|9822312|FG000|STARTED|Analysis Population (Baseline)||25
8772015|NCT01281137|9822313|FG001|STARTED|Analysis Population (Baseline)||78
8772016|NCT01281137|9822312|FG000|COMPLETED|Analysis Population (Baseline)||21
8772017|NCT01281137|9822313|FG001|COMPLETED|Analysis Population (Baseline)||69
8772018|NCT01281137|9822312|FG000|NOT COMPLETED|Analysis Population (Baseline)||4
8772019|NCT01281137|9822313|FG001|NOT COMPLETED|Analysis Population (Baseline)||9
8772020|NCT01281137|9822312|FG000|STARTED|Analysis Population (9 Months)||21
8772021|NCT01281137|9822313|FG001|STARTED|Analysis Population (9 Months)||69
8772022|NCT01281137|9822312|FG000|COMPLETED|Analysis Population (9 Months)||21
8772023|NCT01281137|9822313|FG001|COMPLETED|Analysis Population (9 Months)||64
8772024|NCT01281137|9822312|FG000|NOT COMPLETED|Analysis Population (9 Months)||0
8772025|NCT01281137|9822313|FG001|NOT COMPLETED|Analysis Population (9 Months)||5
8772026|NCT01281137|9822312|FG000|STARTED|Analysis Population (10.5 Months)||21
8772027|NCT01281137|9822313|FG001|STARTED|Analysis Population (10.5 Months)||64
8772028|NCT01281137|9822312|FG000|COMPLETED|Analysis Population (10.5 Months)||20
8772029|NCT01281137|9822313|FG001|COMPLETED|Analysis Population (10.5 Months)||64
8772030|NCT01281137|9822312|FG000|NOT COMPLETED|Analysis Population (10.5 Months)||1
8772031|NCT01281137|9822313|FG001|NOT COMPLETED|Analysis Population (10.5 Months)||0
8772032|NCT01281137|9822312|FG000|STARTED|Analysis Population (12 Months)||20
8772033|NCT01281137|9822313|FG001|STARTED|Analysis Population (12 Months)||64
8772034|NCT01281137|9822312|FG000|COMPLETED|Analysis Population (12 Months)||19
8772035|NCT01281137|9822313|FG001|COMPLETED|Analysis Population (12 Months)||62
8772036|NCT01281137|9822312|FG000|NOT COMPLETED|Analysis Population (12 Months)||1
8772037|NCT01281137|9822313|FG001|NOT COMPLETED|Analysis Population (12 Months)||2
8772038|NCT01281189|9822339|FG000|STARTED|Overall Study||468
8772039|NCT01281189|9822340|FG001|STARTED|Overall Study||474
8772040|NCT01281189|9822339|FG000|COMPLETED|Overall Study||321
8772041|NCT01281189|9822340|FG001|COMPLETED|Overall Study||331
8772042|NCT01281189|9822339|FG000|NOT COMPLETED|Overall Study||147
8772043|NCT01281189|9822340|FG001|NOT COMPLETED|Overall Study||143
8772044|NCT01281202|9822348|FG000|STARTED|Overall Study||103
8772045|NCT01281202|9822349|FG001|STARTED|Overall Study||104
8772046|NCT01281202|9822348|FG000|COMPLETED|Overall Study||75
8772047|NCT01281202|9822349|FG001|COMPLETED|Overall Study||68
8772048|NCT01281202|9822348|FG000|NOT COMPLETED|Overall Study||28
8772049|NCT01281202|9822349|FG001|NOT COMPLETED|Overall Study||36
8772050|NCT01281306|9822364|FG000|STARTED|Overall Study||144
8772051|NCT01281306|9822365|FG001|STARTED|Overall Study||145
8772052|NCT01281306|9822366|FG002|STARTED|Overall Study||141
8772053|NCT01281306|9822367|FG003|STARTED|Overall Study||134
8772054|NCT01281306|9822368|FG004|STARTED|Overall Study||143
8772055|NCT01281306|9822369|FG005|STARTED|Overall Study||142
8772056|NCT01281306|9822370|FG006|STARTED|Overall Study||58
8916085|NCT02180061|9975613|FG001|COMPLETED|Overall Study||0
8916086|NCT02180061|9975612|FG000|NOT COMPLETED|Overall Study||25
8916087|NCT02180061|9975613|FG001|NOT COMPLETED|Overall Study||8
8916088|NCT02180100|9975621|FG000|STARTED|Overall Study||70
8916089|NCT02180100|9975622|FG001|STARTED|Overall Study||70
8916090|NCT02180100|9975621|FG000|COMPLETED|Overall Study||58
8916091|NCT02180100|9975622|FG001|COMPLETED|Overall Study||66
8916092|NCT02180100|9975621|FG000|NOT COMPLETED|Overall Study||12
8916093|NCT02180100|9975622|FG001|NOT COMPLETED|Overall Study||4
8916094|NCT02180165|9975632|FG000|STARTED|Overall Study||15
8916095|NCT02180165|9975633|FG001|STARTED|Overall Study||7
8916096|NCT02180165|9975634|FG002|STARTED|Overall Study||63
8916097|NCT02180165|9975635|FG003|STARTED|Overall Study||31
8916098|NCT02180165|9975632|FG000|Treated Participants|Overall Study||15
8916099|NCT02180165|9975633|FG001|Treated Participants|Overall Study||7
8916100|NCT02180165|9975634|FG002|Treated Participants|Overall Study||62
8916101|NCT02180165|9975635|FG003|Treated Participants|Overall Study||31
8916102|NCT02180165|9975632|FG000|Type of Aspergillosis|Overall Study|Chronic Pulmonary Aspergillosis|15
8916103|NCT02180165|9975633|FG001|Type of Aspergillosis|Overall Study|Chronic Pulmonary Aspergillosis|7
8916104|NCT02180165|9975634|FG002|Type of Aspergillosis|Overall Study|Invasive Aspergillosis and Chronic Pulmonary Aspergillosis|57
8916105|NCT02180165|9975635|FG003|Type of Aspergillosis|Overall Study|Invasive Aspergillosis and Chronic Pulmonary Aspergillosis|27
8916106|NCT02180165|9975632|FG000|COMPLETED|Overall Study||4
8916107|NCT02180165|9975633|FG001|COMPLETED|Overall Study||6
8916108|NCT02180165|9975634|FG002|COMPLETED|Overall Study||34
8916109|NCT02180165|9975635|FG003|COMPLETED|Overall Study||25
8916110|NCT02180165|9975632|FG000|NOT COMPLETED|Overall Study||11
8916111|NCT02180165|9975633|FG001|NOT COMPLETED|Overall Study||1
8916112|NCT02180165|9975634|FG002|NOT COMPLETED|Overall Study||29
8916113|NCT02180165|9975635|FG003|NOT COMPLETED|Overall Study||6
8916114|NCT02180230|9975647|FG000|STARTED|Overall Study||38
8916115|NCT02180230|9975647|FG000|COMPLETED|Overall Study||31
8916116|NCT02180230|9975647|FG000|NOT COMPLETED|Overall Study||7
8916117|NCT02180438|9975651|FG000|STARTED|Overall Study||30
8916118|NCT02180438|9975651|FG000|COMPLETED|Overall Study||29
8916119|NCT02180438|9975651|FG000|NOT COMPLETED|Overall Study||1
8916120|NCT02180646|9975657|FG000|STARTED|First Intervention (7 Days)||6
9028241|NCT03198507|10090585|FG001|STARTED|Overall Study||227
9028242|NCT03198507|10090584|FG000|COMPLETED|Overall Study||227
9028243|NCT03198507|10090585|FG001|COMPLETED|Overall Study||227
9028244|NCT03198507|10090584|FG000|NOT COMPLETED|Overall Study||1
9028245|NCT03198507|10090585|FG001|NOT COMPLETED|Overall Study||0
9028246|NCT03198520|10090591|FG000|STARTED|Overall Study||46
9028247|NCT03198520|10090591|FG000|COMPLETED|Overall Study||40
9028248|NCT03198520|10090591|FG000|NOT COMPLETED|Overall Study||6
9028249|NCT03198715|10090608|FG000|STARTED|Overall Study||6
9028250|NCT03198715|10090609|FG001|STARTED|Overall Study||12
9028251|NCT03198715|10090610|FG002|STARTED|Overall Study||12
9028252|NCT03198715|10090611|FG003|STARTED|Overall Study||3
9028253|NCT03198715|10090612|FG004|STARTED|Overall Study||9
9028254|NCT03198715|10090608|FG000|COMPLETED|Overall Study||6
9028255|NCT03198715|10090609|FG001|COMPLETED|Overall Study||11
9028256|NCT03198715|10090610|FG002|COMPLETED|Overall Study||10
9028257|NCT03198715|10090611|FG003|COMPLETED|Overall Study||3
9028258|NCT03198715|10090612|FG004|COMPLETED|Overall Study||7
9028259|NCT03198715|10090608|FG000|NOT COMPLETED|Overall Study||0
9028260|NCT03198715|10090609|FG001|NOT COMPLETED|Overall Study||1
9028261|NCT03198715|10090610|FG002|NOT COMPLETED|Overall Study||2
9028262|NCT03198715|10090611|FG003|NOT COMPLETED|Overall Study||0
9028263|NCT03198715|10090612|FG004|NOT COMPLETED|Overall Study||2
9028264|NCT03198754|10090626|FG000|STARTED|Overall Study||38
8916121|NCT02180646|9975658|FG001|STARTED|First Intervention (7 Days)||6
9028265|NCT03198754|10090627|FG001|STARTED|Overall Study||35
9028266|NCT03198754|10090626|FG000|COMPLETED|Overall Study||27
8916122|NCT02180646|9975657|FG000|COMPLETED|First Intervention (7 Days)||6
8916123|NCT02180646|9975658|FG001|COMPLETED|First Intervention (7 Days)||6
9028267|NCT03198754|10090627|FG001|COMPLETED|Overall Study||27
9028268|NCT03198754|10090626|FG000|NOT COMPLETED|Overall Study||11
9028269|NCT03198754|10090627|FG001|NOT COMPLETED|Overall Study||8
9028270|NCT03198767|10090640|FG000|STARTED|Overall Study||8
9028271|NCT03198767|10090641|FG001|STARTED|Overall Study||8
8772057|NCT01281306|9822364|FG000|Full Analysis Set|Overall Study||143
8772058|NCT01281306|9822365|FG001|Full Analysis Set|Overall Study||145
8772059|NCT01281306|9822366|FG002|Full Analysis Set|Overall Study||141
8772060|NCT01281306|9822367|FG003|Full Analysis Set|Overall Study||133
8772061|NCT01281306|9822368|FG004|Full Analysis Set|Overall Study||143
8772062|NCT01281306|9822369|FG005|Full Analysis Set|Overall Study||142
8772063|NCT01281306|9822370|FG006|Full Analysis Set|Overall Study||58
8772064|NCT01281306|9822364|FG000|Safety Set|Overall Study||143
8772065|NCT01281306|9822365|FG001|Safety Set|Overall Study||145
8772066|NCT01281306|9822366|FG002|Safety Set|Overall Study||141
8772067|NCT01281306|9822367|FG003|Safety Set|Overall Study||133
8772068|NCT01281306|9822368|FG004|Safety Set|Overall Study||143
8772069|NCT01281306|9822369|FG005|Safety Set|Overall Study||142
8772070|NCT01281306|9822370|FG006|Safety Set|Overall Study||58
8772071|NCT01281306|9822364|FG000|Ambulatory Blood Pressure Monitoring Set|Overall Study||95
8772072|NCT01281306|9822365|FG001|Ambulatory Blood Pressure Monitoring Set|Overall Study||99
8772073|NCT01281306|9822366|FG002|Ambulatory Blood Pressure Monitoring Set|Overall Study||92
8772074|NCT01281306|9822367|FG003|Ambulatory Blood Pressure Monitoring Set|Overall Study||95
8772075|NCT01281306|9822368|FG004|Ambulatory Blood Pressure Monitoring Set|Overall Study||93
8772076|NCT01281306|9822369|FG005|Ambulatory Blood Pressure Monitoring Set|Overall Study||91
8772077|NCT01281306|9822370|FG006|Ambulatory Blood Pressure Monitoring Set|Overall Study||35
8772078|NCT01281306|9822364|FG000|COMPLETED|Overall Study||136
8772079|NCT01281306|9822365|FG001|COMPLETED|Overall Study||141
8772080|NCT01281306|9822366|FG002|COMPLETED|Overall Study||133
8772081|NCT01281306|9822367|FG003|COMPLETED|Overall Study||123
8772082|NCT01281306|9822368|FG004|COMPLETED|Overall Study||134
8772083|NCT01281306|9822369|FG005|COMPLETED|Overall Study||135
8772084|NCT01281306|9822370|FG006|COMPLETED|Overall Study||51
8772085|NCT01281306|9822364|FG000|NOT COMPLETED|Overall Study||8
8772086|NCT01281306|9822365|FG001|NOT COMPLETED|Overall Study||4
8772087|NCT01281306|9822366|FG002|NOT COMPLETED|Overall Study||8
8772088|NCT01281306|9822367|FG003|NOT COMPLETED|Overall Study||11
8772089|NCT01281306|9822368|FG004|NOT COMPLETED|Overall Study||9
8772090|NCT01281306|9822369|FG005|NOT COMPLETED|Overall Study||7
8772091|NCT01281306|9822370|FG006|NOT COMPLETED|Overall Study||7
8772092|NCT01281475|9822388|FG000|STARTED|Overall Study||33
8772093|NCT01281475|9822389|FG001|STARTED|Overall Study||34
8772094|NCT01281475|9822388|FG000|COMPLETED|Overall Study||29
8772095|NCT01281475|9822389|FG001|COMPLETED|Overall Study||26
8772096|NCT01281475|9822388|FG000|NOT COMPLETED|Overall Study||4
8772097|NCT01281475|9822389|FG001|NOT COMPLETED|Overall Study||8
8772098|NCT01281501|9822399|FG000|STARTED|Overall Study||44
8772099|NCT01281501|9822400|FG001|STARTED|Overall Study||43
8772100|NCT01281501|9822399|FG000|COMPLETED|Overall Study||44
8772101|NCT01281501|9822400|FG001|COMPLETED|Overall Study||43
8772102|NCT01281501|9822399|FG000|NOT COMPLETED|Overall Study||0
8772103|NCT01281501|9822400|FG001|NOT COMPLETED|Overall Study||0
8772104|NCT01281839|9822408|FG000|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|260
8772105|NCT01281839|9822409|FG001|STARTED|Overall Study||133
8772106|NCT01281839|9822408|FG000|COMPLETED|Overall Study||250
8772107|NCT01281839|9822409|FG001|COMPLETED|Overall Study||119
8772108|NCT01281839|9822408|FG000|NOT COMPLETED|Overall Study||10
8772109|NCT01281839|9822409|FG001|NOT COMPLETED|Overall Study||14
8772110|NCT01281865|9822417|FG000|STARTED|Overall Study||12
8772111|NCT01281865|9822418|FG001|STARTED|Overall Study||2
8772112|NCT01281865|9822417|FG000|COMPLETED|Overall Study||9
8772113|NCT01281865|9822418|FG001|COMPLETED|Overall Study||1
8772114|NCT01281865|9822417|FG000|NOT COMPLETED|Overall Study||3
8772115|NCT01281865|9822418|FG001|NOT COMPLETED|Overall Study||1
8772116|NCT01281917|9822424|FG000|STARTED|Overall Study||40
8772117|NCT01281917|9822424|FG000|COMPLETED|Overall Study||39
8772118|NCT01281917|9822424|FG000|NOT COMPLETED|Overall Study||1
8772119|NCT01281956|9822428|FG000|STARTED|1st Intervention (3 Months)||5
8772120|NCT01281956|9822429|FG001|STARTED|1st Intervention (3 Months)||5
8772121|NCT01281956|9822428|FG000|COMPLETED|1st Intervention (3 Months)||5
8772122|NCT01281956|9822429|FG001|COMPLETED|1st Intervention (3 Months)||5
8772123|NCT01281956|9822428|FG000|NOT COMPLETED|1st Intervention (3 Months)||0
8772124|NCT01281956|9822429|FG001|NOT COMPLETED|1st Intervention (3 Months)||0
8772125|NCT01281956|9822428|FG000|STARTED|2nd Intervention (3 Months)||5
8772126|NCT01281956|9822429|FG001|STARTED|2nd Intervention (3 Months)||5
8772127|NCT01281956|9822428|FG000|COMPLETED|2nd Intervention (3 Months)||4
8772128|NCT01281956|9822429|FG001|COMPLETED|2nd Intervention (3 Months)||5
8772129|NCT01281956|9822428|FG000|NOT COMPLETED|2nd Intervention (3 Months)||1
8772130|NCT01281956|9822429|FG001|NOT COMPLETED|2nd Intervention (3 Months)||0
8772131|NCT01281969|9822440|FG000|STARTED|Overall Study||18
8772132|NCT01281969|9822441|FG001|STARTED|Overall Study||18
8772133|NCT01281969|9822442|FG002|STARTED|Overall Study||12
8772134|NCT01281969|9822440|FG000|COMPLETED|Overall Study||17
8772135|NCT01281969|9822441|FG001|COMPLETED|Overall Study||18
8772136|NCT01281969|9822442|FG002|COMPLETED|Overall Study||0
8772137|NCT01281969|9822440|FG000|NOT COMPLETED|Overall Study||1
8772138|NCT01281969|9822441|FG001|NOT COMPLETED|Overall Study||0
8772139|NCT01281969|9822442|FG002|NOT COMPLETED|Overall Study||12
8772140|NCT01282086|9822450|FG000|STARTED|Overall Study||1365
8772141|NCT01282086|9822450|FG000|COMPLETED|Overall Study||1365
8772142|NCT01282086|9822450|FG000|NOT COMPLETED|Overall Study||0
8772143|NCT01282138|9822457|FG000|STARTED|EEC||6
8772144|NCT01282138|9822458|FG001|STARTED|EEC||7
8772145|NCT01282138|9822457|FG000|COMPLETED|EEC||6
8772146|NCT01282138|9822458|FG001|COMPLETED|EEC||7
8772147|NCT01282138|9822457|FG000|NOT COMPLETED|EEC||0
8772148|NCT01282138|9822458|FG001|NOT COMPLETED|EEC||0
8772149|NCT01282138|9822457|FG000|STARTED|CAPT||6
8772150|NCT01282138|9822458|FG001|STARTED|CAPT||7
8772151|NCT01282138|9822457|FG000|COMPLETED|CAPT||6
8772152|NCT01282138|9822458|FG001|COMPLETED|CAPT||7
8772153|NCT01282138|9822457|FG000|NOT COMPLETED|CAPT||0
8772154|NCT01282138|9822458|FG001|NOT COMPLETED|CAPT||0
8772155|NCT01282164|9822466|FG000|STARTED|Overall Study||29
8772156|NCT01282164|9822467|FG001|STARTED|Overall Study||14
8772157|NCT01282164|9822466|FG000|COMPLETED|Overall Study||28
8772158|NCT01282164|9822467|FG001|COMPLETED|Overall Study||14
8772159|NCT01282164|9822466|FG000|NOT COMPLETED|Overall Study||1
8772160|NCT01282164|9822467|FG001|NOT COMPLETED|Overall Study||0
8772161|NCT01282203|9822481|FG000|STARTED|Overall Study||1122
8772162|NCT01282203|9822481|FG000|COMPLETED|Overall Study||1121
8772163|NCT01282203|9822481|FG000|NOT COMPLETED|Overall Study||1
8772164|NCT01282229|9822488|FG000|STARTED|Overall Study|59 Participants contributed 236 quadrants (59*4)|59
8772165|NCT01282229|9822488|FG000|COMPLETED|Overall Study|57 Participants contributed 228 quadrants (57*4)|57
8772166|NCT01282229|9822488|FG000|NOT COMPLETED|Overall Study||2
8772167|NCT01282242|9822508|FG000|STARTED|Overall Study||80
8772168|NCT01282242|9822509|FG001|STARTED|Overall Study||8
8772169|NCT01282242|9822508|FG000|COMPLETED|Overall Study||80
8772170|NCT01282242|9822509|FG001|COMPLETED|Overall Study||8
8772171|NCT01282242|9822508|FG000|NOT COMPLETED|Overall Study||0
8772172|NCT01282242|9822509|FG001|NOT COMPLETED|Overall Study||0
8772173|NCT01282294|9822515|FG000|STARTED|Overall Study||100
8772174|NCT01282294|9822515|FG000|Intra-operative|Overall Study||99
8772175|NCT01282294|9822515|FG000|Post-operative|Overall Study||99
8772176|NCT01282294|9822515|FG000|6 Weeks|Overall Study||95
8772177|NCT01282294|9822515|FG000|3 Months|Overall Study||95
8772178|NCT01282294|9822515|FG000|6 Months|Overall Study||94
8772179|NCT01282294|9822515|FG000|12 Months|Overall Study||86
8772180|NCT01282294|9822515|FG000|COMPLETED|Overall Study||81
8772181|NCT01282294|9822515|FG000|NOT COMPLETED|Overall Study||19
8772182|NCT01282372|9822519|FG000|STARTED|Overall Study||500
8772183|NCT01282372|9822519|FG000|COMPLETED|Overall Study||421
8772184|NCT01282372|9822519|FG000|NOT COMPLETED|Overall Study||79
8772185|NCT01282424|9822530|FG000|STARTED|Treatment Period (TP) (81 Months)||125
8772186|NCT01282424|9822530|FG000|Completed: Disease Progression|Treatment Period (TP) (81 Months)||70
8772187|NCT01282424|9822530|FG000|Completed: Death|Treatment Period (TP) (81 Months)||9
8772188|NCT01282424|9822530|FG000|COMPLETED|Treatment Period (TP) (81 Months)||79
8772189|NCT01282424|9822530|FG000|NOT COMPLETED|Treatment Period (TP) (81 Months)||46
8772190|NCT01282424|9822530|FG000|STARTED|Long-term Follow-up Period (5 Years)|Participants did not have to complete the TP in order to enter the Long-term Follow-up Period.|84
8772191|NCT01282424|9822530|FG000|COMPLETED|Long-term Follow-up Period (5 Years)||20
8772192|NCT01282424|9822530|FG000|NOT COMPLETED|Long-term Follow-up Period (5 Years)||64
8772193|NCT01282463|9822537|FG000|STARTED|Overall Study||49
8772194|NCT01282463|9822538|FG001|STARTED|Overall Study||49
8772195|NCT01282463|9822539|FG002|STARTED|Overall Study||50
8772196|NCT01282463|9822537|FG000|Received at Least 1 Dose of Study Drug|Overall Study||45
8772197|NCT01282463|9822538|FG001|Received at Least 1 Dose of Study Drug|Overall Study||46
8772198|NCT01282463|9822539|FG002|Received at Least 1 Dose of Study Drug|Overall Study||49
8772199|NCT01282463|9822537|FG000|COMPLETED|Overall Study||41
8772200|NCT01282463|9822538|FG001|COMPLETED|Overall Study||45
8772201|NCT01282463|9822539|FG002|COMPLETED|Overall Study||46
8772202|NCT01282463|9822537|FG000|NOT COMPLETED|Overall Study||8
8772203|NCT01282463|9822538|FG001|NOT COMPLETED|Overall Study||4
8772204|NCT01282463|9822539|FG002|NOT COMPLETED|Overall Study||4
8772205|NCT01282476|9822555|FG000|STARTED|Overall Study||18
8772206|NCT01282476|9822555|FG000|COMPLETED|Overall Study||7
8772207|NCT01282476|9822555|FG000|NOT COMPLETED|Overall Study||11
8772208|NCT01282710|9822559|FG000|STARTED|Overall Study||20
8772209|NCT01282710|9822559|FG000|COMPLETED|Overall Study||20
8772210|NCT01282710|9822559|FG000|NOT COMPLETED|Overall Study||0
8772211|NCT01282723|9822563|FG000|STARTED|Overall Study||20
8772212|NCT01282723|9822563|FG000|COMPLETED|Overall Study||20
8772213|NCT01282723|9822563|FG000|NOT COMPLETED|Overall Study||0
8772214|NCT01282801|9822569|FG000|STARTED|First Intervention||9
8772215|NCT01282801|9822570|FG001|STARTED|First Intervention||9
8772216|NCT01282801|9822569|FG000|COMPLETED|First Intervention||9
8772217|NCT01282801|9822570|FG001|COMPLETED|First Intervention||9
8772218|NCT01282801|9822569|FG000|NOT COMPLETED|First Intervention||0
8772219|NCT01282801|9822570|FG001|NOT COMPLETED|First Intervention||0
8772220|NCT01282801|9822569|FG000|STARTED|Washout of 7 Days||9
8772221|NCT01282801|9822570|FG001|STARTED|Washout of 7 Days||9
8772222|NCT01282801|9822569|FG000|COMPLETED|Washout of 7 Days||9
8772223|NCT01282801|9822570|FG001|COMPLETED|Washout of 7 Days||9
8772224|NCT01282801|9822569|FG000|NOT COMPLETED|Washout of 7 Days||0
8772225|NCT01282801|9822570|FG001|NOT COMPLETED|Washout of 7 Days||0
8772226|NCT01282801|9822569|FG000|STARTED|Second Intervention||9
8772227|NCT01282801|9822570|FG001|STARTED|Second Intervention||9
8772228|NCT01282801|9822569|FG000|COMPLETED|Second Intervention||9
8772229|NCT01282801|9822570|FG001|COMPLETED|Second Intervention||8
8772230|NCT01282801|9822569|FG000|NOT COMPLETED|Second Intervention||0
8772231|NCT01282801|9822570|FG001|NOT COMPLETED|Second Intervention||1
8772232|NCT01282814|9822578|FG000|STARTED|First Intervention||12
8772233|NCT01282814|9822579|FG001|STARTED|First Intervention||12
8772234|NCT01282814|9822578|FG000|COMPLETED|First Intervention||12
8772235|NCT01282814|9822579|FG001|COMPLETED|First Intervention||9
8772236|NCT01282814|9822578|FG000|NOT COMPLETED|First Intervention||0
8772237|NCT01282814|9822579|FG001|NOT COMPLETED|First Intervention||3
8772238|NCT01282814|9822578|FG000|STARTED|Washout of 7 Days||12
8772239|NCT01282814|9822579|FG001|STARTED|Washout of 7 Days||9
8772240|NCT01282814|9822578|FG000|COMPLETED|Washout of 7 Days||10
8772241|NCT01282814|9822579|FG001|COMPLETED|Washout of 7 Days||9
8772242|NCT01282814|9822578|FG000|NOT COMPLETED|Washout of 7 Days||2
8772243|NCT01282814|9822579|FG001|NOT COMPLETED|Washout of 7 Days||0
8772244|NCT01282814|9822578|FG000|STARTED|Second Intervention||10
8772245|NCT01282814|9822579|FG001|STARTED|Second Intervention||9
8772246|NCT01282814|9822578|FG000|COMPLETED|Second Intervention||10
8772247|NCT01282814|9822579|FG001|COMPLETED|Second Intervention||9
8772248|NCT01282814|9822578|FG000|NOT COMPLETED|Second Intervention||0
8772249|NCT01282814|9822579|FG001|NOT COMPLETED|Second Intervention||0
8772250|NCT01282866|9822585|FG000|STARTED|Overall Study||35
8772251|NCT01282866|9822585|FG000|COMPLETED|Overall Study||34
8772252|NCT01282866|9822585|FG000|NOT COMPLETED|Overall Study||1
8772253|NCT01283009|9822591|FG000|STARTED|Overall Study||287
8772254|NCT01283009|9822592|FG001|STARTED|Overall Study||297
8772255|NCT01283009|9822591|FG000|COMPLETED|Overall Study||169
8772256|NCT01283009|9822592|FG001|COMPLETED|Overall Study||180
8772257|NCT01283009|9822591|FG000|NOT COMPLETED|Overall Study||118
8772258|NCT01283009|9822592|FG001|NOT COMPLETED|Overall Study||117
8772259|NCT01283022|9822598|FG000|STARTED|Overall Study||24
8772260|NCT01283022|9822598|FG000|COMPLETED|Overall Study||24
8772261|NCT01283022|9822598|FG000|NOT COMPLETED|Overall Study||0
8772262|NCT01283035|9822603|FG000|STARTED|Overall Study||6
8772263|NCT01283035|9822603|FG000|COMPLETED|Overall Study||5
8772264|NCT01283035|9822603|FG000|NOT COMPLETED|Overall Study||1
8772265|NCT01283139|9822611|FG000|STARTED|Overall Study||108
8772266|NCT01283139|9822612|FG001|STARTED|Overall Study||108
8772267|NCT01283139|9822613|FG002|STARTED|Overall Study||109
8772268|NCT01283139|9822614|FG003|STARTED|Overall Study||107
8772269|NCT01283139|9822611|FG000|COMPLETED|Overall Study||91
8772270|NCT01283139|9822612|FG001|COMPLETED|Overall Study||90
8772271|NCT01283139|9822613|FG002|COMPLETED|Overall Study||91
8772272|NCT01283139|9822614|FG003|COMPLETED|Overall Study||92
8772273|NCT01283139|9822611|FG000|NOT COMPLETED|Overall Study||17
8772274|NCT01283139|9822612|FG001|NOT COMPLETED|Overall Study||18
9028272|NCT03198767|10090642|FG002|STARTED|Overall Study||8
9028273|NCT03198767|10090643|FG003|STARTED|Overall Study||6
9028274|NCT03198767|10090644|FG004|STARTED|Overall Study||8
9028275|NCT03198767|10090645|FG005|STARTED|Overall Study||8
9028276|NCT03198767|10090646|FG006|STARTED|Overall Study||8
9028277|NCT03198767|10090640|FG000|COMPLETED|Overall Study||8
9028278|NCT03198767|10090641|FG001|COMPLETED|Overall Study||8
9028279|NCT03198767|10090642|FG002|COMPLETED|Overall Study||8
9028280|NCT03198767|10090643|FG003|COMPLETED|Overall Study||0
9028281|NCT03198767|10090644|FG004|COMPLETED|Overall Study||8
9028282|NCT03198767|10090645|FG005|COMPLETED|Overall Study||8
9028283|NCT03198767|10090646|FG006|COMPLETED|Overall Study||8
9028284|NCT03198767|10090640|FG000|NOT COMPLETED|Overall Study||0
9028285|NCT03198767|10090641|FG001|NOT COMPLETED|Overall Study||0
9028286|NCT03198767|10090642|FG002|NOT COMPLETED|Overall Study||0
9028287|NCT03198767|10090643|FG003|NOT COMPLETED|Overall Study||6
9028288|NCT03198767|10090644|FG004|NOT COMPLETED|Overall Study||0
9028289|NCT03198767|10090645|FG005|NOT COMPLETED|Overall Study||0
9028290|NCT03198767|10090646|FG006|NOT COMPLETED|Overall Study||0
9028291|NCT03198871|10090663|FG000|STARTED|Overall Study||90
9028292|NCT03198871|10090664|FG001|STARTED|Overall Study||90
9028293|NCT03198871|10090663|FG000|COMPLETED|Overall Study||76
9028294|NCT03198871|10090664|FG001|COMPLETED|Overall Study||78
9028295|NCT03198871|10090663|FG000|NOT COMPLETED|Overall Study||14
9028296|NCT03198871|10090664|FG001|NOT COMPLETED|Overall Study||12
9028297|NCT03198884|10090670|FG000|STARTED|Overall Study||20
8671373|NCT00750360|9714664|FG001|COMPLETED|Overall Study||1
8671374|NCT00750360|9714665|FG002|COMPLETED|Overall Study||384
8671375|NCT00750360|9714666|FG003|COMPLETED|Overall Study||79
8671376|NCT00750360|9714667|FG004|COMPLETED|Overall Study||46
8671377|NCT00750360|9714668|FG005|COMPLETED|Overall Study||71
8671378|NCT00750360|9714663|FG000|NOT COMPLETED|Overall Study||0
8671379|NCT00750360|9714664|FG001|NOT COMPLETED|Overall Study||0
8671380|NCT00750360|9714665|FG002|NOT COMPLETED|Overall Study||0
8671381|NCT00750360|9714666|FG003|NOT COMPLETED|Overall Study||0
8671382|NCT00750360|9714667|FG004|NOT COMPLETED|Overall Study||0
8772275|NCT01283139|9822613|FG002|NOT COMPLETED|Overall Study||18
8772276|NCT01283139|9822614|FG003|NOT COMPLETED|Overall Study||15
8772277|NCT01283152|9822626|FG000|STARTED|Overall Study||25
8772278|NCT01283152|9822627|FG001|STARTED|Overall Study||25
8772279|NCT01283152|9822626|FG000|ITT Population|Overall Study||25
8772280|NCT01283152|9822627|FG001|ITT Population|Overall Study||25
9028298|NCT03198884|10090670|FG000|COMPLETED|Overall Study||20
9028299|NCT03198884|10090670|FG000|NOT COMPLETED|Overall Study||0
9028300|NCT03199079|10090686|FG000|STARTED|Overall Study||10
9028301|NCT03199079|10090687|FG001|STARTED|Overall Study||10
9028302|NCT03199079|10090686|FG000|COMPLETED|Overall Study||10
9028303|NCT03199079|10090687|FG001|COMPLETED|Overall Study||10
8772281|NCT01283152|9822626|FG000|Study Treatment Received|Overall Study||25
8772282|NCT01283152|9822627|FG001|Study Treatment Received|Overall Study||25
8772283|NCT01283152|9822626|FG000|24-hr HESA Attempted|Overall Study||25
8772284|NCT01283152|9822627|FG001|24-hr HESA Attempted|Overall Study||25
8772285|NCT01283152|9822626|FG000|COMPLETED|Overall Study||23
8772286|NCT01283152|9822627|FG001|COMPLETED|Overall Study||25
8772287|NCT01283152|9822626|FG000|NOT COMPLETED|Overall Study||2
8772288|NCT01283152|9822627|FG001|NOT COMPLETED|Overall Study||0
8772289|NCT01283282|9822633|FG000|STARTED|First Intervention (6 Weeks)||25
8772290|NCT01283282|9822634|FG001|STARTED|First Intervention (6 Weeks)||23
8772291|NCT01283282|9822633|FG000|COMPLETED|First Intervention (6 Weeks)||22
8772292|NCT01283282|9822634|FG001|COMPLETED|First Intervention (6 Weeks)||19
8772293|NCT01283282|9822633|FG000|NOT COMPLETED|First Intervention (6 Weeks)||3
8772294|NCT01283282|9822634|FG001|NOT COMPLETED|First Intervention (6 Weeks)||4
8772295|NCT01283282|9822633|FG000|STARTED|Second Intervention (6 Weeks)||22
8772296|NCT01283282|9822634|FG001|STARTED|Second Intervention (6 Weeks)||19
8772297|NCT01283282|9822633|FG000|COMPLETED|Second Intervention (6 Weeks)||22
8772298|NCT01283282|9822634|FG001|COMPLETED|Second Intervention (6 Weeks)||19
8772299|NCT01283282|9822633|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
8772300|NCT01283282|9822634|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0
8772301|NCT01283321|9822643|FG000|STARTED|Overall Study||10
8772302|NCT01283321|9822644|FG001|STARTED|Overall Study||10
8772303|NCT01283321|9822643|FG000|COMPLETED|Overall Study||10
8772304|NCT01283321|9822644|FG001|COMPLETED|Overall Study||10
8772305|NCT01283321|9822643|FG000|NOT COMPLETED|Overall Study||0
8772306|NCT01283321|9822644|FG001|NOT COMPLETED|Overall Study||0
8772307|NCT01283334|9822652|FG000|STARTED|Overall Study||20
8772308|NCT01283334|9822652|FG000|COMPLETED|Overall Study||13
8772309|NCT01283334|9822652|FG000|NOT COMPLETED|Overall Study||7
8772310|NCT01283386|9822660|FG000|STARTED|Overall Study||10
8772311|NCT01283386|9822661|FG001|STARTED|Overall Study||16
8772312|NCT01283386|9822660|FG000|COMPLETED|Overall Study||2
8772313|NCT01283386|9822661|FG001|COMPLETED|Overall Study||4
8772314|NCT01283386|9822660|FG000|NOT COMPLETED|Overall Study||8
8772315|NCT01283386|9822661|FG001|NOT COMPLETED|Overall Study||12
8772316|NCT01283464|9822669|FG000|STARTED|Overall Study||12
8772317|NCT01283464|9822670|FG001|STARTED|Overall Study||12
8772318|NCT01283464|9822669|FG000|COMPLETED|Overall Study||10
8772319|NCT01283464|9822670|FG001|COMPLETED|Overall Study||11
8772320|NCT01283464|9822669|FG000|NOT COMPLETED|Overall Study||2
8772321|NCT01283464|9822670|FG001|NOT COMPLETED|Overall Study||1
8772322|NCT01283516|9822685|FG000|STARTED|Overall Study|Started = Full Analysis Set and Safety Set|2
8772323|NCT01283516|9822686|FG001|STARTED|Overall Study||2
8772324|NCT01283516|9822687|FG002|STARTED|Overall Study||3
8772325|NCT01283516|9822688|FG003|STARTED|Overall Study||3
8772326|NCT01283516|9822689|FG004|STARTED|Overall Study||14
8772327|NCT01283516|9822690|FG005|STARTED|Overall Study||10
8772328|NCT01283516|9822691|FG006|STARTED|Overall Study||10
8772329|NCT01283516|9822692|FG007|STARTED|Overall Study||5
8772330|NCT01283516|9822693|FG008|STARTED|Overall Study||255
8772331|NCT01283516|9822685|FG000|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||2
8772332|NCT01283516|9822686|FG001|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||1
8772333|NCT01283516|9822687|FG002|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||2
8772334|NCT01283516|9822688|FG003|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||3
8772335|NCT01283516|9822689|FG004|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||12
8772336|NCT01283516|9822690|FG005|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||10
8772337|NCT01283516|9822691|FG006|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||9
8772338|NCT01283516|9822692|FG007|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||5
8772339|NCT01283516|9822693|FG008|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||246
8772340|NCT01283516|9822685|FG000|Dose-Determining Set (DDS)|Overall Study||2
8772341|NCT01283516|9822686|FG001|Dose-Determining Set (DDS)|Overall Study||1
9028304|NCT03199079|10090686|FG000|NOT COMPLETED|Overall Study||0
9028305|NCT03199079|10090687|FG001|NOT COMPLETED|Overall Study||0
9028306|NCT03199118|10090695|FG000|STARTED|Overall Study||14
9028307|NCT03199118|10090696|FG001|STARTED|Overall Study||14
9028308|NCT03199118|10090695|FG000|COMPLETED|Overall Study|6 months follow-up|14
9028309|NCT03199118|10090696|FG001|COMPLETED|Overall Study|6 months follow-up|14
9028310|NCT03199118|10090695|FG000|NOT COMPLETED|Overall Study||0
9028311|NCT03199118|10090696|FG001|NOT COMPLETED|Overall Study||0
9028312|NCT03199872|10090707|FG000|STARTED|Overall Study||22
9028313|NCT03199872|10090707|FG000|COMPLETED|Overall Study||22
9028314|NCT03199872|10090707|FG000|NOT COMPLETED|Overall Study||0
9028315|NCT03199911|10090713|FG000|STARTED|Overall Study||208
9028316|NCT03199911|10090714|FG001|STARTED|Overall Study||193
9028317|NCT03199911|10090713|FG000|Did Not Proceed With Surgery|Overall Study||2
9028318|NCT03199911|10090714|FG001|Did Not Proceed With Surgery|Overall Study||1
9028319|NCT03199911|10090713|FG000|Received Allocated Treatment|Overall Study||206
9028320|NCT03199911|10090714|FG001|Received Allocated Treatment|Overall Study||192
9028321|NCT03199911|10090713|FG000|Lost to Follow-up|Overall Study||5
9028322|NCT03199911|10090714|FG001|Lost to Follow-up|Overall Study||5
9028323|NCT03199911|10090713|FG000|Primary Outcome Analyzed|Overall Study||201
9028324|NCT03199911|10090714|FG001|Primary Outcome Analyzed|Overall Study||187
9028325|NCT03199911|10090713|FG000|COMPLETED|Overall Study||201
9028326|NCT03199911|10090714|FG001|COMPLETED|Overall Study||187
9028327|NCT03199911|10090713|FG000|NOT COMPLETED|Overall Study||7
8772342|NCT01283516|9822687|FG002|Dose-Determining Set (DDS)|Overall Study||3
8772343|NCT01283516|9822688|FG003|Dose-Determining Set (DDS)|Overall Study||3
8772344|NCT01283516|9822689|FG004|Dose-Determining Set (DDS)|Overall Study||14
8772345|NCT01283516|9822690|FG005|Dose-Determining Set (DDS)|Overall Study||8
8772346|NCT01283516|9822691|FG006|Dose-Determining Set (DDS)|Overall Study||10
8772347|NCT01283516|9822692|FG007|Dose-Determining Set (DDS)|Overall Study||5
8772348|NCT01283516|9822693|FG008|Dose-Determining Set (DDS)|Overall Study||8
8772349|NCT01283516|9822685|FG000|Non-NSCLC|Overall Study||0
8772350|NCT01283516|9822686|FG001|Non-NSCLC|Overall Study||1
8772351|NCT01283516|9822687|FG002|Non-NSCLC|Overall Study||1
8772352|NCT01283516|9822688|FG003|Non-NSCLC|Overall Study||0
8772353|NCT01283516|9822689|FG004|Non-NSCLC|Overall Study||2
8772354|NCT01283516|9822690|FG005|Non-NSCLC|Overall Study||0
8772355|NCT01283516|9822691|FG006|Non-NSCLC|Overall Study||1
8772356|NCT01283516|9822692|FG007|Non-NSCLC|Overall Study||0
8772357|NCT01283516|9822693|FG008|Non-NSCLC|Overall Study|Small number of patients at 750 mg - non-NSCLC, assessment limited, not included in efficacy tables|9
8772358|NCT01283516|9822685|FG000|COMPLETED|Overall Study|Completed - see explanation in Recruitment Details.|0
8772359|NCT01283516|9822686|FG001|COMPLETED|Overall Study||0
8772360|NCT01283516|9822687|FG002|COMPLETED|Overall Study||0
8772361|NCT01283516|9822688|FG003|COMPLETED|Overall Study||0
8772362|NCT01283516|9822689|FG004|COMPLETED|Overall Study||0
8772363|NCT01283516|9822690|FG005|COMPLETED|Overall Study||0
8772364|NCT01283516|9822691|FG006|COMPLETED|Overall Study||0
8772365|NCT01283516|9822692|FG007|COMPLETED|Overall Study||0
8772366|NCT01283516|9822693|FG008|COMPLETED|Overall Study||0
8772367|NCT01283516|9822685|FG000|NOT COMPLETED|Overall Study||2
8772368|NCT01283516|9822686|FG001|NOT COMPLETED|Overall Study||2
8772369|NCT01283516|9822687|FG002|NOT COMPLETED|Overall Study||3
8772370|NCT01283516|9822688|FG003|NOT COMPLETED|Overall Study||3
8772371|NCT01283516|9822689|FG004|NOT COMPLETED|Overall Study||14
8772372|NCT01283516|9822690|FG005|NOT COMPLETED|Overall Study||10
8772373|NCT01283516|9822691|FG006|NOT COMPLETED|Overall Study||10
8772374|NCT01283516|9822692|FG007|NOT COMPLETED|Overall Study||5
8772375|NCT01283516|9822693|FG008|NOT COMPLETED|Overall Study||255
8772376|NCT01283542|9822721|FG000|STARTED|Main Phase||20
8772377|NCT01283542|9822721|FG000|Full Analysis Set (FAS)|Main Phase||20
8772378|NCT01283542|9822721|FG000|Safety Analysis Set|Main Phase||20
8772379|NCT01283542|9822721|FG000|COMPLETED|Main Phase||13
8772380|NCT01283542|9822721|FG000|NOT COMPLETED|Main Phase||7
8772381|NCT01283542|9822721|FG000|STARTED|Extension Phase||13
8772382|NCT01283542|9822721|FG000|Full Analysis Set (FAS)|Extension Phase||13
8772383|NCT01283542|9822721|FG000|Safety Analysis Set|Extension Phase||13
9028328|NCT03199911|10090714|FG001|NOT COMPLETED|Overall Study||6
9028329|NCT03199963|10090722|FG000|STARTED|Blinded Phase - Overall Study||149
9028330|NCT03199963|10090723|FG001|STARTED|Blinded Phase - Overall Study||74
9028331|NCT03199963|10090722|FG000|Received at Least 1 Gel Application|Blinded Phase - Overall Study||149
9028332|NCT03199963|10090723|FG001|Received at Least 1 Gel Application|Blinded Phase - Overall Study||73
9028333|NCT03199963|10090722|FG000|COMPLETED|Blinded Phase - Overall Study||16
9028334|NCT03199963|10090723|FG001|COMPLETED|Blinded Phase - Overall Study||8
9028335|NCT03199963|10090722|FG000|NOT COMPLETED|Blinded Phase - Overall Study||133
9028336|NCT03199963|10090723|FG001|NOT COMPLETED|Blinded Phase - Overall Study||66
9028337|NCT03199963|10090722|FG000|STARTED|Optional Open-Label Phase - BHR-700||7
9028338|NCT03199963|10090723|FG001|STARTED|Optional Open-Label Phase - BHR-700||6
9028339|NCT03199963|10090722|FG000|COMPLETED|Optional Open-Label Phase - BHR-700||0
9028340|NCT03199963|10090723|FG001|COMPLETED|Optional Open-Label Phase - BHR-700||0
9028341|NCT03199963|10090722|FG000|NOT COMPLETED|Optional Open-Label Phase - BHR-700||7
9028342|NCT03199963|10090723|FG001|NOT COMPLETED|Optional Open-Label Phase - BHR-700||6
9028343|NCT03200366|10090734|FG000|STARTED|Baseline Interview With Randomization||123
9028344|NCT03200366|10090735|FG001|STARTED|Baseline Interview With Randomization||120
9028345|NCT03200366|10090736|FG002|STARTED|Baseline Interview With Randomization||128
9028346|NCT03200366|10090734|FG000|COMPLETED|Baseline Interview With Randomization||123
9028347|NCT03200366|10090735|FG001|COMPLETED|Baseline Interview With Randomization||120
9028348|NCT03200366|10090736|FG002|COMPLETED|Baseline Interview With Randomization||128
9028349|NCT03200366|10090734|FG000|NOT COMPLETED|Baseline Interview With Randomization||0
9028350|NCT03200366|10090735|FG001|NOT COMPLETED|Baseline Interview With Randomization||0
9028351|NCT03200366|10090736|FG002|NOT COMPLETED|Baseline Interview With Randomization||0
9028352|NCT03200366|10090734|FG000|STARTED|Tailored DVD Intervention Given||123
9028353|NCT03200366|10090735|FG001|STARTED|Tailored DVD Intervention Given||120
9028354|NCT03200366|10090736|FG002|STARTED|Tailored DVD Intervention Given||0
9028355|NCT03200366|10090734|FG000|COMPLETED|Tailored DVD Intervention Given||123
9028356|NCT03200366|10090735|FG001|COMPLETED|Tailored DVD Intervention Given||120
9028357|NCT03200366|10090736|FG002|COMPLETED|Tailored DVD Intervention Given||0
9028358|NCT03200366|10090734|FG000|NOT COMPLETED|Tailored DVD Intervention Given||0
9028359|NCT03200366|10090735|FG001|NOT COMPLETED|Tailored DVD Intervention Given||0
8575173|NCT00133575|9607673|FG006|STARTED|Overall Study||12
8772384|NCT01283542|9822721|FG000|COMPLETED|Extension Phase||10
8772385|NCT01283542|9822721|FG000|NOT COMPLETED|Extension Phase||3
8772386|NCT01283555|9822743|FG000|STARTED|First Intervention||13
8772387|NCT01283555|9822744|FG001|STARTED|First Intervention||12
8772388|NCT01283555|9822743|FG000|COMPLETED|First Intervention||13
8772389|NCT01283555|9822744|FG001|COMPLETED|First Intervention||12
8772390|NCT01283555|9822743|FG000|NOT COMPLETED|First Intervention||0
8772391|NCT01283555|9822744|FG001|NOT COMPLETED|First Intervention||0
8772392|NCT01283555|9822743|FG000|STARTED|Washout Period of at Least 21 Days||13
8772393|NCT01283555|9822744|FG001|STARTED|Washout Period of at Least 21 Days||12
8772394|NCT01283555|9822743|FG000|COMPLETED|Washout Period of at Least 21 Days||13
8772395|NCT01283555|9822744|FG001|COMPLETED|Washout Period of at Least 21 Days||12
8772396|NCT01283555|9822743|FG000|NOT COMPLETED|Washout Period of at Least 21 Days||0
8772397|NCT01283555|9822744|FG001|NOT COMPLETED|Washout Period of at Least 21 Days||0
8772398|NCT01283555|9822743|FG000|STARTED|Second Intervention||13
8772399|NCT01283555|9822744|FG001|STARTED|Second Intervention||12
8772400|NCT01283555|9822743|FG000|COMPLETED|Second Intervention||13
8772401|NCT01283555|9822744|FG001|COMPLETED|Second Intervention||12
8772402|NCT01283555|9822743|FG000|NOT COMPLETED|Second Intervention||0
8772403|NCT01283555|9822744|FG001|NOT COMPLETED|Second Intervention||0
8808631|NCT01491022|9860845|FG000|COMPLETED|Intervention 2||8
8808632|NCT01491022|9860846|FG001|COMPLETED|Intervention 2||11
8808633|NCT01491022|9860845|FG000|NOT COMPLETED|Intervention 2||1
8808634|NCT01491022|9860846|FG001|NOT COMPLETED|Intervention 2||0
8808635|NCT01491035|9860864|FG000|STARTED|Overall Study||6
8808636|NCT01491035|9860865|FG001|STARTED|Overall Study||6
8808637|NCT01491035|9860866|FG002|STARTED|Overall Study||6
8808638|NCT01491035|9860867|FG003|STARTED|Overall Study||6
8808639|NCT01491035|9860868|FG004|STARTED|Overall Study||6
8808640|NCT01491035|9860869|FG005|STARTED|Overall Study||6
8808641|NCT01491035|9860870|FG006|STARTED|Overall Study||6
8808642|NCT01491035|9860871|FG007|STARTED|Overall Study||6
8808643|NCT01491035|9860864|FG000|COMPLETED|Overall Study||6
8808644|NCT01491035|9860865|FG001|COMPLETED|Overall Study||6
8808645|NCT01491035|9860866|FG002|COMPLETED|Overall Study||6
8808646|NCT01491035|9860867|FG003|COMPLETED|Overall Study||6
8808647|NCT01491035|9860868|FG004|COMPLETED|Overall Study||5
8808648|NCT01491035|9860869|FG005|COMPLETED|Overall Study||6
8808649|NCT01491035|9860870|FG006|COMPLETED|Overall Study||6
8808650|NCT01491035|9860871|FG007|COMPLETED|Overall Study||6
8808651|NCT01491035|9860864|FG000|NOT COMPLETED|Overall Study||0
8808652|NCT01491035|9860865|FG001|NOT COMPLETED|Overall Study||0
8808653|NCT01491035|9860866|FG002|NOT COMPLETED|Overall Study||0
8808654|NCT01491035|9860867|FG003|NOT COMPLETED|Overall Study||0
8808655|NCT01491035|9860868|FG004|NOT COMPLETED|Overall Study||1
8808656|NCT01491035|9860869|FG005|NOT COMPLETED|Overall Study||0
8808657|NCT01491035|9860870|FG006|NOT COMPLETED|Overall Study||0
8808658|NCT01491035|9860871|FG007|NOT COMPLETED|Overall Study||0
8808659|NCT01491113|9860894|FG000|STARTED|Overall Study||6
8808660|NCT01491113|9860895|FG001|STARTED|Overall Study||6
8808661|NCT01491113|9860896|FG002|STARTED|Overall Study||6
8808662|NCT01491113|9860897|FG003|STARTED|Overall Study||6
8808663|NCT01491113|9860898|FG004|STARTED|Overall Study||6
8808664|NCT01491113|9860894|FG000|COMPLETED|Overall Study||6
8808665|NCT01491113|9860895|FG001|COMPLETED|Overall Study||6
8808666|NCT01491113|9860896|FG002|COMPLETED|Overall Study||6
8808667|NCT01491113|9860897|FG003|COMPLETED|Overall Study||6
8808668|NCT01491113|9860898|FG004|COMPLETED|Overall Study||6
8808669|NCT01491113|9860894|FG000|NOT COMPLETED|Overall Study||0
8808670|NCT01491113|9860895|FG001|NOT COMPLETED|Overall Study||0
8808671|NCT01491113|9860896|FG002|NOT COMPLETED|Overall Study||0
8808672|NCT01491113|9860897|FG003|NOT COMPLETED|Overall Study||0
8808673|NCT01491113|9860898|FG004|NOT COMPLETED|Overall Study||0
8808674|NCT01491178|9860912|FG000|STARTED|Overall Study|Started are the enrolled subjects who followed registration rule and for who eCRF was collected.|6443
8808675|NCT01491178|9860912|FG000|COMPLETED|Overall Study|Completed is defined as 104 weeks follow-up after enrollment.|3649
8808676|NCT01491178|9860912|FG000|NOT COMPLETED|Overall Study||2794
8808677|NCT01491490|9860918|FG000|STARTED|Overall Study||1
8808678|NCT01491490|9860919|FG001|STARTED|Overall Study||1
8808679|NCT01491490|9860918|FG000|COMPLETED|Overall Study||1
8808680|NCT01491490|9860919|FG001|COMPLETED|Overall Study||1
8808681|NCT01491490|9860918|FG000|NOT COMPLETED|Overall Study||0
8808682|NCT01491490|9860919|FG001|NOT COMPLETED|Overall Study||0
8808683|NCT01491607|9860929|FG000|STARTED|Overall Study||200
8808684|NCT01491607|9860929|FG000|COMPLETED|Overall Study||190
8808685|NCT01491607|9860929|FG000|NOT COMPLETED|Overall Study||10
8808686|NCT01491633|9860995|FG000|STARTED|Overall Study||5
8808687|NCT01491633|9860995|FG000|COMPLETED|Overall Study||0
8808688|NCT01491633|9860995|FG000|NOT COMPLETED|Overall Study||5
8808689|NCT01491672|9861002|FG000|STARTED|Overall Study||58
8808690|NCT01491672|9861003|FG001|STARTED|Overall Study|1 participant died prior to treatment initiation.|62
8808691|NCT01491672|9861004|FG002|STARTED|Overall Study||14
8808692|NCT01491672|9861002|FG000|Safety Set|Overall Study||58
8808693|NCT01491672|9861003|FG001|Safety Set|Overall Study||61
8808694|NCT01491672|9861004|FG002|Safety Set|Overall Study||14
8808695|NCT01491672|9861002|FG000|COMPLETED|Overall Study||2
8808696|NCT01491672|9861003|FG001|COMPLETED|Overall Study||2
8808697|NCT01491672|9861004|FG002|COMPLETED|Overall Study||3
8808698|NCT01491672|9861002|FG000|NOT COMPLETED|Overall Study||56
8808699|NCT01491672|9861003|FG001|NOT COMPLETED|Overall Study||60
8808700|NCT01491672|9861004|FG002|NOT COMPLETED|Overall Study||11
8808701|NCT01491737|9861016|FG000|STARTED|Overall Study||129
8808702|NCT01491737|9861017|FG001|STARTED|Overall Study||129
8808703|NCT01491737|9861016|FG000|Received at Least One Dose of Study Drug|Overall Study||127
8808704|NCT01491737|9861017|FG001|Received at Least One Dose of Study Drug|Overall Study||124
8808705|NCT01491737|9861016|FG000|Entered Follow-Up (Post-Treatment)|Overall Study||120
8808706|NCT01491737|9861017|FG001|Entered Follow-Up (Post-Treatment)|Overall Study||116
8772404|NCT01283581|9822757|FG000|STARTED|Overall Study||81
8772405|NCT01283581|9822758|FG001|STARTED|Overall Study||77
8772406|NCT01283581|9822759|FG002|STARTED|Overall Study||98
8772407|NCT01283581|9822757|FG000|COMPLETED|Overall Study||69
8772408|NCT01283581|9822758|FG001|COMPLETED|Overall Study||63
8772409|NCT01283581|9822759|FG002|COMPLETED|Overall Study||78
8772410|NCT01283581|9822757|FG000|NOT COMPLETED|Overall Study||12
8772411|NCT01283581|9822758|FG001|NOT COMPLETED|Overall Study||14
8772412|NCT01283581|9822759|FG002|NOT COMPLETED|Overall Study||20
8772413|NCT01283971|9822772|FG000|STARTED|Overall Study||48
8772414|NCT01283971|9822773|FG001|STARTED|Overall Study||48
8772415|NCT01283971|9822772|FG000|Intent to Treat Population|Overall Study||46
8772416|NCT01283971|9822773|FG001|Intent to Treat Population|Overall Study||48
8772417|NCT01283971|9822772|FG000|COMPLETED|Overall Study||33
8772418|NCT01283971|9822773|FG001|COMPLETED|Overall Study||36
8772419|NCT01283971|9822772|FG000|NOT COMPLETED|Overall Study||15
8772420|NCT01283971|9822773|FG001|NOT COMPLETED|Overall Study||12
8772421|NCT01284062|9822783|FG000|STARTED|Overall Study||21
8772422|NCT01284062|9822784|FG001|STARTED|Overall Study||21
8772423|NCT01284062|9822785|FG002|STARTED|Overall Study||21
8772424|NCT01284062|9822786|FG003|STARTED|Overall Study||21
8772425|NCT01284062|9822783|FG000|COMPLETED|Overall Study||10
8772426|NCT01284062|9822784|FG001|COMPLETED|Overall Study||13
8772427|NCT01284062|9822785|FG002|COMPLETED|Overall Study||15
8772428|NCT01284062|9822786|FG003|COMPLETED|Overall Study||7
8772429|NCT01284062|9822783|FG000|NOT COMPLETED|Overall Study||11
8772430|NCT01284062|9822784|FG001|NOT COMPLETED|Overall Study||8
8772431|NCT01284062|9822785|FG002|NOT COMPLETED|Overall Study||6
8772432|NCT01284062|9822786|FG003|NOT COMPLETED|Overall Study||14
8772433|NCT01284114|9822799|FG000|STARTED|Overall Study||23
8772434|NCT01284114|9822799|FG000|COMPLETED|Overall Study||19
8772435|NCT01284114|9822799|FG000|NOT COMPLETED|Overall Study||4
8772436|NCT01284127|9822804|FG000|STARTED|Overall Study||38
8772437|NCT01284127|9822804|FG000|COMPLETED|Overall Study||31
8772438|NCT01284127|9822804|FG000|NOT COMPLETED|Overall Study||7
8772439|NCT01284140|9822810|FG000|STARTED|Randomization and Intervention||11
8772440|NCT01284140|9822811|FG001|STARTED|Randomization and Intervention||11
8772441|NCT01284140|9822810|FG000|COMPLETED|Randomization and Intervention||11
8772442|NCT01284140|9822811|FG001|COMPLETED|Randomization and Intervention||11
8772443|NCT01284140|9822810|FG000|NOT COMPLETED|Randomization and Intervention||0
8772444|NCT01284140|9822811|FG001|NOT COMPLETED|Randomization and Intervention||0
8772445|NCT01284140|9822810|FG000|STARTED|Subjects With Paired 24hr Collections||11
8772446|NCT01284140|9822811|FG001|STARTED|Subjects With Paired 24hr Collections||11
8772447|NCT01284140|9822810|FG000|COMPLETED|Subjects With Paired 24hr Collections||6
8772448|NCT01284140|9822811|FG001|COMPLETED|Subjects With Paired 24hr Collections||5
8772449|NCT01284140|9822810|FG000|NOT COMPLETED|Subjects With Paired 24hr Collections||5
8772450|NCT01284140|9822811|FG001|NOT COMPLETED|Subjects With Paired 24hr Collections||6
8772451|NCT01284244|9822819|FG000|STARTED|Overall Study||18
8772452|NCT01284244|9822820|FG001|STARTED|Overall Study||18
8772453|NCT01284244|9822819|FG000|COMPLETED|Overall Study||18
8772454|NCT01284244|9822820|FG001|COMPLETED|Overall Study||18
8772455|NCT01284244|9822819|FG000|NOT COMPLETED|Overall Study||0
8772456|NCT01284244|9822820|FG001|NOT COMPLETED|Overall Study||0
8772457|NCT01284296|9822826|FG000|STARTED|Overall Study||20
8772458|NCT01284296|9822826|FG000|COMPLETED|Overall Study||20
8772459|NCT01284296|9822826|FG000|NOT COMPLETED|Overall Study||0
8772460|NCT01284335|9822844|FG000|STARTED|Overall Study||25
8772461|NCT01284335|9822845|FG001|STARTED|Overall Study||33
8772462|NCT01284335|9822846|FG002|STARTED|Overall Study||5
8772463|NCT01284335|9822847|FG003|STARTED|Overall Study||5
8772464|NCT01284335|9822848|FG004|STARTED|Overall Study||24
8772465|NCT01284335|9822849|FG005|STARTED|Overall Study||26
8772466|NCT01284335|9822850|FG006|STARTED|Overall Study||19
8772467|NCT01284335|9822851|FG007|STARTED|Overall Study||6
8772468|NCT01284335|9822852|FG008|STARTED|Overall Study||4
8772469|NCT01284335|9822853|FG009|STARTED|Overall Study||14
8772470|NCT01284335|9822854|FG010|STARTED|Overall Study||45
8772471|NCT01284335|9822855|FG011|STARTED|Overall Study||16
8772472|NCT01284335|9822856|FG012|STARTED|Overall Study||12
8772473|NCT01284335|9822844|FG000|Received at Least One Dose of Study Drug|Overall Study||25
8772474|NCT01284335|9822845|FG001|Received at Least One Dose of Study Drug|Overall Study||33
8772475|NCT01284335|9822846|FG002|Received at Least One Dose of Study Drug|Overall Study||5
8772476|NCT01284335|9822847|FG003|Received at Least One Dose of Study Drug|Overall Study||5
8772477|NCT01284335|9822848|FG004|Received at Least One Dose of Study Drug|Overall Study||24
8772478|NCT01284335|9822849|FG005|Received at Least One Dose of Study Drug|Overall Study||26
8772479|NCT01284335|9822850|FG006|Received at Least One Dose of Study Drug|Overall Study||19
8772480|NCT01284335|9822851|FG007|Received at Least One Dose of Study Drug|Overall Study||6
8772481|NCT01284335|9822852|FG008|Received at Least One Dose of Study Drug|Overall Study||4
8772482|NCT01284335|9822853|FG009|Received at Least One Dose of Study Drug|Overall Study||14
8772483|NCT01284335|9822854|FG010|Received at Least One Dose of Study Drug|Overall Study||45
8772484|NCT01284335|9822855|FG011|Received at Least One Dose of Study Drug|Overall Study||16
8772485|NCT01284335|9822856|FG012|Received at Least One Dose of Study Drug|Overall Study||12
8772486|NCT01284335|9822844|FG000|COMPLETED|Overall Study||25
8772487|NCT01284335|9822845|FG001|COMPLETED|Overall Study||33
8772488|NCT01284335|9822846|FG002|COMPLETED|Overall Study||5
8772489|NCT01284335|9822847|FG003|COMPLETED|Overall Study||5
8772490|NCT01284335|9822848|FG004|COMPLETED|Overall Study||24
8772491|NCT01284335|9822849|FG005|COMPLETED|Overall Study||26
8772492|NCT01284335|9822850|FG006|COMPLETED|Overall Study||19
8772493|NCT01284335|9822851|FG007|COMPLETED|Overall Study||6
8772494|NCT01284335|9822852|FG008|COMPLETED|Overall Study||4
8772495|NCT01284335|9822853|FG009|COMPLETED|Overall Study||14
8772496|NCT01284335|9822854|FG010|COMPLETED|Overall Study||45
8772497|NCT01284335|9822855|FG011|COMPLETED|Overall Study||16
8772498|NCT01284335|9822856|FG012|COMPLETED|Overall Study||12
8772499|NCT01284335|9822844|FG000|NOT COMPLETED|Overall Study||0
8772500|NCT01284335|9822845|FG001|NOT COMPLETED|Overall Study||0
8772501|NCT01284335|9822846|FG002|NOT COMPLETED|Overall Study||0
8772502|NCT01284335|9822847|FG003|NOT COMPLETED|Overall Study||0
8772503|NCT01284335|9822848|FG004|NOT COMPLETED|Overall Study||0
8772504|NCT01284335|9822849|FG005|NOT COMPLETED|Overall Study||0
8772505|NCT01284335|9822850|FG006|NOT COMPLETED|Overall Study||0
8772506|NCT01284335|9822851|FG007|NOT COMPLETED|Overall Study||0
8772507|NCT01284335|9822852|FG008|NOT COMPLETED|Overall Study||0
8916124|NCT02180646|9975657|FG000|NOT COMPLETED|First Intervention (7 Days)||0
8916125|NCT02180646|9975658|FG001|NOT COMPLETED|First Intervention (7 Days)||0
8916126|NCT02180646|9975657|FG000|STARTED|Washout (7 Days)||6
8916127|NCT02180646|9975658|FG001|STARTED|Washout (7 Days)||6
8916128|NCT02180646|9975657|FG000|COMPLETED|Washout (7 Days)||6
8916129|NCT02180646|9975658|FG001|COMPLETED|Washout (7 Days)||6
8916130|NCT02180646|9975657|FG000|NOT COMPLETED|Washout (7 Days)||0
8916131|NCT02180646|9975658|FG001|NOT COMPLETED|Washout (7 Days)||0
8916132|NCT02180646|9975657|FG000|STARTED|Second Intervention (7 Days)||6
8916133|NCT02180646|9975658|FG001|STARTED|Second Intervention (7 Days)||6
8916134|NCT02180646|9975657|FG000|COMPLETED|Second Intervention (7 Days)||6
8916135|NCT02180646|9975658|FG001|COMPLETED|Second Intervention (7 Days)||6
8916136|NCT02180646|9975657|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
8916137|NCT02180646|9975658|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
8916138|NCT02180659|9975668|FG000|STARTED|Overall Study||87
8916139|NCT02180659|9975669|FG001|STARTED|Overall Study|N=90 randomized, however N=89 received study medication|89
8916140|NCT02180659|9975668|FG000|COMPLETED|Overall Study||81
8916141|NCT02180659|9975669|FG001|COMPLETED|Overall Study||84
8916142|NCT02180659|9975668|FG000|NOT COMPLETED|Overall Study||6
8916143|NCT02180659|9975669|FG001|NOT COMPLETED|Overall Study||5
8916144|NCT02180672|9975677|FG000|STARTED|Overall Study||91
8916145|NCT02180672|9975678|FG001|STARTED|Overall Study||43
8772508|NCT01284335|9822853|FG009|NOT COMPLETED|Overall Study||0
8772509|NCT01284335|9822854|FG010|NOT COMPLETED|Overall Study||0
8772510|NCT01284335|9822855|FG011|NOT COMPLETED|Overall Study||0
8772511|NCT01284335|9822856|FG012|NOT COMPLETED|Overall Study||0
8772512|NCT01284361|9822896|FG000|STARTED|Overall Study||91
8772513|NCT01284361|9822896|FG000|COMPLETED|Overall Study||82
8772514|NCT01284361|9822896|FG000|NOT COMPLETED|Overall Study||9
8772515|NCT01284426|9822903|FG000|STARTED|Overall Study||94
8772516|NCT01284426|9822903|FG000|COMPLETED|Overall Study||92
8772517|NCT01284426|9822903|FG000|NOT COMPLETED|Overall Study||2
8772518|NCT01284517|9822909|FG000|STARTED|Overall Study||180
8772519|NCT01284517|9822910|FG001|STARTED|Overall Study||176
8772520|NCT01284517|9822909|FG000|COMPLETED|Overall Study||148
8772521|NCT01284517|9822910|FG001|COMPLETED|Overall Study||140
8772522|NCT01284517|9822909|FG000|NOT COMPLETED|Overall Study||32
8772523|NCT01284517|9822910|FG001|NOT COMPLETED|Overall Study||36
8772524|NCT01284621|9822916|FG000|STARTED|First Intervention (8 Days)||3
8772525|NCT01284621|9822917|FG001|STARTED|First Intervention (8 Days)||4
8772526|NCT01284621|9822918|FG002|STARTED|First Intervention (8 Days)||4
8772527|NCT01284621|9822919|FG003|STARTED|First Intervention (8 Days)||4
8772528|NCT01284621|9822920|FG004|STARTED|First Intervention (8 Days)||4
8772529|NCT01284621|9822921|FG005|STARTED|First Intervention (8 Days)||4
8772530|NCT01284621|9822916|FG000|COMPLETED|First Intervention (8 Days)||3
8772531|NCT01284621|9822917|FG001|COMPLETED|First Intervention (8 Days)||4
8772532|NCT01284621|9822918|FG002|COMPLETED|First Intervention (8 Days)||4
8772533|NCT01284621|9822919|FG003|COMPLETED|First Intervention (8 Days)||4
8772534|NCT01284621|9822920|FG004|COMPLETED|First Intervention (8 Days)||4
8772535|NCT01284621|9822921|FG005|COMPLETED|First Intervention (8 Days)||4
8772536|NCT01284621|9822916|FG000|NOT COMPLETED|First Intervention (8 Days)||0
8772537|NCT01284621|9822917|FG001|NOT COMPLETED|First Intervention (8 Days)||0
8772538|NCT01284621|9822918|FG002|NOT COMPLETED|First Intervention (8 Days)||0
8772539|NCT01284621|9822919|FG003|NOT COMPLETED|First Intervention (8 Days)||0
8772540|NCT01284621|9822920|FG004|NOT COMPLETED|First Intervention (8 Days)||0
8772541|NCT01284621|9822921|FG005|NOT COMPLETED|First Intervention (8 Days)||0
8772542|NCT01284621|9822916|FG000|STARTED|Washout Period 1 (7 Days)||3
8772543|NCT01284621|9822917|FG001|STARTED|Washout Period 1 (7 Days)||4
8772544|NCT01284621|9822918|FG002|STARTED|Washout Period 1 (7 Days)||4
8772545|NCT01284621|9822919|FG003|STARTED|Washout Period 1 (7 Days)||4
8772546|NCT01284621|9822920|FG004|STARTED|Washout Period 1 (7 Days)||4
8772547|NCT01284621|9822921|FG005|STARTED|Washout Period 1 (7 Days)||4
8772548|NCT01284621|9822916|FG000|COMPLETED|Washout Period 1 (7 Days)||3
8772549|NCT01284621|9822917|FG001|COMPLETED|Washout Period 1 (7 Days)||4
8772550|NCT01284621|9822918|FG002|COMPLETED|Washout Period 1 (7 Days)||4
8772551|NCT01284621|9822919|FG003|COMPLETED|Washout Period 1 (7 Days)||4
8772552|NCT01284621|9822920|FG004|COMPLETED|Washout Period 1 (7 Days)||3
8916146|NCT02180672|9975677|FG000|COMPLETED|Overall Study||86
8916147|NCT02180672|9975678|FG001|COMPLETED|Overall Study||36
8772553|NCT01284621|9822921|FG005|COMPLETED|Washout Period 1 (7 Days)||4
8772554|NCT01284621|9822916|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
8772555|NCT01284621|9822917|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
8772556|NCT01284621|9822918|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
8772557|NCT01284621|9822919|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
8772558|NCT01284621|9822920|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||1
8772559|NCT01284621|9822921|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||0
8772560|NCT01284621|9822916|FG000|STARTED|Second Intervention (8 Days)||3
8772561|NCT01284621|9822917|FG001|STARTED|Second Intervention (8 Days)||4
8772562|NCT01284621|9822918|FG002|STARTED|Second Intervention (8 Days)||4
8772563|NCT01284621|9822919|FG003|STARTED|Second Intervention (8 Days)||4
8772564|NCT01284621|9822920|FG004|STARTED|Second Intervention (8 Days)||3
8772565|NCT01284621|9822921|FG005|STARTED|Second Intervention (8 Days)||4
8772566|NCT01284621|9822916|FG000|COMPLETED|Second Intervention (8 Days)||3
8772567|NCT01284621|9822917|FG001|COMPLETED|Second Intervention (8 Days)||4
8772568|NCT01284621|9822918|FG002|COMPLETED|Second Intervention (8 Days)||4
8772569|NCT01284621|9822919|FG003|COMPLETED|Second Intervention (8 Days)||4
8772570|NCT01284621|9822920|FG004|COMPLETED|Second Intervention (8 Days)||3
8772571|NCT01284621|9822921|FG005|COMPLETED|Second Intervention (8 Days)||4
9028360|NCT03200366|10090736|FG002|NOT COMPLETED|Tailored DVD Intervention Given||0
9028361|NCT03200366|10090734|FG000|STARTED|Patient Navigation Intervention Given||0
9028362|NCT03200366|10090735|FG001|STARTED|Patient Navigation Intervention Given||120
9028363|NCT03200366|10090736|FG002|STARTED|Patient Navigation Intervention Given||0
9028364|NCT03200366|10090734|FG000|COMPLETED|Patient Navigation Intervention Given||0
9028365|NCT03200366|10090735|FG001|COMPLETED|Patient Navigation Intervention Given||89
9028366|NCT03200366|10090736|FG002|COMPLETED|Patient Navigation Intervention Given||0
9028367|NCT03200366|10090734|FG000|NOT COMPLETED|Patient Navigation Intervention Given||0
9028368|NCT03200366|10090735|FG001|NOT COMPLETED|Patient Navigation Intervention Given||31
9028369|NCT03200366|10090736|FG002|NOT COMPLETED|Patient Navigation Intervention Given||0
9028370|NCT03200366|10090734|FG000|STARTED|6 Month Post-Baseline Interview||123
9028371|NCT03200366|10090735|FG001|STARTED|6 Month Post-Baseline Interview||118
9028372|NCT03200366|10090736|FG002|STARTED|6 Month Post-Baseline Interview||128
9028373|NCT03200366|10090734|FG000|COMPLETED|6 Month Post-Baseline Interview||93
9028374|NCT03200366|10090735|FG001|COMPLETED|6 Month Post-Baseline Interview||95
9028375|NCT03200366|10090736|FG002|COMPLETED|6 Month Post-Baseline Interview||109
8772572|NCT01284621|9822916|FG000|NOT COMPLETED|Second Intervention (8 Days)||0
8772573|NCT01284621|9822917|FG001|NOT COMPLETED|Second Intervention (8 Days)||0
8772574|NCT01284621|9822918|FG002|NOT COMPLETED|Second Intervention (8 Days)||0
8772575|NCT01284621|9822919|FG003|NOT COMPLETED|Second Intervention (8 Days)||0
8772576|NCT01284621|9822920|FG004|NOT COMPLETED|Second Intervention (8 Days)||0
8772577|NCT01284621|9822921|FG005|NOT COMPLETED|Second Intervention (8 Days)||0
8772578|NCT01284621|9822916|FG000|STARTED|Washout Period 2 (7 Days)||3
8772579|NCT01284621|9822917|FG001|STARTED|Washout Period 2 (7 Days)||4
8772580|NCT01284621|9822918|FG002|STARTED|Washout Period 2 (7 Days)||4
8772581|NCT01284621|9822919|FG003|STARTED|Washout Period 2 (7 Days)||4
8772582|NCT01284621|9822920|FG004|STARTED|Washout Period 2 (7 Days)||3
8772583|NCT01284621|9822921|FG005|STARTED|Washout Period 2 (7 Days)||4
8772584|NCT01284621|9822916|FG000|COMPLETED|Washout Period 2 (7 Days)||3
8772585|NCT01284621|9822917|FG001|COMPLETED|Washout Period 2 (7 Days)||4
8772586|NCT01284621|9822918|FG002|COMPLETED|Washout Period 2 (7 Days)||4
8772587|NCT01284621|9822919|FG003|COMPLETED|Washout Period 2 (7 Days)||4
8772588|NCT01284621|9822920|FG004|COMPLETED|Washout Period 2 (7 Days)||3
8772589|NCT01284621|9822921|FG005|COMPLETED|Washout Period 2 (7 Days)||4
8772590|NCT01284621|9822916|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
8772591|NCT01284621|9822917|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
8772592|NCT01284621|9822918|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
8772593|NCT01284621|9822919|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
8772594|NCT01284621|9822920|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0
8772595|NCT01284621|9822921|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0
8772596|NCT01284621|9822916|FG000|STARTED|Third Intervention (8 Days)||3
8772597|NCT01284621|9822917|FG001|STARTED|Third Intervention (8 Days)||4
8772598|NCT01284621|9822918|FG002|STARTED|Third Intervention (8 Days)||4
8772599|NCT01284621|9822919|FG003|STARTED|Third Intervention (8 Days)||4
8772600|NCT01284621|9822920|FG004|STARTED|Third Intervention (8 Days)||3
8772601|NCT01284621|9822921|FG005|STARTED|Third Intervention (8 Days)||4
8772602|NCT01284621|9822916|FG000|COMPLETED|Third Intervention (8 Days)||3
8772603|NCT01284621|9822917|FG001|COMPLETED|Third Intervention (8 Days)||4
8772604|NCT01284621|9822918|FG002|COMPLETED|Third Intervention (8 Days)||4
8772605|NCT01284621|9822919|FG003|COMPLETED|Third Intervention (8 Days)||4
8772606|NCT01284621|9822920|FG004|COMPLETED|Third Intervention (8 Days)||3
8772607|NCT01284621|9822921|FG005|COMPLETED|Third Intervention (8 Days)||4
8772608|NCT01284621|9822916|FG000|NOT COMPLETED|Third Intervention (8 Days)||0
8772609|NCT01284621|9822917|FG001|NOT COMPLETED|Third Intervention (8 Days)||0
8772610|NCT01284621|9822918|FG002|NOT COMPLETED|Third Intervention (8 Days)||0
8772611|NCT01284621|9822919|FG003|NOT COMPLETED|Third Intervention (8 Days)||0
8772612|NCT01284621|9822920|FG004|NOT COMPLETED|Third Intervention (8 Days)||0
8772613|NCT01284621|9822921|FG005|NOT COMPLETED|Third Intervention (8 Days)||0
8772614|NCT01284634|9822935|FG000|STARTED|Overall Study||7
8772615|NCT01284634|9822936|FG001|STARTED|Overall Study||6
8772616|NCT01284634|9822937|FG002|STARTED|Overall Study||7
8772617|NCT01284634|9822938|FG003|STARTED|Overall Study||5
8772618|NCT01284634|9822935|FG000|Received at Least 1 Dose of Study Drug|Overall Study||7
8772619|NCT01284634|9822936|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
8772620|NCT01284634|9822937|FG002|Received at Least 1 Dose of Study Drug|Overall Study||7
8772621|NCT01284634|9822938|FG003|Received at Least 1 Dose of Study Drug|Overall Study||5
8772622|NCT01284634|9822935|FG000|Intent to Treat (ITT) Analysis Set|Overall Study||7
8772623|NCT01284634|9822936|FG001|Intent to Treat (ITT) Analysis Set|Overall Study||6
8772624|NCT01284634|9822937|FG002|Intent to Treat (ITT) Analysis Set|Overall Study||7
8772625|NCT01284634|9822938|FG003|Intent to Treat (ITT) Analysis Set|Overall Study||5
8772626|NCT01284634|9822935|FG000|COMPLETED|Overall Study||6
8772627|NCT01284634|9822936|FG001|COMPLETED|Overall Study||6
8772628|NCT01284634|9822937|FG002|COMPLETED|Overall Study||5
8772629|NCT01284634|9822938|FG003|COMPLETED|Overall Study||4
8772630|NCT01284634|9822935|FG000|NOT COMPLETED|Overall Study||1
8772631|NCT01284634|9822936|FG001|NOT COMPLETED|Overall Study||0
8772632|NCT01284634|9822937|FG002|NOT COMPLETED|Overall Study||2
8772633|NCT01284634|9822938|FG003|NOT COMPLETED|Overall Study||1
8772634|NCT01284959|9822951|FG000|STARTED|Overall Study||11
8772635|NCT01284959|9822952|FG001|STARTED|Overall Study||12
8772636|NCT01284959|9822953|FG002|STARTED|Overall Study||11
8772637|NCT01284959|9822951|FG000|COMPLETED|Overall Study||10
8772638|NCT01284959|9822952|FG001|COMPLETED|Overall Study||12
8772639|NCT01284959|9822953|FG002|COMPLETED|Overall Study||10
8772640|NCT01284959|9822951|FG000|NOT COMPLETED|Overall Study||1
8772641|NCT01284959|9822952|FG001|NOT COMPLETED|Overall Study||0
8772642|NCT01284959|9822953|FG002|NOT COMPLETED|Overall Study||1
8772643|NCT01285024|9822963|FG000|STARTED|Overall Study||49
8772644|NCT01285024|9822964|FG001|STARTED|Overall Study||60
8772645|NCT01285024|9822963|FG000|COMPLETED|Overall Study||49
8772646|NCT01285024|9822964|FG001|COMPLETED|Overall Study||60
8772647|NCT01285024|9822963|FG000|NOT COMPLETED|Overall Study||0
8772648|NCT01285024|9822964|FG001|NOT COMPLETED|Overall Study||0
8772649|NCT01285050|9822970|FG000|STARTED|Overall Study||20
8772650|NCT01285050|9822970|FG000|COMPLETED|Overall Study||19
8772651|NCT01285050|9822970|FG000|NOT COMPLETED|Overall Study||1
8772652|NCT01285076|9822975|FG000|STARTED|Overall Study||834
8772653|NCT01285076|9822975|FG000|COMPLETED|Overall Study||834
8772654|NCT01285076|9822975|FG000|NOT COMPLETED|Overall Study||0
8772655|NCT01285310|9822982|FG000|STARTED|Placebo Controlled Phase: Weeks 0-24||79
8772656|NCT01285310|9822983|FG001|STARTED|Placebo Controlled Phase: Weeks 0-24||82
8772657|NCT01285310|9822984|FG002|STARTED|Placebo Controlled Phase: Weeks 0-24||76
8772658|NCT01285310|9822985|FG003|STARTED|Placebo Controlled Phase: Weeks 0-24||0
8772659|NCT01285310|9822986|FG004|STARTED|Placebo Controlled Phase: Weeks 0-24||0
8772660|NCT01285310|9822982|FG000|COMPLETED|Placebo Controlled Phase: Weeks 0-24|1 participant chose not to enter the active treatment phase|70
8772661|NCT01285310|9822983|FG001|COMPLETED|Placebo Controlled Phase: Weeks 0-24|Four participants chose not to enter the active treatment phase|67
8772662|NCT01285310|9822984|FG002|COMPLETED|Placebo Controlled Phase: Weeks 0-24|1 participant chose not to enter active treatment phase|61
8772663|NCT01285310|9822985|FG003|COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
8772664|NCT01285310|9822986|FG004|COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
8772665|NCT01285310|9822982|FG000|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||9
8772666|NCT01285310|9822983|FG001|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||15
8772667|NCT01285310|9822984|FG002|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||15
8772668|NCT01285310|9822985|FG003|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
9028376|NCT03200366|10090734|FG000|NOT COMPLETED|6 Month Post-Baseline Interview||30
9028377|NCT03200366|10090735|FG001|NOT COMPLETED|6 Month Post-Baseline Interview||23
9028378|NCT03200366|10090736|FG002|NOT COMPLETED|6 Month Post-Baseline Interview||19
9028379|NCT03200366|10090734|FG000|STARTED|9 Month Post-Baseline Interview||121
9028380|NCT03200366|10090735|FG001|STARTED|9 Month Post-Baseline Interview||116
9028381|NCT03200366|10090736|FG002|STARTED|9 Month Post-Baseline Interview||127
9028382|NCT03200366|10090734|FG000|COMPLETED|9 Month Post-Baseline Interview||97
9028383|NCT03200366|10090735|FG001|COMPLETED|9 Month Post-Baseline Interview||95
9028384|NCT03200366|10090736|FG002|COMPLETED|9 Month Post-Baseline Interview||116
9028385|NCT03200366|10090734|FG000|NOT COMPLETED|9 Month Post-Baseline Interview||24
8772669|NCT01285310|9822986|FG004|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
8772670|NCT01285310|9822982|FG000|STARTED|Active Treatment Phase: Weeks 25-52||0
8772671|NCT01285310|9822983|FG001|STARTED|Active Treatment Phase: Weeks 25-52||63
8772672|NCT01285310|9822984|FG002|STARTED|Active Treatment Phase: Weeks 25-52||60
8772673|NCT01285310|9822985|FG003|STARTED|Active Treatment Phase: Weeks 25-52||27
8772674|NCT01285310|9822986|FG004|STARTED|Active Treatment Phase: Weeks 25-52||42
8772675|NCT01285310|9822982|FG000|COMPLETED|Active Treatment Phase: Weeks 25-52||0
8772676|NCT01285310|9822983|FG001|COMPLETED|Active Treatment Phase: Weeks 25-52||31
8772677|NCT01285310|9822984|FG002|COMPLETED|Active Treatment Phase: Weeks 25-52||34
8772678|NCT01285310|9822985|FG003|COMPLETED|Active Treatment Phase: Weeks 25-52||17
8772679|NCT01285310|9822986|FG004|COMPLETED|Active Treatment Phase: Weeks 25-52||23
8772680|NCT01285310|9822982|FG000|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||0
8772681|NCT01285310|9822983|FG001|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||32
8772682|NCT01285310|9822984|FG002|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||26
8772683|NCT01285310|9822985|FG003|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||10
8772684|NCT01285310|9822986|FG004|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||19
8772685|NCT01285323|9823026|FG000|STARTED|Overall Study||232
8772686|NCT01285323|9823027|FG001|STARTED|Overall Study||232
8772687|NCT01285323|9823026|FG000|Full Analysis Set|Overall Study|Randomized participants who received at least 1 dose of study drug|232
8772688|NCT01285323|9823027|FG001|Full Analysis Set|Overall Study||232
8772689|NCT01285323|9823026|FG000|Safety Analysis Set|Overall Study|Participants who received at least 1 dose of study drug|232
8772690|NCT01285323|9823027|FG001|Safety Analysis Set|Overall Study||232
8772691|NCT01285323|9823026|FG000|COMPLETED|Overall Study||199
8772692|NCT01285323|9823027|FG001|COMPLETED|Overall Study||202
8772693|NCT01285323|9823026|FG000|NOT COMPLETED|Overall Study||33
8772694|NCT01285323|9823027|FG001|NOT COMPLETED|Overall Study||30
8772695|NCT01285349|9823036|FG000|STARTED|Overall Study||190
8772696|NCT01285349|9823037|FG001|STARTED|Overall Study||190
8772697|NCT01285349|9823038|FG002|STARTED|Overall Study||184
8772698|NCT01285349|9823036|FG000|COMPLETED|Overall Study||163
8772699|NCT01285349|9823037|FG001|COMPLETED|Overall Study||170
8772700|NCT01285349|9823038|FG002|COMPLETED|Overall Study||157
8772701|NCT01285349|9823036|FG000|NOT COMPLETED|Overall Study||27
8772702|NCT01285349|9823037|FG001|NOT COMPLETED|Overall Study||20
8772703|NCT01285349|9823038|FG002|NOT COMPLETED|Overall Study||27
8772704|NCT01285401|9823049|FG000|STARTED|Overall Study||115
8772705|NCT01285401|9823050|FG001|STARTED|Overall Study||117
8772706|NCT01285401|9823049|FG000|Treated|Overall Study||113
8772707|NCT01285401|9823050|FG001|Treated|Overall Study||116
8772708|NCT01285401|9823049|FG000|COMPLETED|Overall Study||98
8772709|NCT01285401|9823050|FG001|COMPLETED|Overall Study||88
8772710|NCT01285401|9823049|FG000|NOT COMPLETED|Overall Study||17
8772711|NCT01285401|9823050|FG001|NOT COMPLETED|Overall Study||29
8772712|NCT01285427|9823056|FG000|STARTED|Overall Study||300
8772713|NCT01285427|9823056|FG000|COMPLETED|Overall Study|One sample be discarded per FDA, sample drawn with heparin tube, not specified in protocol.|299
8772714|NCT01285427|9823056|FG000|NOT COMPLETED|Overall Study||1
8772715|NCT01285492|9823070|FG000|STARTED|Overall Study|All patients randomized to this group|121
8772716|NCT01285492|9823071|FG001|STARTED|Overall Study|All patients randomized to this group|39
8772717|NCT01285492|9823070|FG000|Safety Set (for Demographics)|Overall Study|All patients who took study drug; 2 patients did not|119
8772718|NCT01285492|9823071|FG001|Safety Set (for Demographics)|Overall Study|All patients who took study drug|39
8772719|NCT01285492|9823070|FG000|COMPLETED|Overall Study||104
8772720|NCT01285492|9823071|FG001|COMPLETED|Overall Study||38
8772721|NCT01285492|9823070|FG000|NOT COMPLETED|Overall Study||17
8772722|NCT01285492|9823071|FG001|NOT COMPLETED|Overall Study||1
8772723|NCT01285518|9823085|FG000|STARTED|Overall Study||10
8772724|NCT01285518|9823086|FG001|STARTED|Overall Study||10
8772725|NCT01285518|9823087|FG002|STARTED|Overall Study||10
8772726|NCT01285518|9823088|FG003|STARTED|Overall Study||10
8772727|NCT01285518|9823089|FG004|STARTED|Overall Study||10
8772728|NCT01285518|9823090|FG005|STARTED|Overall Study||10
8772729|NCT01285518|9823091|FG006|STARTED|Overall Study||10
8772730|NCT01285518|9823092|FG007|STARTED|Overall Study||14
8772731|NCT01285518|9823085|FG000|COMPLETED|Overall Study||10
8772732|NCT01285518|9823086|FG001|COMPLETED|Overall Study||10
8772733|NCT01285518|9823087|FG002|COMPLETED|Overall Study||10
8772734|NCT01285518|9823088|FG003|COMPLETED|Overall Study||10
8772735|NCT01285518|9823089|FG004|COMPLETED|Overall Study||10
8772736|NCT01285518|9823090|FG005|COMPLETED|Overall Study||9
8772737|NCT01285518|9823091|FG006|COMPLETED|Overall Study||10
8772738|NCT01285518|9823092|FG007|COMPLETED|Overall Study||14
8772739|NCT01285518|9823085|FG000|NOT COMPLETED|Overall Study||0
8772740|NCT01285518|9823086|FG001|NOT COMPLETED|Overall Study||0
8772741|NCT01285518|9823087|FG002|NOT COMPLETED|Overall Study||0
8772742|NCT01285518|9823088|FG003|NOT COMPLETED|Overall Study||0
8772743|NCT01285518|9823089|FG004|NOT COMPLETED|Overall Study||0
8772744|NCT01285518|9823090|FG005|NOT COMPLETED|Overall Study||1
8772745|NCT01285518|9823091|FG006|NOT COMPLETED|Overall Study||0
8772746|NCT01285518|9823092|FG007|NOT COMPLETED|Overall Study||0
8772747|NCT01285609|9823113|FG000|STARTED|Randomized|Represents participants randomized to this arm prior to 1st dose of chemotherapy treatment|479
8772748|NCT01285609|9823114|FG001|STARTED|Randomized|Represents participants randomized to this arm prior to 1st dose of chemotherapy treatment|477
8772749|NCT01285609|9823113|FG000|Treated With Chemotherapy (1st Dose)|Randomized||475
8772750|NCT01285609|9823114|FG001|Treated With Chemotherapy (1st Dose)|Randomized||473
8772751|NCT01285609|9823113|FG000|COMPLETED|Randomized||388
8772752|NCT01285609|9823114|FG001|COMPLETED|Randomized||361
8772753|NCT01285609|9823113|FG000|NOT COMPLETED|Randomized||91
8772754|NCT01285609|9823114|FG001|NOT COMPLETED|Randomized||116
8772755|NCT01285609|9823113|FG000|STARTED|Treated With Blinded Therapy||388
8772756|NCT01285609|9823114|FG001|STARTED|Treated With Blinded Therapy||361
8772757|NCT01285609|9823113|FG000|COMPLETED|Treated With Blinded Therapy||1
8772758|NCT01285609|9823114|FG001|COMPLETED|Treated With Blinded Therapy||2
8772759|NCT01285609|9823113|FG000|NOT COMPLETED|Treated With Blinded Therapy||387
8772760|NCT01285609|9823114|FG001|NOT COMPLETED|Treated With Blinded Therapy||359
8772761|NCT01285635|9823125|FG000|STARTED|First Intervention (2 Weeks)||13
8772762|NCT01285635|9823126|FG001|STARTED|First Intervention (2 Weeks)||11
8772763|NCT01285635|9823127|FG002|STARTED|First Intervention (2 Weeks)||11
8772764|NCT01285635|9823125|FG000|COMPLETED|First Intervention (2 Weeks)||13
8772765|NCT01285635|9823126|FG001|COMPLETED|First Intervention (2 Weeks)||11
8772766|NCT01285635|9823127|FG002|COMPLETED|First Intervention (2 Weeks)||11
8772767|NCT01285635|9823125|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0
8772768|NCT01285635|9823126|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0
8772769|NCT01285635|9823127|FG002|NOT COMPLETED|First Intervention (2 Weeks)||0
8772770|NCT01285635|9823125|FG000|STARTED|Second Intervention (10, 3 Week Cycles)||13
8772771|NCT01285635|9823126|FG001|STARTED|Second Intervention (10, 3 Week Cycles)||11
8772772|NCT01285635|9823127|FG002|STARTED|Second Intervention (10, 3 Week Cycles)||11
8772773|NCT01285635|9823125|FG000|COMPLETED|Second Intervention (10, 3 Week Cycles)||13
8772774|NCT01285635|9823126|FG001|COMPLETED|Second Intervention (10, 3 Week Cycles)||11
8772775|NCT01285635|9823127|FG002|COMPLETED|Second Intervention (10, 3 Week Cycles)||11
8772776|NCT01285635|9823125|FG000|NOT COMPLETED|Second Intervention (10, 3 Week Cycles)||0
8772777|NCT01285635|9823126|FG001|NOT COMPLETED|Second Intervention (10, 3 Week Cycles)||0
8772778|NCT01285635|9823127|FG002|NOT COMPLETED|Second Intervention (10, 3 Week Cycles)||0
8772779|NCT01285713|9823140|FG000|STARTED|Overall Study||42
8772780|NCT01285713|9823141|FG001|STARTED|Overall Study||41
8772781|NCT01285713|9823140|FG000|COMPLETED|Overall Study||42
8772782|NCT01285713|9823141|FG001|COMPLETED|Overall Study||41
8772783|NCT01285713|9823140|FG000|NOT COMPLETED|Overall Study||0
8772784|NCT01285713|9823141|FG001|NOT COMPLETED|Overall Study||0
8772785|NCT01285791|9823150|FG000|STARTED|Overall Study||11
8772786|NCT01285791|9823151|FG001|STARTED|Overall Study||15
8772787|NCT01285791|9823152|FG002|STARTED|Overall Study||13
8772788|NCT01285791|9823150|FG000|COMPLETED|Overall Study||11
8772789|NCT01285791|9823151|FG001|COMPLETED|Overall Study||15
8772790|NCT01285791|9823152|FG002|COMPLETED|Overall Study||13
8772791|NCT01285791|9823150|FG000|NOT COMPLETED|Overall Study||0
8772792|NCT01285791|9823151|FG001|NOT COMPLETED|Overall Study||0
8772793|NCT01285791|9823152|FG002|NOT COMPLETED|Overall Study||0
8772794|NCT01285843|9823162|FG000|STARTED|Overall Study||20
8772795|NCT01285843|9823163|FG001|STARTED|Overall Study||20
8772796|NCT01285843|9823162|FG000|COMPLETED|Overall Study||18
8772797|NCT01285843|9823163|FG001|COMPLETED|Overall Study||18
8772798|NCT01285843|9823162|FG000|NOT COMPLETED|Overall Study||2
8772799|NCT01285843|9823163|FG001|NOT COMPLETED|Overall Study||2
8772800|NCT01285908|9823169|FG000|STARTED|Baseline Measurement||6
8772801|NCT01285908|9823170|FG001|STARTED|Baseline Measurement||0
8772802|NCT01285908|9823171|FG002|STARTED|Baseline Measurement||0
8772803|NCT01285908|9823169|FG000|COMPLETED|Baseline Measurement||3
8772804|NCT01285908|9823170|FG001|COMPLETED|Baseline Measurement||0
8772805|NCT01285908|9823171|FG002|COMPLETED|Baseline Measurement||0
8772806|NCT01285908|9823169|FG000|NOT COMPLETED|Baseline Measurement||3
8772807|NCT01285908|9823170|FG001|NOT COMPLETED|Baseline Measurement||0
8772808|NCT01285908|9823171|FG002|NOT COMPLETED|Baseline Measurement||0
8772809|NCT01285908|9823169|FG000|STARTED|Treatment Crossover||0
8772810|NCT01285908|9823170|FG001|STARTED|Treatment Crossover|One subject in treatment crossover did not complete baseline testing as unable to complete tasks|2
8772811|NCT01285908|9823171|FG002|STARTED|Treatment Crossover||2
8772812|NCT01285908|9823169|FG000|COMPLETED|Treatment Crossover||0
8772813|NCT01285908|9823170|FG001|COMPLETED|Treatment Crossover||2
8772814|NCT01285908|9823171|FG002|COMPLETED|Treatment Crossover||2
8772815|NCT01285908|9823169|FG000|NOT COMPLETED|Treatment Crossover||0
8772816|NCT01285908|9823170|FG001|NOT COMPLETED|Treatment Crossover||0
8772817|NCT01285908|9823171|FG002|NOT COMPLETED|Treatment Crossover||0
8772818|NCT01285960|9823201|FG000|STARTED|Overall Study|2 subjects receiving fewer than 10 sonications were added to the 106 for safety population of 108|108
8772819|NCT01285960|9823201|FG000|COMPLETED|Overall Study|An additional 2 subjects receiving fewer than 10 sonications were included in the safety population|102
8772820|NCT01285960|9823201|FG000|NOT COMPLETED|Overall Study||6
8772821|NCT01286012|9823207|FG000|STARTED|Overall Study|2 patients randomized to SFP did not receive study drug.|54
8772822|NCT01286012|9823208|FG001|STARTED|Overall Study|3 patients randomized to placebo did not receive study drug.|54
8772823|NCT01286012|9823207|FG000|COMPLETED|Overall Study||41
8772824|NCT01286012|9823208|FG001|COMPLETED|Overall Study||40
8772825|NCT01286012|9823207|FG000|NOT COMPLETED|Overall Study||13
8772826|NCT01286012|9823208|FG001|NOT COMPLETED|Overall Study||14
8772827|NCT01286077|9823217|FG000|STARTED|Overall Study|One patient did not start treatment and was excluded from the Intent to Treat (ITT) population.|51
8772828|NCT01286077|9823218|FG001|STARTED|Overall Study|One patient did not have any post-baseline assessment and was excluded from the ITT population.|53
8772829|NCT01286077|9823217|FG000|COMPLETED|Overall Study||41
8772830|NCT01286077|9823218|FG001|COMPLETED|Overall Study||46
8772831|NCT01286077|9823217|FG000|NOT COMPLETED|Overall Study||10
8772832|NCT01286077|9823218|FG001|NOT COMPLETED|Overall Study||7
8772833|NCT01286129|9823226|FG000|STARTED|Overall Study||27
8772834|NCT01286129|9823227|FG001|STARTED|Overall Study||18
8772835|NCT01286129|9823226|FG000|COMPLETED|Overall Study||19
8772836|NCT01286129|9823227|FG001|COMPLETED|Overall Study||13
8772837|NCT01286129|9823226|FG000|NOT COMPLETED|Overall Study||8
8772838|NCT01286129|9823227|FG001|NOT COMPLETED|Overall Study||5
8772839|NCT01286168|9823235|FG000|STARTED|Overall Study||104
8772840|NCT01286168|9823235|FG000|COMPLETED|Overall Study||101
8772841|NCT01286168|9823235|FG000|NOT COMPLETED|Overall Study||3
8772842|NCT01286259|9823240|FG000|STARTED|Overall Study||16
8772843|NCT01286259|9823240|FG000|COMPLETED|Overall Study||16
8772844|NCT01286259|9823240|FG000|NOT COMPLETED|Overall Study||0
8772845|NCT01286311|9823246|FG000|STARTED|Overall Study|218 patients (of the 14 physician randomized to the intervention) started the study.|232
8772846|NCT01286311|9823247|FG001|STARTED|Overall Study|217 patients (of the 15 physician randomized to the intervention) started the study.|232
8808707|NCT01491737|9861016|FG000|COMPLETED|Overall Study||0
8772847|NCT01286311|9823246|FG000|COMPLETED|Overall Study|204 patients (of the 14 physician randomized to the intervention) completed the study.|218
8772848|NCT01286311|9823247|FG001|COMPLETED|Overall Study|217 patients (of the 15 physician randomized to the intervention) completed the study.|232
8772849|NCT01286311|9823246|FG000|NOT COMPLETED|Overall Study||14
8772850|NCT01286311|9823247|FG001|NOT COMPLETED|Overall Study||0
8772851|NCT01286324|9823255|FG000|STARTED|Overall Study||17
8772852|NCT01286324|9823256|FG001|STARTED|Overall Study||17
8772853|NCT01286324|9823255|FG000|COMPLETED|Overall Study||17
8772854|NCT01286324|9823256|FG001|COMPLETED|Overall Study||17
8772855|NCT01286324|9823255|FG000|NOT COMPLETED|Overall Study||0
8772856|NCT01286324|9823256|FG001|NOT COMPLETED|Overall Study||0
8772857|NCT01286402|9823264|FG000|STARTED|Overall Study||5
8772858|NCT01286402|9823265|FG001|STARTED|Overall Study||6
8772859|NCT01286402|9823264|FG000|COMPLETED|Overall Study||5
8772860|NCT01286402|9823265|FG001|COMPLETED|Overall Study||6
8772861|NCT01286402|9823264|FG000|NOT COMPLETED|Overall Study||0
8772862|NCT01286402|9823265|FG001|NOT COMPLETED|Overall Study||0
8772863|NCT01286441|9823275|FG000|STARTED|Overall Study||45
8772864|NCT01286441|9823276|FG001|STARTED|Overall Study||44
8772865|NCT01286441|9823277|FG002|STARTED|Overall Study||46
8772866|NCT01286441|9823278|FG003|STARTED|Overall Study||48
8772867|NCT01286441|9823275|FG000|COMPLETED|Overall Study||38
8772868|NCT01286441|9823276|FG001|COMPLETED|Overall Study||37
8772869|NCT01286441|9823277|FG002|COMPLETED|Overall Study||39
8772870|NCT01286441|9823278|FG003|COMPLETED|Overall Study||37
8772871|NCT01286441|9823275|FG000|NOT COMPLETED|Overall Study||7
8772872|NCT01286441|9823276|FG001|NOT COMPLETED|Overall Study||7
8772873|NCT01286441|9823277|FG002|NOT COMPLETED|Overall Study||7
8772874|NCT01286441|9823278|FG003|NOT COMPLETED|Overall Study||11
8772875|NCT01286454|9823288|FG000|STARTED|Part I- First Intervention Period||2
8772876|NCT01286454|9823289|FG001|STARTED|Part I- First Intervention Period||2
8772877|NCT01286454|9823290|FG002|STARTED|Part I- First Intervention Period||2
8772878|NCT01286454|9823291|FG003|STARTED|Part I- First Intervention Period||2
8772879|NCT01286454|9823292|FG004|STARTED|Part I- First Intervention Period||2
8772880|NCT01286454|9823293|FG005|STARTED|Part I- First Intervention Period||2
8772881|NCT01286454|9823294|FG006|STARTED|Part I- First Intervention Period||2
8772882|NCT01286454|9823295|FG007|STARTED|Part I- First Intervention Period||2
8772883|NCT01286454|9823296|FG008|STARTED|Part I- First Intervention Period||2
8772884|NCT01286454|9823297|FG009|STARTED|Part I- First Intervention Period||2
8772885|NCT01286454|9823298|FG010|STARTED|Part I- First Intervention Period||0
8772886|NCT01286454|9823288|FG000|COMPLETED|Part I- First Intervention Period||2
8772887|NCT01286454|9823289|FG001|COMPLETED|Part I- First Intervention Period||2
8772888|NCT01286454|9823290|FG002|COMPLETED|Part I- First Intervention Period||2
8772889|NCT01286454|9823291|FG003|COMPLETED|Part I- First Intervention Period||2
8772890|NCT01286454|9823292|FG004|COMPLETED|Part I- First Intervention Period||2
8772891|NCT01286454|9823293|FG005|COMPLETED|Part I- First Intervention Period||2
8772892|NCT01286454|9823294|FG006|COMPLETED|Part I- First Intervention Period||2
8772893|NCT01286454|9823295|FG007|COMPLETED|Part I- First Intervention Period||2
8772894|NCT01286454|9823296|FG008|COMPLETED|Part I- First Intervention Period||2
8772895|NCT01286454|9823297|FG009|COMPLETED|Part I- First Intervention Period||2
8772896|NCT01286454|9823298|FG010|COMPLETED|Part I- First Intervention Period||0
8772897|NCT01286454|9823288|FG000|NOT COMPLETED|Part I- First Intervention Period||0
8772898|NCT01286454|9823289|FG001|NOT COMPLETED|Part I- First Intervention Period||0
8772899|NCT01286454|9823290|FG002|NOT COMPLETED|Part I- First Intervention Period||0
8772900|NCT01286454|9823291|FG003|NOT COMPLETED|Part I- First Intervention Period||0
8772901|NCT01286454|9823292|FG004|NOT COMPLETED|Part I- First Intervention Period||0
8772902|NCT01286454|9823293|FG005|NOT COMPLETED|Part I- First Intervention Period||0
8772903|NCT01286454|9823294|FG006|NOT COMPLETED|Part I- First Intervention Period||0
8772904|NCT01286454|9823295|FG007|NOT COMPLETED|Part I- First Intervention Period||0
8772905|NCT01286454|9823296|FG008|NOT COMPLETED|Part I- First Intervention Period||0
8772906|NCT01286454|9823297|FG009|NOT COMPLETED|Part I- First Intervention Period||0
8772907|NCT01286454|9823298|FG010|NOT COMPLETED|Part I- First Intervention Period||0
8772908|NCT01286454|9823288|FG000|STARTED|Washout Period (At Least 3 Days)||2
8772909|NCT01286454|9823289|FG001|STARTED|Washout Period (At Least 3 Days)||2
8772910|NCT01286454|9823290|FG002|STARTED|Washout Period (At Least 3 Days)||2
8772911|NCT01286454|9823291|FG003|STARTED|Washout Period (At Least 3 Days)||2
8772912|NCT01286454|9823292|FG004|STARTED|Washout Period (At Least 3 Days)||2
8772913|NCT01286454|9823293|FG005|STARTED|Washout Period (At Least 3 Days)||2
8772914|NCT01286454|9823294|FG006|STARTED|Washout Period (At Least 3 Days)||2
8772915|NCT01286454|9823295|FG007|STARTED|Washout Period (At Least 3 Days)||2
8772916|NCT01286454|9823296|FG008|STARTED|Washout Period (At Least 3 Days)||2
8772917|NCT01286454|9823297|FG009|STARTED|Washout Period (At Least 3 Days)||2
8772918|NCT01286454|9823298|FG010|STARTED|Washout Period (At Least 3 Days)||0
8772919|NCT01286454|9823288|FG000|COMPLETED|Washout Period (At Least 3 Days)||2
8772920|NCT01286454|9823289|FG001|COMPLETED|Washout Period (At Least 3 Days)||2
8772921|NCT01286454|9823290|FG002|COMPLETED|Washout Period (At Least 3 Days)||2
8772922|NCT01286454|9823291|FG003|COMPLETED|Washout Period (At Least 3 Days)||2
8772923|NCT01286454|9823292|FG004|COMPLETED|Washout Period (At Least 3 Days)||2
8772924|NCT01286454|9823293|FG005|COMPLETED|Washout Period (At Least 3 Days)||2
8772925|NCT01286454|9823294|FG006|COMPLETED|Washout Period (At Least 3 Days)||2
8772926|NCT01286454|9823295|FG007|COMPLETED|Washout Period (At Least 3 Days)||2
8772927|NCT01286454|9823296|FG008|COMPLETED|Washout Period (At Least 3 Days)||2
8772928|NCT01286454|9823297|FG009|COMPLETED|Washout Period (At Least 3 Days)||2
8772929|NCT01286454|9823298|FG010|COMPLETED|Washout Period (At Least 3 Days)||0
8772930|NCT01286454|9823288|FG000|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8772931|NCT01286454|9823289|FG001|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8772932|NCT01286454|9823290|FG002|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8772933|NCT01286454|9823291|FG003|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8772934|NCT01286454|9823292|FG004|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8772935|NCT01286454|9823293|FG005|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8772936|NCT01286454|9823294|FG006|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8772937|NCT01286454|9823295|FG007|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8772938|NCT01286454|9823296|FG008|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8772939|NCT01286454|9823297|FG009|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8772940|NCT01286454|9823298|FG010|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8772941|NCT01286454|9823288|FG000|STARTED|Second Intervention Period||2
8772942|NCT01286454|9823289|FG001|STARTED|Second Intervention Period||2
8772943|NCT01286454|9823290|FG002|STARTED|Second Intervention Period||2
8772944|NCT01286454|9823291|FG003|STARTED|Second Intervention Period||2
8772945|NCT01286454|9823292|FG004|STARTED|Second Intervention Period||2
8916148|NCT02180672|9975677|FG000|NOT COMPLETED|Overall Study||5
8916149|NCT02180672|9975678|FG001|NOT COMPLETED|Overall Study||7
8916150|NCT02180828|9975686|FG000|STARTED|Overall Study||120
8916151|NCT02180828|9975687|FG001|STARTED|Overall Study||120
8916152|NCT02180828|9975686|FG000|COMPLETED|Overall Study||115
8916153|NCT02180828|9975687|FG001|COMPLETED|Overall Study||113
8916154|NCT02180828|9975686|FG000|NOT COMPLETED|Overall Study||5
8916155|NCT02180828|9975687|FG001|NOT COMPLETED|Overall Study||7
8916156|NCT02180893|9975695|FG000|STARTED|Overall Study||30
8916157|NCT02180893|9975696|FG001|STARTED|Overall Study||30
8916158|NCT02180893|9975695|FG000|COMPLETED|Overall Study||27
8916159|NCT02180893|9975696|FG001|COMPLETED|Overall Study||23
8916160|NCT02180893|9975695|FG000|NOT COMPLETED|Overall Study||3
8916161|NCT02180893|9975696|FG001|NOT COMPLETED|Overall Study||7
8916162|NCT02181075|9975704|FG000|STARTED|Overall Study||6
8916163|NCT02181075|9975705|FG001|STARTED|Overall Study||4
8916164|NCT02181075|9975704|FG000|COMPLETED|Overall Study||6
8916165|NCT02181075|9975705|FG001|COMPLETED|Overall Study||4
8916166|NCT02181075|9975704|FG000|NOT COMPLETED|Overall Study||0
8916167|NCT02181075|9975705|FG001|NOT COMPLETED|Overall Study||0
8916168|NCT02181127|9975715|FG000|STARTED|Overall Study||22
8916169|NCT02181127|9975715|FG000|COMPLETED|Overall Study||22
8916170|NCT02181127|9975715|FG000|NOT COMPLETED|Overall Study||0
8916171|NCT02181140|9975722|FG000|STARTED|Overall Study||56
8916172|NCT02181140|9975722|FG000|COMPLETED|Overall Study||56
8916173|NCT02181140|9975722|FG000|NOT COMPLETED|Overall Study||0
8916174|NCT02181231|9975730|FG000|STARTED|Overall Study||12
8916175|NCT02181231|9975731|FG001|STARTED|Overall Study||6
8916176|NCT02181231|9975730|FG000|COMPLETED|Overall Study||10
8916177|NCT02181231|9975731|FG001|COMPLETED|Overall Study||6
8916178|NCT02181231|9975730|FG000|NOT COMPLETED|Overall Study||2
8916179|NCT02181231|9975731|FG001|NOT COMPLETED|Overall Study||0
8916180|NCT02181296|9975739|FG000|STARTED|Overall Study||25
9028386|NCT03200366|10090735|FG001|NOT COMPLETED|9 Month Post-Baseline Interview||21
9028387|NCT03200366|10090736|FG002|NOT COMPLETED|9 Month Post-Baseline Interview||11
9028388|NCT03200535|10090750|FG000|STARTED|Overall Study||1863
9028389|NCT03200535|10090751|FG001|STARTED|Overall Study||1863
9028390|NCT03200535|10090752|FG002|STARTED|Overall Study||1862
9028391|NCT03200535|10090753|FG003|STARTED|Overall Study||1000
9028392|NCT03200535|10090750|FG000|COMPLETED|Overall Study||1863
9028393|NCT03200535|10090751|FG001|COMPLETED|Overall Study||1863
9028394|NCT03200535|10090752|FG002|COMPLETED|Overall Study||1862
9028395|NCT03200535|10090753|FG003|COMPLETED|Overall Study||1000
9028396|NCT03200535|10090750|FG000|NOT COMPLETED|Overall Study||0
9028397|NCT03200535|10090751|FG001|NOT COMPLETED|Overall Study||0
9028398|NCT03200535|10090752|FG002|NOT COMPLETED|Overall Study||0
9028399|NCT03200535|10090753|FG003|NOT COMPLETED|Overall Study||0
9028400|NCT03200860|10090765|FG000|STARTED|Overall Study||41
9028401|NCT03200860|10090766|FG001|STARTED|Overall Study||39
9028402|NCT03200860|10090765|FG000|COMPLETED|Overall Study||40
9028403|NCT03200860|10090766|FG001|COMPLETED|Overall Study||39
9028404|NCT03200860|10090765|FG000|NOT COMPLETED|Overall Study||1
9028405|NCT03200860|10090766|FG001|NOT COMPLETED|Overall Study||0
9028406|NCT03200912|10090775|FG000|STARTED|Overall Study||170
9028407|NCT03200912|10090776|FG001|STARTED|Overall Study||169
9028408|NCT03200912|10090777|FG002|STARTED|Overall Study||168
9028409|NCT03200912|10090775|FG000|COMPLETED|Overall Study||166
9028410|NCT03200912|10090776|FG001|COMPLETED|Overall Study||166
9028411|NCT03200912|10090777|FG002|COMPLETED|Overall Study||164
9028412|NCT03200912|10090775|FG000|NOT COMPLETED|Overall Study||4
9028413|NCT03200912|10090776|FG001|NOT COMPLETED|Overall Study||3
9028414|NCT03200912|10090777|FG002|NOT COMPLETED|Overall Study||4
9028415|NCT03200925|10090787|FG000|STARTED|Overall Study||120
9028416|NCT03200925|10090788|FG001|STARTED|Overall Study||120
8916181|NCT02181296|9975740|FG001|STARTED|Overall Study||25
9028417|NCT03200925|10090787|FG000|COMPLETED|Overall Study||120
9028418|NCT03200925|10090788|FG001|COMPLETED|Overall Study||120
9028419|NCT03200925|10090787|FG000|NOT COMPLETED|Overall Study||0
9028420|NCT03200925|10090788|FG001|NOT COMPLETED|Overall Study||0
9028421|NCT03201003|10090796|FG000|STARTED|Overall Study||132
8772946|NCT01286454|9823293|FG005|STARTED|Second Intervention Period||2
8772947|NCT01286454|9823294|FG006|STARTED|Second Intervention Period||2
8772948|NCT01286454|9823295|FG007|STARTED|Second Intervention Period||2
8772949|NCT01286454|9823296|FG008|STARTED|Second Intervention Period||2
8772950|NCT01286454|9823297|FG009|STARTED|Second Intervention Period||2
8772951|NCT01286454|9823298|FG010|STARTED|Second Intervention Period||0
8772952|NCT01286454|9823288|FG000|COMPLETED|Second Intervention Period||2
8772953|NCT01286454|9823289|FG001|COMPLETED|Second Intervention Period||2
8772954|NCT01286454|9823290|FG002|COMPLETED|Second Intervention Period||2
8772955|NCT01286454|9823291|FG003|COMPLETED|Second Intervention Period||2
8772956|NCT01286454|9823292|FG004|COMPLETED|Second Intervention Period||2
8772957|NCT01286454|9823293|FG005|COMPLETED|Second Intervention Period||2
8772958|NCT01286454|9823294|FG006|COMPLETED|Second Intervention Period||2
8772959|NCT01286454|9823295|FG007|COMPLETED|Second Intervention Period||2
8772960|NCT01286454|9823296|FG008|COMPLETED|Second Intervention Period||2
8772961|NCT01286454|9823297|FG009|COMPLETED|Second Intervention Period||2
8772962|NCT01286454|9823298|FG010|COMPLETED|Second Intervention Period||0
8772963|NCT01286454|9823288|FG000|NOT COMPLETED|Second Intervention Period||0
8772964|NCT01286454|9823289|FG001|NOT COMPLETED|Second Intervention Period||0
8772965|NCT01286454|9823290|FG002|NOT COMPLETED|Second Intervention Period||0
8772966|NCT01286454|9823291|FG003|NOT COMPLETED|Second Intervention Period||0
8772967|NCT01286454|9823292|FG004|NOT COMPLETED|Second Intervention Period||0
8772968|NCT01286454|9823293|FG005|NOT COMPLETED|Second Intervention Period||0
8772969|NCT01286454|9823294|FG006|NOT COMPLETED|Second Intervention Period||0
8772970|NCT01286454|9823295|FG007|NOT COMPLETED|Second Intervention Period||0
8772971|NCT01286454|9823296|FG008|NOT COMPLETED|Second Intervention Period||0
8772972|NCT01286454|9823297|FG009|NOT COMPLETED|Second Intervention Period||0
8772973|NCT01286454|9823298|FG010|NOT COMPLETED|Second Intervention Period||0
8772974|NCT01286454|9823288|FG000|STARTED|Washout Period (At Least 3 Days)||2
8772975|NCT01286454|9823289|FG001|STARTED|Washout Period (At Least 3 Days)||2
8772976|NCT01286454|9823290|FG002|STARTED|Washout Period (At Least 3 Days)||2
8772977|NCT01286454|9823291|FG003|STARTED|Washout Period (At Least 3 Days)||2
8772978|NCT01286454|9823292|FG004|STARTED|Washout Period (At Least 3 Days)||2
8772979|NCT01286454|9823293|FG005|STARTED|Washout Period (At Least 3 Days)||2
8772980|NCT01286454|9823294|FG006|STARTED|Washout Period (At Least 3 Days)||2
8772981|NCT01286454|9823295|FG007|STARTED|Washout Period (At Least 3 Days)||2
8772982|NCT01286454|9823296|FG008|STARTED|Washout Period (At Least 3 Days)||2
8772983|NCT01286454|9823297|FG009|STARTED|Washout Period (At Least 3 Days)||2
8772984|NCT01286454|9823298|FG010|STARTED|Washout Period (At Least 3 Days)||0
8772985|NCT01286454|9823288|FG000|COMPLETED|Washout Period (At Least 3 Days)||2
8772986|NCT01286454|9823289|FG001|COMPLETED|Washout Period (At Least 3 Days)||2
8772987|NCT01286454|9823290|FG002|COMPLETED|Washout Period (At Least 3 Days)||2
8772988|NCT01286454|9823291|FG003|COMPLETED|Washout Period (At Least 3 Days)||2
8772989|NCT01286454|9823292|FG004|COMPLETED|Washout Period (At Least 3 Days)||2
8772990|NCT01286454|9823293|FG005|COMPLETED|Washout Period (At Least 3 Days)||2
8772991|NCT01286454|9823294|FG006|COMPLETED|Washout Period (At Least 3 Days)||2
8772992|NCT01286454|9823295|FG007|COMPLETED|Washout Period (At Least 3 Days)||2
8772993|NCT01286454|9823296|FG008|COMPLETED|Washout Period (At Least 3 Days)||2
8772994|NCT01286454|9823297|FG009|COMPLETED|Washout Period (At Least 3 Days)||2
8772995|NCT01286454|9823298|FG010|COMPLETED|Washout Period (At Least 3 Days)||0
8772996|NCT01286454|9823288|FG000|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8772997|NCT01286454|9823289|FG001|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8772998|NCT01286454|9823290|FG002|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8772999|NCT01286454|9823291|FG003|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8773000|NCT01286454|9823292|FG004|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8773001|NCT01286454|9823293|FG005|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8773002|NCT01286454|9823294|FG006|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8773003|NCT01286454|9823295|FG007|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8773004|NCT01286454|9823296|FG008|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8773005|NCT01286454|9823297|FG009|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8773006|NCT01286454|9823298|FG010|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8773007|NCT01286454|9823288|FG000|STARTED|Third Intervention Period||2
8773008|NCT01286454|9823289|FG001|STARTED|Third Intervention Period||2
8773009|NCT01286454|9823290|FG002|STARTED|Third Intervention Period||2
8773010|NCT01286454|9823291|FG003|STARTED|Third Intervention Period||2
8773011|NCT01286454|9823292|FG004|STARTED|Third Intervention Period||2
8773012|NCT01286454|9823293|FG005|STARTED|Third Intervention Period||2
8773013|NCT01286454|9823294|FG006|STARTED|Third Intervention Period||2
8773014|NCT01286454|9823295|FG007|STARTED|Third Intervention Period||2
8773015|NCT01286454|9823296|FG008|STARTED|Third Intervention Period||2
8773016|NCT01286454|9823297|FG009|STARTED|Third Intervention Period||2
8773017|NCT01286454|9823298|FG010|STARTED|Third Intervention Period||0
8773018|NCT01286454|9823288|FG000|COMPLETED|Third Intervention Period||2
8773019|NCT01286454|9823289|FG001|COMPLETED|Third Intervention Period||2
8773020|NCT01286454|9823290|FG002|COMPLETED|Third Intervention Period||2
8773021|NCT01286454|9823291|FG003|COMPLETED|Third Intervention Period||2
8773022|NCT01286454|9823292|FG004|COMPLETED|Third Intervention Period||2
8773023|NCT01286454|9823293|FG005|COMPLETED|Third Intervention Period||2
8773024|NCT01286454|9823294|FG006|COMPLETED|Third Intervention Period||2
8773025|NCT01286454|9823295|FG007|COMPLETED|Third Intervention Period||2
8773026|NCT01286454|9823296|FG008|COMPLETED|Third Intervention Period||2
8773027|NCT01286454|9823297|FG009|COMPLETED|Third Intervention Period||2
8773028|NCT01286454|9823298|FG010|COMPLETED|Third Intervention Period||0
8773029|NCT01286454|9823288|FG000|NOT COMPLETED|Third Intervention Period||0
8773030|NCT01286454|9823289|FG001|NOT COMPLETED|Third Intervention Period||0
8773031|NCT01286454|9823290|FG002|NOT COMPLETED|Third Intervention Period||0
8773032|NCT01286454|9823291|FG003|NOT COMPLETED|Third Intervention Period||0
8773033|NCT01286454|9823292|FG004|NOT COMPLETED|Third Intervention Period||0
8773034|NCT01286454|9823293|FG005|NOT COMPLETED|Third Intervention Period||0
8773035|NCT01286454|9823294|FG006|NOT COMPLETED|Third Intervention Period||0
8773036|NCT01286454|9823295|FG007|NOT COMPLETED|Third Intervention Period||0
8773037|NCT01286454|9823296|FG008|NOT COMPLETED|Third Intervention Period||0
8773038|NCT01286454|9823297|FG009|NOT COMPLETED|Third Intervention Period||0
8773039|NCT01286454|9823298|FG010|NOT COMPLETED|Third Intervention Period||0
8773040|NCT01286454|9823288|FG000|STARTED|Washout Period (At Least 3 Days)||2
8773041|NCT01286454|9823289|FG001|STARTED|Washout Period (At Least 3 Days)||2
8773042|NCT01286454|9823290|FG002|STARTED|Washout Period (At Least 3 Days)||2
8773043|NCT01286454|9823291|FG003|STARTED|Washout Period (At Least 3 Days)||2
8773044|NCT01286454|9823292|FG004|STARTED|Washout Period (At Least 3 Days)||2
8773045|NCT01286454|9823293|FG005|STARTED|Washout Period (At Least 3 Days)||2
8773046|NCT01286454|9823294|FG006|STARTED|Washout Period (At Least 3 Days)||2
8773047|NCT01286454|9823295|FG007|STARTED|Washout Period (At Least 3 Days)||2
8773048|NCT01286454|9823296|FG008|STARTED|Washout Period (At Least 3 Days)||2
8773049|NCT01286454|9823297|FG009|STARTED|Washout Period (At Least 3 Days)||2
8773050|NCT01286454|9823298|FG010|STARTED|Washout Period (At Least 3 Days)||0
8773051|NCT01286454|9823288|FG000|COMPLETED|Washout Period (At Least 3 Days)||2
8773052|NCT01286454|9823289|FG001|COMPLETED|Washout Period (At Least 3 Days)||2
8773053|NCT01286454|9823290|FG002|COMPLETED|Washout Period (At Least 3 Days)||2
8773054|NCT01286454|9823291|FG003|COMPLETED|Washout Period (At Least 3 Days)||2
8773055|NCT01286454|9823292|FG004|COMPLETED|Washout Period (At Least 3 Days)||2
8773056|NCT01286454|9823293|FG005|COMPLETED|Washout Period (At Least 3 Days)||2
8773057|NCT01286454|9823294|FG006|COMPLETED|Washout Period (At Least 3 Days)||2
8773058|NCT01286454|9823295|FG007|COMPLETED|Washout Period (At Least 3 Days)||2
8773059|NCT01286454|9823296|FG008|COMPLETED|Washout Period (At Least 3 Days)||2
8773060|NCT01286454|9823297|FG009|COMPLETED|Washout Period (At Least 3 Days)||2
8773061|NCT01286454|9823298|FG010|COMPLETED|Washout Period (At Least 3 Days)||0
8773062|NCT01286454|9823288|FG000|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8773063|NCT01286454|9823289|FG001|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8773064|NCT01286454|9823290|FG002|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8773065|NCT01286454|9823291|FG003|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8773066|NCT01286454|9823292|FG004|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8773067|NCT01286454|9823293|FG005|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8773068|NCT01286454|9823294|FG006|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8773069|NCT01286454|9823295|FG007|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8773070|NCT01286454|9823296|FG008|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8773071|NCT01286454|9823297|FG009|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8773072|NCT01286454|9823298|FG010|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8773073|NCT01286454|9823288|FG000|STARTED|Fourth Intervention Period||2
8773074|NCT01286454|9823289|FG001|STARTED|Fourth Intervention Period||2
8773075|NCT01286454|9823290|FG002|STARTED|Fourth Intervention Period||2
8773076|NCT01286454|9823291|FG003|STARTED|Fourth Intervention Period||2
8773077|NCT01286454|9823292|FG004|STARTED|Fourth Intervention Period||2
8773078|NCT01286454|9823293|FG005|STARTED|Fourth Intervention Period||2
8773079|NCT01286454|9823294|FG006|STARTED|Fourth Intervention Period||2
8773080|NCT01286454|9823295|FG007|STARTED|Fourth Intervention Period||2
8773081|NCT01286454|9823296|FG008|STARTED|Fourth Intervention Period||2
8773082|NCT01286454|9823297|FG009|STARTED|Fourth Intervention Period||2
8773083|NCT01286454|9823298|FG010|STARTED|Fourth Intervention Period||0
8773084|NCT01286454|9823288|FG000|COMPLETED|Fourth Intervention Period||2
8773085|NCT01286454|9823289|FG001|COMPLETED|Fourth Intervention Period||2
8773086|NCT01286454|9823290|FG002|COMPLETED|Fourth Intervention Period||2
9028422|NCT03201003|10090797|FG001|STARTED|Overall Study||43
9028423|NCT03201003|10090796|FG000|COMPLETED|Overall Study||106
9028424|NCT03201003|10090797|FG001|COMPLETED|Overall Study||40
9028425|NCT03201003|10090796|FG000|NOT COMPLETED|Overall Study||26
9028426|NCT03201003|10090797|FG001|NOT COMPLETED|Overall Study||3
9028427|NCT03201211|10090806|FG000|STARTED|Overall Study||27
9028428|NCT03201211|10090807|FG001|STARTED|Overall Study||26
9028429|NCT03201211|10090808|FG002|STARTED|Overall Study||28
9028430|NCT03201211|10090806|FG000|COMPLETED|Overall Study||25
9028431|NCT03201211|10090807|FG001|COMPLETED|Overall Study||25
9028432|NCT03201211|10090808|FG002|COMPLETED|Overall Study||27
9028433|NCT03201211|10090806|FG000|NOT COMPLETED|Overall Study||2
9028434|NCT03201211|10090807|FG001|NOT COMPLETED|Overall Study||1
9028435|NCT03201211|10090808|FG002|NOT COMPLETED|Overall Study||1
9028436|NCT03201562|10090819|FG000|STARTED|Overall Study||18
9028437|NCT03201562|10090820|FG001|STARTED|Overall Study||20
9028438|NCT03201562|10090821|FG002|STARTED|Overall Study||20
9028439|NCT03201562|10090819|FG000|COMPLETED|Overall Study||18
9028440|NCT03201562|10090820|FG001|COMPLETED|Overall Study||19
9028441|NCT03201562|10090821|FG002|COMPLETED|Overall Study||16
9028442|NCT03201562|10090819|FG000|NOT COMPLETED|Overall Study||0
8773087|NCT01286454|9823291|FG003|COMPLETED|Fourth Intervention Period||2
8773088|NCT01286454|9823292|FG004|COMPLETED|Fourth Intervention Period||2
8773089|NCT01286454|9823293|FG005|COMPLETED|Fourth Intervention Period||2
8773090|NCT01286454|9823294|FG006|COMPLETED|Fourth Intervention Period||2
8773091|NCT01286454|9823295|FG007|COMPLETED|Fourth Intervention Period||2
8773092|NCT01286454|9823296|FG008|COMPLETED|Fourth Intervention Period||2
8773093|NCT01286454|9823297|FG009|COMPLETED|Fourth Intervention Period||2
8773094|NCT01286454|9823298|FG010|COMPLETED|Fourth Intervention Period||0
8773095|NCT01286454|9823288|FG000|NOT COMPLETED|Fourth Intervention Period||0
8773096|NCT01286454|9823289|FG001|NOT COMPLETED|Fourth Intervention Period||0
8773097|NCT01286454|9823290|FG002|NOT COMPLETED|Fourth Intervention Period||0
8773098|NCT01286454|9823291|FG003|NOT COMPLETED|Fourth Intervention Period||0
8773099|NCT01286454|9823292|FG004|NOT COMPLETED|Fourth Intervention Period||0
8773100|NCT01286454|9823293|FG005|NOT COMPLETED|Fourth Intervention Period||0
9028443|NCT03201562|10090820|FG001|NOT COMPLETED|Overall Study||1
9028444|NCT03201562|10090821|FG002|NOT COMPLETED|Overall Study||4
9028445|NCT03201809|10090831|FG000|STARTED|Overall Study||6
9028446|NCT03201809|10090832|FG001|STARTED|Overall Study||6
9028447|NCT03201809|10090831|FG000|COMPLETED|Overall Study||4
9028448|NCT03201809|10090832|FG001|COMPLETED|Overall Study||6
9028449|NCT03201809|10090831|FG000|NOT COMPLETED|Overall Study||2
9028450|NCT03201809|10090832|FG001|NOT COMPLETED|Overall Study||0
9028451|NCT03201900|10090838|FG000|STARTED|Treatment Phase (Up to 62 Weeks)||91
9028452|NCT03201900|10090838|FG000|Treated|Treatment Phase (Up to 62 Weeks)||89
9028453|NCT03201900|10090838|FG000|COMPLETED|Treatment Phase (Up to 62 Weeks)||54
9028454|NCT03201900|10090838|FG000|NOT COMPLETED|Treatment Phase (Up to 62 Weeks)||37
9028455|NCT03201900|10090838|FG000|STARTED|Extension Phase (From Week 63 to 156)|Eligible participants who completed Treatment Phase and agreed to continue in the Extension Phase.|46
9028456|NCT03201900|10090838|FG000|COMPLETED|Extension Phase (From Week 63 to 156)||38
9028457|NCT03201900|10090838|FG000|NOT COMPLETED|Extension Phase (From Week 63 to 156)||8
9028458|NCT03202134|10090844|FG000|STARTED|Overall Study||55
9028459|NCT03202134|10090845|FG001|STARTED|Overall Study||149
9028460|NCT03202134|10090844|FG000|COMPLETED|Overall Study||55
9028461|NCT03202134|10090845|FG001|COMPLETED|Overall Study||149
9028462|NCT03202134|10090844|FG000|NOT COMPLETED|Overall Study||0
9028463|NCT03202134|10090845|FG001|NOT COMPLETED|Overall Study||0
9028464|NCT03202264|10090853|FG000|STARTED|Overall Study||30
9028465|NCT03202264|10090853|FG000|COMPLETED|Overall Study||14
9028466|NCT03202264|10090853|FG000|NOT COMPLETED|Overall Study||16
9028467|NCT03202472|10090857|FG000|STARTED|Overall Study||50
9028468|NCT03202472|10090857|FG000|COMPLETED|Overall Study||50
9028469|NCT03202472|10090857|FG000|NOT COMPLETED|Overall Study||0
9028470|NCT03202511|10090861|FG000|STARTED|Overall Study||8
9028471|NCT03202511|10090862|FG001|STARTED|Overall Study||7
9028472|NCT03202511|10090861|FG000|COMPLETED|Overall Study||7
9028473|NCT03202511|10090862|FG001|COMPLETED|Overall Study||7
9028474|NCT03202511|10090861|FG000|NOT COMPLETED|Overall Study||1
9028475|NCT03202511|10090862|FG001|NOT COMPLETED|Overall Study||0
9028476|NCT03202550|10090870|FG000|STARTED|Overall Study||13
9028477|NCT03202550|10090871|FG001|STARTED|Overall Study||11
9028478|NCT03202550|10090870|FG000|COMPLETED|Overall Study||13
9028479|NCT03202550|10090871|FG001|COMPLETED|Overall Study||11
9028480|NCT03202550|10090870|FG000|NOT COMPLETED|Overall Study||0
9028481|NCT03202550|10090871|FG001|NOT COMPLETED|Overall Study||0
9028482|NCT03203291|10090877|FG000|STARTED|Overall Study||12
9028483|NCT03203291|10090877|FG000|COMPLETED|Overall Study||11
9028484|NCT03203291|10090877|FG000|NOT COMPLETED|Overall Study||1
9028485|NCT03203447|10090883|FG000|STARTED|Overall Study|Two patients were randomized to the Active arm, but did not receive study drug.|162
9028486|NCT03203447|10090884|FG001|STARTED|Overall Study|One patient was randomized to the Control arm, but did not receive study drug.|163
9028487|NCT03203447|10090883|FG000|COMPLETED|Overall Study||0
9028488|NCT03203447|10090884|FG001|COMPLETED|Overall Study||0
9028489|NCT03203447|10090883|FG000|NOT COMPLETED|Overall Study||162
9028490|NCT03203447|10090884|FG001|NOT COMPLETED|Overall Study||163
9028491|NCT03203564|10090894|FG000|STARTED|Overall Study||8
9028492|NCT03203564|10090895|FG001|STARTED|Overall Study||8
9028493|NCT03203564|10090896|FG002|STARTED|Overall Study||8
9028494|NCT03203564|10090897|FG003|STARTED|Overall Study||9
9028495|NCT03203564|10090894|FG000|COMPLETED|Overall Study||8
9028496|NCT03203564|10090895|FG001|COMPLETED|Overall Study||8
9028497|NCT03203564|10090896|FG002|COMPLETED|Overall Study||8
9028498|NCT03203564|10090897|FG003|COMPLETED|Overall Study||9
9028499|NCT03203564|10090894|FG000|NOT COMPLETED|Overall Study||0
9028500|NCT03203564|10090895|FG001|NOT COMPLETED|Overall Study||0
9028501|NCT03203564|10090896|FG002|NOT COMPLETED|Overall Study||0
9028502|NCT03203564|10090897|FG003|NOT COMPLETED|Overall Study||0
9028503|NCT03203681|10090907|FG000|STARTED|Overall Study||60
9028504|NCT03203681|10090907|FG000|3 Month|Overall Study||44
9028505|NCT03203681|10090907|FG000|6 Months|Overall Study||33
9028506|NCT03203681|10090907|FG000|COMPLETED|Overall Study||33
9028507|NCT03203681|10090907|FG000|NOT COMPLETED|Overall Study||27
9028508|NCT03204279|10090913|FG000|STARTED|Overall Study||34
9028509|NCT03204279|10090914|FG001|STARTED|Overall Study||33
9028510|NCT03204279|10090913|FG000|COMPLETED|Overall Study||34
9028511|NCT03204279|10090914|FG001|COMPLETED|Overall Study||32
9028512|NCT03204279|10090913|FG000|NOT COMPLETED|Overall Study||0
9028513|NCT03204279|10090914|FG001|NOT COMPLETED|Overall Study||1
9028514|NCT03204526|10090921|FG000|STARTED|Overall Study||15
9028515|NCT03204526|10090921|FG000|COMPLETED|Overall Study||15
8773101|NCT01286454|9823294|FG006|NOT COMPLETED|Fourth Intervention Period||0
8773102|NCT01286454|9823295|FG007|NOT COMPLETED|Fourth Intervention Period||0
8773103|NCT01286454|9823296|FG008|NOT COMPLETED|Fourth Intervention Period||0
8773104|NCT01286454|9823297|FG009|NOT COMPLETED|Fourth Intervention Period||0
8773105|NCT01286454|9823298|FG010|NOT COMPLETED|Fourth Intervention Period||0
8773106|NCT01286454|9823288|FG000|STARTED|Washout Period (At Least 3 Days)||2
8773107|NCT01286454|9823289|FG001|STARTED|Washout Period (At Least 3 Days)||2
8773108|NCT01286454|9823290|FG002|STARTED|Washout Period (At Least 3 Days)||2
8773109|NCT01286454|9823291|FG003|STARTED|Washout Period (At Least 3 Days)||2
8773110|NCT01286454|9823292|FG004|STARTED|Washout Period (At Least 3 Days)||2
8773111|NCT01286454|9823293|FG005|STARTED|Washout Period (At Least 3 Days)||2
8773112|NCT01286454|9823294|FG006|STARTED|Washout Period (At Least 3 Days)||2
8773113|NCT01286454|9823295|FG007|STARTED|Washout Period (At Least 3 Days)||2
8773114|NCT01286454|9823296|FG008|STARTED|Washout Period (At Least 3 Days)||2
8773115|NCT01286454|9823297|FG009|STARTED|Washout Period (At Least 3 Days)||2
8773116|NCT01286454|9823298|FG010|STARTED|Washout Period (At Least 3 Days)||0
8773117|NCT01286454|9823288|FG000|COMPLETED|Washout Period (At Least 3 Days)||2
8773118|NCT01286454|9823289|FG001|COMPLETED|Washout Period (At Least 3 Days)||2
8773119|NCT01286454|9823290|FG002|COMPLETED|Washout Period (At Least 3 Days)||2
8773120|NCT01286454|9823291|FG003|COMPLETED|Washout Period (At Least 3 Days)||2
8773121|NCT01286454|9823292|FG004|COMPLETED|Washout Period (At Least 3 Days)||2
8773122|NCT01286454|9823293|FG005|COMPLETED|Washout Period (At Least 3 Days)||2
8773123|NCT01286454|9823294|FG006|COMPLETED|Washout Period (At Least 3 Days)||2
9028516|NCT03204526|10090921|FG000|NOT COMPLETED|Overall Study||0
9028517|NCT03204942|10090928|FG000|STARTED|Overall Study||23
9028518|NCT03204942|10090929|FG001|STARTED|Overall Study||23
9028519|NCT03204942|10090930|FG002|STARTED|Overall Study||23
9028520|NCT03204942|10090928|FG000|COMPLETED|Overall Study||23
9028521|NCT03204942|10090929|FG001|COMPLETED|Overall Study||23
9028522|NCT03204942|10090930|FG002|COMPLETED|Overall Study||23
9028523|NCT03204942|10090928|FG000|NOT COMPLETED|Overall Study||0
9028524|NCT03204942|10090929|FG001|NOT COMPLETED|Overall Study||0
9028525|NCT03204942|10090930|FG002|NOT COMPLETED|Overall Study||0
9028526|NCT03204981|10090943|FG000|STARTED|Overall Study||52
9028527|NCT03204981|10090943|FG000|COMPLETED|Overall Study||46
9028528|NCT03204981|10090943|FG000|NOT COMPLETED|Overall Study||6
9028529|NCT03205046|10090951|FG000|STARTED|Overall Study||13
9028530|NCT03205046|10090952|FG001|STARTED|Overall Study||12
9028531|NCT03205046|10090951|FG000|COMPLETED|Overall Study||0
9028532|NCT03205046|10090952|FG001|COMPLETED|Overall Study||2
9028533|NCT03205046|10090951|FG000|NOT COMPLETED|Overall Study||13
9028534|NCT03205046|10090952|FG001|NOT COMPLETED|Overall Study||10
9028535|NCT03205150|10090961|FG000|STARTED|Overall Study||43
9028536|NCT03205150|10090962|FG001|STARTED|Overall Study||43
9028537|NCT03205150|10090963|FG002|STARTED|Overall Study||21
9028538|NCT03205150|10090961|FG000|Safety Analysis Set|Overall Study||43
9028539|NCT03205150|10090962|FG001|Safety Analysis Set|Overall Study||43
9028540|NCT03205150|10090963|FG002|Safety Analysis Set|Overall Study||21
9028541|NCT03205150|10090961|FG000|Pharmacokinetics (PK) Analysis Set|Overall Study|all patients with valid PK measurements|42
9028542|NCT03205150|10090962|FG001|Pharmacokinetics (PK) Analysis Set|Overall Study|all patients with valid PK measurements|36
9028543|NCT03205150|10090963|FG002|Pharmacokinetics (PK) Analysis Set|Overall Study|Placebo patients were excluded from the PK analyses|0
9028544|NCT03205150|10090961|FG000|Pharmacodynamics (PD) Analysis Set|Overall Study|all patients with available PD data and no protocol deviations|43
9028545|NCT03205150|10090962|FG001|Pharmacodynamics (PD) Analysis Set|Overall Study|all patients with available PD data and no protocol deviations|41
9028546|NCT03205150|10090963|FG002|Pharmacodynamics (PD) Analysis Set|Overall Study|all patients with available PD data and no protocol deviations|21
9028547|NCT03205150|10090961|FG000|COMPLETED|Overall Study||41
9028548|NCT03205150|10090962|FG001|COMPLETED|Overall Study||36
9028549|NCT03205150|10090963|FG002|COMPLETED|Overall Study||19
9028550|NCT03205150|10090961|FG000|NOT COMPLETED|Overall Study||2
9028551|NCT03205150|10090962|FG001|NOT COMPLETED|Overall Study||7
9028552|NCT03205150|10090963|FG002|NOT COMPLETED|Overall Study||2
9028553|NCT03205488|10090975|FG000|STARTED|Overall Study||25
9028554|NCT03205488|10090976|FG001|STARTED|Overall Study||25
9028555|NCT03205488|10090977|FG002|STARTED|Overall Study||26
9028556|NCT03205488|10090975|FG000|COMPLETED|Overall Study||24
9028557|NCT03205488|10090976|FG001|COMPLETED|Overall Study||23
9028558|NCT03205488|10090977|FG002|COMPLETED|Overall Study||21
9028559|NCT03205488|10090975|FG000|NOT COMPLETED|Overall Study||1
9028560|NCT03205488|10090976|FG001|NOT COMPLETED|Overall Study||2
9028561|NCT03205488|10090977|FG002|NOT COMPLETED|Overall Study||5
9028562|NCT03205566|10090991|FG000|STARTED|Phase 1|One participant withdrawn and replaced. Data obtained from first participant still used in analysis|19
9028563|NCT03205566|10090992|FG001|STARTED|Phase 1|One participant withdrawn and replaced. Data obtained from first participant still used in analysis|19
9028564|NCT03205566|10090991|FG000|COMPLETED|Phase 1||18
9028565|NCT03205566|10090992|FG001|COMPLETED|Phase 1||18
9028566|NCT03205566|10090991|FG000|NOT COMPLETED|Phase 1||1
9028567|NCT03205566|10090992|FG001|NOT COMPLETED|Phase 1||1
9028568|NCT03205566|10090991|FG000|STARTED|Phase 2||18
9028569|NCT03205566|10090992|FG001|STARTED|Phase 2||18
9028570|NCT03205566|10090991|FG000|COMPLETED|Phase 2||18
8773124|NCT01286454|9823295|FG007|COMPLETED|Washout Period (At Least 3 Days)||2
8773125|NCT01286454|9823296|FG008|COMPLETED|Washout Period (At Least 3 Days)||2
8773126|NCT01286454|9823297|FG009|COMPLETED|Washout Period (At Least 3 Days)||2
8773127|NCT01286454|9823298|FG010|COMPLETED|Washout Period (At Least 3 Days)||0
8773128|NCT01286454|9823288|FG000|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8773129|NCT01286454|9823289|FG001|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8773130|NCT01286454|9823290|FG002|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8773131|NCT01286454|9823291|FG003|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8773132|NCT01286454|9823292|FG004|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8773133|NCT01286454|9823293|FG005|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8773134|NCT01286454|9823294|FG006|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8773135|NCT01286454|9823295|FG007|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8773136|NCT01286454|9823296|FG008|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8773137|NCT01286454|9823297|FG009|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8773138|NCT01286454|9823298|FG010|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8773139|NCT01286454|9823288|FG000|STARTED|Fifth Intervention Period||2
8773140|NCT01286454|9823289|FG001|STARTED|Fifth Intervention Period||2
8773141|NCT01286454|9823290|FG002|STARTED|Fifth Intervention Period||2
8773142|NCT01286454|9823291|FG003|STARTED|Fifth Intervention Period||2
8773143|NCT01286454|9823292|FG004|STARTED|Fifth Intervention Period||2
8773144|NCT01286454|9823293|FG005|STARTED|Fifth Intervention Period||2
8773145|NCT01286454|9823294|FG006|STARTED|Fifth Intervention Period||2
8773146|NCT01286454|9823295|FG007|STARTED|Fifth Intervention Period||2
8773147|NCT01286454|9823296|FG008|STARTED|Fifth Intervention Period||2
8773148|NCT01286454|9823297|FG009|STARTED|Fifth Intervention Period||2
8773149|NCT01286454|9823298|FG010|STARTED|Fifth Intervention Period||0
8773150|NCT01286454|9823288|FG000|COMPLETED|Fifth Intervention Period||2
8773151|NCT01286454|9823289|FG001|COMPLETED|Fifth Intervention Period||2
8773152|NCT01286454|9823290|FG002|COMPLETED|Fifth Intervention Period||2
8773153|NCT01286454|9823291|FG003|COMPLETED|Fifth Intervention Period||2
8773154|NCT01286454|9823292|FG004|COMPLETED|Fifth Intervention Period||2
8773155|NCT01286454|9823293|FG005|COMPLETED|Fifth Intervention Period||2
8773156|NCT01286454|9823294|FG006|COMPLETED|Fifth Intervention Period||2
8773157|NCT01286454|9823295|FG007|COMPLETED|Fifth Intervention Period||2
8773158|NCT01286454|9823296|FG008|COMPLETED|Fifth Intervention Period||2
8773159|NCT01286454|9823297|FG009|COMPLETED|Fifth Intervention Period||2
8773160|NCT01286454|9823298|FG010|COMPLETED|Fifth Intervention Period||0
8773161|NCT01286454|9823288|FG000|NOT COMPLETED|Fifth Intervention Period||0
8773162|NCT01286454|9823289|FG001|NOT COMPLETED|Fifth Intervention Period||0
8773163|NCT01286454|9823290|FG002|NOT COMPLETED|Fifth Intervention Period||0
8773164|NCT01286454|9823291|FG003|NOT COMPLETED|Fifth Intervention Period||0
8773165|NCT01286454|9823292|FG004|NOT COMPLETED|Fifth Intervention Period||0
8773166|NCT01286454|9823293|FG005|NOT COMPLETED|Fifth Intervention Period||0
8773167|NCT01286454|9823294|FG006|NOT COMPLETED|Fifth Intervention Period||0
8773168|NCT01286454|9823295|FG007|NOT COMPLETED|Fifth Intervention Period||0
8773169|NCT01286454|9823296|FG008|NOT COMPLETED|Fifth Intervention Period||0
8773170|NCT01286454|9823297|FG009|NOT COMPLETED|Fifth Intervention Period||0
8773171|NCT01286454|9823298|FG010|NOT COMPLETED|Fifth Intervention Period||0
8773172|NCT01286454|9823288|FG000|STARTED|Washout Period (Approximately 2 Weeks)||2
8773173|NCT01286454|9823289|FG001|STARTED|Washout Period (Approximately 2 Weeks)||2
8773174|NCT01286454|9823290|FG002|STARTED|Washout Period (Approximately 2 Weeks)||2
8773175|NCT01286454|9823291|FG003|STARTED|Washout Period (Approximately 2 Weeks)||2
8773176|NCT01286454|9823292|FG004|STARTED|Washout Period (Approximately 2 Weeks)||2
8773177|NCT01286454|9823293|FG005|STARTED|Washout Period (Approximately 2 Weeks)||2
8773178|NCT01286454|9823294|FG006|STARTED|Washout Period (Approximately 2 Weeks)||2
8773179|NCT01286454|9823295|FG007|STARTED|Washout Period (Approximately 2 Weeks)||2
8773180|NCT01286454|9823296|FG008|STARTED|Washout Period (Approximately 2 Weeks)||2
8773181|NCT01286454|9823297|FG009|STARTED|Washout Period (Approximately 2 Weeks)||2
8773182|NCT01286454|9823298|FG010|STARTED|Washout Period (Approximately 2 Weeks)||0
8773183|NCT01286454|9823288|FG000|COMPLETED|Washout Period (Approximately 2 Weeks)||2
8773184|NCT01286454|9823289|FG001|COMPLETED|Washout Period (Approximately 2 Weeks)||2
8773185|NCT01286454|9823290|FG002|COMPLETED|Washout Period (Approximately 2 Weeks)||2
8773186|NCT01286454|9823291|FG003|COMPLETED|Washout Period (Approximately 2 Weeks)||2
8773187|NCT01286454|9823292|FG004|COMPLETED|Washout Period (Approximately 2 Weeks)||2
8773188|NCT01286454|9823293|FG005|COMPLETED|Washout Period (Approximately 2 Weeks)||2
8773189|NCT01286454|9823294|FG006|COMPLETED|Washout Period (Approximately 2 Weeks)||2
8773190|NCT01286454|9823295|FG007|COMPLETED|Washout Period (Approximately 2 Weeks)||2
8773191|NCT01286454|9823296|FG008|COMPLETED|Washout Period (Approximately 2 Weeks)||2
8773192|NCT01286454|9823297|FG009|COMPLETED|Washout Period (Approximately 2 Weeks)||2
8773193|NCT01286454|9823298|FG010|COMPLETED|Washout Period (Approximately 2 Weeks)||0
8773194|NCT01286454|9823288|FG000|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
8773195|NCT01286454|9823289|FG001|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
8773196|NCT01286454|9823290|FG002|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
8773197|NCT01286454|9823291|FG003|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
8773198|NCT01286454|9823292|FG004|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
8773199|NCT01286454|9823293|FG005|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
8773200|NCT01286454|9823294|FG006|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
8773201|NCT01286454|9823295|FG007|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
8773202|NCT01286454|9823296|FG008|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
8773203|NCT01286454|9823297|FG009|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
8773204|NCT01286454|9823298|FG010|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
8773205|NCT01286454|9823288|FG000|STARTED|Part II- Sixth Intervention Period||0
8773206|NCT01286454|9823289|FG001|STARTED|Part II- Sixth Intervention Period||0
8773207|NCT01286454|9823290|FG002|STARTED|Part II- Sixth Intervention Period||0
8773208|NCT01286454|9823291|FG003|STARTED|Part II- Sixth Intervention Period||0
8773209|NCT01286454|9823292|FG004|STARTED|Part II- Sixth Intervention Period||0
8773210|NCT01286454|9823293|FG005|STARTED|Part II- Sixth Intervention Period||0
8773211|NCT01286454|9823294|FG006|STARTED|Part II- Sixth Intervention Period||0
8773212|NCT01286454|9823295|FG007|STARTED|Part II- Sixth Intervention Period||0
8773213|NCT01286454|9823296|FG008|STARTED|Part II- Sixth Intervention Period||0
8773214|NCT01286454|9823297|FG009|STARTED|Part II- Sixth Intervention Period||0
8773215|NCT01286454|9823298|FG010|STARTED|Part II- Sixth Intervention Period||20
8773216|NCT01286454|9823288|FG000|COMPLETED|Part II- Sixth Intervention Period||0
8773217|NCT01286454|9823289|FG001|COMPLETED|Part II- Sixth Intervention Period||0
8773218|NCT01286454|9823290|FG002|COMPLETED|Part II- Sixth Intervention Period||0
8773219|NCT01286454|9823291|FG003|COMPLETED|Part II- Sixth Intervention Period||0
8773220|NCT01286454|9823292|FG004|COMPLETED|Part II- Sixth Intervention Period||0
8773221|NCT01286454|9823293|FG005|COMPLETED|Part II- Sixth Intervention Period||0
8773222|NCT01286454|9823294|FG006|COMPLETED|Part II- Sixth Intervention Period||0
8773223|NCT01286454|9823295|FG007|COMPLETED|Part II- Sixth Intervention Period||0
8773224|NCT01286454|9823296|FG008|COMPLETED|Part II- Sixth Intervention Period||0
8773225|NCT01286454|9823297|FG009|COMPLETED|Part II- Sixth Intervention Period||0
8773226|NCT01286454|9823298|FG010|COMPLETED|Part II- Sixth Intervention Period||20
8773227|NCT01286454|9823288|FG000|NOT COMPLETED|Part II- Sixth Intervention Period||0
8773228|NCT01286454|9823289|FG001|NOT COMPLETED|Part II- Sixth Intervention Period||0
8773229|NCT01286454|9823290|FG002|NOT COMPLETED|Part II- Sixth Intervention Period||0
8773230|NCT01286454|9823291|FG003|NOT COMPLETED|Part II- Sixth Intervention Period||0
8773231|NCT01286454|9823292|FG004|NOT COMPLETED|Part II- Sixth Intervention Period||0
8773232|NCT01286454|9823293|FG005|NOT COMPLETED|Part II- Sixth Intervention Period||0
8773233|NCT01286454|9823294|FG006|NOT COMPLETED|Part II- Sixth Intervention Period||0
8773234|NCT01286454|9823295|FG007|NOT COMPLETED|Part II- Sixth Intervention Period||0
8773235|NCT01286454|9823296|FG008|NOT COMPLETED|Part II- Sixth Intervention Period||0
8773236|NCT01286454|9823297|FG009|NOT COMPLETED|Part II- Sixth Intervention Period||0
8773237|NCT01286454|9823298|FG010|NOT COMPLETED|Part II- Sixth Intervention Period||0
8773238|NCT01286480|9823314|FG000|STARTED|Overall Study||32
8773239|NCT01286480|9823315|FG001|STARTED|Overall Study||34
8773240|NCT01286480|9823314|FG000|COMPLETED|Overall Study||27
8773241|NCT01286480|9823315|FG001|COMPLETED|Overall Study||31
8773242|NCT01286480|9823314|FG000|NOT COMPLETED|Overall Study||5
8773243|NCT01286480|9823315|FG001|NOT COMPLETED|Overall Study||3
8773244|NCT01286493|9823321|FG000|STARTED|Overall Study||33
8773245|NCT01286493|9823321|FG000|COMPLETED|Overall Study||30
8773246|NCT01286493|9823321|FG000|NOT COMPLETED|Overall Study||3
8773247|NCT01286558|9823327|FG000|STARTED|Overall Study||112
8773248|NCT01286558|9823328|FG001|STARTED|Overall Study||113
8773249|NCT01286558|9823327|FG000|COMPLETED|Overall Study||111
8773250|NCT01286558|9823328|FG001|COMPLETED|Overall Study||111
8773251|NCT01286558|9823327|FG000|NOT COMPLETED|Overall Study||1
8773252|NCT01286558|9823328|FG001|NOT COMPLETED|Overall Study||2
8773253|NCT01286740|9823334|FG000|STARTED|Overall Study||50
8773254|NCT01286740|9823334|FG000|Enrolled and Treated|Overall Study||49
8773255|NCT01286740|9823334|FG000|Week 12 (Primary Endpoint)|Overall Study||49
8773256|NCT01286740|9823334|FG000|COMPLETED|Overall Study||48
8773257|NCT01286740|9823334|FG000|NOT COMPLETED|Overall Study||2
8773258|NCT01286753|9823340|FG000|STARTED|Overall Study||26
8773259|NCT01286753|9823341|FG001|STARTED|Overall Study||25
8773260|NCT01286753|9823340|FG000|COMPLETED|Overall Study||0
8773261|NCT01286753|9823341|FG001|COMPLETED|Overall Study||0
8773262|NCT01286753|9823340|FG000|NOT COMPLETED|Overall Study||26
8773263|NCT01286753|9823341|FG001|NOT COMPLETED|Overall Study||25
8773264|NCT01286779|9823348|FG000|STARTED|Overall Study||115
8773265|NCT01286779|9823348|FG000|COMPLETED|Overall Study||96
8773266|NCT01286779|9823348|FG000|NOT COMPLETED|Overall Study||19
8773267|NCT01286805|9823364|FG000|STARTED|Overall Study||41
8773268|NCT01286805|9823365|FG001|STARTED|Overall Study||42
8773269|NCT01286805|9823364|FG000|COMPLETED|Overall Study||41
8773270|NCT01286805|9823365|FG001|COMPLETED|Overall Study||41
9028571|NCT03205566|10090992|FG001|COMPLETED|Phase 2||18
9028572|NCT03205566|10090991|FG000|NOT COMPLETED|Phase 2||0
9028573|NCT03205566|10090992|FG001|NOT COMPLETED|Phase 2||0
9028574|NCT03206749|10091005|FG000|STARTED|Overall Study||80
9028575|NCT03206749|10091006|FG001|STARTED|Overall Study||81
9028576|NCT03206749|10091007|FG002|STARTED|Overall Study||82
9028577|NCT03206749|10091005|FG000|COMPLETED|Overall Study||75
9028578|NCT03206749|10091006|FG001|COMPLETED|Overall Study||78
9028579|NCT03206749|10091007|FG002|COMPLETED|Overall Study||75
9028580|NCT03206749|10091005|FG000|NOT COMPLETED|Overall Study||5
8773271|NCT01286805|9823364|FG000|NOT COMPLETED|Overall Study||0
8773272|NCT01286805|9823365|FG001|NOT COMPLETED|Overall Study||1
8773273|NCT01286818|9823371|FG000|STARTED|Overall Study||6
8773274|NCT01286818|9823371|FG000|Completed DLT Assessment Period|Overall Study||5
9028581|NCT03206749|10091006|FG001|NOT COMPLETED|Overall Study||3
8773275|NCT01286818|9823371|FG000|COMPLETED|Overall Study||6
9028582|NCT03206749|10091007|FG002|NOT COMPLETED|Overall Study||7
9028583|NCT03206788|10091018|FG000|STARTED|Overall Study||2
8773276|NCT01286818|9823371|FG000|NOT COMPLETED|Overall Study||0
8773277|NCT01286870|9823375|FG000|STARTED|Overall Study||11
8773278|NCT01286870|9823375|FG000|COMPLETED|Overall Study||11
8773279|NCT01286870|9823375|FG000|NOT COMPLETED|Overall Study||0
8773280|NCT01286987|9823394|FG000|STARTED|Part 1: Dose Escalation||3
8773281|NCT01286987|9823395|FG001|STARTED|Part 1: Dose Escalation||3
8773282|NCT01286987|9823396|FG002|STARTED|Part 1: Dose Escalation||3
8773283|NCT01286987|9823397|FG003|STARTED|Part 1: Dose Escalation||3
8773284|NCT01286987|9823398|FG004|STARTED|Part 1: Dose Escalation||3
8773285|NCT01286987|9823399|FG005|STARTED|Part 1: Dose Escalation||6
8773286|NCT01286987|9823400|FG006|STARTED|Part 1: Dose Escalation||6
8773287|NCT01286987|9823401|FG007|STARTED|Part 1: Dose Escalation||6
8773288|NCT01286987|9823402|FG008|STARTED|Part 1: Dose Escalation||6
8773289|NCT01286987|9823403|FG009|STARTED|Part 1: Dose Escalation||0
8773290|NCT01286987|9823404|FG010|STARTED|Part 1: Dose Escalation||0
8773291|NCT01286987|9823405|FG011|STARTED|Part 1: Dose Escalation||0
8773292|NCT01286987|9823406|FG012|STARTED|Part 1: Dose Escalation||0
8773293|NCT01286987|9823407|FG013|STARTED|Part 1: Dose Escalation||0
8773294|NCT01286987|9823408|FG014|STARTED|Part 1: Dose Escalation||0
8773295|NCT01286987|9823394|FG000|Colorectal Cancer|Part 1: Dose Escalation||1
8773296|NCT01286987|9823395|FG001|Colorectal Cancer|Part 1: Dose Escalation||0
8773297|NCT01286987|9823396|FG002|Colorectal Cancer|Part 1: Dose Escalation||1
8773298|NCT01286987|9823397|FG003|Colorectal Cancer|Part 1: Dose Escalation||0
8773299|NCT01286987|9823398|FG004|Colorectal Cancer|Part 1: Dose Escalation||0
8773300|NCT01286987|9823399|FG005|Colorectal Cancer|Part 1: Dose Escalation||0
8773301|NCT01286987|9823400|FG006|Colorectal Cancer|Part 1: Dose Escalation||0
8773302|NCT01286987|9823401|FG007|Colorectal Cancer|Part 1: Dose Escalation||0
8773303|NCT01286987|9823402|FG008|Colorectal Cancer|Part 1: Dose Escalation||0
8773304|NCT01286987|9823403|FG009|Colorectal Cancer|Part 1: Dose Escalation||0
8773305|NCT01286987|9823404|FG010|Colorectal Cancer|Part 1: Dose Escalation||0
8773306|NCT01286987|9823405|FG011|Colorectal Cancer|Part 1: Dose Escalation||0
8773307|NCT01286987|9823406|FG012|Colorectal Cancer|Part 1: Dose Escalation||0
8773308|NCT01286987|9823407|FG013|Colorectal Cancer|Part 1: Dose Escalation||0
8773309|NCT01286987|9823408|FG014|Colorectal Cancer|Part 1: Dose Escalation||0
8773310|NCT01286987|9823394|FG000|Prostate Cancer|Part 1: Dose Escalation||0
8773311|NCT01286987|9823395|FG001|Prostate Cancer|Part 1: Dose Escalation||0
8773312|NCT01286987|9823396|FG002|Prostate Cancer|Part 1: Dose Escalation||0
8773313|NCT01286987|9823397|FG003|Prostate Cancer|Part 1: Dose Escalation||0
8773314|NCT01286987|9823398|FG004|Prostate Cancer|Part 1: Dose Escalation||0
8773315|NCT01286987|9823399|FG005|Prostate Cancer|Part 1: Dose Escalation||1
8773316|NCT01286987|9823400|FG006|Prostate Cancer|Part 1: Dose Escalation||0
8773317|NCT01286987|9823401|FG007|Prostate Cancer|Part 1: Dose Escalation||0
8773318|NCT01286987|9823402|FG008|Prostate Cancer|Part 1: Dose Escalation||0
8773319|NCT01286987|9823403|FG009|Prostate Cancer|Part 1: Dose Escalation||0
8773320|NCT01286987|9823404|FG010|Prostate Cancer|Part 1: Dose Escalation||0
8773321|NCT01286987|9823405|FG011|Prostate Cancer|Part 1: Dose Escalation||0
8773322|NCT01286987|9823406|FG012|Prostate Cancer|Part 1: Dose Escalation||0
8773323|NCT01286987|9823407|FG013|Prostate Cancer|Part 1: Dose Escalation||0
8773324|NCT01286987|9823408|FG014|Prostate Cancer|Part 1: Dose Escalation||0
8773325|NCT01286987|9823394|FG000|Ewing Cancer|Part 1: Dose Escalation||0
8773326|NCT01286987|9823395|FG001|Ewing Cancer|Part 1: Dose Escalation||0
8773327|NCT01286987|9823396|FG002|Ewing Cancer|Part 1: Dose Escalation||0
8773328|NCT01286987|9823397|FG003|Ewing Cancer|Part 1: Dose Escalation||0
8773329|NCT01286987|9823398|FG004|Ewing Cancer|Part 1: Dose Escalation||0
8773330|NCT01286987|9823399|FG005|Ewing Cancer|Part 1: Dose Escalation||0
8773331|NCT01286987|9823400|FG006|Ewing Cancer|Part 1: Dose Escalation||0
8773332|NCT01286987|9823401|FG007|Ewing Cancer|Part 1: Dose Escalation||1
8773333|NCT01286987|9823402|FG008|Ewing Cancer|Part 1: Dose Escalation||1
8773334|NCT01286987|9823403|FG009|Ewing Cancer|Part 1: Dose Escalation||0
8773335|NCT01286987|9823404|FG010|Ewing Cancer|Part 1: Dose Escalation||0
8773336|NCT01286987|9823405|FG011|Ewing Cancer|Part 1: Dose Escalation||0
8773337|NCT01286987|9823406|FG012|Ewing Cancer|Part 1: Dose Escalation||0
8773338|NCT01286987|9823407|FG013|Ewing Cancer|Part 1: Dose Escalation||0
8773339|NCT01286987|9823408|FG014|Ewing Cancer|Part 1: Dose Escalation||0
8773340|NCT01286987|9823394|FG000|Pancreatic Cancer|Part 1: Dose Escalation||1
8773341|NCT01286987|9823395|FG001|Pancreatic Cancer|Part 1: Dose Escalation||2
8773342|NCT01286987|9823396|FG002|Pancreatic Cancer|Part 1: Dose Escalation||0
8773343|NCT01286987|9823397|FG003|Pancreatic Cancer|Part 1: Dose Escalation||0
8773344|NCT01286987|9823398|FG004|Pancreatic Cancer|Part 1: Dose Escalation||0
8773345|NCT01286987|9823399|FG005|Pancreatic Cancer|Part 1: Dose Escalation||0
8773346|NCT01286987|9823400|FG006|Pancreatic Cancer|Part 1: Dose Escalation||0
8773347|NCT01286987|9823401|FG007|Pancreatic Cancer|Part 1: Dose Escalation||0
8773348|NCT01286987|9823402|FG008|Pancreatic Cancer|Part 1: Dose Escalation||0
8773349|NCT01286987|9823403|FG009|Pancreatic Cancer|Part 1: Dose Escalation||0
8773350|NCT01286987|9823404|FG010|Pancreatic Cancer|Part 1: Dose Escalation||0
8773351|NCT01286987|9823405|FG011|Pancreatic Cancer|Part 1: Dose Escalation||0
8773352|NCT01286987|9823406|FG012|Pancreatic Cancer|Part 1: Dose Escalation||0
8773353|NCT01286987|9823407|FG013|Pancreatic Cancer|Part 1: Dose Escalation||0
8773354|NCT01286987|9823408|FG014|Pancreatic Cancer|Part 1: Dose Escalation||0
8773355|NCT01286987|9823394|FG000|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||1
8773356|NCT01286987|9823395|FG001|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||1
8773357|NCT01286987|9823396|FG002|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||2
8773358|NCT01286987|9823397|FG003|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||3
8773359|NCT01286987|9823398|FG004|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||3
8773360|NCT01286987|9823399|FG005|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||4
8773361|NCT01286987|9823400|FG006|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||4
8773362|NCT01286987|9823401|FG007|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||3
8773363|NCT01286987|9823402|FG008|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||2
8773364|NCT01286987|9823403|FG009|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
8773365|NCT01286987|9823404|FG010|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
8773366|NCT01286987|9823405|FG011|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
8773367|NCT01286987|9823406|FG012|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
8773368|NCT01286987|9823407|FG013|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
8773369|NCT01286987|9823408|FG014|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
8773370|NCT01286987|9823394|FG000|Breast Cancer|Part 1: Dose Escalation||0
8773371|NCT01286987|9823395|FG001|Breast Cancer|Part 1: Dose Escalation||0
8773372|NCT01286987|9823396|FG002|Breast Cancer|Part 1: Dose Escalation||0
8773373|NCT01286987|9823397|FG003|Breast Cancer|Part 1: Dose Escalation||0
8773374|NCT01286987|9823398|FG004|Breast Cancer|Part 1: Dose Escalation||0
8773375|NCT01286987|9823399|FG005|Breast Cancer|Part 1: Dose Escalation||1
8773376|NCT01286987|9823400|FG006|Breast Cancer|Part 1: Dose Escalation||2
8773377|NCT01286987|9823401|FG007|Breast Cancer|Part 1: Dose Escalation||2
8773378|NCT01286987|9823402|FG008|Breast Cancer|Part 1: Dose Escalation||3
8773379|NCT01286987|9823403|FG009|Breast Cancer|Part 1: Dose Escalation||0
8773380|NCT01286987|9823404|FG010|Breast Cancer|Part 1: Dose Escalation||0
8773381|NCT01286987|9823405|FG011|Breast Cancer|Part 1: Dose Escalation||0
8773382|NCT01286987|9823406|FG012|Breast Cancer|Part 1: Dose Escalation||0
8773383|NCT01286987|9823407|FG013|Breast Cancer|Part 1: Dose Escalation||0
8773384|NCT01286987|9823408|FG014|Breast Cancer|Part 1: Dose Escalation||0
8773385|NCT01286987|9823394|FG000|COMPLETED|Part 1: Dose Escalation||0
8773386|NCT01286987|9823395|FG001|COMPLETED|Part 1: Dose Escalation||0
8773387|NCT01286987|9823396|FG002|COMPLETED|Part 1: Dose Escalation||0
8773388|NCT01286987|9823397|FG003|COMPLETED|Part 1: Dose Escalation||0
8773389|NCT01286987|9823398|FG004|COMPLETED|Part 1: Dose Escalation||0
8773390|NCT01286987|9823399|FG005|COMPLETED|Part 1: Dose Escalation||0
8773391|NCT01286987|9823400|FG006|COMPLETED|Part 1: Dose Escalation||1
8773392|NCT01286987|9823401|FG007|COMPLETED|Part 1: Dose Escalation||1
8773393|NCT01286987|9823402|FG008|COMPLETED|Part 1: Dose Escalation||0
8773394|NCT01286987|9823403|FG009|COMPLETED|Part 1: Dose Escalation||0
8773395|NCT01286987|9823404|FG010|COMPLETED|Part 1: Dose Escalation||0
8773396|NCT01286987|9823405|FG011|COMPLETED|Part 1: Dose Escalation||0
8773397|NCT01286987|9823406|FG012|COMPLETED|Part 1: Dose Escalation||0
8773398|NCT01286987|9823407|FG013|COMPLETED|Part 1: Dose Escalation||0
8773399|NCT01286987|9823408|FG014|COMPLETED|Part 1: Dose Escalation||0
8773400|NCT01286987|9823394|FG000|NOT COMPLETED|Part 1: Dose Escalation||3
8773401|NCT01286987|9823395|FG001|NOT COMPLETED|Part 1: Dose Escalation||3
8773402|NCT01286987|9823396|FG002|NOT COMPLETED|Part 1: Dose Escalation||3
8773403|NCT01286987|9823397|FG003|NOT COMPLETED|Part 1: Dose Escalation||3
8773404|NCT01286987|9823398|FG004|NOT COMPLETED|Part 1: Dose Escalation||3
8773405|NCT01286987|9823399|FG005|NOT COMPLETED|Part 1: Dose Escalation||6
8773406|NCT01286987|9823400|FG006|NOT COMPLETED|Part 1: Dose Escalation||5
8773407|NCT01286987|9823401|FG007|NOT COMPLETED|Part 1: Dose Escalation||5
8773408|NCT01286987|9823402|FG008|NOT COMPLETED|Part 1: Dose Escalation||6
8773409|NCT01286987|9823403|FG009|NOT COMPLETED|Part 1: Dose Escalation||0
9028584|NCT03206788|10091019|FG001|STARTED|Overall Study||5
9028585|NCT03206788|10091018|FG000|COMPLETED|Overall Study||2
9028586|NCT03206788|10091019|FG001|COMPLETED|Overall Study||2
9028587|NCT03206788|10091018|FG000|NOT COMPLETED|Overall Study||0
9028588|NCT03206788|10091019|FG001|NOT COMPLETED|Overall Study||3
9028589|NCT03206918|10091025|FG000|STARTED|Overall Study||91
9028590|NCT03206918|10091025|FG000|COMPLETED|Overall Study||0
9028591|NCT03206918|10091025|FG000|NOT COMPLETED|Overall Study||91
9028592|NCT03206970|10091030|FG000|STARTED|Overall Study||86
9028593|NCT03206970|10091030|FG000|Received at Least 1 Dose of Study Drug|Overall Study||86
9028594|NCT03206970|10091030|FG000|COMPLETED|Overall Study||0
9028595|NCT03206970|10091030|FG000|NOT COMPLETED|Overall Study||86
9028596|NCT03207022|10091036|FG000|STARTED|Overall Study||12
9028597|NCT03207022|10091037|FG001|STARTED|Overall Study||12
9028598|NCT03207022|10091036|FG000|COMPLETED|Overall Study||12
9028599|NCT03207022|10091037|FG001|COMPLETED|Overall Study||12
9028600|NCT03207022|10091036|FG000|NOT COMPLETED|Overall Study||0
9028601|NCT03207022|10091037|FG001|NOT COMPLETED|Overall Study||0
9028602|NCT03207035|10091045|FG000|STARTED|Overall Study||10
9028603|NCT03207035|10091046|FG001|STARTED|Overall Study||10
9028604|NCT03207035|10091045|FG000|COMPLETED|Overall Study||10
9028605|NCT03207035|10091046|FG001|COMPLETED|Overall Study||10
8773410|NCT01286987|9823404|FG010|NOT COMPLETED|Part 1: Dose Escalation||0
8773411|NCT01286987|9823405|FG011|NOT COMPLETED|Part 1: Dose Escalation||0
9028606|NCT03207035|10091045|FG000|NOT COMPLETED|Overall Study||0
9028607|NCT03207035|10091046|FG001|NOT COMPLETED|Overall Study||0
8773412|NCT01286987|9823406|FG012|NOT COMPLETED|Part 1: Dose Escalation||0
9028608|NCT03207074|10091052|FG000|STARTED|Overall Study||150
9028609|NCT03207074|10091052|FG000|COMPLETED|Overall Study||150
9028610|NCT03207074|10091052|FG000|NOT COMPLETED|Overall Study||0
9028611|NCT03207243|10091058|FG000|STARTED|Overall Study||82
8773413|NCT01286987|9823407|FG013|NOT COMPLETED|Part 1: Dose Escalation||0
8773414|NCT01286987|9823408|FG014|NOT COMPLETED|Part 1: Dose Escalation||0
8773415|NCT01286987|9823394|FG000|STARTED|Part 2: Dose Expansion||0
8773416|NCT01286987|9823395|FG001|STARTED|Part 2: Dose Expansion||0
8773417|NCT01286987|9823396|FG002|STARTED|Part 2: Dose Expansion||0
8773418|NCT01286987|9823397|FG003|STARTED|Part 2: Dose Expansion||0
8773419|NCT01286987|9823398|FG004|STARTED|Part 2: Dose Expansion||0
8773420|NCT01286987|9823399|FG005|STARTED|Part 2: Dose Expansion||0
8773421|NCT01286987|9823400|FG006|STARTED|Part 2: Dose Expansion||0
8773422|NCT01286987|9823401|FG007|STARTED|Part 2: Dose Expansion||0
8773423|NCT01286987|9823402|FG008|STARTED|Part 2: Dose Expansion||0
8773424|NCT01286987|9823403|FG009|STARTED|Part 2: Dose Expansion||12
8773425|NCT01286987|9823404|FG010|STARTED|Part 2: Dose Expansion||12
8773426|NCT01286987|9823405|FG011|STARTED|Part 2: Dose Expansion||11
8773427|NCT01286987|9823406|FG012|STARTED|Part 2: Dose Expansion||12
8773428|NCT01286987|9823407|FG013|STARTED|Part 2: Dose Expansion||24
8773429|NCT01286987|9823408|FG014|STARTED|Part 2: Dose Expansion||3
8773430|NCT01286987|9823394|FG000|Treated|Part 2: Dose Expansion||0
8773431|NCT01286987|9823395|FG001|Treated|Part 2: Dose Expansion||0
8773432|NCT01286987|9823396|FG002|Treated|Part 2: Dose Expansion||0
8773433|NCT01286987|9823397|FG003|Treated|Part 2: Dose Expansion||0
8773434|NCT01286987|9823398|FG004|Treated|Part 2: Dose Expansion||0
8773435|NCT01286987|9823399|FG005|Treated|Part 2: Dose Expansion||0
8773436|NCT01286987|9823400|FG006|Treated|Part 2: Dose Expansion||0
8773437|NCT01286987|9823401|FG007|Treated|Part 2: Dose Expansion||0
8773438|NCT01286987|9823402|FG008|Treated|Part 2: Dose Expansion||0
8773439|NCT01286987|9823403|FG009|Treated|Part 2: Dose Expansion||12
8773440|NCT01286987|9823404|FG010|Treated|Part 2: Dose Expansion||11
8773441|NCT01286987|9823405|FG011|Treated|Part 2: Dose Expansion||10
8773442|NCT01286987|9823406|FG012|Treated|Part 2: Dose Expansion||12
8773443|NCT01286987|9823407|FG013|Treated|Part 2: Dose Expansion||23
8773444|NCT01286987|9823408|FG014|Treated|Part 2: Dose Expansion||3
8773445|NCT01286987|9823394|FG000|COMPLETED|Part 2: Dose Expansion||0
8773446|NCT01286987|9823395|FG001|COMPLETED|Part 2: Dose Expansion||0
8773447|NCT01286987|9823396|FG002|COMPLETED|Part 2: Dose Expansion||0
8773448|NCT01286987|9823397|FG003|COMPLETED|Part 2: Dose Expansion||0
8773449|NCT01286987|9823398|FG004|COMPLETED|Part 2: Dose Expansion||0
8773450|NCT01286987|9823399|FG005|COMPLETED|Part 2: Dose Expansion||0
8773451|NCT01286987|9823400|FG006|COMPLETED|Part 2: Dose Expansion||0
8773452|NCT01286987|9823401|FG007|COMPLETED|Part 2: Dose Expansion||0
8773453|NCT01286987|9823402|FG008|COMPLETED|Part 2: Dose Expansion||0
8773454|NCT01286987|9823403|FG009|COMPLETED|Part 2: Dose Expansion||1
8773455|NCT01286987|9823404|FG010|COMPLETED|Part 2: Dose Expansion||2
8773456|NCT01286987|9823405|FG011|COMPLETED|Part 2: Dose Expansion||1
8773457|NCT01286987|9823406|FG012|COMPLETED|Part 2: Dose Expansion||0
8773458|NCT01286987|9823407|FG013|COMPLETED|Part 2: Dose Expansion||0
8773459|NCT01286987|9823408|FG014|COMPLETED|Part 2: Dose Expansion||1
8773460|NCT01286987|9823394|FG000|NOT COMPLETED|Part 2: Dose Expansion||0
8773461|NCT01286987|9823395|FG001|NOT COMPLETED|Part 2: Dose Expansion||0
8773462|NCT01286987|9823396|FG002|NOT COMPLETED|Part 2: Dose Expansion||0
8773463|NCT01286987|9823397|FG003|NOT COMPLETED|Part 2: Dose Expansion||0
8773464|NCT01286987|9823398|FG004|NOT COMPLETED|Part 2: Dose Expansion||0
8773465|NCT01286987|9823399|FG005|NOT COMPLETED|Part 2: Dose Expansion||0
8773466|NCT01286987|9823400|FG006|NOT COMPLETED|Part 2: Dose Expansion||0
8773467|NCT01286987|9823401|FG007|NOT COMPLETED|Part 2: Dose Expansion||0
8773468|NCT01286987|9823402|FG008|NOT COMPLETED|Part 2: Dose Expansion||0
8773469|NCT01286987|9823403|FG009|NOT COMPLETED|Part 2: Dose Expansion||11
8773470|NCT01286987|9823404|FG010|NOT COMPLETED|Part 2: Dose Expansion||10
8773471|NCT01286987|9823405|FG011|NOT COMPLETED|Part 2: Dose Expansion||10
8773472|NCT01286987|9823406|FG012|NOT COMPLETED|Part 2: Dose Expansion||12
8773473|NCT01286987|9823407|FG013|NOT COMPLETED|Part 2: Dose Expansion||24
8773474|NCT01286987|9823408|FG014|NOT COMPLETED|Part 2: Dose Expansion||2
8773475|NCT01287013|9823452|FG000|STARTED|Overall Study||32
8773476|NCT01287013|9823453|FG001|STARTED|Overall Study||34
8773477|NCT01287013|9823454|FG002|STARTED|Overall Study||21
8773478|NCT01287013|9823452|FG000|COMPLETED|Overall Study||29
8773479|NCT01287013|9823453|FG001|COMPLETED|Overall Study||29
8773480|NCT01287013|9823454|FG002|COMPLETED|Overall Study||0
8773481|NCT01287013|9823452|FG000|NOT COMPLETED|Overall Study||3
8773482|NCT01287013|9823453|FG001|NOT COMPLETED|Overall Study||5
8773483|NCT01287013|9823454|FG002|NOT COMPLETED|Overall Study||21
8773484|NCT01287039|9823464|FG000|STARTED|Overall Study||244
8773485|NCT01287039|9823465|FG001|STARTED|Overall Study||245
8773486|NCT01287039|9823464|FG000|COMPLETED|Overall Study||215
8773487|NCT01287039|9823465|FG001|COMPLETED|Overall Study||218
8773488|NCT01287039|9823464|FG000|NOT COMPLETED|Overall Study||29
8773489|NCT01287039|9823465|FG001|NOT COMPLETED|Overall Study||27
8773490|NCT01287065|9823471|FG000|STARTED|Treatment Period 1||4
8773491|NCT01287065|9823472|FG001|STARTED|Treatment Period 1||4
8773492|NCT01287065|9823473|FG002|STARTED|Treatment Period 1||4
8773493|NCT01287065|9823474|FG003|STARTED|Treatment Period 1||4
8773494|NCT01287065|9823475|FG004|STARTED|Treatment Period 1||5
8773495|NCT01287065|9823476|FG005|STARTED|Treatment Period 1||5
8773496|NCT01287065|9823471|FG000|COMPLETED|Treatment Period 1||4
8773497|NCT01287065|9823472|FG001|COMPLETED|Treatment Period 1||4
8773498|NCT01287065|9823473|FG002|COMPLETED|Treatment Period 1||4
8773499|NCT01287065|9823474|FG003|COMPLETED|Treatment Period 1||4
8773500|NCT01287065|9823475|FG004|COMPLETED|Treatment Period 1||4
8773501|NCT01287065|9823476|FG005|COMPLETED|Treatment Period 1||4
8773502|NCT01287065|9823471|FG000|NOT COMPLETED|Treatment Period 1||0
8773503|NCT01287065|9823472|FG001|NOT COMPLETED|Treatment Period 1||0
8773504|NCT01287065|9823473|FG002|NOT COMPLETED|Treatment Period 1||0
8773505|NCT01287065|9823474|FG003|NOT COMPLETED|Treatment Period 1||0
8773506|NCT01287065|9823475|FG004|NOT COMPLETED|Treatment Period 1||1
8773507|NCT01287065|9823476|FG005|NOT COMPLETED|Treatment Period 1||1
8773508|NCT01287065|9823471|FG000|STARTED|Washout Period 1||4
8773509|NCT01287065|9823472|FG001|STARTED|Washout Period 1||4
8773510|NCT01287065|9823473|FG002|STARTED|Washout Period 1||4
8773511|NCT01287065|9823474|FG003|STARTED|Washout Period 1||4
8773512|NCT01287065|9823475|FG004|STARTED|Washout Period 1||4
8773513|NCT01287065|9823476|FG005|STARTED|Washout Period 1||4
8773514|NCT01287065|9823471|FG000|COMPLETED|Washout Period 1||4
8773515|NCT01287065|9823472|FG001|COMPLETED|Washout Period 1||4
8773516|NCT01287065|9823473|FG002|COMPLETED|Washout Period 1||4
8773517|NCT01287065|9823474|FG003|COMPLETED|Washout Period 1||4
8773518|NCT01287065|9823475|FG004|COMPLETED|Washout Period 1||4
8773519|NCT01287065|9823476|FG005|COMPLETED|Washout Period 1||4
8773520|NCT01287065|9823471|FG000|NOT COMPLETED|Washout Period 1||0
8773521|NCT01287065|9823472|FG001|NOT COMPLETED|Washout Period 1||0
8773522|NCT01287065|9823473|FG002|NOT COMPLETED|Washout Period 1||0
8773523|NCT01287065|9823474|FG003|NOT COMPLETED|Washout Period 1||0
8773524|NCT01287065|9823475|FG004|NOT COMPLETED|Washout Period 1||0
8773525|NCT01287065|9823476|FG005|NOT COMPLETED|Washout Period 1||0
8773526|NCT01287065|9823471|FG000|STARTED|Treatment Period 2||4
8773527|NCT01287065|9823472|FG001|STARTED|Treatment Period 2||4
8773528|NCT01287065|9823473|FG002|STARTED|Treatment Period 2||4
8773529|NCT01287065|9823474|FG003|STARTED|Treatment Period 2||4
8773530|NCT01287065|9823475|FG004|STARTED|Treatment Period 2||4
8773531|NCT01287065|9823476|FG005|STARTED|Treatment Period 2||4
8773532|NCT01287065|9823471|FG000|COMPLETED|Treatment Period 2||4
8773533|NCT01287065|9823472|FG001|COMPLETED|Treatment Period 2||4
8773534|NCT01287065|9823473|FG002|COMPLETED|Treatment Period 2||4
8773535|NCT01287065|9823474|FG003|COMPLETED|Treatment Period 2||4
8773536|NCT01287065|9823475|FG004|COMPLETED|Treatment Period 2||4
8773537|NCT01287065|9823476|FG005|COMPLETED|Treatment Period 2||4
8773538|NCT01287065|9823471|FG000|NOT COMPLETED|Treatment Period 2||0
8773539|NCT01287065|9823472|FG001|NOT COMPLETED|Treatment Period 2||0
8773540|NCT01287065|9823473|FG002|NOT COMPLETED|Treatment Period 2||0
8773541|NCT01287065|9823474|FG003|NOT COMPLETED|Treatment Period 2||0
8773542|NCT01287065|9823475|FG004|NOT COMPLETED|Treatment Period 2||0
8773543|NCT01287065|9823476|FG005|NOT COMPLETED|Treatment Period 2||0
8773544|NCT01287065|9823471|FG000|STARTED|Washout Period 2||4
8773545|NCT01287065|9823472|FG001|STARTED|Washout Period 2||4
8773546|NCT01287065|9823473|FG002|STARTED|Washout Period 2||4
8773547|NCT01287065|9823474|FG003|STARTED|Washout Period 2||4
8773548|NCT01287065|9823475|FG004|STARTED|Washout Period 2||4
8773549|NCT01287065|9823476|FG005|STARTED|Washout Period 2||4
8773550|NCT01287065|9823471|FG000|COMPLETED|Washout Period 2||4
8773551|NCT01287065|9823472|FG001|COMPLETED|Washout Period 2||4
8773552|NCT01287065|9823473|FG002|COMPLETED|Washout Period 2||4
8773553|NCT01287065|9823474|FG003|COMPLETED|Washout Period 2||4
8773554|NCT01287065|9823475|FG004|COMPLETED|Washout Period 2||4
8773555|NCT01287065|9823476|FG005|COMPLETED|Washout Period 2||4
8773556|NCT01287065|9823471|FG000|NOT COMPLETED|Washout Period 2||0
8773557|NCT01287065|9823472|FG001|NOT COMPLETED|Washout Period 2||0
8773558|NCT01287065|9823473|FG002|NOT COMPLETED|Washout Period 2||0
8773559|NCT01287065|9823474|FG003|NOT COMPLETED|Washout Period 2||0
8773560|NCT01287065|9823475|FG004|NOT COMPLETED|Washout Period 2||0
8773561|NCT01287065|9823476|FG005|NOT COMPLETED|Washout Period 2||0
8773562|NCT01287065|9823471|FG000|STARTED|Treatment Period 3||4
8773563|NCT01287065|9823472|FG001|STARTED|Treatment Period 3||4
8773564|NCT01287065|9823473|FG002|STARTED|Treatment Period 3||4
8773565|NCT01287065|9823474|FG003|STARTED|Treatment Period 3||4
8773566|NCT01287065|9823475|FG004|STARTED|Treatment Period 3||4
8773567|NCT01287065|9823476|FG005|STARTED|Treatment Period 3||4
8773568|NCT01287065|9823471|FG000|COMPLETED|Treatment Period 3||4
8773569|NCT01287065|9823472|FG001|COMPLETED|Treatment Period 3||4
8773570|NCT01287065|9823473|FG002|COMPLETED|Treatment Period 3||4
8773571|NCT01287065|9823474|FG003|COMPLETED|Treatment Period 3||4
8773572|NCT01287065|9823475|FG004|COMPLETED|Treatment Period 3||4
8773573|NCT01287065|9823476|FG005|COMPLETED|Treatment Period 3||4
8773574|NCT01287065|9823471|FG000|NOT COMPLETED|Treatment Period 3||0
8773575|NCT01287065|9823472|FG001|NOT COMPLETED|Treatment Period 3||0
8773576|NCT01287065|9823473|FG002|NOT COMPLETED|Treatment Period 3||0
8773577|NCT01287065|9823474|FG003|NOT COMPLETED|Treatment Period 3||0
8773578|NCT01287065|9823475|FG004|NOT COMPLETED|Treatment Period 3||0
8773579|NCT01287065|9823476|FG005|NOT COMPLETED|Treatment Period 3||0
8773580|NCT01287078|9823486|FG000|STARTED|Overall Study||20
8773581|NCT01287078|9823487|FG001|STARTED|Overall Study||3
8773582|NCT01287078|9823486|FG000|COMPLETED|Overall Study||10
8773583|NCT01287078|9823487|FG001|COMPLETED|Overall Study||1
8773584|NCT01287078|9823486|FG000|NOT COMPLETED|Overall Study||10
8773585|NCT01287078|9823487|FG001|NOT COMPLETED|Overall Study||2
8773586|NCT01287104|9823497|FG000|STARTED|Overall Study||4
8773587|NCT01287104|9823498|FG001|STARTED|Overall Study||7
8773588|NCT01287104|9823499|FG002|STARTED|Overall Study||12
8773589|NCT01287104|9823500|FG003|STARTED|Overall Study||11
8773590|NCT01287104|9823497|FG000|COMPLETED|Overall Study||3
8773591|NCT01287104|9823498|FG001|COMPLETED|Overall Study||2
8773592|NCT01287104|9823499|FG002|COMPLETED|Overall Study||5
8773593|NCT01287104|9823500|FG003|COMPLETED|Overall Study||8
8773594|NCT01287104|9823497|FG000|NOT COMPLETED|Overall Study||1
8773595|NCT01287104|9823498|FG001|NOT COMPLETED|Overall Study||5
8773596|NCT01287104|9823499|FG002|NOT COMPLETED|Overall Study||7
8773597|NCT01287104|9823500|FG003|NOT COMPLETED|Overall Study||3
8773598|NCT01287117|9823521|FG000|STARTED|Overall Study||80
8773599|NCT01287117|9823522|FG001|STARTED|Overall Study||78
8773600|NCT01287117|9823523|FG002|STARTED|Overall Study||80
8773601|NCT01287117|9823524|FG003|STARTED|Overall Study||81
8773602|NCT01287117|9823521|FG000|Received Treatment|Overall Study||80
8773603|NCT01287117|9823522|FG001|Received Treatment|Overall Study||77
8773604|NCT01287117|9823523|FG002|Received Treatment|Overall Study||80
8773605|NCT01287117|9823524|FG003|Received Treatment|Overall Study||81
8773606|NCT01287117|9823521|FG000|COMPLETED|Overall Study||65
8773607|NCT01287117|9823522|FG001|COMPLETED|Overall Study||64
8773608|NCT01287117|9823523|FG002|COMPLETED|Overall Study||64
8773609|NCT01287117|9823524|FG003|COMPLETED|Overall Study||69
8773610|NCT01287117|9823521|FG000|NOT COMPLETED|Overall Study||15
8773611|NCT01287117|9823522|FG001|NOT COMPLETED|Overall Study||14
8773612|NCT01287117|9823523|FG002|NOT COMPLETED|Overall Study||16
8773613|NCT01287117|9823524|FG003|NOT COMPLETED|Overall Study||12
8773614|NCT01287195|9823534|FG000|STARTED|Overall Study||6
8773615|NCT01287195|9823534|FG000|COMPLETED|Overall Study||4
8773616|NCT01287195|9823534|FG000|NOT COMPLETED|Overall Study||2
8773617|NCT01287208|9823540|FG000|STARTED|Phase 1: Randomized Phase||52
8773618|NCT01287208|9823541|FG001|STARTED|Phase 1: Randomized Phase||52
8773619|NCT01287208|9823540|FG000|COMPLETED|Phase 1: Randomized Phase||50
8773620|NCT01287208|9823541|FG001|COMPLETED|Phase 1: Randomized Phase||49
8773621|NCT01287208|9823540|FG000|NOT COMPLETED|Phase 1: Randomized Phase||2
8773622|NCT01287208|9823541|FG001|NOT COMPLETED|Phase 1: Randomized Phase||3
8773623|NCT01287208|9823540|FG000|STARTED|Phase 2: Team Competition||50
8773624|NCT01287208|9823541|FG001|STARTED|Phase 2: Team Competition||49
8773625|NCT01287208|9823540|FG000|COMPLETED|Phase 2: Team Competition||50
8773626|NCT01287208|9823541|FG001|COMPLETED|Phase 2: Team Competition||49
8773627|NCT01287208|9823540|FG000|NOT COMPLETED|Phase 2: Team Competition||0
8773628|NCT01287208|9823541|FG001|NOT COMPLETED|Phase 2: Team Competition||0
8773629|NCT01287221|9823551|FG000|STARTED|Overall Study||50
8773630|NCT01287221|9823552|FG001|STARTED|Overall Study||50
8773631|NCT01287221|9823551|FG000|Completed 3 Months Follow-up|Overall Study||49
8773632|NCT01287221|9823552|FG001|Completed 3 Months Follow-up|Overall Study||50
8773633|NCT01287221|9823551|FG000|Completed 6 Months Follow-up|Overall Study||47
8773634|NCT01287221|9823552|FG001|Completed 6 Months Follow-up|Overall Study||43
8773635|NCT01287221|9823551|FG000|Completed 9 Months Follow-up|Overall Study||42
8773636|NCT01287221|9823552|FG001|Completed 9 Months Follow-up|Overall Study||40
8773637|NCT01287221|9823551|FG000|Completed 12 Months Follow-up|Overall Study||40
8773638|NCT01287221|9823552|FG001|Completed 12 Months Follow-up|Overall Study||39
8773639|NCT01287221|9823551|FG000|COMPLETED|Overall Study||46
8773640|NCT01287221|9823552|FG001|COMPLETED|Overall Study||45
8773641|NCT01287221|9823551|FG000|NOT COMPLETED|Overall Study||4
8773642|NCT01287221|9823552|FG001|NOT COMPLETED|Overall Study||5
8773643|NCT01287364|9823560|FG000|STARTED|Overall Study||94
8773644|NCT01287364|9823561|FG001|STARTED|Overall Study||91
8773645|NCT01287364|9823560|FG000|COMPLETED|Overall Study||85
8773646|NCT01287364|9823561|FG001|COMPLETED|Overall Study||81
8773647|NCT01287364|9823560|FG000|NOT COMPLETED|Overall Study||9
8773648|NCT01287364|9823561|FG001|NOT COMPLETED|Overall Study||10
8773649|NCT01287377|9823583|FG000|STARTED|Overall Study||80
8916182|NCT02181296|9975739|FG000|COMPLETED|Overall Study||18
8916183|NCT02181296|9975740|FG001|COMPLETED|Overall Study||19
8916184|NCT02181296|9975739|FG000|NOT COMPLETED|Overall Study||7
8916185|NCT02181296|9975740|FG001|NOT COMPLETED|Overall Study||6
8916186|NCT02181387|9975748|FG000|STARTED|Overall Study||14
8916187|NCT02181387|9975749|FG001|STARTED|Overall Study||19
8916188|NCT02181387|9975748|FG000|COMPLETED|Overall Study||12
8916189|NCT02181387|9975749|FG001|COMPLETED|Overall Study||15
8916190|NCT02181387|9975748|FG000|NOT COMPLETED|Overall Study||2
8916191|NCT02181387|9975749|FG001|NOT COMPLETED|Overall Study||4
8916192|NCT02181400|9975758|FG000|STARTED|Overall Study||7
8916193|NCT02181400|9975759|FG001|STARTED|Overall Study||7
8916194|NCT02181400|9975760|FG002|STARTED|Overall Study||7
8916195|NCT02181400|9975758|FG000|COMPLETED|Overall Study||7
8916196|NCT02181400|9975759|FG001|COMPLETED|Overall Study||7
8916197|NCT02181400|9975760|FG002|COMPLETED|Overall Study||7
8916198|NCT02181400|9975758|FG000|NOT COMPLETED|Overall Study||0
8916199|NCT02181400|9975759|FG001|NOT COMPLETED|Overall Study||0
8916200|NCT02181400|9975760|FG002|NOT COMPLETED|Overall Study||0
8916201|NCT02181426|9975772|FG000|STARTED|Overall Study||28
8916202|NCT02181426|9975773|FG001|STARTED|Overall Study||28
8916203|NCT02181426|9975774|FG002|STARTED|Overall Study||28
8916204|NCT02181426|9975775|FG003|STARTED|Overall Study||28
8916205|NCT02181426|9975772|FG000|COMPLETED|Overall Study||28
8916206|NCT02181426|9975773|FG001|COMPLETED|Overall Study||28
8916207|NCT02181426|9975774|FG002|COMPLETED|Overall Study||28
9028612|NCT03207243|10091059|FG001|STARTED|Overall Study||83
8773650|NCT01287377|9823584|FG001|STARTED|Overall Study||81
8773651|NCT01287377|9823585|FG002|STARTED|Overall Study||82
8916208|NCT02181426|9975775|FG003|COMPLETED|Overall Study||28
8773652|NCT01287377|9823583|FG000|COMPLETED|Overall Study|Study Complete|80
8773653|NCT01287377|9823584|FG001|COMPLETED|Overall Study|Study Complete|81
8773654|NCT01287377|9823585|FG002|COMPLETED|Overall Study|Study Complete|82
8773655|NCT01287377|9823583|FG000|NOT COMPLETED|Overall Study||0
8773656|NCT01287377|9823584|FG001|NOT COMPLETED|Overall Study||0
8773657|NCT01287377|9823585|FG002|NOT COMPLETED|Overall Study||0
8773658|NCT01287403|9823593|FG000|STARTED|Diet Restriction (7 Days)||14
8773659|NCT01287403|9823593|FG000|COMPLETED|Diet Restriction (7 Days)||14
8773660|NCT01287403|9823593|FG000|NOT COMPLETED|Diet Restriction (7 Days)||0
8773661|NCT01287403|9823593|FG000|STARTED|1st Intervention (1 Day)||14
8773662|NCT01287403|9823593|FG000|COMPLETED|1st Intervention (1 Day)|"The adverse event was linked to the intake of refined wheat flour"|13
8773663|NCT01287403|9823593|FG000|NOT COMPLETED|1st Intervention (1 Day)||1
8773664|NCT01287403|9823593|FG000|STARTED|Washout 7 Days||13
8773665|NCT01287403|9823593|FG000|COMPLETED|Washout 7 Days||13
8773666|NCT01287403|9823593|FG000|NOT COMPLETED|Washout 7 Days||0
8773667|NCT01287403|9823593|FG000|STARTED|2nd Intervention (1 Day)||13
8773668|NCT01287403|9823593|FG000|COMPLETED|2nd Intervention (1 Day)||13
8773669|NCT01287403|9823593|FG000|NOT COMPLETED|2nd Intervention (1 Day)||0
8773670|NCT01287403|9823593|FG000|STARTED|Washout (7 Days)||13
8773671|NCT01287403|9823593|FG000|COMPLETED|Washout (7 Days)||13
8773672|NCT01287403|9823593|FG000|NOT COMPLETED|Washout (7 Days)||0
8773673|NCT01287403|9823593|FG000|STARTED|3rd Intervention (1 Day)||13
8773674|NCT01287403|9823593|FG000|COMPLETED|3rd Intervention (1 Day)||13
8773675|NCT01287403|9823593|FG000|NOT COMPLETED|3rd Intervention (1 Day)||0
8773676|NCT01287403|9823593|FG000|STARTED|Washout (7 Days)||13
8773677|NCT01287403|9823593|FG000|COMPLETED|Washout (7 Days)||13
8773678|NCT01287403|9823593|FG000|NOT COMPLETED|Washout (7 Days)||0
8773679|NCT01287403|9823593|FG000|STARTED|4th Intervention (1 Day)||13
8773680|NCT01287403|9823593|FG000|COMPLETED|4th Intervention (1 Day)||13
8773681|NCT01287403|9823593|FG000|NOT COMPLETED|4th Intervention (1 Day)||0
8773682|NCT01287403|9823593|FG000|STARTED|Washout (7 Days)||13
8773683|NCT01287403|9823593|FG000|COMPLETED|Washout (7 Days)||13
8773684|NCT01287403|9823593|FG000|NOT COMPLETED|Washout (7 Days)||0
8773685|NCT01287403|9823593|FG000|STARTED|5th Intervention (1 Day)||13
8773686|NCT01287403|9823593|FG000|COMPLETED|5th Intervention (1 Day)||13
8773687|NCT01287403|9823593|FG000|NOT COMPLETED|5th Intervention (1 Day)||0
8773688|NCT01287403|9823593|FG000|STARTED|Washout (7 Days)||13
8773689|NCT01287403|9823593|FG000|COMPLETED|Washout (7 Days)||13
8773690|NCT01287403|9823593|FG000|NOT COMPLETED|Washout (7 Days)||0
8773691|NCT01287403|9823593|FG000|STARTED|6th and Last Intervention (1 Day)||13
8773692|NCT01287403|9823593|FG000|COMPLETED|6th and Last Intervention (1 Day)||13
8773693|NCT01287403|9823593|FG000|NOT COMPLETED|6th and Last Intervention (1 Day)||0
8773694|NCT01287416|9823609|FG000|STARTED|Pre-post Training|number of people that were invited to participate based on eligibility and consent received|48
8773695|NCT01287416|9823610|FG001|STARTED|Pre-post Training|number of people that were invited to participate based on eligibility and consent received|48
8773696|NCT01287416|9823609|FG000|Training Workshop|Pre-post Training|number of people that showed up for the training session|31
8773697|NCT01287416|9823610|FG001|Training Workshop|Pre-post Training|number of people that showed up for the training session|24
8773698|NCT01287416|9823609|FG000|Post Training Questionnaire|Pre-post Training||26
8773699|NCT01287416|9823610|FG001|Post Training Questionnaire|Pre-post Training||23
8773700|NCT01287416|9823609|FG000|COMPLETED|Pre-post Training||26
8773701|NCT01287416|9823610|FG001|COMPLETED|Pre-post Training||23
8773702|NCT01287416|9823609|FG000|NOT COMPLETED|Pre-post Training||22
8773703|NCT01287416|9823610|FG001|NOT COMPLETED|Pre-post Training||25
8773704|NCT01287416|9823609|FG000|STARTED|6 Month Follow-up|all participants that had completed the baseline measure were invited to do the follow-up|31
8773705|NCT01287416|9823610|FG001|STARTED|6 Month Follow-up|all participants that had completed the baseline measure were invited to do the follow-up|24
8773706|NCT01287416|9823609|FG000|COMPLETED|6 Month Follow-up||28
8773707|NCT01287416|9823610|FG001|COMPLETED|6 Month Follow-up||22
8773708|NCT01287416|9823609|FG000|NOT COMPLETED|6 Month Follow-up||3
8773709|NCT01287416|9823610|FG001|NOT COMPLETED|6 Month Follow-up||2
8773710|NCT01287520|9823625|FG000|STARTED|Overall Study||3
8773711|NCT01287520|9823626|FG001|STARTED|Overall Study|One participant who received study drug but did not complete Cycle 1 was replaced.|7
8773712|NCT01287520|9823627|FG002|STARTED|Overall Study||5
8773713|NCT01287520|9823628|FG003|STARTED|Overall Study|One participant who received study drug but did not complete Cycle 1 was replaced.|7
8773714|NCT01287520|9823629|FG004|STARTED|Overall Study||3
8773715|NCT01287520|9823630|FG005|STARTED|Overall Study||4
8773716|NCT01287520|9823631|FG006|STARTED|Overall Study||2
8773717|NCT01287520|9823632|FG007|STARTED|Overall Study||5
8773718|NCT01287520|9823633|FG008|STARTED|Overall Study||5
8773719|NCT01287520|9823625|FG000|COMPLETED|Overall Study||0
8773720|NCT01287520|9823626|FG001|COMPLETED|Overall Study||0
8773721|NCT01287520|9823627|FG002|COMPLETED|Overall Study||0
8773722|NCT01287520|9823628|FG003|COMPLETED|Overall Study||0
8773723|NCT01287520|9823629|FG004|COMPLETED|Overall Study||0
8773724|NCT01287520|9823630|FG005|COMPLETED|Overall Study||0
8773725|NCT01287520|9823631|FG006|COMPLETED|Overall Study||0
8773726|NCT01287520|9823632|FG007|COMPLETED|Overall Study||0
8773727|NCT01287520|9823633|FG008|COMPLETED|Overall Study||0
8773728|NCT01287520|9823625|FG000|NOT COMPLETED|Overall Study||3
8773729|NCT01287520|9823626|FG001|NOT COMPLETED|Overall Study||7
8773730|NCT01287520|9823627|FG002|NOT COMPLETED|Overall Study||5
8773731|NCT01287520|9823628|FG003|NOT COMPLETED|Overall Study||7
8773732|NCT01287520|9823629|FG004|NOT COMPLETED|Overall Study||3
8773733|NCT01287520|9823630|FG005|NOT COMPLETED|Overall Study||4
8773734|NCT01287520|9823631|FG006|NOT COMPLETED|Overall Study||2
8773735|NCT01287520|9823632|FG007|NOT COMPLETED|Overall Study||5
8773736|NCT01287520|9823633|FG008|NOT COMPLETED|Overall Study||5
8773737|NCT01287754|9823684|FG000|STARTED|Overall Study||3
8773738|NCT01287754|9823685|FG001|STARTED|Overall Study||21
8773739|NCT01287754|9823684|FG000|COMPLETED|Overall Study||0
8773740|NCT01287754|9823685|FG001|COMPLETED|Overall Study||0
8773741|NCT01287754|9823684|FG000|NOT COMPLETED|Overall Study||3
8773742|NCT01287754|9823685|FG001|NOT COMPLETED|Overall Study||21
8773743|NCT01287832|9823693|FG000|STARTED|Overall Study||6
8773744|NCT01287832|9823694|FG001|STARTED|Overall Study||5
8773745|NCT01287832|9823693|FG000|COMPLETED|Overall Study||5
8773746|NCT01287832|9823694|FG001|COMPLETED|Overall Study||4
8773747|NCT01287832|9823693|FG000|NOT COMPLETED|Overall Study||1
8773748|NCT01287832|9823694|FG001|NOT COMPLETED|Overall Study||1
8773749|NCT01287897|9823704|FG000|STARTED|Overall Study||70
8773750|NCT01287897|9823705|FG001|STARTED|Overall Study||69
8773751|NCT01287897|9823706|FG002|STARTED|Overall Study||71
8773752|NCT01287897|9823707|FG003|STARTED|Overall Study|Enrollment was halted before reaching the planned sample size due to safety findings in NCT01405196.|40
9028613|NCT03207243|10091058|FG000|COMPLETED|Overall Study||23
9028614|NCT03207243|10091059|FG001|COMPLETED|Overall Study||39
9028615|NCT03207243|10091058|FG000|NOT COMPLETED|Overall Study||59
9028616|NCT03207243|10091059|FG001|NOT COMPLETED|Overall Study||44
9028617|NCT03207386|10091066|FG000|STARTED|Overall Study||2647
9028618|NCT03207386|10091066|FG000|COMPLETED|Overall Study||1487
9028619|NCT03207386|10091066|FG000|NOT COMPLETED|Overall Study||1160
9028620|NCT03207399|10091073|FG000|STARTED|Overall Study||1
9028621|NCT03207399|10091073|FG000|COMPLETED|Overall Study||1
9028622|NCT03207399|10091073|FG000|NOT COMPLETED|Overall Study||0
9028623|NCT03207438|10091081|FG000|STARTED|Overall Study||167
9028624|NCT03207438|10091082|FG001|STARTED|Overall Study||166
9028625|NCT03207438|10091083|FG002|STARTED|Overall Study||875
9028626|NCT03207438|10091084|FG003|STARTED|Overall Study||582
9028627|NCT03207438|10091081|FG000|COMPLETED|Overall Study||148
9028628|NCT03207438|10091082|FG001|COMPLETED|Overall Study||145
9028629|NCT03207438|10091083|FG002|COMPLETED|Overall Study||643
9028630|NCT03207438|10091084|FG003|COMPLETED|Overall Study||470
9028631|NCT03207438|10091081|FG000|NOT COMPLETED|Overall Study||19
9028632|NCT03207438|10091082|FG001|NOT COMPLETED|Overall Study||21
9028633|NCT03207438|10091083|FG002|NOT COMPLETED|Overall Study||232
9028634|NCT03207438|10091084|FG003|NOT COMPLETED|Overall Study||112
9028635|NCT03207750|10091099|FG000|STARTED|Overall Study||632
9028636|NCT03207750|10091100|FG001|STARTED|Overall Study||640
9028637|NCT03207750|10091099|FG000|COMPLETED|Overall Study||574
9028638|NCT03207750|10091100|FG001|COMPLETED|Overall Study||574
9028639|NCT03207750|10091099|FG000|NOT COMPLETED|Overall Study||58
9028640|NCT03207750|10091100|FG001|NOT COMPLETED|Overall Study||66
9028641|NCT03207763|10091108|FG000|STARTED|Overall Study||8
9028642|NCT03207763|10091109|FG001|STARTED|Overall Study||25
9028643|NCT03207763|10091108|FG000|Eligible and Opted for Patches 2 and 3|Overall Study||5
9028644|NCT03207763|10091109|FG001|Eligible and Opted for Patches 2 and 3|Overall Study||23
9028645|NCT03207763|10091108|FG000|Completed Patches 2 and 3 Study|Overall Study||5
9028646|NCT03207763|10091109|FG001|Completed Patches 2 and 3 Study|Overall Study||23
9028647|NCT03207763|10091108|FG000|COMPLETED|Overall Study||7
9028648|NCT03207763|10091109|FG001|COMPLETED|Overall Study||25
9028649|NCT03207763|10091108|FG000|NOT COMPLETED|Overall Study||1
9028650|NCT03207763|10091109|FG001|NOT COMPLETED|Overall Study||0
8773753|NCT01287897|9823704|FG000|Treated|Overall Study||69
9028651|NCT03208088|10091124|FG000|STARTED|Period 1||10
9028652|NCT03208088|10091125|FG001|STARTED|Period 1||9
9028653|NCT03208088|10091126|FG002|STARTED|Period 1||10
9028654|NCT03208088|10091127|FG003|STARTED|Period 1||9
9028655|NCT03208088|10091128|FG004|STARTED|Period 1||9
9028656|NCT03208088|10091129|FG005|STARTED|Period 1||9
9028657|NCT03208088|10091130|FG006|STARTED|Period 1||8
9028658|NCT03208088|10091131|FG007|STARTED|Period 1||10
9028659|NCT03208088|10091132|FG008|STARTED|Period 1||8
9028660|NCT03208088|10091133|FG009|STARTED|Period 1||9
9028661|NCT03208088|10091124|FG000|COMPLETED|Period 1||10
9028662|NCT03208088|10091125|FG001|COMPLETED|Period 1||9
9028663|NCT03208088|10091126|FG002|COMPLETED|Period 1||10
9028664|NCT03208088|10091127|FG003|COMPLETED|Period 1||9
9028665|NCT03208088|10091128|FG004|COMPLETED|Period 1||9
9028666|NCT03208088|10091129|FG005|COMPLETED|Period 1||9
9028667|NCT03208088|10091130|FG006|COMPLETED|Period 1||8
8773754|NCT01287897|9823705|FG001|Treated|Overall Study||67
8773755|NCT01287897|9823706|FG002|Treated|Overall Study||71
9028668|NCT03208088|10091131|FG007|COMPLETED|Period 1||10
9028669|NCT03208088|10091132|FG008|COMPLETED|Period 1||8
9028670|NCT03208088|10091133|FG009|COMPLETED|Period 1||9
9028671|NCT03208088|10091124|FG000|NOT COMPLETED|Period 1||0
9028672|NCT03208088|10091125|FG001|NOT COMPLETED|Period 1||0
9028673|NCT03208088|10091126|FG002|NOT COMPLETED|Period 1||0
9028674|NCT03208088|10091127|FG003|NOT COMPLETED|Period 1||0
9028675|NCT03208088|10091128|FG004|NOT COMPLETED|Period 1||0
9028676|NCT03208088|10091129|FG005|NOT COMPLETED|Period 1||0
9028677|NCT03208088|10091130|FG006|NOT COMPLETED|Period 1||0
9028678|NCT03208088|10091131|FG007|NOT COMPLETED|Period 1||0
9028679|NCT03208088|10091132|FG008|NOT COMPLETED|Period 1||0
9028680|NCT03208088|10091133|FG009|NOT COMPLETED|Period 1||0
8773756|NCT01287897|9823707|FG003|Treated|Overall Study||40
8773757|NCT01287897|9823704|FG000|Completed Treatment Period|Overall Study||58
8773758|NCT01287897|9823705|FG001|Completed Treatment Period|Overall Study||52
8773759|NCT01287897|9823706|FG002|Completed Treatment Period|Overall Study||58
8773760|NCT01287897|9823707|FG003|Completed Treatment Period|Overall Study||29
8773761|NCT01287897|9823704|FG000|Completed Follow-up Period|Overall Study||3
8773762|NCT01287897|9823705|FG001|Completed Follow-up Period|Overall Study||8
8773763|NCT01287897|9823706|FG002|Completed Follow-up Period|Overall Study||3
8773764|NCT01287897|9823707|FG003|Completed Follow-up Period|Overall Study||4
8773765|NCT01287897|9823704|FG000|Enrolled in NCT01345318|Overall Study||56
8773766|NCT01287897|9823705|FG001|Enrolled in NCT01345318|Overall Study||50
8773767|NCT01287897|9823706|FG002|Enrolled in NCT01345318|Overall Study||56
8773768|NCT01287897|9823707|FG003|Enrolled in NCT01345318|Overall Study||29
8773769|NCT01287897|9823704|FG000|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|59
8773770|NCT01287897|9823705|FG001|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|58
8773771|NCT01287897|9823706|FG002|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|59
8773772|NCT01287897|9823707|FG003|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|33
8773773|NCT01287897|9823704|FG000|NOT COMPLETED|Overall Study||11
8773774|NCT01287897|9823705|FG001|NOT COMPLETED|Overall Study||11
8773775|NCT01287897|9823706|FG002|NOT COMPLETED|Overall Study||12
8773776|NCT01287897|9823707|FG003|NOT COMPLETED|Overall Study||7
8773777|NCT01288027|9823721|FG000|STARTED|Overall Study||16
8773778|NCT01288027|9823721|FG000|Full Analysis Set (FAS)|Overall Study|All participants who received at least 1 complete infusion of alglucosidase alfa.|16
8773779|NCT01288027|9823721|FG000|COMPLETED|Overall Study||16
8773780|NCT01288027|9823721|FG000|NOT COMPLETED|Overall Study||0
8773781|NCT01288053|9823725|FG000|STARTED|Overall Study||9
8773782|NCT01288053|9823725|FG000|COMPLETED|Overall Study||8
8773783|NCT01288053|9823725|FG000|NOT COMPLETED|Overall Study||1
8773784|NCT01288079|9823733|FG000|STARTED|Overall Study||37
8773785|NCT01288079|9823734|FG001|STARTED|Overall Study||36
8773786|NCT01288079|9823735|FG002|STARTED|Overall Study||37
8773787|NCT01288079|9823736|FG003|STARTED|Overall Study||35
8773788|NCT01288079|9823733|FG000|COMPLETED|Overall Study||17
8773789|NCT01288079|9823734|FG001|COMPLETED|Overall Study||9
8773790|NCT01288079|9823735|FG002|COMPLETED|Overall Study||18
8773791|NCT01288079|9823736|FG003|COMPLETED|Overall Study||18
8773792|NCT01288079|9823733|FG000|NOT COMPLETED|Overall Study||20
8773793|NCT01288079|9823734|FG001|NOT COMPLETED|Overall Study||27
8773794|NCT01288079|9823735|FG002|NOT COMPLETED|Overall Study||19
8773795|NCT01288079|9823736|FG003|NOT COMPLETED|Overall Study||17
8773796|NCT01288209|9823748|FG000|STARTED|Overall Study||53
8773797|NCT01288209|9823749|FG001|STARTED|Overall Study||53
8773798|NCT01288209|9823748|FG000|COMPLETED|Overall Study||51
8773799|NCT01288209|9823749|FG001|COMPLETED|Overall Study||50
8773800|NCT01288209|9823748|FG000|NOT COMPLETED|Overall Study||2
8773801|NCT01288209|9823749|FG001|NOT COMPLETED|Overall Study||3
8773802|NCT01288287|9823755|FG000|STARTED|Overall Study||149
8773803|NCT01288287|9823755|FG000|Safety Set|Overall Study||147
8773804|NCT01288287|9823755|FG000|Full Analysis Set|Overall Study||111
8773805|NCT01288287|9823755|FG000|COMPLETED|Overall Study||103
8773806|NCT01288287|9823755|FG000|NOT COMPLETED|Overall Study||46
8916209|NCT02181426|9975772|FG000|NOT COMPLETED|Overall Study||0
8916210|NCT02181426|9975773|FG001|NOT COMPLETED|Overall Study||0
8916211|NCT02181426|9975774|FG002|NOT COMPLETED|Overall Study||0
8916212|NCT02181426|9975775|FG003|NOT COMPLETED|Overall Study||0
8916213|NCT02181504|9975788|FG000|STARTED|Overall Study||10
8916214|NCT02181504|9975789|FG001|STARTED|Overall Study||10
8916215|NCT02181504|9975790|FG002|STARTED|Overall Study||5
8916216|NCT02181504|9975788|FG000|COMPLETED|Overall Study||9
8916217|NCT02181504|9975789|FG001|COMPLETED|Overall Study||9
8916218|NCT02181504|9975790|FG002|COMPLETED|Overall Study||4
8916219|NCT02181504|9975788|FG000|NOT COMPLETED|Overall Study||1
8916220|NCT02181504|9975789|FG001|NOT COMPLETED|Overall Study||1
8916221|NCT02181504|9975790|FG002|NOT COMPLETED|Overall Study||1
8916222|NCT02181517|9975802|FG000|STARTED|Overall Study||10
8916223|NCT02181517|9975803|FG001|STARTED|Overall Study||10
8916224|NCT02181517|9975804|FG002|STARTED|Overall Study||5
8916225|NCT02181517|9975802|FG000|COMPLETED|Overall Study||10
8916226|NCT02181517|9975803|FG001|COMPLETED|Overall Study||10
8916227|NCT02181517|9975804|FG002|COMPLETED|Overall Study||5
8916228|NCT02181517|9975802|FG000|NOT COMPLETED|Overall Study||0
8916229|NCT02181517|9975803|FG001|NOT COMPLETED|Overall Study||0
8916230|NCT02181517|9975804|FG002|NOT COMPLETED|Overall Study||0
8916231|NCT02181530|9975812|FG000|STARTED|Overall Study||43
8916232|NCT02181530|9975812|FG000|COMPLETED|Overall Study||43
8916233|NCT02181530|9975812|FG000|NOT COMPLETED|Overall Study||0
8916234|NCT02181556|9975816|FG000|STARTED|Overall Study||41
8916235|NCT02181556|9975816|FG000|COMPLETED|Overall Study||40
8916236|NCT02181556|9975816|FG000|NOT COMPLETED|Overall Study||1
8916237|NCT02181634|9975820|FG000|STARTED|Overall Study||74
8916238|NCT02181634|9975820|FG000|Eligible and Treated|Overall Study||73
8916239|NCT02181634|9975820|FG000|COMPLETED|Overall Study||2
8916240|NCT02181634|9975820|FG000|NOT COMPLETED|Overall Study||72
8916241|NCT02181673|9975826|FG000|STARTED|Up to Week 24||239
8916242|NCT02181673|9975827|FG001|STARTED|Up to Week 24||0
8916243|NCT02181673|9975828|FG002|STARTED|Up to Week 24||241
8773807|NCT01288430|9823770|FG000|STARTED|Part 1||2
8773808|NCT01288430|9823771|FG001|STARTED|Part 1||3
8773809|NCT01288430|9823772|FG002|STARTED|Part 1||5
8773810|NCT01288430|9823773|FG003|STARTED|Part 1||7
8773811|NCT01288430|9823774|FG004|STARTED|Part 1||3
8773812|NCT01288430|9823775|FG005|STARTED|Part 1||6
8773813|NCT01288430|9823776|FG006|STARTED|Part 1||7
8773814|NCT01288430|9823777|FG007|STARTED|Part 1||0
8773815|NCT01288430|9823778|FG008|STARTED|Part 1||0
8773816|NCT01288430|9823779|FG009|STARTED|Part 1||0
8773817|NCT01288430|9823770|FG000|COMPLETED|Part 1||0
8773818|NCT01288430|9823771|FG001|COMPLETED|Part 1||0
8773819|NCT01288430|9823772|FG002|COMPLETED|Part 1||0
8773820|NCT01288430|9823773|FG003|COMPLETED|Part 1||0
8773821|NCT01288430|9823774|FG004|COMPLETED|Part 1||0
8773822|NCT01288430|9823775|FG005|COMPLETED|Part 1||0
8773823|NCT01288430|9823776|FG006|COMPLETED|Part 1||0
8773824|NCT01288430|9823777|FG007|COMPLETED|Part 1||0
8773825|NCT01288430|9823778|FG008|COMPLETED|Part 1||0
8773826|NCT01288430|9823779|FG009|COMPLETED|Part 1||0
8773827|NCT01288430|9823770|FG000|NOT COMPLETED|Part 1||2
8773828|NCT01288430|9823771|FG001|NOT COMPLETED|Part 1||3
8773829|NCT01288430|9823772|FG002|NOT COMPLETED|Part 1||5
8773830|NCT01288430|9823773|FG003|NOT COMPLETED|Part 1||7
8773831|NCT01288430|9823774|FG004|NOT COMPLETED|Part 1||3
8773832|NCT01288430|9823775|FG005|NOT COMPLETED|Part 1||6
8773833|NCT01288430|9823776|FG006|NOT COMPLETED|Part 1||7
8773834|NCT01288430|9823777|FG007|NOT COMPLETED|Part 1||0
8773835|NCT01288430|9823778|FG008|NOT COMPLETED|Part 1||0
8773836|NCT01288430|9823779|FG009|NOT COMPLETED|Part 1||0
8773837|NCT01288430|9823770|FG000|STARTED|Part 2||0
8773838|NCT01288430|9823771|FG001|STARTED|Part 2||0
8773839|NCT01288430|9823772|FG002|STARTED|Part 2||0
8773840|NCT01288430|9823773|FG003|STARTED|Part 2||0
8773841|NCT01288430|9823774|FG004|STARTED|Part 2||0
8773842|NCT01288430|9823775|FG005|STARTED|Part 2||0
8773843|NCT01288430|9823776|FG006|STARTED|Part 2||0
8773844|NCT01288430|9823777|FG007|STARTED|Part 2||12
8773845|NCT01288430|9823778|FG008|STARTED|Part 2||12
8773846|NCT01288430|9823779|FG009|STARTED|Part 2||3
8773847|NCT01288430|9823770|FG000|COMPLETED|Part 2||0
8773848|NCT01288430|9823771|FG001|COMPLETED|Part 2||0
8773849|NCT01288430|9823772|FG002|COMPLETED|Part 2||0
8773850|NCT01288430|9823773|FG003|COMPLETED|Part 2||0
8773851|NCT01288430|9823774|FG004|COMPLETED|Part 2||0
8773852|NCT01288430|9823775|FG005|COMPLETED|Part 2||0
8773853|NCT01288430|9823776|FG006|COMPLETED|Part 2||0
8773854|NCT01288430|9823777|FG007|COMPLETED|Part 2||0
8773855|NCT01288430|9823778|FG008|COMPLETED|Part 2||0
8773856|NCT01288430|9823779|FG009|COMPLETED|Part 2||0
8773857|NCT01288430|9823770|FG000|NOT COMPLETED|Part 2||0
8773858|NCT01288430|9823771|FG001|NOT COMPLETED|Part 2||0
8773859|NCT01288430|9823772|FG002|NOT COMPLETED|Part 2||0
8773860|NCT01288430|9823773|FG003|NOT COMPLETED|Part 2||0
8773861|NCT01288430|9823774|FG004|NOT COMPLETED|Part 2||0
8773862|NCT01288430|9823775|FG005|NOT COMPLETED|Part 2||0
8773863|NCT01288430|9823776|FG006|NOT COMPLETED|Part 2||0
8916244|NCT02181673|9975826|FG000|Treated|Up to Week 24||239
8916245|NCT02181673|9975827|FG001|Treated|Up to Week 24||0
8916246|NCT02181673|9975828|FG002|Treated|Up to Week 24||240
8916247|NCT02181673|9975826|FG000|COMPLETED|Up to Week 24||222
8916248|NCT02181673|9975827|FG001|COMPLETED|Up to Week 24||0
8916249|NCT02181673|9975828|FG002|COMPLETED|Up to Week 24||230
8916250|NCT02181673|9975826|FG000|NOT COMPLETED|Up to Week 24||17
8916251|NCT02181673|9975827|FG001|NOT COMPLETED|Up to Week 24||0
9028681|NCT03208088|10091124|FG000|STARTED|Period 2||10
9028682|NCT03208088|10091125|FG001|STARTED|Period 2||9
9028683|NCT03208088|10091126|FG002|STARTED|Period 2||10
9028684|NCT03208088|10091127|FG003|STARTED|Period 2||9
9028685|NCT03208088|10091128|FG004|STARTED|Period 2||9
9028686|NCT03208088|10091129|FG005|STARTED|Period 2||9
9028687|NCT03208088|10091130|FG006|STARTED|Period 2||8
9028688|NCT03208088|10091131|FG007|STARTED|Period 2||10
8773864|NCT01288430|9823777|FG007|NOT COMPLETED|Part 2||12
8773865|NCT01288430|9823778|FG008|NOT COMPLETED|Part 2||12
8773866|NCT01288430|9823779|FG009|NOT COMPLETED|Part 2||3
8773867|NCT01288443|9823812|FG000|STARTED|Overall Study|Randomized|31
8773868|NCT01288443|9823813|FG001|STARTED|Overall Study|Randomized|30
8916252|NCT02181673|9975828|FG002|NOT COMPLETED|Up to Week 24||11
8773869|NCT01288443|9823814|FG002|STARTED|Overall Study|Randomized|31
8773870|NCT01288443|9823815|FG003|STARTED|Overall Study|Randomized|31
8773871|NCT01288443|9823816|FG004|STARTED|Overall Study|Randomized|30
8773872|NCT01288443|9823817|FG005|STARTED|Overall Study|Randomized|30
8773873|NCT01288443|9823812|FG000|Treated|Overall Study||31
8773874|NCT01288443|9823813|FG001|Treated|Overall Study||30
8773875|NCT01288443|9823814|FG002|Treated|Overall Study||31
8916253|NCT02181673|9975826|FG000|STARTED|Week 24-Week 60||0
8916254|NCT02181673|9975827|FG001|STARTED|Week 24-Week 60||222
8773876|NCT01288443|9823815|FG003|Treated|Overall Study||31
8773877|NCT01288443|9823816|FG004|Treated|Overall Study||29
8773878|NCT01288443|9823817|FG005|Treated|Overall Study||30
8773879|NCT01288443|9823812|FG000|COMPLETED|Overall Study||31
8773880|NCT01288443|9823813|FG001|COMPLETED|Overall Study||29
8773881|NCT01288443|9823814|FG002|COMPLETED|Overall Study||30
8916255|NCT02181673|9975828|FG002|STARTED|Week 24-Week 60||230
9028689|NCT03208088|10091132|FG008|STARTED|Period 2||8
9028690|NCT03208088|10091133|FG009|STARTED|Period 2||9
9028691|NCT03208088|10091124|FG000|COMPLETED|Period 2||10
9028692|NCT03208088|10091125|FG001|COMPLETED|Period 2||9
9028693|NCT03208088|10091126|FG002|COMPLETED|Period 2||10
9028694|NCT03208088|10091127|FG003|COMPLETED|Period 2||9
8773882|NCT01288443|9823815|FG003|COMPLETED|Overall Study||27
8773883|NCT01288443|9823816|FG004|COMPLETED|Overall Study||23
8773884|NCT01288443|9823817|FG005|COMPLETED|Overall Study||25
8773885|NCT01288443|9823812|FG000|NOT COMPLETED|Overall Study||0
8773886|NCT01288443|9823813|FG001|NOT COMPLETED|Overall Study||1
8773887|NCT01288443|9823814|FG002|NOT COMPLETED|Overall Study||1
8773888|NCT01288443|9823815|FG003|NOT COMPLETED|Overall Study||4
8773889|NCT01288443|9823816|FG004|NOT COMPLETED|Overall Study||7
8773890|NCT01288443|9823817|FG005|NOT COMPLETED|Overall Study||5
8773891|NCT01288469|9823834|FG000|STARTED|Overall Study|Randomized|31
8773892|NCT01288469|9823835|FG001|STARTED|Overall Study|Randomized|31
8773893|NCT01288469|9823836|FG002|STARTED|Overall Study|Randomized|30
8773894|NCT01288469|9823834|FG000|Treated|Overall Study||31
8773895|NCT01288469|9823835|FG001|Treated|Overall Study||31
8773896|NCT01288469|9823836|FG002|Treated|Overall Study||30
8773897|NCT01288469|9823834|FG000|COMPLETED|Overall Study||24
8773898|NCT01288469|9823835|FG001|COMPLETED|Overall Study||28
8773899|NCT01288469|9823836|FG002|COMPLETED|Overall Study||28
8773900|NCT01288469|9823834|FG000|NOT COMPLETED|Overall Study||7
8773901|NCT01288469|9823835|FG001|NOT COMPLETED|Overall Study||3
8773902|NCT01288469|9823836|FG002|NOT COMPLETED|Overall Study||2
8773903|NCT01288521|9823846|FG000|STARTED|Overall Study||3
8773904|NCT01288521|9823847|FG001|STARTED|Overall Study||5
8773905|NCT01288521|9823846|FG000|COMPLETED|Overall Study||3
8773906|NCT01288521|9823847|FG001|COMPLETED|Overall Study||5
8773907|NCT01288521|9823846|FG000|NOT COMPLETED|Overall Study||0
8773908|NCT01288521|9823847|FG001|NOT COMPLETED|Overall Study||0
8773909|NCT01288534|9823853|FG000|STARTED|Overall Study||68
8773910|NCT01288534|9823853|FG000|COMPLETED|Overall Study||68
8773911|NCT01288534|9823853|FG000|NOT COMPLETED|Overall Study||0
8773912|NCT01288612|9823860|FG000|STARTED|Overall Study||150
8773913|NCT01288612|9823861|FG001|STARTED|Overall Study||151
8773914|NCT01288612|9823862|FG002|STARTED|Overall Study||158
8773915|NCT01288612|9823860|FG000|Contacted|Overall Study||139
8773916|NCT01288612|9823861|FG001|Contacted|Overall Study||135
8773917|NCT01288612|9823862|FG002|Contacted|Overall Study||138
8773918|NCT01288612|9823860|FG000|Agreed to Take Part|Overall Study||61
8773919|NCT01288612|9823861|FG001|Agreed to Take Part|Overall Study||72
8773920|NCT01288612|9823862|FG002|Agreed to Take Part|Overall Study||76
8773921|NCT01288612|9823860|FG000|COMPLETED|Overall Study||61
8773922|NCT01288612|9823861|FG001|COMPLETED|Overall Study||69
8773923|NCT01288612|9823862|FG002|COMPLETED|Overall Study||76
8773924|NCT01288612|9823860|FG000|NOT COMPLETED|Overall Study||89
8671383|NCT00750360|9714668|FG005|NOT COMPLETED|Overall Study||0
8671384|NCT00750373|9714690|FG000|STARTED|Overall Study||39
8671385|NCT00750373|9714691|FG001|STARTED|Overall Study||37
8773925|NCT01288612|9823861|FG001|NOT COMPLETED|Overall Study||82
8773926|NCT01288612|9823862|FG002|NOT COMPLETED|Overall Study||82
8773927|NCT01288729|9823872|FG000|STARTED|Overall Study||10
8773928|NCT01288729|9823873|FG001|STARTED|Overall Study||10
8773929|NCT01288729|9823872|FG000|COMPLETED|Overall Study||9
8773930|NCT01288729|9823873|FG001|COMPLETED|Overall Study||10
8773931|NCT01288729|9823872|FG000|NOT COMPLETED|Overall Study||1
8773932|NCT01288729|9823873|FG001|NOT COMPLETED|Overall Study||0
8773933|NCT01288781|9823881|FG000|STARTED|Overall Study||11
8773934|NCT01288781|9823882|FG001|STARTED|Overall Study||12
8773935|NCT01288781|9823881|FG000|COMPLETED|Overall Study||11
8773936|NCT01288781|9823882|FG001|COMPLETED|Overall Study||12
8773937|NCT01288781|9823881|FG000|NOT COMPLETED|Overall Study||0
8773938|NCT01288781|9823882|FG001|NOT COMPLETED|Overall Study||0
8773939|NCT01288807|9823888|FG000|STARTED|Overall Study||8
8773940|NCT01288807|9823888|FG000|COMPLETED|Overall Study||8
8773941|NCT01288807|9823888|FG000|NOT COMPLETED|Overall Study||0
8773942|NCT01288833|9823894|FG000|STARTED|Overall Study||277
8773943|NCT01288833|9823895|FG001|STARTED|Overall Study||281
8773944|NCT01288833|9823894|FG000|COMPLETED|Overall Study||277
8773945|NCT01288833|9823895|FG001|COMPLETED|Overall Study||281
8773946|NCT01288833|9823894|FG000|NOT COMPLETED|Overall Study||0
8773947|NCT01288833|9823895|FG001|NOT COMPLETED|Overall Study||0
8773948|NCT01288859|9823901|FG000|STARTED|Free Then Encapsulated Curcumin (1 Day)||5
8773949|NCT01288859|9823902|FG001|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
8773950|NCT01288859|9823903|FG002|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
8773951|NCT01288859|9823904|FG003|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
8773952|NCT01288859|9823905|FG004|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
8773953|NCT01288859|9823906|FG005|STARTED|Free Then Encapsulated Curcumin (1 Day)||5
8671386|NCT00750373|9714690|FG000|COMPLETED|Overall Study||39
8671387|NCT00750373|9714691|FG001|COMPLETED|Overall Study||37
8671388|NCT00750373|9714690|FG000|NOT COMPLETED|Overall Study||0
8671389|NCT00750373|9714691|FG001|NOT COMPLETED|Overall Study||0
8671390|NCT00750438|9714699|FG000|STARTED|Overall Study||31
8671391|NCT00750438|9714700|FG001|STARTED|Overall Study||29
8671392|NCT00750438|9714699|FG000|COMPLETED|Overall Study||24
8671393|NCT00750438|9714700|FG001|COMPLETED|Overall Study||25
8671394|NCT00750438|9714699|FG000|NOT COMPLETED|Overall Study||7
8671395|NCT00750438|9714700|FG001|NOT COMPLETED|Overall Study||4
8671396|NCT00750737|9714708|FG000|STARTED|Overall Study||24
8671397|NCT00750737|9714709|FG001|STARTED|Overall Study||22
8671398|NCT00750737|9714708|FG000|COMPLETED|Overall Study||21
8671399|NCT00750737|9714709|FG001|COMPLETED|Overall Study||19
8671400|NCT00750737|9714708|FG000|NOT COMPLETED|Overall Study||3
8671401|NCT00750737|9714709|FG001|NOT COMPLETED|Overall Study||3
8773954|NCT01288859|9823901|FG000|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||5
8773955|NCT01288859|9823902|FG001|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
8773956|NCT01288859|9823903|FG002|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
8773957|NCT01288859|9823904|FG003|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
8773958|NCT01288859|9823905|FG004|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
8773959|NCT01288859|9823906|FG005|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||5
8773960|NCT01288859|9823901|FG000|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
8773961|NCT01288859|9823902|FG001|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
8773962|NCT01288859|9823903|FG002|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
8773963|NCT01288859|9823904|FG003|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
8773964|NCT01288859|9823905|FG004|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
8773965|NCT01288859|9823906|FG005|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
8773966|NCT01288859|9823901|FG000|STARTED|Washout Period of 1 Week||5
8773967|NCT01288859|9823902|FG001|STARTED|Washout Period of 1 Week||0
8773968|NCT01288859|9823903|FG002|STARTED|Washout Period of 1 Week||0
8773969|NCT01288859|9823904|FG003|STARTED|Washout Period of 1 Week||0
8773970|NCT01288859|9823905|FG004|STARTED|Washout Period of 1 Week||0
8773971|NCT01288859|9823906|FG005|STARTED|Washout Period of 1 Week||5
8773972|NCT01288859|9823901|FG000|COMPLETED|Washout Period of 1 Week||5
8773973|NCT01288859|9823902|FG001|COMPLETED|Washout Period of 1 Week||0
8773974|NCT01288859|9823903|FG002|COMPLETED|Washout Period of 1 Week||0
8773975|NCT01288859|9823904|FG003|COMPLETED|Washout Period of 1 Week||0
8773976|NCT01288859|9823905|FG004|COMPLETED|Washout Period of 1 Week||0
8773977|NCT01288859|9823906|FG005|COMPLETED|Washout Period of 1 Week||5
8773978|NCT01288859|9823901|FG000|NOT COMPLETED|Washout Period of 1 Week||0
8773979|NCT01288859|9823902|FG001|NOT COMPLETED|Washout Period of 1 Week||0
8773980|NCT01288859|9823903|FG002|NOT COMPLETED|Washout Period of 1 Week||0
8773981|NCT01288859|9823904|FG003|NOT COMPLETED|Washout Period of 1 Week||0
8773982|NCT01288859|9823905|FG004|NOT COMPLETED|Washout Period of 1 Week||0
8773983|NCT01288859|9823906|FG005|NOT COMPLETED|Washout Period of 1 Week||0
8773984|NCT01288859|9823901|FG000|STARTED|Encapsulated Then Free Curcumin (1 Day)||5
8773985|NCT01288859|9823902|FG001|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
8773986|NCT01288859|9823903|FG002|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
8773987|NCT01288859|9823904|FG003|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
8773988|NCT01288859|9823905|FG004|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
8773989|NCT01288859|9823906|FG005|STARTED|Encapsulated Then Free Curcumin (1 Day)||5
8773990|NCT01288859|9823901|FG000|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||5
8773991|NCT01288859|9823902|FG001|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
8773992|NCT01288859|9823903|FG002|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
8773993|NCT01288859|9823904|FG003|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
8773994|NCT01288859|9823905|FG004|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
8773995|NCT01288859|9823906|FG005|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||5
8773996|NCT01288859|9823901|FG000|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
8773997|NCT01288859|9823902|FG001|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
8773998|NCT01288859|9823903|FG002|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
8773999|NCT01288859|9823904|FG003|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
8774000|NCT01288859|9823905|FG004|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
8774001|NCT01288859|9823906|FG005|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
8774002|NCT01288859|9823901|FG000|STARTED|Washout Period of 1 Week||5
8774003|NCT01288859|9823902|FG001|STARTED|Washout Period of 1 Week||0
8774004|NCT01288859|9823903|FG002|STARTED|Washout Period of 1 Week||0
8774005|NCT01288859|9823904|FG003|STARTED|Washout Period of 1 Week||0
8774006|NCT01288859|9823905|FG004|STARTED|Washout Period of 1 Week||0
8774007|NCT01288859|9823906|FG005|STARTED|Washout Period of 1 Week||5
8774008|NCT01288859|9823901|FG000|COMPLETED|Washout Period of 1 Week||5
8774009|NCT01288859|9823902|FG001|COMPLETED|Washout Period of 1 Week||0
8774010|NCT01288859|9823903|FG002|COMPLETED|Washout Period of 1 Week||0
8774011|NCT01288859|9823904|FG003|COMPLETED|Washout Period of 1 Week||0
8774012|NCT01288859|9823905|FG004|COMPLETED|Washout Period of 1 Week||0
8774013|NCT01288859|9823906|FG005|COMPLETED|Washout Period of 1 Week||5
8774014|NCT01288859|9823901|FG000|NOT COMPLETED|Washout Period of 1 Week||0
8774015|NCT01288859|9823902|FG001|NOT COMPLETED|Washout Period of 1 Week||0
8774016|NCT01288859|9823903|FG002|NOT COMPLETED|Washout Period of 1 Week||0
8774017|NCT01288859|9823904|FG003|NOT COMPLETED|Washout Period of 1 Week||0
8774018|NCT01288859|9823905|FG004|NOT COMPLETED|Washout Period of 1 Week||0
8774019|NCT01288859|9823906|FG005|NOT COMPLETED|Washout Period of 1 Week||0
8774020|NCT01288859|9823901|FG000|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
8774021|NCT01288859|9823902|FG001|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
8774022|NCT01288859|9823903|FG002|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
8774023|NCT01288859|9823904|FG003|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
8774024|NCT01288859|9823905|FG004|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
8774025|NCT01288859|9823906|FG005|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
8774026|NCT01288859|9823901|FG000|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
8774027|NCT01288859|9823902|FG001|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
8774028|NCT01288859|9823903|FG002|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
8774029|NCT01288859|9823904|FG003|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
8774030|NCT01288859|9823905|FG004|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
8774031|NCT01288859|9823906|FG005|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
8774032|NCT01288859|9823901|FG000|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
8774033|NCT01288859|9823902|FG001|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
8774034|NCT01288859|9823903|FG002|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
8774035|NCT01288859|9823904|FG003|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
8774036|NCT01288859|9823905|FG004|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
8774037|NCT01288859|9823906|FG005|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
8774038|NCT01288859|9823901|FG000|STARTED|Washout Period of 1 Week||0
8774039|NCT01288859|9823902|FG001|STARTED|Washout Period of 1 Week||5
8774040|NCT01288859|9823903|FG002|STARTED|Washout Period of 1 Week||5
8774041|NCT01288859|9823904|FG003|STARTED|Washout Period of 1 Week||0
8774042|NCT01288859|9823905|FG004|STARTED|Washout Period of 1 Week||0
8774043|NCT01288859|9823906|FG005|STARTED|Washout Period of 1 Week||0
8774044|NCT01288859|9823901|FG000|COMPLETED|Washout Period of 1 Week||0
8774045|NCT01288859|9823902|FG001|COMPLETED|Washout Period of 1 Week||5
8774046|NCT01288859|9823903|FG002|COMPLETED|Washout Period of 1 Week||5
8774047|NCT01288859|9823904|FG003|COMPLETED|Washout Period of 1 Week||0
8774048|NCT01288859|9823905|FG004|COMPLETED|Washout Period of 1 Week||0
8774049|NCT01288859|9823906|FG005|COMPLETED|Washout Period of 1 Week||0
8774050|NCT01288859|9823901|FG000|NOT COMPLETED|Washout Period of 1 Week||0
8774051|NCT01288859|9823902|FG001|NOT COMPLETED|Washout Period of 1 Week||0
8774052|NCT01288859|9823903|FG002|NOT COMPLETED|Washout Period of 1 Week||0
8774053|NCT01288859|9823904|FG003|NOT COMPLETED|Washout Period of 1 Week||0
8774054|NCT01288859|9823905|FG004|NOT COMPLETED|Washout Period of 1 Week||0
8774055|NCT01288859|9823906|FG005|NOT COMPLETED|Washout Period of 1 Week||0
8774056|NCT01288859|9823901|FG000|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
8774057|NCT01288859|9823902|FG001|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
8774058|NCT01288859|9823903|FG002|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
8774059|NCT01288859|9823904|FG003|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
8774060|NCT01288859|9823905|FG004|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
8774061|NCT01288859|9823906|FG005|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
8774062|NCT01288859|9823901|FG000|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
8774063|NCT01288859|9823902|FG001|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
8774064|NCT01288859|9823903|FG002|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
8774065|NCT01288859|9823904|FG003|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
8774066|NCT01288859|9823905|FG004|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
8774067|NCT01288859|9823906|FG005|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
8774068|NCT01288859|9823901|FG000|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
8774069|NCT01288859|9823902|FG001|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
8774070|NCT01288859|9823903|FG002|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
8774071|NCT01288859|9823904|FG003|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
8774072|NCT01288859|9823905|FG004|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
8774073|NCT01288859|9823906|FG005|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
8774074|NCT01288859|9823901|FG000|STARTED|Washout Period of 1 Week||0
8774075|NCT01288859|9823902|FG001|STARTED|Washout Period of 1 Week||0
8774076|NCT01288859|9823903|FG002|STARTED|Washout Period of 1 Week||0
8774077|NCT01288859|9823904|FG003|STARTED|Washout Period of 1 Week||5
8774078|NCT01288859|9823905|FG004|STARTED|Washout Period of 1 Week||5
8774079|NCT01288859|9823906|FG005|STARTED|Washout Period of 1 Week||0
8774080|NCT01288859|9823901|FG000|COMPLETED|Washout Period of 1 Week||0
8774081|NCT01288859|9823902|FG001|COMPLETED|Washout Period of 1 Week||0
8774082|NCT01288859|9823903|FG002|COMPLETED|Washout Period of 1 Week||0
8774083|NCT01288859|9823904|FG003|COMPLETED|Washout Period of 1 Week||5
8774084|NCT01288859|9823905|FG004|COMPLETED|Washout Period of 1 Week||5
8774085|NCT01288859|9823906|FG005|COMPLETED|Washout Period of 1 Week||0
8774086|NCT01288859|9823901|FG000|NOT COMPLETED|Washout Period of 1 Week||0
8774087|NCT01288859|9823902|FG001|NOT COMPLETED|Washout Period of 1 Week||0
8774088|NCT01288859|9823903|FG002|NOT COMPLETED|Washout Period of 1 Week||0
8774089|NCT01288859|9823904|FG003|NOT COMPLETED|Washout Period of 1 Week||0
9028695|NCT03208088|10091128|FG004|COMPLETED|Period 2||9
9028696|NCT03208088|10091129|FG005|COMPLETED|Period 2||9
9028697|NCT03208088|10091130|FG006|COMPLETED|Period 2||8
9028698|NCT03208088|10091131|FG007|COMPLETED|Period 2||10
9028699|NCT03208088|10091132|FG008|COMPLETED|Period 2||7
9028700|NCT03208088|10091133|FG009|COMPLETED|Period 2||9
9028701|NCT03208088|10091124|FG000|NOT COMPLETED|Period 2||0
9028702|NCT03208088|10091125|FG001|NOT COMPLETED|Period 2||0
9028703|NCT03208088|10091126|FG002|NOT COMPLETED|Period 2||0
9028704|NCT03208088|10091127|FG003|NOT COMPLETED|Period 2||0
9028705|NCT03208088|10091128|FG004|NOT COMPLETED|Period 2||0
9028706|NCT03208088|10091129|FG005|NOT COMPLETED|Period 2||0
9028707|NCT03208088|10091130|FG006|NOT COMPLETED|Period 2||0
9028708|NCT03208088|10091131|FG007|NOT COMPLETED|Period 2||0
9028709|NCT03208088|10091132|FG008|NOT COMPLETED|Period 2||1
9028710|NCT03208088|10091133|FG009|NOT COMPLETED|Period 2||0
9028711|NCT03208088|10091124|FG000|STARTED|Period 3||10
9028712|NCT03208088|10091125|FG001|STARTED|Period 3||9
9028713|NCT03208088|10091126|FG002|STARTED|Period 3||10
9028714|NCT03208088|10091127|FG003|STARTED|Period 3||9
9028715|NCT03208088|10091128|FG004|STARTED|Period 3||9
9028716|NCT03208088|10091129|FG005|STARTED|Period 3||9
9028717|NCT03208088|10091130|FG006|STARTED|Period 3||8
9028718|NCT03208088|10091131|FG007|STARTED|Period 3||10
8774090|NCT01288859|9823905|FG004|NOT COMPLETED|Washout Period of 1 Week||0
8774091|NCT01288859|9823906|FG005|NOT COMPLETED|Washout Period of 1 Week||0
8774092|NCT01288859|9823901|FG000|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
8774093|NCT01288859|9823902|FG001|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
8774094|NCT01288859|9823903|FG002|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
8774095|NCT01288859|9823904|FG003|STARTED|Enc Polyph. Then Control Cream (1 Day)||5
8774096|NCT01288859|9823905|FG004|STARTED|Enc Polyph. Then Control Cream (1 Day)||5
8774097|NCT01288859|9823906|FG005|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
8774098|NCT01288859|9823901|FG000|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
8774099|NCT01288859|9823902|FG001|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
8774100|NCT01288859|9823903|FG002|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
8774101|NCT01288859|9823904|FG003|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||5
8774102|NCT01288859|9823905|FG004|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||5
8774103|NCT01288859|9823906|FG005|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
8774104|NCT01288859|9823901|FG000|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
8774105|NCT01288859|9823902|FG001|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
8774106|NCT01288859|9823903|FG002|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
8774107|NCT01288859|9823904|FG003|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
8774108|NCT01288859|9823905|FG004|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
8774109|NCT01288859|9823906|FG005|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
8774110|NCT01288859|9823901|FG000|STARTED|Washout Period of 1 Week||0
8774111|NCT01288859|9823902|FG001|STARTED|Washout Period of 1 Week||0
8774112|NCT01288859|9823903|FG002|STARTED|Washout Period of 1 Week||0
8774113|NCT01288859|9823904|FG003|STARTED|Washout Period of 1 Week||5
8774114|NCT01288859|9823905|FG004|STARTED|Washout Period of 1 Week||5
8774115|NCT01288859|9823906|FG005|STARTED|Washout Period of 1 Week||0
8774116|NCT01288859|9823901|FG000|COMPLETED|Washout Period of 1 Week||0
8774117|NCT01288859|9823902|FG001|COMPLETED|Washout Period of 1 Week||0
8774118|NCT01288859|9823903|FG002|COMPLETED|Washout Period of 1 Week||0
8774119|NCT01288859|9823904|FG003|COMPLETED|Washout Period of 1 Week||5
8774120|NCT01288859|9823905|FG004|COMPLETED|Washout Period of 1 Week||5
8774121|NCT01288859|9823906|FG005|COMPLETED|Washout Period of 1 Week||0
8774122|NCT01288859|9823901|FG000|NOT COMPLETED|Washout Period of 1 Week||0
8774123|NCT01288859|9823902|FG001|NOT COMPLETED|Washout Period of 1 Week||0
8774124|NCT01288859|9823903|FG002|NOT COMPLETED|Washout Period of 1 Week||0
8774125|NCT01288859|9823904|FG003|NOT COMPLETED|Washout Period of 1 Week||0
8774126|NCT01288859|9823905|FG004|NOT COMPLETED|Washout Period of 1 Week||0
8774127|NCT01288859|9823906|FG005|NOT COMPLETED|Washout Period of 1 Week||0
8774128|NCT01288859|9823901|FG000|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
8774129|NCT01288859|9823902|FG001|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
8774130|NCT01288859|9823903|FG002|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
8774131|NCT01288859|9823904|FG003|STARTED|Control Cream Then Enc Polyph. (1 Day)||5
8774132|NCT01288859|9823905|FG004|STARTED|Control Cream Then Enc Polyph. (1 Day)||5
8774133|NCT01288859|9823906|FG005|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
8774134|NCT01288859|9823901|FG000|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
8774135|NCT01288859|9823902|FG001|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
8774136|NCT01288859|9823903|FG002|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
8774137|NCT01288859|9823904|FG003|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||5
8774138|NCT01288859|9823905|FG004|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||5
8774139|NCT01288859|9823906|FG005|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
8774140|NCT01288859|9823901|FG000|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
8774141|NCT01288859|9823902|FG001|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
8774142|NCT01288859|9823903|FG002|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
8774143|NCT01288859|9823904|FG003|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
8774144|NCT01288859|9823905|FG004|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
8774145|NCT01288859|9823906|FG005|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
8774146|NCT01288911|9823928|FG000|STARTED|Double-blind Period||184
8774147|NCT01288911|9823929|FG001|STARTED|Double-blind Period||191
8774148|NCT01288911|9823928|FG000|Received Treatment|Double-blind Period||183
8774149|NCT01288911|9823929|FG001|Received Treatment|Double-blind Period||189
8774150|NCT01288911|9823928|FG000|COMPLETED|Double-blind Period|Indicates participants were still receiving treatment at the data cut-off date of 19 October 2014.|42
8774151|NCT01288911|9823929|FG001|COMPLETED|Double-blind Period|Indicates participants were still receiving treatment at the data cut-off date of 19 October 2014.|9
8774152|NCT01288911|9823928|FG000|NOT COMPLETED|Double-blind Period||142
8774153|NCT01288911|9823929|FG001|NOT COMPLETED|Double-blind Period||182
8774154|NCT01288911|9823928|FG000|STARTED|Open-label Period (All Enzalutamide)||42
8774155|NCT01288911|9823929|FG001|STARTED|Open-label Period (All Enzalutamide)||9
8774156|NCT01288911|9823928|FG000|Received Treatment|Open-label Period (All Enzalutamide)||42
8774157|NCT01288911|9823929|FG001|Received Treatment|Open-label Period (All Enzalutamide)||9
8774158|NCT01288911|9823928|FG000|COMPLETED|Open-label Period (All Enzalutamide)||0
8774159|NCT01288911|9823929|FG001|COMPLETED|Open-label Period (All Enzalutamide)||0
8774160|NCT01288911|9823928|FG000|NOT COMPLETED|Open-label Period (All Enzalutamide)||42
8774161|NCT01288911|9823929|FG001|NOT COMPLETED|Open-label Period (All Enzalutamide)||9
8774162|NCT01288937|9823940|FG000|STARTED|Overall Study||4
8774163|NCT01288937|9823941|FG001|STARTED|Overall Study||2
8774164|NCT01288937|9823940|FG000|COMPLETED|Overall Study||3
8774165|NCT01288937|9823941|FG001|COMPLETED|Overall Study||2
8774166|NCT01288937|9823940|FG000|NOT COMPLETED|Overall Study||1
8774167|NCT01288937|9823941|FG001|NOT COMPLETED|Overall Study||0
8774168|NCT01288976|9823950|FG000|STARTED|Overall Study||567
8774169|NCT01288976|9823951|FG001|STARTED|Overall Study||49
8774170|NCT01288976|9823952|FG002|STARTED|Overall Study||105
8774171|NCT01288976|9823950|FG000|COMPLETED|Overall Study||389
8774172|NCT01288976|9823951|FG001|COMPLETED|Overall Study||22
8774173|NCT01288976|9823952|FG002|COMPLETED|Overall Study||85
8774174|NCT01288976|9823950|FG000|NOT COMPLETED|Overall Study||178
8774175|NCT01288976|9823951|FG001|NOT COMPLETED|Overall Study||27
8774176|NCT01288976|9823952|FG002|NOT COMPLETED|Overall Study||20
8774177|NCT01288989|9823963|FG000|STARTED|Overall Study||6
8774178|NCT01288989|9823964|FG001|STARTED|Overall Study||3
8774179|NCT01288989|9823965|FG002|STARTED|Overall Study||3
8774180|NCT01288989|9823966|FG003|STARTED|Overall Study||11
8774181|NCT01288989|9823967|FG004|STARTED|Overall Study||21
8774182|NCT01288989|9823963|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
8774183|NCT01288989|9823964|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
8774184|NCT01288989|9823965|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
8774185|NCT01288989|9823966|FG003|Received at Least 1 Dose of Study Drug|Overall Study||11
8774186|NCT01288989|9823967|FG004|Received at Least 1 Dose of Study Drug|Overall Study||21
8774187|NCT01288989|9823963|FG000|COMPLETED|Overall Study||5
8774188|NCT01288989|9823964|FG001|COMPLETED|Overall Study||3
8774189|NCT01288989|9823965|FG002|COMPLETED|Overall Study||3
8774190|NCT01288989|9823966|FG003|COMPLETED|Overall Study||10
8774191|NCT01288989|9823967|FG004|COMPLETED|Overall Study||15
8774192|NCT01288989|9823963|FG000|NOT COMPLETED|Overall Study||1
8774193|NCT01288989|9823964|FG001|NOT COMPLETED|Overall Study||0
8774194|NCT01288989|9823965|FG002|NOT COMPLETED|Overall Study||0
8774195|NCT01288989|9823966|FG003|NOT COMPLETED|Overall Study||1
8774196|NCT01288989|9823967|FG004|NOT COMPLETED|Overall Study||6
8774197|NCT01289015|9823987|FG000|STARTED|Overall Study||571
8774198|NCT01289015|9823988|FG001|STARTED|Overall Study||284
8774199|NCT01289015|9823987|FG000|COMPLETED|Overall Study||472
8774200|NCT01289015|9823988|FG001|COMPLETED|Overall Study||230
8774201|NCT01289015|9823987|FG000|NOT COMPLETED|Overall Study||99
8774202|NCT01289015|9823988|FG001|NOT COMPLETED|Overall Study||54
8774203|NCT01289028|9823994|FG000|STARTED|Overall Study||125
8774204|NCT01289028|9823994|FG000|COMPLETED|Overall Study||42
8774205|NCT01289028|9823994|FG000|NOT COMPLETED|Overall Study||83
8774206|NCT01289041|9824000|FG000|STARTED|Overall Study||70
8774207|NCT01289041|9824000|FG000|COMPLETED|Overall Study||0
8774208|NCT01289041|9824000|FG000|NOT COMPLETED|Overall Study||70
8774209|NCT01289067|9824006|FG000|STARTED|Overall Study||13
8774210|NCT01289067|9824006|FG000|COMPLETED|Overall Study||13
8774211|NCT01289067|9824006|FG000|NOT COMPLETED|Overall Study||0
8774212|NCT01289080|9824012|FG000|STARTED|Overall Study||9
8774213|NCT01289080|9824013|FG001|STARTED|Overall Study||10
8774214|NCT01289080|9824012|FG000|COMPLETED|Overall Study||9
8774215|NCT01289080|9824013|FG001|COMPLETED|Overall Study||10
8774216|NCT01289080|9824012|FG000|NOT COMPLETED|Overall Study||0
8774217|NCT01289080|9824013|FG001|NOT COMPLETED|Overall Study||0
8774218|NCT01289119|9824026|FG000|STARTED|Overall Study||93
8774219|NCT01289119|9824027|FG001|STARTED|Overall Study||92
8774220|NCT01289119|9824028|FG002|STARTED|Overall Study||98
8774221|NCT01289119|9824029|FG003|STARTED|Overall Study||99
8774222|NCT01289119|9824030|FG004|STARTED|Overall Study||63
8774223|NCT01289119|9824031|FG005|STARTED|Overall Study||61
8774224|NCT01289119|9824026|FG000|Treated|Overall Study|Patients who took at least one dose of double-blind study drug.|92
8774225|NCT01289119|9824027|FG001|Treated|Overall Study||92
8774226|NCT01289119|9824028|FG002|Treated|Overall Study||98
8774227|NCT01289119|9824029|FG003|Treated|Overall Study||99
8774228|NCT01289119|9824030|FG004|Treated|Overall Study||63
8774229|NCT01289119|9824031|FG005|Treated|Overall Study||61
8774230|NCT01289119|9824026|FG000|COMPLETED|Overall Study||84
8774231|NCT01289119|9824027|FG001|COMPLETED|Overall Study||83
8774232|NCT01289119|9824028|FG002|COMPLETED|Overall Study||89
8774233|NCT01289119|9824029|FG003|COMPLETED|Overall Study||93
8774234|NCT01289119|9824030|FG004|COMPLETED|Overall Study||58
8774235|NCT01289119|9824031|FG005|COMPLETED|Overall Study||57
8774236|NCT01289119|9824026|FG000|NOT COMPLETED|Overall Study||9
8774237|NCT01289119|9824027|FG001|NOT COMPLETED|Overall Study||9
8774238|NCT01289119|9824028|FG002|NOT COMPLETED|Overall Study||9
8774239|NCT01289119|9824029|FG003|NOT COMPLETED|Overall Study||6
8774240|NCT01289119|9824030|FG004|NOT COMPLETED|Overall Study||5
8774241|NCT01289119|9824031|FG005|NOT COMPLETED|Overall Study||4
8774242|NCT01289210|9824045|FG000|STARTED|Overall Study||2
8774243|NCT01289210|9824045|FG000|COMPLETED|Overall Study||1
8774244|NCT01289210|9824045|FG000|NOT COMPLETED|Overall Study||1
8774245|NCT01289275|9824053|FG000|STARTED|Overall Study||317
8774246|NCT01289275|9824054|FG001|STARTED|Overall Study||320
8774247|NCT01289275|9824055|FG002|STARTED|Overall Study||317
8774248|NCT01289275|9824056|FG003|STARTED|Overall Study||316
8774249|NCT01289275|9824053|FG000|COMPLETED|Overall Study||317
8774250|NCT01289275|9824054|FG001|COMPLETED|Overall Study||320
8774251|NCT01289275|9824055|FG002|COMPLETED|Overall Study||317
8774252|NCT01289275|9824056|FG003|COMPLETED|Overall Study||316
8774253|NCT01289275|9824053|FG000|NOT COMPLETED|Overall Study||0
8774254|NCT01289275|9824054|FG001|NOT COMPLETED|Overall Study||0
8774255|NCT01289275|9824055|FG002|NOT COMPLETED|Overall Study||0
8774256|NCT01289275|9824056|FG003|NOT COMPLETED|Overall Study||0
8774257|NCT01289353|9824070|FG000|STARTED|Overall Study||92
8774258|NCT01289353|9824070|FG000|COMPLETED|Overall Study||90
8774259|NCT01289353|9824070|FG000|NOT COMPLETED|Overall Study||2
8774260|NCT01289392|9824077|FG000|STARTED|Overall Study||9
8774261|NCT01289392|9824078|FG001|STARTED|Overall Study||9
8774262|NCT01289392|9824079|FG002|STARTED|Overall Study||7
8774263|NCT01289392|9824077|FG000|COMPLETED|Overall Study||9
8774264|NCT01289392|9824078|FG001|COMPLETED|Overall Study||9
8774265|NCT01289392|9824079|FG002|COMPLETED|Overall Study||7
8774266|NCT01289392|9824077|FG000|NOT COMPLETED|Overall Study||0
8774267|NCT01289392|9824078|FG001|NOT COMPLETED|Overall Study||0
8774268|NCT01289392|9824079|FG002|NOT COMPLETED|Overall Study||0
8774269|NCT01289418|9824090|FG000|STARTED|Day 8 Survey||6525
8774270|NCT01289418|9824090|FG000|COMPLETED|Day 8 Survey||4307
8774271|NCT01289418|9824090|FG000|NOT COMPLETED|Day 8 Survey||2218
8774272|NCT01289418|9824090|FG000|STARTED|Day 29 Survey||6525
8774273|NCT01289418|9824090|FG000|COMPLETED|Day 29 Survey||4057
8774274|NCT01289418|9824090|FG000|NOT COMPLETED|Day 29 Survey||2468
8808708|NCT01491737|9861017|FG001|COMPLETED|Overall Study||0
8808709|NCT01491737|9861016|FG000|NOT COMPLETED|Overall Study||129
8808710|NCT01491737|9861017|FG001|NOT COMPLETED|Overall Study||129
9028719|NCT03208088|10091132|FG008|STARTED|Period 3||7
9028720|NCT03208088|10091133|FG009|STARTED|Period 3||9
8808711|NCT01491802|9861023|FG000|STARTED|Overall Study||9
8808712|NCT01491802|9861024|FG001|STARTED|Overall Study||8
8808713|NCT01491802|9861023|FG000|COMPLETED|Overall Study||8
8808714|NCT01491802|9861024|FG001|COMPLETED|Overall Study||6
8808715|NCT01491802|9861023|FG000|NOT COMPLETED|Overall Study||1
8808716|NCT01491802|9861024|FG001|NOT COMPLETED|Overall Study||2
8808717|NCT01491841|9861031|FG000|STARTED|Overall Study||33
8808718|NCT01491841|9861031|FG000|COMPLETED|Overall Study||22
8808719|NCT01491841|9861031|FG000|NOT COMPLETED|Overall Study||11
8808720|NCT01491854|9861043|FG000|STARTED|Overall Study||130
8808721|NCT01491854|9861043|FG000|COMPLETED|Overall Study||0
8808722|NCT01491854|9861043|FG000|NOT COMPLETED|Overall Study||130
8808723|NCT01491919|9861050|FG000|STARTED|Overall Study||13
8808724|NCT01491919|9861051|FG001|STARTED|Overall Study||10
8808725|NCT01491919|9861052|FG002|STARTED|Overall Study||3
8808726|NCT01491919|9861050|FG000|COMPLETED|Overall Study||12
8808727|NCT01491919|9861051|FG001|COMPLETED|Overall Study||8
8808728|NCT01491919|9861052|FG002|COMPLETED|Overall Study||2
8808729|NCT01491919|9861050|FG000|NOT COMPLETED|Overall Study||1
8808730|NCT01491919|9861051|FG001|NOT COMPLETED|Overall Study||2
8808731|NCT01491919|9861052|FG002|NOT COMPLETED|Overall Study||1
8808732|NCT01491945|9861062|FG000|STARTED|Overall Study||76
8808733|NCT01491945|9861062|FG000|COMPLETED|Overall Study||25
8808734|NCT01491945|9861062|FG000|NOT COMPLETED|Overall Study||51
8808735|NCT01491958|9861069|FG000|STARTED|Overall Study||40
8808736|NCT01491958|9861070|FG001|STARTED|Overall Study||40
8808737|NCT01491958|9861069|FG000|COMPLETED|Overall Study||40
8808738|NCT01491958|9861070|FG001|COMPLETED|Overall Study||40
8808739|NCT01491958|9861069|FG000|NOT COMPLETED|Overall Study||0
8808740|NCT01491958|9861070|FG001|NOT COMPLETED|Overall Study||0
8808741|NCT01491984|9861077|FG000|STARTED|Overall Study||49
8808742|NCT01491984|9861078|FG001|STARTED|Overall Study||45
8808743|NCT01491984|9861077|FG000|COMPLETED|Overall Study||47
8808744|NCT01491984|9861078|FG001|COMPLETED|Overall Study||44
8808745|NCT01491984|9861077|FG000|NOT COMPLETED|Overall Study||2
8808746|NCT01491984|9861078|FG001|NOT COMPLETED|Overall Study||1
8808747|NCT01492088|9861087|FG000|STARTED|Overall Study||3
8808748|NCT01492088|9861088|FG001|STARTED|Overall Study||16
8808749|NCT01492088|9861089|FG002|STARTED|Overall Study||17
8808750|NCT01492088|9861087|FG000|COMPLETED|Overall Study||0
8808751|NCT01492088|9861088|FG001|COMPLETED|Overall Study||2
8808752|NCT01492088|9861089|FG002|COMPLETED|Overall Study||3
8808753|NCT01492088|9861087|FG000|NOT COMPLETED|Overall Study||3
8808754|NCT01492088|9861088|FG001|NOT COMPLETED|Overall Study||14
8808755|NCT01492088|9861089|FG002|NOT COMPLETED|Overall Study||14
8808756|NCT01492101|9861102|FG000|STARTED|Overall Study||429
8808757|NCT01492101|9861103|FG001|STARTED|Overall Study||423
8808758|NCT01492101|9861102|FG000|COMPLETED|Overall Study||92
8808759|NCT01492101|9861103|FG001|COMPLETED|Overall Study||81
8808760|NCT01492101|9861102|FG000|NOT COMPLETED|Overall Study||337
8808761|NCT01492101|9861103|FG001|NOT COMPLETED|Overall Study||342
8808762|NCT01492309|9861111|FG000|STARTED|Overall Study||11
8808763|NCT01492309|9861112|FG001|STARTED|Overall Study||11
8808764|NCT01492309|9861111|FG000|COMPLETED|Overall Study||11
8808765|NCT01492309|9861112|FG001|COMPLETED|Overall Study||11
8808766|NCT01492309|9861111|FG000|NOT COMPLETED|Overall Study||0
8808767|NCT01492309|9861112|FG001|NOT COMPLETED|Overall Study||0
8808768|NCT01492400|9861120|FG000|STARTED|Overall Study||181
8808769|NCT01492400|9861121|FG001|STARTED|Overall Study||182
8808770|NCT01492400|9861120|FG000|COMPLETED|Overall Study||165
8808771|NCT01492400|9861121|FG001|COMPLETED|Overall Study||166
9028721|NCT03208088|10091124|FG000|COMPLETED|Period 3||10
8808772|NCT01492400|9861120|FG000|NOT COMPLETED|Overall Study||16
8808773|NCT01492400|9861121|FG001|NOT COMPLETED|Overall Study||16
8808774|NCT01492426|9861129|FG000|STARTED|Treatment||402
8808775|NCT01492426|9861130|FG001|STARTED|Treatment||200
8774275|NCT01289431|9824103|FG000|STARTED|Overall Study||34
8774276|NCT01289431|9824104|FG001|STARTED|Overall Study||34
8774277|NCT01289431|9824105|FG002|STARTED|Overall Study||34
8774278|NCT01289431|9824106|FG003|STARTED|Overall Study||33
8774279|NCT01289431|9824107|FG004|STARTED|Overall Study||34
8774280|NCT01289431|9824108|FG005|STARTED|Overall Study||33
8774281|NCT01289431|9824109|FG006|STARTED|Overall Study||34
8774282|NCT01289431|9824103|FG000|COMPLETED|Overall Study||29
8774283|NCT01289431|9824104|FG001|COMPLETED|Overall Study||32
8774284|NCT01289431|9824105|FG002|COMPLETED|Overall Study||30
8774285|NCT01289431|9824106|FG003|COMPLETED|Overall Study||28
8774286|NCT01289431|9824107|FG004|COMPLETED|Overall Study||32
8774287|NCT01289431|9824108|FG005|COMPLETED|Overall Study||31
8774288|NCT01289431|9824109|FG006|COMPLETED|Overall Study||33
8774289|NCT01289431|9824103|FG000|NOT COMPLETED|Overall Study||5
8774290|NCT01289431|9824104|FG001|NOT COMPLETED|Overall Study||2
8774291|NCT01289431|9824105|FG002|NOT COMPLETED|Overall Study||4
8774292|NCT01289431|9824106|FG003|NOT COMPLETED|Overall Study||5
8774293|NCT01289431|9824107|FG004|NOT COMPLETED|Overall Study||2
8774294|NCT01289431|9824108|FG005|NOT COMPLETED|Overall Study||2
8774295|NCT01289431|9824109|FG006|NOT COMPLETED|Overall Study||1
8774296|NCT01289457|9824128|FG000|STARTED|Overall Study||12
8774297|NCT01289457|9824129|FG001|STARTED|Overall Study||157
8774298|NCT01289457|9824130|FG002|STARTED|Overall Study||113
8774299|NCT01289457|9824128|FG000|COMPLETED|Overall Study||12
8774300|NCT01289457|9824129|FG001|COMPLETED|Overall Study||157
8774301|NCT01289457|9824130|FG002|COMPLETED|Overall Study||113
8774302|NCT01289457|9824128|FG000|NOT COMPLETED|Overall Study||0
8774303|NCT01289457|9824129|FG001|NOT COMPLETED|Overall Study||0
8774304|NCT01289457|9824130|FG002|NOT COMPLETED|Overall Study||0
8774305|NCT01289522|9824138|FG000|STARTED|Overall Study||54
8774306|NCT01289522|9824138|FG000|COMPLETED|Overall Study||43
8774307|NCT01289522|9824138|FG000|NOT COMPLETED|Overall Study||11
8774308|NCT01289548|9824145|FG000|STARTED|Overall Study|include both donors and recipients listed as milestones below|40
8774309|NCT01289548|9824146|FG001|STARTED|Overall Study|include both donors and recipients listed as milestones below|40
8774310|NCT01289548|9824147|FG002|STARTED|Overall Study|include both donors and recipients listed as milestones below|40
8774311|NCT01289548|9824145|FG000|Donors|Overall Study||20
8774312|NCT01289548|9824146|FG001|Donors|Overall Study||20
8774313|NCT01289548|9824147|FG002|Donors|Overall Study||20
8774314|NCT01289548|9824145|FG000|Recipients|Overall Study||20
8774315|NCT01289548|9824146|FG001|Recipients|Overall Study||20
8774316|NCT01289548|9824147|FG002|Recipients|Overall Study||20
8774317|NCT01289548|9824145|FG000|COMPLETED|Overall Study||40
8774318|NCT01289548|9824146|FG001|COMPLETED|Overall Study||40
8774319|NCT01289548|9824147|FG002|COMPLETED|Overall Study||40
8774320|NCT01289548|9824145|FG000|NOT COMPLETED|Overall Study||0
8774321|NCT01289548|9824146|FG001|NOT COMPLETED|Overall Study||0
8774322|NCT01289548|9824147|FG002|NOT COMPLETED|Overall Study||0
8774323|NCT01289574|9824158|FG000|STARTED|Overall Study||58
8774324|NCT01289574|9824159|FG001|STARTED|Overall Study||60
8774325|NCT01289574|9824160|FG002|STARTED|Overall Study||63
8774326|NCT01289574|9824158|FG000|COMPLETED|Overall Study||51
8774327|NCT01289574|9824159|FG001|COMPLETED|Overall Study||57
8774328|NCT01289574|9824160|FG002|COMPLETED|Overall Study||60
8774329|NCT01289574|9824158|FG000|NOT COMPLETED|Overall Study||7
8774330|NCT01289574|9824159|FG001|NOT COMPLETED|Overall Study||3
8774331|NCT01289574|9824160|FG002|NOT COMPLETED|Overall Study||3
8774332|NCT01289639|9824172|FG000|STARTED|Overall Study||5
8774333|NCT01289639|9824173|FG001|STARTED|Overall Study||6
8774334|NCT01289639|9824174|FG002|STARTED|Overall Study||0
8774335|NCT01289639|9824172|FG000|COMPLETED|Overall Study||4
8774336|NCT01289639|9824173|FG001|COMPLETED|Overall Study||6
8774337|NCT01289639|9824174|FG002|COMPLETED|Overall Study||0
8774338|NCT01289639|9824172|FG000|NOT COMPLETED|Overall Study||1
8774339|NCT01289639|9824173|FG001|NOT COMPLETED|Overall Study||0
8774340|NCT01289639|9824174|FG002|NOT COMPLETED|Overall Study||0
8774341|NCT01289665|9824184|FG000|STARTED|Overall Study||60
8774342|NCT01289665|9824185|FG001|STARTED|Overall Study||60
8774343|NCT01289665|9824184|FG000|COMPLETED|Overall Study||59
8774344|NCT01289665|9824185|FG001|COMPLETED|Overall Study||60
8774345|NCT01289665|9824184|FG000|NOT COMPLETED|Overall Study||1
8774346|NCT01289665|9824185|FG001|NOT COMPLETED|Overall Study||0
8774347|NCT01289678|9824191|FG000|STARTED|Overall Study||18
8774348|NCT01289678|9824191|FG000|COMPLETED|Overall Study||12
8774349|NCT01289678|9824191|FG000|NOT COMPLETED|Overall Study||6
8774350|NCT01289782|9824197|FG000|STARTED|Overall Study||264
8774351|NCT01289782|9824198|FG001|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|130
8774352|NCT01289782|9824197|FG000|COMPLETED|Overall Study||239
8774353|NCT01289782|9824198|FG001|COMPLETED|Overall Study||118
8774354|NCT01289782|9824197|FG000|NOT COMPLETED|Overall Study||25
8774355|NCT01289782|9824198|FG001|NOT COMPLETED|Overall Study||12
8774356|NCT01289821|9824204|FG000|STARTED|Treatment Period||54
8774357|NCT01289821|9824204|FG000|Participants Received Regorafenib|Treatment Period||54
8774358|NCT01289821|9824204|FG000|COMPLETED|Treatment Period||0
8774359|NCT01289821|9824204|FG000|NOT COMPLETED|Treatment Period||54
8774360|NCT01289821|9824204|FG000|STARTED|Safety Follow-up Period||54
8774361|NCT01289821|9824204|FG000|COMPLETED|Safety Follow-up Period||49
8774362|NCT01289821|9824204|FG000|NOT COMPLETED|Safety Follow-up Period||5
8774363|NCT01289821|9824204|FG000|STARTED|Survival Follow-up Period||52
8808776|NCT01492426|9861129|FG000|COMPLETED|Treatment||319
8774364|NCT01289821|9824204|FG000|COMPLETED|Survival Follow-up Period|34 participants died and completed survival follow-up period.|34
8774365|NCT01289821|9824204|FG000|NOT COMPLETED|Survival Follow-up Period||18
8774366|NCT01289847|9824208|FG000|STARTED|Overall Study||25
8774367|NCT01289847|9824208|FG000|COMPLETED|Overall Study||24
8774368|NCT01289847|9824208|FG000|NOT COMPLETED|Overall Study||1
8774369|NCT01289912|9824214|FG000|STARTED|Overall Study||32
8774370|NCT01289912|9824215|FG001|STARTED|Overall Study||15
8774371|NCT01289912|9824214|FG000|COMPLETED|Overall Study||29
8774372|NCT01289912|9824215|FG001|COMPLETED|Overall Study||13
8774373|NCT01289912|9824214|FG000|NOT COMPLETED|Overall Study||3
8774374|NCT01289912|9824215|FG001|NOT COMPLETED|Overall Study||2
8774375|NCT01289990|9824244|FG000|STARTED|Overall Study||224
8774376|NCT01289990|9824245|FG001|STARTED|Overall Study||224
8774377|NCT01289990|9824246|FG002|STARTED|Overall Study||228
8774378|NCT01289990|9824247|FG003|STARTED|Overall Study||223
8774379|NCT01289990|9824248|FG004|STARTED|Overall Study||165
8774380|NCT01289990|9824249|FG005|STARTED|Overall Study||168
8774381|NCT01289990|9824250|FG006|STARTED|Overall Study||166
8774382|NCT01289990|9824251|FG007|STARTED|Overall Study||217
8774383|NCT01289990|9824252|FG008|STARTED|Overall Study||214
8774384|NCT01289990|9824253|FG009|STARTED|Overall Study||207
8774385|NCT01289990|9824254|FG010|STARTED|Overall Study||226
8774386|NCT01289990|9824255|FG011|STARTED|Overall Study||218
8774387|NCT01289990|9824256|FG012|STARTED|Overall Study||225
8774388|NCT01289990|9824244|FG000|COMPLETED|Overall Study||147
8774389|NCT01289990|9824245|FG001|COMPLETED|Overall Study||143
8774390|NCT01289990|9824246|FG002|COMPLETED|Overall Study||119
8774391|NCT01289990|9824247|FG003|COMPLETED|Overall Study||136
8774392|NCT01289990|9824248|FG004|COMPLETED|Overall Study||93
8774393|NCT01289990|9824249|FG005|COMPLETED|Overall Study||94
8774394|NCT01289990|9824250|FG006|COMPLETED|Overall Study||78
8774395|NCT01289990|9824251|FG007|COMPLETED|Overall Study||162
8774396|NCT01289990|9824252|FG008|COMPLETED|Overall Study||139
8774397|NCT01289990|9824253|FG009|COMPLETED|Overall Study||121
8774398|NCT01289990|9824254|FG010|COMPLETED|Overall Study||150
8774399|NCT01289990|9824255|FG011|COMPLETED|Overall Study||150
8774400|NCT01289990|9824256|FG012|COMPLETED|Overall Study||127
8774401|NCT01289990|9824244|FG000|NOT COMPLETED|Overall Study||77
8774402|NCT01289990|9824245|FG001|NOT COMPLETED|Overall Study||81
8774403|NCT01289990|9824246|FG002|NOT COMPLETED|Overall Study||109
8774404|NCT01289990|9824247|FG003|NOT COMPLETED|Overall Study||87
8774405|NCT01289990|9824248|FG004|NOT COMPLETED|Overall Study||72
8774406|NCT01289990|9824249|FG005|NOT COMPLETED|Overall Study||74
8774407|NCT01289990|9824250|FG006|NOT COMPLETED|Overall Study||88
8774408|NCT01289990|9824251|FG007|NOT COMPLETED|Overall Study||55
8774409|NCT01289990|9824252|FG008|NOT COMPLETED|Overall Study||75
8774410|NCT01289990|9824253|FG009|NOT COMPLETED|Overall Study||86
8774411|NCT01289990|9824254|FG010|NOT COMPLETED|Overall Study||76
8774412|NCT01289990|9824255|FG011|NOT COMPLETED|Overall Study||68
8774413|NCT01289990|9824256|FG012|NOT COMPLETED|Overall Study||98
8774414|NCT01290029|9824284|FG000|STARTED|Overall Study||14
8774415|NCT01290029|9824284|FG000|Received Study Treatment|Overall Study||12
8774416|NCT01290029|9824284|FG000|COMPLETED|Overall Study||12
8774417|NCT01290029|9824284|FG000|NOT COMPLETED|Overall Study||2
8774418|NCT01290068|9824290|FG000|STARTED|Overall Study||108
8774419|NCT01290068|9824291|FG001|STARTED|Overall Study||100
8774420|NCT01290068|9824290|FG000|Implanted|Overall Study||108
8774421|NCT01290068|9824291|FG001|Implanted|Overall Study||98
8774422|NCT01290068|9824290|FG000|COMPLETED|Overall Study||101
8774423|NCT01290068|9824291|FG001|COMPLETED|Overall Study||94
8774424|NCT01290068|9824290|FG000|NOT COMPLETED|Overall Study||7
8774425|NCT01290068|9824291|FG001|NOT COMPLETED|Overall Study||6
8774426|NCT01290094|9824297|FG000|STARTED|Overall Study||41
8774427|NCT01290094|9824297|FG000|COMPLETED|Overall Study||35
8774428|NCT01290094|9824297|FG000|NOT COMPLETED|Overall Study||6
8774429|NCT01290224|9824301|FG000|STARTED|Overall Study||10
8774430|NCT01290224|9824301|FG000|COMPLETED|Overall Study||5
8774431|NCT01290224|9824301|FG000|NOT COMPLETED|Overall Study||5
8774432|NCT01290237|9824309|FG000|STARTED|Overall Study||30
8774433|NCT01290237|9824310|FG001|STARTED|Overall Study||29
8774434|NCT01290237|9824309|FG000|COMPLETED|Overall Study||19
8774435|NCT01290237|9824310|FG001|COMPLETED|Overall Study||27
8774436|NCT01290237|9824309|FG000|NOT COMPLETED|Overall Study||11
8774437|NCT01290237|9824310|FG001|NOT COMPLETED|Overall Study||2
8774438|NCT01290263|9824320|FG000|STARTED|Overall Study||11
8774439|NCT01290263|9824321|FG001|STARTED|Overall Study||3
8774440|NCT01290263|9824322|FG002|STARTED|Overall Study||7
8774441|NCT01290263|9824323|FG003|STARTED|Overall Study||27
8774442|NCT01290263|9824324|FG004|STARTED|Overall Study||37
8774443|NCT01290263|9824320|FG000|COMPLETED|Overall Study||0
8774444|NCT01290263|9824321|FG001|COMPLETED|Overall Study||0
8774445|NCT01290263|9824322|FG002|COMPLETED|Overall Study||0
8774446|NCT01290263|9824323|FG003|COMPLETED|Overall Study||0
8774447|NCT01290263|9824324|FG004|COMPLETED|Overall Study||0
8774448|NCT01290263|9824320|FG000|NOT COMPLETED|Overall Study||11
8774449|NCT01290263|9824321|FG001|NOT COMPLETED|Overall Study||3
8774450|NCT01290263|9824322|FG002|NOT COMPLETED|Overall Study||7
8774451|NCT01290263|9824323|FG003|NOT COMPLETED|Overall Study||27
8774452|NCT01290263|9824324|FG004|NOT COMPLETED|Overall Study||37
8774453|NCT01290315|9824336|FG000|STARTED|Overall Study||14
8774454|NCT01290315|9824337|FG001|STARTED|Overall Study||12
8774455|NCT01290315|9824338|FG002|STARTED|Overall Study||10
8774456|NCT01290315|9824339|FG003|STARTED|Overall Study||13
8671402|NCT00750815|9714717|FG000|STARTED|Overall Study||12
8671403|NCT00750815|9714718|FG001|STARTED|Overall Study||46
8671404|NCT00750815|9714717|FG000|COMPLETED|Overall Study||12
8671405|NCT00750815|9714718|FG001|COMPLETED|Overall Study||46
8671406|NCT00750815|9714717|FG000|NOT COMPLETED|Overall Study||0
8671407|NCT00750815|9714718|FG001|NOT COMPLETED|Overall Study||0
8671408|NCT00750867|9714728|FG000|STARTED|Overall Study||9
8671409|NCT00750867|9714728|FG000|COMPLETED|Overall Study||7
8671410|NCT00750867|9714728|FG000|NOT COMPLETED|Overall Study||2
8671411|NCT00750880|9714732|FG000|STARTED|Overall Study||1681
8671412|NCT00750880|9714732|FG000|COMPLETED|Overall Study||1466
8671413|NCT00750880|9714732|FG000|NOT COMPLETED|Overall Study||215
8671414|NCT00750893|9714737|FG000|STARTED|Overall Study||3111
8671415|NCT00750893|9714737|FG000|COMPLETED|Overall Study||2569
8671416|NCT00750893|9714737|FG000|NOT COMPLETED|Overall Study||542
8671417|NCT00750919|9714741|FG000|STARTED|Overall Study||184
8671418|NCT00750919|9714741|FG000|COMPLETED|Overall Study||126
8671419|NCT00750919|9714741|FG000|NOT COMPLETED|Overall Study||58
8671420|NCT00751023|9714747|FG000|STARTED|Overall Study||20
8671421|NCT00751023|9714748|FG001|STARTED|Overall Study||20
8671422|NCT00751023|9714747|FG000|COMPLETED|Overall Study||9
8671423|NCT00751023|9714748|FG001|COMPLETED|Overall Study||13
8671424|NCT00751023|9714747|FG000|NOT COMPLETED|Overall Study||11
8671425|NCT00751023|9714748|FG001|NOT COMPLETED|Overall Study||7
8671426|NCT00751036|9714756|FG000|STARTED|Overall Study|Started = Treated|48
8671427|NCT00751036|9714757|FG001|STARTED|Overall Study|Started = Treated|46
8671428|NCT00751036|9714756|FG000|COMPLETED|Overall Study|Reason Not Completed = Reason for End of Treatment|0
8671429|NCT00751036|9714757|FG001|COMPLETED|Overall Study|Reason Not Completed = Reason for End of Treatment|0
8671430|NCT00751036|9714756|FG000|NOT COMPLETED|Overall Study||48
8671431|NCT00751036|9714757|FG001|NOT COMPLETED|Overall Study||46
8671432|NCT00751101|9714765|FG000|STARTED|Overall Study||12
8671433|NCT00751101|9714766|FG001|STARTED|Overall Study||12
8671434|NCT00751101|9714765|FG000|Started Capecitabine|Overall Study||11
8671435|NCT00751101|9714766|FG001|Started Capecitabine|Overall Study||11
8671436|NCT00751101|9714765|FG000|COMPLETED|Overall Study||10
8671437|NCT00751101|9714766|FG001|COMPLETED|Overall Study||7
8671438|NCT00751101|9714765|FG000|NOT COMPLETED|Overall Study||2
8671439|NCT00751101|9714766|FG001|NOT COMPLETED|Overall Study||5
8671440|NCT00751114|9714778|FG000|STARTED|Overall Study|randomized|250
8671441|NCT00751114|9714779|FG001|STARTED|Overall Study||265
8671442|NCT00751114|9714778|FG000|TREATED = Safety Population|Overall Study|safety population: randomized patients who received at least one dose of investigational product|237
8671443|NCT00751114|9714779|FG001|TREATED = Safety Population|Overall Study||264
8671444|NCT00751114|9714778|FG000|mITT Population|Overall Study|modified Intent-To-Treat population: treated patients with at least 1 on-treatment efficacy measure|227
8671445|NCT00751114|9714779|FG001|mITT Population|Overall Study||253
8671446|NCT00751114|9714778|FG000|COMPLETED|Overall Study||212
8671447|NCT00751114|9714779|FG001|COMPLETED|Overall Study||233
8671448|NCT00751114|9714778|FG000|NOT COMPLETED|Overall Study||38
8671449|NCT00751114|9714779|FG001|NOT COMPLETED|Overall Study||32
8671450|NCT00751140|9714785|FG000|STARTED|Overall Study||20
8671451|NCT00751140|9714785|FG000|COMPLETED|Overall Study||19
8671452|NCT00751140|9714785|FG000|NOT COMPLETED|Overall Study||1
8671453|NCT00751179|9714795|FG000|STARTED|Overall Study|10 of 76 randomized were not treated with sugammadex; 4 of these 10 received rocuronium only|76
8671454|NCT00751179|9714796|FG001|STARTED|Overall Study|5 of 85 randomized were not treated with succinylcholine|85
8671455|NCT00751179|9714795|FG000|COMPLETED|Overall Study||62
8671456|NCT00751179|9714796|FG001|COMPLETED|Overall Study||70
8671457|NCT00751179|9714795|FG000|NOT COMPLETED|Overall Study||14
8671458|NCT00751179|9714796|FG001|NOT COMPLETED|Overall Study||15
8671459|NCT00751296|9714803|FG000|STARTED|Overall Study|The start date of the study was 25 August 2006.|27
8671460|NCT00751296|9714803|FG000|COMPLETED|Overall Study||25
8671461|NCT00751296|9714803|FG000|NOT COMPLETED|Overall Study||2
8671462|NCT00751348|9714809|FG000|STARTED|Overall Study||313
8671463|NCT00751348|9714810|FG001|STARTED|Overall Study||161
8671464|NCT00751348|9714809|FG000|COMPLETED|Overall Study||307
8671465|NCT00751348|9714810|FG001|COMPLETED|Overall Study||159
8671466|NCT00751348|9714809|FG000|NOT COMPLETED|Overall Study||6
8671467|NCT00751348|9714810|FG001|NOT COMPLETED|Overall Study||2
8671468|NCT00751400|9714816|FG000|STARTED|Overall Study||497
8671469|NCT00751400|9714816|FG000|Subjects Provided Drug|Overall Study||497
8671470|NCT00751400|9714816|FG000|Subjects Consumed Drug|Overall Study||485
8671471|NCT00751400|9714816|FG000|Subjects Provided Detailed Use Data|Overall Study||467
8671472|NCT00751400|9714816|FG000|COMPLETED|Overall Study||487
8671473|NCT00751400|9714816|FG000|NOT COMPLETED|Overall Study||10
8671474|NCT00751530|9714822|FG000|STARTED|Overall Study||332
8671475|NCT00751530|9714823|FG001|STARTED|Overall Study||110
8671476|NCT00751530|9714822|FG000|COMPLETED|Overall Study||332
8671477|NCT00751530|9714823|FG001|COMPLETED|Overall Study||110
8671478|NCT00751530|9714822|FG000|NOT COMPLETED|Overall Study||0
8671479|NCT00751530|9714823|FG001|NOT COMPLETED|Overall Study||0
8671480|NCT00751621|9714829|FG000|STARTED|Overall Study||40
8671481|NCT00751621|9714829|FG000|COMPLETED|Overall Study||36
8671482|NCT00751621|9714829|FG000|NOT COMPLETED|Overall Study||4
8671483|NCT00751634|9714835|FG000|STARTED|Overall Study||20
8671484|NCT00751634|9714835|FG000|COMPLETED|Overall Study||20
8774457|NCT01290315|9824336|FG000|COMPLETED|Overall Study||11
8774458|NCT01290315|9824337|FG001|COMPLETED|Overall Study||9
8774459|NCT01290315|9824338|FG002|COMPLETED|Overall Study||10
8774460|NCT01290315|9824339|FG003|COMPLETED|Overall Study||8
8774461|NCT01290315|9824336|FG000|NOT COMPLETED|Overall Study||3
8774462|NCT01290315|9824337|FG001|NOT COMPLETED|Overall Study||3
8774463|NCT01290315|9824338|FG002|NOT COMPLETED|Overall Study||0
8774464|NCT01290315|9824339|FG003|NOT COMPLETED|Overall Study||5
8774465|NCT01290341|9824350|FG000|STARTED|Overall Study||573
8774466|NCT01290341|9824351|FG001|STARTED|Overall Study||287
8774467|NCT01290341|9824350|FG000|COMPLETED|Overall Study||481
8774468|NCT01290341|9824351|FG001|COMPLETED|Overall Study||258
8774469|NCT01290341|9824350|FG000|NOT COMPLETED|Overall Study||92
8774470|NCT01290341|9824351|FG001|NOT COMPLETED|Overall Study||29
8774471|NCT01290445|9824360|FG000|STARTED|Overall Study||335
8774472|NCT01290445|9824361|FG001|STARTED|Overall Study||78412
8774473|NCT01290445|9824362|FG002|STARTED|Overall Study||806438
8774474|NCT01290445|9824360|FG000|COMPLETED|Overall Study||335
8774475|NCT01290445|9824361|FG001|COMPLETED|Overall Study||78412
8774476|NCT01290445|9824362|FG002|COMPLETED|Overall Study||806438
8774477|NCT01290445|9824360|FG000|NOT COMPLETED|Overall Study||0
8774478|NCT01290445|9824361|FG001|NOT COMPLETED|Overall Study||0
8774479|NCT01290445|9824362|FG002|NOT COMPLETED|Overall Study||0
8774480|NCT01290484|9824370|FG000|STARTED|Overall Study||7
8774481|NCT01290484|9824370|FG000|COMPLETED|Overall Study||7
8774482|NCT01290484|9824370|FG000|NOT COMPLETED|Overall Study||0
8774483|NCT01290523|9824374|FG000|STARTED|Overall Study||14
8774484|NCT01290523|9824374|FG000|COMPLETED|Overall Study||11
8774485|NCT01290523|9824374|FG000|NOT COMPLETED|Overall Study||3
8774486|NCT01290536|9824378|FG000|STARTED|Overall Study||42
8774487|NCT01290536|9824378|FG000|COMPLETED|Overall Study||42
8774488|NCT01290536|9824378|FG000|NOT COMPLETED|Overall Study||0
8774489|NCT01290601|9824387|FG000|STARTED|Overall Study||46
8774490|NCT01290601|9824388|FG001|STARTED|Overall Study||24
8774491|NCT01290601|9824389|FG002|STARTED|Overall Study||0
8774492|NCT01290601|9824390|FG003|STARTED|Overall Study||0
8774493|NCT01290601|9824387|FG000|COMPLETED|Overall Study||35
8774494|NCT01290601|9824388|FG001|COMPLETED|Overall Study||19
8774495|NCT01290601|9824389|FG002|COMPLETED|Overall Study||0
8774496|NCT01290601|9824390|FG003|COMPLETED|Overall Study||0
8774497|NCT01290601|9824387|FG000|NOT COMPLETED|Overall Study||11
8774498|NCT01290601|9824388|FG001|NOT COMPLETED|Overall Study||5
8774499|NCT01290601|9824389|FG002|NOT COMPLETED|Overall Study||0
8774500|NCT01290601|9824390|FG003|NOT COMPLETED|Overall Study||0
8774501|NCT01290614|9824398|FG000|STARTED|Overall Study||1070
8774502|NCT01290614|9824399|FG001|STARTED|Overall Study||1129
8774503|NCT01290614|9824398|FG000|COMPLETED|Overall Study||518
8774504|NCT01290614|9824399|FG001|COMPLETED|Overall Study||1129
8774505|NCT01290614|9824398|FG000|NOT COMPLETED|Overall Study||552
8774506|NCT01290614|9824399|FG001|NOT COMPLETED|Overall Study||0
8774507|NCT01290627|9824408|FG000|STARTED|Overall Study||10
8774508|NCT01290627|9824409|FG001|STARTED|Overall Study||10
8774509|NCT01290627|9824410|FG002|STARTED|Overall Study||10
8774510|NCT01290627|9824408|FG000|COMPLETED|Overall Study||10
8774511|NCT01290627|9824409|FG001|COMPLETED|Overall Study||10
8774512|NCT01290627|9824410|FG002|COMPLETED|Overall Study||10
8774513|NCT01290627|9824408|FG000|NOT COMPLETED|Overall Study||0
8774514|NCT01290627|9824409|FG001|NOT COMPLETED|Overall Study||0
8774515|NCT01290627|9824410|FG002|NOT COMPLETED|Overall Study||0
8774516|NCT01290640|9824420|FG000|STARTED|Overall Study||12
8774517|NCT01290640|9824421|FG001|STARTED|Overall Study||10
8774518|NCT01290640|9824420|FG000|COMPLETED|Overall Study||12
8774519|NCT01290640|9824421|FG001|COMPLETED|Overall Study||10
8774520|NCT01290640|9824420|FG000|NOT COMPLETED|Overall Study||0
8774521|NCT01290640|9824421|FG001|NOT COMPLETED|Overall Study||0
8774522|NCT01290666|9824427|FG000|STARTED|Overall Study||93
8774523|NCT01290666|9824427|FG000|COMPLETED|Overall Study||55
8774524|NCT01290666|9824427|FG000|NOT COMPLETED|Overall Study||38
8774525|NCT01290679|9824433|FG000|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|257
8774526|NCT01290679|9824434|FG001|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|134
8774527|NCT01290679|9824433|FG000|COMPLETED|Overall Study||241
8774528|NCT01290679|9824434|FG001|COMPLETED|Overall Study||113
8774529|NCT01290679|9824433|FG000|NOT COMPLETED|Overall Study||16
8774530|NCT01290679|9824434|FG001|NOT COMPLETED|Overall Study||21
8774531|NCT01290731|9824440|FG000|STARTED|Overall Study||49
8774532|NCT01290731|9824440|FG000|COMPLETED|Overall Study||48
8774533|NCT01290731|9824440|FG000|NOT COMPLETED|Overall Study||1
8774534|NCT01290757|9824446|FG000|STARTED|Overall Study||90
8774535|NCT01290757|9824447|FG001|STARTED|Overall Study||90
8774536|NCT01290757|9824446|FG000|COMPLETED|Overall Study||88
8774537|NCT01290757|9824447|FG001|COMPLETED|Overall Study||88
8774538|NCT01290757|9824446|FG000|NOT COMPLETED|Overall Study||2
8774539|NCT01290757|9824447|FG001|NOT COMPLETED|Overall Study||2
8774540|NCT01290796|9824453|FG000|STARTED|Overall Study||153
8774541|NCT01290796|9824453|FG000|COMPLETED|Overall Study||123
8774542|NCT01290796|9824453|FG000|NOT COMPLETED|Overall Study||30
8774543|NCT01290874|9824459|FG000|STARTED|Overall Study||532
8774544|NCT01290874|9824460|FG001|STARTED|Overall Study||538
8774545|NCT01290874|9824459|FG000|COMPLETED|Overall Study||122
8774546|NCT01290874|9824460|FG001|COMPLETED|Overall Study||134
8774547|NCT01290874|9824459|FG000|NOT COMPLETED|Overall Study||410
8774548|NCT01290874|9824460|FG001|NOT COMPLETED|Overall Study||404
8774549|NCT01290887|9824469|FG000|STARTED|Overall Study||481
8774550|NCT01290887|9824470|FG001|STARTED|Overall Study||571
8774551|NCT01290887|9824469|FG000|Safety Analysis Set|Overall Study|One patient was enrolled but not treated.|480
8774552|NCT01290887|9824470|FG001|Safety Analysis Set|Overall Study||571
8774553|NCT01290887|9824469|FG000|COMPLETED|Overall Study|Completed study includes completion of the 104 week treatment phase and the 90-day follow-up.|15
8774554|NCT01290887|9824470|FG001|COMPLETED|Overall Study|Completed study includes completion of the 104 week treatment phase and the 90-day follow-up.|35
8774555|NCT01290887|9824469|FG000|NOT COMPLETED|Overall Study||466
8774556|NCT01290887|9824470|FG001|NOT COMPLETED|Overall Study||536
8774557|NCT01290913|9824476|FG000|STARTED|Overall Study||13
8774558|NCT01290913|9824476|FG000|COMPLETED|Overall Study||12
8774559|NCT01290913|9824476|FG000|NOT COMPLETED|Overall Study||1
8774560|NCT01290952|9824482|FG000|STARTED|Overall Study||204
8774561|NCT01290952|9824483|FG001|STARTED|Overall Study||207
8774562|NCT01290952|9824482|FG000|COMPLETED|Overall Study||192
8774563|NCT01290952|9824483|FG001|COMPLETED|Overall Study||193
8774564|NCT01290952|9824482|FG000|NOT COMPLETED|Overall Study||12
8774565|NCT01290952|9824483|FG001|NOT COMPLETED|Overall Study||14
8774566|NCT01290978|9824491|FG000|STARTED|Overall Study||22
8774567|NCT01290978|9824491|FG000|COMPLETED|Overall Study||22
8774568|NCT01290978|9824491|FG000|NOT COMPLETED|Overall Study||0
8774569|NCT01291017|9824496|FG000|STARTED|Overall Study||19
8774570|NCT01291017|9824496|FG000|COMPLETED|Overall Study||14
8774571|NCT01291017|9824496|FG000|NOT COMPLETED|Overall Study||5
8774572|NCT01291056|9824502|FG000|STARTED|Intervention One (Menstraution Day 3-7)||10
8774573|NCT01291056|9824503|FG001|STARTED|Intervention One (Menstraution Day 3-7)||10
8774574|NCT01291056|9824502|FG000|COMPLETED|Intervention One (Menstraution Day 3-7)||10
8774575|NCT01291056|9824503|FG001|COMPLETED|Intervention One (Menstraution Day 3-7)||10
8774576|NCT01291056|9824502|FG000|NOT COMPLETED|Intervention One (Menstraution Day 3-7)||0
8774577|NCT01291056|9824503|FG001|NOT COMPLETED|Intervention One (Menstraution Day 3-7)||0
8774578|NCT01291056|9824502|FG000|STARTED|Washout||10
8774579|NCT01291056|9824503|FG001|STARTED|Washout||10
8774580|NCT01291056|9824502|FG000|COMPLETED|Washout||10
8774581|NCT01291056|9824503|FG001|COMPLETED|Washout||10
8774582|NCT01291056|9824502|FG000|NOT COMPLETED|Washout||0
8774583|NCT01291056|9824503|FG001|NOT COMPLETED|Washout||0
8774584|NCT01291056|9824502|FG000|STARTED|Intervention Two (Menstration Days 3-7)||10
8774585|NCT01291056|9824503|FG001|STARTED|Intervention Two (Menstration Days 3-7)||10
8774586|NCT01291056|9824502|FG000|COMPLETED|Intervention Two (Menstration Days 3-7)||10
8774587|NCT01291056|9824503|FG001|COMPLETED|Intervention Two (Menstration Days 3-7)||10
8774588|NCT01291056|9824502|FG000|NOT COMPLETED|Intervention Two (Menstration Days 3-7)||0
8774589|NCT01291056|9824503|FG001|NOT COMPLETED|Intervention Two (Menstration Days 3-7)||0
8774590|NCT01291108|9824513|FG000|STARTED|Month 1 (Monotherapy)||65
8774591|NCT01291108|9824514|FG001|STARTED|Month 1 (Monotherapy)||0
8774592|NCT01291108|9824515|FG002|STARTED|Month 1 (Monotherapy)||0
8774593|NCT01291108|9824516|FG003|STARTED|Month 1 (Monotherapy)||60
8774594|NCT01291108|9824517|FG004|STARTED|Month 1 (Monotherapy)||0
8774595|NCT01291108|9824518|FG005|STARTED|Month 1 (Monotherapy)||0
8774596|NCT01291108|9824513|FG000|COMPLETED|Month 1 (Monotherapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|64
8774597|NCT01291108|9824514|FG001|COMPLETED|Month 1 (Monotherapy)||0
8774598|NCT01291108|9824515|FG002|COMPLETED|Month 1 (Monotherapy)||0
8774599|NCT01291108|9824516|FG003|COMPLETED|Month 1 (Monotherapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|60
8916256|NCT02181673|9975826|FG000|Treated|Week 24-Week 60||0
8916257|NCT02181673|9975827|FG001|Treated|Week 24-Week 60||220
8916258|NCT02181673|9975828|FG002|Treated|Week 24-Week 60||230
8916259|NCT02181673|9975826|FG000|COMPLETED|Week 24-Week 60||0
8916260|NCT02181673|9975827|FG001|COMPLETED|Week 24-Week 60||214
8916261|NCT02181673|9975828|FG002|COMPLETED|Week 24-Week 60||213
8916262|NCT02181673|9975826|FG000|NOT COMPLETED|Week 24-Week 60||0
8916263|NCT02181673|9975827|FG001|NOT COMPLETED|Week 24-Week 60||8
8916264|NCT02181673|9975828|FG002|NOT COMPLETED|Week 24-Week 60||17
8916265|NCT02181738|9975839|FG000|STARTED|Overall Study||63
8916266|NCT02181738|9975840|FG001|STARTED|Overall Study||80
8916267|NCT02181738|9975841|FG002|STARTED|Overall Study||100
8916268|NCT02181738|9975842|FG003|STARTED|Overall Study||51
8916269|NCT02181738|9975839|FG000|COMPLETED|Overall Study||61
8916270|NCT02181738|9975840|FG001|COMPLETED|Overall Study||71
8916271|NCT02181738|9975841|FG002|COMPLETED|Overall Study||90
8916272|NCT02181738|9975842|FG003|COMPLETED|Overall Study||49
8916273|NCT02181738|9975839|FG000|NOT COMPLETED|Overall Study||2
8916274|NCT02181738|9975840|FG001|NOT COMPLETED|Overall Study||9
8916275|NCT02181738|9975841|FG002|NOT COMPLETED|Overall Study||10
8916276|NCT02181738|9975842|FG003|NOT COMPLETED|Overall Study||2
8916277|NCT02181803|9975861|FG000|STARTED|Overall Study||1
8916278|NCT02181803|9975862|FG001|STARTED|Overall Study||13
8916279|NCT02181803|9975863|FG002|STARTED|Overall Study||4
8916280|NCT02181803|9975864|FG003|STARTED|Overall Study||13
8916281|NCT02181803|9975865|FG004|STARTED|Overall Study||6
8916282|NCT02181803|9975866|FG005|STARTED|Overall Study||6
8916283|NCT02181803|9975867|FG006|STARTED|Overall Study||9
8916284|NCT02181803|9975868|FG007|STARTED|Overall Study||1
8916285|NCT02181803|9975869|FG008|STARTED|Overall Study||2
8916286|NCT02181803|9975861|FG000|COMPLETED|Overall Study||1
8916287|NCT02181803|9975862|FG001|COMPLETED|Overall Study||9
8916288|NCT02181803|9975863|FG002|COMPLETED|Overall Study||4
8774600|NCT01291108|9824517|FG004|COMPLETED|Month 1 (Monotherapy)||0
8774601|NCT01291108|9824518|FG005|COMPLETED|Month 1 (Monotherapy)||0
8774602|NCT01291108|9824513|FG000|NOT COMPLETED|Month 1 (Monotherapy)||1
8774603|NCT01291108|9824514|FG001|NOT COMPLETED|Month 1 (Monotherapy)||0
8774604|NCT01291108|9824515|FG002|NOT COMPLETED|Month 1 (Monotherapy)||0
8774605|NCT01291108|9824516|FG003|NOT COMPLETED|Month 1 (Monotherapy)||0
8774606|NCT01291108|9824517|FG004|NOT COMPLETED|Month 1 (Monotherapy)||0
8774607|NCT01291108|9824518|FG005|NOT COMPLETED|Month 1 (Monotherapy)||0
8774608|NCT01291108|9824513|FG000|STARTED|Month 2 (Adjunctive Therapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|0
8774609|NCT01291108|9824514|FG001|STARTED|Month 2 (Adjunctive Therapy)||40
8774610|NCT01291108|9824515|FG002|STARTED|Month 2 (Adjunctive Therapy)||24
8774611|NCT01291108|9824516|FG003|STARTED|Month 2 (Adjunctive Therapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|0
8774612|NCT01291108|9824517|FG004|STARTED|Month 2 (Adjunctive Therapy)||34
8774613|NCT01291108|9824518|FG005|STARTED|Month 2 (Adjunctive Therapy)||26
8774614|NCT01291108|9824513|FG000|COMPLETED|Month 2 (Adjunctive Therapy)||0
8774615|NCT01291108|9824514|FG001|COMPLETED|Month 2 (Adjunctive Therapy)||38
8774616|NCT01291108|9824515|FG002|COMPLETED|Month 2 (Adjunctive Therapy)||24
8774617|NCT01291108|9824516|FG003|COMPLETED|Month 2 (Adjunctive Therapy)||0
8774618|NCT01291108|9824517|FG004|COMPLETED|Month 2 (Adjunctive Therapy)||34
8774619|NCT01291108|9824518|FG005|COMPLETED|Month 2 (Adjunctive Therapy)||25
8774620|NCT01291108|9824513|FG000|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
8774621|NCT01291108|9824514|FG001|NOT COMPLETED|Month 2 (Adjunctive Therapy)||2
8774622|NCT01291108|9824515|FG002|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
8774623|NCT01291108|9824516|FG003|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
8774624|NCT01291108|9824517|FG004|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
8774625|NCT01291108|9824518|FG005|NOT COMPLETED|Month 2 (Adjunctive Therapy)||1
8774626|NCT01291160|9824531|FG000|STARTED|Overall Study||66
8774627|NCT01291160|9824532|FG001|STARTED|Overall Study||64
8774628|NCT01291160|9824531|FG000|COMPLETED|Overall Study||48
8774629|NCT01291160|9824532|FG001|COMPLETED|Overall Study||48
8774630|NCT01291160|9824531|FG000|NOT COMPLETED|Overall Study||18
8774631|NCT01291160|9824532|FG001|NOT COMPLETED|Overall Study||16
8774632|NCT01291173|9824542|FG000|STARTED|Overall Study||64
8774633|NCT01291173|9824543|FG001|STARTED|Overall Study||66
8774634|NCT01291173|9824544|FG002|STARTED|Overall Study||65
8774635|NCT01291173|9824545|FG003|STARTED|Overall Study||65
8774636|NCT01291173|9824542|FG000|COMPLETED|Overall Study||47
9028722|NCT03208088|10091125|FG001|COMPLETED|Period 3||9
9028723|NCT03208088|10091126|FG002|COMPLETED|Period 3||10
9028724|NCT03208088|10091127|FG003|COMPLETED|Period 3||8
9028725|NCT03208088|10091128|FG004|COMPLETED|Period 3||9
9028726|NCT03208088|10091129|FG005|COMPLETED|Period 3||9
9028727|NCT03208088|10091130|FG006|COMPLETED|Period 3||8
8774637|NCT01291173|9824543|FG001|COMPLETED|Overall Study||51
8774638|NCT01291173|9824544|FG002|COMPLETED|Overall Study||52
8774639|NCT01291173|9824545|FG003|COMPLETED|Overall Study||52
8774640|NCT01291173|9824542|FG000|NOT COMPLETED|Overall Study||17
8774641|NCT01291173|9824543|FG001|NOT COMPLETED|Overall Study||15
8774642|NCT01291173|9824544|FG002|NOT COMPLETED|Overall Study||13
8774643|NCT01291173|9824545|FG003|NOT COMPLETED|Overall Study||13
8774644|NCT01291225|9824557|FG000|STARTED|Overall Study||151
8774645|NCT01291225|9824558|FG001|STARTED|Overall Study||160
8774646|NCT01291225|9824557|FG000|COMPLETED|Overall Study||66
9028728|NCT03208088|10091131|FG007|COMPLETED|Period 3||10
9028729|NCT03208088|10091132|FG008|COMPLETED|Period 3||7
9028730|NCT03208088|10091133|FG009|COMPLETED|Period 3||9
9028731|NCT03208088|10091124|FG000|NOT COMPLETED|Period 3||0
9028732|NCT03208088|10091125|FG001|NOT COMPLETED|Period 3||0
9028733|NCT03208088|10091126|FG002|NOT COMPLETED|Period 3||0
9028734|NCT03208088|10091127|FG003|NOT COMPLETED|Period 3||1
9028735|NCT03208088|10091128|FG004|NOT COMPLETED|Period 3||0
9028736|NCT03208088|10091129|FG005|NOT COMPLETED|Period 3||0
9028737|NCT03208088|10091130|FG006|NOT COMPLETED|Period 3||0
9028738|NCT03208088|10091131|FG007|NOT COMPLETED|Period 3||0
9028739|NCT03208088|10091132|FG008|NOT COMPLETED|Period 3||0
9028740|NCT03208088|10091133|FG009|NOT COMPLETED|Period 3||0
9028741|NCT03208088|10091124|FG000|STARTED|Period 4||10
9028742|NCT03208088|10091125|FG001|STARTED|Period 4||9
9028743|NCT03208088|10091126|FG002|STARTED|Period 4||10
9028744|NCT03208088|10091127|FG003|STARTED|Period 4||8
9028745|NCT03208088|10091128|FG004|STARTED|Period 4||9
8774647|NCT01291225|9824558|FG001|COMPLETED|Overall Study||121
8774648|NCT01291225|9824557|FG000|NOT COMPLETED|Overall Study||85
8774649|NCT01291225|9824558|FG001|NOT COMPLETED|Overall Study||39
8774650|NCT01291264|9824568|FG000|STARTED|Overall Study||260
8774651|NCT01291264|9824568|FG000|COMPLETED|Overall Study||260
8774652|NCT01291264|9824568|FG000|NOT COMPLETED|Overall Study||0
8774653|NCT01291277|9824574|FG000|STARTED|Overall Study||45
8774654|NCT01291277|9824575|FG001|STARTED|Overall Study||45
8774655|NCT01291277|9824574|FG000|COMPLETED|Overall Study||40
8774656|NCT01291277|9824575|FG001|COMPLETED|Overall Study||42
8774657|NCT01291277|9824574|FG000|NOT COMPLETED|Overall Study||5
8774658|NCT01291277|9824575|FG001|NOT COMPLETED|Overall Study||3
9028746|NCT03208088|10091129|FG005|STARTED|Period 4||9
9028747|NCT03208088|10091130|FG006|STARTED|Period 4||8
9028748|NCT03208088|10091131|FG007|STARTED|Period 4||10
9028749|NCT03208088|10091132|FG008|STARTED|Period 4||7
9028750|NCT03208088|10091133|FG009|STARTED|Period 4||9
9028751|NCT03208088|10091124|FG000|COMPLETED|Period 4||10
8774659|NCT01291498|9824581|FG000|STARTED|Overall Study||1
8774660|NCT01291498|9824581|FG000|COMPLETED|Overall Study||0
8774661|NCT01291498|9824581|FG000|NOT COMPLETED|Overall Study||1
8774662|NCT01291784|9824587|FG000|STARTED|Overall Study||1
8774663|NCT01291784|9824588|FG001|STARTED|Overall Study||1
8774664|NCT01291784|9824589|FG002|STARTED|Overall Study||1
8774665|NCT01291784|9824587|FG000|COMPLETED|Overall Study||1
8774666|NCT01291784|9824588|FG001|COMPLETED|Overall Study||0
8774667|NCT01291784|9824589|FG002|COMPLETED|Overall Study||1
8774668|NCT01291784|9824587|FG000|NOT COMPLETED|Overall Study||0
8774669|NCT01291784|9824588|FG001|NOT COMPLETED|Overall Study||1
8774670|NCT01291784|9824589|FG002|NOT COMPLETED|Overall Study||0
8774671|NCT01291836|9824597|FG000|STARTED|Overall Study||930
8774672|NCT01291836|9824598|FG001|STARTED|Overall Study||71
8774673|NCT01291836|9824597|FG000|COMPLETED|Overall Study||930
8774674|NCT01291836|9824598|FG001|COMPLETED|Overall Study||71
8774675|NCT01291836|9824597|FG000|NOT COMPLETED|Overall Study||0
8774676|NCT01291836|9824598|FG001|NOT COMPLETED|Overall Study||0
8774677|NCT01292005|9824606|FG000|STARTED|Overall Study||14
8774678|NCT01292005|9824607|FG001|STARTED|Overall Study||14
8774679|NCT01292005|9824606|FG000|COMPLETED|Overall Study||14
8774680|NCT01292005|9824607|FG001|COMPLETED|Overall Study||14
8774681|NCT01292005|9824606|FG000|NOT COMPLETED|Overall Study||0
8774682|NCT01292005|9824607|FG001|NOT COMPLETED|Overall Study||0
8774683|NCT01292057|9824615|FG000|STARTED|Overall Study||49
8774684|NCT01292057|9824616|FG001|STARTED|Overall Study||50
8774685|NCT01292057|9824615|FG000|COMPLETED|Overall Study||47
8774686|NCT01292057|9824616|FG001|COMPLETED|Overall Study||48
8774687|NCT01292057|9824615|FG000|NOT COMPLETED|Overall Study||2
8774688|NCT01292057|9824616|FG001|NOT COMPLETED|Overall Study||2
8774689|NCT01292135|9824624|FG000|STARTED|Overall Study||3
8774690|NCT01292135|9824625|FG001|STARTED|Overall Study||30
8774691|NCT01292135|9824624|FG000|COMPLETED|Overall Study||3
8774692|NCT01292135|9824625|FG001|COMPLETED|Overall Study||21
8774693|NCT01292135|9824624|FG000|NOT COMPLETED|Overall Study||0
8774694|NCT01292135|9824625|FG001|NOT COMPLETED|Overall Study||9
8774695|NCT01292187|9824635|FG000|STARTED|Overall Study||86
8774696|NCT01292187|9824636|FG001|STARTED|Overall Study||43
8774697|NCT01292187|9824635|FG000|COMPLETED|Overall Study||69
8774698|NCT01292187|9824636|FG001|COMPLETED|Overall Study||30
8774699|NCT01292187|9824635|FG000|NOT COMPLETED|Overall Study||17
8774700|NCT01292187|9824636|FG001|NOT COMPLETED|Overall Study||13
8774701|NCT01292226|9824643|FG000|STARTED|Overall Study||45
8774702|NCT01292226|9824643|FG000|COMPLETED|Overall Study||32
8774703|NCT01292226|9824643|FG000|NOT COMPLETED|Overall Study||13
8774704|NCT01292239|9824649|FG000|STARTED|Overall Study||123
8774705|NCT01292239|9824650|FG001|STARTED|Overall Study||60
8774706|NCT01292239|9824649|FG000|COMPLETED|Overall Study||119
8774707|NCT01292239|9824650|FG001|COMPLETED|Overall Study||53
8774708|NCT01292239|9824649|FG000|NOT COMPLETED|Overall Study||4
8774709|NCT01292239|9824650|FG001|NOT COMPLETED|Overall Study||7
8774710|NCT01292252|9824658|FG000|STARTED|Overall Study||21
8774711|NCT01292252|9824659|FG001|STARTED|Overall Study||15
8774712|NCT01292252|9824658|FG000|COMPLETED|Overall Study||21
8774713|NCT01292252|9824659|FG001|COMPLETED|Overall Study||14
8774714|NCT01292252|9824658|FG000|NOT COMPLETED|Overall Study||0
8774715|NCT01292252|9824659|FG001|NOT COMPLETED|Overall Study||1
8774716|NCT01292304|9824665|FG000|STARTED|Overall Study||10
8774717|NCT01292304|9824665|FG000|COMPLETED|Overall Study||10
8774718|NCT01292304|9824665|FG000|NOT COMPLETED|Overall Study||0
8774719|NCT01292447|9824671|FG000|STARTED|Overall Study||75
8774720|NCT01292447|9824672|FG001|STARTED|Overall Study||75
8774721|NCT01292447|9824671|FG000|COMPLETED|Overall Study||73
8774722|NCT01292447|9824672|FG001|COMPLETED|Overall Study||72
8774723|NCT01292447|9824671|FG000|NOT COMPLETED|Overall Study||2
8774724|NCT01292447|9824672|FG001|NOT COMPLETED|Overall Study||3
8774725|NCT01292473|9824682|FG000|STARTED|Overall Study||79
8774726|NCT01292473|9824683|FG001|STARTED|Overall Study||82
8774727|NCT01292473|9824684|FG002|STARTED|Overall Study||83
8774728|NCT01292473|9824685|FG003|STARTED|Overall Study||79
8774729|NCT01292473|9824682|FG000|COMPLETED|Overall Study||74
8774730|NCT01292473|9824683|FG001|COMPLETED|Overall Study||75
8774731|NCT01292473|9824684|FG002|COMPLETED|Overall Study||74
8774732|NCT01292473|9824685|FG003|COMPLETED|Overall Study||67
8774733|NCT01292473|9824682|FG000|NOT COMPLETED|Overall Study||5
8774734|NCT01292473|9824683|FG001|NOT COMPLETED|Overall Study||7
8774735|NCT01292473|9824684|FG002|NOT COMPLETED|Overall Study||9
8774736|NCT01292473|9824685|FG003|NOT COMPLETED|Overall Study||12
8774737|NCT01292486|9824699|FG000|STARTED|Overall Study||32
8774738|NCT01292486|9824699|FG000|COMPLETED|Overall Study||26
8774739|NCT01292486|9824699|FG000|NOT COMPLETED|Overall Study||6
8774740|NCT01292538|9824706|FG000|STARTED|Overall Study||35
8774741|NCT01292538|9824707|FG001|STARTED|Overall Study||32
8774742|NCT01292538|9824706|FG000|COMPLETED|Overall Study||35
8774743|NCT01292538|9824707|FG001|COMPLETED|Overall Study||32
8774744|NCT01292538|9824706|FG000|NOT COMPLETED|Overall Study||0
8774745|NCT01292538|9824707|FG001|NOT COMPLETED|Overall Study||0
8774746|NCT01292603|9824718|FG000|STARTED|Part 1: Pilot Dose Selection Period||16
8774747|NCT01292603|9824719|FG001|STARTED|Part 1: Pilot Dose Selection Period||17
8774748|NCT01292603|9824720|FG002|STARTED|Part 1: Pilot Dose Selection Period|1 participant received a dose of 1000mg of rituximab by oversight.|23
8774749|NCT01292603|9824721|FG003|STARTED|Part 1: Pilot Dose Selection Period|These participants were withdrawn prior to SC treatment.|8
8774750|NCT01292603|9824722|FG004|STARTED|Part 1: Pilot Dose Selection Period||0
8774751|NCT01292603|9824723|FG005|STARTED|Part 1: Pilot Dose Selection Period||0
8774752|NCT01292603|9824718|FG000|COMPLETED|Part 1: Pilot Dose Selection Period||16
8774753|NCT01292603|9824719|FG001|COMPLETED|Part 1: Pilot Dose Selection Period||17
8774754|NCT01292603|9824720|FG002|COMPLETED|Part 1: Pilot Dose Selection Period||23
8774755|NCT01292603|9824721|FG003|COMPLETED|Part 1: Pilot Dose Selection Period||0
8774756|NCT01292603|9824722|FG004|COMPLETED|Part 1: Pilot Dose Selection Period||0
8774757|NCT01292603|9824723|FG005|COMPLETED|Part 1: Pilot Dose Selection Period||0
8774758|NCT01292603|9824718|FG000|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
8774759|NCT01292603|9824719|FG001|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
8774760|NCT01292603|9824720|FG002|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
8774761|NCT01292603|9824721|FG003|NOT COMPLETED|Part 1: Pilot Dose Selection Period||8
8774762|NCT01292603|9824722|FG004|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
8774763|NCT01292603|9824723|FG005|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
8774764|NCT01292603|9824718|FG000|STARTED|Part 1: Regular Follow-Up Period||16
8774765|NCT01292603|9824719|FG001|STARTED|Part 1: Regular Follow-Up Period||17
8774766|NCT01292603|9824720|FG002|STARTED|Part 1: Regular Follow-Up Period||23
8774767|NCT01292603|9824721|FG003|STARTED|Part 1: Regular Follow-Up Period||8
8774768|NCT01292603|9824722|FG004|STARTED|Part 1: Regular Follow-Up Period||0
8774769|NCT01292603|9824723|FG005|STARTED|Part 1: Regular Follow-Up Period||0
8774770|NCT01292603|9824718|FG000|COMPLETED|Part 1: Regular Follow-Up Period|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|10
8774771|NCT01292603|9824719|FG001|COMPLETED|Part 1: Regular Follow-Up Period|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|10
8774772|NCT01292603|9824720|FG002|COMPLETED|Part 1: Regular Follow-Up Period|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|17
8774773|NCT01292603|9824721|FG003|COMPLETED|Part 1: Regular Follow-Up Period||7
8774774|NCT01292603|9824722|FG004|COMPLETED|Part 1: Regular Follow-Up Period||0
8774775|NCT01292603|9824723|FG005|COMPLETED|Part 1: Regular Follow-Up Period||0
8774776|NCT01292603|9824718|FG000|NOT COMPLETED|Part 1: Regular Follow-Up Period||6
8774777|NCT01292603|9824719|FG001|NOT COMPLETED|Part 1: Regular Follow-Up Period||7
8774778|NCT01292603|9824720|FG002|NOT COMPLETED|Part 1: Regular Follow-Up Period||6
8774779|NCT01292603|9824721|FG003|NOT COMPLETED|Part 1: Regular Follow-Up Period||1
8774780|NCT01292603|9824722|FG004|NOT COMPLETED|Part 1: Regular Follow-Up Period||0
8774781|NCT01292603|9824723|FG005|NOT COMPLETED|Part 1: Regular Follow-Up Period||0
8774782|NCT01292603|9824718|FG000|STARTED|Part 2: Dose Confirmation Period||0
8774783|NCT01292603|9824719|FG001|STARTED|Part 2: Dose Confirmation Period||0
8774784|NCT01292603|9824720|FG002|STARTED|Part 2: Dose Confirmation Period||0
8774785|NCT01292603|9824721|FG003|STARTED|Part 2: Dose Confirmation Period||0
8774786|NCT01292603|9824722|FG004|STARTED|Part 2: Dose Confirmation Period||88
8774787|NCT01292603|9824723|FG005|STARTED|Part 2: Dose Confirmation Period||88
8774788|NCT01292603|9824718|FG000|COMPLETED|Part 2: Dose Confirmation Period||0
8774789|NCT01292603|9824719|FG001|COMPLETED|Part 2: Dose Confirmation Period||0
8774790|NCT01292603|9824720|FG002|COMPLETED|Part 2: Dose Confirmation Period||0
8774791|NCT01292603|9824721|FG003|COMPLETED|Part 2: Dose Confirmation Period||0
8774792|NCT01292603|9824722|FG004|COMPLETED|Part 2: Dose Confirmation Period||72
8774793|NCT01292603|9824723|FG005|COMPLETED|Part 2: Dose Confirmation Period||73
8774794|NCT01292603|9824718|FG000|NOT COMPLETED|Part 2: Dose Confirmation Period||0
8774795|NCT01292603|9824719|FG001|NOT COMPLETED|Part 2: Dose Confirmation Period||0
8774796|NCT01292603|9824720|FG002|NOT COMPLETED|Part 2: Dose Confirmation Period||0
8774797|NCT01292603|9824721|FG003|NOT COMPLETED|Part 2: Dose Confirmation Period||0
8774798|NCT01292603|9824722|FG004|NOT COMPLETED|Part 2: Dose Confirmation Period||16
8774799|NCT01292603|9824723|FG005|NOT COMPLETED|Part 2: Dose Confirmation Period||15
8774800|NCT01292603|9824718|FG000|STARTED|Part 2: Regular Follow-Up||0
8774801|NCT01292603|9824719|FG001|STARTED|Part 2: Regular Follow-Up||0
8774802|NCT01292603|9824720|FG002|STARTED|Part 2: Regular Follow-Up||0
8774803|NCT01292603|9824721|FG003|STARTED|Part 2: Regular Follow-Up||0
8774804|NCT01292603|9824722|FG004|STARTED|Part 2: Regular Follow-Up|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|87
8774805|NCT01292603|9824723|FG005|STARTED|Part 2: Regular Follow-Up|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|87
8774806|NCT01292603|9824718|FG000|COMPLETED|Part 2: Regular Follow-Up||0
8774807|NCT01292603|9824719|FG001|COMPLETED|Part 2: Regular Follow-Up||0
8774808|NCT01292603|9824720|FG002|COMPLETED|Part 2: Regular Follow-Up||0
8774809|NCT01292603|9824721|FG003|COMPLETED|Part 2: Regular Follow-Up||0
8774810|NCT01292603|9824722|FG004|COMPLETED|Part 2: Regular Follow-Up||68
8774811|NCT01292603|9824723|FG005|COMPLETED|Part 2: Regular Follow-Up||75
8774812|NCT01292603|9824718|FG000|NOT COMPLETED|Part 2: Regular Follow-Up||0
8774813|NCT01292603|9824719|FG001|NOT COMPLETED|Part 2: Regular Follow-Up||0
8774814|NCT01292603|9824720|FG002|NOT COMPLETED|Part 2: Regular Follow-Up||0
9028752|NCT03208088|10091125|FG001|COMPLETED|Period 4||9
9028753|NCT03208088|10091126|FG002|COMPLETED|Period 4||10
9028754|NCT03208088|10091127|FG003|COMPLETED|Period 4||7
9028755|NCT03208088|10091128|FG004|COMPLETED|Period 4||9
9028756|NCT03208088|10091129|FG005|COMPLETED|Period 4||9
9028757|NCT03208088|10091130|FG006|COMPLETED|Period 4||8
9028758|NCT03208088|10091131|FG007|COMPLETED|Period 4||10
9028759|NCT03208088|10091132|FG008|COMPLETED|Period 4||7
9028760|NCT03208088|10091133|FG009|COMPLETED|Period 4||9
9028761|NCT03208088|10091124|FG000|NOT COMPLETED|Period 4||0
9028762|NCT03208088|10091125|FG001|NOT COMPLETED|Period 4||0
9028763|NCT03208088|10091126|FG002|NOT COMPLETED|Period 4||0
9028764|NCT03208088|10091127|FG003|NOT COMPLETED|Period 4||1
9028765|NCT03208088|10091128|FG004|NOT COMPLETED|Period 4||0
9028766|NCT03208088|10091129|FG005|NOT COMPLETED|Period 4||0
9028767|NCT03208088|10091130|FG006|NOT COMPLETED|Period 4||0
9028768|NCT03208088|10091131|FG007|NOT COMPLETED|Period 4||0
9028769|NCT03208088|10091132|FG008|NOT COMPLETED|Period 4||0
9028770|NCT03208088|10091133|FG009|NOT COMPLETED|Period 4||0
9028771|NCT03208088|10091124|FG000|STARTED|Period 5||10
9028772|NCT03208088|10091125|FG001|STARTED|Period 5||9
9028773|NCT03208088|10091126|FG002|STARTED|Period 5||10
9028774|NCT03208088|10091127|FG003|STARTED|Period 5||7
9028775|NCT03208088|10091128|FG004|STARTED|Period 5||9
9028776|NCT03208088|10091129|FG005|STARTED|Period 5||9
9028777|NCT03208088|10091130|FG006|STARTED|Period 5||8
9028778|NCT03208088|10091131|FG007|STARTED|Period 5||10
9028779|NCT03208088|10091132|FG008|STARTED|Period 5||7
9028780|NCT03208088|10091133|FG009|STARTED|Period 5||9
9028781|NCT03208088|10091124|FG000|COMPLETED|Period 5||10
8774815|NCT01292603|9824721|FG003|NOT COMPLETED|Part 2: Regular Follow-Up||0
8774816|NCT01292603|9824722|FG004|NOT COMPLETED|Part 2: Regular Follow-Up||19
8774817|NCT01292603|9824723|FG005|NOT COMPLETED|Part 2: Regular Follow-Up||12
8774818|NCT01292603|9824718|FG000|STARTED|Overall Survival Status||16
8774819|NCT01292603|9824719|FG001|STARTED|Overall Survival Status||17
8774820|NCT01292603|9824720|FG002|STARTED|Overall Survival Status||23
8774821|NCT01292603|9824721|FG003|STARTED|Overall Survival Status||8
8774822|NCT01292603|9824722|FG004|STARTED|Overall Survival Status||88
8774823|NCT01292603|9824723|FG005|STARTED|Overall Survival Status||88
8774824|NCT01292603|9824718|FG000|COMPLETED|Overall Survival Status||13
8774825|NCT01292603|9824719|FG001|COMPLETED|Overall Survival Status||16
8774826|NCT01292603|9824720|FG002|COMPLETED|Overall Survival Status||20
8774827|NCT01292603|9824721|FG003|COMPLETED|Overall Survival Status||7
8774828|NCT01292603|9824722|FG004|COMPLETED|Overall Survival Status||72
8774829|NCT01292603|9824723|FG005|COMPLETED|Overall Survival Status||78
8774830|NCT01292603|9824718|FG000|NOT COMPLETED|Overall Survival Status||3
8774831|NCT01292603|9824719|FG001|NOT COMPLETED|Overall Survival Status||1
8774832|NCT01292603|9824720|FG002|NOT COMPLETED|Overall Survival Status||3
8774833|NCT01292603|9824721|FG003|NOT COMPLETED|Overall Survival Status||1
8774834|NCT01292603|9824722|FG004|NOT COMPLETED|Overall Survival Status||16
8774835|NCT01292603|9824723|FG005|NOT COMPLETED|Overall Survival Status||10
8774836|NCT01292629|9824744|FG000|STARTED|Overall Study||125
8774837|NCT01292629|9824744|FG000|COMPLETED|Overall Study||125
8774838|NCT01292629|9824744|FG000|NOT COMPLETED|Overall Study||0
8774839|NCT01292642|9824749|FG000|STARTED|Overall Study||12
8774840|NCT01292642|9824749|FG000|COMPLETED|Overall Study||7
8774841|NCT01292642|9824749|FG000|NOT COMPLETED|Overall Study||5
8774842|NCT01292746|9824757|FG000|STARTED|Overall Study||14
8774843|NCT01292746|9824757|FG000|COMPLETED|Overall Study||14
8774844|NCT01292746|9824757|FG000|NOT COMPLETED|Overall Study||0
8774845|NCT01292798|9824761|FG000|STARTED|Overall Study||43
8774846|NCT01292798|9824761|FG000|Persistent DME After 3 Months|Overall Study|Subjects with persistent DME after 3 monthly injections of 0.5 mg of ranibizumab|29
8774847|NCT01292798|9824761|FG000|COMPLETED|Overall Study||43
8774848|NCT01292798|9824761|FG000|NOT COMPLETED|Overall Study||0
8774849|NCT01292837|9824765|FG000|STARTED|Overall Study||13
8774850|NCT01292837|9824765|FG000|COMPLETED|Overall Study||11
9028782|NCT03208088|10091125|FG001|COMPLETED|Period 5||9
9028783|NCT03208088|10091126|FG002|COMPLETED|Period 5||10
9028784|NCT03208088|10091127|FG003|COMPLETED|Period 5||7
9028785|NCT03208088|10091128|FG004|COMPLETED|Period 5||9
9028786|NCT03208088|10091129|FG005|COMPLETED|Period 5||9
9028787|NCT03208088|10091130|FG006|COMPLETED|Period 5||8
9028788|NCT03208088|10091131|FG007|COMPLETED|Period 5||10
9028789|NCT03208088|10091132|FG008|COMPLETED|Period 5||7
9028790|NCT03208088|10091133|FG009|COMPLETED|Period 5||9
9028791|NCT03208088|10091124|FG000|NOT COMPLETED|Period 5||0
9028792|NCT03208088|10091125|FG001|NOT COMPLETED|Period 5||0
9028793|NCT03208088|10091126|FG002|NOT COMPLETED|Period 5||0
9028794|NCT03208088|10091127|FG003|NOT COMPLETED|Period 5||0
9028795|NCT03208088|10091128|FG004|NOT COMPLETED|Period 5||0
9028796|NCT03208088|10091129|FG005|NOT COMPLETED|Period 5||0
9028797|NCT03208088|10091130|FG006|NOT COMPLETED|Period 5||0
9028798|NCT03208088|10091131|FG007|NOT COMPLETED|Period 5||0
9028799|NCT03208088|10091132|FG008|NOT COMPLETED|Period 5||0
9028800|NCT03208088|10091133|FG009|NOT COMPLETED|Period 5||0
9028801|NCT03208166|10091147|FG000|STARTED|Overall Study||1
9028802|NCT03208166|10091148|FG001|STARTED|Overall Study||1
9028803|NCT03208166|10091147|FG000|COMPLETED|Overall Study||1
9028804|NCT03208166|10091148|FG001|COMPLETED|Overall Study||1
9028805|NCT03208166|10091147|FG000|NOT COMPLETED|Overall Study||0
9028806|NCT03208166|10091148|FG001|NOT COMPLETED|Overall Study||0
9028807|NCT03208192|10091156|FG000|STARTED|Overall Study||32
9028808|NCT03208192|10091157|FG001|STARTED|Overall Study||36
9028809|NCT03208192|10091156|FG000|COMPLETED|Overall Study||32
9028810|NCT03208192|10091157|FG001|COMPLETED|Overall Study||36
9028811|NCT03208192|10091156|FG000|NOT COMPLETED|Overall Study||0
9028812|NCT03208192|10091157|FG001|NOT COMPLETED|Overall Study||0
9028813|NCT03208673|10091165|FG000|STARTED|Overall Study||32
9028814|NCT03208673|10091165|FG000|COMPLETED|Overall Study||32
9028815|NCT03208673|10091165|FG000|NOT COMPLETED|Overall Study||0
9028816|NCT03208933|10091169|FG000|STARTED|Overall Study||60
9028817|NCT03208933|10091169|FG000|COMPLETED|Overall Study||47
8774851|NCT01292837|9824765|FG000|NOT COMPLETED|Overall Study||2
8774852|NCT01292876|9824769|FG000|STARTED|Overall Study||17
8774853|NCT01292876|9824769|FG000|COMPLETED|Overall Study||13
8774854|NCT01292876|9824769|FG000|NOT COMPLETED|Overall Study||4
8774855|NCT01292928|9824775|FG000|STARTED|Overall Study||299
8774856|NCT01292928|9824775|FG000|Completed 12-Month Clinical Follow-up|Overall Study||266
8774857|NCT01292928|9824775|FG000|COMPLETED|Overall Study||275
8774858|NCT01292928|9824775|FG000|NOT COMPLETED|Overall Study||24
8774859|NCT01293006|9824785|FG000|STARTED|Period 1||11
8774860|NCT01293006|9824786|FG001|STARTED|Period 1||2
8774861|NCT01293006|9824787|FG002|STARTED|Period 1||9
8774862|NCT01293006|9824788|FG003|STARTED|Period 1||3
8774863|NCT01293006|9824785|FG000|COMPLETED|Period 1||11
8774864|NCT01293006|9824786|FG001|COMPLETED|Period 1||2
8774865|NCT01293006|9824787|FG002|COMPLETED|Period 1||9
8774866|NCT01293006|9824788|FG003|COMPLETED|Period 1||3
8774867|NCT01293006|9824785|FG000|NOT COMPLETED|Period 1||0
8774868|NCT01293006|9824786|FG001|NOT COMPLETED|Period 1||0
8774869|NCT01293006|9824787|FG002|NOT COMPLETED|Period 1||0
8774870|NCT01293006|9824788|FG003|NOT COMPLETED|Period 1||0
8774871|NCT01293006|9824785|FG000|STARTED|Washout||11
8774872|NCT01293006|9824786|FG001|STARTED|Washout||2
8774873|NCT01293006|9824787|FG002|STARTED|Washout||9
8774874|NCT01293006|9824788|FG003|STARTED|Washout||3
8774875|NCT01293006|9824785|FG000|COMPLETED|Washout||11
8774876|NCT01293006|9824786|FG001|COMPLETED|Washout||2
8774877|NCT01293006|9824787|FG002|COMPLETED|Washout||9
8774878|NCT01293006|9824788|FG003|COMPLETED|Washout||3
8774879|NCT01293006|9824785|FG000|NOT COMPLETED|Washout||0
8774880|NCT01293006|9824786|FG001|NOT COMPLETED|Washout||0
8774881|NCT01293006|9824787|FG002|NOT COMPLETED|Washout||0
8774882|NCT01293006|9824788|FG003|NOT COMPLETED|Washout||0
8774883|NCT01293006|9824785|FG000|STARTED|Period 2||11
8774884|NCT01293006|9824786|FG001|STARTED|Period 2||2
8774885|NCT01293006|9824787|FG002|STARTED|Period 2||9
8774886|NCT01293006|9824788|FG003|STARTED|Period 2||3
8774887|NCT01293006|9824785|FG000|COMPLETED|Period 2||10
8774888|NCT01293006|9824786|FG001|COMPLETED|Period 2||2
8774889|NCT01293006|9824787|FG002|COMPLETED|Period 2||9
8774890|NCT01293006|9824788|FG003|COMPLETED|Period 2||3
8774891|NCT01293006|9824785|FG000|NOT COMPLETED|Period 2||1
8774892|NCT01293006|9824786|FG001|NOT COMPLETED|Period 2||0
8774893|NCT01293006|9824787|FG002|NOT COMPLETED|Period 2||0
8774894|NCT01293006|9824788|FG003|NOT COMPLETED|Period 2||0
8774895|NCT01293032|9824807|FG000|STARTED|Recurrence Score(RS)Assigned/Randomized||12
8774896|NCT01293032|9824808|FG001|STARTED|Recurrence Score(RS)Assigned/Randomized||17
8774897|NCT01293032|9824809|FG002|STARTED|Recurrence Score(RS)Assigned/Randomized||16
8774898|NCT01293032|9824810|FG003|STARTED|Recurrence Score(RS)Assigned/Randomized||14
8774899|NCT01293032|9824807|FG000|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||12
8774900|NCT01293032|9824808|FG001|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||17
8774901|NCT01293032|9824809|FG002|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||16
8774902|NCT01293032|9824810|FG003|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||14
8774903|NCT01293032|9824807|FG000|COMPLETED|Recurrence Score(RS)Assigned/Randomized||12
8774904|NCT01293032|9824808|FG001|COMPLETED|Recurrence Score(RS)Assigned/Randomized||17
8774905|NCT01293032|9824809|FG002|COMPLETED|Recurrence Score(RS)Assigned/Randomized|2/5 subjects who refused Arm 2(chemo) were treated with Arm 1(hormonal) and evaluable for response.|11
8774906|NCT01293032|9824810|FG003|COMPLETED|Recurrence Score(RS)Assigned/Randomized||14
8774907|NCT01293032|9824807|FG000|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||0
8774908|NCT01293032|9824808|FG001|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||0
8774909|NCT01293032|9824809|FG002|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||5
8774910|NCT01293032|9824810|FG003|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||0
8774911|NCT01293032|9824807|FG000|STARTED|Treatment||12
8774912|NCT01293032|9824808|FG001|STARTED|Treatment|2/5 subjects who refused Arm 2(chemo) were treated with Arm 1(hormonal) and evaluable for response.|19
8774913|NCT01293032|9824809|FG002|STARTED|Treatment||11
8774914|NCT01293032|9824810|FG003|STARTED|Treatment||14
8774915|NCT01293032|9824807|FG000|COMPLETED|Treatment||10
8774916|NCT01293032|9824808|FG001|COMPLETED|Treatment||14
8774917|NCT01293032|9824809|FG002|COMPLETED|Treatment||10
8774918|NCT01293032|9824810|FG003|COMPLETED|Treatment||13
8774919|NCT01293032|9824807|FG000|NOT COMPLETED|Treatment||2
8774920|NCT01293032|9824808|FG001|NOT COMPLETED|Treatment||5
8774921|NCT01293032|9824809|FG002|NOT COMPLETED|Treatment||1
8774922|NCT01293032|9824810|FG003|NOT COMPLETED|Treatment||1
8774923|NCT01293084|9824817|FG000|STARTED|Overall Study||17
8774924|NCT01293084|9824817|FG000|COMPLETED|Overall Study||12
8774925|NCT01293084|9824817|FG000|NOT COMPLETED|Overall Study||5
8774926|NCT01293240|9824823|FG000|STARTED|Overall Study||117
8774927|NCT01293240|9824823|FG000|COMPLETED|Overall Study||115
8774928|NCT01293240|9824823|FG000|NOT COMPLETED|Overall Study||2
8774929|NCT01293396|9824827|FG000|STARTED|First Intervention||6
8774930|NCT01293396|9824828|FG001|STARTED|First Intervention||7
8774931|NCT01293396|9824829|FG002|STARTED|First Intervention||7
8774932|NCT01293396|9824827|FG000|COMPLETED|First Intervention||6
8774933|NCT01293396|9824828|FG001|COMPLETED|First Intervention||7
8774934|NCT01293396|9824829|FG002|COMPLETED|First Intervention||7
8774935|NCT01293396|9824827|FG000|NOT COMPLETED|First Intervention||0
8774936|NCT01293396|9824828|FG001|NOT COMPLETED|First Intervention||0
8774937|NCT01293396|9824829|FG002|NOT COMPLETED|First Intervention||0
8774938|NCT01293396|9824827|FG000|STARTED|Wash Out Period 1 (3 Days)||6
8774939|NCT01293396|9824828|FG001|STARTED|Wash Out Period 1 (3 Days)||7
8774940|NCT01293396|9824829|FG002|STARTED|Wash Out Period 1 (3 Days)||7
8774941|NCT01293396|9824827|FG000|COMPLETED|Wash Out Period 1 (3 Days)||6
8774942|NCT01293396|9824828|FG001|COMPLETED|Wash Out Period 1 (3 Days)||7
8774943|NCT01293396|9824829|FG002|COMPLETED|Wash Out Period 1 (3 Days)||7
8774944|NCT01293396|9824827|FG000|NOT COMPLETED|Wash Out Period 1 (3 Days)||0
8774945|NCT01293396|9824828|FG001|NOT COMPLETED|Wash Out Period 1 (3 Days)||0
8774946|NCT01293396|9824829|FG002|NOT COMPLETED|Wash Out Period 1 (3 Days)||0
8774947|NCT01293396|9824827|FG000|STARTED|Second Intervention||5
8774948|NCT01293396|9824828|FG001|STARTED|Second Intervention||5
8774949|NCT01293396|9824829|FG002|STARTED|Second Intervention||10
8774950|NCT01293396|9824827|FG000|COMPLETED|Second Intervention||5
8774951|NCT01293396|9824828|FG001|COMPLETED|Second Intervention||5
8774952|NCT01293396|9824829|FG002|COMPLETED|Second Intervention||10
8774953|NCT01293396|9824827|FG000|NOT COMPLETED|Second Intervention||0
8774954|NCT01293396|9824828|FG001|NOT COMPLETED|Second Intervention||0
8774955|NCT01293396|9824829|FG002|NOT COMPLETED|Second Intervention||0
8774956|NCT01293396|9824827|FG000|STARTED|Wash Out Period 2 (3 Days)||5
8774957|NCT01293396|9824828|FG001|STARTED|Wash Out Period 2 (3 Days)||5
8774958|NCT01293396|9824829|FG002|STARTED|Wash Out Period 2 (3 Days)||10
8774959|NCT01293396|9824827|FG000|COMPLETED|Wash Out Period 2 (3 Days)||5
8774960|NCT01293396|9824828|FG001|COMPLETED|Wash Out Period 2 (3 Days)||5
8774961|NCT01293396|9824829|FG002|COMPLETED|Wash Out Period 2 (3 Days)||10
8774962|NCT01293396|9824827|FG000|NOT COMPLETED|Wash Out Period 2 (3 Days)||0
8774963|NCT01293396|9824828|FG001|NOT COMPLETED|Wash Out Period 2 (3 Days)||0
8774964|NCT01293396|9824829|FG002|NOT COMPLETED|Wash Out Period 2 (3 Days)||0
8774965|NCT01293396|9824827|FG000|STARTED|Third Intervention||9
8774966|NCT01293396|9824828|FG001|STARTED|Third Intervention||8
8774967|NCT01293396|9824829|FG002|STARTED|Third Intervention||3
8774968|NCT01293396|9824827|FG000|COMPLETED|Third Intervention||9
8774969|NCT01293396|9824828|FG001|COMPLETED|Third Intervention||8
8774970|NCT01293396|9824829|FG002|COMPLETED|Third Intervention||3
8774971|NCT01293396|9824827|FG000|NOT COMPLETED|Third Intervention||0
8774972|NCT01293396|9824828|FG001|NOT COMPLETED|Third Intervention||0
8774973|NCT01293396|9824829|FG002|NOT COMPLETED|Third Intervention||0
8774974|NCT01293539|9824837|FG000|STARTED|Overall Study||10
8774975|NCT01293539|9824837|FG000|COMPLETED|Overall Study||9
8774976|NCT01293539|9824837|FG000|NOT COMPLETED|Overall Study||1
8774977|NCT01293695|9824843|FG000|STARTED|Overall Study||93
8774978|NCT01293695|9824844|FG001|STARTED|Overall Study||94
8774979|NCT01293695|9824843|FG000|COMPLETED|Overall Study||78
8774980|NCT01293695|9824844|FG001|COMPLETED|Overall Study||87
8774981|NCT01293695|9824843|FG000|NOT COMPLETED|Overall Study||15
8774982|NCT01293695|9824844|FG001|NOT COMPLETED|Overall Study||7
8774983|NCT01293825|9824853|FG000|STARTED|Overall Study||30
8774984|NCT01293825|9824853|FG000|COMPLETED|Overall Study||20
8774985|NCT01293825|9824853|FG000|NOT COMPLETED|Overall Study||10
8774986|NCT01293968|9824859|FG000|STARTED|Overall Study||20
8774987|NCT01293968|9824860|FG001|STARTED|Overall Study||17
9028818|NCT03208933|10091169|FG000|NOT COMPLETED|Overall Study||13
9028819|NCT03209050|10091173|FG000|STARTED|Overall Study||30
9028820|NCT03209050|10091173|FG000|COMPLETED|Overall Study||27
9028821|NCT03209050|10091173|FG000|NOT COMPLETED|Overall Study||3
9028822|NCT03209362|10091180|FG000|STARTED|Overall Study||39
9028823|NCT03209362|10091181|FG001|STARTED|Overall Study||41
9028824|NCT03209362|10091180|FG000|COMPLETED|Overall Study||37
9028825|NCT03209362|10091181|FG001|COMPLETED|Overall Study||38
9028826|NCT03209362|10091180|FG000|NOT COMPLETED|Overall Study||2
9028827|NCT03209362|10091181|FG001|NOT COMPLETED|Overall Study||3
9028828|NCT03209492|10091187|FG000|STARTED|Overall Study||333
9028829|NCT03209492|10091187|FG000|COMPLETED|Overall Study||328
9028830|NCT03209492|10091187|FG000|NOT COMPLETED|Overall Study||5
8671485|NCT00751634|9714835|FG000|NOT COMPLETED|Overall Study||0
8671486|NCT00751777|9714842|FG000|STARTED|Overall Study||81
8671487|NCT00751777|9714843|FG001|STARTED|Overall Study||39
8671488|NCT00751777|9714842|FG000|COMPLETED|Overall Study|Day 380: study completion for LT group|70
8671489|NCT00751777|9714843|FG001|COMPLETED|Overall Study|Day 194: study completion for placebo group|36
8671490|NCT00751777|9714842|FG000|NOT COMPLETED|Overall Study||11
8671491|NCT00751777|9714843|FG001|NOT COMPLETED|Overall Study||3
8671492|NCT00751790|9714849|FG000|STARTED|Overall Study||120
8774988|NCT01293968|9824859|FG000|COMPLETED|Overall Study||17
8774989|NCT01293968|9824860|FG001|COMPLETED|Overall Study||14
8774990|NCT01293968|9824859|FG000|NOT COMPLETED|Overall Study||3
8774991|NCT01293968|9824860|FG001|NOT COMPLETED|Overall Study||3
8774992|NCT01294098|9824869|FG000|STARTED|Overall Study||0
8916289|NCT02181803|9975864|FG003|COMPLETED|Overall Study||11
8916290|NCT02181803|9975865|FG004|COMPLETED|Overall Study||6
8916291|NCT02181803|9975866|FG005|COMPLETED|Overall Study||6
8916292|NCT02181803|9975867|FG006|COMPLETED|Overall Study||8
8916293|NCT02181803|9975868|FG007|COMPLETED|Overall Study||0
8916294|NCT02181803|9975869|FG008|COMPLETED|Overall Study||2
8916295|NCT02181803|9975861|FG000|NOT COMPLETED|Overall Study||0
8916296|NCT02181803|9975862|FG001|NOT COMPLETED|Overall Study||4
8916297|NCT02181803|9975863|FG002|NOT COMPLETED|Overall Study||0
8916298|NCT02181803|9975864|FG003|NOT COMPLETED|Overall Study||2
8916299|NCT02181803|9975865|FG004|NOT COMPLETED|Overall Study||0
8916300|NCT02181803|9975866|FG005|NOT COMPLETED|Overall Study||0
8916301|NCT02181803|9975867|FG006|NOT COMPLETED|Overall Study||1
8774993|NCT01294098|9824870|FG001|STARTED|Overall Study||1
8774994|NCT01294098|9824871|FG002|STARTED|Overall Study||1
8774995|NCT01294098|9824869|FG000|COMPLETED|Overall Study||0
8774996|NCT01294098|9824870|FG001|COMPLETED|Overall Study||0
8774997|NCT01294098|9824871|FG002|COMPLETED|Overall Study||0
8774998|NCT01294098|9824869|FG000|NOT COMPLETED|Overall Study||0
8774999|NCT01294098|9824870|FG001|NOT COMPLETED|Overall Study||1
8775000|NCT01294098|9824871|FG002|NOT COMPLETED|Overall Study||1
8775001|NCT01294150|9824881|FG000|STARTED|Overall Study||140
8775002|NCT01294150|9824882|FG001|STARTED|Overall Study||66
8775003|NCT01294150|9824881|FG000|COMPLETED|Overall Study||138
8775004|NCT01294150|9824882|FG001|COMPLETED|Overall Study||64
8775005|NCT01294150|9824881|FG000|NOT COMPLETED|Overall Study||2
8775006|NCT01294150|9824882|FG001|NOT COMPLETED|Overall Study||2
8775007|NCT01294163|9824893|FG000|STARTED|Overall Study||178
8775008|NCT01294163|9824894|FG001|STARTED|Overall Study||165
8775009|NCT01294163|9824895|FG002|STARTED|Overall Study||166
8775010|NCT01294163|9824893|FG000|COMPLETED|Overall Study||177
8775011|NCT01294163|9824894|FG001|COMPLETED|Overall Study||165
8775012|NCT01294163|9824895|FG002|COMPLETED|Overall Study||163
8775013|NCT01294163|9824893|FG000|NOT COMPLETED|Overall Study||1
8775014|NCT01294163|9824894|FG001|NOT COMPLETED|Overall Study||0
8775015|NCT01294163|9824895|FG002|NOT COMPLETED|Overall Study||3
8775016|NCT01294228|9824902|FG000|STARTED|Overall Study||1001
8775017|NCT01294228|9824902|FG000|COMPLETED|Overall Study||1001
8775018|NCT01294228|9824902|FG000|NOT COMPLETED|Overall Study||0
8775019|NCT01294241|9824906|FG000|STARTED|Overall Study||10
8775020|NCT01294241|9824906|FG000|COMPLETED|Overall Study||10
8775021|NCT01294241|9824906|FG000|NOT COMPLETED|Overall Study||0
8775022|NCT01294267|9824912|FG000|STARTED|Overall Study||20
8775023|NCT01294267|9824912|FG000|COMPLETED|Overall Study||20
8775024|NCT01294267|9824912|FG000|NOT COMPLETED|Overall Study||0
8775025|NCT01294306|9824918|FG000|STARTED|Overall Study||45
8775026|NCT01294306|9824919|FG001|STARTED|Overall Study||35
8775027|NCT01294306|9824918|FG000|COMPLETED|Overall Study||45
8775028|NCT01294306|9824919|FG001|COMPLETED|Overall Study||35
8775029|NCT01294306|9824918|FG000|NOT COMPLETED|Overall Study||0
8775030|NCT01294306|9824919|FG001|NOT COMPLETED|Overall Study||0
8775031|NCT01294319|9824933|FG000|STARTED|Overall Study||4
8775032|NCT01294319|9824934|FG001|STARTED|Overall Study||6
8775033|NCT01294319|9824935|FG002|STARTED|Overall Study||5
8775034|NCT01294319|9824936|FG003|STARTED|Overall Study||5
8775035|NCT01294319|9824937|FG004|STARTED|Overall Study||5
8775036|NCT01294319|9824938|FG005|STARTED|Overall Study||4
8775037|NCT01294319|9824939|FG006|STARTED|Overall Study||5
8775038|NCT01294319|9824940|FG007|STARTED|Overall Study||5
8775039|NCT01294319|9824933|FG000|COMPLETED|Overall Study||4
8775040|NCT01294319|9824934|FG001|COMPLETED|Overall Study||6
8775041|NCT01294319|9824935|FG002|COMPLETED|Overall Study||5
8775042|NCT01294319|9824936|FG003|COMPLETED|Overall Study||5
8775043|NCT01294319|9824937|FG004|COMPLETED|Overall Study||5
8775044|NCT01294319|9824938|FG005|COMPLETED|Overall Study||4
8775045|NCT01294319|9824939|FG006|COMPLETED|Overall Study||5
8775046|NCT01294319|9824940|FG007|COMPLETED|Overall Study||5
8775047|NCT01294319|9824933|FG000|NOT COMPLETED|Overall Study||0
8775048|NCT01294319|9824934|FG001|NOT COMPLETED|Overall Study||0
8775049|NCT01294319|9824935|FG002|NOT COMPLETED|Overall Study||0
8775050|NCT01294319|9824936|FG003|NOT COMPLETED|Overall Study||0
8775051|NCT01294319|9824937|FG004|NOT COMPLETED|Overall Study||0
8775052|NCT01294319|9824938|FG005|NOT COMPLETED|Overall Study||0
8775053|NCT01294319|9824939|FG006|NOT COMPLETED|Overall Study||0
8775054|NCT01294319|9824940|FG007|NOT COMPLETED|Overall Study||0
8775055|NCT01294358|9824947|FG000|STARTED|Cohort 1: 5/11/11-11/9/11||4
8775056|NCT01294358|9824948|FG001|STARTED|Cohort 1: 5/11/11-11/9/11||0
8775057|NCT01294358|9824949|FG002|STARTED|Cohort 1: 5/11/11-11/9/11||0
8775058|NCT01294358|9824950|FG003|STARTED|Cohort 1: 5/11/11-11/9/11||0
8775059|NCT01294358|9824951|FG004|STARTED|Cohort 1: 5/11/11-11/9/11||0
8775060|NCT01294358|9824947|FG000|COMPLETED|Cohort 1: 5/11/11-11/9/11||4
8775061|NCT01294358|9824948|FG001|COMPLETED|Cohort 1: 5/11/11-11/9/11||0
8775062|NCT01294358|9824949|FG002|COMPLETED|Cohort 1: 5/11/11-11/9/11||0
8775063|NCT01294358|9824950|FG003|COMPLETED|Cohort 1: 5/11/11-11/9/11||0
9028831|NCT03209505|10091191|FG000|STARTED|Overall Study||10
9028832|NCT03209505|10091192|FG001|STARTED|Overall Study||10
9028833|NCT03209505|10091191|FG000|COMPLETED|Overall Study||10
9028834|NCT03209505|10091192|FG001|COMPLETED|Overall Study||10
9028835|NCT03209505|10091191|FG000|NOT COMPLETED|Overall Study||0
9028836|NCT03209505|10091192|FG001|NOT COMPLETED|Overall Study||0
9028837|NCT03209518|10091198|FG000|STARTED|Overall Study||312
9028838|NCT03209518|10091198|FG000|COMPLETED|Overall Study||310
9028839|NCT03209518|10091198|FG000|NOT COMPLETED|Overall Study||2
8775064|NCT01294358|9824951|FG004|COMPLETED|Cohort 1: 5/11/11-11/9/11||0
8775065|NCT01294358|9824947|FG000|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
8775066|NCT01294358|9824948|FG001|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
8775067|NCT01294358|9824949|FG002|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
8775068|NCT01294358|9824950|FG003|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
9028840|NCT03209570|10091204|FG000|STARTED|Overall Study||24
9028841|NCT03209570|10091205|FG001|STARTED|Overall Study||25
9028842|NCT03209570|10091204|FG000|COMPLETED|Overall Study||14
9028843|NCT03209570|10091205|FG001|COMPLETED|Overall Study||12
9028844|NCT03209570|10091204|FG000|NOT COMPLETED|Overall Study||10
9028845|NCT03209570|10091205|FG001|NOT COMPLETED|Overall Study||13
9028846|NCT03209882|10091213|FG000|STARTED|Overall Study||6
8775069|NCT01294358|9824951|FG004|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
8775070|NCT01294358|9824947|FG000|STARTED|Cohort 2: 6/9/11-9/17/12||0
8775071|NCT01294358|9824948|FG001|STARTED|Cohort 2: 6/9/11-9/17/12|4 participants from 18mg move to 36mg and 2 additional participants were enrolled at this dose.|6
8775072|NCT01294358|9824949|FG002|STARTED|Cohort 2: 6/9/11-9/17/12||0
8775073|NCT01294358|9824950|FG003|STARTED|Cohort 2: 6/9/11-9/17/12||0
8775074|NCT01294358|9824951|FG004|STARTED|Cohort 2: 6/9/11-9/17/12||0
8775075|NCT01294358|9824947|FG000|COMPLETED|Cohort 2: 6/9/11-9/17/12||0
8775076|NCT01294358|9824948|FG001|COMPLETED|Cohort 2: 6/9/11-9/17/12||4
8775077|NCT01294358|9824949|FG002|COMPLETED|Cohort 2: 6/9/11-9/17/12||0
8775078|NCT01294358|9824950|FG003|COMPLETED|Cohort 2: 6/9/11-9/17/12||0
8775079|NCT01294358|9824951|FG004|COMPLETED|Cohort 2: 6/9/11-9/17/12||0
8775080|NCT01294358|9824947|FG000|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||0
8775081|NCT01294358|9824948|FG001|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||2
8775082|NCT01294358|9824949|FG002|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||0
8775083|NCT01294358|9824950|FG003|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||0
8775084|NCT01294358|9824951|FG004|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||0
8775085|NCT01294358|9824947|FG000|STARTED|Cohort 3: 12/1/11-10/6/12||0
8775086|NCT01294358|9824948|FG001|STARTED|Cohort 3: 12/1/11-10/6/12||0
8775087|NCT01294358|9824949|FG002|STARTED|Cohort 3: 12/1/11-10/6/12|4 participants from 36mg move to 72mg.|4
8775088|NCT01294358|9824950|FG003|STARTED|Cohort 3: 12/1/11-10/6/12||0
8775089|NCT01294358|9824951|FG004|STARTED|Cohort 3: 12/1/11-10/6/12||0
8775090|NCT01294358|9824947|FG000|COMPLETED|Cohort 3: 12/1/11-10/6/12||0
8775091|NCT01294358|9824948|FG001|COMPLETED|Cohort 3: 12/1/11-10/6/12||0
8775092|NCT01294358|9824949|FG002|COMPLETED|Cohort 3: 12/1/11-10/6/12||2
8775093|NCT01294358|9824950|FG003|COMPLETED|Cohort 3: 12/1/11-10/6/12||0
8775094|NCT01294358|9824951|FG004|COMPLETED|Cohort 3: 12/1/11-10/6/12||0
8775095|NCT01294358|9824947|FG000|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||0
8775096|NCT01294358|9824948|FG001|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||0
8775097|NCT01294358|9824949|FG002|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||2
8775098|NCT01294358|9824950|FG003|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||0
8775099|NCT01294358|9824951|FG004|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||0
8775100|NCT01294358|9824947|FG000|STARTED|Cohort 4: 12/30/11-2/17/17||0
8775101|NCT01294358|9824948|FG001|STARTED|Cohort 4: 12/30/11-2/17/17||0
8775102|NCT01294358|9824949|FG002|STARTED|Cohort 4: 12/30/11-2/17/17||0
8775103|NCT01294358|9824950|FG003|STARTED|Cohort 4: 12/30/11-2/17/17|2 participants from 72mg move to 96mg.|2
8775104|NCT01294358|9824951|FG004|STARTED|Cohort 4: 12/30/11-2/17/17||0
8775105|NCT01294358|9824947|FG000|COMPLETED|Cohort 4: 12/30/11-2/17/17||0
8775106|NCT01294358|9824948|FG001|COMPLETED|Cohort 4: 12/30/11-2/17/17||0
8775107|NCT01294358|9824949|FG002|COMPLETED|Cohort 4: 12/30/11-2/17/17||0
8775108|NCT01294358|9824950|FG003|COMPLETED|Cohort 4: 12/30/11-2/17/17||1
8775109|NCT01294358|9824951|FG004|COMPLETED|Cohort 4: 12/30/11-2/17/17||0
8775110|NCT01294358|9824947|FG000|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||0
8775111|NCT01294358|9824948|FG001|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||0
8775112|NCT01294358|9824949|FG002|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||0
8775113|NCT01294358|9824950|FG003|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||1
8775114|NCT01294358|9824951|FG004|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||0
8775115|NCT01294358|9824947|FG000|STARTED|Cohort 5: 3/8/12-3/9/12||0
8775116|NCT01294358|9824948|FG001|STARTED|Cohort 5: 3/8/12-3/9/12||0
8775117|NCT01294358|9824949|FG002|STARTED|Cohort 5: 3/8/12-3/9/12||0
8775118|NCT01294358|9824950|FG003|STARTED|Cohort 5: 3/8/12-3/9/12||0
8775119|NCT01294358|9824951|FG004|STARTED|Cohort 5: 3/8/12-3/9/12|1 participant from 96mg move to 115mg.|1
8775120|NCT01294358|9824947|FG000|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
8775121|NCT01294358|9824948|FG001|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
8775122|NCT01294358|9824949|FG002|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
8775123|NCT01294358|9824950|FG003|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
8775124|NCT01294358|9824951|FG004|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
8775125|NCT01294358|9824947|FG000|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||0
8775126|NCT01294358|9824948|FG001|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||0
8775127|NCT01294358|9824949|FG002|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||0
8775128|NCT01294358|9824950|FG003|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||0
8775129|NCT01294358|9824951|FG004|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||1
8775130|NCT01294371|9824968|FG000|STARTED|Overall Study||391
8775131|NCT01294371|9824968|FG000|Treated|Overall Study||390
8775132|NCT01294371|9824968|FG000|COMPLETED|Overall Study||357
8775133|NCT01294371|9824968|FG000|NOT COMPLETED|Overall Study||34
8775134|NCT01294384|9824978|FG000|STARTED|Overall Study||101
8775135|NCT01294384|9824979|FG001|STARTED|Overall Study||100
8775136|NCT01294384|9824980|FG002|STARTED|Overall Study||104
8775137|NCT01294384|9824978|FG000|COMPLETED|Overall Study||97
8775138|NCT01294384|9824979|FG001|COMPLETED|Overall Study||94
8775139|NCT01294384|9824980|FG002|COMPLETED|Overall Study||95
8775140|NCT01294384|9824978|FG000|NOT COMPLETED|Overall Study||4
8775141|NCT01294384|9824979|FG001|NOT COMPLETED|Overall Study||6
8775142|NCT01294384|9824980|FG002|NOT COMPLETED|Overall Study||9
8775143|NCT01294397|9824988|FG000|STARTED|Overall Study||19
8775144|NCT01294397|9824988|FG000|COMPLETED|Overall Study||17
8775145|NCT01294397|9824988|FG000|NOT COMPLETED|Overall Study||2
8775146|NCT01294423|9824997|FG000|STARTED|Overall Study||86
8775147|NCT01294423|9824998|FG001|STARTED|Overall Study||88
8775148|NCT01294423|9824999|FG002|STARTED|Overall Study||87
8775149|NCT01294423|9824997|FG000|COMPLETED|Overall Study||81
8775150|NCT01294423|9824998|FG001|COMPLETED|Overall Study||79
8775151|NCT01294423|9824999|FG002|COMPLETED|Overall Study||79
9028847|NCT03209882|10091214|FG001|STARTED|Overall Study||3
9028848|NCT03209882|10091213|FG000|COMPLETED|Overall Study||6
9028849|NCT03209882|10091214|FG001|COMPLETED|Overall Study||3
9028850|NCT03209882|10091213|FG000|NOT COMPLETED|Overall Study||0
9028851|NCT03209882|10091214|FG001|NOT COMPLETED|Overall Study||0
9028852|NCT03209973|10091222|FG000|STARTED|Overall Study||70
9028853|NCT03209973|10091222|FG000|Completed Primary Outcome Period|Overall Study||66
9028854|NCT03209973|10091222|FG000|COMPLETED|Overall Study||0
9028855|NCT03209973|10091222|FG000|NOT COMPLETED|Overall Study||70
9028856|NCT03210155|10091230|FG000|STARTED|Overall Study||0
9028857|NCT03210155|10091231|FG001|STARTED|Overall Study||1
9028858|NCT03210155|10091230|FG000|COMPLETED|Overall Study||0
9028859|NCT03210155|10091231|FG001|COMPLETED|Overall Study||1
9028860|NCT03210155|10091230|FG000|NOT COMPLETED|Overall Study||0
9028861|NCT03210155|10091231|FG001|NOT COMPLETED|Overall Study||0
9028862|NCT03210220|10091239|FG000|STARTED|Overall Study||20
9028863|NCT03210220|10091240|FG001|STARTED|Overall Study||20
9028864|NCT03210220|10091239|FG000|COMPLETED|Overall Study||19
9028865|NCT03210220|10091240|FG001|COMPLETED|Overall Study||20
9028866|NCT03210220|10091239|FG000|NOT COMPLETED|Overall Study||1
9028867|NCT03210220|10091240|FG001|NOT COMPLETED|Overall Study||0
9028868|NCT03210259|10091248|FG000|STARTED|12-Week Run-in Period||21
9028869|NCT03210259|10091249|FG001|STARTED|12-Week Run-in Period||118
9028870|NCT03210259|10091250|FG002|STARTED|12-Week Run-in Period||120
9028871|NCT03210259|10091248|FG000|COMPLETED|12-Week Run-in Period||0
9028872|NCT03210259|10091249|FG001|COMPLETED|12-Week Run-in Period||118
9028873|NCT03210259|10091250|FG002|COMPLETED|12-Week Run-in Period||120
9028874|NCT03210259|10091248|FG000|NOT COMPLETED|12-Week Run-in Period||21
9028875|NCT03210259|10091249|FG001|NOT COMPLETED|12-Week Run-in Period||0
9028876|NCT03210259|10091250|FG002|NOT COMPLETED|12-Week Run-in Period||0
8671493|NCT00751790|9714849|FG000|COMPLETED|Overall Study||115
8671494|NCT00751790|9714849|FG000|NOT COMPLETED|Overall Study||5
8671495|NCT00751881|9714856|FG000|STARTED|Core Treatment Period|Randomized|389
8671496|NCT00751881|9714857|FG001|STARTED|Core Treatment Period|Randomized|408
8671497|NCT00751881|9714858|FG002|STARTED|Core Treatment Period|Randomized|372
8671498|NCT00751881|9714856|FG000|Treated|Core Treatment Period|1 participant received teriflunomide 7 mg and 2 participants teriflunomide 14 mg (at least 1 dose)|388
8671499|NCT00751881|9714857|FG001|Treated|Core Treatment Period|1 participant received placebo (at least 1 dose)|407
8671500|NCT00751881|9714858|FG002|Treated|Core Treatment Period|1 participant received teriflunomide 7 mg and 1 participant placebo (at least 1 dose)|370
8671501|NCT00751881|9714856|FG000|COMPLETED|Core Treatment Period||263
8671502|NCT00751881|9714857|FG001|COMPLETED|Core Treatment Period||273
8671503|NCT00751881|9714858|FG002|COMPLETED|Core Treatment Period||244
8671504|NCT00751881|9714856|FG000|NOT COMPLETED|Core Treatment Period||126
8671505|NCT00751881|9714857|FG001|NOT COMPLETED|Core Treatment Period||135
8671506|NCT00751881|9714858|FG002|NOT COMPLETED|Core Treatment Period||128
8671507|NCT00751881|9714856|FG000|STARTED|Extension Study Period|10 participants completed core treatment period but did not enter in extension treatment period.|253
8671508|NCT00751881|9714857|FG001|STARTED|Extension Study Period|8 participants completed core treatment period but did not enter in extension treatment period.|265
8671509|NCT00751881|9714858|FG002|STARTED|Extension Study Period|11 participants completed core treatment period but did not enter in extension treatment period.|233
8671510|NCT00751881|9714856|FG000|COMPLETED|Extension Study Period||188
8671511|NCT00751881|9714857|FG001|COMPLETED|Extension Study Period||194
8671512|NCT00751881|9714858|FG002|COMPLETED|Extension Study Period||167
8671513|NCT00751881|9714856|FG000|NOT COMPLETED|Extension Study Period||65
8671514|NCT00751881|9714857|FG001|NOT COMPLETED|Extension Study Period||71
8671515|NCT00751881|9714858|FG002|NOT COMPLETED|Extension Study Period||66
8671516|NCT00751972|9714874|FG000|STARTED|Overall Study||140
8671517|NCT00751972|9714875|FG001|STARTED|Overall Study||499
8671518|NCT00751972|9714874|FG000|COMPLETED|Overall Study||140
8671519|NCT00751972|9714875|FG001|COMPLETED|Overall Study||499
8671520|NCT00751972|9714874|FG000|NOT COMPLETED|Overall Study||0
8671521|NCT00751972|9714875|FG001|NOT COMPLETED|Overall Study||0
8671522|NCT00751998|9714880|FG000|STARTED|Overall Study||297
8671523|NCT00751998|9714880|FG000|COMPLETED|Overall Study||277
8671524|NCT00751998|9714880|FG000|NOT COMPLETED|Overall Study||20
8671525|NCT00752089|9714884|FG000|STARTED|Overall Study||20
8671526|NCT00752089|9714884|FG000|Received NaF/ KNO3/ 2% Isopentane|Overall Study||19
8671527|NCT00752089|9714884|FG000|Received NaF/KNO3/ 0% Isopentane|Overall Study||17
8671528|NCT00752089|9714884|FG000|Received NaF|Overall Study||18
8671529|NCT00752089|9714884|FG000|Received Placebo|Overall Study||18
9028877|NCT03210259|10091248|FG000|STARTED|48-Week Randomized Responder Period||0
9028878|NCT03210259|10091249|FG001|STARTED|48-Week Randomized Responder Period||118
9028879|NCT03210259|10091250|FG002|STARTED|48-Week Randomized Responder Period||120
9028880|NCT03210259|10091248|FG000|COMPLETED|48-Week Randomized Responder Period||0
9028881|NCT03210259|10091249|FG001|COMPLETED|48-Week Randomized Responder Period||107
9028882|NCT03210259|10091250|FG002|COMPLETED|48-Week Randomized Responder Period||91
9028883|NCT03210259|10091248|FG000|NOT COMPLETED|48-Week Randomized Responder Period||0
9028884|NCT03210259|10091249|FG001|NOT COMPLETED|48-Week Randomized Responder Period||11
9028885|NCT03210259|10091250|FG002|NOT COMPLETED|48-Week Randomized Responder Period||29
9028886|NCT03210337|10091259|FG000|STARTED|Overall Study||78
9028887|NCT03210337|10091260|FG001|STARTED|Overall Study||79
9028888|NCT03210337|10091259|FG000|COMPLETED|Overall Study||70
8775152|NCT01294423|9824997|FG000|NOT COMPLETED|Overall Study||5
8775153|NCT01294423|9824998|FG001|NOT COMPLETED|Overall Study||9
8775154|NCT01294423|9824999|FG002|NOT COMPLETED|Overall Study||8
8775155|NCT01294436|9825009|FG000|STARTED|Overall Study||249
8775156|NCT01294436|9825010|FG001|STARTED|Overall Study||479
8775157|NCT01294436|9825009|FG000|COMPLETED|Overall Study||221
8775158|NCT01294436|9825010|FG001|COMPLETED|Overall Study||409
8775159|NCT01294436|9825009|FG000|NOT COMPLETED|Overall Study||28
8775160|NCT01294436|9825010|FG001|NOT COMPLETED|Overall Study||70
8775161|NCT01294449|9825018|FG000|STARTED|Overall Study||156
8775162|NCT01294449|9825019|FG001|STARTED|Overall Study||252
8775163|NCT01294449|9825018|FG000|Consent to Registry|Overall Study||149
8775164|NCT01294449|9825019|FG001|Consent to Registry|Overall Study||245
8775165|NCT01294449|9825018|FG000|COMPLETED|Overall Study||144
8775166|NCT01294449|9825019|FG001|COMPLETED|Overall Study||237
8775167|NCT01294449|9825018|FG000|NOT COMPLETED|Overall Study||12
8775168|NCT01294449|9825019|FG001|NOT COMPLETED|Overall Study||15
8775169|NCT01294462|9825027|FG000|STARTED|Overall Study||401
8775170|NCT01294462|9825028|FG001|STARTED|Overall Study||400
8775171|NCT01294462|9825027|FG000|Received Randomized Treatment|Overall Study||387
8775172|NCT01294462|9825028|FG001|Received Randomized Treatment|Overall Study||380
8775173|NCT01294462|9825027|FG000|COMPLETED|Overall Study||335
8775174|NCT01294462|9825028|FG001|COMPLETED|Overall Study||337
8775175|NCT01294462|9825027|FG000|NOT COMPLETED|Overall Study||66
8775176|NCT01294462|9825028|FG001|NOT COMPLETED|Overall Study||63
8775177|NCT01294514|9825034|FG000|STARTED|Overall Study||27
8775178|NCT01294514|9825034|FG000|COMPLETED|Overall Study||26
8775179|NCT01294514|9825034|FG000|NOT COMPLETED|Overall Study||1
8775180|NCT01294553|9825042|FG000|STARTED|Overall Study||982
8775181|NCT01294553|9825042|FG000|COMPLETED|Overall Study||713
8775182|NCT01294553|9825042|FG000|NOT COMPLETED|Overall Study||269
8775183|NCT01294579|9825047|FG000|STARTED|Overall Study||49
8775184|NCT01294579|9825047|FG000|COMPLETED|Overall Study||14
8775185|NCT01294579|9825047|FG000|NOT COMPLETED|Overall Study||35
8775186|NCT01294592|9825053|FG000|STARTED|Overall Study||369
8775187|NCT01294592|9825054|FG001|STARTED|Overall Study||373
8775188|NCT01294592|9825053|FG000|COMPLETED|Overall Study||292
8775189|NCT01294592|9825054|FG001|COMPLETED|Overall Study||300
8775190|NCT01294592|9825053|FG000|NOT COMPLETED|Overall Study||77
8775191|NCT01294592|9825054|FG001|NOT COMPLETED|Overall Study||73
8775192|NCT01294644|9825066|FG000|STARTED|Overall Study||121
8775193|NCT01294644|9825067|FG001|STARTED|Overall Study||122
8775194|NCT01294644|9825068|FG002|STARTED|Overall Study||117
8775195|NCT01294644|9825066|FG000|Received Treatment|Overall Study||118
8775196|NCT01294644|9825067|FG001|Received Treatment|Overall Study||122
8775197|NCT01294644|9825068|FG002|Received Treatment|Overall Study||114
8775198|NCT01294644|9825066|FG000|COMPLETED|Overall Study||111
8775199|NCT01294644|9825067|FG001|COMPLETED|Overall Study||112
8775200|NCT01294644|9825068|FG002|COMPLETED|Overall Study||103
8775201|NCT01294644|9825066|FG000|NOT COMPLETED|Overall Study||10
8775202|NCT01294644|9825067|FG001|NOT COMPLETED|Overall Study||10
8775203|NCT01294644|9825068|FG002|NOT COMPLETED|Overall Study||14
8808777|NCT01492426|9861130|FG001|COMPLETED|Treatment||160
8808778|NCT01492426|9861129|FG000|NOT COMPLETED|Treatment||83
8808779|NCT01492426|9861130|FG001|NOT COMPLETED|Treatment||40
8808780|NCT01492426|9861129|FG000|STARTED|Follow-Up|This total number includes 319 who completed treatment plus 65 who rejoined for follow-up.|384
8808781|NCT01492426|9861130|FG001|STARTED|Follow-Up|This total number includes 160 who completed treatment plus 31 who rejoined for follow-up.|191
8808782|NCT01492426|9861129|FG000|COMPLETED|Follow-Up||359
8808783|NCT01492426|9861130|FG001|COMPLETED|Follow-Up||181
8808784|NCT01492426|9861129|FG000|NOT COMPLETED|Follow-Up||25
8808785|NCT01492426|9861130|FG001|NOT COMPLETED|Follow-Up||10
8808786|NCT01492439|9861142|FG000|STARTED|Overall Study||19
8808787|NCT01492439|9861143|FG001|STARTED|Overall Study||18
8808788|NCT01492439|9861142|FG000|Post-intervention|Overall Study||18
8808789|NCT01492439|9861143|FG001|Post-intervention|Overall Study||13
8808790|NCT01492439|9861142|FG000|COMPLETED|Overall Study||15
8808791|NCT01492439|9861143|FG001|COMPLETED|Overall Study||9
8808792|NCT01492439|9861142|FG000|NOT COMPLETED|Overall Study||4
8808793|NCT01492439|9861143|FG001|NOT COMPLETED|Overall Study||9
8808794|NCT01492582|9861151|FG000|STARTED|Overall Study|Consented to the vaccine arm (265 quadrivalent vaccine; 188 nonavalent vaccine)|453
8808795|NCT01492582|9861152|FG001|STARTED|Overall Study|Consented to the survey arm of the study|1046
8808796|NCT01492582|9861151|FG000|Received First Quadrivalent Vaccine Dose|Overall Study||254
8808797|NCT01492582|9861152|FG001|Received First Quadrivalent Vaccine Dose|Overall Study|Does not apply|0
8808798|NCT01492582|9861151|FG000|Received First Nonavalent Vaccine Dose|Overall Study||182
8808799|NCT01492582|9861152|FG001|Received First Nonavalent Vaccine Dose|Overall Study||0
8808800|NCT01492582|9861151|FG000|COMPLETED|Overall Study|Received 3 vaccine doses and completed Month 7 blood draw (224 quadrivalent; 160 nonavalent)|384
8808801|NCT01492582|9861152|FG001|COMPLETED|Overall Study|Returned evaluable survey|982
8808802|NCT01492582|9861151|FG000|NOT COMPLETED|Overall Study||69
8808803|NCT01492582|9861152|FG001|NOT COMPLETED|Overall Study||64
8808804|NCT01492673|9861175|FG000|STARTED|Overall Study||9
8808805|NCT01492673|9861175|FG000|COMPLETED|Overall Study||9
8808806|NCT01492673|9861175|FG000|NOT COMPLETED|Overall Study||0
8808807|NCT01492686|9861181|FG000|STARTED|Double-blind Phase||69
8808808|NCT01492686|9861182|FG001|STARTED|Double-blind Phase||68
8808809|NCT01492686|9861181|FG000|COMPLETED|Double-blind Phase||67
8808810|NCT01492686|9861182|FG001|COMPLETED|Double-blind Phase||60
8775204|NCT01294683|9825078|FG000|STARTED|Precrossover (Periods I/II)||489
8775205|NCT01294683|9825079|FG001|STARTED|Precrossover (Periods I/II)||488
8775206|NCT01294683|9825078|FG000|Treated|Precrossover (Periods I/II)||486
8775207|NCT01294683|9825079|FG001|Treated|Precrossover (Periods I/II)||486
8775208|NCT01294683|9825078|FG000|COMPLETED|Precrossover (Periods I/II)||232
8775209|NCT01294683|9825079|FG001|COMPLETED|Precrossover (Periods I/II)||222
8775210|NCT01294683|9825078|FG000|NOT COMPLETED|Precrossover (Periods I/II)||257
8775211|NCT01294683|9825079|FG001|NOT COMPLETED|Precrossover (Periods I/II)||266
8775212|NCT01294683|9825078|FG000|STARTED|Post Crossover (Period III)||232
8775213|NCT01294683|9825079|FG001|STARTED|Post Crossover (Period III)||222
8775214|NCT01294683|9825078|FG000|COMPLETED|Post Crossover (Period III)||199
8775215|NCT01294683|9825079|FG001|COMPLETED|Post Crossover (Period III)||190
8775216|NCT01294683|9825078|FG000|NOT COMPLETED|Post Crossover (Period III)||33
8775217|NCT01294683|9825079|FG001|NOT COMPLETED|Post Crossover (Period III)||32
8775218|NCT01294709|9825091|FG000|STARTED|Period 1||31
8775219|NCT01294709|9825092|FG001|STARTED|Period 1||33
8775220|NCT01294709|9825091|FG000|COMPLETED|Period 1||30
8775221|NCT01294709|9825092|FG001|COMPLETED|Period 1||32
8775222|NCT01294709|9825091|FG000|NOT COMPLETED|Period 1||1
8775223|NCT01294709|9825092|FG001|NOT COMPLETED|Period 1||1
8775224|NCT01294709|9825091|FG000|STARTED|Washout Period||30
8775225|NCT01294709|9825092|FG001|STARTED|Washout Period||32
8775226|NCT01294709|9825091|FG000|COMPLETED|Washout Period||29
8775227|NCT01294709|9825092|FG001|COMPLETED|Washout Period||31
8775228|NCT01294709|9825091|FG000|NOT COMPLETED|Washout Period||1
8775229|NCT01294709|9825092|FG001|NOT COMPLETED|Washout Period||1
8775230|NCT01294709|9825091|FG000|STARTED|Period 2||29
8775231|NCT01294709|9825092|FG001|STARTED|Period 2||31
8775232|NCT01294709|9825091|FG000|COMPLETED|Period 2||28
8775233|NCT01294709|9825092|FG001|COMPLETED|Period 2||31
8775234|NCT01294709|9825091|FG000|NOT COMPLETED|Period 2||1
8775235|NCT01294709|9825092|FG001|NOT COMPLETED|Period 2||0
8775236|NCT01294748|9825105|FG000|STARTED|Overall Study||123
8775237|NCT01294748|9825106|FG001|STARTED|Overall Study||61
8775238|NCT01294748|9825105|FG000|COMPLETED|Overall Study|At 270 days|118
8775239|NCT01294748|9825106|FG001|COMPLETED|Overall Study|At 270 days|59
8775240|NCT01294748|9825105|FG000|NOT COMPLETED|Overall Study||5
8775241|NCT01294748|9825106|FG001|NOT COMPLETED|Overall Study||2
8775242|NCT01294787|9825112|FG000|STARTED|Period 1||12
8775243|NCT01294787|9825113|FG001|STARTED|Period 1||16
8775244|NCT01294787|9825114|FG002|STARTED|Period 1||14
8775245|NCT01294787|9825115|FG003|STARTED|Period 1||12
8775246|NCT01294787|9825116|FG004|STARTED|Period 1||16
8775247|NCT01294787|9825117|FG005|STARTED|Period 1|One randomized participant did not receive study drug|15
8775248|NCT01294787|9825112|FG000|COMPLETED|Period 1||12
8775249|NCT01294787|9825113|FG001|COMPLETED|Period 1||16
8775250|NCT01294787|9825114|FG002|COMPLETED|Period 1||13
8775251|NCT01294787|9825115|FG003|COMPLETED|Period 1||11
8775252|NCT01294787|9825116|FG004|COMPLETED|Period 1||14
8775253|NCT01294787|9825117|FG005|COMPLETED|Period 1||13
8775254|NCT01294787|9825112|FG000|NOT COMPLETED|Period 1||0
8775255|NCT01294787|9825113|FG001|NOT COMPLETED|Period 1||0
8775256|NCT01294787|9825114|FG002|NOT COMPLETED|Period 1||1
8775257|NCT01294787|9825115|FG003|NOT COMPLETED|Period 1||1
8775258|NCT01294787|9825116|FG004|NOT COMPLETED|Period 1||2
8775259|NCT01294787|9825117|FG005|NOT COMPLETED|Period 1||2
8775260|NCT01294787|9825112|FG000|STARTED|Period 2||12
8775261|NCT01294787|9825113|FG001|STARTED|Period 2||16
8775262|NCT01294787|9825114|FG002|STARTED|Period 2||13
8775263|NCT01294787|9825115|FG003|STARTED|Period 2||11
8775264|NCT01294787|9825116|FG004|STARTED|Period 2||14
8775265|NCT01294787|9825117|FG005|STARTED|Period 2||13
8775266|NCT01294787|9825112|FG000|COMPLETED|Period 2||12
8775267|NCT01294787|9825113|FG001|COMPLETED|Period 2||13
8775268|NCT01294787|9825114|FG002|COMPLETED|Period 2||13
8775269|NCT01294787|9825115|FG003|COMPLETED|Period 2||9
8775270|NCT01294787|9825116|FG004|COMPLETED|Period 2||14
8775271|NCT01294787|9825117|FG005|COMPLETED|Period 2||13
8775272|NCT01294787|9825112|FG000|NOT COMPLETED|Period 2||0
8775273|NCT01294787|9825113|FG001|NOT COMPLETED|Period 2||3
8775274|NCT01294787|9825114|FG002|NOT COMPLETED|Period 2||0
8775275|NCT01294787|9825115|FG003|NOT COMPLETED|Period 2||2
8775276|NCT01294787|9825116|FG004|NOT COMPLETED|Period 2||0
8775277|NCT01294787|9825117|FG005|NOT COMPLETED|Period 2||0
8775278|NCT01294787|9825112|FG000|STARTED|Period 3||12
8775279|NCT01294787|9825113|FG001|STARTED|Period 3||13
8775280|NCT01294787|9825114|FG002|STARTED|Period 3||13
8775281|NCT01294787|9825115|FG003|STARTED|Period 3||9
8775282|NCT01294787|9825116|FG004|STARTED|Period 3||14
8775283|NCT01294787|9825117|FG005|STARTED|Period 3||13
8775284|NCT01294787|9825112|FG000|COMPLETED|Period 3||12
8775285|NCT01294787|9825113|FG001|COMPLETED|Period 3||13
8775286|NCT01294787|9825114|FG002|COMPLETED|Period 3||13
8775287|NCT01294787|9825115|FG003|COMPLETED|Period 3||9
8775288|NCT01294787|9825116|FG004|COMPLETED|Period 3||13
8775289|NCT01294787|9825117|FG005|COMPLETED|Period 3||13
8775290|NCT01294787|9825112|FG000|NOT COMPLETED|Period 3||0
8775291|NCT01294787|9825113|FG001|NOT COMPLETED|Period 3||0
8775292|NCT01294787|9825114|FG002|NOT COMPLETED|Period 3||0
8775293|NCT01294787|9825115|FG003|NOT COMPLETED|Period 3||0
8775294|NCT01294787|9825116|FG004|NOT COMPLETED|Period 3||1
8775295|NCT01294787|9825117|FG005|NOT COMPLETED|Period 3||0
8775296|NCT01294800|9825132|FG000|STARTED|Overall Study||111
8775297|NCT01294800|9825133|FG001|STARTED|Overall Study||113
8775298|NCT01294800|9825134|FG002|STARTED|Overall Study||113
8775299|NCT01294800|9825135|FG003|STARTED|Overall Study||113
8775300|NCT01294800|9825132|FG000|COMPLETED|Overall Study||100
8775301|NCT01294800|9825133|FG001|COMPLETED|Overall Study||103
8775302|NCT01294800|9825134|FG002|COMPLETED|Overall Study||96
8775303|NCT01294800|9825135|FG003|COMPLETED|Overall Study||97
8775304|NCT01294800|9825132|FG000|NOT COMPLETED|Overall Study||11
8775305|NCT01294800|9825133|FG001|NOT COMPLETED|Overall Study||10
8775306|NCT01294800|9825134|FG002|NOT COMPLETED|Overall Study||17
8775307|NCT01294800|9825135|FG003|NOT COMPLETED|Overall Study||16
8775308|NCT01294917|9825145|FG000|STARTED|Overall Study||42
8775309|NCT01294917|9825145|FG000|Received Investigational MPS|Overall Study||36
8775310|NCT01294917|9825145|FG000|Received Clear Care|Overall Study||36
8775311|NCT01294917|9825145|FG000|Received OptiFree RepleniSH MPS|Overall Study||36
8775312|NCT01294917|9825145|FG000|COMPLETED|Overall Study||36
8775313|NCT01294917|9825145|FG000|NOT COMPLETED|Overall Study||6
8775314|NCT01295034|9825153|FG000|STARTED|Overall Study||32
8775315|NCT01295034|9825154|FG001|STARTED|Overall Study||30
8775316|NCT01295034|9825153|FG000|COMPLETED|Overall Study||27
8775317|NCT01295034|9825154|FG001|COMPLETED|Overall Study||25
8775318|NCT01295034|9825153|FG000|NOT COMPLETED|Overall Study||5
8775319|NCT01295034|9825154|FG001|NOT COMPLETED|Overall Study||5
8775320|NCT01295112|9825163|FG000|STARTED|Overall Study||35
8775321|NCT01295112|9825164|FG001|STARTED|Overall Study||33
8775322|NCT01295112|9825163|FG000|COMPLETED|Overall Study||35
8775323|NCT01295112|9825164|FG001|COMPLETED|Overall Study||33
8775324|NCT01295112|9825163|FG000|NOT COMPLETED|Overall Study||0
8775325|NCT01295112|9825164|FG001|NOT COMPLETED|Overall Study||0
8775326|NCT01295216|9825172|FG000|STARTED|Overall Study||316
8775327|NCT01295216|9825173|FG001|STARTED|Overall Study||321
8775328|NCT01295216|9825172|FG000|COMPLETED|Overall Study||266
8775329|NCT01295216|9825173|FG001|COMPLETED|Overall Study||287
8775330|NCT01295216|9825172|FG000|NOT COMPLETED|Overall Study||50
8775331|NCT01295216|9825173|FG001|NOT COMPLETED|Overall Study||34
8775332|NCT01295281|9825181|FG000|STARTED|First Intervention (7 Days)||53
8775333|NCT01295281|9825182|FG001|STARTED|First Intervention (7 Days)||52
8775334|NCT01295281|9825181|FG000|COMPLETED|First Intervention (7 Days)||53
8775335|NCT01295281|9825182|FG001|COMPLETED|First Intervention (7 Days)||51
8775336|NCT01295281|9825181|FG000|NOT COMPLETED|First Intervention (7 Days)||0
8775337|NCT01295281|9825182|FG001|NOT COMPLETED|First Intervention (7 Days)||1
8775338|NCT01295281|9825181|FG000|STARTED|Second Intervention (7days)||53
8775339|NCT01295281|9825182|FG001|STARTED|Second Intervention (7days)||51
8775340|NCT01295281|9825181|FG000|COMPLETED|Second Intervention (7days)||53
8775341|NCT01295281|9825182|FG001|COMPLETED|Second Intervention (7days)||51
8775342|NCT01295281|9825181|FG000|NOT COMPLETED|Second Intervention (7days)||0
8775343|NCT01295281|9825182|FG001|NOT COMPLETED|Second Intervention (7days)||0
8775344|NCT01295320|9825188|FG000|STARTED|Overall Study||129
8775345|NCT01295320|9825188|FG000|COMPLETED|Overall Study||119
8775346|NCT01295320|9825188|FG000|NOT COMPLETED|Overall Study||10
8775347|NCT01295515|9825192|FG000|STARTED|Overall Study||7
8775348|NCT01295515|9825192|FG000|COMPLETED|Overall Study||7
8775349|NCT01295515|9825192|FG000|NOT COMPLETED|Overall Study||0
8775350|NCT01295580|9825198|FG000|STARTED|Overall Study||174
8775351|NCT01295580|9825199|FG001|STARTED|Overall Study||175
8775352|NCT01295580|9825198|FG000|COMPLETED|Overall Study||164
8775353|NCT01295580|9825199|FG001|COMPLETED|Overall Study||167
8775354|NCT01295580|9825198|FG000|NOT COMPLETED|Overall Study||10
8775355|NCT01295580|9825199|FG001|NOT COMPLETED|Overall Study||8
8775356|NCT01295671|9825208|FG000|STARTED|Overall Study||67
8775357|NCT01295671|9825209|FG001|STARTED|Overall Study||67
8775358|NCT01295671|9825210|FG002|STARTED|Overall Study||69
8775359|NCT01295671|9825208|FG000|COMPLETED|Overall Study||60
8775360|NCT01295671|9825209|FG001|COMPLETED|Overall Study||60
8775361|NCT01295671|9825210|FG002|COMPLETED|Overall Study||66
8775362|NCT01295671|9825208|FG000|NOT COMPLETED|Overall Study||7
8775363|NCT01295671|9825209|FG001|NOT COMPLETED|Overall Study||7
8775364|NCT01295671|9825210|FG002|NOT COMPLETED|Overall Study||3
8775365|NCT01295710|9825220|FG000|STARTED|Overall Study|Randomized and treated|126
8775366|NCT01295710|9825221|FG001|STARTED|Overall Study|Randomized and treated|128
8775367|NCT01295710|9825220|FG000|COMPLETED|Overall Study||48
8775368|NCT01295710|9825221|FG001|COMPLETED|Overall Study||78
8671530|NCT00752089|9714884|FG000|COMPLETED|Overall Study||14
8671531|NCT00752089|9714884|FG000|NOT COMPLETED|Overall Study||6
8671532|NCT00752102|9714897|FG000|STARTED|Overall Study||22
8671533|NCT00752102|9714898|FG001|STARTED|Overall Study||22
8671534|NCT00752102|9714897|FG000|COMPLETED|Overall Study||19
8671535|NCT00752102|9714898|FG001|COMPLETED|Overall Study||21
8671536|NCT00752102|9714897|FG000|NOT COMPLETED|Overall Study||3
8671537|NCT00752102|9714898|FG001|NOT COMPLETED|Overall Study||1
8671538|NCT00752128|9714904|FG000|STARTED|Overall Study||2349
8671539|NCT00752128|9714904|FG000|COMPLETED|Overall Study||2345
8671540|NCT00752128|9714904|FG000|NOT COMPLETED|Overall Study||4
8692653|NCT00862654|9738218|FG002|NOT COMPLETED|Overall Study||6
8692654|NCT00862654|9738219|FG003|NOT COMPLETED|Overall Study||6
8692655|NCT00862719|9738233|FG000|STARTED|Overall Study||17
8692656|NCT00862719|9738234|FG001|STARTED|Overall Study||7
8692657|NCT00862719|9738235|FG002|STARTED|Overall Study||4
8775369|NCT01295710|9825220|FG000|NOT COMPLETED|Overall Study||78
8775370|NCT01295710|9825221|FG001|NOT COMPLETED|Overall Study||50
8775371|NCT01295814|9825229|FG000|STARTED|Overall Study||22
8775372|NCT01295814|9825230|FG001|STARTED|Overall Study||21
8775373|NCT01295814|9825229|FG000|COMPLETED|Overall Study||20
8775374|NCT01295814|9825230|FG001|COMPLETED|Overall Study||19
8775375|NCT01295814|9825229|FG000|NOT COMPLETED|Overall Study||2
8775376|NCT01295814|9825230|FG001|NOT COMPLETED|Overall Study||2
8775377|NCT01295827|9825248|FG000|STARTED|Overall Study||4
8775378|NCT01295827|9825249|FG001|STARTED|Overall Study||3
8775379|NCT01295827|9825250|FG002|STARTED|Overall Study||12
8775380|NCT01295827|9825251|FG003|STARTED|Overall Study||4
8775381|NCT01295827|9825252|FG004|STARTED|Overall Study||3
8775382|NCT01295827|9825253|FG005|STARTED|Overall Study||6
8775383|NCT01295827|9825254|FG006|STARTED|Overall Study||164
8775384|NCT01295827|9825255|FG007|STARTED|Overall Study||321
8775385|NCT01295827|9825256|FG008|STARTED|Overall Study||183
8775386|NCT01295827|9825257|FG009|STARTED|Overall Study||61
8775387|NCT01295827|9825258|FG010|STARTED|Overall Study||296
8775388|NCT01295827|9825259|FG011|STARTED|Overall Study||203
8775389|NCT01295827|9825260|FG012|STARTED|Overall Study||0
8775390|NCT01295827|9825261|FG013|STARTED|Overall Study||0
8775391|NCT01295827|9825262|FG014|STARTED|Overall Study||0
8775392|NCT01295827|9825248|FG000|Treated (All Treated Population)|Overall Study||4
8775393|NCT01295827|9825249|FG001|Treated (All Treated Population)|Overall Study||3
8775394|NCT01295827|9825250|FG002|Treated (All Treated Population)|Overall Study||10
8775395|NCT01295827|9825251|FG003|Treated (All Treated Population)|Overall Study||4
8775396|NCT01295827|9825252|FG004|Treated (All Treated Population)|Overall Study||3
8775397|NCT01295827|9825253|FG005|Treated (All Treated Population)|Overall Study||6
8775398|NCT01295827|9825254|FG006|Treated (All Treated Population)|Overall Study||162
8775399|NCT01295827|9825255|FG007|Treated (All Treated Population)|Overall Study||313
8775400|NCT01295827|9825256|FG008|Treated (All Treated Population)|Overall Study||180
8775401|NCT01295827|9825257|FG009|Treated (All Treated Population)|Overall Study||61
8775402|NCT01295827|9825258|FG010|Treated (All Treated Population)|Overall Study||287
8775403|NCT01295827|9825259|FG011|Treated (All Treated Population)|Overall Study||202
8775404|NCT01295827|9825260|FG012|Treated (All Treated Population)|Overall Study||0
8775405|NCT01295827|9825261|FG013|Treated (All Treated Population)|Overall Study||0
8775406|NCT01295827|9825262|FG014|Treated (All Treated Population)|Overall Study||0
8775407|NCT01295827|9825248|FG000|COMPLETED|Overall Study||0
8775408|NCT01295827|9825249|FG001|COMPLETED|Overall Study||0
8775409|NCT01295827|9825250|FG002|COMPLETED|Overall Study||0
8775410|NCT01295827|9825251|FG003|COMPLETED|Overall Study||0
8775411|NCT01295827|9825252|FG004|COMPLETED|Overall Study||1
8775412|NCT01295827|9825253|FG005|COMPLETED|Overall Study||0
8775413|NCT01295827|9825254|FG006|COMPLETED|Overall Study||18
8775414|NCT01295827|9825255|FG007|COMPLETED|Overall Study||24
8775415|NCT01295827|9825256|FG008|COMPLETED|Overall Study||14
8775416|NCT01295827|9825257|FG009|COMPLETED|Overall Study||6
8775417|NCT01295827|9825258|FG010|COMPLETED|Overall Study||20
8775418|NCT01295827|9825259|FG011|COMPLETED|Overall Study||17
8775419|NCT01295827|9825260|FG012|COMPLETED|Overall Study||0
8775420|NCT01295827|9825261|FG013|COMPLETED|Overall Study||0
8775421|NCT01295827|9825262|FG014|COMPLETED|Overall Study||0
8775422|NCT01295827|9825248|FG000|NOT COMPLETED|Overall Study||4
8775423|NCT01295827|9825249|FG001|NOT COMPLETED|Overall Study||3
8775424|NCT01295827|9825250|FG002|NOT COMPLETED|Overall Study||12
8775425|NCT01295827|9825251|FG003|NOT COMPLETED|Overall Study||4
8775426|NCT01295827|9825252|FG004|NOT COMPLETED|Overall Study||2
8775427|NCT01295827|9825253|FG005|NOT COMPLETED|Overall Study||6
8775428|NCT01295827|9825254|FG006|NOT COMPLETED|Overall Study||146
8775429|NCT01295827|9825255|FG007|NOT COMPLETED|Overall Study||297
8775430|NCT01295827|9825256|FG008|NOT COMPLETED|Overall Study||169
8775431|NCT01295827|9825257|FG009|NOT COMPLETED|Overall Study||55
8775432|NCT01295827|9825258|FG010|NOT COMPLETED|Overall Study||276
8775433|NCT01295827|9825259|FG011|NOT COMPLETED|Overall Study||186
8775434|NCT01295827|9825260|FG012|NOT COMPLETED|Overall Study||0
8775435|NCT01295827|9825261|FG013|NOT COMPLETED|Overall Study||0
9028889|NCT03210337|10091260|FG001|COMPLETED|Overall Study||74
9028890|NCT03210337|10091259|FG000|NOT COMPLETED|Overall Study||8
9028891|NCT03210337|10091260|FG001|NOT COMPLETED|Overall Study||5
9028892|NCT03210376|10091268|FG000|STARTED|Overall Study||50
9028893|NCT03210376|10091269|FG001|STARTED|Overall Study||50
9028894|NCT03210376|10091268|FG000|COMPLETED|Overall Study||50
8775436|NCT01295827|9825262|FG014|NOT COMPLETED|Overall Study||0
8775437|NCT01295840|9825315|FG000|STARTED|Overall Study||51
8775438|NCT01295840|9825315|FG000|COMPLETED|Overall Study||50
8775439|NCT01295840|9825315|FG000|NOT COMPLETED|Overall Study||1
8775440|NCT01295879|9825321|FG000|STARTED|Overall Study||29
8775441|NCT01295879|9825321|FG000|COMPLETED|Overall Study||29
8775442|NCT01295879|9825321|FG000|NOT COMPLETED|Overall Study||0
8775443|NCT01295905|9825327|FG000|STARTED|Overall Study||60
8775444|NCT01295905|9825328|FG001|STARTED|Overall Study||30
8775445|NCT01295905|9825327|FG000|COMPLETED|Overall Study||58
8775446|NCT01295905|9825328|FG001|COMPLETED|Overall Study||30
8775447|NCT01295905|9825327|FG000|NOT COMPLETED|Overall Study||2
8775448|NCT01295905|9825328|FG001|NOT COMPLETED|Overall Study||0
8775449|NCT01296035|9825334|FG000|STARTED|Overall Study||8
8775450|NCT01296035|9825334|FG000|COMPLETED|Overall Study||7
8775451|NCT01296035|9825334|FG000|NOT COMPLETED|Overall Study||1
8775452|NCT01296152|9825338|FG000|STARTED|Overall Study||25
9028895|NCT03210376|10091269|FG001|COMPLETED|Overall Study||50
9028896|NCT03210376|10091268|FG000|NOT COMPLETED|Overall Study||0
9028897|NCT03210376|10091269|FG001|NOT COMPLETED|Overall Study||0
9028898|NCT03210519|10091277|FG000|STARTED|Overall Study||11
9028899|NCT03210519|10091278|FG001|STARTED|Overall Study||10
9028900|NCT03210519|10091277|FG000|COMPLETED|Overall Study||9
9028901|NCT03210519|10091278|FG001|COMPLETED|Overall Study||10
9028902|NCT03210519|10091277|FG000|NOT COMPLETED|Overall Study||2
9028903|NCT03210519|10091278|FG001|NOT COMPLETED|Overall Study||0
9028904|NCT03210701|10091284|FG000|STARTED|Overall Study||123
9028905|NCT03210701|10091284|FG000|COMPLETED|Overall Study||123
9028906|NCT03210701|10091284|FG000|NOT COMPLETED|Overall Study||0
9028907|NCT03210961|10091303|FG000|STARTED|Overall Study||4
9028908|NCT03210961|10091304|FG001|STARTED|Overall Study||9
9028909|NCT03210961|10091305|FG002|STARTED|Overall Study||1
9028910|NCT03210961|10091306|FG003|STARTED|Overall Study||2
9028911|NCT03210961|10091307|FG004|STARTED|Overall Study||6
9028912|NCT03210961|10091308|FG005|STARTED|Overall Study||6
9028913|NCT03210961|10091309|FG006|STARTED|Overall Study||8
9028914|NCT03210961|10091310|FG007|STARTED|Overall Study||7
9028915|NCT03210961|10091311|FG008|STARTED|Overall Study||8
9028916|NCT03210961|10091312|FG009|STARTED|Overall Study||6
9028917|NCT03210961|10091313|FG010|STARTED|Overall Study||7
9028918|NCT03210961|10091314|FG011|STARTED|Overall Study||5
9028919|NCT03210961|10091315|FG012|STARTED|Overall Study||14
8775453|NCT01296152|9825338|FG000|COMPLETED|Overall Study||24
8775454|NCT01296152|9825338|FG000|NOT COMPLETED|Overall Study||1
8775455|NCT01296191|9825344|FG000|STARTED|Overall Study||60
8775456|NCT01296191|9825345|FG001|STARTED|Overall Study||60
8775457|NCT01296191|9825344|FG000|COMPLETED|Overall Study||57
8775458|NCT01296191|9825345|FG001|COMPLETED|Overall Study||59
8775459|NCT01296191|9825344|FG000|NOT COMPLETED|Overall Study||3
8775460|NCT01296191|9825345|FG001|NOT COMPLETED|Overall Study||1
8775461|NCT01296347|9825353|FG000|STARTED|Allocation||38
8775462|NCT01296347|9825354|FG001|STARTED|Allocation||39
8775463|NCT01296347|9825353|FG000|COMPLETED|Allocation||35
8775464|NCT01296347|9825354|FG001|COMPLETED|Allocation||35
8775465|NCT01296347|9825353|FG000|NOT COMPLETED|Allocation||3
8775466|NCT01296347|9825354|FG001|NOT COMPLETED|Allocation||4
8775467|NCT01296347|9825353|FG000|STARTED|6 Week Follow up||35
8775468|NCT01296347|9825354|FG001|STARTED|6 Week Follow up||35
8775469|NCT01296347|9825353|FG000|COMPLETED|6 Week Follow up||35
8775470|NCT01296347|9825354|FG001|COMPLETED|6 Week Follow up||34
8775471|NCT01296347|9825353|FG000|NOT COMPLETED|6 Week Follow up||0
8775472|NCT01296347|9825354|FG001|NOT COMPLETED|6 Week Follow up||1
8775473|NCT01296347|9825353|FG000|STARTED|3 Month Follow up||35
8775474|NCT01296347|9825354|FG001|STARTED|3 Month Follow up||34
8775475|NCT01296347|9825353|FG000|COMPLETED|3 Month Follow up||34
8775476|NCT01296347|9825354|FG001|COMPLETED|3 Month Follow up||33
8775477|NCT01296347|9825353|FG000|NOT COMPLETED|3 Month Follow up||1
8775478|NCT01296347|9825354|FG001|NOT COMPLETED|3 Month Follow up||1
8775479|NCT01296347|9825353|FG000|STARTED|6 Month Follow up||34
8775480|NCT01296347|9825354|FG001|STARTED|6 Month Follow up||33
8775481|NCT01296347|9825353|FG000|COMPLETED|6 Month Follow up||32
8775482|NCT01296347|9825354|FG001|COMPLETED|6 Month Follow up||31
8775483|NCT01296347|9825353|FG000|NOT COMPLETED|6 Month Follow up||2
8775484|NCT01296347|9825354|FG001|NOT COMPLETED|6 Month Follow up||2
8775485|NCT01296347|9825353|FG000|STARTED|12 Month Follow up||32
8775486|NCT01296347|9825354|FG001|STARTED|12 Month Follow up||31
8775487|NCT01296347|9825353|FG000|COMPLETED|12 Month Follow up||28
8775488|NCT01296347|9825354|FG001|COMPLETED|12 Month Follow up||28
8775489|NCT01296347|9825353|FG000|NOT COMPLETED|12 Month Follow up||4
8775490|NCT01296347|9825354|FG001|NOT COMPLETED|12 Month Follow up||3
8775491|NCT01296360|9825365|FG000|STARTED|Overall Study||150
8775492|NCT01296360|9825366|FG001|STARTED|Overall Study||150
8775493|NCT01296360|9825365|FG000|Visit 2 (Month 12)|Overall Study|booster was administered|148
8775494|NCT01296360|9825366|FG001|Visit 2 (Month 12)|Overall Study||149
8775495|NCT01296360|9825365|FG000|Visit 2a (Month 13)|Overall Study|visit in Booster Group only: ~13 months after immunization in IC51-323 (i.e., 1 month post booster)|148
8775496|NCT01296360|9825366|FG001|Visit 2a (Month 13)|Overall Study||0
8775497|NCT01296360|9825365|FG000|COMPLETED|Overall Study||144
8775498|NCT01296360|9825366|FG001|COMPLETED|Overall Study||142
8775499|NCT01296360|9825365|FG000|NOT COMPLETED|Overall Study||6
8775500|NCT01296360|9825366|FG001|NOT COMPLETED|Overall Study||8
8775501|NCT01296412|9825374|FG000|STARTED|Overall Study||326
8775502|NCT01296412|9825375|FG001|STARTED|Overall Study||327
8775503|NCT01296412|9825374|FG000|COMPLETED|Overall Study||275
8775504|NCT01296412|9825375|FG001|COMPLETED|Overall Study||257
8775505|NCT01296412|9825374|FG000|NOT COMPLETED|Overall Study||51
8775506|NCT01296412|9825375|FG001|NOT COMPLETED|Overall Study||70
8775507|NCT01296542|9825383|FG000|STARTED|Overall Study||30
8775508|NCT01296542|9825384|FG001|STARTED|Overall Study||30
8775509|NCT01296542|9825383|FG000|COMPLETED|Overall Study||30
8775510|NCT01296542|9825384|FG001|COMPLETED|Overall Study||28
8775511|NCT01296542|9825383|FG000|NOT COMPLETED|Overall Study||0
8775512|NCT01296542|9825384|FG001|NOT COMPLETED|Overall Study||2
8775513|NCT01296568|9825390|FG000|STARTED|[^14C]LY2603618 Single Dose and Washout||3
8775514|NCT01296568|9825390|FG000|COMPLETED|[^14C]LY2603618 Single Dose and Washout||3
8775515|NCT01296568|9825390|FG000|NOT COMPLETED|[^14C]LY2603618 Single Dose and Washout||0
8775516|NCT01296568|9825390|FG000|STARTED|Continued Access Phase||3
8775517|NCT01296568|9825390|FG000|COMPLETED|Continued Access Phase|After study discontinuation participants assessed for disease progression (21-day safety follow-up).|0
9028920|NCT03210961|10091316|FG013|STARTED|Overall Study||15
9028921|NCT03210961|10091317|FG014|STARTED|Overall Study||11
9028922|NCT03210961|10091303|FG000|COMPLETED|Overall Study||4
8775518|NCT01296568|9825390|FG000|NOT COMPLETED|Continued Access Phase||3
8775519|NCT01296646|9825398|FG000|STARTED|Overall Study||40
8775520|NCT01296646|9825399|FG001|STARTED|Overall Study||40
8775521|NCT01296646|9825398|FG000|COMPLETED|Overall Study||29
8775522|NCT01296646|9825399|FG001|COMPLETED|Overall Study||29
8775523|NCT01296646|9825398|FG000|NOT COMPLETED|Overall Study||11
8775524|NCT01296646|9825399|FG001|NOT COMPLETED|Overall Study||11
8775525|NCT01296672|9825407|FG000|STARTED|Overall Study||306
8775526|NCT01296672|9825408|FG001|STARTED|Overall Study||77
8775527|NCT01296672|9825407|FG000|COMPLETED|Overall Study||233
8775528|NCT01296672|9825408|FG001|COMPLETED|Overall Study||59
8775529|NCT01296672|9825407|FG000|NOT COMPLETED|Overall Study||73
8775530|NCT01296672|9825408|FG001|NOT COMPLETED|Overall Study||18
8775531|NCT01296698|9825418|FG000|STARTED|Overall Study||244
8775532|NCT01296698|9825419|FG001|STARTED|Overall Study||13
8775533|NCT01296698|9825418|FG000|COMPLETED|Overall Study||0
8775534|NCT01296698|9825419|FG001|COMPLETED|Overall Study||0
8775535|NCT01296698|9825418|FG000|NOT COMPLETED|Overall Study||244
8775536|NCT01296698|9825419|FG001|NOT COMPLETED|Overall Study||13
8775537|NCT01296763|9825428|FG000|STARTED|Overall Study||7
8775538|NCT01296763|9825429|FG001|STARTED|Overall Study||5
8775539|NCT01296763|9825430|FG002|STARTED|Overall Study||6
8775540|NCT01296763|9825428|FG000|COMPLETED|Overall Study||7
8775541|NCT01296763|9825429|FG001|COMPLETED|Overall Study||5
8775542|NCT01296763|9825430|FG002|COMPLETED|Overall Study||6
8775543|NCT01296763|9825428|FG000|NOT COMPLETED|Overall Study||0
8775544|NCT01296763|9825429|FG001|NOT COMPLETED|Overall Study||0
8775545|NCT01296763|9825430|FG002|NOT COMPLETED|Overall Study||0
8775546|NCT01296815|9825440|FG000|STARTED|Overall Study||7
8775547|NCT01296815|9825441|FG001|STARTED|Overall Study||7
8775548|NCT01296815|9825440|FG000|COMPLETED|Overall Study||7
8775549|NCT01296815|9825441|FG001|COMPLETED|Overall Study||7
8775550|NCT01296815|9825440|FG000|NOT COMPLETED|Overall Study||0
8775551|NCT01296815|9825441|FG001|NOT COMPLETED|Overall Study||0
8775552|NCT01296841|9825449|FG000|STARTED|Overall Study||19
8775553|NCT01296841|9825450|FG001|STARTED|Overall Study||15
8775554|NCT01296841|9825449|FG000|COMPLETED|Overall Study||19
8775555|NCT01296841|9825450|FG001|COMPLETED|Overall Study||15
8775556|NCT01296841|9825449|FG000|NOT COMPLETED|Overall Study||0
8775557|NCT01296841|9825450|FG001|NOT COMPLETED|Overall Study||0
8775558|NCT01296932|9825467|FG000|STARTED|Overall Study||3
8916302|NCT02181803|9975868|FG007|NOT COMPLETED|Overall Study||1
8916303|NCT02181803|9975869|FG008|NOT COMPLETED|Overall Study||0
8916304|NCT02181816|9975914|FG000|STARTED|Overall Study||1090
8916305|NCT02181816|9975914|FG000|COMPLETED|Overall Study||1031
8916306|NCT02181816|9975914|FG000|NOT COMPLETED|Overall Study||59
8916307|NCT02181829|9975918|FG000|STARTED|Overall Study||10
8916308|NCT02181829|9975918|FG000|COMPLETED|Overall Study||10
8916309|NCT02181829|9975918|FG000|NOT COMPLETED|Overall Study||0
8916310|NCT02181842|9975922|FG000|STARTED|Overall Study||246
8916311|NCT02181842|9975922|FG000|COMPLETED|Overall Study||244
8916312|NCT02181842|9975922|FG000|NOT COMPLETED|Overall Study||2
8916313|NCT02182115|9975928|FG000|STARTED|Overall Study||53
8916314|NCT02182115|9975929|FG001|STARTED|Overall Study||57
8916315|NCT02182115|9975928|FG000|COMPLETED|Overall Study||53
8916316|NCT02182115|9975929|FG001|COMPLETED|Overall Study||57
8916317|NCT02182115|9975928|FG000|NOT COMPLETED|Overall Study||0
8916318|NCT02182115|9975929|FG001|NOT COMPLETED|Overall Study||0
8916319|NCT02182440|9975939|FG000|STARTED|Overall Study||116
8916320|NCT02182440|9975940|FG001|STARTED|Overall Study||39
8916321|NCT02182440|9975941|FG002|STARTED|Overall Study||35
8916322|NCT02182440|9975942|FG003|STARTED|Overall Study||111
8916323|NCT02182440|9975939|FG000|ITTcombined|Overall Study||116
8916324|NCT02182440|9975940|FG001|ITTcombined|Overall Study||31
8916325|NCT02182440|9975941|FG002|ITTcombined|Overall Study||32
8916326|NCT02182440|9975942|FG003|ITTcombined|Overall Study||111
8916327|NCT02182440|9975939|FG000|ITTinterim|Overall Study||30
8916328|NCT02182440|9975940|FG001|ITTinterim|Overall Study||31
8916329|NCT02182440|9975941|FG002|ITTinterim|Overall Study||32
9028923|NCT03210961|10091304|FG001|COMPLETED|Overall Study||9
8775559|NCT01296932|9825468|FG001|STARTED|Overall Study||3
8775560|NCT01296932|9825469|FG002|STARTED|Overall Study||6
8775561|NCT01296932|9825470|FG003|STARTED|Overall Study||6
8775562|NCT01296932|9825471|FG004|STARTED|Overall Study||3
8775563|NCT01296932|9825472|FG005|STARTED|Overall Study||3
8775564|NCT01296932|9825473|FG006|STARTED|Overall Study||6
8775565|NCT01296932|9825474|FG007|STARTED|Overall Study||3
8775566|NCT01296932|9825475|FG008|STARTED|Overall Study||4
8775567|NCT01296932|9825467|FG000|COMPLETED|Overall Study||0
8775568|NCT01296932|9825468|FG001|COMPLETED|Overall Study||0
8775569|NCT01296932|9825469|FG002|COMPLETED|Overall Study||0
8775570|NCT01296932|9825470|FG003|COMPLETED|Overall Study||0
8775571|NCT01296932|9825471|FG004|COMPLETED|Overall Study||0
8775572|NCT01296932|9825472|FG005|COMPLETED|Overall Study||0
8775573|NCT01296932|9825473|FG006|COMPLETED|Overall Study||0
8775574|NCT01296932|9825474|FG007|COMPLETED|Overall Study||1
8775575|NCT01296932|9825475|FG008|COMPLETED|Overall Study||0
8916330|NCT02182440|9975942|FG003|ITTinterim|Overall Study||29
8916331|NCT02182440|9975939|FG000|Safety Population|Overall Study||112
8916332|NCT02182440|9975940|FG001|Safety Population|Overall Study||38
8916333|NCT02182440|9975941|FG002|Safety Population|Overall Study||35
8916334|NCT02182440|9975942|FG003|Safety Population|Overall Study||109
8916335|NCT02182440|9975939|FG000|COMPLETED|Overall Study||71
8916336|NCT02182440|9975940|FG001|COMPLETED|Overall Study||25
8775576|NCT01296932|9825467|FG000|NOT COMPLETED|Overall Study||3
8775577|NCT01296932|9825468|FG001|NOT COMPLETED|Overall Study||3
8775578|NCT01296932|9825469|FG002|NOT COMPLETED|Overall Study||6
8775579|NCT01296932|9825470|FG003|NOT COMPLETED|Overall Study||6
8775580|NCT01296932|9825471|FG004|NOT COMPLETED|Overall Study||3
8775581|NCT01296932|9825472|FG005|NOT COMPLETED|Overall Study||3
8775582|NCT01296932|9825473|FG006|NOT COMPLETED|Overall Study||6
8775583|NCT01296932|9825474|FG007|NOT COMPLETED|Overall Study||2
8775584|NCT01296932|9825475|FG008|NOT COMPLETED|Overall Study||4
8775585|NCT01297062|9825502|FG000|STARTED|Overall Study||15
8775586|NCT01297062|9825503|FG001|STARTED|Overall Study||14
8775587|NCT01297062|9825504|FG002|STARTED|Overall Study||14
8775588|NCT01297062|9825505|FG003|STARTED|Overall Study||14
8775589|NCT01297062|9825506|FG004|STARTED|Overall Study||15
8775590|NCT01297062|9825507|FG005|STARTED|Overall Study||14
8775591|NCT01297062|9825508|FG006|STARTED|Overall Study||8
8775592|NCT01297062|9825502|FG000|Intent to Treat (ITT)|Overall Study||15
8775593|NCT01297062|9825503|FG001|Intent to Treat (ITT)|Overall Study||14
8775594|NCT01297062|9825504|FG002|Intent to Treat (ITT)|Overall Study||14
8775595|NCT01297062|9825505|FG003|Intent to Treat (ITT)|Overall Study||14
8775596|NCT01297062|9825506|FG004|Intent to Treat (ITT)|Overall Study||15
8775597|NCT01297062|9825507|FG005|Intent to Treat (ITT)|Overall Study||14
8775598|NCT01297062|9825508|FG006|Intent to Treat (ITT)|Overall Study||0
8775599|NCT01297062|9825502|FG000|Evaluable Population|Overall Study||11
8775600|NCT01297062|9825503|FG001|Evaluable Population|Overall Study||12
8775601|NCT01297062|9825504|FG002|Evaluable Population|Overall Study||12
8775602|NCT01297062|9825505|FG003|Evaluable Population|Overall Study||13
8775603|NCT01297062|9825506|FG004|Evaluable Population|Overall Study||13
8775604|NCT01297062|9825507|FG005|Evaluable Population|Overall Study||13
8775605|NCT01297062|9825508|FG006|Evaluable Population|Overall Study||0
8775606|NCT01297062|9825502|FG000|COMPLETED|Overall Study||11
8775607|NCT01297062|9825503|FG001|COMPLETED|Overall Study||13
8775608|NCT01297062|9825504|FG002|COMPLETED|Overall Study||12
8775609|NCT01297062|9825505|FG003|COMPLETED|Overall Study||13
8775610|NCT01297062|9825506|FG004|COMPLETED|Overall Study||13
8775611|NCT01297062|9825507|FG005|COMPLETED|Overall Study||13
8775612|NCT01297062|9825508|FG006|COMPLETED|Overall Study||0
8775613|NCT01297062|9825502|FG000|NOT COMPLETED|Overall Study||4
8775614|NCT01297062|9825503|FG001|NOT COMPLETED|Overall Study||1
8775615|NCT01297062|9825504|FG002|NOT COMPLETED|Overall Study||2
8775616|NCT01297062|9825505|FG003|NOT COMPLETED|Overall Study||1
8775617|NCT01297062|9825506|FG004|NOT COMPLETED|Overall Study||2
8775618|NCT01297062|9825507|FG005|NOT COMPLETED|Overall Study||1
8775619|NCT01297062|9825508|FG006|NOT COMPLETED|Overall Study||8
8775620|NCT01297244|9825518|FG000|STARTED|Overall Study||90
8775621|NCT01297244|9825519|FG001|STARTED|Overall Study||15
8775622|NCT01297244|9825518|FG000|COMPLETED|Overall Study||55
8775623|NCT01297244|9825519|FG001|COMPLETED|Overall Study||9
8775624|NCT01297244|9825518|FG000|NOT COMPLETED|Overall Study||35
8775625|NCT01297244|9825519|FG001|NOT COMPLETED|Overall Study||6
8775626|NCT01297257|9825526|FG000|STARTED|Overall Study||7740
8775627|NCT01297257|9825526|FG000|COMPLETED|Overall Study||7740
8775628|NCT01297257|9825526|FG000|NOT COMPLETED|Overall Study||0
8775629|NCT01297270|9825534|FG000|STARTED|Overall Study||262
8775630|NCT01297270|9825535|FG001|STARTED|Overall Study||264
8775631|NCT01297270|9825536|FG002|STARTED|Overall Study||132
8775632|NCT01297270|9825534|FG000|COMPLETED|Overall Study||217
8775633|NCT01297270|9825535|FG001|COMPLETED|Overall Study||192
8775634|NCT01297270|9825536|FG002|COMPLETED|Overall Study||103
9028924|NCT03210961|10091305|FG002|COMPLETED|Overall Study||1
9028925|NCT03210961|10091306|FG003|COMPLETED|Overall Study||1
9028926|NCT03210961|10091307|FG004|COMPLETED|Overall Study||6
9028927|NCT03210961|10091308|FG005|COMPLETED|Overall Study||6
9028928|NCT03210961|10091309|FG006|COMPLETED|Overall Study||7
9028929|NCT03210961|10091310|FG007|COMPLETED|Overall Study||7
9028930|NCT03210961|10091311|FG008|COMPLETED|Overall Study||8
8775635|NCT01297270|9825534|FG000|NOT COMPLETED|Overall Study||45
8775636|NCT01297270|9825535|FG001|NOT COMPLETED|Overall Study||72
8775637|NCT01297270|9825536|FG002|NOT COMPLETED|Overall Study||29
8775638|NCT01297283|9825544|FG000|STARTED|Overall Study||195
8775639|NCT01297283|9825544|FG000|COMPLETED|Overall Study||176
8775640|NCT01297283|9825544|FG000|NOT COMPLETED|Overall Study||19
8775641|NCT01297309|9825548|FG000|STARTED|Overall Study||51
8775642|NCT01297309|9825548|FG000|Treated|Overall Study||49
8775643|NCT01297309|9825548|FG000|Started Extension Period|Overall Study||46
8775644|NCT01297309|9825548|FG000|COMPLETED|Overall Study||37
8775645|NCT01297309|9825548|FG000|NOT COMPLETED|Overall Study||14
8775646|NCT01297322|9825554|FG000|STARTED|Overall Study||142
8775647|NCT01297322|9825555|FG001|STARTED|Overall Study||278
9028931|NCT03210961|10091312|FG009|COMPLETED|Overall Study||6
9028932|NCT03210961|10091313|FG010|COMPLETED|Overall Study||6
9028933|NCT03210961|10091314|FG011|COMPLETED|Overall Study||5
9028934|NCT03210961|10091315|FG012|COMPLETED|Overall Study||12
9028935|NCT03210961|10091316|FG013|COMPLETED|Overall Study||11
9028936|NCT03210961|10091317|FG014|COMPLETED|Overall Study||9
9028937|NCT03210961|10091303|FG000|NOT COMPLETED|Overall Study||0
9028938|NCT03210961|10091304|FG001|NOT COMPLETED|Overall Study||0
8775648|NCT01297322|9825554|FG000|COMPLETED|Overall Study||141
8775649|NCT01297322|9825555|FG001|COMPLETED|Overall Study||274
9028939|NCT03210961|10091305|FG002|NOT COMPLETED|Overall Study||0
8775650|NCT01297322|9825554|FG000|NOT COMPLETED|Overall Study||1
8775651|NCT01297322|9825555|FG001|NOT COMPLETED|Overall Study||4
8775652|NCT01297335|9825562|FG000|STARTED|Overall Study||10
8775653|NCT01297335|9825562|FG000|COMPLETED|Overall Study||10
8775654|NCT01297335|9825562|FG000|NOT COMPLETED|Overall Study||0
8775655|NCT01297348|9825570|FG000|STARTED|Overall Study||12281
8775656|NCT01297348|9825571|FG001|STARTED|Overall Study||586401
8775657|NCT01297348|9825570|FG000|COMPLETED|Overall Study||12281
8775658|NCT01297348|9825571|FG001|COMPLETED|Overall Study||586401
8775659|NCT01297348|9825570|FG000|NOT COMPLETED|Overall Study||0
8775660|NCT01297348|9825571|FG001|NOT COMPLETED|Overall Study||0
8775661|NCT01297465|9825580|FG000|STARTED|Overall Study||99
8775662|NCT01297465|9825581|FG001|STARTED|Overall Study||103
8775663|NCT01297465|9825580|FG000|COMPLETED|Overall Study||91
8775664|NCT01297465|9825581|FG001|COMPLETED|Overall Study||93
8775665|NCT01297465|9825580|FG000|NOT COMPLETED|Overall Study||8
8775666|NCT01297465|9825581|FG001|NOT COMPLETED|Overall Study||10
8775667|NCT01297491|9825589|FG000|STARTED|Overall Study||30
8775668|NCT01297491|9825590|FG001|STARTED|Overall Study||33
8775669|NCT01297491|9825589|FG000|COMPLETED|Overall Study||0
8775670|NCT01297491|9825590|FG001|COMPLETED|Overall Study||0
8775671|NCT01297491|9825589|FG000|NOT COMPLETED|Overall Study||30
8775672|NCT01297491|9825590|FG001|NOT COMPLETED|Overall Study||33
8775673|NCT01297504|9825596|FG000|STARTED|Overall Study||464
8775674|NCT01297504|9825596|FG000|Participants Studied|Overall Study|Six participants were eliminated due to invalid consent, previous palivizumab or no study visits|458
8775675|NCT01297504|9825596|FG000|COMPLETED|Overall Study||397
8775676|NCT01297504|9825596|FG000|NOT COMPLETED|Overall Study||67
8775677|NCT01297517|9825607|FG000|STARTED|Overall Study||214
8775678|NCT01297517|9825608|FG001|STARTED|Overall Study||226
8775679|NCT01297517|9825609|FG002|STARTED|Overall Study||220
8775680|NCT01297517|9825607|FG000|COMPLETED|Overall Study||187
8775681|NCT01297517|9825608|FG001|COMPLETED|Overall Study||214
8775682|NCT01297517|9825609|FG002|COMPLETED|Overall Study||193
8775683|NCT01297517|9825607|FG000|NOT COMPLETED|Overall Study||27
8775684|NCT01297517|9825608|FG001|NOT COMPLETED|Overall Study||12
8775685|NCT01297517|9825609|FG002|NOT COMPLETED|Overall Study||27
8775686|NCT01297595|9825617|FG000|STARTED|First Intervention Period||11
8775687|NCT01297595|9825618|FG001|STARTED|First Intervention Period||11
8775688|NCT01297595|9825617|FG000|COMPLETED|First Intervention Period||11
8775689|NCT01297595|9825618|FG001|COMPLETED|First Intervention Period||11
8775690|NCT01297595|9825617|FG000|NOT COMPLETED|First Intervention Period||0
8775691|NCT01297595|9825618|FG001|NOT COMPLETED|First Intervention Period||0
8775692|NCT01297595|9825617|FG000|STARTED|Washout Period (At Least 14 Days)||11
8775693|NCT01297595|9825618|FG001|STARTED|Washout Period (At Least 14 Days)||11
8775694|NCT01297595|9825617|FG000|COMPLETED|Washout Period (At Least 14 Days)||11
8775695|NCT01297595|9825618|FG001|COMPLETED|Washout Period (At Least 14 Days)||11
8775696|NCT01297595|9825617|FG000|NOT COMPLETED|Washout Period (At Least 14 Days)||0
8775697|NCT01297595|9825618|FG001|NOT COMPLETED|Washout Period (At Least 14 Days)||0
8775698|NCT01297595|9825617|FG000|STARTED|Second Intervention Period||11
8775699|NCT01297595|9825618|FG001|STARTED|Second Intervention Period||11
8775700|NCT01297595|9825617|FG000|COMPLETED|Second Intervention Period||11
8775701|NCT01297595|9825618|FG001|COMPLETED|Second Intervention Period||11
8775702|NCT01297595|9825617|FG000|NOT COMPLETED|Second Intervention Period||0
8775703|NCT01297595|9825618|FG001|NOT COMPLETED|Second Intervention Period||0
8775704|NCT01297920|9825627|FG000|STARTED|Overall Study||221
8775705|NCT01297920|9825628|FG001|STARTED|Overall Study||234
8775706|NCT01297920|9825629|FG002|STARTED|Overall Study||235
8775707|NCT01297920|9825627|FG000|COMPLETED|Overall Study||163
8775708|NCT01297920|9825628|FG001|COMPLETED|Overall Study||207
8775709|NCT01297920|9825629|FG002|COMPLETED|Overall Study||178
8775710|NCT01297920|9825627|FG000|NOT COMPLETED|Overall Study||58
8775711|NCT01297920|9825628|FG001|NOT COMPLETED|Overall Study||27
8775712|NCT01297920|9825629|FG002|NOT COMPLETED|Overall Study||57
8775713|NCT01297959|9825639|FG000|STARTED|Overall Study||261
8775714|NCT01297959|9825640|FG001|STARTED|Overall Study||242
8775715|NCT01297959|9825639|FG000|COMPLETED|Overall Study||241
8775716|NCT01297959|9825640|FG001|COMPLETED|Overall Study||226
8775717|NCT01297959|9825639|FG000|NOT COMPLETED|Overall Study||20
8775718|NCT01297959|9825640|FG001|NOT COMPLETED|Overall Study||16
8775719|NCT01297985|9825648|FG000|STARTED|Overall Study||212
8775720|NCT01297985|9825649|FG001|STARTED|Overall Study||216
8775721|NCT01297985|9825648|FG000|COMPLETED|Overall Study||157
8775722|NCT01297985|9825649|FG001|COMPLETED|Overall Study||163
8775723|NCT01297985|9825648|FG000|NOT COMPLETED|Overall Study||55
8775724|NCT01297985|9825649|FG001|NOT COMPLETED|Overall Study||53
8775725|NCT01298063|9825660|FG000|STARTED|Overall Study||8
8775726|NCT01298063|9825661|FG001|STARTED|Overall Study||3
8775727|NCT01298063|9825662|FG002|STARTED|Overall Study||8
8775728|NCT01298063|9825663|FG003|STARTED|Overall Study||8
8775729|NCT01298063|9825664|FG004|STARTED|Overall Study||8
8775730|NCT01298063|9825660|FG000|COMPLETED|Overall Study||8
8775731|NCT01298063|9825661|FG001|COMPLETED|Overall Study||3
8775732|NCT01298063|9825662|FG002|COMPLETED|Overall Study||8
8775733|NCT01298063|9825663|FG003|COMPLETED|Overall Study||8
8775734|NCT01298063|9825664|FG004|COMPLETED|Overall Study||8
8775735|NCT01298063|9825660|FG000|NOT COMPLETED|Overall Study||0
8775736|NCT01298063|9825661|FG001|NOT COMPLETED|Overall Study||0
8775737|NCT01298063|9825662|FG002|NOT COMPLETED|Overall Study||0
8775738|NCT01298063|9825663|FG003|NOT COMPLETED|Overall Study||0
8775739|NCT01298063|9825664|FG004|NOT COMPLETED|Overall Study||0
8775740|NCT01298128|9825679|FG000|STARTED|Overall Study||35
8775741|NCT01298128|9825680|FG001|STARTED|Overall Study||35
8775742|NCT01298128|9825679|FG000|COMPLETED|Overall Study||26
8775743|NCT01298128|9825680|FG001|COMPLETED|Overall Study||27
8775744|NCT01298128|9825679|FG000|NOT COMPLETED|Overall Study||9
8775745|NCT01298128|9825680|FG001|NOT COMPLETED|Overall Study||8
8775746|NCT01298141|9825686|FG000|STARTED|Overall Study||171
8775747|NCT01298141|9825686|FG000|Treated|Overall Study||167
8775748|NCT01298141|9825686|FG000|COMPLETED|Overall Study||140
8775749|NCT01298141|9825686|FG000|NOT COMPLETED|Overall Study||31
8775750|NCT01298167|9825692|FG000|STARTED|Overall Study||6
8775751|NCT01298167|9825693|FG001|STARTED|Overall Study||8
8775752|NCT01298167|9825692|FG000|COMPLETED|Overall Study||5
8775753|NCT01298167|9825693|FG001|COMPLETED|Overall Study||8
8775754|NCT01298167|9825692|FG000|NOT COMPLETED|Overall Study||1
8775755|NCT01298167|9825693|FG001|NOT COMPLETED|Overall Study||0
8775756|NCT01298193|9825699|FG000|STARTED|Observational Phase (First Cycle)||212
8775757|NCT01298193|9825699|FG000|COMPLETED|Observational Phase (First Cycle)|From these 185 completed patients, only 24 experiment emesis on Cycle 1 (NCR) (efficacy phase).|185
8775758|NCT01298193|9825699|FG000|NOT COMPLETED|Observational Phase (First Cycle)||27
8775759|NCT01298193|9825699|FG000|STARTED|Efficacy Phase (Second Cycle)||24
8775760|NCT01298193|9825699|FG000|COMPLETED|Efficacy Phase (Second Cycle)||23
8775761|NCT01298193|9825699|FG000|NOT COMPLETED|Efficacy Phase (Second Cycle)||1
8775762|NCT01298219|9825708|FG000|STARTED|Overall Study||219
8775763|NCT01298219|9825709|FG001|STARTED|Overall Study||220
8775764|NCT01298219|9825708|FG000|Intention to Treat (ITT)|Overall Study||219
8775765|NCT01298219|9825709|FG001|Intention to Treat (ITT)|Overall Study||220
8775766|NCT01298219|9825708|FG000|Safety Analysis Set|Overall Study||219
8775767|NCT01298219|9825709|FG001|Safety Analysis Set|Overall Study||220
8775768|NCT01298219|9825708|FG000|COMPLETED|Overall Study||169
8775769|NCT01298219|9825709|FG001|COMPLETED|Overall Study||184
8775770|NCT01298219|9825708|FG000|NOT COMPLETED|Overall Study||50
8775771|NCT01298219|9825709|FG001|NOT COMPLETED|Overall Study||36
8775772|NCT01298323|9825717|FG000|STARTED|Overall Study||102
8775773|NCT01298323|9825718|FG001|STARTED|Overall Study||103
8775774|NCT01298323|9825717|FG000|Ongoing|Overall Study||55
8775775|NCT01298323|9825718|FG001|Ongoing|Overall Study||55
8775776|NCT01298323|9825717|FG000|COMPLETED|Overall Study||16
8775777|NCT01298323|9825718|FG001|COMPLETED|Overall Study||15
8775778|NCT01298323|9825717|FG000|NOT COMPLETED|Overall Study||86
8775779|NCT01298323|9825718|FG001|NOT COMPLETED|Overall Study||88
8775780|NCT01298362|9825726|FG000|STARTED|Overall Study||124
8775781|NCT01298362|9825727|FG001|STARTED|Overall Study||166
8775782|NCT01298362|9825726|FG000|COMPLETED|Overall Study||86
8775783|NCT01298362|9825727|FG001|COMPLETED|Overall Study||123
8775784|NCT01298362|9825726|FG000|NOT COMPLETED|Overall Study||38
8775785|NCT01298362|9825727|FG001|NOT COMPLETED|Overall Study||43
8775786|NCT01298492|9825735|FG000|STARTED|Overall Study||268
8775787|NCT01298492|9825735|FG000|COMPLETED|Overall Study||149
8775788|NCT01298492|9825735|FG000|NOT COMPLETED|Overall Study||119
8775789|NCT01298518|9825742|FG000|STARTED|Overall Study||16
8775790|NCT01298518|9825743|FG001|STARTED|Overall Study||16
8775791|NCT01298518|9825744|FG002|STARTED|Overall Study||16
8775792|NCT01298518|9825742|FG000|COMPLETED|Overall Study||16
8775793|NCT01298518|9825743|FG001|COMPLETED|Overall Study||16
8775794|NCT01298518|9825744|FG002|COMPLETED|Overall Study||15
8775795|NCT01298518|9825742|FG000|NOT COMPLETED|Overall Study||0
8775796|NCT01298518|9825743|FG001|NOT COMPLETED|Overall Study||0
8775797|NCT01298518|9825744|FG002|NOT COMPLETED|Overall Study||1
8775798|NCT01298531|9825754|FG000|STARTED|Overall Study||42
8775799|NCT01298531|9825755|FG001|STARTED|Overall Study||48
8775800|NCT01298531|9825754|FG000|COMPLETED|Overall Study||33
8775801|NCT01298531|9825755|FG001|COMPLETED|Overall Study||41
8775802|NCT01298531|9825754|FG000|NOT COMPLETED|Overall Study||9
8775803|NCT01298531|9825755|FG001|NOT COMPLETED|Overall Study||7
8775804|NCT01298544|9825762|FG000|STARTED|Overall Study||335
8775805|NCT01298544|9825762|FG000|COMPLETED|Overall Study||335
8775806|NCT01298544|9825762|FG000|NOT COMPLETED|Overall Study||0
8775807|NCT01298570|9825770|FG000|STARTED|Overall Study||120
8775808|NCT01298570|9825771|FG001|STARTED|Overall Study||61
8775809|NCT01298570|9825770|FG000|COMPLETED|Overall Study||0
8775810|NCT01298570|9825771|FG001|COMPLETED|Overall Study||0
8775811|NCT01298570|9825770|FG000|NOT COMPLETED|Overall Study||120
8775812|NCT01298570|9825771|FG001|NOT COMPLETED|Overall Study||61
8775813|NCT01298596|9825779|FG000|STARTED|Overall Study||200
8775814|NCT01298596|9825780|FG001|STARTED|Overall Study||200
8775815|NCT01298596|9825779|FG000|COMPLETED|Overall Study||172
8775816|NCT01298596|9825780|FG001|COMPLETED|Overall Study||167
8775817|NCT01298596|9825779|FG000|NOT COMPLETED|Overall Study||28
8775818|NCT01298596|9825780|FG001|NOT COMPLETED|Overall Study||33
8775819|NCT01298648|9825786|FG000|STARTED|Overall Study||1716
8775820|NCT01298648|9825786|FG000|COMPLETED|Overall Study||1693
8775821|NCT01298648|9825786|FG000|NOT COMPLETED|Overall Study||23
8775822|NCT01298661|9825793|FG000|STARTED|Overall Study||33
8775823|NCT01298661|9825794|FG001|STARTED|Overall Study||24
8775824|NCT01298661|9825795|FG002|STARTED|Overall Study||34
8775825|NCT01298661|9825793|FG000|COMPLETED|Overall Study||31
8775826|NCT01298661|9825794|FG001|COMPLETED|Overall Study||24
8775827|NCT01298661|9825795|FG002|COMPLETED|Overall Study||32
8775828|NCT01298661|9825793|FG000|NOT COMPLETED|Overall Study||2
8775829|NCT01298661|9825794|FG001|NOT COMPLETED|Overall Study||0
8775830|NCT01298661|9825795|FG002|NOT COMPLETED|Overall Study||2
8775831|NCT01298700|9825806|FG000|STARTED|Overall Study||403
8775832|NCT01298700|9825807|FG001|STARTED|Overall Study||403
8775833|NCT01298700|9825806|FG000|Safety Population: Received Study Drug|Overall Study||400
8775834|NCT01298700|9825807|FG001|Safety Population: Received Study Drug|Overall Study||398
8775835|NCT01298700|9825806|FG000|COMPLETED|Overall Study||302
8775836|NCT01298700|9825807|FG001|COMPLETED|Overall Study||303
8775837|NCT01298700|9825806|FG000|NOT COMPLETED|Overall Study||101
8775838|NCT01298700|9825807|FG001|NOT COMPLETED|Overall Study||100
8775839|NCT01298752|9825815|FG000|STARTED|Overall Study||120
8775840|NCT01298752|9825816|FG001|STARTED|Overall Study||57
8775841|NCT01298752|9825815|FG000|COMPLETED|Overall Study||77
8775842|NCT01298752|9825816|FG001|COMPLETED|Overall Study||31
8775843|NCT01298752|9825815|FG000|NOT COMPLETED|Overall Study||43
8775844|NCT01298752|9825816|FG001|NOT COMPLETED|Overall Study||26
8775845|NCT01298765|9825822|FG000|STARTED|Titration Period||302
8775846|NCT01298765|9825822|FG000|COMPLETED|Titration Period||226
8775847|NCT01298765|9825822|FG000|NOT COMPLETED|Titration Period||76
8775848|NCT01298765|9825822|FG000|STARTED|Long-Term Treatment Period||226
8775849|NCT01298765|9825822|FG000|COMPLETED|Long-Term Treatment Period||127
8775850|NCT01298765|9825822|FG000|NOT COMPLETED|Long-Term Treatment Period||99
8775851|NCT01298778|9825828|FG000|STARTED|Overall Study||33
8775852|NCT01298778|9825829|FG001|STARTED|Overall Study||36
8775853|NCT01298778|9825828|FG000|COMPLETED|Overall Study||30
8775854|NCT01298778|9825829|FG001|COMPLETED|Overall Study||30
8775855|NCT01298778|9825828|FG000|NOT COMPLETED|Overall Study||3
8775856|NCT01298778|9825829|FG001|NOT COMPLETED|Overall Study||6
8775857|NCT01298999|9825839|FG000|STARTED|Overall Study||13
8775858|NCT01298999|9825840|FG001|STARTED|Overall Study||11
8775859|NCT01298999|9825839|FG000|COMPLETED|Overall Study||10
8775860|NCT01298999|9825840|FG001|COMPLETED|Overall Study||10
8775861|NCT01298999|9825839|FG000|NOT COMPLETED|Overall Study||3
8775862|NCT01298999|9825840|FG001|NOT COMPLETED|Overall Study||1
8775863|NCT01299025|9825848|FG000|STARTED|Overall Study||42
8775864|NCT01299025|9825849|FG001|STARTED|Overall Study||42
8775865|NCT01299025|9825848|FG000|COMPLETED|Overall Study||39
8775866|NCT01299025|9825849|FG001|COMPLETED|Overall Study||41
8775867|NCT01299025|9825848|FG000|NOT COMPLETED|Overall Study||3
8775868|NCT01299025|9825849|FG001|NOT COMPLETED|Overall Study||1
8775869|NCT01299038|9825857|FG000|STARTED|Overall Study|Consented|10
8775870|NCT01299038|9825858|FG001|STARTED|Overall Study|Consented|10
8775871|NCT01299038|9825857|FG000|COMPLETED|Overall Study|Evaluable|9
8775872|NCT01299038|9825858|FG001|COMPLETED|Overall Study|Evaluable|10
8775873|NCT01299038|9825857|FG000|NOT COMPLETED|Overall Study||1
8775874|NCT01299038|9825858|FG001|NOT COMPLETED|Overall Study||0
8775875|NCT01299077|9825864|FG000|STARTED|Overall Study||478
8775876|NCT01299077|9825864|FG000|COMPLETED|Overall Study||478
8775877|NCT01299077|9825864|FG000|NOT COMPLETED|Overall Study||0
8775878|NCT01299090|9825868|FG000|STARTED|Overall Study||49
8775879|NCT01299090|9825868|FG000|COMPLETED|Overall Study||49
8775880|NCT01299090|9825868|FG000|NOT COMPLETED|Overall Study||0
8775881|NCT01299103|9825875|FG000|STARTED|Overall Study||15
8775882|NCT01299103|9825876|FG001|STARTED|Overall Study||15
8775883|NCT01299103|9825877|FG002|STARTED|Overall Study||10
8775884|NCT01299103|9825875|FG000|COMPLETED|Overall Study||15
8775885|NCT01299103|9825876|FG001|COMPLETED|Overall Study||13
8775886|NCT01299103|9825877|FG002|COMPLETED|Overall Study||8
8775887|NCT01299103|9825875|FG000|NOT COMPLETED|Overall Study||0
8775888|NCT01299103|9825876|FG001|NOT COMPLETED|Overall Study||2
8775889|NCT01299103|9825877|FG002|NOT COMPLETED|Overall Study||2
8775890|NCT01299116|9825888|FG000|STARTED|Overall Study||522
8775891|NCT01299116|9825889|FG001|STARTED|Overall Study||177
8775892|NCT01299116|9825890|FG002|STARTED|Overall Study||195
8775893|NCT01299116|9825888|FG000|COMPLETED|Overall Study||457
8775894|NCT01299116|9825889|FG001|COMPLETED|Overall Study||168
8775895|NCT01299116|9825890|FG002|COMPLETED|Overall Study||184
8775896|NCT01299116|9825888|FG000|NOT COMPLETED|Overall Study||65
8775897|NCT01299116|9825889|FG001|NOT COMPLETED|Overall Study||9
8775898|NCT01299116|9825890|FG002|NOT COMPLETED|Overall Study||11
8775899|NCT01299272|9825901|FG000|STARTED|Acute Open-label (OL) Period||1249
8775900|NCT01299272|9825902|FG001|STARTED|Acute Open-label (OL) Period||0
8775901|NCT01299272|9825903|FG002|STARTED|Acute Open-label (OL) Period||0
8775902|NCT01299272|9825904|FG003|STARTED|Acute Open-label (OL) Period||0
8775903|NCT01299272|9825901|FG000|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period|Participants who discontinued the Acute OL Period had the option to enter the DC Period.|271
8775904|NCT01299272|9825902|FG001|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period||0
8775905|NCT01299272|9825903|FG002|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period||0
8775906|NCT01299272|9825904|FG003|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period||0
8775907|NCT01299272|9825901|FG000|COMPLETED|Acute Open-label (OL) Period|Participants who completed the Acute OL Period entered the Stabilization OL Period.|835
8775908|NCT01299272|9825902|FG001|COMPLETED|Acute Open-label (OL) Period||0
8775909|NCT01299272|9825903|FG002|COMPLETED|Acute Open-label (OL) Period||0
8775910|NCT01299272|9825904|FG003|COMPLETED|Acute Open-label (OL) Period||0
8775911|NCT01299272|9825901|FG000|NOT COMPLETED|Acute Open-label (OL) Period||414
8775912|NCT01299272|9825902|FG001|NOT COMPLETED|Acute Open-label (OL) Period||0
8775913|NCT01299272|9825903|FG002|NOT COMPLETED|Acute Open-label (OL) Period||0
8775914|NCT01299272|9825904|FG003|NOT COMPLETED|Acute Open-label (OL) Period||0
8775915|NCT01299272|9825901|FG000|STARTED|Stabilization Open-label (OL) Period||0
9028940|NCT03210961|10091306|FG003|NOT COMPLETED|Overall Study||1
9028941|NCT03210961|10091307|FG004|NOT COMPLETED|Overall Study||0
9028942|NCT03210961|10091308|FG005|NOT COMPLETED|Overall Study||0
9028943|NCT03210961|10091309|FG006|NOT COMPLETED|Overall Study||1
9028944|NCT03210961|10091310|FG007|NOT COMPLETED|Overall Study||0
9028945|NCT03210961|10091311|FG008|NOT COMPLETED|Overall Study||0
9028946|NCT03210961|10091312|FG009|NOT COMPLETED|Overall Study||0
9028947|NCT03210961|10091313|FG010|NOT COMPLETED|Overall Study||1
9028948|NCT03210961|10091314|FG011|NOT COMPLETED|Overall Study||0
9028949|NCT03210961|10091315|FG012|NOT COMPLETED|Overall Study||2
9028950|NCT03210961|10091316|FG013|NOT COMPLETED|Overall Study||4
9028951|NCT03210961|10091317|FG014|NOT COMPLETED|Overall Study||2
9028952|NCT03211117|10091368|FG000|STARTED|Overall Study||0
9028953|NCT03211117|10091369|FG001|STARTED|Overall Study||3
9028954|NCT03211117|10091368|FG000|COMPLETED|Overall Study||0
9028955|NCT03211117|10091369|FG001|COMPLETED|Overall Study||3
9028956|NCT03211117|10091368|FG000|NOT COMPLETED|Overall Study||0
9028957|NCT03211117|10091369|FG001|NOT COMPLETED|Overall Study||0
9028958|NCT03211156|10091377|FG000|STARTED|Overall Study||49
9028959|NCT03211156|10091378|FG001|STARTED|Overall Study||48
9028960|NCT03211156|10091377|FG000|Received Study Drug|Overall Study||47
9028961|NCT03211156|10091378|FG001|Received Study Drug|Overall Study||45
9028962|NCT03211156|10091377|FG000|COMPLETED|Overall Study||47
9028963|NCT03211156|10091378|FG001|COMPLETED|Overall Study||45
8671541|NCT00752206|9714911|FG000|STARTED|Overall Study||19
8671542|NCT00752206|9714912|FG001|STARTED|Overall Study||19
8671543|NCT00752206|9714911|FG000|COMPLETED|Overall Study||10
8671544|NCT00752206|9714912|FG001|COMPLETED|Overall Study||8
8671545|NCT00752206|9714911|FG000|NOT COMPLETED|Overall Study||9
8671546|NCT00752206|9714912|FG001|NOT COMPLETED|Overall Study||11
8671547|NCT00752219|9714920|FG000|STARTED|Overall Study||102
8671548|NCT00752219|9714921|FG001|STARTED|Overall Study||102
8671549|NCT00752219|9714920|FG000|Treated|Overall Study||101
8671550|NCT00752219|9714921|FG001|Treated|Overall Study||102
8671551|NCT00752219|9714920|FG000|COMPLETED|Overall Study||91
8671552|NCT00752219|9714921|FG001|COMPLETED|Overall Study||96
8671553|NCT00752219|9714920|FG000|NOT COMPLETED|Overall Study||11
8671554|NCT00752219|9714921|FG001|NOT COMPLETED|Overall Study||6
8671555|NCT00752232|9714934|FG000|STARTED|Overall Study||6
8671556|NCT00752232|9714935|FG001|STARTED|Overall Study||6
8671557|NCT00752232|9714936|FG002|STARTED|Overall Study||6
8671558|NCT00752232|9714937|FG003|STARTED|Overall Study||6
8671559|NCT00752232|9714938|FG004|STARTED|Overall Study||6
8671560|NCT00752232|9714939|FG005|STARTED|Overall Study||6
8671561|NCT00752232|9714940|FG006|STARTED|Overall Study||4
8671562|NCT00752232|9714934|FG000|COMPLETED|Overall Study||4
8671563|NCT00752232|9714935|FG001|COMPLETED|Overall Study||6
8671564|NCT00752232|9714936|FG002|COMPLETED|Overall Study||5
8671565|NCT00752232|9714937|FG003|COMPLETED|Overall Study||5
8671566|NCT00752232|9714938|FG004|COMPLETED|Overall Study||3
8671567|NCT00752232|9714939|FG005|COMPLETED|Overall Study||5
8671568|NCT00752232|9714940|FG006|COMPLETED|Overall Study||4
8671569|NCT00752232|9714934|FG000|NOT COMPLETED|Overall Study||2
8671570|NCT00752232|9714935|FG001|NOT COMPLETED|Overall Study||0
8671571|NCT00752232|9714936|FG002|NOT COMPLETED|Overall Study||1
8671572|NCT00752232|9714937|FG003|NOT COMPLETED|Overall Study||1
8671573|NCT00752232|9714938|FG004|NOT COMPLETED|Overall Study||3
8671574|NCT00752232|9714939|FG005|NOT COMPLETED|Overall Study||1
8671575|NCT00752232|9714940|FG006|NOT COMPLETED|Overall Study||0
8671576|NCT00752557|9714960|FG000|STARTED|Overall Study||17
8671577|NCT00752557|9714961|FG001|STARTED|Overall Study||16
8671578|NCT00752557|9714962|FG002|STARTED|Overall Study||17
8775916|NCT01299272|9825902|FG001|STARTED|Stabilization Open-label (OL) Period||835
8775917|NCT01299272|9825903|FG002|STARTED|Stabilization Open-label (OL) Period||0
8775918|NCT01299272|9825904|FG003|STARTED|Stabilization Open-label (OL) Period||0
8775919|NCT01299272|9825901|FG000|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period||0
8775920|NCT01299272|9825902|FG001|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period|Participants who discontinued the Stabilization OL Period had the option to enter the DC Period.|164
9028964|NCT03211156|10091377|FG000|NOT COMPLETED|Overall Study||2
9028965|NCT03211156|10091378|FG001|NOT COMPLETED|Overall Study||3
9028966|NCT03211234|10091387|FG000|STARTED|Overall Study||17
9028967|NCT03211234|10091388|FG001|STARTED|Overall Study||31
9028968|NCT03211234|10091389|FG002|STARTED|Overall Study||28
9028969|NCT03211234|10091387|FG000|COMPLETED|Overall Study||16
8671579|NCT00752557|9714960|FG000|COMPLETED|Overall Study||12
8671580|NCT00752557|9714961|FG001|COMPLETED|Overall Study||11
8671581|NCT00752557|9714962|FG002|COMPLETED|Overall Study||11
8671582|NCT00752557|9714960|FG000|NOT COMPLETED|Overall Study||5
9028970|NCT03211234|10091388|FG001|COMPLETED|Overall Study||30
9028971|NCT03211234|10091389|FG002|COMPLETED|Overall Study||25
9028972|NCT03211234|10091387|FG000|NOT COMPLETED|Overall Study||1
9028973|NCT03211234|10091388|FG001|NOT COMPLETED|Overall Study||1
9028974|NCT03211234|10091389|FG002|NOT COMPLETED|Overall Study||3
8671583|NCT00752557|9714961|FG001|NOT COMPLETED|Overall Study||5
8671584|NCT00752557|9714962|FG002|NOT COMPLETED|Overall Study||6
8671585|NCT00752609|9714974|FG000|STARTED|Overall Study||53
8671586|NCT00752609|9714975|FG001|STARTED|Overall Study||49
9028975|NCT03212261|10091397|FG000|STARTED|Overall Study|Enrolled: eligible at time of approach and signed a consent.|37
8775921|NCT01299272|9825903|FG002|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period||0
8775922|NCT01299272|9825904|FG003|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period||0
8775923|NCT01299272|9825901|FG000|COMPLETED|Stabilization Open-label (OL) Period||0
8775924|NCT01299272|9825902|FG001|COMPLETED|Stabilization Open-label (OL) Period|Participants who completed the Stabilization OL Period were randomized to the DB Period.|586
8775925|NCT01299272|9825903|FG002|COMPLETED|Stabilization Open-label (OL) Period||0
8775926|NCT01299272|9825904|FG003|COMPLETED|Stabilization Open-label (OL) Period||0
8775927|NCT01299272|9825901|FG000|NOT COMPLETED|Stabilization Open-label (OL) Period||0
8775928|NCT01299272|9825902|FG001|NOT COMPLETED|Stabilization Open-label (OL) Period||249
8775929|NCT01299272|9825903|FG002|NOT COMPLETED|Stabilization Open-label (OL) Period||0
8775930|NCT01299272|9825904|FG003|NOT COMPLETED|Stabilization Open-label (OL) Period||0
8775931|NCT01299272|9825901|FG000|STARTED|Double-blind (DB) Randomized Period||0
8775932|NCT01299272|9825902|FG001|STARTED|Double-blind (DB) Randomized Period||0
8775933|NCT01299272|9825903|FG002|STARTED|Double-blind (DB) Randomized Period||294
8775934|NCT01299272|9825904|FG003|STARTED|Double-blind (DB) Randomized Period||292
8775935|NCT01299272|9825901|FG000|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period||0
8775936|NCT01299272|9825902|FG001|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period||0
8775937|NCT01299272|9825903|FG002|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period|Participants who completed or discontinued the DB Period were randomized to the taper DC Period.|129
8775938|NCT01299272|9825904|FG003|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period||0
8775939|NCT01299272|9825901|FG000|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period||0
8775940|NCT01299272|9825902|FG001|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period||0
8775941|NCT01299272|9825903|FG002|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period|Participants who completed or discontinued the DB Period were randomized to the abrupt DC Period.|132
8775942|NCT01299272|9825904|FG003|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period|Participants who completed or discontinued the DB Period entered the DC Period.|268
8775943|NCT01299272|9825901|FG000|COMPLETED|Double-blind (DB) Randomized Period||0
8775944|NCT01299272|9825902|FG001|COMPLETED|Double-blind (DB) Randomized Period||0
8775945|NCT01299272|9825903|FG002|COMPLETED|Double-blind (DB) Randomized Period||224
8775946|NCT01299272|9825904|FG003|COMPLETED|Double-blind (DB) Randomized Period||234
8775947|NCT01299272|9825901|FG000|NOT COMPLETED|Double-blind (DB) Randomized Period||0
8775948|NCT01299272|9825902|FG001|NOT COMPLETED|Double-blind (DB) Randomized Period||0
8775949|NCT01299272|9825903|FG002|NOT COMPLETED|Double-blind (DB) Randomized Period||70
8775950|NCT01299272|9825904|FG003|NOT COMPLETED|Double-blind (DB) Randomized Period||58
8775951|NCT01299285|9825918|FG000|STARTED|Overall Study||6
8775952|NCT01299285|9825918|FG000|COMPLETED|Overall Study||6
9028976|NCT03212261|10091397|FG000|Remained Eligible|Overall Study||35
9028977|NCT03212261|10091397|FG000|Baseline Completion|Overall Study|Lost patients: Technology difficulties (n=2), Family Emergency (n=1), Too busy (n=3), LTFU (n=1)|30
9028978|NCT03212261|10091397|FG000|Program Initiation|Overall Study|Lost patients: Tech trouble no first visit (n=1), Too busy/no time (n=2), LTFU (n=1)|26
9028979|NCT03212261|10091397|FG000|Post-intervention Survey|Overall Study|Lost to follow up (n=4)|22
9028980|NCT03212261|10091397|FG000|One Month Follow-up|Overall Study|Lost to follow up (n=1)|21
9028981|NCT03212261|10091397|FG000|COMPLETED|Overall Study||21
9028982|NCT03212261|10091397|FG000|NOT COMPLETED|Overall Study||16
9028983|NCT03212326|10091402|FG000|STARTED|Overall Study||24
9028984|NCT03212326|10091402|FG000|COMPLETED|Overall Study||20
9028985|NCT03212326|10091402|FG000|NOT COMPLETED|Overall Study||4
9028986|NCT03212365|10091408|FG000|STARTED|Overall Study||151
9028987|NCT03212365|10091409|FG001|STARTED|Overall Study||144
9028988|NCT03212365|10091408|FG000|COMPLETED|Overall Study||128
9028989|NCT03212365|10091409|FG001|COMPLETED|Overall Study||130
9028990|NCT03212365|10091408|FG000|NOT COMPLETED|Overall Study||23
9028991|NCT03212365|10091409|FG001|NOT COMPLETED|Overall Study||14
9028992|NCT03212521|10091415|FG000|STARTED|Overall Study||230
9028993|NCT03212521|10091415|FG000|COMPLETED|Overall Study||223
9028994|NCT03212521|10091415|FG000|NOT COMPLETED|Overall Study||7
9028995|NCT03212638|10091421|FG000|STARTED|Period 1||8
9028996|NCT03212638|10091422|FG001|STARTED|Period 1||8
9028997|NCT03212638|10091423|FG002|STARTED|Period 1||8
9028998|NCT03212638|10091424|FG003|STARTED|Period 1||0
9028999|NCT03212638|10091425|FG004|STARTED|Period 1||0
9029000|NCT03212638|10091421|FG000|Received at Least 1 Dose of Study Drug|Period 1||8
9029001|NCT03212638|10091422|FG001|Received at Least 1 Dose of Study Drug|Period 1||8
9029002|NCT03212638|10091423|FG002|Received at Least 1 Dose of Study Drug|Period 1||8
9029003|NCT03212638|10091424|FG003|Received at Least 1 Dose of Study Drug|Period 1||0
9029004|NCT03212638|10091425|FG004|Received at Least 1 Dose of Study Drug|Period 1||0
9029005|NCT03212638|10091421|FG000|COMPLETED|Period 1||8
9029006|NCT03212638|10091422|FG001|COMPLETED|Period 1||8
9029007|NCT03212638|10091423|FG002|COMPLETED|Period 1||8
9029008|NCT03212638|10091424|FG003|COMPLETED|Period 1||0
9029009|NCT03212638|10091425|FG004|COMPLETED|Period 1||0
9029010|NCT03212638|10091421|FG000|NOT COMPLETED|Period 1||0
9029011|NCT03212638|10091422|FG001|NOT COMPLETED|Period 1||0
9029012|NCT03212638|10091423|FG002|NOT COMPLETED|Period 1||0
9029013|NCT03212638|10091424|FG003|NOT COMPLETED|Period 1||0
9029014|NCT03212638|10091425|FG004|NOT COMPLETED|Period 1||0
9029015|NCT03212638|10091421|FG000|STARTED|Period 2||8
9029016|NCT03212638|10091422|FG001|STARTED|Period 2||8
9029017|NCT03212638|10091423|FG002|STARTED|Period 2||8
9029018|NCT03212638|10091424|FG003|STARTED|Period 2||0
8775953|NCT01299285|9825918|FG000|NOT COMPLETED|Overall Study||0
8775954|NCT01299376|9825926|FG000|STARTED|Double-blind Treatment (Weeks 1 to 8)||141
8775955|NCT01299376|9825927|FG001|STARTED|Double-blind Treatment (Weeks 1 to 8)||145
8775956|NCT01299376|9825926|FG000|COMPLETED|Double-blind Treatment (Weeks 1 to 8)||134
8775957|NCT01299376|9825927|FG001|COMPLETED|Double-blind Treatment (Weeks 1 to 8)||133
8775958|NCT01299376|9825926|FG000|NOT COMPLETED|Double-blind Treatment (Weeks 1 to 8)||7
8775959|NCT01299376|9825927|FG001|NOT COMPLETED|Double-blind Treatment (Weeks 1 to 8)||12
8775960|NCT01299376|9825926|FG000|STARTED|Extension (Weeks 9 to 52)||134
8775961|NCT01299376|9825927|FG001|STARTED|Extension (Weeks 9 to 52)||133
8775962|NCT01299376|9825926|FG000|COMPLETED|Extension (Weeks 9 to 52)||124
8775963|NCT01299376|9825927|FG001|COMPLETED|Extension (Weeks 9 to 52)||118
8775964|NCT01299376|9825926|FG000|NOT COMPLETED|Extension (Weeks 9 to 52)||10
8775965|NCT01299376|9825927|FG001|NOT COMPLETED|Extension (Weeks 9 to 52)||15
8775966|NCT01299389|9825939|FG000|STARTED|Double-blind||164
8775967|NCT01299389|9825940|FG001|STARTED|Double-blind||159
8775968|NCT01299389|9825941|FG002|STARTED|Double-blind||0
8775969|NCT01299389|9825942|FG003|STARTED|Double-blind||0
8775970|NCT01299389|9825939|FG000|COMPLETED|Double-blind||55
8775971|NCT01299389|9825940|FG001|COMPLETED|Double-blind||95
8775972|NCT01299389|9825941|FG002|COMPLETED|Double-blind||0
8775973|NCT01299389|9825942|FG003|COMPLETED|Double-blind||0
9029019|NCT03212638|10091425|FG004|STARTED|Period 2||0
9029020|NCT03212638|10091421|FG000|Received at Least 1 Dose of Study Drug|Period 2||8
9029021|NCT03212638|10091422|FG001|Received at Least 1 Dose of Study Drug|Period 2||8
9029022|NCT03212638|10091423|FG002|Received at Least 1 Dose of Study Drug|Period 2||8
9029023|NCT03212638|10091424|FG003|Received at Least 1 Dose of Study Drug|Period 2||0
9029024|NCT03212638|10091425|FG004|Received at Least 1 Dose of Study Drug|Period 2||0
9029025|NCT03212638|10091421|FG000|COMPLETED|Period 2||8
9029026|NCT03212638|10091422|FG001|COMPLETED|Period 2||8
9029027|NCT03212638|10091423|FG002|COMPLETED|Period 2||8
9029028|NCT03212638|10091424|FG003|COMPLETED|Period 2||0
9029029|NCT03212638|10091425|FG004|COMPLETED|Period 2||0
9029030|NCT03212638|10091421|FG000|NOT COMPLETED|Period 2||0
9029031|NCT03212638|10091422|FG001|NOT COMPLETED|Period 2||0
9029032|NCT03212638|10091423|FG002|NOT COMPLETED|Period 2||0
9029033|NCT03212638|10091424|FG003|NOT COMPLETED|Period 2||0
9029034|NCT03212638|10091425|FG004|NOT COMPLETED|Period 2||0
9029035|NCT03212638|10091421|FG000|STARTED|Period 3||8
9029036|NCT03212638|10091422|FG001|STARTED|Period 3||8
9029037|NCT03212638|10091423|FG002|STARTED|Period 3||8
9029038|NCT03212638|10091424|FG003|STARTED|Period 3||0
9029039|NCT03212638|10091425|FG004|STARTED|Period 3||0
9029040|NCT03212638|10091421|FG000|Received at Least 1 Dose of Study Drug|Period 3||8
9029041|NCT03212638|10091422|FG001|Received at Least 1 Dose of Study Drug|Period 3||8
9029042|NCT03212638|10091423|FG002|Received at Least 1 Dose of Study Drug|Period 3||8
9029043|NCT03212638|10091424|FG003|Received at Least 1 Dose of Study Drug|Period 3||0
9029044|NCT03212638|10091425|FG004|Received at Least 1 Dose of Study Drug|Period 3||0
9029045|NCT03212638|10091421|FG000|COMPLETED|Period 3||8
9029046|NCT03212638|10091422|FG001|COMPLETED|Period 3||8
9029047|NCT03212638|10091423|FG002|COMPLETED|Period 3||8
9029048|NCT03212638|10091424|FG003|COMPLETED|Period 3||0
9029049|NCT03212638|10091425|FG004|COMPLETED|Period 3||0
9029050|NCT03212638|10091421|FG000|NOT COMPLETED|Period 3||0
9029051|NCT03212638|10091422|FG001|NOT COMPLETED|Period 3||0
9029052|NCT03212638|10091423|FG002|NOT COMPLETED|Period 3||0
9029053|NCT03212638|10091424|FG003|NOT COMPLETED|Period 3||0
9029054|NCT03212638|10091425|FG004|NOT COMPLETED|Period 3||0
9029055|NCT03212638|10091421|FG000|STARTED|Period 4|Participants were not allowed to participate in Part B and have completed study.|0
9029056|NCT03212638|10091422|FG001|STARTED|Period 4|Participants were not allowed to participate in Part B and have completed study.|0
9029057|NCT03212638|10091423|FG002|STARTED|Period 4|Participants were not allowed to participate in Part B and have completed study.|0
9029058|NCT03212638|10091424|FG003|STARTED|Period 4|New Participants in Part B, no participants from Part A participated in Part B.|9
9029059|NCT03212638|10091425|FG004|STARTED|Period 4|New Participants in Part B, no participants from Part A participated in Part B.|9
9029060|NCT03212638|10091421|FG000|Received at Least 1 Dose of Study Drug|Period 4||0
9029061|NCT03212638|10091422|FG001|Received at Least 1 Dose of Study Drug|Period 4||0
9029062|NCT03212638|10091423|FG002|Received at Least 1 Dose of Study Drug|Period 4||0
9029063|NCT03212638|10091424|FG003|Received at Least 1 Dose of Study Drug|Period 4||9
9029064|NCT03212638|10091425|FG004|Received at Least 1 Dose of Study Drug|Period 4||9
9029065|NCT03212638|10091421|FG000|COMPLETED|Period 4||0
9029066|NCT03212638|10091422|FG001|COMPLETED|Period 4||0
9029067|NCT03212638|10091423|FG002|COMPLETED|Period 4||0
9029068|NCT03212638|10091424|FG003|COMPLETED|Period 4||9
9029069|NCT03212638|10091425|FG004|COMPLETED|Period 4||9
9029070|NCT03212638|10091421|FG000|NOT COMPLETED|Period 4||0
9029071|NCT03212638|10091422|FG001|NOT COMPLETED|Period 4||0
9029072|NCT03212638|10091423|FG002|NOT COMPLETED|Period 4||0
9029073|NCT03212638|10091424|FG003|NOT COMPLETED|Period 4||0
9029074|NCT03212638|10091425|FG004|NOT COMPLETED|Period 4||0
9029075|NCT03212638|10091421|FG000|STARTED|Period 5||0
9029076|NCT03212638|10091422|FG001|STARTED|Period 5||0
9029077|NCT03212638|10091423|FG002|STARTED|Period 5||0
8775974|NCT01299389|9825939|FG000|NOT COMPLETED|Double-blind||109
8775975|NCT01299389|9825940|FG001|NOT COMPLETED|Double-blind||64
8775976|NCT01299389|9825941|FG002|NOT COMPLETED|Double-blind||0
8775977|NCT01299389|9825942|FG003|NOT COMPLETED|Double-blind||0
9029078|NCT03212638|10091424|FG003|STARTED|Period 5||9
9029079|NCT03212638|10091425|FG004|STARTED|Period 5||9
8775978|NCT01299389|9825939|FG000|STARTED|Post-observational||0
8775979|NCT01299389|9825940|FG001|STARTED|Post-observational||0
8775980|NCT01299389|9825941|FG002|STARTED|Post-observational||156
8775981|NCT01299389|9825942|FG003|STARTED|Post-observational||155
8775982|NCT01299389|9825939|FG000|COMPLETED|Post-observational||0
8775983|NCT01299389|9825940|FG001|COMPLETED|Post-observational||0
8775984|NCT01299389|9825941|FG002|COMPLETED|Post-observational||144
8775985|NCT01299389|9825942|FG003|COMPLETED|Post-observational||149
8775986|NCT01299389|9825939|FG000|NOT COMPLETED|Post-observational||0
8775987|NCT01299389|9825940|FG001|NOT COMPLETED|Post-observational||0
8775988|NCT01299389|9825941|FG002|NOT COMPLETED|Post-observational||12
8775989|NCT01299389|9825942|FG003|NOT COMPLETED|Post-observational||6
8775990|NCT01299454|9825955|FG000|STARTED|Overall Study||8
8775991|NCT01299454|9825956|FG001|STARTED|Overall Study||8
8775992|NCT01299454|9825957|FG002|STARTED|Overall Study||6
8775993|NCT01299454|9825958|FG003|STARTED|Overall Study||23
8775994|NCT01299454|9825955|FG000|COMPLETED|Overall Study||8
8775995|NCT01299454|9825956|FG001|COMPLETED|Overall Study||8
8775996|NCT01299454|9825957|FG002|COMPLETED|Overall Study||6
8775997|NCT01299454|9825958|FG003|COMPLETED|Overall Study||23
8775998|NCT01299454|9825955|FG000|NOT COMPLETED|Overall Study||0
8775999|NCT01299454|9825956|FG001|NOT COMPLETED|Overall Study||0
8776000|NCT01299454|9825957|FG002|NOT COMPLETED|Overall Study||0
8776001|NCT01299454|9825958|FG003|NOT COMPLETED|Overall Study||0
8776002|NCT01299480|9825999|FG000|STARTED|Overall Study||427
8776003|NCT01299480|9826000|FG001|STARTED|Overall Study||430
8776004|NCT01299480|9826001|FG002|STARTED|Overall Study||427
8776005|NCT01299480|9826002|FG003|STARTED|Overall Study||286
8776006|NCT01299480|9826003|FG004|STARTED|Overall Study||143
8776007|NCT01299480|9825999|FG000|COMPLETED|Overall Study||385
8776008|NCT01299480|9826000|FG001|COMPLETED|Overall Study||395
8776009|NCT01299480|9826001|FG002|COMPLETED|Overall Study||386
8776010|NCT01299480|9826002|FG003|COMPLETED|Overall Study||261
8776011|NCT01299480|9826003|FG004|COMPLETED|Overall Study||123
8776012|NCT01299480|9825999|FG000|NOT COMPLETED|Overall Study||42
8776013|NCT01299480|9826000|FG001|NOT COMPLETED|Overall Study||35
8776014|NCT01299480|9826001|FG002|NOT COMPLETED|Overall Study||41
8776015|NCT01299480|9826002|FG003|NOT COMPLETED|Overall Study||25
8776016|NCT01299480|9826003|FG004|NOT COMPLETED|Overall Study||20
8776017|NCT01299571|9826016|FG000|STARTED|Overall Study||3977
8776018|NCT01299571|9826016|FG000|COMPLETED|Overall Study||3870
8776019|NCT01299571|9826016|FG000|NOT COMPLETED|Overall Study||107
8776020|NCT01299584|9826021|FG000|STARTED|Overall Study||775
8776021|NCT01299584|9826021|FG000|COMPLETED|Overall Study||766
8776022|NCT01299584|9826021|FG000|NOT COMPLETED|Overall Study||9
8776023|NCT01299610|9826028|FG000|STARTED|Overall Study||10
8776024|NCT01299610|9826029|FG001|STARTED|Overall Study||5
8776025|NCT01299610|9826030|FG002|STARTED|Overall Study||10
8776026|NCT01299610|9826028|FG000|COMPLETED|Overall Study||10
8776027|NCT01299610|9826029|FG001|COMPLETED|Overall Study||5
8776028|NCT01299610|9826030|FG002|COMPLETED|Overall Study||10
8776029|NCT01299610|9826028|FG000|NOT COMPLETED|Overall Study||0
8776030|NCT01299610|9826029|FG001|NOT COMPLETED|Overall Study||0
8776031|NCT01299610|9826030|FG002|NOT COMPLETED|Overall Study||0
8776032|NCT01299727|9826045|FG000|STARTED|Overall Study||4
8776033|NCT01299727|9826046|FG001|STARTED|Overall Study||4
8776034|NCT01299727|9826047|FG002|STARTED|Overall Study||4
8776035|NCT01299727|9826045|FG000|COMPLETED|Overall Study||0
8776036|NCT01299727|9826046|FG001|COMPLETED|Overall Study||0
8776037|NCT01299727|9826047|FG002|COMPLETED|Overall Study||0
8776038|NCT01299727|9826045|FG000|NOT COMPLETED|Overall Study||4
8776039|NCT01299727|9826046|FG001|NOT COMPLETED|Overall Study||4
8776040|NCT01299727|9826047|FG002|NOT COMPLETED|Overall Study||4
8776041|NCT01299766|9826057|FG000|STARTED|Overall Study||111
8776042|NCT01299766|9826058|FG001|STARTED|Overall Study||110
8776043|NCT01299766|9826057|FG000|COMPLETED|Overall Study||77
8776044|NCT01299766|9826058|FG001|COMPLETED|Overall Study||87
8776045|NCT01299766|9826057|FG000|NOT COMPLETED|Overall Study||34
8776046|NCT01299766|9826058|FG001|NOT COMPLETED|Overall Study||23
8776047|NCT01299805|9826066|FG000|STARTED|Overall Study||12
8776048|NCT01299805|9826067|FG001|STARTED|Overall Study||5
8776049|NCT01299805|9826066|FG000|COMPLETED|Overall Study||10
8776050|NCT01299805|9826067|FG001|COMPLETED|Overall Study||5
8776051|NCT01299805|9826066|FG000|NOT COMPLETED|Overall Study||2
8776052|NCT01299805|9826067|FG001|NOT COMPLETED|Overall Study||0
8776053|NCT01299896|9826075|FG000|STARTED|Overall Study||319
8776054|NCT01299896|9826076|FG001|STARTED|Overall Study||314
8776055|NCT01299896|9826075|FG000|COMPLETED|Overall Study||318
8776056|NCT01299896|9826076|FG001|COMPLETED|Overall Study||296
8776057|NCT01299896|9826075|FG000|NOT COMPLETED|Overall Study||1
8776058|NCT01299896|9826076|FG001|NOT COMPLETED|Overall Study||18
8776059|NCT01299909|9826085|FG000|STARTED|Overall Study||68
8776060|NCT01299909|9826086|FG001|STARTED|Overall Study||67
8776061|NCT01299909|9826087|FG002|STARTED|Overall Study||40
8776062|NCT01299909|9826085|FG000|COMPLETED|Overall Study||46
8776063|NCT01299909|9826086|FG001|COMPLETED|Overall Study||49
8776064|NCT01299909|9826087|FG002|COMPLETED|Overall Study||23
8776065|NCT01299909|9826085|FG000|NOT COMPLETED|Overall Study||22
8776066|NCT01299909|9826086|FG001|NOT COMPLETED|Overall Study||18
8776067|NCT01299909|9826087|FG002|NOT COMPLETED|Overall Study||17
8776068|NCT01299961|9826094|FG000|STARTED|Overall Study||25
8776069|NCT01299961|9826094|FG000|COMPLETED|Overall Study||19
8776070|NCT01299961|9826094|FG000|NOT COMPLETED|Overall Study||6
8776071|NCT01300052|9826100|FG000|STARTED|Overall Study||46
8776072|NCT01300052|9826101|FG001|STARTED|Overall Study||22
8776073|NCT01300052|9826100|FG000|COMPLETED|Overall Study||40
8776074|NCT01300052|9826101|FG001|COMPLETED|Overall Study||19
8776075|NCT01300052|9826100|FG000|NOT COMPLETED|Overall Study||6
8776076|NCT01300052|9826101|FG001|NOT COMPLETED|Overall Study||3
8776077|NCT01300065|9826109|FG000|STARTED|Overall Study||221
8776078|NCT01300065|9826110|FG001|STARTED|Overall Study||220
8776079|NCT01300065|9826109|FG000|COMPLETED|Overall Study||215
8776080|NCT01300065|9826110|FG001|COMPLETED|Overall Study||217
8776081|NCT01300065|9826109|FG000|NOT COMPLETED|Overall Study||6
8776082|NCT01300065|9826110|FG001|NOT COMPLETED|Overall Study||3
8776083|NCT01300234|9826118|FG000|STARTED|Overall Study||257
8776084|NCT01300234|9826119|FG001|STARTED|Overall Study||255
8776085|NCT01300234|9826118|FG000|COMPLETED|Overall Study||229
8776086|NCT01300234|9826119|FG001|COMPLETED|Overall Study||228
8776087|NCT01300234|9826118|FG000|NOT COMPLETED|Overall Study||28
8776088|NCT01300234|9826119|FG001|NOT COMPLETED|Overall Study||27
8776089|NCT01300247|9826138|FG000|STARTED|Overall Study||21
8776090|NCT01300247|9826139|FG001|STARTED|Overall Study||20
8776091|NCT01300247|9826138|FG000|COMPLETED|Overall Study||17
8776092|NCT01300247|9826139|FG001|COMPLETED|Overall Study||18
8776093|NCT01300247|9826138|FG000|NOT COMPLETED|Overall Study||4
8776094|NCT01300247|9826139|FG001|NOT COMPLETED|Overall Study||2
8776095|NCT01300260|9826147|FG000|STARTED|Period 1 of Study: First Intervention||15
8776096|NCT01300260|9826148|FG001|STARTED|Period 1 of Study: First Intervention||17
8776097|NCT01300260|9826147|FG000|Received at Least 1 Dose of Study Drug|Period 1 of Study: First Intervention||15
8776098|NCT01300260|9826148|FG001|Received at Least 1 Dose of Study Drug|Period 1 of Study: First Intervention||17
8776099|NCT01300260|9826147|FG000|COMPLETED|Period 1 of Study: First Intervention||14
8776100|NCT01300260|9826148|FG001|COMPLETED|Period 1 of Study: First Intervention||16
8776101|NCT01300260|9826147|FG000|NOT COMPLETED|Period 1 of Study: First Intervention||1
8776102|NCT01300260|9826148|FG001|NOT COMPLETED|Period 1 of Study: First Intervention||1
8776103|NCT01300260|9826147|FG000|STARTED|Washout Period of at Least 28 Days||14
8776104|NCT01300260|9826148|FG001|STARTED|Washout Period of at Least 28 Days||16
8776105|NCT01300260|9826147|FG000|COMPLETED|Washout Period of at Least 28 Days||14
8776106|NCT01300260|9826148|FG001|COMPLETED|Washout Period of at Least 28 Days||16
9029080|NCT03212638|10091421|FG000|Received at Least 1 Dose of Study Drug|Period 5||0
9029081|NCT03212638|10091422|FG001|Received at Least 1 Dose of Study Drug|Period 5||0
9029082|NCT03212638|10091423|FG002|Received at Least 1 Dose of Study Drug|Period 5||0
9029083|NCT03212638|10091424|FG003|Received at Least 1 Dose of Study Drug|Period 5||9
9029084|NCT03212638|10091425|FG004|Received at Least 1 Dose of Study Drug|Period 5||9
9029085|NCT03212638|10091421|FG000|COMPLETED|Period 5||0
9029086|NCT03212638|10091422|FG001|COMPLETED|Period 5||0
9029087|NCT03212638|10091423|FG002|COMPLETED|Period 5||0
9029088|NCT03212638|10091424|FG003|COMPLETED|Period 5||9
9029089|NCT03212638|10091425|FG004|COMPLETED|Period 5||9
9029090|NCT03212638|10091421|FG000|NOT COMPLETED|Period 5||0
9029091|NCT03212638|10091422|FG001|NOT COMPLETED|Period 5||0
9029092|NCT03212638|10091423|FG002|NOT COMPLETED|Period 5||0
9029093|NCT03212638|10091424|FG003|NOT COMPLETED|Period 5||0
9029094|NCT03212638|10091425|FG004|NOT COMPLETED|Period 5||0
9029095|NCT03212690|10091437|FG000|STARTED|Overall Study||57
9029096|NCT03212690|10091437|FG000|COMPLETED|Overall Study||56
9029097|NCT03212690|10091437|FG000|NOT COMPLETED|Overall Study||1
9029098|NCT03213210|10091441|FG000|STARTED|Overall Study||5
9029099|NCT03213210|10091441|FG000|6-month Follow-up|Overall Study||3
9029100|NCT03213210|10091441|FG000|COMPLETED|Overall Study||0
9029101|NCT03213210|10091441|FG000|NOT COMPLETED|Overall Study||5
9029102|NCT03213366|10091447|FG000|STARTED|Overall Study||81
8776107|NCT01300260|9826147|FG000|NOT COMPLETED|Washout Period of at Least 28 Days||0
8776108|NCT01300260|9826148|FG001|NOT COMPLETED|Washout Period of at Least 28 Days||0
8776109|NCT01300260|9826147|FG000|STARTED|Period 2 of Study: Second Intervention||14
8776110|NCT01300260|9826148|FG001|STARTED|Period 2 of Study: Second Intervention||16
8776111|NCT01300260|9826147|FG000|COMPLETED|Period 2 of Study: Second Intervention||14
8776112|NCT01300260|9826148|FG001|COMPLETED|Period 2 of Study: Second Intervention||15
8776113|NCT01300260|9826147|FG000|NOT COMPLETED|Period 2 of Study: Second Intervention||0
8776114|NCT01300260|9826148|FG001|NOT COMPLETED|Period 2 of Study: Second Intervention||1
8776115|NCT01300286|9826165|FG000|STARTED|Overall Study||23
8776116|NCT01300286|9826165|FG000|COMPLETED|Overall Study||22
8776117|NCT01300286|9826165|FG000|NOT COMPLETED|Overall Study||1
8808811|NCT01492686|9861181|FG000|NOT COMPLETED|Double-blind Phase||2
8808812|NCT01492686|9861182|FG001|NOT COMPLETED|Double-blind Phase||8
8808813|NCT01492686|9861181|FG000|STARTED|Open-label Phase||65
8808814|NCT01492686|9861182|FG001|STARTED|Open-label Phase||58
8808815|NCT01492686|9861181|FG000|COMPLETED|Open-label Phase||53
8808816|NCT01492686|9861182|FG001|COMPLETED|Open-label Phase||40
8808817|NCT01492686|9861181|FG000|NOT COMPLETED|Open-label Phase||12
9029103|NCT03213366|10091448|FG001|STARTED|Overall Study||71
9029104|NCT03213366|10091447|FG000|COMPLETED|Overall Study||72
9029105|NCT03213366|10091448|FG001|COMPLETED|Overall Study||67
9029106|NCT03213366|10091447|FG000|NOT COMPLETED|Overall Study||9
8808818|NCT01492686|9861182|FG001|NOT COMPLETED|Open-label Phase||18
8808819|NCT01493024|9861194|FG000|STARTED|Overall Study||30
8808820|NCT01493024|9861195|FG001|STARTED|Overall Study||12
9029107|NCT03213366|10091448|FG001|NOT COMPLETED|Overall Study||4
9029108|NCT03213405|10091458|FG000|STARTED|Overall Study||6
8776118|NCT01300338|9826172|FG000|STARTED|Overall Study||25
8776119|NCT01300338|9826173|FG001|STARTED|Overall Study||25
8776120|NCT01300338|9826172|FG000|COMPLETED|Overall Study||20
8776121|NCT01300338|9826173|FG001|COMPLETED|Overall Study||25
8776122|NCT01300338|9826172|FG000|NOT COMPLETED|Overall Study||5
8776123|NCT01300338|9826173|FG001|NOT COMPLETED|Overall Study||0
8776124|NCT01300351|9826181|FG000|STARTED|Overall Study||111
8776125|NCT01300351|9826182|FG001|STARTED|Overall Study||110
8776126|NCT01300351|9826181|FG000|Received Study Treatment|Overall Study||109
8776127|NCT01300351|9826182|FG001|Received Study Treatment|Overall Study||110
8776128|NCT01300351|9826181|FG000|COMPLETED|Overall Study||75
8776129|NCT01300351|9826182|FG001|COMPLETED|Overall Study||72
8776130|NCT01300351|9826181|FG000|NOT COMPLETED|Overall Study||36
8776131|NCT01300351|9826182|FG001|NOT COMPLETED|Overall Study||38
8776132|NCT01300455|9826190|FG000|STARTED|Period 1||13
8776133|NCT01300455|9826191|FG001|STARTED|Period 1||13
8776134|NCT01300455|9826190|FG000|COMPLETED|Period 1||13
8776135|NCT01300455|9826191|FG001|COMPLETED|Period 1||13
8776136|NCT01300455|9826190|FG000|NOT COMPLETED|Period 1||0
8776137|NCT01300455|9826191|FG001|NOT COMPLETED|Period 1||0
8776138|NCT01300455|9826190|FG000|STARTED|Washout||13
8776139|NCT01300455|9826191|FG001|STARTED|Washout||13
8776140|NCT01300455|9826190|FG000|COMPLETED|Washout||12
8776141|NCT01300455|9826191|FG001|COMPLETED|Washout||13
8776142|NCT01300455|9826190|FG000|NOT COMPLETED|Washout||1
8776143|NCT01300455|9826191|FG001|NOT COMPLETED|Washout||0
8776144|NCT01300455|9826190|FG000|STARTED|Period 2||12
8776145|NCT01300455|9826191|FG001|STARTED|Period 2||13
8776146|NCT01300455|9826190|FG000|COMPLETED|Period 2||12
8776147|NCT01300455|9826191|FG001|COMPLETED|Period 2||13
8776148|NCT01300455|9826190|FG000|NOT COMPLETED|Period 2||0
8776149|NCT01300455|9826191|FG001|NOT COMPLETED|Period 2||0
8776150|NCT01300546|9826199|FG000|STARTED|Overall Study||19
8776151|NCT01300546|9826200|FG001|STARTED|Overall Study||20
8776152|NCT01300546|9826199|FG000|COMPLETED|Overall Study||18
8776153|NCT01300546|9826200|FG001|COMPLETED|Overall Study||14
8776154|NCT01300546|9826199|FG000|NOT COMPLETED|Overall Study||1
8776155|NCT01300546|9826200|FG001|NOT COMPLETED|Overall Study||6
8776156|NCT01300559|9826208|FG000|STARTED|Overall Study||30
8776157|NCT01300559|9826209|FG001|STARTED|Overall Study||30
8776158|NCT01300559|9826208|FG000|COMPLETED|Overall Study||30
8776159|NCT01300559|9826209|FG001|COMPLETED|Overall Study||30
8776160|NCT01300559|9826208|FG000|NOT COMPLETED|Overall Study||0
8776161|NCT01300559|9826209|FG001|NOT COMPLETED|Overall Study||0
8776162|NCT01300572|9826215|FG000|STARTED|Overall Study||16
8776163|NCT01300572|9826215|FG000|COMPLETED|Overall Study||15
8776164|NCT01300572|9826215|FG000|NOT COMPLETED|Overall Study||1
8776165|NCT01300624|9826220|FG000|STARTED|Overall Study||11
8776166|NCT01300624|9826220|FG000|COMPLETED|Overall Study||11
8776167|NCT01300624|9826220|FG000|NOT COMPLETED|Overall Study||0
8776168|NCT01300650|9826225|FG000|STARTED|Overall Study||8
8776169|NCT01300650|9826225|FG000|COMPLETED|Overall Study||7
8776170|NCT01300650|9826225|FG000|NOT COMPLETED|Overall Study||1
8776171|NCT01300728|9826232|FG000|STARTED|Overall Study||26
8776172|NCT01300728|9826233|FG001|STARTED|Overall Study||26
8776173|NCT01300728|9826232|FG000|COMPLETED|Overall Study||24
8776174|NCT01300728|9826233|FG001|COMPLETED|Overall Study||25
8776175|NCT01300728|9826232|FG000|NOT COMPLETED|Overall Study||2
8776176|NCT01300728|9826233|FG001|NOT COMPLETED|Overall Study||1
8776177|NCT01300741|9826239|FG000|STARTED|Overall Study||75
8776178|NCT01300741|9826239|FG000|COMPLETED|Overall Study||72
8776179|NCT01300741|9826239|FG000|NOT COMPLETED|Overall Study||3
8776180|NCT01300767|9826245|FG000|STARTED|Overall Study||74
8776181|NCT01300767|9826245|FG000|COMPLETED|Overall Study||70
8776182|NCT01300767|9826245|FG000|NOT COMPLETED|Overall Study||4
8776183|NCT01300819|9826253|FG000|STARTED|Overall Study||125
8776184|NCT01300819|9826254|FG001|STARTED|Overall Study||224
8776185|NCT01300819|9826253|FG000|COMPLETED|Overall Study||103
8776186|NCT01300819|9826254|FG001|COMPLETED|Overall Study||180
8776187|NCT01300819|9826253|FG000|NOT COMPLETED|Overall Study||22
8776188|NCT01300819|9826254|FG001|NOT COMPLETED|Overall Study||44
8776189|NCT01300923|9826260|FG000|STARTED|Overall Study||12
8776190|NCT01300923|9826261|FG001|STARTED|Overall Study||2
8776191|NCT01300923|9826260|FG000|COMPLETED|Overall Study||12
8776192|NCT01300923|9826261|FG001|COMPLETED|Overall Study||0
8776193|NCT01300923|9826260|FG000|NOT COMPLETED|Overall Study||0
8776194|NCT01300923|9826261|FG001|NOT COMPLETED|Overall Study||2
8776195|NCT01300949|9826269|FG000|STARTED|Overall Study||154
8776196|NCT01300949|9826270|FG001|STARTED|Overall Study||125
8776197|NCT01300949|9826271|FG002|STARTED|Overall Study||35
8776198|NCT01300949|9826269|FG000|COMPLETED|Overall Study||154
8776199|NCT01300949|9826270|FG001|COMPLETED|Overall Study||125
8776200|NCT01300949|9826271|FG002|COMPLETED|Overall Study||35
8776201|NCT01300949|9826269|FG000|NOT COMPLETED|Overall Study||0
8776202|NCT01300949|9826270|FG001|NOT COMPLETED|Overall Study||0
8776203|NCT01300949|9826271|FG002|NOT COMPLETED|Overall Study||0
8776204|NCT01301001|9826279|FG000|STARTED|First Intervention||44
8776205|NCT01301001|9826280|FG001|STARTED|First Intervention||45
8776206|NCT01301001|9826279|FG000|COMPLETED|First Intervention||34
8776207|NCT01301001|9826280|FG001|COMPLETED|First Intervention||36
8776208|NCT01301001|9826279|FG000|NOT COMPLETED|First Intervention||10
8776209|NCT01301001|9826280|FG001|NOT COMPLETED|First Intervention||9
8776210|NCT01301001|9826279|FG000|STARTED|Washout (2 Weeks)||34
8776211|NCT01301001|9826280|FG001|STARTED|Washout (2 Weeks)||36
8776212|NCT01301001|9826279|FG000|COMPLETED|Washout (2 Weeks)||34
8776213|NCT01301001|9826280|FG001|COMPLETED|Washout (2 Weeks)||36
8776214|NCT01301001|9826279|FG000|NOT COMPLETED|Washout (2 Weeks)||0
8776215|NCT01301001|9826280|FG001|NOT COMPLETED|Washout (2 Weeks)||0
8776216|NCT01301001|9826279|FG000|STARTED|Second Intervention||34
8776217|NCT01301001|9826280|FG001|STARTED|Second Intervention||36
8776218|NCT01301001|9826279|FG000|COMPLETED|Second Intervention||30
8776219|NCT01301001|9826280|FG001|COMPLETED|Second Intervention||36
8776220|NCT01301001|9826279|FG000|NOT COMPLETED|Second Intervention||4
8776221|NCT01301001|9826280|FG001|NOT COMPLETED|Second Intervention||0
8776222|NCT01301027|9826289|FG000|STARTED|Overall Study||48
8776223|NCT01301027|9826290|FG001|STARTED|Overall Study||47
8776224|NCT01301027|9826289|FG000|COMPLETED|Overall Study||40
8776225|NCT01301027|9826290|FG001|COMPLETED|Overall Study||37
8776226|NCT01301027|9826289|FG000|NOT COMPLETED|Overall Study||8
8776227|NCT01301027|9826290|FG001|NOT COMPLETED|Overall Study||10
8776228|NCT01301066|9826298|FG000|STARTED|Overall Study||126
8776229|NCT01301066|9826299|FG001|STARTED|Overall Study||126
8776230|NCT01301066|9826298|FG000|COMPLETED|Overall Study||99
8776231|NCT01301066|9826299|FG001|COMPLETED|Overall Study||91
8776232|NCT01301066|9826298|FG000|NOT COMPLETED|Overall Study||27
8776233|NCT01301066|9826299|FG001|NOT COMPLETED|Overall Study||35
8776234|NCT01301079|9826307|FG000|STARTED|Overall Study||30
8776235|NCT01301079|9826308|FG001|STARTED|Overall Study||30
8776236|NCT01301079|9826307|FG000|COMPLETED|Overall Study||28
8776237|NCT01301079|9826308|FG001|COMPLETED|Overall Study||28
8776238|NCT01301079|9826307|FG000|NOT COMPLETED|Overall Study||2
8776239|NCT01301079|9826308|FG001|NOT COMPLETED|Overall Study||2
8776240|NCT01301092|9826321|FG000|STARTED|Overall Study||6
8776241|NCT01301092|9826322|FG001|STARTED|Overall Study||16
8776242|NCT01301092|9826323|FG002|STARTED|Overall Study||8
8776243|NCT01301092|9826321|FG000|COMPLETED|Overall Study||6
8776244|NCT01301092|9826322|FG001|COMPLETED|Overall Study||16
8776245|NCT01301092|9826323|FG002|COMPLETED|Overall Study||7
8776246|NCT01301092|9826321|FG000|NOT COMPLETED|Overall Study||0
8776247|NCT01301092|9826322|FG001|NOT COMPLETED|Overall Study||0
8776248|NCT01301092|9826323|FG002|NOT COMPLETED|Overall Study||1
8776249|NCT01301183|9826338|FG000|STARTED|Overall Study||38
8776250|NCT01301183|9826339|FG001|STARTED|Overall Study||37
8776251|NCT01301183|9826338|FG000|COMPLETED|Overall Study||12
8776252|NCT01301183|9826339|FG001|COMPLETED|Overall Study||21
8776253|NCT01301183|9826338|FG000|NOT COMPLETED|Overall Study||26
8776254|NCT01301183|9826339|FG001|NOT COMPLETED|Overall Study||16
8776255|NCT01301274|9826347|FG000|STARTED|Overall Study||34
8776256|NCT01301274|9826348|FG001|STARTED|Overall Study||32
8776257|NCT01301274|9826347|FG000|COMPLETED|Overall Study||32
8776258|NCT01301274|9826348|FG001|COMPLETED|Overall Study||31
8776259|NCT01301274|9826347|FG000|NOT COMPLETED|Overall Study||2
8776260|NCT01301274|9826348|FG001|NOT COMPLETED|Overall Study||1
8776261|NCT01301391|9826359|FG000|STARTED|Overall Study|On treatment until disease progression, patient withdrawal of consent, or unacceptable toxicity.|30
8776262|NCT01301391|9826359|FG000|COMPLETED|Overall Study||4
8776263|NCT01301391|9826359|FG000|NOT COMPLETED|Overall Study||26
8776264|NCT01301456|9826375|FG000|STARTED|Stage 1||15
8776265|NCT01301456|9826376|FG001|STARTED|Stage 1||5
8776266|NCT01301456|9826377|FG002|STARTED|Stage 1||6
8776267|NCT01301456|9826378|FG003|STARTED|Stage 1||6
8776268|NCT01301456|9826379|FG004|STARTED|Stage 1||7
8776269|NCT01301456|9826380|FG005|STARTED|Stage 1||5
8776270|NCT01301456|9826381|FG006|STARTED|Stage 1||8
8776271|NCT01301456|9826382|FG007|STARTED|Stage 1||0
8776272|NCT01301456|9826383|FG008|STARTED|Stage 1||0
8776273|NCT01301456|9826384|FG009|STARTED|Stage 1||0
8776274|NCT01301456|9826385|FG010|STARTED|Stage 1||0
8776275|NCT01301456|9826386|FG011|STARTED|Stage 1||0
8776276|NCT01301456|9826375|FG000|Received Treatment|Stage 1||15
8776277|NCT01301456|9826376|FG001|Received Treatment|Stage 1||5
8776278|NCT01301456|9826377|FG002|Received Treatment|Stage 1||6
8776279|NCT01301456|9826378|FG003|Received Treatment|Stage 1||6
8776280|NCT01301456|9826379|FG004|Received Treatment|Stage 1||7
8776281|NCT01301456|9826380|FG005|Received Treatment|Stage 1||5
8776282|NCT01301456|9826381|FG006|Received Treatment|Stage 1||7
8776283|NCT01301456|9826382|FG007|Received Treatment|Stage 1||0
8776284|NCT01301456|9826383|FG008|Received Treatment|Stage 1||0
8776285|NCT01301456|9826384|FG009|Received Treatment|Stage 1||0
8776286|NCT01301456|9826385|FG010|Received Treatment|Stage 1||0
8776287|NCT01301456|9826386|FG011|Received Treatment|Stage 1||0
8776288|NCT01301456|9826375|FG000|COMPLETED|Stage 1||15
8776289|NCT01301456|9826376|FG001|COMPLETED|Stage 1||5
8776290|NCT01301456|9826377|FG002|COMPLETED|Stage 1||5
8776291|NCT01301456|9826378|FG003|COMPLETED|Stage 1||6
8776292|NCT01301456|9826379|FG004|COMPLETED|Stage 1||6
8776293|NCT01301456|9826380|FG005|COMPLETED|Stage 1||5
8776294|NCT01301456|9826381|FG006|COMPLETED|Stage 1||7
8776295|NCT01301456|9826382|FG007|COMPLETED|Stage 1||0
8776296|NCT01301456|9826383|FG008|COMPLETED|Stage 1||0
8776297|NCT01301456|9826384|FG009|COMPLETED|Stage 1||0
8776298|NCT01301456|9826385|FG010|COMPLETED|Stage 1||0
8776299|NCT01301456|9826386|FG011|COMPLETED|Stage 1||0
8776300|NCT01301456|9826375|FG000|NOT COMPLETED|Stage 1||0
8776301|NCT01301456|9826376|FG001|NOT COMPLETED|Stage 1||0
8776302|NCT01301456|9826377|FG002|NOT COMPLETED|Stage 1||1
8776303|NCT01301456|9826378|FG003|NOT COMPLETED|Stage 1||0
8776304|NCT01301456|9826379|FG004|NOT COMPLETED|Stage 1||1
8776305|NCT01301456|9826380|FG005|NOT COMPLETED|Stage 1||0
8776306|NCT01301456|9826381|FG006|NOT COMPLETED|Stage 1||1
8776307|NCT01301456|9826382|FG007|NOT COMPLETED|Stage 1||0
8776308|NCT01301456|9826383|FG008|NOT COMPLETED|Stage 1||0
8776309|NCT01301456|9826384|FG009|NOT COMPLETED|Stage 1||0
8776310|NCT01301456|9826385|FG010|NOT COMPLETED|Stage 1||0
8776311|NCT01301456|9826386|FG011|NOT COMPLETED|Stage 1||0
8776312|NCT01301456|9826375|FG000|STARTED|Stage 2||0
8776313|NCT01301456|9826376|FG001|STARTED|Stage 2||0
8776314|NCT01301456|9826377|FG002|STARTED|Stage 2||0
8776315|NCT01301456|9826378|FG003|STARTED|Stage 2||0
8776316|NCT01301456|9826379|FG004|STARTED|Stage 2||0
8776317|NCT01301456|9826380|FG005|STARTED|Stage 2||0
8776318|NCT01301456|9826381|FG006|STARTED|Stage 2||0
8776319|NCT01301456|9826382|FG007|STARTED|Stage 2||7
8776320|NCT01301456|9826383|FG008|STARTED|Stage 2||5
8776321|NCT01301456|9826384|FG009|STARTED|Stage 2||7
8776322|NCT01301456|9826385|FG010|STARTED|Stage 2||7
8776323|NCT01301456|9826386|FG011|STARTED|Stage 2||6
8776324|NCT01301456|9826375|FG000|Received Treatment|Stage 2||0
8776325|NCT01301456|9826376|FG001|Received Treatment|Stage 2||0
8776326|NCT01301456|9826377|FG002|Received Treatment|Stage 2||0
8776327|NCT01301456|9826378|FG003|Received Treatment|Stage 2||0
8776328|NCT01301456|9826379|FG004|Received Treatment|Stage 2||0
8776329|NCT01301456|9826380|FG005|Received Treatment|Stage 2||0
8776330|NCT01301456|9826381|FG006|Received Treatment|Stage 2||0
8776331|NCT01301456|9826382|FG007|Received Treatment|Stage 2||7
8776332|NCT01301456|9826383|FG008|Received Treatment|Stage 2||5
8776333|NCT01301456|9826384|FG009|Received Treatment|Stage 2||7
8776334|NCT01301456|9826385|FG010|Received Treatment|Stage 2||7
8776335|NCT01301456|9826386|FG011|Received Treatment|Stage 2||6
8776336|NCT01301456|9826375|FG000|COMPLETED|Stage 2||0
8776337|NCT01301456|9826376|FG001|COMPLETED|Stage 2||0
8776338|NCT01301456|9826377|FG002|COMPLETED|Stage 2||0
8776339|NCT01301456|9826378|FG003|COMPLETED|Stage 2||0
8776340|NCT01301456|9826379|FG004|COMPLETED|Stage 2||0
8776341|NCT01301456|9826380|FG005|COMPLETED|Stage 2||0
8776342|NCT01301456|9826381|FG006|COMPLETED|Stage 2||0
8776343|NCT01301456|9826382|FG007|COMPLETED|Stage 2||7
8776344|NCT01301456|9826383|FG008|COMPLETED|Stage 2||5
8776345|NCT01301456|9826384|FG009|COMPLETED|Stage 2||7
8776346|NCT01301456|9826385|FG010|COMPLETED|Stage 2||6
8776347|NCT01301456|9826386|FG011|COMPLETED|Stage 2||6
8776348|NCT01301456|9826375|FG000|NOT COMPLETED|Stage 2||0
8776349|NCT01301456|9826376|FG001|NOT COMPLETED|Stage 2||0
8776350|NCT01301456|9826377|FG002|NOT COMPLETED|Stage 2||0
8776351|NCT01301456|9826378|FG003|NOT COMPLETED|Stage 2||0
8776352|NCT01301456|9826379|FG004|NOT COMPLETED|Stage 2||0
8776353|NCT01301456|9826380|FG005|NOT COMPLETED|Stage 2||0
8776354|NCT01301456|9826381|FG006|NOT COMPLETED|Stage 2||0
8776355|NCT01301456|9826382|FG007|NOT COMPLETED|Stage 2||0
8776356|NCT01301456|9826383|FG008|NOT COMPLETED|Stage 2||0
8776357|NCT01301456|9826384|FG009|NOT COMPLETED|Stage 2||0
8776358|NCT01301456|9826385|FG010|NOT COMPLETED|Stage 2||1
8776359|NCT01301456|9826386|FG011|NOT COMPLETED|Stage 2||0
8776360|NCT01301508|9826432|FG000|STARTED|Overall Study||21
8776361|NCT01301508|9826433|FG001|STARTED|Overall Study||25
8776362|NCT01301508|9826432|FG000|COMPLETED|Overall Study||20
8776363|NCT01301508|9826433|FG001|COMPLETED|Overall Study||22
8671587|NCT00752609|9714974|FG000|Full Analysis Set|Overall Study|One patient withdrew consent before receiving any study medication.|52
8671588|NCT00752609|9714975|FG001|Full Analysis Set|Overall Study||49
8671589|NCT00752609|9714974|FG000|COMPLETED|Overall Study||44
8671590|NCT00752609|9714975|FG001|COMPLETED|Overall Study||47
8671591|NCT00752609|9714974|FG000|NOT COMPLETED|Overall Study||9
8671592|NCT00752609|9714975|FG001|NOT COMPLETED|Overall Study||2
8671593|NCT00752622|9714984|FG000|STARTED|Induction Phase|The ELIG population comprised of 98 participants|100
8671594|NCT00752622|9714984|FG000|COMPLETED|Induction Phase||65
8671595|NCT00752622|9714984|FG000|NOT COMPLETED|Induction Phase||35
8671596|NCT00752622|9714984|FG000|STARTED|Observational Phase||65
8671597|NCT00752622|9714984|FG000|COMPLETED|Observational Phase|14 completed without loss of response 8 had loss of response & randomized into interventional phase|22
8776364|NCT01301508|9826432|FG000|NOT COMPLETED|Overall Study||1
8776365|NCT01301508|9826433|FG001|NOT COMPLETED|Overall Study||3
8776366|NCT01301625|9826439|FG000|STARTED|Overall Study||78
8776367|NCT01301625|9826439|FG000|COMPLETED|Overall Study||43
8776368|NCT01301625|9826439|FG000|NOT COMPLETED|Overall Study||35
8776369|NCT01301729|9826443|FG000|STARTED|Overall Study||32
8776370|NCT01301729|9826443|FG000|COMPLETED|Overall Study||28
8776371|NCT01301729|9826443|FG000|NOT COMPLETED|Overall Study||4
8776372|NCT01301742|9826448|FG000|STARTED|First Intervention||9
8776373|NCT01301742|9826449|FG001|STARTED|First Intervention||9
8776374|NCT01301742|9826448|FG000|COMPLETED|First Intervention||9
8776375|NCT01301742|9826449|FG001|COMPLETED|First Intervention||9
8776376|NCT01301742|9826448|FG000|NOT COMPLETED|First Intervention||0
8776377|NCT01301742|9826449|FG001|NOT COMPLETED|First Intervention||0
8776378|NCT01301742|9826448|FG000|STARTED|Washout Period of at Least 7 Days||9
8776379|NCT01301742|9826449|FG001|STARTED|Washout Period of at Least 7 Days||9
8776380|NCT01301742|9826448|FG000|COMPLETED|Washout Period of at Least 7 Days||9
8776381|NCT01301742|9826449|FG001|COMPLETED|Washout Period of at Least 7 Days||9
8776382|NCT01301742|9826448|FG000|NOT COMPLETED|Washout Period of at Least 7 Days||0
8776383|NCT01301742|9826449|FG001|NOT COMPLETED|Washout Period of at Least 7 Days||0
8776384|NCT01301742|9826448|FG000|STARTED|Second Intervention||9
8776385|NCT01301742|9826449|FG001|STARTED|Second Intervention||9
8776386|NCT01301742|9826448|FG000|COMPLETED|Second Intervention||9
8776387|NCT01301742|9826449|FG001|COMPLETED|Second Intervention||9
8776388|NCT01301742|9826448|FG000|NOT COMPLETED|Second Intervention||0
8776389|NCT01301742|9826449|FG001|NOT COMPLETED|Second Intervention||0
8776390|NCT01301833|9826460|FG000|STARTED|Overall Study||212
8776391|NCT01301833|9826461|FG001|STARTED|Overall Study||80
8776392|NCT01301833|9826462|FG002|STARTED|Overall Study||95
8776393|NCT01301833|9826463|FG003|STARTED|Overall Study||75
8776394|NCT01301833|9826460|FG000|COMPLETED|Overall Study||197
8776395|NCT01301833|9826461|FG001|COMPLETED|Overall Study||72
8776396|NCT01301833|9826462|FG002|COMPLETED|Overall Study||88
8776397|NCT01301833|9826463|FG003|COMPLETED|Overall Study||68
8776398|NCT01301833|9826460|FG000|NOT COMPLETED|Overall Study||15
8776399|NCT01301833|9826461|FG001|NOT COMPLETED|Overall Study||8
8776400|NCT01301833|9826462|FG002|NOT COMPLETED|Overall Study||7
8776401|NCT01301833|9826463|FG003|NOT COMPLETED|Overall Study||7
8776402|NCT01301950|9826475|FG000|STARTED|Overall Study||15
8776403|NCT01301950|9826476|FG001|STARTED|Overall Study||15
8776404|NCT01301950|9826475|FG000|COMPLETED|Overall Study||15
8776405|NCT01301950|9826476|FG001|COMPLETED|Overall Study||14
8776406|NCT01301950|9826475|FG000|NOT COMPLETED|Overall Study||0
8776407|NCT01301950|9826476|FG001|NOT COMPLETED|Overall Study||1
8776408|NCT01302041|9826482|FG000|STARTED|Overall Study||67
8776409|NCT01302041|9826482|FG000|Treatment Received|Overall Study||67
8776410|NCT01302041|9826482|FG000|COMPLETED|Overall Study|Participants who discontinued treatment and completed the 30-day follow-up visit|27
8776411|NCT01302041|9826482|FG000|NOT COMPLETED|Overall Study||40
8776412|NCT01302054|9826487|FG000|STARTED|Tolterodine Open-Label Run-In Phase||990
8776413|NCT01302054|9826488|FG001|STARTED|Tolterodine Open-Label Run-In Phase||0
8776414|NCT01302054|9826489|FG002|STARTED|Tolterodine Open-Label Run-In Phase||0
8776415|NCT01302054|9826487|FG000|COMPLETED|Tolterodine Open-Label Run-In Phase||611
8776416|NCT01302054|9826488|FG001|COMPLETED|Tolterodine Open-Label Run-In Phase||0
8776417|NCT01302054|9826489|FG002|COMPLETED|Tolterodine Open-Label Run-In Phase||0
8776418|NCT01302054|9826487|FG000|NOT COMPLETED|Tolterodine Open-Label Run-In Phase||379
8776419|NCT01302054|9826488|FG001|NOT COMPLETED|Tolterodine Open-Label Run-In Phase||0
8776420|NCT01302054|9826489|FG002|NOT COMPLETED|Tolterodine Open-Label Run-In Phase||0
8776421|NCT01302054|9826487|FG000|STARTED|Between Open-Label and Double Blind||611
8776422|NCT01302054|9826488|FG001|STARTED|Between Open-Label and Double Blind||0
8776423|NCT01302054|9826489|FG002|STARTED|Between Open-Label and Double Blind||0
8776424|NCT01302054|9826487|FG000|COMPLETED|Between Open-Label and Double Blind||609
8776425|NCT01302054|9826488|FG001|COMPLETED|Between Open-Label and Double Blind||0
8776426|NCT01302054|9826489|FG002|COMPLETED|Between Open-Label and Double Blind||0
8776427|NCT01302054|9826487|FG000|NOT COMPLETED|Between Open-Label and Double Blind||2
8776428|NCT01302054|9826488|FG001|NOT COMPLETED|Between Open-Label and Double Blind||0
8776429|NCT01302054|9826489|FG002|NOT COMPLETED|Between Open-Label and Double Blind||0
8776430|NCT01302054|9826487|FG000|STARTED|Double-Blind Treatment Phase||0
8776431|NCT01302054|9826488|FG001|STARTED|Double-Blind Treatment Phase||308
8776432|NCT01302054|9826489|FG002|STARTED|Double-Blind Treatment Phase||301
8776433|NCT01302054|9826487|FG000|COMPLETED|Double-Blind Treatment Phase||0
8776434|NCT01302054|9826488|FG001|COMPLETED|Double-Blind Treatment Phase||281
8776435|NCT01302054|9826489|FG002|COMPLETED|Double-Blind Treatment Phase||255
8776436|NCT01302054|9826487|FG000|NOT COMPLETED|Double-Blind Treatment Phase||0
8776437|NCT01302054|9826488|FG001|NOT COMPLETED|Double-Blind Treatment Phase||27
8776438|NCT01302054|9826489|FG002|NOT COMPLETED|Double-Blind Treatment Phase||46
8776439|NCT01302067|9826501|FG000|STARTED|Overall Study||790
8776440|NCT01302067|9826502|FG001|STARTED|Overall Study||386
8776441|NCT01302067|9826503|FG002|STARTED|Overall Study||779
8776442|NCT01302067|9826501|FG000|COMPLETED|Overall Study||712
8776443|NCT01302067|9826502|FG001|COMPLETED|Overall Study||352
8776444|NCT01302067|9826503|FG002|COMPLETED|Overall Study||681
8776445|NCT01302067|9826501|FG000|NOT COMPLETED|Overall Study||78
8776446|NCT01302067|9826502|FG001|NOT COMPLETED|Overall Study||34
8776447|NCT01302067|9826503|FG002|NOT COMPLETED|Overall Study||98
8776448|NCT01302080|9826514|FG000|STARTED|Overall Study|Out of 696 participants, 1 participant started treatment with another antidepressant alone or along with psychotherapy.|696
8776449|NCT01302080|9826515|FG001|STARTED|Overall Study|Out of 245 participants, 2 participants started treatment with another antidepressant alone or along with psychotherapy.|245
8776450|NCT01302080|9826514|FG000|COMPLETED|Overall Study||330
8776451|NCT01302080|9826515|FG001|COMPLETED|Overall Study||102
8776452|NCT01302080|9826514|FG000|NOT COMPLETED|Overall Study||366
8776453|NCT01302080|9826515|FG001|NOT COMPLETED|Overall Study||143
8776454|NCT01302119|9826547|FG000|STARTED|Overall Study||399
8776455|NCT01302119|9826548|FG001|STARTED|Overall Study||205
8776456|NCT01302119|9826547|FG000|COMPLETED|Overall Study||349
8776457|NCT01302119|9826548|FG001|COMPLETED|Overall Study||177
8776458|NCT01302119|9826547|FG000|NOT COMPLETED|Overall Study||50
8776459|NCT01302119|9826548|FG001|NOT COMPLETED|Overall Study||28
8776460|NCT01302366|9826554|FG000|STARTED|Overall Study||20
8776461|NCT01302366|9826554|FG000|COMPLETED|Overall Study||15
8776462|NCT01302366|9826554|FG000|NOT COMPLETED|Overall Study||5
8776463|NCT01302379|9826562|FG000|STARTED|Overall Study||83
8776464|NCT01302379|9826563|FG001|STARTED|Overall Study||83
8776465|NCT01302379|9826564|FG002|STARTED|Overall Study||84
8776466|NCT01302379|9826565|FG003|STARTED|Overall Study||83
8776467|NCT01302379|9826562|FG000|COMPLETED|Overall Study||76
8776468|NCT01302379|9826563|FG001|COMPLETED|Overall Study||78
8776469|NCT01302379|9826564|FG002|COMPLETED|Overall Study||80
8776470|NCT01302379|9826565|FG003|COMPLETED|Overall Study||79
8776471|NCT01302379|9826562|FG000|NOT COMPLETED|Overall Study||7
8776472|NCT01302379|9826563|FG001|NOT COMPLETED|Overall Study||5
8776473|NCT01302379|9826564|FG002|NOT COMPLETED|Overall Study||4
8776474|NCT01302379|9826565|FG003|NOT COMPLETED|Overall Study||4
8776475|NCT01302392|9826575|FG000|STARTED|Overall Study||158
8776476|NCT01302392|9826576|FG001|STARTED|Overall Study||157
8776477|NCT01302392|9826575|FG000|Treated|Overall Study||153
8776478|NCT01302392|9826576|FG001|Treated|Overall Study||157
8776479|NCT01302392|9826575|FG000|COMPLETED|Overall Study||151
8776480|NCT01302392|9826576|FG001|COMPLETED|Overall Study||156
8776481|NCT01302392|9826575|FG000|NOT COMPLETED|Overall Study||7
8776482|NCT01302392|9826576|FG001|NOT COMPLETED|Overall Study||1
8776483|NCT01302418|9826582|FG000|STARTED|Overall Study||272
8776484|NCT01302418|9826582|FG000|COMPLETED|Overall Study||254
8776485|NCT01302418|9826582|FG000|NOT COMPLETED|Overall Study||18
8776486|NCT01302483|9826588|FG000|STARTED|Overall Study||30
8776487|NCT01302483|9826589|FG001|STARTED|Overall Study||15
8776488|NCT01302483|9826588|FG000|COMPLETED|Overall Study||30
8776489|NCT01302483|9826589|FG001|COMPLETED|Overall Study||15
8776490|NCT01302483|9826588|FG000|NOT COMPLETED|Overall Study||0
8776491|NCT01302483|9826589|FG001|NOT COMPLETED|Overall Study||0
8776492|NCT01302548|9826603|FG000|STARTED|Overall Study||14
8776493|NCT01302548|9826604|FG001|STARTED|Overall Study||19
8776494|NCT01302548|9826603|FG000|COMPLETED|Overall Study||12
8776495|NCT01302548|9826604|FG001|COMPLETED|Overall Study||18
8776496|NCT01302548|9826603|FG000|NOT COMPLETED|Overall Study||2
8776497|NCT01302548|9826604|FG001|NOT COMPLETED|Overall Study||1
8776498|NCT01302691|9826612|FG000|STARTED|Overall Study||164
8776499|NCT01302691|9826613|FG001|STARTED|Overall Study||163
8776500|NCT01302691|9826612|FG000|COMPLETED|Overall Study||154
8776501|NCT01302691|9826613|FG001|COMPLETED|Overall Study||157
8776502|NCT01302691|9826612|FG000|NOT COMPLETED|Overall Study||10
8776503|NCT01302691|9826613|FG001|NOT COMPLETED|Overall Study||6
8776504|NCT01302743|9826622|FG000|STARTED|Overall Study||7
8776505|NCT01302743|9826623|FG001|STARTED|Overall Study||8
8776506|NCT01302743|9826624|FG002|STARTED|Overall Study||10
8776507|NCT01302743|9826622|FG000|COMPLETED|Overall Study||6
8776508|NCT01302743|9826623|FG001|COMPLETED|Overall Study||7
8776509|NCT01302743|9826624|FG002|COMPLETED|Overall Study||8
8776510|NCT01302743|9826622|FG000|NOT COMPLETED|Overall Study||1
8776511|NCT01302743|9826623|FG001|NOT COMPLETED|Overall Study||1
8776512|NCT01302743|9826624|FG002|NOT COMPLETED|Overall Study||2
8776513|NCT01302808|9826636|FG000|STARTED|Overall Study||3
8776514|NCT01302808|9826637|FG001|STARTED|Overall Study||7
8776515|NCT01302808|9826638|FG002|STARTED|Overall Study||4
8776516|NCT01302808|9826639|FG003|STARTED|Overall Study||3
8776517|NCT01302808|9826636|FG000|COMPLETED|Overall Study||3
8776518|NCT01302808|9826637|FG001|COMPLETED|Overall Study||7
8776519|NCT01302808|9826638|FG002|COMPLETED|Overall Study||4
8776520|NCT01302808|9826639|FG003|COMPLETED|Overall Study||3
8776521|NCT01302808|9826636|FG000|NOT COMPLETED|Overall Study||0
8776522|NCT01302808|9826637|FG001|NOT COMPLETED|Overall Study||0
8776523|NCT01302808|9826638|FG002|NOT COMPLETED|Overall Study||0
8776524|NCT01302808|9826639|FG003|NOT COMPLETED|Overall Study||0
8776525|NCT01302834|9826653|FG000|STARTED|Overall Study||424
8776526|NCT01302834|9826654|FG001|STARTED|Overall Study||425
8776527|NCT01302834|9826653|FG000|Eligible|Overall Study||406
8776528|NCT01302834|9826654|FG001|Eligible|Overall Study||399
8776529|NCT01302834|9826653|FG000|Started Treatment|Overall Study||398
8776530|NCT01302834|9826654|FG001|Started Treatment|Overall Study||394
8776531|NCT01302834|9826653|FG000|AE Assessed 1 Month Post-treatment (PT)|Overall Study||369
8776532|NCT01302834|9826654|FG001|AE Assessed 1 Month Post-treatment (PT)|Overall Study||363
8776533|NCT01302834|9826653|FG000|AE Assessed 3 Months PT|Overall Study||359
8776534|NCT01302834|9826654|FG001|AE Assessed 3 Months PT|Overall Study||367
8776535|NCT01302834|9826653|FG000|AE Assessed 6 Months PT|Overall Study||361
8776536|NCT01302834|9826654|FG001|AE Assessed 6 Months PT|Overall Study||352
8776537|NCT01302834|9826653|FG000|AE Assessment 1 Year PT|Overall Study||360
8776538|NCT01302834|9826654|FG001|AE Assessment 1 Year PT|Overall Study||351
8776539|NCT01302834|9826653|FG000|AE Assessed 2 Years PT|Overall Study||311
8776540|NCT01302834|9826654|FG001|AE Assessed 2 Years PT|Overall Study||303
8776541|NCT01302834|9826653|FG000|AE Assessed 5 Years PT|Overall Study||92
8776542|NCT01302834|9826654|FG001|AE Assessed 5 Years PT|Overall Study||86
8776543|NCT01302834|9826653|FG000|Dental Health Assessed 1 Year PT|Overall Study||267
8776544|NCT01302834|9826654|FG001|Dental Health Assessed 1 Year PT|Overall Study||267
8776545|NCT01302834|9826653|FG000|Dental Health Assessed 2 Years PT|Overall Study||208
8776546|NCT01302834|9826654|FG001|Dental Health Assessed 2 Years PT|Overall Study||201
8776547|NCT01302834|9826653|FG000|Dental Health Assessed 5 Years PT|Overall Study||44
8776548|NCT01302834|9826654|FG001|Dental Health Assessed 5 Years PT|Overall Study||43
8776549|NCT01302834|9826653|FG000|Feeding Tube Assessed|Overall Study||368
8776550|NCT01302834|9826654|FG001|Feeding Tube Assessed|Overall Study||356
8776551|NCT01302834|9826653|FG000|Progressed|Overall Study||76
8776552|NCT01302834|9826654|FG001|Progressed|Overall Study||122
8776553|NCT01302834|9826653|FG000|COMPLETED|Overall Study||406
8776554|NCT01302834|9826654|FG001|COMPLETED|Overall Study||399
8776555|NCT01302834|9826653|FG000|NOT COMPLETED|Overall Study||18
8671598|NCT00752622|9714984|FG000|NOT COMPLETED|Observational Phase||43
8671599|NCT00752622|9714984|FG000|STARTED|Interventional Phase|5 participants randomized into increased dose group and 3 randomized into shortened interval group|8
9029109|NCT03213405|10091459|FG001|STARTED|Overall Study||6
9029110|NCT03213405|10091460|FG002|STARTED|Overall Study||6
8671600|NCT00752622|9714984|FG000|COMPLETED|Interventional Phase|8 participants received at least 1 infusion of interventional treatment, but none completed trial|0
8671601|NCT00752622|9714984|FG000|NOT COMPLETED|Interventional Phase||8
8671602|NCT00752726|9714991|FG000|STARTED|Overall Study||65
8671603|NCT00752726|9714992|FG001|STARTED|Overall Study||66
8692658|NCT00862719|9738236|FG003|STARTED|Overall Study||1
8776556|NCT01302834|9826654|FG001|NOT COMPLETED|Overall Study||26
8776557|NCT01302860|9826660|FG000|STARTED|Overall Study||17
8776558|NCT01302860|9826660|FG000|COMPLETED|Overall Study||17
8776559|NCT01302860|9826660|FG000|NOT COMPLETED|Overall Study||0
8776560|NCT01302899|9826666|FG000|STARTED|Period 1 (Day 1 to End of Week 6)||4
8776561|NCT01302899|9826667|FG001|STARTED|Period 1 (Day 1 to End of Week 6)||4
8776562|NCT01302899|9826666|FG000|COMPLETED|Period 1 (Day 1 to End of Week 6)||4
8776563|NCT01302899|9826667|FG001|COMPLETED|Period 1 (Day 1 to End of Week 6)||4
8776564|NCT01302899|9826666|FG000|NOT COMPLETED|Period 1 (Day 1 to End of Week 6)||0
8776565|NCT01302899|9826667|FG001|NOT COMPLETED|Period 1 (Day 1 to End of Week 6)||0
8776566|NCT01302899|9826666|FG000|STARTED|Period 2 (Weeks 7 to 12)||4
8776567|NCT01302899|9826667|FG001|STARTED|Period 2 (Weeks 7 to 12)||4
8776568|NCT01302899|9826666|FG000|COMPLETED|Period 2 (Weeks 7 to 12)||3
8776569|NCT01302899|9826667|FG001|COMPLETED|Period 2 (Weeks 7 to 12)||3
8776570|NCT01302899|9826666|FG000|NOT COMPLETED|Period 2 (Weeks 7 to 12)||1
8776571|NCT01302899|9826667|FG001|NOT COMPLETED|Period 2 (Weeks 7 to 12)||1
9029111|NCT03213405|10091461|FG003|STARTED|Overall Study||6
9029112|NCT03213405|10091458|FG000|COMPLETED|Overall Study||6
9029113|NCT03213405|10091459|FG001|COMPLETED|Overall Study||6
9029114|NCT03213405|10091460|FG002|COMPLETED|Overall Study||6
9029115|NCT03213405|10091461|FG003|COMPLETED|Overall Study||6
9029116|NCT03213405|10091458|FG000|NOT COMPLETED|Overall Study||0
9029117|NCT03213405|10091459|FG001|NOT COMPLETED|Overall Study||0
9029118|NCT03213405|10091460|FG002|NOT COMPLETED|Overall Study||0
9029119|NCT03213405|10091461|FG003|NOT COMPLETED|Overall Study||0
8776572|NCT01302899|9826666|FG000|STARTED|Period 3 (Weeks 13 to 18)||3
8776573|NCT01302899|9826667|FG001|STARTED|Period 3 (Weeks 13 to 18)||3
8776574|NCT01302899|9826666|FG000|COMPLETED|Period 3 (Weeks 13 to 18)||3
8776575|NCT01302899|9826667|FG001|COMPLETED|Period 3 (Weeks 13 to 18)||3
8776576|NCT01302899|9826666|FG000|NOT COMPLETED|Period 3 (Weeks 13 to 18)||0
8776577|NCT01302899|9826667|FG001|NOT COMPLETED|Period 3 (Weeks 13 to 18)||0
8776578|NCT01302899|9826666|FG000|STARTED|Period 4 (Weeks 19 to 26)||3
8776579|NCT01302899|9826667|FG001|STARTED|Period 4 (Weeks 19 to 26)||3
8776580|NCT01302899|9826666|FG000|COMPLETED|Period 4 (Weeks 19 to 26)||3
8776581|NCT01302899|9826667|FG001|COMPLETED|Period 4 (Weeks 19 to 26)||3
8776582|NCT01302899|9826666|FG000|NOT COMPLETED|Period 4 (Weeks 19 to 26)||0
8776583|NCT01302899|9826667|FG001|NOT COMPLETED|Period 4 (Weeks 19 to 26)||0
8776584|NCT01302938|9826679|FG000|STARTED|Overall Study||12
8776585|NCT01302938|9826680|FG001|STARTED|Overall Study||6
8776586|NCT01302938|9826679|FG000|COMPLETED|Overall Study||10
8776587|NCT01302938|9826680|FG001|COMPLETED|Overall Study||6
8776588|NCT01302938|9826679|FG000|NOT COMPLETED|Overall Study||2
8776589|NCT01302938|9826680|FG001|NOT COMPLETED|Overall Study||0
8776590|NCT01302964|9826689|FG000|STARTED|Overall Study||20
8776591|NCT01302964|9826690|FG001|STARTED|Overall Study||10
8776592|NCT01302964|9826689|FG000|COMPLETED|Overall Study||19
8776593|NCT01302964|9826690|FG001|COMPLETED|Overall Study||10
8776594|NCT01302964|9826689|FG000|NOT COMPLETED|Overall Study||1
8776595|NCT01302964|9826690|FG001|NOT COMPLETED|Overall Study||0
8776596|NCT01303068|9826698|FG000|STARTED|Overall Study||6
8776597|NCT01303068|9826699|FG001|STARTED|Overall Study||6
8776598|NCT01303068|9826698|FG000|COMPLETED|Overall Study||6
8776599|NCT01303068|9826699|FG001|COMPLETED|Overall Study||6
8776600|NCT01303068|9826698|FG000|NOT COMPLETED|Overall Study||0
8776601|NCT01303068|9826699|FG001|NOT COMPLETED|Overall Study||0
8776602|NCT01303159|9826705|FG000|STARTED|Overall Study||29
8776603|NCT01303159|9826705|FG000|COMPLETED|Overall Study||6
8776604|NCT01303159|9826705|FG000|NOT COMPLETED|Overall Study||23
8776605|NCT01303172|9826711|FG000|STARTED|Overall Study||75
8776606|NCT01303172|9826712|FG001|STARTED|Overall Study||35
8776607|NCT01303172|9826711|FG000|COMPLETED|Overall Study||12
8776608|NCT01303172|9826712|FG001|COMPLETED|Overall Study||1
8776609|NCT01303172|9826711|FG000|NOT COMPLETED|Overall Study||63
8776610|NCT01303172|9826712|FG001|NOT COMPLETED|Overall Study||34
8776611|NCT01303224|9826723|FG000|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|141
8776612|NCT01303224|9826724|FG001|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|142
8776613|NCT01303224|9826725|FG002|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|139
8776614|NCT01303224|9826726|FG003|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|143
8776615|NCT01303224|9826723|FG000|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|140
8776616|NCT01303224|9826724|FG001|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|138
8776617|NCT01303224|9826725|FG002|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|139
8776618|NCT01303224|9826726|FG003|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|142
8776619|NCT01303224|9826723|FG000|COMPLETED|Overall Study||130
8776620|NCT01303224|9826724|FG001|COMPLETED|Overall Study||131
8776621|NCT01303224|9826725|FG002|COMPLETED|Overall Study||133
8776622|NCT01303224|9826726|FG003|COMPLETED|Overall Study||133
8776623|NCT01303224|9826723|FG000|NOT COMPLETED|Overall Study||11
8776624|NCT01303224|9826724|FG001|NOT COMPLETED|Overall Study||11
8776625|NCT01303224|9826725|FG002|NOT COMPLETED|Overall Study||6
8776626|NCT01303224|9826726|FG003|NOT COMPLETED|Overall Study||10
8776627|NCT01303380|9826736|FG000|STARTED|Overall Study||9
8776628|NCT01303380|9826736|FG000|COMPLETED|Overall Study||8
8776629|NCT01303380|9826736|FG000|NOT COMPLETED|Overall Study||1
8776630|NCT01303406|9826742|FG000|STARTED|Overall Study||13
8776631|NCT01303406|9826743|FG001|STARTED|Overall Study||16
8776632|NCT01303406|9826742|FG000|COMPLETED|Overall Study||13
8776633|NCT01303406|9826743|FG001|COMPLETED|Overall Study||15
8776634|NCT01303406|9826742|FG000|NOT COMPLETED|Overall Study||0
8776635|NCT01303406|9826743|FG001|NOT COMPLETED|Overall Study||1
8776636|NCT01303419|9826749|FG000|STARTED|Overall Study|Subjects who met all Inclusion and none of the Exclusion criteria|224
8776637|NCT01303419|9826749|FG000|COMPLETED|Overall Study||128
8776638|NCT01303419|9826749|FG000|NOT COMPLETED|Overall Study||96
8776639|NCT01303445|9826753|FG000|STARTED|First Intervention (7 Days)||30
8776640|NCT01303445|9826754|FG001|STARTED|First Intervention (7 Days)||30
8776641|NCT01303445|9826753|FG000|COMPLETED|First Intervention (7 Days)||29
8776642|NCT01303445|9826754|FG001|COMPLETED|First Intervention (7 Days)||30
8776643|NCT01303445|9826753|FG000|NOT COMPLETED|First Intervention (7 Days)||1
8776644|NCT01303445|9826754|FG001|NOT COMPLETED|First Intervention (7 Days)||0
8776645|NCT01303445|9826753|FG000|STARTED|Second Intervention (7 Days)||29
8776646|NCT01303445|9826754|FG001|STARTED|Second Intervention (7 Days)||30
8776647|NCT01303445|9826753|FG000|COMPLETED|Second Intervention (7 Days)||28
8776648|NCT01303445|9826754|FG001|COMPLETED|Second Intervention (7 Days)||28
8776649|NCT01303445|9826753|FG000|NOT COMPLETED|Second Intervention (7 Days)||1
8776650|NCT01303445|9826754|FG001|NOT COMPLETED|Second Intervention (7 Days)||2
8776651|NCT01303445|9826753|FG000|STARTED|Washout (14 Days)||28
8776652|NCT01303445|9826754|FG001|STARTED|Washout (14 Days)||28
8776653|NCT01303445|9826753|FG000|COMPLETED|Washout (14 Days)||27
8776654|NCT01303445|9826754|FG001|COMPLETED|Washout (14 Days)||26
8776655|NCT01303445|9826753|FG000|NOT COMPLETED|Washout (14 Days)||1
8776656|NCT01303445|9826754|FG001|NOT COMPLETED|Washout (14 Days)||2
8776657|NCT01303445|9826753|FG000|STARTED|Third Intervention (7 Days)||27
8776658|NCT01303445|9826754|FG001|STARTED|Third Intervention (7 Days)||26
8776659|NCT01303445|9826753|FG000|COMPLETED|Third Intervention (7 Days)||27
8776660|NCT01303445|9826754|FG001|COMPLETED|Third Intervention (7 Days)||26
8776661|NCT01303445|9826753|FG000|NOT COMPLETED|Third Intervention (7 Days)||0
8776662|NCT01303445|9826754|FG001|NOT COMPLETED|Third Intervention (7 Days)||0
8776663|NCT01303445|9826753|FG000|STARTED|Fourth Intervention (7 Days)||27
8776664|NCT01303445|9826754|FG001|STARTED|Fourth Intervention (7 Days)||26
8776665|NCT01303445|9826753|FG000|COMPLETED|Fourth Intervention (7 Days)||26
8776666|NCT01303445|9826754|FG001|COMPLETED|Fourth Intervention (7 Days)||26
8776667|NCT01303445|9826753|FG000|NOT COMPLETED|Fourth Intervention (7 Days)||1
8776668|NCT01303445|9826754|FG001|NOT COMPLETED|Fourth Intervention (7 Days)||0
8776669|NCT01303445|9826753|FG000|STARTED|Follow-up Period (14 Days)||26
8776670|NCT01303445|9826754|FG001|STARTED|Follow-up Period (14 Days)||26
8776671|NCT01303445|9826753|FG000|COMPLETED|Follow-up Period (14 Days)||26
8776672|NCT01303445|9826754|FG001|COMPLETED|Follow-up Period (14 Days)||25
8776673|NCT01303445|9826753|FG000|NOT COMPLETED|Follow-up Period (14 Days)||0
8776674|NCT01303445|9826754|FG001|NOT COMPLETED|Follow-up Period (14 Days)||1
8776675|NCT01303510|9826766|FG000|STARTED|Overall Study||55
8776676|NCT01303510|9826767|FG001|STARTED|Overall Study||56
8776677|NCT01303510|9826766|FG000|COMPLETED|Overall Study||54
8776678|NCT01303510|9826767|FG001|COMPLETED|Overall Study||56
8776679|NCT01303510|9826766|FG000|NOT COMPLETED|Overall Study||1
8776680|NCT01303510|9826767|FG001|NOT COMPLETED|Overall Study||0
8776681|NCT01303627|9826775|FG000|STARTED|Overall Study||21
8776682|NCT01303627|9826776|FG001|STARTED|Overall Study||21
8776683|NCT01303627|9826775|FG000|COMPLETED|Overall Study||21
8776684|NCT01303627|9826776|FG001|COMPLETED|Overall Study|One patient excluded from the study because of the failure while performing uretero-renoscopy|20
8776685|NCT01303627|9826775|FG000|NOT COMPLETED|Overall Study||0
8776686|NCT01303627|9826776|FG001|NOT COMPLETED|Overall Study||1
8776687|NCT01303744|9826786|FG000|STARTED|Overall Study||24
8776688|NCT01303744|9826787|FG001|STARTED|Overall Study||24
8776689|NCT01303744|9826788|FG002|STARTED|Overall Study||24
8776690|NCT01303744|9826789|FG003|STARTED|Overall Study||24
8776691|NCT01303744|9826786|FG000|COMPLETED|Overall Study||24
8776692|NCT01303744|9826787|FG001|COMPLETED|Overall Study||24
8776693|NCT01303744|9826788|FG002|COMPLETED|Overall Study||24
8776694|NCT01303744|9826789|FG003|COMPLETED|Overall Study||24
8776695|NCT01303744|9826786|FG000|NOT COMPLETED|Overall Study||0
8776696|NCT01303744|9826787|FG001|NOT COMPLETED|Overall Study||0
8776697|NCT01303744|9826788|FG002|NOT COMPLETED|Overall Study||0
8776698|NCT01303744|9826789|FG003|NOT COMPLETED|Overall Study||0
8776699|NCT01303835|9826801|FG000|STARTED|Overall Study||54
8776700|NCT01303835|9826802|FG001|STARTED|Overall Study||56
8776701|NCT01303835|9826801|FG000|COMPLETED|Overall Study||35
8776702|NCT01303835|9826802|FG001|COMPLETED|Overall Study||31
8776703|NCT01303835|9826801|FG000|NOT COMPLETED|Overall Study||19
8776704|NCT01303835|9826802|FG001|NOT COMPLETED|Overall Study||25
8776705|NCT01303861|9826813|FG000|STARTED|Overall Study||109
8776706|NCT01303861|9826814|FG001|STARTED|Overall Study||50
8776707|NCT01303861|9826815|FG002|STARTED|Overall Study||55
8776708|NCT01303861|9826816|FG003|STARTED|Overall Study||113
8776709|NCT01303861|9826813|FG000|Finished Treatment Phase|Overall Study||71
8776710|NCT01303861|9826814|FG001|Finished Treatment Phase|Overall Study||34
8776711|NCT01303861|9826815|FG002|Finished Treatment Phase|Overall Study||39
8776712|NCT01303861|9826816|FG003|Finished Treatment Phase|Overall Study||72
8776713|NCT01303861|9826813|FG000|COMPLETED|Overall Study||51
8776714|NCT01303861|9826814|FG001|COMPLETED|Overall Study||25
8776715|NCT01303861|9826815|FG002|COMPLETED|Overall Study||19
8776716|NCT01303861|9826816|FG003|COMPLETED|Overall Study||54
8776717|NCT01303861|9826813|FG000|NOT COMPLETED|Overall Study||58
8776718|NCT01303861|9826814|FG001|NOT COMPLETED|Overall Study||25
8776719|NCT01303861|9826815|FG002|NOT COMPLETED|Overall Study||36
8776720|NCT01303861|9826816|FG003|NOT COMPLETED|Overall Study||59
8776721|NCT01303939|9826829|FG000|STARTED|Overall Study||22
8776722|NCT01303939|9826830|FG001|STARTED|Overall Study||15
8776723|NCT01303939|9826829|FG000|COMPLETED|Overall Study|Matched controls not found for comparisons. Only best matched glaucoma patients were included.|15
8776724|NCT01303939|9826830|FG001|COMPLETED|Overall Study||15
8776725|NCT01303939|9826829|FG000|NOT COMPLETED|Overall Study||7
8776726|NCT01303939|9826830|FG001|NOT COMPLETED|Overall Study||0
8776727|NCT01303965|9826840|FG000|STARTED|Overall Study||3
8776728|NCT01303965|9826841|FG001|STARTED|Overall Study||11
8776729|NCT01303965|9826840|FG000|COMPLETED|Overall Study||0
8776730|NCT01303965|9826841|FG001|COMPLETED|Overall Study||1
8776731|NCT01303965|9826840|FG000|NOT COMPLETED|Overall Study||3
8776732|NCT01303965|9826841|FG001|NOT COMPLETED|Overall Study||10
8776733|NCT01304082|9826847|FG000|STARTED|Overall Study||3
8776734|NCT01304082|9826848|FG001|STARTED|Overall Study||2
8776735|NCT01304082|9826849|FG002|STARTED|Overall Study||11
8776736|NCT01304082|9826850|FG003|STARTED|Overall Study||8
8776737|NCT01304082|9826851|FG004|STARTED|Overall Study||5
8776738|NCT01304082|9826847|FG000|First Intervention|Overall Study||3
8776739|NCT01304082|9826848|FG001|First Intervention|Overall Study||2
8776740|NCT01304082|9826849|FG002|First Intervention|Overall Study||11
8776741|NCT01304082|9826850|FG003|First Intervention|Overall Study||8
8776742|NCT01304082|9826851|FG004|First Intervention|Overall Study||5
8776743|NCT01304082|9826847|FG000|Second Intervention|Overall Study||3
8776744|NCT01304082|9826848|FG001|Second Intervention|Overall Study||2
8776745|NCT01304082|9826849|FG002|Second Intervention|Overall Study||11
8776746|NCT01304082|9826850|FG003|Second Intervention|Overall Study||8
8776747|NCT01304082|9826851|FG004|Second Intervention|Overall Study||5
8776748|NCT01304082|9826847|FG000|Third Intervention|Overall Study||3
8776749|NCT01304082|9826848|FG001|Third Intervention|Overall Study||2
8776750|NCT01304082|9826849|FG002|Third Intervention|Overall Study||11
8776751|NCT01304082|9826850|FG003|Third Intervention|Overall Study||8
8776752|NCT01304082|9826851|FG004|Third Intervention|Overall Study||5
8776753|NCT01304082|9826847|FG000|COMPLETED|Overall Study||3
8776754|NCT01304082|9826848|FG001|COMPLETED|Overall Study||2
8776755|NCT01304082|9826849|FG002|COMPLETED|Overall Study||11
8776756|NCT01304082|9826850|FG003|COMPLETED|Overall Study||8
8776757|NCT01304082|9826851|FG004|COMPLETED|Overall Study||5
8776758|NCT01304082|9826847|FG000|NOT COMPLETED|Overall Study||0
8776759|NCT01304082|9826848|FG001|NOT COMPLETED|Overall Study||0
8776760|NCT01304082|9826849|FG002|NOT COMPLETED|Overall Study||0
8776761|NCT01304082|9826850|FG003|NOT COMPLETED|Overall Study||0
8776762|NCT01304082|9826851|FG004|NOT COMPLETED|Overall Study||0
8776763|NCT01304147|9826859|FG000|STARTED|First Intervention (7days)||10
8776764|NCT01304147|9826860|FG001|STARTED|First Intervention (7days)||10
8776765|NCT01304147|9826859|FG000|COMPLETED|First Intervention (7days)||10
8776766|NCT01304147|9826860|FG001|COMPLETED|First Intervention (7days)||10
8776767|NCT01304147|9826859|FG000|NOT COMPLETED|First Intervention (7days)||0
8776768|NCT01304147|9826860|FG001|NOT COMPLETED|First Intervention (7days)||0
9029120|NCT03213509|10091473|FG000|STARTED|Overall Study||80
9029121|NCT03213509|10091474|FG001|STARTED|Overall Study||90
9029122|NCT03213509|10091473|FG000|COMPLETED|Overall Study||76
9029123|NCT03213509|10091474|FG001|COMPLETED|Overall Study||85
9029124|NCT03213509|10091473|FG000|NOT COMPLETED|Overall Study||4
9029125|NCT03213509|10091474|FG001|NOT COMPLETED|Overall Study||5
9029126|NCT03213626|10091481|FG000|STARTED|Overall Study||7
9029127|NCT03213626|10091481|FG000|COMPLETED|Overall Study||0
9029128|NCT03213626|10091481|FG000|NOT COMPLETED|Overall Study||7
9029129|NCT03213938|10091487|FG000|STARTED|Overall Study||220
9029130|NCT03213938|10091488|FG001|STARTED|Overall Study||220
9029131|NCT03213938|10091487|FG000|COMPLETED|Overall Study||206
9029132|NCT03213938|10091488|FG001|COMPLETED|Overall Study||208
9029133|NCT03213938|10091487|FG000|NOT COMPLETED|Overall Study||14
9029134|NCT03213938|10091488|FG001|NOT COMPLETED|Overall Study||12
9029135|NCT03214081|10091494|FG000|STARTED|Overall Study||1237
9029136|NCT03214081|10091494|FG000|COMPLETED|Overall Study||1174
9029137|NCT03214081|10091494|FG000|NOT COMPLETED|Overall Study||63
9029138|NCT03214094|10091498|FG000|STARTED|Overall Study||1119
9029139|NCT03214094|10091498|FG000|COMPLETED|Overall Study||1059
9029140|NCT03214094|10091498|FG000|NOT COMPLETED|Overall Study||60
9029141|NCT03214198|10091502|FG000|STARTED|Overall Study||1304
9029142|NCT03214198|10091502|FG000|COMPLETED|Overall Study||1268
9029143|NCT03214198|10091502|FG000|NOT COMPLETED|Overall Study||36
9029144|NCT03214224|10091506|FG000|STARTED|Overall Study|Subjects did both standard and remote assessments in the validation study. Total enrollment 49.|49
9029145|NCT03214224|10091506|FG000|COMPLETED|Overall Study|3 therapists enrolled. 3 ctrls enrolled (not incl. in analysis). 3 pts enr. but not completed.|40
9029146|NCT03214224|10091506|FG000|NOT COMPLETED|Overall Study||9
9029147|NCT03214367|10091516|FG000|STARTED|Lead-in Period||1316
9029148|NCT03214367|10091517|FG001|STARTED|Lead-in Period||0
9029149|NCT03214367|10091518|FG002|STARTED|Lead-in Period||0
9029150|NCT03214367|10091519|FG003|STARTED|Lead-in Period||0
8776769|NCT01304147|9826859|FG000|STARTED|Washout (1 Day)||10
8776770|NCT01304147|9826860|FG001|STARTED|Washout (1 Day)||10
8776771|NCT01304147|9826859|FG000|COMPLETED|Washout (1 Day)||10
8776772|NCT01304147|9826860|FG001|COMPLETED|Washout (1 Day)||10
8776773|NCT01304147|9826859|FG000|NOT COMPLETED|Washout (1 Day)||0
8776774|NCT01304147|9826860|FG001|NOT COMPLETED|Washout (1 Day)||0
8776775|NCT01304147|9826859|FG000|STARTED|Second Intervention (7days)||10
8776776|NCT01304147|9826860|FG001|STARTED|Second Intervention (7days)||10
8776777|NCT01304147|9826859|FG000|COMPLETED|Second Intervention (7days)||9
8776778|NCT01304147|9826860|FG001|COMPLETED|Second Intervention (7days)||9
8776779|NCT01304147|9826859|FG000|NOT COMPLETED|Second Intervention (7days)||1
8776780|NCT01304147|9826860|FG001|NOT COMPLETED|Second Intervention (7days)||1
8776781|NCT01304238|9826876|FG000|STARTED|Overall Study||32
8776782|NCT01304238|9826877|FG001|STARTED|Overall Study||4
8776783|NCT01304238|9826878|FG002|STARTED|Overall Study||46
8776784|NCT01304238|9826879|FG003|STARTED|Overall Study||78
8776785|NCT01304238|9826880|FG004|STARTED|Overall Study||11
8776786|NCT01304238|9826881|FG005|STARTED|Overall Study||11
8776787|NCT01304238|9826882|FG006|STARTED|Overall Study||5
9029151|NCT03214367|10091520|FG004|STARTED|Lead-in Period||76
9029152|NCT03214367|10091521|FG005|STARTED|Lead-in Period||0
9029153|NCT03214367|10091522|FG006|STARTED|Lead-in Period||0
9029154|NCT03214367|10091523|FG007|STARTED|Lead-in Period||0
9029155|NCT03214367|10091516|FG000|COMPLETED|Lead-in Period||1222
9029156|NCT03214367|10091517|FG001|COMPLETED|Lead-in Period||0
9029157|NCT03214367|10091518|FG002|COMPLETED|Lead-in Period||0
9029158|NCT03214367|10091519|FG003|COMPLETED|Lead-in Period||0
9029159|NCT03214367|10091520|FG004|COMPLETED|Lead-in Period||74
9029160|NCT03214367|10091521|FG005|COMPLETED|Lead-in Period||0
9029161|NCT03214367|10091522|FG006|COMPLETED|Lead-in Period||0
9029162|NCT03214367|10091523|FG007|COMPLETED|Lead-in Period||0
9029163|NCT03214367|10091516|FG000|NOT COMPLETED|Lead-in Period||94
9029164|NCT03214367|10091517|FG001|NOT COMPLETED|Lead-in Period||0
9029165|NCT03214367|10091518|FG002|NOT COMPLETED|Lead-in Period||0
9029166|NCT03214367|10091519|FG003|NOT COMPLETED|Lead-in Period||0
9029167|NCT03214367|10091520|FG004|NOT COMPLETED|Lead-in Period||2
9029168|NCT03214367|10091521|FG005|NOT COMPLETED|Lead-in Period||0
9029169|NCT03214367|10091522|FG006|NOT COMPLETED|Lead-in Period||0
9029170|NCT03214367|10091523|FG007|NOT COMPLETED|Lead-in Period||0
9029171|NCT03214367|10091516|FG000|STARTED|Treatment Period|Participants received Insulin Lispro during Lead-in Period.|0
9029172|NCT03214367|10091517|FG001|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|442
9029173|NCT03214367|10091518|FG002|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|451
9029174|NCT03214367|10091519|FG003|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|329
9029175|NCT03214367|10091520|FG004|STARTED|Treatment Period|Participants received Insulin Lispro during Lead-in Period.|0
9029176|NCT03214367|10091521|FG005|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|31
9029177|NCT03214367|10091522|FG006|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|21
9029178|NCT03214367|10091523|FG007|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|22
9029179|NCT03214367|10091516|FG000|COMPLETED|Treatment Period||0
9029180|NCT03214367|10091517|FG001|COMPLETED|Treatment Period||408
9029181|NCT03214367|10091518|FG002|COMPLETED|Treatment Period||418
9029182|NCT03214367|10091519|FG003|COMPLETED|Treatment Period||310
9029183|NCT03214367|10091520|FG004|COMPLETED|Treatment Period||0
9029184|NCT03214367|10091521|FG005|COMPLETED|Treatment Period||28
9029185|NCT03214367|10091522|FG006|COMPLETED|Treatment Period||19
9029186|NCT03214367|10091523|FG007|COMPLETED|Treatment Period||21
9029187|NCT03214367|10091516|FG000|NOT COMPLETED|Treatment Period||0
9029188|NCT03214367|10091517|FG001|NOT COMPLETED|Treatment Period||34
9029189|NCT03214367|10091518|FG002|NOT COMPLETED|Treatment Period||33
9029190|NCT03214367|10091519|FG003|NOT COMPLETED|Treatment Period||19
9029191|NCT03214367|10091520|FG004|NOT COMPLETED|Treatment Period||0
9029192|NCT03214367|10091521|FG005|NOT COMPLETED|Treatment Period||3
9029193|NCT03214367|10091522|FG006|NOT COMPLETED|Treatment Period||2
9029194|NCT03214367|10091523|FG007|NOT COMPLETED|Treatment Period||1
9029195|NCT03214380|10091541|FG000|STARTED|Lead-in||750
9029196|NCT03214380|10091542|FG001|STARTED|Lead-in||0
9029197|NCT03214380|10091543|FG002|STARTED|Lead-in||0
9029198|NCT03214380|10091544|FG003|STARTED|Lead-in||183
9029199|NCT03214380|10091545|FG004|STARTED|Lead-in||0
9029200|NCT03214380|10091546|FG005|STARTED|Lead-in||0
9029201|NCT03214380|10091541|FG000|Received at Least 1 Dose Lead-in Insulin|Lead-in||750
9029202|NCT03214380|10091542|FG001|Received at Least 1 Dose Lead-in Insulin|Lead-in||0
8671604|NCT00752726|9714991|FG000|Safety Population|Overall Study|2 participants were never dosed with the study medication.|63
8671605|NCT00752726|9714992|FG001|Safety Population|Overall Study|2 participants were never dosed with the study medication.|64
8671606|NCT00752726|9714991|FG000|Intention to Treat (ITT) Population|Overall Study|ITT population had atleast 1 post treatment efficacy measurement.|62
8671607|NCT00752726|9714992|FG001|Intention to Treat (ITT) Population|Overall Study|ITT population had atleast 1 post treatment efficacy measurement.|61
8671608|NCT00752726|9714991|FG000|COMPLETED|Overall Study||54
8671609|NCT00752726|9714992|FG001|COMPLETED|Overall Study||53
8671610|NCT00752726|9714991|FG000|NOT COMPLETED|Overall Study||11
8671611|NCT00752726|9714992|FG001|NOT COMPLETED|Overall Study||13
8671612|NCT00752791|9714998|FG000|STARTED|Overall Study||59
8671613|NCT00752791|9714998|FG000|COMPLETED|Overall Study||43
8671614|NCT00752791|9714998|FG000|NOT COMPLETED|Overall Study||16
8671615|NCT00752856|9715004|FG000|STARTED|Overall Study||26
8671616|NCT00752856|9715005|FG001|STARTED|Overall Study||25
8776788|NCT01304238|9826883|FG007|STARTED|Overall Study||4
8776789|NCT01304238|9826884|FG008|STARTED|Overall Study||1
8776790|NCT01304238|9826885|FG009|STARTED|Overall Study||3
8776791|NCT01304238|9826876|FG000|COMPLETED|Overall Study||32
8776792|NCT01304238|9826877|FG001|COMPLETED|Overall Study||4
8776793|NCT01304238|9826878|FG002|COMPLETED|Overall Study||46
8776794|NCT01304238|9826879|FG003|COMPLETED|Overall Study||78
8776795|NCT01304238|9826880|FG004|COMPLETED|Overall Study||11
8776796|NCT01304238|9826881|FG005|COMPLETED|Overall Study||11
8776797|NCT01304238|9826882|FG006|COMPLETED|Overall Study||5
8776798|NCT01304238|9826883|FG007|COMPLETED|Overall Study||4
8776799|NCT01304238|9826884|FG008|COMPLETED|Overall Study||1
8776800|NCT01304238|9826885|FG009|COMPLETED|Overall Study||3
8776801|NCT01304238|9826876|FG000|NOT COMPLETED|Overall Study||0
8776802|NCT01304238|9826877|FG001|NOT COMPLETED|Overall Study||0
8776803|NCT01304238|9826878|FG002|NOT COMPLETED|Overall Study||0
8776804|NCT01304238|9826879|FG003|NOT COMPLETED|Overall Study||0
8776805|NCT01304238|9826880|FG004|NOT COMPLETED|Overall Study||0
8776806|NCT01304238|9826881|FG005|NOT COMPLETED|Overall Study||0
8776807|NCT01304238|9826882|FG006|NOT COMPLETED|Overall Study||0
8776808|NCT01304238|9826883|FG007|NOT COMPLETED|Overall Study||0
8776809|NCT01304238|9826884|FG008|NOT COMPLETED|Overall Study||0
8776810|NCT01304238|9826885|FG009|NOT COMPLETED|Overall Study||0
8776811|NCT01304277|9826907|FG000|STARTED|Screening (Replagal RB, Week 0- Week 2)||17
8776812|NCT01304277|9826907|FG000|COMPLETED|Screening (Replagal RB, Week 0- Week 2)||17
8776813|NCT01304277|9826907|FG000|NOT COMPLETED|Screening (Replagal RB, Week 0- Week 2)||0
8776814|NCT01304277|9826907|FG000|STARTED|Treatment (Replagal AF, Week 2- EOS)||17
8776815|NCT01304277|9826907|FG000|COMPLETED|Treatment (Replagal AF, Week 2- EOS)||17
8776816|NCT01304277|9826907|FG000|NOT COMPLETED|Treatment (Replagal AF, Week 2- EOS)||0
8776817|NCT01304329|9826914|FG000|STARTED|First Intervention (3 Days)||3
8776818|NCT01304329|9826915|FG001|STARTED|First Intervention (3 Days)||3
8776819|NCT01304329|9826916|FG002|STARTED|First Intervention (3 Days)||3
8776820|NCT01304329|9826917|FG003|STARTED|First Intervention (3 Days)||3
8776821|NCT01304329|9826918|FG004|STARTED|First Intervention (3 Days)||3
8776822|NCT01304329|9826919|FG005|STARTED|First Intervention (3 Days)||3
8776823|NCT01304329|9826914|FG000|COMPLETED|First Intervention (3 Days)||3
8776824|NCT01304329|9826915|FG001|COMPLETED|First Intervention (3 Days)||3
8776825|NCT01304329|9826916|FG002|COMPLETED|First Intervention (3 Days)||3
8776826|NCT01304329|9826917|FG003|COMPLETED|First Intervention (3 Days)||3
8776827|NCT01304329|9826918|FG004|COMPLETED|First Intervention (3 Days)||3
8776828|NCT01304329|9826919|FG005|COMPLETED|First Intervention (3 Days)||3
8776829|NCT01304329|9826914|FG000|NOT COMPLETED|First Intervention (3 Days)||0
8776830|NCT01304329|9826915|FG001|NOT COMPLETED|First Intervention (3 Days)||0
8776831|NCT01304329|9826916|FG002|NOT COMPLETED|First Intervention (3 Days)||0
8776832|NCT01304329|9826917|FG003|NOT COMPLETED|First Intervention (3 Days)||0
8776833|NCT01304329|9826918|FG004|NOT COMPLETED|First Intervention (3 Days)||0
8776834|NCT01304329|9826919|FG005|NOT COMPLETED|First Intervention (3 Days)||0
8776835|NCT01304329|9826914|FG000|STARTED|Second Intervention (3 Days)||3
8776836|NCT01304329|9826915|FG001|STARTED|Second Intervention (3 Days)||3
8776837|NCT01304329|9826916|FG002|STARTED|Second Intervention (3 Days)||3
8776838|NCT01304329|9826917|FG003|STARTED|Second Intervention (3 Days)||3
8776839|NCT01304329|9826918|FG004|STARTED|Second Intervention (3 Days)||3
8776840|NCT01304329|9826919|FG005|STARTED|Second Intervention (3 Days)||3
8776841|NCT01304329|9826914|FG000|COMPLETED|Second Intervention (3 Days)||3
8776842|NCT01304329|9826915|FG001|COMPLETED|Second Intervention (3 Days)||3
8776843|NCT01304329|9826916|FG002|COMPLETED|Second Intervention (3 Days)||3
8776844|NCT01304329|9826917|FG003|COMPLETED|Second Intervention (3 Days)||3
8776845|NCT01304329|9826918|FG004|COMPLETED|Second Intervention (3 Days)||3
8776846|NCT01304329|9826919|FG005|COMPLETED|Second Intervention (3 Days)||3
9029203|NCT03214380|10091543|FG002|Received at Least 1 Dose Lead-in Insulin|Lead-in||0
9029204|NCT03214380|10091544|FG003|Received at Least 1 Dose Lead-in Insulin|Lead-in||183
9029205|NCT03214380|10091545|FG004|Received at Least 1 Dose Lead-in Insulin|Lead-in||0
9029206|NCT03214380|10091546|FG005|Received at Least 1 Dose Lead-in Insulin|Lead-in||0
9029207|NCT03214380|10091541|FG000|COMPLETED|Lead-in||673
9029208|NCT03214380|10091542|FG001|COMPLETED|Lead-in||0
9029209|NCT03214380|10091543|FG002|COMPLETED|Lead-in||0
9029210|NCT03214380|10091544|FG003|COMPLETED|Lead-in||164
9029211|NCT03214380|10091545|FG004|COMPLETED|Lead-in||0
9029212|NCT03214380|10091546|FG005|COMPLETED|Lead-in||0
9029213|NCT03214380|10091541|FG000|NOT COMPLETED|Lead-in||77
9029214|NCT03214380|10091542|FG001|NOT COMPLETED|Lead-in||0
8776847|NCT01304329|9826914|FG000|NOT COMPLETED|Second Intervention (3 Days)||0
8776848|NCT01304329|9826915|FG001|NOT COMPLETED|Second Intervention (3 Days)||0
8776849|NCT01304329|9826916|FG002|NOT COMPLETED|Second Intervention (3 Days)||0
8776850|NCT01304329|9826917|FG003|NOT COMPLETED|Second Intervention (3 Days)||0
8776851|NCT01304329|9826918|FG004|NOT COMPLETED|Second Intervention (3 Days)||0
8776852|NCT01304329|9826919|FG005|NOT COMPLETED|Second Intervention (3 Days)||0
8776853|NCT01304329|9826914|FG000|STARTED|Third Intervention (3 Days)||3
8776854|NCT01304329|9826915|FG001|STARTED|Third Intervention (3 Days)||3
8776855|NCT01304329|9826916|FG002|STARTED|Third Intervention (3 Days)||3
8776856|NCT01304329|9826917|FG003|STARTED|Third Intervention (3 Days)||3
9029215|NCT03214380|10091543|FG002|NOT COMPLETED|Lead-in||0
9029216|NCT03214380|10091544|FG003|NOT COMPLETED|Lead-in||19
9029217|NCT03214380|10091545|FG004|NOT COMPLETED|Lead-in||0
9029218|NCT03214380|10091546|FG005|NOT COMPLETED|Lead-in||0
8776857|NCT01304329|9826918|FG004|STARTED|Third Intervention (3 Days)||3
8776858|NCT01304329|9826919|FG005|STARTED|Third Intervention (3 Days)||3
8776859|NCT01304329|9826914|FG000|COMPLETED|Third Intervention (3 Days)||3
8776860|NCT01304329|9826915|FG001|COMPLETED|Third Intervention (3 Days)||2
8776861|NCT01304329|9826916|FG002|COMPLETED|Third Intervention (3 Days)||3
8776862|NCT01304329|9826917|FG003|COMPLETED|Third Intervention (3 Days)||3
8776863|NCT01304329|9826918|FG004|COMPLETED|Third Intervention (3 Days)||3
8776864|NCT01304329|9826919|FG005|COMPLETED|Third Intervention (3 Days)||3
8776865|NCT01304329|9826914|FG000|NOT COMPLETED|Third Intervention (3 Days)||0
8776866|NCT01304329|9826915|FG001|NOT COMPLETED|Third Intervention (3 Days)||1
8776867|NCT01304329|9826916|FG002|NOT COMPLETED|Third Intervention (3 Days)||0
8776868|NCT01304329|9826917|FG003|NOT COMPLETED|Third Intervention (3 Days)||0
8776869|NCT01304329|9826918|FG004|NOT COMPLETED|Third Intervention (3 Days)||0
8776870|NCT01304329|9826919|FG005|NOT COMPLETED|Third Intervention (3 Days)||0
8776871|NCT01304407|9826927|FG000|STARTED|Overall Study||29
8776872|NCT01304407|9826927|FG000|COMPLETED|Overall Study||29
8776873|NCT01304407|9826927|FG000|NOT COMPLETED|Overall Study||0
8776874|NCT01304498|9826933|FG000|STARTED|Overall Study||300
8776875|NCT01304498|9826934|FG001|STARTED|Overall Study||300
8776876|NCT01304498|9826933|FG000|Received ≥1 Dose|Overall Study||300
8776877|NCT01304498|9826934|FG001|Received ≥1 Dose|Overall Study||300
8776878|NCT01304498|9826933|FG000|COMPLETED|Overall Study||294
8776879|NCT01304498|9826934|FG001|COMPLETED|Overall Study||295
8776880|NCT01304498|9826933|FG000|NOT COMPLETED|Overall Study||6
8776881|NCT01304498|9826934|FG001|NOT COMPLETED|Overall Study||5
8776882|NCT01304589|9826940|FG000|STARTED|Overall Study||31
8776883|NCT01304589|9826940|FG000|COMPLETED|Overall Study||18
9029219|NCT03214380|10091541|FG000|STARTED|Treatment Period|Participants received Insulin Lispro during Lead-in Period.|0
9029220|NCT03214380|10091542|FG001|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro for Intensive Treatment Period.|337
9029221|NCT03214380|10091543|FG002|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro for Intensive Treatment Period.|336
9029222|NCT03214380|10091544|FG003|STARTED|Treatment Period|Participants received Insulin Lispro during Lead-in Period.|0
9029223|NCT03214380|10091545|FG004|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro for Intensive Treatment Period.|82
9029224|NCT03214380|10091546|FG005|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro for Intensive Treatment Period.|82
9029225|NCT03214380|10091541|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||0
9029226|NCT03214380|10091542|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||337
9029227|NCT03214380|10091543|FG002|Received at Least 1 Dose of Study Drug|Treatment Period||336
9029228|NCT03214380|10091544|FG003|Received at Least 1 Dose of Study Drug|Treatment Period||0
9029229|NCT03214380|10091545|FG004|Received at Least 1 Dose of Study Drug|Treatment Period||82
9029230|NCT03214380|10091546|FG005|Received at Least 1 Dose of Study Drug|Treatment Period||82
9029231|NCT03214380|10091541|FG000|COMPLETED|Treatment Period||0
9029232|NCT03214380|10091542|FG001|COMPLETED|Treatment Period||319
9029233|NCT03214380|10091543|FG002|COMPLETED|Treatment Period||320
9029234|NCT03214380|10091544|FG003|COMPLETED|Treatment Period||0
9029235|NCT03214380|10091545|FG004|COMPLETED|Treatment Period||73
9029236|NCT03214380|10091546|FG005|COMPLETED|Treatment Period||71
9029237|NCT03214380|10091541|FG000|NOT COMPLETED|Treatment Period||0
9029238|NCT03214380|10091542|FG001|NOT COMPLETED|Treatment Period||18
9029239|NCT03214380|10091543|FG002|NOT COMPLETED|Treatment Period||16
9029240|NCT03214380|10091544|FG003|NOT COMPLETED|Treatment Period||0
9029241|NCT03214380|10091545|FG004|NOT COMPLETED|Treatment Period||9
9029242|NCT03214380|10091546|FG005|NOT COMPLETED|Treatment Period||11
9029243|NCT03214406|10091560|FG000|STARTED|Overall Study||88
9029244|NCT03214406|10091561|FG001|STARTED|Overall Study||93
9029245|NCT03214406|10091560|FG000|COMPLETED|Overall Study||78
9029246|NCT03214406|10091561|FG001|COMPLETED|Overall Study||78
9029247|NCT03214406|10091560|FG000|NOT COMPLETED|Overall Study||10
9029248|NCT03214406|10091561|FG001|NOT COMPLETED|Overall Study||15
9029249|NCT03214588|10091570|FG000|STARTED|Overall Study||27
9029250|NCT03214588|10091571|FG001|STARTED|Overall Study||14
9029251|NCT03214588|10091572|FG002|STARTED|Overall Study||26
9029252|NCT03214588|10091570|FG000|COMPLETED|Overall Study||26
9029253|NCT03214588|10091571|FG001|COMPLETED|Overall Study||13
9029254|NCT03214588|10091572|FG002|COMPLETED|Overall Study||24
9029255|NCT03214588|10091570|FG000|NOT COMPLETED|Overall Study||1
9029256|NCT03214588|10091571|FG001|NOT COMPLETED|Overall Study||1
9029257|NCT03214588|10091572|FG002|NOT COMPLETED|Overall Study||2
9029258|NCT03214640|10091584|FG000|STARTED|Overall Study||31
9029259|NCT03214640|10091585|FG001|STARTED|Overall Study||32
9029260|NCT03214640|10091586|FG002|STARTED|Overall Study||31
9029261|NCT03214640|10091587|FG003|STARTED|Overall Study||34
9029262|NCT03214640|10091584|FG000|COMPLETED|Overall Study||30
9029263|NCT03214640|10091585|FG001|COMPLETED|Overall Study||30
9029264|NCT03214640|10091586|FG002|COMPLETED|Overall Study||30
9029265|NCT03214640|10091587|FG003|COMPLETED|Overall Study||30
9029266|NCT03214640|10091584|FG000|NOT COMPLETED|Overall Study||1
9029267|NCT03214640|10091585|FG001|NOT COMPLETED|Overall Study||2
9029268|NCT03214640|10091586|FG002|NOT COMPLETED|Overall Study||1
9029269|NCT03214640|10091587|FG003|NOT COMPLETED|Overall Study||4
9029270|NCT03214952|10091597|FG000|STARTED|Overall Study||3183
9029271|NCT03214952|10091597|FG000|COMPLETED|Overall Study||3125
9029272|NCT03214952|10091597|FG000|NOT COMPLETED|Overall Study||58
8776884|NCT01304589|9826940|FG000|NOT COMPLETED|Overall Study||13
8776885|NCT01304641|9826947|FG000|STARTED|Overall Study||11470
8776886|NCT01304641|9826948|FG001|STARTED|Overall Study||20132
8776887|NCT01304641|9826947|FG000|COMPLETED|Overall Study||11470
8776888|NCT01304641|9826948|FG001|COMPLETED|Overall Study||20132
8776889|NCT01304641|9826947|FG000|NOT COMPLETED|Overall Study||0
8776890|NCT01304641|9826948|FG001|NOT COMPLETED|Overall Study||0
8776891|NCT01304693|9826959|FG000|STARTED|Overall Study||10
8776892|NCT01304693|9826960|FG001|STARTED|Overall Study||35
8776893|NCT01304693|9826961|FG002|STARTED|Overall Study||48
8776894|NCT01304693|9826962|FG003|STARTED|Overall Study||40
8776895|NCT01304693|9826963|FG004|STARTED|Overall Study||61
8776896|NCT01304693|9826959|FG000|COMPLETED|Overall Study||10
8776897|NCT01304693|9826960|FG001|COMPLETED|Overall Study||35
8776898|NCT01304693|9826961|FG002|COMPLETED|Overall Study||47
8776899|NCT01304693|9826962|FG003|COMPLETED|Overall Study||39
8776900|NCT01304693|9826963|FG004|COMPLETED|Overall Study||60
8776901|NCT01304693|9826959|FG000|NOT COMPLETED|Overall Study||0
8776902|NCT01304693|9826960|FG001|NOT COMPLETED|Overall Study||0
8776903|NCT01304693|9826961|FG002|NOT COMPLETED|Overall Study||1
8776904|NCT01304693|9826962|FG003|NOT COMPLETED|Overall Study||1
8776905|NCT01304693|9826963|FG004|NOT COMPLETED|Overall Study||1
8776906|NCT01304706|9826975|FG000|STARTED|Overall Study||121
8776907|NCT01304706|9826975|FG000|COMPLETED|Overall Study||104
8776908|NCT01304706|9826975|FG000|NOT COMPLETED|Overall Study||17
8776909|NCT01304940|9826981|FG000|STARTED|Overall Study||25
8776910|NCT01304940|9826982|FG001|STARTED|Overall Study||25
8776911|NCT01304940|9826981|FG000|Completed Study|Overall Study|recruitment ended when 25 participants completed study procedures|25
8776912|NCT01304940|9826982|FG001|Completed Study|Overall Study|recruitment ended when 25 participants completed study procedures|25
8776913|NCT01304940|9826981|FG000|COMPLETED|Overall Study|these participants met severity requirement and were included in study analyses|22
8776914|NCT01304940|9826982|FG001|COMPLETED|Overall Study||25
8776915|NCT01304940|9826981|FG000|NOT COMPLETED|Overall Study||3
8776916|NCT01304940|9826982|FG001|NOT COMPLETED|Overall Study||0
8776917|NCT01304966|9826988|FG000|STARTED|Overall Study||15
8776918|NCT01304966|9826988|FG000|COMPLETED|Overall Study||15
8776919|NCT01304966|9826988|FG000|NOT COMPLETED|Overall Study||0
8776920|NCT01305044|9826996|FG000|STARTED|Overall Study||32
8776921|NCT01305044|9826997|FG001|STARTED|Overall Study||31
8776922|NCT01305044|9826996|FG000|COMPLETED|Overall Study||29
8776923|NCT01305044|9826997|FG001|COMPLETED|Overall Study||25
8776924|NCT01305044|9826996|FG000|NOT COMPLETED|Overall Study||3
8776925|NCT01305044|9826997|FG001|NOT COMPLETED|Overall Study||6
8776926|NCT01305200|9827006|FG000|STARTED|Overall Study||111
8776927|NCT01305200|9827007|FG001|STARTED|Overall Study||112
8776928|NCT01305200|9827008|FG002|STARTED|Overall Study||3
8776929|NCT01305200|9827006|FG000|COMPLETED|Overall Study||82
8776930|NCT01305200|9827007|FG001|COMPLETED|Overall Study||81
8776931|NCT01305200|9827008|FG002|COMPLETED|Overall Study||0
8776932|NCT01305200|9827006|FG000|NOT COMPLETED|Overall Study||29
8776933|NCT01305200|9827007|FG001|NOT COMPLETED|Overall Study||31
8776934|NCT01305200|9827008|FG002|NOT COMPLETED|Overall Study||3
8776935|NCT01305213|9827016|FG000|STARTED|Overall Study||53
8776936|NCT01305213|9827017|FG001|STARTED|Overall Study||54
8776937|NCT01305213|9827016|FG000|COMPLETED|Overall Study||53
8776938|NCT01305213|9827017|FG001|COMPLETED|Overall Study||54
8776939|NCT01305213|9827016|FG000|NOT COMPLETED|Overall Study||0
8776940|NCT01305213|9827017|FG001|NOT COMPLETED|Overall Study||0
8776941|NCT01305239|9827026|FG000|STARTED|Overall Study||398
8776942|NCT01305239|9827026|FG000|Safety Set|Overall Study||397
8776943|NCT01305239|9827026|FG000|Intent to Treat Population|Overall Study||287
8776944|NCT01305239|9827026|FG000|COMPLETED|Overall Study||375
8776945|NCT01305239|9827026|FG000|NOT COMPLETED|Overall Study||23
8776946|NCT01305252|9827032|FG000|STARTED|Overall Study||10
8776947|NCT01305252|9827033|FG001|STARTED|Overall Study||11
8776948|NCT01305252|9827032|FG000|COMPLETED|Overall Study||9
8776949|NCT01305252|9827033|FG001|COMPLETED|Overall Study||11
8776950|NCT01305252|9827032|FG000|NOT COMPLETED|Overall Study||1
8776951|NCT01305252|9827033|FG001|NOT COMPLETED|Overall Study||0
8776952|NCT01305265|9827045|FG000|STARTED|Overall Study||71
8776953|NCT01305265|9827046|FG001|STARTED|Overall Study||70
8776954|NCT01305265|9827045|FG000|COMPLETED|Overall Study||69
8776955|NCT01305265|9827046|FG001|COMPLETED|Overall Study||64
8776956|NCT01305265|9827045|FG000|NOT COMPLETED|Overall Study||2
8776957|NCT01305265|9827046|FG001|NOT COMPLETED|Overall Study||6
8776958|NCT01305356|9827054|FG000|STARTED|Overall Study||132
8776959|NCT01305356|9827055|FG001|STARTED|Overall Study||167
8776960|NCT01305356|9827054|FG000|COMPLETED|Overall Study||132
8916337|NCT02182440|9975941|FG002|COMPLETED|Overall Study||24
8776961|NCT01305356|9827055|FG001|COMPLETED|Overall Study||167
8776962|NCT01305356|9827054|FG000|NOT COMPLETED|Overall Study||0
8776963|NCT01305356|9827055|FG001|NOT COMPLETED|Overall Study||0
8776964|NCT01305408|9827063|FG000|STARTED|Overall Study||199
8776965|NCT01305408|9827064|FG001|STARTED|Overall Study||200
8776966|NCT01305408|9827063|FG000|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|198
8776967|NCT01305408|9827064|FG001|Safety Population|Overall Study|Treated participants.|200
8776968|NCT01305408|9827063|FG000|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|196
8776969|NCT01305408|9827064|FG001|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|197
8776970|NCT01305408|9827063|FG000|COMPLETED|Overall Study||167
8916338|NCT02182440|9975942|FG003|COMPLETED|Overall Study||81
8776971|NCT01305408|9827064|FG001|COMPLETED|Overall Study||169
8776972|NCT01305408|9827063|FG000|NOT COMPLETED|Overall Study||32
8776973|NCT01305408|9827064|FG001|NOT COMPLETED|Overall Study||31
8776974|NCT01305473|9827070|FG000|STARTED|Overall Study||90
8776975|NCT01305473|9827070|FG000|COMPLETED|Overall Study||90
8776976|NCT01305473|9827070|FG000|NOT COMPLETED|Overall Study||0
8776977|NCT01305564|9827074|FG000|STARTED|Overall Study||200
8776978|NCT01305564|9827074|FG000|COMPLETED|Overall Study||163
8776979|NCT01305564|9827074|FG000|NOT COMPLETED|Overall Study||37
8776980|NCT01305577|9827092|FG000|STARTED|Overall Study||120
8776981|NCT01305577|9827093|FG001|STARTED|Overall Study||121
8776982|NCT01305577|9827094|FG002|STARTED|Overall Study||122
8776983|NCT01305577|9827092|FG000|Received Treatment|Overall Study||119
8776984|NCT01305577|9827093|FG001|Received Treatment|Overall Study||121
8776985|NCT01305577|9827094|FG002|Received Treatment|Overall Study||122
8776986|NCT01305577|9827092|FG000|COMPLETED|Overall Study||107
8776987|NCT01305577|9827093|FG001|COMPLETED|Overall Study||110
8776988|NCT01305577|9827094|FG002|COMPLETED|Overall Study||112
8776989|NCT01305577|9827092|FG000|NOT COMPLETED|Overall Study||13
8776990|NCT01305577|9827093|FG001|NOT COMPLETED|Overall Study||11
8776991|NCT01305577|9827094|FG002|NOT COMPLETED|Overall Study||10
8776992|NCT01305655|9827102|FG000|STARTED|Overall Study|July 2008|47
8776993|NCT01305655|9827102|FG000|COMPLETED|Overall Study|December 31, 2014|47
8776994|NCT01305655|9827102|FG000|NOT COMPLETED|Overall Study||0
8776995|NCT01305772|9827108|FG000|STARTED|Overall Study||5
8776996|NCT01305772|9827109|FG001|STARTED|Overall Study||1
8776997|NCT01305772|9827108|FG000|Genomic Screening + Biopsy #1|Overall Study||5
8776998|NCT01305772|9827109|FG001|Genomic Screening + Biopsy #1|Overall Study||1
8776999|NCT01305772|9827108|FG000|Research PET/CT #1|Overall Study||5
8777000|NCT01305772|9827109|FG001|Research PET/CT #1|Overall Study||1
8777001|NCT01305772|9827108|FG000|Panitumumab Dose #1|Overall Study||5
8777002|NCT01305772|9827109|FG001|Panitumumab Dose #1|Overall Study||1
8777003|NCT01305772|9827108|FG000|Research PET/CT #2|Overall Study||5
8777004|NCT01305772|9827109|FG001|Research PET/CT #2|Overall Study||1
8777005|NCT01305772|9827108|FG000|Surgery/Biopsy #2|Overall Study|2nd research tissue sample not collected for 4 patients due to safety risk to subject.|1
8777006|NCT01305772|9827109|FG001|Surgery/Biopsy #2|Overall Study||1
8777007|NCT01305772|9827108|FG000|RT + Panitumumab Dose #2 / #3|Overall Study|RT and doses #2 and #3 of panitumumab administered to patients regardless of 2nd biopsy status.|5
8777008|NCT01305772|9827109|FG001|RT + Panitumumab Dose #2 / #3|Overall Study||1
8777009|NCT01305772|9827108|FG000|COMPLETED|Overall Study||5
8777010|NCT01305772|9827109|FG001|COMPLETED|Overall Study||1
8777011|NCT01305772|9827108|FG000|NOT COMPLETED|Overall Study||0
8777012|NCT01305772|9827109|FG001|NOT COMPLETED|Overall Study||0
8777013|NCT01305811|9827116|FG000|STARTED|Overall Study||52
8777014|NCT01305811|9827117|FG001|STARTED|Overall Study||52
8777015|NCT01305811|9827116|FG000|COMPLETED|Overall Study||44
8777016|NCT01305811|9827117|FG001|COMPLETED|Overall Study||41
8777017|NCT01305811|9827116|FG000|NOT COMPLETED|Overall Study||8
8777018|NCT01305811|9827117|FG001|NOT COMPLETED|Overall Study||11
8777019|NCT01305941|9827125|FG000|STARTED|Overall Study||32
8777020|NCT01305941|9827125|FG000|COMPLETED|Overall Study||22
8777021|NCT01305941|9827125|FG000|NOT COMPLETED|Overall Study||10
8777022|NCT01306032|9827135|FG000|STARTED|First Intervention||22
8777023|NCT01306032|9827136|FG001|STARTED|First Intervention|Not all participants on the Cyclophosphamide Alone Arm met eligibility criteria to crossover.|20
8777024|NCT01306032|9827137|FG002|STARTED|First Intervention||37
8777025|NCT01306032|9827138|FG003|STARTED|First Intervention|Not all participants on the Cyclophosphamide Alone Arm met eligibility criteria to crossover.|38
8777026|NCT01306032|9827139|FG004|STARTED|First Intervention||2
8777027|NCT01306032|9827140|FG005|STARTED|First Intervention||2
8777028|NCT01306032|9827135|FG000|COMPLETED|First Intervention||21
8777029|NCT01306032|9827136|FG001|COMPLETED|First Intervention||18
8777030|NCT01306032|9827137|FG002|COMPLETED|First Intervention||35
8777031|NCT01306032|9827138|FG003|COMPLETED|First Intervention||37
8777032|NCT01306032|9827139|FG004|COMPLETED|First Intervention||0
8777033|NCT01306032|9827140|FG005|COMPLETED|First Intervention||0
8777034|NCT01306032|9827135|FG000|NOT COMPLETED|First Intervention||1
8777035|NCT01306032|9827136|FG001|NOT COMPLETED|First Intervention||2
8777036|NCT01306032|9827137|FG002|NOT COMPLETED|First Intervention||2
8777037|NCT01306032|9827138|FG003|NOT COMPLETED|First Intervention||1
8777038|NCT01306032|9827139|FG004|NOT COMPLETED|First Intervention||2
8777039|NCT01306032|9827140|FG005|NOT COMPLETED|First Intervention||2
8777040|NCT01306032|9827135|FG000|STARTED|Disease Progression/Crossover||0
8777041|NCT01306032|9827136|FG001|STARTED|Disease Progression/Crossover||16
8777042|NCT01306032|9827137|FG002|STARTED|Disease Progression/Crossover||0
8777043|NCT01306032|9827138|FG003|STARTED|Disease Progression/Crossover||29
8777044|NCT01306032|9827139|FG004|STARTED|Disease Progression/Crossover||0
8777045|NCT01306032|9827140|FG005|STARTED|Disease Progression/Crossover||0
8777046|NCT01306032|9827135|FG000|COMPLETED|Disease Progression/Crossover||0
8777047|NCT01306032|9827136|FG001|COMPLETED|Disease Progression/Crossover||14
8777048|NCT01306032|9827137|FG002|COMPLETED|Disease Progression/Crossover||0
8777049|NCT01306032|9827138|FG003|COMPLETED|Disease Progression/Crossover||26
8777050|NCT01306032|9827139|FG004|COMPLETED|Disease Progression/Crossover||0
8777051|NCT01306032|9827140|FG005|COMPLETED|Disease Progression/Crossover||0
8777052|NCT01306032|9827135|FG000|NOT COMPLETED|Disease Progression/Crossover||0
8777053|NCT01306032|9827136|FG001|NOT COMPLETED|Disease Progression/Crossover||2
8777054|NCT01306032|9827137|FG002|NOT COMPLETED|Disease Progression/Crossover||0
8777055|NCT01306032|9827138|FG003|NOT COMPLETED|Disease Progression/Crossover||3
8777056|NCT01306032|9827139|FG004|NOT COMPLETED|Disease Progression/Crossover||0
8777057|NCT01306032|9827140|FG005|NOT COMPLETED|Disease Progression/Crossover||0
8777058|NCT01306058|9827166|FG000|STARTED|Overall Study||27
8777059|NCT01306058|9827166|FG000|COMPLETED|Overall Study||25
8777060|NCT01306058|9827166|FG000|NOT COMPLETED|Overall Study||2
8777061|NCT01306162|9827174|FG000|STARTED|Period 1||9
8777062|NCT01306162|9827175|FG001|STARTED|Period 1||9
8777063|NCT01306162|9827176|FG002|STARTED|Period 1||9
8777064|NCT01306162|9827177|FG003|STARTED|Period 1||9
8777065|NCT01306162|9827174|FG000|COMPLETED|Period 1||9
8777066|NCT01306162|9827175|FG001|COMPLETED|Period 1||9
8777067|NCT01306162|9827176|FG002|COMPLETED|Period 1||9
8777068|NCT01306162|9827177|FG003|COMPLETED|Period 1||8
8777069|NCT01306162|9827174|FG000|NOT COMPLETED|Period 1||0
8777070|NCT01306162|9827175|FG001|NOT COMPLETED|Period 1||0
8777071|NCT01306162|9827176|FG002|NOT COMPLETED|Period 1||0
8777072|NCT01306162|9827177|FG003|NOT COMPLETED|Period 1||1
8777073|NCT01306162|9827174|FG000|STARTED|Washout 1|Treatment A was followed by a washout period of at least 96 hours.|9
8777074|NCT01306162|9827175|FG001|STARTED|Washout 1|Treatment A was followed by a washout period of at least 96 hours.|9
8777075|NCT01306162|9827176|FG002|STARTED|Washout 1|No washout period. Treatment D followed directly after treatment B.|9
8777076|NCT01306162|9827177|FG003|STARTED|Washout 1|No washout period.Treatment E followed directly after treatment C.|8
8777077|NCT01306162|9827174|FG000|COMPLETED|Washout 1||9
8777078|NCT01306162|9827175|FG001|COMPLETED|Washout 1||8
8777079|NCT01306162|9827176|FG002|COMPLETED|Washout 1||9
8777080|NCT01306162|9827177|FG003|COMPLETED|Washout 1||8
8777081|NCT01306162|9827174|FG000|NOT COMPLETED|Washout 1||0
8777082|NCT01306162|9827175|FG001|NOT COMPLETED|Washout 1||1
8777083|NCT01306162|9827176|FG002|NOT COMPLETED|Washout 1||0
8777084|NCT01306162|9827177|FG003|NOT COMPLETED|Washout 1||0
8777085|NCT01306162|9827174|FG000|STARTED|Period 2|No washout phase after Period 2.|9
8777086|NCT01306162|9827175|FG001|STARTED|Period 2|No washout phase after Period 2.|8
8777087|NCT01306162|9827176|FG002|STARTED|Period 2|No washout phase after Period 2.|9
8777088|NCT01306162|9827177|FG003|STARTED|Period 2|No washout phase after Period 2.|8
8777089|NCT01306162|9827174|FG000|COMPLETED|Period 2||9
8777090|NCT01306162|9827175|FG001|COMPLETED|Period 2||8
8777091|NCT01306162|9827176|FG002|COMPLETED|Period 2||9
8777092|NCT01306162|9827177|FG003|COMPLETED|Period 2||8
8777093|NCT01306162|9827174|FG000|NOT COMPLETED|Period 2||0
8777094|NCT01306162|9827175|FG001|NOT COMPLETED|Period 2||0
8777095|NCT01306162|9827176|FG002|NOT COMPLETED|Period 2||0
8777096|NCT01306162|9827177|FG003|NOT COMPLETED|Period 2||0
8777097|NCT01306162|9827174|FG000|STARTED|Period 3||9
8777098|NCT01306162|9827175|FG001|STARTED|Period 3||8
8777099|NCT01306162|9827176|FG002|STARTED|Period 3||9
8777100|NCT01306162|9827177|FG003|STARTED|Period 3||8
8777101|NCT01306162|9827174|FG000|COMPLETED|Period 3||9
8777102|NCT01306162|9827175|FG001|COMPLETED|Period 3||8
8777103|NCT01306162|9827176|FG002|COMPLETED|Period 3||9
8777104|NCT01306162|9827177|FG003|COMPLETED|Period 3||8
8777105|NCT01306162|9827174|FG000|NOT COMPLETED|Period 3||0
8777106|NCT01306162|9827175|FG001|NOT COMPLETED|Period 3||0
8777107|NCT01306162|9827176|FG002|NOT COMPLETED|Period 3||0
8777108|NCT01306162|9827177|FG003|NOT COMPLETED|Period 3||0
8777109|NCT01306162|9827174|FG000|STARTED|Washout 2|No washout period. Treatment E followed directly after treatment D.|9
8777110|NCT01306162|9827175|FG001|STARTED|Washout 2|No washout period. Treatment D followed directly after treatment E.|8
8777111|NCT01306162|9827176|FG002|STARTED|Washout 2|The last dose of Dronedarone was followed by a washout period of at least 10 days.|9
8777112|NCT01306162|9827177|FG003|STARTED|Washout 2|The last dose of Dronedarone was followed by a washout period of at least 10 days.|8
8777113|NCT01306162|9827174|FG000|COMPLETED|Washout 2||9
8777114|NCT01306162|9827175|FG001|COMPLETED|Washout 2||8
8777115|NCT01306162|9827176|FG002|COMPLETED|Washout 2||9
8777116|NCT01306162|9827177|FG003|COMPLETED|Washout 2||8
8777117|NCT01306162|9827174|FG000|NOT COMPLETED|Washout 2||0
8777118|NCT01306162|9827175|FG001|NOT COMPLETED|Washout 2||0
8777119|NCT01306162|9827176|FG002|NOT COMPLETED|Washout 2||0
8777120|NCT01306162|9827177|FG003|NOT COMPLETED|Washout 2||0
8777121|NCT01306162|9827174|FG000|STARTED|Period 4||9
8777122|NCT01306162|9827175|FG001|STARTED|Period 4||8
8777123|NCT01306162|9827176|FG002|STARTED|Period 4||9
8777124|NCT01306162|9827177|FG003|STARTED|Period 4||8
8777125|NCT01306162|9827174|FG000|COMPLETED|Period 4||9
8777126|NCT01306162|9827175|FG001|COMPLETED|Period 4||8
8777127|NCT01306162|9827176|FG002|COMPLETED|Period 4||9
8777128|NCT01306162|9827177|FG003|COMPLETED|Period 4||8
8777129|NCT01306162|9827174|FG000|NOT COMPLETED|Period 4||0
8777130|NCT01306162|9827175|FG001|NOT COMPLETED|Period 4||0
8777131|NCT01306162|9827176|FG002|NOT COMPLETED|Period 4||0
8777132|NCT01306162|9827177|FG003|NOT COMPLETED|Period 4||0
8777133|NCT01306175|9827190|FG000|STARTED|First Intervention||20
8777134|NCT01306175|9827190|FG000|COMPLETED|First Intervention||20
8777135|NCT01306175|9827190|FG000|NOT COMPLETED|First Intervention||0
8777136|NCT01306175|9827190|FG000|STARTED|Washout Period of at Least 14 Days||20
8777137|NCT01306175|9827190|FG000|COMPLETED|Washout Period of at Least 14 Days||20
8777138|NCT01306175|9827190|FG000|NOT COMPLETED|Washout Period of at Least 14 Days||0
8777139|NCT01306175|9827190|FG000|STARTED|Second Intervention||20
8777140|NCT01306175|9827190|FG000|COMPLETED|Second Intervention||20
8777141|NCT01306175|9827190|FG000|NOT COMPLETED|Second Intervention||0
8777142|NCT01306201|9827196|FG000|STARTED|Overall Study||63
8777143|NCT01306201|9827196|FG000|COMPLETED|Overall Study|Total of 10 subjects were excluded from analysis|53
8777144|NCT01306201|9827196|FG000|NOT COMPLETED|Overall Study||10
8777145|NCT01306214|9827207|FG000|STARTED|Overall Study||189
8777146|NCT01306214|9827208|FG001|STARTED|Overall Study||187
8777147|NCT01306214|9827209|FG002|STARTED|Overall Study||190
8777148|NCT01306214|9827207|FG000|COMPLETED|Overall Study||161
8777149|NCT01306214|9827208|FG001|COMPLETED|Overall Study||159
8777150|NCT01306214|9827209|FG002|COMPLETED|Overall Study||168
8777151|NCT01306214|9827207|FG000|NOT COMPLETED|Overall Study||28
8777152|NCT01306214|9827208|FG001|NOT COMPLETED|Overall Study||28
8777153|NCT01306214|9827209|FG002|NOT COMPLETED|Overall Study||22
8777154|NCT01306253|9827219|FG000|STARTED|Overall Study||57
8777155|NCT01306253|9827220|FG001|STARTED|Overall Study||57
8777156|NCT01306253|9827219|FG000|COMPLETED|Overall Study||56
8777157|NCT01306253|9827220|FG001|COMPLETED|Overall Study||56
8777158|NCT01306253|9827219|FG000|NOT COMPLETED|Overall Study||1
8777159|NCT01306253|9827220|FG001|NOT COMPLETED|Overall Study||1
8777160|NCT01306292|9827228|FG000|STARTED|First Injection||10
8777161|NCT01306292|9827229|FG001|STARTED|First Injection||8
8777162|NCT01306292|9827230|FG002|STARTED|First Injection||8
8777163|NCT01306292|9827231|FG003|STARTED|First Injection||10
8777164|NCT01306292|9827228|FG000|COMPLETED|First Injection||10
8777165|NCT01306292|9827229|FG001|COMPLETED|First Injection||8
8777166|NCT01306292|9827230|FG002|COMPLETED|First Injection||8
8777167|NCT01306292|9827231|FG003|COMPLETED|First Injection||10
8777168|NCT01306292|9827228|FG000|NOT COMPLETED|First Injection||0
8777169|NCT01306292|9827229|FG001|NOT COMPLETED|First Injection||0
8777170|NCT01306292|9827230|FG002|NOT COMPLETED|First Injection||0
8777171|NCT01306292|9827231|FG003|NOT COMPLETED|First Injection||0
8777172|NCT01306292|9827228|FG000|STARTED|Washout (at Least 10 Minutes)||10
8777173|NCT01306292|9827229|FG001|STARTED|Washout (at Least 10 Minutes)||8
8777174|NCT01306292|9827230|FG002|STARTED|Washout (at Least 10 Minutes)||8
8777175|NCT01306292|9827231|FG003|STARTED|Washout (at Least 10 Minutes)||10
8777176|NCT01306292|9827228|FG000|COMPLETED|Washout (at Least 10 Minutes)||10
8777177|NCT01306292|9827229|FG001|COMPLETED|Washout (at Least 10 Minutes)||8
8777178|NCT01306292|9827230|FG002|COMPLETED|Washout (at Least 10 Minutes)||8
8777179|NCT01306292|9827231|FG003|COMPLETED|Washout (at Least 10 Minutes)||10
8777180|NCT01306292|9827228|FG000|NOT COMPLETED|Washout (at Least 10 Minutes)||0
8777181|NCT01306292|9827229|FG001|NOT COMPLETED|Washout (at Least 10 Minutes)||0
8777182|NCT01306292|9827230|FG002|NOT COMPLETED|Washout (at Least 10 Minutes)||0
8777183|NCT01306292|9827231|FG003|NOT COMPLETED|Washout (at Least 10 Minutes)||0
8777184|NCT01306292|9827228|FG000|STARTED|Second Injection||10
8777185|NCT01306292|9827229|FG001|STARTED|Second Injection||8
8777186|NCT01306292|9827230|FG002|STARTED|Second Injection||8
8777187|NCT01306292|9827231|FG003|STARTED|Second Injection||10
8777188|NCT01306292|9827228|FG000|COMPLETED|Second Injection||10
8777189|NCT01306292|9827229|FG001|COMPLETED|Second Injection||8
8777190|NCT01306292|9827230|FG002|COMPLETED|Second Injection|1 subject completed both injections but not 24-hour follow-up; all other values were recorded.|7
8777191|NCT01306292|9827231|FG003|COMPLETED|Second Injection||10
8777192|NCT01306292|9827228|FG000|NOT COMPLETED|Second Injection||0
8777193|NCT01306292|9827229|FG001|NOT COMPLETED|Second Injection||0
8777194|NCT01306292|9827230|FG002|NOT COMPLETED|Second Injection||1
8777195|NCT01306292|9827231|FG003|NOT COMPLETED|Second Injection||0
8777196|NCT01306305|9827241|FG000|STARTED|Overall Study||55
8777197|NCT01306305|9827242|FG001|STARTED|Overall Study||55
8777198|NCT01306305|9827241|FG000|COMPLETED|Overall Study||53
8777199|NCT01306305|9827242|FG001|COMPLETED|Overall Study||55
8777200|NCT01306305|9827241|FG000|NOT COMPLETED|Overall Study||2
8777201|NCT01306305|9827242|FG001|NOT COMPLETED|Overall Study||0
8808821|NCT01493024|9861196|FG002|STARTED|Overall Study||24
8808822|NCT01493024|9861197|FG003|STARTED|Overall Study||24
8808823|NCT01493024|9861194|FG000|COMPLETED|Overall Study||30
8808824|NCT01493024|9861195|FG001|COMPLETED|Overall Study||12
8808825|NCT01493024|9861196|FG002|COMPLETED|Overall Study||24
8808826|NCT01493024|9861197|FG003|COMPLETED|Overall Study||24
8808827|NCT01493024|9861194|FG000|NOT COMPLETED|Overall Study||0
8808828|NCT01493024|9861195|FG001|NOT COMPLETED|Overall Study||0
8808829|NCT01493024|9861196|FG002|NOT COMPLETED|Overall Study||0
8808830|NCT01493024|9861197|FG003|NOT COMPLETED|Overall Study||0
8808831|NCT01493089|9861210|FG000|STARTED|Overall Study||122
8808832|NCT01493089|9861211|FG001|STARTED|Overall Study||117
8808833|NCT01493089|9861210|FG000|COMPLETED|Overall Study||119
8808834|NCT01493089|9861211|FG001|COMPLETED|Overall Study||114
8808835|NCT01493089|9861210|FG000|NOT COMPLETED|Overall Study||3
8808836|NCT01493089|9861211|FG001|NOT COMPLETED|Overall Study||3
8808837|NCT01493167|9861219|FG000|STARTED|Overall Study||97
8808838|NCT01493167|9861219|FG000|COMPLETED|Overall Study||97
8808839|NCT01493167|9861219|FG000|NOT COMPLETED|Overall Study||0
8808840|NCT01493180|9861225|FG000|STARTED|Overall Study||51
8808841|NCT01493180|9861226|FG001|STARTED|Overall Study||51
8808842|NCT01493180|9861225|FG000|COMPLETED|Overall Study||48
8808843|NCT01493180|9861226|FG001|COMPLETED|Overall Study||49
8808844|NCT01493180|9861225|FG000|NOT COMPLETED|Overall Study||3
8808845|NCT01493180|9861226|FG001|NOT COMPLETED|Overall Study||2
8808846|NCT01493284|9861232|FG000|STARTED|Overall Study||222
8808847|NCT01493284|9861232|FG000|COMPLETED|Overall Study||161
8808848|NCT01493284|9861232|FG000|NOT COMPLETED|Overall Study||61
8777202|NCT01306331|9827250|FG000|STARTED|Overall Study||1659
8777203|NCT01306331|9827251|FG001|STARTED|Overall Study||1665
8777204|NCT01306331|9827250|FG000|COMPLETED|Overall Study||758
8777205|NCT01306331|9827251|FG001|COMPLETED|Overall Study||788
8777206|NCT01306331|9827250|FG000|NOT COMPLETED|Overall Study||901
8777207|NCT01306331|9827251|FG001|NOT COMPLETED|Overall Study||877
8777208|NCT01306617|9827260|FG000|STARTED|Overall Study||19
8777209|NCT01306617|9827261|FG001|STARTED|Overall Study||14
8777210|NCT01306617|9827262|FG002|STARTED|Overall Study||17
8777211|NCT01306617|9827260|FG000|COMPLETED|Overall Study|The number of participants who completed study drug|18
8777212|NCT01306617|9827261|FG001|COMPLETED|Overall Study|The number of participants who completed study drug|13
8777213|NCT01306617|9827262|FG002|COMPLETED|Overall Study|The number of participants who completed study drug|12
8777214|NCT01306617|9827260|FG000|NOT COMPLETED|Overall Study||1
8777215|NCT01306617|9827261|FG001|NOT COMPLETED|Overall Study||1
8777216|NCT01306617|9827262|FG002|NOT COMPLETED|Overall Study||5
8777217|NCT01306643|9827270|FG000|STARTED|Overall Study||18
8777218|NCT01306643|9827270|FG000|COMPLETED|Overall Study|Completed Study was defined as participants who completed through Cycle 12 (Week 48) per protocol.|5
8777219|NCT01306643|9827270|FG000|NOT COMPLETED|Overall Study||13
8777220|NCT01306656|9827276|FG000|STARTED|Overall Study||7
8777221|NCT01306656|9827277|FG001|STARTED|Overall Study||2
8777222|NCT01306656|9827276|FG000|COMPLETED|Overall Study||6
8777223|NCT01306656|9827277|FG001|COMPLETED|Overall Study||2
8777224|NCT01306656|9827276|FG000|NOT COMPLETED|Overall Study||1
8777225|NCT01306656|9827277|FG001|NOT COMPLETED|Overall Study||0
8777226|NCT01306877|9827287|FG000|STARTED|Overall Study||78
8777227|NCT01306877|9827288|FG001|STARTED|Overall Study||71
8777228|NCT01306877|9827287|FG000|COMPLETED|Overall Study||75
8777229|NCT01306877|9827288|FG001|COMPLETED|Overall Study||67
8777230|NCT01306877|9827287|FG000|NOT COMPLETED|Overall Study||3
8777231|NCT01306877|9827288|FG001|NOT COMPLETED|Overall Study||4
8777232|NCT01306890|9827294|FG000|STARTED|Overall Study||1976
8777233|NCT01306890|9827294|FG000|COMPLETED|Overall Study|Subjects were alive at the end of the study and had completed at least 3 years of follow up.|457
8777234|NCT01306890|9827294|FG000|NOT COMPLETED|Overall Study||1519
8777235|NCT01306942|9827301|FG000|STARTED|Phase I||6
8777236|NCT01306942|9827302|FG001|STARTED|Phase I||4
8777237|NCT01306942|9827303|FG002|STARTED|Phase I||0
8777238|NCT01306942|9827304|FG003|STARTED|Phase I||0
8777239|NCT01306942|9827301|FG000|COMPLETED|Phase I||1
8777240|NCT01306942|9827302|FG001|COMPLETED|Phase I||1
8777241|NCT01306942|9827303|FG002|COMPLETED|Phase I||0
8777242|NCT01306942|9827304|FG003|COMPLETED|Phase I||0
8777243|NCT01306942|9827301|FG000|NOT COMPLETED|Phase I||5
8777244|NCT01306942|9827302|FG001|NOT COMPLETED|Phase I||3
8777245|NCT01306942|9827303|FG002|NOT COMPLETED|Phase I||0
8777246|NCT01306942|9827304|FG003|NOT COMPLETED|Phase I||0
8777247|NCT01306942|9827301|FG000|STARTED|Phase II|Two patients from phase I with measurable disease and RP2D were included in the phase II analyses.|2
8777248|NCT01306942|9827302|FG001|STARTED|Phase II|Dasatinib 140mg was not the RP2D, so these patients were not included in the phase II analyses.|0
8777249|NCT01306942|9827303|FG002|STARTED|Phase II||0
8777250|NCT01306942|9827304|FG003|STARTED|Phase II||27
8777251|NCT01306942|9827301|FG000|COMPLETED|Phase II||0
8777252|NCT01306942|9827302|FG001|COMPLETED|Phase II||0
8777253|NCT01306942|9827303|FG002|COMPLETED|Phase II||0
8777254|NCT01306942|9827304|FG003|COMPLETED|Phase II||11
8777255|NCT01306942|9827301|FG000|NOT COMPLETED|Phase II||2
8777256|NCT01306942|9827302|FG001|NOT COMPLETED|Phase II||0
8777257|NCT01306942|9827303|FG002|NOT COMPLETED|Phase II||0
8777258|NCT01306942|9827304|FG003|NOT COMPLETED|Phase II||16
8777259|NCT01306968|9827320|FG000|STARTED|Overall Study||7
8777260|NCT01306968|9827321|FG001|STARTED|Overall Study||23
8777261|NCT01306968|9827322|FG002|STARTED|Overall Study||24
8777262|NCT01306968|9827323|FG003|STARTED|Overall Study|2 participants withdrew before chamber sessions were initiated|25
8777263|NCT01306968|9827320|FG000|COMPLETED|Overall Study||6
8777264|NCT01306968|9827321|FG001|COMPLETED|Overall Study||20
8777265|NCT01306968|9827322|FG002|COMPLETED|Overall Study||23
8777266|NCT01306968|9827323|FG003|COMPLETED|Overall Study||21
8777267|NCT01306968|9827320|FG000|NOT COMPLETED|Overall Study||1
8777268|NCT01306968|9827321|FG001|NOT COMPLETED|Overall Study||3
8777269|NCT01306968|9827322|FG002|NOT COMPLETED|Overall Study||1
8777270|NCT01306968|9827323|FG003|NOT COMPLETED|Overall Study||4
8671617|NCT00752856|9715004|FG000|COMPLETED|Overall Study||26
8671618|NCT00752856|9715005|FG001|COMPLETED|Overall Study||24
8671619|NCT00752856|9715004|FG000|NOT COMPLETED|Overall Study||0
8671620|NCT00752856|9715005|FG001|NOT COMPLETED|Overall Study||1
8671621|NCT00752895|9715013|FG000|STARTED|Overall Study||147
8671622|NCT00752895|9715014|FG001|STARTED|Overall Study||146
8671623|NCT00752895|9715013|FG000|COMPLETED|Overall Study||139
8671624|NCT00752895|9715014|FG001|COMPLETED|Overall Study||143
8671625|NCT00752895|9715013|FG000|NOT COMPLETED|Overall Study||8
8671626|NCT00752895|9715014|FG001|NOT COMPLETED|Overall Study||3
8671627|NCT00752908|9715022|FG000|STARTED|Overall Study||14
8671628|NCT00752908|9715023|FG001|STARTED|Overall Study||13
8671629|NCT00752908|9715022|FG000|COMPLETED|Overall Study||14
8671630|NCT00752908|9715023|FG001|COMPLETED|Overall Study||13
8671631|NCT00752908|9715022|FG000|NOT COMPLETED|Overall Study||0
8777271|NCT01307007|9827337|FG000|STARTED|Overall Study||25
8777272|NCT01307007|9827338|FG001|STARTED|Overall Study||30
8777273|NCT01307007|9827337|FG000|COMPLETED|Overall Study||25
8777274|NCT01307007|9827338|FG001|COMPLETED|Overall Study||30
8777275|NCT01307007|9827337|FG000|NOT COMPLETED|Overall Study||0
8777276|NCT01307007|9827338|FG001|NOT COMPLETED|Overall Study||0
8777277|NCT01307020|9827354|FG000|STARTED|Overall Study||61
8777278|NCT01307020|9827355|FG001|STARTED|Overall Study||63
8777279|NCT01307020|9827356|FG002|STARTED|Overall Study||63
8777280|NCT01307020|9827357|FG003|STARTED|Overall Study||61
8777281|NCT01307020|9827358|FG004|STARTED|Overall Study||60
8777282|NCT01307020|9827359|FG005|STARTED|Overall Study||61
8777283|NCT01307020|9827360|FG006|STARTED|Overall Study||59
8777284|NCT01307020|9827361|FG007|STARTED|Overall Study||60
8777285|NCT01307020|9827362|FG008|STARTED|Overall Study||61
8777286|NCT01307020|9827363|FG009|STARTED|Overall Study||62
8777287|NCT01307020|9827354|FG000|Safety Population|Overall Study||61
8777288|NCT01307020|9827355|FG001|Safety Population|Overall Study||63
8777289|NCT01307020|9827356|FG002|Safety Population|Overall Study||63
8777290|NCT01307020|9827357|FG003|Safety Population|Overall Study||61
8777291|NCT01307020|9827358|FG004|Safety Population|Overall Study||60
8777292|NCT01307020|9827359|FG005|Safety Population|Overall Study||61
9029273|NCT03215667|10091601|FG000|STARTED|Overall Study||9
9029274|NCT03215667|10091601|FG000|COMPLETED|Overall Study||5
9029275|NCT03215667|10091601|FG000|NOT COMPLETED|Overall Study||4
9029276|NCT03215758|10091607|FG000|STARTED|Overall Study||339
9029277|NCT03215758|10091608|FG001|STARTED|Overall Study||336
9029278|NCT03215758|10091607|FG000|COMPLETED|Overall Study||334
9029279|NCT03215758|10091608|FG001|COMPLETED|Overall Study||328
9029280|NCT03215758|10091607|FG000|NOT COMPLETED|Overall Study||5
9029281|NCT03215758|10091608|FG001|NOT COMPLETED|Overall Study||8
9029282|NCT03215771|10091614|FG000|STARTED|Overall Study||16
9029283|NCT03215771|10091614|FG000|Stroke Subjects|Overall Study||8
9029284|NCT03215771|10091614|FG000|TBI Subjects|Overall Study||8
9029285|NCT03215771|10091614|FG000|COMPLETED|Overall Study||13
9029286|NCT03215771|10091614|FG000|NOT COMPLETED|Overall Study||3
9029287|NCT03215901|10091622|FG000|STARTED|Overall Study||199
9029288|NCT03215901|10091623|FG001|STARTED|Overall Study||112
9029289|NCT03215901|10091624|FG002|STARTED|Overall Study||116
9029290|NCT03215901|10091622|FG000|COMPLETED|Overall Study||199
9029291|NCT03215901|10091623|FG001|COMPLETED|Overall Study||112
9029292|NCT03215901|10091624|FG002|COMPLETED|Overall Study||116
9029293|NCT03215901|10091622|FG000|NOT COMPLETED|Overall Study||0
9029294|NCT03215901|10091623|FG001|NOT COMPLETED|Overall Study||0
9029295|NCT03215901|10091624|FG002|NOT COMPLETED|Overall Study||0
9029296|NCT03216200|10091632|FG000|STARTED|Overall Study||5
9029297|NCT03216200|10091632|FG000|COMPLETED|Overall Study||5
9029298|NCT03216200|10091632|FG000|NOT COMPLETED|Overall Study||0
9029299|NCT03216226|10091638|FG000|STARTED|Overall Study||57
9029300|NCT03216226|10091639|FG001|STARTED|Overall Study||55
9029301|NCT03216226|10091638|FG000|Randomized and Treated|Overall Study||57
9029302|NCT03216226|10091639|FG001|Randomized and Treated|Overall Study||54
9029303|NCT03216226|10091638|FG000|COMPLETED|Overall Study||52
9029304|NCT03216226|10091639|FG001|COMPLETED|Overall Study||50
9029305|NCT03216226|10091638|FG000|NOT COMPLETED|Overall Study||5
9029306|NCT03216226|10091639|FG001|NOT COMPLETED|Overall Study||5
9029307|NCT03216265|10091648|FG000|STARTED|Overall Study||22
9029308|NCT03216265|10091649|FG001|STARTED|Overall Study||22
9029309|NCT03216265|10091650|FG002|STARTED|Overall Study||22
9029310|NCT03216265|10091648|FG000|COMPLETED|Overall Study||20
9029311|NCT03216265|10091649|FG001|COMPLETED|Overall Study||21
9029312|NCT03216265|10091650|FG002|COMPLETED|Overall Study||19
9029313|NCT03216265|10091648|FG000|NOT COMPLETED|Overall Study||2
9029314|NCT03216265|10091649|FG001|NOT COMPLETED|Overall Study||1
9029315|NCT03216265|10091650|FG002|NOT COMPLETED|Overall Study||3
9029316|NCT03216382|10091667|FG000|STARTED|Overall Study||41
9029317|NCT03216382|10091668|FG001|STARTED|Overall Study||54
9029318|NCT03216382|10091667|FG000|COMPLETED|Overall Study||34
9029319|NCT03216382|10091668|FG001|COMPLETED|Overall Study||44
9029320|NCT03216382|10091667|FG000|NOT COMPLETED|Overall Study||7
9029321|NCT03216382|10091668|FG001|NOT COMPLETED|Overall Study||10
9029322|NCT03216512|10091676|FG000|STARTED|Overall Study||17
9029323|NCT03216512|10091677|FG001|STARTED|Overall Study||14
9029324|NCT03216512|10091676|FG000|COMPLETED|Overall Study||17
9029325|NCT03216512|10091677|FG001|COMPLETED|Overall Study||13
9029326|NCT03216512|10091676|FG000|NOT COMPLETED|Overall Study||0
9029327|NCT03216512|10091677|FG001|NOT COMPLETED|Overall Study||1
9029328|NCT03216746|10091689|FG000|STARTED|Overall Study||72
9029329|NCT03216746|10091690|FG001|STARTED|Overall Study||79
9029330|NCT03216746|10091691|FG002|STARTED|Overall Study||68
9029331|NCT03216746|10091692|FG003|STARTED|Overall Study||69
9029332|NCT03216746|10091689|FG000|COMPLETED|Overall Study||66
9029333|NCT03216746|10091690|FG001|COMPLETED|Overall Study||71
9029334|NCT03216746|10091691|FG002|COMPLETED|Overall Study||63
9029335|NCT03216746|10091692|FG003|COMPLETED|Overall Study||63
9029336|NCT03216746|10091689|FG000|NOT COMPLETED|Overall Study||6
9029337|NCT03216746|10091690|FG001|NOT COMPLETED|Overall Study||8
9029338|NCT03216746|10091691|FG002|NOT COMPLETED|Overall Study||5
9029339|NCT03216746|10091692|FG003|NOT COMPLETED|Overall Study||6
9029340|NCT03216850|10091702|FG000|STARTED|Overall Study||15
9029341|NCT03216850|10091702|FG000|COMPLETED|Overall Study|6 patients did not complete the study because of the pre-analytical error.|9
9029342|NCT03216850|10091702|FG000|NOT COMPLETED|Overall Study||6
8777293|NCT01307020|9827360|FG006|Safety Population|Overall Study||59
9029343|NCT03216902|10091712|FG000|STARTED|Overall Study||22
9029344|NCT03216902|10091713|FG001|STARTED|Overall Study||44
9029345|NCT03216902|10091714|FG002|STARTED|Overall Study||43
8777294|NCT01307020|9827361|FG007|Safety Population|Overall Study||60
8777295|NCT01307020|9827362|FG008|Safety Population|Overall Study||61
8777296|NCT01307020|9827363|FG009|Safety Population|Overall Study||62
8777297|NCT01307020|9827354|FG000|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
8777298|NCT01307020|9827355|FG001|ITT (>= 1 Assessment Post Randomization)|Overall Study||62
8777299|NCT01307020|9827356|FG002|ITT (>= 1 Assessment Post Randomization)|Overall Study||63
8777300|NCT01307020|9827357|FG003|ITT (>= 1 Assessment Post Randomization)|Overall Study||61
8777301|NCT01307020|9827358|FG004|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
8777302|NCT01307020|9827359|FG005|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
8777303|NCT01307020|9827360|FG006|ITT (>= 1 Assessment Post Randomization)|Overall Study||59
8777304|NCT01307020|9827361|FG007|ITT (>= 1 Assessment Post Randomization)|Overall Study||59
8777305|NCT01307020|9827362|FG008|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
8777306|NCT01307020|9827363|FG009|ITT (>= 1 Assessment Post Randomization)|Overall Study||62
8777307|NCT01307020|9827354|FG000|COMPLETED|Overall Study||61
8777308|NCT01307020|9827355|FG001|COMPLETED|Overall Study||62
8777309|NCT01307020|9827356|FG002|COMPLETED|Overall Study||62
8777310|NCT01307020|9827357|FG003|COMPLETED|Overall Study||60
8777311|NCT01307020|9827358|FG004|COMPLETED|Overall Study||60
8777312|NCT01307020|9827359|FG005|COMPLETED|Overall Study||61
8777313|NCT01307020|9827360|FG006|COMPLETED|Overall Study||58
8777314|NCT01307020|9827361|FG007|COMPLETED|Overall Study||60
8777315|NCT01307020|9827362|FG008|COMPLETED|Overall Study||61
8777316|NCT01307020|9827363|FG009|COMPLETED|Overall Study||62
8777317|NCT01307020|9827354|FG000|NOT COMPLETED|Overall Study||0
8777318|NCT01307020|9827355|FG001|NOT COMPLETED|Overall Study||1
8777319|NCT01307020|9827356|FG002|NOT COMPLETED|Overall Study||1
8777320|NCT01307020|9827357|FG003|NOT COMPLETED|Overall Study||1
8777321|NCT01307020|9827358|FG004|NOT COMPLETED|Overall Study||0
8777322|NCT01307020|9827359|FG005|NOT COMPLETED|Overall Study||0
8777323|NCT01307020|9827360|FG006|NOT COMPLETED|Overall Study||1
8777324|NCT01307020|9827361|FG007|NOT COMPLETED|Overall Study||0
8777325|NCT01307020|9827362|FG008|NOT COMPLETED|Overall Study||0
8777326|NCT01307020|9827363|FG009|NOT COMPLETED|Overall Study||0
8777327|NCT01307098|9827388|FG000|STARTED|Overall Study||3
8777328|NCT01307098|9827389|FG001|STARTED|Overall Study||3
8777329|NCT01307098|9827390|FG002|STARTED|Overall Study||3
8777330|NCT01307098|9827388|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
8777331|NCT01307098|9827389|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
8777332|NCT01307098|9827390|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
8777333|NCT01307098|9827388|FG000|COMPLETED|Overall Study||3
8777334|NCT01307098|9827389|FG001|COMPLETED|Overall Study||3
8777335|NCT01307098|9827390|FG002|COMPLETED|Overall Study||3
8777336|NCT01307098|9827388|FG000|NOT COMPLETED|Overall Study||0
8777337|NCT01307098|9827389|FG001|NOT COMPLETED|Overall Study||0
8777338|NCT01307098|9827390|FG002|NOT COMPLETED|Overall Study||0
8777339|NCT01307111|9827401|FG000|STARTED|IUD Insertion||42
8777340|NCT01307111|9827402|FG001|STARTED|IUD Insertion||40
8777341|NCT01307111|9827401|FG000|COMPLETED|IUD Insertion||40
8777342|NCT01307111|9827402|FG001|COMPLETED|IUD Insertion||40
8777343|NCT01307111|9827401|FG000|NOT COMPLETED|IUD Insertion||2
8777344|NCT01307111|9827402|FG001|NOT COMPLETED|IUD Insertion||0
8777345|NCT01307111|9827401|FG000|STARTED|1-2 Week IUD Check up||40
8777346|NCT01307111|9827402|FG001|STARTED|1-2 Week IUD Check up||40
8777347|NCT01307111|9827401|FG000|COMPLETED|1-2 Week IUD Check up||38
8777348|NCT01307111|9827402|FG001|COMPLETED|1-2 Week IUD Check up||38
8777349|NCT01307111|9827401|FG000|NOT COMPLETED|1-2 Week IUD Check up||2
8777350|NCT01307111|9827402|FG001|NOT COMPLETED|1-2 Week IUD Check up||2
8777351|NCT01307267|9827431|FG000|STARTED|Overall Study||4
8777352|NCT01307267|9827432|FG001|STARTED|Overall Study||3
8777353|NCT01307267|9827433|FG002|STARTED|Overall Study||6
8777354|NCT01307267|9827434|FG003|STARTED|Overall Study||4
8777355|NCT01307267|9827435|FG004|STARTED|Overall Study||3
8777356|NCT01307267|9827436|FG005|STARTED|Overall Study||42
8777357|NCT01307267|9827437|FG006|STARTED|Overall Study||3
8777358|NCT01307267|9827438|FG007|STARTED|Overall Study||4
8777359|NCT01307267|9827439|FG008|STARTED|Overall Study||31
8777360|NCT01307267|9827440|FG009|STARTED|Overall Study||5
8777361|NCT01307267|9827441|FG010|STARTED|Overall Study||6
8777362|NCT01307267|9827442|FG011|STARTED|Overall Study||11
8777363|NCT01307267|9827443|FG012|STARTED|Overall Study||3
8777364|NCT01307267|9827444|FG013|STARTED|Overall Study||3
8777365|NCT01307267|9827445|FG014|STARTED|Overall Study||4
8777366|NCT01307267|9827446|FG015|STARTED|Overall Study||3
8777367|NCT01307267|9827447|FG016|STARTED|Overall Study||3
8777368|NCT01307267|9827448|FG017|STARTED|Overall Study||3
8777369|NCT01307267|9827449|FG018|STARTED|Overall Study||4
8777370|NCT01307267|9827450|FG019|STARTED|Overall Study||32
8777371|NCT01307267|9827451|FG020|STARTED|Overall Study||3
8777372|NCT01307267|9827452|FG021|STARTED|Overall Study||5
8777373|NCT01307267|9827453|FG022|STARTED|Overall Study||4
8777374|NCT01307267|9827431|FG000|COMPLETED|Overall Study||0
8777375|NCT01307267|9827432|FG001|COMPLETED|Overall Study||0
8777376|NCT01307267|9827433|FG002|COMPLETED|Overall Study||1
8777377|NCT01307267|9827434|FG003|COMPLETED|Overall Study||1
8777378|NCT01307267|9827435|FG004|COMPLETED|Overall Study||2
8777379|NCT01307267|9827436|FG005|COMPLETED|Overall Study||1
8777380|NCT01307267|9827437|FG006|COMPLETED|Overall Study||1
8777381|NCT01307267|9827438|FG007|COMPLETED|Overall Study||0
8777382|NCT01307267|9827439|FG008|COMPLETED|Overall Study||1
8777383|NCT01307267|9827440|FG009|COMPLETED|Overall Study||0
8777384|NCT01307267|9827441|FG010|COMPLETED|Overall Study||0
8777385|NCT01307267|9827442|FG011|COMPLETED|Overall Study||0
8777386|NCT01307267|9827443|FG012|COMPLETED|Overall Study||2
8777387|NCT01307267|9827444|FG013|COMPLETED|Overall Study||3
8777388|NCT01307267|9827445|FG014|COMPLETED|Overall Study||2
8777389|NCT01307267|9827446|FG015|COMPLETED|Overall Study||2
8777390|NCT01307267|9827447|FG016|COMPLETED|Overall Study||2
8777391|NCT01307267|9827448|FG017|COMPLETED|Overall Study||2
8777392|NCT01307267|9827449|FG018|COMPLETED|Overall Study||2
8777393|NCT01307267|9827450|FG019|COMPLETED|Overall Study||0
8777394|NCT01307267|9827451|FG020|COMPLETED|Overall Study||0
8777395|NCT01307267|9827452|FG021|COMPLETED|Overall Study||0
8777396|NCT01307267|9827453|FG022|COMPLETED|Overall Study||0
8777397|NCT01307267|9827431|FG000|NOT COMPLETED|Overall Study||4
8777398|NCT01307267|9827432|FG001|NOT COMPLETED|Overall Study||3
8777399|NCT01307267|9827433|FG002|NOT COMPLETED|Overall Study||5
8777400|NCT01307267|9827434|FG003|NOT COMPLETED|Overall Study||3
8777401|NCT01307267|9827435|FG004|NOT COMPLETED|Overall Study||1
8777402|NCT01307267|9827436|FG005|NOT COMPLETED|Overall Study||41
8777403|NCT01307267|9827437|FG006|NOT COMPLETED|Overall Study||2
8777404|NCT01307267|9827438|FG007|NOT COMPLETED|Overall Study||4
8777405|NCT01307267|9827439|FG008|NOT COMPLETED|Overall Study||30
8777406|NCT01307267|9827440|FG009|NOT COMPLETED|Overall Study||5
8777407|NCT01307267|9827441|FG010|NOT COMPLETED|Overall Study||6
8777408|NCT01307267|9827442|FG011|NOT COMPLETED|Overall Study||11
8777409|NCT01307267|9827443|FG012|NOT COMPLETED|Overall Study||1
8777410|NCT01307267|9827444|FG013|NOT COMPLETED|Overall Study||0
8777411|NCT01307267|9827445|FG014|NOT COMPLETED|Overall Study||2
8777412|NCT01307267|9827446|FG015|NOT COMPLETED|Overall Study||1
8777413|NCT01307267|9827447|FG016|NOT COMPLETED|Overall Study||1
8777414|NCT01307267|9827448|FG017|NOT COMPLETED|Overall Study||1
8777415|NCT01307267|9827449|FG018|NOT COMPLETED|Overall Study||2
8777416|NCT01307267|9827450|FG019|NOT COMPLETED|Overall Study||32
8777417|NCT01307267|9827451|FG020|NOT COMPLETED|Overall Study||3
8777418|NCT01307267|9827452|FG021|NOT COMPLETED|Overall Study||5
8777419|NCT01307267|9827453|FG022|NOT COMPLETED|Overall Study||4
8777420|NCT01307319|9827515|FG000|STARTED|Overall Study|Randomized|239
8777421|NCT01307319|9827516|FG001|STARTED|Overall Study|Randomized|242
8777422|NCT01307319|9827517|FG002|STARTED|Overall Study|Randomized|234
8777423|NCT01307319|9827515|FG000|Safety Population|Overall Study||239
8777424|NCT01307319|9827516|FG001|Safety Population|Overall Study|One participant was randomized in error and did not receive study medication.|241
8777425|NCT01307319|9827517|FG002|Safety Population|Overall Study||234
8777426|NCT01307319|9827515|FG000|ITT Population|Overall Study|One participant provided no post-baseline assessment.|238
8777427|NCT01307319|9827516|FG001|ITT Population|Overall Study||241
8777428|NCT01307319|9827517|FG002|ITT Population|Overall Study||234
8777429|NCT01307319|9827515|FG000|COMPLETED|Overall Study||235
8777430|NCT01307319|9827516|FG001|COMPLETED|Overall Study||234
8777431|NCT01307319|9827517|FG002|COMPLETED|Overall Study||227
8777432|NCT01307319|9827515|FG000|NOT COMPLETED|Overall Study||4
8777433|NCT01307319|9827516|FG001|NOT COMPLETED|Overall Study||8
8777434|NCT01307319|9827517|FG002|NOT COMPLETED|Overall Study||7
8777435|NCT01307397|9827525|FG000|STARTED|Overall Study||3219
8777436|NCT01307397|9827525|FG000|COMPLETED|Overall Study|A participant completed study in case of progressive disease, adverse events or consent withdrawn|3219
8777437|NCT01307397|9827525|FG000|NOT COMPLETED|Overall Study||0
8777438|NCT01307423|9827532|FG000|STARTED|Placebo-controlled Phase (Week 0 - 24)||176
8777439|NCT01307423|9827533|FG001|STARTED|Placebo-controlled Phase (Week 0 - 24)||175
8777440|NCT01307423|9827534|FG002|STARTED|Placebo-controlled Phase (Week 0 - 24)||177
8777441|NCT01307423|9827535|FG003|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
8777442|NCT01307423|9827536|FG004|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
8777443|NCT01307423|9827537|FG005|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
8777444|NCT01307423|9827538|FG006|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
8777445|NCT01307423|9827539|FG007|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
8777446|NCT01307423|9827540|FG008|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
8777447|NCT01307423|9827532|FG000|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||176
8777448|NCT01307423|9827533|FG001|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||175
8777449|NCT01307423|9827534|FG002|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||175
8777450|NCT01307423|9827535|FG003|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
8777451|NCT01307423|9827536|FG004|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
8777452|NCT01307423|9827537|FG005|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
8777453|NCT01307423|9827538|FG006|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
8777454|NCT01307423|9827539|FG007|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
8777455|NCT01307423|9827540|FG008|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
8777456|NCT01307423|9827532|FG000|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||166
8777457|NCT01307423|9827533|FG001|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||168
8777458|NCT01307423|9827534|FG002|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||166
8777459|NCT01307423|9827535|FG003|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8777460|NCT01307423|9827536|FG004|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8777461|NCT01307423|9827537|FG005|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8777462|NCT01307423|9827538|FG006|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8777463|NCT01307423|9827539|FG007|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8777464|NCT01307423|9827540|FG008|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8777465|NCT01307423|9827532|FG000|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|One participant who escaped early did not complete Week 24|103
8777466|NCT01307423|9827533|FG001|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||73
8777467|NCT01307423|9827534|FG002|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||79
8777468|NCT01307423|9827535|FG003|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8777469|NCT01307423|9827536|FG004|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8777470|NCT01307423|9827537|FG005|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8777471|NCT01307423|9827538|FG006|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8777472|NCT01307423|9827539|FG007|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8777473|NCT01307423|9827540|FG008|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8777474|NCT01307423|9827532|FG000|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|Two participants did not escape early and finished Week 24 did not enter the active treatment phase|156
8777475|NCT01307423|9827533|FG001|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||160
8777476|NCT01307423|9827534|FG002|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||155
8777477|NCT01307423|9827535|FG003|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8777478|NCT01307423|9827536|FG004|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8777479|NCT01307423|9827537|FG005|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8777480|NCT01307423|9827538|FG006|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8777481|NCT01307423|9827539|FG007|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8777482|NCT01307423|9827540|FG008|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8777483|NCT01307423|9827532|FG000|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||20
8777484|NCT01307423|9827533|FG001|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||15
8777485|NCT01307423|9827534|FG002|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||22
8777486|NCT01307423|9827535|FG003|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8777487|NCT01307423|9827536|FG004|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8777488|NCT01307423|9827537|FG005|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8777489|NCT01307423|9827538|FG006|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8777490|NCT01307423|9827539|FG007|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8777491|NCT01307423|9827540|FG008|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8777492|NCT01307423|9827532|FG000|STARTED|Active Treatment Phase (Week 25-52)||0
8777493|NCT01307423|9827533|FG001|STARTED|Active Treatment Phase (Week 25-52)|Nine participants who completed Week 24 did not enter active treatment phase|151
8777494|NCT01307423|9827534|FG002|STARTED|Active Treatment Phase (Week 25-52)|Five participants who completed Week 24 did not enter active treatment phase|150
8777495|NCT01307423|9827535|FG003|STARTED|Active Treatment Phase (Week 25-52)|Four participants who escaped early and completed Week 24 did not enter the active treatment phase.|46
8777496|NCT01307423|9827536|FG004|STARTED|Active Treatment Phase (Week 25-52)||26
8777497|NCT01307423|9827537|FG005|STARTED|Active Treatment Phase (Week 25-52)|Six participants who escaped early and completed Week 24 did not enter the active treatment phase|46
8777498|NCT01307423|9827538|FG006|STARTED|Active Treatment Phase (Week 25-52)||26
8777499|NCT01307423|9827539|FG007|STARTED|Active Treatment Phase (Week 25-52)||0
8777500|NCT01307423|9827540|FG008|STARTED|Active Treatment Phase (Week 25-52)||0
8777501|NCT01307423|9827532|FG000|COMPLETED|Active Treatment Phase (Week 25-52)||0
8777502|NCT01307423|9827533|FG001|COMPLETED|Active Treatment Phase (Week 25-52)||132
8777503|NCT01307423|9827534|FG002|COMPLETED|Active Treatment Phase (Week 25-52)||141
8777504|NCT01307423|9827535|FG003|COMPLETED|Active Treatment Phase (Week 25-52)||38
8777505|NCT01307423|9827536|FG004|COMPLETED|Active Treatment Phase (Week 25-52)||23
8777506|NCT01307423|9827537|FG005|COMPLETED|Active Treatment Phase (Week 25-52)||43
8777507|NCT01307423|9827538|FG006|COMPLETED|Active Treatment Phase (Week 25-52)||25
8777508|NCT01307423|9827539|FG007|COMPLETED|Active Treatment Phase (Week 25-52)||0
8777509|NCT01307423|9827540|FG008|COMPLETED|Active Treatment Phase (Week 25-52)||0
8777510|NCT01307423|9827532|FG000|NOT COMPLETED|Active Treatment Phase (Week 25-52)||0
8777511|NCT01307423|9827533|FG001|NOT COMPLETED|Active Treatment Phase (Week 25-52)||19
8777512|NCT01307423|9827534|FG002|NOT COMPLETED|Active Treatment Phase (Week 25-52)||9
8777513|NCT01307423|9827535|FG003|NOT COMPLETED|Active Treatment Phase (Week 25-52)||8
8777514|NCT01307423|9827536|FG004|NOT COMPLETED|Active Treatment Phase (Week 25-52)||3
8777515|NCT01307423|9827537|FG005|NOT COMPLETED|Active Treatment Phase (Week 25-52)||3
8777516|NCT01307423|9827538|FG006|NOT COMPLETED|Active Treatment Phase (Week 25-52)||1
8777517|NCT01307423|9827539|FG007|NOT COMPLETED|Active Treatment Phase (Week 25-52)||0
8777518|NCT01307423|9827540|FG008|NOT COMPLETED|Active Treatment Phase (Week 25-52)||0
8777519|NCT01307423|9827532|FG000|STARTED|Long-term Safety Phase (Year 2)||0
8777520|NCT01307423|9827533|FG001|STARTED|Long-term Safety Phase (Year 2)|10 participants who completed Week 52 did not enter the long-term safety phase|122
8777521|NCT01307423|9827534|FG002|STARTED|Long-term Safety Phase (Year 2)|7 participants who completed Week 52 did not enter the long-term safety phase|134
8777522|NCT01307423|9827535|FG003|STARTED|Long-term Safety Phase (Year 2)||0
8777523|NCT01307423|9827536|FG004|STARTED|Long-term Safety Phase (Year 2)||0
8777524|NCT01307423|9827537|FG005|STARTED|Long-term Safety Phase (Year 2)||0
8777525|NCT01307423|9827538|FG006|STARTED|Long-term Safety Phase (Year 2)||0
8777526|NCT01307423|9827539|FG007|STARTED|Long-term Safety Phase (Year 2)|Patients from the PBO/APR 20 mg EE and XO are combined;15 patients finished Wk 52;no entry into LTSP|57
8777527|NCT01307423|9827540|FG008|STARTED|Long-term Safety Phase (Year 2)|Patients from the PBO/APR 30 mg EE and XO are combined;5 patients finished Wk 52;no entry into LTSP|67
8777528|NCT01307423|9827532|FG000|COMPLETED|Long-term Safety Phase (Year 2)||0
8777529|NCT01307423|9827533|FG001|COMPLETED|Long-term Safety Phase (Year 2)||99
8777530|NCT01307423|9827534|FG002|COMPLETED|Long-term Safety Phase (Year 2)||109
8777531|NCT01307423|9827535|FG003|COMPLETED|Long-term Safety Phase (Year 2)||0
8777532|NCT01307423|9827536|FG004|COMPLETED|Long-term Safety Phase (Year 2)||0
8777533|NCT01307423|9827537|FG005|COMPLETED|Long-term Safety Phase (Year 2)||0
8777534|NCT01307423|9827538|FG006|COMPLETED|Long-term Safety Phase (Year 2)||0
8777535|NCT01307423|9827539|FG007|COMPLETED|Long-term Safety Phase (Year 2)||48
8777536|NCT01307423|9827540|FG008|COMPLETED|Long-term Safety Phase (Year 2)||60
8777537|NCT01307423|9827532|FG000|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
8777538|NCT01307423|9827533|FG001|NOT COMPLETED|Long-term Safety Phase (Year 2)||23
8777539|NCT01307423|9827534|FG002|NOT COMPLETED|Long-term Safety Phase (Year 2)||25
8777540|NCT01307423|9827535|FG003|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
8777541|NCT01307423|9827536|FG004|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
8777542|NCT01307423|9827537|FG005|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
8777543|NCT01307423|9827538|FG006|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
8777544|NCT01307423|9827539|FG007|NOT COMPLETED|Long-term Safety Phase (Year 2)||9
8777545|NCT01307423|9827540|FG008|NOT COMPLETED|Long-term Safety Phase (Year 2)||7
8777546|NCT01307423|9827532|FG000|STARTED|Long-term Safety Phase (Year 3)||0
8777547|NCT01307423|9827533|FG001|STARTED|Long-term Safety Phase (Year 3)||99
8777548|NCT01307423|9827534|FG002|STARTED|Long-term Safety Phase (Year 3)||109
8777549|NCT01307423|9827535|FG003|STARTED|Long-term Safety Phase (Year 3)||0
8777550|NCT01307423|9827536|FG004|STARTED|Long-term Safety Phase (Year 3)||0
8777551|NCT01307423|9827537|FG005|STARTED|Long-term Safety Phase (Year 3)||0
8777552|NCT01307423|9827538|FG006|STARTED|Long-term Safety Phase (Year 3)||0
8777553|NCT01307423|9827539|FG007|STARTED|Long-term Safety Phase (Year 3)||48
8777554|NCT01307423|9827540|FG008|STARTED|Long-term Safety Phase (Year 3)||60
8777555|NCT01307423|9827532|FG000|COMPLETED|Long-term Safety Phase (Year 3)||0
8777556|NCT01307423|9827533|FG001|COMPLETED|Long-term Safety Phase (Year 3)||90
8777557|NCT01307423|9827534|FG002|COMPLETED|Long-term Safety Phase (Year 3)||91
8777558|NCT01307423|9827535|FG003|COMPLETED|Long-term Safety Phase (Year 3)||0
8777559|NCT01307423|9827536|FG004|COMPLETED|Long-term Safety Phase (Year 3)||0
8777560|NCT01307423|9827537|FG005|COMPLETED|Long-term Safety Phase (Year 3)||0
8777561|NCT01307423|9827538|FG006|COMPLETED|Long-term Safety Phase (Year 3)||0
8777562|NCT01307423|9827539|FG007|COMPLETED|Long-term Safety Phase (Year 3)||40
8777563|NCT01307423|9827540|FG008|COMPLETED|Long-term Safety Phase (Year 3)||49
8777564|NCT01307423|9827532|FG000|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
8777565|NCT01307423|9827533|FG001|NOT COMPLETED|Long-term Safety Phase (Year 3)||9
8777566|NCT01307423|9827534|FG002|NOT COMPLETED|Long-term Safety Phase (Year 3)||18
8777567|NCT01307423|9827535|FG003|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
8777568|NCT01307423|9827536|FG004|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
8777569|NCT01307423|9827537|FG005|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
8777570|NCT01307423|9827538|FG006|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
8777571|NCT01307423|9827539|FG007|NOT COMPLETED|Long-term Safety Phase (Year 3)||8
8777572|NCT01307423|9827540|FG008|NOT COMPLETED|Long-term Safety Phase (Year 3)||11
8777573|NCT01307423|9827532|FG000|STARTED|Long-term Safety Phase (Year 4)||0
8777574|NCT01307423|9827533|FG001|STARTED|Long-term Safety Phase (Year 4)|1 participant who completed Year 3 did not continue treatment in Year 4|89
8777575|NCT01307423|9827534|FG002|STARTED|Long-term Safety Phase (Year 4)||91
8777576|NCT01307423|9827535|FG003|STARTED|Long-term Safety Phase (Year 4)||0
8777577|NCT01307423|9827536|FG004|STARTED|Long-term Safety Phase (Year 4)||0
8777578|NCT01307423|9827537|FG005|STARTED|Long-term Safety Phase (Year 4)||0
8777579|NCT01307423|9827538|FG006|STARTED|Long-term Safety Phase (Year 4)||0
8777580|NCT01307423|9827539|FG007|STARTED|Long-term Safety Phase (Year 4)||40
8777581|NCT01307423|9827540|FG008|STARTED|Long-term Safety Phase (Year 4)||49
8777582|NCT01307423|9827532|FG000|COMPLETED|Long-term Safety Phase (Year 4)||0
8777583|NCT01307423|9827533|FG001|COMPLETED|Long-term Safety Phase (Year 4)||81
8777584|NCT01307423|9827534|FG002|COMPLETED|Long-term Safety Phase (Year 4)||86
8777585|NCT01307423|9827535|FG003|COMPLETED|Long-term Safety Phase (Year 4)||0
8777586|NCT01307423|9827536|FG004|COMPLETED|Long-term Safety Phase (Year 4)||0
8777587|NCT01307423|9827537|FG005|COMPLETED|Long-term Safety Phase (Year 4)||0
8777588|NCT01307423|9827538|FG006|COMPLETED|Long-term Safety Phase (Year 4)||0
8777589|NCT01307423|9827539|FG007|COMPLETED|Long-term Safety Phase (Year 4)||38
8777590|NCT01307423|9827540|FG008|COMPLETED|Long-term Safety Phase (Year 4)||44
8777591|NCT01307423|9827532|FG000|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
8777592|NCT01307423|9827533|FG001|NOT COMPLETED|Long-term Safety Phase (Year 4)||8
9029346|NCT03216902|10091715|FG003|STARTED|Overall Study||43
9029347|NCT03216902|10091716|FG004|STARTED|Overall Study||44
9029348|NCT03216902|10091717|FG005|STARTED|Overall Study||45
9029349|NCT03216902|10091712|FG000|COMPLETED|Overall Study||20
9029350|NCT03216902|10091713|FG001|COMPLETED|Overall Study||43
9029351|NCT03216902|10091714|FG002|COMPLETED|Overall Study||42
9029352|NCT03216902|10091715|FG003|COMPLETED|Overall Study||43
9029353|NCT03216902|10091716|FG004|COMPLETED|Overall Study||43
9029354|NCT03216902|10091717|FG005|COMPLETED|Overall Study||42
8777593|NCT01307423|9827534|FG002|NOT COMPLETED|Long-term Safety Phase (Year 4)||5
8777594|NCT01307423|9827535|FG003|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
8777595|NCT01307423|9827536|FG004|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
9029355|NCT03216902|10091712|FG000|NOT COMPLETED|Overall Study||2
9029356|NCT03216902|10091713|FG001|NOT COMPLETED|Overall Study||1
9029357|NCT03216902|10091714|FG002|NOT COMPLETED|Overall Study||1
9029358|NCT03216902|10091715|FG003|NOT COMPLETED|Overall Study||0
8777596|NCT01307423|9827537|FG005|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
8777597|NCT01307423|9827538|FG006|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
8777598|NCT01307423|9827539|FG007|NOT COMPLETED|Long-term Safety Phase (Year 4)||2
8777599|NCT01307423|9827540|FG008|NOT COMPLETED|Long-term Safety Phase (Year 4)||5
8777600|NCT01307423|9827532|FG000|STARTED|Long-term Safety Phase (Year 5)||0
9029359|NCT03216902|10091716|FG004|NOT COMPLETED|Overall Study||1
9029360|NCT03216902|10091717|FG005|NOT COMPLETED|Overall Study||3
9029361|NCT03216954|10091739|FG000|STARTED|Overall Study||4
9029362|NCT03216954|10091740|FG001|STARTED|Overall Study||3
9029363|NCT03216954|10091741|FG002|STARTED|Overall Study||3
9029364|NCT03216954|10091742|FG003|STARTED|Overall Study||3
9029365|NCT03216954|10091743|FG004|STARTED|Overall Study||1
9029366|NCT03216954|10091739|FG000|COMPLETED|Overall Study||2
9029367|NCT03216954|10091740|FG001|COMPLETED|Overall Study||2
9029368|NCT03216954|10091741|FG002|COMPLETED|Overall Study||2
9029369|NCT03216954|10091742|FG003|COMPLETED|Overall Study||3
9029370|NCT03216954|10091743|FG004|COMPLETED|Overall Study||0
9029371|NCT03216954|10091739|FG000|NOT COMPLETED|Overall Study||2
9029372|NCT03216954|10091740|FG001|NOT COMPLETED|Overall Study||1
9029373|NCT03216954|10091741|FG002|NOT COMPLETED|Overall Study||1
9029374|NCT03216954|10091742|FG003|NOT COMPLETED|Overall Study||0
9029375|NCT03216954|10091743|FG004|NOT COMPLETED|Overall Study||1
9029376|NCT03217968|10091751|FG000|STARTED|Overall Study||59
9029377|NCT03217968|10091751|FG000|COMPLETED|Overall Study||48
9029378|NCT03217968|10091751|FG000|NOT COMPLETED|Overall Study||11
9029379|NCT03218397|10091757|FG000|STARTED|Overall Study||249
9029380|NCT03218397|10091758|FG001|STARTED|Overall Study||251
9029381|NCT03218397|10091757|FG000|COMPLETED|Overall Study||226
9029382|NCT03218397|10091758|FG001|COMPLETED|Overall Study||222
9029383|NCT03218397|10091757|FG000|NOT COMPLETED|Overall Study||23
9029384|NCT03218397|10091758|FG001|NOT COMPLETED|Overall Study||29
9029385|NCT03218566|10091764|FG000|STARTED|Overall Study||119
9029386|NCT03218566|10091764|FG000|COMPLETED|Overall Study||110
9029387|NCT03218566|10091764|FG000|NOT COMPLETED|Overall Study||9
9029388|NCT03218592|10091771|FG000|STARTED|Phase 1: 1 Dose||12
9029389|NCT03218592|10091772|FG001|STARTED|Phase 1: 1 Dose||12
9029390|NCT03218592|10091773|FG002|STARTED|Phase 1: 1 Dose||12
9029391|NCT03218592|10091771|FG000|COMPLETED|Phase 1: 1 Dose||12
9029392|NCT03218592|10091772|FG001|COMPLETED|Phase 1: 1 Dose||12
9029393|NCT03218592|10091773|FG002|COMPLETED|Phase 1: 1 Dose||12
9029394|NCT03218592|10091771|FG000|NOT COMPLETED|Phase 1: 1 Dose||0
9029395|NCT03218592|10091772|FG001|NOT COMPLETED|Phase 1: 1 Dose||0
9029396|NCT03218592|10091773|FG002|NOT COMPLETED|Phase 1: 1 Dose||0
9029397|NCT03218592|10091771|FG000|STARTED|Phase 2: Daily Doses x 28 Days||12
9029398|NCT03218592|10091772|FG001|STARTED|Phase 2: Daily Doses x 28 Days||12
9029399|NCT03218592|10091773|FG002|STARTED|Phase 2: Daily Doses x 28 Days||12
9029400|NCT03218592|10091771|FG000|COMPLETED|Phase 2: Daily Doses x 28 Days||12
9029401|NCT03218592|10091772|FG001|COMPLETED|Phase 2: Daily Doses x 28 Days||12
9029402|NCT03218592|10091773|FG002|COMPLETED|Phase 2: Daily Doses x 28 Days||12
9029403|NCT03218592|10091771|FG000|NOT COMPLETED|Phase 2: Daily Doses x 28 Days||0
9029404|NCT03218592|10091772|FG001|NOT COMPLETED|Phase 2: Daily Doses x 28 Days||0
9029405|NCT03218592|10091773|FG002|NOT COMPLETED|Phase 2: Daily Doses x 28 Days||0
9029406|NCT03218592|10091771|FG000|STARTED|Phase 3: 0 Doses Per Week||4
9029407|NCT03218592|10091772|FG001|STARTED|Phase 3: 0 Doses Per Week||4
9029408|NCT03218592|10091773|FG002|STARTED|Phase 3: 0 Doses Per Week||4
9029409|NCT03218592|10091771|FG000|4 Patients Per Group|Phase 3: 0 Doses Per Week||4
9029410|NCT03218592|10091772|FG001|4 Patients Per Group|Phase 3: 0 Doses Per Week||4
9029411|NCT03218592|10091773|FG002|4 Patients Per Group|Phase 3: 0 Doses Per Week||4
9029412|NCT03218592|10091771|FG000|COMPLETED|Phase 3: 0 Doses Per Week||4
9029413|NCT03218592|10091772|FG001|COMPLETED|Phase 3: 0 Doses Per Week||4
9029414|NCT03218592|10091773|FG002|COMPLETED|Phase 3: 0 Doses Per Week||4
9029415|NCT03218592|10091771|FG000|NOT COMPLETED|Phase 3: 0 Doses Per Week||0
9029416|NCT03218592|10091772|FG001|NOT COMPLETED|Phase 3: 0 Doses Per Week||0
9029417|NCT03218592|10091773|FG002|NOT COMPLETED|Phase 3: 0 Doses Per Week||0
9029418|NCT03218592|10091771|FG000|STARTED|Phase 3: 1 Dose Per Period||4
9029419|NCT03218592|10091772|FG001|STARTED|Phase 3: 1 Dose Per Period||4
9029420|NCT03218592|10091773|FG002|STARTED|Phase 3: 1 Dose Per Period||4
9029421|NCT03218592|10091771|FG000|4 Patients Per Group|Phase 3: 1 Dose Per Period||4
9029422|NCT03218592|10091772|FG001|4 Patients Per Group|Phase 3: 1 Dose Per Period||4
9029423|NCT03218592|10091773|FG002|4 Patients Per Group|Phase 3: 1 Dose Per Period||4
9029424|NCT03218592|10091771|FG000|COMPLETED|Phase 3: 1 Dose Per Period||4
9029425|NCT03218592|10091772|FG001|COMPLETED|Phase 3: 1 Dose Per Period||4
9029426|NCT03218592|10091773|FG002|COMPLETED|Phase 3: 1 Dose Per Period||4
9029427|NCT03218592|10091771|FG000|NOT COMPLETED|Phase 3: 1 Dose Per Period||0
9029428|NCT03218592|10091772|FG001|NOT COMPLETED|Phase 3: 1 Dose Per Period||0
9029429|NCT03218592|10091773|FG002|NOT COMPLETED|Phase 3: 1 Dose Per Period||0
9029430|NCT03218592|10091771|FG000|STARTED|Phase 3: 3 Doses Per Week||4
9029431|NCT03218592|10091772|FG001|STARTED|Phase 3: 3 Doses Per Week||4
9029432|NCT03218592|10091773|FG002|STARTED|Phase 3: 3 Doses Per Week||4
9029433|NCT03218592|10091771|FG000|4 Patients Per Group|Phase 3: 3 Doses Per Week||4
9029434|NCT03218592|10091772|FG001|4 Patients Per Group|Phase 3: 3 Doses Per Week||4
9029435|NCT03218592|10091773|FG002|4 Patients Per Group|Phase 3: 3 Doses Per Week||4
9029436|NCT03218592|10091771|FG000|COMPLETED|Phase 3: 3 Doses Per Week||4
9029437|NCT03218592|10091772|FG001|COMPLETED|Phase 3: 3 Doses Per Week||4
9029438|NCT03218592|10091773|FG002|COMPLETED|Phase 3: 3 Doses Per Week||4
8777601|NCT01307423|9827533|FG001|STARTED|Long-term Safety Phase (Year 5)||81
8777602|NCT01307423|9827534|FG002|STARTED|Long-term Safety Phase (Year 5)||86
8777603|NCT01307423|9827535|FG003|STARTED|Long-term Safety Phase (Year 5)||0
8777604|NCT01307423|9827536|FG004|STARTED|Long-term Safety Phase (Year 5)||0
8777605|NCT01307423|9827537|FG005|STARTED|Long-term Safety Phase (Year 5)||0
8777606|NCT01307423|9827538|FG006|STARTED|Long-term Safety Phase (Year 5)||0
8777607|NCT01307423|9827539|FG007|STARTED|Long-term Safety Phase (Year 5)||38
8777608|NCT01307423|9827540|FG008|STARTED|Long-term Safety Phase (Year 5)||44
8777609|NCT01307423|9827532|FG000|COMPLETED|Long-term Safety Phase (Year 5)||0
8777610|NCT01307423|9827533|FG001|COMPLETED|Long-term Safety Phase (Year 5)||71
8777611|NCT01307423|9827534|FG002|COMPLETED|Long-term Safety Phase (Year 5)||80
8777612|NCT01307423|9827535|FG003|COMPLETED|Long-term Safety Phase (Year 5)||0
8777613|NCT01307423|9827536|FG004|COMPLETED|Long-term Safety Phase (Year 5)||0
8777614|NCT01307423|9827537|FG005|COMPLETED|Long-term Safety Phase (Year 5)||0
8777615|NCT01307423|9827538|FG006|COMPLETED|Long-term Safety Phase (Year 5)||0
8777616|NCT01307423|9827539|FG007|COMPLETED|Long-term Safety Phase (Year 5)||37
8777617|NCT01307423|9827540|FG008|COMPLETED|Long-term Safety Phase (Year 5)||41
8777618|NCT01307423|9827532|FG000|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
8777619|NCT01307423|9827533|FG001|NOT COMPLETED|Long-term Safety Phase (Year 5)||10
8777620|NCT01307423|9827534|FG002|NOT COMPLETED|Long-term Safety Phase (Year 5)||6
8777621|NCT01307423|9827535|FG003|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
8777622|NCT01307423|9827536|FG004|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
8777623|NCT01307423|9827537|FG005|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
8777624|NCT01307423|9827538|FG006|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
8777625|NCT01307423|9827539|FG007|NOT COMPLETED|Long-term Safety Phase (Year 5)||1
8777626|NCT01307423|9827540|FG008|NOT COMPLETED|Long-term Safety Phase (Year 5)||3
8777627|NCT01307449|9827576|FG000|STARTED|Overall Study||33
8777628|NCT01307449|9827577|FG001|STARTED|Overall Study||33
8777629|NCT01307449|9827578|FG002|STARTED|Overall Study||11
8777630|NCT01307449|9827579|FG003|STARTED|Overall Study||11
8777631|NCT01307449|9827576|FG000|COMPLETED|Overall Study||32
8777632|NCT01307449|9827577|FG001|COMPLETED|Overall Study||33
8777633|NCT01307449|9827578|FG002|COMPLETED|Overall Study||11
8777634|NCT01307449|9827579|FG003|COMPLETED|Overall Study||11
8777635|NCT01307449|9827576|FG000|NOT COMPLETED|Overall Study||1
8777636|NCT01307449|9827577|FG001|NOT COMPLETED|Overall Study||0
8777637|NCT01307449|9827578|FG002|NOT COMPLETED|Overall Study||0
8777638|NCT01307449|9827579|FG003|NOT COMPLETED|Overall Study||0
8777639|NCT01307462|9827589|FG000|STARTED|Overall Study||36
8777640|NCT01307462|9827589|FG000|COMPLETED|Overall Study||35
8777641|NCT01307462|9827589|FG000|NOT COMPLETED|Overall Study||1
8777642|NCT01307501|9827593|FG000|STARTED|Overall Study||40
8777643|NCT01307501|9827593|FG000|Intent-to-Treat (ITT) Population|Overall Study||40
8777644|NCT01307501|9827593|FG000|COMPLETED|Overall Study||17
8777645|NCT01307501|9827593|FG000|NOT COMPLETED|Overall Study||23
8777646|NCT01307579|9827599|FG000|STARTED|Overall Study||257
8777647|NCT01307579|9827600|FG001|STARTED|Overall Study||260
8777648|NCT01307579|9827599|FG000|COMPLETED|Overall Study||117
8777649|NCT01307579|9827600|FG001|COMPLETED|Overall Study||115
8777650|NCT01307579|9827599|FG000|NOT COMPLETED|Overall Study||140
8777651|NCT01307579|9827600|FG001|NOT COMPLETED|Overall Study||145
8777652|NCT01307618|9827608|FG000|STARTED|Overall Study||5
8777653|NCT01307618|9827609|FG001|STARTED|Overall Study||5
8777654|NCT01307618|9827608|FG000|COMPLETED|Overall Study||5
8777655|NCT01307618|9827609|FG001|COMPLETED|Overall Study||5
8777656|NCT01307618|9827608|FG000|NOT COMPLETED|Overall Study||0
8777657|NCT01307618|9827609|FG001|NOT COMPLETED|Overall Study||0
8777658|NCT01307748|9827618|FG000|STARTED|Overall Study||31
8777659|NCT01307748|9827619|FG001|STARTED|Overall Study||31
8777660|NCT01307748|9827620|FG002|STARTED|Overall Study||30
8777661|NCT01307748|9827618|FG000|COMPLETED|Overall Study||31
8777662|NCT01307748|9827619|FG001|COMPLETED|Overall Study||31
8777663|NCT01307748|9827620|FG002|COMPLETED|Overall Study||30
8777664|NCT01307748|9827618|FG000|NOT COMPLETED|Overall Study||0
8777665|NCT01307748|9827619|FG001|NOT COMPLETED|Overall Study||0
8777666|NCT01307748|9827620|FG002|NOT COMPLETED|Overall Study||0
8777667|NCT01307891|9827636|FG000|STARTED|Overall Study||42
8777668|NCT01307891|9827637|FG001|STARTED|Overall Study||22
8777669|NCT01307891|9827636|FG000|COMPLETED|Overall Study||39
8777670|NCT01307891|9827637|FG001|COMPLETED|Overall Study||21
8777671|NCT01307891|9827636|FG000|NOT COMPLETED|Overall Study||3
8777672|NCT01307891|9827637|FG001|NOT COMPLETED|Overall Study||1
8777673|NCT01307930|9827643|FG000|STARTED|Overall Study||20
8777674|NCT01307930|9827643|FG000|COMPLETED|Overall Study||18
8777675|NCT01307930|9827643|FG000|NOT COMPLETED|Overall Study||2
8777676|NCT01307956|9827647|FG000|STARTED|Overall Study||11
8777677|NCT01307956|9827647|FG000|COMPLETED|Overall Study||11
8777678|NCT01307956|9827647|FG000|NOT COMPLETED|Overall Study||0
8777679|NCT01308008|9827653|FG000|STARTED|4 Weeks||71
8777680|NCT01308008|9827654|FG001|STARTED|4 Weeks||73
8777681|NCT01308008|9827653|FG000|COMPLETED|4 Weeks||62
8777682|NCT01308008|9827654|FG001|COMPLETED|4 Weeks||71
8777683|NCT01308008|9827653|FG000|NOT COMPLETED|4 Weeks||9
8777684|NCT01308008|9827654|FG001|NOT COMPLETED|4 Weeks||2
8777685|NCT01308008|9827653|FG000|STARTED|6 Months||62
8777686|NCT01308008|9827654|FG001|STARTED|6 Months||71
8777687|NCT01308008|9827653|FG000|COMPLETED|6 Months||54
8777688|NCT01308008|9827654|FG001|COMPLETED|6 Months||62
8777689|NCT01308008|9827653|FG000|NOT COMPLETED|6 Months||8
8777690|NCT01308008|9827654|FG001|NOT COMPLETED|6 Months||9
8777691|NCT01308008|9827653|FG000|STARTED|12 Months||54
8777692|NCT01308008|9827654|FG001|STARTED|12 Months||62
8777693|NCT01308008|9827653|FG000|COMPLETED|12 Months||46
8777694|NCT01308008|9827654|FG001|COMPLETED|12 Months||58
8777695|NCT01308008|9827653|FG000|NOT COMPLETED|12 Months||8
8777696|NCT01308008|9827654|FG001|NOT COMPLETED|12 Months||4
8777697|NCT01308060|9827662|FG000|STARTED|Part A||252
8777698|NCT01308060|9827663|FG001|STARTED|Part A||83
8777699|NCT01308060|9827662|FG000|COMPLETED|Part A||238
8777700|NCT01308060|9827663|FG001|COMPLETED|Part A||77
8777701|NCT01308060|9827662|FG000|NOT COMPLETED|Part A||14
8777702|NCT01308060|9827663|FG001|NOT COMPLETED|Part A||6
8777703|NCT01308060|9827662|FG000|STARTED|Part B||238
8777704|NCT01308060|9827663|FG001|STARTED|Part B||77
8777705|NCT01308060|9827662|FG000|COMPLETED|Part B||219
8777706|NCT01308060|9827663|FG001|COMPLETED|Part B||69
8777707|NCT01308060|9827662|FG000|NOT COMPLETED|Part B||19
8777708|NCT01308060|9827663|FG001|NOT COMPLETED|Part B||8
8777709|NCT01308294|9827673|FG000|STARTED|Cycle 1||10
8777710|NCT01308294|9827674|FG001|STARTED|Cycle 1||6
8777711|NCT01308294|9827675|FG002|STARTED|Cycle 1||0
8777712|NCT01308294|9827673|FG000|COMPLETED|Cycle 1||10
8777713|NCT01308294|9827674|FG001|COMPLETED|Cycle 1||6
8777714|NCT01308294|9827675|FG002|COMPLETED|Cycle 1||0
8777715|NCT01308294|9827673|FG000|NOT COMPLETED|Cycle 1||0
8777716|NCT01308294|9827674|FG001|NOT COMPLETED|Cycle 1||0
8777717|NCT01308294|9827675|FG002|NOT COMPLETED|Cycle 1||0
8777718|NCT01308294|9827673|FG000|STARTED|Cycle 2||10
8777719|NCT01308294|9827674|FG001|STARTED|Cycle 2||6
8777720|NCT01308294|9827675|FG002|STARTED|Cycle 2||0
8777721|NCT01308294|9827673|FG000|COMPLETED|Cycle 2||10
8777722|NCT01308294|9827674|FG001|COMPLETED|Cycle 2||5
8777723|NCT01308294|9827675|FG002|COMPLETED|Cycle 2||0
8777724|NCT01308294|9827673|FG000|NOT COMPLETED|Cycle 2||0
8777725|NCT01308294|9827674|FG001|NOT COMPLETED|Cycle 2||1
8777726|NCT01308294|9827675|FG002|NOT COMPLETED|Cycle 2||0
8777727|NCT01308294|9827673|FG000|STARTED|Cycle 3||10
8777728|NCT01308294|9827674|FG001|STARTED|Cycle 3||5
8777729|NCT01308294|9827675|FG002|STARTED|Cycle 3||0
8777730|NCT01308294|9827673|FG000|COMPLETED|Cycle 3||10
8777731|NCT01308294|9827674|FG001|COMPLETED|Cycle 3||4
8777732|NCT01308294|9827675|FG002|COMPLETED|Cycle 3||0
8777733|NCT01308294|9827673|FG000|NOT COMPLETED|Cycle 3||0
8777734|NCT01308294|9827674|FG001|NOT COMPLETED|Cycle 3||1
8777735|NCT01308294|9827675|FG002|NOT COMPLETED|Cycle 3||0
8777736|NCT01308424|9827688|FG000|STARTED|Baseline Eligibility||242
8777737|NCT01308424|9827689|FG001|STARTED|Baseline Eligibility||0
8777738|NCT01308424|9827690|FG002|STARTED|Baseline Eligibility||0
8777739|NCT01308424|9827688|FG000|COMPLETED|Baseline Eligibility|Completed baseline run in and were eligible for randomization|171
8777740|NCT01308424|9827689|FG001|COMPLETED|Baseline Eligibility||0
8777741|NCT01308424|9827690|FG002|COMPLETED|Baseline Eligibility||0
8777742|NCT01308424|9827688|FG000|NOT COMPLETED|Baseline Eligibility||71
8777743|NCT01308424|9827689|FG001|NOT COMPLETED|Baseline Eligibility||0
8777744|NCT01308424|9827690|FG002|NOT COMPLETED|Baseline Eligibility||0
9029439|NCT03218592|10091771|FG000|NOT COMPLETED|Phase 3: 3 Doses Per Week||0
9029440|NCT03218592|10091772|FG001|NOT COMPLETED|Phase 3: 3 Doses Per Week||0
9029441|NCT03218592|10091773|FG002|NOT COMPLETED|Phase 3: 3 Doses Per Week||0
9029442|NCT03218787|10091786|FG000|STARTED|Overall Study||2047
9029443|NCT03218787|10091786|FG000|COMPLETED|Overall Study||1841
9029444|NCT03218787|10091786|FG000|NOT COMPLETED|Overall Study||206
9029445|NCT03219216|10091792|FG000|STARTED|Overall Study||75
9029446|NCT03219216|10091793|FG001|STARTED|Overall Study||25
9029447|NCT03219216|10091792|FG000|COMPLETED|Overall Study||75
9029448|NCT03219216|10091793|FG001|COMPLETED|Overall Study||24
9029449|NCT03219216|10091792|FG000|NOT COMPLETED|Overall Study||0
9029450|NCT03219216|10091793|FG001|NOT COMPLETED|Overall Study||1
9029451|NCT03219294|10091800|FG000|STARTED|Overall Study||58
9029452|NCT03219294|10091801|FG001|STARTED|Overall Study||58
9029453|NCT03219294|10091800|FG000|COMPLETED|Overall Study||58
9029454|NCT03219294|10091801|FG001|COMPLETED|Overall Study||58
9029455|NCT03219294|10091800|FG000|NOT COMPLETED|Overall Study||0
9029456|NCT03219294|10091801|FG001|NOT COMPLETED|Overall Study||0
9029457|NCT03219320|10091811|FG000|STARTED|Overall Study||75
9029458|NCT03219320|10091812|FG001|STARTED|Overall Study||77
8777745|NCT01308424|9827688|FG000|STARTED|Randomization||0
8777746|NCT01308424|9827689|FG001|STARTED|Randomization||87
8777747|NCT01308424|9827690|FG002|STARTED|Randomization||84
8777748|NCT01308424|9827688|FG000|COMPLETED|Randomization||0
8777749|NCT01308424|9827689|FG001|COMPLETED|Randomization||84
8777750|NCT01308424|9827690|FG002|COMPLETED|Randomization||82
8777751|NCT01308424|9827688|FG000|NOT COMPLETED|Randomization||0
8777752|NCT01308424|9827689|FG001|NOT COMPLETED|Randomization||3
8777753|NCT01308424|9827690|FG002|NOT COMPLETED|Randomization||2
9029459|NCT03219320|10091813|FG002|STARTED|Overall Study||77
9029460|NCT03219320|10091814|FG003|STARTED|Overall Study||72
9029461|NCT03219320|10091811|FG000|COMPLETED|Overall Study||73
9029462|NCT03219320|10091812|FG001|COMPLETED|Overall Study||74
8777754|NCT01308450|9827697|FG000|STARTED|Overall Study|302 subjects were screen. 300 subjects were enrolled in this one site, one visit study.|302
8777755|NCT01308450|9827697|FG000|COMPLETED|Overall Study|Last subject was enrolled 06/28/2011|300
8777756|NCT01308450|9827697|FG000|NOT COMPLETED|Overall Study||2
8777757|NCT01308463|9827701|FG000|STARTED|Overall Study||29
8777758|NCT01308463|9827701|FG000|6 Months|Overall Study||23
8777759|NCT01308463|9827701|FG000|1 Year|Overall Study||21
8777760|NCT01308463|9827701|FG000|2 Years|Overall Study||18
8777761|NCT01308463|9827701|FG000|3 Years|Overall Study||17
8777762|NCT01308463|9827701|FG000|4 Years|Overall Study||20
8777763|NCT01308463|9827701|FG000|5 Years|Overall Study||20
8777764|NCT01308463|9827701|FG000|6 Years|Overall Study||11
8777765|NCT01308463|9827701|FG000|7 Years|Overall Study||12
8777766|NCT01308463|9827701|FG000|8 Years|Overall Study||14
8777767|NCT01308463|9827701|FG000|9 Years|Overall Study||11
8777768|NCT01308463|9827701|FG000|10 Years|Overall Study||8
8777769|NCT01308463|9827701|FG000|11 Years|Overall Study||8
8777770|NCT01308463|9827701|FG000|12 Years|Overall Study||2
8777771|NCT01308463|9827701|FG000|COMPLETED|Overall Study||0
8777772|NCT01308463|9827701|FG000|NOT COMPLETED|Overall Study||29
8777773|NCT01308476|9827707|FG000|STARTED|Overall Study|Entered and treated.|48
8777774|NCT01308476|9827708|FG001|STARTED|Overall Study|Entered and treated.|47
8777775|NCT01308476|9827707|FG000|COMPLETED|Overall Study||45
8777776|NCT01308476|9827708|FG001|COMPLETED|Overall Study||45
8777777|NCT01308476|9827707|FG000|NOT COMPLETED|Overall Study||3
8777778|NCT01308476|9827708|FG001|NOT COMPLETED|Overall Study||2
8777779|NCT01308567|9827717|FG000|STARTED|Overall Study|Randomized|391
8777780|NCT01308567|9827718|FG001|STARTED|Overall Study|Randomized|389
8777781|NCT01308567|9827719|FG002|STARTED|Overall Study|Randomized|388
8777782|NCT01308567|9827717|FG000|Treated|Overall Study|For 1 participant, actual treatment received was Cabazitaxel 25 mg/m^2.|388
8777783|NCT01308567|9827718|FG001|Treated|Overall Study|For 15 participants, actual treatment received was Cabazitaxel 25 mg/m^2.|382
8777784|NCT01308567|9827719|FG002|Treated|Overall Study|For 2 participants, actual treatment received was Cabazitaxel 20 mg/m^2.|377
8777785|NCT01308567|9827717|FG000|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival.|389
8777786|NCT01308567|9827718|FG001|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival.|385
8777787|NCT01308567|9827719|FG002|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival.|384
8777788|NCT01308567|9827717|FG000|NOT COMPLETED|Overall Study||2
8777789|NCT01308567|9827718|FG001|NOT COMPLETED|Overall Study||4
8777790|NCT01308567|9827719|FG002|NOT COMPLETED|Overall Study||4
8777791|NCT01308580|9827729|FG000|STARTED|Overall Study||598
8777792|NCT01308580|9827730|FG001|STARTED|Overall Study||602
8777793|NCT01308580|9827729|FG000|Treated|Overall Study|Random assignment, was not actual treatment in some cases|587
8777794|NCT01308580|9827730|FG001|Treated|Overall Study|Random assignment, was not actual treatment in some cases|588
8777795|NCT01308580|9827729|FG000|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival|586
8777796|NCT01308580|9827730|FG001|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival|595
8777797|NCT01308580|9827729|FG000|NOT COMPLETED|Overall Study||12
8777798|NCT01308580|9827730|FG001|NOT COMPLETED|Overall Study||7
8777799|NCT01308619|9827739|FG000|STARTED|Overall Study||84
8777800|NCT01308619|9827740|FG001|STARTED|Overall Study||86
8777801|NCT01308619|9827739|FG000|COMPLETED|Overall Study||77
8777802|NCT01308619|9827740|FG001|COMPLETED|Overall Study||83
8777803|NCT01308619|9827739|FG000|NOT COMPLETED|Overall Study||7
8777804|NCT01308619|9827740|FG001|NOT COMPLETED|Overall Study||3
8777805|NCT01308736|9827750|FG000|STARTED|Overall Study||31
8777806|NCT01308736|9827751|FG001|STARTED|Overall Study||32
8777807|NCT01308736|9827750|FG000|COMPLETED|Overall Study||25
8777808|NCT01308736|9827751|FG001|COMPLETED|Overall Study||27
8777809|NCT01308736|9827750|FG000|NOT COMPLETED|Overall Study||6
8777810|NCT01308736|9827751|FG001|NOT COMPLETED|Overall Study||5
8777811|NCT01308749|9827759|FG000|STARTED|Period 1: Double Blind Treatment||12
8777812|NCT01308749|9827760|FG001|STARTED|Period 1: Double Blind Treatment||13
8777813|NCT01308749|9827759|FG000|COMPLETED|Period 1: Double Blind Treatment||11
9029463|NCT03219320|10091813|FG002|COMPLETED|Overall Study||72
9029464|NCT03219320|10091814|FG003|COMPLETED|Overall Study||69
9029465|NCT03219320|10091811|FG000|NOT COMPLETED|Overall Study||2
9029466|NCT03219320|10091812|FG001|NOT COMPLETED|Overall Study||3
9029467|NCT03219320|10091813|FG002|NOT COMPLETED|Overall Study||5
9029468|NCT03219320|10091814|FG003|NOT COMPLETED|Overall Study||3
9029469|NCT03219723|10091824|FG000|STARTED|Overall Study||560
9029470|NCT03219723|10091824|FG000|COMPLETED|Overall Study||550
9029471|NCT03219723|10091824|FG000|NOT COMPLETED|Overall Study||10
9029472|NCT03219840|10091828|FG000|STARTED|Overall Study||38
9029473|NCT03219840|10091829|FG001|STARTED|Overall Study||31
9029474|NCT03219840|10091828|FG000|Day 1 Visit for 1st Period|Overall Study||37
9029475|NCT03219840|10091829|FG001|Day 1 Visit for 1st Period|Overall Study||31
9029476|NCT03219840|10091828|FG000|1st Intervention Period of 21 Days|Overall Study||34
9029477|NCT03219840|10091829|FG001|1st Intervention Period of 21 Days|Overall Study||31
9029478|NCT03219840|10091828|FG000|Day 22 Visit for 1st Period|Overall Study||34
9029479|NCT03219840|10091829|FG001|Day 22 Visit for 1st Period|Overall Study||31
9029480|NCT03219840|10091828|FG000|Washout Period of 21 Days|Overall Study||34
9029481|NCT03219840|10091829|FG001|Washout Period of 21 Days|Overall Study||31
9029482|NCT03219840|10091828|FG000|Day 1 Visit for 2nd Period|Overall Study||34
9029483|NCT03219840|10091829|FG001|Day 1 Visit for 2nd Period|Overall Study||31
8777814|NCT01308749|9827760|FG001|COMPLETED|Period 1: Double Blind Treatment||13
8777815|NCT01308749|9827759|FG000|NOT COMPLETED|Period 1: Double Blind Treatment||1
8777816|NCT01308749|9827760|FG001|NOT COMPLETED|Period 1: Double Blind Treatment||0
8777817|NCT01308749|9827759|FG000|STARTED|Period 2: Open Label Treatment||11
9029484|NCT03219840|10091828|FG000|2nd Intervention Period of 21 Days|Overall Study||34
8777818|NCT01308749|9827760|FG001|STARTED|Period 2: Open Label Treatment||13
8777819|NCT01308749|9827759|FG000|COMPLETED|Period 2: Open Label Treatment||11
8777820|NCT01308749|9827760|FG001|COMPLETED|Period 2: Open Label Treatment||11
8777821|NCT01308749|9827759|FG000|NOT COMPLETED|Period 2: Open Label Treatment||0
8777822|NCT01308749|9827760|FG001|NOT COMPLETED|Period 2: Open Label Treatment||2
8777823|NCT01308762|9827783|FG000|STARTED|Overall Study||6
8777824|NCT01308762|9827784|FG001|STARTED|Overall Study||7
8777825|NCT01308762|9827785|FG002|STARTED|Overall Study||6
8777826|NCT01308762|9827783|FG000|COMPLETED|Overall Study||6
8777827|NCT01308762|9827784|FG001|COMPLETED|Overall Study|One patient was withdrawn as they were retrospecively found to have been ineligible at study entry|6
8777828|NCT01308762|9827785|FG002|COMPLETED|Overall Study||6
8777829|NCT01308762|9827783|FG000|NOT COMPLETED|Overall Study||0
8777830|NCT01308762|9827784|FG001|NOT COMPLETED|Overall Study||1
8777831|NCT01308762|9827785|FG002|NOT COMPLETED|Overall Study||0
8777832|NCT01308788|9827798|FG000|STARTED|6-month Treatment||14
8777833|NCT01308788|9827799|FG001|STARTED|6-month Treatment||21
8777834|NCT01308788|9827798|FG000|COMPLETED|6-month Treatment||14
8777835|NCT01308788|9827799|FG001|COMPLETED|6-month Treatment||21
8777836|NCT01308788|9827798|FG000|NOT COMPLETED|6-month Treatment||0
8777837|NCT01308788|9827799|FG001|NOT COMPLETED|6-month Treatment||0
8777838|NCT01308788|9827798|FG000|STARTED|2-year Treatment||14
8777839|NCT01308788|9827799|FG001|STARTED|2-year Treatment||21
8777840|NCT01308788|9827798|FG000|COMPLETED|2-year Treatment||10
8777841|NCT01308788|9827799|FG001|COMPLETED|2-year Treatment||10
8777842|NCT01308788|9827798|FG000|NOT COMPLETED|2-year Treatment||4
8777843|NCT01308788|9827799|FG001|NOT COMPLETED|2-year Treatment||11
8777844|NCT01308814|9827807|FG000|STARTED|Overall Study||86
8777845|NCT01308814|9827808|FG001|STARTED|Overall Study||86
8777846|NCT01308814|9827807|FG000|COMPLETED|Overall Study||69
8777847|NCT01308814|9827808|FG001|COMPLETED|Overall Study||63
8777848|NCT01308814|9827807|FG000|NOT COMPLETED|Overall Study||17
8777849|NCT01308814|9827808|FG001|NOT COMPLETED|Overall Study||23
8777850|NCT01308840|9827814|FG000|STARTED|Overall Study||31
8777851|NCT01308840|9827814|FG000|COMPLETED|Overall Study||31
8777852|NCT01308840|9827814|FG000|NOT COMPLETED|Overall Study||0
8777853|NCT01308853|9827818|FG000|STARTED|Overall Study||24
8777854|NCT01308853|9827818|FG000|COMPLETED|Overall Study||20
8777855|NCT01308853|9827818|FG000|NOT COMPLETED|Overall Study||4
8777856|NCT01308918|9827822|FG000|STARTED|Overall Study||50
8777857|NCT01308918|9827822|FG000|COMPLETED|Overall Study||50
8777858|NCT01308918|9827822|FG000|NOT COMPLETED|Overall Study||0
8777859|NCT01309100|9827826|FG000|STARTED|Overall Study||144
8777860|NCT01309100|9827826|FG000|COMPLETED|Overall Study||142
8777861|NCT01309100|9827826|FG000|NOT COMPLETED|Overall Study||2
8777862|NCT01309165|9827835|FG000|STARTED|Overall Study||19
8777863|NCT01309165|9827836|FG001|STARTED|Overall Study||16
8777864|NCT01309165|9827835|FG000|Received Allocated Intervention|Overall Study||16
8777865|NCT01309165|9827836|FG001|Received Allocated Intervention|Overall Study||14
8777866|NCT01309165|9827835|FG000|Included in Primary Analysis|Overall Study||14
8777867|NCT01309165|9827836|FG001|Included in Primary Analysis|Overall Study||12
8777868|NCT01309165|9827835|FG000|COMPLETED|Overall Study||13
8777869|NCT01309165|9827836|FG001|COMPLETED|Overall Study||9
8777870|NCT01309165|9827835|FG000|NOT COMPLETED|Overall Study||6
8777871|NCT01309165|9827836|FG001|NOT COMPLETED|Overall Study||7
8777872|NCT01309204|9827845|FG000|STARTED|Overall Study||452
8777873|NCT01309204|9827846|FG001|STARTED|Overall Study||436
8777874|NCT01309204|9827845|FG000|COMPLETED|Overall Study||385
8777875|NCT01309204|9827846|FG001|COMPLETED|Overall Study||361
8777876|NCT01309204|9827845|FG000|NOT COMPLETED|Overall Study||67
8777877|NCT01309204|9827846|FG001|NOT COMPLETED|Overall Study||75
8777878|NCT01309243|9827854|FG000|STARTED|Randomized Phase Through Week 96||400
8777879|NCT01309243|9827855|FG001|STARTED|Randomized Phase Through Week 96||399
8777880|NCT01309243|9827854|FG000|Randomized and Treated|Randomized Phase Through Week 96||394
8777881|NCT01309243|9827855|FG001|Randomized and Treated|Randomized Phase Through Week 96||392
8777882|NCT01309243|9827854|FG000|COMPLETED|Randomized Phase Through Week 96||316
8777883|NCT01309243|9827855|FG001|COMPLETED|Randomized Phase Through Week 96||290
8777884|NCT01309243|9827854|FG000|NOT COMPLETED|Randomized Phase Through Week 96||84
8777885|NCT01309243|9827855|FG001|NOT COMPLETED|Randomized Phase Through Week 96||109
8777886|NCT01309243|9827854|FG000|STARTED|Extension Phase|40 participants from the Randomized Phase continued the study in the Extension Phase.|40
8777887|NCT01309243|9827855|FG001|STARTED|Extension Phase|117 participants from the Randomized Phase continued the study in the Extension Phase.|117
8777888|NCT01309243|9827854|FG000|COMPLETED|Extension Phase||34
8777889|NCT01309243|9827855|FG001|COMPLETED|Extension Phase||117
8777890|NCT01309243|9827854|FG000|NOT COMPLETED|Extension Phase||6
8777891|NCT01309243|9827855|FG001|NOT COMPLETED|Extension Phase||0
8777892|NCT01309269|9827861|FG000|STARTED|Overall Study||1085
8777893|NCT01309269|9827861|FG000|Treated|Overall Study||978
8777894|NCT01309269|9827861|FG000|COMPLETED|Overall Study||245
8777895|NCT01309269|9827861|FG000|NOT COMPLETED|Overall Study||840
8777896|NCT01309282|9827865|FG000|STARTED|Overall Study||9
8777897|NCT01309282|9827865|FG000|COMPLETED|Overall Study||8
8777898|NCT01309282|9827865|FG000|NOT COMPLETED|Overall Study||1
8777899|NCT01309308|9827871|FG000|STARTED|Overall Study||75
8777900|NCT01309308|9827872|FG001|STARTED|Overall Study||75
8777901|NCT01309308|9827871|FG000|COMPLETED|Overall Study||69
8777902|NCT01309308|9827872|FG001|COMPLETED|Overall Study||71
8777903|NCT01309308|9827871|FG000|NOT COMPLETED|Overall Study||6
9029485|NCT03219840|10091829|FG001|2nd Intervention Period of 21 Days|Overall Study||31
9029486|NCT03219840|10091828|FG000|Day 22 Visit for 2nd Period|Overall Study||34
9029487|NCT03219840|10091829|FG001|Day 22 Visit for 2nd Period|Overall Study||31
9029488|NCT03219840|10091828|FG000|COMPLETED|Overall Study||34
9029489|NCT03219840|10091829|FG001|COMPLETED|Overall Study||31
9029490|NCT03219840|10091828|FG000|NOT COMPLETED|Overall Study||4
9029491|NCT03219840|10091829|FG001|NOT COMPLETED|Overall Study||0
9029492|NCT03219866|10091837|FG000|STARTED|Overall Study||21
9029493|NCT03219866|10091838|FG001|STARTED|Overall Study||19
9029494|NCT03219866|10091837|FG000|COMPLETED|Overall Study||21
9029495|NCT03219866|10091838|FG001|COMPLETED|Overall Study||19
9029496|NCT03219866|10091837|FG000|NOT COMPLETED|Overall Study||0
9029497|NCT03219866|10091838|FG001|NOT COMPLETED|Overall Study||0
9029498|NCT03219892|10091846|FG000|STARTED|Overall Study||20
9029499|NCT03219892|10091847|FG001|STARTED|Overall Study||10
9029500|NCT03219892|10091846|FG000|COMPLETED|Overall Study||20
9029501|NCT03219892|10091847|FG001|COMPLETED|Overall Study||10
9029502|NCT03219892|10091846|FG000|NOT COMPLETED|Overall Study||0
9029503|NCT03219892|10091847|FG001|NOT COMPLETED|Overall Study||0
9029504|NCT03220048|10091856|FG000|STARTED|Overall Study||11
9029505|NCT03220048|10091857|FG001|STARTED|Overall Study||27
9029506|NCT03220048|10091858|FG002|STARTED|Overall Study||28
9029507|NCT03220048|10091856|FG000|COMPLETED|Overall Study||11
9029508|NCT03220048|10091857|FG001|COMPLETED|Overall Study||25
9029509|NCT03220048|10091858|FG002|COMPLETED|Overall Study||27
9029510|NCT03220048|10091856|FG000|NOT COMPLETED|Overall Study||0
9029511|NCT03220048|10091857|FG001|NOT COMPLETED|Overall Study||2
9029512|NCT03220048|10091858|FG002|NOT COMPLETED|Overall Study||1
9029513|NCT03220204|10091874|FG000|STARTED|Overall Study||15
9029514|NCT03220204|10091875|FG001|STARTED|Overall Study||15
9029515|NCT03220204|10091876|FG002|STARTED|Overall Study||15
9029516|NCT03220204|10091874|FG000|COMPLETED|Overall Study||14
9029517|NCT03220204|10091875|FG001|COMPLETED|Overall Study||13
9029518|NCT03220204|10091876|FG002|COMPLETED|Overall Study||12
9029519|NCT03220204|10091874|FG000|NOT COMPLETED|Overall Study||1
9029520|NCT03220204|10091875|FG001|NOT COMPLETED|Overall Study||2
9029521|NCT03220204|10091876|FG002|NOT COMPLETED|Overall Study||3
9029522|NCT03220217|10091890|FG000|STARTED|Overall Study||8
9029523|NCT03220217|10091891|FG001|STARTED|Overall Study||10
9029524|NCT03220217|10091892|FG002|STARTED|Overall Study||11
9029525|NCT03220217|10091890|FG000|COMPLETED|Overall Study||8
9029526|NCT03220217|10091891|FG001|COMPLETED|Overall Study||9
9029527|NCT03220217|10091892|FG002|COMPLETED|Overall Study||10
9029528|NCT03220217|10091890|FG000|NOT COMPLETED|Overall Study||0
9029529|NCT03220217|10091891|FG001|NOT COMPLETED|Overall Study||1
9029530|NCT03220217|10091892|FG002|NOT COMPLETED|Overall Study||1
9029531|NCT03220230|10091921|FG000|STARTED|Overall Study||4240
9029532|NCT03220230|10091921|FG000|COMPLETED|Overall Study||4240
9029533|NCT03220230|10091921|FG000|NOT COMPLETED|Overall Study||0
9029534|NCT03220412|10091927|FG000|STARTED|Overall Study||54
9029535|NCT03220412|10091928|FG001|STARTED|Overall Study||50
9029536|NCT03220412|10091927|FG000|COMPLETED|Overall Study||54
9029537|NCT03220412|10091928|FG001|COMPLETED|Overall Study||50
9029538|NCT03220412|10091927|FG000|NOT COMPLETED|Overall Study||0
9029539|NCT03220412|10091928|FG001|NOT COMPLETED|Overall Study||0
9029540|NCT03220737|10091943|FG000|STARTED|Main Study (Day 1 - 181)||163
9029541|NCT03220737|10091944|FG001|STARTED|Main Study (Day 1 - 181)||26
9029542|NCT03220737|10091945|FG002|STARTED|Main Study (Day 1 - 181)||158
9029543|NCT03220737|10091946|FG003|STARTED|Main Study (Day 1 - 181)||27
9029544|NCT03220737|10091947|FG004|STARTED|Main Study (Day 1 - 181)||150
9029545|NCT03220737|10091948|FG005|STARTED|Main Study (Day 1 - 181)||26
9029546|NCT03220737|10091949|FG006|STARTED|Main Study (Day 1 - 181)||2688
9029547|NCT03220737|10091943|FG000|COMPLETED|Main Study (Day 1 - 181)||157
9029548|NCT03220737|10091944|FG001|COMPLETED|Main Study (Day 1 - 181)||24
9029549|NCT03220737|10091945|FG002|COMPLETED|Main Study (Day 1 - 181)||146
9029550|NCT03220737|10091946|FG003|COMPLETED|Main Study (Day 1 - 181)||24
9029551|NCT03220737|10091947|FG004|COMPLETED|Main Study (Day 1 - 181)||130
9029552|NCT03220737|10091948|FG005|COMPLETED|Main Study (Day 1 - 181)||25
9029553|NCT03220737|10091949|FG006|COMPLETED|Main Study (Day 1 - 181)||2687
9029554|NCT03220737|10091943|FG000|NOT COMPLETED|Main Study (Day 1 - 181)||6
9029555|NCT03220737|10091944|FG001|NOT COMPLETED|Main Study (Day 1 - 181)||2
9029556|NCT03220737|10091945|FG002|NOT COMPLETED|Main Study (Day 1 - 181)||12
8671632|NCT00752908|9715023|FG001|NOT COMPLETED|Overall Study||0
8671633|NCT00752973|9715029|FG000|STARTED|Overall Study||12
8671634|NCT00752973|9715029|FG000|COMPLETED|Overall Study||12
8671635|NCT00752973|9715029|FG000|NOT COMPLETED|Overall Study||0
8671636|NCT00753012|9715037|FG000|STARTED|Overall Study||15
8671637|NCT00753012|9715038|FG001|STARTED|Overall Study||9
8671638|NCT00753012|9715037|FG000|COMPLETED|Overall Study||7
9029557|NCT03220737|10091946|FG003|NOT COMPLETED|Main Study (Day 1 - 181)||3
9029558|NCT03220737|10091947|FG004|NOT COMPLETED|Main Study (Day 1 - 181)||20
9029559|NCT03220737|10091948|FG005|NOT COMPLETED|Main Study (Day 1 - 181)||1
9029560|NCT03220737|10091949|FG006|NOT COMPLETED|Main Study (Day 1 - 181)||1
8671639|NCT00753012|9715038|FG001|COMPLETED|Overall Study||8
8671640|NCT00753012|9715037|FG000|NOT COMPLETED|Overall Study||8
8671641|NCT00753012|9715038|FG001|NOT COMPLETED|Overall Study||1
8671642|NCT00753142|9715048|FG000|STARTED|Overall Study||8
8671643|NCT00753142|9715049|FG001|STARTED|Overall Study||7
9029561|NCT03220737|10091943|FG000|STARTED|Placebo Crossover (Day 181-365)|Only placebo subjects who opted to receive Vaxchora were included in the crossover group.|13
8777904|NCT01309308|9827872|FG001|NOT COMPLETED|Overall Study||4
8777905|NCT01309360|9827881|FG000|STARTED|Overall Study||40
8777906|NCT01309360|9827882|FG001|STARTED|Overall Study||40
8777907|NCT01309360|9827883|FG002|STARTED|Overall Study||40
8777908|NCT01309360|9827881|FG000|COMPLETED|Overall Study||40
8777909|NCT01309360|9827882|FG001|COMPLETED|Overall Study||40
8777910|NCT01309360|9827883|FG002|COMPLETED|Overall Study||40
8777911|NCT01309360|9827881|FG000|NOT COMPLETED|Overall Study||0
8777912|NCT01309360|9827882|FG001|NOT COMPLETED|Overall Study||0
8777913|NCT01309360|9827883|FG002|NOT COMPLETED|Overall Study||0
8777914|NCT01309386|9827893|FG000|STARTED|Overall Study||50
8777915|NCT01309386|9827894|FG001|STARTED|Overall Study||50
8777916|NCT01309386|9827893|FG000|COMPLETED|Overall Study||28
8777917|NCT01309386|9827894|FG001|COMPLETED|Overall Study||29
8777918|NCT01309386|9827893|FG000|NOT COMPLETED|Overall Study||22
8777919|NCT01309386|9827894|FG001|NOT COMPLETED|Overall Study||21
8777920|NCT01309451|9827902|FG000|STARTED|Overall Study|unit of measure is number of eyes|19
8777921|NCT01309451|9827903|FG001|STARTED|Overall Study|unit of measure is number of eyes|21
8777922|NCT01309451|9827902|FG000|COMPLETED|Overall Study|unit of measure is number of eyes|17
8777923|NCT01309451|9827903|FG001|COMPLETED|Overall Study|unit of measure is number of eyes|18
8777924|NCT01309451|9827902|FG000|NOT COMPLETED|Overall Study||2
8777925|NCT01309451|9827903|FG001|NOT COMPLETED|Overall Study||3
8777926|NCT01309646|9827913|FG000|STARTED|Overall Study||224
8777927|NCT01309646|9827914|FG001|STARTED|Overall Study||227
8777928|NCT01309646|9827913|FG000|COMPLETED|Overall Study||224
8777929|NCT01309646|9827914|FG001|COMPLETED|Overall Study||227
8777930|NCT01309646|9827913|FG000|NOT COMPLETED|Overall Study||0
8777931|NCT01309646|9827914|FG001|NOT COMPLETED|Overall Study||0
8777932|NCT01309659|9827922|FG000|STARTED|Overall Study||9
8777933|NCT01309659|9827923|FG001|STARTED|Overall Study||10
8777934|NCT01309659|9827922|FG000|COMPLETED|Overall Study||9
8777935|NCT01309659|9827923|FG001|COMPLETED|Overall Study||9
8777936|NCT01309659|9827922|FG000|NOT COMPLETED|Overall Study||0
8777937|NCT01309659|9827923|FG001|NOT COMPLETED|Overall Study||1
8777938|NCT01309737|9827932|FG000|STARTED|Week 0 to 16||383
8777939|NCT01309737|9827933|FG001|STARTED|Week 0 to 16||381
8777940|NCT01309737|9827934|FG002|STARTED|Week 0 to 16||196
8777941|NCT01309737|9827935|FG003|STARTED|Week 0 to 16||0
8777942|NCT01309737|9827936|FG004|STARTED|Week 0 to 16||0
8777943|NCT01309737|9827932|FG000|Treated|Week 0 to 16||382
8777944|NCT01309737|9827933|FG001|Treated|Week 0 to 16||381
8777945|NCT01309737|9827934|FG002|Treated|Week 0 to 16||196
8777946|NCT01309737|9827935|FG003|Treated|Week 0 to 16||0
8777947|NCT01309737|9827936|FG004|Treated|Week 0 to 16||0
8777948|NCT01309737|9827932|FG000|COMPLETED|Week 0 to 16||331
8777949|NCT01309737|9827933|FG001|COMPLETED|Week 0 to 16||341
8777950|NCT01309737|9827934|FG002|COMPLETED|Week 0 to 16||152
8777951|NCT01309737|9827935|FG003|COMPLETED|Week 0 to 16||0
8777952|NCT01309737|9827936|FG004|COMPLETED|Week 0 to 16||0
8777953|NCT01309737|9827932|FG000|NOT COMPLETED|Week 0 to 16||52
8777954|NCT01309737|9827933|FG001|NOT COMPLETED|Week 0 to 16||40
8777955|NCT01309737|9827934|FG002|NOT COMPLETED|Week 0 to 16||44
8777956|NCT01309737|9827935|FG003|NOT COMPLETED|Week 0 to 16||0
8777957|NCT01309737|9827936|FG004|NOT COMPLETED|Week 0 to 16||0
8777958|NCT01309737|9827932|FG000|STARTED|Week 16 to 52||331
8777959|NCT01309737|9827933|FG001|STARTED|Week 16 to 52||341
8777960|NCT01309737|9827934|FG002|STARTED|Week 16 to 52||0
8777961|NCT01309737|9827935|FG003|STARTED|Week 16 to 52||75
8777962|NCT01309737|9827936|FG004|STARTED|Week 16 to 52||77
8777963|NCT01309737|9827932|FG000|COMPLETED|Week 16 to 52||198
8777964|NCT01309737|9827933|FG001|COMPLETED|Week 16 to 52||238
8777965|NCT01309737|9827934|FG002|COMPLETED|Week 16 to 52||0
8777966|NCT01309737|9827935|FG003|COMPLETED|Week 16 to 52||41
8777967|NCT01309737|9827936|FG004|COMPLETED|Week 16 to 52||44
8777968|NCT01309737|9827932|FG000|NOT COMPLETED|Week 16 to 52||133
8777969|NCT01309737|9827933|FG001|NOT COMPLETED|Week 16 to 52||103
8777970|NCT01309737|9827934|FG002|NOT COMPLETED|Week 16 to 52||0
8777971|NCT01309737|9827935|FG003|NOT COMPLETED|Week 16 to 52||34
8777972|NCT01309737|9827936|FG004|NOT COMPLETED|Week 16 to 52||33
8777973|NCT01309802|9827961|FG000|STARTED|Overall Study||25
8777974|NCT01309802|9827962|FG001|STARTED|Overall Study||23
8777975|NCT01309802|9827961|FG000|COMPLETED|Overall Study||13
8777976|NCT01309802|9827962|FG001|COMPLETED|Overall Study||14
8777977|NCT01309802|9827961|FG000|NOT COMPLETED|Overall Study||12
8777978|NCT01309802|9827962|FG001|NOT COMPLETED|Overall Study||9
8777979|NCT01309828|9827970|FG000|STARTED|Overall Study||77
8777980|NCT01309828|9827971|FG001|STARTED|Overall Study||76
8777981|NCT01309828|9827970|FG000|COMPLETED|Overall Study||61
8777982|NCT01309828|9827971|FG001|COMPLETED|Overall Study||60
8777983|NCT01309828|9827970|FG000|NOT COMPLETED|Overall Study||16
8777984|NCT01309828|9827971|FG001|NOT COMPLETED|Overall Study||16
8777985|NCT01309841|9827980|FG000|STARTED|Overall Study||217
8777986|NCT01309841|9827981|FG001|STARTED|Overall Study||218
8777987|NCT01309841|9827982|FG002|STARTED|Overall Study||217
8777988|NCT01309841|9827980|FG000|COMPLETED|Overall Study||178
8777989|NCT01309841|9827981|FG001|COMPLETED|Overall Study||177
8777990|NCT01309841|9827982|FG002|COMPLETED|Overall Study||180
8777991|NCT01309841|9827980|FG000|NOT COMPLETED|Overall Study||39
8777992|NCT01309841|9827981|FG001|NOT COMPLETED|Overall Study||41
8777993|NCT01309841|9827982|FG002|NOT COMPLETED|Overall Study||37
8777994|NCT01309867|9827990|FG000|STARTED|Overall Study||151
8777995|NCT01309867|9827991|FG001|STARTED|Overall Study||151
8777996|NCT01309867|9827990|FG000|COMPLETED|Overall Study||148
8777997|NCT01309867|9827991|FG001|COMPLETED|Overall Study||139
8777998|NCT01309867|9827990|FG000|NOT COMPLETED|Overall Study||3
8777999|NCT01309867|9827991|FG001|NOT COMPLETED|Overall Study||12
8778000|NCT01309880|9827997|FG000|STARTED|Overall Study||33
8778001|NCT01309880|9827998|FG001|STARTED|Overall Study||33
8778002|NCT01309880|9827997|FG000|COMPLETED|Overall Study||33
8778003|NCT01309880|9827998|FG001|COMPLETED|Overall Study||33
8778004|NCT01309880|9827997|FG000|NOT COMPLETED|Overall Study||0
8778005|NCT01309880|9827998|FG001|NOT COMPLETED|Overall Study||0
8778006|NCT01309893|9828004|FG000|STARTED|Week 1 - First Intervention||33
8778007|NCT01309893|9828005|FG001|STARTED|Week 1 - First Intervention||33
8778008|NCT01309893|9828004|FG000|COMPLETED|Week 1 - First Intervention||33
8778009|NCT01309893|9828005|FG001|COMPLETED|Week 1 - First Intervention||33
8778010|NCT01309893|9828004|FG000|NOT COMPLETED|Week 1 - First Intervention||0
8916339|NCT02182440|9975939|FG000|NOT COMPLETED|Overall Study||45
8916340|NCT02182440|9975940|FG001|NOT COMPLETED|Overall Study||14
8916341|NCT02182440|9975941|FG002|NOT COMPLETED|Overall Study||11
8916342|NCT02182440|9975942|FG003|NOT COMPLETED|Overall Study||30
8916343|NCT02182492|9975956|FG000|STARTED|Overall Study|CRSsNP: 28; Non-Eos CRSwNP: 34; Eos CRSwNP: 31|93
8916344|NCT02182492|9975957|FG001|STARTED|Overall Study|CRSsNP: 30; Non-Eos CRSwNP: 32; Eos CRSwNP: 32|94
8916345|NCT02182492|9975956|FG000|COMPLETED|Overall Study|CRSsNP: 27; Non-Eos CRSwNP: 31; Eos CRSwNP: 28|86
8916346|NCT02182492|9975957|FG001|COMPLETED|Overall Study|CRSsNP: 29; Non-Eos CRSwNP: 28; Eos CRSwNP: 29|86
8916347|NCT02182492|9975956|FG000|NOT COMPLETED|Overall Study||7
8916348|NCT02182492|9975957|FG001|NOT COMPLETED|Overall Study||8
8916349|NCT02182804|9975963|FG000|STARTED|Overall Study||44
8916350|NCT02182804|9975963|FG000|COMPLETED|Overall Study||44
8916351|NCT02182804|9975963|FG000|NOT COMPLETED|Overall Study||0
8916352|NCT02182830|9975969|FG000|STARTED|Overall Study||83
8916353|NCT02182830|9975970|FG001|STARTED|Overall Study||83
8916354|NCT02182830|9975969|FG000|Randomised Set (RS)|Overall Study|From started, 2 duplicate patients and 2 patients from one site were removed|79
8916355|NCT02182830|9975970|FG001|Randomised Set (RS)|Overall Study|From started, 1 patient from one site was removed|82
8916356|NCT02182830|9975969|FG000|Treated Set (TS)|Overall Study|From RS, 1 duplicate patient and 1 non treated patient was removed|77
8916357|NCT02182830|9975970|FG001|Treated Set (TS)|Overall Study|From RS, 1 duplicate patient and 1 non treated patient was removed|80
8916358|NCT02182830|9975969|FG000|COMPLETED|Overall Study||68
8916359|NCT02182830|9975970|FG001|COMPLETED|Overall Study||68
8916360|NCT02182830|9975969|FG000|NOT COMPLETED|Overall Study||15
8916361|NCT02182830|9975970|FG001|NOT COMPLETED|Overall Study||15
8916362|NCT02182843|9975976|FG000|STARTED|Overall Study||81
8916363|NCT02182843|9975976|FG000|COMPLETED|Overall Study||71
8916364|NCT02182843|9975976|FG000|NOT COMPLETED|Overall Study||10
8916365|NCT02182895|9975982|FG000|STARTED|Overall Study||35
8916366|NCT02182895|9975983|FG001|STARTED|Overall Study||37
8916367|NCT02182895|9975982|FG000|COMPLETED|Overall Study||33
8916368|NCT02182895|9975983|FG001|COMPLETED|Overall Study||33
8916369|NCT02182895|9975982|FG000|NOT COMPLETED|Overall Study||2
8916370|NCT02182895|9975983|FG001|NOT COMPLETED|Overall Study||4
8916371|NCT02182947|9975989|FG000|STARTED|Overall Study||45
8916372|NCT02182947|9975989|FG000|COMPLETED|Overall Study||27
8916373|NCT02182947|9975989|FG000|NOT COMPLETED|Overall Study||18
8916374|NCT02182973|9975995|FG000|STARTED|Overall Study||12
8916375|NCT02182973|9975996|FG001|STARTED|Overall Study||9
8916376|NCT02182973|9975995|FG000|COMPLETED|Overall Study||9
8916377|NCT02182973|9975996|FG001|COMPLETED|Overall Study||9
8916378|NCT02182973|9975995|FG000|NOT COMPLETED|Overall Study||3
8916379|NCT02182973|9975996|FG001|NOT COMPLETED|Overall Study||0
8916380|NCT02182999|9976005|FG000|STARTED|Overall Study||25
8916381|NCT02182999|9976006|FG001|STARTED|Overall Study||25
8916382|NCT02182999|9976005|FG000|COMPLETED|Overall Study||20
8916383|NCT02182999|9976006|FG001|COMPLETED|Overall Study||22
8916384|NCT02182999|9976005|FG000|NOT COMPLETED|Overall Study||5
8916385|NCT02182999|9976006|FG001|NOT COMPLETED|Overall Study||3
8916386|NCT02183519|9976014|FG000|STARTED|Overall Study||28
8916387|NCT02183519|9976015|FG001|STARTED|Overall Study||16
8916388|NCT02183519|9976014|FG000|COMPLETED|Overall Study||25
8916389|NCT02183519|9976015|FG001|COMPLETED|Overall Study||13
8916390|NCT02183519|9976014|FG000|NOT COMPLETED|Overall Study||3
8916391|NCT02183519|9976015|FG001|NOT COMPLETED|Overall Study||3
8916392|NCT02183675|9976027|FG000|STARTED|Treatment Period 1 (10 Days)||6
8916393|NCT02183675|9976028|FG001|STARTED|Treatment Period 1 (10 Days)||6
8916394|NCT02183675|9976029|FG002|STARTED|Treatment Period 1 (10 Days)||6
8916395|NCT02183675|9976030|FG003|STARTED|Treatment Period 1 (10 Days)||6
8778011|NCT01309893|9828005|FG001|NOT COMPLETED|Week 1 - First Intervention||0
8778012|NCT01309893|9828004|FG000|STARTED|Week 2 - Crossover Intervention||33
8778013|NCT01309893|9828005|FG001|STARTED|Week 2 - Crossover Intervention||33
8778014|NCT01309893|9828004|FG000|COMPLETED|Week 2 - Crossover Intervention||32
8916396|NCT02183675|9976031|FG004|STARTED|Treatment Period 1 (10 Days)||6
8916397|NCT02183675|9976032|FG005|STARTED|Treatment Period 1 (10 Days)||6
8916398|NCT02183675|9976027|FG000|COMPLETED|Treatment Period 1 (10 Days)||6
8916399|NCT02183675|9976028|FG001|COMPLETED|Treatment Period 1 (10 Days)||6
8916400|NCT02183675|9976029|FG002|COMPLETED|Treatment Period 1 (10 Days)||6
8916401|NCT02183675|9976030|FG003|COMPLETED|Treatment Period 1 (10 Days)||6
8916402|NCT02183675|9976031|FG004|COMPLETED|Treatment Period 1 (10 Days)||6
8916403|NCT02183675|9976032|FG005|COMPLETED|Treatment Period 1 (10 Days)||6
8778015|NCT01309893|9828005|FG001|COMPLETED|Week 2 - Crossover Intervention||32
8778016|NCT01309893|9828004|FG000|NOT COMPLETED|Week 2 - Crossover Intervention||1
8778017|NCT01309893|9828005|FG001|NOT COMPLETED|Week 2 - Crossover Intervention||1
8778018|NCT01309906|9828011|FG000|STARTED|Overall Study||33
8778019|NCT01309906|9828012|FG001|STARTED|Overall Study||33
8778020|NCT01309906|9828011|FG000|COMPLETED|Overall Study||32
8778021|NCT01309906|9828012|FG001|COMPLETED|Overall Study||32
8778022|NCT01309906|9828011|FG000|NOT COMPLETED|Overall Study||1
8778023|NCT01309906|9828012|FG001|NOT COMPLETED|Overall Study||1
8778024|NCT01309919|9828020|FG000|STARTED|Overall Study||75
8778025|NCT01309919|9828021|FG001|STARTED|Overall Study||75
8778026|NCT01309919|9828020|FG000|COMPLETED|Overall Study||58
8778027|NCT01309919|9828021|FG001|COMPLETED|Overall Study||27
8778028|NCT01309919|9828020|FG000|NOT COMPLETED|Overall Study||17
8778029|NCT01309919|9828021|FG001|NOT COMPLETED|Overall Study||48
8778030|NCT01309997|9828029|FG000|STARTED|Overall Study||35
8778031|NCT01309997|9828030|FG001|STARTED|Overall Study||37
8778032|NCT01309997|9828029|FG000|Remained on First Arm Only|Overall Study||16
8778033|NCT01309997|9828030|FG001|Remained on First Arm Only|Overall Study||14
8916404|NCT02183675|9976027|FG000|NOT COMPLETED|Treatment Period 1 (10 Days)||0
8916405|NCT02183675|9976028|FG001|NOT COMPLETED|Treatment Period 1 (10 Days)||0
8916406|NCT02183675|9976029|FG002|NOT COMPLETED|Treatment Period 1 (10 Days)||0
8916407|NCT02183675|9976030|FG003|NOT COMPLETED|Treatment Period 1 (10 Days)||0
8916408|NCT02183675|9976031|FG004|NOT COMPLETED|Treatment Period 1 (10 Days)||0
8916409|NCT02183675|9976032|FG005|NOT COMPLETED|Treatment Period 1 (10 Days)||0
8916410|NCT02183675|9976027|FG000|STARTED|Treatment Period 2 (10 Days)||6
8916411|NCT02183675|9976028|FG001|STARTED|Treatment Period 2 (10 Days)||6
8916412|NCT02183675|9976029|FG002|STARTED|Treatment Period 2 (10 Days)||6
8916413|NCT02183675|9976030|FG003|STARTED|Treatment Period 2 (10 Days)||6
8916414|NCT02183675|9976031|FG004|STARTED|Treatment Period 2 (10 Days)||6
8916415|NCT02183675|9976032|FG005|STARTED|Treatment Period 2 (10 Days)||6
8916416|NCT02183675|9976027|FG000|COMPLETED|Treatment Period 2 (10 Days)||6
8916417|NCT02183675|9976028|FG001|COMPLETED|Treatment Period 2 (10 Days)||6
8916418|NCT02183675|9976029|FG002|COMPLETED|Treatment Period 2 (10 Days)||6
8916419|NCT02183675|9976030|FG003|COMPLETED|Treatment Period 2 (10 Days)||6
8916420|NCT02183675|9976031|FG004|COMPLETED|Treatment Period 2 (10 Days)||6
8916421|NCT02183675|9976032|FG005|COMPLETED|Treatment Period 2 (10 Days)|Patients withdrew after completion of treatment period 2 but before beginning of treatment period 3|4
8916422|NCT02183675|9976027|FG000|NOT COMPLETED|Treatment Period 2 (10 Days)||0
8916423|NCT02183675|9976028|FG001|NOT COMPLETED|Treatment Period 2 (10 Days)||0
8916424|NCT02183675|9976029|FG002|NOT COMPLETED|Treatment Period 2 (10 Days)||0
8916425|NCT02183675|9976030|FG003|NOT COMPLETED|Treatment Period 2 (10 Days)||0
8916426|NCT02183675|9976031|FG004|NOT COMPLETED|Treatment Period 2 (10 Days)||0
8916427|NCT02183675|9976032|FG005|NOT COMPLETED|Treatment Period 2 (10 Days)||2
8916428|NCT02183675|9976027|FG000|STARTED|Treatment Period 3 (10 Days)||6
8916429|NCT02183675|9976028|FG001|STARTED|Treatment Period 3 (10 Days)||6
8916430|NCT02183675|9976029|FG002|STARTED|Treatment Period 3 (10 Days)||6
8916431|NCT02183675|9976030|FG003|STARTED|Treatment Period 3 (10 Days)||6
8916432|NCT02183675|9976031|FG004|STARTED|Treatment Period 3 (10 Days)||6
8916433|NCT02183675|9976032|FG005|STARTED|Treatment Period 3 (10 Days)||4
8916434|NCT02183675|9976027|FG000|COMPLETED|Treatment Period 3 (10 Days)||6
8916435|NCT02183675|9976028|FG001|COMPLETED|Treatment Period 3 (10 Days)||6
8916436|NCT02183675|9976029|FG002|COMPLETED|Treatment Period 3 (10 Days)||6
8916437|NCT02183675|9976030|FG003|COMPLETED|Treatment Period 3 (10 Days)||6
8916438|NCT02183675|9976031|FG004|COMPLETED|Treatment Period 3 (10 Days)||6
8916439|NCT02183675|9976032|FG005|COMPLETED|Treatment Period 3 (10 Days)||4
8916440|NCT02183675|9976027|FG000|NOT COMPLETED|Treatment Period 3 (10 Days)||0
8916441|NCT02183675|9976028|FG001|NOT COMPLETED|Treatment Period 3 (10 Days)||0
8916442|NCT02183675|9976029|FG002|NOT COMPLETED|Treatment Period 3 (10 Days)||0
8916443|NCT02183675|9976030|FG003|NOT COMPLETED|Treatment Period 3 (10 Days)||0
8916444|NCT02183675|9976031|FG004|NOT COMPLETED|Treatment Period 3 (10 Days)||0
8916445|NCT02183675|9976032|FG005|NOT COMPLETED|Treatment Period 3 (10 Days)||0
8916446|NCT02183792|9976044|FG000|STARTED|Overall Study||18
8916447|NCT02183792|9976045|FG001|STARTED|Overall Study||15
9029562|NCT03220737|10091944|FG001|STARTED|Placebo Crossover (Day 181-365)|Placebo subjects from Main study opted to cross over to the active group to receive Vaxchora.|0
9029563|NCT03220737|10091945|FG002|STARTED|Placebo Crossover (Day 181-365)|Only placebo subjects who opted to receive Vaxchora were included in the crossover group.|11
9029564|NCT03220737|10091946|FG003|STARTED|Placebo Crossover (Day 181-365)|Placebo subjects from Main study opted to cross over to the active group to receive Vaxchora|0
8916448|NCT02183792|9976044|FG000|COMPLETED|Overall Study||18
8916449|NCT02183792|9976045|FG001|COMPLETED|Overall Study||15
8916450|NCT02183792|9976044|FG000|NOT COMPLETED|Overall Study||0
8916451|NCT02183792|9976045|FG001|NOT COMPLETED|Overall Study||0
8916452|NCT02184143|9976053|FG000|STARTED|Overall Study|124 participants randomized; 118 participant received intervention|124
8916453|NCT02184143|9976054|FG001|STARTED|Overall Study|124 participants randomized; 121 received intervention|124
8916454|NCT02184143|9976053|FG000|COMPLETED|Overall Study|114 patients completed PROs. 98 actigraph valid wear time.|114
8916455|NCT02184143|9976054|FG001|COMPLETED|Overall Study|117 patients completed PROs. 100 actigraph valid wear time.|117
8916456|NCT02184143|9976053|FG000|NOT COMPLETED|Overall Study||10
8916457|NCT02184143|9976054|FG001|NOT COMPLETED|Overall Study||7
8778034|NCT01309997|9828029|FG000|Crossed Over to Second Arm|Overall Study||19
8778035|NCT01309997|9828030|FG001|Crossed Over to Second Arm|Overall Study||23
8778036|NCT01309997|9828029|FG000|COMPLETED|Overall Study||30
8778037|NCT01309997|9828030|FG001|COMPLETED|Overall Study||31
8778038|NCT01309997|9828029|FG000|NOT COMPLETED|Overall Study||5
8778039|NCT01309997|9828030|FG001|NOT COMPLETED|Overall Study||6
8778040|NCT01310036|9828047|FG000|STARTED|Overall Study||208
8778041|NCT01310036|9828047|FG000|COMPLETED|Overall Study||6
8778042|NCT01310036|9828047|FG000|NOT COMPLETED|Overall Study||202
8778043|NCT01310075|9828053|FG000|STARTED|Overall Study||45
8778044|NCT01310075|9828054|FG001|STARTED|Overall Study||45
8778045|NCT01310075|9828053|FG000|COMPLETED|Overall Study||31
8778046|NCT01310075|9828054|FG001|COMPLETED|Overall Study||35
8778047|NCT01310075|9828053|FG000|NOT COMPLETED|Overall Study||14
8778048|NCT01310075|9828054|FG001|NOT COMPLETED|Overall Study||10
8778049|NCT01310127|9828062|FG000|STARTED|Overall Study||12
8778050|NCT01310127|9828063|FG001|STARTED|Overall Study||11
8778051|NCT01310127|9828062|FG000|COMPLETED|Overall Study||10
8778052|NCT01310127|9828063|FG001|COMPLETED|Overall Study||10
8778053|NCT01310127|9828062|FG000|NOT COMPLETED|Overall Study||2
8778054|NCT01310127|9828063|FG001|NOT COMPLETED|Overall Study||1
8778055|NCT01310179|9828069|FG000|STARTED|Overall Study||12
8778056|NCT01310179|9828069|FG000|COMPLETED|Overall Study||12
8778057|NCT01310179|9828069|FG000|NOT COMPLETED|Overall Study||0
8778058|NCT01310231|9828075|FG000|STARTED|Overall Study||22
8778059|NCT01310231|9828076|FG001|STARTED|Overall Study||18
8778060|NCT01310231|9828075|FG000|Received Intervention|Overall Study||22
8778061|NCT01310231|9828076|FG001|Received Intervention|Overall Study||17
8778062|NCT01310231|9828075|FG000|Discontinued Intervention|Overall Study||0
8778063|NCT01310231|9828076|FG001|Discontinued Intervention|Overall Study||1
8778064|NCT01310231|9828075|FG000|Analyzed for Survival|Overall Study||22
8778065|NCT01310231|9828076|FG001|Analyzed for Survival|Overall Study||18
8778066|NCT01310231|9828075|FG000|Analyzed for Response, Toxicity, QOL|Overall Study||22
8778067|NCT01310231|9828076|FG001|Analyzed for Response, Toxicity, QOL|Overall Study||17
8778068|NCT01310231|9828075|FG000|COMPLETED|Overall Study||22
8778069|NCT01310231|9828076|FG001|COMPLETED|Overall Study||17
8778070|NCT01310231|9828075|FG000|NOT COMPLETED|Overall Study||0
8778071|NCT01310231|9828076|FG001|NOT COMPLETED|Overall Study||1
8778072|NCT01310400|9828085|FG000|STARTED|Overall Study||452
8778073|NCT01310400|9828086|FG001|STARTED|Overall Study||452
8778074|NCT01310400|9828087|FG002|STARTED|Overall Study||452
8778075|NCT01310400|9828085|FG000|COMPLETED|Overall Study||424
8778076|NCT01310400|9828086|FG001|COMPLETED|Overall Study||420
8778077|NCT01310400|9828087|FG002|COMPLETED|Overall Study||422
8778078|NCT01310400|9828085|FG000|NOT COMPLETED|Overall Study||28
8778079|NCT01310400|9828086|FG001|NOT COMPLETED|Overall Study||32
8778080|NCT01310400|9828087|FG002|NOT COMPLETED|Overall Study||30
8778081|NCT01310413|9828104|FG000|STARTED|Day 0 to Day 385||199
8778082|NCT01310413|9828105|FG001|STARTED|Day 0 to Day 385||198
8778083|NCT01310413|9828106|FG002|STARTED|Day 0 to Day 385||210
8778084|NCT01310413|9828107|FG003|STARTED|Day 0 to Day 385||75
8778085|NCT01310413|9828108|FG004|STARTED|Day 0 to Day 385||76
8778086|NCT01310413|9828109|FG005|STARTED|Day 0 to Day 385||80
8778087|NCT01310413|9828110|FG006|STARTED|Day 0 to Day 385|This group is only followed during the Unblinded Phase of the study, from Days U0 to U385.|0
8778088|NCT01310413|9828104|FG000|COMPLETED|Day 0 to Day 385||172
8778089|NCT01310413|9828105|FG001|COMPLETED|Day 0 to Day 385||190
8778090|NCT01310413|9828106|FG002|COMPLETED|Day 0 to Day 385||203
8778091|NCT01310413|9828107|FG003|COMPLETED|Day 0 to Day 385||67
8778092|NCT01310413|9828108|FG004|COMPLETED|Day 0 to Day 385||73
8778093|NCT01310413|9828109|FG005|COMPLETED|Day 0 to Day 385||77
8778094|NCT01310413|9828110|FG006|COMPLETED|Day 0 to Day 385|This group is only followed during the Unblinded Phase of the study, from Days U0 to U385.|0
8778095|NCT01310413|9828104|FG000|NOT COMPLETED|Day 0 to Day 385||27
8778096|NCT01310413|9828105|FG001|NOT COMPLETED|Day 0 to Day 385||8
8778097|NCT01310413|9828106|FG002|NOT COMPLETED|Day 0 to Day 385||7
8778098|NCT01310413|9828107|FG003|NOT COMPLETED|Day 0 to Day 385||8
8778099|NCT01310413|9828108|FG004|NOT COMPLETED|Day 0 to Day 385||3
8778100|NCT01310413|9828109|FG005|NOT COMPLETED|Day 0 to Day 385||3
8778101|NCT01310413|9828110|FG006|NOT COMPLETED|Day 0 to Day 385||0
8778102|NCT01310413|9828104|FG000|STARTED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
8778103|NCT01310413|9828105|FG001|STARTED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
8778104|NCT01310413|9828106|FG002|STARTED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
8778105|NCT01310413|9828107|FG003|STARTED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
8778106|NCT01310413|9828108|FG004|STARTED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
8778107|NCT01310413|9828109|FG005|STARTED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
8778108|NCT01310413|9828110|FG006|STARTED|From Day U0 to Day U385|Upto Day U42|155
8778109|NCT01310413|9828104|FG000|COMPLETED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
8778110|NCT01310413|9828105|FG001|COMPLETED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
8808849|NCT01493414|9861236|FG000|STARTED|Overall Study||2233
8808850|NCT01493414|9861236|FG000|COMPLETED|Overall Study||1283
8778111|NCT01310413|9828106|FG002|COMPLETED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
8778112|NCT01310413|9828107|FG003|COMPLETED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
8778113|NCT01310413|9828108|FG004|COMPLETED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
8778114|NCT01310413|9828109|FG005|COMPLETED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
8778115|NCT01310413|9828110|FG006|COMPLETED|From Day U0 to Day U385|Upto Day U42|152
8778116|NCT01310413|9828104|FG000|NOT COMPLETED|From Day U0 to Day U385||0
8778117|NCT01310413|9828105|FG001|NOT COMPLETED|From Day U0 to Day U385||0
8778118|NCT01310413|9828106|FG002|NOT COMPLETED|From Day U0 to Day U385||0
8778119|NCT01310413|9828107|FG003|NOT COMPLETED|From Day U0 to Day U385||0
8778120|NCT01310413|9828108|FG004|NOT COMPLETED|From Day U0 to Day U385||0
8778121|NCT01310413|9828109|FG005|NOT COMPLETED|From Day U0 to Day U385||0
8778122|NCT01310413|9828110|FG006|NOT COMPLETED|From Day U0 to Day U385||3
8778123|NCT01310582|9828141|FG000|STARTED|Overall Study||31
8778124|NCT01310582|9828142|FG001|STARTED|Overall Study||26
8778125|NCT01310582|9828141|FG000|COMPLETED|Overall Study||31
8778126|NCT01310582|9828142|FG001|COMPLETED|Overall Study||26
8778127|NCT01310582|9828141|FG000|NOT COMPLETED|Overall Study||0
8778128|NCT01310582|9828142|FG001|NOT COMPLETED|Overall Study||0
8778129|NCT01310699|9828150|FG000|STARTED|Overall Study||132
8778130|NCT01310699|9828151|FG001|STARTED|Overall Study||149
8778131|NCT01310699|9828150|FG000|COMPLETED|Overall Study||128
8778132|NCT01310699|9828151|FG001|COMPLETED|Overall Study||143
8778133|NCT01310699|9828150|FG000|NOT COMPLETED|Overall Study||4
8778134|NCT01310699|9828151|FG001|NOT COMPLETED|Overall Study||6
8778135|NCT01310777|9828162|FG000|STARTED|Overall Study||193
8778136|NCT01310777|9828163|FG001|STARTED|Overall Study||192
8778137|NCT01310777|9828164|FG002|STARTED|Overall Study||175
8778138|NCT01310777|9828162|FG000|COMPLETED|Overall Study||160
8778139|NCT01310777|9828163|FG001|COMPLETED|Overall Study||178
8778140|NCT01310777|9828164|FG002|COMPLETED|Overall Study||145
8778141|NCT01310777|9828162|FG000|NOT COMPLETED|Overall Study||33
8778142|NCT01310777|9828163|FG001|NOT COMPLETED|Overall Study||14
8778143|NCT01310777|9828164|FG002|NOT COMPLETED|Overall Study||30
8778144|NCT01310855|9828174|FG000|STARTED|Overall Study||19
8778145|NCT01310855|9828175|FG001|STARTED|Overall Study||19
8778146|NCT01310855|9828174|FG000|COMPLETED|Overall Study||19
8778147|NCT01310855|9828175|FG001|COMPLETED|Overall Study||19
8778148|NCT01310855|9828174|FG000|NOT COMPLETED|Overall Study||0
8778149|NCT01310855|9828175|FG001|NOT COMPLETED|Overall Study||0
8778150|NCT01310868|9828181|FG000|STARTED|Overall Study||72
8778151|NCT01310868|9828181|FG000|COMPLETED|Overall Study||59
8778152|NCT01310868|9828181|FG000|NOT COMPLETED|Overall Study||13
8778153|NCT01311024|9828187|FG000|STARTED|Overall Study||1530
8778154|NCT01311024|9828188|FG001|STARTED|Overall Study||811
8778155|NCT01311024|9828187|FG000|COMPLETED|Overall Study||1495
8778156|NCT01311024|9828188|FG001|COMPLETED|Overall Study||789
8778157|NCT01311024|9828187|FG000|NOT COMPLETED|Overall Study||35
8778158|NCT01311024|9828188|FG001|NOT COMPLETED|Overall Study||22
8778159|NCT01311102|9828196|FG000|STARTED|Overall Study||20
8778160|NCT01311102|9828197|FG001|STARTED|Overall Study||20
8778161|NCT01311102|9828196|FG000|COMPLETED|Overall Study||20
8778162|NCT01311102|9828197|FG001|COMPLETED|Overall Study||20
8778163|NCT01311102|9828196|FG000|NOT COMPLETED|Overall Study||0
8778164|NCT01311102|9828197|FG001|NOT COMPLETED|Overall Study||0
8778165|NCT01311362|9828205|FG000|STARTED|Ambrisentan Single Dose|All 20 study participants completed each study period. Total number of study participants: 20|20
8778166|NCT01311362|9828205|FG000|COMPLETED|Ambrisentan Single Dose||20
8778167|NCT01311362|9828205|FG000|NOT COMPLETED|Ambrisentan Single Dose||0
8778168|NCT01311362|9828205|FG000|STARTED|Ambrisentan Steady-state||20
8778169|NCT01311362|9828205|FG000|COMPLETED|Ambrisentan Steady-state||20
8778170|NCT01311362|9828205|FG000|NOT COMPLETED|Ambrisentan Steady-state||0
8778171|NCT01311362|9828205|FG000|STARTED|Ambrisentan and SJW||20
8778172|NCT01311362|9828205|FG000|COMPLETED|Ambrisentan and SJW||20
8778173|NCT01311362|9828205|FG000|NOT COMPLETED|Ambrisentan and SJW||0
8778174|NCT01311505|9828214|FG000|STARTED|First Intervention Period||10
8778175|NCT01311505|9828215|FG001|STARTED|First Intervention Period||11
8778176|NCT01311505|9828214|FG000|COMPLETED|First Intervention Period||10
8778177|NCT01311505|9828215|FG001|COMPLETED|First Intervention Period||10
8778178|NCT01311505|9828214|FG000|NOT COMPLETED|First Intervention Period||0
8778179|NCT01311505|9828215|FG001|NOT COMPLETED|First Intervention Period||1
8778180|NCT01311505|9828214|FG000|STARTED|Washout Period (at Least 7 Days)||10
8778181|NCT01311505|9828215|FG001|STARTED|Washout Period (at Least 7 Days)||10
8778182|NCT01311505|9828214|FG000|COMPLETED|Washout Period (at Least 7 Days)||10
8778183|NCT01311505|9828215|FG001|COMPLETED|Washout Period (at Least 7 Days)||10
8778184|NCT01311505|9828214|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8778185|NCT01311505|9828215|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8778186|NCT01311505|9828214|FG000|STARTED|Second Intervention Period||10
8778187|NCT01311505|9828215|FG001|STARTED|Second Intervention Period||10
8778188|NCT01311505|9828214|FG000|COMPLETED|Second Intervention Period||10
8778189|NCT01311505|9828215|FG001|COMPLETED|Second Intervention Period||10
8778190|NCT01311505|9828214|FG000|NOT COMPLETED|Second Intervention Period||0
8778191|NCT01311505|9828215|FG001|NOT COMPLETED|Second Intervention Period||0
8778192|NCT01311557|9828226|FG000|STARTED|Overall Study||651
8778193|NCT01311557|9828227|FG001|STARTED|Overall Study||651
8778194|NCT01311557|9828226|FG000|COMPLETED|Overall Study||646
8778195|NCT01311557|9828227|FG001|COMPLETED|Overall Study||645
8778196|NCT01311557|9828226|FG000|NOT COMPLETED|Overall Study||5
8778197|NCT01311557|9828227|FG001|NOT COMPLETED|Overall Study||6
8778198|NCT01311648|9828236|FG000|STARTED|Main Study||51
8778199|NCT01311648|9828237|FG001|STARTED|Main Study||43
8778200|NCT01311648|9828236|FG000|Started 0-<6 Years|Main Study||25
8778201|NCT01311648|9828237|FG001|Started 0-<6 Years|Main Study||43
8778202|NCT01311648|9828236|FG000|Started 6-12 Years|Main Study||26
8778203|NCT01311648|9828237|FG001|Started 6-12 Years|Main Study||0
8778204|NCT01311648|9828236|FG000|COMPLETED|Main Study||51
8778205|NCT01311648|9828237|FG001|COMPLETED|Main Study||22
8778206|NCT01311648|9828236|FG000|NOT COMPLETED|Main Study||0
8778207|NCT01311648|9828237|FG001|NOT COMPLETED|Main Study||21
8778208|NCT01311648|9828236|FG000|STARTED|Extension Study||46
8778209|NCT01311648|9828237|FG001|STARTED|Extension Study||36
8778210|NCT01311648|9828236|FG000|COMPLETED|Extension Study||45
8778211|NCT01311648|9828237|FG001|COMPLETED|Extension Study||25
8778212|NCT01311648|9828236|FG000|NOT COMPLETED|Extension Study||1
8778213|NCT01311648|9828237|FG001|NOT COMPLETED|Extension Study||11
9029565|NCT03220737|10091947|FG004|STARTED|Placebo Crossover (Day 181-365)|Only placebo subjects who opted to receive Vaxchora were included in the crossover group.|7
9029566|NCT03220737|10091948|FG005|STARTED|Placebo Crossover (Day 181-365)|Placebo subjects from Main study opted to cross over to the active group to receive Vaxchora|0
9029567|NCT03220737|10091949|FG006|STARTED|Placebo Crossover (Day 181-365)||0
9029568|NCT03220737|10091943|FG000|COMPLETED|Placebo Crossover (Day 181-365)||13
9029569|NCT03220737|10091944|FG001|COMPLETED|Placebo Crossover (Day 181-365)||0
9029570|NCT03220737|10091945|FG002|COMPLETED|Placebo Crossover (Day 181-365)||11
9029571|NCT03220737|10091946|FG003|COMPLETED|Placebo Crossover (Day 181-365)||0
9029572|NCT03220737|10091947|FG004|COMPLETED|Placebo Crossover (Day 181-365)||5
9029573|NCT03220737|10091948|FG005|COMPLETED|Placebo Crossover (Day 181-365)||0
9029574|NCT03220737|10091949|FG006|COMPLETED|Placebo Crossover (Day 181-365)||0
9029575|NCT03220737|10091943|FG000|NOT COMPLETED|Placebo Crossover (Day 181-365)||0
9029576|NCT03220737|10091944|FG001|NOT COMPLETED|Placebo Crossover (Day 181-365)||0
9029577|NCT03220737|10091945|FG002|NOT COMPLETED|Placebo Crossover (Day 181-365)||0
9029578|NCT03220737|10091946|FG003|NOT COMPLETED|Placebo Crossover (Day 181-365)||0
9029579|NCT03220737|10091947|FG004|NOT COMPLETED|Placebo Crossover (Day 181-365)||2
9029580|NCT03220737|10091948|FG005|NOT COMPLETED|Placebo Crossover (Day 181-365)||0
9029581|NCT03220737|10091949|FG006|NOT COMPLETED|Placebo Crossover (Day 181-365)||0
9029582|NCT03220737|10091943|FG000|STARTED|Long-term Follow-up (Day 365-730)|Cohort 1 subjects from the main study had to opt to be included in the Long-term follow-up study.|73
9029583|NCT03220737|10091944|FG001|STARTED|Long-term Follow-up (Day 365-730)||0
9029584|NCT03220737|10091945|FG002|STARTED|Long-term Follow-up (Day 365-730)|Cohort 2 subjects were not eligible for the Long-term follow-up study.|0
9029585|NCT03220737|10091946|FG003|STARTED|Long-term Follow-up (Day 365-730)||0
9029586|NCT03220737|10091947|FG004|STARTED|Long-term Follow-up (Day 365-730)|Cohort 3 subjects were not eligible for the Long-term follow-up study.|0
9029587|NCT03220737|10091948|FG005|STARTED|Long-term Follow-up (Day 365-730)||0
9029588|NCT03220737|10091949|FG006|STARTED|Long-term Follow-up (Day 365-730)||0
9029589|NCT03220737|10091943|FG000|COMPLETED|Long-term Follow-up (Day 365-730)||62
9029590|NCT03220737|10091944|FG001|COMPLETED|Long-term Follow-up (Day 365-730)||0
9029591|NCT03220737|10091945|FG002|COMPLETED|Long-term Follow-up (Day 365-730)||0
9029592|NCT03220737|10091946|FG003|COMPLETED|Long-term Follow-up (Day 365-730)||0
9029593|NCT03220737|10091947|FG004|COMPLETED|Long-term Follow-up (Day 365-730)||0
9029594|NCT03220737|10091948|FG005|COMPLETED|Long-term Follow-up (Day 365-730)||0
9029595|NCT03220737|10091949|FG006|COMPLETED|Long-term Follow-up (Day 365-730)||0
9029596|NCT03220737|10091943|FG000|NOT COMPLETED|Long-term Follow-up (Day 365-730)||11
9029597|NCT03220737|10091944|FG001|NOT COMPLETED|Long-term Follow-up (Day 365-730)||0
9029598|NCT03220737|10091945|FG002|NOT COMPLETED|Long-term Follow-up (Day 365-730)||0
9029599|NCT03220737|10091946|FG003|NOT COMPLETED|Long-term Follow-up (Day 365-730)||0
9029600|NCT03220737|10091947|FG004|NOT COMPLETED|Long-term Follow-up (Day 365-730)||0
9029601|NCT03220737|10091948|FG005|NOT COMPLETED|Long-term Follow-up (Day 365-730)||0
9029602|NCT03220737|10091949|FG006|NOT COMPLETED|Long-term Follow-up (Day 365-730)||0
9029603|NCT03220958|10091973|FG000|STARTED|Overall Study||81
9029604|NCT03220958|10091974|FG001|STARTED|Overall Study||79
9029605|NCT03220958|10091973|FG000|COMPLETED|Overall Study||81
9029606|NCT03220958|10091974|FG001|COMPLETED|Overall Study||79
9029607|NCT03220958|10091973|FG000|NOT COMPLETED|Overall Study||0
9029608|NCT03220958|10091974|FG001|NOT COMPLETED|Overall Study||0
9029609|NCT03221192|10091980|FG000|STARTED|Overall Study||27
9029610|NCT03221192|10091980|FG000|COMPLETED|Overall Study||27
9029611|NCT03221192|10091980|FG000|NOT COMPLETED|Overall Study||0
9029612|NCT03221387|10091984|FG000|STARTED|Overall Study||30
9029613|NCT03221387|10091984|FG000|COMPLETED|Overall Study||28
9029614|NCT03221387|10091984|FG000|NOT COMPLETED|Overall Study||2
9029615|NCT03221595|10091990|FG000|STARTED|Overall Study||51
9029616|NCT03221595|10091991|FG001|STARTED|Overall Study||59
9029617|NCT03221595|10091990|FG000|COMPLETED|Overall Study||51
9029618|NCT03221595|10091991|FG001|COMPLETED|Overall Study||59
9029619|NCT03221595|10091990|FG000|NOT COMPLETED|Overall Study||0
9029620|NCT03221595|10091991|FG001|NOT COMPLETED|Overall Study||0
9029621|NCT03221738|10091997|FG000|STARTED|Overall Study||10
8778214|NCT01311661|9828250|FG000|STARTED|Overall Study|Entered and treated|206
8778215|NCT01311661|9828250|FG000|Received Placebo|Overall Study||201
8778216|NCT01311661|9828250|FG000|Received Olo 2.5 mcg Bid|Overall Study||101
8778217|NCT01311661|9828250|FG000|Received Olo 5 mcg qd|Overall Study||101
8778218|NCT01311661|9828250|FG000|Received Olo 5 mcg Bid|Overall Study||101
8778219|NCT01311661|9828250|FG000|Received Olo 10 mcg qd|Overall Study||102
8778220|NCT01311661|9828250|FG000|COMPLETED|Overall Study||199
8778221|NCT01311661|9828250|FG000|NOT COMPLETED|Overall Study||7
8778222|NCT01311674|9828264|FG000|STARTED|Overall Study||72
8778223|NCT01311674|9828265|FG001|STARTED|Overall Study||69
8778224|NCT01311674|9828264|FG000|COMPLETED|Overall Study||28
8778225|NCT01311674|9828265|FG001|COMPLETED|Overall Study||29
8778226|NCT01311674|9828264|FG000|NOT COMPLETED|Overall Study||44
8778227|NCT01311674|9828265|FG001|NOT COMPLETED|Overall Study||40
8778228|NCT01311687|9828274|FG000|STARTED|Treatment Phase||302
8778229|NCT01311687|9828275|FG001|STARTED|Treatment Phase||153
8778230|NCT01311687|9828274|FG000|Received Study Drug|Treatment Phase||300
8778231|NCT01311687|9828275|FG001|Received Study Drug|Treatment Phase||150
8778232|NCT01311687|9828274|FG000|Crossed-over to Pomalidomide|Treatment Phase|Not applicable to participants initially randomized to receive pomalidomide|0
8778233|NCT01311687|9828275|FG001|Crossed-over to Pomalidomide|Treatment Phase|After Amendment 4 participants still on HD-Dex treatment were permitted to crossover to pomalidomide|11
8778234|NCT01311687|9828274|FG000|COMPLETED|Treatment Phase||302
8778235|NCT01311687|9828275|FG001|COMPLETED|Treatment Phase||153
8778236|NCT01311687|9828274|FG000|NOT COMPLETED|Treatment Phase||0
8778237|NCT01311687|9828275|FG001|NOT COMPLETED|Treatment Phase||0
8778238|NCT01311687|9828274|FG000|STARTED|PFS Follow-up Phase||11
8778239|NCT01311687|9828275|FG001|STARTED|PFS Follow-up Phase||8
8778240|NCT01311687|9828274|FG000|Crossed-over to Pomalidomide|PFS Follow-up Phase||11
8778241|NCT01311687|9828275|FG001|Crossed-over to Pomalidomide|PFS Follow-up Phase||0
8778242|NCT01311687|9828274|FG000|COMPLETED|PFS Follow-up Phase||11
8778243|NCT01311687|9828275|FG001|COMPLETED|PFS Follow-up Phase||8
8778244|NCT01311687|9828274|FG000|NOT COMPLETED|PFS Follow-up Phase||0
8778245|NCT01311687|9828275|FG001|NOT COMPLETED|PFS Follow-up Phase||0
8778246|NCT01311895|9828286|FG000|STARTED|Overall Study||175
8778247|NCT01311895|9828287|FG001|STARTED|Overall Study||175
8778248|NCT01311895|9828286|FG000|COMPLETED|Overall Study||175
8778249|NCT01311895|9828287|FG001|COMPLETED|Overall Study||175
8778250|NCT01311895|9828286|FG000|NOT COMPLETED|Overall Study||0
8778251|NCT01311895|9828287|FG001|NOT COMPLETED|Overall Study||0
8778252|NCT01312038|9828295|FG000|STARTED|Overall Study||13
8778253|NCT01312038|9828296|FG001|STARTED|Overall Study||12
8778254|NCT01312038|9828295|FG000|COMPLETED|Overall Study||13
8778255|NCT01312038|9828296|FG001|COMPLETED|Overall Study||12
8778256|NCT01312038|9828295|FG000|NOT COMPLETED|Overall Study||0
8778257|NCT01312038|9828296|FG001|NOT COMPLETED|Overall Study||0
8778258|NCT01312129|9828304|FG000|STARTED|First Intervention (24 Hours)||6
8778259|NCT01312129|9828305|FG001|STARTED|First Intervention (24 Hours)||7
8778260|NCT01312129|9828304|FG000|Control Cue|First Intervention (24 Hours)||6
8778261|NCT01312129|9828305|FG001|Control Cue|First Intervention (24 Hours)||7
8778262|NCT01312129|9828304|FG000|Alcohol Cue|First Intervention (24 Hours)||6
8778263|NCT01312129|9828305|FG001|Alcohol Cue|First Intervention (24 Hours)||7
8778264|NCT01312129|9828304|FG000|COMPLETED|First Intervention (24 Hours)||6
8778265|NCT01312129|9828305|FG001|COMPLETED|First Intervention (24 Hours)||7
8778266|NCT01312129|9828304|FG000|NOT COMPLETED|First Intervention (24 Hours)||0
8778267|NCT01312129|9828305|FG001|NOT COMPLETED|First Intervention (24 Hours)||0
9029622|NCT03221738|10091997|FG000|COMPLETED|Overall Study||10
9029623|NCT03221738|10091997|FG000|NOT COMPLETED|Overall Study||0
9029624|NCT03221764|10092001|FG000|STARTED|Overall Study||20
9029625|NCT03221764|10092001|FG000|COMPLETED|Overall Study||20
9029626|NCT03221764|10092001|FG000|NOT COMPLETED|Overall Study||0
9029627|NCT03222037|10092005|FG000|STARTED|Period 1||21
9029628|NCT03222037|10092006|FG001|STARTED|Period 1||22
9029629|NCT03222037|10092005|FG000|COMPLETED|Period 1||21
9029630|NCT03222037|10092006|FG001|COMPLETED|Period 1||22
9029631|NCT03222037|10092005|FG000|NOT COMPLETED|Period 1||0
9029632|NCT03222037|10092006|FG001|NOT COMPLETED|Period 1||0
9029633|NCT03222037|10092005|FG000|STARTED|Period 2||21
9029634|NCT03222037|10092006|FG001|STARTED|Period 2||22
9029635|NCT03222037|10092005|FG000|COMPLETED|Period 2||21
9029636|NCT03222037|10092006|FG001|COMPLETED|Period 2||22
9029637|NCT03222037|10092005|FG000|NOT COMPLETED|Period 2||0
9029638|NCT03222037|10092006|FG001|NOT COMPLETED|Period 2||0
9029639|NCT03222141|10092012|FG000|STARTED|Overall Study||583
9029640|NCT03222141|10092012|FG000|COMPLETED|Overall Study||565
9029641|NCT03222141|10092012|FG000|NOT COMPLETED|Overall Study||18
9029642|NCT03222349|10092017|FG000|STARTED|Overall Study||11
8778268|NCT01312129|9828304|FG000|STARTED|Washout (1 Week)||6
8778269|NCT01312129|9828305|FG001|STARTED|Washout (1 Week)||7
9029643|NCT03222349|10092018|FG001|STARTED|Overall Study||13
9029644|NCT03222349|10092017|FG000|COMPLETED|Overall Study||3
9029645|NCT03222349|10092018|FG001|COMPLETED|Overall Study||6
9029646|NCT03222349|10092017|FG000|NOT COMPLETED|Overall Study||8
9029647|NCT03222349|10092018|FG001|NOT COMPLETED|Overall Study||7
9029648|NCT03222414|10092033|FG000|STARTED|Overall Study||0
9029649|NCT03222414|10092034|FG001|STARTED|Overall Study||1
9029650|NCT03222414|10092033|FG000|COMPLETED|Overall Study||0
9029651|NCT03222414|10092034|FG001|COMPLETED|Overall Study||1
8778270|NCT01312129|9828304|FG000|COMPLETED|Washout (1 Week)||6
8778271|NCT01312129|9828305|FG001|COMPLETED|Washout (1 Week)||7
8778272|NCT01312129|9828304|FG000|NOT COMPLETED|Washout (1 Week)||0
9029652|NCT03222414|10092033|FG000|NOT COMPLETED|Overall Study||0
8778273|NCT01312129|9828305|FG001|NOT COMPLETED|Washout (1 Week)||0
8778274|NCT01312129|9828304|FG000|STARTED|Second Intervention (24 Hours)||6
8778275|NCT01312129|9828305|FG001|STARTED|Second Intervention (24 Hours)||7
8778276|NCT01312129|9828304|FG000|Control Cue|Second Intervention (24 Hours)||6
8778277|NCT01312129|9828305|FG001|Control Cue|Second Intervention (24 Hours)||6
8778278|NCT01312129|9828304|FG000|Alcohol Cue|Second Intervention (24 Hours)||6
8778279|NCT01312129|9828305|FG001|Alcohol Cue|Second Intervention (24 Hours)||6
8778280|NCT01312129|9828304|FG000|COMPLETED|Second Intervention (24 Hours)||6
8778281|NCT01312129|9828305|FG001|COMPLETED|Second Intervention (24 Hours)||6
8778282|NCT01312129|9828304|FG000|NOT COMPLETED|Second Intervention (24 Hours)||0
8778283|NCT01312129|9828305|FG001|NOT COMPLETED|Second Intervention (24 Hours)||1
8778284|NCT01312181|9828314|FG000|STARTED|Overall Study||80
8778285|NCT01312181|9828315|FG001|STARTED|Overall Study||77
8778286|NCT01312181|9828316|FG002|STARTED|Overall Study||83
8778287|NCT01312181|9828314|FG000|COMPLETED|Overall Study||78
8778288|NCT01312181|9828315|FG001|COMPLETED|Overall Study||71
8778289|NCT01312181|9828316|FG002|COMPLETED|Overall Study||75
8778290|NCT01312181|9828314|FG000|NOT COMPLETED|Overall Study||2
8778291|NCT01312181|9828315|FG001|NOT COMPLETED|Overall Study||6
8778292|NCT01312181|9828316|FG002|NOT COMPLETED|Overall Study||8
8778293|NCT01312233|9828327|FG000|STARTED|Overall Study||44
8778294|NCT01312233|9828328|FG001|STARTED|Overall Study||44
8778295|NCT01312233|9828329|FG002|STARTED|Overall Study||43
8778296|NCT01312233|9828327|FG000|COMPLETED|Overall Study||42
8778297|NCT01312233|9828328|FG001|COMPLETED|Overall Study||44
8778298|NCT01312233|9828329|FG002|COMPLETED|Overall Study||36
8778299|NCT01312233|9828327|FG000|NOT COMPLETED|Overall Study||2
8778300|NCT01312233|9828328|FG001|NOT COMPLETED|Overall Study||0
8778301|NCT01312233|9828329|FG002|NOT COMPLETED|Overall Study||7
8778302|NCT01312272|9828339|FG000|STARTED|Overall Study||12
8778303|NCT01312272|9828340|FG001|STARTED|Overall Study||12
8778304|NCT01312272|9828339|FG000|COMPLETED|Overall Study||12
8778305|NCT01312272|9828340|FG001|COMPLETED|Overall Study||11
8778306|NCT01312272|9828339|FG000|NOT COMPLETED|Overall Study||0
8778307|NCT01312272|9828340|FG001|NOT COMPLETED|Overall Study||1
8778308|NCT01312389|9828349|FG000|STARTED|Phase 1||3
8778309|NCT01312389|9828350|FG001|STARTED|Phase 1||0
8778310|NCT01312389|9828351|FG002|STARTED|Phase 1||0
8778311|NCT01312389|9828349|FG000|COMPLETED|Phase 1||3
8778312|NCT01312389|9828350|FG001|COMPLETED|Phase 1||0
8778313|NCT01312389|9828351|FG002|COMPLETED|Phase 1||0
8778314|NCT01312389|9828349|FG000|NOT COMPLETED|Phase 1||0
8778315|NCT01312389|9828350|FG001|NOT COMPLETED|Phase 1||0
8778316|NCT01312389|9828351|FG002|NOT COMPLETED|Phase 1||0
8778317|NCT01312389|9828349|FG000|STARTED|Phase 2||0
8778318|NCT01312389|9828350|FG001|STARTED|Phase 2||0
8778319|NCT01312389|9828351|FG002|STARTED|Phase 2||0
8778320|NCT01312389|9828349|FG000|COMPLETED|Phase 2||0
8778321|NCT01312389|9828350|FG001|COMPLETED|Phase 2||0
8778322|NCT01312389|9828351|FG002|COMPLETED|Phase 2||0
8778323|NCT01312389|9828349|FG000|NOT COMPLETED|Phase 2||0
8778324|NCT01312389|9828350|FG001|NOT COMPLETED|Phase 2||0
8778325|NCT01312389|9828351|FG002|NOT COMPLETED|Phase 2||0
8778326|NCT01312467|9828359|FG000|STARTED|Overall Study||45
8778327|NCT01312467|9828359|FG000|COMPLETED|Overall Study||32
8778328|NCT01312467|9828359|FG000|NOT COMPLETED|Overall Study||13
8778329|NCT01312519|9828366|FG000|STARTED|Overall Study||26
8778330|NCT01312519|9828367|FG001|STARTED|Overall Study||24
8778331|NCT01312519|9828366|FG000|COMPLETED|Overall Study||26
8778332|NCT01312519|9828367|FG001|COMPLETED|Overall Study||24
8778333|NCT01312519|9828366|FG000|NOT COMPLETED|Overall Study||0
8778334|NCT01312519|9828367|FG001|NOT COMPLETED|Overall Study||0
8778335|NCT01312675|9828375|FG000|STARTED|Overall Study||9
8778336|NCT01312675|9828376|FG001|STARTED|Overall Study||7
8778337|NCT01312675|9828375|FG000|COMPLETED|Overall Study||9
8778338|NCT01312675|9828376|FG001|COMPLETED|Overall Study||7
8778339|NCT01312675|9828375|FG000|NOT COMPLETED|Overall Study||0
8778340|NCT01312675|9828376|FG001|NOT COMPLETED|Overall Study||0
8778341|NCT01312766|9828384|FG000|STARTED|Overall Study||135
8778342|NCT01312766|9828385|FG001|STARTED|Overall Study||135
8778343|NCT01312766|9828384|FG000|COMPLETED|Overall Study||129
8778344|NCT01312766|9828385|FG001|COMPLETED|Overall Study||130
8778345|NCT01312766|9828384|FG000|NOT COMPLETED|Overall Study||6
8778346|NCT01312766|9828385|FG001|NOT COMPLETED|Overall Study||5
8778347|NCT01312779|9828391|FG000|STARTED|Overall Study||39
8778348|NCT01312779|9828391|FG000|Implanted With Device|Overall Study||12
8778349|NCT01312779|9828391|FG000|COMPLETED|Overall Study||7
8778350|NCT01312779|9828391|FG000|NOT COMPLETED|Overall Study||32
8778351|NCT01312805|9828406|FG000|STARTED|Overall Study||1016
8778352|NCT01312805|9828407|FG001|STARTED|Overall Study||1082
8778353|NCT01312805|9828406|FG000|COMPLETED|Overall Study||1016
8778354|NCT01312805|9828407|FG001|COMPLETED|Overall Study||1082
8778355|NCT01312805|9828406|FG000|NOT COMPLETED|Overall Study||0
8778356|NCT01312805|9828407|FG001|NOT COMPLETED|Overall Study||0
8778357|NCT01312818|9828413|FG000|STARTED|Overall Study||2
8778358|NCT01312818|9828413|FG000|COMPLETED|Overall Study||2
8778359|NCT01312818|9828413|FG000|NOT COMPLETED|Overall Study||0
8808851|NCT01493414|9861236|FG000|NOT COMPLETED|Overall Study||950
8808852|NCT01493427|9861244|FG000|STARTED|Overall Study||199
8808853|NCT01493427|9861244|FG000|COMPLETED|Overall Study||179
8808854|NCT01493427|9861244|FG000|NOT COMPLETED|Overall Study||20
8808855|NCT01493531|9861251|FG000|STARTED|Overall Study||204
8808856|NCT01493531|9861252|FG001|STARTED|Overall Study||200
8778360|NCT01312844|9828421|FG000|STARTED|Overall Study||4
8778361|NCT01312844|9828422|FG001|STARTED|Overall Study||3
8778362|NCT01312844|9828421|FG000|COMPLETED|Overall Study||4
8778363|NCT01312844|9828422|FG001|COMPLETED|Overall Study||3
8778364|NCT01312844|9828421|FG000|NOT COMPLETED|Overall Study||0
8778365|NCT01312844|9828422|FG001|NOT COMPLETED|Overall Study||0
8778366|NCT01312909|9828431|FG000|STARTED|Overall Study||109
8778367|NCT01312909|9828432|FG001|STARTED|Overall Study||103
8778368|NCT01312909|9828433|FG002|STARTED|Overall Study||100
8778369|NCT01312909|9828431|FG000|Treated|Overall Study||108
8778370|NCT01312909|9828432|FG001|Treated|Overall Study||100
8778371|NCT01312909|9828433|FG002|Treated|Overall Study||99
8778372|NCT01312909|9828431|FG000|COMPLETED|Overall Study||67
8778373|NCT01312909|9828432|FG001|COMPLETED|Overall Study||67
8778374|NCT01312909|9828433|FG002|COMPLETED|Overall Study||53
8778375|NCT01312909|9828431|FG000|NOT COMPLETED|Overall Study||42
8778376|NCT01312909|9828432|FG001|NOT COMPLETED|Overall Study||36
8778377|NCT01312909|9828433|FG002|NOT COMPLETED|Overall Study||47
8778378|NCT01312948|9828441|FG000|STARTED|Overall Study||6
8778379|NCT01312948|9828441|FG000|COMPLETED|Overall Study||6
8778380|NCT01312948|9828441|FG000|NOT COMPLETED|Overall Study||0
8778381|NCT01312961|9828450|FG000|STARTED|Overall Study||52
8778382|NCT01312961|9828451|FG001|STARTED|Overall Study||52
8778383|NCT01312961|9828450|FG000|Treated|Overall Study||52
8778384|NCT01312961|9828451|FG001|Treated|Overall Study||52
8778385|NCT01312961|9828450|FG000|COMPLETED|Overall Study||35
8778386|NCT01312961|9828451|FG001|COMPLETED|Overall Study||45
8778387|NCT01312961|9828450|FG000|NOT COMPLETED|Overall Study||17
8778388|NCT01312961|9828451|FG001|NOT COMPLETED|Overall Study||7
8778389|NCT01313039|9828458|FG000|STARTED|Overall Study||4
8778390|NCT01313039|9828458|FG000|COMPLETED|Overall Study||2
8778391|NCT01313039|9828458|FG000|NOT COMPLETED|Overall Study||2
8778392|NCT01313078|9828462|FG000|STARTED|Overall Study||4
8778393|NCT01313078|9828462|FG000|COMPLETED|Overall Study||1
8778394|NCT01313078|9828462|FG000|NOT COMPLETED|Overall Study||3
8778395|NCT01313117|9828466|FG000|STARTED|Cohort 1: Dose Level 1 (ALA 300mg Daily)||2
8778396|NCT01313117|9828466|FG000|COMPLETED|Cohort 1: Dose Level 1 (ALA 300mg Daily)||2
8778397|NCT01313117|9828466|FG000|NOT COMPLETED|Cohort 1: Dose Level 1 (ALA 300mg Daily)||0
8778398|NCT01313117|9828466|FG000|STARTED|Cohort 2: Dose Level 2 (ALA 600mg Daily)||2
8778399|NCT01313117|9828466|FG000|COMPLETED|Cohort 2: Dose Level 2 (ALA 600mg Daily)||1
8778400|NCT01313117|9828466|FG000|NOT COMPLETED|Cohort 2: Dose Level 2 (ALA 600mg Daily)||1
8778401|NCT01313117|9828466|FG000|STARTED|Cohort 3: Dose Level 3 (ALA 400mg Daily)||2
8778402|NCT01313117|9828466|FG000|COMPLETED|Cohort 3: Dose Level 3 (ALA 400mg Daily)||2
8778403|NCT01313117|9828466|FG000|NOT COMPLETED|Cohort 3: Dose Level 3 (ALA 400mg Daily)||0
8778404|NCT01313117|9828466|FG000|STARTED|Cohort 4: Dose Level 4 (ALA 500mg Daily)||2
8778405|NCT01313117|9828466|FG000|COMPLETED|Cohort 4: Dose Level 4 (ALA 500mg Daily)||2
8778406|NCT01313117|9828466|FG000|NOT COMPLETED|Cohort 4: Dose Level 4 (ALA 500mg Daily)||0
8778407|NCT01313117|9828466|FG000|STARTED|Cohort 5: Dose Level 2 (ALA 600mg Daily)||1
8778408|NCT01313117|9828466|FG000|COMPLETED|Cohort 5: Dose Level 2 (ALA 600mg Daily)||0
8778409|NCT01313117|9828466|FG000|NOT COMPLETED|Cohort 5: Dose Level 2 (ALA 600mg Daily)||1
8778410|NCT01313182|9828473|FG000|STARTED|Overall Study||842
8778411|NCT01313182|9828474|FG001|STARTED|Overall Study||855
8778412|NCT01313182|9828473|FG000|COMPLETED|Overall Study||776
8778413|NCT01313182|9828474|FG001|COMPLETED|Overall Study||763
8778414|NCT01313182|9828473|FG000|NOT COMPLETED|Overall Study||66
8778415|NCT01313182|9828474|FG001|NOT COMPLETED|Overall Study||92
8778416|NCT01313208|9828482|FG000|STARTED|Double-blind Phase (Weeks 1 - 12)||104
8778417|NCT01313208|9828483|FG001|STARTED|Double-blind Phase (Weeks 1 - 12)||106
8778418|NCT01313208|9828482|FG000|COMPLETED|Double-blind Phase (Weeks 1 - 12)||98
8778419|NCT01313208|9828483|FG001|COMPLETED|Double-blind Phase (Weeks 1 - 12)||101
8778420|NCT01313208|9828482|FG000|NOT COMPLETED|Double-blind Phase (Weeks 1 - 12)||6
8778421|NCT01313208|9828483|FG001|NOT COMPLETED|Double-blind Phase (Weeks 1 - 12)||5
8778422|NCT01313208|9828482|FG000|STARTED|Open-label Phase (Weeks 13 - 24)||98
8778423|NCT01313208|9828483|FG001|STARTED|Open-label Phase (Weeks 13 - 24)||101
8778424|NCT01313208|9828482|FG000|COMPLETED|Open-label Phase (Weeks 13 - 24)||92
8778425|NCT01313208|9828483|FG001|COMPLETED|Open-label Phase (Weeks 13 - 24)||98
8778426|NCT01313208|9828482|FG000|NOT COMPLETED|Open-label Phase (Weeks 13 - 24)||6
8778427|NCT01313208|9828483|FG001|NOT COMPLETED|Open-label Phase (Weeks 13 - 24)||3
8778428|NCT01313221|9828494|FG000|STARTED|Overall Study||144
8778429|NCT01313221|9828495|FG001|STARTED|Overall Study||143
8778430|NCT01313221|9828496|FG002|STARTED|Overall Study||23
8778431|NCT01313221|9828494|FG000|Randomized|Overall Study||144
8778432|NCT01313221|9828495|FG001|Randomized|Overall Study||143
8778433|NCT01313221|9828496|FG002|Randomized|Overall Study||0
8778434|NCT01313221|9828494|FG000|COMPLETED|Overall Study||132
8778435|NCT01313221|9828495|FG001|COMPLETED|Overall Study||135
8778436|NCT01313221|9828496|FG002|COMPLETED|Overall Study||0
8778437|NCT01313221|9828494|FG000|NOT COMPLETED|Overall Study||12
8778438|NCT01313221|9828495|FG001|NOT COMPLETED|Overall Study||8
8778439|NCT01313221|9828496|FG002|NOT COMPLETED|Overall Study||23
8778440|NCT01313286|9828504|FG000|STARTED|Period 1||8
8778441|NCT01313286|9828505|FG001|STARTED|Period 1||8
8778442|NCT01313286|9828504|FG000|COMPLETED|Period 1||6
8778443|NCT01313286|9828505|FG001|COMPLETED|Period 1||8
8778444|NCT01313286|9828504|FG000|NOT COMPLETED|Period 1||2
8778445|NCT01313286|9828505|FG001|NOT COMPLETED|Period 1||0
8778446|NCT01313286|9828504|FG000|STARTED|Period 2||6
8778447|NCT01313286|9828505|FG001|STARTED|Period 2||8
8778448|NCT01313286|9828504|FG000|COMPLETED|Period 2||6
8778449|NCT01313286|9828505|FG001|COMPLETED|Period 2||8
8778450|NCT01313286|9828504|FG000|NOT COMPLETED|Period 2||0
8778451|NCT01313286|9828505|FG001|NOT COMPLETED|Period 2||0
8778452|NCT01313299|9828514|FG000|STARTED|Overall Study||81
8778453|NCT01313299|9828515|FG001|STARTED|Overall Study||81
8778454|NCT01313299|9828516|FG002|STARTED|Overall Study||81
8778455|NCT01313299|9828514|FG000|COMPLETED|Overall Study||74
8778456|NCT01313299|9828515|FG001|COMPLETED|Overall Study||78
8778457|NCT01313299|9828516|FG002|COMPLETED|Overall Study||77
8778458|NCT01313299|9828514|FG000|NOT COMPLETED|Overall Study||7
8778459|NCT01313299|9828515|FG001|NOT COMPLETED|Overall Study||3
8778460|NCT01313299|9828516|FG002|NOT COMPLETED|Overall Study||4
8778461|NCT01313312|9828524|FG000|STARTED|Overall Study||258
8778462|NCT01313312|9828524|FG000|Cycle 1|Overall Study||254
8778463|NCT01313312|9828524|FG000|Cycle 2|Overall Study||229
8778464|NCT01313312|9828524|FG000|Cycle 3|Overall Study||175
8778465|NCT01313312|9828524|FG000|Cycle 4|Overall Study||81
8778466|NCT01313312|9828524|FG000|Cycle 5|Overall Study||11
8778467|NCT01313312|9828524|FG000|COMPLETED|Overall Study||222
8778468|NCT01313312|9828524|FG000|NOT COMPLETED|Overall Study||36
8778469|NCT01313494|9828530|FG000|STARTED|Overall Study||313
8778470|NCT01313494|9828531|FG001|STARTED|Overall Study||313
8778471|NCT01313494|9828530|FG000|Safety Set|Overall Study|2 patients in the placebo arm were misallocated and may have received roflumilast in error.|315
8778472|NCT01313494|9828531|FG001|Safety Set|Overall Study|2 patients in the placebo arm were misallocated and may have received roflumilast in error.|311
8778473|NCT01313494|9828530|FG000|COMPLETED|Overall Study||246
8778474|NCT01313494|9828531|FG001|COMPLETED|Overall Study||263
8778475|NCT01313494|9828530|FG000|NOT COMPLETED|Overall Study||67
8778476|NCT01313494|9828531|FG001|NOT COMPLETED|Overall Study||50
8778477|NCT01313507|9828537|FG000|STARTED|Overall Study||21
8778478|NCT01313507|9828537|FG000|COMPLETED|Overall Study||21
8778479|NCT01313507|9828537|FG000|NOT COMPLETED|Overall Study||0
8778480|NCT01313520|9828543|FG000|STARTED|Overall Study||30
8778481|NCT01313520|9828544|FG001|STARTED|Overall Study||31
8778482|NCT01313520|9828543|FG000|COMPLETED|Overall Study||30
8778483|NCT01313520|9828544|FG001|COMPLETED|Overall Study||31
8778484|NCT01313520|9828543|FG000|NOT COMPLETED|Overall Study||0
8778485|NCT01313520|9828544|FG001|NOT COMPLETED|Overall Study||0
8778486|NCT01313559|9828554|FG000|STARTED|Overall Study||4
8778487|NCT01313559|9828555|FG001|STARTED|Overall Study||2
8778488|NCT01313559|9828554|FG000|COMPLETED|Overall Study||0
8778489|NCT01313559|9828555|FG001|COMPLETED|Overall Study||0
8778490|NCT01313559|9828554|FG000|NOT COMPLETED|Overall Study||4
8778491|NCT01313559|9828555|FG001|NOT COMPLETED|Overall Study||2
8778492|NCT01313624|9828563|FG000|STARTED|Double-Blind Phase||134
8778493|NCT01313624|9828564|FG001|STARTED|Double-Blind Phase||132
8778494|NCT01313624|9828563|FG000|COMPLETED|Double-Blind Phase||96
8778495|NCT01313624|9828564|FG001|COMPLETED|Double-Blind Phase||122
8778496|NCT01313624|9828563|FG000|NOT COMPLETED|Double-Blind Phase||38
8778497|NCT01313624|9828564|FG001|NOT COMPLETED|Double-Blind Phase||10
8778498|NCT01313624|9828563|FG000|STARTED|Open-Label Phase||96
8778499|NCT01313624|9828564|FG001|STARTED|Open-Label Phase||122
8778500|NCT01313624|9828563|FG000|COMPLETED|Open-Label Phase||92
8778501|NCT01313624|9828564|FG001|COMPLETED|Open-Label Phase||109
8778502|NCT01313624|9828563|FG000|NOT COMPLETED|Open-Label Phase||4
8778503|NCT01313624|9828564|FG001|NOT COMPLETED|Open-Label Phase||13
9029653|NCT03222414|10092034|FG001|NOT COMPLETED|Overall Study||0
9029654|NCT03222427|10092040|FG000|STARTED|Overall Study||8
9029655|NCT03222427|10092040|FG000|Received One Dose of Study Drug|Overall Study||8
9029656|NCT03222427|10092040|FG000|COMPLETED|Overall Study||8
9029657|NCT03222427|10092040|FG000|NOT COMPLETED|Overall Study||0
9029658|NCT03222505|10092047|FG000|STARTED|Overall Study||5
9029659|NCT03222505|10092048|FG001|STARTED|Overall Study||7
9029660|NCT03222505|10092047|FG000|COMPLETED|Overall Study||5
9029661|NCT03222505|10092048|FG001|COMPLETED|Overall Study||7
9029662|NCT03222505|10092047|FG000|NOT COMPLETED|Overall Study||0
9029663|NCT03222505|10092048|FG001|NOT COMPLETED|Overall Study||0
9029664|NCT03222583|10092057|FG000|STARTED|Overall Study||363
9029665|NCT03222583|10092058|FG001|STARTED|Overall Study||183
9029666|NCT03222583|10092057|FG000|Received Double-blind Treatment|Overall Study||362
9029667|NCT03222583|10092058|FG001|Received Double-blind Treatment|Overall Study||183
9029668|NCT03222583|10092057|FG000|Completed Double-blind Period|Overall Study||360
9029669|NCT03222583|10092058|FG001|Completed Double-blind Period|Overall Study||183
9029670|NCT03222583|10092057|FG000|Entered Open-label Period|Overall Study||0
9029671|NCT03222583|10092058|FG001|Entered Open-label Period|Overall Study||182
9029672|NCT03222583|10092057|FG000|Completed Open-label Period|Overall Study||0
9029673|NCT03222583|10092058|FG001|Completed Open-label Period|Overall Study||181
9029674|NCT03222583|10092057|FG000|COMPLETED|Overall Study||358
9029675|NCT03222583|10092058|FG001|COMPLETED|Overall Study||177
9029676|NCT03222583|10092057|FG000|NOT COMPLETED|Overall Study||5
9029677|NCT03222583|10092058|FG001|NOT COMPLETED|Overall Study||6
8778504|NCT01313637|9828576|FG000|STARTED|Overall Study||275
8778505|NCT01313637|9828577|FG001|STARTED|Overall Study||407
8778506|NCT01313637|9828578|FG002|STARTED|Overall Study||404
8778507|NCT01313637|9828579|FG003|STARTED|Overall Study||403
8778508|NCT01313637|9828576|FG000|COMPLETED|Overall Study||183
8778509|NCT01313637|9828577|FG001|COMPLETED|Overall Study||312
8778510|NCT01313637|9828578|FG002|COMPLETED|Overall Study||298
8778511|NCT01313637|9828579|FG003|COMPLETED|Overall Study||325
8778512|NCT01313637|9828576|FG000|NOT COMPLETED|Overall Study||92
8778513|NCT01313637|9828577|FG001|NOT COMPLETED|Overall Study||95
8778514|NCT01313637|9828578|FG002|NOT COMPLETED|Overall Study||106
8778515|NCT01313637|9828579|FG003|NOT COMPLETED|Overall Study||78
8778516|NCT01313650|9828593|FG000|STARTED|Overall Study||280
8778517|NCT01313650|9828594|FG001|STARTED|Overall Study||418
8778518|NCT01313650|9828595|FG002|STARTED|Overall Study||421
8778519|NCT01313650|9828596|FG003|STARTED|Overall Study||413
8778520|NCT01313650|9828593|FG000|COMPLETED|Overall Study||204
8778521|NCT01313650|9828594|FG001|COMPLETED|Overall Study||324
8778522|NCT01313650|9828595|FG002|COMPLETED|Overall Study||318
8778523|NCT01313650|9828596|FG003|COMPLETED|Overall Study||332
8778524|NCT01313650|9828593|FG000|NOT COMPLETED|Overall Study||76
8778525|NCT01313650|9828594|FG001|NOT COMPLETED|Overall Study||94
8778526|NCT01313650|9828595|FG002|NOT COMPLETED|Overall Study||103
8778527|NCT01313650|9828596|FG003|NOT COMPLETED|Overall Study||81
8778528|NCT01313663|9828608|FG000|STARTED|Overall Study||9
8778529|NCT01313663|9828609|FG001|STARTED|Overall Study||11
8778530|NCT01313663|9828608|FG000|COMPLETED|Overall Study||5
8778531|NCT01313663|9828609|FG001|COMPLETED|Overall Study||3
8778532|NCT01313663|9828608|FG000|NOT COMPLETED|Overall Study||4
8778533|NCT01313663|9828609|FG001|NOT COMPLETED|Overall Study||8
8778534|NCT01313676|9828619|FG000|STARTED|Overall Study||4131
8778535|NCT01313676|9828620|FG001|STARTED|Overall Study||4157
8778536|NCT01313676|9828621|FG002|STARTED|Overall Study||4140
8778537|NCT01313676|9828622|FG003|STARTED|Overall Study||4140
8778538|NCT01313676|9828619|FG000|COMPLETED|Overall Study||2881
8778539|NCT01313676|9828620|FG001|COMPLETED|Overall Study||3044
8778540|NCT01313676|9828621|FG002|COMPLETED|Overall Study||3052
8778541|NCT01313676|9828622|FG003|COMPLETED|Overall Study||3146
8778542|NCT01313676|9828619|FG000|NOT COMPLETED|Overall Study||1250
8778543|NCT01313676|9828620|FG001|NOT COMPLETED|Overall Study||1113
8778544|NCT01313676|9828621|FG002|NOT COMPLETED|Overall Study||1088
8778545|NCT01313676|9828622|FG003|NOT COMPLETED|Overall Study||994
8778546|NCT01313728|9828633|FG000|STARTED|Informed Consent to Baseline||26
8778547|NCT01313728|9828633|FG000|COMPLETED|Informed Consent to Baseline|One subject withdrew after signing informed consent, but prior to Baseline measurements being taken.|25
8778548|NCT01313728|9828633|FG000|NOT COMPLETED|Informed Consent to Baseline||1
8778549|NCT01313728|9828633|FG000|STARTED|Baseline to Completion||25
8778550|NCT01313728|9828633|FG000|COMPLETED|Baseline to Completion||25
8778551|NCT01313728|9828633|FG000|NOT COMPLETED|Baseline to Completion||0
8778552|NCT01313767|9828640|FG000|STARTED|Overall Study||98
8778553|NCT01313767|9828641|FG001|STARTED|Overall Study||98
8778554|NCT01313767|9828640|FG000|COMPLETED|Overall Study||91
8778555|NCT01313767|9828641|FG001|COMPLETED|Overall Study||96
8778556|NCT01313767|9828640|FG000|NOT COMPLETED|Overall Study||7
8778557|NCT01313767|9828641|FG001|NOT COMPLETED|Overall Study||2
8778558|NCT01313780|9828649|FG000|STARTED|Overall Study|FAS|58
8778559|NCT01313780|9828650|FG001|STARTED|Overall Study|FAS|59
8778560|NCT01313780|9828649|FG000|COMPLETED|Overall Study|PPS|33
8778561|NCT01313780|9828650|FG001|COMPLETED|Overall Study|PPS|31
8778562|NCT01313780|9828649|FG000|NOT COMPLETED|Overall Study||25
8778563|NCT01313780|9828650|FG001|NOT COMPLETED|Overall Study||28
8778564|NCT01313858|9828659|FG000|STARTED|Overall Study||524
8778565|NCT01313858|9828660|FG001|STARTED|Overall Study||546
8778566|NCT01313858|9828661|FG002|STARTED|Overall Study||543
8778567|NCT01313858|9828659|FG000|COMPLETED|Overall Study||238
8778568|NCT01313858|9828660|FG001|COMPLETED|Overall Study||276
8778569|NCT01313858|9828661|FG002|COMPLETED|Overall Study||305
8778570|NCT01313858|9828659|FG000|NOT COMPLETED|Overall Study||286
9029678|NCT03223246|10092066|FG000|STARTED|48-72 Hours||83
9029679|NCT03223246|10092067|FG001|STARTED|48-72 Hours||66
9029680|NCT03223246|10092066|FG000|COMPLETED|48-72 Hours||62
8778571|NCT01313858|9828660|FG001|NOT COMPLETED|Overall Study||270
8778572|NCT01313858|9828661|FG002|NOT COMPLETED|Overall Study||238
8778573|NCT01313884|9828667|FG000|STARTED|Overall Study||3
8778574|NCT01313884|9828667|FG000|COMPLETED|Overall Study||2
8778575|NCT01313884|9828667|FG000|NOT COMPLETED|Overall Study||1
8778576|NCT01313897|9828671|FG000|STARTED|Overall Study||10
8778577|NCT01313897|9828671|FG000|COMPLETED|Overall Study||8
8778578|NCT01313897|9828671|FG000|NOT COMPLETED|Overall Study||2
8778579|NCT01313910|9828675|FG000|STARTED|Overall Study||8
8778580|NCT01313910|9828675|FG000|COMPLETED|Overall Study||8
8778581|NCT01313910|9828675|FG000|NOT COMPLETED|Overall Study||0
8778582|NCT01313936|9828681|FG000|STARTED|Overall Study||6
8778583|NCT01313936|9828682|FG001|STARTED|Overall Study||26
8778584|NCT01313936|9828681|FG000|COMPLETED|Overall Study||6
8916458|NCT02184169|9976064|FG000|STARTED|Overall Study||21
8916459|NCT02184169|9976065|FG001|STARTED|Overall Study||6
8916460|NCT02184169|9976064|FG000|COMPLETED|Overall Study||21
8916461|NCT02184169|9976065|FG001|COMPLETED|Overall Study||6
8916462|NCT02184169|9976064|FG000|NOT COMPLETED|Overall Study||0
8778585|NCT01313936|9828682|FG001|COMPLETED|Overall Study||26
8778586|NCT01313936|9828681|FG000|NOT COMPLETED|Overall Study||0
8778587|NCT01313936|9828682|FG001|NOT COMPLETED|Overall Study||0
8778588|NCT01314001|9828697|FG000|STARTED|Overall Study||215
8778589|NCT01314001|9828698|FG001|STARTED|Overall Study||193
8778590|NCT01314001|9828699|FG002|STARTED|Overall Study||227
8778591|NCT01314001|9828700|FG003|STARTED|Overall Study||191
8916463|NCT02184169|9976065|FG001|NOT COMPLETED|Overall Study||0
8916464|NCT02184208|9976073|FG000|STARTED|Overall Study||278
8916465|NCT02184208|9976073|FG000|COMPLETED|Overall Study||222
8778592|NCT01314001|9828701|FG004|STARTED|Overall Study||220
8778593|NCT01314001|9828702|FG005|STARTED|Overall Study||200
8778594|NCT01314001|9828697|FG000|End-of-Treatment Visit|Overall Study||156
8778595|NCT01314001|9828698|FG001|End-of-Treatment Visit|Overall Study||141
8778596|NCT01314001|9828699|FG002|End-of-Treatment Visit|Overall Study||179
8778597|NCT01314001|9828700|FG003|End-of-Treatment Visit|Overall Study||146
8778598|NCT01314001|9828701|FG004|End-of-Treatment Visit|Overall Study||174
8778599|NCT01314001|9828702|FG005|End-of-Treatment Visit|Overall Study||160
8778600|NCT01314001|9828697|FG000|6-Month Follow Up Survey|Overall Study||146
8778601|NCT01314001|9828698|FG001|6-Month Follow Up Survey|Overall Study||137
8778602|NCT01314001|9828699|FG002|6-Month Follow Up Survey|Overall Study||165
8778603|NCT01314001|9828700|FG003|6-Month Follow Up Survey|Overall Study||135
8778604|NCT01314001|9828701|FG004|6-Month Follow Up Survey|Overall Study||157
8778605|NCT01314001|9828702|FG005|6-Month Follow Up Survey|Overall Study||139
8778606|NCT01314001|9828697|FG000|COMPLETED|Overall Study||140
8778607|NCT01314001|9828698|FG001|COMPLETED|Overall Study||124
8778608|NCT01314001|9828699|FG002|COMPLETED|Overall Study||158
8778609|NCT01314001|9828700|FG003|COMPLETED|Overall Study||122
8778610|NCT01314001|9828701|FG004|COMPLETED|Overall Study||148
9029681|NCT03223246|10092067|FG001|COMPLETED|48-72 Hours||35
9029682|NCT03223246|10092066|FG000|NOT COMPLETED|48-72 Hours||21
9029683|NCT03223246|10092067|FG001|NOT COMPLETED|48-72 Hours||31
9029684|NCT03223246|10092066|FG000|STARTED|5-7 Days||83
9029685|NCT03223246|10092067|FG001|STARTED|5-7 Days||66
9029686|NCT03223246|10092066|FG000|COMPLETED|5-7 Days||41
9029687|NCT03223246|10092067|FG001|COMPLETED|5-7 Days||35
9029688|NCT03223246|10092066|FG000|NOT COMPLETED|5-7 Days||42
9029689|NCT03223246|10092067|FG001|NOT COMPLETED|5-7 Days||31
9029690|NCT03223272|10092073|FG000|STARTED|Overall Study||7
9029691|NCT03223272|10092073|FG000|COMPLETED|Overall Study||6
9029692|NCT03223272|10092073|FG000|NOT COMPLETED|Overall Study||1
9029693|NCT03223337|10092081|FG000|STARTED|Part 1 (Up to 16 Days)||8
9029694|NCT03223337|10092082|FG001|STARTED|Part 1 (Up to 16 Days)||8
9029695|NCT03223337|10092083|FG002|STARTED|Part 1 (Up to 16 Days)||0
9029696|NCT03223337|10092084|FG003|STARTED|Part 1 (Up to 16 Days)||0
9029697|NCT03223337|10092081|FG000|COMPLETED|Part 1 (Up to 16 Days)||8
9029698|NCT03223337|10092082|FG001|COMPLETED|Part 1 (Up to 16 Days)||8
9029699|NCT03223337|10092083|FG002|COMPLETED|Part 1 (Up to 16 Days)||0
9029700|NCT03223337|10092084|FG003|COMPLETED|Part 1 (Up to 16 Days)||0
9029701|NCT03223337|10092081|FG000|NOT COMPLETED|Part 1 (Up to 16 Days)||0
9029702|NCT03223337|10092082|FG001|NOT COMPLETED|Part 1 (Up to 16 Days)||0
9029703|NCT03223337|10092083|FG002|NOT COMPLETED|Part 1 (Up to 16 Days)||0
9029704|NCT03223337|10092084|FG003|NOT COMPLETED|Part 1 (Up to 16 Days)||0
9029705|NCT03223337|10092081|FG000|STARTED|Part 2 (Up to 16 Days)||0
9029706|NCT03223337|10092082|FG001|STARTED|Part 2 (Up to 16 Days)||0
9029707|NCT03223337|10092083|FG002|STARTED|Part 2 (Up to 16 Days)||12
9029708|NCT03223337|10092084|FG003|STARTED|Part 2 (Up to 16 Days)||9
9029709|NCT03223337|10092081|FG000|COMPLETED|Part 2 (Up to 16 Days)||0
9029710|NCT03223337|10092082|FG001|COMPLETED|Part 2 (Up to 16 Days)||0
9029711|NCT03223337|10092083|FG002|COMPLETED|Part 2 (Up to 16 Days)||12
9029712|NCT03223337|10092084|FG003|COMPLETED|Part 2 (Up to 16 Days)||9
9029713|NCT03223337|10092081|FG000|NOT COMPLETED|Part 2 (Up to 16 Days)||0
9029714|NCT03223337|10092082|FG001|NOT COMPLETED|Part 2 (Up to 16 Days)||0
9029715|NCT03223337|10092083|FG002|NOT COMPLETED|Part 2 (Up to 16 Days)||0
9029716|NCT03223337|10092084|FG003|NOT COMPLETED|Part 2 (Up to 16 Days)||0
9029717|NCT03223649|10092096|FG000|STARTED|Overall Study||52
9029718|NCT03223649|10092097|FG001|STARTED|Overall Study||57
9029719|NCT03223649|10092096|FG000|COMPLETED|Overall Study||42
9029720|NCT03223649|10092097|FG001|COMPLETED|Overall Study||51
9029721|NCT03223649|10092096|FG000|NOT COMPLETED|Overall Study||10
9029722|NCT03223649|10092097|FG001|NOT COMPLETED|Overall Study||6
9029723|NCT03223909|10092106|FG000|STARTED|Overall Study||120
9029724|NCT03223909|10092107|FG001|STARTED|Overall Study||109
9029725|NCT03223909|10092108|FG002|STARTED|Overall Study||97
9029726|NCT03223909|10092106|FG000|COMPLETED|Overall Study||72
9029727|NCT03223909|10092107|FG001|COMPLETED|Overall Study||64
9029728|NCT03223909|10092108|FG002|COMPLETED|Overall Study||81
9029729|NCT03223909|10092106|FG000|NOT COMPLETED|Overall Study||48
9029730|NCT03223909|10092107|FG001|NOT COMPLETED|Overall Study||45
9029731|NCT03223909|10092108|FG002|NOT COMPLETED|Overall Study||16
9029732|NCT03224130|10092118|FG000|STARTED|Overall Study||483
9029733|NCT03224130|10092119|FG001|STARTED|Overall Study||483
9029734|NCT03224130|10092118|FG000|COMPLETED|Overall Study||483
9029735|NCT03224130|10092119|FG001|COMPLETED|Overall Study||482
9029736|NCT03224130|10092118|FG000|NOT COMPLETED|Overall Study||0
9029737|NCT03224130|10092119|FG001|NOT COMPLETED|Overall Study||1
9029738|NCT03224182|10092127|FG000|STARTED|Overall Study||81
9029739|NCT03224182|10092128|FG001|STARTED|Overall Study||37
9029740|NCT03224182|10092127|FG000|Safety Population|Overall Study||73
9029741|NCT03224182|10092128|FG001|Safety Population|Overall Study||36
9029742|NCT03224182|10092127|FG000|COMPLETED|Overall Study||0
8778611|NCT01314001|9828702|FG005|COMPLETED|Overall Study||129
9029743|NCT03224182|10092128|FG001|COMPLETED|Overall Study||1
9029744|NCT03224182|10092127|FG000|NOT COMPLETED|Overall Study||81
9029745|NCT03224182|10092128|FG001|NOT COMPLETED|Overall Study||36
9029746|NCT03224234|10092138|FG000|STARTED|Main Study||40
9029747|NCT03224234|10092139|FG001|STARTED|Main Study||40
9029748|NCT03224234|10092138|FG000|COMPLETED|Main Study||35
8778612|NCT01314001|9828697|FG000|NOT COMPLETED|Overall Study||75
8778613|NCT01314001|9828698|FG001|NOT COMPLETED|Overall Study||69
8778614|NCT01314001|9828699|FG002|NOT COMPLETED|Overall Study||69
8778615|NCT01314001|9828700|FG003|NOT COMPLETED|Overall Study||69
8778616|NCT01314001|9828701|FG004|NOT COMPLETED|Overall Study||72
8778617|NCT01314001|9828702|FG005|NOT COMPLETED|Overall Study||71
8778618|NCT01314014|9828716|FG000|STARTED|Overall Study||22
8778619|NCT01314014|9828716|FG000|COMPLETED|Overall Study|Treatment continued for as long as the subject derived benefit.|22
8778620|NCT01314014|9828716|FG000|NOT COMPLETED|Overall Study||0
8778621|NCT01314105|9828722|FG000|STARTED|Overall Study||7
8778622|NCT01314105|9828723|FG001|STARTED|Overall Study||12
8778623|NCT01314105|9828722|FG000|COMPLETED|Overall Study||0
8778624|NCT01314105|9828723|FG001|COMPLETED|Overall Study||0
8778625|NCT01314105|9828722|FG000|NOT COMPLETED|Overall Study||7
8778626|NCT01314105|9828723|FG001|NOT COMPLETED|Overall Study||12
8778627|NCT01314261|9828735|FG000|STARTED|Overall Study||9
8778628|NCT01314261|9828736|FG001|STARTED|Overall Study||9
8778629|NCT01314261|9828737|FG002|STARTED|Overall Study||10
8778630|NCT01314261|9828738|FG003|STARTED|Overall Study||9
8778631|NCT01314261|9828735|FG000|Discontinued ABT-267 or Placebo|Overall Study||1
8778632|NCT01314261|9828736|FG001|Discontinued ABT-267 or Placebo|Overall Study||0
8778633|NCT01314261|9828737|FG002|Discontinued ABT-267 or Placebo|Overall Study||1
8778634|NCT01314261|9828738|FG003|Discontinued ABT-267 or Placebo|Overall Study||0
8778635|NCT01314261|9828735|FG000|Discontinued pegIFN/RBV|Overall Study||1
8778636|NCT01314261|9828736|FG001|Discontinued pegIFN/RBV|Overall Study||4
8778637|NCT01314261|9828737|FG002|Discontinued pegIFN/RBV|Overall Study||5
8778638|NCT01314261|9828738|FG003|Discontinued pegIFN/RBV|Overall Study||1
8778639|NCT01314261|9828735|FG000|COMPLETED|Overall Study||7
8778640|NCT01314261|9828736|FG001|COMPLETED|Overall Study||5
8778641|NCT01314261|9828737|FG002|COMPLETED|Overall Study||7
8778642|NCT01314261|9828738|FG003|COMPLETED|Overall Study||6
8778643|NCT01314261|9828735|FG000|NOT COMPLETED|Overall Study||2
8778644|NCT01314261|9828736|FG001|NOT COMPLETED|Overall Study||4
8778645|NCT01314261|9828737|FG002|NOT COMPLETED|Overall Study||3
8778646|NCT01314261|9828738|FG003|NOT COMPLETED|Overall Study||3
8778647|NCT01314313|9828750|FG000|STARTED|Overall Study||1011
8778648|NCT01314313|9828751|FG001|STARTED|Overall Study||1021
8778649|NCT01314313|9828750|FG000|As Treated|Overall Study||994
8778650|NCT01314313|9828751|FG001|As Treated|Overall Study||944
8778651|NCT01314313|9828750|FG000|Valve Implanted|Overall Study||974
8778652|NCT01314313|9828751|FG001|Valve Implanted|Overall Study||936
8778653|NCT01314313|9828750|FG000|COMPLETED|Overall Study||784
8778654|NCT01314313|9828751|FG001|COMPLETED|Overall Study||710
8778655|NCT01314313|9828750|FG000|NOT COMPLETED|Overall Study||227
8778656|NCT01314313|9828751|FG001|NOT COMPLETED|Overall Study||311
8778657|NCT01314417|9828759|FG000|STARTED|Overall Study||2
8778658|NCT01314417|9828759|FG000|COMPLETED|Overall Study||2
8778659|NCT01314417|9828759|FG000|NOT COMPLETED|Overall Study||0
8778660|NCT01314443|9828767|FG000|STARTED|Overall Study||18
8778661|NCT01314443|9828768|FG001|STARTED|Overall Study||19
8778662|NCT01314443|9828769|FG002|STARTED|Overall Study||15
8778663|NCT01314443|9828770|FG003|STARTED|Overall Study||15
8778664|NCT01314443|9828767|FG000|COMPLETED|Overall Study||14
8778665|NCT01314443|9828768|FG001|COMPLETED|Overall Study||16
8778666|NCT01314443|9828769|FG002|COMPLETED|Overall Study||13
8778667|NCT01314443|9828770|FG003|COMPLETED|Overall Study||13
8778668|NCT01314443|9828767|FG000|NOT COMPLETED|Overall Study||4
8778669|NCT01314443|9828768|FG001|NOT COMPLETED|Overall Study||3
8778670|NCT01314443|9828769|FG002|NOT COMPLETED|Overall Study||2
8778671|NCT01314443|9828770|FG003|NOT COMPLETED|Overall Study||2
8778672|NCT01314703|9828780|FG000|STARTED|Overall Study||35
8778673|NCT01314703|9828780|FG000|Signed Informed Consent|Overall Study||35
8778674|NCT01314703|9828780|FG000|Completed Screen Visit|Overall Study||33
8778675|NCT01314703|9828780|FG000|Completed Treatment Visit|Overall Study||27
8778676|NCT01314703|9828780|FG000|Completed Study|Overall Study||27
8778677|NCT01314703|9828780|FG000|Excluded Prior to Screening Baseline|Overall Study||2
8778678|NCT01314703|9828780|FG000|Non Qualified Bacterial Screening Counts|Overall Study||3
8778679|NCT01314703|9828780|FG000|Discontinued When Enrollment Completed|Overall Study||3
8778680|NCT01314703|9828780|FG000|COMPLETED|Overall Study||27
8778681|NCT01314703|9828780|FG000|NOT COMPLETED|Overall Study||8
8778682|NCT01314716|9828787|FG000|STARTED|Double-Blind Phase||136
8778683|NCT01314716|9828788|FG001|STARTED|Double-Blind Phase||138
8778684|NCT01314716|9828787|FG000|Randomized and Treated|Double-Blind Phase||135
8778685|NCT01314716|9828788|FG001|Randomized and Treated|Double-Blind Phase||137
8778686|NCT01314716|9828787|FG000|COMPLETED|Double-Blind Phase||119
8778687|NCT01314716|9828788|FG001|COMPLETED|Double-Blind Phase||123
8778688|NCT01314716|9828787|FG000|NOT COMPLETED|Double-Blind Phase||17
8778689|NCT01314716|9828788|FG001|NOT COMPLETED|Double-Blind Phase||15
8778690|NCT01314716|9828787|FG000|STARTED|Open-Label Phase|7 participants in this group did not continue from the randomized to the open-label phase.|112
8778691|NCT01314716|9828788|FG001|STARTED|Open-Label Phase|13 participants in this group did not continue from the randomized to the open-label phase.|110
8778692|NCT01314716|9828787|FG000|COMPLETED|Open-Label Phase||102
8778693|NCT01314716|9828788|FG001|COMPLETED|Open-Label Phase||98
8778694|NCT01314716|9828787|FG000|NOT COMPLETED|Open-Label Phase||10
8778695|NCT01314716|9828788|FG001|NOT COMPLETED|Open-Label Phase||12
8778696|NCT01314742|9828798|FG000|STARTED|Overall Study||20
8778697|NCT01314742|9828799|FG001|STARTED|Overall Study||21
8778698|NCT01314742|9828798|FG000|COMPLETED|Overall Study||20
8778699|NCT01314742|9828799|FG001|COMPLETED|Overall Study||21
8778700|NCT01314742|9828798|FG000|NOT COMPLETED|Overall Study||0
8778701|NCT01314742|9828799|FG001|NOT COMPLETED|Overall Study||0
8778702|NCT01314872|9828818|FG000|STARTED|Treatment Period 1||141
8778703|NCT01314872|9828819|FG001|STARTED|Treatment Period 1||144
8778704|NCT01314872|9828820|FG002|STARTED|Treatment Period 1||134
8778705|NCT01314872|9828821|FG003|STARTED|Treatment Period 1||150
8778706|NCT01314872|9828822|FG004|STARTED|Treatment Period 1||149
8778707|NCT01314872|9828823|FG005|STARTED|Treatment Period 1||135
8778708|NCT01314872|9828824|FG006|STARTED|Treatment Period 1||134
8778709|NCT01314872|9828825|FG007|STARTED|Treatment Period 1||64
8778710|NCT01314872|9828826|FG008|STARTED|Treatment Period 1||112
8778711|NCT01314872|9828827|FG009|STARTED|Treatment Period 1||122
8778712|NCT01314872|9828828|FG010|STARTED|Treatment Period 1||110
8778713|NCT01314872|9828829|FG011|STARTED|Treatment Period 1||0
8778714|NCT01314872|9828830|FG012|STARTED|Treatment Period 1||0
8778715|NCT01314872|9828831|FG013|STARTED|Treatment Period 1||0
8778716|NCT01314872|9828832|FG014|STARTED|Treatment Period 1||0
8778717|NCT01314872|9828818|FG000|COMPLETED|Treatment Period 1||131
8778718|NCT01314872|9828819|FG001|COMPLETED|Treatment Period 1||138
8778719|NCT01314872|9828820|FG002|COMPLETED|Treatment Period 1||128
8778720|NCT01314872|9828821|FG003|COMPLETED|Treatment Period 1||143
8778721|NCT01314872|9828822|FG004|COMPLETED|Treatment Period 1||142
8778722|NCT01314872|9828823|FG005|COMPLETED|Treatment Period 1||128
8778723|NCT01314872|9828824|FG006|COMPLETED|Treatment Period 1||126
8778724|NCT01314872|9828825|FG007|COMPLETED|Treatment Period 1||57
8778725|NCT01314872|9828826|FG008|COMPLETED|Treatment Period 1||106
8778726|NCT01314872|9828827|FG009|COMPLETED|Treatment Period 1||118
8778727|NCT01314872|9828828|FG010|COMPLETED|Treatment Period 1||107
8778728|NCT01314872|9828829|FG011|COMPLETED|Treatment Period 1||0
8778729|NCT01314872|9828830|FG012|COMPLETED|Treatment Period 1||0
8778730|NCT01314872|9828831|FG013|COMPLETED|Treatment Period 1||0
8778731|NCT01314872|9828832|FG014|COMPLETED|Treatment Period 1||0
8778732|NCT01314872|9828818|FG000|NOT COMPLETED|Treatment Period 1||10
8778733|NCT01314872|9828819|FG001|NOT COMPLETED|Treatment Period 1||6
8778734|NCT01314872|9828820|FG002|NOT COMPLETED|Treatment Period 1||6
8778735|NCT01314872|9828821|FG003|NOT COMPLETED|Treatment Period 1||7
8778736|NCT01314872|9828822|FG004|NOT COMPLETED|Treatment Period 1||7
8778737|NCT01314872|9828823|FG005|NOT COMPLETED|Treatment Period 1||7
8778738|NCT01314872|9828824|FG006|NOT COMPLETED|Treatment Period 1||8
8778739|NCT01314872|9828825|FG007|NOT COMPLETED|Treatment Period 1||7
8778740|NCT01314872|9828826|FG008|NOT COMPLETED|Treatment Period 1||6
8778741|NCT01314872|9828827|FG009|NOT COMPLETED|Treatment Period 1||4
8778742|NCT01314872|9828828|FG010|NOT COMPLETED|Treatment Period 1||3
8778743|NCT01314872|9828829|FG011|NOT COMPLETED|Treatment Period 1||0
8778744|NCT01314872|9828830|FG012|NOT COMPLETED|Treatment Period 1||0
8778745|NCT01314872|9828831|FG013|NOT COMPLETED|Treatment Period 1||0
8778746|NCT01314872|9828832|FG014|NOT COMPLETED|Treatment Period 1||0
8778747|NCT01314872|9828818|FG000|STARTED|Period 2||0
8778748|NCT01314872|9828819|FG001|STARTED|Period 2||0
8778749|NCT01314872|9828820|FG002|STARTED|Period 2||0
8778750|NCT01314872|9828821|FG003|STARTED|Period 2||0
8778751|NCT01314872|9828822|FG004|STARTED|Period 2||0
8778752|NCT01314872|9828823|FG005|STARTED|Period 2||0
8778753|NCT01314872|9828824|FG006|STARTED|Period 2||0
8778754|NCT01314872|9828825|FG007|STARTED|Period 2||0
8778755|NCT01314872|9828826|FG008|STARTED|Period 2||0
8778756|NCT01314872|9828827|FG009|STARTED|Period 2||0
8778757|NCT01314872|9828828|FG010|STARTED|Period 2||0
8778758|NCT01314872|9828829|FG011|STARTED|Period 2||223
8778759|NCT01314872|9828830|FG012|STARTED|Period 2||248
8778760|NCT01314872|9828831|FG013|STARTED|Period 2||240
8778761|NCT01314872|9828832|FG014|STARTED|Period 2||134
8778762|NCT01314872|9828818|FG000|COMPLETED|Period 2||0
8778763|NCT01314872|9828819|FG001|COMPLETED|Period 2||0
8778764|NCT01314872|9828820|FG002|COMPLETED|Period 2||0
8778765|NCT01314872|9828821|FG003|COMPLETED|Period 2||0
8778766|NCT01314872|9828822|FG004|COMPLETED|Period 2||0
8778767|NCT01314872|9828823|FG005|COMPLETED|Period 2||0
8778768|NCT01314872|9828824|FG006|COMPLETED|Period 2||0
8778769|NCT01314872|9828825|FG007|COMPLETED|Period 2||0
8778770|NCT01314872|9828826|FG008|COMPLETED|Period 2||0
8778771|NCT01314872|9828827|FG009|COMPLETED|Period 2||0
8778772|NCT01314872|9828828|FG010|COMPLETED|Period 2||0
8778773|NCT01314872|9828829|FG011|COMPLETED|Period 2||175
8778774|NCT01314872|9828830|FG012|COMPLETED|Period 2||188
8778775|NCT01314872|9828831|FG013|COMPLETED|Period 2||187
8778776|NCT01314872|9828832|FG014|COMPLETED|Period 2||110
8778777|NCT01314872|9828818|FG000|NOT COMPLETED|Period 2||0
8778778|NCT01314872|9828819|FG001|NOT COMPLETED|Period 2||0
8778779|NCT01314872|9828820|FG002|NOT COMPLETED|Period 2||0
8778780|NCT01314872|9828821|FG003|NOT COMPLETED|Period 2||0
8778781|NCT01314872|9828822|FG004|NOT COMPLETED|Period 2||0
8778782|NCT01314872|9828823|FG005|NOT COMPLETED|Period 2||0
8778783|NCT01314872|9828824|FG006|NOT COMPLETED|Period 2||0
8778784|NCT01314872|9828825|FG007|NOT COMPLETED|Period 2||0
8778785|NCT01314872|9828826|FG008|NOT COMPLETED|Period 2||0
8778786|NCT01314872|9828827|FG009|NOT COMPLETED|Period 2||0
8778787|NCT01314872|9828828|FG010|NOT COMPLETED|Period 2||0
8778788|NCT01314872|9828829|FG011|NOT COMPLETED|Period 2||48
8778789|NCT01314872|9828830|FG012|NOT COMPLETED|Period 2||60
8778790|NCT01314872|9828831|FG013|NOT COMPLETED|Period 2||53
8778791|NCT01314872|9828832|FG014|NOT COMPLETED|Period 2||24
8778792|NCT01314911|9828866|FG000|STARTED|Overall Study||278
8778793|NCT01314911|9828867|FG001|STARTED|Overall Study||280
8778794|NCT01314911|9828866|FG000|COMPLETED|Overall Study||273
8778795|NCT01314911|9828867|FG001|COMPLETED|Overall Study||274
8778796|NCT01314911|9828866|FG000|NOT COMPLETED|Overall Study||5
8778797|NCT01314911|9828867|FG001|NOT COMPLETED|Overall Study||6
8778798|NCT01314963|9828873|FG000|STARTED|Overall Study||50
8778799|NCT01314963|9828873|FG000|COMPLETED|Overall Study||50
8778800|NCT01314963|9828873|FG000|NOT COMPLETED|Overall Study||0
8778801|NCT01315002|9828879|FG000|STARTED|Overall Study||61
8778802|NCT01315002|9828880|FG001|STARTED|Overall Study||60
8778803|NCT01315002|9828879|FG000|COMPLETED|Overall Study||56
8778804|NCT01315002|9828880|FG001|COMPLETED|Overall Study||55
8778805|NCT01315002|9828879|FG000|NOT COMPLETED|Overall Study||5
8778806|NCT01315002|9828880|FG001|NOT COMPLETED|Overall Study||5
8778807|NCT01315028|9828888|FG000|STARTED|Overall Study||10
8778808|NCT01315028|9828889|FG001|STARTED|Overall Study||10
8778809|NCT01315028|9828888|FG000|COMPLETED|Overall Study||9
8778810|NCT01315028|9828889|FG001|COMPLETED|Overall Study||9
8778811|NCT01315028|9828888|FG000|NOT COMPLETED|Overall Study||1
8778812|NCT01315028|9828889|FG001|NOT COMPLETED|Overall Study||1
8778813|NCT01315132|9828895|FG000|STARTED|Overall Study||47
8778814|NCT01315132|9828895|FG000|COMPLETED|Overall Study||46
8778815|NCT01315132|9828895|FG000|NOT COMPLETED|Overall Study||1
8778816|NCT01315145|9828901|FG000|STARTED|Overall Study||122
8778817|NCT01315145|9828902|FG001|STARTED|Overall Study||16
8778818|NCT01315145|9828901|FG000|COMPLETED|Overall Study||105
8778819|NCT01315145|9828902|FG001|COMPLETED|Overall Study||11
8778820|NCT01315145|9828901|FG000|NOT COMPLETED|Overall Study||17
8778821|NCT01315145|9828902|FG001|NOT COMPLETED|Overall Study||5
8778822|NCT01315158|9828910|FG000|STARTED|Overall Study||17
8778823|NCT01315158|9828911|FG001|STARTED|Overall Study||19
8778824|NCT01315158|9828910|FG000|COMPLETED|Overall Study||17
8778825|NCT01315158|9828911|FG001|COMPLETED|Overall Study||19
8778826|NCT01315158|9828910|FG000|NOT COMPLETED|Overall Study||0
8778827|NCT01315158|9828911|FG001|NOT COMPLETED|Overall Study||0
8778828|NCT01315236|9828919|FG000|STARTED|Double-blind Phase||44
8778829|NCT01315236|9828920|FG001|STARTED|Double-blind Phase||45
8778830|NCT01315236|9828919|FG000|COMPLETED|Double-blind Phase||40
8778831|NCT01315236|9828920|FG001|COMPLETED|Double-blind Phase||45
8778832|NCT01315236|9828919|FG000|NOT COMPLETED|Double-blind Phase||4
8778833|NCT01315236|9828920|FG001|NOT COMPLETED|Double-blind Phase||0
8778834|NCT01315236|9828919|FG000|STARTED|Open-label Phase|Some subjects did not consent to the open label after the double blind phase.|35
8778835|NCT01315236|9828920|FG001|STARTED|Open-label Phase|Some subjects did not consent to the open label after the double blind phase.|43
8778836|NCT01315236|9828919|FG000|COMPLETED|Open-label Phase||34
8778837|NCT01315236|9828920|FG001|COMPLETED|Open-label Phase||41
8778838|NCT01315236|9828919|FG000|NOT COMPLETED|Open-label Phase||1
8778839|NCT01315236|9828920|FG001|NOT COMPLETED|Open-label Phase||2
8778840|NCT01315236|9828919|FG000|STARTED|12-Month Follow-up Period|Some subjects did not consent to the 12 month safety.|27
8778841|NCT01315236|9828920|FG001|STARTED|12-Month Follow-up Period|Some subjects did not consent to the 12 month safety.|32
8778842|NCT01315236|9828919|FG000|COMPLETED|12-Month Follow-up Period||26
8778843|NCT01315236|9828920|FG001|COMPLETED|12-Month Follow-up Period||31
8778844|NCT01315236|9828919|FG000|NOT COMPLETED|12-Month Follow-up Period||1
8778845|NCT01315236|9828920|FG001|NOT COMPLETED|12-Month Follow-up Period||1
8778846|NCT01315249|9828930|FG000|STARTED|Overall Study||259
8778847|NCT01315249|9828931|FG001|STARTED|Overall Study||264
8778848|NCT01315249|9828930|FG000|COMPLETED|Overall Study||215
8778849|NCT01315249|9828931|FG001|COMPLETED|Overall Study||217
8778850|NCT01315249|9828930|FG000|NOT COMPLETED|Overall Study||44
8778851|NCT01315249|9828931|FG001|NOT COMPLETED|Overall Study||47
8778852|NCT01315574|9828939|FG000|STARTED|Overall Study||7
8778853|NCT01315574|9828940|FG001|STARTED|Overall Study||7
8778854|NCT01315574|9828939|FG000|COMPLETED|Overall Study||7
8778855|NCT01315574|9828940|FG001|COMPLETED|Overall Study||7
8778856|NCT01315574|9828939|FG000|NOT COMPLETED|Overall Study||0
8778857|NCT01315574|9828940|FG001|NOT COMPLETED|Overall Study||0
8778858|NCT01315665|9828948|FG000|STARTED|Overall Study||10
8778859|NCT01315665|9828949|FG001|STARTED|Overall Study||5
8778860|NCT01315665|9828948|FG000|COMPLETED|Overall Study||10
8778861|NCT01315665|9828949|FG001|COMPLETED|Overall Study||5
8778862|NCT01315665|9828948|FG000|NOT COMPLETED|Overall Study||0
8778863|NCT01315665|9828949|FG001|NOT COMPLETED|Overall Study||0
8778864|NCT01315678|9828959|FG000|STARTED|Overall Study||148
8778865|NCT01315678|9828960|FG001|STARTED|Overall Study||146
8778866|NCT01315678|9828959|FG000|COMPLETED|Overall Study||134
8778867|NCT01315678|9828960|FG001|COMPLETED|Overall Study||140
8778868|NCT01315678|9828959|FG000|NOT COMPLETED|Overall Study||14
8778869|NCT01315678|9828960|FG001|NOT COMPLETED|Overall Study||6
8778870|NCT01315847|9828970|FG000|STARTED|Part I, Period 1|Subjects who participated in Part I did not participate in Part III.|5
8778871|NCT01315847|9828971|FG001|STARTED|Part I, Period 1||0
8778872|NCT01315847|9828970|FG000|Received Telcagepant|Part I, Period 1||5
8778873|NCT01315847|9828971|FG001|Received Telcagepant|Part I, Period 1||0
8778874|NCT01315847|9828970|FG000|Received [11C]MK-4232|Part I, Period 1|One of these participants received [11C]MK-4232 only at baseline.|5
8778875|NCT01315847|9828971|FG001|Received [11C]MK-4232|Part I, Period 1||0
8778876|NCT01315847|9828970|FG000|COMPLETED|Part I, Period 1||2
8778877|NCT01315847|9828971|FG001|COMPLETED|Part I, Period 1||0
8778878|NCT01315847|9828970|FG000|NOT COMPLETED|Part I, Period 1||3
8778879|NCT01315847|9828971|FG001|NOT COMPLETED|Part I, Period 1||0
8778880|NCT01315847|9828970|FG000|STARTED|Part I, Period 2|One of these subjects did not participate in Part I, Period 1.|3
8778881|NCT01315847|9828971|FG001|STARTED|Part I, Period 2||0
8778882|NCT01315847|9828970|FG000|Received Telcagepant|Part I, Period 2||3
8778883|NCT01315847|9828971|FG001|Received Telcagepant|Part I, Period 2||0
8778884|NCT01315847|9828970|FG000|Received [11C]MK-4232|Part I, Period 2||3
8778885|NCT01315847|9828971|FG001|Received [11C]MK-4232|Part I, Period 2||0
8778886|NCT01315847|9828970|FG000|COMPLETED|Part I, Period 2||3
8778887|NCT01315847|9828971|FG001|COMPLETED|Part I, Period 2||0
8778888|NCT01315847|9828970|FG000|NOT COMPLETED|Part I, Period 2||0
8778889|NCT01315847|9828971|FG001|NOT COMPLETED|Part I, Period 2||0
8778890|NCT01315847|9828970|FG000|STARTED|Part III, Period 1||0
8778891|NCT01315847|9828971|FG001|STARTED|Part III, Period 1|Subjects who participated in Part III did not participate in Part I.|4
8778892|NCT01315847|9828970|FG000|Received Telcagepant|Part III, Period 1||0
8778893|NCT01315847|9828971|FG001|Received Telcagepant|Part III, Period 1||4
8778894|NCT01315847|9828970|FG000|Received [11C]MK-4232|Part III, Period 1||0
8778895|NCT01315847|9828971|FG001|Received [11C]MK-4232|Part III, Period 1|One of these participants received [11C]MK-4232 only at baseline.|4
8778896|NCT01315847|9828970|FG000|COMPLETED|Part III, Period 1||0
8778897|NCT01315847|9828971|FG001|COMPLETED|Part III, Period 1||3
8778898|NCT01315847|9828970|FG000|NOT COMPLETED|Part III, Period 1||0
8778899|NCT01315847|9828971|FG001|NOT COMPLETED|Part III, Period 1||1
8778900|NCT01315847|9828970|FG000|STARTED|Part III, Period 2||0
8778901|NCT01315847|9828971|FG001|STARTED|Part III, Period 2||3
8778902|NCT01315847|9828970|FG000|Received Telcagepant|Part III, Period 2||0
8778903|NCT01315847|9828971|FG001|Received Telcagepant|Part III, Period 2||3
8778904|NCT01315847|9828970|FG000|Received [11C]MK-4232|Part III, Period 2||0
8778905|NCT01315847|9828971|FG001|Received [11C]MK-4232|Part III, Period 2||3
8778906|NCT01315847|9828970|FG000|COMPLETED|Part III, Period 2||0
8778907|NCT01315847|9828971|FG001|COMPLETED|Part III, Period 2||3
8778908|NCT01315847|9828970|FG000|NOT COMPLETED|Part III, Period 2||0
8778909|NCT01315847|9828971|FG001|NOT COMPLETED|Part III, Period 2||0
8778910|NCT01316042|9828979|FG000|STARTED|Overall Study||2
8778911|NCT01316042|9828980|FG001|STARTED|Overall Study||2
8778912|NCT01316042|9828979|FG000|COMPLETED|Overall Study||2
8778913|NCT01316042|9828980|FG001|COMPLETED|Overall Study||1
8778914|NCT01316042|9828979|FG000|NOT COMPLETED|Overall Study||0
8778915|NCT01316042|9828980|FG001|NOT COMPLETED|Overall Study||1
8778916|NCT01316055|9828989|FG000|STARTED|Overall Study||13
8778917|NCT01316055|9828990|FG001|STARTED|Overall Study||17
8778918|NCT01316055|9828991|FG002|STARTED|Overall Study||12
8778919|NCT01316055|9828989|FG000|COMPLETED|Overall Study||12
8778920|NCT01316055|9828990|FG001|COMPLETED|Overall Study||17
8778921|NCT01316055|9828991|FG002|COMPLETED|Overall Study||12
8778922|NCT01316055|9828989|FG000|NOT COMPLETED|Overall Study||1
8778923|NCT01316055|9828990|FG001|NOT COMPLETED|Overall Study||0
8778924|NCT01316055|9828991|FG002|NOT COMPLETED|Overall Study||0
8778925|NCT01316211|9829004|FG000|STARTED|Overall Study||116
8778926|NCT01316211|9829005|FG001|STARTED|Overall Study||123
8778927|NCT01316211|9829004|FG000|COMPLETED|Overall Study||105
8778928|NCT01316211|9829005|FG001|COMPLETED|Overall Study||111
8778929|NCT01316211|9829004|FG000|NOT COMPLETED|Overall Study||11
8778930|NCT01316211|9829005|FG001|NOT COMPLETED|Overall Study||12
8778931|NCT01316224|9829011|FG000|STARTED|Overall Study||52
8778932|NCT01316224|9829011|FG000|Completed Visit 1 to Dermatologist|Overall Study||52
8778933|NCT01316224|9829011|FG000|Completed Visit 1 to Rheumatologist|Overall Study||49
8778934|NCT01316224|9829011|FG000|Completed Visit 2 to Dermatologist|Overall Study||51
8778935|NCT01316224|9829011|FG000|Completed Visit 3 to Dermatologist|Overall Study||48
8778936|NCT01316224|9829011|FG000|Completed Visit 3 to Rheumatologist|Overall Study||39
8778937|NCT01316224|9829011|FG000|Completed Visit 4 to Dermatologist|Overall Study||42
8778938|NCT01316224|9829011|FG000|Completed Visit 4 to Rheumatologist|Overall Study||28
8778939|NCT01316224|9829011|FG000|COMPLETED|Overall Study||42
8778940|NCT01316224|9829011|FG000|NOT COMPLETED|Overall Study||10
8778941|NCT01316263|9829017|FG000|STARTED|Overall Study||7
8778942|NCT01316263|9829018|FG001|STARTED|Overall Study||14
8778943|NCT01316263|9829017|FG000|Received Any Study Drug|Overall Study||7
8778944|NCT01316263|9829018|FG001|Received Any Study Drug|Overall Study||14
8778945|NCT01316263|9829017|FG000|COMPLETED|Overall Study||7
8778946|NCT01316263|9829018|FG001|COMPLETED|Overall Study||14
8778947|NCT01316263|9829017|FG000|NOT COMPLETED|Overall Study||0
8778948|NCT01316263|9829018|FG001|NOT COMPLETED|Overall Study||0
8778949|NCT01316276|9829026|FG000|STARTED|Overall Study||206
8778950|NCT01316276|9829026|FG000|COMPLETED|Overall Study||139
8778951|NCT01316276|9829026|FG000|NOT COMPLETED|Overall Study||67
8778952|NCT01316302|9829033|FG000|STARTED|Overall Study||30
8778953|NCT01316302|9829034|FG001|STARTED|Overall Study||33
8778954|NCT01316302|9829033|FG000|COMPLETED|Overall Study||20
8778955|NCT01316302|9829034|FG001|COMPLETED|Overall Study||22
8778956|NCT01316302|9829033|FG000|NOT COMPLETED|Overall Study||10
8778957|NCT01316302|9829034|FG001|NOT COMPLETED|Overall Study||11
8778958|NCT01316315|9829044|FG000|STARTED|Sequence 1||7
8778959|NCT01316315|9829045|FG001|STARTED|Sequence 1||7
8778960|NCT01316315|9829044|FG000|COMPLETED|Sequence 1||7
8778961|NCT01316315|9829045|FG001|COMPLETED|Sequence 1||7
8778962|NCT01316315|9829044|FG000|NOT COMPLETED|Sequence 1||0
8778963|NCT01316315|9829045|FG001|NOT COMPLETED|Sequence 1||0
8778964|NCT01316315|9829044|FG000|STARTED|Sequence 2||7
8778965|NCT01316315|9829045|FG001|STARTED|Sequence 2||7
8778966|NCT01316315|9829044|FG000|COMPLETED|Sequence 2||7
8778967|NCT01316315|9829045|FG001|COMPLETED|Sequence 2||7
8778968|NCT01316315|9829044|FG000|NOT COMPLETED|Sequence 2||0
8778969|NCT01316315|9829045|FG001|NOT COMPLETED|Sequence 2||0
8778970|NCT01316341|9829056|FG000|STARTED|Overall Study||6
8778971|NCT01316341|9829057|FG001|STARTED|Overall Study||9
8778972|NCT01316341|9829058|FG002|STARTED|Overall Study||9
8778973|NCT01316341|9829056|FG000|COMPLETED|Overall Study||6
8778974|NCT01316341|9829057|FG001|COMPLETED|Overall Study||9
8778975|NCT01316341|9829058|FG002|COMPLETED|Overall Study||9
8778976|NCT01316341|9829056|FG000|NOT COMPLETED|Overall Study||0
8778977|NCT01316341|9829057|FG001|NOT COMPLETED|Overall Study||0
8778978|NCT01316341|9829058|FG002|NOT COMPLETED|Overall Study||0
8778979|NCT01316380|9829078|FG000|STARTED|Overall Study||156
8778980|NCT01316380|9829079|FG001|STARTED|Overall Study||154
8778981|NCT01316380|9829080|FG002|STARTED|Overall Study||155
8778982|NCT01316380|9829078|FG000|COMPLETED|Overall Study||154
8778983|NCT01316380|9829079|FG001|COMPLETED|Overall Study||149
8778984|NCT01316380|9829080|FG002|COMPLETED|Overall Study||152
8778985|NCT01316380|9829078|FG000|NOT COMPLETED|Overall Study||2
8778986|NCT01316380|9829079|FG001|NOT COMPLETED|Overall Study||5
8778987|NCT01316380|9829080|FG002|NOT COMPLETED|Overall Study||3
8778988|NCT01316419|9829088|FG000|STARTED|Overall Study||2089
8778989|NCT01316419|9829088|FG000|COMPLETED|Overall Study||1824
8778990|NCT01316419|9829088|FG000|NOT COMPLETED|Overall Study||265
8778991|NCT01316510|9829094|FG000|STARTED|Overall Study||12
8778992|NCT01316510|9829095|FG001|STARTED|Overall Study||12
8778993|NCT01316510|9829094|FG000|COMPLETED|Overall Study||12
8778994|NCT01316510|9829095|FG001|COMPLETED|Overall Study||12
8778995|NCT01316510|9829094|FG000|NOT COMPLETED|Overall Study||0
8778996|NCT01316510|9829095|FG001|NOT COMPLETED|Overall Study||0
8778997|NCT01316575|9829103|FG000|STARTED|Overall Study||20
8778998|NCT01316575|9829104|FG001|STARTED|Overall Study||20
8778999|NCT01316575|9829103|FG000|COMPLETED|Overall Study||18
8779000|NCT01316575|9829104|FG001|COMPLETED|Overall Study||19
8779001|NCT01316575|9829103|FG000|NOT COMPLETED|Overall Study||2
8779002|NCT01316575|9829104|FG001|NOT COMPLETED|Overall Study||1
8779003|NCT01316614|9829110|FG000|STARTED|Overall Study||137
8779004|NCT01316614|9829110|FG000|COMPLETED|Overall Study||100
8779005|NCT01316614|9829110|FG000|NOT COMPLETED|Overall Study||37
8779006|NCT01316692|9829115|FG000|STARTED|Overall Study||12
8779007|NCT01316692|9829115|FG000|COMPLETED|Overall Study||0
8779008|NCT01316692|9829115|FG000|NOT COMPLETED|Overall Study||12
8779009|NCT01316770|9829119|FG000|STARTED|Overall Study|Each study participant received the dexamethasone parotid irrigation on one side of mouth.|9
8779010|NCT01316770|9829120|FG001|STARTED|Overall Study|Each study participant received the placebo parotid irrigation on the other side of mouth.|9
8779011|NCT01316770|9829119|FG000|COMPLETED|Overall Study||9
8779012|NCT01316770|9829120|FG001|COMPLETED|Overall Study||9
8779013|NCT01316770|9829119|FG000|NOT COMPLETED|Overall Study||0
8779014|NCT01316770|9829120|FG001|NOT COMPLETED|Overall Study||0
8779015|NCT01316887|9829133|FG000|STARTED|Overall Study||109
8779016|NCT01316887|9829134|FG001|STARTED|Overall Study||227
8779017|NCT01316887|9829135|FG002|STARTED|Overall Study||226
8779018|NCT01316887|9829133|FG000|COMPLETED|Overall Study||66
8779019|NCT01316887|9829134|FG001|COMPLETED|Overall Study||133
8779020|NCT01316887|9829135|FG002|COMPLETED|Overall Study||143
8779021|NCT01316887|9829133|FG000|NOT COMPLETED|Overall Study||43
8779022|NCT01316887|9829134|FG001|NOT COMPLETED|Overall Study||94
8779023|NCT01316887|9829135|FG002|NOT COMPLETED|Overall Study||83
8779024|NCT01316900|9829148|FG000|STARTED|Overall Study||209
8779025|NCT01316900|9829149|FG001|STARTED|Overall Study||212
8779026|NCT01316900|9829150|FG002|STARTED|Overall Study||214
8779027|NCT01316900|9829151|FG003|STARTED|Overall Study||208
8779028|NCT01316900|9829148|FG000|COMPLETED|Overall Study||165
8779029|NCT01316900|9829149|FG001|COMPLETED|Overall Study||181
8779030|NCT01316900|9829150|FG002|COMPLETED|Overall Study||173
8779031|NCT01316900|9829151|FG003|COMPLETED|Overall Study||177
8779032|NCT01316900|9829148|FG000|NOT COMPLETED|Overall Study||44
8779033|NCT01316900|9829149|FG001|NOT COMPLETED|Overall Study||31
8779034|NCT01316900|9829150|FG002|NOT COMPLETED|Overall Study||41
8779035|NCT01316900|9829151|FG003|NOT COMPLETED|Overall Study||31
8779036|NCT01316913|9829165|FG000|STARTED|Overall Study||222
8779037|NCT01316913|9829166|FG001|STARTED|Overall Study||217
8779038|NCT01316913|9829167|FG002|STARTED|Overall Study||215
8779039|NCT01316913|9829168|FG003|STARTED|Overall Study||215
8779040|NCT01316913|9829165|FG000|COMPLETED|Overall Study||165
8779041|NCT01316913|9829166|FG001|COMPLETED|Overall Study||163
8779042|NCT01316913|9829167|FG002|COMPLETED|Overall Study||166
8779043|NCT01316913|9829168|FG003|COMPLETED|Overall Study||176
8779044|NCT01316913|9829165|FG000|NOT COMPLETED|Overall Study||57
8779045|NCT01316913|9829166|FG001|NOT COMPLETED|Overall Study||54
8779046|NCT01316913|9829167|FG002|NOT COMPLETED|Overall Study||49
8779047|NCT01316913|9829168|FG003|NOT COMPLETED|Overall Study||39
8779048|NCT01316926|9829179|FG000|STARTED|Period 1||30
8779049|NCT01316926|9829180|FG001|STARTED|Period 1||30
8779050|NCT01316926|9829179|FG000|COMPLETED|Period 1||30
8779051|NCT01316926|9829180|FG001|COMPLETED|Period 1||30
8779052|NCT01316926|9829179|FG000|NOT COMPLETED|Period 1||0
8779053|NCT01316926|9829180|FG001|NOT COMPLETED|Period 1||0
8779054|NCT01316926|9829179|FG000|STARTED|Period 2|One participant completed Period 1, but did not appear in Period 2|29
8779055|NCT01316926|9829180|FG001|STARTED|Period 2||30
8779056|NCT01316926|9829179|FG000|COMPLETED|Period 2||29
8779057|NCT01316926|9829180|FG001|COMPLETED|Period 2||30
8779058|NCT01316926|9829179|FG000|NOT COMPLETED|Period 2||0
8779059|NCT01316926|9829180|FG001|NOT COMPLETED|Period 2||0
8779060|NCT01316939|9829190|FG000|STARTED|Overall Study||76
8779061|NCT01316939|9829191|FG001|STARTED|Overall Study||77
8779062|NCT01316939|9829192|FG002|STARTED|Overall Study||76
8779063|NCT01316939|9829190|FG000|COMPLETED|Overall Study||13
8779064|NCT01316939|9829191|FG001|COMPLETED|Overall Study||9
8779065|NCT01316939|9829192|FG002|COMPLETED|Overall Study||7
8779066|NCT01316939|9829190|FG000|NOT COMPLETED|Overall Study||63
8779067|NCT01316939|9829191|FG001|NOT COMPLETED|Overall Study||68
8779068|NCT01316939|9829192|FG002|NOT COMPLETED|Overall Study||69
8779069|NCT01317004|9829202|FG000|STARTED|Overall Study||51
8779070|NCT01317004|9829203|FG001|STARTED|Overall Study||14
8779071|NCT01317004|9829202|FG000|Safety Set|Overall Study||50
8779072|NCT01317004|9829203|FG001|Safety Set|Overall Study||11
8779073|NCT01317004|9829202|FG000|COMPLETED|Overall Study||47
8779074|NCT01317004|9829203|FG001|COMPLETED|Overall Study||5
8779075|NCT01317004|9829202|FG000|NOT COMPLETED|Overall Study||4
8779076|NCT01317004|9829203|FG001|NOT COMPLETED|Overall Study||9
8779077|NCT01317030|9829211|FG000|STARTED|Overall Study||12
8779078|NCT01317030|9829212|FG001|STARTED|Overall Study||13
8779079|NCT01317030|9829211|FG000|COMPLETED|Overall Study||12
8779080|NCT01317030|9829212|FG001|COMPLETED|Overall Study||13
8779081|NCT01317030|9829211|FG000|NOT COMPLETED|Overall Study||0
8779082|NCT01317030|9829212|FG001|NOT COMPLETED|Overall Study||0
8779083|NCT01317095|9829220|FG000|STARTED|Overall Study||39
8779084|NCT01317095|9829221|FG001|STARTED|Overall Study||41
8779085|NCT01317095|9829220|FG000|COMPLETED|Overall Study||39
8779086|NCT01317095|9829221|FG001|COMPLETED|Overall Study||41
8779087|NCT01317095|9829220|FG000|NOT COMPLETED|Overall Study||0
8779088|NCT01317095|9829221|FG001|NOT COMPLETED|Overall Study||0
8779089|NCT01317199|9829231|FG000|STARTED|Dose-escalation Phase 1||14
8779090|NCT01317199|9829232|FG001|STARTED|Dose-escalation Phase 1||0
8779091|NCT01317199|9829233|FG002|STARTED|Dose-escalation Phase 1||0
8779092|NCT01317199|9829234|FG003|STARTED|Dose-escalation Phase 1||0
8779093|NCT01317199|9829231|FG000|Cycle 1: 500mg MPX Once Daily for 28 Day|Dose-escalation Phase 1||2
8779094|NCT01317199|9829232|FG001|Cycle 1: 500mg MPX Once Daily for 28 Day|Dose-escalation Phase 1||0
8779095|NCT01317199|9829233|FG002|Cycle 1: 500mg MPX Once Daily for 28 Day|Dose-escalation Phase 1||0
8779096|NCT01317199|9829234|FG003|Cycle 1: 500mg MPX Once Daily for 28 Day|Dose-escalation Phase 1||0
8779097|NCT01317199|9829231|FG000|Cycle 2: 1000mg MPX Daily for 28 Days|Dose-escalation Phase 1||2
8779098|NCT01317199|9829232|FG001|Cycle 2: 1000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
8779099|NCT01317199|9829233|FG002|Cycle 2: 1000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
8779100|NCT01317199|9829234|FG003|Cycle 2: 1000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
8779101|NCT01317199|9829231|FG000|Cycle 3: 2000mg MPX Daily for 28 Days|Dose-escalation Phase 1||2
8779102|NCT01317199|9829232|FG001|Cycle 3: 2000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
8779103|NCT01317199|9829233|FG002|Cycle 3: 2000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
8779104|NCT01317199|9829234|FG003|Cycle 3: 2000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
8779105|NCT01317199|9829231|FG000|Cycle 4: 3000mg MPX Daily for 28 Days|Dose-escalation Phase 1||2
8779106|NCT01317199|9829232|FG001|Cycle 4: 3000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
8779107|NCT01317199|9829233|FG002|Cycle 4: 3000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
8779108|NCT01317199|9829234|FG003|Cycle 4: 3000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
8779109|NCT01317199|9829231|FG000|Cycle 5: 4000mg MPX Daily for 28 Days|Dose-escalation Phase 1||6
8808857|NCT01493531|9861253|FG002|STARTED|Overall Study||206
8808858|NCT01493531|9861251|FG000|COMPLETED|Overall Study||163
8808859|NCT01493531|9861252|FG001|COMPLETED|Overall Study||150
8808860|NCT01493531|9861253|FG002|COMPLETED|Overall Study||158
8808861|NCT01493531|9861251|FG000|NOT COMPLETED|Overall Study||41
8808862|NCT01493531|9861252|FG001|NOT COMPLETED|Overall Study||50
8808863|NCT01493531|9861253|FG002|NOT COMPLETED|Overall Study||48
8808864|NCT01493557|9861264|FG000|STARTED|Not Randomized to Management Strategies||0
8808865|NCT01493557|9861265|FG001|STARTED|Not Randomized to Management Strategies||0
8808866|NCT01493557|9861266|FG002|STARTED|Not Randomized to Management Strategies||950
8808867|NCT01493557|9861264|FG000|Without Experiencing GIS|Not Randomized to Management Strategies||0
8808868|NCT01493557|9861265|FG001|Without Experiencing GIS|Not Randomized to Management Strategies||0
8808869|NCT01493557|9861266|FG002|Without Experiencing GIS|Not Randomized to Management Strategies|754 patients completed the trial.|854
8808870|NCT01493557|9861264|FG000|Reported GIS Prior to EOT Visit|Not Randomized to Management Strategies||0
8808871|NCT01493557|9861265|FG001|Reported GIS Prior to EOT Visit|Not Randomized to Management Strategies||0
8808872|NCT01493557|9861266|FG002|Reported GIS Prior to EOT Visit|Not Randomized to Management Strategies|32 patients completed the trial.|48
8808873|NCT01493557|9861264|FG000|Reported GIS Only at EOT Visit|Not Randomized to Management Strategies||0
8808874|NCT01493557|9861265|FG001|Reported GIS Only at EOT Visit|Not Randomized to Management Strategies||0
8808875|NCT01493557|9861266|FG002|Reported GIS Only at EOT Visit|Not Randomized to Management Strategies|26 patients completed (GIS resolved ) and 4 patients completed (GIS not resolved ) the trial.|48
8808876|NCT01493557|9861264|FG000|COMPLETED|Not Randomized to Management Strategies||0
8808877|NCT01493557|9861265|FG001|COMPLETED|Not Randomized to Management Strategies||0
8808878|NCT01493557|9861266|FG002|COMPLETED|Not Randomized to Management Strategies||816
8808879|NCT01493557|9861264|FG000|NOT COMPLETED|Not Randomized to Management Strategies||0
8808880|NCT01493557|9861265|FG001|NOT COMPLETED|Not Randomized to Management Strategies||0
8808881|NCT01493557|9861266|FG002|NOT COMPLETED|Not Randomized to Management Strategies||134
8779110|NCT01317199|9829232|FG001|Cycle 5: 4000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
8779111|NCT01317199|9829233|FG002|Cycle 5: 4000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
8779112|NCT01317199|9829234|FG003|Cycle 5: 4000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
8779113|NCT01317199|9829231|FG000|COMPLETED|Dose-escalation Phase 1||7
8779114|NCT01317199|9829232|FG001|COMPLETED|Dose-escalation Phase 1||0
8779115|NCT01317199|9829233|FG002|COMPLETED|Dose-escalation Phase 1||0
8779116|NCT01317199|9829234|FG003|COMPLETED|Dose-escalation Phase 1||0
8779117|NCT01317199|9829231|FG000|NOT COMPLETED|Dose-escalation Phase 1||7
8779118|NCT01317199|9829232|FG001|NOT COMPLETED|Dose-escalation Phase 1||0
8779119|NCT01317199|9829233|FG002|NOT COMPLETED|Dose-escalation Phase 1||0
8779120|NCT01317199|9829234|FG003|NOT COMPLETED|Dose-escalation Phase 1||0
8779121|NCT01317199|9829231|FG000|STARTED|Randomized Phase 2||0
8779122|NCT01317199|9829232|FG001|STARTED|Randomized Phase 2||24
8779123|NCT01317199|9829233|FG002|STARTED|Randomized Phase 2||56
8779124|NCT01317199|9829234|FG003|STARTED|Randomized Phase 2||49
8779125|NCT01317199|9829231|FG000|COMPLETED|Randomized Phase 2||0
8779126|NCT01317199|9829232|FG001|COMPLETED|Randomized Phase 2||13
8779127|NCT01317199|9829233|FG002|COMPLETED|Randomized Phase 2||35
8779128|NCT01317199|9829234|FG003|COMPLETED|Randomized Phase 2||32
8779129|NCT01317199|9829231|FG000|NOT COMPLETED|Randomized Phase 2||0
8779130|NCT01317199|9829232|FG001|NOT COMPLETED|Randomized Phase 2||11
8779131|NCT01317199|9829233|FG002|NOT COMPLETED|Randomized Phase 2||21
8779132|NCT01317199|9829234|FG003|NOT COMPLETED|Randomized Phase 2||17
8779133|NCT01317277|9829253|FG000|STARTED|Overall Study||50
8779134|NCT01317277|9829254|FG001|STARTED|Overall Study||25
8779135|NCT01317277|9829253|FG000|COMPLETED|Overall Study||43
8779136|NCT01317277|9829254|FG001|COMPLETED|Overall Study||23
8779137|NCT01317277|9829253|FG000|NOT COMPLETED|Overall Study||7
8779138|NCT01317277|9829254|FG001|NOT COMPLETED|Overall Study||2
8779139|NCT01317472|9829262|FG000|STARTED|Overall Study||9
8779140|NCT01317472|9829263|FG001|STARTED|Overall Study||2
8779141|NCT01317472|9829262|FG000|COMPLETED|Overall Study||7
8779142|NCT01317472|9829263|FG001|COMPLETED|Overall Study||2
8779143|NCT01317472|9829262|FG000|NOT COMPLETED|Overall Study||2
8779144|NCT01317472|9829263|FG001|NOT COMPLETED|Overall Study||0
8779145|NCT01317550|9829273|FG000|STARTED|Overall Study||5
8779146|NCT01317550|9829274|FG001|STARTED|Overall Study||3
8779147|NCT01317550|9829275|FG002|STARTED|Overall Study||3
8779148|NCT01317550|9829276|FG003|STARTED|Overall Study||3
8779149|NCT01317550|9829273|FG000|COMPLETED|Overall Study||3
8779150|NCT01317550|9829274|FG001|COMPLETED|Overall Study||3
8779151|NCT01317550|9829275|FG002|COMPLETED|Overall Study||3
8779152|NCT01317550|9829276|FG003|COMPLETED|Overall Study||3
8779153|NCT01317550|9829273|FG000|NOT COMPLETED|Overall Study||2
8779154|NCT01317550|9829274|FG001|NOT COMPLETED|Overall Study||0
8779155|NCT01317550|9829275|FG002|NOT COMPLETED|Overall Study||0
8779156|NCT01317550|9829276|FG003|NOT COMPLETED|Overall Study||0
8779157|NCT01317615|9829286|FG000|STARTED|Overall Study||49
8779158|NCT01317615|9829286|FG000|COMPLETED|Overall Study||0
8779159|NCT01317615|9829286|FG000|NOT COMPLETED|Overall Study||49
8779160|NCT01317641|9829299|FG000|STARTED|Overall Study||4
8779161|NCT01317641|9829300|FG001|STARTED|Overall Study||7
8779162|NCT01317641|9829301|FG002|STARTED|Overall Study||3
8779163|NCT01317641|9829302|FG003|STARTED|Overall Study||4
8779164|NCT01317641|9829303|FG004|STARTED|Overall Study||3
8779165|NCT01317641|9829304|FG005|STARTED|Overall Study||3
8779166|NCT01317641|9829305|FG006|STARTED|Overall Study||38
8779167|NCT01317641|9829306|FG007|STARTED|Overall Study||38
8779168|NCT01317641|9829307|FG008|STARTED|Overall Study||36
8779169|NCT01317641|9829299|FG000|COMPLETED|Overall Study||3
8779170|NCT01317641|9829300|FG001|COMPLETED|Overall Study||6
8779171|NCT01317641|9829301|FG002|COMPLETED|Overall Study||3
8779172|NCT01317641|9829302|FG003|COMPLETED|Overall Study||3
8779173|NCT01317641|9829303|FG004|COMPLETED|Overall Study||3
8779174|NCT01317641|9829304|FG005|COMPLETED|Overall Study||3
8779175|NCT01317641|9829305|FG006|COMPLETED|Overall Study||35
8779176|NCT01317641|9829306|FG007|COMPLETED|Overall Study||33
8779177|NCT01317641|9829307|FG008|COMPLETED|Overall Study||31
8779178|NCT01317641|9829299|FG000|NOT COMPLETED|Overall Study||1
8779179|NCT01317641|9829300|FG001|NOT COMPLETED|Overall Study||1
8779180|NCT01317641|9829301|FG002|NOT COMPLETED|Overall Study||0
8779181|NCT01317641|9829302|FG003|NOT COMPLETED|Overall Study||1
8779182|NCT01317641|9829303|FG004|NOT COMPLETED|Overall Study||0
8779183|NCT01317641|9829304|FG005|NOT COMPLETED|Overall Study||0
8779184|NCT01317641|9829305|FG006|NOT COMPLETED|Overall Study||3
8779185|NCT01317641|9829306|FG007|NOT COMPLETED|Overall Study||5
8779186|NCT01317641|9829307|FG008|NOT COMPLETED|Overall Study||5
8779187|NCT01317667|9829346|FG000|STARTED|Overall Study||10
8779188|NCT01317667|9829347|FG001|STARTED|Overall Study||10
8779189|NCT01317667|9829348|FG002|STARTED|Overall Study||10
8779190|NCT01317667|9829346|FG000|COMPLETED|Overall Study||10
8779191|NCT01317667|9829347|FG001|COMPLETED|Overall Study||10
8779192|NCT01317667|9829348|FG002|COMPLETED|Overall Study|The original trial design was modified to limit the number of vaccinations in Group 3 to 1 dose.|10
8779193|NCT01317667|9829346|FG000|NOT COMPLETED|Overall Study||0
8779194|NCT01317667|9829347|FG001|NOT COMPLETED|Overall Study||0
8779195|NCT01317667|9829348|FG002|NOT COMPLETED|Overall Study||0
8779196|NCT01317797|9829359|FG000|STARTED|Overall Study||8
8779197|NCT01317797|9829360|FG001|STARTED|Overall Study||7
8779198|NCT01317797|9829361|FG002|STARTED|Overall Study||9
8779199|NCT01317797|9829359|FG000|COMPLETED|Overall Study||8
8779200|NCT01317797|9829360|FG001|COMPLETED|Overall Study||6
8779201|NCT01317797|9829361|FG002|COMPLETED|Overall Study||8
8779202|NCT01317797|9829359|FG000|NOT COMPLETED|Overall Study||0
8779203|NCT01317797|9829360|FG001|NOT COMPLETED|Overall Study||1
8779204|NCT01317797|9829361|FG002|NOT COMPLETED|Overall Study||1
8779205|NCT01317901|9829371|FG000|STARTED|Overall Study||6
8779206|NCT01317901|9829372|FG001|STARTED|Overall Study||6
8779207|NCT01317901|9829371|FG000|COMPLETED|Overall Study||6
8779208|NCT01317901|9829372|FG001|COMPLETED|Overall Study||6
8779209|NCT01317901|9829371|FG000|NOT COMPLETED|Overall Study||0
8779210|NCT01317901|9829372|FG001|NOT COMPLETED|Overall Study||0
8779211|NCT01317940|9829384|FG000|STARTED|Overall Study||19
8779212|NCT01317940|9829385|FG001|STARTED|Overall Study||10
8779213|NCT01317940|9829386|FG002|STARTED|Overall Study||20
8779214|NCT01317940|9829387|FG003|STARTED|Overall Study||6
8779215|NCT01317940|9829388|FG004|STARTED|Overall Study||13
8779216|NCT01317940|9829389|FG005|STARTED|Overall Study||4
8779217|NCT01317940|9829384|FG000|COMPLETED|Overall Study||18
8779218|NCT01317940|9829385|FG001|COMPLETED|Overall Study||10
8779219|NCT01317940|9829386|FG002|COMPLETED|Overall Study||15
8779220|NCT01317940|9829387|FG003|COMPLETED|Overall Study||5
8779221|NCT01317940|9829388|FG004|COMPLETED|Overall Study||12
8779222|NCT01317940|9829389|FG005|COMPLETED|Overall Study||4
8779223|NCT01317940|9829384|FG000|NOT COMPLETED|Overall Study||1
8779224|NCT01317940|9829385|FG001|NOT COMPLETED|Overall Study||0
8779225|NCT01317940|9829386|FG002|NOT COMPLETED|Overall Study||5
8779226|NCT01317940|9829387|FG003|NOT COMPLETED|Overall Study||1
8779227|NCT01317940|9829388|FG004|NOT COMPLETED|Overall Study||1
8779228|NCT01317940|9829389|FG005|NOT COMPLETED|Overall Study||0
8779229|NCT01318018|9829406|FG000|STARTED|Overall Study||10
8779230|NCT01318018|9829407|FG001|STARTED|Overall Study||10
8779231|NCT01318018|9829406|FG000|COMPLETED|Overall Study||10
8779232|NCT01318018|9829407|FG001|COMPLETED|Overall Study||10
8779233|NCT01318018|9829406|FG000|NOT COMPLETED|Overall Study||0
8779234|NCT01318018|9829407|FG001|NOT COMPLETED|Overall Study||0
8779235|NCT01318070|9829416|FG000|STARTED|Overall Study||111
8779236|NCT01318070|9829417|FG001|STARTED|Overall Study||113
8779237|NCT01318070|9829418|FG002|STARTED|Overall Study||115
8779238|NCT01318070|9829416|FG000|COMPLETED|Overall Study||109
8779239|NCT01318070|9829417|FG001|COMPLETED|Overall Study||111
8779240|NCT01318070|9829418|FG002|COMPLETED|Overall Study||108
8779241|NCT01318070|9829416|FG000|NOT COMPLETED|Overall Study||2
8779242|NCT01318070|9829417|FG001|NOT COMPLETED|Overall Study||2
8779243|NCT01318070|9829418|FG002|NOT COMPLETED|Overall Study||7
8779244|NCT01318083|9829429|FG000|STARTED|Overall Study||105
8779245|NCT01318083|9829430|FG001|STARTED|Overall Study||104
8779246|NCT01318083|9829431|FG002|STARTED|Overall Study||103
8779247|NCT01318083|9829429|FG000|COMPLETED|Overall Study||99
8779248|NCT01318083|9829430|FG001|COMPLETED|Overall Study||102
8779249|NCT01318083|9829431|FG002|COMPLETED|Overall Study||98
8779250|NCT01318083|9829429|FG000|NOT COMPLETED|Overall Study||6
8779251|NCT01318083|9829430|FG001|NOT COMPLETED|Overall Study||2
8779252|NCT01318083|9829431|FG002|NOT COMPLETED|Overall Study||5
8779253|NCT01318109|9829442|FG000|STARTED|Overall Study||92
8779254|NCT01318109|9829443|FG001|STARTED|Overall Study||96
8779255|NCT01318109|9829444|FG002|STARTED|Overall Study||100
8779256|NCT01318109|9829442|FG000|COMPLETED|Overall Study||91
8779257|NCT01318109|9829443|FG001|COMPLETED|Overall Study||93
8779258|NCT01318109|9829444|FG002|COMPLETED|Overall Study||100
8779259|NCT01318109|9829442|FG000|NOT COMPLETED|Overall Study||1
8779260|NCT01318109|9829443|FG001|NOT COMPLETED|Overall Study||3
8779261|NCT01318109|9829444|FG002|NOT COMPLETED|Overall Study||0
8779262|NCT01318122|9829454|FG000|STARTED|Enrolled - Long-Term Extension Study|5 randomized participants from alogliptin 12.5 & 25 mg group CCT-004 study did not enter this study|106
8779263|NCT01318122|9829455|FG001|STARTED|Enrolled - Long-Term Extension Study|5 randomized participants from alogliptin 12.5 & 25 mg group CCT-004 study did not enter this study|110
8779264|NCT01318122|9829456|FG002|STARTED|Enrolled - Long-Term Extension Study||57
8779265|NCT01318122|9829457|FG003|STARTED|Enrolled - Long-Term Extension Study||53
8779266|NCT01318122|9829454|FG000|COMPLETED|Enrolled - Long-Term Extension Study||105
8779267|NCT01318122|9829455|FG001|COMPLETED|Enrolled - Long-Term Extension Study||110
8779268|NCT01318122|9829456|FG002|COMPLETED|Enrolled - Long-Term Extension Study||55
8779269|NCT01318122|9829457|FG003|COMPLETED|Enrolled - Long-Term Extension Study||52
8779270|NCT01318122|9829454|FG000|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
8779271|NCT01318122|9829455|FG001|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
8779272|NCT01318122|9829456|FG002|NOT COMPLETED|Enrolled - Long-Term Extension Study||2
8779273|NCT01318122|9829457|FG003|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
8779274|NCT01318122|9829454|FG000|STARTED|Entered - Long-Term Extension Study||105
8779275|NCT01318122|9829455|FG001|STARTED|Entered - Long-Term Extension Study||110
8779276|NCT01318122|9829456|FG002|STARTED|Entered - Long-Term Extension Study||55
8779277|NCT01318122|9829457|FG003|STARTED|Entered - Long-Term Extension Study||52
8779278|NCT01318122|9829454|FG000|COMPLETED|Entered - Long-Term Extension Study||96
8779279|NCT01318122|9829455|FG001|COMPLETED|Entered - Long-Term Extension Study||99
8779280|NCT01318122|9829456|FG002|COMPLETED|Entered - Long-Term Extension Study||49
8779281|NCT01318122|9829457|FG003|COMPLETED|Entered - Long-Term Extension Study||48
8779282|NCT01318122|9829454|FG000|NOT COMPLETED|Entered - Long-Term Extension Study||9
8779283|NCT01318122|9829455|FG001|NOT COMPLETED|Entered - Long-Term Extension Study||11
8779284|NCT01318122|9829456|FG002|NOT COMPLETED|Entered - Long-Term Extension Study||6
8779285|NCT01318122|9829457|FG003|NOT COMPLETED|Entered - Long-Term Extension Study||4
8779286|NCT01318135|9829467|FG000|STARTED|Enrolled - Long-Term Extension Study||99
8779287|NCT01318135|9829468|FG001|STARTED|Enrolled - Long-Term Extension Study||102
8779288|NCT01318135|9829469|FG002|STARTED|Enrolled - Long-Term Extension Study||46
8779289|NCT01318135|9829470|FG003|STARTED|Enrolled - Long-Term Extension Study||49
8779290|NCT01318135|9829471|FG004|STARTED|Enrolled - Long-Term Extension Study||91
8779291|NCT01318135|9829472|FG005|STARTED|Enrolled - Long-Term Extension Study||90
8779292|NCT01318135|9829473|FG006|STARTED|Enrolled - Long-Term Extension Study||50
8779293|NCT01318135|9829474|FG007|STARTED|Enrolled - Long-Term Extension Study||49
8779294|NCT01318135|9829467|FG000|COMPLETED|Enrolled - Long-Term Extension Study||97
8779295|NCT01318135|9829468|FG001|COMPLETED|Enrolled - Long-Term Extension Study||102
8779296|NCT01318135|9829469|FG002|COMPLETED|Enrolled - Long-Term Extension Study||46
8779297|NCT01318135|9829470|FG003|COMPLETED|Enrolled - Long-Term Extension Study||49
8779298|NCT01318135|9829471|FG004|COMPLETED|Enrolled - Long-Term Extension Study||91
8779299|NCT01318135|9829472|FG005|COMPLETED|Enrolled - Long-Term Extension Study||90
8779300|NCT01318135|9829473|FG006|COMPLETED|Enrolled - Long-Term Extension Study||50
8779301|NCT01318135|9829474|FG007|COMPLETED|Enrolled - Long-Term Extension Study||49
8779302|NCT01318135|9829467|FG000|NOT COMPLETED|Enrolled - Long-Term Extension Study||2
8779303|NCT01318135|9829468|FG001|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
8779304|NCT01318135|9829469|FG002|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
8779305|NCT01318135|9829470|FG003|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
8779306|NCT01318135|9829471|FG004|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
8779307|NCT01318135|9829472|FG005|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
8779308|NCT01318135|9829473|FG006|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
8779309|NCT01318135|9829474|FG007|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
8779310|NCT01318135|9829467|FG000|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|97
8779311|NCT01318135|9829468|FG001|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|102
8779312|NCT01318135|9829469|FG002|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|46
8779313|NCT01318135|9829470|FG003|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|49
8779314|NCT01318135|9829471|FG004|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|90
8779315|NCT01318135|9829472|FG005|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|87
8808882|NCT01493557|9861264|FG000|STARTED|Randomized to Management Strategies||59
9029749|NCT03224234|10092139|FG001|COMPLETED|Main Study||35
9029750|NCT03224234|10092138|FG000|NOT COMPLETED|Main Study||5
9029751|NCT03224234|10092139|FG001|NOT COMPLETED|Main Study||5
9029752|NCT03224234|10092138|FG000|STARTED|Pilot||11
9029753|NCT03224234|10092139|FG001|STARTED|Pilot||7
9029754|NCT03224234|10092138|FG000|COMPLETED|Pilot||11
9029755|NCT03224234|10092139|FG001|COMPLETED|Pilot||7
9029756|NCT03224234|10092138|FG000|NOT COMPLETED|Pilot||0
9029757|NCT03224234|10092139|FG001|NOT COMPLETED|Pilot||0
9029758|NCT03224299|10092151|FG000|STARTED|Overall Study||131
9029759|NCT03224299|10092152|FG001|STARTED|Overall Study||424
9029760|NCT03224299|10092151|FG000|Treated With IP#1|Overall Study||65
9029761|NCT03224299|10092152|FG001|Treated With IP#1|Overall Study||101
9029762|NCT03224299|10092151|FG000|Treated With IP#2|Overall Study||66
9029763|NCT03224299|10092152|FG001|Treated With IP#2|Overall Study||107
9029764|NCT03224299|10092151|FG000|Treated With AC|Overall Study||66
9029765|NCT03224299|10092152|FG001|Treated With AC|Overall Study||110
9029766|NCT03224299|10092151|FG000|Treated With NC|Overall Study||65
9029767|NCT03224299|10092152|FG001|Treated With NC|Overall Study||106
9029768|NCT03224299|10092151|FG000|COMPLETED|Overall Study||131
9029769|NCT03224299|10092152|FG001|COMPLETED|Overall Study||424
9029770|NCT03224299|10092151|FG000|NOT COMPLETED|Overall Study||0
9029771|NCT03224299|10092152|FG001|NOT COMPLETED|Overall Study||0
9029772|NCT03224325|10092173|FG000|STARTED|Overall Study||13
9029773|NCT03224325|10092174|FG001|STARTED|Overall Study||6
9029774|NCT03224325|10092175|FG002|STARTED|Overall Study||6
9029775|NCT03224325|10092176|FG003|STARTED|Overall Study||6
9029776|NCT03224325|10092177|FG004|STARTED|Overall Study||6
9029777|NCT03224325|10092178|FG005|STARTED|Overall Study||6
9029778|NCT03224325|10092179|FG006|STARTED|Overall Study||7
9029779|NCT03224325|10092173|FG000|COMPLETED|Overall Study||12
9029780|NCT03224325|10092174|FG001|COMPLETED|Overall Study||6
9029781|NCT03224325|10092175|FG002|COMPLETED|Overall Study||6
9029782|NCT03224325|10092176|FG003|COMPLETED|Overall Study||5
9029783|NCT03224325|10092177|FG004|COMPLETED|Overall Study||6
9029784|NCT03224325|10092178|FG005|COMPLETED|Overall Study||6
9029785|NCT03224325|10092179|FG006|COMPLETED|Overall Study||6
9029786|NCT03224325|10092173|FG000|NOT COMPLETED|Overall Study||1
9029787|NCT03224325|10092174|FG001|NOT COMPLETED|Overall Study||0
9029788|NCT03224325|10092175|FG002|NOT COMPLETED|Overall Study||0
9029789|NCT03224325|10092176|FG003|NOT COMPLETED|Overall Study||1
9029790|NCT03224325|10092177|FG004|NOT COMPLETED|Overall Study||0
9029791|NCT03224325|10092178|FG005|NOT COMPLETED|Overall Study||0
9029792|NCT03224325|10092179|FG006|NOT COMPLETED|Overall Study||1
9029793|NCT03224351|10092209|FG000|STARTED|Overall Study||10
9029794|NCT03224351|10092210|FG001|STARTED|Overall Study||11
8779316|NCT01318135|9829473|FG006|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|50
8779317|NCT01318135|9829474|FG007|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|49
8779318|NCT01318135|9829467|FG000|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|80
8779319|NCT01318135|9829468|FG001|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|89
8779320|NCT01318135|9829469|FG002|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|38
8779321|NCT01318135|9829470|FG003|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|42
8779322|NCT01318135|9829471|FG004|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|81
8779323|NCT01318135|9829472|FG005|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|83
8779324|NCT01318135|9829473|FG006|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|49
8779325|NCT01318135|9829474|FG007|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|46
8779326|NCT01318135|9829467|FG000|NOT COMPLETED|Entered - Long-Term Extension Study||17
8779327|NCT01318135|9829468|FG001|NOT COMPLETED|Entered - Long-Term Extension Study||13
8779328|NCT01318135|9829469|FG002|NOT COMPLETED|Entered - Long-Term Extension Study||8
8779329|NCT01318135|9829470|FG003|NOT COMPLETED|Entered - Long-Term Extension Study||7
8779330|NCT01318135|9829471|FG004|NOT COMPLETED|Entered - Long-Term Extension Study||9
8779331|NCT01318135|9829472|FG005|NOT COMPLETED|Entered - Long-Term Extension Study||4
8779332|NCT01318135|9829473|FG006|NOT COMPLETED|Entered - Long-Term Extension Study||1
8779333|NCT01318135|9829474|FG007|NOT COMPLETED|Entered - Long-Term Extension Study||3
8779334|NCT01318278|9829487|FG000|STARTED|Overall Study||10
8779335|NCT01318278|9829488|FG001|STARTED|Overall Study||10
8779336|NCT01318278|9829489|FG002|STARTED|Overall Study||50
8779337|NCT01318278|9829487|FG000|COMPLETED|Overall Study||10
8779338|NCT01318278|9829488|FG001|COMPLETED|Overall Study||10
8779339|NCT01318278|9829489|FG002|COMPLETED|Overall Study||50
8779340|NCT01318278|9829487|FG000|NOT COMPLETED|Overall Study||0
8779341|NCT01318278|9829488|FG001|NOT COMPLETED|Overall Study||0
8779342|NCT01318278|9829489|FG002|NOT COMPLETED|Overall Study||0
8779343|NCT01318356|9829501|FG000|STARTED|Overall Study||51
8779344|NCT01318356|9829502|FG001|STARTED|Overall Study||52
8779345|NCT01318356|9829503|FG002|STARTED|Overall Study||52
8779346|NCT01318356|9829501|FG000|COMPLETED|Overall Study||43
8779347|NCT01318356|9829502|FG001|COMPLETED|Overall Study||49
8779348|NCT01318356|9829503|FG002|COMPLETED|Overall Study||50
8779349|NCT01318356|9829501|FG000|NOT COMPLETED|Overall Study||8
8779350|NCT01318356|9829502|FG001|NOT COMPLETED|Overall Study||3
8779351|NCT01318356|9829503|FG002|NOT COMPLETED|Overall Study||2
8779352|NCT01318382|9829511|FG000|STARTED|Overall Study||302
8779353|NCT01318382|9829511|FG000|COMPLETED|Overall Study||289
8779354|NCT01318382|9829511|FG000|NOT COMPLETED|Overall Study||13
8779355|NCT01318408|9829516|FG000|STARTED|Overall Study||24
8779356|NCT01318408|9829516|FG000|COMPLETED|Overall Study||16
8779357|NCT01318408|9829516|FG000|NOT COMPLETED|Overall Study||8
8779358|NCT01318499|9829523|FG000|STARTED|Overall Study||540
8779359|NCT01318499|9829524|FG001|STARTED|Overall Study||534
8779360|NCT01318499|9829525|FG002|STARTED|Overall Study||268
8779361|NCT01318499|9829523|FG000|COMPLETED|Overall Study||475
8779362|NCT01318499|9829524|FG001|COMPLETED|Overall Study||458
8779363|NCT01318499|9829525|FG002|COMPLETED|Overall Study||121
8779364|NCT01318499|9829523|FG000|NOT COMPLETED|Overall Study||65
8779365|NCT01318499|9829524|FG001|NOT COMPLETED|Overall Study||76
9029795|NCT03224351|10092211|FG002|STARTED|Overall Study||20
9029796|NCT03224351|10092212|FG003|STARTED|Overall Study||22
9029797|NCT03224351|10092213|FG004|STARTED|Overall Study||11
9029798|NCT03224351|10092214|FG005|STARTED|Overall Study||18
9029799|NCT03224351|10092215|FG006|STARTED|Overall Study||6
9029800|NCT03224351|10092216|FG007|STARTED|Overall Study||19
9029801|NCT03224351|10092209|FG000|COMPLETED|Overall Study||10
9029802|NCT03224351|10092210|FG001|COMPLETED|Overall Study||11
9029803|NCT03224351|10092211|FG002|COMPLETED|Overall Study||20
9029804|NCT03224351|10092212|FG003|COMPLETED|Overall Study||22
9029805|NCT03224351|10092213|FG004|COMPLETED|Overall Study||11
9029806|NCT03224351|10092214|FG005|COMPLETED|Overall Study||18
9029807|NCT03224351|10092215|FG006|COMPLETED|Overall Study||6
9029808|NCT03224351|10092216|FG007|COMPLETED|Overall Study||19
9029809|NCT03224351|10092209|FG000|NOT COMPLETED|Overall Study||0
9029810|NCT03224351|10092210|FG001|NOT COMPLETED|Overall Study||0
9029811|NCT03224351|10092211|FG002|NOT COMPLETED|Overall Study||0
9029812|NCT03224351|10092212|FG003|NOT COMPLETED|Overall Study||0
9029813|NCT03224351|10092213|FG004|NOT COMPLETED|Overall Study||0
9029814|NCT03224351|10092214|FG005|NOT COMPLETED|Overall Study||0
9029815|NCT03224351|10092215|FG006|NOT COMPLETED|Overall Study||0
9029816|NCT03224351|10092216|FG007|NOT COMPLETED|Overall Study||0
9029817|NCT03224390|10092244|FG000|STARTED|Overall Study||56
9029818|NCT03224390|10092245|FG001|STARTED|Overall Study||56
9029819|NCT03224390|10092244|FG000|COMPLETED|Overall Study||29
9029820|NCT03224390|10092245|FG001|COMPLETED|Overall Study||21
9029821|NCT03224390|10092244|FG000|NOT COMPLETED|Overall Study||27
9029822|NCT03224390|10092245|FG001|NOT COMPLETED|Overall Study||35
8779366|NCT01318499|9829525|FG002|NOT COMPLETED|Overall Study||147
8779367|NCT01318512|9829535|FG000|STARTED|Titration Period (4 Months)||340
8779368|NCT01318512|9829535|FG000|COMPLETED|Titration Period (4 Months)||340
8779369|NCT01318512|9829535|FG000|NOT COMPLETED|Titration Period (4 Months)||0
8779370|NCT01318512|9829535|FG000|STARTED|Maintenance Period (6 Months)||340
8779371|NCT01318512|9829535|FG000|COMPLETED|Maintenance Period (6 Months)||329
8779372|NCT01318512|9829535|FG000|NOT COMPLETED|Maintenance Period (6 Months)||11
8808883|NCT01493557|9861265|FG001|STARTED|Randomized to Management Strategies||58
8808884|NCT01493557|9861266|FG002|STARTED|Randomized to Management Strategies||0
8808885|NCT01493557|9861264|FG000|COMPLETED|Randomized to Management Strategies||44
8808886|NCT01493557|9861265|FG001|COMPLETED|Randomized to Management Strategies||47
8808887|NCT01493557|9861266|FG002|COMPLETED|Randomized to Management Strategies||0
8808888|NCT01493557|9861264|FG000|NOT COMPLETED|Randomized to Management Strategies||15
8808889|NCT01493557|9861265|FG001|NOT COMPLETED|Randomized to Management Strategies||11
8808890|NCT01493557|9861266|FG002|NOT COMPLETED|Randomized to Management Strategies||0
8808891|NCT01493557|9861264|FG000|STARTED|Adding the Second Strategy||14
8808892|NCT01493557|9861265|FG001|STARTED|Adding the Second Strategy||15
8808893|NCT01493557|9861266|FG002|STARTED|Adding the Second Strategy||0
8808894|NCT01493557|9861264|FG000|COMPLETED|Adding the Second Strategy||12
8808895|NCT01493557|9861265|FG001|COMPLETED|Adding the Second Strategy||11
8808896|NCT01493557|9861266|FG002|COMPLETED|Adding the Second Strategy||0
8808897|NCT01493557|9861264|FG000|NOT COMPLETED|Adding the Second Strategy||2
8808898|NCT01493557|9861265|FG001|NOT COMPLETED|Adding the Second Strategy||4
8808899|NCT01493557|9861266|FG002|NOT COMPLETED|Adding the Second Strategy||0
8808900|NCT01493596|9861280|FG000|STARTED|Overall Study||8
8808901|NCT01493596|9861281|FG001|STARTED|Overall Study||8
8808902|NCT01493596|9861282|FG002|STARTED|Overall Study|Repeat of dose cohort because of incidences of hyperkalemia observed in cohort 2(a).|7
8808903|NCT01493596|9861283|FG003|STARTED|Overall Study||8
8808904|NCT01493596|9861284|FG004|STARTED|Overall Study||8
8808905|NCT01493596|9861285|FG005|STARTED|Overall Study||8
8808906|NCT01493596|9861286|FG006|STARTED|Overall Study||8
8808907|NCT01493596|9861280|FG000|COMPLETED|Overall Study||8
8808908|NCT01493596|9861281|FG001|COMPLETED|Overall Study||8
8808909|NCT01493596|9861282|FG002|COMPLETED|Overall Study||7
8808910|NCT01493596|9861283|FG003|COMPLETED|Overall Study||8
8808911|NCT01493596|9861284|FG004|COMPLETED|Overall Study||8
8808912|NCT01493596|9861285|FG005|COMPLETED|Overall Study||8
8808913|NCT01493596|9861286|FG006|COMPLETED|Overall Study||8
8808914|NCT01493596|9861280|FG000|NOT COMPLETED|Overall Study||0
8808915|NCT01493596|9861281|FG001|NOT COMPLETED|Overall Study||0
8808916|NCT01493596|9861282|FG002|NOT COMPLETED|Overall Study||0
8808917|NCT01493596|9861283|FG003|NOT COMPLETED|Overall Study||0
8808918|NCT01493596|9861284|FG004|NOT COMPLETED|Overall Study||0
8808919|NCT01493596|9861285|FG005|NOT COMPLETED|Overall Study||0
8808920|NCT01493596|9861286|FG006|NOT COMPLETED|Overall Study||0
8808921|NCT01493687|9861302|FG000|STARTED|Part A Vehicle Control (12 Weeks)||451
8808922|NCT01493687|9861303|FG001|STARTED|Part A Vehicle Control (12 Weeks)||232
8808923|NCT01493687|9861302|FG000|COMPLETED|Part A Vehicle Control (12 Weeks)||414
8808924|NCT01493687|9861303|FG001|COMPLETED|Part A Vehicle Control (12 Weeks)||210
8808925|NCT01493687|9861302|FG000|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||37
8808926|NCT01493687|9861303|FG001|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||22
8808927|NCT01493687|9861302|FG000|STARTED|Part B Long Term Active Control 40 Weeks|414 completed Part A. Then 2 discontinued (lack of efficacy, subject request) prior to Part B.|412
8808928|NCT01493687|9861303|FG001|STARTED|Part B Long Term Active Control 40 Weeks||210
8808929|NCT01493687|9861302|FG000|COMPLETED|Part B Long Term Active Control 40 Weeks||351
8808930|NCT01493687|9861303|FG001|COMPLETED|Part B Long Term Active Control 40 Weeks||175
8808931|NCT01493687|9861302|FG000|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||61
8808932|NCT01493687|9861303|FG001|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||35
8808933|NCT01493687|9861302|FG000|STARTED|Part C Safety Follow up (4 Weeks)|351 completed Part B. Then 1 discontinued (subject request) prior to Part C.|350
8808934|NCT01493687|9861303|FG001|STARTED|Part C Safety Follow up (4 Weeks)||175
8808935|NCT01493687|9861302|FG000|COMPLETED|Part C Safety Follow up (4 Weeks)||350
8808936|NCT01493687|9861303|FG001|COMPLETED|Part C Safety Follow up (4 Weeks)||174
8808937|NCT01493687|9861302|FG000|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||0
8808938|NCT01493687|9861303|FG001|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||1
8808939|NCT01493778|9861315|FG000|STARTED|Overall Study||60
8808940|NCT01493778|9861315|FG000|COMPLETED|Overall Study||52
8808941|NCT01493778|9861315|FG000|NOT COMPLETED|Overall Study||8
8808942|NCT01493947|9861330|FG000|STARTED|Period A Efficacy and Safety Data||478
8808943|NCT01493947|9861331|FG001|STARTED|Period A Efficacy and Safety Data||484
8808944|NCT01493947|9861330|FG000|COMPLETED|Period A Efficacy and Safety Data||446
8808945|NCT01493947|9861331|FG001|COMPLETED|Period A Efficacy and Safety Data||456
8808946|NCT01493947|9861330|FG000|NOT COMPLETED|Period A Efficacy and Safety Data||32
8808947|NCT01493947|9861331|FG001|NOT COMPLETED|Period A Efficacy and Safety Data||28
8808948|NCT01493947|9861330|FG000|STARTED|Period B Extension Period|Only 399 /446 subjects were eligible to enter in Period B (i.e IGA=0 or1 at end of Period A).|399
8808949|NCT01493947|9861331|FG001|STARTED|Period B Extension Period|358 / 456 subjects were eligible to enter in Period B (i.e IGA =0 or 1 at end of Period A).|358
8808950|NCT01493947|9861330|FG000|COMPLETED|Period B Extension Period||366
8808951|NCT01493947|9861331|FG001|COMPLETED|Period B Extension Period||326
8808952|NCT01493947|9861330|FG000|NOT COMPLETED|Period B Extension Period||33
8779373|NCT01318538|9829543|FG000|STARTED|Overall Study||52
8779374|NCT01318538|9829544|FG001|STARTED|Overall Study||106
8779375|NCT01318538|9829545|FG002|STARTED|Overall Study||8
8779376|NCT01318538|9829543|FG000|COMPLETED|Overall Study||52
8779377|NCT01318538|9829544|FG001|COMPLETED|Overall Study||106
8779378|NCT01318538|9829545|FG002|COMPLETED|Overall Study||8
8779379|NCT01318538|9829543|FG000|NOT COMPLETED|Overall Study||0
8779380|NCT01318538|9829544|FG001|NOT COMPLETED|Overall Study||0
8779381|NCT01318538|9829545|FG002|NOT COMPLETED|Overall Study||0
8779382|NCT01318577|9829555|FG000|STARTED|Overall Study||224
8779383|NCT01318577|9829556|FG001|STARTED|Overall Study||220
8779384|NCT01318577|9829555|FG000|COMPLETED|Overall Study||211
8779385|NCT01318577|9829556|FG001|COMPLETED|Overall Study||212
8779386|NCT01318577|9829555|FG000|NOT COMPLETED|Overall Study||13
8779387|NCT01318577|9829556|FG001|NOT COMPLETED|Overall Study||8
8779388|NCT01318694|9829566|FG000|STARTED|Overall Study||275
8779389|NCT01318694|9829567|FG001|STARTED|Overall Study||270
8779390|NCT01318694|9829568|FG002|STARTED|Overall Study||268
8779391|NCT01318694|9829569|FG003|STARTED|Overall Study||268
8779392|NCT01318694|9829566|FG000|Full Analysis Set|Overall Study||274
8779393|NCT01318694|9829567|FG001|Full Analysis Set|Overall Study||270
8779394|NCT01318694|9829568|FG002|Full Analysis Set|Overall Study||265
8779395|NCT01318694|9829569|FG003|Full Analysis Set|Overall Study||268
8779396|NCT01318694|9829566|FG000|Safety Set|Overall Study||273
8779397|NCT01318694|9829567|FG001|Safety Set|Overall Study||268
8779398|NCT01318694|9829568|FG002|Safety Set|Overall Study||265
8779399|NCT01318694|9829569|FG003|Safety Set|Overall Study||265
8779400|NCT01318694|9829566|FG000|COMPLETED|Overall Study||223
8779401|NCT01318694|9829567|FG001|COMPLETED|Overall Study||212
8779402|NCT01318694|9829568|FG002|COMPLETED|Overall Study||225
8779403|NCT01318694|9829569|FG003|COMPLETED|Overall Study||200
8779404|NCT01318694|9829566|FG000|NOT COMPLETED|Overall Study||52
8779405|NCT01318694|9829567|FG001|NOT COMPLETED|Overall Study||58
8779406|NCT01318694|9829568|FG002|NOT COMPLETED|Overall Study||43
8779407|NCT01318694|9829569|FG003|NOT COMPLETED|Overall Study||68
8779408|NCT01318733|9829579|FG000|STARTED|Overall Study||449
8779409|NCT01318733|9829579|FG000|COMPLETED|Overall Study||279
8779410|NCT01318733|9829579|FG000|NOT COMPLETED|Overall Study||170
8779411|NCT01318811|9829585|FG000|STARTED|Overall Study||4
8779412|NCT01318811|9829586|FG001|STARTED|Overall Study||8
8779413|NCT01318811|9829585|FG000|COMPLETED|Overall Study||3
8779414|NCT01318811|9829586|FG001|COMPLETED|Overall Study||4
8779415|NCT01318811|9829585|FG000|NOT COMPLETED|Overall Study||1
8779416|NCT01318811|9829586|FG001|NOT COMPLETED|Overall Study||4
8779417|NCT01318876|9829592|FG000|STARTED|Day 8 Survey||7645
8779418|NCT01318876|9829592|FG000|COMPLETED|Day 8 Survey||5825
8779419|NCT01318876|9829592|FG000|NOT COMPLETED|Day 8 Survey||1820
8779420|NCT01318876|9829592|FG000|STARTED|Day 29 Survey|All participants with a valid e-mail, have received the second survey|7549
8779421|NCT01318876|9829592|FG000|COMPLETED|Day 29 Survey||5724
8779422|NCT01318876|9829592|FG000|NOT COMPLETED|Day 29 Survey||1825
8779423|NCT01318902|9829600|FG000|STARTED|Overall Study||6
8779424|NCT01318902|9829601|FG001|STARTED|Overall Study||5
8779425|NCT01318902|9829602|FG002|STARTED|Overall Study||5
8779426|NCT01318902|9829603|FG003|STARTED|Overall Study||11
8779427|NCT01318902|9829600|FG000|COMPLETED|Overall Study||5
8779428|NCT01318902|9829601|FG001|COMPLETED|Overall Study||2
8779429|NCT01318902|9829602|FG002|COMPLETED|Overall Study||3
8779430|NCT01318902|9829603|FG003|COMPLETED|Overall Study||5
8779431|NCT01318902|9829600|FG000|NOT COMPLETED|Overall Study||1
8779432|NCT01318902|9829601|FG001|NOT COMPLETED|Overall Study||3
8779433|NCT01318902|9829602|FG002|NOT COMPLETED|Overall Study||2
8779434|NCT01318902|9829603|FG003|NOT COMPLETED|Overall Study||6
8779435|NCT01318915|9829615|FG000|STARTED|Overall Study||10
8779436|NCT01318915|9829615|FG000|COMPLETED|Overall Study||9
8779437|NCT01318915|9829615|FG000|NOT COMPLETED|Overall Study||1
8779438|NCT01318967|9829621|FG000|STARTED|Overall Study||10
8779439|NCT01318967|9829621|FG000|COMPLETED|Overall Study||10
8779440|NCT01318967|9829621|FG000|NOT COMPLETED|Overall Study||0
8779441|NCT01319045|9829626|FG000|STARTED|Overall Study||5
8779442|NCT01319045|9829626|FG000|COMPLETED|Overall Study|Study was discontinued due to low enrollment|3
8779443|NCT01319045|9829626|FG000|NOT COMPLETED|Overall Study||2
8779444|NCT01319110|9829632|FG000|STARTED|Overall Study||5
8779445|NCT01319110|9829633|FG001|STARTED|Overall Study||5
8779446|NCT01319110|9829632|FG000|COMPLETED|Overall Study||5
8779447|NCT01319110|9829633|FG001|COMPLETED|Overall Study||5
8779448|NCT01319110|9829632|FG000|NOT COMPLETED|Overall Study||0
8779449|NCT01319110|9829633|FG001|NOT COMPLETED|Overall Study||0
8779450|NCT01319318|9829639|FG000|STARTED|Overall Study||25
8779451|NCT01319318|9829639|FG000|COMPLETED|Overall Study||25
8779452|NCT01319318|9829639|FG000|NOT COMPLETED|Overall Study||0
8779453|NCT01319383|9829643|FG000|STARTED|Overall Study||12
8779454|NCT01319383|9829644|FG001|STARTED|Overall Study||13
8779455|NCT01319383|9829643|FG000|Step 1|Overall Study||8
8779456|NCT01319383|9829644|FG001|Step 1|Overall Study|The 2 participants without an ex vivo response were terminated from the study.|11
8779457|NCT01319383|9829643|FG000|Step 2|Overall Study|These participants demonstrated an ex vivo response in Step 1|8
8779458|NCT01319383|9829644|FG001|Step 2|Overall Study|The 7 participants without an in vivo response to single dose of VOR 400 mg PO were terminated.|4
8779459|NCT01319383|9829643|FG000|Step 2|Overall Study|The 4 without ex vivo response (Step 1) took a single dose to see if in vivo response would occur|4
8779460|NCT01319383|9829644|FG001|Step 2|Overall Study||0
8779461|NCT01319383|9829643|FG000|Step 3|Overall Study|None who qualified for the 2 series of 11 doses of VOR (taken M-T-W & off for 4 days for 4 wks).|0
8779462|NCT01319383|9829644|FG001|Step 3|Overall Study|3 Arm 1 participants enrolled here; 6/7 had in vivo response to 2 VOR doses given 72 hours apart.|6
8779463|NCT01319383|9829643|FG000|Step 4|Overall Study|Arm 1 did not have a Step 4|0
8779464|NCT01319383|9829644|FG001|Step 4|Overall Study|Only 3/6 completed the study.|3
8779465|NCT01319383|9829643|FG000|COMPLETED|Overall Study||0
8779466|NCT01319383|9829644|FG001|COMPLETED|Overall Study||3
8779467|NCT01319383|9829643|FG000|NOT COMPLETED|Overall Study||12
8779468|NCT01319383|9829644|FG001|NOT COMPLETED|Overall Study||10
8779469|NCT01319396|9829661|FG000|STARTED|Overall Study||24
8779470|NCT01319396|9829661|FG000|COMPLETED|Overall Study||24
8779471|NCT01319396|9829661|FG000|NOT COMPLETED|Overall Study||0
8779472|NCT01319422|9829667|FG000|STARTED|Overall Study||20
8779473|NCT01319422|9829668|FG001|STARTED|Overall Study||20
8779474|NCT01319422|9829667|FG000|COMPLETED|Overall Study||19
8779475|NCT01319422|9829668|FG001|COMPLETED|Overall Study||20
8779476|NCT01319422|9829667|FG000|NOT COMPLETED|Overall Study||1
8779477|NCT01319422|9829668|FG001|NOT COMPLETED|Overall Study||0
8779478|NCT01319500|9829676|FG000|STARTED|Overall Study||1187
8779479|NCT01319500|9829677|FG001|STARTED|Overall Study||2589
8779480|NCT01319500|9829676|FG000|COMPLETED|Overall Study||1187
8779481|NCT01319500|9829677|FG001|COMPLETED|Overall Study||2589
8779482|NCT01319500|9829676|FG000|NOT COMPLETED|Overall Study||0
8779483|NCT01319500|9829677|FG001|NOT COMPLETED|Overall Study||0
8779484|NCT01319539|9829688|FG000|STARTED|Overall Study||12
8779485|NCT01319539|9829688|FG000|COMPLETED|Overall Study||12
8779486|NCT01319539|9829688|FG000|NOT COMPLETED|Overall Study||0
8779487|NCT01319552|9829694|FG000|STARTED|Overall Study||14
8779488|NCT01319552|9829694|FG000|COMPLETED|Overall Study||14
8779489|NCT01319552|9829694|FG000|NOT COMPLETED|Overall Study||0
8779490|NCT01319617|9829699|FG000|STARTED|Overall Study||41
8779491|NCT01319617|9829699|FG000|COMPLETED|Overall Study||40
8779492|NCT01319617|9829699|FG000|NOT COMPLETED|Overall Study||1
8779493|NCT01319721|9829705|FG000|STARTED|Overall Study|The unit of measure is eyes.|48
8779494|NCT01319721|9829706|FG001|STARTED|Overall Study|The unit of measure is eyes.|48
8779495|NCT01319721|9829705|FG000|COMPLETED|Overall Study|The unit of measure is eyes.|47
8779496|NCT01319721|9829706|FG001|COMPLETED|Overall Study|The unit of measure is eyes.|42
8779497|NCT01319721|9829705|FG000|NOT COMPLETED|Overall Study||1
8779498|NCT01319721|9829706|FG001|NOT COMPLETED|Overall Study||6
8779499|NCT01319773|9829717|FG000|STARTED|Overall Study||10
8779500|NCT01319773|9829718|FG001|STARTED|Overall Study||10
8779501|NCT01319773|9829719|FG002|STARTED|Overall Study||8
8779502|NCT01319773|9829720|FG003|STARTED|Overall Study||8
8779503|NCT01319773|9829721|FG004|STARTED|Overall Study||8
8779504|NCT01319773|9829717|FG000|COMPLETED|Overall Study||10
8779505|NCT01319773|9829718|FG001|COMPLETED|Overall Study||10
8779506|NCT01319773|9829719|FG002|COMPLETED|Overall Study||8
8779507|NCT01319773|9829720|FG003|COMPLETED|Overall Study||8
8779508|NCT01319773|9829721|FG004|COMPLETED|Overall Study||8
8779509|NCT01319773|9829717|FG000|NOT COMPLETED|Overall Study||0
8779510|NCT01319773|9829718|FG001|NOT COMPLETED|Overall Study||0
8779511|NCT01319773|9829719|FG002|NOT COMPLETED|Overall Study||0
8779512|NCT01319773|9829720|FG003|NOT COMPLETED|Overall Study||0
9029823|NCT03224403|10092257|FG000|STARTED|Overall Study||59
9029824|NCT03224403|10092258|FG001|STARTED|Overall Study||249
9029825|NCT03224403|10092259|FG002|STARTED|Overall Study||232
9029826|NCT03224403|10092260|FG003|STARTED|Overall Study||124
9029827|NCT03224403|10092257|FG000|COMPLETED|Overall Study||59
9029828|NCT03224403|10092258|FG001|COMPLETED|Overall Study||249
9029829|NCT03224403|10092259|FG002|COMPLETED|Overall Study||232
9029830|NCT03224403|10092260|FG003|COMPLETED|Overall Study||124
9029831|NCT03224403|10092257|FG000|NOT COMPLETED|Overall Study||0
9029832|NCT03224403|10092258|FG001|NOT COMPLETED|Overall Study||0
9029833|NCT03224403|10092259|FG002|NOT COMPLETED|Overall Study||0
9029834|NCT03224403|10092260|FG003|NOT COMPLETED|Overall Study||0
9029835|NCT03224520|10092274|FG000|STARTED|Overall Study||371
9029836|NCT03224520|10092275|FG001|STARTED|Overall Study||370
9029837|NCT03224520|10092276|FG002|STARTED|Overall Study||374
9029838|NCT03224520|10092277|FG003|STARTED|Overall Study||372
9029839|NCT03224520|10092274|FG000|COMPLETED|Overall Study||205
9029840|NCT03224520|10092275|FG001|COMPLETED|Overall Study||207
9029841|NCT03224520|10092276|FG002|COMPLETED|Overall Study||190
9029842|NCT03224520|10092277|FG003|COMPLETED|Overall Study||199
9029843|NCT03224520|10092274|FG000|NOT COMPLETED|Overall Study||166
9029844|NCT03224520|10092275|FG001|NOT COMPLETED|Overall Study||163
9029845|NCT03224520|10092276|FG002|NOT COMPLETED|Overall Study||184
9029846|NCT03224520|10092277|FG003|NOT COMPLETED|Overall Study||173
9029847|NCT03224585|10092289|FG000|STARTED|Overall Study||2
9029848|NCT03224585|10092290|FG001|STARTED|Overall Study||3
9029849|NCT03224585|10092289|FG000|COMPLETED|Overall Study||2
8779513|NCT01319773|9829721|FG004|NOT COMPLETED|Overall Study||0
8779514|NCT01319799|9829731|FG000|STARTED|Overall Study||10
8779515|NCT01319799|9829731|FG000|COMPLETED|Overall Study||10
8779516|NCT01319799|9829731|FG000|NOT COMPLETED|Overall Study||0
8779517|NCT01319812|9829737|FG000|STARTED|Overall Study||161
8779518|NCT01319812|9829738|FG001|STARTED|Overall Study||302
8779519|NCT01319812|9829737|FG000|COMPLETED|Overall Study||145
8779520|NCT01319812|9829738|FG001|COMPLETED|Overall Study||280
8779521|NCT01319812|9829737|FG000|NOT COMPLETED|Overall Study||16
8779522|NCT01319812|9829738|FG001|NOT COMPLETED|Overall Study||22
8779523|NCT01319851|9829751|FG000|STARTED|Overall Study||3
8779524|NCT01319851|9829751|FG000|COMPLETED|Overall Study||3
8779525|NCT01319851|9829751|FG000|NOT COMPLETED|Overall Study||0
8779526|NCT01319877|9829757|FG000|STARTED|Overall Study||453
8779527|NCT01319877|9829758|FG001|STARTED|Overall Study||153
8779528|NCT01319877|9829757|FG000|COMPLETED|Overall Study||345
8779529|NCT01319877|9829758|FG001|COMPLETED|Overall Study||108
8779530|NCT01319877|9829757|FG000|NOT COMPLETED|Overall Study||108
8779531|NCT01319877|9829758|FG001|NOT COMPLETED|Overall Study||45
8779532|NCT01319929|9829765|FG000|STARTED|First Treatment Period (4 Weeks)||20
8779533|NCT01319929|9829766|FG001|STARTED|First Treatment Period (4 Weeks)||19
8779534|NCT01319929|9829765|FG000|COMPLETED|First Treatment Period (4 Weeks)||17
8779535|NCT01319929|9829766|FG001|COMPLETED|First Treatment Period (4 Weeks)||17
8779536|NCT01319929|9829765|FG000|NOT COMPLETED|First Treatment Period (4 Weeks)||3
8779537|NCT01319929|9829766|FG001|NOT COMPLETED|First Treatment Period (4 Weeks)||2
8779538|NCT01319929|9829765|FG000|STARTED|Washout Period (3 Weeks)||17
8779539|NCT01319929|9829766|FG001|STARTED|Washout Period (3 Weeks)||17
8779540|NCT01319929|9829765|FG000|COMPLETED|Washout Period (3 Weeks)||17
8779541|NCT01319929|9829766|FG001|COMPLETED|Washout Period (3 Weeks)||17
8779542|NCT01319929|9829765|FG000|NOT COMPLETED|Washout Period (3 Weeks)||0
8779543|NCT01319929|9829766|FG001|NOT COMPLETED|Washout Period (3 Weeks)||0
8779544|NCT01319929|9829765|FG000|STARTED|Second Treatment Period (4 Weeks)||17
8779545|NCT01319929|9829766|FG001|STARTED|Second Treatment Period (4 Weeks)||17
8779546|NCT01319929|9829765|FG000|COMPLETED|Second Treatment Period (4 Weeks)||16
8779547|NCT01319929|9829766|FG001|COMPLETED|Second Treatment Period (4 Weeks)||16
8779548|NCT01319929|9829765|FG000|NOT COMPLETED|Second Treatment Period (4 Weeks)||1
8779549|NCT01319929|9829766|FG001|NOT COMPLETED|Second Treatment Period (4 Weeks)||1
9029850|NCT03224585|10092290|FG001|COMPLETED|Overall Study||3
9029851|NCT03224585|10092289|FG000|NOT COMPLETED|Overall Study||0
9029852|NCT03224585|10092290|FG001|NOT COMPLETED|Overall Study||0
9029853|NCT03224598|10092298|FG000|STARTED|Overall Study||9
9029854|NCT03224598|10092299|FG001|STARTED|Overall Study||17
9029855|NCT03224598|10092300|FG002|STARTED|Overall Study||13
9029856|NCT03224598|10092298|FG000|COMPLETED|Overall Study||9
9029857|NCT03224598|10092299|FG001|COMPLETED|Overall Study||14
9029858|NCT03224598|10092300|FG002|COMPLETED|Overall Study||13
9029859|NCT03224598|10092298|FG000|NOT COMPLETED|Overall Study||0
9029860|NCT03224598|10092299|FG001|NOT COMPLETED|Overall Study||3
9029861|NCT03224598|10092300|FG002|NOT COMPLETED|Overall Study||0
9029862|NCT03225001|10092308|FG000|STARTED|Overall Study||197
9029863|NCT03225001|10092308|FG000|Valve-Implanted|Overall Study||195
9029864|NCT03225001|10092308|FG000|COMPLETED|Overall Study||188
9029865|NCT03225001|10092308|FG000|NOT COMPLETED|Overall Study||9
9029866|NCT03225313|10092315|FG000|STARTED|Overall Study|25 Patients|25
9029867|NCT03225313|10092316|FG001|STARTED|Overall Study|25 Patients|25
9029868|NCT03225313|10092317|FG002|STARTED|Overall Study|25 Patients|25
9029869|NCT03225313|10092315|FG000|COMPLETED|Overall Study|25 Patients|25
9029870|NCT03225313|10092316|FG001|COMPLETED|Overall Study|25 Patients|25
9029871|NCT03225313|10092317|FG002|COMPLETED|Overall Study|25 Patients|25
9029872|NCT03225313|10092315|FG000|NOT COMPLETED|Overall Study||0
9029873|NCT03225313|10092316|FG001|NOT COMPLETED|Overall Study||0
9029874|NCT03225313|10092317|FG002|NOT COMPLETED|Overall Study||0
9029875|NCT03225573|10092327|FG000|STARTED|Overall Study||60
9029876|NCT03225573|10092327|FG000|COMPLETED|Overall Study||60
9029877|NCT03225573|10092327|FG000|NOT COMPLETED|Overall Study||0
9029878|NCT03225599|10092331|FG000|STARTED|Overall Study||9
9029879|NCT03225599|10092331|FG000|COMPLETED|Overall Study||7
9029880|NCT03225599|10092331|FG000|NOT COMPLETED|Overall Study||2
9029881|NCT03225859|10092335|FG000|STARTED|Overall Study||12
9029882|NCT03225859|10092335|FG000|COMPLETED|Overall Study||11
9029883|NCT03225859|10092335|FG000|NOT COMPLETED|Overall Study||1
9029884|NCT03226223|10092341|FG000|STARTED|Overall Study||10
9029885|NCT03226223|10092342|FG001|STARTED|Overall Study||8
9029886|NCT03226223|10092341|FG000|COMPLETED|Overall Study||8
9029887|NCT03226223|10092342|FG001|COMPLETED|Overall Study||6
9029888|NCT03226223|10092341|FG000|NOT COMPLETED|Overall Study||2
9029889|NCT03226223|10092342|FG001|NOT COMPLETED|Overall Study||2
9029890|NCT03226249|10092348|FG000|STARTED|PEM Induction Cycles 1-3, and PET#2||30
9029891|NCT03226249|10092348|FG000|PEM Cycle 1|PEM Induction Cycles 1-3, and PET#2||30
9029892|NCT03226249|10092348|FG000|PEM Cycle 2|PEM Induction Cycles 1-3, and PET#2||30
9029893|NCT03226249|10092348|FG000|PEM Cycle 3|PEM Induction Cycles 1-3, and PET#2||30
9029894|NCT03226249|10092348|FG000|PET#2|PEM Induction Cycles 1-3, and PET#2||30
9029895|NCT03226249|10092348|FG000|COMPLETED|PEM Induction Cycles 1-3, and PET#2||30
9029896|NCT03226249|10092348|FG000|NOT COMPLETED|PEM Induction Cycles 1-3, and PET#2||0
9029897|NCT03226249|10092348|FG000|STARTED|2 Cycles of AVD + PET#3||30
9029898|NCT03226249|10092348|FG000|AVD Cycle 1|2 Cycles of AVD + PET#3||30
9029899|NCT03226249|10092348|FG000|AVD Cycle 2|2 Cycles of AVD + PET#3||30
9029900|NCT03226249|10092348|FG000|PET#3|2 Cycles of AVD + PET#3||30
9029901|NCT03226249|10092348|FG000|COMPLETED|2 Cycles of AVD + PET#3||30
8779550|NCT01319994|9829775|FG000|STARTED|Overall Study||26
8779551|NCT01319994|9829776|FG001|STARTED|Overall Study||27
8779552|NCT01319994|9829775|FG000|Abto Keep Appoinment Shedule|Overall Study||23
8779553|NCT01319994|9829776|FG001|Abto Keep Appoinment Shedule|Overall Study||24
8779554|NCT01319994|9829775|FG000|Tolerated at Least 1.7g/Day Dose|Overall Study||19
8779555|NCT01319994|9829776|FG001|Tolerated at Least 1.7g/Day Dose|Overall Study||24
8779556|NCT01319994|9829775|FG000|Glucocorticoid Dose as Inc Cri|Overall Study||19
8779557|NCT01319994|9829776|FG001|Glucocorticoid Dose as Inc Cri|Overall Study||22
8779558|NCT01319994|9829775|FG000|Did Not Develop Overt Diabetes|Overall Study||19
8779559|NCT01319994|9829776|FG001|Did Not Develop Overt Diabetes|Overall Study||21
8779560|NCT01319994|9829775|FG000|COMPLETED|Overall Study||19
8779561|NCT01319994|9829776|FG001|COMPLETED|Overall Study||21
8779562|NCT01319994|9829775|FG000|NOT COMPLETED|Overall Study||7
8779563|NCT01319994|9829776|FG001|NOT COMPLETED|Overall Study||6
8779564|NCT01320033|9829785|FG000|STARTED|Overall Study||216
8779565|NCT01320033|9829786|FG001|STARTED|Overall Study||224
8779566|NCT01320033|9829787|FG002|STARTED|Overall Study||222
8779567|NCT01320033|9829785|FG000|COMPLETED|Overall Study||158
8779568|NCT01320033|9829786|FG001|COMPLETED|Overall Study||160
8779569|NCT01320033|9829787|FG002|COMPLETED|Overall Study||169
8779570|NCT01320033|9829785|FG000|NOT COMPLETED|Overall Study||58
8779571|NCT01320033|9829786|FG001|NOT COMPLETED|Overall Study||64
8779572|NCT01320033|9829787|FG002|NOT COMPLETED|Overall Study||53
8779573|NCT01320085|9829798|FG000|STARTED|Overall Study||41
8779574|NCT01320085|9829799|FG001|STARTED|Overall Study||117
8779575|NCT01320085|9829800|FG002|STARTED|Overall Study||25
8779576|NCT01320085|9829798|FG000|COMPLETED|Overall Study||0
8779577|NCT01320085|9829799|FG001|COMPLETED|Overall Study||0
8779578|NCT01320085|9829800|FG002|COMPLETED|Overall Study||0
8779579|NCT01320085|9829798|FG000|NOT COMPLETED|Overall Study||41
8779580|NCT01320085|9829799|FG001|NOT COMPLETED|Overall Study||117
8779581|NCT01320085|9829800|FG002|NOT COMPLETED|Overall Study||25
8779582|NCT01320137|9829810|FG000|STARTED|Overall Study||40
9029902|NCT03226249|10092348|FG000|NOT COMPLETED|2 Cycles of AVD + PET#3||0
9029903|NCT03226249|10092348|FG000|STARTED|2-4 Cycles of AVD +/- Chemo & RT, PET#4||30
9029904|NCT03226249|10092348|FG000|2-4 Cycles of AVD +/- Chemo & RT|2-4 Cycles of AVD +/- Chemo & RT, PET#4||29
9029905|NCT03226249|10092348|FG000|PET#4|2-4 Cycles of AVD +/- Chemo & RT, PET#4||29
9029906|NCT03226249|10092348|FG000|COMPLETED|2-4 Cycles of AVD +/- Chemo & RT, PET#4||29
9029907|NCT03226249|10092348|FG000|NOT COMPLETED|2-4 Cycles of AVD +/- Chemo & RT, PET#4||1
9029908|NCT03226249|10092348|FG000|STARTED|PEM Consolidation (1-2 Years)||29
9029909|NCT03226249|10092348|FG000|COMPLETED|PEM Consolidation (1-2 Years)||0
9029910|NCT03226249|10092348|FG000|NOT COMPLETED|PEM Consolidation (1-2 Years)||29
9029911|NCT03226249|10092348|FG000|STARTED|Survival Follow-up|All patients that are treated with one dose of study drug go into follow-up.|30
9029912|NCT03226249|10092348|FG000|COMPLETED|Survival Follow-up||0
9029913|NCT03226249|10092348|FG000|NOT COMPLETED|Survival Follow-up||30
9029914|NCT03226275|10092356|FG000|STARTED|Treatment Period 1 (8 Days)||8
9029915|NCT03226275|10092357|FG001|STARTED|Treatment Period 1 (8 Days)||8
9029916|NCT03226275|10092358|FG002|STARTED|Treatment Period 1 (8 Days)||8
9029917|NCT03226275|10092359|FG003|STARTED|Treatment Period 1 (8 Days)||8
9029918|NCT03226275|10092356|FG000|COMPLETED|Treatment Period 1 (8 Days)||8
9029919|NCT03226275|10092357|FG001|COMPLETED|Treatment Period 1 (8 Days)||8
9029920|NCT03226275|10092358|FG002|COMPLETED|Treatment Period 1 (8 Days)||7
9029921|NCT03226275|10092359|FG003|COMPLETED|Treatment Period 1 (8 Days)||7
9029922|NCT03226275|10092356|FG000|NOT COMPLETED|Treatment Period 1 (8 Days)||0
9029923|NCT03226275|10092357|FG001|NOT COMPLETED|Treatment Period 1 (8 Days)||0
9029924|NCT03226275|10092358|FG002|NOT COMPLETED|Treatment Period 1 (8 Days)||1
9029925|NCT03226275|10092359|FG003|NOT COMPLETED|Treatment Period 1 (8 Days)||1
9029926|NCT03226275|10092356|FG000|STARTED|Treatment Period 2 (8 Days)||8
9029927|NCT03226275|10092357|FG001|STARTED|Treatment Period 2 (8 Days)||8
9029928|NCT03226275|10092358|FG002|STARTED|Treatment Period 2 (8 Days)||7
9029929|NCT03226275|10092359|FG003|STARTED|Treatment Period 2 (8 Days)||7
9029930|NCT03226275|10092356|FG000|COMPLETED|Treatment Period 2 (8 Days)||8
9029931|NCT03226275|10092357|FG001|COMPLETED|Treatment Period 2 (8 Days)||8
9029932|NCT03226275|10092358|FG002|COMPLETED|Treatment Period 2 (8 Days)||7
9029933|NCT03226275|10092359|FG003|COMPLETED|Treatment Period 2 (8 Days)||7
9029934|NCT03226275|10092356|FG000|NOT COMPLETED|Treatment Period 2 (8 Days)||0
9029935|NCT03226275|10092357|FG001|NOT COMPLETED|Treatment Period 2 (8 Days)||0
9029936|NCT03226275|10092358|FG002|NOT COMPLETED|Treatment Period 2 (8 Days)||0
9029937|NCT03226275|10092359|FG003|NOT COMPLETED|Treatment Period 2 (8 Days)||0
9029938|NCT03226353|10092369|FG000|STARTED|Overall Study||77
9029939|NCT03226353|10092369|FG000|Habitual Wearers of Proclear 1 Day|Overall Study||2
9029940|NCT03226353|10092369|FG000|Other Habitual Lens Types|Overall Study||75
9029941|NCT03226353|10092369|FG000|COMPLETED|Overall Study|Study participants completed includes the Omafilcon A habitual wearers.|71
9029942|NCT03226353|10092369|FG000|NOT COMPLETED|Overall Study||6
8779583|NCT01320137|9829811|FG001|STARTED|Overall Study||40
9029943|NCT03226366|10092380|FG000|STARTED|Overall Study||911
9029944|NCT03226366|10092381|FG001|STARTED|Overall Study||495
9029945|NCT03226366|10092382|FG002|STARTED|Overall Study||1183
9029946|NCT03226366|10092383|FG003|STARTED|Overall Study||641
9029947|NCT03226366|10092380|FG000|COMPLETED|Overall Study||911
9029948|NCT03226366|10092381|FG001|COMPLETED|Overall Study||495
8779584|NCT01320137|9829810|FG000|COMPLETED|Overall Study||40
8779585|NCT01320137|9829811|FG001|COMPLETED|Overall Study||40
8779586|NCT01320137|9829810|FG000|NOT COMPLETED|Overall Study||0
8779587|NCT01320137|9829811|FG001|NOT COMPLETED|Overall Study||0
8779588|NCT01320150|9829819|FG000|STARTED|Overall Study||311
8779589|NCT01320150|9829819|FG000|PPP|Overall Study||34
8779590|NCT01320150|9829819|FG000|Non-PPP|Overall Study||211
8779591|NCT01320150|9829819|FG000|COMPLETED|Overall Study||245
8779592|NCT01320150|9829819|FG000|NOT COMPLETED|Overall Study||66
8779593|NCT01320202|9829825|FG000|STARTED|Overall Study||152
8779594|NCT01320202|9829826|FG001|STARTED|Overall Study||153
8779595|NCT01320202|9829825|FG000|Comp 48 Wks in St 2|Overall Study||27
8779596|NCT01320202|9829826|FG001|Comp 48 Wks in St 2|Overall Study||27
8779597|NCT01320202|9829825|FG000|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||69
8779598|NCT01320202|9829826|FG001|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||82
8779599|NCT01320202|9829825|FG000|Enrolled in St 3|Overall Study||98
8779600|NCT01320202|9829826|FG001|Enrolled in St 3|Overall Study||109
8779601|NCT01320202|9829825|FG000|Completed St 3|Overall Study||79
8779602|NCT01320202|9829826|FG001|Completed St 3|Overall Study||82
8779603|NCT01320202|9829825|FG000|COMPLETED|Overall Study||96
8779604|NCT01320202|9829826|FG001|COMPLETED|Overall Study||109
8779605|NCT01320202|9829825|FG000|NOT COMPLETED|Overall Study||56
8779606|NCT01320202|9829826|FG001|NOT COMPLETED|Overall Study||44
8779607|NCT01320293|9829835|FG000|STARTED|Overall Study||18
8779608|NCT01320293|9829835|FG000|COMPLETED|Overall Study||16
8779609|NCT01320293|9829835|FG000|NOT COMPLETED|Overall Study||2
8779610|NCT01320553|9829843|FG000|STARTED|Overall Study||31
8779611|NCT01320553|9829844|FG001|STARTED|Overall Study||30
8779612|NCT01320553|9829845|FG002|STARTED|Overall Study||31
8779613|NCT01320553|9829846|FG003|STARTED|Overall Study||30
8779614|NCT01320553|9829843|FG000|COMPLETED|Overall Study||30
8779615|NCT01320553|9829844|FG001|COMPLETED|Overall Study||26
8779616|NCT01320553|9829845|FG002|COMPLETED|Overall Study||29
8779617|NCT01320553|9829846|FG003|COMPLETED|Overall Study||29
8779618|NCT01320553|9829843|FG000|NOT COMPLETED|Overall Study||1
8779619|NCT01320553|9829844|FG001|NOT COMPLETED|Overall Study||4
8779620|NCT01320553|9829845|FG002|NOT COMPLETED|Overall Study||2
8779621|NCT01320553|9829846|FG003|NOT COMPLETED|Overall Study||1
8779622|NCT01320722|9829861|FG000|STARTED|Overall Study||46
8779623|NCT01320722|9829862|FG001|STARTED|Overall Study||47
8779624|NCT01320722|9829863|FG002|STARTED|Overall Study||47
8779625|NCT01320722|9829864|FG003|STARTED|Overall Study||49
8779626|NCT01320722|9829865|FG004|STARTED|Overall Study||53
8779627|NCT01320722|9829861|FG000|Received Intervention|Overall Study||43
8779628|NCT01320722|9829862|FG001|Received Intervention|Overall Study||45
8779629|NCT01320722|9829863|FG002|Received Intervention|Overall Study||46
8779630|NCT01320722|9829864|FG003|Received Intervention|Overall Study||48
8779631|NCT01320722|9829865|FG004|Received Intervention|Overall Study||51
8779632|NCT01320722|9829861|FG000|COMPLETED|Overall Study||43
8779633|NCT01320722|9829862|FG001|COMPLETED|Overall Study||41
8779634|NCT01320722|9829863|FG002|COMPLETED|Overall Study||40
8779635|NCT01320722|9829864|FG003|COMPLETED|Overall Study||35
8779636|NCT01320722|9829865|FG004|COMPLETED|Overall Study||45
8779637|NCT01320722|9829861|FG000|NOT COMPLETED|Overall Study||3
8779638|NCT01320722|9829862|FG001|NOT COMPLETED|Overall Study||6
8779639|NCT01320722|9829863|FG002|NOT COMPLETED|Overall Study||7
8779640|NCT01320722|9829864|FG003|NOT COMPLETED|Overall Study||14
8779641|NCT01320722|9829865|FG004|NOT COMPLETED|Overall Study||8
8779642|NCT01320735|9829880|FG000|STARTED|Overall Study||300
8779643|NCT01320735|9829880|FG000|COMPLETED|Overall Study||194
8779644|NCT01320735|9829880|FG000|NOT COMPLETED|Overall Study||106
8779645|NCT01320826|9829884|FG000|STARTED|Overall Study||577
8779646|NCT01320826|9829884|FG000|COMPLETED|Overall Study||577
8779647|NCT01320826|9829884|FG000|NOT COMPLETED|Overall Study||0
8779648|NCT01320943|9829901|FG000|STARTED|Overall Study|13 participants did not restart TDF; 8 participants restarted TDF during the study.|21
8779649|NCT01320943|9829902|FG001|STARTED|Overall Study||22
8779650|NCT01320943|9829901|FG000|COMPLETED|Overall Study||20
8779651|NCT01320943|9829902|FG001|COMPLETED|Overall Study||20
8779652|NCT01320943|9829901|FG000|NOT COMPLETED|Overall Study||1
8779653|NCT01320943|9829902|FG001|NOT COMPLETED|Overall Study||2
8779654|NCT01321073|9829915|FG000|STARTED|Overall Study||64
8779655|NCT01321073|9829915|FG000|COMPLETED|Overall Study||57
8779656|NCT01321073|9829915|FG000|NOT COMPLETED|Overall Study||7
8779657|NCT01321151|9829921|FG000|STARTED|Overall Study|The boxer was treated once-a-day for 30 days.|6
8779658|NCT01321151|9829922|FG001|STARTED|Overall Study|The boxer was treated with once-a-day for 30 days.|6
8779659|NCT01321151|9829921|FG000|COMPLETED|Overall Study||6
8779660|NCT01321151|9829922|FG001|COMPLETED|Overall Study||6
8779661|NCT01321151|9829921|FG000|NOT COMPLETED|Overall Study||0
9029949|NCT03226366|10092382|FG002|COMPLETED|Overall Study||1183
9029950|NCT03226366|10092383|FG003|COMPLETED|Overall Study||641
8779662|NCT01321151|9829922|FG001|NOT COMPLETED|Overall Study||0
8779663|NCT01321177|9829930|FG000|STARTED|Overall Study||223
8779664|NCT01321177|9829931|FG001|STARTED|Overall Study||181
8779665|NCT01321177|9829930|FG000|COMPLETED|Overall Study||147
8779666|NCT01321177|9829931|FG001|COMPLETED|Overall Study||84
8779667|NCT01321177|9829930|FG000|NOT COMPLETED|Overall Study||76
8779668|NCT01321177|9829931|FG001|NOT COMPLETED|Overall Study||97
8779669|NCT01321437|9829937|FG000|STARTED|Overall Study||11
8779670|NCT01321437|9829937|FG000|COMPLETED|Overall Study||11
8779671|NCT01321437|9829937|FG000|NOT COMPLETED|Overall Study||0
8779672|NCT01321541|9829943|FG000|STARTED|Overall Study||155
8779673|NCT01321541|9829944|FG001|STARTED|Overall Study||157
8779674|NCT01321541|9829943|FG000|COMPLETED|Overall Study||72
8779675|NCT01321541|9829944|FG001|COMPLETED|Overall Study||61
8779676|NCT01321541|9829943|FG000|NOT COMPLETED|Overall Study||83
8779677|NCT01321541|9829944|FG001|NOT COMPLETED|Overall Study||96
8779678|NCT01321554|9829952|FG000|STARTED|Randomization Phase||261
8779679|NCT01321554|9829953|FG001|STARTED|Randomization Phase||131
8779680|NCT01321554|9829954|FG002|STARTED|Randomization Phase||0
8779681|NCT01321554|9829955|FG003|STARTED|Randomization Phase||0
8779682|NCT01321554|9829952|FG000|COMPLETED|Randomization Phase||261
8779683|NCT01321554|9829953|FG001|COMPLETED|Randomization Phase||131
8779684|NCT01321554|9829954|FG002|COMPLETED|Randomization Phase||0
8779685|NCT01321554|9829955|FG003|COMPLETED|Randomization Phase||0
8779686|NCT01321554|9829952|FG000|NOT COMPLETED|Randomization Phase||0
8779687|NCT01321554|9829953|FG001|NOT COMPLETED|Randomization Phase||0
8779688|NCT01321554|9829954|FG002|NOT COMPLETED|Randomization Phase||0
8779689|NCT01321554|9829955|FG003|NOT COMPLETED|Randomization Phase||0
8779690|NCT01321554|9829952|FG000|STARTED|OOL Lenvatinib Treatment Period||0
8779691|NCT01321554|9829953|FG001|STARTED|OOL Lenvatinib Treatment Period||0
8779692|NCT01321554|9829954|FG002|STARTED|OOL Lenvatinib Treatment Period|Participants from randomization phase were re-randomized to OOL, treatment period.|85
8779693|NCT01321554|9829955|FG003|STARTED|OOL Lenvatinib Treatment Period|Participants from randomization phase were re-randomized to OOL, treatment period.|30
8779694|NCT01321554|9829952|FG000|COMPLETED|OOL Lenvatinib Treatment Period||0
8779695|NCT01321554|9829953|FG001|COMPLETED|OOL Lenvatinib Treatment Period||0
8779696|NCT01321554|9829954|FG002|COMPLETED|OOL Lenvatinib Treatment Period||85
8779697|NCT01321554|9829955|FG003|COMPLETED|OOL Lenvatinib Treatment Period||30
8779698|NCT01321554|9829952|FG000|NOT COMPLETED|OOL Lenvatinib Treatment Period||0
8779699|NCT01321554|9829953|FG001|NOT COMPLETED|OOL Lenvatinib Treatment Period||0
8779700|NCT01321554|9829954|FG002|NOT COMPLETED|OOL Lenvatinib Treatment Period||0
8779701|NCT01321554|9829955|FG003|NOT COMPLETED|OOL Lenvatinib Treatment Period||0
8779702|NCT01321606|9829965|FG000|STARTED|Overall Study||18
8779703|NCT01321606|9829966|FG001|STARTED|Overall Study||32
8779704|NCT01321606|9829967|FG002|STARTED|Overall Study||34
8779705|NCT01321606|9829968|FG003|STARTED|Overall Study||29
8779706|NCT01321606|9829965|FG000|COMPLETED|Overall Study||18
8779707|NCT01321606|9829966|FG001|COMPLETED|Overall Study||32
8779708|NCT01321606|9829967|FG002|COMPLETED|Overall Study||34
8779709|NCT01321606|9829968|FG003|COMPLETED|Overall Study||28
8779710|NCT01321606|9829965|FG000|NOT COMPLETED|Overall Study||0
8779711|NCT01321606|9829966|FG001|NOT COMPLETED|Overall Study||0
8779712|NCT01321606|9829967|FG002|NOT COMPLETED|Overall Study||0
8779713|NCT01321606|9829968|FG003|NOT COMPLETED|Overall Study||1
8779714|NCT01321710|9829981|FG000|STARTED|Overall Study||50
8779715|NCT01321710|9829982|FG001|STARTED|Overall Study||58
8779716|NCT01321710|9829983|FG002|STARTED|Overall Study||44
8779717|NCT01321710|9829981|FG000|COMPLETED|Overall Study||46
8779718|NCT01321710|9829982|FG001|COMPLETED|Overall Study||53
8779719|NCT01321710|9829983|FG002|COMPLETED|Overall Study||44
8779720|NCT01321710|9829981|FG000|NOT COMPLETED|Overall Study||4
8779721|NCT01321710|9829982|FG001|NOT COMPLETED|Overall Study||5
8779722|NCT01321710|9829983|FG002|NOT COMPLETED|Overall Study||0
8779723|NCT01321723|9829996|FG000|STARTED|Overall Study||32
8779724|NCT01321723|9829997|FG001|STARTED|Overall Study||33
8779725|NCT01321723|9829998|FG002|STARTED|Overall Study||32
8779726|NCT01321723|9829996|FG000|COMPLETED|Overall Study||27
8779727|NCT01321723|9829997|FG001|COMPLETED|Overall Study||28
8779728|NCT01321723|9829998|FG002|COMPLETED|Overall Study||28
8779729|NCT01321723|9829996|FG000|NOT COMPLETED|Overall Study||5
8779730|NCT01321723|9829997|FG001|NOT COMPLETED|Overall Study||5
8779731|NCT01321723|9829998|FG002|NOT COMPLETED|Overall Study||4
8779732|NCT01321749|9830008|FG000|STARTED|Overall Study||51
8779733|NCT01321749|9830009|FG001|STARTED|Overall Study||52
8779734|NCT01321749|9830008|FG000|COMPLETED|Overall Study||38
8779735|NCT01321749|9830009|FG001|COMPLETED|Overall Study||30
8779736|NCT01321749|9830008|FG000|NOT COMPLETED|Overall Study||13
9029951|NCT03226366|10092380|FG000|NOT COMPLETED|Overall Study||0
9029952|NCT03226366|10092381|FG001|NOT COMPLETED|Overall Study||0
9029953|NCT03226366|10092382|FG002|NOT COMPLETED|Overall Study||0
8671644|NCT00753142|9715050|FG002|STARTED|Overall Study||13
8671645|NCT00753142|9715048|FG000|COMPLETED|Overall Study||8
8779737|NCT01321749|9830009|FG001|NOT COMPLETED|Overall Study||22
8671646|NCT00753142|9715049|FG001|COMPLETED|Overall Study||7
8671647|NCT00753142|9715050|FG002|COMPLETED|Overall Study||13
8671648|NCT00753142|9715048|FG000|NOT COMPLETED|Overall Study||0
8671649|NCT00753142|9715049|FG001|NOT COMPLETED|Overall Study||0
8671650|NCT00753142|9715050|FG002|NOT COMPLETED|Overall Study||0
8671651|NCT00753220|9715058|FG000|STARTED|Overall Study||7
8671652|NCT00753220|9715058|FG000|COMPLETED|Overall Study||2
8671653|NCT00753220|9715058|FG000|NOT COMPLETED|Overall Study||5
8671654|NCT00753272|9715064|FG000|STARTED|Overall Study||21893
8671655|NCT00753272|9715065|FG001|STARTED|Overall Study||21802
8671656|NCT00753272|9715064|FG000|COMPLETED|Overall Study||16911
8671657|NCT00753272|9715065|FG001|COMPLETED|Overall Study||16895
8671658|NCT00753272|9715064|FG000|NOT COMPLETED|Overall Study||4982
8779738|NCT01321879|9830015|FG000|STARTED|Overall Study||39
8779739|NCT01321879|9830015|FG000|COMPLETED|Overall Study||25
8779740|NCT01321879|9830015|FG000|NOT COMPLETED|Overall Study||14
8779741|NCT01322009|9830021|FG000|STARTED|Overall Study||7
8779742|NCT01322009|9830022|FG001|STARTED|Overall Study||7
9029954|NCT03226366|10092383|FG003|NOT COMPLETED|Overall Study||0
8779743|NCT01322009|9830021|FG000|COMPLETED|Overall Study||7
8779744|NCT01322009|9830022|FG001|COMPLETED|Overall Study||4
8779745|NCT01322009|9830021|FG000|NOT COMPLETED|Overall Study||0
8779746|NCT01322009|9830022|FG001|NOT COMPLETED|Overall Study||3
8779747|NCT01322022|9830030|FG000|STARTED|Overall Study||20
8779748|NCT01322022|9830031|FG001|STARTED|Overall Study||20
8779749|NCT01322022|9830030|FG000|Week 4|Overall Study||15
8779750|NCT01322022|9830031|FG001|Week 4|Overall Study||18
8779751|NCT01322022|9830030|FG000|COMPLETED|Overall Study||15
8779752|NCT01322022|9830031|FG001|COMPLETED|Overall Study||18
8779753|NCT01322022|9830030|FG000|NOT COMPLETED|Overall Study||5
8779754|NCT01322022|9830031|FG001|NOT COMPLETED|Overall Study||2
8779755|NCT01322048|9830039|FG000|STARTED|Overall Study||21
8779756|NCT01322048|9830040|FG001|STARTED|Overall Study||26
8779757|NCT01322048|9830039|FG000|COMPLETED|Overall Study||21
8779758|NCT01322048|9830040|FG001|COMPLETED|Overall Study||26
8779759|NCT01322048|9830039|FG000|NOT COMPLETED|Overall Study||0
8779760|NCT01322048|9830040|FG001|NOT COMPLETED|Overall Study||0
8779761|NCT01322347|9830048|FG000|STARTED|Overall Study||147
8779762|NCT01322347|9830049|FG001|STARTED|Overall Study||147
8779763|NCT01322347|9830048|FG000|Completed 48 Wks in St 2|Overall Study||28
8779764|NCT01322347|9830049|FG001|Completed 48 Wks in St 2|Overall Study||22
8779765|NCT01322347|9830048|FG000|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||68
8779766|NCT01322347|9830049|FG001|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||90
8779767|NCT01322347|9830048|FG000|Enrolled in St 3|Overall Study||101
8779768|NCT01322347|9830049|FG001|Enrolled in St 3|Overall Study||113
8779769|NCT01322347|9830048|FG000|Completed St 3|Overall Study||82
8779770|NCT01322347|9830049|FG001|Completed St 3|Overall Study||86
8779771|NCT01322347|9830048|FG000|COMPLETED|Overall Study||96
8779772|NCT01322347|9830049|FG001|COMPLETED|Overall Study||112
8779773|NCT01322347|9830048|FG000|NOT COMPLETED|Overall Study||51
8779774|NCT01322347|9830049|FG001|NOT COMPLETED|Overall Study||35
8779775|NCT01322360|9830056|FG000|STARTED|Overall Study||50
8779776|NCT01322360|9830056|FG000|COMPLETED|Overall Study||50
8779777|NCT01322360|9830056|FG000|NOT COMPLETED|Overall Study||0
8779778|NCT01322386|9830063|FG000|STARTED|Overall Study||10
8779779|NCT01322386|9830064|FG001|STARTED|Overall Study||11
8779780|NCT01322386|9830063|FG000|COMPLETED|Overall Study||10
8779781|NCT01322386|9830064|FG001|COMPLETED|Overall Study||9
8779782|NCT01322386|9830063|FG000|NOT COMPLETED|Overall Study||0
8779783|NCT01322386|9830064|FG001|NOT COMPLETED|Overall Study||2
8779784|NCT01322490|9830075|FG000|STARTED|Treatment Period||432
8779785|NCT01322490|9830076|FG001|STARTED|Treatment Period||432
8779786|NCT01322490|9830077|FG002|STARTED|Treatment Period||433
8779787|NCT01322490|9830075|FG000|Treated|Treatment Period||429
8779788|NCT01322490|9830076|FG001|Treated|Treatment Period||429
8779789|NCT01322490|9830077|FG002|Treated|Treatment Period||428
8779790|NCT01322490|9830075|FG000|COMPLETED|Treatment Period||300
8779791|NCT01322490|9830076|FG001|COMPLETED|Treatment Period||279
8779792|NCT01322490|9830077|FG002|COMPLETED|Treatment Period||280
8779793|NCT01322490|9830075|FG000|NOT COMPLETED|Treatment Period||132
8779794|NCT01322490|9830076|FG001|NOT COMPLETED|Treatment Period||153
8779795|NCT01322490|9830077|FG002|NOT COMPLETED|Treatment Period||153
8779796|NCT01322490|9830075|FG000|STARTED|Long Term Follow-up Period|You did not have to complete treatment to enter follow up.|409
8779797|NCT01322490|9830076|FG001|STARTED|Long Term Follow-up Period|You did not have to complete treatment to enter follow up.|408
8779798|NCT01322490|9830077|FG002|STARTED|Long Term Follow-up Period|You did not have to complete treatment to enter follow up.|413
8779799|NCT01322490|9830075|FG000|COMPLETED|Long Term Follow-up Period||0
8779800|NCT01322490|9830076|FG001|COMPLETED|Long Term Follow-up Period||0
8779801|NCT01322490|9830077|FG002|COMPLETED|Long Term Follow-up Period||0
8779802|NCT01322490|9830075|FG000|NOT COMPLETED|Long Term Follow-up Period||409
8779803|NCT01322490|9830076|FG001|NOT COMPLETED|Long Term Follow-up Period||408
8779804|NCT01322490|9830077|FG002|NOT COMPLETED|Long Term Follow-up Period||413
8779805|NCT01322594|9830091|FG000|STARTED|Overall Study|RANDOMIZED SUBJECTS THROUGH STUDY DAY 240-300|6
8779806|NCT01322594|9830092|FG001|STARTED|Overall Study||3
8779807|NCT01322594|9830093|FG002|STARTED|Overall Study||3
8779808|NCT01322594|9830094|FG003|STARTED|Overall Study||6
8779809|NCT01322594|9830095|FG004|STARTED|Overall Study||7
8779810|NCT01322594|9830096|FG005|STARTED|Overall Study||6
8779811|NCT01322594|9830091|FG000|COMPLETED|Overall Study||6
8779812|NCT01322594|9830092|FG001|COMPLETED|Overall Study||3
8779813|NCT01322594|9830093|FG002|COMPLETED|Overall Study||3
8779814|NCT01322594|9830094|FG003|COMPLETED|Overall Study||6
8779815|NCT01322594|9830095|FG004|COMPLETED|Overall Study||7
8779816|NCT01322594|9830096|FG005|COMPLETED|Overall Study||6
8779817|NCT01322594|9830091|FG000|NOT COMPLETED|Overall Study||0
8779818|NCT01322594|9830092|FG001|NOT COMPLETED|Overall Study||0
8779819|NCT01322594|9830093|FG002|NOT COMPLETED|Overall Study||0
8779820|NCT01322594|9830094|FG003|NOT COMPLETED|Overall Study||0
8779821|NCT01322594|9830095|FG004|NOT COMPLETED|Overall Study||0
8779822|NCT01322594|9830096|FG005|NOT COMPLETED|Overall Study||0
8779823|NCT01322607|9830112|FG000|STARTED|Overall Study||11
8779824|NCT01322607|9830113|FG001|STARTED|Overall Study||9
8779825|NCT01322607|9830112|FG000|COMPLETED|Overall Study||10
8779826|NCT01322607|9830113|FG001|COMPLETED|Overall Study||9
8779827|NCT01322607|9830112|FG000|NOT COMPLETED|Overall Study||1
8779828|NCT01322607|9830113|FG001|NOT COMPLETED|Overall Study||0
8779829|NCT01322633|9830121|FG000|STARTED|Overall Study||34178
8779830|NCT01322633|9830122|FG001|STARTED|Overall Study||27686
8779831|NCT01322633|9830121|FG000|COMPLETED|Overall Study||34178
8779832|NCT01322633|9830122|FG001|COMPLETED|Overall Study||27686
8779833|NCT01322633|9830121|FG000|NOT COMPLETED|Overall Study||0
8779834|NCT01322633|9830122|FG001|NOT COMPLETED|Overall Study||0
8779835|NCT01322815|9830130|FG000|STARTED|Overall Study||7
8779836|NCT01322815|9830131|FG001|STARTED|Overall Study||4
8779837|NCT01322815|9830130|FG000|COMPLETED|Overall Study||7
8779838|NCT01322815|9830131|FG001|COMPLETED|Overall Study||4
8779839|NCT01322815|9830130|FG000|NOT COMPLETED|Overall Study||0
8779840|NCT01322815|9830131|FG001|NOT COMPLETED|Overall Study||0
8779841|NCT01322841|9830139|FG000|STARTED|Overall Study||1116
8779842|NCT01322841|9830140|FG001|STARTED|Overall Study||1123
8779843|NCT01322841|9830139|FG000|COMPLETED|Overall Study||1116
8779844|NCT01322841|9830140|FG001|COMPLETED|Overall Study||1123
8779845|NCT01322841|9830139|FG000|NOT COMPLETED|Overall Study||0
8779846|NCT01322841|9830140|FG001|NOT COMPLETED|Overall Study||0
8779847|NCT01322945|9830148|FG000|STARTED|Overall Study||52
8779848|NCT01322945|9830149|FG001|STARTED|Overall Study||42
8779849|NCT01322945|9830148|FG000|COMPLETED|Overall Study||52
8779850|NCT01322945|9830149|FG001|COMPLETED|Overall Study||42
8779851|NCT01322945|9830148|FG000|NOT COMPLETED|Overall Study||0
8779852|NCT01322945|9830149|FG001|NOT COMPLETED|Overall Study||0
8779853|NCT01323010|9830159|FG000|STARTED|Overall Study||60
8779854|NCT01323010|9830160|FG001|STARTED|Overall Study||59
8779855|NCT01323010|9830159|FG000|COMPLETED|Overall Study||60
8779856|NCT01323010|9830160|FG001|COMPLETED|Overall Study||59
8779857|NCT01323010|9830159|FG000|NOT COMPLETED|Overall Study||0
8779858|NCT01323010|9830160|FG001|NOT COMPLETED|Overall Study||0
8779859|NCT01323140|9830178|FG000|STARTED|Overall Study||40
8779860|NCT01323140|9830178|FG000|COMPLETED|Overall Study||38
8779861|NCT01323140|9830178|FG000|NOT COMPLETED|Overall Study||2
8779862|NCT01323153|9830184|FG000|STARTED|Overall Study||150
8779863|NCT01323153|9830185|FG001|STARTED|Overall Study||150
8779864|NCT01323153|9830184|FG000|COMPLETED|Overall Study||133
8779865|NCT01323153|9830185|FG001|COMPLETED|Overall Study||142
8779866|NCT01323153|9830184|FG000|NOT COMPLETED|Overall Study||17
8779867|NCT01323153|9830185|FG001|NOT COMPLETED|Overall Study||8
8808953|NCT01493947|9861331|FG001|NOT COMPLETED|Period B Extension Period||32
8808954|NCT01493960|9861342|FG000|STARTED|Overall Study||87
8808955|NCT01493960|9861343|FG001|STARTED|Overall Study||44
8808956|NCT01493960|9861342|FG000|Received Study Drug|Overall Study||87
8808957|NCT01493960|9861343|FG001|Received Study Drug|Overall Study||43
8808958|NCT01493960|9861342|FG000|COMPLETED|Overall Study||55
8808959|NCT01493960|9861343|FG001|COMPLETED|Overall Study||26
8808960|NCT01493960|9861342|FG000|NOT COMPLETED|Overall Study||32
8808961|NCT01493960|9861343|FG001|NOT COMPLETED|Overall Study||18
8808962|NCT01494038|9861351|FG000|STARTED|Overall Study||477
8808963|NCT01494038|9861352|FG001|STARTED|Overall Study||479
8808964|NCT01494038|9861351|FG000|COMPLETED|Overall Study||389
8808965|NCT01494038|9861352|FG001|COMPLETED|Overall Study||396
8808966|NCT01494038|9861351|FG000|NOT COMPLETED|Overall Study||88
8808967|NCT01494038|9861352|FG001|NOT COMPLETED|Overall Study||83
8808968|NCT01494051|9861375|FG000|STARTED|Overall Study||6
8808969|NCT01494051|9861376|FG001|STARTED|Overall Study||7
8808970|NCT01494051|9861375|FG000|COMPLETED|Overall Study||6
8808971|NCT01494051|9861376|FG001|COMPLETED|Overall Study||7
8808972|NCT01494051|9861375|FG000|NOT COMPLETED|Overall Study||0
8808973|NCT01494051|9861376|FG001|NOT COMPLETED|Overall Study||0
8808974|NCT01494298|9861384|FG000|STARTED|Overall Study||56
8808975|NCT01494298|9861385|FG001|STARTED|Overall Study||55
8808976|NCT01494298|9861384|FG000|COMPLETED|Overall Study||54
8808977|NCT01494298|9861385|FG001|COMPLETED|Overall Study||47
8808978|NCT01494298|9861384|FG000|NOT COMPLETED|Overall Study||2
8808979|NCT01494298|9861385|FG001|NOT COMPLETED|Overall Study||8
8808980|NCT01494350|9861393|FG000|STARTED|Overall Study||50
8808981|NCT01494350|9861393|FG000|COMPLETED|Overall Study||49
8808982|NCT01494350|9861393|FG000|NOT COMPLETED|Overall Study||1
8808983|NCT01494467|9861399|FG000|STARTED|Part A Vehicle Control (12 Weeks)||459
8808984|NCT01494467|9861400|FG001|STARTED|Part A Vehicle Control (12 Weeks)||229
8808985|NCT01494467|9861399|FG000|COMPLETED|Part A Vehicle Control (12 Weeks)||429
8808986|NCT01494467|9861400|FG001|COMPLETED|Part A Vehicle Control (12 Weeks)||208
8808987|NCT01494467|9861399|FG000|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||30
8808988|NCT01494467|9861400|FG001|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||21
8808989|NCT01494467|9861399|FG000|STARTED|Part B Long Term Active Control 40 Weeks|429 completed Part A. Subsequently, one subject discontinued so only 428 entered Part B|428
8808990|NCT01494467|9861400|FG001|STARTED|Part B Long Term Active Control 40 Weeks||208
8808991|NCT01494467|9861399|FG000|COMPLETED|Part B Long Term Active Control 40 Weeks||353
8808992|NCT01494467|9861400|FG001|COMPLETED|Part B Long Term Active Control 40 Weeks||159
8808993|NCT01494467|9861399|FG000|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||75
8808994|NCT01494467|9861400|FG001|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||49
8808995|NCT01494467|9861399|FG000|STARTED|Part C Safety Follow up (4 Weeks)||353
8808996|NCT01494467|9861400|FG001|STARTED|Part C Safety Follow up (4 Weeks)||159
8808997|NCT01494467|9861399|FG000|COMPLETED|Part C Safety Follow up (4 Weeks)||353
8808998|NCT01494467|9861400|FG001|COMPLETED|Part C Safety Follow up (4 Weeks)||159
8808999|NCT01494467|9861399|FG000|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||0
8809000|NCT01494467|9861400|FG001|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||0
8809001|NCT01494506|9861415|FG000|STARTED|Overall Study|Started = Intent to Treat Population and includes all randomized participants|151
8809002|NCT01494506|9861416|FG001|STARTED|Overall Study||149
8779868|NCT01323192|9830193|FG000|STARTED|Overall Study||143
8779869|NCT01323192|9830194|FG001|STARTED|Overall Study||141
8779870|NCT01323192|9830193|FG000|COMPLETED|Overall Study||134
8779871|NCT01323192|9830194|FG001|COMPLETED|Overall Study||135
8779872|NCT01323192|9830193|FG000|NOT COMPLETED|Overall Study||9
8779873|NCT01323192|9830194|FG001|NOT COMPLETED|Overall Study||6
8779874|NCT01323270|9830202|FG000|STARTED|Overall Study||373
8779875|NCT01323270|9830203|FG001|STARTED|Overall Study||376
8779876|NCT01323270|9830202|FG000|COMPLETED|Overall Study||330
8779877|NCT01323270|9830203|FG001|COMPLETED|Overall Study||347
8779878|NCT01323270|9830202|FG000|NOT COMPLETED|Overall Study||43
8779879|NCT01323270|9830203|FG001|NOT COMPLETED|Overall Study||29
8779880|NCT01323387|9830210|FG000|STARTED|Overall Study||178
8779881|NCT01323387|9830210|FG000|COMPLETED|Overall Study||94
8779882|NCT01323387|9830210|FG000|NOT COMPLETED|Overall Study||84
8779883|NCT01323478|9830216|FG000|STARTED|Overall Study||71
8779884|NCT01323478|9830216|FG000|COMPLETED|Overall Study||47
8779885|NCT01323478|9830216|FG000|NOT COMPLETED|Overall Study||24
8779886|NCT01323517|9830220|FG000|STARTED|Overall Study||26
8779887|NCT01323517|9830220|FG000|COMPLETED|Overall Study||26
8779888|NCT01323517|9830220|FG000|NOT COMPLETED|Overall Study||0
8779889|NCT01323530|9830231|FG000|STARTED|Phase 1b (Dose Escalation Phase)||8
8779890|NCT01323530|9830232|FG001|STARTED|Phase 1b (Dose Escalation Phase)||6
8779891|NCT01323530|9830233|FG002|STARTED|Phase 1b (Dose Escalation Phase)||5
8779892|NCT01323530|9830234|FG003|STARTED|Phase 1b (Dose Escalation Phase)||3
8779893|NCT01323530|9830235|FG004|STARTED|Phase 1b (Dose Escalation Phase)||6
8779894|NCT01323530|9830236|FG005|STARTED|Phase 1b (Dose Escalation Phase)||6
8779895|NCT01323530|9830237|FG006|STARTED|Phase 1b (Dose Escalation Phase)||0
8779896|NCT01323530|9830231|FG000|COMPLETED|Phase 1b (Dose Escalation Phase)||5
8779897|NCT01323530|9830232|FG001|COMPLETED|Phase 1b (Dose Escalation Phase)||4
8779898|NCT01323530|9830233|FG002|COMPLETED|Phase 1b (Dose Escalation Phase)||4
8779899|NCT01323530|9830234|FG003|COMPLETED|Phase 1b (Dose Escalation Phase)||3
8779900|NCT01323530|9830235|FG004|COMPLETED|Phase 1b (Dose Escalation Phase)||3
8779901|NCT01323530|9830236|FG005|COMPLETED|Phase 1b (Dose Escalation Phase)||3
8779902|NCT01323530|9830237|FG006|COMPLETED|Phase 1b (Dose Escalation Phase)||0
8779903|NCT01323530|9830231|FG000|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||3
8779904|NCT01323530|9830232|FG001|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||2
8779905|NCT01323530|9830233|FG002|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||1
8779906|NCT01323530|9830234|FG003|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||0
8779907|NCT01323530|9830235|FG004|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||3
8779908|NCT01323530|9830236|FG005|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||3
8779909|NCT01323530|9830237|FG006|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||0
8779910|NCT01323530|9830231|FG000|STARTED|Phase 2 (Dose-confirmation Phase)||0
8779911|NCT01323530|9830232|FG001|STARTED|Phase 2 (Dose-confirmation Phase)||0
8779912|NCT01323530|9830233|FG002|STARTED|Phase 2 (Dose-confirmation Phase)||0
8779913|NCT01323530|9830234|FG003|STARTED|Phase 2 (Dose-confirmation Phase)||0
8779914|NCT01323530|9830235|FG004|STARTED|Phase 2 (Dose-confirmation Phase)||0
8779915|NCT01323530|9830236|FG005|STARTED|Phase 2 (Dose-confirmation Phase)||0
8779916|NCT01323530|9830237|FG006|STARTED|Phase 2 (Dose-confirmation Phase)||42
8779917|NCT01323530|9830231|FG000|COMPLETED|Phase 2 (Dose-confirmation Phase)||0
8779918|NCT01323530|9830232|FG001|COMPLETED|Phase 2 (Dose-confirmation Phase)||0
8779919|NCT01323530|9830233|FG002|COMPLETED|Phase 2 (Dose-confirmation Phase)||0
8779920|NCT01323530|9830234|FG003|COMPLETED|Phase 2 (Dose-confirmation Phase)||0
8779921|NCT01323530|9830235|FG004|COMPLETED|Phase 2 (Dose-confirmation Phase)||0
8779922|NCT01323530|9830236|FG005|COMPLETED|Phase 2 (Dose-confirmation Phase)||0
8779923|NCT01323530|9830237|FG006|COMPLETED|Phase 2 (Dose-confirmation Phase)||25
8779924|NCT01323530|9830231|FG000|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0
8779925|NCT01323530|9830232|FG001|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0
8779926|NCT01323530|9830233|FG002|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0
8779927|NCT01323530|9830234|FG003|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0
8779928|NCT01323530|9830235|FG004|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0
8779929|NCT01323530|9830236|FG005|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0
8779930|NCT01323530|9830237|FG006|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||17
8779931|NCT01323582|9830256|FG000|STARTED|Weeks 1-4 (First Period)||12
8779932|NCT01323582|9830257|FG001|STARTED|Weeks 1-4 (First Period)||14
8779933|NCT01323582|9830256|FG000|COMPLETED|Weeks 1-4 (First Period)||10
8779934|NCT01323582|9830257|FG001|COMPLETED|Weeks 1-4 (First Period)||12
8779935|NCT01323582|9830256|FG000|NOT COMPLETED|Weeks 1-4 (First Period)||2
8779936|NCT01323582|9830257|FG001|NOT COMPLETED|Weeks 1-4 (First Period)||2
8779937|NCT01323582|9830256|FG000|STARTED|Weeks 5-7 (Washout)||10
8779938|NCT01323582|9830257|FG001|STARTED|Weeks 5-7 (Washout)||12
8779939|NCT01323582|9830256|FG000|COMPLETED|Weeks 5-7 (Washout)||10
8779940|NCT01323582|9830257|FG001|COMPLETED|Weeks 5-7 (Washout)||11
8779941|NCT01323582|9830256|FG000|NOT COMPLETED|Weeks 5-7 (Washout)||0
8779942|NCT01323582|9830257|FG001|NOT COMPLETED|Weeks 5-7 (Washout)||1
8779943|NCT01323582|9830256|FG000|STARTED|Weeks 8-11 (Period 2)||10
8779944|NCT01323582|9830257|FG001|STARTED|Weeks 8-11 (Period 2)||11
8779945|NCT01323582|9830256|FG000|COMPLETED|Weeks 8-11 (Period 2)||10
8779946|NCT01323582|9830257|FG001|COMPLETED|Weeks 8-11 (Period 2)||10
8779947|NCT01323582|9830256|FG000|NOT COMPLETED|Weeks 8-11 (Period 2)||0
8779948|NCT01323582|9830257|FG001|NOT COMPLETED|Weeks 8-11 (Period 2)||1
8779949|NCT01323595|9830267|FG000|STARTED|Overall Study||39
8779950|NCT01323595|9830268|FG001|STARTED|Overall Study||39
8779951|NCT01323595|9830267|FG000|COMPLETED|Overall Study|Remaining subjects did not return questionnaire|16
8779952|NCT01323595|9830268|FG001|COMPLETED|Overall Study|Remaining subjects did not return questionaire|18
8779953|NCT01323595|9830267|FG000|NOT COMPLETED|Overall Study||23
8779954|NCT01323595|9830268|FG001|NOT COMPLETED|Overall Study||21
8779955|NCT01323621|9830278|FG000|STARTED|2-week, Single-blind Run In Period||739
8779956|NCT01323621|9830279|FG001|STARTED|2-week, Single-blind Run In Period||0
8779957|NCT01323621|9830280|FG002|STARTED|2-week, Single-blind Run In Period||0
8779958|NCT01323621|9830278|FG000|COMPLETED|2-week, Single-blind Run In Period||511
8779959|NCT01323621|9830279|FG001|COMPLETED|2-week, Single-blind Run In Period||0
8779960|NCT01323621|9830280|FG002|COMPLETED|2-week, Single-blind Run In Period||0
8779961|NCT01323621|9830278|FG000|NOT COMPLETED|2-week, Single-blind Run In Period||228
8779962|NCT01323621|9830279|FG001|NOT COMPLETED|2-week, Single-blind Run In Period||0
8779963|NCT01323621|9830280|FG002|NOT COMPLETED|2-week, Single-blind Run In Period||0
8779964|NCT01323621|9830278|FG000|STARTED|12-week, Double-blind Treatment Period||0
8779965|NCT01323621|9830279|FG001|STARTED|12-week, Double-blind Treatment Period||252
8779966|NCT01323621|9830280|FG002|STARTED|12-week, Double-blind Treatment Period||259
8779967|NCT01323621|9830278|FG000|COMPLETED|12-week, Double-blind Treatment Period||0
8779968|NCT01323621|9830279|FG001|COMPLETED|12-week, Double-blind Treatment Period||237
8779969|NCT01323621|9830280|FG002|COMPLETED|12-week, Double-blind Treatment Period||239
8779970|NCT01323621|9830278|FG000|NOT COMPLETED|12-week, Double-blind Treatment Period||0
8779971|NCT01323621|9830279|FG001|NOT COMPLETED|12-week, Double-blind Treatment Period||15
8779972|NCT01323621|9830280|FG002|NOT COMPLETED|12-week, Double-blind Treatment Period||20
8779973|NCT01323634|9830288|FG000|STARTED|2-week Run-in Period||733
8779974|NCT01323634|9830289|FG001|STARTED|2-week Run-in Period||0
8779975|NCT01323634|9830290|FG002|STARTED|2-week Run-in Period||0
8779976|NCT01323634|9830288|FG000|COMPLETED|2-week Run-in Period||521
8779977|NCT01323634|9830289|FG001|COMPLETED|2-week Run-in Period||0
8779978|NCT01323634|9830290|FG002|COMPLETED|2-week Run-in Period||0
8779979|NCT01323634|9830288|FG000|NOT COMPLETED|2-week Run-in Period||212
8779980|NCT01323634|9830289|FG001|NOT COMPLETED|2-week Run-in Period||0
8779981|NCT01323634|9830290|FG002|NOT COMPLETED|2-week Run-in Period||0
8779982|NCT01323634|9830288|FG000|STARTED|Double-Blind (DB) Treatment Period||0
8779983|NCT01323634|9830289|FG001|STARTED|Double-Blind (DB) Treatment Period||260
8779984|NCT01323634|9830290|FG002|STARTED|Double-Blind (DB) Treatment Period||261
8779985|NCT01323634|9830288|FG000|COMPLETED|Double-Blind (DB) Treatment Period||0
8779986|NCT01323634|9830289|FG001|COMPLETED|Double-Blind (DB) Treatment Period||235
8779987|NCT01323634|9830290|FG002|COMPLETED|Double-Blind (DB) Treatment Period||239
8779988|NCT01323634|9830288|FG000|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
8779989|NCT01323634|9830289|FG001|NOT COMPLETED|Double-Blind (DB) Treatment Period||25
8779990|NCT01323634|9830290|FG002|NOT COMPLETED|Double-Blind (DB) Treatment Period||22
8779991|NCT01323647|9830298|FG000|STARTED|Overall Study||470
8779992|NCT01323647|9830299|FG001|STARTED|Overall Study||487
8779993|NCT01323647|9830298|FG000|COMPLETED|Overall Study||461
8779994|NCT01323647|9830299|FG001|COMPLETED|Overall Study||487
8779995|NCT01323647|9830298|FG000|NOT COMPLETED|Overall Study||9
8779996|NCT01323647|9830299|FG001|NOT COMPLETED|Overall Study||0
8779997|NCT01323660|9830305|FG000|STARTED|Treatment Period 1 (12 Weeks)||84
8779998|NCT01323660|9830306|FG001|STARTED|Treatment Period 1 (12 Weeks)||22
8779999|NCT01323660|9830307|FG002|STARTED|Treatment Period 1 (12 Weeks)||24
8780000|NCT01323660|9830308|FG003|STARTED|Treatment Period 1 (12 Weeks)||36
8780001|NCT01323660|9830309|FG004|STARTED|Treatment Period 1 (12 Weeks)||71
8780002|NCT01323660|9830310|FG005|STARTED|Treatment Period 1 (12 Weeks)||70
8780003|NCT01323660|9830305|FG000|COMPLETED|Treatment Period 1 (12 Weeks)||65
8780004|NCT01323660|9830306|FG001|COMPLETED|Treatment Period 1 (12 Weeks)||21
8780005|NCT01323660|9830307|FG002|COMPLETED|Treatment Period 1 (12 Weeks)||19
8780006|NCT01323660|9830308|FG003|COMPLETED|Treatment Period 1 (12 Weeks)||31
8780007|NCT01323660|9830309|FG004|COMPLETED|Treatment Period 1 (12 Weeks)||61
8780008|NCT01323660|9830310|FG005|COMPLETED|Treatment Period 1 (12 Weeks)||61
8780009|NCT01323660|9830305|FG000|NOT COMPLETED|Treatment Period 1 (12 Weeks)||19
8780010|NCT01323660|9830306|FG001|NOT COMPLETED|Treatment Period 1 (12 Weeks)||1
8780011|NCT01323660|9830307|FG002|NOT COMPLETED|Treatment Period 1 (12 Weeks)||5
8780012|NCT01323660|9830308|FG003|NOT COMPLETED|Treatment Period 1 (12 Weeks)||5
8780013|NCT01323660|9830309|FG004|NOT COMPLETED|Treatment Period 1 (12 Weeks)||10
8780014|NCT01323660|9830310|FG005|NOT COMPLETED|Treatment Period 1 (12 Weeks)||9
8780015|NCT01323660|9830305|FG000|STARTED|Washout Period (14 Days)||65
8780016|NCT01323660|9830306|FG001|STARTED|Washout Period (14 Days)||21
8780017|NCT01323660|9830307|FG002|STARTED|Washout Period (14 Days)||19
8780018|NCT01323660|9830308|FG003|STARTED|Washout Period (14 Days)||31
8780019|NCT01323660|9830309|FG004|STARTED|Washout Period (14 Days)||61
8780020|NCT01323660|9830310|FG005|STARTED|Washout Period (14 Days)||61
8780021|NCT01323660|9830305|FG000|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|65
8780022|NCT01323660|9830306|FG001|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|21
8780023|NCT01323660|9830307|FG002|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|18
8780024|NCT01323660|9830308|FG003|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|28
8780025|NCT01323660|9830309|FG004|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|58
8780026|NCT01323660|9830310|FG005|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|59
8780027|NCT01323660|9830305|FG000|NOT COMPLETED|Washout Period (14 Days)||0
8780028|NCT01323660|9830306|FG001|NOT COMPLETED|Washout Period (14 Days)||0
8780029|NCT01323660|9830307|FG002|NOT COMPLETED|Washout Period (14 Days)||1
8780030|NCT01323660|9830308|FG003|NOT COMPLETED|Washout Period (14 Days)||3
8780031|NCT01323660|9830309|FG004|NOT COMPLETED|Washout Period (14 Days)||3
8780032|NCT01323660|9830310|FG005|NOT COMPLETED|Washout Period (14 Days)||2
8780033|NCT01323660|9830305|FG000|STARTED|Treatment Period 2 (12 Weeks)|"By crossover design, participants were assigned to a different treatment arm in each period."|67
8780034|NCT01323660|9830306|FG001|STARTED|Treatment Period 2 (12 Weeks)|"By crossover design, participants were assigned to a different treatment arm in each period."|18
8780035|NCT01323660|9830307|FG002|STARTED|Treatment Period 2 (12 Weeks)|"By crossover design, participants were assigned to a different treatment arm in each period."|17
8780036|NCT01323660|9830308|FG003|STARTED|Treatment Period 2 (12 Weeks)|"By crossover design, participants were assigned to a different treatment arm in each period."|28
8780037|NCT01323660|9830309|FG004|STARTED|Treatment Period 2 (12 Weeks)|"By crossover design, participants were assigned to a different treatment arm in each period."|59
8780038|NCT01323660|9830310|FG005|STARTED|Treatment Period 2 (12 Weeks)|"By crossover design, participants were assigned to a different treatment arm in each period."|58
8780039|NCT01323660|9830305|FG000|COMPLETED|Treatment Period 2 (12 Weeks)||55
8780040|NCT01323660|9830306|FG001|COMPLETED|Treatment Period 2 (12 Weeks)||17
8780041|NCT01323660|9830307|FG002|COMPLETED|Treatment Period 2 (12 Weeks)||14
8780042|NCT01323660|9830308|FG003|COMPLETED|Treatment Period 2 (12 Weeks)||25
8780043|NCT01323660|9830309|FG004|COMPLETED|Treatment Period 2 (12 Weeks)||55
8780044|NCT01323660|9830310|FG005|COMPLETED|Treatment Period 2 (12 Weeks)||51
8780045|NCT01323660|9830305|FG000|NOT COMPLETED|Treatment Period 2 (12 Weeks)||12
8780046|NCT01323660|9830306|FG001|NOT COMPLETED|Treatment Period 2 (12 Weeks)||1
8780047|NCT01323660|9830307|FG002|NOT COMPLETED|Treatment Period 2 (12 Weeks)||3
8780048|NCT01323660|9830308|FG003|NOT COMPLETED|Treatment Period 2 (12 Weeks)||3
8780049|NCT01323660|9830309|FG004|NOT COMPLETED|Treatment Period 2 (12 Weeks)||4
8780050|NCT01323660|9830310|FG005|NOT COMPLETED|Treatment Period 2 (12 Weeks)||7
8780051|NCT01323673|9830326|FG000|STARTED|Overall Study||62
8780052|NCT01323673|9830327|FG001|STARTED|Overall Study||63
8780053|NCT01323673|9830326|FG000|COMPLETED|Overall Study||59
8780054|NCT01323673|9830327|FG001|COMPLETED|Overall Study||58
8780055|NCT01323673|9830326|FG000|NOT COMPLETED|Overall Study||3
8780056|NCT01323673|9830327|FG001|NOT COMPLETED|Overall Study||5
8780057|NCT01323777|9830333|FG000|STARTED|Overall Study||65
8780058|NCT01323777|9830333|FG000|COMPLETED|Overall Study||65
8780059|NCT01323777|9830333|FG000|NOT COMPLETED|Overall Study||0
8780060|NCT01323790|9830347|FG000|STARTED|Overall Study||233
8780061|NCT01323790|9830348|FG001|STARTED|Overall Study||234
8780062|NCT01323790|9830349|FG002|STARTED|Overall Study||233
8780063|NCT01323790|9830347|FG000|COMPLETED|Overall Study||178
8780064|NCT01323790|9830348|FG001|COMPLETED|Overall Study||174
8780065|NCT01323790|9830349|FG002|COMPLETED|Overall Study||188
8780066|NCT01323790|9830347|FG000|NOT COMPLETED|Overall Study||55
8780067|NCT01323790|9830348|FG001|NOT COMPLETED|Overall Study||60
8780068|NCT01323790|9830349|FG002|NOT COMPLETED|Overall Study||45
8780069|NCT01323855|9830362|FG000|STARTED|Overall Study||9
8780070|NCT01323855|9830363|FG001|STARTED|Overall Study||9
8780071|NCT01323855|9830364|FG002|STARTED|Overall Study||8
8780072|NCT01323855|9830365|FG003|STARTED|Overall Study||9
8780073|NCT01323855|9830366|FG004|STARTED|Overall Study||11
8780074|NCT01323855|9830362|FG000|COMPLETED|Overall Study||9
8780075|NCT01323855|9830363|FG001|COMPLETED|Overall Study||9
8780076|NCT01323855|9830364|FG002|COMPLETED|Overall Study||8
8780077|NCT01323855|9830365|FG003|COMPLETED|Overall Study||9
8780078|NCT01323855|9830366|FG004|COMPLETED|Overall Study||11
8780079|NCT01323855|9830362|FG000|NOT COMPLETED|Overall Study||0
8780080|NCT01323855|9830363|FG001|NOT COMPLETED|Overall Study||0
8780081|NCT01323855|9830364|FG002|NOT COMPLETED|Overall Study||0
8780082|NCT01323855|9830365|FG003|NOT COMPLETED|Overall Study||0
8780083|NCT01323855|9830366|FG004|NOT COMPLETED|Overall Study||0
8780084|NCT01323920|9830378|FG000|STARTED|Overall Study||35
8780085|NCT01323920|9830378|FG000|COMPLETED|Overall Study||29
9029955|NCT03226392|10092395|FG000|STARTED|Overall Study||352
9029956|NCT03226392|10092396|FG001|STARTED|Overall Study||352
9029957|NCT03226392|10092395|FG000|FAS|Overall Study||352
9029958|NCT03226392|10092396|FG001|FAS|Overall Study|"2 patients in the placebo were mis-randomized, not treated, not included due to technical problems"|350
9029959|NCT03226392|10092395|FG000|COMPLETED|Overall Study||341
9029960|NCT03226392|10092396|FG001|COMPLETED|Overall Study||344
9029961|NCT03226392|10092395|FG000|NOT COMPLETED|Overall Study||11
9029962|NCT03226392|10092396|FG001|NOT COMPLETED|Overall Study||8
9029963|NCT03226457|10092402|FG000|STARTED|Treatment 1: 6 Weeks||12
9029964|NCT03226457|10092403|FG001|STARTED|Treatment 1: 6 Weeks||11
9029965|NCT03226457|10092402|FG000|COMPLETED|Treatment 1: 6 Weeks||12
9029966|NCT03226457|10092403|FG001|COMPLETED|Treatment 1: 6 Weeks||11
9029967|NCT03226457|10092402|FG000|NOT COMPLETED|Treatment 1: 6 Weeks||0
9029968|NCT03226457|10092403|FG001|NOT COMPLETED|Treatment 1: 6 Weeks||0
9029969|NCT03226457|10092402|FG000|STARTED|Washout Period: Minimum 2 Weeks||12
9029970|NCT03226457|10092403|FG001|STARTED|Washout Period: Minimum 2 Weeks||11
9029971|NCT03226457|10092402|FG000|COMPLETED|Washout Period: Minimum 2 Weeks||12
8780086|NCT01323920|9830378|FG000|NOT COMPLETED|Overall Study||6
8780087|NCT01323946|9830385|FG000|STARTED|Overall Study||46
9029972|NCT03226457|10092403|FG001|COMPLETED|Washout Period: Minimum 2 Weeks||11
9029973|NCT03226457|10092402|FG000|NOT COMPLETED|Washout Period: Minimum 2 Weeks||0
9029974|NCT03226457|10092403|FG001|NOT COMPLETED|Washout Period: Minimum 2 Weeks||0
9029975|NCT03226457|10092402|FG000|STARTED|Treatment 2: 6 Weeks||12
9029976|NCT03226457|10092403|FG001|STARTED|Treatment 2: 6 Weeks||11
9029977|NCT03226457|10092402|FG000|COMPLETED|Treatment 2: 6 Weeks||12
9029978|NCT03226457|10092403|FG001|COMPLETED|Treatment 2: 6 Weeks||11
9029979|NCT03226457|10092402|FG000|NOT COMPLETED|Treatment 2: 6 Weeks||0
9029980|NCT03226457|10092403|FG001|NOT COMPLETED|Treatment 2: 6 Weeks||0
9029981|NCT03226652|10092409|FG000|STARTED|Overall Study||101
9029982|NCT03226652|10092409|FG000|COMPLETED|Overall Study||101
9029983|NCT03226652|10092409|FG000|NOT COMPLETED|Overall Study||0
9029984|NCT03226691|10092413|FG000|STARTED|Overall Study||15
9029985|NCT03226691|10092413|FG000|COMPLETED|Overall Study||15
9029986|NCT03226691|10092413|FG000|NOT COMPLETED|Overall Study||0
9029987|NCT03226769|10092419|FG000|STARTED|Overall Study||29
9029988|NCT03226769|10092420|FG001|STARTED|Overall Study||28
9029989|NCT03226769|10092419|FG000|COMPLETED|Overall Study||29
9029990|NCT03226769|10092420|FG001|COMPLETED|Overall Study||27
9029991|NCT03226769|10092419|FG000|NOT COMPLETED|Overall Study||0
9029992|NCT03226769|10092420|FG001|NOT COMPLETED|Overall Study||1
9029993|NCT03226899|10092428|FG000|STARTED|Overall Study||118
9029994|NCT03226899|10092429|FG001|STARTED|Overall Study||124
9029995|NCT03226899|10092428|FG000|COMPLETED|Overall Study||0
9029996|NCT03226899|10092429|FG001|COMPLETED|Overall Study||0
9029997|NCT03226899|10092428|FG000|NOT COMPLETED|Overall Study||118
9029998|NCT03226899|10092429|FG001|NOT COMPLETED|Overall Study||124
9029999|NCT03227445|10092435|FG000|STARTED|Period 1 (28 Days)||60
9030000|NCT03227445|10092436|FG001|STARTED|Period 1 (28 Days)||59
9030001|NCT03227445|10092437|FG002|STARTED|Period 1 (28 Days)||60
9030002|NCT03227445|10092438|FG003|STARTED|Period 1 (28 Days)||60
9030003|NCT03227445|10092435|FG000|COMPLETED|Period 1 (28 Days)||58
9030004|NCT03227445|10092436|FG001|COMPLETED|Period 1 (28 Days)||57
9030005|NCT03227445|10092437|FG002|COMPLETED|Period 1 (28 Days)||59
9030006|NCT03227445|10092438|FG003|COMPLETED|Period 1 (28 Days)||58
9030007|NCT03227445|10092435|FG000|NOT COMPLETED|Period 1 (28 Days)||2
9030008|NCT03227445|10092436|FG001|NOT COMPLETED|Period 1 (28 Days)||2
9030009|NCT03227445|10092437|FG002|NOT COMPLETED|Period 1 (28 Days)||1
9030010|NCT03227445|10092438|FG003|NOT COMPLETED|Period 1 (28 Days)||2
9030011|NCT03227445|10092435|FG000|STARTED|Period 2 (28 Days)||58
9030012|NCT03227445|10092436|FG001|STARTED|Period 2 (28 Days)||57
9030013|NCT03227445|10092437|FG002|STARTED|Period 2 (28 Days)||59
9030014|NCT03227445|10092438|FG003|STARTED|Period 2 (28 Days)||58
9030015|NCT03227445|10092435|FG000|COMPLETED|Period 2 (28 Days)||57
9030016|NCT03227445|10092436|FG001|COMPLETED|Period 2 (28 Days)||56
9030017|NCT03227445|10092437|FG002|COMPLETED|Period 2 (28 Days)||57
8671659|NCT00753272|9715065|FG001|NOT COMPLETED|Overall Study||4907
8671660|NCT00753298|9715076|FG000|STARTED|Overall Study||97
8671661|NCT00753298|9715077|FG001|STARTED|Overall Study||98
8671662|NCT00753298|9715076|FG000|COMPLETED|Overall Study||89
8671663|NCT00753298|9715077|FG001|COMPLETED|Overall Study||94
8671664|NCT00753298|9715076|FG000|NOT COMPLETED|Overall Study||8
8671665|NCT00753298|9715077|FG001|NOT COMPLETED|Overall Study||4
8671666|NCT00753337|9715083|FG000|STARTED|Overall Study||123
8671667|NCT00753337|9715083|FG000|COMPLETED|Overall Study||123
8671668|NCT00753337|9715083|FG000|NOT COMPLETED|Overall Study||0
8671669|NCT00753363|9715090|FG000|STARTED|Overall Study||59
8671670|NCT00753363|9715091|FG001|STARTED|Overall Study||60
8671671|NCT00753363|9715090|FG000|COMPLETED|Overall Study||19
8671672|NCT00753363|9715091|FG001|COMPLETED|Overall Study||21
8671673|NCT00753363|9715090|FG000|NOT COMPLETED|Overall Study||40
8671674|NCT00753363|9715091|FG001|NOT COMPLETED|Overall Study||39
8671675|NCT00753415|9715102|FG000|STARTED|Part A||3
8671676|NCT00753415|9715103|FG001|STARTED|Part A||3
8671677|NCT00753415|9715104|FG002|STARTED|Part A||10
8671678|NCT00753415|9715105|FG003|STARTED|Part A||11
8671679|NCT00753415|9715106|FG004|STARTED|Part A||10
8671680|NCT00753415|9715107|FG005|STARTED|Part A||0
8671681|NCT00753415|9715108|FG006|STARTED|Part A||0
8671682|NCT00753415|9715109|FG007|STARTED|Part A||0
8671683|NCT00753415|9715110|FG008|STARTED|Part A||0
8671684|NCT00753415|9715111|FG009|STARTED|Part A||0
8671685|NCT00753415|9715102|FG000|COMPLETED|Part A||2
8671686|NCT00753415|9715103|FG001|COMPLETED|Part A||3
8671687|NCT00753415|9715104|FG002|COMPLETED|Part A||8
8671688|NCT00753415|9715105|FG003|COMPLETED|Part A||9
8671689|NCT00753415|9715106|FG004|COMPLETED|Part A||10
8671690|NCT00753415|9715107|FG005|COMPLETED|Part A||0
8671691|NCT00753415|9715108|FG006|COMPLETED|Part A||0
8671692|NCT00753415|9715109|FG007|COMPLETED|Part A||0
8671693|NCT00753415|9715110|FG008|COMPLETED|Part A||0
8671694|NCT00753415|9715111|FG009|COMPLETED|Part A||0
8671695|NCT00753415|9715102|FG000|NOT COMPLETED|Part A||1
8671696|NCT00753415|9715103|FG001|NOT COMPLETED|Part A||0
8671697|NCT00753415|9715104|FG002|NOT COMPLETED|Part A||2
8671698|NCT00753415|9715105|FG003|NOT COMPLETED|Part A||2
8671699|NCT00753415|9715106|FG004|NOT COMPLETED|Part A||0
8671700|NCT00753415|9715107|FG005|NOT COMPLETED|Part A||0
8671701|NCT00753415|9715108|FG006|NOT COMPLETED|Part A||0
8671702|NCT00753415|9715109|FG007|NOT COMPLETED|Part A||0
9030018|NCT03227445|10092438|FG003|COMPLETED|Period 2 (28 Days)||55
9030019|NCT03227445|10092435|FG000|NOT COMPLETED|Period 2 (28 Days)||1
9030020|NCT03227445|10092436|FG001|NOT COMPLETED|Period 2 (28 Days)||1
8780088|NCT01323946|9830386|FG001|STARTED|Overall Study||34
8780089|NCT01323946|9830387|FG002|STARTED|Overall Study||33
8780090|NCT01323946|9830385|FG000|COMPLETED|Overall Study||43
8780091|NCT01323946|9830386|FG001|COMPLETED|Overall Study||31
8780092|NCT01323946|9830387|FG002|COMPLETED|Overall Study||33
8780093|NCT01323946|9830385|FG000|NOT COMPLETED|Overall Study||3
8780094|NCT01323946|9830386|FG001|NOT COMPLETED|Overall Study||3
8780095|NCT01323946|9830387|FG002|NOT COMPLETED|Overall Study||0
8780096|NCT01323959|9830400|FG000|STARTED|Overall Study||67
8780097|NCT01323959|9830401|FG001|STARTED|Overall Study||72
8780098|NCT01323959|9830402|FG002|STARTED|Overall Study||72
8780099|NCT01323959|9830400|FG000|COMPLETED|Overall Study||67
8780100|NCT01323959|9830401|FG001|COMPLETED|Overall Study||72
8780101|NCT01323959|9830402|FG002|COMPLETED|Overall Study||72
8780102|NCT01323959|9830400|FG000|NOT COMPLETED|Overall Study||0
8780103|NCT01323959|9830401|FG001|NOT COMPLETED|Overall Study||0
8780104|NCT01323959|9830402|FG002|NOT COMPLETED|Overall Study||0
8780105|NCT01323972|9830414|FG000|STARTED|Overall Study||81
8780106|NCT01323972|9830415|FG001|STARTED|Overall Study||79
8780107|NCT01323972|9830416|FG002|STARTED|Overall Study||80
8780108|NCT01323972|9830417|FG003|STARTED|Overall Study||80
8780109|NCT01323972|9830414|FG000|COMPLETED|Overall Study||79
8780110|NCT01323972|9830415|FG001|COMPLETED|Overall Study||76
8780111|NCT01323972|9830416|FG002|COMPLETED|Overall Study||78
8780112|NCT01323972|9830417|FG003|COMPLETED|Overall Study||79
8780113|NCT01323972|9830414|FG000|NOT COMPLETED|Overall Study||2
8780114|NCT01323972|9830415|FG001|NOT COMPLETED|Overall Study||3
8780115|NCT01323972|9830416|FG002|NOT COMPLETED|Overall Study||2
8780116|NCT01323972|9830417|FG003|NOT COMPLETED|Overall Study||1
8780117|NCT01323998|9830434|FG000|STARTED|Overall Study||200631
8780118|NCT01323998|9830435|FG001|STARTED|Overall Study||18681
8780119|NCT01323998|9830436|FG002|STARTED|Overall Study||10294
8780120|NCT01323998|9830437|FG003|STARTED|Overall Study||12052
8780121|NCT01323998|9830438|FG004|STARTED|Overall Study||6735
8780122|NCT01323998|9830434|FG000|COMPLETED|Overall Study||200631
8780123|NCT01323998|9830435|FG001|COMPLETED|Overall Study||18681
8780124|NCT01323998|9830436|FG002|COMPLETED|Overall Study||10294
8780125|NCT01323998|9830437|FG003|COMPLETED|Overall Study||12052
8780126|NCT01323998|9830438|FG004|COMPLETED|Overall Study||6735
8780127|NCT01323998|9830434|FG000|NOT COMPLETED|Overall Study||0
8780128|NCT01323998|9830435|FG001|NOT COMPLETED|Overall Study||0
8780129|NCT01323998|9830436|FG002|NOT COMPLETED|Overall Study||0
8780130|NCT01323998|9830437|FG003|NOT COMPLETED|Overall Study||0
8780131|NCT01323998|9830438|FG004|NOT COMPLETED|Overall Study||0
8780132|NCT01324024|9830450|FG000|STARTED|First Intervention (4 Weeks)||18
8780133|NCT01324024|9830451|FG001|STARTED|First Intervention (4 Weeks)||17
8780134|NCT01324024|9830450|FG000|COMPLETED|First Intervention (4 Weeks)||18
8780135|NCT01324024|9830451|FG001|COMPLETED|First Intervention (4 Weeks)||17
8780136|NCT01324024|9830450|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0
8780137|NCT01324024|9830451|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0
8780138|NCT01324024|9830450|FG000|STARTED|Washout (2 Weeks)||18
8780139|NCT01324024|9830451|FG001|STARTED|Washout (2 Weeks)||17
8780140|NCT01324024|9830450|FG000|COMPLETED|Washout (2 Weeks)||18
8780141|NCT01324024|9830451|FG001|COMPLETED|Washout (2 Weeks)||17
8780142|NCT01324024|9830450|FG000|NOT COMPLETED|Washout (2 Weeks)||0
8780143|NCT01324024|9830451|FG001|NOT COMPLETED|Washout (2 Weeks)||0
8780144|NCT01324024|9830450|FG000|STARTED|Second Intervention (4 Weeks)||18
8780145|NCT01324024|9830451|FG001|STARTED|Second Intervention (4 Weeks)||17
8780146|NCT01324024|9830450|FG000|COMPLETED|Second Intervention (4 Weeks)||16
8780147|NCT01324024|9830451|FG001|COMPLETED|Second Intervention (4 Weeks)||16
8780148|NCT01324024|9830450|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||2
8780149|NCT01324024|9830451|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||1
8780150|NCT01324102|9830463|FG000|STARTED|Overall Study|Yoga groups 3 and 5 (not including pre-randomization group)|11
8780151|NCT01324102|9830464|FG001|STARTED|Overall Study|Yoga group 4 and 6|12
8780152|NCT01324102|9830463|FG000|COMPLETED|Overall Study||10
8780153|NCT01324102|9830464|FG001|COMPLETED|Overall Study||6
8780154|NCT01324102|9830463|FG000|NOT COMPLETED|Overall Study||1
8780155|NCT01324102|9830464|FG001|NOT COMPLETED|Overall Study||6
8780156|NCT01324128|9830473|FG000|STARTED|Stage 1||710
8780157|NCT01324128|9830474|FG001|STARTED|Stage 1||349
8780158|NCT01324128|9830475|FG002|STARTED|Stage 1||0
8780159|NCT01324128|9830476|FG003|STARTED|Stage 1||0
8780160|NCT01324128|9830473|FG000|COMPLETED|Stage 1||515
8780161|NCT01324128|9830474|FG001|COMPLETED|Stage 1||293
8780162|NCT01324128|9830475|FG002|COMPLETED|Stage 1||0
8780163|NCT01324128|9830476|FG003|COMPLETED|Stage 1||0
8780164|NCT01324128|9830473|FG000|NOT COMPLETED|Stage 1||195
8780165|NCT01324128|9830474|FG001|NOT COMPLETED|Stage 1||56
8916466|NCT02184208|9976073|FG000|NOT COMPLETED|Overall Study||56
8780166|NCT01324128|9830475|FG002|NOT COMPLETED|Stage 1||0
8780167|NCT01324128|9830476|FG003|NOT COMPLETED|Stage 1||0
8780168|NCT01324128|9830473|FG000|STARTED|Stage 2||0
8780169|NCT01324128|9830474|FG001|STARTED|Stage 2||0
8780170|NCT01324128|9830475|FG002|STARTED|Stage 2||50
8780171|NCT01324128|9830476|FG003|STARTED|Stage 2||49
8780172|NCT01324128|9830473|FG000|COMPLETED|Stage 2||0
8780173|NCT01324128|9830474|FG001|COMPLETED|Stage 2||0
8780174|NCT01324128|9830475|FG002|COMPLETED|Stage 2||42
8780175|NCT01324128|9830476|FG003|COMPLETED|Stage 2||46
8780176|NCT01324128|9830473|FG000|NOT COMPLETED|Stage 2||0
8780177|NCT01324128|9830474|FG001|NOT COMPLETED|Stage 2||0
8780178|NCT01324128|9830475|FG002|NOT COMPLETED|Stage 2||8
8780179|NCT01324128|9830476|FG003|NOT COMPLETED|Stage 2||3
8780180|NCT01324141|9830486|FG000|STARTED|Overall Study||6
8780181|NCT01324141|9830486|FG000|COMPLETED|Overall Study||4
8780182|NCT01324141|9830486|FG000|NOT COMPLETED|Overall Study||2
8780183|NCT01324232|9830504|FG000|STARTED|Overall Study||49
8780184|NCT01324232|9830505|FG001|STARTED|Overall Study||53
8780185|NCT01324232|9830506|FG002|STARTED|Overall Study||54
8780186|NCT01324232|9830507|FG003|STARTED|Overall Study||53
8780187|NCT01324232|9830504|FG000|COMPLETED|Overall Study||44
8780188|NCT01324232|9830505|FG001|COMPLETED|Overall Study||42
8780189|NCT01324232|9830506|FG002|COMPLETED|Overall Study||41
8780190|NCT01324232|9830507|FG003|COMPLETED|Overall Study||42
8780191|NCT01324232|9830504|FG000|NOT COMPLETED|Overall Study||5
8780192|NCT01324232|9830505|FG001|NOT COMPLETED|Overall Study||11
8780193|NCT01324232|9830506|FG002|NOT COMPLETED|Overall Study||13
8780194|NCT01324232|9830507|FG003|NOT COMPLETED|Overall Study||11
8780195|NCT01324271|9830522|FG000|STARTED|Overall Study||57
8780196|NCT01324271|9830523|FG001|STARTED|Overall Study||28
8780197|NCT01324271|9830522|FG000|COMPLETED|Overall Study||53
8780198|NCT01324271|9830523|FG001|COMPLETED|Overall Study||28
8780199|NCT01324271|9830522|FG000|NOT COMPLETED|Overall Study||4
8780200|NCT01324271|9830523|FG001|NOT COMPLETED|Overall Study||0
8780201|NCT01324310|9830529|FG000|STARTED|Overall Study||15
8780202|NCT01324310|9830529|FG000|COMPLETED|Overall Study||13
8780203|NCT01324310|9830529|FG000|NOT COMPLETED|Overall Study||2
8780204|NCT01324323|9830535|FG000|STARTED|Overall Study||14
8780205|NCT01324323|9830535|FG000|COMPLETED|Overall Study||13
8780206|NCT01324323|9830535|FG000|NOT COMPLETED|Overall Study||1
8780207|NCT01324349|9830549|FG000|STARTED|Overall Study||32
8780208|NCT01324349|9830550|FG001|STARTED|Overall Study||18
8780209|NCT01324349|9830549|FG000|COMPLETED|Overall Study||31
8780210|NCT01324349|9830550|FG001|COMPLETED|Overall Study||16
8780211|NCT01324349|9830549|FG000|NOT COMPLETED|Overall Study||1
8780212|NCT01324349|9830550|FG001|NOT COMPLETED|Overall Study||2
8780213|NCT01324388|9830559|FG000|STARTED|Part 1 of Study||23
8780214|NCT01324388|9830560|FG001|STARTED|Part 1 of Study||8
8780215|NCT01324388|9830561|FG002|STARTED|Part 1 of Study||0
8780216|NCT01324388|9830562|FG003|STARTED|Part 1 of Study||0
8780217|NCT01324388|9830559|FG000|Received at Least 1 Dose|Part 1 of Study||23
8780218|NCT01324388|9830560|FG001|Received at Least 1 Dose|Part 1 of Study||8
8780219|NCT01324388|9830561|FG002|Received at Least 1 Dose|Part 1 of Study||0
8780220|NCT01324388|9830562|FG003|Received at Least 1 Dose|Part 1 of Study||0
8780221|NCT01324388|9830559|FG000|COMPLETED|Part 1 of Study||19
8780222|NCT01324388|9830560|FG001|COMPLETED|Part 1 of Study||6
8780223|NCT01324388|9830561|FG002|COMPLETED|Part 1 of Study||0
9030021|NCT03227445|10092437|FG002|NOT COMPLETED|Period 2 (28 Days)||2
9030022|NCT03227445|10092438|FG003|NOT COMPLETED|Period 2 (28 Days)||3
9030023|NCT03227692|10092449|FG000|STARTED|Overall Study||47
9030024|NCT03227692|10092450|FG001|STARTED|Overall Study||46
9030025|NCT03227692|10092449|FG000|COMPLETED|Overall Study||42
9030026|NCT03227692|10092450|FG001|COMPLETED|Overall Study||41
9030027|NCT03227692|10092449|FG000|NOT COMPLETED|Overall Study||5
9030028|NCT03227692|10092450|FG001|NOT COMPLETED|Overall Study||5
9030029|NCT03227861|10092456|FG000|STARTED|Main Study Period (Week 0 to Week 48)||109
9030030|NCT03227861|10092456|FG000|COMPLETED|Main Study Period (Week 0 to Week 48)||97
9030031|NCT03227861|10092456|FG000|NOT COMPLETED|Main Study Period (Week 0 to Week 48)||12
9030032|NCT03227861|10092456|FG000|STARTED|Extension Period (Week 48 to Week 96)|17 participants were not willing to enter extension study and discontinued after main study.|80
9030033|NCT03227861|10092456|FG000|COMPLETED|Extension Period (Week 48 to Week 96)||0
9030034|NCT03227861|10092456|FG000|NOT COMPLETED|Extension Period (Week 48 to Week 96)||80
9030035|NCT03228017|10092464|FG000|STARTED|Overall Study||45
9030036|NCT03228017|10092465|FG001|STARTED|Overall Study||18
9030037|NCT03228017|10092464|FG000|COMPLETED|Overall Study||45
9030038|NCT03228017|10092465|FG001|COMPLETED|Overall Study||18
9030039|NCT03228017|10092464|FG000|NOT COMPLETED|Overall Study||0
9030040|NCT03228017|10092465|FG001|NOT COMPLETED|Overall Study||0
9030041|NCT03228212|10092471|FG000|STARTED|Period 1||65
9030042|NCT03228212|10092472|FG001|STARTED|Period 1||65
9030043|NCT03228212|10092471|FG000|COMPLETED|Period 1||64
9030044|NCT03228212|10092472|FG001|COMPLETED|Period 1||64
9030045|NCT03228212|10092471|FG000|NOT COMPLETED|Period 1||1
9030046|NCT03228212|10092472|FG001|NOT COMPLETED|Period 1||1
9030047|NCT03228212|10092471|FG000|STARTED|Period 2||64
9030048|NCT03228212|10092472|FG001|STARTED|Period 2||64
9030049|NCT03228212|10092471|FG000|COMPLETED|Period 2||63
9030050|NCT03228212|10092472|FG001|COMPLETED|Period 2||64
9030051|NCT03228212|10092471|FG000|NOT COMPLETED|Period 2||1
9030052|NCT03228212|10092472|FG001|NOT COMPLETED|Period 2||0
9030053|NCT03228212|10092471|FG000|STARTED|Period 3||63
9030054|NCT03228212|10092472|FG001|STARTED|Period 3||64
9030055|NCT03228212|10092471|FG000|COMPLETED|Period 3||63
9030056|NCT03228212|10092472|FG001|COMPLETED|Period 3||64
8780224|NCT01324388|9830562|FG003|COMPLETED|Part 1 of Study||0
8780225|NCT01324388|9830559|FG000|NOT COMPLETED|Part 1 of Study||4
8780226|NCT01324388|9830560|FG001|NOT COMPLETED|Part 1 of Study||2
8780227|NCT01324388|9830561|FG002|NOT COMPLETED|Part 1 of Study||0
9030057|NCT03228212|10092471|FG000|NOT COMPLETED|Period 3||0
9030058|NCT03228212|10092472|FG001|NOT COMPLETED|Period 3||0
9030059|NCT03228420|10092480|FG000|STARTED|Overall Study||113
9030060|NCT03228420|10092481|FG001|STARTED|Overall Study||103
9030061|NCT03228420|10092480|FG000|Month-1|Overall Study||95
9030062|NCT03228420|10092481|FG001|Month-1|Overall Study||101
9030063|NCT03228420|10092480|FG000|Month-3|Overall Study||93
9030064|NCT03228420|10092481|FG001|Month-3|Overall Study||98
8780228|NCT01324388|9830562|FG003|NOT COMPLETED|Part 1 of Study||0
8780229|NCT01324388|9830559|FG000|STARTED|Part 2 of Study: First Intervention||0
8780230|NCT01324388|9830560|FG001|STARTED|Part 2 of Study: First Intervention||0
8780231|NCT01324388|9830561|FG002|STARTED|Part 2 of Study: First Intervention||10
8780232|NCT01324388|9830562|FG003|STARTED|Part 2 of Study: First Intervention||10
8780233|NCT01324388|9830559|FG000|COMPLETED|Part 2 of Study: First Intervention||0
8780234|NCT01324388|9830560|FG001|COMPLETED|Part 2 of Study: First Intervention||0
8780235|NCT01324388|9830561|FG002|COMPLETED|Part 2 of Study: First Intervention||10
8780236|NCT01324388|9830562|FG003|COMPLETED|Part 2 of Study: First Intervention||9
8780237|NCT01324388|9830559|FG000|NOT COMPLETED|Part 2 of Study: First Intervention||0
8780238|NCT01324388|9830560|FG001|NOT COMPLETED|Part 2 of Study: First Intervention||0
8780239|NCT01324388|9830561|FG002|NOT COMPLETED|Part 2 of Study: First Intervention||0
8780240|NCT01324388|9830562|FG003|NOT COMPLETED|Part 2 of Study: First Intervention||1
8780241|NCT01324388|9830559|FG000|STARTED|Part 2: Washout of at Least 21 Days||0
8780242|NCT01324388|9830560|FG001|STARTED|Part 2: Washout of at Least 21 Days||0
8780243|NCT01324388|9830561|FG002|STARTED|Part 2: Washout of at Least 21 Days||10
8780244|NCT01324388|9830562|FG003|STARTED|Part 2: Washout of at Least 21 Days||9
8780245|NCT01324388|9830559|FG000|COMPLETED|Part 2: Washout of at Least 21 Days||0
8780246|NCT01324388|9830560|FG001|COMPLETED|Part 2: Washout of at Least 21 Days||0
8780247|NCT01324388|9830561|FG002|COMPLETED|Part 2: Washout of at Least 21 Days||10
8780248|NCT01324388|9830562|FG003|COMPLETED|Part 2: Washout of at Least 21 Days||9
8780249|NCT01324388|9830559|FG000|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
8780250|NCT01324388|9830560|FG001|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
8780251|NCT01324388|9830561|FG002|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
8780252|NCT01324388|9830562|FG003|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
8780253|NCT01324388|9830559|FG000|STARTED|Part 2 of Study: Second Intervention||0
8780254|NCT01324388|9830560|FG001|STARTED|Part 2 of Study: Second Intervention||0
8780255|NCT01324388|9830561|FG002|STARTED|Part 2 of Study: Second Intervention||10
8780256|NCT01324388|9830562|FG003|STARTED|Part 2 of Study: Second Intervention||9
8780257|NCT01324388|9830559|FG000|COMPLETED|Part 2 of Study: Second Intervention||0
8780258|NCT01324388|9830560|FG001|COMPLETED|Part 2 of Study: Second Intervention||0
8780259|NCT01324388|9830561|FG002|COMPLETED|Part 2 of Study: Second Intervention||9
8780260|NCT01324388|9830562|FG003|COMPLETED|Part 2 of Study: Second Intervention||9
8780261|NCT01324388|9830559|FG000|NOT COMPLETED|Part 2 of Study: Second Intervention||0
8780262|NCT01324388|9830560|FG001|NOT COMPLETED|Part 2 of Study: Second Intervention||0
8780263|NCT01324388|9830561|FG002|NOT COMPLETED|Part 2 of Study: Second Intervention||1
8780264|NCT01324388|9830562|FG003|NOT COMPLETED|Part 2 of Study: Second Intervention||0
8780265|NCT01324401|9830576|FG000|STARTED|Overall Study||4
8780266|NCT01324401|9830577|FG001|STARTED|Overall Study|3 excluded from ITT analysis: 1 screen fail, 2 voluntary withdrawal pre-treatment|26
8780267|NCT01324401|9830576|FG000|COMPLETED|Overall Study|one (1) could not tolerate minimum starting dose|3
8780268|NCT01324401|9830577|FG001|COMPLETED|Overall Study|three (3) unable to complete due to adverse events|20
8780269|NCT01324401|9830576|FG000|NOT COMPLETED|Overall Study||1
8780270|NCT01324401|9830577|FG001|NOT COMPLETED|Overall Study||6
9030065|NCT03228420|10092480|FG000|COMPLETED|Overall Study||93
9030066|NCT03228420|10092481|FG001|COMPLETED|Overall Study||98
9030067|NCT03228420|10092480|FG000|NOT COMPLETED|Overall Study||20
9030068|NCT03228420|10092481|FG001|NOT COMPLETED|Overall Study||5
9030069|NCT03228433|10092493|FG000|STARTED|Overall Study||10
9030070|NCT03228433|10092494|FG001|STARTED|Overall Study||6
9030071|NCT03228433|10092495|FG002|STARTED|Overall Study||6
9030072|NCT03228433|10092496|FG003|STARTED|Overall Study||6
9030073|NCT03228433|10092497|FG004|STARTED|Overall Study||6
9030074|NCT03228433|10092498|FG005|STARTED|Overall Study||6
9030075|NCT03228433|10092493|FG000|COMPLETED|Overall Study||9
8780271|NCT01324440|9830585|FG000|STARTED|Overall Study||32
8780272|NCT01324440|9830586|FG001|STARTED|Overall Study||32
8780273|NCT01324440|9830585|FG000|COMPLETED|Overall Study||32
8780274|NCT01324440|9830586|FG001|COMPLETED|Overall Study||31
8780275|NCT01324440|9830585|FG000|NOT COMPLETED|Overall Study||0
8780276|NCT01324440|9830586|FG001|NOT COMPLETED|Overall Study||1
8780277|NCT01324453|9830594|FG000|STARTED|Overall Study||54
8780278|NCT01324453|9830595|FG001|STARTED|Overall Study||49
8780279|NCT01324453|9830594|FG000|COMPLETED|Overall Study||54
8780280|NCT01324453|9830595|FG001|COMPLETED|Overall Study||49
8780281|NCT01324453|9830594|FG000|NOT COMPLETED|Overall Study||0
8780282|NCT01324453|9830595|FG001|NOT COMPLETED|Overall Study||0
8780283|NCT01324518|9830604|FG000|STARTED|Overall Study||33
8780284|NCT01324518|9830605|FG001|STARTED|Overall Study||33
8780285|NCT01324518|9830606|FG002|STARTED|Overall Study||34
8780286|NCT01324518|9830604|FG000|COMPLETED|Overall Study||28
8916467|NCT02184442|9976081|FG000|STARTED|Overall Study||284
8916468|NCT02184442|9976082|FG001|STARTED|Overall Study||276
8916469|NCT02184442|9976081|FG000|As-Treated|Overall Study||282
8916470|NCT02184442|9976082|FG001|As-Treated|Overall Study||271
8916471|NCT02184442|9976081|FG000|Valve-Implant|Overall Study||280
8916472|NCT02184442|9976082|FG001|Valve-Implant|Overall Study||263
8916473|NCT02184442|9976081|FG000|COMPLETED|Overall Study||220
8916474|NCT02184442|9976082|FG001|COMPLETED|Overall Study||200
8916475|NCT02184442|9976081|FG000|NOT COMPLETED|Overall Study||64
8916476|NCT02184442|9976082|FG001|NOT COMPLETED|Overall Study||76
8780287|NCT01324518|9830605|FG001|COMPLETED|Overall Study||30
8780288|NCT01324518|9830606|FG002|COMPLETED|Overall Study||33
8780289|NCT01324518|9830604|FG000|NOT COMPLETED|Overall Study||5
8780290|NCT01324518|9830605|FG001|NOT COMPLETED|Overall Study||3
8780291|NCT01324518|9830606|FG002|NOT COMPLETED|Overall Study||1
8809003|NCT01494506|9861417|FG002|STARTED|Overall Study||117
8809004|NCT01494506|9861415|FG000|Treated Population|Overall Study|Treated population: Patients who received at least 1 dose of study drug.|147
8809005|NCT01494506|9861416|FG001|Treated Population|Overall Study||134
8809006|NCT01494506|9861417|FG002|Treated Population|Overall Study|2 randomized Arm C patients did not receive study drug. 1 patient each in A and B received Arm C.|117
8809007|NCT01494506|9861415|FG000|COMPLETED|Overall Study|Completed = Subjects remaining on treatment at the time of the primary analysis data cut off.|3
8809008|NCT01494506|9861416|FG001|COMPLETED|Overall Study||6
8809009|NCT01494506|9861417|FG002|COMPLETED|Overall Study||14
8809010|NCT01494506|9861415|FG000|NOT COMPLETED|Overall Study||148
8809011|NCT01494506|9861416|FG001|NOT COMPLETED|Overall Study||143
8809012|NCT01494506|9861417|FG002|NOT COMPLETED|Overall Study||103
8809013|NCT01494532|9861433|FG000|STARTED|Overall Study||75
8809014|NCT01494532|9861434|FG001|STARTED|Overall Study||25
8809015|NCT01494532|9861435|FG002|STARTED|Overall Study||76
8809016|NCT01494532|9861436|FG003|STARTED|Overall Study||75
8809017|NCT01494532|9861437|FG004|STARTED|Overall Study||76
8809018|NCT01494532|9861438|FG005|STARTED|Overall Study||25
8809019|NCT01494532|9861433|FG000|COMPLETED|Overall Study||65
8809020|NCT01494532|9861434|FG001|COMPLETED|Overall Study||21
8809021|NCT01494532|9861435|FG002|COMPLETED|Overall Study||59
8809022|NCT01494532|9861436|FG003|COMPLETED|Overall Study||60
8809023|NCT01494532|9861437|FG004|COMPLETED|Overall Study||64
8809024|NCT01494532|9861438|FG005|COMPLETED|Overall Study||25
8809025|NCT01494532|9861433|FG000|NOT COMPLETED|Overall Study||10
8809026|NCT01494532|9861434|FG001|NOT COMPLETED|Overall Study||4
8809027|NCT01494532|9861435|FG002|NOT COMPLETED|Overall Study||17
8809028|NCT01494532|9861436|FG003|NOT COMPLETED|Overall Study||15
8809029|NCT01494532|9861437|FG004|NOT COMPLETED|Overall Study||12
8809030|NCT01494532|9861438|FG005|NOT COMPLETED|Overall Study||0
8809031|NCT01494545|9861453|FG000|STARTED|Overall Study||102
8809032|NCT01494545|9861453|FG000|COMPLETED|Overall Study||92
8809033|NCT01494545|9861453|FG000|NOT COMPLETED|Overall Study||10
8809034|NCT01494584|9861460|FG000|STARTED|Overall Study||5
8809035|NCT01494584|9861460|FG000|COMPLETED|Overall Study||4
8809036|NCT01494584|9861460|FG000|NOT COMPLETED|Overall Study||1
8809037|NCT01494610|9861483|FG000|STARTED|Period 1||31
8809038|NCT01494610|9861484|FG001|STARTED|Period 1||29
8809039|NCT01494610|9861483|FG000|COMPLETED|Period 1||30
8809040|NCT01494610|9861484|FG001|COMPLETED|Period 1||28
8809041|NCT01494610|9861483|FG000|NOT COMPLETED|Period 1||1
8809042|NCT01494610|9861484|FG001|NOT COMPLETED|Period 1||1
8809043|NCT01494610|9861483|FG000|STARTED|Period 2||30
8809044|NCT01494610|9861484|FG001|STARTED|Period 2||28
8809045|NCT01494610|9861483|FG000|COMPLETED|Period 2||30
8809046|NCT01494610|9861484|FG001|COMPLETED|Period 2||28
8809047|NCT01494610|9861483|FG000|NOT COMPLETED|Period 2||0
8809048|NCT01494610|9861484|FG001|NOT COMPLETED|Period 2||0
8809049|NCT01494610|9861483|FG000|STARTED|Period 3||30
8809050|NCT01494610|9861484|FG001|STARTED|Period 3||28
8809051|NCT01494610|9861483|FG000|COMPLETED|Period 3||28
8809052|NCT01494610|9861484|FG001|COMPLETED|Period 3||28
8809053|NCT01494610|9861483|FG000|NOT COMPLETED|Period 3||2
8809054|NCT01494610|9861484|FG001|NOT COMPLETED|Period 3||0
8809055|NCT01494610|9861483|FG000|STARTED|Period 4||28
8809056|NCT01494610|9861484|FG001|STARTED|Period 4||28
8809057|NCT01494610|9861483|FG000|COMPLETED|Period 4||27
8809058|NCT01494610|9861484|FG001|COMPLETED|Period 4||28
8809059|NCT01494610|9861483|FG000|NOT COMPLETED|Period 4||1
8809060|NCT01494610|9861484|FG001|NOT COMPLETED|Period 4||0
8809061|NCT01494649|9861498|FG000|STARTED|Overall Study||59
8809062|NCT01494649|9861499|FG001|STARTED|Overall Study||59
8809063|NCT01494649|9861498|FG000|COMPLETED|Overall Study||59
8809064|NCT01494649|9861499|FG001|COMPLETED|Overall Study||58
8809065|NCT01494649|9861498|FG000|NOT COMPLETED|Overall Study||0
8809066|NCT01494649|9861499|FG001|NOT COMPLETED|Overall Study||1
8809067|NCT01494753|9861509|FG000|STARTED|Day0-Day42||15
8809068|NCT01494753|9861510|FG001|STARTED|Day0-Day42||15
8809069|NCT01494753|9861509|FG000|COMPLETED|Day0-Day42||15
8809070|NCT01494753|9861510|FG001|COMPLETED|Day0-Day42||15
8809071|NCT01494753|9861509|FG000|NOT COMPLETED|Day0-Day42||0
8809072|NCT01494753|9861510|FG001|NOT COMPLETED|Day0-Day42||0
8809073|NCT01494753|9861509|FG000|STARTED|Day42-Day84||15
8809074|NCT01494753|9861510|FG001|STARTED|Day42-Day84||15
8809075|NCT01494753|9861509|FG000|COMPLETED|Day42-Day84||15
8809076|NCT01494753|9861510|FG001|COMPLETED|Day42-Day84||15
8809077|NCT01494753|9861509|FG000|NOT COMPLETED|Day42-Day84||0
8809078|NCT01494753|9861510|FG001|NOT COMPLETED|Day42-Day84||0
8809079|NCT01494818|9861518|FG000|STARTED|Overall Study||39
8809080|NCT01494818|9861519|FG001|STARTED|Overall Study||39
8809081|NCT01494818|9861518|FG000|COMPLETED|Overall Study||37
8809082|NCT01494818|9861519|FG001|COMPLETED|Overall Study||37
8809083|NCT01494818|9861518|FG000|NOT COMPLETED|Overall Study||2
8809084|NCT01494818|9861519|FG001|NOT COMPLETED|Overall Study||2
8809085|NCT01494922|9861525|FG000|STARTED|Overall Study||14
8809086|NCT01494922|9861525|FG000|COMPLETED|Overall Study||13
8809087|NCT01494922|9861525|FG000|NOT COMPLETED|Overall Study||1
8916477|NCT02184455|9976088|FG000|STARTED|Overall Study||11
8916478|NCT02184455|9976088|FG000|COMPLETED|Overall Study||10
8780292|NCT01324570|9830616|FG000|STARTED|Overall Study||6
8780293|NCT01324570|9830617|FG001|STARTED|Overall Study||35
8780294|NCT01324570|9830616|FG000|COMPLETED|Overall Study||2
8780295|NCT01324570|9830617|FG001|COMPLETED|Overall Study||21
8780296|NCT01324570|9830616|FG000|NOT COMPLETED|Overall Study||4
8780297|NCT01324570|9830617|FG001|NOT COMPLETED|Overall Study||14
8780298|NCT01324622|9830627|FG000|STARTED|Overall Study||13
8780299|NCT01324622|9830628|FG001|STARTED|Overall Study||11
8780300|NCT01324622|9830627|FG000|COMPLETED|Overall Study||4
8780301|NCT01324622|9830628|FG001|COMPLETED|Overall Study||4
8780302|NCT01324622|9830627|FG000|NOT COMPLETED|Overall Study||9
8780303|NCT01324622|9830628|FG001|NOT COMPLETED|Overall Study||7
8780304|NCT01324687|9830637|FG000|STARTED|Overall Study||1058
8780305|NCT01324687|9830638|FG001|STARTED|Overall Study||494
8780306|NCT01324687|9830637|FG000|COMPLETED|Overall Study||1058
8780307|NCT01324687|9830638|FG001|COMPLETED|Overall Study||479
8780308|NCT01324687|9830637|FG000|NOT COMPLETED|Overall Study||0
8780309|NCT01324687|9830638|FG001|NOT COMPLETED|Overall Study||15
8780310|NCT01324700|9830648|FG000|STARTED|Overall Study||22
8780311|NCT01324700|9830649|FG001|STARTED|Overall Study||20
8780312|NCT01324700|9830650|FG002|STARTED|Overall Study||49
8780313|NCT01324700|9830651|FG003|STARTED|Overall Study||48
8780314|NCT01324700|9830648|FG000|COMPLETED|Overall Study||13
8780315|NCT01324700|9830649|FG001|COMPLETED|Overall Study||16
8780316|NCT01324700|9830650|FG002|COMPLETED|Overall Study||33
8780317|NCT01324700|9830651|FG003|COMPLETED|Overall Study||37
8780318|NCT01324700|9830648|FG000|NOT COMPLETED|Overall Study||9
8780319|NCT01324700|9830649|FG001|NOT COMPLETED|Overall Study||4
8780320|NCT01324700|9830650|FG002|NOT COMPLETED|Overall Study||16
8780321|NCT01324700|9830651|FG003|NOT COMPLETED|Overall Study||11
8780322|NCT01324830|9830680|FG000|STARTED|Overall Study||3
8780323|NCT01324830|9830681|FG001|STARTED|Overall Study||3
8780324|NCT01324830|9830682|FG002|STARTED|Overall Study||3
8780325|NCT01324830|9830683|FG003|STARTED|Overall Study||3
8780326|NCT01324830|9830684|FG004|STARTED|Overall Study||7
8780327|NCT01324830|9830685|FG005|STARTED|Overall Study||7
8780328|NCT01324830|9830686|FG006|STARTED|Overall Study||3
8780329|NCT01324830|9830687|FG007|STARTED|Overall Study||3
8780330|NCT01324830|9830688|FG008|STARTED|Overall Study||5
8780331|NCT01324830|9830689|FG009|STARTED|Overall Study||6
8780332|NCT01324830|9830690|FG010|STARTED|Overall Study||4
8780333|NCT01324830|9830691|FG011|STARTED|Overall Study||1
8780334|NCT01324830|9830692|FG012|STARTED|Overall Study||1
8780335|NCT01324830|9830693|FG013|STARTED|Overall Study||1
8780336|NCT01324830|9830694|FG014|STARTED|Overall Study||1
8780337|NCT01324830|9830695|FG015|STARTED|Overall Study||3
8780338|NCT01324830|9830696|FG016|STARTED|Overall Study||3
8780339|NCT01324830|9830697|FG017|STARTED|Overall Study||6
8780340|NCT01324830|9830698|FG018|STARTED|Overall Study||6
8780341|NCT01324830|9830680|FG000|COMPLETED|Overall Study||0
8780342|NCT01324830|9830681|FG001|COMPLETED|Overall Study||0
8780343|NCT01324830|9830682|FG002|COMPLETED|Overall Study||0
8780344|NCT01324830|9830683|FG003|COMPLETED|Overall Study||0
8780345|NCT01324830|9830684|FG004|COMPLETED|Overall Study||0
8780346|NCT01324830|9830685|FG005|COMPLETED|Overall Study||0
8780347|NCT01324830|9830686|FG006|COMPLETED|Overall Study||0
8780348|NCT01324830|9830687|FG007|COMPLETED|Overall Study||0
8780349|NCT01324830|9830688|FG008|COMPLETED|Overall Study||0
8780350|NCT01324830|9830689|FG009|COMPLETED|Overall Study||0
8780351|NCT01324830|9830690|FG010|COMPLETED|Overall Study||0
8780352|NCT01324830|9830691|FG011|COMPLETED|Overall Study||0
8780353|NCT01324830|9830692|FG012|COMPLETED|Overall Study||0
8780354|NCT01324830|9830693|FG013|COMPLETED|Overall Study||0
8780355|NCT01324830|9830694|FG014|COMPLETED|Overall Study||0
8780356|NCT01324830|9830695|FG015|COMPLETED|Overall Study||0
8780357|NCT01324830|9830696|FG016|COMPLETED|Overall Study||0
8780358|NCT01324830|9830697|FG017|COMPLETED|Overall Study||0
8780359|NCT01324830|9830698|FG018|COMPLETED|Overall Study||0
8780360|NCT01324830|9830680|FG000|NOT COMPLETED|Overall Study||3
8780361|NCT01324830|9830681|FG001|NOT COMPLETED|Overall Study||3
8780362|NCT01324830|9830682|FG002|NOT COMPLETED|Overall Study||3
8780363|NCT01324830|9830683|FG003|NOT COMPLETED|Overall Study||3
8780364|NCT01324830|9830684|FG004|NOT COMPLETED|Overall Study||7
8780365|NCT01324830|9830685|FG005|NOT COMPLETED|Overall Study||7
8780366|NCT01324830|9830686|FG006|NOT COMPLETED|Overall Study||3
8780367|NCT01324830|9830687|FG007|NOT COMPLETED|Overall Study||3
8780368|NCT01324830|9830688|FG008|NOT COMPLETED|Overall Study||5
8780369|NCT01324830|9830689|FG009|NOT COMPLETED|Overall Study||6
8780370|NCT01324830|9830690|FG010|NOT COMPLETED|Overall Study||4
8780371|NCT01324830|9830691|FG011|NOT COMPLETED|Overall Study||1
8780372|NCT01324830|9830692|FG012|NOT COMPLETED|Overall Study||1
8780373|NCT01324830|9830693|FG013|NOT COMPLETED|Overall Study||1
8780374|NCT01324830|9830694|FG014|NOT COMPLETED|Overall Study||1
8780375|NCT01324830|9830695|FG015|NOT COMPLETED|Overall Study||3
8780376|NCT01324830|9830696|FG016|NOT COMPLETED|Overall Study||3
8780377|NCT01324830|9830697|FG017|NOT COMPLETED|Overall Study||6
8780378|NCT01324830|9830698|FG018|NOT COMPLETED|Overall Study||6
8780379|NCT01324882|9830746|FG000|STARTED|Overall Study|27 patients were randomized to this arm.|27
8780380|NCT01324882|9830747|FG001|STARTED|Overall Study|30 patients were randomized to this arm|30
8780381|NCT01324882|9830746|FG000|COMPLETED|Overall Study|27 patients had the colonoscopy|27
8780382|NCT01324882|9830747|FG001|COMPLETED|Overall Study|30 patients had the colonoscopy|30
8780383|NCT01324882|9830746|FG000|NOT COMPLETED|Overall Study||0
8780384|NCT01324882|9830747|FG001|NOT COMPLETED|Overall Study||0
8780385|NCT01324947|9830755|FG000|STARTED|Overall Study||74
8780386|NCT01324947|9830755|FG000|Safety Population|Overall Study|Safety Population includes those who were enrolled and received at least one dose of study drug|73
8780387|NCT01324947|9830755|FG000|Efficacy Evaluable Population (EEP)|Overall Study|Participants who received ≥ 1 dose of study drug and had at least 1 postbaseline efficacy assessment|64
8780388|NCT01324947|9830755|FG000|COMPLETED|Overall Study||0
8780389|NCT01324947|9830755|FG000|NOT COMPLETED|Overall Study||74
8780390|NCT01324999|9830761|FG000|STARTED|Overall Study||12
8780391|NCT01324999|9830761|FG000|COMPLETED|Overall Study||7
8780392|NCT01324999|9830761|FG000|NOT COMPLETED|Overall Study||5
8780393|NCT01325181|9830767|FG000|STARTED|Overall Study||18
8780394|NCT01325181|9830768|FG001|STARTED|Overall Study||16
8780395|NCT01325181|9830767|FG000|COMPLETED|Overall Study||18
8780396|NCT01325181|9830768|FG001|COMPLETED|Overall Study||14
8780397|NCT01325181|9830767|FG000|NOT COMPLETED|Overall Study||0
8780398|NCT01325181|9830768|FG001|NOT COMPLETED|Overall Study||2
8780399|NCT01325207|9830780|FG000|STARTED|Completed 4 Weeks/1 Cycle of Treatment||3
8780400|NCT01325207|9830781|FG001|STARTED|Completed 4 Weeks/1 Cycle of Treatment||3
8780401|NCT01325207|9830782|FG002|STARTED|Completed 4 Weeks/1 Cycle of Treatment||1
8780402|NCT01325207|9830783|FG003|STARTED|Completed 4 Weeks/1 Cycle of Treatment||1
8780403|NCT01325207|9830784|FG004|STARTED|Completed 4 Weeks/1 Cycle of Treatment||7
8780404|NCT01325207|9830785|FG005|STARTED|Completed 4 Weeks/1 Cycle of Treatment||19
8780405|NCT01325207|9830780|FG000|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||3
8780406|NCT01325207|9830781|FG001|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||3
8780407|NCT01325207|9830782|FG002|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||1
8780408|NCT01325207|9830783|FG003|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||1
8780409|NCT01325207|9830784|FG004|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||5
8780410|NCT01325207|9830785|FG005|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||19
8780411|NCT01325207|9830780|FG000|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0
8780412|NCT01325207|9830781|FG001|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0
8780413|NCT01325207|9830782|FG002|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0
8780414|NCT01325207|9830783|FG003|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0
8780415|NCT01325207|9830784|FG004|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||2
8780416|NCT01325207|9830785|FG005|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0
8780417|NCT01325207|9830780|FG000|STARTED|Completed 8 Weeks/2 Cycles of Treatment||3
8780418|NCT01325207|9830781|FG001|STARTED|Completed 8 Weeks/2 Cycles of Treatment||3
8780419|NCT01325207|9830782|FG002|STARTED|Completed 8 Weeks/2 Cycles of Treatment||1
8780420|NCT01325207|9830783|FG003|STARTED|Completed 8 Weeks/2 Cycles of Treatment||1
8780421|NCT01325207|9830784|FG004|STARTED|Completed 8 Weeks/2 Cycles of Treatment||5
8780422|NCT01325207|9830785|FG005|STARTED|Completed 8 Weeks/2 Cycles of Treatment||19
8780423|NCT01325207|9830780|FG000|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||2
8780424|NCT01325207|9830781|FG001|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||2
8780425|NCT01325207|9830782|FG002|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||1
8780426|NCT01325207|9830783|FG003|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||1
8780427|NCT01325207|9830784|FG004|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||3
8780428|NCT01325207|9830785|FG005|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||14
8780429|NCT01325207|9830780|FG000|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||1
8780430|NCT01325207|9830781|FG001|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||1
8780431|NCT01325207|9830782|FG002|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||0
8780432|NCT01325207|9830783|FG003|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||0
8780433|NCT01325207|9830784|FG004|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||2
8780434|NCT01325207|9830785|FG005|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||5
8780435|NCT01325207|9830780|FG000|STARTED|Started 9th Week/Cycle 3 of Treatment||2
8780436|NCT01325207|9830781|FG001|STARTED|Started 9th Week/Cycle 3 of Treatment||2
8780437|NCT01325207|9830782|FG002|STARTED|Started 9th Week/Cycle 3 of Treatment||1
8780438|NCT01325207|9830783|FG003|STARTED|Started 9th Week/Cycle 3 of Treatment||1
8780439|NCT01325207|9830784|FG004|STARTED|Started 9th Week/Cycle 3 of Treatment||3
8780440|NCT01325207|9830785|FG005|STARTED|Started 9th Week/Cycle 3 of Treatment||14
8780441|NCT01325207|9830780|FG000|COMPLETED|Started 9th Week/Cycle 3 of Treatment||1
8780442|NCT01325207|9830781|FG001|COMPLETED|Started 9th Week/Cycle 3 of Treatment||0
8780443|NCT01325207|9830782|FG002|COMPLETED|Started 9th Week/Cycle 3 of Treatment||0
8780444|NCT01325207|9830783|FG003|COMPLETED|Started 9th Week/Cycle 3 of Treatment||0
8780445|NCT01325207|9830784|FG004|COMPLETED|Started 9th Week/Cycle 3 of Treatment||3
8780446|NCT01325207|9830785|FG005|COMPLETED|Started 9th Week/Cycle 3 of Treatment||9
8780447|NCT01325207|9830780|FG000|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||1
8780448|NCT01325207|9830781|FG001|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||2
8780449|NCT01325207|9830782|FG002|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||1
8780450|NCT01325207|9830783|FG003|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||1
8780451|NCT01325207|9830784|FG004|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||0
8780452|NCT01325207|9830785|FG005|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||5
8780453|NCT01325207|9830780|FG000|STARTED|Follow-up Every 3 Months Until Death||3
8780454|NCT01325207|9830781|FG001|STARTED|Follow-up Every 3 Months Until Death||3
8780455|NCT01325207|9830782|FG002|STARTED|Follow-up Every 3 Months Until Death||1
8780456|NCT01325207|9830783|FG003|STARTED|Follow-up Every 3 Months Until Death||1
8780457|NCT01325207|9830784|FG004|STARTED|Follow-up Every 3 Months Until Death||7
8780458|NCT01325207|9830785|FG005|STARTED|Follow-up Every 3 Months Until Death||19
8780459|NCT01325207|9830780|FG000|COMPLETED|Follow-up Every 3 Months Until Death||3
8780460|NCT01325207|9830781|FG001|COMPLETED|Follow-up Every 3 Months Until Death||3
8780461|NCT01325207|9830782|FG002|COMPLETED|Follow-up Every 3 Months Until Death||1
8780462|NCT01325207|9830783|FG003|COMPLETED|Follow-up Every 3 Months Until Death||1
8780463|NCT01325207|9830784|FG004|COMPLETED|Follow-up Every 3 Months Until Death||6
8780464|NCT01325207|9830785|FG005|COMPLETED|Follow-up Every 3 Months Until Death||18
8780465|NCT01325207|9830780|FG000|NOT COMPLETED|Follow-up Every 3 Months Until Death||0
8780466|NCT01325207|9830781|FG001|NOT COMPLETED|Follow-up Every 3 Months Until Death||0
8780467|NCT01325207|9830782|FG002|NOT COMPLETED|Follow-up Every 3 Months Until Death||0
8780468|NCT01325207|9830783|FG003|NOT COMPLETED|Follow-up Every 3 Months Until Death||0
8780469|NCT01325207|9830784|FG004|NOT COMPLETED|Follow-up Every 3 Months Until Death||1
8780470|NCT01325207|9830785|FG005|NOT COMPLETED|Follow-up Every 3 Months Until Death||1
8780471|NCT01325311|9830802|FG000|STARTED|Overall Study||8
8780472|NCT01325311|9830803|FG001|STARTED|Overall Study||7
8780473|NCT01325311|9830802|FG000|COMPLETED|Overall Study||8
8780474|NCT01325311|9830803|FG001|COMPLETED|Overall Study||7
8780475|NCT01325311|9830802|FG000|NOT COMPLETED|Overall Study||0
8780476|NCT01325311|9830803|FG001|NOT COMPLETED|Overall Study||0
8780477|NCT01325337|9830814|FG000|STARTED|Overall Study||61
8780478|NCT01325337|9830815|FG001|STARTED|Overall Study||61
8780479|NCT01325337|9830816|FG002|STARTED|Overall Study||62
8780480|NCT01325337|9830817|FG003|STARTED|Overall Study||62
8780481|NCT01325337|9830818|FG004|STARTED|Overall Study||61
8780482|NCT01325337|9830814|FG000|COMPLETED|Overall Study||56
8780483|NCT01325337|9830815|FG001|COMPLETED|Overall Study||52
8780484|NCT01325337|9830816|FG002|COMPLETED|Overall Study||53
8780485|NCT01325337|9830817|FG003|COMPLETED|Overall Study||52
8780486|NCT01325337|9830818|FG004|COMPLETED|Overall Study||53
8780487|NCT01325337|9830814|FG000|NOT COMPLETED|Overall Study||5
8780488|NCT01325337|9830815|FG001|NOT COMPLETED|Overall Study||9
8780489|NCT01325337|9830816|FG002|NOT COMPLETED|Overall Study||9
8780490|NCT01325337|9830817|FG003|NOT COMPLETED|Overall Study||10
8780491|NCT01325337|9830818|FG004|NOT COMPLETED|Overall Study||8
8780492|NCT01325350|9830835|FG000|STARTED|Overall Study||61
8780493|NCT01325350|9830836|FG001|STARTED|Overall Study||61
8780494|NCT01325350|9830837|FG002|STARTED|Overall Study||61
8780495|NCT01325350|9830838|FG003|STARTED|Overall Study||61
8780496|NCT01325350|9830839|FG004|STARTED|Overall Study||62
8780497|NCT01325350|9830835|FG000|COMPLETED|Overall Study||55
8780498|NCT01325350|9830836|FG001|COMPLETED|Overall Study||56
8780499|NCT01325350|9830837|FG002|COMPLETED|Overall Study||44
8780500|NCT01325350|9830838|FG003|COMPLETED|Overall Study||52
8780501|NCT01325350|9830839|FG004|COMPLETED|Overall Study||50
8780502|NCT01325350|9830835|FG000|NOT COMPLETED|Overall Study||6
8780503|NCT01325350|9830836|FG001|NOT COMPLETED|Overall Study||5
8780504|NCT01325350|9830837|FG002|NOT COMPLETED|Overall Study||17
8780505|NCT01325350|9830838|FG003|NOT COMPLETED|Overall Study||9
8780506|NCT01325350|9830839|FG004|NOT COMPLETED|Overall Study||12
8780507|NCT01325428|9830851|FG000|STARTED|Part A||26
8780508|NCT01325428|9830851|FG000|COMPLETED|Part A||10
8780509|NCT01325428|9830851|FG000|NOT COMPLETED|Part A||16
8780510|NCT01325428|9830851|FG000|STARTED|Part B||10
8780511|NCT01325428|9830851|FG000|COMPLETED|Part B||7
8780512|NCT01325428|9830851|FG000|NOT COMPLETED|Part B||3
8780513|NCT01325493|9830862|FG000|STARTED|Overall Study||30
8780514|NCT01325493|9830863|FG001|STARTED|Overall Study||24
8780515|NCT01325493|9830862|FG000|COMPLETED|Overall Study||29
8780516|NCT01325493|9830863|FG001|COMPLETED|Overall Study||21
8780517|NCT01325493|9830862|FG000|NOT COMPLETED|Overall Study||1
8780518|NCT01325493|9830863|FG001|NOT COMPLETED|Overall Study||3
8780519|NCT01325532|9830871|FG000|STARTED|Overall Study||17
8780520|NCT01325532|9830872|FG001|STARTED|Overall Study||13
8780521|NCT01325532|9830871|FG000|COMPLETED|Overall Study||15
8780522|NCT01325532|9830872|FG001|COMPLETED|Overall Study||13
8780523|NCT01325532|9830871|FG000|NOT COMPLETED|Overall Study||2
8780524|NCT01325532|9830872|FG001|NOT COMPLETED|Overall Study||0
8780525|NCT01325584|9830878|FG000|STARTED|Overall Study||12
8780526|NCT01325584|9830878|FG000|COMPLETED|Overall Study||11
8780527|NCT01325584|9830878|FG000|NOT COMPLETED|Overall Study||1
8780528|NCT01325623|9830882|FG000|STARTED|Overall Study||31
8780529|NCT01325623|9830882|FG000|COMPLETED|Overall Study||28
8780530|NCT01325623|9830882|FG000|NOT COMPLETED|Overall Study||3
8780531|NCT01325701|9830921|FG000|STARTED|Overall Study||70
8780532|NCT01325701|9830922|FG001|STARTED|Overall Study||8
8780533|NCT01325701|9830921|FG000|COMPLETED|Overall Study||49
8780534|NCT01325701|9830922|FG001|COMPLETED|Overall Study||5
8780535|NCT01325701|9830921|FG000|NOT COMPLETED|Overall Study||21
8780536|NCT01325701|9830922|FG001|NOT COMPLETED|Overall Study||3
8780537|NCT01325714|9830931|FG000|STARTED|Overall Study||101
8780538|NCT01325714|9830932|FG001|STARTED|Overall Study||102
8780539|NCT01325714|9830931|FG000|3 Month Assessment|Overall Study||82
8780540|NCT01325714|9830932|FG001|3 Month Assessment|Overall Study||86
8780541|NCT01325714|9830931|FG000|6 Month Asessment|Overall Study||75
8780542|NCT01325714|9830932|FG001|6 Month Asessment|Overall Study||82
8780543|NCT01325714|9830931|FG000|12 Month Assessment|Overall Study||67
8780544|NCT01325714|9830932|FG001|12 Month Assessment|Overall Study||71
8780545|NCT01325714|9830931|FG000|COMPLETED|Overall Study||67
8780546|NCT01325714|9830932|FG001|COMPLETED|Overall Study||71
8780547|NCT01325714|9830931|FG000|NOT COMPLETED|Overall Study||34
8780548|NCT01325714|9830932|FG001|NOT COMPLETED|Overall Study||31
8780549|NCT01325792|9830940|FG000|STARTED|Overall Study||104
8780550|NCT01325792|9830940|FG000|COMPLETED|Overall Study||87
8780551|NCT01325792|9830940|FG000|NOT COMPLETED|Overall Study||17
8780552|NCT01325870|9830947|FG000|STARTED|Overall Study||18
8780553|NCT01325870|9830948|FG001|STARTED|Overall Study||16
8780554|NCT01325870|9830949|FG002|STARTED|Overall Study||14
8780555|NCT01325870|9830947|FG000|COMPLETED|Overall Study||7
8780556|NCT01325870|9830948|FG001|COMPLETED|Overall Study||3
8780557|NCT01325870|9830949|FG002|COMPLETED|Overall Study||6
8780558|NCT01325870|9830947|FG000|NOT COMPLETED|Overall Study||11
8780559|NCT01325870|9830948|FG001|NOT COMPLETED|Overall Study||13
8780560|NCT01325870|9830949|FG002|NOT COMPLETED|Overall Study||8
8780561|NCT01326026|9830959|FG000|STARTED|Overall Study||111
8780562|NCT01326026|9830960|FG001|STARTED|Overall Study||111
8780563|NCT01326026|9830959|FG000|Exposed|Overall Study|One subject withdrew before exposure to trial drug|110
8780564|NCT01326026|9830960|FG001|Exposed|Overall Study||111
8780565|NCT01326026|9830959|FG000|COMPLETED|Overall Study||99
8780566|NCT01326026|9830960|FG001|COMPLETED|Overall Study||98
8780567|NCT01326026|9830959|FG000|NOT COMPLETED|Overall Study||12
8780568|NCT01326026|9830960|FG001|NOT COMPLETED|Overall Study||13
8780569|NCT01326481|9830966|FG000|STARTED|7.5 mg/kg TRC105, 1000 mg/m2 Cape||4
8780570|NCT01326481|9830966|FG000|COMPLETED|7.5 mg/kg TRC105, 1000 mg/m2 Cape||3
8780571|NCT01326481|9830966|FG000|NOT COMPLETED|7.5 mg/kg TRC105, 1000 mg/m2 Cape||1
8780572|NCT01326481|9830966|FG000|STARTED|10 mg/kg TRC105, 1000 mg/m2 Cape||15
8780573|NCT01326481|9830966|FG000|COMPLETED|10 mg/kg TRC105, 1000 mg/m2 Cape||15
8780574|NCT01326481|9830966|FG000|NOT COMPLETED|10 mg/kg TRC105, 1000 mg/m2 Cape||0
8780575|NCT01326533|9830974|FG000|STARTED|Overall Study||17
8780576|NCT01326533|9830975|FG001|STARTED|Overall Study||15
8780577|NCT01326533|9830974|FG000|COMPLETED|Overall Study||13
8780578|NCT01326533|9830975|FG001|COMPLETED|Overall Study||15
8780579|NCT01326533|9830974|FG000|NOT COMPLETED|Overall Study||4
8780580|NCT01326533|9830975|FG001|NOT COMPLETED|Overall Study||0
8780581|NCT01326546|9830983|FG000|STARTED|Overall Study||189
8780582|NCT01326546|9830984|FG001|STARTED|Overall Study||189
8780583|NCT01326546|9830983|FG000|COMPLETED|Overall Study||172
8780584|NCT01326546|9830984|FG001|COMPLETED|Overall Study||176
8780585|NCT01326546|9830983|FG000|NOT COMPLETED|Overall Study||17
8780586|NCT01326546|9830984|FG001|NOT COMPLETED|Overall Study||13
8780587|NCT01326702|9830997|FG000|STARTED|Overall Study||3
8780588|NCT01326702|9830998|FG001|STARTED|Overall Study||3
8780589|NCT01326702|9830999|FG002|STARTED|Overall Study||6
8780590|NCT01326702|9831000|FG003|STARTED|Overall Study||4
8780591|NCT01326702|9831001|FG004|STARTED|Overall Study||5
8780592|NCT01326702|9831002|FG005|STARTED|Overall Study||15
8780593|NCT01326702|9831003|FG006|STARTED|Overall Study||7
8780594|NCT01326702|9830997|FG000|COMPLETED|Overall Study||1
8780595|NCT01326702|9830998|FG001|COMPLETED|Overall Study||1
8780596|NCT01326702|9830999|FG002|COMPLETED|Overall Study||1
8780597|NCT01326702|9831000|FG003|COMPLETED|Overall Study||1
8780598|NCT01326702|9831001|FG004|COMPLETED|Overall Study||1
8780599|NCT01326702|9831002|FG005|COMPLETED|Overall Study||7
8780600|NCT01326702|9831003|FG006|COMPLETED|Overall Study||0
8780601|NCT01326702|9830997|FG000|NOT COMPLETED|Overall Study||2
8780602|NCT01326702|9830998|FG001|NOT COMPLETED|Overall Study||2
8780603|NCT01326702|9830999|FG002|NOT COMPLETED|Overall Study||5
8780604|NCT01326702|9831000|FG003|NOT COMPLETED|Overall Study||3
8780605|NCT01326702|9831001|FG004|NOT COMPLETED|Overall Study||4
8780606|NCT01326702|9831002|FG005|NOT COMPLETED|Overall Study||8
8780607|NCT01326702|9831003|FG006|NOT COMPLETED|Overall Study||7
8780608|NCT01326728|9831024|FG000|STARTED|Overall Study||47
8780609|NCT01326728|9831025|FG001|STARTED|Overall Study||9
8780610|NCT01326728|9831024|FG000|COMPLETED|Overall Study||0
8780611|NCT01326728|9831025|FG001|COMPLETED|Overall Study||0
8780612|NCT01326728|9831024|FG000|NOT COMPLETED|Overall Study||47
8780613|NCT01326728|9831025|FG001|NOT COMPLETED|Overall Study||9
8780614|NCT01326780|9831034|FG000|STARTED|Overall Study||106
8780615|NCT01326780|9831035|FG001|STARTED|Overall Study||109
8780616|NCT01326780|9831036|FG002|STARTED|Overall Study||109
8780617|NCT01326780|9831037|FG003|STARTED|Overall Study||107
8780618|NCT01326780|9831034|FG000|COMPLETED|Overall Study||93
8780619|NCT01326780|9831035|FG001|COMPLETED|Overall Study||100
8780620|NCT01326780|9831036|FG002|COMPLETED|Overall Study||103
8780621|NCT01326780|9831037|FG003|COMPLETED|Overall Study||94
8780622|NCT01326780|9831034|FG000|NOT COMPLETED|Overall Study||13
8780623|NCT01326780|9831035|FG001|NOT COMPLETED|Overall Study||9
8780624|NCT01326780|9831036|FG002|NOT COMPLETED|Overall Study||6
8780625|NCT01326780|9831037|FG003|NOT COMPLETED|Overall Study||13
8780626|NCT01326910|9831049|FG000|STARTED|Overall Study||45
8780627|NCT01326910|9831050|FG001|STARTED|Overall Study||45
8780628|NCT01326910|9831049|FG000|COMPLETED|Overall Study||41
8780629|NCT01326910|9831050|FG001|COMPLETED|Overall Study||42
8780630|NCT01326910|9831049|FG000|NOT COMPLETED|Overall Study||4
8780631|NCT01326910|9831050|FG001|NOT COMPLETED|Overall Study||3
8780632|NCT01326962|9831056|FG000|STARTED|Overall Study||28
8780633|NCT01326962|9831056|FG000|COMPLETED|Overall Study||21
8780634|NCT01326962|9831056|FG000|NOT COMPLETED|Overall Study||7
8780635|NCT01327053|9831062|FG000|STARTED|Overall Study||79
8780636|NCT01327053|9831063|FG001|STARTED|Overall Study||151
8780637|NCT01327053|9831062|FG000|Untreated|Overall Study||0
8780638|NCT01327053|9831063|FG001|Untreated|Overall Study|one patient randomized to LDE225 (sonidegib) 800 mg did not receive study treatment|1
8780639|NCT01327053|9831062|FG000|Patients Cont. to Next Phase of Trial|Overall Study||52
8780640|NCT01327053|9831063|FG001|Patients Cont. to Next Phase of Trial|Overall Study||89
8780641|NCT01327053|9831062|FG000|Survival Follow-up|Overall Study||33
8780642|NCT01327053|9831063|FG001|Survival Follow-up|Overall Study||49
8780643|NCT01327053|9831062|FG000|Post-treatment Follow-up|Overall Study||19
8780644|NCT01327053|9831063|FG001|Post-treatment Follow-up|Overall Study||40
8780645|NCT01327053|9831062|FG000|COMPLETED|Overall Study||0
8780646|NCT01327053|9831063|FG001|COMPLETED|Overall Study||0
8780647|NCT01327053|9831062|FG000|NOT COMPLETED|Overall Study||79
8780648|NCT01327053|9831063|FG001|NOT COMPLETED|Overall Study||151
8780649|NCT01327157|9831075|FG000|STARTED|01-90||7
8780650|NCT01327157|9831076|FG001|STARTED|01-90||7
8780651|NCT01327157|9831075|FG000|COMPLETED|01-90||7
9030076|NCT03228433|10092494|FG001|COMPLETED|Overall Study||6
9030077|NCT03228433|10092495|FG002|COMPLETED|Overall Study||6
9030078|NCT03228433|10092496|FG003|COMPLETED|Overall Study||5
9030079|NCT03228433|10092497|FG004|COMPLETED|Overall Study||6
9030080|NCT03228433|10092498|FG005|COMPLETED|Overall Study||6
9030081|NCT03228433|10092493|FG000|NOT COMPLETED|Overall Study||1
9030082|NCT03228433|10092494|FG001|NOT COMPLETED|Overall Study||0
9030083|NCT03228433|10092495|FG002|NOT COMPLETED|Overall Study||0
9030084|NCT03228433|10092496|FG003|NOT COMPLETED|Overall Study||1
9030085|NCT03228433|10092497|FG004|NOT COMPLETED|Overall Study||0
9030086|NCT03228433|10092498|FG005|NOT COMPLETED|Overall Study||0
9030087|NCT03228836|10092520|FG000|STARTED|Overall Study||28
8780652|NCT01327157|9831076|FG001|COMPLETED|01-90||7
8780653|NCT01327157|9831075|FG000|NOT COMPLETED|01-90||0
8780654|NCT01327157|9831076|FG001|NOT COMPLETED|01-90||0
8780655|NCT01327157|9831075|FG000|STARTED|91-180||7
8780656|NCT01327157|9831076|FG001|STARTED|91-180||0
8780657|NCT01327157|9831075|FG000|COMPLETED|91-180||7
8780658|NCT01327157|9831076|FG001|COMPLETED|91-180||0
8780659|NCT01327157|9831075|FG000|NOT COMPLETED|91-180||0
8780660|NCT01327157|9831076|FG001|NOT COMPLETED|91-180||0
8780661|NCT01327274|9831087|FG000|STARTED|Overall Study||15
8780662|NCT01327274|9831087|FG000|COMPLETED|Overall Study||15
8780663|NCT01327274|9831087|FG000|NOT COMPLETED|Overall Study||0
8780664|NCT01327300|9831092|FG000|STARTED|First Intervention (12 Weeks)||5
8780665|NCT01327300|9831093|FG001|STARTED|First Intervention (12 Weeks)||2
8780666|NCT01327300|9831092|FG000|COMPLETED|First Intervention (12 Weeks)||5
8780667|NCT01327300|9831093|FG001|COMPLETED|First Intervention (12 Weeks)||2
8780668|NCT01327300|9831092|FG000|NOT COMPLETED|First Intervention (12 Weeks)||0
8780669|NCT01327300|9831093|FG001|NOT COMPLETED|First Intervention (12 Weeks)||0
8780670|NCT01327300|9831092|FG000|STARTED|Washout (3 Weeks)||5
8780671|NCT01327300|9831093|FG001|STARTED|Washout (3 Weeks)||2
8780672|NCT01327300|9831092|FG000|COMPLETED|Washout (3 Weeks)||4
8780673|NCT01327300|9831093|FG001|COMPLETED|Washout (3 Weeks)||2
8780674|NCT01327300|9831092|FG000|NOT COMPLETED|Washout (3 Weeks)||1
8780675|NCT01327300|9831093|FG001|NOT COMPLETED|Washout (3 Weeks)||0
8780676|NCT01327300|9831092|FG000|STARTED|Second Intervention (12 Weeks)||4
8780677|NCT01327300|9831093|FG001|STARTED|Second Intervention (12 Weeks)||2
8780678|NCT01327300|9831092|FG000|COMPLETED|Second Intervention (12 Weeks)||4
8780679|NCT01327300|9831093|FG001|COMPLETED|Second Intervention (12 Weeks)||2
8780680|NCT01327300|9831092|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||0
8780681|NCT01327300|9831093|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||0
8780682|NCT01327313|9831113|FG000|STARTED|Overall Study||8
8780683|NCT01327313|9831114|FG001|STARTED|Overall Study||6
8780684|NCT01327313|9831115|FG002|STARTED|Overall Study||6
8780685|NCT01327313|9831116|FG003|STARTED|Overall Study||7
8780686|NCT01327313|9831113|FG000|COMPLETED|Overall Study||8
8780687|NCT01327313|9831114|FG001|COMPLETED|Overall Study||6
8780688|NCT01327313|9831115|FG002|COMPLETED|Overall Study||6
8780689|NCT01327313|9831116|FG003|COMPLETED|Overall Study||7
8780690|NCT01327313|9831113|FG000|NOT COMPLETED|Overall Study||0
8780691|NCT01327313|9831114|FG001|NOT COMPLETED|Overall Study||0
8780692|NCT01327313|9831115|FG002|NOT COMPLETED|Overall Study||0
8780693|NCT01327313|9831116|FG003|NOT COMPLETED|Overall Study||0
8780694|NCT01327339|9831126|FG000|STARTED|Overall Study||755
8780695|NCT01327339|9831126|FG000|COMPLETED|Overall Study||747
8780696|NCT01327339|9831126|FG000|NOT COMPLETED|Overall Study||8
8780697|NCT01327482|9831130|FG000|STARTED|Overall Study||10
8780698|NCT01327482|9831130|FG000|COMPLETED|Overall Study|The 10th participant completed 2/3 visits|9
8780699|NCT01327482|9831130|FG000|NOT COMPLETED|Overall Study||1
8780700|NCT01327495|9831140|FG000|STARTED|Overall Study||10
8780701|NCT01327495|9831141|FG001|STARTED|Overall Study||11
8780702|NCT01327495|9831142|FG002|STARTED|Overall Study||10
8780703|NCT01327495|9831143|FG003|STARTED|Overall Study||9
8780704|NCT01327495|9831144|FG004|STARTED|Overall Study||11
8780705|NCT01327495|9831145|FG005|STARTED|Overall Study||11
8780706|NCT01327495|9831140|FG000|COMPLETED|Overall Study|1 dropped due to decreased libido & energy, 1 dropped due to too much pain with acyline injections|8
8780707|NCT01327495|9831141|FG001|COMPLETED|Overall Study|1 subject declined prostate biopsy & no-showed to final visit, 1 subject dropped d/t elevated LFTs.|9
8780708|NCT01327495|9831142|FG002|COMPLETED|Overall Study|1 withdrawn due to injection AE. 1 drop-out (declined prostate biopsy and final visit).|8
8780709|NCT01327495|9831143|FG003|COMPLETED|Overall Study||9
8780710|NCT01327495|9831144|FG004|COMPLETED|Overall Study|1 dropped out pre drug finish, 2 non-compliant subjects dropped|8
9030088|NCT03228836|10092520|FG000|Treated|Overall Study||28
9030089|NCT03228836|10092520|FG000|COMPLETED|Overall Study||11
8780711|NCT01327495|9831145|FG005|COMPLETED|Overall Study|1 subject withdrawn d/t elevated LFTs, 1 dropped out d/t ski accident|9
8780712|NCT01327495|9831140|FG000|NOT COMPLETED|Overall Study||2
8780713|NCT01327495|9831141|FG001|NOT COMPLETED|Overall Study||2
8780714|NCT01327495|9831142|FG002|NOT COMPLETED|Overall Study||2
8780715|NCT01327495|9831143|FG003|NOT COMPLETED|Overall Study||0
8780716|NCT01327495|9831144|FG004|NOT COMPLETED|Overall Study||3
8780717|NCT01327495|9831145|FG005|NOT COMPLETED|Overall Study||2
8780718|NCT01327508|9831167|FG000|STARTED|Overall Study||30
8780719|NCT01327508|9831168|FG001|STARTED|Overall Study||30
8780720|NCT01327508|9831167|FG000|COMPLETED|Overall Study||30
8780721|NCT01327508|9831168|FG001|COMPLETED|Overall Study||30
8780722|NCT01327508|9831167|FG000|NOT COMPLETED|Overall Study||0
8780723|NCT01327508|9831168|FG001|NOT COMPLETED|Overall Study||0
8780724|NCT01327547|9831176|FG000|STARTED|Overall Study||70
8780725|NCT01327547|9831177|FG001|STARTED|Overall Study||67
8780726|NCT01327547|9831176|FG000|Randomized and Not Treated|Overall Study||0
8780727|NCT01327547|9831177|FG001|Randomized and Not Treated|Overall Study|Randomized but was withdrawn prior to receiving treatment due to poor venous access.|1
8780728|NCT01327547|9831176|FG000|COMPLETED|Overall Study||50
8780729|NCT01327547|9831177|FG001|COMPLETED|Overall Study||45
8780730|NCT01327547|9831176|FG000|NOT COMPLETED|Overall Study||20
8780731|NCT01327547|9831177|FG001|NOT COMPLETED|Overall Study||22
8780732|NCT01327573|9831194|FG000|STARTED|Overall Study||11
8780733|NCT01327573|9831195|FG001|STARTED|Overall Study||5
8780734|NCT01327573|9831194|FG000|Received Treatment/Control as Allocated|Overall Study||10
8780735|NCT01327573|9831195|FG001|Received Treatment/Control as Allocated|Overall Study||5
8780736|NCT01327573|9831194|FG000|COMPLETED|Overall Study||8
8780737|NCT01327573|9831195|FG001|COMPLETED|Overall Study||4
8780738|NCT01327573|9831194|FG000|NOT COMPLETED|Overall Study||3
8780739|NCT01327573|9831195|FG001|NOT COMPLETED|Overall Study||1
8780740|NCT01327599|9831202|FG000|STARTED|Overall Study||60
8780741|NCT01327599|9831202|FG000|COMPLETED|Overall Study||57
8780742|NCT01327599|9831202|FG000|NOT COMPLETED|Overall Study||3
8780743|NCT01327612|9831213|FG000|STARTED|Overall Study||2
8780744|NCT01327612|9831214|FG001|STARTED|Overall Study||1
8780745|NCT01327612|9831215|FG002|STARTED|Overall Study||1
8780746|NCT01327612|9831216|FG003|STARTED|Overall Study||1
8780747|NCT01327612|9831217|FG004|STARTED|Overall Study||2
8780748|NCT01327612|9831218|FG005|STARTED|Overall Study||3
8780749|NCT01327612|9831219|FG006|STARTED|Overall Study||2
8780750|NCT01327612|9831213|FG000|COMPLETED|Overall Study||1
8780751|NCT01327612|9831214|FG001|COMPLETED|Overall Study||0
8780752|NCT01327612|9831215|FG002|COMPLETED|Overall Study||0
8780753|NCT01327612|9831216|FG003|COMPLETED|Overall Study||0
8780754|NCT01327612|9831217|FG004|COMPLETED|Overall Study||0
8780755|NCT01327612|9831218|FG005|COMPLETED|Overall Study||0
8780756|NCT01327612|9831219|FG006|COMPLETED|Overall Study||0
8780757|NCT01327612|9831213|FG000|NOT COMPLETED|Overall Study||1
8780758|NCT01327612|9831214|FG001|NOT COMPLETED|Overall Study||1
8780759|NCT01327612|9831215|FG002|NOT COMPLETED|Overall Study||1
8780760|NCT01327612|9831216|FG003|NOT COMPLETED|Overall Study||1
8780761|NCT01327612|9831217|FG004|NOT COMPLETED|Overall Study||2
8780762|NCT01327612|9831218|FG005|NOT COMPLETED|Overall Study||3
8780763|NCT01327612|9831219|FG006|NOT COMPLETED|Overall Study||2
8780764|NCT01327651|9831245|FG000|STARTED|Self-administered Dosing Period||60
8780765|NCT01327651|9831246|FG001|STARTED|Self-administered Dosing Period||59
8780766|NCT01327651|9831247|FG002|STARTED|Self-administered Dosing Period||60
8780767|NCT01327651|9831248|FG003|STARTED|Self-administered Dosing Period||60
8780768|NCT01327651|9831249|FG004|STARTED|Self-administered Dosing Period||59
8780769|NCT01327651|9831250|FG005|STARTED|Self-administered Dosing Period||59
8780770|NCT01327651|9831251|FG006|STARTED|Self-administered Dosing Period||59
8780771|NCT01327651|9831252|FG007|STARTED|Self-administered Dosing Period||60
8780772|NCT01327651|9831253|FG008|STARTED|Self-administered Dosing Period||60
8780773|NCT01327651|9831245|FG000|Week 10|Self-administered Dosing Period||59
8780774|NCT01327651|9831246|FG001|Week 10|Self-administered Dosing Period||58
8780775|NCT01327651|9831247|FG002|Week 10|Self-administered Dosing Period||60
8780776|NCT01327651|9831248|FG003|Week 10|Self-administered Dosing Period||60
8780777|NCT01327651|9831249|FG004|Week 10|Self-administered Dosing Period||59
8780778|NCT01327651|9831250|FG005|Week 10|Self-administered Dosing Period||59
8780779|NCT01327651|9831251|FG006|Week 10|Self-administered Dosing Period||57
8780780|NCT01327651|9831252|FG007|Week 10|Self-administered Dosing Period||57
8780781|NCT01327651|9831253|FG008|Week 10|Self-administered Dosing Period||56
8780782|NCT01327651|9831245|FG000|Week 14|Self-administered Dosing Period||59
8780783|NCT01327651|9831246|FG001|Week 14|Self-administered Dosing Period||55
8575174|NCT00133575|9607667|FG000|COMPLETED|Overall Study||10
8780784|NCT01327651|9831247|FG002|Week 14|Self-administered Dosing Period||57
8780785|NCT01327651|9831248|FG003|Week 14|Self-administered Dosing Period||60
8780786|NCT01327651|9831249|FG004|Week 14|Self-administered Dosing Period||58
8780787|NCT01327651|9831250|FG005|Week 14|Self-administered Dosing Period||59
8780788|NCT01327651|9831251|FG006|Week 14|Self-administered Dosing Period||54
8780789|NCT01327651|9831252|FG007|Week 14|Self-administered Dosing Period||51
8780790|NCT01327651|9831253|FG008|Week 14|Self-administered Dosing Period||54
8780791|NCT01327651|9831245|FG000|Week 18|Self-administered Dosing Period||57
8780792|NCT01327651|9831246|FG001|Week 18|Self-administered Dosing Period||56
8780793|NCT01327651|9831247|FG002|Week 18|Self-administered Dosing Period||56
8780794|NCT01327651|9831248|FG003|Week 18|Self-administered Dosing Period||60
9030090|NCT03228836|10092520|FG000|NOT COMPLETED|Overall Study||17
9030091|NCT03228914|10092524|FG000|STARTED|Overall Study||20
9030092|NCT03228914|10092525|FG001|STARTED|Overall Study||20
9030093|NCT03228914|10092524|FG000|COMPLETED|Overall Study||20
9030094|NCT03228914|10092525|FG001|COMPLETED|Overall Study||20
9030095|NCT03228914|10092524|FG000|NOT COMPLETED|Overall Study||0
9030096|NCT03228914|10092525|FG001|NOT COMPLETED|Overall Study||0
9030097|NCT03229109|10092535|FG000|STARTED|Overall Study||50
9030098|NCT03229109|10092536|FG001|STARTED|Overall Study||50
8780795|NCT01327651|9831249|FG004|Week 18|Self-administered Dosing Period||57
8780796|NCT01327651|9831250|FG005|Week 18|Self-administered Dosing Period||59
8780797|NCT01327651|9831251|FG006|Week 18|Self-administered Dosing Period||53
8780798|NCT01327651|9831252|FG007|Week 18|Self-administered Dosing Period||49
8780799|NCT01327651|9831253|FG008|Week 18|Self-administered Dosing Period||53
8780800|NCT01327651|9831245|FG000|Week 22|Self-administered Dosing Period||59
8780801|NCT01327651|9831246|FG001|Week 22|Self-administered Dosing Period||56
8780802|NCT01327651|9831247|FG002|Week 22|Self-administered Dosing Period||55
8780803|NCT01327651|9831248|FG003|Week 22|Self-administered Dosing Period||58
8780804|NCT01327651|9831249|FG004|Week 22|Self-administered Dosing Period||56
8780805|NCT01327651|9831250|FG005|Week 22|Self-administered Dosing Period||59
8780806|NCT01327651|9831251|FG006|Week 22|Self-administered Dosing Period||50
8780807|NCT01327651|9831252|FG007|Week 22|Self-administered Dosing Period||50
8780808|NCT01327651|9831253|FG008|Week 22|Self-administered Dosing Period||51
8780809|NCT01327651|9831245|FG000|Week 26|Self-administered Dosing Period||58
8780810|NCT01327651|9831246|FG001|Week 26|Self-administered Dosing Period||56
8780811|NCT01327651|9831247|FG002|Week 26|Self-administered Dosing Period||53
8780812|NCT01327651|9831248|FG003|Week 26|Self-administered Dosing Period||57
8780813|NCT01327651|9831249|FG004|Week 26|Self-administered Dosing Period||56
8780814|NCT01327651|9831250|FG005|Week 26|Self-administered Dosing Period||58
8780815|NCT01327651|9831251|FG006|Week 26|Self-administered Dosing Period||50
8780816|NCT01327651|9831252|FG007|Week 26|Self-administered Dosing Period||51
8780817|NCT01327651|9831253|FG008|Week 26|Self-administered Dosing Period||49
8780818|NCT01327651|9831245|FG000|COMPLETED|Self-administered Dosing Period||56
8780819|NCT01327651|9831246|FG001|COMPLETED|Self-administered Dosing Period||56
8780820|NCT01327651|9831247|FG002|COMPLETED|Self-administered Dosing Period||56
8780821|NCT01327651|9831248|FG003|COMPLETED|Self-administered Dosing Period||57
8780822|NCT01327651|9831249|FG004|COMPLETED|Self-administered Dosing Period||56
9030099|NCT03229109|10092537|FG002|STARTED|Overall Study||50
9030100|NCT03229109|10092538|FG003|STARTED|Overall Study||51
9030101|NCT03229109|10092535|FG000|COMPLETED|Overall Study||50
9030102|NCT03229109|10092536|FG001|COMPLETED|Overall Study||50
9030103|NCT03229109|10092537|FG002|COMPLETED|Overall Study||50
9030104|NCT03229109|10092538|FG003|COMPLETED|Overall Study||50
9030105|NCT03229109|10092535|FG000|NOT COMPLETED|Overall Study||0
9030106|NCT03229109|10092536|FG001|NOT COMPLETED|Overall Study||0
9030107|NCT03229109|10092537|FG002|NOT COMPLETED|Overall Study||0
9030108|NCT03229109|10092538|FG003|NOT COMPLETED|Overall Study||1
9030109|NCT03229252|10092551|FG000|STARTED|Overall Study||31
9030110|NCT03229252|10092552|FG001|STARTED|Overall Study||15
9030111|NCT03229252|10092553|FG002|STARTED|Overall Study||45
9030112|NCT03229252|10092551|FG000|COMPLETED|Overall Study||29
9030113|NCT03229252|10092552|FG001|COMPLETED|Overall Study||15
9030114|NCT03229252|10092553|FG002|COMPLETED|Overall Study||39
9030115|NCT03229252|10092551|FG000|NOT COMPLETED|Overall Study||2
9030116|NCT03229252|10092552|FG001|NOT COMPLETED|Overall Study||0
9030117|NCT03229252|10092553|FG002|NOT COMPLETED|Overall Study||6
8780823|NCT01327651|9831250|FG005|COMPLETED|Self-administered Dosing Period||59
8780824|NCT01327651|9831251|FG006|COMPLETED|Self-administered Dosing Period||49
8780825|NCT01327651|9831252|FG007|COMPLETED|Self-administered Dosing Period||50
8780826|NCT01327651|9831253|FG008|COMPLETED|Self-administered Dosing Period||49
8780827|NCT01327651|9831245|FG000|NOT COMPLETED|Self-administered Dosing Period||4
8780828|NCT01327651|9831246|FG001|NOT COMPLETED|Self-administered Dosing Period||3
8780829|NCT01327651|9831247|FG002|NOT COMPLETED|Self-administered Dosing Period||4
8780830|NCT01327651|9831248|FG003|NOT COMPLETED|Self-administered Dosing Period||3
8780831|NCT01327651|9831249|FG004|NOT COMPLETED|Self-administered Dosing Period||3
8780832|NCT01327651|9831250|FG005|NOT COMPLETED|Self-administered Dosing Period||0
8780833|NCT01327651|9831251|FG006|NOT COMPLETED|Self-administered Dosing Period||10
8780834|NCT01327651|9831252|FG007|NOT COMPLETED|Self-administered Dosing Period||10
8780835|NCT01327651|9831253|FG008|NOT COMPLETED|Self-administered Dosing Period||11
8780836|NCT01327651|9831245|FG000|STARTED|Post Study Follow-up||56
8780837|NCT01327651|9831246|FG001|STARTED|Post Study Follow-up||56
8780838|NCT01327651|9831247|FG002|STARTED|Post Study Follow-up||56
8780839|NCT01327651|9831248|FG003|STARTED|Post Study Follow-up||57
8780840|NCT01327651|9831249|FG004|STARTED|Post Study Follow-up||56
8780841|NCT01327651|9831250|FG005|STARTED|Post Study Follow-up||59
8780842|NCT01327651|9831251|FG006|STARTED|Post Study Follow-up||49
8780843|NCT01327651|9831252|FG007|STARTED|Post Study Follow-up||50
8780844|NCT01327651|9831253|FG008|STARTED|Post Study Follow-up||49
8780845|NCT01327651|9831245|FG000|COMPLETED|Post Study Follow-up||56
8780846|NCT01327651|9831246|FG001|COMPLETED|Post Study Follow-up||55
8780847|NCT01327651|9831247|FG002|COMPLETED|Post Study Follow-up||55
8780848|NCT01327651|9831248|FG003|COMPLETED|Post Study Follow-up||57
8780849|NCT01327651|9831249|FG004|COMPLETED|Post Study Follow-up||56
8780850|NCT01327651|9831250|FG005|COMPLETED|Post Study Follow-up||59
8780851|NCT01327651|9831251|FG006|COMPLETED|Post Study Follow-up||45
8780852|NCT01327651|9831252|FG007|COMPLETED|Post Study Follow-up||49
8780853|NCT01327651|9831253|FG008|COMPLETED|Post Study Follow-up||47
8780854|NCT01327651|9831245|FG000|NOT COMPLETED|Post Study Follow-up||0
8780855|NCT01327651|9831246|FG001|NOT COMPLETED|Post Study Follow-up||1
8780856|NCT01327651|9831247|FG002|NOT COMPLETED|Post Study Follow-up||1
8780857|NCT01327651|9831248|FG003|NOT COMPLETED|Post Study Follow-up||0
8780858|NCT01327651|9831249|FG004|NOT COMPLETED|Post Study Follow-up||0
8780859|NCT01327651|9831250|FG005|NOT COMPLETED|Post Study Follow-up||0
8780860|NCT01327651|9831251|FG006|NOT COMPLETED|Post Study Follow-up||4
8780861|NCT01327651|9831252|FG007|NOT COMPLETED|Post Study Follow-up||1
8780862|NCT01327651|9831253|FG008|NOT COMPLETED|Post Study Follow-up||2
8780863|NCT01327677|9831294|FG000|STARTED|Overall Study||68
8780864|NCT01327677|9831295|FG001|STARTED|Overall Study||69
8780865|NCT01327677|9831294|FG000|COMPLETED|Overall Study||48
8780866|NCT01327677|9831295|FG001|COMPLETED|Overall Study||56
8780867|NCT01327677|9831294|FG000|NOT COMPLETED|Overall Study||20
8780868|NCT01327677|9831295|FG001|NOT COMPLETED|Overall Study||13
8780869|NCT01327703|9831303|FG000|STARTED|First Treatment Period||42
8780870|NCT01327703|9831304|FG001|STARTED|First Treatment Period||45
8780871|NCT01327703|9831303|FG000|COMPLETED|First Treatment Period||42
8780872|NCT01327703|9831304|FG001|COMPLETED|First Treatment Period||45
8780873|NCT01327703|9831303|FG000|NOT COMPLETED|First Treatment Period||0
8780874|NCT01327703|9831304|FG001|NOT COMPLETED|First Treatment Period||0
8780875|NCT01327703|9831303|FG000|STARTED|Second Treatment Period|Two participants discontinued between first and second treatment periods due to adverse event.|40
8780876|NCT01327703|9831304|FG001|STARTED|Second Treatment Period|One participant discontinued between first and second treatment periods due to adverse event.|44
8780877|NCT01327703|9831303|FG000|COMPLETED|Second Treatment Period||39
8780878|NCT01327703|9831304|FG001|COMPLETED|Second Treatment Period||42
8780879|NCT01327703|9831303|FG000|NOT COMPLETED|Second Treatment Period||1
8780880|NCT01327703|9831304|FG001|NOT COMPLETED|Second Treatment Period||2
8780881|NCT01327846|9831317|FG000|STARTED|Core Phase||2263
8780882|NCT01327846|9831318|FG001|STARTED|Core Phase||2284
8780883|NCT01327846|9831319|FG002|STARTED|Core Phase||2170
8780884|NCT01327846|9831320|FG003|STARTED|Core Phase||3344
8780885|NCT01327846|9831317|FG000|COMPLETED|Core Phase||2235
8780886|NCT01327846|9831318|FG001|COMPLETED|Core Phase||2252
8780887|NCT01327846|9831319|FG002|COMPLETED|Core Phase||2144
8780888|NCT01327846|9831320|FG003|COMPLETED|Core Phase||3311
8780889|NCT01327846|9831317|FG000|NOT COMPLETED|Core Phase||28
8780890|NCT01327846|9831318|FG001|NOT COMPLETED|Core Phase||32
8780891|NCT01327846|9831319|FG002|NOT COMPLETED|Core Phase||26
8780892|NCT01327846|9831320|FG003|NOT COMPLETED|Core Phase||33
8780893|NCT01327846|9831317|FG000|STARTED|Extension Phase||1267
8780894|NCT01327846|9831318|FG001|STARTED|Extension Phase||1287
8780895|NCT01327846|9831319|FG002|STARTED|Extension Phase||1279
8780896|NCT01327846|9831320|FG003|STARTED|Extension Phase||1944
8780897|NCT01327846|9831317|FG000|Stopped/Discontinued Study at Washout|Extension Phase||127
8780898|NCT01327846|9831318|FG001|Stopped/Discontinued Study at Washout|Extension Phase||97
8780899|NCT01327846|9831319|FG002|Stopped/Discontinued Study at Washout|Extension Phase||137
8780900|NCT01327846|9831320|FG003|Stopped/Discontinued Study at Washout|Extension Phase||178
8780901|NCT01327846|9831317|FG000|Completed Treatment Period|Extension Phase||41
8780902|NCT01327846|9831318|FG001|Completed Treatment Period|Extension Phase||45
8780903|NCT01327846|9831319|FG002|Completed Treatment Period|Extension Phase||49
8780904|NCT01327846|9831320|FG003|Completed Treatment Period|Extension Phase||60
8780905|NCT01327846|9831317|FG000|Details Missing|Extension Phase||0
8780906|NCT01327846|9831318|FG001|Details Missing|Extension Phase||1
8780907|NCT01327846|9831319|FG002|Details Missing|Extension Phase||1
8780908|NCT01327846|9831320|FG003|Details Missing|Extension Phase||0
8780909|NCT01327846|9831317|FG000|COMPLETED|Extension Phase||168
8780910|NCT01327846|9831318|FG001|COMPLETED|Extension Phase||143
8780911|NCT01327846|9831319|FG002|COMPLETED|Extension Phase||187
8780912|NCT01327846|9831320|FG003|COMPLETED|Extension Phase||238
8780913|NCT01327846|9831317|FG000|NOT COMPLETED|Extension Phase||1099
8780914|NCT01327846|9831318|FG001|NOT COMPLETED|Extension Phase||1144
8780915|NCT01327846|9831319|FG002|NOT COMPLETED|Extension Phase||1092
8780916|NCT01327846|9831320|FG003|NOT COMPLETED|Extension Phase||1706
8780917|NCT01327885|9831333|FG000|STARTED|Overall Study||228
8780918|NCT01327885|9831334|FG001|STARTED|Overall Study||224
8780919|NCT01327885|9831333|FG000|COMPLETED|Overall Study||0
8780920|NCT01327885|9831334|FG001|COMPLETED|Overall Study||0
8780921|NCT01327885|9831333|FG000|NOT COMPLETED|Overall Study||228
8780922|NCT01327885|9831334|FG001|NOT COMPLETED|Overall Study||224
8780923|NCT01327963|9831341|FG000|STARTED|Overall Study||110
8780924|NCT01327963|9831341|FG000|COMPLETED|Overall Study|110 participants signed informed consent to be included in the study.|110
8780925|NCT01327963|9831341|FG000|NOT COMPLETED|Overall Study||0
8780926|NCT01327976|9831349|FG000|STARTED|Overall Study||162
8780927|NCT01327976|9831350|FG001|STARTED|Overall Study||77
8780928|NCT01327976|9831349|FG000|COMPLETED|Overall Study||154
8780929|NCT01327976|9831350|FG001|COMPLETED|Overall Study||70
8780930|NCT01327976|9831349|FG000|NOT COMPLETED|Overall Study||8
8780931|NCT01327976|9831350|FG001|NOT COMPLETED|Overall Study||7
8780932|NCT01327989|9831358|FG000|STARTED|Overall Study||202
8780933|NCT01327989|9831358|FG000|COMPLETED|Overall Study||188
8780934|NCT01327989|9831358|FG000|NOT COMPLETED|Overall Study||14
8780935|NCT01328002|9831362|FG000|STARTED|Open-Label Period||116
8780936|NCT01328002|9831363|FG001|STARTED|Open-Label Period||0
8780937|NCT01328002|9831362|FG000|COMPLETED|Open-Label Period||20
8780938|NCT01328002|9831363|FG001|COMPLETED|Open-Label Period||0
8780939|NCT01328002|9831362|FG000|NOT COMPLETED|Open-Label Period||96
8780940|NCT01328002|9831363|FG001|NOT COMPLETED|Open-Label Period||0
8780941|NCT01328002|9831362|FG000|STARTED|Double-Blind Period||14
8780942|NCT01328002|9831363|FG001|STARTED|Double-Blind Period||6
8780943|NCT01328002|9831362|FG000|COMPLETED|Double-Blind Period||12
8780944|NCT01328002|9831363|FG001|COMPLETED|Double-Blind Period||6
8780945|NCT01328002|9831362|FG000|NOT COMPLETED|Double-Blind Period||2
8780946|NCT01328002|9831363|FG001|NOT COMPLETED|Double-Blind Period||0
8780947|NCT01328041|9831370|FG000|STARTED|Overall Study||183
8780948|NCT01328041|9831370|FG000|COMPLETED|Overall Study||126
8780949|NCT01328041|9831370|FG000|NOT COMPLETED|Overall Study||57
8780950|NCT01328054|9831374|FG000|STARTED|Placebo on Day 1 and Day 2 (2 Days)||57
8780951|NCT01328054|9831375|FG001|STARTED|Placebo on Day 1 and Day 2 (2 Days)||0
8780952|NCT01328054|9831374|FG000|COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||57
8780953|NCT01328054|9831375|FG001|COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||0
8780954|NCT01328054|9831374|FG000|NOT COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||0
8780955|NCT01328054|9831375|FG001|NOT COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||0
8780956|NCT01328054|9831374|FG000|STARTED|Lapatinib on Day 3 and Day 4 (2 Days)||0
8780957|NCT01328054|9831375|FG001|STARTED|Lapatinib on Day 3 and Day 4 (2 Days)|One par. was double dosed with lapatinib due to a dosing error - reason for difference in # Started.|58
8780958|NCT01328054|9831374|FG000|COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||0
8780959|NCT01328054|9831375|FG001|COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||53
8780960|NCT01328054|9831374|FG000|NOT COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||0
8780961|NCT01328054|9831375|FG001|NOT COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||5
8780962|NCT01328080|9831387|FG000|STARTED|Overall Study|11 subjects consented; 1 withdrew consent before first UVB treatment|11
8780963|NCT01328080|9831387|FG000|COMPLETED|Overall Study||6
8780964|NCT01328080|9831387|FG000|NOT COMPLETED|Overall Study||5
8780965|NCT01328158|9831391|FG000|STARTED|Overall Study||220
8780966|NCT01328158|9831391|FG000|COMPLETED|Overall Study||220
8780967|NCT01328158|9831391|FG000|NOT COMPLETED|Overall Study||0
8780968|NCT01328184|9831398|FG000|STARTED|Overall Study||18
8780969|NCT01328184|9831398|FG000|COMPLETED|Overall Study||18
8780970|NCT01328184|9831398|FG000|NOT COMPLETED|Overall Study||0
8780971|NCT01328249|9831406|FG000|STARTED|Overall Study||55
8780972|NCT01328249|9831407|FG001|STARTED|Overall Study||26
8780973|NCT01328249|9831406|FG000|COMPLETED|Overall Study||48
8780974|NCT01328249|9831407|FG001|COMPLETED|Overall Study||23
8780975|NCT01328249|9831406|FG000|NOT COMPLETED|Overall Study||7
8780976|NCT01328249|9831407|FG001|NOT COMPLETED|Overall Study||3
8780977|NCT01328366|9831415|FG000|STARTED|Overall Study||153
8780978|NCT01328366|9831415|FG000|COMPLETED|Overall Study||143
8780979|NCT01328366|9831415|FG000|NOT COMPLETED|Overall Study||10
8780980|NCT01328379|9831422|FG000|STARTED|Overall Study||143
8780981|NCT01328379|9831423|FG001|STARTED|Overall Study||144
8780982|NCT01328379|9831424|FG002|STARTED|Overall Study||143
8780983|NCT01328379|9831422|FG000|COMPLETED|Overall Study||142
8780984|NCT01328379|9831423|FG001|COMPLETED|Overall Study||144
8780985|NCT01328379|9831424|FG002|COMPLETED|Overall Study||143
8780986|NCT01328379|9831422|FG000|NOT COMPLETED|Overall Study||1
8780987|NCT01328379|9831423|FG001|NOT COMPLETED|Overall Study||0
8780988|NCT01328379|9831424|FG002|NOT COMPLETED|Overall Study||0
8780989|NCT01328405|9831434|FG000|STARTED|Overall Study||52
8780990|NCT01328405|9831435|FG001|STARTED|Overall Study||48
8780991|NCT01328405|9831434|FG000|COMPLETED|Overall Study||52
8780992|NCT01328405|9831435|FG001|COMPLETED|Overall Study||48
8780993|NCT01328405|9831434|FG000|NOT COMPLETED|Overall Study||0
8780994|NCT01328405|9831435|FG001|NOT COMPLETED|Overall Study||0
8780995|NCT01328431|9831443|FG000|STARTED|Baseline||390
8780996|NCT01328431|9831444|FG001|STARTED|Baseline||390
8780997|NCT01328431|9831443|FG000|COMPLETED|Baseline||390
8780998|NCT01328431|9831444|FG001|COMPLETED|Baseline|Two subjects enrolled in study twice. Protocol violation.|388
8780999|NCT01328431|9831443|FG000|NOT COMPLETED|Baseline||0
8781000|NCT01328431|9831444|FG001|NOT COMPLETED|Baseline||2
8781001|NCT01328431|9831443|FG000|STARTED|1 Month (1M)||390
8781002|NCT01328431|9831444|FG001|STARTED|1 Month (1M)||388
8781003|NCT01328431|9831443|FG000|COMPLETED|1 Month (1M)||335
8781004|NCT01328431|9831444|FG001|COMPLETED|1 Month (1M)||330
8671703|NCT00753415|9715110|FG008|NOT COMPLETED|Part A||0
8781005|NCT01328431|9831443|FG000|NOT COMPLETED|1 Month (1M)||55
8781006|NCT01328431|9831444|FG001|NOT COMPLETED|1 Month (1M)||58
8781007|NCT01328431|9831443|FG000|STARTED|3 Month (3M)|Attempted to contact all subjects for 3M follow-up, regardless of whether they completed 1M.|390
8781008|NCT01328431|9831444|FG001|STARTED|3 Month (3M)|Attempted to contact all subjects for 3M follow-up, regardless of whether they completed 1M.|388
8781009|NCT01328431|9831443|FG000|COMPLETED|3 Month (3M)||313
8781010|NCT01328431|9831444|FG001|COMPLETED|3 Month (3M)||316
8781011|NCT01328431|9831443|FG000|NOT COMPLETED|3 Month (3M)||77
8781012|NCT01328431|9831444|FG001|NOT COMPLETED|3 Month (3M)||72
8781013|NCT01328431|9831443|FG000|STARTED|12 Month (12M)|Attempted to contact all subjects at 12M follow-up. Deceased subjects excluded.|388
8781014|NCT01328431|9831444|FG001|STARTED|12 Month (12M)|Attempted to contact all subjects at 12M follow-up. Deceased subjects excluded.|386
8781015|NCT01328431|9831443|FG000|COMPLETED|12 Month (12M)||304
8781016|NCT01328431|9831444|FG001|COMPLETED|12 Month (12M)||289
8781017|NCT01328431|9831443|FG000|NOT COMPLETED|12 Month (12M)||84
8781018|NCT01328431|9831444|FG001|NOT COMPLETED|12 Month (12M)||97
8781019|NCT01328444|9831450|FG000|STARTED|Treatment Period 1 (12 Weeks)||94
8781020|NCT01328444|9831451|FG001|STARTED|Treatment Period 1 (12 Weeks)||26
8781021|NCT01328444|9831452|FG002|STARTED|Treatment Period 1 (12 Weeks)||28
8781022|NCT01328444|9831453|FG003|STARTED|Treatment Period 1 (12 Weeks)||41
8781023|NCT01328444|9831454|FG004|STARTED|Treatment Period 1 (12 Weeks)||81
8781024|NCT01328444|9831455|FG005|STARTED|Treatment Period 1 (12 Weeks)||78
8781025|NCT01328444|9831450|FG000|COMPLETED|Treatment Period 1 (12 Weeks)||83
8781026|NCT01328444|9831451|FG001|COMPLETED|Treatment Period 1 (12 Weeks)||21
8781027|NCT01328444|9831452|FG002|COMPLETED|Treatment Period 1 (12 Weeks)||25
8781028|NCT01328444|9831453|FG003|COMPLETED|Treatment Period 1 (12 Weeks)||33
8781029|NCT01328444|9831454|FG004|COMPLETED|Treatment Period 1 (12 Weeks)||67
8781030|NCT01328444|9831455|FG005|COMPLETED|Treatment Period 1 (12 Weeks)||72
8781031|NCT01328444|9831450|FG000|NOT COMPLETED|Treatment Period 1 (12 Weeks)||11
8781032|NCT01328444|9831451|FG001|NOT COMPLETED|Treatment Period 1 (12 Weeks)||5
8781033|NCT01328444|9831452|FG002|NOT COMPLETED|Treatment Period 1 (12 Weeks)||3
8781034|NCT01328444|9831453|FG003|NOT COMPLETED|Treatment Period 1 (12 Weeks)||8
8781035|NCT01328444|9831454|FG004|NOT COMPLETED|Treatment Period 1 (12 Weeks)||14
8781036|NCT01328444|9831455|FG005|NOT COMPLETED|Treatment Period 1 (12 Weeks)||6
8781037|NCT01328444|9831450|FG000|STARTED|Washout Period (14 Days)||83
8781038|NCT01328444|9831451|FG001|STARTED|Washout Period (14 Days)||21
8781039|NCT01328444|9831452|FG002|STARTED|Washout Period (14 Days)||25
8781040|NCT01328444|9831453|FG003|STARTED|Washout Period (14 Days)||33
8781041|NCT01328444|9831454|FG004|STARTED|Washout Period (14 Days)||67
8781042|NCT01328444|9831455|FG005|STARTED|Washout Period (14 Days)||72
8781043|NCT01328444|9831450|FG000|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|82
8781044|NCT01328444|9831451|FG001|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
8781045|NCT01328444|9831452|FG002|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|25
8781046|NCT01328444|9831453|FG003|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|32
8781047|NCT01328444|9831454|FG004|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|66
8781048|NCT01328444|9831455|FG005|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|68
8781049|NCT01328444|9831450|FG000|NOT COMPLETED|Washout Period (14 Days)||1
8781050|NCT01328444|9831451|FG001|NOT COMPLETED|Washout Period (14 Days)||1
8781051|NCT01328444|9831452|FG002|NOT COMPLETED|Washout Period (14 Days)||0
8781052|NCT01328444|9831453|FG003|NOT COMPLETED|Washout Period (14 Days)||1
8781053|NCT01328444|9831454|FG004|NOT COMPLETED|Washout Period (14 Days)||1
8781054|NCT01328444|9831455|FG005|NOT COMPLETED|Washout Period (14 Days)||4
8781055|NCT01328444|9831450|FG000|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|76
8781056|NCT01328444|9831451|FG001|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|23
8809088|NCT01494987|9861531|FG000|STARTED|Overall Study||216
8671704|NCT00753415|9715111|FG009|NOT COMPLETED|Part A||0
8671705|NCT00753415|9715102|FG000|STARTED|Part B||0
8671706|NCT00753415|9715103|FG001|STARTED|Part B||0
8671707|NCT00753415|9715104|FG002|STARTED|Part B||0
8671708|NCT00753415|9715105|FG003|STARTED|Part B||0
8671709|NCT00753415|9715106|FG004|STARTED|Part B||0
8671710|NCT00753415|9715107|FG005|STARTED|Part B|Of 2 eligible participants who completed Part A, 1 chose to enter Part B|1
8671711|NCT00753415|9715108|FG006|STARTED|Part B|Of 3 eligible participants who completed Part A, 2 chose to enter Part B|2
8671712|NCT00753415|9715109|FG007|STARTED|Part B|Of 8 eligible participants who completed Part A, 7 chose to enter Part B|7
8671713|NCT00753415|9715110|FG008|STARTED|Part B|9 participants who completed Part A were eligible and enrolled in Part B|9
8671714|NCT00753415|9715111|FG009|STARTED|Part B|Of 10 eligible participants who completed Part A, 9 chose to enter Part B|9
8671715|NCT00753415|9715102|FG000|COMPLETED|Part B||0
8671716|NCT00753415|9715103|FG001|COMPLETED|Part B||0
8671717|NCT00753415|9715104|FG002|COMPLETED|Part B||0
8671718|NCT00753415|9715105|FG003|COMPLETED|Part B||0
8671719|NCT00753415|9715106|FG004|COMPLETED|Part B||0
8671720|NCT00753415|9715107|FG005|COMPLETED|Part B||1
8671721|NCT00753415|9715108|FG006|COMPLETED|Part B||2
8671722|NCT00753415|9715109|FG007|COMPLETED|Part B||6
8781057|NCT01328444|9831452|FG002|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|22
8781058|NCT01328444|9831453|FG003|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|35
8781059|NCT01328444|9831454|FG004|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|71
8781060|NCT01328444|9831455|FG005|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|66
8781061|NCT01328444|9831450|FG000|COMPLETED|Treatment Period 2 (12 Weeks)||65
8781062|NCT01328444|9831451|FG001|COMPLETED|Treatment Period 2 (12 Weeks)||22
8781063|NCT01328444|9831452|FG002|COMPLETED|Treatment Period 2 (12 Weeks)||19
8781064|NCT01328444|9831453|FG003|COMPLETED|Treatment Period 2 (12 Weeks)||30
8781065|NCT01328444|9831454|FG004|COMPLETED|Treatment Period 2 (12 Weeks)||63
8781066|NCT01328444|9831455|FG005|COMPLETED|Treatment Period 2 (12 Weeks)||59
9030118|NCT03229486|10092563|FG000|STARTED|Overall Study||20
9030119|NCT03229486|10092564|FG001|STARTED|Overall Study||20
9030120|NCT03229486|10092563|FG000|COMPLETED|Overall Study||20
9030121|NCT03229486|10092564|FG001|COMPLETED|Overall Study||19
9030122|NCT03229486|10092563|FG000|NOT COMPLETED|Overall Study||0
9030123|NCT03229486|10092564|FG001|NOT COMPLETED|Overall Study||1
9030124|NCT03229759|10092570|FG000|STARTED|Overall Study||99
9030125|NCT03229759|10092570|FG000|Participants Treated|Overall Study||69
9030126|NCT03229759|10092570|FG000|Treated With Investigational Product|Overall Study||45
9030127|NCT03229759|10092570|FG000|Treated With Vehicle Control|Overall Study||47
9030128|NCT03229759|10092570|FG000|Treated With Saline Control|Overall Study||46
9030129|NCT03229759|10092570|FG000|COMPLETED|Overall Study||69
9030130|NCT03229759|10092570|FG000|NOT COMPLETED|Overall Study||30
9030131|NCT03230175|10092576|FG000|STARTED|Overall Study||32
9030132|NCT03230175|10092576|FG000|COMPLETED|Overall Study||30
9030133|NCT03230175|10092576|FG000|NOT COMPLETED|Overall Study||2
9030134|NCT03230864|10092583|FG000|STARTED|Prospective Confirmation (PC) Period||68
9030135|NCT03230864|10092584|FG001|STARTED|Prospective Confirmation (PC) Period||51
9030136|NCT03230864|10092585|FG002|STARTED|Prospective Confirmation (PC) Period||0
9030137|NCT03230864|10092586|FG003|STARTED|Prospective Confirmation (PC) Period||0
9030138|NCT03230864|10092583|FG000|COMPLETED|Prospective Confirmation (PC) Period||36
9030139|NCT03230864|10092584|FG001|COMPLETED|Prospective Confirmation (PC) Period||32
9030140|NCT03230864|10092585|FG002|COMPLETED|Prospective Confirmation (PC) Period||0
9030141|NCT03230864|10092586|FG003|COMPLETED|Prospective Confirmation (PC) Period||0
9030142|NCT03230864|10092583|FG000|NOT COMPLETED|Prospective Confirmation (PC) Period||32
9030143|NCT03230864|10092584|FG001|NOT COMPLETED|Prospective Confirmation (PC) Period||19
9030144|NCT03230864|10092585|FG002|NOT COMPLETED|Prospective Confirmation (PC) Period||0
9030145|NCT03230864|10092586|FG003|NOT COMPLETED|Prospective Confirmation (PC) Period||0
9030146|NCT03230864|10092583|FG000|STARTED|Double Blind Treatment (DBT) Period||0
9030147|NCT03230864|10092584|FG001|STARTED|Double Blind Treatment (DBT) Period||0
9030148|NCT03230864|10092585|FG002|STARTED|Double Blind Treatment (DBT) Period||35
9030149|NCT03230864|10092586|FG003|STARTED|Double Blind Treatment (DBT) Period||33
9030150|NCT03230864|10092583|FG000|COMPLETED|Double Blind Treatment (DBT) Period||0
9030151|NCT03230864|10092584|FG001|COMPLETED|Double Blind Treatment (DBT) Period||0
9030152|NCT03230864|10092585|FG002|COMPLETED|Double Blind Treatment (DBT) Period||27
9030153|NCT03230864|10092586|FG003|COMPLETED|Double Blind Treatment (DBT) Period||31
9030154|NCT03230864|10092583|FG000|NOT COMPLETED|Double Blind Treatment (DBT) Period||0
9030155|NCT03230864|10092584|FG001|NOT COMPLETED|Double Blind Treatment (DBT) Period||0
9030156|NCT03230864|10092585|FG002|NOT COMPLETED|Double Blind Treatment (DBT) Period||8
9030157|NCT03230864|10092586|FG003|NOT COMPLETED|Double Blind Treatment (DBT) Period||2
9030158|NCT03231228|10092598|FG000|STARTED|Overall Study||33
9030159|NCT03231228|10092599|FG001|STARTED|Overall Study||28
9030160|NCT03231228|10092598|FG000|COMPLETED|Overall Study||30
9030161|NCT03231228|10092599|FG001|COMPLETED|Overall Study||28
9030162|NCT03231228|10092598|FG000|NOT COMPLETED|Overall Study||3
9030163|NCT03231228|10092599|FG001|NOT COMPLETED|Overall Study||0
9030164|NCT03231345|10092605|FG000|STARTED|Overall Study||35
9030165|NCT03231345|10092605|FG000|COMPLETED|Overall Study||35
9030166|NCT03231345|10092605|FG000|NOT COMPLETED|Overall Study||0
9030167|NCT03231371|10092609|FG000|STARTED|Overall Study||22
9030168|NCT03231371|10092609|FG000|Optional and Age Limited (12 Yrs+) MRI|Overall Study||9
9030169|NCT03231371|10092609|FG000|COMPLETED|Overall Study||9
9030170|NCT03231371|10092609|FG000|NOT COMPLETED|Overall Study||13
9030171|NCT03231709|10092615|FG000|STARTED|Treatment Period 1||30
9030172|NCT03231709|10092616|FG001|STARTED|Treatment Period 1||30
9030173|NCT03231709|10092615|FG000|COMPLETED|Treatment Period 1||30
9030174|NCT03231709|10092616|FG001|COMPLETED|Treatment Period 1||29
9030175|NCT03231709|10092615|FG000|NOT COMPLETED|Treatment Period 1||0
9030176|NCT03231709|10092616|FG001|NOT COMPLETED|Treatment Period 1||1
9030177|NCT03231709|10092615|FG000|STARTED|Treatment Period 2||30
9030178|NCT03231709|10092616|FG001|STARTED|Treatment Period 2||29
9030179|NCT03231709|10092615|FG000|COMPLETED|Treatment Period 2||30
9030180|NCT03231709|10092616|FG001|COMPLETED|Treatment Period 2||28
9030181|NCT03231709|10092615|FG000|NOT COMPLETED|Treatment Period 2||0
9030182|NCT03231709|10092616|FG001|NOT COMPLETED|Treatment Period 2||1
9030183|NCT03231800|10092628|FG000|STARTED|Overall Study||48
9030184|NCT03231800|10092629|FG001|STARTED|Overall Study||47
9030185|NCT03231800|10092628|FG000|Safety Population|Overall Study||47
8781067|NCT01328444|9831450|FG000|NOT COMPLETED|Treatment Period 2 (12 Weeks)||11
8781068|NCT01328444|9831451|FG001|NOT COMPLETED|Treatment Period 2 (12 Weeks)||1
8781069|NCT01328444|9831452|FG002|NOT COMPLETED|Treatment Period 2 (12 Weeks)||3
8781070|NCT01328444|9831453|FG003|NOT COMPLETED|Treatment Period 2 (12 Weeks)||5
8781071|NCT01328444|9831454|FG004|NOT COMPLETED|Treatment Period 2 (12 Weeks)||8
8781072|NCT01328444|9831455|FG005|NOT COMPLETED|Treatment Period 2 (12 Weeks)||7
8781073|NCT01328496|9831471|FG000|STARTED|Overall Study||10
8781074|NCT01328496|9831472|FG001|STARTED|Overall Study||4
8781075|NCT01328496|9831471|FG000|COMPLETED|Overall Study||9
8781076|NCT01328496|9831472|FG001|COMPLETED|Overall Study||4
8781077|NCT01328496|9831471|FG000|NOT COMPLETED|Overall Study||1
8781078|NCT01328496|9831472|FG001|NOT COMPLETED|Overall Study||0
8781079|NCT01328535|9831481|FG000|STARTED|Overall Study||25
8781080|NCT01328535|9831481|FG000|COMPLETED|Overall Study||24
8781081|NCT01328535|9831481|FG000|NOT COMPLETED|Overall Study||1
8781082|NCT01328548|9831489|FG000|STARTED|Overall Study||191
8781083|NCT01328548|9831490|FG001|STARTED|Overall Study||50
8781084|NCT01328548|9831489|FG000|COMPLETED|Overall Study||187
8781085|NCT01328548|9831490|FG001|COMPLETED|Overall Study||50
8781086|NCT01328548|9831489|FG000|NOT COMPLETED|Overall Study||4
8781087|NCT01328548|9831490|FG001|NOT COMPLETED|Overall Study||0
8781088|NCT01328574|9831496|FG000|STARTED|Overall Study||13
8781089|NCT01328574|9831496|FG000|COMPLETED|Overall Study||12
8781090|NCT01328574|9831496|FG000|NOT COMPLETED|Overall Study||1
8781091|NCT01328717|9831505|FG000|STARTED|Overall Study||78
8781092|NCT01328717|9831505|FG000|COMPLETED|Overall Study||77
8916479|NCT02184455|9976088|FG000|NOT COMPLETED|Overall Study||1
8916480|NCT02184494|9976095|FG000|STARTED|Overall Study||13
8916481|NCT02184494|9976096|FG001|STARTED|Overall Study||13
8916482|NCT02184494|9976097|FG002|STARTED|Overall Study||8
8916483|NCT02184494|9976095|FG000|COMPLETED|Overall Study||12
8916484|NCT02184494|9976096|FG001|COMPLETED|Overall Study||11
8916485|NCT02184494|9976097|FG002|COMPLETED|Overall Study||8
8916486|NCT02184494|9976095|FG000|NOT COMPLETED|Overall Study||1
8916487|NCT02184494|9976096|FG001|NOT COMPLETED|Overall Study||2
8916488|NCT02184494|9976097|FG002|NOT COMPLETED|Overall Study||0
8916489|NCT02184572|9976107|FG000|STARTED|Overall Study||1164
8916490|NCT02184572|9976108|FG001|STARTED|Overall Study||572
8916491|NCT02184572|9976107|FG000|COMPLETED|Overall Study||1117
8916492|NCT02184572|9976108|FG001|COMPLETED|Overall Study||542
8916493|NCT02184572|9976107|FG000|NOT COMPLETED|Overall Study||47
8916494|NCT02184572|9976108|FG001|NOT COMPLETED|Overall Study||30
8916495|NCT02184611|9976118|FG000|STARTED|Overall Study||101
8916496|NCT02184611|9976119|FG001|STARTED|Overall Study||205
8916497|NCT02184611|9976118|FG000|COMPLETED|Overall Study||80
8916498|NCT02184611|9976119|FG001|COMPLETED|Overall Study||177
8916499|NCT02184611|9976118|FG000|NOT COMPLETED|Overall Study||21
8916500|NCT02184611|9976119|FG001|NOT COMPLETED|Overall Study||28
8916501|NCT02184624|9976130|FG000|STARTED|Overall Study||171
8916502|NCT02184624|9976131|FG001|STARTED|Overall Study||80
8916503|NCT02184624|9976132|FG002|STARTED|Overall Study||100
8916504|NCT02184624|9976133|FG003|STARTED|Overall Study||118
9030186|NCT03231800|10092629|FG001|Safety Population|Overall Study||47
9030187|NCT03231800|10092628|FG000|COMPLETED|Overall Study||45
9030188|NCT03231800|10092629|FG001|COMPLETED|Overall Study||44
9030189|NCT03231800|10092628|FG000|NOT COMPLETED|Overall Study||3
9030190|NCT03231800|10092629|FG001|NOT COMPLETED|Overall Study||3
9030191|NCT03231917|10092637|FG000|STARTED|Overall Study||60
9030192|NCT03231917|10092638|FG001|STARTED|Overall Study||61
9030193|NCT03231917|10092637|FG000|COMPLETED|Overall Study||60
9030194|NCT03231917|10092638|FG001|COMPLETED|Overall Study||61
9030195|NCT03231917|10092637|FG000|NOT COMPLETED|Overall Study||0
9030196|NCT03231917|10092638|FG001|NOT COMPLETED|Overall Study||0
9030197|NCT03231943|10092651|FG000|STARTED|Part 1, Period 1 (up to Day 15)||2
9030198|NCT03231943|10092652|FG001|STARTED|Part 1, Period 1 (up to Day 15)||2
9030199|NCT03231943|10092653|FG002|STARTED|Part 1, Period 1 (up to Day 15)||2
9030200|NCT03231943|10092654|FG003|STARTED|Part 1, Period 1 (up to Day 15)||2
9030201|NCT03231943|10092655|FG004|STARTED|Part 1, Period 1 (up to Day 15)||2
9030202|NCT03231943|10092656|FG005|STARTED|Part 1, Period 1 (up to Day 15)||2
9030203|NCT03231943|10092657|FG006|STARTED|Part 1, Period 1 (up to Day 15)||2
9030204|NCT03231943|10092658|FG007|STARTED|Part 1, Period 1 (up to Day 15)||2
9030205|NCT03231943|10092659|FG008|STARTED|Part 1, Period 1 (up to Day 15)||0
9030206|NCT03231943|10092660|FG009|STARTED|Part 1, Period 1 (up to Day 15)||0
9030207|NCT03231943|10092661|FG010|STARTED|Part 1, Period 1 (up to Day 15)||0
9030208|NCT03231943|10092662|FG011|STARTED|Part 1, Period 1 (up to Day 15)||0
9030209|NCT03231943|10092663|FG012|STARTED|Part 1, Period 1 (up to Day 15)||0
9030210|NCT03231943|10092651|FG000|COMPLETED|Part 1, Period 1 (up to Day 15)||2
9030211|NCT03231943|10092652|FG001|COMPLETED|Part 1, Period 1 (up to Day 15)||2
9030212|NCT03231943|10092653|FG002|COMPLETED|Part 1, Period 1 (up to Day 15)||2
9030213|NCT03231943|10092654|FG003|COMPLETED|Part 1, Period 1 (up to Day 15)||2
9030214|NCT03231943|10092655|FG004|COMPLETED|Part 1, Period 1 (up to Day 15)||2
9030215|NCT03231943|10092656|FG005|COMPLETED|Part 1, Period 1 (up to Day 15)||2
9030216|NCT03231943|10092657|FG006|COMPLETED|Part 1, Period 1 (up to Day 15)||2
8781093|NCT01328717|9831505|FG000|NOT COMPLETED|Overall Study||1
8781094|NCT01328743|9831511|FG000|STARTED|Overall Study||91
8781095|NCT01328743|9831512|FG001|STARTED|Overall Study||89
8781096|NCT01328743|9831511|FG000|COMPLETED|Overall Study||82
8781097|NCT01328743|9831512|FG001|COMPLETED|Overall Study||79
8916505|NCT02184624|9976134|FG004|STARTED|Overall Study||98
8781098|NCT01328743|9831511|FG000|NOT COMPLETED|Overall Study||9
8781099|NCT01328743|9831512|FG001|NOT COMPLETED|Overall Study||10
8781100|NCT01328756|9831518|FG000|STARTED|Overall Study||314
8781101|NCT01328756|9831518|FG000|COMPLETED|Overall Study||191
8781102|NCT01328756|9831518|FG000|NOT COMPLETED|Overall Study||123
8781103|NCT01328769|9831524|FG000|STARTED|Overall Study||25
8781104|NCT01328769|9831525|FG001|STARTED|Overall Study||24
8781105|NCT01328769|9831524|FG000|COMPLETED|Overall Study||25
8781106|NCT01328769|9831525|FG001|COMPLETED|Overall Study||23
8781107|NCT01328769|9831524|FG000|NOT COMPLETED|Overall Study||0
8781108|NCT01328769|9831525|FG001|NOT COMPLETED|Overall Study||1
8781109|NCT01328782|9831534|FG000|STARTED|Overall Study||43
8781110|NCT01328782|9831535|FG001|STARTED|Overall Study||42
8781111|NCT01328782|9831536|FG002|STARTED|Overall Study||39
8781112|NCT01328782|9831534|FG000|COMPLETED|Overall Study||43
8916506|NCT02184624|9976130|FG000|COMPLETED|Overall Study||171
9030217|NCT03231943|10092658|FG007|COMPLETED|Part 1, Period 1 (up to Day 15)||2
9030218|NCT03231943|10092659|FG008|COMPLETED|Part 1, Period 1 (up to Day 15)||0
9030219|NCT03231943|10092660|FG009|COMPLETED|Part 1, Period 1 (up to Day 15)||0
9030220|NCT03231943|10092661|FG010|COMPLETED|Part 1, Period 1 (up to Day 15)||0
9030221|NCT03231943|10092662|FG011|COMPLETED|Part 1, Period 1 (up to Day 15)||0
9030222|NCT03231943|10092663|FG012|COMPLETED|Part 1, Period 1 (up to Day 15)||0
9030223|NCT03231943|10092651|FG000|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
9030224|NCT03231943|10092652|FG001|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
9030225|NCT03231943|10092653|FG002|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
9030226|NCT03231943|10092654|FG003|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
9030227|NCT03231943|10092655|FG004|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
9030228|NCT03231943|10092656|FG005|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
9030229|NCT03231943|10092657|FG006|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
9030230|NCT03231943|10092658|FG007|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
9030231|NCT03231943|10092659|FG008|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
9030232|NCT03231943|10092660|FG009|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
9030233|NCT03231943|10092661|FG010|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
9030234|NCT03231943|10092662|FG011|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
9030235|NCT03231943|10092663|FG012|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
9030236|NCT03231943|10092651|FG000|STARTED|Part 1, Period 2 (up to Day 30)||2
9030237|NCT03231943|10092652|FG001|STARTED|Part 1, Period 2 (up to Day 30)||2
9030238|NCT03231943|10092653|FG002|STARTED|Part 1, Period 2 (up to Day 30)||2
9030239|NCT03231943|10092654|FG003|STARTED|Part 1, Period 2 (up to Day 30)||2
9030240|NCT03231943|10092655|FG004|STARTED|Part 1, Period 2 (up to Day 30)||2
9030241|NCT03231943|10092656|FG005|STARTED|Part 1, Period 2 (up to Day 30)||2
9030242|NCT03231943|10092657|FG006|STARTED|Part 1, Period 2 (up to Day 30)||2
9030243|NCT03231943|10092658|FG007|STARTED|Part 1, Period 2 (up to Day 30)||2
9030244|NCT03231943|10092659|FG008|STARTED|Part 1, Period 2 (up to Day 30)||0
9030245|NCT03231943|10092660|FG009|STARTED|Part 1, Period 2 (up to Day 30)||0
9030246|NCT03231943|10092661|FG010|STARTED|Part 1, Period 2 (up to Day 30)||0
9030247|NCT03231943|10092662|FG011|STARTED|Part 1, Period 2 (up to Day 30)||0
9030248|NCT03231943|10092663|FG012|STARTED|Part 1, Period 2 (up to Day 30)||0
9030249|NCT03231943|10092651|FG000|COMPLETED|Part 1, Period 2 (up to Day 30)||2
9030250|NCT03231943|10092652|FG001|COMPLETED|Part 1, Period 2 (up to Day 30)|Two participants withdrawn were replaced|0
9030251|NCT03231943|10092653|FG002|COMPLETED|Part 1, Period 2 (up to Day 30)|One participant withdrawn was replaced|1
9030252|NCT03231943|10092654|FG003|COMPLETED|Part 1, Period 2 (up to Day 30)||2
9030253|NCT03231943|10092655|FG004|COMPLETED|Part 1, Period 2 (up to Day 30)||2
9030254|NCT03231943|10092656|FG005|COMPLETED|Part 1, Period 2 (up to Day 30)||2
9030255|NCT03231943|10092657|FG006|COMPLETED|Part 1, Period 2 (up to Day 30)||2
9030256|NCT03231943|10092658|FG007|COMPLETED|Part 1, Period 2 (up to Day 30)||2
9030257|NCT03231943|10092659|FG008|COMPLETED|Part 1, Period 2 (up to Day 30)||0
9030258|NCT03231943|10092660|FG009|COMPLETED|Part 1, Period 2 (up to Day 30)||0
9030259|NCT03231943|10092661|FG010|COMPLETED|Part 1, Period 2 (up to Day 30)||0
9030260|NCT03231943|10092662|FG011|COMPLETED|Part 1, Period 2 (up to Day 30)||0
9030261|NCT03231943|10092663|FG012|COMPLETED|Part 1, Period 2 (up to Day 30)||0
9030262|NCT03231943|10092651|FG000|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
9030263|NCT03231943|10092652|FG001|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||2
9030264|NCT03231943|10092653|FG002|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||1
9030265|NCT03231943|10092654|FG003|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
9030266|NCT03231943|10092655|FG004|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
9030267|NCT03231943|10092656|FG005|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
9030268|NCT03231943|10092657|FG006|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
9030269|NCT03231943|10092658|FG007|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
8781113|NCT01328782|9831535|FG001|COMPLETED|Overall Study||42
8781114|NCT01328782|9831536|FG002|COMPLETED|Overall Study||39
8781115|NCT01328782|9831534|FG000|NOT COMPLETED|Overall Study||0
8781116|NCT01328782|9831535|FG001|NOT COMPLETED|Overall Study||0
8916507|NCT02184624|9976131|FG001|COMPLETED|Overall Study||80
8916508|NCT02184624|9976132|FG002|COMPLETED|Overall Study||100
8916509|NCT02184624|9976133|FG003|COMPLETED|Overall Study||118
8916510|NCT02184624|9976134|FG004|COMPLETED|Overall Study||98
8916511|NCT02184624|9976130|FG000|NOT COMPLETED|Overall Study||0
8916512|NCT02184624|9976131|FG001|NOT COMPLETED|Overall Study||0
8916513|NCT02184624|9976132|FG002|NOT COMPLETED|Overall Study||0
8916514|NCT02184624|9976133|FG003|NOT COMPLETED|Overall Study||0
8916515|NCT02184624|9976134|FG004|NOT COMPLETED|Overall Study||0
9030270|NCT03231943|10092659|FG008|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
9030271|NCT03231943|10092660|FG009|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
8671723|NCT00753415|9715110|FG008|COMPLETED|Part B||6
8671724|NCT00753415|9715111|FG009|COMPLETED|Part B||8
8671725|NCT00753415|9715102|FG000|NOT COMPLETED|Part B||0
8671726|NCT00753415|9715103|FG001|NOT COMPLETED|Part B||0
8671727|NCT00753415|9715104|FG002|NOT COMPLETED|Part B||0
8671728|NCT00753415|9715105|FG003|NOT COMPLETED|Part B||0
8671729|NCT00753415|9715106|FG004|NOT COMPLETED|Part B||0
8671730|NCT00753415|9715107|FG005|NOT COMPLETED|Part B||0
8671731|NCT00753415|9715108|FG006|NOT COMPLETED|Part B||0
8671732|NCT00753415|9715109|FG007|NOT COMPLETED|Part B||1
8671733|NCT00753415|9715110|FG008|NOT COMPLETED|Part B||3
8671734|NCT00753415|9715111|FG009|NOT COMPLETED|Part B||1
8671735|NCT00753454|9715135|FG000|STARTED|Overall Study||168
8671736|NCT00753454|9715135|FG000|COMPLETED|Overall Study||154
8671737|NCT00753454|9715135|FG000|NOT COMPLETED|Overall Study||14
8671738|NCT00753506|9715141|FG000|STARTED|Overall Study||33
8671739|NCT00753506|9715142|FG001|STARTED|Overall Study||33
8671740|NCT00753506|9715141|FG000|COMPLETED|Overall Study||26
8671741|NCT00753506|9715142|FG001|COMPLETED|Overall Study||31
8671742|NCT00753506|9715141|FG000|NOT COMPLETED|Overall Study||7
8671743|NCT00753506|9715142|FG001|NOT COMPLETED|Overall Study||2
8671744|NCT00753519|9715150|FG000|STARTED|Overall Study||13
8671745|NCT00753519|9715151|FG001|STARTED|Overall Study||15
8671746|NCT00753519|9715150|FG000|COMPLETED|Overall Study||13
8671747|NCT00753519|9715151|FG001|COMPLETED|Overall Study||13
8671748|NCT00753519|9715150|FG000|NOT COMPLETED|Overall Study||0
8671749|NCT00753519|9715151|FG001|NOT COMPLETED|Overall Study||2
8671750|NCT00753623|9715161|FG000|STARTED|Phase I (14 Days)||11
8671751|NCT00753623|9715162|FG001|STARTED|Phase I (14 Days)||12
8671752|NCT00753623|9715161|FG000|COMPLETED|Phase I (14 Days)||9
8671753|NCT00753623|9715162|FG001|COMPLETED|Phase I (14 Days)||8
8671754|NCT00753623|9715161|FG000|NOT COMPLETED|Phase I (14 Days)||2
8671755|NCT00753623|9715162|FG001|NOT COMPLETED|Phase I (14 Days)||4
8671756|NCT00753623|9715161|FG000|STARTED|Washout (7 Days)||9
8671757|NCT00753623|9715162|FG001|STARTED|Washout (7 Days)||8
8671758|NCT00753623|9715161|FG000|COMPLETED|Washout (7 Days)||8
8671759|NCT00753623|9715162|FG001|COMPLETED|Washout (7 Days)||8
8671760|NCT00753623|9715161|FG000|NOT COMPLETED|Washout (7 Days)||1
8671761|NCT00753623|9715162|FG001|NOT COMPLETED|Washout (7 Days)||0
8671762|NCT00753623|9715161|FG000|STARTED|Phase II (14 Days)||8
8671763|NCT00753623|9715162|FG001|STARTED|Phase II (14 Days)||8
8671764|NCT00753623|9715161|FG000|COMPLETED|Phase II (14 Days)||8
8671765|NCT00753623|9715162|FG001|COMPLETED|Phase II (14 Days)||7
8671766|NCT00753623|9715161|FG000|NOT COMPLETED|Phase II (14 Days)||0
8671767|NCT00753623|9715162|FG001|NOT COMPLETED|Phase II (14 Days)||1
8671768|NCT00753636|9715168|FG000|STARTED|Overall Study||31
8671769|NCT00753636|9715168|FG000|COMPLETED|Overall Study||25
8671770|NCT00753636|9715168|FG000|NOT COMPLETED|Overall Study||6
8671771|NCT00753649|9715174|FG000|STARTED|Overall Study||112
8671772|NCT00753649|9715175|FG001|STARTED|Overall Study||112
8671773|NCT00753649|9715174|FG000|COMPLETED|Overall Study||105
8671774|NCT00753649|9715175|FG001|COMPLETED|Overall Study||112
8671775|NCT00753649|9715174|FG000|NOT COMPLETED|Overall Study||7
8671776|NCT00753649|9715175|FG001|NOT COMPLETED|Overall Study||0
8671777|NCT00753675|9715184|FG000|STARTED|Overall Study||59
8671778|NCT00753675|9715185|FG001|STARTED|Overall Study||59
8671779|NCT00753675|9715186|FG002|STARTED|Overall Study||56
8671780|NCT00753675|9715184|FG000|COMPLETED|Overall Study||0
8671781|NCT00753675|9715185|FG001|COMPLETED|Overall Study||0
8671782|NCT00753675|9715186|FG002|COMPLETED|Overall Study||0
8671783|NCT00753675|9715184|FG000|NOT COMPLETED|Overall Study||59
8671784|NCT00753675|9715185|FG001|NOT COMPLETED|Overall Study||59
8671785|NCT00753675|9715186|FG002|NOT COMPLETED|Overall Study||56
8671786|NCT00753688|9715196|FG000|STARTED|Overall Study||123
8671787|NCT00753688|9715197|FG001|STARTED|Overall Study||246
8671788|NCT00753688|9715196|FG000|Ongoing - in Follow-up|Overall Study||15
8671789|NCT00753688|9715197|FG001|Ongoing - in Follow-up|Overall Study||31
8671790|NCT00753688|9715196|FG000|COMPLETED|Overall Study||0
8671791|NCT00753688|9715197|FG001|COMPLETED|Overall Study||0
8671792|NCT00753688|9715196|FG000|NOT COMPLETED|Overall Study||123
8671793|NCT00753688|9715197|FG001|NOT COMPLETED|Overall Study||246
8671794|NCT00753714|9715205|FG000|STARTED|Overall Study||61
8671795|NCT00753714|9715206|FG001|STARTED|Overall Study||63
8671796|NCT00753714|9715205|FG000|COMPLETED|Overall Study||1
8671797|NCT00753714|9715206|FG001|COMPLETED|Overall Study||1
8671798|NCT00753714|9715205|FG000|NOT COMPLETED|Overall Study||60
8671799|NCT00753714|9715206|FG001|NOT COMPLETED|Overall Study||62
8671800|NCT00753766|9715217|FG000|STARTED|Overall Study||1
8671801|NCT00753766|9715218|FG001|STARTED|Overall Study||0
8671802|NCT00753766|9715217|FG000|COMPLETED|Overall Study||0
8671803|NCT00753766|9715218|FG001|COMPLETED|Overall Study||0
8671804|NCT00753766|9715217|FG000|NOT COMPLETED|Overall Study||1
8671805|NCT00753766|9715218|FG001|NOT COMPLETED|Overall Study||0
8671806|NCT00753896|9715225|FG000|STARTED|Overall Study||134
8671807|NCT00753896|9715225|FG000|COMPLETED|Overall Study||118
8671808|NCT00753896|9715225|FG000|NOT COMPLETED|Overall Study||16
8671809|NCT00753922|9715233|FG000|STARTED|Overall Study||552
8671810|NCT00753922|9715234|FG001|STARTED|Overall Study||251
8781117|NCT01328782|9831536|FG002|NOT COMPLETED|Overall Study||0
8781118|NCT01328873|9831544|FG000|STARTED|Overall Study||49
8781119|NCT01328873|9831544|FG000|COMPLETED|Overall Study||49
8781120|NCT01328873|9831544|FG000|NOT COMPLETED|Overall Study||0
8781121|NCT01328951|9831552|FG000|STARTED|Overall Study||321
8781122|NCT01328951|9831553|FG001|STARTED|Overall Study||322
8781123|NCT01328951|9831552|FG000|COMPLETED|Overall Study||0
8781124|NCT01328951|9831553|FG001|COMPLETED|Overall Study||0
8781125|NCT01328951|9831552|FG000|NOT COMPLETED|Overall Study||321
8781126|NCT01328951|9831553|FG001|NOT COMPLETED|Overall Study||322
8781127|NCT01328964|9831566|FG000|STARTED|Overall Study||2212
8781128|NCT01328964|9831567|FG001|STARTED|Overall Study||3270
8781129|NCT01328964|9831568|FG002|STARTED|Overall Study||4424
8781130|NCT01328964|9831566|FG000|COMPLETED|Overall Study||2212
8781131|NCT01328964|9831567|FG001|COMPLETED|Overall Study||3270
8781132|NCT01328964|9831568|FG002|COMPLETED|Overall Study||4424
8781133|NCT01328964|9831566|FG000|NOT COMPLETED|Overall Study||0
8781134|NCT01328964|9831567|FG001|NOT COMPLETED|Overall Study||0
8781135|NCT01328964|9831568|FG002|NOT COMPLETED|Overall Study||0
8781136|NCT01329029|9831578|FG000|STARTED|Overall Study||973
8781137|NCT01329029|9831579|FG001|STARTED|Overall Study||972
8781138|NCT01329029|9831578|FG000|Full Analysis Set (FAS)|Overall Study||969
8781139|NCT01329029|9831579|FG001|Full Analysis Set (FAS)|Overall Study||966
8781140|NCT01329029|9831578|FG000|Safety Population|Overall Study||968
8781141|NCT01329029|9831579|FG001|Safety Population|Overall Study||967
8781142|NCT01329029|9831578|FG000|COMPLETED|Overall Study||704
8781143|NCT01329029|9831579|FG001|COMPLETED|Overall Study||780
8781144|NCT01329029|9831578|FG000|NOT COMPLETED|Overall Study||269
8781145|NCT01329029|9831579|FG001|NOT COMPLETED|Overall Study||192
8781146|NCT01329185|9831587|FG000|STARTED|Overall Study||10
8781147|NCT01329185|9831588|FG001|STARTED|Overall Study||7
8781148|NCT01329185|9831587|FG000|CMV Disease|Overall Study||1
8781149|NCT01329185|9831588|FG001|CMV Disease|Overall Study||0
8781150|NCT01329185|9831587|FG000|PTLD|Overall Study||1
8781151|NCT01329185|9831588|FG001|PTLD|Overall Study||0
8781152|NCT01329185|9831587|FG000|COMPLETED|Overall Study||10
8781153|NCT01329185|9831588|FG001|COMPLETED|Overall Study||7
8781154|NCT01329185|9831587|FG000|NOT COMPLETED|Overall Study||0
8781155|NCT01329185|9831588|FG001|NOT COMPLETED|Overall Study||0
8781156|NCT01329198|9831596|FG000|STARTED|Overall Study||3
8781157|NCT01329198|9831597|FG001|STARTED|Overall Study||2
8781158|NCT01329198|9831596|FG000|COMPLETED|Overall Study||3
8781159|NCT01329198|9831597|FG001|COMPLETED|Overall Study||2
8781160|NCT01329198|9831596|FG000|NOT COMPLETED|Overall Study||0
8781161|NCT01329198|9831597|FG001|NOT COMPLETED|Overall Study||0
8781162|NCT01329263|9831610|FG000|STARTED|Overall Study||15
8781163|NCT01329263|9831611|FG001|STARTED|Overall Study||45
8781164|NCT01329263|9831610|FG000|Completed Period 1 Own Menthol|Overall Study||15
8781165|NCT01329263|9831611|FG001|Completed Period 1 Own Menthol|Overall Study||45
8781166|NCT01329263|9831610|FG000|Completed Period 2 Own or CCrush Menthol|Overall Study||10
8781167|NCT01329263|9831611|FG001|Completed Period 2 Own or CCrush Menthol|Overall Study||30
8781168|NCT01329263|9831610|FG000|CompletedPer 3 Own or CCrush Non-menthol|Overall Study||10
8781169|NCT01329263|9831611|FG001|CompletedPer 3 Own or CCrush Non-menthol|Overall Study||22
8781170|NCT01329263|9831610|FG000|COMPLETED|Overall Study||10
8781171|NCT01329263|9831611|FG001|COMPLETED|Overall Study||22
8781172|NCT01329263|9831610|FG000|NOT COMPLETED|Overall Study||5
8781173|NCT01329263|9831611|FG001|NOT COMPLETED|Overall Study||23
8781174|NCT01329328|9831622|FG000|STARTED|Overall Study||15
8781175|NCT01329328|9831623|FG001|STARTED|Overall Study||17
8781176|NCT01329328|9831624|FG002|STARTED|Overall Study||18
8781177|NCT01329328|9831622|FG000|COMPLETED|Overall Study||13
8781178|NCT01329328|9831623|FG001|COMPLETED|Overall Study||13
8781179|NCT01329328|9831624|FG002|COMPLETED|Overall Study||15
8781180|NCT01329328|9831622|FG000|NOT COMPLETED|Overall Study||2
8781181|NCT01329328|9831623|FG001|NOT COMPLETED|Overall Study||4
8781182|NCT01329328|9831624|FG002|NOT COMPLETED|Overall Study||3
8781183|NCT01329380|9831632|FG000|STARTED|Overall Study||403
8781184|NCT01329380|9831632|FG000|Safety Population|Overall Study||396
8781185|NCT01329380|9831632|FG000|COMPLETED|Overall Study||374
8781186|NCT01329380|9831632|FG000|NOT COMPLETED|Overall Study||29
8781187|NCT01329419|9831636|FG000|STARTED|Overall Study||4393
8781188|NCT01329419|9831636|FG000|COMPLETED|Overall Study||4158
8781189|NCT01329419|9831636|FG000|NOT COMPLETED|Overall Study||235
8781190|NCT01329562|9831643|FG000|STARTED|Overall Study||20
8781191|NCT01329562|9831644|FG001|STARTED|Overall Study||21
8781192|NCT01329562|9831643|FG000|COMPLETED|Overall Study||11
8781193|NCT01329562|9831644|FG001|COMPLETED|Overall Study||14
8781194|NCT01329562|9831643|FG000|NOT COMPLETED|Overall Study||9
8781195|NCT01329562|9831644|FG001|NOT COMPLETED|Overall Study||7
8781196|NCT01329679|9831652|FG000|STARTED|Overall Study||13
8781197|NCT01329679|9831653|FG001|STARTED|Overall Study||13
8781198|NCT01329679|9831652|FG000|COMPLETED|Overall Study||13
8781199|NCT01329679|9831653|FG001|COMPLETED|Overall Study||13
8781200|NCT01329679|9831652|FG000|NOT COMPLETED|Overall Study||0
8781201|NCT01329679|9831653|FG001|NOT COMPLETED|Overall Study||0
8781202|NCT01329848|9831661|FG000|STARTED|Overall Study||83
8781203|NCT01329848|9831661|FG000|COMPLETED|Overall Study||54
8781204|NCT01329848|9831661|FG000|NOT COMPLETED|Overall Study||29
8781205|NCT01329900|9831665|FG000|STARTED|Overall Study||50
8781206|NCT01329900|9831665|FG000|COMPLETED|Overall Study||49
8781207|NCT01329900|9831665|FG000|NOT COMPLETED|Overall Study||1
8781208|NCT01329939|9831673|FG000|STARTED|Overall Study||7
8781209|NCT01329939|9831674|FG001|STARTED|Overall Study||5
8781210|NCT01329939|9831675|FG002|STARTED|Overall Study||5
8781211|NCT01329939|9831676|FG003|STARTED|Overall Study||9
8781212|NCT01329939|9831673|FG000|COMPLETED|Overall Study||4
8781213|NCT01329939|9831674|FG001|COMPLETED|Overall Study||4
8781214|NCT01329939|9831675|FG002|COMPLETED|Overall Study||4
8781215|NCT01329939|9831676|FG003|COMPLETED|Overall Study||4
8781216|NCT01329939|9831673|FG000|NOT COMPLETED|Overall Study||3
8781217|NCT01329939|9831674|FG001|NOT COMPLETED|Overall Study||1
8781218|NCT01329939|9831675|FG002|NOT COMPLETED|Overall Study||1
8781219|NCT01329939|9831676|FG003|NOT COMPLETED|Overall Study||5
8781220|NCT01329978|9831689|FG000|STARTED|Sofosbuvir+PEG+RBV Treatment Period||52
8781221|NCT01329978|9831690|FG001|STARTED|Sofosbuvir+PEG+RBV Treatment Period||125
8781222|NCT01329978|9831691|FG002|STARTED|Sofosbuvir+PEG+RBV Treatment Period||155
8781223|NCT01329978|9831692|FG003|STARTED|Sofosbuvir+PEG+RBV Treatment Period||0
8781224|NCT01329978|9831693|FG004|STARTED|Sofosbuvir+PEG+RBV Treatment Period||0
8781225|NCT01329978|9831689|FG000|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period|Participants in this group were not re-randomized for further treatment|48
8781226|NCT01329978|9831690|FG001|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period|Participants in this group were not re-randomized for further treatment|112
8781227|NCT01329978|9831691|FG002|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period|150 participants were re-randomized after 12 weeks of treatment.|150
8781228|NCT01329978|9831692|FG003|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
8781229|NCT01329978|9831693|FG004|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
8781230|NCT01329978|9831689|FG000|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||4
8781231|NCT01329978|9831690|FG001|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||13
8781232|NCT01329978|9831691|FG002|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||5
8781233|NCT01329978|9831692|FG003|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
8781234|NCT01329978|9831693|FG004|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
8781235|NCT01329978|9831689|FG000|STARTED|Rerandomization Treatment Period||0
8781236|NCT01329978|9831690|FG001|STARTED|Rerandomization Treatment Period||0
8781237|NCT01329978|9831691|FG002|STARTED|Rerandomization Treatment Period||0
8781238|NCT01329978|9831692|FG003|STARTED|Rerandomization Treatment Period|This group includes participants rerandomized from the SOF+PEG+RBV 12 week/Rerandomization Group.|75
8781239|NCT01329978|9831693|FG004|STARTED|Rerandomization Treatment Period|This group includes participants rerandomized from the SOF+PEG+RBV 12 week/Rerandomization Group.|75
8781240|NCT01329978|9831689|FG000|COMPLETED|Rerandomization Treatment Period||0
8781241|NCT01329978|9831690|FG001|COMPLETED|Rerandomization Treatment Period||0
8781242|NCT01329978|9831691|FG002|COMPLETED|Rerandomization Treatment Period||0
8781243|NCT01329978|9831692|FG003|COMPLETED|Rerandomization Treatment Period||70
8781244|NCT01329978|9831693|FG004|COMPLETED|Rerandomization Treatment Period||71
8781245|NCT01329978|9831689|FG000|NOT COMPLETED|Rerandomization Treatment Period||0
8781246|NCT01329978|9831690|FG001|NOT COMPLETED|Rerandomization Treatment Period||0
8781247|NCT01329978|9831691|FG002|NOT COMPLETED|Rerandomization Treatment Period||0
8781248|NCT01329978|9831692|FG003|NOT COMPLETED|Rerandomization Treatment Period||5
8781249|NCT01329978|9831693|FG004|NOT COMPLETED|Rerandomization Treatment Period||4
8781250|NCT01330017|9831710|FG000|STARTED|Overall Study||109
8781251|NCT01330017|9831711|FG001|STARTED|Overall Study||108
8781252|NCT01330017|9831712|FG002|STARTED|Overall Study||107
8781253|NCT01330017|9831713|FG003|STARTED|Overall Study||112
8781254|NCT01330017|9831714|FG004|STARTED|Overall Study||103
8781255|NCT01330017|9831710|FG000|COMPLETED|Overall Study||104
8781256|NCT01330017|9831711|FG001|COMPLETED|Overall Study||104
8781257|NCT01330017|9831712|FG002|COMPLETED|Overall Study||99
8781258|NCT01330017|9831713|FG003|COMPLETED|Overall Study||100
8781259|NCT01330017|9831714|FG004|COMPLETED|Overall Study||100
8781260|NCT01330017|9831710|FG000|NOT COMPLETED|Overall Study||5
8781261|NCT01330017|9831711|FG001|NOT COMPLETED|Overall Study||4
8781262|NCT01330017|9831712|FG002|NOT COMPLETED|Overall Study||8
8781263|NCT01330017|9831713|FG003|NOT COMPLETED|Overall Study||12
8781264|NCT01330017|9831714|FG004|NOT COMPLETED|Overall Study||3
8781265|NCT01330030|9831728|FG000|STARTED|Overall Study||121
8781266|NCT01330030|9831729|FG001|STARTED|Overall Study||122
8781267|NCT01330030|9831728|FG000|COMPLETED|Overall Study|number assessed at week 52 follow-up|105
8781268|NCT01330030|9831729|FG001|COMPLETED|Overall Study|number assessed at week 52 follow-up|105
8781269|NCT01330030|9831728|FG000|NOT COMPLETED|Overall Study||16
8781270|NCT01330030|9831729|FG001|NOT COMPLETED|Overall Study||17
8781271|NCT01330043|9831737|FG000|STARTED|Overall Study||111
8781272|NCT01330043|9831738|FG001|STARTED|Overall Study||112
8781273|NCT01330043|9831737|FG000|COMPLETED|Overall Study||111
8781274|NCT01330043|9831738|FG001|COMPLETED|Overall Study||108
8781275|NCT01330043|9831737|FG000|NOT COMPLETED|Overall Study||0
8781276|NCT01330043|9831738|FG001|NOT COMPLETED|Overall Study||4
8781277|NCT01330108|9831744|FG000|STARTED|Overall Study||32
8781278|NCT01330108|9831744|FG000|COMPLETED|Overall Study||28
8781279|NCT01330108|9831744|FG000|NOT COMPLETED|Overall Study||4
8781280|NCT01330134|9831750|FG000|STARTED|Overall Study||244
8781281|NCT01330134|9831751|FG001|STARTED|Overall Study||237
8781282|NCT01330134|9831750|FG000|COMPLETED|Overall Study||244
8781283|NCT01330134|9831751|FG001|COMPLETED|Overall Study||237
8781284|NCT01330134|9831750|FG000|NOT COMPLETED|Overall Study||0
8781285|NCT01330134|9831751|FG001|NOT COMPLETED|Overall Study||0
8781286|NCT01330290|9831757|FG000|STARTED|Overall Study||148
8781287|NCT01330290|9831757|FG000|COMPLETED|Overall Study|As this is a cross-sectional study, the terms completed/not completed are not applicable.|148
8781288|NCT01330290|9831757|FG000|NOT COMPLETED|Overall Study||0
8781289|NCT01330303|9831761|FG000|STARTED|Period 1||20
8781290|NCT01330303|9831762|FG001|STARTED|Period 1||20
8781291|NCT01330303|9831761|FG000|COMPLETED|Period 1||19
8781292|NCT01330303|9831762|FG001|COMPLETED|Period 1||18
8781293|NCT01330303|9831761|FG000|NOT COMPLETED|Period 1||1
8781294|NCT01330303|9831762|FG001|NOT COMPLETED|Period 1||2
8781295|NCT01330303|9831761|FG000|STARTED|7-Day Washout Period||19
8781296|NCT01330303|9831762|FG001|STARTED|7-Day Washout Period||18
8781297|NCT01330303|9831761|FG000|COMPLETED|7-Day Washout Period||19
8781298|NCT01330303|9831762|FG001|COMPLETED|7-Day Washout Period||18
8781299|NCT01330303|9831761|FG000|NOT COMPLETED|7-Day Washout Period||0
8781300|NCT01330303|9831762|FG001|NOT COMPLETED|7-Day Washout Period||0
8781301|NCT01330303|9831761|FG000|STARTED|Period 2||19
8781302|NCT01330303|9831762|FG001|STARTED|Period 2||18
8781303|NCT01330303|9831761|FG000|COMPLETED|Period 2||19
8781304|NCT01330303|9831762|FG001|COMPLETED|Period 2||18
8781305|NCT01330303|9831761|FG000|NOT COMPLETED|Period 2||0
8781306|NCT01330303|9831762|FG001|NOT COMPLETED|Period 2||0
8781307|NCT01330316|9831771|FG000|STARTED|Overall Study||43
8781308|NCT01330316|9831772|FG001|STARTED|Overall Study||75
8781309|NCT01330316|9831771|FG000|COMPLETED|Overall Study||41
8781310|NCT01330316|9831772|FG001|COMPLETED|Overall Study||60
8781311|NCT01330316|9831771|FG000|NOT COMPLETED|Overall Study||2
8781312|NCT01330316|9831772|FG001|NOT COMPLETED|Overall Study||15
8781313|NCT01330355|9831780|FG000|STARTED|Overall Study||16
8781314|NCT01330355|9831781|FG001|STARTED|Overall Study||17
8781315|NCT01330355|9831780|FG000|COMPLETED|Overall Study||16
8781316|NCT01330355|9831781|FG001|COMPLETED|Overall Study||17
8781317|NCT01330355|9831780|FG000|NOT COMPLETED|Overall Study||0
8781318|NCT01330355|9831781|FG001|NOT COMPLETED|Overall Study||0
8781319|NCT01330381|9831789|FG000|STARTED|Double-blind Treatment Period (8 Weeks)||107
8781320|NCT01330381|9831790|FG001|STARTED|Double-blind Treatment Period (8 Weeks)||108
8781321|NCT01330381|9831791|FG002|STARTED|Double-blind Treatment Period (8 Weeks)||0
8781322|NCT01330381|9831789|FG000|Received Treatment|Double-blind Treatment Period (8 Weeks)||106
8781323|NCT01330381|9831790|FG001|Received Treatment|Double-blind Treatment Period (8 Weeks)||107
8781324|NCT01330381|9831791|FG002|Received Treatment|Double-blind Treatment Period (8 Weeks)||0
8781325|NCT01330381|9831789|FG000|COMPLETED|Double-blind Treatment Period (8 Weeks)||96
8781326|NCT01330381|9831790|FG001|COMPLETED|Double-blind Treatment Period (8 Weeks)||101
8781327|NCT01330381|9831791|FG002|COMPLETED|Double-blind Treatment Period (8 Weeks)||0
8781328|NCT01330381|9831789|FG000|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||11
8781329|NCT01330381|9831790|FG001|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||7
8781330|NCT01330381|9831791|FG002|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||0
8781331|NCT01330381|9831789|FG000|STARTED|Open-label Treatment Period (16 Weeks)||98
8781332|NCT01330381|9831790|FG001|STARTED|Open-label Treatment Period (16 Weeks)||0
8781333|NCT01330381|9831791|FG002|STARTED|Open-label Treatment Period (16 Weeks)||99
8781334|NCT01330381|9831789|FG000|COMPLETED|Open-label Treatment Period (16 Weeks)||88
8781335|NCT01330381|9831790|FG001|COMPLETED|Open-label Treatment Period (16 Weeks)||0
8781336|NCT01330381|9831791|FG002|COMPLETED|Open-label Treatment Period (16 Weeks)||81
8781337|NCT01330381|9831789|FG000|NOT COMPLETED|Open-label Treatment Period (16 Weeks)||10
8781338|NCT01330381|9831790|FG001|NOT COMPLETED|Open-label Treatment Period (16 Weeks)||0
8781339|NCT01330381|9831791|FG002|NOT COMPLETED|Open-label Treatment Period (16 Weeks)||18
8781340|NCT01330394|9831802|FG000|STARTED|Overall Study||17
8781341|NCT01330394|9831803|FG001|STARTED|Overall Study||16
8781342|NCT01330394|9831802|FG000|COMPLETED|Overall Study||17
8781343|NCT01330394|9831803|FG001|COMPLETED|Overall Study||16
8781344|NCT01330394|9831802|FG000|NOT COMPLETED|Overall Study||0
8781345|NCT01330394|9831803|FG001|NOT COMPLETED|Overall Study||0
8809089|NCT01494987|9861532|FG001|STARTED|Overall Study||215
8809090|NCT01494987|9861531|FG000|COMPLETED|Overall Study||188
8809091|NCT01494987|9861532|FG001|COMPLETED|Overall Study||187
8809092|NCT01494987|9861531|FG000|NOT COMPLETED|Overall Study||28
8809093|NCT01494987|9861532|FG001|NOT COMPLETED|Overall Study||28
8809094|NCT01495000|9861540|FG000|STARTED|Overall Study||124
8809095|NCT01495000|9861541|FG001|STARTED|Overall Study||126
8809096|NCT01495000|9861540|FG000|COMPLETED|Overall Study||111
8809097|NCT01495000|9861541|FG001|COMPLETED|Overall Study||114
8809098|NCT01495000|9861540|FG000|NOT COMPLETED|Overall Study||13
8809099|NCT01495000|9861541|FG001|NOT COMPLETED|Overall Study||12
8809100|NCT01495221|9861547|FG000|STARTED|Overall Study|First Patient enrolled December 2011.|9
8809101|NCT01495221|9861547|FG000|COMPLETED|Overall Study|Last patient enrolled May 2012.|9
8809102|NCT01495221|9861547|FG000|NOT COMPLETED|Overall Study||0
8809103|NCT01495286|9861551|FG000|STARTED|Overall Study||30
8809104|NCT01495286|9861551|FG000|COMPLETED|Overall Study||30
8809105|NCT01495286|9861551|FG000|NOT COMPLETED|Overall Study||0
8809106|NCT01495481|9861555|FG000|STARTED|Adenosine|Patients first received adenosine and then dexmedetomidine.|22
8809107|NCT01495481|9861555|FG000|COMPLETED|Adenosine||22
8809108|NCT01495481|9861555|FG000|NOT COMPLETED|Adenosine||0
8809109|NCT01495481|9861555|FG000|STARTED|Washout||22
8809110|NCT01495481|9861555|FG000|COMPLETED|Washout||22
8809111|NCT01495481|9861555|FG000|NOT COMPLETED|Washout||0
8809112|NCT01495481|9861555|FG000|STARTED|Dexmedetomidine||22
8809113|NCT01495481|9861555|FG000|COMPLETED|Dexmedetomidine||22
8809114|NCT01495481|9861555|FG000|NOT COMPLETED|Dexmedetomidine||0
8809115|NCT01495572|9861565|FG000|STARTED|Overall Study||0
8809116|NCT01495572|9861566|FG001|STARTED|Overall Study||5
8916516|NCT02184988|9976146|FG000|STARTED|Overall Study||352
8916517|NCT02184988|9976146|FG000|COMPLETED|Overall Study||297
8916518|NCT02184988|9976146|FG000|NOT COMPLETED|Overall Study||55
8916519|NCT02185014|9976150|FG000|STARTED|Overall Study||252
8916520|NCT02185014|9976150|FG000|COMPLETED|Overall Study||198
8916521|NCT02185014|9976150|FG000|NOT COMPLETED|Overall Study||54
8916522|NCT02185040|9976159|FG000|STARTED|Part 1 Treatment Phase||8
8916523|NCT02185040|9976160|FG001|STARTED|Part 1 Treatment Phase||8
8916524|NCT02185040|9976161|FG002|STARTED|Part 1 Treatment Phase||8
8916525|NCT02185040|9976162|FG003|STARTED|Part 1 Treatment Phase||9
8916526|NCT02185040|9976163|FG004|STARTED|Part 1 Treatment Phase||9
8916527|NCT02185040|9976164|FG005|STARTED|Part 1 Treatment Phase||0
8916528|NCT02185040|9976165|FG006|STARTED|Part 1 Treatment Phase||0
8916529|NCT02185040|9976159|FG000|COMPLETED|Part 1 Treatment Phase||7
8916530|NCT02185040|9976160|FG001|COMPLETED|Part 1 Treatment Phase||6
8916531|NCT02185040|9976161|FG002|COMPLETED|Part 1 Treatment Phase||7
8916532|NCT02185040|9976162|FG003|COMPLETED|Part 1 Treatment Phase||7
8916533|NCT02185040|9976163|FG004|COMPLETED|Part 1 Treatment Phase||6
8781346|NCT01330420|9831809|FG000|STARTED|Overall Study||28
8781347|NCT01330420|9831809|FG000|COMPLETED|Overall Study||24
8781348|NCT01330420|9831809|FG000|NOT COMPLETED|Overall Study||4
8781349|NCT01330433|9831815|FG000|STARTED|Overall Study||16
8781350|NCT01330433|9831816|FG001|STARTED|Overall Study||19
8781351|NCT01330433|9831815|FG000|COMPLETED|Overall Study||14
8781352|NCT01330433|9831816|FG001|COMPLETED|Overall Study||16
8781353|NCT01330433|9831815|FG000|NOT COMPLETED|Overall Study||2
8781354|NCT01330433|9831816|FG001|NOT COMPLETED|Overall Study||3
8781355|NCT01330459|9831824|FG000|STARTED|Overall Study||61
8781356|NCT01330459|9831825|FG001|STARTED|Overall Study||60
8781357|NCT01330459|9831824|FG000|COMPLETED|Overall Study||61
8781358|NCT01330459|9831825|FG001|COMPLETED|Overall Study||58
8781359|NCT01330459|9831824|FG000|NOT COMPLETED|Overall Study||0
8781360|NCT01330459|9831825|FG001|NOT COMPLETED|Overall Study||2
8781361|NCT01330628|9831835|FG000|STARTED|Overall Study||170
8781362|NCT01330628|9831836|FG001|STARTED|Overall Study||82
8781363|NCT01330628|9831835|FG000|30 Day Follow-up|Overall Study||165
8781364|NCT01330628|9831836|FG001|30 Day Follow-up|Overall Study||73
8781365|NCT01330628|9831835|FG000|6 Month Follow-up|Overall Study||135
8781366|NCT01330628|9831836|FG001|6 Month Follow-up|Overall Study||60
8781367|NCT01330628|9831835|FG000|COMPLETED|Overall Study||100
8781368|NCT01330628|9831836|FG001|COMPLETED|Overall Study||42
8781369|NCT01330628|9831835|FG000|NOT COMPLETED|Overall Study||70
8781370|NCT01330628|9831836|FG001|NOT COMPLETED|Overall Study||40
8781371|NCT01330914|9831842|FG000|STARTED|Overall Study||55
8781372|NCT01330914|9831842|FG000|COMPLETED|Overall Study||48
8781373|NCT01330914|9831842|FG000|NOT COMPLETED|Overall Study||7
8781374|NCT01330953|9831851|FG000|STARTED|Overall Study||8
8781375|NCT01330953|9831852|FG001|STARTED|Overall Study||6
8781376|NCT01330953|9831853|FG002|STARTED|Overall Study||6
8781377|NCT01330953|9831854|FG003|STARTED|Overall Study||6
8781378|NCT01330953|9831855|FG004|STARTED|Overall Study||6
8781379|NCT01330953|9831851|FG000|COMPLETED|Overall Study||8
8781380|NCT01330953|9831852|FG001|COMPLETED|Overall Study||6
8781381|NCT01330953|9831853|FG002|COMPLETED|Overall Study||6
8781382|NCT01330953|9831854|FG003|COMPLETED|Overall Study||6
8781383|NCT01330953|9831855|FG004|COMPLETED|Overall Study||6
8781384|NCT01330953|9831851|FG000|NOT COMPLETED|Overall Study||0
8781385|NCT01330953|9831852|FG001|NOT COMPLETED|Overall Study||0
8781386|NCT01330953|9831853|FG002|NOT COMPLETED|Overall Study||0
8781387|NCT01330953|9831854|FG003|NOT COMPLETED|Overall Study||0
8781388|NCT01330953|9831855|FG004|NOT COMPLETED|Overall Study||0
8781389|NCT01330966|9831872|FG000|STARTED|Overall Study||47
8781390|NCT01330966|9831872|FG000|COMPLETED|Overall Study|Tumor responses evaluable in 42 of 47 pts; 5 pts discontinued prior to first tumor assessment.|42
8781391|NCT01330966|9831872|FG000|NOT COMPLETED|Overall Study||5
8781392|NCT01331005|9831878|FG000|STARTED|Overall Study||64
8781393|NCT01331005|9831879|FG001|STARTED|Overall Study||61
8781394|NCT01331005|9831878|FG000|COMPLETED|Overall Study||60
8781395|NCT01331005|9831879|FG001|COMPLETED|Overall Study||57
8781396|NCT01331005|9831878|FG000|NOT COMPLETED|Overall Study||4
8781397|NCT01331005|9831879|FG001|NOT COMPLETED|Overall Study||4
8781398|NCT01331083|9831887|FG000|STARTED|Overall Study||43
8781399|NCT01331083|9831888|FG001|STARTED|Overall Study||25
8781400|NCT01331083|9831887|FG000|COMPLETED|Overall Study||43
8781401|NCT01331083|9831888|FG001|COMPLETED|Overall Study||25
8781402|NCT01331083|9831887|FG000|NOT COMPLETED|Overall Study||0
8781403|NCT01331083|9831888|FG001|NOT COMPLETED|Overall Study||0
8781404|NCT01331109|9831894|FG000|STARTED|Overall Study||57
8781405|NCT01331109|9831894|FG000|COMPLETED|Overall Study||0
8781406|NCT01331109|9831894|FG000|NOT COMPLETED|Overall Study||57
8781407|NCT01331161|9831900|FG000|STARTED|Overall Study||44
8781408|NCT01331161|9831901|FG001|STARTED|Overall Study||33
8781409|NCT01331161|9831900|FG000|COMPLETED|Overall Study||43
8781410|NCT01331161|9831901|FG001|COMPLETED|Overall Study||31
8781411|NCT01331161|9831900|FG000|NOT COMPLETED|Overall Study||1
8781412|NCT01331161|9831901|FG001|NOT COMPLETED|Overall Study||2
8916534|NCT02185040|9976164|FG005|COMPLETED|Part 1 Treatment Phase||0
8781413|NCT01331213|9831911|FG000|STARTED|Overall Study||8
8781414|NCT01331213|9831912|FG001|STARTED|Overall Study||10
8781415|NCT01331213|9831911|FG000|COMPLETED|Overall Study||8
8781416|NCT01331213|9831912|FG001|COMPLETED|Overall Study||10
8781417|NCT01331213|9831911|FG000|NOT COMPLETED|Overall Study||0
8781418|NCT01331213|9831912|FG001|NOT COMPLETED|Overall Study||0
8781419|NCT01331239|9831920|FG000|STARTED|Part I: Core Study||12
8781420|NCT01331239|9831921|FG001|STARTED|Part I: Core Study||0
8781421|NCT01331239|9831922|FG002|STARTED|Part I: Core Study||0
8781422|NCT01331239|9831920|FG000|COMPLETED|Part I: Core Study||12
8781423|NCT01331239|9831921|FG001|COMPLETED|Part I: Core Study||0
8781424|NCT01331239|9831922|FG002|COMPLETED|Part I: Core Study||0
8781425|NCT01331239|9831920|FG000|NOT COMPLETED|Part I: Core Study||0
8781426|NCT01331239|9831921|FG001|NOT COMPLETED|Part I: Core Study||0
8781427|NCT01331239|9831922|FG002|NOT COMPLETED|Part I: Core Study||0
8781428|NCT01331239|9831920|FG000|STARTED|Part II: Core Study||0
8781429|NCT01331239|9831921|FG001|STARTED|Part II: Core Study||15
8781430|NCT01331239|9831922|FG002|STARTED|Part II: Core Study||4
8781431|NCT01331239|9831920|FG000|COMPLETED|Part II: Core Study||0
8781432|NCT01331239|9831921|FG001|COMPLETED|Part II: Core Study||7
8781433|NCT01331239|9831922|FG002|COMPLETED|Part II: Core Study||3
9030272|NCT03231943|10092661|FG010|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
9030273|NCT03231943|10092662|FG011|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
9030274|NCT03231943|10092663|FG012|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
9030275|NCT03231943|10092651|FG000|STARTED|Part 1, Period 3 (up to Day 45)||2
9030276|NCT03231943|10092652|FG001|STARTED|Part 1, Period 3 (up to Day 45)||2
9030277|NCT03231943|10092653|FG002|STARTED|Part 1, Period 3 (up to Day 45)||2
9030278|NCT03231943|10092654|FG003|STARTED|Part 1, Period 3 (up to Day 45)||2
9030279|NCT03231943|10092655|FG004|STARTED|Part 1, Period 3 (up to Day 45)||2
9030280|NCT03231943|10092656|FG005|STARTED|Part 1, Period 3 (up to Day 45)||2
9030281|NCT03231943|10092657|FG006|STARTED|Part 1, Period 3 (up to Day 45)||2
9030282|NCT03231943|10092658|FG007|STARTED|Part 1, Period 3 (up to Day 45)||2
9030283|NCT03231943|10092659|FG008|STARTED|Part 1, Period 3 (up to Day 45)||0
9030284|NCT03231943|10092660|FG009|STARTED|Part 1, Period 3 (up to Day 45)||0
9030285|NCT03231943|10092661|FG010|STARTED|Part 1, Period 3 (up to Day 45)||0
9030286|NCT03231943|10092662|FG011|STARTED|Part 1, Period 3 (up to Day 45)||0
9030287|NCT03231943|10092663|FG012|STARTED|Part 1, Period 3 (up to Day 45)||0
9030288|NCT03231943|10092651|FG000|COMPLETED|Part 1, Period 3 (up to Day 45)|One participant withdrawn was replaced|1
9030289|NCT03231943|10092652|FG001|COMPLETED|Part 1, Period 3 (up to Day 45)||2
9030290|NCT03231943|10092653|FG002|COMPLETED|Part 1, Period 3 (up to Day 45)||2
9030291|NCT03231943|10092654|FG003|COMPLETED|Part 1, Period 3 (up to Day 45)||2
9030292|NCT03231943|10092655|FG004|COMPLETED|Part 1, Period 3 (up to Day 45)||2
9030293|NCT03231943|10092656|FG005|COMPLETED|Part 1, Period 3 (up to Day 45)||2
9030294|NCT03231943|10092657|FG006|COMPLETED|Part 1, Period 3 (up to Day 45)||2
9030295|NCT03231943|10092658|FG007|COMPLETED|Part 1, Period 3 (up to Day 45)||2
9030296|NCT03231943|10092659|FG008|COMPLETED|Part 1, Period 3 (up to Day 45)||0
9030297|NCT03231943|10092660|FG009|COMPLETED|Part 1, Period 3 (up to Day 45)||0
9030298|NCT03231943|10092661|FG010|COMPLETED|Part 1, Period 3 (up to Day 45)||0
9030299|NCT03231943|10092662|FG011|COMPLETED|Part 1, Period 3 (up to Day 45)||0
9030300|NCT03231943|10092663|FG012|COMPLETED|Part 1, Period 3 (up to Day 45)||0
9030301|NCT03231943|10092651|FG000|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||1
9030302|NCT03231943|10092652|FG001|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
9030303|NCT03231943|10092653|FG002|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
9030304|NCT03231943|10092654|FG003|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
9030305|NCT03231943|10092655|FG004|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
9030306|NCT03231943|10092656|FG005|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
9030307|NCT03231943|10092657|FG006|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
9030308|NCT03231943|10092658|FG007|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
9030309|NCT03231943|10092659|FG008|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
9030310|NCT03231943|10092660|FG009|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
9030311|NCT03231943|10092661|FG010|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
9030312|NCT03231943|10092662|FG011|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
9030313|NCT03231943|10092663|FG012|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
9030314|NCT03231943|10092651|FG000|STARTED|Part 1 Period 4 (up to Day 60)||2
9030315|NCT03231943|10092652|FG001|STARTED|Part 1 Period 4 (up to Day 60)||2
9030316|NCT03231943|10092653|FG002|STARTED|Part 1 Period 4 (up to Day 60)||2
9030317|NCT03231943|10092654|FG003|STARTED|Part 1 Period 4 (up to Day 60)||2
9030318|NCT03231943|10092655|FG004|STARTED|Part 1 Period 4 (up to Day 60)||2
9030319|NCT03231943|10092656|FG005|STARTED|Part 1 Period 4 (up to Day 60)||2
9030320|NCT03231943|10092657|FG006|STARTED|Part 1 Period 4 (up to Day 60)||2
9030321|NCT03231943|10092658|FG007|STARTED|Part 1 Period 4 (up to Day 60)||2
9030322|NCT03231943|10092659|FG008|STARTED|Part 1 Period 4 (up to Day 60)||0
9030323|NCT03231943|10092660|FG009|STARTED|Part 1 Period 4 (up to Day 60)||0
9030324|NCT03231943|10092661|FG010|STARTED|Part 1 Period 4 (up to Day 60)||0
9030325|NCT03231943|10092662|FG011|STARTED|Part 1 Period 4 (up to Day 60)||0
9030326|NCT03231943|10092663|FG012|STARTED|Part 1 Period 4 (up to Day 60)||0
9030327|NCT03231943|10092651|FG000|COMPLETED|Part 1 Period 4 (up to Day 60)||2
9030328|NCT03231943|10092652|FG001|COMPLETED|Part 1 Period 4 (up to Day 60)||2
8781434|NCT01331239|9831920|FG000|NOT COMPLETED|Part II: Core Study||0
8781435|NCT01331239|9831921|FG001|NOT COMPLETED|Part II: Core Study||8
8781436|NCT01331239|9831922|FG002|NOT COMPLETED|Part II: Core Study||1
8781437|NCT01331291|9831940|FG000|STARTED|Overall Study||2
8781438|NCT01331291|9831941|FG001|STARTED|Overall Study||9
8781439|NCT01331291|9831940|FG000|COMPLETED|Overall Study||0
8781440|NCT01331291|9831941|FG001|COMPLETED|Overall Study||0
8781441|NCT01331291|9831940|FG000|NOT COMPLETED|Overall Study||2
8781442|NCT01331291|9831941|FG001|NOT COMPLETED|Overall Study||9
8781443|NCT01331304|9831948|FG000|STARTED|Overall Study||240
8781444|NCT01331304|9831949|FG001|STARTED|Overall Study||242
8781445|NCT01331304|9831948|FG000|COMPLETED|Overall Study||182
8781446|NCT01331304|9831949|FG001|COMPLETED|Overall Study||182
8781447|NCT01331304|9831948|FG000|NOT COMPLETED|Overall Study||58
8781448|NCT01331304|9831949|FG001|NOT COMPLETED|Overall Study||60
8781449|NCT01331408|9831956|FG000|STARTED|Overall Study||61
8781450|NCT01331408|9831956|FG000|COMPLETED|Overall Study||50
8781451|NCT01331408|9831956|FG000|NOT COMPLETED|Overall Study||11
8781452|NCT01331681|9831963|FG000|STARTED|Overall Study|randomized|136
8781453|NCT01331681|9831964|FG001|STARTED|Overall Study|randomized|135
8781454|NCT01331681|9831965|FG002|STARTED|Overall Study|randomized|135
8781455|NCT01331681|9831963|FG000|Participants Received Treatment|Overall Study|safety population|136
8781456|NCT01331681|9831964|FG001|Participants Received Treatment|Overall Study|safety population|135
8781457|NCT01331681|9831965|FG002|Participants Received Treatment|Overall Study|safety population|133
8781458|NCT01331681|9831963|FG000|Completed Week 52|Overall Study||125
8781459|NCT01331681|9831964|FG001|Completed Week 52|Overall Study||121
8781460|NCT01331681|9831965|FG002|Completed Week 52|Overall Study||115
8781461|NCT01331681|9831963|FG000|Completed Week 100|Overall Study||115
8781462|NCT01331681|9831964|FG001|Completed Week 100|Overall Study||110
8781463|NCT01331681|9831965|FG002|Completed Week 100|Overall Study||105
8781464|NCT01331681|9831963|FG000|Completed Week 148|Overall Study||101
8781465|NCT01331681|9831964|FG001|Completed Week 148|Overall Study||101
8781466|NCT01331681|9831965|FG002|Completed Week 148|Overall Study||100
8781467|NCT01331681|9831963|FG000|COMPLETED|Overall Study|Completed Week 148|101
8781468|NCT01331681|9831964|FG001|COMPLETED|Overall Study|Completed Week 148|101
8781469|NCT01331681|9831965|FG002|COMPLETED|Overall Study|Completed Week 148|100
8781470|NCT01331681|9831963|FG000|NOT COMPLETED|Overall Study||35
8781471|NCT01331681|9831964|FG001|NOT COMPLETED|Overall Study||34
8781472|NCT01331681|9831965|FG002|NOT COMPLETED|Overall Study||35
8781473|NCT01331694|9831979|FG000|STARTED|Overall Study||16684
8781474|NCT01331694|9831980|FG001|STARTED|Overall Study||14449
8781475|NCT01331694|9831981|FG002|STARTED|Overall Study||12659
8781476|NCT01331694|9831982|FG003|STARTED|Overall Study||12595
8781477|NCT01331694|9831983|FG004|STARTED|Overall Study||10617
8781478|NCT01331694|9831984|FG005|STARTED|Overall Study||9126
8781479|NCT01331694|9831979|FG000|COMPLETED|Overall Study||16684
8781480|NCT01331694|9831980|FG001|COMPLETED|Overall Study||14449
8781481|NCT01331694|9831981|FG002|COMPLETED|Overall Study||12659
8781482|NCT01331694|9831982|FG003|COMPLETED|Overall Study||12595
8781483|NCT01331694|9831983|FG004|COMPLETED|Overall Study||10617
8781484|NCT01331694|9831984|FG005|COMPLETED|Overall Study||9126
8781485|NCT01331694|9831979|FG000|NOT COMPLETED|Overall Study||0
8781486|NCT01331694|9831980|FG001|NOT COMPLETED|Overall Study||0
8781487|NCT01331694|9831981|FG002|NOT COMPLETED|Overall Study||0
8781488|NCT01331694|9831982|FG003|NOT COMPLETED|Overall Study||0
8781489|NCT01331694|9831983|FG004|NOT COMPLETED|Overall Study||0
8781490|NCT01331694|9831984|FG005|NOT COMPLETED|Overall Study||0
8781491|NCT01331824|9831998|FG000|STARTED|Overall Study||22
8781492|NCT01331824|9831998|FG000|COMPLETED|Overall Study||9
8781493|NCT01331824|9831998|FG000|NOT COMPLETED|Overall Study||13
8781494|NCT01331837|9832004|FG000|STARTED|Overall Study||1538
8781495|NCT01331837|9832005|FG001|STARTED|Overall Study||1542
8781496|NCT01331837|9832004|FG000|COMPLETED|Overall Study||1482
8781497|NCT01331837|9832005|FG001|COMPLETED|Overall Study||1475
8781498|NCT01331837|9832004|FG000|NOT COMPLETED|Overall Study||56
8781499|NCT01331837|9832005|FG001|NOT COMPLETED|Overall Study||67
8781500|NCT01332019|9832013|FG000|STARTED|Overall Study||530
8781501|NCT01332019|9832014|FG001|STARTED|Overall Study||547
8781502|NCT01332019|9832013|FG000|COMPLETED|Overall Study||417
8781503|NCT01332019|9832014|FG001|COMPLETED|Overall Study||425
8781504|NCT01332019|9832013|FG000|NOT COMPLETED|Overall Study||113
8781505|NCT01332019|9832014|FG001|NOT COMPLETED|Overall Study||122
8781506|NCT01332071|9832020|FG000|STARTED|Period 1||13
8781507|NCT01332071|9832021|FG001|STARTED|Period 1||13
8781508|NCT01332071|9832020|FG000|COMPLETED|Period 1||13
8781509|NCT01332071|9832021|FG001|COMPLETED|Period 1||13
8781510|NCT01332071|9832020|FG000|NOT COMPLETED|Period 1||0
8781511|NCT01332071|9832021|FG001|NOT COMPLETED|Period 1||0
8781512|NCT01332071|9832020|FG000|STARTED|7-Day Washout Period||13
8781513|NCT01332071|9832021|FG001|STARTED|7-Day Washout Period||13
8781514|NCT01332071|9832020|FG000|COMPLETED|7-Day Washout Period||13
8781515|NCT01332071|9832021|FG001|COMPLETED|7-Day Washout Period||13
8781516|NCT01332071|9832020|FG000|NOT COMPLETED|7-Day Washout Period||0
8781517|NCT01332071|9832021|FG001|NOT COMPLETED|7-Day Washout Period||0
8781518|NCT01332071|9832020|FG000|STARTED|Period 2||13
8781519|NCT01332071|9832021|FG001|STARTED|Period 2||13
8781520|NCT01332071|9832020|FG000|COMPLETED|Period 2||13
8781521|NCT01332071|9832021|FG001|COMPLETED|Period 2||13
8781522|NCT01332071|9832020|FG000|NOT COMPLETED|Period 2||0
8781523|NCT01332071|9832021|FG001|NOT COMPLETED|Period 2||0
8781524|NCT01332123|9832029|FG000|STARTED|Overall Study||10
8781525|NCT01332123|9832029|FG000|COMPLETED|Overall Study||10
8781526|NCT01332123|9832029|FG000|NOT COMPLETED|Overall Study||0
8781527|NCT01332149|9832036|FG000|STARTED|Overall Study|Assigned to study treatment.|314
8781528|NCT01332149|9832037|FG001|STARTED|Overall Study|Assigned to study treatment.|309
8781529|NCT01332149|9832036|FG000|Treated|Overall Study||313
8781530|NCT01332149|9832037|FG001|Treated|Overall Study||307
8781531|NCT01332149|9832036|FG000|COMPLETED|Overall Study||284
8781532|NCT01332149|9832037|FG001|COMPLETED|Overall Study||271
8781533|NCT01332149|9832036|FG000|NOT COMPLETED|Overall Study||30
8781534|NCT01332149|9832037|FG001|NOT COMPLETED|Overall Study||38
8781535|NCT01332188|9832047|FG000|STARTED|Overall Study||25
8781536|NCT01332188|9832048|FG001|STARTED|Overall Study||26
8781537|NCT01332188|9832049|FG002|STARTED|Overall Study||25
8781538|NCT01332188|9832050|FG003|STARTED|Overall Study||25
8781539|NCT01332188|9832047|FG000|COMPLETED|Overall Study||23
8781540|NCT01332188|9832048|FG001|COMPLETED|Overall Study||25
8781541|NCT01332188|9832049|FG002|COMPLETED|Overall Study||21
8781542|NCT01332188|9832050|FG003|COMPLETED|Overall Study||25
8781543|NCT01332188|9832047|FG000|NOT COMPLETED|Overall Study||2
8781544|NCT01332188|9832048|FG001|NOT COMPLETED|Overall Study||1
8781545|NCT01332188|9832049|FG002|NOT COMPLETED|Overall Study||4
8781546|NCT01332188|9832050|FG003|NOT COMPLETED|Overall Study||0
8781547|NCT01332227|9832062|FG000|STARTED|Overall Study|Participants who received treatment|72
8781548|NCT01332227|9832063|FG001|STARTED|Overall Study|Participants who received treatment|37
8781549|NCT01332227|9832062|FG000|COMPLETED|Overall Study||56
8781550|NCT01332227|9832063|FG001|COMPLETED|Overall Study||32
8781551|NCT01332227|9832062|FG000|NOT COMPLETED|Overall Study||16
8781552|NCT01332227|9832063|FG001|NOT COMPLETED|Overall Study||5
8781553|NCT01332253|9832071|FG000|STARTED|Overall Study||82
8781554|NCT01332253|9832072|FG001|STARTED|Overall Study||79
8781555|NCT01332253|9832071|FG000|COMPLETED|Overall Study||82
8781556|NCT01332253|9832072|FG001|COMPLETED|Overall Study||79
8781557|NCT01332253|9832071|FG000|NOT COMPLETED|Overall Study||0
8781558|NCT01332253|9832072|FG001|NOT COMPLETED|Overall Study||0
8781559|NCT01332292|9832078|FG000|STARTED|Treatment Period 1 (14 Days)||14
8781560|NCT01332292|9832079|FG001|STARTED|Treatment Period 1 (14 Days)||13
8781561|NCT01332292|9832078|FG000|COMPLETED|Treatment Period 1 (14 Days)||12
8781562|NCT01332292|9832079|FG001|COMPLETED|Treatment Period 1 (14 Days)||12
9030329|NCT03231943|10092653|FG002|COMPLETED|Part 1 Period 4 (up to Day 60)||2
9030330|NCT03231943|10092654|FG003|COMPLETED|Part 1 Period 4 (up to Day 60)||2
9030331|NCT03231943|10092655|FG004|COMPLETED|Part 1 Period 4 (up to Day 60)||2
9030332|NCT03231943|10092656|FG005|COMPLETED|Part 1 Period 4 (up to Day 60)||2
9030333|NCT03231943|10092657|FG006|COMPLETED|Part 1 Period 4 (up to Day 60)||2
9030334|NCT03231943|10092658|FG007|COMPLETED|Part 1 Period 4 (up to Day 60)||2
9030335|NCT03231943|10092659|FG008|COMPLETED|Part 1 Period 4 (up to Day 60)||0
8781563|NCT01332292|9832078|FG000|NOT COMPLETED|Treatment Period 1 (14 Days)||2
8781564|NCT01332292|9832079|FG001|NOT COMPLETED|Treatment Period 1 (14 Days)||1
8781565|NCT01332292|9832078|FG000|STARTED|Washout Period (>=7 Days)||12
8781566|NCT01332292|9832079|FG001|STARTED|Washout Period (>=7 Days)||12
8781567|NCT01332292|9832078|FG000|COMPLETED|Washout Period (>=7 Days)||12
8781568|NCT01332292|9832079|FG001|COMPLETED|Washout Period (>=7 Days)||12
8781569|NCT01332292|9832078|FG000|NOT COMPLETED|Washout Period (>=7 Days)||0
8781570|NCT01332292|9832079|FG001|NOT COMPLETED|Washout Period (>=7 Days)||0
8781571|NCT01332292|9832078|FG000|STARTED|Treatment Period 2 (14 Days)||12
8781572|NCT01332292|9832079|FG001|STARTED|Treatment Period 2 (14 Days)||12
8781573|NCT01332292|9832078|FG000|COMPLETED|Treatment Period 2 (14 Days)||11
8781574|NCT01332292|9832079|FG001|COMPLETED|Treatment Period 2 (14 Days)||11
8781575|NCT01332292|9832078|FG000|NOT COMPLETED|Treatment Period 2 (14 Days)||1
8781576|NCT01332292|9832079|FG001|NOT COMPLETED|Treatment Period 2 (14 Days)||1
8781577|NCT01332305|9832092|FG000|STARTED|Overall Study||41
8781578|NCT01332305|9832093|FG001|STARTED|Overall Study||48
8781579|NCT01332305|9832094|FG002|STARTED|Overall Study||45
8781580|NCT01332305|9832095|FG003|STARTED|Overall Study||38
8781581|NCT01332305|9832096|FG004|STARTED|Overall Study||45
8781582|NCT01332305|9832092|FG000|COMPLETED|Overall Study||31
8781583|NCT01332305|9832093|FG001|COMPLETED|Overall Study||34
8781584|NCT01332305|9832094|FG002|COMPLETED|Overall Study||31
8781585|NCT01332305|9832095|FG003|COMPLETED|Overall Study||30
8781586|NCT01332305|9832096|FG004|COMPLETED|Overall Study||33
8781587|NCT01332305|9832092|FG000|NOT COMPLETED|Overall Study||10
8781588|NCT01332305|9832093|FG001|NOT COMPLETED|Overall Study||14
8781589|NCT01332305|9832094|FG002|NOT COMPLETED|Overall Study||14
8781590|NCT01332305|9832095|FG003|NOT COMPLETED|Overall Study||8
8781591|NCT01332305|9832096|FG004|NOT COMPLETED|Overall Study||12
8781592|NCT01332318|9832112|FG000|STARTED|Overall Study||34
8781593|NCT01332318|9832113|FG001|STARTED|Overall Study||32
8781594|NCT01332318|9832114|FG002|STARTED|Overall Study||34
8781595|NCT01332318|9832115|FG003|STARTED|Overall Study||30
8781596|NCT01332318|9832112|FG000|COMPLETED|Overall Study||32
8781597|NCT01332318|9832113|FG001|COMPLETED|Overall Study||28
8781598|NCT01332318|9832114|FG002|COMPLETED|Overall Study||33
8781599|NCT01332318|9832115|FG003|COMPLETED|Overall Study||28
8781600|NCT01332318|9832112|FG000|NOT COMPLETED|Overall Study||2
8781601|NCT01332318|9832113|FG001|NOT COMPLETED|Overall Study||4
8781602|NCT01332318|9832114|FG002|NOT COMPLETED|Overall Study||1
8781603|NCT01332318|9832115|FG003|NOT COMPLETED|Overall Study||2
8781604|NCT01332331|9832128|FG000|STARTED|Overall Study||21
8781605|NCT01332331|9832129|FG001|STARTED|Overall Study||20
8781606|NCT01332331|9832128|FG000|COMPLETED|Overall Study||19
8781607|NCT01332331|9832129|FG001|COMPLETED|Overall Study||18
8781608|NCT01332331|9832128|FG000|NOT COMPLETED|Overall Study||2
8781609|NCT01332331|9832129|FG001|NOT COMPLETED|Overall Study||2
8781610|NCT01332357|9832136|FG000|STARTED|Overall Study||6139
9030336|NCT03231943|10092660|FG009|COMPLETED|Part 1 Period 4 (up to Day 60)||0
8781611|NCT01332357|9832136|FG000|COMPLETED|Overall Study||6139
8781612|NCT01332357|9832136|FG000|NOT COMPLETED|Overall Study||0
8781613|NCT01332435|9832144|FG000|STARTED|Overall Study||1572
8781614|NCT01332435|9832145|FG001|STARTED|Overall Study||1064
8781615|NCT01332435|9832146|FG002|STARTED|Overall Study||2604
8781616|NCT01332435|9832147|FG003|STARTED|Overall Study||1656
8781617|NCT01332435|9832144|FG000|COMPLETED|Overall Study||1572
8781618|NCT01332435|9832145|FG001|COMPLETED|Overall Study||1064
8781619|NCT01332435|9832146|FG002|COMPLETED|Overall Study||2604
8781620|NCT01332435|9832147|FG003|COMPLETED|Overall Study||1656
8781621|NCT01332435|9832144|FG000|NOT COMPLETED|Overall Study||0
8781622|NCT01332435|9832145|FG001|NOT COMPLETED|Overall Study||0
8781623|NCT01332435|9832146|FG002|NOT COMPLETED|Overall Study||0
8781624|NCT01332435|9832147|FG003|NOT COMPLETED|Overall Study||0
8781625|NCT01332461|9832160|FG000|STARTED|Overall Study||1291
8781626|NCT01332461|9832161|FG001|STARTED|Overall Study||4386
8781627|NCT01332461|9832160|FG000|COMPLETED|Overall Study||1291
8781628|NCT01332461|9832161|FG001|COMPLETED|Overall Study||4386
8781629|NCT01332461|9832160|FG000|NOT COMPLETED|Overall Study||0
8781630|NCT01332461|9832161|FG001|NOT COMPLETED|Overall Study||0
8781631|NCT01332487|9832169|FG000|STARTED|Overall Study||5554
8781632|NCT01332487|9832170|FG001|STARTED|Overall Study||3063
8781633|NCT01332487|9832169|FG000|COMPLETED|Overall Study||5554
8781634|NCT01332487|9832170|FG001|COMPLETED|Overall Study||3063
8781635|NCT01332487|9832169|FG000|NOT COMPLETED|Overall Study||0
8781636|NCT01332487|9832170|FG001|NOT COMPLETED|Overall Study||0
8781637|NCT01332500|9832180|FG000|STARTED|Overall Study||13257
8781638|NCT01332500|9832181|FG001|STARTED|Overall Study||39771
8781639|NCT01332500|9832182|FG002|STARTED|Overall Study||2903
8781640|NCT01332500|9832183|FG003|STARTED|Overall Study||5806
8781641|NCT01332500|9832180|FG000|COMPLETED|Overall Study||13257
8781642|NCT01332500|9832181|FG001|COMPLETED|Overall Study||39771
8781643|NCT01332500|9832182|FG002|COMPLETED|Overall Study||2903
8781644|NCT01332500|9832183|FG003|COMPLETED|Overall Study||5806
8781645|NCT01332500|9832180|FG000|NOT COMPLETED|Overall Study||0
8781646|NCT01332500|9832181|FG001|NOT COMPLETED|Overall Study||0
8781647|NCT01332500|9832182|FG002|NOT COMPLETED|Overall Study||0
8781648|NCT01332500|9832183|FG003|NOT COMPLETED|Overall Study||0
8781649|NCT01332578|9832193|FG000|STARTED|Period I||12
8781650|NCT01332578|9832194|FG001|STARTED|Period I||13
8781651|NCT01332578|9832193|FG000|COMPLETED|Period I||12
8781652|NCT01332578|9832194|FG001|COMPLETED|Period I||13
8781653|NCT01332578|9832193|FG000|NOT COMPLETED|Period I||0
8781654|NCT01332578|9832194|FG001|NOT COMPLETED|Period I||0
8781655|NCT01332578|9832193|FG000|STARTED|Washout Period||12
8781656|NCT01332578|9832194|FG001|STARTED|Washout Period||13
8781657|NCT01332578|9832193|FG000|COMPLETED|Washout Period||12
8781658|NCT01332578|9832194|FG001|COMPLETED|Washout Period||13
8781659|NCT01332578|9832193|FG000|NOT COMPLETED|Washout Period||0
8781660|NCT01332578|9832194|FG001|NOT COMPLETED|Washout Period||0
8781661|NCT01332578|9832193|FG000|STARTED|Period II||12
8781662|NCT01332578|9832194|FG001|STARTED|Period II||13
8781663|NCT01332578|9832193|FG000|COMPLETED|Period II||12
8781664|NCT01332578|9832194|FG001|COMPLETED|Period II||13
8781665|NCT01332578|9832193|FG000|NOT COMPLETED|Period II||0
8781666|NCT01332578|9832194|FG001|NOT COMPLETED|Period II||0
8781667|NCT01332630|9832201|FG000|STARTED|Overall Study||24
8781668|NCT01332630|9832201|FG000|COMPLETED|Overall Study||21
8781669|NCT01332630|9832201|FG000|NOT COMPLETED|Overall Study||3
8781670|NCT01332721|9832205|FG000|STARTED|Overall Study||38
8781671|NCT01332721|9832205|FG000|COMPLETED|Overall Study||38
8781672|NCT01332721|9832205|FG000|NOT COMPLETED|Overall Study||0
8781673|NCT01332851|9832211|FG000|STARTED|Overall Study||124
8781674|NCT01332851|9832212|FG001|STARTED|Overall Study||123
8781675|NCT01332851|9832211|FG000|Completed Intervention|Overall Study|9 no intervention, 8 <full dose, 107 full dose; 3 new caregivers enrolled-initial parent dropped out|107
8781676|NCT01332851|9832212|FG001|Completed Intervention|Overall Study|4 no intervention, 9 <full dose, 110 full dose; 4 new caregivers enrolled-initial parent dropped out|110
8781677|NCT01332851|9832211|FG000|Completed Follow up 1|Overall Study||116
8781678|NCT01332851|9832212|FG001|Completed Follow up 1|Overall Study|Includes 1 new caregiver enrolled due to initial parent no longer parenting|112
9030337|NCT03231943|10092661|FG010|COMPLETED|Part 1 Period 4 (up to Day 60)||0
9030338|NCT03231943|10092662|FG011|COMPLETED|Part 1 Period 4 (up to Day 60)||0
9030339|NCT03231943|10092663|FG012|COMPLETED|Part 1 Period 4 (up to Day 60)||0
9030340|NCT03231943|10092651|FG000|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
9030341|NCT03231943|10092652|FG001|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
9030342|NCT03231943|10092653|FG002|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
9030343|NCT03231943|10092654|FG003|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
9030344|NCT03231943|10092655|FG004|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
9030345|NCT03231943|10092656|FG005|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
9030346|NCT03231943|10092657|FG006|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
9030347|NCT03231943|10092658|FG007|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
9030348|NCT03231943|10092659|FG008|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
9030349|NCT03231943|10092660|FG009|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
9030350|NCT03231943|10092661|FG010|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
9030351|NCT03231943|10092662|FG011|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
8781679|NCT01332851|9832211|FG000|Completed Follow up 2|Overall Study|Includes 1 new caregiver enrolled due to initial parent no longer parenting|111
8781680|NCT01332851|9832212|FG001|Completed Follow up 2|Overall Study|Includes 4 new caregivers enrolled due to initial parent no longer parenting|111
8781681|NCT01332851|9832211|FG000|Completed Follow up 3|Overall Study|Includes 3 new caregivers enrolled due to initial parent no longer parenting|113
8781682|NCT01332851|9832212|FG001|Completed Follow up 3|Overall Study|Includes 3 new caregivers enrolled due to initial parent no longer parenting|110
8781683|NCT01332851|9832211|FG000|COMPLETED|Overall Study||113
8781684|NCT01332851|9832212|FG001|COMPLETED|Overall Study||110
8781685|NCT01332851|9832211|FG000|NOT COMPLETED|Overall Study||11
8781686|NCT01332851|9832212|FG001|NOT COMPLETED|Overall Study||13
8781687|NCT01332981|9832222|FG000|STARTED|Overall Study||220
8781688|NCT01332981|9832222|FG000|COMPLETED|Overall Study||220
8781689|NCT01332981|9832222|FG000|NOT COMPLETED|Overall Study||0
8781690|NCT01332994|9832229|FG000|STARTED|Overall Study||519
8781691|NCT01332994|9832229|FG000|Completed Week 16|Overall Study||463
8781692|NCT01332994|9832229|FG000|Completed Week 32 (TCZ/TCZ)|Overall Study||200
8781693|NCT01332994|9832229|FG000|Completed Week 32 (TCZ/RTX)|Overall Study||26
8781694|NCT01332994|9832229|FG000|Completed Week 66 (TCZ/RTX)|Overall Study||25
8781695|NCT01332994|9832229|FG000|COMPLETED|Overall Study||448
8781696|NCT01332994|9832229|FG000|NOT COMPLETED|Overall Study||71
8781697|NCT01333033|9832235|FG000|STARTED|Overall Study||72
8781698|NCT01333033|9832236|FG001|STARTED|Overall Study||39
8781699|NCT01333033|9832237|FG002|STARTED|Overall Study||64
8781700|NCT01333033|9832238|FG003|STARTED|Overall Study||50
8781701|NCT01333033|9832239|FG004|STARTED|Overall Study||14
8781702|NCT01333033|9832240|FG005|STARTED|Overall Study||18
8781703|NCT01333033|9832235|FG000|COMPLETED|Overall Study||72
8781704|NCT01333033|9832236|FG001|COMPLETED|Overall Study||39
8781705|NCT01333033|9832237|FG002|COMPLETED|Overall Study||64
8781706|NCT01333033|9832238|FG003|COMPLETED|Overall Study||50
8781707|NCT01333033|9832239|FG004|COMPLETED|Overall Study||0
8781708|NCT01333033|9832240|FG005|COMPLETED|Overall Study||0
8781709|NCT01333033|9832235|FG000|NOT COMPLETED|Overall Study||0
8781710|NCT01333033|9832236|FG001|NOT COMPLETED|Overall Study||0
8781711|NCT01333033|9832237|FG002|NOT COMPLETED|Overall Study||0
8781712|NCT01333033|9832238|FG003|NOT COMPLETED|Overall Study||0
8781713|NCT01333033|9832239|FG004|NOT COMPLETED|Overall Study||14
8781714|NCT01333033|9832240|FG005|NOT COMPLETED|Overall Study||18
8781715|NCT01333059|9832260|FG000|STARTED|Overall Study||14
8781716|NCT01333059|9832261|FG001|STARTED|Overall Study||11
8781717|NCT01333059|9832260|FG000|COMPLETED|Overall Study||8
8781718|NCT01333059|9832261|FG001|COMPLETED|Overall Study||8
8781719|NCT01333059|9832260|FG000|NOT COMPLETED|Overall Study||6
9030352|NCT03231943|10092663|FG012|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
9030353|NCT03231943|10092651|FG000|STARTED|Part 2||0
9030354|NCT03231943|10092652|FG001|STARTED|Part 2||0
9030355|NCT03231943|10092653|FG002|STARTED|Part 2||0
9030356|NCT03231943|10092654|FG003|STARTED|Part 2||0
9030357|NCT03231943|10092655|FG004|STARTED|Part 2||0
9030358|NCT03231943|10092656|FG005|STARTED|Part 2||0
9030359|NCT03231943|10092657|FG006|STARTED|Part 2||0
9030360|NCT03231943|10092658|FG007|STARTED|Part 2||0
9030361|NCT03231943|10092659|FG008|STARTED|Part 2||6
9030362|NCT03231943|10092660|FG009|STARTED|Part 2||6
9030363|NCT03231943|10092661|FG010|STARTED|Part 2||25
9030364|NCT03231943|10092662|FG011|STARTED|Part 2||7
9030365|NCT03231943|10092663|FG012|STARTED|Part 2||14
9030366|NCT03231943|10092651|FG000|COMPLETED|Part 2||0
9030367|NCT03231943|10092652|FG001|COMPLETED|Part 2||0
9030368|NCT03231943|10092653|FG002|COMPLETED|Part 2||0
9030369|NCT03231943|10092654|FG003|COMPLETED|Part 2||0
9030370|NCT03231943|10092655|FG004|COMPLETED|Part 2||0
9030371|NCT03231943|10092656|FG005|COMPLETED|Part 2||0
9030372|NCT03231943|10092657|FG006|COMPLETED|Part 2||0
9030373|NCT03231943|10092658|FG007|COMPLETED|Part 2||0
9030374|NCT03231943|10092659|FG008|COMPLETED|Part 2||6
9030375|NCT03231943|10092660|FG009|COMPLETED|Part 2||6
9030376|NCT03231943|10092661|FG010|COMPLETED|Part 2||24
9030377|NCT03231943|10092662|FG011|COMPLETED|Part 2||6
9030378|NCT03231943|10092663|FG012|COMPLETED|Part 2||14
9030379|NCT03231943|10092651|FG000|NOT COMPLETED|Part 2||0
9030380|NCT03231943|10092652|FG001|NOT COMPLETED|Part 2||0
9030381|NCT03231943|10092653|FG002|NOT COMPLETED|Part 2||0
9030382|NCT03231943|10092654|FG003|NOT COMPLETED|Part 2||0
9030383|NCT03231943|10092655|FG004|NOT COMPLETED|Part 2||0
9030384|NCT03231943|10092656|FG005|NOT COMPLETED|Part 2||0
9030385|NCT03231943|10092657|FG006|NOT COMPLETED|Part 2||0
9030386|NCT03231943|10092658|FG007|NOT COMPLETED|Part 2||0
9030387|NCT03231943|10092659|FG008|NOT COMPLETED|Part 2||0
9030388|NCT03231943|10092660|FG009|NOT COMPLETED|Part 2||0
9030389|NCT03231943|10092661|FG010|NOT COMPLETED|Part 2||1
9030390|NCT03231943|10092662|FG011|NOT COMPLETED|Part 2||1
8781720|NCT01333059|9832261|FG001|NOT COMPLETED|Overall Study||3
8781721|NCT01333072|9832271|FG000|STARTED|Overall Study||30
9030391|NCT03231943|10092663|FG012|NOT COMPLETED|Part 2||0
9030392|NCT03231969|10092697|FG000|STARTED|Overall Study||30
9030393|NCT03231969|10092698|FG001|STARTED|Overall Study||30
9030394|NCT03231969|10092699|FG002|STARTED|Overall Study||31
9030395|NCT03231969|10092700|FG003|STARTED|Overall Study||30
8781722|NCT01333072|9832272|FG001|STARTED|Overall Study||31
8781723|NCT01333072|9832271|FG000|COMPLETED|Overall Study||24
8781724|NCT01333072|9832272|FG001|COMPLETED|Overall Study||27
8781725|NCT01333072|9832271|FG000|NOT COMPLETED|Overall Study||6
8781726|NCT01333072|9832272|FG001|NOT COMPLETED|Overall Study||4
8781727|NCT01333098|9832278|FG000|STARTED|Overall Study||15
9030396|NCT03231969|10092697|FG000|COMPLETED|Overall Study||28
9030397|NCT03231969|10092698|FG001|COMPLETED|Overall Study||28
9030398|NCT03231969|10092699|FG002|COMPLETED|Overall Study||30
9030399|NCT03231969|10092700|FG003|COMPLETED|Overall Study||30
9030400|NCT03231969|10092697|FG000|NOT COMPLETED|Overall Study||2
9030401|NCT03231969|10092698|FG001|NOT COMPLETED|Overall Study||2
8781728|NCT01333098|9832278|FG000|COMPLETED|Overall Study||12
8781729|NCT01333098|9832278|FG000|NOT COMPLETED|Overall Study||3
8781730|NCT01333111|9832287|FG000|STARTED|Overall Study||30
8781731|NCT01333111|9832288|FG001|STARTED|Overall Study||29
8781732|NCT01333111|9832289|FG002|STARTED|Overall Study||15
8781733|NCT01333111|9832287|FG000|COMPLETED|Overall Study||28
8781734|NCT01333111|9832288|FG001|COMPLETED|Overall Study||26
8781735|NCT01333111|9832289|FG002|COMPLETED|Overall Study||13
8781736|NCT01333111|9832287|FG000|NOT COMPLETED|Overall Study||2
8781737|NCT01333111|9832288|FG001|NOT COMPLETED|Overall Study||3
8781738|NCT01333111|9832289|FG002|NOT COMPLETED|Overall Study||2
8781739|NCT01333189|9832299|FG000|STARTED|Overall Study||13
8781740|NCT01333189|9832300|FG001|STARTED|Overall Study||13
8781741|NCT01333189|9832299|FG000|COMPLETED|Overall Study||11
8781742|NCT01333189|9832300|FG001|COMPLETED|Overall Study||11
8781743|NCT01333189|9832299|FG000|NOT COMPLETED|Overall Study||2
8781744|NCT01333189|9832300|FG001|NOT COMPLETED|Overall Study||2
8781745|NCT01333397|9832311|FG000|STARTED|Overall Study||35
8781746|NCT01333397|9832312|FG001|STARTED|Overall Study||36
8781747|NCT01333397|9832313|FG002|STARTED|Overall Study||35
8781748|NCT01333397|9832314|FG003|STARTED|Overall Study||35
8781749|NCT01333397|9832315|FG004|STARTED|Overall Study||35
8781750|NCT01333397|9832311|FG000|COMPLETED|Overall Study||34
8781751|NCT01333397|9832312|FG001|COMPLETED|Overall Study||36
8781752|NCT01333397|9832313|FG002|COMPLETED|Overall Study||35
8781753|NCT01333397|9832314|FG003|COMPLETED|Overall Study||34
8781754|NCT01333397|9832315|FG004|COMPLETED|Overall Study||35
8781755|NCT01333397|9832311|FG000|NOT COMPLETED|Overall Study||1
8781756|NCT01333397|9832312|FG001|NOT COMPLETED|Overall Study||0
8781757|NCT01333397|9832313|FG002|NOT COMPLETED|Overall Study||0
8781758|NCT01333397|9832314|FG003|NOT COMPLETED|Overall Study||1
8781759|NCT01333397|9832315|FG004|NOT COMPLETED|Overall Study||0
8781760|NCT01333475|9832338|FG000|STARTED|Overall Study||12
8781761|NCT01333475|9832339|FG001|STARTED|Overall Study||9
8781762|NCT01333475|9832338|FG000|COMPLETED|Overall Study||10
8781763|NCT01333475|9832339|FG001|COMPLETED|Overall Study||6
8781764|NCT01333475|9832338|FG000|NOT COMPLETED|Overall Study||2
8781765|NCT01333475|9832339|FG001|NOT COMPLETED|Overall Study||3
8781766|NCT01333488|9832349|FG000|STARTED|Overall Study||2
8781767|NCT01333488|9832350|FG001|STARTED|Overall Study||1
8781768|NCT01333488|9832351|FG002|STARTED|Overall Study||3
8781769|NCT01333488|9832349|FG000|COMPLETED|Overall Study||2
8781770|NCT01333488|9832350|FG001|COMPLETED|Overall Study||1
8781771|NCT01333488|9832351|FG002|COMPLETED|Overall Study||3
8781772|NCT01333488|9832349|FG000|NOT COMPLETED|Overall Study||0
8781773|NCT01333488|9832350|FG001|NOT COMPLETED|Overall Study||0
8781774|NCT01333488|9832351|FG002|NOT COMPLETED|Overall Study||0
8781775|NCT01333501|9832362|FG000|STARTED|Overall Study||106
8781776|NCT01333501|9832363|FG001|STARTED|Overall Study||51
8781777|NCT01333501|9832362|FG000|Full Analysis Set (FAS)|Overall Study||80
8781778|NCT01333501|9832363|FG001|Full Analysis Set (FAS)|Overall Study||28
8781779|NCT01333501|9832362|FG000|Safety Population|Overall Study||104
8781780|NCT01333501|9832363|FG001|Safety Population|Overall Study||47
8781781|NCT01333501|9832362|FG000|COMPLETED|Overall Study||97
8781782|NCT01333501|9832363|FG001|COMPLETED|Overall Study||30
8781783|NCT01333501|9832362|FG000|NOT COMPLETED|Overall Study||9
8781784|NCT01333501|9832363|FG001|NOT COMPLETED|Overall Study||21
8781785|NCT01333527|9832371|FG000|STARTED|Overall Study||105
8781786|NCT01333527|9832372|FG001|STARTED|Overall Study||106
8781787|NCT01333527|9832371|FG000|COMPLETED|Overall Study||87
8781788|NCT01333527|9832372|FG001|COMPLETED|Overall Study||89
8781789|NCT01333527|9832371|FG000|NOT COMPLETED|Overall Study||18
8781790|NCT01333527|9832372|FG001|NOT COMPLETED|Overall Study||17
8781791|NCT01333592|9832380|FG000|STARTED|Overall Study||67
8781792|NCT01333592|9832381|FG001|STARTED|Overall Study||69
8781793|NCT01333592|9832380|FG000|COMPLETED|Overall Study||58
8781794|NCT01333592|9832381|FG001|COMPLETED|Overall Study||52
8781795|NCT01333592|9832380|FG000|NOT COMPLETED|Overall Study||9
8781796|NCT01333592|9832381|FG001|NOT COMPLETED|Overall Study||17
8781797|NCT01333722|9832389|FG000|STARTED|Overall Study||51
8781798|NCT01333722|9832390|FG001|STARTED|Overall Study||49
8781799|NCT01333722|9832389|FG000|COMPLETED|Overall Study||51
8781800|NCT01333722|9832390|FG001|COMPLETED|Overall Study||46
8781801|NCT01333722|9832389|FG000|NOT COMPLETED|Overall Study||0
8781802|NCT01333722|9832390|FG001|NOT COMPLETED|Overall Study||3
8781803|NCT01333813|9832398|FG000|STARTED|Overall Study||297
8781804|NCT01333813|9832398|FG000|COMPLETED|Overall Study||297
8781805|NCT01333813|9832398|FG000|NOT COMPLETED|Overall Study||0
8781806|NCT01333865|9832402|FG000|STARTED|Overall Study|25 participants signed consent, but only 19 completed screening and were analyzed at baseline.|19
8781807|NCT01333865|9832402|FG000|COMPLETED|Overall Study|2 participants were withdrawn. One was still analyzed, but one was withdrawn too early for analysis|17
8781808|NCT01333865|9832402|FG000|NOT COMPLETED|Overall Study||2
8781809|NCT01333956|9832410|FG000|STARTED|Overall Study||30
8781810|NCT01333956|9832411|FG001|STARTED|Overall Study||30
8781811|NCT01333956|9832412|FG002|STARTED|Overall Study||30
8781812|NCT01333956|9832413|FG003|STARTED|Overall Study||30
8781813|NCT01333956|9832410|FG000|COMPLETED|Overall Study||28
8781814|NCT01333956|9832411|FG001|COMPLETED|Overall Study||26
8781815|NCT01333956|9832412|FG002|COMPLETED|Overall Study||29
8781816|NCT01333956|9832413|FG003|COMPLETED|Overall Study||28
8781817|NCT01333956|9832410|FG000|NOT COMPLETED|Overall Study||2
8781818|NCT01333956|9832411|FG001|NOT COMPLETED|Overall Study||4
8781819|NCT01333956|9832412|FG002|NOT COMPLETED|Overall Study||1
8781820|NCT01333956|9832413|FG003|NOT COMPLETED|Overall Study||2
8781821|NCT01334086|9832424|FG000|STARTED|Overall Study||41
8781822|NCT01334086|9832424|FG000|COMPLETED|Overall Study||41
8781823|NCT01334086|9832424|FG000|NOT COMPLETED|Overall Study||0
8781824|NCT01334125|9832430|FG000|STARTED|Overall Study||15
8781825|NCT01334125|9832431|FG001|STARTED|Overall Study||13
8781826|NCT01334125|9832430|FG000|COMPLETED|Overall Study|3 subjects move to another city|12
8781827|NCT01334125|9832431|FG001|COMPLETED|Overall Study|3 subjects left for college and moved out of the area|10
8781828|NCT01334125|9832430|FG000|NOT COMPLETED|Overall Study||3
8781829|NCT01334125|9832431|FG001|NOT COMPLETED|Overall Study||3
8781830|NCT01334216|9832440|FG000|STARTED|Overall Study||168
8781831|NCT01334216|9832441|FG001|STARTED|Overall Study||194
8781832|NCT01334216|9832440|FG000|COMPLETED|Overall Study||168
8781833|NCT01334216|9832441|FG001|COMPLETED|Overall Study||194
8781834|NCT01334216|9832440|FG000|NOT COMPLETED|Overall Study||0
8781835|NCT01334216|9832441|FG001|NOT COMPLETED|Overall Study||0
8781836|NCT01334229|9832449|FG000|STARTED|Overall Study||11
8781837|NCT01334229|9832450|FG001|STARTED|Overall Study||11
8781838|NCT01334229|9832449|FG000|COMPLETED|Overall Study||11
8781839|NCT01334229|9832450|FG001|COMPLETED|Overall Study||11
8781840|NCT01334229|9832449|FG000|NOT COMPLETED|Overall Study||0
8781841|NCT01334229|9832450|FG001|NOT COMPLETED|Overall Study||0
8781842|NCT01334515|9832458|FG000|STARTED|Overall Study||16
8781843|NCT01334515|9832459|FG001|STARTED|Overall Study||36
8781844|NCT01334515|9832458|FG000|COMPLETED|Overall Study||4
8781845|NCT01334515|9832459|FG001|COMPLETED|Overall Study||7
8781846|NCT01334515|9832458|FG000|NOT COMPLETED|Overall Study||12
8781847|NCT01334515|9832459|FG001|NOT COMPLETED|Overall Study||29
8781848|NCT01334554|9832467|FG000|STARTED|Overall Study||23
8781849|NCT01334554|9832468|FG001|STARTED|Overall Study||23
8781850|NCT01334554|9832467|FG000|COMPLETED|Overall Study||19
8781851|NCT01334554|9832468|FG001|COMPLETED|Overall Study||21
8781852|NCT01334554|9832467|FG000|NOT COMPLETED|Overall Study||4
8781853|NCT01334554|9832468|FG001|NOT COMPLETED|Overall Study||2
8781854|NCT01334710|9832476|FG000|STARTED|Overall Study||3
8781855|NCT01334710|9832476|FG000|COMPLETED|Overall Study|Due to safety signals in a parallel trial ON OSI906 in hepatocellular cancer the trial was stopped.|0
8781856|NCT01334710|9832476|FG000|NOT COMPLETED|Overall Study||3
8781857|NCT01334723|9832483|FG000|STARTED|Overall Study||17293
8781858|NCT01334723|9832484|FG001|STARTED|Overall Study||17739
8781859|NCT01334723|9832483|FG000|COMPLETED|Overall Study||17293
8781860|NCT01334723|9832484|FG001|COMPLETED|Overall Study||17739
8781861|NCT01334723|9832483|FG000|NOT COMPLETED|Overall Study||0
8781862|NCT01334723|9832484|FG001|NOT COMPLETED|Overall Study||0
8781863|NCT01334827|9832504|FG000|STARTED|Overall Study||48
8781864|NCT01334827|9832504|FG000|COMPLETED|Overall Study||48
8781865|NCT01334827|9832504|FG000|NOT COMPLETED|Overall Study||0
8781866|NCT01334866|9832510|FG000|STARTED|Overall Study|91 subjects were enrolled in the study; with 89 subjects receiving the study treatment.|91
8781867|NCT01334866|9832510|FG000|COMPLETED|Overall Study||72
8781868|NCT01334866|9832510|FG000|NOT COMPLETED|Overall Study||19
8781869|NCT01334918|9832518|FG000|STARTED|Overall Study||63
8781870|NCT01334918|9832519|FG001|STARTED|Overall Study||61
8781871|NCT01334918|9832518|FG000|Randomized + 1 Stress Scan|Overall Study|Equates to Safety Analysis Set (SAF)|57
8781872|NCT01334918|9832519|FG001|Randomized + 1 Stress Scan|Overall Study|Equates to Safety Analysis Set (SAF)|61
8781873|NCT01334918|9832518|FG000|COMPLETED|Overall Study||55
8781874|NCT01334918|9832519|FG001|COMPLETED|Overall Study||60
8781875|NCT01334918|9832518|FG000|NOT COMPLETED|Overall Study||8
8781876|NCT01334918|9832519|FG001|NOT COMPLETED|Overall Study||1
8781877|NCT01334944|9832536|FG000|STARTED|Overall Study||11
8781878|NCT01334944|9832537|FG001|STARTED|Overall Study||139
8781879|NCT01334944|9832536|FG000|Received Singel Dose|Overall Study||1
8781880|NCT01334944|9832537|FG001|Received Singel Dose|Overall Study||96
8781881|NCT01334944|9832536|FG000|Received Multiple Doses|Overall Study||10
8781882|NCT01334944|9832537|FG001|Received Multiple Doses|Overall Study||43
8781883|NCT01334944|9832536|FG000|COMPLETED|Overall Study||11
8781884|NCT01334944|9832537|FG001|COMPLETED|Overall Study||139
8781885|NCT01334944|9832536|FG000|NOT COMPLETED|Overall Study||0
8781886|NCT01334944|9832537|FG001|NOT COMPLETED|Overall Study||0
8781887|NCT01334957|9832546|FG000|STARTED|Overall Study||300
8781888|NCT01334957|9832546|FG000|Received Single Dose|Overall Study||252
8781889|NCT01334957|9832546|FG000|Received Multiple Doses|Overall Study||48
8781890|NCT01334957|9832546|FG000|COMPLETED|Overall Study||300
8781891|NCT01334957|9832546|FG000|NOT COMPLETED|Overall Study||0
8781892|NCT01335009|9832552|FG000|STARTED|Overall Study||40
8781893|NCT01335009|9832553|FG001|STARTED|Overall Study||36
8781894|NCT01335009|9832552|FG000|COMPLETED|Overall Study||9
8781895|NCT01335009|9832553|FG001|COMPLETED|Overall Study||3
8781896|NCT01335009|9832552|FG000|NOT COMPLETED|Overall Study||31
8781897|NCT01335009|9832553|FG001|NOT COMPLETED|Overall Study||33
8781898|NCT01335061|9832559|FG000|STARTED|Overall Study||25
8781899|NCT01335061|9832559|FG000|COMPLETED|Overall Study||25
8781900|NCT01335061|9832559|FG000|NOT COMPLETED|Overall Study||0
8781901|NCT01335191|9832572|FG000|STARTED|Overall Study||16
8781902|NCT01335191|9832573|FG001|STARTED|Overall Study||11
8781903|NCT01335191|9832572|FG000|COMPLETED|Overall Study||16
8781904|NCT01335191|9832573|FG001|COMPLETED|Overall Study||11
8781905|NCT01335191|9832572|FG000|NOT COMPLETED|Overall Study||0
8781906|NCT01335191|9832573|FG001|NOT COMPLETED|Overall Study||0
8781907|NCT01335204|9832579|FG000|STARTED|Overall Study||4
8781908|NCT01335204|9832579|FG000|COMPLETED|Overall Study||4
8781909|NCT01335204|9832579|FG000|NOT COMPLETED|Overall Study||0
8781910|NCT01335230|9832587|FG000|STARTED|Overall Study|subjects|10
8781911|NCT01335230|9832588|FG001|STARTED|Overall Study|subjects|10
8781912|NCT01335230|9832589|FG002|STARTED|Overall Study|subjects|10
8781913|NCT01335230|9832590|FG003|STARTED|Overall Study|subjects|10
8781914|NCT01335230|9832587|FG000|COMPLETED|Overall Study|subjects|10
8781915|NCT01335230|9832588|FG001|COMPLETED|Overall Study|subjects|10
8781916|NCT01335230|9832589|FG002|COMPLETED|Overall Study|subjects|10
8781917|NCT01335230|9832590|FG003|COMPLETED|Overall Study|subjects|10
8781918|NCT01335230|9832587|FG000|NOT COMPLETED|Overall Study||0
8781919|NCT01335230|9832588|FG001|NOT COMPLETED|Overall Study||0
8781920|NCT01335230|9832589|FG002|NOT COMPLETED|Overall Study||0
8781921|NCT01335230|9832590|FG003|NOT COMPLETED|Overall Study||0
8781922|NCT01335308|9832603|FG000|STARTED|Overall Study||198
8781923|NCT01335308|9832604|FG001|STARTED|Overall Study||212
8781924|NCT01335308|9832605|FG002|STARTED|Overall Study||235
8781925|NCT01335308|9832603|FG000|COMPLETED|Overall Study||158
8781926|NCT01335308|9832604|FG001|COMPLETED|Overall Study||145
8781927|NCT01335308|9832605|FG002|COMPLETED|Overall Study||154
8781928|NCT01335308|9832603|FG000|NOT COMPLETED|Overall Study||40
8781929|NCT01335308|9832604|FG001|NOT COMPLETED|Overall Study||67
8781930|NCT01335308|9832605|FG002|NOT COMPLETED|Overall Study||81
8781931|NCT01335464|9832615|FG000|STARTED|Overall Study||206
8781932|NCT01335464|9832616|FG001|STARTED|Overall Study||309
8781933|NCT01335464|9832615|FG000|COMPLETED|Overall Study||174
8781934|NCT01335464|9832616|FG001|COMPLETED|Overall Study||260
8781935|NCT01335464|9832615|FG000|NOT COMPLETED|Overall Study||32
8781936|NCT01335464|9832616|FG001|NOT COMPLETED|Overall Study||49
8781937|NCT01335477|9832624|FG000|STARTED|Overall Study||220
8781938|NCT01335477|9832625|FG001|STARTED|Overall Study||331
8781939|NCT01335477|9832624|FG000|COMPLETED|Overall Study||179
8781940|NCT01335477|9832625|FG001|COMPLETED|Overall Study||272
8781941|NCT01335477|9832624|FG000|NOT COMPLETED|Overall Study||41
8781942|NCT01335477|9832625|FG001|NOT COMPLETED|Overall Study||59
8781943|NCT01335542|9832633|FG000|STARTED|Overall Study||45
8781944|NCT01335542|9832634|FG001|STARTED|Overall Study||45
8781945|NCT01335542|9832633|FG000|COMPLETED|Overall Study||45
8781946|NCT01335542|9832634|FG001|COMPLETED|Overall Study||45
8781947|NCT01335542|9832633|FG000|NOT COMPLETED|Overall Study||0
8781948|NCT01335542|9832634|FG001|NOT COMPLETED|Overall Study||0
8781949|NCT01335620|9832640|FG000|STARTED|Overall Study||19
8781950|NCT01335620|9832640|FG000|COMPLETED|Overall Study||19
8781951|NCT01335620|9832640|FG000|NOT COMPLETED|Overall Study||0
8781952|NCT01335698|9832649|FG000|STARTED|Treatment Stage 1||23
8781953|NCT01335698|9832650|FG001|STARTED|Treatment Stage 1||12
8781954|NCT01335698|9832651|FG002|STARTED|Treatment Stage 1||21
8781955|NCT01335698|9832652|FG003|STARTED|Treatment Stage 1||35
8781956|NCT01335698|9832653|FG004|STARTED|Treatment Stage 1||8
8781957|NCT01335698|9832649|FG000|COMPLETED|Treatment Stage 1||15
8781958|NCT01335698|9832650|FG001|COMPLETED|Treatment Stage 1||4
8781959|NCT01335698|9832651|FG002|COMPLETED|Treatment Stage 1||16
8781960|NCT01335698|9832652|FG003|COMPLETED|Treatment Stage 1||26
8781961|NCT01335698|9832653|FG004|COMPLETED|Treatment Stage 1||6
8781962|NCT01335698|9832649|FG000|NOT COMPLETED|Treatment Stage 1||8
8781963|NCT01335698|9832650|FG001|NOT COMPLETED|Treatment Stage 1||8
8781964|NCT01335698|9832651|FG002|NOT COMPLETED|Treatment Stage 1||5
8781965|NCT01335698|9832652|FG003|NOT COMPLETED|Treatment Stage 1||9
8781966|NCT01335698|9832653|FG004|NOT COMPLETED|Treatment Stage 1||2
8781967|NCT01335698|9832649|FG000|STARTED|Treatment Stage 2||15
8781968|NCT01335698|9832650|FG001|STARTED|Treatment Stage 2||4
8781969|NCT01335698|9832651|FG002|STARTED|Treatment Stage 2||16
8781970|NCT01335698|9832652|FG003|STARTED|Treatment Stage 2||26
8781971|NCT01335698|9832653|FG004|STARTED|Treatment Stage 2||6
8781972|NCT01335698|9832649|FG000|COMPLETED|Treatment Stage 2||4
8781973|NCT01335698|9832650|FG001|COMPLETED|Treatment Stage 2||1
8781974|NCT01335698|9832651|FG002|COMPLETED|Treatment Stage 2||11
8781975|NCT01335698|9832652|FG003|COMPLETED|Treatment Stage 2||18
8781976|NCT01335698|9832653|FG004|COMPLETED|Treatment Stage 2||5
8781977|NCT01335698|9832649|FG000|NOT COMPLETED|Treatment Stage 2||11
8781978|NCT01335698|9832650|FG001|NOT COMPLETED|Treatment Stage 2||3
8781979|NCT01335698|9832651|FG002|NOT COMPLETED|Treatment Stage 2||5
8781980|NCT01335698|9832652|FG003|NOT COMPLETED|Treatment Stage 2||8
8781981|NCT01335698|9832653|FG004|NOT COMPLETED|Treatment Stage 2||1
8781982|NCT01335724|9832669|FG000|STARTED|Overall Study||36
8781983|NCT01335724|9832670|FG001|STARTED|Overall Study||36
8781984|NCT01335724|9832669|FG000|COMPLETED|Overall Study||36
8781985|NCT01335724|9832670|FG001|COMPLETED|Overall Study||36
8781986|NCT01335724|9832669|FG000|NOT COMPLETED|Overall Study||0
8781987|NCT01335724|9832670|FG001|NOT COMPLETED|Overall Study||0
8781988|NCT01335750|9832676|FG000|STARTED|Overall Study||32
8781989|NCT01335750|9832676|FG000|COMPLETED|Overall Study||32
8781990|NCT01335750|9832676|FG000|NOT COMPLETED|Overall Study||0
8781991|NCT01335789|9832690|FG000|STARTED|Overall Study||8
8781992|NCT01335789|9832691|FG001|STARTED|Overall Study||8
8781993|NCT01335789|9832690|FG000|COMPLETED|Overall Study||8
8781994|NCT01335789|9832691|FG001|COMPLETED|Overall Study||8
8781995|NCT01335789|9832690|FG000|NOT COMPLETED|Overall Study||0
8781996|NCT01335789|9832691|FG001|NOT COMPLETED|Overall Study||0
8781997|NCT01335867|9832699|FG000|STARTED|Overall Study||16
8781998|NCT01335867|9832700|FG001|STARTED|Overall Study||16
8781999|NCT01335867|9832699|FG000|COMPLETED|Overall Study||9
8782000|NCT01335867|9832700|FG001|COMPLETED|Overall Study||12
8782001|NCT01335867|9832699|FG000|NOT COMPLETED|Overall Study||7
8782002|NCT01335867|9832700|FG001|NOT COMPLETED|Overall Study||4
8782003|NCT01335932|9832715|FG000|STARTED|Overall Study||84
8782004|NCT01335932|9832716|FG001|STARTED|Overall Study||76
8782005|NCT01335932|9832715|FG000|COMPLETED|Overall Study||84
8782006|NCT01335932|9832716|FG001|COMPLETED|Overall Study||72
8782007|NCT01335932|9832715|FG000|NOT COMPLETED|Overall Study||0
8782008|NCT01335932|9832716|FG001|NOT COMPLETED|Overall Study||4
8782009|NCT01335971|9832725|FG000|STARTED|Overall Study||31
8782010|NCT01335971|9832726|FG001|STARTED|Overall Study||29
8782011|NCT01335971|9832727|FG002|STARTED|Overall Study||29
8782012|NCT01335971|9832725|FG000|COMPLETED|Overall Study||29
8782013|NCT01335971|9832726|FG001|COMPLETED|Overall Study||28
8782014|NCT01335971|9832727|FG002|COMPLETED|Overall Study||28
8782015|NCT01335971|9832725|FG000|NOT COMPLETED|Overall Study||2
8782016|NCT01335971|9832726|FG001|NOT COMPLETED|Overall Study||1
8782017|NCT01335971|9832727|FG002|NOT COMPLETED|Overall Study||1
8782018|NCT01336023|9832738|FG000|STARTED|Week 0 to Week 26||414
8782019|NCT01336023|9832739|FG001|STARTED|Week 0 to Week 26||834
8782020|NCT01336023|9832740|FG002|STARTED|Week 0 to Week 26||415
8782021|NCT01336023|9832738|FG000|Exposed|Week 0 to Week 26|1 subject withdrew before exposure to trial drug and was not included in the analysis|413
8782022|NCT01336023|9832739|FG001|Exposed|Week 0 to Week 26|8 subjects withdrew before exposure to trial drug and were not included in the analysis|826
8782023|NCT01336023|9832740|FG002|Exposed|Week 0 to Week 26|2 subjects withdrew before exposure to trial drug and were not included in the analysis|413
8782024|NCT01336023|9832738|FG000|COMPLETED|Week 0 to Week 26||366
8782025|NCT01336023|9832739|FG001|COMPLETED|Week 0 to Week 26||736
8782026|NCT01336023|9832740|FG002|COMPLETED|Week 0 to Week 26||342
8782027|NCT01336023|9832738|FG000|NOT COMPLETED|Week 0 to Week 26||48
8782028|NCT01336023|9832739|FG001|NOT COMPLETED|Week 0 to Week 26||98
8782029|NCT01336023|9832740|FG002|NOT COMPLETED|Week 0 to Week 26||73
8782030|NCT01336023|9832738|FG000|STARTED|Week 27 to 52|From the main trial, 33 subjects were not enrolled in the extension (week 27-52).|333
8782031|NCT01336023|9832739|FG001|STARTED|Week 27 to 52|From the main trial, 71 subjects were not enrolled in the extension (week 27-52).|665
8782032|NCT01336023|9832740|FG002|STARTED|Week 27 to 52|From the main trial, 29 subjects were not enrolled in the extension (week 27-52).|313
8782033|NCT01336023|9832738|FG000|COMPLETED|Week 27 to 52||305
8782034|NCT01336023|9832739|FG001|COMPLETED|Week 27 to 52||621
8782035|NCT01336023|9832740|FG002|COMPLETED|Week 27 to 52||285
8782036|NCT01336023|9832738|FG000|NOT COMPLETED|Week 27 to 52||28
8782037|NCT01336023|9832739|FG001|NOT COMPLETED|Week 27 to 52||44
8782038|NCT01336023|9832740|FG002|NOT COMPLETED|Week 27 to 52||28
8782039|NCT01336140|9832750|FG000|STARTED|Overall Study||150
8782040|NCT01336140|9832751|FG001|STARTED|Overall Study||150
8782041|NCT01336140|9832750|FG000|COMPLETED|Overall Study||150
8782042|NCT01336140|9832751|FG001|COMPLETED|Overall Study||150
8782043|NCT01336140|9832750|FG000|NOT COMPLETED|Overall Study||0
8782044|NCT01336140|9832751|FG001|NOT COMPLETED|Overall Study||0
8782045|NCT01336205|9832759|FG000|STARTED|Overall Study||563
8782046|NCT01336205|9832760|FG001|STARTED|Overall Study||281
8782047|NCT01336205|9832759|FG000|COMPLETED|Overall Study||330
8782048|NCT01336205|9832760|FG001|COMPLETED|Overall Study||192
8782049|NCT01336205|9832759|FG000|NOT COMPLETED|Overall Study||233
8782050|NCT01336205|9832760|FG001|NOT COMPLETED|Overall Study||89
8782051|NCT01336296|9832768|FG000|STARTED|Overall Study||40
8782052|NCT01336296|9832769|FG001|STARTED|Overall Study||21
8782053|NCT01336296|9832768|FG000|COMPLETED|Overall Study||35
8782054|NCT01336296|9832769|FG001|COMPLETED|Overall Study||17
8782055|NCT01336296|9832768|FG000|NOT COMPLETED|Overall Study||5
8782056|NCT01336296|9832769|FG001|NOT COMPLETED|Overall Study||4
8782057|NCT01336413|9832777|FG000|STARTED|Overall Study||27
8782058|NCT01336413|9832778|FG001|STARTED|Overall Study||26
8782059|NCT01336413|9832777|FG000|COMPLETED|Overall Study||26
8782060|NCT01336413|9832778|FG001|COMPLETED|Overall Study||18
8782061|NCT01336413|9832777|FG000|NOT COMPLETED|Overall Study||1
9030402|NCT03231969|10092699|FG002|NOT COMPLETED|Overall Study||1
9030403|NCT03231969|10092700|FG003|NOT COMPLETED|Overall Study||0
9030404|NCT03232281|10092712|FG000|STARTED|Overall Study||150
9030405|NCT03232281|10092713|FG001|STARTED|Overall Study||150
9030406|NCT03232281|10092712|FG000|Received Treatment|Overall Study||149
9030407|NCT03232281|10092713|FG001|Received Treatment|Overall Study||150
9030408|NCT03232281|10092712|FG000|Completed Week 12|Overall Study||143
9030409|NCT03232281|10092713|FG001|Completed Week 12|Overall Study||148
9030410|NCT03232281|10092712|FG000|Completed Week 24|Overall Study||143
9030411|NCT03232281|10092713|FG001|Completed Week 24|Overall Study||144
9030412|NCT03232281|10092712|FG000|COMPLETED|Overall Study||143
9030413|NCT03232281|10092713|FG001|COMPLETED|Overall Study||144
9030414|NCT03232281|10092712|FG000|NOT COMPLETED|Overall Study||7
9030415|NCT03232281|10092713|FG001|NOT COMPLETED|Overall Study||6
9030416|NCT03232333|10092719|FG000|STARTED|Overall Study||53
9030417|NCT03232333|10092719|FG000|COMPLETED|Overall Study||38
9030418|NCT03232333|10092719|FG000|NOT COMPLETED|Overall Study||15
9030419|NCT03232567|10092727|FG000|STARTED|Overall Study||15
8782062|NCT01336413|9832778|FG001|NOT COMPLETED|Overall Study||8
8782063|NCT01336569|9832786|FG000|STARTED|Overall Study||49
9030420|NCT03232567|10092728|FG001|STARTED|Overall Study||15
9030421|NCT03232567|10092729|FG002|STARTED|Overall Study||15
9030422|NCT03232567|10092730|FG003|STARTED|Overall Study||15
8782064|NCT01336569|9832786|FG000|COMPLETED|Overall Study||45
8782065|NCT01336569|9832786|FG000|NOT COMPLETED|Overall Study||4
8782066|NCT01336608|9832793|FG000|STARTED|2-week, Single-blind Run-In Period||559
8782067|NCT01336608|9832794|FG001|STARTED|2-week, Single-blind Run-In Period||0
8782068|NCT01336608|9832795|FG002|STARTED|2-week, Single-blind Run-In Period||0
8782069|NCT01336608|9832796|FG003|STARTED|2-week, Single-blind Run-In Period||0
8782070|NCT01336608|9832793|FG000|COMPLETED|2-week, Single-blind Run-In Period||444
8782071|NCT01336608|9832794|FG001|COMPLETED|2-week, Single-blind Run-In Period||0
8782072|NCT01336608|9832795|FG002|COMPLETED|2-week, Single-blind Run-In Period||0
8782073|NCT01336608|9832796|FG003|COMPLETED|2-week, Single-blind Run-In Period||0
8782074|NCT01336608|9832793|FG000|NOT COMPLETED|2-week, Single-blind Run-In Period||115
8782075|NCT01336608|9832794|FG001|NOT COMPLETED|2-week, Single-blind Run-In Period||0
8782076|NCT01336608|9832795|FG002|NOT COMPLETED|2-week, Single-blind Run-In Period||0
8782077|NCT01336608|9832796|FG003|NOT COMPLETED|2-week, Single-blind Run-In Period||0
8782078|NCT01336608|9832793|FG000|STARTED|24-week, Double-blind Treatment Period||0
8782079|NCT01336608|9832794|FG001|STARTED|24-week, Double-blind Treatment Period||141
8782080|NCT01336608|9832795|FG002|STARTED|24-week, Double-blind Treatment Period||154
8782081|NCT01336608|9832796|FG003|STARTED|24-week, Double-blind Treatment Period||135
8782082|NCT01336608|9832793|FG000|Completed the Treatment Period|24-week, Double-blind Treatment Period||0
8782083|NCT01336608|9832794|FG001|Completed the Treatment Period|24-week, Double-blind Treatment Period|Par. were considered to have completed the TP if they attended Visit 6 (Week 24).|96
8782084|NCT01336608|9832795|FG002|Completed the Treatment Period|24-week, Double-blind Treatment Period|Par. were considered to have completed the TP if they attended Visit 6 (Week 24).|124
8782085|NCT01336608|9832796|FG003|Completed the Treatment Period|24-week, Double-blind Treatment Period|Par. were considered to have completed the TP if they attended Visit 6 (Week 24).|110
8782086|NCT01336608|9832793|FG000|COMPLETED|24-week, Double-blind Treatment Period||0
8782087|NCT01336608|9832794|FG001|COMPLETED|24-week, Double-blind Treatment Period|Par. completed study if attended Wk 24, had 1-wk follow-up contact and no early withdrawal.|97
8782088|NCT01336608|9832795|FG002|COMPLETED|24-week, Double-blind Treatment Period|Par. completed study if attended Wk 24, had 1-wk follow-up contact and no early withdrawal.|124
8782089|NCT01336608|9832796|FG003|COMPLETED|24-week, Double-blind Treatment Period|Par. completed study if attended Wk 24, had 1-wk follow-up contact and no early withdrawal.|111
8782090|NCT01336608|9832793|FG000|NOT COMPLETED|24-week, Double-blind Treatment Period||0
8782091|NCT01336608|9832794|FG001|NOT COMPLETED|24-week, Double-blind Treatment Period||44
8782092|NCT01336608|9832795|FG002|NOT COMPLETED|24-week, Double-blind Treatment Period||30
8782093|NCT01336608|9832796|FG003|NOT COMPLETED|24-week, Double-blind Treatment Period||24
8782094|NCT01336647|9832807|FG000|STARTED|Overall Study||46
8782095|NCT01336647|9832808|FG001|STARTED|Overall Study||49
8782096|NCT01336647|9832809|FG002|STARTED|Overall Study||47
8782097|NCT01336647|9832807|FG000|COMPLETED|Overall Study||42
8782098|NCT01336647|9832808|FG001|COMPLETED|Overall Study||48
8782099|NCT01336647|9832809|FG002|COMPLETED|Overall Study||44
8782100|NCT01336647|9832807|FG000|NOT COMPLETED|Overall Study||4
8782101|NCT01336647|9832808|FG001|NOT COMPLETED|Overall Study||1
8782102|NCT01336647|9832809|FG002|NOT COMPLETED|Overall Study||3
8782103|NCT01336712|9832819|FG000|STARTED|Overall Study||30
8782104|NCT01336712|9832819|FG000|COMPLETED|Overall Study||27
8782105|NCT01336712|9832819|FG000|NOT COMPLETED|Overall Study||3
8782106|NCT01336738|9832828|FG000|STARTED|Overall Study||52
8782107|NCT01336738|9832829|FG001|STARTED|Overall Study||54
8782108|NCT01336738|9832830|FG002|STARTED|Overall Study||53
8782109|NCT01336738|9832831|FG003|STARTED|Overall Study||54
8782110|NCT01336738|9832832|FG004|STARTED|Overall Study||53
8782111|NCT01336738|9832828|FG000|COMPLETED|Overall Study||45
8782112|NCT01336738|9832829|FG001|COMPLETED|Overall Study||45
8782113|NCT01336738|9832830|FG002|COMPLETED|Overall Study||45
8782114|NCT01336738|9832831|FG003|COMPLETED|Overall Study||47
8782115|NCT01336738|9832832|FG004|COMPLETED|Overall Study||43
8782116|NCT01336738|9832828|FG000|NOT COMPLETED|Overall Study||7
8782117|NCT01336738|9832829|FG001|NOT COMPLETED|Overall Study||9
8782118|NCT01336738|9832830|FG002|NOT COMPLETED|Overall Study||8
8782119|NCT01336738|9832831|FG003|NOT COMPLETED|Overall Study||7
8782120|NCT01336738|9832832|FG004|NOT COMPLETED|Overall Study||10
8782121|NCT01336764|9832846|FG000|STARTED|Overall Study||12
8782122|NCT01336764|9832847|FG001|STARTED|Overall Study||10
8782123|NCT01336764|9832846|FG000|COMPLETED|Overall Study||7
8782124|NCT01336764|9832847|FG001|COMPLETED|Overall Study||5
9030423|NCT03232567|10092727|FG000|COMPLETED|Overall Study||15
9030424|NCT03232567|10092728|FG001|COMPLETED|Overall Study||14
9030425|NCT03232567|10092729|FG002|COMPLETED|Overall Study||15
9030426|NCT03232567|10092730|FG003|COMPLETED|Overall Study||15
9030427|NCT03232567|10092727|FG000|NOT COMPLETED|Overall Study||0
9030428|NCT03232567|10092728|FG001|NOT COMPLETED|Overall Study||1
9030429|NCT03232567|10092729|FG002|NOT COMPLETED|Overall Study||0
9030430|NCT03232567|10092730|FG003|NOT COMPLETED|Overall Study||0
9030431|NCT03232580|10092740|FG000|STARTED|Overall Study||5
9030432|NCT03232580|10092740|FG000|COMPLETED|Overall Study||5
9030433|NCT03232580|10092740|FG000|NOT COMPLETED|Overall Study||0
9030434|NCT03232645|10092744|FG000|STARTED|Overall Study||62
9030435|NCT03232645|10092744|FG000|COMPLETED|Overall Study||58
9030436|NCT03232645|10092744|FG000|NOT COMPLETED|Overall Study||4
9030437|NCT03232749|10092749|FG000|STARTED|Overall Study||25
9030438|NCT03232749|10092749|FG000|COMPLETED|Overall Study||21
9030439|NCT03232749|10092749|FG000|NOT COMPLETED|Overall Study||4
9030440|NCT03232827|10092753|FG000|STARTED|Flavored-sweetened (FS)||80
8782125|NCT01336764|9832846|FG000|NOT COMPLETED|Overall Study||5
8782126|NCT01336764|9832847|FG001|NOT COMPLETED|Overall Study||5
8782127|NCT01336803|9832853|FG000|STARTED|Overall Study||21
8782128|NCT01336803|9832853|FG000|Bone Sarcoma|Overall Study||10
8782129|NCT01336803|9832853|FG000|Osteomyelitis|Overall Study||4
8782130|NCT01336803|9832853|FG000|Lymphoma|Overall Study||7
8782131|NCT01336803|9832853|FG000|COMPLETED|Overall Study||21
8782132|NCT01336803|9832853|FG000|NOT COMPLETED|Overall Study||0
8809117|NCT01495572|9861565|FG000|COMPLETED|Overall Study||0
8809118|NCT01495572|9861566|FG001|COMPLETED|Overall Study||5
8809119|NCT01495572|9861565|FG000|NOT COMPLETED|Overall Study||0
8809120|NCT01495572|9861566|FG001|NOT COMPLETED|Overall Study||0
8809121|NCT01495585|9861576|FG000|STARTED|Overall Study||4
8809122|NCT01495585|9861577|FG001|STARTED|Overall Study||6
8809123|NCT01495585|9861578|FG002|STARTED|Overall Study||4
8809124|NCT01495585|9861576|FG000|Open Label Lonafarnib 200 mg|Overall Study||2
8809125|NCT01495585|9861577|FG001|Open Label Lonafarnib 200 mg|Overall Study||0
8809126|NCT01495585|9861578|FG002|Open Label Lonafarnib 200 mg|Overall Study||0
8809127|NCT01495585|9861576|FG000|COMPLETED|Overall Study||4
8809128|NCT01495585|9861577|FG001|COMPLETED|Overall Study||6
8809129|NCT01495585|9861578|FG002|COMPLETED|Overall Study||4
8809130|NCT01495585|9861576|FG000|NOT COMPLETED|Overall Study||0
8809131|NCT01495585|9861577|FG001|NOT COMPLETED|Overall Study||0
8809132|NCT01495585|9861578|FG002|NOT COMPLETED|Overall Study||0
8809133|NCT01495689|9861588|FG000|STARTED|Overall Study||26
8809134|NCT01495689|9861589|FG001|STARTED|Overall Study||23
8809135|NCT01495689|9861588|FG000|COMPLETED|Overall Study||16
8809136|NCT01495689|9861589|FG001|COMPLETED|Overall Study||16
8809137|NCT01495689|9861588|FG000|NOT COMPLETED|Overall Study||10
8809138|NCT01495689|9861589|FG001|NOT COMPLETED|Overall Study||7
8809139|NCT01495702|9861597|FG000|STARTED|Randomized Phase||292
8809140|NCT01495702|9861598|FG001|STARTED|Randomized Phase||147
8809141|NCT01495702|9861597|FG000|COMPLETED|Randomized Phase||266
8809142|NCT01495702|9861598|FG001|COMPLETED|Randomized Phase||119
8809143|NCT01495702|9861597|FG000|NOT COMPLETED|Randomized Phase||26
8809144|NCT01495702|9861598|FG001|NOT COMPLETED|Randomized Phase||28
8809145|NCT01495702|9861597|FG000|STARTED|Extension Phase||26
8809146|NCT01495702|9861598|FG001|STARTED|Extension Phase||2
8809147|NCT01495702|9861597|FG000|COMPLETED|Extension Phase||26
8809148|NCT01495702|9861598|FG001|COMPLETED|Extension Phase||2
8809149|NCT01495702|9861597|FG000|NOT COMPLETED|Extension Phase||0
8809150|NCT01495702|9861598|FG001|NOT COMPLETED|Extension Phase||0
8809151|NCT01495793|9861605|FG000|STARTED|Overall Study||24
8809152|NCT01495793|9861605|FG000|COMPLETED|Overall Study||22
8809153|NCT01495793|9861605|FG000|NOT COMPLETED|Overall Study||2
8809154|NCT01495819|9861609|FG000|STARTED|Overall Study||34
8809155|NCT01495819|9861609|FG000|Nicotine 0.0125|Overall Study||31
8809156|NCT01495819|9861609|FG000|Nicotine 0.025|Overall Study||32
8809157|NCT01495819|9861609|FG000|Nicotine 0.05|Overall Study||33
8809158|NCT01495819|9861609|FG000|Nicotine 0.1|Overall Study||31
8809159|NCT01495819|9861609|FG000|NIcotine 0.2|Overall Study||33
8809160|NCT01495819|9861609|FG000|COMPLETED|Overall Study||30
8809161|NCT01495819|9861609|FG000|NOT COMPLETED|Overall Study||4
8809162|NCT01495858|9861621|FG000|STARTED|Overall Study||107
8809163|NCT01495858|9861622|FG001|STARTED|Overall Study||106
8809164|NCT01495858|9861623|FG002|STARTED|Overall Study||54
8809165|NCT01495858|9861621|FG000|COMPLETED|Overall Study||107
8809166|NCT01495858|9861622|FG001|COMPLETED|Overall Study||106
8809167|NCT01495858|9861623|FG002|COMPLETED|Overall Study||54
8809168|NCT01495858|9861621|FG000|NOT COMPLETED|Overall Study||0
8809169|NCT01495858|9861622|FG001|NOT COMPLETED|Overall Study||0
8809170|NCT01495858|9861623|FG002|NOT COMPLETED|Overall Study||0
8809171|NCT01495923|9861633|FG000|STARTED|Overall Study||73
8809172|NCT01495923|9861634|FG001|STARTED|Overall Study||72
8809173|NCT01495923|9861633|FG000|COMPLETED|Overall Study||73
8809174|NCT01495923|9861634|FG001|COMPLETED|Overall Study||72
8809175|NCT01495923|9861633|FG000|NOT COMPLETED|Overall Study||0
8809176|NCT01495923|9861634|FG001|NOT COMPLETED|Overall Study||0
8809177|NCT01495975|9861644|FG000|STARTED|Overall Study||15
8809178|NCT01495975|9861645|FG001|STARTED|Overall Study||14
8809179|NCT01495975|9861644|FG000|COMPLETED|Overall Study||14
8809180|NCT01495975|9861645|FG001|COMPLETED|Overall Study||14
8809181|NCT01495975|9861644|FG000|NOT COMPLETED|Overall Study||1
8809182|NCT01495975|9861645|FG001|NOT COMPLETED|Overall Study||0
8809183|NCT01496066|9861653|FG000|STARTED|Overall Study||403
8809184|NCT01496066|9861654|FG001|STARTED|Overall Study||197
8809185|NCT01496066|9861653|FG000|COMPLETED|Overall Study||391
8809186|NCT01496066|9861654|FG001|COMPLETED|Overall Study||188
8809187|NCT01496066|9861653|FG000|NOT COMPLETED|Overall Study||12
8809188|NCT01496066|9861654|FG001|NOT COMPLETED|Overall Study||9
8809189|NCT01496131|9861669|FG000|STARTED|Overall Study||14
8809190|NCT01496131|9861670|FG001|STARTED|Overall Study||14
8809191|NCT01496131|9861669|FG000|COMPLETED|Overall Study||14
8809192|NCT01496131|9861670|FG001|COMPLETED|Overall Study||14
8809193|NCT01496131|9861669|FG000|NOT COMPLETED|Overall Study||0
8809194|NCT01496131|9861670|FG001|NOT COMPLETED|Overall Study||0
8809195|NCT01496157|9861676|FG000|STARTED|Overall Study||13
8809196|NCT01496157|9861676|FG000|COMPLETED|Overall Study||13
8809197|NCT01496157|9861676|FG000|NOT COMPLETED|Overall Study||0
8916535|NCT02185040|9976165|FG006|COMPLETED|Part 1 Treatment Phase||0
8916536|NCT02185040|9976159|FG000|NOT COMPLETED|Part 1 Treatment Phase||1
8916537|NCT02185040|9976160|FG001|NOT COMPLETED|Part 1 Treatment Phase||2
8782133|NCT01336894|9832867|FG000|STARTED|Protocol Interventions||4
8782134|NCT01336894|9832868|FG001|STARTED|Protocol Interventions||7
8782135|NCT01336894|9832867|FG000|COMPLETED|Protocol Interventions||4
8782136|NCT01336894|9832868|FG001|COMPLETED|Protocol Interventions||7
8782137|NCT01336894|9832867|FG000|NOT COMPLETED|Protocol Interventions||0
8782138|NCT01336894|9832868|FG001|NOT COMPLETED|Protocol Interventions||0
8782139|NCT01336894|9832867|FG000|STARTED|Follow-up||4
8782140|NCT01336894|9832868|FG001|STARTED|Follow-up||7
8782141|NCT01336894|9832867|FG000|COMPLETED|Follow-up||2
8782142|NCT01336894|9832868|FG001|COMPLETED|Follow-up||0
8782143|NCT01336894|9832867|FG000|NOT COMPLETED|Follow-up||2
8782144|NCT01336894|9832868|FG001|NOT COMPLETED|Follow-up||7
8782145|NCT01336933|9832874|FG000|STARTED|Overall Study||34
8782146|NCT01336933|9832874|FG000|COMPLETED|Overall Study||33
8782147|NCT01336933|9832874|FG000|NOT COMPLETED|Overall Study||1
8782148|NCT01336959|9832882|FG000|STARTED|Overall Study||8
8782149|NCT01336959|9832883|FG001|STARTED|Overall Study||42
8782150|NCT01336959|9832884|FG002|STARTED|Overall Study||41
8782151|NCT01336959|9832882|FG000|COMPLETED|Overall Study||8
8782152|NCT01336959|9832883|FG001|COMPLETED|Overall Study||37
8782153|NCT01336959|9832884|FG002|COMPLETED|Overall Study||40
8782154|NCT01336959|9832882|FG000|NOT COMPLETED|Overall Study||0
8782155|NCT01336959|9832883|FG001|NOT COMPLETED|Overall Study||5
8782156|NCT01336959|9832884|FG002|NOT COMPLETED|Overall Study||1
9030441|NCT03232827|10092753|FG000|COMPLETED|Flavored-sweetened (FS)||80
9030442|NCT03232827|10092753|FG000|NOT COMPLETED|Flavored-sweetened (FS)||0
9030443|NCT03232827|10092753|FG000|STARTED|Unflavored-sweetened (US)||86
9030444|NCT03232827|10092753|FG000|COMPLETED|Unflavored-sweetened (US)||86
9030445|NCT03232827|10092753|FG000|NOT COMPLETED|Unflavored-sweetened (US)||0
9030446|NCT03232827|10092753|FG000|STARTED|Unflavored-very Low Sweetened (UU)||66
9030447|NCT03232827|10092753|FG000|COMPLETED|Unflavored-very Low Sweetened (UU)||66
9030448|NCT03232827|10092753|FG000|NOT COMPLETED|Unflavored-very Low Sweetened (UU)||0
9030449|NCT03232827|10092753|FG000|STARTED|Flavored-very Low Sweetened||66
9030450|NCT03232827|10092753|FG000|COMPLETED|Flavored-very Low Sweetened||66
9030451|NCT03232827|10092753|FG000|NOT COMPLETED|Flavored-very Low Sweetened||0
9030452|NCT03232983|10092763|FG000|STARTED|Period 1||7
9030453|NCT03232983|10092764|FG001|STARTED|Period 1||7
9030454|NCT03232983|10092765|FG002|STARTED|Period 1||7
9030455|NCT03232983|10092766|FG003|STARTED|Period 1||7
9030456|NCT03232983|10092763|FG000|Received at Least One Dose of Study Drug|Period 1||7
9030457|NCT03232983|10092764|FG001|Received at Least One Dose of Study Drug|Period 1||7
9030458|NCT03232983|10092765|FG002|Received at Least One Dose of Study Drug|Period 1||7
9030459|NCT03232983|10092766|FG003|Received at Least One Dose of Study Drug|Period 1||7
9030460|NCT03232983|10092763|FG000|COMPLETED|Period 1||7
9030461|NCT03232983|10092764|FG001|COMPLETED|Period 1||7
9030462|NCT03232983|10092765|FG002|COMPLETED|Period 1||6
9030463|NCT03232983|10092766|FG003|COMPLETED|Period 1||7
9030464|NCT03232983|10092763|FG000|NOT COMPLETED|Period 1||0
9030465|NCT03232983|10092764|FG001|NOT COMPLETED|Period 1||0
9030466|NCT03232983|10092765|FG002|NOT COMPLETED|Period 1||1
9030467|NCT03232983|10092766|FG003|NOT COMPLETED|Period 1||0
9030468|NCT03232983|10092763|FG000|STARTED|Washout Period 1||7
9030469|NCT03232983|10092764|FG001|STARTED|Washout Period 1||7
9030470|NCT03232983|10092765|FG002|STARTED|Washout Period 1||6
9030471|NCT03232983|10092766|FG003|STARTED|Washout Period 1||7
9030472|NCT03232983|10092763|FG000|COMPLETED|Washout Period 1||7
9030473|NCT03232983|10092764|FG001|COMPLETED|Washout Period 1||7
9030474|NCT03232983|10092765|FG002|COMPLETED|Washout Period 1||6
9030475|NCT03232983|10092766|FG003|COMPLETED|Washout Period 1||7
9030476|NCT03232983|10092763|FG000|NOT COMPLETED|Washout Period 1||0
9030477|NCT03232983|10092764|FG001|NOT COMPLETED|Washout Period 1||0
9030478|NCT03232983|10092765|FG002|NOT COMPLETED|Washout Period 1||0
9030479|NCT03232983|10092766|FG003|NOT COMPLETED|Washout Period 1||0
9030480|NCT03232983|10092763|FG000|STARTED|Period 2||7
9030481|NCT03232983|10092764|FG001|STARTED|Period 2||7
9030482|NCT03232983|10092765|FG002|STARTED|Period 2||6
9030483|NCT03232983|10092766|FG003|STARTED|Period 2||7
9030484|NCT03232983|10092763|FG000|COMPLETED|Period 2||7
9030485|NCT03232983|10092764|FG001|COMPLETED|Period 2||7
9030486|NCT03232983|10092765|FG002|COMPLETED|Period 2||6
9030487|NCT03232983|10092766|FG003|COMPLETED|Period 2||7
9030488|NCT03232983|10092763|FG000|NOT COMPLETED|Period 2||0
9030489|NCT03232983|10092764|FG001|NOT COMPLETED|Period 2||0
9030490|NCT03232983|10092765|FG002|NOT COMPLETED|Period 2||0
9030491|NCT03232983|10092766|FG003|NOT COMPLETED|Period 2||0
9030492|NCT03232983|10092763|FG000|STARTED|Washout Period 2||7
9030493|NCT03232983|10092764|FG001|STARTED|Washout Period 2||7
9030494|NCT03232983|10092765|FG002|STARTED|Washout Period 2||6
9030495|NCT03232983|10092766|FG003|STARTED|Washout Period 2||7
9030496|NCT03232983|10092763|FG000|COMPLETED|Washout Period 2||7
9030497|NCT03232983|10092764|FG001|COMPLETED|Washout Period 2||7
9030498|NCT03232983|10092765|FG002|COMPLETED|Washout Period 2||5
9030499|NCT03232983|10092766|FG003|COMPLETED|Washout Period 2||6
9030500|NCT03232983|10092763|FG000|NOT COMPLETED|Washout Period 2||0
9030501|NCT03232983|10092764|FG001|NOT COMPLETED|Washout Period 2||0
8782157|NCT01336972|9832898|FG000|STARTED|Overall Study||10
8782158|NCT01336972|9832899|FG001|STARTED|Overall Study||10
8782159|NCT01336972|9832900|FG002|STARTED|Overall Study||9
9030502|NCT03232983|10092765|FG002|NOT COMPLETED|Washout Period 2||1
8782160|NCT01336972|9832898|FG000|COMPLETED|Overall Study||9
8782161|NCT01336972|9832899|FG001|COMPLETED|Overall Study||9
8782162|NCT01336972|9832900|FG002|COMPLETED|Overall Study||9
8782163|NCT01336972|9832898|FG000|NOT COMPLETED|Overall Study||1
8782164|NCT01336972|9832899|FG001|NOT COMPLETED|Overall Study||1
8782165|NCT01336972|9832900|FG002|NOT COMPLETED|Overall Study||0
8782166|NCT01337050|9832912|FG000|STARTED|Overall Study||4
8782167|NCT01337050|9832913|FG001|STARTED|Overall Study||13
8782168|NCT01337050|9832914|FG002|STARTED|Overall Study||19
8782169|NCT01337050|9832912|FG000|COMPLETED|Overall Study||0
8782170|NCT01337050|9832913|FG001|COMPLETED|Overall Study||0
8782171|NCT01337050|9832914|FG002|COMPLETED|Overall Study||0
8782172|NCT01337050|9832912|FG000|NOT COMPLETED|Overall Study||4
8782173|NCT01337050|9832913|FG001|NOT COMPLETED|Overall Study||13
8782174|NCT01337050|9832914|FG002|NOT COMPLETED|Overall Study||19
8782175|NCT01337076|9832923|FG000|STARTED|Overall Study|subjects implanted|21
8782176|NCT01337076|9832923|FG000|COMPLETED|Overall Study|subjects met the primary endpoint of 6 months postimplant activation|19
8782177|NCT01337076|9832923|FG000|NOT COMPLETED|Overall Study||2
8782178|NCT01337089|9832927|FG000|STARTED|Overall Study||660
8782179|NCT01337089|9832927|FG000|Received at Least 1 Dose of Study Drug|Overall Study||660
8782180|NCT01337089|9832927|FG000|Safety Population|Overall Study||660
8782181|NCT01337089|9832927|FG000|Efficacy Dataset|Overall Study|One participant withdrew after administering nabiximols, but no efficacy data were collected.|659
8782182|NCT01337089|9832927|FG000|COMPLETED|Overall Study||256
8782183|NCT01337089|9832927|FG000|NOT COMPLETED|Overall Study||404
8782184|NCT01337115|9832933|FG000|STARTED|Overall Study||25
8782185|NCT01337115|9832934|FG001|STARTED|Overall Study||25
8782186|NCT01337115|9832933|FG000|COMPLETED|Overall Study|2 patients could not be assessed after 12h because of catheter dislocation|23
8782187|NCT01337115|9832934|FG001|COMPLETED|Overall Study||25
8782188|NCT01337115|9832933|FG000|NOT COMPLETED|Overall Study||2
8782189|NCT01337115|9832934|FG001|NOT COMPLETED|Overall Study||0
8782190|NCT01337167|9832944|FG000|STARTED|Infant Series||986
8782191|NCT01337167|9832945|FG001|STARTED|Infant Series||487
8782192|NCT01337167|9832944|FG000|COMPLETED|Infant Series||924
8782193|NCT01337167|9832945|FG001|COMPLETED|Infant Series||460
8782194|NCT01337167|9832944|FG000|NOT COMPLETED|Infant Series||62
8782195|NCT01337167|9832945|FG001|NOT COMPLETED|Infant Series||27
8782196|NCT01337167|9832944|FG000|STARTED|Interim Period||924
8782197|NCT01337167|9832945|FG001|STARTED|Interim Period||460
8782198|NCT01337167|9832944|FG000|COMPLETED|Interim Period||843
8782199|NCT01337167|9832945|FG001|COMPLETED|Interim Period||420
8782200|NCT01337167|9832944|FG000|NOT COMPLETED|Interim Period||81
8782201|NCT01337167|9832945|FG001|NOT COMPLETED|Interim Period||40
8782202|NCT01337167|9832944|FG000|STARTED|Toddler Vaccinations||843
8782203|NCT01337167|9832945|FG001|STARTED|Toddler Vaccinations||420
8782204|NCT01337167|9832944|FG000|COMPLETED|Toddler Vaccinations||829
8782205|NCT01337167|9832945|FG001|COMPLETED|Toddler Vaccinations||407
8782206|NCT01337167|9832944|FG000|NOT COMPLETED|Toddler Vaccinations||14
8782207|NCT01337167|9832945|FG001|NOT COMPLETED|Toddler Vaccinations||13
8782208|NCT01337297|9832953|FG000|STARTED|Overall Study||11
8782209|NCT01337297|9832954|FG001|STARTED|Overall Study||9
8782210|NCT01337297|9832953|FG000|COMPLETED|Overall Study||6
8782211|NCT01337297|9832954|FG001|COMPLETED|Overall Study||3
8782212|NCT01337297|9832953|FG000|NOT COMPLETED|Overall Study||5
8782213|NCT01337297|9832954|FG001|NOT COMPLETED|Overall Study||6
8782214|NCT01337336|9832962|FG000|STARTED|Overall Study||1078
8782215|NCT01337336|9832963|FG001|STARTED|Overall Study||2923
8782216|NCT01337336|9832962|FG000|COMPLETED|Overall Study||1078
8782217|NCT01337336|9832963|FG001|COMPLETED|Overall Study||2923
8782218|NCT01337336|9832962|FG000|NOT COMPLETED|Overall Study||0
8782219|NCT01337336|9832963|FG001|NOT COMPLETED|Overall Study||0
8782220|NCT01337596|9832978|FG000|STARTED|Overall Study||7
8782221|NCT01337596|9832979|FG001|STARTED|Overall Study||7
8782222|NCT01337596|9832980|FG002|STARTED|Overall Study||7
8782223|NCT01337596|9832981|FG003|STARTED|Overall Study||7
8782224|NCT01337596|9832982|FG004|STARTED|Overall Study||7
8782225|NCT01337596|9832983|FG005|STARTED|Overall Study||7
8782226|NCT01337596|9832984|FG006|STARTED|Overall Study||12
8782227|NCT01337596|9832985|FG007|STARTED|Overall Study||2
8782228|NCT01337596|9832986|FG008|STARTED|Overall Study||7
8782229|NCT01337596|9832978|FG000|Safety Population|Overall Study||7
8782230|NCT01337596|9832979|FG001|Safety Population|Overall Study||7
8782231|NCT01337596|9832980|FG002|Safety Population|Overall Study||7
8782232|NCT01337596|9832981|FG003|Safety Population|Overall Study||7
8782233|NCT01337596|9832982|FG004|Safety Population|Overall Study||7
8782234|NCT01337596|9832983|FG005|Safety Population|Overall Study||7
9030503|NCT03232983|10092766|FG003|NOT COMPLETED|Washout Period 2||1
9030504|NCT03232983|10092763|FG000|STARTED|Period 3||7
8782235|NCT01337596|9832984|FG006|Safety Population|Overall Study||12
8782236|NCT01337596|9832985|FG007|Safety Population|Overall Study||2
8782237|NCT01337596|9832986|FG008|Safety Population|Overall Study||7
8782238|NCT01337596|9832978|FG000|COMPLETED|Overall Study||7
8782239|NCT01337596|9832979|FG001|COMPLETED|Overall Study||7
8782240|NCT01337596|9832980|FG002|COMPLETED|Overall Study||7
8782241|NCT01337596|9832981|FG003|COMPLETED|Overall Study||7
8782242|NCT01337596|9832982|FG004|COMPLETED|Overall Study||5
8782243|NCT01337596|9832983|FG005|COMPLETED|Overall Study||7
8782244|NCT01337596|9832984|FG006|COMPLETED|Overall Study||12
8782245|NCT01337596|9832985|FG007|COMPLETED|Overall Study||2
8782246|NCT01337596|9832986|FG008|COMPLETED|Overall Study||7
8782247|NCT01337596|9832978|FG000|NOT COMPLETED|Overall Study||0
8782248|NCT01337596|9832979|FG001|NOT COMPLETED|Overall Study||0
8782249|NCT01337596|9832980|FG002|NOT COMPLETED|Overall Study||0
9030505|NCT03232983|10092764|FG001|STARTED|Period 3||7
9030506|NCT03232983|10092765|FG002|STARTED|Period 3||5
9030507|NCT03232983|10092766|FG003|STARTED|Period 3||6
9030508|NCT03232983|10092763|FG000|COMPLETED|Period 3||7
9030509|NCT03232983|10092764|FG001|COMPLETED|Period 3||7
9030510|NCT03232983|10092765|FG002|COMPLETED|Period 3||5
9030511|NCT03232983|10092766|FG003|COMPLETED|Period 3||6
9030512|NCT03232983|10092763|FG000|NOT COMPLETED|Period 3||0
9030513|NCT03232983|10092764|FG001|NOT COMPLETED|Period 3||0
9030514|NCT03232983|10092765|FG002|NOT COMPLETED|Period 3||0
9030515|NCT03232983|10092766|FG003|NOT COMPLETED|Period 3||0
9030516|NCT03232983|10092763|FG000|STARTED|Washout Period 3||7
9030517|NCT03232983|10092764|FG001|STARTED|Washout Period 3||7
9030518|NCT03232983|10092765|FG002|STARTED|Washout Period 3||5
8782250|NCT01337596|9832981|FG003|NOT COMPLETED|Overall Study||0
8782251|NCT01337596|9832982|FG004|NOT COMPLETED|Overall Study||2
8782252|NCT01337596|9832983|FG005|NOT COMPLETED|Overall Study||0
8782253|NCT01337596|9832984|FG006|NOT COMPLETED|Overall Study||0
8782254|NCT01337596|9832985|FG007|NOT COMPLETED|Overall Study||0
8782255|NCT01337596|9832986|FG008|NOT COMPLETED|Overall Study||0
8782256|NCT01337635|9833011|FG000|STARTED|Overall Study||3
8782257|NCT01337635|9833012|FG001|STARTED|Overall Study||4
8782258|NCT01337635|9833011|FG000|COMPLETED|Overall Study||3
8782259|NCT01337635|9833012|FG001|COMPLETED|Overall Study||3
8782260|NCT01337635|9833011|FG000|NOT COMPLETED|Overall Study||0
8782261|NCT01337635|9833012|FG001|NOT COMPLETED|Overall Study||1
8782262|NCT01337674|9833020|FG000|STARTED|Treatment Period 1||6
8782263|NCT01337674|9833021|FG001|STARTED|Treatment Period 1|The discontinued participant was replaced|7
8782264|NCT01337674|9833022|FG002|STARTED|Treatment Period 1||6
8782265|NCT01337674|9833023|FG003|STARTED|Treatment Period 1|The discontinued participant was replaced|7
8782266|NCT01337674|9833020|FG000|COMPLETED|Treatment Period 1||6
8782267|NCT01337674|9833021|FG001|COMPLETED|Treatment Period 1||6
8782268|NCT01337674|9833022|FG002|COMPLETED|Treatment Period 1||6
8782269|NCT01337674|9833023|FG003|COMPLETED|Treatment Period 1||6
8782270|NCT01337674|9833020|FG000|NOT COMPLETED|Treatment Period 1||0
8782271|NCT01337674|9833021|FG001|NOT COMPLETED|Treatment Period 1||1
8782272|NCT01337674|9833022|FG002|NOT COMPLETED|Treatment Period 1||0
8782273|NCT01337674|9833023|FG003|NOT COMPLETED|Treatment Period 1||1
8782274|NCT01337674|9833020|FG000|STARTED|Two-week Washout Period||6
8782275|NCT01337674|9833021|FG001|STARTED|Two-week Washout Period||6
8782276|NCT01337674|9833022|FG002|STARTED|Two-week Washout Period||6
8782277|NCT01337674|9833023|FG003|STARTED|Two-week Washout Period||6
8782278|NCT01337674|9833020|FG000|COMPLETED|Two-week Washout Period||6
8782279|NCT01337674|9833021|FG001|COMPLETED|Two-week Washout Period||6
8782280|NCT01337674|9833022|FG002|COMPLETED|Two-week Washout Period||6
8782281|NCT01337674|9833023|FG003|COMPLETED|Two-week Washout Period||6
8782282|NCT01337674|9833020|FG000|NOT COMPLETED|Two-week Washout Period||0
8782283|NCT01337674|9833021|FG001|NOT COMPLETED|Two-week Washout Period||0
8782284|NCT01337674|9833022|FG002|NOT COMPLETED|Two-week Washout Period||0
8782285|NCT01337674|9833023|FG003|NOT COMPLETED|Two-week Washout Period||0
8782286|NCT01337674|9833020|FG000|STARTED|Treatment Period 2||6
8782287|NCT01337674|9833021|FG001|STARTED|Treatment Period 2||6
8782288|NCT01337674|9833022|FG002|STARTED|Treatment Period 2||6
8782289|NCT01337674|9833023|FG003|STARTED|Treatment Period 2||6
8782290|NCT01337674|9833020|FG000|COMPLETED|Treatment Period 2||6
8782291|NCT01337674|9833021|FG001|COMPLETED|Treatment Period 2||6
8782292|NCT01337674|9833022|FG002|COMPLETED|Treatment Period 2||5
8782293|NCT01337674|9833023|FG003|COMPLETED|Treatment Period 2||6
8782294|NCT01337674|9833020|FG000|NOT COMPLETED|Treatment Period 2||0
8782295|NCT01337674|9833021|FG001|NOT COMPLETED|Treatment Period 2||0
8782296|NCT01337674|9833022|FG002|NOT COMPLETED|Treatment Period 2||1
8782297|NCT01337674|9833023|FG003|NOT COMPLETED|Treatment Period 2||0
8782298|NCT01337687|9833038|FG000|STARTED|Overall Study||10
8782299|NCT01337687|9833039|FG001|STARTED|Overall Study||9
8782300|NCT01337687|9833038|FG000|COMPLETED|Overall Study||10
8782301|NCT01337687|9833039|FG001|COMPLETED|Overall Study||9
8782302|NCT01337687|9833038|FG000|NOT COMPLETED|Overall Study||0
8782303|NCT01337687|9833039|FG001|NOT COMPLETED|Overall Study||0
8782304|NCT01337700|9833047|FG000|STARTED|Overall Study||5
8782305|NCT01337700|9833048|FG001|STARTED|Overall Study||5
8782306|NCT01337700|9833047|FG000|COMPLETED|Overall Study||5
8782307|NCT01337700|9833048|FG001|COMPLETED|Overall Study||5
8782308|NCT01337700|9833047|FG000|NOT COMPLETED|Overall Study||0
8782309|NCT01337700|9833048|FG001|NOT COMPLETED|Overall Study||0
8782310|NCT01337739|9833056|FG000|STARTED|Overall Study||6
8782311|NCT01337739|9833057|FG001|STARTED|Overall Study||4
8782312|NCT01337739|9833056|FG000|COMPLETED|Overall Study||6
8782313|NCT01337739|9833057|FG001|COMPLETED|Overall Study||4
8782314|NCT01337739|9833056|FG000|NOT COMPLETED|Overall Study||0
8782315|NCT01337739|9833057|FG001|NOT COMPLETED|Overall Study||0
8782316|NCT01337960|9833066|FG000|STARTED|Overall Study||14
8782317|NCT01337960|9833067|FG001|STARTED|Overall Study||14
8782318|NCT01337960|9833068|FG002|STARTED|Overall Study||6
8782319|NCT01337960|9833066|FG000|COMPLETED|Overall Study||12
8782320|NCT01337960|9833067|FG001|COMPLETED|Overall Study||14
8782321|NCT01337960|9833068|FG002|COMPLETED|Overall Study||6
8782322|NCT01337960|9833066|FG000|NOT COMPLETED|Overall Study||2
8782323|NCT01337960|9833067|FG001|NOT COMPLETED|Overall Study||0
9030519|NCT03232983|10092766|FG003|STARTED|Washout Period 3||6
9030520|NCT03232983|10092763|FG000|COMPLETED|Washout Period 3||7
8782324|NCT01337960|9833068|FG002|NOT COMPLETED|Overall Study||0
8782325|NCT01337973|9833079|FG000|STARTED|Overall Study||60
8782326|NCT01337973|9833080|FG001|STARTED|Overall Study||60
8782327|NCT01337973|9833081|FG002|STARTED|Overall Study||60
8782328|NCT01337973|9833079|FG000|COMPLETED|Overall Study||44
8782329|NCT01337973|9833080|FG001|COMPLETED|Overall Study||45
8782330|NCT01337973|9833081|FG002|COMPLETED|Overall Study||49
8782331|NCT01337973|9833079|FG000|NOT COMPLETED|Overall Study||16
8782332|NCT01337973|9833080|FG001|NOT COMPLETED|Overall Study||15
8782333|NCT01337973|9833081|FG002|NOT COMPLETED|Overall Study||11
8782334|NCT01337986|9833091|FG000|STARTED|Overall Study||23
8782335|NCT01337986|9833092|FG001|STARTED|Overall Study||23
8782336|NCT01337986|9833091|FG000|COMPLETED|Overall Study||20
8782337|NCT01337986|9833092|FG001|COMPLETED|Overall Study||18
8782338|NCT01337986|9833091|FG000|NOT COMPLETED|Overall Study||3
8782339|NCT01337986|9833092|FG001|NOT COMPLETED|Overall Study||5
8782340|NCT01338012|9833114|FG000|STARTED|Overall Study||8
8782341|NCT01338012|9833114|FG000|COMPLETED|Overall Study||0
8782342|NCT01338012|9833114|FG000|NOT COMPLETED|Overall Study||8
8782343|NCT01338025|9833120|FG000|STARTED|Overall Study||16
8782344|NCT01338025|9833121|FG001|STARTED|Overall Study||17
8782345|NCT01338025|9833120|FG000|COMPLETED|Overall Study||5
8782346|NCT01338025|9833121|FG001|COMPLETED|Overall Study||6
8782347|NCT01338025|9833120|FG000|NOT COMPLETED|Overall Study||11
8782348|NCT01338025|9833121|FG001|NOT COMPLETED|Overall Study||11
8782349|NCT01338298|9833129|FG000|STARTED|Overall Study||24
8782350|NCT01338298|9833130|FG001|STARTED|Overall Study||18
8782351|NCT01338298|9833129|FG000|COMPLETED|Overall Study||20
8782352|NCT01338298|9833130|FG001|COMPLETED|Overall Study||15
8782353|NCT01338298|9833129|FG000|NOT COMPLETED|Overall Study||4
8782354|NCT01338298|9833130|FG001|NOT COMPLETED|Overall Study||3
8782355|NCT01338415|9833138|FG000|STARTED|Core + Extension||33
8782356|NCT01338415|9833139|FG001|STARTED|Core + Extension||31
8782357|NCT01338415|9833140|FG002|STARTED|Core + Extension||0
8782358|NCT01338415|9833138|FG000|Enrolled in FUTURE 3 Extension|Core + Extension||31
8782359|NCT01338415|9833139|FG001|Enrolled in FUTURE 3 Extension|Core + Extension||27
8782360|NCT01338415|9833140|FG002|Enrolled in FUTURE 3 Extension|Core + Extension||0
8782361|NCT01338415|9833138|FG000|COMPLETED|Core + Extension||23
8782362|NCT01338415|9833139|FG001|COMPLETED|Core + Extension||22
8782363|NCT01338415|9833140|FG002|COMPLETED|Core + Extension||0
8782364|NCT01338415|9833138|FG000|NOT COMPLETED|Core + Extension||10
8782365|NCT01338415|9833139|FG001|NOT COMPLETED|Core + Extension||9
8782366|NCT01338415|9833140|FG002|NOT COMPLETED|Core + Extension||0
8782367|NCT01338415|9833138|FG000|STARTED|Exceptional Use Treatment Period||0
8782368|NCT01338415|9833139|FG001|STARTED|Exceptional Use Treatment Period||0
8782369|NCT01338415|9833140|FG002|STARTED|Exceptional Use Treatment Period||10
8782370|NCT01338415|9833138|FG000|COMPLETED|Exceptional Use Treatment Period||0
8782371|NCT01338415|9833139|FG001|COMPLETED|Exceptional Use Treatment Period||0
8782372|NCT01338415|9833140|FG002|COMPLETED|Exceptional Use Treatment Period||4
8782373|NCT01338415|9833138|FG000|NOT COMPLETED|Exceptional Use Treatment Period||0
8782374|NCT01338415|9833139|FG001|NOT COMPLETED|Exceptional Use Treatment Period||0
8782375|NCT01338415|9833140|FG002|NOT COMPLETED|Exceptional Use Treatment Period||6
8782376|NCT01338493|9833148|FG000|STARTED|Enrolled||139
8782377|NCT01338493|9833148|FG000|COMPLETED|Enrolled||134
8782378|NCT01338493|9833148|FG000|NOT COMPLETED|Enrolled||5
8782379|NCT01338493|9833148|FG000|STARTED|Implant||134
8782380|NCT01338493|9833148|FG000|COMPLETED|Implant||134
8782381|NCT01338493|9833148|FG000|NOT COMPLETED|Implant||0
8782382|NCT01338493|9833148|FG000|STARTED|Discharge||134
8782383|NCT01338493|9833148|FG000|COMPLETED|Discharge||132
8782384|NCT01338493|9833148|FG000|NOT COMPLETED|Discharge||2
8782385|NCT01338493|9833148|FG000|STARTED|6 Months Follow up||132
8782386|NCT01338493|9833148|FG000|COMPLETED|6 Months Follow up||113
8782387|NCT01338493|9833148|FG000|NOT COMPLETED|6 Months Follow up||19
8782388|NCT01338493|9833148|FG000|STARTED|12 Months Follow up||113
8782389|NCT01338493|9833148|FG000|COMPLETED|12 Months Follow up||104
8782390|NCT01338493|9833148|FG000|NOT COMPLETED|12 Months Follow up||9
8782391|NCT01338493|9833148|FG000|STARTED|24 Months Follow up||104
8782392|NCT01338493|9833148|FG000|COMPLETED|24 Months Follow up||104
8782393|NCT01338493|9833148|FG000|NOT COMPLETED|24 Months Follow up||0
8782394|NCT01338506|9833154|FG000|STARTED|Overall Study||54
8782395|NCT01338506|9833155|FG001|STARTED|Overall Study||27
8782396|NCT01338506|9833154|FG000|COMPLETED|Overall Study||29
8782397|NCT01338506|9833155|FG001|COMPLETED|Overall Study||13
8782398|NCT01338506|9833154|FG000|NOT COMPLETED|Overall Study||25
8782399|NCT01338506|9833155|FG001|NOT COMPLETED|Overall Study||14
8782400|NCT01338610|9833168|FG000|STARTED|Overall Study||39
8782401|NCT01338610|9833169|FG001|STARTED|Overall Study||56
8782402|NCT01338610|9833170|FG002|STARTED|Overall Study||29
8782403|NCT01338610|9833168|FG000|COMPLETED|Overall Study||34
8782404|NCT01338610|9833169|FG001|COMPLETED|Overall Study||55
8782405|NCT01338610|9833170|FG002|COMPLETED|Overall Study||28
8782406|NCT01338610|9833168|FG000|NOT COMPLETED|Overall Study||5
8782407|NCT01338610|9833169|FG001|NOT COMPLETED|Overall Study||1
8782408|NCT01338610|9833170|FG002|NOT COMPLETED|Overall Study||1
8782409|NCT01338649|9833179|FG000|STARTED|Overall Study||13
8782410|NCT01338649|9833180|FG001|STARTED|Overall Study||14
8782411|NCT01338649|9833179|FG000|COMPLETED|Overall Study||13
8782412|NCT01338649|9833180|FG001|COMPLETED|Overall Study||14
8782413|NCT01338649|9833179|FG000|NOT COMPLETED|Overall Study||0
8782414|NCT01338649|9833180|FG001|NOT COMPLETED|Overall Study||0
8782415|NCT01338792|9833186|FG000|STARTED|Overall Study||47
8782416|NCT01338792|9833186|FG000|COMPLETED|Overall Study||43
8782417|NCT01338792|9833186|FG000|NOT COMPLETED|Overall Study||4
8782418|NCT01338818|9833190|FG000|STARTED|Overall Study||298
8782419|NCT01338818|9833190|FG000|COMPLETED|Overall Study||262
8782420|NCT01338818|9833190|FG000|NOT COMPLETED|Overall Study||36
8782421|NCT01338857|9833194|FG000|STARTED|Overall Study||12
8782422|NCT01338857|9833194|FG000|COMPLETED|Overall Study||1
8782423|NCT01338857|9833194|FG000|NOT COMPLETED|Overall Study||11
8782424|NCT01338870|9833204|FG000|STARTED|Overall Study||50
8782425|NCT01338870|9833205|FG001|STARTED|Overall Study||49
8782426|NCT01338870|9833206|FG002|STARTED|Overall Study||50
8782427|NCT01338870|9833207|FG003|STARTED|Overall Study||50
8782428|NCT01338870|9833208|FG004|STARTED|Overall Study||52
8782429|NCT01338870|9833209|FG005|STARTED|Overall Study||50
8782430|NCT01338870|9833204|FG000|COMPLETED|Overall Study||41
8782431|NCT01338870|9833205|FG001|COMPLETED|Overall Study||37
8782432|NCT01338870|9833206|FG002|COMPLETED|Overall Study||39
8782433|NCT01338870|9833207|FG003|COMPLETED|Overall Study||41
8782434|NCT01338870|9833208|FG004|COMPLETED|Overall Study||46
8782435|NCT01338870|9833209|FG005|COMPLETED|Overall Study||44
8782436|NCT01338870|9833204|FG000|NOT COMPLETED|Overall Study||9
8782437|NCT01338870|9833205|FG001|NOT COMPLETED|Overall Study||12
8782438|NCT01338870|9833206|FG002|NOT COMPLETED|Overall Study||11
8782439|NCT01338870|9833207|FG003|NOT COMPLETED|Overall Study||9
8782440|NCT01338870|9833208|FG004|NOT COMPLETED|Overall Study||6
8782441|NCT01338870|9833209|FG005|NOT COMPLETED|Overall Study||6
8782442|NCT01338987|9833228|FG000|STARTED|Overall Study||12
8782443|NCT01338987|9833229|FG001|STARTED|Overall Study||9
8782444|NCT01338987|9833230|FG002|STARTED|Overall Study||22
8782445|NCT01338987|9833231|FG003|STARTED|Overall Study||31
8782446|NCT01338987|9833232|FG004|STARTED|Overall Study||2
8782447|NCT01338987|9833228|FG000|COMPLETED|Overall Study||10
8782448|NCT01338987|9833229|FG001|COMPLETED|Overall Study||8
8782449|NCT01338987|9833230|FG002|COMPLETED|Overall Study||20
8782450|NCT01338987|9833231|FG003|COMPLETED|Overall Study||31
8782451|NCT01338987|9833232|FG004|COMPLETED|Overall Study||2
8782452|NCT01338987|9833228|FG000|NOT COMPLETED|Overall Study||2
8782453|NCT01338987|9833229|FG001|NOT COMPLETED|Overall Study||1
8782454|NCT01338987|9833230|FG002|NOT COMPLETED|Overall Study||2
8782455|NCT01338987|9833231|FG003|NOT COMPLETED|Overall Study||0
8782456|NCT01338987|9833232|FG004|NOT COMPLETED|Overall Study||0
8782457|NCT01339000|9833248|FG000|STARTED|Overall Study|The patient received day 1, 29, 36, 43, 50, and 57 vaccines but did not receive interleukin-7 (IL-7)|1
8782458|NCT01339000|9833249|FG001|STARTED|Overall Study||0
8782459|NCT01339000|9833248|FG000|COMPLETED|Overall Study||0
8782460|NCT01339000|9833249|FG001|COMPLETED|Overall Study||0
8782461|NCT01339000|9833248|FG000|NOT COMPLETED|Overall Study||1
8782462|NCT01339000|9833249|FG001|NOT COMPLETED|Overall Study||0
8782463|NCT01339013|9833258|FG000|STARTED|Overall Study||6
8782464|NCT01339013|9833258|FG000|COMPLETED|Overall Study||6
8782465|NCT01339013|9833258|FG000|NOT COMPLETED|Overall Study||0
8782466|NCT01339052|9833264|FG000|STARTED|Overall Study||15
8782467|NCT01339052|9833265|FG001|STARTED|Overall Study||50
8782468|NCT01339052|9833264|FG000|Measurable Disease|Overall Study||11
8782469|NCT01339052|9833265|FG001|Measurable Disease|Overall Study|Radiographic response evaluated on participants with measurable disease only.|40
8782470|NCT01339052|9833264|FG000|Evaluable Tumor Sample at Surgery|Overall Study||14
8782471|NCT01339052|9833265|FG001|Evaluable Tumor Sample at Surgery|Overall Study|Milestone is not relevant for non-surgical cohort.|0
8782472|NCT01339052|9833264|FG000|Evaluable Plasma Sample at Surgery|Overall Study||13
8782473|NCT01339052|9833265|FG001|Evaluable Plasma Sample at Surgery|Overall Study|Milestone is not relevant for non-surgical cohort.|0
8782474|NCT01339052|9833264|FG000|COMPLETED|Overall Study||0
9030521|NCT03232983|10092764|FG001|COMPLETED|Washout Period 3||7
9030522|NCT03232983|10092765|FG002|COMPLETED|Washout Period 3||5
9030523|NCT03232983|10092766|FG003|COMPLETED|Washout Period 3||6
9030524|NCT03232983|10092763|FG000|NOT COMPLETED|Washout Period 3||0
9030525|NCT03232983|10092764|FG001|NOT COMPLETED|Washout Period 3||0
9030526|NCT03232983|10092765|FG002|NOT COMPLETED|Washout Period 3||0
9030527|NCT03232983|10092766|FG003|NOT COMPLETED|Washout Period 3||0
9030528|NCT03232983|10092763|FG000|STARTED|Period 4||7
9030529|NCT03232983|10092764|FG001|STARTED|Period 4||7
9030530|NCT03232983|10092765|FG002|STARTED|Period 4||5
9030531|NCT03232983|10092766|FG003|STARTED|Period 4||6
9030532|NCT03232983|10092763|FG000|COMPLETED|Period 4||6
9030533|NCT03232983|10092764|FG001|COMPLETED|Period 4||7
9030534|NCT03232983|10092765|FG002|COMPLETED|Period 4||5
9030535|NCT03232983|10092766|FG003|COMPLETED|Period 4||6
9030536|NCT03232983|10092763|FG000|NOT COMPLETED|Period 4||1
9030537|NCT03232983|10092764|FG001|NOT COMPLETED|Period 4||0
9030538|NCT03232983|10092765|FG002|NOT COMPLETED|Period 4||0
9030539|NCT03232983|10092766|FG003|NOT COMPLETED|Period 4||0
9030540|NCT03233009|10092778|FG000|STARTED|Overall Study||40
8782475|NCT01339052|9833265|FG001|COMPLETED|Overall Study||0
8782476|NCT01339052|9833264|FG000|NOT COMPLETED|Overall Study||15
8782477|NCT01339052|9833265|FG001|NOT COMPLETED|Overall Study||50
8782478|NCT01339091|9833276|FG000|STARTED|Overall Study||288
8782479|NCT01339091|9833277|FG001|STARTED|Overall Study||285
8782480|NCT01339091|9833276|FG000|Safety Population|Overall Study||284
9030541|NCT03233009|10092778|FG000|Test Product 1|Overall Study||39
9030542|NCT03233009|10092778|FG000|Test Product 2|Overall Study||39
9030543|NCT03233009|10092778|FG000|Test Product 3|Overall Study||39
8782481|NCT01339091|9833277|FG001|Safety Population|Overall Study||284
8782482|NCT01339091|9833276|FG000|COMPLETED|Overall Study||261
8782483|NCT01339091|9833277|FG001|COMPLETED|Overall Study||257
8782484|NCT01339091|9833276|FG000|NOT COMPLETED|Overall Study||27
8782485|NCT01339091|9833277|FG001|NOT COMPLETED|Overall Study||28
8782486|NCT01339247|9833283|FG000|STARTED|Period 1||30
8782487|NCT01339247|9833284|FG001|STARTED|Period 1||30
8782488|NCT01339247|9833283|FG000|COMPLETED|Period 1||30
8782489|NCT01339247|9833284|FG001|COMPLETED|Period 1||30
8782490|NCT01339247|9833283|FG000|NOT COMPLETED|Period 1||0
8782491|NCT01339247|9833284|FG001|NOT COMPLETED|Period 1||0
8782492|NCT01339247|9833283|FG000|STARTED|Period 2||30
8782493|NCT01339247|9833284|FG001|STARTED|Period 2||30
8782494|NCT01339247|9833283|FG000|COMPLETED|Period 2||30
8782495|NCT01339247|9833284|FG001|COMPLETED|Period 2||30
8782496|NCT01339247|9833283|FG000|NOT COMPLETED|Period 2||0
8782497|NCT01339247|9833284|FG001|NOT COMPLETED|Period 2||0
8782498|NCT01339260|9833292|FG000|STARTED|Cycle 1|Intent-To-Treat: randomized patients|726
8782499|NCT01339260|9833293|FG001|STARTED|Cycle 1|Intent-To-Treat: randomized patients|729
8782500|NCT01339260|9833292|FG000|Safety Population|Cycle 1|Patients receiving netupitant/palonosetron combination|725
8782501|NCT01339260|9833293|FG001|Safety Population|Cycle 1|Patients receiving palonosetron|725
8782502|NCT01339260|9833292|FG000|Full Analysis Set|Cycle 1|Patients receiving chemotherapy and randomized to netupitant/palonosetron combination|724
8782503|NCT01339260|9833293|FG001|Full Analysis Set|Cycle 1|Patients receiving chemotherapy and randomized to palonosetron|725
8782504|NCT01339260|9833292|FG000|COMPLETED|Cycle 1||719
8782505|NCT01339260|9833293|FG001|COMPLETED|Cycle 1||719
8782506|NCT01339260|9833292|FG000|NOT COMPLETED|Cycle 1||7
8782507|NCT01339260|9833293|FG001|NOT COMPLETED|Cycle 1||10
8782508|NCT01339260|9833292|FG000|STARTED|Multi-cycle Extension|Patients scheduled to netupitant/palonosetron combination|635
8782509|NCT01339260|9833293|FG001|STARTED|Multi-cycle Extension|Patients scheduled to palonosetron|651
8782510|NCT01339260|9833292|FG000|Safety Population|Multi-cycle Extension|Patients receiving netupitant/palonosetron combination|635
8782511|NCT01339260|9833293|FG001|Safety Population|Multi-cycle Extension|Patients receiving palonosetron|651
8782512|NCT01339260|9833292|FG000|COMPLETED|Multi-cycle Extension|Patients completing at least number of cycles they were scheduled to|449
8782513|NCT01339260|9833293|FG001|COMPLETED|Multi-cycle Extension|Patients completing at least number of cycles they were scheduled to|458
8782514|NCT01339260|9833292|FG000|NOT COMPLETED|Multi-cycle Extension||186
8782515|NCT01339260|9833293|FG001|NOT COMPLETED|Multi-cycle Extension||193
8782516|NCT01339273|9833303|FG000|STARTED|Overall Study||36
8782517|NCT01339273|9833304|FG001|STARTED|Overall Study||36
8782518|NCT01339273|9833303|FG000|COMPLETED|Overall Study||28
8782519|NCT01339273|9833304|FG001|COMPLETED|Overall Study||28
8782520|NCT01339273|9833303|FG000|NOT COMPLETED|Overall Study||8
8782521|NCT01339273|9833304|FG001|NOT COMPLETED|Overall Study||8
8782522|NCT01339299|9833312|FG000|STARTED|Overall Study||50
8782523|NCT01339299|9833313|FG001|STARTED|Overall Study||50
8782524|NCT01339299|9833312|FG000|COMPLETED|Overall Study||50
8782525|NCT01339299|9833313|FG001|COMPLETED|Overall Study||50
8782526|NCT01339299|9833312|FG000|NOT COMPLETED|Overall Study||0
8782527|NCT01339299|9833313|FG001|NOT COMPLETED|Overall Study||0
8782528|NCT01339390|9833321|FG000|STARTED|Overall Study||1571
8782529|NCT01339390|9833322|FG001|STARTED|Overall Study||1598
8782530|NCT01339390|9833321|FG000|COMPLETED|Overall Study||1414
8782531|NCT01339390|9833322|FG001|COMPLETED|Overall Study||1442
8782532|NCT01339390|9833321|FG000|NOT COMPLETED|Overall Study||157
8782533|NCT01339390|9833322|FG001|NOT COMPLETED|Overall Study||156
8782534|NCT01339403|9833330|FG000|STARTED|Overall Study||24768
8782535|NCT01339403|9833331|FG001|STARTED|Overall Study||257600
8782536|NCT01339403|9833330|FG000|COMPLETED|Overall Study||24768
8782537|NCT01339403|9833331|FG001|COMPLETED|Overall Study||257600
8782538|NCT01339403|9833330|FG000|NOT COMPLETED|Overall Study||0
8782539|NCT01339403|9833331|FG001|NOT COMPLETED|Overall Study||0
8782540|NCT01339416|9833337|FG000|STARTED|Overall Study||8202
8782541|NCT01339416|9833337|FG000|COMPLETED|Overall Study||8202
8782542|NCT01339416|9833337|FG000|NOT COMPLETED|Overall Study||0
8782543|NCT01339429|9833341|FG000|STARTED|Overall Study||41
8782544|NCT01339429|9833341|FG000|COMPLETED|Overall Study||37
8782545|NCT01339429|9833341|FG000|NOT COMPLETED|Overall Study||4
8782546|NCT01339559|9833345|FG000|STARTED|Overall Study||766
8782547|NCT01339559|9833345|FG000|COMPLETED|Overall Study||368
8782548|NCT01339559|9833345|FG000|NOT COMPLETED|Overall Study||398
8782549|NCT01339832|9833350|FG000|STARTED|Overall Study||51
8782550|NCT01339832|9833350|FG000|COMPLETED|Overall Study||37
8782551|NCT01339832|9833350|FG000|NOT COMPLETED|Overall Study||14
8782552|NCT01339858|9833356|FG000|STARTED|Overall Study||30
8782553|NCT01339858|9833357|FG001|STARTED|Overall Study||30
8782554|NCT01339858|9833356|FG000|COMPLETED|Overall Study||14
8782555|NCT01339858|9833357|FG001|COMPLETED|Overall Study||18
8782556|NCT01339858|9833356|FG000|NOT COMPLETED|Overall Study||16
8782557|NCT01339858|9833357|FG001|NOT COMPLETED|Overall Study||12
8782558|NCT01339897|9833369|FG000|STARTED|Overall Study||7
8782559|NCT01339897|9833370|FG001|STARTED|Overall Study||6
8782560|NCT01339897|9833371|FG002|STARTED|Overall Study||6
8782561|NCT01339897|9833372|FG003|STARTED|Overall Study||6
8782562|NCT01339897|9833369|FG000|COMPLETED|Overall Study||6
8782563|NCT01339897|9833370|FG001|COMPLETED|Overall Study||6
8782564|NCT01339897|9833371|FG002|COMPLETED|Overall Study||6
8782565|NCT01339897|9833372|FG003|COMPLETED|Overall Study||5
8782566|NCT01339897|9833369|FG000|NOT COMPLETED|Overall Study||1
8782567|NCT01339897|9833370|FG001|NOT COMPLETED|Overall Study||0
8782568|NCT01339897|9833371|FG002|NOT COMPLETED|Overall Study||0
8782569|NCT01339897|9833372|FG003|NOT COMPLETED|Overall Study||1
8782570|NCT01339910|9833386|FG000|STARTED|Overall Study||135
8782571|NCT01339910|9833387|FG001|STARTED|Overall Study||137
8782572|NCT01339910|9833386|FG000|COMPLETED|Overall Study||132
8782573|NCT01339910|9833387|FG001|COMPLETED|Overall Study||133
8782574|NCT01339910|9833386|FG000|NOT COMPLETED|Overall Study||3
8782575|NCT01339910|9833387|FG001|NOT COMPLETED|Overall Study||4
8782576|NCT01339923|9833400|FG000|STARTED|Overall Study||253
8782577|NCT01339923|9833401|FG001|STARTED|Overall Study||250
8782578|NCT01339923|9833402|FG002|STARTED|Overall Study||251
8782579|NCT01339923|9833403|FG003|STARTED|Overall Study||104
8782580|NCT01339923|9833404|FG004|STARTED|Overall Study||300
8782581|NCT01339923|9833405|FG005|STARTED|Overall Study||126
8782582|NCT01339923|9833406|FG006|STARTED|Overall Study||125
8782583|NCT01339923|9833400|FG000|COMPLETED|Overall Study||239
8782584|NCT01339923|9833401|FG001|COMPLETED|Overall Study||234
8782585|NCT01339923|9833402|FG002|COMPLETED|Overall Study||243
8782586|NCT01339923|9833403|FG003|COMPLETED|Overall Study||100
8782587|NCT01339923|9833404|FG004|COMPLETED|Overall Study||295
8782588|NCT01339923|9833405|FG005|COMPLETED|Overall Study||117
8782589|NCT01339923|9833406|FG006|COMPLETED|Overall Study||111
8782590|NCT01339923|9833400|FG000|NOT COMPLETED|Overall Study||14
8782591|NCT01339923|9833401|FG001|NOT COMPLETED|Overall Study||16
8782592|NCT01339923|9833402|FG002|NOT COMPLETED|Overall Study||8
8782593|NCT01339923|9833403|FG003|NOT COMPLETED|Overall Study||4
8782594|NCT01339923|9833404|FG004|NOT COMPLETED|Overall Study||5
8782595|NCT01339923|9833405|FG005|NOT COMPLETED|Overall Study||9
8782596|NCT01339923|9833406|FG006|NOT COMPLETED|Overall Study||14
8782597|NCT01339936|9833435|FG000|STARTED|Overall Study|plus 2 screen failures|38
8782598|NCT01339936|9833435|FG000|COMPLETED|Overall Study|plus 1 excluded from analysis set|36
8782599|NCT01339936|9833435|FG000|NOT COMPLETED|Overall Study||2
8782600|NCT01340014|9833441|FG000|STARTED|Period 1, First 7 Days||55
8782601|NCT01340014|9833442|FG001|STARTED|Period 1, First 7 Days||57
8782602|NCT01340014|9833441|FG000|COMPLETED|Period 1, First 7 Days||53
8782603|NCT01340014|9833442|FG001|COMPLETED|Period 1, First 7 Days||57
8782604|NCT01340014|9833441|FG000|NOT COMPLETED|Period 1, First 7 Days||2
8782605|NCT01340014|9833442|FG001|NOT COMPLETED|Period 1, First 7 Days||0
8782606|NCT01340014|9833441|FG000|STARTED|Period 2, Second 7 Days||53
8782607|NCT01340014|9833442|FG001|STARTED|Period 2, Second 7 Days||57
8782608|NCT01340014|9833441|FG000|COMPLETED|Period 2, Second 7 Days||53
8782609|NCT01340014|9833442|FG001|COMPLETED|Period 2, Second 7 Days||56
8782610|NCT01340014|9833441|FG000|NOT COMPLETED|Period 2, Second 7 Days||0
8782611|NCT01340014|9833442|FG001|NOT COMPLETED|Period 2, Second 7 Days||1
8782612|NCT01340027|9833460|FG000|STARTED|Overall Study||81
8782613|NCT01340027|9833461|FG001|STARTED|Overall Study||78
8782614|NCT01340027|9833462|FG002|STARTED|Overall Study||79
8782615|NCT01340027|9833463|FG003|STARTED|Overall Study||79
8782616|NCT01340027|9833464|FG004|STARTED|Overall Study||156
8782617|NCT01340027|9833465|FG005|STARTED|Overall Study||78
8782618|NCT01340027|9833466|FG006|STARTED|Overall Study||149
8782619|NCT01340027|9833467|FG007|STARTED|Overall Study||149
8782620|NCT01340027|9833468|FG008|STARTED|Overall Study||144
8782621|NCT01340027|9833469|FG009|STARTED|Overall Study||152
8782622|NCT01340027|9833470|FG010|STARTED|Overall Study||81
8782623|NCT01340027|9833471|FG011|STARTED|Overall Study||81
8782624|NCT01340027|9833460|FG000|Received Treatment|Overall Study||81
8782625|NCT01340027|9833461|FG001|Received Treatment|Overall Study||78
8782626|NCT01340027|9833462|FG002|Received Treatment|Overall Study||78
8782627|NCT01340027|9833463|FG003|Received Treatment|Overall Study||79
8782628|NCT01340027|9833464|FG004|Received Treatment|Overall Study||156
8782629|NCT01340027|9833465|FG005|Received Treatment|Overall Study||78
8782630|NCT01340027|9833466|FG006|Received Treatment|Overall Study||149
8782631|NCT01340027|9833467|FG007|Received Treatment|Overall Study||149
8782632|NCT01340027|9833468|FG008|Received Treatment|Overall Study||144
8782633|NCT01340027|9833469|FG009|Received Treatment|Overall Study||152
8782634|NCT01340027|9833470|FG010|Received Treatment|Overall Study||81
8782635|NCT01340027|9833471|FG011|Received Treatment|Overall Study||81
8782636|NCT01340027|9833460|FG000|COMPLETED|Overall Study||76
8782637|NCT01340027|9833461|FG001|COMPLETED|Overall Study||71
8782638|NCT01340027|9833462|FG002|COMPLETED|Overall Study||75
8782639|NCT01340027|9833463|FG003|COMPLETED|Overall Study||75
8782640|NCT01340027|9833464|FG004|COMPLETED|Overall Study||146
8782641|NCT01340027|9833465|FG005|COMPLETED|Overall Study||74
8782642|NCT01340027|9833466|FG006|COMPLETED|Overall Study||142
8782643|NCT01340027|9833467|FG007|COMPLETED|Overall Study||142
8782644|NCT01340027|9833468|FG008|COMPLETED|Overall Study||136
8782645|NCT01340027|9833469|FG009|COMPLETED|Overall Study||146
8782646|NCT01340027|9833470|FG010|COMPLETED|Overall Study||79
8782647|NCT01340027|9833471|FG011|COMPLETED|Overall Study||77
8782648|NCT01340027|9833460|FG000|NOT COMPLETED|Overall Study||5
8782649|NCT01340027|9833461|FG001|NOT COMPLETED|Overall Study||7
8782650|NCT01340027|9833462|FG002|NOT COMPLETED|Overall Study||4
8782651|NCT01340027|9833463|FG003|NOT COMPLETED|Overall Study||4
8782652|NCT01340027|9833464|FG004|NOT COMPLETED|Overall Study||10
8782653|NCT01340027|9833465|FG005|NOT COMPLETED|Overall Study||4
8782654|NCT01340027|9833466|FG006|NOT COMPLETED|Overall Study||7
8782655|NCT01340027|9833467|FG007|NOT COMPLETED|Overall Study||7
8782656|NCT01340027|9833468|FG008|NOT COMPLETED|Overall Study||8
8782657|NCT01340027|9833469|FG009|NOT COMPLETED|Overall Study||6
8782658|NCT01340027|9833470|FG010|NOT COMPLETED|Overall Study||2
8782659|NCT01340027|9833471|FG011|NOT COMPLETED|Overall Study||4
8782660|NCT01340053|9833501|FG000|STARTED|Overall Study||47
8782661|NCT01340053|9833502|FG001|STARTED|Overall Study||46
8782662|NCT01340053|9833503|FG002|STARTED|Overall Study||47
8782663|NCT01340053|9833504|FG003|STARTED|Overall Study||46
8782664|NCT01340053|9833501|FG000|COMPLETED|Overall Study||43
8782665|NCT01340053|9833502|FG001|COMPLETED|Overall Study||44
8782666|NCT01340053|9833503|FG002|COMPLETED|Overall Study||43
8782667|NCT01340053|9833504|FG003|COMPLETED|Overall Study||43
8782668|NCT01340053|9833501|FG000|NOT COMPLETED|Overall Study||4
8782669|NCT01340053|9833502|FG001|NOT COMPLETED|Overall Study||2
8782670|NCT01340053|9833503|FG002|NOT COMPLETED|Overall Study||4
8782671|NCT01340053|9833504|FG003|NOT COMPLETED|Overall Study||3
8782672|NCT01340066|9833516|FG000|STARTED|Placebo Run in Period||94
8782673|NCT01340066|9833517|FG001|STARTED|Placebo Run in Period||0
8782674|NCT01340066|9833518|FG002|STARTED|Placebo Run in Period||0
8782675|NCT01340066|9833516|FG000|COMPLETED|Placebo Run in Period|Completed run in period and were eligible for randomization|67
8782676|NCT01340066|9833517|FG001|COMPLETED|Placebo Run in Period||0
8782677|NCT01340066|9833518|FG002|COMPLETED|Placebo Run in Period||0
8782678|NCT01340066|9833516|FG000|NOT COMPLETED|Placebo Run in Period||27
8782679|NCT01340066|9833517|FG001|NOT COMPLETED|Placebo Run in Period||0
8782680|NCT01340066|9833518|FG002|NOT COMPLETED|Placebo Run in Period||0
8782681|NCT01340066|9833516|FG000|STARTED|5 Week Double Blind Randomization Period||0
8782682|NCT01340066|9833517|FG001|STARTED|5 Week Double Blind Randomization Period||33
8782683|NCT01340066|9833518|FG002|STARTED|5 Week Double Blind Randomization Period||34
8782684|NCT01340066|9833516|FG000|COMPLETED|5 Week Double Blind Randomization Period||0
8782685|NCT01340066|9833517|FG001|COMPLETED|5 Week Double Blind Randomization Period||28
8782686|NCT01340066|9833518|FG002|COMPLETED|5 Week Double Blind Randomization Period||31
8782687|NCT01340066|9833516|FG000|NOT COMPLETED|5 Week Double Blind Randomization Period||0
8782688|NCT01340066|9833517|FG001|NOT COMPLETED|5 Week Double Blind Randomization Period||5
8782689|NCT01340066|9833518|FG002|NOT COMPLETED|5 Week Double Blind Randomization Period||3
8782690|NCT01340144|9833527|FG000|STARTED|Overall Study||625
8782691|NCT01340144|9833528|FG001|STARTED|Overall Study||625
8782692|NCT01340144|9833527|FG000|COMPLETED|Overall Study||553
8782693|NCT01340144|9833528|FG001|COMPLETED|Overall Study||567
8782694|NCT01340144|9833527|FG000|NOT COMPLETED|Overall Study||72
8782695|NCT01340144|9833528|FG001|NOT COMPLETED|Overall Study||58
8782696|NCT01340196|9833534|FG000|STARTED|Treat. Period 1 (Tenofovir)||16
8782697|NCT01340196|9833534|FG000|COMPLETED|Treat. Period 1 (Tenofovir)||16
8782698|NCT01340196|9833534|FG000|NOT COMPLETED|Treat. Period 1 (Tenofovir)||0
8782699|NCT01340196|9833534|FG000|STARTED|Treat. Period 2 (Tenofovir/Faldaprevir)||16
8782700|NCT01340196|9833534|FG000|COMPLETED|Treat. Period 2 (Tenofovir/Faldaprevir)||16
8782701|NCT01340196|9833534|FG000|NOT COMPLETED|Treat. Period 2 (Tenofovir/Faldaprevir)||0
8782702|NCT01340196|9833534|FG000|STARTED|Treat. Period 3 (Faldaprevir)||16
8782703|NCT01340196|9833534|FG000|COMPLETED|Treat. Period 3 (Faldaprevir)||14
8782704|NCT01340196|9833534|FG000|NOT COMPLETED|Treat. Period 3 (Faldaprevir)||2
8782705|NCT01340209|9833546|FG000|STARTED|Overall Study||57
8782706|NCT01340209|9833547|FG001|STARTED|Overall Study||114
9030544|NCT03233009|10092778|FG000|Test Product 4|Overall Study||39
9030545|NCT03233009|10092778|FG000|Reference Product|Overall Study||39
9030546|NCT03233009|10092778|FG000|COMPLETED|Overall Study||39
9030547|NCT03233009|10092778|FG000|NOT COMPLETED|Overall Study||1
9030548|NCT03233230|10092795|FG000|STARTED|Overall Study||97
9030549|NCT03233230|10092796|FG001|STARTED|Overall Study||98
9030550|NCT03233230|10092797|FG002|STARTED|Overall Study||96
9030551|NCT03233230|10092798|FG003|STARTED|Overall Study||99
9030552|NCT03233230|10092795|FG000|COMPLETED|Overall Study||82
9030553|NCT03233230|10092796|FG001|COMPLETED|Overall Study||83
9030554|NCT03233230|10092797|FG002|COMPLETED|Overall Study||84
9030555|NCT03233230|10092798|FG003|COMPLETED|Overall Study||91
9030556|NCT03233230|10092795|FG000|NOT COMPLETED|Overall Study||15
9030557|NCT03233230|10092796|FG001|NOT COMPLETED|Overall Study||15
9030558|NCT03233230|10092797|FG002|NOT COMPLETED|Overall Study||12
9030559|NCT03233230|10092798|FG003|NOT COMPLETED|Overall Study||8
9030560|NCT03233308|10092808|FG000|STARTED|Overall Study||20
9030561|NCT03233308|10092808|FG000|COMPLETED|Overall Study||18
9030562|NCT03233308|10092808|FG000|NOT COMPLETED|Overall Study||2
9030563|NCT03233438|10092821|FG000|STARTED|Overall Study||48
9030564|NCT03233438|10092822|FG001|STARTED|Overall Study||43
9030565|NCT03233438|10092821|FG000|COMPLETED|Overall Study||42
9030566|NCT03233438|10092822|FG001|COMPLETED|Overall Study||32
9030567|NCT03233438|10092821|FG000|NOT COMPLETED|Overall Study||6
9030568|NCT03233438|10092822|FG001|NOT COMPLETED|Overall Study||11
9030569|NCT03233529|10092828|FG000|STARTED|Double-Blind Period (Day 1 to Day 15)||40
9030570|NCT03233529|10092828|FG000|COMPLETED|Double-Blind Period (Day 1 to Day 15)||39
9030571|NCT03233529|10092828|FG000|NOT COMPLETED|Double-Blind Period (Day 1 to Day 15)||1
9030572|NCT03233529|10092828|FG000|STARTED|Open-Label Period (Day 15 to Day 71)||39
9030573|NCT03233529|10092828|FG000|COMPLETED|Open-Label Period (Day 15 to Day 71)||38
9030574|NCT03233529|10092828|FG000|NOT COMPLETED|Open-Label Period (Day 15 to Day 71)||1
9030575|NCT03233737|10092841|FG000|STARTED|Overall Study||10
9030576|NCT03233737|10092842|FG001|STARTED|Overall Study||10
8782707|NCT01340209|9833548|FG002|STARTED|Overall Study||114
8782708|NCT01340209|9833546|FG000|COMPLETED|Overall Study||52
9030577|NCT03233737|10092843|FG002|STARTED|Overall Study||5
9030578|NCT03233737|10092844|FG003|STARTED|Overall Study||24
8782709|NCT01340209|9833547|FG001|COMPLETED|Overall Study||106
8782710|NCT01340209|9833548|FG002|COMPLETED|Overall Study||106
8782711|NCT01340209|9833546|FG000|NOT COMPLETED|Overall Study||5
8782712|NCT01340209|9833547|FG001|NOT COMPLETED|Overall Study||8
8782713|NCT01340209|9833548|FG002|NOT COMPLETED|Overall Study||8
8782714|NCT01340300|9833560|FG000|STARTED|Overall Study||35
8782715|NCT01340300|9833561|FG001|STARTED|Overall Study||35
8782716|NCT01340300|9833562|FG002|STARTED|Overall Study||35
8782717|NCT01340300|9833563|FG003|STARTED|Overall Study||34
8782718|NCT01340300|9833560|FG000|Baseline Blood Sample|Overall Study||33
8782719|NCT01340300|9833561|FG001|Baseline Blood Sample|Overall Study||34
8782720|NCT01340300|9833562|FG002|Baseline Blood Sample|Overall Study||32
8782721|NCT01340300|9833563|FG003|Baseline Blood Sample|Overall Study||29
8782722|NCT01340300|9833560|FG000|Follow-up Blood Sample|Overall Study||25
8782723|NCT01340300|9833561|FG001|Follow-up Blood Sample|Overall Study||26
8782724|NCT01340300|9833562|FG002|Follow-up Blood Sample|Overall Study||19
8782725|NCT01340300|9833563|FG003|Follow-up Blood Sample|Overall Study||18
9030579|NCT03233737|10092845|FG004|STARTED|Overall Study||26
9030580|NCT03233737|10092841|FG000|COMPLETED|Overall Study||10
9030581|NCT03233737|10092842|FG001|COMPLETED|Overall Study||10
9030582|NCT03233737|10092843|FG002|COMPLETED|Overall Study||5
9030583|NCT03233737|10092844|FG003|COMPLETED|Overall Study||24
9030584|NCT03233737|10092845|FG004|COMPLETED|Overall Study||26
8782726|NCT01340300|9833560|FG000|COMPLETED|Overall Study||26
8782727|NCT01340300|9833561|FG001|COMPLETED|Overall Study||26
8782728|NCT01340300|9833562|FG002|COMPLETED|Overall Study||20
8782729|NCT01340300|9833563|FG003|COMPLETED|Overall Study||20
8782730|NCT01340300|9833560|FG000|NOT COMPLETED|Overall Study||9
8782731|NCT01340300|9833561|FG001|NOT COMPLETED|Overall Study||9
8782732|NCT01340300|9833562|FG002|NOT COMPLETED|Overall Study||15
8782733|NCT01340300|9833563|FG003|NOT COMPLETED|Overall Study||14
8782734|NCT01340482|9833576|FG000|STARTED|Overall Study||27
8782735|NCT01340482|9833577|FG001|STARTED|Overall Study||1
8782736|NCT01340482|9833578|FG002|STARTED|Overall Study||1
8782737|NCT01340482|9833576|FG000|COMPLETED|Overall Study||25
8782738|NCT01340482|9833577|FG001|COMPLETED|Overall Study||1
8782739|NCT01340482|9833578|FG002|COMPLETED|Overall Study||1
8782740|NCT01340482|9833576|FG000|NOT COMPLETED|Overall Study||2
8782741|NCT01340482|9833577|FG001|NOT COMPLETED|Overall Study||0
8782742|NCT01340482|9833578|FG002|NOT COMPLETED|Overall Study||0
8782743|NCT01340495|9833588|FG000|STARTED|Overall Study||70
8782744|NCT01340495|9833588|FG000|COMPLETED|Overall Study||69
8782745|NCT01340495|9833588|FG000|NOT COMPLETED|Overall Study||1
8782746|NCT01340586|9833594|FG000|STARTED|Overall Study||8
8782747|NCT01340586|9833595|FG001|STARTED|Overall Study||8
8782748|NCT01340586|9833594|FG000|COMPLETED|Overall Study||8
8782749|NCT01340586|9833595|FG001|COMPLETED|Overall Study||8
8782750|NCT01340586|9833594|FG000|NOT COMPLETED|Overall Study||0
8782751|NCT01340586|9833595|FG001|NOT COMPLETED|Overall Study||0
8782752|NCT01340625|9833608|FG000|STARTED|First Intervention||18
8782753|NCT01340625|9833609|FG001|STARTED|First Intervention||18
8782754|NCT01340625|9833608|FG000|COMPLETED|First Intervention||17
8782755|NCT01340625|9833609|FG001|COMPLETED|First Intervention||18
8782756|NCT01340625|9833608|FG000|NOT COMPLETED|First Intervention||1
8782757|NCT01340625|9833609|FG001|NOT COMPLETED|First Intervention||0
8782758|NCT01340625|9833608|FG000|STARTED|Washout Period of 28 Days||17
8782759|NCT01340625|9833609|FG001|STARTED|Washout Period of 28 Days||18
8782760|NCT01340625|9833608|FG000|COMPLETED|Washout Period of 28 Days||16
8782761|NCT01340625|9833609|FG001|COMPLETED|Washout Period of 28 Days||18
8782762|NCT01340625|9833608|FG000|NOT COMPLETED|Washout Period of 28 Days||1
8782763|NCT01340625|9833609|FG001|NOT COMPLETED|Washout Period of 28 Days||0
8782764|NCT01340625|9833608|FG000|STARTED|Second Intervention||16
8782765|NCT01340625|9833609|FG001|STARTED|Second Intervention||18
8782766|NCT01340625|9833608|FG000|COMPLETED|Second Intervention||16
8782767|NCT01340625|9833609|FG001|COMPLETED|Second Intervention||18
8782768|NCT01340625|9833608|FG000|NOT COMPLETED|Second Intervention||0
8782769|NCT01340625|9833609|FG001|NOT COMPLETED|Second Intervention||0
8782770|NCT01340651|9833615|FG000|STARTED|Overall Study||41
8782771|NCT01340651|9833615|FG000|COMPLETED|Overall Study||24
8782772|NCT01340651|9833615|FG000|NOT COMPLETED|Overall Study||17
8782773|NCT01340664|9833624|FG000|STARTED|Overall Study||93
8782774|NCT01340664|9833625|FG001|STARTED|Overall Study||93
8782775|NCT01340664|9833626|FG002|STARTED|Overall Study||93
8782776|NCT01340664|9833624|FG000|COMPLETED|Overall Study||86
8782777|NCT01340664|9833625|FG001|COMPLETED|Overall Study||85
8782778|NCT01340664|9833626|FG002|COMPLETED|Overall Study||80
8782779|NCT01340664|9833624|FG000|NOT COMPLETED|Overall Study||7
8782780|NCT01340664|9833625|FG001|NOT COMPLETED|Overall Study||8
8782781|NCT01340664|9833626|FG002|NOT COMPLETED|Overall Study||13
8782782|NCT01340768|9833636|FG000|STARTED|Overall Study||436
8782783|NCT01340768|9833637|FG001|STARTED|Overall Study||434
8782784|NCT01340768|9833636|FG000|COMPLETED|Overall Study||419
8782785|NCT01340768|9833637|FG001|COMPLETED|Overall Study||429
8782786|NCT01340768|9833636|FG000|NOT COMPLETED|Overall Study||17
8782787|NCT01340768|9833637|FG001|NOT COMPLETED|Overall Study||5
8782788|NCT01340794|9833645|FG000|STARTED|Overall Study||2
8782789|NCT01340794|9833646|FG001|STARTED|Overall Study||5
8782790|NCT01340794|9833645|FG000|COMPLETED|Overall Study||2
8782791|NCT01340794|9833646|FG001|COMPLETED|Overall Study||4
9030585|NCT03233737|10092841|FG000|NOT COMPLETED|Overall Study||0
9030586|NCT03233737|10092842|FG001|NOT COMPLETED|Overall Study||0
8782792|NCT01340794|9833645|FG000|NOT COMPLETED|Overall Study||0
8916538|NCT02185040|9976161|FG002|NOT COMPLETED|Part 1 Treatment Phase||1
8916539|NCT02185040|9976162|FG003|NOT COMPLETED|Part 1 Treatment Phase||2
8916540|NCT02185040|9976163|FG004|NOT COMPLETED|Part 1 Treatment Phase||3
8916541|NCT02185040|9976164|FG005|NOT COMPLETED|Part 1 Treatment Phase||0
8916542|NCT02185040|9976165|FG006|NOT COMPLETED|Part 1 Treatment Phase||0
8916543|NCT02185040|9976159|FG000|STARTED|Active Treatment Extension Phase||0
8916544|NCT02185040|9976160|FG001|STARTED|Active Treatment Extension Phase||0
8916545|NCT02185040|9976161|FG002|STARTED|Active Treatment Extension Phase||0
8916546|NCT02185040|9976162|FG003|STARTED|Active Treatment Extension Phase||0
8916547|NCT02185040|9976163|FG004|STARTED|Active Treatment Extension Phase||0
8916548|NCT02185040|9976164|FG005|STARTED|Active Treatment Extension Phase||9
8916549|NCT02185040|9976165|FG006|STARTED|Active Treatment Extension Phase||8
8916550|NCT02185040|9976159|FG000|COMPLETED|Active Treatment Extension Phase||0
8916551|NCT02185040|9976160|FG001|COMPLETED|Active Treatment Extension Phase||0
8916552|NCT02185040|9976161|FG002|COMPLETED|Active Treatment Extension Phase||0
8916553|NCT02185040|9976162|FG003|COMPLETED|Active Treatment Extension Phase||0
8916554|NCT02185040|9976163|FG004|COMPLETED|Active Treatment Extension Phase||0
8916555|NCT02185040|9976164|FG005|COMPLETED|Active Treatment Extension Phase||6
8916556|NCT02185040|9976165|FG006|COMPLETED|Active Treatment Extension Phase||1
8916557|NCT02185040|9976159|FG000|NOT COMPLETED|Active Treatment Extension Phase||0
8916558|NCT02185040|9976160|FG001|NOT COMPLETED|Active Treatment Extension Phase||0
8916559|NCT02185040|9976161|FG002|NOT COMPLETED|Active Treatment Extension Phase||0
8916560|NCT02185040|9976162|FG003|NOT COMPLETED|Active Treatment Extension Phase||0
8916561|NCT02185040|9976163|FG004|NOT COMPLETED|Active Treatment Extension Phase||0
8916562|NCT02185040|9976164|FG005|NOT COMPLETED|Active Treatment Extension Phase||3
8916563|NCT02185040|9976165|FG006|NOT COMPLETED|Active Treatment Extension Phase||7
8916564|NCT02185053|9976185|FG000|STARTED|Solifenacin Dose Escalation Phase||41
8916565|NCT02185053|9976186|FG001|STARTED|Solifenacin Dose Escalation Phase||0
8916566|NCT02185053|9976187|FG002|STARTED|Solifenacin Dose Escalation Phase||0
8916567|NCT02185053|9976185|FG000|COMPLETED|Solifenacin Dose Escalation Phase||38
8916568|NCT02185053|9976186|FG001|COMPLETED|Solifenacin Dose Escalation Phase||0
8916569|NCT02185053|9976187|FG002|COMPLETED|Solifenacin Dose Escalation Phase||0
8916570|NCT02185053|9976185|FG000|NOT COMPLETED|Solifenacin Dose Escalation Phase||3
8916571|NCT02185053|9976186|FG001|NOT COMPLETED|Solifenacin Dose Escalation Phase||0
8916572|NCT02185053|9976187|FG002|NOT COMPLETED|Solifenacin Dose Escalation Phase||0
8916573|NCT02185053|9976185|FG000|STARTED|Donepezil Dose Escalation Phase||0
8916574|NCT02185053|9976186|FG001|STARTED|Donepezil Dose Escalation Phase||38
8916575|NCT02185053|9976187|FG002|STARTED|Donepezil Dose Escalation Phase||0
9030587|NCT03233737|10092843|FG002|NOT COMPLETED|Overall Study||0
9030588|NCT03233737|10092844|FG003|NOT COMPLETED|Overall Study||0
9030589|NCT03233737|10092845|FG004|NOT COMPLETED|Overall Study||0
9030590|NCT03234036|10092861|FG000|STARTED|Part 1: Treatment Period 1(Up to 7 Days)||8
9030591|NCT03234036|10092862|FG001|STARTED|Part 1: Treatment Period 1(Up to 7 Days)||8
9030592|NCT03234036|10092863|FG002|STARTED|Part 1: Treatment Period 1(Up to 7 Days)||0
9030593|NCT03234036|10092864|FG003|STARTED|Part 1: Treatment Period 1(Up to 7 Days)||0
9030594|NCT03234036|10092861|FG000|COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||8
9030595|NCT03234036|10092862|FG001|COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||8
9030596|NCT03234036|10092863|FG002|COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
9030597|NCT03234036|10092864|FG003|COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
9030598|NCT03234036|10092861|FG000|NOT COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
9030599|NCT03234036|10092862|FG001|NOT COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
9030600|NCT03234036|10092863|FG002|NOT COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
9030601|NCT03234036|10092864|FG003|NOT COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
9030602|NCT03234036|10092861|FG000|STARTED|Part 1:Washout Period 1 (Up to 10 Days)||8
9030603|NCT03234036|10092862|FG001|STARTED|Part 1:Washout Period 1 (Up to 10 Days)||8
9030604|NCT03234036|10092863|FG002|STARTED|Part 1:Washout Period 1 (Up to 10 Days)||0
9030605|NCT03234036|10092864|FG003|STARTED|Part 1:Washout Period 1 (Up to 10 Days)||0
9030606|NCT03234036|10092861|FG000|COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||7
9030607|NCT03234036|10092862|FG001|COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||7
9030608|NCT03234036|10092863|FG002|COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||0
9030609|NCT03234036|10092864|FG003|COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||0
9030610|NCT03234036|10092861|FG000|NOT COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||1
9030611|NCT03234036|10092862|FG001|NOT COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||1
9030612|NCT03234036|10092863|FG002|NOT COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||0
9030613|NCT03234036|10092864|FG003|NOT COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||0
9030614|NCT03234036|10092861|FG000|STARTED|Part 1: Treatment Period 2(Up to 7 Days)||7
9030615|NCT03234036|10092862|FG001|STARTED|Part 1: Treatment Period 2(Up to 7 Days)||7
9030616|NCT03234036|10092863|FG002|STARTED|Part 1: Treatment Period 2(Up to 7 Days)||0
9030617|NCT03234036|10092864|FG003|STARTED|Part 1: Treatment Period 2(Up to 7 Days)||0
9030618|NCT03234036|10092861|FG000|COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||7
9030619|NCT03234036|10092862|FG001|COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||7
9030620|NCT03234036|10092863|FG002|COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
9030621|NCT03234036|10092864|FG003|COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
8782793|NCT01340794|9833646|FG001|NOT COMPLETED|Overall Study||1
8782794|NCT01340872|9833656|FG000|STARTED|Double-blind Phase||64
8782795|NCT01340872|9833657|FG001|STARTED|Double-blind Phase||64
8782796|NCT01340872|9833658|FG002|STARTED|Double-blind Phase|Not Applicable to double-blind phase|0
8782797|NCT01340872|9833659|FG003|STARTED|Double-blind Phase|Not Applicable to double-blind phase|0
8782798|NCT01340872|9833656|FG000|COMPLETED|Double-blind Phase||55
8782799|NCT01340872|9833657|FG001|COMPLETED|Double-blind Phase||53
8782800|NCT01340872|9833658|FG002|COMPLETED|Double-blind Phase|Not Applicable to double-blind phase|0
8782801|NCT01340872|9833659|FG003|COMPLETED|Double-blind Phase|Not Applicable to double-blind phase|0
8782802|NCT01340872|9833656|FG000|NOT COMPLETED|Double-blind Phase||9
8782803|NCT01340872|9833657|FG001|NOT COMPLETED|Double-blind Phase||11
8782804|NCT01340872|9833658|FG002|NOT COMPLETED|Double-blind Phase||0
8782805|NCT01340872|9833659|FG003|NOT COMPLETED|Double-blind Phase||0
8782806|NCT01340872|9833656|FG000|STARTED|Open-label Phase|Not Applicable to open-label phase|0
8782807|NCT01340872|9833657|FG001|STARTED|Open-label Phase|Not Applicable to open-label phase|0
8782808|NCT01340872|9833658|FG002|STARTED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|50
8782809|NCT01340872|9833659|FG003|STARTED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|47
8782810|NCT01340872|9833656|FG000|COMPLETED|Open-label Phase|Not Applicable to open-label phase|0
8782811|NCT01340872|9833657|FG001|COMPLETED|Open-label Phase|Not Applicable to open-label phase|0
8782812|NCT01340872|9833658|FG002|COMPLETED|Open-label Phase||37
8782813|NCT01340872|9833659|FG003|COMPLETED|Open-label Phase||36
8782814|NCT01340872|9833656|FG000|NOT COMPLETED|Open-label Phase||0
8782815|NCT01340872|9833657|FG001|NOT COMPLETED|Open-label Phase||0
8782816|NCT01340872|9833658|FG002|NOT COMPLETED|Open-label Phase||13
8782817|NCT01340872|9833659|FG003|NOT COMPLETED|Open-label Phase||11
8782818|NCT01340898|9833674|FG000|STARTED|Primary Phase||376
8782819|NCT01340898|9833675|FG001|STARTED|Primary Phase||187
8782820|NCT01340898|9833676|FG002|STARTED|Primary Phase||187
8782821|NCT01340898|9833674|FG000|COMPLETED|Primary Phase||360
8782822|NCT01340898|9833675|FG001|COMPLETED|Primary Phase||178
8782823|NCT01340898|9833676|FG002|COMPLETED|Primary Phase||181
8782824|NCT01340898|9833674|FG000|NOT COMPLETED|Primary Phase||16
8782825|NCT01340898|9833675|FG001|NOT COMPLETED|Primary Phase||9
8782826|NCT01340898|9833676|FG002|NOT COMPLETED|Primary Phase||6
8782827|NCT01340898|9833674|FG000|STARTED|Booster Phase||342
8782828|NCT01340898|9833675|FG001|STARTED|Booster Phase||166
8782829|NCT01340898|9833676|FG002|STARTED|Booster Phase||170
8782830|NCT01340898|9833674|FG000|COMPLETED|Booster Phase||332
8782831|NCT01340898|9833675|FG001|COMPLETED|Booster Phase||164
8782832|NCT01340898|9833676|FG002|COMPLETED|Booster Phase||163
8782833|NCT01340898|9833674|FG000|NOT COMPLETED|Booster Phase||10
8782834|NCT01340898|9833675|FG001|NOT COMPLETED|Booster Phase||2
8782835|NCT01340898|9833676|FG002|NOT COMPLETED|Booster Phase||7
8782836|NCT01340937|9833690|FG000|STARTED|Period 1: Infant Series||800
8782837|NCT01340937|9833691|FG001|STARTED|Period 1: Infant Series||797
8782838|NCT01340937|9833692|FG002|STARTED|Period 1: Infant Series||809
8782839|NCT01340937|9833693|FG003|STARTED|Period 1: Infant Series||402
8782840|NCT01340937|9833690|FG000|COMPLETED|Period 1: Infant Series||742
8782841|NCT01340937|9833691|FG001|COMPLETED|Period 1: Infant Series||737
8782842|NCT01340937|9833692|FG002|COMPLETED|Period 1: Infant Series||753
8782843|NCT01340937|9833693|FG003|COMPLETED|Period 1: Infant Series||370
8782844|NCT01340937|9833690|FG000|NOT COMPLETED|Period 1: Infant Series||58
8782845|NCT01340937|9833691|FG001|NOT COMPLETED|Period 1: Infant Series||60
8782846|NCT01340937|9833692|FG002|NOT COMPLETED|Period 1: Infant Series||56
8782847|NCT01340937|9833693|FG003|NOT COMPLETED|Period 1: Infant Series||32
8782848|NCT01340937|9833690|FG000|STARTED|Period 2: Interim Period||742
8782849|NCT01340937|9833691|FG001|STARTED|Period 2: Interim Period||737
8782850|NCT01340937|9833692|FG002|STARTED|Period 2: Interim Period||753
8782851|NCT01340937|9833693|FG003|STARTED|Period 2: Interim Period||370
8782852|NCT01340937|9833690|FG000|COMPLETED|Period 2: Interim Period||675
8782853|NCT01340937|9833691|FG001|COMPLETED|Period 2: Interim Period||658
8782854|NCT01340937|9833692|FG002|COMPLETED|Period 2: Interim Period||669
8782855|NCT01340937|9833693|FG003|COMPLETED|Period 2: Interim Period||329
8782856|NCT01340937|9833690|FG000|NOT COMPLETED|Period 2: Interim Period||67
8782857|NCT01340937|9833691|FG001|NOT COMPLETED|Period 2: Interim Period||79
8782858|NCT01340937|9833692|FG002|NOT COMPLETED|Period 2: Interim Period||84
8782859|NCT01340937|9833693|FG003|NOT COMPLETED|Period 2: Interim Period||41
8782860|NCT01340937|9833690|FG000|STARTED|Period 3: Toddler Vaccinations||675
8782861|NCT01340937|9833691|FG001|STARTED|Period 3: Toddler Vaccinations||658
8782862|NCT01340937|9833692|FG002|STARTED|Period 3: Toddler Vaccinations||669
8782863|NCT01340937|9833693|FG003|STARTED|Period 3: Toddler Vaccinations||329
8782864|NCT01340937|9833690|FG000|COMPLETED|Period 3: Toddler Vaccinations||666
8782865|NCT01340937|9833691|FG001|COMPLETED|Period 3: Toddler Vaccinations||641
8782866|NCT01340937|9833692|FG002|COMPLETED|Period 3: Toddler Vaccinations||660
8782867|NCT01340937|9833693|FG003|COMPLETED|Period 3: Toddler Vaccinations||319
8782868|NCT01340937|9833690|FG000|NOT COMPLETED|Period 3: Toddler Vaccinations||9
8782869|NCT01340937|9833691|FG001|NOT COMPLETED|Period 3: Toddler Vaccinations||17
8782870|NCT01340937|9833692|FG002|NOT COMPLETED|Period 3: Toddler Vaccinations||9
8782871|NCT01340937|9833693|FG003|NOT COMPLETED|Period 3: Toddler Vaccinations||10
8782872|NCT01340976|9833715|FG000|STARTED|Overall Study||4
8782873|NCT01340976|9833716|FG001|STARTED|Overall Study||3
8782874|NCT01340976|9833717|FG002|STARTED|Overall Study||7
8782875|NCT01340976|9833718|FG003|STARTED|Overall Study||5
8782876|NCT01340976|9833719|FG004|STARTED|Overall Study||7
8782877|NCT01340976|9833720|FG005|STARTED|Overall Study||7
8782878|NCT01340976|9833715|FG000|Received at Least 1 Dose of Study Drug|Overall Study||4
8782879|NCT01340976|9833716|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
8782880|NCT01340976|9833717|FG002|Received at Least 1 Dose of Study Drug|Overall Study||7
8782881|NCT01340976|9833718|FG003|Received at Least 1 Dose of Study Drug|Overall Study||5
8782882|NCT01340976|9833719|FG004|Received at Least 1 Dose of Study Drug|Overall Study||7
8782883|NCT01340976|9833720|FG005|Received at Least 1 Dose of Study Drug|Overall Study||7
8782884|NCT01340976|9833715|FG000|COMPLETED|Overall Study||0
8782885|NCT01340976|9833716|FG001|COMPLETED|Overall Study||1
8782886|NCT01340976|9833717|FG002|COMPLETED|Overall Study||4
8782887|NCT01340976|9833718|FG003|COMPLETED|Overall Study||2
8782888|NCT01340976|9833719|FG004|COMPLETED|Overall Study||5
8782889|NCT01340976|9833720|FG005|COMPLETED|Overall Study||6
8782890|NCT01340976|9833715|FG000|NOT COMPLETED|Overall Study||4
8782891|NCT01340976|9833716|FG001|NOT COMPLETED|Overall Study||2
8782892|NCT01340976|9833717|FG002|NOT COMPLETED|Overall Study||3
8782893|NCT01340976|9833718|FG003|NOT COMPLETED|Overall Study||3
8782894|NCT01340976|9833719|FG004|NOT COMPLETED|Overall Study||2
8782895|NCT01340976|9833720|FG005|NOT COMPLETED|Overall Study||1
8782896|NCT01341067|9833740|FG000|STARTED|Overall Study||30
8782897|NCT01341067|9833740|FG000|COMPLETED|Overall Study||26
8782898|NCT01341067|9833740|FG000|NOT COMPLETED|Overall Study||4
8782899|NCT01341301|9833744|FG000|STARTED|Overall Study||25
8782900|NCT01341301|9833744|FG000|COMPLETED|Overall Study||25
8782901|NCT01341301|9833744|FG000|NOT COMPLETED|Overall Study||0
8782902|NCT01341444|9833752|FG000|STARTED|Overall Study||31
8782903|NCT01341444|9833753|FG001|STARTED|Overall Study||32
8782904|NCT01341444|9833752|FG000|COMPLETED|Overall Study||26
8782905|NCT01341444|9833753|FG001|COMPLETED|Overall Study||29
8782906|NCT01341444|9833752|FG000|NOT COMPLETED|Overall Study||5
8782907|NCT01341444|9833753|FG001|NOT COMPLETED|Overall Study||3
8782908|NCT01341457|9833761|FG000|STARTED|Overall Study||7
8782909|NCT01341457|9833762|FG001|STARTED|Overall Study||10
8782910|NCT01341457|9833761|FG000|Received at Least One Dose of Study Drug|Overall Study||7
8782911|NCT01341457|9833762|FG001|Received at Least One Dose of Study Drug|Overall Study||10
8782912|NCT01341457|9833761|FG000|COMPLETED|Overall Study||5
8782913|NCT01341457|9833762|FG001|COMPLETED|Overall Study||10
8782914|NCT01341457|9833761|FG000|NOT COMPLETED|Overall Study||2
8782915|NCT01341457|9833762|FG001|NOT COMPLETED|Overall Study||0
8782916|NCT01341470|9833775|FG000|STARTED|Overall Study||6
8782917|NCT01341470|9833776|FG001|STARTED|Overall Study||9
8782918|NCT01341470|9833777|FG002|STARTED|Overall Study||10
8782919|NCT01341470|9833778|FG003|STARTED|Overall Study||10
8782920|NCT01341470|9833779|FG004|STARTED|Overall Study||2
8782921|NCT01341470|9833780|FG005|STARTED|Overall Study||10
8782922|NCT01341470|9833775|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
8782923|NCT01341470|9833776|FG001|Received at Least 1 Dose of Study Drug|Overall Study||9
8782924|NCT01341470|9833777|FG002|Received at Least 1 Dose of Study Drug|Overall Study||10
8782925|NCT01341470|9833778|FG003|Received at Least 1 Dose of Study Drug|Overall Study||10
9030622|NCT03234036|10092861|FG000|NOT COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
9030623|NCT03234036|10092862|FG001|NOT COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
9030624|NCT03234036|10092863|FG002|NOT COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
8782926|NCT01341470|9833779|FG004|Received at Least 1 Dose of Study Drug|Overall Study||2
9030625|NCT03234036|10092864|FG003|NOT COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
9030626|NCT03234036|10092861|FG000|STARTED|Part 1:Washout Period 2 (Up to 15 Days)||7
9030627|NCT03234036|10092862|FG001|STARTED|Part 1:Washout Period 2 (Up to 15 Days)||7
9030628|NCT03234036|10092863|FG002|STARTED|Part 1:Washout Period 2 (Up to 15 Days)||0
8782927|NCT01341470|9833780|FG005|Received at Least 1 Dose of Study Drug|Overall Study||10
8782928|NCT01341470|9833775|FG000|COMPLETED|Overall Study||6
8782929|NCT01341470|9833776|FG001|COMPLETED|Overall Study||9
8782930|NCT01341470|9833777|FG002|COMPLETED|Overall Study||9
8782931|NCT01341470|9833778|FG003|COMPLETED|Overall Study||9
8782932|NCT01341470|9833779|FG004|COMPLETED|Overall Study||2
8782933|NCT01341470|9833780|FG005|COMPLETED|Overall Study||9
8782934|NCT01341470|9833775|FG000|NOT COMPLETED|Overall Study||0
8782935|NCT01341470|9833776|FG001|NOT COMPLETED|Overall Study||0
8782936|NCT01341470|9833777|FG002|NOT COMPLETED|Overall Study||1
8782937|NCT01341470|9833778|FG003|NOT COMPLETED|Overall Study||1
8782938|NCT01341470|9833779|FG004|NOT COMPLETED|Overall Study||0
8782939|NCT01341470|9833780|FG005|NOT COMPLETED|Overall Study||1
8782940|NCT01341639|9833798|FG000|STARTED|Infant Series||628
8782941|NCT01341639|9833799|FG001|STARTED|Infant Series||622
8782942|NCT01341639|9833798|FG000|Site 0048 Excluded|Infant Series||611
8782943|NCT01341639|9833799|FG001|Site 0048 Excluded|Infant Series||606
8782944|NCT01341639|9833798|FG000|Treated|Infant Series||610
8782945|NCT01341639|9833799|FG001|Treated|Infant Series||605
8782946|NCT01341639|9833798|FG000|COMPLETED|Infant Series||599
8782947|NCT01341639|9833799|FG001|COMPLETED|Infant Series||590
8782948|NCT01341639|9833798|FG000|NOT COMPLETED|Infant Series||29
8782949|NCT01341639|9833799|FG001|NOT COMPLETED|Infant Series||32
8782950|NCT01341639|9833798|FG000|STARTED|Interim Period||599
8782951|NCT01341639|9833799|FG001|STARTED|Interim Period||590
8782952|NCT01341639|9833798|FG000|COMPLETED|Interim Period||591
8782953|NCT01341639|9833799|FG001|COMPLETED|Interim Period||581
8782954|NCT01341639|9833798|FG000|NOT COMPLETED|Interim Period||8
8782955|NCT01341639|9833799|FG001|NOT COMPLETED|Interim Period||9
8782956|NCT01341639|9833798|FG000|STARTED|Toddler Dose|One participant randomized to the PR5I group mistakenly received INFANRIX™ hexa instead|590
8782957|NCT01341639|9833799|FG001|STARTED|Toddler Dose|One participant randomized to the PR5I group mistakenly received INFANRIX™ hexa instead|582
8782958|NCT01341639|9833798|FG000|COMPLETED|Toddler Dose||539
8782959|NCT01341639|9833799|FG001|COMPLETED|Toddler Dose||548
8782960|NCT01341639|9833798|FG000|NOT COMPLETED|Toddler Dose||51
8782961|NCT01341639|9833799|FG001|NOT COMPLETED|Toddler Dose||34
8782962|NCT01341639|9833798|FG000|STARTED|Post-Treatment||539
8782963|NCT01341639|9833799|FG001|STARTED|Post-Treatment||548
8782964|NCT01341639|9833798|FG000|COMPLETED|Post-Treatment||539
8782965|NCT01341639|9833799|FG001|COMPLETED|Post-Treatment||545
8782966|NCT01341639|9833798|FG000|NOT COMPLETED|Post-Treatment||0
8782967|NCT01341639|9833799|FG001|NOT COMPLETED|Post-Treatment||3
8782968|NCT01341652|9833807|FG000|STARTED|Overall Study||49
8782969|NCT01341652|9833808|FG001|STARTED|Overall Study||50
8782970|NCT01341652|9833807|FG000|COMPLETED|Overall Study||49
8782971|NCT01341652|9833808|FG001|COMPLETED|Overall Study||48
8782972|NCT01341652|9833807|FG000|NOT COMPLETED|Overall Study||0
8782973|NCT01341652|9833808|FG001|NOT COMPLETED|Overall Study||2
8782974|NCT01341730|9833816|FG000|STARTED|Overall Study||20
8782975|NCT01341730|9833817|FG001|STARTED|Overall Study||21
8782976|NCT01341730|9833816|FG000|COMPLETED|Overall Study||16
8782977|NCT01341730|9833817|FG001|COMPLETED|Overall Study||17
8782978|NCT01341730|9833816|FG000|NOT COMPLETED|Overall Study||4
8782979|NCT01341730|9833817|FG001|NOT COMPLETED|Overall Study||4
8782980|NCT01341782|9833827|FG000|STARTED|Overall Study||127
8782981|NCT01341782|9833828|FG001|STARTED|Overall Study||128
8782982|NCT01341782|9833827|FG000|COMPLETED|Overall Study||112
8782983|NCT01341782|9833828|FG001|COMPLETED|Overall Study||114
8782984|NCT01341782|9833827|FG000|NOT COMPLETED|Overall Study||15
8782985|NCT01341782|9833828|FG001|NOT COMPLETED|Overall Study||14
8782986|NCT01341912|9833834|FG000|STARTED|Overall Study||3
8782987|NCT01341912|9833834|FG000|COMPLETED|Overall Study||3
8782988|NCT01341912|9833834|FG000|NOT COMPLETED|Overall Study||0
8782989|NCT01341977|9833840|FG000|STARTED|Overall Study||288
8782990|NCT01341977|9833841|FG001|STARTED|Overall Study||285
8782991|NCT01341977|9833840|FG000|COMPLETED|Overall Study||274
8782992|NCT01341977|9833841|FG001|COMPLETED|Overall Study||270
8782993|NCT01341977|9833840|FG000|NOT COMPLETED|Overall Study||14
8782994|NCT01341977|9833841|FG001|NOT COMPLETED|Overall Study||15
8782995|NCT01341990|9833849|FG000|STARTED|Overall Study||35
8782996|NCT01341990|9833850|FG001|STARTED|Overall Study||33
8782997|NCT01341990|9833849|FG000|COMPLETED|Overall Study||32
8782998|NCT01341990|9833850|FG001|COMPLETED|Overall Study||32
8782999|NCT01341990|9833849|FG000|NOT COMPLETED|Overall Study||3
8783000|NCT01341990|9833850|FG001|NOT COMPLETED|Overall Study||1
8783001|NCT01342029|9833856|FG000|STARTED|Period 1||70
8783002|NCT01342029|9833857|FG001|STARTED|Period 1||72
8783003|NCT01342029|9833856|FG000|Dropout|Period 1||3
8783004|NCT01342029|9833857|FG001|Dropout|Period 1||1
8783005|NCT01342029|9833856|FG000|COMPLETED|Period 1||67
8783006|NCT01342029|9833857|FG001|COMPLETED|Period 1||71
8783007|NCT01342029|9833856|FG000|NOT COMPLETED|Period 1||3
8783008|NCT01342029|9833857|FG001|NOT COMPLETED|Period 1||1
8783009|NCT01342029|9833856|FG000|STARTED|Washout||67
8783010|NCT01342029|9833857|FG001|STARTED|Washout||71
8783011|NCT01342029|9833856|FG000|COMPLETED|Washout||67
8783012|NCT01342029|9833857|FG001|COMPLETED|Washout||67
8783013|NCT01342029|9833856|FG000|NOT COMPLETED|Washout||0
8783014|NCT01342029|9833857|FG001|NOT COMPLETED|Washout||4
8783015|NCT01342029|9833856|FG000|STARTED|Period 2||67
8783016|NCT01342029|9833857|FG001|STARTED|Period 2||67
8783017|NCT01342029|9833856|FG000|Dropout|Period 2||2
8783018|NCT01342029|9833857|FG001|Dropout|Period 2||0
8783019|NCT01342029|9833856|FG000|COMPLETED|Period 2||65
8783020|NCT01342029|9833857|FG001|COMPLETED|Period 2||67
8783021|NCT01342029|9833856|FG000|NOT COMPLETED|Period 2||2
8783022|NCT01342029|9833857|FG001|NOT COMPLETED|Period 2||0
8783023|NCT01342081|9833868|FG000|STARTED|Overall Study||161
8783024|NCT01342081|9833869|FG001|STARTED|Overall Study||164
8783025|NCT01342081|9833870|FG002|STARTED|Overall Study||164
8783026|NCT01342081|9833868|FG000|COMPLETED|Overall Study||159
8783027|NCT01342081|9833869|FG001|COMPLETED|Overall Study||162
8783028|NCT01342081|9833870|FG002|COMPLETED|Overall Study||163
8783029|NCT01342081|9833868|FG000|NOT COMPLETED|Overall Study||2
8783030|NCT01342081|9833869|FG001|NOT COMPLETED|Overall Study||2
8783031|NCT01342081|9833870|FG002|NOT COMPLETED|Overall Study||1
8783032|NCT01342094|9833880|FG000|STARTED|Overall Study||82
8783033|NCT01342094|9833881|FG001|STARTED|Overall Study||84
8783034|NCT01342094|9833880|FG000|COMPLETED|Overall Study||77
8783035|NCT01342094|9833881|FG001|COMPLETED|Overall Study||81
8783036|NCT01342094|9833880|FG000|NOT COMPLETED|Overall Study||5
8783037|NCT01342094|9833881|FG001|NOT COMPLETED|Overall Study||3
8783038|NCT01342107|9833889|FG000|STARTED|Overall Study||34
8783039|NCT01342107|9833890|FG001|STARTED|Overall Study||32
8783040|NCT01342107|9833889|FG000|COMPLETED|Overall Study||34
8783041|NCT01342107|9833890|FG001|COMPLETED|Overall Study||32
8783042|NCT01342107|9833889|FG000|NOT COMPLETED|Overall Study||0
8783043|NCT01342107|9833890|FG001|NOT COMPLETED|Overall Study||0
8783044|NCT01342172|9833896|FG000|STARTED|Overall Study||9
8783045|NCT01342172|9833896|FG000|COMPLETED|Overall Study||9
8783046|NCT01342172|9833896|FG000|NOT COMPLETED|Overall Study||0
8783047|NCT01342211|9833906|FG000|STARTED|Overall Study||19
8783048|NCT01342211|9833907|FG001|STARTED|Overall Study||19
8783049|NCT01342211|9833908|FG002|STARTED|Overall Study||18
8783050|NCT01342211|9833909|FG003|STARTED|Overall Study||19
8783051|NCT01342211|9833910|FG004|STARTED|Overall Study||18
8783052|NCT01342211|9833906|FG000|Treated|Overall Study||19
8783053|NCT01342211|9833907|FG001|Treated|Overall Study||17
8783054|NCT01342211|9833908|FG002|Treated|Overall Study||18
8783055|NCT01342211|9833909|FG003|Treated|Overall Study||19
8783056|NCT01342211|9833910|FG004|Treated|Overall Study||17
8783057|NCT01342211|9833906|FG000|COMPLETED|Overall Study||19
8783058|NCT01342211|9833907|FG001|COMPLETED|Overall Study||17
8783059|NCT01342211|9833908|FG002|COMPLETED|Overall Study||18
8783060|NCT01342211|9833909|FG003|COMPLETED|Overall Study||17
8783061|NCT01342211|9833910|FG004|COMPLETED|Overall Study||16
8783062|NCT01342211|9833906|FG000|NOT COMPLETED|Overall Study||0
8783063|NCT01342211|9833907|FG001|NOT COMPLETED|Overall Study||2
8783064|NCT01342211|9833908|FG002|NOT COMPLETED|Overall Study||0
8783065|NCT01342211|9833909|FG003|NOT COMPLETED|Overall Study||2
8783066|NCT01342211|9833910|FG004|NOT COMPLETED|Overall Study||2
8783067|NCT01342341|9833928|FG000|STARTED|Overall Study||24
8783068|NCT01342341|9833929|FG001|STARTED|Overall Study||24
8783069|NCT01342341|9833928|FG000|COMPLETED|Overall Study||20
8783070|NCT01342341|9833929|FG001|COMPLETED|Overall Study||20
8783071|NCT01342341|9833928|FG000|NOT COMPLETED|Overall Study||4
8783072|NCT01342341|9833929|FG001|NOT COMPLETED|Overall Study||4
8783073|NCT01342367|9833937|FG000|STARTED|Overall Study||32
8783074|NCT01342367|9833938|FG001|STARTED|Overall Study||42
8783075|NCT01342367|9833937|FG000|COMPLETED|Overall Study||30
8783076|NCT01342367|9833938|FG001|COMPLETED|Overall Study||40
8783077|NCT01342367|9833937|FG000|NOT COMPLETED|Overall Study||2
8783078|NCT01342367|9833938|FG001|NOT COMPLETED|Overall Study||2
8783079|NCT01342445|9833946|FG000|STARTED|Overall Study||26
8783080|NCT01342445|9833947|FG001|STARTED|Overall Study||24
8783081|NCT01342445|9833946|FG000|COMPLETED|Overall Study||26
8783082|NCT01342445|9833947|FG001|COMPLETED|Overall Study||22
8783083|NCT01342445|9833946|FG000|NOT COMPLETED|Overall Study||0
8783084|NCT01342445|9833947|FG001|NOT COMPLETED|Overall Study||2
8783085|NCT01342458|9833959|FG000|STARTED|Overall Study||28
8783086|NCT01342458|9833960|FG001|STARTED|Overall Study||28
8783087|NCT01342458|9833959|FG000|COMPLETED|Overall Study||26
8783088|NCT01342458|9833960|FG001|COMPLETED|Overall Study||24
8783089|NCT01342458|9833959|FG000|NOT COMPLETED|Overall Study||2
8783090|NCT01342458|9833960|FG001|NOT COMPLETED|Overall Study||4
8783091|NCT01342471|9833982|FG000|STARTED|Overall Study||29
8783092|NCT01342471|9833983|FG001|STARTED|Overall Study||29
8783093|NCT01342471|9833982|FG000|COMPLETED|Overall Study||24
8783094|NCT01342471|9833983|FG001|COMPLETED|Overall Study||23
8783095|NCT01342471|9833982|FG000|NOT COMPLETED|Overall Study||5
8783096|NCT01342471|9833983|FG001|NOT COMPLETED|Overall Study||6
8783097|NCT01342484|9833992|FG000|STARTED|Overall Study||15
8783098|NCT01342484|9833993|FG001|STARTED|Overall Study||10
8783099|NCT01342484|9833994|FG002|STARTED|Overall Study||14
8783100|NCT01342484|9833992|FG000|COMPLETED|Overall Study||13
8783101|NCT01342484|9833993|FG001|COMPLETED|Overall Study||10
8783102|NCT01342484|9833994|FG002|COMPLETED|Overall Study||13
8783103|NCT01342484|9833992|FG000|NOT COMPLETED|Overall Study||2
8783104|NCT01342484|9833993|FG001|NOT COMPLETED|Overall Study||0
8783105|NCT01342484|9833994|FG002|NOT COMPLETED|Overall Study||1
8783106|NCT01342510|9834006|FG000|STARTED|Overall Study||50
8783107|NCT01342510|9834007|FG001|STARTED|Overall Study||50
8783108|NCT01342510|9834008|FG002|STARTED|Overall Study||50
8783109|NCT01342510|9834009|FG003|STARTED|Overall Study||50
8783110|NCT01342510|9834006|FG000|COMPLETED|Overall Study||38
8783111|NCT01342510|9834007|FG001|COMPLETED|Overall Study||44
8783112|NCT01342510|9834008|FG002|COMPLETED|Overall Study||37
8783113|NCT01342510|9834009|FG003|COMPLETED|Overall Study||39
8783114|NCT01342510|9834006|FG000|NOT COMPLETED|Overall Study||12
8783115|NCT01342510|9834007|FG001|NOT COMPLETED|Overall Study||6
8783116|NCT01342510|9834008|FG002|NOT COMPLETED|Overall Study||13
8783117|NCT01342510|9834009|FG003|NOT COMPLETED|Overall Study||11
8783118|NCT01342523|9834055|FG000|STARTED|Overall Study||35
8783119|NCT01342523|9834056|FG001|STARTED|Overall Study||32
8783120|NCT01342523|9834057|FG002|STARTED|Overall Study||36
8783121|NCT01342523|9834058|FG003|STARTED|Overall Study||33
8783122|NCT01342523|9834059|FG004|STARTED|Overall Study||36
8783123|NCT01342523|9834060|FG005|STARTED|Overall Study||36
9030629|NCT03234036|10092864|FG003|STARTED|Part 1:Washout Period 2 (Up to 15 Days)||0
8783124|NCT01342523|9834061|FG006|STARTED|Overall Study||22
8783125|NCT01342523|9834062|FG007|STARTED|Overall Study||27
8783126|NCT01342523|9834063|FG008|STARTED|Overall Study||28
8783127|NCT01342523|9834064|FG009|STARTED|Overall Study||28
8783128|NCT01342523|9834065|FG010|STARTED|Overall Study||38
8783129|NCT01342523|9834066|FG011|STARTED|Overall Study||38
8916576|NCT02185053|9976185|FG000|COMPLETED|Donepezil Dose Escalation Phase||0
8916577|NCT02185053|9976186|FG001|COMPLETED|Donepezil Dose Escalation Phase||33
8916578|NCT02185053|9976187|FG002|COMPLETED|Donepezil Dose Escalation Phase||0
8916579|NCT02185053|9976185|FG000|NOT COMPLETED|Donepezil Dose Escalation Phase||0
8783130|NCT01342523|9834067|FG012|STARTED|Overall Study||39
8783131|NCT01342523|9834068|FG013|STARTED|Overall Study||38
8783132|NCT01342523|9834069|FG014|STARTED|Overall Study||38
8783133|NCT01342523|9834070|FG015|STARTED|Overall Study||32
8783134|NCT01342523|9834071|FG016|STARTED|Overall Study||29
8783135|NCT01342523|9834072|FG017|STARTED|Overall Study||27
8783136|NCT01342523|9834073|FG018|STARTED|Overall Study||21
8783137|NCT01342523|9834074|FG019|STARTED|Overall Study||27
8783138|NCT01342523|9834075|FG020|STARTED|Overall Study||29
8783139|NCT01342523|9834076|FG021|STARTED|Overall Study||30
8783140|NCT01342523|9834077|FG022|STARTED|Overall Study||36
8783141|NCT01342523|9834078|FG023|STARTED|Overall Study||36
8783142|NCT01342523|9834079|FG024|STARTED|Overall Study||37
8783143|NCT01342523|9834080|FG025|STARTED|Overall Study||38
8783144|NCT01342523|9834081|FG026|STARTED|Overall Study||34
8783145|NCT01342523|9834082|FG027|STARTED|Overall Study||31
8783146|NCT01342523|9834083|FG028|STARTED|Overall Study||35
8783147|NCT01342523|9834084|FG029|STARTED|Overall Study||29
8783148|NCT01342523|9834085|FG030|STARTED|Overall Study||31
8783149|NCT01342523|9834086|FG031|STARTED|Overall Study||28
8783150|NCT01342523|9834055|FG000|COMPLETED|Overall Study||34
8783151|NCT01342523|9834056|FG001|COMPLETED|Overall Study||32
8783152|NCT01342523|9834057|FG002|COMPLETED|Overall Study||36
8783153|NCT01342523|9834058|FG003|COMPLETED|Overall Study||32
8783154|NCT01342523|9834059|FG004|COMPLETED|Overall Study||36
8783155|NCT01342523|9834060|FG005|COMPLETED|Overall Study||36
8783156|NCT01342523|9834061|FG006|COMPLETED|Overall Study||22
8783157|NCT01342523|9834062|FG007|COMPLETED|Overall Study||27
8783158|NCT01342523|9834063|FG008|COMPLETED|Overall Study||28
8783159|NCT01342523|9834064|FG009|COMPLETED|Overall Study||28
8783160|NCT01342523|9834065|FG010|COMPLETED|Overall Study||38
8783161|NCT01342523|9834066|FG011|COMPLETED|Overall Study||36
8783162|NCT01342523|9834067|FG012|COMPLETED|Overall Study||39
8783163|NCT01342523|9834068|FG013|COMPLETED|Overall Study||36
8783164|NCT01342523|9834069|FG014|COMPLETED|Overall Study||37
8783165|NCT01342523|9834070|FG015|COMPLETED|Overall Study||32
8783166|NCT01342523|9834071|FG016|COMPLETED|Overall Study||28
8783167|NCT01342523|9834072|FG017|COMPLETED|Overall Study||27
8783168|NCT01342523|9834073|FG018|COMPLETED|Overall Study||21
8783169|NCT01342523|9834074|FG019|COMPLETED|Overall Study||27
8783170|NCT01342523|9834075|FG020|COMPLETED|Overall Study||29
8783171|NCT01342523|9834076|FG021|COMPLETED|Overall Study||30
8783172|NCT01342523|9834077|FG022|COMPLETED|Overall Study||36
8783173|NCT01342523|9834078|FG023|COMPLETED|Overall Study||35
8783174|NCT01342523|9834079|FG024|COMPLETED|Overall Study||36
8783175|NCT01342523|9834080|FG025|COMPLETED|Overall Study||36
8783176|NCT01342523|9834081|FG026|COMPLETED|Overall Study||33
8783177|NCT01342523|9834082|FG027|COMPLETED|Overall Study||30
8783178|NCT01342523|9834083|FG028|COMPLETED|Overall Study||34
8783179|NCT01342523|9834084|FG029|COMPLETED|Overall Study||28
8783180|NCT01342523|9834085|FG030|COMPLETED|Overall Study||30
8783181|NCT01342523|9834086|FG031|COMPLETED|Overall Study||27
8783182|NCT01342523|9834055|FG000|NOT COMPLETED|Overall Study||1
8783183|NCT01342523|9834056|FG001|NOT COMPLETED|Overall Study||0
8783184|NCT01342523|9834057|FG002|NOT COMPLETED|Overall Study||0
8783185|NCT01342523|9834058|FG003|NOT COMPLETED|Overall Study||1
8783186|NCT01342523|9834059|FG004|NOT COMPLETED|Overall Study||0
8783187|NCT01342523|9834060|FG005|NOT COMPLETED|Overall Study||0
8783188|NCT01342523|9834061|FG006|NOT COMPLETED|Overall Study||0
8783189|NCT01342523|9834062|FG007|NOT COMPLETED|Overall Study||0
8783190|NCT01342523|9834063|FG008|NOT COMPLETED|Overall Study||0
8783191|NCT01342523|9834064|FG009|NOT COMPLETED|Overall Study||0
8783192|NCT01342523|9834065|FG010|NOT COMPLETED|Overall Study||0
8783193|NCT01342523|9834066|FG011|NOT COMPLETED|Overall Study||2
8783194|NCT01342523|9834067|FG012|NOT COMPLETED|Overall Study||0
8783195|NCT01342523|9834068|FG013|NOT COMPLETED|Overall Study||2
8783196|NCT01342523|9834069|FG014|NOT COMPLETED|Overall Study||1
8783197|NCT01342523|9834070|FG015|NOT COMPLETED|Overall Study||0
8783198|NCT01342523|9834071|FG016|NOT COMPLETED|Overall Study||1
8783199|NCT01342523|9834072|FG017|NOT COMPLETED|Overall Study||0
8783200|NCT01342523|9834073|FG018|NOT COMPLETED|Overall Study||0
8783201|NCT01342523|9834074|FG019|NOT COMPLETED|Overall Study||0
8783202|NCT01342523|9834075|FG020|NOT COMPLETED|Overall Study||0
8783203|NCT01342523|9834076|FG021|NOT COMPLETED|Overall Study||0
8783204|NCT01342523|9834077|FG022|NOT COMPLETED|Overall Study||0
8783205|NCT01342523|9834078|FG023|NOT COMPLETED|Overall Study||1
8783206|NCT01342523|9834079|FG024|NOT COMPLETED|Overall Study||1
8783207|NCT01342523|9834080|FG025|NOT COMPLETED|Overall Study||2
8783208|NCT01342523|9834081|FG026|NOT COMPLETED|Overall Study||1
8783209|NCT01342523|9834082|FG027|NOT COMPLETED|Overall Study||1
8783210|NCT01342523|9834083|FG028|NOT COMPLETED|Overall Study||1
8783211|NCT01342523|9834084|FG029|NOT COMPLETED|Overall Study||1
8783212|NCT01342523|9834085|FG030|NOT COMPLETED|Overall Study||1
8783213|NCT01342523|9834086|FG031|NOT COMPLETED|Overall Study||1
8783214|NCT01342549|9834101|FG000|STARTED|Overall Study||31
8783215|NCT01342549|9834102|FG001|STARTED|Overall Study||31
8783216|NCT01342549|9834101|FG000|COMPLETED|Overall Study||31
8783217|NCT01342549|9834102|FG001|COMPLETED|Overall Study||31
8783218|NCT01342549|9834101|FG000|NOT COMPLETED|Overall Study||0
8783219|NCT01342549|9834102|FG001|NOT COMPLETED|Overall Study||0
8783220|NCT01342640|9834108|FG000|STARTED|Overall Study||70
8783221|NCT01342640|9834108|FG000|COMPLETED|Overall Study||29
8783222|NCT01342640|9834108|FG000|NOT COMPLETED|Overall Study||41
8916580|NCT02185053|9976186|FG001|NOT COMPLETED|Donepezil Dose Escalation Phase||5
8916581|NCT02185053|9976187|FG002|NOT COMPLETED|Donepezil Dose Escalation Phase||0
8916582|NCT02185053|9976185|FG000|STARTED|Donepezil Dose Maintenance Phase||0
8916583|NCT02185053|9976186|FG001|STARTED|Donepezil Dose Maintenance Phase||0
8916584|NCT02185053|9976187|FG002|STARTED|Donepezil Dose Maintenance Phase||33
8916585|NCT02185053|9976185|FG000|COMPLETED|Donepezil Dose Maintenance Phase||0
8783223|NCT01342666|9834114|FG000|STARTED|Overall Study||26
8783224|NCT01342666|9834115|FG001|STARTED|Overall Study||24
8783225|NCT01342666|9834114|FG000|COMPLETED|Overall Study||26
8783226|NCT01342666|9834115|FG001|COMPLETED|Overall Study||24
8783227|NCT01342666|9834114|FG000|NOT COMPLETED|Overall Study||0
8783228|NCT01342666|9834115|FG001|NOT COMPLETED|Overall Study||0
8783229|NCT01342757|9834121|FG000|STARTED|Overall Study||12
8783230|NCT01342757|9834121|FG000|COMPLETED|Overall Study||12
8783231|NCT01342757|9834121|FG000|NOT COMPLETED|Overall Study||0
8783232|NCT01342770|9834125|FG000|STARTED|Overall Study||6
8783233|NCT01342770|9834125|FG000|COMPLETED|Overall Study||6
8783234|NCT01342770|9834125|FG000|NOT COMPLETED|Overall Study||0
8783235|NCT01342796|9834131|FG000|STARTED|Overall Study||43
8783236|NCT01342796|9834132|FG001|STARTED|Overall Study||41
8783237|NCT01342796|9834131|FG000|COMPLETED|Overall Study||40
8783238|NCT01342796|9834132|FG001|COMPLETED|Overall Study||38
8783239|NCT01342796|9834131|FG000|NOT COMPLETED|Overall Study||3
8783240|NCT01342796|9834132|FG001|NOT COMPLETED|Overall Study||3
8783241|NCT01342887|9834138|FG000|STARTED|Overall Study||6
8783242|NCT01342887|9834138|FG000|COMPLETED|Overall Study||4
8783243|NCT01342887|9834138|FG000|NOT COMPLETED|Overall Study||2
8783244|NCT01342913|9834144|FG000|STARTED|2-week Run-in Period||702
8783245|NCT01342913|9834145|FG001|STARTED|2-week Run-in Period||0
8783246|NCT01342913|9834146|FG002|STARTED|2-week Run-in Period||0
8783247|NCT01342913|9834144|FG000|COMPLETED|2-week Run-in Period||528
8783248|NCT01342913|9834145|FG001|COMPLETED|2-week Run-in Period||0
8783249|NCT01342913|9834146|FG002|COMPLETED|2-week Run-in Period||0
8783250|NCT01342913|9834144|FG000|NOT COMPLETED|2-week Run-in Period||174
8783251|NCT01342913|9834145|FG001|NOT COMPLETED|2-week Run-in Period||0
8783252|NCT01342913|9834146|FG002|NOT COMPLETED|2-week Run-in Period||0
8783253|NCT01342913|9834144|FG000|STARTED|Double-Blind Treatment Period||0
8783254|NCT01342913|9834145|FG001|STARTED|Double-Blind Treatment Period||262
8783255|NCT01342913|9834146|FG002|STARTED|Double-Blind Treatment Period||266
8783256|NCT01342913|9834144|FG000|COMPLETED|Double-Blind Treatment Period||0
9030630|NCT03234036|10092861|FG000|COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||7
9030631|NCT03234036|10092862|FG001|COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||7
9030632|NCT03234036|10092863|FG002|COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
9030633|NCT03234036|10092864|FG003|COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
9030634|NCT03234036|10092861|FG000|NOT COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
9030635|NCT03234036|10092862|FG001|NOT COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
9030636|NCT03234036|10092863|FG002|NOT COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
9030637|NCT03234036|10092864|FG003|NOT COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
9030638|NCT03234036|10092861|FG000|STARTED|Part 1:Treatment Period 3 (Up to 7 Days)||7
9030639|NCT03234036|10092862|FG001|STARTED|Part 1:Treatment Period 3 (Up to 7 Days)||7
9030640|NCT03234036|10092863|FG002|STARTED|Part 1:Treatment Period 3 (Up to 7 Days)||0
9030641|NCT03234036|10092864|FG003|STARTED|Part 1:Treatment Period 3 (Up to 7 Days)||0
9030642|NCT03234036|10092861|FG000|COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||7
9030643|NCT03234036|10092862|FG001|COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||7
9030644|NCT03234036|10092863|FG002|COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
9030645|NCT03234036|10092864|FG003|COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
8783257|NCT01342913|9834145|FG001|COMPLETED|Double-Blind Treatment Period||246
8783258|NCT01342913|9834146|FG002|COMPLETED|Double-Blind Treatment Period||243
8783259|NCT01342913|9834144|FG000|NOT COMPLETED|Double-Blind Treatment Period||0
8783260|NCT01342913|9834145|FG001|NOT COMPLETED|Double-Blind Treatment Period||16
8783261|NCT01342913|9834146|FG002|NOT COMPLETED|Double-Blind Treatment Period||23
8783262|NCT01342926|9834156|FG000|STARTED|Overall Study||46
8783263|NCT01342926|9834157|FG001|STARTED|Overall Study||46
8783264|NCT01342926|9834158|FG002|STARTED|Overall Study||48
8783265|NCT01342926|9834159|FG003|STARTED|Overall Study||51
8783266|NCT01342926|9834156|FG000|COMPLETED|Overall Study||37
8783267|NCT01342926|9834157|FG001|COMPLETED|Overall Study||31
8783268|NCT01342926|9834158|FG002|COMPLETED|Overall Study||34
9030646|NCT03234036|10092861|FG000|NOT COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
9030647|NCT03234036|10092862|FG001|NOT COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
9030648|NCT03234036|10092863|FG002|NOT COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
9030649|NCT03234036|10092864|FG003|NOT COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
9030650|NCT03234036|10092861|FG000|STARTED|Part 2 (Up to 25 Days)||0
9030651|NCT03234036|10092862|FG001|STARTED|Part 2 (Up to 25 Days)||0
9030652|NCT03234036|10092863|FG002|STARTED|Part 2 (Up to 25 Days)||3
9030653|NCT03234036|10092864|FG003|STARTED|Part 2 (Up to 25 Days)||7
8783269|NCT01342926|9834159|FG003|COMPLETED|Overall Study||39
8783270|NCT01342926|9834156|FG000|NOT COMPLETED|Overall Study||9
8783271|NCT01342926|9834157|FG001|NOT COMPLETED|Overall Study||15
8783272|NCT01342926|9834158|FG002|NOT COMPLETED|Overall Study||14
8783273|NCT01342926|9834159|FG003|NOT COMPLETED|Overall Study||12
8783274|NCT01342965|9834171|FG000|STARTED|Overall Study||110
8783275|NCT01342965|9834172|FG001|STARTED|Overall Study||107
8783276|NCT01342965|9834171|FG000|Received Treatment|Overall Study||110
8783277|NCT01342965|9834172|FG001|Received Treatment|Overall Study||104
8783278|NCT01342965|9834171|FG000|COMPLETED|Overall Study||1
8783279|NCT01342965|9834172|FG001|COMPLETED|Overall Study||0
8783280|NCT01342965|9834171|FG000|NOT COMPLETED|Overall Study||109
8783281|NCT01342965|9834172|FG001|NOT COMPLETED|Overall Study||107
8783282|NCT01343004|9834181|FG000|STARTED|Overall Study||821
8783283|NCT01343004|9834182|FG001|STARTED|Overall Study||824
8783284|NCT01343004|9834183|FG002|STARTED|Overall Study||818
8783285|NCT01343004|9834181|FG000|COMPLETED|Overall Study||637
8783286|NCT01343004|9834182|FG001|COMPLETED|Overall Study||606
8783287|NCT01343004|9834183|FG002|COMPLETED|Overall Study||658
8783288|NCT01343004|9834181|FG000|NOT COMPLETED|Overall Study||184
8783289|NCT01343004|9834182|FG001|NOT COMPLETED|Overall Study||218
8783290|NCT01343004|9834183|FG002|NOT COMPLETED|Overall Study||160
8783291|NCT01343043|9834195|FG000|STARTED|Overall Study||15
8783292|NCT01343043|9834196|FG001|STARTED|Overall Study||14
8783293|NCT01343043|9834197|FG002|STARTED|Overall Study||5
8783294|NCT01343043|9834198|FG003|STARTED|Overall Study||16
8783295|NCT01343043|9834195|FG000|Received T-cell Infusion|Overall Study||12
8783296|NCT01343043|9834196|FG001|Received T-cell Infusion|Overall Study||13
8783297|NCT01343043|9834197|FG002|Received T-cell Infusion|Overall Study||5
8783298|NCT01343043|9834198|FG003|Received T-cell Infusion|Overall Study||15
8783299|NCT01343043|9834195|FG000|COMPLETED|Overall Study||12
8783300|NCT01343043|9834196|FG001|COMPLETED|Overall Study||13
8783301|NCT01343043|9834197|FG002|COMPLETED|Overall Study||5
8783302|NCT01343043|9834198|FG003|COMPLETED|Overall Study||15
8783303|NCT01343043|9834195|FG000|NOT COMPLETED|Overall Study||3
8783304|NCT01343043|9834196|FG001|NOT COMPLETED|Overall Study||1
8783305|NCT01343043|9834197|FG002|NOT COMPLETED|Overall Study||0
8783306|NCT01343043|9834198|FG003|NOT COMPLETED|Overall Study||1
8783307|NCT01343056|9834215|FG000|STARTED|Overall Study||35
8783308|NCT01343056|9834216|FG001|STARTED|Overall Study||36
8783309|NCT01343056|9834217|FG002|STARTED|Overall Study||32
8783310|NCT01343056|9834218|FG003|STARTED|Overall Study||38
8783311|NCT01343056|9834215|FG000|COMPLETED|Overall Study||28
9030654|NCT03234036|10092861|FG000|COMPLETED|Part 2 (Up to 25 Days)||0
9030655|NCT03234036|10092862|FG001|COMPLETED|Part 2 (Up to 25 Days)||0
9030656|NCT03234036|10092863|FG002|COMPLETED|Part 2 (Up to 25 Days)||3
9030657|NCT03234036|10092864|FG003|COMPLETED|Part 2 (Up to 25 Days)||7
9030658|NCT03234036|10092861|FG000|NOT COMPLETED|Part 2 (Up to 25 Days)||0
9030659|NCT03234036|10092862|FG001|NOT COMPLETED|Part 2 (Up to 25 Days)||0
9030660|NCT03234036|10092863|FG002|NOT COMPLETED|Part 2 (Up to 25 Days)||0
9030661|NCT03234036|10092864|FG003|NOT COMPLETED|Part 2 (Up to 25 Days)||0
9030662|NCT03234374|10092882|FG000|STARTED|Overall Study||35
9030663|NCT03234374|10092883|FG001|STARTED|Overall Study||17
9030664|NCT03234374|10092882|FG000|COMPLETED|Overall Study||34
9030665|NCT03234374|10092883|FG001|COMPLETED|Overall Study||16
9030666|NCT03234374|10092882|FG000|NOT COMPLETED|Overall Study||1
9030667|NCT03234374|10092883|FG001|NOT COMPLETED|Overall Study||1
9030668|NCT03234465|10092891|FG000|STARTED|Overall Study||100
9030669|NCT03234465|10092892|FG001|STARTED|Overall Study||100
9030670|NCT03234465|10092891|FG000|COMPLETED|Overall Study||67
9030671|NCT03234465|10092892|FG001|COMPLETED|Overall Study||60
9030672|NCT03234465|10092891|FG000|NOT COMPLETED|Overall Study||33
9030673|NCT03234465|10092892|FG001|NOT COMPLETED|Overall Study||40
9030674|NCT03234608|10092900|FG000|STARTED|Overall Study||127
9030675|NCT03234608|10092901|FG001|STARTED|Overall Study||117
9030676|NCT03234608|10092900|FG000|COMPLETED|Overall Study||104
9030677|NCT03234608|10092901|FG001|COMPLETED|Overall Study||96
9030678|NCT03234608|10092900|FG000|NOT COMPLETED|Overall Study||23
9030679|NCT03234608|10092901|FG001|NOT COMPLETED|Overall Study||21
9030680|NCT03235050|10092912|FG000|STARTED|Overall Study||112
9030681|NCT03235050|10092913|FG001|STARTED|Overall Study||110
9030682|NCT03235050|10092914|FG002|STARTED|Overall Study||100
9030683|NCT03235050|10092915|FG003|STARTED|Overall Study||256
9030684|NCT03235050|10092916|FG004|STARTED|Overall Study||256
9030685|NCT03235050|10092912|FG000|COMPLETED|Overall Study||108
9030686|NCT03235050|10092913|FG001|COMPLETED|Overall Study||105
9030687|NCT03235050|10092914|FG002|COMPLETED|Overall Study||96
9030688|NCT03235050|10092915|FG003|COMPLETED|Overall Study||242
9030689|NCT03235050|10092916|FG004|COMPLETED|Overall Study||245
9030690|NCT03235050|10092912|FG000|NOT COMPLETED|Overall Study||4
9030691|NCT03235050|10092913|FG001|NOT COMPLETED|Overall Study||5
9030692|NCT03235050|10092914|FG002|NOT COMPLETED|Overall Study||4
9030693|NCT03235050|10092915|FG003|NOT COMPLETED|Overall Study||14
9030694|NCT03235050|10092916|FG004|NOT COMPLETED|Overall Study||11
9030695|NCT03235089|10092928|FG000|STARTED|Overall Study||31
9030696|NCT03235089|10092929|FG001|STARTED|Overall Study||31
9030697|NCT03235089|10092928|FG000|COMPLETED|Overall Study||28
9030698|NCT03235089|10092929|FG001|COMPLETED|Overall Study||28
9030699|NCT03235089|10092928|FG000|NOT COMPLETED|Overall Study||3
9030700|NCT03235089|10092929|FG001|NOT COMPLETED|Overall Study||3
9030701|NCT03235115|10092936|FG000|STARTED|First Intervention (1 Hour, Visit 2)||9
8783312|NCT01343056|9834216|FG001|COMPLETED|Overall Study||31
8783313|NCT01343056|9834217|FG002|COMPLETED|Overall Study||29
8783314|NCT01343056|9834218|FG003|COMPLETED|Overall Study||29
8783315|NCT01343056|9834215|FG000|NOT COMPLETED|Overall Study||7
8783316|NCT01343056|9834216|FG001|NOT COMPLETED|Overall Study||5
8783317|NCT01343056|9834217|FG002|NOT COMPLETED|Overall Study||3
8783318|NCT01343056|9834218|FG003|NOT COMPLETED|Overall Study||9
8783319|NCT01343082|9834232|FG000|STARTED|The run-in Period||51
9030702|NCT03235115|10092937|FG001|STARTED|First Intervention (1 Hour, Visit 2)||6
9030703|NCT03235115|10092938|FG002|STARTED|First Intervention (1 Hour, Visit 2)||7
9030704|NCT03235115|10092939|FG003|STARTED|First Intervention (1 Hour, Visit 2)||6
9030705|NCT03235115|10092940|FG004|STARTED|First Intervention (1 Hour, Visit 2)||6
9030706|NCT03235115|10092941|FG005|STARTED|First Intervention (1 Hour, Visit 2)||6
8783320|NCT01343082|9834233|FG001|STARTED|The run-in Period||49
8783321|NCT01343082|9834234|FG002|STARTED|The run-in Period||48
8783322|NCT01343082|9834232|FG000|COMPLETED|The run-in Period||48
8783323|NCT01343082|9834233|FG001|COMPLETED|The run-in Period||45
8783324|NCT01343082|9834234|FG002|COMPLETED|The run-in Period||43
8783325|NCT01343082|9834232|FG000|NOT COMPLETED|The run-in Period||3
8783326|NCT01343082|9834233|FG001|NOT COMPLETED|The run-in Period||4
8783327|NCT01343082|9834234|FG002|NOT COMPLETED|The run-in Period||5
8783328|NCT01343082|9834232|FG000|STARTED|Treatment Period , Switched to DE-111||48
8783329|NCT01343082|9834233|FG001|STARTED|Treatment Period , Switched to DE-111||45
8783330|NCT01343082|9834234|FG002|STARTED|Treatment Period , Switched to DE-111||43
8783331|NCT01343082|9834232|FG000|COMPLETED|Treatment Period , Switched to DE-111||43
8783332|NCT01343082|9834233|FG001|COMPLETED|Treatment Period , Switched to DE-111||36
8783333|NCT01343082|9834234|FG002|COMPLETED|Treatment Period , Switched to DE-111||31
8783334|NCT01343082|9834232|FG000|NOT COMPLETED|Treatment Period , Switched to DE-111||5
8783335|NCT01343082|9834233|FG001|NOT COMPLETED|Treatment Period , Switched to DE-111||9
8783336|NCT01343082|9834234|FG002|NOT COMPLETED|Treatment Period , Switched to DE-111||12
8783337|NCT01343095|9834241|FG000|STARTED|Overall Study||2
8783338|NCT01343095|9834242|FG001|STARTED|Overall Study||3
8783339|NCT01343095|9834243|FG002|STARTED|Overall Study||3
8783340|NCT01343095|9834241|FG000|COMPLETED|Overall Study||2
8783341|NCT01343095|9834242|FG001|COMPLETED|Overall Study||3
8783342|NCT01343095|9834243|FG002|COMPLETED|Overall Study||3
8783343|NCT01343095|9834241|FG000|NOT COMPLETED|Overall Study||0
8783344|NCT01343095|9834242|FG001|NOT COMPLETED|Overall Study||0
8783345|NCT01343095|9834243|FG002|NOT COMPLETED|Overall Study||0
8783346|NCT01343160|9834253|FG000|STARTED|Overall Study||36
8783347|NCT01343160|9834253|FG000|COMPLETED|Overall Study||31
8783348|NCT01343160|9834253|FG000|NOT COMPLETED|Overall Study||5
8783349|NCT01343251|9834260|FG000|STARTED|Overall Study||16
8783350|NCT01343251|9834261|FG001|STARTED|Overall Study||17
8783351|NCT01343251|9834260|FG000|COMPLETED|Overall Study||16
8783352|NCT01343251|9834261|FG001|COMPLETED|Overall Study||17
8783353|NCT01343251|9834260|FG000|NOT COMPLETED|Overall Study||0
8783354|NCT01343251|9834261|FG001|NOT COMPLETED|Overall Study||0
8783355|NCT01343277|9834272|FG000|STARTED|Overall Study||384
8783356|NCT01343277|9834273|FG001|STARTED|Overall Study||193
8783357|NCT01343277|9834272|FG000|Treated|Overall Study||378
8783358|NCT01343277|9834273|FG001|Treated|Overall Study||172
8783359|NCT01343277|9834272|FG000|COMPLETED|Overall Study||0
8783360|NCT01343277|9834273|FG001|COMPLETED|Overall Study||0
8783361|NCT01343277|9834272|FG000|NOT COMPLETED|Overall Study||384
8783362|NCT01343277|9834273|FG001|NOT COMPLETED|Overall Study||193
8783363|NCT01343368|9834281|FG000|STARTED|Overall Study||9
8783364|NCT01343368|9834282|FG001|STARTED|Overall Study||10
8783365|NCT01343368|9834281|FG000|COMPLETED|Overall Study||7
8783366|NCT01343368|9834282|FG001|COMPLETED|Overall Study||10
8783367|NCT01343368|9834281|FG000|NOT COMPLETED|Overall Study||2
8783368|NCT01343368|9834282|FG001|NOT COMPLETED|Overall Study||0
8783369|NCT01343407|9834288|FG000|STARTED|First Treatment Period (Part 2)||2
8783370|NCT01343407|9834289|FG001|STARTED|First Treatment Period (Part 2)||2
8783371|NCT01343407|9834290|FG002|STARTED|First Treatment Period (Part 2)||3
8783372|NCT01343407|9834291|FG003|STARTED|First Treatment Period (Part 2)||3
8783373|NCT01343407|9834292|FG004|STARTED|First Treatment Period (Part 2)||3
8783374|NCT01343407|9834293|FG005|STARTED|First Treatment Period (Part 2)||3
8783375|NCT01343407|9834288|FG000|COMPLETED|First Treatment Period (Part 2)||2
8783376|NCT01343407|9834289|FG001|COMPLETED|First Treatment Period (Part 2)||2
8783377|NCT01343407|9834290|FG002|COMPLETED|First Treatment Period (Part 2)||3
8783378|NCT01343407|9834291|FG003|COMPLETED|First Treatment Period (Part 2)||3
8783379|NCT01343407|9834292|FG004|COMPLETED|First Treatment Period (Part 2)||3
8783380|NCT01343407|9834293|FG005|COMPLETED|First Treatment Period (Part 2)||3
8783381|NCT01343407|9834288|FG000|NOT COMPLETED|First Treatment Period (Part 2)||0
8783382|NCT01343407|9834289|FG001|NOT COMPLETED|First Treatment Period (Part 2)||0
8783383|NCT01343407|9834290|FG002|NOT COMPLETED|First Treatment Period (Part 2)||0
8783384|NCT01343407|9834291|FG003|NOT COMPLETED|First Treatment Period (Part 2)||0
8783385|NCT01343407|9834292|FG004|NOT COMPLETED|First Treatment Period (Part 2)||0
8783386|NCT01343407|9834293|FG005|NOT COMPLETED|First Treatment Period (Part 2)||0
8783387|NCT01343407|9834288|FG000|STARTED|First Washout (Part 2)||2
8783388|NCT01343407|9834289|FG001|STARTED|First Washout (Part 2)||2
8783389|NCT01343407|9834290|FG002|STARTED|First Washout (Part 2)||3
8783390|NCT01343407|9834291|FG003|STARTED|First Washout (Part 2)||3
8783391|NCT01343407|9834292|FG004|STARTED|First Washout (Part 2)||3
8783392|NCT01343407|9834293|FG005|STARTED|First Washout (Part 2)||3
8783393|NCT01343407|9834288|FG000|COMPLETED|First Washout (Part 2)||2
8783394|NCT01343407|9834289|FG001|COMPLETED|First Washout (Part 2)||2
8783395|NCT01343407|9834290|FG002|COMPLETED|First Washout (Part 2)||3
8783396|NCT01343407|9834291|FG003|COMPLETED|First Washout (Part 2)||3
8783397|NCT01343407|9834292|FG004|COMPLETED|First Washout (Part 2)||3
8783398|NCT01343407|9834293|FG005|COMPLETED|First Washout (Part 2)||3
8783399|NCT01343407|9834288|FG000|NOT COMPLETED|First Washout (Part 2)||0
8783400|NCT01343407|9834289|FG001|NOT COMPLETED|First Washout (Part 2)||0
8783401|NCT01343407|9834290|FG002|NOT COMPLETED|First Washout (Part 2)||0
8783402|NCT01343407|9834291|FG003|NOT COMPLETED|First Washout (Part 2)||0
8783403|NCT01343407|9834292|FG004|NOT COMPLETED|First Washout (Part 2)||0
8783404|NCT01343407|9834293|FG005|NOT COMPLETED|First Washout (Part 2)||0
8783405|NCT01343407|9834288|FG000|STARTED|Second Treatment Period (Part 2)||2
8783406|NCT01343407|9834289|FG001|STARTED|Second Treatment Period (Part 2)||2
8783407|NCT01343407|9834290|FG002|STARTED|Second Treatment Period (Part 2)||3
8783408|NCT01343407|9834291|FG003|STARTED|Second Treatment Period (Part 2)||3
8783409|NCT01343407|9834292|FG004|STARTED|Second Treatment Period (Part 2)||3
8783410|NCT01343407|9834293|FG005|STARTED|Second Treatment Period (Part 2)||3
8783411|NCT01343407|9834288|FG000|COMPLETED|Second Treatment Period (Part 2)||2
8783412|NCT01343407|9834289|FG001|COMPLETED|Second Treatment Period (Part 2)||2
8783413|NCT01343407|9834290|FG002|COMPLETED|Second Treatment Period (Part 2)||2
8783414|NCT01343407|9834291|FG003|COMPLETED|Second Treatment Period (Part 2)||3
8783415|NCT01343407|9834292|FG004|COMPLETED|Second Treatment Period (Part 2)||3
8783416|NCT01343407|9834293|FG005|COMPLETED|Second Treatment Period (Part 2)||3
8783417|NCT01343407|9834288|FG000|NOT COMPLETED|Second Treatment Period (Part 2)||0
8783418|NCT01343407|9834289|FG001|NOT COMPLETED|Second Treatment Period (Part 2)||0
8783419|NCT01343407|9834290|FG002|NOT COMPLETED|Second Treatment Period (Part 2)||1
8783420|NCT01343407|9834291|FG003|NOT COMPLETED|Second Treatment Period (Part 2)||0
8783421|NCT01343407|9834292|FG004|NOT COMPLETED|Second Treatment Period (Part 2)||0
8783422|NCT01343407|9834293|FG005|NOT COMPLETED|Second Treatment Period (Part 2)||0
8783423|NCT01343407|9834288|FG000|STARTED|Second Washout (Part 2)||2
8783424|NCT01343407|9834289|FG001|STARTED|Second Washout (Part 2)||2
8783425|NCT01343407|9834290|FG002|STARTED|Second Washout (Part 2)||2
8783426|NCT01343407|9834291|FG003|STARTED|Second Washout (Part 2)||3
8783427|NCT01343407|9834292|FG004|STARTED|Second Washout (Part 2)||3
8783428|NCT01343407|9834293|FG005|STARTED|Second Washout (Part 2)||3
8783429|NCT01343407|9834288|FG000|COMPLETED|Second Washout (Part 2)||2
8783430|NCT01343407|9834289|FG001|COMPLETED|Second Washout (Part 2)||2
8783431|NCT01343407|9834290|FG002|COMPLETED|Second Washout (Part 2)||1
8783432|NCT01343407|9834291|FG003|COMPLETED|Second Washout (Part 2)||3
8783433|NCT01343407|9834292|FG004|COMPLETED|Second Washout (Part 2)||3
8783434|NCT01343407|9834293|FG005|COMPLETED|Second Washout (Part 2)||3
8783435|NCT01343407|9834288|FG000|NOT COMPLETED|Second Washout (Part 2)||0
8783436|NCT01343407|9834289|FG001|NOT COMPLETED|Second Washout (Part 2)||0
8783437|NCT01343407|9834290|FG002|NOT COMPLETED|Second Washout (Part 2)||1
8783438|NCT01343407|9834291|FG003|NOT COMPLETED|Second Washout (Part 2)||0
8783439|NCT01343407|9834292|FG004|NOT COMPLETED|Second Washout (Part 2)||0
8783440|NCT01343407|9834293|FG005|NOT COMPLETED|Second Washout (Part 2)||0
8783441|NCT01343407|9834288|FG000|STARTED|Third Treatment Period (Part 2)||2
8783442|NCT01343407|9834289|FG001|STARTED|Third Treatment Period (Part 2)||2
8783443|NCT01343407|9834290|FG002|STARTED|Third Treatment Period (Part 2)||1
8783444|NCT01343407|9834291|FG003|STARTED|Third Treatment Period (Part 2)||3
8783445|NCT01343407|9834292|FG004|STARTED|Third Treatment Period (Part 2)||3
8783446|NCT01343407|9834293|FG005|STARTED|Third Treatment Period (Part 2)||3
8783447|NCT01343407|9834288|FG000|COMPLETED|Third Treatment Period (Part 2)||2
8783448|NCT01343407|9834289|FG001|COMPLETED|Third Treatment Period (Part 2)||2
8783449|NCT01343407|9834290|FG002|COMPLETED|Third Treatment Period (Part 2)||1
8783450|NCT01343407|9834291|FG003|COMPLETED|Third Treatment Period (Part 2)||3
8783451|NCT01343407|9834292|FG004|COMPLETED|Third Treatment Period (Part 2)||3
8783452|NCT01343407|9834293|FG005|COMPLETED|Third Treatment Period (Part 2)||3
8783453|NCT01343407|9834288|FG000|NOT COMPLETED|Third Treatment Period (Part 2)||0
8783454|NCT01343407|9834289|FG001|NOT COMPLETED|Third Treatment Period (Part 2)||0
8783455|NCT01343407|9834290|FG002|NOT COMPLETED|Third Treatment Period (Part 2)||0
8783456|NCT01343407|9834291|FG003|NOT COMPLETED|Third Treatment Period (Part 2)||0
8783457|NCT01343407|9834292|FG004|NOT COMPLETED|Third Treatment Period (Part 2)||0
8783458|NCT01343407|9834293|FG005|NOT COMPLETED|Third Treatment Period (Part 2)||0
8783459|NCT01343485|9834303|FG000|STARTED|Overall Study||185
8783460|NCT01343485|9834304|FG001|STARTED|Overall Study||180
8783461|NCT01343485|9834303|FG000|COMPLETED|Overall Study||36
8783462|NCT01343485|9834304|FG001|COMPLETED|Overall Study||46
8783463|NCT01343485|9834303|FG000|NOT COMPLETED|Overall Study||149
8783464|NCT01343485|9834304|FG001|NOT COMPLETED|Overall Study||134
8783465|NCT01343667|9834312|FG000|STARTED|Overall Study||425
8783466|NCT01343667|9834313|FG001|STARTED|Overall Study||972
8783467|NCT01343667|9834312|FG000|COMPLETED|Overall Study||413
8783468|NCT01343667|9834313|FG001|COMPLETED|Overall Study||916
8783469|NCT01343667|9834312|FG000|NOT COMPLETED|Overall Study||12
8783470|NCT01343667|9834313|FG001|NOT COMPLETED|Overall Study||56
8783471|NCT01343693|9834319|FG000|STARTED|Overall Study||119
8783472|NCT01343693|9834319|FG000|COMPLETED|Overall Study||110
8783473|NCT01343693|9834319|FG000|NOT COMPLETED|Overall Study||9
8783474|NCT01343823|9834327|FG000|STARTED|Overall Study||20
8783475|NCT01343823|9834328|FG001|STARTED|Overall Study||20
8783476|NCT01343823|9834329|FG002|STARTED|Overall Study||19
8783477|NCT01343823|9834330|FG003|STARTED|Overall Study||20
8783478|NCT01343823|9834327|FG000|COMPLETED|Overall Study||18
8783479|NCT01343823|9834328|FG001|COMPLETED|Overall Study||20
8783480|NCT01343823|9834329|FG002|COMPLETED|Overall Study||19
8783481|NCT01343823|9834330|FG003|COMPLETED|Overall Study||19
8783482|NCT01343823|9834327|FG000|NOT COMPLETED|Overall Study||2
8783483|NCT01343823|9834328|FG001|NOT COMPLETED|Overall Study||0
8783484|NCT01343823|9834329|FG002|NOT COMPLETED|Overall Study||0
8783485|NCT01343823|9834330|FG003|NOT COMPLETED|Overall Study||1
8783486|NCT01343888|9834343|FG000|STARTED|Overall Study|261 subject randomized; 259 subjects treated with at least one dose; 2 subjects were not treated|259
8916586|NCT02185053|9976186|FG001|COMPLETED|Donepezil Dose Maintenance Phase||0
8783487|NCT01343888|9834344|FG001|STARTED|Overall Study|262 subject randomized; 261 subjects treated with at least one dose; 1 subject was not treated|261
8783488|NCT01343888|9834345|FG002|STARTED|Overall Study|133 subject randomized; 132 subjects treated with at least one dose; 1 subject was not treated|132
8783489|NCT01343888|9834343|FG000|COMPLETED|Overall Study||234
8783490|NCT01343888|9834344|FG001|COMPLETED|Overall Study||222
8783491|NCT01343888|9834345|FG002|COMPLETED|Overall Study||110
8783492|NCT01343888|9834343|FG000|NOT COMPLETED|Overall Study||25
8783493|NCT01343888|9834344|FG001|NOT COMPLETED|Overall Study||39
8783494|NCT01343888|9834345|FG002|NOT COMPLETED|Overall Study||22
8783495|NCT01343901|9834353|FG000|STARTED|Overall Study||210
8783496|NCT01343901|9834353|FG000|Efficacy Population|Overall Study||205
8783497|NCT01343901|9834353|FG000|COMPLETED|Overall Study||97
8783498|NCT01343901|9834353|FG000|NOT COMPLETED|Overall Study||113
8783499|NCT01344057|9834357|FG000|STARTED|Overall Study||63
8783500|NCT01344057|9834357|FG000|COMPLETED|Overall Study||62
8783501|NCT01344057|9834357|FG000|NOT COMPLETED|Overall Study||1
8783502|NCT01344161|9834363|FG000|STARTED|Overall Study||43
8783503|NCT01344161|9834364|FG001|STARTED|Overall Study||42
8783504|NCT01344161|9834363|FG000|COMPLETED|Overall Study||38
8783505|NCT01344161|9834364|FG001|COMPLETED|Overall Study||39
8783506|NCT01344161|9834363|FG000|NOT COMPLETED|Overall Study||5
8783507|NCT01344161|9834364|FG001|NOT COMPLETED|Overall Study||3
8783508|NCT01344226|9834370|FG000|STARTED|Overall Study||49
8783509|NCT01344226|9834370|FG000|COMPLETED|Overall Study||41
8783510|NCT01344226|9834370|FG000|NOT COMPLETED|Overall Study||8
8783511|NCT01344356|9834376|FG000|STARTED|Overall Study||1
8783512|NCT01344356|9834377|FG001|STARTED|Overall Study||18
8783513|NCT01344356|9834376|FG000|COMPLETED|Overall Study||1
8783514|NCT01344356|9834377|FG001|COMPLETED|Overall Study||9
8783515|NCT01344356|9834376|FG000|NOT COMPLETED|Overall Study||0
8783516|NCT01344356|9834377|FG001|NOT COMPLETED|Overall Study||9
8783517|NCT01344369|9834387|FG000|STARTED|First Intervention||18
8783518|NCT01344369|9834388|FG001|STARTED|First Intervention||18
8783519|NCT01344369|9834387|FG000|COMPLETED|First Intervention||18
8783520|NCT01344369|9834388|FG001|COMPLETED|First Intervention||18
8783521|NCT01344369|9834387|FG000|NOT COMPLETED|First Intervention||0
8783522|NCT01344369|9834388|FG001|NOT COMPLETED|First Intervention||0
8783523|NCT01344369|9834387|FG000|STARTED|Washout of 28 Days||18
8783524|NCT01344369|9834388|FG001|STARTED|Washout of 28 Days||18
8783525|NCT01344369|9834387|FG000|COMPLETED|Washout of 28 Days||17
8783526|NCT01344369|9834388|FG001|COMPLETED|Washout of 28 Days||17
8783527|NCT01344369|9834387|FG000|NOT COMPLETED|Washout of 28 Days||1
8783528|NCT01344369|9834388|FG001|NOT COMPLETED|Washout of 28 Days||1
8783529|NCT01344369|9834387|FG000|STARTED|Second Intervention||17
8783530|NCT01344369|9834388|FG001|STARTED|Second Intervention||17
8783531|NCT01344369|9834387|FG000|COMPLETED|Second Intervention||17
8783532|NCT01344369|9834388|FG001|COMPLETED|Second Intervention||16
8783533|NCT01344369|9834387|FG000|NOT COMPLETED|Second Intervention||0
8783534|NCT01344369|9834388|FG001|NOT COMPLETED|Second Intervention||1
8783535|NCT01344447|9834394|FG000|STARTED|Overall Study|Participant received study drug; Safety analysis set|479
8783536|NCT01344447|9834394|FG000|Fulfilled Requirement of FAS Population|Overall Study|Full Analysis Set (FAS)|457
8783537|NCT01344447|9834394|FG000|COMPLETED|Overall Study||471
8783538|NCT01344447|9834394|FG000|NOT COMPLETED|Overall Study||8
8783539|NCT01344460|9834402|FG000|STARTED|Overall Study|Participants received study drug; Safety analysis set|315
8783540|NCT01344460|9834402|FG000|Fulfilled Requirements of FAS Population|Overall Study|Full analysis set (FAS)|292
8783541|NCT01344460|9834402|FG000|COMPLETED|Overall Study||312
8783542|NCT01344460|9834402|FG000|NOT COMPLETED|Overall Study||3
8783543|NCT01344538|9834412|FG000|STARTED|Overall Study||16
9030707|NCT03235115|10092936|FG000|COMPLETED|First Intervention (1 Hour, Visit 2)||9
9030708|NCT03235115|10092937|FG001|COMPLETED|First Intervention (1 Hour, Visit 2)||6
9030709|NCT03235115|10092938|FG002|COMPLETED|First Intervention (1 Hour, Visit 2)||7
9030710|NCT03235115|10092939|FG003|COMPLETED|First Intervention (1 Hour, Visit 2)||6
9030711|NCT03235115|10092940|FG004|COMPLETED|First Intervention (1 Hour, Visit 2)||6
9030712|NCT03235115|10092941|FG005|COMPLETED|First Intervention (1 Hour, Visit 2)||5
9030713|NCT03235115|10092936|FG000|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
9030714|NCT03235115|10092937|FG001|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
9030715|NCT03235115|10092938|FG002|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
9030716|NCT03235115|10092939|FG003|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
9030717|NCT03235115|10092940|FG004|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
9030718|NCT03235115|10092941|FG005|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||1
9030719|NCT03235115|10092936|FG000|STARTED|Second Intervention (1 Hour, Visit 4)||9
9030720|NCT03235115|10092937|FG001|STARTED|Second Intervention (1 Hour, Visit 4)||6
9030721|NCT03235115|10092938|FG002|STARTED|Second Intervention (1 Hour, Visit 4)||7
9030722|NCT03235115|10092939|FG003|STARTED|Second Intervention (1 Hour, Visit 4)||6
9030723|NCT03235115|10092940|FG004|STARTED|Second Intervention (1 Hour, Visit 4)||6
9030724|NCT03235115|10092941|FG005|STARTED|Second Intervention (1 Hour, Visit 4)||5
9030725|NCT03235115|10092936|FG000|COMPLETED|Second Intervention (1 Hour, Visit 4)||9
9030726|NCT03235115|10092937|FG001|COMPLETED|Second Intervention (1 Hour, Visit 4)||6
9030727|NCT03235115|10092938|FG002|COMPLETED|Second Intervention (1 Hour, Visit 4)||7
8783544|NCT01344538|9834413|FG001|STARTED|Overall Study||17
8783545|NCT01344538|9834412|FG000|COMPLETED|Overall Study||14
8783546|NCT01344538|9834413|FG001|COMPLETED|Overall Study||16
8783547|NCT01344538|9834412|FG000|NOT COMPLETED|Overall Study||2
8783548|NCT01344538|9834413|FG001|NOT COMPLETED|Overall Study||1
8783549|NCT01344616|9834421|FG000|STARTED|Overall Study||244
8783550|NCT01344616|9834422|FG001|STARTED|Overall Study||238
8783551|NCT01344616|9834421|FG000|COMPLETED|Overall Study||209
8783552|NCT01344616|9834422|FG001|COMPLETED|Overall Study||194
8783553|NCT01344616|9834421|FG000|NOT COMPLETED|Overall Study||35
8783554|NCT01344616|9834422|FG001|NOT COMPLETED|Overall Study||44
8783555|NCT01344629|9834430|FG000|STARTED|Crossover Period 1||32
8783556|NCT01344629|9834431|FG001|STARTED|Crossover Period 1||32
8783557|NCT01344629|9834430|FG000|COMPLETED|Crossover Period 1||32
8783558|NCT01344629|9834431|FG001|COMPLETED|Crossover Period 1||32
8783559|NCT01344629|9834430|FG000|NOT COMPLETED|Crossover Period 1||0
8783560|NCT01344629|9834431|FG001|NOT COMPLETED|Crossover Period 1||0
8783561|NCT01344629|9834430|FG000|STARTED|Crossover Period 2||32
8783562|NCT01344629|9834431|FG001|STARTED|Crossover Period 2||32
8783563|NCT01344629|9834430|FG000|COMPLETED|Crossover Period 2||32
8783564|NCT01344629|9834431|FG001|COMPLETED|Crossover Period 2||31
8783565|NCT01344629|9834430|FG000|NOT COMPLETED|Crossover Period 2||0
8783566|NCT01344629|9834431|FG001|NOT COMPLETED|Crossover Period 2||1
8783567|NCT01344629|9834430|FG000|STARTED|Crossover Period 3||32
8783568|NCT01344629|9834431|FG001|STARTED|Crossover Period 3||31
8783569|NCT01344629|9834430|FG000|COMPLETED|Crossover Period 3||32
8783570|NCT01344629|9834431|FG001|COMPLETED|Crossover Period 3||31
8783571|NCT01344629|9834430|FG000|NOT COMPLETED|Crossover Period 3||0
8783572|NCT01344629|9834431|FG001|NOT COMPLETED|Crossover Period 3||0
8783573|NCT01344629|9834430|FG000|STARTED|Crossover Period 4||32
8783574|NCT01344629|9834431|FG001|STARTED|Crossover Period 4||31
8783575|NCT01344629|9834430|FG000|COMPLETED|Crossover Period 4||32
8783576|NCT01344629|9834431|FG001|COMPLETED|Crossover Period 4||31
8783577|NCT01344629|9834430|FG000|NOT COMPLETED|Crossover Period 4||0
8783578|NCT01344629|9834431|FG001|NOT COMPLETED|Crossover Period 4||0
8783579|NCT01344759|9834439|FG000|STARTED|Overall Study||30
8783580|NCT01344759|9834440|FG001|STARTED|Overall Study||30
8783581|NCT01344759|9834439|FG000|COMPLETED|Overall Study||30
8783582|NCT01344759|9834440|FG001|COMPLETED|Overall Study|Two of the original DEX group subjects were removed, due to receiving dexmedetomidine and propofol.|28
8783583|NCT01344759|9834439|FG000|NOT COMPLETED|Overall Study||0
8783584|NCT01344759|9834440|FG001|NOT COMPLETED|Overall Study||2
8783585|NCT01344824|9834452|FG000|STARTED|Overall Study||38
8783586|NCT01344824|9834452|FG000|COMPLETED|Overall Study||1
8783587|NCT01344824|9834452|FG000|NOT COMPLETED|Overall Study||37
9030728|NCT03235115|10092939|FG003|COMPLETED|Second Intervention (1 Hour, Visit 4)||6
9030729|NCT03235115|10092940|FG004|COMPLETED|Second Intervention (1 Hour, Visit 4)||6
9030730|NCT03235115|10092941|FG005|COMPLETED|Second Intervention (1 Hour, Visit 4)||5
9030731|NCT03235115|10092936|FG000|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
9030732|NCT03235115|10092937|FG001|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
8783588|NCT01344876|9834457|FG000|STARTED|Overall Study||4
8783589|NCT01344876|9834458|FG001|STARTED|Overall Study||3
8783590|NCT01344876|9834459|FG002|STARTED|Overall Study||4
8783591|NCT01344876|9834460|FG003|STARTED|Overall Study||6
8783592|NCT01344876|9834461|FG004|STARTED|Overall Study||3
8783593|NCT01344876|9834457|FG000|COMPLETED|Overall Study||3
8783594|NCT01344876|9834458|FG001|COMPLETED|Overall Study||3
8783595|NCT01344876|9834459|FG002|COMPLETED|Overall Study||3
8783596|NCT01344876|9834460|FG003|COMPLETED|Overall Study||3
8783597|NCT01344876|9834461|FG004|COMPLETED|Overall Study||2
8783598|NCT01344876|9834457|FG000|NOT COMPLETED|Overall Study||1
8783599|NCT01344876|9834458|FG001|NOT COMPLETED|Overall Study||0
8783600|NCT01344876|9834459|FG002|NOT COMPLETED|Overall Study||1
8783601|NCT01344876|9834460|FG003|NOT COMPLETED|Overall Study||3
8783602|NCT01344876|9834461|FG004|NOT COMPLETED|Overall Study||1
8783603|NCT01345019|9834476|FG000|STARTED|Blinded Treatment Phase||859
8783604|NCT01345019|9834477|FG001|STARTED|Blinded Treatment Phase||859
8783605|NCT01345019|9834476|FG000|Received Treatment|Blinded Treatment Phase||852
8783606|NCT01345019|9834477|FG001|Received Treatment|Blinded Treatment Phase||850
8783607|NCT01345019|9834476|FG000|COMPLETED|Blinded Treatment Phase||541
8783608|NCT01345019|9834477|FG001|COMPLETED|Blinded Treatment Phase||555
8783609|NCT01345019|9834476|FG000|NOT COMPLETED|Blinded Treatment Phase||318
8783610|NCT01345019|9834477|FG001|NOT COMPLETED|Blinded Treatment Phase||304
8783611|NCT01345019|9834476|FG000|STARTED|Open Label Treatment Phase||418
8783612|NCT01345019|9834477|FG001|STARTED|Open Label Treatment Phase||426
8783613|NCT01345019|9834476|FG000|COMPLETED|Open Label Treatment Phase||227
9030733|NCT03235115|10092938|FG002|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
8783614|NCT01345019|9834477|FG001|COMPLETED|Open Label Treatment Phase||233
8783615|NCT01345019|9834476|FG000|NOT COMPLETED|Open Label Treatment Phase||191
8783616|NCT01345019|9834477|FG001|NOT COMPLETED|Open Label Treatment Phase||193
8783617|NCT01345058|9834487|FG000|STARTED|Overall Study||20
8783618|NCT01345058|9834488|FG001|STARTED|Overall Study||36
8783619|NCT01345058|9834487|FG000|Received Lacosamide|Overall Study||19
8783620|NCT01345058|9834488|FG001|Received Lacosamide|Overall Study||0
8783621|NCT01345058|9834487|FG000|COMPLETED|Overall Study||15
8783622|NCT01345058|9834488|FG001|COMPLETED|Overall Study||36
8783623|NCT01345058|9834487|FG000|NOT COMPLETED|Overall Study||5
8783624|NCT01345058|9834488|FG001|NOT COMPLETED|Overall Study||0
8783625|NCT01345123|9834497|FG000|STARTED|Overall Study||3323
8783626|NCT01345123|9834498|FG001|STARTED|Overall Study||3311
8783627|NCT01345123|9834499|FG002|STARTED|Overall Study||3291
8783628|NCT01345123|9834497|FG000|COMPLETED|Overall Study|3323 - 79 study participants who were no longer health plan eligible members (zero eligible months)|3244
8783629|NCT01345123|9834498|FG001|COMPLETED|Overall Study|3311 - 85 study participants who were no longer health plan eligible members (zero eligible months)|3226
8783630|NCT01345123|9834499|FG002|COMPLETED|Overall Study|3291 - 88 study participants who were no longer health plan eligible members (zero eligible months)|3203
8783631|NCT01345123|9834497|FG000|NOT COMPLETED|Overall Study||79
8783632|NCT01345123|9834498|FG001|NOT COMPLETED|Overall Study||85
8783633|NCT01345123|9834499|FG002|NOT COMPLETED|Overall Study||88
8783634|NCT01345162|9834510|FG000|STARTED|Overall Study||100
8783635|NCT01345162|9834511|FG001|STARTED|Overall Study||100
8783636|NCT01345162|9834510|FG000|COMPLETED|Overall Study||98
8783637|NCT01345162|9834511|FG001|COMPLETED|Overall Study||96
8783638|NCT01345162|9834510|FG000|NOT COMPLETED|Overall Study||2
8783639|NCT01345162|9834511|FG001|NOT COMPLETED|Overall Study||4
8783640|NCT01345188|9834517|FG000|STARTED|Randomization Ranolazine/Placebo 6 Weeks||28
8783641|NCT01345188|9834517|FG000|COMPLETED|Randomization Ranolazine/Placebo 6 Weeks||26
8783642|NCT01345188|9834517|FG000|NOT COMPLETED|Randomization Ranolazine/Placebo 6 Weeks||2
8783643|NCT01345188|9834517|FG000|STARTED|Crossover Ranolazine/Placebo 6 Weeks||26
8783644|NCT01345188|9834517|FG000|COMPLETED|Crossover Ranolazine/Placebo 6 Weeks||25
8783645|NCT01345188|9834517|FG000|NOT COMPLETED|Crossover Ranolazine/Placebo 6 Weeks||1
8783646|NCT01345253|9834526|FG000|STARTED|Double-blind (DB) Phase (52 Weeks)||226
8783647|NCT01345253|9834527|FG001|STARTED|Double-blind (DB) Phase (52 Weeks)||451
8783648|NCT01345253|9834526|FG000|COMPLETED|Double-blind (DB) Phase (52 Weeks)||170
8783649|NCT01345253|9834527|FG001|COMPLETED|Double-blind (DB) Phase (52 Weeks)||372
8783650|NCT01345253|9834526|FG000|NOT COMPLETED|Double-blind (DB) Phase (52 Weeks)||56
8783651|NCT01345253|9834527|FG001|NOT COMPLETED|Double-blind (DB) Phase (52 Weeks)||79
8783652|NCT01345253|9834526|FG000|STARTED|Open-label Phase (Up to Year 5 Week 44)|Only eligible China par. enrolled in OL phase from MITT + additional 9 China par. from Safety Pop|134
8783653|NCT01345253|9834527|FG001|STARTED|Open-label Phase (Up to Year 5 Week 44)|Only eligible China par. enrolled in OL phase from MITT + additional 16 China par. from Safety Pop|290
8783654|NCT01345253|9834526|FG000|COMPLETED|Open-label Phase (Up to Year 5 Week 44)||69
8783655|NCT01345253|9834527|FG001|COMPLETED|Open-label Phase (Up to Year 5 Week 44)||146
8783656|NCT01345253|9834526|FG000|NOT COMPLETED|Open-label Phase (Up to Year 5 Week 44)||65
8783657|NCT01345253|9834527|FG001|NOT COMPLETED|Open-label Phase (Up to Year 5 Week 44)||144
8783658|NCT01345292|9834538|FG000|STARTED|Overall Study||75
8783659|NCT01345292|9834539|FG001|STARTED|Overall Study||76
8783660|NCT01345292|9834540|FG002|STARTED|Overall Study||75
8783661|NCT01345292|9834538|FG000|COMPLETED|Overall Study||73
8783662|NCT01345292|9834539|FG001|COMPLETED|Overall Study||76
8783663|NCT01345292|9834540|FG002|COMPLETED|Overall Study||74
8783664|NCT01345292|9834538|FG000|NOT COMPLETED|Overall Study||2
8783665|NCT01345292|9834539|FG001|NOT COMPLETED|Overall Study||0
8783666|NCT01345292|9834540|FG002|NOT COMPLETED|Overall Study||1
8783667|NCT01345318|9834548|FG000|STARTED|Overall Study||191
8783668|NCT01345318|9834548|FG000|COMPLETED|Overall Study||111
8783669|NCT01345318|9834548|FG000|NOT COMPLETED|Overall Study||80
8783670|NCT01345513|9834553|FG000|STARTED|Overall Study||50
8783671|NCT01345513|9834553|FG000|COMPLETED|Overall Study||50
8783672|NCT01345513|9834553|FG000|NOT COMPLETED|Overall Study||0
8916587|NCT02185053|9976187|FG002|COMPLETED|Donepezil Dose Maintenance Phase||30
8916588|NCT02185053|9976185|FG000|NOT COMPLETED|Donepezil Dose Maintenance Phase||0
8916589|NCT02185053|9976186|FG001|NOT COMPLETED|Donepezil Dose Maintenance Phase||0
8916590|NCT02185053|9976187|FG002|NOT COMPLETED|Donepezil Dose Maintenance Phase||3
8916591|NCT02185105|9976196|FG000|STARTED|Overall Study||30
8916592|NCT02185105|9976196|FG000|COMPLETED|Overall Study||30
8916593|NCT02185105|9976196|FG000|NOT COMPLETED|Overall Study||0
8916594|NCT02185131|9976209|FG000|STARTED|Overall Study||7
8916595|NCT02185131|9976210|FG001|STARTED|Overall Study||9
8916596|NCT02185131|9976209|FG000|COMPLETED|Overall Study||6
8916597|NCT02185131|9976210|FG001|COMPLETED|Overall Study||8
8916598|NCT02185131|9976209|FG000|NOT COMPLETED|Overall Study||1
8916599|NCT02185131|9976210|FG001|NOT COMPLETED|Overall Study||1
8916600|NCT02185183|9976216|FG000|STARTED|Overall Study||14
8916601|NCT02185183|9976216|FG000|COMPLETED|Overall Study||14
8783673|NCT01345591|9834557|FG000|STARTED|Overall Study||20
8783674|NCT01345591|9834557|FG000|COMPLETED|Overall Study||19
8783675|NCT01345591|9834557|FG000|NOT COMPLETED|Overall Study||1
8783676|NCT01345630|9834568|FG000|STARTED|Overall Study||396
8783677|NCT01345630|9834569|FG001|STARTED|Overall Study||401
8783678|NCT01345630|9834568|FG000|COMPLETED|Overall Study||35
8783679|NCT01345630|9834569|FG001|COMPLETED|Overall Study||42
8783680|NCT01345630|9834568|FG000|NOT COMPLETED|Overall Study||361
8783681|NCT01345630|9834569|FG001|NOT COMPLETED|Overall Study||359
8783682|NCT01345669|9834581|FG000|STARTED|Overall Study||411
8783683|NCT01345669|9834582|FG001|STARTED|Overall Study||206
8783684|NCT01345669|9834581|FG000|COMPLETED|Overall Study||124
8783685|NCT01345669|9834582|FG001|COMPLETED|Overall Study||87
8783686|NCT01345669|9834581|FG000|NOT COMPLETED|Overall Study||287
8783687|NCT01345669|9834582|FG001|NOT COMPLETED|Overall Study||119
8783688|NCT01345682|9834590|FG000|STARTED|Overall Study|Randomised|322
8783689|NCT01345682|9834591|FG001|STARTED|Overall Study|Randomised|161
8783690|NCT01345682|9834590|FG000|COMPLETED|Overall Study||0
8783691|NCT01345682|9834591|FG001|COMPLETED|Overall Study||0
8783692|NCT01345682|9834590|FG000|NOT COMPLETED|Overall Study||322
8783693|NCT01345682|9834591|FG001|NOT COMPLETED|Overall Study||161
8783694|NCT01345721|9834600|FG000|STARTED|Overall Study||74
8783695|NCT01345721|9834601|FG001|STARTED|Overall Study||66
8783696|NCT01345721|9834602|FG002|STARTED|Overall Study||65
8783697|NCT01345721|9834600|FG000|COMPLETED|Overall Study||74
8783698|NCT01345721|9834601|FG001|COMPLETED|Overall Study||66
8783699|NCT01345721|9834602|FG002|COMPLETED|Overall Study||65
8783700|NCT01345721|9834600|FG000|NOT COMPLETED|Overall Study||0
8783701|NCT01345721|9834601|FG001|NOT COMPLETED|Overall Study||0
8783702|NCT01345721|9834602|FG002|NOT COMPLETED|Overall Study||0
8783703|NCT01345929|9834616|FG000|STARTED|Overall Study||533
8783704|NCT01345929|9834617|FG001|STARTED|Overall Study||535
8783705|NCT01345929|9834616|FG000|COMPLETED|Overall Study||512
8783706|NCT01345929|9834617|FG001|COMPLETED|Overall Study||516
8783707|NCT01345929|9834616|FG000|NOT COMPLETED|Overall Study||21
8783708|NCT01345929|9834617|FG001|NOT COMPLETED|Overall Study||19
8783709|NCT01346059|9834625|FG000|STARTED|Overall Study||1
8783710|NCT01346059|9834626|FG001|STARTED|Overall Study||1
8783711|NCT01346059|9834625|FG000|COMPLETED|Overall Study||0
8783712|NCT01346059|9834626|FG001|COMPLETED|Overall Study||1
8783713|NCT01346059|9834625|FG000|NOT COMPLETED|Overall Study||1
8783714|NCT01346059|9834626|FG001|NOT COMPLETED|Overall Study||0
8783715|NCT01346072|9834634|FG000|STARTED|Overall Study||11
8783716|NCT01346072|9834635|FG001|STARTED|Overall Study||10
8783717|NCT01346072|9834634|FG000|COMPLETED|Overall Study||11
8783718|NCT01346072|9834635|FG001|COMPLETED|Overall Study||10
8783719|NCT01346072|9834634|FG000|NOT COMPLETED|Overall Study||0
8783720|NCT01346072|9834635|FG001|NOT COMPLETED|Overall Study||0
8783721|NCT01346085|9834641|FG000|STARTED|Overall Study||10
8783722|NCT01346085|9834641|FG000|COMPLETED|Overall Study||10
8783723|NCT01346085|9834641|FG000|NOT COMPLETED|Overall Study||0
8783724|NCT01346176|9834648|FG000|STARTED|Recruited||49
8783725|NCT01346176|9834649|FG001|STARTED|Recruited||40
8783726|NCT01346176|9834650|FG002|STARTED|Recruited||43
8783727|NCT01346176|9834648|FG000|COMPLETED|Recruited||48
8783728|NCT01346176|9834649|FG001|COMPLETED|Recruited||40
8783729|NCT01346176|9834650|FG002|COMPLETED|Recruited||43
8783730|NCT01346176|9834648|FG000|NOT COMPLETED|Recruited||1
8783731|NCT01346176|9834649|FG001|NOT COMPLETED|Recruited||0
8783732|NCT01346176|9834650|FG002|NOT COMPLETED|Recruited||0
8783733|NCT01346176|9834648|FG000|STARTED|Completed Advance Directive||48
8783734|NCT01346176|9834649|FG001|STARTED|Completed Advance Directive||40
8783735|NCT01346176|9834650|FG002|STARTED|Completed Advance Directive||43
8783736|NCT01346176|9834648|FG000|COMPLETED|Completed Advance Directive||35
8783737|NCT01346176|9834649|FG001|COMPLETED|Completed Advance Directive||26
8783738|NCT01346176|9834650|FG002|COMPLETED|Completed Advance Directive||33
8783739|NCT01346176|9834648|FG000|NOT COMPLETED|Completed Advance Directive||13
8783740|NCT01346176|9834649|FG001|NOT COMPLETED|Completed Advance Directive||14
8783741|NCT01346176|9834650|FG002|NOT COMPLETED|Completed Advance Directive||10
8783742|NCT01346176|9834648|FG000|STARTED|Completed Satisfaction Survey||35
8783743|NCT01346176|9834649|FG001|STARTED|Completed Satisfaction Survey||26
8783744|NCT01346176|9834650|FG002|STARTED|Completed Satisfaction Survey||33
8783745|NCT01346176|9834648|FG000|COMPLETED|Completed Satisfaction Survey||29
8783746|NCT01346176|9834649|FG001|COMPLETED|Completed Satisfaction Survey||22
8783747|NCT01346176|9834650|FG002|COMPLETED|Completed Satisfaction Survey||27
8783748|NCT01346176|9834648|FG000|NOT COMPLETED|Completed Satisfaction Survey||6
8783749|NCT01346176|9834649|FG001|NOT COMPLETED|Completed Satisfaction Survey||4
8783750|NCT01346176|9834650|FG002|NOT COMPLETED|Completed Satisfaction Survey||6
8783751|NCT01346189|9834662|FG000|STARTED|Overall Study||433
8783752|NCT01346189|9834663|FG001|STARTED|Overall Study||358
8783753|NCT01346189|9834664|FG002|STARTED|Overall Study||346
8783754|NCT01346189|9834665|FG003|STARTED|Overall Study||366
8783755|NCT01346189|9834662|FG000|COMPLETED|Overall Study|433 patients (64 primary care physicians) included in analysis|417
8783756|NCT01346189|9834663|FG001|COMPLETED|Overall Study|358 Patients (58 primary care physicians) included in analysis|341
8783757|NCT01346189|9834664|FG002|COMPLETED|Overall Study|346 patients (58 primary care physicians) included in analysis|332
8783758|NCT01346189|9834665|FG003|COMPLETED|Overall Study|366 patients (58 primary care physicians) included in analysis|355
8783759|NCT01346189|9834662|FG000|NOT COMPLETED|Overall Study||16
8783760|NCT01346189|9834663|FG001|NOT COMPLETED|Overall Study||17
8783761|NCT01346189|9834664|FG002|NOT COMPLETED|Overall Study||14
8783762|NCT01346189|9834665|FG003|NOT COMPLETED|Overall Study||11
8783763|NCT01346267|9834677|FG000|STARTED|Overall Study||93
8783764|NCT01346267|9834678|FG001|STARTED|Overall Study||94
8783765|NCT01346267|9834677|FG000|COMPLETED|Overall Study||70
8783766|NCT01346267|9834678|FG001|COMPLETED|Overall Study||67
8783767|NCT01346267|9834677|FG000|NOT COMPLETED|Overall Study||23
8783768|NCT01346267|9834678|FG001|NOT COMPLETED|Overall Study||27
8783769|NCT01346293|9834686|FG000|STARTED|Overall Study||2743
8783770|NCT01346293|9834687|FG001|STARTED|Overall Study||629
8783771|NCT01346293|9834686|FG000|COMPLETED|Overall Study||2676
8783772|NCT01346293|9834687|FG001|COMPLETED|Overall Study||608
8783773|NCT01346293|9834686|FG000|NOT COMPLETED|Overall Study||67
8783774|NCT01346293|9834687|FG001|NOT COMPLETED|Overall Study||21
8783775|NCT01346371|9834697|FG000|STARTED|Overall Study||20
8783776|NCT01346371|9834698|FG001|STARTED|Overall Study||20
8783777|NCT01346371|9834697|FG000|COMPLETED|Overall Study||18
8783778|NCT01346371|9834698|FG001|COMPLETED|Overall Study||20
8783779|NCT01346371|9834697|FG000|NOT COMPLETED|Overall Study||2
8783780|NCT01346371|9834698|FG001|NOT COMPLETED|Overall Study||0
8783781|NCT01346397|9834706|FG000|STARTED|Overall Study||85
8783782|NCT01346397|9834707|FG001|STARTED|Overall Study||85
8783783|NCT01346397|9834706|FG000|COMPLETED|Overall Study||85
8783784|NCT01346397|9834707|FG001|COMPLETED|Overall Study||85
8783785|NCT01346397|9834706|FG000|NOT COMPLETED|Overall Study||0
8783786|NCT01346397|9834707|FG001|NOT COMPLETED|Overall Study||0
8783787|NCT01346410|9834713|FG000|STARTED|Overall Study||1
8783788|NCT01346410|9834713|FG000|COMPLETED|Overall Study||0
8783789|NCT01346410|9834713|FG000|NOT COMPLETED|Overall Study||1
8783790|NCT01346475|9834719|FG000|STARTED|First Intervention||22
8783791|NCT01346475|9834720|FG001|STARTED|First Intervention||28
8783792|NCT01346475|9834719|FG000|COMPLETED|First Intervention||18
8783793|NCT01346475|9834720|FG001|COMPLETED|First Intervention||25
8783794|NCT01346475|9834719|FG000|NOT COMPLETED|First Intervention||4
8783795|NCT01346475|9834720|FG001|NOT COMPLETED|First Intervention||3
8783796|NCT01346475|9834719|FG000|STARTED|Second Intervention||18
8783797|NCT01346475|9834720|FG001|STARTED|Second Intervention||25
8783798|NCT01346475|9834719|FG000|COMPLETED|Second Intervention||18
8783799|NCT01346475|9834720|FG001|COMPLETED|Second Intervention||25
8783800|NCT01346475|9834719|FG000|NOT COMPLETED|Second Intervention||0
8783801|NCT01346475|9834720|FG001|NOT COMPLETED|Second Intervention||0
8783802|NCT01346488|9834726|FG000|STARTED|Overall Study||1968
8783803|NCT01346488|9834726|FG000|COMPLETED|Overall Study||1262
8783804|NCT01346488|9834726|FG000|NOT COMPLETED|Overall Study||706
8783805|NCT01346501|9834732|FG000|STARTED|Overall Study||79
8783806|NCT01346501|9834733|FG001|STARTED|Overall Study||93
8783807|NCT01346501|9834732|FG000|COMPLETED|Overall Study||68
8783808|NCT01346501|9834733|FG001|COMPLETED|Overall Study||80
8783809|NCT01346501|9834732|FG000|NOT COMPLETED|Overall Study||11
8783810|NCT01346501|9834733|FG001|NOT COMPLETED|Overall Study||13
8783811|NCT01346514|9834743|FG000|STARTED|Overall Study||91
8783812|NCT01346514|9834744|FG001|STARTED|Overall Study||90
8783813|NCT01346514|9834743|FG000|3 Month Assessment|Overall Study||83
8783814|NCT01346514|9834744|FG001|3 Month Assessment|Overall Study||68
8783815|NCT01346514|9834743|FG000|6 Month Assessment|Overall Study||74
8783816|NCT01346514|9834744|FG001|6 Month Assessment|Overall Study||61
8783817|NCT01346514|9834743|FG000|9 Month Assessment|Overall Study||67
8783818|NCT01346514|9834744|FG001|9 Month Assessment|Overall Study||59
8783819|NCT01346514|9834743|FG000|12 Month Assessment|Overall Study||62
8783820|NCT01346514|9834744|FG001|12 Month Assessment|Overall Study||53
8783821|NCT01346514|9834743|FG000|COMPLETED|Overall Study|Number of patients completing BL-12 months|62
8783822|NCT01346514|9834744|FG001|COMPLETED|Overall Study|Number of patients completing BL-12 months.|53
8783823|NCT01346514|9834743|FG000|NOT COMPLETED|Overall Study||29
8783824|NCT01346514|9834744|FG001|NOT COMPLETED|Overall Study||37
8783825|NCT01346540|9834754|FG000|STARTED|Overall Study||4
8783826|NCT01346540|9834755|FG001|STARTED|Overall Study||12
8783827|NCT01346540|9834754|FG000|COMPLETED|Overall Study||1
8783828|NCT01346540|9834755|FG001|COMPLETED|Overall Study||0
8783829|NCT01346540|9834754|FG000|NOT COMPLETED|Overall Study||3
8783830|NCT01346540|9834755|FG001|NOT COMPLETED|Overall Study||12
8783831|NCT01346592|9834765|FG000|STARTED|Overall Study||3136
8783832|NCT01346592|9834766|FG001|STARTED|Overall Study||1478
8783833|NCT01346592|9834767|FG002|STARTED|Overall Study||1486
8783834|NCT01346592|9834765|FG000|COMPLETED|Overall Study||2983
8783835|NCT01346592|9834766|FG001|COMPLETED|Overall Study||1389
8783836|NCT01346592|9834767|FG002|COMPLETED|Overall Study||1408
8783837|NCT01346592|9834765|FG000|NOT COMPLETED|Overall Study||153
8783838|NCT01346592|9834766|FG001|NOT COMPLETED|Overall Study||89
8783839|NCT01346592|9834767|FG002|NOT COMPLETED|Overall Study||78
8783840|NCT01346683|9834792|FG000|STARTED|Overall Study||45
8783841|NCT01346683|9834792|FG000|COMPLETED|Overall Study||45
8783842|NCT01346683|9834792|FG000|NOT COMPLETED|Overall Study||0
8783843|NCT01346696|9834796|FG000|STARTED|Overall Study||45
8783844|NCT01346696|9834796|FG000|COMPLETED|Overall Study||44
8783845|NCT01346696|9834796|FG000|NOT COMPLETED|Overall Study||1
8783846|NCT01346774|9834802|FG000|STARTED|Overall Study||80
8783847|NCT01346774|9834803|FG001|STARTED|Overall Study||80
8783848|NCT01346774|9834802|FG000|COMPLETED|Overall Study||67
8783849|NCT01346774|9834803|FG001|COMPLETED|Overall Study||63
8783850|NCT01346774|9834802|FG000|NOT COMPLETED|Overall Study||13
8783851|NCT01346774|9834803|FG001|NOT COMPLETED|Overall Study||17
8783852|NCT01346839|9834811|FG000|STARTED|Overall Study||683
8783853|NCT01346839|9834812|FG001|STARTED|Overall Study||573
8783854|NCT01346839|9834811|FG000|COMPLETED|Overall Study||369
8783855|NCT01346839|9834812|FG001|COMPLETED|Overall Study|All triggers were applied retrospectively on 7/19/2012.|364
8783856|NCT01346839|9834811|FG000|NOT COMPLETED|Overall Study||314
8783857|NCT01346839|9834812|FG001|NOT COMPLETED|Overall Study||209
8783858|NCT01346852|9834820|FG000|STARTED|Overall Study||41753
8783859|NCT01346852|9834821|FG001|STARTED|Overall Study||59684
8783860|NCT01346852|9834820|FG000|COMPLETED|Overall Study||41753
8783861|NCT01346852|9834821|FG001|COMPLETED|Overall Study||59684
8783862|NCT01346852|9834820|FG000|NOT COMPLETED|Overall Study||0
8783863|NCT01346852|9834821|FG001|NOT COMPLETED|Overall Study||0
8783864|NCT01346969|9834831|FG000|STARTED|Overall Study||28
8783865|NCT01346969|9834832|FG001|STARTED|Overall Study||14
8783866|NCT01346969|9834833|FG002|STARTED|Overall Study||13
8783867|NCT01346969|9834834|FG003|STARTED|Overall Study||13
8783868|NCT01346969|9834831|FG000|Safety Population|Overall Study||27
8783869|NCT01346969|9834832|FG001|Safety Population|Overall Study||14
8783870|NCT01346969|9834833|FG002|Safety Population|Overall Study||13
8783871|NCT01346969|9834834|FG003|Safety Population|Overall Study||13
8783872|NCT01346969|9834831|FG000|COMPLETED|Overall Study||26
8783873|NCT01346969|9834832|FG001|COMPLETED|Overall Study||14
8783874|NCT01346969|9834833|FG002|COMPLETED|Overall Study||10
8783875|NCT01346969|9834834|FG003|COMPLETED|Overall Study||12
8783876|NCT01346969|9834831|FG000|NOT COMPLETED|Overall Study||2
8783877|NCT01346969|9834832|FG001|NOT COMPLETED|Overall Study||0
8783878|NCT01346969|9834833|FG002|NOT COMPLETED|Overall Study||3
8783879|NCT01346969|9834834|FG003|NOT COMPLETED|Overall Study||1
8783880|NCT01347008|9834846|FG000|STARTED|Overall Study||21
8783881|NCT01347008|9834847|FG001|STARTED|Overall Study||20
8783882|NCT01347008|9834846|FG000|COMPLETED|Overall Study||21
8783883|NCT01347008|9834847|FG001|COMPLETED|Overall Study||20
8783884|NCT01347008|9834846|FG000|NOT COMPLETED|Overall Study||0
8783885|NCT01347008|9834847|FG001|NOT COMPLETED|Overall Study||0
8783886|NCT01347034|9834855|FG000|STARTED|Overall Study||6
8783887|NCT01347034|9834856|FG001|STARTED|Overall Study||14
8783888|NCT01347034|9834855|FG000|COMPLETED|Overall Study||6
8783889|NCT01347034|9834856|FG001|COMPLETED|Overall Study||14
8783890|NCT01347034|9834855|FG000|NOT COMPLETED|Overall Study||0
8783891|NCT01347034|9834856|FG001|NOT COMPLETED|Overall Study||0
8783892|NCT01347060|9834864|FG000|STARTED|Overall Study||9868
8783893|NCT01347060|9834865|FG001|STARTED|Overall Study||7580
8783894|NCT01347060|9834864|FG000|COMPLETED|Overall Study||9868
8783895|NCT01347060|9834865|FG001|COMPLETED|Overall Study||7580
8783896|NCT01347060|9834864|FG000|NOT COMPLETED|Overall Study||0
8783897|NCT01347060|9834865|FG001|NOT COMPLETED|Overall Study||0
8783898|NCT01347073|9834871|FG000|STARTED|Overall Study||23
8783899|NCT01347073|9834871|FG000|COMPLETED|Overall Study||21
8783900|NCT01347073|9834871|FG000|NOT COMPLETED|Overall Study||2
8783901|NCT01347086|9834891|FG000|STARTED|Overall Study||2
8783902|NCT01347086|9834892|FG001|STARTED|Overall Study||6
8783903|NCT01347086|9834893|FG002|STARTED|Overall Study|"2 participants were treated together with each dose level of Deleobuvir.~1 subject was not treated."|7
8783904|NCT01347086|9834894|FG003|STARTED|Overall Study||6
8783905|NCT01347086|9834895|FG004|STARTED|Overall Study||6
8783906|NCT01347086|9834896|FG005|STARTED|Overall Study||6
8783907|NCT01347086|9834897|FG006|STARTED|Overall Study|"2 participants treated together with each dose level of Deleobuvir.~1 subject was not treated."|7
8783908|NCT01347086|9834898|FG007|STARTED|Overall Study|One subject was not treated.|7
8783909|NCT01347086|9834899|FG008|STARTED|Overall Study||6
8783910|NCT01347086|9834900|FG009|STARTED|Overall Study|One subject was not treated.|7
8783911|NCT01347086|9834891|FG000|COMPLETED|Overall Study||2
8783912|NCT01347086|9834892|FG001|COMPLETED|Overall Study||6
8783913|NCT01347086|9834893|FG002|COMPLETED|Overall Study||6
8783914|NCT01347086|9834894|FG003|COMPLETED|Overall Study||6
8783915|NCT01347086|9834895|FG004|COMPLETED|Overall Study||6
8783916|NCT01347086|9834896|FG005|COMPLETED|Overall Study||6
8783917|NCT01347086|9834897|FG006|COMPLETED|Overall Study||6
8783918|NCT01347086|9834898|FG007|COMPLETED|Overall Study||6
8783919|NCT01347086|9834899|FG008|COMPLETED|Overall Study||6
8783920|NCT01347086|9834900|FG009|COMPLETED|Overall Study||6
8783921|NCT01347086|9834891|FG000|NOT COMPLETED|Overall Study||0
8783922|NCT01347086|9834892|FG001|NOT COMPLETED|Overall Study||0
8783923|NCT01347086|9834893|FG002|NOT COMPLETED|Overall Study||1
8783924|NCT01347086|9834894|FG003|NOT COMPLETED|Overall Study||0
8783925|NCT01347086|9834895|FG004|NOT COMPLETED|Overall Study||0
8783926|NCT01347086|9834896|FG005|NOT COMPLETED|Overall Study||0
8783927|NCT01347086|9834897|FG006|NOT COMPLETED|Overall Study||1
8783928|NCT01347086|9834898|FG007|NOT COMPLETED|Overall Study||1
8783929|NCT01347086|9834899|FG008|NOT COMPLETED|Overall Study||0
8783930|NCT01347086|9834900|FG009|NOT COMPLETED|Overall Study||1
8783931|NCT01347112|9834934|FG000|STARTED|Overall Study||16
8783932|NCT01347112|9834935|FG001|STARTED|Overall Study||17
8783933|NCT01347112|9834934|FG000|COMPLETED|Overall Study||12
8783934|NCT01347112|9834935|FG001|COMPLETED|Overall Study||5
8783935|NCT01347112|9834934|FG000|NOT COMPLETED|Overall Study||4
8783936|NCT01347112|9834935|FG001|NOT COMPLETED|Overall Study||12
8783937|NCT01347255|9834942|FG000|STARTED|Overall Study||24
8783938|NCT01347255|9834942|FG000|COMPLETED|Overall Study||24
8783939|NCT01347255|9834942|FG000|NOT COMPLETED|Overall Study||0
8783940|NCT01347307|9834951|FG000|STARTED|Overall Study||3
8783941|NCT01347307|9834952|FG001|STARTED|Overall Study||33
8783942|NCT01347307|9834951|FG000|COMPLETED|Overall Study||3
8783943|NCT01347307|9834952|FG001|COMPLETED|Overall Study||28
8783944|NCT01347307|9834951|FG000|NOT COMPLETED|Overall Study||0
8783945|NCT01347307|9834952|FG001|NOT COMPLETED|Overall Study||5
8783946|NCT01347333|9834960|FG000|STARTED|Overall Study||23
8783947|NCT01347333|9834961|FG001|STARTED|Overall Study|No participants were enrolled in the Primary Liver Tumor arm.|0
8783948|NCT01347333|9834960|FG000|COMPLETED|Overall Study||23
8783949|NCT01347333|9834961|FG001|COMPLETED|Overall Study||0
8783950|NCT01347333|9834960|FG000|NOT COMPLETED|Overall Study||0
8783951|NCT01347333|9834961|FG001|NOT COMPLETED|Overall Study||0
8783952|NCT01347541|9834969|FG000|STARTED|Overall Study||3
8783953|NCT01347541|9834970|FG001|STARTED|Overall Study||1
8783954|NCT01347541|9834969|FG000|COMPLETED|Overall Study||3
8783955|NCT01347541|9834970|FG001|COMPLETED|Overall Study||1
8783956|NCT01347541|9834969|FG000|NOT COMPLETED|Overall Study||0
8783957|NCT01347541|9834970|FG001|NOT COMPLETED|Overall Study||0
8783958|NCT01347554|9834978|FG000|STARTED|Overall Study||237
8783959|NCT01347554|9834979|FG001|STARTED|Overall Study||242
8783960|NCT01347554|9834978|FG000|COMPLETED|Overall Study|Final TIMI flow grade 0 or 1 patients or failed PCI cases (N=7) were excluded.|230
8783961|NCT01347554|9834979|FG001|COMPLETED|Overall Study|Final TIMI flow grade 0 or 1 patients or failed PCI cases (N=11) were excluded.|231
8783962|NCT01347554|9834978|FG000|NOT COMPLETED|Overall Study||7
8783963|NCT01347554|9834979|FG001|NOT COMPLETED|Overall Study||11
8783964|NCT01347580|9834987|FG000|STARTED|Overall Study|based on randomized treatment|909
8783965|NCT01347580|9834988|FG001|STARTED|Overall Study|based on randomized treatment|953
8783966|NCT01347580|9834987|FG000|Modified Intent to Treat Population|Overall Study|based on randomized treatment|906
8783967|NCT01347580|9834988|FG001|Modified Intent to Treat Population|Overall Study|based on randomized treatment|952
8783968|NCT01347580|9834987|FG000|Safety Population|Overall Study|based on actual treatment|908
8783969|NCT01347580|9834988|FG001|Safety Population|Overall Study|based on actual treatment|950
8783970|NCT01347580|9834987|FG000|COMPLETED|Overall Study|based on randomized treatment|844
8783971|NCT01347580|9834988|FG001|COMPLETED|Overall Study|based on randomized treatment|897
8916602|NCT02185183|9976216|FG000|NOT COMPLETED|Overall Study||0
8916603|NCT02185339|9976222|FG000|STARTED|Overall Study||30
8916604|NCT02185339|9976223|FG001|STARTED|Overall Study||31
8916605|NCT02185339|9976222|FG000|COMPLETED|Overall Study||30
8916606|NCT02185339|9976223|FG001|COMPLETED|Overall Study||30
8916607|NCT02185339|9976222|FG000|NOT COMPLETED|Overall Study||0
8916608|NCT02185339|9976223|FG001|NOT COMPLETED|Overall Study||1
9030734|NCT03235115|10092939|FG003|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
9030735|NCT03235115|10092940|FG004|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
9030736|NCT03235115|10092941|FG005|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
9030737|NCT03235115|10092936|FG000|STARTED|Third Intervention ( 1 Hour, Visit 6)||9
9030738|NCT03235115|10092937|FG001|STARTED|Third Intervention ( 1 Hour, Visit 6)||6
9030739|NCT03235115|10092938|FG002|STARTED|Third Intervention ( 1 Hour, Visit 6)||7
9030740|NCT03235115|10092939|FG003|STARTED|Third Intervention ( 1 Hour, Visit 6)||6
9030741|NCT03235115|10092940|FG004|STARTED|Third Intervention ( 1 Hour, Visit 6)||6
9030742|NCT03235115|10092941|FG005|STARTED|Third Intervention ( 1 Hour, Visit 6)||5
9030743|NCT03235115|10092936|FG000|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||9
9030744|NCT03235115|10092937|FG001|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||6
9030745|NCT03235115|10092938|FG002|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||7
9030746|NCT03235115|10092939|FG003|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||6
9030747|NCT03235115|10092940|FG004|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||6
9030748|NCT03235115|10092941|FG005|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||5
9030749|NCT03235115|10092936|FG000|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
9030750|NCT03235115|10092937|FG001|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
9030751|NCT03235115|10092938|FG002|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
8783972|NCT01347580|9834987|FG000|NOT COMPLETED|Overall Study||65
8783973|NCT01347580|9834988|FG001|NOT COMPLETED|Overall Study||56
8783974|NCT01347710|9834994|FG000|STARTED|Overall Study||795
8783975|NCT01347710|9834994|FG000|COMPLETED|Overall Study||764
8783976|NCT01347710|9834994|FG000|NOT COMPLETED|Overall Study||31
8783977|NCT01347762|9835006|FG000|STARTED|Overall Study||10
8783978|NCT01347762|9835007|FG001|STARTED|Overall Study||8
8783979|NCT01347762|9835008|FG002|STARTED|Overall Study||16
8783980|NCT01347762|9835009|FG003|STARTED|Overall Study||18
8783981|NCT01347762|9835006|FG000|COMPLETED|Overall Study||6
8783982|NCT01347762|9835007|FG001|COMPLETED|Overall Study||6
8783983|NCT01347762|9835008|FG002|COMPLETED|Overall Study||7
8783984|NCT01347762|9835009|FG003|COMPLETED|Overall Study||10
8783985|NCT01347762|9835006|FG000|NOT COMPLETED|Overall Study||4
8783986|NCT01347762|9835007|FG001|NOT COMPLETED|Overall Study||2
8783987|NCT01347762|9835008|FG002|NOT COMPLETED|Overall Study||9
8783988|NCT01347762|9835009|FG003|NOT COMPLETED|Overall Study||8
8783989|NCT01347788|9835019|FG000|STARTED|Overall Study||11
8783990|NCT01347788|9835020|FG001|STARTED|Overall Study||10
8783991|NCT01347788|9835021|FG002|STARTED|Overall Study||13
8783992|NCT01347788|9835019|FG000|COMPLETED|Overall Study||11
8783993|NCT01347788|9835020|FG001|COMPLETED|Overall Study||10
8783994|NCT01347788|9835021|FG002|COMPLETED|Overall Study||13
8783995|NCT01347788|9835019|FG000|NOT COMPLETED|Overall Study||0
8783996|NCT01347788|9835020|FG001|NOT COMPLETED|Overall Study||0
8783997|NCT01347788|9835021|FG002|NOT COMPLETED|Overall Study||0
8783998|NCT01347866|9835046|FG000|STARTED|Overall Study||5
8783999|NCT01347866|9835047|FG001|STARTED|Overall Study||1
8784000|NCT01347866|9835048|FG002|STARTED|Overall Study||1
8784001|NCT01347866|9835049|FG003|STARTED|Overall Study||7
8784002|NCT01347866|9835050|FG004|STARTED|Overall Study||7
8784003|NCT01347866|9835051|FG005|STARTED|Overall Study||3
8784004|NCT01347866|9835052|FG006|STARTED|Overall Study||6
8784005|NCT01347866|9835053|FG007|STARTED|Overall Study||4
8784006|NCT01347866|9835054|FG008|STARTED|Overall Study||31
8784007|NCT01347866|9835055|FG009|STARTED|Overall Study||7
8784008|NCT01347866|9835056|FG010|STARTED|Overall Study||3
8784009|NCT01347866|9835057|FG011|STARTED|Overall Study||4
8784010|NCT01347866|9835058|FG012|STARTED|Overall Study||7
8784011|NCT01347866|9835059|FG013|STARTED|Overall Study||7
8784012|NCT01347866|9835060|FG014|STARTED|Overall Study||3
8784013|NCT01347866|9835061|FG015|STARTED|Overall Study||4
8784014|NCT01347866|9835062|FG016|STARTED|Overall Study||2
8784015|NCT01347866|9835046|FG000|COMPLETED|Overall Study||0
8784016|NCT01347866|9835047|FG001|COMPLETED|Overall Study||0
8784017|NCT01347866|9835048|FG002|COMPLETED|Overall Study||0
8784018|NCT01347866|9835049|FG003|COMPLETED|Overall Study||0
8784019|NCT01347866|9835050|FG004|COMPLETED|Overall Study||0
8784020|NCT01347866|9835051|FG005|COMPLETED|Overall Study||0
8784021|NCT01347866|9835052|FG006|COMPLETED|Overall Study||0
8784022|NCT01347866|9835053|FG007|COMPLETED|Overall Study||0
8784023|NCT01347866|9835054|FG008|COMPLETED|Overall Study||0
8784024|NCT01347866|9835055|FG009|COMPLETED|Overall Study||0
8784025|NCT01347866|9835056|FG010|COMPLETED|Overall Study||0
8784026|NCT01347866|9835057|FG011|COMPLETED|Overall Study||0
8784027|NCT01347866|9835058|FG012|COMPLETED|Overall Study||0
8784028|NCT01347866|9835059|FG013|COMPLETED|Overall Study||0
8784029|NCT01347866|9835060|FG014|COMPLETED|Overall Study||0
8784030|NCT01347866|9835061|FG015|COMPLETED|Overall Study||0
8784031|NCT01347866|9835062|FG016|COMPLETED|Overall Study||0
8784032|NCT01347866|9835046|FG000|NOT COMPLETED|Overall Study||5
8784033|NCT01347866|9835047|FG001|NOT COMPLETED|Overall Study||1
8784034|NCT01347866|9835048|FG002|NOT COMPLETED|Overall Study||1
8784035|NCT01347866|9835049|FG003|NOT COMPLETED|Overall Study||7
8784036|NCT01347866|9835050|FG004|NOT COMPLETED|Overall Study||7
8784037|NCT01347866|9835051|FG005|NOT COMPLETED|Overall Study||3
8784038|NCT01347866|9835052|FG006|NOT COMPLETED|Overall Study||6
8784039|NCT01347866|9835053|FG007|NOT COMPLETED|Overall Study||4
8784040|NCT01347866|9835054|FG008|NOT COMPLETED|Overall Study||31
8784041|NCT01347866|9835055|FG009|NOT COMPLETED|Overall Study||7
8784042|NCT01347866|9835056|FG010|NOT COMPLETED|Overall Study||3
8784043|NCT01347866|9835057|FG011|NOT COMPLETED|Overall Study||4
8784044|NCT01347866|9835058|FG012|NOT COMPLETED|Overall Study||7
8784045|NCT01347866|9835059|FG013|NOT COMPLETED|Overall Study||7
8784046|NCT01347866|9835060|FG014|NOT COMPLETED|Overall Study||3
8784047|NCT01347866|9835061|FG015|NOT COMPLETED|Overall Study||4
8784048|NCT01347866|9835062|FG016|NOT COMPLETED|Overall Study||2
8784049|NCT01347879|9835135|FG000|STARTED|Overall Study||53
8784050|NCT01347879|9835136|FG001|STARTED|Overall Study||100
8784051|NCT01347879|9835135|FG000|COMPLETED|Overall Study||46
8784052|NCT01347879|9835136|FG001|COMPLETED|Overall Study||83
8784053|NCT01347879|9835135|FG000|NOT COMPLETED|Overall Study||7
8784054|NCT01347879|9835136|FG001|NOT COMPLETED|Overall Study||17
8784055|NCT01347931|9835142|FG000|STARTED|Standard Oxygen Therapy||30
8784056|NCT01347931|9835142|FG000|COMPLETED|Standard Oxygen Therapy||29
8784057|NCT01347931|9835142|FG000|NOT COMPLETED|Standard Oxygen Therapy||1
8784058|NCT01347931|9835142|FG000|STARTED|NIOV System||29
8784059|NCT01347931|9835142|FG000|COMPLETED|NIOV System||29
8784060|NCT01347931|9835142|FG000|NOT COMPLETED|NIOV System||0
8784061|NCT01348087|9835148|FG000|STARTED|Overall Study||148
8784062|NCT01348087|9835148|FG000|COMPLETED|Overall Study||0
8784063|NCT01348087|9835148|FG000|NOT COMPLETED|Overall Study||148
8784064|NCT01348100|9835169|FG000|STARTED|Overall Study||2
8784065|NCT01348100|9835170|FG001|STARTED|Overall Study||2
8784066|NCT01348100|9835171|FG002|STARTED|Overall Study||15
8784067|NCT01348100|9835172|FG003|STARTED|Overall Study||15
8784068|NCT01348100|9835173|FG004|STARTED|Overall Study||15
8784069|NCT01348100|9835174|FG005|STARTED|Overall Study||16
8784070|NCT01348100|9835175|FG006|STARTED|Overall Study||16
8784071|NCT01348100|9835169|FG000|COMPLETED|Overall Study||2
8784072|NCT01348100|9835170|FG001|COMPLETED|Overall Study||2
8784073|NCT01348100|9835171|FG002|COMPLETED|Overall Study||13
8784074|NCT01348100|9835172|FG003|COMPLETED|Overall Study||14
8784075|NCT01348100|9835173|FG004|COMPLETED|Overall Study||14
8784076|NCT01348100|9835174|FG005|COMPLETED|Overall Study||14
8784077|NCT01348100|9835175|FG006|COMPLETED|Overall Study||13
8784078|NCT01348100|9835169|FG000|NOT COMPLETED|Overall Study||0
8784079|NCT01348100|9835170|FG001|NOT COMPLETED|Overall Study||0
8784080|NCT01348100|9835171|FG002|NOT COMPLETED|Overall Study||2
8784081|NCT01348100|9835172|FG003|NOT COMPLETED|Overall Study||1
8784082|NCT01348100|9835173|FG004|NOT COMPLETED|Overall Study||1
8784083|NCT01348100|9835174|FG005|NOT COMPLETED|Overall Study||2
8784084|NCT01348100|9835175|FG006|NOT COMPLETED|Overall Study||3
8784085|NCT01348139|9835196|FG000|STARTED|Period 1||5
8784086|NCT01348139|9835197|FG001|STARTED|Period 1||4
8784087|NCT01348139|9835198|FG002|STARTED|Period 1||4
8784088|NCT01348139|9835199|FG003|STARTED|Period 1||4
8784089|NCT01348139|9835200|FG004|STARTED|Period 1||5
8784090|NCT01348139|9835201|FG005|STARTED|Period 1||4
8784091|NCT01348139|9835196|FG000|COMPLETED|Period 1||4
8784092|NCT01348139|9835197|FG001|COMPLETED|Period 1||4
8784093|NCT01348139|9835198|FG002|COMPLETED|Period 1||4
9030752|NCT03235115|10092939|FG003|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
9030753|NCT03235115|10092940|FG004|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
9030754|NCT03235115|10092941|FG005|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
9030755|NCT03235154|10092949|FG000|STARTED|Overall Study||11
9030756|NCT03235154|10092949|FG000|Completed Epclusa. Treatment|Overall Study||8
9030757|NCT03235154|10092949|FG000|12-wk Post-treatment HCV RNA Measured|Overall Study||7
9030758|NCT03235154|10092949|FG000|COMPLETED|Overall Study||7
9030759|NCT03235154|10092949|FG000|NOT COMPLETED|Overall Study||4
9030760|NCT03235180|10092955|FG000|STARTED|Overall Study||9
9030761|NCT03235180|10092955|FG000|COMPLETED|Overall Study||9
9030762|NCT03235180|10092955|FG000|NOT COMPLETED|Overall Study||0
9030763|NCT03235284|10092962|FG000|STARTED|Overall Study||15
9030764|NCT03235284|10092963|FG001|STARTED|Overall Study||15
9030765|NCT03235284|10092964|FG002|STARTED|Overall Study||15
9030766|NCT03235284|10092962|FG000|COMPLETED|Overall Study||14
9030767|NCT03235284|10092963|FG001|COMPLETED|Overall Study||13
9030768|NCT03235284|10092964|FG002|COMPLETED|Overall Study||14
9030769|NCT03235284|10092962|FG000|NOT COMPLETED|Overall Study||1
9030770|NCT03235284|10092963|FG001|NOT COMPLETED|Overall Study||2
9030771|NCT03235284|10092964|FG002|NOT COMPLETED|Overall Study||1
9030772|NCT03235349|10092972|FG000|STARTED|Overall Study||160
9030773|NCT03235349|10092972|FG000|COMPLETED|Overall Study||158
9030774|NCT03235349|10092972|FG000|NOT COMPLETED|Overall Study||2
9030775|NCT03235414|10092976|FG000|STARTED|Overall Study||101
9030776|NCT03235414|10092976|FG000|COMPLETED|Overall Study||101
9030777|NCT03235414|10092976|FG000|NOT COMPLETED|Overall Study||0
9030778|NCT03235479|10092982|FG000|STARTED|Overall Study||582
9030779|NCT03235479|10092983|FG001|STARTED|Overall Study||580
9030780|NCT03235479|10092982|FG000|Treated|Overall Study||546
9030781|NCT03235479|10092983|FG001|Treated|Overall Study||549
9030782|NCT03235479|10092982|FG000|COMPLETED|Overall Study||541
9030783|NCT03235479|10092983|FG001|COMPLETED|Overall Study||540
9030784|NCT03235479|10092982|FG000|NOT COMPLETED|Overall Study||41
9030785|NCT03235479|10092983|FG001|NOT COMPLETED|Overall Study||40
9030786|NCT03235726|10092997|FG000|STARTED|Part 1 (Cohort A 60 mg - Day 1)||6
9030787|NCT03235726|10092998|FG001|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
9030788|NCT03235726|10092999|FG002|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
9030789|NCT03235726|10093000|FG003|STARTED|Part 1 (Cohort A 60 mg - Day 1)||2
9030790|NCT03235726|10093001|FG004|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
9030791|NCT03235726|10093002|FG005|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
9030792|NCT03235726|10093003|FG006|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
9030793|NCT03235726|10093004|FG007|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
9030794|NCT03235726|10093005|FG008|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
9030795|NCT03235726|10093006|FG009|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
9030796|NCT03235726|10092997|FG000|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||6
9030797|NCT03235726|10092998|FG001|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
9030798|NCT03235726|10092999|FG002|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
9030799|NCT03235726|10093000|FG003|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||2
9030800|NCT03235726|10093001|FG004|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
9030801|NCT03235726|10093002|FG005|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
9030802|NCT03235726|10093003|FG006|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
9030803|NCT03235726|10093004|FG007|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
9030804|NCT03235726|10093005|FG008|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
9030805|NCT03235726|10093006|FG009|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
8784094|NCT01348139|9835199|FG003|COMPLETED|Period 1||4
8784095|NCT01348139|9835200|FG004|COMPLETED|Period 1||5
9030806|NCT03235726|10092997|FG000|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
9030807|NCT03235726|10092998|FG001|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
9030808|NCT03235726|10092999|FG002|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
9030809|NCT03235726|10093000|FG003|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
9030810|NCT03235726|10093001|FG004|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
9030811|NCT03235726|10093002|FG005|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
9030812|NCT03235726|10093003|FG006|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
9030813|NCT03235726|10093004|FG007|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
9030814|NCT03235726|10093005|FG008|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
8784096|NCT01348139|9835201|FG005|COMPLETED|Period 1||4
8784097|NCT01348139|9835196|FG000|NOT COMPLETED|Period 1||1
8784098|NCT01348139|9835197|FG001|NOT COMPLETED|Period 1||0
8784099|NCT01348139|9835198|FG002|NOT COMPLETED|Period 1||0
8784100|NCT01348139|9835199|FG003|NOT COMPLETED|Period 1||0
8784101|NCT01348139|9835200|FG004|NOT COMPLETED|Period 1||0
8784102|NCT01348139|9835201|FG005|NOT COMPLETED|Period 1||0
8784103|NCT01348139|9835196|FG000|STARTED|Period 2||4
8784104|NCT01348139|9835197|FG001|STARTED|Period 2||4
8784105|NCT01348139|9835198|FG002|STARTED|Period 2||4
8784106|NCT01348139|9835199|FG003|STARTED|Period 2||4
8784107|NCT01348139|9835200|FG004|STARTED|Period 2||5
8784108|NCT01348139|9835201|FG005|STARTED|Period 2||4
8784109|NCT01348139|9835196|FG000|COMPLETED|Period 2||4
8784110|NCT01348139|9835197|FG001|COMPLETED|Period 2||4
8784111|NCT01348139|9835198|FG002|COMPLETED|Period 2||4
8784112|NCT01348139|9835199|FG003|COMPLETED|Period 2||4
8784113|NCT01348139|9835200|FG004|COMPLETED|Period 2||5
8784114|NCT01348139|9835201|FG005|COMPLETED|Period 2||4
8784115|NCT01348139|9835196|FG000|NOT COMPLETED|Period 2||0
8784116|NCT01348139|9835197|FG001|NOT COMPLETED|Period 2||0
8784117|NCT01348139|9835198|FG002|NOT COMPLETED|Period 2||0
8784118|NCT01348139|9835199|FG003|NOT COMPLETED|Period 2||0
8784119|NCT01348139|9835200|FG004|NOT COMPLETED|Period 2||0
8784120|NCT01348139|9835201|FG005|NOT COMPLETED|Period 2||0
8784121|NCT01348139|9835196|FG000|STARTED|Period 3||4
8784122|NCT01348139|9835197|FG001|STARTED|Period 3||4
9030815|NCT03235726|10093006|FG009|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
9030816|NCT03235726|10092997|FG000|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
9030817|NCT03235726|10092998|FG001|STARTED|Part 1 (Cohort A 120 mg - Day 3)||6
9030818|NCT03235726|10092999|FG002|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
8784123|NCT01348139|9835198|FG002|STARTED|Period 3||4
8784124|NCT01348139|9835199|FG003|STARTED|Period 3||4
8784125|NCT01348139|9835200|FG004|STARTED|Period 3||5
8784126|NCT01348139|9835201|FG005|STARTED|Period 3||4
8784127|NCT01348139|9835196|FG000|COMPLETED|Period 3||4
8784128|NCT01348139|9835197|FG001|COMPLETED|Period 3||4
8784129|NCT01348139|9835198|FG002|COMPLETED|Period 3||4
8784130|NCT01348139|9835199|FG003|COMPLETED|Period 3||4
8784131|NCT01348139|9835200|FG004|COMPLETED|Period 3||5
8784132|NCT01348139|9835201|FG005|COMPLETED|Period 3||4
8784133|NCT01348139|9835196|FG000|NOT COMPLETED|Period 3||0
8784134|NCT01348139|9835197|FG001|NOT COMPLETED|Period 3||0
8784135|NCT01348139|9835198|FG002|NOT COMPLETED|Period 3||0
8784136|NCT01348139|9835199|FG003|NOT COMPLETED|Period 3||0
8784137|NCT01348139|9835200|FG004|NOT COMPLETED|Period 3||0
8784138|NCT01348139|9835201|FG005|NOT COMPLETED|Period 3||0
8784139|NCT01348139|9835196|FG000|STARTED|Period 4||4
8784140|NCT01348139|9835197|FG001|STARTED|Period 4||4
8784141|NCT01348139|9835198|FG002|STARTED|Period 4||4
8784142|NCT01348139|9835199|FG003|STARTED|Period 4||4
8784143|NCT01348139|9835200|FG004|STARTED|Period 4||5
8784144|NCT01348139|9835201|FG005|STARTED|Period 4||4
8784145|NCT01348139|9835196|FG000|COMPLETED|Period 4||4
8784146|NCT01348139|9835197|FG001|COMPLETED|Period 4||4
8784147|NCT01348139|9835198|FG002|COMPLETED|Period 4||4
8784148|NCT01348139|9835199|FG003|COMPLETED|Period 4||4
8784149|NCT01348139|9835200|FG004|COMPLETED|Period 4||5
8784150|NCT01348139|9835201|FG005|COMPLETED|Period 4||4
8784151|NCT01348139|9835196|FG000|NOT COMPLETED|Period 4||0
8784152|NCT01348139|9835197|FG001|NOT COMPLETED|Period 4||0
8784153|NCT01348139|9835198|FG002|NOT COMPLETED|Period 4||0
8784154|NCT01348139|9835199|FG003|NOT COMPLETED|Period 4||0
8784155|NCT01348139|9835200|FG004|NOT COMPLETED|Period 4||0
8784156|NCT01348139|9835201|FG005|NOT COMPLETED|Period 4||0
8784157|NCT01348139|9835196|FG000|STARTED|Period 5||4
8784158|NCT01348139|9835197|FG001|STARTED|Period 5||4
8784159|NCT01348139|9835198|FG002|STARTED|Period 5||4
8784160|NCT01348139|9835199|FG003|STARTED|Period 5||4
8784161|NCT01348139|9835200|FG004|STARTED|Period 5||5
8784162|NCT01348139|9835201|FG005|STARTED|Period 5||4
8784163|NCT01348139|9835196|FG000|COMPLETED|Period 5||4
8784164|NCT01348139|9835197|FG001|COMPLETED|Period 5||4
8784165|NCT01348139|9835198|FG002|COMPLETED|Period 5||4
8784166|NCT01348139|9835199|FG003|COMPLETED|Period 5||4
8784167|NCT01348139|9835200|FG004|COMPLETED|Period 5||5
8784168|NCT01348139|9835201|FG005|COMPLETED|Period 5||4
8784169|NCT01348139|9835196|FG000|NOT COMPLETED|Period 5||0
8784170|NCT01348139|9835197|FG001|NOT COMPLETED|Period 5||0
8784171|NCT01348139|9835198|FG002|NOT COMPLETED|Period 5||0
8784172|NCT01348139|9835199|FG003|NOT COMPLETED|Period 5||0
8784173|NCT01348139|9835200|FG004|NOT COMPLETED|Period 5||0
8784174|NCT01348139|9835201|FG005|NOT COMPLETED|Period 5||0
8784175|NCT01348139|9835196|FG000|STARTED|Period 6||4
8784176|NCT01348139|9835197|FG001|STARTED|Period 6||4
8784177|NCT01348139|9835198|FG002|STARTED|Period 6||4
8784178|NCT01348139|9835199|FG003|STARTED|Period 6||4
8784179|NCT01348139|9835200|FG004|STARTED|Period 6||5
8784180|NCT01348139|9835201|FG005|STARTED|Period 6||4
8784181|NCT01348139|9835196|FG000|COMPLETED|Period 6||4
8784182|NCT01348139|9835197|FG001|COMPLETED|Period 6||4
9030819|NCT03235726|10093000|FG003|STARTED|Part 1 (Cohort A 120 mg - Day 3)||2
8784183|NCT01348139|9835198|FG002|COMPLETED|Period 6||4
8784184|NCT01348139|9835199|FG003|COMPLETED|Period 6||4
8784185|NCT01348139|9835200|FG004|COMPLETED|Period 6||5
8784186|NCT01348139|9835201|FG005|COMPLETED|Period 6||4
8784187|NCT01348139|9835196|FG000|NOT COMPLETED|Period 6||0
8784188|NCT01348139|9835197|FG001|NOT COMPLETED|Period 6||0
8784189|NCT01348139|9835198|FG002|NOT COMPLETED|Period 6||0
8784190|NCT01348139|9835199|FG003|NOT COMPLETED|Period 6||0
8784191|NCT01348139|9835200|FG004|NOT COMPLETED|Period 6||0
8784192|NCT01348139|9835201|FG005|NOT COMPLETED|Period 6||0
8784193|NCT01348165|9835222|FG000|STARTED|Overall Study||10
8784194|NCT01348165|9835223|FG001|STARTED|Overall Study||5
8784195|NCT01348165|9835224|FG002|STARTED|Overall Study||6
8784196|NCT01348165|9835225|FG003|STARTED|Overall Study||6
9030820|NCT03235726|10093001|FG004|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
9030821|NCT03235726|10093002|FG005|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
9030822|NCT03235726|10093003|FG006|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
9030823|NCT03235726|10093004|FG007|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
9030824|NCT03235726|10093005|FG008|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
9030825|NCT03235726|10093006|FG009|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
9030826|NCT03235726|10092997|FG000|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
9030827|NCT03235726|10092998|FG001|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||6
9030828|NCT03235726|10092999|FG002|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
9030829|NCT03235726|10093000|FG003|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||2
9030830|NCT03235726|10093001|FG004|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
9030831|NCT03235726|10093002|FG005|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
9030832|NCT03235726|10093003|FG006|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
9030833|NCT03235726|10093004|FG007|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
9030834|NCT03235726|10093005|FG008|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
9030835|NCT03235726|10093006|FG009|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
9030836|NCT03235726|10092997|FG000|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
9030837|NCT03235726|10092998|FG001|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
9030838|NCT03235726|10092999|FG002|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
9030839|NCT03235726|10093000|FG003|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
9030840|NCT03235726|10093001|FG004|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
9030841|NCT03235726|10093002|FG005|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
9030842|NCT03235726|10093003|FG006|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
9030843|NCT03235726|10093004|FG007|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
9030844|NCT03235726|10093005|FG008|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
9030845|NCT03235726|10093006|FG009|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
9030846|NCT03235726|10092997|FG000|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
9030847|NCT03235726|10092998|FG001|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
9030848|NCT03235726|10092999|FG002|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||6
9030849|NCT03235726|10093000|FG003|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||2
9030850|NCT03235726|10093001|FG004|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
9030851|NCT03235726|10093002|FG005|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
9030852|NCT03235726|10093003|FG006|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
9030853|NCT03235726|10093004|FG007|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
9030854|NCT03235726|10093005|FG008|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
9030855|NCT03235726|10093006|FG009|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
9030856|NCT03235726|10092997|FG000|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
9030857|NCT03235726|10092998|FG001|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
9030858|NCT03235726|10092999|FG002|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||6
9030859|NCT03235726|10093000|FG003|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||2
9030860|NCT03235726|10093001|FG004|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
9030861|NCT03235726|10093002|FG005|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8784197|NCT01348165|9835226|FG004|STARTED|Overall Study||6
8784198|NCT01348165|9835227|FG005|STARTED|Overall Study||1
8784199|NCT01348165|9835228|FG006|STARTED|Overall Study||6
8784200|NCT01348165|9835222|FG000|COMPLETED|Overall Study||10
8784201|NCT01348165|9835223|FG001|COMPLETED|Overall Study||5
8784202|NCT01348165|9835224|FG002|COMPLETED|Overall Study||6
8784203|NCT01348165|9835225|FG003|COMPLETED|Overall Study||6
8784204|NCT01348165|9835226|FG004|COMPLETED|Overall Study||6
8784205|NCT01348165|9835227|FG005|COMPLETED|Overall Study||1
8784206|NCT01348165|9835228|FG006|COMPLETED|Overall Study||5
8784207|NCT01348165|9835222|FG000|NOT COMPLETED|Overall Study||0
8784208|NCT01348165|9835223|FG001|NOT COMPLETED|Overall Study||0
8784209|NCT01348165|9835224|FG002|NOT COMPLETED|Overall Study||0
8784210|NCT01348165|9835225|FG003|NOT COMPLETED|Overall Study||0
8784211|NCT01348165|9835226|FG004|NOT COMPLETED|Overall Study||0
8784212|NCT01348165|9835227|FG005|NOT COMPLETED|Overall Study||0
8784213|NCT01348165|9835228|FG006|NOT COMPLETED|Overall Study||1
8784214|NCT01348347|9835251|FG000|STARTED|Overall Study||3
8784215|NCT01348347|9835252|FG001|STARTED|Overall Study||6
8784216|NCT01348347|9835253|FG002|STARTED|Overall Study||6
8784217|NCT01348347|9835251|FG000|COMPLETED|Overall Study||0
8784218|NCT01348347|9835252|FG001|COMPLETED|Overall Study||0
8784219|NCT01348347|9835253|FG002|COMPLETED|Overall Study||0
8784220|NCT01348347|9835251|FG000|NOT COMPLETED|Overall Study||3
8784221|NCT01348347|9835252|FG001|NOT COMPLETED|Overall Study||6
8784222|NCT01348347|9835253|FG002|NOT COMPLETED|Overall Study||6
8784223|NCT01348425|9835264|FG000|STARTED|Overall Study||31
8784224|NCT01348425|9835265|FG001|STARTED|Overall Study||14
8784225|NCT01348425|9835264|FG000|COMPLETED|Overall Study||30
8784226|NCT01348425|9835265|FG001|COMPLETED|Overall Study||13
8784227|NCT01348425|9835264|FG000|NOT COMPLETED|Overall Study||1
8784228|NCT01348425|9835265|FG001|NOT COMPLETED|Overall Study||1
8784229|NCT01348490|9835270|FG000|STARTED|Overall Study||66
8784230|NCT01348490|9835270|FG000|COMPLETED|Overall Study||42
8784231|NCT01348490|9835270|FG000|NOT COMPLETED|Overall Study||24
8784232|NCT01348542|9835293|FG000|STARTED|Overall Study||13
8784233|NCT01348542|9835294|FG001|STARTED|Overall Study||11
8784234|NCT01348542|9835293|FG000|COMPLETED|Overall Study||10
8784235|NCT01348542|9835294|FG001|COMPLETED|Overall Study||11
8784236|NCT01348542|9835293|FG000|NOT COMPLETED|Overall Study||3
8784237|NCT01348542|9835294|FG001|NOT COMPLETED|Overall Study||0
8916609|NCT02185404|9976229|FG000|STARTED|Overall Study||6
9030862|NCT03235726|10093003|FG006|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
9030863|NCT03235726|10093004|FG007|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
9030864|NCT03235726|10093005|FG008|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
9030865|NCT03235726|10093006|FG009|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
9030866|NCT03235726|10092997|FG000|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
9030867|NCT03235726|10092998|FG001|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
9030868|NCT03235726|10092999|FG002|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
9030869|NCT03235726|10093000|FG003|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
9030870|NCT03235726|10093001|FG004|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
9030871|NCT03235726|10093002|FG005|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
9030872|NCT03235726|10093003|FG006|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
9030873|NCT03235726|10093004|FG007|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
9030874|NCT03235726|10093005|FG008|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
9030875|NCT03235726|10093006|FG009|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
9030876|NCT03235726|10092997|FG000|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
9030877|NCT03235726|10092998|FG001|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
9030878|NCT03235726|10092999|FG002|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
9030879|NCT03235726|10093000|FG003|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
9030880|NCT03235726|10093001|FG004|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||12
9030881|NCT03235726|10093002|FG005|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||2
9030882|NCT03235726|10093003|FG006|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||14
9030883|NCT03235726|10093004|FG007|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
9030884|NCT03235726|10093005|FG008|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
9030885|NCT03235726|10093006|FG009|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
9030886|NCT03235726|10092997|FG000|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
9030887|NCT03235726|10092998|FG001|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
8916610|NCT02185404|9976229|FG000|COMPLETED|Overall Study||6
8916611|NCT02185404|9976229|FG000|NOT COMPLETED|Overall Study||0
8916612|NCT02185521|9976233|FG000|STARTED|Overall Study||127
8916613|NCT02185521|9976233|FG000|COMPLETED|Overall Study||125
8916614|NCT02185521|9976233|FG000|NOT COMPLETED|Overall Study||2
8916615|NCT02185534|9976244|FG000|STARTED|First Period||14
8916616|NCT02185534|9976245|FG001|STARTED|First Period||14
8916617|NCT02185534|9976246|FG002|STARTED|First Period||14
8916618|NCT02185534|9976247|FG003|STARTED|First Period||14
8916619|NCT02185534|9976248|FG004|STARTED|First Period||14
8916620|NCT02185534|9976249|FG005|STARTED|First Period||14
8916621|NCT02185534|9976244|FG000|COMPLETED|First Period||14
8916622|NCT02185534|9976245|FG001|COMPLETED|First Period||14
8784238|NCT01348607|9835303|FG000|STARTED|Overall Study||1
8784239|NCT01348607|9835304|FG001|STARTED|Overall Study||0
8784240|NCT01348607|9835305|FG002|STARTED|Overall Study||0
8784241|NCT01348607|9835303|FG000|COMPLETED|Overall Study||1
8784242|NCT01348607|9835304|FG001|COMPLETED|Overall Study||0
8784243|NCT01348607|9835305|FG002|COMPLETED|Overall Study||0
8784244|NCT01348607|9835303|FG000|NOT COMPLETED|Overall Study||0
8784245|NCT01348607|9835304|FG001|NOT COMPLETED|Overall Study||0
8784246|NCT01348607|9835305|FG002|NOT COMPLETED|Overall Study||0
8784247|NCT01348698|9835313|FG000|STARTED|Overall Study||74
8784248|NCT01348698|9835313|FG000|COMPLETED|Overall Study||2
8784249|NCT01348698|9835313|FG000|NOT COMPLETED|Overall Study||72
8784250|NCT01348763|9835317|FG000|STARTED|With Tenofovir/Emtricitabine (10 Days)||13
8784251|NCT01348763|9835317|FG000|COMPLETED|With Tenofovir/Emtricitabine (10 Days)||11
8784252|NCT01348763|9835317|FG000|NOT COMPLETED|With Tenofovir/Emtricitabine (10 Days)||2
8784253|NCT01348763|9835317|FG000|STARTED|Without Tenofovir/Emtricitabine (11 Day)||11
8784254|NCT01348763|9835317|FG000|COMPLETED|Without Tenofovir/Emtricitabine (11 Day)||11
8784255|NCT01348763|9835317|FG000|NOT COMPLETED|Without Tenofovir/Emtricitabine (11 Day)||0
8784256|NCT01348776|9835321|FG000|STARTED|Overall Study|3 subjects were lost to follow-up: 2 after the 1-month follow-up, 1 after performing 4 treatments|87
8784257|NCT01348776|9835321|FG000|COMPLETED|Overall Study||84
8784258|NCT01348776|9835321|FG000|NOT COMPLETED|Overall Study||3
8784259|NCT01348789|9835334|FG000|STARTED|Overall Study||37
8784260|NCT01348789|9835334|FG000|COMPLETED|Overall Study|4 subjects did not complete all 3 treatments but were evaluated for primary and secondary endpoints.|33
8784261|NCT01348789|9835334|FG000|NOT COMPLETED|Overall Study||4
8784262|NCT01348828|9835345|FG000|STARTED|Overall Study||49
8784263|NCT01348828|9835345|FG000|COMPLETED|Overall Study||16
8784264|NCT01348828|9835345|FG000|NOT COMPLETED|Overall Study||33
8784265|NCT01348854|9835351|FG000|STARTED|Overall Study|53 eyes of 34 participants|34
8784266|NCT01348854|9835352|FG001|STARTED|Overall Study|10 eyes of 6 participants|6
8784267|NCT01348854|9835351|FG000|COMPLETED|Overall Study|47 eyes of 31 participants|31
8784268|NCT01348854|9835352|FG001|COMPLETED|Overall Study|9 eyes of 5 participants|5
8784269|NCT01348854|9835351|FG000|NOT COMPLETED|Overall Study||3
8784270|NCT01348854|9835352|FG001|NOT COMPLETED|Overall Study||1
8784271|NCT01349036|9835360|FG000|STARTED|Overall Study||14
8784272|NCT01349036|9835361|FG001|STARTED|Overall Study||24
8784273|NCT01349036|9835360|FG000|COMPLETED|Overall Study||0
8784274|NCT01349036|9835361|FG001|COMPLETED|Overall Study||0
8784275|NCT01349036|9835360|FG000|NOT COMPLETED|Overall Study||14
8784276|NCT01349036|9835361|FG001|NOT COMPLETED|Overall Study||24
8784277|NCT01349049|9835380|FG000|STARTED|Overall Study||3
8784278|NCT01349049|9835381|FG001|STARTED|Overall Study||7
8784279|NCT01349049|9835382|FG002|STARTED|Overall Study||3
8784280|NCT01349049|9835383|FG003|STARTED|Overall Study||3
8784281|NCT01349049|9835384|FG004|STARTED|Overall Study||3
8784282|NCT01349049|9835385|FG005|STARTED|Overall Study||6
8784283|NCT01349049|9835386|FG006|STARTED|Overall Study||5
8784284|NCT01349049|9835387|FG007|STARTED|Overall Study||4
8784285|NCT01349049|9835388|FG008|STARTED|Overall Study||56
8784286|NCT01349049|9835380|FG000|COMPLETED|Overall Study||0
8784287|NCT01349049|9835381|FG001|COMPLETED|Overall Study||0
8784288|NCT01349049|9835382|FG002|COMPLETED|Overall Study||0
8784289|NCT01349049|9835383|FG003|COMPLETED|Overall Study||0
8784290|NCT01349049|9835384|FG004|COMPLETED|Overall Study||0
8784291|NCT01349049|9835385|FG005|COMPLETED|Overall Study||0
8784292|NCT01349049|9835386|FG006|COMPLETED|Overall Study||0
8784293|NCT01349049|9835387|FG007|COMPLETED|Overall Study||0
8784294|NCT01349049|9835388|FG008|COMPLETED|Overall Study||1
8784295|NCT01349049|9835380|FG000|NOT COMPLETED|Overall Study||3
8784296|NCT01349049|9835381|FG001|NOT COMPLETED|Overall Study||7
8784297|NCT01349049|9835382|FG002|NOT COMPLETED|Overall Study||3
8784298|NCT01349049|9835383|FG003|NOT COMPLETED|Overall Study||3
8784299|NCT01349049|9835384|FG004|NOT COMPLETED|Overall Study||3
8784300|NCT01349049|9835385|FG005|NOT COMPLETED|Overall Study||6
8784301|NCT01349049|9835386|FG006|NOT COMPLETED|Overall Study||5
8784302|NCT01349049|9835387|FG007|NOT COMPLETED|Overall Study||4
8784303|NCT01349049|9835388|FG008|NOT COMPLETED|Overall Study||55
8784304|NCT01349114|9835422|FG000|STARTED|Overall Study||10
8784305|NCT01349114|9835423|FG001|STARTED|Overall Study||11
8784306|NCT01349114|9835422|FG000|COMPLETED|Overall Study||10
8784307|NCT01349114|9835423|FG001|COMPLETED|Overall Study||11
8784308|NCT01349114|9835422|FG000|NOT COMPLETED|Overall Study||0
8784309|NCT01349114|9835423|FG001|NOT COMPLETED|Overall Study||0
8784310|NCT01349140|9835431|FG000|STARTED|Overall Study|"We enrolled 14 subjects, and therefore Protocol Enrollment is 14. However, each leg of each subject was treated separately with a different dose of liposomal bupivacaine (Exparel); and, therefore the number of units for each subject was 2 and the total number of units analyzed was 28."|14
8784311|NCT01349140|9835431|FG000|COMPLETED|Overall Study|"We enrolled 14 subjects, and therefore Protocol Enrollment is 14. However, each leg of each subject was treated separately with a different dose of liposomal bupivacaine (Exparel); and, therefore the number of units for each subject was 2 and the total number of units analyzed was 28."|14
8784312|NCT01349140|9835431|FG000|NOT COMPLETED|Overall Study||0
8784313|NCT01349192|9835437|FG000|STARTED|Overall Study||24
8784314|NCT01349192|9835438|FG001|STARTED|Overall Study||23
8784315|NCT01349192|9835437|FG000|Evaluable for Primary Endpoint|Overall Study||22
8784316|NCT01349192|9835438|FG001|Evaluable for Primary Endpoint|Overall Study||19
9030888|NCT03235726|10092999|FG002|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
8784317|NCT01349192|9835437|FG000|Withdrawals|Overall Study||3
8784318|NCT01349192|9835438|FG001|Withdrawals|Overall Study||6
8784319|NCT01349192|9835437|FG000|COMPLETED|Overall Study||21
8784320|NCT01349192|9835438|FG001|COMPLETED|Overall Study||17
8784321|NCT01349192|9835437|FG000|NOT COMPLETED|Overall Study||3
8784322|NCT01349192|9835438|FG001|NOT COMPLETED|Overall Study||6
8784323|NCT01349231|9835446|FG000|STARTED|Overall Study||10
8784324|NCT01349231|9835446|FG000|COMPLETED|Overall Study||10
8784325|NCT01349231|9835446|FG000|NOT COMPLETED|Overall Study||0
8784326|NCT01349465|9835452|FG000|STARTED|Overall Study||200
8784327|NCT01349465|9835453|FG001|STARTED|Overall Study||49
8784328|NCT01349465|9835452|FG000|COMPLETED|Overall Study||182
8784329|NCT01349465|9835453|FG001|COMPLETED|Overall Study||27
8784330|NCT01349465|9835452|FG000|NOT COMPLETED|Overall Study||18
8784331|NCT01349465|9835453|FG001|NOT COMPLETED|Overall Study||22
8784332|NCT01349491|9835463|FG000|STARTED|Overall Study||5
8784333|NCT01349491|9835464|FG001|STARTED|Overall Study||5
8784334|NCT01349491|9835463|FG000|COMPLETED|Overall Study||5
8784335|NCT01349491|9835464|FG001|COMPLETED|Overall Study||5
8784336|NCT01349491|9835463|FG000|NOT COMPLETED|Overall Study||0
8784337|NCT01349491|9835464|FG001|NOT COMPLETED|Overall Study||0
8784338|NCT01349569|9835470|FG000|STARTED|Overall Study||16
8784339|NCT01349569|9835470|FG000|COMPLETED|Overall Study||12
8784340|NCT01349569|9835470|FG000|NOT COMPLETED|Overall Study||4
8784341|NCT01349660|9835480|FG000|STARTED|Overall Study||6
8784342|NCT01349660|9835481|FG001|STARTED|Overall Study||6
8784343|NCT01349660|9835482|FG002|STARTED|Overall Study||76
8784344|NCT01349660|9835480|FG000|COMPLETED|Overall Study||0
8784345|NCT01349660|9835481|FG001|COMPLETED|Overall Study||0
8784346|NCT01349660|9835482|FG002|COMPLETED|Overall Study||0
8784347|NCT01349660|9835480|FG000|NOT COMPLETED|Overall Study||6
8784348|NCT01349660|9835481|FG001|NOT COMPLETED|Overall Study||6
8784349|NCT01349660|9835482|FG002|NOT COMPLETED|Overall Study||76
8784350|NCT01349673|9835497|FG000|STARTED|Overall Study||114
8784351|NCT01349673|9835497|FG000|Participants Entered Cycle 1|Overall Study||114
8784352|NCT01349673|9835497|FG000|Participants Entered Cycle 2|Overall Study||65
8784353|NCT01349673|9835497|FG000|Participants Entered Cycle 3|Overall Study||41
8784354|NCT01349673|9835497|FG000|Participants Entered Cycle 4|Overall Study||22
8784355|NCT01349673|9835497|FG000|Participants Entered Cycle 5|Overall Study||12
8784356|NCT01349673|9835497|FG000|Participants Entered Cycle 6|Overall Study||5
8784357|NCT01349673|9835497|FG000|Participants Entered Cycle 7|Overall Study||3
8784358|NCT01349673|9835497|FG000|Participants Entered Cycle 8|Overall Study||1
8784359|NCT01349673|9835497|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||114
8784360|NCT01349673|9835497|FG000|COMPLETED|Overall Study||0
8784361|NCT01349673|9835497|FG000|NOT COMPLETED|Overall Study||114
8784362|NCT01349790|9835501|FG000|STARTED|Overall Study||40
8784363|NCT01349790|9835501|FG000|COMPLETED|Overall Study||31
8784364|NCT01349790|9835501|FG000|NOT COMPLETED|Overall Study||9
8784365|NCT01349803|9835509|FG000|STARTED|Overall Study||60
8784366|NCT01349803|9835510|FG001|STARTED|Overall Study||58
8784367|NCT01349803|9835511|FG002|STARTED|Overall Study||60
8784368|NCT01349803|9835512|FG003|STARTED|Overall Study||59
8784369|NCT01349803|9835509|FG000|COMPLETED|Overall Study||59
8784370|NCT01349803|9835510|FG001|COMPLETED|Overall Study||57
8784371|NCT01349803|9835511|FG002|COMPLETED|Overall Study||57
8784372|NCT01349803|9835512|FG003|COMPLETED|Overall Study||57
8784373|NCT01349803|9835509|FG000|NOT COMPLETED|Overall Study||1
8784374|NCT01349803|9835510|FG001|NOT COMPLETED|Overall Study||1
8784375|NCT01349803|9835511|FG002|NOT COMPLETED|Overall Study||3
8784376|NCT01349803|9835512|FG003|NOT COMPLETED|Overall Study||2
8784377|NCT01349816|9835530|FG000|STARTED|Overall Study||185
8784378|NCT01349816|9835530|FG000|GP MDI 36 µg|Overall Study||61
8784379|NCT01349816|9835530|FG000|GFF MDI 36/7.2 µg|Overall Study||58
8784380|NCT01349816|9835530|FG000|GFF MDI 36/9.6 µg|Overall Study||56
8784381|NCT01349816|9835530|FG000|GFF MDI 18/9.6 µg|Overall Study||57
8784382|NCT01349816|9835530|FG000|GFF MDI 9/9.6 µg|Overall Study||57
8784383|NCT01349816|9835530|FG000|FF MDI 9.6 µg|Overall Study||61
8784384|NCT01349816|9835530|FG000|COMPLETED|Overall Study||155
8784385|NCT01349816|9835530|FG000|NOT COMPLETED|Overall Study||30
8784386|NCT01349829|9835546|FG000|STARTED|Overall Study||126
8784387|NCT01349829|9835547|FG001|STARTED|Overall Study||125
8784388|NCT01349829|9835546|FG000|COMPLETED|Overall Study||117
8784389|NCT01349829|9835547|FG001|COMPLETED|Overall Study||102
8784390|NCT01349829|9835546|FG000|NOT COMPLETED|Overall Study||9
8784391|NCT01349829|9835547|FG001|NOT COMPLETED|Overall Study||23
8784392|NCT01349920|9835555|FG000|STARTED|Overall Study||15
8784393|NCT01349920|9835555|FG000|COMPLETED|Overall Study||15
8784394|NCT01349920|9835555|FG000|NOT COMPLETED|Overall Study||0
8784395|NCT01349933|9835561|FG000|STARTED|Overall Study||21
8784396|NCT01349933|9835561|FG000|COMPLETED|Overall Study||21
8784397|NCT01349933|9835561|FG000|NOT COMPLETED|Overall Study||0
8784398|NCT01349972|9835567|FG000|STARTED|Overall Study||114
8784399|NCT01349972|9835568|FG001|STARTED|Overall Study||58
8784400|NCT01349972|9835567|FG000|COMPLETED|Overall Study||109
8784401|NCT01349972|9835568|FG001|COMPLETED|Overall Study||56
8784402|NCT01349972|9835567|FG000|NOT COMPLETED|Overall Study||5
8784403|NCT01349972|9835568|FG001|NOT COMPLETED|Overall Study||2
8784404|NCT01350102|9835578|FG000|STARTED|Overall Study||0
8784405|NCT01350102|9835579|FG001|STARTED|Overall Study||1
8784406|NCT01350102|9835580|FG002|STARTED|Overall Study||1
8784407|NCT01350102|9835581|FG003|STARTED|Overall Study||0
8784408|NCT01350102|9835578|FG000|COMPLETED|Overall Study||0
8784409|NCT01350102|9835579|FG001|COMPLETED|Overall Study||1
8784410|NCT01350102|9835580|FG002|COMPLETED|Overall Study||0
8784411|NCT01350102|9835581|FG003|COMPLETED|Overall Study||0
8784412|NCT01350102|9835578|FG000|NOT COMPLETED|Overall Study||0
8784413|NCT01350102|9835579|FG001|NOT COMPLETED|Overall Study||0
8784414|NCT01350102|9835580|FG002|NOT COMPLETED|Overall Study||1
8784415|NCT01350102|9835581|FG003|NOT COMPLETED|Overall Study||0
8784416|NCT01350115|9835593|FG000|STARTED|Core Study (All Patients)||8
8784417|NCT01350115|9835594|FG001|STARTED|Core Study (All Patients)||2
8784418|NCT01350115|9835593|FG000|Safety Anlysis Set|Core Study (All Patients)||8
8784419|NCT01350115|9835594|FG001|Safety Anlysis Set|Core Study (All Patients)||2
8784420|NCT01350115|9835593|FG000|Pharmacodynamic Set|Core Study (All Patients)||7
8784421|NCT01350115|9835594|FG001|Pharmacodynamic Set|Core Study (All Patients)||2
8784422|NCT01350115|9835593|FG000|COMPLETED|Core Study (All Patients)||8
8784423|NCT01350115|9835594|FG001|COMPLETED|Core Study (All Patients)||2
8784424|NCT01350115|9835593|FG000|NOT COMPLETED|Core Study (All Patients)||0
8784425|NCT01350115|9835594|FG001|NOT COMPLETED|Core Study (All Patients)||0
8784426|NCT01350115|9835593|FG000|STARTED|Long Term Follow-Up (All Patients)||8
8784427|NCT01350115|9835594|FG001|STARTED|Long Term Follow-Up (All Patients)||2
8784428|NCT01350115|9835593|FG000|COMPLETED|Long Term Follow-Up (All Patients)||7
8784429|NCT01350115|9835594|FG001|COMPLETED|Long Term Follow-Up (All Patients)||0
8784430|NCT01350115|9835593|FG000|NOT COMPLETED|Long Term Follow-Up (All Patients)||1
8784431|NCT01350115|9835594|FG001|NOT COMPLETED|Long Term Follow-Up (All Patients)||2
8784432|NCT01350128|9835602|FG000|STARTED|Overall Study||103
8784433|NCT01350128|9835602|FG000|GP MDI 36 µg BID|Overall Study|Glycopyrronium Metered Dose Inhaler|49
8784434|NCT01350128|9835602|FG000|GP MDI 18 µg BID|Overall Study||49
8784435|NCT01350128|9835602|FG000|GP MDI 9 µg BID|Overall Study||49
8784436|NCT01350128|9835602|FG000|GP MDI 4.6 µg BID|Overall Study||45
8784437|NCT01350128|9835602|FG000|Placebo MDI BID|Overall Study||48
8784438|NCT01350128|9835602|FG000|Atrovent HFA 34 µg BID|Overall Study||48
8784439|NCT01350128|9835602|FG000|COMPLETED|Overall Study||89
8784440|NCT01350128|9835602|FG000|NOT COMPLETED|Overall Study||14
8784441|NCT01350141|9835619|FG000|STARTED|Overall Study||15
8784442|NCT01350141|9835620|FG001|STARTED|Overall Study||15
8784443|NCT01350141|9835621|FG002|STARTED|Overall Study||16
8784444|NCT01350141|9835619|FG000|Treated|Overall Study||14
8784445|NCT01350141|9835620|FG001|Treated|Overall Study||15
8784446|NCT01350141|9835621|FG002|Treated|Overall Study||16
8784447|NCT01350141|9835619|FG000|COMPLETED|Overall Study||12
8784448|NCT01350141|9835620|FG001|COMPLETED|Overall Study||15
8784449|NCT01350141|9835621|FG002|COMPLETED|Overall Study||15
8784450|NCT01350141|9835619|FG000|NOT COMPLETED|Overall Study||3
8784451|NCT01350141|9835620|FG001|NOT COMPLETED|Overall Study||0
8784452|NCT01350141|9835621|FG002|NOT COMPLETED|Overall Study||1
8784453|NCT01350245|9835631|FG000|STARTED|Overall Study||28
8784454|NCT01350245|9835631|FG000|COMPLETED|Overall Study||28
8784455|NCT01350245|9835631|FG000|NOT COMPLETED|Overall Study||0
8784456|NCT01350271|9835638|FG000|STARTED|Overall Study||70
8784457|NCT01350271|9835639|FG001|STARTED|Overall Study||70
8784458|NCT01350271|9835640|FG002|STARTED|Overall Study||74
8784459|NCT01350271|9835638|FG000|COMPLETED|Overall Study||49
8784460|NCT01350271|9835639|FG001|COMPLETED|Overall Study||53
8784461|NCT01350271|9835640|FG002|COMPLETED|Overall Study||48
8784462|NCT01350271|9835638|FG000|NOT COMPLETED|Overall Study||21
8784463|NCT01350271|9835639|FG001|NOT COMPLETED|Overall Study||17
8784464|NCT01350271|9835640|FG002|NOT COMPLETED|Overall Study||26
8784465|NCT01350336|9835651|FG000|STARTED|Overall Study||284
8784466|NCT01350336|9835651|FG000|COMPLETED|Overall Study||227
8784467|NCT01350336|9835651|FG000|NOT COMPLETED|Overall Study||57
8784468|NCT01350388|9835702|FG000|STARTED|Overall Study||40
8784469|NCT01350388|9835703|FG001|STARTED|Overall Study||40
8784470|NCT01350388|9835702|FG000|COMPLETED|Overall Study||37
8784471|NCT01350388|9835703|FG001|COMPLETED|Overall Study||39
8784472|NCT01350388|9835702|FG000|NOT COMPLETED|Overall Study||3
8784473|NCT01350388|9835703|FG001|NOT COMPLETED|Overall Study||1
8784474|NCT01350401|9835709|FG000|STARTED|Overall Study||4
8784475|NCT01350401|9835709|FG000|COMPLETED|Overall Study||4
8784476|NCT01350401|9835709|FG000|NOT COMPLETED|Overall Study||0
8784477|NCT01350414|9835717|FG000|STARTED|Overall Study||181
8784478|NCT01350414|9835717|FG000|Year 2|Overall Study||165
8784479|NCT01350414|9835717|FG000|Year 3|Overall Study||162
8784480|NCT01350414|9835717|FG000|Year 4|Overall Study||159
8784481|NCT01350414|9835717|FG000|Year 5|Overall Study||162
8784482|NCT01350414|9835717|FG000|COMPLETED|Overall Study||162
8784483|NCT01350414|9835717|FG000|NOT COMPLETED|Overall Study||19
8784484|NCT01350453|9835729|FG000|STARTED|Overall Study||11
8784485|NCT01350453|9835730|FG001|STARTED|Overall Study||8
8784486|NCT01350453|9835729|FG000|COMPLETED|Overall Study||9
8784487|NCT01350453|9835730|FG001|COMPLETED|Overall Study||7
8784488|NCT01350453|9835729|FG000|NOT COMPLETED|Overall Study||2
8784489|NCT01350453|9835730|FG001|NOT COMPLETED|Overall Study||1
8784490|NCT01350479|9835740|FG000|STARTED|Overall Study||94
8784491|NCT01350479|9835741|FG001|STARTED|Overall Study||106
8784492|NCT01350479|9835740|FG000|COMPLETED|Overall Study||94
8784493|NCT01350479|9835741|FG001|COMPLETED|Overall Study||106
8784494|NCT01350479|9835740|FG000|NOT COMPLETED|Overall Study||0
8784495|NCT01350479|9835741|FG001|NOT COMPLETED|Overall Study||0
8784496|NCT01350492|9835749|FG000|STARTED|Intervention||28
8784497|NCT01350492|9835750|FG001|STARTED|Intervention||26
9030889|NCT03235726|10093000|FG003|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
9030890|NCT03235726|10093001|FG004|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||10
9030891|NCT03235726|10093002|FG005|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||2
9030892|NCT03235726|10093003|FG006|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||14
9030893|NCT03235726|10093004|FG007|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
9030894|NCT03235726|10093005|FG008|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
9030895|NCT03235726|10093006|FG009|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
9030896|NCT03235726|10092997|FG000|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
9030897|NCT03235726|10092998|FG001|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
9030898|NCT03235726|10092999|FG002|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
9030899|NCT03235726|10093000|FG003|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
9030900|NCT03235726|10093001|FG004|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||2
9030901|NCT03235726|10093002|FG005|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
9030902|NCT03235726|10093003|FG006|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
9030903|NCT03235726|10093004|FG007|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
9030904|NCT03235726|10093005|FG008|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
9030905|NCT03235726|10093006|FG009|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
9030906|NCT03235726|10092997|FG000|STARTED|Part 2 (Cohort A - Day 1)||0
9030907|NCT03235726|10092998|FG001|STARTED|Part 2 (Cohort A - Day 1)||0
9030908|NCT03235726|10092999|FG002|STARTED|Part 2 (Cohort A - Day 1)||0
9030909|NCT03235726|10093000|FG003|STARTED|Part 2 (Cohort A - Day 1)||0
8671811|NCT00753922|9715235|FG002|STARTED|Overall Study||145
8671812|NCT00753922|9715236|FG003|STARTED|Overall Study||60
8671813|NCT00753922|9715233|FG000|COMPLETED|Overall Study||306
8671814|NCT00753922|9715234|FG001|COMPLETED|Overall Study||157
8671815|NCT00753922|9715235|FG002|COMPLETED|Overall Study||82
8671816|NCT00753922|9715236|FG003|COMPLETED|Overall Study||37
8671817|NCT00753922|9715233|FG000|NOT COMPLETED|Overall Study||246
8671818|NCT00753922|9715234|FG001|NOT COMPLETED|Overall Study||94
8671819|NCT00753922|9715235|FG002|NOT COMPLETED|Overall Study||63
8671820|NCT00753922|9715236|FG003|NOT COMPLETED|Overall Study||23
8671821|NCT00753935|9715248|FG000|STARTED|Overall Study||45
8671822|NCT00753935|9715249|FG001|STARTED|Overall Study||47
8671823|NCT00753935|9715248|FG000|COMPLETED|Overall Study||45
8671824|NCT00753935|9715249|FG001|COMPLETED|Overall Study||47
8671825|NCT00753935|9715248|FG000|NOT COMPLETED|Overall Study||0
8671826|NCT00753935|9715249|FG001|NOT COMPLETED|Overall Study||0
8671827|NCT00753948|9715258|FG000|STARTED|Overall Study||9
8671828|NCT00753948|9715259|FG001|STARTED|Overall Study||7
8671829|NCT00753948|9715260|FG002|STARTED|Overall Study||7
8671830|NCT00753948|9715258|FG000|COMPLETED|Overall Study||9
8671831|NCT00753948|9715259|FG001|COMPLETED|Overall Study||7
8671832|NCT00753948|9715260|FG002|COMPLETED|Overall Study||7
8671833|NCT00753948|9715258|FG000|NOT COMPLETED|Overall Study||0
8671834|NCT00753948|9715259|FG001|NOT COMPLETED|Overall Study||0
8671835|NCT00753948|9715260|FG002|NOT COMPLETED|Overall Study||0
8671836|NCT00754065|9715270|FG000|STARTED|Overall Study||203
8671837|NCT00754065|9715271|FG001|STARTED|Overall Study||206
8671838|NCT00754065|9715270|FG000|Participants Received Treatment|Overall Study||191
8671839|NCT00754065|9715271|FG001|Participants Received Treatment|Overall Study||204
8671840|NCT00754065|9715270|FG000|Cycle 6|Overall Study||141
8671841|NCT00754065|9715271|FG001|Cycle 6|Overall Study||153
8671842|NCT00754065|9715270|FG000|COMPLETED|Overall Study||122
8671843|NCT00754065|9715271|FG001|COMPLETED|Overall Study||126
8671844|NCT00754065|9715270|FG000|NOT COMPLETED|Overall Study||81
8671845|NCT00754065|9715271|FG001|NOT COMPLETED|Overall Study||80
8671846|NCT00754130|9715283|FG000|STARTED|Period 1 (5 Days)||2
8671847|NCT00754130|9715284|FG001|STARTED|Period 1 (5 Days)||2
8671848|NCT00754130|9715285|FG002|STARTED|Period 1 (5 Days)||4
8671849|NCT00754130|9715286|FG003|STARTED|Period 1 (5 Days)||2
8671850|NCT00754130|9715287|FG004|STARTED|Period 1 (5 Days)||2
8671851|NCT00754130|9715288|FG005|STARTED|Period 1 (5 Days)|One participant received MK-0941 10 mg in both Periods 1 and 2.|4
8671852|NCT00754130|9715283|FG000|COMPLETED|Period 1 (5 Days)||2
8671853|NCT00754130|9715284|FG001|COMPLETED|Period 1 (5 Days)||2
8671854|NCT00754130|9715285|FG002|COMPLETED|Period 1 (5 Days)||4
8671855|NCT00754130|9715286|FG003|COMPLETED|Period 1 (5 Days)||2
8671856|NCT00754130|9715287|FG004|COMPLETED|Period 1 (5 Days)||2
8671857|NCT00754130|9715288|FG005|COMPLETED|Period 1 (5 Days)||4
8671858|NCT00754130|9715283|FG000|NOT COMPLETED|Period 1 (5 Days)||0
8671859|NCT00754130|9715284|FG001|NOT COMPLETED|Period 1 (5 Days)||0
8671860|NCT00754130|9715285|FG002|NOT COMPLETED|Period 1 (5 Days)||0
8671861|NCT00754130|9715286|FG003|NOT COMPLETED|Period 1 (5 Days)||0
8671862|NCT00754130|9715287|FG004|NOT COMPLETED|Period 1 (5 Days)||0
8671863|NCT00754130|9715288|FG005|NOT COMPLETED|Period 1 (5 Days)||0
8671864|NCT00754130|9715283|FG000|STARTED|Washout Period (>=8 Days)||2
8671865|NCT00754130|9715284|FG001|STARTED|Washout Period (>=8 Days)||2
8671866|NCT00754130|9715285|FG002|STARTED|Washout Period (>=8 Days)||4
8671867|NCT00754130|9715286|FG003|STARTED|Washout Period (>=8 Days)||2
8671868|NCT00754130|9715287|FG004|STARTED|Washout Period (>=8 Days)||2
8671869|NCT00754130|9715288|FG005|STARTED|Washout Period (>=8 Days)||4
8671870|NCT00754130|9715283|FG000|COMPLETED|Washout Period (>=8 Days)||2
8671871|NCT00754130|9715284|FG001|COMPLETED|Washout Period (>=8 Days)||2
8671872|NCT00754130|9715285|FG002|COMPLETED|Washout Period (>=8 Days)||4
8784498|NCT01350492|9835749|FG000|6-week MRI Scan|Intervention||24
8784499|NCT01350492|9835750|FG001|6-week MRI Scan|Intervention||22
8784500|NCT01350492|9835749|FG000|11-week MRI Scan|Intervention||23
8784501|NCT01350492|9835750|FG001|11-week MRI Scan|Intervention||21
8784502|NCT01350492|9835749|FG000|COMPLETED|Intervention||23
8784503|NCT01350492|9835750|FG001|COMPLETED|Intervention||20
8784504|NCT01350492|9835749|FG000|NOT COMPLETED|Intervention||5
8784505|NCT01350492|9835750|FG001|NOT COMPLETED|Intervention||6
8784506|NCT01350492|9835749|FG000|STARTED|Post Intervention Follow-Up||23
8784507|NCT01350492|9835750|FG001|STARTED|Post Intervention Follow-Up||20
8784508|NCT01350492|9835749|FG000|6-month MRI Scan|Post Intervention Follow-Up||20
8784509|NCT01350492|9835750|FG001|6-month MRI Scan|Post Intervention Follow-Up||20
8784510|NCT01350492|9835749|FG000|COMPLETED|Post Intervention Follow-Up||17
8784511|NCT01350492|9835750|FG001|COMPLETED|Post Intervention Follow-Up||18
8784512|NCT01350492|9835749|FG000|NOT COMPLETED|Post Intervention Follow-Up||6
8784513|NCT01350492|9835750|FG001|NOT COMPLETED|Post Intervention Follow-Up||2
8784514|NCT01350505|9835756|FG000|STARTED|Overall Study||21
8784515|NCT01350505|9835756|FG000|COMPLETED|Overall Study||17
8784516|NCT01350505|9835756|FG000|NOT COMPLETED|Overall Study||4
8784517|NCT01350544|9835762|FG000|STARTED|Overall Study||108
8784518|NCT01350544|9835763|FG001|STARTED|Overall Study||108
8784519|NCT01350544|9835762|FG000|COMPLETED|Overall Study||85
8784520|NCT01350544|9835763|FG001|COMPLETED|Overall Study||86
8784521|NCT01350544|9835762|FG000|NOT COMPLETED|Overall Study||23
8784522|NCT01350544|9835763|FG001|NOT COMPLETED|Overall Study||22
8784523|NCT01350804|9835773|FG000|STARTED|Core Study||138
8784524|NCT01350804|9835774|FG001|STARTED|Core Study||137
8784525|NCT01350804|9835775|FG002|STARTED|Core Study||138
8784526|NCT01350804|9835776|FG003|STARTED|Core Study||138
8784527|NCT01350804|9835773|FG000|Safety Set|Core Study|1 participant actually received placebo; participant was reassigned to placebo for safety analysis.|137
8784528|NCT01350804|9835774|FG001|Safety Set|Core Study|1 participant did not receive treatment; therefore participant was not counted in safety analysis.|136
8784529|NCT01350804|9835775|FG002|Safety Set|Core Study|1 participant actually received placebo; participant was reassigned to placebo for safety analysis.|139
8784530|NCT01350804|9835776|FG003|Safety Set|Core Study|1 participant did not receive treatment; therefore participant was not counted in safety analysis.|137
8784531|NCT01350804|9835773|FG000|Tratment Switch to AIN457 at Week 16|Core Study||0
8784532|NCT01350804|9835774|FG001|Tratment Switch to AIN457 at Week 16|Core Study||0
8784533|NCT01350804|9835775|FG002|Tratment Switch to AIN457 at Week 16|Core Study|15 participantsdiscontinued prior to the treatment switch|78
8916623|NCT02185534|9976246|FG002|COMPLETED|First Period||14
8916624|NCT02185534|9976247|FG003|COMPLETED|First Period||13
8916625|NCT02185534|9976248|FG004|COMPLETED|First Period||14
8916626|NCT02185534|9976249|FG005|COMPLETED|First Period||14
8916627|NCT02185534|9976244|FG000|NOT COMPLETED|First Period||0
8916628|NCT02185534|9976245|FG001|NOT COMPLETED|First Period||0
8916629|NCT02185534|9976246|FG002|NOT COMPLETED|First Period||0
8916630|NCT02185534|9976247|FG003|NOT COMPLETED|First Period||1
8916631|NCT02185534|9976248|FG004|NOT COMPLETED|First Period||0
8916632|NCT02185534|9976249|FG005|NOT COMPLETED|First Period||0
8916633|NCT02185534|9976244|FG000|STARTED|First Washout Period||14
8916634|NCT02185534|9976245|FG001|STARTED|First Washout Period||14
8916635|NCT02185534|9976246|FG002|STARTED|First Washout Period||14
8916636|NCT02185534|9976247|FG003|STARTED|First Washout Period||13
8916637|NCT02185534|9976248|FG004|STARTED|First Washout Period||14
8916638|NCT02185534|9976249|FG005|STARTED|First Washout Period||14
8916639|NCT02185534|9976244|FG000|COMPLETED|First Washout Period||13
8916640|NCT02185534|9976245|FG001|COMPLETED|First Washout Period||14
8916641|NCT02185534|9976246|FG002|COMPLETED|First Washout Period||14
8916642|NCT02185534|9976247|FG003|COMPLETED|First Washout Period||13
8916643|NCT02185534|9976248|FG004|COMPLETED|First Washout Period||13
8916644|NCT02185534|9976249|FG005|COMPLETED|First Washout Period||13
8916645|NCT02185534|9976244|FG000|NOT COMPLETED|First Washout Period||1
8916646|NCT02185534|9976245|FG001|NOT COMPLETED|First Washout Period||0
8916647|NCT02185534|9976246|FG002|NOT COMPLETED|First Washout Period||0
8916648|NCT02185534|9976247|FG003|NOT COMPLETED|First Washout Period||0
8916649|NCT02185534|9976248|FG004|NOT COMPLETED|First Washout Period||1
8916650|NCT02185534|9976249|FG005|NOT COMPLETED|First Washout Period||1
8916651|NCT02185534|9976244|FG000|STARTED|Second Period||13
8916652|NCT02185534|9976245|FG001|STARTED|Second Period||14
8916653|NCT02185534|9976246|FG002|STARTED|Second Period||14
8916654|NCT02185534|9976247|FG003|STARTED|Second Period||13
8916655|NCT02185534|9976248|FG004|STARTED|Second Period||13
8916656|NCT02185534|9976249|FG005|STARTED|Second Period||13
8916657|NCT02185534|9976244|FG000|COMPLETED|Second Period||13
8916658|NCT02185534|9976245|FG001|COMPLETED|Second Period||14
8916659|NCT02185534|9976246|FG002|COMPLETED|Second Period||14
8916660|NCT02185534|9976247|FG003|COMPLETED|Second Period||13
8916661|NCT02185534|9976248|FG004|COMPLETED|Second Period||13
8916662|NCT02185534|9976249|FG005|COMPLETED|Second Period||13
8916663|NCT02185534|9976244|FG000|NOT COMPLETED|Second Period||0
8916664|NCT02185534|9976245|FG001|NOT COMPLETED|Second Period||0
8916665|NCT02185534|9976246|FG002|NOT COMPLETED|Second Period||0
8916666|NCT02185534|9976247|FG003|NOT COMPLETED|Second Period||0
8916667|NCT02185534|9976248|FG004|NOT COMPLETED|Second Period||0
8916668|NCT02185534|9976249|FG005|NOT COMPLETED|Second Period||0
8916669|NCT02185534|9976244|FG000|STARTED|Second Washout Period||13
8916670|NCT02185534|9976245|FG001|STARTED|Second Washout Period||14
8784534|NCT01350804|9835776|FG003|Tratment Switch to AIN457 at Week 16|Core Study||0
8784535|NCT01350804|9835773|FG000|Treatment Switch to AIN457 at Week 24|Core Study||0
8784536|NCT01350804|9835774|FG001|Treatment Switch to AIN457 at Week 24|Core Study||0
8784537|NCT01350804|9835775|FG002|Treatment Switch to AIN457 at Week 24|Core Study||45
8784538|NCT01350804|9835776|FG003|Treatment Switch to AIN457 at Week 24|Core Study||37
8784539|NCT01350804|9835773|FG000|Full Analysis Set|Core Study||138
8784540|NCT01350804|9835774|FG001|Full Analysis Set|Core Study||137
8784541|NCT01350804|9835775|FG002|Full Analysis Set|Core Study||138
8784542|NCT01350804|9835776|FG003|Full Analysis Set|Core Study||138
8784543|NCT01350804|9835773|FG000|COMPLETED|Core Study||97
8784544|NCT01350804|9835774|FG001|COMPLETED|Core Study||90
8784545|NCT01350804|9835775|FG002|COMPLETED|Core Study||91
8784546|NCT01350804|9835776|FG003|COMPLETED|Core Study||112
8784547|NCT01350804|9835773|FG000|NOT COMPLETED|Core Study||41
8784548|NCT01350804|9835774|FG001|NOT COMPLETED|Core Study||47
8784549|NCT01350804|9835775|FG002|NOT COMPLETED|Core Study||47
8784550|NCT01350804|9835776|FG003|NOT COMPLETED|Core Study||26
8784551|NCT01350804|9835773|FG000|STARTED|Extension Study, Weeks 52 - 260||80
8784552|NCT01350804|9835774|FG001|STARTED|Extension Study, Weeks 52 - 260||79
8784553|NCT01350804|9835775|FG002|STARTED|Extension Study, Weeks 52 - 260|During the extension, these participants received AIN457.|72
8784554|NCT01350804|9835776|FG003|STARTED|Extension Study, Weeks 52 - 260|During the extension, these participants received AIN457.|23
8784555|NCT01350804|9835773|FG000|COMPLETED|Extension Study, Weeks 52 - 260||0
8784556|NCT01350804|9835774|FG001|COMPLETED|Extension Study, Weeks 52 - 260||0
8784557|NCT01350804|9835775|FG002|COMPLETED|Extension Study, Weeks 52 - 260||0
8784558|NCT01350804|9835776|FG003|COMPLETED|Extension Study, Weeks 52 - 260||0
8784559|NCT01350804|9835773|FG000|NOT COMPLETED|Extension Study, Weeks 52 - 260||80
8784560|NCT01350804|9835774|FG001|NOT COMPLETED|Extension Study, Weeks 52 - 260||79
8784561|NCT01350804|9835775|FG002|NOT COMPLETED|Extension Study, Weeks 52 - 260||72
8784562|NCT01350804|9835776|FG003|NOT COMPLETED|Extension Study, Weeks 52 - 260||23
8784563|NCT01350947|9835796|FG000|STARTED|Overall Study||11
8784564|NCT01350947|9835796|FG000|COMPLETED|Overall Study||11
8784565|NCT01350947|9835796|FG000|NOT COMPLETED|Overall Study||0
8784566|NCT01350973|9835803|FG000|STARTED|Overall Study||206
8784567|NCT01350973|9835804|FG001|STARTED|Overall Study||210
8784568|NCT01350973|9835805|FG002|STARTED|Overall Study||195
8784569|NCT01350973|9835803|FG000|Received Treatment|Overall Study||205
8784570|NCT01350973|9835804|FG001|Received Treatment|Overall Study||210
8784571|NCT01350973|9835805|FG002|Received Treatment|Overall Study||195
8784572|NCT01350973|9835803|FG000|COMPLETED|Overall Study||200
8784573|NCT01350973|9835804|FG001|COMPLETED|Overall Study||202
8784574|NCT01350973|9835805|FG002|COMPLETED|Overall Study||187
8784575|NCT01350973|9835803|FG000|NOT COMPLETED|Overall Study||6
8784576|NCT01350973|9835804|FG001|NOT COMPLETED|Overall Study||8
8784577|NCT01350973|9835805|FG002|NOT COMPLETED|Overall Study||8
8784578|NCT01350999|9835816|FG000|STARTED|Overall Study||165
8784579|NCT01350999|9835817|FG001|STARTED|Overall Study||171
8784580|NCT01350999|9835818|FG002|STARTED|Overall Study||167
8784581|NCT01350999|9835816|FG000|Treated|Overall Study||165
8784582|NCT01350999|9835817|FG001|Treated|Overall Study||171
8784583|NCT01350999|9835818|FG002|Treated|Overall Study||167
8784584|NCT01350999|9835816|FG000|COMPLETED|Overall Study||157
8784585|NCT01350999|9835817|FG001|COMPLETED|Overall Study||157
8784586|NCT01350999|9835818|FG002|COMPLETED|Overall Study||146
8784587|NCT01350999|9835816|FG000|NOT COMPLETED|Overall Study||8
8784588|NCT01350999|9835817|FG001|NOT COMPLETED|Overall Study||14
8784589|NCT01350999|9835818|FG002|NOT COMPLETED|Overall Study||21
8784590|NCT01351025|9835828|FG000|STARTED|Week 0 - 20||46
8784591|NCT01351025|9835829|FG001|STARTED|Week 0 - 20||48
8784592|NCT01351025|9835828|FG000|COMPLETED|Week 0 - 20||43
8784593|NCT01351025|9835829|FG001|COMPLETED|Week 0 - 20||47
8784594|NCT01351025|9835828|FG000|NOT COMPLETED|Week 0 - 20||3
8784595|NCT01351025|9835829|FG001|NOT COMPLETED|Week 0 - 20||1
8784596|NCT01351025|9835828|FG000|STARTED|Week 20 - 24||43
8784597|NCT01351025|9835829|FG001|STARTED|Week 20 - 24||47
8784598|NCT01351025|9835828|FG000|COMPLETED|Week 20 - 24||43
8784599|NCT01351025|9835829|FG001|COMPLETED|Week 20 - 24||47
8784600|NCT01351025|9835828|FG000|NOT COMPLETED|Week 20 - 24||0
8784601|NCT01351025|9835829|FG001|NOT COMPLETED|Week 20 - 24||0
8784602|NCT01351025|9835828|FG000|STARTED|Week 24 - 44||43
8784603|NCT01351025|9835829|FG001|STARTED|Week 24 - 44||47
8784604|NCT01351025|9835828|FG000|COMPLETED|Week 24 - 44||42
8784605|NCT01351025|9835829|FG001|COMPLETED|Week 24 - 44||43
8784606|NCT01351025|9835828|FG000|NOT COMPLETED|Week 24 - 44||1
8784607|NCT01351025|9835829|FG001|NOT COMPLETED|Week 24 - 44||4
8784608|NCT01351025|9835828|FG000|STARTED|Week 44 - 48||42
8784609|NCT01351025|9835829|FG001|STARTED|Week 44 - 48||43
8784610|NCT01351025|9835828|FG000|COMPLETED|Week 44 - 48||42
8784611|NCT01351025|9835829|FG001|COMPLETED|Week 44 - 48||43
8784612|NCT01351025|9835828|FG000|NOT COMPLETED|Week 44 - 48||0
8784613|NCT01351025|9835829|FG001|NOT COMPLETED|Week 44 - 48||0
8784614|NCT01351064|9835843|FG000|STARTED|Overall Study||42
8784615|NCT01351064|9835844|FG001|STARTED|Overall Study||42
8784616|NCT01351064|9835843|FG000|COMPLETED|Overall Study||42
8784617|NCT01351064|9835844|FG001|COMPLETED|Overall Study||42
8784618|NCT01351064|9835843|FG000|NOT COMPLETED|Overall Study||0
8784619|NCT01351064|9835844|FG001|NOT COMPLETED|Overall Study||0
8784620|NCT01351077|9835852|FG000|STARTED|Overall Study||180
8784621|NCT01351077|9835853|FG001|STARTED|Overall Study||180
8784622|NCT01351077|9835852|FG000|COMPLETED|Overall Study||180
8784623|NCT01351077|9835853|FG001|COMPLETED|Overall Study||180
8784624|NCT01351077|9835852|FG000|NOT COMPLETED|Overall Study||0
8784625|NCT01351077|9835853|FG001|NOT COMPLETED|Overall Study||0
8784626|NCT01351090|9835862|FG000|STARTED|Overall Study||43
8784627|NCT01351090|9835863|FG001|STARTED|Overall Study||42
8784628|NCT01351090|9835864|FG002|STARTED|Overall Study||42
8784629|NCT01351090|9835862|FG000|COMPLETED|Overall Study||32
8784630|NCT01351090|9835863|FG001|COMPLETED|Overall Study||31
8784631|NCT01351090|9835864|FG002|COMPLETED|Overall Study||36
8784632|NCT01351090|9835862|FG000|NOT COMPLETED|Overall Study||11
8784633|NCT01351090|9835863|FG001|NOT COMPLETED|Overall Study||11
8784634|NCT01351090|9835864|FG002|NOT COMPLETED|Overall Study||6
8784635|NCT01351337|9835872|FG000|STARTED|Overall Study||58
8784636|NCT01351337|9835872|FG000|COMPLETED|Overall Study||58
8784637|NCT01351337|9835872|FG000|NOT COMPLETED|Overall Study||0
8784638|NCT01351350|9835882|FG000|STARTED|Overall Study||8
8784639|NCT01351350|9835883|FG001|STARTED|Overall Study||29
8784640|NCT01351350|9835884|FG002|STARTED|Overall Study||11
8784641|NCT01351350|9835885|FG003|STARTED|Overall Study||13
8784642|NCT01351350|9835886|FG004|STARTED|Overall Study||7
8784643|NCT01351350|9835882|FG000|Treated|Overall Study||8
8784644|NCT01351350|9835883|FG001|Treated|Overall Study||29
8784645|NCT01351350|9835884|FG002|Treated|Overall Study||10
8784646|NCT01351350|9835885|FG003|Treated|Overall Study||13
8784647|NCT01351350|9835886|FG004|Treated|Overall Study||7
8784648|NCT01351350|9835882|FG000|Dose-escalation Evaluable|Overall Study||7
8784649|NCT01351350|9835883|FG001|Dose-escalation Evaluable|Overall Study||23
8784650|NCT01351350|9835884|FG002|Dose-escalation Evaluable|Overall Study||10
8784651|NCT01351350|9835885|FG003|Dose-escalation Evaluable|Overall Study||0
8784652|NCT01351350|9835886|FG004|Dose-escalation Evaluable|Overall Study||0
8784653|NCT01351350|9835882|FG000|COMPLETED|Overall Study||0
8784654|NCT01351350|9835883|FG001|COMPLETED|Overall Study||0
8784655|NCT01351350|9835884|FG002|COMPLETED|Overall Study||0
8784656|NCT01351350|9835885|FG003|COMPLETED|Overall Study||0
8784657|NCT01351350|9835886|FG004|COMPLETED|Overall Study||0
8784658|NCT01351350|9835882|FG000|NOT COMPLETED|Overall Study||8
8784659|NCT01351350|9835883|FG001|NOT COMPLETED|Overall Study||29
8784660|NCT01351350|9835884|FG002|NOT COMPLETED|Overall Study||11
8784661|NCT01351350|9835885|FG003|NOT COMPLETED|Overall Study||13
8784662|NCT01351350|9835886|FG004|NOT COMPLETED|Overall Study||7
8784663|NCT01351376|9835913|FG000|STARTED|Overall Study||10
8784664|NCT01351376|9835914|FG001|STARTED|Overall Study||11
8784665|NCT01351376|9835913|FG000|COMPLETED|Overall Study||10
8784666|NCT01351376|9835914|FG001|COMPLETED|Overall Study||11
8784667|NCT01351376|9835913|FG000|NOT COMPLETED|Overall Study||0
8784668|NCT01351376|9835914|FG001|NOT COMPLETED|Overall Study||0
8784669|NCT01351415|9835922|FG000|STARTED|Overall Study||245
8784670|NCT01351415|9835923|FG001|STARTED|Overall Study||240
8784671|NCT01351415|9835922|FG000|Treated Participants|Overall Study||243
8784672|NCT01351415|9835923|FG001|Treated Participants|Overall Study||232
8784673|NCT01351415|9835922|FG000|COMPLETED|Overall Study||0
8784674|NCT01351415|9835923|FG001|COMPLETED|Overall Study||0
8784675|NCT01351415|9835922|FG000|NOT COMPLETED|Overall Study||245
8784676|NCT01351415|9835923|FG001|NOT COMPLETED|Overall Study||240
8784677|NCT01351480|9835929|FG000|STARTED|Overall Study||34
8784678|NCT01351480|9835929|FG000|COMPLETED|Overall Study||26
8784679|NCT01351480|9835929|FG000|NOT COMPLETED|Overall Study||8
8784680|NCT01351506|9835935|FG000|STARTED|Overall Study||602
8784681|NCT01351506|9835935|FG000|COMPLETED|Overall Study||465
8784682|NCT01351506|9835935|FG000|NOT COMPLETED|Overall Study||137
8784683|NCT01351623|9835941|FG000|STARTED|Overall Study||44
8784684|NCT01351623|9835941|FG000|COMPLETED|Overall Study||35
8784685|NCT01351623|9835941|FG000|NOT COMPLETED|Overall Study||9
8784686|NCT01351740|9835947|FG000|STARTED|Overall Study||25
8784687|NCT01351740|9835948|FG001|STARTED|Overall Study||25
8784688|NCT01351740|9835947|FG000|COMPLETED|Overall Study||23
8784689|NCT01351740|9835948|FG001|COMPLETED|Overall Study||19
8784690|NCT01351740|9835947|FG000|NOT COMPLETED|Overall Study||2
8784691|NCT01351740|9835948|FG001|NOT COMPLETED|Overall Study||6
8784692|NCT01351753|9835961|FG000|STARTED|Overall Study||22
8784693|NCT01351753|9835962|FG001|STARTED|Overall Study||20
8784694|NCT01351753|9835963|FG002|STARTED|Overall Study||21
8784695|NCT01351753|9835964|FG003|STARTED|Overall Study||21
8784696|NCT01351753|9835965|FG004|STARTED|Overall Study||21
8784697|NCT01351753|9835966|FG005|STARTED|Overall Study||23
8784698|NCT01351753|9835961|FG000|COMPLETED|Overall Study||15
8784699|NCT01351753|9835962|FG001|COMPLETED|Overall Study||13
8784700|NCT01351753|9835963|FG002|COMPLETED|Overall Study||14
8784701|NCT01351753|9835964|FG003|COMPLETED|Overall Study||21
8784702|NCT01351753|9835965|FG004|COMPLETED|Overall Study||14
8784703|NCT01351753|9835966|FG005|COMPLETED|Overall Study||22
8784704|NCT01351753|9835961|FG000|NOT COMPLETED|Overall Study||7
8784705|NCT01351753|9835962|FG001|NOT COMPLETED|Overall Study||7
8784706|NCT01351753|9835963|FG002|NOT COMPLETED|Overall Study||7
8784707|NCT01351753|9835964|FG003|NOT COMPLETED|Overall Study||0
8784708|NCT01351753|9835965|FG004|NOT COMPLETED|Overall Study||7
8784709|NCT01351753|9835966|FG005|NOT COMPLETED|Overall Study||1
8784710|NCT01351805|9835986|FG000|STARTED|Overall Study||6463
8784711|NCT01351805|9835987|FG001|STARTED|Overall Study||6464
8784712|NCT01351805|9835988|FG002|STARTED|Overall Study||6470
8784713|NCT01351805|9835989|FG003|STARTED|Overall Study||6474
8784714|NCT01351805|9835986|FG000|Knee Pain Cohort Within VITAL Trial|Overall Study||342
8784715|NCT01351805|9835987|FG001|Knee Pain Cohort Within VITAL Trial|Overall Study||332
8784716|NCT01351805|9835988|FG002|Knee Pain Cohort Within VITAL Trial|Overall Study||353
8784717|NCT01351805|9835989|FG003|Knee Pain Cohort Within VITAL Trial|Overall Study||371
8784718|NCT01351805|9835986|FG000|Biomarkers of Systemic Inflammation Cohort Within VITAL Trial|Overall Study||392
8784719|NCT01351805|9835987|FG001|Biomarkers of Systemic Inflammation Cohort Within VITAL Trial|Overall Study||392
8784720|NCT01351805|9835988|FG002|Biomarkers of Systemic Inflammation Cohort Within VITAL Trial|Overall Study||392
8784721|NCT01351805|9835989|FG003|Biomarkers of Systemic Inflammation Cohort Within VITAL Trial|Overall Study||385
8784722|NCT01351805|9835986|FG000|COMPLETED|Overall Study||6463
8784723|NCT01351805|9835987|FG001|COMPLETED|Overall Study||6464
8784724|NCT01351805|9835988|FG002|COMPLETED|Overall Study||6470
8784725|NCT01351805|9835989|FG003|COMPLETED|Overall Study||6474
8784726|NCT01351805|9835986|FG000|NOT COMPLETED|Overall Study||0
8784727|NCT01351805|9835987|FG001|NOT COMPLETED|Overall Study||0
8784728|NCT01351805|9835988|FG002|NOT COMPLETED|Overall Study||0
8784729|NCT01351805|9835989|FG003|NOT COMPLETED|Overall Study||0
8784730|NCT01352117|9836005|FG000|STARTED|Overall Study||96
8784731|NCT01352117|9836006|FG001|STARTED|Overall Study||96
8784732|NCT01352117|9836005|FG000|Entered Step 2 to Initiate Delayed ET|Overall Study||32
8784733|NCT01352117|9836006|FG001|Entered Step 2 to Initiate Delayed ET|Overall Study|Only Arm A participants could enter Step 2 to receive delayed ET.|0
8784734|NCT01352117|9836005|FG000|Study Week 48 Data Potential|Overall Study||80
8784735|NCT01352117|9836006|FG001|Study Week 48 Data Potential|Overall Study||83
8784736|NCT01352117|9836005|FG000|Study Week 96 Data Potential|Overall Study||58
8784737|NCT01352117|9836006|FG001|Study Week 96 Data Potential|Overall Study||61
8784738|NCT01352117|9836005|FG000|COMPLETED|Overall Study||75
8784739|NCT01352117|9836006|FG001|COMPLETED|Overall Study||72
8784740|NCT01352117|9836005|FG000|NOT COMPLETED|Overall Study||21
8784741|NCT01352117|9836006|FG001|NOT COMPLETED|Overall Study||24
8784742|NCT01352182|9836017|FG000|STARTED|Overall Study||8
8784743|NCT01352182|9836018|FG001|STARTED|Overall Study||4
8784744|NCT01352182|9836017|FG000|COMPLETED|Overall Study||8
8784745|NCT01352182|9836018|FG001|COMPLETED|Overall Study||4
8784746|NCT01352182|9836017|FG000|NOT COMPLETED|Overall Study||0
8784747|NCT01352182|9836018|FG001|NOT COMPLETED|Overall Study||0
8784748|NCT01352221|9836028|FG000|STARTED|Double-blind Phase||64
8784749|NCT01352221|9836029|FG001|STARTED|Double-blind Phase||64
8784750|NCT01352221|9836030|FG002|STARTED|Double-blind Phase|Not Applicable to double-blind phase|0
8784751|NCT01352221|9836031|FG003|STARTED|Double-blind Phase|Not Applicable to double-blind phase|0
8784752|NCT01352221|9836028|FG000|COMPLETED|Double-blind Phase||55
8784753|NCT01352221|9836029|FG001|COMPLETED|Double-blind Phase||53
8784754|NCT01352221|9836030|FG002|COMPLETED|Double-blind Phase|Not Applicable to double-blind phase|0
8784755|NCT01352221|9836031|FG003|COMPLETED|Double-blind Phase|Not Applicable to double-blind phase|0
8784756|NCT01352221|9836028|FG000|NOT COMPLETED|Double-blind Phase||9
8784757|NCT01352221|9836029|FG001|NOT COMPLETED|Double-blind Phase||11
8784758|NCT01352221|9836030|FG002|NOT COMPLETED|Double-blind Phase||0
8784759|NCT01352221|9836031|FG003|NOT COMPLETED|Double-blind Phase||0
8784760|NCT01352221|9836028|FG000|STARTED|Open-label Phase|Not Applicable to open-label phase|0
8784761|NCT01352221|9836029|FG001|STARTED|Open-label Phase|Not Applicable to open-label phase|0
8784762|NCT01352221|9836030|FG002|STARTED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|50
8784763|NCT01352221|9836031|FG003|STARTED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|47
8784764|NCT01352221|9836028|FG000|COMPLETED|Open-label Phase|Not Applicable to open-label phase|0
8784765|NCT01352221|9836029|FG001|COMPLETED|Open-label Phase|Not Applicable to open-label phase|0
8784766|NCT01352221|9836030|FG002|COMPLETED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|37
8784767|NCT01352221|9836031|FG003|COMPLETED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|36
8784768|NCT01352221|9836028|FG000|NOT COMPLETED|Open-label Phase||0
8784769|NCT01352221|9836029|FG001|NOT COMPLETED|Open-label Phase||0
8784770|NCT01352221|9836030|FG002|NOT COMPLETED|Open-label Phase||13
8784771|NCT01352221|9836031|FG003|NOT COMPLETED|Open-label Phase||11
8784772|NCT01352286|9836043|FG000|STARTED|Overall Study||25
8784773|NCT01352286|9836043|FG000|Received T-cells|Overall Study||25
8784774|NCT01352286|9836043|FG000|COMPLETED|Overall Study||25
8784775|NCT01352286|9836043|FG000|NOT COMPLETED|Overall Study||0
8784776|NCT01352442|9836048|FG000|STARTED|Overall Study||151
8784777|NCT01352442|9836048|FG000|COMPLETED|Overall Study||139
8784778|NCT01352442|9836048|FG000|NOT COMPLETED|Overall Study||12
8784779|NCT01352468|9836054|FG000|STARTED|Overall Study||22
8784780|NCT01352468|9836055|FG001|STARTED|Overall Study||22
8784781|NCT01352468|9836054|FG000|COMPLETED|Overall Study||17
8784782|NCT01352468|9836055|FG001|COMPLETED|Overall Study||18
8784783|NCT01352468|9836054|FG000|NOT COMPLETED|Overall Study||5
8784784|NCT01352468|9836055|FG001|NOT COMPLETED|Overall Study||4
8784785|NCT01352507|9836063|FG000|STARTED|Treatment Period 1||190
8784786|NCT01352507|9836064|FG001|STARTED|Treatment Period 1||193
8784787|NCT01352507|9836063|FG000|Received Treatment|Treatment Period 1||182
8784788|NCT01352507|9836064|FG001|Received Treatment|Treatment Period 1||188
8784789|NCT01352507|9836063|FG000|COMPLETED|Treatment Period 1||176
8784790|NCT01352507|9836064|FG001|COMPLETED|Treatment Period 1||184
8784791|NCT01352507|9836063|FG000|NOT COMPLETED|Treatment Period 1||14
8784792|NCT01352507|9836064|FG001|NOT COMPLETED|Treatment Period 1||9
8784793|NCT01352507|9836063|FG000|STARTED|Washout Period||176
8784794|NCT01352507|9836064|FG001|STARTED|Washout Period||184
8784795|NCT01352507|9836063|FG000|COMPLETED|Washout Period||176
8784796|NCT01352507|9836064|FG001|COMPLETED|Washout Period||183
8784797|NCT01352507|9836063|FG000|NOT COMPLETED|Washout Period||0
8784798|NCT01352507|9836064|FG001|NOT COMPLETED|Washout Period||1
8784799|NCT01352507|9836063|FG000|STARTED|Treatment Period 2||176
8784800|NCT01352507|9836064|FG001|STARTED|Treatment Period 2||183
8784801|NCT01352507|9836063|FG000|Received Treatment|Treatment Period 2||173
8784802|NCT01352507|9836064|FG001|Received Treatment|Treatment Period 2||181
8784803|NCT01352507|9836063|FG000|COMPLETED|Treatment Period 2|Six participants who completed Treatment Period 2 chose not to enter the Extension Phase.|170
8784804|NCT01352507|9836064|FG001|COMPLETED|Treatment Period 2|Seven participants who completed Treatment Period 2 chose not to enter the Extension Phase.|180
8784805|NCT01352507|9836063|FG000|NOT COMPLETED|Treatment Period 2||6
8784806|NCT01352507|9836064|FG001|NOT COMPLETED|Treatment Period 2||3
8784807|NCT01352507|9836063|FG000|STARTED|Extension Phase||164
8784808|NCT01352507|9836064|FG001|STARTED|Extension Phase||173
8784809|NCT01352507|9836063|FG000|COMPLETED|Extension Phase||164
8784810|NCT01352507|9836064|FG001|COMPLETED|Extension Phase||173
8784811|NCT01352507|9836063|FG000|NOT COMPLETED|Extension Phase||0
8784812|NCT01352507|9836064|FG001|NOT COMPLETED|Extension Phase||0
8784813|NCT01352546|9836076|FG000|STARTED|Overall Study||31
8916671|NCT02185534|9976246|FG002|STARTED|Second Washout Period||14
8916672|NCT02185534|9976247|FG003|STARTED|Second Washout Period||13
8916673|NCT02185534|9976248|FG004|STARTED|Second Washout Period||13
8784814|NCT01352546|9836076|FG000|COMPLETED|Overall Study||31
8784815|NCT01352546|9836076|FG000|NOT COMPLETED|Overall Study||0
8784816|NCT01352585|9836082|FG000|STARTED|Overall Study||23
8784817|NCT01352585|9836083|FG001|STARTED|Overall Study||24
9030910|NCT03235726|10093001|FG004|STARTED|Part 2 (Cohort A - Day 1)||0
9030911|NCT03235726|10093002|FG005|STARTED|Part 2 (Cohort A - Day 1)||0
9030912|NCT03235726|10093003|FG006|STARTED|Part 2 (Cohort A - Day 1)||0
9030913|NCT03235726|10093004|FG007|STARTED|Part 2 (Cohort A - Day 1)||6
9030914|NCT03235726|10093005|FG008|STARTED|Part 2 (Cohort A - Day 1)||2
9030915|NCT03235726|10093006|FG009|STARTED|Part 2 (Cohort A - Day 1)||0
8784818|NCT01352585|9836082|FG000|COMPLETED|Overall Study||15
8784819|NCT01352585|9836083|FG001|COMPLETED|Overall Study||21
8784820|NCT01352585|9836082|FG000|NOT COMPLETED|Overall Study||8
8784821|NCT01352585|9836083|FG001|NOT COMPLETED|Overall Study||3
8784822|NCT01352598|9836090|FG000|STARTED|Overall Study||84
8916674|NCT02185534|9976249|FG005|STARTED|Second Washout Period||13
8916675|NCT02185534|9976244|FG000|COMPLETED|Second Washout Period||13
8916676|NCT02185534|9976245|FG001|COMPLETED|Second Washout Period||14
8916677|NCT02185534|9976246|FG002|COMPLETED|Second Washout Period||14
8916678|NCT02185534|9976247|FG003|COMPLETED|Second Washout Period||13
8916679|NCT02185534|9976248|FG004|COMPLETED|Second Washout Period||13
8916680|NCT02185534|9976249|FG005|COMPLETED|Second Washout Period||13
8916681|NCT02185534|9976244|FG000|NOT COMPLETED|Second Washout Period||0
8916682|NCT02185534|9976245|FG001|NOT COMPLETED|Second Washout Period||0
8916683|NCT02185534|9976246|FG002|NOT COMPLETED|Second Washout Period||0
8916684|NCT02185534|9976247|FG003|NOT COMPLETED|Second Washout Period||0
8916685|NCT02185534|9976248|FG004|NOT COMPLETED|Second Washout Period||0
8916686|NCT02185534|9976249|FG005|NOT COMPLETED|Second Washout Period||0
8916687|NCT02185534|9976244|FG000|STARTED|Third Period||13
8916688|NCT02185534|9976245|FG001|STARTED|Third Period||14
8916689|NCT02185534|9976246|FG002|STARTED|Third Period||14
8916690|NCT02185534|9976247|FG003|STARTED|Third Period||13
8916691|NCT02185534|9976248|FG004|STARTED|Third Period||13
8916692|NCT02185534|9976249|FG005|STARTED|Third Period||13
8916693|NCT02185534|9976244|FG000|COMPLETED|Third Period||13
8916694|NCT02185534|9976245|FG001|COMPLETED|Third Period||14
8916695|NCT02185534|9976246|FG002|COMPLETED|Third Period||14
8916696|NCT02185534|9976247|FG003|COMPLETED|Third Period||13
8916697|NCT02185534|9976248|FG004|COMPLETED|Third Period||13
8916698|NCT02185534|9976249|FG005|COMPLETED|Third Period||13
8916699|NCT02185534|9976244|FG000|NOT COMPLETED|Third Period||0
8916700|NCT02185534|9976245|FG001|NOT COMPLETED|Third Period||0
8916701|NCT02185534|9976246|FG002|NOT COMPLETED|Third Period||0
8916702|NCT02185534|9976247|FG003|NOT COMPLETED|Third Period||0
8916703|NCT02185534|9976248|FG004|NOT COMPLETED|Third Period||0
8916704|NCT02185534|9976249|FG005|NOT COMPLETED|Third Period||0
8916705|NCT02185729|9976258|FG000|STARTED|0 Hour (Baseline) of Saline Infusion||12
8916706|NCT02185729|9976258|FG000|COMPLETED|0 Hour (Baseline) of Saline Infusion||12
8916707|NCT02185729|9976258|FG000|NOT COMPLETED|0 Hour (Baseline) of Saline Infusion||0
8916708|NCT02185729|9976258|FG000|STARTED|4 Hours Into Saline Infusion||12
8916709|NCT02185729|9976258|FG000|COMPLETED|4 Hours Into Saline Infusion||12
8916710|NCT02185729|9976258|FG000|NOT COMPLETED|4 Hours Into Saline Infusion||0
8916711|NCT02185729|9976258|FG000|STARTED|24 Hours Into Saline Infusion||12
8916712|NCT02185729|9976258|FG000|COMPLETED|24 Hours Into Saline Infusion||12
8916713|NCT02185729|9976258|FG000|NOT COMPLETED|24 Hours Into Saline Infusion||0
8916714|NCT02185729|9976258|FG000|STARTED|0 Hour (Baseline) of Intralipid Infusion||12
8916715|NCT02185729|9976258|FG000|COMPLETED|0 Hour (Baseline) of Intralipid Infusion||12
8784823|NCT01352598|9836090|FG000|COMPLETED|Overall Study||72
8916716|NCT02185729|9976258|FG000|NOT COMPLETED|0 Hour (Baseline) of Intralipid Infusion||0
8916717|NCT02185729|9976258|FG000|STARTED|4 Hours Into Intralipid Infusion||12
8784824|NCT01352598|9836090|FG000|NOT COMPLETED|Overall Study||12
8784825|NCT01352637|9836098|FG000|STARTED|Exposure Therapy||97
8784826|NCT01352637|9836099|FG001|STARTED|Exposure Therapy||95
8784827|NCT01352637|9836100|FG002|STARTED|Exposure Therapy||0
8784828|NCT01352637|9836101|FG003|STARTED|Exposure Therapy||0
8784829|NCT01352637|9836098|FG000|COMPLETED|Exposure Therapy||70
8784830|NCT01352637|9836099|FG001|COMPLETED|Exposure Therapy||62
8784831|NCT01352637|9836100|FG002|COMPLETED|Exposure Therapy||0
8784832|NCT01352637|9836101|FG003|COMPLETED|Exposure Therapy||0
8784833|NCT01352637|9836098|FG000|NOT COMPLETED|Exposure Therapy||27
8784834|NCT01352637|9836099|FG001|NOT COMPLETED|Exposure Therapy||33
8784835|NCT01352637|9836100|FG002|NOT COMPLETED|Exposure Therapy||0
8784836|NCT01352637|9836101|FG003|NOT COMPLETED|Exposure Therapy||0
8784837|NCT01352637|9836098|FG000|STARTED|Drug||0
8784838|NCT01352637|9836099|FG001|STARTED|Drug||0
8784839|NCT01352637|9836100|FG002|STARTED|Drug||95
8784840|NCT01352637|9836101|FG003|STARTED|Drug||97
8784841|NCT01352637|9836098|FG000|COMPLETED|Drug||0
8784842|NCT01352637|9836099|FG001|COMPLETED|Drug||0
8784843|NCT01352637|9836100|FG002|COMPLETED|Drug||70
8784844|NCT01352637|9836101|FG003|COMPLETED|Drug||62
8784845|NCT01352637|9836098|FG000|NOT COMPLETED|Drug||0
8784846|NCT01352637|9836099|FG001|NOT COMPLETED|Drug||0
8784847|NCT01352637|9836100|FG002|NOT COMPLETED|Drug||25
8784848|NCT01352637|9836101|FG003|NOT COMPLETED|Drug||35
8784849|NCT01352715|9836113|FG000|STARTED|Overall Study||260
8784850|NCT01352715|9836114|FG001|STARTED|Overall Study||255
8784851|NCT01352715|9836113|FG000|COMPLETED|Overall Study||215
8784852|NCT01352715|9836114|FG001|COMPLETED|Overall Study||209
8784853|NCT01352715|9836113|FG000|NOT COMPLETED|Overall Study||45
8784854|NCT01352715|9836114|FG001|NOT COMPLETED|Overall Study||46
8784855|NCT01352741|9836120|FG000|STARTED|Open-label Tapentadol Titration Period|All participants started with 2 x 50 mg tapentadol PR and titrated upwards in steps of 100 mg/day.|445
8784856|NCT01352741|9836121|FG001|STARTED|Open-label Tapentadol Titration Period||0
8784857|NCT01352741|9836120|FG000|Switched to Open-label Continuation Arm|Open-label Tapentadol Titration Period||59
8784858|NCT01352741|9836121|FG001|Switched to Open-label Continuation Arm|Open-label Tapentadol Titration Period||0
8784859|NCT01352741|9836120|FG000|Full Analysis Set|Open-label Tapentadol Titration Period||436
8784860|NCT01352741|9836121|FG001|Full Analysis Set|Open-label Tapentadol Titration Period||0
8784861|NCT01352741|9836120|FG000|COMPLETED|Open-label Tapentadol Titration Period|59 of 73 participants not completing the titration period entered the open-label continuation arm.|372
8784862|NCT01352741|9836121|FG001|COMPLETED|Open-label Tapentadol Titration Period||0
8784863|NCT01352741|9836120|FG000|NOT COMPLETED|Open-label Tapentadol Titration Period||73
8784864|NCT01352741|9836121|FG001|NOT COMPLETED|Open-label Tapentadol Titration Period||0
8784865|NCT01352741|9836120|FG000|STARTED|Double-blind Comparative Period|Of the 313 participants that qualified for randomization 154 were randomized to tapentadol.|154
8784866|NCT01352741|9836121|FG001|STARTED|Double-blind Comparative Period|159 of the 313 participants that qualified were randomized to tapentadol and pregabalin treatment.|159
8784867|NCT01352741|9836120|FG000|Switched to Open-label Pick-up Arm|Double-blind Comparative Period||19
8784868|NCT01352741|9836121|FG001|Switched to Open-label Pick-up Arm|Double-blind Comparative Period||18
8784869|NCT01352741|9836120|FG000|No Pain Assessments Available|Double-blind Comparative Period||2
8784870|NCT01352741|9836121|FG001|No Pain Assessments Available|Double-blind Comparative Period||2
8784871|NCT01352741|9836120|FG000|Full Analysis Set|Double-blind Comparative Period||152
8784872|NCT01352741|9836121|FG001|Full Analysis Set|Double-blind Comparative Period||157
8784873|NCT01352741|9836120|FG000|Major Protocol Deviations|Double-blind Comparative Period||13
8784874|NCT01352741|9836121|FG001|Major Protocol Deviations|Double-blind Comparative Period||8
8784875|NCT01352741|9836120|FG000|Per Protocol Set|Double-blind Comparative Period||139
8784876|NCT01352741|9836121|FG001|Per Protocol Set|Double-blind Comparative Period||149
8784877|NCT01352741|9836120|FG000|painDetect Per Protocol Set|Double-blind Comparative Period||109
8784878|NCT01352741|9836121|FG001|painDetect Per Protocol Set|Double-blind Comparative Period||127
8784879|NCT01352741|9836120|FG000|SF-12 Per Protocol Set|Double-blind Comparative Period||131
8784880|NCT01352741|9836121|FG001|SF-12 Per Protocol Set|Double-blind Comparative Period||143
8784881|NCT01352741|9836120|FG000|EQ-5D Per Protocol Set|Double-blind Comparative Period||131
8784882|NCT01352741|9836121|FG001|EQ-5D Per Protocol Set|Double-blind Comparative Period||143
8784883|NCT01352741|9836120|FG000|HADS Per Protocol Set (PPS)|Double-blind Comparative Period||123
8671873|NCT00754130|9715286|FG003|COMPLETED|Washout Period (>=8 Days)||2
8784884|NCT01352741|9836121|FG001|HADS Per Protocol Set (PPS)|Double-blind Comparative Period||137
8784885|NCT01352741|9836120|FG000|Sleep Evaluation (Latency) PPS|Double-blind Comparative Period||123
8784886|NCT01352741|9836121|FG001|Sleep Evaluation (Latency) PPS|Double-blind Comparative Period||137
8784887|NCT01352741|9836120|FG000|Sleep Evaluations (Awakenings) PPS|Double-blind Comparative Period||123
8784888|NCT01352741|9836121|FG001|Sleep Evaluations (Awakenings) PPS|Double-blind Comparative Period||137
9030916|NCT03235726|10092997|FG000|COMPLETED|Part 2 (Cohort A - Day 1)||0
8671874|NCT00754130|9715287|FG004|COMPLETED|Washout Period (>=8 Days)||2
8671875|NCT00754130|9715288|FG005|COMPLETED|Washout Period (>=8 Days)||4
8671876|NCT00754130|9715283|FG000|NOT COMPLETED|Washout Period (>=8 Days)||0
8671877|NCT00754130|9715284|FG001|NOT COMPLETED|Washout Period (>=8 Days)||0
8671878|NCT00754130|9715285|FG002|NOT COMPLETED|Washout Period (>=8 Days)||0
8671879|NCT00754130|9715286|FG003|NOT COMPLETED|Washout Period (>=8 Days)||0
8671880|NCT00754130|9715287|FG004|NOT COMPLETED|Washout Period (>=8 Days)||0
8671881|NCT00754130|9715288|FG005|NOT COMPLETED|Washout Period (>=8 Days)||0
8784889|NCT01352741|9836120|FG000|Sleep Evaluations (Hours Slept) PPS|Double-blind Comparative Period||123
8784890|NCT01352741|9836121|FG001|Sleep Evaluations (Hours Slept) PPS|Double-blind Comparative Period||137
8784891|NCT01352741|9836120|FG000|COMPLETED|Double-blind Comparative Period||126
8784892|NCT01352741|9836121|FG001|COMPLETED|Double-blind Comparative Period||133
8784893|NCT01352741|9836120|FG000|NOT COMPLETED|Double-blind Comparative Period||28
8784894|NCT01352741|9836121|FG001|NOT COMPLETED|Double-blind Comparative Period||26
8784895|NCT01352741|9836120|FG000|STARTED|Open-Label Tapentadol Continuation Arm|59 of the 73 participants that did not qualify for the comparative period entered this arm.|59
8784896|NCT01352741|9836121|FG001|STARTED|Open-Label Tapentadol Continuation Arm|In this period no tapentadol PR and pregabalin treatment was planned by the protocol.|0
8784897|NCT01352741|9836120|FG000|Major Protocol Deviation|Open-Label Tapentadol Continuation Arm||2
8784898|NCT01352741|9836121|FG001|Major Protocol Deviation|Open-Label Tapentadol Continuation Arm||0
8784899|NCT01352741|9836120|FG000|Full Analysis Set|Open-Label Tapentadol Continuation Arm||57
8784900|NCT01352741|9836121|FG001|Full Analysis Set|Open-Label Tapentadol Continuation Arm||0
8784901|NCT01352741|9836120|FG000|COMPLETED|Open-Label Tapentadol Continuation Arm||51
8784902|NCT01352741|9836121|FG001|COMPLETED|Open-Label Tapentadol Continuation Arm||0
8784903|NCT01352741|9836120|FG000|NOT COMPLETED|Open-Label Tapentadol Continuation Arm||8
8784904|NCT01352741|9836121|FG001|NOT COMPLETED|Open-Label Tapentadol Continuation Arm||0
8784905|NCT01352741|9836120|FG000|STARTED|Open-Label Tapentadol Pick-Up Arm|19 from tapentadol in the comparative phase and 18 from tapentadol & pregabalin entered this arm.|37
8784906|NCT01352741|9836121|FG001|STARTED|Open-Label Tapentadol Pick-Up Arm|Participants did not continue treatment. They were switched to tapentadol PR or discontinued.|0
8784907|NCT01352741|9836120|FG000|COMPLETED|Open-Label Tapentadol Pick-Up Arm||37
9030917|NCT03235726|10092998|FG001|COMPLETED|Part 2 (Cohort A - Day 1)||0
9030918|NCT03235726|10092999|FG002|COMPLETED|Part 2 (Cohort A - Day 1)||0
9030919|NCT03235726|10093000|FG003|COMPLETED|Part 2 (Cohort A - Day 1)||0
9030920|NCT03235726|10093001|FG004|COMPLETED|Part 2 (Cohort A - Day 1)||0
9030921|NCT03235726|10093002|FG005|COMPLETED|Part 2 (Cohort A - Day 1)||0
9030922|NCT03235726|10093003|FG006|COMPLETED|Part 2 (Cohort A - Day 1)||0
9030923|NCT03235726|10093004|FG007|COMPLETED|Part 2 (Cohort A - Day 1)||6
9030924|NCT03235726|10093005|FG008|COMPLETED|Part 2 (Cohort A - Day 1)||2
9030925|NCT03235726|10093006|FG009|COMPLETED|Part 2 (Cohort A - Day 1)||0
9030926|NCT03235726|10092997|FG000|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
9030927|NCT03235726|10092998|FG001|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
9030928|NCT03235726|10092999|FG002|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
9030929|NCT03235726|10093000|FG003|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
9030930|NCT03235726|10093001|FG004|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
9030931|NCT03235726|10093002|FG005|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
9030932|NCT03235726|10093003|FG006|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
9030933|NCT03235726|10093004|FG007|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
9030934|NCT03235726|10093005|FG008|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
9030935|NCT03235726|10093006|FG009|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
9030936|NCT03235726|10092997|FG000|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
9030937|NCT03235726|10092998|FG001|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
9030938|NCT03235726|10092999|FG002|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
9030939|NCT03235726|10093000|FG003|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
9030940|NCT03235726|10093001|FG004|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
9030941|NCT03235726|10093002|FG005|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
9030942|NCT03235726|10093003|FG006|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
9030943|NCT03235726|10093004|FG007|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
9030944|NCT03235726|10093005|FG008|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
9030945|NCT03235726|10093006|FG009|STARTED|Part 2 (Cohort B - Days 1 to 14)||8
9030946|NCT03235726|10092997|FG000|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
9030947|NCT03235726|10092998|FG001|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
9030948|NCT03235726|10092999|FG002|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
9030949|NCT03235726|10093000|FG003|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
9030950|NCT03235726|10093001|FG004|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
9030951|NCT03235726|10093002|FG005|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
9030952|NCT03235726|10093003|FG006|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
9030953|NCT03235726|10093004|FG007|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
9030954|NCT03235726|10093005|FG008|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
9030955|NCT03235726|10093006|FG009|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||8
9030956|NCT03235726|10092997|FG000|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
9030957|NCT03235726|10092998|FG001|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
9030958|NCT03235726|10092999|FG002|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
9030959|NCT03235726|10093000|FG003|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
9030960|NCT03235726|10093001|FG004|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
9030961|NCT03235726|10093002|FG005|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
9030962|NCT03235726|10093003|FG006|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
9030963|NCT03235726|10093004|FG007|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
9030964|NCT03235726|10093005|FG008|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
9030965|NCT03235726|10093006|FG009|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
9030966|NCT03236168|10093041|FG000|STARTED|Overall Study||118
9030967|NCT03236168|10093041|FG000|COMPLETED|Overall Study||107
9030968|NCT03236168|10093041|FG000|NOT COMPLETED|Overall Study||11
9030969|NCT03236246|10093047|FG000|STARTED|24-Week Dose Titration Period||104
8784908|NCT01352741|9836121|FG001|COMPLETED|Open-Label Tapentadol Pick-Up Arm||0
8784909|NCT01352741|9836120|FG000|NOT COMPLETED|Open-Label Tapentadol Pick-Up Arm||0
8784910|NCT01352741|9836121|FG001|NOT COMPLETED|Open-Label Tapentadol Pick-Up Arm||0
8784911|NCT01352793|9836143|FG000|STARTED|Overall Study||3804
8784912|NCT01352793|9836144|FG001|STARTED|Overall Study||1908
8784913|NCT01352793|9836143|FG000|Vaccination 1|Overall Study||3796
8784914|NCT01352793|9836144|FG001|Vaccination 1|Overall Study||1908
8784915|NCT01352793|9836143|FG000|Vaccination 2|Overall Study||3530
8784916|NCT01352793|9836144|FG001|Vaccination 2|Overall Study||1806
8784917|NCT01352793|9836143|FG000|Vaccination 3|Overall Study||3314
8784918|NCT01352793|9836144|FG001|Vaccination 3|Overall Study||1710
8784919|NCT01352793|9836143|FG000|COMPLETED|Overall Study||3219
8784920|NCT01352793|9836144|FG001|COMPLETED|Overall Study||1663
8784921|NCT01352793|9836143|FG000|NOT COMPLETED|Overall Study||585
8784922|NCT01352793|9836144|FG001|NOT COMPLETED|Overall Study||245
8784923|NCT01352845|9836152|FG000|STARTED|Overall Study||2471
8784924|NCT01352845|9836153|FG001|STARTED|Overall Study||822
8784925|NCT01352845|9836152|FG000|COMPLETED|Overall Study||1800
8784926|NCT01352845|9836153|FG001|COMPLETED|Overall Study||619
8784927|NCT01352845|9836152|FG000|NOT COMPLETED|Overall Study||671
8784928|NCT01352845|9836153|FG001|NOT COMPLETED|Overall Study||203
8784929|NCT01353079|9836161|FG000|STARTED|Overall Study||218
8784930|NCT01353079|9836162|FG001|STARTED|Overall Study||211
8784931|NCT01353079|9836161|FG000|COMPLETED|Overall Study||191
8784932|NCT01353079|9836162|FG001|COMPLETED|Overall Study||190
8784933|NCT01353079|9836161|FG000|NOT COMPLETED|Overall Study||27
8784934|NCT01353079|9836162|FG001|NOT COMPLETED|Overall Study||21
8784935|NCT01353144|9836172|FG000|STARTED|Overall Study||89
8784936|NCT01353144|9836173|FG001|STARTED|Overall Study||89
8784937|NCT01353144|9836172|FG000|COMPLETED|Overall Study||80
8784938|NCT01353144|9836173|FG001|COMPLETED|Overall Study||81
8784939|NCT01353144|9836172|FG000|NOT COMPLETED|Overall Study||9
8784940|NCT01353144|9836173|FG001|NOT COMPLETED|Overall Study||8
8784941|NCT01353196|9836183|FG000|STARTED|Overall Study||100
8784942|NCT01353196|9836184|FG001|STARTED|Overall Study||70
8784943|NCT01353196|9836183|FG000|COMPLETED|Overall Study||71
8784944|NCT01353196|9836184|FG001|COMPLETED|Overall Study||59
8784945|NCT01353196|9836183|FG000|NOT COMPLETED|Overall Study||29
8784946|NCT01353196|9836184|FG001|NOT COMPLETED|Overall Study||11
8784947|NCT01353222|9836192|FG000|STARTED|Overall Study||70
8784948|NCT01353222|9836193|FG001|STARTED|Overall Study||72
8784949|NCT01353222|9836192|FG000|DN24-02 Arm ≥1 Leukapheresis|Overall Study||67
8784950|NCT01353222|9836193|FG001|DN24-02 Arm ≥1 Leukapheresis|Overall Study||0
8784951|NCT01353222|9836192|FG000|Standard Care Arm ≥1 Post-baseline Visit|Overall Study||0
8784952|NCT01353222|9836193|FG001|Standard Care Arm ≥1 Post-baseline Visit|Overall Study||72
8784953|NCT01353222|9836192|FG000|COMPLETED|Overall Study||0
8784954|NCT01353222|9836193|FG001|COMPLETED|Overall Study||0
8784955|NCT01353222|9836192|FG000|NOT COMPLETED|Overall Study||70
8784956|NCT01353222|9836193|FG001|NOT COMPLETED|Overall Study||72
8784957|NCT01353274|9836199|FG000|STARTED|Overall Study||1157
8784958|NCT01353274|9836199|FG000|COMPLETED|Overall Study||1129
8784959|NCT01353274|9836199|FG000|NOT COMPLETED|Overall Study||28
8784960|NCT01353495|9836205|FG000|STARTED|Overall Study||19
8784961|NCT01353495|9836206|FG001|STARTED|Overall Study||20
9030970|NCT03236246|10093048|FG001|STARTED|24-Week Dose Titration Period||102
9030971|NCT03236246|10093047|FG000|COMPLETED|24-Week Dose Titration Period||80
9030972|NCT03236246|10093048|FG001|COMPLETED|24-Week Dose Titration Period||75
9030973|NCT03236246|10093047|FG000|NOT COMPLETED|24-Week Dose Titration Period||24
9030974|NCT03236246|10093048|FG001|NOT COMPLETED|24-Week Dose Titration Period||27
9030975|NCT03236246|10093047|FG000|STARTED|24-Week Dose Maintenance Period|Not all participants completing the Dose Titration Period opted to enter the Dose Maintenance Period|76
9030976|NCT03236246|10093048|FG001|STARTED|24-Week Dose Maintenance Period|Not all participants completing the Dose Titration Period opted to enter the Dose Maintenance Period|72
9030977|NCT03236246|10093047|FG000|COMPLETED|24-Week Dose Maintenance Period||73
9030978|NCT03236246|10093048|FG001|COMPLETED|24-Week Dose Maintenance Period||66
9030979|NCT03236246|10093047|FG000|NOT COMPLETED|24-Week Dose Maintenance Period||3
9030980|NCT03236246|10093048|FG001|NOT COMPLETED|24-Week Dose Maintenance Period||6
9030981|NCT03236506|10093057|FG000|STARTED|Overall Study||39
9030982|NCT03236506|10093058|FG001|STARTED|Overall Study||42
8784962|NCT01353495|9836205|FG000|COMPLETED|Overall Study||19
8784963|NCT01353495|9836206|FG001|COMPLETED|Overall Study||20
8784964|NCT01353495|9836205|FG000|NOT COMPLETED|Overall Study||0
8784965|NCT01353495|9836206|FG001|NOT COMPLETED|Overall Study||0
8784966|NCT01353508|9836216|FG000|STARTED|Period 1 - First Intervention (7 Days)||8
8784967|NCT01353508|9836217|FG001|STARTED|Period 1 - First Intervention (7 Days)||8
8784968|NCT01353508|9836218|FG002|STARTED|Period 1 - First Intervention (7 Days)||8
8784969|NCT01353508|9836219|FG003|STARTED|Period 1 - First Intervention (7 Days)||8
8784970|NCT01353508|9836216|FG000|COMPLETED|Period 1 - First Intervention (7 Days)||8
8784971|NCT01353508|9836217|FG001|COMPLETED|Period 1 - First Intervention (7 Days)||8
8784972|NCT01353508|9836218|FG002|COMPLETED|Period 1 - First Intervention (7 Days)||8
8784973|NCT01353508|9836219|FG003|COMPLETED|Period 1 - First Intervention (7 Days)||7
8784974|NCT01353508|9836216|FG000|NOT COMPLETED|Period 1 - First Intervention (7 Days)||0
8784975|NCT01353508|9836217|FG001|NOT COMPLETED|Period 1 - First Intervention (7 Days)||0
8784976|NCT01353508|9836218|FG002|NOT COMPLETED|Period 1 - First Intervention (7 Days)||0
8784977|NCT01353508|9836219|FG003|NOT COMPLETED|Period 1 - First Intervention (7 Days)||1
8784978|NCT01353508|9836216|FG000|STARTED|Period 2 - Second Intervention (7 Days)||8
8784979|NCT01353508|9836217|FG001|STARTED|Period 2 - Second Intervention (7 Days)||8
8784980|NCT01353508|9836218|FG002|STARTED|Period 2 - Second Intervention (7 Days)||8
8784981|NCT01353508|9836219|FG003|STARTED|Period 2 - Second Intervention (7 Days)||7
8784982|NCT01353508|9836216|FG000|COMPLETED|Period 2 - Second Intervention (7 Days)||7
8784983|NCT01353508|9836217|FG001|COMPLETED|Period 2 - Second Intervention (7 Days)||8
8784984|NCT01353508|9836218|FG002|COMPLETED|Period 2 - Second Intervention (7 Days)||8
8784985|NCT01353508|9836219|FG003|COMPLETED|Period 2 - Second Intervention (7 Days)||7
8784986|NCT01353508|9836216|FG000|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||1
8784987|NCT01353508|9836217|FG001|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||0
8784988|NCT01353508|9836218|FG002|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||0
8784989|NCT01353508|9836219|FG003|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||0
8784990|NCT01353586|9836231|FG000|STARTED|Overall Study||167
8784991|NCT01353586|9836232|FG001|STARTED|Overall Study||19
8784992|NCT01353586|9836231|FG000|Participated in Workflow Phase|Overall Study||20
8784993|NCT01353586|9836232|FG001|Participated in Workflow Phase|Overall Study||0
8784994|NCT01353586|9836231|FG000|Participated in Roll-in Phase|Overall Study||22
8784995|NCT01353586|9836232|FG001|Participated in Roll-in Phase|Overall Study||0
8784996|NCT01353586|9836231|FG000|Participated in SNA Substudy|Overall Study||19
8784997|NCT01353586|9836232|FG001|Participated in SNA Substudy|Overall Study||19
8784998|NCT01353586|9836231|FG000|COMPLETED|Overall Study||160
8784999|NCT01353586|9836232|FG001|COMPLETED|Overall Study||17
8785000|NCT01353586|9836231|FG000|NOT COMPLETED|Overall Study||7
8785001|NCT01353586|9836232|FG001|NOT COMPLETED|Overall Study||2
8785002|NCT01353664|9836241|FG000|STARTED|Overall Study|Participants who received at least 1 dose of study drug.|19
8785003|NCT01353664|9836241|FG000|COMPLETED|Overall Study|Completed = Number of participants who continued on Romidepsin treatment|0
8785004|NCT01353664|9836241|FG000|NOT COMPLETED|Overall Study||19
8785005|NCT01353703|9836247|FG000|STARTED|Overall Study||112
8785006|NCT01353703|9836248|FG001|STARTED|Overall Study||112
8785007|NCT01353703|9836247|FG000|COMPLETED|Overall Study||111
8785008|NCT01353703|9836248|FG001|COMPLETED|Overall Study||112
8785009|NCT01353703|9836247|FG000|NOT COMPLETED|Overall Study||1
8785010|NCT01353703|9836248|FG001|NOT COMPLETED|Overall Study||0
8785011|NCT01353859|9836256|FG000|STARTED|Overall Study||39
8785012|NCT01353859|9836256|FG000|COMPLETED|Overall Study||35
8785013|NCT01353859|9836256|FG000|NOT COMPLETED|Overall Study||4
8785014|NCT01353898|9836266|FG000|STARTED|Overall Study||2
8785015|NCT01353898|9836267|FG001|STARTED|Overall Study||2
8785016|NCT01353898|9836268|FG002|STARTED|Overall Study||2
8785017|NCT01353898|9836269|FG003|STARTED|Overall Study||2
8785018|NCT01353898|9836270|FG004|STARTED|Overall Study||2
8785019|NCT01353898|9836271|FG005|STARTED|Overall Study||2
8785020|NCT01353898|9836266|FG000|COMPLETED|Overall Study||2
8785021|NCT01353898|9836267|FG001|COMPLETED|Overall Study||2
8785022|NCT01353898|9836268|FG002|COMPLETED|Overall Study||2
8785023|NCT01353898|9836269|FG003|COMPLETED|Overall Study||2
8785024|NCT01353898|9836270|FG004|COMPLETED|Overall Study||2
8785025|NCT01353898|9836271|FG005|COMPLETED|Overall Study||1
8785026|NCT01353898|9836266|FG000|NOT COMPLETED|Overall Study||0
8785027|NCT01353898|9836267|FG001|NOT COMPLETED|Overall Study||0
8785028|NCT01353898|9836268|FG002|NOT COMPLETED|Overall Study||0
8785029|NCT01353898|9836269|FG003|NOT COMPLETED|Overall Study||0
8785030|NCT01353898|9836270|FG004|NOT COMPLETED|Overall Study||0
8785031|NCT01353898|9836271|FG005|NOT COMPLETED|Overall Study||1
8785032|NCT01353911|9836293|FG000|STARTED|Overall Study||36
8785033|NCT01353911|9836294|FG001|STARTED|Overall Study||66
8785034|NCT01353911|9836295|FG002|STARTED|Overall Study||68
8785035|NCT01353911|9836296|FG003|STARTED|Overall Study||24
8916718|NCT02185729|9976258|FG000|COMPLETED|4 Hours Into Intralipid Infusion||12
8916719|NCT02185729|9976258|FG000|NOT COMPLETED|4 Hours Into Intralipid Infusion||0
8916720|NCT02185729|9976258|FG000|STARTED|24 Hours Into Intralipid Infusion||12
8916721|NCT02185729|9976258|FG000|COMPLETED|24 Hours Into Intralipid Infusion||12
8916722|NCT02185729|9976258|FG000|NOT COMPLETED|24 Hours Into Intralipid Infusion||0
8916723|NCT02185729|9976258|FG000|STARTED|0 Hour (Baseline) of ClinOleic Infusion||12
8916724|NCT02185729|9976258|FG000|COMPLETED|0 Hour (Baseline) of ClinOleic Infusion||12
8916725|NCT02185729|9976258|FG000|NOT COMPLETED|0 Hour (Baseline) of ClinOleic Infusion||0
8916726|NCT02185729|9976258|FG000|STARTED|4 Hours Into ClinOleic Infusion||12
8916727|NCT02185729|9976258|FG000|COMPLETED|4 Hours Into ClinOleic Infusion||12
8916728|NCT02185729|9976258|FG000|NOT COMPLETED|4 Hours Into ClinOleic Infusion||0
8916729|NCT02185729|9976258|FG000|STARTED|24 Hours Into ClinOleic Infusion||12
8916730|NCT02185729|9976258|FG000|COMPLETED|24 Hours Into ClinOleic Infusion||12
8916731|NCT02185729|9976258|FG000|NOT COMPLETED|24 Hours Into ClinOleic Infusion||0
8916732|NCT02185729|9976258|FG000|STARTED|0 Hour (Baseline) of Dextrose Infusion||12
8916733|NCT02185729|9976258|FG000|COMPLETED|0 Hour (Baseline) of Dextrose Infusion||12
8916734|NCT02185729|9976258|FG000|NOT COMPLETED|0 Hour (Baseline) of Dextrose Infusion||0
8916735|NCT02185729|9976258|FG000|STARTED|4 Hours Into Dextrose Infusion||12
8916736|NCT02185729|9976258|FG000|COMPLETED|4 Hours Into Dextrose Infusion||12
8916737|NCT02185729|9976258|FG000|NOT COMPLETED|4 Hours Into Dextrose Infusion||0
8916738|NCT02185729|9976258|FG000|STARTED|24 Hours Into Dextrose Infusion||12
8916739|NCT02185729|9976258|FG000|COMPLETED|24 Hours Into Dextrose Infusion||12
8785036|NCT01353911|9836297|FG004|STARTED|Overall Study||29
8785037|NCT01353911|9836298|FG005|STARTED|Overall Study||43
8785038|NCT01353911|9836299|FG006|STARTED|Overall Study||36
8785039|NCT01353911|9836300|FG007|STARTED|Overall Study||66
8785040|NCT01353911|9836293|FG000|COMPLETED|Overall Study||28
8785041|NCT01353911|9836294|FG001|COMPLETED|Overall Study||57
8785042|NCT01353911|9836295|FG002|COMPLETED|Overall Study||59
8785043|NCT01353911|9836296|FG003|COMPLETED|Overall Study||22
8785044|NCT01353911|9836297|FG004|COMPLETED|Overall Study||23
8785045|NCT01353911|9836298|FG005|COMPLETED|Overall Study||36
8785046|NCT01353911|9836299|FG006|COMPLETED|Overall Study||30
8785047|NCT01353911|9836300|FG007|COMPLETED|Overall Study||51
8785048|NCT01353911|9836293|FG000|NOT COMPLETED|Overall Study||8
8785049|NCT01353911|9836294|FG001|NOT COMPLETED|Overall Study||9
8785050|NCT01353911|9836295|FG002|NOT COMPLETED|Overall Study||9
8785051|NCT01353911|9836296|FG003|NOT COMPLETED|Overall Study||2
8785052|NCT01353911|9836297|FG004|NOT COMPLETED|Overall Study||6
8785053|NCT01353911|9836298|FG005|NOT COMPLETED|Overall Study||7
8785054|NCT01353911|9836299|FG006|NOT COMPLETED|Overall Study||6
8785055|NCT01353911|9836300|FG007|NOT COMPLETED|Overall Study||15
8785056|NCT01353963|9836318|FG000|STARTED|Overall Study||13
8785057|NCT01353963|9836318|FG000|COMPLETED|Overall Study||11
8785058|NCT01353963|9836318|FG000|NOT COMPLETED|Overall Study||2
8785059|NCT01353976|9836324|FG000|STARTED|Overall Study||130
8785060|NCT01353976|9836325|FG001|STARTED|Overall Study||134
8785061|NCT01353976|9836324|FG000|COMPLETED|Overall Study||82
8785062|NCT01353976|9836325|FG001|COMPLETED|Overall Study||83
8785063|NCT01353976|9836324|FG000|NOT COMPLETED|Overall Study||48
8785064|NCT01353976|9836325|FG001|NOT COMPLETED|Overall Study||51
8785065|NCT01354015|9836333|FG000|STARTED|Overall Study||50
8785066|NCT01354015|9836334|FG001|STARTED|Overall Study||48
8785067|NCT01354015|9836333|FG000|COMPLETED|Overall Study||44
8785068|NCT01354015|9836334|FG001|COMPLETED|Overall Study||43
8785069|NCT01354015|9836333|FG000|NOT COMPLETED|Overall Study||6
8785070|NCT01354015|9836334|FG001|NOT COMPLETED|Overall Study||5
8785071|NCT01354028|9836340|FG000|STARTED|Overall Study||15
8785072|NCT01354028|9836341|FG001|STARTED|Overall Study||15
8785073|NCT01354028|9836340|FG000|COMPLETED|Overall Study||13
8785074|NCT01354028|9836341|FG001|COMPLETED|Overall Study||10
8785075|NCT01354028|9836340|FG000|NOT COMPLETED|Overall Study||2
8785076|NCT01354028|9836341|FG001|NOT COMPLETED|Overall Study||5
8785077|NCT01354106|9836353|FG000|STARTED|Overall Study||26
8785078|NCT01354106|9836353|FG000|COMPLETED|Overall Study||24
8785079|NCT01354106|9836353|FG000|NOT COMPLETED|Overall Study||2
8785080|NCT01354132|9836361|FG000|STARTED|Randomization|1 never took study medication dropped by physician decision (White matter lesion on MRI)|32
8785081|NCT01354132|9836362|FG001|STARTED|Randomization|1 never took study medication due to subject withdrawal|31
8785082|NCT01354132|9836361|FG000|COMPLETED|Randomization||31
8785083|NCT01354132|9836362|FG001|COMPLETED|Randomization||30
8785084|NCT01354132|9836361|FG000|NOT COMPLETED|Randomization||1
8785085|NCT01354132|9836362|FG001|NOT COMPLETED|Randomization||1
8785086|NCT01354132|9836361|FG000|STARTED|Double Blind (Visits 1-7)|9 did not compete 7 study visits|31
8785087|NCT01354132|9836362|FG001|STARTED|Double Blind (Visits 1-7)|11 did not compete 7 study visits|30
8785088|NCT01354132|9836361|FG000|Completed More Than 1 Visit|Double Blind (Visits 1-7)||4
8785089|NCT01354132|9836362|FG001|Completed More Than 1 Visit|Double Blind (Visits 1-7)||5
8785090|NCT01354132|9836361|FG000|Stopped After First Visit|Double Blind (Visits 1-7)||3
8785091|NCT01354132|9836362|FG001|Stopped After First Visit|Double Blind (Visits 1-7)||2
8785092|NCT01354132|9836361|FG000|Didn't Complete at Least 1 Visit|Double Blind (Visits 1-7)||2
8785093|NCT01354132|9836362|FG001|Didn't Complete at Least 1 Visit|Double Blind (Visits 1-7)||4
8785094|NCT01354132|9836361|FG000|COMPLETED|Double Blind (Visits 1-7)||22
8785095|NCT01354132|9836362|FG001|COMPLETED|Double Blind (Visits 1-7)||19
8785096|NCT01354132|9836361|FG000|NOT COMPLETED|Double Blind (Visits 1-7)||9
8785097|NCT01354132|9836362|FG001|NOT COMPLETED|Double Blind (Visits 1-7)||11
8785098|NCT01354132|9836361|FG000|STARTED|1 Month Post Study Medication||22
8785099|NCT01354132|9836362|FG001|STARTED|1 Month Post Study Medication||19
8785100|NCT01354132|9836361|FG000|1 Follow-up Visit (Visit 8)|1 Month Post Study Medication||21
8785101|NCT01354132|9836362|FG001|1 Follow-up Visit (Visit 8)|1 Month Post Study Medication||16
8785102|NCT01354132|9836361|FG000|COMPLETED|1 Month Post Study Medication||21
8785103|NCT01354132|9836362|FG001|COMPLETED|1 Month Post Study Medication||16
8785104|NCT01354132|9836361|FG000|NOT COMPLETED|1 Month Post Study Medication||1
8785105|NCT01354132|9836362|FG001|NOT COMPLETED|1 Month Post Study Medication||3
8785106|NCT01354145|9836373|FG000|STARTED|Overall Study||97
8785107|NCT01354145|9836374|FG001|STARTED|Overall Study||97
8785108|NCT01354145|9836373|FG000|COMPLETED|Overall Study||58
8785109|NCT01354145|9836374|FG001|COMPLETED|Overall Study||63
8785110|NCT01354145|9836373|FG000|NOT COMPLETED|Overall Study||39
8785111|NCT01354145|9836374|FG001|NOT COMPLETED|Overall Study||34
8785112|NCT01354197|9836382|FG000|STARTED|Overall Study||4652
8785113|NCT01354197|9836382|FG000|COMPLETED|Overall Study||4652
8785114|NCT01354197|9836382|FG000|NOT COMPLETED|Overall Study||0
8785115|NCT01354223|9836389|FG000|STARTED|Overall Study||60
8785116|NCT01354223|9836390|FG001|STARTED|Overall Study||30
8785117|NCT01354223|9836389|FG000|COMPLETED|Overall Study||57
8785118|NCT01354223|9836390|FG001|COMPLETED|Overall Study||29
8785119|NCT01354223|9836389|FG000|NOT COMPLETED|Overall Study||3
8785120|NCT01354223|9836390|FG001|NOT COMPLETED|Overall Study||1
8785121|NCT01354314|9836400|FG000|STARTED|Overall Study||12
8785122|NCT01354314|9836401|FG001|STARTED|Overall Study||11
8785123|NCT01354314|9836402|FG002|STARTED|Overall Study||11
8785124|NCT01354314|9836403|FG003|STARTED|Overall Study||11
8785125|NCT01354314|9836400|FG000|Completed (ITT)|Overall Study||11
8785126|NCT01354314|9836401|FG001|Completed (ITT)|Overall Study||11
8785127|NCT01354314|9836402|FG002|Completed (ITT)|Overall Study||9
8785128|NCT01354314|9836403|FG003|Completed (ITT)|Overall Study||10
8785129|NCT01354314|9836400|FG000|COMPLETED|Overall Study||6
8785130|NCT01354314|9836401|FG001|COMPLETED|Overall Study||8
8785131|NCT01354314|9836402|FG002|COMPLETED|Overall Study||3
8785132|NCT01354314|9836403|FG003|COMPLETED|Overall Study||5
8785133|NCT01354314|9836400|FG000|NOT COMPLETED|Overall Study||6
8785134|NCT01354314|9836401|FG001|NOT COMPLETED|Overall Study||3
8785135|NCT01354314|9836402|FG002|NOT COMPLETED|Overall Study||8
8785136|NCT01354314|9836403|FG003|NOT COMPLETED|Overall Study||6
8785137|NCT01354353|9836421|FG000|STARTED|Overall Study||16
8785138|NCT01354353|9836422|FG001|STARTED|Overall Study|Included in this arm are six participants who erroneously received oral 80 mg LY2140023 BID.|12
8785139|NCT01354353|9836423|FG002|STARTED|Overall Study||11
8785140|NCT01354353|9836424|FG003|STARTED|Overall Study||12
8785141|NCT01354353|9836425|FG004|STARTED|Overall Study||12
8785142|NCT01354353|9836426|FG005|STARTED|Overall Study||12
8785143|NCT01354353|9836421|FG000|Received at Least One Dose of Study Drug|Overall Study||16
8785144|NCT01354353|9836422|FG001|Received at Least One Dose of Study Drug|Overall Study||11
8785145|NCT01354353|9836423|FG002|Received at Least One Dose of Study Drug|Overall Study||10
8785146|NCT01354353|9836424|FG003|Received at Least One Dose of Study Drug|Overall Study||11
8785147|NCT01354353|9836425|FG004|Received at Least One Dose of Study Drug|Overall Study||11
8785148|NCT01354353|9836426|FG005|Received at Least One Dose of Study Drug|Overall Study||11
8785149|NCT01354353|9836421|FG000|COMPLETED|Overall Study||13
8785150|NCT01354353|9836422|FG001|COMPLETED|Overall Study||11
8785151|NCT01354353|9836423|FG002|COMPLETED|Overall Study||9
8785152|NCT01354353|9836424|FG003|COMPLETED|Overall Study||7
8785153|NCT01354353|9836425|FG004|COMPLETED|Overall Study||11
8785154|NCT01354353|9836426|FG005|COMPLETED|Overall Study||6
8785155|NCT01354353|9836421|FG000|NOT COMPLETED|Overall Study||3
8785156|NCT01354353|9836422|FG001|NOT COMPLETED|Overall Study||1
8785157|NCT01354353|9836423|FG002|NOT COMPLETED|Overall Study||2
8785158|NCT01354353|9836424|FG003|NOT COMPLETED|Overall Study||5
8785159|NCT01354353|9836425|FG004|NOT COMPLETED|Overall Study||1
8785160|NCT01354353|9836426|FG005|NOT COMPLETED|Overall Study||6
8785161|NCT01354444|9836449|FG000|STARTED|Overall Study||14
8916740|NCT02185729|9976258|FG000|NOT COMPLETED|24 Hours Into Dextrose Infusion||0
9030983|NCT03236506|10093059|FG002|STARTED|Overall Study||47
9030984|NCT03236506|10093057|FG000|COMPLETED|Overall Study||33
9030985|NCT03236506|10093058|FG001|COMPLETED|Overall Study||37
9030986|NCT03236506|10093059|FG002|COMPLETED|Overall Study||40
9030987|NCT03236506|10093057|FG000|NOT COMPLETED|Overall Study||6
9030988|NCT03236506|10093058|FG001|NOT COMPLETED|Overall Study||5
9030989|NCT03236506|10093059|FG002|NOT COMPLETED|Overall Study||7
9030990|NCT03236779|10093069|FG000|STARTED|Overall Study||51
9030991|NCT03236779|10093070|FG001|STARTED|Overall Study||51
9030992|NCT03236779|10093069|FG000|COMPLETED|Overall Study||38
9030993|NCT03236779|10093070|FG001|COMPLETED|Overall Study||30
9030994|NCT03236779|10093069|FG000|NOT COMPLETED|Overall Study||13
9030995|NCT03236779|10093070|FG001|NOT COMPLETED|Overall Study||21
9030996|NCT03237013|10093081|FG000|STARTED|Baseline to Immediate Post-treatment||73
9030997|NCT03237013|10093082|FG001|STARTED|Baseline to Immediate Post-treatment||73
9030998|NCT03237013|10093083|FG002|STARTED|Baseline to Immediate Post-treatment||73
9030999|NCT03237013|10093081|FG000|COMPLETED|Baseline to Immediate Post-treatment||73
8785162|NCT01354444|9836450|FG001|STARTED|Overall Study||15
8785163|NCT01354444|9836449|FG000|COMPLETED|Overall Study||6
8785164|NCT01354444|9836450|FG001|COMPLETED|Overall Study||11
8916741|NCT02185794|9976271|FG000|STARTED|Overall Study||9
8916742|NCT02185794|9976272|FG001|STARTED|Overall Study||20
8916743|NCT02185794|9976273|FG002|STARTED|Overall Study||33
8916744|NCT02185794|9976274|FG003|STARTED|Overall Study||16
8916745|NCT02185794|9976275|FG004|STARTED|Overall Study||7
8916746|NCT02185794|9976276|FG005|STARTED|Overall Study||16
8916747|NCT02185794|9976271|FG000|COMPLETED|Overall Study||4
8916748|NCT02185794|9976272|FG001|COMPLETED|Overall Study||7
8916749|NCT02185794|9976273|FG002|COMPLETED|Overall Study||17
8916750|NCT02185794|9976274|FG003|COMPLETED|Overall Study||8
8916751|NCT02185794|9976275|FG004|COMPLETED|Overall Study||4
8916752|NCT02185794|9976276|FG005|COMPLETED|Overall Study||0
8916753|NCT02185794|9976271|FG000|NOT COMPLETED|Overall Study||5
8916754|NCT02185794|9976272|FG001|NOT COMPLETED|Overall Study||13
8916755|NCT02185794|9976273|FG002|NOT COMPLETED|Overall Study||16
8916756|NCT02185794|9976274|FG003|NOT COMPLETED|Overall Study||8
8916757|NCT02185794|9976275|FG004|NOT COMPLETED|Overall Study||3
9031000|NCT03237013|10093082|FG001|COMPLETED|Baseline to Immediate Post-treatment||73
9031001|NCT03237013|10093083|FG002|COMPLETED|Baseline to Immediate Post-treatment||73
9031002|NCT03237013|10093081|FG000|NOT COMPLETED|Baseline to Immediate Post-treatment||0
9031003|NCT03237013|10093082|FG001|NOT COMPLETED|Baseline to Immediate Post-treatment||0
9031004|NCT03237013|10093083|FG002|NOT COMPLETED|Baseline to Immediate Post-treatment||0
9031005|NCT03237013|10093081|FG000|STARTED|Immediate Post-treatment to 1-mo F/u||73
9031006|NCT03237013|10093082|FG001|STARTED|Immediate Post-treatment to 1-mo F/u||73
8785165|NCT01354444|9836449|FG000|NOT COMPLETED|Overall Study||8
8785166|NCT01354444|9836450|FG001|NOT COMPLETED|Overall Study||4
8785167|NCT01354496|9836460|FG000|STARTED|Period 1||6
8785168|NCT01354496|9836461|FG001|STARTED|Period 1||6
8785169|NCT01354496|9836462|FG002|STARTED|Period 1||6
8785170|NCT01354496|9836463|FG003|STARTED|Period 1||6
8785171|NCT01354496|9836464|FG004|STARTED|Period 1||5
8785172|NCT01354496|9836465|FG005|STARTED|Period 1||6
8785173|NCT01354496|9836460|FG000|Received at Least 1 Dose of Study Drug|Period 1||6
8785174|NCT01354496|9836461|FG001|Received at Least 1 Dose of Study Drug|Period 1||6
8785175|NCT01354496|9836462|FG002|Received at Least 1 Dose of Study Drug|Period 1||6
8785176|NCT01354496|9836463|FG003|Received at Least 1 Dose of Study Drug|Period 1||6
9031007|NCT03237013|10093083|FG002|STARTED|Immediate Post-treatment to 1-mo F/u||73
9031008|NCT03237013|10093081|FG000|COMPLETED|Immediate Post-treatment to 1-mo F/u||30
9031009|NCT03237013|10093082|FG001|COMPLETED|Immediate Post-treatment to 1-mo F/u||43
9031010|NCT03237013|10093083|FG002|COMPLETED|Immediate Post-treatment to 1-mo F/u||36
9031011|NCT03237013|10093081|FG000|NOT COMPLETED|Immediate Post-treatment to 1-mo F/u||43
9031012|NCT03237013|10093082|FG001|NOT COMPLETED|Immediate Post-treatment to 1-mo F/u||30
9031013|NCT03237013|10093083|FG002|NOT COMPLETED|Immediate Post-treatment to 1-mo F/u||37
9031014|NCT03237065|10093093|FG000|STARTED|Overall Study||61
9031015|NCT03237065|10093094|FG001|STARTED|Overall Study||61
9031016|NCT03237065|10093093|FG000|Safety Analysis Set|Overall Study|1 subject from ferric carboxymaltose group received iron isomaltoside/ferric derisomaltose in error.|62
9031017|NCT03237065|10093094|FG001|Safety Analysis Set|Overall Study||57
9031018|NCT03237065|10093093|FG000|COMPLETED|Overall Study||57
9031019|NCT03237065|10093094|FG001|COMPLETED|Overall Study||57
9031020|NCT03237065|10093093|FG000|NOT COMPLETED|Overall Study||4
9031021|NCT03237065|10093094|FG001|NOT COMPLETED|Overall Study||4
9031022|NCT03237156|10093104|FG000|STARTED|Overall Study||6
9031023|NCT03237156|10093105|FG001|STARTED|Overall Study||6
9031024|NCT03237156|10093106|FG002|STARTED|Overall Study||6
9031025|NCT03237156|10093107|FG003|STARTED|Overall Study||6
9031026|NCT03237156|10093104|FG000|COMPLETED|Overall Study||6
9031027|NCT03237156|10093105|FG001|COMPLETED|Overall Study||6
9031028|NCT03237156|10093106|FG002|COMPLETED|Overall Study||6
9031029|NCT03237156|10093107|FG003|COMPLETED|Overall Study||6
9031030|NCT03237156|10093104|FG000|NOT COMPLETED|Overall Study||0
9031031|NCT03237156|10093105|FG001|NOT COMPLETED|Overall Study||0
9031032|NCT03237156|10093106|FG002|NOT COMPLETED|Overall Study||0
9031033|NCT03237156|10093107|FG003|NOT COMPLETED|Overall Study||0
9031034|NCT03237481|10093123|FG000|STARTED|Overall Study||164
9031035|NCT03237481|10093124|FG001|STARTED|Overall Study||172
9031036|NCT03237481|10093125|FG002|STARTED|Overall Study||82
9031037|NCT03237481|10093123|FG000|COMPLETED|Overall Study||159
9031038|NCT03237481|10093124|FG001|COMPLETED|Overall Study||170
9031039|NCT03237481|10093125|FG002|COMPLETED|Overall Study||81
9031040|NCT03237481|10093123|FG000|NOT COMPLETED|Overall Study||5
9031041|NCT03237481|10093124|FG001|NOT COMPLETED|Overall Study||2
9031042|NCT03237481|10093125|FG002|NOT COMPLETED|Overall Study||1
9031043|NCT03237845|10093135|FG000|STARTED|Overall Study||594
9031044|NCT03237845|10093136|FG001|STARTED|Overall Study||592
9031045|NCT03237845|10093135|FG000|Treated|Overall Study||543
9031046|NCT03237845|10093136|FG001|Treated|Overall Study||543
9031047|NCT03237845|10093135|FG000|COMPLETED|Overall Study||538
9031048|NCT03237845|10093136|FG001|COMPLETED|Overall Study||542
9031049|NCT03237845|10093135|FG000|NOT COMPLETED|Overall Study||56
9031050|NCT03237845|10093136|FG001|NOT COMPLETED|Overall Study||50
9031051|NCT03237871|10093142|FG000|STARTED|Overall Study||17
9031052|NCT03237871|10093142|FG000|COMPLETED|Overall Study||11
9031053|NCT03237871|10093142|FG000|NOT COMPLETED|Overall Study||6
9031054|NCT03238001|10093146|FG000|STARTED|Visit 1 (Primary Endpoint Cohort)||436
9031055|NCT03238001|10093146|FG000|COMPLETED|Visit 1 (Primary Endpoint Cohort)||432
9031056|NCT03238001|10093146|FG000|NOT COMPLETED|Visit 1 (Primary Endpoint Cohort)||4
9031057|NCT03238001|10093146|FG000|STARTED|Visit 2 (Secondary Endpoint Cohort)||432
9031058|NCT03238001|10093146|FG000|COMPLETED|Visit 2 (Secondary Endpoint Cohort)||403
9031059|NCT03238001|10093146|FG000|NOT COMPLETED|Visit 2 (Secondary Endpoint Cohort)||29
9031060|NCT03238352|10093161|FG000|STARTED|Overall Study||43
9031061|NCT03238352|10093162|FG001|STARTED|Overall Study||23
9031062|NCT03238352|10093163|FG002|STARTED|Overall Study||23
9031063|NCT03238352|10093161|FG000|COMPLETED|Overall Study||43
9031064|NCT03238352|10093162|FG001|COMPLETED|Overall Study||20
9031065|NCT03238352|10093163|FG002|COMPLETED|Overall Study||22
9031066|NCT03238352|10093161|FG000|NOT COMPLETED|Overall Study||0
8671882|NCT00754130|9715283|FG000|STARTED|Period 2 (5 Days)|One participant received MK-0941 15 mg starting with Dose 2 on Day 2.|2
8671883|NCT00754130|9715284|FG001|STARTED|Period 2 (5 Days)||2
8671884|NCT00754130|9715285|FG002|STARTED|Period 2 (5 Days)||4
8671885|NCT00754130|9715286|FG003|STARTED|Period 2 (5 Days)||2
8671886|NCT00754130|9715287|FG004|STARTED|Period 2 (5 Days)||2
8671887|NCT00754130|9715288|FG005|STARTED|Period 2 (5 Days)|One participant received MK-0941 35 mg starting with Dose 3 on Day 3.|4
8671888|NCT00754130|9715283|FG000|COMPLETED|Period 2 (5 Days)||2
8671889|NCT00754130|9715284|FG001|COMPLETED|Period 2 (5 Days)||2
8671890|NCT00754130|9715285|FG002|COMPLETED|Period 2 (5 Days)||4
8671891|NCT00754130|9715286|FG003|COMPLETED|Period 2 (5 Days)||2
8671892|NCT00754130|9715287|FG004|COMPLETED|Period 2 (5 Days)||2
8671893|NCT00754130|9715288|FG005|COMPLETED|Period 2 (5 Days)||4
8671894|NCT00754130|9715283|FG000|NOT COMPLETED|Period 2 (5 Days)||0
8671895|NCT00754130|9715284|FG001|NOT COMPLETED|Period 2 (5 Days)||0
8785177|NCT01354496|9836464|FG004|Received at Least 1 Dose of Study Drug|Period 1||5
8785178|NCT01354496|9836465|FG005|Received at Least 1 Dose of Study Drug|Period 1||6
8785179|NCT01354496|9836460|FG000|COMPLETED|Period 1||6
8785180|NCT01354496|9836461|FG001|COMPLETED|Period 1||6
8785181|NCT01354496|9836462|FG002|COMPLETED|Period 1||4
8785182|NCT01354496|9836463|FG003|COMPLETED|Period 1||6
8785183|NCT01354496|9836464|FG004|COMPLETED|Period 1||5
8785184|NCT01354496|9836465|FG005|COMPLETED|Period 1||6
8785185|NCT01354496|9836460|FG000|NOT COMPLETED|Period 1||0
8785186|NCT01354496|9836461|FG001|NOT COMPLETED|Period 1||0
8785187|NCT01354496|9836462|FG002|NOT COMPLETED|Period 1||2
8785188|NCT01354496|9836463|FG003|NOT COMPLETED|Period 1||0
8785189|NCT01354496|9836464|FG004|NOT COMPLETED|Period 1||0
8785190|NCT01354496|9836465|FG005|NOT COMPLETED|Period 1||0
8785191|NCT01354496|9836460|FG000|STARTED|Washout (at Least 14 Days)||6
8785192|NCT01354496|9836461|FG001|STARTED|Washout (at Least 14 Days)||6
8785193|NCT01354496|9836462|FG002|STARTED|Washout (at Least 14 Days)||4
8785194|NCT01354496|9836463|FG003|STARTED|Washout (at Least 14 Days)||6
8785195|NCT01354496|9836464|FG004|STARTED|Washout (at Least 14 Days)||5
8785196|NCT01354496|9836465|FG005|STARTED|Washout (at Least 14 Days)||6
8785197|NCT01354496|9836460|FG000|COMPLETED|Washout (at Least 14 Days)||6
8785198|NCT01354496|9836461|FG001|COMPLETED|Washout (at Least 14 Days)||6
8785199|NCT01354496|9836462|FG002|COMPLETED|Washout (at Least 14 Days)||4
8785200|NCT01354496|9836463|FG003|COMPLETED|Washout (at Least 14 Days)||6
8785201|NCT01354496|9836464|FG004|COMPLETED|Washout (at Least 14 Days)||5
8785202|NCT01354496|9836465|FG005|COMPLETED|Washout (at Least 14 Days)||6
8785203|NCT01354496|9836460|FG000|NOT COMPLETED|Washout (at Least 14 Days)||0
8785204|NCT01354496|9836461|FG001|NOT COMPLETED|Washout (at Least 14 Days)||0
8785205|NCT01354496|9836462|FG002|NOT COMPLETED|Washout (at Least 14 Days)||0
8785206|NCT01354496|9836463|FG003|NOT COMPLETED|Washout (at Least 14 Days)||0
8785207|NCT01354496|9836464|FG004|NOT COMPLETED|Washout (at Least 14 Days)||0
8785208|NCT01354496|9836465|FG005|NOT COMPLETED|Washout (at Least 14 Days)||0
8785209|NCT01354496|9836460|FG000|STARTED|Period 2||6
8785210|NCT01354496|9836461|FG001|STARTED|Period 2||6
8785211|NCT01354496|9836462|FG002|STARTED|Period 2||4
8785212|NCT01354496|9836463|FG003|STARTED|Period 2||6
8785213|NCT01354496|9836464|FG004|STARTED|Period 2||5
8785214|NCT01354496|9836465|FG005|STARTED|Period 2||6
8785215|NCT01354496|9836460|FG000|COMPLETED|Period 2||6
8785216|NCT01354496|9836461|FG001|COMPLETED|Period 2||6
8785217|NCT01354496|9836462|FG002|COMPLETED|Period 2||4
8785218|NCT01354496|9836463|FG003|COMPLETED|Period 2||5
8785219|NCT01354496|9836464|FG004|COMPLETED|Period 2||5
8785220|NCT01354496|9836465|FG005|COMPLETED|Period 2||6
8785221|NCT01354496|9836460|FG000|NOT COMPLETED|Period 2||0
8785222|NCT01354496|9836461|FG001|NOT COMPLETED|Period 2||0
8785223|NCT01354496|9836462|FG002|NOT COMPLETED|Period 2||0
8785224|NCT01354496|9836463|FG003|NOT COMPLETED|Period 2||1
8785225|NCT01354496|9836464|FG004|NOT COMPLETED|Period 2||0
8785226|NCT01354496|9836465|FG005|NOT COMPLETED|Period 2||0
8785227|NCT01354496|9836460|FG000|STARTED|Washout (at Least 14 Days)||6
8785228|NCT01354496|9836461|FG001|STARTED|Washout (at Least 14 Days)||6
8785229|NCT01354496|9836462|FG002|STARTED|Washout (at Least 14 Days)||4
8785230|NCT01354496|9836463|FG003|STARTED|Washout (at Least 14 Days)||5
8785231|NCT01354496|9836464|FG004|STARTED|Washout (at Least 14 Days)||5
8785232|NCT01354496|9836465|FG005|STARTED|Washout (at Least 14 Days)||6
8785233|NCT01354496|9836460|FG000|COMPLETED|Washout (at Least 14 Days)||6
8785234|NCT01354496|9836461|FG001|COMPLETED|Washout (at Least 14 Days)||5
8785235|NCT01354496|9836462|FG002|COMPLETED|Washout (at Least 14 Days)||4
8785236|NCT01354496|9836463|FG003|COMPLETED|Washout (at Least 14 Days)||4
8785237|NCT01354496|9836464|FG004|COMPLETED|Washout (at Least 14 Days)||5
8785238|NCT01354496|9836465|FG005|COMPLETED|Washout (at Least 14 Days)||6
8785239|NCT01354496|9836460|FG000|NOT COMPLETED|Washout (at Least 14 Days)||0
8785240|NCT01354496|9836461|FG001|NOT COMPLETED|Washout (at Least 14 Days)||1
8785241|NCT01354496|9836462|FG002|NOT COMPLETED|Washout (at Least 14 Days)||0
8785242|NCT01354496|9836463|FG003|NOT COMPLETED|Washout (at Least 14 Days)||1
8785243|NCT01354496|9836464|FG004|NOT COMPLETED|Washout (at Least 14 Days)||0
8785244|NCT01354496|9836465|FG005|NOT COMPLETED|Washout (at Least 14 Days)||0
8785245|NCT01354496|9836460|FG000|STARTED|Period 3||6
8785246|NCT01354496|9836461|FG001|STARTED|Period 3||5
8785247|NCT01354496|9836462|FG002|STARTED|Period 3||4
8785248|NCT01354496|9836463|FG003|STARTED|Period 3||4
8785249|NCT01354496|9836464|FG004|STARTED|Period 3||5
8785250|NCT01354496|9836465|FG005|STARTED|Period 3||6
8785251|NCT01354496|9836460|FG000|COMPLETED|Period 3||6
8785252|NCT01354496|9836461|FG001|COMPLETED|Period 3||5
8785253|NCT01354496|9836462|FG002|COMPLETED|Period 3||4
8785254|NCT01354496|9836463|FG003|COMPLETED|Period 3||4
8785255|NCT01354496|9836464|FG004|COMPLETED|Period 3||5
8785256|NCT01354496|9836465|FG005|COMPLETED|Period 3||6
8785257|NCT01354496|9836460|FG000|NOT COMPLETED|Period 3||0
8785258|NCT01354496|9836461|FG001|NOT COMPLETED|Period 3||0
8785259|NCT01354496|9836462|FG002|NOT COMPLETED|Period 3||0
8785260|NCT01354496|9836463|FG003|NOT COMPLETED|Period 3||0
8785261|NCT01354496|9836464|FG004|NOT COMPLETED|Period 3||0
8785262|NCT01354496|9836465|FG005|NOT COMPLETED|Period 3||0
8785263|NCT01354652|9836489|FG000|STARTED|Overall Study||3
8785264|NCT01354652|9836490|FG001|STARTED|Overall Study||2
8785265|NCT01354652|9836491|FG002|STARTED|Overall Study||0
8785266|NCT01354652|9836489|FG000|COMPLETED|Overall Study||0
8785267|NCT01354652|9836490|FG001|COMPLETED|Overall Study||0
8785268|NCT01354652|9836491|FG002|COMPLETED|Overall Study||0
8785269|NCT01354652|9836489|FG000|NOT COMPLETED|Overall Study||3
8785270|NCT01354652|9836490|FG001|NOT COMPLETED|Overall Study||2
8785271|NCT01354652|9836491|FG002|NOT COMPLETED|Overall Study||0
8785272|NCT01354691|9836502|FG000|STARTED|Overall Study||101
8785273|NCT01354691|9836503|FG001|STARTED|Overall Study||99
8785274|NCT01354691|9836502|FG000|ITT|Overall Study||99
8785275|NCT01354691|9836503|FG001|ITT|Overall Study||96
8785276|NCT01354691|9836502|FG000|PP|Overall Study||79
8785277|NCT01354691|9836503|FG001|PP|Overall Study||75
8785278|NCT01354691|9836502|FG000|COMPLETED|Overall Study||80
8785279|NCT01354691|9836503|FG001|COMPLETED|Overall Study||77
8785280|NCT01354691|9836502|FG000|NOT COMPLETED|Overall Study||21
8785281|NCT01354691|9836503|FG001|NOT COMPLETED|Overall Study||22
8785282|NCT01354899|9836509|FG000|STARTED|Overall Study||24
8785283|NCT01354899|9836509|FG000|COMPLETED|Overall Study||21
8785284|NCT01354899|9836509|FG000|NOT COMPLETED|Overall Study||3
8785285|NCT01354938|9836513|FG000|STARTED|Overall Study||220
8785286|NCT01354938|9836513|FG000|COMPLETED|Overall Study||219
8785287|NCT01354938|9836513|FG000|NOT COMPLETED|Overall Study||1
8785288|NCT01354964|9836519|FG000|STARTED|Overall Study||11
8785289|NCT01354964|9836520|FG001|STARTED|Overall Study||8
8785290|NCT01354964|9836519|FG000|COMPLETED|Overall Study||7
8785291|NCT01354964|9836520|FG001|COMPLETED|Overall Study||7
8785292|NCT01354964|9836519|FG000|NOT COMPLETED|Overall Study||4
8785293|NCT01354964|9836520|FG001|NOT COMPLETED|Overall Study||1
8785294|NCT01354990|9836528|FG000|STARTED|Overall Study||2974
8785295|NCT01354990|9836528|FG000|COMPLETED|Overall Study||2974
8785296|NCT01354990|9836528|FG000|NOT COMPLETED|Overall Study||0
8785297|NCT01355068|9836532|FG000|STARTED|First Intervention Period||13
8785298|NCT01355068|9836533|FG001|STARTED|First Intervention Period||13
8785299|NCT01355068|9836532|FG000|COMPLETED|First Intervention Period||13
8785300|NCT01355068|9836533|FG001|COMPLETED|First Intervention Period||11
8785301|NCT01355068|9836532|FG000|NOT COMPLETED|First Intervention Period||0
8785302|NCT01355068|9836533|FG001|NOT COMPLETED|First Intervention Period||2
8785303|NCT01355068|9836532|FG000|STARTED|Washout Period (at Least 7 Days)||13
8785304|NCT01355068|9836533|FG001|STARTED|Washout Period (at Least 7 Days)||11
8785305|NCT01355068|9836532|FG000|COMPLETED|Washout Period (at Least 7 Days)||13
8785306|NCT01355068|9836533|FG001|COMPLETED|Washout Period (at Least 7 Days)||11
8785307|NCT01355068|9836532|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8785308|NCT01355068|9836533|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8785309|NCT01355068|9836532|FG000|STARTED|Second Intervention Period||13
8785310|NCT01355068|9836533|FG001|STARTED|Second Intervention Period||11
8785311|NCT01355068|9836532|FG000|COMPLETED|Second Intervention Period||13
8785312|NCT01355068|9836533|FG001|COMPLETED|Second Intervention Period||11
8785313|NCT01355068|9836532|FG000|NOT COMPLETED|Second Intervention Period||0
8785314|NCT01355068|9836533|FG001|NOT COMPLETED|Second Intervention Period||0
8785315|NCT01355081|9836542|FG000|STARTED|Overall Study||119
8785316|NCT01355081|9836543|FG001|STARTED|Overall Study||123
8785317|NCT01355081|9836544|FG002|STARTED|Overall Study||124
8785318|NCT01355081|9836542|FG000|COMPLETED|Overall Study||112
8785319|NCT01355081|9836543|FG001|COMPLETED|Overall Study||113
8785320|NCT01355081|9836544|FG002|COMPLETED|Overall Study||113
8785321|NCT01355081|9836542|FG000|NOT COMPLETED|Overall Study||7
8785322|NCT01355081|9836543|FG001|NOT COMPLETED|Overall Study||10
8785323|NCT01355081|9836544|FG002|NOT COMPLETED|Overall Study||11
8785324|NCT01355159|9836554|FG000|STARTED|Overall Study||1228
8785325|NCT01355159|9836555|FG001|STARTED|Overall Study||1236
8785326|NCT01355159|9836554|FG000|COMPLETED|Overall Study||1144
8785327|NCT01355159|9836555|FG001|COMPLETED|Overall Study||1157
8785328|NCT01355159|9836554|FG000|NOT COMPLETED|Overall Study||84
8785329|NCT01355159|9836555|FG001|NOT COMPLETED|Overall Study||79
8785330|NCT01355224|9836565|FG000|STARTED|Overall Study||198
8785331|NCT01355224|9836566|FG001|STARTED|Overall Study||203
8785332|NCT01355224|9836567|FG002|STARTED|Overall Study||196
8785333|NCT01355224|9836568|FG003|STARTED|Overall Study||201
8785334|NCT01355224|9836565|FG000|Competed Baseline|Overall Study||191
8785335|NCT01355224|9836566|FG001|Competed Baseline|Overall Study||200
8785336|NCT01355224|9836567|FG002|Competed Baseline|Overall Study||193
8785337|NCT01355224|9836568|FG003|Competed Baseline|Overall Study||193
8785338|NCT01355224|9836565|FG000|COMPLETED|Overall Study||167
8785339|NCT01355224|9836566|FG001|COMPLETED|Overall Study||180
8785340|NCT01355224|9836567|FG002|COMPLETED|Overall Study||177
8785341|NCT01355224|9836568|FG003|COMPLETED|Overall Study||172
8785342|NCT01355224|9836565|FG000|NOT COMPLETED|Overall Study||31
8785343|NCT01355224|9836566|FG001|NOT COMPLETED|Overall Study||23
8785344|NCT01355224|9836567|FG002|NOT COMPLETED|Overall Study||19
8785345|NCT01355224|9836568|FG003|NOT COMPLETED|Overall Study||29
8785346|NCT01355289|9836590|FG000|STARTED|Core Study||17
8785347|NCT01355289|9836591|FG001|STARTED|Core Study||16
8785348|NCT01355289|9836592|FG002|STARTED|Core Study||18
8785349|NCT01355289|9836593|FG003|STARTED|Core Study||14
8785350|NCT01355289|9836594|FG004|STARTED|Core Study||0
8785351|NCT01355289|9836590|FG000|COMPLETED|Core Study||16
8785352|NCT01355289|9836591|FG001|COMPLETED|Core Study||16
8785353|NCT01355289|9836592|FG002|COMPLETED|Core Study||18
8785354|NCT01355289|9836593|FG003|COMPLETED|Core Study||12
8785355|NCT01355289|9836594|FG004|COMPLETED|Core Study||0
8785356|NCT01355289|9836590|FG000|NOT COMPLETED|Core Study||1
8785357|NCT01355289|9836591|FG001|NOT COMPLETED|Core Study||0
8785358|NCT01355289|9836592|FG002|NOT COMPLETED|Core Study||0
8785359|NCT01355289|9836593|FG003|NOT COMPLETED|Core Study||2
8785360|NCT01355289|9836594|FG004|NOT COMPLETED|Core Study||0
8785361|NCT01355289|9836590|FG000|STARTED|Open Label Extension||0
8785362|NCT01355289|9836591|FG001|STARTED|Open Label Extension||0
8785363|NCT01355289|9836592|FG002|STARTED|Open Label Extension||0
8785364|NCT01355289|9836593|FG003|STARTED|Open Label Extension||0
8785365|NCT01355289|9836594|FG004|STARTED|Open Label Extension||62
8785366|NCT01355289|9836590|FG000|COMPLETED|Open Label Extension||0
8785367|NCT01355289|9836591|FG001|COMPLETED|Open Label Extension||0
8785368|NCT01355289|9836592|FG002|COMPLETED|Open Label Extension||0
8785369|NCT01355289|9836593|FG003|COMPLETED|Open Label Extension||0
8785370|NCT01355289|9836594|FG004|COMPLETED|Open Label Extension||28
8785371|NCT01355289|9836590|FG000|NOT COMPLETED|Open Label Extension||0
8785372|NCT01355289|9836591|FG001|NOT COMPLETED|Open Label Extension||0
8785373|NCT01355289|9836592|FG002|NOT COMPLETED|Open Label Extension||0
8785374|NCT01355289|9836593|FG003|NOT COMPLETED|Open Label Extension||0
8785375|NCT01355289|9836594|FG004|NOT COMPLETED|Open Label Extension||34
8785376|NCT01355302|9836607|FG000|STARTED|Phase 1b|Replaced 1 subject; who discontinued study drug in first cycle|7
8785377|NCT01355302|9836608|FG001|STARTED|Phase 1b||0
8785378|NCT01355302|9836609|FG002|STARTED|Phase 1b||0
8785379|NCT01355302|9836607|FG000|COMPLETED|Phase 1b|The subject who completed 6 cycles was withdrawn by sponsor request.|1
8785380|NCT01355302|9836608|FG001|COMPLETED|Phase 1b||0
8785381|NCT01355302|9836609|FG002|COMPLETED|Phase 1b||0
8785382|NCT01355302|9836607|FG000|NOT COMPLETED|Phase 1b||6
8785383|NCT01355302|9836608|FG001|NOT COMPLETED|Phase 1b||0
8785384|NCT01355302|9836609|FG002|NOT COMPLETED|Phase 1b||0
8785385|NCT01355302|9836607|FG000|STARTED|Phase 2|Treatment arm not designated for phase 2.|0
8785386|NCT01355302|9836608|FG001|STARTED|Phase 2|The study was terminated prior to enrollment|0
8785387|NCT01355302|9836609|FG002|STARTED|Phase 2|The study was terminated prior to enrollment|0
8785388|NCT01355302|9836607|FG000|COMPLETED|Phase 2||0
8785389|NCT01355302|9836608|FG001|COMPLETED|Phase 2||0
8785390|NCT01355302|9836609|FG002|COMPLETED|Phase 2||0
8785391|NCT01355302|9836607|FG000|NOT COMPLETED|Phase 2||0
8785392|NCT01355302|9836608|FG001|NOT COMPLETED|Phase 2||0
8785393|NCT01355302|9836609|FG002|NOT COMPLETED|Phase 2||0
8785394|NCT01355419|9836617|FG000|STARTED|Overall Study||150
8785395|NCT01355419|9836617|FG000|COMPLETED|Overall Study||142
8785396|NCT01355419|9836617|FG000|NOT COMPLETED|Overall Study||8
8785397|NCT01355458|9836623|FG000|STARTED|Overall Study||129
8785398|NCT01355458|9836624|FG001|STARTED|Overall Study||131
8785399|NCT01355458|9836623|FG000|COMPLETED|Overall Study||127
8785400|NCT01355458|9836624|FG001|COMPLETED|Overall Study||127
8785401|NCT01355458|9836623|FG000|NOT COMPLETED|Overall Study||2
8916758|NCT02185794|9976276|FG005|NOT COMPLETED|Overall Study||16
8916759|NCT02186015|9976306|FG000|STARTED|Overall Study||11
8916760|NCT02186015|9976307|FG001|STARTED|Overall Study||31
8916761|NCT02186015|9976306|FG000|COMPLETED|Overall Study||10
8916762|NCT02186015|9976307|FG001|COMPLETED|Overall Study||31
8916763|NCT02186015|9976306|FG000|NOT COMPLETED|Overall Study||1
8916764|NCT02186015|9976307|FG001|NOT COMPLETED|Overall Study||0
8916765|NCT02186171|9976316|FG000|STARTED|Overall Study||82
8916766|NCT02186171|9976317|FG001|STARTED|Overall Study||163
8916767|NCT02186171|9976316|FG000|Received Treatment|Overall Study||81
8916768|NCT02186171|9976317|FG001|Received Treatment|Overall Study||163
8916769|NCT02186171|9976316|FG000|COMPLETED|Overall Study||78
8916770|NCT02186171|9976317|FG001|COMPLETED|Overall Study||148
9031067|NCT03238352|10093162|FG001|NOT COMPLETED|Overall Study||3
9031068|NCT03238352|10093163|FG002|NOT COMPLETED|Overall Study||1
9031069|NCT03238417|10093173|FG000|STARTED|Overall||1330
9031070|NCT03238417|10093174|FG001|STARTED|Overall||2632
9031071|NCT03238417|10093173|FG000|COMPLETED|Overall||327
9031072|NCT03238417|10093174|FG001|COMPLETED|Overall||644
9031073|NCT03238417|10093173|FG000|NOT COMPLETED|Overall||1003
9031074|NCT03238417|10093174|FG001|NOT COMPLETED|Overall||1988
9031075|NCT03238417|10093173|FG000|STARTED|Baseline||513
9031076|NCT03238417|10093174|FG001|STARTED|Baseline||934
9031077|NCT03238417|10093173|FG000|COMPLETED|Baseline||124
9031078|NCT03238417|10093174|FG001|COMPLETED|Baseline||217
9031079|NCT03238417|10093173|FG000|NOT COMPLETED|Baseline||389
9031080|NCT03238417|10093174|FG001|NOT COMPLETED|Baseline||717
9031081|NCT03238417|10093173|FG000|STARTED|12-month||400
9031082|NCT03238417|10093174|FG001|STARTED|12-month||911
9031083|NCT03238417|10093173|FG000|COMPLETED|12-month||81
9031084|NCT03238417|10093174|FG001|COMPLETED|12-month||205
9031085|NCT03238417|10093173|FG000|NOT COMPLETED|12-month||319
9031086|NCT03238417|10093174|FG001|NOT COMPLETED|12-month||706
9031087|NCT03238417|10093173|FG000|STARTED|24-month||417
8785402|NCT01355458|9836624|FG001|NOT COMPLETED|Overall Study||4
8785403|NCT01355471|9836632|FG000|STARTED|Overall Study||148
8785404|NCT01355471|9836633|FG001|STARTED|Overall Study||145
8785405|NCT01355471|9836632|FG000|COMPLETED|Overall Study||141
8785406|NCT01355471|9836633|FG001|COMPLETED|Overall Study||142
8785407|NCT01355471|9836632|FG000|NOT COMPLETED|Overall Study||7
8916771|NCT02186171|9976316|FG000|NOT COMPLETED|Overall Study||4
8916772|NCT02186171|9976317|FG001|NOT COMPLETED|Overall Study||15
8916773|NCT02186210|9976325|FG000|STARTED|Overall Study||20
8916774|NCT02186210|9976326|FG001|STARTED|Overall Study||20
8916775|NCT02186210|9976325|FG000|COMPLETED|Overall Study||20
8916776|NCT02186210|9976326|FG001|COMPLETED|Overall Study||20
8916777|NCT02186210|9976325|FG000|NOT COMPLETED|Overall Study||0
8916778|NCT02186210|9976326|FG001|NOT COMPLETED|Overall Study||0
9031088|NCT03238417|10093174|FG001|STARTED|24-month||847
8785408|NCT01355471|9836633|FG001|NOT COMPLETED|Overall Study||3
8785409|NCT01355484|9836641|FG000|STARTED|Overall Study||160
8785410|NCT01355484|9836642|FG001|STARTED|Overall Study||161
9031089|NCT03238417|10093173|FG000|COMPLETED|24-month||122
8785411|NCT01355484|9836641|FG000|COMPLETED|Overall Study||109
8785412|NCT01355484|9836642|FG001|COMPLETED|Overall Study||107
8785413|NCT01355484|9836641|FG000|NOT COMPLETED|Overall Study||51
8785414|NCT01355484|9836642|FG001|NOT COMPLETED|Overall Study||54
8785415|NCT01355497|9836650|FG000|STARTED|Overall Study||165
8785416|NCT01355497|9836651|FG001|STARTED|Overall Study||165
8785417|NCT01355497|9836650|FG000|COMPLETED|Overall Study||99
8785418|NCT01355497|9836651|FG001|COMPLETED|Overall Study||102
8785419|NCT01355497|9836650|FG000|NOT COMPLETED|Overall Study||66
8785420|NCT01355497|9836651|FG001|NOT COMPLETED|Overall Study||63
8785421|NCT01355523|9836659|FG000|STARTED|Overall Study||28
8785422|NCT01355523|9836660|FG001|STARTED|Overall Study||26
8785423|NCT01355523|9836659|FG000|COMPLETED|Overall Study||27
8785424|NCT01355523|9836660|FG001|COMPLETED|Overall Study||16
8785425|NCT01355523|9836659|FG000|NOT COMPLETED|Overall Study||1
8785426|NCT01355523|9836660|FG001|NOT COMPLETED|Overall Study||10
8785427|NCT01355575|9836666|FG000|STARTED|Overall Study||15
8785428|NCT01355575|9836666|FG000|COMPLETED|Overall Study||13
8785429|NCT01355575|9836666|FG000|NOT COMPLETED|Overall Study||2
8785430|NCT01355588|9836678|FG000|STARTED|First Intervention (Day 1)||4
8785431|NCT01355588|9836679|FG001|STARTED|First Intervention (Day 1)||4
8785432|NCT01355588|9836680|FG002|STARTED|First Intervention (Day 1)||4
8785433|NCT01355588|9836681|FG003|STARTED|First Intervention (Day 1)||4
8785434|NCT01355588|9836678|FG000|COMPLETED|First Intervention (Day 1)||4
8785435|NCT01355588|9836679|FG001|COMPLETED|First Intervention (Day 1)||4
8785436|NCT01355588|9836680|FG002|COMPLETED|First Intervention (Day 1)||4
8785437|NCT01355588|9836681|FG003|COMPLETED|First Intervention (Day 1)||4
8785438|NCT01355588|9836678|FG000|NOT COMPLETED|First Intervention (Day 1)||0
8785439|NCT01355588|9836679|FG001|NOT COMPLETED|First Intervention (Day 1)||0
8785440|NCT01355588|9836680|FG002|NOT COMPLETED|First Intervention (Day 1)||0
8785441|NCT01355588|9836681|FG003|NOT COMPLETED|First Intervention (Day 1)||0
8785442|NCT01355588|9836678|FG000|STARTED|Washout (3-7 Days)||4
8785443|NCT01355588|9836679|FG001|STARTED|Washout (3-7 Days)||4
8785444|NCT01355588|9836680|FG002|STARTED|Washout (3-7 Days)||4
8785445|NCT01355588|9836681|FG003|STARTED|Washout (3-7 Days)||4
8785446|NCT01355588|9836678|FG000|COMPLETED|Washout (3-7 Days)||4
8785447|NCT01355588|9836679|FG001|COMPLETED|Washout (3-7 Days)||4
8785448|NCT01355588|9836680|FG002|COMPLETED|Washout (3-7 Days)||4
8785449|NCT01355588|9836681|FG003|COMPLETED|Washout (3-7 Days)||4
8785450|NCT01355588|9836678|FG000|NOT COMPLETED|Washout (3-7 Days)||0
8785451|NCT01355588|9836679|FG001|NOT COMPLETED|Washout (3-7 Days)||0
8785452|NCT01355588|9836680|FG002|NOT COMPLETED|Washout (3-7 Days)||0
8785453|NCT01355588|9836681|FG003|NOT COMPLETED|Washout (3-7 Days)||0
8785454|NCT01355588|9836678|FG000|STARTED|Second Intervention (After Washout)||4
8785455|NCT01355588|9836679|FG001|STARTED|Second Intervention (After Washout)||4
8785456|NCT01355588|9836680|FG002|STARTED|Second Intervention (After Washout)||4
8785457|NCT01355588|9836681|FG003|STARTED|Second Intervention (After Washout)||4
8785458|NCT01355588|9836678|FG000|COMPLETED|Second Intervention (After Washout)||4
8785459|NCT01355588|9836679|FG001|COMPLETED|Second Intervention (After Washout)||4
8785460|NCT01355588|9836680|FG002|COMPLETED|Second Intervention (After Washout)||4
8785461|NCT01355588|9836681|FG003|COMPLETED|Second Intervention (After Washout)||4
8785462|NCT01355588|9836678|FG000|NOT COMPLETED|Second Intervention (After Washout)||0
8785463|NCT01355588|9836679|FG001|NOT COMPLETED|Second Intervention (After Washout)||0
8785464|NCT01355588|9836680|FG002|NOT COMPLETED|Second Intervention (After Washout)||0
8785465|NCT01355588|9836681|FG003|NOT COMPLETED|Second Intervention (After Washout)||0
8785466|NCT01355588|9836678|FG000|STARTED|Washout (3-7 Days)||4
8785467|NCT01355588|9836679|FG001|STARTED|Washout (3-7 Days)||4
8785468|NCT01355588|9836680|FG002|STARTED|Washout (3-7 Days)||4
8785469|NCT01355588|9836681|FG003|STARTED|Washout (3-7 Days)||4
8785470|NCT01355588|9836678|FG000|COMPLETED|Washout (3-7 Days)||4
8785471|NCT01355588|9836679|FG001|COMPLETED|Washout (3-7 Days)||4
8785472|NCT01355588|9836680|FG002|COMPLETED|Washout (3-7 Days)||4
8785473|NCT01355588|9836681|FG003|COMPLETED|Washout (3-7 Days)||4
8785474|NCT01355588|9836678|FG000|NOT COMPLETED|Washout (3-7 Days)||0
8785475|NCT01355588|9836679|FG001|NOT COMPLETED|Washout (3-7 Days)||0
8785476|NCT01355588|9836680|FG002|NOT COMPLETED|Washout (3-7 Days)||0
8785477|NCT01355588|9836681|FG003|NOT COMPLETED|Washout (3-7 Days)||0
8785478|NCT01355588|9836678|FG000|STARTED|Third Intervention (After Washout)||4
8785479|NCT01355588|9836679|FG001|STARTED|Third Intervention (After Washout)||4
8785480|NCT01355588|9836680|FG002|STARTED|Third Intervention (After Washout)||4
8785481|NCT01355588|9836681|FG003|STARTED|Third Intervention (After Washout)||4
8785482|NCT01355588|9836678|FG000|COMPLETED|Third Intervention (After Washout)||4
8785483|NCT01355588|9836679|FG001|COMPLETED|Third Intervention (After Washout)||4
8785484|NCT01355588|9836680|FG002|COMPLETED|Third Intervention (After Washout)||4
8785485|NCT01355588|9836681|FG003|COMPLETED|Third Intervention (After Washout)||4
8785486|NCT01355588|9836678|FG000|NOT COMPLETED|Third Intervention (After Washout)||0
8785487|NCT01355588|9836679|FG001|NOT COMPLETED|Third Intervention (After Washout)||0
8785488|NCT01355588|9836680|FG002|NOT COMPLETED|Third Intervention (After Washout)||0
8785489|NCT01355588|9836681|FG003|NOT COMPLETED|Third Intervention (After Washout)||0
8785490|NCT01355588|9836678|FG000|STARTED|Washout (3-7 Days)||4
8785491|NCT01355588|9836679|FG001|STARTED|Washout (3-7 Days)||4
8785492|NCT01355588|9836680|FG002|STARTED|Washout (3-7 Days)||4
8785493|NCT01355588|9836681|FG003|STARTED|Washout (3-7 Days)||4
8785494|NCT01355588|9836678|FG000|COMPLETED|Washout (3-7 Days)||4
8671896|NCT00754130|9715285|FG002|NOT COMPLETED|Period 2 (5 Days)||0
8671897|NCT00754130|9715286|FG003|NOT COMPLETED|Period 2 (5 Days)||0
8671898|NCT00754130|9715287|FG004|NOT COMPLETED|Period 2 (5 Days)||0
8671899|NCT00754130|9715288|FG005|NOT COMPLETED|Period 2 (5 Days)||0
8671900|NCT00754156|9715306|FG000|STARTED|Overall Study||8
8671901|NCT00754156|9715307|FG001|STARTED|Overall Study||6
8671902|NCT00754156|9715306|FG000|COMPLETED|Overall Study||8
8671903|NCT00754156|9715307|FG001|COMPLETED|Overall Study||6
8671904|NCT00754156|9715306|FG000|NOT COMPLETED|Overall Study||0
8671905|NCT00754156|9715307|FG001|NOT COMPLETED|Overall Study||0
8671906|NCT00754208|9715319|FG000|STARTED|Overall Study||7
8671907|NCT00754208|9715319|FG000|COMPLETED|Overall Study||7
8671908|NCT00754208|9715319|FG000|NOT COMPLETED|Overall Study||0
8671909|NCT00754234|9715324|FG000|STARTED|Overall Study|7 Menus were consumed in randomized order|16
8671910|NCT00754234|9715324|FG000|COMPLETED|Overall Study|2 participants did not receive the Day 1,4,5,6 menu and 1 did not receive the Day 2 menu|13
8671911|NCT00754234|9715324|FG000|NOT COMPLETED|Overall Study||3
8671912|NCT00754247|9715331|FG000|STARTED|Overall Study||10
8671913|NCT00754247|9715332|FG001|STARTED|Overall Study||10
8671914|NCT00754247|9715333|FG002|STARTED|Overall Study||10
8671915|NCT00754247|9715331|FG000|COMPLETED|Overall Study||5
8671916|NCT00754247|9715332|FG001|COMPLETED|Overall Study||5
8671917|NCT00754247|9715333|FG002|COMPLETED|Overall Study||5
8671918|NCT00754247|9715331|FG000|NOT COMPLETED|Overall Study||5
8671919|NCT00754247|9715332|FG001|NOT COMPLETED|Overall Study||5
8671920|NCT00754247|9715333|FG002|NOT COMPLETED|Overall Study||5
8671921|NCT00754325|9715343|FG000|STARTED|Initial Treatment||50
8671922|NCT00754325|9715344|FG001|STARTED|Initial Treatment||49
8671923|NCT00754325|9715343|FG000|COMPLETED|Initial Treatment||0
8671924|NCT00754325|9715344|FG001|COMPLETED|Initial Treatment||0
8671925|NCT00754325|9715343|FG000|NOT COMPLETED|Initial Treatment||50
8671926|NCT00754325|9715344|FG001|NOT COMPLETED|Initial Treatment||49
8671927|NCT00754325|9715343|FG000|STARTED|Progression and Cross-over|Arm 1 participants with dasatinib-related toxicity stop dasatinib, continue fulvestrant (Arm 1b).|0
8671928|NCT00754325|9715344|FG001|STARTED|Progression and Cross-over|Progressive disease participants in Arm 2 could add dasatinib (Arm 2b) at investigator discretion.|21
8671929|NCT00754325|9715343|FG000|COMPLETED|Progression and Cross-over||0
8671930|NCT00754325|9715344|FG001|COMPLETED|Progression and Cross-over||0
8671931|NCT00754325|9715343|FG000|NOT COMPLETED|Progression and Cross-over||0
8671932|NCT00754325|9715344|FG001|NOT COMPLETED|Progression and Cross-over||21
8671933|NCT00754338|9715355|FG000|STARTED|First Intervention for Phase1&Phase2||17
8671934|NCT00754338|9715356|FG001|STARTED|First Intervention for Phase1&Phase2||21
8671935|NCT00754338|9715357|FG002|STARTED|First Intervention for Phase1&Phase2||19
8671936|NCT00754338|9715358|FG003|STARTED|First Intervention for Phase1&Phase2||19
8671937|NCT00754338|9715355|FG000|COMPLETED|First Intervention for Phase1&Phase2||17
8671938|NCT00754338|9715356|FG001|COMPLETED|First Intervention for Phase1&Phase2||18
8671939|NCT00754338|9715357|FG002|COMPLETED|First Intervention for Phase1&Phase2||16
8671940|NCT00754338|9715358|FG003|COMPLETED|First Intervention for Phase1&Phase2||19
8671941|NCT00754338|9715355|FG000|NOT COMPLETED|First Intervention for Phase1&Phase2||0
8671942|NCT00754338|9715356|FG001|NOT COMPLETED|First Intervention for Phase1&Phase2||3
8671943|NCT00754338|9715357|FG002|NOT COMPLETED|First Intervention for Phase1&Phase2||3
8671944|NCT00754338|9715358|FG003|NOT COMPLETED|First Intervention for Phase1&Phase2||0
8671945|NCT00754338|9715355|FG000|STARTED|Second Intervention for Phase1&Phase2||17
8671946|NCT00754338|9715356|FG001|STARTED|Second Intervention for Phase1&Phase2||18
8671947|NCT00754338|9715357|FG002|STARTED|Second Intervention for Phase1&Phase2||16
8671948|NCT00754338|9715358|FG003|STARTED|Second Intervention for Phase1&Phase2||19
8671949|NCT00754338|9715355|FG000|COMPLETED|Second Intervention for Phase1&Phase2||17
8671950|NCT00754338|9715356|FG001|COMPLETED|Second Intervention for Phase1&Phase2||17
8671951|NCT00754338|9715357|FG002|COMPLETED|Second Intervention for Phase1&Phase2||16
8671952|NCT00754338|9715358|FG003|COMPLETED|Second Intervention for Phase1&Phase2||18
8671953|NCT00754338|9715355|FG000|NOT COMPLETED|Second Intervention for Phase1&Phase2||0
8671954|NCT00754338|9715356|FG001|NOT COMPLETED|Second Intervention for Phase1&Phase2||1
8671955|NCT00754338|9715357|FG002|NOT COMPLETED|Second Intervention for Phase1&Phase2||0
8671956|NCT00754338|9715358|FG003|NOT COMPLETED|Second Intervention for Phase1&Phase2||1
8671957|NCT00754377|9715372|FG000|STARTED|Overall Study||50
8671958|NCT00754377|9715373|FG001|STARTED|Overall Study||42
8671959|NCT00754377|9715372|FG000|COMPLETED|Overall Study||50
8671960|NCT00754377|9715373|FG001|COMPLETED|Overall Study||42
8671961|NCT00754377|9715372|FG000|NOT COMPLETED|Overall Study||0
8671962|NCT00754377|9715373|FG001|NOT COMPLETED|Overall Study||0
8671963|NCT00754390|9715381|FG000|STARTED|Ca/Phytate Test Meal 1 (Randomized)||17
8671964|NCT00754390|9715381|FG000|COMPLETED|Ca/Phytate Test Meal 1 (Randomized)||12
8671965|NCT00754390|9715381|FG000|NOT COMPLETED|Ca/Phytate Test Meal 1 (Randomized)||5
8671966|NCT00754390|9715381|FG000|STARTED|Ca/Phytate Test Meal 2 (Randomized)||12
8671967|NCT00754390|9715381|FG000|COMPLETED|Ca/Phytate Test Meal 2 (Randomized)||12
8671968|NCT00754390|9715381|FG000|NOT COMPLETED|Ca/Phytate Test Meal 2 (Randomized)||0
8671969|NCT00754390|9715381|FG000|STARTED|Ca/Phytate Test Meal 3 (Randomized)||12
8671970|NCT00754390|9715381|FG000|COMPLETED|Ca/Phytate Test Meal 3 (Randomized)||11
8671971|NCT00754390|9715381|FG000|NOT COMPLETED|Ca/Phytate Test Meal 3 (Randomized)||1
8785495|NCT01355588|9836679|FG001|COMPLETED|Washout (3-7 Days)||4
8785496|NCT01355588|9836680|FG002|COMPLETED|Washout (3-7 Days)||4
8785497|NCT01355588|9836681|FG003|COMPLETED|Washout (3-7 Days)||4
8785498|NCT01355588|9836678|FG000|NOT COMPLETED|Washout (3-7 Days)||0
8785499|NCT01355588|9836679|FG001|NOT COMPLETED|Washout (3-7 Days)||0
8785500|NCT01355588|9836680|FG002|NOT COMPLETED|Washout (3-7 Days)||0
8785501|NCT01355588|9836681|FG003|NOT COMPLETED|Washout (3-7 Days)||0
8785502|NCT01355588|9836678|FG000|STARTED|Fourth Intervention (After Washout)||4
8785503|NCT01355588|9836679|FG001|STARTED|Fourth Intervention (After Washout)||4
8785504|NCT01355588|9836680|FG002|STARTED|Fourth Intervention (After Washout)||4
8785505|NCT01355588|9836681|FG003|STARTED|Fourth Intervention (After Washout)||4
8785506|NCT01355588|9836678|FG000|COMPLETED|Fourth Intervention (After Washout)||4
8785507|NCT01355588|9836679|FG001|COMPLETED|Fourth Intervention (After Washout)||4
8785508|NCT01355588|9836680|FG002|COMPLETED|Fourth Intervention (After Washout)||4
8785509|NCT01355588|9836681|FG003|COMPLETED|Fourth Intervention (After Washout)||4
8785510|NCT01355588|9836678|FG000|NOT COMPLETED|Fourth Intervention (After Washout)||0
8785511|NCT01355588|9836679|FG001|NOT COMPLETED|Fourth Intervention (After Washout)||0
8785512|NCT01355588|9836680|FG002|NOT COMPLETED|Fourth Intervention (After Washout)||0
8785513|NCT01355588|9836681|FG003|NOT COMPLETED|Fourth Intervention (After Washout)||0
8785514|NCT01355627|9836693|FG000|STARTED|Overall Study||362
8785515|NCT01355627|9836694|FG001|STARTED|Overall Study||364
8785516|NCT01355627|9836693|FG000|Safety Analysis Set|Overall Study||362
8785517|NCT01355627|9836694|FG001|Safety Analysis Set|Overall Study||364
8785518|NCT01355627|9836693|FG000|Full Analysis Set|Overall Study|One participant's data for final follow-up is missing, completion status could not be confirmed.|361
8785519|NCT01355627|9836694|FG001|Full Analysis Set|Overall Study|One participant randomized to Current Practice actually received TachoSil®.|365
8785520|NCT01355627|9836693|FG000|COMPLETED|Overall Study||329
8785521|NCT01355627|9836694|FG001|COMPLETED|Overall Study||326
8785522|NCT01355627|9836693|FG000|NOT COMPLETED|Overall Study||33
8785523|NCT01355627|9836694|FG001|NOT COMPLETED|Overall Study||38
8785524|NCT01355705|9836700|FG000|STARTED|Overall Study||14
8785525|NCT01355705|9836700|FG000|COMPLETED|Overall Study||14
8785526|NCT01355705|9836700|FG000|NOT COMPLETED|Overall Study||0
8785527|NCT01355796|9836705|FG000|STARTED|Overall Study||15
8785528|NCT01355796|9836706|FG001|STARTED|Overall Study||15
8785529|NCT01355796|9836705|FG000|First Intervention for 14 Days|Overall Study||15
8785530|NCT01355796|9836706|FG001|First Intervention for 14 Days|Overall Study||15
8785531|NCT01355796|9836705|FG000|Washout Period for 7 Days|Overall Study||15
8785532|NCT01355796|9836706|FG001|Washout Period for 7 Days|Overall Study||15
8785533|NCT01355796|9836705|FG000|Second Intervention for 14 Days|Overall Study||15
8785534|NCT01355796|9836706|FG001|Second Intervention for 14 Days|Overall Study||15
8785535|NCT01355796|9836705|FG000|COMPLETED|Overall Study||15
8785536|NCT01355796|9836706|FG001|COMPLETED|Overall Study||15
8785537|NCT01355796|9836705|FG000|NOT COMPLETED|Overall Study||0
8785538|NCT01355796|9836706|FG001|NOT COMPLETED|Overall Study||0
8785539|NCT01355978|9836712|FG000|STARTED|Overall Study||22
8785540|NCT01355978|9836712|FG000|COMPLETED|Overall Study||18
8785541|NCT01355978|9836712|FG000|NOT COMPLETED|Overall Study||4
8785542|NCT01356147|9836718|FG000|STARTED|Overall Study||5
8785543|NCT01356147|9836719|FG001|STARTED|Overall Study||6
8785544|NCT01356147|9836718|FG000|COMPLETED|Overall Study||5
8785545|NCT01356147|9836719|FG001|COMPLETED|Overall Study||6
8785546|NCT01356147|9836718|FG000|NOT COMPLETED|Overall Study||0
8785547|NCT01356147|9836719|FG001|NOT COMPLETED|Overall Study||0
8785548|NCT01356277|9836727|FG000|STARTED|Run-in||81
8785549|NCT01356277|9836728|FG001|STARTED|Run-in||88
8785550|NCT01356277|9836727|FG000|COMPLETED|Run-in||76
8785551|NCT01356277|9836728|FG001|COMPLETED|Run-in||88
8785552|NCT01356277|9836727|FG000|NOT COMPLETED|Run-in||5
8785553|NCT01356277|9836728|FG001|NOT COMPLETED|Run-in||0
8785554|NCT01356277|9836727|FG000|STARTED|Intervention Interval||76
8785555|NCT01356277|9836728|FG001|STARTED|Intervention Interval||88
8785556|NCT01356277|9836727|FG000|COMPLETED|Intervention Interval||66
8785557|NCT01356277|9836728|FG001|COMPLETED|Intervention Interval||81
8785558|NCT01356277|9836727|FG000|NOT COMPLETED|Intervention Interval||10
8785559|NCT01356277|9836728|FG001|NOT COMPLETED|Intervention Interval||7
8785560|NCT01356407|9836738|FG000|STARTED|Overall Study||150
8785561|NCT01356407|9836739|FG001|STARTED|Overall Study||150
8785562|NCT01356407|9836738|FG000|COMPLETED|Overall Study||144
8785563|NCT01356407|9836739|FG001|COMPLETED|Overall Study||146
8785564|NCT01356407|9836738|FG000|NOT COMPLETED|Overall Study||6
8785565|NCT01356407|9836739|FG001|NOT COMPLETED|Overall Study||4
8785566|NCT01356498|9836751|FG000|STARTED|Overall Study||35
8785567|NCT01356498|9836752|FG001|STARTED|Overall Study|2 other patients received no investigational drug in C0407 but elected to be followed in Observation|25
8785568|NCT01356498|9836753|FG002|STARTED|Overall Study||23
8785569|NCT01356498|9836754|FG003|STARTED|Overall Study||22
8785570|NCT01356498|9836755|FG004|STARTED|Overall Study||28
8785571|NCT01356498|9836756|FG005|STARTED|Overall Study||16
8785572|NCT01356498|9836751|FG000|COMPLETED|Overall Study||24
8785573|NCT01356498|9836752|FG001|COMPLETED|Overall Study||17
8785574|NCT01356498|9836753|FG002|COMPLETED|Overall Study||11
8785575|NCT01356498|9836754|FG003|COMPLETED|Overall Study||8
8785576|NCT01356498|9836755|FG004|COMPLETED|Overall Study||8
8785577|NCT01356498|9836756|FG005|COMPLETED|Overall Study||2
8785578|NCT01356498|9836751|FG000|NOT COMPLETED|Overall Study||11
8785579|NCT01356498|9836752|FG001|NOT COMPLETED|Overall Study||8
8785580|NCT01356498|9836753|FG002|NOT COMPLETED|Overall Study||12
8785581|NCT01356498|9836754|FG003|NOT COMPLETED|Overall Study||14
8785582|NCT01356498|9836755|FG004|NOT COMPLETED|Overall Study||20
8785583|NCT01356498|9836756|FG005|NOT COMPLETED|Overall Study||14
8785584|NCT01356589|9836776|FG000|STARTED|Overall Study||1288
8785585|NCT01356589|9836776|FG000|Treated|Overall Study||1285
8785586|NCT01356589|9836776|FG000|COMPLETED|Overall Study||1283
8785587|NCT01356589|9836776|FG000|NOT COMPLETED|Overall Study||5
8785588|NCT01356602|9836783|FG000|STARTED|Overall Study||133
8785589|NCT01356602|9836784|FG001|STARTED|Overall Study||132
8785590|NCT01356602|9836785|FG002|STARTED|Overall Study||132
8785591|NCT01356602|9836783|FG000|Safety Set|Overall Study|In this arm, 1 patient had only 3 placebo injections and 3 patients also took other active drug.|133
8785592|NCT01356602|9836784|FG001|Safety Set|Overall Study|In this arm, 3 patients also took other active drug.|133
8785593|NCT01356602|9836785|FG002|Safety Set|Overall Study|In this arm, 3 patients also took other active drug.|133
8785594|NCT01356602|9836783|FG000|Full Analysis Set|Overall Study||131
8785595|NCT01356602|9836784|FG001|Full Analysis Set|Overall Study||129
8785596|NCT01356602|9836785|FG002|Full Analysis Set|Overall Study||129
8785597|NCT01356602|9836783|FG000|COMPLETED|Overall Study||124
8785598|NCT01356602|9836784|FG001|COMPLETED|Overall Study||117
8785599|NCT01356602|9836785|FG002|COMPLETED|Overall Study||108
8785600|NCT01356602|9836783|FG000|NOT COMPLETED|Overall Study||9
8785601|NCT01356602|9836784|FG001|NOT COMPLETED|Overall Study||15
8785602|NCT01356602|9836785|FG002|NOT COMPLETED|Overall Study||24
8785603|NCT01356628|9836793|FG000|STARTED|Overall Study||23
8785604|NCT01356628|9836793|FG000|COMPLETED|Overall Study||23
8785605|NCT01356628|9836793|FG000|NOT COMPLETED|Overall Study||0
8785606|NCT01356940|9836799|FG000|STARTED|First Intervention (28 Days)||22
8785607|NCT01356940|9836800|FG001|STARTED|First Intervention (28 Days)||21
8785608|NCT01356940|9836799|FG000|COMPLETED|First Intervention (28 Days)||21
8785609|NCT01356940|9836800|FG001|COMPLETED|First Intervention (28 Days)||21
8785610|NCT01356940|9836799|FG000|NOT COMPLETED|First Intervention (28 Days)||1
8785611|NCT01356940|9836800|FG001|NOT COMPLETED|First Intervention (28 Days)||0
8785612|NCT01356940|9836799|FG000|STARTED|Washout (14 Days)||21
8785613|NCT01356940|9836800|FG001|STARTED|Washout (14 Days)||21
8785614|NCT01356940|9836799|FG000|COMPLETED|Washout (14 Days)||21
8785615|NCT01356940|9836800|FG001|COMPLETED|Washout (14 Days)||21
8785616|NCT01356940|9836799|FG000|NOT COMPLETED|Washout (14 Days)||0
8785617|NCT01356940|9836800|FG001|NOT COMPLETED|Washout (14 Days)||0
8785618|NCT01356940|9836799|FG000|STARTED|Second Intervention (28 Days)||21
8785619|NCT01356940|9836800|FG001|STARTED|Second Intervention (28 Days)||21
8785620|NCT01356940|9836799|FG000|COMPLETED|Second Intervention (28 Days)||20
9031090|NCT03238417|10093174|FG001|COMPLETED|24-month||222
9031091|NCT03238417|10093173|FG000|NOT COMPLETED|24-month||295
9031092|NCT03238417|10093174|FG001|NOT COMPLETED|24-month||625
9031093|NCT03238651|10093185|FG000|STARTED|Overall Study||3
9031094|NCT03238651|10093186|FG001|STARTED|Overall Study||6
9031095|NCT03238651|10093187|FG002|STARTED|Overall Study||4
9031096|NCT03238651|10093188|FG003|STARTED|Overall Study||3
9031097|NCT03238651|10093189|FG004|STARTED|Overall Study||1
9031098|NCT03238651|10093185|FG000|COMPLETED|Overall Study||0
9031099|NCT03238651|10093186|FG001|COMPLETED|Overall Study||0
9031100|NCT03238651|10093187|FG002|COMPLETED|Overall Study||0
9031101|NCT03238651|10093188|FG003|COMPLETED|Overall Study||0
9031102|NCT03238651|10093189|FG004|COMPLETED|Overall Study||0
9031103|NCT03238651|10093185|FG000|NOT COMPLETED|Overall Study||3
9031104|NCT03238651|10093186|FG001|NOT COMPLETED|Overall Study||6
9031105|NCT03238651|10093187|FG002|NOT COMPLETED|Overall Study||4
9031106|NCT03238651|10093188|FG003|NOT COMPLETED|Overall Study||3
9031107|NCT03238651|10093189|FG004|NOT COMPLETED|Overall Study||1
9031108|NCT03238781|10093205|FG000|STARTED|Overall Study||137
9031109|NCT03238781|10093206|FG001|STARTED|Overall Study||104
9031110|NCT03238781|10093207|FG002|STARTED|Overall Study||102
9031111|NCT03238781|10093205|FG000|COMPLETED|Overall Study||111
9031112|NCT03238781|10093206|FG001|COMPLETED|Overall Study||87
9031113|NCT03238781|10093207|FG002|COMPLETED|Overall Study||82
9031114|NCT03238781|10093205|FG000|NOT COMPLETED|Overall Study||26
9031115|NCT03238781|10093206|FG001|NOT COMPLETED|Overall Study||17
9031116|NCT03238781|10093207|FG002|NOT COMPLETED|Overall Study||20
9031117|NCT03238911|10093217|FG000|STARTED|Overall Study||62
9031118|NCT03238911|10093218|FG001|STARTED|Overall Study||61
9031119|NCT03238911|10093217|FG000|Safety Analysis Set|Overall Study|1 subject from ferric carboxymaltose group received iron isomaltoside/ferric derisomaltose in error.|63
9031120|NCT03238911|10093218|FG001|Safety Analysis Set|Overall Study|1 subject from ferric carboxymaltose group received iron isomaltoside/ferric derisomaltose in error.|60
9031121|NCT03238911|10093217|FG000|COMPLETED|Overall Study||59
9031122|NCT03238911|10093218|FG001|COMPLETED|Overall Study||58
9031123|NCT03238911|10093217|FG000|NOT COMPLETED|Overall Study||3
9031124|NCT03238911|10093218|FG001|NOT COMPLETED|Overall Study||3
9031125|NCT03238924|10093227|FG000|STARTED|Overall Study||8
9031126|NCT03238924|10093228|FG001|STARTED|Overall Study||9
9031127|NCT03238924|10093227|FG000|COMPLETED|Overall Study||6
9031128|NCT03238924|10093228|FG001|COMPLETED|Overall Study||7
9031129|NCT03238924|10093227|FG000|NOT COMPLETED|Overall Study||2
9031130|NCT03238924|10093228|FG001|NOT COMPLETED|Overall Study||2
9031131|NCT03238963|10093236|FG000|STARTED|Overall Study||40
9031132|NCT03238963|10093237|FG001|STARTED|Overall Study||39
8785621|NCT01356940|9836800|FG001|COMPLETED|Second Intervention (28 Days)||21
8785622|NCT01356940|9836799|FG000|NOT COMPLETED|Second Intervention (28 Days)||1
8785623|NCT01356940|9836800|FG001|NOT COMPLETED|Second Intervention (28 Days)||0
8785624|NCT01356966|9836810|FG000|STARTED|Overall Study||18
8785625|NCT01356966|9836811|FG001|STARTED|Overall Study||14
8785626|NCT01356966|9836810|FG000|COMPLETED|Overall Study||16
8785627|NCT01356966|9836811|FG001|COMPLETED|Overall Study||12
8785628|NCT01356966|9836810|FG000|NOT COMPLETED|Overall Study||2
8785629|NCT01356966|9836811|FG001|NOT COMPLETED|Overall Study||2
8785630|NCT01357135|9836820|FG000|STARTED|Overall Study||1874
8785631|NCT01357135|9836821|FG001|STARTED|Overall Study||733
8785632|NCT01357135|9836822|FG002|STARTED|Overall Study||846
8785633|NCT01357135|9836820|FG000|COMPLETED|Overall Study||1276
8785634|NCT01357135|9836821|FG001|COMPLETED|Overall Study||510
8785635|NCT01357135|9836822|FG002|COMPLETED|Overall Study||583
8785636|NCT01357135|9836820|FG000|NOT COMPLETED|Overall Study||598
8785637|NCT01357135|9836821|FG001|NOT COMPLETED|Overall Study||223
8785638|NCT01357135|9836822|FG002|NOT COMPLETED|Overall Study||263
8785639|NCT01357148|9836829|FG000|STARTED|Overall Study||143
8785640|NCT01357148|9836829|FG000|COMPLETED|Overall Study||143
8785641|NCT01357148|9836829|FG000|NOT COMPLETED|Overall Study||0
8785642|NCT01357161|9836837|FG000|STARTED|Part 1 (Open Label Run-in)||15
8785643|NCT01357161|9836838|FG001|STARTED|Part 1 (Open Label Run-in)||0
8785644|NCT01357161|9836839|FG002|STARTED|Part 1 (Open Label Run-in)||0
8785645|NCT01357161|9836837|FG000|COMPLETED|Part 1 (Open Label Run-in)||0
8785646|NCT01357161|9836838|FG001|COMPLETED|Part 1 (Open Label Run-in)||0
8785647|NCT01357161|9836839|FG002|COMPLETED|Part 1 (Open Label Run-in)||0
8785648|NCT01357161|9836837|FG000|NOT COMPLETED|Part 1 (Open Label Run-in)||15
8785649|NCT01357161|9836838|FG001|NOT COMPLETED|Part 1 (Open Label Run-in)||0
8785650|NCT01357161|9836839|FG002|NOT COMPLETED|Part 1 (Open Label Run-in)||0
8785651|NCT01357161|9836837|FG000|STARTED|Part 2 (Double-Blind Comparison)||0
8785652|NCT01357161|9836838|FG001|STARTED|Part 2 (Double-Blind Comparison)|New participants enrolled in Part 2.|59
8785653|NCT01357161|9836839|FG002|STARTED|Part 2 (Double-Blind Comparison)|New participants enrolled in Part 2.|62
8785654|NCT01357161|9836837|FG000|Treated|Part 2 (Double-Blind Comparison)||0
8785655|NCT01357161|9836838|FG001|Treated|Part 2 (Double-Blind Comparison)||59
8785656|NCT01357161|9836839|FG002|Treated|Part 2 (Double-Blind Comparison)||60
8785657|NCT01357161|9836837|FG000|COMPLETED|Part 2 (Double-Blind Comparison)||0
8785658|NCT01357161|9836838|FG001|COMPLETED|Part 2 (Double-Blind Comparison)||0
8785659|NCT01357161|9836839|FG002|COMPLETED|Part 2 (Double-Blind Comparison)||0
8785660|NCT01357161|9836837|FG000|NOT COMPLETED|Part 2 (Double-Blind Comparison)||0
8785661|NCT01357161|9836838|FG001|NOT COMPLETED|Part 2 (Double-Blind Comparison)||59
8785662|NCT01357161|9836839|FG002|NOT COMPLETED|Part 2 (Double-Blind Comparison)||62
8785663|NCT01357239|9836851|FG000|STARTED|Stratum: All Patients||31
8785664|NCT01357239|9836852|FG001|STARTED|Stratum: All Patients||27
8785665|NCT01357239|9836853|FG002|STARTED|Stratum: All Patients||39
8785666|NCT01357239|9836854|FG003|STARTED|Stratum: All Patients||42
8785667|NCT01357239|9836851|FG000|COMPLETED|Stratum: All Patients||31
8785668|NCT01357239|9836852|FG001|COMPLETED|Stratum: All Patients||27
8785669|NCT01357239|9836853|FG002|COMPLETED|Stratum: All Patients||37
8785670|NCT01357239|9836854|FG003|COMPLETED|Stratum: All Patients||40
8785671|NCT01357239|9836851|FG000|NOT COMPLETED|Stratum: All Patients||0
8785672|NCT01357239|9836852|FG001|NOT COMPLETED|Stratum: All Patients||0
8785673|NCT01357239|9836853|FG002|NOT COMPLETED|Stratum: All Patients||2
8785674|NCT01357239|9836854|FG003|NOT COMPLETED|Stratum: All Patients||2
8785675|NCT01357239|9836851|FG000|STARTED|Stratum I: Fully-Methylated||8
8785676|NCT01357239|9836852|FG001|STARTED|Stratum I: Fully-Methylated||6
8785677|NCT01357239|9836853|FG002|STARTED|Stratum I: Fully-Methylated||17
8785678|NCT01357239|9836854|FG003|STARTED|Stratum I: Fully-Methylated||22
8785679|NCT01357239|9836851|FG000|COMPLETED|Stratum I: Fully-Methylated||8
8785680|NCT01357239|9836852|FG001|COMPLETED|Stratum I: Fully-Methylated||6
8785681|NCT01357239|9836853|FG002|COMPLETED|Stratum I: Fully-Methylated||16
8785682|NCT01357239|9836854|FG003|COMPLETED|Stratum I: Fully-Methylated||22
8785683|NCT01357239|9836851|FG000|NOT COMPLETED|Stratum I: Fully-Methylated||0
8785684|NCT01357239|9836852|FG001|NOT COMPLETED|Stratum I: Fully-Methylated||0
8785685|NCT01357239|9836853|FG002|NOT COMPLETED|Stratum I: Fully-Methylated||1
8785686|NCT01357239|9836854|FG003|NOT COMPLETED|Stratum I: Fully-Methylated||0
8785687|NCT01357239|9836851|FG000|STARTED|Stratum II: Partially-Methylated||23
8785688|NCT01357239|9836852|FG001|STARTED|Stratum II: Partially-Methylated||21
8785689|NCT01357239|9836853|FG002|STARTED|Stratum II: Partially-Methylated||22
8785690|NCT01357239|9836854|FG003|STARTED|Stratum II: Partially-Methylated||20
8785691|NCT01357239|9836851|FG000|COMPLETED|Stratum II: Partially-Methylated||23
8785692|NCT01357239|9836852|FG001|COMPLETED|Stratum II: Partially-Methylated||21
8785693|NCT01357239|9836853|FG002|COMPLETED|Stratum II: Partially-Methylated||21
8785694|NCT01357239|9836854|FG003|COMPLETED|Stratum II: Partially-Methylated||18
8785695|NCT01357239|9836851|FG000|NOT COMPLETED|Stratum II: Partially-Methylated||0
8785696|NCT01357239|9836852|FG001|NOT COMPLETED|Stratum II: Partially-Methylated||0
8785697|NCT01357239|9836853|FG002|NOT COMPLETED|Stratum II: Partially-Methylated||1
8785698|NCT01357239|9836854|FG003|NOT COMPLETED|Stratum II: Partially-Methylated||2
8785699|NCT01357356|9836871|FG000|STARTED|Overall Study||188
8785700|NCT01357356|9836872|FG001|STARTED|Overall Study||188
8785701|NCT01357356|9836873|FG002|STARTED|Overall Study||186
8785702|NCT01357356|9836874|FG003|STARTED|Overall Study||188
8785703|NCT01357356|9836871|FG000|COMPLETED|Overall Study||166
8785704|NCT01357356|9836872|FG001|COMPLETED|Overall Study||163
8785705|NCT01357356|9836873|FG002|COMPLETED|Overall Study||158
8785706|NCT01357356|9836874|FG003|COMPLETED|Overall Study||171
8785707|NCT01357356|9836871|FG000|NOT COMPLETED|Overall Study||22
8785708|NCT01357356|9836872|FG001|NOT COMPLETED|Overall Study||25
8785709|NCT01357356|9836873|FG002|NOT COMPLETED|Overall Study||28
8785710|NCT01357356|9836874|FG003|NOT COMPLETED|Overall Study||17
8785711|NCT01357512|9836888|FG000|STARTED|Overall Study||65
8785712|NCT01357512|9836889|FG001|STARTED|Overall Study||65
8785713|NCT01357512|9836888|FG000|COMPLETED|Overall Study||53
8785714|NCT01357512|9836889|FG001|COMPLETED|Overall Study||60
8785715|NCT01357512|9836888|FG000|NOT COMPLETED|Overall Study||12
8785716|NCT01357512|9836889|FG001|NOT COMPLETED|Overall Study||5
8785717|NCT01357525|9836895|FG000|STARTED|Overall Study||50
8785718|NCT01357525|9836895|FG000|COMPLETED|Overall Study||49
8785719|NCT01357525|9836895|FG000|NOT COMPLETED|Overall Study||1
8785720|NCT01357551|9836901|FG000|STARTED|Overall Study||110
8785721|NCT01357551|9836902|FG001|STARTED|Overall Study||112
8785722|NCT01357551|9836901|FG000|COMPLETED|Overall Study||88
8785723|NCT01357551|9836902|FG001|COMPLETED|Overall Study||101
8785724|NCT01357551|9836901|FG000|NOT COMPLETED|Overall Study||22
8785725|NCT01357551|9836902|FG001|NOT COMPLETED|Overall Study||11
8785726|NCT01357564|9836913|FG000|STARTED|Short-term (4-month) Follow up||154
8785727|NCT01357564|9836914|FG001|STARTED|Short-term (4-month) Follow up||168
8785728|NCT01357564|9836913|FG000|COMPLETED|Short-term (4-month) Follow up||106
8785729|NCT01357564|9836914|FG001|COMPLETED|Short-term (4-month) Follow up||118
8785730|NCT01357564|9836913|FG000|NOT COMPLETED|Short-term (4-month) Follow up||48
8785731|NCT01357564|9836914|FG001|NOT COMPLETED|Short-term (4-month) Follow up||50
8785732|NCT01357564|9836913|FG000|STARTED|Long-term (8-month) Follow-up||106
8785733|NCT01357564|9836914|FG001|STARTED|Long-term (8-month) Follow-up||118
8785734|NCT01357564|9836913|FG000|COMPLETED|Long-term (8-month) Follow-up||104
8785735|NCT01357564|9836914|FG001|COMPLETED|Long-term (8-month) Follow-up||102
8785736|NCT01357564|9836913|FG000|NOT COMPLETED|Long-term (8-month) Follow-up||2
8785737|NCT01357564|9836914|FG001|NOT COMPLETED|Long-term (8-month) Follow-up||16
8785738|NCT01357577|9836924|FG000|STARTED|Overall Study||64
8785739|NCT01357577|9836925|FG001|STARTED|Overall Study||65
8785740|NCT01357577|9836924|FG000|Post-Treatment Assessment Completed|Overall Study||24
8785741|NCT01357577|9836925|FG001|Post-Treatment Assessment Completed|Overall Study||39
8785742|NCT01357577|9836924|FG000|COMPLETED|Overall Study||27
8785743|NCT01357577|9836925|FG001|COMPLETED|Overall Study||39
8785744|NCT01357577|9836924|FG000|NOT COMPLETED|Overall Study||37
8785745|NCT01357577|9836925|FG001|NOT COMPLETED|Overall Study||26
8785746|NCT01357616|9836934|FG000|STARTED|Overall Study||166
8785747|NCT01357616|9836935|FG001|STARTED|Overall Study||162
8785748|NCT01357616|9836934|FG000|COMPLETED|Overall Study||156
8785749|NCT01357616|9836935|FG001|COMPLETED|Overall Study||153
8785750|NCT01357616|9836934|FG000|NOT COMPLETED|Overall Study||10
8785751|NCT01357616|9836935|FG001|NOT COMPLETED|Overall Study||9
8785752|NCT01357655|9836943|FG000|STARTED|Overall Study||66
8785753|NCT01357655|9836944|FG001|STARTED|Overall Study||0
8785754|NCT01357655|9836943|FG000|COMPLETED|Overall Study||0
8785755|NCT01357655|9836944|FG001|COMPLETED|Overall Study||0
8785756|NCT01357655|9836943|FG000|NOT COMPLETED|Overall Study||66
8785757|NCT01357655|9836944|FG001|NOT COMPLETED|Overall Study||0
8785758|NCT01357720|9836951|FG000|STARTED|Overall Study||200
8785759|NCT01357720|9836952|FG001|STARTED|Overall Study||200
8785760|NCT01357720|9836951|FG000|COMPLETED|Overall Study||198
8785761|NCT01357720|9836952|FG001|COMPLETED|Overall Study||195
8785762|NCT01357720|9836951|FG000|NOT COMPLETED|Overall Study||2
8785763|NCT01357720|9836952|FG001|NOT COMPLETED|Overall Study||5
8785764|NCT01357850|9836962|FG000|STARTED|Overall Study||30
8785765|NCT01357850|9836963|FG001|STARTED|Overall Study||12
8785766|NCT01357850|9836964|FG002|STARTED|Overall Study||13
8785767|NCT01357850|9836965|FG003|STARTED|Overall Study||27
8785768|NCT01357850|9836962|FG000|COMPLETED|Overall Study||29
8785769|NCT01357850|9836963|FG001|COMPLETED|Overall Study||12
8785770|NCT01357850|9836964|FG002|COMPLETED|Overall Study||13
8785771|NCT01357850|9836965|FG003|COMPLETED|Overall Study||27
8785772|NCT01357850|9836962|FG000|NOT COMPLETED|Overall Study||1
8785773|NCT01357850|9836963|FG001|NOT COMPLETED|Overall Study||0
8785774|NCT01357850|9836964|FG002|NOT COMPLETED|Overall Study||0
8785775|NCT01357850|9836965|FG003|NOT COMPLETED|Overall Study||0
8785776|NCT01357889|9836978|FG000|STARTED|Single-dose Phase (BE Phase: 28 Days)||86
8785777|NCT01357889|9836979|FG001|STARTED|Single-dose Phase (BE Phase: 28 Days)||81
8785778|NCT01357889|9836978|FG000|COMPLETED|Single-dose Phase (BE Phase: 28 Days)||82
8785779|NCT01357889|9836979|FG001|COMPLETED|Single-dose Phase (BE Phase: 28 Days)||79
8785780|NCT01357889|9836978|FG000|NOT COMPLETED|Single-dose Phase (BE Phase: 28 Days)||4
8785781|NCT01357889|9836979|FG001|NOT COMPLETED|Single-dose Phase (BE Phase: 28 Days)||2
8785782|NCT01357889|9836978|FG000|STARTED|Multiple-dose Phase (MDP) (Overall)|After completion of the BE Phase, additional participants were randomized to the Overall Phase.|141
8785783|NCT01357889|9836979|FG001|STARTED|Multiple-dose Phase (MDP) (Overall)|After completion of the BE Phase, additional participants were randomized to the Overall Phase.|142
8785784|NCT01357889|9836978|FG000|COMPLETED|Multiple-dose Phase (MDP) (Overall)||125
8785785|NCT01357889|9836979|FG001|COMPLETED|Multiple-dose Phase (MDP) (Overall)||126
8785786|NCT01357889|9836978|FG000|NOT COMPLETED|Multiple-dose Phase (MDP) (Overall)||16
8785787|NCT01357889|9836979|FG001|NOT COMPLETED|Multiple-dose Phase (MDP) (Overall)||16
8785788|NCT01357889|9836978|FG000|STARTED|Follow-up Phase (FUP) (8 Weeks)|All participants who started the MDP entered the FUP, regardless of MDP completion status.|141
8916779|NCT02186223|9976334|FG000|STARTED|Overall Study||172
8785789|NCT01357889|9836979|FG001|STARTED|Follow-up Phase (FUP) (8 Weeks)|All participants who started the MDP entered the FUP, regardless of MDP completion status.|142
8785790|NCT01357889|9836978|FG000|COMPLETED|Follow-up Phase (FUP) (8 Weeks)||138
8785791|NCT01357889|9836979|FG001|COMPLETED|Follow-up Phase (FUP) (8 Weeks)||138
8785792|NCT01357889|9836978|FG000|NOT COMPLETED|Follow-up Phase (FUP) (8 Weeks)||3
8785793|NCT01357889|9836979|FG001|NOT COMPLETED|Follow-up Phase (FUP) (8 Weeks)||4
8785794|NCT01357915|9836989|FG000|STARTED|Overall Study||30
8785795|NCT01357915|9836990|FG001|STARTED|Overall Study||17
8785796|NCT01357915|9836989|FG000|COMPLETED|Overall Study||27
8785797|NCT01357915|9836990|FG001|COMPLETED|Overall Study||17
8785798|NCT01357915|9836989|FG000|NOT COMPLETED|Overall Study||3
8785799|NCT01357915|9836990|FG001|NOT COMPLETED|Overall Study||0
8785800|NCT01357980|9837000|FG000|STARTED|Overall Study||16
8785801|NCT01357980|9837001|FG001|STARTED|Overall Study||7
8785802|NCT01357980|9837002|FG002|STARTED|Overall Study||17
8785803|NCT01357980|9837003|FG003|STARTED|Overall Study||7
8785804|NCT01357980|9837000|FG000|COMPLETED|Overall Study||16
8785805|NCT01357980|9837001|FG001|COMPLETED|Overall Study||6
8785806|NCT01357980|9837002|FG002|COMPLETED|Overall Study||16
8785807|NCT01357980|9837003|FG003|COMPLETED|Overall Study||7
8785808|NCT01357980|9837000|FG000|NOT COMPLETED|Overall Study||0
8785809|NCT01357980|9837001|FG001|NOT COMPLETED|Overall Study||1
8785810|NCT01357980|9837002|FG002|NOT COMPLETED|Overall Study||1
8785811|NCT01357980|9837003|FG003|NOT COMPLETED|Overall Study||0
8785812|NCT01358175|9837016|FG000|STARTED|Overall Study||124
8785813|NCT01358175|9837017|FG001|STARTED|Overall Study||125
8785814|NCT01358175|9837018|FG002|STARTED|Overall Study||122
8785815|NCT01358175|9837016|FG000|COMPLETED|Overall Study||103
8785816|NCT01358175|9837017|FG001|COMPLETED|Overall Study||97
8785817|NCT01358175|9837018|FG002|COMPLETED|Overall Study||90
8671972|NCT00754390|9715381|FG000|STARTED|Ca/Phytate Test Meal 4 (Randomized)||11
8671973|NCT00754390|9715381|FG000|COMPLETED|Ca/Phytate Test Meal 4 (Randomized)||10
8671974|NCT00754390|9715381|FG000|NOT COMPLETED|Ca/Phytate Test Meal 4 (Randomized)||1
8671975|NCT00754442|9715390|FG000|STARTED|Overall Study|controls 11|11
8671976|NCT00754442|9715391|FG001|STARTED|Overall Study|patients 9|9
8671977|NCT00754442|9715390|FG000|COMPLETED|Overall Study||6
8671978|NCT00754442|9715391|FG001|COMPLETED|Overall Study||6
8671979|NCT00754442|9715390|FG000|NOT COMPLETED|Overall Study||5
8671980|NCT00754442|9715391|FG001|NOT COMPLETED|Overall Study||3
8671981|NCT00754468|9715400|FG000|STARTED|Overall Study||4
8671982|NCT00754468|9715401|FG001|STARTED|Overall Study||3
8785818|NCT01358175|9837016|FG000|NOT COMPLETED|Overall Study||21
8785819|NCT01358175|9837017|FG001|NOT COMPLETED|Overall Study||28
8785820|NCT01358175|9837018|FG002|NOT COMPLETED|Overall Study||32
8785821|NCT01358266|9837033|FG000|STARTED|Double-Masked Period||208
8785822|NCT01358266|9837034|FG001|STARTED|Double-Masked Period||208
8785823|NCT01358266|9837035|FG002|STARTED|Double-Masked Period||176
8785824|NCT01358266|9837033|FG000|COMPLETED|Double-Masked Period||175
8785825|NCT01358266|9837034|FG001|COMPLETED|Double-Masked Period||162
8785826|NCT01358266|9837035|FG002|COMPLETED|Double-Masked Period||137
8785827|NCT01358266|9837033|FG000|NOT COMPLETED|Double-Masked Period||33
8785828|NCT01358266|9837034|FG001|NOT COMPLETED|Double-Masked Period||46
8785829|NCT01358266|9837035|FG002|NOT COMPLETED|Double-Masked Period||39
8785830|NCT01358266|9837033|FG000|STARTED|Open-Label Period||119
8785831|NCT01358266|9837034|FG001|STARTED|Open-Label Period||102
8785832|NCT01358266|9837035|FG002|STARTED|Open-Label Period||114
8785833|NCT01358266|9837033|FG000|COMPLETED|Open-Label Period||63
8785834|NCT01358266|9837034|FG001|COMPLETED|Open-Label Period||58
8785835|NCT01358266|9837035|FG002|COMPLETED|Open-Label Period||44
8785836|NCT01358266|9837033|FG000|NOT COMPLETED|Open-Label Period||56
8785837|NCT01358266|9837034|FG001|NOT COMPLETED|Open-Label Period||44
8785838|NCT01358266|9837035|FG002|NOT COMPLETED|Open-Label Period||70
8785839|NCT01358331|9837050|FG000|STARTED|Overall Study||2
8785840|NCT01358331|9837051|FG001|STARTED|Overall Study||3
8785841|NCT01358331|9837052|FG002|STARTED|Overall Study||4
8785842|NCT01358331|9837053|FG003|STARTED|Overall Study||3
8785843|NCT01358331|9837054|FG004|STARTED|Overall Study||7
8785844|NCT01358331|9837055|FG005|STARTED|Overall Study||6
8785845|NCT01358331|9837050|FG000|COMPLETED|Overall Study||0
8785846|NCT01358331|9837051|FG001|COMPLETED|Overall Study||0
8785847|NCT01358331|9837052|FG002|COMPLETED|Overall Study||0
8785848|NCT01358331|9837053|FG003|COMPLETED|Overall Study||0
8916780|NCT02186223|9976334|FG000|Device Placed|Overall Study||163
8916781|NCT02186223|9976334|FG000|COMPLETED|Overall Study||151
8916782|NCT02186223|9976334|FG000|NOT COMPLETED|Overall Study||21
8916783|NCT02186301|9976342|FG000|STARTED|Overall Study||20
8916784|NCT02186301|9976343|FG001|STARTED|Overall Study||30
8916785|NCT02186301|9976344|FG002|STARTED|Overall Study||50
8916786|NCT02186301|9976342|FG000|COMPLETED|Overall Study|Patients who are off study for any reason.|0
8916787|NCT02186301|9976343|FG001|COMPLETED|Overall Study|Patients who are off study for any reason.|0
8916788|NCT02186301|9976344|FG002|COMPLETED|Overall Study|Patients who are off study for any reason.|0
8916789|NCT02186301|9976342|FG000|NOT COMPLETED|Overall Study||20
8916790|NCT02186301|9976343|FG001|NOT COMPLETED|Overall Study||30
8916791|NCT02186301|9976344|FG002|NOT COMPLETED|Overall Study||50
8916792|NCT02186509|9976354|FG000|STARTED|Overall Study||17
8785849|NCT01358331|9837054|FG004|COMPLETED|Overall Study||0
8785850|NCT01358331|9837055|FG005|COMPLETED|Overall Study||0
8785851|NCT01358331|9837050|FG000|NOT COMPLETED|Overall Study||2
8785852|NCT01358331|9837051|FG001|NOT COMPLETED|Overall Study||3
8785853|NCT01358331|9837052|FG002|NOT COMPLETED|Overall Study||4
8785854|NCT01358331|9837053|FG003|NOT COMPLETED|Overall Study||3
8785855|NCT01358331|9837054|FG004|NOT COMPLETED|Overall Study||7
8785856|NCT01358331|9837055|FG005|NOT COMPLETED|Overall Study||6
8785857|NCT01358357|9837071|FG000|STARTED|Open Label Phase||0
8785858|NCT01358357|9837072|FG001|STARTED|Open Label Phase||0
8785859|NCT01358357|9837073|FG002|STARTED|Open Label Phase||965
8785860|NCT01358357|9837071|FG000|COMPLETED|Open Label Phase||0
8785861|NCT01358357|9837072|FG001|COMPLETED|Open Label Phase||0
8785862|NCT01358357|9837073|FG002|COMPLETED|Open Label Phase||503
8785863|NCT01358357|9837071|FG000|NOT COMPLETED|Open Label Phase||0
8785864|NCT01358357|9837072|FG001|NOT COMPLETED|Open Label Phase||0
8785865|NCT01358357|9837073|FG002|NOT COMPLETED|Open Label Phase||462
8785866|NCT01358357|9837071|FG000|STARTED|Double-Blind Phase||246
8785867|NCT01358357|9837072|FG001|STARTED|Double-Blind Phase||250
8785868|NCT01358357|9837073|FG002|STARTED|Double-Blind Phase||0
8785869|NCT01358357|9837071|FG000|COMPLETED|Double-Blind Phase||166
8785870|NCT01358357|9837072|FG001|COMPLETED|Double-Blind Phase||150
8785871|NCT01358357|9837073|FG002|COMPLETED|Double-Blind Phase||0
8785872|NCT01358357|9837071|FG000|NOT COMPLETED|Double-Blind Phase||80
8785873|NCT01358357|9837072|FG001|NOT COMPLETED|Double-Blind Phase||100
8785874|NCT01358357|9837073|FG002|NOT COMPLETED|Double-Blind Phase||0
8785875|NCT01358526|9837082|FG000|STARTED|Open-label Titration Period||1095
8785876|NCT01358526|9837083|FG001|STARTED|Open-label Titration Period||0
8785877|NCT01358526|9837084|FG002|STARTED|Open-label Titration Period||0
8785878|NCT01358526|9837082|FG000|COMPLETED|Open-label Titration Period|1 subject was randomized but never received double-blind treatment: Randomized Safety Population=600|601
8785879|NCT01358526|9837083|FG001|COMPLETED|Open-label Titration Period||0
8785880|NCT01358526|9837084|FG002|COMPLETED|Open-label Titration Period||0
8785881|NCT01358526|9837082|FG000|NOT COMPLETED|Open-label Titration Period||494
8785882|NCT01358526|9837083|FG001|NOT COMPLETED|Open-label Titration Period||0
8785883|NCT01358526|9837084|FG002|NOT COMPLETED|Open-label Titration Period||0
8785884|NCT01358526|9837082|FG000|STARTED|Double-blind Phase||0
8785885|NCT01358526|9837083|FG001|STARTED|Double-blind Phase|1 subject was randomized but never received double-blind treatment: Randomized Safety Population=600|298
8785886|NCT01358526|9837084|FG002|STARTED|Double-blind Phase|1 subject was randomized but never received double-blind treatment: Randomized Safety Population=600|302
8785887|NCT01358526|9837082|FG000|COMPLETED|Double-blind Phase||0
8785888|NCT01358526|9837083|FG001|COMPLETED|Double-blind Phase||218
8785889|NCT01358526|9837084|FG002|COMPLETED|Double-blind Phase||181
8785890|NCT01358526|9837082|FG000|NOT COMPLETED|Double-blind Phase||0
8785891|NCT01358526|9837083|FG001|NOT COMPLETED|Double-blind Phase||80
8785892|NCT01358526|9837084|FG002|NOT COMPLETED|Double-blind Phase||121
8785893|NCT01358578|9837095|FG000|STARTED|Induction Period||327
8785894|NCT01358578|9837096|FG001|STARTED|Induction Period||327
8785895|NCT01358578|9837097|FG002|STARTED|Induction Period||326
8785896|NCT01358578|9837098|FG003|STARTED|Induction Period||326
8785897|NCT01358578|9837099|FG004|STARTED|Induction Period|These groups are populated after the induction period|0
8785898|NCT01358578|9837100|FG005|STARTED|Induction Period|These groups are populated after the induction period|0
8785899|NCT01358578|9837095|FG000|COMPLETED|Induction Period||315
8785900|NCT01358578|9837096|FG001|COMPLETED|Induction Period||312
8785901|NCT01358578|9837097|FG002|COMPLETED|Induction Period||301
8785902|NCT01358578|9837098|FG003|COMPLETED|Induction Period||305
8785903|NCT01358578|9837099|FG004|COMPLETED|Induction Period|These groups are populated after the induction period|0
8785904|NCT01358578|9837100|FG005|COMPLETED|Induction Period|These groups are populated after the induction period|0
8785905|NCT01358578|9837095|FG000|NOT COMPLETED|Induction Period||12
8785906|NCT01358578|9837096|FG001|NOT COMPLETED|Induction Period||15
8785907|NCT01358578|9837097|FG002|NOT COMPLETED|Induction Period||25
8785908|NCT01358578|9837098|FG003|NOT COMPLETED|Induction Period||21
8785909|NCT01358578|9837099|FG004|NOT COMPLETED|Induction Period||0
8785910|NCT01358578|9837100|FG005|NOT COMPLETED|Induction Period||0
8785911|NCT01358578|9837095|FG000|STARTED|Maintenance Period||315
8785912|NCT01358578|9837096|FG001|STARTED|Maintenance Period||312
8785913|NCT01358578|9837097|FG002|STARTED|Maintenance Period||17
8785914|NCT01358578|9837098|FG003|STARTED|Maintenance Period||305
8785915|NCT01358578|9837099|FG004|STARTED|Maintenance Period||142
8785916|NCT01358578|9837100|FG005|STARTED|Maintenance Period||142
8785917|NCT01358578|9837095|FG000|COMPLETED|Maintenance Period||276
8785918|NCT01358578|9837096|FG001|COMPLETED|Maintenance Period||290
8785919|NCT01358578|9837097|FG002|COMPLETED|Maintenance Period||15
8785920|NCT01358578|9837098|FG003|COMPLETED|Maintenance Period||263
8785921|NCT01358578|9837099|FG004|COMPLETED|Maintenance Period||125
8785922|NCT01358578|9837100|FG005|COMPLETED|Maintenance Period||131
8785923|NCT01358578|9837095|FG000|NOT COMPLETED|Maintenance Period||39
8785924|NCT01358578|9837096|FG001|NOT COMPLETED|Maintenance Period||22
8785925|NCT01358578|9837097|FG002|NOT COMPLETED|Maintenance Period||2
8785926|NCT01358578|9837098|FG003|NOT COMPLETED|Maintenance Period||42
8785927|NCT01358578|9837099|FG004|NOT COMPLETED|Maintenance Period||17
8785928|NCT01358578|9837100|FG005|NOT COMPLETED|Maintenance Period||11
8785929|NCT01358578|9837095|FG000|STARTED|Follow-up Period|Patients prior to follow up who did not enter the extension study but received the 150 mg dose|148
8785930|NCT01358578|9837096|FG001|STARTED|Follow-up Period|Patients prior to follow up who did not enter the extension study but received the 300 mg dose|125
8785931|NCT01358578|9837097|FG002|STARTED|Follow-up Period|contains patients who participated in follow up period from induction and maintenance|26
8785932|NCT01358578|9837098|FG003|STARTED|Follow-up Period|contains patients who participated in follow up period from induction and maintenance|279
8785933|NCT01358578|9837099|FG004|STARTED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
8785934|NCT01358578|9837100|FG005|STARTED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
8785935|NCT01358578|9837095|FG000|COMPLETED|Follow-up Period||138
8785936|NCT01358578|9837096|FG001|COMPLETED|Follow-up Period||119
8785937|NCT01358578|9837097|FG002|COMPLETED|Follow-up Period|contains patients who completed follow up period from induction and maintenance|21
8785938|NCT01358578|9837098|FG003|COMPLETED|Follow-up Period|contains patients who completed follow up period from induction and maintenance|260
8785939|NCT01358578|9837099|FG004|COMPLETED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
8785940|NCT01358578|9837100|FG005|COMPLETED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
8785941|NCT01358578|9837095|FG000|NOT COMPLETED|Follow-up Period||10
8785942|NCT01358578|9837096|FG001|NOT COMPLETED|Follow-up Period||6
8785943|NCT01358578|9837097|FG002|NOT COMPLETED|Follow-up Period||5
8785944|NCT01358578|9837098|FG003|NOT COMPLETED|Follow-up Period||19
8785945|NCT01358578|9837099|FG004|NOT COMPLETED|Follow-up Period||0
8785946|NCT01358578|9837100|FG005|NOT COMPLETED|Follow-up Period||0
8785947|NCT01358708|9837130|FG000|STARTED|Double-Blind Treatment Phase||13
8785948|NCT01358708|9837131|FG001|STARTED|Double-Blind Treatment Phase||13
8785949|NCT01358708|9837130|FG000|Randomized|Double-Blind Treatment Phase||13
8785950|NCT01358708|9837131|FG001|Randomized|Double-Blind Treatment Phase||13
8785951|NCT01358708|9837130|FG000|Received Study Medication|Double-Blind Treatment Phase|For 1 subject, unused med not returned to the site and intake of study medication not confirmed.|12
8785952|NCT01358708|9837131|FG001|Received Study Medication|Double-Blind Treatment Phase||13
8785953|NCT01358708|9837130|FG000|COMPLETED|Double-Blind Treatment Phase||10
8785954|NCT01358708|9837131|FG001|COMPLETED|Double-Blind Treatment Phase||13
8785955|NCT01358708|9837130|FG000|NOT COMPLETED|Double-Blind Treatment Phase||3
8785956|NCT01358708|9837131|FG001|NOT COMPLETED|Double-Blind Treatment Phase||0
8785957|NCT01358708|9837130|FG000|STARTED|Open-Label Treatment Phase|Number of subjects on LACTEOL® during double-blind treatment and entering the Open-Label Phase|5
8785958|NCT01358708|9837131|FG001|STARTED|Open-Label Treatment Phase|Number of subjects on PLACEBO during double-blind treatment and entering the Open-Label Phase|12
8785959|NCT01358708|9837130|FG000|COMPLETED|Open-Label Treatment Phase||5
8785960|NCT01358708|9837131|FG001|COMPLETED|Open-Label Treatment Phase||12
8785961|NCT01358708|9837130|FG000|NOT COMPLETED|Open-Label Treatment Phase||0
8785962|NCT01358708|9837131|FG001|NOT COMPLETED|Open-Label Treatment Phase||0
8785963|NCT01358721|9837145|FG000|STARTED|Overall Study||22
8785964|NCT01358721|9837146|FG001|STARTED|Overall Study||22
8785965|NCT01358721|9837147|FG002|STARTED|Overall Study||23
8785966|NCT01358721|9837148|FG003|STARTED|Overall Study||24
8785967|NCT01358721|9837145|FG000|COMPLETED|Overall Study||1
8785968|NCT01358721|9837146|FG001|COMPLETED|Overall Study||0
8785969|NCT01358721|9837147|FG002|COMPLETED|Overall Study||1
8785970|NCT01358721|9837148|FG003|COMPLETED|Overall Study||0
8785971|NCT01358721|9837145|FG000|NOT COMPLETED|Overall Study||21
8785972|NCT01358721|9837146|FG001|NOT COMPLETED|Overall Study||22
8785973|NCT01358721|9837147|FG002|NOT COMPLETED|Overall Study||22
8785974|NCT01358721|9837148|FG003|NOT COMPLETED|Overall Study||24
8785975|NCT01358734|9837161|FG000|STARTED|Overall Study||15
8785976|NCT01358734|9837162|FG001|STARTED|Overall Study||39
8785977|NCT01358734|9837163|FG002|STARTED|Overall Study||34
8785978|NCT01358734|9837161|FG000|Safety Population|Overall Study|The safety population includes all participants who received at least one dose of study drug.|14
8785979|NCT01358734|9837162|FG001|Safety Population|Overall Study|The safety population includes all participants who received at least one dose of study drug.|38
8785980|NCT01358734|9837163|FG002|Safety Population|Overall Study|The safety population includes all participants who received at least one dose of study drug.|32
8785981|NCT01358734|9837161|FG000|COMPLETED|Overall Study||0
8785982|NCT01358734|9837162|FG001|COMPLETED|Overall Study||0
8785983|NCT01358734|9837163|FG002|COMPLETED|Overall Study||0
8785984|NCT01358734|9837161|FG000|NOT COMPLETED|Overall Study||15
8785985|NCT01358734|9837162|FG001|NOT COMPLETED|Overall Study||39
8785986|NCT01358734|9837163|FG002|NOT COMPLETED|Overall Study||34
8785987|NCT01358760|9837174|FG000|STARTED|Overall Study||152
8785988|NCT01358760|9837175|FG001|STARTED|Overall Study||148
8785989|NCT01358760|9837176|FG002|STARTED|Overall Study||150
8785990|NCT01358760|9837174|FG000|Safety Population|Overall Study||150
8785991|NCT01358760|9837175|FG001|Safety Population|Overall Study||143
8785992|NCT01358760|9837176|FG002|Safety Population|Overall Study||148
8785993|NCT01358760|9837174|FG000|ITT Population|Overall Study||139
8785994|NCT01358760|9837175|FG001|ITT Population|Overall Study||134
8785995|NCT01358760|9837176|FG002|ITT Population|Overall Study||134
8785996|NCT01358760|9837174|FG000|COMPLETED|Overall Study||130
8785997|NCT01358760|9837175|FG001|COMPLETED|Overall Study||128
8785998|NCT01358760|9837176|FG002|COMPLETED|Overall Study||125
8785999|NCT01358760|9837174|FG000|NOT COMPLETED|Overall Study||22
8786000|NCT01358760|9837175|FG001|NOT COMPLETED|Overall Study||20
8786001|NCT01358760|9837176|FG002|NOT COMPLETED|Overall Study||25
8786002|NCT01358825|9837186|FG000|STARTED|Overall Study||12
8786003|NCT01358825|9837187|FG001|STARTED|Overall Study||46
8786004|NCT01358825|9837186|FG000|COMPLETED|Overall Study||12
8786005|NCT01358825|9837187|FG001|COMPLETED|Overall Study||45
8786006|NCT01358825|9837186|FG000|NOT COMPLETED|Overall Study||0
8786007|NCT01358825|9837187|FG001|NOT COMPLETED|Overall Study||1
8786008|NCT01358864|9837201|FG000|STARTED|Overall Study||49
8786009|NCT01358864|9837202|FG001|STARTED|Overall Study||99
8786010|NCT01358864|9837203|FG002|STARTED|Overall Study||103
8786011|NCT01358864|9837204|FG003|STARTED|Overall Study||29
8786012|NCT01358864|9837205|FG004|STARTED|Overall Study||57
8786013|NCT01358864|9837206|FG005|STARTED|Overall Study||55
8786014|NCT01358864|9837207|FG006|STARTED|Overall Study||146
8786015|NCT01358864|9837208|FG007|STARTED|Overall Study||140
8786016|NCT01358864|9837201|FG000|COMPLETED|Overall Study||18
8786017|NCT01358864|9837202|FG001|COMPLETED|Overall Study||86
8786018|NCT01358864|9837203|FG002|COMPLETED|Overall Study||87
8786019|NCT01358864|9837204|FG003|COMPLETED|Overall Study||10
8786020|NCT01358864|9837205|FG004|COMPLETED|Overall Study||46
8786021|NCT01358864|9837206|FG005|COMPLETED|Overall Study||42
8786022|NCT01358864|9837207|FG006|COMPLETED|Overall Study||81
8786023|NCT01358864|9837208|FG007|COMPLETED|Overall Study||85
8786024|NCT01358864|9837201|FG000|NOT COMPLETED|Overall Study||31
8786025|NCT01358864|9837202|FG001|NOT COMPLETED|Overall Study||13
8786026|NCT01358864|9837203|FG002|NOT COMPLETED|Overall Study||16
8786027|NCT01358864|9837204|FG003|NOT COMPLETED|Overall Study||19
8786028|NCT01358864|9837205|FG004|NOT COMPLETED|Overall Study||11
8786029|NCT01358864|9837206|FG005|NOT COMPLETED|Overall Study||13
8786030|NCT01358864|9837207|FG006|NOT COMPLETED|Overall Study||65
8786031|NCT01358864|9837208|FG007|NOT COMPLETED|Overall Study||55
8786032|NCT01358968|9837228|FG000|STARTED|Period 1||20
8786033|NCT01358968|9837229|FG001|STARTED|Period 1||0
8786034|NCT01358968|9837230|FG002|STARTED|Period 1||0
8786035|NCT01358968|9837231|FG003|STARTED|Period 1||0
8786036|NCT01358968|9837228|FG000|Received at Least 1 Dose of Study Drug|Period 1||20
8786037|NCT01358968|9837229|FG001|Received at Least 1 Dose of Study Drug|Period 1||0
8786038|NCT01358968|9837230|FG002|Received at Least 1 Dose of Study Drug|Period 1||0
8786039|NCT01358968|9837231|FG003|Received at Least 1 Dose of Study Drug|Period 1||0
8786040|NCT01358968|9837228|FG000|COMPLETED|Period 1||20
8786041|NCT01358968|9837229|FG001|COMPLETED|Period 1||0
8786042|NCT01358968|9837230|FG002|COMPLETED|Period 1||0
8786043|NCT01358968|9837231|FG003|COMPLETED|Period 1||0
8786044|NCT01358968|9837228|FG000|NOT COMPLETED|Period 1||0
8786045|NCT01358968|9837229|FG001|NOT COMPLETED|Period 1||0
8786046|NCT01358968|9837230|FG002|NOT COMPLETED|Period 1||0
8786047|NCT01358968|9837231|FG003|NOT COMPLETED|Period 1||0
8786048|NCT01358968|9837228|FG000|STARTED|Period 2||0
8786049|NCT01358968|9837229|FG001|STARTED|Period 2||20
8786050|NCT01358968|9837230|FG002|STARTED|Period 2||0
8786051|NCT01358968|9837231|FG003|STARTED|Period 2||0
8786052|NCT01358968|9837228|FG000|Received at Least 1 Dose of Study Drug|Period 2||0
8786053|NCT01358968|9837229|FG001|Received at Least 1 Dose of Study Drug|Period 2||19
8786054|NCT01358968|9837230|FG002|Received at Least 1 Dose of Study Drug|Period 2||0
8786055|NCT01358968|9837231|FG003|Received at Least 1 Dose of Study Drug|Period 2||0
8786056|NCT01358968|9837228|FG000|COMPLETED|Period 2||0
8786057|NCT01358968|9837229|FG001|COMPLETED|Period 2||19
8786058|NCT01358968|9837230|FG002|COMPLETED|Period 2||0
8786059|NCT01358968|9837231|FG003|COMPLETED|Period 2||0
8786060|NCT01358968|9837228|FG000|NOT COMPLETED|Period 2||0
8786061|NCT01358968|9837229|FG001|NOT COMPLETED|Period 2||1
8786062|NCT01358968|9837230|FG002|NOT COMPLETED|Period 2||0
8786063|NCT01358968|9837231|FG003|NOT COMPLETED|Period 2||0
8786064|NCT01358968|9837228|FG000|STARTED|Continued Access Phase||0
8786065|NCT01358968|9837229|FG001|STARTED|Continued Access Phase||0
8786066|NCT01358968|9837230|FG002|STARTED|Continued Access Phase||12
8786067|NCT01358968|9837231|FG003|STARTED|Continued Access Phase||7
8786068|NCT01358968|9837228|FG000|Received at Least 1 Dose of Study Drug|Continued Access Phase||0
8786069|NCT01358968|9837229|FG001|Received at Least 1 Dose of Study Drug|Continued Access Phase||0
8786070|NCT01358968|9837230|FG002|Received at Least 1 Dose of Study Drug|Continued Access Phase||12
8786071|NCT01358968|9837231|FG003|Received at Least 1 Dose of Study Drug|Continued Access Phase||7
8786072|NCT01358968|9837228|FG000|COMPLETED|Continued Access Phase||0
8786073|NCT01358968|9837229|FG001|COMPLETED|Continued Access Phase||0
8786074|NCT01358968|9837230|FG002|COMPLETED|Continued Access Phase||0
8786075|NCT01358968|9837231|FG003|COMPLETED|Continued Access Phase||0
8786076|NCT01358968|9837228|FG000|NOT COMPLETED|Continued Access Phase||0
8786077|NCT01358968|9837229|FG001|NOT COMPLETED|Continued Access Phase||0
8786078|NCT01358968|9837230|FG002|NOT COMPLETED|Continued Access Phase||12
8786079|NCT01358968|9837231|FG003|NOT COMPLETED|Continued Access Phase||7
8786080|NCT01358981|9837248|FG000|STARTED|Period 1||2
8786081|NCT01358981|9837249|FG001|STARTED|Period 1||2
8786082|NCT01358981|9837250|FG002|STARTED|Period 1||2
8786083|NCT01358981|9837251|FG003|STARTED|Period 1||2
8786084|NCT01358981|9837252|FG004|STARTED|Period 1||3
8786085|NCT01358981|9837253|FG005|STARTED|Period 1||3
8786086|NCT01358981|9837254|FG006|STARTED|Period 1||3
8786087|NCT01358981|9837248|FG000|Received at Least 1dose of Study Drug|Period 1||2
8786088|NCT01358981|9837249|FG001|Received at Least 1dose of Study Drug|Period 1||2
8786089|NCT01358981|9837250|FG002|Received at Least 1dose of Study Drug|Period 1||2
8786090|NCT01358981|9837251|FG003|Received at Least 1dose of Study Drug|Period 1||2
8786091|NCT01358981|9837252|FG004|Received at Least 1dose of Study Drug|Period 1||3
8786092|NCT01358981|9837253|FG005|Received at Least 1dose of Study Drug|Period 1||3
8786093|NCT01358981|9837254|FG006|Received at Least 1dose of Study Drug|Period 1||3
8786094|NCT01358981|9837248|FG000|COMPLETED|Period 1||2
8786095|NCT01358981|9837249|FG001|COMPLETED|Period 1||2
8786096|NCT01358981|9837250|FG002|COMPLETED|Period 1||2
8786097|NCT01358981|9837251|FG003|COMPLETED|Period 1||1
8786098|NCT01358981|9837252|FG004|COMPLETED|Period 1||3
8786099|NCT01358981|9837253|FG005|COMPLETED|Period 1||3
8786100|NCT01358981|9837254|FG006|COMPLETED|Period 1||3
8786101|NCT01358981|9837248|FG000|NOT COMPLETED|Period 1||0
8786102|NCT01358981|9837249|FG001|NOT COMPLETED|Period 1||0
8786103|NCT01358981|9837250|FG002|NOT COMPLETED|Period 1||0
8786104|NCT01358981|9837251|FG003|NOT COMPLETED|Period 1||1
8786105|NCT01358981|9837252|FG004|NOT COMPLETED|Period 1||0
8786106|NCT01358981|9837253|FG005|NOT COMPLETED|Period 1||0
8786107|NCT01358981|9837254|FG006|NOT COMPLETED|Period 1||0
8786108|NCT01358981|9837248|FG000|STARTED|Period 2||2
8786109|NCT01358981|9837249|FG001|STARTED|Period 2||2
8786110|NCT01358981|9837250|FG002|STARTED|Period 2||2
8786111|NCT01358981|9837251|FG003|STARTED|Period 2|One participant who withdrew in period 1 was replaced by another participant in period 2.|2
8786112|NCT01358981|9837252|FG004|STARTED|Period 2||3
8786113|NCT01358981|9837253|FG005|STARTED|Period 2||3
8786114|NCT01358981|9837254|FG006|STARTED|Period 2||3
8786115|NCT01358981|9837248|FG000|COMPLETED|Period 2||2
8786116|NCT01358981|9837249|FG001|COMPLETED|Period 2||2
8786117|NCT01358981|9837250|FG002|COMPLETED|Period 2||2
8786118|NCT01358981|9837251|FG003|COMPLETED|Period 2||2
8786119|NCT01358981|9837252|FG004|COMPLETED|Period 2||3
8786120|NCT01358981|9837253|FG005|COMPLETED|Period 2||3
8786121|NCT01358981|9837254|FG006|COMPLETED|Period 2||3
8786122|NCT01358981|9837248|FG000|NOT COMPLETED|Period 2||0
8786123|NCT01358981|9837249|FG001|NOT COMPLETED|Period 2||0
8786124|NCT01358981|9837250|FG002|NOT COMPLETED|Period 2||0
8786125|NCT01358981|9837251|FG003|NOT COMPLETED|Period 2||0
8786126|NCT01358981|9837252|FG004|NOT COMPLETED|Period 2||0
8786127|NCT01358981|9837253|FG005|NOT COMPLETED|Period 2||0
8786128|NCT01358981|9837254|FG006|NOT COMPLETED|Period 2||0
8786129|NCT01358981|9837248|FG000|STARTED|Period 3||2
8786130|NCT01358981|9837249|FG001|STARTED|Period 3||2
8786131|NCT01358981|9837250|FG002|STARTED|Period 3||2
8786132|NCT01358981|9837251|FG003|STARTED|Period 3||2
8786133|NCT01358981|9837252|FG004|STARTED|Period 3||3
8786134|NCT01358981|9837253|FG005|STARTED|Period 3||3
8786135|NCT01358981|9837254|FG006|STARTED|Period 3||3
8786136|NCT01358981|9837248|FG000|COMPLETED|Period 3||2
8786137|NCT01358981|9837249|FG001|COMPLETED|Period 3||2
8786138|NCT01358981|9837250|FG002|COMPLETED|Period 3||2
8786139|NCT01358981|9837251|FG003|COMPLETED|Period 3||2
8786140|NCT01358981|9837252|FG004|COMPLETED|Period 3||3
8786141|NCT01358981|9837253|FG005|COMPLETED|Period 3||3
8786142|NCT01358981|9837254|FG006|COMPLETED|Period 3||3
8786143|NCT01358981|9837248|FG000|NOT COMPLETED|Period 3||0
8786144|NCT01358981|9837249|FG001|NOT COMPLETED|Period 3||0
8786145|NCT01358981|9837250|FG002|NOT COMPLETED|Period 3||0
8786146|NCT01358981|9837251|FG003|NOT COMPLETED|Period 3||0
8786147|NCT01358981|9837252|FG004|NOT COMPLETED|Period 3||0
8786148|NCT01358981|9837253|FG005|NOT COMPLETED|Period 3||0
8786149|NCT01358981|9837254|FG006|NOT COMPLETED|Period 3||0
8786150|NCT01358981|9837248|FG000|STARTED|Period 4||2
8786151|NCT01358981|9837249|FG001|STARTED|Period 4||2
8786152|NCT01358981|9837250|FG002|STARTED|Period 4||2
8786153|NCT01358981|9837251|FG003|STARTED|Period 4||2
8786154|NCT01358981|9837252|FG004|STARTED|Period 4|Part B was planned for only 3 dosing periods.|0
8786155|NCT01358981|9837253|FG005|STARTED|Period 4|Part B was planned for only 3 dosing periods.|0
8786156|NCT01358981|9837254|FG006|STARTED|Period 4|Part B was planned for only 3 dosing periods.|0
8786157|NCT01358981|9837248|FG000|COMPLETED|Period 4||2
8786158|NCT01358981|9837249|FG001|COMPLETED|Period 4||2
8786159|NCT01358981|9837250|FG002|COMPLETED|Period 4||2
8786160|NCT01358981|9837251|FG003|COMPLETED|Period 4||2
8786161|NCT01358981|9837252|FG004|COMPLETED|Period 4||0
8786162|NCT01358981|9837253|FG005|COMPLETED|Period 4||0
8786163|NCT01358981|9837254|FG006|COMPLETED|Period 4||0
8786164|NCT01358981|9837248|FG000|NOT COMPLETED|Period 4||0
8786165|NCT01358981|9837249|FG001|NOT COMPLETED|Period 4||0
8786166|NCT01358981|9837250|FG002|NOT COMPLETED|Period 4||0
8786167|NCT01358981|9837251|FG003|NOT COMPLETED|Period 4||0
8786168|NCT01358981|9837252|FG004|NOT COMPLETED|Period 4||0
8786169|NCT01358981|9837253|FG005|NOT COMPLETED|Period 4||0
8786170|NCT01358981|9837254|FG006|NOT COMPLETED|Period 4||0
8786171|NCT01359007|9837279|FG000|STARTED|Overall Study||5
8786172|NCT01359007|9837279|FG000|COMPLETED|Overall Study||3
8786173|NCT01359007|9837279|FG000|NOT COMPLETED|Overall Study||2
8786174|NCT01359046|9837286|FG000|STARTED|Overall Study||144
8786175|NCT01359046|9837287|FG001|STARTED|Overall Study||144
8786176|NCT01359046|9837286|FG000|COMPLETED|Overall Study||137
8786177|NCT01359046|9837287|FG001|COMPLETED|Overall Study||127
8786178|NCT01359046|9837286|FG000|NOT COMPLETED|Overall Study||7
8786179|NCT01359046|9837287|FG001|NOT COMPLETED|Overall Study||17
8786180|NCT01359111|9837293|FG000|STARTED|Overall Study||20
8786181|NCT01359111|9837293|FG000|COMPLETED|Overall Study||20
8786182|NCT01359111|9837293|FG000|NOT COMPLETED|Overall Study||0
8786183|NCT01359150|9837301|FG000|STARTED|Overall Study||112
8786184|NCT01359150|9837302|FG001|STARTED|Overall Study||111
8786185|NCT01359150|9837301|FG000|COMPLETED|Overall Study||105
8786186|NCT01359150|9837302|FG001|COMPLETED|Overall Study||106
8786187|NCT01359150|9837301|FG000|NOT COMPLETED|Overall Study||7
8786188|NCT01359150|9837302|FG001|NOT COMPLETED|Overall Study||5
8786189|NCT01359371|9837308|FG000|STARTED|Overall Study||131
8786190|NCT01359371|9837308|FG000|COMPLETED|Overall Study||131
8786191|NCT01359371|9837308|FG000|NOT COMPLETED|Overall Study||0
8786192|NCT01359410|9837319|FG000|STARTED|Overall Study||54
8786193|NCT01359410|9837320|FG001|STARTED|Overall Study||46
8786194|NCT01359410|9837319|FG000|COMPLETED|Overall Study||54
8786195|NCT01359410|9837320|FG001|COMPLETED|Overall Study||46
8786196|NCT01359410|9837319|FG000|NOT COMPLETED|Overall Study||0
8786197|NCT01359410|9837320|FG001|NOT COMPLETED|Overall Study||0
8786198|NCT01359449|9837328|FG000|STARTED|Overall Study||61
8786199|NCT01359449|9837329|FG001|STARTED|Overall Study||62
8786200|NCT01359449|9837328|FG000|COMPLETED|Overall Study||57
8786201|NCT01359449|9837329|FG001|COMPLETED|Overall Study||58
8786202|NCT01359449|9837328|FG000|NOT COMPLETED|Overall Study||4
8786203|NCT01359449|9837329|FG001|NOT COMPLETED|Overall Study||4
8786204|NCT01359592|9837335|FG000|STARTED|Initial Registration||158
8786205|NCT01359592|9837336|FG001|STARTED|Initial Registration||1
8786206|NCT01359592|9837337|FG002|STARTED|Initial Registration||0
8786207|NCT01359592|9837338|FG003|STARTED|Initial Registration||0
8786208|NCT01359592|9837335|FG000|Eligible and Evaluable|Initial Registration||132
8786209|NCT01359592|9837336|FG001|Eligible and Evaluable|Initial Registration||1
8786210|NCT01359592|9837337|FG002|Eligible and Evaluable|Initial Registration||0
8786211|NCT01359592|9837338|FG003|Eligible and Evaluable|Initial Registration||0
8786212|NCT01359592|9837335|FG000|COMPLETED|Initial Registration||129
8786213|NCT01359592|9837336|FG001|COMPLETED|Initial Registration||1
8786214|NCT01359592|9837337|FG002|COMPLETED|Initial Registration||0
8786215|NCT01359592|9837338|FG003|COMPLETED|Initial Registration||0
8786216|NCT01359592|9837335|FG000|NOT COMPLETED|Initial Registration||29
8786217|NCT01359592|9837336|FG001|NOT COMPLETED|Initial Registration||0
8786218|NCT01359592|9837337|FG002|NOT COMPLETED|Initial Registration||0
8786219|NCT01359592|9837338|FG003|NOT COMPLETED|Initial Registration||0
8786220|NCT01359592|9837335|FG000|STARTED|PET-Directed Therapy||0
8786221|NCT01359592|9837336|FG001|STARTED|PET-Directed Therapy||0
8786222|NCT01359592|9837337|FG002|STARTED|PET-Directed Therapy||137
8786223|NCT01359592|9837338|FG003|STARTED|PET-Directed Therapy||12
8786224|NCT01359592|9837335|FG000|Eligible and Evaluable|PET-Directed Therapy||0
8786225|NCT01359592|9837336|FG001|Eligible and Evaluable|PET-Directed Therapy||0
8786226|NCT01359592|9837337|FG002|Eligible and Evaluable|PET-Directed Therapy||113
8786227|NCT01359592|9837338|FG003|Eligible and Evaluable|PET-Directed Therapy||12
8786228|NCT01359592|9837335|FG000|COMPLETED|PET-Directed Therapy||0
8786229|NCT01359592|9837336|FG001|COMPLETED|PET-Directed Therapy||0
8786230|NCT01359592|9837337|FG002|COMPLETED|PET-Directed Therapy||111
8786231|NCT01359592|9837338|FG003|COMPLETED|PET-Directed Therapy||12
8786232|NCT01359592|9837335|FG000|NOT COMPLETED|PET-Directed Therapy||0
8786233|NCT01359592|9837336|FG001|NOT COMPLETED|PET-Directed Therapy||0
8786234|NCT01359592|9837337|FG002|NOT COMPLETED|PET-Directed Therapy||26
8786235|NCT01359592|9837338|FG003|NOT COMPLETED|PET-Directed Therapy||0
8786236|NCT01359644|9837363|FG000|STARTED|Treatment Period||15
8786237|NCT01359644|9837364|FG001|STARTED|Treatment Period||16
8786238|NCT01359644|9837365|FG002|STARTED|Treatment Period||14
8786239|NCT01359644|9837366|FG003|STARTED|Treatment Period||14
8786240|NCT01359644|9837367|FG004|STARTED|Treatment Period||15
8786241|NCT01359644|9837368|FG005|STARTED|Treatment Period||14
8786242|NCT01359644|9837369|FG006|STARTED|Treatment Period||41
8786243|NCT01359644|9837370|FG007|STARTED|Treatment Period||41
8786244|NCT01359644|9837371|FG008|STARTED|Treatment Period||21
8786245|NCT01359644|9837372|FG009|STARTED|Treatment Period||20
8786246|NCT01359644|9837363|FG000|COMPLETED|Treatment Period||15
8786247|NCT01359644|9837364|FG001|COMPLETED|Treatment Period||15
8786248|NCT01359644|9837365|FG002|COMPLETED|Treatment Period||13
8786249|NCT01359644|9837366|FG003|COMPLETED|Treatment Period||14
8786250|NCT01359644|9837367|FG004|COMPLETED|Treatment Period||15
8786251|NCT01359644|9837368|FG005|COMPLETED|Treatment Period||12
8786252|NCT01359644|9837369|FG006|COMPLETED|Treatment Period||41
8786253|NCT01359644|9837370|FG007|COMPLETED|Treatment Period||41
8786254|NCT01359644|9837371|FG008|COMPLETED|Treatment Period||21
8786255|NCT01359644|9837372|FG009|COMPLETED|Treatment Period||20
8786256|NCT01359644|9837363|FG000|NOT COMPLETED|Treatment Period||0
8786257|NCT01359644|9837364|FG001|NOT COMPLETED|Treatment Period||1
8786258|NCT01359644|9837365|FG002|NOT COMPLETED|Treatment Period||1
8786259|NCT01359644|9837366|FG003|NOT COMPLETED|Treatment Period||0
8786260|NCT01359644|9837367|FG004|NOT COMPLETED|Treatment Period||0
8786261|NCT01359644|9837368|FG005|NOT COMPLETED|Treatment Period||2
8786262|NCT01359644|9837369|FG006|NOT COMPLETED|Treatment Period||0
8786263|NCT01359644|9837370|FG007|NOT COMPLETED|Treatment Period||0
8786264|NCT01359644|9837371|FG008|NOT COMPLETED|Treatment Period||0
8786265|NCT01359644|9837372|FG009|NOT COMPLETED|Treatment Period||0
8786266|NCT01359644|9837363|FG000|STARTED|Follow-up Period||15
8786267|NCT01359644|9837364|FG001|STARTED|Follow-up Period||16
8786268|NCT01359644|9837365|FG002|STARTED|Follow-up Period||14
8786269|NCT01359644|9837366|FG003|STARTED|Follow-up Period||14
8786270|NCT01359644|9837367|FG004|STARTED|Follow-up Period||15
8786271|NCT01359644|9837368|FG005|STARTED|Follow-up Period||13
8786272|NCT01359644|9837369|FG006|STARTED|Follow-up Period||41
8786273|NCT01359644|9837370|FG007|STARTED|Follow-up Period||41
8786274|NCT01359644|9837371|FG008|STARTED|Follow-up Period||21
8786275|NCT01359644|9837372|FG009|STARTED|Follow-up Period||20
8786276|NCT01359644|9837363|FG000|COMPLETED|Follow-up Period||15
8786277|NCT01359644|9837364|FG001|COMPLETED|Follow-up Period||16
8786278|NCT01359644|9837365|FG002|COMPLETED|Follow-up Period||14
8786279|NCT01359644|9837366|FG003|COMPLETED|Follow-up Period||14
8786280|NCT01359644|9837367|FG004|COMPLETED|Follow-up Period||15
8786281|NCT01359644|9837368|FG005|COMPLETED|Follow-up Period||12
8786282|NCT01359644|9837369|FG006|COMPLETED|Follow-up Period||40
8786283|NCT01359644|9837370|FG007|COMPLETED|Follow-up Period||39
8786284|NCT01359644|9837371|FG008|COMPLETED|Follow-up Period||21
8786285|NCT01359644|9837372|FG009|COMPLETED|Follow-up Period||20
8786286|NCT01359644|9837363|FG000|NOT COMPLETED|Follow-up Period||0
8786287|NCT01359644|9837364|FG001|NOT COMPLETED|Follow-up Period||0
8786288|NCT01359644|9837365|FG002|NOT COMPLETED|Follow-up Period||0
8786289|NCT01359644|9837366|FG003|NOT COMPLETED|Follow-up Period||0
8786290|NCT01359644|9837367|FG004|NOT COMPLETED|Follow-up Period||0
8786291|NCT01359644|9837368|FG005|NOT COMPLETED|Follow-up Period||1
8786292|NCT01359644|9837369|FG006|NOT COMPLETED|Follow-up Period||1
8786293|NCT01359644|9837370|FG007|NOT COMPLETED|Follow-up Period||2
8786294|NCT01359644|9837371|FG008|NOT COMPLETED|Follow-up Period||0
8786295|NCT01359644|9837372|FG009|NOT COMPLETED|Follow-up Period||0
8786296|NCT01359735|9837407|FG000|STARTED|Overall Study||4
8786297|NCT01359735|9837408|FG001|STARTED|Overall Study||4
8786298|NCT01359735|9837407|FG000|COMPLETED|Overall Study||4
8786299|NCT01359735|9837408|FG001|COMPLETED|Overall Study||4
8786300|NCT01359735|9837407|FG000|NOT COMPLETED|Overall Study||0
8786301|NCT01359735|9837408|FG001|NOT COMPLETED|Overall Study||0
8786302|NCT01359748|9837418|FG000|STARTED|Overall Study||48
8786303|NCT01359748|9837419|FG001|STARTED|Overall Study||20
8786304|NCT01359748|9837420|FG002|STARTED|Overall Study||10
8786305|NCT01359748|9837421|FG003|STARTED|Overall Study||11
8786306|NCT01359748|9837418|FG000|COMPLETED|Overall Study||48
8786307|NCT01359748|9837419|FG001|COMPLETED|Overall Study||20
8786308|NCT01359748|9837420|FG002|COMPLETED|Overall Study||10
8786309|NCT01359748|9837421|FG003|COMPLETED|Overall Study||11
8786310|NCT01359748|9837418|FG000|NOT COMPLETED|Overall Study||0
8786311|NCT01359748|9837419|FG001|NOT COMPLETED|Overall Study||0
8786312|NCT01359748|9837420|FG002|NOT COMPLETED|Overall Study||0
8786313|NCT01359748|9837421|FG003|NOT COMPLETED|Overall Study||0
8786314|NCT01359904|9837431|FG000|STARTED|Overall Study||15
8786315|NCT01359904|9837432|FG001|STARTED|Overall Study||19
8786316|NCT01359904|9837431|FG000|COMPLETED|Overall Study||14
8786317|NCT01359904|9837432|FG001|COMPLETED|Overall Study||19
8786318|NCT01359904|9837431|FG000|NOT COMPLETED|Overall Study||1
8786319|NCT01359904|9837432|FG001|NOT COMPLETED|Overall Study||0
8786320|NCT01359943|9837441|FG000|STARTED|Double-blind (Weeks 0 - 16)||88
8786321|NCT01359943|9837442|FG001|STARTED|Double-blind (Weeks 0 - 16)||89
8786322|NCT01359943|9837443|FG002|STARTED|Double-blind (Weeks 0 - 16)||44
8786323|NCT01359943|9837441|FG000|COMPLETED|Double-blind (Weeks 0 - 16)||86
8786324|NCT01359943|9837442|FG001|COMPLETED|Double-blind (Weeks 0 - 16)||85
8786325|NCT01359943|9837443|FG002|COMPLETED|Double-blind (Weeks 0 - 16)||44
8786326|NCT01359943|9837441|FG000|NOT COMPLETED|Double-blind (Weeks 0 - 16)||2
8786327|NCT01359943|9837442|FG001|NOT COMPLETED|Double-blind (Weeks 0 - 16)||4
8786328|NCT01359943|9837443|FG002|NOT COMPLETED|Double-blind (Weeks 0 - 16)||0
8786329|NCT01359943|9837441|FG000|STARTED|Open Label 150 mg s.c. (Weeks 16 - 52)||86
8786330|NCT01359943|9837442|FG001|STARTED|Open Label 150 mg s.c. (Weeks 16 - 52)|One participant, who was continuing as of week 12, did not receive study drug at week 16.|84
8786331|NCT01359943|9837443|FG002|STARTED|Open Label 150 mg s.c. (Weeks 16 - 52)||44
8786332|NCT01359943|9837441|FG000|COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||78
8786333|NCT01359943|9837442|FG001|COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||71
8786334|NCT01359943|9837443|FG002|COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||36
8786335|NCT01359943|9837441|FG000|NOT COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||8
8786336|NCT01359943|9837442|FG001|NOT COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||13
8786337|NCT01359943|9837443|FG002|NOT COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||8
8786338|NCT01359943|9837441|FG000|STARTED|Follow-up (Weeks 52 - 60)||86
8786339|NCT01359943|9837442|FG001|STARTED|Follow-up (Weeks 52 - 60)||84
8786340|NCT01359943|9837443|FG002|STARTED|Follow-up (Weeks 52 - 60)||44
8786341|NCT01359943|9837441|FG000|COMPLETED|Follow-up (Weeks 52 - 60)||78
8786342|NCT01359943|9837442|FG001|COMPLETED|Follow-up (Weeks 52 - 60)||69
8786343|NCT01359943|9837443|FG002|COMPLETED|Follow-up (Weeks 52 - 60)||36
8786344|NCT01359943|9837441|FG000|NOT COMPLETED|Follow-up (Weeks 52 - 60)||8
8786345|NCT01359943|9837442|FG001|NOT COMPLETED|Follow-up (Weeks 52 - 60)||15
8786346|NCT01359943|9837443|FG002|NOT COMPLETED|Follow-up (Weeks 52 - 60)||8
8786347|NCT01359956|9837457|FG000|STARTED|Overall Study||67
8786348|NCT01359956|9837458|FG001|STARTED|Overall Study||69
8786349|NCT01359956|9837459|FG002|STARTED|Overall Study||71
8786350|NCT01359956|9837460|FG003|STARTED|Overall Study||62
8786351|NCT01359956|9837457|FG000|COMPLETED|Overall Study||6
8786352|NCT01359956|9837458|FG001|COMPLETED|Overall Study||5
8786353|NCT01359956|9837459|FG002|COMPLETED|Overall Study||4
8786354|NCT01359956|9837460|FG003|COMPLETED|Overall Study||4
8786355|NCT01359956|9837457|FG000|NOT COMPLETED|Overall Study||61
8786356|NCT01359956|9837458|FG001|NOT COMPLETED|Overall Study||64
8786357|NCT01359956|9837459|FG002|NOT COMPLETED|Overall Study||67
8786358|NCT01359956|9837460|FG003|NOT COMPLETED|Overall Study||58
8786359|NCT01360021|9837473|FG000|STARTED|Overall Study|Patients randomized|71
8786360|NCT01360021|9837474|FG001|STARTED|Overall Study|Patients randomized|71
8786361|NCT01360021|9837475|FG002|STARTED|Overall Study|Patients randomized|72
8786362|NCT01360021|9837473|FG000|COMPLETED|Overall Study|Patients who completed study|63
8786363|NCT01360021|9837474|FG001|COMPLETED|Overall Study|Patients who completed study|67
8786364|NCT01360021|9837475|FG002|COMPLETED|Overall Study|Patients who completed study|65
8786365|NCT01360021|9837473|FG000|NOT COMPLETED|Overall Study||8
8786366|NCT01360021|9837474|FG001|NOT COMPLETED|Overall Study||4
8786367|NCT01360021|9837475|FG002|NOT COMPLETED|Overall Study||7
8786368|NCT01360229|9837485|FG000|STARTED|Overall Study||47
8786369|NCT01360229|9837486|FG001|STARTED|Overall Study||47
8786370|NCT01360229|9837485|FG000|COMPLETED|Overall Study||44
8786371|NCT01360229|9837486|FG001|COMPLETED|Overall Study||45
8786372|NCT01360229|9837485|FG000|NOT COMPLETED|Overall Study||3
8786373|NCT01360229|9837486|FG001|NOT COMPLETED|Overall Study||2
8786374|NCT01360398|9837492|FG000|STARTED|Overall Study||127
8786375|NCT01360398|9837492|FG000|COMPLETED|Overall Study||105
8786376|NCT01360398|9837492|FG000|NOT COMPLETED|Overall Study||22
8786377|NCT01360450|9837498|FG000|STARTED|Overall Study||6
8786378|NCT01360450|9837499|FG001|STARTED|Overall Study||6
8786379|NCT01360450|9837498|FG000|Completed Treatment|Overall Study||6
8786380|NCT01360450|9837499|FG001|Completed Treatment|Overall Study||6
8786381|NCT01360450|9837498|FG000|COMPLETED|Overall Study||6
8786382|NCT01360450|9837499|FG001|COMPLETED|Overall Study||6
8786383|NCT01360450|9837498|FG000|NOT COMPLETED|Overall Study||0
8786384|NCT01360450|9837499|FG001|NOT COMPLETED|Overall Study||0
8786385|NCT01360554|9837508|FG000|STARTED|Overall Study|Three participants were randomized but not treated.|439
8786386|NCT01360554|9837509|FG001|STARTED|Overall Study|Three participants were randomized but not treated.|439
8786387|NCT01360554|9837508|FG000|Treated|Overall Study||436
8786388|NCT01360554|9837509|FG001|Treated|Overall Study||436
8786389|NCT01360554|9837508|FG000|COMPLETED|Overall Study||0
8786390|NCT01360554|9837509|FG001|COMPLETED|Overall Study||0
8786391|NCT01360554|9837508|FG000|NOT COMPLETED|Overall Study||439
8786392|NCT01360554|9837509|FG001|NOT COMPLETED|Overall Study||439
8786393|NCT01360632|9837518|FG000|STARTED|Phase A (8 Weeks)|A total of 1539 participants were enrolled, 7 discontinued before taking any sponsor-provided ADT|1532
8786394|NCT01360632|9837519|FG001|STARTED|Phase A (8 Weeks)|These participants were from the randomized sample.|0
8786395|NCT01360632|9837520|FG002|STARTED|Phase A (8 Weeks)|These participants were from the randomized sample.|0
8786396|NCT01360632|9837521|FG003|STARTED|Phase A (8 Weeks)|These participants were from the randomized sample.|0
8786397|NCT01360632|9837522|FG004|STARTED|Phase A (8 Weeks)||0
8786398|NCT01360632|9837518|FG000|COMPLETED|Phase A (8 Weeks)||1277
8786399|NCT01360632|9837519|FG001|COMPLETED|Phase A (8 Weeks)||0
8786400|NCT01360632|9837520|FG002|COMPLETED|Phase A (8 Weeks)||0
8786401|NCT01360632|9837521|FG003|COMPLETED|Phase A (8 Weeks)||0
8786402|NCT01360632|9837522|FG004|COMPLETED|Phase A (8 Weeks)||0
8786403|NCT01360632|9837518|FG000|NOT COMPLETED|Phase A (8 Weeks)||255
8786404|NCT01360632|9837519|FG001|NOT COMPLETED|Phase A (8 Weeks)||0
8786405|NCT01360632|9837520|FG002|NOT COMPLETED|Phase A (8 Weeks)||0
8786406|NCT01360632|9837521|FG003|NOT COMPLETED|Phase A (8 Weeks)||0
8786407|NCT01360632|9837522|FG004|NOT COMPLETED|Phase A (8 Weeks)||0
8786408|NCT01360632|9837518|FG000|STARTED|Phase B (6 Weeks)||0
8786409|NCT01360632|9837519|FG001|STARTED|Phase B (6 Weeks)|These participants were from the randomized sample.|226
8786410|NCT01360632|9837520|FG002|STARTED|Phase B (6 Weeks)|These participants were from the randomized sample.|230
8786411|NCT01360632|9837521|FG003|STARTED|Phase B (6 Weeks)|These participants were from the randomized sample.|221
8786412|NCT01360632|9837522|FG004|STARTED|Phase B (6 Weeks)||0
8786413|NCT01360632|9837518|FG000|COMPLETED|Phase B (6 Weeks)||0
8786414|NCT01360632|9837519|FG001|COMPLETED|Phase B (6 Weeks)||216
8786415|NCT01360632|9837520|FG002|COMPLETED|Phase B (6 Weeks)||210
8786416|NCT01360632|9837521|FG003|COMPLETED|Phase B (6 Weeks)||208
8786417|NCT01360632|9837522|FG004|COMPLETED|Phase B (6 Weeks)||0
8786418|NCT01360632|9837518|FG000|NOT COMPLETED|Phase B (6 Weeks)||0
8786419|NCT01360632|9837519|FG001|NOT COMPLETED|Phase B (6 Weeks)||10
8786420|NCT01360632|9837520|FG002|NOT COMPLETED|Phase B (6 Weeks)||20
8786421|NCT01360632|9837521|FG003|NOT COMPLETED|Phase B (6 Weeks)||13
8786422|NCT01360632|9837522|FG004|NOT COMPLETED|Phase B (6 Weeks)||0
8786423|NCT01360632|9837518|FG000|STARTED|Phase A+||0
8786424|NCT01360632|9837519|FG001|STARTED|Phase A+||0
8786425|NCT01360632|9837520|FG002|STARTED|Phase A+||0
8786426|NCT01360632|9837521|FG003|STARTED|Phase A+||0
8786427|NCT01360632|9837522|FG004|STARTED|Phase A+||600
8786428|NCT01360632|9837518|FG000|COMPLETED|Phase A+||0
8786429|NCT01360632|9837519|FG001|COMPLETED|Phase A+||0
8786430|NCT01360632|9837520|FG002|COMPLETED|Phase A+||0
8786431|NCT01360632|9837521|FG003|COMPLETED|Phase A+||0
8786432|NCT01360632|9837522|FG004|COMPLETED|Phase A+||575
9031133|NCT03238963|10093236|FG000|COMPLETED|Overall Study||35
9031134|NCT03238963|10093237|FG001|COMPLETED|Overall Study||37
9031135|NCT03238963|10093236|FG000|NOT COMPLETED|Overall Study||5
9031136|NCT03238963|10093237|FG001|NOT COMPLETED|Overall Study||2
9031137|NCT03239106|10093243|FG000|STARTED|Overall Study||10
9031138|NCT03239106|10093243|FG000|COMPLETED|Overall Study||3
8671983|NCT00754468|9715400|FG000|COMPLETED|Overall Study||4
8671984|NCT00754468|9715401|FG001|COMPLETED|Overall Study||3
8671985|NCT00754468|9715400|FG000|NOT COMPLETED|Overall Study||0
8671986|NCT00754468|9715401|FG001|NOT COMPLETED|Overall Study||0
8671987|NCT00754494|9715412|FG000|STARTED|Overall Study||15
8671988|NCT00754494|9715413|FG001|STARTED|Overall Study||15
8671989|NCT00754494|9715414|FG002|STARTED|Overall Study||15
8671990|NCT00754494|9715412|FG000|COMPLETED|Overall Study||13
8671991|NCT00754494|9715413|FG001|COMPLETED|Overall Study||15
8671992|NCT00754494|9715414|FG002|COMPLETED|Overall Study||14
8786433|NCT01360632|9837518|FG000|NOT COMPLETED|Phase A+||0
8786434|NCT01360632|9837519|FG001|NOT COMPLETED|Phase A+||0
8786435|NCT01360632|9837520|FG002|NOT COMPLETED|Phase A+||0
8786436|NCT01360632|9837521|FG003|NOT COMPLETED|Phase A+||0
8786437|NCT01360632|9837522|FG004|NOT COMPLETED|Phase A+||25
8786438|NCT01360645|9837532|FG000|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)|826 participants were enrolled but 2 participants discontinued trial before taking study medication.|824
8786439|NCT01360645|9837533|FG001|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
8786440|NCT01360645|9837534|FG002|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
8786441|NCT01360645|9837535|FG003|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
8786442|NCT01360645|9837532|FG000|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||710
8786443|NCT01360645|9837533|FG001|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
8786444|NCT01360645|9837534|FG002|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
8786445|NCT01360645|9837535|FG003|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
8786446|NCT01360645|9837532|FG000|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||114
8786447|NCT01360645|9837533|FG001|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
8786448|NCT01360645|9837534|FG002|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
8786449|NCT01360645|9837535|FG003|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
8786450|NCT01360645|9837532|FG000|STARTED|Phase B (6 Weeks)||0
8786451|NCT01360645|9837533|FG001|STARTED|Phase B (6 Weeks)||188
8786452|NCT01360645|9837534|FG002|STARTED|Phase B (6 Weeks)||191
8786453|NCT01360645|9837535|FG003|STARTED|Phase B (6 Weeks)||0
8786454|NCT01360645|9837532|FG000|COMPLETED|Phase B (6 Weeks)||0
8786455|NCT01360645|9837533|FG001|COMPLETED|Phase B (6 Weeks)||174
8786456|NCT01360645|9837534|FG002|COMPLETED|Phase B (6 Weeks)||178
8786457|NCT01360645|9837535|FG003|COMPLETED|Phase B (6 Weeks)||0
8786458|NCT01360645|9837532|FG000|NOT COMPLETED|Phase B (6 Weeks)||0
8786459|NCT01360645|9837533|FG001|NOT COMPLETED|Phase B (6 Weeks)||14
8786460|NCT01360645|9837534|FG002|NOT COMPLETED|Phase B (6 Weeks)||13
8786461|NCT01360645|9837535|FG003|NOT COMPLETED|Phase B (6 Weeks)||0
8786462|NCT01360645|9837532|FG000|STARTED|Phase A+||0
8786463|NCT01360645|9837533|FG001|STARTED|Phase A+||0
8786464|NCT01360645|9837534|FG002|STARTED|Phase A+||0
8786465|NCT01360645|9837535|FG003|STARTED|Phase A+||331
8786466|NCT01360645|9837532|FG000|COMPLETED|Phase A+||0
8786467|NCT01360645|9837533|FG001|COMPLETED|Phase A+||0
8786468|NCT01360645|9837534|FG002|COMPLETED|Phase A+||0
8786469|NCT01360645|9837535|FG003|COMPLETED|Phase A+||307
8786470|NCT01360645|9837532|FG000|NOT COMPLETED|Phase A+||0
8786471|NCT01360645|9837533|FG001|NOT COMPLETED|Phase A+||0
8786472|NCT01360645|9837534|FG002|NOT COMPLETED|Phase A+||0
8786473|NCT01360645|9837535|FG003|NOT COMPLETED|Phase A+||24
8786474|NCT01360762|9837541|FG000|STARTED|Main Study Period (12-month Treatment)||74
8786475|NCT01360762|9837541|FG000|COMPLETED|Main Study Period (12-month Treatment)||45
8786476|NCT01360762|9837541|FG000|NOT COMPLETED|Main Study Period (12-month Treatment)||29
8786477|NCT01360762|9837541|FG000|STARTED|Whole Study Period||74
8786478|NCT01360762|9837541|FG000|COMPLETED|Whole Study Period||38
8786479|NCT01360762|9837541|FG000|NOT COMPLETED|Whole Study Period||36
8786480|NCT01360840|9837548|FG000|STARTED|Overall Study||60
8786481|NCT01360840|9837549|FG001|STARTED|Overall Study||60
8786482|NCT01360840|9837550|FG002|STARTED|Overall Study||60
8786483|NCT01360840|9837548|FG000|COMPLETED|Overall Study||50
8786484|NCT01360840|9837549|FG001|COMPLETED|Overall Study||50
8786485|NCT01360840|9837550|FG002|COMPLETED|Overall Study||51
8786486|NCT01360840|9837548|FG000|NOT COMPLETED|Overall Study||10
8786487|NCT01360840|9837549|FG001|NOT COMPLETED|Overall Study||10
8786488|NCT01360840|9837550|FG002|NOT COMPLETED|Overall Study||9
8786489|NCT01360866|9837564|FG000|STARTED|Overall Study||516
8786490|NCT01360866|9837565|FG001|STARTED|Overall Study||707
8786491|NCT01360866|9837566|FG002|STARTED|Overall Study||1645
8786492|NCT01360866|9837567|FG003|STARTED|Overall Study||76
8786493|NCT01360866|9837564|FG000|COMPLETED|Overall Study||295
8786494|NCT01360866|9837565|FG001|COMPLETED|Overall Study||420
8786495|NCT01360866|9837566|FG002|COMPLETED|Overall Study||1126
8786496|NCT01360866|9837567|FG003|COMPLETED|Overall Study||54
8786497|NCT01360866|9837564|FG000|NOT COMPLETED|Overall Study||221
8786498|NCT01360866|9837565|FG001|NOT COMPLETED|Overall Study||287
8786499|NCT01360866|9837566|FG002|NOT COMPLETED|Overall Study||519
8786500|NCT01360866|9837567|FG003|NOT COMPLETED|Overall Study||22
8786501|NCT01360996|9837580|FG000|STARTED|Overall Study||20
8786502|NCT01360996|9837581|FG001|STARTED|Overall Study||21
8786503|NCT01360996|9837582|FG002|STARTED|Overall Study||23
8786504|NCT01360996|9837580|FG000|COMPLETED|Overall Study||14
8786505|NCT01360996|9837581|FG001|COMPLETED|Overall Study||18
8786506|NCT01360996|9837582|FG002|COMPLETED|Overall Study||21
8786507|NCT01360996|9837580|FG000|NOT COMPLETED|Overall Study||6
8786508|NCT01360996|9837581|FG001|NOT COMPLETED|Overall Study||3
8786509|NCT01360996|9837582|FG002|NOT COMPLETED|Overall Study||2
8786510|NCT01361009|9837589|FG000|STARTED|Overall Study||2017
8786511|NCT01361009|9837589|FG000|COMPLETED|Overall Study||1901
8786512|NCT01361009|9837589|FG000|NOT COMPLETED|Overall Study||116
8786513|NCT01361048|9837596|FG000|STARTED|Overall Study||20
8786514|NCT01361048|9837597|FG001|STARTED|Overall Study||10
8786515|NCT01361048|9837598|FG002|STARTED|Overall Study||10
8786516|NCT01361048|9837596|FG000|COMPLETED|Overall Study||20
8786517|NCT01361048|9837597|FG001|COMPLETED|Overall Study||10
8786518|NCT01361048|9837598|FG002|COMPLETED|Overall Study||9
8786519|NCT01361048|9837596|FG000|NOT COMPLETED|Overall Study||0
8786520|NCT01361048|9837597|FG001|NOT COMPLETED|Overall Study||0
8786521|NCT01361048|9837598|FG002|NOT COMPLETED|Overall Study||1
8786522|NCT01361113|9837609|FG000|STARTED|Overall Study||21
8786523|NCT01361113|9837609|FG000|COMPLETED|Overall Study||21
8786524|NCT01361113|9837609|FG000|NOT COMPLETED|Overall Study||0
8786525|NCT01361126|9837617|FG000|STARTED|Overall Study||13
8786526|NCT01361126|9837618|FG001|STARTED|Overall Study||4
8786527|NCT01361126|9837617|FG000|COMPLETED|Overall Study||13
8786528|NCT01361126|9837618|FG001|COMPLETED|Overall Study||2
8786529|NCT01361126|9837617|FG000|NOT COMPLETED|Overall Study||0
8786530|NCT01361126|9837618|FG001|NOT COMPLETED|Overall Study||2
8786531|NCT01361178|9837627|FG000|STARTED|Overall Study||122
8786532|NCT01361178|9837628|FG001|STARTED|Overall Study||11
8786533|NCT01361178|9837627|FG000|COMPLETED|Overall Study||109
8786534|NCT01361178|9837628|FG001|COMPLETED|Overall Study||11
8786535|NCT01361178|9837627|FG000|NOT COMPLETED|Overall Study||13
8786536|NCT01361178|9837628|FG001|NOT COMPLETED|Overall Study||0
8786537|NCT01361217|9837634|FG000|STARTED|Overall Study||10
8786538|NCT01361217|9837634|FG000|COMPLETED|Overall Study||10
8786539|NCT01361217|9837634|FG000|NOT COMPLETED|Overall Study||0
8786540|NCT01361308|9837642|FG000|STARTED|Overall Study||306
8786541|NCT01361308|9837643|FG001|STARTED|Overall Study||308
8786542|NCT01361308|9837642|FG000|COMPLETED|Overall Study||271
8786543|NCT01361308|9837643|FG001|COMPLETED|Overall Study||278
8786544|NCT01361308|9837642|FG000|NOT COMPLETED|Overall Study||35
8786545|NCT01361308|9837643|FG001|NOT COMPLETED|Overall Study||30
8786546|NCT01361464|9837649|FG000|STARTED|Overall Study||21
8786547|NCT01361464|9837649|FG000|COMPLETED|Overall Study||18
8786548|NCT01361464|9837649|FG000|NOT COMPLETED|Overall Study||3
8786549|NCT01361568|9837659|FG000|STARTED|Overall Study||71
8786550|NCT01361568|9837660|FG001|STARTED|Overall Study||71
8786551|NCT01361568|9837661|FG002|STARTED|Overall Study||20
8786552|NCT01361568|9837662|FG003|STARTED|Overall Study||21
8786553|NCT01361568|9837663|FG004|STARTED|Overall Study||7
8786554|NCT01361568|9837664|FG005|STARTED|Overall Study||13
8786555|NCT01361568|9837659|FG000|COMPLETED|Overall Study||69
8786556|NCT01361568|9837660|FG001|COMPLETED|Overall Study||70
8786557|NCT01361568|9837661|FG002|COMPLETED|Overall Study||20
8786558|NCT01361568|9837662|FG003|COMPLETED|Overall Study||21
8786559|NCT01361568|9837663|FG004|COMPLETED|Overall Study||6
8786560|NCT01361568|9837664|FG005|COMPLETED|Overall Study||11
8786561|NCT01361568|9837659|FG000|NOT COMPLETED|Overall Study||2
8786562|NCT01361568|9837660|FG001|NOT COMPLETED|Overall Study||1
8786563|NCT01361568|9837661|FG002|NOT COMPLETED|Overall Study||0
8786564|NCT01361568|9837662|FG003|NOT COMPLETED|Overall Study||0
8786565|NCT01361568|9837663|FG004|NOT COMPLETED|Overall Study||1
8786566|NCT01361568|9837664|FG005|NOT COMPLETED|Overall Study||2
8786567|NCT01361594|9837681|FG000|STARTED|Overall Study||152
8786568|NCT01361594|9837682|FG001|STARTED|Overall Study||153
8786569|NCT01361594|9837681|FG000|COMPLETED|Overall Study||151
8786570|NCT01361594|9837682|FG001|COMPLETED|Overall Study||151
8786571|NCT01361594|9837681|FG000|NOT COMPLETED|Overall Study||1
8786572|NCT01361594|9837682|FG001|NOT COMPLETED|Overall Study||2
8786573|NCT01361607|9837690|FG000|STARTED|Overall Study|Two participants randomized to nabiximols did not receive any study drug|200
8786574|NCT01361607|9837691|FG001|STARTED|Overall Study||199
8786575|NCT01361607|9837690|FG000|Received at Least 1 Dose of Study Drug|Overall Study||198
8786576|NCT01361607|9837691|FG001|Received at Least 1 Dose of Study Drug|Overall Study||199
8786577|NCT01361607|9837690|FG000|Safety Population|Overall Study|One participant randomized to nabiximols received placebo Day 22 but analyzed as nabiximols-treated|199
8786578|NCT01361607|9837691|FG001|Safety Population|Overall Study|One participant randomized to placebo received nabiximols Day 1 but analyzed as nabiximols-treated|198
8786579|NCT01361607|9837690|FG000|ITT Population|Overall Study||198
8786580|NCT01361607|9837691|FG001|ITT Population|Overall Study|One participant randomized to placebo received nabiximols Day 1 but analyzed as placebo-treated|199
8786581|NCT01361607|9837690|FG000|COMPLETED|Overall Study||136
8786582|NCT01361607|9837691|FG001|COMPLETED|Overall Study||158
8786583|NCT01361607|9837690|FG000|NOT COMPLETED|Overall Study||64
8786584|NCT01361607|9837691|FG001|NOT COMPLETED|Overall Study||41
8786585|NCT01361620|9837698|FG000|STARTED|Overall Study||132
8786586|NCT01361620|9837698|FG000|COMPLETED|Overall Study||132
8786587|NCT01361620|9837698|FG000|NOT COMPLETED|Overall Study||0
8916793|NCT02186509|9976354|FG000|COMPLETED|Overall Study||17
8916794|NCT02186509|9976354|FG000|NOT COMPLETED|Overall Study||0
8916795|NCT02186561|9976358|FG000|STARTED|Enrollment||197
8916796|NCT02186561|9976358|FG000|COMPLETED|Enrollment||141
8916797|NCT02186561|9976358|FG000|NOT COMPLETED|Enrollment||56
8916798|NCT02186561|9976358|FG000|STARTED|Subjects Implanted With Device||141
8916799|NCT02186561|9976358|FG000|COMPLETED|Subjects Implanted With Device||141
8916800|NCT02186561|9976358|FG000|NOT COMPLETED|Subjects Implanted With Device||0
8916801|NCT02186561|9976358|FG000|STARTED|30-Day Post Index Procedure Visit||141
8916802|NCT02186561|9976358|FG000|COMPLETED|30-Day Post Index Procedure Visit||140
8916803|NCT02186561|9976358|FG000|NOT COMPLETED|30-Day Post Index Procedure Visit||1
8916804|NCT02186561|9976358|FG000|STARTED|180- Day Post Index Procedure Visit||141
8916805|NCT02186561|9976358|FG000|COMPLETED|180- Day Post Index Procedure Visit||134
8916806|NCT02186561|9976358|FG000|NOT COMPLETED|180- Day Post Index Procedure Visit||7
8916807|NCT02186561|9976358|FG000|STARTED|1- Year Post Index Procedure Visit||141
8916808|NCT02186561|9976358|FG000|COMPLETED|1- Year Post Index Procedure Visit||139
8916809|NCT02186561|9976358|FG000|NOT COMPLETED|1- Year Post Index Procedure Visit||2
8916810|NCT02186561|9976358|FG000|STARTED|2 - Year Post Index Procedure Visit||141
8786588|NCT01361633|9837704|FG000|STARTED|Overall Study||25
8786589|NCT01361633|9837705|FG001|STARTED|Overall Study||26
8786590|NCT01361633|9837704|FG000|COMPLETED|Overall Study||19
8786591|NCT01361633|9837705|FG001|COMPLETED|Overall Study||23
8786592|NCT01361633|9837704|FG000|NOT COMPLETED|Overall Study||6
8786593|NCT01361633|9837705|FG001|NOT COMPLETED|Overall Study||3
8786594|NCT01361711|9837713|FG000|STARTED|Trial Entry (Registration)||53
8786595|NCT01361711|9837713|FG000|Received Dose of Study Drug|Trial Entry (Registration)||52
8786596|NCT01361711|9837713|FG000|COMPLETED|Trial Entry (Registration)||52
8786597|NCT01361711|9837713|FG000|NOT COMPLETED|Trial Entry (Registration)||1
8786598|NCT01361711|9837713|FG000|STARTED|Week 9 Bone Marrow Response Assessment||52
8786599|NCT01361711|9837713|FG000|COMPLETED|Week 9 Bone Marrow Response Assessment||51
8786600|NCT01361711|9837713|FG000|NOT COMPLETED|Week 9 Bone Marrow Response Assessment||1
8786601|NCT01361711|9837713|FG000|STARTED|Continued Treatment After 9 Weeks||51
8786602|NCT01361711|9837713|FG000|COMPLETED|Continued Treatment After 9 Weeks||44
8786603|NCT01361711|9837713|FG000|NOT COMPLETED|Continued Treatment After 9 Weeks||7
8786604|NCT01361711|9837713|FG000|STARTED|Continued Treatment After 12 Weeks||44
8786605|NCT01361711|9837713|FG000|COMPLETED|Continued Treatment After 12 Weeks||41
8786606|NCT01361711|9837713|FG000|NOT COMPLETED|Continued Treatment After 12 Weeks||3
8786607|NCT01361711|9837713|FG000|STARTED|Completed Week 18 of Treatment||41
8786608|NCT01361711|9837713|FG000|COMPLETED|Completed Week 18 of Treatment||30
8786609|NCT01361711|9837713|FG000|NOT COMPLETED|Completed Week 18 of Treatment||11
8786610|NCT01361711|9837713|FG000|STARTED|10 Year Follow-up|All patients who receive at least one dose of study drug go into follow-up.|52
8786611|NCT01361711|9837713|FG000|COMPLETED|10 Year Follow-up||2
8786612|NCT01361711|9837713|FG000|NOT COMPLETED|10 Year Follow-up||50
8786613|NCT01361854|9837717|FG000|STARTED|Day 1||51
8786614|NCT01361854|9837718|FG001|STARTED|Day 1||51
8786615|NCT01361854|9837717|FG000|COMPLETED|Day 1||47
8786616|NCT01361854|9837718|FG001|COMPLETED|Day 1||48
8786617|NCT01361854|9837717|FG000|NOT COMPLETED|Day 1||4
8786618|NCT01361854|9837718|FG001|NOT COMPLETED|Day 1||3
8786619|NCT01361854|9837717|FG000|STARTED|Wash-out, Maximum 2 Weeks||47
8786620|NCT01361854|9837718|FG001|STARTED|Wash-out, Maximum 2 Weeks||48
8786621|NCT01361854|9837717|FG000|COMPLETED|Wash-out, Maximum 2 Weeks||47
8786622|NCT01361854|9837718|FG001|COMPLETED|Wash-out, Maximum 2 Weeks||48
8786623|NCT01361854|9837717|FG000|NOT COMPLETED|Wash-out, Maximum 2 Weeks||0
8786624|NCT01361854|9837718|FG001|NOT COMPLETED|Wash-out, Maximum 2 Weeks||0
8786625|NCT01361854|9837717|FG000|STARTED|Second Intervention||47
8786626|NCT01361854|9837718|FG001|STARTED|Second Intervention||48
8786627|NCT01361854|9837717|FG000|COMPLETED|Second Intervention||47
8786628|NCT01361854|9837718|FG001|COMPLETED|Second Intervention||48
8786629|NCT01361854|9837717|FG000|NOT COMPLETED|Second Intervention||0
8786630|NCT01361854|9837718|FG001|NOT COMPLETED|Second Intervention||0
8786631|NCT01361867|9837724|FG000|STARTED|Overall Study||15
8786632|NCT01361867|9837724|FG000|COMPLETED|Overall Study||15
8786633|NCT01361867|9837724|FG000|NOT COMPLETED|Overall Study||0
8786634|NCT01361919|9837731|FG000|STARTED|Overall Study||100
8786635|NCT01361919|9837732|FG001|STARTED|Overall Study||100
8786636|NCT01361919|9837733|FG002|STARTED|Overall Study||98
8786637|NCT01361919|9837731|FG000|COMPLETED|Overall Study||90
8786638|NCT01361919|9837732|FG001|COMPLETED|Overall Study||88
8786639|NCT01361919|9837733|FG002|COMPLETED|Overall Study||88
8786640|NCT01361919|9837731|FG000|NOT COMPLETED|Overall Study||10
8786641|NCT01361919|9837732|FG001|NOT COMPLETED|Overall Study||12
8786642|NCT01361919|9837733|FG002|NOT COMPLETED|Overall Study||10
8786643|NCT01362049|9837745|FG000|STARTED|Follow-Up at 7 Weeks||26
8786644|NCT01362049|9837746|FG001|STARTED|Follow-Up at 7 Weeks||19
8786645|NCT01362049|9837747|FG002|STARTED|Follow-Up at 7 Weeks||32
8786646|NCT01362049|9837748|FG003|STARTED|Follow-Up at 7 Weeks||25
9031139|NCT03239106|10093243|FG000|NOT COMPLETED|Overall Study||7
9031140|NCT03239470|10093248|FG000|STARTED|Blood Donation||5
9031141|NCT03239470|10093249|FG001|STARTED|Blood Donation||0
9031142|NCT03239470|10093248|FG000|COMPLETED|Blood Donation||5
9031143|NCT03239470|10093249|FG001|COMPLETED|Blood Donation||0
9031144|NCT03239470|10093248|FG000|NOT COMPLETED|Blood Donation||0
9031145|NCT03239470|10093249|FG001|NOT COMPLETED|Blood Donation||0
9031146|NCT03239470|10093248|FG000|STARTED|Polyclonal Treg Infusion|Started includes all participants who completed the pre-infusion checklist at the infusion visit.|5
9031147|NCT03239470|10093249|FG001|STARTED|Polyclonal Treg Infusion||0
9031148|NCT03239470|10093248|FG000|COMPLETED|Polyclonal Treg Infusion|Participants who did not meet eligibility, per the pre-infusion checklist, did not complete study infusion.|4
9031149|NCT03239470|10093249|FG001|COMPLETED|Polyclonal Treg Infusion||0
8786647|NCT01362049|9837745|FG000|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||26
8786648|NCT01362049|9837746|FG001|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||18
8786649|NCT01362049|9837747|FG002|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||32
8786650|NCT01362049|9837748|FG003|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||25
8786651|NCT01362049|9837745|FG000|COMPLETED|Follow-Up at 7 Weeks||23
8786652|NCT01362049|9837746|FG001|COMPLETED|Follow-Up at 7 Weeks||16
8786653|NCT01362049|9837747|FG002|COMPLETED|Follow-Up at 7 Weeks||30
8786654|NCT01362049|9837748|FG003|COMPLETED|Follow-Up at 7 Weeks||24
8786655|NCT01362049|9837745|FG000|NOT COMPLETED|Follow-Up at 7 Weeks||3
8786656|NCT01362049|9837746|FG001|NOT COMPLETED|Follow-Up at 7 Weeks||3
8786657|NCT01362049|9837747|FG002|NOT COMPLETED|Follow-Up at 7 Weeks||2
8786658|NCT01362049|9837748|FG003|NOT COMPLETED|Follow-Up at 7 Weeks||1
8786659|NCT01362049|9837745|FG000|STARTED|Follow-Up at 52 Weeks (12 Months)||23
8786660|NCT01362049|9837746|FG001|STARTED|Follow-Up at 52 Weeks (12 Months)||16
8786661|NCT01362049|9837747|FG002|STARTED|Follow-Up at 52 Weeks (12 Months)||30
8786662|NCT01362049|9837748|FG003|STARTED|Follow-Up at 52 Weeks (12 Months)||24
8786663|NCT01362049|9837745|FG000|COMPLETED|Follow-Up at 52 Weeks (12 Months)||18
8786664|NCT01362049|9837746|FG001|COMPLETED|Follow-Up at 52 Weeks (12 Months)||13
8786665|NCT01362049|9837747|FG002|COMPLETED|Follow-Up at 52 Weeks (12 Months)||28
8786666|NCT01362049|9837748|FG003|COMPLETED|Follow-Up at 52 Weeks (12 Months)||21
8786667|NCT01362049|9837745|FG000|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||5
8786668|NCT01362049|9837746|FG001|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||3
8786669|NCT01362049|9837747|FG002|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||2
8786670|NCT01362049|9837748|FG003|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||3
8786671|NCT01362062|9837764|FG000|STARTED|Overall Study||48
8786672|NCT01362062|9837765|FG001|STARTED|Overall Study||62
8786673|NCT01362062|9837764|FG000|COMPLETED|Overall Study||22
8786674|NCT01362062|9837765|FG001|COMPLETED|Overall Study||62
8786675|NCT01362062|9837764|FG000|NOT COMPLETED|Overall Study||26
8786676|NCT01362062|9837765|FG001|NOT COMPLETED|Overall Study||0
8786677|NCT01362127|9837772|FG000|STARTED|Overall Study||90
8786678|NCT01362127|9837773|FG001|STARTED|Overall Study||91
8786679|NCT01362127|9837772|FG000|COMPLETED|Overall Study||90
8786680|NCT01362127|9837773|FG001|COMPLETED|Overall Study||91
8786681|NCT01362127|9837772|FG000|NOT COMPLETED|Overall Study||0
8786682|NCT01362127|9837773|FG001|NOT COMPLETED|Overall Study||0
8786683|NCT01362140|9837781|FG000|STARTED|Overall Study||49
9031150|NCT03239470|10093248|FG000|NOT COMPLETED|Polyclonal Treg Infusion||1
9031151|NCT03239470|10093249|FG001|NOT COMPLETED|Polyclonal Treg Infusion||0
9031152|NCT03239483|10093255|FG000|STARTED|Overall Study||19
9031153|NCT03239483|10093256|FG001|STARTED|Overall Study||9
9031154|NCT03239483|10093255|FG000|COMPLETED|Overall Study||17
9031155|NCT03239483|10093256|FG001|COMPLETED|Overall Study||9
9031156|NCT03239483|10093255|FG000|NOT COMPLETED|Overall Study||2
9031157|NCT03239483|10093256|FG001|NOT COMPLETED|Overall Study||0
9031158|NCT03239496|10093266|FG000|STARTED|Overall Study||200
9031159|NCT03239496|10093267|FG001|STARTED|Overall Study||178
9031160|NCT03239496|10093268|FG002|STARTED|Overall Study||178
9031161|NCT03239496|10093269|FG003|STARTED|Overall Study||217
9031162|NCT03239496|10093266|FG000|COMPLETED|Overall Study||186
9031163|NCT03239496|10093267|FG001|COMPLETED|Overall Study||168
9031164|NCT03239496|10093268|FG002|COMPLETED|Overall Study||166
9031165|NCT03239496|10093269|FG003|COMPLETED|Overall Study||203
9031166|NCT03239496|10093266|FG000|NOT COMPLETED|Overall Study||14
9031167|NCT03239496|10093267|FG001|NOT COMPLETED|Overall Study||10
9031168|NCT03239496|10093268|FG002|NOT COMPLETED|Overall Study||12
9031169|NCT03239496|10093269|FG003|NOT COMPLETED|Overall Study||14
9031170|NCT03239522|10093283|FG000|STARTED|Treatment Period 1 (Up to 7 Days)||6
9031171|NCT03239522|10093283|FG000|COMPLETED|Treatment Period 1 (Up to 7 Days)||6
9031172|NCT03239522|10093283|FG000|NOT COMPLETED|Treatment Period 1 (Up to 7 Days)||0
9031173|NCT03239522|10093283|FG000|STARTED|Washout Period (Up to 7 Days)||6
9031174|NCT03239522|10093283|FG000|COMPLETED|Washout Period (Up to 7 Days)||6
9031175|NCT03239522|10093283|FG000|NOT COMPLETED|Washout Period (Up to 7 Days)||0
9031176|NCT03239522|10093283|FG000|STARTED|Treatment Period 2 (Up to 15 Days)||6
9031177|NCT03239522|10093283|FG000|COMPLETED|Treatment Period 2 (Up to 15 Days)||6
9031178|NCT03239522|10093283|FG000|NOT COMPLETED|Treatment Period 2 (Up to 15 Days)||0
9031179|NCT03239574|10093294|FG000|STARTED|Overall Study||34
9031180|NCT03239574|10093294|FG000|COMPLETED|Overall Study||34
9031181|NCT03239574|10093294|FG000|NOT COMPLETED|Overall Study||0
9031182|NCT03239665|10093300|FG000|STARTED|Overall Study||175
9031183|NCT03239665|10093301|FG001|STARTED|Overall Study||160
9031184|NCT03239665|10093300|FG000|Met Inclusion Criteria|Overall Study||150
9031185|NCT03239665|10093301|FG001|Met Inclusion Criteria|Overall Study||144
9031186|NCT03239665|10093300|FG000|Submitted Survey Data|Overall Study||147
9031187|NCT03239665|10093301|FG001|Submitted Survey Data|Overall Study||140
9031188|NCT03239665|10093300|FG000|COMPLETED|Overall Study||147
9031189|NCT03239665|10093301|FG001|COMPLETED|Overall Study||140
9031190|NCT03239665|10093300|FG000|NOT COMPLETED|Overall Study||28
9031191|NCT03239665|10093301|FG001|NOT COMPLETED|Overall Study||20
9031192|NCT03239873|10093309|FG000|STARTED|Overall Study||300
9031193|NCT03239873|10093310|FG001|STARTED|Overall Study||300
9031194|NCT03239873|10093309|FG000|Vaccination 1|Overall Study||299
9031195|NCT03239873|10093310|FG001|Vaccination 1|Overall Study||300
9031196|NCT03239873|10093309|FG000|Vaccination 2|Overall Study||276
9031197|NCT03239873|10093310|FG001|Vaccination 2|Overall Study||282
9031198|NCT03239873|10093309|FG000|COMPLETED|Overall Study||268
9031199|NCT03239873|10093310|FG001|COMPLETED|Overall Study||273
9031200|NCT03239873|10093309|FG000|NOT COMPLETED|Overall Study||32
9031201|NCT03239873|10093310|FG001|NOT COMPLETED|Overall Study||27
9031202|NCT03240081|10093318|FG000|STARTED|Overall Study||25
9031203|NCT03240081|10093319|FG001|STARTED|Overall Study||25
9031204|NCT03240081|10093318|FG000|COMPLETED|Overall Study||25
9031205|NCT03240081|10093319|FG001|COMPLETED|Overall Study||22
9031206|NCT03240081|10093318|FG000|NOT COMPLETED|Overall Study||0
9031207|NCT03240081|10093319|FG001|NOT COMPLETED|Overall Study||3
8786684|NCT01362140|9837782|FG001|STARTED|Overall Study||98
8786685|NCT01362140|9837781|FG000|Received Treatment|Overall Study||49
9031208|NCT03240133|10093328|FG000|STARTED|Overall Study||33
9031209|NCT03240133|10093329|FG001|STARTED|Overall Study||14
9031210|NCT03240133|10093330|FG002|STARTED|Overall Study||11
8786686|NCT01362140|9837782|FG001|Received Treatment|Overall Study||97
8786687|NCT01362140|9837781|FG000|COMPLETED|Overall Study|Completed treatment in the double-blind treatment period|39
8786688|NCT01362140|9837782|FG001|COMPLETED|Overall Study|Completed treatment in the double-blind treatment period|87
8786689|NCT01362140|9837781|FG000|NOT COMPLETED|Overall Study||10
8786690|NCT01362140|9837782|FG001|NOT COMPLETED|Overall Study||11
8786691|NCT01362192|9837788|FG000|STARTED|Overall Study||20
8786692|NCT01362192|9837788|FG000|COMPLETED|Overall Study||16
8786693|NCT01362192|9837788|FG000|NOT COMPLETED|Overall Study||4
8786694|NCT01362205|9837794|FG000|STARTED|Overall Study||22
8786695|NCT01362205|9837795|FG001|STARTED|Overall Study||27
8786696|NCT01362205|9837794|FG000|COMPLETED|Overall Study||22
8786697|NCT01362205|9837795|FG001|COMPLETED|Overall Study||27
8786698|NCT01362205|9837794|FG000|NOT COMPLETED|Overall Study||0
8786699|NCT01362205|9837795|FG001|NOT COMPLETED|Overall Study||0
8786700|NCT01362244|9837803|FG000|STARTED|Overall Study||54
8786701|NCT01362244|9837804|FG001|STARTED|Overall Study||51
8786702|NCT01362244|9837803|FG000|COMPLETED|Overall Study||22
8786703|NCT01362244|9837804|FG001|COMPLETED|Overall Study||19
8786704|NCT01362244|9837803|FG000|NOT COMPLETED|Overall Study||32
9031211|NCT03240133|10093328|FG000|Completed Period 1|Overall Study||33
9031212|NCT03240133|10093329|FG001|Completed Period 1|Overall Study||14
9031213|NCT03240133|10093330|FG002|Completed Period 1|Overall Study||11
9031214|NCT03240133|10093328|FG000|Completed Period 2|Overall Study||32
9031215|NCT03240133|10093329|FG001|Completed Period 2|Overall Study||11
9031216|NCT03240133|10093330|FG002|Completed Period 2|Overall Study||11
9031217|NCT03240133|10093328|FG000|Completed Period 3|Overall Study||30
9031218|NCT03240133|10093329|FG001|Completed Period 3|Overall Study||11
9031219|NCT03240133|10093330|FG002|Completed Period 3|Overall Study||11
9031220|NCT03240133|10093328|FG000|COMPLETED|Overall Study||30
9031221|NCT03240133|10093329|FG001|COMPLETED|Overall Study||11
9031222|NCT03240133|10093330|FG002|COMPLETED|Overall Study||10
9031223|NCT03240133|10093328|FG000|NOT COMPLETED|Overall Study||3
9031224|NCT03240133|10093329|FG001|NOT COMPLETED|Overall Study||3
9031225|NCT03240133|10093330|FG002|NOT COMPLETED|Overall Study||1
9031226|NCT03240575|10093358|FG000|STARTED|Overall Study||146
9031227|NCT03240575|10093359|FG001|STARTED|Overall Study||145
9031228|NCT03240575|10093360|FG002|STARTED|Overall Study||6
9031229|NCT03240575|10093361|FG003|STARTED|Overall Study||5
9031230|NCT03240575|10093358|FG000|COMPLETED|Overall Study||144
9031231|NCT03240575|10093359|FG001|COMPLETED|Overall Study||131
9031232|NCT03240575|10093360|FG002|COMPLETED|Overall Study||6
9031233|NCT03240575|10093361|FG003|COMPLETED|Overall Study||3
9031234|NCT03240575|10093358|FG000|NOT COMPLETED|Overall Study||2
9031235|NCT03240575|10093359|FG001|NOT COMPLETED|Overall Study||14
9031236|NCT03240575|10093360|FG002|NOT COMPLETED|Overall Study||0
9031237|NCT03240575|10093361|FG003|NOT COMPLETED|Overall Study||2
9031238|NCT03241030|10093371|FG000|STARTED|Overall Study||50
9031239|NCT03241030|10093372|FG001|STARTED|Overall Study||52
9031240|NCT03241030|10093371|FG000|COMPLETED|Overall Study||49
9031241|NCT03241030|10093372|FG001|COMPLETED|Overall Study||51
9031242|NCT03241030|10093371|FG000|NOT COMPLETED|Overall Study||1
9031243|NCT03241030|10093372|FG001|NOT COMPLETED|Overall Study||1
9031244|NCT03241342|10093381|FG000|STARTED|Overall Study||163
9031245|NCT03241342|10093382|FG001|STARTED|Overall Study||163
9031246|NCT03241342|10093383|FG002|STARTED|Overall Study||165
9031247|NCT03241342|10093381|FG000|COMPLETED|Overall Study||141
9031248|NCT03241342|10093382|FG001|COMPLETED|Overall Study||132
9031249|NCT03241342|10093383|FG002|COMPLETED|Overall Study||138
9031250|NCT03241342|10093381|FG000|NOT COMPLETED|Overall Study||22
9031251|NCT03241342|10093382|FG001|NOT COMPLETED|Overall Study||31
9031252|NCT03241342|10093383|FG002|NOT COMPLETED|Overall Study||27
9031253|NCT03241368|10093391|FG000|STARTED|Overall Study||158
9031254|NCT03241368|10093391|FG000|COMPLETED|Overall Study||119
9031255|NCT03241368|10093391|FG000|NOT COMPLETED|Overall Study||39
9031256|NCT03241485|10093398|FG000|STARTED|Overall Study||42
9031257|NCT03241485|10093399|FG001|STARTED|Overall Study||37
9031258|NCT03241485|10093398|FG000|COMPLETED|Overall Study||37
9031259|NCT03241485|10093399|FG001|COMPLETED|Overall Study||33
9031260|NCT03241485|10093398|FG000|NOT COMPLETED|Overall Study||5
9031261|NCT03241485|10093399|FG001|NOT COMPLETED|Overall Study||4
9031262|NCT03241810|10093411|FG000|STARTED|Overall Study||11
9031263|NCT03241810|10093412|FG001|STARTED|Overall Study||11
9031264|NCT03241810|10093411|FG000|COMPLETED|Overall Study|Safety population: includes patients receiving at least one dose of study medication.|11
9031265|NCT03241810|10093412|FG001|COMPLETED|Overall Study|Safety population: includes patients receiving at least one dose of study medication.|11
9031266|NCT03241810|10093411|FG000|NOT COMPLETED|Overall Study||0
9031267|NCT03241810|10093412|FG001|NOT COMPLETED|Overall Study||0
9031268|NCT03241862|10093419|FG000|STARTED|Overall Study||20
9031269|NCT03241862|10093419|FG000|COMPLETED|Overall Study||20
9031270|NCT03241862|10093419|FG000|NOT COMPLETED|Overall Study||0
9031271|NCT03241927|10093423|FG000|STARTED|Overall Study||1
9031272|NCT03241927|10093424|FG001|STARTED|Overall Study||0
9031273|NCT03241927|10093423|FG000|COMPLETED|Overall Study||0
8786705|NCT01362244|9837804|FG001|NOT COMPLETED|Overall Study||32
8786706|NCT01362270|9837812|FG000|STARTED|Overall Study||7
8786707|NCT01362270|9837813|FG001|STARTED|Overall Study||8
9031274|NCT03241927|10093424|FG001|COMPLETED|Overall Study||0
9031275|NCT03241927|10093423|FG000|NOT COMPLETED|Overall Study||1
9031276|NCT03241927|10093424|FG001|NOT COMPLETED|Overall Study||0
9031277|NCT03242018|10093433|FG000|STARTED|Overall Study||93
9031278|NCT03242018|10093434|FG001|STARTED|Overall Study||92
8786708|NCT01362270|9837812|FG000|COMPLETED|Overall Study||5
8786709|NCT01362270|9837813|FG001|COMPLETED|Overall Study||6
8786710|NCT01362270|9837812|FG000|NOT COMPLETED|Overall Study||2
8786711|NCT01362270|9837813|FG001|NOT COMPLETED|Overall Study||2
8786712|NCT01362296|9837821|FG000|STARTED|Randomized Phase (RP)||87
8786713|NCT01362296|9837822|FG001|STARTED|Randomized Phase (RP)||43
8786714|NCT01362296|9837823|FG002|STARTED|Randomized Phase (RP)||0
8786715|NCT01362296|9837824|FG003|STARTED|Randomized Phase (RP)||0
8786716|NCT01362296|9837821|FG000|COMPLETED|Randomized Phase (RP)||0
8786717|NCT01362296|9837822|FG001|COMPLETED|Randomized Phase (RP)||0
8786718|NCT01362296|9837823|FG002|COMPLETED|Randomized Phase (RP)||0
8786719|NCT01362296|9837824|FG003|COMPLETED|Randomized Phase (RP)||0
8786720|NCT01362296|9837821|FG000|NOT COMPLETED|Randomized Phase (RP)||87
8786721|NCT01362296|9837822|FG001|NOT COMPLETED|Randomized Phase (RP)||43
8786722|NCT01362296|9837823|FG002|NOT COMPLETED|Randomized Phase (RP)||0
8786723|NCT01362296|9837824|FG003|NOT COMPLETED|Randomized Phase (RP)||0
8786724|NCT01362296|9837821|FG000|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|0
8786725|NCT01362296|9837822|FG001|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|0
8786726|NCT01362296|9837823|FG002|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|23
8786727|NCT01362296|9837824|FG003|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|2
8786728|NCT01362296|9837821|FG000|COMPLETED|Crossover Phase||0
8786729|NCT01362296|9837822|FG001|COMPLETED|Crossover Phase||0
8786730|NCT01362296|9837823|FG002|COMPLETED|Crossover Phase||0
8786731|NCT01362296|9837824|FG003|COMPLETED|Crossover Phase||0
8786732|NCT01362296|9837821|FG000|NOT COMPLETED|Crossover Phase||0
8786733|NCT01362296|9837822|FG001|NOT COMPLETED|Crossover Phase||0
8786734|NCT01362296|9837823|FG002|NOT COMPLETED|Crossover Phase||23
8786735|NCT01362296|9837824|FG003|NOT COMPLETED|Crossover Phase||2
8786736|NCT01362322|9837836|FG000|STARTED|Overall Study||335
8786737|NCT01362322|9837837|FG001|STARTED|Overall Study||336
8786738|NCT01362322|9837836|FG000|COMPLETED|Overall Study||330
8786739|NCT01362322|9837837|FG001|COMPLETED|Overall Study||329
8786740|NCT01362322|9837836|FG000|NOT COMPLETED|Overall Study||5
8786741|NCT01362322|9837837|FG001|NOT COMPLETED|Overall Study||7
8786742|NCT01362348|9837843|FG000|STARTED|Overall Study||19
8786743|NCT01362348|9837843|FG000|COMPLETED|Overall Study||5
8786744|NCT01362348|9837843|FG000|NOT COMPLETED|Overall Study||14
8786745|NCT01362439|9837847|FG000|STARTED|Overall Study||133
8786746|NCT01362439|9837847|FG000|COMPLETED|Overall Study||118
8786747|NCT01362439|9837847|FG000|NOT COMPLETED|Overall Study||15
8786748|NCT01362491|9837855|FG000|STARTED|Overall Study||91
8786749|NCT01362491|9837856|FG001|STARTED|Overall Study||89
8786750|NCT01362491|9837857|FG002|STARTED|Overall Study||46
8786751|NCT01362491|9837855|FG000|COMPLETED|Overall Study||90
8786752|NCT01362491|9837856|FG001|COMPLETED|Overall Study||89
8786753|NCT01362491|9837857|FG002|COMPLETED|Overall Study||46
8786754|NCT01362491|9837855|FG000|NOT COMPLETED|Overall Study||1
8786755|NCT01362491|9837856|FG001|NOT COMPLETED|Overall Study||0
8786756|NCT01362491|9837857|FG002|NOT COMPLETED|Overall Study||0
8786757|NCT01362517|9837866|FG000|STARTED|Overall Study||131
8786758|NCT01362517|9837866|FG000|COMPLETED|Overall Study||129
8786759|NCT01362517|9837866|FG000|NOT COMPLETED|Overall Study||2
8786760|NCT01362530|9837875|FG000|STARTED|Base Study (Cycle 1)||155
9031279|NCT03242018|10093435|FG002|STARTED|Overall Study||92
9031280|NCT03242018|10093433|FG000|COMPLETED|Overall Study||75
9031281|NCT03242018|10093434|FG001|COMPLETED|Overall Study||78
9031282|NCT03242018|10093435|FG002|COMPLETED|Overall Study||78
9031283|NCT03242018|10093433|FG000|NOT COMPLETED|Overall Study||18
8786761|NCT01362530|9837876|FG001|STARTED|Base Study (Cycle 1)||152
8786762|NCT01362530|9837875|FG000|Received Study Treatment|Base Study (Cycle 1)||152
8786763|NCT01362530|9837876|FG001|Received Study Treatment|Base Study (Cycle 1)||150
8786764|NCT01362530|9837875|FG000|COMPLETED|Base Study (Cycle 1)||150
8786765|NCT01362530|9837876|FG001|COMPLETED|Base Study (Cycle 1)||149
8786766|NCT01362530|9837875|FG000|NOT COMPLETED|Base Study (Cycle 1)||5
8786767|NCT01362530|9837876|FG001|NOT COMPLETED|Base Study (Cycle 1)||3
8786768|NCT01362530|9837875|FG000|STARTED|Optional Extension (Cycles 2-6)||171
8786769|NCT01362530|9837876|FG001|STARTED|Optional Extension (Cycles 2-6)||0
8786770|NCT01362530|9837875|FG000|COMPLETED|Optional Extension (Cycles 2-6)||46
8786771|NCT01362530|9837876|FG001|COMPLETED|Optional Extension (Cycles 2-6)||0
8786772|NCT01362530|9837875|FG000|NOT COMPLETED|Optional Extension (Cycles 2-6)||125
8786773|NCT01362530|9837876|FG001|NOT COMPLETED|Optional Extension (Cycles 2-6)||0
8786774|NCT01362608|9837885|FG000|STARTED|Overall Study||67
8786775|NCT01362608|9837886|FG001|STARTED|Overall Study||69
8786776|NCT01362608|9837885|FG000|COMPLETED|Overall Study||63
8786777|NCT01362608|9837886|FG001|COMPLETED|Overall Study||61
8786778|NCT01362608|9837885|FG000|NOT COMPLETED|Overall Study||4
8786779|NCT01362608|9837886|FG001|NOT COMPLETED|Overall Study||8
8786780|NCT01362686|9837895|FG000|STARTED|Overall Study||67
8786781|NCT01362686|9837896|FG001|STARTED|Overall Study||66
8786782|NCT01362686|9837897|FG002|STARTED|Overall Study||63
9031284|NCT03242018|10093434|FG001|NOT COMPLETED|Overall Study||14
9031285|NCT03242018|10093435|FG002|NOT COMPLETED|Overall Study||14
8786783|NCT01362686|9837895|FG000|COMPLETED|Overall Study||59
8786784|NCT01362686|9837896|FG001|COMPLETED|Overall Study||54
8786785|NCT01362686|9837897|FG002|COMPLETED|Overall Study||53
9031286|NCT03242148|10093444|FG000|STARTED|Overall Study||38
8786786|NCT01362686|9837895|FG000|NOT COMPLETED|Overall Study||8
8786787|NCT01362686|9837896|FG001|NOT COMPLETED|Overall Study||12
8786788|NCT01362686|9837897|FG002|NOT COMPLETED|Overall Study||10
8786789|NCT01362790|9837911|FG000|STARTED|Pilot Phase & Phase 2||11
8786790|NCT01362790|9837912|FG001|STARTED|Pilot Phase & Phase 2||8
8786791|NCT01362790|9837913|FG002|STARTED|Pilot Phase & Phase 2||7
8786792|NCT01362790|9837914|FG003|STARTED|Pilot Phase & Phase 2||15
8786793|NCT01362790|9837915|FG004|STARTED|Pilot Phase & Phase 2||0
8786794|NCT01362790|9837916|FG005|STARTED|Pilot Phase & Phase 2||4
8786795|NCT01362790|9837917|FG006|STARTED|Pilot Phase & Phase 2||0
8786796|NCT01362790|9837911|FG000|COMPLETED|Pilot Phase & Phase 2||1
8786797|NCT01362790|9837912|FG001|COMPLETED|Pilot Phase & Phase 2||0
8786798|NCT01362790|9837913|FG002|COMPLETED|Pilot Phase & Phase 2||2
8786799|NCT01362790|9837914|FG003|COMPLETED|Pilot Phase & Phase 2||1
8786800|NCT01362790|9837915|FG004|COMPLETED|Pilot Phase & Phase 2||0
8786801|NCT01362790|9837916|FG005|COMPLETED|Pilot Phase & Phase 2||0
8786802|NCT01362790|9837917|FG006|COMPLETED|Pilot Phase & Phase 2||0
8786803|NCT01362790|9837911|FG000|NOT COMPLETED|Pilot Phase & Phase 2||10
8786804|NCT01362790|9837912|FG001|NOT COMPLETED|Pilot Phase & Phase 2||8
8786805|NCT01362790|9837913|FG002|NOT COMPLETED|Pilot Phase & Phase 2||5
8786806|NCT01362790|9837914|FG003|NOT COMPLETED|Pilot Phase & Phase 2||14
8786807|NCT01362790|9837915|FG004|NOT COMPLETED|Pilot Phase & Phase 2||0
8786808|NCT01362790|9837916|FG005|NOT COMPLETED|Pilot Phase & Phase 2||4
8786809|NCT01362790|9837917|FG006|NOT COMPLETED|Pilot Phase & Phase 2||0
8786810|NCT01362790|9837911|FG000|STARTED|Dose De-escalation of Regimen A||0
8786811|NCT01362790|9837912|FG001|STARTED|Dose De-escalation of Regimen A||0
8786812|NCT01362790|9837913|FG002|STARTED|Dose De-escalation of Regimen A||0
8786813|NCT01362790|9837914|FG003|STARTED|Dose De-escalation of Regimen A||0
8786814|NCT01362790|9837915|FG004|STARTED|Dose De-escalation of Regimen A||8
8786815|NCT01362790|9837916|FG005|STARTED|Dose De-escalation of Regimen A||0
8786816|NCT01362790|9837917|FG006|STARTED|Dose De-escalation of Regimen A||0
8786817|NCT01362790|9837911|FG000|COMPLETED|Dose De-escalation of Regimen A||0
8786818|NCT01362790|9837912|FG001|COMPLETED|Dose De-escalation of Regimen A||0
8786819|NCT01362790|9837913|FG002|COMPLETED|Dose De-escalation of Regimen A||0
8786820|NCT01362790|9837914|FG003|COMPLETED|Dose De-escalation of Regimen A||0
8786821|NCT01362790|9837915|FG004|COMPLETED|Dose De-escalation of Regimen A||2
8786822|NCT01362790|9837916|FG005|COMPLETED|Dose De-escalation of Regimen A||0
8786823|NCT01362790|9837917|FG006|COMPLETED|Dose De-escalation of Regimen A||0
8786824|NCT01362790|9837911|FG000|NOT COMPLETED|Dose De-escalation of Regimen A||0
8786825|NCT01362790|9837912|FG001|NOT COMPLETED|Dose De-escalation of Regimen A||0
8786826|NCT01362790|9837913|FG002|NOT COMPLETED|Dose De-escalation of Regimen A||0
8786827|NCT01362790|9837914|FG003|NOT COMPLETED|Dose De-escalation of Regimen A||0
8786828|NCT01362790|9837915|FG004|NOT COMPLETED|Dose De-escalation of Regimen A||6
8786829|NCT01362790|9837916|FG005|NOT COMPLETED|Dose De-escalation of Regimen A||0
8786830|NCT01362790|9837917|FG006|NOT COMPLETED|Dose De-escalation of Regimen A||0
8786831|NCT01362894|9837937|FG000|STARTED|Period One, 1 Week|One participant was not dispensed lenses until Period 2.|119
8786832|NCT01362894|9837938|FG001|STARTED|Period One, 1 Week|One participant was not dispensed lenses until Period 2.|117
8786833|NCT01362894|9837937|FG000|COMPLETED|Period One, 1 Week||119
8786834|NCT01362894|9837938|FG001|COMPLETED|Period One, 1 Week||117
8786835|NCT01362894|9837937|FG000|NOT COMPLETED|Period One, 1 Week||0
8786836|NCT01362894|9837938|FG001|NOT COMPLETED|Period One, 1 Week||0
8786837|NCT01362894|9837937|FG000|STARTED|Period Two, 1 Week|Two participants discontinued between Periods 1 and 2 due to discomfort (1) and poor fit (1).|118
8786838|NCT01362894|9837938|FG001|STARTED|Period Two, 1 Week|Three participants discontinued between Periods 1 and 2 due to unacceptable vision.|115
8786839|NCT01362894|9837937|FG000|COMPLETED|Period Two, 1 Week||118
8786840|NCT01362894|9837938|FG001|COMPLETED|Period Two, 1 Week||115
8786841|NCT01362894|9837937|FG000|NOT COMPLETED|Period Two, 1 Week||0
8786842|NCT01362894|9837938|FG001|NOT COMPLETED|Period Two, 1 Week||0
8786843|NCT01362907|9837944|FG000|STARTED|Period 1, One Week||20
8786844|NCT01362907|9837945|FG001|STARTED|Period 1, One Week||20
8786845|NCT01362907|9837944|FG000|COMPLETED|Period 1, One Week||20
8786846|NCT01362907|9837945|FG001|COMPLETED|Period 1, One Week||20
8786847|NCT01362907|9837944|FG000|NOT COMPLETED|Period 1, One Week||0
8786848|NCT01362907|9837945|FG001|NOT COMPLETED|Period 1, One Week||0
8786849|NCT01362907|9837944|FG000|STARTED|Period 2, One Week||20
8786850|NCT01362907|9837945|FG001|STARTED|Period 2, One Week||20
8786851|NCT01362907|9837944|FG000|COMPLETED|Period 2, One Week||20
8786852|NCT01362907|9837945|FG001|COMPLETED|Period 2, One Week||20
8786853|NCT01362907|9837944|FG000|NOT COMPLETED|Period 2, One Week||0
8786854|NCT01362907|9837945|FG001|NOT COMPLETED|Period 2, One Week||0
8786855|NCT01362946|9837951|FG000|STARTED|First Behavior Modification Block||24
8786856|NCT01362946|9837952|FG001|STARTED|First Behavior Modification Block||24
8786857|NCT01362946|9837951|FG000|COMPLETED|First Behavior Modification Block||24
8786858|NCT01362946|9837952|FG001|COMPLETED|First Behavior Modification Block||24
8786859|NCT01362946|9837951|FG000|NOT COMPLETED|First Behavior Modification Block||0
8786860|NCT01362946|9837952|FG001|NOT COMPLETED|First Behavior Modification Block||0
8786861|NCT01362946|9837951|FG000|STARTED|Second Behavior Modification Block|1 participant withdrew after last but before this treatment period - illness unrelated to study.|23
8786862|NCT01362946|9837952|FG001|STARTED|Second Behavior Modification Block||24
8786863|NCT01362946|9837951|FG000|COMPLETED|Second Behavior Modification Block||23
8786864|NCT01362946|9837952|FG001|COMPLETED|Second Behavior Modification Block||24
8786865|NCT01362946|9837951|FG000|NOT COMPLETED|Second Behavior Modification Block||0
8786866|NCT01362946|9837952|FG001|NOT COMPLETED|Second Behavior Modification Block||0
8786867|NCT01362959|9837960|FG000|STARTED|Overall Study||21
8786868|NCT01362959|9837961|FG001|STARTED|Overall Study||26
8786869|NCT01362959|9837960|FG000|COMPLETED|Overall Study||21
8786870|NCT01362959|9837961|FG001|COMPLETED|Overall Study||26
8786871|NCT01362959|9837960|FG000|NOT COMPLETED|Overall Study||0
8786872|NCT01362959|9837961|FG001|NOT COMPLETED|Overall Study||0
8786873|NCT01363011|9837969|FG000|STARTED|Main Study||33
8786874|NCT01363011|9837970|FG001|STARTED|Main Study||73
8786875|NCT01363011|9837969|FG000|COMPLETED|Main Study||29
8786876|NCT01363011|9837970|FG001|COMPLETED|Main Study||64
8786877|NCT01363011|9837969|FG000|NOT COMPLETED|Main Study||4
8786878|NCT01363011|9837970|FG001|NOT COMPLETED|Main Study||9
8786879|NCT01363011|9837969|FG000|STARTED|Extension Phase|11 participants who completed the main study did not enroll into the extension phase.|18
8786880|NCT01363011|9837970|FG001|STARTED|Extension Phase|15 participants who completed the main study did not enroll into the extension phase.|49
8786881|NCT01363011|9837969|FG000|COMPLETED|Extension Phase||13
8786882|NCT01363011|9837970|FG001|COMPLETED|Extension Phase||41
8786883|NCT01363011|9837969|FG000|NOT COMPLETED|Extension Phase||5
8786884|NCT01363011|9837970|FG001|NOT COMPLETED|Extension Phase||8
8786885|NCT01363050|9837976|FG000|STARTED|Overall Study||15
8786886|NCT01363050|9837976|FG000|COMPLETED|Overall Study||15
8786887|NCT01363050|9837976|FG000|NOT COMPLETED|Overall Study||0
8786888|NCT01363076|9837984|FG000|STARTED|Overall Study||7
8786889|NCT01363076|9837985|FG001|STARTED|Overall Study||13
8786890|NCT01363076|9837984|FG000|COMPLETED|Overall Study||7
8786891|NCT01363076|9837985|FG001|COMPLETED|Overall Study||12
8786892|NCT01363076|9837984|FG000|NOT COMPLETED|Overall Study||0
8786893|NCT01363076|9837985|FG001|NOT COMPLETED|Overall Study||1
8786894|NCT01363128|9837991|FG000|STARTED|Overall Study||69
8786895|NCT01363128|9837991|FG000|COMPLETED|Overall Study||69
8786896|NCT01363128|9837991|FG000|NOT COMPLETED|Overall Study||0
8786897|NCT01363258|9837997|FG000|STARTED|Overall Study||54
8786898|NCT01363258|9837998|FG001|STARTED|Overall Study||46
8786899|NCT01363258|9837997|FG000|COMPLETED|Overall Study||54
8786900|NCT01363258|9837998|FG001|COMPLETED|Overall Study||46
8786901|NCT01363258|9837997|FG000|NOT COMPLETED|Overall Study||0
8786902|NCT01363258|9837998|FG001|NOT COMPLETED|Overall Study||0
8786903|NCT01363297|9838009|FG000|STARTED|Overall Study||3
8786904|NCT01363297|9838010|FG001|STARTED|Overall Study||12
8786905|NCT01363297|9838011|FG002|STARTED|Overall Study||9
8786906|NCT01363297|9838012|FG003|STARTED|Overall Study||13
8786907|NCT01363297|9838013|FG004|STARTED|Overall Study||35
8786908|NCT01363297|9838009|FG000|COMPLETED|Overall Study||0
8786909|NCT01363297|9838010|FG001|COMPLETED|Overall Study||6
8786910|NCT01363297|9838011|FG002|COMPLETED|Overall Study||3
8786911|NCT01363297|9838012|FG003|COMPLETED|Overall Study||3
8786912|NCT01363297|9838013|FG004|COMPLETED|Overall Study||4
8786913|NCT01363297|9838009|FG000|NOT COMPLETED|Overall Study||3
8786914|NCT01363297|9838010|FG001|NOT COMPLETED|Overall Study||6
8786915|NCT01363297|9838011|FG002|NOT COMPLETED|Overall Study||6
8786916|NCT01363297|9838012|FG003|NOT COMPLETED|Overall Study||10
8786917|NCT01363297|9838013|FG004|NOT COMPLETED|Overall Study||31
8786918|NCT01363349|9838032|FG000|STARTED|Overall Study||133
8786919|NCT01363349|9838033|FG001|STARTED|Overall Study||136
8786920|NCT01363349|9838032|FG000|Randomized|Overall Study||133
8786921|NCT01363349|9838033|FG001|Randomized|Overall Study||136
8786922|NCT01363349|9838032|FG000|COMPLETED|Overall Study||66
8786923|NCT01363349|9838033|FG001|COMPLETED|Overall Study||66
8786924|NCT01363349|9838032|FG000|NOT COMPLETED|Overall Study||67
8786925|NCT01363349|9838033|FG001|NOT COMPLETED|Overall Study||70
8786926|NCT01363388|9838042|FG000|STARTED|Overall Study||23
8786927|NCT01363388|9838043|FG001|STARTED|Overall Study||22
8786928|NCT01363388|9838044|FG002|STARTED|Overall Study||22
8786929|NCT01363388|9838042|FG000|COMPLETED|Overall Study||18
8786930|NCT01363388|9838043|FG001|COMPLETED|Overall Study||19
8786931|NCT01363388|9838044|FG002|COMPLETED|Overall Study||18
8786932|NCT01363388|9838042|FG000|NOT COMPLETED|Overall Study||5
8786933|NCT01363388|9838043|FG001|NOT COMPLETED|Overall Study||3
8916811|NCT02186561|9976358|FG000|COMPLETED|2 - Year Post Index Procedure Visit||134
8916812|NCT02186561|9976358|FG000|NOT COMPLETED|2 - Year Post Index Procedure Visit||7
8916813|NCT02186561|9976358|FG000|STARTED|3 - Year Post Index Procedure Visit||141
8916814|NCT02186561|9976358|FG000|COMPLETED|3 - Year Post Index Procedure Visit||128
8916815|NCT02186561|9976358|FG000|NOT COMPLETED|3 - Year Post Index Procedure Visit||13
8916816|NCT02186587|9976366|FG000|STARTED|Overall Study||28
8916817|NCT02186587|9976367|FG001|STARTED|Overall Study||0
8916818|NCT02186587|9976366|FG000|COMPLETED|Overall Study||23
8916819|NCT02186587|9976367|FG001|COMPLETED|Overall Study||0
8916820|NCT02186587|9976366|FG000|NOT COMPLETED|Overall Study||5
8916821|NCT02186587|9976367|FG001|NOT COMPLETED|Overall Study||0
8916822|NCT02186652|9976374|FG000|STARTED|Overall Study||19
8916823|NCT02186652|9976375|FG001|STARTED|Overall Study||22
8916824|NCT02186652|9976374|FG000|COMPLETED|Overall Study||17
8916825|NCT02186652|9976375|FG001|COMPLETED|Overall Study||22
8786934|NCT01363388|9838044|FG002|NOT COMPLETED|Overall Study||4
8786935|NCT01363440|9838055|FG000|STARTED|Overall Study|randomized|156
8786936|NCT01363440|9838056|FG001|STARTED|Overall Study|randomized|156
8786937|NCT01363440|9838057|FG002|STARTED|Overall Study|randomized|154
8786938|NCT01363440|9838055|FG000|Participants Received Treatment|Overall Study|safety analysis set (SAF)|154
8786939|NCT01363440|9838056|FG001|Participants Received Treatment|Overall Study|safety analysis set (SAF)|155
8786940|NCT01363440|9838057|FG002|Participants Received Treatment|Overall Study|safety analysis set (SAF)|152
8786941|NCT01363440|9838055|FG000|Completed Week 52|Overall Study||145
8786942|NCT01363440|9838056|FG001|Completed Week 52|Overall Study||146
8786943|NCT01363440|9838057|FG002|Completed Week 52|Overall Study||144
8786944|NCT01363440|9838055|FG000|Completed Week 100|Overall Study||133
8786945|NCT01363440|9838056|FG001|Completed Week 100|Overall Study||125
8786946|NCT01363440|9838057|FG002|Completed Week 100|Overall Study||127
8786947|NCT01363440|9838055|FG000|COMPLETED|Overall Study|Completed Week 100|133
8786948|NCT01363440|9838056|FG001|COMPLETED|Overall Study|Completed Week 100|125
8786949|NCT01363440|9838057|FG002|COMPLETED|Overall Study|Completed Week 100|127
8786950|NCT01363440|9838055|FG000|NOT COMPLETED|Overall Study||23
8786951|NCT01363440|9838056|FG001|NOT COMPLETED|Overall Study||31
8786952|NCT01363440|9838057|FG002|NOT COMPLETED|Overall Study||27
8786953|NCT01363479|9838070|FG000|STARTED|Overall Study|number of randomised patients|371
8786954|NCT01363479|9838071|FG001|STARTED|Overall Study|number of randomised patients|372
8786955|NCT01363479|9838070|FG000|COMPLETED|Overall Study||359
8786956|NCT01363479|9838071|FG001|COMPLETED|Overall Study||351
8786957|NCT01363479|9838070|FG000|NOT COMPLETED|Overall Study||12
8786958|NCT01363479|9838071|FG001|NOT COMPLETED|Overall Study||21
8786959|NCT01363492|9838077|FG000|STARTED|Overall Study||14
8786960|NCT01363492|9838077|FG000|COMPLETED|Overall Study||14
8786961|NCT01363492|9838077|FG000|NOT COMPLETED|Overall Study||0
8786962|NCT01363661|9838085|FG000|STARTED|Overall Study||32
8786963|NCT01363661|9838086|FG001|STARTED|Overall Study||32
8786964|NCT01363661|9838085|FG000|COMPLETED|Overall Study||18
8786965|NCT01363661|9838086|FG001|COMPLETED|Overall Study||28
8786966|NCT01363661|9838085|FG000|NOT COMPLETED|Overall Study||14
8786967|NCT01363661|9838086|FG001|NOT COMPLETED|Overall Study||4
8786968|NCT01363700|9838095|FG000|STARTED|Epinastine vs Placebo Period1||43
8786969|NCT01363700|9838096|FG001|STARTED|Epinastine vs Placebo Period1||22
8786970|NCT01363700|9838097|FG002|STARTED|Epinastine vs Placebo Period1||22
8786971|NCT01363700|9838098|FG003|STARTED|Epinastine vs Placebo Period1|No Allocation|0
8786972|NCT01363700|9838099|FG004|STARTED|Epinastine vs Placebo Period1|No Allocation|0
8786973|NCT01363700|9838095|FG000|COMPLETED|Epinastine vs Placebo Period1||43
8786974|NCT01363700|9838096|FG001|COMPLETED|Epinastine vs Placebo Period1||21
8786975|NCT01363700|9838097|FG002|COMPLETED|Epinastine vs Placebo Period1||22
8786976|NCT01363700|9838098|FG003|COMPLETED|Epinastine vs Placebo Period1||0
8786977|NCT01363700|9838099|FG004|COMPLETED|Epinastine vs Placebo Period1||0
8786978|NCT01363700|9838095|FG000|NOT COMPLETED|Epinastine vs Placebo Period1||0
8786979|NCT01363700|9838096|FG001|NOT COMPLETED|Epinastine vs Placebo Period1||1
8786980|NCT01363700|9838097|FG002|NOT COMPLETED|Epinastine vs Placebo Period1||0
8786981|NCT01363700|9838098|FG003|NOT COMPLETED|Epinastine vs Placebo Period1||0
8786982|NCT01363700|9838099|FG004|NOT COMPLETED|Epinastine vs Placebo Period1||0
8786983|NCT01363700|9838095|FG000|STARTED|Epinastine vs Olopatadine Period2|No Allocation|0
8786984|NCT01363700|9838096|FG001|STARTED|Epinastine vs Olopatadine Period2|No Allocation|0
8786985|NCT01363700|9838097|FG002|STARTED|Epinastine vs Olopatadine Period2|No Allocation|0
8786986|NCT01363700|9838098|FG003|STARTED|Epinastine vs Olopatadine Period2||43
8786987|NCT01363700|9838099|FG004|STARTED|Epinastine vs Olopatadine Period2||43
8786988|NCT01363700|9838095|FG000|COMPLETED|Epinastine vs Olopatadine Period2||0
8786989|NCT01363700|9838096|FG001|COMPLETED|Epinastine vs Olopatadine Period2||0
8786990|NCT01363700|9838097|FG002|COMPLETED|Epinastine vs Olopatadine Period2||0
8786991|NCT01363700|9838098|FG003|COMPLETED|Epinastine vs Olopatadine Period2||43
8786992|NCT01363700|9838099|FG004|COMPLETED|Epinastine vs Olopatadine Period2||43
8786993|NCT01363700|9838095|FG000|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
8786994|NCT01363700|9838096|FG001|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
8786995|NCT01363700|9838097|FG002|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
8786996|NCT01363700|9838098|FG003|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
8786997|NCT01363700|9838099|FG004|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
8786998|NCT01363713|9838110|FG000|STARTED|Overall Study|Assessed for eligibility|130
8786999|NCT01363713|9838110|FG000|ALLOCATED|Overall Study||130
8787000|NCT01363713|9838110|FG000|COMPLETED|Overall Study|Analysed (n=130)|124
8787001|NCT01363713|9838110|FG000|NOT COMPLETED|Overall Study||6
8787002|NCT01363765|9838116|FG000|STARTED|Overall Study|This is number of participants enrolled, each with one sample submitted to Xpert in intervention arm|18322
8787003|NCT01363765|9838117|FG001|STARTED|Overall Study|This is number of participants enrolled, each with one sample considered in baseline arm.|16436
8787004|NCT01363765|9838116|FG000|COMPLETED|Overall Study|Excluded were duplicates, non-residents, missing age, unavailability of system (smears done instead)|12522
8787005|NCT01363765|9838117|FG001|COMPLETED|Overall Study|Samples contributing to observation arm. Excluded were duplicates, non-residents, missing age.|11705
8787006|NCT01363765|9838116|FG000|NOT COMPLETED|Overall Study||5800
8787007|NCT01363765|9838117|FG001|NOT COMPLETED|Overall Study||4731
8787008|NCT01363843|9838125|FG000|STARTED|Overall Study||39
8787009|NCT01363843|9838125|FG000|COMPLETED|Overall Study|39 enrolled, 36 completed 8 cycles of mFOLFOX6, 35 completed chemo-radiation, 38 underwent surgery.|38
8787010|NCT01363843|9838125|FG000|NOT COMPLETED|Overall Study||1
8787011|NCT01363908|9838132|FG000|STARTED|Screening/Enrollment||14
8787012|NCT01363908|9838133|FG001|STARTED|Screening/Enrollment||16
8787013|NCT01363908|9838132|FG000|COMPLETED|Screening/Enrollment|One participant did not receive investigational product.|13
8787014|NCT01363908|9838133|FG001|COMPLETED|Screening/Enrollment||16
8787015|NCT01363908|9838132|FG000|NOT COMPLETED|Screening/Enrollment||1
8787016|NCT01363908|9838133|FG001|NOT COMPLETED|Screening/Enrollment||0
8787017|NCT01363908|9838132|FG000|STARTED|Pharmacokinetic (PK) Phase|Per study design, at least 8 participants in each age cohort participated in the PK phase.|8
8787018|NCT01363908|9838133|FG001|STARTED|Pharmacokinetic (PK) Phase|Per study design, at least 8 participants in each age cohort participated in the PK phase.|8
8787019|NCT01363908|9838132|FG000|COMPLETED|Pharmacokinetic (PK) Phase||8
8787020|NCT01363908|9838133|FG001|COMPLETED|Pharmacokinetic (PK) Phase||8
8787021|NCT01363908|9838132|FG000|NOT COMPLETED|Pharmacokinetic (PK) Phase||0
8787022|NCT01363908|9838133|FG001|NOT COMPLETED|Pharmacokinetic (PK) Phase||0
8787023|NCT01363908|9838132|FG000|STARTED|Chronic Dosing (CD) Phase|The CD phase enrolled willing participants who completed the PK phase plus additional participants.|13
8787024|NCT01363908|9838133|FG001|STARTED|Chronic Dosing (CD) Phase|The CD phase enrolled willing participants who completed the PK phase plus additional participants.|16
8787025|NCT01363908|9838132|FG000|COMPLETED|Chronic Dosing (CD) Phase||3
8787026|NCT01363908|9838133|FG001|COMPLETED|Chronic Dosing (CD) Phase||10
8787027|NCT01363908|9838132|FG000|NOT COMPLETED|Chronic Dosing (CD) Phase||10
8787028|NCT01363908|9838133|FG001|NOT COMPLETED|Chronic Dosing (CD) Phase||6
8787029|NCT01363986|9838139|FG000|STARTED|Overall Study||3
8787030|NCT01363986|9838139|FG000|COMPLETED|Overall Study||2
8787031|NCT01363986|9838139|FG000|NOT COMPLETED|Overall Study||1
8787032|NCT01363999|9838143|FG000|STARTED|A: RO5317116/F01 Bilayer Tablet||24
8787033|NCT01363999|9838143|FG000|COMPLETED|A: RO5317116/F01 Bilayer Tablet||24
8787034|NCT01363999|9838143|FG000|NOT COMPLETED|A: RO5317116/F01 Bilayer Tablet||0
8787035|NCT01363999|9838143|FG000|STARTED|B: RO5317116/F03 Bilayer Tablet||24
8787036|NCT01363999|9838143|FG000|COMPLETED|B: RO5317116/F03 Bilayer Tablet||24
8787037|NCT01363999|9838143|FG000|NOT COMPLETED|B: RO5317116/F03 Bilayer Tablet||0
8787038|NCT01363999|9838143|FG000|STARTED|C: RO5317116/ F04 Active-coated Tablet||24
8787039|NCT01363999|9838143|FG000|COMPLETED|C: RO5317116/ F04 Active-coated Tablet||24
8787040|NCT01363999|9838143|FG000|NOT COMPLETED|C: RO5317116/ F04 Active-coated Tablet||0
8787041|NCT01363999|9838143|FG000|STARTED|D: RO4607381/ F49 Tablet||24
8787042|NCT01363999|9838143|FG000|COMPLETED|D: RO4607381/ F49 Tablet||24
8787043|NCT01363999|9838143|FG000|NOT COMPLETED|D: RO4607381/ F49 Tablet||0
8787044|NCT01364090|9838153|FG000|STARTED|Overall Study||61
8787045|NCT01364090|9838154|FG001|STARTED|Overall Study||26
8787046|NCT01364090|9838155|FG002|STARTED|Overall Study||6
8787047|NCT01364090|9838153|FG000|COMPLETED|Overall Study||58
8787048|NCT01364090|9838154|FG001|COMPLETED|Overall Study||12
8787049|NCT01364090|9838155|FG002|COMPLETED|Overall Study||0
8787050|NCT01364090|9838153|FG000|NOT COMPLETED|Overall Study||3
8787051|NCT01364090|9838154|FG001|NOT COMPLETED|Overall Study||14
8787052|NCT01364090|9838155|FG002|NOT COMPLETED|Overall Study||6
8787053|NCT01364207|9838163|FG000|STARTED|First Visit (~1.5-2 Hours)||54
8787054|NCT01364207|9838164|FG001|STARTED|First Visit (~1.5-2 Hours)||58
8787055|NCT01364207|9838163|FG000|COMPLETED|First Visit (~1.5-2 Hours)||54
8787056|NCT01364207|9838164|FG001|COMPLETED|First Visit (~1.5-2 Hours)||58
8787057|NCT01364207|9838163|FG000|NOT COMPLETED|First Visit (~1.5-2 Hours)||0
8787058|NCT01364207|9838164|FG001|NOT COMPLETED|First Visit (~1.5-2 Hours)||0
8787059|NCT01364207|9838163|FG000|STARTED|Time Between Visits (2 Days to 4 Weeks)||54
8787060|NCT01364207|9838164|FG001|STARTED|Time Between Visits (2 Days to 4 Weeks)||58
8787061|NCT01364207|9838163|FG000|COMPLETED|Time Between Visits (2 Days to 4 Weeks)||52
8787062|NCT01364207|9838164|FG001|COMPLETED|Time Between Visits (2 Days to 4 Weeks)||54
8787063|NCT01364207|9838163|FG000|NOT COMPLETED|Time Between Visits (2 Days to 4 Weeks)||2
8787064|NCT01364207|9838164|FG001|NOT COMPLETED|Time Between Visits (2 Days to 4 Weeks)||4
8787065|NCT01364207|9838163|FG000|STARTED|Second Visit (~1.5-2 Hours)||52
8787066|NCT01364207|9838164|FG001|STARTED|Second Visit (~1.5-2 Hours)||54
8787067|NCT01364207|9838163|FG000|COMPLETED|Second Visit (~1.5-2 Hours)||52
8787068|NCT01364207|9838164|FG001|COMPLETED|Second Visit (~1.5-2 Hours)||54
8787069|NCT01364207|9838163|FG000|NOT COMPLETED|Second Visit (~1.5-2 Hours)||0
8787070|NCT01364207|9838164|FG001|NOT COMPLETED|Second Visit (~1.5-2 Hours)||0
8787071|NCT01364233|9838170|FG000|STARTED|Overall Study||10
8787072|NCT01364233|9838170|FG000|COMPLETED|Overall Study||9
8787073|NCT01364233|9838170|FG000|NOT COMPLETED|Overall Study||1
8787074|NCT01364259|9838176|FG000|STARTED|Overall Study||9
8787075|NCT01364259|9838177|FG001|STARTED|Overall Study||8
8787076|NCT01364259|9838176|FG000|COMPLETED|Overall Study||9
8787077|NCT01364259|9838177|FG001|COMPLETED|Overall Study||8
8787078|NCT01364259|9838176|FG000|NOT COMPLETED|Overall Study||0
8787079|NCT01364259|9838177|FG001|NOT COMPLETED|Overall Study||0
8787080|NCT01364298|9838185|FG000|STARTED|Overall Study||176
8787081|NCT01364298|9838186|FG001|STARTED|Overall Study||177
8787082|NCT01364298|9838185|FG000|Treated|Overall Study||174
8787083|NCT01364298|9838186|FG001|Treated|Overall Study||174
8787084|NCT01364298|9838185|FG000|COMPLETED|Overall Study||162
8787085|NCT01364298|9838186|FG001|COMPLETED|Overall Study||154
8787086|NCT01364298|9838185|FG000|NOT COMPLETED|Overall Study||14
8787087|NCT01364298|9838186|FG001|NOT COMPLETED|Overall Study||23
8787088|NCT01364389|9838195|FG000|STARTED|Overall Study||5
8787089|NCT01364389|9838196|FG001|STARTED|Overall Study||6
8787090|NCT01364389|9838197|FG002|STARTED|Overall Study||5
8787091|NCT01364389|9838195|FG000|Pharmacodynamic (PD) Analysis Set|Overall Study||5
8787092|NCT01364389|9838196|FG001|Pharmacodynamic (PD) Analysis Set|Overall Study||6
9031287|NCT03242148|10093444|FG000|COMPLETED|Overall Study||38
9031288|NCT03242148|10093444|FG000|NOT COMPLETED|Overall Study||0
9031289|NCT03242252|10093451|FG000|STARTED|Overall Study||260
8787093|NCT01364389|9838197|FG002|Pharmacodynamic (PD) Analysis Set|Overall Study|One patient excluded: did not receive study drug; received placebo caps. and infusion only in error.|4
8787094|NCT01364389|9838195|FG000|COMPLETED|Overall Study||3
8787095|NCT01364389|9838196|FG001|COMPLETED|Overall Study||5
8787096|NCT01364389|9838197|FG002|COMPLETED|Overall Study||4
8787097|NCT01364389|9838195|FG000|NOT COMPLETED|Overall Study||2
8787098|NCT01364389|9838196|FG001|NOT COMPLETED|Overall Study||1
8787099|NCT01364389|9838197|FG002|NOT COMPLETED|Overall Study||1
8787100|NCT01364428|9838207|FG000|STARTED|Overall Study||186
8787101|NCT01364428|9838208|FG001|STARTED|Overall Study||187
8787102|NCT01364428|9838207|FG000|Exposed|Overall Study|Two subjects were randomised in error and withdrew prior to exposure to drug|184
8787103|NCT01364428|9838208|FG001|Exposed|Overall Study||187
8787104|NCT01364428|9838207|FG000|COMPLETED|Overall Study||166
8787105|NCT01364428|9838208|FG001|COMPLETED|Overall Study||172
8787106|NCT01364428|9838207|FG000|NOT COMPLETED|Overall Study||20
8787107|NCT01364428|9838208|FG001|NOT COMPLETED|Overall Study||15
8787108|NCT01364467|9838216|FG000|STARTED|Overall Study||10
8787109|NCT01364467|9838217|FG001|STARTED|Overall Study||20
8787110|NCT01364467|9838216|FG000|COMPLETED|Overall Study||9
8787111|NCT01364467|9838217|FG001|COMPLETED|Overall Study||18
8787112|NCT01364467|9838216|FG000|NOT COMPLETED|Overall Study||1
8787113|NCT01364467|9838217|FG001|NOT COMPLETED|Overall Study||2
8787114|NCT01364558|9838223|FG000|STARTED|Dose One||8
8787115|NCT01364558|9838224|FG001|STARTED|Dose One||8
8787116|NCT01364558|9838225|FG002|STARTED|Dose One||8
8787117|NCT01364558|9838223|FG000|COMPLETED|Dose One||8
8787118|NCT01364558|9838224|FG001|COMPLETED|Dose One||8
8787119|NCT01364558|9838225|FG002|COMPLETED|Dose One||8
8787120|NCT01364558|9838223|FG000|NOT COMPLETED|Dose One||0
8787121|NCT01364558|9838224|FG001|NOT COMPLETED|Dose One||0
8787122|NCT01364558|9838225|FG002|NOT COMPLETED|Dose One||0
8787123|NCT01364558|9838223|FG000|STARTED|Dose Two||8
8787124|NCT01364558|9838224|FG001|STARTED|Dose Two||8
8787125|NCT01364558|9838225|FG002|STARTED|Dose Two||8
8787126|NCT01364558|9838223|FG000|COMPLETED|Dose Two||8
8787127|NCT01364558|9838224|FG001|COMPLETED|Dose Two||8
8787128|NCT01364558|9838225|FG002|COMPLETED|Dose Two||8
8787129|NCT01364558|9838223|FG000|NOT COMPLETED|Dose Two||0
8787130|NCT01364558|9838224|FG001|NOT COMPLETED|Dose Two||0
8787131|NCT01364558|9838225|FG002|NOT COMPLETED|Dose Two||0
8787132|NCT01364558|9838223|FG000|STARTED|Dose Three||8
8787133|NCT01364558|9838224|FG001|STARTED|Dose Three||8
8787134|NCT01364558|9838225|FG002|STARTED|Dose Three||8
8787135|NCT01364558|9838223|FG000|COMPLETED|Dose Three||8
8787136|NCT01364558|9838224|FG001|COMPLETED|Dose Three||8
9031290|NCT03242252|10093452|FG001|STARTED|Overall Study||263
9031291|NCT03242252|10093453|FG002|STARTED|Overall Study||264
9031292|NCT03242252|10093451|FG000|COMPLETED|Overall Study||224
9031293|NCT03242252|10093452|FG001|COMPLETED|Overall Study||240
9031294|NCT03242252|10093453|FG002|COMPLETED|Overall Study||232
9031295|NCT03242252|10093451|FG000|NOT COMPLETED|Overall Study||36
9031296|NCT03242252|10093452|FG001|NOT COMPLETED|Overall Study||23
9031297|NCT03242252|10093453|FG002|NOT COMPLETED|Overall Study||32
9031298|NCT03242408|10093467|FG000|STARTED|Overall Study||100
9031299|NCT03242408|10093467|FG000|COMPLETED|Overall Study||98
9031300|NCT03242408|10093467|FG000|NOT COMPLETED|Overall Study||2
9031301|NCT03242434|10093473|FG000|STARTED|Overall Study||15
9031302|NCT03242434|10093474|FG001|STARTED|Overall Study||3
9031303|NCT03242434|10093473|FG000|COMPLETED|Overall Study||15
9031304|NCT03242434|10093474|FG001|COMPLETED|Overall Study||1
9031305|NCT03242434|10093473|FG000|NOT COMPLETED|Overall Study||0
9031306|NCT03242434|10093474|FG001|NOT COMPLETED|Overall Study||2
9031307|NCT03242590|10093481|FG000|STARTED|Overall Study||95
9031308|NCT03242590|10093481|FG000|COMPLETED|Overall Study||95
9031309|NCT03242590|10093481|FG000|NOT COMPLETED|Overall Study||0
9031310|NCT03242759|10093487|FG000|STARTED|Overall Study||88
9031311|NCT03242759|10093488|FG001|STARTED|Overall Study||13
9031312|NCT03242759|10093487|FG000|COMPLETED|Overall Study||53
9031313|NCT03242759|10093488|FG001|COMPLETED|Overall Study||6
9031314|NCT03242759|10093487|FG000|NOT COMPLETED|Overall Study||35
9031315|NCT03242759|10093488|FG001|NOT COMPLETED|Overall Study||7
9031316|NCT03242863|10093494|FG000|STARTED|Study Week 1||13
9031317|NCT03242863|10093495|FG001|STARTED|Study Week 1||16
9031318|NCT03242863|10093496|FG002|STARTED|Study Week 1||4
9031319|NCT03242863|10093497|FG003|STARTED|Study Week 1||4
9031320|NCT03242863|10093498|FG004|STARTED|Study Week 1||15
9031321|NCT03242863|10093499|FG005|STARTED|Study Week 1||5
9031322|NCT03242863|10093494|FG000|COMPLETED|Study Week 1||13
8787137|NCT01364558|9838225|FG002|COMPLETED|Dose Three||8
8787138|NCT01364558|9838223|FG000|NOT COMPLETED|Dose Three||0
9031323|NCT03242863|10093495|FG001|COMPLETED|Study Week 1||15
9031324|NCT03242863|10093496|FG002|COMPLETED|Study Week 1||4
9031325|NCT03242863|10093497|FG003|COMPLETED|Study Week 1||4
9031326|NCT03242863|10093498|FG004|COMPLETED|Study Week 1||12
9031327|NCT03242863|10093499|FG005|COMPLETED|Study Week 1||5
9031328|NCT03242863|10093494|FG000|NOT COMPLETED|Study Week 1||0
9031329|NCT03242863|10093495|FG001|NOT COMPLETED|Study Week 1||1
8787139|NCT01364558|9838224|FG001|NOT COMPLETED|Dose Three||0
8787140|NCT01364558|9838225|FG002|NOT COMPLETED|Dose Three||0
8787141|NCT01364584|9838235|FG000|STARTED|Overall Study||11
8787142|NCT01364584|9838236|FG001|STARTED|Overall Study||12
8787143|NCT01364584|9838235|FG000|COMPLETED|Overall Study||11
8787144|NCT01364584|9838236|FG001|COMPLETED|Overall Study||12
8787145|NCT01364584|9838235|FG000|NOT COMPLETED|Overall Study||0
8787146|NCT01364584|9838236|FG001|NOT COMPLETED|Overall Study||0
8787147|NCT01364623|9838247|FG000|STARTED|Single Dose||8
8787148|NCT01364623|9838248|FG001|STARTED|Single Dose||8
8787149|NCT01364623|9838249|FG002|STARTED|Single Dose||8
8787150|NCT01364623|9838250|FG003|STARTED|Single Dose||0
8787151|NCT01364623|9838247|FG000|COMPLETED|Single Dose||8
8787152|NCT01364623|9838248|FG001|COMPLETED|Single Dose||8
8787153|NCT01364623|9838249|FG002|COMPLETED|Single Dose||8
8787154|NCT01364623|9838250|FG003|COMPLETED|Single Dose||0
8787155|NCT01364623|9838247|FG000|NOT COMPLETED|Single Dose||0
8787156|NCT01364623|9838248|FG001|NOT COMPLETED|Single Dose||0
8787157|NCT01364623|9838249|FG002|NOT COMPLETED|Single Dose||0
8787158|NCT01364623|9838250|FG003|NOT COMPLETED|Single Dose||0
8787159|NCT01364623|9838247|FG000|STARTED|Multiple Dose||0
8787160|NCT01364623|9838248|FG001|STARTED|Multiple Dose||0
8787161|NCT01364623|9838249|FG002|STARTED|Multiple Dose||0
8787162|NCT01364623|9838250|FG003|STARTED|Multiple Dose||8
8787163|NCT01364623|9838247|FG000|COMPLETED|Multiple Dose||0
8787164|NCT01364623|9838248|FG001|COMPLETED|Multiple Dose||0
8787165|NCT01364623|9838249|FG002|COMPLETED|Multiple Dose||0
8787166|NCT01364623|9838250|FG003|COMPLETED|Multiple Dose||8
8787167|NCT01364623|9838247|FG000|NOT COMPLETED|Multiple Dose||0
8787168|NCT01364623|9838248|FG001|NOT COMPLETED|Multiple Dose||0
8787169|NCT01364623|9838249|FG002|NOT COMPLETED|Multiple Dose||0
8787170|NCT01364623|9838250|FG003|NOT COMPLETED|Multiple Dose||0
8787171|NCT01364649|9838267|FG000|STARTED|Overall Study||225
8787172|NCT01364649|9838268|FG001|STARTED|Overall Study||222
8787173|NCT01364649|9838267|FG000|COMPLETED|Overall Study||169
8787174|NCT01364649|9838268|FG001|COMPLETED|Overall Study||179
8787175|NCT01364649|9838267|FG000|NOT COMPLETED|Overall Study||56
8787176|NCT01364649|9838268|FG001|NOT COMPLETED|Overall Study||43
8787177|NCT01364727|9838274|FG000|STARTED|Overall Study||35
8787178|NCT01364727|9838274|FG000|COMPLETED|Overall Study||33
8787179|NCT01364727|9838274|FG000|NOT COMPLETED|Overall Study||2
8787180|NCT01364740|9838280|FG000|STARTED|Overall Study||10
8787181|NCT01364740|9838280|FG000|COMPLETED|Overall Study||10
8787182|NCT01364740|9838280|FG000|NOT COMPLETED|Overall Study||0
8787183|NCT01364870|9838288|FG000|STARTED|Overall Study||122
8787184|NCT01364870|9838289|FG001|STARTED|Overall Study||123
8787185|NCT01364870|9838290|FG002|STARTED|Overall Study||72
8787186|NCT01364870|9838288|FG000|COMPLETED|Overall Study||100
8787187|NCT01364870|9838289|FG001|COMPLETED|Overall Study||93
8787188|NCT01364870|9838290|FG002|COMPLETED|Overall Study||58
8787189|NCT01364870|9838288|FG000|NOT COMPLETED|Overall Study||22
8787190|NCT01364870|9838289|FG001|NOT COMPLETED|Overall Study||30
8787191|NCT01364870|9838290|FG002|NOT COMPLETED|Overall Study||14
8787192|NCT01364896|9838298|FG000|STARTED|Overall Study||46
8787193|NCT01364896|9838298|FG000|COMPLETED|Overall Study||46
8787194|NCT01364896|9838298|FG000|NOT COMPLETED|Overall Study||0
8787195|NCT01364922|9838305|FG000|STARTED|Open-label (OL) Period||168
8787196|NCT01364922|9838306|FG001|STARTED|Open-label (OL) Period||0
8787197|NCT01364922|9838307|FG002|STARTED|Open-label (OL) Period||0
8787198|NCT01364922|9838305|FG000|COMPLETED|Open-label (OL) Period||146
8787199|NCT01364922|9838306|FG001|COMPLETED|Open-label (OL) Period||0
8787200|NCT01364922|9838307|FG002|COMPLETED|Open-label (OL) Period||0
8787201|NCT01364922|9838305|FG000|NOT COMPLETED|Open-label (OL) Period||22
9031330|NCT03242863|10093496|FG002|NOT COMPLETED|Study Week 1||0
9031331|NCT03242863|10093497|FG003|NOT COMPLETED|Study Week 1||0
9031332|NCT03242863|10093498|FG004|NOT COMPLETED|Study Week 1||3
9031333|NCT03242863|10093499|FG005|NOT COMPLETED|Study Week 1||0
9031334|NCT03242863|10093494|FG000|STARTED|Study Week 2||13
9031335|NCT03242863|10093495|FG001|STARTED|Study Week 2||15
9031336|NCT03242863|10093496|FG002|STARTED|Study Week 2||4
9031337|NCT03242863|10093497|FG003|STARTED|Study Week 2||4
9031338|NCT03242863|10093498|FG004|STARTED|Study Week 2||12
9031339|NCT03242863|10093499|FG005|STARTED|Study Week 2||5
9031340|NCT03242863|10093494|FG000|COMPLETED|Study Week 2||13
9031341|NCT03242863|10093495|FG001|COMPLETED|Study Week 2||15
9031342|NCT03242863|10093496|FG002|COMPLETED|Study Week 2||4
9031343|NCT03242863|10093497|FG003|COMPLETED|Study Week 2||4
9031344|NCT03242863|10093498|FG004|COMPLETED|Study Week 2||12
9031345|NCT03242863|10093499|FG005|COMPLETED|Study Week 2||5
9031346|NCT03242863|10093494|FG000|NOT COMPLETED|Study Week 2||0
9031347|NCT03242863|10093495|FG001|NOT COMPLETED|Study Week 2||0
9031348|NCT03242863|10093496|FG002|NOT COMPLETED|Study Week 2||0
9031349|NCT03242863|10093497|FG003|NOT COMPLETED|Study Week 2||0
9031350|NCT03242863|10093498|FG004|NOT COMPLETED|Study Week 2||0
9031351|NCT03242863|10093499|FG005|NOT COMPLETED|Study Week 2||0
9031352|NCT03242863|10093494|FG000|STARTED|Study Week 3||13
9031353|NCT03242863|10093495|FG001|STARTED|Study Week 3||15
9031354|NCT03242863|10093496|FG002|STARTED|Study Week 3||4
9031355|NCT03242863|10093497|FG003|STARTED|Study Week 3||4
9031356|NCT03242863|10093498|FG004|STARTED|Study Week 3||12
9031357|NCT03242863|10093499|FG005|STARTED|Study Week 3||5
8787202|NCT01364922|9838306|FG001|NOT COMPLETED|Open-label (OL) Period||0
8787203|NCT01364922|9838307|FG002|NOT COMPLETED|Open-label (OL) Period||0
8787204|NCT01364922|9838305|FG000|STARTED|Double-Blind (DB) Period||0
8787205|NCT01364922|9838306|FG001|STARTED|Double-Blind (DB) Period||99
8787206|NCT01364922|9838307|FG002|STARTED|Double-Blind (DB) Period||47
8787207|NCT01364922|9838305|FG000|COMPLETED|Double-Blind (DB) Period||0
8787208|NCT01364922|9838306|FG001|COMPLETED|Double-Blind (DB) Period||94
8787209|NCT01364922|9838307|FG002|COMPLETED|Double-Blind (DB) Period||42
8787210|NCT01364922|9838305|FG000|NOT COMPLETED|Double-Blind (DB) Period||0
8787211|NCT01364922|9838306|FG001|NOT COMPLETED|Double-Blind (DB) Period||5
8787212|NCT01364922|9838307|FG002|NOT COMPLETED|Double-Blind (DB) Period||5
8787213|NCT01365039|9838316|FG000|STARTED|Overall Study||86
8787214|NCT01365039|9838317|FG001|STARTED|Overall Study||87
8787215|NCT01365039|9838316|FG000|COMPLETED|Overall Study||85
8787216|NCT01365039|9838317|FG001|COMPLETED|Overall Study||87
8787217|NCT01365039|9838316|FG000|NOT COMPLETED|Overall Study||1
8787218|NCT01365039|9838317|FG001|NOT COMPLETED|Overall Study||0
8787219|NCT01365052|9838326|FG000|STARTED|Overall Study||217
8787220|NCT01365052|9838327|FG001|STARTED|Overall Study||109
8787221|NCT01365052|9838326|FG000|COMPLETED|Overall Study||213
8787222|NCT01365052|9838327|FG001|COMPLETED|Overall Study||105
8787223|NCT01365052|9838326|FG000|NOT COMPLETED|Overall Study||4
8787224|NCT01365052|9838327|FG001|NOT COMPLETED|Overall Study||4
8787225|NCT01365091|9838337|FG000|STARTED|Period 1||28
8787226|NCT01365091|9838338|FG001|STARTED|Period 1||28
8787227|NCT01365091|9838339|FG002|STARTED|Period 1||28
8787228|NCT01365091|9838340|FG003|STARTED|Period 1||28
8787229|NCT01365091|9838337|FG000|COMPLETED|Period 1||26
8787230|NCT01365091|9838338|FG001|COMPLETED|Period 1||26
8787231|NCT01365091|9838339|FG002|COMPLETED|Period 1||25
8787232|NCT01365091|9838340|FG003|COMPLETED|Period 1||25
8787233|NCT01365091|9838337|FG000|NOT COMPLETED|Period 1||2
8787234|NCT01365091|9838338|FG001|NOT COMPLETED|Period 1||2
8787235|NCT01365091|9838339|FG002|NOT COMPLETED|Period 1||3
8787236|NCT01365091|9838340|FG003|NOT COMPLETED|Period 1||3
8787237|NCT01365091|9838337|FG000|STARTED|Period 2||26
8787238|NCT01365091|9838338|FG001|STARTED|Period 2||26
8787239|NCT01365091|9838339|FG002|STARTED|Period 2||25
8787240|NCT01365091|9838340|FG003|STARTED|Period 2||25
8787241|NCT01365091|9838337|FG000|COMPLETED|Period 2||25
8787242|NCT01365091|9838338|FG001|COMPLETED|Period 2||26
8787243|NCT01365091|9838339|FG002|COMPLETED|Period 2||24
8787244|NCT01365091|9838340|FG003|COMPLETED|Period 2||25
8787245|NCT01365091|9838337|FG000|NOT COMPLETED|Period 2||1
8787246|NCT01365091|9838338|FG001|NOT COMPLETED|Period 2||0
8787247|NCT01365091|9838339|FG002|NOT COMPLETED|Period 2||1
8787248|NCT01365091|9838340|FG003|NOT COMPLETED|Period 2||0
8787249|NCT01365130|9838364|FG000|STARTED|Overall Study|15 patients were enrolled to the study but only 13 went on to begin treatment|15
8787250|NCT01365130|9838364|FG000|COMPLETED|Overall Study||13
8787251|NCT01365130|9838364|FG000|NOT COMPLETED|Overall Study||2
8787252|NCT01365273|9838370|FG000|STARTED|Overall Study||22
8787253|NCT01365273|9838371|FG001|STARTED|Overall Study||21
8787254|NCT01365273|9838370|FG000|Compl. Pts, Not Evaluable for Pain.|Overall Study||2
8787255|NCT01365273|9838371|FG001|Compl. Pts, Not Evaluable for Pain.|Overall Study||4
8787256|NCT01365273|9838370|FG000|COMPLETED|Overall Study||20
8787257|NCT01365273|9838371|FG001|COMPLETED|Overall Study||20
8787258|NCT01365273|9838370|FG000|NOT COMPLETED|Overall Study||2
8787259|NCT01365273|9838371|FG001|NOT COMPLETED|Overall Study||1
8787260|NCT01365455|9838380|FG000|STARTED|Induction Period||245
8787261|NCT01365455|9838381|FG001|STARTED|Induction Period||245
8787262|NCT01365455|9838382|FG002|STARTED|Induction Period||248
8787263|NCT01365455|9838383|FG003|STARTED|Induction Period||0
8787264|NCT01365455|9838384|FG004|STARTED|Induction Period||0
8787265|NCT01365455|9838380|FG000|COMPLETED|Induction Period||230
8787266|NCT01365455|9838381|FG001|COMPLETED|Induction Period||238
8787267|NCT01365455|9838382|FG002|COMPLETED|Induction Period||232
8787268|NCT01365455|9838383|FG003|COMPLETED|Induction Period||0
8787269|NCT01365455|9838384|FG004|COMPLETED|Induction Period||0
8787270|NCT01365455|9838380|FG000|NOT COMPLETED|Induction Period||15
8787271|NCT01365455|9838381|FG001|NOT COMPLETED|Induction Period||7
8787272|NCT01365455|9838382|FG002|NOT COMPLETED|Induction Period||16
8787273|NCT01365455|9838383|FG003|NOT COMPLETED|Induction Period||0
8787274|NCT01365455|9838384|FG004|NOT COMPLETED|Induction Period||0
8787275|NCT01365455|9838380|FG000|STARTED|Maintenance Period||230
8787276|NCT01365455|9838381|FG001|STARTED|Maintenance Period||238
8787277|NCT01365455|9838382|FG002|STARTED|Maintenance Period||18
8787278|NCT01365455|9838383|FG003|STARTED|Maintenance Period||109
8787279|NCT01365455|9838384|FG004|STARTED|Maintenance Period||105
8787280|NCT01365455|9838380|FG000|COMPLETED|Maintenance Period||201
8787281|NCT01365455|9838381|FG001|COMPLETED|Maintenance Period||215
8787282|NCT01365455|9838382|FG002|COMPLETED|Maintenance Period||15
8787283|NCT01365455|9838383|FG003|COMPLETED|Maintenance Period||100
8787284|NCT01365455|9838384|FG004|COMPLETED|Maintenance Period||92
8787285|NCT01365455|9838380|FG000|NOT COMPLETED|Maintenance Period||29
8787286|NCT01365455|9838381|FG001|NOT COMPLETED|Maintenance Period||23
8787287|NCT01365455|9838382|FG002|NOT COMPLETED|Maintenance Period||3
8787288|NCT01365455|9838383|FG003|NOT COMPLETED|Maintenance Period||9
8787289|NCT01365455|9838384|FG004|NOT COMPLETED|Maintenance Period||13
8787290|NCT01365455|9838380|FG000|STARTED|Follow-up Period||58
8787291|NCT01365455|9838381|FG001|STARTED|Follow-up Period||47
8787292|NCT01365455|9838382|FG002|STARTED|Follow-up Period||18
8787293|NCT01365455|9838383|FG003|STARTED|Follow-up Period||0
8787294|NCT01365455|9838384|FG004|STARTED|Follow-up Period||0
8787295|NCT01365455|9838380|FG000|COMPLETED|Follow-up Period||58
8787296|NCT01365455|9838381|FG001|COMPLETED|Follow-up Period||47
8787297|NCT01365455|9838382|FG002|COMPLETED|Follow-up Period||18
8787298|NCT01365455|9838383|FG003|COMPLETED|Follow-up Period||0
8787299|NCT01365455|9838384|FG004|COMPLETED|Follow-up Period||0
8787300|NCT01365455|9838380|FG000|NOT COMPLETED|Follow-up Period||0
8787301|NCT01365455|9838381|FG001|NOT COMPLETED|Follow-up Period||0
8787302|NCT01365455|9838382|FG002|NOT COMPLETED|Follow-up Period||0
8787303|NCT01365455|9838383|FG003|NOT COMPLETED|Follow-up Period||0
8787304|NCT01365455|9838384|FG004|NOT COMPLETED|Follow-up Period||0
8787305|NCT01365468|9838404|FG000|STARTED|Overall Study||4
8787306|NCT01365468|9838405|FG001|STARTED|Overall Study||5
8787307|NCT01365468|9838404|FG000|COMPLETED|Overall Study||0
8787308|NCT01365468|9838405|FG001|COMPLETED|Overall Study||5
8787309|NCT01365468|9838404|FG000|NOT COMPLETED|Overall Study||4
8787310|NCT01365468|9838405|FG001|NOT COMPLETED|Overall Study||0
8787311|NCT01365481|9838416|FG000|STARTED|Overall Study||23
8787312|NCT01365481|9838417|FG001|STARTED|Overall Study||52
8787313|NCT01365481|9838418|FG002|STARTED|Overall Study||18
8787314|NCT01365481|9838419|FG003|STARTED|Overall Study||57
8787315|NCT01365481|9838416|FG000|COMPLETED|Overall Study||16
8787316|NCT01365481|9838417|FG001|COMPLETED|Overall Study||37
8787317|NCT01365481|9838418|FG002|COMPLETED|Overall Study||14
8787318|NCT01365481|9838419|FG003|COMPLETED|Overall Study||50
8787319|NCT01365481|9838416|FG000|NOT COMPLETED|Overall Study||7
8787320|NCT01365481|9838417|FG001|NOT COMPLETED|Overall Study||15
8787321|NCT01365481|9838418|FG002|NOT COMPLETED|Overall Study||4
8787322|NCT01365481|9838419|FG003|NOT COMPLETED|Overall Study||7
8787323|NCT01365494|9838431|FG000|STARTED|Overall Study||126
8787324|NCT01365494|9838432|FG001|STARTED|Overall Study||124
8787325|NCT01365494|9838431|FG000|COMPLETED|Overall Study||124
8787326|NCT01365494|9838432|FG001|COMPLETED|Overall Study||121
8787327|NCT01365494|9838431|FG000|NOT COMPLETED|Overall Study||2
8787328|NCT01365494|9838432|FG001|NOT COMPLETED|Overall Study||3
8787329|NCT01365507|9838441|FG000|STARTED|Overall Study||136
8787330|NCT01365507|9838442|FG001|STARTED|Overall Study||140
8787331|NCT01365507|9838441|FG000|Exposed|Overall Study|Two subjects withdrew before exposure to trial drug|134
8787332|NCT01365507|9838442|FG001|Exposed|Overall Study||140
8787333|NCT01365507|9838441|FG000|COMPLETED|Overall Study||127
8787334|NCT01365507|9838442|FG001|COMPLETED|Overall Study||131
8787335|NCT01365507|9838441|FG000|NOT COMPLETED|Overall Study||9
8787336|NCT01365507|9838442|FG001|NOT COMPLETED|Overall Study||9
8787337|NCT01365546|9838448|FG000|STARTED|Overall Study|in this study 41 patients were screened but only 30 patients completed the study.|41
8787338|NCT01365546|9838448|FG000|COMPLETED|Overall Study||30
8787339|NCT01365546|9838448|FG000|NOT COMPLETED|Overall Study||11
8787340|NCT01365585|9838456|FG000|STARTED|Overall Study||227
8787341|NCT01365585|9838456|FG000|COMPLETED|Overall Study||227
8787342|NCT01365585|9838456|FG000|NOT COMPLETED|Overall Study||0
8787343|NCT01365611|9838460|FG000|STARTED|Overall Study||36
8787344|NCT01365611|9838460|FG000|COMPLETED|Overall Study||36
8787345|NCT01365611|9838460|FG000|NOT COMPLETED|Overall Study||0
8787346|NCT01365624|9838468|FG000|STARTED|Overall Study||15
8787347|NCT01365624|9838469|FG001|STARTED|Overall Study||15
8787348|NCT01365624|9838468|FG000|COMPLETED|Overall Study||15
8787349|NCT01365624|9838469|FG001|COMPLETED|Overall Study||15
8787350|NCT01365624|9838468|FG000|NOT COMPLETED|Overall Study||0
8787351|NCT01365624|9838469|FG001|NOT COMPLETED|Overall Study||0
8787352|NCT01365650|9838475|FG000|STARTED|Treatment A||24
8787353|NCT01365650|9838475|FG000|COMPLETED|Treatment A||24
8787354|NCT01365650|9838475|FG000|NOT COMPLETED|Treatment A||0
8787355|NCT01365650|9838475|FG000|STARTED|Treatment B||24
8787356|NCT01365650|9838475|FG000|COMPLETED|Treatment B||24
8787357|NCT01365650|9838475|FG000|NOT COMPLETED|Treatment B||0
8787358|NCT01365650|9838475|FG000|STARTED|Treatment C||24
8787359|NCT01365650|9838475|FG000|COMPLETED|Treatment C||24
8787360|NCT01365650|9838475|FG000|NOT COMPLETED|Treatment C||0
8787361|NCT01365793|9838487|FG000|STARTED|Overall Study||344
8787362|NCT01365793|9838488|FG001|STARTED|Overall Study||351
8787363|NCT01365793|9838489|FG002|STARTED|Overall Study||345
8787364|NCT01365793|9838490|FG003|STARTED|Overall Study||349
8787365|NCT01365793|9838487|FG000|COMPLETED|Overall Study||342
8787366|NCT01365793|9838488|FG001|COMPLETED|Overall Study||344
8787367|NCT01365793|9838489|FG002|COMPLETED|Overall Study||338
8787368|NCT01365793|9838490|FG003|COMPLETED|Overall Study||347
8787369|NCT01365793|9838487|FG000|NOT COMPLETED|Overall Study||2
8787370|NCT01365793|9838488|FG001|NOT COMPLETED|Overall Study||7
8787371|NCT01365793|9838489|FG002|NOT COMPLETED|Overall Study||7
8787372|NCT01365793|9838490|FG003|NOT COMPLETED|Overall Study||2
8787373|NCT01365819|9838502|FG000|STARTED|Overall Study||25
8787374|NCT01365819|9838503|FG001|STARTED|Overall Study||27
8787375|NCT01365819|9838502|FG000|COMPLETED|Overall Study||12
8787376|NCT01365819|9838503|FG001|COMPLETED|Overall Study||14
8787377|NCT01365819|9838502|FG000|NOT COMPLETED|Overall Study||13
8787378|NCT01365819|9838503|FG001|NOT COMPLETED|Overall Study||13
8787379|NCT01365845|9838509|FG000|STARTED|Induction Phase||18
8787380|NCT01365845|9838510|FG001|STARTED|Induction Phase||0
8787381|NCT01365845|9838511|FG002|STARTED|Induction Phase||0
8787382|NCT01365845|9838509|FG000|COMPLETED|Induction Phase||18
8787383|NCT01365845|9838510|FG001|COMPLETED|Induction Phase||0
8787384|NCT01365845|9838511|FG002|COMPLETED|Induction Phase||0
8787385|NCT01365845|9838509|FG000|NOT COMPLETED|Induction Phase||0
8787386|NCT01365845|9838510|FG001|NOT COMPLETED|Induction Phase||0
8787387|NCT01365845|9838511|FG002|NOT COMPLETED|Induction Phase||0
8787388|NCT01365845|9838509|FG000|STARTED|Treatment Phase||0
8787389|NCT01365845|9838510|FG001|STARTED|Treatment Phase||0
8787390|NCT01365845|9838511|FG002|STARTED|Treatment Phase||18
8787391|NCT01365845|9838509|FG000|COMPLETED|Treatment Phase||0
8787392|NCT01365845|9838510|FG001|COMPLETED|Treatment Phase||0
8787393|NCT01365845|9838511|FG002|COMPLETED|Treatment Phase||18
8787394|NCT01365845|9838509|FG000|NOT COMPLETED|Treatment Phase||0
8787395|NCT01365845|9838510|FG001|NOT COMPLETED|Treatment Phase||0
8787396|NCT01365845|9838511|FG002|NOT COMPLETED|Treatment Phase||0
8787397|NCT01365910|9838516|FG000|STARTED|Overall Study||30
8787398|NCT01365910|9838516|FG000|COMPLETED|Overall Study||0
8787399|NCT01365910|9838516|FG000|NOT COMPLETED|Overall Study||30
8787400|NCT01366196|9838522|FG000|STARTED|Overall Study||43
8787401|NCT01366196|9838523|FG001|STARTED|Overall Study||43
8787402|NCT01366196|9838522|FG000|COMPLETED|Overall Study||43
8787403|NCT01366196|9838523|FG001|COMPLETED|Overall Study||43
8787404|NCT01366196|9838522|FG000|NOT COMPLETED|Overall Study||0
8787405|NCT01366196|9838523|FG001|NOT COMPLETED|Overall Study||0
8787406|NCT01366209|9838531|FG000|STARTED|Overall Study||278
8787407|NCT01366209|9838532|FG001|STARTED|Overall Study||277
8787408|NCT01366209|9838531|FG000|COMPLETED|Overall Study|Participants completing study assessment at Week 52 were completers, even if treatment was withdrawn|243
8787409|NCT01366209|9838532|FG001|COMPLETED|Overall Study||241
8787410|NCT01366209|9838531|FG000|NOT COMPLETED|Overall Study||35
8787411|NCT01366209|9838532|FG001|NOT COMPLETED|Overall Study||36
8787412|NCT01366417|9838538|FG000|STARTED|Overall Study||43
8787413|NCT01366417|9838538|FG000|Signed Informed Consent|Overall Study|Microbial samples were taken from 43 subjects for screening baseline.|43
8787414|NCT01366417|9838538|FG000|Completed Screen Visit|Overall Study|33 subjects had qualifying screening bacterial counts and were eligible for the Treatment Visit|33
8787415|NCT01366417|9838538|FG000|Completed Treatment Visit|Overall Study|28 subjects were treated with ChloraPrep and 70% Isopropyl Alcohol (single topical treatment)|28
8787416|NCT01366417|9838538|FG000|Completed the Study|Overall Study|treatment baseline microbial counts not available until after treatment; subjects not evaluable|28
8787417|NCT01366417|9838538|FG000|Discontinued Prior to Treatment|Overall Study|5 eligible subjects were not treated because enrollment target of 25 was met and enrollment closed.|5
8787418|NCT01366417|9838538|FG000|Excluded From Analysis|Overall Study|3 subjects did not have qualifying Treatment Day microbial counts and were excluded from analysis|3
8787419|NCT01366417|9838538|FG000|COMPLETED|Overall Study|25 subjects included in the analysis|25
8787420|NCT01366417|9838538|FG000|NOT COMPLETED|Overall Study||18
8787421|NCT01366443|9838543|FG000|STARTED|Overall Study||288
8787422|NCT01366443|9838543|FG000|COMPLETED|Overall Study||285
8787423|NCT01366443|9838543|FG000|NOT COMPLETED|Overall Study||3
8787424|NCT01366495|9838552|FG000|STARTED|Testing Study||0
8787425|NCT01366495|9838553|FG001|STARTED|Testing Study||0
8787426|NCT01366495|9838554|FG002|STARTED|Testing Study||349
8787427|NCT01366495|9838555|FG003|STARTED|Testing Study||348
8787428|NCT01366495|9838552|FG000|COMPLETED|Testing Study||0
8787429|NCT01366495|9838553|FG001|COMPLETED|Testing Study||0
8787430|NCT01366495|9838554|FG002|COMPLETED|Testing Study||349
8787431|NCT01366495|9838555|FG003|COMPLETED|Testing Study||348
8787432|NCT01366495|9838552|FG000|NOT COMPLETED|Testing Study||0
8787433|NCT01366495|9838553|FG001|NOT COMPLETED|Testing Study||0
8787434|NCT01366495|9838554|FG002|NOT COMPLETED|Testing Study||0
8787435|NCT01366495|9838555|FG003|NOT COMPLETED|Testing Study||0
8787436|NCT01366495|9838552|FG000|STARTED|HIV Study||50
8787437|NCT01366495|9838553|FG001|STARTED|HIV Study||50
8787438|NCT01366495|9838554|FG002|STARTED|HIV Study||0
8787439|NCT01366495|9838555|FG003|STARTED|HIV Study||0
8787440|NCT01366495|9838552|FG000|COMPLETED|HIV Study||49
8787441|NCT01366495|9838553|FG001|COMPLETED|HIV Study||50
8787442|NCT01366495|9838554|FG002|COMPLETED|HIV Study||0
8787443|NCT01366495|9838555|FG003|COMPLETED|HIV Study||0
8787444|NCT01366495|9838552|FG000|NOT COMPLETED|HIV Study||1
8787445|NCT01366495|9838553|FG001|NOT COMPLETED|HIV Study||0
8787446|NCT01366495|9838554|FG002|NOT COMPLETED|HIV Study||0
8787447|NCT01366495|9838555|FG003|NOT COMPLETED|HIV Study||0
8787448|NCT01366521|9838569|FG000|STARTED|Overall Study||21
8787449|NCT01366521|9838570|FG001|STARTED|Overall Study||15
8787450|NCT01366521|9838571|FG002|STARTED|Overall Study||23
8787451|NCT01366521|9838572|FG003|STARTED|Overall Study||11
8787452|NCT01366521|9838569|FG000|COMPLETED|Overall Study||20
8787453|NCT01366521|9838570|FG001|COMPLETED|Overall Study||14
8787454|NCT01366521|9838571|FG002|COMPLETED|Overall Study||21
8787455|NCT01366521|9838572|FG003|COMPLETED|Overall Study||11
8787456|NCT01366521|9838569|FG000|NOT COMPLETED|Overall Study||1
8787457|NCT01366521|9838570|FG001|NOT COMPLETED|Overall Study||1
8787458|NCT01366521|9838571|FG002|NOT COMPLETED|Overall Study||2
8787459|NCT01366521|9838572|FG003|NOT COMPLETED|Overall Study||0
8787460|NCT01366534|9838587|FG000|STARTED|Overall Study||28
8787461|NCT01366534|9838588|FG001|STARTED|Overall Study||27
8787462|NCT01366534|9838589|FG002|STARTED|Overall Study||12
8787463|NCT01366534|9838587|FG000|COMPLETED|Overall Study||26
8787464|NCT01366534|9838588|FG001|COMPLETED|Overall Study||25
8787465|NCT01366534|9838589|FG002|COMPLETED|Overall Study||12
8787466|NCT01366534|9838587|FG000|NOT COMPLETED|Overall Study||2
8787467|NCT01366534|9838588|FG001|NOT COMPLETED|Overall Study||2
8787468|NCT01366534|9838589|FG002|NOT COMPLETED|Overall Study||0
8787469|NCT01366638|9838600|FG000|STARTED|Overall Study||24
8787470|NCT01366638|9838601|FG001|STARTED|Overall Study||29
8787471|NCT01366638|9838602|FG002|STARTED|Overall Study||26
8787472|NCT01366638|9838600|FG000|COMPLETED|Overall Study||23
8787473|NCT01366638|9838601|FG001|COMPLETED|Overall Study||29
8787474|NCT01366638|9838602|FG002|COMPLETED|Overall Study||20
8787475|NCT01366638|9838600|FG000|NOT COMPLETED|Overall Study||1
8787476|NCT01366638|9838601|FG001|NOT COMPLETED|Overall Study||0
8787477|NCT01366638|9838602|FG002|NOT COMPLETED|Overall Study||6
8787478|NCT01366846|9838614|FG000|STARTED|Overall Study||235
8787479|NCT01366846|9838615|FG001|STARTED|Overall Study||228
8787480|NCT01366846|9838616|FG002|STARTED|Overall Study||47
8787481|NCT01366846|9838617|FG003|STARTED|Overall Study||46
8787482|NCT01366846|9838614|FG000|COMPLETED|Overall Study||232
8787483|NCT01366846|9838615|FG001|COMPLETED|Overall Study||224
8787484|NCT01366846|9838616|FG002|COMPLETED|Overall Study||46
8787485|NCT01366846|9838617|FG003|COMPLETED|Overall Study||45
8787486|NCT01366846|9838614|FG000|NOT COMPLETED|Overall Study||3
8787487|NCT01366846|9838615|FG001|NOT COMPLETED|Overall Study||4
8787488|NCT01366846|9838616|FG002|NOT COMPLETED|Overall Study||1
8787489|NCT01366846|9838617|FG003|NOT COMPLETED|Overall Study||1
8787490|NCT01366872|9838630|FG000|STARTED|Overall Study||50
8787491|NCT01366872|9838630|FG000|COMPLETED|Overall Study||50
8787492|NCT01366872|9838630|FG000|NOT COMPLETED|Overall Study||0
8787493|NCT01366885|9838634|FG000|STARTED|Overall Study|We started recruiting in February 2008 and recruited 20 mothers.|20
8787494|NCT01366885|9838634|FG000|COMPLETED|Overall Study|We completed our study when the last child born had reached 36 months of age.|19
8787495|NCT01366885|9838634|FG000|NOT COMPLETED|Overall Study||1
8787496|NCT01366976|9838640|FG000|STARTED|Overall Study||30
8787497|NCT01366976|9838641|FG001|STARTED|Overall Study||30
8787498|NCT01366976|9838640|FG000|COMPLETED|Overall Study||30
8787499|NCT01366976|9838641|FG001|COMPLETED|Overall Study||30
8787500|NCT01366976|9838640|FG000|NOT COMPLETED|Overall Study||0
8787501|NCT01366976|9838641|FG001|NOT COMPLETED|Overall Study||0
8787502|NCT01367080|9838649|FG000|STARTED|1st Administration||6
8787503|NCT01367080|9838650|FG001|STARTED|1st Administration||6
8787504|NCT01367080|9838649|FG000|COMPLETED|1st Administration||6
8787505|NCT01367080|9838650|FG001|COMPLETED|1st Administration||6
8787506|NCT01367080|9838649|FG000|NOT COMPLETED|1st Administration||0
8787507|NCT01367080|9838650|FG001|NOT COMPLETED|1st Administration||0
8787508|NCT01367080|9838649|FG000|STARTED|2nd Administration||6
8787509|NCT01367080|9838650|FG001|STARTED|2nd Administration||6
8787510|NCT01367080|9838649|FG000|COMPLETED|2nd Administration||6
8787511|NCT01367080|9838650|FG001|COMPLETED|2nd Administration||6
8787512|NCT01367080|9838649|FG000|NOT COMPLETED|2nd Administration||0
8787513|NCT01367080|9838650|FG001|NOT COMPLETED|2nd Administration||0
8787514|NCT01367119|9838660|FG000|STARTED|Overall Study||21
8787515|NCT01367119|9838661|FG001|STARTED|Overall Study||17
8787516|NCT01367119|9838660|FG000|COMPLETED|Overall Study||19
8787517|NCT01367119|9838661|FG001|COMPLETED|Overall Study||16
8787518|NCT01367119|9838660|FG000|NOT COMPLETED|Overall Study||2
8787519|NCT01367119|9838661|FG001|NOT COMPLETED|Overall Study||1
8787520|NCT01367158|9838678|FG000|STARTED|Overall Study||25
8787521|NCT01367158|9838679|FG001|STARTED|Overall Study||49
8787522|NCT01367158|9838680|FG002|STARTED|Overall Study||24
8787523|NCT01367158|9838681|FG003|STARTED|Overall Study||49
8787524|NCT01367158|9838682|FG004|STARTED|Overall Study||25
8787525|NCT01367158|9838683|FG005|STARTED|Overall Study||48
8787526|NCT01367158|9838684|FG006|STARTED|Overall Study||25
8787527|NCT01367158|9838685|FG007|STARTED|Overall Study||49
8787528|NCT01367158|9838686|FG008|STARTED|Overall Study||23
8787529|NCT01367158|9838687|FG009|STARTED|Overall Study||50
8787530|NCT01367158|9838688|FG010|STARTED|Overall Study||73
8787531|NCT01367158|9838678|FG000|COMPLETED|Overall Study||25
8787532|NCT01367158|9838679|FG001|COMPLETED|Overall Study||46
8787533|NCT01367158|9838680|FG002|COMPLETED|Overall Study||23
8787534|NCT01367158|9838681|FG003|COMPLETED|Overall Study||48
8787535|NCT01367158|9838682|FG004|COMPLETED|Overall Study||23
8787536|NCT01367158|9838683|FG005|COMPLETED|Overall Study||46
8787537|NCT01367158|9838684|FG006|COMPLETED|Overall Study||25
8787538|NCT01367158|9838685|FG007|COMPLETED|Overall Study||47
8787539|NCT01367158|9838686|FG008|COMPLETED|Overall Study||23
8787540|NCT01367158|9838687|FG009|COMPLETED|Overall Study||50
8787541|NCT01367158|9838688|FG010|COMPLETED|Overall Study||72
8787542|NCT01367158|9838678|FG000|NOT COMPLETED|Overall Study||0
8787543|NCT01367158|9838679|FG001|NOT COMPLETED|Overall Study||3
8787544|NCT01367158|9838680|FG002|NOT COMPLETED|Overall Study||1
8787545|NCT01367158|9838681|FG003|NOT COMPLETED|Overall Study||1
8787546|NCT01367158|9838682|FG004|NOT COMPLETED|Overall Study||2
8787547|NCT01367158|9838683|FG005|NOT COMPLETED|Overall Study||2
8787548|NCT01367158|9838684|FG006|NOT COMPLETED|Overall Study||0
8787549|NCT01367158|9838685|FG007|NOT COMPLETED|Overall Study||2
8787550|NCT01367158|9838686|FG008|NOT COMPLETED|Overall Study||0
8787551|NCT01367158|9838687|FG009|NOT COMPLETED|Overall Study||0
8787552|NCT01367158|9838688|FG010|NOT COMPLETED|Overall Study||1
8787553|NCT01367236|9838725|FG000|STARTED|Overall Study||30
8787554|NCT01367236|9838726|FG001|STARTED|Overall Study||30
8787555|NCT01367236|9838725|FG000|COMPLETED|Overall Study||27
8787556|NCT01367236|9838726|FG001|COMPLETED|Overall Study||29
8787557|NCT01367236|9838725|FG000|NOT COMPLETED|Overall Study||3
8787558|NCT01367236|9838726|FG001|NOT COMPLETED|Overall Study||1
8787559|NCT01367249|9838734|FG000|STARTED|Overall Study||222
8787560|NCT01367249|9838735|FG001|STARTED|Overall Study||218
8787561|NCT01367249|9838734|FG000|COMPLETED|Overall Study||213
8787562|NCT01367249|9838735|FG001|COMPLETED|Overall Study||202
8787563|NCT01367249|9838734|FG000|NOT COMPLETED|Overall Study||9
8787564|NCT01367249|9838735|FG001|NOT COMPLETED|Overall Study||16
8787565|NCT01367262|9838741|FG000|STARTED|Overall Study||6
8787566|NCT01367262|9838741|FG000|COMPLETED|Overall Study||6
8787567|NCT01367262|9838741|FG000|NOT COMPLETED|Overall Study||0
8916826|NCT02186652|9976374|FG000|NOT COMPLETED|Overall Study||2
8916827|NCT02186652|9976375|FG001|NOT COMPLETED|Overall Study||0
8787568|NCT01367275|9838745|FG000|STARTED|Overall Study||8
8787569|NCT01367275|9838745|FG000|COMPLETED|Overall Study||5
8787570|NCT01367275|9838745|FG000|NOT COMPLETED|Overall Study||3
8787571|NCT01367444|9838756|FG000|STARTED|Overall Study||4
8787572|NCT01367444|9838757|FG001|STARTED|Overall Study||4
8787573|NCT01367444|9838758|FG002|STARTED|Overall Study||4
8787574|NCT01367444|9838759|FG003|STARTED|Overall Study||4
9031358|NCT03242863|10093494|FG000|COMPLETED|Study Week 3||13
9031359|NCT03242863|10093495|FG001|COMPLETED|Study Week 3||15
9031360|NCT03242863|10093496|FG002|COMPLETED|Study Week 3||4
9031361|NCT03242863|10093497|FG003|COMPLETED|Study Week 3||4
9031362|NCT03242863|10093498|FG004|COMPLETED|Study Week 3||12
9031363|NCT03242863|10093499|FG005|COMPLETED|Study Week 3||5
9031364|NCT03242863|10093494|FG000|NOT COMPLETED|Study Week 3||0
9031365|NCT03242863|10093495|FG001|NOT COMPLETED|Study Week 3||0
9031366|NCT03242863|10093496|FG002|NOT COMPLETED|Study Week 3||0
9031367|NCT03242863|10093497|FG003|NOT COMPLETED|Study Week 3||0
9031368|NCT03242863|10093498|FG004|NOT COMPLETED|Study Week 3||0
9031369|NCT03242863|10093499|FG005|NOT COMPLETED|Study Week 3||0
9031370|NCT03242928|10093509|FG000|STARTED|Overall Study||31
9031371|NCT03242928|10093510|FG001|STARTED|Overall Study||37
9031372|NCT03242928|10093509|FG000|COMPLETED|Overall Study||22
9031373|NCT03242928|10093510|FG001|COMPLETED|Overall Study||32
9031374|NCT03242928|10093509|FG000|NOT COMPLETED|Overall Study||9
9031375|NCT03242928|10093510|FG001|NOT COMPLETED|Overall Study||5
9031376|NCT03242941|10093516|FG000|STARTED|Overall Study||16
9031377|NCT03242941|10093516|FG000|COMPLETED|Overall Study||14
9031378|NCT03242941|10093516|FG000|NOT COMPLETED|Overall Study||2
9031379|NCT03242954|10093525|FG000|STARTED|Overall Study||43
9031380|NCT03242954|10093526|FG001|STARTED|Overall Study||45
9031381|NCT03242954|10093527|FG002|STARTED|Overall Study||41
9031382|NCT03242954|10093528|FG003|STARTED|Overall Study||125
9031383|NCT03242954|10093525|FG000|COMPLETED|Overall Study||43
9031384|NCT03242954|10093526|FG001|COMPLETED|Overall Study||45
9031385|NCT03242954|10093527|FG002|COMPLETED|Overall Study||41
9031386|NCT03242954|10093528|FG003|COMPLETED|Overall Study||125
9031387|NCT03242954|10093525|FG000|NOT COMPLETED|Overall Study||0
9031388|NCT03242954|10093526|FG001|NOT COMPLETED|Overall Study||0
9031389|NCT03242954|10093527|FG002|NOT COMPLETED|Overall Study||0
9031390|NCT03242954|10093528|FG003|NOT COMPLETED|Overall Study||0
9031391|NCT03243084|10093540|FG000|STARTED|Session 1||11
9031392|NCT03243084|10093541|FG001|STARTED|Session 1||10
9031393|NCT03243084|10093540|FG000|COMPLETED|Session 1||11
9031394|NCT03243084|10093541|FG001|COMPLETED|Session 1||10
9031395|NCT03243084|10093540|FG000|NOT COMPLETED|Session 1||0
9031396|NCT03243084|10093541|FG001|NOT COMPLETED|Session 1||0
9031397|NCT03243084|10093540|FG000|STARTED|Washout (1-3 Weeks)||11
9031398|NCT03243084|10093541|FG001|STARTED|Washout (1-3 Weeks)||10
9031399|NCT03243084|10093540|FG000|COMPLETED|Washout (1-3 Weeks)||10
9031400|NCT03243084|10093541|FG001|COMPLETED|Washout (1-3 Weeks)||10
9031401|NCT03243084|10093540|FG000|NOT COMPLETED|Washout (1-3 Weeks)||1
9031402|NCT03243084|10093541|FG001|NOT COMPLETED|Washout (1-3 Weeks)||0
9031403|NCT03243084|10093540|FG000|STARTED|Session 2||10
9031404|NCT03243084|10093541|FG001|STARTED|Session 2||10
9031405|NCT03243084|10093540|FG000|COMPLETED|Session 2||10
9031406|NCT03243084|10093541|FG001|COMPLETED|Session 2||10
9031407|NCT03243084|10093540|FG000|NOT COMPLETED|Session 2||0
9031408|NCT03243084|10093541|FG001|NOT COMPLETED|Session 2||0
9031409|NCT03243305|10093548|FG000|STARTED|Overall Study||1384
9031410|NCT03243305|10093548|FG000|COMPLETED|Overall Study||449
9031411|NCT03243305|10093548|FG000|NOT COMPLETED|Overall Study||935
9031412|NCT03243630|10093552|FG000|STARTED|Overall Study||24
9031413|NCT03243630|10093552|FG000|Menthol E-liquid Saline|Overall Study||22
9031414|NCT03243630|10093552|FG000|Menthol E-liquid Higher|Overall Study||22
9031415|NCT03243630|10093552|FG000|Menthol E-liquid Lower|Overall Study||22
9031416|NCT03243630|10093552|FG000|Green Apple E-liquid Saline|Overall Study||20
9031417|NCT03243630|10093552|FG000|Green Apple E-liquid Higher|Overall Study||20
9031418|NCT03243630|10093552|FG000|Green Apple E-liquid Lower|Overall Study||20
9031419|NCT03243630|10093552|FG000|Green Apple and Menthol E-liquid Saline|Overall Study||21
9031420|NCT03243630|10093552|FG000|Green Apple and Menthol E-liquid Higher|Overall Study||21
9031421|NCT03243630|10093552|FG000|Green Apple and Menthol E-liquid Lower|Overall Study||21
9031422|NCT03243630|10093552|FG000|COMPLETED|Overall Study||22
9031423|NCT03243630|10093552|FG000|NOT COMPLETED|Overall Study||2
9031424|NCT03243981|10093560|FG000|STARTED|Overall Study||5
9031425|NCT03243981|10093560|FG000|COMPLETED|Overall Study||5
9031426|NCT03243981|10093560|FG000|NOT COMPLETED|Overall Study||0
9031427|NCT03244618|10093571|FG000|STARTED|Overall Study||132
9031428|NCT03244618|10093572|FG001|STARTED|Overall Study||131
9031429|NCT03244618|10093571|FG000|Week 2|Overall Study||128
9031430|NCT03244618|10093572|FG001|Week 2|Overall Study||125
9031431|NCT03244618|10093571|FG000|COMPLETED|Overall Study||125
9031432|NCT03244618|10093572|FG001|COMPLETED|Overall Study||122
9031433|NCT03244618|10093571|FG000|NOT COMPLETED|Overall Study||7
9031434|NCT03244618|10093572|FG001|NOT COMPLETED|Overall Study||9
9031435|NCT03244800|10093582|FG000|STARTED|Overall Study||13
9031436|NCT03244800|10093583|FG001|STARTED|Overall Study||26
9031437|NCT03244800|10093584|FG002|STARTED|Overall Study||6
8787575|NCT01367444|9838760|FG004|STARTED|Overall Study||6
8787576|NCT01367444|9838761|FG005|STARTED|Overall Study||4
8787577|NCT01367444|9838762|FG006|STARTED|Overall Study||1
9031438|NCT03244800|10093585|FG003|STARTED|Overall Study||20
9031439|NCT03244800|10093582|FG000|COMPLETED|Overall Study||13
8787578|NCT01367444|9838756|FG000|COMPLETED|Overall Study||4
8787579|NCT01367444|9838757|FG001|COMPLETED|Overall Study||4
8787580|NCT01367444|9838758|FG002|COMPLETED|Overall Study||4
8787581|NCT01367444|9838759|FG003|COMPLETED|Overall Study||4
8787582|NCT01367444|9838760|FG004|COMPLETED|Overall Study||6
8787583|NCT01367444|9838761|FG005|COMPLETED|Overall Study||4
8787584|NCT01367444|9838762|FG006|COMPLETED|Overall Study||1
8787585|NCT01367444|9838756|FG000|NOT COMPLETED|Overall Study||0
8787586|NCT01367444|9838757|FG001|NOT COMPLETED|Overall Study||0
8787587|NCT01367444|9838758|FG002|NOT COMPLETED|Overall Study||0
8787588|NCT01367444|9838759|FG003|NOT COMPLETED|Overall Study||0
8787589|NCT01367444|9838760|FG004|NOT COMPLETED|Overall Study||0
8787590|NCT01367444|9838761|FG005|NOT COMPLETED|Overall Study||0
8787591|NCT01367444|9838762|FG006|NOT COMPLETED|Overall Study||0
8787592|NCT01367457|9838781|FG000|STARTED|Overall Study||193
8787593|NCT01367457|9838782|FG001|STARTED|Overall Study||23
8787594|NCT01367457|9838783|FG002|STARTED|Overall Study||26
8787595|NCT01367457|9838781|FG000|COMPLETED|Overall Study||5
8787596|NCT01367457|9838782|FG001|COMPLETED|Overall Study||23
8787597|NCT01367457|9838783|FG002|COMPLETED|Overall Study||26
8787598|NCT01367457|9838781|FG000|NOT COMPLETED|Overall Study||188
8787599|NCT01367457|9838782|FG001|NOT COMPLETED|Overall Study||0
8787600|NCT01367457|9838783|FG002|NOT COMPLETED|Overall Study||0
8787601|NCT01367665|9838793|FG000|STARTED|Overall Study||1119
8787602|NCT01367665|9838794|FG001|STARTED|Overall Study||96
8787603|NCT01367665|9838793|FG000|COMPLETED|Overall Study||677
8787604|NCT01367665|9838794|FG001|COMPLETED|Overall Study||41
8787605|NCT01367665|9838793|FG000|NOT COMPLETED|Overall Study||442
8787606|NCT01367665|9838794|FG001|NOT COMPLETED|Overall Study||55
8787607|NCT01367704|9838803|FG000|STARTED|Overall Study||998
8787608|NCT01367704|9838804|FG001|STARTED|Overall Study||1008
8787609|NCT01367704|9838803|FG000|COMPLETED|Overall Study||951
8787610|NCT01367704|9838804|FG001|COMPLETED|Overall Study||847
8787611|NCT01367704|9838803|FG000|NOT COMPLETED|Overall Study||47
8787612|NCT01367704|9838804|FG001|NOT COMPLETED|Overall Study||161
8787613|NCT01367834|9838812|FG000|STARTED|Overall Study||11
8787614|NCT01367834|9838813|FG001|STARTED|Overall Study||6
8787615|NCT01367834|9838812|FG000|COMPLETED|Overall Study||9
8787616|NCT01367834|9838813|FG001|COMPLETED|Overall Study||3
8787617|NCT01367834|9838812|FG000|NOT COMPLETED|Overall Study||2
8787618|NCT01367834|9838813|FG001|NOT COMPLETED|Overall Study||3
8787619|NCT01367847|9838821|FG000|STARTED|Overall Study||10
8787620|NCT01367847|9838822|FG001|STARTED|Overall Study||9
8787621|NCT01367847|9838821|FG000|COMPLETED|Overall Study||8
8787622|NCT01367847|9838822|FG001|COMPLETED|Overall Study||7
8787623|NCT01367847|9838821|FG000|NOT COMPLETED|Overall Study||2
8787624|NCT01367847|9838822|FG001|NOT COMPLETED|Overall Study||2
8787625|NCT01367860|9838831|FG000|STARTED|Overall Study||20
8787626|NCT01367860|9838832|FG001|STARTED|Overall Study||20
8787627|NCT01367860|9838831|FG000|COMPLETED|Overall Study||20
8787628|NCT01367860|9838832|FG001|COMPLETED|Overall Study||20
8787629|NCT01367860|9838831|FG000|NOT COMPLETED|Overall Study||0
8787630|NCT01367860|9838832|FG001|NOT COMPLETED|Overall Study||0
8787631|NCT01367886|9838838|FG000|STARTED|Overall Study||21
8787632|NCT01367886|9838838|FG000|COMPLETED|Overall Study||14
8787633|NCT01367886|9838838|FG000|NOT COMPLETED|Overall Study||7
8787634|NCT01368042|9838843|FG000|STARTED|Overall Study||265
8787635|NCT01368042|9838843|FG000|COMPLETED|Overall Study||235
8787636|NCT01368042|9838843|FG000|NOT COMPLETED|Overall Study||30
8787637|NCT01368081|9838860|FG000|STARTED|Overall Study||136
8787638|NCT01368081|9838861|FG001|STARTED|Overall Study||137
8787639|NCT01368081|9838862|FG002|STARTED|Overall Study||63
8787640|NCT01368081|9838863|FG003|STARTED|Overall Study||68
8787641|NCT01368081|9838864|FG004|STARTED|Overall Study||65
8787642|NCT01368081|9838865|FG005|STARTED|Overall Study||137
8787643|NCT01368081|9838866|FG006|STARTED|Overall Study||136
8787644|NCT01368081|9838867|FG007|STARTED|Overall Study||69
8787645|NCT01368081|9838868|FG008|STARTED|Overall Study||70
8787646|NCT01368081|9838869|FG009|STARTED|Overall Study||68
8787647|NCT01368081|9838870|FG010|STARTED|Overall Study||71
8787648|NCT01368081|9838871|FG011|STARTED|Overall Study||70
8787649|NCT01368081|9838872|FG012|STARTED|Overall Study||70
8787650|NCT01368081|9838860|FG000|COMPLETED|Overall Study||126
8787651|NCT01368081|9838861|FG001|COMPLETED|Overall Study||128
8787652|NCT01368081|9838862|FG002|COMPLETED|Overall Study||59
8787653|NCT01368081|9838863|FG003|COMPLETED|Overall Study||63
8787654|NCT01368081|9838864|FG004|COMPLETED|Overall Study||63
8787655|NCT01368081|9838865|FG005|COMPLETED|Overall Study||127
8787656|NCT01368081|9838866|FG006|COMPLETED|Overall Study||124
8787657|NCT01368081|9838867|FG007|COMPLETED|Overall Study||62
8787658|NCT01368081|9838868|FG008|COMPLETED|Overall Study||62
8787659|NCT01368081|9838869|FG009|COMPLETED|Overall Study||58
8787660|NCT01368081|9838870|FG010|COMPLETED|Overall Study||62
8787661|NCT01368081|9838871|FG011|COMPLETED|Overall Study||67
8787662|NCT01368081|9838872|FG012|COMPLETED|Overall Study||63
8787663|NCT01368081|9838860|FG000|NOT COMPLETED|Overall Study||10
8787664|NCT01368081|9838861|FG001|NOT COMPLETED|Overall Study||9
8787665|NCT01368081|9838862|FG002|NOT COMPLETED|Overall Study||4
8787666|NCT01368081|9838863|FG003|NOT COMPLETED|Overall Study||5
8787667|NCT01368081|9838864|FG004|NOT COMPLETED|Overall Study||2
8787668|NCT01368081|9838865|FG005|NOT COMPLETED|Overall Study||10
8787669|NCT01368081|9838866|FG006|NOT COMPLETED|Overall Study||12
8787670|NCT01368081|9838867|FG007|NOT COMPLETED|Overall Study||7
8787671|NCT01368081|9838868|FG008|NOT COMPLETED|Overall Study||8
8787672|NCT01368081|9838869|FG009|NOT COMPLETED|Overall Study||10
8787673|NCT01368081|9838870|FG010|NOT COMPLETED|Overall Study||9
8787674|NCT01368081|9838871|FG011|NOT COMPLETED|Overall Study||3
8787675|NCT01368081|9838872|FG012|NOT COMPLETED|Overall Study||7
8787676|NCT01368211|9838902|FG000|STARTED|First Platelets Transfusion||8
8787677|NCT01368211|9838903|FG001|STARTED|First Platelets Transfusion||7
8787678|NCT01368211|9838902|FG000|COMPLETED|First Platelets Transfusion||8
8787679|NCT01368211|9838903|FG001|COMPLETED|First Platelets Transfusion||7
8787680|NCT01368211|9838902|FG000|NOT COMPLETED|First Platelets Transfusion||0
8787681|NCT01368211|9838903|FG001|NOT COMPLETED|First Platelets Transfusion||0
8787682|NCT01368211|9838902|FG000|STARTED|Second Platelets Transfusion||8
8787683|NCT01368211|9838903|FG001|STARTED|Second Platelets Transfusion||7
8787684|NCT01368211|9838902|FG000|COMPLETED|Second Platelets Transfusion||7
8787685|NCT01368211|9838903|FG001|COMPLETED|Second Platelets Transfusion||5
8787686|NCT01368211|9838902|FG000|NOT COMPLETED|Second Platelets Transfusion||1
8787687|NCT01368211|9838903|FG001|NOT COMPLETED|Second Platelets Transfusion||2
8787688|NCT01368263|9838912|FG000|STARTED|Overall Study||6
8787689|NCT01368263|9838913|FG001|STARTED|Overall Study||1
8787690|NCT01368263|9838914|FG002|STARTED|Overall Study||1
8787691|NCT01368263|9838912|FG000|COMPLETED|Overall Study||6
8787692|NCT01368263|9838913|FG001|COMPLETED|Overall Study||1
8787693|NCT01368263|9838914|FG002|COMPLETED|Overall Study||1
8787694|NCT01368263|9838912|FG000|NOT COMPLETED|Overall Study||0
8787695|NCT01368263|9838913|FG001|NOT COMPLETED|Overall Study||0
8787696|NCT01368263|9838914|FG002|NOT COMPLETED|Overall Study||0
8787697|NCT01368276|9838924|FG000|STARTED|Overall Study||3
8787698|NCT01368276|9838925|FG001|STARTED|Overall Study||28
8787699|NCT01368276|9838924|FG000|COMPLETED|Overall Study||2
8787700|NCT01368276|9838925|FG001|COMPLETED|Overall Study||18
8787701|NCT01368276|9838924|FG000|NOT COMPLETED|Overall Study||1
8787702|NCT01368276|9838925|FG001|NOT COMPLETED|Overall Study||10
8787703|NCT01368406|9838933|FG000|STARTED|Overall Study||81
8787704|NCT01368406|9838934|FG001|STARTED|Overall Study||79
8787705|NCT01368406|9838933|FG000|COMPLETED|Overall Study||60
8787706|NCT01368406|9838934|FG001|COMPLETED|Overall Study||66
8787707|NCT01368406|9838933|FG000|NOT COMPLETED|Overall Study||21
8787708|NCT01368406|9838934|FG001|NOT COMPLETED|Overall Study||13
8787709|NCT01368432|9838942|FG000|STARTED|Overall Study||6
8787710|NCT01368432|9838943|FG001|STARTED|Overall Study||8
8787711|NCT01368432|9838942|FG000|COMPLETED|Overall Study||6
8787712|NCT01368432|9838943|FG001|COMPLETED|Overall Study||7
8787713|NCT01368432|9838942|FG000|NOT COMPLETED|Overall Study||0
8787714|NCT01368432|9838943|FG001|NOT COMPLETED|Overall Study||1
8787715|NCT01368536|9838966|FG000|STARTED|Overall Study||138
8787716|NCT01368536|9838967|FG001|STARTED|Overall Study||137
8787717|NCT01368536|9838968|FG002|STARTED|Overall Study||142
8787718|NCT01368536|9838966|FG000|Full Analysis Set|Overall Study||138
8787719|NCT01368536|9838967|FG001|Full Analysis Set|Overall Study||137
8787720|NCT01368536|9838968|FG002|Full Analysis Set|Overall Study|One patient was excluded from efficacy analysis as there was no post baseline data|141
8787721|NCT01368536|9838966|FG000|COMPLETED|Overall Study||87
8787722|NCT01368536|9838967|FG001|COMPLETED|Overall Study||78
8787723|NCT01368536|9838968|FG002|COMPLETED|Overall Study||83
8787724|NCT01368536|9838966|FG000|NOT COMPLETED|Overall Study||51
8787725|NCT01368536|9838967|FG001|NOT COMPLETED|Overall Study||59
8787726|NCT01368536|9838968|FG002|NOT COMPLETED|Overall Study||59
8787727|NCT01368562|9838977|FG000|STARTED|Overall Study||26
8787728|NCT01368562|9838977|FG000|Received at Least 1 Dose of Study Drug|Overall Study||25
8787729|NCT01368562|9838977|FG000|COMPLETED|Overall Study||7
8787730|NCT01368562|9838977|FG000|NOT COMPLETED|Overall Study||19
8787731|NCT01368614|9838981|FG000|STARTED|Screening Period||90
8787732|NCT01368614|9838982|FG001|STARTED|Screening Period||0
8787733|NCT01368614|9838983|FG002|STARTED|Screening Period||0
8787734|NCT01368614|9838984|FG003|STARTED|Screening Period||0
9031440|NCT03244800|10093583|FG001|COMPLETED|Overall Study||25
9031441|NCT03244800|10093584|FG002|COMPLETED|Overall Study||6
9031442|NCT03244800|10093585|FG003|COMPLETED|Overall Study||18
9031443|NCT03244800|10093582|FG000|NOT COMPLETED|Overall Study||0
9031444|NCT03244800|10093583|FG001|NOT COMPLETED|Overall Study||1
9031445|NCT03244800|10093584|FG002|NOT COMPLETED|Overall Study||0
9031446|NCT03244800|10093585|FG003|NOT COMPLETED|Overall Study||2
9031447|NCT03244865|10093598|FG000|STARTED|Overall Study||35
9031448|NCT03244865|10093598|FG000|COMPLETED|Overall Study||35
9031449|NCT03244865|10093598|FG000|NOT COMPLETED|Overall Study||0
9031450|NCT03244917|10093604|FG000|STARTED|Overall Study||201
9031451|NCT03244917|10093605|FG001|STARTED|Overall Study||229
9031452|NCT03244917|10093604|FG000|COMPLETED|Overall Study||199
9031453|NCT03244917|10093605|FG001|COMPLETED|Overall Study||227
9031454|NCT03244917|10093604|FG000|NOT COMPLETED|Overall Study||2
9031455|NCT03244917|10093605|FG001|NOT COMPLETED|Overall Study||2
9031456|NCT03245372|10093613|FG000|STARTED|Overall Study||15
9031457|NCT03245372|10093614|FG001|STARTED|Overall Study||15
8787735|NCT01368614|9838981|FG000|COMPLETED|Screening Period||32
8787736|NCT01368614|9838982|FG001|COMPLETED|Screening Period||0
8787737|NCT01368614|9838983|FG002|COMPLETED|Screening Period||0
8787738|NCT01368614|9838984|FG003|COMPLETED|Screening Period||0
8787739|NCT01368614|9838981|FG000|NOT COMPLETED|Screening Period||58
8787740|NCT01368614|9838982|FG001|NOT COMPLETED|Screening Period||0
9031458|NCT03245372|10093613|FG000|COMPLETED|Overall Study||15
9031459|NCT03245372|10093614|FG001|COMPLETED|Overall Study||15
8787741|NCT01368614|9838983|FG002|NOT COMPLETED|Screening Period||0
8787742|NCT01368614|9838984|FG003|NOT COMPLETED|Screening Period||0
8787743|NCT01368614|9838981|FG000|STARTED|Study Period||0
8787744|NCT01368614|9838982|FG001|STARTED|Study Period||11
8787745|NCT01368614|9838983|FG002|STARTED|Study Period||10
8787746|NCT01368614|9838984|FG003|STARTED|Study Period||11
8787747|NCT01368614|9838981|FG000|COMPLETED|Study Period||0
8787748|NCT01368614|9838982|FG001|COMPLETED|Study Period||10
8787749|NCT01368614|9838983|FG002|COMPLETED|Study Period||8
8787750|NCT01368614|9838984|FG003|COMPLETED|Study Period||8
8787751|NCT01368614|9838981|FG000|NOT COMPLETED|Study Period||0
8787752|NCT01368614|9838982|FG001|NOT COMPLETED|Study Period||1
8787753|NCT01368614|9838983|FG002|NOT COMPLETED|Study Period||2
8787754|NCT01368614|9838984|FG003|NOT COMPLETED|Study Period||3
8787755|NCT01368653|9838994|FG000|STARTED|Overall Study||47
8787756|NCT01368653|9838995|FG001|STARTED|Overall Study||46
8787757|NCT01368653|9838994|FG000|Completed 4-week Follow-up|Overall Study||44
8787758|NCT01368653|9838995|FG001|Completed 4-week Follow-up|Overall Study||37
8787759|NCT01368653|9838994|FG000|Smoked in Past 7 Days at 4-weeks|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|29
8787760|NCT01368653|9838995|FG001|Smoked in Past 7 Days at 4-weeks|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|20
8787761|NCT01368653|9838994|FG000|Randomized to Phase 2|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|21
8787762|NCT01368653|9838995|FG001|Randomized to Phase 2|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|19
8787763|NCT01368653|9838994|FG000|Randomized to VLNC in Phase 2|Overall Study|VLNC=6-week supply of Very Low Nicotine Cigarettes plus Advice to Quit (vs. Advice Only)|11
8787764|NCT01368653|9838995|FG001|Randomized to VLNC in Phase 2|Overall Study|VLNC=6-week supply of Very Low Nicotine Cigarettes plus Advice to Quit (vs. Advice Only)|9
8787765|NCT01368653|9838994|FG000|Randomized to Advice Only in Phase 2|Overall Study||10
8787766|NCT01368653|9838995|FG001|Randomized to Advice Only in Phase 2|Overall Study||10
8787767|NCT01368653|9838994|FG000|COMPLETED|Overall Study||41
8787768|NCT01368653|9838995|FG001|COMPLETED|Overall Study||37
8787769|NCT01368653|9838994|FG000|NOT COMPLETED|Overall Study||6
8787770|NCT01368653|9838995|FG001|NOT COMPLETED|Overall Study||9
8787771|NCT01368809|9839010|FG000|STARTED|Overall Study||50
8787772|NCT01368809|9839011|FG001|STARTED|Overall Study||50
8787773|NCT01368809|9839010|FG000|COMPLETED|Overall Study||50
8787774|NCT01368809|9839011|FG001|COMPLETED|Overall Study||50
8787775|NCT01368809|9839010|FG000|NOT COMPLETED|Overall Study||0
8787776|NCT01368809|9839011|FG001|NOT COMPLETED|Overall Study||0
8787777|NCT01368835|9839019|FG000|STARTED|Overall Study|103 Subjects Enrolled|103
8787778|NCT01368835|9839019|FG000|COMPLETED|Overall Study||70
8787779|NCT01368835|9839019|FG000|NOT COMPLETED|Overall Study||33
8787780|NCT01368874|9839027|FG000|STARTED|Overall Study||34
8787781|NCT01368874|9839028|FG001|STARTED|Overall Study||5
8787782|NCT01368874|9839029|FG002|STARTED|Overall Study||25
8787783|NCT01368874|9839027|FG000|COMPLETED|Overall Study||31
8787784|NCT01368874|9839028|FG001|COMPLETED|Overall Study||5
8787785|NCT01368874|9839029|FG002|COMPLETED|Overall Study||24
8787786|NCT01368874|9839027|FG000|NOT COMPLETED|Overall Study||3
8787787|NCT01368874|9839028|FG001|NOT COMPLETED|Overall Study||0
8787788|NCT01368874|9839029|FG002|NOT COMPLETED|Overall Study||1
8787789|NCT01368900|9839071|FG000|STARTED|Overall Study||68
8787790|NCT01368900|9839071|FG000|COMPLETED|Overall Study||61
8787791|NCT01368900|9839071|FG000|NOT COMPLETED|Overall Study||7
8787792|NCT01368965|9839077|FG000|STARTED|Overall Study|Two subjects withdrew consent prior to study treatment. Data analyses are based on 52 subjects.|52
8787793|NCT01368965|9839077|FG000|Subject Withdrawal Prior to Treatment|Overall Study||2
8787794|NCT01368965|9839077|FG000|COMPLETED|Overall Study||40
8787795|NCT01368965|9839077|FG000|NOT COMPLETED|Overall Study||12
8787796|NCT01369030|9839083|FG000|STARTED|Overall Study||594
8787797|NCT01369030|9839083|FG000|COMPLETED|Overall Study||554
8787798|NCT01369030|9839083|FG000|NOT COMPLETED|Overall Study||40
8787799|NCT01369069|9839089|FG000|STARTED|Overall Study||581
8787800|NCT01369069|9839090|FG001|STARTED|Overall Study||570
8787801|NCT01369069|9839089|FG000|COMPLETED|Overall Study||564
8787802|NCT01369069|9839090|FG001|COMPLETED|Overall Study||554
8787803|NCT01369069|9839089|FG000|NOT COMPLETED|Overall Study||17
8787804|NCT01369069|9839090|FG001|NOT COMPLETED|Overall Study||16
8787805|NCT01369108|9839096|FG000|STARTED|Overall Study|120 teeth|60
8787806|NCT01369108|9839096|FG000|COMPLETED|Overall Study||49
8787807|NCT01369108|9839096|FG000|NOT COMPLETED|Overall Study||11
8787808|NCT01369225|9839107|FG000|STARTED|Overall Study||6
8787809|NCT01369225|9839108|FG001|STARTED|Overall Study||3
8787810|NCT01369225|9839109|FG002|STARTED|Overall Study||12
8787811|NCT01369225|9839110|FG003|STARTED|Overall Study||10
8787812|NCT01369225|9839111|FG004|STARTED|Overall Study||12
8787813|NCT01369225|9839112|FG005|STARTED|Overall Study||9
8787814|NCT01369225|9839107|FG000|COMPLETED|Overall Study||4
8787815|NCT01369225|9839108|FG001|COMPLETED|Overall Study||3
8787816|NCT01369225|9839109|FG002|COMPLETED|Overall Study||9
8787817|NCT01369225|9839110|FG003|COMPLETED|Overall Study||8
8787818|NCT01369225|9839111|FG004|COMPLETED|Overall Study||10
8787819|NCT01369225|9839112|FG005|COMPLETED|Overall Study||9
8787820|NCT01369225|9839107|FG000|NOT COMPLETED|Overall Study||2
8787821|NCT01369225|9839108|FG001|NOT COMPLETED|Overall Study||0
8787822|NCT01369225|9839109|FG002|NOT COMPLETED|Overall Study||3
8787823|NCT01369225|9839110|FG003|NOT COMPLETED|Overall Study||2
8787824|NCT01369225|9839111|FG004|NOT COMPLETED|Overall Study||2
8787825|NCT01369225|9839112|FG005|NOT COMPLETED|Overall Study||0
8787826|NCT01369329|9839129|FG000|STARTED|Overall Study||256
8787827|NCT01369329|9839130|FG001|STARTED|Overall Study||254
8787828|NCT01369329|9839131|FG002|STARTED|Overall Study||259
8787829|NCT01369329|9839129|FG000|COMPLETED|Overall Study||244
8787830|NCT01369329|9839130|FG001|COMPLETED|Overall Study||243
8787831|NCT01369329|9839131|FG002|COMPLETED|Overall Study||245
8787832|NCT01369329|9839129|FG000|NOT COMPLETED|Overall Study||12
8787833|NCT01369329|9839130|FG001|NOT COMPLETED|Overall Study||11
8787834|NCT01369329|9839131|FG002|NOT COMPLETED|Overall Study||14
8787835|NCT01369342|9839142|FG000|STARTED|Overall Study||214
8787836|NCT01369342|9839143|FG001|STARTED|Overall Study||213
8787837|NCT01369342|9839144|FG002|STARTED|Overall Study||213
8787838|NCT01369342|9839142|FG000|COMPLETED|Overall Study||201
8787839|NCT01369342|9839143|FG001|COMPLETED|Overall Study||204
8787840|NCT01369342|9839144|FG002|COMPLETED|Overall Study||210
8787841|NCT01369342|9839142|FG000|NOT COMPLETED|Overall Study||13
8787842|NCT01369342|9839143|FG001|NOT COMPLETED|Overall Study||9
8787843|NCT01369342|9839144|FG002|NOT COMPLETED|Overall Study||3
8787844|NCT01369355|9839158|FG000|STARTED|Week 0 - Week 44 (Maintenance)||133
8787845|NCT01369355|9839159|FG001|STARTED|Week 0 - Week 44 (Maintenance)||132
8787846|NCT01369355|9839160|FG002|STARTED|Week 0 - Week 44 (Maintenance)||132
8787847|NCT01369355|9839161|FG003|STARTED|Week 0 - Week 44 (Maintenance)||123
8787848|NCT01369355|9839162|FG004|STARTED|Week 0 - Week 44 (Maintenance)||285
8787849|NCT01369355|9839163|FG005|STARTED|Week 0 - Week 44 (Maintenance)||476
8787850|NCT01369355|9839164|FG006|STARTED|Week 0 - Week 44 (Maintenance)||0
8787851|NCT01369355|9839165|FG007|STARTED|Week 0 - Week 44 (Maintenance)||0
8787852|NCT01369355|9839166|FG008|STARTED|Week 0 - Week 44 (Maintenance)||0
8787853|NCT01369355|9839158|FG000|COMPLETED|Week 0 - Week 44 (Maintenance)||102
8787854|NCT01369355|9839159|FG001|COMPLETED|Week 0 - Week 44 (Maintenance)||103
8787855|NCT01369355|9839160|FG002|COMPLETED|Week 0 - Week 44 (Maintenance)||101
8787856|NCT01369355|9839161|FG003|COMPLETED|Week 0 - Week 44 (Maintenance)||93
8787857|NCT01369355|9839162|FG004|COMPLETED|Week 0 - Week 44 (Maintenance)||131
8787858|NCT01369355|9839163|FG005|COMPLETED|Week 0 - Week 44 (Maintenance)||204
8787859|NCT01369355|9839164|FG006|COMPLETED|Week 0 - Week 44 (Maintenance)||0
8787860|NCT01369355|9839165|FG007|COMPLETED|Week 0 - Week 44 (Maintenance)||0
8787861|NCT01369355|9839166|FG008|COMPLETED|Week 0 - Week 44 (Maintenance)||0
8787862|NCT01369355|9839158|FG000|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||31
8787863|NCT01369355|9839159|FG001|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||29
8787864|NCT01369355|9839160|FG002|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||31
8787865|NCT01369355|9839161|FG003|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||30
8787866|NCT01369355|9839162|FG004|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||154
8787867|NCT01369355|9839163|FG005|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||272
8787868|NCT01369355|9839164|FG006|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||0
8787869|NCT01369355|9839165|FG007|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||0
8787870|NCT01369355|9839166|FG008|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||0
8787871|NCT01369355|9839158|FG000|STARTED|Long-term Extension (Week 44-272)||0
8787872|NCT01369355|9839159|FG001|STARTED|Long-term Extension (Week 44-272)||0
8787873|NCT01369355|9839160|FG002|STARTED|Long-term Extension (Week 44-272)||0
8787874|NCT01369355|9839161|FG003|STARTED|Long-term Extension (Week 44-272)||0
8787875|NCT01369355|9839162|FG004|STARTED|Long-term Extension (Week 44-272)||0
8787876|NCT01369355|9839163|FG005|STARTED|Long-term Extension (Week 44-272)||0
8787877|NCT01369355|9839164|FG006|STARTED|Long-term Extension (Week 44-272)||151
8787878|NCT01369355|9839165|FG007|STARTED|Long-term Extension (Week 44-272)||213
8787879|NCT01369355|9839166|FG008|STARTED|Long-term Extension (Week 44-272)||354
8787880|NCT01369355|9839158|FG000|COMPLETED|Long-term Extension (Week 44-272)||0
8787881|NCT01369355|9839159|FG001|COMPLETED|Long-term Extension (Week 44-272)||0
8787882|NCT01369355|9839160|FG002|COMPLETED|Long-term Extension (Week 44-272)||0
8787883|NCT01369355|9839161|FG003|COMPLETED|Long-term Extension (Week 44-272)||0
8787884|NCT01369355|9839162|FG004|COMPLETED|Long-term Extension (Week 44-272)||0
8787885|NCT01369355|9839163|FG005|COMPLETED|Long-term Extension (Week 44-272)||0
8787886|NCT01369355|9839164|FG006|COMPLETED|Long-term Extension (Week 44-272)||0
8787887|NCT01369355|9839165|FG007|COMPLETED|Long-term Extension (Week 44-272)||107
8787888|NCT01369355|9839166|FG008|COMPLETED|Long-term Extension (Week 44-272)||183
8787889|NCT01369355|9839158|FG000|NOT COMPLETED|Long-term Extension (Week 44-272)||0
8787890|NCT01369355|9839159|FG001|NOT COMPLETED|Long-term Extension (Week 44-272)||0
8787891|NCT01369355|9839160|FG002|NOT COMPLETED|Long-term Extension (Week 44-272)||0
8787892|NCT01369355|9839161|FG003|NOT COMPLETED|Long-term Extension (Week 44-272)||0
8787893|NCT01369355|9839162|FG004|NOT COMPLETED|Long-term Extension (Week 44-272)||0
8787894|NCT01369355|9839163|FG005|NOT COMPLETED|Long-term Extension (Week 44-272)||0
8787895|NCT01369355|9839164|FG006|NOT COMPLETED|Long-term Extension (Week 44-272)||151
8787896|NCT01369355|9839165|FG007|NOT COMPLETED|Long-term Extension (Week 44-272)||106
8787897|NCT01369355|9839166|FG008|NOT COMPLETED|Long-term Extension (Week 44-272)||171
8787898|NCT01369433|9839185|FG000|STARTED|Overall Study||209
8787899|NCT01369433|9839186|FG001|STARTED|Overall Study||16
8787900|NCT01369433|9839185|FG000|COMPLETED|Overall Study||0
8787901|NCT01369433|9839186|FG001|COMPLETED|Overall Study||0
8787902|NCT01369433|9839185|FG000|NOT COMPLETED|Overall Study||209
8787903|NCT01369433|9839186|FG001|NOT COMPLETED|Overall Study||16
8787904|NCT01369485|9839194|FG000|STARTED|Randomized Phase (Day 0 to Week 12)||80
8787905|NCT01369485|9839195|FG001|STARTED|Randomized Phase (Day 0 to Week 12)||83
8787906|NCT01369485|9839194|FG000|COMPLETED|Randomized Phase (Day 0 to Week 12)||57
8787907|NCT01369485|9839195|FG001|COMPLETED|Randomized Phase (Day 0 to Week 12)||66
8787908|NCT01369485|9839194|FG000|NOT COMPLETED|Randomized Phase (Day 0 to Week 12)||23
8575175|NCT00133575|9607668|FG001|COMPLETED|Overall Study||10
8787909|NCT01369485|9839195|FG001|NOT COMPLETED|Randomized Phase (Day 0 to Week 12)||17
8787910|NCT01369485|9839194|FG000|STARTED|Open Label Phase (Week 12 to Month 12)||57
8787911|NCT01369485|9839195|FG001|STARTED|Open Label Phase (Week 12 to Month 12)||66
8787912|NCT01369485|9839194|FG000|COMPLETED|Open Label Phase (Week 12 to Month 12)||24
8787913|NCT01369485|9839195|FG001|COMPLETED|Open Label Phase (Week 12 to Month 12)||26
8787914|NCT01369485|9839194|FG000|NOT COMPLETED|Open Label Phase (Week 12 to Month 12)||33
8916828|NCT02186665|9976390|FG000|STARTED|Overall Study||8
8916829|NCT02186665|9976391|FG001|STARTED|Overall Study||11
8916830|NCT02186665|9976390|FG000|COMPLETED|Overall Study||8
8916831|NCT02186665|9976391|FG001|COMPLETED|Overall Study||10
8916832|NCT02186665|9976390|FG000|NOT COMPLETED|Overall Study||0
8916833|NCT02186665|9976391|FG001|NOT COMPLETED|Overall Study||1
8916834|NCT02186795|9976399|FG000|STARTED|Overall Study||24
8916835|NCT02186795|9976400|FG001|STARTED|Overall Study||24
8916836|NCT02186795|9976399|FG000|COMPLETED|Overall Study||24
8916837|NCT02186795|9976400|FG001|COMPLETED|Overall Study||24
8916838|NCT02186795|9976399|FG000|NOT COMPLETED|Overall Study||0
8916839|NCT02186795|9976400|FG001|NOT COMPLETED|Overall Study||0
8916840|NCT02186808|9976406|FG000|STARTED|Overall Study||80
8916841|NCT02186808|9976406|FG000|COMPLETED|Overall Study||67
8916842|NCT02186808|9976406|FG000|NOT COMPLETED|Overall Study||13
8916843|NCT02186821|9976410|FG000|STARTED|Overall Study||47
8916844|NCT02186821|9976410|FG000|COMPLETED|Overall Study||0
8916845|NCT02186821|9976410|FG000|NOT COMPLETED|Overall Study||47
8916846|NCT02186873|9976416|FG000|STARTED|Overall Study||103
8916847|NCT02186873|9976417|FG001|STARTED|Overall Study||105
8916848|NCT02186873|9976416|FG000|End of Control Period|Overall Study|Participants taking placebo crossed over to golimumab|99
8916849|NCT02186873|9976417|FG001|End of Control Period|Overall Study|Participants continued to receive golimumab|105
8916850|NCT02186873|9976416|FG000|COMPLETED|Overall Study||94
8916851|NCT02186873|9976417|FG001|COMPLETED|Overall Study||97
8916852|NCT02186873|9976416|FG000|NOT COMPLETED|Overall Study||9
8916853|NCT02186873|9976417|FG001|NOT COMPLETED|Overall Study||8
8916854|NCT02186938|9976426|FG000|STARTED|Overall Study|2012|47
8916855|NCT02186938|9976427|FG001|STARTED|Overall Study||47
8916856|NCT02186938|9976426|FG000|COMPLETED|Overall Study||38
8916857|NCT02186938|9976427|FG001|COMPLETED|Overall Study||44
8916858|NCT02186938|9976426|FG000|NOT COMPLETED|Overall Study||9
8916859|NCT02186938|9976427|FG001|NOT COMPLETED|Overall Study||3
8916860|NCT02187016|9976437|FG000|STARTED|Overall Study||80
8916861|NCT02187016|9976438|FG001|STARTED|Overall Study||80
8916862|NCT02187016|9976439|FG002|STARTED|Overall Study||79
8916863|NCT02187016|9976440|FG003|STARTED|Overall Study||51
8916864|NCT02187016|9976437|FG000|COMPLETED|Overall Study||79
8916865|NCT02187016|9976438|FG001|COMPLETED|Overall Study||78
8916866|NCT02187016|9976439|FG002|COMPLETED|Overall Study||78
8916867|NCT02187016|9976440|FG003|COMPLETED|Overall Study||51
8916868|NCT02187016|9976437|FG000|NOT COMPLETED|Overall Study||1
8916869|NCT02187016|9976438|FG001|NOT COMPLETED|Overall Study||2
8916870|NCT02187016|9976439|FG002|NOT COMPLETED|Overall Study||1
8916871|NCT02187016|9976440|FG003|NOT COMPLETED|Overall Study||0
8916872|NCT02187029|9976454|FG000|STARTED|Overall Study||7
8916873|NCT02187029|9976455|FG001|STARTED|Overall Study||3
8916874|NCT02187029|9976456|FG002|STARTED|Overall Study||11
8916875|NCT02187029|9976457|FG003|STARTED|Overall Study||9
8916876|NCT02187029|9976454|FG000|COMPLETED|Overall Study||6
8916877|NCT02187029|9976455|FG001|COMPLETED|Overall Study||2
8916878|NCT02187029|9976456|FG002|COMPLETED|Overall Study||0
8916879|NCT02187029|9976457|FG003|COMPLETED|Overall Study||6
8916880|NCT02187029|9976454|FG000|NOT COMPLETED|Overall Study||1
8916881|NCT02187029|9976455|FG001|NOT COMPLETED|Overall Study||1
8916882|NCT02187029|9976456|FG002|NOT COMPLETED|Overall Study||11
8916883|NCT02187029|9976457|FG003|NOT COMPLETED|Overall Study||3
8916884|NCT02187042|9976469|FG000|STARTED|Overall Study||42
8916885|NCT02187042|9976470|FG001|STARTED|Overall Study||27
8916886|NCT02187042|9976469|FG000|COMPLETED|Overall Study||29
8916887|NCT02187042|9976470|FG001|COMPLETED|Overall Study||13
8916888|NCT02187042|9976469|FG000|NOT COMPLETED|Overall Study||13
8916889|NCT02187042|9976470|FG001|NOT COMPLETED|Overall Study||14
8916890|NCT02187055|9976480|FG000|STARTED|Overall Study|Treated|384
8916891|NCT02187055|9976481|FG001|STARTED|Overall Study|Treated|376
8916892|NCT02187055|9976482|FG002|STARTED|Overall Study|Treated|386
8916893|NCT02187055|9976480|FG000|COMPLETED|Overall Study||315
8916894|NCT02187055|9976481|FG001|COMPLETED|Overall Study||303
8916895|NCT02187055|9976482|FG002|COMPLETED|Overall Study||312
8916896|NCT02187055|9976480|FG000|NOT COMPLETED|Overall Study||69
8916897|NCT02187055|9976481|FG001|NOT COMPLETED|Overall Study||73
8916898|NCT02187055|9976482|FG002|NOT COMPLETED|Overall Study||74
8916899|NCT02187159|9976494|FG000|STARTED|Overall Study||318
8916900|NCT02187159|9976495|FG001|STARTED|Overall Study||317
8916901|NCT02187159|9976496|FG002|STARTED|Overall Study||318
8916902|NCT02187159|9976497|FG003|STARTED|Overall Study||317
8916903|NCT02187159|9976494|FG000|COMPLETED|Overall Study||249
8787915|NCT01369485|9839195|FG001|NOT COMPLETED|Open Label Phase (Week 12 to Month 12)||40
8787916|NCT01369498|9839213|FG000|STARTED|Overall Study||12
8787917|NCT01369498|9839214|FG001|STARTED|Overall Study||12
8787918|NCT01369498|9839215|FG002|STARTED|Overall Study||15
8787919|NCT01369498|9839216|FG003|STARTED|Overall Study||15
8787920|NCT01369498|9839213|FG000|COMPLETED|Overall Study||0
8787921|NCT01369498|9839214|FG001|COMPLETED|Overall Study||0
8787922|NCT01369498|9839215|FG002|COMPLETED|Overall Study||0
8787923|NCT01369498|9839216|FG003|COMPLETED|Overall Study||0
8787924|NCT01369498|9839213|FG000|NOT COMPLETED|Overall Study||12
8787925|NCT01369498|9839214|FG001|NOT COMPLETED|Overall Study||12
8787926|NCT01369498|9839215|FG002|NOT COMPLETED|Overall Study||15
8787927|NCT01369498|9839216|FG003|NOT COMPLETED|Overall Study||15
8787928|NCT01369511|9839231|FG000|STARTED|Overall Study||98
8787929|NCT01369511|9839232|FG001|STARTED|Overall Study||104
8787930|NCT01369511|9839233|FG002|STARTED|Overall Study||98
8787931|NCT01369511|9839234|FG003|STARTED|Overall Study||100
8787932|NCT01369511|9839231|FG000|Received at Least 1 Dose of Study Drug|Overall Study||98
8787933|NCT01369511|9839232|FG001|Received at Least 1 Dose of Study Drug|Overall Study|One participant was a screen failure and inadvertently randomized but did not receive study drug.|103
8787934|NCT01369511|9839233|FG002|Received at Least 1 Dose of Study Drug|Overall Study||98
8787935|NCT01369511|9839234|FG003|Received at Least 1 Dose of Study Drug|Overall Study||100
8787936|NCT01369511|9839231|FG000|COMPLETED|Overall Study||85
8787937|NCT01369511|9839232|FG001|COMPLETED|Overall Study||91
8787938|NCT01369511|9839233|FG002|COMPLETED|Overall Study||87
8787939|NCT01369511|9839234|FG003|COMPLETED|Overall Study||89
8787940|NCT01369511|9839231|FG000|NOT COMPLETED|Overall Study||13
8787941|NCT01369511|9839232|FG001|NOT COMPLETED|Overall Study||13
8787942|NCT01369511|9839233|FG002|NOT COMPLETED|Overall Study||11
8787943|NCT01369511|9839234|FG003|NOT COMPLETED|Overall Study||11
8787944|NCT01369615|9839246|FG000|STARTED|Overall Study||9
8787945|NCT01369615|9839247|FG001|STARTED|Overall Study||14
8787946|NCT01369615|9839246|FG000|COMPLETED|Overall Study||9
8787947|NCT01369615|9839247|FG001|COMPLETED|Overall Study||12
8787948|NCT01369615|9839246|FG000|NOT COMPLETED|Overall Study||0
8787949|NCT01369615|9839247|FG001|NOT COMPLETED|Overall Study||2
8787950|NCT01369680|9839257|FG000|STARTED|Overall Study||3
8787951|NCT01369680|9839258|FG001|STARTED|Overall Study||3
8787952|NCT01369680|9839259|FG002|STARTED|Overall Study||3
8787953|NCT01369680|9839260|FG003|STARTED|Overall Study||3
8787954|NCT01369680|9839257|FG000|COMPLETED|Overall Study||3
8787955|NCT01369680|9839258|FG001|COMPLETED|Overall Study||3
8787956|NCT01369680|9839259|FG002|COMPLETED|Overall Study||2
8787957|NCT01369680|9839260|FG003|COMPLETED|Overall Study||1
8787958|NCT01369680|9839257|FG000|NOT COMPLETED|Overall Study||0
8787959|NCT01369680|9839258|FG001|NOT COMPLETED|Overall Study||0
8787960|NCT01369680|9839259|FG002|NOT COMPLETED|Overall Study||1
8787961|NCT01369680|9839260|FG003|NOT COMPLETED|Overall Study||2
8787962|NCT01369706|9839281|FG000|STARTED|Overall Study||388
8787963|NCT01369706|9839281|FG000|COMPLETED|Overall Study||388
8787964|NCT01369706|9839281|FG000|NOT COMPLETED|Overall Study||0
8787965|NCT01369732|9839287|FG000|STARTED|Overall Study||33
8787966|NCT01369732|9839288|FG001|STARTED|Overall Study||33
8787967|NCT01369732|9839287|FG000|COMPLETED|Overall Study||29
8787968|NCT01369732|9839288|FG001|COMPLETED|Overall Study||31
8787969|NCT01369732|9839287|FG000|NOT COMPLETED|Overall Study||4
8787970|NCT01369732|9839288|FG001|NOT COMPLETED|Overall Study||2
8787971|NCT01369745|9839299|FG000|STARTED|Overall Study||32
8787972|NCT01369745|9839300|FG001|STARTED|Overall Study||41
8787973|NCT01369745|9839301|FG002|STARTED|Overall Study||18
8787974|NCT01369745|9839302|FG003|STARTED|Overall Study||84
8787975|NCT01369745|9839303|FG004|STARTED|Overall Study||83
9031460|NCT03245372|10093613|FG000|NOT COMPLETED|Overall Study||0
9031461|NCT03245372|10093614|FG001|NOT COMPLETED|Overall Study||0
9031462|NCT03245398|10093622|FG000|STARTED|Overall Study||93
9031463|NCT03245398|10093623|FG001|STARTED|Overall Study||93
9031464|NCT03245398|10093622|FG000|COMPLETED|Overall Study||92
9031465|NCT03245398|10093623|FG001|COMPLETED|Overall Study||93
9031466|NCT03245398|10093622|FG000|NOT COMPLETED|Overall Study||1
9031467|NCT03245398|10093623|FG001|NOT COMPLETED|Overall Study||0
9031468|NCT03245463|10093633|FG000|STARTED|Overall Study||12
9031469|NCT03245463|10093634|FG001|STARTED|Overall Study||12
9031470|NCT03245463|10093633|FG000|COMPLETED|Overall Study||12
9031471|NCT03245463|10093634|FG001|COMPLETED|Overall Study||12
9031472|NCT03245463|10093633|FG000|NOT COMPLETED|Overall Study||0
9031473|NCT03245463|10093634|FG001|NOT COMPLETED|Overall Study||0
9031474|NCT03245619|10093657|FG000|STARTED|Part A (Up to Day 22)||5
9031475|NCT03245619|10093658|FG001|STARTED|Part A (Up to Day 22)||6
9031476|NCT03245619|10093659|FG002|STARTED|Part A (Up to Day 22)||6
9031477|NCT03245619|10093660|FG003|STARTED|Part A (Up to Day 22)||1
9031478|NCT03245619|10093661|FG004|STARTED|Part A (Up to Day 22)||0
8787976|NCT01369745|9839299|FG000|COMPLETED|Overall Study||25
8787977|NCT01369745|9839300|FG001|COMPLETED|Overall Study||28
8787978|NCT01369745|9839301|FG002|COMPLETED|Overall Study||16
8787979|NCT01369745|9839302|FG003|COMPLETED|Overall Study||64
8787980|NCT01369745|9839303|FG004|COMPLETED|Overall Study||65
9031479|NCT03245619|10093662|FG005|STARTED|Part A (Up to Day 22)||0
9031480|NCT03245619|10093663|FG006|STARTED|Part A (Up to Day 22)||0
9031481|NCT03245619|10093664|FG007|STARTED|Part A (Up to Day 22)||0
9031482|NCT03245619|10093665|FG008|STARTED|Part A (Up to Day 22)||0
9031483|NCT03245619|10093666|FG009|STARTED|Part A (Up to Day 22)||0
8787981|NCT01369745|9839299|FG000|NOT COMPLETED|Overall Study||7
8787982|NCT01369745|9839300|FG001|NOT COMPLETED|Overall Study||13
8787983|NCT01369745|9839301|FG002|NOT COMPLETED|Overall Study||2
8787984|NCT01369745|9839302|FG003|NOT COMPLETED|Overall Study||20
8787985|NCT01369745|9839303|FG004|NOT COMPLETED|Overall Study||18
8787986|NCT01369758|9839315|FG000|STARTED|Overall Study||290
8787987|NCT01369758|9839315|FG000|COMPLETED|Overall Study||290
8787988|NCT01369758|9839315|FG000|NOT COMPLETED|Overall Study||0
8787989|NCT01369784|9839319|FG000|STARTED|Overall Study||158
8787990|NCT01369784|9839319|FG000|COMPLETED|Overall Study||146
8787991|NCT01369784|9839319|FG000|NOT COMPLETED|Overall Study||12
8787992|NCT01369849|9839326|FG000|STARTED|Overall Study||6
8787993|NCT01369849|9839327|FG001|STARTED|Overall Study||4
8787994|NCT01369849|9839328|FG002|STARTED|Overall Study||5
8787995|NCT01369849|9839326|FG000|COMPLETED|Overall Study||6
8787996|NCT01369849|9839327|FG001|COMPLETED|Overall Study||3
8787997|NCT01369849|9839328|FG002|COMPLETED|Overall Study||4
8787998|NCT01369849|9839326|FG000|NOT COMPLETED|Overall Study||0
8787999|NCT01369849|9839327|FG001|NOT COMPLETED|Overall Study||1
8788000|NCT01369849|9839328|FG002|NOT COMPLETED|Overall Study||1
8788001|NCT01369875|9839340|FG000|STARTED|Overall Study||1
8788002|NCT01369875|9839341|FG001|STARTED|Overall Study||1
8788003|NCT01369875|9839340|FG000|COMPLETED|Overall Study||1
8788004|NCT01369875|9839341|FG001|COMPLETED|Overall Study||1
8788005|NCT01369875|9839340|FG000|NOT COMPLETED|Overall Study||0
8788006|NCT01369875|9839341|FG001|NOT COMPLETED|Overall Study||0
8788007|NCT01369888|9839351|FG000|STARTED|Overall Study||1
8788008|NCT01369888|9839352|FG001|STARTED|Overall Study||2
8788009|NCT01369888|9839353|FG002|STARTED|Overall Study||0
8788010|NCT01369888|9839354|FG003|STARTED|Overall Study||0
8788011|NCT01369888|9839351|FG000|COMPLETED|Overall Study||1
8788012|NCT01369888|9839352|FG001|COMPLETED|Overall Study||2
8788013|NCT01369888|9839353|FG002|COMPLETED|Overall Study||0
8788014|NCT01369888|9839354|FG003|COMPLETED|Overall Study||0
8788015|NCT01369888|9839351|FG000|NOT COMPLETED|Overall Study||0
8788016|NCT01369888|9839352|FG001|NOT COMPLETED|Overall Study||0
8788017|NCT01369888|9839353|FG002|NOT COMPLETED|Overall Study||0
8788018|NCT01369888|9839354|FG003|NOT COMPLETED|Overall Study||0
8788019|NCT01370005|9839363|FG000|STARTED|Overall Study||272
8788020|NCT01370005|9839364|FG001|STARTED|Overall Study||276
8788021|NCT01370005|9839365|FG002|STARTED|Overall Study||277
8788022|NCT01370005|9839363|FG000|COMPLETED|Overall Study||256
8788023|NCT01370005|9839364|FG001|COMPLETED|Overall Study||265
8788024|NCT01370005|9839365|FG002|COMPLETED|Overall Study||266
8788025|NCT01370005|9839363|FG000|NOT COMPLETED|Overall Study||16
8788026|NCT01370005|9839364|FG001|NOT COMPLETED|Overall Study||11
8788027|NCT01370005|9839365|FG002|NOT COMPLETED|Overall Study||11
8788028|NCT01370018|9839373|FG000|STARTED|Overall Study||4
8788029|NCT01370018|9839373|FG000|COMPLETED|Overall Study||3
8788030|NCT01370018|9839373|FG000|NOT COMPLETED|Overall Study||1
8788031|NCT01370083|9839379|FG000|STARTED|Overall Study||7
8788032|NCT01370083|9839380|FG001|STARTED|Overall Study||7
8788033|NCT01370083|9839379|FG000|COMPLETED|Overall Study||5
8788034|NCT01370083|9839380|FG001|COMPLETED|Overall Study||6
8788035|NCT01370083|9839379|FG000|NOT COMPLETED|Overall Study||2
8788036|NCT01370083|9839380|FG001|NOT COMPLETED|Overall Study||1
8788037|NCT01370174|9839390|FG000|STARTED|Overall Study||25
8788038|NCT01370174|9839391|FG001|STARTED|Overall Study||26
8788039|NCT01370174|9839392|FG002|STARTED|Overall Study||25
8788040|NCT01370174|9839393|FG003|STARTED|Overall Study||26
8788041|NCT01370174|9839390|FG000|COMPLETED|Overall Study||18
8788042|NCT01370174|9839391|FG001|COMPLETED|Overall Study||15
8788043|NCT01370174|9839392|FG002|COMPLETED|Overall Study||13
8788044|NCT01370174|9839393|FG003|COMPLETED|Overall Study||17
8788045|NCT01370174|9839390|FG000|NOT COMPLETED|Overall Study||7
8788046|NCT01370174|9839391|FG001|NOT COMPLETED|Overall Study||11
8788047|NCT01370174|9839392|FG002|NOT COMPLETED|Overall Study||12
8788048|NCT01370174|9839393|FG003|NOT COMPLETED|Overall Study||9
8788049|NCT01370213|9839406|FG000|STARTED|Overall Study||7
8788050|NCT01370213|9839407|FG001|STARTED|Overall Study||17
8788051|NCT01370213|9839408|FG002|STARTED|Overall Study||1
8788052|NCT01370213|9839406|FG000|COMPLETED|Overall Study||6
8788053|NCT01370213|9839407|FG001|COMPLETED|Overall Study||15
8788054|NCT01370213|9839408|FG002|COMPLETED|Overall Study||1
8788055|NCT01370213|9839406|FG000|NOT COMPLETED|Overall Study||1
8788056|NCT01370213|9839407|FG001|NOT COMPLETED|Overall Study||2
8788057|NCT01370213|9839408|FG002|NOT COMPLETED|Overall Study||0
8788058|NCT01370265|9839415|FG000|STARTED|Resting Myocardial Blood Flow (MBF)||6
8788059|NCT01370265|9839416|FG001|STARTED|Resting Myocardial Blood Flow (MBF)||6
8788060|NCT01370265|9839415|FG000|COMPLETED|Resting Myocardial Blood Flow (MBF)||6
8788061|NCT01370265|9839416|FG001|COMPLETED|Resting Myocardial Blood Flow (MBF)||6
8788062|NCT01370265|9839415|FG000|NOT COMPLETED|Resting Myocardial Blood Flow (MBF)||0
8788063|NCT01370265|9839416|FG001|NOT COMPLETED|Resting Myocardial Blood Flow (MBF)||0
8788064|NCT01370265|9839415|FG000|STARTED|Washout Period (50-minute Period Decay)||6
8788065|NCT01370265|9839416|FG001|STARTED|Washout Period (50-minute Period Decay)||6
8788066|NCT01370265|9839415|FG000|COMPLETED|Washout Period (50-minute Period Decay)||6
8788067|NCT01370265|9839416|FG001|COMPLETED|Washout Period (50-minute Period Decay)||6
8788068|NCT01370265|9839415|FG000|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
8788069|NCT01370265|9839416|FG001|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
8788070|NCT01370265|9839415|FG000|STARTED|First Intervention||6
8788071|NCT01370265|9839416|FG001|STARTED|First Intervention||6
8788072|NCT01370265|9839415|FG000|COMPLETED|First Intervention||5
8788073|NCT01370265|9839416|FG001|COMPLETED|First Intervention||5
8788074|NCT01370265|9839415|FG000|NOT COMPLETED|First Intervention||1
8788075|NCT01370265|9839416|FG001|NOT COMPLETED|First Intervention||1
8788076|NCT01370265|9839415|FG000|STARTED|Washout Period (50-minute Period Decay)||5
9031484|NCT03245619|10093667|FG010|STARTED|Part A (Up to Day 22)||0
9031485|NCT03245619|10093668|FG011|STARTED|Part A (Up to Day 22)||0
9031486|NCT03245619|10093669|FG012|STARTED|Part A (Up to Day 22)||0
9031487|NCT03245619|10093670|FG013|STARTED|Part A (Up to Day 22)||0
9031488|NCT03245619|10093671|FG014|STARTED|Part A (Up to Day 22)||0
9031489|NCT03245619|10093672|FG015|STARTED|Part A (Up to Day 22)||0
9031490|NCT03245619|10093673|FG016|STARTED|Part A (Up to Day 22)||0
9031491|NCT03245619|10093657|FG000|COMPLETED|Part A (Up to Day 22)||1
9031492|NCT03245619|10093658|FG001|COMPLETED|Part A (Up to Day 22)||0
9031493|NCT03245619|10093659|FG002|COMPLETED|Part A (Up to Day 22)||0
9031494|NCT03245619|10093660|FG003|COMPLETED|Part A (Up to Day 22)||1
9031495|NCT03245619|10093661|FG004|COMPLETED|Part A (Up to Day 22)||0
9031496|NCT03245619|10093662|FG005|COMPLETED|Part A (Up to Day 22)||0
9031497|NCT03245619|10093663|FG006|COMPLETED|Part A (Up to Day 22)||0
9031498|NCT03245619|10093664|FG007|COMPLETED|Part A (Up to Day 22)||0
9031499|NCT03245619|10093665|FG008|COMPLETED|Part A (Up to Day 22)||0
9031500|NCT03245619|10093666|FG009|COMPLETED|Part A (Up to Day 22)||0
9031501|NCT03245619|10093667|FG010|COMPLETED|Part A (Up to Day 22)||0
9031502|NCT03245619|10093668|FG011|COMPLETED|Part A (Up to Day 22)||0
9031503|NCT03245619|10093669|FG012|COMPLETED|Part A (Up to Day 22)||0
9031504|NCT03245619|10093670|FG013|COMPLETED|Part A (Up to Day 22)||0
9031505|NCT03245619|10093671|FG014|COMPLETED|Part A (Up to Day 22)||0
9031506|NCT03245619|10093672|FG015|COMPLETED|Part A (Up to Day 22)||0
9031507|NCT03245619|10093673|FG016|COMPLETED|Part A (Up to Day 22)||0
9031508|NCT03245619|10093657|FG000|NOT COMPLETED|Part A (Up to Day 22)||4
9031509|NCT03245619|10093658|FG001|NOT COMPLETED|Part A (Up to Day 22)||6
9031510|NCT03245619|10093659|FG002|NOT COMPLETED|Part A (Up to Day 22)||6
9031511|NCT03245619|10093660|FG003|NOT COMPLETED|Part A (Up to Day 22)||0
9031512|NCT03245619|10093661|FG004|NOT COMPLETED|Part A (Up to Day 22)||0
9031513|NCT03245619|10093662|FG005|NOT COMPLETED|Part A (Up to Day 22)||0
9031514|NCT03245619|10093663|FG006|NOT COMPLETED|Part A (Up to Day 22)||0
9031515|NCT03245619|10093664|FG007|NOT COMPLETED|Part A (Up to Day 22)||0
9031516|NCT03245619|10093665|FG008|NOT COMPLETED|Part A (Up to Day 22)||0
9031517|NCT03245619|10093666|FG009|NOT COMPLETED|Part A (Up to Day 22)||0
9031518|NCT03245619|10093667|FG010|NOT COMPLETED|Part A (Up to Day 22)||0
9031519|NCT03245619|10093668|FG011|NOT COMPLETED|Part A (Up to Day 22)||0
9031520|NCT03245619|10093669|FG012|NOT COMPLETED|Part A (Up to Day 22)||0
9031521|NCT03245619|10093670|FG013|NOT COMPLETED|Part A (Up to Day 22)||0
9031522|NCT03245619|10093671|FG014|NOT COMPLETED|Part A (Up to Day 22)||0
9031523|NCT03245619|10093672|FG015|NOT COMPLETED|Part A (Up to Day 22)||0
9031524|NCT03245619|10093673|FG016|NOT COMPLETED|Part A (Up to Day 22)||0
9031525|NCT03245619|10093657|FG000|STARTED|Part B (Up to 34 Days)||0
9031526|NCT03245619|10093658|FG001|STARTED|Part B (Up to 34 Days)||0
9031527|NCT03245619|10093659|FG002|STARTED|Part B (Up to 34 Days)||0
9031528|NCT03245619|10093660|FG003|STARTED|Part B (Up to 34 Days)||0
9031529|NCT03245619|10093661|FG004|STARTED|Part B (Up to 34 Days)||0
9031530|NCT03245619|10093662|FG005|STARTED|Part B (Up to 34 Days)||0
9031531|NCT03245619|10093663|FG006|STARTED|Part B (Up to 34 Days)||0
9031532|NCT03245619|10093664|FG007|STARTED|Part B (Up to 34 Days)||0
9031533|NCT03245619|10093665|FG008|STARTED|Part B (Up to 34 Days)||0
9031534|NCT03245619|10093666|FG009|STARTED|Part B (Up to 34 Days)||0
9031535|NCT03245619|10093667|FG010|STARTED|Part B (Up to 34 Days)||0
9031536|NCT03245619|10093668|FG011|STARTED|Part B (Up to 34 Days)||0
9031537|NCT03245619|10093669|FG012|STARTED|Part B (Up to 34 Days)||0
9031538|NCT03245619|10093670|FG013|STARTED|Part B (Up to 34 Days)||0
9031539|NCT03245619|10093671|FG014|STARTED|Part B (Up to 34 Days)||0
9031540|NCT03245619|10093672|FG015|STARTED|Part B (Up to 34 Days)||0
9031541|NCT03245619|10093673|FG016|STARTED|Part B (Up to 34 Days)||0
9031542|NCT03245619|10093657|FG000|COMPLETED|Part B (Up to 34 Days)||0
9031543|NCT03245619|10093658|FG001|COMPLETED|Part B (Up to 34 Days)||0
9031544|NCT03245619|10093659|FG002|COMPLETED|Part B (Up to 34 Days)||0
9031545|NCT03245619|10093660|FG003|COMPLETED|Part B (Up to 34 Days)||0
9031546|NCT03245619|10093661|FG004|COMPLETED|Part B (Up to 34 Days)||0
9031547|NCT03245619|10093662|FG005|COMPLETED|Part B (Up to 34 Days)||0
9031548|NCT03245619|10093663|FG006|COMPLETED|Part B (Up to 34 Days)||0
9031549|NCT03245619|10093664|FG007|COMPLETED|Part B (Up to 34 Days)||0
9031550|NCT03245619|10093665|FG008|COMPLETED|Part B (Up to 34 Days)||0
9031551|NCT03245619|10093666|FG009|COMPLETED|Part B (Up to 34 Days)||0
9031552|NCT03245619|10093667|FG010|COMPLETED|Part B (Up to 34 Days)||0
9031553|NCT03245619|10093668|FG011|COMPLETED|Part B (Up to 34 Days)||0
9031554|NCT03245619|10093669|FG012|COMPLETED|Part B (Up to 34 Days)||0
9031555|NCT03245619|10093670|FG013|COMPLETED|Part B (Up to 34 Days)||0
8788077|NCT01370265|9839416|FG001|STARTED|Washout Period (50-minute Period Decay)||5
9031556|NCT03245619|10093671|FG014|COMPLETED|Part B (Up to 34 Days)||0
9031557|NCT03245619|10093672|FG015|COMPLETED|Part B (Up to 34 Days)||0
9031558|NCT03245619|10093673|FG016|COMPLETED|Part B (Up to 34 Days)||0
9031559|NCT03245619|10093657|FG000|NOT COMPLETED|Part B (Up to 34 Days)||0
9031560|NCT03245619|10093658|FG001|NOT COMPLETED|Part B (Up to 34 Days)||0
9031561|NCT03245619|10093659|FG002|NOT COMPLETED|Part B (Up to 34 Days)||0
9031562|NCT03245619|10093660|FG003|NOT COMPLETED|Part B (Up to 34 Days)||0
8788078|NCT01370265|9839415|FG000|COMPLETED|Washout Period (50-minute Period Decay)||5
8788079|NCT01370265|9839416|FG001|COMPLETED|Washout Period (50-minute Period Decay)||5
8788080|NCT01370265|9839415|FG000|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
8788081|NCT01370265|9839416|FG001|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
8788082|NCT01370265|9839415|FG000|STARTED|Second Intervention||5
8788083|NCT01370265|9839416|FG001|STARTED|Second Intervention||5
8788084|NCT01370265|9839415|FG000|COMPLETED|Second Intervention||5
8788085|NCT01370265|9839416|FG001|COMPLETED|Second Intervention||5
8788086|NCT01370265|9839415|FG000|NOT COMPLETED|Second Intervention||0
8788087|NCT01370265|9839416|FG001|NOT COMPLETED|Second Intervention||0
8788088|NCT01370317|9839425|FG000|STARTED|Overall Study||18
8788089|NCT01370317|9839426|FG001|STARTED|Overall Study||9
8788090|NCT01370317|9839425|FG000|COMPLETED|Overall Study||17
8788091|NCT01370317|9839426|FG001|COMPLETED|Overall Study||8
8788092|NCT01370317|9839425|FG000|NOT COMPLETED|Overall Study||1
8788093|NCT01370317|9839426|FG001|NOT COMPLETED|Overall Study||1
8788094|NCT01370356|9839434|FG000|STARTED|Overall Study||751
8788095|NCT01370356|9839435|FG001|STARTED|Overall Study||742
8788096|NCT01370356|9839434|FG000|COMPLETED|Overall Study||559
8788097|NCT01370356|9839435|FG001|COMPLETED|Overall Study||515
8788098|NCT01370356|9839434|FG000|NOT COMPLETED|Overall Study||192
8788099|NCT01370356|9839435|FG001|NOT COMPLETED|Overall Study||227
8788100|NCT01370369|9839441|FG000|STARTED|Overall Study||20
8788101|NCT01370369|9839441|FG000|COMPLETED|Overall Study||20
8788102|NCT01370369|9839441|FG000|NOT COMPLETED|Overall Study||0
8788103|NCT01370408|9839454|FG000|STARTED|Overall Study||85
8788104|NCT01370408|9839454|FG000|COMPLETED|Overall Study||76
8788105|NCT01370408|9839454|FG000|NOT COMPLETED|Overall Study||9
8788106|NCT01370460|9839460|FG000|STARTED|Overall Study||50
8788107|NCT01370460|9839461|FG001|STARTED|Overall Study||51
8788108|NCT01370460|9839460|FG000|COMPLETED|Overall Study||50
8788109|NCT01370460|9839461|FG001|COMPLETED|Overall Study||51
8788110|NCT01370460|9839460|FG000|NOT COMPLETED|Overall Study||0
8788111|NCT01370460|9839461|FG001|NOT COMPLETED|Overall Study||0
9031563|NCT03245619|10093661|FG004|NOT COMPLETED|Part B (Up to 34 Days)||0
9031564|NCT03245619|10093662|FG005|NOT COMPLETED|Part B (Up to 34 Days)||0
9031565|NCT03245619|10093663|FG006|NOT COMPLETED|Part B (Up to 34 Days)||0
9031566|NCT03245619|10093664|FG007|NOT COMPLETED|Part B (Up to 34 Days)||0
9031567|NCT03245619|10093665|FG008|NOT COMPLETED|Part B (Up to 34 Days)||0
9031568|NCT03245619|10093666|FG009|NOT COMPLETED|Part B (Up to 34 Days)||0
9031569|NCT03245619|10093667|FG010|NOT COMPLETED|Part B (Up to 34 Days)||0
9031570|NCT03245619|10093668|FG011|NOT COMPLETED|Part B (Up to 34 Days)||0
9031571|NCT03245619|10093669|FG012|NOT COMPLETED|Part B (Up to 34 Days)||0
9031572|NCT03245619|10093670|FG013|NOT COMPLETED|Part B (Up to 34 Days)||0
9031573|NCT03245619|10093671|FG014|NOT COMPLETED|Part B (Up to 34 Days)||0
9031574|NCT03245619|10093672|FG015|NOT COMPLETED|Part B (Up to 34 Days)||0
8788112|NCT01370499|9839470|FG000|STARTED|Overall Study||195
8788113|NCT01370499|9839471|FG001|STARTED|Overall Study||93
8788114|NCT01370499|9839470|FG000|Entered Abrupt Discontinuation Phase|Overall Study||188
9031575|NCT03245619|10093673|FG016|NOT COMPLETED|Part B (Up to 34 Days)||0
9031576|NCT03245619|10093657|FG000|STARTED|Part C (Up to 34 Days)||0
9031577|NCT03245619|10093658|FG001|STARTED|Part C (Up to 34 Days)||0
9031578|NCT03245619|10093659|FG002|STARTED|Part C (Up to 34 Days)||0
9031579|NCT03245619|10093660|FG003|STARTED|Part C (Up to 34 Days)||0
9031580|NCT03245619|10093661|FG004|STARTED|Part C (Up to 34 Days)||0
9031581|NCT03245619|10093662|FG005|STARTED|Part C (Up to 34 Days)||0
9031582|NCT03245619|10093663|FG006|STARTED|Part C (Up to 34 Days)||0
9031583|NCT03245619|10093664|FG007|STARTED|Part C (Up to 34 Days)||0
9031584|NCT03245619|10093665|FG008|STARTED|Part C (Up to 34 Days)||0
9031585|NCT03245619|10093666|FG009|STARTED|Part C (Up to 34 Days)||0
9031586|NCT03245619|10093667|FG010|STARTED|Part C (Up to 34 Days)||0
9031587|NCT03245619|10093668|FG011|STARTED|Part C (Up to 34 Days)||0
9031588|NCT03245619|10093669|FG012|STARTED|Part C (Up to 34 Days)||0
9031589|NCT03245619|10093670|FG013|STARTED|Part C (Up to 34 Days)||0
9031590|NCT03245619|10093671|FG014|STARTED|Part C (Up to 34 Days)||0
9031591|NCT03245619|10093672|FG015|STARTED|Part C (Up to 34 Days)||0
9031592|NCT03245619|10093673|FG016|STARTED|Part C (Up to 34 Days)||0
9031593|NCT03245619|10093657|FG000|COMPLETED|Part C (Up to 34 Days)||0
9031594|NCT03245619|10093658|FG001|COMPLETED|Part C (Up to 34 Days)||0
9031595|NCT03245619|10093659|FG002|COMPLETED|Part C (Up to 34 Days)||0
9031596|NCT03245619|10093660|FG003|COMPLETED|Part C (Up to 34 Days)||0
9031597|NCT03245619|10093661|FG004|COMPLETED|Part C (Up to 34 Days)||0
9031598|NCT03245619|10093662|FG005|COMPLETED|Part C (Up to 34 Days)||0
9031599|NCT03245619|10093663|FG006|COMPLETED|Part C (Up to 34 Days)||0
9031600|NCT03245619|10093664|FG007|COMPLETED|Part C (Up to 34 Days)||0
9031601|NCT03245619|10093665|FG008|COMPLETED|Part C (Up to 34 Days)||0
9031602|NCT03245619|10093666|FG009|COMPLETED|Part C (Up to 34 Days)||0
9031603|NCT03245619|10093667|FG010|COMPLETED|Part C (Up to 34 Days)||0
9031604|NCT03245619|10093668|FG011|COMPLETED|Part C (Up to 34 Days)||0
9031605|NCT03245619|10093669|FG012|COMPLETED|Part C (Up to 34 Days)||0
9031606|NCT03245619|10093670|FG013|COMPLETED|Part C (Up to 34 Days)||0
9031607|NCT03245619|10093671|FG014|COMPLETED|Part C (Up to 34 Days)||0
9031608|NCT03245619|10093672|FG015|COMPLETED|Part C (Up to 34 Days)||0
9031609|NCT03245619|10093673|FG016|COMPLETED|Part C (Up to 34 Days)||0
9031610|NCT03245619|10093657|FG000|NOT COMPLETED|Part C (Up to 34 Days)||0
9031611|NCT03245619|10093658|FG001|NOT COMPLETED|Part C (Up to 34 Days)||0
9031612|NCT03245619|10093659|FG002|NOT COMPLETED|Part C (Up to 34 Days)||0
8788115|NCT01370499|9839471|FG001|Entered Abrupt Discontinuation Phase|Overall Study|One participant who entered the abrupt discontinuation phase did not receive study drug.|85
8788116|NCT01370499|9839470|FG000|Received at Least 1 Dose of Study Drug|Overall Study||195
8788117|NCT01370499|9839471|FG001|Received at Least 1 Dose of Study Drug|Overall Study||92
8788118|NCT01370499|9839470|FG000|COMPLETED|Overall Study||84
8788119|NCT01370499|9839471|FG001|COMPLETED|Overall Study||49
8788120|NCT01370499|9839470|FG000|NOT COMPLETED|Overall Study||111
8788121|NCT01370499|9839471|FG001|NOT COMPLETED|Overall Study||44
8788122|NCT01370525|9839481|FG000|STARTED|Overall Study||171
8788123|NCT01370525|9839482|FG001|STARTED|Overall Study||169
8788124|NCT01370525|9839481|FG000|Patients Who Received Treatment|Overall Study||168
8788125|NCT01370525|9839482|FG001|Patients Who Received Treatment|Overall Study||163
8788126|NCT01370525|9839481|FG000|Patients Who Completed Treatment|Overall Study||163
8788127|NCT01370525|9839482|FG001|Patients Who Completed Treatment|Overall Study||158
8788128|NCT01370525|9839481|FG000|COMPLETED|Overall Study||163
8788129|NCT01370525|9839482|FG001|COMPLETED|Overall Study||158
8788130|NCT01370525|9839481|FG000|NOT COMPLETED|Overall Study||8
8788131|NCT01370525|9839482|FG001|NOT COMPLETED|Overall Study||11
8788132|NCT01370538|9839490|FG000|STARTED|Overall Study||170
8788133|NCT01370538|9839491|FG001|STARTED|Overall Study||171
8788134|NCT01370538|9839490|FG000|Patients Who Received Treatment|Overall Study||165
8788135|NCT01370538|9839491|FG001|Patients Who Received Treatment|Overall Study||161
8788136|NCT01370538|9839490|FG000|Patients Who Completed Treatment|Overall Study||151
8788137|NCT01370538|9839491|FG001|Patients Who Completed Treatment|Overall Study||152
8788138|NCT01370538|9839490|FG000|COMPLETED|Overall Study||151
8788139|NCT01370538|9839491|FG001|COMPLETED|Overall Study||152
8788140|NCT01370538|9839490|FG000|NOT COMPLETED|Overall Study||19
8788141|NCT01370538|9839491|FG001|NOT COMPLETED|Overall Study||19
8788142|NCT01370564|9839497|FG000|STARTED|Overall Study||21
8788143|NCT01370564|9839497|FG000|COMPLETED|Overall Study||21
8788144|NCT01370564|9839497|FG000|NOT COMPLETED|Overall Study||0
8788145|NCT01370616|9839503|FG000|STARTED|Overall Study|Participants randomized|282
8788146|NCT01370616|9839504|FG001|STARTED|Overall Study|Participants randomized|283
8788147|NCT01370616|9839503|FG000|Treated|Overall Study||275
8788148|NCT01370616|9839504|FG001|Treated|Overall Study||275
8788149|NCT01370616|9839503|FG000|COMPLETED|Overall Study||220
8788150|NCT01370616|9839504|FG001|COMPLETED|Overall Study||216
8788151|NCT01370616|9839503|FG000|NOT COMPLETED|Overall Study||62
8788152|NCT01370616|9839504|FG001|NOT COMPLETED|Overall Study||67
8788153|NCT01370629|9839510|FG000|STARTED|Overall Study||2015
8788154|NCT01370629|9839510|FG000|COMPLETED|Overall Study||2009
8788155|NCT01370629|9839510|FG000|NOT COMPLETED|Overall Study||6
8788156|NCT01370642|9839517|FG000|STARTED|Overall Study||98
8788157|NCT01370642|9839518|FG001|STARTED|Overall Study||98
8788158|NCT01370642|9839519|FG002|STARTED|Overall Study||98
8788159|NCT01370642|9839517|FG000|FAS Population|Overall Study||98
8788160|NCT01370642|9839518|FG001|FAS Population|Overall Study||97
8788161|NCT01370642|9839519|FG002|FAS Population|Overall Study||98
8788162|NCT01370642|9839517|FG000|COMPLETED|Overall Study||90
8788163|NCT01370642|9839518|FG001|COMPLETED|Overall Study||92
8788164|NCT01370642|9839519|FG002|COMPLETED|Overall Study||69
8788165|NCT01370642|9839517|FG000|NOT COMPLETED|Overall Study||8
8788166|NCT01370642|9839518|FG001|NOT COMPLETED|Overall Study||6
8788167|NCT01370642|9839519|FG002|NOT COMPLETED|Overall Study||29
8788168|NCT01370655|9839539|FG000|STARTED|Period 1||7
8788169|NCT01370655|9839540|FG001|STARTED|Period 1||7
8788170|NCT01370655|9839541|FG002|STARTED|Period 1||3
8788171|NCT01370655|9839542|FG003|STARTED|Period 1||3
8788172|NCT01370655|9839543|FG004|STARTED|Period 1||3
8788173|NCT01370655|9839544|FG005|STARTED|Period 1||4
8788174|NCT01370655|9839545|FG006|STARTED|Period 1||4
8788175|NCT01370655|9839546|FG007|STARTED|Period 1||4
8788176|NCT01370655|9839547|FG008|STARTED|Period 1||3
8788177|NCT01370655|9839548|FG009|STARTED|Period 1||2
8788178|NCT01370655|9839549|FG010|STARTED|Period 1||3
8788179|NCT01370655|9839550|FG011|STARTED|Period 1||3
8788180|NCT01370655|9839539|FG000|COMPLETED|Period 1||5
8788181|NCT01370655|9839540|FG001|COMPLETED|Period 1||7
8788182|NCT01370655|9839541|FG002|COMPLETED|Period 1||3
8788183|NCT01370655|9839542|FG003|COMPLETED|Period 1||3
8788184|NCT01370655|9839543|FG004|COMPLETED|Period 1||3
8788185|NCT01370655|9839544|FG005|COMPLETED|Period 1||4
8788186|NCT01370655|9839545|FG006|COMPLETED|Period 1||3
8788187|NCT01370655|9839546|FG007|COMPLETED|Period 1||4
8788188|NCT01370655|9839547|FG008|COMPLETED|Period 1||3
8788189|NCT01370655|9839548|FG009|COMPLETED|Period 1||2
8788190|NCT01370655|9839549|FG010|COMPLETED|Period 1||3
8788191|NCT01370655|9839550|FG011|COMPLETED|Period 1||3
8788192|NCT01370655|9839539|FG000|NOT COMPLETED|Period 1||2
8788193|NCT01370655|9839540|FG001|NOT COMPLETED|Period 1||0
8788194|NCT01370655|9839541|FG002|NOT COMPLETED|Period 1||0
8788195|NCT01370655|9839542|FG003|NOT COMPLETED|Period 1||0
8788196|NCT01370655|9839543|FG004|NOT COMPLETED|Period 1||0
8788197|NCT01370655|9839544|FG005|NOT COMPLETED|Period 1||0
8788198|NCT01370655|9839545|FG006|NOT COMPLETED|Period 1||1
8788199|NCT01370655|9839546|FG007|NOT COMPLETED|Period 1||0
8788200|NCT01370655|9839547|FG008|NOT COMPLETED|Period 1||0
8788201|NCT01370655|9839548|FG009|NOT COMPLETED|Period 1||0
8788202|NCT01370655|9839549|FG010|NOT COMPLETED|Period 1||0
8788203|NCT01370655|9839550|FG011|NOT COMPLETED|Period 1||0
8788204|NCT01370655|9839539|FG000|STARTED|Period 2||5
8788205|NCT01370655|9839540|FG001|STARTED|Period 2||7
8788206|NCT01370655|9839541|FG002|STARTED|Period 2||3
8788207|NCT01370655|9839542|FG003|STARTED|Period 2||3
8788208|NCT01370655|9839543|FG004|STARTED|Period 2||3
8788209|NCT01370655|9839544|FG005|STARTED|Period 2||4
8788210|NCT01370655|9839545|FG006|STARTED|Period 2||3
8788211|NCT01370655|9839546|FG007|STARTED|Period 2||4
8788212|NCT01370655|9839547|FG008|STARTED|Period 2||3
8788213|NCT01370655|9839548|FG009|STARTED|Period 2||2
8788214|NCT01370655|9839549|FG010|STARTED|Period 2||3
8788215|NCT01370655|9839550|FG011|STARTED|Period 2||3
8788216|NCT01370655|9839539|FG000|COMPLETED|Period 2||5
8788217|NCT01370655|9839540|FG001|COMPLETED|Period 2||7
8788218|NCT01370655|9839541|FG002|COMPLETED|Period 2||1
8788219|NCT01370655|9839542|FG003|COMPLETED|Period 2||3
8788220|NCT01370655|9839543|FG004|COMPLETED|Period 2||2
8788221|NCT01370655|9839544|FG005|COMPLETED|Period 2||4
8788222|NCT01370655|9839545|FG006|COMPLETED|Period 2||2
8788223|NCT01370655|9839546|FG007|COMPLETED|Period 2||3
8788224|NCT01370655|9839547|FG008|COMPLETED|Period 2||1
8788225|NCT01370655|9839548|FG009|COMPLETED|Period 2||2
8788226|NCT01370655|9839549|FG010|COMPLETED|Period 2||2
9031613|NCT03245619|10093660|FG003|NOT COMPLETED|Part C (Up to 34 Days)||0
9031614|NCT03245619|10093661|FG004|NOT COMPLETED|Part C (Up to 34 Days)||0
9031615|NCT03245619|10093662|FG005|NOT COMPLETED|Part C (Up to 34 Days)||0
9031616|NCT03245619|10093663|FG006|NOT COMPLETED|Part C (Up to 34 Days)||0
9031617|NCT03245619|10093664|FG007|NOT COMPLETED|Part C (Up to 34 Days)||0
9031618|NCT03245619|10093665|FG008|NOT COMPLETED|Part C (Up to 34 Days)||0
9031619|NCT03245619|10093666|FG009|NOT COMPLETED|Part C (Up to 34 Days)||0
9031620|NCT03245619|10093667|FG010|NOT COMPLETED|Part C (Up to 34 Days)||0
9031621|NCT03245619|10093668|FG011|NOT COMPLETED|Part C (Up to 34 Days)||0
9031622|NCT03245619|10093669|FG012|NOT COMPLETED|Part C (Up to 34 Days)||0
9031623|NCT03245619|10093670|FG013|NOT COMPLETED|Part C (Up to 34 Days)||0
9031624|NCT03245619|10093671|FG014|NOT COMPLETED|Part C (Up to 34 Days)||0
9031625|NCT03245619|10093672|FG015|NOT COMPLETED|Part C (Up to 34 Days)||0
9031626|NCT03245619|10093673|FG016|NOT COMPLETED|Part C (Up to 34 Days)||0
9031627|NCT03245723|10093734|FG000|STARTED|Overall Study||32
9031628|NCT03245723|10093735|FG001|STARTED|Overall Study||18
9031629|NCT03245723|10093734|FG000|COMPLETED|Overall Study||27
9031630|NCT03245723|10093735|FG001|COMPLETED|Overall Study||17
9031631|NCT03245723|10093734|FG000|NOT COMPLETED|Overall Study||5
9031632|NCT03245723|10093735|FG001|NOT COMPLETED|Overall Study||1
8671993|NCT00754494|9715412|FG000|NOT COMPLETED|Overall Study||2
8671994|NCT00754494|9715413|FG001|NOT COMPLETED|Overall Study||0
8671995|NCT00754494|9715414|FG002|NOT COMPLETED|Overall Study||1
8671996|NCT00754546|9715422|FG000|STARTED|Overall Study||20
8671997|NCT00754546|9715422|FG000|COMPLETED|Overall Study||20
8671998|NCT00754546|9715422|FG000|NOT COMPLETED|Overall Study||0
8671999|NCT00754559|9715432|FG000|STARTED|Overall Study||286
8672000|NCT00754559|9715432|FG000|COMPLETED|Overall Study||239
8672001|NCT00754559|9715432|FG000|NOT COMPLETED|Overall Study||47
8672002|NCT00754572|9715439|FG000|STARTED|Overall Study||418
8672003|NCT00754572|9715439|FG000|COMPLETED|Overall Study||347
8672004|NCT00754572|9715439|FG000|NOT COMPLETED|Overall Study||71
8788227|NCT01370655|9839550|FG011|COMPLETED|Period 2||3
8788228|NCT01370655|9839539|FG000|NOT COMPLETED|Period 2||0
8788229|NCT01370655|9839540|FG001|NOT COMPLETED|Period 2||0
8788230|NCT01370655|9839541|FG002|NOT COMPLETED|Period 2||2
8788231|NCT01370655|9839542|FG003|NOT COMPLETED|Period 2||0
8788232|NCT01370655|9839543|FG004|NOT COMPLETED|Period 2||1
8788233|NCT01370655|9839544|FG005|NOT COMPLETED|Period 2||0
8788234|NCT01370655|9839545|FG006|NOT COMPLETED|Period 2||1
8788235|NCT01370655|9839546|FG007|NOT COMPLETED|Period 2||1
8788236|NCT01370655|9839547|FG008|NOT COMPLETED|Period 2||2
8788237|NCT01370655|9839548|FG009|NOT COMPLETED|Period 2||0
8788238|NCT01370655|9839549|FG010|NOT COMPLETED|Period 2||1
8788239|NCT01370655|9839550|FG011|NOT COMPLETED|Period 2||0
8788240|NCT01370694|9839560|FG000|STARTED|Overall Study||7
8788241|NCT01370694|9839560|FG000|COMPLETED|Overall Study||1
8788242|NCT01370694|9839560|FG000|NOT COMPLETED|Overall Study||6
8788243|NCT01370733|9839566|FG000|STARTED|Overall Study||103
8788244|NCT01370733|9839567|FG001|STARTED|Overall Study||99
8788245|NCT01370733|9839566|FG000|COMPLETED|Overall Study||86
8788246|NCT01370733|9839567|FG001|COMPLETED|Overall Study||77
8788247|NCT01370733|9839566|FG000|NOT COMPLETED|Overall Study||17
8788248|NCT01370733|9839567|FG001|NOT COMPLETED|Overall Study||22
8788249|NCT01370837|9839576|FG000|STARTED|Overall Study||12
8788250|NCT01370837|9839577|FG001|STARTED|Overall Study||12
8788251|NCT01370837|9839578|FG002|STARTED|Overall Study||17
8788252|NCT01370837|9839576|FG000|COMPLETED|Overall Study||12
8788253|NCT01370837|9839577|FG001|COMPLETED|Overall Study||12
8788254|NCT01370837|9839578|FG002|COMPLETED|Overall Study||17
8788255|NCT01370837|9839576|FG000|NOT COMPLETED|Overall Study||0
8788256|NCT01370837|9839577|FG001|NOT COMPLETED|Overall Study||0
8788257|NCT01370837|9839578|FG002|NOT COMPLETED|Overall Study||0
8788258|NCT01370863|9839588|FG000|STARTED|Overall Study||34
8788259|NCT01370863|9839589|FG001|STARTED|Overall Study||33
8788260|NCT01370863|9839588|FG000|COMPLETED|Overall Study||32
8788261|NCT01370863|9839589|FG001|COMPLETED|Overall Study||30
8788262|NCT01370863|9839588|FG000|NOT COMPLETED|Overall Study||2
8788263|NCT01370863|9839589|FG001|NOT COMPLETED|Overall Study||3
8788264|NCT01371006|9839597|FG000|STARTED|Overall Study||14
8788265|NCT01371006|9839598|FG001|STARTED|Overall Study||15
8788266|NCT01371006|9839597|FG000|COMPLETED|Overall Study||13
8788267|NCT01371006|9839598|FG001|COMPLETED|Overall Study||15
8788268|NCT01371006|9839597|FG000|NOT COMPLETED|Overall Study||1
8788269|NCT01371006|9839598|FG001|NOT COMPLETED|Overall Study||0
8788270|NCT01371032|9839626|FG000|STARTED|Overall Study||14
8788271|NCT01371032|9839627|FG001|STARTED|Overall Study||14
8788272|NCT01371032|9839626|FG000|COMPLETED|Overall Study||14
8788273|NCT01371032|9839627|FG001|COMPLETED|Overall Study||14
8788274|NCT01371032|9839626|FG000|NOT COMPLETED|Overall Study||0
8788275|NCT01371032|9839627|FG001|NOT COMPLETED|Overall Study||0
8788276|NCT01371110|9839637|FG000|STARTED|Overall Study||1
8788277|NCT01371110|9839638|FG001|STARTED|Overall Study||2
8788278|NCT01371110|9839637|FG000|COMPLETED|Overall Study||1
8788279|NCT01371110|9839638|FG001|COMPLETED|Overall Study||2
8788280|NCT01371110|9839637|FG000|NOT COMPLETED|Overall Study||0
8788281|NCT01371110|9839638|FG001|NOT COMPLETED|Overall Study||0
8788282|NCT01371539|9839644|FG000|STARTED|Period One: One Week||53
8788283|NCT01371539|9839645|FG001|STARTED|Period One: One Week||51
8788284|NCT01371539|9839644|FG000|COMPLETED|Period One: One Week||53
8788285|NCT01371539|9839645|FG001|COMPLETED|Period One: One Week||50
8788286|NCT01371539|9839644|FG000|NOT COMPLETED|Period One: One Week||0
8788287|NCT01371539|9839645|FG001|NOT COMPLETED|Period One: One Week||1
8788288|NCT01371539|9839644|FG000|STARTED|Period Two: One Week||53
8788289|NCT01371539|9839645|FG001|STARTED|Period Two: One Week||50
8788290|NCT01371539|9839644|FG000|COMPLETED|Period Two: One Week||53
8788291|NCT01371539|9839645|FG001|COMPLETED|Period Two: One Week||47
8788292|NCT01371539|9839644|FG000|NOT COMPLETED|Period Two: One Week||0
8788293|NCT01371539|9839645|FG001|NOT COMPLETED|Period Two: One Week||3
8788294|NCT01371552|9839651|FG000|STARTED|Part 1, First 3 Days||19
8788295|NCT01371552|9839652|FG001|STARTED|Part 1, First 3 Days||17
8788296|NCT01371552|9839653|FG002|STARTED|Part 1, First 3 Days||20
8788297|NCT01371552|9839654|FG003|STARTED|Part 1, First 3 Days||20
8788298|NCT01371552|9839655|FG004|STARTED|Part 1, First 3 Days||15
8788299|NCT01371552|9839656|FG005|STARTED|Part 1, First 3 Days||18
8788300|NCT01371552|9839651|FG000|COMPLETED|Part 1, First 3 Days||19
8788301|NCT01371552|9839652|FG001|COMPLETED|Part 1, First 3 Days||17
8788302|NCT01371552|9839653|FG002|COMPLETED|Part 1, First 3 Days||19
8788303|NCT01371552|9839654|FG003|COMPLETED|Part 1, First 3 Days||20
8788304|NCT01371552|9839655|FG004|COMPLETED|Part 1, First 3 Days||15
8788305|NCT01371552|9839656|FG005|COMPLETED|Part 1, First 3 Days||18
8788306|NCT01371552|9839651|FG000|NOT COMPLETED|Part 1, First 3 Days||0
8788307|NCT01371552|9839652|FG001|NOT COMPLETED|Part 1, First 3 Days||0
8788308|NCT01371552|9839653|FG002|NOT COMPLETED|Part 1, First 3 Days||1
8788309|NCT01371552|9839654|FG003|NOT COMPLETED|Part 1, First 3 Days||0
8788310|NCT01371552|9839655|FG004|NOT COMPLETED|Part 1, First 3 Days||0
8788311|NCT01371552|9839656|FG005|NOT COMPLETED|Part 1, First 3 Days||0
8788312|NCT01371552|9839651|FG000|STARTED|Part 1, Second 3 Days||19
8788313|NCT01371552|9839652|FG001|STARTED|Part 1, Second 3 Days||17
8788314|NCT01371552|9839653|FG002|STARTED|Part 1, Second 3 Days|1 subject discontinued after First 3 days due to positive slit lamp findings unrelated to lens wear|18
8788315|NCT01371552|9839654|FG003|STARTED|Part 1, Second 3 Days||20
8788316|NCT01371552|9839655|FG004|STARTED|Part 1, Second 3 Days||15
8788317|NCT01371552|9839656|FG005|STARTED|Part 1, Second 3 Days||18
8916904|NCT02187159|9976495|FG001|COMPLETED|Overall Study||238
8788318|NCT01371552|9839651|FG000|COMPLETED|Part 1, Second 3 Days|One subject did not complete period due to discomfort but continued to next, as allowed by protocol|18
8788319|NCT01371552|9839652|FG001|COMPLETED|Part 1, Second 3 Days||17
8788320|NCT01371552|9839653|FG002|COMPLETED|Part 1, Second 3 Days||18
8788321|NCT01371552|9839654|FG003|COMPLETED|Part 1, Second 3 Days||20
8788322|NCT01371552|9839655|FG004|COMPLETED|Part 1, Second 3 Days||15
8788323|NCT01371552|9839656|FG005|COMPLETED|Part 1, Second 3 Days||18
8788324|NCT01371552|9839651|FG000|NOT COMPLETED|Part 1, Second 3 Days||1
8788325|NCT01371552|9839652|FG001|NOT COMPLETED|Part 1, Second 3 Days||0
8788326|NCT01371552|9839653|FG002|NOT COMPLETED|Part 1, Second 3 Days||0
8788327|NCT01371552|9839654|FG003|NOT COMPLETED|Part 1, Second 3 Days||0
8788328|NCT01371552|9839655|FG004|NOT COMPLETED|Part 1, Second 3 Days||0
8788329|NCT01371552|9839656|FG005|NOT COMPLETED|Part 1, Second 3 Days||0
8788330|NCT01371552|9839651|FG000|STARTED|Part 1, Third 3 Days||19
8788331|NCT01371552|9839652|FG001|STARTED|Part 1, Third 3 Days||17
8788332|NCT01371552|9839653|FG002|STARTED|Part 1, Third 3 Days||18
8788333|NCT01371552|9839654|FG003|STARTED|Part 1, Third 3 Days||20
8788334|NCT01371552|9839655|FG004|STARTED|Part 1, Third 3 Days||15
8788335|NCT01371552|9839656|FG005|STARTED|Part 1, Third 3 Days||18
8788336|NCT01371552|9839651|FG000|COMPLETED|Part 1, Third 3 Days||19
8788337|NCT01371552|9839652|FG001|COMPLETED|Part 1, Third 3 Days||17
8788338|NCT01371552|9839653|FG002|COMPLETED|Part 1, Third 3 Days||18
8788339|NCT01371552|9839654|FG003|COMPLETED|Part 1, Third 3 Days||20
8788340|NCT01371552|9839655|FG004|COMPLETED|Part 1, Third 3 Days|One subject did not complete period due to randomization error, but continued into Part 2.|14
8788341|NCT01371552|9839656|FG005|COMPLETED|Part 1, Third 3 Days|One subject did not complete period due to discomfort, but continued into Part 2.|17
8788342|NCT01371552|9839651|FG000|NOT COMPLETED|Part 1, Third 3 Days||0
8788343|NCT01371552|9839652|FG001|NOT COMPLETED|Part 1, Third 3 Days||0
8788344|NCT01371552|9839653|FG002|NOT COMPLETED|Part 1, Third 3 Days||0
8788345|NCT01371552|9839654|FG003|NOT COMPLETED|Part 1, Third 3 Days||0
8788346|NCT01371552|9839655|FG004|NOT COMPLETED|Part 1, Third 3 Days||1
8788347|NCT01371552|9839656|FG005|NOT COMPLETED|Part 1, Third 3 Days||1
8788348|NCT01371552|9839651|FG000|STARTED|Part 2, One Week|One participant discontinued between Part 1 and Part 2 due to inconvenience|18
8788349|NCT01371552|9839652|FG001|STARTED|Part 2, One Week||17
8788350|NCT01371552|9839653|FG002|STARTED|Part 2, One Week||18
8788351|NCT01371552|9839654|FG003|STARTED|Part 2, One Week||20
8788352|NCT01371552|9839655|FG004|STARTED|Part 2, One Week||15
8788353|NCT01371552|9839656|FG005|STARTED|Part 2, One Week||18
8788354|NCT01371552|9839651|FG000|COMPLETED|Part 2, One Week||18
8788355|NCT01371552|9839652|FG001|COMPLETED|Part 2, One Week||17
8788356|NCT01371552|9839653|FG002|COMPLETED|Part 2, One Week||18
8788357|NCT01371552|9839654|FG003|COMPLETED|Part 2, One Week||20
8788358|NCT01371552|9839655|FG004|COMPLETED|Part 2, One Week||15
8788359|NCT01371552|9839656|FG005|COMPLETED|Part 2, One Week||18
8788360|NCT01371552|9839651|FG000|NOT COMPLETED|Part 2, One Week||0
8788361|NCT01371552|9839652|FG001|NOT COMPLETED|Part 2, One Week||0
8788362|NCT01371552|9839653|FG002|NOT COMPLETED|Part 2, One Week||0
8788363|NCT01371552|9839654|FG003|NOT COMPLETED|Part 2, One Week||0
8788364|NCT01371552|9839655|FG004|NOT COMPLETED|Part 2, One Week||0
8788365|NCT01371552|9839656|FG005|NOT COMPLETED|Part 2, One Week||0
8788366|NCT01371565|9839665|FG000|STARTED|Overall Study||4
8788367|NCT01371565|9839665|FG000|COMPLETED|Overall Study||1
8788368|NCT01371565|9839665|FG000|NOT COMPLETED|Overall Study||3
8788369|NCT01371643|9839671|FG000|STARTED|Overall Study||15
8788370|NCT01371643|9839672|FG001|STARTED|Overall Study||26
8788371|NCT01371643|9839671|FG000|COMPLETED|Overall Study||12
8788372|NCT01371643|9839672|FG001|COMPLETED|Overall Study||26
8788373|NCT01371643|9839671|FG000|NOT COMPLETED|Overall Study||3
8788374|NCT01371643|9839672|FG001|NOT COMPLETED|Overall Study||0
8788375|NCT01371656|9839680|FG000|STARTED|Overall Study||314
8788376|NCT01371656|9839681|FG001|STARTED|Overall Study||310
8788377|NCT01371656|9839680|FG000|COMPLETED|Overall Study||250
8788378|NCT01371656|9839681|FG001|COMPLETED|Overall Study||296
8788379|NCT01371656|9839680|FG000|NOT COMPLETED|Overall Study||64
8788380|NCT01371656|9839681|FG001|NOT COMPLETED|Overall Study||14
8788381|NCT01371708|9839690|FG000|STARTED|Overall Study||92
8788382|NCT01371708|9839691|FG001|STARTED|Overall Study||93
8788383|NCT01371708|9839692|FG002|STARTED|Overall Study||98
8788384|NCT01371708|9839690|FG000|Received Treatment|Overall Study||91
8788385|NCT01371708|9839691|FG001|Received Treatment|Overall Study||93
8788386|NCT01371708|9839692|FG002|Received Treatment|Overall Study||97
8788387|NCT01371708|9839690|FG000|COMPLETED|Overall Study||66
8788388|NCT01371708|9839691|FG001|COMPLETED|Overall Study||63
8788389|NCT01371708|9839692|FG002|COMPLETED|Overall Study||59
8788390|NCT01371708|9839690|FG000|NOT COMPLETED|Overall Study||26
8788391|NCT01371708|9839691|FG001|NOT COMPLETED|Overall Study||30
8788392|NCT01371708|9839692|FG002|NOT COMPLETED|Overall Study||39
8788393|NCT01371721|9839705|FG000|STARTED|Overall Study||88
8788394|NCT01371721|9839706|FG001|STARTED|Overall Study||89
8788395|NCT01371721|9839707|FG002|STARTED|Overall Study||92
8788396|NCT01371721|9839705|FG000|Treated|Overall Study||87
8788397|NCT01371721|9839706|FG001|Treated|Overall Study||89
8788398|NCT01371721|9839707|FG002|Treated|Overall Study||92
8788399|NCT01371721|9839705|FG000|COMPLETED|Overall Study||59
8788400|NCT01371721|9839706|FG001|COMPLETED|Overall Study||65
8788401|NCT01371721|9839707|FG002|COMPLETED|Overall Study||62
8788402|NCT01371721|9839705|FG000|NOT COMPLETED|Overall Study||29
8788403|NCT01371721|9839706|FG001|NOT COMPLETED|Overall Study||24
8788404|NCT01371721|9839707|FG002|NOT COMPLETED|Overall Study||30
8788405|NCT01371734|9839720|FG000|STARTED|Overall Study||120
8788406|NCT01371734|9839721|FG001|STARTED|Overall Study||122
8788407|NCT01371734|9839722|FG002|STARTED|Overall Study||121
8788408|NCT01371734|9839720|FG000|COMPLETED|Overall Study||97
8788409|NCT01371734|9839721|FG001|COMPLETED|Overall Study||103
8788410|NCT01371734|9839722|FG002|COMPLETED|Overall Study||104
8788411|NCT01371734|9839720|FG000|NOT COMPLETED|Overall Study||23
8788412|NCT01371734|9839721|FG001|NOT COMPLETED|Overall Study||19
8788413|NCT01371734|9839722|FG002|NOT COMPLETED|Overall Study||17
8788414|NCT01371747|9839736|FG000|STARTED|Overall Study||74
8788415|NCT01371747|9839737|FG001|STARTED|Overall Study||74
8788416|NCT01371747|9839738|FG002|STARTED|Overall Study||74
8788417|NCT01371747|9839739|FG003|STARTED|Overall Study||26
8788418|NCT01371747|9839740|FG004|STARTED|Overall Study||28
8788419|NCT01371747|9839741|FG005|STARTED|Overall Study||30
8788420|NCT01371747|9839736|FG000|COMPLETED|Overall Study||56
8916905|NCT02187159|9976496|FG002|COMPLETED|Overall Study||241
8916906|NCT02187159|9976497|FG003|COMPLETED|Overall Study||221
8916907|NCT02187159|9976494|FG000|NOT COMPLETED|Overall Study||69
8916908|NCT02187159|9976495|FG001|NOT COMPLETED|Overall Study||79
8916909|NCT02187159|9976496|FG002|NOT COMPLETED|Overall Study||77
8916910|NCT02187159|9976497|FG003|NOT COMPLETED|Overall Study||96
8916911|NCT02187172|9976509|FG000|STARTED|Overall Study||22
8916912|NCT02187172|9976510|FG001|STARTED|Overall Study||21
9031633|NCT03245736|10093741|FG000|STARTED|Overall Study||5
9031634|NCT03245736|10093741|FG000|COMPLETED|Overall Study||0
9031635|NCT03245736|10093741|FG000|NOT COMPLETED|Overall Study||5
9031636|NCT03245762|10093747|FG000|STARTED|Overall Study||10
9031637|NCT03245762|10093748|FG001|STARTED|Overall Study||5
9031638|NCT03245762|10093747|FG000|COMPLETED|Overall Study||10
9031639|NCT03245762|10093748|FG001|COMPLETED|Overall Study||5
9031640|NCT03245762|10093747|FG000|NOT COMPLETED|Overall Study||0
9031641|NCT03245762|10093748|FG001|NOT COMPLETED|Overall Study||0
9031642|NCT03246061|10093756|FG000|STARTED|Overall Study||66
9031643|NCT03246061|10093757|FG001|STARTED|Overall Study||74
9031644|NCT03246061|10093756|FG000|Interim Analysis|Overall Study||51
9031645|NCT03246061|10093757|FG001|Interim Analysis|Overall Study||53
9031646|NCT03246061|10093756|FG000|COMPLETED|Overall Study||51
9031647|NCT03246061|10093757|FG001|COMPLETED|Overall Study||53
9031648|NCT03246061|10093756|FG000|NOT COMPLETED|Overall Study||15
9031649|NCT03246061|10093757|FG001|NOT COMPLETED|Overall Study||21
9031650|NCT03246152|10093765|FG000|STARTED|Overall Study||31
9031651|NCT03246152|10093765|FG000|COMPLETED|Overall Study||28
9031652|NCT03246152|10093765|FG000|NOT COMPLETED|Overall Study||3
9031653|NCT03246646|10093771|FG000|STARTED|Overall Study||26
9031654|NCT03246646|10093772|FG001|STARTED|Overall Study||26
9031655|NCT03246646|10093771|FG000|COMPLETED|Overall Study|15 participants completed either 6-month or 12-month follow-up or both.|15
9031656|NCT03246646|10093772|FG001|COMPLETED|Overall Study|Follow-up was limited to chart follow-up in CIC services|26
9031657|NCT03246646|10093771|FG000|NOT COMPLETED|Overall Study||11
9031658|NCT03246646|10093772|FG001|NOT COMPLETED|Overall Study||0
9031659|NCT03246672|10093778|FG000|STARTED|Overall Study||30
9031660|NCT03246672|10093778|FG000|Completed First Phone Call|Overall Study||29
9031661|NCT03246672|10093778|FG000|COMPLETED|Overall Study||28
9031662|NCT03246672|10093778|FG000|NOT COMPLETED|Overall Study||2
9031663|NCT03246724|10093786|FG000|STARTED|Overall Study||99
9031664|NCT03246724|10093787|FG001|STARTED|Overall Study||91
9031665|NCT03246724|10093788|FG002|STARTED|Overall Study||85
9031666|NCT03246724|10093789|FG003|STARTED|Overall Study||52
9031667|NCT03246724|10093786|FG000|COMPLETED|Overall Study||85
9031668|NCT03246724|10093787|FG001|COMPLETED|Overall Study||84
9031669|NCT03246724|10093788|FG002|COMPLETED|Overall Study||70
9031670|NCT03246724|10093789|FG003|COMPLETED|Overall Study||44
9031671|NCT03246724|10093786|FG000|NOT COMPLETED|Overall Study||14
9031672|NCT03246724|10093787|FG001|NOT COMPLETED|Overall Study||7
8916913|NCT02187172|9976509|FG000|RCT Phase Completed|Overall Study||22
8916914|NCT02187172|9976510|FG001|RCT Phase Completed|Overall Study||19
8916915|NCT02187172|9976509|FG000|COMPLETED|Overall Study||19
9031673|NCT03246724|10093788|FG002|NOT COMPLETED|Overall Study||15
9031674|NCT03246724|10093789|FG003|NOT COMPLETED|Overall Study||8
9031675|NCT03247322|10093801|FG000|STARTED|Overall Study||68
9031676|NCT03247322|10093802|FG001|STARTED|Overall Study||68
9031677|NCT03247322|10093801|FG000|COMPLETED|Overall Study||66
9031678|NCT03247322|10093802|FG001|COMPLETED|Overall Study||68
9031679|NCT03247322|10093801|FG000|NOT COMPLETED|Overall Study||2
9031680|NCT03247322|10093802|FG001|NOT COMPLETED|Overall Study||0
9031681|NCT03247517|10093813|FG000|STARTED|Overall Study||104
9031682|NCT03247517|10093814|FG001|STARTED|Overall Study||98
9031683|NCT03247517|10093815|FG002|STARTED|Overall Study|One subject randomized to the 400mg/day SPN-812 arm received 200mg/day SPN-812 during the trial|106
9031684|NCT03247517|10093813|FG000|COMPLETED|Overall Study||96
8788421|NCT01371747|9839737|FG001|COMPLETED|Overall Study||51
8788422|NCT01371747|9839738|FG002|COMPLETED|Overall Study||50
8788423|NCT01371747|9839739|FG003|COMPLETED|Overall Study||17
8788424|NCT01371747|9839740|FG004|COMPLETED|Overall Study||21
8788425|NCT01371747|9839741|FG005|COMPLETED|Overall Study||16
8788426|NCT01371747|9839736|FG000|NOT COMPLETED|Overall Study||18
8788427|NCT01371747|9839737|FG001|NOT COMPLETED|Overall Study||23
8788428|NCT01371747|9839738|FG002|NOT COMPLETED|Overall Study||24
8916916|NCT02187172|9976510|FG001|COMPLETED|Overall Study||15
8916917|NCT02187172|9976509|FG000|NOT COMPLETED|Overall Study||3
8788429|NCT01371747|9839739|FG003|NOT COMPLETED|Overall Study||9
8788430|NCT01371747|9839740|FG004|NOT COMPLETED|Overall Study||7
8788431|NCT01371747|9839741|FG005|NOT COMPLETED|Overall Study||14
8788432|NCT01371786|9839758|FG000|STARTED|Overall Study||7
8788433|NCT01371786|9839759|FG001|STARTED|Overall Study||7
8788434|NCT01371786|9839758|FG000|COMPLETED|Overall Study||7
8788435|NCT01371786|9839759|FG001|COMPLETED|Overall Study||7
8788436|NCT01371786|9839758|FG000|NOT COMPLETED|Overall Study||0
8788437|NCT01371786|9839759|FG001|NOT COMPLETED|Overall Study||0
8788438|NCT01371825|9839765|FG000|STARTED|Overall Study||9
8788439|NCT01371825|9839765|FG000|Received at Least 1 Dose of Study Drug|Overall Study||9
8788440|NCT01371825|9839765|FG000|COMPLETED|Overall Study||5
8788441|NCT01371825|9839765|FG000|NOT COMPLETED|Overall Study||4
8788442|NCT01371838|9839771|FG000|STARTED|Overall Study||381
8788443|NCT01371838|9839772|FG001|STARTED|Overall Study||383
8788444|NCT01371838|9839771|FG000|COMPLETED|Overall Study||332
8788445|NCT01371838|9839772|FG001|COMPLETED|Overall Study||317
8788446|NCT01371838|9839771|FG000|NOT COMPLETED|Overall Study||49
8788447|NCT01371838|9839772|FG001|NOT COMPLETED|Overall Study||66
8788448|NCT01371851|9839780|FG000|STARTED|Overall Study|Eligible participants who showed up on day 1 of week 1 and received at least one dose of study med.|11
8788449|NCT01371851|9839781|FG001|STARTED|Overall Study|Eligible participants who showed up on day 1 of week 1 and received at least one dose of study med.|11
8788450|NCT01371851|9839780|FG000|COMPLETED|Overall Study||3
8788451|NCT01371851|9839781|FG001|COMPLETED|Overall Study||2
8788452|NCT01371851|9839780|FG000|NOT COMPLETED|Overall Study||8
8788453|NCT01371851|9839781|FG001|NOT COMPLETED|Overall Study||9
8788454|NCT01371877|9839789|FG000|STARTED|Overall Study||21
8788455|NCT01371877|9839790|FG001|STARTED|Overall Study||21
8788456|NCT01371877|9839789|FG000|COMPLETED|Overall Study||21
8788457|NCT01371877|9839790|FG001|COMPLETED|Overall Study||17
8788458|NCT01371877|9839789|FG000|NOT COMPLETED|Overall Study||0
8788459|NCT01371877|9839790|FG001|NOT COMPLETED|Overall Study||4
8788460|NCT01371994|9839798|FG000|STARTED|Overall Study||320
8788461|NCT01371994|9839799|FG001|STARTED|Overall Study||320
8788462|NCT01371994|9839798|FG000|Received Treatment|Overall Study||310
8788463|NCT01371994|9839799|FG001|Received Treatment|Overall Study||313
8788464|NCT01371994|9839798|FG000|COMPLETED|Overall Study||263
8788465|NCT01371994|9839799|FG001|COMPLETED|Overall Study||278
8788466|NCT01371994|9839798|FG000|NOT COMPLETED|Overall Study||57
8788467|NCT01371994|9839799|FG001|NOT COMPLETED|Overall Study||42
8788468|NCT01372085|9839815|FG000|STARTED|First Intervention (Period 1)||8
8788469|NCT01372085|9839816|FG001|STARTED|First Intervention (Period 1)||2
8788470|NCT01372085|9839817|FG002|STARTED|First Intervention (Period 1)||2
8788471|NCT01372085|9839818|FG003|STARTED|First Intervention (Period 1)||1
9031685|NCT03247517|10093814|FG001|COMPLETED|Overall Study||78
9031686|NCT03247517|10093815|FG002|COMPLETED|Overall Study||92
9031687|NCT03247517|10093813|FG000|NOT COMPLETED|Overall Study||8
9031688|NCT03247517|10093814|FG001|NOT COMPLETED|Overall Study||20
9031689|NCT03247517|10093815|FG002|NOT COMPLETED|Overall Study||14
9031690|NCT03247530|10093826|FG000|STARTED|Overall Study||159
9031691|NCT03247530|10093827|FG001|STARTED|Overall Study||154
9031692|NCT03247530|10093828|FG002|STARTED|Overall Study||161
9031693|NCT03247530|10093826|FG000|COMPLETED|Overall Study||132
9031694|NCT03247530|10093827|FG001|COMPLETED|Overall Study||126
9031695|NCT03247530|10093828|FG002|COMPLETED|Overall Study||141
9031696|NCT03247530|10093826|FG000|NOT COMPLETED|Overall Study||27
9031697|NCT03247530|10093827|FG001|NOT COMPLETED|Overall Study||28
9031698|NCT03247530|10093828|FG002|NOT COMPLETED|Overall Study||20
9031699|NCT03247543|10093842|FG000|STARTED|Overall Study||102
9031700|NCT03247543|10093843|FG001|STARTED|Overall Study||107
9031701|NCT03247543|10093844|FG002|STARTED|Overall Study|One subject randomized to the 400mg/day SPN-812 arm received Placebo during the trial.|101
9031702|NCT03247543|10093842|FG000|COMPLETED|Overall Study||85
9031703|NCT03247543|10093843|FG001|COMPLETED|Overall Study||88
9031704|NCT03247543|10093844|FG002|COMPLETED|Overall Study||78
9031705|NCT03247543|10093842|FG000|NOT COMPLETED|Overall Study||17
9031706|NCT03247543|10093843|FG001|NOT COMPLETED|Overall Study||19
9031707|NCT03247543|10093844|FG002|NOT COMPLETED|Overall Study||23
9031708|NCT03247556|10093857|FG000|STARTED|Overall Study||97
8788472|NCT01372085|9839819|FG004|STARTED|First Intervention (Period 1)|Replacement participant repeated Periods 1, 2 to fulfill treatment arm comparison requirements.|3
8788473|NCT01372085|9839820|FG005|STARTED|First Intervention (Period 1)||5
8788474|NCT01372085|9839821|FG006|STARTED|First Intervention (Period 1)||3
8788475|NCT01372085|9839822|FG007|STARTED|First Intervention (Period 1)||1
8788476|NCT01372085|9839823|FG008|STARTED|First Intervention (Period 1)||1
8788477|NCT01372085|9839824|FG009|STARTED|First Intervention (Period 1)||0
8788478|NCT01372085|9839815|FG000|COMPLETED|First Intervention (Period 1)||8
8788479|NCT01372085|9839816|FG001|COMPLETED|First Intervention (Period 1)||2
8788480|NCT01372085|9839817|FG002|COMPLETED|First Intervention (Period 1)||2
8788481|NCT01372085|9839818|FG003|COMPLETED|First Intervention (Period 1)||1
8788482|NCT01372085|9839819|FG004|COMPLETED|First Intervention (Period 1)||3
8788483|NCT01372085|9839820|FG005|COMPLETED|First Intervention (Period 1)||5
8788484|NCT01372085|9839821|FG006|COMPLETED|First Intervention (Period 1)||3
8788485|NCT01372085|9839822|FG007|COMPLETED|First Intervention (Period 1)||1
9031709|NCT03247556|10093858|FG001|STARTED|Overall Study||100
9031710|NCT03247556|10093859|FG002|STARTED|Overall Study||99
9031711|NCT03247556|10093857|FG000|COMPLETED|Overall Study||85
9031712|NCT03247556|10093858|FG001|COMPLETED|Overall Study||88
9031713|NCT03247556|10093859|FG002|COMPLETED|Overall Study||81
8788486|NCT01372085|9839823|FG008|COMPLETED|First Intervention (Period 1)||1
8788487|NCT01372085|9839824|FG009|COMPLETED|First Intervention (Period 1)||0
8788488|NCT01372085|9839815|FG000|NOT COMPLETED|First Intervention (Period 1)||0
8788489|NCT01372085|9839816|FG001|NOT COMPLETED|First Intervention (Period 1)||0
8788490|NCT01372085|9839817|FG002|NOT COMPLETED|First Intervention (Period 1)||0
8788491|NCT01372085|9839818|FG003|NOT COMPLETED|First Intervention (Period 1)||0
8788492|NCT01372085|9839819|FG004|NOT COMPLETED|First Intervention (Period 1)||0
8788493|NCT01372085|9839820|FG005|NOT COMPLETED|First Intervention (Period 1)||0
8788494|NCT01372085|9839821|FG006|NOT COMPLETED|First Intervention (Period 1)||0
8788495|NCT01372085|9839822|FG007|NOT COMPLETED|First Intervention (Period 1)||0
8788496|NCT01372085|9839823|FG008|NOT COMPLETED|First Intervention (Period 1)||0
8788497|NCT01372085|9839824|FG009|NOT COMPLETED|First Intervention (Period 1)||0
8788498|NCT01372085|9839815|FG000|STARTED|Washout Period 1|Pts completed one period and did not enter washout for Part A.|0
8788499|NCT01372085|9839816|FG001|STARTED|Washout Period 1|Pts completed one period and did not enter washout for Part A.|0
8788500|NCT01372085|9839817|FG002|STARTED|Washout Period 1||2
8788501|NCT01372085|9839818|FG003|STARTED|Washout Period 1||1
8788502|NCT01372085|9839819|FG004|STARTED|Washout Period 1||3
8788503|NCT01372085|9839820|FG005|STARTED|Washout Period 1||5
8788504|NCT01372085|9839821|FG006|STARTED|Washout Period 1||3
8788505|NCT01372085|9839822|FG007|STARTED|Washout Period 1||1
8788506|NCT01372085|9839823|FG008|STARTED|Washout Period 1||1
8788507|NCT01372085|9839824|FG009|STARTED|Washout Period 1||0
8788508|NCT01372085|9839815|FG000|COMPLETED|Washout Period 1||0
8788509|NCT01372085|9839816|FG001|COMPLETED|Washout Period 1||0
8788510|NCT01372085|9839817|FG002|COMPLETED|Washout Period 1||2
8788511|NCT01372085|9839818|FG003|COMPLETED|Washout Period 1||1
8788512|NCT01372085|9839819|FG004|COMPLETED|Washout Period 1||3
8788513|NCT01372085|9839820|FG005|COMPLETED|Washout Period 1||5
8788514|NCT01372085|9839821|FG006|COMPLETED|Washout Period 1||3
8788515|NCT01372085|9839822|FG007|COMPLETED|Washout Period 1||1
8788516|NCT01372085|9839823|FG008|COMPLETED|Washout Period 1||1
8788517|NCT01372085|9839824|FG009|COMPLETED|Washout Period 1||0
8788518|NCT01372085|9839815|FG000|NOT COMPLETED|Washout Period 1||0
8788519|NCT01372085|9839816|FG001|NOT COMPLETED|Washout Period 1||0
8788520|NCT01372085|9839817|FG002|NOT COMPLETED|Washout Period 1||0
8788521|NCT01372085|9839818|FG003|NOT COMPLETED|Washout Period 1||0
8788522|NCT01372085|9839819|FG004|NOT COMPLETED|Washout Period 1||0
8788523|NCT01372085|9839820|FG005|NOT COMPLETED|Washout Period 1||0
8788524|NCT01372085|9839821|FG006|NOT COMPLETED|Washout Period 1||0
8788525|NCT01372085|9839822|FG007|NOT COMPLETED|Washout Period 1||0
8788526|NCT01372085|9839823|FG008|NOT COMPLETED|Washout Period 1||0
8788527|NCT01372085|9839824|FG009|NOT COMPLETED|Washout Period 1||0
8788528|NCT01372085|9839815|FG000|STARTED|Second Intervention (Period 2)||0
8788529|NCT01372085|9839816|FG001|STARTED|Second Intervention (Period 2)||0
8788530|NCT01372085|9839817|FG002|STARTED|Second Intervention (Period 2)||2
8788531|NCT01372085|9839818|FG003|STARTED|Second Intervention (Period 2)||1
8788532|NCT01372085|9839819|FG004|STARTED|Second Intervention (Period 2)||3
8788533|NCT01372085|9839820|FG005|STARTED|Second Intervention (Period 2)||5
8788534|NCT01372085|9839821|FG006|STARTED|Second Intervention (Period 2)||3
8788535|NCT01372085|9839822|FG007|STARTED|Second Intervention (Period 2)||1
8788536|NCT01372085|9839823|FG008|STARTED|Second Intervention (Period 2)||1
8788537|NCT01372085|9839824|FG009|STARTED|Second Intervention (Period 2)||0
8788538|NCT01372085|9839815|FG000|COMPLETED|Second Intervention (Period 2)||0
8788539|NCT01372085|9839816|FG001|COMPLETED|Second Intervention (Period 2)||0
8788540|NCT01372085|9839817|FG002|COMPLETED|Second Intervention (Period 2)||2
8788541|NCT01372085|9839818|FG003|COMPLETED|Second Intervention (Period 2)||1
8788542|NCT01372085|9839819|FG004|COMPLETED|Second Intervention (Period 2)||3
8788543|NCT01372085|9839820|FG005|COMPLETED|Second Intervention (Period 2)||5
8788544|NCT01372085|9839821|FG006|COMPLETED|Second Intervention (Period 2)||3
8788545|NCT01372085|9839822|FG007|COMPLETED|Second Intervention (Period 2)||1
8788546|NCT01372085|9839823|FG008|COMPLETED|Second Intervention (Period 2)||1
8788547|NCT01372085|9839824|FG009|COMPLETED|Second Intervention (Period 2)||0
8788548|NCT01372085|9839815|FG000|NOT COMPLETED|Second Intervention (Period 2)||0
8788549|NCT01372085|9839816|FG001|NOT COMPLETED|Second Intervention (Period 2)||0
8788550|NCT01372085|9839817|FG002|NOT COMPLETED|Second Intervention (Period 2)||0
8788551|NCT01372085|9839818|FG003|NOT COMPLETED|Second Intervention (Period 2)||0
8788552|NCT01372085|9839819|FG004|NOT COMPLETED|Second Intervention (Period 2)||0
8788553|NCT01372085|9839820|FG005|NOT COMPLETED|Second Intervention (Period 2)||0
8788554|NCT01372085|9839821|FG006|NOT COMPLETED|Second Intervention (Period 2)||0
8788555|NCT01372085|9839822|FG007|NOT COMPLETED|Second Intervention (Period 2)||0
8788556|NCT01372085|9839823|FG008|NOT COMPLETED|Second Intervention (Period 2)||0
8788557|NCT01372085|9839824|FG009|NOT COMPLETED|Second Intervention (Period 2)||0
8788558|NCT01372085|9839815|FG000|STARTED|Washout Period 2||0
8788559|NCT01372085|9839816|FG001|STARTED|Washout Period 2||0
8788560|NCT01372085|9839817|FG002|STARTED|Washout Period 2||2
8788561|NCT01372085|9839818|FG003|STARTED|Washout Period 2||1
8788562|NCT01372085|9839819|FG004|STARTED|Washout Period 2||3
8788563|NCT01372085|9839820|FG005|STARTED|Washout Period 2||5
8788564|NCT01372085|9839821|FG006|STARTED|Washout Period 2||3
8788565|NCT01372085|9839822|FG007|STARTED|Washout Period 2||1
8788566|NCT01372085|9839823|FG008|STARTED|Washout Period 2||1
8788567|NCT01372085|9839824|FG009|STARTED|Washout Period 2||0
8788568|NCT01372085|9839815|FG000|COMPLETED|Washout Period 2||0
8788569|NCT01372085|9839816|FG001|COMPLETED|Washout Period 2||0
8788570|NCT01372085|9839817|FG002|COMPLETED|Washout Period 2||2
8788571|NCT01372085|9839818|FG003|COMPLETED|Washout Period 2||1
8788572|NCT01372085|9839819|FG004|COMPLETED|Washout Period 2|One participant discontinued Washout Period 2 and was replaced in Period 1.|2
8788573|NCT01372085|9839820|FG005|COMPLETED|Washout Period 2||5
8788574|NCT01372085|9839821|FG006|COMPLETED|Washout Period 2||3
8788575|NCT01372085|9839822|FG007|COMPLETED|Washout Period 2||1
8788576|NCT01372085|9839823|FG008|COMPLETED|Washout Period 2||1
8788577|NCT01372085|9839824|FG009|COMPLETED|Washout Period 2||0
8788578|NCT01372085|9839815|FG000|NOT COMPLETED|Washout Period 2||0
8788579|NCT01372085|9839816|FG001|NOT COMPLETED|Washout Period 2||0
8788580|NCT01372085|9839817|FG002|NOT COMPLETED|Washout Period 2||0
8788581|NCT01372085|9839818|FG003|NOT COMPLETED|Washout Period 2||0
8788582|NCT01372085|9839819|FG004|NOT COMPLETED|Washout Period 2||1
8788583|NCT01372085|9839820|FG005|NOT COMPLETED|Washout Period 2||0
8788584|NCT01372085|9839821|FG006|NOT COMPLETED|Washout Period 2||0
8788585|NCT01372085|9839822|FG007|NOT COMPLETED|Washout Period 2||0
8788586|NCT01372085|9839823|FG008|NOT COMPLETED|Washout Period 2||0
8788587|NCT01372085|9839824|FG009|NOT COMPLETED|Washout Period 2||0
8788588|NCT01372085|9839815|FG000|STARTED|Third Intervention (Period 3)||0
8788589|NCT01372085|9839816|FG001|STARTED|Third Intervention (Period 3)||0
8788590|NCT01372085|9839817|FG002|STARTED|Third Intervention (Period 3)||2
8788591|NCT01372085|9839818|FG003|STARTED|Third Intervention (Period 3)||1
8788592|NCT01372085|9839819|FG004|STARTED|Third Intervention (Period 3)||2
8788593|NCT01372085|9839820|FG005|STARTED|Third Intervention (Period 3)|Replacement pts repeated Period (P) 3 to fulfill requirement for P3 versus P4a comparison.|7
8788594|NCT01372085|9839821|FG006|STARTED|Third Intervention (Period 3)||3
8788595|NCT01372085|9839822|FG007|STARTED|Third Intervention (Period 3)||1
8788596|NCT01372085|9839823|FG008|STARTED|Third Intervention (Period 3)||1
8788597|NCT01372085|9839824|FG009|STARTED|Third Intervention (Period 3)||0
8788598|NCT01372085|9839815|FG000|COMPLETED|Third Intervention (Period 3)||0
8788599|NCT01372085|9839816|FG001|COMPLETED|Third Intervention (Period 3)||0
8788600|NCT01372085|9839817|FG002|COMPLETED|Third Intervention (Period 3)||2
8788601|NCT01372085|9839818|FG003|COMPLETED|Third Intervention (Period 3)||1
8788602|NCT01372085|9839819|FG004|COMPLETED|Third Intervention (Period 3)||2
8788603|NCT01372085|9839820|FG005|COMPLETED|Third Intervention (Period 3)||7
8788604|NCT01372085|9839821|FG006|COMPLETED|Third Intervention (Period 3)||3
8788605|NCT01372085|9839822|FG007|COMPLETED|Third Intervention (Period 3)||1
8788606|NCT01372085|9839823|FG008|COMPLETED|Third Intervention (Period 3)||1
8788607|NCT01372085|9839824|FG009|COMPLETED|Third Intervention (Period 3)||0
8788608|NCT01372085|9839815|FG000|NOT COMPLETED|Third Intervention (Period 3)||0
8788609|NCT01372085|9839816|FG001|NOT COMPLETED|Third Intervention (Period 3)||0
8788610|NCT01372085|9839817|FG002|NOT COMPLETED|Third Intervention (Period 3)||0
8788611|NCT01372085|9839818|FG003|NOT COMPLETED|Third Intervention (Period 3)||0
8788612|NCT01372085|9839819|FG004|NOT COMPLETED|Third Intervention (Period 3)||0
8788613|NCT01372085|9839820|FG005|NOT COMPLETED|Third Intervention (Period 3)||0
8788614|NCT01372085|9839821|FG006|NOT COMPLETED|Third Intervention (Period 3)||0
8788615|NCT01372085|9839822|FG007|NOT COMPLETED|Third Intervention (Period 3)||0
8788616|NCT01372085|9839823|FG008|NOT COMPLETED|Third Intervention (Period 3)||0
8788617|NCT01372085|9839824|FG009|NOT COMPLETED|Third Intervention (Period 3)||0
8788618|NCT01372085|9839815|FG000|STARTED|Washout Period 3||0
8788619|NCT01372085|9839816|FG001|STARTED|Washout Period 3||0
8788620|NCT01372085|9839817|FG002|STARTED|Washout Period 3||2
8788621|NCT01372085|9839818|FG003|STARTED|Washout Period 3||1
8788622|NCT01372085|9839819|FG004|STARTED|Washout Period 3||2
8788623|NCT01372085|9839820|FG005|STARTED|Washout Period 3||7
8788624|NCT01372085|9839821|FG006|STARTED|Washout Period 3||3
8788625|NCT01372085|9839822|FG007|STARTED|Washout Period 3||1
8788626|NCT01372085|9839823|FG008|STARTED|Washout Period 3||1
8788627|NCT01372085|9839824|FG009|STARTED|Washout Period 3||0
8788628|NCT01372085|9839815|FG000|COMPLETED|Washout Period 3||0
8788629|NCT01372085|9839816|FG001|COMPLETED|Washout Period 3||0
8788630|NCT01372085|9839817|FG002|COMPLETED|Washout Period 3||2
8788631|NCT01372085|9839818|FG003|COMPLETED|Washout Period 3||1
8788632|NCT01372085|9839819|FG004|COMPLETED|Washout Period 3||2
8788633|NCT01372085|9839820|FG005|COMPLETED|Washout Period 3|Two participants (pts) discontinued Washout P3 and were replaced in P3.|5
8788634|NCT01372085|9839821|FG006|COMPLETED|Washout Period 3||3
8788635|NCT01372085|9839822|FG007|COMPLETED|Washout Period 3||1
8788636|NCT01372085|9839823|FG008|COMPLETED|Washout Period 3||1
8788637|NCT01372085|9839824|FG009|COMPLETED|Washout Period 3||0
8788638|NCT01372085|9839815|FG000|NOT COMPLETED|Washout Period 3||0
8788639|NCT01372085|9839816|FG001|NOT COMPLETED|Washout Period 3||0
8788640|NCT01372085|9839817|FG002|NOT COMPLETED|Washout Period 3||0
8788641|NCT01372085|9839818|FG003|NOT COMPLETED|Washout Period 3||0
8788642|NCT01372085|9839819|FG004|NOT COMPLETED|Washout Period 3||0
8788643|NCT01372085|9839820|FG005|NOT COMPLETED|Washout Period 3||2
8788644|NCT01372085|9839821|FG006|NOT COMPLETED|Washout Period 3||0
8788645|NCT01372085|9839822|FG007|NOT COMPLETED|Washout Period 3||0
8788646|NCT01372085|9839823|FG008|NOT COMPLETED|Washout Period 3||0
8788647|NCT01372085|9839824|FG009|NOT COMPLETED|Washout Period 3||0
8788648|NCT01372085|9839815|FG000|STARTED|Forth Intervention (Period 4a/4b)||0
8788649|NCT01372085|9839816|FG001|STARTED|Forth Intervention (Period 4a/4b)||0
8788650|NCT01372085|9839817|FG002|STARTED|Forth Intervention (Period 4a/4b)||2
8788651|NCT01372085|9839818|FG003|STARTED|Forth Intervention (Period 4a/4b)||1
8788652|NCT01372085|9839819|FG004|STARTED|Forth Intervention (Period 4a/4b)||2
8788653|NCT01372085|9839820|FG005|STARTED|Forth Intervention (Period 4a/4b)||5
8788654|NCT01372085|9839821|FG006|STARTED|Forth Intervention (Period 4a/4b)||3
8788655|NCT01372085|9839822|FG007|STARTED|Forth Intervention (Period 4a/4b)||1
8788656|NCT01372085|9839823|FG008|STARTED|Forth Intervention (Period 4a/4b)||1
8788657|NCT01372085|9839824|FG009|STARTED|Forth Intervention (Period 4a/4b)|One pt was enrolled directly into P4b to fulfill requirement for safety and tolerability assessment.|1
8788658|NCT01372085|9839815|FG000|COMPLETED|Forth Intervention (Period 4a/4b)||0
8788659|NCT01372085|9839816|FG001|COMPLETED|Forth Intervention (Period 4a/4b)||0
8788660|NCT01372085|9839817|FG002|COMPLETED|Forth Intervention (Period 4a/4b)||2
8788661|NCT01372085|9839818|FG003|COMPLETED|Forth Intervention (Period 4a/4b)||1
8788662|NCT01372085|9839819|FG004|COMPLETED|Forth Intervention (Period 4a/4b)||2
8788663|NCT01372085|9839820|FG005|COMPLETED|Forth Intervention (Period 4a/4b)||5
8788664|NCT01372085|9839821|FG006|COMPLETED|Forth Intervention (Period 4a/4b)||3
8788665|NCT01372085|9839822|FG007|COMPLETED|Forth Intervention (Period 4a/4b)||1
8788666|NCT01372085|9839823|FG008|COMPLETED|Forth Intervention (Period 4a/4b)||1
8788667|NCT01372085|9839824|FG009|COMPLETED|Forth Intervention (Period 4a/4b)||1
8788668|NCT01372085|9839815|FG000|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
8788669|NCT01372085|9839816|FG001|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
8788670|NCT01372085|9839817|FG002|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
8788671|NCT01372085|9839818|FG003|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
8788672|NCT01372085|9839819|FG004|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
8788673|NCT01372085|9839820|FG005|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
8788674|NCT01372085|9839821|FG006|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
8788675|NCT01372085|9839822|FG007|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
8788676|NCT01372085|9839823|FG008|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
8788677|NCT01372085|9839824|FG009|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
8788678|NCT01372150|9839851|FG000|STARTED|Overall Study||112
8788679|NCT01372150|9839852|FG001|STARTED|Overall Study||113
8788680|NCT01372150|9839853|FG002|STARTED|Overall Study||115
8788681|NCT01372150|9839851|FG000|Treated|Overall Study||112
8788682|NCT01372150|9839852|FG001|Treated|Overall Study||112
8788683|NCT01372150|9839853|FG002|Treated|Overall Study||115
8788684|NCT01372150|9839851|FG000|COMPLETED|Overall Study||99
8788685|NCT01372150|9839852|FG001|COMPLETED|Overall Study||99
8788686|NCT01372150|9839853|FG002|COMPLETED|Overall Study||99
8788687|NCT01372150|9839851|FG000|NOT COMPLETED|Overall Study||13
8788688|NCT01372150|9839852|FG001|NOT COMPLETED|Overall Study||14
8788689|NCT01372150|9839853|FG002|NOT COMPLETED|Overall Study||16
8788690|NCT01372202|9839864|FG000|STARTED|Overall Study||13
8788691|NCT01372202|9839865|FG001|STARTED|Overall Study||9
8788692|NCT01372202|9839866|FG002|STARTED|Overall Study||9
8788693|NCT01372202|9839864|FG000|COMPLETED|Overall Study||13
8788694|NCT01372202|9839865|FG001|COMPLETED|Overall Study||9
8788695|NCT01372202|9839866|FG002|COMPLETED|Overall Study||9
8788696|NCT01372202|9839864|FG000|NOT COMPLETED|Overall Study||0
8788697|NCT01372202|9839865|FG001|NOT COMPLETED|Overall Study||0
8788698|NCT01372202|9839866|FG002|NOT COMPLETED|Overall Study||0
8788699|NCT01372384|9839879|FG000|STARTED|Overall Study||6
8788700|NCT01372384|9839879|FG000|COMPLETED|Overall Study||3
9031714|NCT03247556|10093857|FG000|NOT COMPLETED|Overall Study||12
9031715|NCT03247556|10093858|FG001|NOT COMPLETED|Overall Study||12
9031716|NCT03247556|10093859|FG002|NOT COMPLETED|Overall Study||18
9031717|NCT03247673|10093870|FG000|STARTED|Overall Study||46
9031718|NCT03247673|10093871|FG001|STARTED|Overall Study||47
9031719|NCT03247673|10093872|FG002|STARTED|Overall Study||48
9031720|NCT03247673|10093870|FG000|COMPLETED|Overall Study||45
9031721|NCT03247673|10093871|FG001|COMPLETED|Overall Study||47
9031722|NCT03247673|10093872|FG002|COMPLETED|Overall Study||44
8788701|NCT01372384|9839879|FG000|NOT COMPLETED|Overall Study||3
8788702|NCT01372410|9839883|FG000|STARTED|Treatment Period 1 (7 Days)||20
8788703|NCT01372410|9839884|FG001|STARTED|Treatment Period 1 (7 Days)||21
8788704|NCT01372410|9839885|FG002|STARTED|Treatment Period 1 (7 Days)||19
8788705|NCT01372410|9839886|FG003|STARTED|Treatment Period 1 (7 Days)||20
8788706|NCT01372410|9839887|FG004|STARTED|Treatment Period 1 (7 Days)||21
8788707|NCT01372410|9839888|FG005|STARTED|Treatment Period 1 (7 Days)||21
8788708|NCT01372410|9839889|FG006|STARTED|Treatment Period 1 (7 Days)||22
8788709|NCT01372410|9839890|FG007|STARTED|Treatment Period 1 (7 Days)||19
8788710|NCT01372410|9839883|FG000|COMPLETED|Treatment Period 1 (7 Days)||19
8788711|NCT01372410|9839884|FG001|COMPLETED|Treatment Period 1 (7 Days)||19
8788712|NCT01372410|9839885|FG002|COMPLETED|Treatment Period 1 (7 Days)||19
8788713|NCT01372410|9839886|FG003|COMPLETED|Treatment Period 1 (7 Days)||20
8788714|NCT01372410|9839887|FG004|COMPLETED|Treatment Period 1 (7 Days)||19
8788715|NCT01372410|9839888|FG005|COMPLETED|Treatment Period 1 (7 Days)||21
8788716|NCT01372410|9839889|FG006|COMPLETED|Treatment Period 1 (7 Days)||20
8788717|NCT01372410|9839890|FG007|COMPLETED|Treatment Period 1 (7 Days)||19
8788718|NCT01372410|9839883|FG000|NOT COMPLETED|Treatment Period 1 (7 Days)||1
8788719|NCT01372410|9839884|FG001|NOT COMPLETED|Treatment Period 1 (7 Days)||2
8788720|NCT01372410|9839885|FG002|NOT COMPLETED|Treatment Period 1 (7 Days)||0
9031723|NCT03247673|10093870|FG000|NOT COMPLETED|Overall Study||1
9031724|NCT03247673|10093871|FG001|NOT COMPLETED|Overall Study||0
9031725|NCT03247673|10093872|FG002|NOT COMPLETED|Overall Study||4
9031726|NCT03247686|10093882|FG000|STARTED|Overall Study||8
8788721|NCT01372410|9839886|FG003|NOT COMPLETED|Treatment Period 1 (7 Days)||0
8788722|NCT01372410|9839887|FG004|NOT COMPLETED|Treatment Period 1 (7 Days)||2
8788723|NCT01372410|9839888|FG005|NOT COMPLETED|Treatment Period 1 (7 Days)||0
8788724|NCT01372410|9839889|FG006|NOT COMPLETED|Treatment Period 1 (7 Days)||2
8788725|NCT01372410|9839890|FG007|NOT COMPLETED|Treatment Period 1 (7 Days)||0
8788726|NCT01372410|9839883|FG000|STARTED|Washout Period 1 (10-14 Days)||19
8788727|NCT01372410|9839884|FG001|STARTED|Washout Period 1 (10-14 Days)||19
8788728|NCT01372410|9839885|FG002|STARTED|Washout Period 1 (10-14 Days)||19
8788729|NCT01372410|9839886|FG003|STARTED|Washout Period 1 (10-14 Days)||20
8788730|NCT01372410|9839887|FG004|STARTED|Washout Period 1 (10-14 Days)||19
8788731|NCT01372410|9839888|FG005|STARTED|Washout Period 1 (10-14 Days)||21
8788732|NCT01372410|9839889|FG006|STARTED|Washout Period 1 (10-14 Days)||20
8788733|NCT01372410|9839890|FG007|STARTED|Washout Period 1 (10-14 Days)||19
8788734|NCT01372410|9839883|FG000|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|18
8788735|NCT01372410|9839884|FG001|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
8788736|NCT01372410|9839885|FG002|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
8788737|NCT01372410|9839886|FG003|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
8788738|NCT01372410|9839887|FG004|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
8788739|NCT01372410|9839888|FG005|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|21
8788740|NCT01372410|9839889|FG006|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
8788741|NCT01372410|9839890|FG007|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|18
8788742|NCT01372410|9839883|FG000|NOT COMPLETED|Washout Period 1 (10-14 Days)||1
8788743|NCT01372410|9839884|FG001|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
8788744|NCT01372410|9839885|FG002|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
8788745|NCT01372410|9839886|FG003|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
8788746|NCT01372410|9839887|FG004|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
8788747|NCT01372410|9839888|FG005|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
8788748|NCT01372410|9839889|FG006|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
8788749|NCT01372410|9839890|FG007|NOT COMPLETED|Washout Period 1 (10-14 Days)||1
8788750|NCT01372410|9839883|FG000|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
8788751|NCT01372410|9839884|FG001|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|21
8788752|NCT01372410|9839885|FG002|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|22
8788753|NCT01372410|9839886|FG003|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|17
8916918|NCT02187172|9976510|FG001|NOT COMPLETED|Overall Study||6
8916919|NCT02187471|9976522|FG000|STARTED|Overall Study||325
8916920|NCT02187471|9976523|FG001|STARTED|Overall Study||324
8916921|NCT02187471|9976524|FG002|STARTED|Overall Study||326
8916922|NCT02187471|9976525|FG003|STARTED|Overall Study||326
8916923|NCT02187471|9976522|FG000|COMPLETED|Overall Study||249
8916924|NCT02187471|9976523|FG001|COMPLETED|Overall Study||242
8916925|NCT02187471|9976524|FG002|COMPLETED|Overall Study||240
8916926|NCT02187471|9976525|FG003|COMPLETED|Overall Study||246
8916927|NCT02187471|9976522|FG000|NOT COMPLETED|Overall Study||76
8916928|NCT02187471|9976523|FG001|NOT COMPLETED|Overall Study||82
8916929|NCT02187471|9976524|FG002|NOT COMPLETED|Overall Study||86
8916930|NCT02187471|9976525|FG003|NOT COMPLETED|Overall Study||80
8916931|NCT02187744|9976538|FG000|STARTED|Study|Received treatment|113
8916932|NCT02187744|9976539|FG001|STARTED|Study|Received treatment|112
8916933|NCT02187744|9976538|FG000|COMPLETED|Study||109
8916934|NCT02187744|9976539|FG001|COMPLETED|Study||106
8916935|NCT02187744|9976538|FG000|NOT COMPLETED|Study||4
8916936|NCT02187744|9976539|FG001|NOT COMPLETED|Study||6
8916937|NCT02187744|9976538|FG000|STARTED|Treatment||113
8916938|NCT02187744|9976539|FG001|STARTED|Treatment||112
8916939|NCT02187744|9976538|FG000|COMPLETED|Treatment||109
8916940|NCT02187744|9976539|FG001|COMPLETED|Treatment||107
8916941|NCT02187744|9976538|FG000|NOT COMPLETED|Treatment||4
8916942|NCT02187744|9976539|FG001|NOT COMPLETED|Treatment||5
8916943|NCT02187783|9976545|FG000|STARTED|Overall Study||106
8916944|NCT02187783|9976545|FG000|Patients With Solid Tumors|Overall Study||105
8916945|NCT02187783|9976545|FG000|COMPLETED|Overall Study||0
8916946|NCT02187783|9976545|FG000|NOT COMPLETED|Overall Study||106
8916947|NCT02187809|9976549|FG000|STARTED|Overall Study||3
8916948|NCT02187809|9976549|FG000|Treated|Overall Study||1
8916949|NCT02187809|9976549|FG000|COMPLETED|Overall Study||0
8916950|NCT02187809|9976549|FG000|NOT COMPLETED|Overall Study||3
8916951|NCT02187861|9976557|FG000|STARTED|Overall Study||9
8916952|NCT02187861|9976558|FG001|STARTED|Overall Study||52
8916953|NCT02187861|9976559|FG002|STARTED|Overall Study||51
8916954|NCT02187861|9976560|FG003|STARTED|Overall Study||51
8916955|NCT02187861|9976557|FG000|Treated|Overall Study||9
8916956|NCT02187861|9976558|FG001|Treated|Overall Study||52
8916957|NCT02187861|9976559|FG002|Treated|Overall Study||49
8916958|NCT02187861|9976560|FG003|Treated|Overall Study||50
8916959|NCT02187861|9976557|FG000|COMPLETED|Overall Study||3
8916960|NCT02187861|9976558|FG001|COMPLETED|Overall Study||4
8788754|NCT01372410|9839887|FG004|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
8788755|NCT01372410|9839888|FG005|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|16
8788756|NCT01372410|9839889|FG006|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|21
8788757|NCT01372410|9839890|FG007|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
8788758|NCT01372410|9839883|FG000|COMPLETED|Treatment Period 2 (7 Days)||19
8788759|NCT01372410|9839884|FG001|COMPLETED|Treatment Period 2 (7 Days)||21
8788760|NCT01372410|9839885|FG002|COMPLETED|Treatment Period 2 (7 Days)||22
8788761|NCT01372410|9839886|FG003|COMPLETED|Treatment Period 2 (7 Days)||17
8788762|NCT01372410|9839887|FG004|COMPLETED|Treatment Period 2 (7 Days)||19
8788763|NCT01372410|9839888|FG005|COMPLETED|Treatment Period 2 (7 Days)||16
8788764|NCT01372410|9839889|FG006|COMPLETED|Treatment Period 2 (7 Days)||21
8788765|NCT01372410|9839890|FG007|COMPLETED|Treatment Period 2 (7 Days)||19
8788766|NCT01372410|9839883|FG000|NOT COMPLETED|Treatment Period 2 (7 Days)||0
8788767|NCT01372410|9839884|FG001|NOT COMPLETED|Treatment Period 2 (7 Days)||0
8788768|NCT01372410|9839885|FG002|NOT COMPLETED|Treatment Period 2 (7 Days)||0
8788769|NCT01372410|9839886|FG003|NOT COMPLETED|Treatment Period 2 (7 Days)||0
8788770|NCT01372410|9839887|FG004|NOT COMPLETED|Treatment Period 2 (7 Days)||0
8788771|NCT01372410|9839888|FG005|NOT COMPLETED|Treatment Period 2 (7 Days)||0
8788772|NCT01372410|9839889|FG006|NOT COMPLETED|Treatment Period 2 (7 Days)||0
8788773|NCT01372410|9839890|FG007|NOT COMPLETED|Treatment Period 2 (7 Days)||0
8788774|NCT01372410|9839883|FG000|STARTED|Washout Period 2 (10-14 Days)||19
8788775|NCT01372410|9839884|FG001|STARTED|Washout Period 2 (10-14 Days)||21
8788776|NCT01372410|9839885|FG002|STARTED|Washout Period 2 (10-14 Days)||22
8788777|NCT01372410|9839886|FG003|STARTED|Washout Period 2 (10-14 Days)||17
8788778|NCT01372410|9839887|FG004|STARTED|Washout Period 2 (10-14 Days)||19
8788779|NCT01372410|9839888|FG005|STARTED|Washout Period 2 (10-14 Days)||16
8788780|NCT01372410|9839889|FG006|STARTED|Washout Period 2 (10-14 Days)||21
8788781|NCT01372410|9839890|FG007|STARTED|Washout Period 2 (10-14 Days)||19
8788782|NCT01372410|9839883|FG000|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
8788783|NCT01372410|9839884|FG001|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|21
8788784|NCT01372410|9839885|FG002|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|22
8788785|NCT01372410|9839886|FG003|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|17
8788786|NCT01372410|9839887|FG004|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|17
8788787|NCT01372410|9839888|FG005|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|16
8788788|NCT01372410|9839889|FG006|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
9031727|NCT03247686|10093883|FG001|STARTED|Overall Study||20
9031728|NCT03247686|10093882|FG000|COMPLETED|Overall Study||7
9031729|NCT03247686|10093883|FG001|COMPLETED|Overall Study||18
9031730|NCT03247686|10093882|FG000|NOT COMPLETED|Overall Study||1
9031731|NCT03247686|10093883|FG001|NOT COMPLETED|Overall Study||2
9031732|NCT03247738|10093894|FG000|STARTED|Overall Study||25
9031733|NCT03247738|10093895|FG001|STARTED|Overall Study||25
9031734|NCT03247738|10093894|FG000|COMPLETED|Overall Study||25
9031735|NCT03247738|10093895|FG001|COMPLETED|Overall Study||25
9031736|NCT03247738|10093894|FG000|NOT COMPLETED|Overall Study||0
9031737|NCT03247738|10093895|FG001|NOT COMPLETED|Overall Study||0
9031738|NCT03247790|10093901|FG000|STARTED|Period 1: Migraine Attack||16
9031739|NCT03247790|10093901|FG000|Received at Least One Dose of Study Drug|Period 1: Migraine Attack||16
9031740|NCT03247790|10093901|FG000|COMPLETED|Period 1: Migraine Attack||16
9031741|NCT03247790|10093901|FG000|NOT COMPLETED|Period 1: Migraine Attack||0
9031742|NCT03247790|10093901|FG000|STARTED|Period 2: Inter-ictal Period||16
9031743|NCT03247790|10093901|FG000|COMPLETED|Period 2: Inter-ictal Period||16
9031744|NCT03247790|10093901|FG000|NOT COMPLETED|Period 2: Inter-ictal Period||0
9031745|NCT03247816|10093907|FG000|STARTED|Overall Study||59
9031746|NCT03247816|10093907|FG000|COMPLETED|Overall Study||30
9031747|NCT03247816|10093907|FG000|NOT COMPLETED|Overall Study||29
9031748|NCT03247985|10093915|FG000|STARTED|Overall Study||19
9031749|NCT03247985|10093916|FG001|STARTED|Overall Study||19
9031750|NCT03247985|10093915|FG000|COMPLETED|Overall Study||19
9031751|NCT03247985|10093916|FG001|COMPLETED|Overall Study||19
9031752|NCT03247985|10093915|FG000|NOT COMPLETED|Overall Study||0
9031753|NCT03247985|10093916|FG001|NOT COMPLETED|Overall Study||0
9031754|NCT03248037|10093924|FG000|STARTED|Overall Study|Fellow eyes could be enrolled and were automatically assigned to the opposite treatment arm.|95
9031755|NCT03248037|10093925|FG001|STARTED|Overall Study|Fellow eyes could be enrolled and were automatically assigned to the opposite treatment arm.|96
9031756|NCT03248037|10093924|FG000|COMPLETED|Overall Study||74
9031757|NCT03248037|10093925|FG001|COMPLETED|Overall Study||87
9031758|NCT03248037|10093924|FG000|NOT COMPLETED|Overall Study||21
9031759|NCT03248037|10093925|FG001|NOT COMPLETED|Overall Study||9
9031760|NCT03248440|10093933|FG000|STARTED|Overall Study||131
9031761|NCT03248440|10093934|FG001|STARTED|Overall Study||132
9031762|NCT03248440|10093933|FG000|COMPLETED|Overall Study||116
9031763|NCT03248440|10093934|FG001|COMPLETED|Overall Study||120
9031764|NCT03248440|10093933|FG000|NOT COMPLETED|Overall Study||15
8788789|NCT01372410|9839890|FG007|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|17
8788790|NCT01372410|9839883|FG000|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
8788791|NCT01372410|9839884|FG001|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
8788792|NCT01372410|9839885|FG002|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
8788793|NCT01372410|9839886|FG003|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
8788794|NCT01372410|9839887|FG004|NOT COMPLETED|Washout Period 2 (10-14 Days)||2
8788795|NCT01372410|9839888|FG005|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
8788796|NCT01372410|9839889|FG006|NOT COMPLETED|Washout Period 2 (10-14 Days)||1
8788797|NCT01372410|9839890|FG007|NOT COMPLETED|Washout Period 2 (10-14 Days)||2
8788798|NCT01372410|9839883|FG000|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|21
8788799|NCT01372410|9839884|FG001|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|18
8788800|NCT01372410|9839885|FG002|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|16
8788801|NCT01372410|9839886|FG003|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|22
8788802|NCT01372410|9839887|FG004|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|20
8788803|NCT01372410|9839888|FG005|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
8788804|NCT01372410|9839889|FG006|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|15
8788805|NCT01372410|9839890|FG007|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|18
8788806|NCT01372410|9839883|FG000|COMPLETED|Treatment Period 3 (7 Days)||21
8788807|NCT01372410|9839884|FG001|COMPLETED|Treatment Period 3 (7 Days)||18
8788808|NCT01372410|9839885|FG002|COMPLETED|Treatment Period 3 (7 Days)||15
8788809|NCT01372410|9839886|FG003|COMPLETED|Treatment Period 3 (7 Days)||22
8788810|NCT01372410|9839887|FG004|COMPLETED|Treatment Period 3 (7 Days)||20
8788811|NCT01372410|9839888|FG005|COMPLETED|Treatment Period 3 (7 Days)||18
8788812|NCT01372410|9839889|FG006|COMPLETED|Treatment Period 3 (7 Days)||15
8788813|NCT01372410|9839890|FG007|COMPLETED|Treatment Period 3 (7 Days)||18
8788814|NCT01372410|9839883|FG000|NOT COMPLETED|Treatment Period 3 (7 Days)||0
8788815|NCT01372410|9839884|FG001|NOT COMPLETED|Treatment Period 3 (7 Days)||0
8788816|NCT01372410|9839885|FG002|NOT COMPLETED|Treatment Period 3 (7 Days)||1
8788817|NCT01372410|9839886|FG003|NOT COMPLETED|Treatment Period 3 (7 Days)||0
8788818|NCT01372410|9839887|FG004|NOT COMPLETED|Treatment Period 3 (7 Days)||0
8788819|NCT01372410|9839888|FG005|NOT COMPLETED|Treatment Period 3 (7 Days)||1
8788820|NCT01372410|9839889|FG006|NOT COMPLETED|Treatment Period 3 (7 Days)||0
8788821|NCT01372410|9839890|FG007|NOT COMPLETED|Treatment Period 3 (7 Days)||0
8788822|NCT01372462|9839909|FG000|STARTED|NIOV - Room Air||15
8788823|NCT01372462|9839909|FG000|COMPLETED|NIOV - Room Air||15
8788824|NCT01372462|9839909|FG000|NOT COMPLETED|NIOV - Room Air||0
8788825|NCT01372462|9839909|FG000|STARTED|NIOV - Oxygen||15
8788826|NCT01372462|9839909|FG000|COMPLETED|NIOV - Oxygen||15
8788827|NCT01372462|9839909|FG000|NOT COMPLETED|NIOV - Oxygen||0
8788828|NCT01372462|9839909|FG000|STARTED|Oxygen Nasal Cannula||15
8788829|NCT01372462|9839909|FG000|COMPLETED|Oxygen Nasal Cannula||15
8788830|NCT01372462|9839909|FG000|NOT COMPLETED|Oxygen Nasal Cannula||0
8788831|NCT01372462|9839909|FG000|STARTED|No Treatment Control||15
8788832|NCT01372462|9839909|FG000|COMPLETED|No Treatment Control||15
8788833|NCT01372462|9839909|FG000|NOT COMPLETED|No Treatment Control||0
8788834|NCT01372501|9839919|FG000|STARTED|Overall Study||19
8788835|NCT01372501|9839919|FG000|COMPLETED|Overall Study||14
8788836|NCT01372501|9839919|FG000|NOT COMPLETED|Overall Study||5
8788837|NCT01372605|9839926|FG000|STARTED|Overall Study||149
8788838|NCT01372605|9839927|FG001|STARTED|Overall Study||155
8788839|NCT01372605|9839926|FG000|COMPLETED|Overall Study||137
8788840|NCT01372605|9839927|FG001|COMPLETED|Overall Study||145
8788841|NCT01372605|9839926|FG000|NOT COMPLETED|Overall Study||12
8788842|NCT01372605|9839927|FG001|NOT COMPLETED|Overall Study||10
8788843|NCT01372748|9839935|FG000|STARTED|Overall Study||11045
8788844|NCT01372748|9839936|FG001|STARTED|Overall Study||12642
8788845|NCT01372748|9839935|FG000|COMPLETED|Overall Study|defined as having vital status|11022
8788846|NCT01372748|9839936|FG001|COMPLETED|Overall Study|defined as having vital status|12603
8788847|NCT01372748|9839935|FG000|NOT COMPLETED|Overall Study||23
8788848|NCT01372748|9839936|FG001|NOT COMPLETED|Overall Study||39
8788849|NCT01372774|9839944|FG000|STARTED|Overall Study||96
8788850|NCT01372774|9839945|FG001|STARTED|Overall Study||98
8788851|NCT01372774|9839944|FG000|COMPLETED|Overall Study||92
8788852|NCT01372774|9839945|FG001|COMPLETED|Overall Study||93
8788853|NCT01372774|9839944|FG000|NOT COMPLETED|Overall Study||4
8788854|NCT01372774|9839945|FG001|NOT COMPLETED|Overall Study||5
8788855|NCT01372813|9839953|FG000|STARTED|Overall Study||3
8788856|NCT01372813|9839953|FG000|COMPLETED|Overall Study||3
8788857|NCT01372813|9839953|FG000|NOT COMPLETED|Overall Study||0
8788858|NCT01372878|9839957|FG000|STARTED|Overall Study||884
8788859|NCT01372878|9839957|FG000|COMPLETED|Overall Study||700
8788860|NCT01372878|9839957|FG000|NOT COMPLETED|Overall Study||184
8788861|NCT01372995|9839964|FG000|STARTED|Overall Study||10
8788862|NCT01372995|9839965|FG001|STARTED|Overall Study||10
8788863|NCT01372995|9839966|FG002|STARTED|Overall Study|One participant was transferred to comfort care prior to completing the intervention.|11
8916961|NCT02187861|9976559|FG002|COMPLETED|Overall Study||19
8788864|NCT01372995|9839964|FG000|COMPLETED|Overall Study||10
8788865|NCT01372995|9839965|FG001|COMPLETED|Overall Study||9
8788866|NCT01372995|9839966|FG002|COMPLETED|Overall Study|The transferred participant was included in the intent to treat analyses.|10
8788867|NCT01372995|9839964|FG000|NOT COMPLETED|Overall Study||0
8788868|NCT01372995|9839965|FG001|NOT COMPLETED|Overall Study||1
8788869|NCT01372995|9839966|FG002|NOT COMPLETED|Overall Study||1
8916962|NCT02187861|9976560|FG003|COMPLETED|Overall Study||19
8916963|NCT02187861|9976557|FG000|NOT COMPLETED|Overall Study||6
8916964|NCT02187861|9976558|FG001|NOT COMPLETED|Overall Study||48
8916965|NCT02187861|9976559|FG002|NOT COMPLETED|Overall Study||32
8916966|NCT02187861|9976560|FG003|NOT COMPLETED|Overall Study||32
8916967|NCT02187887|9976572|FG000|STARTED|Overall Study||393
8916968|NCT02187887|9976573|FG001|STARTED|Overall Study||400
8916969|NCT02187887|9976572|FG000|COMPLETED|Overall Study||388
8916970|NCT02187887|9976573|FG001|COMPLETED|Overall Study||396
8916971|NCT02187887|9976572|FG000|NOT COMPLETED|Overall Study||5
8916972|NCT02187887|9976573|FG001|NOT COMPLETED|Overall Study||4
8916973|NCT02188160|9976581|FG000|STARTED|Overall Study||73
9031765|NCT03248440|10093934|FG001|NOT COMPLETED|Overall Study||12
9031766|NCT03248492|10093945|FG000|STARTED|Overall Study||50
9031767|NCT03248492|10093946|FG001|STARTED|Overall Study||48
9031768|NCT03248492|10093947|FG002|STARTED|Overall Study||21
9031769|NCT03248492|10093948|FG003|STARTED|Overall Study||130
9031770|NCT03248492|10093949|FG004|STARTED|Overall Study||4
9031771|NCT03248492|10093945|FG000|COMPLETED|Overall Study||0
9031772|NCT03248492|10093946|FG001|COMPLETED|Overall Study||0
9031773|NCT03248492|10093947|FG002|COMPLETED|Overall Study||0
9031774|NCT03248492|10093948|FG003|COMPLETED|Overall Study||0
9031775|NCT03248492|10093949|FG004|COMPLETED|Overall Study||0
9031776|NCT03248492|10093945|FG000|NOT COMPLETED|Overall Study||50
9031777|NCT03248492|10093946|FG001|NOT COMPLETED|Overall Study||48
9031778|NCT03248492|10093947|FG002|NOT COMPLETED|Overall Study||21
9031779|NCT03248492|10093948|FG003|NOT COMPLETED|Overall Study||130
9031780|NCT03248492|10093949|FG004|NOT COMPLETED|Overall Study||4
9031781|NCT03248882|10093974|FG000|STARTED|Overall Study||61
9031782|NCT03248882|10093975|FG001|STARTED|Overall Study||63
9031783|NCT03248882|10093976|FG002|STARTED|Overall Study||62
9031784|NCT03248882|10093977|FG003|STARTED|Overall Study||58
9031785|NCT03248882|10093978|FG004|STARTED|Overall Study||61
9031786|NCT03248882|10093974|FG000|Received Treatment|Overall Study||61
9031787|NCT03248882|10093975|FG001|Received Treatment|Overall Study||63
9031788|NCT03248882|10093976|FG002|Received Treatment|Overall Study||62
9031789|NCT03248882|10093977|FG003|Received Treatment|Overall Study||58
9031790|NCT03248882|10093978|FG004|Received Treatment|Overall Study||61
9031791|NCT03248882|10093974|FG000|COMPLETED|Overall Study||54
9031792|NCT03248882|10093975|FG001|COMPLETED|Overall Study||58
9031793|NCT03248882|10093976|FG002|COMPLETED|Overall Study||55
9031794|NCT03248882|10093977|FG003|COMPLETED|Overall Study||48
9031795|NCT03248882|10093978|FG004|COMPLETED|Overall Study||48
9031796|NCT03248882|10093974|FG000|NOT COMPLETED|Overall Study||7
9031797|NCT03248882|10093975|FG001|NOT COMPLETED|Overall Study||5
9031798|NCT03248882|10093976|FG002|NOT COMPLETED|Overall Study||7
9031799|NCT03248882|10093977|FG003|NOT COMPLETED|Overall Study||10
9031800|NCT03248882|10093978|FG004|NOT COMPLETED|Overall Study||13
9031801|NCT03248947|10093990|FG000|STARTED|Overall Study||71
9031802|NCT03248947|10093990|FG000|COMPLETED|Overall Study||63
9031803|NCT03248947|10093990|FG000|NOT COMPLETED|Overall Study||8
9031804|NCT03249116|10094001|FG000|STARTED|Overall Study||25
9031805|NCT03249116|10094002|FG001|STARTED|Overall Study||25
9031806|NCT03249116|10094003|FG002|STARTED|Overall Study||25
9031807|NCT03249116|10094001|FG000|COMPLETED|Overall Study||25
9031808|NCT03249116|10094002|FG001|COMPLETED|Overall Study||25
9031809|NCT03249116|10094003|FG002|COMPLETED|Overall Study||25
9031810|NCT03249116|10094001|FG000|NOT COMPLETED|Overall Study||0
9031811|NCT03249116|10094002|FG001|NOT COMPLETED|Overall Study||0
9031812|NCT03249116|10094003|FG002|NOT COMPLETED|Overall Study||0
9031813|NCT03249272|10094015|FG000|STARTED|Overall Study||19
9031814|NCT03249272|10094016|FG001|STARTED|Overall Study||6
9031815|NCT03249272|10094017|FG002|STARTED|Overall Study||6
9031816|NCT03249272|10094015|FG000|COMPLETED|Overall Study||19
9031817|NCT03249272|10094016|FG001|COMPLETED|Overall Study||6
9031818|NCT03249272|10094017|FG002|COMPLETED|Overall Study||6
9031819|NCT03249272|10094015|FG000|NOT COMPLETED|Overall Study||0
9031820|NCT03249272|10094016|FG001|NOT COMPLETED|Overall Study||0
9031821|NCT03249272|10094017|FG002|NOT COMPLETED|Overall Study||0
9031822|NCT03249454|10094037|FG000|STARTED|Overall Study||1
9031823|NCT03249454|10094038|FG001|STARTED|Overall Study||1
9031824|NCT03249454|10094039|FG002|STARTED|Overall Study||2
9031825|NCT03249454|10094040|FG003|STARTED|Overall Study||1
9031826|NCT03249454|10094041|FG004|STARTED|Overall Study||1
9031827|NCT03249454|10094042|FG005|STARTED|Overall Study||2
9031828|NCT03249454|10094043|FG006|STARTED|Overall Study||1
9031829|NCT03249454|10094044|FG007|STARTED|Overall Study||1
9031830|NCT03249454|10094045|FG008|STARTED|Overall Study||1
9031831|NCT03249454|10094046|FG009|STARTED|Overall Study||1
9031832|NCT03249454|10094047|FG010|STARTED|Overall Study||1
9031833|NCT03249454|10094037|FG000|First Intervention (1 Day)|Overall Study||1
9031834|NCT03249454|10094038|FG001|First Intervention (1 Day)|Overall Study||1
9031835|NCT03249454|10094039|FG002|First Intervention (1 Day)|Overall Study||2
9031836|NCT03249454|10094040|FG003|First Intervention (1 Day)|Overall Study||1
8916974|NCT02188160|9976582|FG001|STARTED|Overall Study||77
8916975|NCT02188160|9976581|FG000|COMPLETED|Overall Study||72
8788870|NCT01373164|9839979|FG000|STARTED|Overall Study||5
8788871|NCT01373164|9839980|FG001|STARTED|Overall Study||4
8788872|NCT01373164|9839981|FG002|STARTED|Overall Study||5
8788873|NCT01373164|9839982|FG003|STARTED|Overall Study||104
8788874|NCT01373164|9839983|FG004|STARTED|Overall Study||52
8788875|NCT01373164|9839979|FG000|Received at Least One Dose|Overall Study||5
8788876|NCT01373164|9839980|FG001|Received at Least One Dose|Overall Study||4
8788877|NCT01373164|9839981|FG002|Received at Least One Dose|Overall Study||5
8788878|NCT01373164|9839982|FG003|Received at Least One Dose|Overall Study||103
8788879|NCT01373164|9839983|FG004|Received at Least One Dose|Overall Study||52
9031837|NCT03249454|10094041|FG004|First Intervention (1 Day)|Overall Study||1
9031838|NCT03249454|10094042|FG005|First Intervention (1 Day)|Overall Study||2
9031839|NCT03249454|10094043|FG006|First Intervention (1 Day)|Overall Study||1
9031840|NCT03249454|10094044|FG007|First Intervention (1 Day)|Overall Study||1
9031841|NCT03249454|10094045|FG008|First Intervention (1 Day)|Overall Study||1
9031842|NCT03249454|10094046|FG009|First Intervention (1 Day)|Overall Study||0
9031843|NCT03249454|10094047|FG010|First Intervention (1 Day)|Overall Study||0
9031844|NCT03249454|10094037|FG000|Washout (1 Week)|Overall Study||1
9031845|NCT03249454|10094038|FG001|Washout (1 Week)|Overall Study||1
9031846|NCT03249454|10094039|FG002|Washout (1 Week)|Overall Study||2
9031847|NCT03249454|10094040|FG003|Washout (1 Week)|Overall Study||1
9031848|NCT03249454|10094041|FG004|Washout (1 Week)|Overall Study||1
9031849|NCT03249454|10094042|FG005|Washout (1 Week)|Overall Study||2
9031850|NCT03249454|10094043|FG006|Washout (1 Week)|Overall Study||1
9031851|NCT03249454|10094044|FG007|Washout (1 Week)|Overall Study||1
9031852|NCT03249454|10094045|FG008|Washout (1 Week)|Overall Study||1
9031853|NCT03249454|10094046|FG009|Washout (1 Week)|Overall Study||0
9031854|NCT03249454|10094047|FG010|Washout (1 Week)|Overall Study||0
9031855|NCT03249454|10094037|FG000|Second Intervention (1 Day)|Overall Study||1
9031856|NCT03249454|10094038|FG001|Second Intervention (1 Day)|Overall Study||1
9031857|NCT03249454|10094039|FG002|Second Intervention (1 Day)|Overall Study||2
9031858|NCT03249454|10094040|FG003|Second Intervention (1 Day)|Overall Study||1
9031859|NCT03249454|10094041|FG004|Second Intervention (1 Day)|Overall Study||1
9031860|NCT03249454|10094042|FG005|Second Intervention (1 Day)|Overall Study||2
9031861|NCT03249454|10094043|FG006|Second Intervention (1 Day)|Overall Study||1
9031862|NCT03249454|10094044|FG007|Second Intervention (1 Day)|Overall Study||1
9031863|NCT03249454|10094045|FG008|Second Intervention (1 Day)|Overall Study||1
9031864|NCT03249454|10094046|FG009|Second Intervention (1 Day)|Overall Study||0
9031865|NCT03249454|10094047|FG010|Second Intervention (1 Day)|Overall Study||0
9031866|NCT03249454|10094037|FG000|Washout (1 Week)|Overall Study||1
9031867|NCT03249454|10094038|FG001|Washout (1 Week)|Overall Study||1
9031868|NCT03249454|10094039|FG002|Washout (1 Week)|Overall Study||2
9031869|NCT03249454|10094040|FG003|Washout (1 Week)|Overall Study||1
9031870|NCT03249454|10094041|FG004|Washout (1 Week)|Overall Study||1
9031871|NCT03249454|10094042|FG005|Washout (1 Week)|Overall Study||2
9031872|NCT03249454|10094043|FG006|Washout (1 Week)|Overall Study||1
9031873|NCT03249454|10094044|FG007|Washout (1 Week)|Overall Study||1
9031874|NCT03249454|10094045|FG008|Washout (1 Week)|Overall Study||1
9031875|NCT03249454|10094046|FG009|Washout (1 Week)|Overall Study||0
9031876|NCT03249454|10094047|FG010|Washout (1 Week)|Overall Study||0
9031877|NCT03249454|10094037|FG000|Third Intervention (1 Day)|Overall Study||1
9031878|NCT03249454|10094038|FG001|Third Intervention (1 Day)|Overall Study||1
9031879|NCT03249454|10094039|FG002|Third Intervention (1 Day)|Overall Study||2
9031880|NCT03249454|10094040|FG003|Third Intervention (1 Day)|Overall Study||1
9031881|NCT03249454|10094041|FG004|Third Intervention (1 Day)|Overall Study||1
9031882|NCT03249454|10094042|FG005|Third Intervention (1 Day)|Overall Study||2
9031883|NCT03249454|10094043|FG006|Third Intervention (1 Day)|Overall Study||1
9031884|NCT03249454|10094044|FG007|Third Intervention (1 Day)|Overall Study||1
9031885|NCT03249454|10094045|FG008|Third Intervention (1 Day)|Overall Study||1
9031886|NCT03249454|10094046|FG009|Third Intervention (1 Day)|Overall Study||0
9031887|NCT03249454|10094047|FG010|Third Intervention (1 Day)|Overall Study||0
9031888|NCT03249454|10094037|FG000|Washout (1 Week)|Overall Study||1
9031889|NCT03249454|10094038|FG001|Washout (1 Week)|Overall Study||1
9031890|NCT03249454|10094039|FG002|Washout (1 Week)|Overall Study||2
9031891|NCT03249454|10094040|FG003|Washout (1 Week)|Overall Study||1
9031892|NCT03249454|10094041|FG004|Washout (1 Week)|Overall Study||1
9031893|NCT03249454|10094042|FG005|Washout (1 Week)|Overall Study||2
9031894|NCT03249454|10094043|FG006|Washout (1 Week)|Overall Study||1
9031895|NCT03249454|10094044|FG007|Washout (1 Week)|Overall Study||1
9031896|NCT03249454|10094045|FG008|Washout (1 Week)|Overall Study||1
9031897|NCT03249454|10094046|FG009|Washout (1 Week)|Overall Study||0
9031898|NCT03249454|10094047|FG010|Washout (1 Week)|Overall Study||0
9031899|NCT03249454|10094037|FG000|Fourth Intervention (1 Day)|Overall Study||1
9031900|NCT03249454|10094038|FG001|Fourth Intervention (1 Day)|Overall Study||1
9031901|NCT03249454|10094039|FG002|Fourth Intervention (1 Day)|Overall Study||2
9031902|NCT03249454|10094040|FG003|Fourth Intervention (1 Day)|Overall Study||1
9031903|NCT03249454|10094041|FG004|Fourth Intervention (1 Day)|Overall Study||1
9031904|NCT03249454|10094042|FG005|Fourth Intervention (1 Day)|Overall Study||2
9031905|NCT03249454|10094043|FG006|Fourth Intervention (1 Day)|Overall Study||1
9031906|NCT03249454|10094044|FG007|Fourth Intervention (1 Day)|Overall Study||1
9031907|NCT03249454|10094045|FG008|Fourth Intervention (1 Day)|Overall Study||1
8788880|NCT01373164|9839979|FG000|COMPLETED|Overall Study||5
8788881|NCT01373164|9839980|FG001|COMPLETED|Overall Study||3
8788882|NCT01373164|9839981|FG002|COMPLETED|Overall Study||4
8788883|NCT01373164|9839982|FG003|COMPLETED|Overall Study||92
8788884|NCT01373164|9839983|FG004|COMPLETED|Overall Study||50
8788885|NCT01373164|9839979|FG000|NOT COMPLETED|Overall Study||0
8788886|NCT01373164|9839980|FG001|NOT COMPLETED|Overall Study||1
8788887|NCT01373164|9839981|FG002|NOT COMPLETED|Overall Study||1
8788888|NCT01373164|9839982|FG003|NOT COMPLETED|Overall Study||12
8788889|NCT01373164|9839983|FG004|NOT COMPLETED|Overall Study||2
8788890|NCT01373229|9839998|FG000|STARTED|Overall Study||15
8788891|NCT01373229|9839998|FG000|COMPLETED|Overall Study||9
8788892|NCT01373229|9839998|FG000|NOT COMPLETED|Overall Study||6
8788893|NCT01373242|9840002|FG000|STARTED|Overall Study||54
8788894|NCT01373242|9840002|FG000|COMPLETED|Overall Study||38
8788895|NCT01373242|9840002|FG000|NOT COMPLETED|Overall Study||16
8788896|NCT01373294|9840010|FG000|STARTED|Overall Study||15
8788897|NCT01373294|9840011|FG001|STARTED|Overall Study||2
8788898|NCT01373294|9840010|FG000|COMPLETED|Overall Study||14
8788899|NCT01373294|9840011|FG001|COMPLETED|Overall Study||2
8788900|NCT01373294|9840010|FG000|NOT COMPLETED|Overall Study||1
8788901|NCT01373294|9840011|FG001|NOT COMPLETED|Overall Study||0
8788902|NCT01373346|9840017|FG000|STARTED|Overall Study||15
8788903|NCT01373346|9840017|FG000|COMPLETED|Overall Study||14
8788904|NCT01373346|9840017|FG000|NOT COMPLETED|Overall Study||1
8788905|NCT01373450|9840026|FG000|STARTED|Crossover Period 1||2
8788906|NCT01373450|9840027|FG001|STARTED|Crossover Period 1||2
8788907|NCT01373450|9840028|FG002|STARTED|Crossover Period 1||2
8788908|NCT01373450|9840029|FG003|STARTED|Crossover Period 1||2
8788909|NCT01373450|9840030|FG004|STARTED|Crossover Period 1||2
8788910|NCT01373450|9840031|FG005|STARTED|Crossover Period 1||2
8788911|NCT01373450|9840026|FG000|COMPLETED|Crossover Period 1||2
8788912|NCT01373450|9840027|FG001|COMPLETED|Crossover Period 1||2
8788913|NCT01373450|9840028|FG002|COMPLETED|Crossover Period 1||2
8788914|NCT01373450|9840029|FG003|COMPLETED|Crossover Period 1||2
8788915|NCT01373450|9840030|FG004|COMPLETED|Crossover Period 1||2
8788916|NCT01373450|9840031|FG005|COMPLETED|Crossover Period 1||2
8788917|NCT01373450|9840026|FG000|NOT COMPLETED|Crossover Period 1||0
8788918|NCT01373450|9840027|FG001|NOT COMPLETED|Crossover Period 1||0
8788919|NCT01373450|9840028|FG002|NOT COMPLETED|Crossover Period 1||0
8788920|NCT01373450|9840029|FG003|NOT COMPLETED|Crossover Period 1||0
8788921|NCT01373450|9840030|FG004|NOT COMPLETED|Crossover Period 1||0
8788922|NCT01373450|9840031|FG005|NOT COMPLETED|Crossover Period 1||0
8788923|NCT01373450|9840026|FG000|STARTED|7 Day Wash-out||2
8788924|NCT01373450|9840027|FG001|STARTED|7 Day Wash-out||2
8788925|NCT01373450|9840028|FG002|STARTED|7 Day Wash-out||2
8788926|NCT01373450|9840029|FG003|STARTED|7 Day Wash-out||2
8788927|NCT01373450|9840030|FG004|STARTED|7 Day Wash-out||2
8788928|NCT01373450|9840031|FG005|STARTED|7 Day Wash-out||2
8788929|NCT01373450|9840026|FG000|COMPLETED|7 Day Wash-out||2
8788930|NCT01373450|9840027|FG001|COMPLETED|7 Day Wash-out||2
8788931|NCT01373450|9840028|FG002|COMPLETED|7 Day Wash-out||2
8788932|NCT01373450|9840029|FG003|COMPLETED|7 Day Wash-out||2
8788933|NCT01373450|9840030|FG004|COMPLETED|7 Day Wash-out||2
8788934|NCT01373450|9840031|FG005|COMPLETED|7 Day Wash-out||2
8788935|NCT01373450|9840026|FG000|NOT COMPLETED|7 Day Wash-out||0
8788936|NCT01373450|9840027|FG001|NOT COMPLETED|7 Day Wash-out||0
8788937|NCT01373450|9840028|FG002|NOT COMPLETED|7 Day Wash-out||0
8788938|NCT01373450|9840029|FG003|NOT COMPLETED|7 Day Wash-out||0
8788939|NCT01373450|9840030|FG004|NOT COMPLETED|7 Day Wash-out||0
8788940|NCT01373450|9840031|FG005|NOT COMPLETED|7 Day Wash-out||0
8788941|NCT01373450|9840026|FG000|STARTED|Crossover Period 2||2
8788942|NCT01373450|9840027|FG001|STARTED|Crossover Period 2||2
8788943|NCT01373450|9840028|FG002|STARTED|Crossover Period 2||2
8788944|NCT01373450|9840029|FG003|STARTED|Crossover Period 2||2
8788945|NCT01373450|9840030|FG004|STARTED|Crossover Period 2||2
8788946|NCT01373450|9840031|FG005|STARTED|Crossover Period 2||2
8788947|NCT01373450|9840026|FG000|COMPLETED|Crossover Period 2||2
8788948|NCT01373450|9840027|FG001|COMPLETED|Crossover Period 2||2
8788949|NCT01373450|9840028|FG002|COMPLETED|Crossover Period 2||2
8788950|NCT01373450|9840029|FG003|COMPLETED|Crossover Period 2||2
8788951|NCT01373450|9840030|FG004|COMPLETED|Crossover Period 2||2
8788952|NCT01373450|9840031|FG005|COMPLETED|Crossover Period 2||2
8788953|NCT01373450|9840026|FG000|NOT COMPLETED|Crossover Period 2||0
8788954|NCT01373450|9840027|FG001|NOT COMPLETED|Crossover Period 2||0
8788955|NCT01373450|9840028|FG002|NOT COMPLETED|Crossover Period 2||0
8788956|NCT01373450|9840029|FG003|NOT COMPLETED|Crossover Period 2||0
8788957|NCT01373450|9840030|FG004|NOT COMPLETED|Crossover Period 2||0
8788958|NCT01373450|9840031|FG005|NOT COMPLETED|Crossover Period 2||0
8788959|NCT01373450|9840026|FG000|STARTED|7 Day Wash-out||2
8788960|NCT01373450|9840027|FG001|STARTED|7 Day Wash-out||2
8788961|NCT01373450|9840028|FG002|STARTED|7 Day Wash-out||2
8788962|NCT01373450|9840029|FG003|STARTED|7 Day Wash-out||2
8788963|NCT01373450|9840030|FG004|STARTED|7 Day Wash-out||2
8788964|NCT01373450|9840031|FG005|STARTED|7 Day Wash-out||2
8788965|NCT01373450|9840026|FG000|COMPLETED|7 Day Wash-out||2
8788966|NCT01373450|9840027|FG001|COMPLETED|7 Day Wash-out||2
8788967|NCT01373450|9840028|FG002|COMPLETED|7 Day Wash-out||2
8788968|NCT01373450|9840029|FG003|COMPLETED|7 Day Wash-out||2
8788969|NCT01373450|9840030|FG004|COMPLETED|7 Day Wash-out||2
8788970|NCT01373450|9840031|FG005|COMPLETED|7 Day Wash-out||2
8788971|NCT01373450|9840026|FG000|NOT COMPLETED|7 Day Wash-out||0
8788972|NCT01373450|9840027|FG001|NOT COMPLETED|7 Day Wash-out||0
8788973|NCT01373450|9840028|FG002|NOT COMPLETED|7 Day Wash-out||0
8788974|NCT01373450|9840029|FG003|NOT COMPLETED|7 Day Wash-out||0
8788975|NCT01373450|9840030|FG004|NOT COMPLETED|7 Day Wash-out||0
8788976|NCT01373450|9840031|FG005|NOT COMPLETED|7 Day Wash-out||0
8788977|NCT01373450|9840026|FG000|STARTED|Crossover Period 3||2
8788978|NCT01373450|9840027|FG001|STARTED|Crossover Period 3||2
8788979|NCT01373450|9840028|FG002|STARTED|Crossover Period 3||2
8788980|NCT01373450|9840029|FG003|STARTED|Crossover Period 3||2
8788981|NCT01373450|9840030|FG004|STARTED|Crossover Period 3||2
8788982|NCT01373450|9840031|FG005|STARTED|Crossover Period 3||2
8788983|NCT01373450|9840026|FG000|COMPLETED|Crossover Period 3||2
8788984|NCT01373450|9840027|FG001|COMPLETED|Crossover Period 3||2
8788985|NCT01373450|9840028|FG002|COMPLETED|Crossover Period 3||2
8788986|NCT01373450|9840029|FG003|COMPLETED|Crossover Period 3||2
8788987|NCT01373450|9840030|FG004|COMPLETED|Crossover Period 3||2
8788988|NCT01373450|9840031|FG005|COMPLETED|Crossover Period 3||2
8788989|NCT01373450|9840026|FG000|NOT COMPLETED|Crossover Period 3||0
8788990|NCT01373450|9840027|FG001|NOT COMPLETED|Crossover Period 3||0
8788991|NCT01373450|9840028|FG002|NOT COMPLETED|Crossover Period 3||0
8788992|NCT01373450|9840029|FG003|NOT COMPLETED|Crossover Period 3||0
8788993|NCT01373450|9840030|FG004|NOT COMPLETED|Crossover Period 3||0
8788994|NCT01373450|9840031|FG005|NOT COMPLETED|Crossover Period 3||0
8788995|NCT01373450|9840026|FG000|STARTED|7 Day Wash-out||2
8788996|NCT01373450|9840027|FG001|STARTED|7 Day Wash-out||2
8788997|NCT01373450|9840028|FG002|STARTED|7 Day Wash-out||2
8788998|NCT01373450|9840029|FG003|STARTED|7 Day Wash-out||2
8788999|NCT01373450|9840030|FG004|STARTED|7 Day Wash-out||2
8789000|NCT01373450|9840031|FG005|STARTED|7 Day Wash-out||2
8789001|NCT01373450|9840026|FG000|COMPLETED|7 Day Wash-out||2
8789002|NCT01373450|9840027|FG001|COMPLETED|7 Day Wash-out||2
8789003|NCT01373450|9840028|FG002|COMPLETED|7 Day Wash-out||2
8789004|NCT01373450|9840029|FG003|COMPLETED|7 Day Wash-out||2
8789005|NCT01373450|9840030|FG004|COMPLETED|7 Day Wash-out||2
8789006|NCT01373450|9840031|FG005|COMPLETED|7 Day Wash-out||2
8789007|NCT01373450|9840026|FG000|NOT COMPLETED|7 Day Wash-out||0
8789008|NCT01373450|9840027|FG001|NOT COMPLETED|7 Day Wash-out||0
8789009|NCT01373450|9840028|FG002|NOT COMPLETED|7 Day Wash-out||0
8789010|NCT01373450|9840029|FG003|NOT COMPLETED|7 Day Wash-out||0
8789011|NCT01373450|9840030|FG004|NOT COMPLETED|7 Day Wash-out||0
8789012|NCT01373450|9840031|FG005|NOT COMPLETED|7 Day Wash-out||0
8789013|NCT01373450|9840026|FG000|STARTED|Crossover Period 4||2
8789014|NCT01373450|9840027|FG001|STARTED|Crossover Period 4||2
8789015|NCT01373450|9840028|FG002|STARTED|Crossover Period 4||2
8789016|NCT01373450|9840029|FG003|STARTED|Crossover Period 4||2
8789017|NCT01373450|9840030|FG004|STARTED|Crossover Period 4||2
8789018|NCT01373450|9840031|FG005|STARTED|Crossover Period 4||2
8789019|NCT01373450|9840026|FG000|COMPLETED|Crossover Period 4||2
8789020|NCT01373450|9840027|FG001|COMPLETED|Crossover Period 4||2
8789021|NCT01373450|9840028|FG002|COMPLETED|Crossover Period 4||2
8789022|NCT01373450|9840029|FG003|COMPLETED|Crossover Period 4||2
8789023|NCT01373450|9840030|FG004|COMPLETED|Crossover Period 4||2
8789024|NCT01373450|9840031|FG005|COMPLETED|Crossover Period 4||2
8789025|NCT01373450|9840026|FG000|NOT COMPLETED|Crossover Period 4||0
8789026|NCT01373450|9840027|FG001|NOT COMPLETED|Crossover Period 4||0
8789027|NCT01373450|9840028|FG002|NOT COMPLETED|Crossover Period 4||0
8789028|NCT01373450|9840029|FG003|NOT COMPLETED|Crossover Period 4||0
8789029|NCT01373450|9840030|FG004|NOT COMPLETED|Crossover Period 4||0
8789030|NCT01373450|9840031|FG005|NOT COMPLETED|Crossover Period 4||0
8789031|NCT01373489|9840047|FG000|STARTED|Overall Study||59
8789032|NCT01373489|9840048|FG001|STARTED|Overall Study||54
8789033|NCT01373489|9840047|FG000|COMPLETED|Overall Study||44
8789034|NCT01373489|9840048|FG001|COMPLETED|Overall Study||41
8789035|NCT01373489|9840047|FG000|NOT COMPLETED|Overall Study||15
8789036|NCT01373489|9840048|FG001|NOT COMPLETED|Overall Study||13
8789037|NCT01373580|9840054|FG000|STARTED|Overall Study||373
8789038|NCT01373580|9840054|FG000|COMPLETED|Overall Study||317
8789039|NCT01373580|9840054|FG000|NOT COMPLETED|Overall Study||56
8789040|NCT01373671|9840058|FG000|STARTED|Overall Study||764
8789041|NCT01373671|9840058|FG000|COMPLETED|Overall Study||672
8789042|NCT01373671|9840058|FG000|NOT COMPLETED|Overall Study||92
8789043|NCT01373918|9840065|FG000|STARTED|Overall Study||20
8789044|NCT01373918|9840066|FG001|STARTED|Overall Study||16
8789045|NCT01373918|9840065|FG000|COMPLETED|Overall Study||20
8789046|NCT01373918|9840066|FG001|COMPLETED|Overall Study||15
8789047|NCT01373918|9840065|FG000|NOT COMPLETED|Overall Study||0
8789048|NCT01373918|9840066|FG001|NOT COMPLETED|Overall Study||1
8789049|NCT01373931|9840074|FG000|STARTED|Lead-in Period||10
8789050|NCT01373931|9840075|FG001|STARTED|Lead-in Period||10
8789051|NCT01373931|9840074|FG000|Received at Least 1 Dose of Study Drug|Lead-in Period||8
8789052|NCT01373931|9840075|FG001|Received at Least 1 Dose of Study Drug|Lead-in Period||10
8789053|NCT01373931|9840074|FG000|COMPLETED|Lead-in Period||8
8789054|NCT01373931|9840075|FG001|COMPLETED|Lead-in Period||10
8789055|NCT01373931|9840074|FG000|NOT COMPLETED|Lead-in Period||2
8789056|NCT01373931|9840075|FG001|NOT COMPLETED|Lead-in Period||0
8789057|NCT01373931|9840074|FG000|STARTED|Period 1||8
8789058|NCT01373931|9840075|FG001|STARTED|Period 1||10
8789059|NCT01373931|9840074|FG000|COMPLETED|Period 1||6
8789060|NCT01373931|9840075|FG001|COMPLETED|Period 1||8
8789061|NCT01373931|9840074|FG000|NOT COMPLETED|Period 1||2
8789062|NCT01373931|9840075|FG001|NOT COMPLETED|Period 1||2
8789063|NCT01373931|9840074|FG000|STARTED|Period 2||6
8789064|NCT01373931|9840075|FG001|STARTED|Period 2||8
8789065|NCT01373931|9840074|FG000|COMPLETED|Period 2||6
8789066|NCT01373931|9840075|FG001|COMPLETED|Period 2||8
8789067|NCT01373931|9840074|FG000|NOT COMPLETED|Period 2||0
8789068|NCT01373931|9840075|FG001|NOT COMPLETED|Period 2||0
8789069|NCT01374087|9840084|FG000|STARTED|Overall Study||16
8789070|NCT01374087|9840085|FG001|STARTED|Overall Study||15
8789071|NCT01374087|9840084|FG000|COMPLETED|Overall Study||0
8789072|NCT01374087|9840085|FG001|COMPLETED|Overall Study||0
8789073|NCT01374087|9840084|FG000|NOT COMPLETED|Overall Study||16
8789074|NCT01374087|9840085|FG001|NOT COMPLETED|Overall Study||15
8789075|NCT01374178|9840091|FG000|STARTED|Period 1 (up to 24 Hours After Dosing)||11
8789076|NCT01374178|9840092|FG001|STARTED|Period 1 (up to 24 Hours After Dosing)||5
8789077|NCT01374178|9840091|FG000|Received at Least 1 Dose of LY2963016|Period 1 (up to 24 Hours After Dosing)||11
8789078|NCT01374178|9840092|FG001|Received at Least 1 Dose of LY2963016|Period 1 (up to 24 Hours After Dosing)||5
8789079|NCT01374178|9840091|FG000|COMPLETED|Period 1 (up to 24 Hours After Dosing)||11
8789080|NCT01374178|9840092|FG001|COMPLETED|Period 1 (up to 24 Hours After Dosing)||5
8789081|NCT01374178|9840091|FG000|NOT COMPLETED|Period 1 (up to 24 Hours After Dosing)||0
8789082|NCT01374178|9840092|FG001|NOT COMPLETED|Period 1 (up to 24 Hours After Dosing)||0
8789083|NCT01374178|9840091|FG000|STARTED|Washout Period of at Least 7 Days||11
8789084|NCT01374178|9840092|FG001|STARTED|Washout Period of at Least 7 Days||5
8789085|NCT01374178|9840091|FG000|COMPLETED|Washout Period of at Least 7 Days||10
8789086|NCT01374178|9840092|FG001|COMPLETED|Washout Period of at Least 7 Days||5
8789087|NCT01374178|9840091|FG000|NOT COMPLETED|Washout Period of at Least 7 Days||1
8789088|NCT01374178|9840092|FG001|NOT COMPLETED|Washout Period of at Least 7 Days||0
8789089|NCT01374178|9840091|FG000|STARTED|Period 2 (up to 24 Hours After Dosing)||10
8789090|NCT01374178|9840092|FG001|STARTED|Period 2 (up to 24 Hours After Dosing)||5
8789091|NCT01374178|9840091|FG000|COMPLETED|Period 2 (up to 24 Hours After Dosing)||8
8789092|NCT01374178|9840092|FG001|COMPLETED|Period 2 (up to 24 Hours After Dosing)||5
8789093|NCT01374178|9840091|FG000|NOT COMPLETED|Period 2 (up to 24 Hours After Dosing)||2
8789094|NCT01374178|9840092|FG001|NOT COMPLETED|Period 2 (up to 24 Hours After Dosing)||0
8789095|NCT01374217|9840098|FG000|STARTED|Overall Study||13
8789096|NCT01374217|9840098|FG000|COMPLETED|Overall Study||0
8789097|NCT01374217|9840098|FG000|NOT COMPLETED|Overall Study||13
8789098|NCT01374269|9840104|FG000|STARTED|Overall Study||46
8789099|NCT01374269|9840105|FG001|STARTED|Overall Study||44
8789100|NCT01374269|9840104|FG000|COMPLETED|Overall Study||40
8789101|NCT01374269|9840105|FG001|COMPLETED|Overall Study||39
8789102|NCT01374269|9840104|FG000|NOT COMPLETED|Overall Study||6
8789103|NCT01374269|9840105|FG001|NOT COMPLETED|Overall Study||5
8789104|NCT01374425|9840113|FG000|STARTED|Overall Study||188
8789105|NCT01374425|9840114|FG001|STARTED|Overall Study||188
8789106|NCT01374425|9840113|FG000|COMPLETED|Overall Study||0
8789107|NCT01374425|9840114|FG001|COMPLETED|Overall Study||0
8789108|NCT01374425|9840113|FG000|NOT COMPLETED|Overall Study||188
8789109|NCT01374425|9840114|FG001|NOT COMPLETED|Overall Study||188
8789110|NCT01374438|9840143|FG000|STARTED|Overall Study||16
8789111|NCT01374438|9840144|FG001|STARTED|Overall Study||13
8789112|NCT01374438|9840143|FG000|COMPLETED|Overall Study||16
8789113|NCT01374438|9840144|FG001|COMPLETED|Overall Study||13
8789114|NCT01374438|9840143|FG000|NOT COMPLETED|Overall Study||0
8789115|NCT01374438|9840144|FG001|NOT COMPLETED|Overall Study||0
8789116|NCT01374451|9840152|FG000|STARTED|Overall Study||79
8789117|NCT01374451|9840153|FG001|STARTED|Overall Study||81
8789118|NCT01374451|9840152|FG000|COMPLETED|Overall Study||78
8789119|NCT01374451|9840153|FG001|COMPLETED|Overall Study||81
8789120|NCT01374451|9840152|FG000|NOT COMPLETED|Overall Study||1
8789121|NCT01374451|9840153|FG001|NOT COMPLETED|Overall Study||0
8789122|NCT01374490|9840159|FG000|STARTED|Overall Study||250
8789123|NCT01374490|9840159|FG000|COMPLETED|Overall Study||190
8789124|NCT01374490|9840159|FG000|NOT COMPLETED|Overall Study||60
8789125|NCT01374568|9840165|FG000|STARTED|Overall Study||2
8789126|NCT01374568|9840166|FG001|STARTED|Overall Study||3
8789127|NCT01374568|9840165|FG000|COMPLETED|Overall Study||2
8789128|NCT01374568|9840166|FG001|COMPLETED|Overall Study||1
8789129|NCT01374568|9840165|FG000|NOT COMPLETED|Overall Study||0
8789130|NCT01374568|9840166|FG001|NOT COMPLETED|Overall Study||2
8789131|NCT01374802|9840172|FG000|STARTED|Overall Study||14
8789132|NCT01374802|9840172|FG000|COMPLETED|Overall Study||14
8789133|NCT01374802|9840172|FG000|NOT COMPLETED|Overall Study||0
8789134|NCT01374906|9840180|FG000|STARTED|Overall Study||74
8789135|NCT01374906|9840181|FG001|STARTED|Overall Study||76
8789136|NCT01374906|9840180|FG000|DC Dur Core Phs at/Prior to Data Cutoff|Overall Study||24
8789137|NCT01374906|9840181|FG001|DC Dur Core Phs at/Prior to Data Cutoff|Overall Study||22
8789138|NCT01374906|9840180|FG000|Completed Core Phase|Overall Study||50
8789139|NCT01374906|9840181|FG001|Completed Core Phase|Overall Study||54
8789140|NCT01374906|9840180|FG000|Completed Core/Did Not Enter Ext. Phase|Overall Study||10
8789141|NCT01374906|9840181|FG001|Completed Core/Did Not Enter Ext. Phase|Overall Study||13
8789142|NCT01374906|9840180|FG000|Completed Core Phase/Entered Ext. Phase|Overall Study||40
8789143|NCT01374906|9840181|FG001|Completed Core Phase/Entered Ext. Phase|Overall Study||41
8789144|NCT01374906|9840180|FG000|DC Dur Ext Phs at/Prior to Data Cutoff|Overall Study||16
8789145|NCT01374906|9840181|FG001|DC Dur Ext Phs at/Prior to Data Cutoff|Overall Study||26
8789146|NCT01374906|9840180|FG000|Completed Extension Phase|Overall Study||24
8789147|NCT01374906|9840181|FG001|Completed Extension Phase|Overall Study||15
8789148|NCT01374906|9840180|FG000|COMPLETED|Overall Study||34
8789149|NCT01374906|9840181|FG001|COMPLETED|Overall Study||28
8789150|NCT01374906|9840180|FG000|NOT COMPLETED|Overall Study||40
8789151|NCT01374906|9840181|FG001|NOT COMPLETED|Overall Study||48
8789152|NCT01374919|9840191|FG000|STARTED|Overall Study||60
8789153|NCT01374919|9840191|FG000|COMPLETED|Overall Study||58
8789154|NCT01374919|9840191|FG000|NOT COMPLETED|Overall Study||2
8789155|NCT01374971|9840195|FG000|STARTED|Overall Study||12
8789156|NCT01374971|9840195|FG000|COMPLETED|Overall Study||11
8789157|NCT01374971|9840195|FG000|NOT COMPLETED|Overall Study||1
8789158|NCT01375010|9840201|FG000|STARTED|Overall Study||43
8789159|NCT01375010|9840202|FG001|STARTED|Overall Study||42
8789160|NCT01375010|9840201|FG000|COMPLETED|Overall Study||31
8789161|NCT01375010|9840202|FG001|COMPLETED|Overall Study||38
8789162|NCT01375010|9840201|FG000|NOT COMPLETED|Overall Study||12
8789163|NCT01375010|9840202|FG001|NOT COMPLETED|Overall Study||4
8789164|NCT01375049|9840208|FG000|STARTED|Overall Study||105
8789165|NCT01375049|9840208|FG000|COMPLETED|Overall Study||55
9031908|NCT03249454|10094046|FG009|Fourth Intervention (1 Day)|Overall Study||0
9031909|NCT03249454|10094047|FG010|Fourth Intervention (1 Day)|Overall Study||0
9031910|NCT03249454|10094037|FG000|Washout (1 Week)|Overall Study||1
9031911|NCT03249454|10094038|FG001|Washout (1 Week)|Overall Study||1
9031912|NCT03249454|10094039|FG002|Washout (1 Week)|Overall Study||2
9031913|NCT03249454|10094040|FG003|Washout (1 Week)|Overall Study||1
9031914|NCT03249454|10094041|FG004|Washout (1 Week)|Overall Study||1
9031915|NCT03249454|10094042|FG005|Washout (1 Week)|Overall Study||2
9031916|NCT03249454|10094043|FG006|Washout (1 Week)|Overall Study||1
9031917|NCT03249454|10094044|FG007|Washout (1 Week)|Overall Study||1
9031918|NCT03249454|10094045|FG008|Washout (1 Week)|Overall Study||1
9031919|NCT03249454|10094046|FG009|Washout (1 Week)|Overall Study||0
9031920|NCT03249454|10094047|FG010|Washout (1 Week)|Overall Study||0
9031921|NCT03249454|10094037|FG000|Fifth Intervention (1 Day)|Overall Study||1
9031922|NCT03249454|10094038|FG001|Fifth Intervention (1 Day)|Overall Study||1
9031923|NCT03249454|10094039|FG002|Fifth Intervention (1 Day)|Overall Study||2
9031924|NCT03249454|10094040|FG003|Fifth Intervention (1 Day)|Overall Study||1
9031925|NCT03249454|10094041|FG004|Fifth Intervention (1 Day)|Overall Study||1
9031926|NCT03249454|10094042|FG005|Fifth Intervention (1 Day)|Overall Study||2
9031927|NCT03249454|10094043|FG006|Fifth Intervention (1 Day)|Overall Study||1
9031928|NCT03249454|10094044|FG007|Fifth Intervention (1 Day)|Overall Study||1
9031929|NCT03249454|10094045|FG008|Fifth Intervention (1 Day)|Overall Study||1
9031930|NCT03249454|10094046|FG009|Fifth Intervention (1 Day)|Overall Study||0
9031931|NCT03249454|10094047|FG010|Fifth Intervention (1 Day)|Overall Study||0
9031932|NCT03249454|10094037|FG000|COMPLETED|Overall Study||1
9031933|NCT03249454|10094038|FG001|COMPLETED|Overall Study||1
9031934|NCT03249454|10094039|FG002|COMPLETED|Overall Study||2
9031935|NCT03249454|10094040|FG003|COMPLETED|Overall Study||1
9031936|NCT03249454|10094041|FG004|COMPLETED|Overall Study||1
9031937|NCT03249454|10094042|FG005|COMPLETED|Overall Study||2
9031938|NCT03249454|10094043|FG006|COMPLETED|Overall Study||1
9031939|NCT03249454|10094044|FG007|COMPLETED|Overall Study||1
9031940|NCT03249454|10094045|FG008|COMPLETED|Overall Study||1
9031941|NCT03249454|10094046|FG009|COMPLETED|Overall Study||0
9031942|NCT03249454|10094047|FG010|COMPLETED|Overall Study||0
9031943|NCT03249454|10094037|FG000|NOT COMPLETED|Overall Study||0
9031944|NCT03249454|10094038|FG001|NOT COMPLETED|Overall Study||0
9031945|NCT03249454|10094039|FG002|NOT COMPLETED|Overall Study||0
9031946|NCT03249454|10094040|FG003|NOT COMPLETED|Overall Study||0
9031947|NCT03249454|10094041|FG004|NOT COMPLETED|Overall Study||0
9031948|NCT03249454|10094042|FG005|NOT COMPLETED|Overall Study||0
9031949|NCT03249454|10094043|FG006|NOT COMPLETED|Overall Study||0
9031950|NCT03249454|10094044|FG007|NOT COMPLETED|Overall Study||0
9031951|NCT03249454|10094045|FG008|NOT COMPLETED|Overall Study||0
9031952|NCT03249454|10094046|FG009|NOT COMPLETED|Overall Study||1
9031953|NCT03249454|10094047|FG010|NOT COMPLETED|Overall Study||1
9031954|NCT03249584|10094060|FG000|STARTED|Overall Study||184
9031955|NCT03249584|10094061|FG001|STARTED|Overall Study||22
9031956|NCT03249584|10094060|FG000|Month 3|Overall Study||132
9031957|NCT03249584|10094061|FG001|Month 3|Overall Study||15
9031958|NCT03249584|10094060|FG000|Month 3 Primary/Secondary Objectives|Overall Study|As prespecified, the primary objective included the first 42 Thoracic/Lumbar RF Ablation subjects to complete Month 3.|42
9031959|NCT03249584|10094061|FG001|Month 3 Primary/Secondary Objectives|Overall Study|As prespecified, the secondary objective included all Periacetabulum/Iliac Crest/Sacrum RF Ablation subjects.|15
9031960|NCT03249584|10094060|FG000|Month 6|Overall Study||101
9031961|NCT03249584|10094061|FG001|Month 6|Overall Study||13
9031962|NCT03249584|10094060|FG000|COMPLETED|Overall Study||51
9031963|NCT03249584|10094061|FG001|COMPLETED|Overall Study||8
9031964|NCT03249584|10094060|FG000|NOT COMPLETED|Overall Study||133
9031965|NCT03249584|10094061|FG001|NOT COMPLETED|Overall Study||14
9031966|NCT03249779|10094066|FG000|STARTED|Overall Study||8
9031967|NCT03249779|10094066|FG000|COMPLETED|Overall Study||8
9031968|NCT03249779|10094066|FG000|NOT COMPLETED|Overall Study||0
9031969|NCT03249909|10094073|FG000|STARTED|Overall Study||78
9031970|NCT03249909|10094074|FG001|STARTED|Overall Study||15
9031971|NCT03249909|10094075|FG002|STARTED|Overall Study||16
9031972|NCT03249909|10094073|FG000|COMPLETED|Overall Study||72
8789166|NCT01375049|9840208|FG000|NOT COMPLETED|Overall Study||50
8789167|NCT01375075|9840222|FG000|STARTED|Overall Study||27
9031973|NCT03249909|10094074|FG001|COMPLETED|Overall Study||14
9031974|NCT03249909|10094075|FG002|COMPLETED|Overall Study||16
8789168|NCT01375075|9840223|FG001|STARTED|Overall Study||28
8789169|NCT01375075|9840224|FG002|STARTED|Overall Study||27
8789170|NCT01375075|9840225|FG003|STARTED|Overall Study||28
8789171|NCT01375075|9840226|FG004|STARTED|Overall Study||27
8789172|NCT01375075|9840227|FG005|STARTED|Overall Study||28
8789173|NCT01375075|9840222|FG000|Received at Least One Dose of Study Drug|Overall Study||27
8789174|NCT01375075|9840223|FG001|Received at Least One Dose of Study Drug|Overall Study||28
8789175|NCT01375075|9840224|FG002|Received at Least One Dose of Study Drug|Overall Study||27
8789176|NCT01375075|9840225|FG003|Received at Least One Dose of Study Drug|Overall Study||28
8789177|NCT01375075|9840226|FG004|Received at Least One Dose of Study Drug|Overall Study||27
8789178|NCT01375075|9840227|FG005|Received at Least One Dose of Study Drug|Overall Study||28
8789179|NCT01375075|9840222|FG000|COMPLETED|Overall Study||26
8789180|NCT01375075|9840223|FG001|COMPLETED|Overall Study||27
8789181|NCT01375075|9840224|FG002|COMPLETED|Overall Study||24
8789182|NCT01375075|9840225|FG003|COMPLETED|Overall Study||27
8789183|NCT01375075|9840226|FG004|COMPLETED|Overall Study||27
8789184|NCT01375075|9840227|FG005|COMPLETED|Overall Study||25
8789185|NCT01375075|9840222|FG000|NOT COMPLETED|Overall Study||1
8789186|NCT01375075|9840223|FG001|NOT COMPLETED|Overall Study||1
8789187|NCT01375075|9840224|FG002|NOT COMPLETED|Overall Study||3
8789188|NCT01375075|9840225|FG003|NOT COMPLETED|Overall Study||1
8789189|NCT01375075|9840226|FG004|NOT COMPLETED|Overall Study||0
8789190|NCT01375075|9840227|FG005|NOT COMPLETED|Overall Study||3
8789191|NCT01375127|9840251|FG000|STARTED|Overall Study||1
8789192|NCT01375127|9840252|FG001|STARTED|Overall Study||1
8789193|NCT01375127|9840253|FG002|STARTED|Overall Study||40
8789194|NCT01375127|9840254|FG003|STARTED|Overall Study||33
8789195|NCT01375127|9840255|FG004|STARTED|Overall Study||5
8789196|NCT01375127|9840256|FG005|STARTED|Overall Study||3
8789197|NCT01375127|9840251|FG000|COMPLETED|Overall Study||1
8789198|NCT01375127|9840252|FG001|COMPLETED|Overall Study||1
8789199|NCT01375127|9840253|FG002|COMPLETED|Overall Study||40
8789200|NCT01375127|9840254|FG003|COMPLETED|Overall Study||33
8789201|NCT01375127|9840255|FG004|COMPLETED|Overall Study||5
8789202|NCT01375127|9840256|FG005|COMPLETED|Overall Study||3
8789203|NCT01375127|9840251|FG000|NOT COMPLETED|Overall Study||0
8789204|NCT01375127|9840252|FG001|NOT COMPLETED|Overall Study||0
8789205|NCT01375127|9840253|FG002|NOT COMPLETED|Overall Study||0
8789206|NCT01375127|9840254|FG003|NOT COMPLETED|Overall Study||0
8789207|NCT01375127|9840255|FG004|NOT COMPLETED|Overall Study||0
8789208|NCT01375127|9840256|FG005|NOT COMPLETED|Overall Study||0
8789209|NCT01375140|9840270|FG000|STARTED|Overall Study||31
8789210|NCT01375140|9840270|FG000|COMPLETED|Overall Study||31
8789211|NCT01375140|9840270|FG000|NOT COMPLETED|Overall Study||0
8789212|NCT01375205|9840276|FG000|STARTED|Overall Study||54
8789213|NCT01375205|9840277|FG001|STARTED|Overall Study||46
8789214|NCT01375205|9840276|FG000|COMPLETED|Overall Study||33
8789215|NCT01375205|9840277|FG001|COMPLETED|Overall Study||33
8789216|NCT01375205|9840276|FG000|NOT COMPLETED|Overall Study||21
8789217|NCT01375205|9840277|FG001|NOT COMPLETED|Overall Study||13
8789218|NCT01375374|9840283|FG000|STARTED|Overall Study||11
8789219|NCT01375374|9840283|FG000|COMPLETED|Overall Study||10
8789220|NCT01375374|9840283|FG000|NOT COMPLETED|Overall Study||1
8789221|NCT01375491|9840290|FG000|STARTED|Overall Study||11
8789222|NCT01375491|9840291|FG001|STARTED|Overall Study||13
8789223|NCT01375491|9840292|FG002|STARTED|Overall Study||15
8789224|NCT01375491|9840290|FG000|COMPLETED|Overall Study||9
8789225|NCT01375491|9840291|FG001|COMPLETED|Overall Study||12
8789226|NCT01375491|9840292|FG002|COMPLETED|Overall Study||15
8789227|NCT01375491|9840290|FG000|NOT COMPLETED|Overall Study||2
8789228|NCT01375491|9840291|FG001|NOT COMPLETED|Overall Study||1
8789229|NCT01375491|9840292|FG002|NOT COMPLETED|Overall Study||0
8789230|NCT01375569|9840299|FG000|STARTED|Overall Study||11
8789231|NCT01375569|9840299|FG000|COMPLETED|Overall Study||11
8789232|NCT01375569|9840299|FG000|NOT COMPLETED|Overall Study||0
8789233|NCT01375608|9840303|FG000|STARTED|Overall Study||10
8789234|NCT01375608|9840303|FG000|COMPLETED|Overall Study||8
8789235|NCT01375608|9840303|FG000|NOT COMPLETED|Overall Study||2
8789236|NCT01375660|9840309|FG000|STARTED|Overall Study||102
8789237|NCT01375660|9840310|FG001|STARTED|Overall Study||103
8789238|NCT01375660|9840309|FG000|COMPLETED|Overall Study||86
8789239|NCT01375660|9840310|FG001|COMPLETED|Overall Study||87
8789240|NCT01375660|9840309|FG000|NOT COMPLETED|Overall Study||16
8789241|NCT01375660|9840310|FG001|NOT COMPLETED|Overall Study||16
8789242|NCT01375673|9840319|FG000|STARTED|Overall Study||7
8789243|NCT01375673|9840320|FG001|STARTED|Overall Study||7
8789244|NCT01375673|9840319|FG000|COMPLETED|Overall Study||7
8789245|NCT01375673|9840320|FG001|COMPLETED|Overall Study||6
8789246|NCT01375673|9840319|FG000|NOT COMPLETED|Overall Study||0
8789247|NCT01375673|9840320|FG001|NOT COMPLETED|Overall Study||1
8789248|NCT01375751|9840329|FG000|STARTED|Overall Study||56
9031975|NCT03249909|10094073|FG000|NOT COMPLETED|Overall Study||6
9031976|NCT03249909|10094074|FG001|NOT COMPLETED|Overall Study||1
8789249|NCT01375751|9840330|FG001|STARTED|Overall Study||56
8789250|NCT01375751|9840331|FG002|STARTED|Overall Study||56
8789251|NCT01375751|9840329|FG000|Received Treatment|Overall Study||56
8789252|NCT01375751|9840330|FG001|Received Treatment|Overall Study||55
8789253|NCT01375751|9840331|FG002|Received Treatment|Overall Study||56
8789254|NCT01375751|9840329|FG000|COMPLETED|Overall Study||56
8789255|NCT01375751|9840330|FG001|COMPLETED|Overall Study||55
8789256|NCT01375751|9840331|FG002|COMPLETED|Overall Study||56
8789257|NCT01375751|9840329|FG000|NOT COMPLETED|Overall Study||0
8789258|NCT01375751|9840330|FG001|NOT COMPLETED|Overall Study||1
8789259|NCT01375751|9840331|FG002|NOT COMPLETED|Overall Study||0
8789260|NCT01375764|9840344|FG000|STARTED|Overall Study||33
8789261|NCT01375764|9840345|FG001|STARTED|Overall Study||31
8789262|NCT01375764|9840346|FG002|STARTED|Overall Study||32
8789263|NCT01375764|9840347|FG003|STARTED|Overall Study||32
8789264|NCT01375764|9840348|FG004|STARTED|Overall Study||32
8789265|NCT01375764|9840344|FG000|Received Treatment|Overall Study||32
8789266|NCT01375764|9840345|FG001|Received Treatment|Overall Study||30
8789267|NCT01375764|9840346|FG002|Received Treatment|Overall Study||32
8789268|NCT01375764|9840347|FG003|Received Treatment|Overall Study||31
8789269|NCT01375764|9840348|FG004|Received Treatment|Overall Study||32
8789270|NCT01375764|9840344|FG000|COMPLETED|Overall Study||31
8789271|NCT01375764|9840345|FG001|COMPLETED|Overall Study||30
8789272|NCT01375764|9840346|FG002|COMPLETED|Overall Study||32
8789273|NCT01375764|9840347|FG003|COMPLETED|Overall Study||31
8789274|NCT01375764|9840348|FG004|COMPLETED|Overall Study||31
8789275|NCT01375764|9840344|FG000|NOT COMPLETED|Overall Study||2
8789276|NCT01375764|9840345|FG001|NOT COMPLETED|Overall Study||1
8789277|NCT01375764|9840346|FG002|NOT COMPLETED|Overall Study||0
8789278|NCT01375764|9840347|FG003|NOT COMPLETED|Overall Study||1
8789279|NCT01375764|9840348|FG004|NOT COMPLETED|Overall Study||1
8789280|NCT01375777|9840369|FG000|STARTED|Overall Study||46
8789281|NCT01375777|9840370|FG001|STARTED|Overall Study||45
8789282|NCT01375777|9840371|FG002|STARTED|Overall Study||46
8789283|NCT01375777|9840372|FG003|STARTED|Overall Study||45
8789284|NCT01375777|9840373|FG004|STARTED|Overall Study||46
8789285|NCT01375777|9840374|FG005|STARTED|Overall Study||45
8789286|NCT01375777|9840375|FG006|STARTED|Overall Study||46
8789287|NCT01375777|9840376|FG007|STARTED|Overall Study||46
8789288|NCT01375777|9840377|FG008|STARTED|Overall Study||46
8789289|NCT01375777|9840369|FG000|Received Treatment|Overall Study||45
8789290|NCT01375777|9840370|FG001|Received Treatment|Overall Study||45
8789291|NCT01375777|9840371|FG002|Received Treatment|Overall Study||45
8789292|NCT01375777|9840372|FG003|Received Treatment|Overall Study||45
8789293|NCT01375777|9840373|FG004|Received Treatment|Overall Study||46
8789294|NCT01375777|9840374|FG005|Received Treatment|Overall Study||45
8789295|NCT01375777|9840375|FG006|Received Treatment|Overall Study||45
8789296|NCT01375777|9840376|FG007|Received Treatment|Overall Study||45
8789297|NCT01375777|9840377|FG008|Received Treatment|Overall Study||45
8789298|NCT01375777|9840369|FG000|COMPLETED|Overall Study||44
8789299|NCT01375777|9840370|FG001|COMPLETED|Overall Study||42
8789300|NCT01375777|9840371|FG002|COMPLETED|Overall Study||45
8789301|NCT01375777|9840372|FG003|COMPLETED|Overall Study||45
8789302|NCT01375777|9840373|FG004|COMPLETED|Overall Study||45
8789303|NCT01375777|9840374|FG005|COMPLETED|Overall Study||44
8789304|NCT01375777|9840375|FG006|COMPLETED|Overall Study||44
9031977|NCT03249909|10094075|FG002|NOT COMPLETED|Overall Study||0
9031978|NCT03249935|10094086|FG000|STARTED|Overall Study||100
9031979|NCT03249935|10094086|FG000|COMPLETED|Overall Study||55
9031980|NCT03249935|10094086|FG000|NOT COMPLETED|Overall Study||45
9031981|NCT03250182|10094092|FG000|STARTED|Overall Study||30
9031982|NCT03250182|10094092|FG000|COMPLETED|Overall Study||29
9031983|NCT03250182|10094092|FG000|NOT COMPLETED|Overall Study||1
9031984|NCT03250234|10094098|FG000|STARTED|Overall Study||6
9031985|NCT03250234|10094099|FG001|STARTED|Overall Study||6
9031986|NCT03250234|10094098|FG000|COMPLETED|Overall Study||6
9031987|NCT03250234|10094099|FG001|COMPLETED|Overall Study||6
9031988|NCT03250234|10094098|FG000|NOT COMPLETED|Overall Study||0
9031989|NCT03250234|10094099|FG001|NOT COMPLETED|Overall Study||0
9031990|NCT03250689|10094107|FG000|STARTED|Overall Study||5
9031991|NCT03250689|10094108|FG001|STARTED|Overall Study||14
9031992|NCT03250689|10094107|FG000|COMPLETED|Overall Study||5
8789305|NCT01375777|9840376|FG007|COMPLETED|Overall Study||44
8789306|NCT01375777|9840377|FG008|COMPLETED|Overall Study||44
8789307|NCT01375777|9840369|FG000|NOT COMPLETED|Overall Study||2
8789308|NCT01375777|9840370|FG001|NOT COMPLETED|Overall Study||3
8789309|NCT01375777|9840371|FG002|NOT COMPLETED|Overall Study||1
8789310|NCT01375777|9840372|FG003|NOT COMPLETED|Overall Study||0
8789311|NCT01375777|9840373|FG004|NOT COMPLETED|Overall Study||1
8789312|NCT01375777|9840374|FG005|NOT COMPLETED|Overall Study||1
8789313|NCT01375777|9840375|FG006|NOT COMPLETED|Overall Study||2
8789314|NCT01375777|9840376|FG007|NOT COMPLETED|Overall Study||2
8789315|NCT01375777|9840377|FG008|NOT COMPLETED|Overall Study||2
8789316|NCT01375946|9840397|FG000|STARTED|Overall Study||4
8789317|NCT01375946|9840398|FG001|STARTED|Overall Study||4
8789318|NCT01375946|9840399|FG002|STARTED|Overall Study||4
8789319|NCT01375946|9840400|FG003|STARTED|Overall Study||4
8789320|NCT01375946|9840401|FG004|STARTED|Overall Study||4
8789321|NCT01375946|9840402|FG005|STARTED|Overall Study||4
8789322|NCT01375946|9840397|FG000|COMPLETED|Overall Study||4
8789323|NCT01375946|9840398|FG001|COMPLETED|Overall Study||4
8789324|NCT01375946|9840399|FG002|COMPLETED|Overall Study||4
8789325|NCT01375946|9840400|FG003|COMPLETED|Overall Study||4
8789326|NCT01375946|9840401|FG004|COMPLETED|Overall Study||4
8789327|NCT01375946|9840402|FG005|COMPLETED|Overall Study||4
8789328|NCT01375946|9840397|FG000|NOT COMPLETED|Overall Study||0
9031993|NCT03250689|10094108|FG001|COMPLETED|Overall Study||14
9031994|NCT03250689|10094107|FG000|NOT COMPLETED|Overall Study||0
9031995|NCT03250689|10094108|FG001|NOT COMPLETED|Overall Study||0
9031996|NCT03250845|10094115|FG000|STARTED|Multigam 5% Infusion (Baseline)||30
9031997|NCT03250845|10094115|FG000|COMPLETED|Multigam 5% Infusion (Baseline)||30
9031998|NCT03250845|10094115|FG000|NOT COMPLETED|Multigam 5% Infusion (Baseline)||0
9031999|NCT03250845|10094115|FG000|STARTED|Multigam 10% Infusion (3-4 Weeks Later)||30
9032000|NCT03250845|10094115|FG000|COMPLETED|Multigam 10% Infusion (3-4 Weeks Later)||30
9032001|NCT03250845|10094115|FG000|NOT COMPLETED|Multigam 10% Infusion (3-4 Weeks Later)||0
9032002|NCT03251482|10094126|FG000|STARTED|Overall Study||39
9032003|NCT03251482|10094127|FG001|STARTED|Overall Study||41
9032004|NCT03251482|10094128|FG002|STARTED|Overall Study||43
9032005|NCT03251482|10094129|FG003|STARTED|Overall Study||122
9032006|NCT03251482|10094130|FG004|STARTED|Overall Study||63
9032007|NCT03251482|10094126|FG000|Treated|Overall Study||38
9032008|NCT03251482|10094127|FG001|Treated|Overall Study||40
9032009|NCT03251482|10094128|FG002|Treated|Overall Study||42
9032010|NCT03251482|10094129|FG003|Treated|Overall Study||122
9032011|NCT03251482|10094130|FG004|Treated|Overall Study||63
9032012|NCT03251482|10094126|FG000|COMPLETED|Overall Study||39
9032013|NCT03251482|10094127|FG001|COMPLETED|Overall Study||40
9032014|NCT03251482|10094128|FG002|COMPLETED|Overall Study||43
9032015|NCT03251482|10094129|FG003|COMPLETED|Overall Study||122
9032016|NCT03251482|10094130|FG004|COMPLETED|Overall Study||63
9032017|NCT03251482|10094126|FG000|NOT COMPLETED|Overall Study||0
9032018|NCT03251482|10094127|FG001|NOT COMPLETED|Overall Study||1
9032019|NCT03251482|10094128|FG002|NOT COMPLETED|Overall Study||0
9032020|NCT03251482|10094129|FG003|NOT COMPLETED|Overall Study||0
9032021|NCT03251482|10094130|FG004|NOT COMPLETED|Overall Study||0
9032022|NCT03251937|10094142|FG000|STARTED|Overall Study||40
9032023|NCT03251937|10094142|FG000|COMPLETED|Overall Study||37
9032024|NCT03251937|10094142|FG000|NOT COMPLETED|Overall Study||3
9032025|NCT03251963|10094148|FG000|STARTED|Overall Study||65
9032026|NCT03251963|10094149|FG001|STARTED|Overall Study||66
9032027|NCT03251963|10094148|FG000|COMPLETED|Overall Study||56
9032028|NCT03251963|10094149|FG001|COMPLETED|Overall Study||61
9032029|NCT03251963|10094148|FG000|NOT COMPLETED|Overall Study||9
9032030|NCT03251963|10094149|FG001|NOT COMPLETED|Overall Study||5
9032031|NCT03252015|10094159|FG000|STARTED|Overall Study||12
9032032|NCT03252015|10094160|FG001|STARTED|Overall Study||28
9032033|NCT03252015|10094161|FG002|STARTED|Overall Study||15
9032034|NCT03252015|10094162|FG003|STARTED|Overall Study||15
9032035|NCT03252015|10094159|FG000|Received at Least 1 Dose of Study Drug|Overall Study||12
9032036|NCT03252015|10094160|FG001|Received at Least 1 Dose of Study Drug|Overall Study||28
9032037|NCT03252015|10094161|FG002|Received at Least 1 Dose of Study Drug|Overall Study||15
9032038|NCT03252015|10094162|FG003|Received at Least 1 Dose of Study Drug|Overall Study||15
9032039|NCT03252015|10094159|FG000|COMPLETED|Overall Study||11
9032040|NCT03252015|10094160|FG001|COMPLETED|Overall Study||27
9032041|NCT03252015|10094161|FG002|COMPLETED|Overall Study||14
9032042|NCT03252015|10094162|FG003|COMPLETED|Overall Study||14
9032043|NCT03252015|10094159|FG000|NOT COMPLETED|Overall Study||1
9032044|NCT03252015|10094160|FG001|NOT COMPLETED|Overall Study||1
9032045|NCT03252015|10094161|FG002|NOT COMPLETED|Overall Study||1
9032046|NCT03252015|10094162|FG003|NOT COMPLETED|Overall Study||1
9032047|NCT03252145|10094188|FG000|STARTED|Overall Study||13
9032048|NCT03252145|10094189|FG001|STARTED|Overall Study||15
9032049|NCT03252145|10094188|FG000|COMPLETED|Overall Study||11
9032050|NCT03252145|10094189|FG001|COMPLETED|Overall Study||13
9032051|NCT03252145|10094188|FG000|NOT COMPLETED|Overall Study||2
9032052|NCT03252145|10094189|FG001|NOT COMPLETED|Overall Study||2
9032053|NCT03252353|10094197|FG000|STARTED|Overall Study||28
9032054|NCT03252353|10094198|FG001|STARTED|Overall Study||28
9032055|NCT03252353|10094197|FG000|COMPLETED|Overall Study||28
9032056|NCT03252353|10094198|FG001|COMPLETED|Overall Study||28
9032057|NCT03252353|10094197|FG000|NOT COMPLETED|Overall Study||0
9032058|NCT03252353|10094198|FG001|NOT COMPLETED|Overall Study||0
9032059|NCT03252431|10094209|FG000|STARTED|Overall Study||197
9032060|NCT03252431|10094210|FG001|STARTED|Overall Study||196
9032061|NCT03252431|10094209|FG000|COMPLETED|Overall Study||186
9032062|NCT03252431|10094210|FG001|COMPLETED|Overall Study||187
9032063|NCT03252431|10094209|FG000|NOT COMPLETED|Overall Study||11
9032064|NCT03252431|10094210|FG001|NOT COMPLETED|Overall Study||9
9032065|NCT03252964|10094216|FG000|STARTED|Overall Study||52
9032066|NCT03252964|10094216|FG000|COMPLETED|Overall Study||20
9032067|NCT03252964|10094216|FG000|NOT COMPLETED|Overall Study||32
9032068|NCT03253094|10094226|FG000|STARTED|Overall Study||32
9032069|NCT03253094|10094227|FG001|STARTED|Overall Study||30
9032070|NCT03253094|10094228|FG002|STARTED|Overall Study||28
8789329|NCT01375946|9840398|FG001|NOT COMPLETED|Overall Study||0
9032071|NCT03253094|10094229|FG003|STARTED|Overall Study||32
9032072|NCT03253094|10094230|FG004|STARTED|Overall Study||32
9032073|NCT03253094|10094231|FG005|STARTED|Overall Study||32
8789330|NCT01375946|9840399|FG002|NOT COMPLETED|Overall Study||0
9032074|NCT03253094|10094226|FG000|Subjects Discontinued|Overall Study||4
9032075|NCT03253094|10094227|FG001|Subjects Discontinued|Overall Study||3
9032076|NCT03253094|10094228|FG002|Subjects Discontinued|Overall Study||6
8789331|NCT01375946|9840400|FG003|NOT COMPLETED|Overall Study||0
8789332|NCT01375946|9840401|FG004|NOT COMPLETED|Overall Study||0
8789333|NCT01375946|9840402|FG005|NOT COMPLETED|Overall Study||0
8789334|NCT01376037|9840408|FG000|STARTED|Overall Study||31
8789335|NCT01376037|9840409|FG001|STARTED|Overall Study||31
8789336|NCT01376037|9840408|FG000|COMPLETED|Overall Study||31
8789337|NCT01376037|9840409|FG001|COMPLETED|Overall Study||29
8789338|NCT01376037|9840408|FG000|NOT COMPLETED|Overall Study||0
8789339|NCT01376037|9840409|FG001|NOT COMPLETED|Overall Study||2
8789340|NCT01376050|9840417|FG000|STARTED|Overall Study||13
8789341|NCT01376050|9840418|FG001|STARTED|Overall Study||11
8789342|NCT01376050|9840417|FG000|COMPLETED|Overall Study||13
8789343|NCT01376050|9840418|FG001|COMPLETED|Overall Study||11
8789344|NCT01376050|9840417|FG000|NOT COMPLETED|Overall Study||0
8789345|NCT01376050|9840418|FG001|NOT COMPLETED|Overall Study||0
8789346|NCT01376089|9840426|FG000|STARTED|Overall Study||151
8789347|NCT01376089|9840427|FG001|STARTED|Overall Study||148
8789348|NCT01376089|9840426|FG000|COMPLETED|Overall Study||148
8789349|NCT01376089|9840427|FG001|COMPLETED|Overall Study||144
8789350|NCT01376089|9840426|FG000|NOT COMPLETED|Overall Study||3
8789351|NCT01376089|9840427|FG001|NOT COMPLETED|Overall Study||4
8789352|NCT01376167|9840440|FG000|STARTED|Overall Study||133
8789353|NCT01376167|9840441|FG001|STARTED|Overall Study||260
8789354|NCT01376167|9840442|FG002|STARTED|Overall Study||129
8789355|NCT01376167|9840440|FG000|COMPLETED|Overall Study||129
8789356|NCT01376167|9840441|FG001|COMPLETED|Overall Study||250
8789357|NCT01376167|9840442|FG002|COMPLETED|Overall Study||123
8789358|NCT01376167|9840440|FG000|NOT COMPLETED|Overall Study||4
8789359|NCT01376167|9840441|FG001|NOT COMPLETED|Overall Study||10
8789360|NCT01376167|9840442|FG002|NOT COMPLETED|Overall Study||6
8789361|NCT01376245|9840457|FG000|STARTED|2-wk Single-blind Placebo Run-in Period||744
8789362|NCT01376245|9840458|FG001|STARTED|2-wk Single-blind Placebo Run-in Period||0
8789363|NCT01376245|9840459|FG002|STARTED|2-wk Single-blind Placebo Run-in Period||0
8789364|NCT01376245|9840460|FG003|STARTED|2-wk Single-blind Placebo Run-in Period||0
8789365|NCT01376245|9840461|FG004|STARTED|2-wk Single-blind Placebo Run-in Period||0
8789366|NCT01376245|9840457|FG000|COMPLETED|2-wk Single-blind Placebo Run-in Period||643
8789367|NCT01376245|9840458|FG001|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
8789368|NCT01376245|9840459|FG002|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
8789369|NCT01376245|9840460|FG003|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
8789370|NCT01376245|9840461|FG004|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
8789371|NCT01376245|9840457|FG000|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||101
8789372|NCT01376245|9840458|FG001|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
8789373|NCT01376245|9840459|FG002|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
8789374|NCT01376245|9840460|FG003|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
8789375|NCT01376245|9840461|FG004|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
8789376|NCT01376245|9840457|FG000|STARTED|24-week, Double-blind Treatment Period||0
8789377|NCT01376245|9840458|FG001|STARTED|24-week, Double-blind Treatment Period||162
8789378|NCT01376245|9840459|FG002|STARTED|24-week, Double-blind Treatment Period||160
8789379|NCT01376245|9840460|FG003|STARTED|24-week, Double-blind Treatment Period||161
8789380|NCT01376245|9840461|FG004|STARTED|24-week, Double-blind Treatment Period||160
8789381|NCT01376245|9840457|FG000|COMPLETED|24-week, Double-blind Treatment Period||0
8789382|NCT01376245|9840458|FG001|COMPLETED|24-week, Double-blind Treatment Period||130
8789383|NCT01376245|9840459|FG002|COMPLETED|24-week, Double-blind Treatment Period||135
8789384|NCT01376245|9840460|FG003|COMPLETED|24-week, Double-blind Treatment Period||138
8789385|NCT01376245|9840461|FG004|COMPLETED|24-week, Double-blind Treatment Period||134
8789386|NCT01376245|9840457|FG000|NOT COMPLETED|24-week, Double-blind Treatment Period||0
8789387|NCT01376245|9840458|FG001|NOT COMPLETED|24-week, Double-blind Treatment Period||32
8789388|NCT01376245|9840459|FG002|NOT COMPLETED|24-week, Double-blind Treatment Period||25
8789389|NCT01376245|9840460|FG003|NOT COMPLETED|24-week, Double-blind Treatment Period||23
8789390|NCT01376245|9840461|FG004|NOT COMPLETED|24-week, Double-blind Treatment Period||26
8789391|NCT01376297|9840473|FG000|STARTED|Overall Study|number of randomised patients|309
8789392|NCT01376297|9840474|FG001|STARTED|Overall Study|number of randomised patients|104
8789393|NCT01376297|9840473|FG000|COMPLETED|Overall Study|number of patients completing planned/unplanned chemotherapy cycles|181
8789394|NCT01376297|9840474|FG001|COMPLETED|Overall Study|number of patients completing planned/unplanned chemotherapy cycles|55
8789395|NCT01376297|9840473|FG000|NOT COMPLETED|Overall Study||128
8789396|NCT01376297|9840474|FG001|NOT COMPLETED|Overall Study||49
8789397|NCT01376310|9840482|FG000|STARTED|Overall Study||126
8789398|NCT01376310|9840483|FG001|STARTED|Overall Study||33
8789399|NCT01376310|9840482|FG000|COMPLETED|Overall Study||90
8789400|NCT01376310|9840483|FG001|COMPLETED|Overall Study||22
8789401|NCT01376310|9840482|FG000|NOT COMPLETED|Overall Study||36
8789402|NCT01376310|9840483|FG001|NOT COMPLETED|Overall Study||11
8789403|NCT01376349|9840492|FG000|STARTED|Raondomized Treatment||147
8789404|NCT01376349|9840493|FG001|STARTED|Raondomized Treatment||149
8789405|NCT01376349|9840494|FG002|STARTED|Raondomized Treatment||147
8789406|NCT01376349|9840492|FG000|COMPLETED|Raondomized Treatment||123
8789407|NCT01376349|9840493|FG001|COMPLETED|Raondomized Treatment||114
8789408|NCT01376349|9840494|FG002|COMPLETED|Raondomized Treatment||118
8789409|NCT01376349|9840492|FG000|NOT COMPLETED|Raondomized Treatment||24
8789410|NCT01376349|9840493|FG001|NOT COMPLETED|Raondomized Treatment||35
8789411|NCT01376349|9840494|FG002|NOT COMPLETED|Raondomized Treatment||29
8789412|NCT01376349|9840492|FG000|STARTED|Optional Continuation Phase||0
8789413|NCT01376349|9840493|FG001|STARTED|Optional Continuation Phase||0
8789414|NCT01376349|9840494|FG002|STARTED|Optional Continuation Phase|Patients completing Arm III Placebo were offered the option of continuing High Dose DHEA|94
8789415|NCT01376349|9840492|FG000|COMPLETED|Optional Continuation Phase||0
8789416|NCT01376349|9840493|FG001|COMPLETED|Optional Continuation Phase||0
8789417|NCT01376349|9840494|FG002|COMPLETED|Optional Continuation Phase||94
8789418|NCT01376349|9840492|FG000|NOT COMPLETED|Optional Continuation Phase||0
8789419|NCT01376349|9840493|FG001|NOT COMPLETED|Optional Continuation Phase||0
8789420|NCT01376349|9840494|FG002|NOT COMPLETED|Optional Continuation Phase||0
8789421|NCT01376362|9840503|FG000|STARTED|Overall Study||5
8789422|NCT01376362|9840503|FG000|COMPLETED|Overall Study||5
8789423|NCT01376362|9840503|FG000|NOT COMPLETED|Overall Study||0
8789424|NCT01376388|9840507|FG000|STARTED|Overall Study||130
8789425|NCT01376388|9840507|FG000|COMPLETED|Overall Study||112
8789426|NCT01376388|9840507|FG000|NOT COMPLETED|Overall Study||18
8789427|NCT01376557|9840516|FG000|STARTED|Overall Study||59
8789428|NCT01376557|9840517|FG001|STARTED|Overall Study||60
8789429|NCT01376557|9840518|FG002|STARTED|Overall Study||60
8789430|NCT01376557|9840519|FG003|STARTED|Overall Study||60
8789431|NCT01376557|9840520|FG004|STARTED|Overall Study||60
8789432|NCT01376557|9840516|FG000|COMPLETED|Overall Study||51
8789433|NCT01376557|9840517|FG001|COMPLETED|Overall Study||54
8789434|NCT01376557|9840518|FG002|COMPLETED|Overall Study||55
8789435|NCT01376557|9840519|FG003|COMPLETED|Overall Study||54
8789436|NCT01376557|9840520|FG004|COMPLETED|Overall Study||53
8789437|NCT01376557|9840516|FG000|NOT COMPLETED|Overall Study||8
8789438|NCT01376557|9840517|FG001|NOT COMPLETED|Overall Study||6
8789439|NCT01376557|9840518|FG002|NOT COMPLETED|Overall Study||5
8789440|NCT01376557|9840519|FG003|NOT COMPLETED|Overall Study||6
8789441|NCT01376557|9840520|FG004|NOT COMPLETED|Overall Study||7
8789442|NCT01376700|9840532|FG000|STARTED|Overall Study||19
8789443|NCT01376700|9840532|FG000|COMPLETED|Overall Study||3
8789444|NCT01376700|9840532|FG000|NOT COMPLETED|Overall Study||16
8789445|NCT01376804|9840539|FG000|STARTED|Treatment Period||57
8789446|NCT01376804|9840539|FG000|Received Study Drug|Treatment Period||56
8789447|NCT01376804|9840539|FG000|COMPLETED|Treatment Period||49
8789448|NCT01376804|9840539|FG000|NOT COMPLETED|Treatment Period||8
8789449|NCT01376804|9840539|FG000|STARTED|Follow-up Period|6 of the 7 patients who withdrew from treatment continued to the Follow-up Period.|55
8789450|NCT01376804|9840539|FG000|COMPLETED|Follow-up Period||55
8789451|NCT01376804|9840539|FG000|NOT COMPLETED|Follow-up Period||0
8789452|NCT01376908|9840545|FG000|STARTED|Overall Study||27
8789453|NCT01376908|9840546|FG001|STARTED|Overall Study||29
8789454|NCT01376908|9840545|FG000|COMPLETED|Overall Study||25
8789455|NCT01376908|9840546|FG001|COMPLETED|Overall Study||26
8789456|NCT01376908|9840545|FG000|NOT COMPLETED|Overall Study||2
8789457|NCT01376908|9840546|FG001|NOT COMPLETED|Overall Study||3
8789458|NCT01377012|9840562|FG000|STARTED|Core Study||210
8789459|NCT01377012|9840563|FG001|STARTED|Core Study||213
8789460|NCT01377012|9840564|FG002|STARTED|Core Study||214
8789461|NCT01377012|9840562|FG000|wk16 Re-randomized to AIN 75mg NR|Core Study||0
8789462|NCT01377012|9840563|FG001|wk16 Re-randomized to AIN 75mg NR|Core Study||0
8789463|NCT01377012|9840564|FG002|wk16 Re-randomized to AIN 75mg NR|Core Study|NR=Non-responder|56
8789464|NCT01377012|9840562|FG000|wk16 Re-randomized to AIN 150mg NR|Core Study||0
8789465|NCT01377012|9840563|FG001|wk16 Re-randomized to AIN 150mg NR|Core Study||0
8789466|NCT01377012|9840564|FG002|wk16 Re-randomized to AIN 150mg NR|Core Study||53
8789467|NCT01377012|9840562|FG000|wk 24 Re-randomized to AIN 75 mg Res|Core Study||0
8789468|NCT01377012|9840563|FG001|wk 24 Re-randomized to AIN 75 mg Res|Core Study||0
8789469|NCT01377012|9840564|FG002|wk 24 Re-randomized to AIN 75 mg Res|Core Study|Res= responder|38
8789470|NCT01377012|9840562|FG000|wk 24 Re-randomized to AIN 150 mg Res|Core Study||0
8789471|NCT01377012|9840563|FG001|wk 24 Re-randomized to AIN 150 mg Res|Core Study||0
8789472|NCT01377012|9840564|FG002|wk 24 Re-randomized to AIN 150 mg Res|Core Study||34
8789473|NCT01377012|9840562|FG000|COMPLETED|Core Study||76
8789474|NCT01377012|9840563|FG001|COMPLETED|Core Study||81
8789475|NCT01377012|9840564|FG002|COMPLETED|Core Study||80
8789476|NCT01377012|9840562|FG000|NOT COMPLETED|Core Study||134
8789477|NCT01377012|9840563|FG001|NOT COMPLETED|Core Study||132
8789478|NCT01377012|9840564|FG002|NOT COMPLETED|Core Study||134
8789479|NCT01377012|9840562|FG000|STARTED|Extension Study, Weeks 104-260||57
8789480|NCT01377012|9840563|FG001|STARTED|Extension Study, Weeks 104-260||71
8789481|NCT01377012|9840564|FG002|STARTED|Extension Study, Weeks 104-260||68
8789482|NCT01377012|9840562|FG000|COMPLETED|Extension Study, Weeks 104-260||0
8789483|NCT01377012|9840563|FG001|COMPLETED|Extension Study, Weeks 104-260||0
8789484|NCT01377012|9840564|FG002|COMPLETED|Extension Study, Weeks 104-260||0
8789485|NCT01377012|9840562|FG000|NOT COMPLETED|Extension Study, Weeks 104-260||57
8789486|NCT01377012|9840563|FG001|NOT COMPLETED|Extension Study, Weeks 104-260||71
8789487|NCT01377012|9840564|FG002|NOT COMPLETED|Extension Study, Weeks 104-260||68
8789488|NCT01377194|9840575|FG000|STARTED|Overall Study||186
8789489|NCT01377194|9840576|FG001|STARTED|Overall Study||188
8789490|NCT01377194|9840577|FG002|STARTED|Overall Study||188
8789491|NCT01377194|9840575|FG000|COMPLETED|Overall Study||154
8789492|NCT01377194|9840576|FG001|COMPLETED|Overall Study||145
8789493|NCT01377194|9840577|FG002|COMPLETED|Overall Study||142
8789494|NCT01377194|9840575|FG000|NOT COMPLETED|Overall Study||32
8789495|NCT01377194|9840576|FG001|NOT COMPLETED|Overall Study||43
8789496|NCT01377194|9840577|FG002|NOT COMPLETED|Overall Study||46
8789497|NCT01377233|9840593|FG000|STARTED|Open-label||46
8789498|NCT01377233|9840594|FG001|STARTED|Open-label||0
8789499|NCT01377233|9840595|FG002|STARTED|Open-label||0
8789500|NCT01377233|9840596|FG003|STARTED|Open-label||0
8789501|NCT01377233|9840597|FG004|STARTED|Open-label||0
8789502|NCT01377233|9840593|FG000|COMPLETED|Open-label||42
8789503|NCT01377233|9840594|FG001|COMPLETED|Open-label||0
8789504|NCT01377233|9840595|FG002|COMPLETED|Open-label||0
8789505|NCT01377233|9840596|FG003|COMPLETED|Open-label||0
8789506|NCT01377233|9840597|FG004|COMPLETED|Open-label||0
8789507|NCT01377233|9840593|FG000|NOT COMPLETED|Open-label||4
8789508|NCT01377233|9840594|FG001|NOT COMPLETED|Open-label||0
8789509|NCT01377233|9840595|FG002|NOT COMPLETED|Open-label||0
8789510|NCT01377233|9840596|FG003|NOT COMPLETED|Open-label||0
8789511|NCT01377233|9840597|FG004|NOT COMPLETED|Open-label||0
8789512|NCT01377233|9840593|FG000|STARTED|Double-blind||0
8789513|NCT01377233|9840594|FG001|STARTED|Double-blind||11
8789514|NCT01377233|9840595|FG002|STARTED|Double-blind||10
8789515|NCT01377233|9840596|FG003|STARTED|Double-blind||11
8789516|NCT01377233|9840597|FG004|STARTED|Double-blind||10
8789517|NCT01377233|9840593|FG000|COMPLETED|Double-blind||0
8789518|NCT01377233|9840594|FG001|COMPLETED|Double-blind||10
8789519|NCT01377233|9840595|FG002|COMPLETED|Double-blind||8
8789520|NCT01377233|9840596|FG003|COMPLETED|Double-blind||7
8789521|NCT01377233|9840597|FG004|COMPLETED|Double-blind||8
8789522|NCT01377233|9840593|FG000|NOT COMPLETED|Double-blind||0
8789523|NCT01377233|9840594|FG001|NOT COMPLETED|Double-blind||1
8789524|NCT01377233|9840595|FG002|NOT COMPLETED|Double-blind||2
8789525|NCT01377233|9840596|FG003|NOT COMPLETED|Double-blind||4
8789526|NCT01377233|9840597|FG004|NOT COMPLETED|Double-blind||2
8789527|NCT01377389|9840613|FG000|STARTED|Overall Study||30
8789528|NCT01377389|9840613|FG000|COMPLETED|Overall Study||27
8789529|NCT01377389|9840613|FG000|NOT COMPLETED|Overall Study||3
8789530|NCT01377402|9840617|FG000|STARTED|Overall Study||982
8789531|NCT01377402|9840617|FG000|COMPLETED|Overall Study||982
8789532|NCT01377402|9840617|FG000|NOT COMPLETED|Overall Study||0
8789533|NCT01377467|9840625|FG000|STARTED|Overall Study||46
8789534|NCT01377467|9840626|FG001|STARTED|Overall Study||44
8789535|NCT01377467|9840625|FG000|COMPLETED|Overall Study||46
8789536|NCT01377467|9840626|FG001|COMPLETED|Overall Study||44
8789537|NCT01377467|9840625|FG000|NOT COMPLETED|Overall Study||0
8789538|NCT01377467|9840626|FG001|NOT COMPLETED|Overall Study||0
8789539|NCT01377480|9840636|FG000|STARTED|Overall Study|Includes 2 participants randomized to POS + BNZ but who only received POS|32
8789540|NCT01377480|9840637|FG001|STARTED|Overall Study||30
8789541|NCT01377480|9840638|FG002|STARTED|Overall Study|2 participants received only POS and were analyzed as part of the posaconazole group|28
8789542|NCT01377480|9840639|FG003|STARTED|Overall Study||30
8789543|NCT01377480|9840636|FG000|COMPLETED|Overall Study||32
8789544|NCT01377480|9840637|FG001|COMPLETED|Overall Study||29
8789545|NCT01377480|9840638|FG002|COMPLETED|Overall Study||18
8789546|NCT01377480|9840639|FG003|COMPLETED|Overall Study||19
8789547|NCT01377480|9840636|FG000|NOT COMPLETED|Overall Study||0
9032077|NCT03253094|10094229|FG003|Subjects Discontinued|Overall Study||4
9032078|NCT03253094|10094230|FG004|Subjects Discontinued|Overall Study||5
9032079|NCT03253094|10094231|FG005|Subjects Discontinued|Overall Study||4
9032080|NCT03253094|10094226|FG000|COMPLETED|Overall Study||28
9032081|NCT03253094|10094227|FG001|COMPLETED|Overall Study||27
9032082|NCT03253094|10094228|FG002|COMPLETED|Overall Study||22
9032083|NCT03253094|10094229|FG003|COMPLETED|Overall Study||28
9032084|NCT03253094|10094230|FG004|COMPLETED|Overall Study||27
9032085|NCT03253094|10094231|FG005|COMPLETED|Overall Study||28
9032086|NCT03253094|10094226|FG000|NOT COMPLETED|Overall Study||4
9032087|NCT03253094|10094227|FG001|NOT COMPLETED|Overall Study||3
9032088|NCT03253094|10094228|FG002|NOT COMPLETED|Overall Study||6
9032089|NCT03253094|10094229|FG003|NOT COMPLETED|Overall Study||4
9032090|NCT03253094|10094230|FG004|NOT COMPLETED|Overall Study||5
9032091|NCT03253094|10094231|FG005|NOT COMPLETED|Overall Study||4
9032092|NCT03254108|10094250|FG000|STARTED|Overall Study||13
9032093|NCT03254108|10094251|FG001|STARTED|Overall Study||12
9032094|NCT03254108|10094252|FG002|STARTED|Overall Study||12
9032095|NCT03254108|10094253|FG003|STARTED|Overall Study||12
9032096|NCT03254108|10094254|FG004|STARTED|Overall Study||12
9032097|NCT03254108|10094250|FG000|Received Treatment|Overall Study||13
9032098|NCT03254108|10094251|FG001|Received Treatment|Overall Study||12
9032099|NCT03254108|10094252|FG002|Received Treatment|Overall Study||12
9032100|NCT03254108|10094253|FG003|Received Treatment|Overall Study||11
9032101|NCT03254108|10094254|FG004|Received Treatment|Overall Study||12
9032102|NCT03254108|10094250|FG000|COMPLETED|Overall Study||13
9032103|NCT03254108|10094251|FG001|COMPLETED|Overall Study||10
8789548|NCT01377480|9840637|FG001|NOT COMPLETED|Overall Study||1
8789549|NCT01377480|9840638|FG002|NOT COMPLETED|Overall Study||10
8789550|NCT01377480|9840639|FG003|NOT COMPLETED|Overall Study||11
8789551|NCT01377584|9840655|FG000|STARTED|Overall Study||8
8789552|NCT01377584|9840656|FG001|STARTED|Overall Study||8
8789553|NCT01377584|9840657|FG002|STARTED|Overall Study||10
8789554|NCT01377584|9840658|FG003|STARTED|Overall Study||10
8789555|NCT01377584|9840659|FG004|STARTED|Overall Study||12
8789556|NCT01377584|9840660|FG005|STARTED|Overall Study||12
8789557|NCT01377584|9840655|FG000|COMPLETED|Overall Study||5
8789558|NCT01377584|9840656|FG001|COMPLETED|Overall Study||5
8789559|NCT01377584|9840657|FG002|COMPLETED|Overall Study||6
8789560|NCT01377584|9840658|FG003|COMPLETED|Overall Study||6
8789561|NCT01377584|9840659|FG004|COMPLETED|Overall Study||9
8789562|NCT01377584|9840660|FG005|COMPLETED|Overall Study||9
8789563|NCT01377584|9840655|FG000|NOT COMPLETED|Overall Study||3
8789564|NCT01377584|9840656|FG001|NOT COMPLETED|Overall Study||3
8789565|NCT01377584|9840657|FG002|NOT COMPLETED|Overall Study||4
8789566|NCT01377584|9840658|FG003|NOT COMPLETED|Overall Study||4
8789567|NCT01377584|9840659|FG004|NOT COMPLETED|Overall Study||3
8789568|NCT01377584|9840660|FG005|NOT COMPLETED|Overall Study||3
8789569|NCT01377623|9840679|FG000|STARTED|Overall Study||33
8789570|NCT01377623|9840680|FG001|STARTED|Overall Study||33
8789571|NCT01377623|9840679|FG000|COMPLETED|Overall Study||26
8789572|NCT01377623|9840680|FG001|COMPLETED|Overall Study||28
8789573|NCT01377623|9840679|FG000|NOT COMPLETED|Overall Study||7
8789574|NCT01377623|9840680|FG001|NOT COMPLETED|Overall Study||5
8789575|NCT01377636|9840686|FG000|STARTED|Overall Study||20
8789576|NCT01377636|9840686|FG000|COMPLETED|Overall Study||20
8789577|NCT01377636|9840686|FG000|NOT COMPLETED|Overall Study||0
8789578|NCT01377844|9840694|FG000|STARTED|Overall Study||145
8789579|NCT01377844|9840695|FG001|STARTED|Overall Study||143
8789580|NCT01377844|9840694|FG000|Safety Population|Overall Study||145
8789581|NCT01377844|9840695|FG001|Safety Population|Overall Study||141
8789582|NCT01377844|9840694|FG000|COMPLETED|Overall Study||109
8789583|NCT01377844|9840695|FG001|COMPLETED|Overall Study||108
8789584|NCT01377844|9840694|FG000|NOT COMPLETED|Overall Study||36
8789585|NCT01377844|9840695|FG001|NOT COMPLETED|Overall Study||35
8789586|NCT01377922|9840704|FG000|STARTED|Overall Study||22
8789587|NCT01377922|9840705|FG001|STARTED|Overall Study||16
8789588|NCT01377922|9840704|FG000|COMPLETED|Overall Study||21
8789589|NCT01377922|9840705|FG001|COMPLETED|Overall Study||16
8789590|NCT01377922|9840704|FG000|NOT COMPLETED|Overall Study||1
8789591|NCT01377922|9840705|FG001|NOT COMPLETED|Overall Study||0
8789592|NCT01377987|9840711|FG000|STARTED|First Intervention (7 Days)||14
8916976|NCT02188160|9976582|FG001|COMPLETED|Overall Study||76
8916977|NCT02188160|9976581|FG000|NOT COMPLETED|Overall Study||1
8916978|NCT02188160|9976582|FG001|NOT COMPLETED|Overall Study||1
8916979|NCT02188303|9976596|FG000|STARTED|Overall Study||6
8916980|NCT02188303|9976597|FG001|STARTED|Overall Study||6
8916981|NCT02188303|9976598|FG002|STARTED|Overall Study||6
8916982|NCT02188303|9976599|FG003|STARTED|Overall Study||6
8916983|NCT02188303|9976600|FG004|STARTED|Overall Study||4
9032104|NCT03254108|10094252|FG002|COMPLETED|Overall Study||12
9032105|NCT03254108|10094253|FG003|COMPLETED|Overall Study||11
9032106|NCT03254108|10094254|FG004|COMPLETED|Overall Study||9
9032107|NCT03254108|10094250|FG000|NOT COMPLETED|Overall Study||0
9032108|NCT03254108|10094251|FG001|NOT COMPLETED|Overall Study||2
9032109|NCT03254108|10094252|FG002|NOT COMPLETED|Overall Study||0
9032110|NCT03254108|10094253|FG003|NOT COMPLETED|Overall Study||1
9032111|NCT03254108|10094254|FG004|NOT COMPLETED|Overall Study||3
9032112|NCT03254134|10094268|FG000|STARTED|Overall Study||5745
9032113|NCT03254134|10094269|FG001|STARTED|Overall Study||16745
9032114|NCT03254134|10094268|FG000|COMPLETED|Overall Study||5146
9032115|NCT03254134|10094269|FG001|COMPLETED|Overall Study||13115
8672005|NCT00754624|9715443|FG000|STARTED|Overall Study||229
8672006|NCT00754624|9715443|FG000|COMPLETED|Overall Study||160
8672007|NCT00754624|9715443|FG000|NOT COMPLETED|Overall Study||69
8672008|NCT00754650|9715447|FG000|STARTED|Overall Study||2
8672009|NCT00754650|9715447|FG000|COMPLETED|Overall Study||0
8672010|NCT00754650|9715447|FG000|NOT COMPLETED|Overall Study||2
8672011|NCT00754741|9715454|FG000|STARTED|Overall Study||567
8672012|NCT00754741|9715455|FG001|STARTED|Overall Study||569
8672013|NCT00754741|9715456|FG002|STARTED|Overall Study||556
8672014|NCT00754741|9715454|FG000|COMPLETED|Overall Study||510
8672015|NCT00754741|9715455|FG001|COMPLETED|Overall Study||500
8672016|NCT00754741|9715456|FG002|COMPLETED|Overall Study||502
8672017|NCT00754741|9715454|FG000|NOT COMPLETED|Overall Study||57
8672018|NCT00754741|9715455|FG001|NOT COMPLETED|Overall Study||69
8672019|NCT00754741|9715456|FG002|NOT COMPLETED|Overall Study||54
8672020|NCT00754832|9715464|FG000|STARTED|First 6 Weeks Intervention||26
8672021|NCT00754832|9715465|FG001|STARTED|First 6 Weeks Intervention||30
8672022|NCT00754832|9715464|FG000|COMPLETED|First 6 Weeks Intervention||18
8672023|NCT00754832|9715465|FG001|COMPLETED|First 6 Weeks Intervention||28
8672024|NCT00754832|9715464|FG000|NOT COMPLETED|First 6 Weeks Intervention||8
8672025|NCT00754832|9715465|FG001|NOT COMPLETED|First 6 Weeks Intervention||2
8672026|NCT00754832|9715464|FG000|STARTED|2 Weeks Washout||18
8672027|NCT00754832|9715465|FG001|STARTED|2 Weeks Washout||28
8672028|NCT00754832|9715464|FG000|COMPLETED|2 Weeks Washout||17
8789593|NCT01377987|9840712|FG001|STARTED|First Intervention (7 Days)||15
9032116|NCT03254134|10094268|FG000|NOT COMPLETED|Overall Study||599
8789594|NCT01377987|9840711|FG000|COMPLETED|First Intervention (7 Days)||14
8916984|NCT02188303|9976601|FG005|STARTED|Overall Study||12
8916985|NCT02188303|9976602|FG006|STARTED|Overall Study||2
8672029|NCT00754832|9715465|FG001|COMPLETED|2 Weeks Washout||26
8789595|NCT01377987|9840712|FG001|COMPLETED|First Intervention (7 Days)||15
8789596|NCT01377987|9840711|FG000|NOT COMPLETED|First Intervention (7 Days)||0
8789597|NCT01377987|9840712|FG001|NOT COMPLETED|First Intervention (7 Days)||0
8789598|NCT01377987|9840711|FG000|STARTED|Washout (7 Days)||14
8789599|NCT01377987|9840712|FG001|STARTED|Washout (7 Days)||15
8789600|NCT01377987|9840711|FG000|COMPLETED|Washout (7 Days)||13
8789601|NCT01377987|9840712|FG001|COMPLETED|Washout (7 Days)||14
8789602|NCT01377987|9840711|FG000|NOT COMPLETED|Washout (7 Days)||1
8789603|NCT01377987|9840712|FG001|NOT COMPLETED|Washout (7 Days)||1
8916986|NCT02188303|9976603|FG007|STARTED|Overall Study||6
8789604|NCT01377987|9840711|FG000|STARTED|Second Intervention (7 Days)||13
8789605|NCT01377987|9840712|FG001|STARTED|Second Intervention (7 Days)||14
8789606|NCT01377987|9840711|FG000|COMPLETED|Second Intervention (7 Days)||13
8789607|NCT01377987|9840712|FG001|COMPLETED|Second Intervention (7 Days)||14
8789608|NCT01377987|9840711|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
8789609|NCT01377987|9840712|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
8789610|NCT01378065|9840718|FG000|STARTED|Overall Study|31 subjects were enrolled/consented. However, 1 subject was not implanted with a study device.|30
8789611|NCT01378065|9840718|FG000|6 Week|Overall Study||30
8789612|NCT01378065|9840718|FG000|3 Months|Overall Study||30
8789613|NCT01378065|9840718|FG000|6 Months|Overall Study||30
8789614|NCT01378065|9840718|FG000|12 Months|Overall Study||30
8789615|NCT01378065|9840718|FG000|COMPLETED|Overall Study||30
8789616|NCT01378065|9840718|FG000|NOT COMPLETED|Overall Study||0
8789617|NCT01378104|9840724|FG000|STARTED|Overall Study||92
8789618|NCT01378104|9840725|FG001|STARTED|Overall Study||86
8789619|NCT01378104|9840724|FG000|COMPLETED|Overall Study||65
8789620|NCT01378104|9840725|FG001|COMPLETED|Overall Study||60
8789621|NCT01378104|9840724|FG000|NOT COMPLETED|Overall Study||27
8789622|NCT01378104|9840725|FG001|NOT COMPLETED|Overall Study||26
8789623|NCT01378117|9840736|FG000|STARTED|Overall Study||31
8789624|NCT01378117|9840737|FG001|STARTED|Overall Study||30
8789625|NCT01378117|9840738|FG002|STARTED|Overall Study||29
8789626|NCT01378117|9840736|FG000|COMPLETED|Overall Study||27
8789627|NCT01378117|9840737|FG001|COMPLETED|Overall Study||29
8789628|NCT01378117|9840738|FG002|COMPLETED|Overall Study||26
8789629|NCT01378117|9840736|FG000|NOT COMPLETED|Overall Study||4
8789630|NCT01378117|9840737|FG001|NOT COMPLETED|Overall Study||1
8789631|NCT01378117|9840738|FG002|NOT COMPLETED|Overall Study||3
8789632|NCT01378195|9840753|FG000|STARTED|Overall Study||75
8789633|NCT01378195|9840754|FG001|STARTED|Overall Study||75
8789634|NCT01378195|9840753|FG000|COMPLETED|Overall Study||46
8789635|NCT01378195|9840754|FG001|COMPLETED|Overall Study||57
8789636|NCT01378195|9840753|FG000|NOT COMPLETED|Overall Study||29
8789637|NCT01378195|9840754|FG001|NOT COMPLETED|Overall Study||18
8789638|NCT01378221|9840762|FG000|STARTED|Overall Study||36
8789639|NCT01378221|9840763|FG001|STARTED|Overall Study||39
8789640|NCT01378221|9840762|FG000|COMPLETED|Overall Study||29
8789641|NCT01378221|9840763|FG001|COMPLETED|Overall Study||30
8789642|NCT01378221|9840762|FG000|NOT COMPLETED|Overall Study||7
8789643|NCT01378221|9840763|FG001|NOT COMPLETED|Overall Study||9
8789644|NCT01378273|9840771|FG000|STARTED|Overall Study||464
8789645|NCT01378273|9840772|FG001|STARTED|Overall Study||477
8789646|NCT01378273|9840771|FG000|COMPLETED|Overall Study||460
8789647|NCT01378273|9840772|FG001|COMPLETED|Overall Study||476
8789648|NCT01378273|9840771|FG000|NOT COMPLETED|Overall Study||4
8789649|NCT01378273|9840772|FG001|NOT COMPLETED|Overall Study||1
8789650|NCT01378299|9840782|FG000|STARTED|Overall Study||105
8789651|NCT01378299|9840782|FG000|BMI group1|Overall Study||38
8789652|NCT01378299|9840782|FG000|BMI Group 2|Overall Study||40
8789653|NCT01378299|9840782|FG000|BMI Group 3|Overall Study||27
8789654|NCT01378299|9840782|FG000|COMPLETED|Overall Study||74
8789655|NCT01378299|9840782|FG000|NOT COMPLETED|Overall Study||31
8789656|NCT01378325|9840814|FG000|STARTED|Overall Study||40
8789657|NCT01378325|9840815|FG001|STARTED|Overall Study||40
8789658|NCT01378325|9840814|FG000|COMPLETED|Overall Study||40
8789659|NCT01378325|9840815|FG001|COMPLETED|Overall Study||39
8789660|NCT01378325|9840814|FG000|NOT COMPLETED|Overall Study||0
8789661|NCT01378325|9840815|FG001|NOT COMPLETED|Overall Study||1
8789662|NCT01378377|9840824|FG000|STARTED|Overall Study||4
8789663|NCT01378377|9840825|FG001|STARTED|Overall Study||23
8789664|NCT01378377|9840826|FG002|STARTED|Overall Study||6
8789665|NCT01378377|9840824|FG000|COMPLETED|Overall Study||4
8789666|NCT01378377|9840825|FG001|COMPLETED|Overall Study||23
8789667|NCT01378377|9840826|FG002|COMPLETED|Overall Study||6
8789668|NCT01378377|9840824|FG000|NOT COMPLETED|Overall Study||0
8789669|NCT01378377|9840825|FG001|NOT COMPLETED|Overall Study||0
8789670|NCT01378377|9840826|FG002|NOT COMPLETED|Overall Study||0
8789671|NCT01378416|9840839|FG000|STARTED|Overall Study||16
8789672|NCT01378416|9840839|FG000|COMPLETED|Overall Study||16
8789673|NCT01378416|9840839|FG000|NOT COMPLETED|Overall Study||0
8789674|NCT01378429|9840845|FG000|STARTED|Overall Study||42
8789675|NCT01378429|9840846|FG001|STARTED|Overall Study||47
8789676|NCT01378429|9840845|FG000|COMPLETED|Overall Study||41
8789677|NCT01378429|9840846|FG001|COMPLETED|Overall Study||47
8789678|NCT01378429|9840845|FG000|NOT COMPLETED|Overall Study||1
8789679|NCT01378429|9840846|FG001|NOT COMPLETED|Overall Study||0
8789680|NCT01378520|9840855|FG000|STARTED|First Intervention (Day 2-3)||10
8789681|NCT01378520|9840856|FG001|STARTED|First Intervention (Day 2-3)||10
8789682|NCT01378520|9840855|FG000|COMPLETED|First Intervention (Day 2-3)||10
8789683|NCT01378520|9840856|FG001|COMPLETED|First Intervention (Day 2-3)||10
8789684|NCT01378520|9840855|FG000|NOT COMPLETED|First Intervention (Day 2-3)||0
8789685|NCT01378520|9840856|FG001|NOT COMPLETED|First Intervention (Day 2-3)||0
8789686|NCT01378520|9840855|FG000|STARTED|Second Intervention (Day 4-6)||10
8789687|NCT01378520|9840856|FG001|STARTED|Second Intervention (Day 4-6)||10
8789688|NCT01378520|9840855|FG000|COMPLETED|Second Intervention (Day 4-6)||10
8789689|NCT01378520|9840856|FG001|COMPLETED|Second Intervention (Day 4-6)||10
8789690|NCT01378520|9840855|FG000|NOT COMPLETED|Second Intervention (Day 4-6)||0
8789691|NCT01378520|9840856|FG001|NOT COMPLETED|Second Intervention (Day 4-6)||0
8789692|NCT01378858|9840864|FG000|STARTED|Overall Study||50
8789693|NCT01378858|9840865|FG001|STARTED|Overall Study||50
8916987|NCT02188303|9976596|FG000|COMPLETED|Overall Study||6
8916988|NCT02188303|9976597|FG001|COMPLETED|Overall Study||6
8916989|NCT02188303|9976598|FG002|COMPLETED|Overall Study||6
8916990|NCT02188303|9976599|FG003|COMPLETED|Overall Study||6
8916991|NCT02188303|9976600|FG004|COMPLETED|Overall Study||4
8916992|NCT02188303|9976601|FG005|COMPLETED|Overall Study||10
8916993|NCT02188303|9976602|FG006|COMPLETED|Overall Study|Protocol-defined dose termination criteria met, dosing stopped on Day 5 and study was terminated.|0
8916994|NCT02188303|9976603|FG007|COMPLETED|Overall Study|Protocol-defined dose termination criteria met, dosing stopped on Day 5 and study was terminated.|0
8916995|NCT02188303|9976596|FG000|NOT COMPLETED|Overall Study||0
8916996|NCT02188303|9976597|FG001|NOT COMPLETED|Overall Study||0
8916997|NCT02188303|9976598|FG002|NOT COMPLETED|Overall Study||0
8916998|NCT02188303|9976599|FG003|NOT COMPLETED|Overall Study||0
8916999|NCT02188303|9976600|FG004|NOT COMPLETED|Overall Study||0
8917000|NCT02188303|9976601|FG005|NOT COMPLETED|Overall Study||2
8917001|NCT02188303|9976602|FG006|NOT COMPLETED|Overall Study||2
8917002|NCT02188303|9976603|FG007|NOT COMPLETED|Overall Study||6
8917003|NCT02188459|9976629|FG000|STARTED|Overall Study||64
8917004|NCT02188459|9976630|FG001|STARTED|Overall Study||65
8917005|NCT02188459|9976629|FG000|COMPLETED|Overall Study||61
8917006|NCT02188459|9976630|FG001|COMPLETED|Overall Study||58
8917007|NCT02188459|9976629|FG000|NOT COMPLETED|Overall Study||3
8917008|NCT02188459|9976630|FG001|NOT COMPLETED|Overall Study||7
8917009|NCT02188485|9976642|FG000|STARTED|Overall Study||32
8917010|NCT02188485|9976643|FG001|STARTED|Overall Study||30
8917011|NCT02188485|9976642|FG000|COMPLETED|Overall Study||30
8917012|NCT02188485|9976643|FG001|COMPLETED|Overall Study||27
8917013|NCT02188485|9976642|FG000|NOT COMPLETED|Overall Study||2
8917014|NCT02188485|9976643|FG001|NOT COMPLETED|Overall Study||3
8917015|NCT02188576|9976651|FG000|STARTED|Overall Study||32
8917016|NCT02188576|9976652|FG001|STARTED|Overall Study||34
8917017|NCT02188576|9976651|FG000|COMPLETED|Overall Study||32
8917018|NCT02188576|9976652|FG001|COMPLETED|Overall Study||34
8917019|NCT02188576|9976651|FG000|NOT COMPLETED|Overall Study||0
8917020|NCT02188576|9976652|FG001|NOT COMPLETED|Overall Study||0
8917021|NCT02188589|9976658|FG000|STARTED|Overall Study||30
8917022|NCT02188589|9976658|FG000|6 Months|Overall Study||30
8917023|NCT02188589|9976658|FG000|12 Months|Overall Study||30
8917024|NCT02188589|9976658|FG000|24 Months|Overall Study||25
8917025|NCT02188589|9976658|FG000|COMPLETED|Overall Study||25
8917026|NCT02188589|9976658|FG000|NOT COMPLETED|Overall Study||5
8917027|NCT02188719|9976667|FG000|STARTED|Overall Study||6
8917028|NCT02188719|9976668|FG001|STARTED|Overall Study||9
8917029|NCT02188719|9976669|FG002|STARTED|Overall Study||0
8917030|NCT02188719|9976670|FG003|STARTED|Overall Study||0
8917031|NCT02188719|9976667|FG000|COMPLETED|Overall Study||6
8917032|NCT02188719|9976668|FG001|COMPLETED|Overall Study||8
8917033|NCT02188719|9976669|FG002|COMPLETED|Overall Study||0
8917034|NCT02188719|9976670|FG003|COMPLETED|Overall Study||0
8917035|NCT02188719|9976667|FG000|NOT COMPLETED|Overall Study||0
8917036|NCT02188719|9976668|FG001|NOT COMPLETED|Overall Study||1
8917037|NCT02188719|9976669|FG002|NOT COMPLETED|Overall Study||0
8917038|NCT02188719|9976670|FG003|NOT COMPLETED|Overall Study||0
8917039|NCT02188784|9976680|FG000|STARTED|Overall Study||111
8917040|NCT02188784|9976681|FG001|STARTED|Overall Study||114
8917041|NCT02188784|9976680|FG000|COMPLETED|Overall Study|Patients completing the protocol excluding death, lost to follow-up and withdrawn consent.|102
8917042|NCT02188784|9976681|FG001|COMPLETED|Overall Study|Patients completing the protocol excluding death, lost to follow-up and withdrawn consent.|101
8917043|NCT02188784|9976680|FG000|NOT COMPLETED|Overall Study||9
8917044|NCT02188784|9976681|FG001|NOT COMPLETED|Overall Study||13
8917045|NCT02188849|9976689|FG000|STARTED|Overall Study||25
8917046|NCT02188849|9976690|FG001|STARTED|Overall Study||25
8917047|NCT02188849|9976689|FG000|COMPLETED|Overall Study||22
8917048|NCT02188849|9976690|FG001|COMPLETED|Overall Study||17
8917049|NCT02188849|9976689|FG000|NOT COMPLETED|Overall Study||3
8917050|NCT02188849|9976690|FG001|NOT COMPLETED|Overall Study||8
8917051|NCT02189122|9976698|FG000|STARTED|Overall Study||18
8917052|NCT02189122|9976699|FG001|STARTED|Overall Study||18
8917053|NCT02189122|9976698|FG000|COMPLETED|Overall Study||18
8917054|NCT02189122|9976699|FG001|COMPLETED|Overall Study||18
8917055|NCT02189122|9976698|FG000|NOT COMPLETED|Overall Study||0
8917056|NCT02189122|9976699|FG001|NOT COMPLETED|Overall Study||0
8917057|NCT02189161|9976707|FG000|STARTED|Overall Study||10
8917058|NCT02189161|9976707|FG000|COMPLETED|Overall Study||10
8917059|NCT02189161|9976707|FG000|NOT COMPLETED|Overall Study||0
8917060|NCT02189213|9976713|FG000|STARTED|Overall Study||13
8917061|NCT02189213|9976714|FG001|STARTED|Overall Study||1
8917062|NCT02189213|9976713|FG000|COMPLETED|Overall Study||7
8917063|NCT02189213|9976714|FG001|COMPLETED|Overall Study||1
8917064|NCT02189213|9976713|FG000|NOT COMPLETED|Overall Study||6
8917065|NCT02189213|9976714|FG001|NOT COMPLETED|Overall Study||0
8917066|NCT02189252|9976724|FG000|STARTED|Period 1 (Visit 4b, Week 4)||4
8917067|NCT02189252|9976725|FG001|STARTED|Period 1 (Visit 4b, Week 4)||4
8917068|NCT02189252|9976726|FG002|STARTED|Period 1 (Visit 4b, Week 4)||3
8917069|NCT02189252|9976727|FG003|STARTED|Period 1 (Visit 4b, Week 4)||4
8917070|NCT02189252|9976724|FG000|COMPLETED|Period 1 (Visit 4b, Week 4)||4
8917071|NCT02189252|9976725|FG001|COMPLETED|Period 1 (Visit 4b, Week 4)||2
8917072|NCT02189252|9976726|FG002|COMPLETED|Period 1 (Visit 4b, Week 4)||3
8917073|NCT02189252|9976727|FG003|COMPLETED|Period 1 (Visit 4b, Week 4)||4
8789694|NCT01378858|9840864|FG000|COMPLETED|Overall Study||46
8789695|NCT01378858|9840865|FG001|COMPLETED|Overall Study||46
8789696|NCT01378858|9840864|FG000|NOT COMPLETED|Overall Study||4
8789697|NCT01378858|9840865|FG001|NOT COMPLETED|Overall Study||4
8789698|NCT01378962|9840871|FG000|STARTED|Overall Study||50
8789699|NCT01378962|9840871|FG000|COMPLETED|Overall Study||33
8789700|NCT01378962|9840871|FG000|NOT COMPLETED|Overall Study||17
8789701|NCT01378975|9840877|FG000|STARTED|Overall Study||90
8789702|NCT01378975|9840878|FG001|STARTED|Overall Study||56
8789703|NCT01378975|9840877|FG000|COMPLETED|Overall Study||4
8789704|NCT01378975|9840878|FG001|COMPLETED|Overall Study||6
8789705|NCT01378975|9840877|FG000|NOT COMPLETED|Overall Study||86
8789706|NCT01378975|9840878|FG001|NOT COMPLETED|Overall Study||50
8789707|NCT01378988|9840887|FG000|STARTED|Overall Study||2
8789708|NCT01378988|9840888|FG001|STARTED|Overall Study||3
8789709|NCT01378988|9840887|FG000|COMPLETED|Overall Study||2
8789710|NCT01378988|9840888|FG001|COMPLETED|Overall Study||3
8789711|NCT01378988|9840887|FG000|NOT COMPLETED|Overall Study||0
8789712|NCT01378988|9840888|FG001|NOT COMPLETED|Overall Study||0
8789713|NCT01379183|9840896|FG000|STARTED|Overall Study||19
8789714|NCT01379183|9840897|FG001|STARTED|Overall Study||21
8789715|NCT01379183|9840896|FG000|COMPLETED|Overall Study||19
8789716|NCT01379183|9840897|FG001|COMPLETED|Overall Study||21
8789717|NCT01379183|9840896|FG000|NOT COMPLETED|Overall Study||0
8789718|NCT01379183|9840897|FG001|NOT COMPLETED|Overall Study||0
8789719|NCT01379222|9840905|FG000|STARTED|Overall Study||178
8789720|NCT01379222|9840905|FG000|COMPLETED|Overall Study||105
8789721|NCT01379222|9840905|FG000|NOT COMPLETED|Overall Study||73
8789722|NCT01379508|9840913|FG000|STARTED|Treatment to Week 104||99
8789723|NCT01379508|9840914|FG001|STARTED|Treatment to Week 104||22
8789724|NCT01379508|9840915|FG002|STARTED|Treatment to Week 104||109
8789725|NCT01379508|9840916|FG003|STARTED|Treatment to Week 104||11
8789726|NCT01379508|9840913|FG000|Completed Wk 24|Treatment to Week 104||93
8789727|NCT01379508|9840914|FG001|Completed Wk 24|Treatment to Week 104||22
8789728|NCT01379508|9840915|FG002|Completed Wk 24|Treatment to Week 104||107
8789729|NCT01379508|9840916|FG003|Completed Wk 24|Treatment to Week 104||11
8789730|NCT01379508|9840913|FG000|Treatment Exposure ≥ 52 Weeks|Treatment to Week 104||91
8789731|NCT01379508|9840914|FG001|Treatment Exposure ≥ 52 Weeks|Treatment to Week 104||21
8789732|NCT01379508|9840915|FG002|Treatment Exposure ≥ 52 Weeks|Treatment to Week 104||105
8789733|NCT01379508|9840916|FG003|Treatment Exposure ≥ 52 Weeks|Treatment to Week 104||11
8789734|NCT01379508|9840913|FG000|COMPLETED|Treatment to Week 104||80
8789735|NCT01379508|9840914|FG001|COMPLETED|Treatment to Week 104||19
8789736|NCT01379508|9840915|FG002|COMPLETED|Treatment to Week 104||96
8789737|NCT01379508|9840916|FG003|COMPLETED|Treatment to Week 104||11
8789738|NCT01379508|9840913|FG000|NOT COMPLETED|Treatment to Week 104||19
8789739|NCT01379508|9840914|FG001|NOT COMPLETED|Treatment to Week 104||3
8789740|NCT01379508|9840915|FG002|NOT COMPLETED|Treatment to Week 104||13
8789741|NCT01379508|9840916|FG003|NOT COMPLETED|Treatment to Week 104||0
8789742|NCT01379508|9840913|FG000|STARTED|Extension Period Weeks 109-156||64
8789743|NCT01379508|9840914|FG001|STARTED|Extension Period Weeks 109-156||17
8789744|NCT01379508|9840915|FG002|STARTED|Extension Period Weeks 109-156||79
8789745|NCT01379508|9840916|FG003|STARTED|Extension Period Weeks 109-156||10
8789746|NCT01379508|9840913|FG000|COMPLETED|Extension Period Weeks 109-156||45
8789747|NCT01379508|9840914|FG001|COMPLETED|Extension Period Weeks 109-156||14
8789748|NCT01379508|9840915|FG002|COMPLETED|Extension Period Weeks 109-156||65
8789749|NCT01379508|9840916|FG003|COMPLETED|Extension Period Weeks 109-156||10
8789750|NCT01379508|9840913|FG000|NOT COMPLETED|Extension Period Weeks 109-156||19
8789751|NCT01379508|9840914|FG001|NOT COMPLETED|Extension Period Weeks 109-156||3
8789752|NCT01379508|9840915|FG002|NOT COMPLETED|Extension Period Weeks 109-156||14
8789753|NCT01379508|9840916|FG003|NOT COMPLETED|Extension Period Weeks 109-156||0
8789754|NCT01379521|9840932|FG000|STARTED|Overall Study -Treatment Period||33
8789755|NCT01379521|9840933|FG001|STARTED|Overall Study -Treatment Period||26
8789756|NCT01379521|9840932|FG000|COMPLETED|Overall Study -Treatment Period||0
8789757|NCT01379521|9840933|FG001|COMPLETED|Overall Study -Treatment Period||0
8789758|NCT01379521|9840932|FG000|NOT COMPLETED|Overall Study -Treatment Period||33
9032117|NCT03254134|10094269|FG001|NOT COMPLETED|Overall Study||3630
9032118|NCT03254147|10094275|FG000|STARTED|Overall Study|The number of patients meeting the inclusion and exclusion criteria|53969
9032119|NCT03254147|10094275|FG000|COMPLETED|Overall Study||53969
9032120|NCT03254147|10094275|FG000|NOT COMPLETED|Overall Study||0
9032121|NCT03254459|10094281|FG000|STARTED|Overall Study||50
9032122|NCT03254459|10094282|FG001|STARTED|Overall Study||50
9032123|NCT03254459|10094281|FG000|COMPLETED|Overall Study||40
9032124|NCT03254459|10094282|FG001|COMPLETED|Overall Study||27
8789759|NCT01379521|9840933|FG001|NOT COMPLETED|Overall Study -Treatment Period||26
8789760|NCT01379521|9840932|FG000|STARTED|Post-Treatment Evaluations||25
8789761|NCT01379521|9840933|FG001|STARTED|Post-Treatment Evaluations||21
8789762|NCT01379521|9840932|FG000|COMPLETED|Post-Treatment Evaluations||0
8789763|NCT01379521|9840933|FG001|COMPLETED|Post-Treatment Evaluations||0
8789764|NCT01379521|9840932|FG000|NOT COMPLETED|Post-Treatment Evaluations||25
8789765|NCT01379521|9840933|FG001|NOT COMPLETED|Post-Treatment Evaluations||21
9032125|NCT03254459|10094281|FG000|NOT COMPLETED|Overall Study||10
9032126|NCT03254459|10094282|FG001|NOT COMPLETED|Overall Study||23
9032127|NCT03254602|10094288|FG000|STARTED|Overall Study||33
9032128|NCT03254602|10094288|FG000|COMPLETED|Overall Study||29
9032129|NCT03254602|10094288|FG000|NOT COMPLETED|Overall Study||4
8789766|NCT01379534|9840941|FG000|STARTED|Treatment Phase||22
8789767|NCT01379534|9840942|FG001|STARTED|Treatment Phase||31
8789768|NCT01379534|9840941|FG000|COMPLETED|Treatment Phase||0
8789769|NCT01379534|9840942|FG001|COMPLETED|Treatment Phase||0
8789770|NCT01379534|9840941|FG000|NOT COMPLETED|Treatment Phase||22
8789771|NCT01379534|9840942|FG001|NOT COMPLETED|Treatment Phase||31
8789772|NCT01379534|9840941|FG000|STARTED|Tumor Assessment Follow-up (f/u) Phase|All participants discontinued the Treatment Phase. Of these, only 6 qualified for f/u tumor assess..|4
8789773|NCT01379534|9840942|FG001|STARTED|Tumor Assessment Follow-up (f/u) Phase||2
8789774|NCT01379534|9840941|FG000|COMPLETED|Tumor Assessment Follow-up (f/u) Phase||0
8789775|NCT01379534|9840942|FG001|COMPLETED|Tumor Assessment Follow-up (f/u) Phase||0
8789776|NCT01379534|9840941|FG000|NOT COMPLETED|Tumor Assessment Follow-up (f/u) Phase||4
8789777|NCT01379534|9840942|FG001|NOT COMPLETED|Tumor Assessment Follow-up (f/u) Phase||2
8789778|NCT01379573|9840948|FG000|STARTED|Overall Study||74
8789779|NCT01379573|9840948|FG000|COMPLETED|Overall Study||63
8789780|NCT01379573|9840948|FG000|NOT COMPLETED|Overall Study||11
8789781|NCT01379625|9840954|FG000|STARTED|Overall Study||16
8789782|NCT01379625|9840955|FG001|STARTED|Overall Study||16
8789783|NCT01379625|9840954|FG000|COMPLETED|Overall Study||16
8789784|NCT01379625|9840955|FG001|COMPLETED|Overall Study||16
8789785|NCT01379625|9840954|FG000|NOT COMPLETED|Overall Study||0
8789786|NCT01379625|9840955|FG001|NOT COMPLETED|Overall Study||0
8789787|NCT01379651|9840963|FG000|STARTED|Overall Study||10
8789788|NCT01379651|9840964|FG001|STARTED|Overall Study||10
8789789|NCT01379651|9840963|FG000|COMPLETED|Overall Study||10
8789790|NCT01379651|9840964|FG001|COMPLETED|Overall Study||10
8789791|NCT01379651|9840963|FG000|NOT COMPLETED|Overall Study||0
8789792|NCT01379651|9840964|FG001|NOT COMPLETED|Overall Study||0
8789793|NCT01379664|9840972|FG000|STARTED|Overall Study||714
8789794|NCT01379664|9840973|FG001|STARTED|Overall Study||870
8789795|NCT01379664|9840972|FG000|COMPLETED|Overall Study||714
8789796|NCT01379664|9840973|FG001|COMPLETED|Overall Study||870
8789797|NCT01379664|9840972|FG000|NOT COMPLETED|Overall Study||0
8789798|NCT01379664|9840973|FG001|NOT COMPLETED|Overall Study||0
8789799|NCT01379703|9840979|FG000|STARTED|Study Start Through 9 Months|Participants taking lopinavir/ritonavir tablets/capsules or oral solution during the study (66/2288)|66
8789800|NCT01379703|9840980|FG001|STARTED|Study Start Through 9 Months|Participants taking the lopinavir/ritonavir capsule formulation (only) during study (1206/2288)|1206
8789801|NCT01379703|9840981|FG002|STARTED|Study Start Through 9 Months|Participants taking the lopinavir/ritonavir tablet formulation (only) during study (1016/2288)|1016
8789802|NCT01379703|9840979|FG000|COMPLETED|Study Start Through 9 Months||62
8789803|NCT01379703|9840980|FG001|COMPLETED|Study Start Through 9 Months|Participants taking the capsule formulation were followed for an additional 9 months (up to 18 mos).|1084
8789804|NCT01379703|9840981|FG002|COMPLETED|Study Start Through 9 Months||873
8789805|NCT01379703|9840979|FG000|NOT COMPLETED|Study Start Through 9 Months||4
8789806|NCT01379703|9840980|FG001|NOT COMPLETED|Study Start Through 9 Months||122
8789807|NCT01379703|9840981|FG002|NOT COMPLETED|Study Start Through 9 Months||143
8789808|NCT01379703|9840979|FG000|STARTED|9 Months Through 18 Months|Participants in this subgroup were followed for 9 months.|0
8789809|NCT01379703|9840980|FG001|STARTED|9 Months Through 18 Months|Participants taking the capsule formulation were followed for an additional 9 months (up to 18 mos).|1084
8789810|NCT01379703|9840981|FG002|STARTED|9 Months Through 18 Months|Participants in this subgroup were followed for 9 months.|0
8789811|NCT01379703|9840979|FG000|COMPLETED|9 Months Through 18 Months||0
8789812|NCT01379703|9840980|FG001|COMPLETED|9 Months Through 18 Months||854
8789813|NCT01379703|9840981|FG002|COMPLETED|9 Months Through 18 Months||0
8789814|NCT01379703|9840979|FG000|NOT COMPLETED|9 Months Through 18 Months||0
8789815|NCT01379703|9840980|FG001|NOT COMPLETED|9 Months Through 18 Months||230
8789816|NCT01379703|9840981|FG002|NOT COMPLETED|9 Months Through 18 Months||0
8789817|NCT01379768|9840993|FG000|STARTED|Overall Study||23
8789818|NCT01379768|9840994|FG001|STARTED|Overall Study||22
8789819|NCT01379768|9840995|FG002|STARTED|Overall Study||20
8789820|NCT01379768|9840993|FG000|COMPLETED|Overall Study||20
8789821|NCT01379768|9840994|FG001|COMPLETED|Overall Study||21
8789822|NCT01379768|9840995|FG002|COMPLETED|Overall Study||20
8789823|NCT01379768|9840993|FG000|NOT COMPLETED|Overall Study||3
8789824|NCT01379768|9840994|FG001|NOT COMPLETED|Overall Study||1
8789825|NCT01379768|9840995|FG002|NOT COMPLETED|Overall Study||0
8789826|NCT01379924|9841005|FG000|STARTED|Baseline||72
8789827|NCT01379924|9841006|FG001|STARTED|Baseline||68
8789828|NCT01379924|9841005|FG000|COMPLETED|Baseline||72
8789829|NCT01379924|9841006|FG001|COMPLETED|Baseline||68
8789830|NCT01379924|9841005|FG000|NOT COMPLETED|Baseline||0
8789831|NCT01379924|9841006|FG001|NOT COMPLETED|Baseline||0
8789832|NCT01379924|9841005|FG000|STARTED|12-month Assessment||72
8789833|NCT01379924|9841006|FG001|STARTED|12-month Assessment||68
8789834|NCT01379924|9841005|FG000|COMPLETED|12-month Assessment||62
8789835|NCT01379924|9841006|FG001|COMPLETED|12-month Assessment||55
8789836|NCT01379924|9841005|FG000|NOT COMPLETED|12-month Assessment||10
8789837|NCT01379924|9841006|FG001|NOT COMPLETED|12-month Assessment||13
8789838|NCT01379924|9841005|FG000|STARTED|24-month Assessment||62
8789839|NCT01379924|9841006|FG001|STARTED|24-month Assessment||55
8789840|NCT01379924|9841005|FG000|COMPLETED|24-month Assessment||55
8789841|NCT01379924|9841006|FG001|COMPLETED|24-month Assessment||52
8789842|NCT01379924|9841005|FG000|NOT COMPLETED|24-month Assessment||7
8789843|NCT01379924|9841006|FG001|NOT COMPLETED|24-month Assessment||3
8789844|NCT01379924|9841005|FG000|STARTED|36-month Assessment||55
8789845|NCT01379924|9841006|FG001|STARTED|36-month Assessment||52
8917074|NCT02189252|9976724|FG000|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||0
9032130|NCT03254719|10094292|FG000|STARTED|Overall Study||40
9032131|NCT03254719|10094292|FG000|COMPLETED|Overall Study||40
9032132|NCT03254719|10094292|FG000|NOT COMPLETED|Overall Study||0
9032133|NCT03255187|10094298|FG000|STARTED|Periodfrom Enrollment to First Follow-up||35
9032134|NCT03255187|10094299|FG001|STARTED|Periodfrom Enrollment to First Follow-up||35
9032135|NCT03255187|10094298|FG000|COMPLETED|Periodfrom Enrollment to First Follow-up||34
9032136|NCT03255187|10094299|FG001|COMPLETED|Periodfrom Enrollment to First Follow-up||32
9032137|NCT03255187|10094298|FG000|NOT COMPLETED|Periodfrom Enrollment to First Follow-up||1
9032138|NCT03255187|10094299|FG001|NOT COMPLETED|Periodfrom Enrollment to First Follow-up||3
9032139|NCT03255187|10094298|FG000|STARTED|Period From First to Second Follow-up||34
9032140|NCT03255187|10094299|FG001|STARTED|Period From First to Second Follow-up||32
9032141|NCT03255187|10094298|FG000|COMPLETED|Period From First to Second Follow-up||34
9032142|NCT03255187|10094299|FG001|COMPLETED|Period From First to Second Follow-up||31
9032143|NCT03255187|10094298|FG000|NOT COMPLETED|Period From First to Second Follow-up||0
9032144|NCT03255187|10094299|FG001|NOT COMPLETED|Period From First to Second Follow-up||1
9032145|NCT03255187|10094298|FG000|STARTED|Period From Second to Third Follow-up||34
9032146|NCT03255187|10094299|FG001|STARTED|Period From Second to Third Follow-up||31
9032147|NCT03255187|10094298|FG000|COMPLETED|Period From Second to Third Follow-up||34
9032148|NCT03255187|10094299|FG001|COMPLETED|Period From Second to Third Follow-up||31
9032149|NCT03255187|10094298|FG000|NOT COMPLETED|Period From Second to Third Follow-up||0
9032150|NCT03255187|10094299|FG001|NOT COMPLETED|Period From Second to Third Follow-up||0
9032151|NCT03255187|10094298|FG000|STARTED|Period From Third to Fourth Follow-up||34
9032152|NCT03255187|10094299|FG001|STARTED|Period From Third to Fourth Follow-up||31
9032153|NCT03255187|10094298|FG000|COMPLETED|Period From Third to Fourth Follow-up||34
9032154|NCT03255187|10094299|FG001|COMPLETED|Period From Third to Fourth Follow-up||31
9032155|NCT03255187|10094298|FG000|NOT COMPLETED|Period From Third to Fourth Follow-up||0
9032156|NCT03255187|10094299|FG001|NOT COMPLETED|Period From Third to Fourth Follow-up||0
9032157|NCT03255187|10094298|FG000|STARTED|Period at Fourth Follow-up||34
9032158|NCT03255187|10094299|FG001|STARTED|Period at Fourth Follow-up||31
9032159|NCT03255187|10094298|FG000|COMPLETED|Period at Fourth Follow-up||34
9032160|NCT03255187|10094299|FG001|COMPLETED|Period at Fourth Follow-up||31
9032161|NCT03255187|10094298|FG000|NOT COMPLETED|Period at Fourth Follow-up||0
9032162|NCT03255187|10094299|FG001|NOT COMPLETED|Period at Fourth Follow-up||0
9032163|NCT03255291|10094311|FG000|STARTED|Overall Study||93
9032164|NCT03255291|10094312|FG001|STARTED|Overall Study||90
9032165|NCT03255291|10094313|FG002|STARTED|Overall Study||91
9032166|NCT03255291|10094314|FG003|STARTED|Overall Study||90
9032167|NCT03255291|10094315|FG004|STARTED|Overall Study||95
9032168|NCT03255291|10094316|FG005|STARTED|Overall Study||95
9032169|NCT03255291|10094311|FG000|COMPLETED|Overall Study||80
9032170|NCT03255291|10094312|FG001|COMPLETED|Overall Study||78
9032171|NCT03255291|10094313|FG002|COMPLETED|Overall Study||85
9032172|NCT03255291|10094314|FG003|COMPLETED|Overall Study||84
9032173|NCT03255291|10094315|FG004|COMPLETED|Overall Study||88
9032174|NCT03255291|10094316|FG005|COMPLETED|Overall Study||85
9032175|NCT03255291|10094311|FG000|NOT COMPLETED|Overall Study||13
9032176|NCT03255291|10094312|FG001|NOT COMPLETED|Overall Study||12
9032177|NCT03255291|10094313|FG002|NOT COMPLETED|Overall Study||6
9032178|NCT03255291|10094314|FG003|NOT COMPLETED|Overall Study||6
9032179|NCT03255291|10094315|FG004|NOT COMPLETED|Overall Study||7
9032180|NCT03255291|10094316|FG005|NOT COMPLETED|Overall Study||10
9032181|NCT03255382|10094336|FG000|STARTED|Overall Study||60
9032182|NCT03255382|10094337|FG001|STARTED|Overall Study||60
9032183|NCT03255382|10094336|FG000|COMPLETED|Overall Study||47
9032184|NCT03255382|10094337|FG001|COMPLETED|Overall Study||60
9032185|NCT03255382|10094336|FG000|NOT COMPLETED|Overall Study||13
9032186|NCT03255382|10094337|FG001|NOT COMPLETED|Overall Study||0
9032187|NCT03255655|10094346|FG000|STARTED|Overall Study||29
9032188|NCT03255655|10094347|FG001|STARTED|Overall Study||12
9032189|NCT03255655|10094346|FG000|COMPLETED|Overall Study||22
9032190|NCT03255655|10094347|FG001|COMPLETED|Overall Study||8
9032191|NCT03255655|10094346|FG000|NOT COMPLETED|Overall Study||7
9032192|NCT03255655|10094347|FG001|NOT COMPLETED|Overall Study||4
9032193|NCT03255733|10094353|FG000|STARTED|Overall Study||29
9032194|NCT03255733|10094353|FG000|COMPLETED|Overall Study||25
9032195|NCT03255733|10094353|FG000|NOT COMPLETED|Overall Study||4
9032196|NCT03255824|10094359|FG000|STARTED|Overall Study||69
9032197|NCT03255824|10094360|FG001|STARTED|Overall Study||75
9032198|NCT03255824|10094359|FG000|COMPLETED|Overall Study||67
9032199|NCT03255824|10094360|FG001|COMPLETED|Overall Study||74
8917075|NCT02189252|9976725|FG001|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||2
8917076|NCT02189252|9976726|FG002|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||0
8917077|NCT02189252|9976727|FG003|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||0
8917078|NCT02189252|9976724|FG000|STARTED|Period 2 (Visit6b, Week 12)||4
8917079|NCT02189252|9976725|FG001|STARTED|Period 2 (Visit6b, Week 12)||2
8917080|NCT02189252|9976726|FG002|STARTED|Period 2 (Visit6b, Week 12)||3
8917081|NCT02189252|9976727|FG003|STARTED|Period 2 (Visit6b, Week 12)||4
8917082|NCT02189252|9976724|FG000|COMPLETED|Period 2 (Visit6b, Week 12)||4
8917083|NCT02189252|9976725|FG001|COMPLETED|Period 2 (Visit6b, Week 12)||2
8917084|NCT02189252|9976726|FG002|COMPLETED|Period 2 (Visit6b, Week 12)||3
8917085|NCT02189252|9976727|FG003|COMPLETED|Period 2 (Visit6b, Week 12)||4
8917086|NCT02189252|9976724|FG000|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
8789846|NCT01379924|9841005|FG000|COMPLETED|36-month Assessment||52
8789847|NCT01379924|9841006|FG001|COMPLETED|36-month Assessment||48
8789848|NCT01379924|9841005|FG000|NOT COMPLETED|36-month Assessment||3
8789849|NCT01379924|9841006|FG001|NOT COMPLETED|36-month Assessment||4
8789850|NCT01379937|9841019|FG000|STARTED|Overall Study||156
8789851|NCT01379937|9841020|FG001|STARTED|Overall Study||156
8789852|NCT01379937|9841021|FG002|STARTED|Overall Study||104
8789853|NCT01379937|9841022|FG003|STARTED|Overall Study||104
8789854|NCT01379937|9841019|FG000|COMPLETED|Overall Study||155
8789855|NCT01379937|9841020|FG001|COMPLETED|Overall Study||153
8789856|NCT01379937|9841021|FG002|COMPLETED|Overall Study||102
8789857|NCT01379937|9841022|FG003|COMPLETED|Overall Study||103
8789858|NCT01379937|9841019|FG000|NOT COMPLETED|Overall Study||1
8789859|NCT01379937|9841020|FG001|NOT COMPLETED|Overall Study||3
8789860|NCT01379937|9841021|FG002|NOT COMPLETED|Overall Study||2
8789861|NCT01379937|9841022|FG003|NOT COMPLETED|Overall Study||1
8789862|NCT01379963|9841037|FG000|STARTED|Overall Study||780
8789863|NCT01379963|9841037|FG000|COMPLETED|Overall Study||780
8789864|NCT01379963|9841037|FG000|NOT COMPLETED|Overall Study||0
8789865|NCT01380080|9841043|FG000|STARTED|Overall Study||424
8789866|NCT01380080|9841044|FG001|STARTED|Overall Study||426
8789867|NCT01380080|9841043|FG000|COMPLETED|Overall Study||339
8789868|NCT01380080|9841044|FG001|COMPLETED|Overall Study||343
8789869|NCT01380080|9841043|FG000|NOT COMPLETED|Overall Study||85
8789870|NCT01380080|9841044|FG001|NOT COMPLETED|Overall Study||83
8789871|NCT01380093|9841050|FG000|STARTED|Naloxone Challenge Phase||80
8789872|NCT01380093|9841051|FG001|STARTED|Naloxone Challenge Phase||0
8789873|NCT01380093|9841052|FG002|STARTED|Naloxone Challenge Phase||0
8789874|NCT01380093|9841053|FG003|STARTED|Naloxone Challenge Phase||0
8789875|NCT01380093|9841054|FG004|STARTED|Naloxone Challenge Phase||0
8789876|NCT01380093|9841055|FG005|STARTED|Naloxone Challenge Phase||0
8789877|NCT01380093|9841056|FG006|STARTED|Naloxone Challenge Phase||0
8789878|NCT01380093|9841057|FG007|STARTED|Naloxone Challenge Phase||0
8789879|NCT01380093|9841058|FG008|STARTED|Naloxone Challenge Phase||0
8789880|NCT01380093|9841050|FG000|TREATED|Naloxone Challenge Phase||59
8789881|NCT01380093|9841051|FG001|TREATED|Naloxone Challenge Phase||0
8789882|NCT01380093|9841052|FG002|TREATED|Naloxone Challenge Phase||0
8789883|NCT01380093|9841053|FG003|TREATED|Naloxone Challenge Phase||0
8789884|NCT01380093|9841054|FG004|TREATED|Naloxone Challenge Phase||0
8789885|NCT01380093|9841055|FG005|TREATED|Naloxone Challenge Phase||0
8789886|NCT01380093|9841056|FG006|TREATED|Naloxone Challenge Phase||0
8789887|NCT01380093|9841057|FG007|TREATED|Naloxone Challenge Phase||0
8789888|NCT01380093|9841058|FG008|TREATED|Naloxone Challenge Phase||0
8789889|NCT01380093|9841050|FG000|COMPLETED|Naloxone Challenge Phase||59
8789890|NCT01380093|9841051|FG001|COMPLETED|Naloxone Challenge Phase||0
8789891|NCT01380093|9841052|FG002|COMPLETED|Naloxone Challenge Phase||0
8789892|NCT01380093|9841053|FG003|COMPLETED|Naloxone Challenge Phase||0
8789893|NCT01380093|9841054|FG004|COMPLETED|Naloxone Challenge Phase||0
8789894|NCT01380093|9841055|FG005|COMPLETED|Naloxone Challenge Phase||0
8789895|NCT01380093|9841056|FG006|COMPLETED|Naloxone Challenge Phase||0
8789896|NCT01380093|9841057|FG007|COMPLETED|Naloxone Challenge Phase||0
8789897|NCT01380093|9841058|FG008|COMPLETED|Naloxone Challenge Phase||0
8789898|NCT01380093|9841050|FG000|NOT COMPLETED|Naloxone Challenge Phase||21
8789899|NCT01380093|9841051|FG001|NOT COMPLETED|Naloxone Challenge Phase||0
8789900|NCT01380093|9841052|FG002|NOT COMPLETED|Naloxone Challenge Phase||0
8789901|NCT01380093|9841053|FG003|NOT COMPLETED|Naloxone Challenge Phase||0
8789902|NCT01380093|9841054|FG004|NOT COMPLETED|Naloxone Challenge Phase||0
8789903|NCT01380093|9841055|FG005|NOT COMPLETED|Naloxone Challenge Phase||0
8789904|NCT01380093|9841056|FG006|NOT COMPLETED|Naloxone Challenge Phase||0
8789905|NCT01380093|9841057|FG007|NOT COMPLETED|Naloxone Challenge Phase||0
8789906|NCT01380093|9841058|FG008|NOT COMPLETED|Naloxone Challenge Phase||0
8789907|NCT01380093|9841050|FG000|STARTED|Drug Discrimination Phase: Day 1||0
8789908|NCT01380093|9841051|FG001|STARTED|Drug Discrimination Phase: Day 1||30
8789909|NCT01380093|9841052|FG002|STARTED|Drug Discrimination Phase: Day 1||29
8789910|NCT01380093|9841053|FG003|STARTED|Drug Discrimination Phase: Day 1||0
8789911|NCT01380093|9841054|FG004|STARTED|Drug Discrimination Phase: Day 1||0
8789912|NCT01380093|9841055|FG005|STARTED|Drug Discrimination Phase: Day 1||0
8789913|NCT01380093|9841056|FG006|STARTED|Drug Discrimination Phase: Day 1||0
8789914|NCT01380093|9841057|FG007|STARTED|Drug Discrimination Phase: Day 1||0
8789915|NCT01380093|9841058|FG008|STARTED|Drug Discrimination Phase: Day 1||0
8789916|NCT01380093|9841050|FG000|COMPLETED|Drug Discrimination Phase: Day 1||0
8789917|NCT01380093|9841051|FG001|COMPLETED|Drug Discrimination Phase: Day 1||29
8789918|NCT01380093|9841052|FG002|COMPLETED|Drug Discrimination Phase: Day 1||29
8789919|NCT01380093|9841053|FG003|COMPLETED|Drug Discrimination Phase: Day 1||0
8789920|NCT01380093|9841054|FG004|COMPLETED|Drug Discrimination Phase: Day 1||0
8789921|NCT01380093|9841055|FG005|COMPLETED|Drug Discrimination Phase: Day 1||0
8789922|NCT01380093|9841056|FG006|COMPLETED|Drug Discrimination Phase: Day 1||0
8789923|NCT01380093|9841057|FG007|COMPLETED|Drug Discrimination Phase: Day 1||0
8789924|NCT01380093|9841058|FG008|COMPLETED|Drug Discrimination Phase: Day 1||0
8789925|NCT01380093|9841050|FG000|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
8789926|NCT01380093|9841051|FG001|NOT COMPLETED|Drug Discrimination Phase: Day 1||1
8789927|NCT01380093|9841052|FG002|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
8789928|NCT01380093|9841053|FG003|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
8789929|NCT01380093|9841054|FG004|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
8789930|NCT01380093|9841055|FG005|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
8789931|NCT01380093|9841056|FG006|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
8789932|NCT01380093|9841057|FG007|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
8789933|NCT01380093|9841058|FG008|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
8789934|NCT01380093|9841050|FG000|STARTED|Drug Discrimination Phase: Day 2||0
8789935|NCT01380093|9841051|FG001|STARTED|Drug Discrimination Phase: Day 2||29
8789936|NCT01380093|9841052|FG002|STARTED|Drug Discrimination Phase: Day 2||29
8789937|NCT01380093|9841053|FG003|STARTED|Drug Discrimination Phase: Day 2||0
8789938|NCT01380093|9841054|FG004|STARTED|Drug Discrimination Phase: Day 2||0
8789939|NCT01380093|9841055|FG005|STARTED|Drug Discrimination Phase: Day 2||0
8789940|NCT01380093|9841056|FG006|STARTED|Drug Discrimination Phase: Day 2||0
8789941|NCT01380093|9841057|FG007|STARTED|Drug Discrimination Phase: Day 2||0
8789942|NCT01380093|9841058|FG008|STARTED|Drug Discrimination Phase: Day 2||0
8789943|NCT01380093|9841050|FG000|COMPLETED|Drug Discrimination Phase: Day 2||0
8789944|NCT01380093|9841051|FG001|COMPLETED|Drug Discrimination Phase: Day 2||20
8789945|NCT01380093|9841052|FG002|COMPLETED|Drug Discrimination Phase: Day 2||16
8789946|NCT01380093|9841053|FG003|COMPLETED|Drug Discrimination Phase: Day 2||0
8789947|NCT01380093|9841054|FG004|COMPLETED|Drug Discrimination Phase: Day 2||0
8789948|NCT01380093|9841055|FG005|COMPLETED|Drug Discrimination Phase: Day 2||0
8789949|NCT01380093|9841056|FG006|COMPLETED|Drug Discrimination Phase: Day 2||0
8789950|NCT01380093|9841057|FG007|COMPLETED|Drug Discrimination Phase: Day 2||0
8789951|NCT01380093|9841058|FG008|COMPLETED|Drug Discrimination Phase: Day 2||0
8789952|NCT01380093|9841050|FG000|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
8789953|NCT01380093|9841051|FG001|NOT COMPLETED|Drug Discrimination Phase: Day 2||9
8789954|NCT01380093|9841052|FG002|NOT COMPLETED|Drug Discrimination Phase: Day 2||13
8789955|NCT01380093|9841053|FG003|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
8789956|NCT01380093|9841054|FG004|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
8789957|NCT01380093|9841055|FG005|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
8789958|NCT01380093|9841056|FG006|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
8789959|NCT01380093|9841057|FG007|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
8789960|NCT01380093|9841058|FG008|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
8789961|NCT01380093|9841050|FG000|STARTED|Treatment Phase: First Intervention||0
8789962|NCT01380093|9841051|FG001|STARTED|Treatment Phase: First Intervention||0
8789963|NCT01380093|9841052|FG002|STARTED|Treatment Phase: First Intervention||0
8789964|NCT01380093|9841053|FG003|STARTED|Treatment Phase: First Intervention||6
8789965|NCT01380093|9841054|FG004|STARTED|Treatment Phase: First Intervention||6
8789966|NCT01380093|9841055|FG005|STARTED|Treatment Phase: First Intervention||6
8789967|NCT01380093|9841056|FG006|STARTED|Treatment Phase: First Intervention||6
8789968|NCT01380093|9841057|FG007|STARTED|Treatment Phase: First Intervention||6
8789969|NCT01380093|9841058|FG008|STARTED|Treatment Phase: First Intervention||6
8789970|NCT01380093|9841050|FG000|COMPLETED|Treatment Phase: First Intervention||0
8789971|NCT01380093|9841051|FG001|COMPLETED|Treatment Phase: First Intervention||0
8789972|NCT01380093|9841052|FG002|COMPLETED|Treatment Phase: First Intervention||0
8789973|NCT01380093|9841053|FG003|COMPLETED|Treatment Phase: First Intervention||6
8789974|NCT01380093|9841054|FG004|COMPLETED|Treatment Phase: First Intervention||6
8789975|NCT01380093|9841055|FG005|COMPLETED|Treatment Phase: First Intervention||6
8789976|NCT01380093|9841056|FG006|COMPLETED|Treatment Phase: First Intervention||6
8789977|NCT01380093|9841057|FG007|COMPLETED|Treatment Phase: First Intervention||6
8789978|NCT01380093|9841058|FG008|COMPLETED|Treatment Phase: First Intervention||6
8789979|NCT01380093|9841050|FG000|NOT COMPLETED|Treatment Phase: First Intervention||0
8789980|NCT01380093|9841051|FG001|NOT COMPLETED|Treatment Phase: First Intervention||0
8789981|NCT01380093|9841052|FG002|NOT COMPLETED|Treatment Phase: First Intervention||0
8789982|NCT01380093|9841053|FG003|NOT COMPLETED|Treatment Phase: First Intervention||0
8789983|NCT01380093|9841054|FG004|NOT COMPLETED|Treatment Phase: First Intervention||0
8789984|NCT01380093|9841055|FG005|NOT COMPLETED|Treatment Phase: First Intervention||0
8789985|NCT01380093|9841056|FG006|NOT COMPLETED|Treatment Phase: First Intervention||0
8789986|NCT01380093|9841057|FG007|NOT COMPLETED|Treatment Phase: First Intervention||0
8789987|NCT01380093|9841058|FG008|NOT COMPLETED|Treatment Phase: First Intervention||0
8789988|NCT01380093|9841050|FG000|STARTED|Treatment Phase: Washout Period||0
8789989|NCT01380093|9841051|FG001|STARTED|Treatment Phase: Washout Period||0
8789990|NCT01380093|9841052|FG002|STARTED|Treatment Phase: Washout Period||0
8789991|NCT01380093|9841053|FG003|STARTED|Treatment Phase: Washout Period||6
8789992|NCT01380093|9841054|FG004|STARTED|Treatment Phase: Washout Period||6
8789993|NCT01380093|9841055|FG005|STARTED|Treatment Phase: Washout Period||6
8789994|NCT01380093|9841056|FG006|STARTED|Treatment Phase: Washout Period||6
8789995|NCT01380093|9841057|FG007|STARTED|Treatment Phase: Washout Period||6
8789996|NCT01380093|9841058|FG008|STARTED|Treatment Phase: Washout Period||6
8789997|NCT01380093|9841050|FG000|COMPLETED|Treatment Phase: Washout Period||0
8789998|NCT01380093|9841051|FG001|COMPLETED|Treatment Phase: Washout Period||0
8789999|NCT01380093|9841052|FG002|COMPLETED|Treatment Phase: Washout Period||0
8790000|NCT01380093|9841053|FG003|COMPLETED|Treatment Phase: Washout Period||6
8790001|NCT01380093|9841054|FG004|COMPLETED|Treatment Phase: Washout Period||6
8790002|NCT01380093|9841055|FG005|COMPLETED|Treatment Phase: Washout Period||6
8790003|NCT01380093|9841056|FG006|COMPLETED|Treatment Phase: Washout Period||6
8790004|NCT01380093|9841057|FG007|COMPLETED|Treatment Phase: Washout Period||6
9032200|NCT03255824|10094359|FG000|NOT COMPLETED|Overall Study||2
9032201|NCT03255824|10094360|FG001|NOT COMPLETED|Overall Study||1
8790005|NCT01380093|9841058|FG008|COMPLETED|Treatment Phase: Washout Period||6
8790006|NCT01380093|9841050|FG000|NOT COMPLETED|Treatment Phase: Washout Period||0
8790007|NCT01380093|9841051|FG001|NOT COMPLETED|Treatment Phase: Washout Period||0
8790008|NCT01380093|9841052|FG002|NOT COMPLETED|Treatment Phase: Washout Period||0
8790009|NCT01380093|9841053|FG003|NOT COMPLETED|Treatment Phase: Washout Period||0
8790010|NCT01380093|9841054|FG004|NOT COMPLETED|Treatment Phase: Washout Period||0
8790011|NCT01380093|9841055|FG005|NOT COMPLETED|Treatment Phase: Washout Period||0
8790012|NCT01380093|9841056|FG006|NOT COMPLETED|Treatment Phase: Washout Period||0
8790013|NCT01380093|9841057|FG007|NOT COMPLETED|Treatment Phase: Washout Period||0
8790014|NCT01380093|9841058|FG008|NOT COMPLETED|Treatment Phase: Washout Period||0
9032202|NCT03255902|10094366|FG000|STARTED|Overall Study||7
9032203|NCT03255902|10094366|FG000|COMPLETED|Overall Study||5
9032204|NCT03255902|10094366|FG000|NOT COMPLETED|Overall Study||2
9032205|NCT03255941|10094374|FG000|STARTED|Overall Study||177
9032206|NCT03255941|10094375|FG001|STARTED|Overall Study||178
9032207|NCT03255941|10094376|FG002|STARTED|Overall Study||53
9032208|NCT03255941|10094377|FG003|STARTED|Overall Study||52
9032209|NCT03255941|10094374|FG000|Deemed Eligible to Receive DMPA|Overall Study||140
9032210|NCT03255941|10094375|FG001|Deemed Eligible to Receive DMPA|Overall Study||134
9032211|NCT03255941|10094376|FG002|Deemed Eligible to Receive DMPA|Overall Study||48
9032212|NCT03255941|10094377|FG003|Deemed Eligible to Receive DMPA|Overall Study||46
9032213|NCT03255941|10094374|FG000|COMPLETED|Overall Study||139
9032214|NCT03255941|10094375|FG001|COMPLETED|Overall Study||132
9032215|NCT03255941|10094376|FG002|COMPLETED|Overall Study||48
9032216|NCT03255941|10094377|FG003|COMPLETED|Overall Study||46
9032217|NCT03255941|10094374|FG000|NOT COMPLETED|Overall Study||38
9032218|NCT03255941|10094375|FG001|NOT COMPLETED|Overall Study||46
9032219|NCT03255941|10094376|FG002|NOT COMPLETED|Overall Study||5
9032220|NCT03255941|10094377|FG003|NOT COMPLETED|Overall Study||6
9032221|NCT03255980|10094403|FG000|STARTED|Overall Study||20
9032222|NCT03255980|10094404|FG001|STARTED|Overall Study||20
9032223|NCT03255980|10094405|FG002|STARTED|Overall Study||20
9032224|NCT03255980|10094406|FG003|STARTED|Overall Study||20
9032225|NCT03255980|10094403|FG000|COMPLETED|Overall Study||17
9032226|NCT03255980|10094404|FG001|COMPLETED|Overall Study||12
9032227|NCT03255980|10094405|FG002|COMPLETED|Overall Study||14
9032228|NCT03255980|10094406|FG003|COMPLETED|Overall Study||8
9032229|NCT03255980|10094403|FG000|NOT COMPLETED|Overall Study||3
9032230|NCT03255980|10094404|FG001|NOT COMPLETED|Overall Study||8
9032231|NCT03255980|10094405|FG002|NOT COMPLETED|Overall Study||6
9032232|NCT03255980|10094406|FG003|NOT COMPLETED|Overall Study||12
9032233|NCT03256136|10094420|FG000|STARTED|Overall Study||3
9032234|NCT03256136|10094421|FG001|STARTED|Overall Study||1
9032235|NCT03256136|10094422|FG002|STARTED|Overall Study||4
9032236|NCT03256136|10094423|FG003|STARTED|Overall Study||1
9032237|NCT03256136|10094420|FG000|COMPLETED|Overall Study||3
9032238|NCT03256136|10094421|FG001|COMPLETED|Overall Study||1
9032239|NCT03256136|10094422|FG002|COMPLETED|Overall Study||4
9032240|NCT03256136|10094423|FG003|COMPLETED|Overall Study||1
9032241|NCT03256136|10094420|FG000|NOT COMPLETED|Overall Study||0
9032242|NCT03256136|10094421|FG001|NOT COMPLETED|Overall Study||0
9032243|NCT03256136|10094422|FG002|NOT COMPLETED|Overall Study||0
9032244|NCT03256136|10094423|FG003|NOT COMPLETED|Overall Study||0
9032245|NCT03256162|10094435|FG000|STARTED|Overall Study||13
9032246|NCT03256162|10094436|FG001|STARTED|Overall Study||12
9032247|NCT03256162|10094435|FG000|COMPLETED|Overall Study||8
9032248|NCT03256162|10094436|FG001|COMPLETED|Overall Study||8
9032249|NCT03256162|10094435|FG000|NOT COMPLETED|Overall Study||5
9032250|NCT03256162|10094436|FG001|NOT COMPLETED|Overall Study||4
9032251|NCT03256253|10094442|FG000|STARTED|Overall Study||18
9032252|NCT03256253|10094442|FG000|COMPLETED|Overall Study||6
9032253|NCT03256253|10094442|FG000|NOT COMPLETED|Overall Study||12
9032254|NCT03256526|10094449|FG000|STARTED|Overall Study||19
9032255|NCT03256526|10094450|FG001|STARTED|Overall Study||17
9032256|NCT03256526|10094451|FG002|STARTED|Overall Study||17
9032257|NCT03256526|10094449|FG000|COMPLETED|Overall Study||17
9032258|NCT03256526|10094450|FG001|COMPLETED|Overall Study||17
9032259|NCT03256526|10094451|FG002|COMPLETED|Overall Study||14
9032260|NCT03256526|10094449|FG000|NOT COMPLETED|Overall Study||2
9032261|NCT03256526|10094450|FG001|NOT COMPLETED|Overall Study||0
9032262|NCT03256526|10094451|FG002|NOT COMPLETED|Overall Study||3
9032263|NCT03256552|10094459|FG000|STARTED|Overall Study||66
9032264|NCT03256552|10094459|FG000|GP MDI 28.8 µg|Overall Study||61
9032265|NCT03256552|10094459|FG000|GP MDI 14.4 µg|Overall Study||63
9032266|NCT03256552|10094459|FG000|GP MDI 7.2 µg|Overall Study||62
9032267|NCT03256552|10094459|FG000|Placebo MDI|Overall Study||65
9032268|NCT03256552|10094459|FG000|COMPLETED|Overall Study||61
9032269|NCT03256552|10094459|FG000|NOT COMPLETED|Overall Study||5
9032270|NCT03256578|10094471|FG000|STARTED|Overall Study||204
9032271|NCT03256578|10094472|FG001|STARTED|Overall Study||206
9032272|NCT03256578|10094471|FG000|COMPLETED|Overall Study||138
9032273|NCT03256578|10094472|FG001|COMPLETED|Overall Study||150
9032274|NCT03256578|10094471|FG000|NOT COMPLETED|Overall Study||66
9032275|NCT03256578|10094472|FG001|NOT COMPLETED|Overall Study||56
9032276|NCT03256695|10094478|FG000|STARTED|Overall Study||405
9032277|NCT03256695|10094478|FG000|Used ABS eMDPI at Least Once|Overall Study||390
9032278|NCT03256695|10094478|FG000|COMPLETED|Overall Study||366
9032279|NCT03256695|10094478|FG000|NOT COMPLETED|Overall Study||39
9032280|NCT03256799|10094482|FG000|STARTED|Overall Study||1
9032281|NCT03256799|10094482|FG000|COMPLETED|Overall Study||1
8790015|NCT01380093|9841050|FG000|STARTED|Treatment Phase: Second Intervention||0
8790016|NCT01380093|9841051|FG001|STARTED|Treatment Phase: Second Intervention||0
8790017|NCT01380093|9841052|FG002|STARTED|Treatment Phase: Second Intervention||0
8790018|NCT01380093|9841053|FG003|STARTED|Treatment Phase: Second Intervention||6
8790019|NCT01380093|9841054|FG004|STARTED|Treatment Phase: Second Intervention||6
8790020|NCT01380093|9841055|FG005|STARTED|Treatment Phase: Second Intervention||6
8790021|NCT01380093|9841056|FG006|STARTED|Treatment Phase: Second Intervention||6
8790022|NCT01380093|9841057|FG007|STARTED|Treatment Phase: Second Intervention||6
8790023|NCT01380093|9841058|FG008|STARTED|Treatment Phase: Second Intervention||6
8790024|NCT01380093|9841050|FG000|COMPLETED|Treatment Phase: Second Intervention||0
8790025|NCT01380093|9841051|FG001|COMPLETED|Treatment Phase: Second Intervention||0
8790026|NCT01380093|9841052|FG002|COMPLETED|Treatment Phase: Second Intervention||0
8790027|NCT01380093|9841053|FG003|COMPLETED|Treatment Phase: Second Intervention||5
8790028|NCT01380093|9841054|FG004|COMPLETED|Treatment Phase: Second Intervention||6
8790029|NCT01380093|9841055|FG005|COMPLETED|Treatment Phase: Second Intervention||6
8790030|NCT01380093|9841056|FG006|COMPLETED|Treatment Phase: Second Intervention||6
8790031|NCT01380093|9841057|FG007|COMPLETED|Treatment Phase: Second Intervention||6
8790032|NCT01380093|9841058|FG008|COMPLETED|Treatment Phase: Second Intervention||6
8790033|NCT01380093|9841050|FG000|NOT COMPLETED|Treatment Phase: Second Intervention||0
8790034|NCT01380093|9841051|FG001|NOT COMPLETED|Treatment Phase: Second Intervention||0
8790035|NCT01380093|9841052|FG002|NOT COMPLETED|Treatment Phase: Second Intervention||0
8790036|NCT01380093|9841053|FG003|NOT COMPLETED|Treatment Phase: Second Intervention||1
8790037|NCT01380093|9841054|FG004|NOT COMPLETED|Treatment Phase: Second Intervention||0
8790038|NCT01380093|9841055|FG005|NOT COMPLETED|Treatment Phase: Second Intervention||0
8790039|NCT01380093|9841056|FG006|NOT COMPLETED|Treatment Phase: Second Intervention||0
8790040|NCT01380093|9841057|FG007|NOT COMPLETED|Treatment Phase: Second Intervention||0
8790041|NCT01380093|9841058|FG008|NOT COMPLETED|Treatment Phase: Second Intervention||0
8790042|NCT01380093|9841050|FG000|STARTED|Treatment Phase: Washout Period||0
8790043|NCT01380093|9841051|FG001|STARTED|Treatment Phase: Washout Period||0
8790044|NCT01380093|9841052|FG002|STARTED|Treatment Phase: Washout Period||0
8790045|NCT01380093|9841053|FG003|STARTED|Treatment Phase: Washout Period||5
8790046|NCT01380093|9841054|FG004|STARTED|Treatment Phase: Washout Period||6
8790047|NCT01380093|9841055|FG005|STARTED|Treatment Phase: Washout Period||6
8790048|NCT01380093|9841056|FG006|STARTED|Treatment Phase: Washout Period||6
8790049|NCT01380093|9841057|FG007|STARTED|Treatment Phase: Washout Period||6
8790050|NCT01380093|9841058|FG008|STARTED|Treatment Phase: Washout Period||6
8790051|NCT01380093|9841050|FG000|COMPLETED|Treatment Phase: Washout Period||0
8790052|NCT01380093|9841051|FG001|COMPLETED|Treatment Phase: Washout Period||0
8790053|NCT01380093|9841052|FG002|COMPLETED|Treatment Phase: Washout Period||0
8790054|NCT01380093|9841053|FG003|COMPLETED|Treatment Phase: Washout Period||5
8790055|NCT01380093|9841054|FG004|COMPLETED|Treatment Phase: Washout Period||6
8790056|NCT01380093|9841055|FG005|COMPLETED|Treatment Phase: Washout Period||6
8790057|NCT01380093|9841056|FG006|COMPLETED|Treatment Phase: Washout Period||6
8790058|NCT01380093|9841057|FG007|COMPLETED|Treatment Phase: Washout Period||6
8790059|NCT01380093|9841058|FG008|COMPLETED|Treatment Phase: Washout Period||6
8790060|NCT01380093|9841050|FG000|NOT COMPLETED|Treatment Phase: Washout Period||0
8790061|NCT01380093|9841051|FG001|NOT COMPLETED|Treatment Phase: Washout Period||0
8790062|NCT01380093|9841052|FG002|NOT COMPLETED|Treatment Phase: Washout Period||0
8790063|NCT01380093|9841053|FG003|NOT COMPLETED|Treatment Phase: Washout Period||0
8790064|NCT01380093|9841054|FG004|NOT COMPLETED|Treatment Phase: Washout Period||0
8790065|NCT01380093|9841055|FG005|NOT COMPLETED|Treatment Phase: Washout Period||0
8790066|NCT01380093|9841056|FG006|NOT COMPLETED|Treatment Phase: Washout Period||0
8790067|NCT01380093|9841057|FG007|NOT COMPLETED|Treatment Phase: Washout Period||0
8790068|NCT01380093|9841058|FG008|NOT COMPLETED|Treatment Phase: Washout Period||0
8790069|NCT01380093|9841050|FG000|STARTED|Treatment Phase: Third Intervention||0
8790070|NCT01380093|9841051|FG001|STARTED|Treatment Phase: Third Intervention||0
8790071|NCT01380093|9841052|FG002|STARTED|Treatment Phase: Third Intervention||0
8790072|NCT01380093|9841053|FG003|STARTED|Treatment Phase: Third Intervention||5
8790073|NCT01380093|9841054|FG004|STARTED|Treatment Phase: Third Intervention||6
8790074|NCT01380093|9841055|FG005|STARTED|Treatment Phase: Third Intervention||6
8790075|NCT01380093|9841056|FG006|STARTED|Treatment Phase: Third Intervention||6
8790076|NCT01380093|9841057|FG007|STARTED|Treatment Phase: Third Intervention||6
8790077|NCT01380093|9841058|FG008|STARTED|Treatment Phase: Third Intervention||6
8790078|NCT01380093|9841050|FG000|COMPLETED|Treatment Phase: Third Intervention||0
8790079|NCT01380093|9841051|FG001|COMPLETED|Treatment Phase: Third Intervention||0
8790080|NCT01380093|9841052|FG002|COMPLETED|Treatment Phase: Third Intervention||0
8790081|NCT01380093|9841053|FG003|COMPLETED|Treatment Phase: Third Intervention||5
8790082|NCT01380093|9841054|FG004|COMPLETED|Treatment Phase: Third Intervention||6
8790083|NCT01380093|9841055|FG005|COMPLETED|Treatment Phase: Third Intervention||6
8790084|NCT01380093|9841056|FG006|COMPLETED|Treatment Phase: Third Intervention||6
8790085|NCT01380093|9841057|FG007|COMPLETED|Treatment Phase: Third Intervention||6
8790086|NCT01380093|9841058|FG008|COMPLETED|Treatment Phase: Third Intervention||4
8790087|NCT01380093|9841050|FG000|NOT COMPLETED|Treatment Phase: Third Intervention||0
8790088|NCT01380093|9841051|FG001|NOT COMPLETED|Treatment Phase: Third Intervention||0
8790089|NCT01380093|9841052|FG002|NOT COMPLETED|Treatment Phase: Third Intervention||0
8790090|NCT01380093|9841053|FG003|NOT COMPLETED|Treatment Phase: Third Intervention||0
8790091|NCT01380093|9841054|FG004|NOT COMPLETED|Treatment Phase: Third Intervention||0
8790092|NCT01380093|9841055|FG005|NOT COMPLETED|Treatment Phase: Third Intervention||0
8790093|NCT01380093|9841056|FG006|NOT COMPLETED|Treatment Phase: Third Intervention||0
8790094|NCT01380093|9841057|FG007|NOT COMPLETED|Treatment Phase: Third Intervention||0
8790095|NCT01380093|9841058|FG008|NOT COMPLETED|Treatment Phase: Third Intervention||2
8790096|NCT01380106|9841074|FG000|STARTED|Overall Study||16
8790097|NCT01380106|9841075|FG001|STARTED|Overall Study||17
8790098|NCT01380106|9841074|FG000|COMPLETED|Overall Study||16
8790099|NCT01380106|9841075|FG001|COMPLETED|Overall Study||17
8790100|NCT01380106|9841074|FG000|NOT COMPLETED|Overall Study||0
8790101|NCT01380106|9841075|FG001|NOT COMPLETED|Overall Study||0
8917087|NCT02189252|9976725|FG001|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
8917088|NCT02189252|9976726|FG002|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
8917089|NCT02189252|9976727|FG003|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
8917090|NCT02189317|9976740|FG000|STARTED|Overall Study||16
8917091|NCT02189317|9976741|FG001|STARTED|Overall Study||16
8917092|NCT02189317|9976740|FG000|COMPLETED|Overall Study||16
8917093|NCT02189317|9976741|FG001|COMPLETED|Overall Study||16
8917094|NCT02189317|9976740|FG000|NOT COMPLETED|Overall Study||0
8917095|NCT02189317|9976741|FG001|NOT COMPLETED|Overall Study||0
8917096|NCT02189382|9976749|FG000|STARTED|Overall Study||35
8917097|NCT02189382|9976750|FG001|STARTED|Overall Study||35
8917098|NCT02189382|9976749|FG000|COMPLETED|Overall Study||35
8917099|NCT02189382|9976750|FG001|COMPLETED|Overall Study||35
8917100|NCT02189382|9976749|FG000|NOT COMPLETED|Overall Study||0
8917101|NCT02189382|9976750|FG001|NOT COMPLETED|Overall Study||0
8917102|NCT02189473|9976758|FG000|STARTED|Overall Study||101
8917103|NCT02189473|9976759|FG001|STARTED|Overall Study||102
8917104|NCT02189473|9976758|FG000|COMPLETED|Overall Study||78
8917105|NCT02189473|9976759|FG001|COMPLETED|Overall Study||77
8917106|NCT02189473|9976758|FG000|NOT COMPLETED|Overall Study||23
8917107|NCT02189473|9976759|FG001|NOT COMPLETED|Overall Study||25
8917108|NCT02189629|9976765|FG000|STARTED|Overall Study||453
8917109|NCT02189629|9976765|FG000|COMPLETED|Overall Study||348
8917110|NCT02189629|9976765|FG000|NOT COMPLETED|Overall Study||105
8917111|NCT02189668|9976771|FG000|STARTED|Overall Study||5
8917112|NCT02189668|9976772|FG001|STARTED|Overall Study||9
8917113|NCT02189668|9976771|FG000|COMPLETED|Overall Study||5
8917114|NCT02189668|9976772|FG001|COMPLETED|Overall Study||9
8917115|NCT02189668|9976771|FG000|NOT COMPLETED|Overall Study||0
8917116|NCT02189668|9976772|FG001|NOT COMPLETED|Overall Study||0
8917117|NCT02189759|9976782|FG000|STARTED|Overall Study||102
8917118|NCT02189759|9976783|FG001|STARTED|Overall Study||101
8917119|NCT02189759|9976784|FG002|STARTED|Overall Study||83
8917120|NCT02189759|9976785|FG003|STARTED|Overall Study||89
8917121|NCT02189759|9976782|FG000|COMPLETED|Overall Study||102
8917122|NCT02189759|9976783|FG001|COMPLETED|Overall Study||101
8917123|NCT02189759|9976784|FG002|COMPLETED|Overall Study||81
8917124|NCT02189759|9976785|FG003|COMPLETED|Overall Study||84
8917125|NCT02189759|9976782|FG000|NOT COMPLETED|Overall Study||0
8917126|NCT02189759|9976783|FG001|NOT COMPLETED|Overall Study||0
8917127|NCT02189759|9976784|FG002|NOT COMPLETED|Overall Study||2
8917128|NCT02189759|9976785|FG003|NOT COMPLETED|Overall Study||5
8917129|NCT02189837|9976801|FG000|STARTED|Overall Study||22
8917130|NCT02189837|9976802|FG001|STARTED|Overall Study||23
8917131|NCT02189837|9976803|FG002|STARTED|Overall Study||23
8917132|NCT02189837|9976804|FG003|STARTED|Overall Study||21
8917133|NCT02189837|9976801|FG000|Received Treatment|Overall Study||21
9032282|NCT03256799|10094482|FG000|NOT COMPLETED|Overall Study||0
9032283|NCT03256851|10094488|FG000|STARTED|Overall Study||10
9032284|NCT03256851|10094489|FG001|STARTED|Overall Study||10
9032285|NCT03256851|10094488|FG000|COMPLETED|Overall Study||9
9032286|NCT03256851|10094489|FG001|COMPLETED|Overall Study||10
8917134|NCT02189837|9976802|FG001|Received Treatment|Overall Study||22
8917135|NCT02189837|9976803|FG002|Received Treatment|Overall Study||22
8917136|NCT02189837|9976804|FG003|Received Treatment|Overall Study||20
8917137|NCT02189837|9976801|FG000|COMPLETED|Overall Study||20
8917138|NCT02189837|9976802|FG001|COMPLETED|Overall Study||22
8917139|NCT02189837|9976803|FG002|COMPLETED|Overall Study||20
8917140|NCT02189837|9976804|FG003|COMPLETED|Overall Study||19
8917141|NCT02189837|9976801|FG000|NOT COMPLETED|Overall Study||2
8917142|NCT02189837|9976802|FG001|NOT COMPLETED|Overall Study||1
8917143|NCT02189837|9976803|FG002|NOT COMPLETED|Overall Study||3
8917144|NCT02189837|9976804|FG003|NOT COMPLETED|Overall Study||2
8917145|NCT02189850|9976816|FG000|STARTED|Overall Study||16
8917146|NCT02189850|9976817|FG001|STARTED|Overall Study||13
8917147|NCT02189850|9976816|FG000|COMPLETED|Overall Study||14
8917148|NCT02189850|9976817|FG001|COMPLETED|Overall Study||11
8917149|NCT02189850|9976816|FG000|NOT COMPLETED|Overall Study||2
8917150|NCT02189850|9976817|FG001|NOT COMPLETED|Overall Study||2
8917151|NCT02189863|9976823|FG000|STARTED|First 2 Weeks||12
8917152|NCT02189863|9976824|FG001|STARTED|First 2 Weeks||15
8917153|NCT02189863|9976823|FG000|COMPLETED|First 2 Weeks||8
8917154|NCT02189863|9976824|FG001|COMPLETED|First 2 Weeks||13
8917155|NCT02189863|9976823|FG000|NOT COMPLETED|First 2 Weeks||4
8917156|NCT02189863|9976824|FG001|NOT COMPLETED|First 2 Weeks||2
8917157|NCT02189863|9976823|FG000|STARTED|Second 2 Weeks||8
8917158|NCT02189863|9976824|FG001|STARTED|Second 2 Weeks||13
8917159|NCT02189863|9976823|FG000|COMPLETED|Second 2 Weeks||8
8917160|NCT02189863|9976824|FG001|COMPLETED|Second 2 Weeks||13
8790102|NCT01380145|9841081|FG000|STARTED|Overall Study||13
8790103|NCT01380145|9841081|FG000|COMPLETED|Overall Study||9
8790104|NCT01380145|9841081|FG000|NOT COMPLETED|Overall Study||4
8790105|NCT01380184|9841087|FG000|STARTED|Part 1 (19 Days)||15
8790106|NCT01380184|9841087|FG000|COMPLETED|Part 1 (19 Days)||14
8790107|NCT01380184|9841087|FG000|NOT COMPLETED|Part 1 (19 Days)||1
8790108|NCT01380184|9841087|FG000|STARTED|Washout Period (≥2 Days)||14
8790109|NCT01380184|9841087|FG000|COMPLETED|Washout Period (≥2 Days)||14
8790110|NCT01380184|9841087|FG000|NOT COMPLETED|Washout Period (≥2 Days)||0
8790111|NCT01380184|9841087|FG000|STARTED|Part 2||14
8790112|NCT01380184|9841087|FG000|COMPLETED|Part 2||0
8790113|NCT01380184|9841087|FG000|NOT COMPLETED|Part 2||14
8790114|NCT01380197|9841093|FG000|STARTED|Overall Study||20
8790115|NCT01380197|9841094|FG001|STARTED|Overall Study||20
8790116|NCT01380197|9841093|FG000|COMPLETED|Overall Study||20
8790117|NCT01380197|9841094|FG001|COMPLETED|Overall Study||20
8790118|NCT01380197|9841093|FG000|NOT COMPLETED|Overall Study||0
8790119|NCT01380197|9841094|FG001|NOT COMPLETED|Overall Study||0
8790120|NCT01380327|9841103|FG000|STARTED|Overall Study|Number in intent-to-treat having reached maximum tolerated dose with =/> 1 one post-baseline measure|30
8790121|NCT01380327|9841104|FG001|STARTED|Overall Study|Number in intent-to-treat having reached maximum tolerated dose with =/> 1 one post-baseline measure|31
8790122|NCT01380327|9841105|FG002|STARTED|Overall Study|Number in intent-to-treat having reached maximum tolerated dose with =/> 1 one post-baseline measure|28
8790123|NCT01380327|9841103|FG000|COMPLETED|Overall Study||27
8790124|NCT01380327|9841104|FG001|COMPLETED|Overall Study||28
8790125|NCT01380327|9841105|FG002|COMPLETED|Overall Study||21
8790126|NCT01380327|9841103|FG000|NOT COMPLETED|Overall Study||3
8790127|NCT01380327|9841104|FG001|NOT COMPLETED|Overall Study||3
8790128|NCT01380327|9841105|FG002|NOT COMPLETED|Overall Study||7
8790129|NCT01380366|9841113|FG000|STARTED|Overall Study||15
8790130|NCT01380366|9841113|FG000|COMPLETED|Overall Study||15
8790131|NCT01380366|9841113|FG000|NOT COMPLETED|Overall Study||0
8790132|NCT01380379|9841118|FG000|STARTED|Overall Study||9
8790133|NCT01380379|9841118|FG000|COMPLETED|Overall Study||8
8790134|NCT01380379|9841118|FG000|NOT COMPLETED|Overall Study||1
8790135|NCT01380535|9841124|FG000|STARTED|Overall Study||29
8790136|NCT01380535|9841125|FG001|STARTED|Overall Study||31
8790137|NCT01380535|9841124|FG000|Baseline Population|Overall Study||29
8790138|NCT01380535|9841125|FG001|Baseline Population|Overall Study||31
8790139|NCT01380535|9841124|FG000|Safety Population|Overall Study||28
8790140|NCT01380535|9841125|FG001|Safety Population|Overall Study||28
8790141|NCT01380535|9841124|FG000|Intent-to-treat Population|Overall Study||29
8790142|NCT01380535|9841125|FG001|Intent-to-treat Population|Overall Study||24
8790143|NCT01380535|9841124|FG000|COMPLETED|Overall Study||22
8790144|NCT01380535|9841125|FG001|COMPLETED|Overall Study||16
8790145|NCT01380535|9841124|FG000|NOT COMPLETED|Overall Study||7
8790146|NCT01380535|9841125|FG001|NOT COMPLETED|Overall Study||15
8790147|NCT01380639|9841133|FG000|STARTED|Overall Study||42
8790148|NCT01380639|9841134|FG001|STARTED|Overall Study||40
8790149|NCT01380639|9841133|FG000|COMPLETED|Overall Study||36
8790150|NCT01380639|9841134|FG001|COMPLETED|Overall Study||36
8790151|NCT01380639|9841133|FG000|NOT COMPLETED|Overall Study||6
8790152|NCT01380639|9841134|FG001|NOT COMPLETED|Overall Study||4
8790153|NCT01380691|9841140|FG000|STARTED|Period 1||7
8790154|NCT01380691|9841141|FG001|STARTED|Period 1||7
8790155|NCT01380691|9841142|FG002|STARTED|Period 1||7
8790156|NCT01380691|9841143|FG003|STARTED|Period 1||7
8790157|NCT01380691|9841140|FG000|COMPLETED|Period 1||7
8790158|NCT01380691|9841141|FG001|COMPLETED|Period 1||7
8790159|NCT01380691|9841142|FG002|COMPLETED|Period 1||7
8790160|NCT01380691|9841143|FG003|COMPLETED|Period 1||7
8790161|NCT01380691|9841140|FG000|NOT COMPLETED|Period 1||0
8790162|NCT01380691|9841141|FG001|NOT COMPLETED|Period 1||0
8790163|NCT01380691|9841142|FG002|NOT COMPLETED|Period 1||0
8790164|NCT01380691|9841143|FG003|NOT COMPLETED|Period 1||0
8790165|NCT01380691|9841140|FG000|STARTED|Washout (7 Days)||7
8790166|NCT01380691|9841141|FG001|STARTED|Washout (7 Days)||7
8790167|NCT01380691|9841142|FG002|STARTED|Washout (7 Days)||7
8790168|NCT01380691|9841143|FG003|STARTED|Washout (7 Days)||7
8790169|NCT01380691|9841140|FG000|COMPLETED|Washout (7 Days)||7
8790170|NCT01380691|9841141|FG001|COMPLETED|Washout (7 Days)||7
8790171|NCT01380691|9841142|FG002|COMPLETED|Washout (7 Days)||6
8790172|NCT01380691|9841143|FG003|COMPLETED|Washout (7 Days)||6
8790173|NCT01380691|9841140|FG000|NOT COMPLETED|Washout (7 Days)||0
8790174|NCT01380691|9841141|FG001|NOT COMPLETED|Washout (7 Days)||0
8790175|NCT01380691|9841142|FG002|NOT COMPLETED|Washout (7 Days)||1
8790176|NCT01380691|9841143|FG003|NOT COMPLETED|Washout (7 Days)||1
8790177|NCT01380691|9841140|FG000|STARTED|Period 2||7
8790178|NCT01380691|9841141|FG001|STARTED|Period 2||7
8790179|NCT01380691|9841142|FG002|STARTED|Period 2||6
8790180|NCT01380691|9841143|FG003|STARTED|Period 2||6
8790181|NCT01380691|9841140|FG000|COMPLETED|Period 2||7
8790182|NCT01380691|9841141|FG001|COMPLETED|Period 2||7
8790183|NCT01380691|9841142|FG002|COMPLETED|Period 2||6
8790184|NCT01380691|9841143|FG003|COMPLETED|Period 2||6
8790185|NCT01380691|9841140|FG000|NOT COMPLETED|Period 2||0
8790186|NCT01380691|9841141|FG001|NOT COMPLETED|Period 2||0
8790187|NCT01380691|9841142|FG002|NOT COMPLETED|Period 2||0
8790188|NCT01380691|9841143|FG003|NOT COMPLETED|Period 2||0
8790189|NCT01380730|9841162|FG000|STARTED|Overall Study||78
8790190|NCT01380730|9841163|FG001|STARTED|Overall Study||79
8790191|NCT01380730|9841164|FG002|STARTED|Overall Study||79
8790192|NCT01380730|9841165|FG003|STARTED|Overall Study||79
8790193|NCT01380730|9841166|FG004|STARTED|Overall Study||78
8790194|NCT01380730|9841167|FG005|STARTED|Overall Study||79
8790195|NCT01380730|9841168|FG006|STARTED|Overall Study||79
8790196|NCT01380730|9841169|FG007|STARTED|Overall Study||80
8790197|NCT01380730|9841162|FG000|Received Treatment|Overall Study||78
8790198|NCT01380730|9841163|FG001|Received Treatment|Overall Study|2 participants did not receive treatment but were followed until the end of study|77
8790199|NCT01380730|9841164|FG002|Received Treatment|Overall Study||79
8790200|NCT01380730|9841165|FG003|Received Treatment|Overall Study||79
8790201|NCT01380730|9841166|FG004|Received Treatment|Overall Study||78
8790202|NCT01380730|9841167|FG005|Received Treatment|Overall Study||79
8790203|NCT01380730|9841168|FG006|Received Treatment|Overall Study||79
8790204|NCT01380730|9841169|FG007|Received Treatment|Overall Study||80
8790205|NCT01380730|9841162|FG000|COMPLETED|Overall Study||78
8790206|NCT01380730|9841163|FG001|COMPLETED|Overall Study||79
8790207|NCT01380730|9841164|FG002|COMPLETED|Overall Study||79
8790208|NCT01380730|9841165|FG003|COMPLETED|Overall Study||79
8790209|NCT01380730|9841166|FG004|COMPLETED|Overall Study||77
8790210|NCT01380730|9841167|FG005|COMPLETED|Overall Study||79
8790211|NCT01380730|9841168|FG006|COMPLETED|Overall Study||79
8790212|NCT01380730|9841169|FG007|COMPLETED|Overall Study||80
8790213|NCT01380730|9841162|FG000|NOT COMPLETED|Overall Study||0
8790214|NCT01380730|9841163|FG001|NOT COMPLETED|Overall Study||0
8790215|NCT01380730|9841164|FG002|NOT COMPLETED|Overall Study||0
8790216|NCT01380730|9841165|FG003|NOT COMPLETED|Overall Study||0
8790217|NCT01380730|9841166|FG004|NOT COMPLETED|Overall Study||1
8790218|NCT01380730|9841167|FG005|NOT COMPLETED|Overall Study||0
8790219|NCT01380730|9841168|FG006|NOT COMPLETED|Overall Study||0
8790220|NCT01380730|9841169|FG007|NOT COMPLETED|Overall Study||0
8790221|NCT01380743|9841191|FG000|STARTED|Overall Study||6
8790222|NCT01380743|9841192|FG001|STARTED|Overall Study||6
8790223|NCT01380743|9841193|FG002|STARTED|Overall Study||6
8790224|NCT01380743|9841194|FG003|STARTED|Overall Study||7
8790225|NCT01380743|9841191|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
8790226|NCT01380743|9841192|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
8790227|NCT01380743|9841193|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
8790228|NCT01380743|9841194|FG003|Received at Least 1 Dose of Study Drug|Overall Study||7
8790229|NCT01380743|9841191|FG000|COMPLETED|Overall Study||6
8790230|NCT01380743|9841192|FG001|COMPLETED|Overall Study||6
8790231|NCT01380743|9841193|FG002|COMPLETED|Overall Study||6
8790232|NCT01380743|9841194|FG003|COMPLETED|Overall Study||7
8790233|NCT01380743|9841191|FG000|NOT COMPLETED|Overall Study||0
8790234|NCT01380743|9841192|FG001|NOT COMPLETED|Overall Study||0
8790235|NCT01380743|9841193|FG002|NOT COMPLETED|Overall Study||0
8790236|NCT01380743|9841194|FG003|NOT COMPLETED|Overall Study||0
8790237|NCT01380769|9841206|FG000|STARTED|Overall Study||100
8790238|NCT01380769|9841207|FG001|STARTED|Overall Study||57
8790239|NCT01380769|9841206|FG000|COMPLETED|Overall Study|subjects in ITT with reported date of death, alive with progression, or alive without progression|91
8790240|NCT01380769|9841207|FG001|COMPLETED|Overall Study|subjects in ITT with reported date of death, alive with progression, or alive without progression|43
8790241|NCT01380769|9841206|FG000|NOT COMPLETED|Overall Study||9
8790242|NCT01380769|9841207|FG001|NOT COMPLETED|Overall Study||14
8790243|NCT01380782|9841215|FG000|STARTED|Overall Study||12
8790244|NCT01380782|9841216|FG001|STARTED|Overall Study||10
8790245|NCT01380782|9841217|FG002|STARTED|Overall Study||11
8790246|NCT01380782|9841218|FG003|STARTED|Overall Study||4
8790247|NCT01380782|9841215|FG000|COMPLETED|Overall Study||0
8790248|NCT01380782|9841216|FG001|COMPLETED|Overall Study||0
8790249|NCT01380782|9841217|FG002|COMPLETED|Overall Study||0
8790250|NCT01380782|9841218|FG003|COMPLETED|Overall Study||0
8790251|NCT01380782|9841215|FG000|NOT COMPLETED|Overall Study||12
8790252|NCT01380782|9841216|FG001|NOT COMPLETED|Overall Study||10
8790253|NCT01380782|9841217|FG002|NOT COMPLETED|Overall Study||11
8790254|NCT01380782|9841218|FG003|NOT COMPLETED|Overall Study||4
8790255|NCT01380834|9841232|FG000|STARTED|Overall Study||42
8790256|NCT01380834|9841233|FG001|STARTED|Overall Study||42
8790257|NCT01380834|9841232|FG000|COMPLETED|Overall Study||41
8790258|NCT01380834|9841233|FG001|COMPLETED|Overall Study||42
8790259|NCT01380834|9841232|FG000|NOT COMPLETED|Overall Study||1
8790260|NCT01380834|9841233|FG001|NOT COMPLETED|Overall Study||0
8790261|NCT01380899|9841242|FG000|STARTED|Overall Study||34
8790262|NCT01380899|9841243|FG001|STARTED|Overall Study||33
8790263|NCT01380899|9841244|FG002|STARTED|Overall Study||20
8790264|NCT01380899|9841242|FG000|COMPLETED|Overall Study||34
8790265|NCT01380899|9841243|FG001|COMPLETED|Overall Study||33
8790266|NCT01380899|9841244|FG002|COMPLETED|Overall Study||20
8790267|NCT01380899|9841242|FG000|NOT COMPLETED|Overall Study||0
8790268|NCT01380899|9841243|FG001|NOT COMPLETED|Overall Study||0
8790269|NCT01380899|9841244|FG002|NOT COMPLETED|Overall Study||0
8790270|NCT01380990|9841254|FG000|STARTED|Overall Study||20
8790271|NCT01380990|9841255|FG001|STARTED|Overall Study||16
8790272|NCT01380990|9841254|FG000|COMPLETED|Overall Study||19
8790273|NCT01380990|9841255|FG001|COMPLETED|Overall Study||15
8790274|NCT01380990|9841254|FG000|NOT COMPLETED|Overall Study||1
8790275|NCT01380990|9841255|FG001|NOT COMPLETED|Overall Study||1
8790276|NCT01381016|9841267|FG000|STARTED|Overall Study||13
8790277|NCT01381016|9841268|FG001|STARTED|Overall Study||17
8790278|NCT01381016|9841267|FG000|COMPLETED|Overall Study||10
8790279|NCT01381016|9841268|FG001|COMPLETED|Overall Study||11
8790280|NCT01381016|9841267|FG000|NOT COMPLETED|Overall Study||3
8790281|NCT01381016|9841268|FG001|NOT COMPLETED|Overall Study||6
8790282|NCT01381068|9841278|FG000|STARTED|Overall Study||25
8790283|NCT01381068|9841279|FG001|STARTED|Overall Study||24
8790284|NCT01381068|9841278|FG000|COMPLETED|Overall Study||24
8790285|NCT01381068|9841279|FG001|COMPLETED|Overall Study||24
8790286|NCT01381068|9841278|FG000|NOT COMPLETED|Overall Study||1
8790287|NCT01381068|9841279|FG001|NOT COMPLETED|Overall Study||0
8790288|NCT01381120|9841287|FG000|STARTED|Overall Study||50
8790289|NCT01381120|9841288|FG001|STARTED|Overall Study||27
8790290|NCT01381120|9841287|FG000|COMPLETED|Overall Study||39
8790291|NCT01381120|9841288|FG001|COMPLETED|Overall Study||18
8790292|NCT01381120|9841287|FG000|NOT COMPLETED|Overall Study||11
8790293|NCT01381120|9841288|FG001|NOT COMPLETED|Overall Study||9
8790294|NCT01381172|9841296|FG000|STARTED|Overall Study||74
8790295|NCT01381172|9841297|FG001|STARTED|Overall Study||86
8790296|NCT01381172|9841296|FG000|COMPLETED|Overall Study||64
8790297|NCT01381172|9841297|FG001|COMPLETED|Overall Study||73
8790298|NCT01381172|9841296|FG000|NOT COMPLETED|Overall Study||10
8790299|NCT01381172|9841297|FG001|NOT COMPLETED|Overall Study||13
8790300|NCT01381406|9841305|FG000|STARTED|Overall Study||2481
8790301|NCT01381406|9841306|FG001|STARTED|Overall Study||852
8790302|NCT01381406|9841305|FG000|COMPLETED|Overall Study||2481
8790303|NCT01381406|9841306|FG001|COMPLETED|Overall Study||852
8790304|NCT01381406|9841305|FG000|NOT COMPLETED|Overall Study||0
8790305|NCT01381406|9841306|FG001|NOT COMPLETED|Overall Study||0
8790306|NCT01381471|9841312|FG000|STARTED|Overall Study||11060
8790307|NCT01381471|9841312|FG000|COMPLETED|Overall Study||11060
8790308|NCT01381471|9841312|FG000|NOT COMPLETED|Overall Study||0
8790309|NCT01381549|9841319|FG000|STARTED|Overall Study||6
8790310|NCT01381549|9841320|FG001|STARTED|Overall Study||8
8790311|NCT01381549|9841321|FG002|STARTED|Overall Study||6
8790312|NCT01381549|9841319|FG000|COMPLETED|Overall Study||6
8790313|NCT01381549|9841320|FG001|COMPLETED|Overall Study||8
8790314|NCT01381549|9841321|FG002|COMPLETED|Overall Study||5
8790315|NCT01381549|9841319|FG000|NOT COMPLETED|Overall Study||0
8790316|NCT01381549|9841320|FG001|NOT COMPLETED|Overall Study||0
8790317|NCT01381549|9841321|FG002|NOT COMPLETED|Overall Study||1
8790318|NCT01381562|9841333|FG000|STARTED|Overall Study||5
8790319|NCT01381562|9841334|FG001|STARTED|Overall Study||4
8790320|NCT01381562|9841335|FG002|STARTED|Overall Study||5
8790321|NCT01381562|9841333|FG000|COMPLETED|Overall Study||5
8790322|NCT01381562|9841334|FG001|COMPLETED|Overall Study||3
8790323|NCT01381562|9841335|FG002|COMPLETED|Overall Study||5
8790324|NCT01381562|9841333|FG000|NOT COMPLETED|Overall Study||0
8790325|NCT01381562|9841334|FG001|NOT COMPLETED|Overall Study||1
8790326|NCT01381562|9841335|FG002|NOT COMPLETED|Overall Study||0
8790327|NCT01381575|9841346|FG000|STARTED|Overall Study||550
8790328|NCT01381575|9841347|FG001|STARTED|Overall Study||482
8790329|NCT01381575|9841348|FG002|STARTED|Overall Study||415
8790330|NCT01381575|9841346|FG000|COMPLETED|Overall Study||524
8790331|NCT01381575|9841347|FG001|COMPLETED|Overall Study||443
8790332|NCT01381575|9841348|FG002|COMPLETED|Overall Study||395
8790333|NCT01381575|9841346|FG000|NOT COMPLETED|Overall Study||26
8790334|NCT01381575|9841347|FG001|NOT COMPLETED|Overall Study||39
8790335|NCT01381575|9841348|FG002|NOT COMPLETED|Overall Study||20
8790336|NCT01381692|9841359|FG000|STARTED|Overall Study||7
8790337|NCT01381692|9841360|FG001|STARTED|Overall Study||2
8790338|NCT01381692|9841361|FG002|STARTED|Overall Study||0
8790339|NCT01381692|9841362|FG003|STARTED|Overall Study||0
8790340|NCT01381692|9841363|FG004|STARTED|Overall Study||0
8790341|NCT01381692|9841364|FG005|STARTED|Overall Study||0
8790342|NCT01381692|9841359|FG000|COMPLETED|Overall Study||6
8790343|NCT01381692|9841360|FG001|COMPLETED|Overall Study||2
8790344|NCT01381692|9841361|FG002|COMPLETED|Overall Study||0
8790345|NCT01381692|9841362|FG003|COMPLETED|Overall Study||0
8790346|NCT01381692|9841363|FG004|COMPLETED|Overall Study||0
8790347|NCT01381692|9841364|FG005|COMPLETED|Overall Study||0
8790348|NCT01381692|9841359|FG000|NOT COMPLETED|Overall Study||1
8790349|NCT01381692|9841360|FG001|NOT COMPLETED|Overall Study||0
8790350|NCT01381692|9841361|FG002|NOT COMPLETED|Overall Study||0
8790351|NCT01381692|9841362|FG003|NOT COMPLETED|Overall Study||0
8790352|NCT01381692|9841363|FG004|NOT COMPLETED|Overall Study||0
8790353|NCT01381692|9841364|FG005|NOT COMPLETED|Overall Study||0
8790354|NCT01381718|9841374|FG000|STARTED|Overall Study||56
8790355|NCT01381718|9841375|FG001|STARTED|Overall Study||56
8790356|NCT01381718|9841374|FG000|COMPLETED|Overall Study||51
8790357|NCT01381718|9841375|FG001|COMPLETED|Overall Study||43
8790358|NCT01381718|9841374|FG000|NOT COMPLETED|Overall Study||5
8790359|NCT01381718|9841375|FG001|NOT COMPLETED|Overall Study||13
8790360|NCT01381861|9841381|FG000|STARTED|Overall Study||23
8790361|NCT01381861|9841381|FG000|COMPLETED|Overall Study||23
8790362|NCT01381861|9841381|FG000|NOT COMPLETED|Overall Study||0
8790363|NCT01381874|9841388|FG000|STARTED|Overall Study||102
8790364|NCT01381874|9841389|FG001|STARTED|Overall Study||89
8790365|NCT01381874|9841390|FG002|STARTED|Overall Study||106
8790366|NCT01381874|9841388|FG000|Treated|Overall Study||102
8790367|NCT01381874|9841389|FG001|Treated|Overall Study||87
8790368|NCT01381874|9841390|FG002|Treated|Overall Study||104
8790369|NCT01381874|9841388|FG000|COMPLETED|Overall Study||25
8790370|NCT01381874|9841389|FG001|COMPLETED|Overall Study||26
8790371|NCT01381874|9841390|FG002|COMPLETED|Overall Study||30
8790372|NCT01381874|9841388|FG000|NOT COMPLETED|Overall Study||77
8790373|NCT01381874|9841389|FG001|NOT COMPLETED|Overall Study||63
8790374|NCT01381874|9841390|FG002|NOT COMPLETED|Overall Study||76
8790375|NCT01381900|9841401|FG000|STARTED|Overall Study||226
8790376|NCT01381900|9841402|FG001|STARTED|Overall Study||223
8790377|NCT01381900|9841403|FG002|STARTED|Overall Study||227
8790378|NCT01381900|9841401|FG000|COMPLETED|Overall Study||217
8790379|NCT01381900|9841402|FG001|COMPLETED|Overall Study||214
8790380|NCT01381900|9841403|FG002|COMPLETED|Overall Study||215
8790381|NCT01381900|9841401|FG000|NOT COMPLETED|Overall Study||9
9032287|NCT03256851|10094488|FG000|NOT COMPLETED|Overall Study||1
9032288|NCT03256851|10094489|FG001|NOT COMPLETED|Overall Study||0
9032289|NCT03256968|10094495|FG000|STARTED|Overall Study||1
9032290|NCT03256968|10094495|FG000|COMPLETED|Overall Study||1
9032291|NCT03256968|10094495|FG000|NOT COMPLETED|Overall Study||0
9032292|NCT03257189|10094499|FG000|STARTED|Overall Study||30
9032293|NCT03257189|10094499|FG000|COMPLETED|Overall Study||30
9032294|NCT03257189|10094499|FG000|NOT COMPLETED|Overall Study||0
9032295|NCT03257202|10094503|FG000|STARTED|Overall Study||12
9032296|NCT03257202|10094503|FG000|COMPLETED|Overall Study||12
9032297|NCT03257202|10094503|FG000|NOT COMPLETED|Overall Study||0
9032298|NCT03257358|10094515|FG000|STARTED|Overall Study||165
9032299|NCT03257358|10094516|FG001|STARTED|Overall Study||217
9032300|NCT03257358|10094515|FG000|Never Received Treatment|Overall Study||2
9032301|NCT03257358|10094516|FG001|Never Received Treatment|Overall Study||0
9032302|NCT03257358|10094515|FG000|COMPLETED|Overall Study||94
9032303|NCT03257358|10094516|FG001|COMPLETED|Overall Study||183
9032304|NCT03257358|10094515|FG000|NOT COMPLETED|Overall Study||71
9032305|NCT03257358|10094516|FG001|NOT COMPLETED|Overall Study||34
9032306|NCT03257371|10094522|FG000|STARTED|Overall Study||10
9032307|NCT03257371|10094522|FG000|COMPLETED|Overall Study||9
9032308|NCT03257371|10094522|FG000|NOT COMPLETED|Overall Study||1
9032309|NCT03257410|10094528|FG000|STARTED|Overall Study||86
9032310|NCT03257410|10094529|FG001|STARTED|Overall Study||86
9032311|NCT03257410|10094528|FG000|COMPLETED|Overall Study||65
9032312|NCT03257410|10094529|FG001|COMPLETED|Overall Study||65
9032313|NCT03257410|10094528|FG000|NOT COMPLETED|Overall Study||21
9032314|NCT03257410|10094529|FG001|NOT COMPLETED|Overall Study||21
9032315|NCT03257657|10094537|FG000|STARTED|Overall Study||22
9032316|NCT03257657|10094538|FG001|STARTED|Overall Study||20
9032317|NCT03257657|10094537|FG000|COMPLETED|Overall Study||22
9032318|NCT03257657|10094538|FG001|COMPLETED|Overall Study||15
9032319|NCT03257657|10094537|FG000|NOT COMPLETED|Overall Study||0
9032320|NCT03257657|10094538|FG001|NOT COMPLETED|Overall Study||5
9032321|NCT03257813|10094547|FG000|STARTED|Overall Study||30
9032322|NCT03257813|10094548|FG001|STARTED|Overall Study||30
9032323|NCT03257813|10094547|FG000|COMPLETED|Overall Study||24
9032324|NCT03257813|10094548|FG001|COMPLETED|Overall Study||27
8672030|NCT00754832|9715464|FG000|NOT COMPLETED|2 Weeks Washout||1
8672031|NCT00754832|9715465|FG001|NOT COMPLETED|2 Weeks Washout||2
8672032|NCT00754832|9715464|FG000|STARTED|Second 6 Weeks Intervention||17
8672033|NCT00754832|9715465|FG001|STARTED|Second 6 Weeks Intervention||26
8672034|NCT00754832|9715464|FG000|COMPLETED|Second 6 Weeks Intervention||17
8672035|NCT00754832|9715465|FG001|COMPLETED|Second 6 Weeks Intervention||24
8672036|NCT00754832|9715464|FG000|NOT COMPLETED|Second 6 Weeks Intervention||0
8672037|NCT00754832|9715465|FG001|NOT COMPLETED|Second 6 Weeks Intervention||2
8672038|NCT00754845|9715473|FG000|STARTED|Overall Study||959
8672039|NCT00754845|9715474|FG001|STARTED|Overall Study||959
8672040|NCT00754845|9715473|FG000|COMPLETED|Overall Study||959
8672041|NCT00754845|9715474|FG001|COMPLETED|Overall Study||959
8672042|NCT00754845|9715473|FG000|NOT COMPLETED|Overall Study||0
8672043|NCT00754845|9715474|FG001|NOT COMPLETED|Overall Study||0
8672044|NCT00754923|9715482|FG000|STARTED|Overall Study||11
8672045|NCT00754923|9715482|FG000|COMPLETED|Overall Study||11
8672046|NCT00754923|9715482|FG000|NOT COMPLETED|Overall Study||0
8672047|NCT00754936|9715486|FG000|STARTED|Overall Study||71
8672048|NCT00754936|9715486|FG000|COMPLETED|Overall Study||59
8672049|NCT00754936|9715486|FG000|NOT COMPLETED|Overall Study||12
8672050|NCT00755040|9715492|FG000|STARTED|Overall Study||83
8672051|NCT00755040|9715493|FG001|STARTED|Overall Study||81
8672052|NCT00755040|9715492|FG000|COMPLETED|Overall Study||40
8672053|NCT00755040|9715493|FG001|COMPLETED|Overall Study||47
8672054|NCT00755040|9715492|FG000|NOT COMPLETED|Overall Study||43
8672055|NCT00755040|9715493|FG001|NOT COMPLETED|Overall Study||34
8672056|NCT00755079|9715501|FG000|STARTED|Overall Study||18
8672057|NCT00755079|9715502|FG001|STARTED|Overall Study||22
8672058|NCT00755079|9715501|FG000|COMPLETED|Overall Study||17
8672059|NCT00755079|9715502|FG001|COMPLETED|Overall Study||16
8672060|NCT00755079|9715501|FG000|NOT COMPLETED|Overall Study||1
8672061|NCT00755079|9715502|FG001|NOT COMPLETED|Overall Study||6
8672062|NCT00755105|9715511|FG000|STARTED|Overall Study||38
8672063|NCT00755105|9715512|FG001|STARTED|Overall Study||30
8672064|NCT00755105|9715513|FG002|STARTED|Overall Study||9
8672065|NCT00755105|9715511|FG000|COMPLETED|Overall Study||29
8672066|NCT00755105|9715512|FG001|COMPLETED|Overall Study||19
9032325|NCT03257813|10094547|FG000|NOT COMPLETED|Overall Study||6
9032326|NCT03257813|10094548|FG001|NOT COMPLETED|Overall Study||3
9032327|NCT03257865|10094559|FG000|STARTED|Overall Study||163
8672067|NCT00755105|9715513|FG002|COMPLETED|Overall Study||5
8672068|NCT00755105|9715511|FG000|NOT COMPLETED|Overall Study||9
8672069|NCT00755105|9715512|FG001|NOT COMPLETED|Overall Study||11
8790382|NCT01381900|9841402|FG001|NOT COMPLETED|Overall Study||9
8790383|NCT01381900|9841403|FG002|NOT COMPLETED|Overall Study||12
9032328|NCT03257865|10094560|FG001|STARTED|Overall Study||170
9032329|NCT03257865|10094559|FG000|Received at Least 1 Dose of Study Drug|Overall Study||162
8790384|NCT01381926|9841413|FG000|STARTED|Low/High Dose of 1st Treatment (2months)||5
8790385|NCT01381926|9841414|FG001|STARTED|Low/High Dose of 1st Treatment (2months)||5
8790386|NCT01381926|9841413|FG000|COMPLETED|Low/High Dose of 1st Treatment (2months)||3
8790387|NCT01381926|9841414|FG001|COMPLETED|Low/High Dose of 1st Treatment (2months)||4
8790388|NCT01381926|9841413|FG000|NOT COMPLETED|Low/High Dose of 1st Treatment (2months)||2
8790389|NCT01381926|9841414|FG001|NOT COMPLETED|Low/High Dose of 1st Treatment (2months)||1
8790390|NCT01381926|9841413|FG000|STARTED|Low/High Dose of 2nd Treatment (2months)||3
8790391|NCT01381926|9841414|FG001|STARTED|Low/High Dose of 2nd Treatment (2months)||4
8790392|NCT01381926|9841413|FG000|COMPLETED|Low/High Dose of 2nd Treatment (2months)||3
8790393|NCT01381926|9841414|FG001|COMPLETED|Low/High Dose of 2nd Treatment (2months)||4
8790394|NCT01381926|9841413|FG000|NOT COMPLETED|Low/High Dose of 2nd Treatment (2months)||0
8790395|NCT01381926|9841414|FG001|NOT COMPLETED|Low/High Dose of 2nd Treatment (2months)||0
8790396|NCT01381952|9841422|FG000|STARTED|Overall Study||20
8790397|NCT01381952|9841422|FG000|Collected Dose and Image Information|Overall Study||20
8790398|NCT01381952|9841422|FG000|COMPLETED|Overall Study||20
8790399|NCT01381952|9841422|FG000|NOT COMPLETED|Overall Study||0
9032330|NCT03257865|10094560|FG001|Received at Least 1 Dose of Study Drug|Overall Study||170
9032331|NCT03257865|10094559|FG000|COMPLETED|Overall Study||128
9032332|NCT03257865|10094560|FG001|COMPLETED|Overall Study||135
9032333|NCT03257865|10094559|FG000|NOT COMPLETED|Overall Study||35
9032334|NCT03257865|10094560|FG001|NOT COMPLETED|Overall Study||35
9032335|NCT03257995|10094566|FG000|STARTED|Overall Study||9
9032336|NCT03257995|10094567|FG001|STARTED|Overall Study||9
9032337|NCT03257995|10094568|FG002|STARTED|Overall Study||9
9032338|NCT03257995|10094569|FG003|STARTED|Overall Study||9
9032339|NCT03257995|10094570|FG004|STARTED|Overall Study||9
9032340|NCT03257995|10094571|FG005|STARTED|Overall Study||9
9032341|NCT03257995|10094566|FG000|COMPLETED|Overall Study||9
9032342|NCT03257995|10094567|FG001|COMPLETED|Overall Study||8
9032343|NCT03257995|10094568|FG002|COMPLETED|Overall Study||9
9032344|NCT03257995|10094569|FG003|COMPLETED|Overall Study||9
9032345|NCT03257995|10094570|FG004|COMPLETED|Overall Study||9
9032346|NCT03257995|10094571|FG005|COMPLETED|Overall Study||7
9032347|NCT03257995|10094566|FG000|NOT COMPLETED|Overall Study||0
9032348|NCT03257995|10094567|FG001|NOT COMPLETED|Overall Study||1
9032349|NCT03257995|10094568|FG002|NOT COMPLETED|Overall Study||0
9032350|NCT03257995|10094569|FG003|NOT COMPLETED|Overall Study||0
9032351|NCT03257995|10094570|FG004|NOT COMPLETED|Overall Study||0
9032352|NCT03257995|10094571|FG005|NOT COMPLETED|Overall Study||2
9032353|NCT03258645|10094583|FG000|STARTED|Overall Study||1489
9032354|NCT03258645|10094583|FG000|COMPLETED|Overall Study||1489
9032355|NCT03258645|10094583|FG000|NOT COMPLETED|Overall Study||0
9032356|NCT03258710|10094593|FG000|STARTED|Overall Study||75
9032357|NCT03258710|10094593|FG000|COMPLETED|Overall Study||72
9032358|NCT03258710|10094593|FG000|NOT COMPLETED|Overall Study||3
9032359|NCT03258762|10094599|FG000|STARTED|Overall Study||7
9032360|NCT03258762|10094600|FG001|STARTED|Overall Study||7
9032361|NCT03258762|10094599|FG000|COMPLETED|Overall Study||7
9032362|NCT03258762|10094600|FG001|COMPLETED|Overall Study||6
9032363|NCT03258762|10094599|FG000|NOT COMPLETED|Overall Study||0
9032364|NCT03258762|10094600|FG001|NOT COMPLETED|Overall Study||1
9032365|NCT03258814|10094609|FG000|STARTED|Overall Study||4
9032366|NCT03258814|10094610|FG001|STARTED|Overall Study||3
9032367|NCT03258814|10094611|FG002|STARTED|Overall Study||10
9032368|NCT03258814|10094609|FG000|COMPLETED|Overall Study||0
9032369|NCT03258814|10094610|FG001|COMPLETED|Overall Study||0
9032370|NCT03258814|10094611|FG002|COMPLETED|Overall Study||0
9032371|NCT03258814|10094609|FG000|NOT COMPLETED|Overall Study||4
9032372|NCT03258814|10094610|FG001|NOT COMPLETED|Overall Study||3
9032373|NCT03258814|10094611|FG002|NOT COMPLETED|Overall Study||10
9032374|NCT03259087|10094623|FG000|STARTED|Part 1 and Period 1 of Part 2||8
9032375|NCT03259087|10094624|FG001|STARTED|Part 1 and Period 1 of Part 2||8
9032376|NCT03259087|10094625|FG002|STARTED|Part 1 and Period 1 of Part 2||8
9032377|NCT03259087|10094626|FG003|STARTED|Part 1 and Period 1 of Part 2||10
9032378|NCT03259087|10094627|FG004|STARTED|Part 1 and Period 1 of Part 2||8
9032379|NCT03259087|10094623|FG000|COMPLETED|Part 1 and Period 1 of Part 2||8
9032380|NCT03259087|10094624|FG001|COMPLETED|Part 1 and Period 1 of Part 2||8
9032381|NCT03259087|10094625|FG002|COMPLETED|Part 1 and Period 1 of Part 2||8
9032382|NCT03259087|10094626|FG003|COMPLETED|Part 1 and Period 1 of Part 2||10
9032383|NCT03259087|10094627|FG004|COMPLETED|Part 1 and Period 1 of Part 2||7
9032384|NCT03259087|10094623|FG000|NOT COMPLETED|Part 1 and Period 1 of Part 2||0
9032385|NCT03259087|10094624|FG001|NOT COMPLETED|Part 1 and Period 1 of Part 2||0
9032386|NCT03259087|10094625|FG002|NOT COMPLETED|Part 1 and Period 1 of Part 2||0
9032387|NCT03259087|10094626|FG003|NOT COMPLETED|Part 1 and Period 1 of Part 2||0
9032388|NCT03259087|10094627|FG004|NOT COMPLETED|Part 1 and Period 1 of Part 2||1
9032389|NCT03259087|10094623|FG000|STARTED|Period 2 of Part 2|Period 2 did not apply to Part 1 participants|0
9032390|NCT03259087|10094624|FG001|STARTED|Period 2 of Part 2|Period 2 did not apply to Part 1 participants|0
9032391|NCT03259087|10094625|FG002|STARTED|Period 2 of Part 2|Period 2 did not apply to Part 1 participants|0
9032392|NCT03259087|10094626|FG003|STARTED|Period 2 of Part 2|Period 2 did not apply to Part 1 participants|0
9032393|NCT03259087|10094627|FG004|STARTED|Period 2 of Part 2||7
8790400|NCT01382108|9841430|FG000|STARTED|Overall Study||20
8790401|NCT01382108|9841431|FG001|STARTED|Overall Study||19
8790402|NCT01382108|9841430|FG000|COMPLETED|Overall Study||20
9032394|NCT03259087|10094623|FG000|COMPLETED|Period 2 of Part 2||0
8790403|NCT01382108|9841431|FG001|COMPLETED|Overall Study||19
8790404|NCT01382108|9841430|FG000|NOT COMPLETED|Overall Study||0
8790405|NCT01382108|9841431|FG001|NOT COMPLETED|Overall Study||0
8790406|NCT01382186|9841440|FG000|STARTED|Overall Study||33
8790407|NCT01382186|9841441|FG001|STARTED|Overall Study||819
8790408|NCT01382186|9841440|FG000|COMPLETED|Overall Study||32
8790409|NCT01382186|9841441|FG001|COMPLETED|Overall Study||819
8790410|NCT01382186|9841440|FG000|NOT COMPLETED|Overall Study||1
8790411|NCT01382186|9841441|FG001|NOT COMPLETED|Overall Study||0
8790412|NCT01382212|9841450|FG000|STARTED|Overall Study||13
8790413|NCT01382212|9841450|FG000|COMPLETED|Overall Study||11
8790414|NCT01382212|9841450|FG000|NOT COMPLETED|Overall Study||2
8790415|NCT01382225|9841456|FG000|STARTED|Overall Study||725
8790416|NCT01382225|9841457|FG001|STARTED|Overall Study||729
8790417|NCT01382225|9841456|FG000|COMPLETED|Overall Study||711
8790418|NCT01382225|9841457|FG001|COMPLETED|Overall Study||722
8790419|NCT01382225|9841456|FG000|NOT COMPLETED|Overall Study||14
8790420|NCT01382225|9841457|FG001|NOT COMPLETED|Overall Study||7
8790421|NCT01382251|9841465|FG000|STARTED|Overall Study||123
8790422|NCT01382251|9841466|FG001|STARTED|Overall Study||123
8790423|NCT01382251|9841465|FG000|COMPLETED|Overall Study||102
8790424|NCT01382251|9841466|FG001|COMPLETED|Overall Study||102
8790425|NCT01382251|9841465|FG000|NOT COMPLETED|Overall Study||21
8790426|NCT01382251|9841466|FG001|NOT COMPLETED|Overall Study||21
8790427|NCT01382303|9841473|FG000|STARTED|Overall Study||87
8790428|NCT01382303|9841474|FG001|STARTED|Overall Study||87
8790429|NCT01382303|9841473|FG000|COMPLETED|Overall Study||52
8790430|NCT01382303|9841474|FG001|COMPLETED|Overall Study||70
8790431|NCT01382303|9841473|FG000|NOT COMPLETED|Overall Study||35
8790432|NCT01382303|9841474|FG001|NOT COMPLETED|Overall Study||17
8790433|NCT01382446|9841482|FG000|STARTED|Overall Study||33
8790434|NCT01382446|9841483|FG001|STARTED|Overall Study||33
8790435|NCT01382446|9841482|FG000|COMPLETED|Overall Study||30
8790436|NCT01382446|9841483|FG001|COMPLETED|Overall Study||29
8790437|NCT01382446|9841482|FG000|NOT COMPLETED|Overall Study||3
8790438|NCT01382446|9841483|FG001|NOT COMPLETED|Overall Study||4
8790439|NCT01382602|9841491|FG000|STARTED|Overall Study||93
8790440|NCT01382602|9841492|FG001|STARTED|Overall Study||50
8790441|NCT01382602|9841491|FG000|COMPLETED|Overall Study||93
8790442|NCT01382602|9841492|FG001|COMPLETED|Overall Study||46
8790443|NCT01382602|9841491|FG000|NOT COMPLETED|Overall Study||0
8790444|NCT01382602|9841492|FG001|NOT COMPLETED|Overall Study||4
8790445|NCT01382719|9841502|FG000|STARTED|Overall Study||98
8790446|NCT01382719|9841503|FG001|STARTED|Overall Study||100
8790447|NCT01382719|9841504|FG002|STARTED|Overall Study||100
8790448|NCT01382719|9841505|FG003|STARTED|Overall Study||99
8917161|NCT02189863|9976823|FG000|NOT COMPLETED|Second 2 Weeks||0
8917162|NCT02189863|9976824|FG001|NOT COMPLETED|Second 2 Weeks||0
8917163|NCT02189889|9976835|FG000|STARTED|Overall Study||2
8917164|NCT02189889|9976836|FG001|STARTED|Overall Study||3
8917165|NCT02189889|9976835|FG000|COMPLETED|Overall Study||2
8917166|NCT02189889|9976836|FG001|COMPLETED|Overall Study||3
8917167|NCT02189889|9976835|FG000|NOT COMPLETED|Overall Study||0
8917168|NCT02189889|9976836|FG001|NOT COMPLETED|Overall Study||0
8917169|NCT02189915|9976842|FG000|STARTED|Overall Study||14
8917170|NCT02189915|9976842|FG000|COMPLETED|Overall Study||11
8917171|NCT02189915|9976842|FG000|NOT COMPLETED|Overall Study||3
8917172|NCT02189941|9976846|FG000|STARTED|Overall Study||4
8917173|NCT02189941|9976847|FG001|STARTED|Overall Study||4
8917174|NCT02189941|9976848|FG002|STARTED|Overall Study||3
8917175|NCT02189941|9976846|FG000|COMPLETED|Overall Study||4
8917176|NCT02189941|9976847|FG001|COMPLETED|Overall Study||4
8917177|NCT02189941|9976848|FG002|COMPLETED|Overall Study||2
8917178|NCT02189941|9976846|FG000|NOT COMPLETED|Overall Study||0
8917179|NCT02189941|9976847|FG001|NOT COMPLETED|Overall Study||0
8917180|NCT02189941|9976848|FG002|NOT COMPLETED|Overall Study||1
8917181|NCT02189954|9976858|FG000|STARTED|Overall Study||45
8917182|NCT02189954|9976859|FG001|STARTED|Overall Study||45
8917183|NCT02189954|9976858|FG000|COMPLETED|Overall Study||45
8917184|NCT02189954|9976859|FG001|COMPLETED|Overall Study||45
8917185|NCT02189954|9976858|FG000|NOT COMPLETED|Overall Study||0
8917186|NCT02189954|9976859|FG001|NOT COMPLETED|Overall Study||0
8917187|NCT02190045|9976867|FG000|STARTED|Overall Study||15
8917188|NCT02190045|9976868|FG001|STARTED|Overall Study||15
8917189|NCT02190045|9976867|FG000|COMPLETED|Overall Study||12
8917190|NCT02190045|9976868|FG001|COMPLETED|Overall Study||15
8917191|NCT02190045|9976867|FG000|NOT COMPLETED|Overall Study||3
8917192|NCT02190045|9976868|FG001|NOT COMPLETED|Overall Study||0
8917193|NCT02190279|9976877|FG000|STARTED|Overall Study||16
8917194|NCT02190279|9976878|FG001|STARTED|Overall Study||69
8917195|NCT02190279|9976879|FG002|STARTED|Overall Study||31
8917196|NCT02190279|9976877|FG000|COMPLETED|Overall Study||13
8917197|NCT02190279|9976878|FG001|COMPLETED|Overall Study||69
8917198|NCT02190279|9976879|FG002|COMPLETED|Overall Study||28
8917199|NCT02190279|9976877|FG000|NOT COMPLETED|Overall Study||3
8917200|NCT02190279|9976878|FG001|NOT COMPLETED|Overall Study||0
8917201|NCT02190279|9976879|FG002|NOT COMPLETED|Overall Study||3
8790449|NCT01382719|9841502|FG000|Subjects Not Dosed|Overall Study||1
8790450|NCT01382719|9841503|FG001|Subjects Not Dosed|Overall Study||0
8790451|NCT01382719|9841504|FG002|Subjects Not Dosed|Overall Study||1
8790452|NCT01382719|9841505|FG003|Subjects Not Dosed|Overall Study||1
8790453|NCT01382719|9841502|FG000|COMPLETED|Overall Study||80
8790454|NCT01382719|9841503|FG001|COMPLETED|Overall Study||81
8790455|NCT01382719|9841504|FG002|COMPLETED|Overall Study||66
8790456|NCT01382719|9841505|FG003|COMPLETED|Overall Study||66
8790457|NCT01382719|9841502|FG000|NOT COMPLETED|Overall Study||18
8790458|NCT01382719|9841503|FG001|NOT COMPLETED|Overall Study||19
8790459|NCT01382719|9841504|FG002|NOT COMPLETED|Overall Study||34
8790460|NCT01382719|9841505|FG003|NOT COMPLETED|Overall Study||33
8790461|NCT01382901|9841517|FG000|STARTED|Overall Study||24
8790462|NCT01382901|9841518|FG001|STARTED|Overall Study||21
8790463|NCT01382901|9841517|FG000|COMPLETED|Overall Study||7
8790464|NCT01382901|9841518|FG001|COMPLETED|Overall Study||7
8790465|NCT01382901|9841517|FG000|NOT COMPLETED|Overall Study||17
8790466|NCT01382901|9841518|FG001|NOT COMPLETED|Overall Study||14
8790467|NCT01382940|9841524|FG000|STARTED|Overall Study||351
8790468|NCT01382940|9841524|FG000|Received Day 1 Infusion|Overall Study||351
8790469|NCT01382940|9841524|FG000|Received Day 15 Infusions|Overall Study||341
8790470|NCT01382940|9841524|FG000|Received Day 168 Infusion|Overall Study||290
8790471|NCT01382940|9841524|FG000|Received Day 182 Infusion|Overall Study||278
8790472|NCT01382940|9841524|FG000|COMPLETED|Overall Study||278
8790473|NCT01382940|9841524|FG000|NOT COMPLETED|Overall Study||73
8790474|NCT01383005|9841530|FG000|STARTED|Overall Study||34
8790475|NCT01383005|9841531|FG001|STARTED|Overall Study||60
8790476|NCT01383005|9841530|FG000|COMPLETED|Overall Study||34
8790477|NCT01383005|9841531|FG001|COMPLETED|Overall Study||60
8790478|NCT01383005|9841530|FG000|NOT COMPLETED|Overall Study||0
8790479|NCT01383005|9841531|FG001|NOT COMPLETED|Overall Study||0
8790480|NCT01383018|9841537|FG000|STARTED|Overall Study||1457
8790481|NCT01383018|9841537|FG000|COMPLETED|Overall Study||1082
8790482|NCT01383018|9841537|FG000|NOT COMPLETED|Overall Study||375
8790483|NCT01383096|9841554|FG000|STARTED|First Intervention (8 Days)||19
8790484|NCT01383096|9841555|FG001|STARTED|First Intervention (8 Days)||17
8790485|NCT01383096|9841556|FG002|STARTED|First Intervention (8 Days)||16
8790486|NCT01383096|9841554|FG000|COMPLETED|First Intervention (8 Days)||19
8790487|NCT01383096|9841555|FG001|COMPLETED|First Intervention (8 Days)||17
8790488|NCT01383096|9841556|FG002|COMPLETED|First Intervention (8 Days)||16
8790489|NCT01383096|9841554|FG000|NOT COMPLETED|First Intervention (8 Days)||0
8790490|NCT01383096|9841555|FG001|NOT COMPLETED|First Intervention (8 Days)||0
8790491|NCT01383096|9841556|FG002|NOT COMPLETED|First Intervention (8 Days)||0
8790492|NCT01383096|9841554|FG000|STARTED|Second Intervention (8 Days)||19
8790493|NCT01383096|9841555|FG001|STARTED|Second Intervention (8 Days)||17
8790494|NCT01383096|9841556|FG002|STARTED|Second Intervention (8 Days)||16
8790495|NCT01383096|9841554|FG000|COMPLETED|Second Intervention (8 Days)||19
8790496|NCT01383096|9841555|FG001|COMPLETED|Second Intervention (8 Days)||16
8790497|NCT01383096|9841556|FG002|COMPLETED|Second Intervention (8 Days)||14
8790498|NCT01383096|9841554|FG000|NOT COMPLETED|Second Intervention (8 Days)||0
8790499|NCT01383096|9841555|FG001|NOT COMPLETED|Second Intervention (8 Days)||1
8790500|NCT01383096|9841556|FG002|NOT COMPLETED|Second Intervention (8 Days)||2
8790501|NCT01383096|9841554|FG000|STARTED|Third Intervention (8 Days)||19
8790502|NCT01383096|9841555|FG001|STARTED|Third Intervention (8 Days)||16
8790503|NCT01383096|9841556|FG002|STARTED|Third Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
8790504|NCT01383096|9841554|FG000|COMPLETED|Third Intervention (8 Days)||15
8790505|NCT01383096|9841555|FG001|COMPLETED|Third Intervention (8 Days)||12
8790506|NCT01383096|9841556|FG002|COMPLETED|Third Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
8790507|NCT01383096|9841554|FG000|NOT COMPLETED|Third Intervention (8 Days)||4
8790508|NCT01383096|9841555|FG001|NOT COMPLETED|Third Intervention (8 Days)||4
8790509|NCT01383096|9841556|FG002|NOT COMPLETED|Third Intervention (8 Days)||0
8790510|NCT01383096|9841554|FG000|STARTED|Fourth Intervention (8 Days)||15
8790511|NCT01383096|9841555|FG001|STARTED|Fourth Intervention (8 Days)||12
8790512|NCT01383096|9841556|FG002|STARTED|Fourth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
8790513|NCT01383096|9841554|FG000|COMPLETED|Fourth Intervention (8 Days)||13
8790514|NCT01383096|9841555|FG001|COMPLETED|Fourth Intervention (8 Days)||12
8790515|NCT01383096|9841556|FG002|COMPLETED|Fourth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
8790516|NCT01383096|9841554|FG000|NOT COMPLETED|Fourth Intervention (8 Days)||2
8790517|NCT01383096|9841555|FG001|NOT COMPLETED|Fourth Intervention (8 Days)||0
8790518|NCT01383096|9841556|FG002|NOT COMPLETED|Fourth Intervention (8 Days)||0
8790519|NCT01383096|9841554|FG000|STARTED|Fifth Intervention (8 Days)||13
8790520|NCT01383096|9841555|FG001|STARTED|Fifth Intervention (8 Days)|Only 4 interventions in Cohort 2.|0
8790521|NCT01383096|9841556|FG002|STARTED|Fifth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
8790522|NCT01383096|9841554|FG000|COMPLETED|Fifth Intervention (8 Days)||11
8790523|NCT01383096|9841555|FG001|COMPLETED|Fifth Intervention (8 Days)|Only 4 interventions in Cohort 2.|0
8790524|NCT01383096|9841556|FG002|COMPLETED|Fifth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
8790525|NCT01383096|9841554|FG000|NOT COMPLETED|Fifth Intervention (8 Days)||2
8790526|NCT01383096|9841555|FG001|NOT COMPLETED|Fifth Intervention (8 Days)||0
8790527|NCT01383096|9841556|FG002|NOT COMPLETED|Fifth Intervention (8 Days)||0
8790528|NCT01383161|9841595|FG000|STARTED|Overall Study||25
8790529|NCT01383161|9841596|FG001|STARTED|Overall Study||21
8790530|NCT01383161|9841595|FG000|COMPLETED|Overall Study||20
8790531|NCT01383161|9841596|FG001|COMPLETED|Overall Study||17
8790532|NCT01383161|9841595|FG000|NOT COMPLETED|Overall Study||5
8790533|NCT01383161|9841596|FG001|NOT COMPLETED|Overall Study||4
8790534|NCT01383174|9841604|FG000|STARTED|Baseline Assessment||76
8790535|NCT01383174|9841605|FG001|STARTED|Baseline Assessment||75
8917202|NCT02190435|9976891|FG000|STARTED|Overall Study||41
8790536|NCT01383174|9841604|FG000|COMPLETED|Baseline Assessment|These 76 completed the baseline assessment and continued in the study.|76
8790537|NCT01383174|9841605|FG001|COMPLETED|Baseline Assessment|These 75 completed the baseline assessment and continued in the study.|75
8790538|NCT01383174|9841604|FG000|NOT COMPLETED|Baseline Assessment||0
8790539|NCT01383174|9841605|FG001|NOT COMPLETED|Baseline Assessment||0
8790540|NCT01383174|9841604|FG000|STARTED|3 Month Assessment||76
8790541|NCT01383174|9841605|FG001|STARTED|3 Month Assessment||75
8790542|NCT01383174|9841604|FG000|COMPLETED|3 Month Assessment|These 70 completed the 3 month assessment and continued in the study.|70
8790543|NCT01383174|9841605|FG001|COMPLETED|3 Month Assessment|These 74 completed the 3 month assessment and continued in the study.|74
8790544|NCT01383174|9841604|FG000|NOT COMPLETED|3 Month Assessment||6
8790545|NCT01383174|9841605|FG001|NOT COMPLETED|3 Month Assessment||1
8790546|NCT01383174|9841604|FG000|STARTED|6 Month Assessment|All 76 people were contacted at 6 months;1 person returned and 5 did not return to study at 6 months|76
8790547|NCT01383174|9841605|FG001|STARTED|6 Month Assessment||74
8790548|NCT01383174|9841604|FG000|COMPLETED|6 Month Assessment|These 71 completed the 6 month assessment and completed the study.|71
8790549|NCT01383174|9841605|FG001|COMPLETED|6 Month Assessment|These 73 completed the 6 month assessment and completed the study.|73
8790550|NCT01383174|9841604|FG000|NOT COMPLETED|6 Month Assessment||5
8790551|NCT01383174|9841605|FG001|NOT COMPLETED|6 Month Assessment||1
8790552|NCT01383200|9841613|FG000|STARTED|Overall Study||5
8790553|NCT01383200|9841614|FG001|STARTED|Overall Study||6
8790554|NCT01383200|9841613|FG000|COMPLETED|Overall Study||5
8790555|NCT01383200|9841614|FG001|COMPLETED|Overall Study||6
8790556|NCT01383200|9841613|FG000|NOT COMPLETED|Overall Study||0
8790557|NCT01383200|9841614|FG001|NOT COMPLETED|Overall Study||0
8790558|NCT01383213|9841622|FG000|STARTED|Overall Study||40
8790559|NCT01383213|9841623|FG001|STARTED|Overall Study||41
8790560|NCT01383213|9841622|FG000|COMPLETED|Overall Study||40
8790561|NCT01383213|9841623|FG001|COMPLETED|Overall Study||41
8790562|NCT01383213|9841622|FG000|NOT COMPLETED|Overall Study||0
8790563|NCT01383213|9841623|FG001|NOT COMPLETED|Overall Study||0
8790564|NCT01383317|9841631|FG000|STARTED|Overall Study||29
8790565|NCT01383317|9841632|FG001|STARTED|Overall Study||35
8790566|NCT01383317|9841631|FG000|COMPLETED|Overall Study||26
8790567|NCT01383317|9841632|FG001|COMPLETED|Overall Study||33
8790568|NCT01383317|9841631|FG000|NOT COMPLETED|Overall Study||3
8790569|NCT01383317|9841632|FG001|NOT COMPLETED|Overall Study||2
8790570|NCT01383356|9841638|FG000|STARTED|Period 1|Entered and treated.|29
8790571|NCT01383356|9841639|FG001|STARTED|Period 1|Entered and treated.|29
8790572|NCT01383356|9841638|FG000|COMPLETED|Period 1|Completed period 1.|21
8790573|NCT01383356|9841639|FG001|COMPLETED|Period 1|Completed period 1.|23
8790574|NCT01383356|9841638|FG000|NOT COMPLETED|Period 1||8
8790575|NCT01383356|9841639|FG001|NOT COMPLETED|Period 1||6
9032395|NCT03259087|10094624|FG001|COMPLETED|Period 2 of Part 2||0
9032396|NCT03259087|10094625|FG002|COMPLETED|Period 2 of Part 2||0
9032397|NCT03259087|10094626|FG003|COMPLETED|Period 2 of Part 2||0
9032398|NCT03259087|10094627|FG004|COMPLETED|Period 2 of Part 2||6
9032399|NCT03259087|10094623|FG000|NOT COMPLETED|Period 2 of Part 2||0
9032400|NCT03259087|10094624|FG001|NOT COMPLETED|Period 2 of Part 2||0
9032401|NCT03259087|10094625|FG002|NOT COMPLETED|Period 2 of Part 2||0
9032402|NCT03259087|10094626|FG003|NOT COMPLETED|Period 2 of Part 2||0
9032403|NCT03259087|10094627|FG004|NOT COMPLETED|Period 2 of Part 2||1
9032404|NCT03259139|10094655|FG000|STARTED|Overall Study||42
9032405|NCT03259139|10094656|FG001|STARTED|Overall Study||42
9032406|NCT03259139|10094657|FG002|STARTED|Overall Study||42
9032407|NCT03259139|10094658|FG003|STARTED|Overall Study||42
9032408|NCT03259139|10094659|FG004|STARTED|Overall Study||41
9032409|NCT03259139|10094660|FG005|STARTED|Overall Study||41
9032410|NCT03259139|10094655|FG000|Eligible|Overall Study||41
9032411|NCT03259139|10094656|FG001|Eligible|Overall Study||41
9032412|NCT03259139|10094657|FG002|Eligible|Overall Study||41
9032413|NCT03259139|10094658|FG003|Eligible|Overall Study||41
9032414|NCT03259139|10094659|FG004|Eligible|Overall Study||41
9032415|NCT03259139|10094660|FG005|Eligible|Overall Study||41
9032416|NCT03259139|10094655|FG000|Outlier Elimination|Overall Study||41
9032417|NCT03259139|10094656|FG001|Outlier Elimination|Overall Study||41
9032418|NCT03259139|10094657|FG002|Outlier Elimination|Overall Study||41
8672070|NCT00755105|9715513|FG002|NOT COMPLETED|Overall Study||4
8672071|NCT00755131|9715523|FG000|STARTED|Overall Study||37
8672072|NCT00755131|9715524|FG001|STARTED|Overall Study||38
8672073|NCT00755131|9715523|FG000|COMPLETED|Overall Study||37
8672074|NCT00755131|9715524|FG001|COMPLETED|Overall Study||38
8672075|NCT00755131|9715523|FG000|NOT COMPLETED|Overall Study||0
8672076|NCT00755131|9715524|FG001|NOT COMPLETED|Overall Study||0
8672077|NCT00755183|9715532|FG000|STARTED|Overall Study||30
8672078|NCT00755183|9715533|FG001|STARTED|Overall Study||30
8672079|NCT00755183|9715532|FG000|COMPLETED|Overall Study||23
8672080|NCT00755183|9715533|FG001|COMPLETED|Overall Study||24
8672081|NCT00755183|9715532|FG000|NOT COMPLETED|Overall Study||7
8672082|NCT00755183|9715533|FG001|NOT COMPLETED|Overall Study||6
8672083|NCT00755196|9715541|FG000|STARTED|Overall Study||30
9032419|NCT03259139|10094658|FG003|Outlier Elimination|Overall Study||41
9032420|NCT03259139|10094659|FG004|Outlier Elimination|Overall Study||39
9032421|NCT03259139|10094660|FG005|Outlier Elimination|Overall Study||39
8672084|NCT00755196|9715541|FG000|COMPLETED|Overall Study||28
8672085|NCT00755196|9715541|FG000|NOT COMPLETED|Overall Study||2
8672086|NCT00755222|9715548|FG000|STARTED|Overall Study||111
8672087|NCT00755222|9715549|FG001|STARTED|Overall Study||36
8790576|NCT01383356|9841638|FG000|STARTED|Washout Period (at Least 35 Days)||21
8790577|NCT01383356|9841639|FG001|STARTED|Washout Period (at Least 35 Days)||23
8790578|NCT01383356|9841638|FG000|COMPLETED|Washout Period (at Least 35 Days)||21
8790579|NCT01383356|9841639|FG001|COMPLETED|Washout Period (at Least 35 Days)||23
8790580|NCT01383356|9841638|FG000|NOT COMPLETED|Washout Period (at Least 35 Days)||0
8790581|NCT01383356|9841639|FG001|NOT COMPLETED|Washout Period (at Least 35 Days)||0
8790582|NCT01383356|9841638|FG000|STARTED|Period 2|Entered and treated.|21
8917203|NCT02190435|9976892|FG001|STARTED|Overall Study||24
8917204|NCT02190435|9976891|FG000|COMPLETED|Overall Study||26
8917205|NCT02190435|9976892|FG001|COMPLETED|Overall Study||24
8917206|NCT02190435|9976891|FG000|NOT COMPLETED|Overall Study||15
8917207|NCT02190435|9976892|FG001|NOT COMPLETED|Overall Study||0
8917208|NCT02190552|9976898|FG000|STARTED|Overall Study||40
8917209|NCT02190552|9976898|FG000|COMPLETED|Overall Study||36
8917210|NCT02190552|9976898|FG000|NOT COMPLETED|Overall Study||4
8917211|NCT02190591|9976905|FG000|STARTED|Overall Study||102
9032422|NCT03259139|10094655|FG000|Found Handgun|Overall Study||38
9032423|NCT03259139|10094656|FG001|Found Handgun|Overall Study||38
9032424|NCT03259139|10094657|FG002|Found Handgun|Overall Study||37
9032425|NCT03259139|10094658|FG003|Found Handgun|Overall Study||37
9032426|NCT03259139|10094659|FG004|Found Handgun|Overall Study||35
9032427|NCT03259139|10094660|FG005|Found Handgun|Overall Study||35
9032428|NCT03259139|10094655|FG000|COMPLETED|Overall Study||38
9032429|NCT03259139|10094656|FG001|COMPLETED|Overall Study||38
9032430|NCT03259139|10094657|FG002|COMPLETED|Overall Study||37
9032431|NCT03259139|10094658|FG003|COMPLETED|Overall Study||37
9032432|NCT03259139|10094659|FG004|COMPLETED|Overall Study||35
9032433|NCT03259139|10094660|FG005|COMPLETED|Overall Study||35
9032434|NCT03259139|10094655|FG000|NOT COMPLETED|Overall Study||4
9032435|NCT03259139|10094656|FG001|NOT COMPLETED|Overall Study||4
9032436|NCT03259139|10094657|FG002|NOT COMPLETED|Overall Study||5
9032437|NCT03259139|10094658|FG003|NOT COMPLETED|Overall Study||5
9032438|NCT03259139|10094659|FG004|NOT COMPLETED|Overall Study||6
9032439|NCT03259139|10094660|FG005|NOT COMPLETED|Overall Study||6
9032440|NCT03259308|10094680|FG000|STARTED|Overall Study||56
9032441|NCT03259308|10094681|FG001|STARTED|Overall Study||111
9032442|NCT03259308|10094682|FG002|STARTED|Overall Study||112
9032443|NCT03259308|10094680|FG000|COMPLETED|Overall Study||49
9032444|NCT03259308|10094681|FG001|COMPLETED|Overall Study||103
9032445|NCT03259308|10094682|FG002|COMPLETED|Overall Study||105
9032446|NCT03259308|10094680|FG000|NOT COMPLETED|Overall Study||7
9032447|NCT03259308|10094681|FG001|NOT COMPLETED|Overall Study||8
9032448|NCT03259308|10094682|FG002|NOT COMPLETED|Overall Study||7
9032449|NCT03259334|10094693|FG000|STARTED|Overall Study||76
9032450|NCT03259334|10094694|FG001|STARTED|Overall Study||153
9032451|NCT03259334|10094695|FG002|STARTED|Overall Study||151
9032452|NCT03259334|10094693|FG000|Treated|Overall Study||76
9032453|NCT03259334|10094694|FG001|Treated|Overall Study||151
9032454|NCT03259334|10094695|FG002|Treated|Overall Study||151
9032455|NCT03259334|10094693|FG000|COMPLETED|Overall Study||66
9032456|NCT03259334|10094694|FG001|COMPLETED|Overall Study||136
9032457|NCT03259334|10094695|FG002|COMPLETED|Overall Study||138
9032458|NCT03259334|10094693|FG000|NOT COMPLETED|Overall Study||10
9032459|NCT03259334|10094694|FG001|NOT COMPLETED|Overall Study||17
9032460|NCT03259334|10094695|FG002|NOT COMPLETED|Overall Study||13
9032461|NCT03259425|10094703|FG000|STARTED|Overall Study||7
9032462|NCT03259425|10094703|FG000|Surgery|Overall Study||6
9032463|NCT03259425|10094703|FG000|COMPLETED|Overall Study||6
9032464|NCT03259425|10094703|FG000|NOT COMPLETED|Overall Study||1
9032465|NCT03259490|10094709|FG000|STARTED|Period 1||15
9032466|NCT03259490|10094710|FG001|STARTED|Period 1||15
9032467|NCT03259490|10094709|FG000|COMPLETED|Period 1||15
9032468|NCT03259490|10094710|FG001|COMPLETED|Period 1||14
9032469|NCT03259490|10094709|FG000|NOT COMPLETED|Period 1||0
9032470|NCT03259490|10094710|FG001|NOT COMPLETED|Period 1||1
9032471|NCT03259490|10094709|FG000|STARTED|Period 2||15
9032472|NCT03259490|10094710|FG001|STARTED|Period 2||14
9032473|NCT03259490|10094709|FG000|COMPLETED|Period 2||14
9032474|NCT03259490|10094710|FG001|COMPLETED|Period 2||14
9032475|NCT03259490|10094709|FG000|NOT COMPLETED|Period 2||1
9032476|NCT03259490|10094710|FG001|NOT COMPLETED|Period 2||0
9032477|NCT03259555|10094718|FG000|STARTED|Overall Study||158
9032478|NCT03259555|10094719|FG001|STARTED|Overall Study||164
9032479|NCT03259555|10094718|FG000|Received At Least 1 Dose of Study Drug|Overall Study||158
9032480|NCT03259555|10094719|FG001|Received At Least 1 Dose of Study Drug|Overall Study||163
9032481|NCT03259555|10094718|FG000|COMPLETED|Overall Study||124
9032482|NCT03259555|10094719|FG001|COMPLETED|Overall Study||134
9032483|NCT03259555|10094718|FG000|NOT COMPLETED|Overall Study||34
9032484|NCT03259555|10094719|FG001|NOT COMPLETED|Overall Study||30
9032485|NCT03259789|10094728|FG000|STARTED|Overall Study||158
9032486|NCT03259789|10094729|FG001|STARTED|Overall Study||159
9032487|NCT03259789|10094730|FG002|STARTED|Overall Study||34
8917212|NCT02190591|9976906|FG001|STARTED|Overall Study||102
8917213|NCT02190591|9976905|FG000|COMPLETED|Overall Study||100
8917214|NCT02190591|9976906|FG001|COMPLETED|Overall Study||91
9032488|NCT03259789|10094728|FG000|COMPLETED|Overall Study||141
9032489|NCT03259789|10094729|FG001|COMPLETED|Overall Study||142
9032490|NCT03259789|10094730|FG002|COMPLETED|Overall Study||28
9032491|NCT03259789|10094728|FG000|NOT COMPLETED|Overall Study||17
9032492|NCT03259789|10094729|FG001|NOT COMPLETED|Overall Study||17
9032493|NCT03259789|10094730|FG002|NOT COMPLETED|Overall Study||6
8790583|NCT01383356|9841639|FG001|STARTED|Period 2|Entered and treated.|23
8790584|NCT01383356|9841638|FG000|COMPLETED|Period 2|Completed period 2.|21
8790585|NCT01383356|9841639|FG001|COMPLETED|Period 2|Completed period 2.|23
8790586|NCT01383356|9841638|FG000|NOT COMPLETED|Period 2||0
8790587|NCT01383356|9841639|FG001|NOT COMPLETED|Period 2||0
8790588|NCT01383421|9841645|FG000|STARTED|Overall Study|ITT population: all enrolled participants who received at least 1 dose of study drug.|1025
8790589|NCT01383421|9841645|FG000|COMPLETED|Overall Study||679
8790590|NCT01383421|9841645|FG000|NOT COMPLETED|Overall Study||346
8790591|NCT01383486|9841653|FG000|STARTED|Overall Study|Number of participants who were provided with investigational products|253
8790592|NCT01383486|9841653|FG000|Treated|Overall Study|Number of participants who took any study medication (Safety Population)|237
8790593|NCT01383486|9841653|FG000|COMPLETED|Overall Study|Took any study medication and gave estimated duration of pain (Selection Evaluation Population)|235
8790594|NCT01383486|9841653|FG000|NOT COMPLETED|Overall Study||18
8790595|NCT01383499|9841658|FG000|STARTED|Period 1 (4 Weeks)||27
8790596|NCT01383499|9841659|FG001|STARTED|Period 1 (4 Weeks)||24
8790597|NCT01383499|9841660|FG002|STARTED|Period 1 (4 Weeks)||25
8790598|NCT01383499|9841661|FG003|STARTED|Period 1 (4 Weeks)||25
8790599|NCT01383499|9841658|FG000|COMPLETED|Period 1 (4 Weeks)||26
8790600|NCT01383499|9841659|FG001|COMPLETED|Period 1 (4 Weeks)||24
8790601|NCT01383499|9841660|FG002|COMPLETED|Period 1 (4 Weeks)||25
8790602|NCT01383499|9841661|FG003|COMPLETED|Period 1 (4 Weeks)||25
8790603|NCT01383499|9841658|FG000|NOT COMPLETED|Period 1 (4 Weeks)||1
8790604|NCT01383499|9841659|FG001|NOT COMPLETED|Period 1 (4 Weeks)||0
8790605|NCT01383499|9841660|FG002|NOT COMPLETED|Period 1 (4 Weeks)||0
8790606|NCT01383499|9841661|FG003|NOT COMPLETED|Period 1 (4 Weeks)||0
8790607|NCT01383499|9841658|FG000|STARTED|Period 2 (4 Weeks)||26
8790608|NCT01383499|9841659|FG001|STARTED|Period 2 (4 Weeks)||24
8790609|NCT01383499|9841660|FG002|STARTED|Period 2 (4 Weeks)||25
8790610|NCT01383499|9841661|FG003|STARTED|Period 2 (4 Weeks)||25
8790611|NCT01383499|9841658|FG000|COMPLETED|Period 2 (4 Weeks)||26
8790612|NCT01383499|9841659|FG001|COMPLETED|Period 2 (4 Weeks)||24
8790613|NCT01383499|9841660|FG002|COMPLETED|Period 2 (4 Weeks)||25
8790614|NCT01383499|9841661|FG003|COMPLETED|Period 2 (4 Weeks)||25
8790615|NCT01383499|9841658|FG000|NOT COMPLETED|Period 2 (4 Weeks)||0
8790616|NCT01383499|9841659|FG001|NOT COMPLETED|Period 2 (4 Weeks)||0
8790617|NCT01383499|9841660|FG002|NOT COMPLETED|Period 2 (4 Weeks)||0
8790618|NCT01383499|9841661|FG003|NOT COMPLETED|Period 2 (4 Weeks)||0
8790619|NCT01383499|9841658|FG000|STARTED|Period 3 (4 Weeks)||26
8790620|NCT01383499|9841659|FG001|STARTED|Period 3 (4 Weeks)||24
8790621|NCT01383499|9841660|FG002|STARTED|Period 3 (4 Weeks)||25
8790622|NCT01383499|9841661|FG003|STARTED|Period 3 (4 Weeks)||25
8790623|NCT01383499|9841658|FG000|COMPLETED|Period 3 (4 Weeks)||26
8790624|NCT01383499|9841659|FG001|COMPLETED|Period 3 (4 Weeks)||24
8790625|NCT01383499|9841660|FG002|COMPLETED|Period 3 (4 Weeks)||25
8790626|NCT01383499|9841661|FG003|COMPLETED|Period 3 (4 Weeks)||25
8790627|NCT01383499|9841658|FG000|NOT COMPLETED|Period 3 (4 Weeks)||0
8790628|NCT01383499|9841659|FG001|NOT COMPLETED|Period 3 (4 Weeks)||0
8790629|NCT01383499|9841660|FG002|NOT COMPLETED|Period 3 (4 Weeks)||0
8790630|NCT01383499|9841661|FG003|NOT COMPLETED|Period 3 (4 Weeks)||0
8790631|NCT01383616|9841676|FG000|STARTED|Overall Study||40
8790632|NCT01383616|9841677|FG001|STARTED|Overall Study||44
8790633|NCT01383616|9841676|FG000|COMPLETED|Overall Study||23
8790634|NCT01383616|9841677|FG001|COMPLETED|Overall Study||21
8790635|NCT01383616|9841676|FG000|NOT COMPLETED|Overall Study||17
8790636|NCT01383616|9841677|FG001|NOT COMPLETED|Overall Study||23
8790637|NCT01383707|9841687|FG000|STARTED|Overall Study||77
8790638|NCT01383707|9841687|FG000|COMPLETED|Overall Study||5
8790639|NCT01383707|9841687|FG000|NOT COMPLETED|Overall Study||72
8790640|NCT01383720|9841691|FG000|STARTED|Overall Study||11
8790641|NCT01383720|9841691|FG000|Primary Endpoint (Discharge/7 Days)|Overall Study||11
8790642|NCT01383720|9841691|FG000|COMPLETED|Overall Study|Study is continuing to 5 years. All patients are still in the study.|11
8790643|NCT01383720|9841691|FG000|NOT COMPLETED|Overall Study||0
8790644|NCT01383759|9841697|FG000|STARTED|Overall Study||19
8790645|NCT01383759|9841698|FG001|STARTED|Overall Study||1
8790646|NCT01383759|9841697|FG000|COMPLETED|Overall Study||19
8790647|NCT01383759|9841698|FG001|COMPLETED|Overall Study||1
8790648|NCT01383759|9841697|FG000|NOT COMPLETED|Overall Study||0
8790649|NCT01383759|9841698|FG001|NOT COMPLETED|Overall Study||0
8790650|NCT01383928|9841707|FG000|STARTED|Overall Study||7
8790651|NCT01383928|9841708|FG001|STARTED|Overall Study||7
8790652|NCT01383928|9841709|FG002|STARTED|Overall Study||50
8790653|NCT01383928|9841707|FG000|COMPLETED|Overall Study||2
8790654|NCT01383928|9841708|FG001|COMPLETED|Overall Study||0
8790655|NCT01383928|9841709|FG002|COMPLETED|Overall Study||10
8790656|NCT01383928|9841707|FG000|NOT COMPLETED|Overall Study||5
8790657|NCT01383928|9841708|FG001|NOT COMPLETED|Overall Study||7
8790658|NCT01383928|9841709|FG002|NOT COMPLETED|Overall Study||40
8790659|NCT01383954|9841719|FG000|STARTED|Overall Study||52
8790660|NCT01383954|9841719|FG000|Safety Population: Received Treatment|Overall Study||48
8790661|NCT01383954|9841719|FG000|COMPLETED|Overall Study||38
8790662|NCT01383954|9841719|FG000|NOT COMPLETED|Overall Study||14
8790663|NCT01383993|9841726|FG000|STARTED|Overall Study||15
8790664|NCT01383993|9841727|FG001|STARTED|Overall Study||4
8790665|NCT01383993|9841728|FG002|STARTED|Overall Study||2
8790666|NCT01383993|9841726|FG000|COMPLETED|Overall Study||12
8790667|NCT01383993|9841727|FG001|COMPLETED|Overall Study||3
8790668|NCT01383993|9841728|FG002|COMPLETED|Overall Study||1
8790669|NCT01383993|9841726|FG000|NOT COMPLETED|Overall Study||3
8790670|NCT01383993|9841727|FG001|NOT COMPLETED|Overall Study||1
8790671|NCT01383993|9841728|FG002|NOT COMPLETED|Overall Study||1
8790672|NCT01384019|9841739|FG000|STARTED|Overall Study||65
8790673|NCT01384019|9841740|FG001|STARTED|Overall Study||61
8790674|NCT01384019|9841739|FG000|COMPLETED|Overall Study||55
8790675|NCT01384019|9841740|FG001|COMPLETED|Overall Study||55
8790676|NCT01384019|9841739|FG000|NOT COMPLETED|Overall Study||10
8790677|NCT01384019|9841740|FG001|NOT COMPLETED|Overall Study||6
8790678|NCT01384292|9841749|FG000|STARTED|Part A||5
8790679|NCT01384292|9841750|FG001|STARTED|Part A||5
8790680|NCT01384292|9841751|FG002|STARTED|Part A||4
8790681|NCT01384292|9841749|FG000|COMPLETED|Part A||5
8790682|NCT01384292|9841750|FG001|COMPLETED|Part A||5
8790683|NCT01384292|9841751|FG002|COMPLETED|Part A||4
8790684|NCT01384292|9841749|FG000|NOT COMPLETED|Part A||0
8790685|NCT01384292|9841750|FG001|NOT COMPLETED|Part A||0
8790686|NCT01384292|9841751|FG002|NOT COMPLETED|Part A||0
8790687|NCT01384292|9841749|FG000|STARTED|Part B||3
8790688|NCT01384292|9841750|FG001|STARTED|Part B||6
8790689|NCT01384292|9841751|FG002|STARTED|Part B||0
8790690|NCT01384292|9841749|FG000|COMPLETED|Part B||2
8790691|NCT01384292|9841750|FG001|COMPLETED|Part B||6
8790692|NCT01384292|9841751|FG002|COMPLETED|Part B||0
8790693|NCT01384292|9841749|FG000|NOT COMPLETED|Part B||1
8790694|NCT01384292|9841750|FG001|NOT COMPLETED|Part B||0
8790695|NCT01384292|9841751|FG002|NOT COMPLETED|Part B||0
8790696|NCT01384539|9841763|FG000|STARTED|Overall Study||64
9032494|NCT03260205|10094744|FG000|STARTED|Overall Study||46
9032495|NCT03260205|10094745|FG001|STARTED|Overall Study||40
9032496|NCT03260205|10094746|FG002|STARTED|Overall Study||37
9032497|NCT03260205|10094747|FG003|STARTED|Overall Study||37
9032498|NCT03260205|10094748|FG004|STARTED|Overall Study||39
9032499|NCT03260205|10094744|FG000|Received Treatment|Overall Study||45
9032500|NCT03260205|10094745|FG001|Received Treatment|Overall Study||39
9032501|NCT03260205|10094746|FG002|Received Treatment|Overall Study||35
9032502|NCT03260205|10094747|FG003|Received Treatment|Overall Study||34
9032503|NCT03260205|10094748|FG004|Received Treatment|Overall Study||38
9032504|NCT03260205|10094744|FG000|COMPLETED|Overall Study||37
9032505|NCT03260205|10094745|FG001|COMPLETED|Overall Study||32
9032506|NCT03260205|10094746|FG002|COMPLETED|Overall Study||26
9032507|NCT03260205|10094747|FG003|COMPLETED|Overall Study||30
9032508|NCT03260205|10094748|FG004|COMPLETED|Overall Study||25
9032509|NCT03260205|10094744|FG000|NOT COMPLETED|Overall Study||9
9032510|NCT03260205|10094745|FG001|NOT COMPLETED|Overall Study||8
9032511|NCT03260205|10094746|FG002|NOT COMPLETED|Overall Study||11
9032512|NCT03260205|10094747|FG003|NOT COMPLETED|Overall Study||7
9032513|NCT03260205|10094748|FG004|NOT COMPLETED|Overall Study||14
9032514|NCT03260426|10094767|FG000|STARTED|Overall Study||50
9032515|NCT03260426|10094768|FG001|STARTED|Overall Study||50
9032516|NCT03260426|10094767|FG000|COMPLETED|Overall Study||50
9032517|NCT03260426|10094768|FG001|COMPLETED|Overall Study||50
9032518|NCT03260426|10094767|FG000|NOT COMPLETED|Overall Study||0
9032519|NCT03260426|10094768|FG001|NOT COMPLETED|Overall Study||0
9032520|NCT03260595|10094777|FG000|STARTED|Overall Study||20
9032521|NCT03260595|10094778|FG001|STARTED|Overall Study||10
9032522|NCT03260595|10094779|FG002|STARTED|Overall Study||2
9032523|NCT03260595|10094777|FG000|COMPLETED|Overall Study||20
9032524|NCT03260595|10094778|FG001|COMPLETED|Overall Study||10
9032525|NCT03260595|10094779|FG002|COMPLETED|Overall Study||2
9032526|NCT03260595|10094777|FG000|NOT COMPLETED|Overall Study||0
9032527|NCT03260595|10094778|FG001|NOT COMPLETED|Overall Study||0
9032528|NCT03260595|10094779|FG002|NOT COMPLETED|Overall Study||0
9032529|NCT03260699|10094789|FG000|STARTED|Overall Study||5
9032530|NCT03260699|10094790|FG001|STARTED|Overall Study||4
9032531|NCT03260699|10094789|FG000|COMPLETED|Overall Study||5
9032532|NCT03260699|10094790|FG001|COMPLETED|Overall Study||2
9032533|NCT03260699|10094789|FG000|NOT COMPLETED|Overall Study||0
9032534|NCT03260699|10094790|FG001|NOT COMPLETED|Overall Study||2
9032535|NCT03260790|10094798|FG000|STARTED|Overall Study||8
9032536|NCT03260790|10094799|FG001|STARTED|Overall Study||9
9032537|NCT03260790|10094798|FG000|COMPLETED|Overall Study||8
9032538|NCT03260790|10094799|FG001|COMPLETED|Overall Study||9
9032539|NCT03260790|10094798|FG000|NOT COMPLETED|Overall Study||0
9032540|NCT03260790|10094799|FG001|NOT COMPLETED|Overall Study||0
9032541|NCT03261037|10094809|FG000|STARTED|Overall Study||68
9032542|NCT03261037|10094810|FG001|STARTED|Overall Study||62
9032543|NCT03261037|10094811|FG002|STARTED|Overall Study||9
9032544|NCT03261037|10094812|FG003|STARTED|Overall Study||39
8790697|NCT01384539|9841764|FG001|STARTED|Overall Study||64
8790698|NCT01384539|9841763|FG000|COMPLETED|Overall Study||58
8790699|NCT01384539|9841764|FG001|COMPLETED|Overall Study||57
8790700|NCT01384539|9841763|FG000|NOT COMPLETED|Overall Study||6
8790701|NCT01384539|9841764|FG001|NOT COMPLETED|Overall Study||7
8790702|NCT01384591|9841773|FG000|STARTED|Overall Study||2
9032545|NCT03261037|10094809|FG000|COMPLETED|Overall Study||64
9032546|NCT03261037|10094810|FG001|COMPLETED|Overall Study||41
9032547|NCT03261037|10094811|FG002|COMPLETED|Overall Study||9
9032548|NCT03261037|10094812|FG003|COMPLETED|Overall Study||11
9032549|NCT03261037|10094809|FG000|NOT COMPLETED|Overall Study||4
9032550|NCT03261037|10094810|FG001|NOT COMPLETED|Overall Study||21
9032551|NCT03261037|10094811|FG002|NOT COMPLETED|Overall Study||0
9032552|NCT03261037|10094812|FG003|NOT COMPLETED|Overall Study||28
9032553|NCT03261167|10094825|FG000|STARTED|Double Blind(Treatment cyc1,Upto Week48)||63
8790703|NCT01384591|9841774|FG001|STARTED|Overall Study||2
8790704|NCT01384591|9841775|FG002|STARTED|Overall Study||2
8790705|NCT01384591|9841773|FG000|COMPLETED|Overall Study||2
8790706|NCT01384591|9841774|FG001|COMPLETED|Overall Study||2
8790707|NCT01384591|9841775|FG002|COMPLETED|Overall Study||2
8790708|NCT01384591|9841773|FG000|NOT COMPLETED|Overall Study||0
8790709|NCT01384591|9841774|FG001|NOT COMPLETED|Overall Study||0
8790710|NCT01384591|9841775|FG002|NOT COMPLETED|Overall Study||0
8790711|NCT01384734|9841788|FG000|STARTED|Overall Study||50
8790712|NCT01384734|9841789|FG001|STARTED|Overall Study||49
8790713|NCT01384734|9841790|FG002|STARTED|Overall Study||51
8790714|NCT01384734|9841791|FG003|STARTED|Overall Study||50
8790715|NCT01384734|9841792|FG004|STARTED|Overall Study||51
8790716|NCT01384734|9841788|FG000|COMPLETED|Overall Study||33
8790717|NCT01384734|9841789|FG001|COMPLETED|Overall Study||25
8790718|NCT01384734|9841790|FG002|COMPLETED|Overall Study||28
8790719|NCT01384734|9841791|FG003|COMPLETED|Overall Study||22
8790720|NCT01384734|9841792|FG004|COMPLETED|Overall Study||22
8790721|NCT01384734|9841788|FG000|NOT COMPLETED|Overall Study||17
8790722|NCT01384734|9841789|FG001|NOT COMPLETED|Overall Study||24
8790723|NCT01384734|9841790|FG002|NOT COMPLETED|Overall Study||23
8790724|NCT01384734|9841791|FG003|NOT COMPLETED|Overall Study||28
8790725|NCT01384734|9841792|FG004|NOT COMPLETED|Overall Study||29
8790726|NCT01384760|9841803|FG000|STARTED|Overall Study||61
8790727|NCT01384760|9841804|FG001|STARTED|Overall Study||43
8790728|NCT01384760|9841803|FG000|Randomized|Overall Study||61
8790729|NCT01384760|9841804|FG001|Randomized|Overall Study||43
8790730|NCT01384760|9841803|FG000|COMPLETED|Overall Study||45
8790731|NCT01384760|9841804|FG001|COMPLETED|Overall Study||37
8790732|NCT01384760|9841803|FG000|NOT COMPLETED|Overall Study||16
8790733|NCT01384760|9841804|FG001|NOT COMPLETED|Overall Study||6
8790734|NCT01384877|9841812|FG000|STARTED|Treatment 1||17
8790735|NCT01384877|9841813|FG001|STARTED|Treatment 1||15
8790736|NCT01384877|9841812|FG000|COMPLETED|Treatment 1||17
8790737|NCT01384877|9841813|FG001|COMPLETED|Treatment 1||15
8790738|NCT01384877|9841812|FG000|NOT COMPLETED|Treatment 1||0
8790739|NCT01384877|9841813|FG001|NOT COMPLETED|Treatment 1||0
8790740|NCT01384877|9841812|FG000|STARTED|Treatment 2|1 Patient died between treatment periods|16
8790741|NCT01384877|9841813|FG001|STARTED|Treatment 2|2 Patients died between treatment periods|13
8790742|NCT01384877|9841812|FG000|COMPLETED|Treatment 2||14
8790743|NCT01384877|9841813|FG001|COMPLETED|Treatment 2||11
8790744|NCT01384877|9841812|FG000|NOT COMPLETED|Treatment 2||2
8790745|NCT01384877|9841813|FG001|NOT COMPLETED|Treatment 2||2
8790746|NCT01385098|9841819|FG000|STARTED|Overall Study||37
8790747|NCT01385098|9841819|FG000|COMPLETED|Overall Study|14 subjects did not complete. 4 subjects loss to follow-up & 10 subjects could not tolerate suppl.|23
8790748|NCT01385098|9841819|FG000|NOT COMPLETED|Overall Study||14
8790749|NCT01385137|9841827|FG000|STARTED|Evaluable at Baseline||131
8790750|NCT01385137|9841828|FG001|STARTED|Evaluable at Baseline||131
8790751|NCT01385137|9841827|FG000|COMPLETED|Evaluable at Baseline||122
8790752|NCT01385137|9841828|FG001|COMPLETED|Evaluable at Baseline||127
8790753|NCT01385137|9841827|FG000|NOT COMPLETED|Evaluable at Baseline||9
8790754|NCT01385137|9841828|FG001|NOT COMPLETED|Evaluable at Baseline||4
8790755|NCT01385137|9841827|FG000|STARTED|Evaluable for Primary Endpoint||131
8790756|NCT01385137|9841828|FG001|STARTED|Evaluable for Primary Endpoint||131
8790757|NCT01385137|9841827|FG000|COMPLETED|Evaluable for Primary Endpoint||102
8790758|NCT01385137|9841828|FG001|COMPLETED|Evaluable for Primary Endpoint||107
8790759|NCT01385137|9841827|FG000|NOT COMPLETED|Evaluable for Primary Endpoint||29
8790760|NCT01385137|9841828|FG001|NOT COMPLETED|Evaluable for Primary Endpoint||24
8790761|NCT01385189|9841839|FG000|STARTED|Overall Study||12
8790762|NCT01385189|9841840|FG001|STARTED|Overall Study||12
8790763|NCT01385189|9841841|FG002|STARTED|Overall Study||4
8790764|NCT01385189|9841842|FG003|STARTED|Overall Study||4
8790765|NCT01385189|9841843|FG004|STARTED|Overall Study||8
8790766|NCT01385189|9841839|FG000|COMPLETED|Overall Study||11
8790767|NCT01385189|9841840|FG001|COMPLETED|Overall Study||11
8790768|NCT01385189|9841841|FG002|COMPLETED|Overall Study||4
8790769|NCT01385189|9841842|FG003|COMPLETED|Overall Study||3
8790770|NCT01385189|9841843|FG004|COMPLETED|Overall Study||6
8790771|NCT01385189|9841839|FG000|NOT COMPLETED|Overall Study||1
8790772|NCT01385189|9841840|FG001|NOT COMPLETED|Overall Study||1
8790773|NCT01385189|9841841|FG002|NOT COMPLETED|Overall Study||0
8790774|NCT01385189|9841842|FG003|NOT COMPLETED|Overall Study||1
8790775|NCT01385189|9841843|FG004|NOT COMPLETED|Overall Study||2
8790776|NCT01385202|9841862|FG000|STARTED|Overall Study|Per protocol, enrolled subjects were defined as those who signed inform consent form.|172
8790777|NCT01385202|9841862|FG000|Study Catheter Inserted|Overall Study||161
8790778|NCT01385202|9841862|FG000|Undergoing Ablation|Overall Study||160
8790779|NCT01385202|9841862|FG000|COMPLETED|Overall Study||154
8790780|NCT01385202|9841862|FG000|NOT COMPLETED|Overall Study||18
8790781|NCT01385293|9841868|FG000|STARTED|Overall Study||30
8790782|NCT01385293|9841868|FG000|COMPLETED|Overall Study||30
8790783|NCT01385293|9841868|FG000|NOT COMPLETED|Overall Study||0
8790784|NCT01385306|9841872|FG000|STARTED|Overall Study||6
8790785|NCT01385306|9841872|FG000|COMPLETED|Overall Study||6
8790786|NCT01385306|9841872|FG000|NOT COMPLETED|Overall Study||0
8790787|NCT01385371|9841878|FG000|STARTED|Overall Study||752
8790788|NCT01385371|9841879|FG001|STARTED|Overall Study||749
8790789|NCT01385371|9841878|FG000|COMPLETED|Overall Study||603
8790790|NCT01385371|9841879|FG001|COMPLETED|Overall Study||652
8790791|NCT01385371|9841878|FG000|NOT COMPLETED|Overall Study||149
8790792|NCT01385371|9841879|FG001|NOT COMPLETED|Overall Study||97
8790793|NCT01385566|9841891|FG000|STARTED|Overall Study||52
8790794|NCT01385566|9841892|FG001|STARTED|Overall Study||34
8790795|NCT01385566|9841893|FG002|STARTED|Overall Study||34
8790796|NCT01385566|9841894|FG003|STARTED|Overall Study||35
8790797|NCT01385566|9841895|FG004|STARTED|Overall Study||34
8790798|NCT01385566|9841896|FG005|STARTED|Overall Study||34
8790799|NCT01385566|9841891|FG000|COMPLETED|Overall Study||51
8790800|NCT01385566|9841892|FG001|COMPLETED|Overall Study||34
8790801|NCT01385566|9841893|FG002|COMPLETED|Overall Study||34
8790802|NCT01385566|9841894|FG003|COMPLETED|Overall Study||34
8790803|NCT01385566|9841895|FG004|COMPLETED|Overall Study||34
8790804|NCT01385566|9841896|FG005|COMPLETED|Overall Study||34
8790805|NCT01385566|9841891|FG000|NOT COMPLETED|Overall Study||1
8790806|NCT01385566|9841892|FG001|NOT COMPLETED|Overall Study||0
8790807|NCT01385566|9841893|FG002|NOT COMPLETED|Overall Study||0
8790808|NCT01385566|9841894|FG003|NOT COMPLETED|Overall Study||1
8790809|NCT01385566|9841895|FG004|NOT COMPLETED|Overall Study||0
8790810|NCT01385566|9841896|FG005|NOT COMPLETED|Overall Study||0
8790811|NCT01385579|9841914|FG000|STARTED|Overall Study||98
8790812|NCT01385579|9841915|FG001|STARTED|Overall Study||104
8790813|NCT01385579|9841914|FG000|COMPLETED|Overall Study||98
8790814|NCT01385579|9841915|FG001|COMPLETED|Overall Study||104
8790815|NCT01385579|9841914|FG000|NOT COMPLETED|Overall Study||0
8790816|NCT01385579|9841915|FG001|NOT COMPLETED|Overall Study||0
8790817|NCT01385644|9841923|FG000|STARTED|Overall Study||4
8790818|NCT01385644|9841924|FG001|STARTED|Overall Study||4
8790819|NCT01385644|9841923|FG000|COMPLETED|Overall Study||4
8790820|NCT01385644|9841924|FG001|COMPLETED|Overall Study||4
8790821|NCT01385644|9841923|FG000|NOT COMPLETED|Overall Study||0
8790822|NCT01385644|9841924|FG001|NOT COMPLETED|Overall Study||0
8790823|NCT01385696|9841930|FG000|STARTED|Overall Study||66
8790824|NCT01385696|9841931|FG001|STARTED|Overall Study|1 patient used Handihaler® once only, Genuair® zero times, & was excluded from the safety population|64
8790825|NCT01385696|9841930|FG000|COMPLETED|Overall Study||66
8790826|NCT01385696|9841931|FG001|COMPLETED|Overall Study||64
8790827|NCT01385696|9841930|FG000|NOT COMPLETED|Overall Study||0
8790828|NCT01385696|9841931|FG001|NOT COMPLETED|Overall Study||0
8790829|NCT01385748|9841941|FG000|STARTED|Overall Study||56
8790830|NCT01385748|9841942|FG001|STARTED|Overall Study||65
8790831|NCT01385748|9841943|FG002|STARTED|Overall Study||62
8790832|NCT01385748|9841941|FG000|COMPLETED|Overall Study||41
8790833|NCT01385748|9841942|FG001|COMPLETED|Overall Study||51
8790834|NCT01385748|9841943|FG002|COMPLETED|Overall Study||49
8790835|NCT01385748|9841941|FG000|NOT COMPLETED|Overall Study||15
8790836|NCT01385748|9841942|FG001|NOT COMPLETED|Overall Study||14
8790837|NCT01385748|9841943|FG002|NOT COMPLETED|Overall Study||13
8790838|NCT01385995|9841957|FG000|STARTED|Period 1, 2 Months||25
8790839|NCT01385995|9841958|FG001|STARTED|Period 1, 2 Months||25
8790840|NCT01385995|9841957|FG000|COMPLETED|Period 1, 2 Months||24
8790841|NCT01385995|9841958|FG001|COMPLETED|Period 1, 2 Months||25
8790842|NCT01385995|9841957|FG000|NOT COMPLETED|Period 1, 2 Months||1
8790843|NCT01385995|9841958|FG001|NOT COMPLETED|Period 1, 2 Months||0
8790844|NCT01385995|9841957|FG000|STARTED|Washout Period, 1 Month||24
8790845|NCT01385995|9841958|FG001|STARTED|Washout Period, 1 Month||25
8790846|NCT01385995|9841957|FG000|COMPLETED|Washout Period, 1 Month||24
8790847|NCT01385995|9841958|FG001|COMPLETED|Washout Period, 1 Month||25
8790848|NCT01385995|9841957|FG000|NOT COMPLETED|Washout Period, 1 Month||0
8790849|NCT01385995|9841958|FG001|NOT COMPLETED|Washout Period, 1 Month||0
8790850|NCT01385995|9841957|FG000|STARTED|Period 2, 2 Months||24
8790851|NCT01385995|9841958|FG001|STARTED|Period 2, 2 Months||25
8790852|NCT01385995|9841957|FG000|COMPLETED|Period 2, 2 Months||24
8790853|NCT01385995|9841958|FG001|COMPLETED|Period 2, 2 Months||25
8790854|NCT01385995|9841957|FG000|NOT COMPLETED|Period 2, 2 Months||0
8790855|NCT01385995|9841958|FG001|NOT COMPLETED|Period 2, 2 Months||0
8790856|NCT01386008|9841966|FG000|STARTED|Overall Study||20
8790857|NCT01386008|9841966|FG000|COMPLETED|Overall Study||0
8790858|NCT01386008|9841966|FG000|NOT COMPLETED|Overall Study||20
8790859|NCT01386528|9841970|FG000|STARTED|Overall Study||13
8790860|NCT01386528|9841970|FG000|COMPLETED|Overall Study||13
8790861|NCT01386528|9841970|FG000|NOT COMPLETED|Overall Study||0
8790862|NCT01386554|9841977|FG000|STARTED|Overall Study||4
8790863|NCT01386554|9841978|FG001|STARTED|Overall Study||35
8790864|NCT01386554|9841979|FG002|STARTED|Overall Study||21
8790865|NCT01386554|9841977|FG000|COMPLETED|Overall Study||1
8790866|NCT01386554|9841978|FG001|COMPLETED|Overall Study||26
8790867|NCT01386554|9841979|FG002|COMPLETED|Overall Study||15
8790868|NCT01386554|9841977|FG000|NOT COMPLETED|Overall Study||3
8790869|NCT01386554|9841978|FG001|NOT COMPLETED|Overall Study||9
8790870|NCT01386554|9841979|FG002|NOT COMPLETED|Overall Study||6
8790871|NCT01386606|9841993|FG000|STARTED|Overall Study||16
8790872|NCT01386606|9841994|FG001|STARTED|Overall Study||14
8790873|NCT01386606|9841995|FG002|STARTED|Overall Study||16
8790874|NCT01386606|9841996|FG003|STARTED|Overall Study||14
8790875|NCT01386606|9841993|FG000|COMPLETED|Overall Study||12
8790876|NCT01386606|9841994|FG001|COMPLETED|Overall Study||10
8790877|NCT01386606|9841995|FG002|COMPLETED|Overall Study||13
8790878|NCT01386606|9841996|FG003|COMPLETED|Overall Study||13
8790879|NCT01386606|9841993|FG000|NOT COMPLETED|Overall Study||4
8790880|NCT01386606|9841994|FG001|NOT COMPLETED|Overall Study||4
8790881|NCT01386606|9841995|FG002|NOT COMPLETED|Overall Study||3
8790882|NCT01386606|9841996|FG003|NOT COMPLETED|Overall Study||1
8790883|NCT01386632|9842012|FG000|STARTED|Overall Study||25
8790884|NCT01386632|9842013|FG001|STARTED|Overall Study||25
8790885|NCT01386632|9842012|FG000|COMPLETED|Overall Study||20
8790886|NCT01386632|9842013|FG001|COMPLETED|Overall Study||21
8790887|NCT01386632|9842012|FG000|NOT COMPLETED|Overall Study||5
8790888|NCT01386632|9842013|FG001|NOT COMPLETED|Overall Study||4
8790889|NCT01386645|9842022|FG000|STARTED|Overall Study||18
8790890|NCT01386645|9842023|FG001|STARTED|Overall Study||19
8790891|NCT01386645|9842024|FG002|STARTED|Overall Study||19
8790892|NCT01386645|9842022|FG000|COMPLETED|Overall Study||18
8790893|NCT01386645|9842023|FG001|COMPLETED|Overall Study||18
8790894|NCT01386645|9842024|FG002|COMPLETED|Overall Study||17
8790895|NCT01386645|9842022|FG000|NOT COMPLETED|Overall Study||0
8790896|NCT01386645|9842023|FG001|NOT COMPLETED|Overall Study||1
8790897|NCT01386645|9842024|FG002|NOT COMPLETED|Overall Study||2
8790898|NCT01386788|9842032|FG000|STARTED|Overall Study||102
8790899|NCT01386788|9842032|FG000|COMPLETED|Overall Study||100
8790900|NCT01386788|9842032|FG000|NOT COMPLETED|Overall Study||2
8790901|NCT01386944|9842036|FG000|STARTED|Overall Study||102
8790902|NCT01386944|9842036|FG000|COMPLETED|Overall Study||46
8790903|NCT01386944|9842036|FG000|NOT COMPLETED|Overall Study||56
8790904|NCT01386970|9842042|FG000|STARTED|Overall Study||20
8790905|NCT01386970|9842043|FG001|STARTED|Overall Study||23
8790906|NCT01386970|9842042|FG000|COMPLETED|Overall Study||16
8790907|NCT01386970|9842043|FG001|COMPLETED|Overall Study||21
8790908|NCT01386970|9842042|FG000|NOT COMPLETED|Overall Study||4
8790909|NCT01386970|9842043|FG001|NOT COMPLETED|Overall Study||2
8790910|NCT01386983|9842053|FG000|STARTED|Overall Study||264
8790911|NCT01386983|9842054|FG001|STARTED|Overall Study||68
8790912|NCT01386983|9842053|FG000|COMPLETED|Overall Study||264
8790913|NCT01386983|9842054|FG001|COMPLETED|Overall Study||68
8790914|NCT01386983|9842053|FG000|NOT COMPLETED|Overall Study||0
8790915|NCT01386983|9842054|FG001|NOT COMPLETED|Overall Study||0
8790916|NCT01387022|9842062|FG000|STARTED|Overall Study||29
8790917|NCT01387022|9842063|FG001|STARTED|Overall Study||30
8790918|NCT01387022|9842062|FG000|COMPLETED|Overall Study||28
8790919|NCT01387022|9842063|FG001|COMPLETED|Overall Study||26
8790920|NCT01387022|9842062|FG000|NOT COMPLETED|Overall Study||1
8790921|NCT01387022|9842063|FG001|NOT COMPLETED|Overall Study||4
8790922|NCT01387074|9842069|FG000|STARTED|Overall Study||108
8790923|NCT01387074|9842069|FG000|COMPLETED|Overall Study||100
8790924|NCT01387074|9842069|FG000|NOT COMPLETED|Overall Study||8
8790925|NCT01387139|9842075|FG000|STARTED|Overall Study||99
8790926|NCT01387139|9842076|FG001|STARTED|Overall Study||84
8790927|NCT01387139|9842075|FG000|COMPLETED|Overall Study||99
8790928|NCT01387139|9842076|FG001|COMPLETED|Overall Study||84
8790929|NCT01387139|9842075|FG000|NOT COMPLETED|Overall Study||0
8790930|NCT01387139|9842076|FG001|NOT COMPLETED|Overall Study||0
8790931|NCT01387178|9842084|FG000|STARTED|Overall Study||11582
8790932|NCT01387178|9842085|FG001|STARTED|Overall Study||10641
8790933|NCT01387178|9842084|FG000|COMPLETED|Overall Study||11582
8790934|NCT01387178|9842085|FG001|COMPLETED|Overall Study||10641
8790935|NCT01387178|9842084|FG000|NOT COMPLETED|Overall Study||0
8790936|NCT01387178|9842085|FG001|NOT COMPLETED|Overall Study||0
8790937|NCT01387230|9842095|FG000|STARTED|Overall Study||68
8790938|NCT01387230|9842096|FG001|STARTED|Overall Study||69
8790939|NCT01387230|9842097|FG002|STARTED|Overall Study||69
8790940|NCT01387230|9842095|FG000|COMPLETED|Overall Study||50
8790941|NCT01387230|9842096|FG001|COMPLETED|Overall Study||62
8790942|NCT01387230|9842097|FG002|COMPLETED|Overall Study||56
8790943|NCT01387230|9842095|FG000|NOT COMPLETED|Overall Study||18
8790944|NCT01387230|9842096|FG001|NOT COMPLETED|Overall Study||7
8790945|NCT01387230|9842097|FG002|NOT COMPLETED|Overall Study||13
8790946|NCT01387269|9842107|FG000|STARTED|Overall Study||323
8790947|NCT01387269|9842108|FG001|STARTED|Overall Study||161
8790948|NCT01387269|9842107|FG000|ITT Population|Overall Study||323
8790949|NCT01387269|9842108|FG001|ITT Population|Overall Study||161
8790950|NCT01387269|9842107|FG000|MITT Population|Overall Study||284
8790951|NCT01387269|9842108|FG001|MITT Population|Overall Study||141
8790952|NCT01387269|9842107|FG000|Safety Population|Overall Study||320
8790953|NCT01387269|9842108|FG001|Safety Population|Overall Study||161
8790954|NCT01387269|9842107|FG000|COMPLETED|Overall Study||231
8790955|NCT01387269|9842108|FG001|COMPLETED|Overall Study||121
8790956|NCT01387269|9842107|FG000|NOT COMPLETED|Overall Study||92
8790957|NCT01387269|9842108|FG001|NOT COMPLETED|Overall Study||40
8790958|NCT01387282|9842116|FG000|STARTED|Overall Study||330
8790959|NCT01387282|9842117|FG001|STARTED|Overall Study||165
8790960|NCT01387282|9842116|FG000|ITT Population|Overall Study||330
8790961|NCT01387282|9842117|FG001|ITT Population|Overall Study||165
8790962|NCT01387282|9842116|FG000|MITT Population|Overall Study||268
8790963|NCT01387282|9842117|FG001|MITT Population|Overall Study||136
8790964|NCT01387282|9842116|FG000|Safety Population|Overall Study||330
8790965|NCT01387282|9842117|FG001|Safety Population|Overall Study||161
8790966|NCT01387282|9842116|FG000|COMPLETED|Overall Study||233
8790967|NCT01387282|9842117|FG001|COMPLETED|Overall Study||118
8790968|NCT01387282|9842116|FG000|NOT COMPLETED|Overall Study||97
8790969|NCT01387282|9842117|FG001|NOT COMPLETED|Overall Study||47
8790970|NCT01387347|9842125|FG000|STARTED|Overall Study||36
8790971|NCT01387347|9842126|FG001|STARTED|Overall Study||36
8790972|NCT01387347|9842125|FG000|COMPLETED|Overall Study||34
8790973|NCT01387347|9842126|FG001|COMPLETED|Overall Study||35
8790974|NCT01387347|9842125|FG000|NOT COMPLETED|Overall Study||2
8790975|NCT01387347|9842126|FG001|NOT COMPLETED|Overall Study||1
8790976|NCT01387464|9842138|FG000|STARTED|Overall Study||30
8790977|NCT01387464|9842139|FG001|STARTED|Overall Study||30
8790978|NCT01387464|9842138|FG000|Safety Population|Overall Study||30
8790979|NCT01387464|9842139|FG001|Safety Population|Overall Study||29
8790980|NCT01387464|9842138|FG000|Per-Protocol Population|Overall Study|Safety subjects who completed surgery|29
8790981|NCT01387464|9842139|FG001|Per-Protocol Population|Overall Study||29
8790982|NCT01387464|9842138|FG000|COMPLETED|Overall Study||29
8790983|NCT01387464|9842139|FG001|COMPLETED|Overall Study||29
8790984|NCT01387464|9842138|FG000|NOT COMPLETED|Overall Study||1
8790985|NCT01387464|9842139|FG001|NOT COMPLETED|Overall Study||1
8790986|NCT01387516|9842149|FG000|STARTED|Overall Study||80
8790987|NCT01387516|9842150|FG001|STARTED|Overall Study||68
8790988|NCT01387516|9842151|FG002|STARTED|Overall Study||79
8790989|NCT01387516|9842152|FG003|STARTED|Overall Study||69
8790990|NCT01387516|9842149|FG000|COMPLETED|Overall Study||75
8790991|NCT01387516|9842150|FG001|COMPLETED|Overall Study||63
8790992|NCT01387516|9842151|FG002|COMPLETED|Overall Study||75
8790993|NCT01387516|9842152|FG003|COMPLETED|Overall Study||65
8790994|NCT01387516|9842149|FG000|NOT COMPLETED|Overall Study||5
8790995|NCT01387516|9842150|FG001|NOT COMPLETED|Overall Study||5
8790996|NCT01387516|9842151|FG002|NOT COMPLETED|Overall Study||4
8790997|NCT01387516|9842152|FG003|NOT COMPLETED|Overall Study||4
8790998|NCT01387542|9842162|FG000|STARTED|Overall Study||40
8790999|NCT01387542|9842162|FG000|Treated|Overall Study||38
8791000|NCT01387542|9842162|FG000|COMPLETED|Overall Study||32
8791001|NCT01387542|9842162|FG000|NOT COMPLETED|Overall Study||8
8791002|NCT01387581|9842169|FG000|STARTED|Overall Study||108
8791003|NCT01387581|9842170|FG001|STARTED|Overall Study||107
8791004|NCT01387581|9842171|FG002|STARTED|Overall Study||12
8791005|NCT01387581|9842169|FG000|COMPLETED|Overall Study||101
8791006|NCT01387581|9842170|FG001|COMPLETED|Overall Study||101
8791007|NCT01387581|9842171|FG002|COMPLETED|Overall Study||9
8791008|NCT01387581|9842169|FG000|NOT COMPLETED|Overall Study||7
8791009|NCT01387581|9842170|FG001|NOT COMPLETED|Overall Study||6
8791010|NCT01387581|9842171|FG002|NOT COMPLETED|Overall Study||3
8791011|NCT01387594|9842181|FG000|STARTED|Overall Study||10
8791012|NCT01387594|9842182|FG001|STARTED|Overall Study||39
8791013|NCT01387594|9842181|FG000|COMPLETED|Overall Study||10
8791014|NCT01387594|9842182|FG001|COMPLETED|Overall Study||36
8791015|NCT01387594|9842181|FG000|NOT COMPLETED|Overall Study||0
8791016|NCT01387594|9842182|FG001|NOT COMPLETED|Overall Study||3
8791017|NCT01387607|9842193|FG000|STARTED|Overall Study||173
8791018|NCT01387607|9842194|FG001|STARTED|Overall Study||170
8791019|NCT01387607|9842193|FG000|Received Treatment|Overall Study||170
8791020|NCT01387607|9842194|FG001|Received Treatment|Overall Study||164
8791021|NCT01387607|9842193|FG000|COMPLETED|Overall Study||122
8791022|NCT01387607|9842194|FG001|COMPLETED|Overall Study||125
8791023|NCT01387607|9842193|FG000|NOT COMPLETED|Overall Study||51
8791024|NCT01387607|9842194|FG001|NOT COMPLETED|Overall Study||45
8791025|NCT01387672|9842206|FG000|STARTED|Overall Study||39
8791026|NCT01387672|9842207|FG001|STARTED|Overall Study||38
8791027|NCT01387672|9842208|FG002|STARTED|Overall Study||38
8791028|NCT01387672|9842209|FG003|STARTED|Overall Study||39
8791029|NCT01387672|9842210|FG004|STARTED|Overall Study||38
8791030|NCT01387672|9842211|FG005|STARTED|Overall Study||37
8791031|NCT01387672|9842206|FG000|COMPLETED|Overall Study||32
8791032|NCT01387672|9842207|FG001|COMPLETED|Overall Study||31
8791033|NCT01387672|9842208|FG002|COMPLETED|Overall Study||33
8791034|NCT01387672|9842209|FG003|COMPLETED|Overall Study||35
8791035|NCT01387672|9842210|FG004|COMPLETED|Overall Study||34
8791036|NCT01387672|9842211|FG005|COMPLETED|Overall Study||37
8791037|NCT01387672|9842206|FG000|NOT COMPLETED|Overall Study||7
8791038|NCT01387672|9842207|FG001|NOT COMPLETED|Overall Study||7
8791039|NCT01387672|9842208|FG002|NOT COMPLETED|Overall Study||5
8791040|NCT01387672|9842209|FG003|NOT COMPLETED|Overall Study||4
8791041|NCT01387672|9842210|FG004|NOT COMPLETED|Overall Study||4
8791042|NCT01387672|9842211|FG005|NOT COMPLETED|Overall Study||0
8791043|NCT01387737|9842228|FG000|STARTED|Overall Study||584
8791044|NCT01387737|9842229|FG001|STARTED|Overall Study||715
8791045|NCT01387737|9842228|FG000|COMPLETED|Overall Study||532
8791046|NCT01387737|9842229|FG001|COMPLETED|Overall Study||641
8791047|NCT01387737|9842228|FG000|NOT COMPLETED|Overall Study||52
8791048|NCT01387737|9842229|FG001|NOT COMPLETED|Overall Study||74
8791049|NCT01387789|9842235|FG000|STARTED|Overall Study||71
8791050|NCT01387789|9842235|FG000|COMPLETED|Overall Study||63
8791051|NCT01387789|9842235|FG000|NOT COMPLETED|Overall Study||8
8791052|NCT01387815|9842241|FG000|STARTED|Overall Study||302
8791053|NCT01387815|9842242|FG001|STARTED|Overall Study||293
8791054|NCT01387815|9842241|FG000|COMPLETED|Overall Study||162
8791055|NCT01387815|9842242|FG001|COMPLETED|Overall Study||189
8791056|NCT01387815|9842241|FG000|NOT COMPLETED|Overall Study||140
8791057|NCT01387815|9842242|FG001|NOT COMPLETED|Overall Study||104
8791058|NCT01387932|9842250|FG000|STARTED|Randomized and Treated||118
8791059|NCT01387932|9842251|FG001|STARTED|Randomized and Treated||117
8791060|NCT01387932|9842250|FG000|COMPLETED|Randomized and Treated||111
8791061|NCT01387932|9842251|FG001|COMPLETED|Randomized and Treated||113
8791062|NCT01387932|9842250|FG000|NOT COMPLETED|Randomized and Treated||7
8791063|NCT01387932|9842251|FG001|NOT COMPLETED|Randomized and Treated||4
8791064|NCT01387932|9842250|FG000|STARTED|Completion of TACE Cycle||111
8791065|NCT01387932|9842251|FG001|STARTED|Completion of TACE Cycle||113
8791066|NCT01387932|9842250|FG000|COMPLETED|Completion of TACE Cycle||111
8791067|NCT01387932|9842251|FG001|COMPLETED|Completion of TACE Cycle||113
8791068|NCT01387932|9842250|FG000|NOT COMPLETED|Completion of TACE Cycle||0
8791069|NCT01387932|9842251|FG001|NOT COMPLETED|Completion of TACE Cycle||0
8791070|NCT01387932|9842250|FG000|STARTED|Survival Follow-up||111
8791071|NCT01387932|9842251|FG001|STARTED|Survival Follow-up||113
8791072|NCT01387932|9842250|FG000|COMPLETED|Survival Follow-up||27
8791073|NCT01387932|9842251|FG001|COMPLETED|Survival Follow-up||23
8791074|NCT01387932|9842250|FG000|NOT COMPLETED|Survival Follow-up||84
8791075|NCT01387932|9842251|FG001|NOT COMPLETED|Survival Follow-up||90
8791076|NCT01388166|9842259|FG000|STARTED|Overall Study||1253
8791077|NCT01388166|9842259|FG000|COMPLETED|Overall Study||1194
8791078|NCT01388166|9842259|FG000|NOT COMPLETED|Overall Study||59
8791079|NCT01388335|9842263|FG000|STARTED|Period 1||13
8791080|NCT01388335|9842263|FG000|Received at Least 1 Dose of Study Drug|Period 1||13
8791081|NCT01388335|9842263|FG000|COMPLETED|Period 1||12
8791082|NCT01388335|9842263|FG000|NOT COMPLETED|Period 1||1
8791083|NCT01388335|9842263|FG000|STARTED|Period 2||12
8791084|NCT01388335|9842263|FG000|Received at Least 1 Dose of Study Drug|Period 2||12
8791085|NCT01388335|9842263|FG000|COMPLETED|Period 2|Only 6 participants who completed Period 2 entered Safety Extension.|9
8791086|NCT01388335|9842263|FG000|NOT COMPLETED|Period 2||3
8791087|NCT01388335|9842263|FG000|STARTED|Safety Extension|Six completed Period 2 and 1 participant who discontinued Period 2 entered Safety Extension.|7
8791088|NCT01388335|9842263|FG000|COMPLETED|Safety Extension||0
8791089|NCT01388335|9842263|FG000|NOT COMPLETED|Safety Extension||7
8791090|NCT01388361|9842278|FG000|STARTED|Overall Study||236
8791091|NCT01388361|9842279|FG001|STARTED|Overall Study||88
8791092|NCT01388361|9842280|FG002|STARTED|Overall Study||89
8791093|NCT01388361|9842278|FG000|Exposed|Overall Study|Two subjects withdrew prior to exposure to IDeg during NN1250-3948|234
8791094|NCT01388361|9842279|FG001|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug.|87
8791095|NCT01388361|9842280|FG002|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial drug.|86
8791096|NCT01388361|9842278|FG000|COMPLETED|Overall Study||224
8791097|NCT01388361|9842279|FG001|COMPLETED|Overall Study||76
8791098|NCT01388361|9842280|FG002|COMPLETED|Overall Study||75
8791099|NCT01388361|9842278|FG000|NOT COMPLETED|Overall Study||12
8791100|NCT01388361|9842279|FG001|NOT COMPLETED|Overall Study||12
8791101|NCT01388361|9842280|FG002|NOT COMPLETED|Overall Study||14
8791102|NCT01388478|9842288|FG000|STARTED|Overall Study||20
8791103|NCT01388478|9842288|FG000|COMPLETED|Overall Study||15
8791104|NCT01388478|9842288|FG000|NOT COMPLETED|Overall Study||5
8791105|NCT01388530|9842292|FG000|STARTED|Overall Study||25
8791106|NCT01388530|9842292|FG000|COMPLETED|Overall Study||20
8791107|NCT01388530|9842292|FG000|NOT COMPLETED|Overall Study||5
8791108|NCT01388543|9842298|FG000|STARTED|Day 7, Primary End Point||15
8791109|NCT01388543|9842299|FG001|STARTED|Day 7, Primary End Point||16
8791110|NCT01388543|9842298|FG000|COMPLETED|Day 7, Primary End Point||15
8791111|NCT01388543|9842299|FG001|COMPLETED|Day 7, Primary End Point||16
8791112|NCT01388543|9842298|FG000|NOT COMPLETED|Day 7, Primary End Point||0
8791113|NCT01388543|9842299|FG001|NOT COMPLETED|Day 7, Primary End Point||0
8791114|NCT01388543|9842298|FG000|STARTED|Day 14||15
8791115|NCT01388543|9842299|FG001|STARTED|Day 14||16
8791116|NCT01388543|9842298|FG000|COMPLETED|Day 14||14
8791117|NCT01388543|9842299|FG001|COMPLETED|Day 14||12
8791118|NCT01388543|9842298|FG000|NOT COMPLETED|Day 14||1
8791119|NCT01388543|9842299|FG001|NOT COMPLETED|Day 14||4
8791120|NCT01388647|9842307|FG000|STARTED|Overall Study||6
8791121|NCT01388647|9842308|FG001|STARTED|Overall Study||6
8791122|NCT01388647|9842307|FG000|COMPLETED|Overall Study|one subject ended study treatment due to adverse events|5
8791123|NCT01388647|9842308|FG001|COMPLETED|Overall Study|two subjects ended study treatment due to adverse events|4
8791124|NCT01388647|9842307|FG000|NOT COMPLETED|Overall Study||1
8791125|NCT01388647|9842308|FG001|NOT COMPLETED|Overall Study||2
8791126|NCT01388777|9842315|FG000|STARTED|Overall Study||1
8791127|NCT01388777|9842315|FG000|Cryoablation|Overall Study||1
8791128|NCT01388777|9842315|FG000|COMPLETED|Overall Study||1
8791129|NCT01388777|9842315|FG000|NOT COMPLETED|Overall Study||0
8791130|NCT01388790|9842319|FG000|STARTED|Overall Study||40
8791131|NCT01388790|9842319|FG000|COMPLETED|Overall Study||32
8791132|NCT01388790|9842319|FG000|NOT COMPLETED|Overall Study||8
8791133|NCT01388816|9842327|FG000|STARTED|Overall Study||45
8791134|NCT01388816|9842328|FG001|STARTED|Overall Study||43
8791135|NCT01388816|9842329|FG002|STARTED|Overall Study||44
8791136|NCT01388816|9842330|FG003|STARTED|Overall Study||44
8791137|NCT01388816|9842327|FG000|COMPLETED|Overall Study||43
8791138|NCT01388816|9842328|FG001|COMPLETED|Overall Study||39
8791139|NCT01388816|9842329|FG002|COMPLETED|Overall Study||41
8791140|NCT01388816|9842330|FG003|COMPLETED|Overall Study||44
8791141|NCT01388816|9842327|FG000|NOT COMPLETED|Overall Study||2
8791142|NCT01388816|9842328|FG001|NOT COMPLETED|Overall Study||4
8791143|NCT01388816|9842329|FG002|NOT COMPLETED|Overall Study||3
8791144|NCT01388816|9842330|FG003|NOT COMPLETED|Overall Study||0
8791145|NCT01388907|9842345|FG000|STARTED|Overall Study||33
8791146|NCT01388907|9842346|FG001|STARTED|Overall Study||28
8791147|NCT01388907|9842345|FG000|COMPLETED|Overall Study||31
8791148|NCT01388907|9842346|FG001|COMPLETED|Overall Study||28
8791149|NCT01388907|9842345|FG000|NOT COMPLETED|Overall Study||2
8791150|NCT01388907|9842346|FG001|NOT COMPLETED|Overall Study||0
8791151|NCT01388946|9842356|FG000|STARTED|Overall Study||55
8791152|NCT01388946|9842357|FG001|STARTED|Overall Study||55
8791153|NCT01388946|9842356|FG000|COMPLETED|Overall Study||49
8791154|NCT01388946|9842357|FG001|COMPLETED|Overall Study||52
8791155|NCT01388946|9842356|FG000|NOT COMPLETED|Overall Study||6
8791156|NCT01388946|9842357|FG001|NOT COMPLETED|Overall Study||3
9032554|NCT03261167|10094826|FG001|STARTED|Double Blind(Treatment cyc1,Upto Week48)||61
9032555|NCT03261167|10094825|FG000|COMPLETED|Double Blind(Treatment cyc1,Upto Week48)||60
9032556|NCT03261167|10094826|FG001|COMPLETED|Double Blind(Treatment cyc1,Upto Week48)||57
9032557|NCT03261167|10094825|FG000|NOT COMPLETED|Double Blind(Treatment cyc1,Upto Week48)||3
9032558|NCT03261167|10094826|FG001|NOT COMPLETED|Double Blind(Treatment cyc1,Upto Week48)||4
9032559|NCT03261167|10094825|FG000|STARTED|Open-label(Treatment cycle2,Upto Week48)||60
9032560|NCT03261167|10094826|FG001|STARTED|Open-label(Treatment cycle2,Upto Week48)||57
9032561|NCT03261167|10094825|FG000|COMPLETED|Open-label(Treatment cycle2,Upto Week48)||58
9032562|NCT03261167|10094826|FG001|COMPLETED|Open-label(Treatment cycle2,Upto Week48)||57
9032563|NCT03261167|10094825|FG000|NOT COMPLETED|Open-label(Treatment cycle2,Upto Week48)||2
9032564|NCT03261167|10094826|FG001|NOT COMPLETED|Open-label(Treatment cycle2,Upto Week48)||0
9032565|NCT03261167|10094825|FG000|STARTED|Open-label(Treatment cycle3,Upto Week48)||55
9032566|NCT03261167|10094826|FG001|STARTED|Open-label(Treatment cycle3,Upto Week48)||56
9032567|NCT03261167|10094825|FG000|COMPLETED|Open-label(Treatment cycle3,Upto Week48)||54
9032568|NCT03261167|10094826|FG001|COMPLETED|Open-label(Treatment cycle3,Upto Week48)||55
9032569|NCT03261167|10094825|FG000|NOT COMPLETED|Open-label(Treatment cycle3,Upto Week48)||1
9032570|NCT03261167|10094826|FG001|NOT COMPLETED|Open-label(Treatment cycle3,Upto Week48)||1
9032571|NCT03261167|10094825|FG000|STARTED|Open-label(Treatment cycle4,Upto Week48)||43
9032572|NCT03261167|10094826|FG001|STARTED|Open-label(Treatment cycle4,Upto Week48)||40
9032573|NCT03261167|10094825|FG000|COMPLETED|Open-label(Treatment cycle4,Upto Week48)||43
9032574|NCT03261167|10094826|FG001|COMPLETED|Open-label(Treatment cycle4,Upto Week48)||40
9032575|NCT03261167|10094825|FG000|NOT COMPLETED|Open-label(Treatment cycle4,Upto Week48)||0
9032576|NCT03261167|10094826|FG001|NOT COMPLETED|Open-label(Treatment cycle4,Upto Week48)||0
9032577|NCT03261336|10094838|FG000|STARTED|Overall Study||1
9032578|NCT03261336|10094838|FG000|COMPLETED|Overall Study||0
9032579|NCT03261336|10094838|FG000|NOT COMPLETED|Overall Study||1
9032580|NCT03261947|10094847|FG000|STARTED|Overall Study||12
9032581|NCT03261947|10094848|FG001|STARTED|Overall Study||15
9032582|NCT03261947|10094849|FG002|STARTED|Overall Study||35
9032583|NCT03261947|10094850|FG003|STARTED|Overall Study||21
9032584|NCT03261947|10094851|FG004|STARTED|Overall Study||18
9032585|NCT03261947|10094847|FG000|COMPLETED|Overall Study||0
9032586|NCT03261947|10094848|FG001|COMPLETED|Overall Study||2
9032587|NCT03261947|10094849|FG002|COMPLETED|Overall Study||5
9032588|NCT03261947|10094850|FG003|COMPLETED|Overall Study||0
9032589|NCT03261947|10094851|FG004|COMPLETED|Overall Study||1
9032590|NCT03261947|10094847|FG000|NOT COMPLETED|Overall Study||12
9032591|NCT03261947|10094848|FG001|NOT COMPLETED|Overall Study||13
9032592|NCT03261947|10094849|FG002|NOT COMPLETED|Overall Study||30
9032593|NCT03261947|10094850|FG003|NOT COMPLETED|Overall Study||21
9032594|NCT03261947|10094851|FG004|NOT COMPLETED|Overall Study||17
9032595|NCT03261960|10094869|FG000|STARTED|Overall Study||190
9032596|NCT03261960|10094870|FG001|STARTED|Overall Study||199
9032597|NCT03261960|10094869|FG000|COMPLETED|Overall Study||176
9032598|NCT03261960|10094870|FG001|COMPLETED|Overall Study||185
9032599|NCT03261960|10094869|FG000|NOT COMPLETED|Overall Study||14
9032600|NCT03261960|10094870|FG001|NOT COMPLETED|Overall Study||14
9032601|NCT03261973|10094876|FG000|STARTED|Overall Study||47
9032602|NCT03261973|10094876|FG000|COMPLETED|Overall Study||43
9032603|NCT03261973|10094876|FG000|NOT COMPLETED|Overall Study||4
8791157|NCT01388985|9842365|FG000|STARTED|Overall Study|1 participant (from the 250 enrolled) did not receive any vaccination because of consent withdrawal.|249
8791158|NCT01388985|9842366|FG001|STARTED|Overall Study|1 participant (from the 250 enrolled) did not receive any vaccination because of consent withdrawal.|249
8791159|NCT01388985|9842365|FG000|Primary Vaccination Period|Overall Study||231
8791160|NCT01388985|9842366|FG001|Primary Vaccination Period|Overall Study||238
8791161|NCT01388985|9842365|FG000|COMPLETED|Overall Study|From those 200, 15 were excluded from the per protocol analysis.|200
8791162|NCT01388985|9842366|FG001|COMPLETED|Overall Study|From those 200, 28 were excluded from the per protocol analysis.|211
8791163|NCT01388985|9842365|FG000|NOT COMPLETED|Overall Study||49
8791164|NCT01388985|9842366|FG001|NOT COMPLETED|Overall Study||38
8791165|NCT01389076|9842372|FG000|STARTED|Overall Study||22
8791166|NCT01389076|9842372|FG000|COMPLETED|Overall Study||22
8791167|NCT01389076|9842372|FG000|NOT COMPLETED|Overall Study||0
8791168|NCT01389102|9842382|FG000|STARTED|Overall Study||75
8791169|NCT01389102|9842383|FG001|STARTED|Overall Study||76
8791170|NCT01389102|9842384|FG002|STARTED|Overall Study||77
8791171|NCT01389102|9842385|FG003|STARTED|Overall Study||76
8791172|NCT01389102|9842386|FG004|STARTED|Overall Study||74
8791173|NCT01389102|9842387|FG005|STARTED|Overall Study||76
8791174|NCT01389102|9842382|FG000|COMPLETED|Overall Study||57
8791175|NCT01389102|9842383|FG001|COMPLETED|Overall Study||64
8791176|NCT01389102|9842384|FG002|COMPLETED|Overall Study||58
8791177|NCT01389102|9842385|FG003|COMPLETED|Overall Study||69
8791178|NCT01389102|9842386|FG004|COMPLETED|Overall Study||61
8791179|NCT01389102|9842387|FG005|COMPLETED|Overall Study||68
8791180|NCT01389102|9842382|FG000|NOT COMPLETED|Overall Study||18
8791181|NCT01389102|9842383|FG001|NOT COMPLETED|Overall Study||12
8791182|NCT01389102|9842384|FG002|NOT COMPLETED|Overall Study||19
8791183|NCT01389102|9842385|FG003|NOT COMPLETED|Overall Study||7
8791184|NCT01389102|9842386|FG004|NOT COMPLETED|Overall Study||13
8791185|NCT01389102|9842387|FG005|NOT COMPLETED|Overall Study||8
8791186|NCT01389128|9842409|FG000|STARTED|Overall Study||40
8791187|NCT01389128|9842410|FG001|STARTED|Overall Study||40
8791188|NCT01389128|9842409|FG000|COMPLETED|Overall Study||35
8791189|NCT01389128|9842410|FG001|COMPLETED|Overall Study||34
8791190|NCT01389128|9842409|FG000|NOT COMPLETED|Overall Study||5
8791191|NCT01389128|9842410|FG001|NOT COMPLETED|Overall Study||6
8791192|NCT01389232|9842420|FG000|STARTED|Overall Study||100
8791193|NCT01389232|9842420|FG000|COMPLETED|Overall Study||81
8791194|NCT01389232|9842420|FG000|NOT COMPLETED|Overall Study||19
8791195|NCT01389245|9842434|FG000|STARTED|Overall Study||42
8791196|NCT01389245|9842434|FG000|COMPLETED|Overall Study||27
8791197|NCT01389245|9842434|FG000|NOT COMPLETED|Overall Study||15
8791198|NCT01389258|9842438|FG000|STARTED|Overall Study||45
8791199|NCT01389258|9842438|FG000|COMPLETED|Overall Study||40
8791200|NCT01389258|9842438|FG000|NOT COMPLETED|Overall Study||5
8791201|NCT01389284|9842445|FG000|STARTED|Overall Study||120
8791202|NCT01389284|9842446|FG001|STARTED|Overall Study||120
8791203|NCT01389284|9842447|FG002|STARTED|Overall Study||60
8791204|NCT01389284|9842445|FG000|COMPLETED|Overall Study||120
8791205|NCT01389284|9842446|FG001|COMPLETED|Overall Study||120
8791206|NCT01389284|9842447|FG002|COMPLETED|Overall Study||60
8791207|NCT01389284|9842445|FG000|NOT COMPLETED|Overall Study||0
8791208|NCT01389284|9842446|FG001|NOT COMPLETED|Overall Study||0
8791209|NCT01389284|9842447|FG002|NOT COMPLETED|Overall Study||0
8791210|NCT01389323|9842455|FG000|STARTED|Treatment Period (up to 48 Weeks)||246
8791211|NCT01389323|9842455|FG000|COMPLETED|Treatment Period (up to 48 Weeks)||151
8791212|NCT01389323|9842455|FG000|NOT COMPLETED|Treatment Period (up to 48 Weeks)||95
8791213|NCT01389323|9842455|FG000|STARTED|Follow-up Period (up to 48 Weeks)|Out of 246 participants who entered the treatment period, 221 continued in the follow-up period.|221
8791214|NCT01389323|9842455|FG000|COMPLETED|Follow-up Period (up to 48 Weeks)||184
8791215|NCT01389323|9842455|FG000|NOT COMPLETED|Follow-up Period (up to 48 Weeks)||37
8791216|NCT01389596|9842469|FG000|STARTED|Overall Study||104
8791217|NCT01389596|9842470|FG001|STARTED|Overall Study||97
8791218|NCT01389596|9842471|FG002|STARTED|Overall Study||94
8791219|NCT01389596|9842469|FG000|COMPLETED|Overall Study||94
8791220|NCT01389596|9842470|FG001|COMPLETED|Overall Study||81
8791221|NCT01389596|9842471|FG002|COMPLETED|Overall Study||84
8791222|NCT01389596|9842469|FG000|NOT COMPLETED|Overall Study||10
8791223|NCT01389596|9842470|FG001|NOT COMPLETED|Overall Study||16
8791224|NCT01389596|9842471|FG002|NOT COMPLETED|Overall Study||10
8791225|NCT01389752|9842479|FG000|STARTED|Study Period 1||11
8791226|NCT01389752|9842480|FG001|STARTED|Study Period 1||11
9032604|NCT03261999|10094880|FG000|STARTED|Overall Study||144
9032605|NCT03261999|10094880|FG000|ITT|Overall Study||144
9032606|NCT03261999|10094880|FG000|PP|Overall Study||132
9032607|NCT03261999|10094880|FG000|COMPLETED|Overall Study||129
9032608|NCT03261999|10094880|FG000|NOT COMPLETED|Overall Study||15
9032609|NCT03262012|10094888|FG000|STARTED|Overall Study||139
9032610|NCT03262012|10094889|FG001|STARTED|Overall Study||138
9032611|NCT03262012|10094890|FG002|STARTED|Overall Study||70
9032612|NCT03262012|10094891|FG003|STARTED|Overall Study||69
9032613|NCT03262012|10094888|FG000|COMPLETED|Overall Study||112
9032614|NCT03262012|10094889|FG001|COMPLETED|Overall Study||102
8791227|NCT01389752|9842479|FG000|COMPLETED|Study Period 1||11
8791228|NCT01389752|9842480|FG001|COMPLETED|Study Period 1||9
8791229|NCT01389752|9842479|FG000|NOT COMPLETED|Study Period 1||0
9032615|NCT03262012|10094890|FG002|COMPLETED|Overall Study||56
9032616|NCT03262012|10094891|FG003|COMPLETED|Overall Study||54
8791230|NCT01389752|9842480|FG001|NOT COMPLETED|Study Period 1||2
8791231|NCT01389752|9842479|FG000|STARTED|Study Period 2||11
8791232|NCT01389752|9842480|FG001|STARTED|Study Period 2||9
8791233|NCT01389752|9842479|FG000|COMPLETED|Study Period 2||10
8791234|NCT01389752|9842480|FG001|COMPLETED|Study Period 2||9
8791235|NCT01389752|9842479|FG000|NOT COMPLETED|Study Period 2||1
8791236|NCT01389752|9842480|FG001|NOT COMPLETED|Study Period 2||0
8791237|NCT01389765|9842487|FG000|STARTED|First Intervention (Day 1)||12
8791238|NCT01389765|9842488|FG001|STARTED|First Intervention (Day 1)||12
8791239|NCT01389765|9842487|FG000|COMPLETED|First Intervention (Day 1)||12
8791240|NCT01389765|9842488|FG001|COMPLETED|First Intervention (Day 1)||12
8791241|NCT01389765|9842487|FG000|NOT COMPLETED|First Intervention (Day 1)||0
8791242|NCT01389765|9842488|FG001|NOT COMPLETED|First Intervention (Day 1)||0
8791243|NCT01389765|9842487|FG000|STARTED|Washout Period (7 Days)||12
8791244|NCT01389765|9842488|FG001|STARTED|Washout Period (7 Days)||12
8791245|NCT01389765|9842487|FG000|COMPLETED|Washout Period (7 Days)||12
8791246|NCT01389765|9842488|FG001|COMPLETED|Washout Period (7 Days)||12
8791247|NCT01389765|9842487|FG000|NOT COMPLETED|Washout Period (7 Days)||0
8791248|NCT01389765|9842488|FG001|NOT COMPLETED|Washout Period (7 Days)||0
8791249|NCT01389765|9842487|FG000|STARTED|Second Intervention (Day 1)||12
8791250|NCT01389765|9842488|FG001|STARTED|Second Intervention (Day 1)||12
8791251|NCT01389765|9842487|FG000|COMPLETED|Second Intervention (Day 1)||12
8791252|NCT01389765|9842488|FG001|COMPLETED|Second Intervention (Day 1)||12
8791253|NCT01389765|9842487|FG000|NOT COMPLETED|Second Intervention (Day 1)||0
8791254|NCT01389765|9842488|FG001|NOT COMPLETED|Second Intervention (Day 1)||0
8791255|NCT01389856|9842496|FG000|STARTED|Overall Study|Randomized and treated. An additional 2 patients were randomized but not treated.|13
8791256|NCT01389856|9842497|FG001|STARTED|Overall Study|Randomized and treated.|8
8791257|NCT01389856|9842496|FG000|COMPLETED|Overall Study||13
8791258|NCT01389856|9842497|FG001|COMPLETED|Overall Study||8
8791259|NCT01389856|9842496|FG000|NOT COMPLETED|Overall Study||0
8791260|NCT01389856|9842497|FG001|NOT COMPLETED|Overall Study||0
8791261|NCT01389882|9842505|FG000|STARTED|Overall Study||13
8791262|NCT01389882|9842506|FG001|STARTED|Overall Study||11
8791263|NCT01389882|9842505|FG000|COMPLETED|Overall Study||12
8791264|NCT01389882|9842506|FG001|COMPLETED|Overall Study||7
8791265|NCT01389882|9842505|FG000|NOT COMPLETED|Overall Study||1
8791266|NCT01389882|9842506|FG001|NOT COMPLETED|Overall Study||4
8791267|NCT01389973|9842512|FG000|STARTED|Overall Study||20
8791268|NCT01389973|9842512|FG000|COMPLETED|Overall Study||0
8791269|NCT01389973|9842512|FG000|NOT COMPLETED|Overall Study||20
8791270|NCT01390038|9842516|FG000|STARTED|Overall Study||157
8791271|NCT01390038|9842516|FG000|COMPLETED|Overall Study||149
8791272|NCT01390038|9842516|FG000|NOT COMPLETED|Overall Study||8
8791273|NCT01390064|9842522|FG000|STARTED|Overall Study||3
8791274|NCT01390064|9842523|FG001|STARTED|Overall Study||3
8791275|NCT01390064|9842522|FG000|COMPLETED|Overall Study||3
8791276|NCT01390064|9842523|FG001|COMPLETED|Overall Study||3
8791277|NCT01390064|9842522|FG000|NOT COMPLETED|Overall Study||0
8791278|NCT01390064|9842523|FG001|NOT COMPLETED|Overall Study||0
8791279|NCT01390077|9842529|FG000|STARTED|Overall Study||8
8791280|NCT01390077|9842529|FG000|Treatment|Overall Study||7
8791281|NCT01390077|9842529|FG000|COMPLETED|Overall Study||7
8791282|NCT01390077|9842529|FG000|NOT COMPLETED|Overall Study||1
8791283|NCT01390220|9842538|FG000|STARTED|Test Dose Phase||292
8791284|NCT01390220|9842539|FG001|STARTED|Test Dose Phase|This arm not applicable in TDP.|0
8791285|NCT01390220|9842540|FG002|STARTED|Test Dose Phase|This arm not applicable in TDP.|0
8791286|NCT01390220|9842538|FG000|COMPLETED|Test Dose Phase||201
8791287|NCT01390220|9842539|FG001|COMPLETED|Test Dose Phase||0
8791288|NCT01390220|9842540|FG002|COMPLETED|Test Dose Phase||0
8791289|NCT01390220|9842538|FG000|NOT COMPLETED|Test Dose Phase||91
8791290|NCT01390220|9842539|FG001|NOT COMPLETED|Test Dose Phase||0
8791291|NCT01390220|9842540|FG002|NOT COMPLETED|Test Dose Phase||0
8791292|NCT01390220|9842538|FG000|STARTED|Comparative Phase|This arm not applicable in CP|0
8791293|NCT01390220|9842539|FG001|STARTED|Comparative Phase||134
8791294|NCT01390220|9842540|FG002|STARTED|Comparative Phase||67
8791295|NCT01390220|9842538|FG000|COMPLETED|Comparative Phase|This arm not applicable in CP|0
8791296|NCT01390220|9842539|FG001|COMPLETED|Comparative Phase||133
8791297|NCT01390220|9842540|FG002|COMPLETED|Comparative Phase||67
8791298|NCT01390220|9842538|FG000|NOT COMPLETED|Comparative Phase||0
8791299|NCT01390220|9842539|FG001|NOT COMPLETED|Comparative Phase||1
8791300|NCT01390220|9842540|FG002|NOT COMPLETED|Comparative Phase||0
8791301|NCT01390233|9842552|FG000|STARTED|Overall Study||35
8791302|NCT01390233|9842553|FG001|STARTED|Overall Study||31
8791303|NCT01390233|9842554|FG002|STARTED|Overall Study||36
8791304|NCT01390233|9842552|FG000|COMPLETED|Overall Study||30
8791305|NCT01390233|9842553|FG001|COMPLETED|Overall Study||29
8791306|NCT01390233|9842554|FG002|COMPLETED|Overall Study||30
8791307|NCT01390233|9842552|FG000|NOT COMPLETED|Overall Study||5
8791308|NCT01390233|9842553|FG001|NOT COMPLETED|Overall Study||2
8791309|NCT01390233|9842554|FG002|NOT COMPLETED|Overall Study||6
8791310|NCT01390246|9842564|FG000|STARTED|Overall Study||30
8791311|NCT01390246|9842565|FG001|STARTED|Overall Study||35
8791312|NCT01390246|9842564|FG000|Visit 2: Quit Day|Overall Study||24
8791313|NCT01390246|9842565|FG001|Visit 2: Quit Day|Overall Study||24
8791314|NCT01390246|9842564|FG000|Visit 6: End of Treatment|Overall Study||15
8791315|NCT01390246|9842565|FG001|Visit 6: End of Treatment|Overall Study||15
8791316|NCT01390246|9842564|FG000|Visit 7: 36-38 Weeks Gestation|Overall Study||10
8791317|NCT01390246|9842565|FG001|Visit 7: 36-38 Weeks Gestation|Overall Study||10
8791318|NCT01390246|9842564|FG000|COMPLETED|Overall Study||10
8791319|NCT01390246|9842565|FG001|COMPLETED|Overall Study||10
8791320|NCT01390246|9842564|FG000|NOT COMPLETED|Overall Study||20
8791321|NCT01390246|9842565|FG001|NOT COMPLETED|Overall Study||25
8791322|NCT01390259|9842571|FG000|STARTED|Overall Study||5
8791323|NCT01390259|9842572|FG001|STARTED|Overall Study||6
8791324|NCT01390259|9842571|FG000|COMPLETED|Overall Study||5
8791325|NCT01390259|9842572|FG001|COMPLETED|Overall Study||6
8791326|NCT01390259|9842571|FG000|NOT COMPLETED|Overall Study||0
8791327|NCT01390259|9842572|FG001|NOT COMPLETED|Overall Study||0
8791328|NCT01390272|9842579|FG000|STARTED|Overall Study||192
8791329|NCT01390272|9842580|FG001|STARTED|Overall Study||193
8791330|NCT01390272|9842579|FG000|6 Month Follow up|Overall Study|30 of 192 participants in the Titration Intervention group had missing blood pressure measurement|162
8791331|NCT01390272|9842580|FG001|6 Month Follow up|Overall Study|22 of 193 in the LPN control group had missing blood pressure measurement|171
8791332|NCT01390272|9842579|FG000|12 Month Follow up|Overall Study|53 of 192 participants in the Titration Intervention group had missing measurement|139
8791333|NCT01390272|9842580|FG001|12 Month Follow up|Overall Study|34 of 193 in the LPN control group had missing blood pressure measurement|159
8791334|NCT01390272|9842579|FG000|18 Month Follow up|Overall Study|37 of 192 participants in the Titration Intervention group had missing blood pressure measurement|155
8791335|NCT01390272|9842580|FG001|18 Month Follow up|Overall Study|33 of 193 in the LPN control group had missing blood pressure measurement|160
8791336|NCT01390272|9842579|FG000|COMPLETED|Overall Study||175
8791337|NCT01390272|9842580|FG001|COMPLETED|Overall Study||178
8791338|NCT01390272|9842579|FG000|NOT COMPLETED|Overall Study||17
8791339|NCT01390272|9842580|FG001|NOT COMPLETED|Overall Study||15
8791340|NCT01390298|9842586|FG000|STARTED|Overall Study||55
8791341|NCT01390298|9842586|FG000|COMPLETED|Overall Study||31
8791342|NCT01390298|9842586|FG000|NOT COMPLETED|Overall Study||24
8791343|NCT01390389|9842592|FG000|STARTED|Overall Study||10
8791344|NCT01390389|9842593|FG001|STARTED|Overall Study||9
8791345|NCT01390389|9842592|FG000|COMPLETED|Overall Study||6
8791346|NCT01390389|9842593|FG001|COMPLETED|Overall Study||8
8791347|NCT01390389|9842592|FG000|NOT COMPLETED|Overall Study||4
8791348|NCT01390389|9842593|FG001|NOT COMPLETED|Overall Study||1
8791349|NCT01390402|9842603|FG000|STARTED|Overall Study||6
8791350|NCT01390402|9842603|FG000|COMPLETED|Overall Study||1
8791351|NCT01390402|9842603|FG000|NOT COMPLETED|Overall Study||5
8791352|NCT01390428|9842613|FG000|STARTED|Overall Study||8
8791353|NCT01390428|9842614|FG001|STARTED|Overall Study||8
8791354|NCT01390428|9842615|FG002|STARTED|Overall Study||9
8791355|NCT01390428|9842616|FG003|STARTED|Overall Study||9
8791356|NCT01390428|9842617|FG004|STARTED|Overall Study||8
8791357|NCT01390428|9842618|FG005|STARTED|Overall Study||8
8791358|NCT01390428|9842613|FG000|COMPLETED|Overall Study||8
8791359|NCT01390428|9842614|FG001|COMPLETED|Overall Study||8
8791360|NCT01390428|9842615|FG002|COMPLETED|Overall Study||8
8791361|NCT01390428|9842616|FG003|COMPLETED|Overall Study||9
8791362|NCT01390428|9842617|FG004|COMPLETED|Overall Study||7
8791363|NCT01390428|9842618|FG005|COMPLETED|Overall Study||8
8791364|NCT01390428|9842613|FG000|NOT COMPLETED|Overall Study||0
8791365|NCT01390428|9842614|FG001|NOT COMPLETED|Overall Study||0
8791366|NCT01390428|9842615|FG002|NOT COMPLETED|Overall Study||1
8791367|NCT01390428|9842616|FG003|NOT COMPLETED|Overall Study||0
8791368|NCT01390428|9842617|FG004|NOT COMPLETED|Overall Study||1
8791369|NCT01390428|9842618|FG005|NOT COMPLETED|Overall Study||0
8791370|NCT01390441|9842637|FG000|STARTED|Treatment Period||23
8791371|NCT01390441|9842638|FG001|STARTED|Treatment Period||22
8791372|NCT01390441|9842639|FG002|STARTED|Treatment Period||18
8791373|NCT01390441|9842640|FG003|STARTED|Treatment Period||19
8791374|NCT01390441|9842641|FG004|STARTED|Treatment Period||18
8791375|NCT01390441|9842637|FG000|COMPLETED|Treatment Period||22
8791376|NCT01390441|9842638|FG001|COMPLETED|Treatment Period||21
8791377|NCT01390441|9842639|FG002|COMPLETED|Treatment Period||8
8791378|NCT01390441|9842640|FG003|COMPLETED|Treatment Period||6
8791379|NCT01390441|9842641|FG004|COMPLETED|Treatment Period||7
8791380|NCT01390441|9842637|FG000|NOT COMPLETED|Treatment Period||1
8791381|NCT01390441|9842638|FG001|NOT COMPLETED|Treatment Period||1
8791382|NCT01390441|9842639|FG002|NOT COMPLETED|Treatment Period||10
8791383|NCT01390441|9842640|FG003|NOT COMPLETED|Treatment Period||13
8791384|NCT01390441|9842641|FG004|NOT COMPLETED|Treatment Period||11
8791385|NCT01390441|9842637|FG000|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|15
8791386|NCT01390441|9842638|FG001|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|13
8791387|NCT01390441|9842639|FG002|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|1
8791388|NCT01390441|9842640|FG003|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|1
8791389|NCT01390441|9842641|FG004|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|3
8791390|NCT01390441|9842637|FG000|COMPLETED|Extension Period||12
8791391|NCT01390441|9842638|FG001|COMPLETED|Extension Period||12
8791392|NCT01390441|9842639|FG002|COMPLETED|Extension Period||1
8791393|NCT01390441|9842640|FG003|COMPLETED|Extension Period||0
8791394|NCT01390441|9842641|FG004|COMPLETED|Extension Period||3
8791395|NCT01390441|9842637|FG000|NOT COMPLETED|Extension Period||3
8791396|NCT01390441|9842638|FG001|NOT COMPLETED|Extension Period||1
8791397|NCT01390441|9842639|FG002|NOT COMPLETED|Extension Period||0
8791398|NCT01390441|9842640|FG003|NOT COMPLETED|Extension Period||1
8791399|NCT01390441|9842641|FG004|NOT COMPLETED|Extension Period||0
8791400|NCT01390584|9842681|FG000|STARTED|Step 1: Induction Tx (ABVD Then PET/CT)||4
8791401|NCT01390584|9842682|FG001|STARTED|Step 1: Induction Tx (ABVD Then PET/CT)||1
8791402|NCT01390584|9842683|FG002|STARTED|Step 1: Induction Tx (ABVD Then PET/CT)||1
8791403|NCT01390584|9842681|FG000|COMPLETED|Step 1: Induction Tx (ABVD Then PET/CT)||4
8791404|NCT01390584|9842682|FG001|COMPLETED|Step 1: Induction Tx (ABVD Then PET/CT)||1
8791405|NCT01390584|9842683|FG002|COMPLETED|Step 1: Induction Tx (ABVD Then PET/CT)||0
8791406|NCT01390584|9842681|FG000|NOT COMPLETED|Step 1: Induction Tx (ABVD Then PET/CT)||0
8791407|NCT01390584|9842682|FG001|NOT COMPLETED|Step 1: Induction Tx (ABVD Then PET/CT)||0
8791408|NCT01390584|9842683|FG002|NOT COMPLETED|Step 1: Induction Tx (ABVD Then PET/CT)||1
8791409|NCT01390584|9842681|FG000|STARTED|Step 2: ABVD or BEACOPP Then INRT||4
8791410|NCT01390584|9842682|FG001|STARTED|Step 2: ABVD or BEACOPP Then INRT||1
8791411|NCT01390584|9842683|FG002|STARTED|Step 2: ABVD or BEACOPP Then INRT||0
8791412|NCT01390584|9842681|FG000|COMPLETED|Step 2: ABVD or BEACOPP Then INRT||4
8791413|NCT01390584|9842682|FG001|COMPLETED|Step 2: ABVD or BEACOPP Then INRT||1
8791414|NCT01390584|9842683|FG002|COMPLETED|Step 2: ABVD or BEACOPP Then INRT||0
8791415|NCT01390584|9842681|FG000|NOT COMPLETED|Step 2: ABVD or BEACOPP Then INRT||0
8791416|NCT01390584|9842682|FG001|NOT COMPLETED|Step 2: ABVD or BEACOPP Then INRT||0
8791417|NCT01390584|9842683|FG002|NOT COMPLETED|Step 2: ABVD or BEACOPP Then INRT||0
8791418|NCT01390649|9842692|FG000|STARTED|Overall Study|Subjects treated with Privigen|57
8791419|NCT01390649|9842692|FG000|COMPLETED|Overall Study||56
8791420|NCT01390649|9842692|FG000|NOT COMPLETED|Overall Study||1
8791421|NCT01390779|9842696|FG000|STARTED|Overall Study||33
8791422|NCT01390779|9842696|FG000|COMPLETED|Overall Study||32
8791423|NCT01390779|9842696|FG000|NOT COMPLETED|Overall Study||1
8791424|NCT01390818|9842715|FG000|STARTED|Overall Study||3
8791425|NCT01390818|9842716|FG001|STARTED|Overall Study||3
8791426|NCT01390818|9842717|FG002|STARTED|Overall Study||3
8791427|NCT01390818|9842718|FG003|STARTED|Overall Study||4
8791428|NCT01390818|9842719|FG004|STARTED|Overall Study||4
8791429|NCT01390818|9842720|FG005|STARTED|Overall Study||3
8791430|NCT01390818|9842721|FG006|STARTED|Overall Study||19
8791431|NCT01390818|9842722|FG007|STARTED|Overall Study||14
8791432|NCT01390818|9842723|FG008|STARTED|Overall Study||3
8791433|NCT01390818|9842724|FG009|STARTED|Overall Study||3
8791434|NCT01390818|9842725|FG010|STARTED|Overall Study||4
8791435|NCT01390818|9842726|FG011|STARTED|Overall Study||26
8791436|NCT01390818|9842727|FG012|STARTED|Overall Study||24
8791437|NCT01390818|9842728|FG013|STARTED|Overall Study||18
8791438|NCT01390818|9842729|FG014|STARTED|Overall Study||15
8791439|NCT01390818|9842715|FG000|COMPLETED|Overall Study||3
8791440|NCT01390818|9842716|FG001|COMPLETED|Overall Study||3
8791441|NCT01390818|9842717|FG002|COMPLETED|Overall Study||3
8791442|NCT01390818|9842718|FG003|COMPLETED|Overall Study||4
8791443|NCT01390818|9842719|FG004|COMPLETED|Overall Study||4
8791444|NCT01390818|9842720|FG005|COMPLETED|Overall Study||3
8791445|NCT01390818|9842721|FG006|COMPLETED|Overall Study||19
8791446|NCT01390818|9842722|FG007|COMPLETED|Overall Study||14
8791447|NCT01390818|9842723|FG008|COMPLETED|Overall Study||3
8791448|NCT01390818|9842724|FG009|COMPLETED|Overall Study||3
8791449|NCT01390818|9842725|FG010|COMPLETED|Overall Study||4
8791450|NCT01390818|9842726|FG011|COMPLETED|Overall Study||26
8791451|NCT01390818|9842727|FG012|COMPLETED|Overall Study||24
8791452|NCT01390818|9842728|FG013|COMPLETED|Overall Study||18
8791453|NCT01390818|9842729|FG014|COMPLETED|Overall Study||15
8791454|NCT01390818|9842715|FG000|NOT COMPLETED|Overall Study||0
8791455|NCT01390818|9842716|FG001|NOT COMPLETED|Overall Study||0
8791456|NCT01390818|9842717|FG002|NOT COMPLETED|Overall Study||0
8791457|NCT01390818|9842718|FG003|NOT COMPLETED|Overall Study||0
8791458|NCT01390818|9842719|FG004|NOT COMPLETED|Overall Study||0
8791459|NCT01390818|9842720|FG005|NOT COMPLETED|Overall Study||0
8791460|NCT01390818|9842721|FG006|NOT COMPLETED|Overall Study||0
8791461|NCT01390818|9842722|FG007|NOT COMPLETED|Overall Study||0
8791462|NCT01390818|9842723|FG008|NOT COMPLETED|Overall Study||0
8791463|NCT01390818|9842724|FG009|NOT COMPLETED|Overall Study||0
8791464|NCT01390818|9842725|FG010|NOT COMPLETED|Overall Study||0
8791465|NCT01390818|9842726|FG011|NOT COMPLETED|Overall Study||0
8791466|NCT01390818|9842727|FG012|NOT COMPLETED|Overall Study||0
8791467|NCT01390818|9842728|FG013|NOT COMPLETED|Overall Study||0
8791468|NCT01390818|9842729|FG014|NOT COMPLETED|Overall Study||0
8791469|NCT01390844|9842833|FG000|STARTED|Treatment Phase||133
8791470|NCT01390844|9842834|FG001|STARTED|Treatment Phase||65
8791471|NCT01390844|9842835|FG002|STARTED|Treatment Phase||57
8791472|NCT01390844|9842836|FG003|STARTED|Treatment Phase||27
8791473|NCT01390844|9842833|FG000|Followed Good Clinical Practice (GCP)|Treatment Phase||133
8791474|NCT01390844|9842834|FG001|Followed Good Clinical Practice (GCP)|Treatment Phase||65
8791475|NCT01390844|9842835|FG002|Followed Good Clinical Practice (GCP)|Treatment Phase||47
8791476|NCT01390844|9842836|FG003|Followed Good Clinical Practice (GCP)|Treatment Phase||24
8791477|NCT01390844|9842833|FG000|COMPLETED|Treatment Phase||93
8791478|NCT01390844|9842834|FG001|COMPLETED|Treatment Phase||37
8791479|NCT01390844|9842835|FG002|COMPLETED|Treatment Phase||26
8791480|NCT01390844|9842836|FG003|COMPLETED|Treatment Phase||8
8791481|NCT01390844|9842833|FG000|NOT COMPLETED|Treatment Phase||40
8791482|NCT01390844|9842834|FG001|NOT COMPLETED|Treatment Phase||28
8791483|NCT01390844|9842835|FG002|NOT COMPLETED|Treatment Phase||31
8791484|NCT01390844|9842836|FG003|NOT COMPLETED|Treatment Phase||19
8791485|NCT01390844|9842833|FG000|STARTED|Follow-Up Phase||93
8791486|NCT01390844|9842834|FG001|STARTED|Follow-Up Phase||37
8791487|NCT01390844|9842835|FG002|STARTED|Follow-Up Phase||26
8791488|NCT01390844|9842836|FG003|STARTED|Follow-Up Phase||8
8791489|NCT01390844|9842833|FG000|COMPLETED|Follow-Up Phase||92
8791490|NCT01390844|9842834|FG001|COMPLETED|Follow-Up Phase||36
8791491|NCT01390844|9842835|FG002|COMPLETED|Follow-Up Phase||25
8791492|NCT01390844|9842836|FG003|COMPLETED|Follow-Up Phase||8
8791493|NCT01390844|9842833|FG000|NOT COMPLETED|Follow-Up Phase||1
8791494|NCT01390844|9842834|FG001|NOT COMPLETED|Follow-Up Phase||1
8791495|NCT01390844|9842835|FG002|NOT COMPLETED|Follow-Up Phase||1
8791496|NCT01390844|9842836|FG003|NOT COMPLETED|Follow-Up Phase||0
8791497|NCT01390857|9842846|FG000|STARTED|Overall Study||379
8791498|NCT01390857|9842846|FG000|COMPLETED|Overall Study||369
8791499|NCT01390857|9842846|FG000|NOT COMPLETED|Overall Study||10
8791500|NCT01390870|9842850|FG000|STARTED|Overall Study||400
8791501|NCT01390870|9842850|FG000|COMPLETED|Overall Study||400
8791502|NCT01390870|9842850|FG000|NOT COMPLETED|Overall Study||0
8791503|NCT01390909|9842860|FG000|STARTED|Overall Study||3454
8791504|NCT01390909|9842861|FG001|STARTED|Overall Study||3552
8791505|NCT01390909|9842862|FG002|STARTED|Overall Study||3552
8791506|NCT01390909|9842863|FG003|STARTED|Overall Study||602
8791507|NCT01390909|9842864|FG004|STARTED|Overall Study||613
8791508|NCT01390909|9842865|FG005|STARTED|Overall Study||613
8791509|NCT01390909|9842860|FG000|Participants in Subgroup|Overall Study||0
8791510|NCT01390909|9842861|FG001|Participants in Subgroup|Overall Study||3454
8791511|NCT01390909|9842862|FG002|Participants in Subgroup|Overall Study||0
8791512|NCT01390909|9842863|FG003|Participants in Subgroup|Overall Study||0
8791513|NCT01390909|9842864|FG004|Participants in Subgroup|Overall Study||602
8791514|NCT01390909|9842865|FG005|Participants in Subgroup|Overall Study||0
8791515|NCT01390909|9842860|FG000|COMPLETED|Overall Study||3454
8791516|NCT01390909|9842861|FG001|COMPLETED|Overall Study||3552
8791517|NCT01390909|9842862|FG002|COMPLETED|Overall Study||3552
8791518|NCT01390909|9842863|FG003|COMPLETED|Overall Study||602
8791519|NCT01390909|9842864|FG004|COMPLETED|Overall Study||613
8791520|NCT01390909|9842865|FG005|COMPLETED|Overall Study||613
8791521|NCT01390909|9842860|FG000|NOT COMPLETED|Overall Study||0
8791522|NCT01390909|9842861|FG001|NOT COMPLETED|Overall Study||0
8791523|NCT01390909|9842862|FG002|NOT COMPLETED|Overall Study||0
8791524|NCT01390909|9842863|FG003|NOT COMPLETED|Overall Study||0
8791525|NCT01390909|9842864|FG004|NOT COMPLETED|Overall Study||0
8791526|NCT01390909|9842865|FG005|NOT COMPLETED|Overall Study||0
8791527|NCT01390948|9842886|FG000|STARTED|Overall Study||59
8791528|NCT01390948|9842887|FG001|STARTED|Overall Study||62
8791529|NCT01390948|9842888|FG002|STARTED|Overall Study||3
8791530|NCT01390948|9842886|FG000|Treated|Overall Study||56
8791531|NCT01390948|9842887|FG001|Treated|Overall Study||60
8791532|NCT01390948|9842888|FG002|Treated|Overall Study||3
8791533|NCT01390948|9842886|FG000|COMPLETED|Overall Study||44
8791534|NCT01390948|9842887|FG001|COMPLETED|Overall Study||44
8791535|NCT01390948|9842888|FG002|COMPLETED|Overall Study||2
8791536|NCT01390948|9842886|FG000|NOT COMPLETED|Overall Study||15
8791537|NCT01390948|9842887|FG001|NOT COMPLETED|Overall Study||18
8791538|NCT01390948|9842888|FG002|NOT COMPLETED|Overall Study||1
8791539|NCT01391000|9842897|FG000|STARTED|Overall Study||35
8791540|NCT01391000|9842898|FG001|STARTED|Overall Study||35
8791541|NCT01391000|9842897|FG000|COMPLETED|Overall Study||33
8791542|NCT01391000|9842898|FG001|COMPLETED|Overall Study||35
8791543|NCT01391000|9842897|FG000|NOT COMPLETED|Overall Study||2
8791544|NCT01391000|9842898|FG001|NOT COMPLETED|Overall Study||0
8791545|NCT01391013|9842906|FG000|STARTED|Overall Study||15
8791546|NCT01391013|9842907|FG001|STARTED|Overall Study||15
8791547|NCT01391013|9842906|FG000|COMPLETED|Overall Study||15
8791548|NCT01391013|9842907|FG001|COMPLETED|Overall Study||15
8791549|NCT01391013|9842906|FG000|NOT COMPLETED|Overall Study||0
8791550|NCT01391013|9842907|FG001|NOT COMPLETED|Overall Study||0
8791551|NCT01391130|9842915|FG000|STARTED|Overall Study||73
8791552|NCT01391130|9842916|FG001|STARTED|Overall Study||37
8791553|NCT01391130|9842915|FG000|Received At Least One Dose of Study Drug|Overall Study||72
8791554|NCT01391130|9842916|FG001|Received At Least One Dose of Study Drug|Overall Study||36
8791555|NCT01391130|9842915|FG000|COMPLETED|Overall Study||67
8791556|NCT01391130|9842916|FG001|COMPLETED|Overall Study||31
8791557|NCT01391130|9842915|FG000|NOT COMPLETED|Overall Study||6
8791558|NCT01391130|9842916|FG001|NOT COMPLETED|Overall Study||6
8791559|NCT01391273|9842924|FG000|STARTED|Overall Study||88
8791560|NCT01391273|9842925|FG001|STARTED|Overall Study||85
8791561|NCT01391273|9842924|FG000|COMPLETED|Overall Study||84
8791562|NCT01391273|9842925|FG001|COMPLETED|Overall Study||83
8791563|NCT01391273|9842924|FG000|NOT COMPLETED|Overall Study||4
8791564|NCT01391273|9842925|FG001|NOT COMPLETED|Overall Study||2
8791565|NCT01391286|9842933|FG000|STARTED|Overall Study||18
8791566|NCT01391286|9842934|FG001|STARTED|Overall Study||18
8791567|NCT01391286|9842933|FG000|COMPLETED|Overall Study||18
8791568|NCT01391286|9842934|FG001|COMPLETED|Overall Study||18
8791569|NCT01391286|9842933|FG000|NOT COMPLETED|Overall Study||0
8791570|NCT01391286|9842934|FG001|NOT COMPLETED|Overall Study||0
8791571|NCT01391299|9842943|FG000|STARTED|Overall Study||57
8791572|NCT01391299|9842944|FG001|STARTED|Overall Study||60
8791573|NCT01391299|9842945|FG002|STARTED|Overall Study||58
8791574|NCT01391299|9842943|FG000|COMPLETED|Overall Study||57
8791575|NCT01391299|9842944|FG001|COMPLETED|Overall Study||59
8791576|NCT01391299|9842945|FG002|COMPLETED|Overall Study||56
8791577|NCT01391299|9842943|FG000|NOT COMPLETED|Overall Study||0
8791578|NCT01391299|9842944|FG001|NOT COMPLETED|Overall Study||1
8791579|NCT01391299|9842945|FG002|NOT COMPLETED|Overall Study||2
8791580|NCT01391312|9842955|FG000|STARTED|Overall Study||20
8791581|NCT01391312|9842956|FG001|STARTED|Overall Study||20
8791582|NCT01391312|9842955|FG000|COMPLETED|Overall Study||18
8791583|NCT01391312|9842956|FG001|COMPLETED|Overall Study||19
8791584|NCT01391312|9842955|FG000|NOT COMPLETED|Overall Study||2
8791585|NCT01391312|9842956|FG001|NOT COMPLETED|Overall Study||1
8791586|NCT01391325|9842962|FG000|STARTED|Overall Study||1732
8791587|NCT01391325|9842962|FG000|COMPLETED|Overall Study||1238
8791588|NCT01391325|9842962|FG000|NOT COMPLETED|Overall Study||494
8791589|NCT01391364|9842968|FG000|STARTED|Overall Study||222
8791590|NCT01391364|9842969|FG001|STARTED|Overall Study||216
8791591|NCT01391364|9842968|FG000|COMPLETED|Overall Study||217
8791592|NCT01391364|9842969|FG001|COMPLETED|Overall Study||214
8791593|NCT01391364|9842968|FG000|NOT COMPLETED|Overall Study||5
8791594|NCT01391364|9842969|FG001|NOT COMPLETED|Overall Study||2
8791595|NCT01391468|9842977|FG000|STARTED|Overall Study||24
8791596|NCT01391468|9842978|FG001|STARTED|Overall Study||23
8791597|NCT01391468|9842977|FG000|COMPLETED|Overall Study||18
8791598|NCT01391468|9842978|FG001|COMPLETED|Overall Study||21
8791599|NCT01391468|9842977|FG000|NOT COMPLETED|Overall Study||6
8791600|NCT01391468|9842978|FG001|NOT COMPLETED|Overall Study||2
8791601|NCT01391507|9842993|FG000|STARTED|Overall Study||10
8791602|NCT01391507|9842994|FG001|STARTED|Overall Study||8
8791603|NCT01391507|9842995|FG002|STARTED|Overall Study||6
8791604|NCT01391507|9842996|FG003|STARTED|Overall Study||12
8791605|NCT01391507|9842993|FG000|COMPLETED|Overall Study||6
8791606|NCT01391507|9842994|FG001|COMPLETED|Overall Study||4
8791607|NCT01391507|9842995|FG002|COMPLETED|Overall Study||2
8791608|NCT01391507|9842996|FG003|COMPLETED|Overall Study||5
8791609|NCT01391507|9842993|FG000|NOT COMPLETED|Overall Study||4
8791610|NCT01391507|9842994|FG001|NOT COMPLETED|Overall Study||4
8791611|NCT01391507|9842995|FG002|NOT COMPLETED|Overall Study||4
8791612|NCT01391507|9842996|FG003|NOT COMPLETED|Overall Study||7
8791613|NCT01391546|9843008|FG000|STARTED|Overall Study||177
8791614|NCT01391546|9843009|FG001|STARTED|Overall Study||177
8791615|NCT01391546|9843008|FG000|Vaccinated|Overall Study||176
8791616|NCT01391546|9843009|FG001|Vaccinated|Overall Study||177
8791617|NCT01391546|9843008|FG000|COMPLETED|Overall Study||176
8791618|NCT01391546|9843009|FG001|COMPLETED|Overall Study||177
8791619|NCT01391546|9843008|FG000|NOT COMPLETED|Overall Study||1
8791620|NCT01391546|9843009|FG001|NOT COMPLETED|Overall Study||0
8791621|NCT01391559|9843016|FG000|STARTED|First Intervention||10
8791622|NCT01391559|9843017|FG001|STARTED|First Intervention||10
8791623|NCT01391559|9843016|FG000|COMPLETED|First Intervention||10
8791624|NCT01391559|9843017|FG001|COMPLETED|First Intervention||10
8791625|NCT01391559|9843016|FG000|NOT COMPLETED|First Intervention||0
8791626|NCT01391559|9843017|FG001|NOT COMPLETED|First Intervention||0
8791627|NCT01391559|9843016|FG000|STARTED|Second Intervention||10
8791628|NCT01391559|9843017|FG001|STARTED|Second Intervention||10
8791629|NCT01391559|9843016|FG000|COMPLETED|Second Intervention||10
8791630|NCT01391559|9843017|FG001|COMPLETED|Second Intervention||10
8791631|NCT01391559|9843016|FG000|NOT COMPLETED|Second Intervention||0
8791632|NCT01391559|9843017|FG001|NOT COMPLETED|Second Intervention||0
8791633|NCT01391611|9843023|FG000|STARTED|Overall Study||25
8791634|NCT01391611|9843023|FG000|COMPLETED|Overall Study||3
8791635|NCT01391611|9843023|FG000|NOT COMPLETED|Overall Study||22
8791636|NCT01391663|9843031|FG000|STARTED|Overall Study||12
8791637|NCT01391663|9843032|FG001|STARTED|Overall Study||12
8791638|NCT01391663|9843033|FG002|STARTED|Overall Study||12
8791639|NCT01391663|9843034|FG003|STARTED|Overall Study||12
8791640|NCT01391663|9843031|FG000|COMPLETED|Overall Study||12
8791641|NCT01391663|9843032|FG001|COMPLETED|Overall Study||12
8791642|NCT01391663|9843033|FG002|COMPLETED|Overall Study||11
8791643|NCT01391663|9843034|FG003|COMPLETED|Overall Study||12
8791644|NCT01391663|9843031|FG000|NOT COMPLETED|Overall Study||0
8791645|NCT01391663|9843032|FG001|NOT COMPLETED|Overall Study||0
8791646|NCT01391663|9843033|FG002|NOT COMPLETED|Overall Study||1
8791647|NCT01391663|9843034|FG003|NOT COMPLETED|Overall Study||0
8791648|NCT01391793|9843046|FG000|STARTED|Overall Study||271
8791649|NCT01391793|9843047|FG001|STARTED|Overall Study||275
8791650|NCT01391793|9843046|FG000|Had a Positive Urine Culture|Overall Study||197
8791651|NCT01391793|9843047|FG001|Had a Positive Urine Culture|Overall Study||188
8791652|NCT01391793|9843046|FG000|COMPLETED|Overall Study||124
8791653|NCT01391793|9843047|FG001|COMPLETED|Overall Study||131
8791654|NCT01391793|9843046|FG000|NOT COMPLETED|Overall Study||147
8791655|NCT01391793|9843047|FG001|NOT COMPLETED|Overall Study||144
8791656|NCT01391819|9843053|FG000|STARTED|Overall Study||2116
8791657|NCT01391819|9843053|FG000|COMPLETED|Overall Study||1714
8791658|NCT01391819|9843053|FG000|NOT COMPLETED|Overall Study||402
8791659|NCT01391832|9843062|FG000|STARTED|Overall Study||49
8791660|NCT01391832|9843063|FG001|STARTED|Overall Study||54
8791661|NCT01391832|9843062|FG000|1 Month Follow-Up|Overall Study||30
8791662|NCT01391832|9843063|FG001|1 Month Follow-Up|Overall Study||31
8791663|NCT01391832|9843062|FG000|3 Month Follow-Up|Overall Study||28
8791664|NCT01391832|9843063|FG001|3 Month Follow-Up|Overall Study||29
8791665|NCT01391832|9843062|FG000|COMPLETED|Overall Study||28
8791666|NCT01391832|9843063|FG001|COMPLETED|Overall Study||31
8791667|NCT01391832|9843062|FG000|NOT COMPLETED|Overall Study||21
8791668|NCT01391832|9843063|FG001|NOT COMPLETED|Overall Study||23
8791669|NCT01391858|9843071|FG000|STARTED|Overall Study||25
8791670|NCT01391858|9843072|FG001|STARTED|Overall Study||24
8791671|NCT01391858|9843071|FG000|COMPLETED|Overall Study||23
8791672|NCT01391858|9843072|FG001|COMPLETED|Overall Study||24
8791673|NCT01391858|9843071|FG000|NOT COMPLETED|Overall Study||2
8791674|NCT01391858|9843072|FG001|NOT COMPLETED|Overall Study||0
8791675|NCT01392053|9843080|FG000|STARTED|Overall Study||23
8791676|NCT01392053|9843081|FG001|STARTED|Overall Study||23
8791677|NCT01392053|9843080|FG000|COMPLETED|Overall Study||23
8791678|NCT01392053|9843081|FG001|COMPLETED|Overall Study||23
8791679|NCT01392053|9843080|FG000|NOT COMPLETED|Overall Study||0
8791680|NCT01392053|9843081|FG001|NOT COMPLETED|Overall Study||0
8791681|NCT01392183|9843089|FG000|STARTED|First Drug Administration||35
8791682|NCT01392183|9843090|FG001|STARTED|First Drug Administration||34
8791683|NCT01392183|9843089|FG000|Eligible to Cross Over to 2nd Drug|First Drug Administration||29
8791684|NCT01392183|9843090|FG001|Eligible to Cross Over to 2nd Drug|First Drug Administration||31
8791685|NCT01392183|9843089|FG000|COMPLETED|First Drug Administration||21
8791686|NCT01392183|9843090|FG001|COMPLETED|First Drug Administration||15
8791687|NCT01392183|9843089|FG000|NOT COMPLETED|First Drug Administration||14
8791688|NCT01392183|9843090|FG001|NOT COMPLETED|First Drug Administration||19
8791689|NCT01392183|9843089|FG000|STARTED|Second Drug Administration||21
8791690|NCT01392183|9843090|FG001|STARTED|Second Drug Administration||15
8791691|NCT01392183|9843089|FG000|Treatment Ended: Progression|Second Drug Administration||18
8791692|NCT01392183|9843090|FG001|Treatment Ended: Progression|Second Drug Administration||11
8791693|NCT01392183|9843089|FG000|Treatment Ended: Adverse Events|Second Drug Administration||1
8791694|NCT01392183|9843090|FG001|Treatment Ended: Adverse Events|Second Drug Administration||2
8791695|NCT01392183|9843089|FG000|Treatment Ended: Participant Withdrew|Second Drug Administration||2
8791696|NCT01392183|9843090|FG001|Treatment Ended: Participant Withdrew|Second Drug Administration||1
8791697|NCT01392183|9843089|FG000|Treatment Ended: Death|Second Drug Administration||0
8791698|NCT01392183|9843090|FG001|Treatment Ended: Death|Second Drug Administration||1
8791699|NCT01392183|9843089|FG000|COMPLETED|Second Drug Administration||21
8791700|NCT01392183|9843090|FG001|COMPLETED|Second Drug Administration||15
8791701|NCT01392183|9843089|FG000|NOT COMPLETED|Second Drug Administration||0
8791702|NCT01392183|9843090|FG001|NOT COMPLETED|Second Drug Administration||0
8791703|NCT01392300|9843100|FG000|STARTED|Main Period (MP)||210
8791704|NCT01392300|9843101|FG001|STARTED|Main Period (MP)||107
8791705|NCT01392300|9843102|FG002|STARTED|Main Period (MP)||0
8791706|NCT01392300|9843100|FG000|COMPLETED|Main Period (MP)||199
8791707|NCT01392300|9843101|FG001|COMPLETED|Main Period (MP)||100
8791708|NCT01392300|9843102|FG002|COMPLETED|Main Period (MP)||0
8791709|NCT01392300|9843100|FG000|NOT COMPLETED|Main Period (MP)||11
8791710|NCT01392300|9843101|FG001|NOT COMPLETED|Main Period (MP)||7
8791711|NCT01392300|9843102|FG002|NOT COMPLETED|Main Period (MP)||0
8791712|NCT01392300|9843100|FG000|STARTED|Open Label Extension (OLEX) Period|Subjects from double-blind arms were switched to arm OLEX IncobotulinumtoxinA (Xeomin) (...)|0
8791713|NCT01392300|9843101|FG001|STARTED|Open Label Extension (OLEX) Period|Subjects from double-blind arms were switched to arm OLEX IncobotulinumtoxinA (Xeomin) (...)|0
8791714|NCT01392300|9843102|FG002|STARTED|Open Label Extension (OLEX) Period|Subjects from double-blind arms were switched to arm OLEX IncobotulinumtoxinA (Xeomin) (...)|299
8791715|NCT01392300|9843100|FG000|COMPLETED|Open Label Extension (OLEX) Period||0
8791716|NCT01392300|9843101|FG001|COMPLETED|Open Label Extension (OLEX) Period||0
8791717|NCT01392300|9843102|FG002|COMPLETED|Open Label Extension (OLEX) Period||248
8791718|NCT01392300|9843100|FG000|NOT COMPLETED|Open Label Extension (OLEX) Period||0
8791719|NCT01392300|9843101|FG001|NOT COMPLETED|Open Label Extension (OLEX) Period||0
8917215|NCT02190591|9976905|FG000|NOT COMPLETED|Overall Study||2
8917216|NCT02190591|9976906|FG001|NOT COMPLETED|Overall Study||11
8917217|NCT02190604|9976931|FG000|STARTED|Part 1 and 2 (Healthy Volunteers)||6
8917218|NCT02190604|9976932|FG001|STARTED|Part 1 and 2 (Healthy Volunteers)||6
8917219|NCT02190604|9976933|FG002|STARTED|Part 1 and 2 (Healthy Volunteers)||6
8917220|NCT02190604|9976934|FG003|STARTED|Part 1 and 2 (Healthy Volunteers)||6
8917221|NCT02190604|9976935|FG004|STARTED|Part 1 and 2 (Healthy Volunteers)||6
9032617|NCT03262012|10094888|FG000|NOT COMPLETED|Overall Study||27
9032618|NCT03262012|10094889|FG001|NOT COMPLETED|Overall Study||36
9032619|NCT03262012|10094890|FG002|NOT COMPLETED|Overall Study||14
9032620|NCT03262012|10094891|FG003|NOT COMPLETED|Overall Study||15
9032621|NCT03262038|10094903|FG000|STARTED|Overall Study||18
9032622|NCT03262038|10094904|FG001|STARTED|Overall Study||28
9032623|NCT03262038|10094903|FG000|COMPLETED|Overall Study||18
9032624|NCT03262038|10094904|FG001|COMPLETED|Overall Study||27
9032625|NCT03262038|10094903|FG000|NOT COMPLETED|Overall Study||0
9032626|NCT03262038|10094904|FG001|NOT COMPLETED|Overall Study||1
9032627|NCT03262233|10094914|FG000|STARTED|Overall Study||53
9032628|NCT03262233|10094915|FG001|STARTED|Overall Study||53
8917222|NCT02190604|9976936|FG005|STARTED|Part 1 and 2 (Healthy Volunteers)||6
8917223|NCT02190604|9976937|FG006|STARTED|Part 1 and 2 (Healthy Volunteers)||6
8917224|NCT02190604|9976938|FG007|STARTED|Part 1 and 2 (Healthy Volunteers)||6
8917225|NCT02190604|9976939|FG008|STARTED|Part 1 and 2 (Healthy Volunteers)||16
8917226|NCT02190604|9976940|FG009|STARTED|Part 1 and 2 (Healthy Volunteers)||6
8917227|NCT02190604|9976941|FG010|STARTED|Part 1 and 2 (Healthy Volunteers)||6
8917228|NCT02190604|9976942|FG011|STARTED|Part 1 and 2 (Healthy Volunteers)||6
8917229|NCT02190604|9976943|FG012|STARTED|Part 1 and 2 (Healthy Volunteers)||6
8917230|NCT02190604|9976944|FG013|STARTED|Part 1 and 2 (Healthy Volunteers)||6
8917231|NCT02190604|9976945|FG014|STARTED|Part 1 and 2 (Healthy Volunteers)||10
8917232|NCT02190604|9976946|FG015|STARTED|Part 1 and 2 (Healthy Volunteers)||0
8791720|NCT01392300|9843102|FG002|NOT COMPLETED|Open Label Extension (OLEX) Period||51
8791721|NCT01392326|9843112|FG000|STARTED|Overall Study||202
8791722|NCT01392326|9843113|FG001|STARTED|Overall Study||202
8791723|NCT01392326|9843114|FG002|STARTED|Overall Study||202
8791724|NCT01392326|9843112|FG000|COMPLETED|Overall Study||155
8791725|NCT01392326|9843113|FG001|COMPLETED|Overall Study||167
8791726|NCT01392326|9843114|FG002|COMPLETED|Overall Study||154
8791727|NCT01392326|9843112|FG000|NOT COMPLETED|Overall Study||47
8791728|NCT01392326|9843113|FG001|NOT COMPLETED|Overall Study||35
8791729|NCT01392326|9843114|FG002|NOT COMPLETED|Overall Study||48
8791730|NCT01392378|9843127|FG000|STARTED|Infant Series||173
8791731|NCT01392378|9843128|FG001|STARTED|Infant Series||176
8791732|NCT01392378|9843129|FG002|STARTED|Infant Series||172
8791733|NCT01392378|9843130|FG003|STARTED|Infant Series||177
8791734|NCT01392378|9843131|FG004|STARTED|Infant Series||210
8791735|NCT01392378|9843127|FG000|Vaccinated Dose 1|Infant Series||173
8791736|NCT01392378|9843128|FG001|Vaccinated Dose 1|Infant Series||176
8791737|NCT01392378|9843129|FG002|Vaccinated Dose 1|Infant Series||172
8791738|NCT01392378|9843130|FG003|Vaccinated Dose 1|Infant Series||177
8791739|NCT01392378|9843131|FG004|Vaccinated Dose 1|Infant Series||210
8791740|NCT01392378|9843127|FG000|Vaccinated Dose 2|Infant Series||171
8791741|NCT01392378|9843128|FG001|Vaccinated Dose 2|Infant Series||174
8791742|NCT01392378|9843129|FG002|Vaccinated Dose 2|Infant Series||172
9032629|NCT03262233|10094916|FG002|STARTED|Overall Study||59
9032630|NCT03262233|10094917|FG003|STARTED|Overall Study||61
9032631|NCT03262233|10094914|FG000|COMPLETED|Overall Study||35
9032632|NCT03262233|10094915|FG001|COMPLETED|Overall Study||32
9032633|NCT03262233|10094916|FG002|COMPLETED|Overall Study||34
9032634|NCT03262233|10094917|FG003|COMPLETED|Overall Study||32
9032635|NCT03262233|10094914|FG000|NOT COMPLETED|Overall Study||18
9032636|NCT03262233|10094915|FG001|NOT COMPLETED|Overall Study||21
9032637|NCT03262233|10094916|FG002|NOT COMPLETED|Overall Study||25
9032638|NCT03262233|10094917|FG003|NOT COMPLETED|Overall Study||29
9032639|NCT03262389|10094928|FG000|STARTED|Overall Study||10
9032640|NCT03262389|10094928|FG000|COMPLETED|Overall Study||7
9032641|NCT03262389|10094928|FG000|NOT COMPLETED|Overall Study||3
9032642|NCT03262441|10094932|FG000|STARTED|Overall Study||5
9032643|NCT03262441|10094932|FG000|COMPLETED|Overall Study||4
9032644|NCT03262441|10094932|FG000|NOT COMPLETED|Overall Study||1
9032645|NCT03263442|10094938|FG000|STARTED|Inpatient Phase||30
9032646|NCT03263442|10094939|FG001|STARTED|Inpatient Phase||34
9032647|NCT03263442|10094938|FG000|COMPLETED|Inpatient Phase||28
9032648|NCT03263442|10094939|FG001|COMPLETED|Inpatient Phase||33
9032649|NCT03263442|10094938|FG000|NOT COMPLETED|Inpatient Phase||2
9032650|NCT03263442|10094939|FG001|NOT COMPLETED|Inpatient Phase||1
9032651|NCT03263442|10094938|FG000|STARTED|1-month Follow-Up||28
9032652|NCT03263442|10094939|FG001|STARTED|1-month Follow-Up||33
9032653|NCT03263442|10094938|FG000|COMPLETED|1-month Follow-Up||27
9032654|NCT03263442|10094939|FG001|COMPLETED|1-month Follow-Up||33
9032655|NCT03263442|10094938|FG000|NOT COMPLETED|1-month Follow-Up||1
9032656|NCT03263442|10094939|FG001|NOT COMPLETED|1-month Follow-Up||0
9032657|NCT03263442|10094938|FG000|STARTED|3-month Follow-Up||27
9032658|NCT03263442|10094939|FG001|STARTED|3-month Follow-Up||33
9032659|NCT03263442|10094938|FG000|COMPLETED|3-month Follow-Up||26
9032660|NCT03263442|10094939|FG001|COMPLETED|3-month Follow-Up||30
9032661|NCT03263442|10094938|FG000|NOT COMPLETED|3-month Follow-Up||1
9032662|NCT03263442|10094939|FG001|NOT COMPLETED|3-month Follow-Up||3
9032663|NCT03263442|10094938|FG000|STARTED|6-month Follow-Up||26
9032664|NCT03263442|10094939|FG001|STARTED|6-month Follow-Up||30
9032665|NCT03263442|10094938|FG000|COMPLETED|6-month Follow-Up||24
9032666|NCT03263442|10094939|FG001|COMPLETED|6-month Follow-Up||28
9032667|NCT03263442|10094938|FG000|NOT COMPLETED|6-month Follow-Up||2
9032668|NCT03263442|10094939|FG001|NOT COMPLETED|6-month Follow-Up||2
9032669|NCT03263702|10094949|FG000|STARTED|Overall Study||38
9032670|NCT03263702|10094950|FG001|STARTED|Overall Study||26
9032671|NCT03263702|10094949|FG000|COMPLETED|Overall Study||35
9032672|NCT03263702|10094950|FG001|COMPLETED|Overall Study||22
9032673|NCT03263702|10094949|FG000|NOT COMPLETED|Overall Study||3
9032674|NCT03263702|10094950|FG001|NOT COMPLETED|Overall Study||4
9032675|NCT03263780|10094956|FG000|STARTED|Overall Study||21
9032676|NCT03263780|10094956|FG000|COMPLETED|Overall Study|13 evaluable for primary outcome, but 11 total completed study.|11
9032677|NCT03263780|10094956|FG000|NOT COMPLETED|Overall Study||10
9032678|NCT03264066|10094966|FG000|STARTED|Overall Study||20
9032679|NCT03264066|10094967|FG001|STARTED|Overall Study||20
9032680|NCT03264066|10094968|FG002|STARTED|Overall Study||17
9032681|NCT03264066|10094969|FG003|STARTED|Overall Study||20
9032682|NCT03264066|10094970|FG004|STARTED|Overall Study||7
8791743|NCT01392378|9843130|FG003|Vaccinated Dose 2|Infant Series||177
9032683|NCT03264066|10094971|FG005|STARTED|Overall Study||3
9032684|NCT03264066|10094966|FG000|COMPLETED|Overall Study||0
8791744|NCT01392378|9843131|FG004|Vaccinated Dose 2|Infant Series||210
8791745|NCT01392378|9843127|FG000|Vaccinated Dose 3|Infant Series||170
8791746|NCT01392378|9843128|FG001|Vaccinated Dose 3|Infant Series||174
8791747|NCT01392378|9843129|FG002|Vaccinated Dose 3|Infant Series||172
8791748|NCT01392378|9843130|FG003|Vaccinated Dose 3|Infant Series||176
8791749|NCT01392378|9843131|FG004|Vaccinated Dose 3|Infant Series||210
8791750|NCT01392378|9843127|FG000|COMPLETED|Infant Series||169
8791751|NCT01392378|9843128|FG001|COMPLETED|Infant Series||174
8791752|NCT01392378|9843129|FG002|COMPLETED|Infant Series||172
9032685|NCT03264066|10094967|FG001|COMPLETED|Overall Study||0
9032686|NCT03264066|10094968|FG002|COMPLETED|Overall Study||0
9032687|NCT03264066|10094969|FG003|COMPLETED|Overall Study||0
8791753|NCT01392378|9843130|FG003|COMPLETED|Infant Series||175
8791754|NCT01392378|9843131|FG004|COMPLETED|Infant Series||210
8791755|NCT01392378|9843127|FG000|NOT COMPLETED|Infant Series||4
8791756|NCT01392378|9843128|FG001|NOT COMPLETED|Infant Series||2
8791757|NCT01392378|9843129|FG002|NOT COMPLETED|Infant Series||0
8791758|NCT01392378|9843130|FG003|NOT COMPLETED|Infant Series||2
8791759|NCT01392378|9843131|FG004|NOT COMPLETED|Infant Series||0
8791760|NCT01392378|9843127|FG000|STARTED|After Infant Series||169
8791761|NCT01392378|9843128|FG001|STARTED|After Infant Series||174
8791762|NCT01392378|9843129|FG002|STARTED|After Infant Series||172
8791763|NCT01392378|9843130|FG003|STARTED|After Infant Series||175
8791764|NCT01392378|9843131|FG004|STARTED|After Infant Series||210
8791765|NCT01392378|9843127|FG000|COMPLETED|After Infant Series||169
8791766|NCT01392378|9843128|FG001|COMPLETED|After Infant Series||173
8791767|NCT01392378|9843129|FG002|COMPLETED|After Infant Series||170
8791768|NCT01392378|9843130|FG003|COMPLETED|After Infant Series||175
8791769|NCT01392378|9843131|FG004|COMPLETED|After Infant Series||209
8791770|NCT01392378|9843127|FG000|NOT COMPLETED|After Infant Series||0
8791771|NCT01392378|9843128|FG001|NOT COMPLETED|After Infant Series||1
8791772|NCT01392378|9843129|FG002|NOT COMPLETED|After Infant Series||2
8791773|NCT01392378|9843130|FG003|NOT COMPLETED|After Infant Series||0
8791774|NCT01392378|9843131|FG004|NOT COMPLETED|After Infant Series||1
8791775|NCT01392378|9843127|FG000|STARTED|Toddler Dose||169
8791776|NCT01392378|9843128|FG001|STARTED|Toddler Dose||173
8791777|NCT01392378|9843129|FG002|STARTED|Toddler Dose||170
8791778|NCT01392378|9843130|FG003|STARTED|Toddler Dose||175
8791779|NCT01392378|9843131|FG004|STARTED|Toddler Dose||209
8791780|NCT01392378|9843127|FG000|COMPLETED|Toddler Dose||169
8791781|NCT01392378|9843128|FG001|COMPLETED|Toddler Dose||172
8791782|NCT01392378|9843129|FG002|COMPLETED|Toddler Dose||170
8791783|NCT01392378|9843130|FG003|COMPLETED|Toddler Dose||173
8791784|NCT01392378|9843131|FG004|COMPLETED|Toddler Dose||208
8791785|NCT01392378|9843127|FG000|NOT COMPLETED|Toddler Dose||0
8791786|NCT01392378|9843128|FG001|NOT COMPLETED|Toddler Dose||1
8791787|NCT01392378|9843129|FG002|NOT COMPLETED|Toddler Dose||0
8791788|NCT01392378|9843130|FG003|NOT COMPLETED|Toddler Dose||2
8791789|NCT01392378|9843131|FG004|NOT COMPLETED|Toddler Dose||1
8791790|NCT01392443|9843153|FG000|STARTED|Overall Study||120
8791791|NCT01392443|9843153|FG000|COMPLETED|Overall Study||52
8791792|NCT01392443|9843153|FG000|NOT COMPLETED|Overall Study||68
8791793|NCT01392469|9843157|FG000|STARTED|Overall Study||21
8791794|NCT01392469|9843157|FG000|COMPLETED|Overall Study||17
8791795|NCT01392469|9843157|FG000|NOT COMPLETED|Overall Study||4
8791796|NCT01392495|9843172|FG000|STARTED|Overall Study||17
8791797|NCT01392495|9843172|FG000|Received 200 mg|Overall Study||4
8791798|NCT01392495|9843172|FG000|Received 400 mg|Overall Study||13
8791799|NCT01392495|9843172|FG000|COMPLETED|Overall Study||1
8791800|NCT01392495|9843172|FG000|NOT COMPLETED|Overall Study||16
8791801|NCT01392547|9843178|FG000|STARTED|Overall Study|567 bleeds by 69 subjects, 340 were treated with vatreptacog alfa and 227 with rFVIIa|72
8791802|NCT01392547|9843178|FG000|COMPLETED|Overall Study||64
8791803|NCT01392547|9843178|FG000|NOT COMPLETED|Overall Study||8
8791804|NCT01392560|9843184|FG000|STARTED|Overall Study||52
8791805|NCT01392560|9843184|FG000|COMPLETED|Overall Study||40
8791806|NCT01392560|9843184|FG000|NOT COMPLETED|Overall Study||12
8791807|NCT01392573|9843192|FG000|STARTED|Overall Study||207
8791808|NCT01392573|9843193|FG001|STARTED|Overall Study||206
8791809|NCT01392573|9843192|FG000|Exposed|Overall Study||207
8791810|NCT01392573|9843193|FG001|Exposed|Overall Study||206
8791811|NCT01392573|9843192|FG000|COMPLETED|Overall Study||175
8791812|NCT01392573|9843193|FG001|COMPLETED|Overall Study||171
8791813|NCT01392573|9843192|FG000|NOT COMPLETED|Overall Study||32
8791814|NCT01392573|9843193|FG001|NOT COMPLETED|Overall Study||35
9032688|NCT03264066|10094970|FG004|COMPLETED|Overall Study||0
9032689|NCT03264066|10094971|FG005|COMPLETED|Overall Study||0
9032690|NCT03264066|10094966|FG000|NOT COMPLETED|Overall Study||20
9032691|NCT03264066|10094967|FG001|NOT COMPLETED|Overall Study||20
9032692|NCT03264066|10094968|FG002|NOT COMPLETED|Overall Study||17
9032693|NCT03264066|10094969|FG003|NOT COMPLETED|Overall Study||20
9032694|NCT03264066|10094970|FG004|NOT COMPLETED|Overall Study||7
9032695|NCT03264066|10094971|FG005|NOT COMPLETED|Overall Study||3
9032696|NCT03264092|10094989|FG000|STARTED|Overall Study||17
9032697|NCT03264092|10094990|FG001|STARTED|Overall Study||20
9032698|NCT03264092|10094991|FG002|STARTED|Overall Study||18
9032699|NCT03264092|10094989|FG000|COMPLETED|Overall Study||17
8791815|NCT01392625|9843201|FG000|STARTED|Overall Study||18
8791816|NCT01392625|9843202|FG001|STARTED|Overall Study||19
8791817|NCT01392625|9843201|FG000|COMPLETED|Overall Study||16
8791818|NCT01392625|9843202|FG001|COMPLETED|Overall Study||18
8791819|NCT01392625|9843201|FG000|NOT COMPLETED|Overall Study||2
8917233|NCT02190604|9976947|FG016|STARTED|Part 1 and 2 (Healthy Volunteers)||0
9032700|NCT03264092|10094990|FG001|COMPLETED|Overall Study||20
8791820|NCT01392625|9843202|FG001|NOT COMPLETED|Overall Study||1
8791821|NCT01392677|9843210|FG000|STARTED|Overall Study||109
8791822|NCT01392677|9843211|FG001|STARTED|Overall Study||109
8791823|NCT01392677|9843210|FG000|COMPLETED|Overall Study||101
8791824|NCT01392677|9843211|FG001|COMPLETED|Overall Study||101
8791825|NCT01392677|9843210|FG000|NOT COMPLETED|Overall Study||8
8791826|NCT01392677|9843211|FG001|NOT COMPLETED|Overall Study||8
8791827|NCT01392703|9843217|FG000|STARTED|Day 1||26
8791828|NCT01392703|9843218|FG001|STARTED|Day 1||26
9032701|NCT03264092|10094991|FG002|COMPLETED|Overall Study||18
8791829|NCT01392703|9843219|FG002|STARTED|Day 1||26
8791830|NCT01392703|9843217|FG000|COMPLETED|Day 1||26
8791831|NCT01392703|9843218|FG001|COMPLETED|Day 1||26
8791832|NCT01392703|9843219|FG002|COMPLETED|Day 1||26
8791833|NCT01392703|9843217|FG000|NOT COMPLETED|Day 1||0
8791834|NCT01392703|9843218|FG001|NOT COMPLETED|Day 1||0
8791835|NCT01392703|9843219|FG002|NOT COMPLETED|Day 1||0
8791836|NCT01392703|9843217|FG000|STARTED|Day 5||26
8791837|NCT01392703|9843218|FG001|STARTED|Day 5|1 participant no longer met dosing criteria and dropped out during washout period prior to Day 5.|25
8917234|NCT02190604|9976948|FG017|STARTED|Part 1 and 2 (Healthy Volunteers)||0
8917235|NCT02190604|9976949|FG018|STARTED|Part 1 and 2 (Healthy Volunteers)||0
8917236|NCT02190604|9976931|FG000|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
8917237|NCT02190604|9976932|FG001|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
8917238|NCT02190604|9976933|FG002|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
8917239|NCT02190604|9976934|FG003|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
8917240|NCT02190604|9976935|FG004|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
8917241|NCT02190604|9976936|FG005|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
8917242|NCT02190604|9976937|FG006|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
8917243|NCT02190604|9976938|FG007|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
8917244|NCT02190604|9976939|FG008|COMPLETED|Part 1 and 2 (Healthy Volunteers)||16
8917245|NCT02190604|9976940|FG009|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
8917246|NCT02190604|9976941|FG010|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
8917247|NCT02190604|9976942|FG011|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
8917248|NCT02190604|9976943|FG012|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
8917249|NCT02190604|9976944|FG013|COMPLETED|Part 1 and 2 (Healthy Volunteers)||5
8917250|NCT02190604|9976945|FG014|COMPLETED|Part 1 and 2 (Healthy Volunteers)||8
8917251|NCT02190604|9976946|FG015|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
8917252|NCT02190604|9976947|FG016|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
8917253|NCT02190604|9976948|FG017|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
8917254|NCT02190604|9976949|FG018|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
8917255|NCT02190604|9976931|FG000|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
8917256|NCT02190604|9976932|FG001|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
8917257|NCT02190604|9976933|FG002|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
8917258|NCT02190604|9976934|FG003|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
8917259|NCT02190604|9976935|FG004|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
8917260|NCT02190604|9976936|FG005|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
8917261|NCT02190604|9976937|FG006|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
8917262|NCT02190604|9976938|FG007|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
8917263|NCT02190604|9976939|FG008|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
8917264|NCT02190604|9976940|FG009|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
8917265|NCT02190604|9976941|FG010|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
8917266|NCT02190604|9976942|FG011|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
8917267|NCT02190604|9976943|FG012|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
8917268|NCT02190604|9976944|FG013|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||1
8917269|NCT02190604|9976945|FG014|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||2
8917270|NCT02190604|9976946|FG015|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
8917271|NCT02190604|9976947|FG016|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
8917272|NCT02190604|9976948|FG017|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
8917273|NCT02190604|9976949|FG018|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
8917274|NCT02190604|9976931|FG000|STARTED|Part 3 (Patients)||0
8917275|NCT02190604|9976932|FG001|STARTED|Part 3 (Patients)||0
8917276|NCT02190604|9976933|FG002|STARTED|Part 3 (Patients)||0
8917277|NCT02190604|9976934|FG003|STARTED|Part 3 (Patients)||0
8917278|NCT02190604|9976935|FG004|STARTED|Part 3 (Patients)||0
8917279|NCT02190604|9976936|FG005|STARTED|Part 3 (Patients)||0
8917280|NCT02190604|9976937|FG006|STARTED|Part 3 (Patients)||0
8917281|NCT02190604|9976938|FG007|STARTED|Part 3 (Patients)||0
8917282|NCT02190604|9976939|FG008|STARTED|Part 3 (Patients)||0
8917283|NCT02190604|9976940|FG009|STARTED|Part 3 (Patients)||0
8917284|NCT02190604|9976941|FG010|STARTED|Part 3 (Patients)||0
8917285|NCT02190604|9976942|FG011|STARTED|Part 3 (Patients)||0
8917286|NCT02190604|9976943|FG012|STARTED|Part 3 (Patients)||0
8917287|NCT02190604|9976944|FG013|STARTED|Part 3 (Patients)||0
8917288|NCT02190604|9976945|FG014|STARTED|Part 3 (Patients)||0
8917289|NCT02190604|9976946|FG015|STARTED|Part 3 (Patients)||6
8917290|NCT02190604|9976947|FG016|STARTED|Part 3 (Patients)||12
8917291|NCT02190604|9976948|FG017|STARTED|Part 3 (Patients)||19
8917292|NCT02190604|9976949|FG018|STARTED|Part 3 (Patients)||12
8917293|NCT02190604|9976931|FG000|COMPLETED|Part 3 (Patients)||0
8917294|NCT02190604|9976932|FG001|COMPLETED|Part 3 (Patients)||0
8917295|NCT02190604|9976933|FG002|COMPLETED|Part 3 (Patients)||0
8917296|NCT02190604|9976934|FG003|COMPLETED|Part 3 (Patients)||0
8917297|NCT02190604|9976935|FG004|COMPLETED|Part 3 (Patients)||0
8917298|NCT02190604|9976936|FG005|COMPLETED|Part 3 (Patients)||0
8917299|NCT02190604|9976937|FG006|COMPLETED|Part 3 (Patients)||0
8917300|NCT02190604|9976938|FG007|COMPLETED|Part 3 (Patients)||0
8917301|NCT02190604|9976939|FG008|COMPLETED|Part 3 (Patients)||0
8917302|NCT02190604|9976940|FG009|COMPLETED|Part 3 (Patients)||0
8917303|NCT02190604|9976941|FG010|COMPLETED|Part 3 (Patients)||0
8917304|NCT02190604|9976942|FG011|COMPLETED|Part 3 (Patients)||0
8917305|NCT02190604|9976943|FG012|COMPLETED|Part 3 (Patients)||0
8917306|NCT02190604|9976944|FG013|COMPLETED|Part 3 (Patients)||0
8791838|NCT01392703|9843219|FG002|STARTED|Day 5||26
8791839|NCT01392703|9843217|FG000|COMPLETED|Day 5||26
8791840|NCT01392703|9843218|FG001|COMPLETED|Day 5||25
8791841|NCT01392703|9843219|FG002|COMPLETED|Day 5||26
8791842|NCT01392703|9843217|FG000|NOT COMPLETED|Day 5||0
8791843|NCT01392703|9843218|FG001|NOT COMPLETED|Day 5||0
8791844|NCT01392703|9843219|FG002|NOT COMPLETED|Day 5||0
8791845|NCT01392703|9843217|FG000|STARTED|Day 9||26
8791846|NCT01392703|9843218|FG001|STARTED|Day 9||26
8791847|NCT01392703|9843219|FG002|STARTED|Day 9||25
8791848|NCT01392703|9843217|FG000|COMPLETED|Day 9||26
8791849|NCT01392703|9843218|FG001|COMPLETED|Day 9||26
8791850|NCT01392703|9843219|FG002|COMPLETED|Day 9||25
8791851|NCT01392703|9843217|FG000|NOT COMPLETED|Day 9||0
8791852|NCT01392703|9843218|FG001|NOT COMPLETED|Day 9||0
8791853|NCT01392703|9843219|FG002|NOT COMPLETED|Day 9||0
8791854|NCT01392742|9843229|FG000|STARTED|Overall Study||443
8791855|NCT01392742|9843229|FG000|COMPLETED|Overall Study||242
8791856|NCT01392742|9843229|FG000|NOT COMPLETED|Overall Study||201
8791857|NCT01392859|9843233|FG000|STARTED|Overall Study||15
8791858|NCT01392859|9843234|FG001|STARTED|Overall Study||13
8791859|NCT01392859|9843235|FG002|STARTED|Overall Study||183
8791860|NCT01392859|9843233|FG000|Wash Out 3-7 Days|Overall Study||15
8791861|NCT01392859|9843234|FG001|Wash Out 3-7 Days|Overall Study||13
8791862|NCT01392859|9843235|FG002|Wash Out 3-7 Days|Overall Study||0
8791863|NCT01392859|9843233|FG000|COMPLETED|Overall Study||13
8791864|NCT01392859|9843234|FG001|COMPLETED|Overall Study||13
8791865|NCT01392859|9843235|FG002|COMPLETED|Overall Study||183
8791866|NCT01392859|9843233|FG000|NOT COMPLETED|Overall Study||2
8791867|NCT01392859|9843234|FG001|NOT COMPLETED|Overall Study||0
8791868|NCT01392859|9843235|FG002|NOT COMPLETED|Overall Study||0
8791869|NCT01392963|9843243|FG000|STARTED|Week 0 (First Intervention)||11
8791870|NCT01392963|9843244|FG001|STARTED|Week 0 (First Intervention)||19
8791871|NCT01392963|9843243|FG000|COMPLETED|Week 0 (First Intervention)||11
8791872|NCT01392963|9843244|FG001|COMPLETED|Week 0 (First Intervention)||17
8791873|NCT01392963|9843243|FG000|NOT COMPLETED|Week 0 (First Intervention)||0
8791874|NCT01392963|9843244|FG001|NOT COMPLETED|Week 0 (First Intervention)||2
8791875|NCT01392963|9843243|FG000|STARTED|Week 12 (Second Intervention)||11
8791876|NCT01392963|9843244|FG001|STARTED|Week 12 (Second Intervention)||17
8791877|NCT01392963|9843243|FG000|COMPLETED|Week 12 (Second Intervention)||11
9032702|NCT03264092|10094989|FG000|NOT COMPLETED|Overall Study||0
9032703|NCT03264092|10094990|FG001|NOT COMPLETED|Overall Study||0
9032704|NCT03264092|10094991|FG002|NOT COMPLETED|Overall Study||0
9032705|NCT03264157|10095007|FG000|STARTED|Overall Study||81
9032706|NCT03264157|10095008|FG001|STARTED|Overall Study||81
9032707|NCT03264157|10095007|FG000|COMPLETED|Overall Study||68
9032708|NCT03264157|10095008|FG001|COMPLETED|Overall Study||74
9032709|NCT03264157|10095007|FG000|NOT COMPLETED|Overall Study||13
9032710|NCT03264157|10095008|FG001|NOT COMPLETED|Overall Study||7
9032711|NCT03264248|10095016|FG000|STARTED|Overall Study||9
9032712|NCT03264248|10095016|FG000|COMPLETED|Overall Study||9
9032713|NCT03264248|10095016|FG000|NOT COMPLETED|Overall Study||0
9032714|NCT03264456|10095020|FG000|STARTED|Overall Study||18
9032715|NCT03264456|10095020|FG000|COMPLETED|Overall Study||14
9032716|NCT03264456|10095020|FG000|NOT COMPLETED|Overall Study||4
9032717|NCT03265119|10095026|FG000|STARTED|Overall Study||34
9032718|NCT03265119|10095027|FG001|STARTED|Overall Study||35
9032719|NCT03265119|10095026|FG000|COMPLETED|Overall Study||24
9032720|NCT03265119|10095027|FG001|COMPLETED|Overall Study||28
9032721|NCT03265119|10095026|FG000|NOT COMPLETED|Overall Study||10
9032722|NCT03265119|10095027|FG001|NOT COMPLETED|Overall Study||7
9032723|NCT03265132|10095035|FG000|STARTED|Overall Study||6
9032724|NCT03265132|10095036|FG001|STARTED|Overall Study|One patient failed disease specific inclusion criteria and was excluded from efficacy analysis|6
9032725|NCT03265132|10095035|FG000|COMPLETED|Overall Study||6
9032726|NCT03265132|10095036|FG001|COMPLETED|Overall Study||0
9032727|NCT03265132|10095035|FG000|NOT COMPLETED|Overall Study||0
9032728|NCT03265132|10095036|FG001|NOT COMPLETED|Overall Study||6
9032729|NCT03265600|10095046|FG000|STARTED|Overall Study||92
9032730|NCT03265600|10095047|FG001|STARTED|Overall Study||44
9032731|NCT03265600|10095046|FG000|COMPLETED|Overall Study|Completed 8 or 9 week Action Plan Initiation Survey|68
9032732|NCT03265600|10095047|FG001|COMPLETED|Overall Study|Completed 8 or 9 week Action Plan Initiation Survey|32
9032733|NCT03265600|10095046|FG000|NOT COMPLETED|Overall Study||24
9032734|NCT03265600|10095047|FG001|NOT COMPLETED|Overall Study||12
9032735|NCT03265938|10095053|FG000|STARTED|Overall Study||100
9032736|NCT03265938|10095053|FG000|COMPLETED|Overall Study||92
9032737|NCT03265938|10095053|FG000|NOT COMPLETED|Overall Study||8
9032738|NCT03266094|10095058|FG000|STARTED|Overall Study||60
9032739|NCT03266094|10095058|FG000|COMPLETED|Overall Study||58
9032740|NCT03266094|10095058|FG000|NOT COMPLETED|Overall Study||2
9032741|NCT03266107|10095064|FG000|STARTED|Enrollment to Procedure||50
9032742|NCT03266107|10095064|FG000|COMPLETED|Enrollment to Procedure||47
9032743|NCT03266107|10095064|FG000|NOT COMPLETED|Enrollment to Procedure||3
8791878|NCT01392963|9843244|FG001|COMPLETED|Week 12 (Second Intervention)||17
8791879|NCT01392963|9843243|FG000|NOT COMPLETED|Week 12 (Second Intervention)||0
8791880|NCT01392963|9843244|FG001|NOT COMPLETED|Week 12 (Second Intervention)||0
8791881|NCT01392963|9843243|FG000|STARTED|Week 24 Follow-up||11
8791882|NCT01392963|9843244|FG001|STARTED|Week 24 Follow-up||17
9032744|NCT03266107|10095064|FG000|STARTED|3-Month Follow-up Visit||47
9032745|NCT03266107|10095064|FG000|COMPLETED|3-Month Follow-up Visit||46
8791883|NCT01392963|9843243|FG000|COMPLETED|Week 24 Follow-up||9
8791884|NCT01392963|9843244|FG001|COMPLETED|Week 24 Follow-up||17
8791885|NCT01392963|9843243|FG000|NOT COMPLETED|Week 24 Follow-up||2
8791886|NCT01392963|9843244|FG001|NOT COMPLETED|Week 24 Follow-up||0
8791887|NCT01392989|9843252|FG000|STARTED|Total Lymphoid Irradiation (TLI)||44
8791888|NCT01392989|9843252|FG000|COMPLETED|Total Lymphoid Irradiation (TLI)||44
8791889|NCT01392989|9843252|FG000|NOT COMPLETED|Total Lymphoid Irradiation (TLI)||0
8791890|NCT01392989|9843252|FG000|STARTED|CIK Cell Infusion||31
8791891|NCT01392989|9843252|FG000|COMPLETED|CIK Cell Infusion||31
8791892|NCT01392989|9843252|FG000|NOT COMPLETED|CIK Cell Infusion||0
8791893|NCT01393106|9843257|FG000|STARTED|Overall Study||25
8791894|NCT01393106|9843257|FG000|COMPLETED|Overall Study|Completed: Disease Progression/Death|20
8791895|NCT01393106|9843257|FG000|NOT COMPLETED|Overall Study||5
8791896|NCT01393132|9843263|FG000|STARTED|Overall Study||6
8791897|NCT01393132|9843264|FG001|STARTED|Overall Study||3
8791898|NCT01393132|9843263|FG000|COMPLETED|Overall Study||6
8791899|NCT01393132|9843264|FG001|COMPLETED|Overall Study||3
8791900|NCT01393132|9843263|FG000|NOT COMPLETED|Overall Study||0
8791901|NCT01393132|9843264|FG001|NOT COMPLETED|Overall Study||0
8791902|NCT01393158|9843274|FG000|STARTED|Overall Study||6
8791903|NCT01393158|9843275|FG001|STARTED|Overall Study||10
8791904|NCT01393158|9843274|FG000|COMPLETED|Overall Study||5
8791905|NCT01393158|9843275|FG001|COMPLETED|Overall Study||10
8791906|NCT01393158|9843274|FG000|NOT COMPLETED|Overall Study||1
8791907|NCT01393158|9843275|FG001|NOT COMPLETED|Overall Study||0
8917307|NCT02190604|9976945|FG014|COMPLETED|Part 3 (Patients)||0
8917308|NCT02190604|9976946|FG015|COMPLETED|Part 3 (Patients)||6
8917309|NCT02190604|9976947|FG016|COMPLETED|Part 3 (Patients)||12
8917310|NCT02190604|9976948|FG017|COMPLETED|Part 3 (Patients)||19
8917311|NCT02190604|9976949|FG018|COMPLETED|Part 3 (Patients)||12
8917312|NCT02190604|9976931|FG000|NOT COMPLETED|Part 3 (Patients)||0
8917313|NCT02190604|9976932|FG001|NOT COMPLETED|Part 3 (Patients)||0
8917314|NCT02190604|9976933|FG002|NOT COMPLETED|Part 3 (Patients)||0
8917315|NCT02190604|9976934|FG003|NOT COMPLETED|Part 3 (Patients)||0
8917316|NCT02190604|9976935|FG004|NOT COMPLETED|Part 3 (Patients)||0
8917317|NCT02190604|9976936|FG005|NOT COMPLETED|Part 3 (Patients)||0
8917318|NCT02190604|9976937|FG006|NOT COMPLETED|Part 3 (Patients)||0
8917319|NCT02190604|9976938|FG007|NOT COMPLETED|Part 3 (Patients)||0
8917320|NCT02190604|9976939|FG008|NOT COMPLETED|Part 3 (Patients)||0
8917321|NCT02190604|9976940|FG009|NOT COMPLETED|Part 3 (Patients)||0
8917322|NCT02190604|9976941|FG010|NOT COMPLETED|Part 3 (Patients)||0
8917323|NCT02190604|9976942|FG011|NOT COMPLETED|Part 3 (Patients)||0
8917324|NCT02190604|9976943|FG012|NOT COMPLETED|Part 3 (Patients)||0
8917325|NCT02190604|9976944|FG013|NOT COMPLETED|Part 3 (Patients)||0
8917326|NCT02190604|9976945|FG014|NOT COMPLETED|Part 3 (Patients)||0
8917327|NCT02190604|9976946|FG015|NOT COMPLETED|Part 3 (Patients)||0
8917328|NCT02190604|9976947|FG016|NOT COMPLETED|Part 3 (Patients)||0
8917329|NCT02190604|9976948|FG017|NOT COMPLETED|Part 3 (Patients)||0
8917330|NCT02190604|9976949|FG018|NOT COMPLETED|Part 3 (Patients)||0
8917331|NCT02190747|9977009|FG000|STARTED|Overall Study||21
8917332|NCT02190747|9977010|FG001|STARTED|Overall Study||9
8917333|NCT02190747|9977011|FG002|STARTED|Overall Study||10
8917334|NCT02190747|9977009|FG000|COMPLETED|Overall Study||21
8917335|NCT02190747|9977010|FG001|COMPLETED|Overall Study||9
8917336|NCT02190747|9977011|FG002|COMPLETED|Overall Study||10
9032746|NCT03266107|10095064|FG000|NOT COMPLETED|3-Month Follow-up Visit||1
9032747|NCT03266107|10095064|FG000|STARTED|12-Month Follow-up Visit||46
9032748|NCT03266107|10095064|FG000|COMPLETED|12-Month Follow-up Visit||45
9032749|NCT03266107|10095064|FG000|NOT COMPLETED|12-Month Follow-up Visit||1
9032750|NCT03266172|10095073|FG000|STARTED|Part A: Period 1(2 Days)||16
9032751|NCT03266172|10095074|FG001|STARTED|Part A: Period 1(2 Days)||0
9032752|NCT03266172|10095075|FG002|STARTED|Part A: Period 1(2 Days)||0
9032753|NCT03266172|10095073|FG000|COMPLETED|Part A: Period 1(2 Days)||15
9032754|NCT03266172|10095074|FG001|COMPLETED|Part A: Period 1(2 Days)||0
9032755|NCT03266172|10095075|FG002|COMPLETED|Part A: Period 1(2 Days)||0
9032756|NCT03266172|10095073|FG000|NOT COMPLETED|Part A: Period 1(2 Days)||1
9032757|NCT03266172|10095074|FG001|NOT COMPLETED|Part A: Period 1(2 Days)||0
9032758|NCT03266172|10095075|FG002|NOT COMPLETED|Part A: Period 1(2 Days)||0
9032759|NCT03266172|10095073|FG000|STARTED|Part A: Washout Period (7 Days)||15
9032760|NCT03266172|10095074|FG001|STARTED|Part A: Washout Period (7 Days)||0
9032761|NCT03266172|10095075|FG002|STARTED|Part A: Washout Period (7 Days)||0
9032762|NCT03266172|10095073|FG000|COMPLETED|Part A: Washout Period (7 Days)||13
9032763|NCT03266172|10095074|FG001|COMPLETED|Part A: Washout Period (7 Days)||0
9032764|NCT03266172|10095075|FG002|COMPLETED|Part A: Washout Period (7 Days)||0
9032765|NCT03266172|10095073|FG000|NOT COMPLETED|Part A: Washout Period (7 Days)||2
9032766|NCT03266172|10095074|FG001|NOT COMPLETED|Part A: Washout Period (7 Days)||0
9032767|NCT03266172|10095075|FG002|NOT COMPLETED|Part A: Washout Period (7 Days)||0
9032768|NCT03266172|10095073|FG000|STARTED|Part A: Period 2 (2 Days)||13
9032769|NCT03266172|10095074|FG001|STARTED|Part A: Period 2 (2 Days)||0
9032770|NCT03266172|10095075|FG002|STARTED|Part A: Period 2 (2 Days)||0
9032771|NCT03266172|10095073|FG000|COMPLETED|Part A: Period 2 (2 Days)||13
9032772|NCT03266172|10095074|FG001|COMPLETED|Part A: Period 2 (2 Days)||0
9032773|NCT03266172|10095075|FG002|COMPLETED|Part A: Period 2 (2 Days)||0
8917337|NCT02190747|9977009|FG000|NOT COMPLETED|Overall Study||0
8917338|NCT02190747|9977010|FG001|NOT COMPLETED|Overall Study||0
8917339|NCT02190747|9977011|FG002|NOT COMPLETED|Overall Study||0
8917340|NCT02190903|9977021|FG000|STARTED|Overall Study||6
8917341|NCT02190903|9977022|FG001|STARTED|Overall Study||6
8791908|NCT01393301|9843289|FG000|STARTED|Overall Study||26
8791909|NCT01393301|9843290|FG001|STARTED|Overall Study||27
8791910|NCT01393301|9843289|FG000|COMPLETED|Overall Study||17
8791911|NCT01393301|9843290|FG001|COMPLETED|Overall Study||24
8791912|NCT01393301|9843289|FG000|NOT COMPLETED|Overall Study||9
8791913|NCT01393301|9843290|FG001|NOT COMPLETED|Overall Study||3
8791914|NCT01393392|9843298|FG000|STARTED|Overall Study||44
8791915|NCT01393392|9843299|FG001|STARTED|Overall Study||43
8791916|NCT01393392|9843298|FG000|COMPLETED|Overall Study||33
8791917|NCT01393392|9843299|FG001|COMPLETED|Overall Study||24
8791918|NCT01393392|9843298|FG000|NOT COMPLETED|Overall Study||11
8791919|NCT01393392|9843299|FG001|NOT COMPLETED|Overall Study||19
8791920|NCT01393405|9843305|FG000|STARTED|Induction Period (week1-16)||179
8791921|NCT01393405|9843306|FG001|STARTED|Induction Period (week1-16)||0
8791922|NCT01393405|9843307|FG002|STARTED|Induction Period (week1-16)||0
8791923|NCT01393405|9843305|FG000|COMPLETED|Induction Period (week1-16)||84
8791924|NCT01393405|9843306|FG001|COMPLETED|Induction Period (week1-16)||0
8791925|NCT01393405|9843307|FG002|COMPLETED|Induction Period (week1-16)||0
8791926|NCT01393405|9843305|FG000|NOT COMPLETED|Induction Period (week1-16)||95
8791927|NCT01393405|9843306|FG001|NOT COMPLETED|Induction Period (week1-16)||0
8791928|NCT01393405|9843307|FG002|NOT COMPLETED|Induction Period (week1-16)||0
8791929|NCT01393405|9843305|FG000|STARTED|Maintenance Period Week||0
8791930|NCT01393405|9843306|FG001|STARTED|Maintenance Period Week||44
8791931|NCT01393405|9843307|FG002|STARTED|Maintenance Period Week||40
8791932|NCT01393405|9843305|FG000|COMPLETED|Maintenance Period Week||0
8791933|NCT01393405|9843306|FG001|COMPLETED|Maintenance Period Week||15
8791934|NCT01393405|9843307|FG002|COMPLETED|Maintenance Period Week||16
8791935|NCT01393405|9843305|FG000|NOT COMPLETED|Maintenance Period Week||0
8791936|NCT01393405|9843306|FG001|NOT COMPLETED|Maintenance Period Week||29
8791937|NCT01393405|9843307|FG002|NOT COMPLETED|Maintenance Period Week||24
8791938|NCT01393444|9843317|FG000|STARTED|Overall Study||6
8791939|NCT01393444|9843317|FG000|First (1st Implanted) Subject Enrolled|Overall Study|2011: Individual with cervical spinal cord injury enrolled and was eligible. Implanted in 2011.|1
8791940|NCT01393444|9843317|FG000|Second Subject Enrolled|Overall Study|2012: Second participant enrolled. Ineligible.|1
8791941|NCT01393444|9843317|FG000|Third Subject Enrolled|Overall Study|2013: Third participant enrolled. Withdrew due to family commitments.|1
8791942|NCT01393444|9843317|FG000|Fourth Subject Enrolled|Overall Study|2013: Fourth participant enrolled. Ineligible.|1
8791943|NCT01393444|9843317|FG000|Fifth (2nd Implanted) Subject Enrolled|Overall Study|2013: Individual with ALS enrolled and was eligible. Implanted in 2014.|1
8791944|NCT01393444|9843317|FG000|Sixth (3rd Implanted) Subject|Overall Study|2014: Individual with brachial plexus injury enrolled and was eligible. Implanted in 2015.|1
8791945|NCT01393444|9843317|FG000|COMPLETED|Overall Study|2015: Third implanted subject completed the study. This fulfilled the requirements of our grant.|3
8791946|NCT01393444|9843317|FG000|NOT COMPLETED|Overall Study||3
8791947|NCT01393457|9843325|FG000|STARTED|Overall Study||26
8791948|NCT01393457|9843326|FG001|STARTED|Overall Study||26
8791949|NCT01393457|9843327|FG002|STARTED|Overall Study||31
8791950|NCT01393457|9843328|FG003|STARTED|Overall Study||27
8791951|NCT01393457|9843325|FG000|COMPLETED|Overall Study||14
8791952|NCT01393457|9843326|FG001|COMPLETED|Overall Study||14
8791953|NCT01393457|9843327|FG002|COMPLETED|Overall Study||16
8791954|NCT01393457|9843328|FG003|COMPLETED|Overall Study||15
8791955|NCT01393457|9843325|FG000|NOT COMPLETED|Overall Study||12
8791956|NCT01393457|9843326|FG001|NOT COMPLETED|Overall Study||12
8791957|NCT01393457|9843327|FG002|NOT COMPLETED|Overall Study||15
8791958|NCT01393457|9843328|FG003|NOT COMPLETED|Overall Study||12
8791959|NCT01393600|9843338|FG000|STARTED|Treatment Period 1 (Day 1 to 14)||9
8791960|NCT01393600|9843339|FG001|STARTED|Treatment Period 1 (Day 1 to 14)||8
8791961|NCT01393600|9843340|FG002|STARTED|Treatment Period 1 (Day 1 to 14)||10
8791962|NCT01393600|9843341|FG003|STARTED|Treatment Period 1 (Day 1 to 14)||10
8791963|NCT01393600|9843338|FG000|COMPLETED|Treatment Period 1 (Day 1 to 14)||9
8791964|NCT01393600|9843339|FG001|COMPLETED|Treatment Period 1 (Day 1 to 14)||7
8791965|NCT01393600|9843340|FG002|COMPLETED|Treatment Period 1 (Day 1 to 14)||9
8791966|NCT01393600|9843341|FG003|COMPLETED|Treatment Period 1 (Day 1 to 14)||9
8791967|NCT01393600|9843338|FG000|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||0
8791968|NCT01393600|9843339|FG001|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||1
8791969|NCT01393600|9843340|FG002|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||1
8791970|NCT01393600|9843341|FG003|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||1
8791971|NCT01393600|9843338|FG000|STARTED|Treatment Period 2 (Day 15 to 28)||9
8791972|NCT01393600|9843339|FG001|STARTED|Treatment Period 2 (Day 15 to 28)||7
8791973|NCT01393600|9843340|FG002|STARTED|Treatment Period 2 (Day 15 to 28)||9
8791974|NCT01393600|9843341|FG003|STARTED|Treatment Period 2 (Day 15 to 28)||9
8791975|NCT01393600|9843338|FG000|COMPLETED|Treatment Period 2 (Day 15 to 28)||9
8791976|NCT01393600|9843339|FG001|COMPLETED|Treatment Period 2 (Day 15 to 28)||7
8791977|NCT01393600|9843340|FG002|COMPLETED|Treatment Period 2 (Day 15 to 28)||7
8791978|NCT01393600|9843341|FG003|COMPLETED|Treatment Period 2 (Day 15 to 28)||8
8791979|NCT01393600|9843338|FG000|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||0
8791980|NCT01393600|9843339|FG001|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||0
8791981|NCT01393600|9843340|FG002|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||2
8791982|NCT01393600|9843341|FG003|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||1
8791983|NCT01393600|9843338|FG000|STARTED|Follow-up Period (Day 29 to 35)||9
8791984|NCT01393600|9843339|FG001|STARTED|Follow-up Period (Day 29 to 35)||7
8791985|NCT01393600|9843340|FG002|STARTED|Follow-up Period (Day 29 to 35)||7
8791986|NCT01393600|9843341|FG003|STARTED|Follow-up Period (Day 29 to 35)||8
8791987|NCT01393600|9843338|FG000|COMPLETED|Follow-up Period (Day 29 to 35)||9
8791988|NCT01393600|9843339|FG001|COMPLETED|Follow-up Period (Day 29 to 35)||7
8791989|NCT01393600|9843340|FG002|COMPLETED|Follow-up Period (Day 29 to 35)||6
8791990|NCT01393600|9843341|FG003|COMPLETED|Follow-up Period (Day 29 to 35)||8
8791991|NCT01393600|9843338|FG000|NOT COMPLETED|Follow-up Period (Day 29 to 35)||0
8791992|NCT01393600|9843339|FG001|NOT COMPLETED|Follow-up Period (Day 29 to 35)||0
8791993|NCT01393600|9843340|FG002|NOT COMPLETED|Follow-up Period (Day 29 to 35)||1
8791994|NCT01393600|9843341|FG003|NOT COMPLETED|Follow-up Period (Day 29 to 35)||0
8791995|NCT01393613|9843357|FG000|STARTED|Overall Study||120
8791996|NCT01393613|9843358|FG001|STARTED|Overall Study||186
8791997|NCT01393613|9843359|FG002|STARTED|Overall Study||184
8791998|NCT01393613|9843360|FG003|STARTED|Overall Study||184
8791999|NCT01393613|9843357|FG000|COMPLETED|Overall Study||81
8792000|NCT01393613|9843358|FG001|COMPLETED|Overall Study||129
8792001|NCT01393613|9843359|FG002|COMPLETED|Overall Study||130
8792002|NCT01393613|9843360|FG003|COMPLETED|Overall Study||118
8792003|NCT01393613|9843357|FG000|NOT COMPLETED|Overall Study||39
8792004|NCT01393613|9843358|FG001|NOT COMPLETED|Overall Study||57
8792005|NCT01393613|9843359|FG002|NOT COMPLETED|Overall Study||54
8792006|NCT01393613|9843360|FG003|NOT COMPLETED|Overall Study||66
8792007|NCT01393626|9843376|FG000|STARTED|Overall Study||91
8792008|NCT01393626|9843377|FG001|STARTED|Overall Study||86
8792009|NCT01393626|9843378|FG002|STARTED|Overall Study||86
8792010|NCT01393626|9843379|FG003|STARTED|Overall Study||16
8792011|NCT01393626|9843376|FG000|COMPLETED|Overall Study||73
8792012|NCT01393626|9843377|FG001|COMPLETED|Overall Study||74
8792013|NCT01393626|9843378|FG002|COMPLETED|Overall Study||74
8792014|NCT01393626|9843379|FG003|COMPLETED|Overall Study||15
8792015|NCT01393626|9843376|FG000|NOT COMPLETED|Overall Study||18
8792016|NCT01393626|9843377|FG001|NOT COMPLETED|Overall Study||12
8792017|NCT01393626|9843378|FG002|NOT COMPLETED|Overall Study||12
8792018|NCT01393626|9843379|FG003|NOT COMPLETED|Overall Study||1
8792019|NCT01393704|9843398|FG000|STARTED|Overall Study||76
8792020|NCT01393704|9843399|FG001|STARTED|Overall Study||76
8792021|NCT01393704|9843398|FG000|COMPLETED|Overall Study||76
8792022|NCT01393704|9843399|FG001|COMPLETED|Overall Study||76
8792023|NCT01393704|9843398|FG000|NOT COMPLETED|Overall Study||0
8792024|NCT01393704|9843399|FG001|NOT COMPLETED|Overall Study||0
8792025|NCT01393717|9843405|FG000|STARTED|Overall Study||37
8792026|NCT01393717|9843406|FG001|STARTED|Overall Study||20
8792027|NCT01393717|9843405|FG000|COMPLETED|Overall Study||37
8792028|NCT01393717|9843406|FG001|COMPLETED|Overall Study||20
8792029|NCT01393717|9843405|FG000|NOT COMPLETED|Overall Study||0
8792030|NCT01393717|9843406|FG001|NOT COMPLETED|Overall Study||0
8792031|NCT01393730|9843416|FG000|STARTED|Overall Study||40
8792032|NCT01393730|9843416|FG000|Treated|Overall Study||38
8792033|NCT01393730|9843416|FG000|Evaluable AR Amplification|Overall Study||21
8792034|NCT01393730|9843416|FG000|Evaluable AR Mutation|Overall Study||14
8792035|NCT01393730|9843416|FG000|COMPLETED|Overall Study||34
8792036|NCT01393730|9843416|FG000|NOT COMPLETED|Overall Study||6
8792037|NCT01393743|9843422|FG000|STARTED|Core Study|Treated|82
8792038|NCT01393743|9843423|FG001|STARTED|Core Study|Treated|81
8792039|NCT01393743|9843424|FG002|STARTED|Core Study||0
8792040|NCT01393743|9843422|FG000|COMPLETED|Core Study||72
8792041|NCT01393743|9843423|FG001|COMPLETED|Core Study||68
8792042|NCT01393743|9843424|FG002|COMPLETED|Core Study||0
8792043|NCT01393743|9843422|FG000|NOT COMPLETED|Core Study||10
8792044|NCT01393743|9843423|FG001|NOT COMPLETED|Core Study||13
8792045|NCT01393743|9843424|FG002|NOT COMPLETED|Core Study||0
8792046|NCT01393743|9843422|FG000|STARTED|Extension Phase||0
8792047|NCT01393743|9843423|FG001|STARTED|Extension Phase||0
8792048|NCT01393743|9843424|FG002|STARTED|Extension Phase|Continuation into the Extension Phase was optional.|138
8792049|NCT01393743|9843422|FG000|COMPLETED|Extension Phase||0
8792050|NCT01393743|9843423|FG001|COMPLETED|Extension Phase||0
8792051|NCT01393743|9843424|FG002|COMPLETED|Extension Phase||78
8792052|NCT01393743|9843422|FG000|NOT COMPLETED|Extension Phase||0
8792053|NCT01393743|9843423|FG001|NOT COMPLETED|Extension Phase||0
8792054|NCT01393743|9843424|FG002|NOT COMPLETED|Extension Phase||60
8792055|NCT01393821|9843437|FG000|STARTED|Overall Study||14
8792056|NCT01393821|9843438|FG001|STARTED|Overall Study||13
8792057|NCT01393821|9843437|FG000|COMPLETED|Overall Study||9
8792058|NCT01393821|9843438|FG001|COMPLETED|Overall Study||10
8792059|NCT01393821|9843437|FG000|NOT COMPLETED|Overall Study||5
8792060|NCT01393821|9843438|FG001|NOT COMPLETED|Overall Study||3
8792061|NCT01393899|9843447|FG000|STARTED|Overall Study||59
8792062|NCT01393899|9843448|FG001|STARTED|Overall Study||60
8792063|NCT01393899|9843449|FG002|STARTED|Overall Study||61
8792064|NCT01393899|9843447|FG000|COMPLETED|Overall Study||27
8792065|NCT01393899|9843448|FG001|COMPLETED|Overall Study||32
8792066|NCT01393899|9843449|FG002|COMPLETED|Overall Study||38
8792067|NCT01393899|9843447|FG000|NOT COMPLETED|Overall Study||32
8792068|NCT01393899|9843448|FG001|NOT COMPLETED|Overall Study||28
8792069|NCT01393899|9843449|FG002|NOT COMPLETED|Overall Study||23
8792070|NCT01393964|9843462|FG000|STARTED|Overall Study||8
8792071|NCT01393964|9843463|FG001|STARTED|Overall Study||9
8792072|NCT01393964|9843464|FG002|STARTED|Overall Study||9
8792073|NCT01393964|9843462|FG000|COMPLETED|Overall Study|Completed=treatment on-going|0
8792074|NCT01393964|9843463|FG001|COMPLETED|Overall Study|Completed=treatment on-going|0
8792075|NCT01393964|9843464|FG002|COMPLETED|Overall Study|Completed=treatment on-going|0
8792076|NCT01393964|9843462|FG000|NOT COMPLETED|Overall Study||8
8792077|NCT01393964|9843463|FG001|NOT COMPLETED|Overall Study||9
8792078|NCT01393964|9843464|FG002|NOT COMPLETED|Overall Study||9
8792079|NCT01393990|9843496|FG000|STARTED|Overall Study||4
8792080|NCT01393990|9843497|FG001|STARTED|Overall Study||3
8792081|NCT01393990|9843498|FG002|STARTED|Overall Study||3
8792082|NCT01393990|9843499|FG003|STARTED|Overall Study||3
8792083|NCT01393990|9843500|FG004|STARTED|Overall Study||5
8792084|NCT01393990|9843501|FG005|STARTED|Overall Study||3
8792085|NCT01393990|9843502|FG006|STARTED|Overall Study||3
8792086|NCT01393990|9843503|FG007|STARTED|Overall Study||7
8792087|NCT01393990|9843504|FG008|STARTED|Overall Study||6
8792088|NCT01393990|9843505|FG009|STARTED|Overall Study||3
8792089|NCT01393990|9843506|FG010|STARTED|Overall Study||3
8792090|NCT01393990|9843507|FG011|STARTED|Overall Study||3
8792091|NCT01393990|9843508|FG012|STARTED|Overall Study||3
8792092|NCT01393990|9843509|FG013|STARTED|Overall Study||5
8792093|NCT01393990|9843510|FG014|STARTED|Overall Study||18
8792094|NCT01393990|9843511|FG015|STARTED|Overall Study||8
8792095|NCT01393990|9843512|FG016|STARTED|Overall Study||3
8792096|NCT01393990|9843513|FG017|STARTED|Overall Study||6
8792097|NCT01393990|9843496|FG000|Received at Least 1 Dose of Study Drug|Overall Study||4
8792098|NCT01393990|9843497|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
8792099|NCT01393990|9843498|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
8792100|NCT01393990|9843499|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
8792101|NCT01393990|9843500|FG004|Received at Least 1 Dose of Study Drug|Overall Study||5
8792102|NCT01393990|9843501|FG005|Received at Least 1 Dose of Study Drug|Overall Study||3
8792103|NCT01393990|9843502|FG006|Received at Least 1 Dose of Study Drug|Overall Study||3
8792104|NCT01393990|9843503|FG007|Received at Least 1 Dose of Study Drug|Overall Study||7
8792105|NCT01393990|9843504|FG008|Received at Least 1 Dose of Study Drug|Overall Study||6
8792106|NCT01393990|9843505|FG009|Received at Least 1 Dose of Study Drug|Overall Study||3
8792107|NCT01393990|9843506|FG010|Received at Least 1 Dose of Study Drug|Overall Study||3
8792108|NCT01393990|9843507|FG011|Received at Least 1 Dose of Study Drug|Overall Study||3
8792109|NCT01393990|9843508|FG012|Received at Least 1 Dose of Study Drug|Overall Study||3
8792110|NCT01393990|9843509|FG013|Received at Least 1 Dose of Study Drug|Overall Study||5
8792111|NCT01393990|9843510|FG014|Received at Least 1 Dose of Study Drug|Overall Study||18
8792112|NCT01393990|9843511|FG015|Received at Least 1 Dose of Study Drug|Overall Study||8
8792113|NCT01393990|9843512|FG016|Received at Least 1 Dose of Study Drug|Overall Study||3
8792114|NCT01393990|9843513|FG017|Received at Least 1 Dose of Study Drug|Overall Study||6
8792115|NCT01393990|9843496|FG000|COMPLETED|Overall Study||3
8792116|NCT01393990|9843497|FG001|COMPLETED|Overall Study||3
8792117|NCT01393990|9843498|FG002|COMPLETED|Overall Study||3
8792118|NCT01393990|9843499|FG003|COMPLETED|Overall Study||2
8792119|NCT01393990|9843500|FG004|COMPLETED|Overall Study||3
8792120|NCT01393990|9843501|FG005|COMPLETED|Overall Study||2
8792121|NCT01393990|9843502|FG006|COMPLETED|Overall Study||2
8792122|NCT01393990|9843503|FG007|COMPLETED|Overall Study||6
8792123|NCT01393990|9843504|FG008|COMPLETED|Overall Study||3
8792124|NCT01393990|9843505|FG009|COMPLETED|Overall Study||2
8792125|NCT01393990|9843506|FG010|COMPLETED|Overall Study||3
8792126|NCT01393990|9843507|FG011|COMPLETED|Overall Study||3
8792127|NCT01393990|9843508|FG012|COMPLETED|Overall Study||3
8792128|NCT01393990|9843509|FG013|COMPLETED|Overall Study||3
8792129|NCT01393990|9843510|FG014|COMPLETED|Overall Study||9
8792130|NCT01393990|9843511|FG015|COMPLETED|Overall Study||5
8792131|NCT01393990|9843512|FG016|COMPLETED|Overall Study||3
8792132|NCT01393990|9843513|FG017|COMPLETED|Overall Study||6
8792133|NCT01393990|9843496|FG000|NOT COMPLETED|Overall Study||1
8792134|NCT01393990|9843497|FG001|NOT COMPLETED|Overall Study||0
8792135|NCT01393990|9843498|FG002|NOT COMPLETED|Overall Study||0
8792136|NCT01393990|9843499|FG003|NOT COMPLETED|Overall Study||1
8792137|NCT01393990|9843500|FG004|NOT COMPLETED|Overall Study||2
8792138|NCT01393990|9843501|FG005|NOT COMPLETED|Overall Study||1
8792139|NCT01393990|9843502|FG006|NOT COMPLETED|Overall Study||1
8792140|NCT01393990|9843503|FG007|NOT COMPLETED|Overall Study||1
8792141|NCT01393990|9843504|FG008|NOT COMPLETED|Overall Study||3
8792142|NCT01393990|9843505|FG009|NOT COMPLETED|Overall Study||1
8792143|NCT01393990|9843506|FG010|NOT COMPLETED|Overall Study||0
8792144|NCT01393990|9843507|FG011|NOT COMPLETED|Overall Study||0
8792145|NCT01393990|9843508|FG012|NOT COMPLETED|Overall Study||0
8792146|NCT01393990|9843509|FG013|NOT COMPLETED|Overall Study||2
8792147|NCT01393990|9843510|FG014|NOT COMPLETED|Overall Study||9
8792148|NCT01393990|9843511|FG015|NOT COMPLETED|Overall Study||3
8792149|NCT01393990|9843512|FG016|NOT COMPLETED|Overall Study||0
8792150|NCT01393990|9843513|FG017|NOT COMPLETED|Overall Study||0
8792151|NCT01394003|9843570|FG000|STARTED|Overall Study||3
8792152|NCT01394003|9843571|FG001|STARTED|Overall Study||8
8792153|NCT01394003|9843572|FG002|STARTED|Overall Study||3
8792154|NCT01394003|9843573|FG003|STARTED|Overall Study||6
8792155|NCT01394003|9843574|FG004|STARTED|Overall Study||3
8792156|NCT01394003|9843575|FG005|STARTED|Overall Study||3
8792157|NCT01394003|9843576|FG006|STARTED|Overall Study||6
8792158|NCT01394003|9843577|FG007|STARTED|Overall Study||2
8792159|NCT01394003|9843570|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
8792160|NCT01394003|9843571|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8
8792161|NCT01394003|9843572|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
8792162|NCT01394003|9843573|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
8792163|NCT01394003|9843574|FG004|Received at Least 1 Dose of Study Drug|Overall Study||3
8792164|NCT01394003|9843575|FG005|Received at Least 1 Dose of Study Drug|Overall Study||3
8792165|NCT01394003|9843576|FG006|Received at Least 1 Dose of Study Drug|Overall Study||6
8792166|NCT01394003|9843577|FG007|Received at Least 1 Dose of Study Drug|Overall Study||2
8792167|NCT01394003|9843570|FG000|COMPLETED|Overall Study||3
8792168|NCT01394003|9843571|FG001|COMPLETED|Overall Study||8
8792169|NCT01394003|9843572|FG002|COMPLETED|Overall Study||3
8792170|NCT01394003|9843573|FG003|COMPLETED|Overall Study||6
8792171|NCT01394003|9843574|FG004|COMPLETED|Overall Study||3
8792172|NCT01394003|9843575|FG005|COMPLETED|Overall Study||3
8792173|NCT01394003|9843576|FG006|COMPLETED|Overall Study||6
8792174|NCT01394003|9843577|FG007|COMPLETED|Overall Study||2
8792175|NCT01394003|9843570|FG000|NOT COMPLETED|Overall Study||0
8792176|NCT01394003|9843571|FG001|NOT COMPLETED|Overall Study||0
8792177|NCT01394003|9843572|FG002|NOT COMPLETED|Overall Study||0
8792178|NCT01394003|9843573|FG003|NOT COMPLETED|Overall Study||0
8792179|NCT01394003|9843574|FG004|NOT COMPLETED|Overall Study||0
8792180|NCT01394003|9843575|FG005|NOT COMPLETED|Overall Study||0
8792181|NCT01394003|9843576|FG006|NOT COMPLETED|Overall Study||0
8792182|NCT01394003|9843577|FG007|NOT COMPLETED|Overall Study||0
8792183|NCT01394081|9843603|FG000|STARTED|Overall Study||101
8792184|NCT01394081|9843604|FG001|STARTED|Overall Study||102
8792185|NCT01394081|9843603|FG000|COMPLETED|Overall Study||101
8792186|NCT01394081|9843604|FG001|COMPLETED|Overall Study||102
8792187|NCT01394081|9843603|FG000|NOT COMPLETED|Overall Study||0
8792188|NCT01394081|9843604|FG001|NOT COMPLETED|Overall Study||0
8792189|NCT01394159|9843614|FG000|STARTED|Overall Study||28
8792190|NCT01394159|9843615|FG001|STARTED|Overall Study||28
8792191|NCT01394159|9843614|FG000|COMPLETED|Overall Study||28
8792192|NCT01394159|9843615|FG001|COMPLETED|Overall Study||28
8792193|NCT01394159|9843614|FG000|NOT COMPLETED|Overall Study||0
8792194|NCT01394159|9843615|FG001|NOT COMPLETED|Overall Study||0
8792195|NCT01394185|9843621|FG000|STARTED|Overall Study||8
8792196|NCT01394185|9843622|FG001|STARTED|Overall Study||2
8792197|NCT01394185|9843623|FG002|STARTED|Overall Study||2
8792198|NCT01394185|9843624|FG003|STARTED|Overall Study||4
8792199|NCT01394185|9843625|FG004|STARTED|Overall Study||6
8792200|NCT01394185|9843626|FG005|STARTED|Overall Study||3
8792201|NCT01394185|9843621|FG000|COMPLETED|Overall Study||2
8792202|NCT01394185|9843622|FG001|COMPLETED|Overall Study||2
8792203|NCT01394185|9843623|FG002|COMPLETED|Overall Study||2
8792204|NCT01394185|9843624|FG003|COMPLETED|Overall Study||3
8792205|NCT01394185|9843625|FG004|COMPLETED|Overall Study||2
8792206|NCT01394185|9843626|FG005|COMPLETED|Overall Study||2
8792207|NCT01394185|9843621|FG000|NOT COMPLETED|Overall Study||6
8792208|NCT01394185|9843622|FG001|NOT COMPLETED|Overall Study||0
8792209|NCT01394185|9843623|FG002|NOT COMPLETED|Overall Study||0
8792210|NCT01394185|9843624|FG003|NOT COMPLETED|Overall Study||1
8792211|NCT01394185|9843625|FG004|NOT COMPLETED|Overall Study||4
8792212|NCT01394185|9843626|FG005|NOT COMPLETED|Overall Study||1
8792213|NCT01394250|9843636|FG000|STARTED|Randomization and IV Placement Attempt||134
8792214|NCT01394250|9843637|FG001|STARTED|Randomization and IV Placement Attempt||134
8792215|NCT01394250|9843636|FG000|COMPLETED|Randomization and IV Placement Attempt||120
8792216|NCT01394250|9843637|FG001|COMPLETED|Randomization and IV Placement Attempt||121
8792217|NCT01394250|9843636|FG000|NOT COMPLETED|Randomization and IV Placement Attempt||14
8792218|NCT01394250|9843637|FG001|NOT COMPLETED|Randomization and IV Placement Attempt||13
8792219|NCT01394250|9843636|FG000|STARTED|Successful IV Placement & Follow-Up||120
8792220|NCT01394250|9843637|FG001|STARTED|Successful IV Placement & Follow-Up||121
8792221|NCT01394250|9843636|FG000|COMPLETED|Successful IV Placement & Follow-Up||114
8792222|NCT01394250|9843637|FG001|COMPLETED|Successful IV Placement & Follow-Up||110
8792223|NCT01394250|9843636|FG000|NOT COMPLETED|Successful IV Placement & Follow-Up||6
8792224|NCT01394250|9843637|FG001|NOT COMPLETED|Successful IV Placement & Follow-Up||11
8792225|NCT01394276|9843643|FG000|STARTED|Overall Study||322
8792226|NCT01394276|9843643|FG000|COMPLETED|Overall Study||260
8792227|NCT01394276|9843643|FG000|NOT COMPLETED|Overall Study||62
8792228|NCT01394510|9843652|FG000|STARTED|Overall Study||13
8792229|NCT01394510|9843652|FG000|COMPLETED|Overall Study||13
8792230|NCT01394510|9843652|FG000|NOT COMPLETED|Overall Study||0
8792231|NCT01394523|9843659|FG000|STARTED|Overall Study||13
8792232|NCT01394523|9843660|FG001|STARTED|Overall Study||13
8792233|NCT01394523|9843661|FG002|STARTED|Overall Study||13
8792234|NCT01394523|9843659|FG000|COMPLETED|Overall Study||12
8792235|NCT01394523|9843660|FG001|COMPLETED|Overall Study||13
8792236|NCT01394523|9843661|FG002|COMPLETED|Overall Study||13
8792237|NCT01394523|9843659|FG000|NOT COMPLETED|Overall Study||1
8792238|NCT01394523|9843660|FG001|NOT COMPLETED|Overall Study||0
8792239|NCT01394523|9843661|FG002|NOT COMPLETED|Overall Study||0
8792240|NCT01394614|9843671|FG000|STARTED|Overall Study||8
9032774|NCT03266172|10095073|FG000|NOT COMPLETED|Part A: Period 2 (2 Days)||0
8792241|NCT01394614|9843672|FG001|STARTED|Overall Study||16
8792242|NCT01394614|9843671|FG000|COMPLETED|Overall Study||8
8792243|NCT01394614|9843672|FG001|COMPLETED|Overall Study||16
8792244|NCT01394614|9843671|FG000|NOT COMPLETED|Overall Study||0
8792245|NCT01394614|9843672|FG001|NOT COMPLETED|Overall Study||0
8792246|NCT01394627|9843678|FG000|STARTED|First Intervention (1 Day)||8
8792247|NCT01394627|9843679|FG001|STARTED|First Intervention (1 Day)||13
8792248|NCT01394627|9843678|FG000|COMPLETED|First Intervention (1 Day)||8
8792249|NCT01394627|9843679|FG001|COMPLETED|First Intervention (1 Day)||12
8792250|NCT01394627|9843678|FG000|NOT COMPLETED|First Intervention (1 Day)||0
8792251|NCT01394627|9843679|FG001|NOT COMPLETED|First Intervention (1 Day)||1
8792252|NCT01394627|9843678|FG000|STARTED|Washout (1-3 Months)||8
8792253|NCT01394627|9843679|FG001|STARTED|Washout (1-3 Months)||12
8792254|NCT01394627|9843678|FG000|COMPLETED|Washout (1-3 Months)||7
8792255|NCT01394627|9843679|FG001|COMPLETED|Washout (1-3 Months)||12
8792256|NCT01394627|9843678|FG000|NOT COMPLETED|Washout (1-3 Months)||1
8792257|NCT01394627|9843679|FG001|NOT COMPLETED|Washout (1-3 Months)||0
8792258|NCT01394627|9843678|FG000|STARTED|Second Intervention (1 Day)||7
8792259|NCT01394627|9843679|FG001|STARTED|Second Intervention (1 Day)||12
8792260|NCT01394627|9843678|FG000|COMPLETED|Second Intervention (1 Day)||7
8792261|NCT01394627|9843679|FG001|COMPLETED|Second Intervention (1 Day)||12
8792262|NCT01394627|9843678|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
8792263|NCT01394627|9843679|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
8792264|NCT01394692|9843687|FG000|STARTED|Overall Study||29
8792265|NCT01394692|9843688|FG001|STARTED|Overall Study||29
8792266|NCT01394692|9843687|FG000|COMPLETED|Overall Study||29
8792267|NCT01394692|9843688|FG001|COMPLETED|Overall Study||29
8792268|NCT01394692|9843687|FG000|NOT COMPLETED|Overall Study||0
8792269|NCT01394692|9843688|FG001|NOT COMPLETED|Overall Study||0
8792270|NCT01394705|9843696|FG000|STARTED|Overall Study||21
8792271|NCT01394705|9843697|FG001|STARTED|Overall Study||21
8792272|NCT01394705|9843696|FG000|COMPLETED|Overall Study||19
8792273|NCT01394705|9843697|FG001|COMPLETED|Overall Study||19
8792274|NCT01394705|9843696|FG000|NOT COMPLETED|Overall Study||2
8792275|NCT01394705|9843697|FG001|NOT COMPLETED|Overall Study||2
8792276|NCT01394718|9843706|FG000|STARTED|Overall Study||30
8792277|NCT01394718|9843707|FG001|STARTED|Overall Study||30
8792278|NCT01394718|9843706|FG000|COMPLETED|Overall Study||28
8792279|NCT01394718|9843707|FG001|COMPLETED|Overall Study||29
8792280|NCT01394718|9843706|FG000|NOT COMPLETED|Overall Study||2
8792281|NCT01394718|9843707|FG001|NOT COMPLETED|Overall Study||1
8792282|NCT01394939|9843717|FG000|STARTED|Overall Study||4
8792283|NCT01394939|9843718|FG001|STARTED|Overall Study||25
8792284|NCT01394939|9843719|FG002|STARTED|Overall Study||4
8792285|NCT01394939|9843720|FG003|STARTED|Overall Study||17
8792286|NCT01394939|9843717|FG000|COMPLETED|Overall Study||3
8792287|NCT01394939|9843718|FG001|COMPLETED|Overall Study||15
8792288|NCT01394939|9843719|FG002|COMPLETED|Overall Study||4
8792289|NCT01394939|9843720|FG003|COMPLETED|Overall Study||10
8792290|NCT01394939|9843717|FG000|NOT COMPLETED|Overall Study||1
8792291|NCT01394939|9843718|FG001|NOT COMPLETED|Overall Study||10
8792292|NCT01394939|9843719|FG002|NOT COMPLETED|Overall Study||0
8792293|NCT01394939|9843720|FG003|NOT COMPLETED|Overall Study||7
8792294|NCT01394952|9843732|FG000|STARTED|Overall Study||4952
8792295|NCT01394952|9843733|FG001|STARTED|Overall Study||4949
8792296|NCT01394952|9843732|FG000|Received at Least One Dose of Study Drug|Overall Study||4949
8792297|NCT01394952|9843733|FG001|Received at Least One Dose of Study Drug|Overall Study||4943
8792298|NCT01394952|9843732|FG000|COMPLETED|Overall Study||4935
8792299|NCT01394952|9843733|FG001|COMPLETED|Overall Study||4932
8792300|NCT01394952|9843732|FG000|NOT COMPLETED|Overall Study||17
8792301|NCT01394952|9843733|FG001|NOT COMPLETED|Overall Study||17
8792302|NCT01394978|9843742|FG000|STARTED|Overall Study||168
8792303|NCT01394978|9843743|FG001|STARTED|Overall Study||276
8792304|NCT01394978|9843742|FG000|COMPLETED|Overall Study||147
8792305|NCT01394978|9843743|FG001|COMPLETED|Overall Study||245
8792306|NCT01394978|9843742|FG000|NOT COMPLETED|Overall Study||21
8792307|NCT01394978|9843743|FG001|NOT COMPLETED|Overall Study||31
8792308|NCT01394991|9843752|FG000|STARTED|Overall Study||242
8792309|NCT01394991|9843753|FG001|STARTED|Overall Study||262
8792310|NCT01394991|9843752|FG000|COMPLETED|Overall Study||183
8792311|NCT01394991|9843753|FG001|COMPLETED|Overall Study||190
8792312|NCT01394991|9843752|FG000|NOT COMPLETED|Overall Study||59
8792313|NCT01394991|9843753|FG001|NOT COMPLETED|Overall Study||72
8792314|NCT01395017|9843761|FG000|STARTED|Overall Study||100
8792315|NCT01395017|9843762|FG001|STARTED|Overall Study||102
8792316|NCT01395017|9843761|FG000|Treated|Overall Study||98
8792317|NCT01395017|9843762|FG001|Treated|Overall Study||101
8792318|NCT01395017|9843761|FG000|COMPLETED|Overall Study||0
8792319|NCT01395017|9843762|FG001|COMPLETED|Overall Study||0
8792320|NCT01395017|9843761|FG000|NOT COMPLETED|Overall Study||100
8792321|NCT01395017|9843762|FG001|NOT COMPLETED|Overall Study||102
8792322|NCT01395030|9843769|FG000|STARTED|Overall Study||64
8792323|NCT01395030|9843769|FG000|Complete FCH PET/CT|Overall Study||57
8792324|NCT01395030|9843769|FG000|Adequate Tissue for Analysis|Overall Study||50
8792325|NCT01395030|9843769|FG000|COMPLETED|Overall Study||57
8792326|NCT01395030|9843769|FG000|NOT COMPLETED|Overall Study||7
8792327|NCT01395043|9843775|FG000|STARTED|Overall Study||15
8792328|NCT01395043|9843775|FG000|COMPLETED|Overall Study||15
8792329|NCT01395043|9843775|FG000|NOT COMPLETED|Overall Study||0
8792330|NCT01395277|9843782|FG000|STARTED|Overall Study||15
8792331|NCT01395277|9843783|FG001|STARTED|Overall Study||15
8792332|NCT01395277|9843782|FG000|COMPLETED|Overall Study||15
8792333|NCT01395277|9843783|FG001|COMPLETED|Overall Study||15
8792334|NCT01395277|9843782|FG000|NOT COMPLETED|Overall Study||0
8792335|NCT01395277|9843783|FG001|NOT COMPLETED|Overall Study||0
8792336|NCT01395316|9843791|FG000|STARTED|Overall Study||8
8792337|NCT01395316|9843791|FG000|COMPLETED|Overall Study||5
8792338|NCT01395316|9843791|FG000|NOT COMPLETED|Overall Study||3
8792339|NCT01395329|9843798|FG000|STARTED|Overall Study||14
8792340|NCT01395329|9843799|FG001|STARTED|Overall Study||14
8792341|NCT01395329|9843800|FG002|STARTED|Overall Study||14
8792342|NCT01395329|9843798|FG000|COMPLETED|Overall Study||14
8792343|NCT01395329|9843799|FG001|COMPLETED|Overall Study||14
8792344|NCT01395329|9843800|FG002|COMPLETED|Overall Study||14
8792345|NCT01395329|9843798|FG000|NOT COMPLETED|Overall Study||0
8792346|NCT01395329|9843799|FG001|NOT COMPLETED|Overall Study||0
8792347|NCT01395329|9843800|FG002|NOT COMPLETED|Overall Study||0
8792348|NCT01395368|9843811|FG000|STARTED|Overall Study||108
8792349|NCT01395368|9843811|FG000|COMPLETED|Overall Study||92
8792350|NCT01395368|9843811|FG000|NOT COMPLETED|Overall Study||16
8792351|NCT01395394|9843818|FG000|STARTED|Baseline Study Visit||4
8792352|NCT01395394|9843819|FG001|STARTED|Baseline Study Visit||3
8792353|NCT01395394|9843820|FG002|STARTED|Baseline Study Visit||5
8792354|NCT01395394|9843818|FG000|COMPLETED|Baseline Study Visit||3
8792355|NCT01395394|9843819|FG001|COMPLETED|Baseline Study Visit||3
8792356|NCT01395394|9843820|FG002|COMPLETED|Baseline Study Visit||5
8792357|NCT01395394|9843818|FG000|NOT COMPLETED|Baseline Study Visit||1
8792358|NCT01395394|9843819|FG001|NOT COMPLETED|Baseline Study Visit||0
8792359|NCT01395394|9843820|FG002|NOT COMPLETED|Baseline Study Visit||0
8792360|NCT01395394|9843818|FG000|STARTED|Study Visit 2 (Non-responders Only)||3
8792361|NCT01395394|9843819|FG001|STARTED|Study Visit 2 (Non-responders Only)||0
8792362|NCT01395394|9843820|FG002|STARTED|Study Visit 2 (Non-responders Only)||0
8792363|NCT01395394|9843818|FG000|COMPLETED|Study Visit 2 (Non-responders Only)||3
8792364|NCT01395394|9843819|FG001|COMPLETED|Study Visit 2 (Non-responders Only)||0
8792365|NCT01395394|9843820|FG002|COMPLETED|Study Visit 2 (Non-responders Only)||0
8792366|NCT01395394|9843818|FG000|NOT COMPLETED|Study Visit 2 (Non-responders Only)||0
8792367|NCT01395394|9843819|FG001|NOT COMPLETED|Study Visit 2 (Non-responders Only)||0
8792368|NCT01395394|9843820|FG002|NOT COMPLETED|Study Visit 2 (Non-responders Only)||0
8792369|NCT01395524|9843831|FG000|STARTED|Overall Study||97
8792370|NCT01395524|9843832|FG001|STARTED|Overall Study||99
8792371|NCT01395524|9843833|FG002|STARTED|Overall Study||106
8792372|NCT01395524|9843831|FG000|COMPLETED|Overall Study||79
8792373|NCT01395524|9843832|FG001|COMPLETED|Overall Study||83
8792374|NCT01395524|9843833|FG002|COMPLETED|Overall Study||89
8792375|NCT01395524|9843831|FG000|NOT COMPLETED|Overall Study||18
8792376|NCT01395524|9843832|FG001|NOT COMPLETED|Overall Study||16
8792377|NCT01395524|9843833|FG002|NOT COMPLETED|Overall Study||17
8792378|NCT01395537|9843841|FG000|STARTED|Phase I||13
8792379|NCT01395537|9843841|FG000|COMPLETED|Phase I||13
8792380|NCT01395537|9843841|FG000|NOT COMPLETED|Phase I||0
8792381|NCT01395537|9843841|FG000|STARTED|Phase II||1
8792382|NCT01395537|9843841|FG000|COMPLETED|Phase II||1
8792383|NCT01395537|9843841|FG000|NOT COMPLETED|Phase II||0
8792384|NCT01395758|9843847|FG000|STARTED|Open-label Treatment Period||51
8792385|NCT01395758|9843848|FG001|STARTED|Open-label Treatment Period||45
8792386|NCT01395758|9843849|FG002|STARTED|Open-label Treatment Period||0
8792387|NCT01395758|9843847|FG000|COMPLETED|Open-label Treatment Period||47
8792388|NCT01395758|9843848|FG001|COMPLETED|Open-label Treatment Period||45
8792389|NCT01395758|9843849|FG002|COMPLETED|Open-label Treatment Period||0
8792390|NCT01395758|9843847|FG000|NOT COMPLETED|Open-label Treatment Period||4
8792391|NCT01395758|9843848|FG001|NOT COMPLETED|Open-label Treatment Period||0
8792392|NCT01395758|9843849|FG002|NOT COMPLETED|Open-label Treatment Period||0
8792393|NCT01395758|9843847|FG000|STARTED|Crossover Period||0
8792394|NCT01395758|9843848|FG001|STARTED|Crossover Period||0
8792395|NCT01395758|9843849|FG002|STARTED|Crossover Period||26
8792396|NCT01395758|9843847|FG000|COMPLETED|Crossover Period||0
8792397|NCT01395758|9843848|FG001|COMPLETED|Crossover Period||0
8792398|NCT01395758|9843849|FG002|COMPLETED|Crossover Period||26
8792399|NCT01395758|9843847|FG000|NOT COMPLETED|Crossover Period||0
8792400|NCT01395758|9843848|FG001|NOT COMPLETED|Crossover Period||0
8792401|NCT01395758|9843849|FG002|NOT COMPLETED|Crossover Period||0
8792402|NCT01395784|9843856|FG000|STARTED|Overall Study||32
8792403|NCT01395784|9843856|FG000|COMPLETED|Overall Study||17
8792404|NCT01395784|9843856|FG000|NOT COMPLETED|Overall Study||15
8792405|NCT01395797|9843866|FG000|STARTED|Overall Study||19
8792406|NCT01395797|9843867|FG001|STARTED|Overall Study||4
8792407|NCT01395797|9843868|FG002|STARTED|Overall Study||18
8792408|NCT01395797|9843869|FG003|STARTED|Overall Study||15
8792409|NCT01395797|9843870|FG004|STARTED|Overall Study||9
8792410|NCT01395797|9843871|FG005|STARTED|Overall Study||17
8792411|NCT01395797|9843866|FG000|COMPLETED|Overall Study||16
8792412|NCT01395797|9843867|FG001|COMPLETED|Overall Study||3
8792413|NCT01395797|9843868|FG002|COMPLETED|Overall Study||14
8792414|NCT01395797|9843869|FG003|COMPLETED|Overall Study||13
8792415|NCT01395797|9843870|FG004|COMPLETED|Overall Study||7
8792416|NCT01395797|9843871|FG005|COMPLETED|Overall Study||14
8792417|NCT01395797|9843866|FG000|NOT COMPLETED|Overall Study||3
8792418|NCT01395797|9843867|FG001|NOT COMPLETED|Overall Study||1
8792419|NCT01395797|9843868|FG002|NOT COMPLETED|Overall Study||4
8792420|NCT01395797|9843869|FG003|NOT COMPLETED|Overall Study||2
8792421|NCT01395797|9843870|FG004|NOT COMPLETED|Overall Study||2
8792422|NCT01395797|9843871|FG005|NOT COMPLETED|Overall Study||3
8792423|NCT01395810|9843895|FG000|STARTED|Overall Study||18
8792424|NCT01395810|9843896|FG001|STARTED|Overall Study||48
8792425|NCT01395810|9843897|FG002|STARTED|Overall Study||0
8792426|NCT01395810|9843898|FG003|STARTED|Overall Study||5
8792427|NCT01395810|9843895|FG000|After Switching the Arms|Overall Study|18 subjects started in this arm and additional 3 subjects from 40 IU/kg switched to this arm|21
8792428|NCT01395810|9843896|FG001|After Switching the Arms|Overall Study|48 subjects started in this arm, 3 subjects in 10 IU/kg+1 subject in on-demand switched to this arm|52
8792429|NCT01395810|9843897|FG002|After Switching the Arms|Overall Study|No subjects started in this arm initially, 2 patients in 40 IU/kg arm switched to this arm.|2
8792430|NCT01395810|9843898|FG003|After Switching the Arms|Overall Study||5
8792431|NCT01395810|9843895|FG000|COMPLETED|Overall Study||16
8792432|NCT01395810|9843896|FG001|COMPLETED|Overall Study||44
8792433|NCT01395810|9843897|FG002|COMPLETED|Overall Study||0
8792434|NCT01395810|9843898|FG003|COMPLETED|Overall Study||5
8792435|NCT01395810|9843895|FG000|NOT COMPLETED|Overall Study||2
8792436|NCT01395810|9843896|FG001|NOT COMPLETED|Overall Study||4
8792437|NCT01395810|9843897|FG002|NOT COMPLETED|Overall Study||0
8792438|NCT01395810|9843898|FG003|NOT COMPLETED|Overall Study||0
8792439|NCT01395823|9843911|FG000|STARTED|Overall Study||137
8792440|NCT01395823|9843912|FG001|STARTED|Overall Study||139
8792441|NCT01395823|9843911|FG000|COMPLETED|Overall Study||122
8792442|NCT01395823|9843912|FG001|COMPLETED|Overall Study||130
8792443|NCT01395823|9843911|FG000|NOT COMPLETED|Overall Study||15
8792444|NCT01395823|9843912|FG001|NOT COMPLETED|Overall Study||9
8792445|NCT01395888|9843920|FG000|STARTED|2-week Run-in Period||279
8792446|NCT01395888|9843921|FG001|STARTED|2-week Run-in Period||0
8792447|NCT01395888|9843922|FG002|STARTED|2-week Run-in Period||0
8792448|NCT01395888|9843920|FG000|COMPLETED|2-week Run-in Period||257
8792449|NCT01395888|9843921|FG001|COMPLETED|2-week Run-in Period||0
8792450|NCT01395888|9843922|FG002|COMPLETED|2-week Run-in Period||0
8792451|NCT01395888|9843920|FG000|NOT COMPLETED|2-week Run-in Period||22
8792452|NCT01395888|9843921|FG001|NOT COMPLETED|2-week Run-in Period||0
8792453|NCT01395888|9843922|FG002|NOT COMPLETED|2-week Run-in Period||0
8792454|NCT01395888|9843920|FG000|STARTED|Treatment Period (TP)||0
8792455|NCT01395888|9843921|FG001|STARTED|Treatment Period (TP)||127
8792456|NCT01395888|9843922|FG002|STARTED|Treatment Period (TP)||130
8792457|NCT01395888|9843920|FG000|Completed the Treatment Period|Treatment Period (TP)||0
8792458|NCT01395888|9843921|FG001|Completed the Treatment Period|Treatment Period (TP)|Participants were considered to have completed the TP if they attended Visit 5 (Week 12).|112
8792459|NCT01395888|9843922|FG002|Completed the Treatment Period|Treatment Period (TP)|Participants were considered to have completed the TP if they attended Visit 5 (Week 12).|113
8792460|NCT01395888|9843920|FG000|COMPLETED|Treatment Period (TP)||0
8792461|NCT01395888|9843921|FG001|COMPLETED|Treatment Period (TP)|Par. completed the study if they completed the TP and a safety follow-up phone contact 1 week later.|112
8792462|NCT01395888|9843922|FG002|COMPLETED|Treatment Period (TP)|Par. completed the study if they completed the TP and a safety follow-up phone contact 1 week later.|113
8792463|NCT01395888|9843920|FG000|NOT COMPLETED|Treatment Period (TP)||0
8792464|NCT01395888|9843921|FG001|NOT COMPLETED|Treatment Period (TP)||15
8792465|NCT01395888|9843922|FG002|NOT COMPLETED|Treatment Period (TP)||17
8792466|NCT01395901|9843930|FG000|STARTED|Overall Study|Randomized Population|336
8792467|NCT01395901|9843931|FG001|STARTED|Overall Study|Randomized Population|334
8792468|NCT01395901|9843930|FG000|COMPLETED|Overall Study|Treated patients completing the study|326
8792469|NCT01395901|9843931|FG001|COMPLETED|Overall Study|Treated patients completing the study|329
8792470|NCT01395901|9843930|FG000|NOT COMPLETED|Overall Study||10
8792471|NCT01395901|9843931|FG001|NOT COMPLETED|Overall Study||5
8792472|NCT01395914|9843939|FG000|STARTED|Overall Study||345
8792473|NCT01395914|9843940|FG001|STARTED|Overall Study||168
8792474|NCT01395914|9843939|FG000|ITT Population|Overall Study||345
8792475|NCT01395914|9843940|FG001|ITT Population|Overall Study||168
8792476|NCT01395914|9843939|FG000|Safety Population|Overall Study||343
8792477|NCT01395914|9843940|FG001|Safety Population|Overall Study||167
8792478|NCT01395914|9843939|FG000|COMPLETED|Overall Study||273
8792479|NCT01395914|9843940|FG001|COMPLETED|Overall Study||131
8792480|NCT01395914|9843939|FG000|NOT COMPLETED|Overall Study||72
8792481|NCT01395914|9843940|FG001|NOT COMPLETED|Overall Study||37
8792482|NCT01395966|9843949|FG000|STARTED|Overall Study||109
8792483|NCT01395966|9843950|FG001|STARTED|Overall Study||110
8792484|NCT01395966|9843951|FG002|STARTED|Overall Study||112
8792485|NCT01395966|9843949|FG000|COMPLETED|Overall Study||99
8792486|NCT01395966|9843950|FG001|COMPLETED|Overall Study||91
8792487|NCT01395966|9843951|FG002|COMPLETED|Overall Study||104
8792488|NCT01395966|9843949|FG000|NOT COMPLETED|Overall Study||10
8792489|NCT01395966|9843950|FG001|NOT COMPLETED|Overall Study||19
8792490|NCT01395966|9843951|FG002|NOT COMPLETED|Overall Study||8
8792491|NCT01396005|9843961|FG000|STARTED|Overall Study||10
8792492|NCT01396005|9843962|FG001|STARTED|Overall Study||11
8792493|NCT01396005|9843961|FG000|COMPLETED|Overall Study||10
8792494|NCT01396005|9843962|FG001|COMPLETED|Overall Study||9
8792495|NCT01396005|9843961|FG000|NOT COMPLETED|Overall Study||0
8792496|NCT01396005|9843962|FG001|NOT COMPLETED|Overall Study||2
8792497|NCT01396044|9843972|FG000|STARTED|Overall Study||125
8792498|NCT01396044|9843973|FG001|STARTED|Overall Study||171
8792499|NCT01396044|9843972|FG000|COMPLETED|Overall Study||125
8792500|NCT01396044|9843973|FG001|COMPLETED|Overall Study||171
8792501|NCT01396044|9843972|FG000|NOT COMPLETED|Overall Study||0
8792502|NCT01396044|9843973|FG001|NOT COMPLETED|Overall Study||0
8792503|NCT01396057|9843981|FG000|STARTED|Overall Study||126
8792504|NCT01396057|9843982|FG001|STARTED|Overall Study||118
8792505|NCT01396057|9843981|FG000|COMPLETED|Overall Study||115
8792506|NCT01396057|9843982|FG001|COMPLETED|Overall Study||100
8792507|NCT01396057|9843981|FG000|NOT COMPLETED|Overall Study||11
8792508|NCT01396057|9843982|FG001|NOT COMPLETED|Overall Study||18
8792509|NCT01396070|9843988|FG000|STARTED|Overall Study||36
8792510|NCT01396070|9843988|FG000|COMPLETED|Overall Study||17
8792511|NCT01396070|9843988|FG000|NOT COMPLETED|Overall Study||19
8792512|NCT01396083|9843995|FG000|STARTED|Overall Study||124
8792513|NCT01396083|9843996|FG001|STARTED|Overall Study||119
8792514|NCT01396083|9843995|FG000|COMPLETED|Overall Study||113
8792515|NCT01396083|9843996|FG001|COMPLETED|Overall Study||72
8792516|NCT01396083|9843995|FG000|NOT COMPLETED|Overall Study||11
9032775|NCT03266172|10095074|FG001|NOT COMPLETED|Part A: Period 2 (2 Days)||0
9032776|NCT03266172|10095075|FG002|NOT COMPLETED|Part A: Period 2 (2 Days)||0
9032777|NCT03266172|10095073|FG000|STARTED|Part A: Washout (7 Days)||13
9032778|NCT03266172|10095074|FG001|STARTED|Part A: Washout (7 Days)||0
9032779|NCT03266172|10095075|FG002|STARTED|Part A: Washout (7 Days)||0
9032780|NCT03266172|10095073|FG000|COMPLETED|Part A: Washout (7 Days)||13
9032781|NCT03266172|10095074|FG001|COMPLETED|Part A: Washout (7 Days)||0
9032782|NCT03266172|10095075|FG002|COMPLETED|Part A: Washout (7 Days)||0
9032783|NCT03266172|10095073|FG000|NOT COMPLETED|Part A: Washout (7 Days)||0
9032784|NCT03266172|10095074|FG001|NOT COMPLETED|Part A: Washout (7 Days)||0
9032785|NCT03266172|10095075|FG002|NOT COMPLETED|Part A: Washout (7 Days)||0
9032786|NCT03266172|10095073|FG000|STARTED|Part A: Period 3 (2 Days)|3 replacement participants were enrolled|16
9032787|NCT03266172|10095074|FG001|STARTED|Part A: Period 3 (2 Days)||0
9032788|NCT03266172|10095075|FG002|STARTED|Part A: Period 3 (2 Days)||0
9032789|NCT03266172|10095073|FG000|COMPLETED|Part A: Period 3 (2 Days)||16
9032790|NCT03266172|10095074|FG001|COMPLETED|Part A: Period 3 (2 Days)||0
9032791|NCT03266172|10095075|FG002|COMPLETED|Part A: Period 3 (2 Days)||0
9032792|NCT03266172|10095073|FG000|NOT COMPLETED|Part A: Period 3 (2 Days)||0
9032793|NCT03266172|10095074|FG001|NOT COMPLETED|Part A: Period 3 (2 Days)||0
9032794|NCT03266172|10095075|FG002|NOT COMPLETED|Part A: Period 3 (2 Days)||0
9032795|NCT03266172|10095073|FG000|STARTED|Part A: Washout (7 Days)||16
9032796|NCT03266172|10095074|FG001|STARTED|Part A: Washout (7 Days)||0
9032797|NCT03266172|10095075|FG002|STARTED|Part A: Washout (7 Days)||0
9032798|NCT03266172|10095073|FG000|COMPLETED|Part A: Washout (7 Days)||16
9032799|NCT03266172|10095074|FG001|COMPLETED|Part A: Washout (7 Days)||0
9032800|NCT03266172|10095075|FG002|COMPLETED|Part A: Washout (7 Days)||0
9032801|NCT03266172|10095073|FG000|NOT COMPLETED|Part A: Washout (7 Days)||0
9032802|NCT03266172|10095074|FG001|NOT COMPLETED|Part A: Washout (7 Days)||0
9032803|NCT03266172|10095075|FG002|NOT COMPLETED|Part A: Washout (7 Days)||0
9032804|NCT03266172|10095073|FG000|STARTED|Part A: Period 4 (2 Days)||16
9032805|NCT03266172|10095074|FG001|STARTED|Part A: Period 4 (2 Days)||0
9032806|NCT03266172|10095075|FG002|STARTED|Part A: Period 4 (2 Days)||0
9032807|NCT03266172|10095073|FG000|COMPLETED|Part A: Period 4 (2 Days)||16
9032808|NCT03266172|10095074|FG001|COMPLETED|Part A: Period 4 (2 Days)||0
9032809|NCT03266172|10095075|FG002|COMPLETED|Part A: Period 4 (2 Days)||0
9032810|NCT03266172|10095073|FG000|NOT COMPLETED|Part A: Period 4 (2 Days)||0
9032811|NCT03266172|10095074|FG001|NOT COMPLETED|Part A: Period 4 (2 Days)||0
9032812|NCT03266172|10095075|FG002|NOT COMPLETED|Part A: Period 4 (2 Days)||0
9032813|NCT03266172|10095073|FG000|STARTED|Part B: Period 1 (4 Days)|Participants from Part A did not enter Part B|0
9032814|NCT03266172|10095074|FG001|STARTED|Part B: Period 1 (4 Days)|New participants were enrolled in Part B of study|10
9032815|NCT03266172|10095075|FG002|STARTED|Part B: Period 1 (4 Days)||0
9032816|NCT03266172|10095073|FG000|COMPLETED|Part B: Period 1 (4 Days)||0
9032817|NCT03266172|10095074|FG001|COMPLETED|Part B: Period 1 (4 Days)||10
9032818|NCT03266172|10095075|FG002|COMPLETED|Part B: Period 1 (4 Days)||0
9032819|NCT03266172|10095073|FG000|NOT COMPLETED|Part B: Period 1 (4 Days)||0
9032820|NCT03266172|10095074|FG001|NOT COMPLETED|Part B: Period 1 (4 Days)||0
9032821|NCT03266172|10095075|FG002|NOT COMPLETED|Part B: Period 1 (4 Days)||0
9032822|NCT03266172|10095073|FG000|STARTED|Part B: Washout (7 Days)||0
9032823|NCT03266172|10095074|FG001|STARTED|Part B: Washout (7 Days)||10
9032824|NCT03266172|10095075|FG002|STARTED|Part B: Washout (7 Days)||0
9032825|NCT03266172|10095073|FG000|COMPLETED|Part B: Washout (7 Days)||0
9032826|NCT03266172|10095074|FG001|COMPLETED|Part B: Washout (7 Days)||10
9032827|NCT03266172|10095075|FG002|COMPLETED|Part B: Washout (7 Days)||0
9032828|NCT03266172|10095073|FG000|NOT COMPLETED|Part B: Washout (7 Days)||0
9032829|NCT03266172|10095074|FG001|NOT COMPLETED|Part B: Washout (7 Days)||0
9032830|NCT03266172|10095075|FG002|NOT COMPLETED|Part B: Washout (7 Days)||0
9032831|NCT03266172|10095073|FG000|STARTED|Part B: Period 2 (4 Days)||0
9032832|NCT03266172|10095074|FG001|STARTED|Part B: Period 2 (4 Days)||10
9032833|NCT03266172|10095075|FG002|STARTED|Part B: Period 2 (4 Days)||0
9032834|NCT03266172|10095073|FG000|COMPLETED|Part B: Period 2 (4 Days)||0
9032835|NCT03266172|10095074|FG001|COMPLETED|Part B: Period 2 (4 Days)||10
9032836|NCT03266172|10095075|FG002|COMPLETED|Part B: Period 2 (4 Days)||0
9032837|NCT03266172|10095073|FG000|NOT COMPLETED|Part B: Period 2 (4 Days)||0
9032838|NCT03266172|10095074|FG001|NOT COMPLETED|Part B: Period 2 (4 Days)||0
9032839|NCT03266172|10095075|FG002|NOT COMPLETED|Part B: Period 2 (4 Days)||0
9032840|NCT03266172|10095073|FG000|STARTED|Part B: Washout (7 Days)||0
8792517|NCT01396083|9843996|FG001|NOT COMPLETED|Overall Study||47
8792518|NCT01396148|9844002|FG000|STARTED|Overall Study||6
8792519|NCT01396148|9844002|FG000|COMPLETED|Overall Study||5
8792520|NCT01396148|9844002|FG000|NOT COMPLETED|Overall Study||1
8792521|NCT01396161|9844015|FG000|STARTED|Overall Study||12
8792522|NCT01396161|9844016|FG001|STARTED|Overall Study||5
8792523|NCT01396161|9844017|FG002|STARTED|Overall Study||9
8792524|NCT01396161|9844018|FG003|STARTED|Overall Study||9
8792525|NCT01396161|9844019|FG004|STARTED|Overall Study||9
8792526|NCT01396161|9844020|FG005|STARTED|Overall Study||9
8792527|NCT01396161|9844021|FG006|STARTED|Overall Study||11
8792528|NCT01396161|9844015|FG000|COMPLETED|Overall Study||12
8792529|NCT01396161|9844016|FG001|COMPLETED|Overall Study||5
8792530|NCT01396161|9844017|FG002|COMPLETED|Overall Study||9
8792531|NCT01396161|9844018|FG003|COMPLETED|Overall Study||9
8792532|NCT01396161|9844019|FG004|COMPLETED|Overall Study||8
8792533|NCT01396161|9844020|FG005|COMPLETED|Overall Study||9
8792534|NCT01396161|9844021|FG006|COMPLETED|Overall Study||10
8792535|NCT01396161|9844015|FG000|NOT COMPLETED|Overall Study||0
8792536|NCT01396161|9844016|FG001|NOT COMPLETED|Overall Study||0
8792537|NCT01396161|9844017|FG002|NOT COMPLETED|Overall Study||0
8792538|NCT01396161|9844018|FG003|NOT COMPLETED|Overall Study||0
8792539|NCT01396161|9844019|FG004|NOT COMPLETED|Overall Study||1
8792540|NCT01396161|9844020|FG005|NOT COMPLETED|Overall Study||0
8792541|NCT01396161|9844021|FG006|NOT COMPLETED|Overall Study||1
8792542|NCT01396187|9844047|FG000|STARTED|Overall Study||8
8792543|NCT01396187|9844048|FG001|STARTED|Overall Study||12
8792544|NCT01396187|9844049|FG002|STARTED|Overall Study||10
8792545|NCT01396187|9844050|FG003|STARTED|Overall Study||10
8792546|NCT01396187|9844051|FG004|STARTED|Overall Study||10
8792547|NCT01396187|9844047|FG000|COMPLETED|Overall Study||7
8792548|NCT01396187|9844048|FG001|COMPLETED|Overall Study||9
8792549|NCT01396187|9844049|FG002|COMPLETED|Overall Study||9
8792550|NCT01396187|9844050|FG003|COMPLETED|Overall Study||10
8792551|NCT01396187|9844051|FG004|COMPLETED|Overall Study||9
8792552|NCT01396187|9844047|FG000|NOT COMPLETED|Overall Study||1
8792553|NCT01396187|9844048|FG001|NOT COMPLETED|Overall Study||3
8792554|NCT01396187|9844049|FG002|NOT COMPLETED|Overall Study||1
8792555|NCT01396187|9844050|FG003|NOT COMPLETED|Overall Study||0
8792556|NCT01396187|9844051|FG004|NOT COMPLETED|Overall Study||1
8792557|NCT01396226|9844069|FG000|STARTED|Overall Study||12
8792558|NCT01396226|9844070|FG001|STARTED|Overall Study||6
8792559|NCT01396226|9844069|FG000|Patients Who Received Treatment|Overall Study||12
8792560|NCT01396226|9844070|FG001|Patients Who Received Treatment|Overall Study||6
8792561|NCT01396226|9844069|FG000|Patients Who Completed Treatment|Overall Study||12
8792562|NCT01396226|9844070|FG001|Patients Who Completed Treatment|Overall Study||6
8792563|NCT01396226|9844069|FG000|COMPLETED|Overall Study||12
8792564|NCT01396226|9844070|FG001|COMPLETED|Overall Study||6
8792565|NCT01396226|9844069|FG000|NOT COMPLETED|Overall Study||0
8792566|NCT01396226|9844070|FG001|NOT COMPLETED|Overall Study||0
8792567|NCT01396239|9844079|FG000|STARTED|Overall Study||4
8792568|NCT01396239|9844080|FG001|STARTED|Overall Study||2
8792569|NCT01396239|9844081|FG002|STARTED|Overall Study||4
8792570|NCT01396239|9844082|FG003|STARTED|Overall Study||2
8792571|NCT01396239|9844079|FG000|COMPLETED|Overall Study||4
8792572|NCT01396239|9844080|FG001|COMPLETED|Overall Study||2
8792573|NCT01396239|9844081|FG002|COMPLETED|Overall Study||4
8792574|NCT01396239|9844082|FG003|COMPLETED|Overall Study||2
8792575|NCT01396239|9844079|FG000|NOT COMPLETED|Overall Study||0
8792576|NCT01396239|9844080|FG001|NOT COMPLETED|Overall Study||0
8792577|NCT01396239|9844081|FG002|NOT COMPLETED|Overall Study||0
8792578|NCT01396239|9844082|FG003|NOT COMPLETED|Overall Study||0
8792579|NCT01396265|9844099|FG000|STARTED|Afatinib||22
8792580|NCT01396265|9844099|FG000|COMPLETED|Afatinib||22
8792581|NCT01396265|9844099|FG000|NOT COMPLETED|Afatinib||0
8792582|NCT01396265|9844099|FG000|STARTED|Washout||22
8792583|NCT01396265|9844099|FG000|COMPLETED|Washout||22
8792584|NCT01396265|9844099|FG000|NOT COMPLETED|Washout||0
8792585|NCT01396265|9844099|FG000|STARTED|Rifa+Afatinib||22
8792586|NCT01396265|9844099|FG000|COMPLETED|Rifa+Afatinib||21
8792587|NCT01396265|9844099|FG000|NOT COMPLETED|Rifa+Afatinib||1
8792588|NCT01396317|9844107|FG000|STARTED|Overall Study||10
8792589|NCT01396317|9844108|FG001|STARTED|Overall Study||10
8792590|NCT01396317|9844107|FG000|COMPLETED|Overall Study||9
8792591|NCT01396317|9844108|FG001|COMPLETED|Overall Study||10
8792592|NCT01396317|9844107|FG000|NOT COMPLETED|Overall Study||1
8792593|NCT01396317|9844108|FG001|NOT COMPLETED|Overall Study||0
8792594|NCT01396382|9844116|FG000|STARTED|Overall Study||97
8792595|NCT01396382|9844116|FG000|COMPLETED|Overall Study||97
8792596|NCT01396382|9844116|FG000|NOT COMPLETED|Overall Study||0
8792597|NCT01396395|9844123|FG000|STARTED|Overall Study||200
8792598|NCT01396395|9844124|FG001|STARTED|Overall Study||202
8792599|NCT01396395|9844123|FG000|Safety Analysis Set|Overall Study|1 subject randomized to standard was included in standard+nicorandil as nicorandil was received.|197
8792600|NCT01396395|9844124|FG001|Safety Analysis Set|Overall Study|4 subjects randomized to standard+nicorandil were included in standard as no nicorandil was received|205
8792601|NCT01396395|9844123|FG000|COMPLETED|Overall Study||160
8792602|NCT01396395|9844124|FG001|COMPLETED|Overall Study||175
8792603|NCT01396395|9844123|FG000|NOT COMPLETED|Overall Study||40
8792604|NCT01396395|9844124|FG001|NOT COMPLETED|Overall Study||27
8792605|NCT01396421|9844136|FG000|STARTED|Overall Study||180
8792606|NCT01396421|9844137|FG001|STARTED|Overall Study||182
8792607|NCT01396421|9844138|FG002|STARTED|Overall Study||90
8792608|NCT01396421|9844139|FG003|STARTED|Overall Study||184
8792609|NCT01396421|9844136|FG000|COMPLETED|Overall Study||121
8792610|NCT01396421|9844137|FG001|COMPLETED|Overall Study||124
8792611|NCT01396421|9844138|FG002|COMPLETED|Overall Study||56
8792612|NCT01396421|9844139|FG003|COMPLETED|Overall Study||109
8792613|NCT01396421|9844136|FG000|NOT COMPLETED|Overall Study||59
8792614|NCT01396421|9844137|FG001|NOT COMPLETED|Overall Study||58
8792615|NCT01396421|9844138|FG002|NOT COMPLETED|Overall Study||34
8792616|NCT01396421|9844139|FG003|NOT COMPLETED|Overall Study||75
8792617|NCT01396434|9844166|FG000|STARTED|Overall Study||2817
8792618|NCT01396434|9844167|FG001|STARTED|Overall Study||175
8792619|NCT01396434|9844168|FG002|STARTED|Overall Study||14
8792620|NCT01396434|9844166|FG000|COMPLETED|Overall Study||2806
8792621|NCT01396434|9844167|FG001|COMPLETED|Overall Study||175
8792622|NCT01396434|9844168|FG002|COMPLETED|Overall Study||14
8792623|NCT01396434|9844166|FG000|NOT COMPLETED|Overall Study||11
8792624|NCT01396434|9844167|FG001|NOT COMPLETED|Overall Study||0
8792625|NCT01396434|9844168|FG002|NOT COMPLETED|Overall Study||0
8792626|NCT01396447|9844180|FG000|STARTED|Overall Study||148
8792627|NCT01396447|9844181|FG001|STARTED|Overall Study||143
8792628|NCT01396447|9844182|FG002|STARTED|Overall Study||147
8792629|NCT01396447|9844183|FG003|STARTED|Overall Study||146
8792630|NCT01396447|9844180|FG000|Received Treatment|Overall Study||145
8792631|NCT01396447|9844181|FG001|Received Treatment|Overall Study||141
8792632|NCT01396447|9844182|FG002|Received Treatment|Overall Study||146
8792633|NCT01396447|9844183|FG003|Received Treatment|Overall Study||146
8792634|NCT01396447|9844180|FG000|COMPLETED|Overall Study||105
8792635|NCT01396447|9844181|FG001|COMPLETED|Overall Study||103
8792636|NCT01396447|9844182|FG002|COMPLETED|Overall Study||117
8792637|NCT01396447|9844183|FG003|COMPLETED|Overall Study||94
8792638|NCT01396447|9844180|FG000|NOT COMPLETED|Overall Study||43
8792639|NCT01396447|9844181|FG001|NOT COMPLETED|Overall Study||40
8792640|NCT01396447|9844182|FG002|NOT COMPLETED|Overall Study||30
8792641|NCT01396447|9844183|FG003|NOT COMPLETED|Overall Study||52
8792642|NCT01396486|9844196|FG000|STARTED|Overall Study||20
8792643|NCT01396486|9844197|FG001|STARTED|Overall Study||19
8792644|NCT01396486|9844198|FG002|STARTED|Overall Study||22
8792645|NCT01396486|9844196|FG000|Exposed|Overall Study||19
8792646|NCT01396486|9844197|FG001|Exposed|Overall Study||16
8792647|NCT01396486|9844198|FG002|Exposed|Overall Study||17
8792648|NCT01396486|9844196|FG000|COMPLETED|Overall Study||10
8792649|NCT01396486|9844197|FG001|COMPLETED|Overall Study||7
8792650|NCT01396486|9844198|FG002|COMPLETED|Overall Study||10
8792651|NCT01396486|9844196|FG000|NOT COMPLETED|Overall Study||10
8792652|NCT01396486|9844197|FG001|NOT COMPLETED|Overall Study||12
8792653|NCT01396486|9844198|FG002|NOT COMPLETED|Overall Study||12
8792654|NCT01396512|9844208|FG000|STARTED|Overall Study||137
8792655|NCT01396512|9844209|FG001|STARTED|Overall Study||137
8792656|NCT01396512|9844208|FG000|COMPLETED|Overall Study||137
8792657|NCT01396512|9844209|FG001|COMPLETED|Overall Study||136
8792658|NCT01396512|9844208|FG000|NOT COMPLETED|Overall Study||0
8917342|NCT02190903|9977021|FG000|COMPLETED|Overall Study||6
8917343|NCT02190903|9977022|FG001|COMPLETED|Overall Study||6
8917344|NCT02190903|9977021|FG000|NOT COMPLETED|Overall Study||0
8917345|NCT02190903|9977022|FG001|NOT COMPLETED|Overall Study||0
8917346|NCT02191033|9977030|FG000|STARTED|Overall Study||20
8917347|NCT02191033|9977031|FG001|STARTED|Overall Study||20
8917348|NCT02191033|9977030|FG000|COMPLETED|Overall Study||18
8917349|NCT02191033|9977031|FG001|COMPLETED|Overall Study||19
8917350|NCT02191033|9977030|FG000|NOT COMPLETED|Overall Study||2
8917351|NCT02191033|9977031|FG001|NOT COMPLETED|Overall Study||1
8917352|NCT02191046|9977039|FG000|STARTED|Overall Study||41
8917353|NCT02191046|9977040|FG001|STARTED|Overall Study||39
8917354|NCT02191046|9977039|FG000|COMPLETED|Overall Study|exclude 5 patients because low compliance|36
8917355|NCT02191046|9977040|FG001|COMPLETED|Overall Study|exclude 1 patient because low compliance|38
8917356|NCT02191046|9977039|FG000|NOT COMPLETED|Overall Study||5
8917357|NCT02191046|9977040|FG001|NOT COMPLETED|Overall Study||1
8917358|NCT02191137|9977046|FG000|STARTED|Treatment||75
8917359|NCT02191137|9977046|FG000|COMPLETED|Treatment||65
9032841|NCT03266172|10095074|FG001|STARTED|Part B: Washout (7 Days)||10
9032842|NCT03266172|10095075|FG002|STARTED|Part B: Washout (7 Days)||0
9032843|NCT03266172|10095073|FG000|COMPLETED|Part B: Washout (7 Days)||0
9032844|NCT03266172|10095074|FG001|COMPLETED|Part B: Washout (7 Days)||8
9032845|NCT03266172|10095075|FG002|COMPLETED|Part B: Washout (7 Days)||0
9032846|NCT03266172|10095073|FG000|NOT COMPLETED|Part B: Washout (7 Days)||0
9032847|NCT03266172|10095074|FG001|NOT COMPLETED|Part B: Washout (7 Days)||2
9032848|NCT03266172|10095075|FG002|NOT COMPLETED|Part B: Washout (7 Days)||0
9032849|NCT03266172|10095073|FG000|STARTED|Part B: Period 3 (4 Days)||0
9032850|NCT03266172|10095074|FG001|STARTED|Part B: Period 3 (4 Days)|Two participants completed Washout Period but withdrew before the start of Period 3.|6
9032851|NCT03266172|10095075|FG002|STARTED|Part B: Period 3 (4 Days)||0
9032852|NCT03266172|10095073|FG000|COMPLETED|Part B: Period 3 (4 Days)||0
9032853|NCT03266172|10095074|FG001|COMPLETED|Part B: Period 3 (4 Days)||6
8917360|NCT02191137|9977046|FG000|NOT COMPLETED|Treatment||10
8792659|NCT01396512|9844209|FG001|NOT COMPLETED|Overall Study||1
8792660|NCT01396525|9844215|FG000|STARTED|Overall Study||153
8792661|NCT01396525|9844215|FG000|COMPLETED|Overall Study||127
8792662|NCT01396525|9844215|FG000|NOT COMPLETED|Overall Study||26
8792663|NCT01396551|9844223|FG000|STARTED|Overall Study||69
8792664|NCT01396551|9844223|FG000|COMPLETED|Overall Study||69
8792665|NCT01396551|9844223|FG000|NOT COMPLETED|Overall Study||0
8792666|NCT01396837|9844227|FG000|STARTED|Overall Study||20
8792667|NCT01396837|9844227|FG000|COMPLETED|Overall Study||16
8792668|NCT01396837|9844227|FG000|NOT COMPLETED|Overall Study||4
8792669|NCT01397071|9844231|FG000|STARTED|Consumption of Beef Patty Alone||11
8792670|NCT01397071|9844231|FG000|COMPLETED|Consumption of Beef Patty Alone||11
8792671|NCT01397071|9844231|FG000|NOT COMPLETED|Consumption of Beef Patty Alone||0
8792672|NCT01397071|9844231|FG000|STARTED|Consumption of Beef Patty With Avocado||11
8792673|NCT01397071|9844231|FG000|COMPLETED|Consumption of Beef Patty With Avocado||11
8792674|NCT01397071|9844231|FG000|NOT COMPLETED|Consumption of Beef Patty With Avocado||0
8792675|NCT01397084|9844239|FG000|STARTED|Overall Study||108
8792676|NCT01397084|9844239|FG000|COMPLETED|Overall Study||100
8792677|NCT01397084|9844239|FG000|NOT COMPLETED|Overall Study||8
8792678|NCT01397253|9844245|FG000|STARTED|Overall Study||443
8792679|NCT01397253|9844246|FG001|STARTED|Overall Study||392
8792680|NCT01397253|9844245|FG000|COMPLETED|Overall Study|Primary analysis, remaining patients included in a sensitivity analysis|317
8792681|NCT01397253|9844246|FG001|COMPLETED|Overall Study|Primary analysis, remaining patients included in a sensitivity analysis|243
8792682|NCT01397253|9844245|FG000|NOT COMPLETED|Overall Study||126
8792683|NCT01397253|9844246|FG001|NOT COMPLETED|Overall Study||149
8792684|NCT01397409|9844262|FG000|STARTED|Stage 1||9
8792685|NCT01397409|9844263|FG001|STARTED|Stage 1||6
8792686|NCT01397409|9844264|FG002|STARTED|Stage 1||6
8792687|NCT01397409|9844265|FG003|STARTED|Stage 1||3
8792688|NCT01397409|9844266|FG004|STARTED|Stage 1||0
8792689|NCT01397409|9844267|FG005|STARTED|Stage 1||0
8792690|NCT01397409|9844268|FG006|STARTED|Stage 1||0
8792691|NCT01397409|9844269|FG007|STARTED|Stage 1||0
8792692|NCT01397409|9844270|FG008|STARTED|Stage 1||0
8792693|NCT01397409|9844271|FG009|STARTED|Stage 1||0
8792694|NCT01397409|9844262|FG000|COMPLETED|Stage 1||9
8792695|NCT01397409|9844263|FG001|COMPLETED|Stage 1||6
8792696|NCT01397409|9844264|FG002|COMPLETED|Stage 1||6
8792697|NCT01397409|9844265|FG003|COMPLETED|Stage 1||3
8792698|NCT01397409|9844266|FG004|COMPLETED|Stage 1||0
8792699|NCT01397409|9844267|FG005|COMPLETED|Stage 1||0
8792700|NCT01397409|9844268|FG006|COMPLETED|Stage 1||0
8792701|NCT01397409|9844269|FG007|COMPLETED|Stage 1||0
8792702|NCT01397409|9844270|FG008|COMPLETED|Stage 1||0
8792703|NCT01397409|9844271|FG009|COMPLETED|Stage 1||0
8792704|NCT01397409|9844262|FG000|NOT COMPLETED|Stage 1||0
8792705|NCT01397409|9844263|FG001|NOT COMPLETED|Stage 1||0
8792706|NCT01397409|9844264|FG002|NOT COMPLETED|Stage 1||0
8792707|NCT01397409|9844265|FG003|NOT COMPLETED|Stage 1||0
8792708|NCT01397409|9844266|FG004|NOT COMPLETED|Stage 1||0
8792709|NCT01397409|9844267|FG005|NOT COMPLETED|Stage 1||0
8792710|NCT01397409|9844268|FG006|NOT COMPLETED|Stage 1||0
8792711|NCT01397409|9844269|FG007|NOT COMPLETED|Stage 1||0
8792712|NCT01397409|9844270|FG008|NOT COMPLETED|Stage 1||0
8792713|NCT01397409|9844271|FG009|NOT COMPLETED|Stage 1||0
8792714|NCT01397409|9844262|FG000|STARTED|Stage 2||0
8792715|NCT01397409|9844263|FG001|STARTED|Stage 2||0
8792716|NCT01397409|9844264|FG002|STARTED|Stage 2||0
8792717|NCT01397409|9844265|FG003|STARTED|Stage 2||0
8792718|NCT01397409|9844266|FG004|STARTED|Stage 2||67
8792719|NCT01397409|9844267|FG005|STARTED|Stage 2||58
8792720|NCT01397409|9844268|FG006|STARTED|Stage 2||58
8792721|NCT01397409|9844269|FG007|STARTED|Stage 2||0
8792722|NCT01397409|9844270|FG008|STARTED|Stage 2||0
8792723|NCT01397409|9844271|FG009|STARTED|Stage 2||0
8792724|NCT01397409|9844262|FG000|COMPLETED|Stage 2||0
8792725|NCT01397409|9844263|FG001|COMPLETED|Stage 2||0
8792726|NCT01397409|9844264|FG002|COMPLETED|Stage 2||0
8792727|NCT01397409|9844265|FG003|COMPLETED|Stage 2||0
8792728|NCT01397409|9844266|FG004|COMPLETED|Stage 2||59
8792729|NCT01397409|9844267|FG005|COMPLETED|Stage 2||54
8792730|NCT01397409|9844268|FG006|COMPLETED|Stage 2||58
8792731|NCT01397409|9844269|FG007|COMPLETED|Stage 2||0
8792732|NCT01397409|9844270|FG008|COMPLETED|Stage 2||0
8792733|NCT01397409|9844271|FG009|COMPLETED|Stage 2||0
8792734|NCT01397409|9844262|FG000|NOT COMPLETED|Stage 2||0
8792735|NCT01397409|9844263|FG001|NOT COMPLETED|Stage 2||0
8792736|NCT01397409|9844264|FG002|NOT COMPLETED|Stage 2||0
8792737|NCT01397409|9844265|FG003|NOT COMPLETED|Stage 2||0
8792738|NCT01397409|9844266|FG004|NOT COMPLETED|Stage 2||8
8792739|NCT01397409|9844267|FG005|NOT COMPLETED|Stage 2||4
8792740|NCT01397409|9844268|FG006|NOT COMPLETED|Stage 2||0
8792741|NCT01397409|9844269|FG007|NOT COMPLETED|Stage 2||0
8792742|NCT01397409|9844270|FG008|NOT COMPLETED|Stage 2||0
8792743|NCT01397409|9844271|FG009|NOT COMPLETED|Stage 2||0
8792744|NCT01397409|9844262|FG000|STARTED|Stage 3||0
8792745|NCT01397409|9844263|FG001|STARTED|Stage 3||0
8792746|NCT01397409|9844264|FG002|STARTED|Stage 3||0
8792747|NCT01397409|9844265|FG003|STARTED|Stage 3||0
8792748|NCT01397409|9844266|FG004|STARTED|Stage 3||0
8792749|NCT01397409|9844267|FG005|STARTED|Stage 3||0
8792750|NCT01397409|9844268|FG006|STARTED|Stage 3||0
8792751|NCT01397409|9844269|FG007|STARTED|Stage 3||23
8792752|NCT01397409|9844270|FG008|STARTED|Stage 3||25
8792753|NCT01397409|9844271|FG009|STARTED|Stage 3||16
8792754|NCT01397409|9844262|FG000|COMPLETED|Stage 3||0
8792755|NCT01397409|9844263|FG001|COMPLETED|Stage 3||0
8792756|NCT01397409|9844264|FG002|COMPLETED|Stage 3||0
8792757|NCT01397409|9844265|FG003|COMPLETED|Stage 3||0
8792758|NCT01397409|9844266|FG004|COMPLETED|Stage 3||0
8792759|NCT01397409|9844267|FG005|COMPLETED|Stage 3||0
8792760|NCT01397409|9844268|FG006|COMPLETED|Stage 3||0
8792761|NCT01397409|9844269|FG007|COMPLETED|Stage 3||21
8792762|NCT01397409|9844270|FG008|COMPLETED|Stage 3||25
8792763|NCT01397409|9844271|FG009|COMPLETED|Stage 3||16
8792764|NCT01397409|9844262|FG000|NOT COMPLETED|Stage 3||0
8792765|NCT01397409|9844263|FG001|NOT COMPLETED|Stage 3||0
8792766|NCT01397409|9844264|FG002|NOT COMPLETED|Stage 3||0
8792767|NCT01397409|9844265|FG003|NOT COMPLETED|Stage 3||0
8792768|NCT01397409|9844266|FG004|NOT COMPLETED|Stage 3||0
8792769|NCT01397409|9844267|FG005|NOT COMPLETED|Stage 3||0
8792770|NCT01397409|9844268|FG006|NOT COMPLETED|Stage 3||0
8792771|NCT01397409|9844269|FG007|NOT COMPLETED|Stage 3||2
8792772|NCT01397409|9844270|FG008|NOT COMPLETED|Stage 3||0
8792773|NCT01397409|9844271|FG009|NOT COMPLETED|Stage 3||0
8792774|NCT01397422|9844298|FG000|STARTED|Overall Study||22
8792775|NCT01397422|9844299|FG001|STARTED|Overall Study||20
8792776|NCT01397422|9844300|FG002|STARTED|Overall Study|Of the 3 participants who discontinued, 1 withdrew due to both an AE and an eGFR < 50 mL/min/1.73m^2|21
8792777|NCT01397422|9844301|FG003|STARTED|Overall Study||20
8792778|NCT01397422|9844298|FG000|COMPLETED|Overall Study||20
8792779|NCT01397422|9844299|FG001|COMPLETED|Overall Study||17
8792780|NCT01397422|9844300|FG002|COMPLETED|Overall Study|AE = adverse event; eGFR = estimated glomerular filtration rate|18
8792781|NCT01397422|9844301|FG003|COMPLETED|Overall Study||12
8792782|NCT01397422|9844298|FG000|NOT COMPLETED|Overall Study||2
8792783|NCT01397422|9844299|FG001|NOT COMPLETED|Overall Study||3
8792784|NCT01397422|9844300|FG002|NOT COMPLETED|Overall Study||3
8792785|NCT01397422|9844301|FG003|NOT COMPLETED|Overall Study||8
8792786|NCT01397448|9844316|FG000|STARTED|Overall Study||156
8792787|NCT01397448|9844317|FG001|STARTED|Overall Study|158 participants were randomized but 1 participant was not treated with drug.|157
8792788|NCT01397448|9844318|FG002|STARTED|Overall Study||158
8792789|NCT01397448|9844316|FG000|COMPLETED|Overall Study||138
8792790|NCT01397448|9844317|FG001|COMPLETED|Overall Study||142
8792791|NCT01397448|9844318|FG002|COMPLETED|Overall Study||140
8792792|NCT01397448|9844316|FG000|NOT COMPLETED|Overall Study||18
8792793|NCT01397448|9844317|FG001|NOT COMPLETED|Overall Study||15
8792794|NCT01397448|9844318|FG002|NOT COMPLETED|Overall Study||18
8792795|NCT01397461|9844329|FG000|STARTED|Overall Study||155
8792796|NCT01397461|9844330|FG001|STARTED|Overall Study||156
8792797|NCT01397461|9844331|FG002|STARTED|Overall Study||154
8792798|NCT01397461|9844329|FG000|COMPLETED|Overall Study||153
8792799|NCT01397461|9844330|FG001|COMPLETED|Overall Study||150
8792800|NCT01397461|9844331|FG002|COMPLETED|Overall Study||152
8792801|NCT01397461|9844329|FG000|NOT COMPLETED|Overall Study||2
8792802|NCT01397461|9844330|FG001|NOT COMPLETED|Overall Study||6
8792803|NCT01397461|9844331|FG002|NOT COMPLETED|Overall Study||2
8792804|NCT01397591|9844339|FG000|STARTED|Overall Study||2
8792805|NCT01397591|9844339|FG000|COMPLETED|Overall Study||2
8792806|NCT01397591|9844339|FG000|NOT COMPLETED|Overall Study||0
8792807|NCT01397617|9844347|FG000|STARTED|Overall Study||64
8792808|NCT01397617|9844348|FG001|STARTED|Overall Study||53
8792809|NCT01397617|9844349|FG002|STARTED|Overall Study||60
8792810|NCT01397617|9844347|FG000|COMPLETED|Overall Study||33
8792811|NCT01397617|9844348|FG001|COMPLETED|Overall Study||30
8792812|NCT01397617|9844349|FG002|COMPLETED|Overall Study||31
8792813|NCT01397617|9844347|FG000|NOT COMPLETED|Overall Study||31
8792814|NCT01397617|9844348|FG001|NOT COMPLETED|Overall Study||23
8792815|NCT01397617|9844349|FG002|NOT COMPLETED|Overall Study||29
8792816|NCT01397656|9844362|FG000|STARTED|Overall Study||33
8792817|NCT01397656|9844363|FG001|STARTED|Overall Study||30
8792818|NCT01397656|9844362|FG000|COMPLETED|Overall Study||33
8792819|NCT01397656|9844363|FG001|COMPLETED|Overall Study||30
8792820|NCT01397656|9844362|FG000|NOT COMPLETED|Overall Study||0
8792821|NCT01397656|9844363|FG001|NOT COMPLETED|Overall Study||0
8792822|NCT01397747|9844371|FG000|STARTED|Overall Study||11016
8792823|NCT01397747|9844371|FG000|COMPLETED|Overall Study||9989
8792824|NCT01397747|9844371|FG000|NOT COMPLETED|Overall Study||1027
8792825|NCT01397786|9844379|FG000|STARTED|Phase A|Subjects in NCT01668797 Phase A at IA-related study termination rolled over to NCT01397786 Phase A.|12
8792826|NCT01397786|9844380|FG001|STARTED|Phase A||0
8792827|NCT01397786|9844381|FG002|STARTED|Phase A||227
8792828|NCT01397786|9844379|FG000|COMPLETED|Phase A||12
8792829|NCT01397786|9844380|FG001|COMPLETED|Phase A||0
8792830|NCT01397786|9844381|FG002|COMPLETED|Phase A||199
8792831|NCT01397786|9844379|FG000|NOT COMPLETED|Phase A||0
8792832|NCT01397786|9844380|FG001|NOT COMPLETED|Phase A||0
8792833|NCT01397786|9844381|FG002|NOT COMPLETED|Phase A||28
8792834|NCT01397786|9844379|FG000|STARTED|Phase B||611
8792835|NCT01397786|9844380|FG001|STARTED|Phase B||204
8792836|NCT01397786|9844381|FG002|STARTED|Phase B||229
8792837|NCT01397786|9844379|FG000|COMPLETED|Phase B||308
8792838|NCT01397786|9844380|FG001|COMPLETED|Phase B||109
8792839|NCT01397786|9844381|FG002|COMPLETED|Phase B||91
8792840|NCT01397786|9844379|FG000|NOT COMPLETED|Phase B||303
8792841|NCT01397786|9844380|FG001|NOT COMPLETED|Phase B||95
8792842|NCT01397786|9844381|FG002|NOT COMPLETED|Phase B||138
8792843|NCT01397825|9844397|FG000|STARTED|Overall Study||13
8792844|NCT01397825|9844398|FG001|STARTED|Overall Study||4
8792845|NCT01397825|9844399|FG002|STARTED|Overall Study||25
8792846|NCT01397825|9844400|FG003|STARTED|Overall Study||3
8792847|NCT01397825|9844401|FG004|STARTED|Overall Study||0
8792848|NCT01397825|9844397|FG000|COMPLETED|Overall Study||0
8792849|NCT01397825|9844398|FG001|COMPLETED|Overall Study||0
8792850|NCT01397825|9844399|FG002|COMPLETED|Overall Study||0
8792851|NCT01397825|9844400|FG003|COMPLETED|Overall Study||0
8792852|NCT01397825|9844401|FG004|COMPLETED|Overall Study||0
8792853|NCT01397825|9844397|FG000|NOT COMPLETED|Overall Study||13
8792854|NCT01397825|9844398|FG001|NOT COMPLETED|Overall Study||4
8792855|NCT01397825|9844399|FG002|NOT COMPLETED|Overall Study||25
8792856|NCT01397825|9844400|FG003|NOT COMPLETED|Overall Study||3
8792857|NCT01397825|9844401|FG004|NOT COMPLETED|Overall Study||0
8792858|NCT01397851|9844417|FG000|STARTED|Overall Study||41634
8792859|NCT01397851|9844418|FG001|STARTED|Overall Study||39963
8792860|NCT01397851|9844417|FG000|COMPLETED|Overall Study||41555
8792861|NCT01397851|9844418|FG001|COMPLETED|Overall Study||39917
8792862|NCT01397851|9844417|FG000|NOT COMPLETED|Overall Study||79
8792863|NCT01397851|9844418|FG001|NOT COMPLETED|Overall Study||46
8792864|NCT01397890|9844426|FG000|STARTED|Overall Study||287
8792865|NCT01397890|9844427|FG001|STARTED|Overall Study||291
8792866|NCT01397890|9844426|FG000|Post-baseline Efficacy Data Collected|Overall Study|'Full Analysis Set' used for efficacy analysis|287
8792867|NCT01397890|9844427|FG001|Post-baseline Efficacy Data Collected|Overall Study|'Full Analysis Set' used for efficacy analysis|290
8792868|NCT01397890|9844426|FG000|Received Correct Randomized Treatment|Overall Study|'Safety Analysis Set' =287+3-1=289. 3 and 1 pts in respective groups received opposite treatment.|286
8792869|NCT01397890|9844427|FG001|Received Correct Randomized Treatment|Overall Study|'Safety Analysis Set' =291+1-3=289.|287
8792870|NCT01397890|9844426|FG000|COMPLETED|Overall Study||264
8792871|NCT01397890|9844427|FG001|COMPLETED|Overall Study||260
8792872|NCT01397890|9844426|FG000|NOT COMPLETED|Overall Study||23
8792873|NCT01397890|9844427|FG001|NOT COMPLETED|Overall Study||31
8792874|NCT01398059|9844433|FG000|STARTED|Overall Study||4
8792875|NCT01398059|9844434|FG001|STARTED|Overall Study||3
8792876|NCT01398059|9844435|FG002|STARTED|Overall Study||4
8792877|NCT01398059|9844436|FG003|STARTED|Overall Study||2
8792878|NCT01398059|9844437|FG004|STARTED|Overall Study||4
8792879|NCT01398059|9844438|FG005|STARTED|Overall Study||2
8792880|NCT01398059|9844433|FG000|COMPLETED|Overall Study||4
8792881|NCT01398059|9844434|FG001|COMPLETED|Overall Study||3
8792882|NCT01398059|9844435|FG002|COMPLETED|Overall Study||4
8792883|NCT01398059|9844436|FG003|COMPLETED|Overall Study||2
8792884|NCT01398059|9844437|FG004|COMPLETED|Overall Study||4
8792885|NCT01398059|9844438|FG005|COMPLETED|Overall Study||2
8792886|NCT01398059|9844433|FG000|NOT COMPLETED|Overall Study||0
8792887|NCT01398059|9844434|FG001|NOT COMPLETED|Overall Study||0
8792888|NCT01398059|9844435|FG002|NOT COMPLETED|Overall Study||0
8792889|NCT01398059|9844436|FG003|NOT COMPLETED|Overall Study||0
8792890|NCT01398059|9844437|FG004|NOT COMPLETED|Overall Study||0
8792891|NCT01398059|9844438|FG005|NOT COMPLETED|Overall Study||0
8792892|NCT01398176|9844448|FG000|STARTED|Overall Study||26
8792893|NCT01398176|9844449|FG001|STARTED|Overall Study||25
8792894|NCT01398176|9844448|FG000|COMPLETED|Overall Study||23
8792895|NCT01398176|9844449|FG001|COMPLETED|Overall Study||19
8792896|NCT01398176|9844448|FG000|NOT COMPLETED|Overall Study||3
8792897|NCT01398176|9844449|FG001|NOT COMPLETED|Overall Study||6
8792898|NCT01398280|9844457|FG000|STARTED|Overall Study||11
8792899|NCT01398280|9844458|FG001|STARTED|Overall Study||4
8792900|NCT01398280|9844457|FG000|COMPLETED|Overall Study||7
8792901|NCT01398280|9844458|FG001|COMPLETED|Overall Study||4
8792902|NCT01398280|9844457|FG000|NOT COMPLETED|Overall Study||4
8792903|NCT01398280|9844458|FG001|NOT COMPLETED|Overall Study||0
8792904|NCT01398358|9844467|FG000|STARTED|Overall Study||218
8792905|NCT01398358|9844468|FG001|STARTED|Overall Study||224
8792906|NCT01398358|9844469|FG002|STARTED|Overall Study||255
8792907|NCT01398358|9844467|FG000|COMPLETED|Overall Study||203
8792908|NCT01398358|9844468|FG001|COMPLETED|Overall Study||201
8792909|NCT01398358|9844469|FG002|COMPLETED|Overall Study||234
8792910|NCT01398358|9844467|FG000|NOT COMPLETED|Overall Study||15
8792911|NCT01398358|9844468|FG001|NOT COMPLETED|Overall Study||23
8792912|NCT01398358|9844469|FG002|NOT COMPLETED|Overall Study||21
8792913|NCT01398410|9844479|FG000|STARTED|Overall Study|Treated participants (all participants who received at least one dose of rabeprazole).|201
8792914|NCT01398410|9844480|FG001|STARTED|Overall Study||204
8792915|NCT01398410|9844479|FG000|COMPLETED|Overall Study||143
8792916|NCT01398410|9844480|FG001|COMPLETED|Overall Study||148
8792917|NCT01398410|9844479|FG000|NOT COMPLETED|Overall Study||58
8792918|NCT01398410|9844480|FG001|NOT COMPLETED|Overall Study||56
8792919|NCT01398475|9844486|FG000|STARTED|Overall Study||4
8792920|NCT01398475|9844487|FG001|STARTED|Overall Study||3
8792921|NCT01398475|9844488|FG002|STARTED|Overall Study||4
8792922|NCT01398475|9844489|FG003|STARTED|Overall Study||4
8792923|NCT01398475|9844486|FG000|Received First Intervention|Overall Study||4
8792924|NCT01398475|9844487|FG001|Received First Intervention|Overall Study||3
8792925|NCT01398475|9844488|FG002|Received First Intervention|Overall Study||4
8792926|NCT01398475|9844489|FG003|Received First Intervention|Overall Study||4
8792927|NCT01398475|9844486|FG000|Received Second Intervention|Overall Study||4
8792928|NCT01398475|9844487|FG001|Received Second Intervention|Overall Study||3
8792929|NCT01398475|9844488|FG002|Received Second Intervention|Overall Study||4
8792930|NCT01398475|9844489|FG003|Received Second Intervention|Overall Study||4
8792931|NCT01398475|9844486|FG000|Received Third Intervention|Overall Study||4
8792932|NCT01398475|9844487|FG001|Received Third Intervention|Overall Study||3
8792933|NCT01398475|9844488|FG002|Received Third Intervention|Overall Study||4
8792934|NCT01398475|9844489|FG003|Received Third Intervention|Overall Study||4
8792935|NCT01398475|9844486|FG000|Received Fourth Intervention|Overall Study||4
8792936|NCT01398475|9844487|FG001|Received Fourth Intervention|Overall Study||3
8792937|NCT01398475|9844488|FG002|Received Fourth Intervention|Overall Study||4
8792938|NCT01398475|9844489|FG003|Received Fourth Intervention|Overall Study||4
8792939|NCT01398475|9844486|FG000|COMPLETED|Overall Study||4
8792940|NCT01398475|9844487|FG001|COMPLETED|Overall Study||3
8792941|NCT01398475|9844488|FG002|COMPLETED|Overall Study||4
8792942|NCT01398475|9844489|FG003|COMPLETED|Overall Study||4
8792943|NCT01398475|9844486|FG000|NOT COMPLETED|Overall Study||0
8792944|NCT01398475|9844487|FG001|NOT COMPLETED|Overall Study||0
8792945|NCT01398475|9844488|FG002|NOT COMPLETED|Overall Study||0
8792946|NCT01398475|9844489|FG003|NOT COMPLETED|Overall Study||0
8792947|NCT01398514|9844501|FG000|STARTED|Overall Study||26
8792948|NCT01398514|9844502|FG001|STARTED|Overall Study||26
8792949|NCT01398514|9844501|FG000|COMPLETED|Overall Study||18
8792950|NCT01398514|9844502|FG001|COMPLETED|Overall Study||20
8792951|NCT01398514|9844501|FG000|NOT COMPLETED|Overall Study||8
8792952|NCT01398514|9844502|FG001|NOT COMPLETED|Overall Study||6
8792953|NCT01398566|9844510|FG000|STARTED|Overall Study|20 enrolled|20
8792954|NCT01398566|9844510|FG000|COMPLETED|Overall Study||20
8792955|NCT01398566|9844510|FG000|NOT COMPLETED|Overall Study||0
8792956|NCT01398787|9844514|FG000|STARTED|Overall Study||198
8792957|NCT01398787|9844514|FG000|COMPLETED|Overall Study||197
8792958|NCT01398787|9844514|FG000|NOT COMPLETED|Overall Study||1
8792959|NCT01398943|9844522|FG000|STARTED|First Intervention (1 Day)||15
8792960|NCT01398943|9844523|FG001|STARTED|First Intervention (1 Day)||15
8792961|NCT01398943|9844524|FG002|STARTED|First Intervention (1 Day)||15
8792962|NCT01398943|9844525|FG003|STARTED|First Intervention (1 Day)||15
8792963|NCT01398943|9844522|FG000|COMPLETED|First Intervention (1 Day)||15
8792964|NCT01398943|9844523|FG001|COMPLETED|First Intervention (1 Day)||15
8792965|NCT01398943|9844524|FG002|COMPLETED|First Intervention (1 Day)||15
8792966|NCT01398943|9844525|FG003|COMPLETED|First Intervention (1 Day)||15
8792967|NCT01398943|9844522|FG000|NOT COMPLETED|First Intervention (1 Day)||0
8792968|NCT01398943|9844523|FG001|NOT COMPLETED|First Intervention (1 Day)||0
8792969|NCT01398943|9844524|FG002|NOT COMPLETED|First Intervention (1 Day)||0
8792970|NCT01398943|9844525|FG003|NOT COMPLETED|First Intervention (1 Day)||0
8792971|NCT01398943|9844522|FG000|STARTED|Washout (2-7 Days)||15
8792972|NCT01398943|9844523|FG001|STARTED|Washout (2-7 Days)||15
8792973|NCT01398943|9844524|FG002|STARTED|Washout (2-7 Days)||15
8792974|NCT01398943|9844525|FG003|STARTED|Washout (2-7 Days)||15
8792975|NCT01398943|9844522|FG000|COMPLETED|Washout (2-7 Days)||15
8792976|NCT01398943|9844523|FG001|COMPLETED|Washout (2-7 Days)||15
8792977|NCT01398943|9844524|FG002|COMPLETED|Washout (2-7 Days)||15
8792978|NCT01398943|9844525|FG003|COMPLETED|Washout (2-7 Days)||15
8792979|NCT01398943|9844522|FG000|NOT COMPLETED|Washout (2-7 Days)||0
8792980|NCT01398943|9844523|FG001|NOT COMPLETED|Washout (2-7 Days)||0
8792981|NCT01398943|9844524|FG002|NOT COMPLETED|Washout (2-7 Days)||0
8792982|NCT01398943|9844525|FG003|NOT COMPLETED|Washout (2-7 Days)||0
8792983|NCT01398943|9844522|FG000|STARTED|Second Intervention (1 Day)||15
8792984|NCT01398943|9844523|FG001|STARTED|Second Intervention (1 Day)||15
8792985|NCT01398943|9844524|FG002|STARTED|Second Intervention (1 Day)||15
8792986|NCT01398943|9844525|FG003|STARTED|Second Intervention (1 Day)||15
8792987|NCT01398943|9844522|FG000|COMPLETED|Second Intervention (1 Day)||15
8792988|NCT01398943|9844523|FG001|COMPLETED|Second Intervention (1 Day)||15
8792989|NCT01398943|9844524|FG002|COMPLETED|Second Intervention (1 Day)||15
8792990|NCT01398943|9844525|FG003|COMPLETED|Second Intervention (1 Day)||15
8792991|NCT01398943|9844522|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
8792992|NCT01398943|9844523|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
8792993|NCT01398943|9844524|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
8792994|NCT01398943|9844525|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
8792995|NCT01398956|9844533|FG000|STARTED|Overall Study||44
8792996|NCT01398956|9844533|FG000|COMPLETED|Overall Study||34
8792997|NCT01398956|9844533|FG000|NOT COMPLETED|Overall Study||10
8917361|NCT02191137|9977046|FG000|STARTED|Follow-up||65
8917362|NCT02191137|9977046|FG000|COMPLETED|Follow-up||60
8917363|NCT02191137|9977046|FG000|NOT COMPLETED|Follow-up||5
8917364|NCT02191267|9977053|FG000|STARTED|Overall Study||20
8917365|NCT02191267|9977054|FG001|STARTED|Overall Study||6
8917366|NCT02191267|9977055|FG002|STARTED|Overall Study||4
8917367|NCT02191267|9977053|FG000|COMPLETED|Overall Study||19
8917368|NCT02191267|9977054|FG001|COMPLETED|Overall Study||6
8917369|NCT02191267|9977055|FG002|COMPLETED|Overall Study||4
8917370|NCT02191267|9977053|FG000|NOT COMPLETED|Overall Study||1
8917371|NCT02191267|9977054|FG001|NOT COMPLETED|Overall Study||0
8917372|NCT02191267|9977055|FG002|NOT COMPLETED|Overall Study||0
8917373|NCT02191397|9977065|FG000|STARTED|Overall Study||266
8917374|NCT02191397|9977066|FG001|STARTED|Overall Study||268
8917375|NCT02191397|9977065|FG000|COMPLETED|Overall Study||183
8917376|NCT02191397|9977066|FG001|COMPLETED|Overall Study||198
8917377|NCT02191397|9977065|FG000|NOT COMPLETED|Overall Study||83
8917378|NCT02191397|9977066|FG001|NOT COMPLETED|Overall Study||70
8917379|NCT02191579|9977074|FG000|STARTED|Treatment 1||140
8917380|NCT02191579|9977075|FG001|STARTED|Treatment 1||142
8917381|NCT02191579|9977074|FG000|COMPLETED|Treatment 1||113
8917382|NCT02191579|9977075|FG001|COMPLETED|Treatment 1||84
8917383|NCT02191579|9977074|FG000|NOT COMPLETED|Treatment 1||27
8917384|NCT02191579|9977075|FG001|NOT COMPLETED|Treatment 1||58
8917385|NCT02191579|9977074|FG000|STARTED|Treatment 2||0
8917386|NCT02191579|9977075|FG001|STARTED|Treatment 2||80
8917387|NCT02191579|9977074|FG000|COMPLETED|Treatment 2||0
8917388|NCT02191579|9977075|FG001|COMPLETED|Treatment 2||55
8917389|NCT02191579|9977074|FG000|NOT COMPLETED|Treatment 2||0
8917390|NCT02191579|9977075|FG001|NOT COMPLETED|Treatment 2||25
8917391|NCT02191605|9977086|FG000|STARTED|Overall Study||15
8917392|NCT02191605|9977087|FG001|STARTED|Overall Study||15
8917393|NCT02191605|9977088|FG002|STARTED|Overall Study||15
8917394|NCT02191605|9977089|FG003|STARTED|Overall Study||8
8917395|NCT02191605|9977090|FG004|STARTED|Overall Study||7
8792998|NCT01398982|9844540|FG000|STARTED|Overall Study||44
8792999|NCT01398982|9844541|FG001|STARTED|Overall Study||49
8793000|NCT01398982|9844540|FG000|COMPLETED|Overall Study||38
8793001|NCT01398982|9844541|FG001|COMPLETED|Overall Study||47
8793002|NCT01398982|9844540|FG000|NOT COMPLETED|Overall Study||6
8793003|NCT01398982|9844541|FG001|NOT COMPLETED|Overall Study||2
8793004|NCT01399008|9844550|FG000|STARTED|Overall Study||35
8793005|NCT01399008|9844551|FG001|STARTED|Overall Study||32
8793006|NCT01399008|9844552|FG002|STARTED|Overall Study||33
8793007|NCT01399008|9844550|FG000|COMPLETED|Overall Study||32
8793008|NCT01399008|9844551|FG001|COMPLETED|Overall Study||27
8793009|NCT01399008|9844552|FG002|COMPLETED|Overall Study||31
8793010|NCT01399008|9844550|FG000|NOT COMPLETED|Overall Study||3
8793011|NCT01399008|9844551|FG001|NOT COMPLETED|Overall Study||5
8793012|NCT01399008|9844552|FG002|NOT COMPLETED|Overall Study||2
8793013|NCT01399047|9844562|FG000|STARTED|Overall Study||10
8793014|NCT01399047|9844563|FG001|STARTED|Overall Study||9
8793015|NCT01399047|9844562|FG000|COMPLETED|Overall Study||10
8793016|NCT01399047|9844563|FG001|COMPLETED|Overall Study||8
8793017|NCT01399047|9844562|FG000|NOT COMPLETED|Overall Study||0
8793018|NCT01399047|9844563|FG001|NOT COMPLETED|Overall Study||1
8793019|NCT01399099|9844571|FG000|STARTED|Overall Study||67
8793020|NCT01399099|9844571|FG000|6 Months|Overall Study||47
8793021|NCT01399099|9844571|FG000|COMPLETED|Overall Study||36
8793022|NCT01399099|9844571|FG000|NOT COMPLETED|Overall Study||31
8793023|NCT01399125|9844578|FG000|STARTED|Overall Study||248
8793024|NCT01399125|9844579|FG001|STARTED|Overall Study||253
8793025|NCT01399125|9844578|FG000|Per Protocol (PP) Population|Overall Study||192
8793026|NCT01399125|9844579|FG001|Per Protocol (PP) Population|Overall Study||188
8793027|NCT01399125|9844578|FG000|COMPLETED|Overall Study||197
8793028|NCT01399125|9844579|FG001|COMPLETED|Overall Study||193
8793029|NCT01399125|9844578|FG000|NOT COMPLETED|Overall Study||51
8793030|NCT01399125|9844579|FG001|NOT COMPLETED|Overall Study||60
8793031|NCT01399190|9844585|FG000|STARTED|Overall Study||68
8793032|NCT01399190|9844585|FG000|Included in Final Analysis|Overall Study||63
8793033|NCT01399190|9844585|FG000|Evaluable for Primary Endpoint Analysis|Overall Study||60
8793034|NCT01399190|9844585|FG000|COMPLETED|Overall Study||48
8793035|NCT01399190|9844585|FG000|NOT COMPLETED|Overall Study||20
8793036|NCT01399229|9844589|FG000|STARTED|Overall Study||20
8793037|NCT01399229|9844590|FG001|STARTED|Overall Study||5
8793038|NCT01399229|9844591|FG002|STARTED|Overall Study||5
8793039|NCT01399229|9844589|FG000|COMPLETED|Overall Study||20
8793040|NCT01399229|9844590|FG001|COMPLETED|Overall Study||5
8793041|NCT01399229|9844591|FG002|COMPLETED|Overall Study||5
8793042|NCT01399229|9844589|FG000|NOT COMPLETED|Overall Study||0
8793043|NCT01399229|9844590|FG001|NOT COMPLETED|Overall Study||0
8793044|NCT01399229|9844591|FG002|NOT COMPLETED|Overall Study||0
8793045|NCT01399268|9844597|FG000|STARTED|Overall Study||15
8793046|NCT01399268|9844598|FG001|STARTED|Overall Study||15
8793047|NCT01399268|9844597|FG000|COMPLETED|Overall Study||15
8793048|NCT01399268|9844598|FG001|COMPLETED|Overall Study||15
8793049|NCT01399268|9844597|FG000|NOT COMPLETED|Overall Study||0
8793050|NCT01399268|9844598|FG001|NOT COMPLETED|Overall Study||0
8793051|NCT01399372|9844606|FG000|STARTED|Overall Study||47
8793052|NCT01399372|9844607|FG001|STARTED|Overall Study||44
8793053|NCT01399372|9844606|FG000|Eligible|Overall Study||44
8793054|NCT01399372|9844607|FG001|Eligible|Overall Study||43
8793055|NCT01399372|9844606|FG000|Eligible and Started Protocol Treatment|Overall Study||43
8793056|NCT01399372|9844607|FG001|Eligible and Started Protocol Treatment|Overall Study||43
8793057|NCT01399372|9844606|FG000|COMPLETED|Overall Study||44
8793058|NCT01399372|9844607|FG001|COMPLETED|Overall Study||43
8793059|NCT01399372|9844606|FG000|NOT COMPLETED|Overall Study||3
8793060|NCT01399372|9844607|FG001|NOT COMPLETED|Overall Study||1
8793061|NCT01399593|9844615|FG000|STARTED|Overall Study||51
8793062|NCT01399593|9844616|FG001|STARTED|Overall Study||51
8793063|NCT01399593|9844615|FG000|COMPLETED|Overall Study||48
8793064|NCT01399593|9844616|FG001|COMPLETED|Overall Study||49
8793065|NCT01399593|9844615|FG000|NOT COMPLETED|Overall Study||3
8793066|NCT01399593|9844616|FG001|NOT COMPLETED|Overall Study||2
8793067|NCT01399619|9844624|FG000|STARTED|Overall Study||123
8793068|NCT01399619|9844625|FG001|STARTED|Overall Study||84
8793069|NCT01399619|9844626|FG002|STARTED|Overall Study||86
8793070|NCT01399619|9844627|FG003|STARTED|Overall Study||17
8793071|NCT01399619|9844624|FG000|COMPLETED|Overall Study||98
8793072|NCT01399619|9844625|FG001|COMPLETED|Overall Study||84
8793073|NCT01399619|9844626|FG002|COMPLETED|Overall Study||74
8793074|NCT01399619|9844627|FG003|COMPLETED|Overall Study||0
8793075|NCT01399619|9844624|FG000|NOT COMPLETED|Overall Study||25
8793076|NCT01399619|9844625|FG001|NOT COMPLETED|Overall Study||0
8793077|NCT01399619|9844626|FG002|NOT COMPLETED|Overall Study||12
8793078|NCT01399619|9844627|FG003|NOT COMPLETED|Overall Study||17
8793079|NCT01399697|9844645|FG000|STARTED|Overall Study||96
8793080|NCT01399697|9844646|FG001|STARTED|Overall Study||83
8793081|NCT01399697|9844647|FG002|STARTED|Overall Study||82
8793082|NCT01399697|9844645|FG000|COMPLETED|Overall Study||55
8793083|NCT01399697|9844646|FG001|COMPLETED|Overall Study||80
8793084|NCT01399697|9844647|FG002|COMPLETED|Overall Study||78
8793085|NCT01399697|9844645|FG000|NOT COMPLETED|Overall Study||41
8793086|NCT01399697|9844646|FG001|NOT COMPLETED|Overall Study||3
8793087|NCT01399697|9844647|FG002|NOT COMPLETED|Overall Study||4
8793088|NCT01399723|9844660|FG000|STARTED|Overall Study||263
8793089|NCT01399723|9844661|FG001|STARTED|Overall Study||264
8793090|NCT01399723|9844660|FG000|COMPLETED|Overall Study||263
8793091|NCT01399723|9844661|FG001|COMPLETED|Overall Study||263
8793092|NCT01399723|9844660|FG000|NOT COMPLETED|Overall Study||0
8793093|NCT01399723|9844661|FG001|NOT COMPLETED|Overall Study||1
8793094|NCT01399736|9844670|FG000|STARTED|Overall Study||295
8793095|NCT01399736|9844671|FG001|STARTED|Overall Study||590
8793096|NCT01399736|9844670|FG000|COMPLETED|Overall Study||291
8793097|NCT01399736|9844671|FG001|COMPLETED|Overall Study||586
8793098|NCT01399736|9844670|FG000|NOT COMPLETED|Overall Study||4
8793099|NCT01399736|9844671|FG001|NOT COMPLETED|Overall Study||4
8793100|NCT01399788|9844685|FG000|STARTED|First Intervention Period||18
8793101|NCT01399788|9844686|FG001|STARTED|First Intervention Period||18
8793102|NCT01399788|9844685|FG000|COMPLETED|First Intervention Period||17
8793103|NCT01399788|9844686|FG001|COMPLETED|First Intervention Period||18
8793104|NCT01399788|9844685|FG000|NOT COMPLETED|First Intervention Period||1
8793105|NCT01399788|9844686|FG001|NOT COMPLETED|First Intervention Period||0
8793106|NCT01399788|9844685|FG000|STARTED|Washout Period (at Least 1 Week)||17
8793107|NCT01399788|9844686|FG001|STARTED|Washout Period (at Least 1 Week)||18
8793108|NCT01399788|9844685|FG000|COMPLETED|Washout Period (at Least 1 Week)||17
8793109|NCT01399788|9844686|FG001|COMPLETED|Washout Period (at Least 1 Week)||18
8793110|NCT01399788|9844685|FG000|NOT COMPLETED|Washout Period (at Least 1 Week)||0
8793111|NCT01399788|9844686|FG001|NOT COMPLETED|Washout Period (at Least 1 Week)||0
8793112|NCT01399788|9844685|FG000|STARTED|Second Intervention Period||17
8793113|NCT01399788|9844686|FG001|STARTED|Second Intervention Period||18
8793114|NCT01399788|9844685|FG000|COMPLETED|Second Intervention Period||17
8793115|NCT01399788|9844686|FG001|COMPLETED|Second Intervention Period||18
8793116|NCT01399788|9844685|FG000|NOT COMPLETED|Second Intervention Period||0
8793117|NCT01399788|9844686|FG001|NOT COMPLETED|Second Intervention Period||0
8793118|NCT01399827|9844694|FG000|STARTED|Overall Study||1
8793119|NCT01399827|9844695|FG001|STARTED|Overall Study||1
8793120|NCT01399827|9844694|FG000|COMPLETED|Overall Study||1
8793121|NCT01399827|9844695|FG001|COMPLETED|Overall Study||1
8793122|NCT01399827|9844694|FG000|NOT COMPLETED|Overall Study||0
8793123|NCT01399827|9844695|FG001|NOT COMPLETED|Overall Study||0
8793124|NCT01399866|9844703|FG000|STARTED|Overall Study||32
8793125|NCT01399866|9844704|FG001|STARTED|Overall Study||30
8793126|NCT01399866|9844703|FG000|COMPLETED|Overall Study||28
8793127|NCT01399866|9844704|FG001|COMPLETED|Overall Study||28
8793128|NCT01399866|9844703|FG000|NOT COMPLETED|Overall Study||4
8793129|NCT01399866|9844704|FG001|NOT COMPLETED|Overall Study||2
8793130|NCT01399905|9844712|FG000|STARTED|Overall Study||7
8793131|NCT01399905|9844713|FG001|STARTED|Overall Study||7
8793132|NCT01399905|9844712|FG000|COMPLETED|Overall Study|Subject withdrew from the study before receiving treatment.|6
8793133|NCT01399905|9844713|FG001|COMPLETED|Overall Study|Subject was treated at least one dose of carbidopa before withdrawing from the study.|6
8793134|NCT01399905|9844712|FG000|NOT COMPLETED|Overall Study||1
8793135|NCT01399905|9844713|FG001|NOT COMPLETED|Overall Study||1
8793136|NCT01400113|9844726|FG000|STARTED|Overall Study||60
8793137|NCT01400113|9844727|FG001|STARTED|Overall Study||60
8793138|NCT01400113|9844726|FG000|COMPLETED|Overall Study||59
8793139|NCT01400113|9844727|FG001|COMPLETED|Overall Study||59
8793140|NCT01400113|9844726|FG000|NOT COMPLETED|Overall Study||1
8793141|NCT01400113|9844727|FG001|NOT COMPLETED|Overall Study||1
8793142|NCT01400139|9844733|FG000|STARTED|HYD Core Study||922
8793143|NCT01400139|9844733|FG000|COMPLETED|HYD Core Study||410
8793144|NCT01400139|9844733|FG000|NOT COMPLETED|HYD Core Study||512
8793145|NCT01400139|9844733|FG000|STARTED|HYD Extension Period|Subjects completing the Core Study were offered an option to enter the 24-week open-label Extension|106
8793146|NCT01400139|9844733|FG000|COMPLETED|HYD Extension Period||83
8793147|NCT01400139|9844733|FG000|NOT COMPLETED|HYD Extension Period||23
8793148|NCT01400243|9844741|FG000|STARTED|Overall Study||64
8793149|NCT01400243|9844742|FG001|STARTED|Overall Study||63
8793150|NCT01400243|9844741|FG000|COMPLETED|Overall Study||56
8793151|NCT01400243|9844742|FG001|COMPLETED|Overall Study||52
8793152|NCT01400243|9844741|FG000|NOT COMPLETED|Overall Study||8
8793153|NCT01400243|9844742|FG001|NOT COMPLETED|Overall Study||11
8793154|NCT01400412|9844752|FG000|STARTED|Overall Study||130
8793155|NCT01400412|9844753|FG001|STARTED|Overall Study||132
8793156|NCT01400412|9844752|FG000|COMPLETED|Overall Study||120
8793157|NCT01400412|9844753|FG001|COMPLETED|Overall Study||115
8793158|NCT01400412|9844752|FG000|NOT COMPLETED|Overall Study||10
8793159|NCT01400412|9844753|FG001|NOT COMPLETED|Overall Study||17
8793160|NCT01400425|9844761|FG000|STARTED|Overall Study||239
8793161|NCT01400425|9844761|FG000|COMPLETED|Overall Study||229
8793162|NCT01400425|9844761|FG000|NOT COMPLETED|Overall Study||10
8793163|NCT01400451|9844770|FG000|STARTED|28 Day Lead In With Vemurafenib Alone||6
8793164|NCT01400451|9844771|FG001|STARTED|28 Day Lead In With Vemurafenib Alone||4
8793165|NCT01400451|9844772|FG002|STARTED|28 Day Lead In With Vemurafenib Alone||2
8793166|NCT01400451|9844770|FG000|COMPLETED|28 Day Lead In With Vemurafenib Alone||6
8793167|NCT01400451|9844771|FG001|COMPLETED|28 Day Lead In With Vemurafenib Alone||4
8793168|NCT01400451|9844772|FG002|COMPLETED|28 Day Lead In With Vemurafenib Alone||2
8793169|NCT01400451|9844770|FG000|NOT COMPLETED|28 Day Lead In With Vemurafenib Alone||0
8793170|NCT01400451|9844771|FG001|NOT COMPLETED|28 Day Lead In With Vemurafenib Alone||0
8793171|NCT01400451|9844772|FG002|NOT COMPLETED|28 Day Lead In With Vemurafenib Alone||0
8793172|NCT01400451|9844770|FG000|STARTED|Combination Treatment (or Intended)||6
8793173|NCT01400451|9844771|FG001|STARTED|Combination Treatment (or Intended)||4
8793174|NCT01400451|9844772|FG002|STARTED|Combination Treatment (or Intended)|Did not start Ipilimumab but remained on vemurafenib alone.|2
8793175|NCT01400451|9844770|FG000|COMPLETED|Combination Treatment (or Intended)||0
8793176|NCT01400451|9844771|FG001|COMPLETED|Combination Treatment (or Intended)||0
8793177|NCT01400451|9844772|FG002|COMPLETED|Combination Treatment (or Intended)||0
8793178|NCT01400451|9844770|FG000|NOT COMPLETED|Combination Treatment (or Intended)||6
8793179|NCT01400451|9844771|FG001|NOT COMPLETED|Combination Treatment (or Intended)||4
8793180|NCT01400451|9844772|FG002|NOT COMPLETED|Combination Treatment (or Intended)||2
8793181|NCT01400477|9844787|FG000|STARTED|Overall Study||40
8793182|NCT01400477|9844788|FG001|STARTED|Overall Study||40
8793183|NCT01400477|9844787|FG000|COMPLETED|Overall Study||38
8793184|NCT01400477|9844788|FG001|COMPLETED|Overall Study||40
8793185|NCT01400477|9844787|FG000|NOT COMPLETED|Overall Study||2
8793186|NCT01400477|9844788|FG001|NOT COMPLETED|Overall Study||0
8793187|NCT01400503|9844794|FG000|STARTED|Overall Study||60
8793188|NCT01400503|9844794|FG000|COMPLETED|Overall Study||0
8793189|NCT01400503|9844794|FG000|NOT COMPLETED|Overall Study||60
8793190|NCT01400516|9844800|FG000|STARTED|Primary Trial||12
8793191|NCT01400516|9844801|FG001|STARTED|Primary Trial||14
8793192|NCT01400516|9844800|FG000|COMPLETED|Primary Trial||12
8793193|NCT01400516|9844801|FG001|COMPLETED|Primary Trial||12
8793194|NCT01400516|9844800|FG000|NOT COMPLETED|Primary Trial||0
8793195|NCT01400516|9844801|FG001|NOT COMPLETED|Primary Trial||2
8793196|NCT01400516|9844800|FG000|STARTED|Extension Trial|Only 6 participants in the Control arm entered the Extension Trial.|6
8793197|NCT01400516|9844801|FG001|STARTED|Extension Trial|Only 7 participants in the Teriparatide arm entered the Extension Trial.|7
8793198|NCT01400516|9844800|FG000|COMPLETED|Extension Trial||6
8793199|NCT01400516|9844801|FG001|COMPLETED|Extension Trial||7
8793200|NCT01400516|9844800|FG000|NOT COMPLETED|Extension Trial||0
8793201|NCT01400516|9844801|FG001|NOT COMPLETED|Extension Trial||0
8793202|NCT01400698|9844811|FG000|STARTED|Overall Study||23
8793203|NCT01400698|9844812|FG001|STARTED|Overall Study||23
8793204|NCT01400698|9844813|FG002|STARTED|Overall Study||2
8793205|NCT01400698|9844814|FG003|STARTED|Overall Study||14
8793206|NCT01400698|9844815|FG004|STARTED|Overall Study||14
8793207|NCT01400698|9844816|FG005|STARTED|Overall Study||15
8793208|NCT01400698|9844811|FG000|COMPLETED|Overall Study||8
8793209|NCT01400698|9844812|FG001|COMPLETED|Overall Study||12
8793210|NCT01400698|9844813|FG002|COMPLETED|Overall Study||0
8793211|NCT01400698|9844814|FG003|COMPLETED|Overall Study||6
8793212|NCT01400698|9844815|FG004|COMPLETED|Overall Study||7
8793213|NCT01400698|9844816|FG005|COMPLETED|Overall Study||9
8793214|NCT01400698|9844811|FG000|NOT COMPLETED|Overall Study||15
8793215|NCT01400698|9844812|FG001|NOT COMPLETED|Overall Study||11
8793216|NCT01400698|9844813|FG002|NOT COMPLETED|Overall Study||2
8793217|NCT01400698|9844814|FG003|NOT COMPLETED|Overall Study||8
8793218|NCT01400698|9844815|FG004|NOT COMPLETED|Overall Study||7
8793219|NCT01400698|9844816|FG005|NOT COMPLETED|Overall Study||6
8793220|NCT01400815|9844828|FG000|STARTED|Overall Study||118
8793221|NCT01400815|9844829|FG001|STARTED|Overall Study||116
8793222|NCT01400815|9844828|FG000|COMPLETED|Overall Study||80
8793223|NCT01400815|9844829|FG001|COMPLETED|Overall Study||95
8793224|NCT01400815|9844828|FG000|NOT COMPLETED|Overall Study||38
8793225|NCT01400815|9844829|FG001|NOT COMPLETED|Overall Study||21
8793226|NCT01400841|9844835|FG000|STARTED|Initial Study Phase (6 Months)|2 of the 18 consented subjects did not receive the device|16
8793227|NCT01400841|9844835|FG000|COMPLETED|Initial Study Phase (6 Months)||15
8793228|NCT01400841|9844835|FG000|NOT COMPLETED|Initial Study Phase (6 Months)||1
8793229|NCT01400841|9844835|FG000|STARTED|Extended Study Phase (2 Years)|"1 subject refused further participation~1 subject death prior to agreeing to extended follow-up"|13
8793230|NCT01400841|9844835|FG000|COMPLETED|Extended Study Phase (2 Years)||11
8793231|NCT01400841|9844835|FG000|NOT COMPLETED|Extended Study Phase (2 Years)||2
8793232|NCT01400880|9844839|FG000|STARTED|Overall Study|patients were added throughout the study. There was not a set number of patients that we began with|103
8793233|NCT01400880|9844839|FG000|COMPLETED|Overall Study|patients were added throughout the study. There was not a set number of patients that we began with|101
8793234|NCT01400880|9844839|FG000|NOT COMPLETED|Overall Study||2
8793235|NCT01400893|9844845|FG000|STARTED|Overall Study||69
8793236|NCT01400893|9844846|FG001|STARTED|Overall Study||65
8793237|NCT01400893|9844845|FG000|COMPLETED|Overall Study||42
8793238|NCT01400893|9844846|FG001|COMPLETED|Overall Study||38
8793239|NCT01400893|9844845|FG000|NOT COMPLETED|Overall Study||27
8793240|NCT01400893|9844846|FG001|NOT COMPLETED|Overall Study||27
8793241|NCT01400906|9844854|FG000|STARTED|Treatment Period 1||6
8793242|NCT01400906|9844855|FG001|STARTED|Treatment Period 1||6
8793243|NCT01400906|9844856|FG002|STARTED|Treatment Period 1||6
8793244|NCT01400906|9844857|FG003|STARTED|Treatment Period 1||6
8793245|NCT01400906|9844858|FG004|STARTED|Treatment Period 1||6
8793246|NCT01400906|9844859|FG005|STARTED|Treatment Period 1||5
8793247|NCT01400906|9844854|FG000|COMPLETED|Treatment Period 1||6
8793248|NCT01400906|9844855|FG001|COMPLETED|Treatment Period 1||6
8793249|NCT01400906|9844856|FG002|COMPLETED|Treatment Period 1||6
8793250|NCT01400906|9844857|FG003|COMPLETED|Treatment Period 1||6
8793251|NCT01400906|9844858|FG004|COMPLETED|Treatment Period 1||6
8793252|NCT01400906|9844859|FG005|COMPLETED|Treatment Period 1||5
8793253|NCT01400906|9844854|FG000|NOT COMPLETED|Treatment Period 1||0
8793254|NCT01400906|9844855|FG001|NOT COMPLETED|Treatment Period 1||0
8793255|NCT01400906|9844856|FG002|NOT COMPLETED|Treatment Period 1||0
8793256|NCT01400906|9844857|FG003|NOT COMPLETED|Treatment Period 1||0
8793257|NCT01400906|9844858|FG004|NOT COMPLETED|Treatment Period 1||0
8793258|NCT01400906|9844859|FG005|NOT COMPLETED|Treatment Period 1||0
8793259|NCT01400906|9844854|FG000|STARTED|Washout Period 1||6
8793260|NCT01400906|9844855|FG001|STARTED|Washout Period 1||6
8793261|NCT01400906|9844856|FG002|STARTED|Washout Period 1||6
8793262|NCT01400906|9844857|FG003|STARTED|Washout Period 1||6
8793263|NCT01400906|9844858|FG004|STARTED|Washout Period 1||6
8793264|NCT01400906|9844859|FG005|STARTED|Washout Period 1||5
8793265|NCT01400906|9844854|FG000|COMPLETED|Washout Period 1||6
8793266|NCT01400906|9844855|FG001|COMPLETED|Washout Period 1||6
8793267|NCT01400906|9844856|FG002|COMPLETED|Washout Period 1||6
8793268|NCT01400906|9844857|FG003|COMPLETED|Washout Period 1||6
8793269|NCT01400906|9844858|FG004|COMPLETED|Washout Period 1||6
8793270|NCT01400906|9844859|FG005|COMPLETED|Washout Period 1||5
8793271|NCT01400906|9844854|FG000|NOT COMPLETED|Washout Period 1||0
8793272|NCT01400906|9844855|FG001|NOT COMPLETED|Washout Period 1||0
8793273|NCT01400906|9844856|FG002|NOT COMPLETED|Washout Period 1||0
8793274|NCT01400906|9844857|FG003|NOT COMPLETED|Washout Period 1||0
8793275|NCT01400906|9844858|FG004|NOT COMPLETED|Washout Period 1||0
8793276|NCT01400906|9844859|FG005|NOT COMPLETED|Washout Period 1||0
8793277|NCT01400906|9844854|FG000|STARTED|Treatment Period 2||6
8793278|NCT01400906|9844855|FG001|STARTED|Treatment Period 2||6
8793279|NCT01400906|9844856|FG002|STARTED|Treatment Period 2||6
8793280|NCT01400906|9844857|FG003|STARTED|Treatment Period 2||6
8793281|NCT01400906|9844858|FG004|STARTED|Treatment Period 2||6
8793282|NCT01400906|9844859|FG005|STARTED|Treatment Period 2||5
8793283|NCT01400906|9844854|FG000|COMPLETED|Treatment Period 2||6
8793284|NCT01400906|9844855|FG001|COMPLETED|Treatment Period 2||6
8793285|NCT01400906|9844856|FG002|COMPLETED|Treatment Period 2||6
8793286|NCT01400906|9844857|FG003|COMPLETED|Treatment Period 2||6
8793287|NCT01400906|9844858|FG004|COMPLETED|Treatment Period 2||6
8793288|NCT01400906|9844859|FG005|COMPLETED|Treatment Period 2||5
8793289|NCT01400906|9844854|FG000|NOT COMPLETED|Treatment Period 2||0
9032854|NCT03266172|10095075|FG002|COMPLETED|Part B: Period 3 (4 Days)||0
9032855|NCT03266172|10095073|FG000|NOT COMPLETED|Part B: Period 3 (4 Days)||0
9032856|NCT03266172|10095074|FG001|NOT COMPLETED|Part B: Period 3 (4 Days)||0
9032857|NCT03266172|10095075|FG002|NOT COMPLETED|Part B: Period 3 (4 Days)||0
9032858|NCT03266172|10095073|FG000|STARTED|Part C: Period 1(2 Days)||0
9032859|NCT03266172|10095074|FG001|STARTED|Part C: Period 1(2 Days)|Participants from Part B did not enter Part C|0
9032860|NCT03266172|10095075|FG002|STARTED|Part C: Period 1(2 Days)|New participants were enrolled in Part C of study|15
9032861|NCT03266172|10095073|FG000|COMPLETED|Part C: Period 1(2 Days)||0
9032862|NCT03266172|10095074|FG001|COMPLETED|Part C: Period 1(2 Days)||0
9032863|NCT03266172|10095075|FG002|COMPLETED|Part C: Period 1(2 Days)||15
9032864|NCT03266172|10095073|FG000|NOT COMPLETED|Part C: Period 1(2 Days)||0
9032865|NCT03266172|10095074|FG001|NOT COMPLETED|Part C: Period 1(2 Days)||0
9032866|NCT03266172|10095075|FG002|NOT COMPLETED|Part C: Period 1(2 Days)||0
9032867|NCT03266172|10095073|FG000|STARTED|Part C Washout Period (7 Days)||0
9032868|NCT03266172|10095074|FG001|STARTED|Part C Washout Period (7 Days)||0
9032869|NCT03266172|10095075|FG002|STARTED|Part C Washout Period (7 Days)||15
9032870|NCT03266172|10095073|FG000|COMPLETED|Part C Washout Period (7 Days)||0
9032871|NCT03266172|10095074|FG001|COMPLETED|Part C Washout Period (7 Days)||0
9032872|NCT03266172|10095075|FG002|COMPLETED|Part C Washout Period (7 Days)||15
9032873|NCT03266172|10095073|FG000|NOT COMPLETED|Part C Washout Period (7 Days)||0
9032874|NCT03266172|10095074|FG001|NOT COMPLETED|Part C Washout Period (7 Days)||0
9032875|NCT03266172|10095075|FG002|NOT COMPLETED|Part C Washout Period (7 Days)||0
9032876|NCT03266172|10095073|FG000|STARTED|Part C Period 2(2 Days)||0
9032877|NCT03266172|10095074|FG001|STARTED|Part C Period 2(2 Days)||0
9032878|NCT03266172|10095075|FG002|STARTED|Part C Period 2(2 Days)||15
9032879|NCT03266172|10095073|FG000|COMPLETED|Part C Period 2(2 Days)||0
9032880|NCT03266172|10095074|FG001|COMPLETED|Part C Period 2(2 Days)||0
9032881|NCT03266172|10095075|FG002|COMPLETED|Part C Period 2(2 Days)||15
9032882|NCT03266172|10095073|FG000|NOT COMPLETED|Part C Period 2(2 Days)||0
9032883|NCT03266172|10095074|FG001|NOT COMPLETED|Part C Period 2(2 Days)||0
9032884|NCT03266172|10095075|FG002|NOT COMPLETED|Part C Period 2(2 Days)||0
9032885|NCT03266172|10095073|FG000|STARTED|Part C Washout Period (7 Days)||0
9032886|NCT03266172|10095074|FG001|STARTED|Part C Washout Period (7 Days)||0
9032887|NCT03266172|10095075|FG002|STARTED|Part C Washout Period (7 Days)||15
9032888|NCT03266172|10095073|FG000|COMPLETED|Part C Washout Period (7 Days)||0
9032889|NCT03266172|10095074|FG001|COMPLETED|Part C Washout Period (7 Days)||0
9032890|NCT03266172|10095075|FG002|COMPLETED|Part C Washout Period (7 Days)||15
8793290|NCT01400906|9844855|FG001|NOT COMPLETED|Treatment Period 2||0
8793291|NCT01400906|9844856|FG002|NOT COMPLETED|Treatment Period 2||0
8793292|NCT01400906|9844857|FG003|NOT COMPLETED|Treatment Period 2||0
8793293|NCT01400906|9844858|FG004|NOT COMPLETED|Treatment Period 2||0
8793294|NCT01400906|9844859|FG005|NOT COMPLETED|Treatment Period 2||0
8793295|NCT01400906|9844854|FG000|STARTED|Washout Period 2||6
8793296|NCT01400906|9844855|FG001|STARTED|Washout Period 2||6
8793297|NCT01400906|9844856|FG002|STARTED|Washout Period 2||6
8793298|NCT01400906|9844857|FG003|STARTED|Washout Period 2||6
8793299|NCT01400906|9844858|FG004|STARTED|Washout Period 2||6
8793300|NCT01400906|9844859|FG005|STARTED|Washout Period 2||5
8793301|NCT01400906|9844854|FG000|COMPLETED|Washout Period 2||6
8793302|NCT01400906|9844855|FG001|COMPLETED|Washout Period 2||6
8793303|NCT01400906|9844856|FG002|COMPLETED|Washout Period 2||6
8793304|NCT01400906|9844857|FG003|COMPLETED|Washout Period 2||6
8793305|NCT01400906|9844858|FG004|COMPLETED|Washout Period 2||6
8793306|NCT01400906|9844859|FG005|COMPLETED|Washout Period 2||5
8793307|NCT01400906|9844854|FG000|NOT COMPLETED|Washout Period 2||0
8793308|NCT01400906|9844855|FG001|NOT COMPLETED|Washout Period 2||0
8793309|NCT01400906|9844856|FG002|NOT COMPLETED|Washout Period 2||0
8793310|NCT01400906|9844857|FG003|NOT COMPLETED|Washout Period 2||0
8793311|NCT01400906|9844858|FG004|NOT COMPLETED|Washout Period 2||0
9032891|NCT03266172|10095073|FG000|NOT COMPLETED|Part C Washout Period (7 Days)||0
9032892|NCT03266172|10095074|FG001|NOT COMPLETED|Part C Washout Period (7 Days)||0
9032893|NCT03266172|10095075|FG002|NOT COMPLETED|Part C Washout Period (7 Days)||0
9032894|NCT03266172|10095073|FG000|STARTED|Part C Period 3(2 Days)||0
9032895|NCT03266172|10095074|FG001|STARTED|Part C Period 3(2 Days)||0
9032896|NCT03266172|10095075|FG002|STARTED|Part C Period 3(2 Days)|1 replacement participant enrolled|16
9032897|NCT03266172|10095073|FG000|COMPLETED|Part C Period 3(2 Days)||0
9032898|NCT03266172|10095074|FG001|COMPLETED|Part C Period 3(2 Days)||0
9032899|NCT03266172|10095075|FG002|COMPLETED|Part C Period 3(2 Days)||16
9032900|NCT03266172|10095073|FG000|NOT COMPLETED|Part C Period 3(2 Days)||0
9032901|NCT03266172|10095074|FG001|NOT COMPLETED|Part C Period 3(2 Days)||0
9032902|NCT03266172|10095075|FG002|NOT COMPLETED|Part C Period 3(2 Days)||0
9032903|NCT03266172|10095073|FG000|STARTED|Part C Washout Period (7 Days)||0
9032904|NCT03266172|10095074|FG001|STARTED|Part C Washout Period (7 Days)||0
9032905|NCT03266172|10095075|FG002|STARTED|Part C Washout Period (7 Days)||16
9032906|NCT03266172|10095073|FG000|COMPLETED|Part C Washout Period (7 Days)||0
9032907|NCT03266172|10095074|FG001|COMPLETED|Part C Washout Period (7 Days)||0
9032908|NCT03266172|10095075|FG002|COMPLETED|Part C Washout Period (7 Days)||16
9032909|NCT03266172|10095073|FG000|NOT COMPLETED|Part C Washout Period (7 Days)||0
9032910|NCT03266172|10095074|FG001|NOT COMPLETED|Part C Washout Period (7 Days)||0
9032911|NCT03266172|10095075|FG002|NOT COMPLETED|Part C Washout Period (7 Days)||0
9032912|NCT03266172|10095073|FG000|STARTED|Part C Period 4(2 Days)||0
9032913|NCT03266172|10095074|FG001|STARTED|Part C Period 4(2 Days)||0
9032914|NCT03266172|10095075|FG002|STARTED|Part C Period 4(2 Days)||16
9032915|NCT03266172|10095073|FG000|COMPLETED|Part C Period 4(2 Days)||0
8793312|NCT01400906|9844859|FG005|NOT COMPLETED|Washout Period 2||0
8793313|NCT01400906|9844854|FG000|STARTED|Treatment Period 3||6
8793314|NCT01400906|9844855|FG001|STARTED|Treatment Period 3||6
8793315|NCT01400906|9844856|FG002|STARTED|Treatment Period 3||6
8793316|NCT01400906|9844857|FG003|STARTED|Treatment Period 3||6
8793317|NCT01400906|9844858|FG004|STARTED|Treatment Period 3||6
9032916|NCT03266172|10095074|FG001|COMPLETED|Part C Period 4(2 Days)||0
9032917|NCT03266172|10095075|FG002|COMPLETED|Part C Period 4(2 Days)||16
9032918|NCT03266172|10095073|FG000|NOT COMPLETED|Part C Period 4(2 Days)||0
9032919|NCT03266172|10095074|FG001|NOT COMPLETED|Part C Period 4(2 Days)||0
9032920|NCT03266172|10095075|FG002|NOT COMPLETED|Part C Period 4(2 Days)||0
9032921|NCT03266172|10095073|FG000|STARTED|Part C Washout Period (7 Days)||0
9032922|NCT03266172|10095074|FG001|STARTED|Part C Washout Period (7 Days)||0
9032923|NCT03266172|10095075|FG002|STARTED|Part C Washout Period (7 Days)||16
9032924|NCT03266172|10095073|FG000|COMPLETED|Part C Washout Period (7 Days)||0
9032925|NCT03266172|10095074|FG001|COMPLETED|Part C Washout Period (7 Days)||0
9032926|NCT03266172|10095075|FG002|COMPLETED|Part C Washout Period (7 Days)||15
9032927|NCT03266172|10095073|FG000|NOT COMPLETED|Part C Washout Period (7 Days)||0
9032928|NCT03266172|10095074|FG001|NOT COMPLETED|Part C Washout Period (7 Days)||0
9032929|NCT03266172|10095075|FG002|NOT COMPLETED|Part C Washout Period (7 Days)||1
9032930|NCT03266172|10095073|FG000|STARTED|Part C Period 5(2 Days)||0
9032931|NCT03266172|10095074|FG001|STARTED|Part C Period 5(2 Days)||0
9032932|NCT03266172|10095075|FG002|STARTED|Part C Period 5(2 Days)||15
9032933|NCT03266172|10095073|FG000|COMPLETED|Part C Period 5(2 Days)||0
9032934|NCT03266172|10095074|FG001|COMPLETED|Part C Period 5(2 Days)||0
9032935|NCT03266172|10095075|FG002|COMPLETED|Part C Period 5(2 Days)||15
9032936|NCT03266172|10095073|FG000|NOT COMPLETED|Part C Period 5(2 Days)||0
9032937|NCT03266172|10095074|FG001|NOT COMPLETED|Part C Period 5(2 Days)||0
9032938|NCT03266172|10095075|FG002|NOT COMPLETED|Part C Period 5(2 Days)||0
9032939|NCT03266172|10095073|FG000|STARTED|Part C Washout Period (7 Days)||0
9032940|NCT03266172|10095074|FG001|STARTED|Part C Washout Period (7 Days)||0
9032941|NCT03266172|10095075|FG002|STARTED|Part C Washout Period (7 Days)||15
9032942|NCT03266172|10095073|FG000|COMPLETED|Part C Washout Period (7 Days)||0
9032943|NCT03266172|10095074|FG001|COMPLETED|Part C Washout Period (7 Days)||0
9032944|NCT03266172|10095075|FG002|COMPLETED|Part C Washout Period (7 Days)||14
9032945|NCT03266172|10095073|FG000|NOT COMPLETED|Part C Washout Period (7 Days)||0
9032946|NCT03266172|10095074|FG001|NOT COMPLETED|Part C Washout Period (7 Days)||0
9032947|NCT03266172|10095075|FG002|NOT COMPLETED|Part C Washout Period (7 Days)||1
9032948|NCT03266172|10095073|FG000|STARTED|Part C Period 6(2 Days)||0
9032949|NCT03266172|10095074|FG001|STARTED|Part C Period 6(2 Days)||0
9032950|NCT03266172|10095075|FG002|STARTED|Part C Period 6(2 Days)||14
9032951|NCT03266172|10095073|FG000|COMPLETED|Part C Period 6(2 Days)||0
9032952|NCT03266172|10095074|FG001|COMPLETED|Part C Period 6(2 Days)||0
9032953|NCT03266172|10095075|FG002|COMPLETED|Part C Period 6(2 Days)||14
9032954|NCT03266172|10095073|FG000|NOT COMPLETED|Part C Period 6(2 Days)||0
9032955|NCT03266172|10095074|FG001|NOT COMPLETED|Part C Period 6(2 Days)||0
9032956|NCT03266172|10095075|FG002|NOT COMPLETED|Part C Period 6(2 Days)||0
9032957|NCT03266419|10095127|FG000|STARTED|Overall Study||51
9032958|NCT03266419|10095128|FG001|STARTED|Overall Study||49
9032959|NCT03266419|10095127|FG000|COMPLETED|Overall Study||51
9032960|NCT03266419|10095128|FG001|COMPLETED|Overall Study||49
9032961|NCT03266419|10095127|FG000|NOT COMPLETED|Overall Study||0
9032962|NCT03266419|10095128|FG001|NOT COMPLETED|Overall Study||0
8793318|NCT01400906|9844859|FG005|STARTED|Treatment Period 3||5
8793319|NCT01400906|9844854|FG000|COMPLETED|Treatment Period 3||6
8793320|NCT01400906|9844855|FG001|COMPLETED|Treatment Period 3||6
8793321|NCT01400906|9844856|FG002|COMPLETED|Treatment Period 3||6
8793322|NCT01400906|9844857|FG003|COMPLETED|Treatment Period 3||6
8793323|NCT01400906|9844858|FG004|COMPLETED|Treatment Period 3||6
8793324|NCT01400906|9844859|FG005|COMPLETED|Treatment Period 3||5
8793325|NCT01400906|9844854|FG000|NOT COMPLETED|Treatment Period 3||0
8793326|NCT01400906|9844855|FG001|NOT COMPLETED|Treatment Period 3||0
8793327|NCT01400906|9844856|FG002|NOT COMPLETED|Treatment Period 3||0
8793328|NCT01400906|9844857|FG003|NOT COMPLETED|Treatment Period 3||0
8793329|NCT01400906|9844858|FG004|NOT COMPLETED|Treatment Period 3||0
8793330|NCT01400906|9844859|FG005|NOT COMPLETED|Treatment Period 3||0
8793331|NCT01400919|9844867|FG000|STARTED|Overall Study||75
8793332|NCT01400919|9844867|FG000|COMPLETED|Overall Study||67
8793333|NCT01400919|9844867|FG000|NOT COMPLETED|Overall Study||8
8793334|NCT01400932|9844873|FG000|STARTED|Overall Study||178
8793335|NCT01400932|9844874|FG001|STARTED|Overall Study||182
8793336|NCT01400932|9844873|FG000|COMPLETED|Overall Study||164
8793337|NCT01400932|9844874|FG001|COMPLETED|Overall Study||167
8793338|NCT01400932|9844873|FG000|NOT COMPLETED|Overall Study||14
8793339|NCT01400932|9844874|FG001|NOT COMPLETED|Overall Study||15
8793340|NCT01400958|9844882|FG000|STARTED|Overall Study||3
8793341|NCT01400958|9844883|FG001|STARTED|Overall Study||3
8793342|NCT01400958|9844882|FG000|COMPLETED|Overall Study||2
8793343|NCT01400958|9844883|FG001|COMPLETED|Overall Study||1
8793344|NCT01400958|9844882|FG000|NOT COMPLETED|Overall Study||1
8793345|NCT01400958|9844883|FG001|NOT COMPLETED|Overall Study||2
9032963|NCT03266588|10095137|FG000|STARTED|Observational Period||1605
8793346|NCT01400971|9844889|FG000|STARTED|Overall Study||4299
8793347|NCT01400971|9844889|FG000|Complete Treatment Data|Overall Study||2528
8793348|NCT01400971|9844889|FG000|COMPLETED|Overall Study||3382
8793349|NCT01400971|9844889|FG000|NOT COMPLETED|Overall Study||917
8793350|NCT01401010|9844895|FG000|STARTED|Overall Study||6
8793351|NCT01401010|9844896|FG001|STARTED|Overall Study||6
8793352|NCT01401010|9844895|FG000|COMPLETED|Overall Study||5
8793353|NCT01401010|9844896|FG001|COMPLETED|Overall Study||6
8793354|NCT01401010|9844895|FG000|NOT COMPLETED|Overall Study||1
8793355|NCT01401010|9844896|FG001|NOT COMPLETED|Overall Study||0
8793356|NCT01401023|9844907|FG000|STARTED|Overall Study||10
8793357|NCT01401023|9844907|FG000|COMPLETED|Overall Study||10
8793358|NCT01401023|9844907|FG000|NOT COMPLETED|Overall Study||0
8793359|NCT01401062|9844915|FG000|STARTED|Overall Study||11
8793360|NCT01401062|9844916|FG001|STARTED|Overall Study||12
8793361|NCT01401062|9844915|FG000|COMPLETED|Overall Study||0
8793362|NCT01401062|9844916|FG001|COMPLETED|Overall Study|At time of data entry, these 4 patients are still undergoing follow-up|4
8793363|NCT01401062|9844915|FG000|NOT COMPLETED|Overall Study||11
8793364|NCT01401062|9844916|FG001|NOT COMPLETED|Overall Study||8
8793365|NCT01401101|9844924|FG000|STARTED|Overall Study||206
8793366|NCT01401101|9844925|FG001|STARTED|Overall Study||198
8793367|NCT01401101|9844924|FG000|COMPLETED|Overall Study||184
8793368|NCT01401101|9844925|FG001|COMPLETED|Overall Study||171
8793369|NCT01401101|9844924|FG000|NOT COMPLETED|Overall Study||22
8793370|NCT01401101|9844925|FG001|NOT COMPLETED|Overall Study||27
8793371|NCT01401153|9844933|FG000|STARTED|First Test Day||66
8793372|NCT01401153|9844934|FG001|STARTED|First Test Day||55
8793373|NCT01401153|9844933|FG000|COMPLETED|First Test Day||65
8793374|NCT01401153|9844934|FG001|COMPLETED|First Test Day||45
8793375|NCT01401153|9844933|FG000|NOT COMPLETED|First Test Day||1
8793376|NCT01401153|9844934|FG001|NOT COMPLETED|First Test Day||10
8793377|NCT01401153|9844933|FG000|STARTED|Second Test Day||45
8793378|NCT01401153|9844934|FG001|STARTED|Second Test Day||65
8793379|NCT01401153|9844933|FG000|COMPLETED|Second Test Day||45
8793380|NCT01401153|9844934|FG001|COMPLETED|Second Test Day||60
8793381|NCT01401153|9844933|FG000|NOT COMPLETED|Second Test Day||0
8793382|NCT01401153|9844934|FG001|NOT COMPLETED|Second Test Day||5
8793383|NCT01401166|9844943|FG000|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 124 participants were randomized, but 2 did not receive any treatment.|122
8793384|NCT01401166|9844944|FG001|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 124 participants were randomized, but 2 did not receive any treatment.|122
8793385|NCT01401166|9844945|FG002|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 121 participants were randomized who all received study treatment.|121
8793386|NCT01401166|9844946|FG003|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 119 participants were randomized, but 1 did not receive any treatment.|118
8793387|NCT01401166|9844943|FG000|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||119
8793388|NCT01401166|9844944|FG001|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||120
8793389|NCT01401166|9844945|FG002|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||119
8793390|NCT01401166|9844946|FG003|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||116
8793391|NCT01401166|9844943|FG000|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||3
8793392|NCT01401166|9844944|FG001|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||2
8793393|NCT01401166|9844945|FG002|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||2
8793394|NCT01401166|9844946|FG003|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||2
8793395|NCT01401166|9844943|FG000|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||119
8793396|NCT01401166|9844944|FG001|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||120
8793397|NCT01401166|9844945|FG002|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||119
8793398|NCT01401166|9844946|FG003|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||116
8793399|NCT01401166|9844943|FG000|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||113
8793400|NCT01401166|9844944|FG001|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||116
8793401|NCT01401166|9844945|FG002|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||107
8793402|NCT01401166|9844946|FG003|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||105
8793403|NCT01401166|9844943|FG000|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||6
8793404|NCT01401166|9844944|FG001|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||4
8793405|NCT01401166|9844945|FG002|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||12
8793406|NCT01401166|9844946|FG003|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||11
8793407|NCT01401166|9844943|FG000|STARTED|Continuation Treatment (Cycles 9 to 18)||113
8793408|NCT01401166|9844944|FG001|STARTED|Continuation Treatment (Cycles 9 to 18)||116
8793409|NCT01401166|9844945|FG002|STARTED|Continuation Treatment (Cycles 9 to 18)||107
8793410|NCT01401166|9844946|FG003|STARTED|Continuation Treatment (Cycles 9 to 18)||105
8793411|NCT01401166|9844943|FG000|COMPLETED|Continuation Treatment (Cycles 9 to 18)||109
8793412|NCT01401166|9844944|FG001|COMPLETED|Continuation Treatment (Cycles 9 to 18)||109
8793413|NCT01401166|9844945|FG002|COMPLETED|Continuation Treatment (Cycles 9 to 18)||105
8793414|NCT01401166|9844946|FG003|COMPLETED|Continuation Treatment (Cycles 9 to 18)||102
8793415|NCT01401166|9844943|FG000|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||4
8793416|NCT01401166|9844944|FG001|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||7
8793417|NCT01401166|9844945|FG002|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||2
8793418|NCT01401166|9844946|FG003|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||3
8793419|NCT01401166|9844943|FG000|STARTED|Safety Follow-Up Period|All 124 randomized participants entered follow-up regardless of whether they received treatment.|124
8793420|NCT01401166|9844944|FG001|STARTED|Safety Follow-Up Period|All 124 randomized participants entered follow-up regardless of whether they received treatment.|124
8793421|NCT01401166|9844945|FG002|STARTED|Safety Follow-Up Period|All 121 randomized participants entered follow-up regardless of whether they received treatment.|121
8793422|NCT01401166|9844946|FG003|STARTED|Safety Follow-Up Period|All 119 randomized participants entered follow-up regardless of whether they received treatment.|119
8793423|NCT01401166|9844943|FG000|COMPLETED|Safety Follow-Up Period||99
8793424|NCT01401166|9844944|FG001|COMPLETED|Safety Follow-Up Period||106
8793425|NCT01401166|9844945|FG002|COMPLETED|Safety Follow-Up Period||104
8793426|NCT01401166|9844946|FG003|COMPLETED|Safety Follow-Up Period||100
8793427|NCT01401166|9844943|FG000|NOT COMPLETED|Safety Follow-Up Period||25
8793428|NCT01401166|9844944|FG001|NOT COMPLETED|Safety Follow-Up Period||18
8793429|NCT01401166|9844945|FG002|NOT COMPLETED|Safety Follow-Up Period||17
8793430|NCT01401166|9844946|FG003|NOT COMPLETED|Safety Follow-Up Period||19
8793431|NCT01401257|9844967|FG000|STARTED|Overall Study||21
8793432|NCT01401257|9844968|FG001|STARTED|Overall Study||21
8793433|NCT01401257|9844969|FG002|STARTED|Overall Study||19
8793434|NCT01401257|9844970|FG003|STARTED|Overall Study||19
8793435|NCT01401257|9844967|FG000|COMPLETED|Overall Study||21
8793436|NCT01401257|9844968|FG001|COMPLETED|Overall Study||19
8793437|NCT01401257|9844969|FG002|COMPLETED|Overall Study||16
8793438|NCT01401257|9844970|FG003|COMPLETED|Overall Study||17
8793439|NCT01401257|9844967|FG000|NOT COMPLETED|Overall Study||0
8793440|NCT01401257|9844968|FG001|NOT COMPLETED|Overall Study||2
8793441|NCT01401257|9844969|FG002|NOT COMPLETED|Overall Study||3
8793442|NCT01401257|9844970|FG003|NOT COMPLETED|Overall Study||2
8793443|NCT01401283|9844982|FG000|STARTED|Overall Study||89
8793444|NCT01401283|9844983|FG001|STARTED|Overall Study||91
8793445|NCT01401283|9844982|FG000|COMPLETED|Overall Study||79
8793446|NCT01401283|9844983|FG001|COMPLETED|Overall Study||81
8793447|NCT01401283|9844982|FG000|NOT COMPLETED|Overall Study||10
8793448|NCT01401283|9844983|FG001|NOT COMPLETED|Overall Study||10
8793449|NCT01401322|9844989|FG000|STARTED|Overall Study||5
8793450|NCT01401322|9844989|FG000|COMPLETED|Overall Study||3
8793451|NCT01401322|9844989|FG000|NOT COMPLETED|Overall Study||2
8793452|NCT01401361|9844993|FG000|STARTED|Overall Study||150
8793453|NCT01401361|9844993|FG000|COMPLETED|Overall Study|16 subjects were withdrawn prior to the use of the investigational device|122
8793454|NCT01401361|9844993|FG000|NOT COMPLETED|Overall Study||28
8793455|NCT01401452|9844997|FG000|STARTED|Overall Study||246
8793456|NCT01401452|9844997|FG000|Visit 1 (Baseline)|Overall Study||246
8793457|NCT01401452|9844997|FG000|Visit 2 (1 Month)|Overall Study||225
8793458|NCT01401452|9844997|FG000|Visit 3 (3 Months)|Overall Study||217
8793459|NCT01401452|9844997|FG000|Visit 4 (6 Months)|Overall Study||172
8793460|NCT01401452|9844997|FG000|Visit 5 (9 Months)|Overall Study||175
8793461|NCT01401452|9844997|FG000|COMPLETED|Overall Study||174
8793462|NCT01401452|9844997|FG000|NOT COMPLETED|Overall Study||72
8793463|NCT01401465|9845003|FG000|STARTED|Treatment Period 1||165
8793464|NCT01401465|9845004|FG001|STARTED|Treatment Period 1||162
8793465|NCT01401465|9845003|FG000|COMPLETED|Treatment Period 1||150
8793466|NCT01401465|9845004|FG001|COMPLETED|Treatment Period 1||146
8793467|NCT01401465|9845003|FG000|NOT COMPLETED|Treatment Period 1||15
8793468|NCT01401465|9845004|FG001|NOT COMPLETED|Treatment Period 1||16
8793469|NCT01401465|9845003|FG000|STARTED|Washout||150
8793470|NCT01401465|9845004|FG001|STARTED|Washout||146
8793471|NCT01401465|9845003|FG000|COMPLETED|Washout||150
8793472|NCT01401465|9845004|FG001|COMPLETED|Washout||146
8793473|NCT01401465|9845003|FG000|NOT COMPLETED|Washout||0
8793474|NCT01401465|9845004|FG001|NOT COMPLETED|Washout||0
8793475|NCT01401465|9845003|FG000|STARTED|Treatment Period 2||150
8793476|NCT01401465|9845004|FG001|STARTED|Treatment Period 2||146
8793477|NCT01401465|9845003|FG000|COMPLETED|Treatment Period 2||150
8793478|NCT01401465|9845004|FG001|COMPLETED|Treatment Period 2||144
8793479|NCT01401465|9845003|FG000|NOT COMPLETED|Treatment Period 2||0
8793480|NCT01401465|9845004|FG001|NOT COMPLETED|Treatment Period 2||2
8793481|NCT01401478|9845013|FG000|STARTED|Overall Study||86
8793482|NCT01401478|9845013|FG000|COMPLETED|Overall Study||55
8793483|NCT01401478|9845013|FG000|NOT COMPLETED|Overall Study||31
8793484|NCT01401517|9845020|FG000|STARTED|Overall Study||18
8793485|NCT01401517|9845021|FG001|STARTED|Overall Study||19
8793486|NCT01401517|9845022|FG002|STARTED|Overall Study||18
8793487|NCT01401517|9845020|FG000|COMPLETED|Overall Study||15
8793488|NCT01401517|9845021|FG001|COMPLETED|Overall Study||17
8793489|NCT01401517|9845022|FG002|COMPLETED|Overall Study||15
8793490|NCT01401517|9845020|FG000|NOT COMPLETED|Overall Study||3
8793491|NCT01401517|9845021|FG001|NOT COMPLETED|Overall Study||2
8793492|NCT01401517|9845022|FG002|NOT COMPLETED|Overall Study||3
8793493|NCT01401530|9845033|FG000|STARTED|Overall Study||3
8793494|NCT01401530|9845034|FG001|STARTED|Overall Study||7
8793495|NCT01401530|9845035|FG002|STARTED|Overall Study||3
8793496|NCT01401530|9845033|FG000|COMPLETED|Overall Study||0
8793497|NCT01401530|9845034|FG001|COMPLETED|Overall Study||1
8793498|NCT01401530|9845035|FG002|COMPLETED|Overall Study||0
8793499|NCT01401530|9845033|FG000|NOT COMPLETED|Overall Study||3
8793500|NCT01401530|9845034|FG001|NOT COMPLETED|Overall Study||6
8793501|NCT01401530|9845035|FG002|NOT COMPLETED|Overall Study||3
8793502|NCT01401543|9845045|FG000|STARTED|First Intervention||6
8793503|NCT01401543|9845046|FG001|STARTED|First Intervention||6
8793504|NCT01401543|9845047|FG002|STARTED|First Intervention||6
8793505|NCT01401543|9845048|FG003|STARTED|First Intervention||6
8793506|NCT01401543|9845045|FG000|COMPLETED|First Intervention||6
8793507|NCT01401543|9845046|FG001|COMPLETED|First Intervention||6
8793508|NCT01401543|9845047|FG002|COMPLETED|First Intervention||6
8793509|NCT01401543|9845048|FG003|COMPLETED|First Intervention||6
8793510|NCT01401543|9845045|FG000|NOT COMPLETED|First Intervention||0
8793511|NCT01401543|9845046|FG001|NOT COMPLETED|First Intervention||0
8793512|NCT01401543|9845047|FG002|NOT COMPLETED|First Intervention||0
8793513|NCT01401543|9845048|FG003|NOT COMPLETED|First Intervention||0
8793514|NCT01401543|9845045|FG000|STARTED|First Washout Period of 1 Week||6
8793515|NCT01401543|9845046|FG001|STARTED|First Washout Period of 1 Week||6
8793516|NCT01401543|9845047|FG002|STARTED|First Washout Period of 1 Week||6
8793517|NCT01401543|9845048|FG003|STARTED|First Washout Period of 1 Week||6
8793518|NCT01401543|9845045|FG000|COMPLETED|First Washout Period of 1 Week||6
8793519|NCT01401543|9845046|FG001|COMPLETED|First Washout Period of 1 Week||6
8793520|NCT01401543|9845047|FG002|COMPLETED|First Washout Period of 1 Week||6
8793521|NCT01401543|9845048|FG003|COMPLETED|First Washout Period of 1 Week||6
8793522|NCT01401543|9845045|FG000|NOT COMPLETED|First Washout Period of 1 Week||0
8793523|NCT01401543|9845046|FG001|NOT COMPLETED|First Washout Period of 1 Week||0
8793524|NCT01401543|9845047|FG002|NOT COMPLETED|First Washout Period of 1 Week||0
8793525|NCT01401543|9845048|FG003|NOT COMPLETED|First Washout Period of 1 Week||0
8793526|NCT01401543|9845045|FG000|STARTED|Second Intervention||6
8793527|NCT01401543|9845046|FG001|STARTED|Second Intervention||6
8793528|NCT01401543|9845047|FG002|STARTED|Second Intervention||6
8793529|NCT01401543|9845048|FG003|STARTED|Second Intervention||6
8793530|NCT01401543|9845045|FG000|COMPLETED|Second Intervention||6
8793531|NCT01401543|9845046|FG001|COMPLETED|Second Intervention||6
8793532|NCT01401543|9845047|FG002|COMPLETED|Second Intervention||6
8793533|NCT01401543|9845048|FG003|COMPLETED|Second Intervention||6
8793534|NCT01401543|9845045|FG000|NOT COMPLETED|Second Intervention||0
8793535|NCT01401543|9845046|FG001|NOT COMPLETED|Second Intervention||0
8793536|NCT01401543|9845047|FG002|NOT COMPLETED|Second Intervention||0
8793537|NCT01401543|9845048|FG003|NOT COMPLETED|Second Intervention||0
8793538|NCT01401543|9845045|FG000|STARTED|Second Washout Period of 1 Week||6
8793539|NCT01401543|9845046|FG001|STARTED|Second Washout Period of 1 Week||6
8793540|NCT01401543|9845047|FG002|STARTED|Second Washout Period of 1 Week||6
8793541|NCT01401543|9845048|FG003|STARTED|Second Washout Period of 1 Week||6
8793542|NCT01401543|9845045|FG000|COMPLETED|Second Washout Period of 1 Week||6
8793543|NCT01401543|9845046|FG001|COMPLETED|Second Washout Period of 1 Week||6
8793544|NCT01401543|9845047|FG002|COMPLETED|Second Washout Period of 1 Week||6
8793545|NCT01401543|9845048|FG003|COMPLETED|Second Washout Period of 1 Week||6
8793546|NCT01401543|9845045|FG000|NOT COMPLETED|Second Washout Period of 1 Week||0
8793547|NCT01401543|9845046|FG001|NOT COMPLETED|Second Washout Period of 1 Week||0
8793548|NCT01401543|9845047|FG002|NOT COMPLETED|Second Washout Period of 1 Week||0
8793549|NCT01401543|9845048|FG003|NOT COMPLETED|Second Washout Period of 1 Week||0
8793550|NCT01401543|9845045|FG000|STARTED|Third Intervention||6
8793551|NCT01401543|9845046|FG001|STARTED|Third Intervention||6
8793552|NCT01401543|9845047|FG002|STARTED|Third Intervention||6
8793553|NCT01401543|9845048|FG003|STARTED|Third Intervention||6
8793554|NCT01401543|9845045|FG000|COMPLETED|Third Intervention||6
8793555|NCT01401543|9845046|FG001|COMPLETED|Third Intervention||6
8793556|NCT01401543|9845047|FG002|COMPLETED|Third Intervention||6
8793557|NCT01401543|9845048|FG003|COMPLETED|Third Intervention||6
8793558|NCT01401543|9845045|FG000|NOT COMPLETED|Third Intervention||0
8793559|NCT01401543|9845046|FG001|NOT COMPLETED|Third Intervention||0
8793560|NCT01401543|9845047|FG002|NOT COMPLETED|Third Intervention||0
8793561|NCT01401543|9845048|FG003|NOT COMPLETED|Third Intervention||0
8793562|NCT01401543|9845045|FG000|STARTED|Third Washout Period of 1 Week||6
8793563|NCT01401543|9845046|FG001|STARTED|Third Washout Period of 1 Week||6
8793564|NCT01401543|9845047|FG002|STARTED|Third Washout Period of 1 Week||6
8793565|NCT01401543|9845048|FG003|STARTED|Third Washout Period of 1 Week||6
8793566|NCT01401543|9845045|FG000|COMPLETED|Third Washout Period of 1 Week||6
8793567|NCT01401543|9845046|FG001|COMPLETED|Third Washout Period of 1 Week||6
8793568|NCT01401543|9845047|FG002|COMPLETED|Third Washout Period of 1 Week||6
8793569|NCT01401543|9845048|FG003|COMPLETED|Third Washout Period of 1 Week||6
8793570|NCT01401543|9845045|FG000|NOT COMPLETED|Third Washout Period of 1 Week||0
8793571|NCT01401543|9845046|FG001|NOT COMPLETED|Third Washout Period of 1 Week||0
8793572|NCT01401543|9845047|FG002|NOT COMPLETED|Third Washout Period of 1 Week||0
8793573|NCT01401543|9845048|FG003|NOT COMPLETED|Third Washout Period of 1 Week||0
8793574|NCT01401543|9845045|FG000|STARTED|Fourth Intervention||6
8793575|NCT01401543|9845046|FG001|STARTED|Fourth Intervention||6
8793576|NCT01401543|9845047|FG002|STARTED|Fourth Intervention||6
8793577|NCT01401543|9845048|FG003|STARTED|Fourth Intervention||6
8793578|NCT01401543|9845045|FG000|COMPLETED|Fourth Intervention||6
8793579|NCT01401543|9845046|FG001|COMPLETED|Fourth Intervention||6
8793580|NCT01401543|9845047|FG002|COMPLETED|Fourth Intervention||6
8793581|NCT01401543|9845048|FG003|COMPLETED|Fourth Intervention||6
8793582|NCT01401543|9845045|FG000|NOT COMPLETED|Fourth Intervention||0
8793583|NCT01401543|9845046|FG001|NOT COMPLETED|Fourth Intervention||0
8793584|NCT01401543|9845047|FG002|NOT COMPLETED|Fourth Intervention||0
8793585|NCT01401543|9845048|FG003|NOT COMPLETED|Fourth Intervention||0
8793586|NCT01401582|9845064|FG000|STARTED|Overall Study||226
8793587|NCT01401582|9845065|FG001|STARTED|Overall Study||408
8793588|NCT01401582|9845064|FG000|Baseline Completed|Overall Study||168
8793589|NCT01401582|9845065|FG001|Baseline Completed|Overall Study||348
8793590|NCT01401582|9845064|FG000|COMPLETED|Overall Study||116
8793591|NCT01401582|9845065|FG001|COMPLETED|Overall Study||291
8793592|NCT01401582|9845064|FG000|NOT COMPLETED|Overall Study||110
8793593|NCT01401582|9845065|FG001|NOT COMPLETED|Overall Study||117
8793594|NCT01401595|9845076|FG000|STARTED|Recruitment and Screening|Of 345 calls, 75 potential NES subjects attended the screening visit and provided informed consent.|75
8793595|NCT01401595|9845077|FG001|STARTED|Recruitment and Screening|Of 32 calls, 12 control subjects attended an initial screening visit.|12
8917396|NCT02191605|9977086|FG000|Completed Intervention Portion|Overall Study||15
8793596|NCT01401595|9845076|FG000|COMPLETED|Recruitment and Screening|Of the 75, 32 remained interested/eligible after the initial screening period.|32
8793597|NCT01401595|9845077|FG001|COMPLETED|Recruitment and Screening|10 of the 12 remained eligible/interested after the initial screening visit.|10
8793598|NCT01401595|9845076|FG000|NOT COMPLETED|Recruitment and Screening||43
8793599|NCT01401595|9845077|FG001|NOT COMPLETED|Recruitment and Screening||2
8793600|NCT01401595|9845076|FG000|STARTED|Imaging and Treatment (for NE Arm)||32
8793601|NCT01401595|9845077|FG001|STARTED|Imaging and Treatment (for NE Arm)||10
8793602|NCT01401595|9845076|FG000|COMPLETED|Imaging and Treatment (for NE Arm)||18
8793603|NCT01401595|9845077|FG001|COMPLETED|Imaging and Treatment (for NE Arm)||10
8793604|NCT01401595|9845076|FG000|NOT COMPLETED|Imaging and Treatment (for NE Arm)||14
8793605|NCT01401595|9845077|FG001|NOT COMPLETED|Imaging and Treatment (for NE Arm)||0
8793606|NCT01401647|9845087|FG000|STARTED|Overall Study||972
8793607|NCT01401647|9845088|FG001|STARTED|Overall Study||993
8793608|NCT01401647|9845089|FG002|STARTED|Overall Study||1059
8793609|NCT01401647|9845087|FG000|COMPLETED|Overall Study||968
8793610|NCT01401647|9845088|FG001|COMPLETED|Overall Study||985
8793611|NCT01401647|9845089|FG002|COMPLETED|Overall Study||1056
8793612|NCT01401647|9845087|FG000|NOT COMPLETED|Overall Study||4
8793613|NCT01401647|9845088|FG001|NOT COMPLETED|Overall Study||8
8793614|NCT01401647|9845089|FG002|NOT COMPLETED|Overall Study||3
8793615|NCT01401699|9845097|FG000|STARTED|Overall Study||109
8793616|NCT01401699|9845097|FG000|COMPLETED|Overall Study||109
8793617|NCT01401699|9845097|FG000|NOT COMPLETED|Overall Study||0
8793618|NCT01401842|9845103|FG000|STARTED|Overall Study||298
8793619|NCT01401842|9845104|FG001|STARTED|Overall Study||284
8793620|NCT01401842|9845103|FG000|COMPLETED|Overall Study||230
8793621|NCT01401842|9845104|FG001|COMPLETED|Overall Study||217
8793622|NCT01401842|9845103|FG000|NOT COMPLETED|Overall Study||68
8793623|NCT01401842|9845104|FG001|NOT COMPLETED|Overall Study||67
8793624|NCT01401907|9845112|FG000|STARTED|Overall Study||175
8793625|NCT01401907|9845113|FG001|STARTED|Overall Study||175
8793626|NCT01401907|9845112|FG000|12 Week Outcomes|Overall Study||148
8793627|NCT01401907|9845113|FG001|12 Week Outcomes|Overall Study||153
8793628|NCT01401907|9845112|FG000|COMPLETED|Overall Study||118
8793629|NCT01401907|9845113|FG001|COMPLETED|Overall Study||124
8793630|NCT01401907|9845112|FG000|NOT COMPLETED|Overall Study||57
8793631|NCT01401907|9845113|FG001|NOT COMPLETED|Overall Study||51
8793632|NCT01401959|9845124|FG000|STARTED|Enrolled||54
8793633|NCT01401959|9845125|FG001|STARTED|Enrolled||42
8793634|NCT01401959|9845126|FG002|STARTED|Enrolled||31
8793635|NCT01401959|9845124|FG000|COMPLETED|Enrolled||53
8793636|NCT01401959|9845125|FG001|COMPLETED|Enrolled||42
8793637|NCT01401959|9845126|FG002|COMPLETED|Enrolled||31
8793638|NCT01401959|9845124|FG000|NOT COMPLETED|Enrolled||1
8793639|NCT01401959|9845125|FG001|NOT COMPLETED|Enrolled||0
8793640|NCT01401959|9845126|FG002|NOT COMPLETED|Enrolled||0
8793641|NCT01401959|9845124|FG000|STARTED|Treated||53
8917397|NCT02191605|9977087|FG001|Completed Intervention Portion|Overall Study||15
8917398|NCT02191605|9977088|FG002|Completed Intervention Portion|Overall Study||15
8917399|NCT02191605|9977089|FG003|Completed Intervention Portion|Overall Study||8
8917400|NCT02191605|9977090|FG004|Completed Intervention Portion|Overall Study||7
8917401|NCT02191605|9977086|FG000|COMPLETED|Overall Study||6
8917402|NCT02191605|9977087|FG001|COMPLETED|Overall Study||11
8917403|NCT02191605|9977088|FG002|COMPLETED|Overall Study||8
8917404|NCT02191605|9977089|FG003|COMPLETED|Overall Study||5
8917405|NCT02191605|9977090|FG004|COMPLETED|Overall Study||3
8917406|NCT02191605|9977086|FG000|NOT COMPLETED|Overall Study||9
8917407|NCT02191605|9977087|FG001|NOT COMPLETED|Overall Study||4
8917408|NCT02191605|9977088|FG002|NOT COMPLETED|Overall Study||7
8917409|NCT02191605|9977089|FG003|NOT COMPLETED|Overall Study||3
8917410|NCT02191605|9977090|FG004|NOT COMPLETED|Overall Study||4
8917411|NCT02191618|9977102|FG000|STARTED|Overall Study||150
8917412|NCT02191618|9977102|FG000|COMPLETED|Overall Study||143
8917413|NCT02191618|9977102|FG000|NOT COMPLETED|Overall Study||7
8917414|NCT02191865|9977109|FG000|STARTED|Overall Study||8
8917415|NCT02191865|9977110|FG001|STARTED|Overall Study||8
8917416|NCT02191865|9977111|FG002|STARTED|Overall Study||17
8917417|NCT02191865|9977109|FG000|COMPLETED|Overall Study||8
8917418|NCT02191865|9977110|FG001|COMPLETED|Overall Study||8
8917419|NCT02191865|9977111|FG002|COMPLETED|Overall Study||17
8917420|NCT02191865|9977109|FG000|NOT COMPLETED|Overall Study||0
8917421|NCT02191865|9977110|FG001|NOT COMPLETED|Overall Study||0
8917422|NCT02191865|9977111|FG002|NOT COMPLETED|Overall Study||0
8917423|NCT02192099|9977122|FG000|STARTED|Overall Study||61
8917424|NCT02192099|9977122|FG000|COMPLETED|Overall Study||0
8917425|NCT02192099|9977122|FG000|NOT COMPLETED|Overall Study||61
8917426|NCT02192164|9977126|FG000|STARTED|Overall Study||126
8917427|NCT02192164|9977126|FG000|Etanercept Treated Population|Overall Study||112
8917428|NCT02192164|9977126|FG000|COMPLETED|Overall Study||112
8917429|NCT02192164|9977126|FG000|NOT COMPLETED|Overall Study||14
8917430|NCT02192190|9977139|FG000|STARTED|Overall Study||76
8917431|NCT02192190|9977140|FG001|STARTED|Overall Study||39
8917432|NCT02192190|9977141|FG002|STARTED|Overall Study||38
8917433|NCT02192190|9977142|FG003|STARTED|Overall Study||38
8917434|NCT02192190|9977143|FG004|STARTED|Overall Study||39
8917435|NCT02192190|9977144|FG005|STARTED|Overall Study||38
8917436|NCT02192190|9977139|FG000|Received at Least 1 Dose of Study Drug|Overall Study||76
8917437|NCT02192190|9977140|FG001|Received at Least 1 Dose of Study Drug|Overall Study||39
8793642|NCT01401959|9845125|FG001|STARTED|Treated||42
8793643|NCT01401959|9845126|FG002|STARTED|Treated||31
8793644|NCT01401959|9845124|FG000|COMPLETED|Treated||46
8793645|NCT01401959|9845125|FG001|COMPLETED|Treated||34
8793646|NCT01401959|9845126|FG002|COMPLETED|Treated||26
8793647|NCT01401959|9845124|FG000|NOT COMPLETED|Treated||7
8793648|NCT01401959|9845125|FG001|NOT COMPLETED|Treated||8
8793649|NCT01401959|9845126|FG002|NOT COMPLETED|Treated||5
8793650|NCT01402011|9845139|FG000|STARTED|Delayed Treatment Period||29
8793651|NCT01402011|9845140|FG001|STARTED|Delayed Treatment Period||23
8793652|NCT01402011|9845141|FG002|STARTED|Delayed Treatment Period||26
8793653|NCT01402011|9845139|FG000|COMPLETED|Delayed Treatment Period|One patient with needle phobia declined to be treated before the 1st set of injections|28
8793654|NCT01402011|9845140|FG001|COMPLETED|Delayed Treatment Period||23
8793655|NCT01402011|9845141|FG002|COMPLETED|Delayed Treatment Period||26
8793656|NCT01402011|9845139|FG000|NOT COMPLETED|Delayed Treatment Period||1
8793657|NCT01402011|9845140|FG001|NOT COMPLETED|Delayed Treatment Period||0
8793658|NCT01402011|9845141|FG002|NOT COMPLETED|Delayed Treatment Period||0
8793659|NCT01402011|9845139|FG000|STARTED|Active Treatment Period||28
8793660|NCT01402011|9845140|FG001|STARTED|Active Treatment Period||23
8793661|NCT01402011|9845141|FG002|STARTED|Active Treatment Period||26
8793662|NCT01402011|9845139|FG000|COMPLETED|Active Treatment Period||27
8793663|NCT01402011|9845140|FG001|COMPLETED|Active Treatment Period||20
8793664|NCT01402011|9845141|FG002|COMPLETED|Active Treatment Period||26
8793665|NCT01402011|9845139|FG000|NOT COMPLETED|Active Treatment Period||1
8793666|NCT01402011|9845140|FG001|NOT COMPLETED|Active Treatment Period||3
8793667|NCT01402011|9845141|FG002|NOT COMPLETED|Active Treatment Period||0
8793668|NCT01402011|9845139|FG000|STARTED|Nine Month Follow-up||27
8793669|NCT01402011|9845140|FG001|STARTED|Nine Month Follow-up||20
8793670|NCT01402011|9845141|FG002|STARTED|Nine Month Follow-up||26
8793671|NCT01402011|9845139|FG000|COMPLETED|Nine Month Follow-up||27
8793672|NCT01402011|9845140|FG001|COMPLETED|Nine Month Follow-up||19
8793673|NCT01402011|9845141|FG002|COMPLETED|Nine Month Follow-up||26
8793674|NCT01402011|9845139|FG000|NOT COMPLETED|Nine Month Follow-up||0
8793675|NCT01402011|9845140|FG001|NOT COMPLETED|Nine Month Follow-up||1
8793676|NCT01402011|9845141|FG002|NOT COMPLETED|Nine Month Follow-up||0
8793677|NCT01402050|9845154|FG000|STARTED|Overall Study||185
8793678|NCT01402050|9845155|FG001|STARTED|Overall Study||191
8793679|NCT01402050|9845154|FG000|COMPLETED|Overall Study||185
8793680|NCT01402050|9845155|FG001|COMPLETED|Overall Study||191
8793681|NCT01402050|9845154|FG000|NOT COMPLETED|Overall Study||0
8793682|NCT01402050|9845155|FG001|NOT COMPLETED|Overall Study||0
8793683|NCT01402063|9845163|FG000|STARTED|Overall Study||42
8793684|NCT01402063|9845164|FG001|STARTED|Overall Study||21
8793685|NCT01402063|9845163|FG000|COMPLETED|Overall Study||39
8793686|NCT01402063|9845164|FG001|COMPLETED|Overall Study||18
8793687|NCT01402063|9845163|FG000|NOT COMPLETED|Overall Study||3
8793688|NCT01402063|9845164|FG001|NOT COMPLETED|Overall Study||3
8793689|NCT01402102|9845172|FG000|STARTED|Overall Study||30
8793690|NCT01402102|9845173|FG001|STARTED|Overall Study||30
8793691|NCT01402102|9845172|FG000|COMPLETED|Overall Study||28
8793692|NCT01402102|9845173|FG001|COMPLETED|Overall Study||27
8793693|NCT01402102|9845172|FG000|NOT COMPLETED|Overall Study||2
8793694|NCT01402102|9845173|FG001|NOT COMPLETED|Overall Study||3
8793695|NCT01402115|9845183|FG000|STARTED|Overall Study||30
8793696|NCT01402115|9845184|FG001|STARTED|Overall Study||30
8793697|NCT01402115|9845183|FG000|COMPLETED|Overall Study||29
8793698|NCT01402115|9845184|FG001|COMPLETED|Overall Study||29
8793699|NCT01402115|9845183|FG000|NOT COMPLETED|Overall Study||1
8793700|NCT01402115|9845184|FG001|NOT COMPLETED|Overall Study||1
8793701|NCT01402128|9845192|FG000|STARTED|Overall Study||40
8793702|NCT01402128|9845193|FG001|STARTED|Overall Study||40
8793703|NCT01402128|9845192|FG000|COMPLETED|Overall Study||39
8793704|NCT01402128|9845193|FG001|COMPLETED|Overall Study||40
8793705|NCT01402128|9845192|FG000|NOT COMPLETED|Overall Study||1
8793706|NCT01402128|9845193|FG001|NOT COMPLETED|Overall Study||0
8793707|NCT01402141|9845201|FG000|STARTED|Overall Study||30
8793708|NCT01402141|9845202|FG001|STARTED|Overall Study||30
8793709|NCT01402141|9845201|FG000|COMPLETED|Overall Study||29
8793710|NCT01402141|9845202|FG001|COMPLETED|Overall Study||28
8793711|NCT01402141|9845201|FG000|NOT COMPLETED|Overall Study||1
8793712|NCT01402141|9845202|FG001|NOT COMPLETED|Overall Study||2
8793713|NCT01402284|9845209|FG000|STARTED|Overall Study||45
8793714|NCT01402284|9845209|FG000|COMPLETED|Overall Study||31
8793715|NCT01402284|9845209|FG000|NOT COMPLETED|Overall Study||14
8793716|NCT01402375|9845219|FG000|STARTED|Overall Study||120
8793717|NCT01402375|9845220|FG001|STARTED|Overall Study||120
8793718|NCT01402375|9845221|FG002|STARTED|Overall Study||120
8793719|NCT01402375|9845222|FG003|STARTED|Overall Study||120
8793720|NCT01402375|9845223|FG004|STARTED|Overall Study||120
8793721|NCT01402375|9845224|FG005|STARTED|Overall Study||120
8793722|NCT01402375|9845219|FG000|COMPLETED|Overall Study||120
8793723|NCT01402375|9845220|FG001|COMPLETED|Overall Study||120
8793724|NCT01402375|9845221|FG002|COMPLETED|Overall Study||120
8793725|NCT01402375|9845222|FG003|COMPLETED|Overall Study||120
8793726|NCT01402375|9845223|FG004|COMPLETED|Overall Study||120
8793727|NCT01402375|9845224|FG005|COMPLETED|Overall Study||120
8793728|NCT01402375|9845219|FG000|NOT COMPLETED|Overall Study||0
8793729|NCT01402375|9845220|FG001|NOT COMPLETED|Overall Study||0
8793730|NCT01402375|9845221|FG002|NOT COMPLETED|Overall Study||0
8793731|NCT01402375|9845222|FG003|NOT COMPLETED|Overall Study||0
8793732|NCT01402375|9845223|FG004|NOT COMPLETED|Overall Study||0
8793733|NCT01402375|9845224|FG005|NOT COMPLETED|Overall Study||0
8793734|NCT01402427|9845240|FG000|STARTED|Overall Study||297
8793735|NCT01402427|9845241|FG001|STARTED|Overall Study||294
8793736|NCT01402427|9845240|FG000|COMPLETED|Overall Study||297
8793737|NCT01402427|9845241|FG001|COMPLETED|Overall Study||294
8793738|NCT01402427|9845240|FG000|NOT COMPLETED|Overall Study||0
8793739|NCT01402427|9845241|FG001|NOT COMPLETED|Overall Study||0
8793740|NCT01402492|9845250|FG000|STARTED|Overall Study||100
8793741|NCT01402492|9845251|FG001|STARTED|Overall Study||100
8793742|NCT01402492|9845252|FG002|STARTED|Overall Study||102
8793743|NCT01402492|9845250|FG000|COMPLETED|Overall Study||79
8793744|NCT01402492|9845251|FG001|COMPLETED|Overall Study||83
8793745|NCT01402492|9845252|FG002|COMPLETED|Overall Study||86
8793746|NCT01402492|9845250|FG000|NOT COMPLETED|Overall Study||21
8793747|NCT01402492|9845251|FG001|NOT COMPLETED|Overall Study||17
8793748|NCT01402492|9845252|FG002|NOT COMPLETED|Overall Study||16
8793749|NCT01402544|9845260|FG000|STARTED|Overall Study||12
8793750|NCT01402544|9845260|FG000|COMPLETED|Overall Study||6
8793751|NCT01402544|9845260|FG000|NOT COMPLETED|Overall Study||6
8793752|NCT01402570|9845264|FG000|STARTED|Overall Study||20
8793753|NCT01402570|9845264|FG000|COMPLETED|Overall Study||19
8793754|NCT01402570|9845264|FG000|NOT COMPLETED|Overall Study||1
8793755|NCT01402700|9845269|FG000|STARTED|Overall Study||75
8793756|NCT01402700|9845269|FG000|COMPLETED|Overall Study||68
8793757|NCT01402700|9845269|FG000|NOT COMPLETED|Overall Study||7
8793758|NCT01402817|9845273|FG000|STARTED|Overall Study||19
8793759|NCT01402817|9845273|FG000|COMPLETED|Overall Study||8
8793760|NCT01402817|9845273|FG000|NOT COMPLETED|Overall Study||11
8793761|NCT01402869|9845281|FG000|STARTED|Overall Study||30
8793762|NCT01402869|9845282|FG001|STARTED|Overall Study||30
8793763|NCT01402869|9845283|FG002|STARTED|Overall Study||31
8793764|NCT01402869|9845281|FG000|COMPLETED|Overall Study||30
8793765|NCT01402869|9845282|FG001|COMPLETED|Overall Study||30
8793766|NCT01402869|9845283|FG002|COMPLETED|Overall Study||30
8793767|NCT01402869|9845281|FG000|NOT COMPLETED|Overall Study||0
8793768|NCT01402869|9845282|FG001|NOT COMPLETED|Overall Study||0
8793769|NCT01402869|9845283|FG002|NOT COMPLETED|Overall Study||1
8793770|NCT01402908|9845293|FG000|STARTED|Overall Study||258
8793771|NCT01402908|9845294|FG001|STARTED|Overall Study||261
8793772|NCT01402908|9845293|FG000|COMPLETED|Overall Study||224
8793773|NCT01402908|9845294|FG001|COMPLETED|Overall Study||243
8793774|NCT01402908|9845293|FG000|NOT COMPLETED|Overall Study||34
8793775|NCT01402908|9845294|FG001|NOT COMPLETED|Overall Study||18
8793776|NCT01402947|9845302|FG000|STARTED|First Intervention||15
8793777|NCT01402947|9845303|FG001|STARTED|First Intervention||15
8793778|NCT01402947|9845302|FG000|COMPLETED|First Intervention||15
8793779|NCT01402947|9845303|FG001|COMPLETED|First Intervention||14
8793780|NCT01402947|9845302|FG000|NOT COMPLETED|First Intervention||0
8793781|NCT01402947|9845303|FG001|NOT COMPLETED|First Intervention||1
8793782|NCT01402947|9845302|FG000|STARTED|Second Intervention||15
8793783|NCT01402947|9845303|FG001|STARTED|Second Intervention||14
8793784|NCT01402947|9845302|FG000|COMPLETED|Second Intervention||15
8793785|NCT01402947|9845303|FG001|COMPLETED|Second Intervention||14
8793786|NCT01402947|9845302|FG000|NOT COMPLETED|Second Intervention||0
8793787|NCT01402947|9845303|FG001|NOT COMPLETED|Second Intervention||0
8793788|NCT01402986|9845313|FG000|STARTED|Overall Study||76
8793789|NCT01402986|9845314|FG001|STARTED|Overall Study||150
8793790|NCT01402986|9845315|FG002|STARTED|Overall Study||75
8793791|NCT01402986|9845316|FG003|STARTED|Overall Study||151
8793792|NCT01402986|9845313|FG000|COMPLETED|Overall Study||67
8793793|NCT01402986|9845314|FG001|COMPLETED|Overall Study||135
8793794|NCT01402986|9845315|FG002|COMPLETED|Overall Study||67
8793795|NCT01402986|9845316|FG003|COMPLETED|Overall Study||129
8793796|NCT01402986|9845313|FG000|NOT COMPLETED|Overall Study||9
8793797|NCT01402986|9845314|FG001|NOT COMPLETED|Overall Study||15
8793798|NCT01402986|9845315|FG002|NOT COMPLETED|Overall Study||8
8793799|NCT01402986|9845316|FG003|NOT COMPLETED|Overall Study||22
8793800|NCT01403051|9845328|FG000|STARTED|Overall Study||81
8793801|NCT01403051|9845329|FG001|STARTED|Overall Study||86
8793802|NCT01403051|9845328|FG000|Initiated Study Treatment|Overall Study||81
8793803|NCT01403051|9845329|FG001|Initiated Study Treatment|Overall Study||86
8793804|NCT01403051|9845328|FG000|COMPLETED|Overall Study||71
8793805|NCT01403051|9845329|FG001|COMPLETED|Overall Study||80
8793806|NCT01403051|9845328|FG000|NOT COMPLETED|Overall Study||10
8793807|NCT01403051|9845329|FG001|NOT COMPLETED|Overall Study||6
8793808|NCT01403064|9845340|FG000|STARTED|Overall Study||24
8793809|NCT01403064|9845341|FG001|STARTED|Overall Study||7
8793810|NCT01403064|9845342|FG002|STARTED|Overall Study||23
8793811|NCT01403064|9845343|FG003|STARTED|Overall Study||22
8793812|NCT01403064|9845340|FG000|COMPLETED|Overall Study||23
8793813|NCT01403064|9845341|FG001|COMPLETED|Overall Study||7
8793814|NCT01403064|9845342|FG002|COMPLETED|Overall Study||19
8793815|NCT01403064|9845343|FG003|COMPLETED|Overall Study||19
8793816|NCT01403064|9845340|FG000|NOT COMPLETED|Overall Study||1
8793817|NCT01403064|9845341|FG001|NOT COMPLETED|Overall Study||0
8793818|NCT01403064|9845342|FG002|NOT COMPLETED|Overall Study||4
8793819|NCT01403064|9845343|FG003|NOT COMPLETED|Overall Study||3
8793820|NCT01403090|9845358|FG000|STARTED|Overall Study||8
8793821|NCT01403090|9845358|FG000|COMPLETED|Overall Study||8
8793822|NCT01403090|9845358|FG000|NOT COMPLETED|Overall Study||0
8793823|NCT01403116|9845364|FG000|STARTED|Overall Study||161
8793824|NCT01403116|9845365|FG001|STARTED|Overall Study||160
8793825|NCT01403116|9845364|FG000|Randomized|Overall Study||162
8793826|NCT01403116|9845365|FG001|Randomized|Overall Study||163
8793827|NCT01403116|9845364|FG000|Randomized in Error/ No Treatment Recvd|Overall Study||1
8793828|NCT01403116|9845365|FG001|Randomized in Error/ No Treatment Recvd|Overall Study||3
8793829|NCT01403116|9845364|FG000|COMPLETED|Overall Study||129
8793830|NCT01403116|9845365|FG001|COMPLETED|Overall Study||133
8793831|NCT01403116|9845364|FG000|NOT COMPLETED|Overall Study||32
8793832|NCT01403116|9845365|FG001|NOT COMPLETED|Overall Study||27
8793833|NCT01403246|9845371|FG000|STARTED|Overall Study||9
8793834|NCT01403246|9845371|FG000|COMPLETED|Overall Study||9
8793835|NCT01403246|9845371|FG000|NOT COMPLETED|Overall Study||0
8793836|NCT01403376|9845378|FG000|STARTED|Overall Study||41
8793837|NCT01403376|9845379|FG001|STARTED|Overall Study||41
8793838|NCT01403376|9845380|FG002|STARTED|Overall Study||46
8793839|NCT01403376|9845378|FG000|COMPLETED|Overall Study||41
8793840|NCT01403376|9845379|FG001|COMPLETED|Overall Study||41
8793841|NCT01403376|9845380|FG002|COMPLETED|Overall Study||46
8793842|NCT01403376|9845378|FG000|NOT COMPLETED|Overall Study||0
8793843|NCT01403376|9845379|FG001|NOT COMPLETED|Overall Study||0
8793844|NCT01403376|9845380|FG002|NOT COMPLETED|Overall Study||0
8793845|NCT01403441|9845388|FG000|STARTED|Overall Study||3
8793846|NCT01403441|9845388|FG000|COMPLETED|Overall Study||3
8793847|NCT01403441|9845388|FG000|NOT COMPLETED|Overall Study||0
8793848|NCT01403584|9845394|FG000|STARTED|First Intervention (1 Night)||11
8793849|NCT01403584|9845395|FG001|STARTED|First Intervention (1 Night)||10
8793850|NCT01403584|9845394|FG000|COMPLETED|First Intervention (1 Night)||11
8793851|NCT01403584|9845395|FG001|COMPLETED|First Intervention (1 Night)||10
8793852|NCT01403584|9845394|FG000|NOT COMPLETED|First Intervention (1 Night)||0
8793853|NCT01403584|9845395|FG001|NOT COMPLETED|First Intervention (1 Night)||0
8793854|NCT01403584|9845394|FG000|STARTED|Second Intervention(1 Night)||10
8793855|NCT01403584|9845395|FG001|STARTED|Second Intervention(1 Night)||11
8793856|NCT01403584|9845394|FG000|COMPLETED|Second Intervention(1 Night)||10
8793857|NCT01403584|9845395|FG001|COMPLETED|Second Intervention(1 Night)||11
8793858|NCT01403584|9845394|FG000|NOT COMPLETED|Second Intervention(1 Night)||0
8793859|NCT01403584|9845395|FG001|NOT COMPLETED|Second Intervention(1 Night)||0
8793860|NCT01403610|9845405|FG000|STARTED|Overall Study||5
8793861|NCT01403610|9845406|FG001|STARTED|Overall Study||6
8793862|NCT01403610|9845407|FG002|STARTED|Overall Study||4
8793863|NCT01403610|9845408|FG003|STARTED|Overall Study||13
8793864|NCT01403610|9845405|FG000|COMPLETED|Overall Study||3
8793865|NCT01403610|9845406|FG001|COMPLETED|Overall Study||3
8793866|NCT01403610|9845407|FG002|COMPLETED|Overall Study||4
8793867|NCT01403610|9845408|FG003|COMPLETED|Overall Study||13
8793868|NCT01403610|9845405|FG000|NOT COMPLETED|Overall Study||2
8793869|NCT01403610|9845406|FG001|NOT COMPLETED|Overall Study||3
8793870|NCT01403610|9845407|FG002|NOT COMPLETED|Overall Study||0
8793871|NCT01403610|9845408|FG003|NOT COMPLETED|Overall Study||0
8793872|NCT01403805|9845420|FG000|STARTED|Overall Study||94
8793873|NCT01403805|9845421|FG001|STARTED|Overall Study||105
8793874|NCT01403805|9845420|FG000|Pneumonia Diagnosis|Overall Study||21
8793875|NCT01403805|9845421|FG001|Pneumonia Diagnosis|Overall Study||2
8793876|NCT01403805|9845420|FG000|COMPLETED|Overall Study||94
8793877|NCT01403805|9845421|FG001|COMPLETED|Overall Study||98
8793878|NCT01403805|9845420|FG000|NOT COMPLETED|Overall Study||0
8793879|NCT01403805|9845421|FG001|NOT COMPLETED|Overall Study||7
8793880|NCT01403987|9845434|FG000|STARTED|Overall Study||34
8793881|NCT01403987|9845435|FG001|STARTED|Overall Study||34
8793882|NCT01403987|9845436|FG002|STARTED|Overall Study||68
8793883|NCT01403987|9845434|FG000|COMPLETED|Overall Study||16
8793884|NCT01403987|9845435|FG001|COMPLETED|Overall Study||17
8793885|NCT01403987|9845436|FG002|COMPLETED|Overall Study||50
8793886|NCT01403987|9845434|FG000|NOT COMPLETED|Overall Study||18
8793887|NCT01403987|9845435|FG001|NOT COMPLETED|Overall Study||17
8793888|NCT01403987|9845436|FG002|NOT COMPLETED|Overall Study||18
8793889|NCT01404039|9845453|FG000|STARTED|Overall Study||5
8793890|NCT01404039|9845454|FG001|STARTED|Overall Study||5
8793891|NCT01404039|9845455|FG002|STARTED|Overall Study||5
8793892|NCT01404039|9845456|FG003|STARTED|Overall Study||10
8793893|NCT01404039|9845457|FG004|STARTED|Overall Study||10
8793894|NCT01404039|9845458|FG005|STARTED|Overall Study||10
8793895|NCT01404039|9845459|FG006|STARTED|Overall Study||10
8793896|NCT01404039|9845460|FG007|STARTED|Overall Study||15
8793897|NCT01404039|9845461|FG008|STARTED|Overall Study||15
8793898|NCT01404039|9845462|FG009|STARTED|Overall Study||15
8793899|NCT01404039|9845463|FG010|STARTED|Overall Study||15
8793900|NCT01404039|9845464|FG011|STARTED|Overall Study||0
8793901|NCT01404039|9845465|FG012|STARTED|Overall Study||0
8793902|NCT01404039|9845453|FG000|COMPLETED|Overall Study||4
8793903|NCT01404039|9845454|FG001|COMPLETED|Overall Study||5
8793904|NCT01404039|9845455|FG002|COMPLETED|Overall Study||5
8793905|NCT01404039|9845456|FG003|COMPLETED|Overall Study||10
8793906|NCT01404039|9845457|FG004|COMPLETED|Overall Study||10
8793907|NCT01404039|9845458|FG005|COMPLETED|Overall Study||10
8793908|NCT01404039|9845459|FG006|COMPLETED|Overall Study||10
8793909|NCT01404039|9845460|FG007|COMPLETED|Overall Study||15
8793910|NCT01404039|9845461|FG008|COMPLETED|Overall Study||15
8793911|NCT01404039|9845462|FG009|COMPLETED|Overall Study||14
8793912|NCT01404039|9845463|FG010|COMPLETED|Overall Study||14
8793913|NCT01404039|9845464|FG011|COMPLETED|Overall Study||0
8793914|NCT01404039|9845465|FG012|COMPLETED|Overall Study||0
8793915|NCT01404039|9845453|FG000|NOT COMPLETED|Overall Study||1
8793916|NCT01404039|9845454|FG001|NOT COMPLETED|Overall Study||0
8793917|NCT01404039|9845455|FG002|NOT COMPLETED|Overall Study||0
8793918|NCT01404039|9845456|FG003|NOT COMPLETED|Overall Study||0
8793919|NCT01404039|9845457|FG004|NOT COMPLETED|Overall Study||0
8793920|NCT01404039|9845458|FG005|NOT COMPLETED|Overall Study||0
8793921|NCT01404039|9845459|FG006|NOT COMPLETED|Overall Study||0
8793922|NCT01404039|9845460|FG007|NOT COMPLETED|Overall Study||0
8793923|NCT01404039|9845461|FG008|NOT COMPLETED|Overall Study||0
8793924|NCT01404039|9845462|FG009|NOT COMPLETED|Overall Study||1
8793925|NCT01404039|9845463|FG010|NOT COMPLETED|Overall Study||1
8793926|NCT01404039|9845464|FG011|NOT COMPLETED|Overall Study||0
8793927|NCT01404039|9845465|FG012|NOT COMPLETED|Overall Study||0
8793928|NCT01404078|9845491|FG000|STARTED|Overall Study|725 Started on Phase 1 run in low dose polycap 645 started on phase 2 run in full dose polycap|261
8793929|NCT01404078|9845492|FG001|STARTED|Overall Study|725 Started on Phase 1 run in low dose polycap 645 started on phase 2 run in full dose polycap|257
8793930|NCT01404078|9845491|FG000|COMPLETED|Overall Study||243
8793931|NCT01404078|9845492|FG001|COMPLETED|Overall Study||237
8793932|NCT01404078|9845491|FG000|NOT COMPLETED|Overall Study||18
8793933|NCT01404078|9845492|FG001|NOT COMPLETED|Overall Study||20
8793934|NCT01404208|9845500|FG000|STARTED|Overall Study||70
8793935|NCT01404208|9845501|FG001|STARTED|Overall Study||72
8793936|NCT01404208|9845500|FG000|COMPLETED|Overall Study||67
8793937|NCT01404208|9845501|FG001|COMPLETED|Overall Study||72
8793938|NCT01404208|9845500|FG000|NOT COMPLETED|Overall Study||3
8793939|NCT01404208|9845501|FG001|NOT COMPLETED|Overall Study||0
8793940|NCT01404234|9845507|FG000|STARTED|Overall Study||61
8793941|NCT01404234|9845507|FG000|COMPLETED|Overall Study||59
8793942|NCT01404234|9845507|FG000|NOT COMPLETED|Overall Study||2
8793943|NCT01404260|9845513|FG000|STARTED|Overall Study||109
8793944|NCT01404260|9845514|FG001|STARTED|Overall Study||110
8793945|NCT01404260|9845513|FG000|COMPLETED|Overall Study||106
8793946|NCT01404260|9845514|FG001|COMPLETED|Overall Study||101
8793947|NCT01404260|9845513|FG000|NOT COMPLETED|Overall Study||3
8793948|NCT01404260|9845514|FG001|NOT COMPLETED|Overall Study||9
8793949|NCT01404325|9845522|FG000|STARTED|Overall Study||67
8793950|NCT01404325|9845523|FG001|STARTED|Overall Study||63
8793951|NCT01404325|9845522|FG000|COMPLETED|Overall Study||63
8793952|NCT01404325|9845523|FG001|COMPLETED|Overall Study||61
8793953|NCT01404325|9845522|FG000|NOT COMPLETED|Overall Study||4
8793954|NCT01404325|9845523|FG001|NOT COMPLETED|Overall Study||2
8793955|NCT01404429|9845531|FG000|STARTED|Overall Study||47
8793956|NCT01404429|9845532|FG001|STARTED|Overall Study||53
8793957|NCT01404429|9845531|FG000|COMPLETED|Overall Study||38
8793958|NCT01404429|9845532|FG001|COMPLETED|Overall Study||46
8793959|NCT01404429|9845531|FG000|NOT COMPLETED|Overall Study||9
8793960|NCT01404429|9845532|FG001|NOT COMPLETED|Overall Study||7
8793961|NCT01404559|9845542|FG000|STARTED|Overall Study||5
8793962|NCT01404559|9845543|FG001|STARTED|Overall Study||5
8793963|NCT01404559|9845544|FG002|STARTED|Overall Study||4
8793964|NCT01404559|9845545|FG003|STARTED|Overall Study||14
8793965|NCT01404559|9845542|FG000|COMPLETED|Overall Study||5
8793966|NCT01404559|9845543|FG001|COMPLETED|Overall Study||5
8793967|NCT01404559|9845544|FG002|COMPLETED|Overall Study||4
8793968|NCT01404559|9845545|FG003|COMPLETED|Overall Study||14
8793969|NCT01404559|9845542|FG000|NOT COMPLETED|Overall Study||0
8793970|NCT01404559|9845543|FG001|NOT COMPLETED|Overall Study||0
8793971|NCT01404559|9845544|FG002|NOT COMPLETED|Overall Study||0
8793972|NCT01404559|9845545|FG003|NOT COMPLETED|Overall Study||0
8793973|NCT01404572|9845552|FG000|STARTED|Overall Study||4
8793974|NCT01404572|9845553|FG001|STARTED|Overall Study||4
8793975|NCT01404572|9845554|FG002|STARTED|Overall Study||4
8793976|NCT01404572|9845552|FG000|COMPLETED|Overall Study||4
8793977|NCT01404572|9845553|FG001|COMPLETED|Overall Study||4
8793978|NCT01404572|9845554|FG002|COMPLETED|Overall Study||4
8793979|NCT01404572|9845552|FG000|NOT COMPLETED|Overall Study||0
8793980|NCT01404572|9845553|FG001|NOT COMPLETED|Overall Study||0
8793981|NCT01404572|9845554|FG002|NOT COMPLETED|Overall Study||0
8793982|NCT01404611|9845568|FG000|STARTED|Overall Study||112
8793983|NCT01404611|9845569|FG001|STARTED|Overall Study||108
8793984|NCT01404611|9845570|FG002|STARTED|Overall Study||111
8793985|NCT01404611|9845568|FG000|COMPLETED|Overall Study||104
8793986|NCT01404611|9845569|FG001|COMPLETED|Overall Study||89
8793987|NCT01404611|9845570|FG002|COMPLETED|Overall Study||106
8793988|NCT01404611|9845568|FG000|NOT COMPLETED|Overall Study||8
8793989|NCT01404611|9845569|FG001|NOT COMPLETED|Overall Study||19
8793990|NCT01404611|9845570|FG002|NOT COMPLETED|Overall Study||5
8917438|NCT02192190|9977141|FG002|Received at Least 1 Dose of Study Drug|Overall Study||38
8917439|NCT02192190|9977142|FG003|Received at Least 1 Dose of Study Drug|Overall Study||38
8917440|NCT02192190|9977143|FG004|Received at Least 1 Dose of Study Drug|Overall Study||38
8917441|NCT02192190|9977144|FG005|Received at Least 1 Dose of Study Drug|Overall Study||37
8917442|NCT02192190|9977139|FG000|COMPLETED|Overall Study||22
8917443|NCT02192190|9977140|FG001|COMPLETED|Overall Study||10
8917444|NCT02192190|9977141|FG002|COMPLETED|Overall Study||13
8917445|NCT02192190|9977142|FG003|COMPLETED|Overall Study||12
8917446|NCT02192190|9977143|FG004|COMPLETED|Overall Study||9
8917447|NCT02192190|9977144|FG005|COMPLETED|Overall Study||9
8917448|NCT02192190|9977139|FG000|NOT COMPLETED|Overall Study||54
8917449|NCT02192190|9977140|FG001|NOT COMPLETED|Overall Study||29
8917450|NCT02192190|9977141|FG002|NOT COMPLETED|Overall Study||25
8793991|NCT01404650|9845578|FG000|STARTED|Overall Study|Twenty-five patients received a median of 2 cycles of AUY922.|25
8793992|NCT01404650|9845578|FG000|COMPLETED|Overall Study||25
8793993|NCT01404650|9845578|FG000|NOT COMPLETED|Overall Study||0
8793994|NCT01404832|9845582|FG000|STARTED|Overall Study||21
8793995|NCT01404832|9845582|FG000|COMPLETED|Overall Study||21
8793996|NCT01404832|9845582|FG000|NOT COMPLETED|Overall Study||0
8793997|NCT01404923|9845588|FG000|STARTED|Overall Study||222
8793998|NCT01404923|9845589|FG001|STARTED|Overall Study||214
8793999|NCT01404923|9845588|FG000|COMPLETED|Overall Study||199
8794000|NCT01404923|9845589|FG001|COMPLETED|Overall Study||197
8794001|NCT01404923|9845588|FG000|NOT COMPLETED|Overall Study||23
8794002|NCT01404923|9845589|FG001|NOT COMPLETED|Overall Study||17
8794003|NCT01404936|9845595|FG000|STARTED|Overall Study||30
8794004|NCT01404936|9845595|FG000|COMPLETED|Overall Study||30
8794005|NCT01404936|9845595|FG000|NOT COMPLETED|Overall Study||0
8794006|NCT01404949|9845599|FG000|STARTED|Overall Study||17
8794007|NCT01404949|9845599|FG000|COMPLETED|Overall Study||16
8794008|NCT01404949|9845599|FG000|NOT COMPLETED|Overall Study||1
8794009|NCT01404988|9845606|FG000|STARTED|Overall Study||33
8794010|NCT01404988|9845607|FG001|STARTED|Overall Study||33
8794011|NCT01404988|9845608|FG002|STARTED|Overall Study||33
8794012|NCT01404988|9845606|FG000|COMPLETED|Overall Study||27
8794013|NCT01404988|9845607|FG001|COMPLETED|Overall Study||29
8794014|NCT01404988|9845608|FG002|COMPLETED|Overall Study||30
8794015|NCT01404988|9845606|FG000|NOT COMPLETED|Overall Study||6
8794016|NCT01404988|9845607|FG001|NOT COMPLETED|Overall Study||4
8794017|NCT01404988|9845608|FG002|NOT COMPLETED|Overall Study||3
8794018|NCT01405027|9845621|FG000|STARTED|Overall Study||84
8794019|NCT01405027|9845622|FG001|STARTED|Overall Study||113
8794020|NCT01405027|9845621|FG000|COMPLETED|Overall Study||52
8794021|NCT01405027|9845622|FG001|COMPLETED|Overall Study||62
8794022|NCT01405027|9845621|FG000|NOT COMPLETED|Overall Study||32
8794023|NCT01405027|9845622|FG001|NOT COMPLETED|Overall Study||51
8794024|NCT01405053|9845632|FG000|STARTED|Overall Study||25
8794025|NCT01405053|9845633|FG001|STARTED|Overall Study||12
8794026|NCT01405053|9845632|FG000|COMPLETED|Overall Study||15
8794027|NCT01405053|9845633|FG001|COMPLETED|Overall Study||4
8794028|NCT01405053|9845632|FG000|NOT COMPLETED|Overall Study||10
8794029|NCT01405053|9845633|FG001|NOT COMPLETED|Overall Study||8
8794030|NCT01405196|9845643|FG000|STARTED|Overall Study||45
8794031|NCT01405196|9845644|FG001|STARTED|Overall Study||47
8794032|NCT01405196|9845645|FG002|STARTED|Overall Study||46
8794033|NCT01405196|9845646|FG003|STARTED|Overall Study||45
8794034|NCT01405196|9845643|FG000|COMPLETED|Overall Study||34
8794035|NCT01405196|9845644|FG001|COMPLETED|Overall Study||35
8794036|NCT01405196|9845645|FG002|COMPLETED|Overall Study||23
8794037|NCT01405196|9845646|FG003|COMPLETED|Overall Study||36
8794038|NCT01405196|9845643|FG000|NOT COMPLETED|Overall Study||11
8794039|NCT01405196|9845644|FG001|NOT COMPLETED|Overall Study||12
8794040|NCT01405196|9845645|FG002|NOT COMPLETED|Overall Study||23
8794041|NCT01405196|9845646|FG003|NOT COMPLETED|Overall Study||9
8794042|NCT01405313|9845657|FG000|STARTED|Overall Study||21
8794043|NCT01405313|9845657|FG000|COMPLETED|Overall Study||21
8794044|NCT01405313|9845657|FG000|NOT COMPLETED|Overall Study||0
8794045|NCT01405456|9845667|FG000|STARTED|Overall Study||25
8794046|NCT01405456|9845668|FG001|STARTED|Overall Study||21
8794047|NCT01405456|9845667|FG000|COMPLETED|Overall Study||22
8794048|NCT01405456|9845668|FG001|COMPLETED|Overall Study||20
8794049|NCT01405456|9845667|FG000|NOT COMPLETED|Overall Study||3
8794050|NCT01405456|9845668|FG001|NOT COMPLETED|Overall Study||1
8794051|NCT01405469|9845674|FG000|STARTED|Overall Study||16
8794052|NCT01405469|9845674|FG000|COMPLETED|Overall Study||16
8794053|NCT01405469|9845674|FG000|NOT COMPLETED|Overall Study||0
8794054|NCT01405508|9845683|FG000|STARTED|Overall Study||26
8794055|NCT01405508|9845684|FG001|STARTED|Overall Study||26
9032964|NCT03266588|10095138|FG001|STARTED|Observational Period||786
9032965|NCT03266588|10095139|FG002|STARTED|Observational Period||476
9032966|NCT03266588|10095137|FG000|COMPLETED|Observational Period||1089
9032967|NCT03266588|10095138|FG001|COMPLETED|Observational Period||511
9032968|NCT03266588|10095139|FG002|COMPLETED|Observational Period||308
9032969|NCT03266588|10095137|FG000|NOT COMPLETED|Observational Period||516
9032970|NCT03266588|10095138|FG001|NOT COMPLETED|Observational Period||275
9032971|NCT03266588|10095139|FG002|NOT COMPLETED|Observational Period||168
9032972|NCT03266588|10095137|FG000|STARTED|Long-term Treatment Period||1089
9032973|NCT03266588|10095138|FG001|STARTED|Long-term Treatment Period||511
9032974|NCT03266588|10095139|FG002|STARTED|Long-term Treatment Period||308
9032975|NCT03266588|10095137|FG000|Treated|Long-term Treatment Period||1033
9032976|NCT03266588|10095138|FG001|Treated|Long-term Treatment Period||481
9032977|NCT03266588|10095139|FG002|Treated|Long-term Treatment Period||286
9032978|NCT03266588|10095137|FG000|COMPLETED|Long-term Treatment Period||683
9032979|NCT03266588|10095138|FG001|COMPLETED|Long-term Treatment Period||271
8794056|NCT01405508|9845685|FG002|STARTED|Overall Study||27
8794057|NCT01405508|9845686|FG003|STARTED|Overall Study||26
8794058|NCT01405508|9845683|FG000|COMPLETED|Overall Study||25
8794059|NCT01405508|9845684|FG001|COMPLETED|Overall Study||25
8794060|NCT01405508|9845685|FG002|COMPLETED|Overall Study||27
8794061|NCT01405508|9845686|FG003|COMPLETED|Overall Study||26
8794062|NCT01405508|9845683|FG000|NOT COMPLETED|Overall Study||1
8794063|NCT01405508|9845684|FG001|NOT COMPLETED|Overall Study||1
8794064|NCT01405508|9845685|FG002|NOT COMPLETED|Overall Study||0
9032980|NCT03266588|10095139|FG002|COMPLETED|Long-term Treatment Period||243
8794065|NCT01405508|9845686|FG003|NOT COMPLETED|Overall Study||0
8794066|NCT01405560|9845696|FG000|STARTED|Overall Study||42
8794067|NCT01405560|9845696|FG000|COMPLETED|Overall Study||41
8794068|NCT01405560|9845696|FG000|NOT COMPLETED|Overall Study||1
8794069|NCT01405742|9845700|FG000|STARTED|Overall Study||2
8794070|NCT01405742|9845701|FG001|STARTED|Overall Study||2
8794071|NCT01405742|9845700|FG000|COMPLETED|Overall Study||1
8794072|NCT01405742|9845701|FG001|COMPLETED|Overall Study||2
8794073|NCT01405742|9845700|FG000|NOT COMPLETED|Overall Study||1
8794074|NCT01405742|9845701|FG001|NOT COMPLETED|Overall Study||0
8794075|NCT01405768|9845709|FG000|STARTED|Overall Study||28
8794076|NCT01405768|9845710|FG001|STARTED|Overall Study||28
8794077|NCT01405768|9845709|FG000|COMPLETED|Overall Study||24
8794078|NCT01405768|9845710|FG001|COMPLETED|Overall Study||28
8794079|NCT01405768|9845709|FG000|NOT COMPLETED|Overall Study||4
8794080|NCT01405768|9845710|FG001|NOT COMPLETED|Overall Study||0
8794081|NCT01405794|9845716|FG000|STARTED|First Dose Placebo (14 Days)||12
8794082|NCT01405794|9845716|FG000|COMPLETED|First Dose Placebo (14 Days)||12
8794083|NCT01405794|9845716|FG000|NOT COMPLETED|First Dose Placebo (14 Days)||0
8794084|NCT01405794|9845716|FG000|STARTED|72 hr Washout||12
8794085|NCT01405794|9845716|FG000|COMPLETED|72 hr Washout||12
8794086|NCT01405794|9845716|FG000|NOT COMPLETED|72 hr Washout||0
8794087|NCT01405794|9845716|FG000|STARTED|Second Dose 32ppm Oral Silver (14 Days)||12
8794088|NCT01405794|9845716|FG000|COMPLETED|Second Dose 32ppm Oral Silver (14 Days)||12
8794089|NCT01405794|9845716|FG000|NOT COMPLETED|Second Dose 32ppm Oral Silver (14 Days)||0
8794090|NCT01405820|9845728|FG000|STARTED|Randomized Treatment Period||54
8794091|NCT01405820|9845729|FG001|STARTED|Randomized Treatment Period||45
8794092|NCT01405820|9845730|FG002|STARTED|Randomized Treatment Period||52
8794093|NCT01405820|9845731|FG003|STARTED|Randomized Treatment Period||54
8794094|NCT01405820|9845732|FG004|STARTED|Randomized Treatment Period||47
8794095|NCT01405820|9845733|FG005|STARTED|Randomized Treatment Period||38
8794096|NCT01405820|9845728|FG000|Safety Population|Randomized Treatment Period||54
8794097|NCT01405820|9845729|FG001|Safety Population|Randomized Treatment Period||45
8794098|NCT01405820|9845730|FG002|Safety Population|Randomized Treatment Period||52
8794099|NCT01405820|9845731|FG003|Safety Population|Randomized Treatment Period|1 participant did not receive any study medication.|53
8794100|NCT01405820|9845732|FG004|Safety Population|Randomized Treatment Period||47
8794101|NCT01405820|9845733|FG005|Safety Population|Randomized Treatment Period||38
8794102|NCT01405820|9845728|FG000|COMPLETED|Randomized Treatment Period||43
8794103|NCT01405820|9845729|FG001|COMPLETED|Randomized Treatment Period||35
8794104|NCT01405820|9845730|FG002|COMPLETED|Randomized Treatment Period||9
8794105|NCT01405820|9845731|FG003|COMPLETED|Randomized Treatment Period||3
8794106|NCT01405820|9845732|FG004|COMPLETED|Randomized Treatment Period||2
8794107|NCT01405820|9845733|FG005|COMPLETED|Randomized Treatment Period||1
8794108|NCT01405820|9845728|FG000|NOT COMPLETED|Randomized Treatment Period||11
8794109|NCT01405820|9845729|FG001|NOT COMPLETED|Randomized Treatment Period||10
8794110|NCT01405820|9845730|FG002|NOT COMPLETED|Randomized Treatment Period||43
8794111|NCT01405820|9845731|FG003|NOT COMPLETED|Randomized Treatment Period||51
8794112|NCT01405820|9845732|FG004|NOT COMPLETED|Randomized Treatment Period||45
8794113|NCT01405820|9845733|FG005|NOT COMPLETED|Randomized Treatment Period||37
8794114|NCT01405820|9845728|FG000|STARTED|Open-Label Treatment Period|1 participant discontinued randomized period due to an adverse event but entered open-label period.|44
8794115|NCT01405820|9845729|FG001|STARTED|Open-Label Treatment Period||35
8794116|NCT01405820|9845730|FG002|STARTED|Open-Label Treatment Period||42
8794117|NCT01405820|9845731|FG003|STARTED|Open-Label Treatment Period||42
8794118|NCT01405820|9845732|FG004|STARTED|Open-Label Treatment Period||42
8794119|NCT01405820|9845733|FG005|STARTED|Open-Label Treatment Period||32
8794120|NCT01405820|9845728|FG000|COMPLETED|Open-Label Treatment Period||40
8794121|NCT01405820|9845729|FG001|COMPLETED|Open-Label Treatment Period||33
8794122|NCT01405820|9845730|FG002|COMPLETED|Open-Label Treatment Period||39
8794123|NCT01405820|9845731|FG003|COMPLETED|Open-Label Treatment Period||37
8794124|NCT01405820|9845732|FG004|COMPLETED|Open-Label Treatment Period||40
8794125|NCT01405820|9845733|FG005|COMPLETED|Open-Label Treatment Period||30
8794126|NCT01405820|9845728|FG000|NOT COMPLETED|Open-Label Treatment Period||4
8794127|NCT01405820|9845729|FG001|NOT COMPLETED|Open-Label Treatment Period||2
8794128|NCT01405820|9845730|FG002|NOT COMPLETED|Open-Label Treatment Period||3
8794129|NCT01405820|9845731|FG003|NOT COMPLETED|Open-Label Treatment Period||5
8794130|NCT01405820|9845732|FG004|NOT COMPLETED|Open-Label Treatment Period||2
8794131|NCT01405820|9845733|FG005|NOT COMPLETED|Open-Label Treatment Period||2
8794132|NCT01405898|9845755|FG000|STARTED|Overall Study||34
8794133|NCT01405898|9845756|FG001|STARTED|Overall Study||34
8794134|NCT01405898|9845755|FG000|COMPLETED|Overall Study||32
8794135|NCT01405898|9845756|FG001|COMPLETED|Overall Study||32
8794136|NCT01405898|9845755|FG000|NOT COMPLETED|Overall Study||2
8794137|NCT01405898|9845756|FG001|NOT COMPLETED|Overall Study||2
8794138|NCT01405911|9845765|FG000|STARTED|Overall Study||83
8794139|NCT01405911|9845766|FG001|STARTED|Overall Study||82
8794140|NCT01405911|9845767|FG002|STARTED|Overall Study||77
8794141|NCT01405911|9845765|FG000|Treated|Overall Study||82
8794142|NCT01405911|9845766|FG001|Treated|Overall Study|1 participant received study drug but was discontinued due to pre-treatment lab AE.|82
8794143|NCT01405911|9845767|FG002|Treated|Overall Study||77
8794144|NCT01405911|9845765|FG000|COMPLETED|Overall Study||79
8794145|NCT01405911|9845766|FG001|COMPLETED|Overall Study||79
8794146|NCT01405911|9845767|FG002|COMPLETED|Overall Study||76
8794147|NCT01405911|9845765|FG000|NOT COMPLETED|Overall Study||4
8794148|NCT01405911|9845766|FG001|NOT COMPLETED|Overall Study||3
8794149|NCT01405911|9845767|FG002|NOT COMPLETED|Overall Study||1
8794150|NCT01405924|9845775|FG000|STARTED|Overall Study||111
8794151|NCT01405924|9845775|FG000|COMPLETED|Overall Study||101
8794152|NCT01405924|9845775|FG000|NOT COMPLETED|Overall Study||10
8794153|NCT01405937|9845783|FG000|STARTED|Overall Study||25
8794154|NCT01405937|9845784|FG001|STARTED|Overall Study||26
8794155|NCT01405937|9845783|FG000|COMPLETED|Overall Study||25
8794156|NCT01405937|9845784|FG001|COMPLETED|Overall Study||26
8794157|NCT01405937|9845783|FG000|NOT COMPLETED|Overall Study||0
8794158|NCT01405937|9845784|FG001|NOT COMPLETED|Overall Study||0
8794159|NCT01405950|9845792|FG000|STARTED|Overall Study||8
8794160|NCT01405950|9845793|FG001|STARTED|Overall Study||2
8794161|NCT01405950|9845794|FG002|STARTED|Overall Study||0
8794162|NCT01405950|9845795|FG003|STARTED|Overall Study||0
8794163|NCT01405950|9845792|FG000|COMPLETED|Overall Study||7
8794164|NCT01405950|9845793|FG001|COMPLETED|Overall Study||2
8794165|NCT01405950|9845794|FG002|COMPLETED|Overall Study||0
8794166|NCT01405950|9845795|FG003|COMPLETED|Overall Study||0
8794167|NCT01405950|9845792|FG000|NOT COMPLETED|Overall Study||1
8794168|NCT01405950|9845793|FG001|NOT COMPLETED|Overall Study||0
8794169|NCT01405950|9845794|FG002|NOT COMPLETED|Overall Study||0
8794170|NCT01405950|9845795|FG003|NOT COMPLETED|Overall Study||0
8794171|NCT01406015|9845805|FG000|STARTED|Overall Study||19
8794172|NCT01406015|9845806|FG001|STARTED|Overall Study||19
8794173|NCT01406015|9845805|FG000|COMPLETED|Overall Study||16
8794174|NCT01406015|9845806|FG001|COMPLETED|Overall Study||16
8794175|NCT01406015|9845805|FG000|NOT COMPLETED|Overall Study||3
8794176|NCT01406015|9845806|FG001|NOT COMPLETED|Overall Study||3
8794177|NCT01406223|9845816|FG000|STARTED|Overall Study||18
8794178|NCT01406223|9845817|FG001|STARTED|Overall Study||19
8794179|NCT01406223|9845818|FG002|STARTED|Overall Study||20
8794180|NCT01406223|9845819|FG003|STARTED|Overall Study||19
9032981|NCT03266588|10095137|FG000|NOT COMPLETED|Long-term Treatment Period||406
9032982|NCT03266588|10095138|FG001|NOT COMPLETED|Long-term Treatment Period||240
9032983|NCT03266588|10095139|FG002|NOT COMPLETED|Long-term Treatment Period||65
9032984|NCT03267212|10095147|FG000|STARTED|First Intervention|Non-invasive ventilation|6
9032985|NCT03267212|10095148|FG001|STARTED|First Intervention|"First Intervention (1 day), Washout (2 days), and Second Intervention (1 day)"|9
9032986|NCT03267212|10095147|FG000|High SCI|First Intervention||2
9032987|NCT03267212|10095148|FG001|High SCI|First Intervention||5
9032988|NCT03267212|10095147|FG000|Low SCI|First Intervention||4
9032989|NCT03267212|10095148|FG001|Low SCI|First Intervention||4
9032990|NCT03267212|10095147|FG000|COMPLETED|First Intervention||5
9032991|NCT03267212|10095148|FG001|COMPLETED|First Intervention||6
9032992|NCT03267212|10095147|FG000|NOT COMPLETED|First Intervention||1
9032993|NCT03267212|10095148|FG001|NOT COMPLETED|First Intervention||3
9032994|NCT03267212|10095147|FG000|STARTED|Washout (Min 2 Days / Max 7 Days)||5
9032995|NCT03267212|10095148|FG001|STARTED|Washout (Min 2 Days / Max 7 Days)||6
9032996|NCT03267212|10095147|FG000|COMPLETED|Washout (Min 2 Days / Max 7 Days)||4
9032997|NCT03267212|10095148|FG001|COMPLETED|Washout (Min 2 Days / Max 7 Days)||6
9032998|NCT03267212|10095147|FG000|NOT COMPLETED|Washout (Min 2 Days / Max 7 Days)||1
9032999|NCT03267212|10095148|FG001|NOT COMPLETED|Washout (Min 2 Days / Max 7 Days)||0
9033000|NCT03267212|10095147|FG000|STARTED|Second Intervention||4
9033001|NCT03267212|10095148|FG001|STARTED|Second Intervention||6
9033002|NCT03267212|10095147|FG000|COMPLETED|Second Intervention||4
9033003|NCT03267212|10095148|FG001|COMPLETED|Second Intervention||6
9033004|NCT03267212|10095147|FG000|NOT COMPLETED|Second Intervention||0
9033005|NCT03267212|10095148|FG001|NOT COMPLETED|Second Intervention||0
9033006|NCT03267264|10095158|FG000|STARTED|Overall Study||66
9033007|NCT03267264|10095159|FG001|STARTED|Overall Study||49
9033008|NCT03267264|10095160|FG002|STARTED|Overall Study||68
9033009|NCT03267264|10095161|FG003|STARTED|Overall Study||65
9033010|NCT03267264|10095158|FG000|Sequence A(Nucleus)|Overall Study||34
9033011|NCT03267264|10095159|FG001|Sequence A(Nucleus)|Overall Study||25
9033012|NCT03267264|10095160|FG002|Sequence A(Nucleus)|Overall Study||33
9033013|NCT03267264|10095161|FG003|Sequence A(Nucleus)|Overall Study||33
9033014|NCT03267264|10095158|FG000|Sequence B(Comparator)|Overall Study||32
9033015|NCT03267264|10095159|FG001|Sequence B(Comparator)|Overall Study||24
9033016|NCT03267264|10095160|FG002|Sequence B(Comparator)|Overall Study||33
9033017|NCT03267264|10095161|FG003|Sequence B(Comparator)|Overall Study||32
9033018|NCT03267264|10095158|FG000|COMPLETED|Overall Study||65
9033019|NCT03267264|10095159|FG001|COMPLETED|Overall Study||49
9033020|NCT03267264|10095160|FG002|COMPLETED|Overall Study||66
9033021|NCT03267264|10095161|FG003|COMPLETED|Overall Study||61
9033022|NCT03267264|10095158|FG000|NOT COMPLETED|Overall Study||1
9033023|NCT03267264|10095159|FG001|NOT COMPLETED|Overall Study||0
9033024|NCT03267264|10095160|FG002|NOT COMPLETED|Overall Study||2
8794181|NCT01406223|9845816|FG000|COMPLETED|Overall Study||6
9033025|NCT03267264|10095161|FG003|NOT COMPLETED|Overall Study||4
9033026|NCT03267511|10095178|FG000|STARTED|Overall Study||31
9033027|NCT03267511|10095179|FG001|STARTED|Overall Study||31
9033028|NCT03267511|10095180|FG002|STARTED|Overall Study||30
8794182|NCT01406223|9845817|FG001|COMPLETED|Overall Study||7
8794183|NCT01406223|9845818|FG002|COMPLETED|Overall Study||2
8794184|NCT01406223|9845819|FG003|COMPLETED|Overall Study||3
8794185|NCT01406223|9845816|FG000|NOT COMPLETED|Overall Study||12
8794186|NCT01406223|9845817|FG001|NOT COMPLETED|Overall Study||12
8794187|NCT01406223|9845818|FG002|NOT COMPLETED|Overall Study||18
8794188|NCT01406223|9845819|FG003|NOT COMPLETED|Overall Study||16
8794189|NCT01406444|9845832|FG000|STARTED|Overall Study||33
8794190|NCT01406444|9845833|FG001|STARTED|Overall Study||33
8794191|NCT01406444|9845834|FG002|STARTED|Overall Study||16
8794192|NCT01406444|9845832|FG000|COMPLETED|Overall Study||23
8794193|NCT01406444|9845833|FG001|COMPLETED|Overall Study||24
8794194|NCT01406444|9845834|FG002|COMPLETED|Overall Study||14
8794195|NCT01406444|9845832|FG000|NOT COMPLETED|Overall Study||10
8794196|NCT01406444|9845833|FG001|NOT COMPLETED|Overall Study||9
8794197|NCT01406444|9845834|FG002|NOT COMPLETED|Overall Study||2
8794198|NCT01406574|9845842|FG000|STARTED|Overall Study||7
8794199|NCT01406574|9845843|FG001|STARTED|Overall Study||4
8794200|NCT01406574|9845844|FG002|STARTED|Overall Study||7
8794201|NCT01406574|9845845|FG003|STARTED|Overall Study||5
8794202|NCT01406574|9845842|FG000|COMPLETED|Overall Study||6
8794203|NCT01406574|9845843|FG001|COMPLETED|Overall Study||3
8794204|NCT01406574|9845844|FG002|COMPLETED|Overall Study||6
8794205|NCT01406574|9845845|FG003|COMPLETED|Overall Study||1
8794206|NCT01406574|9845842|FG000|NOT COMPLETED|Overall Study||1
8794207|NCT01406574|9845843|FG001|NOT COMPLETED|Overall Study||1
8794208|NCT01406574|9845844|FG002|NOT COMPLETED|Overall Study||1
8794209|NCT01406574|9845845|FG003|NOT COMPLETED|Overall Study||4
8794210|NCT01406652|9845858|FG000|STARTED|Overall Study||109
8794211|NCT01406652|9845859|FG001|STARTED|Overall Study||115
8794212|NCT01406652|9845858|FG000|COMPLETED|Overall Study||89
8794213|NCT01406652|9845859|FG001|COMPLETED|Overall Study||95
8794214|NCT01406652|9845858|FG000|NOT COMPLETED|Overall Study||20
8794215|NCT01406652|9845859|FG001|NOT COMPLETED|Overall Study||20
8794216|NCT01406717|9845869|FG000|STARTED|Overall Study||180
8794217|NCT01406717|9845870|FG001|STARTED|Overall Study||180
8794218|NCT01406717|9845869|FG000|COMPLETED|Overall Study||137
8794219|NCT01406717|9845870|FG001|COMPLETED|Overall Study||149
8794220|NCT01406717|9845869|FG000|NOT COMPLETED|Overall Study||43
8794221|NCT01406717|9845870|FG001|NOT COMPLETED|Overall Study||31
8794222|NCT01406795|9845886|FG000|STARTED|Overall Study||1
8794223|NCT01406795|9845886|FG000|COMPLETED|Overall Study||0
8794224|NCT01406795|9845886|FG000|NOT COMPLETED|Overall Study||1
8794225|NCT01406873|9845892|FG000|STARTED|Overall Study||21
8794226|NCT01406873|9845893|FG001|STARTED|Overall Study||21
8794227|NCT01406873|9845892|FG000|COMPLETED|Overall Study||20
8794228|NCT01406873|9845893|FG001|COMPLETED|Overall Study||20
8794229|NCT01406873|9845892|FG000|NOT COMPLETED|Overall Study||1
8794230|NCT01406873|9845893|FG001|NOT COMPLETED|Overall Study||1
8794231|NCT01406938|9845911|FG000|STARTED|Induction Period||482
8794232|NCT01406938|9845912|FG001|STARTED|Induction Period||484
8794233|NCT01406938|9845913|FG002|STARTED|Induction Period||0
8794234|NCT01406938|9845914|FG003|STARTED|Induction Period||0
8794235|NCT01406938|9845915|FG004|STARTED|Induction Period||0
8794236|NCT01406938|9845916|FG005|STARTED|Induction Period||0
8794237|NCT01406938|9845911|FG000|FAS:Patients Assigned Study Treatment|Induction Period||482
8794238|NCT01406938|9845912|FG001|FAS:Patients Assigned Study Treatment|Induction Period||483
8794239|NCT01406938|9845913|FG002|FAS:Patients Assigned Study Treatment|Induction Period||0
8794240|NCT01406938|9845914|FG003|FAS:Patients Assigned Study Treatment|Induction Period||0
8794241|NCT01406938|9845915|FG004|FAS:Patients Assigned Study Treatment|Induction Period||0
8794242|NCT01406938|9845916|FG005|FAS:Patients Assigned Study Treatment|Induction Period||0
8794243|NCT01406938|9845911|FG000|COMPLETED|Induction Period||464
8794244|NCT01406938|9845912|FG001|COMPLETED|Induction Period||464
8794245|NCT01406938|9845913|FG002|COMPLETED|Induction Period||0
8794246|NCT01406938|9845914|FG003|COMPLETED|Induction Period||0
8794247|NCT01406938|9845915|FG004|COMPLETED|Induction Period||0
8794248|NCT01406938|9845916|FG005|COMPLETED|Induction Period||0
8794249|NCT01406938|9845911|FG000|NOT COMPLETED|Induction Period||18
8794250|NCT01406938|9845912|FG001|NOT COMPLETED|Induction Period||20
8794251|NCT01406938|9845913|FG002|NOT COMPLETED|Induction Period||0
8794252|NCT01406938|9845914|FG003|NOT COMPLETED|Induction Period||0
8794253|NCT01406938|9845915|FG004|NOT COMPLETED|Induction Period||0
8794254|NCT01406938|9845916|FG005|NOT COMPLETED|Induction Period||0
8794255|NCT01406938|9845911|FG000|STARTED|Maintenance Period||0
8794256|NCT01406938|9845912|FG001|STARTED|Maintenance Period||0
8794257|NCT01406938|9845913|FG002|STARTED|Maintenance Period||203
8794258|NCT01406938|9845914|FG003|STARTED|Maintenance Period||217
8794259|NCT01406938|9845915|FG004|STARTED|Maintenance Period||206
8794260|NCT01406938|9845916|FG005|STARTED|Maintenance Period||217
8794261|NCT01406938|9845911|FG000|FAS: Patients Assigned Treatment Drug|Maintenance Period||0
8794262|NCT01406938|9845912|FG001|FAS: Patients Assigned Treatment Drug|Maintenance Period||0
8794263|NCT01406938|9845913|FG002|FAS: Patients Assigned Treatment Drug|Maintenance Period||203
8794264|NCT01406938|9845914|FG003|FAS: Patients Assigned Treatment Drug|Maintenance Period||216
8794265|NCT01406938|9845915|FG004|FAS: Patients Assigned Treatment Drug|Maintenance Period||206
8794266|NCT01406938|9845916|FG005|FAS: Patients Assigned Treatment Drug|Maintenance Period||217
8794267|NCT01406938|9845911|FG000|COMPLETED|Maintenance Period||0
8794268|NCT01406938|9845912|FG001|COMPLETED|Maintenance Period||0
8794269|NCT01406938|9845913|FG002|COMPLETED|Maintenance Period||186
8794270|NCT01406938|9845914|FG003|COMPLETED|Maintenance Period||199
8794271|NCT01406938|9845915|FG004|COMPLETED|Maintenance Period||181
8794272|NCT01406938|9845916|FG005|COMPLETED|Maintenance Period||201
8794273|NCT01406938|9845911|FG000|NOT COMPLETED|Maintenance Period||0
8794274|NCT01406938|9845912|FG001|NOT COMPLETED|Maintenance Period||0
8794275|NCT01406938|9845913|FG002|NOT COMPLETED|Maintenance Period||17
8794276|NCT01406938|9845914|FG003|NOT COMPLETED|Maintenance Period||18
8794277|NCT01406938|9845915|FG004|NOT COMPLETED|Maintenance Period||25
8794278|NCT01406938|9845916|FG005|NOT COMPLETED|Maintenance Period||16
8794279|NCT01406938|9845911|FG000|STARTED|Follow up||26
8794280|NCT01406938|9845912|FG001|STARTED|Follow up||23
8794281|NCT01406938|9845913|FG002|STARTED|Follow up||40
8794282|NCT01406938|9845914|FG003|STARTED|Follow up||39
8794283|NCT01406938|9845915|FG004|STARTED|Follow up||40
8794284|NCT01406938|9845916|FG005|STARTED|Follow up||35
8794285|NCT01406938|9845911|FG000|COMPLETED|Follow up||18
8794286|NCT01406938|9845912|FG001|COMPLETED|Follow up||18
8794287|NCT01406938|9845913|FG002|COMPLETED|Follow up||32
8794288|NCT01406938|9845914|FG003|COMPLETED|Follow up||36
8794289|NCT01406938|9845915|FG004|COMPLETED|Follow up||31
8794290|NCT01406938|9845916|FG005|COMPLETED|Follow up||32
8794291|NCT01406938|9845911|FG000|NOT COMPLETED|Follow up||8
8794292|NCT01406938|9845912|FG001|NOT COMPLETED|Follow up||5
8794293|NCT01406938|9845913|FG002|NOT COMPLETED|Follow up||8
8794294|NCT01406938|9845914|FG003|NOT COMPLETED|Follow up||3
8794295|NCT01406938|9845915|FG004|NOT COMPLETED|Follow up||9
8794296|NCT01406938|9845916|FG005|NOT COMPLETED|Follow up||3
8794297|NCT01406990|9845936|FG000|STARTED|Overall Study||15
8794298|NCT01406990|9845936|FG000|COMPLETED|Overall Study||15
8794299|NCT01406990|9845936|FG000|NOT COMPLETED|Overall Study||0
8794300|NCT01407068|9845940|FG000|STARTED|Overall Study||60
8794301|NCT01407068|9845940|FG000|COMPLETED|Overall Study||60
8794302|NCT01407068|9845940|FG000|NOT COMPLETED|Overall Study||0
8794303|NCT01407094|9845949|FG000|STARTED|Stage 1|Stage 1 Sertraline (SERT): 34 exited|146
8794304|NCT01407094|9845950|FG001|STARTED|Stage 1|Stage 1 Placebo (PBO): 27 exited.|150
8794305|NCT01407094|9845951|FG002|STARTED|Stage 1|Bupropion (BUP) was used only in Stage 2 for non-responders to SERT.|0
8794306|NCT01407094|9845949|FG000|COMPLETED|Stage 1|One participant completed Stage 1 but did not continue to Stage 2.|112
8794307|NCT01407094|9845950|FG001|COMPLETED|Stage 1|Four participants completed Stage 1 but did not continue to Stage 2.|123
8794308|NCT01407094|9845951|FG002|COMPLETED|Stage 1||0
8794309|NCT01407094|9845949|FG000|NOT COMPLETED|Stage 1||34
8794310|NCT01407094|9845950|FG001|NOT COMPLETED|Stage 1||27
8794311|NCT01407094|9845951|FG002|NOT COMPLETED|Stage 1||0
8794312|NCT01407094|9845949|FG000|STARTED|Stage 2|Stage 2 SERT includes Stage 1 SERT responders (n=61) and Stage 1 PBO non-responders (n=73).|134
8794313|NCT01407094|9845950|FG001|STARTED|Stage 2|Stage 2 PBO includes Stage 1 PBO responders (n=47); 1 early exit (n=46).|46
8794314|NCT01407094|9845951|FG002|STARTED|Stage 2|Stage 2 BUP includes Stage 1 SERT non-responders (n=54); 1 early exit (n=53).|53
8794315|NCT01407094|9845949|FG000|COMPLETED|Stage 2||113
8794316|NCT01407094|9845950|FG001|COMPLETED|Stage 2||35
8794317|NCT01407094|9845951|FG002|COMPLETED|Stage 2||38
8794318|NCT01407094|9845949|FG000|NOT COMPLETED|Stage 2||21
8794319|NCT01407094|9845950|FG001|NOT COMPLETED|Stage 2||11
8794320|NCT01407094|9845951|FG002|NOT COMPLETED|Stage 2||15
8794321|NCT01407107|9845962|FG000|STARTED|Overall Study||7
8794322|NCT01407107|9845963|FG001|STARTED|Overall Study||3
8794323|NCT01407107|9845964|FG002|STARTED|Overall Study||3
8794324|NCT01407107|9845962|FG000|COMPLETED|Overall Study||7
8794325|NCT01407107|9845963|FG001|COMPLETED|Overall Study||3
8794326|NCT01407107|9845964|FG002|COMPLETED|Overall Study||3
8794327|NCT01407107|9845962|FG000|NOT COMPLETED|Overall Study||0
8794328|NCT01407107|9845963|FG001|NOT COMPLETED|Overall Study||0
8794329|NCT01407107|9845964|FG002|NOT COMPLETED|Overall Study||0
8794330|NCT01407276|9845980|FG000|STARTED|Overall Study||6
8794331|NCT01407276|9845981|FG001|STARTED|Overall Study||6
8794332|NCT01407276|9845982|FG002|STARTED|Overall Study||6
8794333|NCT01407276|9845983|FG003|STARTED|Overall Study||6
8794334|NCT01407276|9845984|FG004|STARTED|Overall Study||6
8794335|NCT01407276|9845985|FG005|STARTED|Overall Study||6
8794336|NCT01407276|9845986|FG006|STARTED|Overall Study||6
8794337|NCT01407276|9845987|FG007|STARTED|Overall Study||7
8794338|NCT01407276|9845980|FG000|COMPLETED|Overall Study||6
8794339|NCT01407276|9845981|FG001|COMPLETED|Overall Study||6
8794340|NCT01407276|9845982|FG002|COMPLETED|Overall Study||6
8794341|NCT01407276|9845983|FG003|COMPLETED|Overall Study||6
8794342|NCT01407276|9845984|FG004|COMPLETED|Overall Study||6
8794343|NCT01407276|9845985|FG005|COMPLETED|Overall Study||6
8794344|NCT01407276|9845986|FG006|COMPLETED|Overall Study||6
8794345|NCT01407276|9845987|FG007|COMPLETED|Overall Study||6
8794346|NCT01407276|9845980|FG000|NOT COMPLETED|Overall Study||0
8794347|NCT01407276|9845981|FG001|NOT COMPLETED|Overall Study||0
8794348|NCT01407276|9845982|FG002|NOT COMPLETED|Overall Study||0
8794349|NCT01407276|9845983|FG003|NOT COMPLETED|Overall Study||0
8794350|NCT01407276|9845984|FG004|NOT COMPLETED|Overall Study||0
8794351|NCT01407276|9845985|FG005|NOT COMPLETED|Overall Study||0
8794352|NCT01407276|9845986|FG006|NOT COMPLETED|Overall Study||0
8794353|NCT01407276|9845987|FG007|NOT COMPLETED|Overall Study||1
8794354|NCT01407354|9846012|FG000|STARTED|First Intervention||20
8794355|NCT01407354|9846013|FG001|STARTED|First Intervention||17
8794356|NCT01407354|9846012|FG000|COMPLETED|First Intervention||18
8794357|NCT01407354|9846013|FG001|COMPLETED|First Intervention||15
8794358|NCT01407354|9846012|FG000|NOT COMPLETED|First Intervention||2
8794359|NCT01407354|9846013|FG001|NOT COMPLETED|First Intervention||2
8794360|NCT01407354|9846012|FG000|STARTED|Second Intervention||18
8794361|NCT01407354|9846013|FG001|STARTED|Second Intervention||15
8794362|NCT01407354|9846012|FG000|COMPLETED|Second Intervention||18
8794363|NCT01407354|9846013|FG001|COMPLETED|Second Intervention||13
8794364|NCT01407354|9846012|FG000|NOT COMPLETED|Second Intervention||0
8794365|NCT01407354|9846013|FG001|NOT COMPLETED|Second Intervention||2
8794366|NCT01407367|9846022|FG000|STARTED|Overall Study||108
8794367|NCT01407367|9846023|FG001|STARTED|Overall Study||242
8794368|NCT01407367|9846022|FG000|COMPLETED|Overall Study||68
8794369|NCT01407367|9846023|FG001|COMPLETED|Overall Study||164
8794370|NCT01407367|9846022|FG000|NOT COMPLETED|Overall Study||40
8794371|NCT01407367|9846023|FG001|NOT COMPLETED|Overall Study||78
8794372|NCT01407523|9846032|FG000|STARTED|Overall Study||16
8794373|NCT01407523|9846032|FG000|COMPLETED|Overall Study||16
8794374|NCT01407523|9846032|FG000|NOT COMPLETED|Overall Study||0
8794375|NCT01407575|9846038|FG000|STARTED|Overall Study||7
8794376|NCT01407575|9846039|FG001|STARTED|Overall Study||6
8794377|NCT01407575|9846038|FG000|COMPLETED|Overall Study||5
8794378|NCT01407575|9846039|FG001|COMPLETED|Overall Study||5
8794379|NCT01407575|9846038|FG000|NOT COMPLETED|Overall Study||2
8794380|NCT01407575|9846039|FG001|NOT COMPLETED|Overall Study||1
8794381|NCT01407926|9846047|FG000|STARTED|Overall Study||142
8794382|NCT01407926|9846047|FG000|COMPLETED|Overall Study||87
8794383|NCT01407926|9846047|FG000|NOT COMPLETED|Overall Study||55
8794384|NCT01407952|9846054|FG000|STARTED|Overall Study||297
8794385|NCT01407952|9846055|FG001|STARTED|Overall Study||303
8794386|NCT01407952|9846054|FG000|COMPLETED|Overall Study||251
8794387|NCT01407952|9846055|FG001|COMPLETED|Overall Study||266
8794388|NCT01407952|9846054|FG000|NOT COMPLETED|Overall Study||46
8794389|NCT01407952|9846055|FG001|NOT COMPLETED|Overall Study||37
8794390|NCT01408030|9846065|FG000|STARTED|Treatment Phase (on Drug)||29
8794391|NCT01408030|9846066|FG001|STARTED|Treatment Phase (on Drug)||31
8794392|NCT01408030|9846067|FG002|STARTED|Treatment Phase (on Drug)||33
8794393|NCT01408030|9846068|FG003|STARTED|Treatment Phase (on Drug)||28
8794394|NCT01408030|9846065|FG000|COMPLETED|Treatment Phase (on Drug)||26
8794395|NCT01408030|9846066|FG001|COMPLETED|Treatment Phase (on Drug)||24
8794396|NCT01408030|9846067|FG002|COMPLETED|Treatment Phase (on Drug)||32
8794397|NCT01408030|9846068|FG003|COMPLETED|Treatment Phase (on Drug)||25
8794398|NCT01408030|9846065|FG000|NOT COMPLETED|Treatment Phase (on Drug)||3
8794399|NCT01408030|9846066|FG001|NOT COMPLETED|Treatment Phase (on Drug)||7
8794400|NCT01408030|9846067|FG002|NOT COMPLETED|Treatment Phase (on Drug)||1
8794401|NCT01408030|9846068|FG003|NOT COMPLETED|Treatment Phase (on Drug)||3
8794402|NCT01408030|9846065|FG000|STARTED|Observation Phase (Off Drug)||26
8794403|NCT01408030|9846066|FG001|STARTED|Observation Phase (Off Drug)||24
8794404|NCT01408030|9846067|FG002|STARTED|Observation Phase (Off Drug)||32
8794405|NCT01408030|9846068|FG003|STARTED|Observation Phase (Off Drug)||25
8794406|NCT01408030|9846065|FG000|COMPLETED|Observation Phase (Off Drug)||22
8794407|NCT01408030|9846066|FG001|COMPLETED|Observation Phase (Off Drug)||18
8794408|NCT01408030|9846067|FG002|COMPLETED|Observation Phase (Off Drug)||26
8794409|NCT01408030|9846068|FG003|COMPLETED|Observation Phase (Off Drug)||21
8794410|NCT01408030|9846065|FG000|NOT COMPLETED|Observation Phase (Off Drug)||4
8794411|NCT01408030|9846066|FG001|NOT COMPLETED|Observation Phase (Off Drug)||6
8794412|NCT01408030|9846067|FG002|NOT COMPLETED|Observation Phase (Off Drug)||6
8794413|NCT01408030|9846068|FG003|NOT COMPLETED|Observation Phase (Off Drug)||4
8794414|NCT01408043|9846078|FG000|STARTED|Overall Study||25
8794415|NCT01408043|9846078|FG000|COMPLETED|Overall Study||24
8794416|NCT01408043|9846078|FG000|NOT COMPLETED|Overall Study||1
8794417|NCT01408147|9846084|FG000|STARTED|Overall Study|174 participants|174
8794418|NCT01408147|9846085|FG001|STARTED|Overall Study|197 participants|197
8794419|NCT01408147|9846084|FG000|COMPLETED|Overall Study|1 clinic withdrew due to low census|174
8794420|NCT01408147|9846085|FG001|COMPLETED|Overall Study||196
8794421|NCT01408147|9846084|FG000|NOT COMPLETED|Overall Study||0
8794422|NCT01408147|9846085|FG001|NOT COMPLETED|Overall Study||1
8794423|NCT01408277|9846093|FG000|STARTED|Overall Study||28
8794424|NCT01408277|9846094|FG001|STARTED|Overall Study||27
8794425|NCT01408277|9846093|FG000|COMPLETED|Overall Study||20
8794426|NCT01408277|9846094|FG001|COMPLETED|Overall Study||23
8794427|NCT01408277|9846093|FG000|NOT COMPLETED|Overall Study||8
8794428|NCT01408277|9846094|FG001|NOT COMPLETED|Overall Study||4
8794429|NCT01408303|9846103|FG000|STARTED|Overall Study||215
8794430|NCT01408303|9846104|FG001|STARTED|Overall Study||216
8794431|NCT01408303|9846105|FG002|STARTED|Overall Study||216
8794432|NCT01408303|9846103|FG000|COMPLETED|Overall Study||209
8794433|NCT01408303|9846104|FG001|COMPLETED|Overall Study||204
8794434|NCT01408303|9846105|FG002|COMPLETED|Overall Study||210
8794435|NCT01408303|9846103|FG000|NOT COMPLETED|Overall Study||6
8794436|NCT01408303|9846104|FG001|NOT COMPLETED|Overall Study||12
8794437|NCT01408303|9846105|FG002|NOT COMPLETED|Overall Study||6
8794438|NCT01408329|9846115|FG000|STARTED|Overall Study||13
8794439|NCT01408329|9846116|FG001|STARTED|Overall Study||15
8794440|NCT01408329|9846115|FG000|COMPLETED|Overall Study||10
8794441|NCT01408329|9846116|FG001|COMPLETED|Overall Study||11
8794442|NCT01408329|9846115|FG000|NOT COMPLETED|Overall Study||3
8794443|NCT01408329|9846116|FG001|NOT COMPLETED|Overall Study||4
8794444|NCT01408459|9846124|FG000|STARTED|Overall Study||22
8794445|NCT01408459|9846125|FG001|STARTED|Overall Study||15
8794446|NCT01408459|9846124|FG000|COMPLETED|Overall Study||21
8794447|NCT01408459|9846125|FG001|COMPLETED|Overall Study||14
8794448|NCT01408459|9846124|FG000|NOT COMPLETED|Overall Study||1
8794449|NCT01408459|9846125|FG001|NOT COMPLETED|Overall Study||1
8794450|NCT01408485|9846132|FG000|STARTED|Overall Study||200
8794451|NCT01408485|9846132|FG000|COMPLETED|Overall Study||179
8794452|NCT01408485|9846132|FG000|NOT COMPLETED|Overall Study||21
8794453|NCT01408537|9846136|FG000|STARTED|Overall Study||152
8794454|NCT01408537|9846136|FG000|COMPLETED|Overall Study||144
8794455|NCT01408537|9846136|FG000|NOT COMPLETED|Overall Study||8
8794456|NCT01408563|9846151|FG000|STARTED|Overall Study||33
8794457|NCT01408563|9846151|FG000|Received Transplant|Overall Study||31
8794458|NCT01408563|9846151|FG000|COMPLETED|Overall Study||31
8794459|NCT01408563|9846151|FG000|NOT COMPLETED|Overall Study||2
8794460|NCT01408576|9846158|FG000|STARTED|Overall Study||244
8794461|NCT01408576|9846159|FG001|STARTED|Overall Study||498
8794462|NCT01408576|9846160|FG002|STARTED|Overall Study||508
8794463|NCT01408576|9846158|FG000|COMPLETED|Overall Study||56
8794464|NCT01408576|9846159|FG001|COMPLETED|Overall Study||0
8794465|NCT01408576|9846160|FG002|COMPLETED|Overall Study||0
8794466|NCT01408576|9846158|FG000|NOT COMPLETED|Overall Study||188
8794467|NCT01408576|9846159|FG001|NOT COMPLETED|Overall Study||498
8794468|NCT01408576|9846160|FG002|NOT COMPLETED|Overall Study||508
8794469|NCT01408628|9846180|FG000|STARTED|Consented||51
8794470|NCT01408628|9846180|FG000|COMPLETED|Consented||39
8794471|NCT01408628|9846180|FG000|NOT COMPLETED|Consented||12
8794472|NCT01408628|9846180|FG000|STARTED|Started Classes/Intervention||39
8794473|NCT01408628|9846180|FG000|COMPLETED|Started Classes/Intervention||39
8794474|NCT01408628|9846180|FG000|NOT COMPLETED|Started Classes/Intervention||0
8794475|NCT01408628|9846180|FG000|STARTED|Completed 6 Month Follow-Up||39
8794476|NCT01408628|9846180|FG000|COMPLETED|Completed 6 Month Follow-Up||25
8794477|NCT01408628|9846180|FG000|NOT COMPLETED|Completed 6 Month Follow-Up||14
8794478|NCT01408706|9846187|FG000|STARTED|Overall Study||30
8794479|NCT01408706|9846188|FG001|STARTED|Overall Study||30
8794480|NCT01408706|9846187|FG000|COMPLETED|Overall Study||29
8794481|NCT01408706|9846188|FG001|COMPLETED|Overall Study||30
8794482|NCT01408706|9846187|FG000|NOT COMPLETED|Overall Study||1
8794483|NCT01408706|9846188|FG001|NOT COMPLETED|Overall Study||0
8794484|NCT01408719|9846216|FG000|STARTED|First Intervention (35 Days)||2
8794485|NCT01408719|9846217|FG001|STARTED|First Intervention (35 Days)||3
8794486|NCT01408719|9846218|FG002|STARTED|First Intervention (35 Days)||2
8794487|NCT01408719|9846219|FG003|STARTED|First Intervention (35 Days)||2
8794488|NCT01408719|9846220|FG004|STARTED|First Intervention (35 Days)||4
8794489|NCT01408719|9846221|FG005|STARTED|First Intervention (35 Days)||3
8794490|NCT01408719|9846222|FG006|STARTED|First Intervention (35 Days)||2
8794491|NCT01408719|9846223|FG007|STARTED|First Intervention (35 Days)||3
8794492|NCT01408719|9846224|FG008|STARTED|First Intervention (35 Days)||2
8794493|NCT01408719|9846225|FG009|STARTED|First Intervention (35 Days)||1
8794494|NCT01408719|9846226|FG010|STARTED|First Intervention (35 Days)||2
8794495|NCT01408719|9846227|FG011|STARTED|First Intervention (35 Days)||2
8794496|NCT01408719|9846228|FG012|STARTED|First Intervention (35 Days)||2
8794497|NCT01408719|9846229|FG013|STARTED|First Intervention (35 Days)||5
8794498|NCT01408719|9846230|FG014|STARTED|First Intervention (35 Days)||1
8794499|NCT01408719|9846231|FG015|STARTED|First Intervention (35 Days)||2
8794500|NCT01408719|9846232|FG016|STARTED|First Intervention (35 Days)||3
8794501|NCT01408719|9846233|FG017|STARTED|First Intervention (35 Days)||2
8794502|NCT01408719|9846234|FG018|STARTED|First Intervention (35 Days)||1
8794503|NCT01408719|9846235|FG019|STARTED|First Intervention (35 Days)||1
8794504|NCT01408719|9846216|FG000|COMPLETED|First Intervention (35 Days)||2
8794505|NCT01408719|9846217|FG001|COMPLETED|First Intervention (35 Days)||3
8794506|NCT01408719|9846218|FG002|COMPLETED|First Intervention (35 Days)||1
8794507|NCT01408719|9846219|FG003|COMPLETED|First Intervention (35 Days)||2
8794508|NCT01408719|9846220|FG004|COMPLETED|First Intervention (35 Days)||3
8794509|NCT01408719|9846221|FG005|COMPLETED|First Intervention (35 Days)||3
8794510|NCT01408719|9846222|FG006|COMPLETED|First Intervention (35 Days)||2
8794511|NCT01408719|9846223|FG007|COMPLETED|First Intervention (35 Days)||3
8794512|NCT01408719|9846224|FG008|COMPLETED|First Intervention (35 Days)||1
8794513|NCT01408719|9846225|FG009|COMPLETED|First Intervention (35 Days)||1
8794514|NCT01408719|9846226|FG010|COMPLETED|First Intervention (35 Days)||2
8794515|NCT01408719|9846227|FG011|COMPLETED|First Intervention (35 Days)||2
8794516|NCT01408719|9846228|FG012|COMPLETED|First Intervention (35 Days)||2
8794517|NCT01408719|9846229|FG013|COMPLETED|First Intervention (35 Days)||4
8794518|NCT01408719|9846230|FG014|COMPLETED|First Intervention (35 Days)||1
8794519|NCT01408719|9846231|FG015|COMPLETED|First Intervention (35 Days)||2
8794520|NCT01408719|9846232|FG016|COMPLETED|First Intervention (35 Days)||2
8794521|NCT01408719|9846233|FG017|COMPLETED|First Intervention (35 Days)||2
8794522|NCT01408719|9846234|FG018|COMPLETED|First Intervention (35 Days)||0
8794523|NCT01408719|9846235|FG019|COMPLETED|First Intervention (35 Days)||1
8794524|NCT01408719|9846216|FG000|NOT COMPLETED|First Intervention (35 Days)||0
8794525|NCT01408719|9846217|FG001|NOT COMPLETED|First Intervention (35 Days)||0
8794526|NCT01408719|9846218|FG002|NOT COMPLETED|First Intervention (35 Days)||1
8794527|NCT01408719|9846219|FG003|NOT COMPLETED|First Intervention (35 Days)||0
8794528|NCT01408719|9846220|FG004|NOT COMPLETED|First Intervention (35 Days)||1
8794529|NCT01408719|9846221|FG005|NOT COMPLETED|First Intervention (35 Days)||0
8794530|NCT01408719|9846222|FG006|NOT COMPLETED|First Intervention (35 Days)||0
8794531|NCT01408719|9846223|FG007|NOT COMPLETED|First Intervention (35 Days)||0
8794532|NCT01408719|9846224|FG008|NOT COMPLETED|First Intervention (35 Days)||1
8794533|NCT01408719|9846225|FG009|NOT COMPLETED|First Intervention (35 Days)||0
8794534|NCT01408719|9846226|FG010|NOT COMPLETED|First Intervention (35 Days)||0
8794535|NCT01408719|9846227|FG011|NOT COMPLETED|First Intervention (35 Days)||0
8794536|NCT01408719|9846228|FG012|NOT COMPLETED|First Intervention (35 Days)||0
8794537|NCT01408719|9846229|FG013|NOT COMPLETED|First Intervention (35 Days)||1
8794538|NCT01408719|9846230|FG014|NOT COMPLETED|First Intervention (35 Days)||0
8794539|NCT01408719|9846231|FG015|NOT COMPLETED|First Intervention (35 Days)||0
8794540|NCT01408719|9846232|FG016|NOT COMPLETED|First Intervention (35 Days)||1
8794541|NCT01408719|9846233|FG017|NOT COMPLETED|First Intervention (35 Days)||0
8794542|NCT01408719|9846234|FG018|NOT COMPLETED|First Intervention (35 Days)||1
8794543|NCT01408719|9846235|FG019|NOT COMPLETED|First Intervention (35 Days)||0
8794544|NCT01408719|9846216|FG000|STARTED|Washout Period (28 Days)||2
8794545|NCT01408719|9846217|FG001|STARTED|Washout Period (28 Days)||3
8794546|NCT01408719|9846218|FG002|STARTED|Washout Period (28 Days)||1
8794547|NCT01408719|9846219|FG003|STARTED|Washout Period (28 Days)||2
8794548|NCT01408719|9846220|FG004|STARTED|Washout Period (28 Days)||3
8794549|NCT01408719|9846221|FG005|STARTED|Washout Period (28 Days)||3
8794550|NCT01408719|9846222|FG006|STARTED|Washout Period (28 Days)||2
8794551|NCT01408719|9846223|FG007|STARTED|Washout Period (28 Days)||3
8794552|NCT01408719|9846224|FG008|STARTED|Washout Period (28 Days)||1
8794553|NCT01408719|9846225|FG009|STARTED|Washout Period (28 Days)||1
8794554|NCT01408719|9846226|FG010|STARTED|Washout Period (28 Days)||2
8794555|NCT01408719|9846227|FG011|STARTED|Washout Period (28 Days)||2
8794556|NCT01408719|9846228|FG012|STARTED|Washout Period (28 Days)||2
8794557|NCT01408719|9846229|FG013|STARTED|Washout Period (28 Days)||4
8794558|NCT01408719|9846230|FG014|STARTED|Washout Period (28 Days)||1
8794559|NCT01408719|9846231|FG015|STARTED|Washout Period (28 Days)||2
8794560|NCT01408719|9846232|FG016|STARTED|Washout Period (28 Days)||2
8794561|NCT01408719|9846233|FG017|STARTED|Washout Period (28 Days)||2
8794562|NCT01408719|9846234|FG018|STARTED|Washout Period (28 Days)||0
8794563|NCT01408719|9846235|FG019|STARTED|Washout Period (28 Days)||1
8794564|NCT01408719|9846216|FG000|COMPLETED|Washout Period (28 Days)||2
8794565|NCT01408719|9846217|FG001|COMPLETED|Washout Period (28 Days)||3
8794566|NCT01408719|9846218|FG002|COMPLETED|Washout Period (28 Days)||1
8794567|NCT01408719|9846219|FG003|COMPLETED|Washout Period (28 Days)||2
8794568|NCT01408719|9846220|FG004|COMPLETED|Washout Period (28 Days)||3
8794569|NCT01408719|9846221|FG005|COMPLETED|Washout Period (28 Days)||3
8794570|NCT01408719|9846222|FG006|COMPLETED|Washout Period (28 Days)||2
8794571|NCT01408719|9846223|FG007|COMPLETED|Washout Period (28 Days)||3
8794572|NCT01408719|9846224|FG008|COMPLETED|Washout Period (28 Days)||1
8794573|NCT01408719|9846225|FG009|COMPLETED|Washout Period (28 Days)||1
8794574|NCT01408719|9846226|FG010|COMPLETED|Washout Period (28 Days)||2
8794575|NCT01408719|9846227|FG011|COMPLETED|Washout Period (28 Days)||2
8794576|NCT01408719|9846228|FG012|COMPLETED|Washout Period (28 Days)||2
8794577|NCT01408719|9846229|FG013|COMPLETED|Washout Period (28 Days)||4
8794578|NCT01408719|9846230|FG014|COMPLETED|Washout Period (28 Days)||1
8794579|NCT01408719|9846231|FG015|COMPLETED|Washout Period (28 Days)||2
8794580|NCT01408719|9846232|FG016|COMPLETED|Washout Period (28 Days)||2
8794581|NCT01408719|9846233|FG017|COMPLETED|Washout Period (28 Days)||2
8794582|NCT01408719|9846234|FG018|COMPLETED|Washout Period (28 Days)||0
8794583|NCT01408719|9846235|FG019|COMPLETED|Washout Period (28 Days)||1
8794584|NCT01408719|9846216|FG000|NOT COMPLETED|Washout Period (28 Days)||0
8794585|NCT01408719|9846217|FG001|NOT COMPLETED|Washout Period (28 Days)||0
8794586|NCT01408719|9846218|FG002|NOT COMPLETED|Washout Period (28 Days)||0
8794587|NCT01408719|9846219|FG003|NOT COMPLETED|Washout Period (28 Days)||0
8794588|NCT01408719|9846220|FG004|NOT COMPLETED|Washout Period (28 Days)||0
8794589|NCT01408719|9846221|FG005|NOT COMPLETED|Washout Period (28 Days)||0
8794590|NCT01408719|9846222|FG006|NOT COMPLETED|Washout Period (28 Days)||0
8794591|NCT01408719|9846223|FG007|NOT COMPLETED|Washout Period (28 Days)||0
8794592|NCT01408719|9846224|FG008|NOT COMPLETED|Washout Period (28 Days)||0
8794593|NCT01408719|9846225|FG009|NOT COMPLETED|Washout Period (28 Days)||0
8794594|NCT01408719|9846226|FG010|NOT COMPLETED|Washout Period (28 Days)||0
8794595|NCT01408719|9846227|FG011|NOT COMPLETED|Washout Period (28 Days)||0
8794596|NCT01408719|9846228|FG012|NOT COMPLETED|Washout Period (28 Days)||0
8794597|NCT01408719|9846229|FG013|NOT COMPLETED|Washout Period (28 Days)||0
8794598|NCT01408719|9846230|FG014|NOT COMPLETED|Washout Period (28 Days)||0
8794599|NCT01408719|9846231|FG015|NOT COMPLETED|Washout Period (28 Days)||0
8794600|NCT01408719|9846232|FG016|NOT COMPLETED|Washout Period (28 Days)||0
8794601|NCT01408719|9846233|FG017|NOT COMPLETED|Washout Period (28 Days)||0
8794602|NCT01408719|9846234|FG018|NOT COMPLETED|Washout Period (28 Days)||0
8794603|NCT01408719|9846235|FG019|NOT COMPLETED|Washout Period (28 Days)||0
8794604|NCT01408719|9846216|FG000|STARTED|Second Intervention (35 Days)||2
8794605|NCT01408719|9846217|FG001|STARTED|Second Intervention (35 Days)||3
8794606|NCT01408719|9846218|FG002|STARTED|Second Intervention (35 Days)||1
8794607|NCT01408719|9846219|FG003|STARTED|Second Intervention (35 Days)||2
8794608|NCT01408719|9846220|FG004|STARTED|Second Intervention (35 Days)||3
8794609|NCT01408719|9846221|FG005|STARTED|Second Intervention (35 Days)||3
8794610|NCT01408719|9846222|FG006|STARTED|Second Intervention (35 Days)||2
8794611|NCT01408719|9846223|FG007|STARTED|Second Intervention (35 Days)||3
8794612|NCT01408719|9846224|FG008|STARTED|Second Intervention (35 Days)||1
8794613|NCT01408719|9846225|FG009|STARTED|Second Intervention (35 Days)||1
8794614|NCT01408719|9846226|FG010|STARTED|Second Intervention (35 Days)||2
8794615|NCT01408719|9846227|FG011|STARTED|Second Intervention (35 Days)||2
8794616|NCT01408719|9846228|FG012|STARTED|Second Intervention (35 Days)||2
8794617|NCT01408719|9846229|FG013|STARTED|Second Intervention (35 Days)||4
8794618|NCT01408719|9846230|FG014|STARTED|Second Intervention (35 Days)||1
8794619|NCT01408719|9846231|FG015|STARTED|Second Intervention (35 Days)||2
8794620|NCT01408719|9846232|FG016|STARTED|Second Intervention (35 Days)||2
8794621|NCT01408719|9846233|FG017|STARTED|Second Intervention (35 Days)||2
8794622|NCT01408719|9846234|FG018|STARTED|Second Intervention (35 Days)||0
8794623|NCT01408719|9846235|FG019|STARTED|Second Intervention (35 Days)||1
8794624|NCT01408719|9846216|FG000|COMPLETED|Second Intervention (35 Days)||2
8794625|NCT01408719|9846217|FG001|COMPLETED|Second Intervention (35 Days)||3
8794626|NCT01408719|9846218|FG002|COMPLETED|Second Intervention (35 Days)||1
8794627|NCT01408719|9846219|FG003|COMPLETED|Second Intervention (35 Days)||2
8794628|NCT01408719|9846220|FG004|COMPLETED|Second Intervention (35 Days)||3
8794629|NCT01408719|9846221|FG005|COMPLETED|Second Intervention (35 Days)||3
8794630|NCT01408719|9846222|FG006|COMPLETED|Second Intervention (35 Days)||2
8794631|NCT01408719|9846223|FG007|COMPLETED|Second Intervention (35 Days)||3
8794632|NCT01408719|9846224|FG008|COMPLETED|Second Intervention (35 Days)||1
8794633|NCT01408719|9846225|FG009|COMPLETED|Second Intervention (35 Days)||1
8794634|NCT01408719|9846226|FG010|COMPLETED|Second Intervention (35 Days)||2
8794635|NCT01408719|9846227|FG011|COMPLETED|Second Intervention (35 Days)||2
8794636|NCT01408719|9846228|FG012|COMPLETED|Second Intervention (35 Days)||2
8794637|NCT01408719|9846229|FG013|COMPLETED|Second Intervention (35 Days)||3
8794638|NCT01408719|9846230|FG014|COMPLETED|Second Intervention (35 Days)||1
8794639|NCT01408719|9846231|FG015|COMPLETED|Second Intervention (35 Days)||2
9033029|NCT03267511|10095181|FG003|STARTED|Overall Study||31
9033030|NCT03267511|10095178|FG000|COMPLETED|Overall Study||31
9033031|NCT03267511|10095179|FG001|COMPLETED|Overall Study||31
8794640|NCT01408719|9846232|FG016|COMPLETED|Second Intervention (35 Days)||2
8794641|NCT01408719|9846233|FG017|COMPLETED|Second Intervention (35 Days)||2
8794642|NCT01408719|9846234|FG018|COMPLETED|Second Intervention (35 Days)||0
8794643|NCT01408719|9846235|FG019|COMPLETED|Second Intervention (35 Days)||1
8794644|NCT01408719|9846216|FG000|NOT COMPLETED|Second Intervention (35 Days)||0
8794645|NCT01408719|9846217|FG001|NOT COMPLETED|Second Intervention (35 Days)||0
8794646|NCT01408719|9846218|FG002|NOT COMPLETED|Second Intervention (35 Days)||0
8794647|NCT01408719|9846219|FG003|NOT COMPLETED|Second Intervention (35 Days)||0
8794648|NCT01408719|9846220|FG004|NOT COMPLETED|Second Intervention (35 Days)||0
8794649|NCT01408719|9846221|FG005|NOT COMPLETED|Second Intervention (35 Days)||0
8794650|NCT01408719|9846222|FG006|NOT COMPLETED|Second Intervention (35 Days)||0
8794651|NCT01408719|9846223|FG007|NOT COMPLETED|Second Intervention (35 Days)||0
8794652|NCT01408719|9846224|FG008|NOT COMPLETED|Second Intervention (35 Days)||0
8794653|NCT01408719|9846225|FG009|NOT COMPLETED|Second Intervention (35 Days)||0
8794654|NCT01408719|9846226|FG010|NOT COMPLETED|Second Intervention (35 Days)||0
8794655|NCT01408719|9846227|FG011|NOT COMPLETED|Second Intervention (35 Days)||0
8794656|NCT01408719|9846228|FG012|NOT COMPLETED|Second Intervention (35 Days)||0
8794657|NCT01408719|9846229|FG013|NOT COMPLETED|Second Intervention (35 Days)||1
8794658|NCT01408719|9846230|FG014|NOT COMPLETED|Second Intervention (35 Days)||0
8794659|NCT01408719|9846231|FG015|NOT COMPLETED|Second Intervention (35 Days)||0
8794660|NCT01408719|9846232|FG016|NOT COMPLETED|Second Intervention (35 Days)||0
8794661|NCT01408719|9846233|FG017|NOT COMPLETED|Second Intervention (35 Days)||0
8794662|NCT01408719|9846234|FG018|NOT COMPLETED|Second Intervention (35 Days)||0
8794663|NCT01408719|9846235|FG019|NOT COMPLETED|Second Intervention (35 Days)||0
8794664|NCT01408719|9846216|FG000|STARTED|Washout Period (28 Days)||2
8794665|NCT01408719|9846217|FG001|STARTED|Washout Period (28 Days)||3
8794666|NCT01408719|9846218|FG002|STARTED|Washout Period (28 Days)||1
8794667|NCT01408719|9846219|FG003|STARTED|Washout Period (28 Days)||2
8794668|NCT01408719|9846220|FG004|STARTED|Washout Period (28 Days)||3
8794669|NCT01408719|9846221|FG005|STARTED|Washout Period (28 Days)||3
8794670|NCT01408719|9846222|FG006|STARTED|Washout Period (28 Days)||2
8794671|NCT01408719|9846223|FG007|STARTED|Washout Period (28 Days)||3
8794672|NCT01408719|9846224|FG008|STARTED|Washout Period (28 Days)||1
8794673|NCT01408719|9846225|FG009|STARTED|Washout Period (28 Days)||1
8794674|NCT01408719|9846226|FG010|STARTED|Washout Period (28 Days)||2
8794675|NCT01408719|9846227|FG011|STARTED|Washout Period (28 Days)||2
8794676|NCT01408719|9846228|FG012|STARTED|Washout Period (28 Days)||2
8794677|NCT01408719|9846229|FG013|STARTED|Washout Period (28 Days)||3
8794678|NCT01408719|9846230|FG014|STARTED|Washout Period (28 Days)||1
8794679|NCT01408719|9846231|FG015|STARTED|Washout Period (28 Days)||1
8794680|NCT01408719|9846232|FG016|STARTED|Washout Period (28 Days)||2
8794681|NCT01408719|9846233|FG017|STARTED|Washout Period (28 Days)||2
8794682|NCT01408719|9846234|FG018|STARTED|Washout Period (28 Days)||0
8794683|NCT01408719|9846235|FG019|STARTED|Washout Period (28 Days)||1
8794684|NCT01408719|9846216|FG000|COMPLETED|Washout Period (28 Days)||2
8794685|NCT01408719|9846217|FG001|COMPLETED|Washout Period (28 Days)||3
8794686|NCT01408719|9846218|FG002|COMPLETED|Washout Period (28 Days)||1
8794687|NCT01408719|9846219|FG003|COMPLETED|Washout Period (28 Days)||2
8794688|NCT01408719|9846220|FG004|COMPLETED|Washout Period (28 Days)||3
9033032|NCT03267511|10095180|FG002|COMPLETED|Overall Study||30
9033033|NCT03267511|10095181|FG003|COMPLETED|Overall Study||30
9033034|NCT03267511|10095178|FG000|NOT COMPLETED|Overall Study||0
9033035|NCT03267511|10095179|FG001|NOT COMPLETED|Overall Study||0
9033036|NCT03267511|10095180|FG002|NOT COMPLETED|Overall Study||0
9033037|NCT03267511|10095181|FG003|NOT COMPLETED|Overall Study||1
9033038|NCT03267576|10095195|FG000|STARTED|Period 1: Day 0 to 27||31
8794689|NCT01408719|9846221|FG005|COMPLETED|Washout Period (28 Days)||3
8794690|NCT01408719|9846222|FG006|COMPLETED|Washout Period (28 Days)||2
8794691|NCT01408719|9846223|FG007|COMPLETED|Washout Period (28 Days)||3
8794692|NCT01408719|9846224|FG008|COMPLETED|Washout Period (28 Days)||1
8794693|NCT01408719|9846225|FG009|COMPLETED|Washout Period (28 Days)||1
8794694|NCT01408719|9846226|FG010|COMPLETED|Washout Period (28 Days)||2
8794695|NCT01408719|9846227|FG011|COMPLETED|Washout Period (28 Days)||2
8794696|NCT01408719|9846228|FG012|COMPLETED|Washout Period (28 Days)||2
8794697|NCT01408719|9846229|FG013|COMPLETED|Washout Period (28 Days)||3
8794698|NCT01408719|9846230|FG014|COMPLETED|Washout Period (28 Days)||1
8794699|NCT01408719|9846231|FG015|COMPLETED|Washout Period (28 Days)||1
8794700|NCT01408719|9846232|FG016|COMPLETED|Washout Period (28 Days)||2
8794701|NCT01408719|9846233|FG017|COMPLETED|Washout Period (28 Days)||2
8794702|NCT01408719|9846234|FG018|COMPLETED|Washout Period (28 Days)||0
8794703|NCT01408719|9846235|FG019|COMPLETED|Washout Period (28 Days)||1
8794704|NCT01408719|9846216|FG000|NOT COMPLETED|Washout Period (28 Days)||0
8794705|NCT01408719|9846217|FG001|NOT COMPLETED|Washout Period (28 Days)||0
8794706|NCT01408719|9846218|FG002|NOT COMPLETED|Washout Period (28 Days)||0
8794707|NCT01408719|9846219|FG003|NOT COMPLETED|Washout Period (28 Days)||0
8917451|NCT02192190|9977142|FG003|NOT COMPLETED|Overall Study||26
8917452|NCT02192190|9977143|FG004|NOT COMPLETED|Overall Study||30
8917453|NCT02192190|9977144|FG005|NOT COMPLETED|Overall Study||29
8917454|NCT02192307|9977161|FG000|STARTED|Overall Study||30
8917455|NCT02192307|9977162|FG001|STARTED|Overall Study||30
8917456|NCT02192307|9977161|FG000|COMPLETED|Overall Study||30
8917457|NCT02192307|9977162|FG001|COMPLETED|Overall Study||30
8917458|NCT02192307|9977161|FG000|NOT COMPLETED|Overall Study||0
8917459|NCT02192307|9977162|FG001|NOT COMPLETED|Overall Study||0
8917460|NCT02192541|9977170|FG000|STARTED|Overall Study||2
8917461|NCT02192541|9977171|FG001|STARTED|Overall Study||3
8917462|NCT02192541|9977170|FG000|Treated|Overall Study||2
8917463|NCT02192541|9977171|FG001|Treated|Overall Study||3
8917464|NCT02192541|9977170|FG000|Evaluable for Response|Overall Study||1
8917465|NCT02192541|9977171|FG001|Evaluable for Response|Overall Study||3
8917466|NCT02192541|9977170|FG000|COMPLETED|Overall Study||2
8917467|NCT02192541|9977171|FG001|COMPLETED|Overall Study||3
8917468|NCT02192541|9977170|FG000|NOT COMPLETED|Overall Study||0
8917469|NCT02192541|9977171|FG001|NOT COMPLETED|Overall Study||0
8917470|NCT02192606|9977180|FG000|STARTED|Overall Study||29
8917471|NCT02192606|9977181|FG001|STARTED|Overall Study||28
8917472|NCT02192606|9977180|FG000|COMPLETED|Overall Study||27
8917473|NCT02192606|9977181|FG001|COMPLETED|Overall Study||24
8917474|NCT02192606|9977180|FG000|NOT COMPLETED|Overall Study||2
8917475|NCT02192606|9977181|FG001|NOT COMPLETED|Overall Study||4
8917476|NCT02192684|9977189|FG000|STARTED|Overall Study||30
8917477|NCT02192684|9977190|FG001|STARTED|Overall Study||15
8917478|NCT02192684|9977189|FG000|COMPLETED|Overall Study||30
8917479|NCT02192684|9977190|FG001|COMPLETED|Overall Study||15
8917480|NCT02192684|9977189|FG000|NOT COMPLETED|Overall Study||0
8917481|NCT02192684|9977190|FG001|NOT COMPLETED|Overall Study||0
8917482|NCT02192814|9977196|FG000|STARTED|Overall Study||9
8917483|NCT02192814|9977196|FG000|COMPLETED|Overall Study||9
8917484|NCT02192814|9977196|FG000|NOT COMPLETED|Overall Study||0
8917485|NCT02192879|9977203|FG000|STARTED|Overall Study||3
8917486|NCT02192879|9977204|FG001|STARTED|Overall Study||4
8917487|NCT02192879|9977205|FG002|STARTED|Overall Study||3
8917488|NCT02192879|9977203|FG000|COMPLETED|Overall Study||3
8917489|NCT02192879|9977204|FG001|COMPLETED|Overall Study||4
8917490|NCT02192879|9977205|FG002|COMPLETED|Overall Study||3
8917491|NCT02192879|9977203|FG000|NOT COMPLETED|Overall Study||0
8917492|NCT02192879|9977204|FG001|NOT COMPLETED|Overall Study||0
8917493|NCT02192879|9977205|FG002|NOT COMPLETED|Overall Study||0
8917494|NCT02192905|9977213|FG000|STARTED|Overall Study||43
8917495|NCT02192905|9977213|FG000|COMPLETED|Overall Study|Reporting a minimum of current weight at 16-week follow-up|42
8917496|NCT02192905|9977213|FG000|NOT COMPLETED|Overall Study||1
8917497|NCT02192970|9977220|FG000|STARTED|Overall Study||101
8917498|NCT02192970|9977221|FG001|STARTED|Overall Study||195
8917499|NCT02192970|9977220|FG000|COMPLETED|Overall Study||95
8917500|NCT02192970|9977221|FG001|COMPLETED|Overall Study||195
8917501|NCT02192970|9977220|FG000|NOT COMPLETED|Overall Study||6
8917502|NCT02192970|9977221|FG001|NOT COMPLETED|Overall Study||0
8917503|NCT02193074|9977229|FG000|STARTED|Overall Study|Randomized and received double-blind treatment.|41
8917504|NCT02193074|9977230|FG001|STARTED|Overall Study|Randomized and received double-blind treatment.|80
8917505|NCT02193074|9977229|FG000|Completed During Follow-Up Period|Overall Study||11
8917506|NCT02193074|9977230|FG001|Completed During Follow-Up Period|Overall Study||26
9033039|NCT03267576|10095196|FG001|STARTED|Period 1: Day 0 to 27||32
8917507|NCT02193074|9977229|FG000|Completed Due to Early Study Termination|Overall Study||13
8917508|NCT02193074|9977230|FG001|Completed Due to Early Study Termination|Overall Study||39
8917509|NCT02193074|9977229|FG000|COMPLETED|Overall Study||24
8917510|NCT02193074|9977230|FG001|COMPLETED|Overall Study||65
8917511|NCT02193074|9977229|FG000|NOT COMPLETED|Overall Study||17
8917512|NCT02193074|9977230|FG001|NOT COMPLETED|Overall Study||15
8917513|NCT02193087|9977240|FG000|STARTED|Overall Study||199
9033040|NCT03267576|10095195|FG000|COMPLETED|Period 1: Day 0 to 27||31
9033041|NCT03267576|10095196|FG001|COMPLETED|Period 1: Day 0 to 27||32
8917514|NCT02193087|9977241|FG001|STARTED|Overall Study||100
8917515|NCT02193087|9977242|FG002|STARTED|Overall Study||100
8794708|NCT01408719|9846220|FG004|NOT COMPLETED|Washout Period (28 Days)||0
8794709|NCT01408719|9846221|FG005|NOT COMPLETED|Washout Period (28 Days)||0
8794710|NCT01408719|9846222|FG006|NOT COMPLETED|Washout Period (28 Days)||0
8794711|NCT01408719|9846223|FG007|NOT COMPLETED|Washout Period (28 Days)||0
8794712|NCT01408719|9846224|FG008|NOT COMPLETED|Washout Period (28 Days)||0
8794713|NCT01408719|9846225|FG009|NOT COMPLETED|Washout Period (28 Days)||0
8794714|NCT01408719|9846226|FG010|NOT COMPLETED|Washout Period (28 Days)||0
8794715|NCT01408719|9846227|FG011|NOT COMPLETED|Washout Period (28 Days)||0
8794716|NCT01408719|9846228|FG012|NOT COMPLETED|Washout Period (28 Days)||0
8794717|NCT01408719|9846229|FG013|NOT COMPLETED|Washout Period (28 Days)||0
8794718|NCT01408719|9846230|FG014|NOT COMPLETED|Washout Period (28 Days)||0
8794719|NCT01408719|9846231|FG015|NOT COMPLETED|Washout Period (28 Days)||0
8794720|NCT01408719|9846232|FG016|NOT COMPLETED|Washout Period (28 Days)||0
8794721|NCT01408719|9846233|FG017|NOT COMPLETED|Washout Period (28 Days)||0
8794722|NCT01408719|9846234|FG018|NOT COMPLETED|Washout Period (28 Days)||0
8794723|NCT01408719|9846235|FG019|NOT COMPLETED|Washout Period (28 Days)||0
8794724|NCT01408719|9846216|FG000|STARTED|Third Intervention (35 Days)||2
8794725|NCT01408719|9846217|FG001|STARTED|Third Intervention (35 Days)||3
8794726|NCT01408719|9846218|FG002|STARTED|Third Intervention (35 Days)||1
8794727|NCT01408719|9846219|FG003|STARTED|Third Intervention (35 Days)||2
8794728|NCT01408719|9846220|FG004|STARTED|Third Intervention (35 Days)||3
8794729|NCT01408719|9846221|FG005|STARTED|Third Intervention (35 Days)||3
8794730|NCT01408719|9846222|FG006|STARTED|Third Intervention (35 Days)||2
8794731|NCT01408719|9846223|FG007|STARTED|Third Intervention (35 Days)||3
8794732|NCT01408719|9846224|FG008|STARTED|Third Intervention (35 Days)||1
8794733|NCT01408719|9846225|FG009|STARTED|Third Intervention (35 Days)||1
8794734|NCT01408719|9846226|FG010|STARTED|Third Intervention (35 Days)||2
8794735|NCT01408719|9846227|FG011|STARTED|Third Intervention (35 Days)||2
8794736|NCT01408719|9846228|FG012|STARTED|Third Intervention (35 Days)||2
8794737|NCT01408719|9846229|FG013|STARTED|Third Intervention (35 Days)||3
8794738|NCT01408719|9846230|FG014|STARTED|Third Intervention (35 Days)||1
8794739|NCT01408719|9846231|FG015|STARTED|Third Intervention (35 Days)||1
8794740|NCT01408719|9846232|FG016|STARTED|Third Intervention (35 Days)||2
8794741|NCT01408719|9846233|FG017|STARTED|Third Intervention (35 Days)||2
8794742|NCT01408719|9846234|FG018|STARTED|Third Intervention (35 Days)||0
8794743|NCT01408719|9846235|FG019|STARTED|Third Intervention (35 Days)||1
8794744|NCT01408719|9846216|FG000|COMPLETED|Third Intervention (35 Days)||2
8794745|NCT01408719|9846217|FG001|COMPLETED|Third Intervention (35 Days)||3
8794746|NCT01408719|9846218|FG002|COMPLETED|Third Intervention (35 Days)||1
8794747|NCT01408719|9846219|FG003|COMPLETED|Third Intervention (35 Days)||2
8794748|NCT01408719|9846220|FG004|COMPLETED|Third Intervention (35 Days)||3
8794749|NCT01408719|9846221|FG005|COMPLETED|Third Intervention (35 Days)||3
8794750|NCT01408719|9846222|FG006|COMPLETED|Third Intervention (35 Days)||2
8794751|NCT01408719|9846223|FG007|COMPLETED|Third Intervention (35 Days)||2
8794752|NCT01408719|9846224|FG008|COMPLETED|Third Intervention (35 Days)||1
8794753|NCT01408719|9846225|FG009|COMPLETED|Third Intervention (35 Days)||1
8794754|NCT01408719|9846226|FG010|COMPLETED|Third Intervention (35 Days)||2
8794755|NCT01408719|9846227|FG011|COMPLETED|Third Intervention (35 Days)||2
8794756|NCT01408719|9846228|FG012|COMPLETED|Third Intervention (35 Days)||2
8794757|NCT01408719|9846229|FG013|COMPLETED|Third Intervention (35 Days)||3
8794758|NCT01408719|9846230|FG014|COMPLETED|Third Intervention (35 Days)||1
8794759|NCT01408719|9846231|FG015|COMPLETED|Third Intervention (35 Days)||1
8794760|NCT01408719|9846232|FG016|COMPLETED|Third Intervention (35 Days)||2
8794761|NCT01408719|9846233|FG017|COMPLETED|Third Intervention (35 Days)||2
8794762|NCT01408719|9846234|FG018|COMPLETED|Third Intervention (35 Days)||0
8794763|NCT01408719|9846235|FG019|COMPLETED|Third Intervention (35 Days)||1
8794764|NCT01408719|9846216|FG000|NOT COMPLETED|Third Intervention (35 Days)||0
8794765|NCT01408719|9846217|FG001|NOT COMPLETED|Third Intervention (35 Days)||0
8794766|NCT01408719|9846218|FG002|NOT COMPLETED|Third Intervention (35 Days)||0
8794767|NCT01408719|9846219|FG003|NOT COMPLETED|Third Intervention (35 Days)||0
8794768|NCT01408719|9846220|FG004|NOT COMPLETED|Third Intervention (35 Days)||0
8794769|NCT01408719|9846221|FG005|NOT COMPLETED|Third Intervention (35 Days)||0
8794770|NCT01408719|9846222|FG006|NOT COMPLETED|Third Intervention (35 Days)||0
8794771|NCT01408719|9846223|FG007|NOT COMPLETED|Third Intervention (35 Days)||1
8794772|NCT01408719|9846224|FG008|NOT COMPLETED|Third Intervention (35 Days)||0
8794773|NCT01408719|9846225|FG009|NOT COMPLETED|Third Intervention (35 Days)||0
8794774|NCT01408719|9846226|FG010|NOT COMPLETED|Third Intervention (35 Days)||0
8794775|NCT01408719|9846227|FG011|NOT COMPLETED|Third Intervention (35 Days)||0
8794776|NCT01408719|9846228|FG012|NOT COMPLETED|Third Intervention (35 Days)||0
8794777|NCT01408719|9846229|FG013|NOT COMPLETED|Third Intervention (35 Days)||0
8794778|NCT01408719|9846230|FG014|NOT COMPLETED|Third Intervention (35 Days)||0
8794779|NCT01408719|9846231|FG015|NOT COMPLETED|Third Intervention (35 Days)||0
8794780|NCT01408719|9846232|FG016|NOT COMPLETED|Third Intervention (35 Days)||0
8794781|NCT01408719|9846233|FG017|NOT COMPLETED|Third Intervention (35 Days)||0
8794782|NCT01408719|9846234|FG018|NOT COMPLETED|Third Intervention (35 Days)||0
8794783|NCT01408719|9846235|FG019|NOT COMPLETED|Third Intervention (35 Days)||0
8794784|NCT01408719|9846216|FG000|STARTED|Washout Period (28 Days)||2
8794785|NCT01408719|9846217|FG001|STARTED|Washout Period (28 Days)||3
8794786|NCT01408719|9846218|FG002|STARTED|Washout Period (28 Days)||1
8794787|NCT01408719|9846219|FG003|STARTED|Washout Period (28 Days)||2
8794788|NCT01408719|9846220|FG004|STARTED|Washout Period (28 Days)||3
8794789|NCT01408719|9846221|FG005|STARTED|Washout Period (28 Days)||3
8794790|NCT01408719|9846222|FG006|STARTED|Washout Period (28 Days)||2
8794791|NCT01408719|9846223|FG007|STARTED|Washout Period (28 Days)||2
8794792|NCT01408719|9846224|FG008|STARTED|Washout Period (28 Days)||1
8794793|NCT01408719|9846225|FG009|STARTED|Washout Period (28 Days)||1
8794794|NCT01408719|9846226|FG010|STARTED|Washout Period (28 Days)||2
8794795|NCT01408719|9846227|FG011|STARTED|Washout Period (28 Days)||2
8794796|NCT01408719|9846228|FG012|STARTED|Washout Period (28 Days)||1
8794797|NCT01408719|9846229|FG013|STARTED|Washout Period (28 Days)||3
8794798|NCT01408719|9846230|FG014|STARTED|Washout Period (28 Days)||1
8794799|NCT01408719|9846231|FG015|STARTED|Washout Period (28 Days)||1
8794800|NCT01408719|9846232|FG016|STARTED|Washout Period (28 Days)||2
8794801|NCT01408719|9846233|FG017|STARTED|Washout Period (28 Days)||2
8794802|NCT01408719|9846234|FG018|STARTED|Washout Period (28 Days)||0
8794803|NCT01408719|9846235|FG019|STARTED|Washout Period (28 Days)||1
8794804|NCT01408719|9846216|FG000|COMPLETED|Washout Period (28 Days)||2
8794805|NCT01408719|9846217|FG001|COMPLETED|Washout Period (28 Days)||3
8794806|NCT01408719|9846218|FG002|COMPLETED|Washout Period (28 Days)||1
8794807|NCT01408719|9846219|FG003|COMPLETED|Washout Period (28 Days)||2
8794808|NCT01408719|9846220|FG004|COMPLETED|Washout Period (28 Days)||3
8794809|NCT01408719|9846221|FG005|COMPLETED|Washout Period (28 Days)||3
8794810|NCT01408719|9846222|FG006|COMPLETED|Washout Period (28 Days)||2
8794811|NCT01408719|9846223|FG007|COMPLETED|Washout Period (28 Days)||2
8794812|NCT01408719|9846224|FG008|COMPLETED|Washout Period (28 Days)||1
8794813|NCT01408719|9846225|FG009|COMPLETED|Washout Period (28 Days)||1
8794814|NCT01408719|9846226|FG010|COMPLETED|Washout Period (28 Days)||2
8794815|NCT01408719|9846227|FG011|COMPLETED|Washout Period (28 Days)||2
8794816|NCT01408719|9846228|FG012|COMPLETED|Washout Period (28 Days)||1
8794817|NCT01408719|9846229|FG013|COMPLETED|Washout Period (28 Days)||3
8794818|NCT01408719|9846230|FG014|COMPLETED|Washout Period (28 Days)||1
8794819|NCT01408719|9846231|FG015|COMPLETED|Washout Period (28 Days)||1
8794820|NCT01408719|9846232|FG016|COMPLETED|Washout Period (28 Days)||2
8794821|NCT01408719|9846233|FG017|COMPLETED|Washout Period (28 Days)||2
8794822|NCT01408719|9846234|FG018|COMPLETED|Washout Period (28 Days)||0
8794823|NCT01408719|9846235|FG019|COMPLETED|Washout Period (28 Days)||1
8794824|NCT01408719|9846216|FG000|NOT COMPLETED|Washout Period (28 Days)||0
8794825|NCT01408719|9846217|FG001|NOT COMPLETED|Washout Period (28 Days)||0
8794826|NCT01408719|9846218|FG002|NOT COMPLETED|Washout Period (28 Days)||0
8794827|NCT01408719|9846219|FG003|NOT COMPLETED|Washout Period (28 Days)||0
8794828|NCT01408719|9846220|FG004|NOT COMPLETED|Washout Period (28 Days)||0
9033042|NCT03267576|10095195|FG000|NOT COMPLETED|Period 1: Day 0 to 27||0
9033043|NCT03267576|10095196|FG001|NOT COMPLETED|Period 1: Day 0 to 27||0
9033044|NCT03267576|10095195|FG000|STARTED|Washout Period: 16 Days||31
9033045|NCT03267576|10095196|FG001|STARTED|Washout Period: 16 Days||32
9033046|NCT03267576|10095195|FG000|COMPLETED|Washout Period: 16 Days||31
9033047|NCT03267576|10095196|FG001|COMPLETED|Washout Period: 16 Days||32
9033048|NCT03267576|10095195|FG000|NOT COMPLETED|Washout Period: 16 Days||0
9033049|NCT03267576|10095196|FG001|NOT COMPLETED|Washout Period: 16 Days||0
9033050|NCT03267576|10095195|FG000|STARTED|Period 2: Day 44 to 71||31
9033051|NCT03267576|10095196|FG001|STARTED|Period 2: Day 44 to 71||32
9033052|NCT03267576|10095195|FG000|COMPLETED|Period 2: Day 44 to 71||30
9033053|NCT03267576|10095196|FG001|COMPLETED|Period 2: Day 44 to 71||30
9033054|NCT03267576|10095195|FG000|NOT COMPLETED|Period 2: Day 44 to 71||1
9033055|NCT03267576|10095196|FG001|NOT COMPLETED|Period 2: Day 44 to 71||2
9033056|NCT03267940|10095208|FG000|STARTED|Run-in Portion (Max. Exposure: 508 Days)||9
9033057|NCT03267940|10095209|FG001|STARTED|Run-in Portion (Max. Exposure: 508 Days)||9
9033058|NCT03267940|10095210|FG002|STARTED|Run-in Portion (Max. Exposure: 508 Days)||0
9033059|NCT03267940|10095211|FG003|STARTED|Run-in Portion (Max. Exposure: 508 Days)||0
9033060|NCT03267940|10095212|FG004|STARTED|Run-in Portion (Max. Exposure: 508 Days)||0
9033061|NCT03267940|10095213|FG005|STARTED|Run-in Portion (Max. Exposure: 508 Days)||0
9033062|NCT03267940|10095208|FG000|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||9
9033063|NCT03267940|10095209|FG001|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||9
9033064|NCT03267940|10095210|FG002|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||0
9033065|NCT03267940|10095211|FG003|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||0
9033066|NCT03267940|10095212|FG004|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||0
9033067|NCT03267940|10095213|FG005|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||0
8575176|NCT00133575|9607669|FG002|COMPLETED|Overall Study||8
8794829|NCT01408719|9846221|FG005|NOT COMPLETED|Washout Period (28 Days)||0
8794830|NCT01408719|9846222|FG006|NOT COMPLETED|Washout Period (28 Days)||0
8794831|NCT01408719|9846223|FG007|NOT COMPLETED|Washout Period (28 Days)||0
8794832|NCT01408719|9846224|FG008|NOT COMPLETED|Washout Period (28 Days)||0
8794833|NCT01408719|9846225|FG009|NOT COMPLETED|Washout Period (28 Days)||0
8794834|NCT01408719|9846226|FG010|NOT COMPLETED|Washout Period (28 Days)||0
8794835|NCT01408719|9846227|FG011|NOT COMPLETED|Washout Period (28 Days)||0
9033068|NCT03267940|10095208|FG000|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||1
9033069|NCT03267940|10095209|FG001|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||2
9033070|NCT03267940|10095210|FG002|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
8794836|NCT01408719|9846228|FG012|NOT COMPLETED|Washout Period (28 Days)||0
8794837|NCT01408719|9846229|FG013|NOT COMPLETED|Washout Period (28 Days)||0
8794838|NCT01408719|9846230|FG014|NOT COMPLETED|Washout Period (28 Days)||0
8794839|NCT01408719|9846231|FG015|NOT COMPLETED|Washout Period (28 Days)||0
8794840|NCT01408719|9846232|FG016|NOT COMPLETED|Washout Period (28 Days)||0
8794841|NCT01408719|9846233|FG017|NOT COMPLETED|Washout Period (28 Days)||0
8794842|NCT01408719|9846234|FG018|NOT COMPLETED|Washout Period (28 Days)||0
8794843|NCT01408719|9846235|FG019|NOT COMPLETED|Washout Period (28 Days)||0
8794844|NCT01408719|9846216|FG000|STARTED|Fourth Intervention (35 Days)||2
8794845|NCT01408719|9846217|FG001|STARTED|Fourth Intervention (35 Days)||3
8794846|NCT01408719|9846218|FG002|STARTED|Fourth Intervention (35 Days)||1
8794847|NCT01408719|9846219|FG003|STARTED|Fourth Intervention (35 Days)||2
8794848|NCT01408719|9846220|FG004|STARTED|Fourth Intervention (35 Days)||3
8794849|NCT01408719|9846221|FG005|STARTED|Fourth Intervention (35 Days)||3
8794850|NCT01408719|9846222|FG006|STARTED|Fourth Intervention (35 Days)||2
8794851|NCT01408719|9846223|FG007|STARTED|Fourth Intervention (35 Days)||2
8794852|NCT01408719|9846224|FG008|STARTED|Fourth Intervention (35 Days)||1
8794853|NCT01408719|9846225|FG009|STARTED|Fourth Intervention (35 Days)||1
8794854|NCT01408719|9846226|FG010|STARTED|Fourth Intervention (35 Days)||2
8794855|NCT01408719|9846227|FG011|STARTED|Fourth Intervention (35 Days)||2
8794856|NCT01408719|9846228|FG012|STARTED|Fourth Intervention (35 Days)||1
8794857|NCT01408719|9846229|FG013|STARTED|Fourth Intervention (35 Days)||3
8794858|NCT01408719|9846230|FG014|STARTED|Fourth Intervention (35 Days)||1
8794859|NCT01408719|9846231|FG015|STARTED|Fourth Intervention (35 Days)||1
8794860|NCT01408719|9846232|FG016|STARTED|Fourth Intervention (35 Days)||2
8794861|NCT01408719|9846233|FG017|STARTED|Fourth Intervention (35 Days)||2
8794862|NCT01408719|9846234|FG018|STARTED|Fourth Intervention (35 Days)||0
8794863|NCT01408719|9846235|FG019|STARTED|Fourth Intervention (35 Days)||1
8794864|NCT01408719|9846216|FG000|COMPLETED|Fourth Intervention (35 Days)||2
8794865|NCT01408719|9846217|FG001|COMPLETED|Fourth Intervention (35 Days)||3
8794866|NCT01408719|9846218|FG002|COMPLETED|Fourth Intervention (35 Days)||1
8794867|NCT01408719|9846219|FG003|COMPLETED|Fourth Intervention (35 Days)||2
8794868|NCT01408719|9846220|FG004|COMPLETED|Fourth Intervention (35 Days)||3
8794869|NCT01408719|9846221|FG005|COMPLETED|Fourth Intervention (35 Days)||3
8794870|NCT01408719|9846222|FG006|COMPLETED|Fourth Intervention (35 Days)||2
8794871|NCT01408719|9846223|FG007|COMPLETED|Fourth Intervention (35 Days)||2
8794872|NCT01408719|9846224|FG008|COMPLETED|Fourth Intervention (35 Days)||1
8794873|NCT01408719|9846225|FG009|COMPLETED|Fourth Intervention (35 Days)||1
8794874|NCT01408719|9846226|FG010|COMPLETED|Fourth Intervention (35 Days)||2
8794875|NCT01408719|9846227|FG011|COMPLETED|Fourth Intervention (35 Days)||2
8794876|NCT01408719|9846228|FG012|COMPLETED|Fourth Intervention (35 Days)||1
8794877|NCT01408719|9846229|FG013|COMPLETED|Fourth Intervention (35 Days)||3
8794878|NCT01408719|9846230|FG014|COMPLETED|Fourth Intervention (35 Days)||1
8794879|NCT01408719|9846231|FG015|COMPLETED|Fourth Intervention (35 Days)||1
8794880|NCT01408719|9846232|FG016|COMPLETED|Fourth Intervention (35 Days)||2
8794881|NCT01408719|9846233|FG017|COMPLETED|Fourth Intervention (35 Days)||2
8794882|NCT01408719|9846234|FG018|COMPLETED|Fourth Intervention (35 Days)||0
8794883|NCT01408719|9846235|FG019|COMPLETED|Fourth Intervention (35 Days)||1
8794884|NCT01408719|9846216|FG000|NOT COMPLETED|Fourth Intervention (35 Days)||0
8794885|NCT01408719|9846217|FG001|NOT COMPLETED|Fourth Intervention (35 Days)||0
8794886|NCT01408719|9846218|FG002|NOT COMPLETED|Fourth Intervention (35 Days)||0
8794887|NCT01408719|9846219|FG003|NOT COMPLETED|Fourth Intervention (35 Days)||0
8794888|NCT01408719|9846220|FG004|NOT COMPLETED|Fourth Intervention (35 Days)||0
8794889|NCT01408719|9846221|FG005|NOT COMPLETED|Fourth Intervention (35 Days)||0
8794890|NCT01408719|9846222|FG006|NOT COMPLETED|Fourth Intervention (35 Days)||0
8794891|NCT01408719|9846223|FG007|NOT COMPLETED|Fourth Intervention (35 Days)||0
8794892|NCT01408719|9846224|FG008|NOT COMPLETED|Fourth Intervention (35 Days)||0
8794893|NCT01408719|9846225|FG009|NOT COMPLETED|Fourth Intervention (35 Days)||0
8794894|NCT01408719|9846226|FG010|NOT COMPLETED|Fourth Intervention (35 Days)||0
8794895|NCT01408719|9846227|FG011|NOT COMPLETED|Fourth Intervention (35 Days)||0
8794896|NCT01408719|9846228|FG012|NOT COMPLETED|Fourth Intervention (35 Days)||0
8794897|NCT01408719|9846229|FG013|NOT COMPLETED|Fourth Intervention (35 Days)||0
8794898|NCT01408719|9846230|FG014|NOT COMPLETED|Fourth Intervention (35 Days)||0
8794899|NCT01408719|9846231|FG015|NOT COMPLETED|Fourth Intervention (35 Days)||0
8794900|NCT01408719|9846232|FG016|NOT COMPLETED|Fourth Intervention (35 Days)||0
8794901|NCT01408719|9846233|FG017|NOT COMPLETED|Fourth Intervention (35 Days)||0
8794902|NCT01408719|9846234|FG018|NOT COMPLETED|Fourth Intervention (35 Days)||0
8794903|NCT01408719|9846235|FG019|NOT COMPLETED|Fourth Intervention (35 Days)||0
8794904|NCT01408732|9846245|FG000|STARTED|Overall Study||9
8794905|NCT01408732|9846246|FG001|STARTED|Overall Study||9
8794906|NCT01408732|9846245|FG000|COMPLETED|Overall Study||7
8794907|NCT01408732|9846246|FG001|COMPLETED|Overall Study||7
8794908|NCT01408732|9846245|FG000|NOT COMPLETED|Overall Study||2
8794909|NCT01408732|9846246|FG001|NOT COMPLETED|Overall Study||2
8794910|NCT01408862|9846252|FG000|STARTED|Overall Study||20
8794911|NCT01408862|9846252|FG000|COMPLETED|Overall Study||20
8794912|NCT01408862|9846252|FG000|NOT COMPLETED|Overall Study||0
8794913|NCT01408888|9846257|FG000|STARTED|First Intervention||18
8794914|NCT01408888|9846258|FG001|STARTED|First Intervention||11
8794915|NCT01408888|9846257|FG000|Received at Least 1 Dose of Drug|First Intervention||18
8794916|NCT01408888|9846258|FG001|Received at Least 1 Dose of Drug|First Intervention||11
8794917|NCT01408888|9846257|FG000|COMPLETED|First Intervention||18
8794918|NCT01408888|9846258|FG001|COMPLETED|First Intervention||8
8794919|NCT01408888|9846257|FG000|NOT COMPLETED|First Intervention||0
8794920|NCT01408888|9846258|FG001|NOT COMPLETED|First Intervention||3
8794921|NCT01408888|9846257|FG000|STARTED|Washout of at Least 21 Days||18
8794922|NCT01408888|9846258|FG001|STARTED|Washout of at Least 21 Days||8
8794923|NCT01408888|9846257|FG000|COMPLETED|Washout of at Least 21 Days||18
8794924|NCT01408888|9846258|FG001|COMPLETED|Washout of at Least 21 Days||8
8794925|NCT01408888|9846257|FG000|NOT COMPLETED|Washout of at Least 21 Days||0
8794926|NCT01408888|9846258|FG001|NOT COMPLETED|Washout of at Least 21 Days||0
8794927|NCT01408888|9846257|FG000|STARTED|Second Intervention||18
8794928|NCT01408888|9846258|FG001|STARTED|Second Intervention||8
8794929|NCT01408888|9846257|FG000|COMPLETED|Second Intervention||16
8794930|NCT01408888|9846258|FG001|COMPLETED|Second Intervention||8
8794931|NCT01408888|9846257|FG000|NOT COMPLETED|Second Intervention||2
8794932|NCT01408888|9846258|FG001|NOT COMPLETED|Second Intervention||0
8794933|NCT01408901|9846278|FG000|STARTED|6-Week Follow-Up||53
8794934|NCT01408901|9846279|FG001|STARTED|6-Week Follow-Up||53
8794935|NCT01408901|9846280|FG002|STARTED|6-Week Follow-Up||53
8794936|NCT01408901|9846281|FG003|STARTED|6-Week Follow-Up||51
8794937|NCT01408901|9846278|FG000|COMPLETED|6-Week Follow-Up||50
8794938|NCT01408901|9846279|FG001|COMPLETED|6-Week Follow-Up||51
8794939|NCT01408901|9846280|FG002|COMPLETED|6-Week Follow-Up||50
8794940|NCT01408901|9846281|FG003|COMPLETED|6-Week Follow-Up||47
8794941|NCT01408901|9846278|FG000|NOT COMPLETED|6-Week Follow-Up||3
8794942|NCT01408901|9846279|FG001|NOT COMPLETED|6-Week Follow-Up||2
8794943|NCT01408901|9846280|FG002|NOT COMPLETED|6-Week Follow-Up||3
8794944|NCT01408901|9846281|FG003|NOT COMPLETED|6-Week Follow-Up||4
8794945|NCT01408901|9846278|FG000|STARTED|12-Week Follow-Up (Primary Endpoint)||50
8794946|NCT01408901|9846279|FG001|STARTED|12-Week Follow-Up (Primary Endpoint)||52
8794947|NCT01408901|9846280|FG002|STARTED|12-Week Follow-Up (Primary Endpoint)||50
8794948|NCT01408901|9846281|FG003|STARTED|12-Week Follow-Up (Primary Endpoint)||49
9033071|NCT03267940|10095211|FG003|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
9033072|NCT03267940|10095212|FG004|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
9033073|NCT03267940|10095213|FG005|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
9033074|NCT03267940|10095208|FG000|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||8
9033075|NCT03267940|10095209|FG001|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||7
9033076|NCT03267940|10095210|FG002|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
9033077|NCT03267940|10095211|FG003|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
9033078|NCT03267940|10095212|FG004|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
9033079|NCT03267940|10095213|FG005|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
9033080|NCT03267940|10095208|FG000|STARTED|Expansion (Maximum Exposure: 421 Days)||0
9033081|NCT03267940|10095209|FG001|STARTED|Expansion (Maximum Exposure: 421 Days)||0
9033082|NCT03267940|10095210|FG002|STARTED|Expansion (Maximum Exposure: 421 Days)||24
9033083|NCT03267940|10095211|FG003|STARTED|Expansion (Maximum Exposure: 421 Days)||22
9033084|NCT03267940|10095212|FG004|STARTED|Expansion (Maximum Exposure: 421 Days)||11
9033085|NCT03267940|10095213|FG005|STARTED|Expansion (Maximum Exposure: 421 Days)||10
9033086|NCT03267940|10095208|FG000|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||0
9033087|NCT03267940|10095209|FG001|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||0
9033088|NCT03267940|10095210|FG002|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||24
9033089|NCT03267940|10095211|FG003|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||22
9033090|NCT03267940|10095212|FG004|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||11
9033091|NCT03267940|10095213|FG005|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||10
9033092|NCT03267940|10095208|FG000|COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
9033093|NCT03267940|10095209|FG001|COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
9033094|NCT03267940|10095210|FG002|COMPLETED|Expansion (Maximum Exposure: 421 Days)||3
9033095|NCT03267940|10095211|FG003|COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
9033096|NCT03267940|10095212|FG004|COMPLETED|Expansion (Maximum Exposure: 421 Days)||1
9033097|NCT03267940|10095213|FG005|COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
9033098|NCT03267940|10095208|FG000|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
9033099|NCT03267940|10095209|FG001|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
9033100|NCT03267940|10095210|FG002|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||21
9033101|NCT03267940|10095211|FG003|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||22
9033102|NCT03267940|10095212|FG004|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||10
9033103|NCT03267940|10095213|FG005|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||10
9033104|NCT03268343|10095231|FG000|STARTED|Overall Study||12
9033105|NCT03268343|10095232|FG001|STARTED|Overall Study||12
9033106|NCT03268343|10095231|FG000|COMPLETED|Overall Study||12
9033107|NCT03268343|10095232|FG001|COMPLETED|Overall Study||12
8794949|NCT01408901|9846278|FG000|COMPLETED|12-Week Follow-Up (Primary Endpoint)||49
8794950|NCT01408901|9846279|FG001|COMPLETED|12-Week Follow-Up (Primary Endpoint)||50
8794951|NCT01408901|9846280|FG002|COMPLETED|12-Week Follow-Up (Primary Endpoint)||50
8794952|NCT01408901|9846281|FG003|COMPLETED|12-Week Follow-Up (Primary Endpoint)||46
8794953|NCT01408901|9846278|FG000|NOT COMPLETED|12-Week Follow-Up (Primary Endpoint)||1
8794954|NCT01408901|9846279|FG001|NOT COMPLETED|12-Week Follow-Up (Primary Endpoint)||2
8794955|NCT01408901|9846280|FG002|NOT COMPLETED|12-Week Follow-Up (Primary Endpoint)||0
8794956|NCT01408901|9846281|FG003|NOT COMPLETED|12-Week Follow-Up (Primary Endpoint)||3
8794957|NCT01408901|9846278|FG000|STARTED|26-Week Follow-Up||49
8794958|NCT01408901|9846279|FG001|STARTED|26-Week Follow-Up||52
8794959|NCT01408901|9846280|FG002|STARTED|26-Week Follow-Up||50
8794960|NCT01408901|9846281|FG003|STARTED|26-Week Follow-Up||47
8794961|NCT01408901|9846278|FG000|COMPLETED|26-Week Follow-Up||48
8794962|NCT01408901|9846279|FG001|COMPLETED|26-Week Follow-Up||50
8794963|NCT01408901|9846280|FG002|COMPLETED|26-Week Follow-Up||50
8794964|NCT01408901|9846281|FG003|COMPLETED|26-Week Follow-Up||46
8794965|NCT01408901|9846278|FG000|NOT COMPLETED|26-Week Follow-Up||1
8794966|NCT01408901|9846279|FG001|NOT COMPLETED|26-Week Follow-Up||2
8794967|NCT01408901|9846280|FG002|NOT COMPLETED|26-Week Follow-Up||0
8794968|NCT01408901|9846281|FG003|NOT COMPLETED|26-Week Follow-Up||1
8794969|NCT01408914|9846296|FG000|STARTED|Overall Study||60
8794970|NCT01408914|9846297|FG001|STARTED|Overall Study||60
8794971|NCT01408914|9846298|FG002|STARTED|Overall Study||60
8794972|NCT01408914|9846296|FG000|COMPLETED|Overall Study||48
8794973|NCT01408914|9846297|FG001|COMPLETED|Overall Study||48
8794974|NCT01408914|9846298|FG002|COMPLETED|Overall Study||47
8794975|NCT01408914|9846296|FG000|NOT COMPLETED|Overall Study||12
8794976|NCT01408914|9846297|FG001|NOT COMPLETED|Overall Study||12
8794977|NCT01408914|9846298|FG002|NOT COMPLETED|Overall Study||13
8794978|NCT01408992|9846306|FG000|STARTED|Overall Study||558
8794979|NCT01408992|9846306|FG000|COMPLETED|Overall Study||558
8794980|NCT01408992|9846306|FG000|NOT COMPLETED|Overall Study||0
8794981|NCT01409096|9846320|FG000|STARTED|Overall Study||40
8794982|NCT01409096|9846321|FG001|STARTED|Overall Study||40
8794983|NCT01409096|9846320|FG000|COMPLETED|Overall Study||38
8794984|NCT01409096|9846321|FG001|COMPLETED|Overall Study||35
8794985|NCT01409096|9846320|FG000|NOT COMPLETED|Overall Study||2
8672088|NCT00755222|9715548|FG000|COMPLETED|Overall Study||103
8672089|NCT00755222|9715549|FG001|COMPLETED|Overall Study||34
8672090|NCT00755222|9715548|FG000|NOT COMPLETED|Overall Study||8
8672091|NCT00755222|9715549|FG001|NOT COMPLETED|Overall Study||2
8672092|NCT00755235|9715557|FG000|STARTED|Overall Study||106
8672093|NCT00755235|9715558|FG001|STARTED|Overall Study||102
8672094|NCT00755235|9715557|FG000|COMPLETED|Overall Study||104
8672095|NCT00755235|9715558|FG001|COMPLETED|Overall Study||93
8672096|NCT00755235|9715557|FG000|NOT COMPLETED|Overall Study||2
8672097|NCT00755235|9715558|FG001|NOT COMPLETED|Overall Study||9
8672098|NCT00755274|9715566|FG000|STARTED|Overall Study||24
8672099|NCT00755274|9715567|FG001|STARTED|Overall Study||8
8672100|NCT00755274|9715566|FG000|COMPLETED|Overall Study||24
8672101|NCT00755274|9715567|FG001|COMPLETED|Overall Study||8
8672102|NCT00755274|9715566|FG000|NOT COMPLETED|Overall Study||0
8672103|NCT00755274|9715567|FG001|NOT COMPLETED|Overall Study||0
8672104|NCT00755326|9715575|FG000|STARTED|Overall Study||47
8672105|NCT00755326|9715576|FG001|STARTED|Overall Study||45
8672106|NCT00755326|9715575|FG000|COMPLETED|Overall Study||45
8672107|NCT00755326|9715576|FG001|COMPLETED|Overall Study||42
8672108|NCT00755326|9715575|FG000|NOT COMPLETED|Overall Study||2
8672109|NCT00755326|9715576|FG001|NOT COMPLETED|Overall Study||3
8672110|NCT00755417|9715586|FG000|STARTED|Overall Study|Number of patients that received assigned treatment; ITT and safety populations|174
8672111|NCT00755417|9715587|FG001|STARTED|Overall Study|Number of patients that received assigned treatment; ITT and safety populations|181
8672112|NCT00755417|9715588|FG002|STARTED|Overall Study|Number of patients that received assigned treatment; ITT and safety populations|177
8672113|NCT00755417|9715586|FG000|COMPLETED|Overall Study||112
8672114|NCT00755417|9715587|FG001|COMPLETED|Overall Study||126
8672115|NCT00755417|9715588|FG002|COMPLETED|Overall Study||135
8672116|NCT00755417|9715586|FG000|NOT COMPLETED|Overall Study||62
8672117|NCT00755417|9715587|FG001|NOT COMPLETED|Overall Study||55
8672118|NCT00755417|9715588|FG002|NOT COMPLETED|Overall Study||42
8672119|NCT00755716|9715599|FG000|STARTED|Overall Study||19
8672120|NCT00755716|9715600|FG001|STARTED|Overall Study||19
8672121|NCT00755716|9715601|FG002|STARTED|Overall Study||19
8672122|NCT00755716|9715599|FG000|COMPLETED|Overall Study||11
8672123|NCT00755716|9715600|FG001|COMPLETED|Overall Study||11
8672124|NCT00755716|9715601|FG002|COMPLETED|Overall Study||16
8672125|NCT00755716|9715599|FG000|NOT COMPLETED|Overall Study||8
8672126|NCT00755716|9715600|FG001|NOT COMPLETED|Overall Study||8
8672127|NCT00755716|9715601|FG002|NOT COMPLETED|Overall Study||3
8672128|NCT00755755|9715612|FG000|STARTED|Overall Study|Safety population|95
8672129|NCT00755755|9715613|FG001|STARTED|Overall Study|Safety population|98
8672130|NCT00755755|9715614|FG002|STARTED|Overall Study|Safety population|48
8672131|NCT00755755|9715612|FG000|COMPLETED|Overall Study|Patients who completed the overall study up to the follow-up visit (visit 6)|89
8672132|NCT00755755|9715613|FG001|COMPLETED|Overall Study|Patients who completed the overall study up to the follow-up visit (visit 6)|90
8672133|NCT00755755|9715614|FG002|COMPLETED|Overall Study|Patients who completed the overall study up to the follow-up visit (visit 6)|45
8672134|NCT00755755|9715612|FG000|NOT COMPLETED|Overall Study||6
8672135|NCT00755755|9715613|FG001|NOT COMPLETED|Overall Study||8
8672136|NCT00755755|9715614|FG002|NOT COMPLETED|Overall Study||3
8672137|NCT00755807|9715624|FG000|STARTED|Acute Phase||118
8672138|NCT00755807|9715625|FG001|STARTED|Acute Phase||121
8672139|NCT00755807|9715624|FG000|COMPLETED|Acute Phase||100
8794986|NCT01409096|9846321|FG001|NOT COMPLETED|Overall Study||5
8794987|NCT01409213|9846327|FG000|STARTED|Overall Study||1523
8794988|NCT01409213|9846327|FG000|COMPLETED|Overall Study||1523
8794989|NCT01409213|9846327|FG000|NOT COMPLETED|Overall Study||0
8794990|NCT01409239|9846333|FG000|STARTED|Overall Study||16
8794991|NCT01409239|9846334|FG001|STARTED|Overall Study||17
8794992|NCT01409239|9846333|FG000|COMPLETED|Overall Study||16
8794993|NCT01409239|9846334|FG001|COMPLETED|Overall Study||17
8794994|NCT01409239|9846333|FG000|NOT COMPLETED|Overall Study||0
8794995|NCT01409239|9846334|FG001|NOT COMPLETED|Overall Study||0
8794996|NCT01409291|9846342|FG000|STARTED|Overall Study||36
8794997|NCT01409291|9846343|FG001|STARTED|Overall Study||28
8794998|NCT01409291|9846342|FG000|COMPLETED|Overall Study||29
8794999|NCT01409291|9846343|FG001|COMPLETED|Overall Study||19
8795000|NCT01409291|9846342|FG000|NOT COMPLETED|Overall Study||7
8795001|NCT01409291|9846343|FG001|NOT COMPLETED|Overall Study||9
8795002|NCT01409382|9846351|FG000|STARTED|Overall Study||240
8795003|NCT01409382|9846352|FG001|STARTED|Overall Study||240
8795004|NCT01409382|9846351|FG000|COMPLETED|Overall Study||159
8795005|NCT01409382|9846352|FG001|COMPLETED|Overall Study||160
8795006|NCT01409382|9846351|FG000|NOT COMPLETED|Overall Study||81
8795007|NCT01409382|9846352|FG001|NOT COMPLETED|Overall Study||80
8795008|NCT01409434|9846362|FG000|STARTED|Overall Study||44
8795009|NCT01409434|9846362|FG000|COMPLETED|Overall Study||40
8795010|NCT01409434|9846362|FG000|NOT COMPLETED|Overall Study||4
8795011|NCT01409564|9846368|FG000|STARTED|Overall Study||23
8795012|NCT01409564|9846369|FG001|STARTED|Overall Study||23
8795013|NCT01409564|9846368|FG000|COMPLETED|Overall Study||18
8795014|NCT01409564|9846369|FG001|COMPLETED|Overall Study||18
8795015|NCT01409564|9846368|FG000|NOT COMPLETED|Overall Study||5
8795016|NCT01409564|9846369|FG001|NOT COMPLETED|Overall Study||5
8795017|NCT01409707|9846382|FG000|STARTED|Overall Study||41
8795018|NCT01409707|9846383|FG001|STARTED|Overall Study||45
8795019|NCT01409707|9846384|FG002|STARTED|Overall Study||40
8795020|NCT01409707|9846382|FG000|COMPLETED|Overall Study||36
8795021|NCT01409707|9846383|FG001|COMPLETED|Overall Study||28
8795022|NCT01409707|9846384|FG002|COMPLETED|Overall Study||24
8795023|NCT01409707|9846382|FG000|NOT COMPLETED|Overall Study||5
8795024|NCT01409707|9846383|FG001|NOT COMPLETED|Overall Study||17
8795025|NCT01409707|9846384|FG002|NOT COMPLETED|Overall Study||16
8795026|NCT01409811|9846391|FG000|STARTED|Overall Study||9
8795027|NCT01409811|9846391|FG000|COMPLETED|Overall Study||8
8795028|NCT01409811|9846391|FG000|NOT COMPLETED|Overall Study||1
8795029|NCT01409837|9846397|FG000|STARTED|Overall Study||17
8795030|NCT01409837|9846398|FG001|STARTED|Overall Study||16
8795031|NCT01409837|9846397|FG000|6th Week|Overall Study||17
8795032|NCT01409837|9846398|FG001|6th Week|Overall Study||16
8795033|NCT01409837|9846397|FG000|12th Week|Overall Study|Moved away to another location|16
8795034|NCT01409837|9846398|FG001|12th Week|Overall Study||16
8795035|NCT01409837|9846397|FG000|24th Week|Overall Study||16
8795036|NCT01409837|9846398|FG001|24th Week|Overall Study|Diagnosed with Lymphocytic Lymphoma and withdrawn|15
8795037|NCT01409837|9846397|FG000|48th Week|Overall Study|Lost to follow-up|15
8795038|NCT01409837|9846398|FG001|48th Week|Overall Study||15
8795039|NCT01409837|9846397|FG000|96th Week|Overall Study||15
8795040|NCT01409837|9846398|FG001|96th Week|Overall Study||15
8795041|NCT01409837|9846397|FG000|102nd Week|Overall Study||15
8795042|NCT01409837|9846398|FG001|102nd Week|Overall Study|Married another wife|14
8795043|NCT01409837|9846397|FG000|114th Week|Overall Study||15
8795044|NCT01409837|9846398|FG001|114th Week|Overall Study||14
8795045|NCT01409837|9846397|FG000|138th Week|Overall Study||15
8795046|NCT01409837|9846398|FG001|138th Week|Overall Study||14
8795047|NCT01409837|9846397|FG000|186th Week|Overall Study|Moved away to another location|14
8795048|NCT01409837|9846398|FG001|186th Week|Overall Study||14
8795049|NCT01409837|9846397|FG000|282nd Week|Overall Study||14
8795050|NCT01409837|9846398|FG001|282nd Week|Overall Study||14
8795051|NCT01409837|9846397|FG000|COMPLETED|Overall Study||14
8795052|NCT01409837|9846398|FG001|COMPLETED|Overall Study||14
8795053|NCT01409837|9846397|FG000|NOT COMPLETED|Overall Study||3
8795054|NCT01409837|9846398|FG001|NOT COMPLETED|Overall Study||2
8795055|NCT01409915|9846408|FG000|STARTED|Overall Study||21
8795056|NCT01409915|9846409|FG001|STARTED|Overall Study||23
8795057|NCT01409915|9846408|FG000|COMPLETED|Overall Study||20
8795058|NCT01409915|9846409|FG001|COMPLETED|Overall Study||20
8795059|NCT01409915|9846408|FG000|NOT COMPLETED|Overall Study||1
8795060|NCT01409915|9846409|FG001|NOT COMPLETED|Overall Study||3
8795061|NCT01409928|9846415|FG000|STARTED|Overall Study||16
8795062|NCT01409928|9846415|FG000|COMPLETED|Overall Study||4
8795063|NCT01409928|9846415|FG000|NOT COMPLETED|Overall Study||12
8795064|NCT01409993|9846421|FG000|STARTED|Overall Study||25
8795065|NCT01409993|9846422|FG001|STARTED|Overall Study||26
8795066|NCT01409993|9846423|FG002|STARTED|Overall Study||14
8795067|NCT01409993|9846424|FG003|STARTED|Overall Study||13
8795068|NCT01409993|9846421|FG000|COMPLETED|Overall Study||21
8795069|NCT01409993|9846422|FG001|COMPLETED|Overall Study||21
8795070|NCT01409993|9846423|FG002|COMPLETED|Overall Study||11
8795071|NCT01409993|9846424|FG003|COMPLETED|Overall Study||8
8795072|NCT01409993|9846421|FG000|NOT COMPLETED|Overall Study||4
8795073|NCT01409993|9846422|FG001|NOT COMPLETED|Overall Study||5
8795074|NCT01409993|9846423|FG002|NOT COMPLETED|Overall Study||3
8795075|NCT01409993|9846424|FG003|NOT COMPLETED|Overall Study||5
8795076|NCT01410058|9846440|FG000|STARTED|Washout Day 0||13
8795077|NCT01410058|9846441|FG001|STARTED|Washout Day 0||6
8795078|NCT01410058|9846440|FG000|COMPLETED|Washout Day 0||13
8795079|NCT01410058|9846441|FG001|COMPLETED|Washout Day 0||6
8795080|NCT01410058|9846440|FG000|NOT COMPLETED|Washout Day 0||0
8795081|NCT01410058|9846441|FG001|NOT COMPLETED|Washout Day 0||0
8795082|NCT01410058|9846440|FG000|STARTED|Baseline Day 22||13
8795083|NCT01410058|9846441|FG001|STARTED|Baseline Day 22||6
8795084|NCT01410058|9846440|FG000|COMPLETED|Baseline Day 22||13
8795085|NCT01410058|9846441|FG001|COMPLETED|Baseline Day 22||6
8795086|NCT01410058|9846440|FG000|NOT COMPLETED|Baseline Day 22||0
8795087|NCT01410058|9846441|FG001|NOT COMPLETED|Baseline Day 22||0
8795088|NCT01410058|9846440|FG000|STARTED|Day 35||13
8795089|NCT01410058|9846441|FG001|STARTED|Day 35||6
8795090|NCT01410058|9846440|FG000|COMPLETED|Day 35||13
8795091|NCT01410058|9846441|FG001|COMPLETED|Day 35||6
8795092|NCT01410058|9846440|FG000|NOT COMPLETED|Day 35||0
8795093|NCT01410058|9846441|FG001|NOT COMPLETED|Day 35||0
8795094|NCT01410084|9846451|FG000|STARTED|Overall Study||38
8795095|NCT01410084|9846452|FG001|STARTED|Overall Study||30
8795096|NCT01410084|9846451|FG000|COMPLETED|Overall Study||37
8795097|NCT01410084|9846452|FG001|COMPLETED|Overall Study||27
8795098|NCT01410084|9846451|FG000|NOT COMPLETED|Overall Study||1
8795099|NCT01410084|9846452|FG001|NOT COMPLETED|Overall Study||3
8795100|NCT01410097|9846460|FG000|STARTED|Overall Study||556
8795101|NCT01410097|9846461|FG001|STARTED|Overall Study||533
8795102|NCT01410097|9846460|FG000|COMPLETED|Overall Study||551
8795103|NCT01410097|9846461|FG001|COMPLETED|Overall Study||530
8795104|NCT01410097|9846460|FG000|NOT COMPLETED|Overall Study||5
8795105|NCT01410097|9846461|FG001|NOT COMPLETED|Overall Study||3
8795106|NCT01410110|9846469|FG000|STARTED|Overall Study||24
8795107|NCT01410110|9846470|FG001|STARTED|Overall Study||24
8795108|NCT01410110|9846469|FG000|Randomization|Overall Study||24
8795109|NCT01410110|9846470|FG001|Randomization|Overall Study||24
8795110|NCT01410110|9846469|FG000|3 Months (End of Intervention)|Overall Study||20
8795111|NCT01410110|9846470|FG001|3 Months (End of Intervention)|Overall Study||22
8795112|NCT01410110|9846469|FG000|6 Month Follow-up|Overall Study||20
8795113|NCT01410110|9846470|FG001|6 Month Follow-up|Overall Study||22
8795114|NCT01410110|9846469|FG000|COMPLETED|Overall Study||20
8795115|NCT01410110|9846470|FG001|COMPLETED|Overall Study||22
8795116|NCT01410110|9846469|FG000|NOT COMPLETED|Overall Study||4
8795117|NCT01410110|9846470|FG001|NOT COMPLETED|Overall Study||2
8795118|NCT01410227|9846476|FG000|STARTED|Overall Study||8
8795119|NCT01410227|9846477|FG001|STARTED|Overall Study||8
8795120|NCT01410227|9846478|FG002|STARTED|Overall Study||15
8795121|NCT01410227|9846479|FG003|STARTED|Overall Study||6
8795122|NCT01410227|9846476|FG000|COMPLETED|Overall Study||4
8795123|NCT01410227|9846477|FG001|COMPLETED|Overall Study||8
8795124|NCT01410227|9846478|FG002|COMPLETED|Overall Study||13
8795125|NCT01410227|9846479|FG003|COMPLETED|Overall Study||5
8795126|NCT01410227|9846476|FG000|NOT COMPLETED|Overall Study||4
8795127|NCT01410227|9846477|FG001|NOT COMPLETED|Overall Study||0
8795128|NCT01410227|9846478|FG002|NOT COMPLETED|Overall Study||2
8795129|NCT01410227|9846479|FG003|NOT COMPLETED|Overall Study||1
8795130|NCT01410240|9846492|FG000|STARTED|Overall Study||53
8795131|NCT01410240|9846493|FG001|STARTED|Overall Study||53
8795132|NCT01410240|9846494|FG002|STARTED|Overall Study||12
8795133|NCT01410240|9846492|FG000|COMPLETED|Overall Study||52
8795134|NCT01410240|9846493|FG001|COMPLETED|Overall Study||52
8795135|NCT01410240|9846494|FG002|COMPLETED|Overall Study||10
8795136|NCT01410240|9846492|FG000|NOT COMPLETED|Overall Study||1
8795137|NCT01410240|9846493|FG001|NOT COMPLETED|Overall Study||1
8795138|NCT01410240|9846494|FG002|NOT COMPLETED|Overall Study||2
8795139|NCT01410344|9846503|FG000|STARTED|Overall Study||20
8795140|NCT01410344|9846503|FG000|COMPLETED|Overall Study||17
8795141|NCT01410344|9846503|FG000|NOT COMPLETED|Overall Study||3
8795142|NCT01410357|9846511|FG000|STARTED|Overall Study||100
8795143|NCT01410357|9846512|FG001|STARTED|Overall Study||100
8795144|NCT01410357|9846511|FG000|COMPLETED|Overall Study||74
8795145|NCT01410357|9846512|FG001|COMPLETED|Overall Study||76
8795146|NCT01410357|9846511|FG000|NOT COMPLETED|Overall Study||26
8795147|NCT01410357|9846512|FG001|NOT COMPLETED|Overall Study||24
8795148|NCT01410409|9846522|FG000|STARTED|Overall Study||50
8795149|NCT01410409|9846523|FG001|STARTED|Overall Study||50
8795150|NCT01410409|9846522|FG000|COMPLETED|Overall Study||49
8795151|NCT01410409|9846523|FG001|COMPLETED|Overall Study||46
8795152|NCT01410409|9846522|FG000|NOT COMPLETED|Overall Study||1
8795153|NCT01410409|9846523|FG001|NOT COMPLETED|Overall Study||4
8795154|NCT01410448|9846531|FG000|STARTED|Overall Study||193
8795155|NCT01410448|9846532|FG001|STARTED|Overall Study||190
8795156|NCT01410448|9846531|FG000|Intent-to Treat (ITT) Analysis Set|Overall Study||193
8795157|NCT01410448|9846532|FG001|Intent-to Treat (ITT) Analysis Set|Overall Study||190
8795158|NCT01410448|9846531|FG000|Modified ITT Analysis Set|Overall Study||161
8795159|NCT01410448|9846532|FG001|Modified ITT Analysis Set|Overall Study||149
8795160|NCT01410448|9846531|FG000|COMPLETED|Overall Study||181
8795161|NCT01410448|9846532|FG001|COMPLETED|Overall Study||155
8795162|NCT01410448|9846531|FG000|NOT COMPLETED|Overall Study||12
8795163|NCT01410448|9846532|FG001|NOT COMPLETED|Overall Study||35
8795164|NCT01410474|9846540|FG000|STARTED|Overall Study||173
8795165|NCT01410474|9846541|FG001|STARTED|Overall Study||168
8795166|NCT01410474|9846540|FG000|COMPLETED|Overall Study||173
8795167|NCT01410474|9846541|FG001|COMPLETED|Overall Study||167
8795168|NCT01410474|9846540|FG000|NOT COMPLETED|Overall Study||0
8795169|NCT01410474|9846541|FG001|NOT COMPLETED|Overall Study||1
8795170|NCT01410552|9846554|FG000|STARTED|Overall Study||1013
8795171|NCT01410552|9846554|FG000|COMPLETED|Overall Study||877
8795172|NCT01410552|9846554|FG000|NOT COMPLETED|Overall Study||136
8795173|NCT01410565|9846560|FG000|STARTED|Open Label Phase Apaziquone||0
8795174|NCT01410565|9846561|FG001|STARTED|Open Label Phase Apaziquone||0
8795175|NCT01410565|9846562|FG002|STARTED|Open Label Phase Apaziquone||66
8795176|NCT01410565|9846560|FG000|COMPLETED|Open Label Phase Apaziquone||0
8795177|NCT01410565|9846561|FG001|COMPLETED|Open Label Phase Apaziquone||0
8795178|NCT01410565|9846562|FG002|COMPLETED|Open Label Phase Apaziquone||58
8795179|NCT01410565|9846560|FG000|NOT COMPLETED|Open Label Phase Apaziquone||0
8795180|NCT01410565|9846561|FG001|NOT COMPLETED|Open Label Phase Apaziquone||0
8795181|NCT01410565|9846562|FG002|NOT COMPLETED|Open Label Phase Apaziquone||8
8795182|NCT01410565|9846560|FG000|STARTED|Double Blind Phase|All 66 patients received one dose of Apaziquone in the open label phase.|13
8795183|NCT01410565|9846561|FG001|STARTED|Double Blind Phase||15
8795184|NCT01410565|9846562|FG002|STARTED|Double Blind Phase||0
8795185|NCT01410565|9846560|FG000|COMPLETED|Double Blind Phase||0
8795186|NCT01410565|9846561|FG001|COMPLETED|Double Blind Phase||0
8795187|NCT01410565|9846562|FG002|COMPLETED|Double Blind Phase||0
8795188|NCT01410565|9846560|FG000|NOT COMPLETED|Double Blind Phase||13
8795189|NCT01410565|9846561|FG001|NOT COMPLETED|Double Blind Phase||15
8795190|NCT01410565|9846562|FG002|NOT COMPLETED|Double Blind Phase||0
8795191|NCT01410604|9846570|FG000|STARTED|Overall Study||15
8795192|NCT01410604|9846571|FG001|STARTED|Overall Study||16
8795193|NCT01410604|9846570|FG000|COMPLETED|Overall Study||12
8795194|NCT01410604|9846571|FG001|COMPLETED|Overall Study||14
8795195|NCT01410604|9846570|FG000|NOT COMPLETED|Overall Study||3
8795196|NCT01410604|9846571|FG001|NOT COMPLETED|Overall Study||2
8795197|NCT01410773|9846577|FG000|STARTED|Overall Study||110
8795198|NCT01410773|9846577|FG000|COMPLETED|Overall Study||110
8795199|NCT01410773|9846577|FG000|NOT COMPLETED|Overall Study||0
8795200|NCT01410812|9846584|FG000|STARTED|Overall Study||75
8795201|NCT01410812|9846585|FG001|STARTED|Overall Study||75
8795202|NCT01410812|9846586|FG002|STARTED|Overall Study||76
8795203|NCT01410812|9846584|FG000|COMPLETED|Overall Study||75
8795204|NCT01410812|9846585|FG001|COMPLETED|Overall Study||75
8795205|NCT01410812|9846586|FG002|COMPLETED|Overall Study||76
8795206|NCT01410812|9846584|FG000|NOT COMPLETED|Overall Study||0
8795207|NCT01410812|9846585|FG001|NOT COMPLETED|Overall Study||0
8795208|NCT01410812|9846586|FG002|NOT COMPLETED|Overall Study||0
8795209|NCT01411085|9846594|FG000|STARTED|Overall Study||10
8795210|NCT01411085|9846594|FG000|COMPLETED|Overall Study||7
8795211|NCT01411085|9846594|FG000|NOT COMPLETED|Overall Study||3
8795212|NCT01411137|9846598|FG000|STARTED|Part 1: Dose Conversion||43
8795213|NCT01411137|9846598|FG000|COMPLETED|Part 1: Dose Conversion||33
8795214|NCT01411137|9846598|FG000|NOT COMPLETED|Part 1: Dose Conversion||10
8795215|NCT01411137|9846598|FG000|STARTED|Part 2: Open-Label Extension|1 subject who completed Part 1 did not elect to continue into Part 2.|32
8795216|NCT01411137|9846598|FG000|COMPLETED|Part 2: Open-Label Extension||25
8795217|NCT01411137|9846598|FG000|NOT COMPLETED|Part 2: Open-Label Extension||7
8795218|NCT01411137|9846598|FG000|STARTED|Part 3: Open-Label Extension|Two sites with 11 completers of Part 2 did not participate in Part 3. Two subjects lost contact.|12
8795219|NCT01411137|9846598|FG000|COMPLETED|Part 3: Open-Label Extension||12
8795220|NCT01411137|9846598|FG000|NOT COMPLETED|Part 3: Open-Label Extension||0
8795221|NCT01411215|9846615|FG000|STARTED|Overall Study||69
8795222|NCT01411215|9846616|FG001|STARTED|Overall Study||91
8795223|NCT01411215|9846615|FG000|Treated|Overall Study||69
8795224|NCT01411215|9846616|FG001|Treated|Overall Study|1 participant was considered as screen failure and therefore not treated.|90
8795225|NCT01411215|9846615|FG000|COMPLETED|Overall Study||3
8795226|NCT01411215|9846616|FG001|COMPLETED|Overall Study||7
8795227|NCT01411215|9846615|FG000|NOT COMPLETED|Overall Study||66
8795228|NCT01411215|9846616|FG001|NOT COMPLETED|Overall Study||84
8795229|NCT01411228|9846625|FG000|STARTED|Overall Study||5
8795230|NCT01411228|9846626|FG001|STARTED|Overall Study||5
8795231|NCT01411228|9846627|FG002|STARTED|Overall Study||5
8795232|NCT01411228|9846625|FG000|COMPLETED|Overall Study||4
8795233|NCT01411228|9846626|FG001|COMPLETED|Overall Study||5
8795234|NCT01411228|9846627|FG002|COMPLETED|Overall Study||4
8795235|NCT01411228|9846625|FG000|NOT COMPLETED|Overall Study||1
8795236|NCT01411228|9846626|FG001|NOT COMPLETED|Overall Study||0
8795237|NCT01411228|9846627|FG002|NOT COMPLETED|Overall Study||1
8795238|NCT01411319|9846635|FG000|STARTED|Overall Study||25
8795239|NCT01411319|9846635|FG000|COMPLETED|Overall Study||24
8795240|NCT01411319|9846635|FG000|NOT COMPLETED|Overall Study||1
8795241|NCT01411488|9846641|FG000|STARTED|Overall Study||41
8795242|NCT01411488|9846642|FG001|STARTED|Overall Study||38
8795243|NCT01411488|9846641|FG000|COMPLETED|Overall Study||41
8795244|NCT01411488|9846642|FG001|COMPLETED|Overall Study||38
8795245|NCT01411488|9846641|FG000|NOT COMPLETED|Overall Study||0
8795246|NCT01411488|9846642|FG001|NOT COMPLETED|Overall Study||0
8795247|NCT01411501|9846652|FG000|STARTED|Overall Study||168
8795248|NCT01411501|9846653|FG001|STARTED|Overall Study||172
8795249|NCT01411501|9846654|FG002|STARTED|Overall Study||165
8795250|NCT01411501|9846655|FG003|STARTED|Overall Study||170
8795251|NCT01411501|9846652|FG000|COMPLETED|Overall Study||158
8795252|NCT01411501|9846653|FG001|COMPLETED|Overall Study||166
8795253|NCT01411501|9846654|FG002|COMPLETED|Overall Study||159
8795254|NCT01411501|9846655|FG003|COMPLETED|Overall Study||163
8795255|NCT01411501|9846652|FG000|NOT COMPLETED|Overall Study||10
8795256|NCT01411501|9846653|FG001|NOT COMPLETED|Overall Study||6
8795257|NCT01411501|9846654|FG002|NOT COMPLETED|Overall Study||6
8795258|NCT01411501|9846655|FG003|NOT COMPLETED|Overall Study||7
8795259|NCT01411527|9846667|FG000|STARTED|Overall Study||1864
8795260|NCT01411527|9846668|FG001|STARTED|Overall Study||93
8795261|NCT01411527|9846667|FG000|COMPLETED|Overall Study||1864
8795262|NCT01411527|9846668|FG001|COMPLETED|Overall Study||93
8795263|NCT01411527|9846667|FG000|NOT COMPLETED|Overall Study||0
8795264|NCT01411527|9846668|FG001|NOT COMPLETED|Overall Study||0
8917516|NCT02193087|9977243|FG003|STARTED|Overall Study||603
8917517|NCT02193087|9977240|FG000|Received Vaccination|Overall Study||197
8917518|NCT02193087|9977241|FG001|Received Vaccination|Overall Study||97
8917519|NCT02193087|9977242|FG002|Received Vaccination|Overall Study||100
8917520|NCT02193087|9977243|FG003|Received Vaccination|Overall Study||602
8917521|NCT02193087|9977240|FG000|COMPLETED|Overall Study||162
8917522|NCT02193087|9977241|FG001|COMPLETED|Overall Study||86
8917523|NCT02193087|9977242|FG002|COMPLETED|Overall Study||93
8917524|NCT02193087|9977243|FG003|COMPLETED|Overall Study||524
8917525|NCT02193087|9977240|FG000|NOT COMPLETED|Overall Study||37
8917526|NCT02193087|9977241|FG001|NOT COMPLETED|Overall Study||14
8917527|NCT02193087|9977242|FG002|NOT COMPLETED|Overall Study||7
8917528|NCT02193087|9977243|FG003|NOT COMPLETED|Overall Study||79
8917529|NCT02193152|9977260|FG000|STARTED|Overall Study||16
8917530|NCT02193152|9977260|FG000|COMPLETED|Overall Study||16
8917531|NCT02193152|9977260|FG000|NOT COMPLETED|Overall Study||0
8917532|NCT02193165|9977267|FG000|STARTED|4 Week Product Use||40
8917533|NCT02193165|9977268|FG001|STARTED|4 Week Product Use||40
8917534|NCT02193165|9977269|FG002|STARTED|4 Week Product Use||40
8917535|NCT02193165|9977267|FG000|COMPLETED|4 Week Product Use|1 subject failed to keep appointments and didn't return to clinical site|39
8917536|NCT02193165|9977268|FG001|COMPLETED|4 Week Product Use|1 subject failed to keep appointments and didn't return to clinical site|39
8917537|NCT02193165|9977269|FG002|COMPLETED|4 Week Product Use|1 subject failed to keep appointments and didn't return to clinical site|39
8917538|NCT02193165|9977267|FG000|NOT COMPLETED|4 Week Product Use||1
8917539|NCT02193165|9977268|FG001|NOT COMPLETED|4 Week Product Use||1
8917540|NCT02193165|9977269|FG002|NOT COMPLETED|4 Week Product Use||1
8917541|NCT02193165|9977267|FG000|STARTED|6 Week Product Use||39
8917542|NCT02193165|9977268|FG001|STARTED|6 Week Product Use||39
8917543|NCT02193165|9977269|FG002|STARTED|6 Week Product Use||39
8917544|NCT02193165|9977267|FG000|COMPLETED|6 Week Product Use||39
8917545|NCT02193165|9977268|FG001|COMPLETED|6 Week Product Use|1 subject failed to keep appointment time and didn't return to clinical site.|38
8917546|NCT02193165|9977269|FG002|COMPLETED|6 Week Product Use||39
8917547|NCT02193165|9977267|FG000|NOT COMPLETED|6 Week Product Use||0
8917548|NCT02193165|9977268|FG001|NOT COMPLETED|6 Week Product Use||1
8917549|NCT02193165|9977269|FG002|NOT COMPLETED|6 Week Product Use||0
8917550|NCT02193178|9977277|FG000|STARTED|Overall Study||15
8917551|NCT02193178|9977277|FG000|COMPLETED|Overall Study||13
8917552|NCT02193178|9977277|FG000|NOT COMPLETED|Overall Study||2
8917553|NCT02193347|9977295|FG000|STARTED|Overall Study||24
8917554|NCT02193347|9977295|FG000|COMPLETED|Overall Study||24
8917555|NCT02193347|9977295|FG000|NOT COMPLETED|Overall Study||0
8917556|NCT02193490|9977301|FG000|STARTED|Overall Study||25
8917557|NCT02193490|9977302|FG001|STARTED|Overall Study||22
8917558|NCT02193490|9977301|FG000|COMPLETED|Overall Study||21
8917559|NCT02193490|9977302|FG001|COMPLETED|Overall Study||20
8917560|NCT02193490|9977301|FG000|NOT COMPLETED|Overall Study||4
8917561|NCT02193490|9977302|FG001|NOT COMPLETED|Overall Study||2
8917562|NCT02193776|9977312|FG000|STARTED|Overall Study||59
8917563|NCT02193776|9977313|FG001|STARTED|Overall Study||60
8917564|NCT02193776|9977314|FG002|STARTED|Overall Study||61
8917565|NCT02193776|9977315|FG003|STARTED|Overall Study||60
8917566|NCT02193776|9977312|FG000|Completed Day 70 Follow-up|Overall Study||54
8917567|NCT02193776|9977313|FG001|Completed Day 70 Follow-up|Overall Study||56
8917568|NCT02193776|9977314|FG002|Completed Day 70 Follow-up|Overall Study||60
8917569|NCT02193776|9977315|FG003|Completed Day 70 Follow-up|Overall Study||60
8917570|NCT02193776|9977312|FG000|Completed Day 140 Follow-up|Overall Study||52
8917571|NCT02193776|9977313|FG001|Completed Day 140 Follow-up|Overall Study||52
8917572|NCT02193776|9977314|FG002|Completed Day 140 Follow-up|Overall Study||58
8917573|NCT02193776|9977315|FG003|Completed Day 140 Follow-up|Overall Study||58
8917574|NCT02193776|9977312|FG000|COMPLETED|Overall Study||51
8917575|NCT02193776|9977313|FG001|COMPLETED|Overall Study||53
8917576|NCT02193776|9977314|FG002|COMPLETED|Overall Study||59
8917577|NCT02193776|9977315|FG003|COMPLETED|Overall Study||58
8917578|NCT02193776|9977312|FG000|NOT COMPLETED|Overall Study||8
8917579|NCT02193776|9977313|FG001|NOT COMPLETED|Overall Study||7
8917580|NCT02193776|9977314|FG002|NOT COMPLETED|Overall Study||2
8917581|NCT02193776|9977315|FG003|NOT COMPLETED|Overall Study||2
8917582|NCT02193815|9977325|FG000|STARTED|Overall Study||15
8917583|NCT02193815|9977325|FG000|COMPLETED|Overall Study||15
8917584|NCT02193815|9977325|FG000|NOT COMPLETED|Overall Study||0
8917585|NCT02193828|9977343|FG000|STARTED|Overall Study||18
8917586|NCT02193828|9977344|FG001|STARTED|Overall Study||18
8917587|NCT02193828|9977345|FG002|STARTED|Overall Study||23
8917588|NCT02193828|9977346|FG003|STARTED|Overall Study||17
8917589|NCT02193828|9977343|FG000|COMPLETED|Overall Study||18
8917590|NCT02193828|9977344|FG001|COMPLETED|Overall Study||18
8917591|NCT02193828|9977345|FG002|COMPLETED|Overall Study||22
8917592|NCT02193828|9977346|FG003|COMPLETED|Overall Study||16
8917593|NCT02193828|9977343|FG000|NOT COMPLETED|Overall Study||0
8917594|NCT02193828|9977344|FG001|NOT COMPLETED|Overall Study||0
8917595|NCT02193828|9977345|FG002|NOT COMPLETED|Overall Study||1
8795265|NCT01411592|9846675|FG000|STARTED|Overall Study||14
8795266|NCT01411592|9846676|FG001|STARTED|Overall Study||16
8795267|NCT01411592|9846675|FG000|5-Year Time Frame|Overall Study||14
8795268|NCT01411592|9846676|FG001|5-Year Time Frame|Overall Study||16
8795269|NCT01411592|9846675|FG000|COMPLETED|Overall Study||14
8795270|NCT01411592|9846676|FG001|COMPLETED|Overall Study||16
8795271|NCT01411592|9846675|FG000|NOT COMPLETED|Overall Study||0
8795272|NCT01411592|9846676|FG001|NOT COMPLETED|Overall Study||0
8795273|NCT01411696|9846682|FG000|STARTED|Overall Study||289
8795274|NCT01411696|9846682|FG000|COMPLETED|Overall Study||289
8795275|NCT01411696|9846682|FG000|NOT COMPLETED|Overall Study||0
8795276|NCT01411774|9846688|FG000|STARTED|Overall Study||72
8795277|NCT01411774|9846689|FG001|STARTED|Overall Study||70
8795278|NCT01411774|9846688|FG000|COMPLETED|Overall Study||72
8795279|NCT01411774|9846689|FG001|COMPLETED|Overall Study||67
8795280|NCT01411774|9846688|FG000|NOT COMPLETED|Overall Study||0
8795281|NCT01411774|9846689|FG001|NOT COMPLETED|Overall Study||3
8795282|NCT01411839|9846697|FG000|STARTED|Overall Study||20
8795283|NCT01411839|9846698|FG001|STARTED|Overall Study||20
8795284|NCT01411839|9846697|FG000|COMPLETED|Overall Study||16
8795285|NCT01411839|9846698|FG001|COMPLETED|Overall Study||17
8795286|NCT01411839|9846697|FG000|NOT COMPLETED|Overall Study||4
8795287|NCT01411839|9846698|FG001|NOT COMPLETED|Overall Study||3
8795288|NCT01411852|9846706|FG000|STARTED|Prehospital Intervention Phase|1 patient randomized to 2000 mL bolus arm but received 250 mL bolus. Analyzed in 2000 mL arm.|95
8795289|NCT01411852|9846707|FG001|STARTED|Prehospital Intervention Phase|One patient was in police custody at the time of enrollment. Patient's data omitted from analyses.|96
8795290|NCT01411852|9846706|FG000|COMPLETED|Prehospital Intervention Phase|12 patients had the intervention stopped prior to hospital arrival|83
8795291|NCT01411852|9846707|FG001|COMPLETED|Prehospital Intervention Phase|7 patients had intervention stopped prior to hospital arrival|89
8795292|NCT01411852|9846706|FG000|NOT COMPLETED|Prehospital Intervention Phase||12
8795293|NCT01411852|9846707|FG001|NOT COMPLETED|Prehospital Intervention Phase||7
8795294|NCT01411852|9846706|FG000|STARTED|Hospital Intervention Phase||83
8795295|NCT01411852|9846707|FG001|STARTED|Hospital Intervention Phase||89
8795296|NCT01411852|9846706|FG000|COMPLETED|Hospital Intervention Phase|24 patients had intervention stopped prior to 2 hours after arrival or hemorrhage control|59
8795297|NCT01411852|9846707|FG001|COMPLETED|Hospital Intervention Phase|18 patients had intervention stopped prior to 2 hours after arrival or hemorrhage control|71
8795298|NCT01411852|9846706|FG000|NOT COMPLETED|Hospital Intervention Phase||24
8795299|NCT01411852|9846707|FG001|NOT COMPLETED|Hospital Intervention Phase||18
8795300|NCT01411891|9846717|FG000|STARTED|Overall Study||50
8795301|NCT01411891|9846718|FG001|STARTED|Overall Study||50
8795302|NCT01411891|9846717|FG000|COMPLETED|Overall Study||47
8795303|NCT01411891|9846718|FG001|COMPLETED|Overall Study||48
8795304|NCT01411891|9846717|FG000|NOT COMPLETED|Overall Study||3
8795305|NCT01411891|9846718|FG001|NOT COMPLETED|Overall Study||2
8795306|NCT01411917|9846726|FG000|STARTED|Overall Study||32
8795307|NCT01411917|9846727|FG001|STARTED|Overall Study||37
8795308|NCT01411917|9846726|FG000|COMPLETED|Overall Study||32
8795309|NCT01411917|9846727|FG001|COMPLETED|Overall Study||36
8795310|NCT01411917|9846726|FG000|NOT COMPLETED|Overall Study||0
8795311|NCT01411917|9846727|FG001|NOT COMPLETED|Overall Study||1
8795312|NCT01411995|9846735|FG000|STARTED|Overall Study||100
8795313|NCT01411995|9846736|FG001|STARTED|Overall Study||100
8795314|NCT01411995|9846735|FG000|COMPLETED|Overall Study||100
8795315|NCT01411995|9846736|FG001|COMPLETED|Overall Study||99
8795316|NCT01411995|9846735|FG000|NOT COMPLETED|Overall Study||0
8795317|NCT01411995|9846736|FG001|NOT COMPLETED|Overall Study||1
8795318|NCT01412021|9846742|FG000|STARTED|Overall Study||375
8795319|NCT01412021|9846742|FG000|Case Report Forms Locked|Overall Study||368
8795320|NCT01412021|9846742|FG000|COMPLETED|Overall Study||356
8795321|NCT01412021|9846742|FG000|NOT COMPLETED|Overall Study||19
8795322|NCT01412060|9846746|FG000|STARTED|Open-label Run-in Period (RIP)||765
8795323|NCT01412060|9846747|FG001|STARTED|Open-label Run-in Period (RIP)||0
8795324|NCT01412060|9846748|FG002|STARTED|Open-label Run-in Period (RIP)||0
8795325|NCT01412060|9846746|FG000|COMPLETED|Open-label Run-in Period (RIP)||418
8795326|NCT01412060|9846747|FG001|COMPLETED|Open-label Run-in Period (RIP)||0
8795327|NCT01412060|9846748|FG002|COMPLETED|Open-label Run-in Period (RIP)||0
8795328|NCT01412060|9846746|FG000|NOT COMPLETED|Open-label Run-in Period (RIP)||347
8795329|NCT01412060|9846747|FG001|NOT COMPLETED|Open-label Run-in Period (RIP)||0
8795330|NCT01412060|9846748|FG002|NOT COMPLETED|Open-label Run-in Period (RIP)||0
8795331|NCT01412060|9846746|FG000|STARTED|Period Between RIP and SP||418
8795332|NCT01412060|9846747|FG001|STARTED|Period Between RIP and SP||0
8795333|NCT01412060|9846748|FG002|STARTED|Period Between RIP and SP||0
8795334|NCT01412060|9846746|FG000|COMPLETED|Period Between RIP and SP||364
8795335|NCT01412060|9846747|FG001|COMPLETED|Period Between RIP and SP||0
8795336|NCT01412060|9846748|FG002|COMPLETED|Period Between RIP and SP||0
8795337|NCT01412060|9846746|FG000|NOT COMPLETED|Period Between RIP and SP||54
8795338|NCT01412060|9846747|FG001|NOT COMPLETED|Period Between RIP and SP||0
8795339|NCT01412060|9846748|FG002|NOT COMPLETED|Period Between RIP and SP||0
8795340|NCT01412060|9846746|FG000|STARTED|Open-label Stabilization Period (SP)||364
8795341|NCT01412060|9846747|FG001|STARTED|Open-label Stabilization Period (SP)||0
8795342|NCT01412060|9846748|FG002|STARTED|Open-label Stabilization Period (SP)||0
8795343|NCT01412060|9846746|FG000|COMPLETED|Open-label Stabilization Period (SP)||264
8795344|NCT01412060|9846747|FG001|COMPLETED|Open-label Stabilization Period (SP)||0
8795345|NCT01412060|9846748|FG002|COMPLETED|Open-label Stabilization Period (SP)||0
8795346|NCT01412060|9846746|FG000|NOT COMPLETED|Open-label Stabilization Period (SP)||100
8795347|NCT01412060|9846747|FG001|NOT COMPLETED|Open-label Stabilization Period (SP)||0
8795348|NCT01412060|9846748|FG002|NOT COMPLETED|Open-label Stabilization Period (SP)||0
8795349|NCT01412060|9846746|FG000|STARTED|Period Between SP and DBP||264
8795350|NCT01412060|9846747|FG001|STARTED|Period Between SP and DBP||0
8795351|NCT01412060|9846748|FG002|STARTED|Period Between SP and DBP||0
8795352|NCT01412060|9846746|FG000|COMPLETED|Period Between SP and DBP||200
8795353|NCT01412060|9846747|FG001|COMPLETED|Period Between SP and DBP||0
8795354|NCT01412060|9846748|FG002|COMPLETED|Period Between SP and DBP||0
8795355|NCT01412060|9846746|FG000|NOT COMPLETED|Period Between SP and DBP||64
8795356|NCT01412060|9846747|FG001|NOT COMPLETED|Period Between SP and DBP||0
8795357|NCT01412060|9846748|FG002|NOT COMPLETED|Period Between SP and DBP||0
8795358|NCT01412060|9846746|FG000|STARTED|Double-blind Treatment Phase (DBP)||0
8795359|NCT01412060|9846747|FG001|STARTED|Double-blind Treatment Phase (DBP)||99
8795360|NCT01412060|9846748|FG002|STARTED|Double-blind Treatment Phase (DBP)||101
8795361|NCT01412060|9846746|FG000|COMPLETED|Double-blind Treatment Phase (DBP)||0
8795362|NCT01412060|9846747|FG001|COMPLETED|Double-blind Treatment Phase (DBP)||16
8795363|NCT01412060|9846748|FG002|COMPLETED|Double-blind Treatment Phase (DBP)||18
8795364|NCT01412060|9846746|FG000|NOT COMPLETED|Double-blind Treatment Phase (DBP)||0
8795365|NCT01412060|9846747|FG001|NOT COMPLETED|Double-blind Treatment Phase (DBP)||83
8795366|NCT01412060|9846748|FG002|NOT COMPLETED|Double-blind Treatment Phase (DBP)||83
8795367|NCT01412086|9846758|FG000|STARTED|Overall Study||112
8795368|NCT01412086|9846758|FG000|COMPLETED|Overall Study||112
8795369|NCT01412086|9846758|FG000|NOT COMPLETED|Overall Study||0
8795370|NCT01412151|9846762|FG000|STARTED|Week 0 - 306 - Treatment Period||10
8795371|NCT01412151|9846762|FG000|COMPLETED|Week 0 - 306 - Treatment Period||5
8795372|NCT01412151|9846762|FG000|NOT COMPLETED|Week 0 - 306 - Treatment Period||5
8795373|NCT01412151|9846762|FG000|STARTED|Week 306 - 310 - Washout Period||5
8795374|NCT01412151|9846762|FG000|COMPLETED|Week 306 - 310 - Washout Period||3
8795375|NCT01412151|9846762|FG000|NOT COMPLETED|Week 306 - 310 - Washout Period||2
8795376|NCT01412164|9846768|FG000|STARTED|Overall Study||730
8795377|NCT01412164|9846768|FG000|COMPLETED|Overall Study||683
8795378|NCT01412164|9846768|FG000|NOT COMPLETED|Overall Study||47
8795379|NCT01412229|9846772|FG000|STARTED|Overall Study||39
8795380|NCT01412229|9846772|FG000|COMPLETED|Overall Study||38
8795381|NCT01412229|9846772|FG000|NOT COMPLETED|Overall Study||1
8795382|NCT01412281|9846781|FG000|STARTED|Overall Study||110
8795383|NCT01412281|9846782|FG001|STARTED|Overall Study||110
8795384|NCT01412281|9846783|FG002|STARTED|Overall Study||110
8795385|NCT01412281|9846784|FG003|STARTED|Overall Study||110
8795386|NCT01412281|9846781|FG000|COMPLETED|Overall Study||110
8795387|NCT01412281|9846782|FG001|COMPLETED|Overall Study||110
8795388|NCT01412281|9846783|FG002|COMPLETED|Overall Study||110
8795389|NCT01412281|9846784|FG003|COMPLETED|Overall Study||110
8795390|NCT01412281|9846781|FG000|NOT COMPLETED|Overall Study||0
8795391|NCT01412281|9846782|FG001|NOT COMPLETED|Overall Study||0
8795392|NCT01412281|9846783|FG002|NOT COMPLETED|Overall Study||0
8795393|NCT01412281|9846784|FG003|NOT COMPLETED|Overall Study||0
8795394|NCT01412372|9846796|FG000|STARTED|Overall Study||30
8795395|NCT01412372|9846797|FG001|STARTED|Overall Study||31
8795396|NCT01412372|9846796|FG000|COMPLETED|Overall Study||26
8795397|NCT01412372|9846797|FG001|COMPLETED|Overall Study||28
8795398|NCT01412372|9846796|FG000|NOT COMPLETED|Overall Study||4
8795399|NCT01412372|9846797|FG001|NOT COMPLETED|Overall Study||3
8795400|NCT01412424|9846803|FG000|STARTED|Core Treatment Period||155
8795401|NCT01412424|9846803|FG000|COMPLETED|Core Treatment Period||102
8795402|NCT01412424|9846803|FG000|NOT COMPLETED|Core Treatment Period||53
8795403|NCT01412424|9846803|FG000|STARTED|Extension Treatment Period|86% of participants who completed the core period voluntarily entered the optional extension period.|88
8795404|NCT01412424|9846803|FG000|COMPLETED|Extension Treatment Period||82
8795405|NCT01412424|9846803|FG000|NOT COMPLETED|Extension Treatment Period||6
8795406|NCT01412541|9846815|FG000|STARTED|Overall Study||372
8795407|NCT01412541|9846816|FG001|STARTED|Overall Study||160
8795408|NCT01412541|9846815|FG000|COMPLETED|Overall Study||246
8795409|NCT01412541|9846816|FG001|COMPLETED|Overall Study||117
8795410|NCT01412541|9846815|FG000|NOT COMPLETED|Overall Study||126
8795411|NCT01412541|9846816|FG001|NOT COMPLETED|Overall Study||43
8795412|NCT01412554|9846825|FG000|STARTED|Overall Study|103 persons re-examined in 2012-13 out of 158 persons originally examined in 1991-96.|103
8795413|NCT01412554|9846825|FG000|COMPLETED|Overall Study||103
8795414|NCT01412554|9846825|FG000|NOT COMPLETED|Overall Study||0
8795415|NCT01412710|9846831|FG000|STARTED|Overall Study||50
8795416|NCT01412710|9846832|FG001|STARTED|Overall Study||27
8795417|NCT01412710|9846831|FG000|COMPLETED|Overall Study||46
8795418|NCT01412710|9846832|FG001|COMPLETED|Overall Study||22
8795419|NCT01412710|9846831|FG000|NOT COMPLETED|Overall Study||4
8795420|NCT01412710|9846832|FG001|NOT COMPLETED|Overall Study||5
8795421|NCT01412801|9846844|FG000|STARTED|Overall Study||91
8795422|NCT01412801|9846845|FG001|STARTED|Overall Study||89
8795423|NCT01412801|9846846|FG002|STARTED|Overall Study||90
8795424|NCT01412801|9846847|FG003|STARTED|Overall Study||91
8795425|NCT01412801|9846848|FG004|STARTED|Overall Study||88
8795426|NCT01412801|9846849|FG005|STARTED|Overall Study||87
8795427|NCT01412801|9846844|FG000|COMPLETED|Overall Study||87
8795428|NCT01412801|9846845|FG001|COMPLETED|Overall Study||84
8795429|NCT01412801|9846846|FG002|COMPLETED|Overall Study||83
8795430|NCT01412801|9846847|FG003|COMPLETED|Overall Study||87
8795431|NCT01412801|9846848|FG004|COMPLETED|Overall Study||85
8795432|NCT01412801|9846849|FG005|COMPLETED|Overall Study||84
8795433|NCT01412801|9846844|FG000|NOT COMPLETED|Overall Study||4
8795434|NCT01412801|9846845|FG001|NOT COMPLETED|Overall Study||5
8795435|NCT01412801|9846846|FG002|NOT COMPLETED|Overall Study||7
8795436|NCT01412801|9846847|FG003|NOT COMPLETED|Overall Study||4
8795437|NCT01412801|9846848|FG004|NOT COMPLETED|Overall Study||3
8795438|NCT01412801|9846849|FG005|NOT COMPLETED|Overall Study||3
8795439|NCT01412866|9846874|FG000|STARTED|Overall Study||58
8795440|NCT01412866|9846875|FG001|STARTED|Overall Study||66
8795441|NCT01412866|9846874|FG000|COMPLETED|Overall Study||57
8795442|NCT01412866|9846875|FG001|COMPLETED|Overall Study||64
8795443|NCT01412866|9846874|FG000|NOT COMPLETED|Overall Study||1
8795444|NCT01412866|9846875|FG001|NOT COMPLETED|Overall Study||2
8795445|NCT01412879|9846883|FG000|STARTED|Initial Registration (Induction Therapy)||18
8795446|NCT01412879|9846884|FG001|STARTED|Initial Registration (Induction Therapy)||35
8795447|NCT01412879|9846885|FG002|STARTED|Initial Registration (Induction Therapy)||0
8795448|NCT01412879|9846883|FG000|Treatment Started|Initial Registration (Induction Therapy)||17
8795449|NCT01412879|9846884|FG001|Treatment Started|Initial Registration (Induction Therapy)||35
8795450|NCT01412879|9846885|FG002|Treatment Started|Initial Registration (Induction Therapy)||0
8795451|NCT01412879|9846883|FG000|COMPLETED|Initial Registration (Induction Therapy)||5
8795452|NCT01412879|9846884|FG001|COMPLETED|Initial Registration (Induction Therapy)||27
8795453|NCT01412879|9846885|FG002|COMPLETED|Initial Registration (Induction Therapy)||0
8795454|NCT01412879|9846883|FG000|NOT COMPLETED|Initial Registration (Induction Therapy)||13
8795455|NCT01412879|9846884|FG001|NOT COMPLETED|Initial Registration (Induction Therapy)||8
8795456|NCT01412879|9846885|FG002|NOT COMPLETED|Initial Registration (Induction Therapy)||0
8795457|NCT01412879|9846883|FG000|STARTED|Consolidation Therapy||0
8795458|NCT01412879|9846884|FG001|STARTED|Consolidation Therapy||0
8795459|NCT01412879|9846885|FG002|STARTED|Consolidation Therapy|Only eligible patients who are able to have stem cell harvested receive consolidation therapy.|26
8795460|NCT01412879|9846883|FG000|COMPLETED|Consolidation Therapy||0
8795461|NCT01412879|9846884|FG001|COMPLETED|Consolidation Therapy||0
8795462|NCT01412879|9846885|FG002|COMPLETED|Consolidation Therapy||26
8795463|NCT01412879|9846883|FG000|NOT COMPLETED|Consolidation Therapy||0
8795464|NCT01412879|9846884|FG001|NOT COMPLETED|Consolidation Therapy||0
8795465|NCT01412879|9846885|FG002|NOT COMPLETED|Consolidation Therapy||0
8795466|NCT01412918|9846897|FG000|STARTED|Overall Study||20
8795467|NCT01412918|9846898|FG001|STARTED|Overall Study||1
8795468|NCT01412918|9846897|FG000|COMPLETED|Overall Study||20
8795469|NCT01412918|9846898|FG001|COMPLETED|Overall Study||1
8795470|NCT01412918|9846897|FG000|NOT COMPLETED|Overall Study||0
8795471|NCT01412918|9846898|FG001|NOT COMPLETED|Overall Study||0
8795472|NCT01412944|9846907|FG000|STARTED|IV: Per Previous CAIN457A2304 Treatment||0
8795473|NCT01412944|9846908|FG001|STARTED|IV: Per Previous CAIN457A2304 Treatment||0
8795474|NCT01412944|9846909|FG002|STARTED|IV: Per Previous CAIN457A2304 Treatment||15
8795475|NCT01412944|9846910|FG003|STARTED|IV: Per Previous CAIN457A2304 Treatment||6
8795476|NCT01412944|9846911|FG004|STARTED|IV: Per Previous CAIN457A2304 Treatment||14
9033108|NCT03268343|10095231|FG000|NOT COMPLETED|Overall Study||0
9033109|NCT03268343|10095232|FG001|NOT COMPLETED|Overall Study||0
9033110|NCT03268590|10095239|FG000|STARTED|Overall Study||33
9033111|NCT03268590|10095239|FG000|COMPLETED|Overall Study|One participant did not complete MRI due to a previously undiagnosed subdermal metal shard in scalp.|32
9033112|NCT03268590|10095239|FG000|NOT COMPLETED|Overall Study||1
9033113|NCT03268746|10095246|FG000|STARTED|Overall Study||45
9033114|NCT03268746|10095246|FG000|COMPLETED|Overall Study||44
9033115|NCT03268746|10095246|FG000|NOT COMPLETED|Overall Study||1
9033116|NCT03268941|10095261|FG000|STARTED|Part 1 (Days 1 to 9)||12
9033117|NCT03268941|10095262|FG001|STARTED|Part 1 (Days 1 to 9)||14
9033118|NCT03268941|10095263|FG002|STARTED|Part 1 (Days 1 to 9)||12
9033119|NCT03268941|10095264|FG003|STARTED|Part 1 (Days 1 to 9)||13
9033120|NCT03268941|10095265|FG004|STARTED|Part 1 (Days 1 to 9)||0
9033121|NCT03268941|10095266|FG005|STARTED|Part 1 (Days 1 to 9)||0
9033122|NCT03268941|10095267|FG006|STARTED|Part 1 (Days 1 to 9)||0
9033123|NCT03268941|10095261|FG000|COMPLETED|Part 1 (Days 1 to 9)||11
9033124|NCT03268941|10095262|FG001|COMPLETED|Part 1 (Days 1 to 9)||14
9033125|NCT03268941|10095263|FG002|COMPLETED|Part 1 (Days 1 to 9)||12
9033126|NCT03268941|10095264|FG003|COMPLETED|Part 1 (Days 1 to 9)||11
9033127|NCT03268941|10095265|FG004|COMPLETED|Part 1 (Days 1 to 9)||0
8795477|NCT01412944|9846912|FG005|STARTED|IV: Per Previous CAIN457A2304 Treatment||8
8795478|NCT01412944|9846907|FG000|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
8795479|NCT01412944|9846908|FG001|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
8795480|NCT01412944|9846909|FG002|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||14
8795481|NCT01412944|9846910|FG003|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||6
8795482|NCT01412944|9846911|FG004|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||14
8795483|NCT01412944|9846912|FG005|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||6
8795484|NCT01412944|9846907|FG000|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
8795485|NCT01412944|9846908|FG001|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
8795486|NCT01412944|9846909|FG002|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||1
8795487|NCT01412944|9846910|FG003|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
9033128|NCT03268941|10095266|FG005|COMPLETED|Part 1 (Days 1 to 9)||0
8795488|NCT01412944|9846911|FG004|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
8795489|NCT01412944|9846912|FG005|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||2
8795490|NCT01412944|9846907|FG000|STARTED|IV: Per CAIN457A2307||21
8795491|NCT01412944|9846908|FG001|STARTED|IV: Per CAIN457A2307||22
8795492|NCT01412944|9846909|FG002|STARTED|IV: Per CAIN457A2307||0
8795493|NCT01412944|9846910|FG003|STARTED|IV: Per CAIN457A2307||0
8795494|NCT01412944|9846911|FG004|STARTED|IV: Per CAIN457A2307||0
8795495|NCT01412944|9846912|FG005|STARTED|IV: Per CAIN457A2307||0
8795496|NCT01412944|9846907|FG000|COMPLETED|IV: Per CAIN457A2307||20
8795497|NCT01412944|9846908|FG001|COMPLETED|IV: Per CAIN457A2307||20
8795498|NCT01412944|9846909|FG002|COMPLETED|IV: Per CAIN457A2307||0
8795499|NCT01412944|9846910|FG003|COMPLETED|IV: Per CAIN457A2307||0
8795500|NCT01412944|9846911|FG004|COMPLETED|IV: Per CAIN457A2307||0
8795501|NCT01412944|9846912|FG005|COMPLETED|IV: Per CAIN457A2307||0
9033129|NCT03268941|10095267|FG006|COMPLETED|Part 1 (Days 1 to 9)||0
9033130|NCT03268941|10095261|FG000|NOT COMPLETED|Part 1 (Days 1 to 9)||1
9033131|NCT03268941|10095262|FG001|NOT COMPLETED|Part 1 (Days 1 to 9)||0
9033132|NCT03268941|10095263|FG002|NOT COMPLETED|Part 1 (Days 1 to 9)||0
9033133|NCT03268941|10095264|FG003|NOT COMPLETED|Part 1 (Days 1 to 9)||2
9033134|NCT03268941|10095265|FG004|NOT COMPLETED|Part 1 (Days 1 to 9)||0
9033135|NCT03268941|10095266|FG005|NOT COMPLETED|Part 1 (Days 1 to 9)||0
9033136|NCT03268941|10095267|FG006|NOT COMPLETED|Part 1 (Days 1 to 9)||0
9033137|NCT03268941|10095261|FG000|STARTED|Part 2: Days 17 to 25||0
9033138|NCT03268941|10095262|FG001|STARTED|Part 2: Days 17 to 25||0
9033139|NCT03268941|10095263|FG002|STARTED|Part 2: Days 17 to 25||0
9033140|NCT03268941|10095264|FG003|STARTED|Part 2: Days 17 to 25||0
9033141|NCT03268941|10095265|FG004|STARTED|Part 2: Days 17 to 25||6
9033142|NCT03268941|10095266|FG005|STARTED|Part 2: Days 17 to 25||0
9033143|NCT03268941|10095267|FG006|STARTED|Part 2: Days 17 to 25||15
9033144|NCT03268941|10095261|FG000|Treated|Part 2: Days 17 to 25||0
9033145|NCT03268941|10095262|FG001|Treated|Part 2: Days 17 to 25||0
9033146|NCT03268941|10095263|FG002|Treated|Part 2: Days 17 to 25||0
9033147|NCT03268941|10095264|FG003|Treated|Part 2: Days 17 to 25||0
9033148|NCT03268941|10095265|FG004|Treated|Part 2: Days 17 to 25||6
9033149|NCT03268941|10095266|FG005|Treated|Part 2: Days 17 to 25||0
9033150|NCT03268941|10095267|FG006|Treated|Part 2: Days 17 to 25||13
9033151|NCT03268941|10095261|FG000|COMPLETED|Part 2: Days 17 to 25||0
9033152|NCT03268941|10095262|FG001|COMPLETED|Part 2: Days 17 to 25||0
9033153|NCT03268941|10095263|FG002|COMPLETED|Part 2: Days 17 to 25||0
9033154|NCT03268941|10095264|FG003|COMPLETED|Part 2: Days 17 to 25||0
9033155|NCT03268941|10095265|FG004|COMPLETED|Part 2: Days 17 to 25||6
9033156|NCT03268941|10095266|FG005|COMPLETED|Part 2: Days 17 to 25||0
9033157|NCT03268941|10095267|FG006|COMPLETED|Part 2: Days 17 to 25||13
9033158|NCT03268941|10095261|FG000|NOT COMPLETED|Part 2: Days 17 to 25||0
9033159|NCT03268941|10095262|FG001|NOT COMPLETED|Part 2: Days 17 to 25||0
9033160|NCT03268941|10095263|FG002|NOT COMPLETED|Part 2: Days 17 to 25||0
9033161|NCT03268941|10095264|FG003|NOT COMPLETED|Part 2: Days 17 to 25||0
9033162|NCT03268941|10095265|FG004|NOT COMPLETED|Part 2: Days 17 to 25||0
9033163|NCT03268941|10095266|FG005|NOT COMPLETED|Part 2: Days 17 to 25||0
9033164|NCT03268941|10095267|FG006|NOT COMPLETED|Part 2: Days 17 to 25||2
9033165|NCT03268941|10095261|FG000|STARTED|Part 2: Period 2: Fasted (Day 25)||0
9033166|NCT03268941|10095262|FG001|STARTED|Part 2: Period 2: Fasted (Day 25)||0
9033167|NCT03268941|10095263|FG002|STARTED|Part 2: Period 2: Fasted (Day 25)||0
9033168|NCT03268941|10095264|FG003|STARTED|Part 2: Period 2: Fasted (Day 25)||0
9033169|NCT03268941|10095265|FG004|STARTED|Part 2: Period 2: Fasted (Day 25)||0
9033170|NCT03268941|10095266|FG005|STARTED|Part 2: Period 2: Fasted (Day 25)||6
9033171|NCT03268941|10095267|FG006|STARTED|Part 2: Period 2: Fasted (Day 25)||0
9033172|NCT03268941|10095261|FG000|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
9033173|NCT03268941|10095262|FG001|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
9033174|NCT03268941|10095263|FG002|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
9033175|NCT03268941|10095264|FG003|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
9033176|NCT03268941|10095265|FG004|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
9033177|NCT03268941|10095266|FG005|COMPLETED|Part 2: Period 2: Fasted (Day 25)||6
9033178|NCT03268941|10095267|FG006|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
9033179|NCT03268941|10095261|FG000|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
9033180|NCT03268941|10095262|FG001|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
9033181|NCT03268941|10095263|FG002|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
9033182|NCT03268941|10095264|FG003|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
9033183|NCT03268941|10095265|FG004|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
9033184|NCT03268941|10095266|FG005|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
9033185|NCT03268941|10095267|FG006|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
9033186|NCT03269435|10095288|FG000|STARTED|Overall Study||51
9033187|NCT03269435|10095289|FG001|STARTED|Overall Study||48
9033188|NCT03269435|10095288|FG000|COMPLETED|Overall Study||51
9033189|NCT03269435|10095289|FG001|COMPLETED|Overall Study||48
9033190|NCT03269435|10095288|FG000|NOT COMPLETED|Overall Study||0
9033191|NCT03269435|10095289|FG001|NOT COMPLETED|Overall Study||0
9033192|NCT03269552|10095295|FG000|STARTED|Overall Study||4
9033193|NCT03269552|10095295|FG000|COMPLETED|Overall Study||2
9033194|NCT03269552|10095295|FG000|NOT COMPLETED|Overall Study||2
8795502|NCT01412944|9846907|FG000|NOT COMPLETED|IV: Per CAIN457A2307||1
8795503|NCT01412944|9846908|FG001|NOT COMPLETED|IV: Per CAIN457A2307||2
8795504|NCT01412944|9846909|FG002|NOT COMPLETED|IV: Per CAIN457A2307||0
8795505|NCT01412944|9846910|FG003|NOT COMPLETED|IV: Per CAIN457A2307||0
8795506|NCT01412944|9846911|FG004|NOT COMPLETED|IV: Per CAIN457A2307||0
8795507|NCT01412944|9846912|FG005|NOT COMPLETED|IV: Per CAIN457A2307||0
8795508|NCT01412944|9846907|FG000|STARTED|Entire: IV + Maintenance||0
8795509|NCT01412944|9846908|FG001|STARTED|Entire: IV + Maintenance||0
8795510|NCT01412944|9846909|FG002|STARTED|Entire: IV + Maintenance||15
8795511|NCT01412944|9846910|FG003|STARTED|Entire: IV + Maintenance||6
8795512|NCT01412944|9846911|FG004|STARTED|Entire: IV + Maintenance||14
8795513|NCT01412944|9846912|FG005|STARTED|Entire: IV + Maintenance||8
8795514|NCT01412944|9846907|FG000|COMPLETED|Entire: IV + Maintenance||0
8795515|NCT01412944|9846908|FG001|COMPLETED|Entire: IV + Maintenance||0
8795516|NCT01412944|9846909|FG002|COMPLETED|Entire: IV + Maintenance||14
8795517|NCT01412944|9846910|FG003|COMPLETED|Entire: IV + Maintenance||5
8795518|NCT01412944|9846911|FG004|COMPLETED|Entire: IV + Maintenance||11
8795519|NCT01412944|9846912|FG005|COMPLETED|Entire: IV + Maintenance||6
8795520|NCT01412944|9846907|FG000|NOT COMPLETED|Entire: IV + Maintenance||0
8795521|NCT01412944|9846908|FG001|NOT COMPLETED|Entire: IV + Maintenance||0
8795522|NCT01412944|9846909|FG002|NOT COMPLETED|Entire: IV + Maintenance||1
8795523|NCT01412944|9846910|FG003|NOT COMPLETED|Entire: IV + Maintenance||1
8795524|NCT01412944|9846911|FG004|NOT COMPLETED|Entire: IV + Maintenance||3
8795525|NCT01412944|9846912|FG005|NOT COMPLETED|Entire: IV + Maintenance||2
8795526|NCT01412944|9846907|FG000|STARTED|Entire: IV + Maintenance||21
8795527|NCT01412944|9846908|FG001|STARTED|Entire: IV + Maintenance||22
8917596|NCT02193828|9977346|FG003|NOT COMPLETED|Overall Study||1
8917597|NCT02193880|9977356|FG000|STARTED|Overall Study||7
8917598|NCT02193880|9977356|FG000|COMPLETED|Overall Study||4
8917599|NCT02193880|9977356|FG000|NOT COMPLETED|Overall Study||3
8917600|NCT02194062|9977363|FG000|STARTED|Overall Study||10
8917601|NCT02194062|9977364|FG001|STARTED|Overall Study||10
8917602|NCT02194062|9977365|FG002|STARTED|Overall Study||12
8917603|NCT02194062|9977363|FG000|COMPLETED|Overall Study||8
8917604|NCT02194062|9977364|FG001|COMPLETED|Overall Study||8
8917605|NCT02194062|9977365|FG002|COMPLETED|Overall Study||7
8917606|NCT02194062|9977363|FG000|NOT COMPLETED|Overall Study||2
8917607|NCT02194062|9977364|FG001|NOT COMPLETED|Overall Study||2
8917608|NCT02194062|9977365|FG002|NOT COMPLETED|Overall Study||5
8917609|NCT02194088|9977375|FG000|STARTED|Overall Study||75
8917610|NCT02194088|9977376|FG001|STARTED|Overall Study||25
8917611|NCT02194088|9977375|FG000|COMPLETED|Overall Study||75
8917612|NCT02194088|9977376|FG001|COMPLETED|Overall Study||25
8917613|NCT02194088|9977375|FG000|NOT COMPLETED|Overall Study||0
8917614|NCT02194088|9977376|FG001|NOT COMPLETED|Overall Study||0
8917615|NCT02194439|9977384|FG000|STARTED|Overall Study||415
8917616|NCT02194439|9977384|FG000|COMPLETED|Overall Study||415
8795528|NCT01412944|9846909|FG002|STARTED|Entire: IV + Maintenance||0
8917617|NCT02194439|9977384|FG000|NOT COMPLETED|Overall Study||0
9033195|NCT03270085|10095302|FG000|STARTED|Overall Study||15
9033196|NCT03270085|10095303|FG001|STARTED|Overall Study||15
9033197|NCT03270085|10095302|FG000|COMPLETED|Overall Study||14
9033198|NCT03270085|10095303|FG001|COMPLETED|Overall Study||15
9033199|NCT03270085|10095302|FG000|NOT COMPLETED|Overall Study||1
9033200|NCT03270085|10095303|FG001|NOT COMPLETED|Overall Study||0
9033201|NCT03270332|10095311|FG000|STARTED|Overall Study||5
9033202|NCT03270332|10095312|FG001|STARTED|Overall Study||5
9033203|NCT03270332|10095311|FG000|COMPLETED|Overall Study||5
9033204|NCT03270332|10095312|FG001|COMPLETED|Overall Study||4
9033205|NCT03270332|10095311|FG000|NOT COMPLETED|Overall Study||0
9033206|NCT03270332|10095312|FG001|NOT COMPLETED|Overall Study||1
9033207|NCT03270436|10095322|FG000|STARTED|Baseline||213
9033208|NCT03270436|10095323|FG001|STARTED|Baseline||167
9033209|NCT03270436|10095322|FG000|COMPLETED|Baseline||212
9033210|NCT03270436|10095323|FG001|COMPLETED|Baseline||166
9033211|NCT03270436|10095322|FG000|NOT COMPLETED|Baseline||1
9033212|NCT03270436|10095323|FG001|NOT COMPLETED|Baseline||1
9033213|NCT03270436|10095322|FG000|STARTED|Immediate Post-Intervention||213
9033214|NCT03270436|10095323|FG001|STARTED|Immediate Post-Intervention||167
9033215|NCT03270436|10095322|FG000|COMPLETED|Immediate Post-Intervention||172
9033216|NCT03270436|10095323|FG001|COMPLETED|Immediate Post-Intervention||111
9033217|NCT03270436|10095322|FG000|NOT COMPLETED|Immediate Post-Intervention||41
9033218|NCT03270436|10095323|FG001|NOT COMPLETED|Immediate Post-Intervention||56
9033219|NCT03270436|10095322|FG000|STARTED|6 Months Post-Intervention||213
9033220|NCT03270436|10095323|FG001|STARTED|6 Months Post-Intervention||167
9033221|NCT03270436|10095322|FG000|COMPLETED|6 Months Post-Intervention||173
9033222|NCT03270436|10095323|FG001|COMPLETED|6 Months Post-Intervention||116
8795529|NCT01412944|9846910|FG003|STARTED|Entire: IV + Maintenance||0
8795530|NCT01412944|9846911|FG004|STARTED|Entire: IV + Maintenance||0
8795531|NCT01412944|9846912|FG005|STARTED|Entire: IV + Maintenance||0
8795532|NCT01412944|9846907|FG000|COMPLETED|Entire: IV + Maintenance||19
8795533|NCT01412944|9846908|FG001|COMPLETED|Entire: IV + Maintenance||17
9033223|NCT03270436|10095322|FG000|NOT COMPLETED|6 Months Post-Intervention||40
9033224|NCT03270436|10095323|FG001|NOT COMPLETED|6 Months Post-Intervention||51
9033225|NCT03270514|10095331|FG000|STARTED|Overall Study||29
9033226|NCT03270514|10095332|FG001|STARTED|Overall Study||31
8795534|NCT01412944|9846909|FG002|COMPLETED|Entire: IV + Maintenance||0
8795535|NCT01412944|9846910|FG003|COMPLETED|Entire: IV + Maintenance||0
8795536|NCT01412944|9846911|FG004|COMPLETED|Entire: IV + Maintenance||0
8795537|NCT01412944|9846912|FG005|COMPLETED|Entire: IV + Maintenance||0
8795538|NCT01412944|9846907|FG000|NOT COMPLETED|Entire: IV + Maintenance||2
8795539|NCT01412944|9846908|FG001|NOT COMPLETED|Entire: IV + Maintenance||5
8795540|NCT01412944|9846909|FG002|NOT COMPLETED|Entire: IV + Maintenance||0
8795541|NCT01412944|9846910|FG003|NOT COMPLETED|Entire: IV + Maintenance||0
8795542|NCT01412944|9846911|FG004|NOT COMPLETED|Entire: IV + Maintenance||0
8795543|NCT01412944|9846912|FG005|NOT COMPLETED|Entire: IV + Maintenance||0
8795544|NCT01412944|9846907|FG000|STARTED|Follow-up||0
8795545|NCT01412944|9846908|FG001|STARTED|Follow-up||0
8795546|NCT01412944|9846909|FG002|STARTED|Follow-up||2
8795547|NCT01412944|9846910|FG003|STARTED|Follow-up||1
8795548|NCT01412944|9846911|FG004|STARTED|Follow-up||2
8795549|NCT01412944|9846912|FG005|STARTED|Follow-up||0
8795550|NCT01412944|9846907|FG000|COMPLETED|Follow-up||0
8795551|NCT01412944|9846908|FG001|COMPLETED|Follow-up||0
8795552|NCT01412944|9846909|FG002|COMPLETED|Follow-up||2
8795553|NCT01412944|9846910|FG003|COMPLETED|Follow-up||1
8795554|NCT01412944|9846911|FG004|COMPLETED|Follow-up||2
8795555|NCT01412944|9846912|FG005|COMPLETED|Follow-up||0
8795556|NCT01412944|9846907|FG000|NOT COMPLETED|Follow-up||0
8795557|NCT01412944|9846908|FG001|NOT COMPLETED|Follow-up||0
8795558|NCT01412944|9846909|FG002|NOT COMPLETED|Follow-up||0
8795559|NCT01412944|9846910|FG003|NOT COMPLETED|Follow-up||0
8795560|NCT01412944|9846911|FG004|NOT COMPLETED|Follow-up||0
8795561|NCT01412944|9846912|FG005|NOT COMPLETED|Follow-up||0
8795562|NCT01412957|9846930|FG000|STARTED|Overall Study||189
8795563|NCT01412957|9846931|FG001|STARTED|Overall Study||188
8795564|NCT01412957|9846930|FG000|COMPLETED|Overall Study|Participants continuing study at the time of data cut-off|40
8795565|NCT01412957|9846931|FG001|COMPLETED|Overall Study|Participants continuing study at the time of data cut-off|31
8795566|NCT01412957|9846930|FG000|NOT COMPLETED|Overall Study||149
8795567|NCT01412957|9846931|FG001|NOT COMPLETED|Overall Study||157
8795568|NCT01412983|9846937|FG000|STARTED|1st Period||50
8795569|NCT01412983|9846938|FG001|STARTED|1st Period||50
8795570|NCT01412983|9846937|FG000|COMPLETED|1st Period||50
8795571|NCT01412983|9846938|FG001|COMPLETED|1st Period||46
8795572|NCT01412983|9846937|FG000|NOT COMPLETED|1st Period||0
8795573|NCT01412983|9846938|FG001|NOT COMPLETED|1st Period||4
8795574|NCT01412983|9846937|FG000|STARTED|2nd Period||50
8795575|NCT01412983|9846938|FG001|STARTED|2nd Period||46
8795576|NCT01412983|9846937|FG000|COMPLETED|2nd Period||50
8795577|NCT01412983|9846938|FG001|COMPLETED|2nd Period||46
8795578|NCT01412983|9846937|FG000|NOT COMPLETED|2nd Period||0
8795579|NCT01412983|9846938|FG001|NOT COMPLETED|2nd Period||0
8795580|NCT01413087|9846947|FG000|STARTED|Overall Study||6
8795581|NCT01413087|9846948|FG001|STARTED|Overall Study||6
8795582|NCT01413087|9846947|FG000|COMPLETED|Overall Study||6
8795583|NCT01413087|9846948|FG001|COMPLETED|Overall Study||6
8795584|NCT01413087|9846947|FG000|NOT COMPLETED|Overall Study||0
8795585|NCT01413087|9846948|FG001|NOT COMPLETED|Overall Study||0
8795586|NCT01413178|9846956|FG000|STARTED|Overall Study||105
8795587|NCT01413178|9846957|FG001|STARTED|Overall Study||100
8795588|NCT01413178|9846956|FG000|COMPLETED|Overall Study||104
8795589|NCT01413178|9846957|FG001|COMPLETED|Overall Study||98
8795590|NCT01413178|9846956|FG000|NOT COMPLETED|Overall Study||1
8795591|NCT01413178|9846957|FG001|NOT COMPLETED|Overall Study||2
8795592|NCT01413191|9846963|FG000|STARTED|Overall Study||18
8795593|NCT01413191|9846963|FG000|COMPLETED|Overall Study||7
8795594|NCT01413191|9846963|FG000|NOT COMPLETED|Overall Study||11
8795595|NCT01413204|9846970|FG000|STARTED|Overall Study||90
8795596|NCT01413204|9846971|FG001|STARTED|Overall Study||89
8795597|NCT01413204|9846972|FG002|STARTED|Overall Study||93
8795598|NCT01413204|9846970|FG000|COMPLETED|Overall Study||84
8795599|NCT01413204|9846971|FG001|COMPLETED|Overall Study||83
8795600|NCT01413204|9846972|FG002|COMPLETED|Overall Study||74
8795601|NCT01413204|9846970|FG000|NOT COMPLETED|Overall Study||6
8795602|NCT01413204|9846971|FG001|NOT COMPLETED|Overall Study||6
8795603|NCT01413204|9846972|FG002|NOT COMPLETED|Overall Study||19
8795604|NCT01413360|9846980|FG000|STARTED|Overall Study||10
8795605|NCT01413360|9846980|FG000|COMPLETED|Overall Study||7
8795606|NCT01413360|9846980|FG000|NOT COMPLETED|Overall Study||3
8795607|NCT01413503|9846984|FG000|STARTED|Overall Study||50
8795608|NCT01413503|9846984|FG000|COMPLETED|Overall Study||49
8795609|NCT01413503|9846984|FG000|NOT COMPLETED|Overall Study||1
8795610|NCT01413516|9846990|FG000|STARTED|Overall Study||8
8795611|NCT01413516|9846991|FG001|STARTED|Overall Study||9
8795612|NCT01413516|9846990|FG000|COMPLETED|Overall Study||8
8795613|NCT01413516|9846991|FG001|COMPLETED|Overall Study||9
8795614|NCT01413516|9846990|FG000|NOT COMPLETED|Overall Study||0
8795615|NCT01413516|9846991|FG001|NOT COMPLETED|Overall Study||0
8795616|NCT01413542|9846999|FG000|STARTED|Overall Study||6
8795617|NCT01413542|9847000|FG001|STARTED|Overall Study||6
8795618|NCT01413542|9847001|FG002|STARTED|Overall Study||9
8795619|NCT01413542|9847002|FG003|STARTED|Overall Study||8
8795620|NCT01413542|9846999|FG000|COMPLETED|Overall Study||5
8795621|NCT01413542|9847000|FG001|COMPLETED|Overall Study||6
8795622|NCT01413542|9847001|FG002|COMPLETED|Overall Study||6
8795623|NCT01413542|9847002|FG003|COMPLETED|Overall Study||7
8795624|NCT01413542|9846999|FG000|NOT COMPLETED|Overall Study||1
8795625|NCT01413542|9847000|FG001|NOT COMPLETED|Overall Study||0
8795626|NCT01413542|9847001|FG002|NOT COMPLETED|Overall Study||3
8795627|NCT01413542|9847002|FG003|NOT COMPLETED|Overall Study||1
8795628|NCT01413750|9847018|FG000|STARTED|Overall Study||6
8795629|NCT01413750|9847019|FG001|STARTED|Overall Study||6
8795630|NCT01413750|9847020|FG002|STARTED|Overall Study||4
8795631|NCT01413750|9847021|FG003|STARTED|Overall Study||7
8795632|NCT01413750|9847018|FG000|COMPLETED|Overall Study||6
8795633|NCT01413750|9847019|FG001|COMPLETED|Overall Study||6
8795634|NCT01413750|9847020|FG002|COMPLETED|Overall Study||4
8795635|NCT01413750|9847021|FG003|COMPLETED|Overall Study||7
8795636|NCT01413750|9847018|FG000|NOT COMPLETED|Overall Study||0
8795637|NCT01413750|9847019|FG001|NOT COMPLETED|Overall Study||0
8795638|NCT01413750|9847020|FG002|NOT COMPLETED|Overall Study||0
8795639|NCT01413750|9847021|FG003|NOT COMPLETED|Overall Study||0
8795640|NCT01413958|9847034|FG000|STARTED|Overall Study||288
8795641|NCT01413958|9847035|FG001|STARTED|Overall Study||287
8795642|NCT01413958|9847034|FG000|COMPLETED|Overall Study||288
8795643|NCT01413958|9847035|FG001|COMPLETED|Overall Study||286
8795644|NCT01413958|9847034|FG000|NOT COMPLETED|Overall Study||0
8795645|NCT01413958|9847035|FG001|NOT COMPLETED|Overall Study||1
8795646|NCT01414010|9847046|FG000|STARTED|Overall Study||8
8795647|NCT01414010|9847047|FG001|STARTED|Overall Study||8
8795648|NCT01414010|9847048|FG002|STARTED|Overall Study||8
8795649|NCT01414010|9847049|FG003|STARTED|Overall Study||8
8795650|NCT01414010|9847046|FG000|COMPLETED|Overall Study||6
8795651|NCT01414010|9847047|FG001|COMPLETED|Overall Study||8
8795652|NCT01414010|9847048|FG002|COMPLETED|Overall Study||8
8795653|NCT01414010|9847049|FG003|COMPLETED|Overall Study||8
8795654|NCT01414010|9847046|FG000|NOT COMPLETED|Overall Study||2
8795655|NCT01414010|9847047|FG001|NOT COMPLETED|Overall Study||0
8795656|NCT01414010|9847048|FG002|NOT COMPLETED|Overall Study||0
8795657|NCT01414010|9847049|FG003|NOT COMPLETED|Overall Study||0
8795658|NCT01414036|9847067|FG000|STARTED|Received Allocated Intervention||23
8795659|NCT01414036|9847068|FG001|STARTED|Received Allocated Intervention||24
8795660|NCT01414036|9847067|FG000|COMPLETED|Received Allocated Intervention||23
8795661|NCT01414036|9847068|FG001|COMPLETED|Received Allocated Intervention||11
8795662|NCT01414036|9847067|FG000|NOT COMPLETED|Received Allocated Intervention||0
8795663|NCT01414036|9847068|FG001|NOT COMPLETED|Received Allocated Intervention||13
8795664|NCT01414036|9847067|FG000|STARTED|Completed 3 Month Survey||23
8795665|NCT01414036|9847068|FG001|STARTED|Completed 3 Month Survey||24
8795666|NCT01414036|9847067|FG000|COMPLETED|Completed 3 Month Survey||14
8795667|NCT01414036|9847068|FG001|COMPLETED|Completed 3 Month Survey||19
8795668|NCT01414036|9847067|FG000|NOT COMPLETED|Completed 3 Month Survey||9
8795669|NCT01414036|9847068|FG001|NOT COMPLETED|Completed 3 Month Survey||5
8795670|NCT01414075|9847078|FG000|STARTED|Overall Study||24
8795671|NCT01414075|9847079|FG001|STARTED|Overall Study||12
8795672|NCT01414075|9847080|FG002|STARTED|Overall Study||12
8795673|NCT01414075|9847081|FG003|STARTED|Overall Study||12
8795674|NCT01414075|9847078|FG000|Efficacy Evaluable (EE) Population|Overall Study||23
8795675|NCT01414075|9847079|FG001|Efficacy Evaluable (EE) Population|Overall Study||12
8795676|NCT01414075|9847080|FG002|Efficacy Evaluable (EE) Population|Overall Study||10
8795677|NCT01414075|9847081|FG003|Efficacy Evaluable (EE) Population|Overall Study||10
8795678|NCT01414075|9847078|FG000|COMPLETED|Overall Study||21
8795679|NCT01414075|9847079|FG001|COMPLETED|Overall Study||12
8795680|NCT01414075|9847080|FG002|COMPLETED|Overall Study||10
8795681|NCT01414075|9847081|FG003|COMPLETED|Overall Study||10
8795682|NCT01414075|9847078|FG000|NOT COMPLETED|Overall Study||3
8795683|NCT01414075|9847079|FG001|NOT COMPLETED|Overall Study||0
8795684|NCT01414075|9847080|FG002|NOT COMPLETED|Overall Study||2
8795685|NCT01414075|9847081|FG003|NOT COMPLETED|Overall Study||2
8795686|NCT01414114|9847091|FG000|STARTED|Overall Study||37
8795687|NCT01414114|9847091|FG000|COMPLETED|Overall Study|Completed 12-week treatment period|32
8795688|NCT01414114|9847091|FG000|NOT COMPLETED|Overall Study||5
8795689|NCT01414153|9847101|FG000|STARTED|Overall Study||38
8795690|NCT01414153|9847102|FG001|STARTED|Overall Study||40
8795691|NCT01414153|9847103|FG002|STARTED|Overall Study||39
8795692|NCT01414153|9847104|FG003|STARTED|Overall Study||41
8795693|NCT01414153|9847101|FG000|COMPLETED|Overall Study||30
8795694|NCT01414153|9847102|FG001|COMPLETED|Overall Study||38
8795695|NCT01414153|9847103|FG002|COMPLETED|Overall Study||35
8795696|NCT01414153|9847104|FG003|COMPLETED|Overall Study||37
8795697|NCT01414153|9847101|FG000|NOT COMPLETED|Overall Study||8
8795698|NCT01414153|9847102|FG001|NOT COMPLETED|Overall Study||2
8795699|NCT01414153|9847103|FG002|NOT COMPLETED|Overall Study||4
8795700|NCT01414153|9847104|FG003|NOT COMPLETED|Overall Study||4
8795701|NCT01414205|9847116|FG000|STARTED|Overall Study||41
8795702|NCT01414205|9847117|FG001|STARTED|Overall Study||39
8795703|NCT01414205|9847116|FG000|Received Study Drug|Overall Study||40
8795704|NCT01414205|9847117|FG001|Received Study Drug|Overall Study||38
8795705|NCT01414205|9847116|FG000|COMPLETED|Overall Study||34
8795706|NCT01414205|9847117|FG001|COMPLETED|Overall Study||32
8795707|NCT01414205|9847116|FG000|NOT COMPLETED|Overall Study||7
8795708|NCT01414205|9847117|FG001|NOT COMPLETED|Overall Study||7
8795709|NCT01414244|9847125|FG000|STARTED|Overall Study||54
8795710|NCT01414244|9847126|FG001|STARTED|Overall Study||52
8795711|NCT01414244|9847125|FG000|COMPLETED|Overall Study||54
8795712|NCT01414244|9847126|FG001|COMPLETED|Overall Study||52
8795713|NCT01414244|9847125|FG000|NOT COMPLETED|Overall Study||0
8795714|NCT01414244|9847126|FG001|NOT COMPLETED|Overall Study||0
8795715|NCT01414257|9847132|FG000|STARTED|Overall Study||2860
8795716|NCT01414257|9847132|FG000|COMPLETED|Overall Study||2838
8795717|NCT01414257|9847132|FG000|NOT COMPLETED|Overall Study||22
8795718|NCT01414413|9847138|FG000|STARTED|Overall Study|Adult population denominator for cluster randomised trial|8194
8795719|NCT01414413|9847139|FG001|STARTED|Overall Study|Adult population denominator for cluster randomised trial|8466
8795720|NCT01414413|9847138|FG000|COMPLETED|Overall Study|Adult population denominator for cluster randomised trial|8194
8795721|NCT01414413|9847139|FG001|COMPLETED|Overall Study|Adult population denominator for cluster randomised trial|8466
8795722|NCT01414413|9847138|FG000|NOT COMPLETED|Overall Study||0
8795723|NCT01414413|9847139|FG001|NOT COMPLETED|Overall Study||0
8795724|NCT01414426|9847147|FG000|STARTED|Overall Study||10
8795725|NCT01414426|9847148|FG001|STARTED|Overall Study||10
8795726|NCT01414426|9847147|FG000|COMPLETED|Overall Study||9
8795727|NCT01414426|9847148|FG001|COMPLETED|Overall Study||8
8795728|NCT01414426|9847147|FG000|NOT COMPLETED|Overall Study||1
8795729|NCT01414426|9847148|FG001|NOT COMPLETED|Overall Study||2
8795730|NCT01414634|9847154|FG000|STARTED|Overall Study||1
8795731|NCT01414634|9847155|FG001|STARTED|Overall Study||1
8795732|NCT01414634|9847156|FG002|STARTED|Overall Study||1
8795733|NCT01414634|9847157|FG003|STARTED|Overall Study||1
8795734|NCT01414634|9847158|FG004|STARTED|Overall Study||1
8795735|NCT01414634|9847159|FG005|STARTED|Overall Study||2
8795736|NCT01414634|9847160|FG006|STARTED|Overall Study||1
8795737|NCT01414634|9847161|FG007|STARTED|Overall Study||1
8795738|NCT01414634|9847154|FG000|COMPLETED|Overall Study||1
8795739|NCT01414634|9847155|FG001|COMPLETED|Overall Study||1
8795740|NCT01414634|9847156|FG002|COMPLETED|Overall Study||1
8795741|NCT01414634|9847157|FG003|COMPLETED|Overall Study||1
8795742|NCT01414634|9847158|FG004|COMPLETED|Overall Study||1
8795743|NCT01414634|9847159|FG005|COMPLETED|Overall Study||2
8795744|NCT01414634|9847160|FG006|COMPLETED|Overall Study||1
8795745|NCT01414634|9847161|FG007|COMPLETED|Overall Study||1
8795746|NCT01414634|9847154|FG000|NOT COMPLETED|Overall Study||0
8795747|NCT01414634|9847155|FG001|NOT COMPLETED|Overall Study||0
8795748|NCT01414634|9847156|FG002|NOT COMPLETED|Overall Study||0
8795749|NCT01414634|9847157|FG003|NOT COMPLETED|Overall Study||0
8795750|NCT01414634|9847158|FG004|NOT COMPLETED|Overall Study||0
8795751|NCT01414634|9847159|FG005|NOT COMPLETED|Overall Study||0
8795752|NCT01414634|9847160|FG006|NOT COMPLETED|Overall Study||0
8795753|NCT01414634|9847161|FG007|NOT COMPLETED|Overall Study||0
8795754|NCT01414738|9847172|FG000|STARTED|Overall Study||49
8795755|NCT01414738|9847172|FG000|Follow-up (3 Months)|Overall Study||18
8795756|NCT01414738|9847172|FG000|Follow-up (6 Months)|Overall Study||8
8795757|NCT01414738|9847172|FG000|Follow-up (9 Months)|Overall Study||5
8795758|NCT01414738|9847172|FG000|COMPLETED|Overall Study||5
8795759|NCT01414738|9847172|FG000|NOT COMPLETED|Overall Study||44
8795760|NCT01414855|9847176|FG000|STARTED|Overall Study||100
8795761|NCT01414855|9847176|FG000|COMPLETED|Overall Study||71
8795762|NCT01414855|9847176|FG000|NOT COMPLETED|Overall Study||29
8795763|NCT01415232|9847180|FG000|STARTED|Overall Study||160
8795764|NCT01415232|9847180|FG000|COMPLETED|Overall Study||160
8795765|NCT01415232|9847180|FG000|NOT COMPLETED|Overall Study||0
8795766|NCT01415349|9847184|FG000|STARTED|Treatment Period 1||21
8795767|NCT01415349|9847185|FG001|STARTED|Treatment Period 1||21
8795768|NCT01415349|9847184|FG000|COMPLETED|Treatment Period 1||21
8795769|NCT01415349|9847185|FG001|COMPLETED|Treatment Period 1||19
8795770|NCT01415349|9847184|FG000|NOT COMPLETED|Treatment Period 1||0
8795771|NCT01415349|9847185|FG001|NOT COMPLETED|Treatment Period 1||2
8795772|NCT01415349|9847184|FG000|STARTED|Treatment Period 2||21
8795773|NCT01415349|9847185|FG001|STARTED|Treatment Period 2||19
8795774|NCT01415349|9847184|FG000|COMPLETED|Treatment Period 2||21
8795775|NCT01415349|9847185|FG001|COMPLETED|Treatment Period 2||19
8795776|NCT01415349|9847184|FG000|NOT COMPLETED|Treatment Period 2||0
8795777|NCT01415349|9847185|FG001|NOT COMPLETED|Treatment Period 2||0
8795778|NCT01415401|9847191|FG000|STARTED|Overall Study||54
8795779|NCT01415401|9847191|FG000|COMPLETED|Overall Study||47
8795780|NCT01415401|9847191|FG000|NOT COMPLETED|Overall Study||7
8795781|NCT01415427|9847199|FG000|STARTED|Overall Study||29
8795782|NCT01415427|9847200|FG001|STARTED|Overall Study||29
8795783|NCT01415427|9847201|FG002|STARTED|Overall Study||59
8795784|NCT01415427|9847202|FG003|STARTED|Overall Study||56
8795785|NCT01415427|9847199|FG000|COMPLETED|Overall Study||0
8795786|NCT01415427|9847200|FG001|COMPLETED|Overall Study||0
8795787|NCT01415427|9847201|FG002|COMPLETED|Overall Study||1
8795788|NCT01415427|9847202|FG003|COMPLETED|Overall Study||0
8795789|NCT01415427|9847199|FG000|NOT COMPLETED|Overall Study||29
8795790|NCT01415427|9847200|FG001|NOT COMPLETED|Overall Study||29
8795791|NCT01415427|9847201|FG002|NOT COMPLETED|Overall Study||58
8795792|NCT01415427|9847202|FG003|NOT COMPLETED|Overall Study||56
8795793|NCT01415440|9847217|FG000|STARTED|Overall Study||41
8795794|NCT01415440|9847218|FG001|STARTED|Overall Study||29
8795795|NCT01415440|9847219|FG002|STARTED|Overall Study||29
8795796|NCT01415440|9847217|FG000|COMPLETED|Overall Study||37
8795797|NCT01415440|9847218|FG001|COMPLETED|Overall Study||28
8795798|NCT01415440|9847219|FG002|COMPLETED|Overall Study||27
8795799|NCT01415440|9847217|FG000|NOT COMPLETED|Overall Study||4
8795800|NCT01415440|9847218|FG001|NOT COMPLETED|Overall Study||1
8795801|NCT01415440|9847219|FG002|NOT COMPLETED|Overall Study||2
8795802|NCT01415453|9847226|FG000|STARTED|Overall Study||1
8795803|NCT01415453|9847226|FG000|Imaging Study|Overall Study||1
8795804|NCT01415453|9847226|FG000|COMPLETED|Overall Study||1
8795805|NCT01415453|9847226|FG000|NOT COMPLETED|Overall Study||0
8795806|NCT01415518|9847232|FG000|STARTED|Overall Study||292
8795807|NCT01415518|9847233|FG001|STARTED|Overall Study||292
8795808|NCT01415518|9847232|FG000|Patients Who Received Study Treatment|Overall Study||290
8795809|NCT01415518|9847233|FG001|Patients Who Received Study Treatment|Overall Study||292
8795810|NCT01415518|9847232|FG000|Pts With Correct Randomized Treatment|Overall Study|Efficacy analysis used 290 patients. Safety analysis used 290+3=293 patients.|290
8795811|NCT01415518|9847233|FG001|Pts With Correct Randomized Treatment|Overall Study|Efficacy analysis used 292 patients. Safety analysis used 292-3=289 patients.|289
8795812|NCT01415518|9847232|FG000|COMPLETED|Overall Study||276
8795813|NCT01415518|9847233|FG001|COMPLETED|Overall Study||261
8795814|NCT01415518|9847232|FG000|NOT COMPLETED|Overall Study||16
8795815|NCT01415518|9847233|FG001|NOT COMPLETED|Overall Study||31
8795816|NCT01415531|9847241|FG000|STARTED|Overall Study||214
8795817|NCT01415531|9847242|FG001|STARTED|Overall Study||427
8795818|NCT01415531|9847241|FG000|COMPLETED|Overall Study||189
8795819|NCT01415531|9847242|FG001|COMPLETED|Overall Study||390
8795820|NCT01415531|9847241|FG000|NOT COMPLETED|Overall Study||25
8795821|NCT01415531|9847242|FG001|NOT COMPLETED|Overall Study||37
8795822|NCT01415583|9847250|FG000|STARTED|Overall Study||157
8795823|NCT01415583|9847251|FG001|STARTED|Overall Study||157
8795824|NCT01415583|9847250|FG000|COMPLETED|Overall Study||157
8795825|NCT01415583|9847251|FG001|COMPLETED|Overall Study||157
8795826|NCT01415583|9847250|FG000|NOT COMPLETED|Overall Study||0
8795827|NCT01415583|9847251|FG001|NOT COMPLETED|Overall Study||0
8795828|NCT01415908|9847259|FG000|STARTED|Overall Study||11
8795829|NCT01415908|9847260|FG001|STARTED|Overall Study||4
8795830|NCT01415908|9847259|FG000|COMPLETED|Overall Study||10
8795831|NCT01415908|9847260|FG001|COMPLETED|Overall Study||4
8795832|NCT01415908|9847259|FG000|NOT COMPLETED|Overall Study||1
8795833|NCT01415908|9847260|FG001|NOT COMPLETED|Overall Study||0
8795834|NCT01415921|9847268|FG000|STARTED|Overall Study||16
8795835|NCT01415921|9847269|FG001|STARTED|Overall Study||17
8795836|NCT01415921|9847268|FG000|COMPLETED|Overall Study||13
8795837|NCT01415921|9847269|FG001|COMPLETED|Overall Study||14
8795838|NCT01415921|9847268|FG000|NOT COMPLETED|Overall Study||3
8795839|NCT01415921|9847269|FG001|NOT COMPLETED|Overall Study||3
8795840|NCT01415934|9847277|FG000|STARTED|Overall Study||192
8795841|NCT01415934|9847278|FG001|STARTED|Overall Study||189
8795842|NCT01415934|9847277|FG000|COMPLETED|Overall Study||189
8795843|NCT01415934|9847278|FG001|COMPLETED|Overall Study||182
8795844|NCT01415934|9847277|FG000|NOT COMPLETED|Overall Study||3
8795845|NCT01415934|9847278|FG001|NOT COMPLETED|Overall Study||7
8795846|NCT01415960|9847284|FG000|STARTED|Overall Study||163
8795847|NCT01415960|9847284|FG000|ITT|Overall Study||161
8795848|NCT01415960|9847284|FG000|PK Subgroup|Overall Study||30
8795849|NCT01415960|9847284|FG000|COMPLETED|Overall Study|Patients completed Study (151) Per protocol Patients (146)|151
8795850|NCT01415960|9847284|FG000|NOT COMPLETED|Overall Study||12
8795851|NCT01416025|9847290|FG000|STARTED|Overall Study||14
8795852|NCT01416025|9847291|FG001|STARTED|Overall Study||15
8795853|NCT01416025|9847290|FG000|COMPLETED|Overall Study||14
8795854|NCT01416025|9847291|FG001|COMPLETED|Overall Study||15
8795855|NCT01416025|9847290|FG000|NOT COMPLETED|Overall Study||0
8795856|NCT01416025|9847291|FG001|NOT COMPLETED|Overall Study||0
8795857|NCT01416129|9847299|FG000|STARTED|Control Condition: Ischial Containment||5
8795858|NCT01416129|9847300|FG001|STARTED|Control Condition: Ischial Containment||5
8795859|NCT01416129|9847299|FG000|COMPLETED|Control Condition: Ischial Containment||5
8795860|NCT01416129|9847300|FG001|COMPLETED|Control Condition: Ischial Containment||5
8795861|NCT01416129|9847299|FG000|NOT COMPLETED|Control Condition: Ischial Containment||0
8795862|NCT01416129|9847300|FG001|NOT COMPLETED|Control Condition: Ischial Containment||0
8795863|NCT01416129|9847299|FG000|STARTED|Experimental Condition: Brimless||5
8795864|NCT01416129|9847300|FG001|STARTED|Experimental Condition: Brimless||5
8795865|NCT01416129|9847299|FG000|COMPLETED|Experimental Condition: Brimless||5
8795866|NCT01416129|9847300|FG001|COMPLETED|Experimental Condition: Brimless||5
8795867|NCT01416129|9847299|FG000|NOT COMPLETED|Experimental Condition: Brimless||0
8795868|NCT01416129|9847300|FG001|NOT COMPLETED|Experimental Condition: Brimless||0
8795869|NCT01416142|9847306|FG000|STARTED|Cross Over at Movie Intermission||32
8795870|NCT01416142|9847307|FG001|STARTED|Cross Over at Movie Intermission||31
8795871|NCT01416142|9847308|FG002|STARTED|Cross Over at Movie Intermission||0
8795872|NCT01416142|9847306|FG000|COMPLETED|Cross Over at Movie Intermission||32
8795873|NCT01416142|9847307|FG001|COMPLETED|Cross Over at Movie Intermission||31
8795874|NCT01416142|9847308|FG002|COMPLETED|Cross Over at Movie Intermission||0
8795875|NCT01416142|9847306|FG000|NOT COMPLETED|Cross Over at Movie Intermission||0
8795876|NCT01416142|9847307|FG001|NOT COMPLETED|Cross Over at Movie Intermission||0
8795877|NCT01416142|9847308|FG002|NOT COMPLETED|Cross Over at Movie Intermission||0
8795878|NCT01416142|9847306|FG000|STARTED|PureVision2 HD||0
8795879|NCT01416142|9847307|FG001|STARTED|PureVision2 HD||0
8795880|NCT01416142|9847308|FG002|STARTED|PureVision2 HD||63
8795881|NCT01416142|9847306|FG000|COMPLETED|PureVision2 HD||0
8795882|NCT01416142|9847307|FG001|COMPLETED|PureVision2 HD||0
8795883|NCT01416142|9847308|FG002|COMPLETED|PureVision2 HD||62
8795884|NCT01416142|9847306|FG000|NOT COMPLETED|PureVision2 HD||0
8795885|NCT01416142|9847307|FG001|NOT COMPLETED|PureVision2 HD||0
8795886|NCT01416142|9847308|FG002|NOT COMPLETED|PureVision2 HD||1
8795887|NCT01416155|9847316|FG000|STARTED|Overall Study||97
8795888|NCT01416155|9847316|FG000|COMPLETED|Overall Study||39
8795889|NCT01416155|9847316|FG000|NOT COMPLETED|Overall Study||58
8795890|NCT01416181|9847322|FG000|STARTED|Part 1||449
8795891|NCT01416181|9847323|FG001|STARTED|Part 1||440
8795892|NCT01416181|9847322|FG000|Withdrew Prior to Dosing|Part 1||0
8795893|NCT01416181|9847323|FG001|Withdrew Prior to Dosing|Part 1||1
8795894|NCT01416181|9847322|FG000|COMPLETED|Part 1|Completed Study through Week 108|312
8795895|NCT01416181|9847323|FG001|COMPLETED|Part 1|Completed Study through Week 108|326
8795896|NCT01416181|9847322|FG000|NOT COMPLETED|Part 1||137
8795897|NCT01416181|9847323|FG001|NOT COMPLETED|Part 1||114
8795898|NCT01416181|9847322|FG000|STARTED|Part 2||274
8795899|NCT01416181|9847323|FG001|STARTED|Part 2||292
8795900|NCT01416181|9847322|FG000|Completed Treatment for 48 Weeks|Part 2|completed study treatment for 48 weeks in Part 2|98
8795901|NCT01416181|9847323|FG001|Completed Treatment for 48 Weeks|Part 2|completed study treatment for 48 weeks in Part 2|111
8795902|NCT01416181|9847322|FG000|Completed Treatment for 96 Weeks|Part 2|completed study treatment for 96 weeks in Part 2|1
8795903|NCT01416181|9847323|FG001|Completed Treatment for 96 Weeks|Part 2|completed study treatment for 96 weeks in Part 2|0
8795904|NCT01416181|9847322|FG000|Completed Treatment for > 96 Weeks|Part 2||1
8795905|NCT01416181|9847323|FG001|Completed Treatment for > 96 Weeks|Part 2||0
8795906|NCT01416181|9847322|FG000|COMPLETED|Part 2||3
8795907|NCT01416181|9847323|FG001|COMPLETED|Part 2||6
8795908|NCT01416181|9847322|FG000|NOT COMPLETED|Part 2||271
8795909|NCT01416181|9847323|FG001|NOT COMPLETED|Part 2||286
8795910|NCT01416194|9847332|FG000|STARTED|Overall Study||1111
8795911|NCT01416194|9847333|FG001|STARTED|Overall Study||2720
8795912|NCT01416194|9847334|FG002|STARTED|Overall Study||6666
8795913|NCT01416194|9847332|FG000|COMPLETED|Overall Study||1111
8795914|NCT01416194|9847333|FG001|COMPLETED|Overall Study||2720
8795915|NCT01416194|9847334|FG002|COMPLETED|Overall Study||6666
8795916|NCT01416194|9847332|FG000|NOT COMPLETED|Overall Study||0
8795917|NCT01416194|9847333|FG001|NOT COMPLETED|Overall Study||0
8795918|NCT01416194|9847334|FG002|NOT COMPLETED|Overall Study||0
8795919|NCT01416389|9847346|FG000|STARTED|Overall Study||26
8795920|NCT01416389|9847347|FG001|STARTED|Overall Study||13
8795921|NCT01416389|9847346|FG000|Received at Least 1 Dose of Study Drug|Overall Study||26
8795922|NCT01416389|9847347|FG001|Received at Least 1 Dose of Study Drug|Overall Study||13
8795923|NCT01416389|9847346|FG000|COMPLETED|Overall Study||23
8795924|NCT01416389|9847347|FG001|COMPLETED|Overall Study||13
8795925|NCT01416389|9847346|FG000|NOT COMPLETED|Overall Study||3
8795926|NCT01416389|9847347|FG001|NOT COMPLETED|Overall Study||0
8795927|NCT01416441|9847355|FG000|STARTED|Overall Study||170
8795928|NCT01416441|9847355|FG000|COMPLETED|Overall Study||89
8795929|NCT01416441|9847355|FG000|NOT COMPLETED|Overall Study||81
8795930|NCT01416571|9847359|FG000|STARTED|Overall Study||78
8795931|NCT01416571|9847359|FG000|COMPLETED|Overall Study|Number of subjects completed at Day 385.|76
8795932|NCT01416571|9847359|FG000|NOT COMPLETED|Overall Study||2
8795933|NCT01416584|9847366|FG000|STARTED|Overall Study||30
8795934|NCT01416584|9847367|FG001|STARTED|Overall Study||35
8795935|NCT01416584|9847368|FG002|STARTED|Overall Study||33
8795936|NCT01416584|9847366|FG000|COMPLETED|Overall Study||27
9033227|NCT03270514|10095331|FG000|COMPLETED|Overall Study||29
9033228|NCT03270514|10095332|FG001|COMPLETED|Overall Study||31
8672140|NCT00755807|9715625|FG001|COMPLETED|Acute Phase||109
8795937|NCT01416584|9847367|FG001|COMPLETED|Overall Study||33
8795938|NCT01416584|9847368|FG002|COMPLETED|Overall Study||32
8795939|NCT01416584|9847366|FG000|NOT COMPLETED|Overall Study||3
8795940|NCT01416584|9847367|FG001|NOT COMPLETED|Overall Study||2
8795941|NCT01416584|9847368|FG002|NOT COMPLETED|Overall Study||1
8795942|NCT01416610|9847382|FG000|STARTED|Overall Study||88
8795943|NCT01416610|9847382|FG000|Intention to Treat|Overall Study||88
8795944|NCT01416610|9847382|FG000|Safety Population|Overall Study||86
8795945|NCT01416610|9847382|FG000|Per Protocol|Overall Study||83
8795946|NCT01416610|9847382|FG000|Completed Treatment|Overall Study||47
8795947|NCT01416610|9847382|FG000|Completed Follow-up|Overall Study||45
8795948|NCT01416610|9847382|FG000|COMPLETED|Overall Study||45
8672141|NCT00755807|9715624|FG000|NOT COMPLETED|Acute Phase||18
8795949|NCT01416610|9847382|FG000|NOT COMPLETED|Overall Study||43
8795950|NCT01416636|9847392|FG000|STARTED|Overall Study||53
8795951|NCT01416636|9847393|FG001|STARTED|Overall Study||52
8795952|NCT01416636|9847392|FG000|COMPLETED|Overall Study||45
8795953|NCT01416636|9847393|FG001|COMPLETED|Overall Study||46
8795954|NCT01416636|9847392|FG000|NOT COMPLETED|Overall Study||8
8795955|NCT01416636|9847393|FG001|NOT COMPLETED|Overall Study||6
8795956|NCT01416805|9847401|FG000|STARTED|Overall Study||49
8795957|NCT01416805|9847402|FG001|STARTED|Overall Study||51
8795958|NCT01416805|9847401|FG000|COMPLETED|Overall Study||45
8795959|NCT01416805|9847402|FG001|COMPLETED|Overall Study||47
8795960|NCT01416805|9847401|FG000|NOT COMPLETED|Overall Study||4
8795961|NCT01416805|9847402|FG001|NOT COMPLETED|Overall Study||4
8795962|NCT01416987|9847408|FG000|STARTED|Overall Study||600
8795963|NCT01416987|9847408|FG000|COMPLETED|Overall Study||600
8795964|NCT01416987|9847408|FG000|NOT COMPLETED|Overall Study||0
8795965|NCT01417000|9847414|FG000|STARTED|Overall Study|62 subjects randomized into Cy/GVAX + CRS-207 arm; 61 subjects received ≥ 1 protocol-specified drug.|61
8795966|NCT01417000|9847415|FG001|STARTED|Overall Study|31 subjects randomized into Cy/GVAX arm; 29 subjects received ≥ 1 protocol-specified drug.|29
8795967|NCT01417000|9847414|FG000|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/death/study close, so no subjects completed study."|0
8795968|NCT01417000|9847415|FG001|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/death/study close, so no subjects completed study."|0
8795969|NCT01417000|9847414|FG000|NOT COMPLETED|Overall Study||61
8795970|NCT01417000|9847415|FG001|NOT COMPLETED|Overall Study||29
8795971|NCT01417026|9847423|FG000|STARTED|Overall Study||16
8795972|NCT01417026|9847424|FG001|STARTED|Overall Study||13
8795973|NCT01417026|9847423|FG000|COMPLETED|Overall Study||14
8795974|NCT01417026|9847424|FG001|COMPLETED|Overall Study||13
8795975|NCT01417026|9847423|FG000|NOT COMPLETED|Overall Study||2
8795976|NCT01417026|9847424|FG001|NOT COMPLETED|Overall Study||0
8795977|NCT01417078|9847430|FG000|STARTED|Overall Study||31
8795978|NCT01417078|9847430|FG000|COMPLETED|Overall Study||30
8795979|NCT01417078|9847430|FG000|NOT COMPLETED|Overall Study||1
8795980|NCT01417104|9847438|FG000|STARTED|Overall Study||34
8795981|NCT01417104|9847439|FG001|STARTED|Overall Study||37
8795982|NCT01417104|9847438|FG000|COMPLETED|Overall Study||28
8795983|NCT01417104|9847439|FG001|COMPLETED|Overall Study||35
8795984|NCT01417104|9847438|FG000|NOT COMPLETED|Overall Study||6
9033229|NCT03270514|10095331|FG000|NOT COMPLETED|Overall Study||0
9033230|NCT03270514|10095332|FG001|NOT COMPLETED|Overall Study||0
9033231|NCT03270644|10095338|FG000|STARTED|Day 1 Lasmiditan Reference||44
9033232|NCT03270644|10095338|FG000|Received at Least One Dose of Study Drug|Day 1 Lasmiditan Reference||44
9033233|NCT03270644|10095338|FG000|COMPLETED|Day 1 Lasmiditan Reference||43
9033234|NCT03270644|10095338|FG000|NOT COMPLETED|Day 1 Lasmiditan Reference||1
9033235|NCT03270644|10095338|FG000|STARTED|Day 4 - 10 Propranolol Reference||43
9033236|NCT03270644|10095338|FG000|Received at Least One Dose of Study Drug|Day 4 - 10 Propranolol Reference||43
9033237|NCT03270644|10095338|FG000|Day 9 Lasmiditan + Propranolol Test|Day 4 - 10 Propranolol Reference||42
8795985|NCT01417104|9847439|FG001|NOT COMPLETED|Overall Study||2
8795986|NCT01417156|9847445|FG000|STARTED|Overall Study||20
8795987|NCT01417156|9847445|FG000|COMPLETED|Overall Study||6
8795988|NCT01417156|9847445|FG000|NOT COMPLETED|Overall Study||14
8795989|NCT01417195|9847451|FG000|STARTED|Overall Study||60
8795990|NCT01417195|9847452|FG001|STARTED|Overall Study||62
8795991|NCT01417195|9847451|FG000|COMPLETED|Overall Study||57
8795992|NCT01417195|9847452|FG001|COMPLETED|Overall Study||61
8795993|NCT01417195|9847451|FG000|NOT COMPLETED|Overall Study||3
8795994|NCT01417195|9847452|FG001|NOT COMPLETED|Overall Study||1
8795995|NCT01417234|9847459|FG000|STARTED|Overall Study||30
9033238|NCT03270644|10095338|FG000|COMPLETED|Day 4 - 10 Propranolol Reference||42
9033239|NCT03270644|10095338|FG000|NOT COMPLETED|Day 4 - 10 Propranolol Reference||1
9033240|NCT03270657|10095349|FG000|STARTED|Overall Study||5
8795996|NCT01417234|9847459|FG000|COMPLETED|Overall Study||27
8795997|NCT01417234|9847459|FG000|NOT COMPLETED|Overall Study||3
8795998|NCT01417455|9847471|FG000|STARTED|Overall Study||16
8795999|NCT01417455|9847472|FG001|STARTED|Overall Study||16
8796000|NCT01417455|9847473|FG002|STARTED|Overall Study||17
8796001|NCT01417455|9847474|FG003|STARTED|Overall Study||17
8796002|NCT01417455|9847475|FG004|STARTED|Overall Study||30
8796003|NCT01417455|9847476|FG005|STARTED|Overall Study||13
8796004|NCT01417455|9847477|FG006|STARTED|Overall Study||13
8796005|NCT01417455|9847478|FG007|STARTED|Overall Study||25
8796006|NCT01417455|9847471|FG000|COMPLETED|Overall Study||16
8796007|NCT01417455|9847472|FG001|COMPLETED|Overall Study||16
8796008|NCT01417455|9847473|FG002|COMPLETED|Overall Study||17
8796009|NCT01417455|9847474|FG003|COMPLETED|Overall Study||17
8796010|NCT01417455|9847475|FG004|COMPLETED|Overall Study||30
8796011|NCT01417455|9847476|FG005|COMPLETED|Overall Study||13
8796012|NCT01417455|9847477|FG006|COMPLETED|Overall Study||13
8796013|NCT01417455|9847478|FG007|COMPLETED|Overall Study||25
8796014|NCT01417455|9847471|FG000|NOT COMPLETED|Overall Study||0
8796015|NCT01417455|9847472|FG001|NOT COMPLETED|Overall Study||0
8796016|NCT01417455|9847473|FG002|NOT COMPLETED|Overall Study||0
8796017|NCT01417455|9847474|FG003|NOT COMPLETED|Overall Study||0
8796018|NCT01417455|9847475|FG004|NOT COMPLETED|Overall Study||0
8796019|NCT01417455|9847476|FG005|NOT COMPLETED|Overall Study||0
8796020|NCT01417455|9847477|FG006|NOT COMPLETED|Overall Study||0
8796021|NCT01417455|9847478|FG007|NOT COMPLETED|Overall Study||0
8796022|NCT01417481|9847498|FG000|STARTED|First Intervention (8 Weeks)||8
8796023|NCT01417481|9847499|FG001|STARTED|First Intervention (8 Weeks)||7
8796024|NCT01417481|9847498|FG000|COMPLETED|First Intervention (8 Weeks)||8
8796025|NCT01417481|9847499|FG001|COMPLETED|First Intervention (8 Weeks)||5
8796026|NCT01417481|9847498|FG000|NOT COMPLETED|First Intervention (8 Weeks)||0
8796027|NCT01417481|9847499|FG001|NOT COMPLETED|First Intervention (8 Weeks)||2
8796028|NCT01417481|9847498|FG000|STARTED|Washout (2 Weeks)||8
9033241|NCT03270657|10095349|FG000|COMPLETED|Overall Study||4
9033242|NCT03270657|10095349|FG000|NOT COMPLETED|Overall Study||1
9033243|NCT03270943|10095355|FG000|STARTED|Intervention Refinement||6
9033244|NCT03270943|10095356|FG001|STARTED|Intervention Refinement||9
9033245|NCT03270943|10095355|FG000|COMPLETED|Intervention Refinement||6
9033246|NCT03270943|10095356|FG001|COMPLETED|Intervention Refinement||6
9033247|NCT03270943|10095355|FG000|NOT COMPLETED|Intervention Refinement||0
8796029|NCT01417481|9847499|FG001|STARTED|Washout (2 Weeks)||5
8796030|NCT01417481|9847498|FG000|COMPLETED|Washout (2 Weeks)||8
8796031|NCT01417481|9847499|FG001|COMPLETED|Washout (2 Weeks)||5
8796032|NCT01417481|9847498|FG000|NOT COMPLETED|Washout (2 Weeks)||0
8796033|NCT01417481|9847499|FG001|NOT COMPLETED|Washout (2 Weeks)||0
8796034|NCT01417481|9847498|FG000|STARTED|Second Period (8 Weeks)||8
8796035|NCT01417481|9847499|FG001|STARTED|Second Period (8 Weeks)||5
8796036|NCT01417481|9847498|FG000|COMPLETED|Second Period (8 Weeks)||8
8796037|NCT01417481|9847499|FG001|COMPLETED|Second Period (8 Weeks)||5
8796038|NCT01417481|9847498|FG000|NOT COMPLETED|Second Period (8 Weeks)||0
8796039|NCT01417481|9847499|FG001|NOT COMPLETED|Second Period (8 Weeks)||0
8796040|NCT01417741|9847507|FG000|STARTED|Overall Study||75
8796041|NCT01417741|9847508|FG001|STARTED|Overall Study||86
8796042|NCT01417741|9847507|FG000|COMPLETED|Overall Study||75
8796043|NCT01417741|9847508|FG001|COMPLETED|Overall Study|only 73 received the post op day phone phone call|86
8796044|NCT01417741|9847507|FG000|NOT COMPLETED|Overall Study||0
8796045|NCT01417741|9847508|FG001|NOT COMPLETED|Overall Study||0
8796046|NCT01417780|9847517|FG000|STARTED|Overall Study||15
8796047|NCT01417780|9847518|FG001|STARTED|Overall Study||17
8796048|NCT01417780|9847519|FG002|STARTED|Overall Study||11
8796049|NCT01417780|9847517|FG000|COMPLETED|Overall Study||14
8796050|NCT01417780|9847518|FG001|COMPLETED|Overall Study||14
8796051|NCT01417780|9847519|FG002|COMPLETED|Overall Study||9
8796052|NCT01417780|9847517|FG000|NOT COMPLETED|Overall Study||1
8796053|NCT01417780|9847518|FG001|NOT COMPLETED|Overall Study||3
8796054|NCT01417780|9847519|FG002|NOT COMPLETED|Overall Study||2
8796055|NCT01417936|9847527|FG000|STARTED|Overall Study||26
8796056|NCT01417936|9847527|FG000|COMPLETED|Overall Study||26
8796057|NCT01417936|9847527|FG000|NOT COMPLETED|Overall Study||0
8796058|NCT01418001|9847531|FG000|STARTED|Overall Study||5
8796059|NCT01418001|9847531|FG000|COMPLETED|Overall Study||5
8796060|NCT01418001|9847531|FG000|NOT COMPLETED|Overall Study||0
8796061|NCT01418209|9847539|FG000|STARTED|Overall Study||97
8796062|NCT01418209|9847540|FG001|STARTED|Overall Study||96
8796063|NCT01418209|9847541|FG002|STARTED|Overall Study||146
8796064|NCT01418209|9847539|FG000|COMPLETED|Overall Study||95
8796065|NCT01418209|9847540|FG001|COMPLETED|Overall Study||93
8796066|NCT01418209|9847541|FG002|COMPLETED|Overall Study||142
8796067|NCT01418209|9847539|FG000|NOT COMPLETED|Overall Study||2
8796068|NCT01418209|9847540|FG001|NOT COMPLETED|Overall Study||3
8796069|NCT01418209|9847541|FG002|NOT COMPLETED|Overall Study||4
8796070|NCT01418339|9847551|FG000|STARTED|Overall Study||90
8796071|NCT01418339|9847552|FG001|STARTED|Overall Study||45
8796072|NCT01418339|9847551|FG000|COMPLETED|Overall Study||78
8796073|NCT01418339|9847552|FG001|COMPLETED|Overall Study||35
8796074|NCT01418339|9847551|FG000|NOT COMPLETED|Overall Study||12
8796075|NCT01418339|9847552|FG001|NOT COMPLETED|Overall Study||10
8796076|NCT01418352|9847562|FG000|STARTED|Overall Study||20
8796077|NCT01418352|9847563|FG001|STARTED|Overall Study||21
8796078|NCT01418352|9847564|FG002|STARTED|Overall Study||21
8796079|NCT01418352|9847565|FG003|STARTED|Overall Study||21
8796080|NCT01418352|9847562|FG000|COMPLETED|Overall Study||17
8796081|NCT01418352|9847563|FG001|COMPLETED|Overall Study||17
8796082|NCT01418352|9847564|FG002|COMPLETED|Overall Study||16
8796083|NCT01418352|9847565|FG003|COMPLETED|Overall Study||18
8796084|NCT01418352|9847562|FG000|NOT COMPLETED|Overall Study||3
8796085|NCT01418352|9847563|FG001|NOT COMPLETED|Overall Study||4
8796086|NCT01418352|9847564|FG002|NOT COMPLETED|Overall Study||5
8796087|NCT01418352|9847565|FG003|NOT COMPLETED|Overall Study||3
8796088|NCT01418365|9847577|FG000|STARTED|First Intervention||15
8796089|NCT01418365|9847578|FG001|STARTED|First Intervention||15
8796090|NCT01418365|9847577|FG000|COMPLETED|First Intervention||14
8796091|NCT01418365|9847578|FG001|COMPLETED|First Intervention||14
8796092|NCT01418365|9847577|FG000|NOT COMPLETED|First Intervention||1
8796093|NCT01418365|9847578|FG001|NOT COMPLETED|First Intervention||1
8796094|NCT01418365|9847577|FG000|STARTED|Second Intervention||14
8796095|NCT01418365|9847578|FG001|STARTED|Second Intervention||14
8796096|NCT01418365|9847577|FG000|COMPLETED|Second Intervention||14
8796097|NCT01418365|9847578|FG001|COMPLETED|Second Intervention||13
8917618|NCT02194465|9977395|FG000|STARTED|Overall Study||51
8917619|NCT02194465|9977396|FG001|STARTED|Overall Study||50
8917620|NCT02194465|9977397|FG002|STARTED|Overall Study||52
8917621|NCT02194465|9977398|FG003|STARTED|Overall Study||49
8917622|NCT02194465|9977399|FG004|STARTED|Overall Study||51
8917623|NCT02194465|9977400|FG005|STARTED|Overall Study||25
8917624|NCT02194465|9977401|FG006|STARTED|Overall Study||26
8917625|NCT02194465|9977395|FG000|Received at Least 1 Dose of Study Drug|Overall Study||51
8917626|NCT02194465|9977396|FG001|Received at Least 1 Dose of Study Drug|Overall Study||50
8917627|NCT02194465|9977397|FG002|Received at Least 1 Dose of Study Drug|Overall Study||51
8917628|NCT02194465|9977398|FG003|Received at Least 1 Dose of Study Drug|Overall Study||49
8917629|NCT02194465|9977399|FG004|Received at Least 1 Dose of Study Drug|Overall Study||51
8917630|NCT02194465|9977400|FG005|Received at Least 1 Dose of Study Drug|Overall Study||25
8917631|NCT02194465|9977401|FG006|Received at Least 1 Dose of Study Drug|Overall Study||26
8917632|NCT02194465|9977395|FG000|COMPLETED|Overall Study||42
8917633|NCT02194465|9977396|FG001|COMPLETED|Overall Study||43
8796098|NCT01418365|9847577|FG000|NOT COMPLETED|Second Intervention||0
8796099|NCT01418365|9847578|FG001|NOT COMPLETED|Second Intervention||1
8796100|NCT01418378|9847586|FG000|STARTED|Overall Study|A total of 191 subjects were enrolled into the study. 13/191 did not receive a study implant|90
8796101|NCT01418378|9847587|FG001|STARTED|Overall Study|A total of 191 subjects were enrolled into the study. 13/191 did not receive a study implant|88
8796102|NCT01418378|9847586|FG000|Subjects Who Received Study Implant|Overall Study|the number of subjects implanted with study implant|90
8796103|NCT01418378|9847587|FG001|Subjects Who Received Study Implant|Overall Study|the number of subjects implanted with study implant|88
8796104|NCT01418378|9847586|FG000|COMPLETED|Overall Study||89
8796105|NCT01418378|9847587|FG001|COMPLETED|Overall Study||83
8796106|NCT01418378|9847586|FG000|NOT COMPLETED|Overall Study||1
8796107|NCT01418378|9847587|FG001|NOT COMPLETED|Overall Study||5
8796108|NCT01418482|9847593|FG000|STARTED|Overall Study||15
8796109|NCT01418482|9847593|FG000|COMPLETED|Overall Study||15
8796110|NCT01418482|9847593|FG000|NOT COMPLETED|Overall Study||0
8796111|NCT01418703|9847599|FG000|STARTED|Overall Study||13
8796112|NCT01418703|9847600|FG001|STARTED|Overall Study||13
8796113|NCT01418703|9847601|FG002|STARTED|Overall Study||6
8796114|NCT01418703|9847602|FG003|STARTED|Overall Study||6
8796115|NCT01418703|9847599|FG000|COMPLETED|Overall Study||13
8796116|NCT01418703|9847600|FG001|COMPLETED|Overall Study||13
8796117|NCT01418703|9847601|FG002|COMPLETED|Overall Study||6
8796118|NCT01418703|9847602|FG003|COMPLETED|Overall Study||6
8796119|NCT01418703|9847599|FG000|NOT COMPLETED|Overall Study||0
8796120|NCT01418703|9847600|FG001|NOT COMPLETED|Overall Study||0
8796121|NCT01418703|9847601|FG002|NOT COMPLETED|Overall Study||0
8796122|NCT01418703|9847602|FG003|NOT COMPLETED|Overall Study||0
8796123|NCT01418937|9847609|FG000|STARTED|Overall Study||164
8796124|NCT01418937|9847609|FG000|COMPLETED|Overall Study||156
8796125|NCT01418937|9847609|FG000|NOT COMPLETED|Overall Study||8
8796126|NCT01419015|9847613|FG000|STARTED|Overall Study||17
8796127|NCT01419015|9847613|FG000|COMPLETED|Overall Study||15
8796128|NCT01419015|9847613|FG000|NOT COMPLETED|Overall Study||2
8796129|NCT01419028|9847617|FG000|STARTED|Overall Study||48
8796130|NCT01419028|9847617|FG000|COMPLETED|Overall Study||48
8796131|NCT01419028|9847617|FG000|NOT COMPLETED|Overall Study||0
8917634|NCT02194465|9977397|FG002|COMPLETED|Overall Study||44
8917635|NCT02194465|9977398|FG003|COMPLETED|Overall Study||41
8917636|NCT02194465|9977399|FG004|COMPLETED|Overall Study||42
8917637|NCT02194465|9977400|FG005|COMPLETED|Overall Study||21
8917638|NCT02194465|9977401|FG006|COMPLETED|Overall Study||24
8917639|NCT02194465|9977395|FG000|NOT COMPLETED|Overall Study||9
8917640|NCT02194465|9977396|FG001|NOT COMPLETED|Overall Study||7
8917641|NCT02194465|9977397|FG002|NOT COMPLETED|Overall Study||8
8917642|NCT02194465|9977398|FG003|NOT COMPLETED|Overall Study||8
8917643|NCT02194465|9977399|FG004|NOT COMPLETED|Overall Study||9
8917644|NCT02194465|9977400|FG005|NOT COMPLETED|Overall Study||4
8917645|NCT02194465|9977401|FG006|NOT COMPLETED|Overall Study||2
8917646|NCT02194621|9977424|FG000|STARTED|Overall Study||43
8917647|NCT02194621|9977425|FG001|STARTED|Overall Study||42
8917648|NCT02194621|9977426|FG002|STARTED|Overall Study||43
8917649|NCT02194621|9977424|FG000|COMPLETED|Overall Study||37
8917650|NCT02194621|9977425|FG001|COMPLETED|Overall Study||36
8917651|NCT02194621|9977426|FG002|COMPLETED|Overall Study||34
8917652|NCT02194621|9977424|FG000|NOT COMPLETED|Overall Study||6
8917653|NCT02194621|9977425|FG001|NOT COMPLETED|Overall Study||6
8917654|NCT02194621|9977426|FG002|NOT COMPLETED|Overall Study||9
8917655|NCT02194699|9977436|FG000|STARTED|Randomised||428
8917656|NCT02194699|9977437|FG001|STARTED|Randomised||428
8917657|NCT02194699|9977436|FG000|COMPLETED|Randomised||420
9033248|NCT03270943|10095356|FG001|NOT COMPLETED|Intervention Refinement||3
9033249|NCT03270943|10095355|FG000|STARTED|Randomized (Willingness to be)||30
9033250|NCT03270943|10095356|FG001|STARTED|Randomized (Willingness to be)||32
9033251|NCT03270943|10095355|FG000|COMPLETED|Randomized (Willingness to be)||30
9033252|NCT03270943|10095356|FG001|COMPLETED|Randomized (Willingness to be)||31
9033253|NCT03270943|10095355|FG000|NOT COMPLETED|Randomized (Willingness to be)||0
9033254|NCT03270943|10095356|FG001|NOT COMPLETED|Randomized (Willingness to be)||1
9033255|NCT03271307|10095367|FG000|STARTED|Overall Study||1951
9033256|NCT03271307|10095368|FG001|STARTED|Overall Study||1837
9033257|NCT03271307|10095369|FG002|STARTED|Overall Study||2097
9033258|NCT03271307|10095370|FG003|STARTED|Overall Study||135
9033259|NCT03271307|10095371|FG004|STARTED|Overall Study||349
9033260|NCT03271307|10095367|FG000|COMPLETED|Overall Study||1951
9033261|NCT03271307|10095368|FG001|COMPLETED|Overall Study||1837
9033262|NCT03271307|10095369|FG002|COMPLETED|Overall Study||2097
9033263|NCT03271307|10095370|FG003|COMPLETED|Overall Study||107
9033264|NCT03271307|10095371|FG004|COMPLETED|Overall Study||258
9033265|NCT03271307|10095367|FG000|NOT COMPLETED|Overall Study||0
9033266|NCT03271307|10095368|FG001|NOT COMPLETED|Overall Study||0
9033267|NCT03271307|10095369|FG002|NOT COMPLETED|Overall Study||0
9033268|NCT03271307|10095370|FG003|NOT COMPLETED|Overall Study||28
8917658|NCT02194699|9977437|FG001|COMPLETED|Randomised||417
8917659|NCT02194699|9977436|FG000|NOT COMPLETED|Randomised||8
8917660|NCT02194699|9977437|FG001|NOT COMPLETED|Randomised||11
8917661|NCT02194699|9977436|FG000|STARTED|With Potential to Receive 52 Weeks of IP|Includes all patients randomised with the potential to receive 52 weeks of IP and receiving any IP.|420
9033269|NCT03271307|10095371|FG004|NOT COMPLETED|Overall Study||91
9033270|NCT03271424|10095389|FG000|STARTED|November 2015||20
8672142|NCT00755807|9715625|FG001|NOT COMPLETED|Acute Phase||12
8672143|NCT00755807|9715624|FG000|STARTED|Open-label Extension Phase||100
9033271|NCT03271424|10095390|FG001|STARTED|November 2015||0
9033272|NCT03271424|10095391|FG002|STARTED|November 2015||0
9033273|NCT03271424|10095389|FG000|COMPLETED|November 2015||20
9033274|NCT03271424|10095390|FG001|COMPLETED|November 2015||0
8672144|NCT00755807|9715625|FG001|STARTED|Open-label Extension Phase||109
8672145|NCT00755807|9715624|FG000|COMPLETED|Open-label Extension Phase||82
8672146|NCT00755807|9715625|FG001|COMPLETED|Open-label Extension Phase||93
8672147|NCT00755807|9715624|FG000|NOT COMPLETED|Open-label Extension Phase||18
8672148|NCT00755807|9715625|FG001|NOT COMPLETED|Open-label Extension Phase||16
8672149|NCT00755846|9715641|FG000|STARTED|Overall Study||43
8672150|NCT00755846|9715642|FG001|STARTED|Overall Study||44
8672151|NCT00755846|9715643|FG002|STARTED|Overall Study||44
8672152|NCT00755846|9715644|FG003|STARTED|Overall Study||45
8672153|NCT00755846|9715645|FG004|STARTED|Overall Study||44
8672154|NCT00755846|9715646|FG005|STARTED|Overall Study||45
8796132|NCT01419171|9847621|FG000|STARTED|Overall Study||328
8796133|NCT01419171|9847621|FG000|COMPLETED|Overall Study||328
8796134|NCT01419171|9847621|FG000|NOT COMPLETED|Overall Study||0
8796135|NCT01419184|9847627|FG000|STARTED|Overall Study||128
8796136|NCT01419184|9847628|FG001|STARTED|Overall Study||121
8796137|NCT01419184|9847627|FG000|Received at Least 1 Dose of Study Drug|Overall Study||118
8796138|NCT01419184|9847628|FG001|Received at Least 1 Dose of Study Drug|Overall Study||106
8796139|NCT01419184|9847627|FG000|COMPLETED|Overall Study|6 participants did not complete the study due to no valid infection-related length of stay (IRLOS)|118
8796140|NCT01419184|9847628|FG001|COMPLETED|Overall Study|13 participants did not complete the study due to no valid infection-related length of stay (IRLOS)|106
8796141|NCT01419184|9847627|FG000|NOT COMPLETED|Overall Study||10
8796142|NCT01419184|9847628|FG001|NOT COMPLETED|Overall Study||15
8796143|NCT01419197|9847636|FG000|STARTED|Overall Study||404
8796144|NCT01419197|9847637|FG001|STARTED|Overall Study||198
8796145|NCT01419197|9847636|FG000|Switched to Trastuzumab Emtansine|Overall Study||0
8796146|NCT01419197|9847637|FG001|Switched to Trastuzumab Emtansine|Overall Study||94
8796147|NCT01419197|9847636|FG000|COMPLETED|Overall Study||0
8796148|NCT01419197|9847637|FG001|COMPLETED|Overall Study||0
8796149|NCT01419197|9847636|FG000|NOT COMPLETED|Overall Study||404
8796150|NCT01419197|9847637|FG001|NOT COMPLETED|Overall Study||198
8796151|NCT01419236|9847646|FG000|STARTED|Overall Study||36
8796152|NCT01419236|9847647|FG001|STARTED|Overall Study||40
8796153|NCT01419236|9847646|FG000|Received at Least 1 Dose of Study Drug|Overall Study||35
8796154|NCT01419236|9847647|FG001|Received at Least 1 Dose of Study Drug|Overall Study||39
8796155|NCT01419236|9847646|FG000|COMPLETED|Overall Study||31
9033275|NCT03271424|10095391|FG002|COMPLETED|November 2015||0
9033276|NCT03271424|10095389|FG000|NOT COMPLETED|November 2015||0
9033277|NCT03271424|10095390|FG001|NOT COMPLETED|November 2015||0
9033278|NCT03271424|10095391|FG002|NOT COMPLETED|November 2015||0
9033279|NCT03271424|10095389|FG000|STARTED|December 2015||0
9033280|NCT03271424|10095390|FG001|STARTED|December 2015||35
9033281|NCT03271424|10095391|FG002|STARTED|December 2015||0
9033282|NCT03271424|10095389|FG000|COMPLETED|December 2015||0
9033283|NCT03271424|10095390|FG001|COMPLETED|December 2015||35
9033284|NCT03271424|10095391|FG002|COMPLETED|December 2015||0
9033285|NCT03271424|10095389|FG000|NOT COMPLETED|December 2015||0
9033286|NCT03271424|10095390|FG001|NOT COMPLETED|December 2015||0
9033287|NCT03271424|10095391|FG002|NOT COMPLETED|December 2015||0
9033288|NCT03271424|10095389|FG000|STARTED|April-May 2016||0
8796156|NCT01419236|9847647|FG001|COMPLETED|Overall Study||35
8796157|NCT01419236|9847646|FG000|NOT COMPLETED|Overall Study||5
8796158|NCT01419236|9847647|FG001|NOT COMPLETED|Overall Study||5
8796159|NCT01419249|9847655|FG000|STARTED|Overall Study||318
8796160|NCT01419249|9847656|FG001|STARTED|Overall Study||140
8796161|NCT01419249|9847655|FG000|COMPLETED|Overall Study||318
8796162|NCT01419249|9847656|FG001|COMPLETED|Overall Study||140
8796163|NCT01419249|9847655|FG000|NOT COMPLETED|Overall Study||0
8796164|NCT01419249|9847656|FG001|NOT COMPLETED|Overall Study||0
8796165|NCT01419275|9847663|FG000|STARTED|Overall Study||126
8796166|NCT01419275|9847663|FG000|COMPLETED|Overall Study||126
8796167|NCT01419275|9847663|FG000|NOT COMPLETED|Overall Study||0
8796168|NCT01419314|9847669|FG000|STARTED|Start of Study|minor comfort issues were reported within the first 2 weeks of the trial|23
8796169|NCT01419314|9847670|FG001|STARTED|Start of Study|No comfort issues reported.|22
8796170|NCT01419314|9847669|FG000|COMPLETED|Start of Study||23
8796171|NCT01419314|9847670|FG001|COMPLETED|Start of Study||22
8796172|NCT01419314|9847669|FG000|NOT COMPLETED|Start of Study||0
8796173|NCT01419314|9847670|FG001|NOT COMPLETED|Start of Study||0
8796174|NCT01419314|9847669|FG000|STARTED|Follow-up at Week 3 of the Trial|3 participants discontinued the trial, 3 failed to return for additional follow-ups.|23
8796175|NCT01419314|9847670|FG001|STARTED|Follow-up at Week 3 of the Trial|one participant failed to return for the 3 week follow-up|22
8796176|NCT01419314|9847669|FG000|COMPLETED|Follow-up at Week 3 of the Trial||17
8796177|NCT01419314|9847670|FG001|COMPLETED|Follow-up at Week 3 of the Trial||21
8796178|NCT01419314|9847669|FG000|NOT COMPLETED|Follow-up at Week 3 of the Trial||6
8796179|NCT01419314|9847670|FG001|NOT COMPLETED|Follow-up at Week 3 of the Trial||1
8796180|NCT01419314|9847669|FG000|STARTED|Follow-up at Week 6 of the Trial||17
8796181|NCT01419314|9847670|FG001|STARTED|Follow-up at Week 6 of the Trial|2 participants did not return for their final follow-up|21
8796182|NCT01419314|9847669|FG000|COMPLETED|Follow-up at Week 6 of the Trial|2 people who missed the first follow-up, returned for the final follow-up at week 6 (n=18).|16
8796183|NCT01419314|9847670|FG001|COMPLETED|Follow-up at Week 6 of the Trial||19
8796184|NCT01419314|9847669|FG000|NOT COMPLETED|Follow-up at Week 6 of the Trial||1
9033289|NCT03271424|10095390|FG001|STARTED|April-May 2016||0
9033290|NCT03271424|10095391|FG002|STARTED|April-May 2016||40
9033291|NCT03271424|10095389|FG000|COMPLETED|April-May 2016||0
8796185|NCT01419314|9847670|FG001|NOT COMPLETED|Follow-up at Week 6 of the Trial||2
8796186|NCT01419535|9847682|FG000|STARTED|Overall Study||9
8796187|NCT01419535|9847683|FG001|STARTED|Overall Study||10
8796188|NCT01419535|9847682|FG000|COMPLETED|Overall Study||8
8796189|NCT01419535|9847683|FG001|COMPLETED|Overall Study||8
8796190|NCT01419535|9847682|FG000|NOT COMPLETED|Overall Study||1
8796191|NCT01419535|9847683|FG001|NOT COMPLETED|Overall Study||2
8796192|NCT01419626|9847692|FG000|STARTED|Overall Study||46
8796193|NCT01419626|9847693|FG001|STARTED|Overall Study||47
8796194|NCT01419626|9847694|FG002|STARTED|Overall Study||47
8796195|NCT01419626|9847692|FG000|COMPLETED|Overall Study||42
8796196|NCT01419626|9847693|FG001|COMPLETED|Overall Study||44
8796197|NCT01419626|9847694|FG002|COMPLETED|Overall Study||44
8796198|NCT01419626|9847692|FG000|NOT COMPLETED|Overall Study||4
8796199|NCT01419626|9847693|FG001|NOT COMPLETED|Overall Study||3
8796200|NCT01419626|9847694|FG002|NOT COMPLETED|Overall Study||3
8796201|NCT01419639|9847702|FG000|STARTED|Overall Study||10
8796202|NCT01419639|9847702|FG000|COMPLETED|Overall Study||9
8796203|NCT01419639|9847702|FG000|NOT COMPLETED|Overall Study||1
8796204|NCT01419665|9847708|FG000|STARTED|Combination Treatment||312
8796205|NCT01419665|9847709|FG001|STARTED|Combination Treatment||315
8796206|NCT01419665|9847708|FG000|COMPLETED|Combination Treatment||274
8796207|NCT01419665|9847709|FG001|COMPLETED|Combination Treatment||274
8796208|NCT01419665|9847708|FG000|NOT COMPLETED|Combination Treatment||38
8796209|NCT01419665|9847709|FG001|NOT COMPLETED|Combination Treatment||41
8796210|NCT01419665|9847708|FG000|STARTED|Maintenance Treatment and/or Follow up||254
8796211|NCT01419665|9847709|FG001|STARTED|Maintenance Treatment and/or Follow up||252
8796212|NCT01419665|9847708|FG000|COMPLETED|Maintenance Treatment and/or Follow up||132
8796213|NCT01419665|9847709|FG001|COMPLETED|Maintenance Treatment and/or Follow up||150
8796214|NCT01419665|9847708|FG000|NOT COMPLETED|Maintenance Treatment and/or Follow up||122
8796215|NCT01419665|9847709|FG001|NOT COMPLETED|Maintenance Treatment and/or Follow up||102
8796216|NCT01419665|9847708|FG000|STARTED|Open Label Phase||44
8796217|NCT01419665|9847709|FG001|STARTED|Open Label Phase||39
8796218|NCT01419665|9847708|FG000|COMPLETED|Open Label Phase||43
8796219|NCT01419665|9847709|FG001|COMPLETED|Open Label Phase||38
8796220|NCT01419665|9847708|FG000|NOT COMPLETED|Open Label Phase||1
8796221|NCT01419665|9847709|FG001|NOT COMPLETED|Open Label Phase||1
8796222|NCT01419717|9847717|FG000|STARTED|Overall Study||129
8796223|NCT01419717|9847717|FG000|Received Denosumab|Overall Study||128
8796224|NCT01419717|9847717|FG000|COMPLETED|Overall Study||4
8796225|NCT01419717|9847717|FG000|NOT COMPLETED|Overall Study||125
8796226|NCT01419769|9847721|FG000|STARTED|Overall Study||33
8796227|NCT01419769|9847721|FG000|COMPLETED|Overall Study||29
8796228|NCT01419769|9847721|FG000|NOT COMPLETED|Overall Study||4
8796229|NCT01419795|9847727|FG000|STARTED|Overall Study||3
8796230|NCT01419795|9847728|FG001|STARTED|Overall Study||0
8796231|NCT01419795|9847727|FG000|COMPLETED|Overall Study||3
8796232|NCT01419795|9847728|FG001|COMPLETED|Overall Study||0
8796233|NCT01419795|9847727|FG000|NOT COMPLETED|Overall Study||0
8796234|NCT01419795|9847728|FG001|NOT COMPLETED|Overall Study||0
8796235|NCT01419977|9847736|FG000|STARTED|Overall Study||16
8796236|NCT01419977|9847737|FG001|STARTED|Overall Study||13
8796237|NCT01419977|9847736|FG000|COMPLETED|Overall Study||16
8796238|NCT01419977|9847737|FG001|COMPLETED|Overall Study||13
8796239|NCT01419977|9847736|FG000|NOT COMPLETED|Overall Study||0
8796240|NCT01419977|9847737|FG001|NOT COMPLETED|Overall Study||0
8796241|NCT01420016|9847745|FG000|STARTED|Primary Analysis||6970
8796242|NCT01420016|9847746|FG001|STARTED|Primary Analysis||6411
8796243|NCT01420016|9847747|FG002|STARTED|Primary Analysis||0
8796244|NCT01420016|9847748|FG003|STARTED|Primary Analysis||0
8796245|NCT01420016|9847745|FG000|COMPLETED|Primary Analysis|Reflects patient participants included in final analysis.|4043
8796246|NCT01420016|9847746|FG001|COMPLETED|Primary Analysis|Reflects patient participants included in final analysis.|3871
8796247|NCT01420016|9847747|FG002|COMPLETED|Primary Analysis||0
8796248|NCT01420016|9847748|FG003|COMPLETED|Primary Analysis||0
8796249|NCT01420016|9847745|FG000|NOT COMPLETED|Primary Analysis||2927
8796250|NCT01420016|9847746|FG001|NOT COMPLETED|Primary Analysis||2540
8796251|NCT01420016|9847747|FG002|NOT COMPLETED|Primary Analysis||0
8796252|NCT01420016|9847748|FG003|NOT COMPLETED|Primary Analysis||0
8796253|NCT01420016|9847745|FG000|STARTED|Safety Analysis||0
8796254|NCT01420016|9847746|FG001|STARTED|Safety Analysis||0
8796255|NCT01420016|9847747|FG002|STARTED|Safety Analysis||6392
8796256|NCT01420016|9847748|FG003|STARTED|Safety Analysis||5159
8796257|NCT01420016|9847745|FG000|COMPLETED|Safety Analysis||0
8796258|NCT01420016|9847746|FG001|COMPLETED|Safety Analysis||0
8796259|NCT01420016|9847747|FG002|COMPLETED|Safety Analysis||6392
8796260|NCT01420016|9847748|FG003|COMPLETED|Safety Analysis||5159
8796261|NCT01420016|9847745|FG000|NOT COMPLETED|Safety Analysis||0
8796262|NCT01420016|9847746|FG001|NOT COMPLETED|Safety Analysis||0
8796263|NCT01420016|9847747|FG002|NOT COMPLETED|Safety Analysis||0
8796264|NCT01420016|9847748|FG003|NOT COMPLETED|Safety Analysis||0
8796265|NCT01420068|9847756|FG000|STARTED|Overall Study||51
8796266|NCT01420068|9847757|FG001|STARTED|Overall Study||55
8796267|NCT01420068|9847756|FG000|COMPLETED|Overall Study||49
8796268|NCT01420068|9847757|FG001|COMPLETED|Overall Study||50
8796269|NCT01420068|9847756|FG000|NOT COMPLETED|Overall Study||2
8796270|NCT01420068|9847757|FG001|NOT COMPLETED|Overall Study||5
8796271|NCT01420081|9847772|FG000|STARTED|Overall Study||3
8796272|NCT01420081|9847773|FG001|STARTED|Overall Study||1
8796273|NCT01420081|9847774|FG002|STARTED|Overall Study||11
8796274|NCT01420081|9847775|FG003|STARTED|Overall Study||3
8796275|NCT01420081|9847776|FG004|STARTED|Overall Study||20
8796276|NCT01420081|9847777|FG005|STARTED|Overall Study||20
8796277|NCT01420081|9847778|FG006|STARTED|Overall Study||3
8796278|NCT01420081|9847779|FG007|STARTED|Overall Study||3
8796279|NCT01420081|9847780|FG008|STARTED|Overall Study||3
8796280|NCT01420081|9847772|FG000|COMPLETED|Overall Study||0
8796281|NCT01420081|9847773|FG001|COMPLETED|Overall Study||0
8796282|NCT01420081|9847774|FG002|COMPLETED|Overall Study||0
8796283|NCT01420081|9847775|FG003|COMPLETED|Overall Study||0
8796284|NCT01420081|9847776|FG004|COMPLETED|Overall Study||0
8796285|NCT01420081|9847777|FG005|COMPLETED|Overall Study||0
8796286|NCT01420081|9847778|FG006|COMPLETED|Overall Study||0
8796287|NCT01420081|9847779|FG007|COMPLETED|Overall Study||0
8796288|NCT01420081|9847780|FG008|COMPLETED|Overall Study||0
8796289|NCT01420081|9847772|FG000|NOT COMPLETED|Overall Study||3
8796290|NCT01420081|9847773|FG001|NOT COMPLETED|Overall Study||1
8796291|NCT01420081|9847774|FG002|NOT COMPLETED|Overall Study||11
8796292|NCT01420081|9847775|FG003|NOT COMPLETED|Overall Study||3
8796293|NCT01420081|9847776|FG004|NOT COMPLETED|Overall Study||20
8796294|NCT01420081|9847777|FG005|NOT COMPLETED|Overall Study||20
8796295|NCT01420081|9847778|FG006|NOT COMPLETED|Overall Study||3
8796296|NCT01420081|9847779|FG007|NOT COMPLETED|Overall Study||3
8796297|NCT01420081|9847780|FG008|NOT COMPLETED|Overall Study||3
8796298|NCT01420146|9847796|FG000|STARTED|Overall Study||20
8796299|NCT01420146|9847796|FG000|COMPLETED|Overall Study||20
8796300|NCT01420146|9847796|FG000|NOT COMPLETED|Overall Study||0
8796301|NCT01420289|9847802|FG000|STARTED|Overall Study||18
8796302|NCT01420289|9847803|FG001|STARTED|Overall Study||16
8796303|NCT01420289|9847802|FG000|COMPLETED|Overall Study||18
8796304|NCT01420289|9847803|FG001|COMPLETED|Overall Study||16
8796305|NCT01420289|9847802|FG000|NOT COMPLETED|Overall Study||0
8796306|NCT01420289|9847803|FG001|NOT COMPLETED|Overall Study||0
8796307|NCT01420536|9847811|FG000|STARTED|Period 1 (30 Days)||22
8796308|NCT01420536|9847812|FG001|STARTED|Period 1 (30 Days)||22
8796309|NCT01420536|9847811|FG000|COMPLETED|Period 1 (30 Days)|Participants declined to participate further before changing interventions.|19
8796310|NCT01420536|9847812|FG001|COMPLETED|Period 1 (30 Days)||22
8796311|NCT01420536|9847811|FG000|NOT COMPLETED|Period 1 (30 Days)||3
8796312|NCT01420536|9847812|FG001|NOT COMPLETED|Period 1 (30 Days)||0
8796313|NCT01420536|9847811|FG000|STARTED|Period 2 (30 Days)||19
8796314|NCT01420536|9847812|FG001|STARTED|Period 2 (30 Days)||22
8796315|NCT01420536|9847811|FG000|COMPLETED|Period 2 (30 Days)||19
8796316|NCT01420536|9847812|FG001|COMPLETED|Period 2 (30 Days)||22
8796317|NCT01420536|9847811|FG000|NOT COMPLETED|Period 2 (30 Days)||0
8796318|NCT01420536|9847812|FG001|NOT COMPLETED|Period 2 (30 Days)||0
8796319|NCT01420549|9847822|FG000|STARTED|Overall Study||66
8796320|NCT01420549|9847823|FG001|STARTED|Overall Study||63
8796321|NCT01420549|9847822|FG000|COMPLETED|Overall Study||59
8796322|NCT01420549|9847823|FG001|COMPLETED|Overall Study||58
8796323|NCT01420549|9847822|FG000|NOT COMPLETED|Overall Study||7
8796324|NCT01420549|9847823|FG001|NOT COMPLETED|Overall Study||5
8796325|NCT01420627|9847829|FG000|STARTED|Adagen Lead-in Period||7
8796326|NCT01420627|9847829|FG000|COMPLETED|Adagen Lead-in Period||7
8796327|NCT01420627|9847829|FG000|NOT COMPLETED|Adagen Lead-in Period||0
8796328|NCT01420627|9847829|FG000|STARTED|EZN-2279 Treatment Period||7
8796329|NCT01420627|9847829|FG000|COMPLETED|EZN-2279 Treatment Period||6
8796330|NCT01420627|9847829|FG000|NOT COMPLETED|EZN-2279 Treatment Period||1
8796331|NCT01420627|9847829|FG000|STARTED|EZN-2279 Maintenance Period||6
8796332|NCT01420627|9847829|FG000|COMPLETED|EZN-2279 Maintenance Period||6
8796333|NCT01420627|9847829|FG000|NOT COMPLETED|EZN-2279 Maintenance Period||0
8796334|NCT01420653|9847841|FG000|STARTED|Overall Study||110
8796335|NCT01420653|9847842|FG001|STARTED|Overall Study||111
8796336|NCT01420653|9847843|FG002|STARTED|Overall Study||112
8796337|NCT01420653|9847844|FG003|STARTED|Overall Study||75
8796338|NCT01420653|9847841|FG000|COMPLETED|Overall Study||107
8796339|NCT01420653|9847842|FG001|COMPLETED|Overall Study||108
8796340|NCT01420653|9847843|FG002|COMPLETED|Overall Study||108
8796341|NCT01420653|9847844|FG003|COMPLETED|Overall Study||68
8796342|NCT01420653|9847841|FG000|NOT COMPLETED|Overall Study||3
8796343|NCT01420653|9847842|FG001|NOT COMPLETED|Overall Study||3
8796344|NCT01420653|9847843|FG002|NOT COMPLETED|Overall Study||4
8796345|NCT01420653|9847844|FG003|NOT COMPLETED|Overall Study||7
8796346|NCT01420679|9847856|FG000|STARTED|Overall Study||14
8796347|NCT01420679|9847857|FG001|STARTED|Overall Study||7
8796348|NCT01420679|9847856|FG000|COMPLETED|Overall Study||0
8796349|NCT01420679|9847857|FG001|COMPLETED|Overall Study||0
8796350|NCT01420679|9847856|FG000|NOT COMPLETED|Overall Study||14
8796351|NCT01420679|9847857|FG001|NOT COMPLETED|Overall Study||7
8796352|NCT01420848|9847866|FG000|STARTED|Overall Study||24
8796353|NCT01420848|9847867|FG001|STARTED|Overall Study||25
8796354|NCT01420848|9847868|FG002|STARTED|Overall Study||22
8796355|NCT01420848|9847866|FG000|COMPLETED|Overall Study||24
8796356|NCT01420848|9847867|FG001|COMPLETED|Overall Study||25
8796357|NCT01420848|9847868|FG002|COMPLETED|Overall Study||22
8796358|NCT01420848|9847866|FG000|NOT COMPLETED|Overall Study||0
8796359|NCT01420848|9847867|FG001|NOT COMPLETED|Overall Study||0
8796360|NCT01420848|9847868|FG002|NOT COMPLETED|Overall Study||0
8796361|NCT01421017|9847879|FG000|STARTED|Overall Study||12
8796362|NCT01421017|9847880|FG001|STARTED|Overall Study||12
8796363|NCT01421017|9847881|FG002|STARTED|Overall Study||7
8796364|NCT01421017|9847879|FG000|COMPLETED|Overall Study||10
8796365|NCT01421017|9847880|FG001|COMPLETED|Overall Study||6
8796366|NCT01421017|9847881|FG002|COMPLETED|Overall Study||4
8796367|NCT01421017|9847879|FG000|NOT COMPLETED|Overall Study||2
8796368|NCT01421017|9847880|FG001|NOT COMPLETED|Overall Study||6
8796369|NCT01421017|9847881|FG002|NOT COMPLETED|Overall Study||3
8796370|NCT01421134|9847891|FG000|STARTED|Overall Study||109
8796371|NCT01421134|9847892|FG001|STARTED|Overall Study||102
8796372|NCT01421134|9847891|FG000|COMPLETED|Overall Study||102
8796373|NCT01421134|9847892|FG001|COMPLETED|Overall Study||87
8796374|NCT01421134|9847891|FG000|NOT COMPLETED|Overall Study||7
8796375|NCT01421134|9847892|FG001|NOT COMPLETED|Overall Study||15
8796376|NCT01421147|9847900|FG000|STARTED|Treatment Period||269
8796377|NCT01421147|9847901|FG001|STARTED|Treatment Period||267
8796378|NCT01421147|9847900|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||268
8796379|NCT01421147|9847901|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||267
8796380|NCT01421147|9847900|FG000|COMPLETED|Treatment Period||253
8796381|NCT01421147|9847901|FG001|COMPLETED|Treatment Period||256
8796382|NCT01421147|9847900|FG000|NOT COMPLETED|Treatment Period||16
8796383|NCT01421147|9847901|FG001|NOT COMPLETED|Treatment Period||11
8796384|NCT01421147|9847900|FG000|STARTED|Extension Period||253
8917662|NCT02194699|9977437|FG001|STARTED|With Potential to Receive 52 Weeks of IP|Includes all patients randomised with the potential to receive 52 weeks of IP and receiving any IP.|417
8917663|NCT02194699|9977436|FG000|COMPLETED|With Potential to Receive 52 Weeks of IP||370
8917664|NCT02194699|9977437|FG001|COMPLETED|With Potential to Receive 52 Weeks of IP||365
8917665|NCT02194699|9977436|FG000|NOT COMPLETED|With Potential to Receive 52 Weeks of IP||50
8917666|NCT02194699|9977437|FG001|NOT COMPLETED|With Potential to Receive 52 Weeks of IP||52
8917667|NCT02194933|9977453|FG000|STARTED|Overall Study||19
8917668|NCT02194933|9977454|FG001|STARTED|Overall Study||19
8917669|NCT02194933|9977453|FG000|COMPLETED|Overall Study||16
8917670|NCT02194933|9977454|FG001|COMPLETED|Overall Study||10
8917671|NCT02194933|9977453|FG000|NOT COMPLETED|Overall Study||3
8917672|NCT02194933|9977454|FG001|NOT COMPLETED|Overall Study||9
8917673|NCT02194985|9977462|FG000|STARTED|Overall Study||84
8917674|NCT02194985|9977462|FG000|Received at Least 1 Dose of Study Drug|Overall Study||84
8917675|NCT02194985|9977462|FG000|COMPLETED|Overall Study||73
8917676|NCT02194985|9977462|FG000|NOT COMPLETED|Overall Study||11
8917677|NCT02194998|9977470|FG000|STARTED|On-HCV Treatment||21
8917678|NCT02194998|9977471|FG001|STARTED|On-HCV Treatment||6
8917679|NCT02194998|9977472|FG002|STARTED|On-HCV Treatment||15
8917680|NCT02194998|9977473|FG003|STARTED|On-HCV Treatment||4
8917681|NCT02194998|9977470|FG000|COMPLETED|On-HCV Treatment||21
8917682|NCT02194998|9977471|FG001|COMPLETED|On-HCV Treatment||5
8917683|NCT02194998|9977472|FG002|COMPLETED|On-HCV Treatment||15
8917684|NCT02194998|9977473|FG003|COMPLETED|On-HCV Treatment||4
8917685|NCT02194998|9977470|FG000|NOT COMPLETED|On-HCV Treatment||0
8917686|NCT02194998|9977471|FG001|NOT COMPLETED|On-HCV Treatment||1
8917687|NCT02194998|9977472|FG002|NOT COMPLETED|On-HCV Treatment||0
8917688|NCT02194998|9977473|FG003|NOT COMPLETED|On-HCV Treatment||0
8917689|NCT02194998|9977470|FG000|STARTED|Post-HCV Treatment Follow-Up||21
8917690|NCT02194998|9977471|FG001|STARTED|Post-HCV Treatment Follow-Up||5
8917691|NCT02194998|9977472|FG002|STARTED|Post-HCV Treatment Follow-Up||15
8917692|NCT02194998|9977473|FG003|STARTED|Post-HCV Treatment Follow-Up||4
8917693|NCT02194998|9977470|FG000|COMPLETED|Post-HCV Treatment Follow-Up||20
8917694|NCT02194998|9977471|FG001|COMPLETED|Post-HCV Treatment Follow-Up||5
8917695|NCT02194998|9977472|FG002|COMPLETED|Post-HCV Treatment Follow-Up||14
8917696|NCT02194998|9977473|FG003|COMPLETED|Post-HCV Treatment Follow-Up||4
8917697|NCT02194998|9977470|FG000|NOT COMPLETED|Post-HCV Treatment Follow-Up||1
8917698|NCT02194998|9977471|FG001|NOT COMPLETED|Post-HCV Treatment Follow-Up||0
8917699|NCT02194998|9977472|FG002|NOT COMPLETED|Post-HCV Treatment Follow-Up||1
8917700|NCT02194998|9977473|FG003|NOT COMPLETED|Post-HCV Treatment Follow-Up||0
8917701|NCT02195011|9977485|FG000|STARTED|Overall Study||25
8917702|NCT02195011|9977486|FG001|STARTED|Overall Study||1
8917703|NCT02195011|9977485|FG000|COMPLETED|Overall Study||0
8917704|NCT02195011|9977486|FG001|COMPLETED|Overall Study||0
8917705|NCT02195011|9977485|FG000|NOT COMPLETED|Overall Study||25
8917706|NCT02195011|9977486|FG001|NOT COMPLETED|Overall Study||1
8917707|NCT02195232|9977494|FG000|STARTED|Overall Study|patients consented|32
8796385|NCT01421147|9847901|FG001|STARTED|Extension Period||256
8796386|NCT01421147|9847900|FG000|COMPLETED|Extension Period||245
8796387|NCT01421147|9847901|FG001|COMPLETED|Extension Period||245
8796388|NCT01421147|9847900|FG000|NOT COMPLETED|Extension Period||8
8796389|NCT01421147|9847901|FG001|NOT COMPLETED|Extension Period||11
8796390|NCT01421186|9847912|FG000|STARTED|Overall Study||31
8796391|NCT01421186|9847913|FG001|STARTED|Overall Study||4
8796392|NCT01421186|9847914|FG002|STARTED|Overall Study||18
8796393|NCT01421186|9847915|FG003|STARTED|Overall Study||21
8796394|NCT01421186|9847916|FG004|STARTED|Overall Study||17
8796395|NCT01421186|9847912|FG000|COMPLETED|Overall Study||31
8796396|NCT01421186|9847913|FG001|COMPLETED|Overall Study||4
8796397|NCT01421186|9847914|FG002|COMPLETED|Overall Study||18
8796398|NCT01421186|9847915|FG003|COMPLETED|Overall Study||21
8796399|NCT01421186|9847916|FG004|COMPLETED|Overall Study||17
8796400|NCT01421186|9847912|FG000|NOT COMPLETED|Overall Study||0
8796401|NCT01421186|9847913|FG001|NOT COMPLETED|Overall Study||0
8796402|NCT01421186|9847914|FG002|NOT COMPLETED|Overall Study||0
8796403|NCT01421186|9847915|FG003|NOT COMPLETED|Overall Study||0
8796404|NCT01421186|9847916|FG004|NOT COMPLETED|Overall Study||0
8796405|NCT01421225|9847936|FG000|STARTED|Overall Study||4
8796406|NCT01421225|9847937|FG001|STARTED|Overall Study||6
8796407|NCT01421225|9847936|FG000|COMPLETED|Overall Study||4
8796408|NCT01421225|9847937|FG001|COMPLETED|Overall Study||5
8796409|NCT01421225|9847936|FG000|NOT COMPLETED|Overall Study||0
8796410|NCT01421225|9847937|FG001|NOT COMPLETED|Overall Study||1
8796411|NCT01421277|9847946|FG000|STARTED|Overall Study||25
8796412|NCT01421277|9847947|FG001|STARTED|Overall Study||191
8796413|NCT01421277|9847946|FG000|COMPLETED|Overall Study|Completed the online survey for at least one migraine attack.|25
8796414|NCT01421277|9847947|FG001|COMPLETED|Overall Study|Completed the online survey for at least one migraine attack.|99
8796415|NCT01421277|9847946|FG000|NOT COMPLETED|Overall Study||0
8796416|NCT01421277|9847947|FG001|NOT COMPLETED|Overall Study||92
8796417|NCT01421303|9847953|FG000|STARTED|Overall Study||80
8796418|NCT01421303|9847953|FG000|COMPLETED|Overall Study||58
8796419|NCT01421303|9847953|FG000|NOT COMPLETED|Overall Study||22
8796420|NCT01421342|9847960|FG000|STARTED|Acute Treatment Phase (12 Weeks)||511
8796421|NCT01421342|9847961|FG001|STARTED|Acute Treatment Phase (12 Weeks)||506
8796422|NCT01421342|9847962|FG002|STARTED|Acute Treatment Phase (12 Weeks)||505
8796423|NCT01421342|9847960|FG000|COMPLETED|Acute Treatment Phase (12 Weeks)||353
8796424|NCT01421342|9847961|FG001|COMPLETED|Acute Treatment Phase (12 Weeks)||378
8796425|NCT01421342|9847962|FG002|COMPLETED|Acute Treatment Phase (12 Weeks)||406
8796426|NCT01421342|9847960|FG000|NOT COMPLETED|Acute Treatment Phase (12 Weeks)||158
8796427|NCT01421342|9847961|FG001|NOT COMPLETED|Acute Treatment Phase (12 Weeks)||128
8796428|NCT01421342|9847962|FG002|NOT COMPLETED|Acute Treatment Phase (12 Weeks)||99
8796429|NCT01421342|9847960|FG000|STARTED|Completed to Week 12 But Then Withdrawn||353
8796430|NCT01421342|9847961|FG001|STARTED|Completed to Week 12 But Then Withdrawn||378
8796431|NCT01421342|9847962|FG002|STARTED|Completed to Week 12 But Then Withdrawn||406
8796432|NCT01421342|9847960|FG000|COMPLETED|Completed to Week 12 But Then Withdrawn||204
8796433|NCT01421342|9847961|FG001|COMPLETED|Completed to Week 12 But Then Withdrawn||253
8796434|NCT01421342|9847962|FG002|COMPLETED|Completed to Week 12 But Then Withdrawn||268
8796435|NCT01421342|9847960|FG000|NOT COMPLETED|Completed to Week 12 But Then Withdrawn||149
8796436|NCT01421342|9847961|FG001|NOT COMPLETED|Completed to Week 12 But Then Withdrawn||125
8796437|NCT01421342|9847962|FG002|NOT COMPLETED|Completed to Week 12 But Then Withdrawn||138
8796438|NCT01421342|9847960|FG000|STARTED|Continuation of Treatment (Week 12 - 36)||204
8796439|NCT01421342|9847961|FG001|STARTED|Continuation of Treatment (Week 12 - 36)||253
8796440|NCT01421342|9847962|FG002|STARTED|Continuation of Treatment (Week 12 - 36)||268
8796441|NCT01421342|9847960|FG000|COMPLETED|Continuation of Treatment (Week 12 - 36)||152
8796442|NCT01421342|9847961|FG001|COMPLETED|Continuation of Treatment (Week 12 - 36)||194
8796443|NCT01421342|9847962|FG002|COMPLETED|Continuation of Treatment (Week 12 - 36)||203
8796444|NCT01421342|9847960|FG000|NOT COMPLETED|Continuation of Treatment (Week 12 - 36)||52
8796445|NCT01421342|9847961|FG001|NOT COMPLETED|Continuation of Treatment (Week 12 - 36)||59
8796446|NCT01421342|9847962|FG002|NOT COMPLETED|Continuation of Treatment (Week 12 - 36)||65
8796447|NCT01421355|9847970|FG000|STARTED|Overall Study||21
8796448|NCT01421355|9847970|FG000|COMPLETED|Overall Study||15
8796449|NCT01421355|9847970|FG000|NOT COMPLETED|Overall Study||6
8796450|NCT01421459|9847976|FG000|STARTED|Overall Study||379
8796451|NCT01421459|9847977|FG001|STARTED|Overall Study||380
8796452|NCT01421459|9847976|FG000|Received at Least 1 Dose of Study Drug|Overall Study||376
8796453|NCT01421459|9847977|FG001|Received at Least 1 Dose of Study Drug|Overall Study||380
9033292|NCT03271424|10095390|FG001|COMPLETED|April-May 2016||0
9033293|NCT03271424|10095391|FG002|COMPLETED|April-May 2016||40
9033294|NCT03271424|10095389|FG000|NOT COMPLETED|April-May 2016||0
9033295|NCT03271424|10095390|FG001|NOT COMPLETED|April-May 2016||0
9033296|NCT03271424|10095391|FG002|NOT COMPLETED|April-May 2016||0
9033297|NCT03271528|10095403|FG000|STARTED|Medication Dispense/Exposure Period 1||13
9033298|NCT03271528|10095404|FG001|STARTED|Medication Dispense/Exposure Period 1||14
9033299|NCT03271528|10095403|FG000|COMPLETED|Medication Dispense/Exposure Period 1||11
9033300|NCT03271528|10095404|FG001|COMPLETED|Medication Dispense/Exposure Period 1||12
8796454|NCT01421459|9847976|FG000|COMPLETED|Overall Study||334
8796455|NCT01421459|9847977|FG001|COMPLETED|Overall Study||328
8796456|NCT01421459|9847976|FG000|NOT COMPLETED|Overall Study||45
8796457|NCT01421459|9847977|FG001|NOT COMPLETED|Overall Study||52
8796458|NCT01421472|9847987|FG000|STARTED|Overall Study||67
8796459|NCT01421472|9847988|FG001|STARTED|Overall Study||33
8796460|NCT01421472|9847989|FG002|STARTED|Overall Study||64
8796461|NCT01421472|9847990|FG003|STARTED|Overall Study||32
8796462|NCT01421472|9847987|FG000|COMPLETED|Overall Study||67
8796463|NCT01421472|9847988|FG001|COMPLETED|Overall Study||33
8796464|NCT01421472|9847989|FG002|COMPLETED|Overall Study||64
8796465|NCT01421472|9847990|FG003|COMPLETED|Overall Study||32
8796466|NCT01421472|9847987|FG000|NOT COMPLETED|Overall Study||0
8796467|NCT01421472|9847988|FG001|NOT COMPLETED|Overall Study||0
8796468|NCT01421472|9847989|FG002|NOT COMPLETED|Overall Study||0
8796469|NCT01421472|9847990|FG003|NOT COMPLETED|Overall Study||0
8796470|NCT01421498|9848002|FG000|STARTED|Overall Study||293
8796471|NCT01421498|9848003|FG001|STARTED|Overall Study||295
8796472|NCT01421498|9848002|FG000|COMPLETED|Overall Study||281
8796473|NCT01421498|9848003|FG001|COMPLETED|Overall Study||284
8796474|NCT01421498|9848002|FG000|NOT COMPLETED|Overall Study||12
8796475|NCT01421498|9848003|FG001|NOT COMPLETED|Overall Study||11
8796476|NCT01421511|9848011|FG000|STARTED|Overall Study||332
8796477|NCT01421511|9848012|FG001|STARTED|Overall Study||334
8796478|NCT01421511|9848011|FG000|COMPLETED|Overall Study||313
8796479|NCT01421511|9848012|FG001|COMPLETED|Overall Study||306
8796480|NCT01421511|9848011|FG000|NOT COMPLETED|Overall Study||19
8796481|NCT01421511|9848012|FG001|NOT COMPLETED|Overall Study||28
8796482|NCT01421589|9848019|FG000|STARTED|Overall Study||15
8796483|NCT01421589|9848019|FG000|COMPLETED|Overall Study||15
8796484|NCT01421589|9848019|FG000|NOT COMPLETED|Overall Study||0
8796485|NCT01421641|9848026|FG000|STARTED|Overall Study||37
8796486|NCT01421641|9848027|FG001|STARTED|Overall Study||37
8796487|NCT01421641|9848026|FG000|COMPLETED|Overall Study||35
8796488|NCT01421641|9848027|FG001|COMPLETED|Overall Study||35
8796489|NCT01421641|9848026|FG000|NOT COMPLETED|Overall Study||2
8796490|NCT01421641|9848027|FG001|NOT COMPLETED|Overall Study||2
8796491|NCT01421654|9848035|FG000|STARTED|Overall Study||11
8796492|NCT01421654|9848036|FG001|STARTED|Overall Study||9
8796493|NCT01421654|9848035|FG000|COMPLETED|Overall Study||11
8796494|NCT01421654|9848036|FG001|COMPLETED|Overall Study|10 subjects completed study, but 1 subject was found to not meet IEC at the end; data was not used.|9
8796495|NCT01421654|9848035|FG000|NOT COMPLETED|Overall Study||0
8796496|NCT01421654|9848036|FG001|NOT COMPLETED|Overall Study||0
8796497|NCT01421667|9848046|FG000|STARTED|Overall Study||35
8796498|NCT01421667|9848047|FG001|STARTED|Overall Study||68
8796499|NCT01421667|9848048|FG002|STARTED|Overall Study||53
8796500|NCT01421667|9848049|FG003|STARTED|Overall Study||16
8796501|NCT01421667|9848046|FG000|COMPLETED|Overall Study|Completed per protocol due to death [24] or study termination by sponsor [11]|35
8796502|NCT01421667|9848047|FG001|COMPLETED|Overall Study|Completed per protocol due to death [45] or study termination by sponsor [21]|66
8796503|NCT01421667|9848048|FG002|COMPLETED|Overall Study|Completed per protocol due to death [33] or study termination by sponsor [18]|51
8796504|NCT01421667|9848049|FG003|COMPLETED|Overall Study|Completed per protocol due to death [7] or study termination by sponsor [8]|15
8796505|NCT01421667|9848046|FG000|NOT COMPLETED|Overall Study||0
8796506|NCT01421667|9848047|FG001|NOT COMPLETED|Overall Study||2
8796507|NCT01421667|9848048|FG002|NOT COMPLETED|Overall Study||2
8796508|NCT01421667|9848049|FG003|NOT COMPLETED|Overall Study||1
8796509|NCT01421719|9848067|FG000|STARTED|Overall Study||20
8796510|NCT01421719|9848067|FG000|COMPLETED|Overall Study||16
8796511|NCT01421719|9848067|FG000|NOT COMPLETED|Overall Study||4
8796512|NCT01422070|9848074|FG000|STARTED|Overall Study|Number of patients admitted to 140 intensive care units|5031
8796513|NCT01422070|9848075|FG001|STARTED|Overall Study|Number of patients admitted to 27 intensive care units.|803
8796514|NCT01422070|9848074|FG000|COMPLETED|Overall Study||5031
8796515|NCT01422070|9848075|FG001|COMPLETED|Overall Study||803
8796516|NCT01422070|9848074|FG000|NOT COMPLETED|Overall Study||0
8796517|NCT01422070|9848075|FG001|NOT COMPLETED|Overall Study||0
8796518|NCT01422135|9848080|FG000|STARTED|Overall Study||4
8796519|NCT01422135|9848081|FG001|STARTED|Overall Study||4
8796520|NCT01422135|9848082|FG002|STARTED|Overall Study||4
8796521|NCT01422135|9848083|FG003|STARTED|Overall Study||4
8796522|NCT01422135|9848084|FG004|STARTED|Overall Study||4
8796523|NCT01422135|9848085|FG005|STARTED|Overall Study||4
8796524|NCT01422135|9848080|FG000|COMPLETED|Overall Study||4
8796525|NCT01422135|9848081|FG001|COMPLETED|Overall Study||4
8796526|NCT01422135|9848082|FG002|COMPLETED|Overall Study||3
8796527|NCT01422135|9848083|FG003|COMPLETED|Overall Study||4
8796528|NCT01422135|9848084|FG004|COMPLETED|Overall Study||4
8796529|NCT01422135|9848085|FG005|COMPLETED|Overall Study||3
8796530|NCT01422135|9848080|FG000|NOT COMPLETED|Overall Study||0
8796531|NCT01422135|9848081|FG001|NOT COMPLETED|Overall Study||0
8796532|NCT01422135|9848082|FG002|NOT COMPLETED|Overall Study||1
8796533|NCT01422135|9848083|FG003|NOT COMPLETED|Overall Study||0
8796534|NCT01422135|9848084|FG004|NOT COMPLETED|Overall Study||0
8796535|NCT01422135|9848085|FG005|NOT COMPLETED|Overall Study||1
8796536|NCT01422161|9848093|FG000|STARTED|Overall Study||10
8796537|NCT01422161|9848094|FG001|STARTED|Overall Study||6
8796538|NCT01422161|9848093|FG000|COMPLETED|Overall Study||10
8796539|NCT01422161|9848094|FG001|COMPLETED|Overall Study||6
8796540|NCT01422161|9848093|FG000|NOT COMPLETED|Overall Study||0
8796541|NCT01422161|9848094|FG001|NOT COMPLETED|Overall Study||0
8796542|NCT01422187|9848111|FG000|STARTED|Overall Study||8
8796543|NCT01422187|9848112|FG001|STARTED|Overall Study||9
8796544|NCT01422187|9848113|FG002|STARTED|Overall Study||2
8796545|NCT01422187|9848111|FG000|COMPLETED|Overall Study||7
8796546|NCT01422187|9848112|FG001|COMPLETED|Overall Study||8
8796547|NCT01422187|9848113|FG002|COMPLETED|Overall Study||2
8796548|NCT01422187|9848111|FG000|NOT COMPLETED|Overall Study||1
8796549|NCT01422187|9848112|FG001|NOT COMPLETED|Overall Study||1
8796550|NCT01422187|9848113|FG002|NOT COMPLETED|Overall Study||0
8796551|NCT01422200|9848123|FG000|STARTED|Overall Study||11
8796552|NCT01422200|9848124|FG001|STARTED|Overall Study||11
8796553|NCT01422200|9848123|FG000|COMPLETED|Overall Study||11
8796554|NCT01422200|9848124|FG001|COMPLETED|Overall Study||11
8796555|NCT01422200|9848123|FG000|NOT COMPLETED|Overall Study||0
8796556|NCT01422200|9848124|FG001|NOT COMPLETED|Overall Study||0
8796557|NCT01422213|9848135|FG000|STARTED|Overall Study||196
8796558|NCT01422213|9848136|FG001|STARTED|Overall Study||195
8796559|NCT01422213|9848137|FG002|STARTED|Overall Study||207
8796560|NCT01422213|9848135|FG000|COMPLETED|Overall Study||163
8796561|NCT01422213|9848136|FG001|COMPLETED|Overall Study||173
8796562|NCT01422213|9848137|FG002|COMPLETED|Overall Study||178
8796563|NCT01422213|9848135|FG000|NOT COMPLETED|Overall Study||33
8796564|NCT01422213|9848136|FG001|NOT COMPLETED|Overall Study||22
8796565|NCT01422213|9848137|FG002|NOT COMPLETED|Overall Study||29
8796566|NCT01422226|9848147|FG000|STARTED|Overall Study||1
8796567|NCT01422226|9848148|FG001|STARTED|Overall Study||2
8796568|NCT01422226|9848147|FG000|COMPLETED|Overall Study||1
8796569|NCT01422226|9848148|FG001|COMPLETED|Overall Study||2
8796570|NCT01422226|9848147|FG000|NOT COMPLETED|Overall Study||0
8796571|NCT01422226|9848148|FG001|NOT COMPLETED|Overall Study||0
8796572|NCT01422239|9848156|FG000|STARTED|Overall Study||14
8796573|NCT01422239|9848157|FG001|STARTED|Overall Study||6
8796574|NCT01422239|9848156|FG000|COMPLETED|Overall Study||10
8796575|NCT01422239|9848157|FG001|COMPLETED|Overall Study||3
8796576|NCT01422239|9848156|FG000|NOT COMPLETED|Overall Study||4
9033301|NCT03271528|10095403|FG000|NOT COMPLETED|Medication Dispense/Exposure Period 1||2
9033302|NCT03271528|10095404|FG001|NOT COMPLETED|Medication Dispense/Exposure Period 1||2
9033303|NCT03271528|10095403|FG000|STARTED|Alcohol Trial 1, Washout Period 1||11
9033304|NCT03271528|10095404|FG001|STARTED|Alcohol Trial 1, Washout Period 1||12
9033305|NCT03271528|10095403|FG000|COMPLETED|Alcohol Trial 1, Washout Period 1||9
9033306|NCT03271528|10095404|FG001|COMPLETED|Alcohol Trial 1, Washout Period 1||11
9033307|NCT03271528|10095403|FG000|NOT COMPLETED|Alcohol Trial 1, Washout Period 1||2
9033308|NCT03271528|10095404|FG001|NOT COMPLETED|Alcohol Trial 1, Washout Period 1||1
9033309|NCT03271528|10095403|FG000|STARTED|Medication Dispense/Exposure Period 2||9
9033310|NCT03271528|10095404|FG001|STARTED|Medication Dispense/Exposure Period 2||11
9033311|NCT03271528|10095403|FG000|COMPLETED|Medication Dispense/Exposure Period 2||8
9033312|NCT03271528|10095404|FG001|COMPLETED|Medication Dispense/Exposure Period 2||11
9033313|NCT03271528|10095403|FG000|NOT COMPLETED|Medication Dispense/Exposure Period 2||1
9033314|NCT03271528|10095404|FG001|NOT COMPLETED|Medication Dispense/Exposure Period 2||0
9033315|NCT03271528|10095403|FG000|STARTED|Alcohol Self-Administration Trial 2||8
9033316|NCT03271528|10095404|FG001|STARTED|Alcohol Self-Administration Trial 2||11
9033317|NCT03271528|10095403|FG000|COMPLETED|Alcohol Self-Administration Trial 2||8
9033318|NCT03271528|10095404|FG001|COMPLETED|Alcohol Self-Administration Trial 2||11
9033319|NCT03271528|10095403|FG000|NOT COMPLETED|Alcohol Self-Administration Trial 2||0
9033320|NCT03271528|10095404|FG001|NOT COMPLETED|Alcohol Self-Administration Trial 2||0
9033321|NCT03273153|10095412|FG000|STARTED|Overall Study||224
9033322|NCT03273153|10095413|FG001|STARTED|Overall Study||222
9033323|NCT03273153|10095412|FG000|COMPLETED|Overall Study||0
9033324|NCT03273153|10095413|FG001|COMPLETED|Overall Study||0
9033325|NCT03273153|10095412|FG000|NOT COMPLETED|Overall Study||224
9033326|NCT03273153|10095413|FG001|NOT COMPLETED|Overall Study||222
9033327|NCT03273166|10095419|FG000|STARTED|Overall Study||82
9033328|NCT03273166|10095419|FG000|COMPLETED|Overall Study||51
9033329|NCT03273166|10095419|FG000|NOT COMPLETED|Overall Study||31
9033330|NCT03273257|10095426|FG000|STARTED|Overall Study||7
9033331|NCT03273257|10095427|FG001|STARTED|Overall Study||7
9033332|NCT03273257|10095426|FG000|Started Treatment|Overall Study||7
9033333|NCT03273257|10095427|FG001|Started Treatment|Overall Study|Only 6 patients from the placebo group started treatment because 1 patient died after randomization (= study start), but before initiating treatment|6
9033334|NCT03273257|10095426|FG000|Underwent PEA|Overall Study||6
9033335|NCT03273257|10095427|FG001|Underwent PEA|Overall Study||5
9033336|NCT03273257|10095426|FG000|COMPLETED|Overall Study||3
9033337|NCT03273257|10095427|FG001|COMPLETED|Overall Study||3
9033338|NCT03273257|10095426|FG000|NOT COMPLETED|Overall Study||4
9033339|NCT03273257|10095427|FG001|NOT COMPLETED|Overall Study||4
9033340|NCT03273270|10095435|FG000|STARTED|Overall Study||12
9033341|NCT03273270|10095436|FG001|STARTED|Overall Study||8
9033342|NCT03273270|10095435|FG000|COMPLETED|Overall Study||12
9033343|NCT03273270|10095436|FG001|COMPLETED|Overall Study||8
9033344|NCT03273270|10095435|FG000|NOT COMPLETED|Overall Study||0
9033345|NCT03273270|10095436|FG001|NOT COMPLETED|Overall Study||0
9033346|NCT03273283|10095444|FG000|STARTED|Overall Study||99
9033347|NCT03273283|10095445|FG001|STARTED|Overall Study||101
8672155|NCT00755846|9715641|FG000|COMPLETED|Overall Study||18
8672156|NCT00755846|9715642|FG001|COMPLETED|Overall Study||27
8672157|NCT00755846|9715643|FG002|COMPLETED|Overall Study||32
8796577|NCT01422239|9848157|FG001|NOT COMPLETED|Overall Study||3
8672158|NCT00755846|9715644|FG003|COMPLETED|Overall Study||32
8796578|NCT01422304|9848165|FG000|STARTED|Overall Study|Randomized|598
8796579|NCT01422304|9848166|FG001|STARTED|Overall Study|Randomized|600
8796580|NCT01422304|9848165|FG000|Treated|Overall Study||595
8796581|NCT01422304|9848166|FG001|Treated|Overall Study|1 given sugammadex; thus All Participants as Treated (APaT) Ns are 596 Sugammadex, 588 Usual Care|589
8796582|NCT01422304|9848165|FG000|COMPLETED|Overall Study||574
8796583|NCT01422304|9848166|FG001|COMPLETED|Overall Study||563
8796584|NCT01422304|9848165|FG000|NOT COMPLETED|Overall Study||24
8796585|NCT01422304|9848166|FG001|NOT COMPLETED|Overall Study||37
8796586|NCT01422356|9848172|FG000|STARTED|Overall Study||200
8796587|NCT01422356|9848172|FG000|COMPLETED|Overall Study||169
8796588|NCT01422356|9848172|FG000|NOT COMPLETED|Overall Study||31
8796589|NCT01422369|9848176|FG000|STARTED|NK-104 4mg QD||28
8796590|NCT01422369|9848176|FG000|COMPLETED|NK-104 4mg QD||28
8796591|NCT01422369|9848176|FG000|NOT COMPLETED|NK-104 4mg QD||0
8796592|NCT01422369|9848176|FG000|STARTED|Prezista 800mg/100mg QD||28
8796593|NCT01422369|9848176|FG000|COMPLETED|Prezista 800mg/100mg QD||28
8796594|NCT01422369|9848176|FG000|NOT COMPLETED|Prezista 800mg/100mg QD||0
8796595|NCT01422369|9848176|FG000|STARTED|NK-104 4mg QD & Prezista 800mg/100mg QD||28
8796596|NCT01422369|9848176|FG000|COMPLETED|NK-104 4mg QD & Prezista 800mg/100mg QD||27
8796597|NCT01422369|9848176|FG000|NOT COMPLETED|NK-104 4mg QD & Prezista 800mg/100mg QD||1
8796598|NCT01422382|9848181|FG000|STARTED|NK-104 4mg Once Daily (QD)||28
8796599|NCT01422382|9848181|FG000|COMPLETED|NK-104 4mg Once Daily (QD)||28
8796600|NCT01422382|9848181|FG000|NOT COMPLETED|NK-104 4mg Once Daily (QD)||0
8796601|NCT01422382|9848181|FG000|STARTED|Diltiazem 240 mg QD||28
8796602|NCT01422382|9848181|FG000|COMPLETED|Diltiazem 240 mg QD||28
8796603|NCT01422382|9848181|FG000|NOT COMPLETED|Diltiazem 240 mg QD||0
8796604|NCT01422382|9848181|FG000|STARTED|NK-104 4mg QD and Diltiazem 240 mg QD||28
8796605|NCT01422382|9848181|FG000|COMPLETED|NK-104 4mg QD and Diltiazem 240 mg QD||27
8796606|NCT01422382|9848181|FG000|NOT COMPLETED|NK-104 4mg QD and Diltiazem 240 mg QD||1
8796607|NCT01422408|9848185|FG000|STARTED|Overall Study||34
8796608|NCT01422408|9848185|FG000|COMPLETED|Overall Study||30
8796609|NCT01422408|9848185|FG000|NOT COMPLETED|Overall Study||4
8796610|NCT01422434|9848192|FG000|STARTED|Overall Study||227
8796611|NCT01422434|9848193|FG001|STARTED|Overall Study||226
8796612|NCT01422434|9848194|FG002|STARTED|Overall Study||223
8796613|NCT01422434|9848192|FG000|COMPLETED|Overall Study||216
8796614|NCT01422434|9848193|FG001|COMPLETED|Overall Study||221
8796615|NCT01422434|9848194|FG002|COMPLETED|Overall Study||217
8796616|NCT01422434|9848192|FG000|NOT COMPLETED|Overall Study||11
8796617|NCT01422434|9848193|FG001|NOT COMPLETED|Overall Study||5
8796618|NCT01422434|9848194|FG002|NOT COMPLETED|Overall Study||6
8796619|NCT01422538|9848205|FG000|STARTED|Overall Study||10
8796620|NCT01422538|9848206|FG001|STARTED|Overall Study||10
8796621|NCT01422538|9848207|FG002|STARTED|Overall Study||10
8796622|NCT01422538|9848205|FG000|COMPLETED|Overall Study||10
8796623|NCT01422538|9848206|FG001|COMPLETED|Overall Study||8
8796624|NCT01422538|9848207|FG002|COMPLETED|Overall Study||8
8796625|NCT01422538|9848205|FG000|NOT COMPLETED|Overall Study||0
8796626|NCT01422538|9848206|FG001|NOT COMPLETED|Overall Study||2
8796627|NCT01422538|9848207|FG002|NOT COMPLETED|Overall Study||2
8796628|NCT01422720|9848216|FG000|STARTED|Overall Study||72
9033348|NCT03273283|10095444|FG000|COMPLETED|Overall Study||72
9033349|NCT03273283|10095445|FG001|COMPLETED|Overall Study||81
9033350|NCT03273283|10095444|FG000|NOT COMPLETED|Overall Study||27
9033351|NCT03273283|10095445|FG001|NOT COMPLETED|Overall Study||20
9033352|NCT03273387|10095453|FG000|STARTED|Overall Study||13
9033353|NCT03273387|10095454|FG001|STARTED|Overall Study||13
9033354|NCT03273387|10095453|FG000|COMPLETED|Overall Study||10
9033355|NCT03273387|10095454|FG001|COMPLETED|Overall Study||10
9033356|NCT03273387|10095453|FG000|NOT COMPLETED|Overall Study||3
9033357|NCT03273387|10095454|FG001|NOT COMPLETED|Overall Study||3
9033358|NCT03273426|10095462|FG000|STARTED|Overall Study||20
9033359|NCT03273426|10095463|FG001|STARTED|Overall Study||20
9033360|NCT03273426|10095462|FG000|COMPLETED|Overall Study||20
9033361|NCT03273426|10095463|FG001|COMPLETED|Overall Study||20
9033362|NCT03273426|10095462|FG000|NOT COMPLETED|Overall Study||0
9033363|NCT03273426|10095463|FG001|NOT COMPLETED|Overall Study||0
8796629|NCT01422720|9848216|FG000|Safety Set|Overall Study||72
8796630|NCT01422720|9848216|FG000|Full Analysis Set (FAS)|Overall Study||71
8796631|NCT01422720|9848216|FG000|Per-Protocol Set (PPS)|Overall Study||55
8796632|NCT01422720|9848216|FG000|COMPLETED|Overall Study||50
8796633|NCT01422720|9848216|FG000|NOT COMPLETED|Overall Study||22
8796634|NCT01422824|9848224|FG000|STARTED|Overall Study||185
8796635|NCT01422824|9848224|FG000|Treated|Overall Study||184
8796636|NCT01422824|9848224|FG000|COMPLETED|Overall Study||147
8796637|NCT01422824|9848224|FG000|NOT COMPLETED|Overall Study||38
8796638|NCT01422850|9848228|FG000|STARTED|Overall Study||21
8796639|NCT01422850|9848228|FG000|Week 4 - First Treatment|Overall Study||21
8796640|NCT01422850|9848228|FG000|Week 5|Overall Study|One patient withdrawn by PI due to progressive disease|20
8796641|NCT01422850|9848228|FG000|Week 9 - Second Treatment|Overall Study||20
8796642|NCT01422850|9848228|FG000|Week 14 - Third Treatment|Overall Study|One patient withdrawn by PI and referred to external radiotherapy due to progressive disease.|19
8796643|NCT01422850|9848228|FG000|Week 15|Overall Study|One patient withdrawn by PI due to increased PSA. Started bicalutamide treatment.|18
8796644|NCT01422850|9848228|FG000|COMPLETED|Overall Study||18
8796645|NCT01422850|9848228|FG000|NOT COMPLETED|Overall Study||3
9033364|NCT03273543|10095472|FG000|STARTED|Overall Study||10
9033365|NCT03273543|10095473|FG001|STARTED|Overall Study||10
8796646|NCT01422876|9848244|FG000|STARTED|Week 24||137
8796647|NCT01422876|9848245|FG001|STARTED|Week 24||136
8796648|NCT01422876|9848246|FG002|STARTED|Week 24||141
8796649|NCT01422876|9848247|FG003|STARTED|Week 24||140
8796650|NCT01422876|9848248|FG004|STARTED|Week 24||132
8796651|NCT01422876|9848249|FG005|STARTED|Week 24||137
8796652|NCT01422876|9848250|FG006|STARTED|Week 24||136
8796653|NCT01422876|9848251|FG007|STARTED|Week 24||135
8796654|NCT01422876|9848252|FG008|STARTED|Week 24||134
8796655|NCT01422876|9848253|FG009|STARTED|Week 24||135
8796656|NCT01422876|9848244|FG000|COMPLETED|Week 24||131
8796657|NCT01422876|9848245|FG001|COMPLETED|Week 24||133
8796658|NCT01422876|9848246|FG002|COMPLETED|Week 24||136
8796659|NCT01422876|9848247|FG003|COMPLETED|Week 24||132
8796660|NCT01422876|9848248|FG004|COMPLETED|Week 24||125
8796661|NCT01422876|9848249|FG005|COMPLETED|Week 24||131
8796662|NCT01422876|9848250|FG006|COMPLETED|Week 24||130
8796663|NCT01422876|9848251|FG007|COMPLETED|Week 24||128
8796664|NCT01422876|9848252|FG008|COMPLETED|Week 24||128
8796665|NCT01422876|9848253|FG009|COMPLETED|Week 24||125
8796666|NCT01422876|9848244|FG000|NOT COMPLETED|Week 24||6
8796667|NCT01422876|9848245|FG001|NOT COMPLETED|Week 24||3
8796668|NCT01422876|9848246|FG002|NOT COMPLETED|Week 24||5
8796669|NCT01422876|9848247|FG003|NOT COMPLETED|Week 24||8
8796670|NCT01422876|9848248|FG004|NOT COMPLETED|Week 24||7
8796671|NCT01422876|9848249|FG005|NOT COMPLETED|Week 24||6
8796672|NCT01422876|9848250|FG006|NOT COMPLETED|Week 24||6
8796673|NCT01422876|9848251|FG007|NOT COMPLETED|Week 24||7
8796674|NCT01422876|9848252|FG008|NOT COMPLETED|Week 24||6
8796675|NCT01422876|9848253|FG009|NOT COMPLETED|Week 24||10
8796676|NCT01422876|9848244|FG000|STARTED|Week 52||137
8796677|NCT01422876|9848245|FG001|STARTED|Week 52||136
8796678|NCT01422876|9848246|FG002|STARTED|Week 52||141
8796679|NCT01422876|9848247|FG003|STARTED|Week 52||140
8796680|NCT01422876|9848248|FG004|STARTED|Week 52||132
8796681|NCT01422876|9848249|FG005|STARTED|Week 52||137
8796682|NCT01422876|9848250|FG006|STARTED|Week 52||136
8796683|NCT01422876|9848251|FG007|STARTED|Week 52||135
8796684|NCT01422876|9848252|FG008|STARTED|Week 52||134
8796685|NCT01422876|9848253|FG009|STARTED|Week 52||135
8796686|NCT01422876|9848244|FG000|COMPLETED|Week 52||125
8796687|NCT01422876|9848245|FG001|COMPLETED|Week 52||126
8796688|NCT01422876|9848246|FG002|COMPLETED|Week 52||128
8796689|NCT01422876|9848247|FG003|COMPLETED|Week 52||122
8796690|NCT01422876|9848248|FG004|COMPLETED|Week 52||117
8796691|NCT01422876|9848249|FG005|COMPLETED|Week 52||120
8796692|NCT01422876|9848250|FG006|COMPLETED|Week 52||120
8796693|NCT01422876|9848251|FG007|COMPLETED|Week 52||112
8796694|NCT01422876|9848252|FG008|COMPLETED|Week 52||113
8796695|NCT01422876|9848253|FG009|COMPLETED|Week 52||118
8796696|NCT01422876|9848244|FG000|NOT COMPLETED|Week 52||12
8796697|NCT01422876|9848245|FG001|NOT COMPLETED|Week 52||10
8796698|NCT01422876|9848246|FG002|NOT COMPLETED|Week 52||13
8796699|NCT01422876|9848247|FG003|NOT COMPLETED|Week 52||18
8796700|NCT01422876|9848248|FG004|NOT COMPLETED|Week 52||15
8796701|NCT01422876|9848249|FG005|NOT COMPLETED|Week 52||17
8796702|NCT01422876|9848250|FG006|NOT COMPLETED|Week 52||16
8796703|NCT01422876|9848251|FG007|NOT COMPLETED|Week 52||23
8796704|NCT01422876|9848252|FG008|NOT COMPLETED|Week 52||21
8796705|NCT01422876|9848253|FG009|NOT COMPLETED|Week 52||17
8796706|NCT01422889|9848271|FG000|STARTED|Overall Study||1120
8796707|NCT01422889|9848271|FG000|COMPLETED|Overall Study|9 subjects did not receive a study stent therefore 1111 subjects were eligible for follow up.|1111
8796708|NCT01422889|9848271|FG000|NOT COMPLETED|Overall Study||9
8796709|NCT01422915|9848275|FG000|STARTED|Overall Study|1 subject with abnormal liver chemistries removed during the first period.|4
8796710|NCT01422915|9848275|FG000|COMPLETED|Overall Study||3
8796711|NCT01422915|9848275|FG000|NOT COMPLETED|Overall Study||1
8796712|NCT01423084|9848282|FG000|STARTED|Overall Study||170
8796713|NCT01423084|9848283|FG001|STARTED|Overall Study||174
8796714|NCT01423084|9848282|FG000|COMPLETED|Overall Study||168
8796715|NCT01423084|9848283|FG001|COMPLETED|Overall Study||170
9033366|NCT03273543|10095472|FG000|COMPLETED|Overall Study||10
9033367|NCT03273543|10095473|FG001|COMPLETED|Overall Study||10
9033368|NCT03273543|10095472|FG000|NOT COMPLETED|Overall Study||0
9033369|NCT03273543|10095473|FG001|NOT COMPLETED|Overall Study||0
9033370|NCT03273673|10095481|FG000|STARTED|Overall Study||18
8796716|NCT01423084|9848282|FG000|NOT COMPLETED|Overall Study||2
8796717|NCT01423084|9848283|FG001|NOT COMPLETED|Overall Study||4
8796718|NCT01423162|9848292|FG000|STARTED|Overall Study||11
8796719|NCT01423162|9848293|FG001|STARTED|Overall Study||9
8796720|NCT01423162|9848292|FG000|COMPLETED|Overall Study|Crossover design: All subjects (n=20) completed both arms|11
8796721|NCT01423162|9848293|FG001|COMPLETED|Overall Study|Crossover design: All subjects (n=20) completed both arms|9
8796722|NCT01423162|9848292|FG000|NOT COMPLETED|Overall Study||0
8796723|NCT01423162|9848293|FG001|NOT COMPLETED|Overall Study||0
8796724|NCT01423253|9848299|FG000|STARTED|Overall Study||48
8796725|NCT01423253|9848299|FG000|COMPLETED|Overall Study||39
8796726|NCT01423253|9848299|FG000|NOT COMPLETED|Overall Study||9
8796727|NCT01423604|9848306|FG000|STARTED|Safety Run-In||9
8796728|NCT01423604|9848307|FG001|STARTED|Safety Run-In||0
8796729|NCT01423604|9848306|FG000|COMPLETED|Safety Run-In||0
8796730|NCT01423604|9848307|FG001|COMPLETED|Safety Run-In||0
8796731|NCT01423604|9848306|FG000|NOT COMPLETED|Safety Run-In||9
8796732|NCT01423604|9848307|FG001|NOT COMPLETED|Safety Run-In||0
8796733|NCT01423604|9848306|FG000|STARTED|Randomized||64
8796734|NCT01423604|9848307|FG001|STARTED|Randomized||63
8917708|NCT02195232|9977495|FG001|STARTED|Overall Study|patients consented|32
9033371|NCT03273673|10095482|FG001|STARTED|Overall Study||22
8796735|NCT01423604|9848306|FG000|COMPLETED|Randomized|As of 07August2015, 1 subject was receiving treatment in the randomized portion.|1
8796736|NCT01423604|9848307|FG001|COMPLETED|Randomized||0
8796737|NCT01423604|9848306|FG000|NOT COMPLETED|Randomized||63
8796738|NCT01423604|9848307|FG001|NOT COMPLETED|Randomized||63
8796739|NCT01423617|9848316|FG000|STARTED|Overall Study||46
8796740|NCT01423617|9848317|FG001|STARTED|Overall Study||46
8796741|NCT01423617|9848316|FG000|COMPLETED|Overall Study||46
8796742|NCT01423617|9848317|FG001|COMPLETED|Overall Study||45
8796743|NCT01423617|9848316|FG000|NOT COMPLETED|Overall Study||0
8796744|NCT01423617|9848317|FG001|NOT COMPLETED|Overall Study||1
8796745|NCT01423760|9848325|FG000|STARTED|Overall Study||14
8796746|NCT01423760|9848326|FG001|STARTED|Overall Study||13
8796747|NCT01423760|9848325|FG000|Number of Tecemotide Subjects|Overall Study||12
8796748|NCT01423760|9848326|FG001|Number of Tecemotide Subjects|Overall Study||8
8796749|NCT01423760|9848325|FG000|Number of Non-treatment Subjects|Overall Study||2
8796750|NCT01423760|9848326|FG001|Number of Non-treatment Subjects|Overall Study||5
8796751|NCT01423760|9848325|FG000|Safety Analysis Set|Overall Study||12
8796752|NCT01423760|9848326|FG001|Safety Analysis Set|Overall Study||8
8796753|NCT01423760|9848325|FG000|COMPLETED|Overall Study||14
8796754|NCT01423760|9848326|FG001|COMPLETED|Overall Study||13
8796755|NCT01423760|9848325|FG000|NOT COMPLETED|Overall Study||0
8796756|NCT01423760|9848326|FG001|NOT COMPLETED|Overall Study||0
8796757|NCT01423773|9848332|FG000|STARTED|Period One, 2 Days||10
8796758|NCT01423773|9848333|FG001|STARTED|Period One, 2 Days||10
8796759|NCT01423773|9848332|FG000|COMPLETED|Period One, 2 Days||10
8796760|NCT01423773|9848333|FG001|COMPLETED|Period One, 2 Days||10
8796761|NCT01423773|9848332|FG000|NOT COMPLETED|Period One, 2 Days||0
8796762|NCT01423773|9848333|FG001|NOT COMPLETED|Period One, 2 Days||0
8796763|NCT01423773|9848332|FG000|STARTED|Period 2, 2 Days||10
8796764|NCT01423773|9848333|FG001|STARTED|Period 2, 2 Days||10
8796765|NCT01423773|9848332|FG000|COMPLETED|Period 2, 2 Days||10
8796766|NCT01423773|9848333|FG001|COMPLETED|Period 2, 2 Days||10
8796767|NCT01423773|9848332|FG000|NOT COMPLETED|Period 2, 2 Days||0
8796768|NCT01423773|9848333|FG001|NOT COMPLETED|Period 2, 2 Days||0
8796769|NCT01423812|9848341|FG000|STARTED|Overall Study||30
8796770|NCT01423812|9848342|FG001|STARTED|Overall Study||30
8796771|NCT01423812|9848341|FG000|COMPLETED|Overall Study||27
8796772|NCT01423812|9848342|FG001|COMPLETED|Overall Study||26
8796773|NCT01423812|9848341|FG000|NOT COMPLETED|Overall Study||3
8796774|NCT01423812|9848342|FG001|NOT COMPLETED|Overall Study||4
8796775|NCT01423916|9848353|FG000|STARTED|Overall Study||74
8796776|NCT01423916|9848354|FG001|STARTED|Overall Study||73
8796777|NCT01423916|9848355|FG002|STARTED|Overall Study||71
8796778|NCT01423916|9848353|FG000|COMPLETED|Overall Study||63
8796779|NCT01423916|9848354|FG001|COMPLETED|Overall Study||53
8796780|NCT01423916|9848355|FG002|COMPLETED|Overall Study||64
8796781|NCT01423916|9848353|FG000|NOT COMPLETED|Overall Study||11
8796782|NCT01423916|9848354|FG001|NOT COMPLETED|Overall Study||20
8796783|NCT01423916|9848355|FG002|NOT COMPLETED|Overall Study||7
8796784|NCT01424033|9848374|FG000|STARTED|Overall Study||5
8796785|NCT01424033|9848374|FG000|COMPLETED|Overall Study||0
8796786|NCT01424033|9848374|FG000|NOT COMPLETED|Overall Study||5
8796787|NCT01424072|9848381|FG000|STARTED|Overall Study||27
8796788|NCT01424072|9848382|FG001|STARTED|Overall Study||26
8796789|NCT01424072|9848383|FG002|STARTED|Overall Study||22
8796790|NCT01424072|9848381|FG000|COMPLETED|Overall Study||27
8796791|NCT01424072|9848382|FG001|COMPLETED|Overall Study||26
8796792|NCT01424072|9848383|FG002|COMPLETED|Overall Study||22
8796793|NCT01424072|9848381|FG000|NOT COMPLETED|Overall Study||0
8796794|NCT01424072|9848382|FG001|NOT COMPLETED|Overall Study||0
8796795|NCT01424072|9848383|FG002|NOT COMPLETED|Overall Study||0
8796796|NCT01424189|9848393|FG000|STARTED|Overall Study||386
8796797|NCT01424189|9848394|FG001|STARTED|Overall Study||188
8796798|NCT01424189|9848393|FG000|COMPLETED|Overall Study||373
8796799|NCT01424189|9848394|FG001|COMPLETED|Overall Study||182
8796800|NCT01424189|9848393|FG000|NOT COMPLETED|Overall Study||13
8796801|NCT01424189|9848394|FG001|NOT COMPLETED|Overall Study||6
8796802|NCT01424215|9848402|FG000|STARTED|Overall Study||50
8796803|NCT01424215|9848403|FG001|STARTED|Overall Study||50
8796804|NCT01424215|9848402|FG000|COMPLETED|Overall Study||50
8796805|NCT01424215|9848403|FG001|COMPLETED|Overall Study||50
8917709|NCT02195232|9977494|FG000|COMPLETED|Overall Study|Evaluated for VTE and safety|28
8796806|NCT01424215|9848402|FG000|NOT COMPLETED|Overall Study||0
8796807|NCT01424215|9848403|FG001|NOT COMPLETED|Overall Study||0
8796808|NCT01424228|9848411|FG000|STARTED|Overall Study||182
8796809|NCT01424228|9848412|FG001|STARTED|Overall Study||182
8796810|NCT01424228|9848411|FG000|COMPLETED|Overall Study||126
8796811|NCT01424228|9848412|FG001|COMPLETED|Overall Study||135
8796812|NCT01424228|9848411|FG000|NOT COMPLETED|Overall Study||56
8796813|NCT01424228|9848412|FG001|NOT COMPLETED|Overall Study||47
8796814|NCT01424293|9848418|FG000|STARTED|Overall Study||7
8796815|NCT01424293|9848418|FG000|COMPLETED|Overall Study||7
8796816|NCT01424293|9848418|FG000|NOT COMPLETED|Overall Study||0
8796817|NCT01424306|9848422|FG000|STARTED|Overall Study||4
8796818|NCT01424306|9848423|FG001|STARTED|Overall Study||4
8796819|NCT01424306|9848424|FG002|STARTED|Overall Study||3
8796820|NCT01424306|9848425|FG003|STARTED|Overall Study||3
8796821|NCT01424306|9848426|FG004|STARTED|Overall Study||5
8796822|NCT01424306|9848427|FG005|STARTED|Overall Study||6
8796823|NCT01424306|9848422|FG000|COMPLETED|Overall Study||4
8796824|NCT01424306|9848423|FG001|COMPLETED|Overall Study||4
8796825|NCT01424306|9848424|FG002|COMPLETED|Overall Study||3
8796826|NCT01424306|9848425|FG003|COMPLETED|Overall Study||3
8796827|NCT01424306|9848426|FG004|COMPLETED|Overall Study||4
8796828|NCT01424306|9848427|FG005|COMPLETED|Overall Study||6
8796829|NCT01424306|9848422|FG000|NOT COMPLETED|Overall Study||0
8796830|NCT01424306|9848423|FG001|NOT COMPLETED|Overall Study||0
8796831|NCT01424306|9848424|FG002|NOT COMPLETED|Overall Study||0
8796832|NCT01424306|9848425|FG003|NOT COMPLETED|Overall Study||0
8796833|NCT01424306|9848426|FG004|NOT COMPLETED|Overall Study||1
8796834|NCT01424306|9848427|FG005|NOT COMPLETED|Overall Study||0
8796835|NCT01424397|9848471|FG000|STARTED|Period-1 (8 Days)||7
8796836|NCT01424397|9848472|FG001|STARTED|Period-1 (8 Days)||8
8796837|NCT01424397|9848473|FG002|STARTED|Period-1 (8 Days)||8
8796838|NCT01424397|9848474|FG003|STARTED|Period-1 (8 Days)||8
8796839|NCT01424397|9848475|FG004|STARTED|Period-1 (8 Days)||8
8796840|NCT01424397|9848476|FG005|STARTED|Period-1 (8 Days)||8
8796841|NCT01424397|9848477|FG006|STARTED|Period-1 (8 Days)||4
8796842|NCT01424397|9848478|FG007|STARTED|Period-1 (8 Days)||4
8796843|NCT01424397|9848479|FG008|STARTED|Period-1 (8 Days)||4
8796844|NCT01424397|9848480|FG009|STARTED|Period-1 (8 Days)||3
8796845|NCT01424397|9848481|FG010|STARTED|Period-1 (8 Days)||4
8796846|NCT01424397|9848482|FG011|STARTED|Period-1 (8 Days)||4
8796847|NCT01424397|9848471|FG000|COMPLETED|Period-1 (8 Days)||7
8796848|NCT01424397|9848472|FG001|COMPLETED|Period-1 (8 Days)||8
8796849|NCT01424397|9848473|FG002|COMPLETED|Period-1 (8 Days)||8
8796850|NCT01424397|9848474|FG003|COMPLETED|Period-1 (8 Days)||8
8796851|NCT01424397|9848475|FG004|COMPLETED|Period-1 (8 Days)||8
8796852|NCT01424397|9848476|FG005|COMPLETED|Period-1 (8 Days)||8
8796853|NCT01424397|9848477|FG006|COMPLETED|Period-1 (8 Days)||4
8796854|NCT01424397|9848478|FG007|COMPLETED|Period-1 (8 Days)||4
8796855|NCT01424397|9848479|FG008|COMPLETED|Period-1 (8 Days)||4
8796856|NCT01424397|9848480|FG009|COMPLETED|Period-1 (8 Days)||3
8796857|NCT01424397|9848481|FG010|COMPLETED|Period-1 (8 Days)||4
8796858|NCT01424397|9848482|FG011|COMPLETED|Period-1 (8 Days)||4
8796859|NCT01424397|9848471|FG000|NOT COMPLETED|Period-1 (8 Days)||0
8796860|NCT01424397|9848472|FG001|NOT COMPLETED|Period-1 (8 Days)||0
8796861|NCT01424397|9848473|FG002|NOT COMPLETED|Period-1 (8 Days)||0
8796862|NCT01424397|9848474|FG003|NOT COMPLETED|Period-1 (8 Days)||0
8796863|NCT01424397|9848475|FG004|NOT COMPLETED|Period-1 (8 Days)||0
8796864|NCT01424397|9848476|FG005|NOT COMPLETED|Period-1 (8 Days)||0
8796865|NCT01424397|9848477|FG006|NOT COMPLETED|Period-1 (8 Days)||0
8796866|NCT01424397|9848478|FG007|NOT COMPLETED|Period-1 (8 Days)||0
8796867|NCT01424397|9848479|FG008|NOT COMPLETED|Period-1 (8 Days)||0
8796868|NCT01424397|9848480|FG009|NOT COMPLETED|Period-1 (8 Days)||0
8796869|NCT01424397|9848481|FG010|NOT COMPLETED|Period-1 (8 Days)||0
8796870|NCT01424397|9848482|FG011|NOT COMPLETED|Period-1 (8 Days)||0
8796871|NCT01424397|9848471|FG000|STARTED|Washout Period-1 (14-20 Days)||7
8796872|NCT01424397|9848472|FG001|STARTED|Washout Period-1 (14-20 Days)||8
8796873|NCT01424397|9848473|FG002|STARTED|Washout Period-1 (14-20 Days)||8
8796874|NCT01424397|9848474|FG003|STARTED|Washout Period-1 (14-20 Days)||8
8796875|NCT01424397|9848475|FG004|STARTED|Washout Period-1 (14-20 Days)||8
8796876|NCT01424397|9848476|FG005|STARTED|Washout Period-1 (14-20 Days)||8
8796877|NCT01424397|9848477|FG006|STARTED|Washout Period-1 (14-20 Days)||4
8796878|NCT01424397|9848478|FG007|STARTED|Washout Period-1 (14-20 Days)||4
8796879|NCT01424397|9848479|FG008|STARTED|Washout Period-1 (14-20 Days)||4
8796880|NCT01424397|9848480|FG009|STARTED|Washout Period-1 (14-20 Days)||3
8796881|NCT01424397|9848481|FG010|STARTED|Washout Period-1 (14-20 Days)||4
8796882|NCT01424397|9848482|FG011|STARTED|Washout Period-1 (14-20 Days)||4
8796883|NCT01424397|9848471|FG000|COMPLETED|Washout Period-1 (14-20 Days)||7
8796884|NCT01424397|9848472|FG001|COMPLETED|Washout Period-1 (14-20 Days)||8
8796885|NCT01424397|9848473|FG002|COMPLETED|Washout Period-1 (14-20 Days)||8
8796886|NCT01424397|9848474|FG003|COMPLETED|Washout Period-1 (14-20 Days)||8
8796887|NCT01424397|9848475|FG004|COMPLETED|Washout Period-1 (14-20 Days)||8
8796888|NCT01424397|9848476|FG005|COMPLETED|Washout Period-1 (14-20 Days)||8
8796889|NCT01424397|9848477|FG006|COMPLETED|Washout Period-1 (14-20 Days)||4
8796890|NCT01424397|9848478|FG007|COMPLETED|Washout Period-1 (14-20 Days)||4
8796891|NCT01424397|9848479|FG008|COMPLETED|Washout Period-1 (14-20 Days)||4
8796892|NCT01424397|9848480|FG009|COMPLETED|Washout Period-1 (14-20 Days)||3
8796893|NCT01424397|9848481|FG010|COMPLETED|Washout Period-1 (14-20 Days)||4
8796894|NCT01424397|9848482|FG011|COMPLETED|Washout Period-1 (14-20 Days)||4
8796895|NCT01424397|9848471|FG000|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
8917710|NCT02195232|9977495|FG001|COMPLETED|Overall Study|Evaluated for VTE and safety|29
8917711|NCT02195232|9977494|FG000|NOT COMPLETED|Overall Study||4
8917712|NCT02195232|9977495|FG001|NOT COMPLETED|Overall Study||3
8917713|NCT02195310|9977507|FG000|STARTED|Overall Study||173
8917714|NCT02195310|9977508|FG001|STARTED|Overall Study||169
8917715|NCT02195310|9977507|FG000|COMPLETED|Overall Study||153
8917716|NCT02195310|9977508|FG001|COMPLETED|Overall Study||153
8917717|NCT02195310|9977507|FG000|NOT COMPLETED|Overall Study||20
8917718|NCT02195310|9977508|FG001|NOT COMPLETED|Overall Study||16
8917719|NCT02195349|9977525|FG000|STARTED|Overall Study||14
8917720|NCT02195349|9977526|FG001|STARTED|Overall Study||1
8917721|NCT02195349|9977527|FG002|STARTED|Overall Study||1
8796896|NCT01424397|9848472|FG001|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
8917722|NCT02195349|9977528|FG003|STARTED|Overall Study||6
8917723|NCT02195349|9977529|FG004|STARTED|Overall Study||6
8917724|NCT02195349|9977530|FG005|STARTED|Overall Study||6
8917725|NCT02195349|9977531|FG006|STARTED|Overall Study||6
8796897|NCT01424397|9848473|FG002|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
8796898|NCT01424397|9848474|FG003|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
8796899|NCT01424397|9848475|FG004|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
8796900|NCT01424397|9848476|FG005|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
8796901|NCT01424397|9848477|FG006|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
8796902|NCT01424397|9848478|FG007|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
8796903|NCT01424397|9848479|FG008|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
8796904|NCT01424397|9848480|FG009|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
8796905|NCT01424397|9848481|FG010|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
8796906|NCT01424397|9848482|FG011|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
8796907|NCT01424397|9848471|FG000|STARTED|Period-2 (8 Days)||7
8796908|NCT01424397|9848472|FG001|STARTED|Period-2 (8 Days)||8
8796909|NCT01424397|9848473|FG002|STARTED|Period-2 (8 Days)||8
8796910|NCT01424397|9848474|FG003|STARTED|Period-2 (8 Days)||8
8796911|NCT01424397|9848475|FG004|STARTED|Period-2 (8 Days)||8
8796912|NCT01424397|9848476|FG005|STARTED|Period-2 (8 Days)||8
8796913|NCT01424397|9848477|FG006|STARTED|Period-2 (8 Days)||4
8796914|NCT01424397|9848478|FG007|STARTED|Period-2 (8 Days)||4
8796915|NCT01424397|9848479|FG008|STARTED|Period-2 (8 Days)||4
8796916|NCT01424397|9848480|FG009|STARTED|Period-2 (8 Days)||3
8796917|NCT01424397|9848481|FG010|STARTED|Period-2 (8 Days)||4
8796918|NCT01424397|9848482|FG011|STARTED|Period-2 (8 Days)||4
8796919|NCT01424397|9848471|FG000|COMPLETED|Period-2 (8 Days)||7
8796920|NCT01424397|9848472|FG001|COMPLETED|Period-2 (8 Days)||8
8796921|NCT01424397|9848473|FG002|COMPLETED|Period-2 (8 Days)||7
8796922|NCT01424397|9848474|FG003|COMPLETED|Period-2 (8 Days)||8
8796923|NCT01424397|9848475|FG004|COMPLETED|Period-2 (8 Days)||8
8796924|NCT01424397|9848476|FG005|COMPLETED|Period-2 (8 Days)||8
8796925|NCT01424397|9848477|FG006|COMPLETED|Period-2 (8 Days)||4
8796926|NCT01424397|9848478|FG007|COMPLETED|Period-2 (8 Days)||4
8796927|NCT01424397|9848479|FG008|COMPLETED|Period-2 (8 Days)||4
8796928|NCT01424397|9848480|FG009|COMPLETED|Period-2 (8 Days)||3
8796929|NCT01424397|9848481|FG010|COMPLETED|Period-2 (8 Days)||4
8796930|NCT01424397|9848482|FG011|COMPLETED|Period-2 (8 Days)||4
8796931|NCT01424397|9848471|FG000|NOT COMPLETED|Period-2 (8 Days)||0
8796932|NCT01424397|9848472|FG001|NOT COMPLETED|Period-2 (8 Days)||0
8796933|NCT01424397|9848473|FG002|NOT COMPLETED|Period-2 (8 Days)||1
8796934|NCT01424397|9848474|FG003|NOT COMPLETED|Period-2 (8 Days)||0
8796935|NCT01424397|9848475|FG004|NOT COMPLETED|Period-2 (8 Days)||0
8796936|NCT01424397|9848476|FG005|NOT COMPLETED|Period-2 (8 Days)||0
8796937|NCT01424397|9848477|FG006|NOT COMPLETED|Period-2 (8 Days)||0
8796938|NCT01424397|9848478|FG007|NOT COMPLETED|Period-2 (8 Days)||0
8796939|NCT01424397|9848479|FG008|NOT COMPLETED|Period-2 (8 Days)||0
8796940|NCT01424397|9848480|FG009|NOT COMPLETED|Period-2 (8 Days)||0
8796941|NCT01424397|9848481|FG010|NOT COMPLETED|Period-2 (8 Days)||0
8796942|NCT01424397|9848482|FG011|NOT COMPLETED|Period-2 (8 Days)||0
8796943|NCT01424397|9848471|FG000|STARTED|Washout Period-2 (14-20 Days)||7
8796944|NCT01424397|9848472|FG001|STARTED|Washout Period-2 (14-20 Days)||8
8796945|NCT01424397|9848473|FG002|STARTED|Washout Period-2 (14-20 Days)||7
8796946|NCT01424397|9848474|FG003|STARTED|Washout Period-2 (14-20 Days)||8
8796947|NCT01424397|9848475|FG004|STARTED|Washout Period-2 (14-20 Days)||8
8796948|NCT01424397|9848476|FG005|STARTED|Washout Period-2 (14-20 Days)||8
8796949|NCT01424397|9848477|FG006|STARTED|Washout Period-2 (14-20 Days)||4
8796950|NCT01424397|9848478|FG007|STARTED|Washout Period-2 (14-20 Days)||4
8796951|NCT01424397|9848479|FG008|STARTED|Washout Period-2 (14-20 Days)||4
8796952|NCT01424397|9848480|FG009|STARTED|Washout Period-2 (14-20 Days)||3
8796953|NCT01424397|9848481|FG010|STARTED|Washout Period-2 (14-20 Days)||4
8796954|NCT01424397|9848482|FG011|STARTED|Washout Period-2 (14-20 Days)||4
8796955|NCT01424397|9848471|FG000|COMPLETED|Washout Period-2 (14-20 Days)||7
8796956|NCT01424397|9848472|FG001|COMPLETED|Washout Period-2 (14-20 Days)||8
8796957|NCT01424397|9848473|FG002|COMPLETED|Washout Period-2 (14-20 Days)||7
8796958|NCT01424397|9848474|FG003|COMPLETED|Washout Period-2 (14-20 Days)||8
8796959|NCT01424397|9848475|FG004|COMPLETED|Washout Period-2 (14-20 Days)||8
8796960|NCT01424397|9848476|FG005|COMPLETED|Washout Period-2 (14-20 Days)||8
8796961|NCT01424397|9848477|FG006|COMPLETED|Washout Period-2 (14-20 Days)||4
8796962|NCT01424397|9848478|FG007|COMPLETED|Washout Period-2 (14-20 Days)||4
8796963|NCT01424397|9848479|FG008|COMPLETED|Washout Period-2 (14-20 Days)||4
8796964|NCT01424397|9848480|FG009|COMPLETED|Washout Period-2 (14-20 Days)||3
8796965|NCT01424397|9848481|FG010|COMPLETED|Washout Period-2 (14-20 Days)||4
8796966|NCT01424397|9848482|FG011|COMPLETED|Washout Period-2 (14-20 Days)||4
8796967|NCT01424397|9848471|FG000|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
8796968|NCT01424397|9848472|FG001|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
8796969|NCT01424397|9848473|FG002|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
8796970|NCT01424397|9848474|FG003|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
8796971|NCT01424397|9848475|FG004|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
8796972|NCT01424397|9848476|FG005|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
8796973|NCT01424397|9848477|FG006|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
8796974|NCT01424397|9848478|FG007|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
8796975|NCT01424397|9848479|FG008|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
8796976|NCT01424397|9848480|FG009|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
8796977|NCT01424397|9848481|FG010|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
8796978|NCT01424397|9848482|FG011|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
8796979|NCT01424397|9848471|FG000|STARTED|Period-3 (8 Days)||7
8796980|NCT01424397|9848472|FG001|STARTED|Period-3 (8 Days)||8
8796981|NCT01424397|9848473|FG002|STARTED|Period-3 (8 Days)||7
8796982|NCT01424397|9848474|FG003|STARTED|Period-3 (8 Days)||8
8796983|NCT01424397|9848475|FG004|STARTED|Period-3 (8 Days)||8
8796984|NCT01424397|9848476|FG005|STARTED|Period-3 (8 Days)||8
8796985|NCT01424397|9848477|FG006|STARTED|Period-3 (8 Days)||4
8796986|NCT01424397|9848478|FG007|STARTED|Period-3 (8 Days)||4
8796987|NCT01424397|9848479|FG008|STARTED|Period-3 (8 Days)||4
8796988|NCT01424397|9848480|FG009|STARTED|Period-3 (8 Days)||3
8796989|NCT01424397|9848481|FG010|STARTED|Period-3 (8 Days)||4
8796990|NCT01424397|9848482|FG011|STARTED|Period-3 (8 Days)||4
8796991|NCT01424397|9848471|FG000|COMPLETED|Period-3 (8 Days)||7
8796992|NCT01424397|9848472|FG001|COMPLETED|Period-3 (8 Days)||8
8796993|NCT01424397|9848473|FG002|COMPLETED|Period-3 (8 Days)||7
8796994|NCT01424397|9848474|FG003|COMPLETED|Period-3 (8 Days)||8
8796995|NCT01424397|9848475|FG004|COMPLETED|Period-3 (8 Days)||8
8796996|NCT01424397|9848476|FG005|COMPLETED|Period-3 (8 Days)||8
8796997|NCT01424397|9848477|FG006|COMPLETED|Period-3 (8 Days)||4
8796998|NCT01424397|9848478|FG007|COMPLETED|Period-3 (8 Days)||4
8796999|NCT01424397|9848479|FG008|COMPLETED|Period-3 (8 Days)||4
8797000|NCT01424397|9848480|FG009|COMPLETED|Period-3 (8 Days)||3
8797001|NCT01424397|9848481|FG010|COMPLETED|Period-3 (8 Days)||4
8797002|NCT01424397|9848482|FG011|COMPLETED|Period-3 (8 Days)||4
8797003|NCT01424397|9848471|FG000|NOT COMPLETED|Period-3 (8 Days)||0
8797004|NCT01424397|9848472|FG001|NOT COMPLETED|Period-3 (8 Days)||0
8797005|NCT01424397|9848473|FG002|NOT COMPLETED|Period-3 (8 Days)||0
8797006|NCT01424397|9848474|FG003|NOT COMPLETED|Period-3 (8 Days)||0
8797007|NCT01424397|9848475|FG004|NOT COMPLETED|Period-3 (8 Days)||0
8797008|NCT01424397|9848476|FG005|NOT COMPLETED|Period-3 (8 Days)||0
8797009|NCT01424397|9848477|FG006|NOT COMPLETED|Period-3 (8 Days)||0
8797010|NCT01424397|9848478|FG007|NOT COMPLETED|Period-3 (8 Days)||0
8797011|NCT01424397|9848479|FG008|NOT COMPLETED|Period-3 (8 Days)||0
8797012|NCT01424397|9848480|FG009|NOT COMPLETED|Period-3 (8 Days)||0
8797013|NCT01424397|9848481|FG010|NOT COMPLETED|Period-3 (8 Days)||0
8797014|NCT01424397|9848482|FG011|NOT COMPLETED|Period-3 (8 Days)||0
8797015|NCT01424501|9848502|FG000|STARTED|Overall Study||7
8797016|NCT01424501|9848503|FG001|STARTED|Overall Study||6
8797017|NCT01424501|9848504|FG002|STARTED|Overall Study||24
8797018|NCT01424501|9848505|FG003|STARTED|Overall Study||25
8797019|NCT01424501|9848506|FG004|STARTED|Overall Study||40
8797020|NCT01424501|9848507|FG005|STARTED|Overall Study||40
8797021|NCT01424501|9848502|FG000|COMPLETED|Overall Study||6
8797022|NCT01424501|9848503|FG001|COMPLETED|Overall Study||5
8797023|NCT01424501|9848504|FG002|COMPLETED|Overall Study||22
8797024|NCT01424501|9848505|FG003|COMPLETED|Overall Study||25
8797025|NCT01424501|9848506|FG004|COMPLETED|Overall Study||40
8797026|NCT01424501|9848507|FG005|COMPLETED|Overall Study||40
8797027|NCT01424501|9848502|FG000|NOT COMPLETED|Overall Study||1
8797028|NCT01424501|9848503|FG001|NOT COMPLETED|Overall Study||1
8797029|NCT01424501|9848504|FG002|NOT COMPLETED|Overall Study||2
8797030|NCT01424501|9848505|FG003|NOT COMPLETED|Overall Study||0
8797031|NCT01424501|9848506|FG004|NOT COMPLETED|Overall Study||0
8797032|NCT01424501|9848507|FG005|NOT COMPLETED|Overall Study||0
8797033|NCT01424514|9848522|FG000|STARTED|Period 1:Intervention Period 1 (14 Days)||20
8797034|NCT01424514|9848523|FG001|STARTED|Period 1:Intervention Period 1 (14 Days)||20
8797035|NCT01424514|9848522|FG000|COMPLETED|Period 1:Intervention Period 1 (14 Days)||19
8797036|NCT01424514|9848523|FG001|COMPLETED|Period 1:Intervention Period 1 (14 Days)||19
8797037|NCT01424514|9848522|FG000|NOT COMPLETED|Period 1:Intervention Period 1 (14 Days)||1
8797038|NCT01424514|9848523|FG001|NOT COMPLETED|Period 1:Intervention Period 1 (14 Days)||1
8797039|NCT01424514|9848522|FG000|STARTED|Period 2:Washout Period (4 Weeks)||19
8797040|NCT01424514|9848523|FG001|STARTED|Period 2:Washout Period (4 Weeks)||19
8797041|NCT01424514|9848522|FG000|COMPLETED|Period 2:Washout Period (4 Weeks)||19
8672159|NCT00755846|9715645|FG004|COMPLETED|Overall Study||27
8797042|NCT01424514|9848523|FG001|COMPLETED|Period 2:Washout Period (4 Weeks)||19
8797043|NCT01424514|9848522|FG000|NOT COMPLETED|Period 2:Washout Period (4 Weeks)||0
8797044|NCT01424514|9848523|FG001|NOT COMPLETED|Period 2:Washout Period (4 Weeks)||0
8797045|NCT01424514|9848522|FG000|STARTED|Period 3:Intervention Period 2 (14 Days)||19
8797046|NCT01424514|9848523|FG001|STARTED|Period 3:Intervention Period 2 (14 Days)||19
8797047|NCT01424514|9848522|FG000|COMPLETED|Period 3:Intervention Period 2 (14 Days)||18
8797048|NCT01424514|9848523|FG001|COMPLETED|Period 3:Intervention Period 2 (14 Days)||19
8797049|NCT01424514|9848522|FG000|NOT COMPLETED|Period 3:Intervention Period 2 (14 Days)||1
8797050|NCT01424514|9848523|FG001|NOT COMPLETED|Period 3:Intervention Period 2 (14 Days)||0
8797051|NCT01424566|9848534|FG000|STARTED|Single-blind Treatment||406
8797052|NCT01424566|9848535|FG001|STARTED|Single-blind Treatment|Participants were not enrolled in this arm in the single-blind period.|0
8797053|NCT01424566|9848536|FG002|STARTED|Single-blind Treatment|Participants were not enrolled in this arm in the single-blind period.|0
8797054|NCT01424566|9848534|FG000|Received at Least 1 Dose of Study Drug|Single-blind Treatment|Two participants did not administer any study drug.|404
8917726|NCT02195349|9977532|FG007|STARTED|Overall Study||9
8797055|NCT01424566|9848535|FG001|Received at Least 1 Dose of Study Drug|Single-blind Treatment||0
8797056|NCT01424566|9848536|FG002|Received at Least 1 Dose of Study Drug|Single-blind Treatment||0
8797057|NCT01424566|9848534|FG000|Single-blind Safety Population|Single-blind Treatment||404
8797058|NCT01424566|9848535|FG001|Single-blind Safety Population|Single-blind Treatment||0
8797059|NCT01424566|9848536|FG002|Single-blind Safety Population|Single-blind Treatment||0
8797060|NCT01424566|9848534|FG000|Met Randomization Criteria|Single-blind Treatment||206
8797061|NCT01424566|9848535|FG001|Met Randomization Criteria|Single-blind Treatment||0
8797062|NCT01424566|9848536|FG002|Met Randomization Criteria|Single-blind Treatment||0
8797063|NCT01424566|9848534|FG000|COMPLETED|Single-blind Treatment||206
8797064|NCT01424566|9848535|FG001|COMPLETED|Single-blind Treatment||0
8797065|NCT01424566|9848536|FG002|COMPLETED|Single-blind Treatment||0
8797066|NCT01424566|9848534|FG000|NOT COMPLETED|Single-blind Treatment||200
8797067|NCT01424566|9848535|FG001|NOT COMPLETED|Single-blind Treatment||0
8797068|NCT01424566|9848536|FG002|NOT COMPLETED|Single-blind Treatment||0
8797069|NCT01424566|9848534|FG000|STARTED|Double-blind Treatment|Participants were not enrolled in this arm in the double-blind period.|0
8797070|NCT01424566|9848535|FG001|STARTED|Double-blind Treatment|Participants were not enrolled in this arm in the single-blind period.|103
8797071|NCT01424566|9848536|FG002|STARTED|Double-blind Treatment|Participants were not enrolled in this arm in the single-blind period.|103
8797072|NCT01424566|9848534|FG000|Received at Least 1 Dose of Study Drug|Double-blind Treatment||0
8797073|NCT01424566|9848535|FG001|Received at Least 1 Dose of Study Drug|Double-blind Treatment||103
8797074|NCT01424566|9848536|FG002|Received at Least 1 Dose of Study Drug|Double-blind Treatment||103
8797075|NCT01424566|9848534|FG000|Randomized Safety Population|Double-blind Treatment||0
8797076|NCT01424566|9848535|FG001|Randomized Safety Population|Double-blind Treatment||103
8797077|NCT01424566|9848536|FG002|Randomized Safety Population|Double-blind Treatment||103
8797078|NCT01424566|9848534|FG000|ITT Population|Double-blind Treatment||0
8797079|NCT01424566|9848535|FG001|ITT Population|Double-blind Treatment||103
8797080|NCT01424566|9848536|FG002|ITT Population|Double-blind Treatment||103
8797081|NCT01424566|9848534|FG000|COMPLETED|Double-blind Treatment||0
8797082|NCT01424566|9848535|FG001|COMPLETED|Double-blind Treatment||78
8797083|NCT01424566|9848536|FG002|COMPLETED|Double-blind Treatment||88
8797084|NCT01424566|9848534|FG000|NOT COMPLETED|Double-blind Treatment||0
8797085|NCT01424566|9848535|FG001|NOT COMPLETED|Double-blind Treatment||25
8797086|NCT01424566|9848536|FG002|NOT COMPLETED|Double-blind Treatment||15
8797087|NCT01424644|9848545|FG000|STARTED|Overall Study||402
8797088|NCT01424644|9848546|FG001|STARTED|Overall Study||399
8797089|NCT01424644|9848545|FG000|COMPLETED|Overall Study||369
8797090|NCT01424644|9848546|FG001|COMPLETED|Overall Study||372
8797091|NCT01424644|9848545|FG000|NOT COMPLETED|Overall Study||33
8797092|NCT01424644|9848546|FG001|NOT COMPLETED|Overall Study||27
8797093|NCT01424670|9848554|FG000|STARTED|6-Month Intensive Period (182 Days)||341
8797094|NCT01424670|9848555|FG001|STARTED|6-Month Intensive Period (182 Days)||170
8797095|NCT01424670|9848554|FG000|Received at Least 1 Dose of Study Drug|6-Month Intensive Period (182 Days)||341
8797096|NCT01424670|9848555|FG001|Received at Least 1 Dose of Study Drug|6-Month Intensive Period (182 Days)||170
8797097|NCT01424670|9848554|FG000|COMPLETED|6-Month Intensive Period (182 Days)||322
8797098|NCT01424670|9848555|FG001|COMPLETED|6-Month Intensive Period (182 Days)||156
8797099|NCT01424670|9848554|FG000|NOT COMPLETED|6-Month Intensive Period (182 Days)||19
8797100|NCT01424670|9848555|FG001|NOT COMPLETED|6-Month Intensive Period (182 Days)||14
8797101|NCT01424670|9848554|FG000|STARTED|Continuation Period||322
8797102|NCT01424670|9848555|FG001|STARTED|Continuation Period||156
8797103|NCT01424670|9848554|FG000|COMPLETED|Continuation Period||288
8797104|NCT01424670|9848555|FG001|COMPLETED|Continuation Period||142
8797105|NCT01424670|9848554|FG000|NOT COMPLETED|Continuation Period||34
8797106|NCT01424670|9848555|FG001|NOT COMPLETED|Continuation Period||14
8797107|NCT01424722|9848563|FG000|STARTED|Overall Study||2258
8797108|NCT01424722|9848563|FG000|COMPLETED|Overall Study||0
8797109|NCT01424722|9848563|FG000|NOT COMPLETED|Overall Study||2258
8797110|NCT01424813|9848569|FG000|STARTED|Overall Study||79
8797111|NCT01424813|9848570|FG001|STARTED|Overall Study||79
8797112|NCT01424813|9848569|FG000|Treated|Overall Study|Safety set and full analysis set|79
8797113|NCT01424813|9848570|FG001|Treated|Overall Study|Safety set and full analysis set|78
8797114|NCT01424813|9848569|FG000|COMPLETED|Overall Study||74
8797115|NCT01424813|9848570|FG001|COMPLETED|Overall Study||77
8797116|NCT01424813|9848569|FG000|NOT COMPLETED|Overall Study||5
8797117|NCT01424813|9848570|FG001|NOT COMPLETED|Overall Study||2
8797118|NCT01424930|9848578|FG000|STARTED|Overall Study||7
8797119|NCT01424930|9848579|FG001|STARTED|Overall Study||18
8797120|NCT01424930|9848578|FG000|Completed Food Safety Evaluation|Overall Study||6
8797121|NCT01424930|9848579|FG001|Completed Food Safety Evaluation|Overall Study||18
8797122|NCT01424930|9848578|FG000|COMPLETED|Overall Study||3
8797123|NCT01424930|9848579|FG001|COMPLETED|Overall Study||4
8797124|NCT01424930|9848578|FG000|NOT COMPLETED|Overall Study||4
8797125|NCT01424930|9848579|FG001|NOT COMPLETED|Overall Study||14
8797126|NCT01424943|9848587|FG000|STARTED|Overall Study||25
8797127|NCT01424943|9848588|FG001|STARTED|Overall Study||24
8797128|NCT01424943|9848587|FG000|COMPLETED|Overall Study||12
8797129|NCT01424943|9848588|FG001|COMPLETED|Overall Study||23
8797130|NCT01424943|9848587|FG000|NOT COMPLETED|Overall Study||13
8797131|NCT01424943|9848588|FG001|NOT COMPLETED|Overall Study||1
8797132|NCT01425190|9848597|FG000|STARTED|Overall Study||16
8797133|NCT01425190|9848598|FG001|STARTED|Overall Study|The study was terminated prior to enrolling participants in Cohort 2.|0
8797134|NCT01425190|9848599|FG002|STARTED|Overall Study|The study was terminated prior to enrolling participants in Cohort 3.|0
8797135|NCT01425190|9848597|FG000|COMPLETED|Overall Study||15
8797136|NCT01425190|9848598|FG001|COMPLETED|Overall Study||0
8797137|NCT01425190|9848599|FG002|COMPLETED|Overall Study||0
8797138|NCT01425190|9848597|FG000|NOT COMPLETED|Overall Study||1
8797139|NCT01425190|9848598|FG001|NOT COMPLETED|Overall Study||0
8797140|NCT01425190|9848599|FG002|NOT COMPLETED|Overall Study||0
8797141|NCT01425203|9848609|FG000|STARTED|Treatment Phase||159
8797142|NCT01425203|9848610|FG001|STARTED|Treatment Phase||79
8797143|NCT01425203|9848611|FG002|STARTED|Treatment Phase||0
8797144|NCT01425203|9848609|FG000|Treated (FAS)|Treatment Phase||159
8797145|NCT01425203|9848610|FG001|Treated (FAS)|Treatment Phase||78
8797146|NCT01425203|9848611|FG002|Treated (FAS)|Treatment Phase||0
8797147|NCT01425203|9848609|FG000|COMPLETED|Treatment Phase||132
8797148|NCT01425203|9848610|FG001|COMPLETED|Treatment Phase||42
8797149|NCT01425203|9848611|FG002|COMPLETED|Treatment Phase||0
8797150|NCT01425203|9848609|FG000|NOT COMPLETED|Treatment Phase||27
8797151|NCT01425203|9848610|FG001|NOT COMPLETED|Treatment Phase||37
8797152|NCT01425203|9848611|FG002|NOT COMPLETED|Treatment Phase||0
8797153|NCT01425203|9848609|FG000|STARTED|Crossover Phase|Phase only for participants in PBO + PR Control arm who failed futility rule at TW12 or 24|0
8797154|NCT01425203|9848610|FG001|STARTED|Crossover Phase|Phase only for participants in PBO + PR Control arm who failed futility rule at TW12 or 24|0
8797155|NCT01425203|9848611|FG002|STARTED|Crossover Phase|Phase only for participants in PBO + PR Control arm who failed futility rule at TW12 or 24|27
8797156|NCT01425203|9848609|FG000|COMPLETED|Crossover Phase||0
8797157|NCT01425203|9848610|FG001|COMPLETED|Crossover Phase||0
8797158|NCT01425203|9848611|FG002|COMPLETED|Crossover Phase||21
8797159|NCT01425203|9848609|FG000|NOT COMPLETED|Crossover Phase||0
8797160|NCT01425203|9848610|FG001|NOT COMPLETED|Crossover Phase||0
8797161|NCT01425203|9848611|FG002|NOT COMPLETED|Crossover Phase||6
8797162|NCT01425203|9848609|FG000|STARTED|Follow-up Phase|6 participants who started treatment in RGT BOC + PR arm did not enter follow-up.|153
8797163|NCT01425203|9848610|FG001|STARTED|Follow-up Phase|27 starting treatment in PBO+PR Control arm switched to Crossover arm and 2 did not enter follow-up|49
8797164|NCT01425203|9848611|FG002|STARTED|Follow-up Phase|All participants treated in crossover arm entered follow-up.|27
8797165|NCT01425203|9848609|FG000|COMPLETED|Follow-up Phase||153
8797166|NCT01425203|9848610|FG001|COMPLETED|Follow-up Phase||49
8797167|NCT01425203|9848611|FG002|COMPLETED|Follow-up Phase||27
8797168|NCT01425203|9848609|FG000|NOT COMPLETED|Follow-up Phase||0
8797169|NCT01425203|9848610|FG001|NOT COMPLETED|Follow-up Phase||0
8797170|NCT01425203|9848611|FG002|NOT COMPLETED|Follow-up Phase||0
8797171|NCT01425229|9848619|FG000|STARTED|Bosentan Single Dose||16
8797172|NCT01425229|9848619|FG000|COMPLETED|Bosentan Single Dose||16
8797173|NCT01425229|9848619|FG000|NOT COMPLETED|Bosentan Single Dose||0
8797174|NCT01425229|9848619|FG000|STARTED|Bosentan Steady-state||16
8797175|NCT01425229|9848619|FG000|COMPLETED|Bosentan Steady-state||16
8797176|NCT01425229|9848619|FG000|NOT COMPLETED|Bosentan Steady-state||0
8797177|NCT01425229|9848619|FG000|STARTED|Bosentan During Clarithromycin||16
8797178|NCT01425229|9848619|FG000|COMPLETED|Bosentan During Clarithromycin||16
8797179|NCT01425229|9848619|FG000|NOT COMPLETED|Bosentan During Clarithromycin||0
8797180|NCT01425268|9848629|FG000|STARTED|Overall Study|106 Subjects Randomized to AeroForm Arm / 98 Subjects Treated (Implanted)|106
8797181|NCT01425268|9848630|FG001|STARTED|Overall Study|52 Subjects Randomized to Saline Arm / 52 Subjects Treated (Implanted)|52
8797182|NCT01425268|9848629|FG000|COMPLETED|Overall Study||98
8797183|NCT01425268|9848630|FG001|COMPLETED|Overall Study||52
8797184|NCT01425268|9848629|FG000|NOT COMPLETED|Overall Study||8
8797185|NCT01425268|9848630|FG001|NOT COMPLETED|Overall Study||0
8797186|NCT01425307|9848638|FG000|STARTED|Overall Study|Randomized Sample: 61; Intention-to Treat Sample:61|61
8797187|NCT01425307|9848639|FG001|STARTED|Overall Study|Randomized Sample: 60; Intention-to Treat Sample:60|60
8797188|NCT01425307|9848638|FG000|COMPLETED|Overall Study|Treatment Phase: 42; 6-Month Follow up: 58|42
8797189|NCT01425307|9848639|FG001|COMPLETED|Overall Study|Treatment Phase: 41; 6-Month Follow-up:59|41
8797190|NCT01425307|9848638|FG000|NOT COMPLETED|Overall Study||19
8797191|NCT01425307|9848639|FG001|NOT COMPLETED|Overall Study||19
8797192|NCT01425359|9848649|FG000|STARTED|Overall Study||476
8797193|NCT01425359|9848650|FG001|STARTED|Overall Study||473
8797194|NCT01425359|9848649|FG000|COMPLETED|Overall Study||457
8797195|NCT01425359|9848650|FG001|COMPLETED|Overall Study||451
8797196|NCT01425359|9848649|FG000|NOT COMPLETED|Overall Study||19
8797197|NCT01425359|9848650|FG001|NOT COMPLETED|Overall Study||22
8797198|NCT01425463|9848659|FG000|STARTED|Overall Study||130
8797199|NCT01425463|9848660|FG001|STARTED|Overall Study||126
8797200|NCT01425463|9848659|FG000|Safety Set|Overall Study||126
8797201|NCT01425463|9848660|FG001|Safety Set|Overall Study||122
8797202|NCT01425463|9848659|FG000|Full Analysis Set|Overall Study||122
8797203|NCT01425463|9848660|FG001|Full Analysis Set|Overall Study||116
8797204|NCT01425463|9848659|FG000|COMPLETED|Overall Study||106
8797205|NCT01425463|9848660|FG001|COMPLETED|Overall Study||102
8797206|NCT01425463|9848659|FG000|NOT COMPLETED|Overall Study||24
8797207|NCT01425463|9848660|FG001|NOT COMPLETED|Overall Study||24
8797208|NCT01425528|9848668|FG000|STARTED|Overall Study||6
8797209|NCT01425528|9848669|FG001|STARTED|Overall Study||6
8797210|NCT01425528|9848668|FG000|COMPLETED|Overall Study||5
8797211|NCT01425528|9848669|FG001|COMPLETED|Overall Study||5
8797212|NCT01425528|9848668|FG000|NOT COMPLETED|Overall Study||1
8797213|NCT01425528|9848669|FG001|NOT COMPLETED|Overall Study||1
8917727|NCT02195349|9977533|FG008|STARTED|Overall Study||6
8917728|NCT02195349|9977534|FG009|STARTED|Overall Study||6
8917729|NCT02195349|9977535|FG010|STARTED|Overall Study||6
8917730|NCT02195349|9977525|FG000|COMPLETED|Overall Study||14
8917731|NCT02195349|9977526|FG001|COMPLETED|Overall Study||1
8917732|NCT02195349|9977527|FG002|COMPLETED|Overall Study||1
8917733|NCT02195349|9977528|FG003|COMPLETED|Overall Study||6
8917734|NCT02195349|9977529|FG004|COMPLETED|Overall Study||6
8917735|NCT02195349|9977530|FG005|COMPLETED|Overall Study||6
8917736|NCT02195349|9977531|FG006|COMPLETED|Overall Study||6
8917737|NCT02195349|9977532|FG007|COMPLETED|Overall Study||9
8917738|NCT02195349|9977533|FG008|COMPLETED|Overall Study||6
8917739|NCT02195349|9977534|FG009|COMPLETED|Overall Study||6
8917740|NCT02195349|9977535|FG010|COMPLETED|Overall Study||6
8917741|NCT02195349|9977525|FG000|NOT COMPLETED|Overall Study||0
8917742|NCT02195349|9977526|FG001|NOT COMPLETED|Overall Study||0
8917743|NCT02195349|9977527|FG002|NOT COMPLETED|Overall Study||0
8917744|NCT02195349|9977528|FG003|NOT COMPLETED|Overall Study||0
8917745|NCT02195349|9977529|FG004|NOT COMPLETED|Overall Study||0
8917746|NCT02195349|9977530|FG005|NOT COMPLETED|Overall Study||0
8917747|NCT02195349|9977531|FG006|NOT COMPLETED|Overall Study||0
8917748|NCT02195349|9977532|FG007|NOT COMPLETED|Overall Study||0
8917749|NCT02195349|9977533|FG008|NOT COMPLETED|Overall Study||0
8917750|NCT02195349|9977534|FG009|NOT COMPLETED|Overall Study||0
8917751|NCT02195349|9977535|FG010|NOT COMPLETED|Overall Study||0
9033372|NCT03273673|10095481|FG000|COMPLETED|Overall Study||14
9033373|NCT03273673|10095482|FG001|COMPLETED|Overall Study||22
9033374|NCT03273673|10095481|FG000|NOT COMPLETED|Overall Study||4
9033375|NCT03273673|10095482|FG001|NOT COMPLETED|Overall Study||0
9033376|NCT03273946|10095488|FG000|STARTED|Overall Study||158
9033377|NCT03273946|10095488|FG000|COMPLETED|Overall Study||149
9033378|NCT03273946|10095488|FG000|NOT COMPLETED|Overall Study||9
9033379|NCT03274076|10095494|FG000|STARTED|24 Weeks Double Blind||10
9033380|NCT03274076|10095495|FG001|STARTED|24 Weeks Double Blind||5
9033381|NCT03274076|10095496|FG002|STARTED|24 Weeks Double Blind||0
9033382|NCT03274076|10095497|FG003|STARTED|24 Weeks Double Blind||0
9033383|NCT03274076|10095494|FG000|COMPLETED|24 Weeks Double Blind||10
9033384|NCT03274076|10095495|FG001|COMPLETED|24 Weeks Double Blind||4
9033385|NCT03274076|10095496|FG002|COMPLETED|24 Weeks Double Blind||0
9033386|NCT03274076|10095497|FG003|COMPLETED|24 Weeks Double Blind||0
9033387|NCT03274076|10095494|FG000|NOT COMPLETED|24 Weeks Double Blind||0
9033388|NCT03274076|10095495|FG001|NOT COMPLETED|24 Weeks Double Blind||1
9033389|NCT03274076|10095496|FG002|NOT COMPLETED|24 Weeks Double Blind||0
9033390|NCT03274076|10095497|FG003|NOT COMPLETED|24 Weeks Double Blind||0
9033391|NCT03274076|10095494|FG000|STARTED|24 Weeks Open Label||0
9033392|NCT03274076|10095495|FG001|STARTED|24 Weeks Open Label||0
9033393|NCT03274076|10095496|FG002|STARTED|24 Weeks Open Label||10
9033394|NCT03274076|10095497|FG003|STARTED|24 Weeks Open Label||4
9033395|NCT03274076|10095494|FG000|COMPLETED|24 Weeks Open Label||0
9033396|NCT03274076|10095495|FG001|COMPLETED|24 Weeks Open Label||0
9033397|NCT03274076|10095496|FG002|COMPLETED|24 Weeks Open Label||8
9033398|NCT03274076|10095497|FG003|COMPLETED|24 Weeks Open Label||3
9033399|NCT03274076|10095494|FG000|NOT COMPLETED|24 Weeks Open Label||0
9033400|NCT03274076|10095495|FG001|NOT COMPLETED|24 Weeks Open Label||0
9033401|NCT03274076|10095496|FG002|NOT COMPLETED|24 Weeks Open Label||2
9033402|NCT03274076|10095497|FG003|NOT COMPLETED|24 Weeks Open Label||1
9033403|NCT03274440|10095516|FG000|STARTED|Overall Study||3
8672160|NCT00755846|9715646|FG005|COMPLETED|Overall Study||31
8672161|NCT00755846|9715641|FG000|NOT COMPLETED|Overall Study||25
8917752|NCT02195414|9977575|FG000|STARTED|Overall Study||31
8917753|NCT02195414|9977575|FG000|Primary Endpoint|Overall Study||31
8917754|NCT02195414|9977575|FG000|COMPLETED|Overall Study||31
8917755|NCT02195414|9977575|FG000|NOT COMPLETED|Overall Study||0
8917756|NCT02195427|9977581|FG000|STARTED|Overall Study||73
8917757|NCT02195427|9977582|FG001|STARTED|Overall Study||74
8917758|NCT02195427|9977581|FG000|N Patients at W24 (Primary Outcome)|Overall Study||67
8917759|NCT02195427|9977582|FG001|N Patients at W24 (Primary Outcome)|Overall Study||62
8917760|NCT02195427|9977581|FG000|N Patients at W36|Overall Study||65
8917761|NCT02195427|9977582|FG001|N Patients at W36|Overall Study||59
8917762|NCT02195427|9977581|FG000|N Patients at W52|Overall Study||63
8917763|NCT02195427|9977582|FG001|N Patients at W52|Overall Study||56
8917764|NCT02195427|9977581|FG000|COMPLETED|Overall Study||47
8917765|NCT02195427|9977582|FG001|COMPLETED|Overall Study||47
8917766|NCT02195427|9977581|FG000|NOT COMPLETED|Overall Study||26
8917767|NCT02195427|9977582|FG001|NOT COMPLETED|Overall Study||27
8917768|NCT02195518|9977592|FG000|STARTED|Overall Study||213
8917769|NCT02195518|9977592|FG000|COMPLETED|Overall Study||204
8917770|NCT02195518|9977592|FG000|NOT COMPLETED|Overall Study||9
8672162|NCT00755846|9715642|FG001|NOT COMPLETED|Overall Study||17
8672163|NCT00755846|9715643|FG002|NOT COMPLETED|Overall Study||12
8672164|NCT00755846|9715644|FG003|NOT COMPLETED|Overall Study||13
8672165|NCT00755846|9715645|FG004|NOT COMPLETED|Overall Study||17
8672166|NCT00755846|9715646|FG005|NOT COMPLETED|Overall Study||14
8672167|NCT00755911|9715662|FG000|STARTED|Overall Study||12
8672168|NCT00755911|9715663|FG001|STARTED|Overall Study||12
8797214|NCT01425281|9848677|FG000|STARTED|At 30-day Clinical Follow-up|Intent-to-Treat (ITT) Population|335
8797215|NCT01425281|9848678|FG001|STARTED|At 30-day Clinical Follow-up|Intent-to-Treat (ITT) Population|166
8797216|NCT01425281|9848677|FG000|COMPLETED|At 30-day Clinical Follow-up||334
8797217|NCT01425281|9848678|FG001|COMPLETED|At 30-day Clinical Follow-up||166
8797218|NCT01425281|9848677|FG000|NOT COMPLETED|At 30-day Clinical Follow-up||1
8797219|NCT01425281|9848678|FG001|NOT COMPLETED|At 30-day Clinical Follow-up||0
8797220|NCT01425281|9848677|FG000|STARTED|At 180-day Clinical Follow-up||334
8797221|NCT01425281|9848678|FG001|STARTED|At 180-day Clinical Follow-up||166
8797222|NCT01425281|9848677|FG000|COMPLETED|At 180-day Clinical Follow-up||331
8797223|NCT01425281|9848678|FG001|COMPLETED|At 180-day Clinical Follow-up||165
8797224|NCT01425281|9848677|FG000|NOT COMPLETED|At 180-day Clinical Follow-up||3
8797225|NCT01425281|9848678|FG001|NOT COMPLETED|At 180-day Clinical Follow-up||1
8797226|NCT01425281|9848677|FG000|STARTED|At 1-year Clinical Follow-up||331
8797227|NCT01425281|9848678|FG001|STARTED|At 1-year Clinical Follow-up||165
8797228|NCT01425281|9848677|FG000|COMPLETED|At 1-year Clinical Follow-up||329
8797229|NCT01425281|9848678|FG001|COMPLETED|At 1-year Clinical Follow-up||164
8797230|NCT01425281|9848677|FG000|NOT COMPLETED|At 1-year Clinical Follow-up||2
8797231|NCT01425281|9848678|FG001|NOT COMPLETED|At 1-year Clinical Follow-up||1
8797232|NCT01425281|9848677|FG000|STARTED|At 2-year Clinical Follow-up||329
8797233|NCT01425281|9848678|FG001|STARTED|At 2-year Clinical Follow-up||164
8797234|NCT01425281|9848677|FG000|COMPLETED|At 2-year Clinical Follow-up||323
8797235|NCT01425281|9848678|FG001|COMPLETED|At 2-year Clinical Follow-up||163
8797236|NCT01425281|9848677|FG000|NOT COMPLETED|At 2-year Clinical Follow-up||6
8797237|NCT01425281|9848678|FG001|NOT COMPLETED|At 2-year Clinical Follow-up||1
8797238|NCT01425281|9848677|FG000|STARTED|At 3-year Clinical Follow-up||323
8797239|NCT01425281|9848678|FG001|STARTED|At 3-year Clinical Follow-up||163
8797240|NCT01425281|9848677|FG000|COMPLETED|At 3-year Clinical Follow-up||318
8797241|NCT01425281|9848678|FG001|COMPLETED|At 3-year Clinical Follow-up||157
8797242|NCT01425281|9848677|FG000|NOT COMPLETED|At 3-year Clinical Follow-up||5
8797243|NCT01425281|9848678|FG001|NOT COMPLETED|At 3-year Clinical Follow-up||6
8797244|NCT01425281|9848677|FG000|STARTED|At 4-year Clinical Follow-up||318
8797245|NCT01425281|9848678|FG001|STARTED|At 4-year Clinical Follow-up||157
8797246|NCT01425281|9848677|FG000|COMPLETED|At 4-year Clinical Follow-up||288
8797247|NCT01425281|9848678|FG001|COMPLETED|At 4-year Clinical Follow-up||136
8797248|NCT01425281|9848677|FG000|NOT COMPLETED|At 4-year Clinical Follow-up||30
8797249|NCT01425281|9848678|FG001|NOT COMPLETED|At 4-year Clinical Follow-up||21
8797250|NCT01425281|9848677|FG000|STARTED|At 5-year Clinical Follow-up||288
8797251|NCT01425281|9848678|FG001|STARTED|At 5-year Clinical Follow-up||136
8797252|NCT01425281|9848677|FG000|COMPLETED|At 5-year Clinical Follow-up||256
8797253|NCT01425281|9848678|FG001|COMPLETED|At 5-year Clinical Follow-up||125
8797254|NCT01425281|9848677|FG000|NOT COMPLETED|At 5-year Clinical Follow-up||32
8797255|NCT01425281|9848678|FG001|NOT COMPLETED|At 5-year Clinical Follow-up||11
8797256|NCT01425632|9848688|FG000|STARTED|Overall Study||161
8797257|NCT01425632|9848689|FG001|STARTED|Overall Study||166
8797258|NCT01425632|9848690|FG002|STARTED|Overall Study||163
8797259|NCT01425632|9848688|FG000|COMPLETED|Overall Study||160
8797260|NCT01425632|9848689|FG001|COMPLETED|Overall Study||165
8797261|NCT01425632|9848690|FG002|COMPLETED|Overall Study||159
8797262|NCT01425632|9848688|FG000|NOT COMPLETED|Overall Study||1
8797263|NCT01425632|9848689|FG001|NOT COMPLETED|Overall Study||1
8797264|NCT01425632|9848690|FG002|NOT COMPLETED|Overall Study||4
8797265|NCT01425723|9848700|FG000|STARTED|Overall Study|13 participants in <6 Years Old Age Cohort and 14 participants in 6 to <12 Years Old Age Cohort.|27
8797266|NCT01425723|9848701|FG001|STARTED|Overall Study||93
8797267|NCT01425723|9848700|FG000|Weekly Prophylaxis|Overall Study||23
8797268|NCT01425723|9848701|FG001|Weekly Prophylaxis|Overall Study||51
8797269|NCT01425723|9848700|FG000|Individualized Prophylaxis|Overall Study||5
8797270|NCT01425723|9848701|FG001|Individualized Prophylaxis|Overall Study||31
8797271|NCT01425723|9848700|FG000|Personalized Prophylaxis|Overall Study||2
8797272|NCT01425723|9848701|FG001|Personalized Prophylaxis|Overall Study||17
8797273|NCT01425723|9848700|FG000|Episodic|Overall Study||0
8797274|NCT01425723|9848701|FG001|Episodic|Overall Study||15
8797275|NCT01425723|9848700|FG000|Surgery Subgroup|Overall Study||1
8797276|NCT01425723|9848701|FG001|Surgery Subgroup|Overall Study||15
8797277|NCT01425723|9848700|FG000|COMPLETED|Overall Study||23
8797278|NCT01425723|9848701|FG001|COMPLETED|Overall Study||75
8797279|NCT01425723|9848700|FG000|NOT COMPLETED|Overall Study||4
8797280|NCT01425723|9848701|FG001|NOT COMPLETED|Overall Study||18
8797281|NCT01425749|9848718|FG000|STARTED|Overall Study||13
8797282|NCT01425749|9848719|FG001|STARTED|Overall Study||12
8797283|NCT01425749|9848718|FG000|COMPLETED|Overall Study||13
8797284|NCT01425749|9848719|FG001|COMPLETED|Overall Study||11
8797285|NCT01425749|9848718|FG000|NOT COMPLETED|Overall Study||0
8797286|NCT01425749|9848719|FG001|NOT COMPLETED|Overall Study||1
8797287|NCT01425801|9848728|FG000|STARTED|Period 1||9
8797288|NCT01425801|9848729|FG001|STARTED|Period 1||9
8797289|NCT01425801|9848730|FG002|STARTED|Period 1||9
8797290|NCT01425801|9848731|FG003|STARTED|Period 1||12
8797291|NCT01425801|9848732|FG004|STARTED|Period 1||13
8797292|NCT01425801|9848733|FG005|STARTED|Period 1||10
8797293|NCT01425801|9848728|FG000|COMPLETED|Period 1||9
8797294|NCT01425801|9848729|FG001|COMPLETED|Period 1||9
8797295|NCT01425801|9848730|FG002|COMPLETED|Period 1||9
8672169|NCT00755911|9715662|FG000|COMPLETED|Overall Study||12
8672170|NCT00755911|9715663|FG001|COMPLETED|Overall Study||12
9033404|NCT03274440|10095517|FG001|STARTED|Overall Study||2
9033405|NCT03274440|10095518|FG002|STARTED|Overall Study||4
9033406|NCT03274440|10095519|FG003|STARTED|Overall Study||1
9033407|NCT03274440|10095520|FG004|STARTED|Overall Study||1
9033408|NCT03274440|10095521|FG005|STARTED|Overall Study||3
9033409|NCT03274440|10095516|FG000|COMPLETED|Overall Study||2
9033410|NCT03274440|10095517|FG001|COMPLETED|Overall Study||2
9033411|NCT03274440|10095518|FG002|COMPLETED|Overall Study||4
9033412|NCT03274440|10095519|FG003|COMPLETED|Overall Study||0
9033413|NCT03274440|10095520|FG004|COMPLETED|Overall Study||1
9033414|NCT03274440|10095521|FG005|COMPLETED|Overall Study||3
9033415|NCT03274440|10095516|FG000|NOT COMPLETED|Overall Study||1
9033416|NCT03274440|10095517|FG001|NOT COMPLETED|Overall Study||0
9033417|NCT03274440|10095518|FG002|NOT COMPLETED|Overall Study||0
9033418|NCT03274440|10095519|FG003|NOT COMPLETED|Overall Study||1
9033419|NCT03274440|10095520|FG004|NOT COMPLETED|Overall Study||0
9033420|NCT03274440|10095521|FG005|NOT COMPLETED|Overall Study||0
9033421|NCT03274453|10095533|FG000|STARTED|Overall Study||38
9033422|NCT03274453|10095534|FG001|STARTED|Overall Study||30
9033423|NCT03274453|10095535|FG002|STARTED|Overall Study||32
9033424|NCT03274453|10095536|FG003|STARTED|Overall Study||29
9033425|NCT03274453|10095533|FG000|COMPLETED|Overall Study||34
9033426|NCT03274453|10095534|FG001|COMPLETED|Overall Study||24
9033427|NCT03274453|10095535|FG002|COMPLETED|Overall Study||28
9033428|NCT03274453|10095536|FG003|COMPLETED|Overall Study||25
9033429|NCT03274453|10095533|FG000|NOT COMPLETED|Overall Study||4
9033430|NCT03274453|10095534|FG001|NOT COMPLETED|Overall Study||6
9033431|NCT03274453|10095535|FG002|NOT COMPLETED|Overall Study||4
9033432|NCT03274453|10095536|FG003|NOT COMPLETED|Overall Study||4
9033433|NCT03274466|10095548|FG000|STARTED|Overall Study||147
9033434|NCT03274466|10095549|FG001|STARTED|Overall Study||147
9033435|NCT03274466|10095548|FG000|COMPLETED|Overall Study||124
9033436|NCT03274466|10095549|FG001|COMPLETED|Overall Study||118
9033437|NCT03274466|10095548|FG000|NOT COMPLETED|Overall Study||23
9033438|NCT03274466|10095549|FG001|NOT COMPLETED|Overall Study||29
9033439|NCT03274518|10095557|FG000|STARTED|First Intervention||8
9033440|NCT03274518|10095558|FG001|STARTED|First Intervention|First intervention: expanded hemodialysis, for 30 days.|8
9033441|NCT03274518|10095557|FG000|COMPLETED|First Intervention||8
9033442|NCT03274518|10095558|FG001|COMPLETED|First Intervention||8
9033443|NCT03274518|10095557|FG000|NOT COMPLETED|First Intervention||0
9033444|NCT03274518|10095558|FG001|NOT COMPLETED|First Intervention||0
9033445|NCT03274518|10095557|FG000|STARTED|Washout Period||8
9033446|NCT03274518|10095558|FG001|STARTED|Washout Period|Patients returned from expanded hemodialysis to conventional hemodialysis for 15 days.|8
9033447|NCT03274518|10095557|FG000|COMPLETED|Washout Period||8
9033448|NCT03274518|10095558|FG001|COMPLETED|Washout Period||8
9033449|NCT03274518|10095557|FG000|NOT COMPLETED|Washout Period||0
9033450|NCT03274518|10095558|FG001|NOT COMPLETED|Washout Period||0
9033451|NCT03274518|10095557|FG000|STARTED|Second Intervention||8
9033452|NCT03274518|10095558|FG001|STARTED|Second Intervention|Second intervention: patients from this group underwent online hemodiafiltration for 30 days.|8
9033453|NCT03274518|10095557|FG000|COMPLETED|Second Intervention||8
9033454|NCT03274518|10095558|FG001|COMPLETED|Second Intervention||8
9033455|NCT03274518|10095557|FG000|NOT COMPLETED|Second Intervention||0
9033456|NCT03274518|10095558|FG001|NOT COMPLETED|Second Intervention||0
9033457|NCT03274804|10095564|FG000|STARTED|Overall Study||20
9033458|NCT03274804|10095564|FG000|COMPLETED|Overall Study||20
9033459|NCT03274804|10095564|FG000|NOT COMPLETED|Overall Study||0
9033460|NCT03274856|10095571|FG000|STARTED|Overall Study||10
9033461|NCT03274856|10095572|FG001|STARTED|Overall Study||9
9033462|NCT03274856|10095571|FG000|COMPLETED|Overall Study||10
9033463|NCT03274856|10095572|FG001|COMPLETED|Overall Study||9
9033464|NCT03274856|10095571|FG000|NOT COMPLETED|Overall Study||0
9033465|NCT03274856|10095572|FG001|NOT COMPLETED|Overall Study||0
9033466|NCT03274986|10095582|FG000|STARTED|Overall Study||107
9033467|NCT03274986|10095583|FG001|STARTED|Overall Study||113
9033468|NCT03274986|10095582|FG000|Successful Implantation, as Treated|Overall Study||107
9033469|NCT03274986|10095583|FG001|Successful Implantation, as Treated|Overall Study||113
9033470|NCT03274986|10095582|FG000|COMPLETED|Overall Study||107
9033471|NCT03274986|10095583|FG001|COMPLETED|Overall Study||111
9033472|NCT03274986|10095582|FG000|NOT COMPLETED|Overall Study||0
9033473|NCT03274986|10095583|FG001|NOT COMPLETED|Overall Study||2
9033474|NCT03274999|10095596|FG000|STARTED|First Intervention (Day 0)||5
9033475|NCT03274999|10095597|FG001|STARTED|First Intervention (Day 0)||5
9033476|NCT03274999|10095596|FG000|COMPLETED|First Intervention (Day 0)||5
9033477|NCT03274999|10095597|FG001|COMPLETED|First Intervention (Day 0)||5
9033478|NCT03274999|10095596|FG000|NOT COMPLETED|First Intervention (Day 0)||0
9033479|NCT03274999|10095597|FG001|NOT COMPLETED|First Intervention (Day 0)||0
9033480|NCT03274999|10095596|FG000|STARTED|Second Intervention (Day 14)||5
9033481|NCT03274999|10095597|FG001|STARTED|Second Intervention (Day 14)||5
9033482|NCT03274999|10095596|FG000|COMPLETED|Second Intervention (Day 14)||5
9033483|NCT03274999|10095597|FG001|COMPLETED|Second Intervention (Day 14)||5
9033484|NCT03274999|10095596|FG000|NOT COMPLETED|Second Intervention (Day 14)||0
9033485|NCT03274999|10095597|FG001|NOT COMPLETED|Second Intervention (Day 14)||0
9033486|NCT03275246|10095603|FG000|STARTED|Overall Study||8
9033487|NCT03275246|10095603|FG000|COMPLETED|Overall Study||2
9033488|NCT03275246|10095603|FG000|NOT COMPLETED|Overall Study||6
8797296|NCT01425801|9848731|FG003|COMPLETED|Period 1||12
8797297|NCT01425801|9848732|FG004|COMPLETED|Period 1||12
8797298|NCT01425801|9848733|FG005|COMPLETED|Period 1||10
8797299|NCT01425801|9848728|FG000|NOT COMPLETED|Period 1||0
8797300|NCT01425801|9848729|FG001|NOT COMPLETED|Period 1||0
8797301|NCT01425801|9848730|FG002|NOT COMPLETED|Period 1||0
8797302|NCT01425801|9848731|FG003|NOT COMPLETED|Period 1||0
8797303|NCT01425801|9848732|FG004|NOT COMPLETED|Period 1||1
8797304|NCT01425801|9848733|FG005|NOT COMPLETED|Period 1||0
8797305|NCT01425801|9848728|FG000|STARTED|Period 2||9
8797306|NCT01425801|9848729|FG001|STARTED|Period 2||9
8797307|NCT01425801|9848730|FG002|STARTED|Period 2||9
8797308|NCT01425801|9848731|FG003|STARTED|Period 2||12
8917771|NCT02195531|9977599|FG000|STARTED|Overall Study||64
9033489|NCT03275389|10095617|FG000|STARTED|Overall Study||45
9033490|NCT03275389|10095618|FG001|STARTED|Overall Study||46
9033491|NCT03275389|10095619|FG002|STARTED|Overall Study||47
9033492|NCT03275389|10095620|FG003|STARTED|Overall Study||47
9033493|NCT03275389|10095621|FG004|STARTED|Overall Study||48
9033494|NCT03275389|10095622|FG005|STARTED|Overall Study||47
9033495|NCT03275389|10095623|FG006|STARTED|Overall Study||47
9033496|NCT03275389|10095624|FG007|STARTED|Overall Study||48
9033497|NCT03275389|10095625|FG008|STARTED|Overall Study||46
9033498|NCT03275389|10095626|FG009|STARTED|Overall Study||47
9033499|NCT03275389|10095617|FG000|COMPLETED|Overall Study||34
9033500|NCT03275389|10095618|FG001|COMPLETED|Overall Study||30
9033501|NCT03275389|10095619|FG002|COMPLETED|Overall Study||24
9033502|NCT03275389|10095620|FG003|COMPLETED|Overall Study||25
9033503|NCT03275389|10095621|FG004|COMPLETED|Overall Study||32
9033504|NCT03275389|10095622|FG005|COMPLETED|Overall Study||29
9033505|NCT03275389|10095623|FG006|COMPLETED|Overall Study||22
9033506|NCT03275389|10095624|FG007|COMPLETED|Overall Study||30
9033507|NCT03275389|10095625|FG008|COMPLETED|Overall Study||31
9033508|NCT03275389|10095626|FG009|COMPLETED|Overall Study||29
9033509|NCT03275389|10095617|FG000|NOT COMPLETED|Overall Study||11
9033510|NCT03275389|10095618|FG001|NOT COMPLETED|Overall Study||16
9033511|NCT03275389|10095619|FG002|NOT COMPLETED|Overall Study||23
9033512|NCT03275389|10095620|FG003|NOT COMPLETED|Overall Study||22
9033513|NCT03275389|10095621|FG004|NOT COMPLETED|Overall Study||16
9033514|NCT03275389|10095622|FG005|NOT COMPLETED|Overall Study||18
9033515|NCT03275389|10095623|FG006|NOT COMPLETED|Overall Study||25
9033516|NCT03275389|10095624|FG007|NOT COMPLETED|Overall Study||18
9033517|NCT03275389|10095625|FG008|NOT COMPLETED|Overall Study||15
9033518|NCT03275389|10095626|FG009|NOT COMPLETED|Overall Study||18
9033519|NCT03275623|10095650|FG000|STARTED|Overall Study||30
9033520|NCT03275623|10095651|FG001|STARTED|Overall Study||30
9033521|NCT03275623|10095650|FG000|COMPLETED|Overall Study||25
9033522|NCT03275623|10095651|FG001|COMPLETED|Overall Study||28
9033523|NCT03275623|10095650|FG000|NOT COMPLETED|Overall Study||5
9033524|NCT03275623|10095651|FG001|NOT COMPLETED|Overall Study||2
9033525|NCT03275766|10095661|FG000|STARTED|Overall Study||12
9033526|NCT03275766|10095662|FG001|STARTED|Overall Study||12
9033527|NCT03275766|10095663|FG002|STARTED|Overall Study||11
9033528|NCT03275766|10095664|FG003|STARTED|Overall Study||10
9033529|NCT03275766|10095661|FG000|Received Intervention|Overall Study||9
9033530|NCT03275766|10095662|FG001|Received Intervention|Overall Study||11
9033531|NCT03275766|10095663|FG002|Received Intervention|Overall Study||10
9033532|NCT03275766|10095664|FG003|Received Intervention|Overall Study||9
9033533|NCT03275766|10095661|FG000|COMPLETED|Overall Study||7
9033534|NCT03275766|10095662|FG001|COMPLETED|Overall Study||5
9033535|NCT03275766|10095663|FG002|COMPLETED|Overall Study||7
9033536|NCT03275766|10095664|FG003|COMPLETED|Overall Study||4
9033537|NCT03275766|10095661|FG000|NOT COMPLETED|Overall Study||5
9033538|NCT03275766|10095662|FG001|NOT COMPLETED|Overall Study||7
9033539|NCT03275766|10095663|FG002|NOT COMPLETED|Overall Study||4
9033540|NCT03275766|10095664|FG003|NOT COMPLETED|Overall Study||6
9033541|NCT03275870|10095674|FG000|STARTED|Overall Study||17
9033542|NCT03275870|10095674|FG000|COMPLETED|Overall Study||3
8672171|NCT00755911|9715662|FG000|NOT COMPLETED|Overall Study||0
8672172|NCT00755911|9715663|FG001|NOT COMPLETED|Overall Study||0
8672173|NCT00755937|9715669|FG000|STARTED|Recruitment|Subjects registered in the program|556
8672174|NCT00755937|9715669|FG000|COMPLETED|Recruitment|Subjects who had a baseline visit and at least 1 additional follow-up visit (analyzed population)|392
8672175|NCT00755937|9715669|FG000|NOT COMPLETED|Recruitment||164
8672176|NCT00755937|9715669|FG000|STARTED|Observational Follow-up||392
8672177|NCT00755937|9715669|FG000|COMPLETED|Observational Follow-up|Subjects followed until end of study/subjects for whom end of participation data were collected|244
8672178|NCT00755937|9715669|FG000|NOT COMPLETED|Observational Follow-up||148
8797309|NCT01425801|9848732|FG004|STARTED|Period 2||12
8797310|NCT01425801|9848733|FG005|STARTED|Period 2||10
8797311|NCT01425801|9848728|FG000|COMPLETED|Period 2||9
8797312|NCT01425801|9848729|FG001|COMPLETED|Period 2||9
8917772|NCT02195531|9977600|FG001|STARTED|Overall Study||49
8917773|NCT02195531|9977601|FG002|STARTED|Overall Study||56
8917774|NCT02195531|9977599|FG000|COMPLETED|Overall Study||63
8917775|NCT02195531|9977600|FG001|COMPLETED|Overall Study||48
8917776|NCT02195531|9977601|FG002|COMPLETED|Overall Study||55
8917777|NCT02195531|9977599|FG000|NOT COMPLETED|Overall Study||1
8917778|NCT02195531|9977600|FG001|NOT COMPLETED|Overall Study||1
8917779|NCT02195531|9977601|FG002|NOT COMPLETED|Overall Study||1
8917780|NCT02195583|9977609|FG000|STARTED|Overall Study||62
8917781|NCT02195583|9977609|FG000|Sodium Fluoride (1150 Ppm)|Overall Study|Discontinuations: 1 due to other reason in Period 5|57
8797313|NCT01425801|9848730|FG002|COMPLETED|Period 2||9
8797314|NCT01425801|9848731|FG003|COMPLETED|Period 2||12
8797315|NCT01425801|9848732|FG004|COMPLETED|Period 2||11
8797316|NCT01425801|9848733|FG005|COMPLETED|Period 2||10
8797317|NCT01425801|9848728|FG000|NOT COMPLETED|Period 2||0
8797318|NCT01425801|9848729|FG001|NOT COMPLETED|Period 2||0
8797319|NCT01425801|9848730|FG002|NOT COMPLETED|Period 2||0
8797320|NCT01425801|9848731|FG003|NOT COMPLETED|Period 2||0
8797321|NCT01425801|9848732|FG004|NOT COMPLETED|Period 2||1
8797322|NCT01425801|9848733|FG005|NOT COMPLETED|Period 2||0
8797323|NCT01425801|9848728|FG000|STARTED|Period 3||9
8797324|NCT01425801|9848729|FG001|STARTED|Period 3||9
8797325|NCT01425801|9848730|FG002|STARTED|Period 3||9
8797326|NCT01425801|9848731|FG003|STARTED|Period 3||12
8797327|NCT01425801|9848732|FG004|STARTED|Period 3||11
8797328|NCT01425801|9848733|FG005|STARTED|Period 3||10
8797329|NCT01425801|9848728|FG000|COMPLETED|Period 3||9
8797330|NCT01425801|9848729|FG001|COMPLETED|Period 3||9
8797331|NCT01425801|9848730|FG002|COMPLETED|Period 3||8
8797332|NCT01425801|9848731|FG003|COMPLETED|Period 3||12
8797333|NCT01425801|9848732|FG004|COMPLETED|Period 3||11
8797334|NCT01425801|9848733|FG005|COMPLETED|Period 3||10
8797335|NCT01425801|9848728|FG000|NOT COMPLETED|Period 3||0
8797336|NCT01425801|9848729|FG001|NOT COMPLETED|Period 3||0
8797337|NCT01425801|9848730|FG002|NOT COMPLETED|Period 3||1
8797338|NCT01425801|9848731|FG003|NOT COMPLETED|Period 3||0
8797339|NCT01425801|9848732|FG004|NOT COMPLETED|Period 3||0
8797340|NCT01425801|9848733|FG005|NOT COMPLETED|Period 3||0
8797341|NCT01425801|9848728|FG000|STARTED|Period 4||9
8797342|NCT01425801|9848729|FG001|STARTED|Period 4||9
8797343|NCT01425801|9848730|FG002|STARTED|Period 4||8
8797344|NCT01425801|9848731|FG003|STARTED|Period 4||12
8797345|NCT01425801|9848732|FG004|STARTED|Period 4||11
8797346|NCT01425801|9848733|FG005|STARTED|Period 4||10
8797347|NCT01425801|9848728|FG000|COMPLETED|Period 4||9
8797348|NCT01425801|9848729|FG001|COMPLETED|Period 4||9
8797349|NCT01425801|9848730|FG002|COMPLETED|Period 4||7
8797350|NCT01425801|9848731|FG003|COMPLETED|Period 4||12
8797351|NCT01425801|9848732|FG004|COMPLETED|Period 4||11
8797352|NCT01425801|9848733|FG005|COMPLETED|Period 4||10
8797353|NCT01425801|9848728|FG000|NOT COMPLETED|Period 4||0
8797354|NCT01425801|9848729|FG001|NOT COMPLETED|Period 4||0
8797355|NCT01425801|9848730|FG002|NOT COMPLETED|Period 4||1
8797356|NCT01425801|9848731|FG003|NOT COMPLETED|Period 4||0
8797357|NCT01425801|9848732|FG004|NOT COMPLETED|Period 4||0
8797358|NCT01425801|9848733|FG005|NOT COMPLETED|Period 4||0
8797359|NCT01425801|9848728|FG000|STARTED|Period 5||9
8797360|NCT01425801|9848729|FG001|STARTED|Period 5||9
8797361|NCT01425801|9848730|FG002|STARTED|Period 5||7
8797362|NCT01425801|9848731|FG003|STARTED|Period 5||12
8797363|NCT01425801|9848732|FG004|STARTED|Period 5||11
8797364|NCT01425801|9848733|FG005|STARTED|Period 5||10
8797365|NCT01425801|9848728|FG000|COMPLETED|Period 5||9
8797366|NCT01425801|9848729|FG001|COMPLETED|Period 5||9
8797367|NCT01425801|9848730|FG002|COMPLETED|Period 5||7
8797368|NCT01425801|9848731|FG003|COMPLETED|Period 5||12
8797369|NCT01425801|9848732|FG004|COMPLETED|Period 5||11
8797370|NCT01425801|9848733|FG005|COMPLETED|Period 5||10
8797371|NCT01425801|9848728|FG000|NOT COMPLETED|Period 5||0
8797372|NCT01425801|9848729|FG001|NOT COMPLETED|Period 5||0
8917782|NCT02195583|9977609|FG000|Sodium Fluoride (0 Ppm)|Overall Study||59
8917783|NCT02195583|9977609|FG000|Sodium Fluoride (1426 Ppm) + Zinc Base A|Overall Study|Discontinuations: 1 withdrawal of consent in Period 3 and 1 withdrawal of consent in Period 4|58
8917784|NCT02195583|9977609|FG000|Sodium Fluoride (250 Ppm)|Overall Study||55
8917785|NCT02195583|9977609|FG000|Sodium Fluoride (1426 Ppm)|Overall Study|Discontinuation:1 lost to follow up, 1 withdrawal of consent in Period 2, 1 other reason in Period 5|59
8917786|NCT02195583|9977609|FG000|Sodium Fluoride (1426 Ppm) + Zinc Base B|Overall Study|Discontinuations: 1 withdrawal of consent in Period 2;1 adverse event each in Period 3 and Period 4|60
8917787|NCT02195583|9977609|FG000|COMPLETED|Overall Study||53
8917788|NCT02195583|9977609|FG000|NOT COMPLETED|Overall Study||9
8917789|NCT02195622|9977626|FG000|STARTED|Overall Study||37
8917790|NCT02195622|9977627|FG001|STARTED|Overall Study||37
8917791|NCT02195622|9977626|FG000|COMPLETED|Overall Study||37
8917792|NCT02195622|9977627|FG001|COMPLETED|Overall Study||37
8917793|NCT02195622|9977626|FG000|NOT COMPLETED|Overall Study||0
8917794|NCT02195622|9977627|FG001|NOT COMPLETED|Overall Study||0
8917795|NCT02195687|9977635|FG000|STARTED|Overall Study||316
8917796|NCT02195687|9977636|FG001|STARTED|Overall Study||101
8797373|NCT01425801|9848730|FG002|NOT COMPLETED|Period 5||0
8797374|NCT01425801|9848731|FG003|NOT COMPLETED|Period 5||0
8797375|NCT01425801|9848732|FG004|NOT COMPLETED|Period 5||0
8797376|NCT01425801|9848733|FG005|NOT COMPLETED|Period 5||0
8797377|NCT01425801|9848728|FG000|STARTED|Period 6||9
8797378|NCT01425801|9848729|FG001|STARTED|Period 6||9
8797379|NCT01425801|9848730|FG002|STARTED|Period 6||7
8797380|NCT01425801|9848731|FG003|STARTED|Period 6||12
8797381|NCT01425801|9848732|FG004|STARTED|Period 6||11
8797382|NCT01425801|9848733|FG005|STARTED|Period 6||10
8797383|NCT01425801|9848728|FG000|COMPLETED|Period 6||9
8797384|NCT01425801|9848729|FG001|COMPLETED|Period 6||9
8797385|NCT01425801|9848730|FG002|COMPLETED|Period 6||7
8797386|NCT01425801|9848731|FG003|COMPLETED|Period 6||12
8797387|NCT01425801|9848732|FG004|COMPLETED|Period 6||11
8797388|NCT01425801|9848733|FG005|COMPLETED|Period 6||10
8797389|NCT01425801|9848728|FG000|NOT COMPLETED|Period 6||0
8797390|NCT01425801|9848729|FG001|NOT COMPLETED|Period 6||0
8797391|NCT01425801|9848730|FG002|NOT COMPLETED|Period 6||0
8797392|NCT01425801|9848731|FG003|NOT COMPLETED|Period 6||0
8797393|NCT01425801|9848732|FG004|NOT COMPLETED|Period 6||0
8797394|NCT01425801|9848733|FG005|NOT COMPLETED|Period 6||0
8797395|NCT01425814|9848747|FG000|STARTED|Period 1||12
8797396|NCT01425814|9848748|FG001|STARTED|Period 1||11
8797397|NCT01425814|9848749|FG002|STARTED|Period 1||12
8797398|NCT01425814|9848750|FG003|STARTED|Period 1||10
8797399|NCT01425814|9848751|FG004|STARTED|Period 1||12
8797400|NCT01425814|9848752|FG005|STARTED|Period 1||13
8797401|NCT01425814|9848747|FG000|COMPLETED|Period 1||12
8797402|NCT01425814|9848748|FG001|COMPLETED|Period 1||10
8797403|NCT01425814|9848749|FG002|COMPLETED|Period 1||12
8797404|NCT01425814|9848750|FG003|COMPLETED|Period 1||10
8797405|NCT01425814|9848751|FG004|COMPLETED|Period 1||12
8797406|NCT01425814|9848752|FG005|COMPLETED|Period 1||13
8797407|NCT01425814|9848747|FG000|NOT COMPLETED|Period 1||0
8797408|NCT01425814|9848748|FG001|NOT COMPLETED|Period 1||1
8797409|NCT01425814|9848749|FG002|NOT COMPLETED|Period 1||0
8797410|NCT01425814|9848750|FG003|NOT COMPLETED|Period 1||0
8797411|NCT01425814|9848751|FG004|NOT COMPLETED|Period 1||0
8917797|NCT02195687|9977635|FG000|COMPLETED|Overall Study||311
8917798|NCT02195687|9977636|FG001|COMPLETED|Overall Study||99
8917799|NCT02195687|9977635|FG000|NOT COMPLETED|Overall Study||5
8917800|NCT02195687|9977636|FG001|NOT COMPLETED|Overall Study||2
8917801|NCT02195700|9977644|FG000|STARTED|Overall Study||58
8917802|NCT02195700|9977645|FG001|STARTED|Overall Study||59
8917803|NCT02195700|9977644|FG000|Safety and ITT Populations|Overall Study||58
8917804|NCT02195700|9977645|FG001|Safety and ITT Populations|Overall Study||59
8917805|NCT02195700|9977644|FG000|Modified ITT Population|Overall Study|ITT who received study drug and >=1 centrally read post-baseline AIMS from weeks 2, 4, 6, 9, or 12|56
8917806|NCT02195700|9977645|FG001|Modified ITT Population|Overall Study|ITT who received study drug and >=1 centrally read post-baseline AIMS from weeks 2, 4, 6, 9, or 12|57
8917807|NCT02195700|9977644|FG000|Maintenance Period|Overall Study||53
8917808|NCT02195700|9977645|FG001|Maintenance Period|Overall Study||54
8917809|NCT02195700|9977644|FG000|COMPLETED|Overall Study||52
8917810|NCT02195700|9977645|FG001|COMPLETED|Overall Study||52
8917811|NCT02195700|9977644|FG000|NOT COMPLETED|Overall Study||6
8917812|NCT02195700|9977645|FG001|NOT COMPLETED|Overall Study||7
8917813|NCT02195713|9977653|FG000|STARTED|Overall Study||10
8917814|NCT02195713|9977654|FG001|STARTED|Overall Study||10
8917815|NCT02195713|9977653|FG000|COMPLETED|Overall Study||10
8917816|NCT02195713|9977654|FG001|COMPLETED|Overall Study||10
8917817|NCT02195713|9977653|FG000|NOT COMPLETED|Overall Study||0
8917818|NCT02195713|9977654|FG001|NOT COMPLETED|Overall Study||0
8917819|NCT02195869|9977660|FG000|STARTED|Overall Study|Phase 1b: 6 patients, 420 mg, no DLT observed. Phase 2: 42 patients, 420 mg|42
8917820|NCT02195869|9977660|FG000|All-Treated Population|Overall Study||42
8917821|NCT02195869|9977660|FG000|COMPLETED|Overall Study||0
8917822|NCT02195869|9977660|FG000|NOT COMPLETED|Overall Study||42
8917823|NCT02195895|9977667|FG000|STARTED|Overall Study||17
8917824|NCT02195895|9977667|FG000|COMPLETED|Overall Study||17
8917825|NCT02195895|9977667|FG000|NOT COMPLETED|Overall Study||0
8917826|NCT02195921|9977675|FG000|STARTED|Overall Study||40
8917827|NCT02195921|9977676|FG001|STARTED|Overall Study||40
8917828|NCT02195921|9977677|FG002|STARTED|Overall Study||40
8917829|NCT02195921|9977678|FG003|STARTED|Overall Study||40
8917830|NCT02195921|9977675|FG000|COMPLETED|Overall Study||39
8917831|NCT02195921|9977676|FG001|COMPLETED|Overall Study||39
8917832|NCT02195921|9977677|FG002|COMPLETED|Overall Study||39
8917833|NCT02195921|9977678|FG003|COMPLETED|Overall Study||40
8917834|NCT02195921|9977675|FG000|NOT COMPLETED|Overall Study||1
8917835|NCT02195921|9977676|FG001|NOT COMPLETED|Overall Study||1
8917836|NCT02195921|9977677|FG002|NOT COMPLETED|Overall Study||1
8917837|NCT02195921|9977678|FG003|NOT COMPLETED|Overall Study||0
8917838|NCT02196038|9977695|FG000|STARTED|Overall Study||174
8917839|NCT02196038|9977696|FG001|STARTED|Overall Study||175
8917840|NCT02196038|9977695|FG000|COMPLETED|Overall Study||157
8917841|NCT02196038|9977696|FG001|COMPLETED|Overall Study||153
8917842|NCT02196038|9977695|FG000|NOT COMPLETED|Overall Study||17
8917843|NCT02196038|9977696|FG001|NOT COMPLETED|Overall Study||22
8917844|NCT02196077|9977702|FG000|STARTED|Overall Study||180
8917845|NCT02196077|9977702|FG000|BFF MDI 320/9.6 μg|Overall Study||155
8917846|NCT02196077|9977702|FG000|BFF MDI 160/9.6 μg|Overall Study||106
8917847|NCT02196077|9977702|FG000|BFF MDI 80/9.6 μg|Overall Study||103
8917848|NCT02196077|9977702|FG000|BD MDI 320 μg|Overall Study||108
8917849|NCT02196077|9977702|FG000|FF MDI 9.6 μg|Overall Study||157
8917850|NCT02196077|9977702|FG000|COMPLETED|Overall Study||133
8917851|NCT02196077|9977702|FG000|NOT COMPLETED|Overall Study||47
8917852|NCT02196168|9977716|FG000|STARTED|Overall Study||6
8917853|NCT02196168|9977717|FG001|STARTED|Overall Study||0
8917854|NCT02196168|9977716|FG000|COMPLETED|Overall Study||6
8917855|NCT02196168|9977717|FG001|COMPLETED|Overall Study||0
8917856|NCT02196168|9977716|FG000|NOT COMPLETED|Overall Study||0
8917857|NCT02196168|9977717|FG001|NOT COMPLETED|Overall Study||0
8917858|NCT02196259|9977726|FG000|STARTED|Overall Study||3
8917859|NCT02196259|9977727|FG001|STARTED|Overall Study||7
8797412|NCT01425814|9848752|FG005|NOT COMPLETED|Period 1||0
8797413|NCT01425814|9848747|FG000|STARTED|Period 2||12
8797414|NCT01425814|9848748|FG001|STARTED|Period 2||10
8797415|NCT01425814|9848749|FG002|STARTED|Period 2||12
8797416|NCT01425814|9848750|FG003|STARTED|Period 2||10
8797417|NCT01425814|9848751|FG004|STARTED|Period 2||12
8797418|NCT01425814|9848752|FG005|STARTED|Period 2||13
8797419|NCT01425814|9848747|FG000|COMPLETED|Period 2||12
8797420|NCT01425814|9848748|FG001|COMPLETED|Period 2||9
8797421|NCT01425814|9848749|FG002|COMPLETED|Period 2||12
8797422|NCT01425814|9848750|FG003|COMPLETED|Period 2||10
8797423|NCT01425814|9848751|FG004|COMPLETED|Period 2||12
8797424|NCT01425814|9848752|FG005|COMPLETED|Period 2||13
8797425|NCT01425814|9848747|FG000|NOT COMPLETED|Period 2||0
8797426|NCT01425814|9848748|FG001|NOT COMPLETED|Period 2||1
8797427|NCT01425814|9848749|FG002|NOT COMPLETED|Period 2||0
8797428|NCT01425814|9848750|FG003|NOT COMPLETED|Period 2||0
8797429|NCT01425814|9848751|FG004|NOT COMPLETED|Period 2||0
8797430|NCT01425814|9848752|FG005|NOT COMPLETED|Period 2||0
8797431|NCT01425814|9848747|FG000|STARTED|Period 3||12
8797432|NCT01425814|9848748|FG001|STARTED|Period 3||9
8797433|NCT01425814|9848749|FG002|STARTED|Period 3||12
8797434|NCT01425814|9848750|FG003|STARTED|Period 3||10
8797435|NCT01425814|9848751|FG004|STARTED|Period 3||12
8797436|NCT01425814|9848752|FG005|STARTED|Period 3||13
8797437|NCT01425814|9848747|FG000|COMPLETED|Period 3||12
8797438|NCT01425814|9848748|FG001|COMPLETED|Period 3||9
8797439|NCT01425814|9848749|FG002|COMPLETED|Period 3||12
8797440|NCT01425814|9848750|FG003|COMPLETED|Period 3||10
8797441|NCT01425814|9848751|FG004|COMPLETED|Period 3||12
8797442|NCT01425814|9848752|FG005|COMPLETED|Period 3||12
8797443|NCT01425814|9848747|FG000|NOT COMPLETED|Period 3||0
8797444|NCT01425814|9848748|FG001|NOT COMPLETED|Period 3||0
8797445|NCT01425814|9848749|FG002|NOT COMPLETED|Period 3||0
8797446|NCT01425814|9848750|FG003|NOT COMPLETED|Period 3||0
8797447|NCT01425814|9848751|FG004|NOT COMPLETED|Period 3||0
8797448|NCT01425814|9848752|FG005|NOT COMPLETED|Period 3||1
8797449|NCT01425814|9848747|FG000|STARTED|Period 4||12
8797450|NCT01425814|9848748|FG001|STARTED|Period 4||9
8797451|NCT01425814|9848749|FG002|STARTED|Period 4||12
8797452|NCT01425814|9848750|FG003|STARTED|Period 4||10
8797453|NCT01425814|9848751|FG004|STARTED|Period 4||12
8797454|NCT01425814|9848752|FG005|STARTED|Period 4||12
8797455|NCT01425814|9848747|FG000|COMPLETED|Period 4||11
8797456|NCT01425814|9848748|FG001|COMPLETED|Period 4||9
8797457|NCT01425814|9848749|FG002|COMPLETED|Period 4||11
8797458|NCT01425814|9848750|FG003|COMPLETED|Period 4||10
8797459|NCT01425814|9848751|FG004|COMPLETED|Period 4||12
8797460|NCT01425814|9848752|FG005|COMPLETED|Period 4||12
8797461|NCT01425814|9848747|FG000|NOT COMPLETED|Period 4||1
8797462|NCT01425814|9848748|FG001|NOT COMPLETED|Period 4||0
8797463|NCT01425814|9848749|FG002|NOT COMPLETED|Period 4||1
8797464|NCT01425814|9848750|FG003|NOT COMPLETED|Period 4||0
8797465|NCT01425814|9848751|FG004|NOT COMPLETED|Period 4||0
8797466|NCT01425814|9848752|FG005|NOT COMPLETED|Period 4||0
8797467|NCT01425814|9848747|FG000|STARTED|Period 5||11
8797468|NCT01425814|9848748|FG001|STARTED|Period 5||9
8797469|NCT01425814|9848749|FG002|STARTED|Period 5||11
8797470|NCT01425814|9848750|FG003|STARTED|Period 5||10
8797471|NCT01425814|9848751|FG004|STARTED|Period 5||12
8797472|NCT01425814|9848752|FG005|STARTED|Period 5||12
8797473|NCT01425814|9848747|FG000|COMPLETED|Period 5||11
8797474|NCT01425814|9848748|FG001|COMPLETED|Period 5||9
8797475|NCT01425814|9848749|FG002|COMPLETED|Period 5||10
8797476|NCT01425814|9848750|FG003|COMPLETED|Period 5||10
8797477|NCT01425814|9848751|FG004|COMPLETED|Period 5||12
8797478|NCT01425814|9848752|FG005|COMPLETED|Period 5||11
8797479|NCT01425814|9848747|FG000|NOT COMPLETED|Period 5||0
8797480|NCT01425814|9848748|FG001|NOT COMPLETED|Period 5||0
8797481|NCT01425814|9848749|FG002|NOT COMPLETED|Period 5||1
8797482|NCT01425814|9848750|FG003|NOT COMPLETED|Period 5||0
8797483|NCT01425814|9848751|FG004|NOT COMPLETED|Period 5||0
8797484|NCT01425814|9848752|FG005|NOT COMPLETED|Period 5||1
8797485|NCT01425853|9848768|FG000|STARTED|Overall Study||304
9033543|NCT03275870|10095674|FG000|NOT COMPLETED|Overall Study||14
9033544|NCT03276026|10095680|FG000|STARTED|Overall Study||35
9033545|NCT03276026|10095681|FG001|STARTED|Overall Study||33
9033546|NCT03276026|10095680|FG000|COMPLETED|Overall Study||34
9033547|NCT03276026|10095681|FG001|COMPLETED|Overall Study||33
9033548|NCT03276026|10095680|FG000|NOT COMPLETED|Overall Study||1
9033549|NCT03276026|10095681|FG001|NOT COMPLETED|Overall Study||0
9033550|NCT03276078|10095687|FG000|STARTED|Overall Study||20
9033551|NCT03276078|10095687|FG000|COMPLETED|Overall Study||19
9033552|NCT03276078|10095687|FG000|NOT COMPLETED|Overall Study||1
9033553|NCT03276494|10095691|FG000|STARTED|Overall Study||6
9033554|NCT03276494|10095691|FG000|COMPLETED|Overall Study||5
9033555|NCT03276494|10095691|FG000|NOT COMPLETED|Overall Study||1
9033556|NCT03276637|10095695|FG000|STARTED|Overall Study||93
8797486|NCT01425853|9848769|FG001|STARTED|Overall Study||302
8797487|NCT01425853|9848768|FG000|Safety Population|Overall Study||304
8797488|NCT01425853|9848769|FG001|Safety Population|Overall Study||299
8797489|NCT01425853|9848768|FG000|Per Protocol (PP)|Overall Study||264
8797490|NCT01425853|9848769|FG001|Per Protocol (PP)|Overall Study||258
8797491|NCT01425853|9848768|FG000|COMPLETED|Overall Study||240
8797492|NCT01425853|9848769|FG001|COMPLETED|Overall Study||225
8797493|NCT01425853|9848768|FG000|NOT COMPLETED|Overall Study||64
8797494|NCT01425853|9848769|FG001|NOT COMPLETED|Overall Study||77
8797495|NCT01425879|9848776|FG000|STARTED|Overall Study||8
8797496|NCT01425879|9848776|FG000|COMPLETED|Overall Study||8
8797497|NCT01425879|9848776|FG000|NOT COMPLETED|Overall Study||0
8797498|NCT01426009|9848780|FG000|STARTED|Period 1-First Intervention (7 Days)||139
9033557|NCT03276637|10095695|FG000|Completed Pre Survey|Overall Study||93
9033558|NCT03276637|10095695|FG000|Underwent Sequencing|Overall Study||75
8797499|NCT01426009|9848780|FG000|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||23
8797500|NCT01426009|9848780|FG000|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||24
8797501|NCT01426009|9848780|FG000|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||22
8797502|NCT01426009|9848780|FG000|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||23
8797503|NCT01426009|9848780|FG000|Ipratropium Bromide|Period 1-First Intervention (7 Days)||23
8797504|NCT01426009|9848780|FG000|Placebo|Period 1-First Intervention (7 Days)||24
8797505|NCT01426009|9848780|FG000|COMPLETED|Period 1-First Intervention (7 Days)||137
8797506|NCT01426009|9848780|FG000|NOT COMPLETED|Period 1-First Intervention (7 Days)||2
8797507|NCT01426009|9848780|FG000|STARTED|Washout 1||137
8797508|NCT01426009|9848780|FG000|COMPLETED|Washout 1||135
8797509|NCT01426009|9848780|FG000|NOT COMPLETED|Washout 1||2
8797510|NCT01426009|9848780|FG000|STARTED|Period 2-Second Intervention (7 Days)||135
8797511|NCT01426009|9848780|FG000|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||22
8797512|NCT01426009|9848780|FG000|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||24
8797513|NCT01426009|9848780|FG000|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||24
8797514|NCT01426009|9848780|FG000|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||23
8797515|NCT01426009|9848780|FG000|Ipratropium Bromide|Period 2-Second Intervention (7 Days)||21
8797516|NCT01426009|9848780|FG000|Placebo|Period 2-Second Intervention (7 Days)||21
8797517|NCT01426009|9848780|FG000|COMPLETED|Period 2-Second Intervention (7 Days)||130
8797518|NCT01426009|9848780|FG000|NOT COMPLETED|Period 2-Second Intervention (7 Days)||5
8797519|NCT01426009|9848780|FG000|STARTED|Washout 2||130
8797520|NCT01426009|9848780|FG000|COMPLETED|Washout 2||129
8797521|NCT01426009|9848780|FG000|NOT COMPLETED|Washout 2||1
8797522|NCT01426009|9848780|FG000|STARTED|Period 3-Third Intervention (7 Days)||129
8797523|NCT01426009|9848780|FG000|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||19
8797524|NCT01426009|9848780|FG000|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||23
8797525|NCT01426009|9848780|FG000|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||22
8797526|NCT01426009|9848780|FG000|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||20
8797527|NCT01426009|9848780|FG000|Ipratropium Bromide|Period 3-Third Intervention (7 Days)||23
8797528|NCT01426009|9848780|FG000|Placebo|Period 3-Third Intervention (7 Days)||22
8797529|NCT01426009|9848780|FG000|COMPLETED|Period 3-Third Intervention (7 Days)||129
8797530|NCT01426009|9848780|FG000|NOT COMPLETED|Period 3-Third Intervention (7 Days)||0
8797531|NCT01426009|9848780|FG000|STARTED|Washout 3||129
8797532|NCT01426009|9848780|FG000|COMPLETED|Washout 3||128
8797533|NCT01426009|9848780|FG000|NOT COMPLETED|Washout 3||1
8797534|NCT01426009|9848780|FG000|STARTED|Period 4-Fourth Intervention (7 Days)||128
8797535|NCT01426009|9848780|FG000|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||10
8797536|NCT01426009|9848780|FG000|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||7
8797537|NCT01426009|9848780|FG000|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||8
8797538|NCT01426009|9848780|FG000|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||9
8797539|NCT01426009|9848780|FG000|Ipratropium Bromide|Period 4-Fourth Intervention (7 Days)||8
8797540|NCT01426009|9848780|FG000|Tiotropium Bromide|Period 4-Fourth Intervention (7 Days)||76
8797541|NCT01426009|9848780|FG000|Placebo|Period 4-Fourth Intervention (7 Days)||10
8797542|NCT01426009|9848780|FG000|COMPLETED|Period 4-Fourth Intervention (7 Days)||127
8797543|NCT01426009|9848780|FG000|NOT COMPLETED|Period 4-Fourth Intervention (7 Days)||1
8797544|NCT01426009|9848780|FG000|STARTED|Washout 4||127
8797545|NCT01426009|9848780|FG000|COMPLETED|Washout 4||126
8797546|NCT01426009|9848780|FG000|NOT COMPLETED|Washout 4||1
8797547|NCT01426191|9848796|FG000|STARTED|Overall Study||2032
8797548|NCT01426191|9848796|FG000|COMPLETED|Overall Study||2032
8797549|NCT01426191|9848796|FG000|NOT COMPLETED|Overall Study||0
8797550|NCT01426217|9848802|FG000|STARTED|Overall Study||314
8797551|NCT01426217|9848803|FG001|STARTED|Overall Study||280
8797552|NCT01426217|9848802|FG000|COMPLETED|Overall Study||306
8797553|NCT01426217|9848803|FG001|COMPLETED|Overall Study||266
8797554|NCT01426217|9848802|FG000|NOT COMPLETED|Overall Study||8
8797555|NCT01426217|9848803|FG001|NOT COMPLETED|Overall Study||14
8797556|NCT01426230|9848811|FG000|STARTED|Overall Study|90 patients were enrolled, but only 86 received study treatment.|86
8797557|NCT01426230|9848812|FG001|STARTED|Overall Study||111
8797558|NCT01426230|9848811|FG000|COMPLETED|Overall Study||55
8797559|NCT01426230|9848812|FG001|COMPLETED|Overall Study||84
8797560|NCT01426230|9848811|FG000|NOT COMPLETED|Overall Study||31
8797561|NCT01426230|9848812|FG001|NOT COMPLETED|Overall Study||27
8797562|NCT01426269|9848817|FG000|STARTED|Period 1: 12 Weeks||235
8797563|NCT01426269|9848818|FG001|STARTED|Period 1: 12 Weeks||0
8917860|NCT02196259|9977728|FG002|STARTED|Overall Study||3
8917861|NCT02196259|9977726|FG000|COMPLETED|Overall Study||3
8917862|NCT02196259|9977727|FG001|COMPLETED|Overall Study||4
8917863|NCT02196259|9977728|FG002|COMPLETED|Overall Study||2
8917864|NCT02196259|9977726|FG000|NOT COMPLETED|Overall Study||0
8917865|NCT02196259|9977727|FG001|NOT COMPLETED|Overall Study||3
8917866|NCT02196259|9977728|FG002|NOT COMPLETED|Overall Study||1
8917867|NCT02196324|9977737|FG000|STARTED|Overall Study||63
8917868|NCT02196324|9977738|FG001|STARTED|Overall Study||65
8917869|NCT02196324|9977737|FG000|COMPLETED|Overall Study||48
8917870|NCT02196324|9977738|FG001|COMPLETED|Overall Study||57
8917871|NCT02196324|9977737|FG000|NOT COMPLETED|Overall Study||15
8917872|NCT02196324|9977738|FG001|NOT COMPLETED|Overall Study||8
8917873|NCT02196506|9977746|FG000|STARTED|Phase A||837
8917874|NCT02196506|9977747|FG001|STARTED|Phase A||0
8917875|NCT02196506|9977748|FG002|STARTED|Phase A||0
8797564|NCT01426269|9848819|FG002|STARTED|Period 1: 12 Weeks||0
8797565|NCT01426269|9848817|FG000|COMPLETED|Period 1: 12 Weeks||180
8797566|NCT01426269|9848818|FG001|COMPLETED|Period 1: 12 Weeks||0
8797567|NCT01426269|9848819|FG002|COMPLETED|Period 1: 12 Weeks||0
8797568|NCT01426269|9848817|FG000|NOT COMPLETED|Period 1: 12 Weeks||55
8797569|NCT01426269|9848818|FG001|NOT COMPLETED|Period 1: 12 Weeks||0
8797570|NCT01426269|9848819|FG002|NOT COMPLETED|Period 1: 12 Weeks||0
8797571|NCT01426269|9848817|FG000|STARTED|Eligibility for Period 2, Randomization||180
8797572|NCT01426269|9848818|FG001|STARTED|Eligibility for Period 2, Randomization||0
8797573|NCT01426269|9848819|FG002|STARTED|Eligibility for Period 2, Randomization||0
8797574|NCT01426269|9848817|FG000|COMPLETED|Eligibility for Period 2, Randomization||130
8797575|NCT01426269|9848818|FG001|COMPLETED|Eligibility for Period 2, Randomization||0
8797576|NCT01426269|9848819|FG002|COMPLETED|Eligibility for Period 2, Randomization||0
8797577|NCT01426269|9848817|FG000|NOT COMPLETED|Eligibility for Period 2, Randomization||50
8797578|NCT01426269|9848818|FG001|NOT COMPLETED|Eligibility for Period 2, Randomization||0
8797579|NCT01426269|9848819|FG002|NOT COMPLETED|Eligibility for Period 2, Randomization||0
8797580|NCT01426269|9848817|FG000|STARTED|Period 2: 40 Weeks||0
8797581|NCT01426269|9848818|FG001|STARTED|Period 2: 40 Weeks||65
8797582|NCT01426269|9848819|FG002|STARTED|Period 2: 40 Weeks||65
8797583|NCT01426269|9848817|FG000|COMPLETED|Period 2: 40 Weeks||0
8797584|NCT01426269|9848818|FG001|COMPLETED|Period 2: 40 Weeks||27
8797585|NCT01426269|9848819|FG002|COMPLETED|Period 2: 40 Weeks||18
8797586|NCT01426269|9848817|FG000|NOT COMPLETED|Period 2: 40 Weeks||0
8797587|NCT01426269|9848818|FG001|NOT COMPLETED|Period 2: 40 Weeks||38
8797588|NCT01426269|9848819|FG002|NOT COMPLETED|Period 2: 40 Weeks||47
8797589|NCT01426347|9848832|FG000|STARTED|Overall Study||41
8797590|NCT01426347|9848833|FG001|STARTED|Overall Study||42
8797591|NCT01426347|9848832|FG000|COMPLETED|Overall Study||34
8797592|NCT01426347|9848833|FG001|COMPLETED|Overall Study||39
8797593|NCT01426347|9848832|FG000|NOT COMPLETED|Overall Study||7
8797594|NCT01426347|9848833|FG001|NOT COMPLETED|Overall Study||3
8797595|NCT01426360|9848841|FG000|STARTED|Overall Study||38
8797596|NCT01426360|9848842|FG001|STARTED|Overall Study||41
8797597|NCT01426360|9848841|FG000|COMPLETED|Overall Study||38
8797598|NCT01426360|9848842|FG001|COMPLETED|Overall Study||41
8797599|NCT01426360|9848841|FG000|NOT COMPLETED|Overall Study||0
8797600|NCT01426360|9848842|FG001|NOT COMPLETED|Overall Study||0
8797601|NCT01426373|9848848|FG000|STARTED|Overall Study||165
8797602|NCT01426373|9848848|FG000|COMPLETED|Overall Study|Completed the last follow-up visit 12 months after last treatment|131
8797603|NCT01426373|9848848|FG000|NOT COMPLETED|Overall Study||34
8797604|NCT01426386|9848860|FG000|STARTED|Overall Study||42
8797605|NCT01426386|9848861|FG001|STARTED|Overall Study||45
8797606|NCT01426386|9848862|FG002|STARTED|Overall Study||44
8797607|NCT01426386|9848863|FG003|STARTED|Overall Study||44
8797608|NCT01426386|9848864|FG004|STARTED|Overall Study||47
8797609|NCT01426386|9848865|FG005|STARTED|Overall Study||43
8797610|NCT01426386|9848860|FG000|COMPLETED|Overall Study||39
8797611|NCT01426386|9848861|FG001|COMPLETED|Overall Study||39
8797612|NCT01426386|9848862|FG002|COMPLETED|Overall Study||42
8797613|NCT01426386|9848863|FG003|COMPLETED|Overall Study||44
8797614|NCT01426386|9848864|FG004|COMPLETED|Overall Study||43
8797615|NCT01426386|9848865|FG005|COMPLETED|Overall Study||42
8797616|NCT01426386|9848860|FG000|NOT COMPLETED|Overall Study||3
8797617|NCT01426386|9848861|FG001|NOT COMPLETED|Overall Study||6
8797618|NCT01426386|9848862|FG002|NOT COMPLETED|Overall Study||2
8797619|NCT01426386|9848863|FG003|NOT COMPLETED|Overall Study||0
8797620|NCT01426386|9848864|FG004|NOT COMPLETED|Overall Study||4
8797621|NCT01426386|9848865|FG005|NOT COMPLETED|Overall Study||1
8797622|NCT01426412|9848888|FG000|STARTED|Overall Study||6
8797623|NCT01426412|9848889|FG001|STARTED|Overall Study||6
8797624|NCT01426412|9848890|FG002|STARTED|Overall Study||6
8797625|NCT01426412|9848891|FG003|STARTED|Overall Study||6
8797626|NCT01426412|9848892|FG004|STARTED|Overall Study||6
8797627|NCT01426412|9848893|FG005|STARTED|Overall Study||6
8797628|NCT01426412|9848894|FG006|STARTED|Overall Study||6
8797629|NCT01426412|9848895|FG007|STARTED|Overall Study||10
8797630|NCT01426412|9848896|FG008|STARTED|Overall Study||17
8797631|NCT01426412|9848888|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
8797632|NCT01426412|9848889|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
8797633|NCT01426412|9848890|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
8797634|NCT01426412|9848891|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
8797635|NCT01426412|9848892|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6
8797636|NCT01426412|9848893|FG005|Received at Least 1 Dose of Study Drug|Overall Study||6
8797637|NCT01426412|9848894|FG006|Received at Least 1 Dose of Study Drug|Overall Study||6
8797638|NCT01426412|9848895|FG007|Received at Least 1 Dose of Study Drug|Overall Study||10
8797639|NCT01426412|9848896|FG008|Received at Least 1 Dose of Study Drug|Overall Study||17
8797640|NCT01426412|9848888|FG000|COMPLETED|Overall Study||5
8797641|NCT01426412|9848889|FG001|COMPLETED|Overall Study||6
8797642|NCT01426412|9848890|FG002|COMPLETED|Overall Study||6
8797643|NCT01426412|9848891|FG003|COMPLETED|Overall Study||6
8797644|NCT01426412|9848892|FG004|COMPLETED|Overall Study||5
8797645|NCT01426412|9848893|FG005|COMPLETED|Overall Study||6
8797646|NCT01426412|9848894|FG006|COMPLETED|Overall Study||6
8797647|NCT01426412|9848895|FG007|COMPLETED|Overall Study||7
8797648|NCT01426412|9848896|FG008|COMPLETED|Overall Study||16
8797649|NCT01426412|9848888|FG000|NOT COMPLETED|Overall Study||1
8797650|NCT01426412|9848889|FG001|NOT COMPLETED|Overall Study||0
8797651|NCT01426412|9848890|FG002|NOT COMPLETED|Overall Study||0
8797652|NCT01426412|9848891|FG003|NOT COMPLETED|Overall Study||0
8797653|NCT01426412|9848892|FG004|NOT COMPLETED|Overall Study||1
8797654|NCT01426412|9848893|FG005|NOT COMPLETED|Overall Study||0
8797655|NCT01426412|9848894|FG006|NOT COMPLETED|Overall Study||0
8797656|NCT01426412|9848895|FG007|NOT COMPLETED|Overall Study||3
8797657|NCT01426412|9848896|FG008|NOT COMPLETED|Overall Study||1
8797658|NCT01426425|9848927|FG000|STARTED|Overall Study||572
8797659|NCT01426425|9848927|FG000|EP Study|Overall Study|EP study used to assess inclusion and exclusion criteria.|550
8797660|NCT01426425|9848927|FG000|Intent to Treat|Overall Study|Met all inclusion and no exclusion criteria.|399
8797661|NCT01426425|9848927|FG000|COMPLETED|Overall Study|The pre-specified modified intent-to-treat analysis set was used for the primary objectives.|397
8797662|NCT01426425|9848927|FG000|NOT COMPLETED|Overall Study||175
8797663|NCT01426438|9848934|FG000|STARTED|Overall Study||50
8797664|NCT01426438|9848935|FG001|STARTED|Overall Study||49
8797665|NCT01426438|9848934|FG000|COMPLETED|Overall Study||35
8797666|NCT01426438|9848935|FG001|COMPLETED|Overall Study||39
8797667|NCT01426438|9848934|FG000|NOT COMPLETED|Overall Study||15
8797668|NCT01426438|9848935|FG001|NOT COMPLETED|Overall Study||10
8797669|NCT01426581|9848943|FG000|STARTED|Overall Study||62
8797670|NCT01426581|9848944|FG001|STARTED|Overall Study||58
8797671|NCT01426581|9848943|FG000|COMPLETED|Overall Study||62
8797672|NCT01426581|9848944|FG001|COMPLETED|Overall Study||58
8797673|NCT01426581|9848943|FG000|NOT COMPLETED|Overall Study||0
8797674|NCT01426581|9848944|FG001|NOT COMPLETED|Overall Study||0
8797675|NCT01426763|9848954|FG000|STARTED|Overall Study||6
8797676|NCT01426763|9848955|FG001|STARTED|Overall Study||6
8797677|NCT01426763|9848954|FG000|COMPLETED|Overall Study||6
8797678|NCT01426763|9848955|FG001|COMPLETED|Overall Study||6
8797679|NCT01426763|9848954|FG000|NOT COMPLETED|Overall Study||0
8797680|NCT01426763|9848955|FG001|NOT COMPLETED|Overall Study||0
8797681|NCT01426789|9848965|FG000|STARTED|Part 1||68
8797682|NCT01426789|9848966|FG001|STARTED|Part 1||32
8797683|NCT01426789|9848967|FG002|STARTED|Part 1||0
8797684|NCT01426789|9848968|FG003|STARTED|Part 1||0
8797685|NCT01426789|9848969|FG004|STARTED|Part 1||0
8797686|NCT01426789|9848970|FG005|STARTED|Part 1||0
8797687|NCT01426789|9848965|FG000|COMPLETED|Part 1||62
8797688|NCT01426789|9848966|FG001|COMPLETED|Part 1||28
8797689|NCT01426789|9848967|FG002|COMPLETED|Part 1||0
8797690|NCT01426789|9848968|FG003|COMPLETED|Part 1||0
8797691|NCT01426789|9848969|FG004|COMPLETED|Part 1||0
8797692|NCT01426789|9848970|FG005|COMPLETED|Part 1||0
8797693|NCT01426789|9848965|FG000|NOT COMPLETED|Part 1||6
8797694|NCT01426789|9848966|FG001|NOT COMPLETED|Part 1||4
8797695|NCT01426789|9848967|FG002|NOT COMPLETED|Part 1||0
8797696|NCT01426789|9848968|FG003|NOT COMPLETED|Part 1||0
8797697|NCT01426789|9848969|FG004|NOT COMPLETED|Part 1||0
8797698|NCT01426789|9848970|FG005|NOT COMPLETED|Part 1||0
8797699|NCT01426789|9848965|FG000|STARTED|Part 2||0
8797700|NCT01426789|9848966|FG001|STARTED|Part 2||0
8797701|NCT01426789|9848967|FG002|STARTED|Part 2||49
8797702|NCT01426789|9848968|FG003|STARTED|Part 2||13
8797703|NCT01426789|9848969|FG004|STARTED|Part 2||27
8797704|NCT01426789|9848970|FG005|STARTED|Part 2||1
8797705|NCT01426789|9848965|FG000|COMPLETED|Part 2||0
8797706|NCT01426789|9848966|FG001|COMPLETED|Part 2||0
8797707|NCT01426789|9848967|FG002|COMPLETED|Part 2||34
8797708|NCT01426789|9848968|FG003|COMPLETED|Part 2||12
8797709|NCT01426789|9848969|FG004|COMPLETED|Part 2||19
8797710|NCT01426789|9848970|FG005|COMPLETED|Part 2||1
8797711|NCT01426789|9848965|FG000|NOT COMPLETED|Part 2||0
8797712|NCT01426789|9848966|FG001|NOT COMPLETED|Part 2||0
8797713|NCT01426789|9848967|FG002|NOT COMPLETED|Part 2||15
8797714|NCT01426789|9848968|FG003|NOT COMPLETED|Part 2||1
8797715|NCT01426789|9848969|FG004|NOT COMPLETED|Part 2||8
8797716|NCT01426789|9848970|FG005|NOT COMPLETED|Part 2||0
8797717|NCT01426828|9848980|FG000|STARTED|Overall Study Evaluations||22
8797718|NCT01426828|9848981|FG001|STARTED|Overall Study Evaluations||18
8797719|NCT01426828|9848980|FG000|COMPLETED|Overall Study Evaluations||17
8797720|NCT01426828|9848981|FG001|COMPLETED|Overall Study Evaluations||15
8797721|NCT01426828|9848980|FG000|NOT COMPLETED|Overall Study Evaluations||5
8797722|NCT01426828|9848981|FG001|NOT COMPLETED|Overall Study Evaluations||3
8797723|NCT01426828|9848980|FG000|STARTED|Immune Response Analysis||17
8797724|NCT01426828|9848981|FG001|STARTED|Immune Response Analysis||15
8797725|NCT01426828|9848980|FG000|COMPLETED|Immune Response Analysis||8
8797726|NCT01426828|9848981|FG001|COMPLETED|Immune Response Analysis||8
8797727|NCT01426828|9848980|FG000|NOT COMPLETED|Immune Response Analysis||9
8797728|NCT01426828|9848981|FG001|NOT COMPLETED|Immune Response Analysis||7
8797729|NCT01426854|9848989|FG000|STARTED|Overall Study||131
8797730|NCT01426854|9848990|FG001|STARTED|Overall Study||129
8797731|NCT01426854|9848989|FG000|COMPLETED|Overall Study||119
8797732|NCT01426854|9848990|FG001|COMPLETED|Overall Study||98
8797733|NCT01426854|9848989|FG000|NOT COMPLETED|Overall Study||12
8797734|NCT01426854|9848990|FG001|NOT COMPLETED|Overall Study||31
8797735|NCT01426867|9848999|FG000|STARTED|Overall Study||33
8797736|NCT01426867|9849000|FG001|STARTED|Overall Study||34
8797737|NCT01426867|9849001|FG002|STARTED|Overall Study||34
8797738|NCT01426867|9848999|FG000|COMPLETED|Overall Study||33
8797739|NCT01426867|9849000|FG001|COMPLETED|Overall Study||34
8797740|NCT01426867|9849001|FG002|COMPLETED|Overall Study||34
8797741|NCT01426867|9848999|FG000|NOT COMPLETED|Overall Study||0
8797742|NCT01426867|9849000|FG001|NOT COMPLETED|Overall Study||0
8797743|NCT01426867|9849001|FG002|NOT COMPLETED|Overall Study||0
8797744|NCT01426958|9849009|FG000|STARTED|Overall Study||24
8797745|NCT01426958|9849009|FG000|COMPLETED|Overall Study||22
8797746|NCT01426958|9849009|FG000|NOT COMPLETED|Overall Study||2
8797747|NCT01427296|9849019|FG000|STARTED|Overall Study||1041
8797748|NCT01427296|9849020|FG001|STARTED|Overall Study||1051
8797749|NCT01427296|9849019|FG000|COMPLETED|Overall Study||1041
8797750|NCT01427296|9849020|FG001|COMPLETED|Overall Study||1051
8797751|NCT01427296|9849019|FG000|NOT COMPLETED|Overall Study||0
8797752|NCT01427296|9849020|FG001|NOT COMPLETED|Overall Study||0
8797753|NCT01427309|9849030|FG000|STARTED|Overall Study||7253
8797754|NCT01427309|9849031|FG001|STARTED|Overall Study||7244
9033559|NCT03276637|10095695|FG000|Completed Post Survey|Overall Study||69
9033560|NCT03276637|10095695|FG000|COMPLETED|Overall Study||69
9033561|NCT03276637|10095695|FG000|NOT COMPLETED|Overall Study||24
9033562|NCT03276871|10095702|FG000|STARTED|Overall Study||21
9033563|NCT03276871|10095703|FG001|STARTED|Overall Study||19
9033564|NCT03276871|10095702|FG000|COMPLETED|Overall Study||21
9033565|NCT03276871|10095703|FG001|COMPLETED|Overall Study||19
9033566|NCT03276871|10095702|FG000|NOT COMPLETED|Overall Study||0
9033567|NCT03276871|10095703|FG001|NOT COMPLETED|Overall Study||0
9033568|NCT03276975|10095711|FG000|STARTED|Overall Study||8
9033569|NCT03276975|10095712|FG001|STARTED|Overall Study||7
9033570|NCT03276975|10095711|FG000|Crossover At 2 Months|Overall Study||0
9033571|NCT03276975|10095712|FG001|Crossover At 2 Months|Overall Study||7
9033572|NCT03276975|10095711|FG000|COMPLETED|Overall Study||7
9033573|NCT03276975|10095712|FG001|COMPLETED|Overall Study||7
9033574|NCT03276975|10095711|FG000|NOT COMPLETED|Overall Study||1
9033575|NCT03276975|10095712|FG001|NOT COMPLETED|Overall Study||0
9033576|NCT03277274|10095721|FG000|STARTED|Overall Study||8
9033577|NCT03277274|10095722|FG001|STARTED|Overall Study||10
9033578|NCT03277274|10095723|FG002|STARTED|Overall Study||7
9033579|NCT03277274|10095721|FG000|COMPLETED|Overall Study||8
9033580|NCT03277274|10095722|FG001|COMPLETED|Overall Study||10
9033581|NCT03277274|10095723|FG002|COMPLETED|Overall Study||7
9033582|NCT03277274|10095721|FG000|NOT COMPLETED|Overall Study||0
9033583|NCT03277274|10095722|FG001|NOT COMPLETED|Overall Study||0
9033584|NCT03277274|10095723|FG002|NOT COMPLETED|Overall Study||0
9033585|NCT03277352|10095731|FG000|STARTED|Overall Study||10
9033586|NCT03277352|10095731|FG000|COMPLETED|Overall Study||0
9033587|NCT03277352|10095731|FG000|NOT COMPLETED|Overall Study||10
9033588|NCT03277378|10095738|FG000|STARTED|Overall Study||135
9033589|NCT03277378|10095739|FG001|STARTED|Overall Study||135
9033590|NCT03277378|10095738|FG000|Received Lead Implant|Overall Study||129
9033591|NCT03277378|10095739|FG001|Received Lead Implant|Overall Study||123
9033592|NCT03277378|10095738|FG000|Completed Initial Trial|Overall Study||126
9033593|NCT03277378|10095739|FG001|Completed Initial Trial|Overall Study||122
9033594|NCT03277378|10095738|FG000|Qualified for Permanent Implant|Overall Study||103
9033595|NCT03277378|10095739|FG001|Qualified for Permanent Implant|Overall Study||93
9033596|NCT03277378|10095738|FG000|Not Qualified for Permanent Implant|Overall Study||19
9033597|NCT03277378|10095739|FG001|Not Qualified for Permanent Implant|Overall Study||20
9033598|NCT03277378|10095738|FG000|Completed Extended Trial With Tonic Stim|Overall Study||8
9033599|NCT03277378|10095739|FG001|Completed Extended Trial With Tonic Stim|Overall Study||12
9033600|NCT03277378|10095738|FG000|Exit Study|Overall Study||11
9033601|NCT03277378|10095739|FG001|Exit Study|Overall Study||8
9033602|NCT03277378|10095738|FG000|COMPLETED|Overall Study||111
9033603|NCT03277378|10095739|FG001|COMPLETED|Overall Study||101
9033604|NCT03277378|10095738|FG000|NOT COMPLETED|Overall Study||24
9033605|NCT03277378|10095739|FG001|NOT COMPLETED|Overall Study||34
9033606|NCT03277794|10095751|FG000|STARTED|Overall Study||31
9033607|NCT03277794|10095752|FG001|STARTED|Overall Study||34
9033608|NCT03277794|10095751|FG000|COMPLETED|Overall Study||28
9033609|NCT03277794|10095752|FG001|COMPLETED|Overall Study||30
9033610|NCT03277794|10095751|FG000|NOT COMPLETED|Overall Study||3
9033611|NCT03277794|10095752|FG001|NOT COMPLETED|Overall Study||4
9033612|NCT03277846|10095761|FG000|STARTED|Overall Study||50
9033613|NCT03277846|10095762|FG001|STARTED|Overall Study||51
9033614|NCT03277846|10095761|FG000|COMPLETED|Overall Study||38
9033615|NCT03277846|10095762|FG001|COMPLETED|Overall Study||40
9033616|NCT03277846|10095761|FG000|NOT COMPLETED|Overall Study||12
9033617|NCT03277846|10095762|FG001|NOT COMPLETED|Overall Study||11
9033618|NCT03278028|10095770|FG000|STARTED|Overall Study||81
9033619|NCT03278028|10095771|FG001|STARTED|Overall Study||78
9033620|NCT03278028|10095770|FG000|COMPLETED|Overall Study||77
9033621|NCT03278028|10095771|FG001|COMPLETED|Overall Study||76
9033622|NCT03278028|10095770|FG000|NOT COMPLETED|Overall Study||4
9033623|NCT03278028|10095771|FG001|NOT COMPLETED|Overall Study||2
9033624|NCT03278067|10095780|FG000|STARTED|Overall Study||16433
9033625|NCT03278067|10095781|FG001|STARTED|Overall Study||3310
9033626|NCT03278067|10095782|FG002|STARTED|Overall Study||4196
9033627|NCT03278067|10095780|FG000|COMPLETED|Overall Study||16433
9033628|NCT03278067|10095781|FG001|COMPLETED|Overall Study||3310
9033629|NCT03278067|10095782|FG002|COMPLETED|Overall Study||4196
9033630|NCT03278067|10095780|FG000|NOT COMPLETED|Overall Study||0
9033631|NCT03278067|10095781|FG001|NOT COMPLETED|Overall Study||0
8575177|NCT00133575|9607670|FG003|COMPLETED|Overall Study||9
8797755|NCT01427309|9849032|FG002|STARTED|Overall Study||8737
9033632|NCT03278067|10095782|FG002|NOT COMPLETED|Overall Study||0
8797756|NCT01427309|9849033|FG003|STARTED|Overall Study||8749
9033633|NCT03278106|10095795|FG000|STARTED|Overall Study||28
9033634|NCT03278106|10095795|FG000|COMPLETED|Overall Study||27
8797757|NCT01427309|9849030|FG000|COMPLETED|Overall Study||6881
8797758|NCT01427309|9849031|FG001|COMPLETED|Overall Study||6837
8797759|NCT01427309|9849032|FG002|COMPLETED|Overall Study||8376
8797760|NCT01427309|9849033|FG003|COMPLETED|Overall Study||8373
8797761|NCT01427309|9849030|FG000|NOT COMPLETED|Overall Study||372
8797762|NCT01427309|9849031|FG001|NOT COMPLETED|Overall Study||407
8797763|NCT01427309|9849032|FG002|NOT COMPLETED|Overall Study||361
8797764|NCT01427309|9849033|FG003|NOT COMPLETED|Overall Study||376
8797765|NCT01427504|9849049|FG000|STARTED|Overall Study||4
8797766|NCT01427504|9849050|FG001|STARTED|Overall Study||3
8797767|NCT01427504|9849051|FG002|STARTED|Overall Study||4
8797768|NCT01427504|9849052|FG003|STARTED|Overall Study||6
8797769|NCT01427504|9849053|FG004|STARTED|Overall Study||3
8797770|NCT01427504|9849054|FG005|STARTED|Overall Study||6
8797771|NCT01427504|9849049|FG000|Received Boceprevir|Overall Study||4
8797772|NCT01427504|9849050|FG001|Received Boceprevir|Overall Study||3
8797773|NCT01427504|9849051|FG002|Received Boceprevir|Overall Study||3
8797774|NCT01427504|9849052|FG003|Received Boceprevir|Overall Study||5
8797775|NCT01427504|9849053|FG004|Received Boceprevir|Overall Study||2
8797776|NCT01427504|9849054|FG005|Received Boceprevir|Overall Study||4
8797777|NCT01427504|9849049|FG000|Received Etravirine|Overall Study||4
8797778|NCT01427504|9849050|FG001|Received Etravirine|Overall Study||2
8797779|NCT01427504|9849051|FG002|Received Etravirine|Overall Study||4
8797780|NCT01427504|9849052|FG003|Received Etravirine|Overall Study||6
8797781|NCT01427504|9849053|FG004|Received Etravirine|Overall Study||2
8797782|NCT01427504|9849054|FG005|Received Etravirine|Overall Study||4
8797783|NCT01427504|9849049|FG000|Received Combination|Overall Study||4
8797784|NCT01427504|9849050|FG001|Received Combination|Overall Study||3
8797785|NCT01427504|9849051|FG002|Received Combination|Overall Study||3
8797786|NCT01427504|9849052|FG003|Received Combination|Overall Study||6
8797787|NCT01427504|9849053|FG004|Received Combination|Overall Study||3
8797788|NCT01427504|9849054|FG005|Received Combination|Overall Study||6
8797789|NCT01427504|9849049|FG000|COMPLETED|Overall Study||4
8797790|NCT01427504|9849050|FG001|COMPLETED|Overall Study||2
8797791|NCT01427504|9849051|FG002|COMPLETED|Overall Study||3
8797792|NCT01427504|9849052|FG003|COMPLETED|Overall Study||5
8797793|NCT01427504|9849053|FG004|COMPLETED|Overall Study||2
8797794|NCT01427504|9849054|FG005|COMPLETED|Overall Study||4
8797795|NCT01427504|9849049|FG000|NOT COMPLETED|Overall Study||0
8797796|NCT01427504|9849050|FG001|NOT COMPLETED|Overall Study||1
8797797|NCT01427504|9849051|FG002|NOT COMPLETED|Overall Study||1
8797798|NCT01427504|9849052|FG003|NOT COMPLETED|Overall Study||1
8797799|NCT01427504|9849053|FG004|NOT COMPLETED|Overall Study||1
8797800|NCT01427504|9849054|FG005|NOT COMPLETED|Overall Study||2
8797801|NCT01427517|9849074|FG000|STARTED|Overall Study||3
8797802|NCT01427517|9849075|FG001|STARTED|Overall Study||3
8797803|NCT01427517|9849076|FG002|STARTED|Overall Study||3
8797804|NCT01427517|9849074|FG000|COMPLETED|Overall Study||3
8797805|NCT01427517|9849075|FG001|COMPLETED|Overall Study||3
8797806|NCT01427517|9849076|FG002|COMPLETED|Overall Study||3
8797807|NCT01427517|9849074|FG000|NOT COMPLETED|Overall Study||0
8797808|NCT01427517|9849075|FG001|NOT COMPLETED|Overall Study||0
8797809|NCT01427517|9849076|FG002|NOT COMPLETED|Overall Study||0
8797810|NCT01427595|9849084|FG000|STARTED|Overall Study||25
8797811|NCT01427595|9849084|FG000|COMPLETED|Overall Study||12
8797812|NCT01427595|9849084|FG000|NOT COMPLETED|Overall Study||13
8797813|NCT01427608|9849090|FG000|STARTED|Overall Study||64
8797814|NCT01427608|9849091|FG001|STARTED|Overall Study||62
8797815|NCT01427608|9849090|FG000|COMPLETED|Overall Study||43
8797816|NCT01427608|9849091|FG001|COMPLETED|Overall Study||24
8797817|NCT01427608|9849090|FG000|NOT COMPLETED|Overall Study||21
8917876|NCT02196506|9977749|FG003|STARTED|Phase A||0
8917877|NCT02196506|9977746|FG000|COMPLETED|Phase A||716
8917878|NCT02196506|9977747|FG001|COMPLETED|Phase A||0
8917879|NCT02196506|9977748|FG002|COMPLETED|Phase A||0
8917880|NCT02196506|9977749|FG003|COMPLETED|Phase A||0
8917881|NCT02196506|9977746|FG000|NOT COMPLETED|Phase A||121
8917882|NCT02196506|9977747|FG001|NOT COMPLETED|Phase A||0
8917883|NCT02196506|9977748|FG002|NOT COMPLETED|Phase A||0
8917884|NCT02196506|9977749|FG003|NOT COMPLETED|Phase A||0
8917885|NCT02196506|9977746|FG000|STARTED|Phase B||0
8917886|NCT02196506|9977747|FG001|STARTED|Phase B||192
8917887|NCT02196506|9977748|FG002|STARTED|Phase B||202
8917888|NCT02196506|9977749|FG003|STARTED|Phase B||0
8917889|NCT02196506|9977746|FG000|COMPLETED|Phase B||0
8917890|NCT02196506|9977747|FG001|COMPLETED|Phase B||177
8917891|NCT02196506|9977748|FG002|COMPLETED|Phase B||196
8917892|NCT02196506|9977749|FG003|COMPLETED|Phase B||0
8917893|NCT02196506|9977746|FG000|NOT COMPLETED|Phase B||0
8917894|NCT02196506|9977747|FG001|NOT COMPLETED|Phase B||15
8917895|NCT02196506|9977748|FG002|NOT COMPLETED|Phase B||6
8917896|NCT02196506|9977749|FG003|NOT COMPLETED|Phase B||0
8917897|NCT02196506|9977746|FG000|STARTED|Phase A+||0
8917898|NCT02196506|9977747|FG001|STARTED|Phase A+||0
8917899|NCT02196506|9977748|FG002|STARTED|Phase A+||0
8917900|NCT02196506|9977749|FG003|STARTED|Phase A+||322
8917901|NCT02196506|9977746|FG000|COMPLETED|Phase A+||0
8797818|NCT01427608|9849091|FG001|NOT COMPLETED|Overall Study||38
8797819|NCT01427738|9849101|FG000|STARTED|Overall Study||110
8797820|NCT01427738|9849102|FG001|STARTED|Overall Study||111
8797821|NCT01427738|9849101|FG000|COMPLETED|Overall Study||91
8797822|NCT01427738|9849102|FG001|COMPLETED|Overall Study||90
8917902|NCT02196506|9977747|FG001|COMPLETED|Phase A+||0
8917903|NCT02196506|9977748|FG002|COMPLETED|Phase A+||0
8917904|NCT02196506|9977749|FG003|COMPLETED|Phase A+||308
8797823|NCT01427738|9849101|FG000|NOT COMPLETED|Overall Study||19
8797824|NCT01427738|9849102|FG001|NOT COMPLETED|Overall Study||21
8797825|NCT01427751|9849110|FG000|STARTED|Overall Study||154
8797826|NCT01427751|9849111|FG001|STARTED|Overall Study||153
8797827|NCT01427751|9849110|FG000|COMPLETED|Overall Study||112
8797828|NCT01427751|9849111|FG001|COMPLETED|Overall Study||139
8797829|NCT01427751|9849110|FG000|NOT COMPLETED|Overall Study||42
8797830|NCT01427751|9849111|FG001|NOT COMPLETED|Overall Study||14
8797831|NCT01427803|9849119|FG000|STARTED|Overall Study||526
8797832|NCT01427803|9849120|FG001|STARTED|Overall Study||252
8797833|NCT01427803|9849119|FG000|Purchased Product|Overall Study|Only 516 participants used e-diary|525
8797834|NCT01427803|9849120|FG001|Purchased Product|Overall Study||252
8797835|NCT01427803|9849119|FG000|Baseline Assessment|Overall Study||516
8797836|NCT01427803|9849120|FG001|Baseline Assessment|Overall Study|only interviewed participants were assessed|130
8797837|NCT01427803|9849119|FG000|Took Product|Overall Study|Those who took at least one dose of investigational product. Only 502 qualified for data analysis.|508
8797838|NCT01427803|9849120|FG001|Took Product|Overall Study|Those who took at least one dose of investigational product as logged in e diary & 1 on Health Log.|237
8797839|NCT01427803|9849119|FG000|COMPLETED|Overall Study||463
8797840|NCT01427803|9849120|FG001|COMPLETED|Overall Study|130 participants interviewed. Remaining subjects continued in trial to collect safety information.|226
8797841|NCT01427803|9849119|FG000|NOT COMPLETED|Overall Study||63
8797842|NCT01427803|9849120|FG001|NOT COMPLETED|Overall Study||26
8797843|NCT01427881|9849124|FG000|STARTED|Overall Study||43
8797844|NCT01427881|9849124|FG000|COMPLETED|Overall Study||43
8797845|NCT01427881|9849124|FG000|NOT COMPLETED|Overall Study||0
8797846|NCT01427907|9849130|FG000|STARTED|Overall Study|Randomized|20
8797847|NCT01427907|9849131|FG001|STARTED|Overall Study|Randomized|18
8797848|NCT01427907|9849130|FG000|COMPLETED|Overall Study|Completed study|17
8797849|NCT01427907|9849131|FG001|COMPLETED|Overall Study|Completed study|14
8797850|NCT01427907|9849130|FG000|NOT COMPLETED|Overall Study||3
8797851|NCT01427907|9849131|FG001|NOT COMPLETED|Overall Study||4
8797852|NCT01427920|9849139|FG000|STARTED|Overall Study||174
8797853|NCT01427920|9849140|FG001|STARTED|Overall Study||174
8797854|NCT01427920|9849139|FG000|Exposed|Overall Study||174
8797855|NCT01427920|9849140|FG001|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|173
8797856|NCT01427920|9849139|FG000|COMPLETED|Overall Study||165
8797857|NCT01427920|9849140|FG001|COMPLETED|Overall Study||157
8797858|NCT01427920|9849139|FG000|NOT COMPLETED|Overall Study||9
8797859|NCT01427920|9849140|FG001|NOT COMPLETED|Overall Study||17
8797860|NCT01427933|9849148|FG000|STARTED|Overall Study||71
8797861|NCT01427933|9849149|FG001|STARTED|Overall Study||70
8797862|NCT01427933|9849148|FG000|Received at Least 1 Dose of Study Drug|Overall Study||69
9033635|NCT03278106|10095795|FG000|NOT COMPLETED|Overall Study||1
9033636|NCT03278223|10095801|FG000|STARTED|Overall Study||125
8672179|NCT00756002|9715675|FG000|STARTED|Placebo Run-in||488
8672180|NCT00756002|9715676|FG001|STARTED|Placebo Run-in||0
8672181|NCT00756002|9715675|FG000|COMPLETED|Placebo Run-in||259
9033637|NCT03278223|10095802|FG001|STARTED|Overall Study||69
9033638|NCT03278223|10095801|FG000|COMPLETED|Overall Study||122
9033639|NCT03278223|10095802|FG001|COMPLETED|Overall Study||65
9033640|NCT03278223|10095801|FG000|NOT COMPLETED|Overall Study||3
9033641|NCT03278223|10095802|FG001|NOT COMPLETED|Overall Study||4
9033642|NCT03278613|10095810|FG000|STARTED|Overall Study||111
9033643|NCT03278613|10095811|FG001|STARTED|Overall Study||55
9033644|NCT03278613|10095810|FG000|COMPLETED|Overall Study||108
9033645|NCT03278613|10095811|FG001|COMPLETED|Overall Study||54
9033646|NCT03278613|10095810|FG000|NOT COMPLETED|Overall Study||3
9033647|NCT03278613|10095811|FG001|NOT COMPLETED|Overall Study||1
9033648|NCT03278886|10095819|FG000|STARTED|Overall Study||8
9033649|NCT03278886|10095820|FG001|STARTED|Overall Study||3
9033650|NCT03278886|10095819|FG000|COMPLETED|Overall Study||8
9033651|NCT03278886|10095820|FG001|COMPLETED|Overall Study||2
9033652|NCT03278886|10095819|FG000|NOT COMPLETED|Overall Study||0
9033653|NCT03278886|10095820|FG001|NOT COMPLETED|Overall Study||1
9033654|NCT03279237|10095826|FG000|STARTED|Overall Study||25
9033655|NCT03279237|10095826|FG000|Chemo-radiation|Overall Study||23
9033656|NCT03279237|10095826|FG000|Surgical Resection|Overall Study||20
9033657|NCT03279237|10095826|FG000|COMPLETED|Overall Study||20
9033658|NCT03279237|10095826|FG000|NOT COMPLETED|Overall Study||5
9033659|NCT03279458|10095830|FG000|STARTED|Overall Study||40
9033660|NCT03279458|10095830|FG000|COMPLETED|Overall Study||40
9033661|NCT03279458|10095830|FG000|NOT COMPLETED|Overall Study||0
9033662|NCT03279731|10095838|FG000|STARTED|Overall Study||19
9033663|NCT03279731|10095839|FG001|STARTED|Overall Study||17
9033664|NCT03279731|10095838|FG000|COMPLETED|Overall Study||13
9033665|NCT03279731|10095839|FG001|COMPLETED|Overall Study||14
8797863|NCT01427933|9849149|FG001|Received at Least 1 Dose of Study Drug|Overall Study||65
8797864|NCT01427933|9849148|FG000|COMPLETED|Overall Study||63
8797865|NCT01427933|9849149|FG001|COMPLETED|Overall Study||57
9033666|NCT03279731|10095838|FG000|NOT COMPLETED|Overall Study||6
9033667|NCT03279731|10095839|FG001|NOT COMPLETED|Overall Study||3
9033668|NCT03280108|10095849|FG000|STARTED|Overall Study||129
9033669|NCT03280108|10095850|FG001|STARTED|Overall Study||114
9033670|NCT03280108|10095849|FG000|COMPLETED|Overall Study||127
9033671|NCT03280108|10095850|FG001|COMPLETED|Overall Study||114
9033672|NCT03280108|10095849|FG000|NOT COMPLETED|Overall Study||2
9033673|NCT03280108|10095850|FG001|NOT COMPLETED|Overall Study||0
8797866|NCT01427933|9849148|FG000|NOT COMPLETED|Overall Study||8
8797867|NCT01427933|9849149|FG001|NOT COMPLETED|Overall Study||13
8797868|NCT01427972|9849168|FG000|STARTED|Treatment Period 1 (21 Days)||3
8797869|NCT01427972|9849169|FG001|STARTED|Treatment Period 1 (21 Days)||4
8797870|NCT01427972|9849170|FG002|STARTED|Treatment Period 1 (21 Days)||4
8797871|NCT01427972|9849171|FG003|STARTED|Treatment Period 1 (21 Days)||3
8797872|NCT01427972|9849172|FG004|STARTED|Treatment Period 1 (21 Days)||4
8797873|NCT01427972|9849173|FG005|STARTED|Treatment Period 1 (21 Days)||3
8797874|NCT01427972|9849174|FG006|STARTED|Treatment Period 1 (21 Days)||3
8797875|NCT01427972|9849175|FG007|STARTED|Treatment Period 1 (21 Days)||5
8797876|NCT01427972|9849176|FG008|STARTED|Treatment Period 1 (21 Days)||3
8797877|NCT01427972|9849177|FG009|STARTED|Treatment Period 1 (21 Days)||3
8797878|NCT01427972|9849178|FG010|STARTED|Treatment Period 1 (21 Days)||3
8797879|NCT01427972|9849179|FG011|STARTED|Treatment Period 1 (21 Days)||4
8797880|NCT01427972|9849168|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
8797881|NCT01427972|9849169|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||4
8797882|NCT01427972|9849170|FG002|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||4
8797883|NCT01427972|9849171|FG003|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
8797884|NCT01427972|9849172|FG004|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||4
8797885|NCT01427972|9849173|FG005|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
8797886|NCT01427972|9849174|FG006|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
8797887|NCT01427972|9849175|FG007|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||5
8797888|NCT01427972|9849176|FG008|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
8797889|NCT01427972|9849177|FG009|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
8797890|NCT01427972|9849178|FG010|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
8797891|NCT01427972|9849179|FG011|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||4
8797892|NCT01427972|9849168|FG000|COMPLETED|Treatment Period 1 (21 Days)||3
8797893|NCT01427972|9849169|FG001|COMPLETED|Treatment Period 1 (21 Days)||4
8797894|NCT01427972|9849170|FG002|COMPLETED|Treatment Period 1 (21 Days)||4
8797895|NCT01427972|9849171|FG003|COMPLETED|Treatment Period 1 (21 Days)||3
8797896|NCT01427972|9849172|FG004|COMPLETED|Treatment Period 1 (21 Days)||4
8797897|NCT01427972|9849173|FG005|COMPLETED|Treatment Period 1 (21 Days)||3
8797898|NCT01427972|9849174|FG006|COMPLETED|Treatment Period 1 (21 Days)||3
8797899|NCT01427972|9849175|FG007|COMPLETED|Treatment Period 1 (21 Days)||4
8797900|NCT01427972|9849176|FG008|COMPLETED|Treatment Period 1 (21 Days)||3
8797901|NCT01427972|9849177|FG009|COMPLETED|Treatment Period 1 (21 Days)||3
8797902|NCT01427972|9849178|FG010|COMPLETED|Treatment Period 1 (21 Days)||3
8797903|NCT01427972|9849179|FG011|COMPLETED|Treatment Period 1 (21 Days)||4
8797904|NCT01427972|9849168|FG000|NOT COMPLETED|Treatment Period 1 (21 Days)||0
8797905|NCT01427972|9849169|FG001|NOT COMPLETED|Treatment Period 1 (21 Days)||0
8797906|NCT01427972|9849170|FG002|NOT COMPLETED|Treatment Period 1 (21 Days)||0
8797907|NCT01427972|9849171|FG003|NOT COMPLETED|Treatment Period 1 (21 Days)||0
8797908|NCT01427972|9849172|FG004|NOT COMPLETED|Treatment Period 1 (21 Days)||0
8797909|NCT01427972|9849173|FG005|NOT COMPLETED|Treatment Period 1 (21 Days)||0
8797910|NCT01427972|9849174|FG006|NOT COMPLETED|Treatment Period 1 (21 Days)||0
8797911|NCT01427972|9849175|FG007|NOT COMPLETED|Treatment Period 1 (21 Days)||1
8797912|NCT01427972|9849176|FG008|NOT COMPLETED|Treatment Period 1 (21 Days)||0
8797913|NCT01427972|9849177|FG009|NOT COMPLETED|Treatment Period 1 (21 Days)||0
8797914|NCT01427972|9849178|FG010|NOT COMPLETED|Treatment Period 1 (21 Days)||0
8797915|NCT01427972|9849179|FG011|NOT COMPLETED|Treatment Period 1 (21 Days)||0
8797916|NCT01427972|9849168|FG000|STARTED|Washout (at Least 28 Days)||3
8797917|NCT01427972|9849169|FG001|STARTED|Washout (at Least 28 Days)||4
8797918|NCT01427972|9849170|FG002|STARTED|Washout (at Least 28 Days)||4
8797919|NCT01427972|9849171|FG003|STARTED|Washout (at Least 28 Days)||3
8797920|NCT01427972|9849172|FG004|STARTED|Washout (at Least 28 Days)||4
8797921|NCT01427972|9849173|FG005|STARTED|Washout (at Least 28 Days)||3
8797922|NCT01427972|9849174|FG006|STARTED|Washout (at Least 28 Days)||3
8797923|NCT01427972|9849175|FG007|STARTED|Washout (at Least 28 Days)||4
8797924|NCT01427972|9849176|FG008|STARTED|Washout (at Least 28 Days)||3
8797925|NCT01427972|9849177|FG009|STARTED|Washout (at Least 28 Days)||3
8797926|NCT01427972|9849178|FG010|STARTED|Washout (at Least 28 Days)||3
8797927|NCT01427972|9849179|FG011|STARTED|Washout (at Least 28 Days)||4
8797928|NCT01427972|9849168|FG000|COMPLETED|Washout (at Least 28 Days)||3
8797929|NCT01427972|9849169|FG001|COMPLETED|Washout (at Least 28 Days)||4
8797930|NCT01427972|9849170|FG002|COMPLETED|Washout (at Least 28 Days)||4
8797931|NCT01427972|9849171|FG003|COMPLETED|Washout (at Least 28 Days)||3
8797932|NCT01427972|9849172|FG004|COMPLETED|Washout (at Least 28 Days)||4
8797933|NCT01427972|9849173|FG005|COMPLETED|Washout (at Least 28 Days)||1
8797934|NCT01427972|9849174|FG006|COMPLETED|Washout (at Least 28 Days)||3
8797935|NCT01427972|9849175|FG007|COMPLETED|Washout (at Least 28 Days)||4
8797936|NCT01427972|9849176|FG008|COMPLETED|Washout (at Least 28 Days)||3
8797937|NCT01427972|9849177|FG009|COMPLETED|Washout (at Least 28 Days)||3
8797938|NCT01427972|9849178|FG010|COMPLETED|Washout (at Least 28 Days)||3
8797939|NCT01427972|9849179|FG011|COMPLETED|Washout (at Least 28 Days)||4
9033674|NCT03280121|10095861|FG000|STARTED|Overall Study||14
9033675|NCT03280121|10095861|FG000|COMPLETED|Overall Study||8
8797940|NCT01427972|9849168|FG000|NOT COMPLETED|Washout (at Least 28 Days)||0
8797941|NCT01427972|9849169|FG001|NOT COMPLETED|Washout (at Least 28 Days)||0
8797942|NCT01427972|9849170|FG002|NOT COMPLETED|Washout (at Least 28 Days)||0
8797943|NCT01427972|9849171|FG003|NOT COMPLETED|Washout (at Least 28 Days)||0
8797944|NCT01427972|9849172|FG004|NOT COMPLETED|Washout (at Least 28 Days)||0
8797945|NCT01427972|9849173|FG005|NOT COMPLETED|Washout (at Least 28 Days)||2
8797946|NCT01427972|9849174|FG006|NOT COMPLETED|Washout (at Least 28 Days)||0
8797947|NCT01427972|9849175|FG007|NOT COMPLETED|Washout (at Least 28 Days)||0
8797948|NCT01427972|9849176|FG008|NOT COMPLETED|Washout (at Least 28 Days)||0
8797949|NCT01427972|9849177|FG009|NOT COMPLETED|Washout (at Least 28 Days)||0
8797950|NCT01427972|9849178|FG010|NOT COMPLETED|Washout (at Least 28 Days)||0
8797951|NCT01427972|9849179|FG011|NOT COMPLETED|Washout (at Least 28 Days)||0
8797952|NCT01427972|9849168|FG000|STARTED|Treatment Period 2 (21 Days)||3
8797953|NCT01427972|9849169|FG001|STARTED|Treatment Period 2 (21 Days)||4
8797954|NCT01427972|9849170|FG002|STARTED|Treatment Period 2 (21 Days)||4
8797955|NCT01427972|9849171|FG003|STARTED|Treatment Period 2 (21 Days)||3
8797956|NCT01427972|9849172|FG004|STARTED|Treatment Period 2 (21 Days)||4
8797957|NCT01427972|9849173|FG005|STARTED|Treatment Period 2 (21 Days)||1
8797958|NCT01427972|9849174|FG006|STARTED|Treatment Period 2 (21 Days)||3
8797959|NCT01427972|9849175|FG007|STARTED|Treatment Period 2 (21 Days)||4
8797960|NCT01427972|9849176|FG008|STARTED|Treatment Period 2 (21 Days)||3
8797961|NCT01427972|9849177|FG009|STARTED|Treatment Period 2 (21 Days)||3
8797962|NCT01427972|9849178|FG010|STARTED|Treatment Period 2 (21 Days)||3
8797963|NCT01427972|9849179|FG011|STARTED|Treatment Period 2 (21 Days)||4
8797964|NCT01427972|9849168|FG000|COMPLETED|Treatment Period 2 (21 Days)||3
8797965|NCT01427972|9849169|FG001|COMPLETED|Treatment Period 2 (21 Days)||3
8797966|NCT01427972|9849170|FG002|COMPLETED|Treatment Period 2 (21 Days)||4
8797967|NCT01427972|9849171|FG003|COMPLETED|Treatment Period 2 (21 Days)||3
8797968|NCT01427972|9849172|FG004|COMPLETED|Treatment Period 2 (21 Days)||4
8797969|NCT01427972|9849173|FG005|COMPLETED|Treatment Period 2 (21 Days)||1
8797970|NCT01427972|9849174|FG006|COMPLETED|Treatment Period 2 (21 Days)||3
8797971|NCT01427972|9849175|FG007|COMPLETED|Treatment Period 2 (21 Days)||4
8797972|NCT01427972|9849176|FG008|COMPLETED|Treatment Period 2 (21 Days)||3
8797973|NCT01427972|9849177|FG009|COMPLETED|Treatment Period 2 (21 Days)||3
8797974|NCT01427972|9849178|FG010|COMPLETED|Treatment Period 2 (21 Days)||3
8797975|NCT01427972|9849179|FG011|COMPLETED|Treatment Period 2 (21 Days)||4
8797976|NCT01427972|9849168|FG000|NOT COMPLETED|Treatment Period 2 (21 Days)||0
8797977|NCT01427972|9849169|FG001|NOT COMPLETED|Treatment Period 2 (21 Days)||1
8797978|NCT01427972|9849170|FG002|NOT COMPLETED|Treatment Period 2 (21 Days)||0
8797979|NCT01427972|9849171|FG003|NOT COMPLETED|Treatment Period 2 (21 Days)||0
8797980|NCT01427972|9849172|FG004|NOT COMPLETED|Treatment Period 2 (21 Days)||0
8797981|NCT01427972|9849173|FG005|NOT COMPLETED|Treatment Period 2 (21 Days)||0
8797982|NCT01427972|9849174|FG006|NOT COMPLETED|Treatment Period 2 (21 Days)||0
8797983|NCT01427972|9849175|FG007|NOT COMPLETED|Treatment Period 2 (21 Days)||0
8797984|NCT01427972|9849176|FG008|NOT COMPLETED|Treatment Period 2 (21 Days)||0
8797985|NCT01427972|9849177|FG009|NOT COMPLETED|Treatment Period 2 (21 Days)||0
8797986|NCT01427972|9849178|FG010|NOT COMPLETED|Treatment Period 2 (21 Days)||0
8797987|NCT01427972|9849179|FG011|NOT COMPLETED|Treatment Period 2 (21 Days)||0
8797988|NCT01428024|9849191|FG000|STARTED|Overall Study||30
8797989|NCT01428024|9849192|FG001|STARTED|Overall Study||30
8797990|NCT01428024|9849191|FG000|COMPLETED|Overall Study||29
8797991|NCT01428024|9849192|FG001|COMPLETED|Overall Study||29
8797992|NCT01428024|9849191|FG000|NOT COMPLETED|Overall Study||1
8797993|NCT01428024|9849192|FG001|NOT COMPLETED|Overall Study||1
8797994|NCT01428063|9849212|FG000|STARTED|Overall Study||99
8797995|NCT01428063|9849213|FG001|STARTED|Overall Study||122
8797996|NCT01428063|9849214|FG002|STARTED|Overall Study||6
8797997|NCT01428063|9849212|FG000|COMPLETED|Overall Study||89
8797998|NCT01428063|9849213|FG001|COMPLETED|Overall Study||112
8797999|NCT01428063|9849214|FG002|COMPLETED|Overall Study||5
8798000|NCT01428063|9849212|FG000|NOT COMPLETED|Overall Study||10
8798001|NCT01428063|9849213|FG001|NOT COMPLETED|Overall Study||10
8798002|NCT01428063|9849214|FG002|NOT COMPLETED|Overall Study||1
8798003|NCT01428076|9849235|FG000|STARTED|Overall Study||9
8798004|NCT01428076|9849236|FG001|STARTED|Overall Study||12
8798005|NCT01428076|9849235|FG000|COMPLETED|Overall Study||9
8798006|NCT01428076|9849236|FG001|COMPLETED|Overall Study||11
8798007|NCT01428076|9849235|FG000|NOT COMPLETED|Overall Study||0
8798008|NCT01428076|9849236|FG001|NOT COMPLETED|Overall Study||1
8798009|NCT01428115|9849244|FG000|STARTED|Overall Study||83
8798010|NCT01428115|9849244|FG000|COMPLETED|Overall Study||62
8798011|NCT01428115|9849244|FG000|NOT COMPLETED|Overall Study||21
8798012|NCT01428128|9849249|FG000|STARTED|Overall Study||50
8798013|NCT01428128|9849249|FG000|COMPLETED|Overall Study||33
8798014|NCT01428128|9849249|FG000|NOT COMPLETED|Overall Study||17
8798015|NCT01428193|9849254|FG000|STARTED|Overall Study||4
8798016|NCT01428193|9849254|FG000|COMPLETED|Overall Study||2
8798017|NCT01428193|9849254|FG000|NOT COMPLETED|Overall Study||2
8798018|NCT01428219|9849258|FG000|STARTED|Overall Study||25
8798019|NCT01428219|9849258|FG000|COMPLETED|Overall Study||22
8798020|NCT01428219|9849258|FG000|NOT COMPLETED|Overall Study||3
8798021|NCT01428245|9849262|FG000|STARTED|Overall Study||1
8798022|NCT01428245|9849262|FG000|COMPLETED|Overall Study||1
8798023|NCT01428245|9849262|FG000|NOT COMPLETED|Overall Study||0
8798024|NCT01428258|9849268|FG000|STARTED|Intervention 1||17
8798025|NCT01428258|9849269|FG001|STARTED|Intervention 1||15
8798026|NCT01428258|9849268|FG000|COMPLETED|Intervention 1||15
8798027|NCT01428258|9849269|FG001|COMPLETED|Intervention 1||15
8798028|NCT01428258|9849268|FG000|NOT COMPLETED|Intervention 1||2
8798029|NCT01428258|9849269|FG001|NOT COMPLETED|Intervention 1||0
8798030|NCT01428258|9849268|FG000|STARTED|Intervention 2||15
8798031|NCT01428258|9849269|FG001|STARTED|Intervention 2||15
8798032|NCT01428258|9849268|FG000|COMPLETED|Intervention 2||15
8798033|NCT01428258|9849269|FG001|COMPLETED|Intervention 2||15
8798034|NCT01428258|9849268|FG000|NOT COMPLETED|Intervention 2||0
8798035|NCT01428258|9849269|FG001|NOT COMPLETED|Intervention 2||0
8798036|NCT01428336|9849285|FG000|STARTED|Overall Study||10
8798037|NCT01428336|9849286|FG001|STARTED|Overall Study||12
8798038|NCT01428336|9849285|FG000|COMPLETED|Overall Study||10
8798039|NCT01428336|9849286|FG001|COMPLETED|Overall Study||12
8798040|NCT01428336|9849285|FG000|NOT COMPLETED|Overall Study||0
8798041|NCT01428336|9849286|FG001|NOT COMPLETED|Overall Study||0
8798042|NCT01428453|9849297|FG000|STARTED|Overall Study||62
8798043|NCT01428453|9849298|FG001|STARTED|Overall Study||61
8798044|NCT01428453|9849297|FG000|COMPLETED|Overall Study||56
8798045|NCT01428453|9849298|FG001|COMPLETED|Overall Study||52
8798046|NCT01428453|9849297|FG000|NOT COMPLETED|Overall Study||6
8798047|NCT01428453|9849298|FG001|NOT COMPLETED|Overall Study||9
8798048|NCT01428583|9849306|FG000|STARTED|Overall Study||395
8798049|NCT01428583|9849306|FG000|COMPLETED|Overall Study||158
8798050|NCT01428583|9849306|FG000|NOT COMPLETED|Overall Study||237
8798051|NCT01428661|9849313|FG000|STARTED|Double-Masked Phase||254
8798052|NCT01428661|9849314|FG001|STARTED|Double-Masked Phase||253
8798053|NCT01428661|9849315|FG002|STARTED|Double-Masked Phase|Does not apply.|0
8798054|NCT01428661|9849313|FG000|COMPLETED|Double-Masked Phase||197
8798055|NCT01428661|9849314|FG001|COMPLETED|Double-Masked Phase||204
8798056|NCT01428661|9849315|FG002|COMPLETED|Double-Masked Phase|Does not apply.|0
8798057|NCT01428661|9849313|FG000|NOT COMPLETED|Double-Masked Phase||57
8798058|NCT01428661|9849314|FG001|NOT COMPLETED|Double-Masked Phase||49
8798059|NCT01428661|9849315|FG002|NOT COMPLETED|Double-Masked Phase||0
8798060|NCT01428661|9849313|FG000|STARTED|Open Label Extension|Does not apply.|0
8798061|NCT01428661|9849314|FG001|STARTED|Open Label Extension|Does not apply.|0
8798062|NCT01428661|9849315|FG002|STARTED|Open Label Extension||339
8798063|NCT01428661|9849313|FG000|COMPLETED|Open Label Extension|Does not apply.|0
8798064|NCT01428661|9849314|FG001|COMPLETED|Open Label Extension|Does not apply.|0
8798065|NCT01428661|9849315|FG002|COMPLETED|Open Label Extension||19
8798066|NCT01428661|9849313|FG000|NOT COMPLETED|Open Label Extension||0
8798067|NCT01428661|9849314|FG001|NOT COMPLETED|Open Label Extension||0
8798068|NCT01428661|9849315|FG002|NOT COMPLETED|Open Label Extension||320
8798069|NCT01428713|9849323|FG000|STARTED|Overall Study||9
8798070|NCT01428713|9849324|FG001|STARTED|Overall Study||8
8798071|NCT01428713|9849323|FG000|COMPLETED|Overall Study||6
8798072|NCT01428713|9849324|FG001|COMPLETED|Overall Study||3
8798073|NCT01428713|9849323|FG000|NOT COMPLETED|Overall Study||3
8798074|NCT01428713|9849324|FG001|NOT COMPLETED|Overall Study||5
8798075|NCT01428765|9849330|FG000|STARTED|Overall Study||1063
8798076|NCT01428765|9849330|FG000|COMPLETED|Overall Study||1063
8798077|NCT01428765|9849330|FG000|NOT COMPLETED|Overall Study||0
8798078|NCT01428882|9849336|FG000|STARTED|Overall Study||67
8798079|NCT01428882|9849337|FG001|STARTED|Overall Study||68
8798080|NCT01428882|9849336|FG000|COMPLETED|Overall Study||61
8917905|NCT02196506|9977746|FG000|NOT COMPLETED|Phase A+||0
8917906|NCT02196506|9977747|FG001|NOT COMPLETED|Phase A+||0
8917907|NCT02196506|9977748|FG002|NOT COMPLETED|Phase A+||0
8917908|NCT02196506|9977749|FG003|NOT COMPLETED|Phase A+||14
8917909|NCT02196558|9977758|FG000|STARTED|Treatment Phase (12 Weeks)||12
8917910|NCT02196558|9977759|FG001|STARTED|Treatment Phase (12 Weeks)||15
8917911|NCT02196558|9977760|FG002|STARTED|Treatment Phase (12 Weeks)||10
8917912|NCT02196558|9977758|FG000|COMPLETED|Treatment Phase (12 Weeks)||12
8917913|NCT02196558|9977759|FG001|COMPLETED|Treatment Phase (12 Weeks)||12
8917914|NCT02196558|9977760|FG002|COMPLETED|Treatment Phase (12 Weeks)||8
8917915|NCT02196558|9977758|FG000|NOT COMPLETED|Treatment Phase (12 Weeks)||0
8917916|NCT02196558|9977759|FG001|NOT COMPLETED|Treatment Phase (12 Weeks)||3
8917917|NCT02196558|9977760|FG002|NOT COMPLETED|Treatment Phase (12 Weeks)||2
8917918|NCT02196558|9977758|FG000|STARTED|Extension Phase (40 Weeks)|Participants who wished to continue, had no safety issues, and had>=20% improvement in joint counts.|11
8917919|NCT02196558|9977759|FG001|STARTED|Extension Phase (40 Weeks)|Participants who wished to continue, had no safety issues, and had>=20% improvement in joint counts.|11
9033676|NCT03280121|10095861|FG000|NOT COMPLETED|Overall Study||6
9033677|NCT03280264|10095865|FG000|STARTED|Overall Study||18
9033678|NCT03280264|10095865|FG000|COMPLETED|Overall Study||15
9033679|NCT03280264|10095865|FG000|NOT COMPLETED|Overall Study||3
9033680|NCT03280381|10095872|FG000|STARTED|Overall Study||101
9033681|NCT03280381|10095873|FG001|STARTED|Overall Study||99
9033682|NCT03280381|10095872|FG000|COMPLETED|Overall Study||101
9033683|NCT03280381|10095873|FG001|COMPLETED|Overall Study||97
8798081|NCT01428882|9849337|FG001|COMPLETED|Overall Study||58
8798082|NCT01428882|9849336|FG000|NOT COMPLETED|Overall Study||6
8798083|NCT01428882|9849337|FG001|NOT COMPLETED|Overall Study||10
9033684|NCT03280381|10095872|FG000|NOT COMPLETED|Overall Study||0
9033685|NCT03280381|10095873|FG001|NOT COMPLETED|Overall Study||2
8798084|NCT01429051|9849343|FG000|STARTED|Titration Phase||45
8798085|NCT01429051|9849343|FG000|COMPLETED|Titration Phase||33
8798086|NCT01429051|9849343|FG000|NOT COMPLETED|Titration Phase||12
8798087|NCT01429051|9849343|FG000|STARTED|Efficacy Phase|Participants titrated to 200 or 400 μg INFS in Titration Phase|15
8798088|NCT01429051|9849343|FG000|COMPLETED|Efficacy Phase||13
8798089|NCT01429051|9849343|FG000|NOT COMPLETED|Efficacy Phase||2
8798090|NCT01429051|9849343|FG000|STARTED|Tolerability Phase|Participants entered directly from the Titration or Efficacy Phase|31
8798091|NCT01429051|9849343|FG000|COMPLETED|Tolerability Phase||16
8798092|NCT01429051|9849343|FG000|NOT COMPLETED|Tolerability Phase||15
8798093|NCT01429064|9849358|FG000|STARTED|Overall Study||19
8798094|NCT01429064|9849359|FG001|STARTED|Overall Study||22
8798095|NCT01429064|9849360|FG002|STARTED|Overall Study||19
8798096|NCT01429064|9849361|FG003|STARTED|Overall Study||16
8798097|NCT01429064|9849358|FG000|COMPLETED|Overall Study||19
8798098|NCT01429064|9849359|FG001|COMPLETED|Overall Study||22
8798099|NCT01429064|9849360|FG002|COMPLETED|Overall Study||19
8798100|NCT01429064|9849361|FG003|COMPLETED|Overall Study||16
8798101|NCT01429064|9849358|FG000|NOT COMPLETED|Overall Study||0
8798102|NCT01429064|9849359|FG001|NOT COMPLETED|Overall Study||0
8798103|NCT01429064|9849360|FG002|NOT COMPLETED|Overall Study||0
8798104|NCT01429064|9849361|FG003|NOT COMPLETED|Overall Study||0
8798105|NCT01429077|9849373|FG000|STARTED|Overall Study||19
8798106|NCT01429077|9849374|FG001|STARTED|Overall Study||17
8798107|NCT01429077|9849373|FG000|Completed 6-week Intervention|Overall Study||19
8798108|NCT01429077|9849374|FG001|Completed 6-week Intervention|Overall Study||17
8798109|NCT01429077|9849373|FG000|COMPLETED|Overall Study||19
8798110|NCT01429077|9849374|FG001|COMPLETED|Overall Study||14
8798111|NCT01429077|9849373|FG000|NOT COMPLETED|Overall Study||0
8798112|NCT01429077|9849374|FG001|NOT COMPLETED|Overall Study||3
8798113|NCT01429259|9849380|FG000|STARTED|Overall Study||30
8798114|NCT01429259|9849380|FG000|COMPLETED|Overall Study||30
8798115|NCT01429259|9849380|FG000|NOT COMPLETED|Overall Study||0
8798116|NCT01429272|9849388|FG000|STARTED|Overall Study||30
8798117|NCT01429272|9849389|FG001|STARTED|Overall Study||31
8798118|NCT01429272|9849390|FG002|STARTED|Overall Study||19
8798119|NCT01429272|9849391|FG003|STARTED|Overall Study||19
8798120|NCT01429272|9849388|FG000|COMPLETED|Overall Study||24
8798121|NCT01429272|9849389|FG001|COMPLETED|Overall Study||22
8798122|NCT01429272|9849390|FG002|COMPLETED|Overall Study||15
8798123|NCT01429272|9849391|FG003|COMPLETED|Overall Study||14
8798124|NCT01429272|9849388|FG000|NOT COMPLETED|Overall Study||6
8798125|NCT01429272|9849389|FG001|NOT COMPLETED|Overall Study||9
8798126|NCT01429272|9849390|FG002|NOT COMPLETED|Overall Study||4
8798127|NCT01429272|9849391|FG003|NOT COMPLETED|Overall Study||5
8798128|NCT01429285|9849403|FG000|STARTED|Overall Study||175
8798129|NCT01429285|9849404|FG001|STARTED|Overall Study||175
8798130|NCT01429285|9849403|FG000|Given IV Opioids|Overall Study|9 patients never given IV opioids|166
8798131|NCT01429285|9849404|FG001|Given IV Opioids|Overall Study|4 patients never given IV opioids|171
8798132|NCT01429285|9849403|FG000|Completed Primary Outcome Data|Overall Study|5 patients had missing data|161
8798133|NCT01429285|9849404|FG001|Completed Primary Outcome Data|Overall Study|3 patients had missing data|168
8798134|NCT01429285|9849403|FG000|Confirmation of no Duplicate Enrollment|Overall Study|8 patients were enrolled twice at two separate ED visits, which was only noted at study conclusion.|153
8798135|NCT01429285|9849404|FG001|Confirmation of no Duplicate Enrollment|Overall Study|2 patients were enrolled twice, at two separate ED visits, which was only noted at study conclusion|166
8798136|NCT01429285|9849403|FG000|COMPLETED|Overall Study||153
8798137|NCT01429285|9849404|FG001|COMPLETED|Overall Study||166
8798138|NCT01429285|9849403|FG000|NOT COMPLETED|Overall Study||22
8798139|NCT01429285|9849404|FG001|NOT COMPLETED|Overall Study||9
8798140|NCT01429298|9849412|FG000|STARTED|Overall Study||175
8798141|NCT01429298|9849413|FG001|STARTED|Overall Study||175
8798142|NCT01429298|9849412|FG000|Given IV Opioids|Overall Study|4 never given IV opioids|171
8798143|NCT01429298|9849413|FG001|Given IV Opioids|Overall Study|6 never given IV opioids|169
8798144|NCT01429298|9849412|FG000|COMPLETED|Overall Study||171
8798145|NCT01429298|9849413|FG001|COMPLETED|Overall Study||169
8798146|NCT01429298|9849412|FG000|NOT COMPLETED|Overall Study||4
8798147|NCT01429298|9849413|FG001|NOT COMPLETED|Overall Study||6
8798148|NCT01429350|9849421|FG000|STARTED|Overall Study||53
8798149|NCT01429350|9849422|FG001|STARTED|Overall Study||55
8798150|NCT01429350|9849421|FG000|As-Treated|Overall Study||62
8798151|NCT01429350|9849422|FG001|As-Treated|Overall Study||43
8798152|NCT01429350|9849421|FG000|Per Protocol|Overall Study||41
8798153|NCT01429350|9849422|FG001|Per Protocol|Overall Study||37
8798154|NCT01429350|9849421|FG000|90 Day|Overall Study||46
8798155|NCT01429350|9849422|FG001|90 Day|Overall Study||50
8798156|NCT01429350|9849421|FG000|COMPLETED|Overall Study||46
8798157|NCT01429350|9849422|FG001|COMPLETED|Overall Study||50
8798158|NCT01429350|9849421|FG000|NOT COMPLETED|Overall Study||7
8798159|NCT01429350|9849422|FG001|NOT COMPLETED|Overall Study||5
8798160|NCT01429441|9849430|FG000|STARTED|Overall Study||146
8798161|NCT01429441|9849431|FG001|STARTED|Overall Study||74
8798162|NCT01429441|9849430|FG000|COMPLETED|Overall Study||108
8798163|NCT01429441|9849431|FG001|COMPLETED|Overall Study||51
8798164|NCT01429441|9849430|FG000|NOT COMPLETED|Overall Study||38
8798165|NCT01429441|9849431|FG001|NOT COMPLETED|Overall Study||23
8798166|NCT01429454|9849439|FG000|STARTED|Overall Study||62
8798167|NCT01429454|9849440|FG001|STARTED|Overall Study||65
8798168|NCT01429454|9849439|FG000|COMPLETED|Overall Study||35
8798169|NCT01429454|9849440|FG001|COMPLETED|Overall Study||35
8798170|NCT01429454|9849439|FG000|NOT COMPLETED|Overall Study||27
8798171|NCT01429454|9849440|FG001|NOT COMPLETED|Overall Study||30
8798172|NCT01429532|9849450|FG000|STARTED|Overall Study||40
8798173|NCT01429532|9849451|FG001|STARTED|Overall Study||40
8798174|NCT01429532|9849452|FG002|STARTED|Overall Study||40
8798175|NCT01429532|9849450|FG000|COMPLETED|Overall Study||40
8798176|NCT01429532|9849451|FG001|COMPLETED|Overall Study||40
8798177|NCT01429532|9849452|FG002|COMPLETED|Overall Study||40
8798178|NCT01429532|9849450|FG000|NOT COMPLETED|Overall Study||0
8798179|NCT01429532|9849451|FG001|NOT COMPLETED|Overall Study||0
8798180|NCT01429532|9849452|FG002|NOT COMPLETED|Overall Study||0
8798181|NCT01429584|9849462|FG000|STARTED|Overall Study||15
8798182|NCT01429584|9849463|FG001|STARTED|Overall Study||15
8798183|NCT01429584|9849462|FG000|COMPLETED|Overall Study||14
8798184|NCT01429584|9849463|FG001|COMPLETED|Overall Study||14
8798185|NCT01429584|9849462|FG000|NOT COMPLETED|Overall Study||1
8798186|NCT01429584|9849463|FG001|NOT COMPLETED|Overall Study||1
8798187|NCT01429623|9849471|FG000|STARTED|Overall Study|103 allocated, 1 withdrew consent prior to first dose, 4 lacked post baseline data|102
8798188|NCT01429623|9849472|FG001|STARTED|Overall Study|107 allocated, 4 lacked post baseline data|107
8798189|NCT01429623|9849471|FG000|Converted to Alzheimer's|Overall Study|14 of 99|14
8798190|NCT01429623|9849472|FG001|Converted to Alzheimer's|Overall Study|21 of 103|21
8798191|NCT01429623|9849471|FG000|COMPLETED|Overall Study||51
8798192|NCT01429623|9849472|FG001|COMPLETED|Overall Study||48
8798193|NCT01429623|9849471|FG000|NOT COMPLETED|Overall Study||51
8798194|NCT01429623|9849472|FG001|NOT COMPLETED|Overall Study||59
8798195|NCT01429792|9849478|FG000|STARTED|Overall Study||1013
8798196|NCT01429792|9849478|FG000|Genotype 1|Overall Study||687
8798197|NCT01429792|9849478|FG000|Genotype 2 & 3|Overall Study||305
8798198|NCT01429792|9849478|FG000|Genotype 4|Overall Study||5
8798199|NCT01429792|9849478|FG000|COMPLETED|Overall Study||607
8798200|NCT01429792|9849478|FG000|NOT COMPLETED|Overall Study||406
8798201|NCT01429987|9849486|FG000|STARTED|Overall Study||238
8798202|NCT01429987|9849487|FG001|STARTED|Overall Study||238
8798203|NCT01429987|9849488|FG002|STARTED|Overall Study||238
8798204|NCT01429987|9849489|FG003|STARTED|Overall Study||237
8798205|NCT01429987|9849486|FG000|COMPLETED|Overall Study||189
8798206|NCT01429987|9849487|FG001|COMPLETED|Overall Study||176
8798207|NCT01429987|9849488|FG002|COMPLETED|Overall Study||202
8798208|NCT01429987|9849489|FG003|COMPLETED|Overall Study||171
8798209|NCT01429987|9849486|FG000|NOT COMPLETED|Overall Study||49
8798210|NCT01429987|9849487|FG001|NOT COMPLETED|Overall Study||62
8798211|NCT01429987|9849488|FG002|NOT COMPLETED|Overall Study||36
8798212|NCT01429987|9849489|FG003|NOT COMPLETED|Overall Study||66
8798213|NCT01430091|9849499|FG000|STARTED|Overall Study||18
8798214|NCT01430091|9849499|FG000|COMPLETED|Overall Study||18
8798215|NCT01430091|9849499|FG000|NOT COMPLETED|Overall Study||0
8798216|NCT01430104|9849513|FG000|STARTED|14-Day Lead-In Period||30
8798217|NCT01430104|9849513|FG000|COMPLETED|14-Day Lead-In Period||30
8798218|NCT01430104|9849513|FG000|NOT COMPLETED|14-Day Lead-In Period||0
8798219|NCT01430104|9849513|FG000|STARTED|28-Day Teriparatide Treatment Period|1 participant withdrew from the study after completing the 14-day Lead-in Period.|29
8798220|NCT01430104|9849513|FG000|Received at Least 1 Dose of Teriparatide|28-Day Teriparatide Treatment Period||29
8798221|NCT01430104|9849513|FG000|COMPLETED|28-Day Teriparatide Treatment Period||28
8798222|NCT01430104|9849513|FG000|NOT COMPLETED|28-Day Teriparatide Treatment Period||1
8798223|NCT01430130|9849520|FG000|STARTED|Overall Study||12
8798224|NCT01430130|9849520|FG000|COMPLETED|Overall Study||10
8798225|NCT01430130|9849520|FG000|NOT COMPLETED|Overall Study||2
8798226|NCT01430169|9849526|FG000|STARTED|Overall Study||20
8798227|NCT01430169|9849526|FG000|COMPLETED|Overall Study||20
8798228|NCT01430169|9849526|FG000|NOT COMPLETED|Overall Study||0
8798229|NCT01430182|9849532|FG000|STARTED|Overall Study||9
8798230|NCT01430182|9849533|FG001|STARTED|Overall Study||8
8798231|NCT01430182|9849532|FG000|COMPLETED|Overall Study||9
8798232|NCT01430182|9849533|FG001|COMPLETED|Overall Study||8
8798233|NCT01430182|9849532|FG000|NOT COMPLETED|Overall Study||0
8798234|NCT01430182|9849533|FG001|NOT COMPLETED|Overall Study||0
8798235|NCT01430299|9849541|FG000|STARTED|Overall Study||20
8798236|NCT01430299|9849542|FG001|STARTED|Overall Study||23
8798237|NCT01430299|9849541|FG000|COMPLETED|Overall Study||16
8798238|NCT01430299|9849542|FG001|COMPLETED|Overall Study||21
8798239|NCT01430299|9849541|FG000|NOT COMPLETED|Overall Study||4
8798240|NCT01430299|9849542|FG001|NOT COMPLETED|Overall Study||2
8798241|NCT01430325|9849552|FG000|STARTED|Overall Study||10
8798242|NCT01430325|9849553|FG001|STARTED|Overall Study||12
8798243|NCT01430325|9849554|FG002|STARTED|Overall Study||8
8798244|NCT01430325|9849555|FG003|STARTED|Overall Study||12
9033686|NCT03280537|10095882|FG000|STARTED|Overall Study||65
8798245|NCT01430325|9849552|FG000|COMPLETED|Overall Study||10
8798246|NCT01430325|9849553|FG001|COMPLETED|Overall Study||12
8798247|NCT01430325|9849554|FG002|COMPLETED|Overall Study||8
8798248|NCT01430325|9849555|FG003|COMPLETED|Overall Study||12
8798249|NCT01430325|9849552|FG000|NOT COMPLETED|Overall Study||0
8798250|NCT01430325|9849553|FG001|NOT COMPLETED|Overall Study||0
8798251|NCT01430325|9849554|FG002|NOT COMPLETED|Overall Study||0
8798252|NCT01430325|9849555|FG003|NOT COMPLETED|Overall Study||0
8798253|NCT01430403|9849568|FG000|STARTED|Overall Study|Intent-to-treat|259
8798254|NCT01430403|9849569|FG001|STARTED|Overall Study|Intent-to-treat|130
8798255|NCT01430403|9849570|FG002|STARTED|Overall Study|Intent-to-treat|89
8798256|NCT01430403|9849568|FG000|COMPLETED|Overall Study||242
8798257|NCT01430403|9849569|FG001|COMPLETED|Overall Study||121
8798258|NCT01430403|9849570|FG002|COMPLETED|Overall Study||81
8798259|NCT01430403|9849568|FG000|NOT COMPLETED|Overall Study||17
8798260|NCT01430403|9849569|FG001|NOT COMPLETED|Overall Study||9
8798261|NCT01430403|9849570|FG002|NOT COMPLETED|Overall Study||8
8798262|NCT01430442|9849591|FG000|STARTED|Overall Study||85
8798263|NCT01430442|9849592|FG001|STARTED|Overall Study||68
8798264|NCT01430442|9849593|FG002|STARTED|Overall Study||91
8798265|NCT01430442|9849594|FG003|STARTED|Overall Study||90
8798266|NCT01430442|9849595|FG004|STARTED|Overall Study||121
8798267|NCT01430442|9849596|FG005|STARTED|Overall Study||92
8798268|NCT01430442|9849597|FG006|STARTED|Overall Study||229
8798269|NCT01430442|9849598|FG007|STARTED|Overall Study||109
8798270|NCT01430442|9849591|FG000|COMPLETED|Overall Study||72
8798271|NCT01430442|9849592|FG001|COMPLETED|Overall Study||62
8798272|NCT01430442|9849593|FG002|COMPLETED|Overall Study||86
8798273|NCT01430442|9849594|FG003|COMPLETED|Overall Study||86
8798274|NCT01430442|9849595|FG004|COMPLETED|Overall Study||112
8798275|NCT01430442|9849596|FG005|COMPLETED|Overall Study||84
8798276|NCT01430442|9849597|FG006|COMPLETED|Overall Study||210
8798277|NCT01430442|9849598|FG007|COMPLETED|Overall Study||100
8798278|NCT01430442|9849591|FG000|NOT COMPLETED|Overall Study||13
8798279|NCT01430442|9849592|FG001|NOT COMPLETED|Overall Study||6
8798280|NCT01430442|9849593|FG002|NOT COMPLETED|Overall Study||5
8798281|NCT01430442|9849594|FG003|NOT COMPLETED|Overall Study||4
8798282|NCT01430442|9849595|FG004|NOT COMPLETED|Overall Study||9
8798283|NCT01430442|9849596|FG005|NOT COMPLETED|Overall Study||8
8798284|NCT01430442|9849597|FG006|NOT COMPLETED|Overall Study||19
8798285|NCT01430442|9849598|FG007|NOT COMPLETED|Overall Study||9
8798286|NCT01430455|9849616|FG000|STARTED|Overall Study||7
8798287|NCT01430455|9849616|FG000|COMPLETED|Overall Study||5
8798288|NCT01430455|9849616|FG000|NOT COMPLETED|Overall Study||2
8798289|NCT01430468|9849622|FG000|STARTED|Overall Study||22
8798290|NCT01430468|9849623|FG001|STARTED|Overall Study||22
8798291|NCT01430468|9849622|FG000|COMPLETED|Overall Study||15
8798292|NCT01430468|9849623|FG001|COMPLETED|Overall Study||16
8798293|NCT01430468|9849622|FG000|NOT COMPLETED|Overall Study||7
8798294|NCT01430468|9849623|FG001|NOT COMPLETED|Overall Study||6
8798295|NCT01430559|9849631|FG000|STARTED|Overall Study||146
8798296|NCT01430559|9849632|FG001|STARTED|Overall Study||147
8798297|NCT01430559|9849631|FG000|Treated|Overall Study||143
8798298|NCT01430559|9849632|FG001|Treated|Overall Study||144
8798299|NCT01430559|9849631|FG000|COMPLETED|Overall Study||126
8798300|NCT01430559|9849632|FG001|COMPLETED|Overall Study||135
8798301|NCT01430559|9849631|FG000|NOT COMPLETED|Overall Study||20
8798302|NCT01430559|9849632|FG001|NOT COMPLETED|Overall Study||12
8798303|NCT01430585|9849643|FG000|STARTED|Overall Study||14
8798304|NCT01430585|9849643|FG000|COMPLETED|Overall Study||0
8798305|NCT01430585|9849643|FG000|NOT COMPLETED|Overall Study||14
8798306|NCT01430611|9849655|FG000|STARTED|Overall Study||332
8798307|NCT01430611|9849656|FG001|STARTED|Overall Study||333
8798308|NCT01430611|9849655|FG000|COMPLETED|Overall Study||315
8798309|NCT01430611|9849656|FG001|COMPLETED|Overall Study||318
8798310|NCT01430611|9849655|FG000|NOT COMPLETED|Overall Study||17
8798311|NCT01430611|9849656|FG001|NOT COMPLETED|Overall Study||15
8798312|NCT01430624|9849665|FG000|STARTED|Overall Study|Initial potential eligible screened enrolled|82
8798313|NCT01430624|9849666|FG001|STARTED|Overall Study||82
8798314|NCT01430624|9849667|FG002|STARTED|Overall Study||81
8798315|NCT01430624|9849665|FG000|Eligible Baseline Completes|Overall Study||77
8798316|NCT01430624|9849666|FG001|Eligible Baseline Completes|Overall Study||77
8798317|NCT01430624|9849667|FG002|Eligible Baseline Completes|Overall Study||79
8798318|NCT01430624|9849665|FG000|COMPLETED|Overall Study|Completed one or more follow-ups|54
8798319|NCT01430624|9849666|FG001|COMPLETED|Overall Study|Completed one or more follow-ups|48
8798320|NCT01430624|9849667|FG002|COMPLETED|Overall Study|Completed one or more follow-ups|52
8798321|NCT01430624|9849665|FG000|NOT COMPLETED|Overall Study||28
8798322|NCT01430624|9849666|FG001|NOT COMPLETED|Overall Study||34
8798323|NCT01430624|9849667|FG002|NOT COMPLETED|Overall Study||29
8798324|NCT01430741|9849683|FG000|STARTED|Overall Study||22
8798325|NCT01430741|9849684|FG001|STARTED|Overall Study||87
8798326|NCT01430741|9849685|FG002|STARTED|Overall Study||47
8798327|NCT01430741|9849686|FG003|STARTED|Overall Study||81
8798328|NCT01430741|9849683|FG000|COMPLETED|Overall Study||22
8798329|NCT01430741|9849684|FG001|COMPLETED|Overall Study||87
8798330|NCT01430741|9849685|FG002|COMPLETED|Overall Study||37
8798331|NCT01430741|9849686|FG003|COMPLETED|Overall Study||81
8798332|NCT01430741|9849683|FG000|NOT COMPLETED|Overall Study||0
8798333|NCT01430741|9849684|FG001|NOT COMPLETED|Overall Study||0
8798334|NCT01430741|9849685|FG002|NOT COMPLETED|Overall Study||10
8798335|NCT01430741|9849686|FG003|NOT COMPLETED|Overall Study||0
8798336|NCT01430754|9849699|FG000|STARTED|Run-In Phase||57
8798337|NCT01430754|9849700|FG001|STARTED|Run-In Phase|During the run-in phase, participants were treated with tasimelteon only.|0
8798338|NCT01430754|9849699|FG000|Entrained - After Run-In Phase|Run-In Phase||24
8798339|NCT01430754|9849700|FG001|Entrained - After Run-In Phase|Run-In Phase||0
8798340|NCT01430754|9849699|FG000|COMPLETED|Run-In Phase|Defined as the number of patients who entered the randomized-withdrawal phase|20
8798341|NCT01430754|9849700|FG001|COMPLETED|Run-In Phase||0
8798342|NCT01430754|9849699|FG000|NOT COMPLETED|Run-In Phase||37
8798343|NCT01430754|9849700|FG001|NOT COMPLETED|Run-In Phase||0
8798344|NCT01430754|9849699|FG000|STARTED|Randomized Phase||10
8798345|NCT01430754|9849700|FG001|STARTED|Randomized Phase||10
8798346|NCT01430754|9849699|FG000|COMPLETED|Randomized Phase||10
8798347|NCT01430754|9849700|FG001|COMPLETED|Randomized Phase||10
8798348|NCT01430754|9849699|FG000|NOT COMPLETED|Randomized Phase||0
8798349|NCT01430754|9849700|FG001|NOT COMPLETED|Randomized Phase||0
8798350|NCT01430819|9849710|FG000|STARTED|Overall Study||150
8798351|NCT01430819|9849711|FG001|STARTED|Overall Study||150
8798352|NCT01430819|9849710|FG000|COMPLETED|Overall Study||150
8798353|NCT01430819|9849711|FG001|COMPLETED|Overall Study||150
8798354|NCT01430819|9849710|FG000|NOT COMPLETED|Overall Study||0
8798355|NCT01430819|9849711|FG001|NOT COMPLETED|Overall Study||0
8798356|NCT01431014|9849719|FG000|STARTED|Overall Study||34
8798357|NCT01431014|9849720|FG001|STARTED|Overall Study||34
8798358|NCT01431014|9849719|FG000|COMPLETED|Overall Study||31
8798359|NCT01431014|9849720|FG001|COMPLETED|Overall Study||25
8798360|NCT01431014|9849719|FG000|NOT COMPLETED|Overall Study||3
8798361|NCT01431014|9849720|FG001|NOT COMPLETED|Overall Study||9
8798362|NCT01431079|9849728|FG000|STARTED|Overall Study||45
8798363|NCT01431079|9849729|FG001|STARTED|Overall Study||45
8798364|NCT01431079|9849728|FG000|Post-test|Overall Study||45
8798365|NCT01431079|9849729|FG001|Post-test|Overall Study||45
8798366|NCT01431079|9849728|FG000|COMPLETED|Overall Study||10
8798367|NCT01431079|9849729|FG001|COMPLETED|Overall Study||6
8798368|NCT01431079|9849728|FG000|NOT COMPLETED|Overall Study||35
8798369|NCT01431079|9849729|FG001|NOT COMPLETED|Overall Study||39
8798370|NCT01431105|9849759|FG000|STARTED|Overall Study||34
8798371|NCT01431105|9849759|FG000|COMPLETED|Overall Study||34
8798372|NCT01431105|9849759|FG000|NOT COMPLETED|Overall Study||0
8917920|NCT02196558|9977760|FG002|STARTED|Extension Phase (40 Weeks)|Participants who wished to continue, had no safety issues, and had>=20% improvement in joint counts.|6
8917921|NCT02196558|9977758|FG000|COMPLETED|Extension Phase (40 Weeks)||9
8917922|NCT02196558|9977759|FG001|COMPLETED|Extension Phase (40 Weeks)||8
8917923|NCT02196558|9977760|FG002|COMPLETED|Extension Phase (40 Weeks)||5
8917924|NCT02196558|9977758|FG000|NOT COMPLETED|Extension Phase (40 Weeks)||2
8917925|NCT02196558|9977759|FG001|NOT COMPLETED|Extension Phase (40 Weeks)||3
8917926|NCT02196558|9977760|FG002|NOT COMPLETED|Extension Phase (40 Weeks)||1
8917927|NCT02196675|9977771|FG000|STARTED|Overall Study||27
8917928|NCT02196675|9977772|FG001|STARTED|Overall Study||70
8917929|NCT02196675|9977773|FG002|STARTED|Overall Study||8
8917930|NCT02196675|9977771|FG000|COMPLETED|Overall Study||25
8917931|NCT02196675|9977772|FG001|COMPLETED|Overall Study||68
8917932|NCT02196675|9977773|FG002|COMPLETED|Overall Study||7
8917933|NCT02196675|9977771|FG000|NOT COMPLETED|Overall Study||2
8917934|NCT02196675|9977772|FG001|NOT COMPLETED|Overall Study||2
8917935|NCT02196675|9977773|FG002|NOT COMPLETED|Overall Study||1
8917936|NCT02196688|9977783|FG000|STARTED|Overall Study||47
8917937|NCT02196688|9977784|FG001|STARTED|Overall Study||24
8917938|NCT02196688|9977783|FG000|COMPLETED|Overall Study||40
8917939|NCT02196688|9977784|FG001|COMPLETED|Overall Study||23
8917940|NCT02196688|9977783|FG000|NOT COMPLETED|Overall Study||7
8917941|NCT02196688|9977784|FG001|NOT COMPLETED|Overall Study||1
8917942|NCT02196701|9977792|FG000|STARTED|Overall Study||46
8917943|NCT02196701|9977792|FG000|COMPLETED|Overall Study||43
8917944|NCT02196701|9977792|FG000|NOT COMPLETED|Overall Study||3
8917945|NCT02196714|9977799|FG000|STARTED|Overall Study||24
8917946|NCT02196714|9977800|FG001|STARTED|Overall Study||23
8917947|NCT02196714|9977801|FG002|STARTED|Overall Study||24
8917948|NCT02196714|9977802|FG003|STARTED|Overall Study||24
8917949|NCT02196714|9977799|FG000|COMPLETED|Overall Study||24
8917950|NCT02196714|9977800|FG001|COMPLETED|Overall Study||23
8917951|NCT02196714|9977801|FG002|COMPLETED|Overall Study||23
8917952|NCT02196714|9977802|FG003|COMPLETED|Overall Study||24
8917953|NCT02196714|9977799|FG000|NOT COMPLETED|Overall Study||0
8917954|NCT02196714|9977800|FG001|NOT COMPLETED|Overall Study||0
8917955|NCT02196714|9977801|FG002|NOT COMPLETED|Overall Study||1
8917956|NCT02196714|9977802|FG003|NOT COMPLETED|Overall Study||0
8917957|NCT02196766|9977814|FG000|STARTED|First Intervention (7 Days)||15
8917958|NCT02196766|9977815|FG001|STARTED|First Intervention (7 Days)||15
8917959|NCT02196766|9977814|FG000|COMPLETED|First Intervention (7 Days)||15
8917960|NCT02196766|9977815|FG001|COMPLETED|First Intervention (7 Days)||15
8917961|NCT02196766|9977814|FG000|NOT COMPLETED|First Intervention (7 Days)||0
8917962|NCT02196766|9977815|FG001|NOT COMPLETED|First Intervention (7 Days)||0
8917963|NCT02196766|9977814|FG000|STARTED|Second Intervention (7 Days)||15
8917964|NCT02196766|9977815|FG001|STARTED|Second Intervention (7 Days)||15
8917965|NCT02196766|9977814|FG000|COMPLETED|Second Intervention (7 Days)||15
8917966|NCT02196766|9977815|FG001|COMPLETED|Second Intervention (7 Days)||15
8917967|NCT02196766|9977814|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
8917968|NCT02196766|9977815|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
8917969|NCT02196831|9977823|FG000|STARTED|Overall Study||30
8917970|NCT02196831|9977824|FG001|STARTED|Overall Study||30
8798373|NCT01431131|9849765|FG000|STARTED|Overall Study||12
8798374|NCT01431131|9849766|FG001|STARTED|Overall Study||12
8798375|NCT01431131|9849765|FG000|COMPLETED|Overall Study||12
8798376|NCT01431131|9849766|FG001|COMPLETED|Overall Study||12
8798377|NCT01431131|9849765|FG000|NOT COMPLETED|Overall Study||0
8798378|NCT01431131|9849766|FG001|NOT COMPLETED|Overall Study||0
8798379|NCT01431144|9849774|FG000|STARTED|Overall Study||13
8798380|NCT01431144|9849775|FG001|STARTED|Overall Study||14
8798381|NCT01431144|9849774|FG000|COMPLETED|Overall Study||11
8798382|NCT01431144|9849775|FG001|COMPLETED|Overall Study||14
8798383|NCT01431144|9849774|FG000|NOT COMPLETED|Overall Study||2
8798384|NCT01431144|9849775|FG001|NOT COMPLETED|Overall Study||0
8798385|NCT01431170|9849783|FG000|STARTED|Overall Study||12
8798386|NCT01431170|9849784|FG001|STARTED|Overall Study||12
8798387|NCT01431170|9849783|FG000|COMPLETED|Overall Study||9
8798388|NCT01431170|9849784|FG001|COMPLETED|Overall Study||11
8798389|NCT01431170|9849783|FG000|NOT COMPLETED|Overall Study||3
8798390|NCT01431170|9849784|FG001|NOT COMPLETED|Overall Study||1
8798391|NCT01431209|9849802|FG000|STARTED|Overall Study||47
8798392|NCT01431209|9849803|FG001|STARTED|Overall Study||13
8798393|NCT01431209|9849802|FG000|COMPLETED|Overall Study||43
8798394|NCT01431209|9849803|FG001|COMPLETED|Overall Study||12
8798395|NCT01431209|9849802|FG000|NOT COMPLETED|Overall Study||4
8798396|NCT01431209|9849803|FG001|NOT COMPLETED|Overall Study||1
8798397|NCT01431274|9849814|FG000|STARTED|Overall Study||528
8798398|NCT01431274|9849815|FG001|STARTED|Overall Study||525
8798399|NCT01431274|9849816|FG002|STARTED|Overall Study||527
8798400|NCT01431274|9849817|FG003|STARTED|Overall Study||522
8798401|NCT01431274|9849818|FG004|STARTED|Overall Study||522
8798402|NCT01431274|9849814|FG000|COMPLETED|Overall Study||431
8798403|NCT01431274|9849815|FG001|COMPLETED|Overall Study||448
8798404|NCT01431274|9849816|FG002|COMPLETED|Overall Study||455
8798405|NCT01431274|9849817|FG003|COMPLETED|Overall Study||462
8798406|NCT01431274|9849818|FG004|COMPLETED|Overall Study||466
8798407|NCT01431274|9849814|FG000|NOT COMPLETED|Overall Study||97
8798408|NCT01431274|9849815|FG001|NOT COMPLETED|Overall Study||77
8798409|NCT01431274|9849816|FG002|NOT COMPLETED|Overall Study||72
8798410|NCT01431274|9849817|FG003|NOT COMPLETED|Overall Study||60
8798411|NCT01431274|9849818|FG004|NOT COMPLETED|Overall Study||56
8798412|NCT01431287|9849835|FG000|STARTED|Overall Study|started are actually the randomized|510
8798413|NCT01431287|9849836|FG001|STARTED|Overall Study||507
8798414|NCT01431287|9849837|FG002|STARTED|Overall Study||507
8798415|NCT01431287|9849838|FG003|STARTED|Overall Study||508
8798416|NCT01431287|9849839|FG004|STARTED|Overall Study||507
8798417|NCT01431287|9849835|FG000|COMPLETED|Overall Study||412
8798418|NCT01431287|9849836|FG001|COMPLETED|Overall Study||409
8798419|NCT01431287|9849837|FG002|COMPLETED|Overall Study||410
8798420|NCT01431287|9849838|FG003|COMPLETED|Overall Study||445
8798421|NCT01431287|9849839|FG004|COMPLETED|Overall Study||430
8798422|NCT01431287|9849835|FG000|NOT COMPLETED|Overall Study||98
8798423|NCT01431287|9849836|FG001|NOT COMPLETED|Overall Study||98
8798424|NCT01431287|9849837|FG002|NOT COMPLETED|Overall Study||97
8798425|NCT01431287|9849838|FG003|NOT COMPLETED|Overall Study||63
9033687|NCT03280537|10095883|FG001|STARTED|Overall Study||62
9033688|NCT03280537|10095882|FG000|COMPLETED|Overall Study||63
9033689|NCT03280537|10095883|FG001|COMPLETED|Overall Study||58
9033690|NCT03280537|10095882|FG000|NOT COMPLETED|Overall Study||2
9033691|NCT03280537|10095883|FG001|NOT COMPLETED|Overall Study||4
9033692|NCT03280550|10095891|FG000|STARTED|Overall Study||66
9033693|NCT03280550|10095892|FG001|STARTED|Overall Study||72
9033694|NCT03280550|10095891|FG000|COMPLETED|Overall Study||64
9033695|NCT03280550|10095892|FG001|COMPLETED|Overall Study||69
9033696|NCT03280550|10095891|FG000|NOT COMPLETED|Overall Study||2
9033697|NCT03280550|10095892|FG001|NOT COMPLETED|Overall Study||3
9033698|NCT03280615|10095900|FG000|STARTED|Overall Study||50
9033699|NCT03280615|10095901|FG001|STARTED|Overall Study||50
9033700|NCT03280615|10095900|FG000|COMPLETED|Overall Study||46
9033701|NCT03280615|10095901|FG001|COMPLETED|Overall Study||45
9033702|NCT03280615|10095900|FG000|NOT COMPLETED|Overall Study||4
9033703|NCT03280615|10095901|FG001|NOT COMPLETED|Overall Study||5
9033704|NCT03281200|10095907|FG000|STARTED|Overall Study||172
9033705|NCT03281200|10095907|FG000|COMPLETED|Overall Study||172
9033706|NCT03281200|10095907|FG000|NOT COMPLETED|Overall Study||0
9033707|NCT03281304|10095913|FG000|STARTED|Overall Study||70
9033708|NCT03281304|10095914|FG001|STARTED|Overall Study||70
9033709|NCT03281304|10095913|FG000|COMPLETED|Overall Study||57
9033710|NCT03281304|10095914|FG001|COMPLETED|Overall Study||58
9033711|NCT03281304|10095913|FG000|NOT COMPLETED|Overall Study||13
9033712|NCT03281304|10095914|FG001|NOT COMPLETED|Overall Study||12
9033713|NCT03281538|10095920|FG000|STARTED|Overall Study||288
9033714|NCT03281538|10095920|FG000|COMPLETED|Overall Study||133
9033715|NCT03281538|10095920|FG000|NOT COMPLETED|Overall Study||155
9033716|NCT03281577|10095928|FG000|STARTED|Overall Study||10
9033717|NCT03281577|10095929|FG001|STARTED|Overall Study||10
9033718|NCT03281577|10095930|FG002|STARTED|Overall Study||9
9033719|NCT03281577|10095931|FG003|STARTED|Overall Study||7
9033720|NCT03281577|10095928|FG000|COMPLETED|Overall Study||9
9033721|NCT03281577|10095929|FG001|COMPLETED|Overall Study||10
8798426|NCT01431287|9849839|FG004|NOT COMPLETED|Overall Study||77
8798427|NCT01431300|9849854|FG000|STARTED|Overall Study|One subject with indeterminate pregnancy test, subject declined to proceed|11
8798428|NCT01431300|9849855|FG001|STARTED|Overall Study||10
8798429|NCT01431300|9849856|FG002|STARTED|Overall Study||10
8798430|NCT01431300|9849854|FG000|COMPLETED|Overall Study||10
8798431|NCT01431300|9849855|FG001|COMPLETED|Overall Study||10
8798432|NCT01431300|9849856|FG002|COMPLETED|Overall Study||10
8798433|NCT01431300|9849854|FG000|NOT COMPLETED|Overall Study||1
8798434|NCT01431300|9849855|FG001|NOT COMPLETED|Overall Study||0
8798435|NCT01431300|9849856|FG002|NOT COMPLETED|Overall Study||0
9033722|NCT03281577|10095930|FG002|COMPLETED|Overall Study||9
8798436|NCT01431313|9849867|FG000|STARTED|Overall Study||20
8798437|NCT01431313|9849868|FG001|STARTED|Overall Study||20
8798438|NCT01431313|9849869|FG002|STARTED|Overall Study||8
8798439|NCT01431313|9849867|FG000|COMPLETED|Overall Study||20
8798440|NCT01431313|9849868|FG001|COMPLETED|Overall Study||20
8798441|NCT01431313|9849869|FG002|COMPLETED|Overall Study||8
8798442|NCT01431313|9849867|FG000|NOT COMPLETED|Overall Study||0
8798443|NCT01431313|9849868|FG001|NOT COMPLETED|Overall Study||0
8798444|NCT01431313|9849869|FG002|NOT COMPLETED|Overall Study||0
8798445|NCT01431339|9849880|FG000|STARTED|Overall Study||371
8798446|NCT01431339|9849881|FG001|STARTED|Overall Study||368
8798447|NCT01431339|9849880|FG000|Safety Population|Overall Study||368
8798448|NCT01431339|9849881|FG001|Safety Population|Overall Study||367
8798449|NCT01431339|9849880|FG000|COMPLETED|Overall Study||332
8798450|NCT01431339|9849881|FG001|COMPLETED|Overall Study||333
8798451|NCT01431339|9849880|FG000|NOT COMPLETED|Overall Study||39
8798452|NCT01431339|9849881|FG001|NOT COMPLETED|Overall Study||35
8798453|NCT01431391|9849889|FG000|STARTED|Overall Study||34
8798454|NCT01431391|9849890|FG001|STARTED|Overall Study||34
8798455|NCT01431391|9849889|FG000|Received ≥1 Leaukapheresis|Overall Study||34
8798456|NCT01431391|9849890|FG001|Received ≥1 Leaukapheresis|Overall Study||34
8798457|NCT01431391|9849889|FG000|COMPLETED|Overall Study||26
8798458|NCT01431391|9849890|FG001|COMPLETED|Overall Study||30
8798459|NCT01431391|9849889|FG000|NOT COMPLETED|Overall Study||8
8798460|NCT01431391|9849890|FG001|NOT COMPLETED|Overall Study||4
8798461|NCT01431521|9849901|FG000|STARTED|Overall Study||10
8798462|NCT01431521|9849902|FG001|STARTED|Overall Study||5
8798463|NCT01431521|9849903|FG002|STARTED|Overall Study||11
8798464|NCT01431521|9849904|FG003|STARTED|Overall Study||5
8798465|NCT01431521|9849901|FG000|Treated|Overall Study||10
8798466|NCT01431521|9849902|FG001|Treated|Overall Study||5
8798467|NCT01431521|9849903|FG002|Treated|Overall Study||10
8798468|NCT01431521|9849904|FG003|Treated|Overall Study||5
8798469|NCT01431521|9849901|FG000|COMPLETED|Overall Study||10
8798470|NCT01431521|9849902|FG001|COMPLETED|Overall Study||5
8798471|NCT01431521|9849903|FG002|COMPLETED|Overall Study||10
8798472|NCT01431521|9849904|FG003|COMPLETED|Overall Study||5
8798473|NCT01431521|9849901|FG000|NOT COMPLETED|Overall Study||0
8798474|NCT01431521|9849902|FG001|NOT COMPLETED|Overall Study||0
8798475|NCT01431521|9849903|FG002|NOT COMPLETED|Overall Study||1
8798476|NCT01431521|9849904|FG003|NOT COMPLETED|Overall Study||0
8798477|NCT01431534|9849916|FG000|STARTED|Treatment Phase||4
8798478|NCT01431534|9849917|FG001|STARTED|Treatment Phase||3
8798479|NCT01431534|9849918|FG002|STARTED|Treatment Phase||13
8798480|NCT01431534|9849916|FG000|COMPLETED|Treatment Phase||0
8798481|NCT01431534|9849917|FG001|COMPLETED|Treatment Phase||0
8798482|NCT01431534|9849918|FG002|COMPLETED|Treatment Phase|Participants completing Treatment Phase could continue in Extension Phase.|2
8798483|NCT01431534|9849916|FG000|NOT COMPLETED|Treatment Phase||4
8798484|NCT01431534|9849917|FG001|NOT COMPLETED|Treatment Phase||3
8798485|NCT01431534|9849918|FG002|NOT COMPLETED|Treatment Phase||11
8798486|NCT01431534|9849916|FG000|STARTED|Extension Phase|No participants continued in Extension Phase.|0
8798487|NCT01431534|9849917|FG001|STARTED|Extension Phase|No participants continued in Extension Phase.|0
8798488|NCT01431534|9849918|FG002|STARTED|Extension Phase|Participants from Treatment Phase who continued in Extension Phase.|2
8798489|NCT01431534|9849916|FG000|COMPLETED|Extension Phase||0
8798490|NCT01431534|9849917|FG001|COMPLETED|Extension Phase||0
8798491|NCT01431534|9849918|FG002|COMPLETED|Extension Phase||2
8798492|NCT01431534|9849916|FG000|NOT COMPLETED|Extension Phase||0
8798493|NCT01431534|9849917|FG001|NOT COMPLETED|Extension Phase||0
8798494|NCT01431534|9849918|FG002|NOT COMPLETED|Extension Phase||0
8798495|NCT01431573|9849926|FG000|STARTED|Overall Study||8
8798496|NCT01431573|9849926|FG000|COMPLETED|Overall Study||8
8798497|NCT01431573|9849926|FG000|NOT COMPLETED|Overall Study||0
8798498|NCT01431638|9849933|FG000|STARTED|Overall Study||133
8798499|NCT01431638|9849934|FG001|STARTED|Overall Study||132
8798500|NCT01431638|9849935|FG002|STARTED|Overall Study||132
8798501|NCT01431638|9849933|FG000|Completed Core Study|Overall Study||124
8798502|NCT01431638|9849934|FG001|Completed Core Study|Overall Study||117
8798503|NCT01431638|9849935|FG002|Completed Core Study|Overall Study||108
8798504|NCT01431638|9849933|FG000|Entered Extension 1 Study|Overall Study||85
8798505|NCT01431638|9849934|FG001|Entered Extension 1 Study|Overall Study||71
8798506|NCT01431638|9849935|FG002|Entered Extension 1 Study|Overall Study||76
8798507|NCT01431638|9849933|FG000|COMPLETED|Overall Study||67
8798508|NCT01431638|9849934|FG001|COMPLETED|Overall Study||61
8798509|NCT01431638|9849935|FG002|COMPLETED|Overall Study||70
8798510|NCT01431638|9849933|FG000|NOT COMPLETED|Overall Study||66
8798511|NCT01431638|9849934|FG001|NOT COMPLETED|Overall Study||71
8798512|NCT01431638|9849935|FG002|NOT COMPLETED|Overall Study||62
8798513|NCT01431703|9849943|FG000|STARTED|Overall Study||326
8798514|NCT01431703|9849943|FG000|COMPLETED|Overall Study||326
8798515|NCT01431703|9849943|FG000|NOT COMPLETED|Overall Study||0
8798516|NCT01431716|9849947|FG000|STARTED|Overall Study||42
8798517|NCT01431716|9849947|FG000|COMPLETED|Overall Study||41
8798518|NCT01431716|9849947|FG000|NOT COMPLETED|Overall Study||1
8798519|NCT01431755|9849951|FG000|STARTED|Overall Study||54
8798520|NCT01431755|9849951|FG000|COMPLETED|Overall Study||49
8798521|NCT01431755|9849951|FG000|NOT COMPLETED|Overall Study||5
8798522|NCT01431794|9849962|FG000|STARTED|Overall Study||13
8798523|NCT01431794|9849963|FG001|STARTED|Overall Study|not started due to early study's termination|0
8917971|NCT02196831|9977823|FG000|Received Follow-up Imaging|Overall Study||26
8798524|NCT01431794|9849964|FG002|STARTED|Overall Study|not started due to early study's termination|0
8798525|NCT01431794|9849965|FG003|STARTED|Overall Study|not started due to early study's termination|0
8798526|NCT01431794|9849966|FG004|STARTED|Overall Study|not started due to early study's termination|0
8798527|NCT01431794|9849962|FG000|COMPLETED|Overall Study||13
8798528|NCT01431794|9849963|FG001|COMPLETED|Overall Study|not started due to early study's termination|0
8798529|NCT01431794|9849964|FG002|COMPLETED|Overall Study|not started due to early study's termination|0
8798530|NCT01431794|9849965|FG003|COMPLETED|Overall Study|not started due to early study's termination|0
8798531|NCT01431794|9849966|FG004|COMPLETED|Overall Study|not started due to early study's termination|0
8798532|NCT01431794|9849962|FG000|NOT COMPLETED|Overall Study||0
8798533|NCT01431794|9849963|FG001|NOT COMPLETED|Overall Study||0
8798534|NCT01431794|9849964|FG002|NOT COMPLETED|Overall Study||0
8798535|NCT01431794|9849965|FG003|NOT COMPLETED|Overall Study||0
8798536|NCT01431794|9849966|FG004|NOT COMPLETED|Overall Study||0
8798537|NCT01431846|9849981|FG000|STARTED|Overall Study||8
8798538|NCT01431846|9849982|FG001|STARTED|Overall Study||3
8798539|NCT01431846|9849983|FG002|STARTED|Overall Study||8
8798540|NCT01431846|9849981|FG000|COMPLETED|Overall Study||8
8798541|NCT01431846|9849982|FG001|COMPLETED|Overall Study||3
8798542|NCT01431846|9849983|FG002|COMPLETED|Overall Study||8
8798543|NCT01431846|9849981|FG000|NOT COMPLETED|Overall Study||0
8798544|NCT01431846|9849982|FG001|NOT COMPLETED|Overall Study||0
8798545|NCT01431846|9849983|FG002|NOT COMPLETED|Overall Study||0
9033723|NCT03281577|10095931|FG003|COMPLETED|Overall Study||6
8798546|NCT01431950|9849993|FG000|STARTED|Overall Study||119
8798547|NCT01431950|9849994|FG001|STARTED|Overall Study||119
8798548|NCT01431950|9849993|FG000|COMPLETED|Overall Study||100
8798549|NCT01431950|9849994|FG001|COMPLETED|Overall Study||104
8798550|NCT01431950|9849993|FG000|NOT COMPLETED|Overall Study||19
8798551|NCT01431950|9849994|FG001|NOT COMPLETED|Overall Study||15
8798552|NCT01431963|9850000|FG000|STARTED|Overall Study||67
8798553|NCT01431963|9850000|FG000|Begin Escalation Phase (EP; 6 Weeks)|Overall Study||67
8798554|NCT01431963|9850000|FG000|Received Treatment|Overall Study||65
8798555|NCT01431963|9850000|FG000|Complete EP (6 Weeks)|Overall Study||52
8798556|NCT01431963|9850000|FG000|Begin Maintenance Phase (MP; 24 Weeks)|Overall Study||52
8798557|NCT01431963|9850000|FG000|Complete MP (24 Weeks)|Overall Study||42
8798558|NCT01431963|9850000|FG000|Begin Extension Phase (ExP; gt= 24weeks)|Overall Study|Only Japanese participants in ExP,lamotrigine monotherapy was available in Korea. (>=24weeks)|19
8798559|NCT01431963|9850000|FG000|Complete ExP (gt= 24 Weeks)|Overall Study|(>=24 weeks); gt= abbreviation for greater than or equal to|19
8798560|NCT01431963|9850000|FG000|COMPLETED|Overall Study||32
8798561|NCT01431963|9850000|FG000|NOT COMPLETED|Overall Study||35
8798562|NCT01431976|9850004|FG000|STARTED|Overall Study||20
8798563|NCT01431976|9850004|FG000|COMPLETED|Overall Study||6
8798564|NCT01431976|9850004|FG000|NOT COMPLETED|Overall Study||14
8798565|NCT01431989|9850008|FG000|STARTED|Period 1||14
8798566|NCT01431989|9850009|FG001|STARTED|Period 1||14
8798567|NCT01431989|9850008|FG000|COMPLETED|Period 1||14
8798568|NCT01431989|9850009|FG001|COMPLETED|Period 1||14
8798569|NCT01431989|9850008|FG000|NOT COMPLETED|Period 1||0
8798570|NCT01431989|9850009|FG001|NOT COMPLETED|Period 1||0
8798571|NCT01431989|9850008|FG000|STARTED|14-Day Washout Period||14
8798572|NCT01431989|9850009|FG001|STARTED|14-Day Washout Period||14
8798573|NCT01431989|9850008|FG000|COMPLETED|14-Day Washout Period||14
8798574|NCT01431989|9850009|FG001|COMPLETED|14-Day Washout Period||14
8798575|NCT01431989|9850008|FG000|NOT COMPLETED|14-Day Washout Period||0
8798576|NCT01431989|9850009|FG001|NOT COMPLETED|14-Day Washout Period||0
8798577|NCT01431989|9850008|FG000|STARTED|Period 2||14
8798578|NCT01431989|9850009|FG001|STARTED|Period 2||14
8798579|NCT01431989|9850008|FG000|COMPLETED|Period 2||14
8798580|NCT01431989|9850009|FG001|COMPLETED|Period 2||14
8798581|NCT01431989|9850008|FG000|NOT COMPLETED|Period 2||0
8798582|NCT01431989|9850009|FG001|NOT COMPLETED|Period 2||0
8798583|NCT01432015|9850017|FG000|STARTED|Overall Study||10
8798584|NCT01432015|9850018|FG001|STARTED|Overall Study||10
8798585|NCT01432015|9850017|FG000|COMPLETED|Overall Study||10
8798586|NCT01432015|9850018|FG001|COMPLETED|Overall Study||10
8798587|NCT01432015|9850017|FG000|NOT COMPLETED|Overall Study||0
8798588|NCT01432015|9850018|FG001|NOT COMPLETED|Overall Study||0
8798589|NCT01432145|9850024|FG000|STARTED|Overall Study|Corrected from 75. 75 was entered in error|74
8798590|NCT01432145|9850024|FG000|COMPLETED|Overall Study||67
8798591|NCT01432145|9850024|FG000|NOT COMPLETED|Overall Study||7
8798592|NCT01432171|9850030|FG000|STARTED|Overall Study||18
8798593|NCT01432171|9850031|FG001|STARTED|Overall Study||19
8798594|NCT01432171|9850030|FG000|COMPLETED|Overall Study||4
8798595|NCT01432171|9850031|FG001|COMPLETED|Overall Study||8
8798596|NCT01432171|9850030|FG000|NOT COMPLETED|Overall Study||14
8798597|NCT01432171|9850031|FG001|NOT COMPLETED|Overall Study||11
8798598|NCT01432236|9850039|FG000|STARTED|Overall Study||96
8798599|NCT01432236|9850040|FG001|STARTED|Overall Study||97
8798600|NCT01432236|9850039|FG000|COMPLETED|Overall Study||70
8798601|NCT01432236|9850040|FG001|COMPLETED|Overall Study||79
8798602|NCT01432236|9850039|FG000|NOT COMPLETED|Overall Study||26
8798603|NCT01432236|9850040|FG001|NOT COMPLETED|Overall Study||18
8798604|NCT01432262|9850055|FG000|STARTED|Overall Study||162
8798605|NCT01432262|9850056|FG001|STARTED|Overall Study||162
8798606|NCT01432262|9850055|FG000|Vaccinated|Overall Study||162
8798607|NCT01432262|9850056|FG001|Vaccinated|Overall Study||161
8798608|NCT01432262|9850055|FG000|COMPLETED|Overall Study||160
8798609|NCT01432262|9850056|FG001|COMPLETED|Overall Study||161
8798610|NCT01432262|9850055|FG000|NOT COMPLETED|Overall Study||2
8798611|NCT01432262|9850056|FG001|NOT COMPLETED|Overall Study||1
8798612|NCT01432275|9850062|FG000|STARTED|First BG Meter System (7 Days)||90
8798613|NCT01432275|9850063|FG001|STARTED|First BG Meter System (7 Days)||87
8798614|NCT01432275|9850062|FG000|COMPLETED|First BG Meter System (7 Days)||90
8798615|NCT01432275|9850063|FG001|COMPLETED|First BG Meter System (7 Days)||84
8798616|NCT01432275|9850062|FG000|NOT COMPLETED|First BG Meter System (7 Days)||0
8798617|NCT01432275|9850063|FG001|NOT COMPLETED|First BG Meter System (7 Days)||3
8798618|NCT01432275|9850062|FG000|STARTED|Second BG Meter System (7 Days)||90
8798619|NCT01432275|9850063|FG001|STARTED|Second BG Meter System (7 Days)||84
8798620|NCT01432275|9850062|FG000|COMPLETED|Second BG Meter System (7 Days)||88
8798621|NCT01432275|9850063|FG001|COMPLETED|Second BG Meter System (7 Days)||81
8798622|NCT01432275|9850062|FG000|NOT COMPLETED|Second BG Meter System (7 Days)||2
8798623|NCT01432275|9850063|FG001|NOT COMPLETED|Second BG Meter System (7 Days)||3
8798624|NCT01432275|9850062|FG000|STARTED|ADC With Calculator (10 Days)||88
8798625|NCT01432275|9850063|FG001|STARTED|ADC With Calculator (10 Days)||81
8798626|NCT01432275|9850062|FG000|COMPLETED|ADC With Calculator (10 Days)||85
8798627|NCT01432275|9850063|FG001|COMPLETED|ADC With Calculator (10 Days)||79
8798628|NCT01432275|9850062|FG000|NOT COMPLETED|ADC With Calculator (10 Days)||3
8798629|NCT01432275|9850063|FG001|NOT COMPLETED|ADC With Calculator (10 Days)||2
8798630|NCT01432327|9850073|FG000|STARTED|Baseline||56
8798631|NCT01432327|9850074|FG001|STARTED|Baseline||57
8798632|NCT01432327|9850075|FG002|STARTED|Baseline||57
8798633|NCT01432327|9850076|FG003|STARTED|Baseline||57
8798634|NCT01432327|9850073|FG000|COMPLETED|Baseline||56
8798635|NCT01432327|9850074|FG001|COMPLETED|Baseline||57
8798636|NCT01432327|9850075|FG002|COMPLETED|Baseline||57
8798637|NCT01432327|9850076|FG003|COMPLETED|Baseline||57
8798638|NCT01432327|9850073|FG000|NOT COMPLETED|Baseline||0
8798639|NCT01432327|9850074|FG001|NOT COMPLETED|Baseline||0
8798640|NCT01432327|9850075|FG002|NOT COMPLETED|Baseline||0
8798641|NCT01432327|9850076|FG003|NOT COMPLETED|Baseline||0
8798642|NCT01432327|9850073|FG000|STARTED|Posttest 3 Months||56
8798643|NCT01432327|9850074|FG001|STARTED|Posttest 3 Months||57
8798644|NCT01432327|9850075|FG002|STARTED|Posttest 3 Months||57
8798645|NCT01432327|9850076|FG003|STARTED|Posttest 3 Months||57
8798646|NCT01432327|9850073|FG000|COMPLETED|Posttest 3 Months||52
8798647|NCT01432327|9850074|FG001|COMPLETED|Posttest 3 Months||55
8798648|NCT01432327|9850075|FG002|COMPLETED|Posttest 3 Months||55
8798649|NCT01432327|9850076|FG003|COMPLETED|Posttest 3 Months||56
8798650|NCT01432327|9850073|FG000|NOT COMPLETED|Posttest 3 Months||4
8798651|NCT01432327|9850074|FG001|NOT COMPLETED|Posttest 3 Months||2
8798652|NCT01432327|9850075|FG002|NOT COMPLETED|Posttest 3 Months||2
8798653|NCT01432327|9850076|FG003|NOT COMPLETED|Posttest 3 Months||1
8798654|NCT01432327|9850073|FG000|STARTED|Posttest 6 Months||52
8798655|NCT01432327|9850074|FG001|STARTED|Posttest 6 Months||55
8798656|NCT01432327|9850075|FG002|STARTED|Posttest 6 Months||55
8798657|NCT01432327|9850076|FG003|STARTED|Posttest 6 Months||56
8798658|NCT01432327|9850073|FG000|COMPLETED|Posttest 6 Months||52
8798659|NCT01432327|9850074|FG001|COMPLETED|Posttest 6 Months||55
8798660|NCT01432327|9850075|FG002|COMPLETED|Posttest 6 Months||50
8798661|NCT01432327|9850076|FG003|COMPLETED|Posttest 6 Months||54
8798662|NCT01432327|9850073|FG000|NOT COMPLETED|Posttest 6 Months||0
8798663|NCT01432327|9850074|FG001|NOT COMPLETED|Posttest 6 Months||0
8798664|NCT01432327|9850075|FG002|NOT COMPLETED|Posttest 6 Months||5
8798665|NCT01432327|9850076|FG003|NOT COMPLETED|Posttest 6 Months||2
8798666|NCT01432327|9850073|FG000|STARTED|Posttest 1 Year||52
8798667|NCT01432327|9850074|FG001|STARTED|Posttest 1 Year||55
8798668|NCT01432327|9850075|FG002|STARTED|Posttest 1 Year||50
8798669|NCT01432327|9850076|FG003|STARTED|Posttest 1 Year||54
8798670|NCT01432327|9850073|FG000|COMPLETED|Posttest 1 Year||28
8798671|NCT01432327|9850074|FG001|COMPLETED|Posttest 1 Year||27
8798672|NCT01432327|9850075|FG002|COMPLETED|Posttest 1 Year||30
8798673|NCT01432327|9850076|FG003|COMPLETED|Posttest 1 Year||31
8798674|NCT01432327|9850073|FG000|NOT COMPLETED|Posttest 1 Year||24
8798675|NCT01432327|9850074|FG001|NOT COMPLETED|Posttest 1 Year||28
8798676|NCT01432327|9850075|FG002|NOT COMPLETED|Posttest 1 Year||20
8798677|NCT01432327|9850076|FG003|NOT COMPLETED|Posttest 1 Year||23
8798678|NCT01432366|9850086|FG000|STARTED|Overall Study||460
8798679|NCT01432366|9850086|FG000|COMPLETED|Overall Study||392
8798680|NCT01432366|9850086|FG000|NOT COMPLETED|Overall Study||68
8798681|NCT01432379|9850090|FG000|STARTED|Overall Study||1168
8917972|NCT02196831|9977824|FG001|Received Follow-up Imaging|Overall Study||28
8798682|NCT01432379|9850090|FG000|COMPLETED|Overall Study||783
8798683|NCT01432379|9850090|FG000|NOT COMPLETED|Overall Study||385
8798684|NCT01432405|9850096|FG000|STARTED|Overall Study||12
8798685|NCT01432405|9850097|FG001|STARTED|Overall Study||12
8798686|NCT01432405|9850096|FG000|COMPLETED|Overall Study||11
8798687|NCT01432405|9850097|FG001|COMPLETED|Overall Study||10
8798688|NCT01432405|9850096|FG000|NOT COMPLETED|Overall Study||1
8798689|NCT01432405|9850097|FG001|NOT COMPLETED|Overall Study||2
8798690|NCT01432444|9850103|FG000|STARTED|Tolerability/Cross-titration Phase||325
8798691|NCT01432444|9850104|FG001|STARTED|Tolerability/Cross-titration Phase||0
8798692|NCT01432444|9850105|FG002|STARTED|Tolerability/Cross-titration Phase||0
8917973|NCT02196831|9977823|FG000|COMPLETED|Overall Study||21
8798693|NCT01432444|9850103|FG000|COMPLETED|Tolerability/Cross-titration Phase||265
8798694|NCT01432444|9850104|FG001|COMPLETED|Tolerability/Cross-titration Phase||0
8798695|NCT01432444|9850105|FG002|COMPLETED|Tolerability/Cross-titration Phase||0
8798696|NCT01432444|9850103|FG000|NOT COMPLETED|Tolerability/Cross-titration Phase||60
8798697|NCT01432444|9850104|FG001|NOT COMPLETED|Tolerability/Cross-titration Phase||0
8798698|NCT01432444|9850105|FG002|NOT COMPLETED|Tolerability/Cross-titration Phase||0
8798699|NCT01432444|9850103|FG000|STARTED|Treatment Phase||0
8798700|NCT01432444|9850104|FG001|STARTED|Treatment Phase||433
8798701|NCT01432444|9850105|FG002|STARTED|Treatment Phase||0
8798702|NCT01432444|9850103|FG000|COMPLETED|Treatment Phase||0
8798703|NCT01432444|9850104|FG001|COMPLETED|Treatment Phase||293
8798704|NCT01432444|9850105|FG002|COMPLETED|Treatment Phase||0
8798705|NCT01432444|9850103|FG000|NOT COMPLETED|Treatment Phase||0
8798706|NCT01432444|9850104|FG001|NOT COMPLETED|Treatment Phase||140
8798707|NCT01432444|9850105|FG002|NOT COMPLETED|Treatment Phase||0
8798708|NCT01432444|9850103|FG000|STARTED|Extension Phase||0
8798709|NCT01432444|9850104|FG001|STARTED|Extension Phase||0
8798710|NCT01432444|9850105|FG002|STARTED|Extension Phase||192
8798711|NCT01432444|9850103|FG000|COMPLETED|Extension Phase||0
8798712|NCT01432444|9850104|FG001|COMPLETED|Extension Phase||0
8798713|NCT01432444|9850105|FG002|COMPLETED|Extension Phase||0
8798714|NCT01432444|9850103|FG000|NOT COMPLETED|Extension Phase||0
8798715|NCT01432444|9850104|FG001|NOT COMPLETED|Extension Phase||0
8798716|NCT01432444|9850105|FG002|NOT COMPLETED|Extension Phase||192
8798717|NCT01432457|9850113|FG000|STARTED|Overall Study||306
8798718|NCT01432457|9850114|FG001|STARTED|Overall Study||306
8798719|NCT01432457|9850115|FG002|STARTED|Overall Study||312
8798720|NCT01432457|9850113|FG000|COMPLETED|Overall Study||269
8798721|NCT01432457|9850114|FG001|COMPLETED|Overall Study||258
8798722|NCT01432457|9850115|FG002|COMPLETED|Overall Study||253
8798723|NCT01432457|9850113|FG000|NOT COMPLETED|Overall Study||37
8798724|NCT01432457|9850114|FG001|NOT COMPLETED|Overall Study||48
8798725|NCT01432457|9850115|FG002|NOT COMPLETED|Overall Study||59
8798726|NCT01432535|9850126|FG000|STARTED|Overall Study||12
8798727|NCT01432535|9850127|FG001|STARTED|Overall Study|One participant later determined ineligible is not included in baseline/efficacy analyses.|7
8798728|NCT01432535|9850128|FG002|STARTED|Overall Study||6
8798729|NCT01432535|9850126|FG000|COMPLETED|Overall Study||12
8798730|NCT01432535|9850127|FG001|COMPLETED|Overall Study||7
8798731|NCT01432535|9850128|FG002|COMPLETED|Overall Study||6
8798732|NCT01432535|9850126|FG000|NOT COMPLETED|Overall Study||0
8798733|NCT01432535|9850127|FG001|NOT COMPLETED|Overall Study||0
8798734|NCT01432535|9850128|FG002|NOT COMPLETED|Overall Study||0
8798735|NCT01432561|9850136|FG000|STARTED|Overall Study||8
8798736|NCT01432561|9850136|FG000|COMPLETED|Overall Study||8
8798737|NCT01432561|9850136|FG000|NOT COMPLETED|Overall Study||0
8798738|NCT01432574|9850140|FG000|STARTED|Overall Study||150
8798739|NCT01432574|9850140|FG000|COMPLETED|Overall Study||147
8798740|NCT01432574|9850140|FG000|NOT COMPLETED|Overall Study||3
8798741|NCT01432600|9850149|FG000|STARTED|Overall Study||10
8798742|NCT01432600|9850150|FG001|STARTED|Overall Study||36
8798743|NCT01432600|9850151|FG002|STARTED|Overall Study||34
8798744|NCT01432600|9850149|FG000|COMPLETED|Overall Study||10
8798745|NCT01432600|9850150|FG001|COMPLETED|Overall Study||35
8798746|NCT01432600|9850151|FG002|COMPLETED|Overall Study||33
8798747|NCT01432600|9850149|FG000|NOT COMPLETED|Overall Study||0
8798748|NCT01432600|9850150|FG001|NOT COMPLETED|Overall Study||1
8798749|NCT01432600|9850151|FG002|NOT COMPLETED|Overall Study||1
8798750|NCT01432626|9850161|FG000|STARTED|Overall Study||10
8798751|NCT01432626|9850161|FG000|COMPLETED|Overall Study|Completed both images|3
8798752|NCT01432626|9850161|FG000|NOT COMPLETED|Overall Study||7
8798753|NCT01432730|9850165|FG000|STARTED|Period 1||12
8798754|NCT01432730|9850166|FG001|STARTED|Period 1||12
8798755|NCT01432730|9850165|FG000|COMPLETED|Period 1||10
8798756|NCT01432730|9850166|FG001|COMPLETED|Period 1||12
8798757|NCT01432730|9850165|FG000|NOT COMPLETED|Period 1||2
8798758|NCT01432730|9850166|FG001|NOT COMPLETED|Period 1||0
8798759|NCT01432730|9850165|FG000|STARTED|Period 2||10
8798760|NCT01432730|9850166|FG001|STARTED|Period 2||12
8798761|NCT01432730|9850165|FG000|COMPLETED|Period 2||10
8798762|NCT01432730|9850166|FG001|COMPLETED|Period 2||8
8798763|NCT01432730|9850165|FG000|NOT COMPLETED|Period 2||0
8798764|NCT01432730|9850166|FG001|NOT COMPLETED|Period 2||4
8798765|NCT01432756|9850176|FG000|STARTED|Overall Study||32
8798766|NCT01432756|9850177|FG001|STARTED|Overall Study||34
8798767|NCT01432756|9850178|FG002|STARTED|Overall Study||32
8798768|NCT01432756|9850179|FG003|STARTED|Overall Study||34
8798769|NCT01432756|9850176|FG000|COMPLETED|Overall Study||31
8798770|NCT01432756|9850177|FG001|COMPLETED|Overall Study||34
8798771|NCT01432756|9850178|FG002|COMPLETED|Overall Study||30
8798772|NCT01432756|9850179|FG003|COMPLETED|Overall Study||33
8798773|NCT01432756|9850176|FG000|NOT COMPLETED|Overall Study||1
8798774|NCT01432756|9850177|FG001|NOT COMPLETED|Overall Study||0
8798775|NCT01432756|9850178|FG002|NOT COMPLETED|Overall Study||2
8798776|NCT01432756|9850179|FG003|NOT COMPLETED|Overall Study||1
8798777|NCT01432886|9850189|FG000|STARTED|Overall Study||6
8798778|NCT01432886|9850190|FG001|STARTED|Overall Study||6
8798779|NCT01432886|9850189|FG000|COMPLETED|Overall Study|Discontinuation met per discontinuation criteria|6
8798780|NCT01432886|9850190|FG001|COMPLETED|Overall Study|Discontinuation met per discontinuation criteria|6
8798781|NCT01432886|9850189|FG000|NOT COMPLETED|Overall Study||0
8798782|NCT01432886|9850190|FG001|NOT COMPLETED|Overall Study||0
8798783|NCT01432938|9850197|FG000|STARTED|First Intervention||14
8798784|NCT01432938|9850198|FG001|STARTED|First Intervention||14
8798785|NCT01432938|9850197|FG000|Received at Least 1 Dose of Study Drug|First Intervention||14
8798786|NCT01432938|9850198|FG001|Received at Least 1 Dose of Study Drug|First Intervention||14
8798787|NCT01432938|9850197|FG000|COMPLETED|First Intervention||12
8798788|NCT01432938|9850198|FG001|COMPLETED|First Intervention||14
8798789|NCT01432938|9850197|FG000|NOT COMPLETED|First Intervention||2
8798790|NCT01432938|9850198|FG001|NOT COMPLETED|First Intervention||0
8798791|NCT01432938|9850197|FG000|STARTED|Washout Period of at Least 24 Days||12
8798792|NCT01432938|9850198|FG001|STARTED|Washout Period of at Least 24 Days||14
8798793|NCT01432938|9850197|FG000|COMPLETED|Washout Period of at Least 24 Days||12
8798794|NCT01432938|9850198|FG001|COMPLETED|Washout Period of at Least 24 Days||14
8798795|NCT01432938|9850197|FG000|NOT COMPLETED|Washout Period of at Least 24 Days||0
8798796|NCT01432938|9850198|FG001|NOT COMPLETED|Washout Period of at Least 24 Days||0
8798797|NCT01432938|9850197|FG000|STARTED|Second Intervention||12
8798798|NCT01432938|9850198|FG001|STARTED|Second Intervention||14
8798799|NCT01432938|9850197|FG000|COMPLETED|Second Intervention||11
8798800|NCT01432938|9850198|FG001|COMPLETED|Second Intervention||14
8798801|NCT01432938|9850197|FG000|NOT COMPLETED|Second Intervention||1
8798802|NCT01432938|9850198|FG001|NOT COMPLETED|Second Intervention||0
8798803|NCT01432951|9850205|FG000|STARTED|Treatment Phase (Day 1 to 30)||26
8798804|NCT01432951|9850205|FG000|Received at Least One Dose of Study Drug|Treatment Phase (Day 1 to 30)||25
8798805|NCT01432951|9850205|FG000|PK Sampling (no Dosing) Days 15-17|Treatment Phase (Day 1 to 30)||23
8798806|NCT01432951|9850205|FG000|Progressive Disease|Treatment Phase (Day 1 to 30)||10
8798807|NCT01432951|9850205|FG000|COMPLETED|Treatment Phase (Day 1 to 30)||25
8798808|NCT01432951|9850205|FG000|NOT COMPLETED|Treatment Phase (Day 1 to 30)||1
8798809|NCT01432951|9850205|FG000|STARTED|Safety Extension Day 30 to End of Study|Participants had the option to continue on to safety extension period.|15
8798810|NCT01432951|9850205|FG000|COMPLETED|Safety Extension Day 30 to End of Study||15
8798811|NCT01432951|9850205|FG000|NOT COMPLETED|Safety Extension Day 30 to End of Study||0
8798812|NCT01433016|9850210|FG000|STARTED|Overall Study||20
8798813|NCT01433016|9850210|FG000|COMPLETED|Overall Study||20
8798814|NCT01433016|9850210|FG000|NOT COMPLETED|Overall Study||0
8798815|NCT01433042|9850214|FG000|STARTED|Overall Study||225
8798816|NCT01433042|9850214|FG000|COMPLETED|Overall Study||224
8798817|NCT01433042|9850214|FG000|NOT COMPLETED|Overall Study||1
8798818|NCT01433055|9850220|FG000|STARTED|Overall Study||29
8798819|NCT01433055|9850221|FG001|STARTED|Overall Study||23
8798820|NCT01433055|9850220|FG000|COMPLETED|Overall Study||27
8798821|NCT01433055|9850221|FG001|COMPLETED|Overall Study||23
8798822|NCT01433055|9850220|FG000|NOT COMPLETED|Overall Study||2
8798823|NCT01433055|9850221|FG001|NOT COMPLETED|Overall Study||0
8798824|NCT01433081|9850229|FG000|STARTED|Overall Study||25
8798825|NCT01433081|9850230|FG001|STARTED|Overall Study||25
8798826|NCT01433081|9850229|FG000|COMPLETED|Overall Study||23
8798827|NCT01433081|9850230|FG001|COMPLETED|Overall Study||23
8798828|NCT01433081|9850229|FG000|NOT COMPLETED|Overall Study||2
8798829|NCT01433081|9850230|FG001|NOT COMPLETED|Overall Study||2
8798830|NCT01433107|9850239|FG000|STARTED|Overall Study||145
8798831|NCT01433107|9850240|FG001|STARTED|Overall Study||145
8798832|NCT01433107|9850239|FG000|COMPLETED|Overall Study||118
8798833|NCT01433107|9850240|FG001|COMPLETED|Overall Study||128
8798834|NCT01433107|9850239|FG000|NOT COMPLETED|Overall Study||27
8798835|NCT01433107|9850240|FG001|NOT COMPLETED|Overall Study||17
8798836|NCT01433159|9850248|FG000|STARTED|Overall Study||9
8798837|NCT01433159|9850249|FG001|STARTED|Overall Study||10
8798838|NCT01433159|9850248|FG000|COMPLETED|Overall Study||7
8798839|NCT01433159|9850249|FG001|COMPLETED|Overall Study||9
8798840|NCT01433159|9850248|FG000|NOT COMPLETED|Overall Study||2
8798841|NCT01433159|9850249|FG001|NOT COMPLETED|Overall Study||1
8798842|NCT01433172|9850258|FG000|STARTED|Overall Study||3
9033724|NCT03281577|10095928|FG000|NOT COMPLETED|Overall Study||1
9033725|NCT03281577|10095929|FG001|NOT COMPLETED|Overall Study||0
9033726|NCT03281577|10095930|FG002|NOT COMPLETED|Overall Study||0
9033727|NCT03281577|10095931|FG003|NOT COMPLETED|Overall Study||1
9033728|NCT03281668|10095944|FG000|STARTED|Overall Study||29
9033729|NCT03281668|10095944|FG000|COMPLETED|Overall Study||21
9033730|NCT03281668|10095944|FG000|NOT COMPLETED|Overall Study||8
8798843|NCT01433172|9850259|FG001|STARTED|Overall Study||37
8798844|NCT01433172|9850260|FG002|STARTED|Overall Study||33
8798845|NCT01433172|9850258|FG000|COMPLETED|Overall Study||3
8798846|NCT01433172|9850259|FG001|COMPLETED|Overall Study||34
8798847|NCT01433172|9850260|FG002|COMPLETED|Overall Study||32
8798848|NCT01433172|9850258|FG000|NOT COMPLETED|Overall Study||0
8798849|NCT01433172|9850259|FG001|NOT COMPLETED|Overall Study||3
8798850|NCT01433172|9850260|FG002|NOT COMPLETED|Overall Study||1
8798851|NCT01433250|9850270|FG000|STARTED|Overall Study||22
8798852|NCT01433250|9850271|FG001|STARTED|Overall Study||17
8798853|NCT01433250|9850270|FG000|COMPLETED|Overall Study||19
8798854|NCT01433250|9850271|FG001|COMPLETED|Overall Study||14
8798855|NCT01433250|9850270|FG000|NOT COMPLETED|Overall Study||3
8798856|NCT01433250|9850271|FG001|NOT COMPLETED|Overall Study||3
8798857|NCT01433263|9850279|FG000|STARTED|Overall Study||29
8798858|NCT01433263|9850280|FG001|STARTED|Overall Study||28
8798859|NCT01433263|9850279|FG000|COMPLETED|Overall Study||10
8798860|NCT01433263|9850280|FG001|COMPLETED|Overall Study||16
8798861|NCT01433263|9850279|FG000|NOT COMPLETED|Overall Study||19
8798862|NCT01433263|9850280|FG001|NOT COMPLETED|Overall Study||12
8798863|NCT01433354|9850289|FG000|STARTED|Overall Study|120 enrolled of which 119 were administered drug|119
8798864|NCT01433354|9850289|FG000|COMPLETED|Overall Study||0
8798865|NCT01433354|9850289|FG000|NOT COMPLETED|Overall Study||119
8798866|NCT01433549|9850303|FG000|STARTED|Phase 1: First Study Product||12
8798867|NCT01433549|9850304|FG001|STARTED|Phase 1: First Study Product||13
8798868|NCT01433549|9850303|FG000|COMPLETED|Phase 1: First Study Product||12
8798869|NCT01433549|9850304|FG001|COMPLETED|Phase 1: First Study Product||13
8798870|NCT01433549|9850303|FG000|NOT COMPLETED|Phase 1: First Study Product||0
8798871|NCT01433549|9850304|FG001|NOT COMPLETED|Phase 1: First Study Product||0
8798872|NCT01433549|9850303|FG000|STARTED|Phase 2: Second Study Product||12
8798873|NCT01433549|9850304|FG001|STARTED|Phase 2: Second Study Product||13
8798874|NCT01433549|9850303|FG000|COMPLETED|Phase 2: Second Study Product||12
8798875|NCT01433549|9850304|FG001|COMPLETED|Phase 2: Second Study Product||12
8798876|NCT01433549|9850303|FG000|NOT COMPLETED|Phase 2: Second Study Product||0
8798877|NCT01433549|9850304|FG001|NOT COMPLETED|Phase 2: Second Study Product||1
8798878|NCT01433731|9850314|FG000|STARTED|Overall Study||3
8798879|NCT01433731|9850315|FG001|STARTED|Overall Study||5
8798880|NCT01433731|9850316|FG002|STARTED|Overall Study||5
8798881|NCT01433731|9850317|FG003|STARTED|Overall Study||5
8798882|NCT01433731|9850314|FG000|COMPLETED|Overall Study||3
8798883|NCT01433731|9850315|FG001|COMPLETED|Overall Study||5
8798884|NCT01433731|9850316|FG002|COMPLETED|Overall Study||5
8798885|NCT01433731|9850317|FG003|COMPLETED|Overall Study||5
8798886|NCT01433731|9850314|FG000|NOT COMPLETED|Overall Study||0
8798887|NCT01433731|9850315|FG001|NOT COMPLETED|Overall Study||0
8798888|NCT01433731|9850316|FG002|NOT COMPLETED|Overall Study||0
8798889|NCT01433731|9850317|FG003|NOT COMPLETED|Overall Study||0
8798890|NCT01433913|9850327|FG000|STARTED|Overall Study||10
8798891|NCT01433913|9850328|FG001|STARTED|Overall Study||10
8798892|NCT01433913|9850327|FG000|COMPLETED|Overall Study||9
8798893|NCT01433913|9850328|FG001|COMPLETED|Overall Study||10
8798894|NCT01433913|9850327|FG000|NOT COMPLETED|Overall Study||1
8798895|NCT01433913|9850328|FG001|NOT COMPLETED|Overall Study||0
8798896|NCT01433978|9850337|FG000|STARTED|Core Study||11
8798897|NCT01433978|9850338|FG001|STARTED|Core Study||12
9033731|NCT03281876|10095950|FG000|STARTED|Overall Study||304
9033732|NCT03281876|10095951|FG001|STARTED|Overall Study||302
9033733|NCT03281876|10095950|FG000|COMPLETED|Overall Study||281
9033734|NCT03281876|10095951|FG001|COMPLETED|Overall Study||263
9033735|NCT03281876|10095950|FG000|NOT COMPLETED|Overall Study||23
9033736|NCT03281876|10095951|FG001|NOT COMPLETED|Overall Study||39
9033737|NCT03282071|10095959|FG000|STARTED|Overall Study||75
9033738|NCT03282071|10095960|FG001|STARTED|Overall Study||69
8798898|NCT01433978|9850339|FG002|STARTED|Core Study||0
8798899|NCT01433978|9850337|FG000|COMPLETED|Core Study||0
8798900|NCT01433978|9850338|FG001|COMPLETED|Core Study||1
8798901|NCT01433978|9850339|FG002|COMPLETED|Core Study||0
8798902|NCT01433978|9850337|FG000|NOT COMPLETED|Core Study||11
8798903|NCT01433978|9850338|FG001|NOT COMPLETED|Core Study||11
8798904|NCT01433978|9850339|FG002|NOT COMPLETED|Core Study||0
8798905|NCT01433978|9850337|FG000|STARTED|Extension Phase||0
8798906|NCT01433978|9850338|FG001|STARTED|Extension Phase||0
8798907|NCT01433978|9850339|FG002|STARTED|Extension Phase||6
8798908|NCT01433978|9850337|FG000|COMPLETED|Extension Phase||0
8798909|NCT01433978|9850338|FG001|COMPLETED|Extension Phase||0
8798910|NCT01433978|9850339|FG002|COMPLETED|Extension Phase||0
8798911|NCT01433978|9850337|FG000|NOT COMPLETED|Extension Phase||0
8798912|NCT01433978|9850338|FG001|NOT COMPLETED|Extension Phase||0
8798913|NCT01433978|9850339|FG002|NOT COMPLETED|Extension Phase||6
8798914|NCT01433991|9850350|FG000|STARTED|Pretreatment Phase (Single Agent Run-in)||5
8798915|NCT01433991|9850351|FG001|STARTED|Pretreatment Phase (Single Agent Run-in)||3
8798916|NCT01433991|9850352|FG002|STARTED|Pretreatment Phase (Single Agent Run-in)||14
8798917|NCT01433991|9850353|FG003|STARTED|Pretreatment Phase (Single Agent Run-in)||8
8798918|NCT01433991|9850350|FG000|COMPLETED|Pretreatment Phase (Single Agent Run-in)||3
8798919|NCT01433991|9850351|FG001|COMPLETED|Pretreatment Phase (Single Agent Run-in)||3
8798920|NCT01433991|9850352|FG002|COMPLETED|Pretreatment Phase (Single Agent Run-in)||14
8798921|NCT01433991|9850353|FG003|COMPLETED|Pretreatment Phase (Single Agent Run-in)||8
8798922|NCT01433991|9850350|FG000|NOT COMPLETED|Pretreatment Phase (Single Agent Run-in)||2
8798923|NCT01433991|9850351|FG001|NOT COMPLETED|Pretreatment Phase (Single Agent Run-in)||0
8798924|NCT01433991|9850352|FG002|NOT COMPLETED|Pretreatment Phase (Single Agent Run-in)||0
9033739|NCT03282071|10095959|FG000|COMPLETED|Overall Study||65
9033740|NCT03282071|10095960|FG001|COMPLETED|Overall Study||60
8798925|NCT01433991|9850353|FG003|NOT COMPLETED|Pretreatment Phase (Single Agent Run-in)||0
8798926|NCT01433991|9850350|FG000|STARTED|Treatment Phase (Combination Agent)||3
8798927|NCT01433991|9850351|FG001|STARTED|Treatment Phase (Combination Agent)||3
8798928|NCT01433991|9850352|FG002|STARTED|Treatment Phase (Combination Agent)||14
8798929|NCT01433991|9850353|FG003|STARTED|Treatment Phase (Combination Agent)||8
8798930|NCT01433991|9850350|FG000|COMPLETED|Treatment Phase (Combination Agent)||1
8798931|NCT01433991|9850351|FG001|COMPLETED|Treatment Phase (Combination Agent)||2
8798932|NCT01433991|9850352|FG002|COMPLETED|Treatment Phase (Combination Agent)||8
8798933|NCT01433991|9850353|FG003|COMPLETED|Treatment Phase (Combination Agent)||2
8798934|NCT01433991|9850350|FG000|NOT COMPLETED|Treatment Phase (Combination Agent)||2
8798935|NCT01433991|9850351|FG001|NOT COMPLETED|Treatment Phase (Combination Agent)||1
8798936|NCT01433991|9850352|FG002|NOT COMPLETED|Treatment Phase (Combination Agent)||6
8798937|NCT01433991|9850353|FG003|NOT COMPLETED|Treatment Phase (Combination Agent)||6
8798938|NCT01434030|9850369|FG000|STARTED|Overall Study||57
8798939|NCT01434030|9850369|FG000|COMPLETED|Overall Study||56
8798940|NCT01434030|9850369|FG000|NOT COMPLETED|Overall Study||1
8798941|NCT01434121|9850377|FG000|STARTED|Overall Study||8
8798942|NCT01434121|9850378|FG001|STARTED|Overall Study||8
8798943|NCT01434121|9850379|FG002|STARTED|Overall Study||8
8798944|NCT01434121|9850377|FG000|COMPLETED|Overall Study||8
8798945|NCT01434121|9850378|FG001|COMPLETED|Overall Study||8
8798946|NCT01434121|9850379|FG002|COMPLETED|Overall Study||8
8798947|NCT01434121|9850377|FG000|NOT COMPLETED|Overall Study||0
8798948|NCT01434121|9850378|FG001|NOT COMPLETED|Overall Study||0
8798949|NCT01434121|9850379|FG002|NOT COMPLETED|Overall Study||0
8798950|NCT01434186|9850392|FG000|STARTED|Overall Study||2
8798951|NCT01434186|9850393|FG001|STARTED|Overall Study||4
8798952|NCT01434186|9850392|FG000|COMPLETED|Overall Study||2
8798953|NCT01434186|9850393|FG001|COMPLETED|Overall Study||4
8798954|NCT01434186|9850392|FG000|NOT COMPLETED|Overall Study||0
8798955|NCT01434186|9850393|FG001|NOT COMPLETED|Overall Study||0
8798956|NCT01434290|9850401|FG000|STARTED|Overall Study||127
8798957|NCT01434290|9850402|FG001|STARTED|Overall Study||128
8798958|NCT01434290|9850401|FG000|COMPLETED|Overall Study|Eligible subjects included in analysis|119
8798959|NCT01434290|9850402|FG001|COMPLETED|Overall Study|Eligible subjects included in analysis|121
8798960|NCT01434290|9850401|FG000|NOT COMPLETED|Overall Study||8
8798961|NCT01434290|9850402|FG001|NOT COMPLETED|Overall Study||7
8798962|NCT01434342|9850411|FG000|STARTED|Overall Study||98
8798963|NCT01434342|9850412|FG001|STARTED|Overall Study||48
8798964|NCT01434342|9850411|FG000|COMPLETED|Overall Study||50
8798965|NCT01434342|9850412|FG001|COMPLETED|Overall Study||31
8798966|NCT01434342|9850411|FG000|NOT COMPLETED|Overall Study||48
8798967|NCT01434342|9850412|FG001|NOT COMPLETED|Overall Study||17
8798968|NCT01434472|9850418|FG000|STARTED|Overall Study||20
8798969|NCT01434472|9850418|FG000|COMPLETED|Overall Study||20
8798970|NCT01434472|9850418|FG000|NOT COMPLETED|Overall Study||0
8798971|NCT01434641|9850422|FG000|STARTED|Overall Study||102
8798972|NCT01434641|9850422|FG000|COMPLETED|Overall Study||102
8798973|NCT01434641|9850422|FG000|NOT COMPLETED|Overall Study||0
8798974|NCT01434654|9850428|FG000|STARTED|Overall Study||7
8798975|NCT01434654|9850429|FG001|STARTED|Overall Study||12
8798976|NCT01434654|9850428|FG000|COMPLETED|Overall Study||5
8798977|NCT01434654|9850429|FG001|COMPLETED|Overall Study||12
8798978|NCT01434654|9850428|FG000|NOT COMPLETED|Overall Study||2
8798979|NCT01434654|9850429|FG001|NOT COMPLETED|Overall Study||0
8798980|NCT01434667|9850439|FG000|STARTED|Overall Study||39
8798981|NCT01434667|9850440|FG001|STARTED|Overall Study||75
8798982|NCT01434667|9850439|FG000|COMPLETED|Overall Study||34
8798983|NCT01434667|9850440|FG001|COMPLETED|Overall Study||65
8798984|NCT01434667|9850439|FG000|NOT COMPLETED|Overall Study||5
8798985|NCT01434667|9850440|FG001|NOT COMPLETED|Overall Study||10
8798986|NCT01434680|9850450|FG000|STARTED|Overall Study||299
8798987|NCT01434680|9850451|FG001|STARTED|Overall Study||268
8798988|NCT01434680|9850452|FG002|STARTED|Overall Study||306
8798989|NCT01434680|9850453|FG003|STARTED|Overall Study||119
8798990|NCT01434680|9850450|FG000|COMPLETED|Overall Study||296
8798991|NCT01434680|9850451|FG001|COMPLETED|Overall Study||266
8798992|NCT01434680|9850452|FG002|COMPLETED|Overall Study||304
8798993|NCT01434680|9850453|FG003|COMPLETED|Overall Study||119
8798994|NCT01434680|9850450|FG000|NOT COMPLETED|Overall Study||3
8798995|NCT01434680|9850451|FG001|NOT COMPLETED|Overall Study||2
8798996|NCT01434680|9850452|FG002|NOT COMPLETED|Overall Study||2
8798997|NCT01434680|9850453|FG003|NOT COMPLETED|Overall Study||0
8798998|NCT01434693|9850467|FG000|STARTED|Overall Study||9
8798999|NCT01434693|9850468|FG001|STARTED|Overall Study||9
8799000|NCT01434693|9850469|FG002|STARTED|Overall Study||9
8799001|NCT01434693|9850470|FG003|STARTED|Overall Study||9
8799002|NCT01434693|9850467|FG000|COMPLETED|Overall Study||6
8799003|NCT01434693|9850468|FG001|COMPLETED|Overall Study||9
8799004|NCT01434693|9850469|FG002|COMPLETED|Overall Study||8
8799005|NCT01434693|9850470|FG003|COMPLETED|Overall Study||8
8799006|NCT01434693|9850467|FG000|NOT COMPLETED|Overall Study||3
8799007|NCT01434693|9850468|FG001|NOT COMPLETED|Overall Study||0
8799008|NCT01434693|9850469|FG002|NOT COMPLETED|Overall Study||1
8799009|NCT01434693|9850470|FG003|NOT COMPLETED|Overall Study||1
8799010|NCT01434810|9850482|FG000|STARTED|Overall Study||224
8799011|NCT01434810|9850483|FG001|STARTED|Overall Study||223
8799012|NCT01434810|9850482|FG000|COMPLETED|Overall Study||201
8799013|NCT01434810|9850483|FG001|COMPLETED|Overall Study||213
8799014|NCT01434810|9850482|FG000|NOT COMPLETED|Overall Study||23
8799015|NCT01434810|9850483|FG001|NOT COMPLETED|Overall Study||10
8799016|NCT01434823|9850491|FG000|STARTED|Overall Study||824
8799017|NCT01434823|9850492|FG001|STARTED|Overall Study||785
8799018|NCT01434823|9850491|FG000|COMPLETED|Overall Study||820
8799019|NCT01434823|9850492|FG001|COMPLETED|Overall Study||778
8799020|NCT01434823|9850491|FG000|NOT COMPLETED|Overall Study||4
8799021|NCT01434823|9850492|FG001|NOT COMPLETED|Overall Study||7
8799022|NCT01435018|9850502|FG000|STARTED|Overall Study||135
8799023|NCT01435018|9850503|FG001|STARTED|Overall Study||60
8799024|NCT01435018|9850504|FG002|STARTED|Overall Study||139
8799025|NCT01435018|9850502|FG000|COMPLETED|Overall Study||88
8799026|NCT01435018|9850503|FG001|COMPLETED|Overall Study||26
8799027|NCT01435018|9850504|FG002|COMPLETED|Overall Study||98
8799028|NCT01435018|9850502|FG000|NOT COMPLETED|Overall Study||47
8799029|NCT01435018|9850503|FG001|NOT COMPLETED|Overall Study||34
8799030|NCT01435018|9850504|FG002|NOT COMPLETED|Overall Study||41
8799031|NCT01435031|9850514|FG000|STARTED|ITT at 1 Month|ITT population|222
8799032|NCT01435031|9850514|FG000|COMPLETED|ITT at 1 Month||216
8799033|NCT01435031|9850514|FG000|NOT COMPLETED|ITT at 1 Month||6
8799034|NCT01435031|9850514|FG000|STARTED|ITT at 6 Months||216
8799035|NCT01435031|9850514|FG000|COMPLETED|ITT at 6 Months||211
8799036|NCT01435031|9850514|FG000|NOT COMPLETED|ITT at 6 Months||5
8799037|NCT01435031|9850514|FG000|STARTED|ITT at 1 Year||211
8799038|NCT01435031|9850514|FG000|COMPLETED|ITT at 1 Year||202
8799039|NCT01435031|9850514|FG000|NOT COMPLETED|ITT at 1 Year||9
8799040|NCT01435031|9850514|FG000|STARTED|ITT at 2 Years||202
8799041|NCT01435031|9850514|FG000|COMPLETED|ITT at 2 Years||189
8799042|NCT01435031|9850514|FG000|NOT COMPLETED|ITT at 2 Years||13
8799043|NCT01435031|9850514|FG000|STARTED|ITT at 3 Years||189
8799044|NCT01435031|9850514|FG000|COMPLETED|ITT at 3 Years||178
8799045|NCT01435031|9850514|FG000|NOT COMPLETED|ITT at 3 Years||11
8799046|NCT01435031|9850514|FG000|STARTED|ITT at 4 Years||178
8799047|NCT01435031|9850514|FG000|COMPLETED|ITT at 4 Years||171
8799048|NCT01435031|9850514|FG000|NOT COMPLETED|ITT at 4 Years||7
8799049|NCT01435122|9850518|FG000|STARTED|Overall Study||30
8799050|NCT01435122|9850518|FG000|COMPLETED|Overall Study||22
8799051|NCT01435122|9850518|FG000|NOT COMPLETED|Overall Study||8
8799052|NCT01435174|9850522|FG000|STARTED|Overall Study||17
8799053|NCT01435174|9850522|FG000|COMPLETED|Overall Study||8
8799054|NCT01435174|9850522|FG000|NOT COMPLETED|Overall Study||9
8799055|NCT01435265|9850528|FG000|STARTED|Overall Study||3
8799056|NCT01435265|9850529|FG001|STARTED|Overall Study||4
8799057|NCT01435265|9850528|FG000|COMPLETED|Overall Study||3
8799058|NCT01435265|9850529|FG001|COMPLETED|Overall Study||3
8799059|NCT01435265|9850528|FG000|NOT COMPLETED|Overall Study||0
8799060|NCT01435265|9850529|FG001|NOT COMPLETED|Overall Study||1
8799061|NCT01435304|9850537|FG000|STARTED|Overall Study||50
8799062|NCT01435304|9850538|FG001|STARTED|Overall Study||50
8799063|NCT01435304|9850537|FG000|COMPLETED|Overall Study||50
8799064|NCT01435304|9850538|FG001|COMPLETED|Overall Study||50
8799065|NCT01435304|9850537|FG000|NOT COMPLETED|Overall Study||0
8799066|NCT01435304|9850538|FG001|NOT COMPLETED|Overall Study||0
8799067|NCT01435356|9850546|FG000|STARTED|Overall Study||48
8799068|NCT01435356|9850547|FG001|STARTED|Overall Study||29
8799069|NCT01435356|9850546|FG000|COMPLETED|Overall Study||16
8799070|NCT01435356|9850547|FG001|COMPLETED|Overall Study||5
8799071|NCT01435356|9850546|FG000|NOT COMPLETED|Overall Study||32
8799072|NCT01435356|9850547|FG001|NOT COMPLETED|Overall Study||24
8799073|NCT01435382|9850557|FG000|STARTED|Overall Study||12
8799074|NCT01435382|9850558|FG001|STARTED|Overall Study||13
8799075|NCT01435382|9850559|FG002|STARTED|Overall Study||13
8799076|NCT01435382|9850560|FG003|STARTED|Overall Study||11
8799077|NCT01435382|9850557|FG000|COMPLETED|Overall Study||11
8799078|NCT01435382|9850558|FG001|COMPLETED|Overall Study||11
8799079|NCT01435382|9850559|FG002|COMPLETED|Overall Study||12
8799080|NCT01435382|9850560|FG003|COMPLETED|Overall Study||10
8799081|NCT01435382|9850557|FG000|NOT COMPLETED|Overall Study||1
8799082|NCT01435382|9850558|FG001|NOT COMPLETED|Overall Study||2
8799083|NCT01435382|9850559|FG002|NOT COMPLETED|Overall Study||1
8799084|NCT01435382|9850560|FG003|NOT COMPLETED|Overall Study||1
8799085|NCT01435460|9850578|FG000|STARTED|Overall Study||151
8799086|NCT01435460|9850579|FG001|STARTED|Overall Study||149
8799087|NCT01435460|9850578|FG000|COMPLETED|Overall Study||140
8799088|NCT01435460|9850579|FG001|COMPLETED|Overall Study||143
8799089|NCT01435460|9850578|FG000|NOT COMPLETED|Overall Study||11
8799090|NCT01435460|9850579|FG001|NOT COMPLETED|Overall Study||6
8799091|NCT01435512|9850587|FG000|STARTED|Overall Study||67
8799092|NCT01435512|9850588|FG001|STARTED|Overall Study||68
8799093|NCT01435512|9850587|FG000|COMPLETED|Overall Study||67
8799094|NCT01435512|9850588|FG001|COMPLETED|Overall Study||68
8799095|NCT01435512|9850587|FG000|NOT COMPLETED|Overall Study||0
8799096|NCT01435512|9850588|FG001|NOT COMPLETED|Overall Study||0
8799097|NCT01435577|9850596|FG000|STARTED|Overall Study||64
8799098|NCT01435577|9850597|FG001|STARTED|Overall Study||65
8799099|NCT01435577|9850596|FG000|COMPLETED|Overall Study||47
8799100|NCT01435577|9850597|FG001|COMPLETED|Overall Study||13
8799101|NCT01435577|9850596|FG000|NOT COMPLETED|Overall Study||17
8799102|NCT01435577|9850597|FG001|NOT COMPLETED|Overall Study||52
8799103|NCT01435603|9850609|FG000|STARTED|Overall Study||167
8799104|NCT01435603|9850610|FG001|STARTED|Overall Study||164
8799105|NCT01435603|9850609|FG000|COMPLETED|Overall Study||128
8799106|NCT01435603|9850610|FG001|COMPLETED|Overall Study||129
8799107|NCT01435603|9850609|FG000|NOT COMPLETED|Overall Study||39
8799108|NCT01435603|9850610|FG001|NOT COMPLETED|Overall Study||35
8799109|NCT01435616|9850618|FG000|STARTED|Overall Study||1003
8799110|NCT01435616|9850619|FG001|STARTED|Overall Study||535
8799111|NCT01435616|9850618|FG000|Received at Least 1 Dose of Study Drug|Overall Study||1003
8799112|NCT01435616|9850619|FG001|Received at Least 1 Dose of Study Drug|Overall Study||535
8799113|NCT01435616|9850618|FG000|COMPLETED|Overall Study||832
8799114|NCT01435616|9850619|FG001|COMPLETED|Overall Study||455
8799115|NCT01435616|9850618|FG000|NOT COMPLETED|Overall Study||171
8799116|NCT01435616|9850619|FG001|NOT COMPLETED|Overall Study||80
8799117|NCT01435655|9850627|FG000|STARTED|Overall Study||10
8799118|NCT01435655|9850627|FG000|COMPLETED|Overall Study||7
8799119|NCT01435655|9850627|FG000|NOT COMPLETED|Overall Study||3
8799120|NCT01435759|9850636|FG000|STARTED|Antidepressant Lead-in Phase|Of these 1197 subjects, 19 subjects were not dosed.|1197
8799121|NCT01435759|9850637|FG001|STARTED|Antidepressant Lead-in Phase||0
8799122|NCT01435759|9850638|FG002|STARTED|Antidepressant Lead-in Phase||0
8799123|NCT01435759|9850639|FG003|STARTED|Antidepressant Lead-in Phase||0
8799124|NCT01435759|9850640|FG004|STARTED|Antidepressant Lead-in Phase||0
8799125|NCT01435759|9850641|FG005|STARTED|Antidepressant Lead-in Phase||0
8799126|NCT01435759|9850636|FG000|COMPLETED|Antidepressant Lead-in Phase||855
8799127|NCT01435759|9850637|FG001|COMPLETED|Antidepressant Lead-in Phase||0
8799128|NCT01435759|9850638|FG002|COMPLETED|Antidepressant Lead-in Phase||0
8799129|NCT01435759|9850639|FG003|COMPLETED|Antidepressant Lead-in Phase||0
8799130|NCT01435759|9850640|FG004|COMPLETED|Antidepressant Lead-in Phase||0
8799131|NCT01435759|9850641|FG005|COMPLETED|Antidepressant Lead-in Phase||0
8799132|NCT01435759|9850636|FG000|NOT COMPLETED|Antidepressant Lead-in Phase||342
8799133|NCT01435759|9850637|FG001|NOT COMPLETED|Antidepressant Lead-in Phase||0
8799134|NCT01435759|9850638|FG002|NOT COMPLETED|Antidepressant Lead-in Phase||0
8799135|NCT01435759|9850639|FG003|NOT COMPLETED|Antidepressant Lead-in Phase||0
8799136|NCT01435759|9850640|FG004|NOT COMPLETED|Antidepressant Lead-in Phase||0
8799137|NCT01435759|9850641|FG005|NOT COMPLETED|Antidepressant Lead-in Phase||0
8799138|NCT01435759|9850636|FG000|STARTED|Double-blind Phase|These subjects were not included in the Safety Dose Response Evaluable Set or Safety Analysis Set.|463
8799139|NCT01435759|9850637|FG001|STARTED|Double-blind Phase||78
8799140|NCT01435759|9850638|FG002|STARTED|Double-blind Phase|One subject was not dosed.|78
8799141|NCT01435759|9850639|FG003|STARTED|Double-blind Phase|Two subjects were not dosed.|78
8799142|NCT01435759|9850640|FG004|STARTED|Double-blind Phase||78
8799143|NCT01435759|9850641|FG005|STARTED|Double-blind Phase||80
8799144|NCT01435759|9850636|FG000|COMPLETED|Double-blind Phase||397
8799145|NCT01435759|9850637|FG001|COMPLETED|Double-blind Phase||71
8799146|NCT01435759|9850638|FG002|COMPLETED|Double-blind Phase||71
8799147|NCT01435759|9850639|FG003|COMPLETED|Double-blind Phase||69
8799148|NCT01435759|9850640|FG004|COMPLETED|Double-blind Phase||69
8799149|NCT01435759|9850641|FG005|COMPLETED|Double-blind Phase||71
8799150|NCT01435759|9850636|FG000|NOT COMPLETED|Double-blind Phase||66
8799151|NCT01435759|9850637|FG001|NOT COMPLETED|Double-blind Phase||7
8799152|NCT01435759|9850638|FG002|NOT COMPLETED|Double-blind Phase||7
8799153|NCT01435759|9850639|FG003|NOT COMPLETED|Double-blind Phase||9
8799154|NCT01435759|9850640|FG004|NOT COMPLETED|Double-blind Phase||9
8799155|NCT01435759|9850641|FG005|NOT COMPLETED|Double-blind Phase||9
8799156|NCT01435772|9850656|FG000|STARTED|Overall Study||3
8799157|NCT01435772|9850657|FG001|STARTED|Overall Study||3
8799158|NCT01435772|9850658|FG002|STARTED|Overall Study||15
8799159|NCT01435772|9850656|FG000|COMPLETED|Overall Study||0
8799160|NCT01435772|9850657|FG001|COMPLETED|Overall Study||0
8799161|NCT01435772|9850658|FG002|COMPLETED|Overall Study||0
8799162|NCT01435772|9850656|FG000|NOT COMPLETED|Overall Study||3
8799163|NCT01435772|9850657|FG001|NOT COMPLETED|Overall Study||3
8799164|NCT01435772|9850658|FG002|NOT COMPLETED|Overall Study||15
8799165|NCT01435798|9850667|FG000|STARTED|Overall Study|Crossover design|26
8799166|NCT01435798|9850667|FG000|0% MTD|Overall Study||25
8799167|NCT01435798|9850667|FG000|25% MTD|Overall Study||26
8799168|NCT01435798|9850667|FG000|50% MTD|Overall Study||25
8799169|NCT01435798|9850667|FG000|100% MTD|Overall Study||25
8917974|NCT02196831|9977824|FG001|COMPLETED|Overall Study||26
8917975|NCT02196831|9977823|FG000|NOT COMPLETED|Overall Study||9
8917976|NCT02196831|9977824|FG001|NOT COMPLETED|Overall Study||4
8917977|NCT02196857|9977831|FG000|STARTED|Overall Study||16
8917978|NCT02196857|9977831|FG000|COMPLETED|Overall Study||16
8917979|NCT02196857|9977831|FG000|NOT COMPLETED|Overall Study||0
8917980|NCT02196922|9977837|FG000|STARTED|Overall Study||58
8917981|NCT02196922|9977838|FG001|STARTED|Overall Study||46
8917982|NCT02196922|9977837|FG000|COMPLETED|Overall Study||58
8917983|NCT02196922|9977838|FG001|COMPLETED|Overall Study||46
8799170|NCT01435798|9850667|FG000|COMPLETED|Overall Study|Crossover design|25
8799171|NCT01435798|9850667|FG000|NOT COMPLETED|Overall Study||1
8799172|NCT01435824|9850677|FG000|STARTED|First Intervention||8
8799173|NCT01435824|9850678|FG001|STARTED|First Intervention||8
8799174|NCT01435824|9850677|FG000|COMPLETED|First Intervention||8
8799175|NCT01435824|9850678|FG001|COMPLETED|First Intervention||8
8799176|NCT01435824|9850677|FG000|NOT COMPLETED|First Intervention||0
8799177|NCT01435824|9850678|FG001|NOT COMPLETED|First Intervention||0
8799178|NCT01435824|9850677|FG000|STARTED|Washout of 1-2 Weeks||8
8799179|NCT01435824|9850678|FG001|STARTED|Washout of 1-2 Weeks||8
8799180|NCT01435824|9850677|FG000|COMPLETED|Washout of 1-2 Weeks||8
8799181|NCT01435824|9850678|FG001|COMPLETED|Washout of 1-2 Weeks||8
8799182|NCT01435824|9850677|FG000|NOT COMPLETED|Washout of 1-2 Weeks||0
8799183|NCT01435824|9850678|FG001|NOT COMPLETED|Washout of 1-2 Weeks||0
8799184|NCT01435824|9850677|FG000|STARTED|Second Intervention||8
8799185|NCT01435824|9850678|FG001|STARTED|Second Intervention||8
8799186|NCT01435824|9850677|FG000|COMPLETED|Second Intervention||8
8799187|NCT01435824|9850678|FG001|COMPLETED|Second Intervention||8
8799188|NCT01435824|9850677|FG000|NOT COMPLETED|Second Intervention||0
8799189|NCT01435824|9850678|FG001|NOT COMPLETED|Second Intervention||0
8799190|NCT01435928|9850686|FG000|STARTED|Open Label Phase - up to 24 Weeks||676
8799191|NCT01435928|9850687|FG001|STARTED|Open Label Phase - up to 24 Weeks||0
8799192|NCT01435928|9850688|FG002|STARTED|Open Label Phase - up to 24 Weeks||0
8799193|NCT01435928|9850686|FG000|COMPLETED|Open Label Phase - up to 24 Weeks||287
8799194|NCT01435928|9850687|FG001|COMPLETED|Open Label Phase - up to 24 Weeks||0
8799195|NCT01435928|9850688|FG002|COMPLETED|Open Label Phase - up to 24 Weeks||0
8799196|NCT01435928|9850686|FG000|NOT COMPLETED|Open Label Phase - up to 24 Weeks||389
8799197|NCT01435928|9850687|FG001|NOT COMPLETED|Open Label Phase - up to 24 Weeks||0
8799198|NCT01435928|9850688|FG002|NOT COMPLETED|Open Label Phase - up to 24 Weeks||0
8799199|NCT01435928|9850686|FG000|STARTED|Double Blind Phase - 28 Weeks||0
8799200|NCT01435928|9850687|FG001|STARTED|Double Blind Phase - 28 Weeks||144
8799201|NCT01435928|9850688|FG002|STARTED|Double Blind Phase - 28 Weeks||141
8799202|NCT01435928|9850686|FG000|COMPLETED|Double Blind Phase - 28 Weeks||0
8799203|NCT01435928|9850687|FG001|COMPLETED|Double Blind Phase - 28 Weeks||28
8799204|NCT01435928|9850688|FG002|COMPLETED|Double Blind Phase - 28 Weeks||20
8799205|NCT01435928|9850686|FG000|NOT COMPLETED|Double Blind Phase - 28 Weeks||0
8799206|NCT01435928|9850687|FG001|NOT COMPLETED|Double Blind Phase - 28 Weeks||116
8799207|NCT01435928|9850688|FG002|NOT COMPLETED|Double Blind Phase - 28 Weeks||121
8799208|NCT01436006|9850695|FG000|STARTED|Overall Study||6700
8799209|NCT01436006|9850695|FG000|COMPLETED|Overall Study||6663
8799210|NCT01436006|9850695|FG000|NOT COMPLETED|Overall Study||37
8799211|NCT01436045|9850707|FG000|STARTED|Overall Study||6
8799212|NCT01436045|9850708|FG001|STARTED|Overall Study||6
8799213|NCT01436045|9850707|FG000|COMPLETED|Overall Study||6
8799214|NCT01436045|9850708|FG001|COMPLETED|Overall Study||6
8799215|NCT01436045|9850707|FG000|NOT COMPLETED|Overall Study||0
8799216|NCT01436045|9850708|FG001|NOT COMPLETED|Overall Study||0
8799217|NCT01436071|9850716|FG000|STARTED|Overall Study|These participants were randomized to trial medication.|124
8799218|NCT01436071|9850717|FG001|STARTED|Overall Study|These participants were randomized to trial medication.|124
8799219|NCT01436071|9850716|FG000|Safety Population|Overall Study|These randomized participants received at least a single dose of trial medication.|121
8799220|NCT01436071|9850717|FG001|Safety Population|Overall Study|These randomized participants received at least a single dose of trial medication.|121
8799221|NCT01436071|9850716|FG000|COMPLETED|Overall Study||98
8799222|NCT01436071|9850717|FG001|COMPLETED|Overall Study||110
8799223|NCT01436071|9850716|FG000|NOT COMPLETED|Overall Study||26
8799224|NCT01436071|9850717|FG001|NOT COMPLETED|Overall Study||14
8799225|NCT01436110|9850726|FG000|STARTED|Overall Study|These participants were randomized to trial medication.|116
8799226|NCT01436110|9850727|FG001|STARTED|Overall Study|These participants were randomized to trial medication.|117
8799227|NCT01436110|9850728|FG002|STARTED|Overall Study|These participants were randomized to trial medication.|118
8799228|NCT01436110|9850726|FG000|Intent-to-Treat Population|Overall Study|These randomized participants received at least a single dose of trial medication.|115
8799229|NCT01436110|9850727|FG001|Intent-to-Treat Population|Overall Study|These randomized participants received at least a single dose of trial medication.|117
8799230|NCT01436110|9850728|FG002|Intent-to-Treat Population|Overall Study|These randomized participants received at least a single dose of trial medication.|115
8799231|NCT01436110|9850726|FG000|COMPLETED|Overall Study||77
8799232|NCT01436110|9850727|FG001|COMPLETED|Overall Study||91
8799233|NCT01436110|9850728|FG002|COMPLETED|Overall Study||95
8799234|NCT01436110|9850726|FG000|NOT COMPLETED|Overall Study||39
8799235|NCT01436110|9850727|FG001|NOT COMPLETED|Overall Study||26
8799236|NCT01436110|9850728|FG002|NOT COMPLETED|Overall Study||23
8799237|NCT01436149|9850738|FG000|STARTED|Antidepressant Lead-in Phase|Twenty-three subjects were enrolled but not dosed.|1262
8799238|NCT01436149|9850739|FG001|STARTED|Antidepressant Lead-in Phase||0
8799239|NCT01436149|9850740|FG002|STARTED|Antidepressant Lead-in Phase||0
8799240|NCT01436149|9850738|FG000|COMPLETED|Antidepressant Lead-in Phase||896
8799241|NCT01436149|9850739|FG001|COMPLETED|Antidepressant Lead-in Phase||0
8799242|NCT01436149|9850740|FG002|COMPLETED|Antidepressant Lead-in Phase||0
8799243|NCT01436149|9850738|FG000|NOT COMPLETED|Antidepressant Lead-in Phase||366
8799244|NCT01436149|9850739|FG001|NOT COMPLETED|Antidepressant Lead-in Phase||0
8799245|NCT01436149|9850740|FG002|NOT COMPLETED|Antidepressant Lead-in Phase||0
8799246|NCT01436149|9850738|FG000|STARTED|Randomized Phase|These subjects were not included in the Safety Analysis Set or Full Analysis Set.|492
8799247|NCT01436149|9850739|FG001|STARTED|Randomized Phase|One subject did not receive at least 1 dose of double-blind treatment.|202
8799248|NCT01436149|9850740|FG002|STARTED|Randomized Phase|One subject did not receive at least 1 dose of double-blind treatment.|202
8799249|NCT01436149|9850738|FG000|COMPLETED|Randomized Phase||415
8799250|NCT01436149|9850739|FG001|COMPLETED|Randomized Phase||164
8799251|NCT01436149|9850740|FG002|COMPLETED|Randomized Phase|1 subject completed the study without a Visit 14 MADRS and was not included in the completers set.|160
8799252|NCT01436149|9850738|FG000|NOT COMPLETED|Randomized Phase||77
8799253|NCT01436149|9850739|FG001|NOT COMPLETED|Randomized Phase||38
9033741|NCT03282071|10095959|FG000|NOT COMPLETED|Overall Study||10
9033742|NCT03282071|10095960|FG001|NOT COMPLETED|Overall Study||9
9033743|NCT03282227|10095968|FG000|STARTED|Overall Study||342
9033744|NCT03282227|10095968|FG000|Completed at Least 6 Months|Overall Study||257
9033745|NCT03282227|10095968|FG000|COMPLETED|Overall Study||127
9033746|NCT03282227|10095968|FG000|NOT COMPLETED|Overall Study||215
9033747|NCT03282357|10095972|FG000|STARTED|Overall Study||181
9033748|NCT03282357|10095972|FG000|Safety Evaluation Set|Overall Study||176
9033749|NCT03282357|10095972|FG000|COMPLETED|Overall Study||164
9033750|NCT03282357|10095972|FG000|NOT COMPLETED|Overall Study||17
9033751|NCT03282591|10095979|FG000|STARTED|Overall Study||92
9033752|NCT03282591|10095980|FG001|STARTED|Overall Study||93
9033753|NCT03282591|10095979|FG000|COMPLETED|Overall Study||88
9033754|NCT03282591|10095980|FG001|COMPLETED|Overall Study||89
9033755|NCT03282591|10095979|FG000|NOT COMPLETED|Overall Study||4
9033756|NCT03282591|10095980|FG001|NOT COMPLETED|Overall Study||4
9033757|NCT03282682|10095990|FG000|STARTED|Overall Study||6
9033758|NCT03282682|10095991|FG001|STARTED|Overall Study||8
9033759|NCT03282682|10095992|FG002|STARTED|Overall Study||8
8672182|NCT00756002|9715676|FG001|COMPLETED|Placebo Run-in||0
8672183|NCT00756002|9715675|FG000|NOT COMPLETED|Placebo Run-in||229
8672184|NCT00756002|9715676|FG001|NOT COMPLETED|Placebo Run-in||0
8672185|NCT00756002|9715675|FG000|STARTED|Double-Blind Treatment Period||129
8672186|NCT00756002|9715676|FG001|STARTED|Double-Blind Treatment Period||130
8672187|NCT00756002|9715675|FG000|COMPLETED|Double-Blind Treatment Period||114
8672188|NCT00756002|9715676|FG001|COMPLETED|Double-Blind Treatment Period||115
8672189|NCT00756002|9715675|FG000|NOT COMPLETED|Double-Blind Treatment Period||15
8672190|NCT00756002|9715676|FG001|NOT COMPLETED|Double-Blind Treatment Period||15
8799254|NCT01436149|9850740|FG002|NOT COMPLETED|Randomized Phase||42
8799255|NCT01436162|9850748|FG000|STARTED|Single-blind Lead-in Phase|Ten subjects were enrolled but not dosed.|1105
8799256|NCT01436162|9850749|FG001|STARTED|Single-blind Lead-in Phase||0
8799257|NCT01436162|9850750|FG002|STARTED|Single-blind Lead-in Phase||0
8799258|NCT01436162|9850748|FG000|COMPLETED|Single-blind Lead-in Phase||823
8799259|NCT01436162|9850749|FG001|COMPLETED|Single-blind Lead-in Phase||0
8799260|NCT01436162|9850750|FG002|COMPLETED|Single-blind Lead-in Phase||0
8799261|NCT01436162|9850748|FG000|NOT COMPLETED|Single-blind Lead-in Phase||282
8799262|NCT01436162|9850749|FG001|NOT COMPLETED|Single-blind Lead-in Phase||0
8799263|NCT01436162|9850750|FG002|NOT COMPLETED|Single-blind Lead-in Phase||0
8799264|NCT01436162|9850748|FG000|STARTED|Randomized Phase|These subjects were not included in the Safety Analysis Set or Full Analysis Set.|397
8799265|NCT01436162|9850749|FG001|STARTED|Randomized Phase|One subject was randomized to this arm but did not receive at least 1 dose of double-blind treatment|212
8799266|NCT01436162|9850750|FG002|STARTED|Randomized Phase|One subject was randomized to this arm but did not receive at least 1 dose of double-blind treatment|214
8799267|NCT01436162|9850748|FG000|COMPLETED|Randomized Phase||353
8799268|NCT01436162|9850749|FG001|COMPLETED|Randomized Phase||181
8799269|NCT01436162|9850750|FG002|COMPLETED|Randomized Phase||189
8799270|NCT01436162|9850748|FG000|NOT COMPLETED|Randomized Phase||44
8799271|NCT01436162|9850749|FG001|NOT COMPLETED|Randomized Phase||31
8799272|NCT01436162|9850750|FG002|NOT COMPLETED|Randomized Phase||25
8799273|NCT01436175|9850758|FG000|STARTED|Overall Study||1570
8799274|NCT01436175|9850758|FG000|COMPLETED|Overall Study||300
8799275|NCT01436175|9850758|FG000|NOT COMPLETED|Overall Study||1270
8799276|NCT01436201|9850763|FG000|STARTED|Overall Study||24
8799277|NCT01436201|9850763|FG000|Received at Least 1 Dose of Study Drug|Overall Study||24
8799278|NCT01436201|9850763|FG000|COMPLETED|Overall Study||20
8799279|NCT01436201|9850763|FG000|NOT COMPLETED|Overall Study||4
8799280|NCT01436266|9850771|FG000|STARTED|Overall Study||1
8799281|NCT01436266|9850772|FG001|STARTED|Overall Study||1
8799282|NCT01436266|9850771|FG000|COMPLETED|Overall Study||1
8799283|NCT01436266|9850772|FG001|COMPLETED|Overall Study||1
8799284|NCT01436266|9850771|FG000|NOT COMPLETED|Overall Study||0
8799285|NCT01436266|9850772|FG001|NOT COMPLETED|Overall Study||0
8799286|NCT01436279|9850780|FG000|STARTED|Overall Study||30
8799287|NCT01436279|9850781|FG001|STARTED|Overall Study||20
8799288|NCT01436279|9850780|FG000|COMPLETED|Overall Study||30
8799289|NCT01436279|9850781|FG001|COMPLETED|Overall Study||20
8799290|NCT01436279|9850780|FG000|NOT COMPLETED|Overall Study||0
8799291|NCT01436279|9850781|FG001|NOT COMPLETED|Overall Study||0
8799292|NCT01436305|9850792|FG000|STARTED|Overall Study||6
8799293|NCT01436305|9850793|FG001|STARTED|Overall Study||6
8799294|NCT01436305|9850794|FG002|STARTED|Overall Study||7
8799295|NCT01436305|9850792|FG000|COMPLETED|Overall Study||4
8799296|NCT01436305|9850793|FG001|COMPLETED|Overall Study||2
9033760|NCT03282682|10095990|FG000|COMPLETED|Overall Study||6
8799297|NCT01436305|9850794|FG002|COMPLETED|Overall Study||7
8799298|NCT01436305|9850792|FG000|NOT COMPLETED|Overall Study||2
8799299|NCT01436305|9850793|FG001|NOT COMPLETED|Overall Study||4
8799300|NCT01436305|9850794|FG002|NOT COMPLETED|Overall Study||0
9033761|NCT03282682|10095991|FG001|COMPLETED|Overall Study||8
9033762|NCT03282682|10095992|FG002|COMPLETED|Overall Study||8
9033763|NCT03282682|10095990|FG000|NOT COMPLETED|Overall Study||0
9033764|NCT03282682|10095991|FG001|NOT COMPLETED|Overall Study||0
9033765|NCT03282682|10095992|FG002|NOT COMPLETED|Overall Study||0
9033766|NCT03283098|10096002|FG000|STARTED|Overall Study||8
8799301|NCT01436357|9850804|FG000|STARTED|Overall Study||274
8799302|NCT01436357|9850805|FG001|STARTED|Overall Study||274
8799303|NCT01436357|9850804|FG000|Stage 1|Overall Study||49
8799304|NCT01436357|9850805|FG001|Stage 1|Overall Study||48
8799305|NCT01436357|9850804|FG000|Stage 2|Overall Study||225
8799306|NCT01436357|9850805|FG001|Stage 2|Overall Study||226
8799307|NCT01436357|9850804|FG000|COMPLETED|Overall Study||152
8799308|NCT01436357|9850805|FG001|COMPLETED|Overall Study||146
8799309|NCT01436357|9850804|FG000|NOT COMPLETED|Overall Study||122
8799310|NCT01436357|9850805|FG001|NOT COMPLETED|Overall Study||128
8799311|NCT01436370|9850819|FG000|STARTED|Overall Study||6
8799312|NCT01436370|9850820|FG001|STARTED|Overall Study||6
8799313|NCT01436370|9850821|FG002|STARTED|Overall Study||10
8799314|NCT01436370|9850822|FG003|STARTED|Overall Study||10
8799315|NCT01436370|9850823|FG004|STARTED|Overall Study||19
8799316|NCT01436370|9850824|FG005|STARTED|Overall Study||19
8799317|NCT01436370|9850825|FG006|STARTED|Overall Study||16
8799318|NCT01436370|9850826|FG007|STARTED|Overall Study||16
8799319|NCT01436370|9850819|FG000|COMPLETED|Overall Study||6
8799320|NCT01436370|9850820|FG001|COMPLETED|Overall Study||6
8917984|NCT02196922|9977837|FG000|NOT COMPLETED|Overall Study||0
8917985|NCT02196922|9977838|FG001|NOT COMPLETED|Overall Study||0
8917986|NCT02197065|9977848|FG000|STARTED|Overall Study||10
8917987|NCT02197065|9977849|FG001|STARTED|Overall Study||10
8917988|NCT02197065|9977848|FG000|COMPLETED|Overall Study||10
8917989|NCT02197065|9977849|FG001|COMPLETED|Overall Study||10
8917990|NCT02197065|9977848|FG000|NOT COMPLETED|Overall Study||0
9033767|NCT03283098|10096003|FG001|STARTED|Overall Study||25
9033768|NCT03283098|10096002|FG000|COMPLETED|Overall Study||8
9033769|NCT03283098|10096003|FG001|COMPLETED|Overall Study||24
9033770|NCT03283098|10096002|FG000|NOT COMPLETED|Overall Study||0
9033771|NCT03283098|10096003|FG001|NOT COMPLETED|Overall Study||1
9033772|NCT03283319|10096015|FG000|STARTED|Overall Study||62
8799321|NCT01436370|9850821|FG002|COMPLETED|Overall Study||10
8799322|NCT01436370|9850822|FG003|COMPLETED|Overall Study||10
8917991|NCT02197065|9977849|FG001|NOT COMPLETED|Overall Study||0
8917992|NCT02197078|9977870|FG000|STARTED|Overall Study||14688
8917993|NCT02197078|9977871|FG001|STARTED|Overall Study||14688
8917994|NCT02197078|9977872|FG002|STARTED|Overall Study||10614
8917995|NCT02197078|9977873|FG003|STARTED|Overall Study||10614
8917996|NCT02197078|9977874|FG004|STARTED|Overall Study||9538
8917997|NCT02197078|9977875|FG005|STARTED|Overall Study||9538
8917998|NCT02197078|9977876|FG006|STARTED|Overall Study||25135
8917999|NCT02197078|9977877|FG007|STARTED|Overall Study||25135
8918000|NCT02197078|9977878|FG008|STARTED|Overall Study||18996
8918001|NCT02197078|9977879|FG009|STARTED|Overall Study||18996
8918002|NCT02197078|9977880|FG010|STARTED|Overall Study||15742
8918003|NCT02197078|9977881|FG011|STARTED|Overall Study||15742
8918004|NCT02197078|9977870|FG000|COMPLETED|Overall Study||14688
8918005|NCT02197078|9977871|FG001|COMPLETED|Overall Study||14688
8918006|NCT02197078|9977872|FG002|COMPLETED|Overall Study||10614
8918007|NCT02197078|9977873|FG003|COMPLETED|Overall Study||10614
8918008|NCT02197078|9977874|FG004|COMPLETED|Overall Study||9538
8918009|NCT02197078|9977875|FG005|COMPLETED|Overall Study||9538
8918010|NCT02197078|9977876|FG006|COMPLETED|Overall Study||25135
8918011|NCT02197078|9977877|FG007|COMPLETED|Overall Study||25135
8918012|NCT02197078|9977878|FG008|COMPLETED|Overall Study||18996
8918013|NCT02197078|9977879|FG009|COMPLETED|Overall Study||18996
8918014|NCT02197078|9977880|FG010|COMPLETED|Overall Study||15742
8918015|NCT02197078|9977881|FG011|COMPLETED|Overall Study||15742
8918016|NCT02197078|9977870|FG000|NOT COMPLETED|Overall Study||0
8918017|NCT02197078|9977871|FG001|NOT COMPLETED|Overall Study||0
8918018|NCT02197078|9977872|FG002|NOT COMPLETED|Overall Study||0
8918019|NCT02197078|9977873|FG003|NOT COMPLETED|Overall Study||0
8918020|NCT02197078|9977874|FG004|NOT COMPLETED|Overall Study||0
8918021|NCT02197078|9977875|FG005|NOT COMPLETED|Overall Study||0
8918022|NCT02197078|9977876|FG006|NOT COMPLETED|Overall Study||0
8918023|NCT02197078|9977877|FG007|NOT COMPLETED|Overall Study||0
8918024|NCT02197078|9977878|FG008|NOT COMPLETED|Overall Study||0
8918025|NCT02197078|9977879|FG009|NOT COMPLETED|Overall Study||0
8918026|NCT02197078|9977880|FG010|NOT COMPLETED|Overall Study||0
8918027|NCT02197078|9977881|FG011|NOT COMPLETED|Overall Study||0
8918028|NCT02197130|9977910|FG000|STARTED|Overall Study||95
8918029|NCT02197130|9977911|FG001|STARTED|Overall Study||89
8918030|NCT02197130|9977912|FG002|STARTED|Overall Study||88
8918031|NCT02197130|9977910|FG000|Received Treatment|Overall Study||95
8918032|NCT02197130|9977911|FG001|Received Treatment|Overall Study||88
8918033|NCT02197130|9977912|FG002|Received Treatment|Overall Study||87
8918034|NCT02197130|9977910|FG000|COMPLETED|Overall Study||79
8918035|NCT02197130|9977911|FG001|COMPLETED|Overall Study||81
8918036|NCT02197130|9977912|FG002|COMPLETED|Overall Study||56
8918037|NCT02197130|9977910|FG000|NOT COMPLETED|Overall Study||16
8918038|NCT02197130|9977911|FG001|NOT COMPLETED|Overall Study||8
8918039|NCT02197130|9977912|FG002|NOT COMPLETED|Overall Study||32
8918040|NCT02197247|9977920|FG000|STARTED|Part A: Day 1-28 (AZD9291 Alone)||41
8918041|NCT02197247|9977920|FG000|COMPLETED|Part A: Day 1-28 (AZD9291 Alone)||41
8918042|NCT02197247|9977920|FG000|NOT COMPLETED|Part A: Day 1-28 (AZD9291 Alone)||0
8918043|NCT02197247|9977920|FG000|STARTED|Part A: Day 29-49 (AZD9291+Rifampicin)||41
8918044|NCT02197247|9977920|FG000|COMPLETED|Part A: Day 29-49 (AZD9291+Rifampicin)||37
9033773|NCT03283319|10096016|FG001|STARTED|Overall Study||60
8799323|NCT01436370|9850823|FG004|COMPLETED|Overall Study||18
8799324|NCT01436370|9850824|FG005|COMPLETED|Overall Study||19
8799325|NCT01436370|9850825|FG006|COMPLETED|Overall Study||16
9033774|NCT03283319|10096017|FG002|STARTED|Overall Study||62
8799326|NCT01436370|9850826|FG007|COMPLETED|Overall Study||16
8799327|NCT01436370|9850819|FG000|NOT COMPLETED|Overall Study||0
8799328|NCT01436370|9850820|FG001|NOT COMPLETED|Overall Study||0
8799329|NCT01436370|9850821|FG002|NOT COMPLETED|Overall Study||0
8799330|NCT01436370|9850822|FG003|NOT COMPLETED|Overall Study||0
8799331|NCT01436370|9850823|FG004|NOT COMPLETED|Overall Study||1
8799332|NCT01436370|9850824|FG005|NOT COMPLETED|Overall Study||0
8799333|NCT01436370|9850825|FG006|NOT COMPLETED|Overall Study||0
8799334|NCT01436370|9850826|FG007|NOT COMPLETED|Overall Study||0
8799335|NCT01436435|9850852|FG000|STARTED|Overall Study||241
8799336|NCT01436435|9850852|FG000|COMPLETED|Overall Study||177
8799337|NCT01436435|9850852|FG000|NOT COMPLETED|Overall Study||64
8799338|NCT01436500|9850858|FG000|STARTED|Overall Study||12
8799339|NCT01436500|9850859|FG001|STARTED|Overall Study||12
8799340|NCT01436500|9850860|FG002|STARTED|Overall Study||12
8799341|NCT01436500|9850861|FG003|STARTED|Overall Study||6
8799342|NCT01436500|9850862|FG004|STARTED|Overall Study||13
8799343|NCT01436500|9850858|FG000|COMPLETED|Overall Study||9
8799344|NCT01436500|9850859|FG001|COMPLETED|Overall Study||9
8799345|NCT01436500|9850860|FG002|COMPLETED|Overall Study||7
8799346|NCT01436500|9850861|FG003|COMPLETED|Overall Study||5
8799347|NCT01436500|9850862|FG004|COMPLETED|Overall Study||9
8799348|NCT01436500|9850858|FG000|NOT COMPLETED|Overall Study||3
8799349|NCT01436500|9850859|FG001|NOT COMPLETED|Overall Study||3
8799350|NCT01436500|9850860|FG002|NOT COMPLETED|Overall Study||5
8799351|NCT01436500|9850861|FG003|NOT COMPLETED|Overall Study||1
8799352|NCT01436500|9850862|FG004|NOT COMPLETED|Overall Study||4
8918045|NCT02197247|9977920|FG000|NOT COMPLETED|Part A: Day 29-49 (AZD9291+Rifampicin)||4
8918046|NCT02197247|9977920|FG000|STARTED|Part A: Day 50-77 (AZD9291 Alone)||37
8918047|NCT02197247|9977920|FG000|COMPLETED|Part A: Day 50-77 (AZD9291 Alone)||32
8918048|NCT02197247|9977920|FG000|NOT COMPLETED|Part A: Day 50-77 (AZD9291 Alone)||5
8918049|NCT02197247|9977920|FG000|STARTED|Part B: Day 78 to End Part B (AZD9291)|32 completed Part A + 2 entered Part B without completing Part A (both due to AE) =34 started Part B|34
8918050|NCT02197247|9977920|FG000|COMPLETED|Part B: Day 78 to End Part B (AZD9291)||19
8918051|NCT02197247|9977920|FG000|NOT COMPLETED|Part B: Day 78 to End Part B (AZD9291)||15
8918052|NCT02197273|9977932|FG000|STARTED|Overall Study||107
8918053|NCT02197273|9977933|FG001|STARTED|Overall Study||104
8918054|NCT02197273|9977932|FG000|COMPLETED|Overall Study||107
8918055|NCT02197273|9977933|FG001|COMPLETED|Overall Study||104
8918056|NCT02197273|9977932|FG000|NOT COMPLETED|Overall Study||0
8918057|NCT02197273|9977933|FG001|NOT COMPLETED|Overall Study||0
8918058|NCT02197377|9977941|FG000|STARTED|Overall Study||30
8918059|NCT02197377|9977942|FG001|STARTED|Overall Study||30
8918060|NCT02197377|9977941|FG000|COMPLETED|Overall Study||30
8918061|NCT02197377|9977942|FG001|COMPLETED|Overall Study||27
8918062|NCT02197377|9977941|FG000|NOT COMPLETED|Overall Study||0
8918063|NCT02197377|9977942|FG001|NOT COMPLETED|Overall Study||3
8918064|NCT02197416|9977951|FG000|STARTED|Overall Study||9
8918065|NCT02197416|9977952|FG001|STARTED|Overall Study||43
8918066|NCT02197416|9977953|FG002|STARTED|Overall Study||161
8918067|NCT02197416|9977951|FG000|COMPLETED|Overall Study||8
8918068|NCT02197416|9977952|FG001|COMPLETED|Overall Study||39
8918069|NCT02197416|9977953|FG002|COMPLETED|Overall Study||153
8918070|NCT02197416|9977951|FG000|NOT COMPLETED|Overall Study||1
8918071|NCT02197416|9977952|FG001|NOT COMPLETED|Overall Study||4
8918072|NCT02197416|9977953|FG002|NOT COMPLETED|Overall Study||8
8918073|NCT02197455|9977959|FG000|STARTED|Overall Study||30
8918074|NCT02197455|9977959|FG000|COMPLETED|Overall Study||30
8918075|NCT02197455|9977959|FG000|NOT COMPLETED|Overall Study||0
8918076|NCT02197481|9977965|FG000|STARTED|Overall Study|October 2014|43
8918077|NCT02197481|9977966|FG001|STARTED|Overall Study||43
8918078|NCT02197481|9977965|FG000|COMPLETED|Overall Study|February 2016|43
8918079|NCT02197481|9977966|FG001|COMPLETED|Overall Study||43
8918080|NCT02197481|9977965|FG000|NOT COMPLETED|Overall Study||0
8918081|NCT02197481|9977966|FG001|NOT COMPLETED|Overall Study||0
8918082|NCT02197520|9977972|FG000|STARTED|Period 1||12
8918083|NCT02197520|9977973|FG001|STARTED|Period 1||12
8918084|NCT02197520|9977972|FG000|COMPLETED|Period 1||11
8918085|NCT02197520|9977973|FG001|COMPLETED|Period 1||12
8918086|NCT02197520|9977972|FG000|NOT COMPLETED|Period 1||1
8918087|NCT02197520|9977973|FG001|NOT COMPLETED|Period 1||0
8918088|NCT02197520|9977972|FG000|STARTED|Period 2||11
8918089|NCT02197520|9977973|FG001|STARTED|Period 2||12
8918090|NCT02197520|9977972|FG000|COMPLETED|Period 2||10
8918091|NCT02197520|9977973|FG001|COMPLETED|Period 2||10
8918092|NCT02197520|9977972|FG000|NOT COMPLETED|Period 2||1
8918093|NCT02197520|9977973|FG001|NOT COMPLETED|Period 2||2
8918094|NCT02197572|9977981|FG000|STARTED|Overall Study||44
8918095|NCT02197572|9977981|FG000|COMPLETED|Overall Study||0
8918096|NCT02197572|9977981|FG000|NOT COMPLETED|Overall Study||44
8918097|NCT02197767|9977985|FG000|STARTED|Overall Study||11
8918098|NCT02197767|9977985|FG000|COMPLETED|Overall Study||11
8918099|NCT02197767|9977985|FG000|NOT COMPLETED|Overall Study||0
8918100|NCT02197806|9977993|FG000|STARTED|Overall Study||15
8918101|NCT02197806|9977994|FG001|STARTED|Overall Study||17
8918102|NCT02197806|9977995|FG002|STARTED|Overall Study||16
8918103|NCT02197806|9977996|FG003|STARTED|Overall Study||17
8918104|NCT02197806|9977993|FG000|COMPLETED|Overall Study||15
8799353|NCT01436526|9850877|FG000|STARTED|Period 1||14
8799354|NCT01436526|9850878|FG001|STARTED|Period 1||14
8799355|NCT01436526|9850877|FG000|Participants Received Treatment|Period 1||14
8799356|NCT01436526|9850878|FG001|Participants Received Treatment|Period 1||14
8799357|NCT01436526|9850877|FG000|COMPLETED|Period 1||14
8799358|NCT01436526|9850878|FG001|COMPLETED|Period 1||14
8799359|NCT01436526|9850877|FG000|NOT COMPLETED|Period 1||0
8799360|NCT01436526|9850878|FG001|NOT COMPLETED|Period 1||0
8799361|NCT01436526|9850877|FG000|STARTED|Period 2|1 participant withdrew his consent after completing the first period.|13
8799362|NCT01436526|9850878|FG001|STARTED|Period 2|1 participant withdrew his consent after completing the first period.|13
8799363|NCT01436526|9850877|FG000|Participants Received Treatment|Period 2||13
8799364|NCT01436526|9850878|FG001|Participants Received Treatment|Period 2||13
8799365|NCT01436526|9850877|FG000|COMPLETED|Period 2||13
8799366|NCT01436526|9850878|FG001|COMPLETED|Period 2||13
8799367|NCT01436526|9850877|FG000|NOT COMPLETED|Period 2||0
8799368|NCT01436526|9850878|FG001|NOT COMPLETED|Period 2||0
8799369|NCT01436643|9850887|FG000|STARTED|2-week Pre-treatment||0
8799370|NCT01436643|9850888|FG001|STARTED|2-week Pre-treatment||0
8799371|NCT01436643|9850889|FG002|STARTED|2-week Pre-treatment||0
8799372|NCT01436643|9850890|FG003|STARTED|2-week Pre-treatment||54
8799373|NCT01436643|9850887|FG000|COMPLETED|2-week Pre-treatment||0
8799374|NCT01436643|9850888|FG001|COMPLETED|2-week Pre-treatment||0
8799375|NCT01436643|9850889|FG002|COMPLETED|2-week Pre-treatment||0
8799376|NCT01436643|9850890|FG003|COMPLETED|2-week Pre-treatment||44
8799377|NCT01436643|9850887|FG000|NOT COMPLETED|2-week Pre-treatment||0
8799378|NCT01436643|9850888|FG001|NOT COMPLETED|2-week Pre-treatment||0
8799379|NCT01436643|9850889|FG002|NOT COMPLETED|2-week Pre-treatment||0
8799380|NCT01436643|9850890|FG003|NOT COMPLETED|2-week Pre-treatment||10
8799381|NCT01436643|9850887|FG000|STARTED|Core Phase (16 Weeks)||17
8799382|NCT01436643|9850888|FG001|STARTED|Core Phase (16 Weeks)||15
8799383|NCT01436643|9850889|FG002|STARTED|Core Phase (16 Weeks)||20
8799384|NCT01436643|9850890|FG003|STARTED|Core Phase (16 Weeks)||0
8799385|NCT01436643|9850887|FG000|COMPLETED|Core Phase (16 Weeks)||16
8799386|NCT01436643|9850888|FG001|COMPLETED|Core Phase (16 Weeks)||11
8799387|NCT01436643|9850889|FG002|COMPLETED|Core Phase (16 Weeks)||17
8799388|NCT01436643|9850890|FG003|COMPLETED|Core Phase (16 Weeks)||0
8799389|NCT01436643|9850887|FG000|NOT COMPLETED|Core Phase (16 Weeks)||1
8799390|NCT01436643|9850888|FG001|NOT COMPLETED|Core Phase (16 Weeks)||4
8799391|NCT01436643|9850889|FG002|NOT COMPLETED|Core Phase (16 Weeks)||3
8799392|NCT01436643|9850890|FG003|NOT COMPLETED|Core Phase (16 Weeks)||0
8799393|NCT01436799|9850902|FG000|STARTED|Overall Study||20
8799394|NCT01436799|9850903|FG001|STARTED|Overall Study||20
8799395|NCT01436799|9850902|FG000|COMPLETED|Overall Study||20
8799396|NCT01436799|9850903|FG001|COMPLETED|Overall Study||20
8799397|NCT01436799|9850902|FG000|NOT COMPLETED|Overall Study||0
8799398|NCT01436799|9850903|FG001|NOT COMPLETED|Overall Study||0
8799399|NCT01437098|9850909|FG000|STARTED|Overall Study||55
8799400|NCT01437098|9850909|FG000|30 Days|Overall Study||51
8799401|NCT01437098|9850909|FG000|6 Months|Overall Study||47
8799402|NCT01437098|9850909|FG000|12 Months|Overall Study||45
8799403|NCT01437098|9850909|FG000|24 Months|Overall Study||42
8799404|NCT01437098|9850909|FG000|36 Months|Overall Study||36
8799405|NCT01437098|9850909|FG000|COMPLETED|Overall Study||42
8799406|NCT01437098|9850909|FG000|NOT COMPLETED|Overall Study||13
8799407|NCT01437124|9850921|FG000|STARTED|Overall Study||83
8799408|NCT01437124|9850921|FG000|COMPLETED|Overall Study||83
8799409|NCT01437124|9850921|FG000|NOT COMPLETED|Overall Study||0
8799410|NCT01437267|9850931|FG000|STARTED|Overall Study||20
8799411|NCT01437267|9850932|FG001|STARTED|Overall Study||20
8799412|NCT01437267|9850933|FG002|STARTED|Overall Study||20
8799413|NCT01437267|9850934|FG003|STARTED|Overall Study||20
8799414|NCT01437267|9850935|FG004|STARTED|Overall Study||20
8799415|NCT01437267|9850936|FG005|STARTED|Overall Study||20
8799416|NCT01437267|9850931|FG000|COMPLETED|Overall Study||20
8799417|NCT01437267|9850932|FG001|COMPLETED|Overall Study||19
8799418|NCT01437267|9850933|FG002|COMPLETED|Overall Study||20
8799419|NCT01437267|9850934|FG003|COMPLETED|Overall Study||19
8799420|NCT01437267|9850935|FG004|COMPLETED|Overall Study||20
8799421|NCT01437267|9850936|FG005|COMPLETED|Overall Study||20
8799422|NCT01437267|9850931|FG000|NOT COMPLETED|Overall Study||0
8799423|NCT01437267|9850932|FG001|NOT COMPLETED|Overall Study||1
8799424|NCT01437267|9850933|FG002|NOT COMPLETED|Overall Study||0
8799425|NCT01437267|9850934|FG003|NOT COMPLETED|Overall Study||1
8799426|NCT01437267|9850935|FG004|NOT COMPLETED|Overall Study||0
8799427|NCT01437267|9850936|FG005|NOT COMPLETED|Overall Study||0
8799428|NCT01437319|9850950|FG000|STARTED|Phase I||282
8799429|NCT01437319|9850951|FG001|STARTED|Phase I||0
8799430|NCT01437319|9850952|FG002|STARTED|Phase I||0
8799431|NCT01437319|9850950|FG000|COMPLETED|Phase I||227
8799432|NCT01437319|9850951|FG001|COMPLETED|Phase I||0
8799433|NCT01437319|9850952|FG002|COMPLETED|Phase I||0
8799434|NCT01437319|9850950|FG000|NOT COMPLETED|Phase I||55
8799435|NCT01437319|9850951|FG001|NOT COMPLETED|Phase I||0
8799436|NCT01437319|9850952|FG002|NOT COMPLETED|Phase I||0
8799437|NCT01437319|9850950|FG000|STARTED|Phase II||0
8799438|NCT01437319|9850951|FG001|STARTED|Phase II||115
8799439|NCT01437319|9850952|FG002|STARTED|Phase II||112
8799440|NCT01437319|9850950|FG000|COMPLETED|Phase II||0
8799441|NCT01437319|9850951|FG001|COMPLETED|Phase II||71
8799442|NCT01437319|9850952|FG002|COMPLETED|Phase II||75
8799443|NCT01437319|9850950|FG000|NOT COMPLETED|Phase II||0
8799444|NCT01437319|9850951|FG001|NOT COMPLETED|Phase II||44
8799445|NCT01437319|9850952|FG002|NOT COMPLETED|Phase II||37
9033775|NCT03283319|10096018|FG003|STARTED|Overall Study||61
9033776|NCT03283319|10096019|FG004|STARTED|Overall Study||60
9033777|NCT03283319|10096020|FG005|STARTED|Overall Study||61
9033778|NCT03283319|10096015|FG000|COMPLETED|Overall Study||55
9033779|NCT03283319|10096016|FG001|COMPLETED|Overall Study||54
9033780|NCT03283319|10096017|FG002|COMPLETED|Overall Study||55
9033781|NCT03283319|10096018|FG003|COMPLETED|Overall Study||54
9033782|NCT03283319|10096019|FG004|COMPLETED|Overall Study||56
9033783|NCT03283319|10096020|FG005|COMPLETED|Overall Study||57
9033784|NCT03283319|10096015|FG000|NOT COMPLETED|Overall Study||7
9033785|NCT03283319|10096016|FG001|NOT COMPLETED|Overall Study||6
9033786|NCT03283319|10096017|FG002|NOT COMPLETED|Overall Study||7
9033787|NCT03283319|10096018|FG003|NOT COMPLETED|Overall Study||7
9033788|NCT03283319|10096019|FG004|NOT COMPLETED|Overall Study||4
9033789|NCT03283319|10096020|FG005|NOT COMPLETED|Overall Study||4
9033790|NCT03283436|10096036|FG000|STARTED|Overall Study||50
9033791|NCT03283436|10096037|FG001|STARTED|Overall Study||50
9033792|NCT03283436|10096036|FG000|COMPLETED|Overall Study||44
9033793|NCT03283436|10096037|FG001|COMPLETED|Overall Study||50
9033794|NCT03283436|10096036|FG000|NOT COMPLETED|Overall Study||6
9033795|NCT03283436|10096037|FG001|NOT COMPLETED|Overall Study||0
9033796|NCT03283553|10096045|FG000|STARTED|Patient Participant Flow||69
9033797|NCT03283553|10096046|FG001|STARTED|Patient Participant Flow||63
9033798|NCT03283553|10096045|FG000|Patient Baseline Interview|Patient Participant Flow||69
9033799|NCT03283553|10096046|FG001|Patient Baseline Interview|Patient Participant Flow||62
9033800|NCT03283553|10096045|FG000|Patient 3-Month Interview|Patient Participant Flow||67
9033801|NCT03283553|10096046|FG001|Patient 3-Month Interview|Patient Participant Flow||60
9033802|NCT03283553|10096045|FG000|Patient 9-Month Interview|Patient Participant Flow||63
9033803|NCT03283553|10096046|FG001|Patient 9-Month Interview|Patient Participant Flow||57
9033804|NCT03283553|10096045|FG000|Patient 12-Month Interview|Patient Participant Flow||59
9033805|NCT03283553|10096046|FG001|Patient 12-Month Interview|Patient Participant Flow||50
9033806|NCT03283553|10096045|FG000|COMPLETED|Patient Participant Flow||59
9033807|NCT03283553|10096046|FG001|COMPLETED|Patient Participant Flow||50
9033808|NCT03283553|10096045|FG000|NOT COMPLETED|Patient Participant Flow||10
9033809|NCT03283553|10096046|FG001|NOT COMPLETED|Patient Participant Flow||13
9033810|NCT03283553|10096045|FG000|STARTED|Care Partner Participant Flow||69
9033811|NCT03283553|10096046|FG001|STARTED|Care Partner Participant Flow||63
9033812|NCT03283553|10096045|FG000|Care Partner Baseline Interview|Care Partner Participant Flow||69
9033813|NCT03283553|10096046|FG001|Care Partner Baseline Interview|Care Partner Participant Flow||63
9033814|NCT03283553|10096045|FG000|Care Partner 3-Month Interview|Care Partner Participant Flow||69
9033815|NCT03283553|10096046|FG001|Care Partner 3-Month Interview|Care Partner Participant Flow||60
9033816|NCT03283553|10096045|FG000|Care Partner 9-Month Interview|Care Partner Participant Flow||64
9033817|NCT03283553|10096046|FG001|Care Partner 9-Month Interview|Care Partner Participant Flow||55
9033818|NCT03283553|10096045|FG000|Care Partner 12-Month Interview|Care Partner Participant Flow||59
9033819|NCT03283553|10096046|FG001|Care Partner 12-Month Interview|Care Partner Participant Flow||48
9033820|NCT03283553|10096045|FG000|COMPLETED|Care Partner Participant Flow||59
9033821|NCT03283553|10096046|FG001|COMPLETED|Care Partner Participant Flow||48
9033822|NCT03283553|10096045|FG000|NOT COMPLETED|Care Partner Participant Flow||10
9033823|NCT03283553|10096046|FG001|NOT COMPLETED|Care Partner Participant Flow||15
9033824|NCT03283696|10096056|FG000|STARTED|Overall Study||16
9033825|NCT03283696|10096057|FG001|STARTED|Overall Study||8
9033826|NCT03283696|10096056|FG000|Received at Least 1 Dose of Study Drug|Overall Study||16
9033827|NCT03283696|10096057|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8
9033828|NCT03283696|10096056|FG000|COMPLETED|Overall Study||9
9033829|NCT03283696|10096057|FG001|COMPLETED|Overall Study||2
9033830|NCT03283696|10096056|FG000|NOT COMPLETED|Overall Study||7
9033831|NCT03283696|10096057|FG001|NOT COMPLETED|Overall Study||6
9033832|NCT03283787|10096066|FG000|STARTED|Overall Study||20
9033833|NCT03283787|10096067|FG001|STARTED|Overall Study||20
9033834|NCT03283787|10096068|FG002|STARTED|Overall Study||20
9033835|NCT03283787|10096066|FG000|COMPLETED|Overall Study||17
9033836|NCT03283787|10096067|FG001|COMPLETED|Overall Study||13
9033837|NCT03283787|10096068|FG002|COMPLETED|Overall Study||13
9033838|NCT03283787|10096066|FG000|NOT COMPLETED|Overall Study||3
9033839|NCT03283787|10096067|FG001|NOT COMPLETED|Overall Study||7
9033840|NCT03283787|10096068|FG002|NOT COMPLETED|Overall Study||7
9033841|NCT03284229|10096079|FG000|STARTED|Overall Study||28
9033842|NCT03284229|10096079|FG000|COMPLETED|Overall Study||25
9033843|NCT03284229|10096079|FG000|NOT COMPLETED|Overall Study||3
9033844|NCT03284359|10096086|FG000|STARTED|Overall Study||93
9033845|NCT03284359|10096087|FG001|STARTED|Overall Study||89
9033846|NCT03284359|10096086|FG000|COMPLETED|Overall Study||93
9033847|NCT03284359|10096087|FG001|COMPLETED|Overall Study||89
9033848|NCT03284359|10096086|FG000|NOT COMPLETED|Overall Study||0
9033849|NCT03284359|10096087|FG001|NOT COMPLETED|Overall Study||0
9033850|NCT03284398|10096095|FG000|STARTED|Overall Study||2753
9033851|NCT03284398|10096096|FG001|STARTED|Overall Study||970
9033852|NCT03284398|10096095|FG000|COMPLETED|Overall Study||2753
9033853|NCT03284398|10096096|FG001|COMPLETED|Overall Study||970
9033854|NCT03284398|10096095|FG000|NOT COMPLETED|Overall Study||0
9033855|NCT03284398|10096096|FG001|NOT COMPLETED|Overall Study||0
9033856|NCT03284411|10096108|FG000|STARTED|Overall Study||30
9033857|NCT03284411|10096108|FG000|COMPLETED|Overall Study||30
8799446|NCT01437397|9850966|FG000|STARTED|Overall Study||338
8799447|NCT01437397|9850967|FG001|STARTED|Overall Study||338
8799448|NCT01437397|9850968|FG002|STARTED|Overall Study||340
8799449|NCT01437397|9850969|FG003|STARTED|Overall Study||339
8799450|NCT01437397|9850970|FG004|STARTED|Overall Study||337
8799451|NCT01437397|9850966|FG000|COMPLETED|Overall Study||272
8799452|NCT01437397|9850967|FG001|COMPLETED|Overall Study||276
8799453|NCT01437397|9850968|FG002|COMPLETED|Overall Study||268
8799454|NCT01437397|9850969|FG003|COMPLETED|Overall Study||270
8799455|NCT01437397|9850970|FG004|COMPLETED|Overall Study||236
8799456|NCT01437397|9850966|FG000|NOT COMPLETED|Overall Study||66
8799457|NCT01437397|9850967|FG001|NOT COMPLETED|Overall Study||62
8799458|NCT01437397|9850968|FG002|NOT COMPLETED|Overall Study||72
8799459|NCT01437397|9850969|FG003|NOT COMPLETED|Overall Study||69
8799460|NCT01437397|9850970|FG004|NOT COMPLETED|Overall Study||101
8799461|NCT01437449|9850982|FG000|STARTED|Overall Study||27
8799462|NCT01437449|9850982|FG000|COMPLETED|Overall Study||27
8918105|NCT02197806|9977994|FG001|COMPLETED|Overall Study||16
8918106|NCT02197806|9977995|FG002|COMPLETED|Overall Study||16
8918107|NCT02197806|9977996|FG003|COMPLETED|Overall Study||16
8918108|NCT02197806|9977993|FG000|NOT COMPLETED|Overall Study||0
8918109|NCT02197806|9977994|FG001|NOT COMPLETED|Overall Study||1
8918110|NCT02197806|9977995|FG002|NOT COMPLETED|Overall Study||0
8918111|NCT02197806|9977996|FG003|NOT COMPLETED|Overall Study||1
8918112|NCT02197897|9978006|FG000|STARTED|Overall Study||15
8918113|NCT02197897|9978006|FG000|COMPLETED|Overall Study||14
8918114|NCT02197897|9978006|FG000|NOT COMPLETED|Overall Study||1
8918115|NCT02198040|9978013|FG000|STARTED|Overall Study||9
8918116|NCT02198040|9978014|FG001|STARTED|Overall Study||9
8918117|NCT02198040|9978015|FG002|STARTED|Overall Study||9
8918118|NCT02198040|9978013|FG000|COMPLETED|Overall Study||9
8918119|NCT02198040|9978014|FG001|COMPLETED|Overall Study||8
8918120|NCT02198040|9978015|FG002|COMPLETED|Overall Study||8
8918121|NCT02198040|9978013|FG000|NOT COMPLETED|Overall Study||0
8918122|NCT02198040|9978014|FG001|NOT COMPLETED|Overall Study||1
8918123|NCT02198040|9978015|FG002|NOT COMPLETED|Overall Study||1
8918124|NCT02198235|9978028|FG000|STARTED|Overall Study||30
8918125|NCT02198235|9978029|FG001|STARTED|Overall Study||30
8918126|NCT02198235|9978030|FG002|STARTED|Overall Study||30
8918127|NCT02198235|9978028|FG000|COMPLETED|Overall Study||27
8918128|NCT02198235|9978029|FG001|COMPLETED|Overall Study||28
8918129|NCT02198235|9978030|FG002|COMPLETED|Overall Study||28
8918130|NCT02198235|9978028|FG000|NOT COMPLETED|Overall Study||3
8918131|NCT02198235|9978029|FG001|NOT COMPLETED|Overall Study||2
8918132|NCT02198235|9978030|FG002|NOT COMPLETED|Overall Study||2
8918133|NCT02198430|9978040|FG000|STARTED|Overall Study||53
8918134|NCT02198430|9978041|FG001|STARTED|Overall Study||51
8918135|NCT02198430|9978040|FG000|COMPLETED|Overall Study||53
8918136|NCT02198430|9978041|FG001|COMPLETED|Overall Study||51
8918137|NCT02198430|9978040|FG000|NOT COMPLETED|Overall Study||0
8918138|NCT02198430|9978041|FG001|NOT COMPLETED|Overall Study||0
8918139|NCT02198651|9978047|FG000|STARTED|Lead-in Period||149
8918140|NCT02198651|9978048|FG001|STARTED|Lead-in Period||0
8918141|NCT02198651|9978049|FG002|STARTED|Lead-in Period||0
8918142|NCT02198651|9978050|FG003|STARTED|Lead-in Period||0
8918143|NCT02198651|9978051|FG004|STARTED|Lead-in Period||0
8918144|NCT02198651|9978047|FG000|Participants Treated in Lead-In Period|Lead-in Period||146
8918145|NCT02198651|9978048|FG001|Participants Treated in Lead-In Period|Lead-in Period||0
8918146|NCT02198651|9978049|FG002|Participants Treated in Lead-In Period|Lead-in Period||0
8918147|NCT02198651|9978050|FG003|Participants Treated in Lead-In Period|Lead-in Period||0
8918148|NCT02198651|9978051|FG004|Participants Treated in Lead-In Period|Lead-in Period||0
8672191|NCT00756002|9715675|FG000|STARTED|Placebo Run-out||114
8918149|NCT02198651|9978047|FG000|COMPLETED|Lead-in Period||112
8918150|NCT02198651|9978048|FG001|COMPLETED|Lead-in Period||0
8918151|NCT02198651|9978049|FG002|COMPLETED|Lead-in Period||0
8918152|NCT02198651|9978050|FG003|COMPLETED|Lead-in Period||0
8918153|NCT02198651|9978051|FG004|COMPLETED|Lead-in Period||0
8918154|NCT02198651|9978047|FG000|NOT COMPLETED|Lead-in Period||37
8918155|NCT02198651|9978048|FG001|NOT COMPLETED|Lead-in Period||0
8918156|NCT02198651|9978049|FG002|NOT COMPLETED|Lead-in Period||0
8918157|NCT02198651|9978050|FG003|NOT COMPLETED|Lead-in Period||0
8918158|NCT02198651|9978051|FG004|NOT COMPLETED|Lead-in Period||0
8918159|NCT02198651|9978047|FG000|STARTED|Double-blind Period||0
8918160|NCT02198651|9978048|FG001|STARTED|Double-blind Period||102
9033858|NCT03284411|10096108|FG000|NOT COMPLETED|Overall Study||0
8799463|NCT01437449|9850982|FG000|NOT COMPLETED|Overall Study||0
8799464|NCT01437488|9850986|FG000|STARTED|Overall Study||14
8799465|NCT01437488|9850986|FG000|COMPLETED|Overall Study||14
8799466|NCT01437488|9850986|FG000|NOT COMPLETED|Overall Study||0
8918161|NCT02198651|9978049|FG002|STARTED|Double-blind Period||20
8918162|NCT02198651|9978050|FG003|STARTED|Double-blind Period||0
8918163|NCT02198651|9978051|FG004|STARTED|Double-blind Period||0
8918164|NCT02198651|9978047|FG000|COMPLETED|Double-blind Period||0
8918165|NCT02198651|9978048|FG001|COMPLETED|Double-blind Period||93
8918166|NCT02198651|9978049|FG002|COMPLETED|Double-blind Period||19
8918167|NCT02198651|9978050|FG003|COMPLETED|Double-blind Period||0
8918168|NCT02198651|9978051|FG004|COMPLETED|Double-blind Period||0
8918169|NCT02198651|9978047|FG000|NOT COMPLETED|Double-blind Period||0
8918170|NCT02198651|9978048|FG001|NOT COMPLETED|Double-blind Period||9
8918171|NCT02198651|9978049|FG002|NOT COMPLETED|Double-blind Period||1
8918172|NCT02198651|9978050|FG003|NOT COMPLETED|Double-blind Period||0
8918173|NCT02198651|9978051|FG004|NOT COMPLETED|Double-blind Period||0
8918174|NCT02198651|9978047|FG000|STARTED|Open-label Rescue Period||0
8918175|NCT02198651|9978048|FG001|STARTED|Open-label Rescue Period||0
8918176|NCT02198651|9978049|FG002|STARTED|Open-label Rescue Period||0
8918177|NCT02198651|9978050|FG003|STARTED|Open-label Rescue Period||31
8918178|NCT02198651|9978051|FG004|STARTED|Open-label Rescue Period||8
8918179|NCT02198651|9978047|FG000|Correctly Entered Open-label Rescue|Open-label Rescue Period||0
8918180|NCT02198651|9978048|FG001|Correctly Entered Open-label Rescue|Open-label Rescue Period||0
8918181|NCT02198651|9978049|FG002|Correctly Entered Open-label Rescue|Open-label Rescue Period||0
8918182|NCT02198651|9978050|FG003|Correctly Entered Open-label Rescue|Open-label Rescue Period||30
8918183|NCT02198651|9978051|FG004|Correctly Entered Open-label Rescue|Open-label Rescue Period||8
8918184|NCT02198651|9978047|FG000|COMPLETED|Open-label Rescue Period||0
8918185|NCT02198651|9978048|FG001|COMPLETED|Open-label Rescue Period||0
8918186|NCT02198651|9978049|FG002|COMPLETED|Open-label Rescue Period||0
8918187|NCT02198651|9978050|FG003|COMPLETED|Open-label Rescue Period||28
8918188|NCT02198651|9978051|FG004|COMPLETED|Open-label Rescue Period||8
8918189|NCT02198651|9978047|FG000|NOT COMPLETED|Open-label Rescue Period||0
8918190|NCT02198651|9978048|FG001|NOT COMPLETED|Open-label Rescue Period||0
8918191|NCT02198651|9978049|FG002|NOT COMPLETED|Open-label Rescue Period||0
8918192|NCT02198651|9978050|FG003|NOT COMPLETED|Open-label Rescue Period||3
8918193|NCT02198651|9978051|FG004|NOT COMPLETED|Open-label Rescue Period||0
8918194|NCT02198664|9978066|FG000|STARTED|Overall Study||26
8918195|NCT02198664|9978067|FG001|STARTED|Overall Study||21
8918196|NCT02198664|9978066|FG000|COMPLETED|Overall Study||10
8918197|NCT02198664|9978067|FG001|COMPLETED|Overall Study||13
8918198|NCT02198664|9978066|FG000|NOT COMPLETED|Overall Study||16
8918199|NCT02198664|9978067|FG001|NOT COMPLETED|Overall Study||8
8918200|NCT02198963|9978075|FG000|STARTED|Overall Study||43
8918201|NCT02198963|9978075|FG000|COMPLETED|Overall Study||36
8918202|NCT02198963|9978075|FG000|NOT COMPLETED|Overall Study||7
8918203|NCT02199028|9978086|FG000|STARTED|Week 1||15
8918204|NCT02199028|9978087|FG001|STARTED|Week 1||15
8918205|NCT02199028|9978086|FG000|COMPLETED|Week 1||14
8918206|NCT02199028|9978087|FG001|COMPLETED|Week 1||15
8918207|NCT02199028|9978086|FG000|NOT COMPLETED|Week 1||1
8918208|NCT02199028|9978087|FG001|NOT COMPLETED|Week 1||0
8918209|NCT02199028|9978086|FG000|STARTED|Week 2||14
8918210|NCT02199028|9978087|FG001|STARTED|Week 2||15
8918211|NCT02199028|9978086|FG000|COMPLETED|Week 2||14
8918212|NCT02199028|9978087|FG001|COMPLETED|Week 2||15
8918213|NCT02199028|9978086|FG000|NOT COMPLETED|Week 2||0
8918214|NCT02199028|9978087|FG001|NOT COMPLETED|Week 2||0
8918215|NCT02199028|9978086|FG000|STARTED|Week 3||14
8918216|NCT02199028|9978087|FG001|STARTED|Week 3||15
8918217|NCT02199028|9978086|FG000|COMPLETED|Week 3||13
8918218|NCT02199028|9978087|FG001|COMPLETED|Week 3||15
8918219|NCT02199028|9978086|FG000|NOT COMPLETED|Week 3||1
8918220|NCT02199028|9978087|FG001|NOT COMPLETED|Week 3||0
8918221|NCT02199028|9978086|FG000|STARTED|Week 4||13
8918222|NCT02199028|9978087|FG001|STARTED|Week 4||15
8918223|NCT02199028|9978086|FG000|COMPLETED|Week 4||13
8918224|NCT02199028|9978087|FG001|COMPLETED|Week 4||15
8918225|NCT02199028|9978086|FG000|NOT COMPLETED|Week 4||0
8918226|NCT02199028|9978087|FG001|NOT COMPLETED|Week 4||0
8918227|NCT02199041|9978094|FG000|STARTED|Overall Study||12
8918228|NCT02199041|9978094|FG000|COMPLETED|Overall Study||12
8918229|NCT02199041|9978094|FG000|NOT COMPLETED|Overall Study||0
8918230|NCT02199080|9978099|FG000|STARTED|Overall Study||2506
8918231|NCT02199080|9978099|FG000|COMPLETED|Overall Study||2494
8918232|NCT02199080|9978099|FG000|NOT COMPLETED|Overall Study||12
8918233|NCT02199197|9978107|FG000|STARTED|Overall Study||35
8918234|NCT02199197|9978108|FG001|STARTED|Overall Study||14
8918235|NCT02199197|9978107|FG000|COMPLETED|Overall Study||35
8918236|NCT02199197|9978108|FG001|COMPLETED|Overall Study||12
8918237|NCT02199197|9978107|FG000|NOT COMPLETED|Overall Study||0
8918238|NCT02199197|9978108|FG001|NOT COMPLETED|Overall Study||2
8918239|NCT02199314|9978115|FG000|STARTED|Overall Study||30
8918240|NCT02199314|9978115|FG000|COMPLETED|Overall Study||14
8918241|NCT02199314|9978115|FG000|NOT COMPLETED|Overall Study||16
8918242|NCT02199496|9978121|FG000|STARTED|Ustekinumab-Single Dose||3
8918243|NCT02199496|9978122|FG001|STARTED|Ustekinumab-Single Dose||0
8918244|NCT02199496|9978121|FG000|COMPLETED|Ustekinumab-Single Dose||3
8918245|NCT02199496|9978122|FG001|COMPLETED|Ustekinumab-Single Dose||0
8918246|NCT02199496|9978121|FG000|NOT COMPLETED|Ustekinumab-Single Dose||0
8918247|NCT02199496|9978122|FG001|NOT COMPLETED|Ustekinumab-Single Dose||0
8918248|NCT02199496|9978121|FG000|STARTED|Ustekinumab-Multi-dose||3
8918249|NCT02199496|9978122|FG001|STARTED|Ustekinumab-Multi-dose|Cohort 2 only participated in multi-dose phase 2|2
8918250|NCT02199496|9978121|FG000|COMPLETED|Ustekinumab-Multi-dose||3
8918251|NCT02199496|9978122|FG001|COMPLETED|Ustekinumab-Multi-dose||2
8918252|NCT02199496|9978121|FG000|NOT COMPLETED|Ustekinumab-Multi-dose||0
8918253|NCT02199496|9978122|FG001|NOT COMPLETED|Ustekinumab-Multi-dose||0
8918254|NCT02199509|9978130|FG000|STARTED|Overall Study||3
8918255|NCT02199509|9978131|FG001|STARTED|Overall Study||4
8918256|NCT02199509|9978130|FG000|COMPLETED|Overall Study||2
8918257|NCT02199509|9978131|FG001|COMPLETED|Overall Study||3
8918258|NCT02199509|9978130|FG000|NOT COMPLETED|Overall Study||1
8918259|NCT02199509|9978131|FG001|NOT COMPLETED|Overall Study||1
8918260|NCT02199574|9978141|FG000|STARTED|Overall Study||12
8918261|NCT02199574|9978141|FG000|COMPLETED|Overall Study||12
8918262|NCT02199574|9978141|FG000|NOT COMPLETED|Overall Study||0
8918263|NCT02199652|9978149|FG000|STARTED|Overall Study||10
8918264|NCT02199652|9978150|FG001|STARTED|Overall Study||10
8918265|NCT02199652|9978149|FG000|COMPLETED|Overall Study||3
8918266|NCT02199652|9978150|FG001|COMPLETED|Overall Study||3
8918267|NCT02199652|9978149|FG000|NOT COMPLETED|Overall Study||7
8918268|NCT02199652|9978150|FG001|NOT COMPLETED|Overall Study||7
8918269|NCT02199717|9978156|FG000|STARTED|Overall Study||66
8918270|NCT02199717|9978156|FG000|COMPLETED|Overall Study||66
8918271|NCT02199717|9978156|FG000|NOT COMPLETED|Overall Study||0
8918272|NCT02199743|9978163|FG000|STARTED|Overall Study||14
9033859|NCT03284424|10096115|FG000|STARTED|Overall Study||105
9033860|NCT03284424|10096116|FG001|STARTED|Overall Study||54
9033861|NCT03284424|10096115|FG000|COMPLETED|Overall Study||0
9033862|NCT03284424|10096116|FG001|COMPLETED|Overall Study||0
9033863|NCT03284424|10096115|FG000|NOT COMPLETED|Overall Study||105
9033864|NCT03284424|10096116|FG001|NOT COMPLETED|Overall Study||54
9033865|NCT03284710|10096125|FG000|STARTED|Overall Study||36
9033866|NCT03284710|10096126|FG001|STARTED|Overall Study||36
9033867|NCT03284710|10096127|FG002|STARTED|Overall Study||36
9033868|NCT03284710|10096128|FG003|STARTED|Overall Study||24
9033869|NCT03284710|10096125|FG000|Month 6.5 Immunogenicity Timepoint|Overall Study||31
9033870|NCT03284710|10096126|FG001|Month 6.5 Immunogenicity Timepoint|Overall Study||31
9033871|NCT03284710|10096127|FG002|Month 6.5 Immunogenicity Timepoint|Overall Study||31
9033872|NCT03284710|10096128|FG003|Month 6.5 Immunogenicity Timepoint|Overall Study||18
9033873|NCT03284710|10096125|FG000|Month 12 Immunogenicity Timepoint|Overall Study||30
9033874|NCT03284710|10096126|FG001|Month 12 Immunogenicity Timepoint|Overall Study||31
9033875|NCT03284710|10096127|FG002|Month 12 Immunogenicity Timepoint|Overall Study||31
9033876|NCT03284710|10096128|FG003|Month 12 Immunogenicity Timepoint|Overall Study||17
9033877|NCT03284710|10096125|FG000|Month 12.5 Immunogenicity Timepoint|Overall Study||0
9033878|NCT03284710|10096126|FG001|Month 12.5 Immunogenicity Timepoint|Overall Study||0
9033879|NCT03284710|10096127|FG002|Month 12.5 Immunogenicity Timepoint|Overall Study||0
9033880|NCT03284710|10096128|FG003|Month 12.5 Immunogenicity Timepoint|Overall Study||0
9033881|NCT03284710|10096125|FG000|Month 18 Immunogenicity Timepoint|Overall Study||0
9033882|NCT03284710|10096126|FG001|Month 18 Immunogenicity Timepoint|Overall Study||0
9033883|NCT03284710|10096127|FG002|Month 18 Immunogenicity Timepoint|Overall Study||0
9033884|NCT03284710|10096128|FG003|Month 18 Immunogenicity Timepoint|Overall Study||0
9033885|NCT03284710|10096125|FG000|COMPLETED|Overall Study||30
9033886|NCT03284710|10096126|FG001|COMPLETED|Overall Study||31
9033887|NCT03284710|10096127|FG002|COMPLETED|Overall Study||32
9033888|NCT03284710|10096128|FG003|COMPLETED|Overall Study||16
9033889|NCT03284710|10096125|FG000|NOT COMPLETED|Overall Study||6
9033890|NCT03284710|10096126|FG001|NOT COMPLETED|Overall Study||5
8918273|NCT02199743|9978164|FG001|STARTED|Overall Study||10
8918274|NCT02199743|9978163|FG000|COMPLETED|Overall Study||14
8918275|NCT02199743|9978164|FG001|COMPLETED|Overall Study||8
8918276|NCT02199743|9978163|FG000|NOT COMPLETED|Overall Study||0
8918277|NCT02199743|9978164|FG001|NOT COMPLETED|Overall Study||2
8918278|NCT02199795|9978174|FG000|STARTED|Overall Study||4
8918279|NCT02199795|9978175|FG001|STARTED|Overall Study||3
8918280|NCT02199795|9978174|FG000|COMPLETED|Overall Study||2
8918281|NCT02199795|9978175|FG001|COMPLETED|Overall Study||3
8918282|NCT02199795|9978174|FG000|NOT COMPLETED|Overall Study||2
8918283|NCT02199795|9978175|FG001|NOT COMPLETED|Overall Study||0
8918284|NCT02199964|9978183|FG000|STARTED|Overall Study||2
8918285|NCT02199964|9978184|FG001|STARTED|Overall Study||2
8918286|NCT02199964|9978183|FG000|COMPLETED|Overall Study||2
8918287|NCT02199964|9978184|FG001|COMPLETED|Overall Study||2
8918288|NCT02199964|9978183|FG000|NOT COMPLETED|Overall Study||0
8918289|NCT02199964|9978184|FG001|NOT COMPLETED|Overall Study||0
8918290|NCT02200055|9978190|FG000|STARTED|Overall Study||86
8918291|NCT02200055|9978190|FG000|COMPLETED|Overall Study||86
8918292|NCT02200055|9978190|FG000|NOT COMPLETED|Overall Study||0
8918293|NCT02200211|9978200|FG000|STARTED|Overall Study||190
8918294|NCT02200211|9978201|FG001|STARTED|Overall Study||195
8918295|NCT02200211|9978202|FG002|STARTED|Overall Study||40
8918296|NCT02200211|9978203|FG003|STARTED|Overall Study||60
8918297|NCT02200211|9978200|FG000|Included in 16-week Primary Analysis|Overall Study||177
8918298|NCT02200211|9978201|FG001|Included in 16-week Primary Analysis|Overall Study||186
8918299|NCT02200211|9978202|FG002|Included in 16-week Primary Analysis|Overall Study||39
9033891|NCT03284710|10096127|FG002|NOT COMPLETED|Overall Study||4
8918300|NCT02200211|9978203|FG003|Included in 16-week Primary Analysis|Overall Study||56
8918301|NCT02200211|9978200|FG000|COMPLETED|Overall Study||182
8918302|NCT02200211|9978201|FG001|COMPLETED|Overall Study||188
8918303|NCT02200211|9978202|FG002|COMPLETED|Overall Study||39
8918304|NCT02200211|9978203|FG003|COMPLETED|Overall Study||58
8918305|NCT02200211|9978200|FG000|NOT COMPLETED|Overall Study||8
8918306|NCT02200211|9978201|FG001|NOT COMPLETED|Overall Study||7
8918307|NCT02200211|9978202|FG002|NOT COMPLETED|Overall Study||1
8918308|NCT02200211|9978203|FG003|NOT COMPLETED|Overall Study||2
8918309|NCT02200445|9978224|FG000|STARTED|Overall Study||4
8918310|NCT02200445|9978225|FG001|STARTED|Overall Study||17
8918311|NCT02200445|9978226|FG002|STARTED|Overall Study||5
8918312|NCT02200445|9978224|FG000|COMPLETED|Overall Study||3
8918313|NCT02200445|9978225|FG001|COMPLETED|Overall Study||13
8918314|NCT02200445|9978226|FG002|COMPLETED|Overall Study||3
8918315|NCT02200445|9978224|FG000|NOT COMPLETED|Overall Study||1
8918316|NCT02200445|9978225|FG001|NOT COMPLETED|Overall Study||4
8918317|NCT02200445|9978226|FG002|NOT COMPLETED|Overall Study||2
8918318|NCT02200458|9978234|FG000|STARTED|Overall Study||62
8918319|NCT02200458|9978234|FG000|COMPLETED|Overall Study||62
8918320|NCT02200458|9978234|FG000|NOT COMPLETED|Overall Study||0
8918321|NCT02200510|9978240|FG000|STARTED|Overall Study|Number who only completed self-management or completed it before portal (could do 6 months later).|31
8918322|NCT02200510|9978241|FG001|STARTED|Overall Study|Number who only completed portal or completed it before self-management (could do 6 months later).|47
8918323|NCT02200510|9978240|FG000|COMPLETED|Overall Study|This is the number of participants with baseline and post data.|22
8918324|NCT02200510|9978241|FG001|COMPLETED|Overall Study|This number is the number of participants with both baseline and post data.|44
8918325|NCT02200510|9978240|FG000|NOT COMPLETED|Overall Study||9
8918326|NCT02200510|9978241|FG001|NOT COMPLETED|Overall Study||3
8918327|NCT02200523|9978249|FG000|STARTED|Overall Study||20
8918328|NCT02200523|9978250|FG001|STARTED|Overall Study||20
8918329|NCT02200523|9978249|FG000|COMPLETED|Overall Study||20
8918330|NCT02200523|9978250|FG001|COMPLETED|Overall Study||20
8918331|NCT02200523|9978249|FG000|NOT COMPLETED|Overall Study||0
8918332|NCT02200523|9978250|FG001|NOT COMPLETED|Overall Study||0
8918333|NCT02200536|9978259|FG000|STARTED|Overall Study||32
8918334|NCT02200536|9978260|FG001|STARTED|Overall Study||30
8918335|NCT02200536|9978261|FG002|STARTED|Overall Study||30
8918336|NCT02200536|9978259|FG000|COMPLETED|Overall Study||32
8918337|NCT02200536|9978260|FG001|COMPLETED|Overall Study||30
8918338|NCT02200536|9978261|FG002|COMPLETED|Overall Study||30
8918339|NCT02200536|9978259|FG000|NOT COMPLETED|Overall Study||0
9033892|NCT03284710|10096128|FG003|NOT COMPLETED|Overall Study||8
9033893|NCT03285061|10096145|FG000|STARTED|Overall Study||37
9033894|NCT03285061|10096146|FG001|STARTED|Overall Study||38
9033895|NCT03285061|10096145|FG000|COMPLETED|Overall Study||36
9033896|NCT03285061|10096146|FG001|COMPLETED|Overall Study||36
9033897|NCT03285061|10096145|FG000|NOT COMPLETED|Overall Study||1
9033898|NCT03285061|10096146|FG001|NOT COMPLETED|Overall Study||2
9033899|NCT03285113|10096152|FG000|STARTED|Overall Study||10
9033900|NCT03285113|10096152|FG000|COMPLETED|Overall Study||8
9033901|NCT03285113|10096152|FG000|NOT COMPLETED|Overall Study||2
9033902|NCT03285295|10096161|FG000|STARTED|Alinity s HBsAg||17095
9033903|NCT03285295|10096162|FG001|STARTED|Alinity s HBsAg||438
9033904|NCT03285295|10096163|FG002|STARTED|Alinity s HBsAg||403
9033905|NCT03285295|10096164|FG003|STARTED|Alinity s HBsAg||0
9033906|NCT03285295|10096165|FG004|STARTED|Alinity s HBsAg||51
9033907|NCT03285295|10096161|FG000|COMPLETED|Alinity s HBsAg||16993
9033908|NCT03285295|10096162|FG001|COMPLETED|Alinity s HBsAg||432
9033909|NCT03285295|10096163|FG002|COMPLETED|Alinity s HBsAg||403
9033910|NCT03285295|10096164|FG003|COMPLETED|Alinity s HBsAg||0
9033911|NCT03285295|10096165|FG004|COMPLETED|Alinity s HBsAg||51
9033912|NCT03285295|10096161|FG000|NOT COMPLETED|Alinity s HBsAg||102
9033913|NCT03285295|10096162|FG001|NOT COMPLETED|Alinity s HBsAg||6
9033914|NCT03285295|10096163|FG002|NOT COMPLETED|Alinity s HBsAg||0
9033915|NCT03285295|10096164|FG003|NOT COMPLETED|Alinity s HBsAg||0
9033916|NCT03285295|10096165|FG004|NOT COMPLETED|Alinity s HBsAg||0
9033917|NCT03285295|10096161|FG000|STARTED|Alinity s HBsAg Confirmatory||8
9033918|NCT03285295|10096162|FG001|STARTED|Alinity s HBsAg Confirmatory||432
9033919|NCT03285295|10096163|FG002|STARTED|Alinity s HBsAg Confirmatory||3
9033920|NCT03285295|10096164|FG003|STARTED|Alinity s HBsAg Confirmatory||0
9033921|NCT03285295|10096165|FG004|STARTED|Alinity s HBsAg Confirmatory||0
9033922|NCT03285295|10096161|FG000|COMPLETED|Alinity s HBsAg Confirmatory||8
9033923|NCT03285295|10096162|FG001|COMPLETED|Alinity s HBsAg Confirmatory||432
9033924|NCT03285295|10096163|FG002|COMPLETED|Alinity s HBsAg Confirmatory||3
9033925|NCT03285295|10096164|FG003|COMPLETED|Alinity s HBsAg Confirmatory||0
9033926|NCT03285295|10096165|FG004|COMPLETED|Alinity s HBsAg Confirmatory||0
9033927|NCT03285295|10096161|FG000|NOT COMPLETED|Alinity s HBsAg Confirmatory||0
9033928|NCT03285295|10096162|FG001|NOT COMPLETED|Alinity s HBsAg Confirmatory||0
9033929|NCT03285295|10096163|FG002|NOT COMPLETED|Alinity s HBsAg Confirmatory||0
9033930|NCT03285295|10096164|FG003|NOT COMPLETED|Alinity s HBsAg Confirmatory||0
9033931|NCT03285295|10096165|FG004|NOT COMPLETED|Alinity s HBsAg Confirmatory||0
9033932|NCT03285295|10096161|FG000|STARTED|Alinity s HBsAg Follow-Up||0
9033933|NCT03285295|10096162|FG001|STARTED|Alinity s HBsAg Follow-Up||0
9033934|NCT03285295|10096163|FG002|STARTED|Alinity s HBsAg Follow-Up||0
9033935|NCT03285295|10096164|FG003|STARTED|Alinity s HBsAg Follow-Up||0
9033936|NCT03285295|10096165|FG004|STARTED|Alinity s HBsAg Follow-Up||0
9033937|NCT03285295|10096161|FG000|COMPLETED|Alinity s HBsAg Follow-Up||0
9033938|NCT03285295|10096162|FG001|COMPLETED|Alinity s HBsAg Follow-Up||0
9033939|NCT03285295|10096163|FG002|COMPLETED|Alinity s HBsAg Follow-Up||0
9033940|NCT03285295|10096164|FG003|COMPLETED|Alinity s HBsAg Follow-Up||0
8918340|NCT02200536|9978260|FG001|NOT COMPLETED|Overall Study||0
8918341|NCT02200536|9978261|FG002|NOT COMPLETED|Overall Study||0
8918342|NCT02200614|9978271|FG000|STARTED|Double Blind Treatment||955
8918343|NCT02200614|9978272|FG001|STARTED|Double Blind Treatment||554
8918344|NCT02200614|9978271|FG000|COMPLETED|Double Blind Treatment||591
8918345|NCT02200614|9978272|FG001|COMPLETED|Double Blind Treatment||170
8918346|NCT02200614|9978271|FG000|NOT COMPLETED|Double Blind Treatment||364
8918347|NCT02200614|9978272|FG001|NOT COMPLETED|Double Blind Treatment||384
8918348|NCT02200614|9978271|FG000|STARTED|Open Label|Not all participants from treatment period entered follow-up|591
8918349|NCT02200614|9978272|FG001|STARTED|Open Label|Not all participants from treatment period entered follow-up|170
8918350|NCT02200614|9978271|FG000|COMPLETED|Open Label||466
8918351|NCT02200614|9978272|FG001|COMPLETED|Open Label||147
8918352|NCT02200614|9978271|FG000|NOT COMPLETED|Open Label||125
8918353|NCT02200614|9978272|FG001|NOT COMPLETED|Open Label||23
8918354|NCT02201056|9978287|FG000|STARTED|Overall Study||12
8918355|NCT02201056|9978288|FG001|STARTED|Overall Study||6
8918356|NCT02201056|9978289|FG002|STARTED|Overall Study||6
8918357|NCT02201056|9978290|FG003|STARTED|Overall Study||6
8918358|NCT02201056|9978291|FG004|STARTED|Overall Study||6
8918359|NCT02201056|9978292|FG005|STARTED|Overall Study||6
8918360|NCT02201056|9978293|FG006|STARTED|Overall Study||6
8918361|NCT02201056|9978287|FG000|COMPLETED|Overall Study||12
8918362|NCT02201056|9978288|FG001|COMPLETED|Overall Study||6
8918363|NCT02201056|9978289|FG002|COMPLETED|Overall Study||6
8918364|NCT02201056|9978290|FG003|COMPLETED|Overall Study||6
8918365|NCT02201056|9978291|FG004|COMPLETED|Overall Study||6
8918366|NCT02201056|9978292|FG005|COMPLETED|Overall Study||6
8918367|NCT02201056|9978293|FG006|COMPLETED|Overall Study||6
8918368|NCT02201056|9978287|FG000|NOT COMPLETED|Overall Study||0
8918369|NCT02201056|9978288|FG001|NOT COMPLETED|Overall Study||0
8918370|NCT02201056|9978289|FG002|NOT COMPLETED|Overall Study||0
8918371|NCT02201056|9978290|FG003|NOT COMPLETED|Overall Study||0
8918372|NCT02201056|9978291|FG004|NOT COMPLETED|Overall Study||0
8918373|NCT02201056|9978292|FG005|NOT COMPLETED|Overall Study||0
8918374|NCT02201056|9978293|FG006|NOT COMPLETED|Overall Study||0
8918375|NCT02201108|9978317|FG000|STARTED|Overall Study||57
8918376|NCT02201108|9978318|FG001|STARTED|Overall Study||109
8918377|NCT02201108|9978317|FG000|On-going Participants|Overall Study||0
8918378|NCT02201108|9978318|FG001|On-going Participants|Overall Study||58
8918379|NCT02201108|9978317|FG000|COMPLETED|Overall Study||53
8918380|NCT02201108|9978318|FG001|COMPLETED|Overall Study||102
8918381|NCT02201108|9978317|FG000|NOT COMPLETED|Overall Study||4
8918382|NCT02201108|9978318|FG001|NOT COMPLETED|Overall Study||7
8918383|NCT02201212|9978327|FG000|STARTED|Overall Study||30
8918384|NCT02201212|9978327|FG000|COMPLETED|Overall Study||30
8918385|NCT02201212|9978327|FG000|NOT COMPLETED|Overall Study||0
8918386|NCT02201277|9978333|FG000|STARTED|Overall Study|24 patients were consented but 1 patient had denali filter placed twice.|24
8918387|NCT02201277|9978334|FG001|STARTED|Overall Study|1 patient was withdrawn after signing consent due to physician preference for the option filter.|21
8918388|NCT02201277|9978333|FG000|Filter Retrieval|Overall Study||17
8918389|NCT02201277|9978334|FG001|Filter Retrieval|Overall Study||16
8918390|NCT02201277|9978333|FG000|Signed ICF But Did Not Enroll|Overall Study|Physician had preference for a specific filter so patient not randomized.|0
8918391|NCT02201277|9978334|FG001|Signed ICF But Did Not Enroll|Overall Study||1
8918392|NCT02201277|9978333|FG000|Filter Ruled to be Permanent|Overall Study||2
8918393|NCT02201277|9978334|FG001|Filter Ruled to be Permanent|Overall Study||2
8918394|NCT02201277|9978333|FG000|Lost to Follow up|Overall Study||2
8918395|NCT02201277|9978334|FG001|Lost to Follow up|Overall Study||1
8918396|NCT02201277|9978333|FG000|Death (Before Removal)|Overall Study||3
8918397|NCT02201277|9978334|FG001|Death (Before Removal)|Overall Study||4
8918398|NCT02201277|9978333|FG000|Complicated Retrieval|Overall Study||2
8918399|NCT02201277|9978334|FG001|Complicated Retrieval|Overall Study||0
8918400|NCT02201277|9978333|FG000|Failed Retrieval (Referred Elsewhere)|Overall Study||1
8918401|NCT02201277|9978334|FG001|Failed Retrieval (Referred Elsewhere)|Overall Study||0
8918402|NCT02201277|9978333|FG000|COMPLETED|Overall Study||17
8918403|NCT02201277|9978334|FG001|COMPLETED|Overall Study||16
8918404|NCT02201277|9978333|FG000|NOT COMPLETED|Overall Study||7
8918405|NCT02201277|9978334|FG001|NOT COMPLETED|Overall Study||5
8918406|NCT02201290|9978344|FG000|STARTED|Overall Study||9
8918407|NCT02201290|9978344|FG000|COMPLETED|Overall Study||4
8918408|NCT02201290|9978344|FG000|NOT COMPLETED|Overall Study||5
8918409|NCT02201329|9978348|FG000|STARTED|Overall Study||5
8918410|NCT02201329|9978348|FG000|COMPLETED|Overall Study||0
8918411|NCT02201329|9978348|FG000|NOT COMPLETED|Overall Study||5
8918412|NCT02201394|9978352|FG000|STARTED|Loading Dose||20
8918413|NCT02201394|9978352|FG000|COMPLETED|Loading Dose||20
8918414|NCT02201394|9978352|FG000|NOT COMPLETED|Loading Dose||0
8918415|NCT02201394|9978352|FG000|STARTED|Maintenance Dose||20
8918416|NCT02201394|9978352|FG000|COMPLETED|Maintenance Dose||20
8918417|NCT02201394|9978352|FG000|NOT COMPLETED|Maintenance Dose||0
8918418|NCT02201420|9978357|FG000|STARTED|Overall Study||5
8918419|NCT02201420|9978357|FG000|COMPLETED|Overall Study||5
8918420|NCT02201420|9978357|FG000|NOT COMPLETED|Overall Study||0
8918421|NCT02201446|9978363|FG000|STARTED|Overall Study||81
8918422|NCT02201446|9978364|FG001|STARTED|Overall Study||58
8918423|NCT02201446|9978363|FG000|COMPLETED|Overall Study||81
8918424|NCT02201446|9978364|FG001|COMPLETED|Overall Study||58
8918425|NCT02201446|9978363|FG000|NOT COMPLETED|Overall Study||0
8918426|NCT02201446|9978364|FG001|NOT COMPLETED|Overall Study||0
8918427|NCT02201524|9978374|FG000|STARTED|Overall Study||14
8918428|NCT02201524|9978375|FG001|STARTED|Overall Study||15
8918429|NCT02201524|9978376|FG002|STARTED|Overall Study||16
8918430|NCT02201524|9978377|FG003|STARTED|Overall Study||14
9033941|NCT03285295|10096165|FG004|COMPLETED|Alinity s HBsAg Follow-Up||0
9033942|NCT03285295|10096161|FG000|NOT COMPLETED|Alinity s HBsAg Follow-Up||0
9033943|NCT03285295|10096162|FG001|NOT COMPLETED|Alinity s HBsAg Follow-Up||0
9033944|NCT03285295|10096163|FG002|NOT COMPLETED|Alinity s HBsAg Follow-Up||0
9033945|NCT03285295|10096164|FG003|NOT COMPLETED|Alinity s HBsAg Follow-Up||0
9033946|NCT03285295|10096165|FG004|NOT COMPLETED|Alinity s HBsAg Follow-Up||0
9033947|NCT03285295|10096161|FG000|STARTED|Alinity s HTLV I/II||15968
9033948|NCT03285295|10096162|FG001|STARTED|Alinity s HTLV I/II||706
9033949|NCT03285295|10096163|FG002|STARTED|Alinity s HTLV I/II||502
9033950|NCT03285295|10096164|FG003|STARTED|Alinity s HTLV I/II||509
9033951|NCT03285295|10096165|FG004|STARTED|Alinity s HTLV I/II||0
9033952|NCT03285295|10096161|FG000|COMPLETED|Alinity s HTLV I/II||15877
9033953|NCT03285295|10096162|FG001|COMPLETED|Alinity s HTLV I/II||706
9033954|NCT03285295|10096163|FG002|COMPLETED|Alinity s HTLV I/II||502
9033955|NCT03285295|10096164|FG003|COMPLETED|Alinity s HTLV I/II||509
9033956|NCT03285295|10096165|FG004|COMPLETED|Alinity s HTLV I/II||0
9033957|NCT03285295|10096161|FG000|NOT COMPLETED|Alinity s HTLV I/II||91
9033958|NCT03285295|10096162|FG001|NOT COMPLETED|Alinity s HTLV I/II||0
9033959|NCT03285295|10096163|FG002|NOT COMPLETED|Alinity s HTLV I/II||0
9033960|NCT03285295|10096164|FG003|NOT COMPLETED|Alinity s HTLV I/II||0
9033961|NCT03285295|10096165|FG004|NOT COMPLETED|Alinity s HTLV I/II||0
9033962|NCT03285295|10096161|FG000|STARTED|Alinity s HTLV I/II Follow-Up||12
9033963|NCT03285295|10096162|FG001|STARTED|Alinity s HTLV I/II Follow-Up||0
9033964|NCT03285295|10096163|FG002|STARTED|Alinity s HTLV I/II Follow-Up||0
9033965|NCT03285295|10096164|FG003|STARTED|Alinity s HTLV I/II Follow-Up||0
9033966|NCT03285295|10096165|FG004|STARTED|Alinity s HTLV I/II Follow-Up||0
9033967|NCT03285295|10096161|FG000|COMPLETED|Alinity s HTLV I/II Follow-Up||8
9033968|NCT03285295|10096162|FG001|COMPLETED|Alinity s HTLV I/II Follow-Up||0
9033969|NCT03285295|10096163|FG002|COMPLETED|Alinity s HTLV I/II Follow-Up||0
9033970|NCT03285295|10096164|FG003|COMPLETED|Alinity s HTLV I/II Follow-Up||0
8918431|NCT02201524|9978374|FG000|COMPLETED|Overall Study||12
8918432|NCT02201524|9978375|FG001|COMPLETED|Overall Study||12
8918433|NCT02201524|9978376|FG002|COMPLETED|Overall Study||12
8918434|NCT02201524|9978377|FG003|COMPLETED|Overall Study||10
8918435|NCT02201524|9978374|FG000|NOT COMPLETED|Overall Study||2
8918436|NCT02201524|9978375|FG001|NOT COMPLETED|Overall Study||3
8918437|NCT02201524|9978376|FG002|NOT COMPLETED|Overall Study||4
8918438|NCT02201524|9978377|FG003|NOT COMPLETED|Overall Study||4
8918439|NCT02201771|9978390|FG000|STARTED|Overall Study||166
8918440|NCT02201771|9978391|FG001|STARTED|Overall Study||168
8918441|NCT02201771|9978392|FG002|STARTED|Overall Study||166
8918442|NCT02201771|9978390|FG000|COMPLETED|Overall Study||153
8918443|NCT02201771|9978391|FG001|COMPLETED|Overall Study||158
8918444|NCT02201771|9978392|FG002|COMPLETED|Overall Study||156
8918445|NCT02201771|9978390|FG000|NOT COMPLETED|Overall Study||13
8918446|NCT02201771|9978391|FG001|NOT COMPLETED|Overall Study||10
8918447|NCT02201771|9978392|FG002|NOT COMPLETED|Overall Study||10
8918448|NCT02201784|9978402|FG000|STARTED|Overall Study||30
8918449|NCT02201784|9978403|FG001|STARTED|Overall Study||30
8918450|NCT02201784|9978402|FG000|COMPLETED|Overall Study||28
8918451|NCT02201784|9978403|FG001|COMPLETED|Overall Study||30
8918452|NCT02201784|9978402|FG000|NOT COMPLETED|Overall Study||2
8918453|NCT02201784|9978403|FG001|NOT COMPLETED|Overall Study||0
8918454|NCT02201901|9978412|FG000|STARTED|Overall Study||90
8918455|NCT02201901|9978413|FG001|STARTED|Overall Study||88
8918456|NCT02201901|9978414|FG002|STARTED|Overall Study||90
8918457|NCT02201901|9978412|FG000|COMPLETED|Overall Study||75
8918458|NCT02201901|9978413|FG001|COMPLETED|Overall Study||79
8918459|NCT02201901|9978414|FG002|COMPLETED|Overall Study||77
8918460|NCT02201901|9978412|FG000|NOT COMPLETED|Overall Study||15
8918461|NCT02201901|9978413|FG001|NOT COMPLETED|Overall Study||9
8918462|NCT02201901|9978414|FG002|NOT COMPLETED|Overall Study||13
8918463|NCT02201940|9978425|FG000|STARTED|Overall Study||625
8918464|NCT02201940|9978426|FG001|STARTED|Overall Study||116
8918465|NCT02201940|9978425|FG000|COMPLETED|Overall Study||613
8918466|NCT02201940|9978426|FG001|COMPLETED|Overall Study||0
8918467|NCT02201940|9978425|FG000|NOT COMPLETED|Overall Study||12
8918468|NCT02201940|9978426|FG001|NOT COMPLETED|Overall Study||116
8918469|NCT02201953|9978434|FG000|STARTED|Overall Study||278
8918470|NCT02201953|9978435|FG001|STARTED|Overall Study||280
8918471|NCT02201953|9978434|FG000|COMPLETED|Overall Study||258
8918472|NCT02201953|9978435|FG001|COMPLETED|Overall Study||224
8918473|NCT02201953|9978434|FG000|NOT COMPLETED|Overall Study||20
8918474|NCT02201953|9978435|FG001|NOT COMPLETED|Overall Study||56
8918475|NCT02202031|9978443|FG000|STARTED|Overall Study||82
8918476|NCT02202031|9978444|FG001|STARTED|Overall Study||79
8918477|NCT02202031|9978443|FG000|COMPLETED|Overall Study||77
8918478|NCT02202031|9978444|FG001|COMPLETED|Overall Study||74
8918479|NCT02202031|9978443|FG000|NOT COMPLETED|Overall Study||5
8918480|NCT02202031|9978444|FG001|NOT COMPLETED|Overall Study||5
8918481|NCT02202109|9978452|FG000|STARTED|Overall Study||302
8918482|NCT02202109|9978453|FG001|STARTED|Overall Study||300
8918483|NCT02202109|9978452|FG000|COMPLETED|Overall Study||212
8918484|NCT02202109|9978453|FG001|COMPLETED|Overall Study||213
8918485|NCT02202109|9978452|FG000|NOT COMPLETED|Overall Study||90
8918486|NCT02202109|9978453|FG001|NOT COMPLETED|Overall Study||87
8918487|NCT02202135|9978459|FG000|STARTED|Overall Study||4
8918488|NCT02202135|9978459|FG000|COMPLETED|Overall Study||4
8918489|NCT02202135|9978459|FG000|NOT COMPLETED|Overall Study||0
8918490|NCT02202161|9978471|FG000|STARTED|Overall Study||13
8918491|NCT02202161|9978472|FG001|STARTED|Overall Study||5
8918492|NCT02202161|9978473|FG002|STARTED|Overall Study||5
8918493|NCT02202161|9978474|FG003|STARTED|Overall Study||9
8918494|NCT02202161|9978475|FG004|STARTED|Overall Study||9
8918495|NCT02202161|9978476|FG005|STARTED|Overall Study||10
8918496|NCT02202161|9978477|FG006|STARTED|Overall Study||13
8918497|NCT02202161|9978478|FG007|STARTED|Overall Study||6
8918498|NCT02202161|9978471|FG000|COMPLETED|Overall Study||12
8918499|NCT02202161|9978472|FG001|COMPLETED|Overall Study||4
8918500|NCT02202161|9978473|FG002|COMPLETED|Overall Study||5
8918501|NCT02202161|9978474|FG003|COMPLETED|Overall Study||9
8918502|NCT02202161|9978475|FG004|COMPLETED|Overall Study||8
8918503|NCT02202161|9978476|FG005|COMPLETED|Overall Study||9
8918504|NCT02202161|9978477|FG006|COMPLETED|Overall Study||13
8918505|NCT02202161|9978478|FG007|COMPLETED|Overall Study||0
8918506|NCT02202161|9978471|FG000|NOT COMPLETED|Overall Study||1
8918507|NCT02202161|9978472|FG001|NOT COMPLETED|Overall Study||1
8918508|NCT02202161|9978473|FG002|NOT COMPLETED|Overall Study||0
8918509|NCT02202161|9978474|FG003|NOT COMPLETED|Overall Study||0
8918510|NCT02202161|9978475|FG004|NOT COMPLETED|Overall Study||1
8918511|NCT02202161|9978476|FG005|NOT COMPLETED|Overall Study||1
8918512|NCT02202161|9978477|FG006|NOT COMPLETED|Overall Study||0
8918513|NCT02202161|9978478|FG007|NOT COMPLETED|Overall Study||6
8918514|NCT02202252|9978499|FG000|STARTED|Overall Study||30
8918515|NCT02202252|9978500|FG001|STARTED|Overall Study||30
8918516|NCT02202252|9978499|FG000|COMPLETED|Overall Study||30
8918517|NCT02202252|9978500|FG001|COMPLETED|Overall Study||30
8918518|NCT02202252|9978499|FG000|NOT COMPLETED|Overall Study||0
8918519|NCT02202252|9978500|FG001|NOT COMPLETED|Overall Study||0
8918520|NCT02202317|9978506|FG000|STARTED|Overall Study||9
8918521|NCT02202317|9978506|FG000|COMPLETED|Overall Study||8
8918522|NCT02202317|9978506|FG000|NOT COMPLETED|Overall Study||1
8918523|NCT02202499|9978513|FG000|STARTED|Overall Study||21
8918524|NCT02202499|9978514|FG001|STARTED|Overall Study||20
8918525|NCT02202499|9978515|FG002|STARTED|Overall Study||21
8918526|NCT02202499|9978513|FG000|COMPLETED|Overall Study||19
8918527|NCT02202499|9978514|FG001|COMPLETED|Overall Study||20
8918528|NCT02202499|9978515|FG002|COMPLETED|Overall Study||19
8918529|NCT02202499|9978513|FG000|NOT COMPLETED|Overall Study||2
8918530|NCT02202499|9978514|FG001|NOT COMPLETED|Overall Study||0
8918531|NCT02202499|9978515|FG002|NOT COMPLETED|Overall Study||2
9033971|NCT03285295|10096165|FG004|COMPLETED|Alinity s HTLV I/II Follow-Up||0
9033972|NCT03285295|10096161|FG000|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||4
9033973|NCT03285295|10096162|FG001|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||0
9033974|NCT03285295|10096163|FG002|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||0
9033975|NCT03285295|10096164|FG003|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||0
9033976|NCT03285295|10096165|FG004|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||0
9033977|NCT03285295|10096161|FG000|STARTED|Alinity s Anti-HCV||17095
9033978|NCT03285295|10096162|FG001|STARTED|Alinity s Anti-HCV||402
9033979|NCT03285295|10096163|FG002|STARTED|Alinity s Anti-HCV||407
9033980|NCT03285295|10096164|FG003|STARTED|Alinity s Anti-HCV||0
9033981|NCT03285295|10096165|FG004|STARTED|Alinity s Anti-HCV||0
9033982|NCT03285295|10096161|FG000|COMPLETED|Alinity s Anti-HCV||16999
9033983|NCT03285295|10096162|FG001|COMPLETED|Alinity s Anti-HCV||402
9033984|NCT03285295|10096163|FG002|COMPLETED|Alinity s Anti-HCV||407
9033985|NCT03285295|10096164|FG003|COMPLETED|Alinity s Anti-HCV||0
9033986|NCT03285295|10096165|FG004|COMPLETED|Alinity s Anti-HCV||0
8918532|NCT02202538|9978528|FG000|STARTED|Overall Study||53
8918533|NCT02202538|9978528|FG000|Screen Failure|Overall Study||2
8918534|NCT02202538|9978528|FG000|COMPLETED|Overall Study||45
8918535|NCT02202538|9978528|FG000|NOT COMPLETED|Overall Study||8
8918536|NCT02202551|9978536|FG000|STARTED|Overall Study||60
8918537|NCT02202551|9978537|FG001|STARTED|Overall Study||78
8918538|NCT02202551|9978538|FG002|STARTED|Overall Study||24
8918539|NCT02202551|9978539|FG003|STARTED|Overall Study||61
8918540|NCT02202551|9978536|FG000|COMPLETED|Overall Study||35
8918541|NCT02202551|9978537|FG001|COMPLETED|Overall Study||41
8918542|NCT02202551|9978538|FG002|COMPLETED|Overall Study||14
8918543|NCT02202551|9978539|FG003|COMPLETED|Overall Study||39
8918544|NCT02202551|9978536|FG000|NOT COMPLETED|Overall Study||25
8918545|NCT02202551|9978537|FG001|NOT COMPLETED|Overall Study||37
8918546|NCT02202551|9978538|FG002|NOT COMPLETED|Overall Study||10
8918547|NCT02202551|9978539|FG003|NOT COMPLETED|Overall Study||22
8918548|NCT02202616|9978553|FG000|STARTED|Overall Study||401
8918549|NCT02202616|9978553|FG000|Intent to Treat Set (ITT)|Overall Study||338
8918550|NCT02202616|9978553|FG000|COMPLETED|Overall Study||301
8918551|NCT02202616|9978553|FG000|NOT COMPLETED|Overall Study||100
8918552|NCT02202746|9978560|FG000|STARTED|Overall Study||109
8918553|NCT02202746|9978561|FG001|STARTED|Overall Study||69
8918554|NCT02202746|9978560|FG000|COMPLETED|Overall Study||109
8918555|NCT02202746|9978561|FG001|COMPLETED|Overall Study||69
8918556|NCT02202746|9978560|FG000|NOT COMPLETED|Overall Study||0
8918557|NCT02202746|9978561|FG001|NOT COMPLETED|Overall Study||0
8918558|NCT02202759|9978573|FG000|STARTED|Overall Study||9
8918559|NCT02202759|9978574|FG001|STARTED|Overall Study||15
8918560|NCT02202759|9978575|FG002|STARTED|Overall Study||14
8918561|NCT02202759|9978573|FG000|COMPLETED|Overall Study||0
8918562|NCT02202759|9978574|FG001|COMPLETED|Overall Study||0
8918563|NCT02202759|9978575|FG002|COMPLETED|Overall Study||0
8918564|NCT02202759|9978573|FG000|NOT COMPLETED|Overall Study||9
8918565|NCT02202759|9978574|FG001|NOT COMPLETED|Overall Study||15
8918566|NCT02202759|9978575|FG002|NOT COMPLETED|Overall Study||14
8918567|NCT02202785|9978585|FG000|STARTED|Overall Study||11
8918568|NCT02202785|9978586|FG001|STARTED|Overall Study||15
8918569|NCT02202785|9978587|FG002|STARTED|Overall Study||17
8918570|NCT02202785|9978585|FG000|COMPLETED|Overall Study||0
8918571|NCT02202785|9978586|FG001|COMPLETED|Overall Study||0
8918572|NCT02202785|9978587|FG002|COMPLETED|Overall Study||0
8918573|NCT02202785|9978585|FG000|NOT COMPLETED|Overall Study||11
8918574|NCT02202785|9978586|FG001|NOT COMPLETED|Overall Study||15
8918575|NCT02202785|9978587|FG002|NOT COMPLETED|Overall Study||17
8918576|NCT02202837|9978597|FG000|STARTED|Overall Study||140
8918577|NCT02202837|9978598|FG001|STARTED|Overall Study||17
8918578|NCT02202837|9978597|FG000|COMPLETED|Overall Study||87
8918579|NCT02202837|9978598|FG001|COMPLETED|Overall Study||12
8918580|NCT02202837|9978597|FG000|NOT COMPLETED|Overall Study||53
8918581|NCT02202837|9978598|FG001|NOT COMPLETED|Overall Study||5
8918582|NCT02202850|9978606|FG000|STARTED|Overall Study||70
8918583|NCT02202850|9978607|FG001|STARTED|Overall Study||14
8918584|NCT02202850|9978606|FG000|COMPLETED|Overall Study||46
8918585|NCT02202850|9978607|FG001|COMPLETED|Overall Study||8
8918586|NCT02202850|9978606|FG000|NOT COMPLETED|Overall Study||24
8918587|NCT02202850|9978607|FG001|NOT COMPLETED|Overall Study||6
8918588|NCT02202980|9978627|FG000|STARTED|Overall Study||14
8918589|NCT02202980|9978628|FG001|STARTED|Overall Study||26
8918590|NCT02202980|9978629|FG002|STARTED|Overall Study||27
8918591|NCT02202980|9978630|FG003|STARTED|Overall Study||32
8918592|NCT02202980|9978631|FG004|STARTED|Overall Study||13
8918593|NCT02202980|9978632|FG005|STARTED|Overall Study||15
8918594|NCT02202980|9978633|FG006|STARTED|Overall Study||15
8918595|NCT02202980|9978634|FG007|STARTED|Overall Study||15
8918596|NCT02202980|9978635|FG008|STARTED|Overall Study||18
8918597|NCT02202980|9978636|FG009|STARTED|Overall Study||17
8918598|NCT02202980|9978637|FG010|STARTED|Overall Study||19
8918599|NCT02202980|9978638|FG011|STARTED|Overall Study||28
8918600|NCT02202980|9978639|FG012|STARTED|Overall Study||30
8918601|NCT02202980|9978640|FG013|STARTED|Overall Study||4
8918602|NCT02202980|9978627|FG000|COMPLETED|Overall Study||13
8918603|NCT02202980|9978628|FG001|COMPLETED|Overall Study||24
9033987|NCT03285295|10096161|FG000|NOT COMPLETED|Alinity s Anti-HCV||96
9033988|NCT03285295|10096162|FG001|NOT COMPLETED|Alinity s Anti-HCV||0
8918604|NCT02202980|9978629|FG002|COMPLETED|Overall Study||17
8918605|NCT02202980|9978630|FG003|COMPLETED|Overall Study||28
8918606|NCT02202980|9978631|FG004|COMPLETED|Overall Study||7
8918607|NCT02202980|9978632|FG005|COMPLETED|Overall Study||14
8918608|NCT02202980|9978633|FG006|COMPLETED|Overall Study||4
8918609|NCT02202980|9978634|FG007|COMPLETED|Overall Study||12
8918610|NCT02202980|9978635|FG008|COMPLETED|Overall Study||14
8918611|NCT02202980|9978636|FG009|COMPLETED|Overall Study||17
8918612|NCT02202980|9978637|FG010|COMPLETED|Overall Study||19
8918613|NCT02202980|9978638|FG011|COMPLETED|Overall Study||25
8918614|NCT02202980|9978639|FG012|COMPLETED|Overall Study||19
8918615|NCT02202980|9978640|FG013|COMPLETED|Overall Study||4
8918616|NCT02202980|9978627|FG000|NOT COMPLETED|Overall Study||1
8918617|NCT02202980|9978628|FG001|NOT COMPLETED|Overall Study||2
8918618|NCT02202980|9978629|FG002|NOT COMPLETED|Overall Study||10
8918619|NCT02202980|9978630|FG003|NOT COMPLETED|Overall Study||4
8918620|NCT02202980|9978631|FG004|NOT COMPLETED|Overall Study||6
8918621|NCT02202980|9978632|FG005|NOT COMPLETED|Overall Study||1
8918622|NCT02202980|9978633|FG006|NOT COMPLETED|Overall Study||11
8918623|NCT02202980|9978634|FG007|NOT COMPLETED|Overall Study||3
8918624|NCT02202980|9978635|FG008|NOT COMPLETED|Overall Study||4
8918625|NCT02202980|9978636|FG009|NOT COMPLETED|Overall Study||0
8918626|NCT02202980|9978637|FG010|NOT COMPLETED|Overall Study||0
8918627|NCT02202980|9978638|FG011|NOT COMPLETED|Overall Study||3
8918628|NCT02202980|9978639|FG012|NOT COMPLETED|Overall Study||11
8918629|NCT02202980|9978640|FG013|NOT COMPLETED|Overall Study||0
8918630|NCT02203019|9978672|FG000|STARTED|Overall Study||19
8918631|NCT02203019|9978673|FG001|STARTED|Overall Study||17
8918632|NCT02203019|9978672|FG000|COMPLETED|Overall Study||19
8918633|NCT02203019|9978673|FG001|COMPLETED|Overall Study||17
8918634|NCT02203019|9978672|FG000|NOT COMPLETED|Overall Study||0
8918635|NCT02203019|9978673|FG001|NOT COMPLETED|Overall Study||0
8918636|NCT02203032|9978679|FG000|STARTED|Open Label Run-in (Week 0 to Week 16)||872
8918637|NCT02203032|9978680|FG001|STARTED|Open Label Run-in (Week 0 to Week 16)||0
8918638|NCT02203032|9978681|FG002|STARTED|Open Label Run-in (Week 0 to Week 16)||0
8918639|NCT02203032|9978682|FG003|STARTED|Open Label Run-in (Week 0 to Week 16)||0
8918640|NCT02203032|9978679|FG000|Treated|Open Label Run-in (Week 0 to Week 16)||871
8918641|NCT02203032|9978680|FG001|Treated|Open Label Run-in (Week 0 to Week 16)||0
8918642|NCT02203032|9978681|FG002|Treated|Open Label Run-in (Week 0 to Week 16)||0
8918643|NCT02203032|9978682|FG003|Treated|Open Label Run-in (Week 0 to Week 16)||0
8918644|NCT02203032|9978679|FG000|COMPLETED|Open Label Run-in (Week 0 to Week 16)||853
8918645|NCT02203032|9978680|FG001|COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
8918646|NCT02203032|9978681|FG002|COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
8918647|NCT02203032|9978682|FG003|COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
8918648|NCT02203032|9978679|FG000|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||19
8918649|NCT02203032|9978680|FG001|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
8918650|NCT02203032|9978681|FG002|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
8918651|NCT02203032|9978682|FG003|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
8918652|NCT02203032|9978679|FG000|STARTED|Blinded Phase (Week 16 to Week 44)||0
8918653|NCT02203032|9978680|FG001|STARTED|Blinded Phase (Week 16 to Week 44)||135
8918654|NCT02203032|9978681|FG002|STARTED|Blinded Phase (Week 16 to Week 44)||133
8918655|NCT02203032|9978682|FG003|STARTED|Blinded Phase (Week 16 to Week 44)||585
8918656|NCT02203032|9978679|FG000|COMPLETED|Blinded Phase (Week 16 to Week 44)||0
8918657|NCT02203032|9978680|FG001|COMPLETED|Blinded Phase (Week 16 to Week 44)||120
8918658|NCT02203032|9978681|FG002|COMPLETED|Blinded Phase (Week 16 to Week 44)||107
8918659|NCT02203032|9978682|FG003|COMPLETED|Blinded Phase (Week 16 to Week 44)||539
8918660|NCT02203032|9978679|FG000|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||0
8918661|NCT02203032|9978680|FG001|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||15
8918662|NCT02203032|9978681|FG002|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||26
8918663|NCT02203032|9978682|FG003|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||46
8918664|NCT02203071|9978692|FG000|STARTED|Overall Study||13
8918665|NCT02203071|9978693|FG001|STARTED|Overall Study||6
8918666|NCT02203071|9978692|FG000|COMPLETED|Overall Study||10
8918667|NCT02203071|9978693|FG001|COMPLETED|Overall Study||5
8918668|NCT02203071|9978692|FG000|NOT COMPLETED|Overall Study||3
8918669|NCT02203071|9978693|FG001|NOT COMPLETED|Overall Study||1
8918670|NCT02203149|9978704|FG000|STARTED|Part 1||31
8918671|NCT02203149|9978705|FG001|STARTED|Part 1||32
8918672|NCT02203149|9978706|FG002|STARTED|Part 1||0
8918673|NCT02203149|9978707|FG003|STARTED|Part 1||0
8918674|NCT02203149|9978708|FG004|STARTED|Part 1||0
8918675|NCT02203149|9978704|FG000|COMPLETED|Part 1||31
8918676|NCT02203149|9978705|FG001|COMPLETED|Part 1||31
8918677|NCT02203149|9978706|FG002|COMPLETED|Part 1||0
8918678|NCT02203149|9978707|FG003|COMPLETED|Part 1||0
8918679|NCT02203149|9978708|FG004|COMPLETED|Part 1||0
8918680|NCT02203149|9978704|FG000|NOT COMPLETED|Part 1||0
8918681|NCT02203149|9978705|FG001|NOT COMPLETED|Part 1||1
8918682|NCT02203149|9978706|FG002|NOT COMPLETED|Part 1||0
8918683|NCT02203149|9978707|FG003|NOT COMPLETED|Part 1||0
8918684|NCT02203149|9978708|FG004|NOT COMPLETED|Part 1||0
8918685|NCT02203149|9978704|FG000|STARTED|Part 2|Participants of Part 1 did not enter Part 2|0
8918686|NCT02203149|9978705|FG001|STARTED|Part 2|Participants of Part 1 did not enter Part 2|0
8918687|NCT02203149|9978706|FG002|STARTED|Part 2||227
8918688|NCT02203149|9978707|FG003|STARTED|Part 2||74
8918689|NCT02203149|9978708|FG004|STARTED|Part 2||35
8918690|NCT02203149|9978704|FG000|Started Deferred Active Treatment|Part 2||0
8918691|NCT02203149|9978705|FG001|Started Deferred Active Treatment|Part 2||0
8918692|NCT02203149|9978706|FG002|Started Deferred Active Treatment|Part 2||0
8918693|NCT02203149|9978707|FG003|Started Deferred Active Treatment|Part 2|1 participant in Deferred Treatment Arm receiving Placebo did not receive Deferred Active Treatment.|73
8918694|NCT02203149|9978708|FG004|Started Deferred Active Treatment|Part 2||0
8918695|NCT02203149|9978704|FG000|COMPLETED|Part 2||0
8918696|NCT02203149|9978705|FG001|COMPLETED|Part 2||0
8918697|NCT02203149|9978706|FG002|COMPLETED|Part 2||226
8918698|NCT02203149|9978707|FG003|COMPLETED|Part 2||71
8918699|NCT02203149|9978708|FG004|COMPLETED|Part 2||34
8918700|NCT02203149|9978704|FG000|NOT COMPLETED|Part 2||0
8918701|NCT02203149|9978705|FG001|NOT COMPLETED|Part 2||0
8918702|NCT02203149|9978706|FG002|NOT COMPLETED|Part 2||1
8918703|NCT02203149|9978707|FG003|NOT COMPLETED|Part 2||3
8918704|NCT02203149|9978708|FG004|NOT COMPLETED|Part 2||1
8918705|NCT02203162|9978730|FG000|STARTED|Overall Study||30
8918706|NCT02203162|9978730|FG000|COMPLETED|Overall Study||30
8918707|NCT02203162|9978730|FG000|NOT COMPLETED|Overall Study||0
8918708|NCT02203331|9978740|FG000|STARTED|Overall Study||52
8918709|NCT02203331|9978741|FG001|STARTED|Overall Study||53
8918710|NCT02203331|9978742|FG002|STARTED|Overall Study||55
8918711|NCT02203331|9978743|FG003|STARTED|Overall Study||53
8918712|NCT02203331|9978744|FG004|STARTED|Overall Study||53
8918713|NCT02203331|9978745|FG005|STARTED|Overall Study||53
8918714|NCT02203331|9978740|FG000|Treated|Overall Study||49
8918715|NCT02203331|9978741|FG001|Treated|Overall Study||50
8918716|NCT02203331|9978742|FG002|Treated|Overall Study||54
8918717|NCT02203331|9978743|FG003|Treated|Overall Study||49
8918718|NCT02203331|9978744|FG004|Treated|Overall Study||50
8918719|NCT02203331|9978745|FG005|Treated|Overall Study||53
8918720|NCT02203331|9978740|FG000|COMPLETED|Overall Study||45
8918721|NCT02203331|9978741|FG001|COMPLETED|Overall Study||39
8918722|NCT02203331|9978742|FG002|COMPLETED|Overall Study||50
8918723|NCT02203331|9978743|FG003|COMPLETED|Overall Study||46
8918724|NCT02203331|9978744|FG004|COMPLETED|Overall Study||46
8918725|NCT02203331|9978745|FG005|COMPLETED|Overall Study||46
8918726|NCT02203331|9978740|FG000|NOT COMPLETED|Overall Study||7
8918727|NCT02203331|9978741|FG001|NOT COMPLETED|Overall Study||14
9033989|NCT03285295|10096163|FG002|NOT COMPLETED|Alinity s Anti-HCV||0
9033990|NCT03285295|10096164|FG003|NOT COMPLETED|Alinity s Anti-HCV||0
9033991|NCT03285295|10096165|FG004|NOT COMPLETED|Alinity s Anti-HCV||0
9033992|NCT03285295|10096161|FG000|STARTED|Alinity s Anti-HCV Follow-Up||20
9033993|NCT03285295|10096162|FG001|STARTED|Alinity s Anti-HCV Follow-Up||0
9033994|NCT03285295|10096163|FG002|STARTED|Alinity s Anti-HCV Follow-Up||0
9033995|NCT03285295|10096164|FG003|STARTED|Alinity s Anti-HCV Follow-Up||0
9033996|NCT03285295|10096165|FG004|STARTED|Alinity s Anti-HCV Follow-Up||0
9033997|NCT03285295|10096161|FG000|COMPLETED|Alinity s Anti-HCV Follow-Up||2
9033998|NCT03285295|10096162|FG001|COMPLETED|Alinity s Anti-HCV Follow-Up||0
9033999|NCT03285295|10096163|FG002|COMPLETED|Alinity s Anti-HCV Follow-Up||0
9034000|NCT03285295|10096164|FG003|COMPLETED|Alinity s Anti-HCV Follow-Up||0
9034001|NCT03285295|10096165|FG004|COMPLETED|Alinity s Anti-HCV Follow-Up||0
9034002|NCT03285295|10096161|FG000|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||18
9034003|NCT03285295|10096162|FG001|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||0
8672192|NCT00756002|9715676|FG001|STARTED|Placebo Run-out||0
8672193|NCT00756002|9715675|FG000|COMPLETED|Placebo Run-out||114
8672194|NCT00756002|9715676|FG001|COMPLETED|Placebo Run-out||0
8672195|NCT00756002|9715675|FG000|NOT COMPLETED|Placebo Run-out||0
8672196|NCT00756002|9715676|FG001|NOT COMPLETED|Placebo Run-out||0
8672197|NCT00756093|9715682|FG000|STARTED|First Intervention||5
8672198|NCT00756093|9715683|FG001|STARTED|First Intervention||5
8672199|NCT00756093|9715684|FG002|STARTED|First Intervention||5
8672200|NCT00756093|9715685|FG003|STARTED|First Intervention||5
9034004|NCT03285295|10096163|FG002|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||0
9034005|NCT03285295|10096164|FG003|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||0
9034006|NCT03285295|10096165|FG004|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||0
9034007|NCT03285295|10096161|FG000|STARTED|Alinity s HIV Ag/Ab Combo||17095
9034008|NCT03285295|10096162|FG001|STARTED|Alinity s HIV Ag/Ab Combo||1336
9034009|NCT03285295|10096163|FG002|STARTED|Alinity s HIV Ag/Ab Combo||605
9034010|NCT03285295|10096164|FG003|STARTED|Alinity s HIV Ag/Ab Combo|Individuals at Increased Risk of HIV Infection from HIV-2 Endemic Areas|535
9034011|NCT03285295|10096165|FG004|STARTED|Alinity s HIV Ag/Ab Combo||0
9034012|NCT03285295|10096161|FG000|COMPLETED|Alinity s HIV Ag/Ab Combo||16996
9034013|NCT03285295|10096162|FG001|COMPLETED|Alinity s HIV Ag/Ab Combo||1336
9034014|NCT03285295|10096163|FG002|COMPLETED|Alinity s HIV Ag/Ab Combo||605
9034015|NCT03285295|10096164|FG003|COMPLETED|Alinity s HIV Ag/Ab Combo|Individuals at Increased Risk of HIV Infection from HIV-2 Endemic Areas|535
9034016|NCT03285295|10096165|FG004|COMPLETED|Alinity s HIV Ag/Ab Combo||0
9034017|NCT03285295|10096161|FG000|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||99
9034018|NCT03285295|10096162|FG001|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||0
9034019|NCT03285295|10096163|FG002|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||0
9034020|NCT03285295|10096164|FG003|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||0
9034021|NCT03285295|10096165|FG004|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||0
9034022|NCT03285295|10096161|FG000|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||15
9034023|NCT03285295|10096162|FG001|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||0
9034024|NCT03285295|10096163|FG002|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||0
9034025|NCT03285295|10096164|FG003|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||0
9034026|NCT03285295|10096165|FG004|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||0
9034027|NCT03285295|10096161|FG000|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||4
9034028|NCT03285295|10096162|FG001|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
9034029|NCT03285295|10096163|FG002|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
8672201|NCT00756093|9715682|FG000|COMPLETED|First Intervention||5
8918728|NCT02203331|9978742|FG002|NOT COMPLETED|Overall Study||5
9034030|NCT03285295|10096164|FG003|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
9034031|NCT03285295|10096165|FG004|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
9034032|NCT03285295|10096161|FG000|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||11
9034033|NCT03285295|10096162|FG001|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
9034034|NCT03285295|10096163|FG002|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
9034035|NCT03285295|10096164|FG003|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
9034036|NCT03285295|10096165|FG004|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
9034037|NCT03285295|10096161|FG000|STARTED|Alinity s Anti-HBc||15968
8918729|NCT02203331|9978743|FG003|NOT COMPLETED|Overall Study||7
8918730|NCT02203331|9978744|FG004|NOT COMPLETED|Overall Study||7
8918731|NCT02203331|9978745|FG005|NOT COMPLETED|Overall Study||7
8918732|NCT02203357|9978762|FG000|STARTED|Overall Study||117
8918733|NCT02203357|9978763|FG001|STARTED|Overall Study||111
8918734|NCT02203357|9978764|FG002|STARTED|Overall Study||125
8918735|NCT02203357|9978762|FG000|mon7/2/3|Overall Study||114
8918736|NCT02203357|9978763|FG001|mon7/2/3|Overall Study||110
8918737|NCT02203357|9978764|FG002|mon7/2/3|Overall Study||124
8918738|NCT02203357|9978762|FG000|mon12|Overall Study||113
8918739|NCT02203357|9978763|FG001|mon12|Overall Study||101
8918740|NCT02203357|9978764|FG002|mon12|Overall Study||122
8918741|NCT02203357|9978762|FG000|mon24|Overall Study||59
8918742|NCT02203357|9978763|FG001|mon24|Overall Study||45
8918743|NCT02203357|9978764|FG002|mon24|Overall Study||55
8918744|NCT02203357|9978762|FG000|COMPLETED|Overall Study||59
8918745|NCT02203357|9978763|FG001|COMPLETED|Overall Study||45
9034038|NCT03285295|10096162|FG001|STARTED|Alinity s Anti-HBc||405
9034039|NCT03285295|10096163|FG002|STARTED|Alinity s Anti-HBc||403
9034040|NCT03285295|10096164|FG003|STARTED|Alinity s Anti-HBc||0
9034041|NCT03285295|10096165|FG004|STARTED|Alinity s Anti-HBc||0
9034042|NCT03285295|10096161|FG000|COMPLETED|Alinity s Anti-HBc||15877
9034043|NCT03285295|10096162|FG001|COMPLETED|Alinity s Anti-HBc||404
9034044|NCT03285295|10096163|FG002|COMPLETED|Alinity s Anti-HBc||403
9034045|NCT03285295|10096164|FG003|COMPLETED|Alinity s Anti-HBc||0
9034046|NCT03285295|10096165|FG004|COMPLETED|Alinity s Anti-HBc||0
9034047|NCT03285295|10096161|FG000|NOT COMPLETED|Alinity s Anti-HBc||91
9034048|NCT03285295|10096162|FG001|NOT COMPLETED|Alinity s Anti-HBc||1
9034049|NCT03285295|10096163|FG002|NOT COMPLETED|Alinity s Anti-HBc||0
9034050|NCT03285295|10096164|FG003|NOT COMPLETED|Alinity s Anti-HBc||0
9034051|NCT03285295|10096165|FG004|NOT COMPLETED|Alinity s Anti-HBc||0
9034052|NCT03285295|10096161|FG000|STARTED|Alinity s Anti-HBc Follow-Up||16
9034053|NCT03285295|10096162|FG001|STARTED|Alinity s Anti-HBc Follow-Up||0
9034054|NCT03285295|10096163|FG002|STARTED|Alinity s Anti-HBc Follow-Up||0
9034055|NCT03285295|10096164|FG003|STARTED|Alinity s Anti-HBc Follow-Up||0
9034056|NCT03285295|10096165|FG004|STARTED|Alinity s Anti-HBc Follow-Up||0
9034057|NCT03285295|10096161|FG000|COMPLETED|Alinity s Anti-HBc Follow-Up||2
9034058|NCT03285295|10096162|FG001|COMPLETED|Alinity s Anti-HBc Follow-Up||0
9034059|NCT03285295|10096163|FG002|COMPLETED|Alinity s Anti-HBc Follow-Up||0
9034060|NCT03285295|10096164|FG003|COMPLETED|Alinity s Anti-HBc Follow-Up||0
9034061|NCT03285295|10096165|FG004|COMPLETED|Alinity s Anti-HBc Follow-Up||0
9034062|NCT03285295|10096161|FG000|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||14
9034063|NCT03285295|10096162|FG001|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||0
9034064|NCT03285295|10096163|FG002|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||0
9034065|NCT03285295|10096164|FG003|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||0
9034066|NCT03285295|10096165|FG004|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||0
9034067|NCT03285295|10096161|FG000|STARTED|Alinity s Chagas||16023
9034068|NCT03285295|10096162|FG001|STARTED|Alinity s Chagas||320
9034069|NCT03285295|10096163|FG002|STARTED|Alinity s Chagas||0
9034070|NCT03285295|10096164|FG003|STARTED|Alinity s Chagas||615
9034071|NCT03285295|10096165|FG004|STARTED|Alinity s Chagas||0
9034072|NCT03285295|10096161|FG000|COMPLETED|Alinity s Chagas||15804
9034073|NCT03285295|10096162|FG001|COMPLETED|Alinity s Chagas||320
9034074|NCT03285295|10096163|FG002|COMPLETED|Alinity s Chagas||0
9034075|NCT03285295|10096164|FG003|COMPLETED|Alinity s Chagas||615
9034076|NCT03285295|10096165|FG004|COMPLETED|Alinity s Chagas||0
9034077|NCT03285295|10096161|FG000|NOT COMPLETED|Alinity s Chagas||219
9034078|NCT03285295|10096162|FG001|NOT COMPLETED|Alinity s Chagas||0
9034079|NCT03285295|10096163|FG002|NOT COMPLETED|Alinity s Chagas||0
9034080|NCT03285295|10096164|FG003|NOT COMPLETED|Alinity s Chagas||0
9034081|NCT03285295|10096165|FG004|NOT COMPLETED|Alinity s Chagas||0
9034082|NCT03285295|10096161|FG000|STARTED|Alinity s Chagas Follow-Up||14
9034083|NCT03285295|10096162|FG001|STARTED|Alinity s Chagas Follow-Up||0
9034084|NCT03285295|10096163|FG002|STARTED|Alinity s Chagas Follow-Up||0
9034085|NCT03285295|10096164|FG003|STARTED|Alinity s Chagas Follow-Up||0
9034086|NCT03285295|10096165|FG004|STARTED|Alinity s Chagas Follow-Up||0
9034087|NCT03285295|10096161|FG000|COMPLETED|Alinity s Chagas Follow-Up||1
9034088|NCT03285295|10096162|FG001|COMPLETED|Alinity s Chagas Follow-Up||0
9034089|NCT03285295|10096163|FG002|COMPLETED|Alinity s Chagas Follow-Up||0
9034090|NCT03285295|10096164|FG003|COMPLETED|Alinity s Chagas Follow-Up||0
9034091|NCT03285295|10096165|FG004|COMPLETED|Alinity s Chagas Follow-Up||0
9034092|NCT03285295|10096161|FG000|NOT COMPLETED|Alinity s Chagas Follow-Up||13
9034093|NCT03285295|10096162|FG001|NOT COMPLETED|Alinity s Chagas Follow-Up||0
9034094|NCT03285295|10096163|FG002|NOT COMPLETED|Alinity s Chagas Follow-Up||0
9034095|NCT03285295|10096164|FG003|NOT COMPLETED|Alinity s Chagas Follow-Up||0
9034096|NCT03285295|10096165|FG004|NOT COMPLETED|Alinity s Chagas Follow-Up||0
9034097|NCT03285308|10096196|FG000|STARTED|Overall Study||167
9034098|NCT03285308|10096197|FG001|STARTED|Overall Study||169
9034099|NCT03285308|10096196|FG000|Safety Population|Overall Study||163
9034100|NCT03285308|10096197|FG001|Safety Population|Overall Study||163
9034101|NCT03285308|10096196|FG000|COMPLETED|Overall Study||147
9034102|NCT03285308|10096197|FG001|COMPLETED|Overall Study||146
9034103|NCT03285308|10096196|FG000|NOT COMPLETED|Overall Study||20
8918746|NCT02203357|9978764|FG002|COMPLETED|Overall Study||55
8918747|NCT02203357|9978762|FG000|NOT COMPLETED|Overall Study||58
9034104|NCT03285308|10096197|FG001|NOT COMPLETED|Overall Study||23
9034105|NCT03285373|10096204|FG000|STARTED|Overall Study||314
9034106|NCT03285373|10096205|FG001|STARTED|Overall Study||253
9034107|NCT03285373|10096206|FG002|STARTED|Overall Study||266
9034108|NCT03285373|10096207|FG003|STARTED|Overall Study||130
9034109|NCT03285373|10096204|FG000|COMPLETED|Overall Study||314
9034110|NCT03285373|10096205|FG001|COMPLETED|Overall Study||253
9034111|NCT03285373|10096206|FG002|COMPLETED|Overall Study||266
9034112|NCT03285373|10096207|FG003|COMPLETED|Overall Study||130
9034113|NCT03285373|10096204|FG000|NOT COMPLETED|Overall Study||0
9034114|NCT03285373|10096205|FG001|NOT COMPLETED|Overall Study||0
9034115|NCT03285373|10096206|FG002|NOT COMPLETED|Overall Study||0
9034116|NCT03285373|10096207|FG003|NOT COMPLETED|Overall Study||0
9034117|NCT03285477|10096218|FG000|STARTED|Treatment and Response Assessment Period||176
9034118|NCT03285477|10096219|FG001|STARTED|Treatment and Response Assessment Period||175
9034119|NCT03285477|10096218|FG000|COMPLETED|Treatment and Response Assessment Period||174
9034120|NCT03285477|10096219|FG001|COMPLETED|Treatment and Response Assessment Period||175
9034121|NCT03285477|10096218|FG000|NOT COMPLETED|Treatment and Response Assessment Period||2
9034122|NCT03285477|10096219|FG001|NOT COMPLETED|Treatment and Response Assessment Period||0
9034123|NCT03285477|10096218|FG000|STARTED|Recurrence Follow-up Period||8
9034124|NCT03285477|10096219|FG001|STARTED|Recurrence Follow-up Period||77
9034125|NCT03285477|10096218|FG000|COMPLETED|Recurrence Follow-up Period||2
9034126|NCT03285477|10096219|FG001|COMPLETED|Recurrence Follow-up Period||22
9034127|NCT03285477|10096218|FG000|NOT COMPLETED|Recurrence Follow-up Period||6
9034128|NCT03285477|10096219|FG001|NOT COMPLETED|Recurrence Follow-up Period||55
9034129|NCT03285490|10096228|FG000|STARTED|Treatment and Response Assessment Period||173
9034130|NCT03285490|10096229|FG001|STARTED|Treatment and Response Assessment Period||178
9034131|NCT03285490|10096228|FG000|COMPLETED|Treatment and Response Assessment Period||173
9034132|NCT03285490|10096229|FG001|COMPLETED|Treatment and Response Assessment Period||178
9034133|NCT03285490|10096228|FG000|NOT COMPLETED|Treatment and Response Assessment Period||0
9034134|NCT03285490|10096229|FG001|NOT COMPLETED|Treatment and Response Assessment Period||0
9034135|NCT03285490|10096228|FG000|STARTED|Recurrence Follow-up Period||22
9034136|NCT03285490|10096229|FG001|STARTED|Recurrence Follow-up Period||97
9034137|NCT03285490|10096228|FG000|COMPLETED|Recurrence Follow-up Period||4
9034138|NCT03285490|10096229|FG001|COMPLETED|Recurrence Follow-up Period||36
9034139|NCT03285490|10096228|FG000|NOT COMPLETED|Recurrence Follow-up Period||18
9034140|NCT03285490|10096229|FG001|NOT COMPLETED|Recurrence Follow-up Period||61
9034141|NCT03285529|10096238|FG000|STARTED|Overall Study||30
9034142|NCT03285529|10096239|FG001|STARTED|Overall Study||30
9034143|NCT03285529|10096238|FG000|COMPLETED|Overall Study||30
9034144|NCT03285529|10096239|FG001|COMPLETED|Overall Study||30
9034145|NCT03285529|10096238|FG000|NOT COMPLETED|Overall Study||0
9034146|NCT03285529|10096239|FG001|NOT COMPLETED|Overall Study||0
9034147|NCT03285542|10096247|FG000|STARTED|Overall Study||30
9034148|NCT03285542|10096248|FG001|STARTED|Overall Study||30
9034149|NCT03285542|10096247|FG000|COMPLETED|Overall Study||30
9034150|NCT03285542|10096248|FG001|COMPLETED|Overall Study||30
9034151|NCT03285542|10096247|FG000|NOT COMPLETED|Overall Study||0
9034152|NCT03285542|10096248|FG001|NOT COMPLETED|Overall Study||0
9034153|NCT03285555|10096256|FG000|STARTED|Overall Study||30
9034154|NCT03285555|10096257|FG001|STARTED|Overall Study||30
9034155|NCT03285555|10096256|FG000|COMPLETED|Overall Study||30
9034156|NCT03285555|10096257|FG001|COMPLETED|Overall Study||30
9034157|NCT03285555|10096256|FG000|NOT COMPLETED|Overall Study||0
9034158|NCT03285555|10096257|FG001|NOT COMPLETED|Overall Study||0
9034159|NCT03285594|10096266|FG000|STARTED|Overall Study||144
8672202|NCT00756093|9715683|FG001|COMPLETED|First Intervention||5
8672203|NCT00756093|9715684|FG002|COMPLETED|First Intervention||5
8672204|NCT00756093|9715685|FG003|COMPLETED|First Intervention||5
9034160|NCT03285594|10096267|FG001|STARTED|Overall Study||141
9034161|NCT03285594|10096268|FG002|STARTED|Overall Study||286
9034162|NCT03285594|10096266|FG000|Treated|Overall Study||144
9034163|NCT03285594|10096267|FG001|Treated|Overall Study||141
9034164|NCT03285594|10096268|FG002|Treated|Overall Study||285
9034165|NCT03285594|10096266|FG000|COMPLETED|Overall Study||129
9034166|NCT03285594|10096267|FG001|COMPLETED|Overall Study||130
9034167|NCT03285594|10096268|FG002|COMPLETED|Overall Study||249
9034168|NCT03285594|10096266|FG000|NOT COMPLETED|Overall Study||15
9034169|NCT03285594|10096267|FG001|NOT COMPLETED|Overall Study||11
9034170|NCT03285594|10096268|FG002|NOT COMPLETED|Overall Study||37
9034171|NCT03285646|10096279|FG000|STARTED|Overall Study||32
9034172|NCT03285646|10096280|FG001|STARTED|Overall Study||31
9034173|NCT03285646|10096279|FG000|COMPLETED|Overall Study||19
9034174|NCT03285646|10096280|FG001|COMPLETED|Overall Study||27
9034175|NCT03285646|10096279|FG000|NOT COMPLETED|Overall Study||13
9034176|NCT03285646|10096280|FG001|NOT COMPLETED|Overall Study||4
9034177|NCT03285711|10096289|FG000|STARTED|Blinded Phase (Up to Week 16)||4
9034178|NCT03285711|10096290|FG001|STARTED|Blinded Phase (Up to Week 16)||5
9034179|NCT03285711|10096291|FG002|STARTED|Blinded Phase (Up to Week 16)||0
9034180|NCT03285711|10096292|FG003|STARTED|Blinded Phase (Up to Week 16)||0
9034181|NCT03285711|10096289|FG000|COMPLETED|Blinded Phase (Up to Week 16)||1
9034182|NCT03285711|10096290|FG001|COMPLETED|Blinded Phase (Up to Week 16)||4
9034183|NCT03285711|10096291|FG002|COMPLETED|Blinded Phase (Up to Week 16)||0
9034184|NCT03285711|10096292|FG003|COMPLETED|Blinded Phase (Up to Week 16)||0
9034185|NCT03285711|10096289|FG000|NOT COMPLETED|Blinded Phase (Up to Week 16)||3
9034186|NCT03285711|10096290|FG001|NOT COMPLETED|Blinded Phase (Up to Week 16)||1
8672205|NCT00756093|9715682|FG000|NOT COMPLETED|First Intervention||0
8672206|NCT00756093|9715683|FG001|NOT COMPLETED|First Intervention||0
9034187|NCT03285711|10096291|FG002|NOT COMPLETED|Blinded Phase (Up to Week 16)||0
9034188|NCT03285711|10096292|FG003|NOT COMPLETED|Blinded Phase (Up to Week 16)||0
9034189|NCT03285711|10096289|FG000|STARTED|Blinded Phase (Week 16 to 32)|1 participant switched treatment to filgotinib.|0
9034190|NCT03285711|10096290|FG001|STARTED|Blinded Phase (Week 16 to 32)|1 participant switched treatment to lanraplenib.|3
9034191|NCT03285711|10096291|FG002|STARTED|Blinded Phase (Week 16 to 32)|1 participant switched treatment from lanraplenib.|1
9034192|NCT03285711|10096292|FG003|STARTED|Blinded Phase (Week 16 to 32)|1 participant switched treatment from filgotinib.|1
9034193|NCT03285711|10096289|FG000|COMPLETED|Blinded Phase (Week 16 to 32)||0
9034194|NCT03285711|10096290|FG001|COMPLETED|Blinded Phase (Week 16 to 32)||3
9034195|NCT03285711|10096291|FG002|COMPLETED|Blinded Phase (Week 16 to 32)||0
9034196|NCT03285711|10096292|FG003|COMPLETED|Blinded Phase (Week 16 to 32)||1
9034197|NCT03285711|10096289|FG000|NOT COMPLETED|Blinded Phase (Week 16 to 32)||0
9034198|NCT03285711|10096290|FG001|NOT COMPLETED|Blinded Phase (Week 16 to 32)||0
9034199|NCT03285711|10096291|FG002|NOT COMPLETED|Blinded Phase (Week 16 to 32)||1
9034200|NCT03285711|10096292|FG003|NOT COMPLETED|Blinded Phase (Week 16 to 32)||0
9034201|NCT03285711|10096289|FG000|STARTED|Extended Blinded Phase (Week 32 to 52)||0
9034202|NCT03285711|10096290|FG001|STARTED|Extended Blinded Phase (Week 32 to 52)||3
9034203|NCT03285711|10096291|FG002|STARTED|Extended Blinded Phase (Week 32 to 52)||0
9034204|NCT03285711|10096292|FG003|STARTED|Extended Blinded Phase (Week 32 to 52)||1
9034205|NCT03285711|10096289|FG000|COMPLETED|Extended Blinded Phase (Week 32 to 52)||0
9034206|NCT03285711|10096290|FG001|COMPLETED|Extended Blinded Phase (Week 32 to 52)||2
9034207|NCT03285711|10096291|FG002|COMPLETED|Extended Blinded Phase (Week 32 to 52)||0
9034208|NCT03285711|10096292|FG003|COMPLETED|Extended Blinded Phase (Week 32 to 52)||1
9034209|NCT03285711|10096289|FG000|NOT COMPLETED|Extended Blinded Phase (Week 32 to 52)||0
9034210|NCT03285711|10096290|FG001|NOT COMPLETED|Extended Blinded Phase (Week 32 to 52)||1
9034211|NCT03285711|10096291|FG002|NOT COMPLETED|Extended Blinded Phase (Week 32 to 52)||0
9034212|NCT03285711|10096292|FG003|NOT COMPLETED|Extended Blinded Phase (Week 32 to 52)||0
9034213|NCT03285724|10096302|FG000|STARTED|Overall Study||1
9034214|NCT03285724|10096302|FG000|COMPLETED|Overall Study||1
9034215|NCT03285724|10096302|FG000|NOT COMPLETED|Overall Study||0
9034216|NCT03285958|10096308|FG000|STARTED|Overall Study||33
9034217|NCT03285958|10096309|FG001|STARTED|Overall Study||24
9034218|NCT03285958|10096308|FG000|COMPLETED|Overall Study||28
9034219|NCT03285958|10096309|FG001|COMPLETED|Overall Study||23
9034220|NCT03285958|10096308|FG000|NOT COMPLETED|Overall Study||5
9034221|NCT03285958|10096309|FG001|NOT COMPLETED|Overall Study||1
9034222|NCT03285984|10096316|FG000|STARTED|Overall Study||56
9034223|NCT03285984|10096316|FG000|Received Test Product 1|Overall Study||56
9034224|NCT03285984|10096316|FG000|Received Test Product 2|Overall Study||56
9034225|NCT03285984|10096316|FG000|Received Test Product 3|Overall Study||56
9034226|NCT03285984|10096316|FG000|Received Test Product 4|Overall Study||56
9034227|NCT03285984|10096316|FG000|COMPLETED|Overall Study||56
9034228|NCT03285984|10096316|FG000|NOT COMPLETED|Overall Study||0
9034229|NCT03286218|10096328|FG000|STARTED|Qualification Phase Period 1||48
9034230|NCT03286218|10096329|FG001|STARTED|Qualification Phase Period 1||48
9034231|NCT03286218|10096330|FG002|STARTED|Qualification Phase Period 1||0
9034232|NCT03286218|10096331|FG003|STARTED|Qualification Phase Period 1||0
9034233|NCT03286218|10096332|FG004|STARTED|Qualification Phase Period 1||0
9034234|NCT03286218|10096333|FG005|STARTED|Qualification Phase Period 1||0
9034235|NCT03286218|10096334|FG006|STARTED|Qualification Phase Period 1||0
9034236|NCT03286218|10096335|FG007|STARTED|Qualification Phase Period 1||0
9034237|NCT03286218|10096336|FG008|STARTED|Qualification Phase Period 1||0
9034238|NCT03286218|10096337|FG009|STARTED|Qualification Phase Period 1||0
9034239|NCT03286218|10096338|FG010|STARTED|Qualification Phase Period 1||0
9034240|NCT03286218|10096339|FG011|STARTED|Qualification Phase Period 1||0
9034241|NCT03286218|10096328|FG000|Received at Least One Dose of Study Drug|Qualification Phase Period 1||47
9034242|NCT03286218|10096329|FG001|Received at Least One Dose of Study Drug|Qualification Phase Period 1||47
9034243|NCT03286218|10096330|FG002|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
9034244|NCT03286218|10096331|FG003|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
9034245|NCT03286218|10096332|FG004|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
9034246|NCT03286218|10096333|FG005|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
9034247|NCT03286218|10096334|FG006|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
9034248|NCT03286218|10096335|FG007|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
9034249|NCT03286218|10096336|FG008|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
9034250|NCT03286218|10096337|FG009|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
9034251|NCT03286218|10096338|FG010|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
9034252|NCT03286218|10096339|FG011|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
9034253|NCT03286218|10096328|FG000|COMPLETED|Qualification Phase Period 1||47
9034254|NCT03286218|10096329|FG001|COMPLETED|Qualification Phase Period 1||47
9034255|NCT03286218|10096330|FG002|COMPLETED|Qualification Phase Period 1||0
9034256|NCT03286218|10096331|FG003|COMPLETED|Qualification Phase Period 1||0
9034257|NCT03286218|10096332|FG004|COMPLETED|Qualification Phase Period 1||0
9034258|NCT03286218|10096333|FG005|COMPLETED|Qualification Phase Period 1||0
9034259|NCT03286218|10096334|FG006|COMPLETED|Qualification Phase Period 1||0
9034260|NCT03286218|10096335|FG007|COMPLETED|Qualification Phase Period 1||0
9034261|NCT03286218|10096336|FG008|COMPLETED|Qualification Phase Period 1||0
9034262|NCT03286218|10096337|FG009|COMPLETED|Qualification Phase Period 1||0
9034263|NCT03286218|10096338|FG010|COMPLETED|Qualification Phase Period 1||0
9034264|NCT03286218|10096339|FG011|COMPLETED|Qualification Phase Period 1||0
9034265|NCT03286218|10096328|FG000|NOT COMPLETED|Qualification Phase Period 1||1
9034266|NCT03286218|10096329|FG001|NOT COMPLETED|Qualification Phase Period 1||1
9034267|NCT03286218|10096330|FG002|NOT COMPLETED|Qualification Phase Period 1||0
9034268|NCT03286218|10096331|FG003|NOT COMPLETED|Qualification Phase Period 1||0
9034269|NCT03286218|10096332|FG004|NOT COMPLETED|Qualification Phase Period 1||0
9034270|NCT03286218|10096333|FG005|NOT COMPLETED|Qualification Phase Period 1||0
9034271|NCT03286218|10096334|FG006|NOT COMPLETED|Qualification Phase Period 1||0
9034272|NCT03286218|10096335|FG007|NOT COMPLETED|Qualification Phase Period 1||0
9034273|NCT03286218|10096336|FG008|NOT COMPLETED|Qualification Phase Period 1||0
9034274|NCT03286218|10096337|FG009|NOT COMPLETED|Qualification Phase Period 1||0
9034275|NCT03286218|10096338|FG010|NOT COMPLETED|Qualification Phase Period 1||0
9034276|NCT03286218|10096339|FG011|NOT COMPLETED|Qualification Phase Period 1||0
9034277|NCT03286218|10096328|FG000|STARTED|Qualification Phase Period 2||47
9034278|NCT03286218|10096329|FG001|STARTED|Qualification Phase Period 2||47
9034279|NCT03286218|10096330|FG002|STARTED|Qualification Phase Period 2||0
9034280|NCT03286218|10096331|FG003|STARTED|Qualification Phase Period 2||0
9034281|NCT03286218|10096332|FG004|STARTED|Qualification Phase Period 2||0
9034282|NCT03286218|10096333|FG005|STARTED|Qualification Phase Period 2||0
9034283|NCT03286218|10096334|FG006|STARTED|Qualification Phase Period 2||0
9034284|NCT03286218|10096335|FG007|STARTED|Qualification Phase Period 2||0
9034285|NCT03286218|10096336|FG008|STARTED|Qualification Phase Period 2||0
9034286|NCT03286218|10096337|FG009|STARTED|Qualification Phase Period 2||0
9034287|NCT03286218|10096338|FG010|STARTED|Qualification Phase Period 2||0
9034288|NCT03286218|10096339|FG011|STARTED|Qualification Phase Period 2||0
9034289|NCT03286218|10096328|FG000|COMPLETED|Qualification Phase Period 2||30
9034290|NCT03286218|10096329|FG001|COMPLETED|Qualification Phase Period 2||28
9034291|NCT03286218|10096330|FG002|COMPLETED|Qualification Phase Period 2||0
9034292|NCT03286218|10096331|FG003|COMPLETED|Qualification Phase Period 2||0
9034293|NCT03286218|10096332|FG004|COMPLETED|Qualification Phase Period 2||0
9034294|NCT03286218|10096333|FG005|COMPLETED|Qualification Phase Period 2||0
9034295|NCT03286218|10096334|FG006|COMPLETED|Qualification Phase Period 2||0
9034296|NCT03286218|10096335|FG007|COMPLETED|Qualification Phase Period 2||0
9034297|NCT03286218|10096336|FG008|COMPLETED|Qualification Phase Period 2||0
9034298|NCT03286218|10096337|FG009|COMPLETED|Qualification Phase Period 2||0
9034299|NCT03286218|10096338|FG010|COMPLETED|Qualification Phase Period 2||0
9034300|NCT03286218|10096339|FG011|COMPLETED|Qualification Phase Period 2||0
9034301|NCT03286218|10096328|FG000|NOT COMPLETED|Qualification Phase Period 2||17
9034302|NCT03286218|10096329|FG001|NOT COMPLETED|Qualification Phase Period 2||19
9034303|NCT03286218|10096330|FG002|NOT COMPLETED|Qualification Phase Period 2||0
9034304|NCT03286218|10096331|FG003|NOT COMPLETED|Qualification Phase Period 2||0
9034305|NCT03286218|10096332|FG004|NOT COMPLETED|Qualification Phase Period 2||0
9034306|NCT03286218|10096333|FG005|NOT COMPLETED|Qualification Phase Period 2||0
9034307|NCT03286218|10096334|FG006|NOT COMPLETED|Qualification Phase Period 2||0
9034308|NCT03286218|10096335|FG007|NOT COMPLETED|Qualification Phase Period 2||0
9034309|NCT03286218|10096336|FG008|NOT COMPLETED|Qualification Phase Period 2||0
9034310|NCT03286218|10096337|FG009|NOT COMPLETED|Qualification Phase Period 2||0
9034311|NCT03286218|10096338|FG010|NOT COMPLETED|Qualification Phase Period 2||0
9034312|NCT03286218|10096339|FG011|NOT COMPLETED|Qualification Phase Period 2||0
9034313|NCT03286218|10096328|FG000|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase prior to entering the Treatment Phase.|0
9034314|NCT03286218|10096329|FG001|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase prior to entering the Treatment Phase.|0
9034315|NCT03286218|10096330|FG002|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
9034316|NCT03286218|10096331|FG003|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
9034317|NCT03286218|10096332|FG004|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|5
9034318|NCT03286218|10096333|FG005|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
9034319|NCT03286218|10096334|FG006|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
9034320|NCT03286218|10096335|FG007|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
9034321|NCT03286218|10096336|FG008|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
9034322|NCT03286218|10096337|FG009|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
9034323|NCT03286218|10096338|FG010|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|5
9034324|NCT03286218|10096339|FG011|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
9034325|NCT03286218|10096328|FG000|Received at Least One Dose of Study Drug|Treatment Phase Period 1||0
9034326|NCT03286218|10096329|FG001|Received at Least One Dose of Study Drug|Treatment Phase Period 1||0
9034327|NCT03286218|10096330|FG002|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
9034328|NCT03286218|10096331|FG003|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
9034329|NCT03286218|10096332|FG004|Received at Least One Dose of Study Drug|Treatment Phase Period 1||5
9034330|NCT03286218|10096333|FG005|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
9034331|NCT03286218|10096334|FG006|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
9034332|NCT03286218|10096335|FG007|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
9034333|NCT03286218|10096336|FG008|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
9034334|NCT03286218|10096337|FG009|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
9034335|NCT03286218|10096338|FG010|Received at Least One Dose of Study Drug|Treatment Phase Period 1||5
9034336|NCT03286218|10096339|FG011|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
9034337|NCT03286218|10096328|FG000|COMPLETED|Treatment Phase Period 1||0
9034338|NCT03286218|10096329|FG001|COMPLETED|Treatment Phase Period 1||0
9034339|NCT03286218|10096330|FG002|COMPLETED|Treatment Phase Period 1||5
9034340|NCT03286218|10096331|FG003|COMPLETED|Treatment Phase Period 1||5
9034341|NCT03286218|10096332|FG004|COMPLETED|Treatment Phase Period 1||5
9034342|NCT03286218|10096333|FG005|COMPLETED|Treatment Phase Period 1||5
9034343|NCT03286218|10096334|FG006|COMPLETED|Treatment Phase Period 1||6
9034344|NCT03286218|10096335|FG007|COMPLETED|Treatment Phase Period 1||6
9034345|NCT03286218|10096336|FG008|COMPLETED|Treatment Phase Period 1||6
9034346|NCT03286218|10096337|FG009|COMPLETED|Treatment Phase Period 1||6
9034347|NCT03286218|10096338|FG010|COMPLETED|Treatment Phase Period 1||5
9034348|NCT03286218|10096339|FG011|COMPLETED|Treatment Phase Period 1||5
9034349|NCT03286218|10096328|FG000|NOT COMPLETED|Treatment Phase Period 1||0
9034350|NCT03286218|10096329|FG001|NOT COMPLETED|Treatment Phase Period 1||0
9034351|NCT03286218|10096330|FG002|NOT COMPLETED|Treatment Phase Period 1||1
9034352|NCT03286218|10096331|FG003|NOT COMPLETED|Treatment Phase Period 1||1
9034353|NCT03286218|10096332|FG004|NOT COMPLETED|Treatment Phase Period 1||0
9034354|NCT03286218|10096333|FG005|NOT COMPLETED|Treatment Phase Period 1||1
9034355|NCT03286218|10096334|FG006|NOT COMPLETED|Treatment Phase Period 1||0
9034356|NCT03286218|10096335|FG007|NOT COMPLETED|Treatment Phase Period 1||0
9034357|NCT03286218|10096336|FG008|NOT COMPLETED|Treatment Phase Period 1||0
9034358|NCT03286218|10096337|FG009|NOT COMPLETED|Treatment Phase Period 1||0
9034359|NCT03286218|10096338|FG010|NOT COMPLETED|Treatment Phase Period 1||0
9034360|NCT03286218|10096339|FG011|NOT COMPLETED|Treatment Phase Period 1||1
9034361|NCT03286218|10096328|FG000|STARTED|Treatment Phase Period 2||0
9034362|NCT03286218|10096329|FG001|STARTED|Treatment Phase Period 2||0
9034363|NCT03286218|10096330|FG002|STARTED|Treatment Phase Period 2||5
9034364|NCT03286218|10096331|FG003|STARTED|Treatment Phase Period 2||5
9034365|NCT03286218|10096332|FG004|STARTED|Treatment Phase Period 2||5
9034366|NCT03286218|10096333|FG005|STARTED|Treatment Phase Period 2||5
9034367|NCT03286218|10096334|FG006|STARTED|Treatment Phase Period 2||6
9034368|NCT03286218|10096335|FG007|STARTED|Treatment Phase Period 2||6
9034369|NCT03286218|10096336|FG008|STARTED|Treatment Phase Period 2||6
9034370|NCT03286218|10096337|FG009|STARTED|Treatment Phase Period 2||6
9034371|NCT03286218|10096338|FG010|STARTED|Treatment Phase Period 2||5
9034372|NCT03286218|10096339|FG011|STARTED|Treatment Phase Period 2||5
9034373|NCT03286218|10096328|FG000|COMPLETED|Treatment Phase Period 2||0
9034374|NCT03286218|10096329|FG001|COMPLETED|Treatment Phase Period 2||0
9034375|NCT03286218|10096330|FG002|COMPLETED|Treatment Phase Period 2||5
9034376|NCT03286218|10096331|FG003|COMPLETED|Treatment Phase Period 2||5
9034377|NCT03286218|10096332|FG004|COMPLETED|Treatment Phase Period 2||5
9034378|NCT03286218|10096333|FG005|COMPLETED|Treatment Phase Period 2||5
9034379|NCT03286218|10096334|FG006|COMPLETED|Treatment Phase Period 2||6
9034380|NCT03286218|10096335|FG007|COMPLETED|Treatment Phase Period 2||6
9034381|NCT03286218|10096336|FG008|COMPLETED|Treatment Phase Period 2||6
9034382|NCT03286218|10096337|FG009|COMPLETED|Treatment Phase Period 2||6
9034383|NCT03286218|10096338|FG010|COMPLETED|Treatment Phase Period 2||5
9034384|NCT03286218|10096339|FG011|COMPLETED|Treatment Phase Period 2||5
9034385|NCT03286218|10096328|FG000|NOT COMPLETED|Treatment Phase Period 2||0
9034386|NCT03286218|10096329|FG001|NOT COMPLETED|Treatment Phase Period 2||0
9034387|NCT03286218|10096330|FG002|NOT COMPLETED|Treatment Phase Period 2||0
9034388|NCT03286218|10096331|FG003|NOT COMPLETED|Treatment Phase Period 2||0
9034389|NCT03286218|10096332|FG004|NOT COMPLETED|Treatment Phase Period 2||0
9034390|NCT03286218|10096333|FG005|NOT COMPLETED|Treatment Phase Period 2||0
9034391|NCT03286218|10096334|FG006|NOT COMPLETED|Treatment Phase Period 2||0
9034392|NCT03286218|10096335|FG007|NOT COMPLETED|Treatment Phase Period 2||0
9034393|NCT03286218|10096336|FG008|NOT COMPLETED|Treatment Phase Period 2||0
9034394|NCT03286218|10096337|FG009|NOT COMPLETED|Treatment Phase Period 2||0
9034395|NCT03286218|10096338|FG010|NOT COMPLETED|Treatment Phase Period 2||0
9034396|NCT03286218|10096339|FG011|NOT COMPLETED|Treatment Phase Period 2||0
9034397|NCT03286218|10096328|FG000|STARTED|Treatment Phase Period 3||0
9034398|NCT03286218|10096329|FG001|STARTED|Treatment Phase Period 3||0
9034399|NCT03286218|10096330|FG002|STARTED|Treatment Phase Period 3||5
9034400|NCT03286218|10096331|FG003|STARTED|Treatment Phase Period 3||5
9034401|NCT03286218|10096332|FG004|STARTED|Treatment Phase Period 3||5
9034402|NCT03286218|10096333|FG005|STARTED|Treatment Phase Period 3||5
9034403|NCT03286218|10096334|FG006|STARTED|Treatment Phase Period 3||6
9034404|NCT03286218|10096335|FG007|STARTED|Treatment Phase Period 3||6
9034405|NCT03286218|10096336|FG008|STARTED|Treatment Phase Period 3||6
9034406|NCT03286218|10096337|FG009|STARTED|Treatment Phase Period 3||6
9034407|NCT03286218|10096338|FG010|STARTED|Treatment Phase Period 3||5
9034408|NCT03286218|10096339|FG011|STARTED|Treatment Phase Period 3||5
9034409|NCT03286218|10096328|FG000|COMPLETED|Treatment Phase Period 3||0
9034410|NCT03286218|10096329|FG001|COMPLETED|Treatment Phase Period 3||0
9034411|NCT03286218|10096330|FG002|COMPLETED|Treatment Phase Period 3||5
9034412|NCT03286218|10096331|FG003|COMPLETED|Treatment Phase Period 3||5
9034413|NCT03286218|10096332|FG004|COMPLETED|Treatment Phase Period 3||5
9034414|NCT03286218|10096333|FG005|COMPLETED|Treatment Phase Period 3||5
9034415|NCT03286218|10096334|FG006|COMPLETED|Treatment Phase Period 3||6
9034416|NCT03286218|10096335|FG007|COMPLETED|Treatment Phase Period 3||6
9034417|NCT03286218|10096336|FG008|COMPLETED|Treatment Phase Period 3||6
9034418|NCT03286218|10096337|FG009|COMPLETED|Treatment Phase Period 3||6
9034419|NCT03286218|10096338|FG010|COMPLETED|Treatment Phase Period 3||5
9034420|NCT03286218|10096339|FG011|COMPLETED|Treatment Phase Period 3||5
9034421|NCT03286218|10096328|FG000|NOT COMPLETED|Treatment Phase Period 3||0
9034422|NCT03286218|10096329|FG001|NOT COMPLETED|Treatment Phase Period 3||0
9034423|NCT03286218|10096330|FG002|NOT COMPLETED|Treatment Phase Period 3||0
9034424|NCT03286218|10096331|FG003|NOT COMPLETED|Treatment Phase Period 3||0
9034425|NCT03286218|10096332|FG004|NOT COMPLETED|Treatment Phase Period 3||0
9034426|NCT03286218|10096333|FG005|NOT COMPLETED|Treatment Phase Period 3||0
9034427|NCT03286218|10096334|FG006|NOT COMPLETED|Treatment Phase Period 3||0
9034428|NCT03286218|10096335|FG007|NOT COMPLETED|Treatment Phase Period 3||0
9034429|NCT03286218|10096336|FG008|NOT COMPLETED|Treatment Phase Period 3||0
9034430|NCT03286218|10096337|FG009|NOT COMPLETED|Treatment Phase Period 3||0
9034431|NCT03286218|10096338|FG010|NOT COMPLETED|Treatment Phase Period 3||0
9034432|NCT03286218|10096339|FG011|NOT COMPLETED|Treatment Phase Period 3||0
9034433|NCT03286218|10096328|FG000|STARTED|Treatment Phase Period 4||0
9034434|NCT03286218|10096329|FG001|STARTED|Treatment Phase Period 4||0
9034435|NCT03286218|10096330|FG002|STARTED|Treatment Phase Period 4||5
9034436|NCT03286218|10096331|FG003|STARTED|Treatment Phase Period 4||5
9034437|NCT03286218|10096332|FG004|STARTED|Treatment Phase Period 4||5
9034438|NCT03286218|10096333|FG005|STARTED|Treatment Phase Period 4||5
9034439|NCT03286218|10096334|FG006|STARTED|Treatment Phase Period 4||6
9034440|NCT03286218|10096335|FG007|STARTED|Treatment Phase Period 4||6
9034441|NCT03286218|10096336|FG008|STARTED|Treatment Phase Period 4||6
9034442|NCT03286218|10096337|FG009|STARTED|Treatment Phase Period 4||6
9034443|NCT03286218|10096338|FG010|STARTED|Treatment Phase Period 4||5
9034444|NCT03286218|10096339|FG011|STARTED|Treatment Phase Period 4||5
9034445|NCT03286218|10096328|FG000|COMPLETED|Treatment Phase Period 4||0
9034446|NCT03286218|10096329|FG001|COMPLETED|Treatment Phase Period 4||0
9034447|NCT03286218|10096330|FG002|COMPLETED|Treatment Phase Period 4||5
9034448|NCT03286218|10096331|FG003|COMPLETED|Treatment Phase Period 4||5
9034449|NCT03286218|10096332|FG004|COMPLETED|Treatment Phase Period 4||5
9034450|NCT03286218|10096333|FG005|COMPLETED|Treatment Phase Period 4||5
9034451|NCT03286218|10096334|FG006|COMPLETED|Treatment Phase Period 4||6
9034452|NCT03286218|10096335|FG007|COMPLETED|Treatment Phase Period 4||6
9034453|NCT03286218|10096336|FG008|COMPLETED|Treatment Phase Period 4||6
9034454|NCT03286218|10096337|FG009|COMPLETED|Treatment Phase Period 4||6
9034455|NCT03286218|10096338|FG010|COMPLETED|Treatment Phase Period 4||5
9034456|NCT03286218|10096339|FG011|COMPLETED|Treatment Phase Period 4||4
9034457|NCT03286218|10096328|FG000|NOT COMPLETED|Treatment Phase Period 4||0
9034458|NCT03286218|10096329|FG001|NOT COMPLETED|Treatment Phase Period 4||0
9034459|NCT03286218|10096330|FG002|NOT COMPLETED|Treatment Phase Period 4||0
9034460|NCT03286218|10096331|FG003|NOT COMPLETED|Treatment Phase Period 4||0
9034461|NCT03286218|10096332|FG004|NOT COMPLETED|Treatment Phase Period 4||0
9034462|NCT03286218|10096333|FG005|NOT COMPLETED|Treatment Phase Period 4||0
9034463|NCT03286218|10096334|FG006|NOT COMPLETED|Treatment Phase Period 4||0
9034464|NCT03286218|10096335|FG007|NOT COMPLETED|Treatment Phase Period 4||0
9034465|NCT03286218|10096336|FG008|NOT COMPLETED|Treatment Phase Period 4||0
9034466|NCT03286218|10096337|FG009|NOT COMPLETED|Treatment Phase Period 4||0
9034467|NCT03286218|10096338|FG010|NOT COMPLETED|Treatment Phase Period 4||0
9034468|NCT03286218|10096339|FG011|NOT COMPLETED|Treatment Phase Period 4||1
9034469|NCT03286218|10096328|FG000|STARTED|Treatment Phase Period 5||0
9034470|NCT03286218|10096329|FG001|STARTED|Treatment Phase Period 5||0
9034471|NCT03286218|10096330|FG002|STARTED|Treatment Phase Period 5||5
9034472|NCT03286218|10096331|FG003|STARTED|Treatment Phase Period 5||5
9034473|NCT03286218|10096332|FG004|STARTED|Treatment Phase Period 5||5
9034474|NCT03286218|10096333|FG005|STARTED|Treatment Phase Period 5||5
9034475|NCT03286218|10096334|FG006|STARTED|Treatment Phase Period 5||6
9034476|NCT03286218|10096335|FG007|STARTED|Treatment Phase Period 5||6
9034477|NCT03286218|10096336|FG008|STARTED|Treatment Phase Period 5||6
9034478|NCT03286218|10096337|FG009|STARTED|Treatment Phase Period 5||6
9034479|NCT03286218|10096338|FG010|STARTED|Treatment Phase Period 5||5
9034480|NCT03286218|10096339|FG011|STARTED|Treatment Phase Period 5||4
9034481|NCT03286218|10096328|FG000|COMPLETED|Treatment Phase Period 5||0
9034482|NCT03286218|10096329|FG001|COMPLETED|Treatment Phase Period 5||0
9034483|NCT03286218|10096330|FG002|COMPLETED|Treatment Phase Period 5||5
9034484|NCT03286218|10096331|FG003|COMPLETED|Treatment Phase Period 5||5
9034485|NCT03286218|10096332|FG004|COMPLETED|Treatment Phase Period 5||5
9034486|NCT03286218|10096333|FG005|COMPLETED|Treatment Phase Period 5||5
9034487|NCT03286218|10096334|FG006|COMPLETED|Treatment Phase Period 5||6
9034488|NCT03286218|10096335|FG007|COMPLETED|Treatment Phase Period 5||6
9034489|NCT03286218|10096336|FG008|COMPLETED|Treatment Phase Period 5||6
9034490|NCT03286218|10096337|FG009|COMPLETED|Treatment Phase Period 5||6
9034491|NCT03286218|10096338|FG010|COMPLETED|Treatment Phase Period 5||5
9034492|NCT03286218|10096339|FG011|COMPLETED|Treatment Phase Period 5||4
9034493|NCT03286218|10096328|FG000|NOT COMPLETED|Treatment Phase Period 5||0
9034494|NCT03286218|10096329|FG001|NOT COMPLETED|Treatment Phase Period 5||0
9034495|NCT03286218|10096330|FG002|NOT COMPLETED|Treatment Phase Period 5||0
9034496|NCT03286218|10096331|FG003|NOT COMPLETED|Treatment Phase Period 5||0
9034497|NCT03286218|10096332|FG004|NOT COMPLETED|Treatment Phase Period 5||0
9034498|NCT03286218|10096333|FG005|NOT COMPLETED|Treatment Phase Period 5||0
9034499|NCT03286218|10096334|FG006|NOT COMPLETED|Treatment Phase Period 5||0
9034500|NCT03286218|10096335|FG007|NOT COMPLETED|Treatment Phase Period 5||0
9034501|NCT03286218|10096336|FG008|NOT COMPLETED|Treatment Phase Period 5||0
9034502|NCT03286218|10096337|FG009|NOT COMPLETED|Treatment Phase Period 5||0
9034503|NCT03286218|10096338|FG010|NOT COMPLETED|Treatment Phase Period 5||0
9034504|NCT03286218|10096339|FG011|NOT COMPLETED|Treatment Phase Period 5||0
9034505|NCT03286283|10096366|FG000|STARTED|Overall Study||55
9034506|NCT03286283|10096366|FG000|COMPLETED|Overall Study||55
9034507|NCT03286283|10096366|FG000|NOT COMPLETED|Overall Study||0
9034508|NCT03286400|10096370|FG000|STARTED|Overall Study||127
9034509|NCT03286400|10096370|FG000|COMPLETED|Overall Study||102
9034510|NCT03286400|10096370|FG000|NOT COMPLETED|Overall Study||25
9034511|NCT03286465|10096376|FG000|STARTED|Overall Study||100
9034512|NCT03286465|10096377|FG001|STARTED|Overall Study||100
9034513|NCT03286465|10096376|FG000|COMPLETED|Overall Study||100
9034514|NCT03286465|10096377|FG001|COMPLETED|Overall Study||100
9034515|NCT03286465|10096376|FG000|NOT COMPLETED|Overall Study||0
9034516|NCT03286465|10096377|FG001|NOT COMPLETED|Overall Study||0
9034517|NCT03286543|10096385|FG000|STARTED|Consented||47
9034518|NCT03286543|10096386|FG001|STARTED|Consented||0
9034519|NCT03286543|10096387|FG002|STARTED|Consented||0
9034520|NCT03286543|10096385|FG000|Randomized|Consented||45
9034521|NCT03286543|10096386|FG001|Randomized|Consented||0
9034522|NCT03286543|10096387|FG002|Randomized|Consented||0
9034523|NCT03286543|10096385|FG000|Enrolled|Consented||41
9034524|NCT03286543|10096386|FG001|Enrolled|Consented||0
9034525|NCT03286543|10096387|FG002|Enrolled|Consented||0
9034526|NCT03286543|10096385|FG000|Intent to Treat Set|Consented||37
9034527|NCT03286543|10096386|FG001|Intent to Treat Set|Consented||0
9034528|NCT03286543|10096387|FG002|Intent to Treat Set|Consented||0
9034529|NCT03286543|10096385|FG000|Per Protocol Set|Consented||23
9034530|NCT03286543|10096386|FG001|Per Protocol Set|Consented||0
9034531|NCT03286543|10096387|FG002|Per Protocol Set|Consented||0
9034532|NCT03286543|10096385|FG000|COMPLETED|Consented||28
9034533|NCT03286543|10096386|FG001|COMPLETED|Consented||0
9034534|NCT03286543|10096387|FG002|COMPLETED|Consented||0
9034535|NCT03286543|10096385|FG000|NOT COMPLETED|Consented||19
9034536|NCT03286543|10096386|FG001|NOT COMPLETED|Consented||0
9034537|NCT03286543|10096387|FG002|NOT COMPLETED|Consented||0
9034538|NCT03286543|10096385|FG000|STARTED|Study Enrollment||0
9034539|NCT03286543|10096386|FG001|STARTED|Study Enrollment||18
9034540|NCT03286543|10096387|FG002|STARTED|Study Enrollment||23
9034541|NCT03286543|10096385|FG000|Intent to Treat Set|Study Enrollment||0
9034542|NCT03286543|10096386|FG001|Intent to Treat Set|Study Enrollment||18
9034543|NCT03286543|10096387|FG002|Intent to Treat Set|Study Enrollment||19
9034544|NCT03286543|10096385|FG000|Per Protocol Set|Study Enrollment||0
9034545|NCT03286543|10096386|FG001|Per Protocol Set|Study Enrollment||7
9034546|NCT03286543|10096387|FG002|Per Protocol Set|Study Enrollment||16
9034547|NCT03286543|10096385|FG000|COMPLETED|Study Enrollment||0
9034548|NCT03286543|10096386|FG001|COMPLETED|Study Enrollment||12
9034549|NCT03286543|10096387|FG002|COMPLETED|Study Enrollment||16
9034550|NCT03286543|10096385|FG000|NOT COMPLETED|Study Enrollment||0
9034551|NCT03286543|10096386|FG001|NOT COMPLETED|Study Enrollment||6
8672207|NCT00756093|9715684|FG002|NOT COMPLETED|First Intervention||0
8672208|NCT00756093|9715685|FG003|NOT COMPLETED|First Intervention||0
8672209|NCT00756093|9715682|FG000|STARTED|Second Intervention||5
8672210|NCT00756093|9715683|FG001|STARTED|Second Intervention||5
8672211|NCT00756093|9715684|FG002|STARTED|Second Intervention||5
8672212|NCT00756093|9715685|FG003|STARTED|Second Intervention||5
8672213|NCT00756093|9715682|FG000|COMPLETED|Second Intervention||5
8672214|NCT00756093|9715683|FG001|COMPLETED|Second Intervention||5
8672215|NCT00756093|9715684|FG002|COMPLETED|Second Intervention||5
8672216|NCT00756093|9715685|FG003|COMPLETED|Second Intervention||5
8672217|NCT00756093|9715682|FG000|NOT COMPLETED|Second Intervention||0
8672218|NCT00756093|9715683|FG001|NOT COMPLETED|Second Intervention||0
8672219|NCT00756093|9715684|FG002|NOT COMPLETED|Second Intervention||0
8799467|NCT01437501|9850995|FG000|STARTED|Overall Study||148
9034552|NCT03286543|10096387|FG002|NOT COMPLETED|Study Enrollment||7
9034553|NCT03286751|10096393|FG000|STARTED|Period 1||7
9034554|NCT03286751|10096394|FG001|STARTED|Period 1||7
9034555|NCT03286751|10096395|FG002|STARTED|Period 1||7
9034556|NCT03286751|10096396|FG003|STARTED|Period 1||7
9034557|NCT03286751|10096397|FG004|STARTED|Period 1||7
9034558|NCT03286751|10096398|FG005|STARTED|Period 1||7
9034559|NCT03286751|10096393|FG000|Received at Least One Dose of Study Drug|Period 1||7
9034560|NCT03286751|10096394|FG001|Received at Least One Dose of Study Drug|Period 1||7
9034561|NCT03286751|10096395|FG002|Received at Least One Dose of Study Drug|Period 1||7
9034562|NCT03286751|10096396|FG003|Received at Least One Dose of Study Drug|Period 1||7
9034563|NCT03286751|10096397|FG004|Received at Least One Dose of Study Drug|Period 1||7
9034564|NCT03286751|10096398|FG005|Received at Least One Dose of Study Drug|Period 1||7
9034565|NCT03286751|10096393|FG000|COMPLETED|Period 1||7
9034566|NCT03286751|10096394|FG001|COMPLETED|Period 1||7
9034567|NCT03286751|10096395|FG002|COMPLETED|Period 1||7
9034568|NCT03286751|10096396|FG003|COMPLETED|Period 1||7
9034569|NCT03286751|10096397|FG004|COMPLETED|Period 1||7
9034570|NCT03286751|10096398|FG005|COMPLETED|Period 1||7
9034571|NCT03286751|10096393|FG000|NOT COMPLETED|Period 1||0
9034572|NCT03286751|10096394|FG001|NOT COMPLETED|Period 1||0
9034573|NCT03286751|10096395|FG002|NOT COMPLETED|Period 1||0
9034574|NCT03286751|10096396|FG003|NOT COMPLETED|Period 1||0
9034575|NCT03286751|10096397|FG004|NOT COMPLETED|Period 1||0
9034576|NCT03286751|10096398|FG005|NOT COMPLETED|Period 1||0
9034577|NCT03286751|10096393|FG000|STARTED|Washout Period 1||7
9034578|NCT03286751|10096394|FG001|STARTED|Washout Period 1||7
9034579|NCT03286751|10096395|FG002|STARTED|Washout Period 1||7
9034580|NCT03286751|10096396|FG003|STARTED|Washout Period 1||7
9034581|NCT03286751|10096397|FG004|STARTED|Washout Period 1||7
9034582|NCT03286751|10096398|FG005|STARTED|Washout Period 1||7
9034583|NCT03286751|10096393|FG000|COMPLETED|Washout Period 1||7
9034584|NCT03286751|10096394|FG001|COMPLETED|Washout Period 1||7
9034585|NCT03286751|10096395|FG002|COMPLETED|Washout Period 1||7
9034586|NCT03286751|10096396|FG003|COMPLETED|Washout Period 1||7
9034587|NCT03286751|10096397|FG004|COMPLETED|Washout Period 1||6
9034588|NCT03286751|10096398|FG005|COMPLETED|Washout Period 1||7
9034589|NCT03286751|10096393|FG000|NOT COMPLETED|Washout Period 1||0
9034590|NCT03286751|10096394|FG001|NOT COMPLETED|Washout Period 1||0
9034591|NCT03286751|10096395|FG002|NOT COMPLETED|Washout Period 1||0
9034592|NCT03286751|10096396|FG003|NOT COMPLETED|Washout Period 1||0
9034593|NCT03286751|10096397|FG004|NOT COMPLETED|Washout Period 1||1
9034594|NCT03286751|10096398|FG005|NOT COMPLETED|Washout Period 1||0
9034595|NCT03286751|10096393|FG000|STARTED|Period 2||7
9034596|NCT03286751|10096394|FG001|STARTED|Period 2||7
9034597|NCT03286751|10096395|FG002|STARTED|Period 2||7
9034598|NCT03286751|10096396|FG003|STARTED|Period 2||7
9034599|NCT03286751|10096397|FG004|STARTED|Period 2||6
9034600|NCT03286751|10096398|FG005|STARTED|Period 2||7
9034601|NCT03286751|10096393|FG000|COMPLETED|Period 2||7
9034602|NCT03286751|10096394|FG001|COMPLETED|Period 2||7
9034603|NCT03286751|10096395|FG002|COMPLETED|Period 2||7
9034604|NCT03286751|10096396|FG003|COMPLETED|Period 2||7
9034605|NCT03286751|10096397|FG004|COMPLETED|Period 2||6
9034606|NCT03286751|10096398|FG005|COMPLETED|Period 2||7
9034607|NCT03286751|10096393|FG000|NOT COMPLETED|Period 2||0
9034608|NCT03286751|10096394|FG001|NOT COMPLETED|Period 2||0
9034609|NCT03286751|10096395|FG002|NOT COMPLETED|Period 2||0
9034610|NCT03286751|10096396|FG003|NOT COMPLETED|Period 2||0
9034611|NCT03286751|10096397|FG004|NOT COMPLETED|Period 2||0
9034612|NCT03286751|10096398|FG005|NOT COMPLETED|Period 2||0
9034613|NCT03286751|10096393|FG000|STARTED|Washout Period 2||7
9034614|NCT03286751|10096394|FG001|STARTED|Washout Period 2||7
9034615|NCT03286751|10096395|FG002|STARTED|Washout Period 2||7
9034616|NCT03286751|10096396|FG003|STARTED|Washout Period 2||7
9034617|NCT03286751|10096397|FG004|STARTED|Washout Period 2||6
9034618|NCT03286751|10096398|FG005|STARTED|Washout Period 2||7
9034619|NCT03286751|10096393|FG000|COMPLETED|Washout Period 2||7
9034620|NCT03286751|10096394|FG001|COMPLETED|Washout Period 2||6
9034621|NCT03286751|10096395|FG002|COMPLETED|Washout Period 2||7
9034622|NCT03286751|10096396|FG003|COMPLETED|Washout Period 2||7
9034623|NCT03286751|10096397|FG004|COMPLETED|Washout Period 2||6
9034624|NCT03286751|10096398|FG005|COMPLETED|Washout Period 2||7
9034625|NCT03286751|10096393|FG000|NOT COMPLETED|Washout Period 2||0
9034626|NCT03286751|10096394|FG001|NOT COMPLETED|Washout Period 2||1
9034627|NCT03286751|10096395|FG002|NOT COMPLETED|Washout Period 2||0
9034628|NCT03286751|10096396|FG003|NOT COMPLETED|Washout Period 2||0
9034629|NCT03286751|10096397|FG004|NOT COMPLETED|Washout Period 2||0
9034630|NCT03286751|10096398|FG005|NOT COMPLETED|Washout Period 2||0
9034631|NCT03286751|10096393|FG000|STARTED|Period 3||7
9034632|NCT03286751|10096394|FG001|STARTED|Period 3||6
9034633|NCT03286751|10096395|FG002|STARTED|Period 3||7
9034634|NCT03286751|10096396|FG003|STARTED|Period 3||7
9034635|NCT03286751|10096397|FG004|STARTED|Period 3||6
9034636|NCT03286751|10096398|FG005|STARTED|Period 3||7
9034637|NCT03286751|10096393|FG000|COMPLETED|Period 3||7
9034638|NCT03286751|10096394|FG001|COMPLETED|Period 3||6
9034639|NCT03286751|10096395|FG002|COMPLETED|Period 3||7
9034640|NCT03286751|10096396|FG003|COMPLETED|Period 3||7
9034641|NCT03286751|10096397|FG004|COMPLETED|Period 3||6
9034642|NCT03286751|10096398|FG005|COMPLETED|Period 3||7
9034643|NCT03286751|10096393|FG000|NOT COMPLETED|Period 3||0
9034644|NCT03286751|10096394|FG001|NOT COMPLETED|Period 3||0
9034645|NCT03286751|10096395|FG002|NOT COMPLETED|Period 3||0
9034646|NCT03286751|10096396|FG003|NOT COMPLETED|Period 3||0
9034647|NCT03286751|10096397|FG004|NOT COMPLETED|Period 3||0
9034648|NCT03286751|10096398|FG005|NOT COMPLETED|Period 3||0
9034649|NCT03286751|10096393|FG000|STARTED|Washout Period 3||7
9034650|NCT03286751|10096394|FG001|STARTED|Washout Period 3||6
9034651|NCT03286751|10096395|FG002|STARTED|Washout Period 3||7
9034652|NCT03286751|10096396|FG003|STARTED|Washout Period 3||7
9034653|NCT03286751|10096397|FG004|STARTED|Washout Period 3||6
9034654|NCT03286751|10096398|FG005|STARTED|Washout Period 3||7
9034655|NCT03286751|10096393|FG000|COMPLETED|Washout Period 3||7
9034656|NCT03286751|10096394|FG001|COMPLETED|Washout Period 3||6
9034657|NCT03286751|10096395|FG002|COMPLETED|Washout Period 3||7
9034658|NCT03286751|10096396|FG003|COMPLETED|Washout Period 3||7
9034659|NCT03286751|10096397|FG004|COMPLETED|Washout Period 3||6
9034660|NCT03286751|10096398|FG005|COMPLETED|Washout Period 3||7
9034661|NCT03286751|10096393|FG000|NOT COMPLETED|Washout Period 3||0
9034662|NCT03286751|10096394|FG001|NOT COMPLETED|Washout Period 3||0
9034663|NCT03286751|10096395|FG002|NOT COMPLETED|Washout Period 3||0
8672220|NCT00756093|9715685|FG003|NOT COMPLETED|Second Intervention||0
8672221|NCT00756093|9715682|FG000|STARTED|Third Intervention||5
8672222|NCT00756093|9715683|FG001|STARTED|Third Intervention||5
8672223|NCT00756093|9715684|FG002|STARTED|Third Intervention||5
8672224|NCT00756093|9715685|FG003|STARTED|Third Intervention||5
8672225|NCT00756093|9715682|FG000|COMPLETED|Third Intervention||5
8672226|NCT00756093|9715683|FG001|COMPLETED|Third Intervention||5
8672227|NCT00756093|9715684|FG002|COMPLETED|Third Intervention||5
8672228|NCT00756093|9715685|FG003|COMPLETED|Third Intervention||5
8672229|NCT00756093|9715682|FG000|NOT COMPLETED|Third Intervention||0
8672230|NCT00756093|9715683|FG001|NOT COMPLETED|Third Intervention||0
8672231|NCT00756093|9715684|FG002|NOT COMPLETED|Third Intervention||0
8672232|NCT00756093|9715685|FG003|NOT COMPLETED|Third Intervention||0
8672233|NCT00756093|9715682|FG000|STARTED|Fourth Intervention||5
8672234|NCT00756093|9715683|FG001|STARTED|Fourth Intervention||5
8672235|NCT00756093|9715684|FG002|STARTED|Fourth Intervention||5
8672236|NCT00756093|9715685|FG003|STARTED|Fourth Intervention||5
8672237|NCT00756093|9715682|FG000|COMPLETED|Fourth Intervention||5
8672238|NCT00756093|9715683|FG001|COMPLETED|Fourth Intervention||5
8672239|NCT00756093|9715684|FG002|COMPLETED|Fourth Intervention||5
8672240|NCT00756093|9715685|FG003|COMPLETED|Fourth Intervention||5
8672241|NCT00756093|9715682|FG000|NOT COMPLETED|Fourth Intervention||0
8672242|NCT00756093|9715683|FG001|NOT COMPLETED|Fourth Intervention||0
8672243|NCT00756093|9715684|FG002|NOT COMPLETED|Fourth Intervention||0
8672244|NCT00756093|9715685|FG003|NOT COMPLETED|Fourth Intervention||0
8672245|NCT00756106|9715695|FG000|STARTED|Overall Study||15
8672246|NCT00756106|9715695|FG000|COMPLETED|Overall Study||3
8672247|NCT00756106|9715695|FG000|NOT COMPLETED|Overall Study||12
8672248|NCT00756236|9715702|FG000|STARTED|Overall Study||20
8672249|NCT00756236|9715703|FG001|STARTED|Overall Study||20
8672250|NCT00756236|9715704|FG002|STARTED|Overall Study||20
8672251|NCT00756236|9715702|FG000|COMPLETED|Overall Study||20
8672252|NCT00756236|9715703|FG001|COMPLETED|Overall Study||20
8672253|NCT00756236|9715704|FG002|COMPLETED|Overall Study||20
8672254|NCT00756236|9715702|FG000|NOT COMPLETED|Overall Study||0
8672255|NCT00756236|9715703|FG001|NOT COMPLETED|Overall Study||0
8672256|NCT00756236|9715704|FG002|NOT COMPLETED|Overall Study||0
8672257|NCT00756275|9715714|FG000|STARTED|Overall Study||60
8672258|NCT00756275|9715715|FG001|STARTED|Overall Study||77
8672259|NCT00756275|9715714|FG000|COMPLETED|Overall Study||31
8672260|NCT00756275|9715715|FG001|COMPLETED|Overall Study||49
8672261|NCT00756275|9715714|FG000|NOT COMPLETED|Overall Study||29
8672262|NCT00756275|9715715|FG001|NOT COMPLETED|Overall Study||28
8672263|NCT00756314|9715723|FG000|STARTED|Overall Study||123
8672264|NCT00756314|9715724|FG001|STARTED|Overall Study||123
8672265|NCT00756314|9715723|FG000|COMPLETED|Overall Study|"2 participants discontinued the intervention and were analyzed by intention to treat analysis."|121
8672266|NCT00756314|9715724|FG001|COMPLETED|Overall Study|"4 participants did not do the follow up, 55 discontinued and were analyzed by intention to treat"|64
8672267|NCT00756314|9715723|FG000|NOT COMPLETED|Overall Study||2
8672268|NCT00756314|9715724|FG001|NOT COMPLETED|Overall Study||59
8672269|NCT00756444|9715732|FG000|STARTED|Overall Study||33
8672270|NCT00756444|9715733|FG001|STARTED|Overall Study||34
8799468|NCT01437501|9850996|FG001|STARTED|Overall Study||143
8799469|NCT01437501|9850995|FG000|COMPLETED|Overall Study||135
8799470|NCT01437501|9850996|FG001|COMPLETED|Overall Study||132
8799471|NCT01437501|9850995|FG000|NOT COMPLETED|Overall Study||13
8799472|NCT01437501|9850996|FG001|NOT COMPLETED|Overall Study||11
8799473|NCT01437540|9851006|FG000|STARTED|Overall Study||392
8799474|NCT01437540|9851007|FG001|STARTED|Overall Study||198
8799475|NCT01437540|9851006|FG000|COMPLETED|Overall Study||265
8799476|NCT01437540|9851007|FG001|COMPLETED|Overall Study||133
8799477|NCT01437540|9851006|FG000|NOT COMPLETED|Overall Study||127
8799478|NCT01437540|9851007|FG001|NOT COMPLETED|Overall Study||65
8799479|NCT01437605|9851015|FG000|STARTED|Overall Study||9
8799480|NCT01437605|9851016|FG001|STARTED|Overall Study||5
8799481|NCT01437605|9851015|FG000|COMPLETED|Overall Study||9
8799482|NCT01437605|9851016|FG001|COMPLETED|Overall Study||5
8799483|NCT01437605|9851015|FG000|NOT COMPLETED|Overall Study||0
8799484|NCT01437605|9851016|FG001|NOT COMPLETED|Overall Study||0
8799485|NCT01437852|9851022|FG000|STARTED|Overall Study||30
8799486|NCT01437852|9851022|FG000|Received StrataGraft Skin Tissue|Overall Study||30
8799487|NCT01437852|9851022|FG000|Received Autograft|Overall Study||30
8799488|NCT01437852|9851022|FG000|COMPLETED|Overall Study||30
8799489|NCT01437852|9851022|FG000|NOT COMPLETED|Overall Study||0
9034664|NCT03286751|10096396|FG003|NOT COMPLETED|Washout Period 3||0
8799490|NCT01437878|9851029|FG000|STARTED|Overall Study|Patient discontinued the study prior to initiation of study treatment|1
8799491|NCT01437878|9851030|FG001|STARTED|Overall Study||1
8799492|NCT01437878|9851029|FG000|COMPLETED|Overall Study||0
8799493|NCT01437878|9851030|FG001|COMPLETED|Overall Study||1
9034665|NCT03286751|10096397|FG004|NOT COMPLETED|Washout Period 3||0
9034666|NCT03286751|10096398|FG005|NOT COMPLETED|Washout Period 3||0
9034667|NCT03286751|10096393|FG000|STARTED|Period 4||7
9034668|NCT03286751|10096394|FG001|STARTED|Period 4||6
9034669|NCT03286751|10096395|FG002|STARTED|Period 4||7
9034670|NCT03286751|10096396|FG003|STARTED|Period 4||7
9034671|NCT03286751|10096397|FG004|STARTED|Period 4||6
9034672|NCT03286751|10096398|FG005|STARTED|Period 4||7
9034673|NCT03286751|10096393|FG000|COMPLETED|Period 4||7
9034674|NCT03286751|10096394|FG001|COMPLETED|Period 4||6
9034675|NCT03286751|10096395|FG002|COMPLETED|Period 4||7
9034676|NCT03286751|10096396|FG003|COMPLETED|Period 4||7
9034677|NCT03286751|10096397|FG004|COMPLETED|Period 4||6
9034678|NCT03286751|10096398|FG005|COMPLETED|Period 4||7
9034679|NCT03286751|10096393|FG000|NOT COMPLETED|Period 4||0
9034680|NCT03286751|10096394|FG001|NOT COMPLETED|Period 4||0
9034681|NCT03286751|10096395|FG002|NOT COMPLETED|Period 4||0
9034682|NCT03286751|10096396|FG003|NOT COMPLETED|Period 4||0
9034683|NCT03286751|10096397|FG004|NOT COMPLETED|Period 4||0
9034684|NCT03286751|10096398|FG005|NOT COMPLETED|Period 4||0
9034685|NCT03286751|10096393|FG000|STARTED|Washout Period 4||7
9034686|NCT03286751|10096394|FG001|STARTED|Washout Period 4||6
9034687|NCT03286751|10096395|FG002|STARTED|Washout Period 4||7
9034688|NCT03286751|10096396|FG003|STARTED|Washout Period 4||7
9034689|NCT03286751|10096397|FG004|STARTED|Washout Period 4||6
9034690|NCT03286751|10096398|FG005|STARTED|Washout Period 4||7
9034691|NCT03286751|10096393|FG000|COMPLETED|Washout Period 4||7
9034692|NCT03286751|10096394|FG001|COMPLETED|Washout Period 4||6
9034693|NCT03286751|10096395|FG002|COMPLETED|Washout Period 4||7
9034694|NCT03286751|10096396|FG003|COMPLETED|Washout Period 4||7
9034695|NCT03286751|10096397|FG004|COMPLETED|Washout Period 4||6
9034696|NCT03286751|10096398|FG005|COMPLETED|Washout Period 4||7
9034697|NCT03286751|10096393|FG000|NOT COMPLETED|Washout Period 4||0
9034698|NCT03286751|10096394|FG001|NOT COMPLETED|Washout Period 4||0
9034699|NCT03286751|10096395|FG002|NOT COMPLETED|Washout Period 4||0
9034700|NCT03286751|10096396|FG003|NOT COMPLETED|Washout Period 4||0
9034701|NCT03286751|10096397|FG004|NOT COMPLETED|Washout Period 4||0
9034702|NCT03286751|10096398|FG005|NOT COMPLETED|Washout Period 4||0
9034703|NCT03286751|10096393|FG000|STARTED|Period 5||7
9034704|NCT03286751|10096394|FG001|STARTED|Period 5||6
9034705|NCT03286751|10096395|FG002|STARTED|Period 5||7
9034706|NCT03286751|10096396|FG003|STARTED|Period 5||7
9034707|NCT03286751|10096397|FG004|STARTED|Period 5||6
9034708|NCT03286751|10096398|FG005|STARTED|Period 5||7
9034709|NCT03286751|10096393|FG000|COMPLETED|Period 5||7
9034710|NCT03286751|10096394|FG001|COMPLETED|Period 5||6
9034711|NCT03286751|10096395|FG002|COMPLETED|Period 5||7
9034712|NCT03286751|10096396|FG003|COMPLETED|Period 5||7
9034713|NCT03286751|10096397|FG004|COMPLETED|Period 5||6
9034714|NCT03286751|10096398|FG005|COMPLETED|Period 5||7
9034715|NCT03286751|10096393|FG000|NOT COMPLETED|Period 5||0
9034716|NCT03286751|10096394|FG001|NOT COMPLETED|Period 5||0
9034717|NCT03286751|10096395|FG002|NOT COMPLETED|Period 5||0
9034718|NCT03286751|10096396|FG003|NOT COMPLETED|Period 5||0
9034719|NCT03286751|10096397|FG004|NOT COMPLETED|Period 5||0
9034720|NCT03286751|10096398|FG005|NOT COMPLETED|Period 5||0
9034721|NCT03286751|10096393|FG000|STARTED|Washout Period 5||7
9034722|NCT03286751|10096394|FG001|STARTED|Washout Period 5||6
9034723|NCT03286751|10096395|FG002|STARTED|Washout Period 5||7
9034724|NCT03286751|10096396|FG003|STARTED|Washout Period 5||7
9034725|NCT03286751|10096397|FG004|STARTED|Washout Period 5||6
9034726|NCT03286751|10096398|FG005|STARTED|Washout Period 5||7
9034727|NCT03286751|10096393|FG000|COMPLETED|Washout Period 5||7
9034728|NCT03286751|10096394|FG001|COMPLETED|Washout Period 5||6
9034729|NCT03286751|10096395|FG002|COMPLETED|Washout Period 5||7
9034730|NCT03286751|10096396|FG003|COMPLETED|Washout Period 5||7
9034731|NCT03286751|10096397|FG004|COMPLETED|Washout Period 5||5
9034732|NCT03286751|10096398|FG005|COMPLETED|Washout Period 5||7
9034733|NCT03286751|10096393|FG000|NOT COMPLETED|Washout Period 5||0
9034734|NCT03286751|10096394|FG001|NOT COMPLETED|Washout Period 5||0
9034735|NCT03286751|10096395|FG002|NOT COMPLETED|Washout Period 5||0
9034736|NCT03286751|10096396|FG003|NOT COMPLETED|Washout Period 5||0
9034737|NCT03286751|10096397|FG004|NOT COMPLETED|Washout Period 5||1
9034738|NCT03286751|10096398|FG005|NOT COMPLETED|Washout Period 5||0
9034739|NCT03286751|10096393|FG000|STARTED|Period 6||7
9034740|NCT03286751|10096394|FG001|STARTED|Period 6||6
9034741|NCT03286751|10096395|FG002|STARTED|Period 6||7
9034742|NCT03286751|10096396|FG003|STARTED|Period 6||7
9034743|NCT03286751|10096397|FG004|STARTED|Period 6||5
9034744|NCT03286751|10096398|FG005|STARTED|Period 6||7
9034745|NCT03286751|10096393|FG000|COMPLETED|Period 6||7
9034746|NCT03286751|10096394|FG001|COMPLETED|Period 6||6
9034747|NCT03286751|10096395|FG002|COMPLETED|Period 6||7
9034748|NCT03286751|10096396|FG003|COMPLETED|Period 6||7
9034749|NCT03286751|10096397|FG004|COMPLETED|Period 6||5
9034750|NCT03286751|10096398|FG005|COMPLETED|Period 6||7
9034751|NCT03286751|10096393|FG000|NOT COMPLETED|Period 6||0
9034752|NCT03286751|10096394|FG001|NOT COMPLETED|Period 6||0
9034753|NCT03286751|10096395|FG002|NOT COMPLETED|Period 6||0
9034754|NCT03286751|10096396|FG003|NOT COMPLETED|Period 6||0
9034755|NCT03286751|10096397|FG004|NOT COMPLETED|Period 6||0
9034756|NCT03286751|10096398|FG005|NOT COMPLETED|Period 6||0
9034757|NCT03286829|10096416|FG000|STARTED|Overall Study||15
9034758|NCT03286829|10096417|FG001|STARTED|Overall Study||15
9034759|NCT03286829|10096418|FG002|STARTED|Overall Study||15
9034760|NCT03286829|10096419|FG003|STARTED|Overall Study||15
9034761|NCT03286829|10096416|FG000|COMPLETED|Overall Study||15
9034762|NCT03286829|10096417|FG001|COMPLETED|Overall Study||15
9034763|NCT03286829|10096418|FG002|COMPLETED|Overall Study||15
9034764|NCT03286829|10096419|FG003|COMPLETED|Overall Study||15
9034765|NCT03286829|10096416|FG000|NOT COMPLETED|Overall Study||0
9034766|NCT03286829|10096417|FG001|NOT COMPLETED|Overall Study||0
9034767|NCT03286829|10096418|FG002|NOT COMPLETED|Overall Study||0
9034768|NCT03286829|10096419|FG003|NOT COMPLETED|Overall Study||0
9034769|NCT03287219|10096433|FG000|STARTED|Overall Study||24
9034770|NCT03287219|10096434|FG001|STARTED|Overall Study||90
9034771|NCT03287219|10096433|FG000|COMPLETED|Overall Study||24
9034772|NCT03287219|10096434|FG001|COMPLETED|Overall Study||88
9034773|NCT03287219|10096433|FG000|NOT COMPLETED|Overall Study||0
9034774|NCT03287219|10096434|FG001|NOT COMPLETED|Overall Study||2
9034775|NCT03287310|10096479|FG000|STARTED|Overall Study||12
9034776|NCT03287310|10096480|FG001|STARTED|Overall Study||6
9034777|NCT03287310|10096481|FG002|STARTED|Overall Study||6
9034778|NCT03287310|10096482|FG003|STARTED|Overall Study||9
9034779|NCT03287310|10096483|FG004|STARTED|Overall Study||9
9034780|NCT03287310|10096484|FG005|STARTED|Overall Study||6
9034781|NCT03287310|10096479|FG000|COMPLETED|Overall Study||12
9034782|NCT03287310|10096480|FG001|COMPLETED|Overall Study||6
9034783|NCT03287310|10096481|FG002|COMPLETED|Overall Study||6
9034784|NCT03287310|10096482|FG003|COMPLETED|Overall Study||9
9034785|NCT03287310|10096483|FG004|COMPLETED|Overall Study||9
9034786|NCT03287310|10096484|FG005|COMPLETED|Overall Study||6
9034787|NCT03287310|10096479|FG000|NOT COMPLETED|Overall Study||0
9034788|NCT03287310|10096480|FG001|NOT COMPLETED|Overall Study||0
9034789|NCT03287310|10096481|FG002|NOT COMPLETED|Overall Study||0
9034790|NCT03287310|10096482|FG003|NOT COMPLETED|Overall Study||0
9034791|NCT03287310|10096483|FG004|NOT COMPLETED|Overall Study||0
9034792|NCT03287310|10096484|FG005|NOT COMPLETED|Overall Study||0
9034793|NCT03287622|10096508|FG000|STARTED|Overall Study||356
9034794|NCT03287622|10096509|FG001|STARTED|Overall Study||356
9034795|NCT03287622|10096508|FG000|Sub-randomized to Nudge/NoNudge|Overall Study||253
9034796|NCT03287622|10096509|FG001|Sub-randomized to Nudge/NoNudge|Overall Study||266
9034797|NCT03287622|10096508|FG000|COMPLETED|Overall Study||298
9034798|NCT03287622|10096509|FG001|COMPLETED|Overall Study||308
9034799|NCT03287622|10096508|FG000|NOT COMPLETED|Overall Study||58
9034800|NCT03287622|10096509|FG001|NOT COMPLETED|Overall Study||48
9034801|NCT03287635|10096522|FG000|STARTED|Overall Study||19
9034802|NCT03287635|10096522|FG000|COMPLETED|Overall Study||12
9034803|NCT03287635|10096522|FG000|NOT COMPLETED|Overall Study||7
9034804|NCT03287674|10096526|FG000|STARTED|Overall Study||7
9034805|NCT03287674|10096526|FG000|All Treated With TILs|Overall Study||6
9034806|NCT03287674|10096526|FG000|COMPLETED|Overall Study||6
9034807|NCT03287674|10096526|FG000|NOT COMPLETED|Overall Study||1
9034808|NCT03287791|10096534|FG000|STARTED|Overall Study||312
9034809|NCT03287791|10096535|FG001|STARTED|Overall Study||312
9034810|NCT03287791|10096536|FG002|STARTED|Overall Study||300
9034811|NCT03287791|10096534|FG000|Safety Population|Overall Study||306
9034812|NCT03287791|10096535|FG001|Safety Population|Overall Study||297
9034813|NCT03287791|10096536|FG002|Safety Population|Overall Study||291
9034814|NCT03287791|10096534|FG000|mITT Population|Overall Study||291
9034815|NCT03287791|10096535|FG001|mITT Population|Overall Study||291
9034816|NCT03287791|10096536|FG002|mITT Population|Overall Study||283
9034817|NCT03287791|10096534|FG000|PP Population|Overall Study||262
9034818|NCT03287791|10096535|FG001|PP Population|Overall Study||259
9034819|NCT03287791|10096536|FG002|PP Population|Overall Study||245
9034820|NCT03287791|10096534|FG000|COMPLETED|Overall Study||280
9034821|NCT03287791|10096535|FG001|COMPLETED|Overall Study||276
9034822|NCT03287791|10096536|FG002|COMPLETED|Overall Study||264
9034823|NCT03287791|10096534|FG000|NOT COMPLETED|Overall Study||32
9034824|NCT03287791|10096535|FG001|NOT COMPLETED|Overall Study||36
9034825|NCT03287791|10096536|FG002|NOT COMPLETED|Overall Study||36
9034826|NCT03287804|10096544|FG000|STARTED|Overall Study||12
9034827|NCT03287804|10096544|FG000|Leukaperesed|Overall Study||12
9034828|NCT03287804|10096544|FG000|Started Pre-conditioning Therapy|Overall Study||11
9034829|NCT03287804|10096544|FG000|Received Study Treatment|Overall Study||11
9034830|NCT03287804|10096544|FG000|COMPLETED|Overall Study||1
9034831|NCT03287804|10096544|FG000|NOT COMPLETED|Overall Study||11
9034832|NCT03287869|10096551|FG000|STARTED|Overall Study||188
9034833|NCT03287869|10096552|FG001|STARTED|Overall Study||193
9034834|NCT03287869|10096551|FG000|Analyzed For Safety (Safety Sample)|Overall Study||184
9034835|NCT03287869|10096552|FG001|Analyzed For Safety (Safety Sample)|Overall Study||184
9034836|NCT03287869|10096551|FG000|COMPLETED|Overall Study||105
9034837|NCT03287869|10096552|FG001|COMPLETED|Overall Study||100
9034838|NCT03287869|10096551|FG000|NOT COMPLETED|Overall Study||83
9034839|NCT03287869|10096552|FG001|NOT COMPLETED|Overall Study||93
9034840|NCT03288714|10096560|FG000|STARTED|Overall Study||59
9034841|NCT03288714|10096561|FG001|STARTED|Overall Study||62
9034842|NCT03288714|10096560|FG000|COMPLETED|Overall Study||49
9034843|NCT03288714|10096561|FG001|COMPLETED|Overall Study||59
9034844|NCT03288714|10096560|FG000|NOT COMPLETED|Overall Study||10
9034845|NCT03288714|10096561|FG001|NOT COMPLETED|Overall Study||3
9034846|NCT03288779|10096569|FG000|STARTED|Overall Study||6
9034847|NCT03288779|10096569|FG000|COMPLETED|Overall Study||3
9034848|NCT03288779|10096569|FG000|NOT COMPLETED|Overall Study||3
9034849|NCT03288987|10096575|FG000|STARTED|Overall Study||82
9034850|NCT03288987|10096576|FG001|STARTED|Overall Study||44
9034851|NCT03288987|10096575|FG000|Patients Receiving Medication|Overall Study||80
9034852|NCT03288987|10096576|FG001|Patients Receiving Medication|Overall Study||44
9034853|NCT03288987|10096575|FG000|COMPLETED|Overall Study|Per protocol population|72
9034854|NCT03288987|10096576|FG001|COMPLETED|Overall Study|Per protocol population|40
9034855|NCT03288987|10096575|FG000|NOT COMPLETED|Overall Study||10
9034856|NCT03288987|10096576|FG001|NOT COMPLETED|Overall Study||4
9034857|NCT03289052|10096585|FG000|STARTED|Overall Study||20
9034858|NCT03289052|10096586|FG001|STARTED|Overall Study||111
9034859|NCT03289052|10096587|FG002|STARTED|Overall Study||37
9034860|NCT03289052|10096585|FG000|COMPLETED|Overall Study||20
9034861|NCT03289052|10096586|FG001|COMPLETED|Overall Study||108
9034862|NCT03289052|10096587|FG002|COMPLETED|Overall Study||32
9034863|NCT03289052|10096585|FG000|NOT COMPLETED|Overall Study||0
9034864|NCT03289052|10096586|FG001|NOT COMPLETED|Overall Study||3
9034865|NCT03289052|10096587|FG002|NOT COMPLETED|Overall Study||5
9034866|NCT03289208|10096598|FG000|STARTED|Overall Study||11
9034867|NCT03289208|10096599|FG001|STARTED|Overall Study||8
9034868|NCT03289208|10096600|FG002|STARTED|Overall Study||11
9034869|NCT03289208|10096598|FG000|COMPLETED|Overall Study||10
9034870|NCT03289208|10096599|FG001|COMPLETED|Overall Study||8
9034871|NCT03289208|10096600|FG002|COMPLETED|Overall Study||11
9034872|NCT03289208|10096598|FG000|NOT COMPLETED|Overall Study||1
9034873|NCT03289208|10096599|FG001|NOT COMPLETED|Overall Study||0
9034874|NCT03289208|10096600|FG002|NOT COMPLETED|Overall Study||0
9034875|NCT03289234|10096611|FG000|STARTED|Overall Study||8
9034876|NCT03289234|10096612|FG001|STARTED|Overall Study||6
9034877|NCT03289234|10096613|FG002|STARTED|Overall Study||8
9034878|NCT03289234|10096611|FG000|COMPLETED|Overall Study||8
9034879|NCT03289234|10096612|FG001|COMPLETED|Overall Study||6
9034880|NCT03289234|10096613|FG002|COMPLETED|Overall Study||8
9034881|NCT03289234|10096611|FG000|NOT COMPLETED|Overall Study||0
9034882|NCT03289234|10096612|FG001|NOT COMPLETED|Overall Study||0
9034883|NCT03289234|10096613|FG002|NOT COMPLETED|Overall Study||0
9034884|NCT03289455|10096624|FG000|STARTED|Overall Study||4
9034885|NCT03289455|10096625|FG001|STARTED|Overall Study||5
9034886|NCT03289455|10096626|FG002|STARTED|Overall Study||6
9034887|NCT03289455|10096624|FG000|COMPLETED|Overall Study|Completed = Received AUTO3 infusion and completed 24 months visit|0
9034888|NCT03289455|10096625|FG001|COMPLETED|Overall Study|Completed = Received AUTO3 infusion and completed 24 months visit|0
9034889|NCT03289455|10096626|FG002|COMPLETED|Overall Study|Completed = Received AUTO3 infusion and completed 24 months visit|0
9034890|NCT03289455|10096624|FG000|NOT COMPLETED|Overall Study||4
9034891|NCT03289455|10096625|FG001|NOT COMPLETED|Overall Study||5
9034892|NCT03289455|10096626|FG002|NOT COMPLETED|Overall Study||6
8918748|NCT02203357|9978763|FG001|NOT COMPLETED|Overall Study||66
8918749|NCT02203357|9978764|FG002|NOT COMPLETED|Overall Study||70
8918750|NCT02203565|9978775|FG000|STARTED|Overall Study||20
8918751|NCT02203565|9978775|FG000|COMPLETED|Overall Study||19
8918752|NCT02203565|9978775|FG000|NOT COMPLETED|Overall Study||1
8918753|NCT02203578|9978779|FG000|STARTED|Overall Study||1
8918754|NCT02203578|9978779|FG000|COMPLETED|Overall Study||1
8918755|NCT02203578|9978779|FG000|NOT COMPLETED|Overall Study||0
8918756|NCT02203591|9978791|FG000|STARTED|Overall Study||343
8918757|NCT02203591|9978792|FG001|STARTED|Overall Study||344
8918758|NCT02203591|9978793|FG002|STARTED|Overall Study||347
8918759|NCT02203591|9978794|FG003|STARTED|Overall Study||104
8918760|NCT02203591|9978795|FG004|STARTED|Overall Study||242
8918761|NCT02203591|9978796|FG005|STARTED|Overall Study||244
8918762|NCT02203591|9978797|FG006|STARTED|Overall Study||248
8918763|NCT02203591|9978798|FG007|STARTED|Overall Study||74
8918764|NCT02203591|9978791|FG000|COMPLETED|Overall Study||196
8918765|NCT02203591|9978792|FG001|COMPLETED|Overall Study||202
8918766|NCT02203591|9978793|FG002|COMPLETED|Overall Study||196
8918767|NCT02203591|9978794|FG003|COMPLETED|Overall Study||59
9034893|NCT03289481|10096637|FG000|STARTED|Overall Study||6
9034894|NCT03289481|10096638|FG001|STARTED|Overall Study||7
9034895|NCT03289481|10096637|FG000|COMPLETED|Overall Study||4
9034896|NCT03289481|10096638|FG001|COMPLETED|Overall Study||5
9034897|NCT03289481|10096637|FG000|NOT COMPLETED|Overall Study||2
9034898|NCT03289481|10096638|FG001|NOT COMPLETED|Overall Study||2
9034899|NCT03289533|10096645|FG000|STARTED|Overall Study||22
9034900|NCT03289533|10096645|FG000|COMPLETED|Overall Study||0
9034901|NCT03289533|10096645|FG000|NOT COMPLETED|Overall Study||22
9034902|NCT03289676|10096651|FG000|STARTED|Overall Study||27
9034903|NCT03289676|10096652|FG001|STARTED|Overall Study||26
9034904|NCT03289676|10096651|FG000|COMPLETED|Overall Study||23
9034905|NCT03289676|10096652|FG001|COMPLETED|Overall Study|Received 80% of the allotted intervention|25
9034906|NCT03289676|10096651|FG000|NOT COMPLETED|Overall Study||4
9034907|NCT03289676|10096652|FG001|NOT COMPLETED|Overall Study||1
9034908|NCT03289858|10096660|FG000|STARTED|Overall Study||27
9034909|NCT03289858|10096661|FG001|STARTED|Overall Study||28
9034910|NCT03289858|10096660|FG000|COMPLETED|Overall Study||25
9034911|NCT03289858|10096661|FG001|COMPLETED|Overall Study||28
9034912|NCT03289858|10096660|FG000|NOT COMPLETED|Overall Study||2
9034913|NCT03289858|10096661|FG001|NOT COMPLETED|Overall Study||0
9034914|NCT03290027|10096669|FG000|STARTED|Overall Study||277
9034915|NCT03290027|10096670|FG001|STARTED|Overall Study||273
9034916|NCT03290027|10096669|FG000|COMPLETED|Overall Study||219
9034917|NCT03290027|10096670|FG001|COMPLETED|Overall Study||228
9034918|NCT03290027|10096669|FG000|NOT COMPLETED|Overall Study||58
9034919|NCT03290027|10096670|FG001|NOT COMPLETED|Overall Study||45
9034920|NCT03290300|10096676|FG000|STARTED|Overall Study||39
9034921|NCT03290300|10096676|FG000|COMPLETED|Overall Study||36
9034922|NCT03290300|10096676|FG000|NOT COMPLETED|Overall Study||3
9034923|NCT03290378|10096688|FG000|STARTED|Overall Study||140
9034924|NCT03290378|10096689|FG001|STARTED|Overall Study||133
9034925|NCT03290378|10096690|FG002|STARTED|Overall Study||136
9034926|NCT03290378|10096688|FG000|COMPLETED|Overall Study||137
9034927|NCT03290378|10096689|FG001|COMPLETED|Overall Study||123
9034928|NCT03290378|10096690|FG002|COMPLETED|Overall Study||120
9034929|NCT03290378|10096688|FG000|NOT COMPLETED|Overall Study||3
9034930|NCT03290378|10096689|FG001|NOT COMPLETED|Overall Study||10
9034931|NCT03290378|10096690|FG002|NOT COMPLETED|Overall Study||16
9034932|NCT03290768|10096698|FG000|STARTED|Overall Study||358
9034933|NCT03290768|10096698|FG000|COMPLETED|Overall Study||193
9034934|NCT03290768|10096698|FG000|NOT COMPLETED|Overall Study||165
9034935|NCT03291041|10096704|FG000|STARTED|Overall Study||13
9034936|NCT03291041|10096705|FG001|STARTED|Overall Study||12
9034937|NCT03291041|10096704|FG000|COMPLETED|Overall Study||13
9034938|NCT03291041|10096705|FG001|COMPLETED|Overall Study||12
9034939|NCT03291041|10096704|FG000|NOT COMPLETED|Overall Study||0
9034940|NCT03291041|10096705|FG001|NOT COMPLETED|Overall Study||0
9034941|NCT03291080|10096713|FG000|STARTED|First Cycle (2 Weeks)||11
9034942|NCT03291080|10096714|FG001|STARTED|First Cycle (2 Weeks)||9
9034943|NCT03291080|10096713|FG000|COMPLETED|First Cycle (2 Weeks)||11
9034944|NCT03291080|10096714|FG001|COMPLETED|First Cycle (2 Weeks)||9
9034945|NCT03291080|10096713|FG000|NOT COMPLETED|First Cycle (2 Weeks)||0
9034946|NCT03291080|10096714|FG001|NOT COMPLETED|First Cycle (2 Weeks)||0
9034947|NCT03291080|10096713|FG000|STARTED|Washout (2 Weeks)||11
9034948|NCT03291080|10096714|FG001|STARTED|Washout (2 Weeks)||9
9034949|NCT03291080|10096713|FG000|COMPLETED|Washout (2 Weeks)||11
9034950|NCT03291080|10096714|FG001|COMPLETED|Washout (2 Weeks)||9
9034951|NCT03291080|10096713|FG000|NOT COMPLETED|Washout (2 Weeks)||0
9034952|NCT03291080|10096714|FG001|NOT COMPLETED|Washout (2 Weeks)||0
9034953|NCT03291080|10096713|FG000|STARTED|Second Cylcle (2 Weeks)||9
9034954|NCT03291080|10096714|FG001|STARTED|Second Cylcle (2 Weeks)||11
9034955|NCT03291080|10096713|FG000|COMPLETED|Second Cylcle (2 Weeks)||8
9034956|NCT03291080|10096714|FG001|COMPLETED|Second Cylcle (2 Weeks)||11
9034957|NCT03291080|10096713|FG000|NOT COMPLETED|Second Cylcle (2 Weeks)||1
9034958|NCT03291080|10096714|FG001|NOT COMPLETED|Second Cylcle (2 Weeks)||0
9034959|NCT03291197|10096721|FG000|STARTED|Overall Study||5
9034960|NCT03291197|10096721|FG000|COMPLETED|Overall Study||5
9034961|NCT03291197|10096721|FG000|NOT COMPLETED|Overall Study||0
9034962|NCT03291288|10096729|FG000|STARTED|Drug-drug Interaction Phase||32
9034963|NCT03291288|10096730|FG001|STARTED|Drug-drug Interaction Phase||0
9034964|NCT03291288|10096729|FG000|COMPLETED|Drug-drug Interaction Phase||26
9034965|NCT03291288|10096730|FG001|COMPLETED|Drug-drug Interaction Phase||0
9034966|NCT03291288|10096729|FG000|NOT COMPLETED|Drug-drug Interaction Phase||6
9034967|NCT03291288|10096730|FG001|NOT COMPLETED|Drug-drug Interaction Phase||0
9034968|NCT03291288|10096729|FG000|STARTED|Pexidartinib Only|This is a crossover trial; participants who completed Part 1 continued to Part 2.|0
9034969|NCT03291288|10096730|FG001|STARTED|Pexidartinib Only||26
9034970|NCT03291288|10096729|FG000|COMPLETED|Pexidartinib Only||0
9034971|NCT03291288|10096730|FG001|COMPLETED|Pexidartinib Only||24
9034972|NCT03291288|10096729|FG000|NOT COMPLETED|Pexidartinib Only||0
9034973|NCT03291288|10096730|FG001|NOT COMPLETED|Pexidartinib Only||2
9034974|NCT03291379|10096744|FG000|STARTED|Overall Study||8
9034975|NCT03291379|10096744|FG000|COMPLETED|Overall Study||8
9034976|NCT03291379|10096744|FG000|NOT COMPLETED|Overall Study||0
9034977|NCT03291613|10096749|FG000|STARTED|Overall Study||13
9034978|NCT03291613|10096749|FG000|COMPLETED|Overall Study||12
9034979|NCT03291613|10096749|FG000|NOT COMPLETED|Overall Study||1
9034980|NCT03292016|10096759|FG000|STARTED|First Intervention||1
9034981|NCT03292016|10096760|FG001|STARTED|First Intervention||1
9034982|NCT03292016|10096761|FG002|STARTED|First Intervention||2
9034983|NCT03292016|10096762|FG003|STARTED|First Intervention||1
9034984|NCT03292016|10096763|FG004|STARTED|First Intervention||1
9034985|NCT03292016|10096764|FG005|STARTED|First Intervention||2
9034986|NCT03292016|10096759|FG000|COMPLETED|First Intervention||1
9034987|NCT03292016|10096760|FG001|COMPLETED|First Intervention||1
9034988|NCT03292016|10096761|FG002|COMPLETED|First Intervention||2
9034989|NCT03292016|10096762|FG003|COMPLETED|First Intervention||1
9034990|NCT03292016|10096763|FG004|COMPLETED|First Intervention||1
9034991|NCT03292016|10096764|FG005|COMPLETED|First Intervention||2
9034992|NCT03292016|10096759|FG000|NOT COMPLETED|First Intervention||0
9034993|NCT03292016|10096760|FG001|NOT COMPLETED|First Intervention||0
9034994|NCT03292016|10096761|FG002|NOT COMPLETED|First Intervention||0
9034995|NCT03292016|10096762|FG003|NOT COMPLETED|First Intervention||0
9034996|NCT03292016|10096763|FG004|NOT COMPLETED|First Intervention||0
9034997|NCT03292016|10096764|FG005|NOT COMPLETED|First Intervention||0
9034998|NCT03292016|10096759|FG000|STARTED|First Washout||1
9034999|NCT03292016|10096760|FG001|STARTED|First Washout||1
9035000|NCT03292016|10096761|FG002|STARTED|First Washout||2
9035001|NCT03292016|10096762|FG003|STARTED|First Washout||1
9035002|NCT03292016|10096763|FG004|STARTED|First Washout||1
9035003|NCT03292016|10096764|FG005|STARTED|First Washout||2
9035004|NCT03292016|10096759|FG000|COMPLETED|First Washout||1
9035005|NCT03292016|10096760|FG001|COMPLETED|First Washout||1
9035006|NCT03292016|10096761|FG002|COMPLETED|First Washout||2
9035007|NCT03292016|10096762|FG003|COMPLETED|First Washout||1
9035008|NCT03292016|10096763|FG004|COMPLETED|First Washout||1
9035009|NCT03292016|10096764|FG005|COMPLETED|First Washout||2
9035010|NCT03292016|10096759|FG000|NOT COMPLETED|First Washout||0
9035011|NCT03292016|10096760|FG001|NOT COMPLETED|First Washout||0
9035012|NCT03292016|10096761|FG002|NOT COMPLETED|First Washout||0
9035013|NCT03292016|10096762|FG003|NOT COMPLETED|First Washout||0
9035014|NCT03292016|10096763|FG004|NOT COMPLETED|First Washout||0
9035015|NCT03292016|10096764|FG005|NOT COMPLETED|First Washout||0
9035016|NCT03292016|10096759|FG000|STARTED|Second Intervention||1
9035017|NCT03292016|10096760|FG001|STARTED|Second Intervention||1
9035018|NCT03292016|10096761|FG002|STARTED|Second Intervention||2
9035019|NCT03292016|10096762|FG003|STARTED|Second Intervention||1
9035020|NCT03292016|10096763|FG004|STARTED|Second Intervention||1
9035021|NCT03292016|10096764|FG005|STARTED|Second Intervention||2
9035022|NCT03292016|10096759|FG000|COMPLETED|Second Intervention||1
9035023|NCT03292016|10096760|FG001|COMPLETED|Second Intervention||1
9035024|NCT03292016|10096761|FG002|COMPLETED|Second Intervention||2
9035025|NCT03292016|10096762|FG003|COMPLETED|Second Intervention||1
9035026|NCT03292016|10096763|FG004|COMPLETED|Second Intervention||1
9035027|NCT03292016|10096764|FG005|COMPLETED|Second Intervention||2
9035028|NCT03292016|10096759|FG000|NOT COMPLETED|Second Intervention||0
9035029|NCT03292016|10096760|FG001|NOT COMPLETED|Second Intervention||0
9035030|NCT03292016|10096761|FG002|NOT COMPLETED|Second Intervention||0
9035031|NCT03292016|10096762|FG003|NOT COMPLETED|Second Intervention||0
9035032|NCT03292016|10096763|FG004|NOT COMPLETED|Second Intervention||0
9035033|NCT03292016|10096764|FG005|NOT COMPLETED|Second Intervention||0
9035034|NCT03292016|10096759|FG000|STARTED|Second Washout||1
9035035|NCT03292016|10096760|FG001|STARTED|Second Washout||1
9035036|NCT03292016|10096761|FG002|STARTED|Second Washout||2
9035037|NCT03292016|10096762|FG003|STARTED|Second Washout||1
9035038|NCT03292016|10096763|FG004|STARTED|Second Washout||1
9035039|NCT03292016|10096764|FG005|STARTED|Second Washout||2
9035040|NCT03292016|10096759|FG000|COMPLETED|Second Washout||1
9035041|NCT03292016|10096760|FG001|COMPLETED|Second Washout||0
9035042|NCT03292016|10096761|FG002|COMPLETED|Second Washout||2
9035043|NCT03292016|10096762|FG003|COMPLETED|Second Washout||1
9035044|NCT03292016|10096763|FG004|COMPLETED|Second Washout||1
9035045|NCT03292016|10096764|FG005|COMPLETED|Second Washout||2
9035046|NCT03292016|10096759|FG000|NOT COMPLETED|Second Washout||0
9035047|NCT03292016|10096760|FG001|NOT COMPLETED|Second Washout||1
9035048|NCT03292016|10096761|FG002|NOT COMPLETED|Second Washout||0
9035049|NCT03292016|10096762|FG003|NOT COMPLETED|Second Washout||0
9035050|NCT03292016|10096763|FG004|NOT COMPLETED|Second Washout||0
9035051|NCT03292016|10096764|FG005|NOT COMPLETED|Second Washout||0
9035052|NCT03292016|10096759|FG000|STARTED|Third Intervention||1
9035053|NCT03292016|10096760|FG001|STARTED|Third Intervention||0
9035054|NCT03292016|10096761|FG002|STARTED|Third Intervention||2
9035055|NCT03292016|10096762|FG003|STARTED|Third Intervention||1
9035056|NCT03292016|10096763|FG004|STARTED|Third Intervention||1
9035057|NCT03292016|10096764|FG005|STARTED|Third Intervention||2
9035058|NCT03292016|10096759|FG000|COMPLETED|Third Intervention||1
9035059|NCT03292016|10096760|FG001|COMPLETED|Third Intervention||0
9035060|NCT03292016|10096761|FG002|COMPLETED|Third Intervention||2
9035061|NCT03292016|10096762|FG003|COMPLETED|Third Intervention||1
9035062|NCT03292016|10096763|FG004|COMPLETED|Third Intervention||1
9035063|NCT03292016|10096764|FG005|COMPLETED|Third Intervention||2
9035064|NCT03292016|10096759|FG000|NOT COMPLETED|Third Intervention||0
9035065|NCT03292016|10096760|FG001|NOT COMPLETED|Third Intervention||0
9035066|NCT03292016|10096761|FG002|NOT COMPLETED|Third Intervention||0
9035067|NCT03292016|10096762|FG003|NOT COMPLETED|Third Intervention||0
9035068|NCT03292016|10096763|FG004|NOT COMPLETED|Third Intervention||0
9035069|NCT03292016|10096764|FG005|NOT COMPLETED|Third Intervention||0
9035070|NCT03292406|10096775|FG000|STARTED|Overall Study||30
9035071|NCT03292406|10096776|FG001|STARTED|Overall Study||28
9035072|NCT03292406|10096777|FG002|STARTED|Overall Study||28
9035073|NCT03292406|10096775|FG000|Participants Treated|Overall Study||30
9035074|NCT03292406|10096776|FG001|Participants Treated|Overall Study||28
9035075|NCT03292406|10096777|FG002|Participants Treated|Overall Study||27
9035076|NCT03292406|10096775|FG000|COMPLETED|Overall Study||17
9035077|NCT03292406|10096776|FG001|COMPLETED|Overall Study||15
9035078|NCT03292406|10096777|FG002|COMPLETED|Overall Study||15
9035079|NCT03292406|10096775|FG000|NOT COMPLETED|Overall Study||13
9035080|NCT03292406|10096776|FG001|NOT COMPLETED|Overall Study||13
9035081|NCT03292406|10096777|FG002|NOT COMPLETED|Overall Study||13
9035082|NCT03292432|10096787|FG000|STARTED|Overall Study||46
9035083|NCT03292432|10096788|FG001|STARTED|Overall Study||43
9035084|NCT03292432|10096787|FG000|Started Study Intervention|Overall Study||45
9035085|NCT03292432|10096788|FG001|Started Study Intervention|Overall Study||43
9035086|NCT03292432|10096787|FG000|COMPLETED|Overall Study||31
9035087|NCT03292432|10096788|FG001|COMPLETED|Overall Study||32
9035088|NCT03292432|10096787|FG000|NOT COMPLETED|Overall Study||15
9035089|NCT03292432|10096788|FG001|NOT COMPLETED|Overall Study||11
9035090|NCT03292562|10096796|FG000|STARTED|Overall Study||35
9035091|NCT03292562|10096797|FG001|STARTED|Overall Study||31
9035092|NCT03292562|10096796|FG000|COMPLETED|Overall Study||29
9035093|NCT03292562|10096797|FG001|COMPLETED|Overall Study||30
9035094|NCT03292562|10096796|FG000|NOT COMPLETED|Overall Study||6
9035095|NCT03292562|10096797|FG001|NOT COMPLETED|Overall Study||1
9035096|NCT03292614|10096803|FG000|STARTED|Overall Study||25
9035097|NCT03292614|10096803|FG000|COMPLETED|Overall Study||25
9035098|NCT03292614|10096803|FG000|NOT COMPLETED|Overall Study||0
9035099|NCT03292640|10096809|FG000|STARTED|Overall Study||275
9035100|NCT03292640|10096810|FG001|STARTED|Overall Study||272
9035101|NCT03292640|10096809|FG000|COMPLETED|Overall Study||214
9035102|NCT03292640|10096810|FG001|COMPLETED|Overall Study||230
9035103|NCT03292640|10096809|FG000|NOT COMPLETED|Overall Study||61
9035104|NCT03292640|10096810|FG001|NOT COMPLETED|Overall Study||42
9035105|NCT03292653|10096823|FG000|STARTED|Overall Study||11
9035106|NCT03292653|10096824|FG001|STARTED|Overall Study||10
9035107|NCT03292653|10096825|FG002|STARTED|Overall Study||11
9035108|NCT03292653|10096823|FG000|COMPLETED|Overall Study||10
9035109|NCT03292653|10096824|FG001|COMPLETED|Overall Study||10
9035110|NCT03292653|10096825|FG002|COMPLETED|Overall Study||10
9035111|NCT03292653|10096823|FG000|NOT COMPLETED|Overall Study||1
9035112|NCT03292653|10096824|FG001|NOT COMPLETED|Overall Study||0
9035113|NCT03292653|10096825|FG002|NOT COMPLETED|Overall Study||1
9035114|NCT03292692|10096836|FG000|STARTED|Overall Study||302
9035115|NCT03292692|10096837|FG001|STARTED|Overall Study||298
9035116|NCT03292692|10096836|FG000|COMPLETED|Overall Study||264
9035117|NCT03292692|10096837|FG001|COMPLETED|Overall Study||260
9035118|NCT03292692|10096836|FG000|NOT COMPLETED|Overall Study||38
9035119|NCT03292692|10096837|FG001|NOT COMPLETED|Overall Study||38
9035120|NCT03292809|10096845|FG000|STARTED|Overall Study||162
9035121|NCT03292809|10096846|FG001|STARTED|Overall Study||166
9035122|NCT03292809|10096845|FG000|COMPLETED|Overall Study||155
9035123|NCT03292809|10096846|FG001|COMPLETED|Overall Study||163
9035124|NCT03292809|10096845|FG000|NOT COMPLETED|Overall Study||7
9035125|NCT03292809|10096846|FG001|NOT COMPLETED|Overall Study||3
9035126|NCT03292952|10096854|FG000|STARTED|Open-Label Dose Optimization||155
9035127|NCT03292952|10096855|FG001|STARTED|Open-Label Dose Optimization|All subjects were treated with open-label KP415 during the Open-Label Phase|0
9035128|NCT03292952|10096856|FG002|STARTED|Open-Label Dose Optimization|All subjects were treated with open-label KP415 during the Open-Label Phase|0
9035129|NCT03292952|10096854|FG000|COMPLETED|Open-Label Dose Optimization||150
9035130|NCT03292952|10096855|FG001|COMPLETED|Open-Label Dose Optimization||0
9035131|NCT03292952|10096856|FG002|COMPLETED|Open-Label Dose Optimization||0
9035132|NCT03292952|10096854|FG000|NOT COMPLETED|Open-Label Dose Optimization||5
9035133|NCT03292952|10096855|FG001|NOT COMPLETED|Open-Label Dose Optimization||0
9035134|NCT03292952|10096856|FG002|NOT COMPLETED|Open-Label Dose Optimization||0
9035135|NCT03292952|10096854|FG000|STARTED|Double-Blind Treatment Phase|Subjects were randomized to the double-blind Treatment Phase after Open-Label Dose Optimization|0
9035136|NCT03292952|10096855|FG001|STARTED|Double-Blind Treatment Phase||74
9035137|NCT03292952|10096856|FG002|STARTED|Double-Blind Treatment Phase||76
9035138|NCT03292952|10096854|FG000|COMPLETED|Double-Blind Treatment Phase||0
9035139|NCT03292952|10096855|FG001|COMPLETED|Double-Blind Treatment Phase||74
9035140|NCT03292952|10096856|FG002|COMPLETED|Double-Blind Treatment Phase||75
9035141|NCT03292952|10096854|FG000|NOT COMPLETED|Double-Blind Treatment Phase||0
9035142|NCT03292952|10096855|FG001|NOT COMPLETED|Double-Blind Treatment Phase||0
9035143|NCT03292952|10096856|FG002|NOT COMPLETED|Double-Blind Treatment Phase||1
9035144|NCT03293238|10096869|FG000|STARTED|Overall Study||19
9035145|NCT03293238|10096870|FG001|STARTED|Overall Study||16
9035146|NCT03293238|10096871|FG002|STARTED|Overall Study||14
9035147|NCT03293238|10096872|FG003|STARTED|Overall Study||14
9035148|NCT03293238|10096869|FG000|COMPLETED|Overall Study||19
9035149|NCT03293238|10096870|FG001|COMPLETED|Overall Study||16
9035150|NCT03293238|10096871|FG002|COMPLETED|Overall Study||14
9035151|NCT03293238|10096872|FG003|COMPLETED|Overall Study||14
9035152|NCT03293238|10096869|FG000|NOT COMPLETED|Overall Study||0
9035153|NCT03293238|10096870|FG001|NOT COMPLETED|Overall Study||0
9035154|NCT03293238|10096871|FG002|NOT COMPLETED|Overall Study||0
9035155|NCT03293238|10096872|FG003|NOT COMPLETED|Overall Study||0
9035156|NCT03293394|10096884|FG000|STARTED|First Intervention (2 Weeks)||20
9035157|NCT03293394|10096885|FG001|STARTED|First Intervention (2 Weeks)||10
9035158|NCT03293394|10096884|FG000|COMPLETED|First Intervention (2 Weeks)||20
9035159|NCT03293394|10096885|FG001|COMPLETED|First Intervention (2 Weeks)||10
9035160|NCT03293394|10096884|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0
9035161|NCT03293394|10096885|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0
9035162|NCT03293394|10096884|FG000|STARTED|Follow-up (6 Months)||20
9035163|NCT03293394|10096885|FG001|STARTED|Follow-up (6 Months)||10
9035164|NCT03293394|10096884|FG000|COMPLETED|Follow-up (6 Months)||16
9035165|NCT03293394|10096885|FG001|COMPLETED|Follow-up (6 Months)||8
9035166|NCT03293394|10096884|FG000|NOT COMPLETED|Follow-up (6 Months)||4
9035167|NCT03293394|10096885|FG001|NOT COMPLETED|Follow-up (6 Months)||2
9035168|NCT03293485|10096891|FG000|STARTED|Overall Study||83
9035169|NCT03293485|10096891|FG000|Treated|Overall Study||81
9035170|NCT03293485|10096891|FG000|COMPLETED|Overall Study||78
9035171|NCT03293485|10096891|FG000|NOT COMPLETED|Overall Study||5
9035172|NCT03293654|10096900|FG000|STARTED|Overall Study||38
9035173|NCT03293654|10096901|FG001|STARTED|Overall Study||38
9035174|NCT03293654|10096902|FG002|STARTED|Overall Study||38
9035175|NCT03293654|10096900|FG000|COMPLETED|Overall Study||38
9035176|NCT03293654|10096901|FG001|COMPLETED|Overall Study||37
9035177|NCT03293654|10096902|FG002|COMPLETED|Overall Study||38
9035178|NCT03293654|10096900|FG000|NOT COMPLETED|Overall Study||0
9035179|NCT03293654|10096901|FG001|NOT COMPLETED|Overall Study||1
9035180|NCT03293654|10096902|FG002|NOT COMPLETED|Overall Study||0
9035181|NCT03294213|10096910|FG000|STARTED|Overall Study||176
9035182|NCT03294213|10096910|FG000|COMPLETED|Overall Study||176
9035183|NCT03294213|10096910|FG000|NOT COMPLETED|Overall Study||0
9035184|NCT03294317|10096914|FG000|STARTED|Overall Study||70
9035185|NCT03294317|10096914|FG000|Implanted With Lead at HIS Bundle|Overall Study||61
9035186|NCT03294317|10096914|FG000|Subjects With Available CT|Overall Study||51
9035187|NCT03294317|10096914|FG000|COMPLETED|Overall Study||50
9035188|NCT03294317|10096914|FG000|NOT COMPLETED|Overall Study||20
9035189|NCT03294538|10096921|FG000|STARTED|Overall Study||268
9035190|NCT03294538|10096922|FG001|STARTED|Overall Study||262
9035191|NCT03294538|10096923|FG002|STARTED|Overall Study||133
9035192|NCT03294538|10096921|FG000|Safety Population|Overall Study||267
9035193|NCT03294538|10096922|FG001|Safety Population|Overall Study||262
9035194|NCT03294538|10096923|FG002|Safety Population|Overall Study||132
9035195|NCT03294538|10096921|FG000|mITT Population|Overall Study||267
9035196|NCT03294538|10096922|FG001|mITT Population|Overall Study||262
9035197|NCT03294538|10096923|FG002|mITT Population|Overall Study||132
9035198|NCT03294538|10096921|FG000|PP Population|Overall Study||244
9035199|NCT03294538|10096922|FG001|PP Population|Overall Study||227
9035200|NCT03294538|10096923|FG002|PP Population|Overall Study||126
9035201|NCT03294538|10096921|FG000|COMPLETED|Overall Study||263
9035202|NCT03294538|10096922|FG001|COMPLETED|Overall Study||257
9035203|NCT03294538|10096923|FG002|COMPLETED|Overall Study||131
9035204|NCT03294538|10096921|FG000|NOT COMPLETED|Overall Study||5
9035205|NCT03294538|10096922|FG001|NOT COMPLETED|Overall Study||5
9035206|NCT03294538|10096923|FG002|NOT COMPLETED|Overall Study||2
9035207|NCT03294629|10096933|FG000|STARTED|First Intervention (2 Weeks)||16
9035208|NCT03294629|10096934|FG001|STARTED|First Intervention (2 Weeks)||19
9035209|NCT03294629|10096933|FG000|COMPLETED|First Intervention (2 Weeks)||14
9035210|NCT03294629|10096934|FG001|COMPLETED|First Intervention (2 Weeks)||15
9035211|NCT03294629|10096933|FG000|NOT COMPLETED|First Intervention (2 Weeks)||2
9035212|NCT03294629|10096934|FG001|NOT COMPLETED|First Intervention (2 Weeks)||4
9035213|NCT03294629|10096933|FG000|STARTED|Second Intervention (2 Weeks)||14
9035214|NCT03294629|10096934|FG001|STARTED|Second Intervention (2 Weeks)||15
9035215|NCT03294629|10096933|FG000|COMPLETED|Second Intervention (2 Weeks)||12
9035216|NCT03294629|10096934|FG001|COMPLETED|Second Intervention (2 Weeks)||13
9035217|NCT03294629|10096933|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||2
9035218|NCT03294629|10096934|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||2
9035219|NCT03294681|10096940|FG000|STARTED|Overall Study||153
9035220|NCT03294681|10096940|FG000|COMPLETED|Overall Study||152
9035221|NCT03294681|10096940|FG000|NOT COMPLETED|Overall Study||1
9035222|NCT03294850|10096946|FG000|STARTED|Overall Study||4
9035223|NCT03294850|10096947|FG001|STARTED|Overall Study||10
9035224|NCT03294850|10096946|FG000|COMPLETED|Overall Study||4
9035225|NCT03294850|10096947|FG001|COMPLETED|Overall Study||10
9035226|NCT03294850|10096946|FG000|NOT COMPLETED|Overall Study||0
9035227|NCT03294850|10096947|FG001|NOT COMPLETED|Overall Study||0
9035228|NCT03294941|10096955|FG000|STARTED|Overall Study||4
9035229|NCT03294941|10096956|FG001|STARTED|Overall Study||13
9035230|NCT03294941|10096955|FG000|COMPLETED|Overall Study||4
9035231|NCT03294941|10096956|FG001|COMPLETED|Overall Study||11
9035232|NCT03294941|10096955|FG000|NOT COMPLETED|Overall Study||0
9035233|NCT03294941|10096956|FG001|NOT COMPLETED|Overall Study||2
9035234|NCT03295201|10096965|FG000|STARTED|Overall Study||11
9035235|NCT03295201|10096966|FG001|STARTED|Overall Study||11
9035236|NCT03295201|10096965|FG000|COMPLETED|Overall Study||10
9035237|NCT03295201|10096966|FG001|COMPLETED|Overall Study||9
9035238|NCT03295201|10096965|FG000|NOT COMPLETED|Overall Study||1
9035239|NCT03295201|10096966|FG001|NOT COMPLETED|Overall Study||2
9035240|NCT03295266|10096974|FG000|STARTED|Overall Study||5
9035241|NCT03295266|10096975|FG001|STARTED|Overall Study||4
9035242|NCT03295266|10096974|FG000|COMPLETED|Overall Study||5
9035243|NCT03295266|10096975|FG001|COMPLETED|Overall Study||4
9035244|NCT03295266|10096974|FG000|NOT COMPLETED|Overall Study||0
9035245|NCT03295266|10096975|FG001|NOT COMPLETED|Overall Study||0
9035246|NCT03295318|10096984|FG000|STARTED|Overall Study||150
9035247|NCT03295318|10096985|FG001|STARTED|Overall Study||150
9035248|NCT03295318|10096986|FG002|STARTED|Overall Study||76
9035249|NCT03295318|10096984|FG000|Received First Vaccination|Overall Study|1 subject withdrew consent after randomization, but prior to vaccination.|149
9035250|NCT03295318|10096985|FG001|Received First Vaccination|Overall Study||150
9035251|NCT03295318|10096986|FG002|Received First Vaccination|Overall Study||76
9035252|NCT03295318|10096984|FG000|Received Second Vaccination|Overall Study||144
9035253|NCT03295318|10096985|FG001|Received Second Vaccination|Overall Study||145
9035254|NCT03295318|10096986|FG002|Received Second Vaccination|Overall Study||73
9035255|NCT03295318|10096984|FG000|COMPLETED|Overall Study||144
9035256|NCT03295318|10096985|FG001|COMPLETED|Overall Study||145
9035257|NCT03295318|10096986|FG002|COMPLETED|Overall Study||71
9035258|NCT03295318|10096984|FG000|NOT COMPLETED|Overall Study||6
9035259|NCT03295318|10096985|FG001|NOT COMPLETED|Overall Study||5
9035260|NCT03295318|10096986|FG002|NOT COMPLETED|Overall Study||5
9035261|NCT03295630|10097012|FG000|STARTED|Overall Study||20
9035262|NCT03295630|10097012|FG000|COMPLETED|Overall Study||20
9035263|NCT03295630|10097012|FG000|NOT COMPLETED|Overall Study||0
9035264|NCT03295721|10097020|FG000|STARTED|Overall Study||157
9035265|NCT03295721|10097021|FG001|STARTED|Overall Study||100
9035266|NCT03295721|10097022|FG002|STARTED|Overall Study||155
9035267|NCT03295721|10097020|FG000|COMPLETED|Overall Study||154
9035268|NCT03295721|10097021|FG001|COMPLETED|Overall Study||99
9035269|NCT03295721|10097022|FG002|COMPLETED|Overall Study||152
9035270|NCT03295721|10097020|FG000|NOT COMPLETED|Overall Study||3
9035271|NCT03295721|10097021|FG001|NOT COMPLETED|Overall Study||1
9035272|NCT03295721|10097022|FG002|NOT COMPLETED|Overall Study||3
9035273|NCT03296072|10097031|FG000|STARTED|Treatment Period 1||10
9035274|NCT03296072|10097032|FG001|STARTED|Treatment Period 1||11
9035275|NCT03296072|10097033|FG002|STARTED|Treatment Period 1||10
9035276|NCT03296072|10097034|FG003|STARTED|Treatment Period 1||10
9035277|NCT03296072|10097035|FG004|STARTED|Treatment Period 1||10
9035278|NCT03296072|10097036|FG005|STARTED|Treatment Period 1||11
9035279|NCT03296072|10097031|FG000|COMPLETED|Treatment Period 1||10
9035280|NCT03296072|10097032|FG001|COMPLETED|Treatment Period 1||11
9035281|NCT03296072|10097033|FG002|COMPLETED|Treatment Period 1||10
9035282|NCT03296072|10097034|FG003|COMPLETED|Treatment Period 1||10
9035283|NCT03296072|10097035|FG004|COMPLETED|Treatment Period 1||10
9035284|NCT03296072|10097036|FG005|COMPLETED|Treatment Period 1||11
9035285|NCT03296072|10097031|FG000|NOT COMPLETED|Treatment Period 1||0
9035286|NCT03296072|10097032|FG001|NOT COMPLETED|Treatment Period 1||0
9035287|NCT03296072|10097033|FG002|NOT COMPLETED|Treatment Period 1||0
9035288|NCT03296072|10097034|FG003|NOT COMPLETED|Treatment Period 1||0
9035289|NCT03296072|10097035|FG004|NOT COMPLETED|Treatment Period 1||0
9035290|NCT03296072|10097036|FG005|NOT COMPLETED|Treatment Period 1||0
9035291|NCT03296072|10097031|FG000|STARTED|Treament Period 1: Wash Out Period||10
9035292|NCT03296072|10097032|FG001|STARTED|Treament Period 1: Wash Out Period||11
9035293|NCT03296072|10097033|FG002|STARTED|Treament Period 1: Wash Out Period||10
9035294|NCT03296072|10097034|FG003|STARTED|Treament Period 1: Wash Out Period||10
9035295|NCT03296072|10097035|FG004|STARTED|Treament Period 1: Wash Out Period||10
9035296|NCT03296072|10097036|FG005|STARTED|Treament Period 1: Wash Out Period||11
9035297|NCT03296072|10097031|FG000|COMPLETED|Treament Period 1: Wash Out Period||10
9035298|NCT03296072|10097032|FG001|COMPLETED|Treament Period 1: Wash Out Period||11
9035299|NCT03296072|10097033|FG002|COMPLETED|Treament Period 1: Wash Out Period||10
9035300|NCT03296072|10097034|FG003|COMPLETED|Treament Period 1: Wash Out Period||10
9035301|NCT03296072|10097035|FG004|COMPLETED|Treament Period 1: Wash Out Period||10
9035302|NCT03296072|10097036|FG005|COMPLETED|Treament Period 1: Wash Out Period||11
9035303|NCT03296072|10097031|FG000|NOT COMPLETED|Treament Period 1: Wash Out Period||0
9035304|NCT03296072|10097032|FG001|NOT COMPLETED|Treament Period 1: Wash Out Period||0
9035305|NCT03296072|10097033|FG002|NOT COMPLETED|Treament Period 1: Wash Out Period||0
9035306|NCT03296072|10097034|FG003|NOT COMPLETED|Treament Period 1: Wash Out Period||0
9035307|NCT03296072|10097035|FG004|NOT COMPLETED|Treament Period 1: Wash Out Period||0
9035308|NCT03296072|10097036|FG005|NOT COMPLETED|Treament Period 1: Wash Out Period||0
9035309|NCT03296072|10097031|FG000|STARTED|Treament Period 2||10
9035310|NCT03296072|10097032|FG001|STARTED|Treament Period 2||11
9035311|NCT03296072|10097033|FG002|STARTED|Treament Period 2||10
9035312|NCT03296072|10097034|FG003|STARTED|Treament Period 2||10
9035313|NCT03296072|10097035|FG004|STARTED|Treament Period 2||10
9035314|NCT03296072|10097036|FG005|STARTED|Treament Period 2||11
9035315|NCT03296072|10097031|FG000|COMPLETED|Treament Period 2||10
9035316|NCT03296072|10097032|FG001|COMPLETED|Treament Period 2||11
9035317|NCT03296072|10097033|FG002|COMPLETED|Treament Period 2||10
9035318|NCT03296072|10097034|FG003|COMPLETED|Treament Period 2||10
9035319|NCT03296072|10097035|FG004|COMPLETED|Treament Period 2||10
9035320|NCT03296072|10097036|FG005|COMPLETED|Treament Period 2||11
9035321|NCT03296072|10097031|FG000|NOT COMPLETED|Treament Period 2||0
9035322|NCT03296072|10097032|FG001|NOT COMPLETED|Treament Period 2||0
9035323|NCT03296072|10097033|FG002|NOT COMPLETED|Treament Period 2||0
9035324|NCT03296072|10097034|FG003|NOT COMPLETED|Treament Period 2||0
9035325|NCT03296072|10097035|FG004|NOT COMPLETED|Treament Period 2||0
9035326|NCT03296072|10097036|FG005|NOT COMPLETED|Treament Period 2||0
9035327|NCT03296072|10097031|FG000|STARTED|Treament Period 2: Wash Out Period||10
9035328|NCT03296072|10097032|FG001|STARTED|Treament Period 2: Wash Out Period||11
9035329|NCT03296072|10097033|FG002|STARTED|Treament Period 2: Wash Out Period||10
9035330|NCT03296072|10097034|FG003|STARTED|Treament Period 2: Wash Out Period||10
9035331|NCT03296072|10097035|FG004|STARTED|Treament Period 2: Wash Out Period||10
9035332|NCT03296072|10097036|FG005|STARTED|Treament Period 2: Wash Out Period||11
9035333|NCT03296072|10097031|FG000|COMPLETED|Treament Period 2: Wash Out Period||10
9035334|NCT03296072|10097032|FG001|COMPLETED|Treament Period 2: Wash Out Period||11
9035335|NCT03296072|10097033|FG002|COMPLETED|Treament Period 2: Wash Out Period||10
9035336|NCT03296072|10097034|FG003|COMPLETED|Treament Period 2: Wash Out Period||10
9035337|NCT03296072|10097035|FG004|COMPLETED|Treament Period 2: Wash Out Period||10
9035338|NCT03296072|10097036|FG005|COMPLETED|Treament Period 2: Wash Out Period||11
9035339|NCT03296072|10097031|FG000|NOT COMPLETED|Treament Period 2: Wash Out Period||0
9035340|NCT03296072|10097032|FG001|NOT COMPLETED|Treament Period 2: Wash Out Period||0
9035341|NCT03296072|10097033|FG002|NOT COMPLETED|Treament Period 2: Wash Out Period||0
9035342|NCT03296072|10097034|FG003|NOT COMPLETED|Treament Period 2: Wash Out Period||0
9035343|NCT03296072|10097035|FG004|NOT COMPLETED|Treament Period 2: Wash Out Period||0
9035344|NCT03296072|10097036|FG005|NOT COMPLETED|Treament Period 2: Wash Out Period||0
9035345|NCT03296072|10097031|FG000|STARTED|Treament Period 3||10
9035346|NCT03296072|10097032|FG001|STARTED|Treament Period 3||11
9035347|NCT03296072|10097033|FG002|STARTED|Treament Period 3||10
9035348|NCT03296072|10097034|FG003|STARTED|Treament Period 3||10
9035349|NCT03296072|10097035|FG004|STARTED|Treament Period 3||10
9035350|NCT03296072|10097036|FG005|STARTED|Treament Period 3||11
9035351|NCT03296072|10097031|FG000|COMPLETED|Treament Period 3||10
9035352|NCT03296072|10097032|FG001|COMPLETED|Treament Period 3||11
9035353|NCT03296072|10097033|FG002|COMPLETED|Treament Period 3||10
9035354|NCT03296072|10097034|FG003|COMPLETED|Treament Period 3||10
9035355|NCT03296072|10097035|FG004|COMPLETED|Treament Period 3||10
9035356|NCT03296072|10097036|FG005|COMPLETED|Treament Period 3||11
9035357|NCT03296072|10097031|FG000|NOT COMPLETED|Treament Period 3||0
9035358|NCT03296072|10097032|FG001|NOT COMPLETED|Treament Period 3||0
9035359|NCT03296072|10097033|FG002|NOT COMPLETED|Treament Period 3||0
9035360|NCT03296072|10097034|FG003|NOT COMPLETED|Treament Period 3||0
9035361|NCT03296072|10097035|FG004|NOT COMPLETED|Treament Period 3||0
9035362|NCT03296072|10097036|FG005|NOT COMPLETED|Treament Period 3||0
9035363|NCT03296163|10097046|FG000|STARTED|Combination Therapy||315
9035364|NCT03296163|10097047|FG001|STARTED|Combination Therapy||312
9035365|NCT03296163|10097046|FG000|COMPLETED|Combination Therapy||207
9035366|NCT03296163|10097047|FG001|COMPLETED|Combination Therapy||220
9035367|NCT03296163|10097046|FG000|NOT COMPLETED|Combination Therapy||108
9035368|NCT03296163|10097047|FG001|NOT COMPLETED|Combination Therapy||92
9035369|NCT03296163|10097046|FG000|STARTED|Monotherapy||207
9035370|NCT03296163|10097047|FG001|STARTED|Monotherapy||220
9035371|NCT03296163|10097046|FG000|COMPLETED|Monotherapy||68
9035372|NCT03296163|10097047|FG001|COMPLETED|Monotherapy||74
9035373|NCT03296163|10097046|FG000|NOT COMPLETED|Monotherapy||139
9035374|NCT03296163|10097047|FG001|NOT COMPLETED|Monotherapy||146
9035375|NCT03296280|10097055|FG000|STARTED|Overall Study||73
9035376|NCT03296280|10097056|FG001|STARTED|Overall Study||43
9035377|NCT03296280|10097055|FG000|COMPLETED|Overall Study||67
9035378|NCT03296280|10097056|FG001|COMPLETED|Overall Study||36
9035379|NCT03296280|10097055|FG000|NOT COMPLETED|Overall Study||6
9035380|NCT03296280|10097056|FG001|NOT COMPLETED|Overall Study||7
9035381|NCT03296345|10097062|FG000|STARTED|Overall Study||62
9035382|NCT03296345|10097062|FG000|COMPLETED|Overall Study||62
9035383|NCT03296345|10097062|FG000|NOT COMPLETED|Overall Study||0
9035384|NCT03296527|10097070|FG000|STARTED|Overall Study||500
9035385|NCT03296527|10097071|FG001|STARTED|Overall Study||511
9035386|NCT03296527|10097070|FG000|Full Analysis Set|Overall Study||499
9035387|NCT03296527|10097071|FG001|Full Analysis Set|Overall Study||510
9035388|NCT03296527|10097070|FG000|COMPLETED|Overall Study||465
9035389|NCT03296527|10097071|FG001|COMPLETED|Overall Study||458
9035390|NCT03296527|10097070|FG000|NOT COMPLETED|Overall Study||35
9035391|NCT03296527|10097071|FG001|NOT COMPLETED|Overall Study||53
9035392|NCT03296566|10097080|FG000|STARTED|Overall Study||145
9035393|NCT03296566|10097081|FG001|STARTED|Overall Study||152
9035394|NCT03296566|10097080|FG000|COMPLETED|Overall Study||126
9035395|NCT03296566|10097081|FG001|COMPLETED|Overall Study||103
9035396|NCT03296566|10097080|FG000|NOT COMPLETED|Overall Study||19
9035397|NCT03296566|10097081|FG001|NOT COMPLETED|Overall Study||49
9035398|NCT03296787|10097091|FG000|STARTED|Overall Study||8
9035399|NCT03296787|10097092|FG001|STARTED|Overall Study||8
9035400|NCT03296787|10097093|FG002|STARTED|Overall Study||9
9035401|NCT03296787|10097094|FG003|STARTED|Overall Study||7
9035402|NCT03296787|10097091|FG000|COMPLETED|Overall Study||8
9035403|NCT03296787|10097092|FG001|COMPLETED|Overall Study||8
9035404|NCT03296787|10097093|FG002|COMPLETED|Overall Study||9
9035405|NCT03296787|10097094|FG003|COMPLETED|Overall Study||7
9035406|NCT03296787|10097091|FG000|NOT COMPLETED|Overall Study||0
9035407|NCT03296787|10097092|FG001|NOT COMPLETED|Overall Study||0
9035408|NCT03296787|10097093|FG002|NOT COMPLETED|Overall Study||0
9035409|NCT03296787|10097094|FG003|NOT COMPLETED|Overall Study||0
9035410|NCT03296800|10097108|FG000|STARTED|Overall Study||16
9035411|NCT03296800|10097109|FG001|STARTED|Overall Study||16
9035412|NCT03296800|10097110|FG002|STARTED|Overall Study||16
9035413|NCT03296800|10097108|FG000|COMPLETED|Overall Study||16
9035414|NCT03296800|10097109|FG001|COMPLETED|Overall Study||16
9035415|NCT03296800|10097110|FG002|COMPLETED|Overall Study||16
9035416|NCT03296800|10097108|FG000|NOT COMPLETED|Overall Study||0
9035417|NCT03296800|10097109|FG001|NOT COMPLETED|Overall Study||0
9035418|NCT03296800|10097110|FG002|NOT COMPLETED|Overall Study||0
9035419|NCT03297021|10097136|FG000|STARTED|Overall Study||48
9035420|NCT03297021|10097137|FG001|STARTED|Overall Study||46
9035421|NCT03297021|10097138|FG002|STARTED|Overall Study||47
9035422|NCT03297021|10097136|FG000|COMPLETED|Overall Study||43
9035423|NCT03297021|10097137|FG001|COMPLETED|Overall Study||42
9035424|NCT03297021|10097138|FG002|COMPLETED|Overall Study||43
9035425|NCT03297021|10097136|FG000|NOT COMPLETED|Overall Study||5
9035426|NCT03297021|10097137|FG001|NOT COMPLETED|Overall Study||4
9035427|NCT03297021|10097138|FG002|NOT COMPLETED|Overall Study||4
9035428|NCT03297112|10097146|FG000|STARTED|Overall Study||12
9035429|NCT03297112|10097146|FG000|COMPLETED|Overall Study||12
9035430|NCT03297112|10097146|FG000|NOT COMPLETED|Overall Study||0
9035431|NCT03297216|10097152|FG000|STARTED|Overall Study||399
9035432|NCT03297216|10097153|FG001|STARTED|Overall Study||401
9035433|NCT03297216|10097152|FG000|Discontinued Intervention|Overall Study||5
9035434|NCT03297216|10097153|FG001|Discontinued Intervention|Overall Study||4
9035435|NCT03297216|10097152|FG000|Infants Born During Study|Overall Study||399
9035436|NCT03297216|10097153|FG001|Infants Born During Study|Overall Study||401
9035437|NCT03297216|10097152|FG000|COMPLETED|Overall Study||396
9035438|NCT03297216|10097153|FG001|COMPLETED|Overall Study||396
9035439|NCT03297216|10097152|FG000|NOT COMPLETED|Overall Study||3
9035440|NCT03297216|10097153|FG001|NOT COMPLETED|Overall Study||5
9035441|NCT03297294|10097168|FG000|STARTED|Double-Blind Treatment Period (DB)||70
9035442|NCT03297294|10097169|FG001|STARTED|Double-Blind Treatment Period (DB)||67
9035443|NCT03297294|10097170|FG002|STARTED|Double-Blind Treatment Period (DB)||0
9035444|NCT03297294|10097171|FG003|STARTED|Double-Blind Treatment Period (DB)||0
9035445|NCT03297294|10097172|FG004|STARTED|Double-Blind Treatment Period (DB)||0
9035446|NCT03297294|10097168|FG000|COMPLETED|Double-Blind Treatment Period (DB)||32
9035447|NCT03297294|10097169|FG001|COMPLETED|Double-Blind Treatment Period (DB)||30
9035448|NCT03297294|10097170|FG002|COMPLETED|Double-Blind Treatment Period (DB)||0
9035449|NCT03297294|10097171|FG003|COMPLETED|Double-Blind Treatment Period (DB)||0
9035450|NCT03297294|10097172|FG004|COMPLETED|Double-Blind Treatment Period (DB)||0
9035451|NCT03297294|10097168|FG000|NOT COMPLETED|Double-Blind Treatment Period (DB)||38
9035452|NCT03297294|10097169|FG001|NOT COMPLETED|Double-Blind Treatment Period (DB)||37
9035453|NCT03297294|10097170|FG002|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
9035454|NCT03297294|10097171|FG003|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
9035455|NCT03297294|10097172|FG004|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
9035456|NCT03297294|10097168|FG000|STARTED|Treatment Withdrawal Period (TW)||0
9035457|NCT03297294|10097169|FG001|STARTED|Treatment Withdrawal Period (TW)||0
9035458|NCT03297294|10097170|FG002|STARTED|Treatment Withdrawal Period (TW)||14
9035459|NCT03297294|10097171|FG003|STARTED|Treatment Withdrawal Period (TW)||12
9035460|NCT03297294|10097172|FG004|STARTED|Treatment Withdrawal Period (TW)||27
9035461|NCT03297294|10097168|FG000|COMPLETED|Treatment Withdrawal Period (TW)||0
9035462|NCT03297294|10097169|FG001|COMPLETED|Treatment Withdrawal Period (TW)||0
9035463|NCT03297294|10097170|FG002|COMPLETED|Treatment Withdrawal Period (TW)||14
9035464|NCT03297294|10097171|FG003|COMPLETED|Treatment Withdrawal Period (TW)||11
9035465|NCT03297294|10097172|FG004|COMPLETED|Treatment Withdrawal Period (TW)||27
9035466|NCT03297294|10097168|FG000|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
9035467|NCT03297294|10097169|FG001|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
9035468|NCT03297294|10097170|FG002|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
9035469|NCT03297294|10097171|FG003|NOT COMPLETED|Treatment Withdrawal Period (TW)||1
9035470|NCT03297294|10097172|FG004|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
9035471|NCT03297398|10097187|FG000|STARTED|Overall Study||36
9035472|NCT03297398|10097188|FG001|STARTED|Overall Study||40
9035473|NCT03297398|10097189|FG002|STARTED|Overall Study||38
9035474|NCT03297398|10097187|FG000|COMPLETED|Overall Study||28
9035475|NCT03297398|10097188|FG001|COMPLETED|Overall Study||23
9035476|NCT03297398|10097189|FG002|COMPLETED|Overall Study||23
9035477|NCT03297398|10097187|FG000|NOT COMPLETED|Overall Study||8
9035478|NCT03297398|10097188|FG001|NOT COMPLETED|Overall Study||17
9035479|NCT03297398|10097189|FG002|NOT COMPLETED|Overall Study||15
9035480|NCT03297944|10097197|FG000|STARTED|Overall Study||15
9035481|NCT03297944|10097197|FG000|2ALP/PLC|Overall Study||15
9035482|NCT03297944|10097197|FG000|1ALP/PLC|Overall Study||15
9035483|NCT03297944|10097197|FG000|0.5ALP/PLC|Overall Study||15
9035484|NCT03297944|10097197|FG000|ZOL/PLC|Overall Study||15
9035485|NCT03297944|10097197|FG000|PLC/PLC|Overall Study||15
9035486|NCT03297944|10097197|FG000|PLC/ALP|Overall Study||15
9035487|NCT03297944|10097197|FG000|COMPLETED|Overall Study||15
9035488|NCT03297944|10097197|FG000|NOT COMPLETED|Overall Study||0
9035489|NCT03298035|10097208|FG000|STARTED|Overall Study||10
9035490|NCT03298035|10097209|FG001|STARTED|Overall Study||9
9035491|NCT03298035|10097208|FG000|Received Intervention|Overall Study||9
9035492|NCT03298035|10097209|FG001|Received Intervention|Overall Study||7
9035493|NCT03298035|10097208|FG000|COMPLETED|Overall Study||9
9035494|NCT03298035|10097209|FG001|COMPLETED|Overall Study||7
9035495|NCT03298035|10097208|FG000|NOT COMPLETED|Overall Study||1
9035496|NCT03298035|10097209|FG001|NOT COMPLETED|Overall Study||2
9035497|NCT03298048|10097218|FG000|STARTED|Overall Study||4
9035498|NCT03298048|10097219|FG001|STARTED|Overall Study||3
9035499|NCT03298048|10097220|FG002|STARTED|Overall Study||8
9035500|NCT03298048|10097218|FG000|COMPLETED|Overall Study||4
9035501|NCT03298048|10097219|FG001|COMPLETED|Overall Study||3
9035502|NCT03298048|10097220|FG002|COMPLETED|Overall Study||8
9035503|NCT03298048|10097218|FG000|NOT COMPLETED|Overall Study||0
9035504|NCT03298048|10097219|FG001|NOT COMPLETED|Overall Study||0
9035505|NCT03298048|10097220|FG002|NOT COMPLETED|Overall Study||0
9035506|NCT03298113|10097230|FG000|STARTED|Overall Study|10 subjects were treated w/ Cavilon Advanced Skin Protectant. Study terminated due to low enrollment|10
9035507|NCT03298113|10097231|FG001|STARTED|Overall Study|10 subjects were treated with IAD Hospital Standard Care. Study terminated due to low enrollment.|10
9035508|NCT03298113|10097230|FG000|IAD 1A|Overall Study||3
9035509|NCT03298113|10097231|FG001|IAD 1A|Overall Study||4
9035510|NCT03298113|10097230|FG000|IAD 2A|Overall Study||7
9035511|NCT03298113|10097231|FG001|IAD 2A|Overall Study||6
9035512|NCT03298113|10097230|FG000|COMPLETED|Overall Study||10
9035513|NCT03298113|10097231|FG001|COMPLETED|Overall Study||10
9035514|NCT03298113|10097230|FG000|NOT COMPLETED|Overall Study||0
9035515|NCT03298113|10097231|FG001|NOT COMPLETED|Overall Study||0
9035516|NCT03298412|10097237|FG000|STARTED|Run-in Period||10
9035517|NCT03298412|10097237|FG000|COMPLETED|Run-in Period||1
9035518|NCT03298412|10097237|FG000|NOT COMPLETED|Run-in Period||9
9035519|NCT03298412|10097237|FG000|STARTED|Treatment Period||1
9035520|NCT03298412|10097237|FG000|COMPLETED|Treatment Period||1
9035521|NCT03298412|10097237|FG000|NOT COMPLETED|Treatment Period||0
9035522|NCT03298841|10097243|FG000|STARTED|Overall Study||25
9035523|NCT03298841|10097244|FG001|STARTED|Overall Study||25
9035524|NCT03298841|10097243|FG000|COMPLETED|Overall Study||25
9035525|NCT03298841|10097244|FG001|COMPLETED|Overall Study||25
9035526|NCT03298841|10097243|FG000|NOT COMPLETED|Overall Study||0
9035527|NCT03298841|10097244|FG001|NOT COMPLETED|Overall Study||0
9035528|NCT03298880|10097251|FG000|STARTED|Overall Study||75
9035529|NCT03298880|10097251|FG000|COMPLETED|Overall Study||75
9035530|NCT03298880|10097251|FG000|NOT COMPLETED|Overall Study||0
9035531|NCT03299101|10097262|FG000|STARTED|Overall Study||35
9035532|NCT03299101|10097262|FG000|COMPLETED|Overall Study||25
9035533|NCT03299101|10097262|FG000|NOT COMPLETED|Overall Study||10
9035534|NCT03299244|10097268|FG000|STARTED|Overall Study||317
9035535|NCT03299244|10097269|FG001|STARTED|Overall Study||320
9035536|NCT03299244|10097268|FG000|Received Treatment|Overall Study||315
9035537|NCT03299244|10097269|FG001|Received Treatment|Overall Study||318
9035538|NCT03299244|10097268|FG000|COMPLETED|Overall Study||270
9035539|NCT03299244|10097269|FG001|COMPLETED|Overall Study||282
9035540|NCT03299244|10097268|FG000|NOT COMPLETED|Overall Study||47
9035541|NCT03299244|10097269|FG001|NOT COMPLETED|Overall Study||38
9035542|NCT03299686|10097278|FG000|STARTED|Treatment Epoch||70
9035543|NCT03299686|10097279|FG001|STARTED|Treatment Epoch||48
9035544|NCT03299686|10097278|FG000|PD (Pharmacodynamics) Analysis Set|Treatment Epoch||69
9035545|NCT03299686|10097279|FG001|PD (Pharmacodynamics) Analysis Set|Treatment Epoch||48
9035546|NCT03299686|10097278|FG000|COMPLETED|Treatment Epoch||59
9035547|NCT03299686|10097279|FG001|COMPLETED|Treatment Epoch||44
9035548|NCT03299686|10097278|FG000|NOT COMPLETED|Treatment Epoch||11
9035549|NCT03299686|10097279|FG001|NOT COMPLETED|Treatment Epoch||4
9035550|NCT03299686|10097278|FG000|STARTED|Follow-up Epoch||59
9035551|NCT03299686|10097279|FG001|STARTED|Follow-up Epoch||44
9035552|NCT03299686|10097278|FG000|COMPLETED|Follow-up Epoch||59
9035553|NCT03299686|10097279|FG001|COMPLETED|Follow-up Epoch||43
9035554|NCT03299686|10097278|FG000|NOT COMPLETED|Follow-up Epoch||0
9035555|NCT03299686|10097279|FG001|NOT COMPLETED|Follow-up Epoch||1
9035556|NCT03299881|10097287|FG000|STARTED|Overall Study||39
9035557|NCT03299881|10097288|FG001|STARTED|Overall Study||38
9035558|NCT03299881|10097287|FG000|COMPLETED|Overall Study||22
9035559|NCT03299881|10097288|FG001|COMPLETED|Overall Study||25
9035560|NCT03299881|10097287|FG000|NOT COMPLETED|Overall Study||17
9035561|NCT03299881|10097288|FG001|NOT COMPLETED|Overall Study||13
9035562|NCT03300050|10097299|FG000|STARTED|Overall Study||20
9035563|NCT03300050|10097300|FG001|STARTED|Overall Study||15
9035564|NCT03300050|10097301|FG002|STARTED|Overall Study||5
9035565|NCT03300050|10097302|FG003|STARTED|Overall Study||16
9035566|NCT03300050|10097303|FG004|STARTED|Overall Study||10
9035567|NCT03300050|10097299|FG000|Received Treatment|Overall Study||19
9035568|NCT03300050|10097300|FG001|Received Treatment|Overall Study||14
9035569|NCT03300050|10097301|FG002|Received Treatment|Overall Study||3
9035570|NCT03300050|10097302|FG003|Received Treatment|Overall Study||15
9035571|NCT03300050|10097303|FG004|Received Treatment|Overall Study||10
9035572|NCT03300050|10097299|FG000|Received All Scheduled Treatments|Overall Study||16
9035573|NCT03300050|10097300|FG001|Received All Scheduled Treatments|Overall Study||13
9035574|NCT03300050|10097301|FG002|Received All Scheduled Treatments|Overall Study||2
9035575|NCT03300050|10097302|FG003|Received All Scheduled Treatments|Overall Study||15
9035576|NCT03300050|10097303|FG004|Received All Scheduled Treatments|Overall Study||10
9035577|NCT03300050|10097299|FG000|COMPLETED|Overall Study||17
9035578|NCT03300050|10097300|FG001|COMPLETED|Overall Study||13
9035579|NCT03300050|10097301|FG002|COMPLETED|Overall Study||2
9035580|NCT03300050|10097302|FG003|COMPLETED|Overall Study||15
9035581|NCT03300050|10097303|FG004|COMPLETED|Overall Study||9
9035582|NCT03300050|10097299|FG000|NOT COMPLETED|Overall Study||3
9035583|NCT03300050|10097300|FG001|NOT COMPLETED|Overall Study||2
9035584|NCT03300050|10097301|FG002|NOT COMPLETED|Overall Study||3
9035585|NCT03300050|10097302|FG003|NOT COMPLETED|Overall Study||1
9035586|NCT03300050|10097303|FG004|NOT COMPLETED|Overall Study||1
9035587|NCT03300466|10097317|FG000|STARTED|Overall Study||10
9035588|NCT03300466|10097318|FG001|STARTED|Overall Study||10
9035589|NCT03300466|10097317|FG000|COMPLETED|Overall Study||9
9035590|NCT03300466|10097318|FG001|COMPLETED|Overall Study||10
9035591|NCT03300466|10097317|FG000|NOT COMPLETED|Overall Study||1
9035592|NCT03300466|10097318|FG001|NOT COMPLETED|Overall Study||0
9035593|NCT03300570|10097326|FG000|STARTED|Overall Study||13
9035594|NCT03300570|10097327|FG001|STARTED|Overall Study||14
9035595|NCT03300570|10097326|FG000|COMPLETED|Overall Study||11
9035596|NCT03300570|10097327|FG001|COMPLETED|Overall Study||13
9035597|NCT03300570|10097326|FG000|NOT COMPLETED|Overall Study||2
9035598|NCT03300570|10097327|FG001|NOT COMPLETED|Overall Study||1
9035599|NCT03300674|10097336|FG000|STARTED|Overall Study||77
9035600|NCT03300674|10097337|FG001|STARTED|Overall Study||77
9035601|NCT03300674|10097336|FG000|COMPLETED|Overall Study||77
9035602|NCT03300674|10097337|FG001|COMPLETED|Overall Study||77
9035603|NCT03300674|10097336|FG000|NOT COMPLETED|Overall Study||0
9035604|NCT03300674|10097337|FG001|NOT COMPLETED|Overall Study||0
9035605|NCT03300752|10097345|FG000|STARTED|Overall Study||40
9035606|NCT03300752|10097346|FG001|STARTED|Overall Study||40
9035607|NCT03300752|10097345|FG000|COMPLETED|Overall Study||38
9035608|NCT03300752|10097346|FG001|COMPLETED|Overall Study||38
9035609|NCT03300752|10097345|FG000|NOT COMPLETED|Overall Study||2
9035610|NCT03300752|10097346|FG001|NOT COMPLETED|Overall Study||2
9035611|NCT03300843|10097352|FG000|STARTED|Overall Study||1
9035612|NCT03300843|10097352|FG000|COMPLETED|Overall Study||1
9035613|NCT03300843|10097352|FG000|NOT COMPLETED|Overall Study||0
9035614|NCT03301155|10097358|FG000|STARTED|Overall Study||528
9035615|NCT03301155|10097359|FG001|STARTED|Overall Study||508
9035616|NCT03301155|10097358|FG000|COMPLETED|Overall Study||520
9035617|NCT03301155|10097359|FG001|COMPLETED|Overall Study||501
9035618|NCT03301155|10097358|FG000|NOT COMPLETED|Overall Study||8
9035619|NCT03301155|10097359|FG001|NOT COMPLETED|Overall Study||7
9035620|NCT03301272|10097367|FG000|STARTED|First Intervention (30 Days)||7
9035621|NCT03301272|10097368|FG001|STARTED|First Intervention (30 Days)||9
9035622|NCT03301272|10097367|FG000|COMPLETED|First Intervention (30 Days)||7
9035623|NCT03301272|10097368|FG001|COMPLETED|First Intervention (30 Days)||9
9035624|NCT03301272|10097367|FG000|NOT COMPLETED|First Intervention (30 Days)||0
9035625|NCT03301272|10097368|FG001|NOT COMPLETED|First Intervention (30 Days)||0
9035626|NCT03301272|10097367|FG000|STARTED|Washout (90 Days From 1st Intervention)||7
9035627|NCT03301272|10097368|FG001|STARTED|Washout (90 Days From 1st Intervention)||9
9035628|NCT03301272|10097367|FG000|COMPLETED|Washout (90 Days From 1st Intervention)||7
9035629|NCT03301272|10097368|FG001|COMPLETED|Washout (90 Days From 1st Intervention)||9
9035630|NCT03301272|10097367|FG000|NOT COMPLETED|Washout (90 Days From 1st Intervention)||0
9035631|NCT03301272|10097368|FG001|NOT COMPLETED|Washout (90 Days From 1st Intervention)||0
9035632|NCT03301272|10097367|FG000|STARTED|Second Intervention (30 Days)||7
9035633|NCT03301272|10097368|FG001|STARTED|Second Intervention (30 Days)||9
9035634|NCT03301272|10097367|FG000|COMPLETED|Second Intervention (30 Days)||7
9035635|NCT03301272|10097368|FG001|COMPLETED|Second Intervention (30 Days)||9
9035636|NCT03301272|10097367|FG000|NOT COMPLETED|Second Intervention (30 Days)||0
9035637|NCT03301272|10097368|FG001|NOT COMPLETED|Second Intervention (30 Days)||0
9035638|NCT03301298|10097381|FG000|STARTED|Unfed Conditions||6
9035639|NCT03301298|10097382|FG001|STARTED|Unfed Conditions||6
9035640|NCT03301298|10097383|FG002|STARTED|Unfed Conditions||6
9035641|NCT03301298|10097384|FG003|STARTED|Unfed Conditions||6
9035642|NCT03301298|10097385|FG004|STARTED|Unfed Conditions||6
9035643|NCT03301298|10097386|FG005|STARTED|Unfed Conditions||6
9035644|NCT03301298|10097387|FG006|STARTED|Unfed Conditions||12
9035645|NCT03301298|10097381|FG000|COMPLETED|Unfed Conditions||6
9035646|NCT03301298|10097382|FG001|COMPLETED|Unfed Conditions||6
9035647|NCT03301298|10097383|FG002|COMPLETED|Unfed Conditions||6
9035648|NCT03301298|10097384|FG003|COMPLETED|Unfed Conditions||6
9035649|NCT03301298|10097385|FG004|COMPLETED|Unfed Conditions||6
9035650|NCT03301298|10097386|FG005|COMPLETED|Unfed Conditions||6
9035651|NCT03301298|10097387|FG006|COMPLETED|Unfed Conditions||12
9035652|NCT03301298|10097381|FG000|NOT COMPLETED|Unfed Conditions||0
9035653|NCT03301298|10097382|FG001|NOT COMPLETED|Unfed Conditions||0
9035654|NCT03301298|10097383|FG002|NOT COMPLETED|Unfed Conditions||0
9035655|NCT03301298|10097384|FG003|NOT COMPLETED|Unfed Conditions||0
9035656|NCT03301298|10097385|FG004|NOT COMPLETED|Unfed Conditions||0
9035657|NCT03301298|10097386|FG005|NOT COMPLETED|Unfed Conditions||0
9035658|NCT03301298|10097387|FG006|NOT COMPLETED|Unfed Conditions||0
9035659|NCT03301298|10097381|FG000|STARTED|Fed Conditions||0
9035660|NCT03301298|10097382|FG001|STARTED|Fed Conditions||0
9035661|NCT03301298|10097383|FG002|STARTED|Fed Conditions||0
9035662|NCT03301298|10097384|FG003|STARTED|Fed Conditions||0
9035663|NCT03301298|10097385|FG004|STARTED|Fed Conditions||5
9035664|NCT03301298|10097386|FG005|STARTED|Fed Conditions||0
9035665|NCT03301298|10097387|FG006|STARTED|Fed Conditions||2
9035666|NCT03301298|10097381|FG000|COMPLETED|Fed Conditions||0
8575178|NCT00133575|9607671|FG004|COMPLETED|Overall Study||6
8672271|NCT00756444|9715732|FG000|COMPLETED|Overall Study||18
8672272|NCT00756444|9715733|FG001|COMPLETED|Overall Study||13
8672273|NCT00756444|9715732|FG000|NOT COMPLETED|Overall Study||15
8672274|NCT00756444|9715733|FG001|NOT COMPLETED|Overall Study||21
8672275|NCT00756457|9715742|FG000|STARTED|Overall Study||20
8672276|NCT00756457|9715743|FG001|STARTED|Overall Study||19
8672277|NCT00756457|9715742|FG000|COMPLETED|Overall Study|One participant in the Active treatment group decided to have surgery after the 2 week follow-up.|19
8672278|NCT00756457|9715743|FG001|COMPLETED|Overall Study|One participant moved overseas; the other participant resumed cancer treatment|17
8672279|NCT00756457|9715742|FG000|NOT COMPLETED|Overall Study||1
8672280|NCT00756457|9715743|FG001|NOT COMPLETED|Overall Study||2
8672281|NCT00756470|9715765|FG000|STARTED|Overall Study||15
8672282|NCT00756470|9715765|FG000|COMPLETED|Overall Study||10
8672283|NCT00756470|9715765|FG000|NOT COMPLETED|Overall Study||5
8672284|NCT00756496|9715769|FG000|STARTED|Overall Study||442
8672285|NCT00756496|9715769|FG000|COMPLETED|Overall Study||442
8672286|NCT00756496|9715769|FG000|NOT COMPLETED|Overall Study||0
8672287|NCT00756548|9715776|FG000|STARTED|Overall Study||186
8672288|NCT00756548|9715777|FG001|STARTED|Overall Study||185
8672289|NCT00756548|9715776|FG000|COMPLETED|Overall Study||184
8672290|NCT00756548|9715777|FG001|COMPLETED|Overall Study||185
8672291|NCT00756548|9715776|FG000|NOT COMPLETED|Overall Study||2
8672292|NCT00756548|9715777|FG001|NOT COMPLETED|Overall Study||0
8672293|NCT00756561|9715785|FG000|STARTED|Overall Study||10
8672294|NCT00756561|9715785|FG000|COMPLETED|Overall Study||10
8672295|NCT00756561|9715785|FG000|NOT COMPLETED|Overall Study||0
8672296|NCT00756600|9715792|FG000|STARTED|Overall Study||287
8672297|NCT00756600|9715793|FG001|STARTED|Overall Study||356
8672298|NCT00756600|9715792|FG000|COMPLETED|Overall Study||287
8672299|NCT00756600|9715793|FG001|COMPLETED|Overall Study||356
8672300|NCT00756600|9715792|FG000|NOT COMPLETED|Overall Study||0
8672301|NCT00756600|9715793|FG001|NOT COMPLETED|Overall Study||0
8672302|NCT00756613|9715802|FG000|STARTED|Overall Study||512
8672303|NCT00756613|9715803|FG001|STARTED|Overall Study||532
8672304|NCT00756613|9715802|FG000|COMPLETED|Overall Study||426
8672305|NCT00756613|9715803|FG001|COMPLETED|Overall Study||462
8672306|NCT00756613|9715802|FG000|NOT COMPLETED|Overall Study||86
8672307|NCT00756613|9715803|FG001|NOT COMPLETED|Overall Study||70
8672308|NCT00756652|9715812|FG000|STARTED|Original Phase||41452
8672309|NCT00756652|9715813|FG001|STARTED|Original Phase||1039
8672310|NCT00756652|9715812|FG000|COMPLETED|Original Phase|At Year 7|6063
8672311|NCT00756652|9715813|FG001|COMPLETED|Original Phase||118
8672312|NCT00756652|9715812|FG000|NOT COMPLETED|Original Phase||35389
8672313|NCT00756652|9715813|FG001|NOT COMPLETED|Original Phase||921
8672314|NCT00756652|9715812|FG000|STARTED|Re-Op Phase||11101
9035667|NCT03301298|10097382|FG001|COMPLETED|Fed Conditions||0
9035668|NCT03301298|10097383|FG002|COMPLETED|Fed Conditions||0
9035669|NCT03301298|10097384|FG003|COMPLETED|Fed Conditions||0
9035670|NCT03301298|10097385|FG004|COMPLETED|Fed Conditions||5
9035671|NCT03301298|10097386|FG005|COMPLETED|Fed Conditions||0
9035672|NCT03301298|10097387|FG006|COMPLETED|Fed Conditions||2
9035673|NCT03301298|10097381|FG000|NOT COMPLETED|Fed Conditions||0
9035674|NCT03301298|10097382|FG001|NOT COMPLETED|Fed Conditions||0
9035675|NCT03301298|10097383|FG002|NOT COMPLETED|Fed Conditions||0
9035676|NCT03301298|10097384|FG003|NOT COMPLETED|Fed Conditions||0
9035677|NCT03301298|10097385|FG004|NOT COMPLETED|Fed Conditions||0
9035678|NCT03301298|10097386|FG005|NOT COMPLETED|Fed Conditions||0
9035679|NCT03301298|10097387|FG006|NOT COMPLETED|Fed Conditions||0
9035680|NCT03301623|10097406|FG000|STARTED|Overall Study||462
9035681|NCT03301623|10097407|FG001|STARTED|Overall Study||521
9035682|NCT03301623|10097406|FG000|COMPLETED|Overall Study||445
9035683|NCT03301623|10097407|FG001|COMPLETED|Overall Study||506
9035684|NCT03301623|10097406|FG000|NOT COMPLETED|Overall Study||17
9035685|NCT03301623|10097407|FG001|NOT COMPLETED|Overall Study||15
9035686|NCT03301649|10097416|FG000|STARTED|Overall Study||399
8692659|NCT00862719|9738233|FG000|COMPLETED|Overall Study||7
8692660|NCT00862719|9738234|FG001|COMPLETED|Overall Study||1
9035687|NCT03301649|10097417|FG001|STARTED|Overall Study||400
9035688|NCT03301649|10097418|FG002|STARTED|Overall Study||112
8672315|NCT00756652|9715813|FG001|STARTED|Re-Op Phase|NA - The Re-Op Phase was limited in scope to data collection for only MemoryGel participants.|0
8672316|NCT00756652|9715812|FG000|COMPLETED|Re-Op Phase||8225
8672317|NCT00756652|9715813|FG001|COMPLETED|Re-Op Phase||0
8672318|NCT00756652|9715812|FG000|NOT COMPLETED|Re-Op Phase||2876
8672319|NCT00756652|9715813|FG001|NOT COMPLETED|Re-Op Phase||0
8672320|NCT00756678|9715817|FG000|STARTED|Overall Study||51
8672321|NCT00756678|9715817|FG000|COMPLETED|Overall Study||50
8672322|NCT00756678|9715817|FG000|NOT COMPLETED|Overall Study||1
8672323|NCT00756717|9715822|FG000|STARTED|Overall Study||22
8672324|NCT00756717|9715822|FG000|COMPLETED|Overall Study||20
8672325|NCT00756717|9715822|FG000|NOT COMPLETED|Overall Study||2
8672326|NCT00756730|9715828|FG000|STARTED|Overall Study||25
8672327|NCT00756730|9715829|FG001|STARTED|Overall Study||24
8672328|NCT00756730|9715828|FG000|COMPLETED|Overall Study||25
8672329|NCT00756730|9715829|FG001|COMPLETED|Overall Study||22
8672330|NCT00756730|9715828|FG000|NOT COMPLETED|Overall Study||0
8672331|NCT00756730|9715829|FG001|NOT COMPLETED|Overall Study||2
8672332|NCT00756886|9715837|FG000|STARTED|Overall Study||41
8672333|NCT00756886|9715838|FG001|STARTED|Overall Study||32
8672334|NCT00756886|9715837|FG000|COMPLETED|Overall Study||30
8672335|NCT00756886|9715838|FG001|COMPLETED|Overall Study||25
8672336|NCT00756886|9715837|FG000|NOT COMPLETED|Overall Study||11
8672337|NCT00756886|9715838|FG001|NOT COMPLETED|Overall Study||7
8672338|NCT00756964|9715846|FG000|STARTED|Overall Study||13
8672339|NCT00756964|9715847|FG001|STARTED|Overall Study||13
8672340|NCT00756964|9715846|FG000|COMPLETED|Overall Study||13
8672341|NCT00756964|9715847|FG001|COMPLETED|Overall Study||13
8672342|NCT00756964|9715846|FG000|NOT COMPLETED|Overall Study||0
8672343|NCT00756964|9715847|FG001|NOT COMPLETED|Overall Study||0
8672344|NCT00756977|9715855|FG000|STARTED|Overall Study||196
8672345|NCT00756977|9715856|FG001|STARTED|Overall Study||198
8672346|NCT00756977|9715855|FG000|COMPLETED|Overall Study||175
8672347|NCT00756977|9715856|FG001|COMPLETED|Overall Study||187
8672348|NCT00756977|9715855|FG000|NOT COMPLETED|Overall Study||21
8672349|NCT00756977|9715856|FG001|NOT COMPLETED|Overall Study||11
8672350|NCT00757003|9715862|FG000|STARTED|Overall Study||100
8672351|NCT00757003|9715862|FG000|COMPLETED|Overall Study||51
8672352|NCT00757003|9715862|FG000|NOT COMPLETED|Overall Study||49
8672353|NCT00757172|9715867|FG000|STARTED|Overall Study||65
8672354|NCT00757172|9715867|FG000|COMPLETED|Overall Study|Participants underwent surgery.|54
8672355|NCT00757172|9715867|FG000|NOT COMPLETED|Overall Study||11
8672356|NCT00757237|9715873|FG000|STARTED|Overall Study||137
8672357|NCT00757237|9715874|FG001|STARTED|Overall Study||136
8672358|NCT00757237|9715873|FG000|Treated|Overall Study||136
8672359|NCT00757237|9715874|FG001|Treated|Overall Study||132
8672360|NCT00757237|9715873|FG000|COMPLETED|Overall Study||124
8672361|NCT00757237|9715874|FG001|COMPLETED|Overall Study||111
8672362|NCT00757237|9715873|FG000|NOT COMPLETED|Overall Study||13
8672363|NCT00757237|9715874|FG001|NOT COMPLETED|Overall Study||25
8672364|NCT00757484|9715880|FG000|STARTED|Overall Study||491
8672365|NCT00757484|9715880|FG000|COMPLETED|Overall Study||491
8672366|NCT00757484|9715880|FG000|NOT COMPLETED|Overall Study||0
8672367|NCT00757588|9715888|FG000|STARTED|Period 1: Short-term (24-week) Phase||304
8672368|NCT00757588|9715889|FG001|STARTED|Period 1: Short-term (24-week) Phase||151
8672369|NCT00757588|9715888|FG000|COMPLETED|Period 1: Short-term (24-week) Phase|Does not include 2 who completed Period 1 but were erroneously reported in the CSR as noncompleters.|268
8672370|NCT00757588|9715889|FG001|COMPLETED|Period 1: Short-term (24-week) Phase||134
8672371|NCT00757588|9715888|FG000|NOT COMPLETED|Period 1: Short-term (24-week) Phase||36
8672372|NCT00757588|9715889|FG001|NOT COMPLETED|Period 1: Short-term (24-week) Phase||17
8672373|NCT00757588|9715888|FG000|STARTED|Period 2: Long-term (52-week) Phase|270 participants completed short-term phase; 2 of these did not enter long-term phase.|268
8672374|NCT00757588|9715889|FG001|STARTED|Period 2: Long-term (52-week) Phase||134
8672375|NCT00757588|9715888|FG000|COMPLETED|Period 2: Long-term (52-week) Phase||246
8672376|NCT00757588|9715889|FG001|COMPLETED|Period 2: Long-term (52-week) Phase||125
8672377|NCT00757588|9715888|FG000|NOT COMPLETED|Period 2: Long-term (52-week) Phase||22
8672378|NCT00757588|9715889|FG001|NOT COMPLETED|Period 2: Long-term (52-week) Phase||9
8692661|NCT00862719|9738235|FG002|COMPLETED|Overall Study||0
8672379|NCT00757601|9715895|FG000|STARTED|Period 1||2
8672380|NCT00757601|9715896|FG001|STARTED|Period 1||2
8672381|NCT00757601|9715897|FG002|STARTED|Period 1||2
8672382|NCT00757601|9715898|FG003|STARTED|Period 1||2
8672383|NCT00757601|9715899|FG004|STARTED|Period 1||2
8672384|NCT00757601|9715900|FG005|STARTED|Period 1||2
8672385|NCT00757601|9715901|FG006|STARTED|Period 1||2
8672386|NCT00757601|9715902|FG007|STARTED|Period 1||2
8672387|NCT00757601|9715903|FG008|STARTED|Period 1||2
8672388|NCT00757601|9715904|FG009|STARTED|Period 1||2
8672389|NCT00757601|9715905|FG010|STARTED|Period 1||2
8672390|NCT00757601|9715906|FG011|STARTED|Period 1||3
8672391|NCT00757601|9715895|FG000|COMPLETED|Period 1||2
8672392|NCT00757601|9715896|FG001|COMPLETED|Period 1||2
8672393|NCT00757601|9715897|FG002|COMPLETED|Period 1||2
8672394|NCT00757601|9715898|FG003|COMPLETED|Period 1||2
8672395|NCT00757601|9715899|FG004|COMPLETED|Period 1||2
8672396|NCT00757601|9715900|FG005|COMPLETED|Period 1||2
8672397|NCT00757601|9715901|FG006|COMPLETED|Period 1||2
8672398|NCT00757601|9715902|FG007|COMPLETED|Period 1||2
8672399|NCT00757601|9715903|FG008|COMPLETED|Period 1||2
8672400|NCT00757601|9715904|FG009|COMPLETED|Period 1||2
8672401|NCT00757601|9715905|FG010|COMPLETED|Period 1||2
8672402|NCT00757601|9715906|FG011|COMPLETED|Period 1||3
8672403|NCT00757601|9715895|FG000|NOT COMPLETED|Period 1||0
8672404|NCT00757601|9715896|FG001|NOT COMPLETED|Period 1||0
8672405|NCT00757601|9715897|FG002|NOT COMPLETED|Period 1||0
8672406|NCT00757601|9715898|FG003|NOT COMPLETED|Period 1||0
8672407|NCT00757601|9715899|FG004|NOT COMPLETED|Period 1||0
8672408|NCT00757601|9715900|FG005|NOT COMPLETED|Period 1||0
8672409|NCT00757601|9715901|FG006|NOT COMPLETED|Period 1||0
8672410|NCT00757601|9715902|FG007|NOT COMPLETED|Period 1||0
8672411|NCT00757601|9715903|FG008|NOT COMPLETED|Period 1||0
8672412|NCT00757601|9715904|FG009|NOT COMPLETED|Period 1||0
8672413|NCT00757601|9715905|FG010|NOT COMPLETED|Period 1||0
8672414|NCT00757601|9715906|FG011|NOT COMPLETED|Period 1||0
8672415|NCT00757601|9715895|FG000|STARTED|Period 2||2
8672416|NCT00757601|9715896|FG001|STARTED|Period 2||2
8672417|NCT00757601|9715897|FG002|STARTED|Period 2||2
8672418|NCT00757601|9715898|FG003|STARTED|Period 2||2
8672419|NCT00757601|9715899|FG004|STARTED|Period 2||2
8672420|NCT00757601|9715900|FG005|STARTED|Period 2||2
8672421|NCT00757601|9715901|FG006|STARTED|Period 2||2
8672422|NCT00757601|9715902|FG007|STARTED|Period 2||2
8672423|NCT00757601|9715903|FG008|STARTED|Period 2||2
8672424|NCT00757601|9715904|FG009|STARTED|Period 2||2
8672425|NCT00757601|9715905|FG010|STARTED|Period 2||2
8672426|NCT00757601|9715906|FG011|STARTED|Period 2||3
8672427|NCT00757601|9715895|FG000|COMPLETED|Period 2||2
8672428|NCT00757601|9715896|FG001|COMPLETED|Period 2||2
8672429|NCT00757601|9715897|FG002|COMPLETED|Period 2||2
8672430|NCT00757601|9715898|FG003|COMPLETED|Period 2||2
8672431|NCT00757601|9715899|FG004|COMPLETED|Period 2||2
8672432|NCT00757601|9715900|FG005|COMPLETED|Period 2||2
8672433|NCT00757601|9715901|FG006|COMPLETED|Period 2||2
8672434|NCT00757601|9715902|FG007|COMPLETED|Period 2||2
8672435|NCT00757601|9715903|FG008|COMPLETED|Period 2||2
8672436|NCT00757601|9715904|FG009|COMPLETED|Period 2||2
8672437|NCT00757601|9715905|FG010|COMPLETED|Period 2||2
8672438|NCT00757601|9715906|FG011|COMPLETED|Period 2|One participant discontinued the study after Period 2 and was replaced by another participant.|2
8672439|NCT00757601|9715895|FG000|NOT COMPLETED|Period 2||0
8672440|NCT00757601|9715896|FG001|NOT COMPLETED|Period 2||0
8672441|NCT00757601|9715897|FG002|NOT COMPLETED|Period 2||0
8672442|NCT00757601|9715898|FG003|NOT COMPLETED|Period 2||0
8672443|NCT00757601|9715899|FG004|NOT COMPLETED|Period 2||0
8672444|NCT00757601|9715900|FG005|NOT COMPLETED|Period 2||0
8672445|NCT00757601|9715901|FG006|NOT COMPLETED|Period 2||0
8672446|NCT00757601|9715902|FG007|NOT COMPLETED|Period 2||0
8672447|NCT00757601|9715903|FG008|NOT COMPLETED|Period 2||0
8672448|NCT00757601|9715904|FG009|NOT COMPLETED|Period 2||0
8672449|NCT00757601|9715905|FG010|NOT COMPLETED|Period 2||0
8672450|NCT00757601|9715906|FG011|NOT COMPLETED|Period 2||1
8672451|NCT00757601|9715895|FG000|STARTED|Period 3||2
8672452|NCT00757601|9715896|FG001|STARTED|Period 3||2
8672453|NCT00757601|9715897|FG002|STARTED|Period 3||2
8672454|NCT00757601|9715898|FG003|STARTED|Period 3||2
8575179|NCT00133575|9607672|FG005|COMPLETED|Overall Study||9
8575180|NCT00133575|9607673|FG006|COMPLETED|Overall Study||9
8575181|NCT00133575|9607667|FG000|NOT COMPLETED|Overall Study||0
8575182|NCT00133575|9607668|FG001|NOT COMPLETED|Overall Study||0
8575183|NCT00133575|9607669|FG002|NOT COMPLETED|Overall Study||2
8575184|NCT00133575|9607670|FG003|NOT COMPLETED|Overall Study||1
8575185|NCT00133575|9607671|FG004|NOT COMPLETED|Overall Study||4
8575186|NCT00133575|9607672|FG005|NOT COMPLETED|Overall Study||1
8575187|NCT00133575|9607673|FG006|NOT COMPLETED|Overall Study||3
8575188|NCT00133705|9607691|FG000|STARTED|Overall Study||22
8575189|NCT00133705|9607692|FG001|STARTED|Overall Study||20
8575190|NCT00133705|9607691|FG000|COMPLETED|Overall Study||20
8575191|NCT00133705|9607692|FG001|COMPLETED|Overall Study||17
8575192|NCT00133705|9607691|FG000|NOT COMPLETED|Overall Study||2
8575193|NCT00133705|9607692|FG001|NOT COMPLETED|Overall Study||3
8577612|NCT00159874|9610367|FG000|COMPLETED|Overall Study||22
8577613|NCT00159874|9610368|FG001|COMPLETED|Overall Study||25
8577614|NCT00159874|9610369|FG002|COMPLETED|Overall Study||34
8577615|NCT00159874|9610370|FG003|COMPLETED|Overall Study||7
8577616|NCT00159874|9610371|FG004|COMPLETED|Overall Study||11
8577617|NCT00159874|9610372|FG005|COMPLETED|Overall Study||11
8577618|NCT00159874|9610373|FG006|COMPLETED|Overall Study||0
8577619|NCT00159874|9610367|FG000|NOT COMPLETED|Overall Study||20
8577620|NCT00159874|9610368|FG001|NOT COMPLETED|Overall Study||30
8577621|NCT00159874|9610369|FG002|NOT COMPLETED|Overall Study||43
8577622|NCT00159874|9610370|FG003|NOT COMPLETED|Overall Study||6
8577623|NCT00159874|9610371|FG004|NOT COMPLETED|Overall Study||8
8577624|NCT00159874|9610372|FG005|NOT COMPLETED|Overall Study||12
8577625|NCT00159874|9610373|FG006|NOT COMPLETED|Overall Study||5
8577626|NCT00159913|9610393|FG000|STARTED|Overall Study||42
8577627|NCT00159913|9610394|FG001|STARTED|Overall Study||55
8577628|NCT00159913|9610395|FG002|STARTED|Overall Study||77
8577629|NCT00159913|9610396|FG003|STARTED|Overall Study||60
8577630|NCT00159913|9610393|FG000|COMPLETED|Overall Study||40
8575194|NCT00133809|9607698|FG000|STARTED|Overall Study||8
8575195|NCT00133809|9607698|FG000|COMPLETED|Overall Study||8
8575196|NCT00133809|9607698|FG000|NOT COMPLETED|Overall Study||0
8575197|NCT00133952|9607704|FG000|STARTED|Overall Study||157
8575198|NCT00133952|9607705|FG001|STARTED|Overall Study||152
8575199|NCT00133952|9607704|FG000|Received at Least One Dose of Study Drug|Overall Study||153
8575200|NCT00133952|9607705|FG001|Received at Least One Dose of Study Drug|Overall Study||149
8575201|NCT00133952|9607704|FG000|COMPLETED|Overall Study||115
8575202|NCT00133952|9607705|FG001|COMPLETED|Overall Study||124
8575203|NCT00133952|9607704|FG000|NOT COMPLETED|Overall Study||42
8575204|NCT00133952|9607705|FG001|NOT COMPLETED|Overall Study||28
8575205|NCT00133978|9607715|FG000|STARTED|Overall Study||303
8575206|NCT00133978|9607716|FG001|STARTED|Overall Study||308
8575207|NCT00133978|9607717|FG002|STARTED|Overall Study||310
8575208|NCT00133978|9607718|FG003|STARTED|Overall Study||302
8575209|NCT00133978|9607715|FG000|COMPLETED|Overall Study||301
8575210|NCT00133978|9607716|FG001|COMPLETED|Overall Study||307
8575211|NCT00133978|9607717|FG002|COMPLETED|Overall Study||310
8575212|NCT00133978|9607718|FG003|COMPLETED|Overall Study||300
8575213|NCT00133978|9607715|FG000|NOT COMPLETED|Overall Study||2
8575214|NCT00133978|9607716|FG001|NOT COMPLETED|Overall Study||1
8575215|NCT00133978|9607717|FG002|NOT COMPLETED|Overall Study||0
8575216|NCT00133978|9607718|FG003|NOT COMPLETED|Overall Study||2
8575217|NCT00133991|9607732|FG000|STARTED|Overall Study||21
8575218|NCT00133991|9607732|FG000|COMPLETED|Overall Study||17
8575219|NCT00133991|9607732|FG000|NOT COMPLETED|Overall Study||4
8575220|NCT00134004|9607736|FG000|STARTED|Overall Study||210
8575221|NCT00134004|9607736|FG000|COMPLETED|Overall Study||210
8575222|NCT00134004|9607736|FG000|NOT COMPLETED|Overall Study||0
8575223|NCT00134017|9607740|FG000|STARTED|Overall Study||142
8575224|NCT00134017|9607740|FG000|COMPLETED|Overall Study||142
8575225|NCT00134017|9607740|FG000|NOT COMPLETED|Overall Study||0
8575226|NCT00134043|9607746|FG000|STARTED|Overall Study||16
8575227|NCT00134043|9607747|FG001|STARTED|Overall Study||3
8575228|NCT00134043|9607746|FG000|COMPLETED|Overall Study||16
8575229|NCT00134043|9607747|FG001|COMPLETED|Overall Study||3
8575230|NCT00134043|9607746|FG000|NOT COMPLETED|Overall Study||0
8575231|NCT00134043|9607747|FG001|NOT COMPLETED|Overall Study||0
8575232|NCT00134056|9607754|FG000|STARTED|Randomization||518
8575233|NCT00134056|9607755|FG001|STARTED|Randomization||520
8575234|NCT00134056|9607754|FG000|COMPLETED|Randomization||496
8575235|NCT00134056|9607755|FG001|COMPLETED|Randomization||500
8575236|NCT00134056|9607754|FG000|NOT COMPLETED|Randomization||22
8575237|NCT00134056|9607755|FG001|NOT COMPLETED|Randomization||20
8575238|NCT00134056|9607754|FG000|STARTED|Eligible for Protocol Assigned Treatment||496
8575239|NCT00134056|9607755|FG001|STARTED|Eligible for Protocol Assigned Treatment||500
8575240|NCT00134056|9607754|FG000|COMPLETED|Eligible for Protocol Assigned Treatment||169
8575241|NCT00134056|9607755|FG001|COMPLETED|Eligible for Protocol Assigned Treatment||185
8575242|NCT00134056|9607754|FG000|NOT COMPLETED|Eligible for Protocol Assigned Treatment||327
8575243|NCT00134056|9607755|FG001|NOT COMPLETED|Eligible for Protocol Assigned Treatment||315
8575244|NCT00134082|9607764|FG000|STARTED|Overall Study||30
8575245|NCT00134082|9607764|FG000|COMPLETED|Overall Study||27
8575246|NCT00134082|9607764|FG000|NOT COMPLETED|Overall Study||3
8575247|NCT00134381|9607768|FG000|STARTED|Overall Study||1
8575248|NCT00134381|9607769|FG001|STARTED|Overall Study||2
8575249|NCT00134381|9607770|FG002|STARTED|Overall Study||1
8575250|NCT00134381|9607771|FG003|STARTED|Overall Study||2
8575251|NCT00134381|9607772|FG004|STARTED|Overall Study||31
8575252|NCT00134381|9607773|FG005|STARTED|Overall Study||31
8575253|NCT00134381|9607768|FG000|COMPLETED|Overall Study||1
8575254|NCT00134381|9607769|FG001|COMPLETED|Overall Study||2
8575255|NCT00134381|9607770|FG002|COMPLETED|Overall Study||1
8575256|NCT00134381|9607771|FG003|COMPLETED|Overall Study||2
8575257|NCT00134381|9607772|FG004|COMPLETED|Overall Study||31
8575258|NCT00134381|9607773|FG005|COMPLETED|Overall Study||29
8575259|NCT00134381|9607768|FG000|NOT COMPLETED|Overall Study||0
8575260|NCT00134381|9607769|FG001|NOT COMPLETED|Overall Study||0
8575261|NCT00134381|9607770|FG002|NOT COMPLETED|Overall Study||0
8575262|NCT00134381|9607771|FG003|NOT COMPLETED|Overall Study||0
8575263|NCT00134381|9607772|FG004|NOT COMPLETED|Overall Study||0
8575264|NCT00134381|9607773|FG005|NOT COMPLETED|Overall Study||2
8575265|NCT00134563|9607793|FG000|STARTED|Overall Study|Randomized|363
8575266|NCT00134563|9607794|FG001|STARTED|Overall Study|Randomized|366
8575267|NCT00134563|9607795|FG002|STARTED|Overall Study|Randomized|359
8575268|NCT00134563|9607793|FG000|Treated|Overall Study|Two participants received doses of Teriflunomide 7 mg, one participant doses of Teriflunomide 14 mg|363
8575269|NCT00134563|9607794|FG001|Treated|Overall Study||365
8575270|NCT00134563|9607795|FG002|Treated|Overall Study|one participant received doses of Teriflunomide 7 mg|358
8575271|NCT00134563|9607793|FG000|COMPLETED|Overall Study|completed treatment period|259
8575272|NCT00134563|9607794|FG001|COMPLETED|Overall Study|completed treatment period|274
8575273|NCT00134563|9607795|FG002|COMPLETED|Overall Study|completed treatment period|263
8575274|NCT00134563|9607793|FG000|NOT COMPLETED|Overall Study||104
8575275|NCT00134563|9607794|FG001|NOT COMPLETED|Overall Study||92
8575276|NCT00134563|9607795|FG002|NOT COMPLETED|Overall Study||96
8575277|NCT00134719|9607806|FG000|STARTED|Primary Vaccination Phase||661
8575278|NCT00134719|9607807|FG001|STARTED|Primary Vaccination Phase||221
8575279|NCT00134719|9607808|FG002|STARTED|Primary Vaccination Phase||221
8575280|NCT00134719|9607806|FG000|COMPLETED|Primary Vaccination Phase||647
8575281|NCT00134719|9607807|FG001|COMPLETED|Primary Vaccination Phase||215
8575282|NCT00134719|9607808|FG002|COMPLETED|Primary Vaccination Phase||216
8575283|NCT00134719|9607806|FG000|NOT COMPLETED|Primary Vaccination Phase||14
8575284|NCT00134719|9607807|FG001|NOT COMPLETED|Primary Vaccination Phase||6
8575285|NCT00134719|9607808|FG002|NOT COMPLETED|Primary Vaccination Phase||5
8575286|NCT00134719|9607806|FG000|STARTED|Fourth Dose Vaccination Phase||625
8575287|NCT00134719|9607807|FG001|STARTED|Fourth Dose Vaccination Phase||206
8575288|NCT00134719|9607808|FG002|STARTED|Fourth Dose Vaccination Phase||204
8575289|NCT00134719|9607806|FG000|COMPLETED|Fourth Dose Vaccination Phase||623
8575290|NCT00134719|9607807|FG001|COMPLETED|Fourth Dose Vaccination Phase||203
8575291|NCT00134719|9607808|FG002|COMPLETED|Fourth Dose Vaccination Phase||203
8575292|NCT00134719|9607806|FG000|NOT COMPLETED|Fourth Dose Vaccination Phase||2
8575293|NCT00134719|9607807|FG001|NOT COMPLETED|Fourth Dose Vaccination Phase||3
8575294|NCT00134719|9607808|FG002|NOT COMPLETED|Fourth Dose Vaccination Phase||1
8575295|NCT00134784|9607820|FG000|STARTED|Overall Study||29
8575296|NCT00134784|9607821|FG001|STARTED|Overall Study||38
8575297|NCT00134784|9607822|FG002|STARTED|Overall Study||37
8575298|NCT00134784|9607823|FG003|STARTED|Overall Study||38
8575299|NCT00134784|9607820|FG000|COMPLETED|Overall Study||27
8575300|NCT00134784|9607821|FG001|COMPLETED|Overall Study||36
8575301|NCT00134784|9607822|FG002|COMPLETED|Overall Study||35
8575302|NCT00134784|9607823|FG003|COMPLETED|Overall Study||37
8575303|NCT00134784|9607820|FG000|NOT COMPLETED|Overall Study||2
8575304|NCT00134784|9607821|FG001|NOT COMPLETED|Overall Study||2
8575305|NCT00134784|9607822|FG002|NOT COMPLETED|Overall Study||2
8575306|NCT00134784|9607823|FG003|NOT COMPLETED|Overall Study||1
8575307|NCT00134901|9607832|FG000|STARTED|Overall Study||39
8575308|NCT00134901|9607833|FG001|STARTED|Overall Study||42
8575309|NCT00134901|9607832|FG000|COMPLETED|Overall Study||22
8672455|NCT00757601|9715899|FG004|STARTED|Period 3||2
8575310|NCT00134901|9607833|FG001|COMPLETED|Overall Study||27
8575311|NCT00134901|9607832|FG000|NOT COMPLETED|Overall Study||17
8575312|NCT00134901|9607833|FG001|NOT COMPLETED|Overall Study||15
8575313|NCT00135226|9607845|FG000|STARTED|Overall Study||3870
8575314|NCT00135226|9607846|FG001|STARTED|Overall Study||3870
8575315|NCT00135226|9607847|FG002|STARTED|Overall Study||3870
8575316|NCT00135226|9607848|FG003|STARTED|Overall Study||3870
8575317|NCT00135226|9607845|FG000|COMPLETED|Overall Study||3836
8575318|NCT00135226|9607846|FG001|COMPLETED|Overall Study||3835
8575319|NCT00135226|9607847|FG002|COMPLETED|Overall Study||3836
8575320|NCT00135226|9607848|FG003|COMPLETED|Overall Study||3834
8575321|NCT00135226|9607845|FG000|NOT COMPLETED|Overall Study||34
8575322|NCT00135226|9607846|FG001|NOT COMPLETED|Overall Study||35
8575323|NCT00135226|9607847|FG002|NOT COMPLETED|Overall Study||34
8575324|NCT00135226|9607848|FG003|NOT COMPLETED|Overall Study||36
8575325|NCT00135330|9607863|FG000|STARTED|Overall Study||45
8575326|NCT00135330|9607864|FG001|STARTED|Overall Study||47
8575327|NCT00135330|9607865|FG002|STARTED|Overall Study||45
8575328|NCT00135330|9607863|FG000|COMPLETED|Overall Study||33
8575329|NCT00135330|9607864|FG001|COMPLETED|Overall Study||34
8575330|NCT00135330|9607865|FG002|COMPLETED|Overall Study||34
8575331|NCT00135330|9607863|FG000|NOT COMPLETED|Overall Study||12
8575332|NCT00135330|9607864|FG001|NOT COMPLETED|Overall Study||13
8575333|NCT00135330|9607865|FG002|NOT COMPLETED|Overall Study||11
8575334|NCT00135356|9607875|FG000|STARTED|Overall Study|Number randomized and treated|131
8575335|NCT00135356|9607876|FG001|STARTED|Overall Study|Number randomized and treated(1 randomized and never treated subject not included in this number.)|69
8575336|NCT00135356|9607875|FG000|Discontinued Prior to Week 96 Visit|Overall Study||16
8575337|NCT00135356|9607876|FG001|Discontinued Prior to Week 96 Visit|Overall Study||9
8575338|NCT00135356|9607875|FG000|Discontinued on or After Week 96 Visit|Overall Study||1
8575339|NCT00135356|9607876|FG001|Discontinued on or After Week 96 Visit|Overall Study||0
8575340|NCT00135356|9607875|FG000|COMPLETED|Overall Study||114
8575341|NCT00135356|9607876|FG001|COMPLETED|Overall Study||60
8575342|NCT00135356|9607875|FG000|NOT COMPLETED|Overall Study||17
8575343|NCT00135356|9607876|FG001|NOT COMPLETED|Overall Study||9
8575344|NCT00135512|9607882|FG000|STARTED|Overall Study||234
8575345|NCT00135512|9607882|FG000|COMPLETED|Overall Study||111
8575346|NCT00135512|9607882|FG000|NOT COMPLETED|Overall Study||123
8575347|NCT00135694|9607889|FG000|STARTED|Overall Study||180
8575348|NCT00135694|9607890|FG001|STARTED|Overall Study||77
8575349|NCT00135694|9607891|FG002|STARTED|Overall Study||18
8575350|NCT00135694|9607889|FG000|COMPLETED|Overall Study|Subjects were assessed as ineligible for random assignment and subsequently terminated per protocol.|0
8575351|NCT00135694|9607890|FG001|COMPLETED|Overall Study||56
8575352|NCT00135694|9607891|FG002|COMPLETED|Overall Study||11
8575353|NCT00135694|9607889|FG000|NOT COMPLETED|Overall Study||180
8575354|NCT00135694|9607890|FG001|NOT COMPLETED|Overall Study||21
8575355|NCT00135694|9607891|FG002|NOT COMPLETED|Overall Study||7
8575356|NCT00135707|9607901|FG000|STARTED|Overall Study||5088
8575357|NCT00135707|9607902|FG001|STARTED|Overall Study||5066
8575358|NCT00135707|9607901|FG000|COMPLETED|Overall Study||4993
8575359|NCT00135707|9607902|FG001|COMPLETED|Overall Study||4976
8575360|NCT00135707|9607901|FG000|NOT COMPLETED|Overall Study||95
8575361|NCT00135707|9607902|FG001|NOT COMPLETED|Overall Study||90
8575362|NCT00135798|9607915|FG000|STARTED|Overall Study||16
8575363|NCT00135798|9607916|FG001|STARTED|Overall Study||31
8672456|NCT00757601|9715900|FG005|STARTED|Period 3||2
8672457|NCT00757601|9715901|FG006|STARTED|Period 3||2
8672458|NCT00757601|9715902|FG007|STARTED|Period 3||2
8672459|NCT00757601|9715903|FG008|STARTED|Period 3||2
8672460|NCT00757601|9715904|FG009|STARTED|Period 3||2
8672461|NCT00757601|9715905|FG010|STARTED|Period 3||2
8672462|NCT00757601|9715906|FG011|STARTED|Period 3||2
8672463|NCT00757601|9715895|FG000|COMPLETED|Period 3||2
8672464|NCT00757601|9715896|FG001|COMPLETED|Period 3||2
8672465|NCT00757601|9715897|FG002|COMPLETED|Period 3||2
8672466|NCT00757601|9715898|FG003|COMPLETED|Period 3||2
8672467|NCT00757601|9715899|FG004|COMPLETED|Period 3||2
8672468|NCT00757601|9715900|FG005|COMPLETED|Period 3||2
8672469|NCT00757601|9715901|FG006|COMPLETED|Period 3||2
8672470|NCT00757601|9715902|FG007|COMPLETED|Period 3||2
8672471|NCT00757601|9715903|FG008|COMPLETED|Period 3||2
8672472|NCT00757601|9715904|FG009|COMPLETED|Period 3||2
8672473|NCT00757601|9715905|FG010|COMPLETED|Period 3||2
8672474|NCT00757601|9715906|FG011|COMPLETED|Period 3||2
8672475|NCT00757601|9715895|FG000|NOT COMPLETED|Period 3||0
8672476|NCT00757601|9715896|FG001|NOT COMPLETED|Period 3||0
8575364|NCT00135798|9607917|FG002|STARTED|Overall Study||32
8575365|NCT00135798|9607915|FG000|COMPLETED|Overall Study||16
8575366|NCT00135798|9607916|FG001|COMPLETED|Overall Study||31
8672477|NCT00757601|9715897|FG002|NOT COMPLETED|Period 3||0
8672478|NCT00757601|9715898|FG003|NOT COMPLETED|Period 3||0
8672479|NCT00757601|9715899|FG004|NOT COMPLETED|Period 3||0
8672480|NCT00757601|9715900|FG005|NOT COMPLETED|Period 3||0
8672481|NCT00757601|9715901|FG006|NOT COMPLETED|Period 3||0
8672482|NCT00757601|9715902|FG007|NOT COMPLETED|Period 3||0
8672483|NCT00757601|9715903|FG008|NOT COMPLETED|Period 3||0
8672484|NCT00757601|9715904|FG009|NOT COMPLETED|Period 3||0
8672485|NCT00757601|9715905|FG010|NOT COMPLETED|Period 3||0
8672486|NCT00757601|9715906|FG011|NOT COMPLETED|Period 3||0
8672487|NCT00757601|9715895|FG000|STARTED|Period 4||2
8672488|NCT00757601|9715896|FG001|STARTED|Period 4||2
8672489|NCT00757601|9715897|FG002|STARTED|Period 4||2
8672490|NCT00757601|9715898|FG003|STARTED|Period 4||2
8672491|NCT00757601|9715899|FG004|STARTED|Period 4||2
8672492|NCT00757601|9715900|FG005|STARTED|Period 4||2
8672493|NCT00757601|9715901|FG006|STARTED|Period 4||2
8672494|NCT00757601|9715902|FG007|STARTED|Period 4||2
8672495|NCT00757601|9715903|FG008|STARTED|Period 4||2
8672496|NCT00757601|9715904|FG009|STARTED|Period 4||2
8672497|NCT00757601|9715905|FG010|STARTED|Period 4||2
8672498|NCT00757601|9715906|FG011|STARTED|Period 4||2
8672499|NCT00757601|9715895|FG000|COMPLETED|Period 4||2
8672500|NCT00757601|9715896|FG001|COMPLETED|Period 4||2
8672501|NCT00757601|9715897|FG002|COMPLETED|Period 4||2
8672502|NCT00757601|9715898|FG003|COMPLETED|Period 4||2
8672503|NCT00757601|9715899|FG004|COMPLETED|Period 4||2
8672504|NCT00757601|9715900|FG005|COMPLETED|Period 4||2
8672505|NCT00757601|9715901|FG006|COMPLETED|Period 4||2
8672506|NCT00757601|9715902|FG007|COMPLETED|Period 4||2
8672507|NCT00757601|9715903|FG008|COMPLETED|Period 4||2
8672508|NCT00757601|9715904|FG009|COMPLETED|Period 4|One participant discontinued after receiving the 230 mg dose of MK1006 and was not replaced|1
8672509|NCT00757601|9715905|FG010|COMPLETED|Period 4||2
8672510|NCT00757601|9715906|FG011|COMPLETED|Period 4|Replacement participant discontinued after receiving placebo to 230mg MK1006 and was not replaced|1
8672511|NCT00757601|9715895|FG000|NOT COMPLETED|Period 4||0
8672512|NCT00757601|9715896|FG001|NOT COMPLETED|Period 4||0
8672513|NCT00757601|9715897|FG002|NOT COMPLETED|Period 4||0
8672514|NCT00757601|9715898|FG003|NOT COMPLETED|Period 4||0
8672515|NCT00757601|9715899|FG004|NOT COMPLETED|Period 4||0
8672516|NCT00757601|9715900|FG005|NOT COMPLETED|Period 4||0
8672517|NCT00757601|9715901|FG006|NOT COMPLETED|Period 4||0
8672518|NCT00757601|9715902|FG007|NOT COMPLETED|Period 4||0
8672519|NCT00757601|9715903|FG008|NOT COMPLETED|Period 4||0
8672520|NCT00757601|9715904|FG009|NOT COMPLETED|Period 4||1
8672521|NCT00757601|9715905|FG010|NOT COMPLETED|Period 4||0
8672522|NCT00757601|9715906|FG011|NOT COMPLETED|Period 4||1
8672523|NCT00757601|9715895|FG000|STARTED|Period 5||2
8672524|NCT00757601|9715896|FG001|STARTED|Period 5||2
8672525|NCT00757601|9715897|FG002|STARTED|Period 5||2
8672526|NCT00757601|9715898|FG003|STARTED|Period 5||2
8672527|NCT00757601|9715899|FG004|STARTED|Period 5||2
8672528|NCT00757601|9715900|FG005|STARTED|Period 5||2
8672529|NCT00757601|9715901|FG006|STARTED|Period 5||2
8672530|NCT00757601|9715902|FG007|STARTED|Period 5||2
8672531|NCT00757601|9715903|FG008|STARTED|Period 5||2
8672532|NCT00757601|9715904|FG009|STARTED|Period 5||1
8672533|NCT00757601|9715905|FG010|STARTED|Period 5||2
8672534|NCT00757601|9715906|FG011|STARTED|Period 5||1
8672535|NCT00757601|9715895|FG000|COMPLETED|Period 5||2
8672536|NCT00757601|9715896|FG001|COMPLETED|Period 5||2
8672537|NCT00757601|9715897|FG002|COMPLETED|Period 5||2
8672538|NCT00757601|9715898|FG003|COMPLETED|Period 5||2
8672539|NCT00757601|9715899|FG004|COMPLETED|Period 5||2
8672540|NCT00757601|9715900|FG005|COMPLETED|Period 5||2
8672541|NCT00757601|9715901|FG006|COMPLETED|Period 5||2
8672542|NCT00757601|9715902|FG007|COMPLETED|Period 5||2
8672543|NCT00757601|9715903|FG008|COMPLETED|Period 5||2
8672544|NCT00757601|9715904|FG009|COMPLETED|Period 5||1
8672545|NCT00757601|9715905|FG010|COMPLETED|Period 5||2
8672546|NCT00757601|9715906|FG011|COMPLETED|Period 5||1
8672547|NCT00757601|9715895|FG000|NOT COMPLETED|Period 5||0
8672548|NCT00757601|9715896|FG001|NOT COMPLETED|Period 5||0
8575367|NCT00135798|9607917|FG002|COMPLETED|Overall Study||32
8575368|NCT00135798|9607915|FG000|NOT COMPLETED|Overall Study||0
8575369|NCT00135798|9607916|FG001|NOT COMPLETED|Overall Study||0
8575370|NCT00135798|9607917|FG002|NOT COMPLETED|Overall Study||0
8575371|NCT00136084|9607926|FG000|STARTED|Overall Study||109
8575372|NCT00136084|9607927|FG001|STARTED|Overall Study||114
8575373|NCT00136084|9607926|FG000|COMPLETED|Overall Study||61
8575374|NCT00136084|9607927|FG001|COMPLETED|Overall Study||72
8575375|NCT00136084|9607926|FG000|NOT COMPLETED|Overall Study||48
8575376|NCT00136084|9607927|FG001|NOT COMPLETED|Overall Study||42
8575377|NCT00136214|9607941|FG000|STARTED|Overall Study||15
8575378|NCT00136214|9607942|FG001|STARTED|Overall Study||7
8575379|NCT00136214|9607941|FG000|COMPLETED|Overall Study||15
8575380|NCT00136214|9607942|FG001|COMPLETED|Overall Study||7
8575381|NCT00136214|9607941|FG000|NOT COMPLETED|Overall Study||0
8575382|NCT00136214|9607942|FG001|NOT COMPLETED|Overall Study||0
8575383|NCT00136318|9607952|FG000|STARTED|Overall Study|Took first dose of study medication|90
8575384|NCT00136318|9607953|FG001|STARTED|Overall Study|Took first dose of study medication|91
8575385|NCT00136318|9607952|FG000|COMPLETED|Overall Study|reached end-point of antiviral treatment|83
8575386|NCT00136318|9607953|FG001|COMPLETED|Overall Study||84
8575387|NCT00136318|9607952|FG000|NOT COMPLETED|Overall Study||7
8575388|NCT00136318|9607953|FG001|NOT COMPLETED|Overall Study||7
8575389|NCT00136357|9607962|FG000|STARTED|Overall Study||41
8575390|NCT00136357|9607963|FG001|STARTED|Overall Study||41
8575391|NCT00136357|9607962|FG000|COMPLETED|Overall Study||38
8575392|NCT00136357|9607963|FG001|COMPLETED|Overall Study||39
8575393|NCT00136357|9607962|FG000|NOT COMPLETED|Overall Study||3
8575394|NCT00136357|9607963|FG001|NOT COMPLETED|Overall Study||2
8575395|NCT00136604|9607974|FG000|STARTED|Overall Study||249
8575396|NCT00136604|9607975|FG001|STARTED|Overall Study||123
8575397|NCT00136604|9607976|FG002|STARTED|Overall Study||79
8575398|NCT00136604|9607977|FG003|STARTED|Overall Study||41
8575399|NCT00136604|9607978|FG004|STARTED|Overall Study||125
8575400|NCT00136604|9607974|FG000|COMPLETED|Overall Study||248
8575401|NCT00136604|9607975|FG001|COMPLETED|Overall Study||122
8575402|NCT00136604|9607976|FG002|COMPLETED|Overall Study||79
8575403|NCT00136604|9607977|FG003|COMPLETED|Overall Study||41
8575404|NCT00136604|9607978|FG004|COMPLETED|Overall Study||124
8575405|NCT00136604|9607974|FG000|NOT COMPLETED|Overall Study||1
8575406|NCT00136604|9607975|FG001|NOT COMPLETED|Overall Study||1
8575407|NCT00136604|9607976|FG002|NOT COMPLETED|Overall Study||0
8575408|NCT00136604|9607977|FG003|NOT COMPLETED|Overall Study||0
8575409|NCT00136604|9607978|FG004|NOT COMPLETED|Overall Study||1
8575410|NCT00136695|9607996|FG000|STARTED|Overall Study||45
8575411|NCT00136695|9607997|FG001|STARTED|Overall Study||43
8575412|NCT00136695|9607996|FG000|COMPLETED|Overall Study||34
8575413|NCT00136695|9607997|FG001|COMPLETED|Overall Study||35
8575414|NCT00136695|9607996|FG000|NOT COMPLETED|Overall Study||11
8575415|NCT00136695|9607997|FG001|NOT COMPLETED|Overall Study||8
8575416|NCT00136760|9608007|FG000|STARTED|Overall Study||12
8575417|NCT00136760|9608008|FG001|STARTED|Overall Study||16
8575418|NCT00136760|9608009|FG002|STARTED|Overall Study||11
8575419|NCT00136760|9608010|FG003|STARTED|Overall Study||13
8575420|NCT00136760|9608007|FG000|COMPLETED|Overall Study||12
8575421|NCT00136760|9608008|FG001|COMPLETED|Overall Study||16
8575422|NCT00136760|9608009|FG002|COMPLETED|Overall Study||11
8575423|NCT00136760|9608010|FG003|COMPLETED|Overall Study||13
8575424|NCT00136760|9608007|FG000|NOT COMPLETED|Overall Study||0
8575425|NCT00136760|9608008|FG001|NOT COMPLETED|Overall Study||0
8575426|NCT00136760|9608009|FG002|NOT COMPLETED|Overall Study||0
8575427|NCT00136760|9608010|FG003|NOT COMPLETED|Overall Study||0
8575428|NCT00136812|9608022|FG000|STARTED|Overall Study||111
8575429|NCT00136812|9608023|FG001|STARTED|Overall Study||113
8575430|NCT00136812|9608022|FG000|COMPLETED|Overall Study||111
8575431|NCT00136812|9608023|FG001|COMPLETED|Overall Study||113
8575432|NCT00136812|9608022|FG000|NOT COMPLETED|Overall Study||0
8575433|NCT00136812|9608023|FG001|NOT COMPLETED|Overall Study||0
8575434|NCT00136838|9608029|FG000|STARTED|First Intervention ( 5 Days)||6
8575435|NCT00136838|9608030|FG001|STARTED|First Intervention ( 5 Days)||6
8575436|NCT00136838|9608029|FG000|COMPLETED|First Intervention ( 5 Days)||6
8575437|NCT00136838|9608030|FG001|COMPLETED|First Intervention ( 5 Days)||6
8575438|NCT00136838|9608029|FG000|NOT COMPLETED|First Intervention ( 5 Days)||0
8575439|NCT00136838|9608030|FG001|NOT COMPLETED|First Intervention ( 5 Days)||0
8575440|NCT00136838|9608029|FG000|STARTED|Second Intervention ( 5 Days)||6
8575441|NCT00136838|9608030|FG001|STARTED|Second Intervention ( 5 Days)||6
8575442|NCT00136838|9608029|FG000|COMPLETED|Second Intervention ( 5 Days)||6
8575443|NCT00136838|9608030|FG001|COMPLETED|Second Intervention ( 5 Days)||6
8575444|NCT00136838|9608029|FG000|NOT COMPLETED|Second Intervention ( 5 Days)||0
8575445|NCT00136838|9608030|FG001|NOT COMPLETED|Second Intervention ( 5 Days)||0
8575446|NCT00136916|9608040|FG000|STARTED|Overall Study||319
8575447|NCT00136916|9608041|FG001|STARTED|Overall Study||316
8575448|NCT00136916|9608040|FG000|Received Treatment|Overall Study||316
8575449|NCT00136916|9608041|FG001|Received Treatment|Overall Study||311
8575450|NCT00136916|9608040|FG000|COMPLETED|Overall Study|At study termination, active subjects completed end-of-study assessment and 3-month follow-up visit|194
8575451|NCT00136916|9608041|FG001|COMPLETED|Overall Study|At study termination, active subjects completed end-of-study assessment and 3-month follow-up visit|212
8575452|NCT00136916|9608040|FG000|NOT COMPLETED|Overall Study||125
8575453|NCT00136916|9608041|FG001|NOT COMPLETED|Overall Study||104
8575454|NCT00136955|9608049|FG000|STARTED|Overall Study||41
8575455|NCT00136955|9608049|FG000|COMPLETED|Overall Study||18
8575456|NCT00136955|9608049|FG000|NOT COMPLETED|Overall Study||23
8575457|NCT00137046|9608055|FG000|STARTED|Overall Study|One subject was randomized to inhaled insulin but never received treatment.|291
8575458|NCT00137046|9608056|FG001|STARTED|Overall Study|One subject was randomized to subcutaneous insulin but never received treatment.|291
8575459|NCT00137046|9608055|FG000|Received Study Treatment|Overall Study||290
8575460|NCT00137046|9608056|FG001|Received Study Treatment|Overall Study||290
8575461|NCT00137046|9608055|FG000|COMPLETED|Overall Study|Completed subjects were those subjects who did not discontinue while on active drug.|192
8575462|NCT00137046|9608056|FG001|COMPLETED|Overall Study||198
8575463|NCT00137046|9608055|FG000|NOT COMPLETED|Overall Study||99
8575464|NCT00137046|9608056|FG001|NOT COMPLETED|Overall Study||93
8575465|NCT00137111|9608070|FG000|STARTED|Window Therapy||0
8575466|NCT00137111|9608071|FG001|STARTED|Window Therapy||176
8575467|NCT00137111|9608072|FG002|STARTED|Window Therapy||180
8575468|NCT00137111|9608073|FG003|STARTED|Window Therapy||142
8575469|NCT00137111|9608070|FG000|COMPLETED|Window Therapy||0
8575470|NCT00137111|9608071|FG001|COMPLETED|Window Therapy||176
8575471|NCT00137111|9608072|FG002|COMPLETED|Window Therapy||180
8575472|NCT00137111|9608073|FG003|COMPLETED|Window Therapy||142
8575473|NCT00137111|9608070|FG000|NOT COMPLETED|Window Therapy||0
8575474|NCT00137111|9608071|FG001|NOT COMPLETED|Window Therapy||0
8575475|NCT00137111|9608072|FG002|NOT COMPLETED|Window Therapy||0
8672549|NCT00757601|9715897|FG002|NOT COMPLETED|Period 5||0
8672550|NCT00757601|9715898|FG003|NOT COMPLETED|Period 5||0
8672551|NCT00757601|9715899|FG004|NOT COMPLETED|Period 5||0
8672552|NCT00757601|9715900|FG005|NOT COMPLETED|Period 5||0
8672553|NCT00757601|9715901|FG006|NOT COMPLETED|Period 5||0
8672554|NCT00757601|9715902|FG007|NOT COMPLETED|Period 5||0
8672555|NCT00757601|9715903|FG008|NOT COMPLETED|Period 5||0
8672556|NCT00757601|9715904|FG009|NOT COMPLETED|Period 5||0
8672557|NCT00757601|9715905|FG010|NOT COMPLETED|Period 5||0
8672558|NCT00757601|9715906|FG011|NOT COMPLETED|Period 5||0
8672559|NCT00757666|9715938|FG000|STARTED|Overall Study||34
8672560|NCT00757666|9715939|FG001|STARTED|Overall Study||34
8672561|NCT00757666|9715938|FG000|COMPLETED|Overall Study|Number of patients with complete CPX test results from 1 month and 2 month visits|12
8672562|NCT00757666|9715939|FG001|COMPLETED|Overall Study|Number of patients with complete CPX test results from 1 month and 2 month visits|11
8672563|NCT00757666|9715938|FG000|NOT COMPLETED|Overall Study||22
8672564|NCT00757666|9715939|FG001|NOT COMPLETED|Overall Study||23
8672565|NCT00757705|9715949|FG000|STARTED|Overall Study||299
8672566|NCT00757705|9715949|FG000|COMPLETED|Overall Study||178
8672567|NCT00757705|9715949|FG000|NOT COMPLETED|Overall Study||121
8672568|NCT00757783|9715955|FG000|STARTED|Overall Study||34
8672569|NCT00757783|9715956|FG001|STARTED|Overall Study||31
8672570|NCT00757783|9715955|FG000|COMPLETED|Overall Study||29
8672571|NCT00757783|9715956|FG001|COMPLETED|Overall Study||25
8672572|NCT00757783|9715955|FG000|NOT COMPLETED|Overall Study||5
8672573|NCT00757783|9715956|FG001|NOT COMPLETED|Overall Study||6
8672574|NCT00757822|9715964|FG000|STARTED|Overall Study||92
8672575|NCT00757822|9715965|FG001|STARTED|Overall Study||88
8672576|NCT00757822|9715964|FG000|Day of Surgery (DOS) Assessment|Overall Study||92
8672577|NCT00757822|9715965|FG001|Day of Surgery (DOS) Assessment|Overall Study||88
8672578|NCT00757822|9715964|FG000|Withdrawal by Subject-no Intervention|Overall Study||1
8672579|NCT00757822|9715965|FG001|Withdrawal by Subject-no Intervention|Overall Study||3
8672580|NCT00757822|9715964|FG000|DOS Withdrawn by Investigator|Overall Study|No longer met inclusion criteria or developed exclusion criteria on DOS|6
8672581|NCT00757822|9715965|FG001|DOS Withdrawn by Investigator|Overall Study|No longer met inclusion criteria or developed exclusion criteria on DOS|11
8672582|NCT00757822|9715964|FG000|Received Study Intervention|Overall Study||85
8672583|NCT00757822|9715965|FG001|Received Study Intervention|Overall Study||74
8672584|NCT00757822|9715964|FG000|DOS: Post-operative Assessments|Overall Study||85
8672585|NCT00757822|9715965|FG001|DOS: Post-operative Assessments|Overall Study||74
8672586|NCT00757822|9715964|FG000|24-48 hr Telephone Assessment|Overall Study||85
8672587|NCT00757822|9715965|FG001|24-48 hr Telephone Assessment|Overall Study||74
8672588|NCT00757822|9715964|FG000|2-6 wk Post-op Assessment|Overall Study||85
8672589|NCT00757822|9715965|FG001|2-6 wk Post-op Assessment|Overall Study||74
8672590|NCT00757822|9715964|FG000|Data Entry, QC Assessment|Overall Study||85
8672591|NCT00757822|9715965|FG001|Data Entry, QC Assessment|Overall Study||74
8672592|NCT00757822|9715964|FG000|Withdrawn-low-risk for PONV|Overall Study|K score for PONV risk<2|12
8672593|NCT00757822|9715965|FG001|Withdrawn-low-risk for PONV|Overall Study|K score for PONV risk < 2|9
8672594|NCT00757822|9715964|FG000|Withdrawn-protocol Deviation|Overall Study||9
8672595|NCT00757822|9715965|FG001|Withdrawn-protocol Deviation|Overall Study||8
8672596|NCT00757822|9715964|FG000|Data Lock, Unblinding Analysis|Overall Study||64
8672597|NCT00757822|9715965|FG001|Data Lock, Unblinding Analysis|Overall Study||57
8672598|NCT00757822|9715964|FG000|COMPLETED|Overall Study||64
8672599|NCT00757822|9715965|FG001|COMPLETED|Overall Study||57
8672600|NCT00757822|9715964|FG000|NOT COMPLETED|Overall Study||28
8672601|NCT00757822|9715965|FG001|NOT COMPLETED|Overall Study||31
8672602|NCT00757848|9715976|FG000|STARTED|Overall Study||27
8672603|NCT00757848|9715977|FG001|STARTED|Overall Study||29
8672604|NCT00757848|9715976|FG000|COMPLETED|Overall Study||24
8672605|NCT00757848|9715977|FG001|COMPLETED|Overall Study||27
8672606|NCT00757848|9715976|FG000|NOT COMPLETED|Overall Study||3
8672607|NCT00757848|9715977|FG001|NOT COMPLETED|Overall Study||2
8672608|NCT00758043|9715987|FG000|STARTED|Overall Study||162
8672609|NCT00758043|9715988|FG001|STARTED|Overall Study||160
8672610|NCT00758043|9715989|FG002|STARTED|Overall Study||118
8672611|NCT00758043|9715990|FG003|STARTED|Overall Study||100
8672612|NCT00758043|9715987|FG000|COMPLETED|Overall Study||161
8672613|NCT00758043|9715988|FG001|COMPLETED|Overall Study||119
8672614|NCT00758043|9715989|FG002|COMPLETED|Overall Study||79
8672615|NCT00758043|9715990|FG003|COMPLETED|Overall Study||0
8672616|NCT00758043|9715987|FG000|NOT COMPLETED|Overall Study||1
8672617|NCT00758043|9715988|FG001|NOT COMPLETED|Overall Study||41
8672618|NCT00758043|9715989|FG002|NOT COMPLETED|Overall Study||39
8672619|NCT00758043|9715990|FG003|NOT COMPLETED|Overall Study||100
8575476|NCT00137111|9608073|FG003|NOT COMPLETED|Window Therapy||0
8575477|NCT00137111|9608070|FG000|STARTED|Total Therapy||498
8575478|NCT00137111|9608071|FG001|STARTED|Total Therapy||0
8575479|NCT00137111|9608072|FG002|STARTED|Total Therapy||0
8575480|NCT00137111|9608073|FG003|STARTED|Total Therapy||0
8672620|NCT00758069|9716009|FG000|STARTED|Overall Study|Study enrolled slightly more than the target of N=20|27
8672621|NCT00758069|9716010|FG001|STARTED|Overall Study|Study enrolled slightly more than the target of N=20|25
8575481|NCT00137111|9608070|FG000|COMPLETED|Total Therapy||458
8575482|NCT00137111|9608071|FG001|COMPLETED|Total Therapy||0
8575483|NCT00137111|9608072|FG002|COMPLETED|Total Therapy||0
8575484|NCT00137111|9608073|FG003|COMPLETED|Total Therapy||0
8575485|NCT00137111|9608070|FG000|NOT COMPLETED|Total Therapy||40
8575486|NCT00137111|9608071|FG001|NOT COMPLETED|Total Therapy||0
8575487|NCT00137111|9608072|FG002|NOT COMPLETED|Total Therapy||0
8575488|NCT00137111|9608073|FG003|NOT COMPLETED|Total Therapy||0
8575489|NCT00137267|9608082|FG000|STARTED|Overall Study||55
8575490|NCT00137267|9608083|FG001|STARTED|Overall Study||47
8575491|NCT00137267|9608082|FG000|COMPLETED|Overall Study||40
8575492|NCT00137267|9608083|FG001|COMPLETED|Overall Study||26
8575493|NCT00137267|9608082|FG000|NOT COMPLETED|Overall Study||15
8575494|NCT00137267|9608083|FG001|NOT COMPLETED|Overall Study||21
8575495|NCT00137280|9608091|FG000|STARTED|Overall Study||389
8575496|NCT00137280|9608092|FG001|STARTED|Overall Study||412
8575497|NCT00137280|9608091|FG000|COMPLETED|Overall Study||305
8575498|NCT00137280|9608092|FG001|COMPLETED|Overall Study||357
8575499|NCT00137280|9608091|FG000|NOT COMPLETED|Overall Study||84
8575500|NCT00137280|9608092|FG001|NOT COMPLETED|Overall Study||55
8575501|NCT00137423|9608100|FG000|STARTED|Overall Study||54
8575502|NCT00137423|9608101|FG001|STARTED|Overall Study||53
8575503|NCT00137423|9608100|FG000|COMPLETED|Overall Study||15
8575504|NCT00137423|9608101|FG001|COMPLETED|Overall Study||9
8575505|NCT00137423|9608100|FG000|NOT COMPLETED|Overall Study||39
8575506|NCT00137423|9608101|FG001|NOT COMPLETED|Overall Study||44
8575507|NCT00137436|9608111|FG000|STARTED|Overall Study|Phase 2 did not include 38 participants from Phase 1.|55
8575508|NCT00137436|9608111|FG000|COMPLETED|Overall Study||12
8575509|NCT00137436|9608111|FG000|NOT COMPLETED|Overall Study||43
8575510|NCT00137449|9608117|FG000|STARTED|Overall Study||30
8575511|NCT00137449|9608118|FG001|STARTED|Overall Study||30
8575512|NCT00137449|9608117|FG000|COMPLETED|Overall Study||14
8575513|NCT00137449|9608118|FG001|COMPLETED|Overall Study||12
8575514|NCT00137449|9608117|FG000|NOT COMPLETED|Overall Study||16
8575515|NCT00137449|9608118|FG001|NOT COMPLETED|Overall Study||18
8575516|NCT00137631|9608127|FG000|STARTED|Overall Study||164
8575517|NCT00137631|9608128|FG001|STARTED|Overall Study||174
8575518|NCT00137631|9608127|FG000|Complete 3-month Follow-up|Overall Study||120
8575519|NCT00137631|9608128|FG001|Complete 3-month Follow-up|Overall Study||125
8575520|NCT00137631|9608127|FG000|Completed 6-month Follow-up|Overall Study|7 participants who were lost to follow-up at 3-months were retained at 6-months|127
8575521|NCT00137631|9608128|FG001|Completed 6-month Follow-up|Overall Study|8 participants who were lost to follow-up at 3-months were retained at 6-months|133
8575522|NCT00137631|9608127|FG000|COMPLETED|Overall Study||127
8575523|NCT00137631|9608128|FG001|COMPLETED|Overall Study||133
8575524|NCT00137631|9608127|FG000|NOT COMPLETED|Overall Study||37
8575525|NCT00137631|9608128|FG001|NOT COMPLETED|Overall Study||41
8575526|NCT00137839|9608134|FG000|STARTED|Overall Study||84
8575527|NCT00137839|9608134|FG000|Treated|Overall Study||83
8575528|NCT00137839|9608134|FG000|COMPLETED|Overall Study|Data on Reason Not Completed reflects Reason Off-Study|0
8575529|NCT00137839|9608134|FG000|NOT COMPLETED|Overall Study||84
8575530|NCT00137969|9608143|FG000|STARTED|Overall Study||174
8575531|NCT00137969|9608144|FG001|STARTED|Overall Study||88
8575532|NCT00137969|9608143|FG000|Received Study Drug|Overall Study||169
8575533|NCT00137969|9608144|FG001|Received Study Drug|Overall Study||88
8575534|NCT00137969|9608143|FG000|COMPLETED|Overall Study||107
8575535|NCT00137969|9608144|FG001|COMPLETED|Overall Study||67
8575536|NCT00137969|9608143|FG000|NOT COMPLETED|Overall Study||67
8575537|NCT00137969|9608144|FG001|NOT COMPLETED|Overall Study||21
8575538|NCT00138034|9608152|FG000|STARTED|Overall Study||26
8575539|NCT00138034|9608153|FG001|STARTED|Overall Study||23
8575540|NCT00138034|9608152|FG000|COMPLETED|Overall Study||23
8575541|NCT00138034|9608153|FG001|COMPLETED|Overall Study||20
8575542|NCT00138034|9608152|FG000|NOT COMPLETED|Overall Study||3
8575543|NCT00138034|9608153|FG001|NOT COMPLETED|Overall Study||3
8575544|NCT00138125|9608159|FG000|STARTED|Overall Study||2
8575545|NCT00138125|9608159|FG000|COMPLETED|Overall Study||2
8575546|NCT00138125|9608159|FG000|NOT COMPLETED|Overall Study||0
8575547|NCT00138203|9608164|FG000|STARTED|Overall Study||16
8575548|NCT00138203|9608164|FG000|COMPLETED|Overall Study||16
8575549|NCT00138203|9608164|FG000|NOT COMPLETED|Overall Study||0
8575550|NCT00138294|9608169|FG000|STARTED|Overall Study||29255
8575551|NCT00138294|9608169|FG000|COMPLETED|Overall Study||29255
8575552|NCT00138294|9608169|FG000|NOT COMPLETED|Overall Study||0
8575553|NCT00138424|9608179|FG000|STARTED|Overall Study||9
8575554|NCT00138424|9608180|FG001|STARTED|Overall Study||5
8575555|NCT00138424|9608181|FG002|STARTED|Overall Study||5
8575556|NCT00138424|9608182|FG003|STARTED|Overall Study||3
8575557|NCT00138424|9608179|FG000|COMPLETED|Overall Study||9
8575558|NCT00138424|9608180|FG001|COMPLETED|Overall Study||4
8575559|NCT00138424|9608181|FG002|COMPLETED|Overall Study||5
8575560|NCT00138424|9608182|FG003|COMPLETED|Overall Study||3
8575561|NCT00138424|9608179|FG000|NOT COMPLETED|Overall Study||0
8575562|NCT00138424|9608180|FG001|NOT COMPLETED|Overall Study||1
8575563|NCT00138424|9608181|FG002|NOT COMPLETED|Overall Study||0
8575564|NCT00138424|9608182|FG003|NOT COMPLETED|Overall Study||0
8575565|NCT00138645|9608196|FG000|STARTED|Overall Study||30
8575566|NCT00138645|9608197|FG001|STARTED|Overall Study||30
8575567|NCT00138645|9608196|FG000|COMPLETED|Overall Study||24
8575568|NCT00138645|9608197|FG001|COMPLETED|Overall Study||23
8575569|NCT00138645|9608196|FG000|NOT COMPLETED|Overall Study||6
8575570|NCT00138645|9608197|FG001|NOT COMPLETED|Overall Study||7
8575571|NCT00138658|9608203|FG000|STARTED|Overall Study||81
8575572|NCT00138658|9608203|FG000|COMPLETED|Overall Study||20
8575573|NCT00138658|9608203|FG000|NOT COMPLETED|Overall Study||61
8575574|NCT00138671|9608211|FG000|STARTED|Overall Study||59
8575575|NCT00138671|9608212|FG001|STARTED|Overall Study||46
8575576|NCT00138671|9608211|FG000|COMPLETED|Overall Study||46
8575577|NCT00138671|9608212|FG001|COMPLETED|Overall Study||30
8575578|NCT00138671|9608211|FG000|NOT COMPLETED|Overall Study||13
8575579|NCT00138671|9608212|FG001|NOT COMPLETED|Overall Study||16
8575580|NCT00139399|9608222|FG000|STARTED|Overall Study||60
8575581|NCT00139399|9608223|FG001|STARTED|Overall Study||82
8575582|NCT00139399|9608222|FG000|COMPLETED|Overall Study||44
8575583|NCT00139399|9608223|FG001|COMPLETED|Overall Study||59
8575584|NCT00139399|9608222|FG000|NOT COMPLETED|Overall Study||16
8575585|NCT00139399|9608223|FG001|NOT COMPLETED|Overall Study||23
8575586|NCT00139477|9608231|FG000|STARTED|First Intervention -Baseline to 6Months||31
8575587|NCT00139477|9608232|FG001|STARTED|First Intervention -Baseline to 6Months||35
8575588|NCT00139477|9608231|FG000|COMPLETED|First Intervention -Baseline to 6Months||19
8575589|NCT00139477|9608232|FG001|COMPLETED|First Intervention -Baseline to 6Months||23
8575590|NCT00139477|9608231|FG000|NOT COMPLETED|First Intervention -Baseline to 6Months||12
8575591|NCT00139477|9608232|FG001|NOT COMPLETED|First Intervention -Baseline to 6Months||12
8575592|NCT00139477|9608231|FG000|STARTED|Second Intervention -6Months to 12Months||19
8575593|NCT00139477|9608232|FG001|STARTED|Second Intervention -6Months to 12Months||23
8575594|NCT00139477|9608231|FG000|COMPLETED|Second Intervention -6Months to 12Months||14
8575595|NCT00139477|9608232|FG001|COMPLETED|Second Intervention -6Months to 12Months||18
8575596|NCT00139477|9608231|FG000|NOT COMPLETED|Second Intervention -6Months to 12Months||5
8575597|NCT00139477|9608232|FG001|NOT COMPLETED|Second Intervention -6Months to 12Months||5
8575598|NCT00139659|9608242|FG000|STARTED|Overall Study|1 subject randomized was DC'd prior to receiving inhaled insulin but received subcutaneous insulin|146
8575599|NCT00139659|9608243|FG001|STARTED|Overall Study|1 subject randomized DC'd before receiving subcutaneous insulin and is not included in # of subjects|141
8575600|NCT00139659|9608242|FG000|COMPLETED|Overall Study||106
8575601|NCT00139659|9608243|FG001|COMPLETED|Overall Study||123
8575602|NCT00139659|9608242|FG000|NOT COMPLETED|Overall Study||40
8575603|NCT00139659|9608243|FG001|NOT COMPLETED|Overall Study||18
8575604|NCT00139737|9608253|FG000|STARTED|Overall Study||344
8575605|NCT00139737|9608253|FG000|Received Treatment|Overall Study||331
8575606|NCT00139737|9608253|FG000|COMPLETED|Overall Study||3
8575607|NCT00139737|9608253|FG000|NOT COMPLETED|Overall Study||341
8575608|NCT00139776|9608259|FG000|STARTED|Period I||1772
8575609|NCT00139776|9608260|FG001|STARTED|Period I||0
8575610|NCT00139776|9608261|FG002|STARTED|Period I||0
8575611|NCT00139776|9608262|FG003|STARTED|Period I||0
8575612|NCT00139776|9608259|FG000|COMPLETED|Period I||1197
8575613|NCT00139776|9608260|FG001|COMPLETED|Period I||0
8575614|NCT00139776|9608261|FG002|COMPLETED|Period I||0
8575615|NCT00139776|9608262|FG003|COMPLETED|Period I||0
8575616|NCT00139776|9608259|FG000|NOT COMPLETED|Period I||575
8575617|NCT00139776|9608260|FG001|NOT COMPLETED|Period I||0
8575618|NCT00139776|9608261|FG002|NOT COMPLETED|Period I||0
8575619|NCT00139776|9608262|FG003|NOT COMPLETED|Period I||0
8575620|NCT00139776|9608259|FG000|STARTED|Period II||0
8575621|NCT00139776|9608260|FG001|STARTED|Period II||1197
8575622|NCT00139776|9608261|FG002|STARTED|Period II||0
8575623|NCT00139776|9608262|FG003|STARTED|Period II||0
8575624|NCT00139776|9608259|FG000|COMPLETED|Period II||0
8575625|NCT00139776|9608260|FG001|COMPLETED|Period II||875
8575626|NCT00139776|9608261|FG002|COMPLETED|Period II||0
8575627|NCT00139776|9608262|FG003|COMPLETED|Period II||0
8575628|NCT00139776|9608259|FG000|NOT COMPLETED|Period II||0
8575629|NCT00139776|9608260|FG001|NOT COMPLETED|Period II||322
8575630|NCT00139776|9608261|FG002|NOT COMPLETED|Period II||0
8575631|NCT00139776|9608262|FG003|NOT COMPLETED|Period II||0
8575632|NCT00139776|9608259|FG000|STARTED|Period III||0
8575633|NCT00139776|9608260|FG001|STARTED|Period III||0
8575634|NCT00139776|9608261|FG002|STARTED|Period III|Randomized 440: 9 participants not treated|431
8575635|NCT00139776|9608262|FG003|STARTED|Period III|Randomized 435: 8 participants not treated|427
8575636|NCT00139776|9608259|FG000|COMPLETED|Period III||0
8575637|NCT00139776|9608260|FG001|COMPLETED|Period III||0
8575638|NCT00139776|9608261|FG002|COMPLETED|Period III||355
8575639|NCT00139776|9608262|FG003|COMPLETED|Period III||321
8575640|NCT00139776|9608259|FG000|NOT COMPLETED|Period III||0
8575641|NCT00139776|9608260|FG001|NOT COMPLETED|Period III||0
8575642|NCT00139776|9608261|FG002|NOT COMPLETED|Period III||76
8575643|NCT00139776|9608262|FG003|NOT COMPLETED|Period III||106
8575644|NCT00139997|9608271|FG000|STARTED|Overall Study||15
8575645|NCT00139997|9608272|FG001|STARTED|Overall Study||11
8575646|NCT00139997|9608271|FG000|COMPLETED|Overall Study||14
8575647|NCT00139997|9608272|FG001|COMPLETED|Overall Study||9
8575648|NCT00139997|9608271|FG000|NOT COMPLETED|Overall Study||1
8575649|NCT00139997|9608272|FG001|NOT COMPLETED|Overall Study||2
8575650|NCT00140140|9608281|FG000|STARTED|Overall Study||4
8575651|NCT00140140|9608282|FG001|STARTED|Overall Study||6
8575652|NCT00140140|9608283|FG002|STARTED|Overall Study||6
8575653|NCT00140140|9608281|FG000|COMPLETED|Overall Study|Progressive disease|2
8575654|NCT00140140|9608282|FG001|COMPLETED|Overall Study|Progressive disease|4
8575655|NCT00140140|9608283|FG002|COMPLETED|Overall Study|Progressive disease|4
8575656|NCT00140140|9608281|FG000|NOT COMPLETED|Overall Study||2
8575657|NCT00140140|9608282|FG001|NOT COMPLETED|Overall Study||2
8575658|NCT00140140|9608283|FG002|NOT COMPLETED|Overall Study||2
8575659|NCT00140205|9608293|FG000|STARTED|Overall Study||5
8575660|NCT00140205|9608294|FG001|STARTED|Overall Study||5
8575661|NCT00140205|9608295|FG002|STARTED|Overall Study||5
8575662|NCT00140205|9608293|FG000|COMPLETED|Overall Study||5
8575663|NCT00140205|9608294|FG001|COMPLETED|Overall Study||5
8575664|NCT00140205|9608295|FG002|COMPLETED|Overall Study||5
8575665|NCT00140205|9608293|FG000|NOT COMPLETED|Overall Study||0
8575666|NCT00140205|9608294|FG001|NOT COMPLETED|Overall Study||0
8575667|NCT00140205|9608295|FG002|NOT COMPLETED|Overall Study||0
8575668|NCT00140231|9608326|FG000|STARTED|Fed State 1 Day- day5||7
8575669|NCT00140231|9608327|FG001|STARTED|Fed State 1 Day- day5||6
8575670|NCT00140231|9608326|FG000|COMPLETED|Fed State 1 Day- day5||7
8575671|NCT00140231|9608327|FG001|COMPLETED|Fed State 1 Day- day5||6
8575672|NCT00140231|9608326|FG000|NOT COMPLETED|Fed State 1 Day- day5||0
8575673|NCT00140231|9608327|FG001|NOT COMPLETED|Fed State 1 Day- day5||0
8575674|NCT00140231|9608326|FG000|STARTED|Washout 8weeks||7
8575675|NCT00140231|9608327|FG001|STARTED|Washout 8weeks||6
8575676|NCT00140231|9608326|FG000|COMPLETED|Washout 8weeks||7
8575677|NCT00140231|9608327|FG001|COMPLETED|Washout 8weeks||6
8575678|NCT00140231|9608326|FG000|NOT COMPLETED|Washout 8weeks||0
8575679|NCT00140231|9608327|FG001|NOT COMPLETED|Washout 8weeks||0
8575680|NCT00140231|9608326|FG000|STARTED|First Fasting State 3 Days With Placebo||7
8575681|NCT00140231|9608327|FG001|STARTED|First Fasting State 3 Days With Placebo||6
8575682|NCT00140231|9608326|FG000|COMPLETED|First Fasting State 3 Days With Placebo||7
8575683|NCT00140231|9608327|FG001|COMPLETED|First Fasting State 3 Days With Placebo||6
8575684|NCT00140231|9608326|FG000|NOT COMPLETED|First Fasting State 3 Days With Placebo||0
8575685|NCT00140231|9608327|FG001|NOT COMPLETED|First Fasting State 3 Days With Placebo||0
8575686|NCT00140231|9608326|FG000|STARTED|Washout 8 Weeks||7
8575687|NCT00140231|9608327|FG001|STARTED|Washout 8 Weeks||6
8575688|NCT00140231|9608326|FG000|COMPLETED|Washout 8 Weeks||7
8575689|NCT00140231|9608327|FG001|COMPLETED|Washout 8 Weeks||6
8575690|NCT00140231|9608326|FG000|NOT COMPLETED|Washout 8 Weeks||0
8575691|NCT00140231|9608327|FG001|NOT COMPLETED|Washout 8 Weeks||0
8575692|NCT00140231|9608326|FG000|STARTED|Fasting State With Leptin and Crossover||7
8575693|NCT00140231|9608327|FG001|STARTED|Fasting State With Leptin and Crossover||6
8575694|NCT00140231|9608326|FG000|COMPLETED|Fasting State With Leptin and Crossover||7
8575695|NCT00140231|9608327|FG001|COMPLETED|Fasting State With Leptin and Crossover||6
8575696|NCT00140231|9608326|FG000|NOT COMPLETED|Fasting State With Leptin and Crossover||0
8575697|NCT00140231|9608327|FG001|NOT COMPLETED|Fasting State With Leptin and Crossover||0
8575698|NCT00140244|9608333|FG000|STARTED|Intervention 1||3
8575699|NCT00140244|9608334|FG001|STARTED|Intervention 1||4
8575700|NCT00140244|9608333|FG000|COMPLETED|Intervention 1||3
8575701|NCT00140244|9608334|FG001|COMPLETED|Intervention 1||4
8575702|NCT00140244|9608333|FG000|NOT COMPLETED|Intervention 1||0
8575703|NCT00140244|9608334|FG001|NOT COMPLETED|Intervention 1||0
8575704|NCT00140244|9608333|FG000|STARTED|Washout||3
8575705|NCT00140244|9608334|FG001|STARTED|Washout||4
8575706|NCT00140244|9608333|FG000|COMPLETED|Washout||3
8575707|NCT00140244|9608334|FG001|COMPLETED|Washout||4
8575708|NCT00140244|9608333|FG000|NOT COMPLETED|Washout||0
8575709|NCT00140244|9608334|FG001|NOT COMPLETED|Washout||0
8575710|NCT00140244|9608333|FG000|STARTED|Intervention 2||3
8575711|NCT00140244|9608334|FG001|STARTED|Intervention 2||4
8575712|NCT00140244|9608333|FG000|COMPLETED|Intervention 2||3
8575713|NCT00140244|9608334|FG001|COMPLETED|Intervention 2||2
8575714|NCT00140244|9608333|FG000|NOT COMPLETED|Intervention 2||0
8575715|NCT00140244|9608334|FG001|NOT COMPLETED|Intervention 2||2
8575716|NCT00140413|9608344|FG000|STARTED|Overall Study||13
8575717|NCT00140413|9608345|FG001|STARTED|Overall Study||7
8575718|NCT00140413|9608344|FG000|Received at Least One Dose of GH|Overall Study||13
8575719|NCT00140413|9608345|FG001|Received at Least One Dose of GH|Overall Study|Controls were crossed over to GH if they met criteria for growth deceleration during the study.|3
8575720|NCT00140413|9608344|FG000|COMPLETED|Overall Study||10
8575721|NCT00140413|9608345|FG001|COMPLETED|Overall Study|Crossed over subjects were treated as controls for purpose of intent to treat analysis.|7
8575722|NCT00140413|9608344|FG000|NOT COMPLETED|Overall Study||3
8575723|NCT00140413|9608345|FG001|NOT COMPLETED|Overall Study||0
8575724|NCT00140426|9608354|FG000|STARTED|Overall Study||22
8575725|NCT00140426|9608355|FG001|STARTED|Overall Study||19
8575726|NCT00140426|9608354|FG000|COMPLETED|Overall Study||22
8575727|NCT00140426|9608355|FG001|COMPLETED|Overall Study||16
8575728|NCT00140426|9608354|FG000|NOT COMPLETED|Overall Study||0
8575729|NCT00140426|9608355|FG001|NOT COMPLETED|Overall Study||3
8575730|NCT00140556|9608366|FG000|STARTED|Pre Radiation Period: Avastin / Tarceva||28
8575731|NCT00140556|9608366|FG000|COMPLETED|Pre Radiation Period: Avastin / Tarceva||28
8575732|NCT00140556|9608366|FG000|NOT COMPLETED|Pre Radiation Period: Avastin / Tarceva||0
8575733|NCT00140556|9608366|FG000|STARTED|Chemoradiotherapy Period||28
8575734|NCT00140556|9608366|FG000|COMPLETED|Chemoradiotherapy Period||28
8575735|NCT00140556|9608366|FG000|NOT COMPLETED|Chemoradiotherapy Period||0
8575736|NCT00140621|9608370|FG000|STARTED|Overall Study||6
8575737|NCT00140621|9608370|FG000|COMPLETED|Overall Study||6
8575738|NCT00140621|9608370|FG000|NOT COMPLETED|Overall Study||0
8575739|NCT00140842|9608376|FG000|STARTED|Overall Study||15
8575740|NCT00140842|9608377|FG001|STARTED|Overall Study||15
8575741|NCT00140842|9608376|FG000|COMPLETED|Overall Study||15
8575742|NCT00140842|9608377|FG001|COMPLETED|Overall Study||15
8575743|NCT00140842|9608376|FG000|NOT COMPLETED|Overall Study||0
8575744|NCT00140842|9608377|FG001|NOT COMPLETED|Overall Study||0
8575745|NCT00140855|9608383|FG000|STARTED|Overall Study||6
8575746|NCT00140855|9608383|FG000|COMPLETED|Overall Study||4
8575747|NCT00140855|9608383|FG000|NOT COMPLETED|Overall Study||2
8575748|NCT00141037|9608389|FG000|STARTED|Overall Study||60
8575749|NCT00141037|9608390|FG001|STARTED|Overall Study||70
8575750|NCT00141037|9608389|FG000|COMPLETED|Overall Study|16 subjects had reduced follow-up|50
8575751|NCT00141037|9608390|FG001|COMPLETED|Overall Study|8 subjects had reduced follow-up|52
8575752|NCT00141037|9608389|FG000|NOT COMPLETED|Overall Study||10
8575753|NCT00141037|9608390|FG001|NOT COMPLETED|Overall Study||18
8575754|NCT00141102|9608398|FG000|STARTED|Overall Study||2238
8575755|NCT00141102|9608399|FG001|STARTED|Overall Study||2246
8575756|NCT00141102|9608398|FG000|Received Treatment|Overall Study||2223
8575757|NCT00141102|9608399|FG001|Received Treatment|Overall Study||2237
8575758|NCT00141102|9608398|FG000|COMPLETED|Overall Study||1730
8575759|NCT00141102|9608399|FG001|COMPLETED|Overall Study||1621
8575760|NCT00141102|9608398|FG000|NOT COMPLETED|Overall Study||508
8575761|NCT00141102|9608399|FG001|NOT COMPLETED|Overall Study||625
8575762|NCT00141115|9608406|FG000|STARTED|Overall Study||3
8575763|NCT00141115|9608406|FG000|COMPLETED|Overall Study||2
8575764|NCT00141115|9608406|FG000|NOT COMPLETED|Overall Study||1
8575765|NCT00141219|9608413|FG000|STARTED|Overall Study||162
8575766|NCT00141219|9608414|FG001|STARTED|Overall Study||78
8575767|NCT00141219|9608413|FG000|COMPLETED|Overall Study||138
8575768|NCT00141219|9608414|FG001|COMPLETED|Overall Study||62
8575769|NCT00141219|9608413|FG000|NOT COMPLETED|Overall Study||24
8575770|NCT00141219|9608414|FG001|NOT COMPLETED|Overall Study||16
8575771|NCT00141271|9608423|FG000|STARTED|Overall Study||171
8575772|NCT00141271|9608424|FG001|STARTED|Overall Study||165
8575773|NCT00141271|9608425|FG002|STARTED|Overall Study||168
8575774|NCT00141271|9608423|FG000|COMPLETED|Overall Study||91
8575775|NCT00141271|9608424|FG001|COMPLETED|Overall Study||102
8575776|NCT00141271|9608425|FG002|COMPLETED|Overall Study||111
8575777|NCT00141271|9608423|FG000|NOT COMPLETED|Overall Study||80
8575778|NCT00141271|9608424|FG001|NOT COMPLETED|Overall Study||63
8575779|NCT00141271|9608425|FG002|NOT COMPLETED|Overall Study||57
8575780|NCT00141297|9608435|FG000|STARTED|Overall Study||3
8575781|NCT00141297|9608436|FG001|STARTED|Overall Study||3
8575782|NCT00141297|9608437|FG002|STARTED|Overall Study||7
8575783|NCT00141297|9608438|FG003|STARTED|Overall Study||3
8575784|NCT00141297|9608439|FG004|STARTED|Overall Study||22
8575785|NCT00141297|9608440|FG005|STARTED|Overall Study||3
8575786|NCT00141297|9608441|FG006|STARTED|Overall Study||3
8575787|NCT00141297|9608442|FG007|STARTED|Overall Study||4
8575788|NCT00141297|9608443|FG008|STARTED|Overall Study||20
8575789|NCT00141297|9608444|FG009|STARTED|Overall Study||6
8575790|NCT00141297|9608435|FG000|COMPLETED|Overall Study||0
8575791|NCT00141297|9608436|FG001|COMPLETED|Overall Study||0
8575792|NCT00141297|9608437|FG002|COMPLETED|Overall Study||0
8575793|NCT00141297|9608438|FG003|COMPLETED|Overall Study||0
8575794|NCT00141297|9608439|FG004|COMPLETED|Overall Study||0
8575795|NCT00141297|9608440|FG005|COMPLETED|Overall Study||0
8575796|NCT00141297|9608441|FG006|COMPLETED|Overall Study||0
8575797|NCT00141297|9608442|FG007|COMPLETED|Overall Study||0
8575798|NCT00141297|9608443|FG008|COMPLETED|Overall Study||0
8575799|NCT00141297|9608444|FG009|COMPLETED|Overall Study||0
8575800|NCT00141297|9608435|FG000|NOT COMPLETED|Overall Study||3
8575801|NCT00141297|9608436|FG001|NOT COMPLETED|Overall Study||3
8575802|NCT00141297|9608437|FG002|NOT COMPLETED|Overall Study||7
8575803|NCT00141297|9608438|FG003|NOT COMPLETED|Overall Study||3
8575804|NCT00141297|9608439|FG004|NOT COMPLETED|Overall Study||22
8575805|NCT00141297|9608440|FG005|NOT COMPLETED|Overall Study||3
8575806|NCT00141297|9608441|FG006|NOT COMPLETED|Overall Study||3
8575807|NCT00141297|9608442|FG007|NOT COMPLETED|Overall Study||4
8575808|NCT00141297|9608443|FG008|NOT COMPLETED|Overall Study||20
8575809|NCT00141297|9608444|FG009|NOT COMPLETED|Overall Study||6
8575810|NCT00141453|9608479|FG000|STARTED|Overall Study||288
8575811|NCT00141453|9608480|FG001|STARTED|Overall Study||289
8575812|NCT00141453|9608479|FG000|COMPLETED|Overall Study||282
8575813|NCT00141453|9608480|FG001|COMPLETED|Overall Study||284
8575814|NCT00141453|9608479|FG000|NOT COMPLETED|Overall Study||6
8575815|NCT00141453|9608480|FG001|NOT COMPLETED|Overall Study||5
8575816|NCT00141518|9608489|FG000|STARTED|Overall Study||37
8575817|NCT00141518|9608490|FG001|STARTED|Overall Study||22
8575818|NCT00141518|9608491|FG002|STARTED|Overall Study||18
8575819|NCT00141518|9608489|FG000|Safety Sample|Overall Study||36
8575820|NCT00141518|9608490|FG001|Safety Sample|Overall Study||22
8575821|NCT00141518|9608491|FG002|Safety Sample|Overall Study||18
8575822|NCT00141518|9608489|FG000|Full Analysis Sample|Overall Study||27
8575823|NCT00141518|9608490|FG001|Full Analysis Sample|Overall Study||22
8575824|NCT00141518|9608491|FG002|Full Analysis Sample|Overall Study||18
8575825|NCT00141518|9608489|FG000|COMPLETED|Overall Study||21
8575826|NCT00141518|9608490|FG001|COMPLETED|Overall Study||16
8575827|NCT00141518|9608491|FG002|COMPLETED|Overall Study||12
8575828|NCT00141518|9608489|FG000|NOT COMPLETED|Overall Study||16
8575829|NCT00141518|9608490|FG001|NOT COMPLETED|Overall Study||6
8575830|NCT00141518|9608491|FG002|NOT COMPLETED|Overall Study||6
8575831|NCT00141726|9608501|FG000|STARTED|Overall Study||34
8575832|NCT00141726|9608501|FG000|COMPLETED|Overall Study||31
8575833|NCT00141726|9608501|FG000|NOT COMPLETED|Overall Study||3
8575834|NCT00141739|9608505|FG000|STARTED|Overall Study|Number of evaluable patients|100
8575835|NCT00141739|9608505|FG000|COMPLETED|Overall Study||100
8575836|NCT00141739|9608505|FG000|NOT COMPLETED|Overall Study||0
8575837|NCT00141765|9608511|FG000|STARTED|Overall Study||25
8575838|NCT00141765|9608511|FG000|COMPLETED|Overall Study||25
8575839|NCT00141765|9608511|FG000|NOT COMPLETED|Overall Study||0
8575840|NCT00141778|9608518|FG000|STARTED|Randomization Prior to Study Med||152
8575841|NCT00141778|9608519|FG001|STARTED|Randomization Prior to Study Med||153
8575842|NCT00141778|9608520|FG002|STARTED|Randomization Prior to Study Med||153
8575843|NCT00141778|9608518|FG000|COMPLETED|Randomization Prior to Study Med||147
8575844|NCT00141778|9608519|FG001|COMPLETED|Randomization Prior to Study Med||151
8575845|NCT00141778|9608520|FG002|COMPLETED|Randomization Prior to Study Med||147
8575846|NCT00141778|9608518|FG000|NOT COMPLETED|Randomization Prior to Study Med||5
8575847|NCT00141778|9608519|FG001|NOT COMPLETED|Randomization Prior to Study Med||2
8575848|NCT00141778|9608520|FG002|NOT COMPLETED|Randomization Prior to Study Med||6
8575849|NCT00141778|9608518|FG000|STARTED|Started Study Medication||147
8575850|NCT00141778|9608519|FG001|STARTED|Started Study Medication||151
8575851|NCT00141778|9608520|FG002|STARTED|Started Study Medication||147
8575852|NCT00141778|9608518|FG000|COMPLETED|Started Study Medication||145
8575853|NCT00141778|9608519|FG001|COMPLETED|Started Study Medication||144
8575854|NCT00141778|9608520|FG002|COMPLETED|Started Study Medication||143
8575855|NCT00141778|9608518|FG000|NOT COMPLETED|Started Study Medication||2
8575856|NCT00141778|9608519|FG001|NOT COMPLETED|Started Study Medication||7
8575857|NCT00141778|9608520|FG002|NOT COMPLETED|Started Study Medication||4
8575858|NCT00141817|9608532|FG000|STARTED|Overall Study||7
8575859|NCT00141817|9608533|FG001|STARTED|Overall Study||10
8575860|NCT00141817|9608534|FG002|STARTED|Overall Study||11
8575861|NCT00141817|9608535|FG003|STARTED|Overall Study||13
8575862|NCT00141817|9608532|FG000|COMPLETED|Overall Study||6
8575863|NCT00141817|9608533|FG001|COMPLETED|Overall Study||10
8575864|NCT00141817|9608534|FG002|COMPLETED|Overall Study||10
8575865|NCT00141817|9608535|FG003|COMPLETED|Overall Study||13
8575866|NCT00141817|9608532|FG000|NOT COMPLETED|Overall Study||1
8575867|NCT00141817|9608533|FG001|NOT COMPLETED|Overall Study||0
8575868|NCT00141817|9608534|FG002|NOT COMPLETED|Overall Study||1
8575869|NCT00141817|9608535|FG003|NOT COMPLETED|Overall Study||0
8575870|NCT00141921|9608545|FG000|STARTED|Overall Study||182
8575871|NCT00141921|9608545|FG000|Received Treatment|Overall Study||181
8575872|NCT00141921|9608545|FG000|COMPLETED|Overall Study||41
8575873|NCT00141921|9608545|FG000|NOT COMPLETED|Overall Study||141
8575874|NCT00142116|9608549|FG000|STARTED|Overall Study||25
8575875|NCT00142116|9608549|FG000|COMPLETED|Overall Study||25
8575876|NCT00142116|9608549|FG000|NOT COMPLETED|Overall Study||0
8575877|NCT00142168|9608554|FG000|STARTED|Overall Study||16
8575878|NCT00142168|9608554|FG000|COMPLETED|Overall Study||16
8575879|NCT00142168|9608554|FG000|NOT COMPLETED|Overall Study||0
8575880|NCT00142298|9608568|FG000|STARTED|Overall Study||667
8575881|NCT00142298|9608569|FG001|STARTED|Overall Study||632
8575882|NCT00142298|9608570|FG002|STARTED|Overall Study||123
8575883|NCT00142298|9608571|FG003|STARTED|Overall Study||206
8575884|NCT00142298|9608572|FG004|STARTED|Overall Study||56
8575885|NCT00142298|9608573|FG005|STARTED|Overall Study||26
8575886|NCT00142298|9608574|FG006|STARTED|Overall Study||23
8575887|NCT00142298|9608575|FG007|STARTED|Overall Study||66
8575888|NCT00142298|9608576|FG008|STARTED|Overall Study||57
8575889|NCT00142298|9608577|FG009|STARTED|Overall Study||13
8575890|NCT00142298|9608568|FG000|Safety Population|Overall Study||655
8575891|NCT00142298|9608569|FG001|Safety Population|Overall Study||626
8575892|NCT00142298|9608570|FG002|Safety Population|Overall Study||122
8575893|NCT00142298|9608571|FG003|Safety Population|Overall Study||206
8575894|NCT00142298|9608572|FG004|Safety Population|Overall Study||50
8575895|NCT00142298|9608573|FG005|Safety Population|Overall Study||26
8575896|NCT00142298|9608574|FG006|Safety Population|Overall Study||23
8575897|NCT00142298|9608575|FG007|Safety Population|Overall Study||66
8575898|NCT00142298|9608576|FG008|Safety Population|Overall Study||57
8575899|NCT00142298|9608577|FG009|Safety Population|Overall Study||13
8575900|NCT00142298|9608568|FG000|Per Protocol Population|Overall Study||635
8575901|NCT00142298|9608569|FG001|Per Protocol Population|Overall Study||606
8575902|NCT00142298|9608570|FG002|Per Protocol Population|Overall Study||120
8575903|NCT00142298|9608571|FG003|Per Protocol Population|Overall Study||202
8575904|NCT00142298|9608572|FG004|Per Protocol Population|Overall Study||50
8575905|NCT00142298|9608573|FG005|Per Protocol Population|Overall Study||25
8575906|NCT00142298|9608574|FG006|Per Protocol Population|Overall Study||19
8575907|NCT00142298|9608575|FG007|Per Protocol Population|Overall Study||64
8575908|NCT00142298|9608576|FG008|Per Protocol Population|Overall Study||56
8575909|NCT00142298|9608577|FG009|Per Protocol Population|Overall Study||13
8575910|NCT00142298|9608568|FG000|COMPLETED|Overall Study|Completed week 104/week 208.|507
8575911|NCT00142298|9608569|FG001|COMPLETED|Overall Study||456
8575912|NCT00142298|9608570|FG002|COMPLETED|Overall Study||90
8575913|NCT00142298|9608571|FG003|COMPLETED|Overall Study||121
8575914|NCT00142298|9608572|FG004|COMPLETED|Overall Study||46
8575915|NCT00142298|9608573|FG005|COMPLETED|Overall Study||10
8575916|NCT00142298|9608574|FG006|COMPLETED|Overall Study||15
8575917|NCT00142298|9608575|FG007|COMPLETED|Overall Study||58
8575918|NCT00142298|9608576|FG008|COMPLETED|Overall Study||52
8575919|NCT00142298|9608577|FG009|COMPLETED|Overall Study||13
8575920|NCT00142298|9608568|FG000|NOT COMPLETED|Overall Study||160
8575921|NCT00142298|9608569|FG001|NOT COMPLETED|Overall Study||176
8575922|NCT00142298|9608570|FG002|NOT COMPLETED|Overall Study||33
8575923|NCT00142298|9608571|FG003|NOT COMPLETED|Overall Study||85
8575924|NCT00142298|9608572|FG004|NOT COMPLETED|Overall Study||10
8575925|NCT00142298|9608573|FG005|NOT COMPLETED|Overall Study||16
8575926|NCT00142298|9608574|FG006|NOT COMPLETED|Overall Study||8
8575927|NCT00142298|9608575|FG007|NOT COMPLETED|Overall Study||8
8575928|NCT00142298|9608576|FG008|NOT COMPLETED|Overall Study||5
8575929|NCT00142298|9608577|FG009|NOT COMPLETED|Overall Study||0
8575930|NCT00142415|9608605|FG000|STARTED|Overall Study||3
8575931|NCT00142415|9608606|FG001|STARTED|Overall Study||3
8575932|NCT00142415|9608607|FG002|STARTED|Overall Study||6
8575933|NCT00142415|9608608|FG003|STARTED|Overall Study||3
8575934|NCT00142415|9608609|FG004|STARTED|Overall Study||3
8575935|NCT00142415|9608610|FG005|STARTED|Overall Study||8
8575936|NCT00142415|9608605|FG000|COMPLETED|Overall Study||3
8575937|NCT00142415|9608606|FG001|COMPLETED|Overall Study||3
8575938|NCT00142415|9608607|FG002|COMPLETED|Overall Study||6
8575939|NCT00142415|9608608|FG003|COMPLETED|Overall Study||3
8575940|NCT00142415|9608609|FG004|COMPLETED|Overall Study||2
8672622|NCT00758069|9716011|FG002|STARTED|Overall Study|Study enrolled slightly more than the target of N=20|28
8672623|NCT00758069|9716009|FG000|COMPLETED|Overall Study||26
8672624|NCT00758069|9716010|FG001|COMPLETED|Overall Study||25
8672625|NCT00758069|9716011|FG002|COMPLETED|Overall Study||27
8672626|NCT00758069|9716009|FG000|NOT COMPLETED|Overall Study||1
8672627|NCT00758069|9716010|FG001|NOT COMPLETED|Overall Study||0
8672628|NCT00758069|9716011|FG002|NOT COMPLETED|Overall Study||1
8672629|NCT00758160|9716019|FG000|STARTED|Overall Study||296
8672630|NCT00758160|9716019|FG000|COMPLETED|Overall Study||230
8672631|NCT00758160|9716019|FG000|NOT COMPLETED|Overall Study||66
8672632|NCT00758264|9716030|FG000|STARTED|Active Phase||182
8672633|NCT00758264|9716031|FG001|STARTED|Active Phase||91
8672634|NCT00758264|9716032|FG002|STARTED|Active Phase||90
8672635|NCT00758264|9716030|FG000|COMPLETED|Active Phase||181
8672636|NCT00758264|9716031|FG001|COMPLETED|Active Phase||91
8672637|NCT00758264|9716032|FG002|COMPLETED|Active Phase||85
8672638|NCT00758264|9716030|FG000|NOT COMPLETED|Active Phase||1
8672639|NCT00758264|9716031|FG001|NOT COMPLETED|Active Phase||0
8672640|NCT00758264|9716032|FG002|NOT COMPLETED|Active Phase||5
8672641|NCT00758264|9716030|FG000|STARTED|Extended Safety Follow Up (ESFU) Phase||181
8672642|NCT00758264|9716031|FG001|STARTED|Extended Safety Follow Up (ESFU) Phase||90
8672643|NCT00758264|9716032|FG002|STARTED|Extended Safety Follow Up (ESFU) Phase||89
8672644|NCT00758264|9716030|FG000|COMPLETED|Extended Safety Follow Up (ESFU) Phase||181
8672645|NCT00758264|9716031|FG001|COMPLETED|Extended Safety Follow Up (ESFU) Phase||90
8672646|NCT00758264|9716032|FG002|COMPLETED|Extended Safety Follow Up (ESFU) Phase||89
8672647|NCT00758264|9716030|FG000|NOT COMPLETED|Extended Safety Follow Up (ESFU) Phase||0
8672648|NCT00758264|9716031|FG001|NOT COMPLETED|Extended Safety Follow Up (ESFU) Phase||0
8672649|NCT00758264|9716032|FG002|NOT COMPLETED|Extended Safety Follow Up (ESFU) Phase||0
8672650|NCT00758342|9716042|FG000|STARTED|Overall Study||19
8672651|NCT00758342|9716043|FG001|STARTED|Overall Study||18
8672652|NCT00758342|9716042|FG000|COMPLETED|Overall Study||15
8672653|NCT00758342|9716043|FG001|COMPLETED|Overall Study||17
8672654|NCT00758342|9716042|FG000|NOT COMPLETED|Overall Study||4
8672655|NCT00758342|9716043|FG001|NOT COMPLETED|Overall Study||1
8672656|NCT00758394|9716053|FG000|STARTED|1st Intervention||8
8672657|NCT00758394|9716054|FG001|STARTED|1st Intervention||7
8672658|NCT00758394|9716055|FG002|STARTED|1st Intervention||6
8672659|NCT00758394|9716056|FG003|STARTED|1st Intervention||8
8672660|NCT00758394|9716053|FG000|COMPLETED|1st Intervention||8
8672661|NCT00758394|9716054|FG001|COMPLETED|1st Intervention||7
8672662|NCT00758394|9716055|FG002|COMPLETED|1st Intervention||6
8672663|NCT00758394|9716056|FG003|COMPLETED|1st Intervention||8
8672664|NCT00758394|9716053|FG000|NOT COMPLETED|1st Intervention||0
8672665|NCT00758394|9716054|FG001|NOT COMPLETED|1st Intervention||0
8672666|NCT00758394|9716055|FG002|NOT COMPLETED|1st Intervention||0
8672667|NCT00758394|9716056|FG003|NOT COMPLETED|1st Intervention||0
8672668|NCT00758394|9716053|FG000|STARTED|Washout After 1st Intervention||8
8672669|NCT00758394|9716054|FG001|STARTED|Washout After 1st Intervention||7
8672670|NCT00758394|9716055|FG002|STARTED|Washout After 1st Intervention||6
8672671|NCT00758394|9716056|FG003|STARTED|Washout After 1st Intervention||8
8672672|NCT00758394|9716053|FG000|COMPLETED|Washout After 1st Intervention||8
8575941|NCT00142415|9608610|FG005|COMPLETED|Overall Study||6
8672673|NCT00758394|9716054|FG001|COMPLETED|Washout After 1st Intervention||7
8672674|NCT00758394|9716055|FG002|COMPLETED|Washout After 1st Intervention||6
8672675|NCT00758394|9716056|FG003|COMPLETED|Washout After 1st Intervention||8
8672676|NCT00758394|9716053|FG000|NOT COMPLETED|Washout After 1st Intervention||0
8672677|NCT00758394|9716054|FG001|NOT COMPLETED|Washout After 1st Intervention||0
8672678|NCT00758394|9716055|FG002|NOT COMPLETED|Washout After 1st Intervention||0
8672679|NCT00758394|9716056|FG003|NOT COMPLETED|Washout After 1st Intervention||0
8672680|NCT00758394|9716053|FG000|STARTED|2nd Intervention Order||8
8672681|NCT00758394|9716054|FG001|STARTED|2nd Intervention Order||7
8672682|NCT00758394|9716055|FG002|STARTED|2nd Intervention Order||6
8672683|NCT00758394|9716056|FG003|STARTED|2nd Intervention Order||8
8672684|NCT00758394|9716053|FG000|COMPLETED|2nd Intervention Order||8
8672685|NCT00758394|9716054|FG001|COMPLETED|2nd Intervention Order||6
8672686|NCT00758394|9716055|FG002|COMPLETED|2nd Intervention Order||6
8672687|NCT00758394|9716056|FG003|COMPLETED|2nd Intervention Order||8
8575942|NCT00142415|9608605|FG000|NOT COMPLETED|Overall Study||0
8575943|NCT00142415|9608606|FG001|NOT COMPLETED|Overall Study||0
8575944|NCT00142415|9608607|FG002|NOT COMPLETED|Overall Study||0
8575945|NCT00142415|9608608|FG003|NOT COMPLETED|Overall Study||0
8575946|NCT00142415|9608609|FG004|NOT COMPLETED|Overall Study||1
8575947|NCT00142415|9608610|FG005|NOT COMPLETED|Overall Study||2
8575948|NCT00142454|9608626|FG000|STARTED|Overall Study||9
8575949|NCT00142454|9608626|FG000|COMPLETED|Overall Study||9
8575950|NCT00142454|9608626|FG000|NOT COMPLETED|Overall Study||0
8575951|NCT00142506|9608632|FG000|STARTED|Overall Study||184
8575952|NCT00142506|9608633|FG001|STARTED|Overall Study||106
8575953|NCT00142506|9608632|FG000|COMPLETED|Overall Study||112
8575954|NCT00142506|9608633|FG001|COMPLETED|Overall Study||77
8575955|NCT00142506|9608632|FG000|NOT COMPLETED|Overall Study||72
8575956|NCT00142506|9608633|FG001|NOT COMPLETED|Overall Study||29
8575957|NCT00142597|9608641|FG000|STARTED|Overall Study|N=10 underwent PET imaging|23
8575958|NCT00142597|9608642|FG001|STARTED|Overall Study|N=10 underwent PET imaging|23
8575959|NCT00142597|9608641|FG000|COMPLETED|Overall Study|N=10 completed PET imaging|20
8575960|NCT00142597|9608642|FG001|COMPLETED|Overall Study|N=10 completed PET imaging|22
8575961|NCT00142597|9608641|FG000|NOT COMPLETED|Overall Study||3
8575962|NCT00142597|9608642|FG001|NOT COMPLETED|Overall Study||1
8575963|NCT00142792|9608651|FG000|STARTED|Overall Study||39
8575964|NCT00142792|9608652|FG001|STARTED|Overall Study||41
8575965|NCT00142792|9608653|FG002|STARTED|Overall Study||42
8575966|NCT00142792|9608651|FG000|Completed Intervention|Overall Study||35
8575967|NCT00142792|9608652|FG001|Completed Intervention|Overall Study||37
8575968|NCT00142792|9608653|FG002|Completed Intervention|Overall Study||37
8575969|NCT00142792|9608651|FG000|COMPLETED|Overall Study||27
8575970|NCT00142792|9608652|FG001|COMPLETED|Overall Study||26
8575971|NCT00142792|9608653|FG002|COMPLETED|Overall Study||30
8575972|NCT00142792|9608651|FG000|NOT COMPLETED|Overall Study||12
8575973|NCT00142792|9608652|FG001|NOT COMPLETED|Overall Study||15
8575974|NCT00142792|9608653|FG002|NOT COMPLETED|Overall Study||12
8575975|NCT00142818|9608665|FG000|STARTED|Overall Study||45
8575976|NCT00142818|9608666|FG001|STARTED|Overall Study||40
8575977|NCT00142818|9608667|FG002|STARTED|Overall Study||37
8575978|NCT00142818|9608668|FG003|STARTED|Overall Study||42
8575979|NCT00142818|9608665|FG000|COMPLETED|Overall Study||28
8575980|NCT00142818|9608666|FG001|COMPLETED|Overall Study||19
8575981|NCT00142818|9608667|FG002|COMPLETED|Overall Study||24
8575982|NCT00142818|9608668|FG003|COMPLETED|Overall Study||20
8575983|NCT00142818|9608665|FG000|NOT COMPLETED|Overall Study||17
8575984|NCT00142818|9608666|FG001|NOT COMPLETED|Overall Study||21
8575985|NCT00142818|9608667|FG002|NOT COMPLETED|Overall Study||13
8575986|NCT00142818|9608668|FG003|NOT COMPLETED|Overall Study||22
8575987|NCT00142909|9608684|FG000|STARTED|Randomization||42
8575988|NCT00142909|9608685|FG001|STARTED|Randomization||44
8575989|NCT00142909|9608684|FG000|COMPLETED|Randomization||35
8575990|NCT00142909|9608685|FG001|COMPLETED|Randomization||34
8575991|NCT00142909|9608684|FG000|NOT COMPLETED|Randomization||7
8575992|NCT00142909|9608685|FG001|NOT COMPLETED|Randomization||10
8575993|NCT00142909|9608684|FG000|STARTED|Medications Begin||35
8575994|NCT00142909|9608685|FG001|STARTED|Medications Begin||34
8575995|NCT00142909|9608684|FG000|COMPLETED|Medications Begin||26
8575996|NCT00142909|9608685|FG001|COMPLETED|Medications Begin||31
8575997|NCT00142909|9608684|FG000|NOT COMPLETED|Medications Begin||9
8575998|NCT00142909|9608685|FG001|NOT COMPLETED|Medications Begin||3
8575999|NCT00142935|9608694|FG000|STARTED|Overall Study||29
8576000|NCT00142935|9608695|FG001|STARTED|Overall Study||28
8576001|NCT00142935|9608696|FG002|STARTED|Overall Study||30
8576002|NCT00142935|9608694|FG000|COMPLETED|Overall Study||26
8576003|NCT00142935|9608695|FG001|COMPLETED|Overall Study||20
8576004|NCT00142935|9608696|FG002|COMPLETED|Overall Study||23
8576005|NCT00142935|9608694|FG000|NOT COMPLETED|Overall Study||3
8576006|NCT00142935|9608695|FG001|NOT COMPLETED|Overall Study||8
8576007|NCT00142935|9608696|FG002|NOT COMPLETED|Overall Study||7
8576008|NCT00143247|9608708|FG000|STARTED|Overall Study|173=total subjects of current + 3 previous protocols|173
8576009|NCT00143247|9608708|FG000|COMPLETED|Overall Study||17
8576010|NCT00143247|9608708|FG000|NOT COMPLETED|Overall Study||156
8576011|NCT00143312|9608712|FG000|STARTED|Overall Study||45
8576012|NCT00143312|9608712|FG000|COMPLETED|Overall Study||29
8576013|NCT00143312|9608712|FG000|NOT COMPLETED|Overall Study||16
8576014|NCT00143390|9608718|FG000|STARTED|Overall Study||149
8576015|NCT00143390|9608719|FG001|STARTED|Overall Study||149
8576016|NCT00143390|9608718|FG000|COMPLETED|Overall Study||0
8576017|NCT00143390|9608719|FG001|COMPLETED|Overall Study||0
8576018|NCT00143390|9608718|FG000|NOT COMPLETED|Overall Study||149
8576019|NCT00143390|9608719|FG001|NOT COMPLETED|Overall Study||149
8576020|NCT00143403|9608727|FG000|STARTED|Overall Study||160
8576021|NCT00143403|9608728|FG001|STARTED|Overall Study||161
8576022|NCT00143403|9608727|FG000|Treated|Overall Study||153
8576023|NCT00143403|9608728|FG001|Treated|Overall Study||153
8576024|NCT00143403|9608727|FG000|COMPLETED|Overall Study|Received maximum number of cycles.|125
8576025|NCT00143403|9608728|FG001|COMPLETED|Overall Study|Received maximum number of cycles.|115
8576026|NCT00143403|9608727|FG000|NOT COMPLETED|Overall Study||35
8576027|NCT00143403|9608728|FG001|NOT COMPLETED|Overall Study||46
8576028|NCT00143455|9608738|FG000|STARTED|Cohort 1||39
8576029|NCT00143455|9608739|FG001|STARTED|Cohort 1||39
8576030|NCT00143455|9608740|FG002|STARTED|Cohort 1||0
8576031|NCT00143455|9608741|FG003|STARTED|Cohort 1||0
8576032|NCT00143455|9608738|FG000|Received Treatment|Cohort 1||39
8576033|NCT00143455|9608739|FG001|Received Treatment|Cohort 1||38
8576034|NCT00143455|9608740|FG002|Received Treatment|Cohort 1||0
8576035|NCT00143455|9608741|FG003|Received Treatment|Cohort 1||0
8576036|NCT00143455|9608738|FG000|COMPLETED|Cohort 1||25
8576037|NCT00143455|9608739|FG001|COMPLETED|Cohort 1||22
8576038|NCT00143455|9608740|FG002|COMPLETED|Cohort 1||0
8576039|NCT00143455|9608741|FG003|COMPLETED|Cohort 1||0
8576040|NCT00143455|9608738|FG000|NOT COMPLETED|Cohort 1||14
8576041|NCT00143455|9608739|FG001|NOT COMPLETED|Cohort 1||17
8576042|NCT00143455|9608740|FG002|NOT COMPLETED|Cohort 1||0
8576043|NCT00143455|9608741|FG003|NOT COMPLETED|Cohort 1||0
8576044|NCT00143455|9608738|FG000|STARTED|Cohort 2||0
8576045|NCT00143455|9608739|FG001|STARTED|Cohort 2||0
8576046|NCT00143455|9608740|FG002|STARTED|Cohort 2||203
8576047|NCT00143455|9608741|FG003|STARTED|Cohort 2||204
8576048|NCT00143455|9608738|FG000|Received Treatment|Cohort 2||0
8576049|NCT00143455|9608739|FG001|Received Treatment|Cohort 2||0
8576050|NCT00143455|9608740|FG002|Received Treatment|Cohort 2||202
8576051|NCT00143455|9608741|FG003|Received Treatment|Cohort 2||203
8576052|NCT00143455|9608738|FG000|COMPLETED|Cohort 2||0
8576053|NCT00143455|9608739|FG001|COMPLETED|Cohort 2||0
8576054|NCT00143455|9608740|FG002|COMPLETED|Cohort 2||97
8576055|NCT00143455|9608741|FG003|COMPLETED|Cohort 2||111
8576056|NCT00143455|9608738|FG000|NOT COMPLETED|Cohort 2||0
8576057|NCT00143455|9608739|FG001|NOT COMPLETED|Cohort 2||0
8576058|NCT00143455|9608740|FG002|NOT COMPLETED|Cohort 2||106
8576059|NCT00143455|9608741|FG003|NOT COMPLETED|Cohort 2||93
8576060|NCT00143507|9608755|FG000|STARTED|Overall Study||5479
8576061|NCT00143507|9608756|FG001|STARTED|Overall Study||5438
8576062|NCT00143507|9608755|FG000|COMPLETED|Overall Study||4792
8576063|NCT00143507|9608756|FG001|COMPLETED|Overall Study||4786
8576064|NCT00143507|9608755|FG000|NOT COMPLETED|Overall Study||687
8576065|NCT00143507|9608756|FG001|NOT COMPLETED|Overall Study||652
8576066|NCT00143598|9608764|FG000|STARTED|Overall Study||410
8576067|NCT00143598|9608765|FG001|STARTED|Overall Study||396
8576068|NCT00143598|9608764|FG000|COMPLETED|Overall Study||318
8576069|NCT00143598|9608765|FG001|COMPLETED|Overall Study||302
8576070|NCT00143598|9608764|FG000|NOT COMPLETED|Overall Study||92
8576071|NCT00143598|9608765|FG001|NOT COMPLETED|Overall Study||94
8576072|NCT00143819|9608773|FG000|STARTED|Overall Study||5
8576073|NCT00143819|9608774|FG001|STARTED|Overall Study||8
8576074|NCT00143819|9608773|FG000|COMPLETED|Overall Study||3
8576075|NCT00143819|9608774|FG001|COMPLETED|Overall Study||5
8576076|NCT00143819|9608773|FG000|NOT COMPLETED|Overall Study||2
8576077|NCT00143819|9608774|FG001|NOT COMPLETED|Overall Study||3
8576078|NCT00143845|9608784|FG000|STARTED|Overall Study||54
8576079|NCT00143845|9608784|FG000|COMPLETED|Overall Study||54
8576080|NCT00143845|9608784|FG000|NOT COMPLETED|Overall Study||0
8577631|NCT00159913|9610394|FG001|COMPLETED|Overall Study||55
8577632|NCT00159913|9610395|FG002|COMPLETED|Overall Study||75
8577633|NCT00159913|9610396|FG003|COMPLETED|Overall Study||58
8577634|NCT00159913|9610393|FG000|NOT COMPLETED|Overall Study||2
8577635|NCT00159913|9610394|FG001|NOT COMPLETED|Overall Study||0
8577636|NCT00159913|9610395|FG002|NOT COMPLETED|Overall Study||2
8577637|NCT00159913|9610396|FG003|NOT COMPLETED|Overall Study||2
8577638|NCT00159965|9610410|FG000|STARTED|Overall Study||19
8577639|NCT00159965|9610411|FG001|STARTED|Overall Study||19
8577640|NCT00159965|9610410|FG000|COMPLETED|Overall Study||12
8577641|NCT00159965|9610411|FG001|COMPLETED|Overall Study||14
8577642|NCT00159965|9610410|FG000|NOT COMPLETED|Overall Study||7
8577643|NCT00159965|9610411|FG001|NOT COMPLETED|Overall Study||5
8577644|NCT00160199|9610419|FG000|STARTED|Overall Study||122
8577645|NCT00160199|9610420|FG001|STARTED|Overall Study||118
8577646|NCT00160199|9610419|FG000|COMPLETED|Overall Study||98
8577647|NCT00160199|9610420|FG001|COMPLETED|Overall Study||81
8577648|NCT00160199|9610419|FG000|NOT COMPLETED|Overall Study||24
8577649|NCT00160199|9610420|FG001|NOT COMPLETED|Overall Study||37
8577650|NCT00160251|9610432|FG000|STARTED|Prior to Amendment 2||15
8577651|NCT00160251|9610433|FG001|STARTED|Prior to Amendment 2||34
8577652|NCT00160251|9610434|FG002|STARTED|Prior to Amendment 2||48
8577653|NCT00160251|9610435|FG003|STARTED|Prior to Amendment 2||49
8577654|NCT00160251|9610436|FG004|STARTED|Prior to Amendment 2||49
8577655|NCT00160251|9610437|FG005|STARTED|Prior to Amendment 2||97
8577656|NCT00160251|9610438|FG006|STARTED|Prior to Amendment 2||65
8577657|NCT00160251|9610439|FG007|STARTED|Prior to Amendment 2||0
8577658|NCT00160251|9610432|FG000|COMPLETED|Prior to Amendment 2||6
8577659|NCT00160251|9610433|FG001|COMPLETED|Prior to Amendment 2||28
8577660|NCT00160251|9610434|FG002|COMPLETED|Prior to Amendment 2||4
8577661|NCT00160251|9610435|FG003|COMPLETED|Prior to Amendment 2||9
8577662|NCT00160251|9610436|FG004|COMPLETED|Prior to Amendment 2||21
8577663|NCT00160251|9610437|FG005|COMPLETED|Prior to Amendment 2||14
8577664|NCT00160251|9610438|FG006|COMPLETED|Prior to Amendment 2||61
8577665|NCT00160251|9610439|FG007|COMPLETED|Prior to Amendment 2||0
8577666|NCT00160251|9610432|FG000|NOT COMPLETED|Prior to Amendment 2||9
8577667|NCT00160251|9610433|FG001|NOT COMPLETED|Prior to Amendment 2||6
8577668|NCT00160251|9610434|FG002|NOT COMPLETED|Prior to Amendment 2||44
8577669|NCT00160251|9610435|FG003|NOT COMPLETED|Prior to Amendment 2||40
8577670|NCT00160251|9610436|FG004|NOT COMPLETED|Prior to Amendment 2||28
8577671|NCT00160251|9610437|FG005|NOT COMPLETED|Prior to Amendment 2||83
8576081|NCT00144027|9608790|FG000|STARTED|Overall Study|participants who consented|39
8576082|NCT00144027|9608791|FG001|STARTED|Overall Study|participants who consented|36
8576083|NCT00144027|9608790|FG000|Completed Baseline Assessment|Overall Study||39
8576084|NCT00144027|9608791|FG001|Completed Baseline Assessment|Overall Study||29
8576085|NCT00144027|9608790|FG000|Completed 6 Month Assessment|Overall Study||37
8576086|NCT00144027|9608791|FG001|Completed 6 Month Assessment|Overall Study||24
8576087|NCT00144027|9608790|FG000|COMPLETED|Overall Study|participants who completed 12-month follow-up|36
8576088|NCT00144027|9608791|FG001|COMPLETED|Overall Study|participants who completed 12-month follow-up|25
8576089|NCT00144027|9608790|FG000|NOT COMPLETED|Overall Study||3
8576090|NCT00144027|9608791|FG001|NOT COMPLETED|Overall Study||11
8576091|NCT00144170|9608799|FG000|STARTED|Overall Study||438
8576092|NCT00144170|9608800|FG001|STARTED|Overall Study||428
8576093|NCT00144170|9608799|FG000|COMPLETED|Overall Study||86
8576094|NCT00144170|9608800|FG001|COMPLETED|Overall Study||32
8576095|NCT00144170|9608799|FG000|NOT COMPLETED|Overall Study||352
8576096|NCT00144170|9608800|FG001|NOT COMPLETED|Overall Study||396
8576097|NCT00144300|9608808|FG000|STARTED|Overall Study||121
8576098|NCT00144300|9608809|FG001|STARTED|Overall Study||125
8576099|NCT00144300|9608808|FG000|COMPLETED|Overall Study||92
8576100|NCT00144300|9608809|FG001|COMPLETED|Overall Study||97
8576101|NCT00144300|9608808|FG000|NOT COMPLETED|Overall Study||29
8576102|NCT00144300|9608809|FG001|NOT COMPLETED|Overall Study||28
8576103|NCT00144339|9608817|FG000|STARTED|Overall Study||3006
8576104|NCT00144339|9608818|FG001|STARTED|Overall Study||2986
8576105|NCT00144339|9608817|FG000|COMPLETED|Overall Study||1648
8576106|NCT00144339|9608818|FG001|COMPLETED|Overall Study||1887
8576107|NCT00144339|9608817|FG000|NOT COMPLETED|Overall Study||1358
8576108|NCT00144339|9608818|FG001|NOT COMPLETED|Overall Study||1099
8576109|NCT00144391|9608826|FG000|STARTED|Overall Study||11
8576110|NCT00144391|9608827|FG001|STARTED|Overall Study||9
8576111|NCT00144391|9608826|FG000|COMPLETED|Overall Study||11
8576112|NCT00144391|9608827|FG001|COMPLETED|Overall Study||9
8576113|NCT00144391|9608826|FG000|NOT COMPLETED|Overall Study||0
8576114|NCT00144391|9608827|FG001|NOT COMPLETED|Overall Study||0
8576115|NCT00144781|9608837|FG000|STARTED|Overall Study||8
8576116|NCT00144781|9608838|FG001|STARTED|Overall Study||9
8576117|NCT00144781|9608839|FG002|STARTED|Overall Study||8
8576118|NCT00144781|9608840|FG003|STARTED|Overall Study||9
8576119|NCT00144781|9608837|FG000|COMPLETED|Overall Study||8
8576120|NCT00144781|9608838|FG001|COMPLETED|Overall Study||7
8576121|NCT00144781|9608839|FG002|COMPLETED|Overall Study||8
8576122|NCT00144781|9608840|FG003|COMPLETED|Overall Study||9
8576123|NCT00144781|9608837|FG000|NOT COMPLETED|Overall Study||0
8576124|NCT00144781|9608838|FG001|NOT COMPLETED|Overall Study||2
8576125|NCT00144781|9608839|FG002|NOT COMPLETED|Overall Study||0
8576126|NCT00144781|9608840|FG003|NOT COMPLETED|Overall Study||0
8576127|NCT00144963|9608850|FG000|STARTED|Overall Study||36
8576128|NCT00144963|9608850|FG000|COMPLETED|Overall Study||36
8576129|NCT00144963|9608850|FG000|NOT COMPLETED|Overall Study||0
8576130|NCT00145041|9608854|FG000|STARTED|Overall Study||7
8576131|NCT00145041|9608854|FG000|COMPLETED|Overall Study||7
8576132|NCT00145041|9608854|FG000|NOT COMPLETED|Overall Study||0
8576133|NCT00145119|9608858|FG000|STARTED|Overall Study||312
8576134|NCT00145119|9608858|FG000|COMPLETED|Overall Study||267
8576135|NCT00145119|9608858|FG000|NOT COMPLETED|Overall Study||45
8576136|NCT00145145|9608862|FG000|STARTED|Overall Study||1
8576137|NCT00145145|9608862|FG000|COMPLETED|Overall Study||1
8576138|NCT00145145|9608862|FG000|NOT COMPLETED|Overall Study||0
8576139|NCT00145249|9608869|FG000|STARTED|Overall Study|47 subjects randomized; 45 subjects treated|47
8576140|NCT00145249|9608870|FG001|STARTED|Overall Study|48 subjects randomized; 47 subjects treated-2 subjects randomized to AmphoB rec'd AmphoB+Fluc400|48
8576141|NCT00145249|9608871|FG002|STARTED|Overall Study|48 subjects randomized; 49 treated-3 subjects randomized to AmphoB+Fluc400 rec'd AmphoB+Fluc800|48
8576142|NCT00145249|9608869|FG000|COMPLETED|Overall Study||36
8576143|NCT00145249|9608870|FG001|COMPLETED|Overall Study||33
8576144|NCT00145249|9608871|FG002|COMPLETED|Overall Study||31
8576145|NCT00145249|9608869|FG000|NOT COMPLETED|Overall Study||11
8576146|NCT00145249|9608870|FG001|NOT COMPLETED|Overall Study||15
8576147|NCT00145249|9608871|FG002|NOT COMPLETED|Overall Study||17
8576148|NCT00145327|9608882|FG000|STARTED|Overall Study|Group Z6 and Group Z3P3 have randomized participants.|616
8576149|NCT00145327|9608883|FG001|STARTED|Overall Study||617
8576150|NCT00145327|9608884|FG002|STARTED|Overall Study|Group P3Z3 have non-randomized participants|1223
8576151|NCT00145327|9608882|FG000|COMPLETED|Overall Study||474
8576152|NCT00145327|9608883|FG001|COMPLETED|Overall Study||493
8576153|NCT00145327|9608884|FG002|COMPLETED|Overall Study||975
8576154|NCT00145327|9608882|FG000|NOT COMPLETED|Overall Study||142
8576155|NCT00145327|9608883|FG001|NOT COMPLETED|Overall Study||124
8576156|NCT00145327|9608884|FG002|NOT COMPLETED|Overall Study||248
8576157|NCT00145418|9608892|FG000|STARTED|Overall Study||15
8576158|NCT00145418|9608892|FG000|COMPLETED|Overall Study||15
8576159|NCT00145418|9608892|FG000|NOT COMPLETED|Overall Study||0
8576160|NCT00145574|9608899|FG000|STARTED|Double Blind||65
8576161|NCT00145574|9608900|FG001|STARTED|Double Blind||65
8576162|NCT00145574|9608901|FG002|STARTED|Double Blind||64
8576163|NCT00145574|9608899|FG000|COMPLETED|Double Blind||64
8576164|NCT00145574|9608900|FG001|COMPLETED|Double Blind||60
8576165|NCT00145574|9608901|FG002|COMPLETED|Double Blind||62
8576166|NCT00145574|9608899|FG000|NOT COMPLETED|Double Blind||1
8576167|NCT00145574|9608900|FG001|NOT COMPLETED|Double Blind||5
8576168|NCT00145574|9608901|FG002|NOT COMPLETED|Double Blind||2
8576169|NCT00145574|9608899|FG000|STARTED|Open Label Long-term Extension||0
8576170|NCT00145574|9608900|FG001|STARTED|Open Label Long-term Extension||0
8576171|NCT00145574|9608901|FG002|STARTED|Open Label Long-term Extension|2 participants discontinued after completing double-blind but before starting open label.|184
8576172|NCT00145574|9608899|FG000|COMPLETED|Open Label Long-term Extension||0
8576173|NCT00145574|9608900|FG001|COMPLETED|Open Label Long-term Extension||0
8576174|NCT00145574|9608901|FG002|COMPLETED|Open Label Long-term Extension||173
8576175|NCT00145574|9608899|FG000|NOT COMPLETED|Open Label Long-term Extension||0
8576176|NCT00145574|9608900|FG001|NOT COMPLETED|Open Label Long-term Extension||0
8576177|NCT00145574|9608901|FG002|NOT COMPLETED|Open Label Long-term Extension||11
8576178|NCT00145587|9608916|FG000|STARTED|Overall Study||5
8576179|NCT00145587|9608917|FG001|STARTED|Overall Study||1
8576180|NCT00145587|9608916|FG000|COMPLETED|Overall Study||5
8576181|NCT00145587|9608917|FG001|COMPLETED|Overall Study||1
8576182|NCT00145587|9608916|FG000|NOT COMPLETED|Overall Study||0
8576183|NCT00145587|9608917|FG001|NOT COMPLETED|Overall Study||0
8576184|NCT00145626|9608925|FG000|STARTED|Overall Study||19
8576185|NCT00145626|9608925|FG000|COMPLETED|Overall Study||14
8576186|NCT00145626|9608925|FG000|NOT COMPLETED|Overall Study||5
8576187|NCT00145795|9608947|FG000|STARTED|Overall Study||10
8576188|NCT00145795|9608948|FG001|STARTED|Overall Study||10
8576189|NCT00145795|9608947|FG000|COMPLETED|Overall Study|1 patient discontinued early due to grade II gastrointestinal symptoms.|9
8576190|NCT00145795|9608948|FG001|COMPLETED|Overall Study||10
8576191|NCT00145795|9608947|FG000|NOT COMPLETED|Overall Study||1
8576192|NCT00145795|9608948|FG001|NOT COMPLETED|Overall Study||0
8576193|NCT00145977|9608956|FG000|STARTED|Overall Study||19
8576194|NCT00145977|9608957|FG001|STARTED|Overall Study||17
8576195|NCT00145977|9608956|FG000|COMPLETED|Overall Study||17
8576196|NCT00145977|9608957|FG001|COMPLETED|Overall Study||13
8576197|NCT00145977|9608956|FG000|NOT COMPLETED|Overall Study||2
8576198|NCT00145977|9608957|FG001|NOT COMPLETED|Overall Study||4
8576199|NCT00146172|9608971|FG000|STARTED|Overall Study||3
8576200|NCT00146172|9608972|FG001|STARTED|Overall Study||4
8576201|NCT00146172|9608973|FG002|STARTED|Overall Study||4
8576202|NCT00146172|9608974|FG003|STARTED|Overall Study||6
8576203|NCT00146172|9608975|FG004|STARTED|Overall Study||3
8576204|NCT00146172|9608976|FG005|STARTED|Overall Study||7
8576205|NCT00146172|9608977|FG006|STARTED|Overall Study||6
8672688|NCT00758394|9716053|FG000|NOT COMPLETED|2nd Intervention Order||0
8672689|NCT00758394|9716054|FG001|NOT COMPLETED|2nd Intervention Order||1
8672690|NCT00758394|9716055|FG002|NOT COMPLETED|2nd Intervention Order||0
8672691|NCT00758394|9716056|FG003|NOT COMPLETED|2nd Intervention Order||0
8672692|NCT00758394|9716053|FG000|STARTED|Washout After 2nd Intervention||8
8672693|NCT00758394|9716054|FG001|STARTED|Washout After 2nd Intervention||6
8672694|NCT00758394|9716055|FG002|STARTED|Washout After 2nd Intervention||6
8672695|NCT00758394|9716056|FG003|STARTED|Washout After 2nd Intervention||8
8672696|NCT00758394|9716053|FG000|COMPLETED|Washout After 2nd Intervention||8
8672697|NCT00758394|9716054|FG001|COMPLETED|Washout After 2nd Intervention||6
8672698|NCT00758394|9716055|FG002|COMPLETED|Washout After 2nd Intervention||6
8672699|NCT00758394|9716056|FG003|COMPLETED|Washout After 2nd Intervention||8
8672700|NCT00758394|9716053|FG000|NOT COMPLETED|Washout After 2nd Intervention||0
8672701|NCT00758394|9716054|FG001|NOT COMPLETED|Washout After 2nd Intervention||0
8672702|NCT00758394|9716055|FG002|NOT COMPLETED|Washout After 2nd Intervention||0
8672703|NCT00758394|9716056|FG003|NOT COMPLETED|Washout After 2nd Intervention||0
8672704|NCT00758394|9716053|FG000|STARTED|3rd Intervention||8
8672705|NCT00758394|9716054|FG001|STARTED|3rd Intervention||6
8672706|NCT00758394|9716055|FG002|STARTED|3rd Intervention||6
8672707|NCT00758394|9716056|FG003|STARTED|3rd Intervention||8
8672708|NCT00758394|9716053|FG000|COMPLETED|3rd Intervention||7
8672709|NCT00758394|9716054|FG001|COMPLETED|3rd Intervention||6
8672710|NCT00758394|9716055|FG002|COMPLETED|3rd Intervention||6
8672711|NCT00758394|9716056|FG003|COMPLETED|3rd Intervention||7
8672712|NCT00758394|9716053|FG000|NOT COMPLETED|3rd Intervention||1
8672713|NCT00758394|9716054|FG001|NOT COMPLETED|3rd Intervention||0
8672714|NCT00758394|9716055|FG002|NOT COMPLETED|3rd Intervention||0
8672715|NCT00758394|9716056|FG003|NOT COMPLETED|3rd Intervention||1
8672716|NCT00758394|9716053|FG000|STARTED|Washout After 3rd Intervention||7
8672717|NCT00758394|9716054|FG001|STARTED|Washout After 3rd Intervention||6
8672718|NCT00758394|9716055|FG002|STARTED|Washout After 3rd Intervention||6
8672719|NCT00758394|9716056|FG003|STARTED|Washout After 3rd Intervention||7
8672720|NCT00758394|9716053|FG000|COMPLETED|Washout After 3rd Intervention||7
8672721|NCT00758394|9716054|FG001|COMPLETED|Washout After 3rd Intervention||6
8672722|NCT00758394|9716055|FG002|COMPLETED|Washout After 3rd Intervention||6
8672723|NCT00758394|9716056|FG003|COMPLETED|Washout After 3rd Intervention||7
8672724|NCT00758394|9716053|FG000|NOT COMPLETED|Washout After 3rd Intervention||0
8672725|NCT00758394|9716054|FG001|NOT COMPLETED|Washout After 3rd Intervention||0
8672726|NCT00758394|9716055|FG002|NOT COMPLETED|Washout After 3rd Intervention||0
8576206|NCT00146172|9608978|FG007|STARTED|Overall Study||40
8576207|NCT00146172|9608971|FG000|Received Drug|Overall Study||3
8576208|NCT00146172|9608972|FG001|Received Drug|Overall Study||4
8576209|NCT00146172|9608973|FG002|Received Drug|Overall Study||4
8576210|NCT00146172|9608974|FG003|Received Drug|Overall Study||6
8799494|NCT01437878|9851029|FG000|NOT COMPLETED|Overall Study||1
8576211|NCT00146172|9608975|FG004|Received Drug|Overall Study||3
8576212|NCT00146172|9608976|FG005|Received Drug|Overall Study||7
8576213|NCT00146172|9608977|FG006|Received Drug|Overall Study||6
8576214|NCT00146172|9608978|FG007|Received Drug|Overall Study||39
8576215|NCT00146172|9608971|FG000|COMPLETED|Overall Study||0
8576216|NCT00146172|9608972|FG001|COMPLETED|Overall Study||0
8576217|NCT00146172|9608973|FG002|COMPLETED|Overall Study||0
8576218|NCT00146172|9608974|FG003|COMPLETED|Overall Study||0
8576219|NCT00146172|9608975|FG004|COMPLETED|Overall Study||0
8576220|NCT00146172|9608976|FG005|COMPLETED|Overall Study||0
8576221|NCT00146172|9608977|FG006|COMPLETED|Overall Study||0
8576222|NCT00146172|9608978|FG007|COMPLETED|Overall Study||0
8576223|NCT00146172|9608971|FG000|NOT COMPLETED|Overall Study||3
8576224|NCT00146172|9608972|FG001|NOT COMPLETED|Overall Study||4
8576225|NCT00146172|9608973|FG002|NOT COMPLETED|Overall Study||4
8576226|NCT00146172|9608974|FG003|NOT COMPLETED|Overall Study||6
8576227|NCT00146172|9608975|FG004|NOT COMPLETED|Overall Study||3
8576228|NCT00146172|9608976|FG005|NOT COMPLETED|Overall Study||7
8576229|NCT00146172|9608977|FG006|NOT COMPLETED|Overall Study||6
8576230|NCT00146172|9608978|FG007|NOT COMPLETED|Overall Study||40
8576231|NCT00146328|9609007|FG000|STARTED|Overall Study||291
8576232|NCT00146328|9609008|FG001|STARTED|Overall Study||255
8576233|NCT00146328|9609009|FG002|STARTED|Overall Study||449
8576234|NCT00146328|9609007|FG000|COMPLETED|Overall Study||150
8576235|NCT00146328|9609008|FG001|COMPLETED|Overall Study||101
8576236|NCT00146328|9609009|FG002|COMPLETED|Overall Study||158
8576237|NCT00146328|9609007|FG000|NOT COMPLETED|Overall Study||141
8576238|NCT00146328|9609008|FG001|NOT COMPLETED|Overall Study||154
8576239|NCT00146328|9609009|FG002|NOT COMPLETED|Overall Study||291
8576240|NCT00146640|9609019|FG000|STARTED|Overall Study||144
8576241|NCT00146640|9609020|FG001|STARTED|Overall Study||144
8576242|NCT00146640|9609019|FG000|COMPLETED|Overall Study||121
8576243|NCT00146640|9609020|FG001|COMPLETED|Overall Study||130
8576244|NCT00146640|9609019|FG000|NOT COMPLETED|Overall Study||23
8576245|NCT00146640|9609020|FG001|NOT COMPLETED|Overall Study||14
8576246|NCT00146757|9609026|FG000|STARTED|Overall Study||16
8576247|NCT00146757|9609027|FG001|STARTED|Overall Study||4
8576248|NCT00146757|9609026|FG000|COMPLETED|Overall Study||14
8576249|NCT00146757|9609027|FG001|COMPLETED|Overall Study||4
8576250|NCT00146757|9609026|FG000|NOT COMPLETED|Overall Study||2
8576251|NCT00146757|9609027|FG001|NOT COMPLETED|Overall Study||0
8576252|NCT00146770|9609035|FG000|STARTED|Overall Study||23
8576253|NCT00146770|9609036|FG001|STARTED|Overall Study||22
8576254|NCT00146770|9609035|FG000|COMPLETED|Overall Study||18
8576255|NCT00146770|9609036|FG001|COMPLETED|Overall Study||22
8576256|NCT00146770|9609035|FG000|NOT COMPLETED|Overall Study||5
8576257|NCT00146770|9609036|FG001|NOT COMPLETED|Overall Study||0
8576258|NCT00146848|9609045|FG000|STARTED|Pre-randomization|Registered|1742
8576259|NCT00146848|9609046|FG001|STARTED|Pre-randomization||0
8576260|NCT00146848|9609047|FG002|STARTED|Pre-randomization||0
8576261|NCT00146848|9609045|FG000|COMPLETED|Pre-randomization|Reached 6-week visit and were randomized|1433
8576262|NCT00146848|9609046|FG001|COMPLETED|Pre-randomization||0
8576263|NCT00146848|9609047|FG002|COMPLETED|Pre-randomization||0
8576264|NCT00146848|9609045|FG000|NOT COMPLETED|Pre-randomization||309
8576265|NCT00146848|9609046|FG001|NOT COMPLETED|Pre-randomization||0
8576266|NCT00146848|9609047|FG002|NOT COMPLETED|Pre-randomization||0
8576267|NCT00146848|9609045|FG000|STARTED|Post-randomization||475
8576268|NCT00146848|9609046|FG001|STARTED|Post-randomization||488
8576269|NCT00146848|9609047|FG002|STARTED|Post-randomization||470
8576270|NCT00146848|9609045|FG000|COMPLETED|Post-randomization||437
8576271|NCT00146848|9609046|FG001|COMPLETED|Post-randomization||441
8576272|NCT00146848|9609047|FG002|COMPLETED|Post-randomization||431
8576273|NCT00146848|9609045|FG000|NOT COMPLETED|Post-randomization||38
8576274|NCT00146848|9609046|FG001|NOT COMPLETED|Post-randomization||47
8576275|NCT00146848|9609047|FG002|NOT COMPLETED|Post-randomization||39
8576276|NCT00147017|9609058|FG000|STARTED|Overall Study||6
8576277|NCT00147017|9609059|FG001|STARTED|Overall Study||7
8576278|NCT00147017|9609060|FG002|STARTED|Overall Study||4
8576279|NCT00147017|9609058|FG000|COMPLETED|Overall Study||6
8576280|NCT00147017|9609059|FG001|COMPLETED|Overall Study||7
8576281|NCT00147017|9609060|FG002|COMPLETED|Overall Study||4
8576282|NCT00147017|9609058|FG000|NOT COMPLETED|Overall Study||0
8576283|NCT00147017|9609059|FG001|NOT COMPLETED|Overall Study||0
8576284|NCT00147017|9609060|FG002|NOT COMPLETED|Overall Study||0
8576285|NCT00147030|9609070|FG000|STARTED|Overall Study||163
8576286|NCT00147030|9609071|FG001|STARTED|Overall Study||162
8576287|NCT00147030|9609070|FG000|COMPLETED|Overall Study||163
8576288|NCT00147030|9609071|FG001|COMPLETED|Overall Study||162
8576289|NCT00147030|9609070|FG000|NOT COMPLETED|Overall Study||0
8576290|NCT00147030|9609071|FG001|NOT COMPLETED|Overall Study||0
8576291|NCT00147043|9609079|FG000|STARTED|Overall Study||5
8576292|NCT00147043|9609079|FG000|COMPLETED|Overall Study||5
8576293|NCT00147043|9609079|FG000|NOT COMPLETED|Overall Study||0
8576294|NCT00147069|9609088|FG000|STARTED|Overall Study||15
8576295|NCT00147069|9609089|FG001|STARTED|Overall Study||15
8576296|NCT00147069|9609090|FG002|STARTED|Overall Study||15
8576297|NCT00147069|9609091|FG003|STARTED|Overall Study||15
8576298|NCT00147069|9609088|FG000|COMPLETED|Overall Study||15
8576299|NCT00147069|9609089|FG001|COMPLETED|Overall Study||15
8576300|NCT00147069|9609090|FG002|COMPLETED|Overall Study||15
8576301|NCT00147069|9609091|FG003|COMPLETED|Overall Study||15
8576302|NCT00147069|9609088|FG000|NOT COMPLETED|Overall Study||0
8576303|NCT00147069|9609089|FG001|NOT COMPLETED|Overall Study||0
8576304|NCT00147069|9609090|FG002|NOT COMPLETED|Overall Study||0
8576305|NCT00147069|9609091|FG003|NOT COMPLETED|Overall Study||0
8576306|NCT00147082|9609104|FG000|STARTED|Overall Study||37
8576307|NCT00147082|9609105|FG001|STARTED|Overall Study||33
8576308|NCT00147082|9609106|FG002|STARTED|Overall Study||30
8576309|NCT00147082|9609104|FG000|COMPLETED|Overall Study||37
8576310|NCT00147082|9609105|FG001|COMPLETED|Overall Study||33
8672727|NCT00758394|9716056|FG003|NOT COMPLETED|Washout After 3rd Intervention||0
8672728|NCT00758394|9716053|FG000|STARTED|4th Intervention||7
8672729|NCT00758394|9716054|FG001|STARTED|4th Intervention||6
8672730|NCT00758394|9716055|FG002|STARTED|4th Intervention||6
8672731|NCT00758394|9716056|FG003|STARTED|4th Intervention||7
8672732|NCT00758394|9716053|FG000|COMPLETED|4th Intervention||7
8672733|NCT00758394|9716054|FG001|COMPLETED|4th Intervention||6
8672734|NCT00758394|9716055|FG002|COMPLETED|4th Intervention||6
8672735|NCT00758394|9716056|FG003|COMPLETED|4th Intervention||7
8672736|NCT00758394|9716053|FG000|NOT COMPLETED|4th Intervention||0
8672737|NCT00758394|9716054|FG001|NOT COMPLETED|4th Intervention||0
8672738|NCT00758394|9716055|FG002|NOT COMPLETED|4th Intervention||0
8672739|NCT00758394|9716056|FG003|NOT COMPLETED|4th Intervention||0
8672740|NCT00758420|9716068|FG000|STARTED|Overall Study||39
8672741|NCT00758420|9716069|FG001|STARTED|Overall Study||38
8672742|NCT00758420|9716068|FG000|COMPLETED|Overall Study||39
8672743|NCT00758420|9716069|FG001|COMPLETED|Overall Study||38
8672744|NCT00758420|9716068|FG000|NOT COMPLETED|Overall Study||0
8672745|NCT00758420|9716069|FG001|NOT COMPLETED|Overall Study||0
8672746|NCT00758459|9716077|FG000|STARTED|Overall Study||35
8672747|NCT00758459|9716078|FG001|STARTED|Overall Study||39
8672748|NCT00758459|9716077|FG000|COMPLETED|Overall Study||32
8672749|NCT00758459|9716078|FG001|COMPLETED|Overall Study||35
8672750|NCT00758459|9716077|FG000|NOT COMPLETED|Overall Study||3
8672751|NCT00758459|9716078|FG001|NOT COMPLETED|Overall Study||4
8672752|NCT00758485|9716086|FG000|STARTED|Overall Study||70
8672753|NCT00758485|9716087|FG001|STARTED|Overall Study||70
8672754|NCT00758485|9716086|FG000|TREATED|Overall Study||69
8672755|NCT00758485|9716087|FG001|TREATED|Overall Study||68
8672756|NCT00758485|9716086|FG000|COMPLETED|Overall Study||69
8672757|NCT00758485|9716087|FG001|COMPLETED|Overall Study||67
8672758|NCT00758485|9716086|FG000|NOT COMPLETED|Overall Study||1
8672759|NCT00758485|9716087|FG001|NOT COMPLETED|Overall Study||3
8672760|NCT00758498|9716097|FG000|STARTED|Overall Study||142
8672761|NCT00758498|9716098|FG001|STARTED|Overall Study||143
8672762|NCT00758498|9716099|FG002|STARTED|Overall Study||142
8672763|NCT00758498|9716097|FG000|COMPLETED|Overall Study||139
8672764|NCT00758498|9716098|FG001|COMPLETED|Overall Study||141
8672765|NCT00758498|9716099|FG002|COMPLETED|Overall Study||137
8672766|NCT00758498|9716097|FG000|NOT COMPLETED|Overall Study||3
8672767|NCT00758498|9716098|FG001|NOT COMPLETED|Overall Study||2
8672768|NCT00758498|9716099|FG002|NOT COMPLETED|Overall Study||5
8672769|NCT00758524|9716113|FG000|STARTED|Core Period (Week 0 to Week 8)||92
8672770|NCT00758524|9716114|FG001|STARTED|Core Period (Week 0 to Week 8)||88
8672771|NCT00758524|9716115|FG002|STARTED|Core Period (Week 0 to Week 8)||86
8672772|NCT00758524|9716116|FG003|STARTED|Core Period (Week 0 to Week 8)|One participant in this arm group was randomized twice and was excluded from Full Analysis Set.|97
8672773|NCT00758524|9716117|FG004|STARTED|Core Period (Week 0 to Week 8)||84
8672774|NCT00758524|9716118|FG005|STARTED|Core Period (Week 0 to Week 8)||77
8672775|NCT00758524|9716119|FG006|STARTED|Core Period (Week 0 to Week 8)||0
8672776|NCT00758524|9716120|FG007|STARTED|Core Period (Week 0 to Week 8)||0
8672777|NCT00758524|9716121|FG008|STARTED|Core Period (Week 0 to Week 8)||0
8672778|NCT00758524|9716122|FG009|STARTED|Core Period (Week 0 to Week 8)||0
8672779|NCT00758524|9716123|FG010|STARTED|Core Period (Week 0 to Week 8)||0
8672780|NCT00758524|9716124|FG011|STARTED|Core Period (Week 0 to Week 8)||0
8672781|NCT00758524|9716125|FG012|STARTED|Core Period (Week 0 to Week 8)||0
8672782|NCT00758524|9716126|FG013|STARTED|Core Period (Week 0 to Week 8)||0
8672783|NCT00758524|9716127|FG014|STARTED|Core Period (Week 0 to Week 8)||0
8672784|NCT00758524|9716128|FG015|STARTED|Core Period (Week 0 to Week 8)||0
8672785|NCT00758524|9716129|FG016|STARTED|Core Period (Week 0 to Week 8)||0
8672786|NCT00758524|9716113|FG000|Treated|Core Period (Week 0 to Week 8)||92
8672787|NCT00758524|9716114|FG001|Treated|Core Period (Week 0 to Week 8)||87
8672788|NCT00758524|9716115|FG002|Treated|Core Period (Week 0 to Week 8)|One participant from LCI699 0.5 mg QD was randomized to LCI699 1.0 mg QD and received LCI699 1.0 mg QD, thus was included in this arm in the Safety Set.|87
8672789|NCT00758524|9716116|FG003|Treated|Core Period (Week 0 to Week 8)||97
8672790|NCT00758524|9716117|FG004|Treated|Core Period (Week 0 to Week 8)||84
8672791|NCT00758524|9716118|FG005|Treated|Core Period (Week 0 to Week 8)||76
8672792|NCT00758524|9716119|FG006|Treated|Core Period (Week 0 to Week 8)||0
8672793|NCT00758524|9716120|FG007|Treated|Core Period (Week 0 to Week 8)||0
8672794|NCT00758524|9716121|FG008|Treated|Core Period (Week 0 to Week 8)||0
8672795|NCT00758524|9716122|FG009|Treated|Core Period (Week 0 to Week 8)||0
8672796|NCT00758524|9716123|FG010|Treated|Core Period (Week 0 to Week 8)||0
8672797|NCT00758524|9716124|FG011|Treated|Core Period (Week 0 to Week 8)||0
8672798|NCT00758524|9716125|FG012|Treated|Core Period (Week 0 to Week 8)||0
8672799|NCT00758524|9716126|FG013|Treated|Core Period (Week 0 to Week 8)||0
8672800|NCT00758524|9716127|FG014|Treated|Core Period (Week 0 to Week 8)||0
8576311|NCT00147082|9609106|FG002|COMPLETED|Overall Study||30
8576312|NCT00147082|9609104|FG000|NOT COMPLETED|Overall Study||0
8576313|NCT00147082|9609105|FG001|NOT COMPLETED|Overall Study||0
8576314|NCT00147082|9609106|FG002|NOT COMPLETED|Overall Study||0
8576315|NCT00147199|9609116|FG000|STARTED|Overall Study||115
8576316|NCT00147199|9609117|FG001|STARTED|Overall Study||120
8576317|NCT00147199|9609116|FG000|COMPLETED|Overall Study||102
8576318|NCT00147199|9609117|FG001|COMPLETED|Overall Study||110
8576319|NCT00147199|9609116|FG000|NOT COMPLETED|Overall Study||13
8576320|NCT00147199|9609117|FG001|NOT COMPLETED|Overall Study||10
8576321|NCT00147212|9609123|FG000|STARTED|Overall Study||50
8576322|NCT00147212|9609123|FG000|COMPLETED|Overall Study||50
8576323|NCT00147212|9609123|FG000|NOT COMPLETED|Overall Study||0
8576324|NCT00147225|9609133|FG000|STARTED|Overall Study||7
8576325|NCT00147225|9609134|FG001|STARTED|Overall Study||6
8576326|NCT00147225|9609135|FG002|STARTED|Overall Study||8
8576327|NCT00147225|9609136|FG003|STARTED|Overall Study||11
8576328|NCT00147225|9609137|FG004|STARTED|Overall Study||11
8576329|NCT00147225|9609138|FG005|STARTED|Overall Study||12
8576330|NCT00147225|9609133|FG000|COMPLETED|Overall Study||6
8576331|NCT00147225|9609134|FG001|COMPLETED|Overall Study||6
8576332|NCT00147225|9609135|FG002|COMPLETED|Overall Study||6
8576333|NCT00147225|9609136|FG003|COMPLETED|Overall Study||10
8576334|NCT00147225|9609137|FG004|COMPLETED|Overall Study||10
8576335|NCT00147225|9609138|FG005|COMPLETED|Overall Study||10
8672801|NCT00758524|9716128|FG015|Treated|Core Period (Week 0 to Week 8)||0
8672802|NCT00758524|9716129|FG016|Treated|Core Period (Week 0 to Week 8)||0
8672803|NCT00758524|9716113|FG000|COMPLETED|Core Period (Week 0 to Week 8)||84
8672804|NCT00758524|9716114|FG001|COMPLETED|Core Period (Week 0 to Week 8)||81
8672805|NCT00758524|9716115|FG002|COMPLETED|Core Period (Week 0 to Week 8)||77
8672806|NCT00758524|9716116|FG003|COMPLETED|Core Period (Week 0 to Week 8)||90
8672807|NCT00758524|9716117|FG004|COMPLETED|Core Period (Week 0 to Week 8)||75
8672808|NCT00758524|9716118|FG005|COMPLETED|Core Period (Week 0 to Week 8)||67
8672809|NCT00758524|9716119|FG006|COMPLETED|Core Period (Week 0 to Week 8)||0
8672810|NCT00758524|9716120|FG007|COMPLETED|Core Period (Week 0 to Week 8)||0
8672811|NCT00758524|9716121|FG008|COMPLETED|Core Period (Week 0 to Week 8)||0
8672812|NCT00758524|9716122|FG009|COMPLETED|Core Period (Week 0 to Week 8)||0
8672813|NCT00758524|9716123|FG010|COMPLETED|Core Period (Week 0 to Week 8)||0
8672814|NCT00758524|9716124|FG011|COMPLETED|Core Period (Week 0 to Week 8)||0
8672815|NCT00758524|9716125|FG012|COMPLETED|Core Period (Week 0 to Week 8)||0
8672816|NCT00758524|9716126|FG013|COMPLETED|Core Period (Week 0 to Week 8)||0
8672817|NCT00758524|9716127|FG014|COMPLETED|Core Period (Week 0 to Week 8)||0
8672818|NCT00758524|9716128|FG015|COMPLETED|Core Period (Week 0 to Week 8)||0
8672819|NCT00758524|9716129|FG016|COMPLETED|Core Period (Week 0 to Week 8)||0
8672820|NCT00758524|9716113|FG000|NOT COMPLETED|Core Period (Week 0 to Week 8)||8
8672821|NCT00758524|9716114|FG001|NOT COMPLETED|Core Period (Week 0 to Week 8)||7
8672822|NCT00758524|9716115|FG002|NOT COMPLETED|Core Period (Week 0 to Week 8)||9
8672823|NCT00758524|9716116|FG003|NOT COMPLETED|Core Period (Week 0 to Week 8)||7
8672824|NCT00758524|9716117|FG004|NOT COMPLETED|Core Period (Week 0 to Week 8)||9
8672825|NCT00758524|9716118|FG005|NOT COMPLETED|Core Period (Week 0 to Week 8)||10
8672826|NCT00758524|9716119|FG006|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
8672827|NCT00758524|9716120|FG007|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
8672828|NCT00758524|9716121|FG008|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
8672829|NCT00758524|9716122|FG009|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
8672830|NCT00758524|9716123|FG010|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
8672831|NCT00758524|9716124|FG011|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
8672832|NCT00758524|9716125|FG012|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
8672833|NCT00758524|9716126|FG013|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
8672834|NCT00758524|9716127|FG014|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
8672835|NCT00758524|9716128|FG015|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
8672836|NCT00758524|9716129|FG016|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
8672837|NCT00758524|9716113|FG000|STARTED|Withdrawal Period (Week 8 to Week 9)||0
8672838|NCT00758524|9716114|FG001|STARTED|Withdrawal Period (Week 8 to Week 9)||0
8672839|NCT00758524|9716115|FG002|STARTED|Withdrawal Period (Week 8 to Week 9)||0
8672840|NCT00758524|9716116|FG003|STARTED|Withdrawal Period (Week 8 to Week 9)||0
8672841|NCT00758524|9716117|FG004|STARTED|Withdrawal Period (Week 8 to Week 9)||0
8672842|NCT00758524|9716118|FG005|STARTED|Withdrawal Period (Week 8 to Week 9)||0
8672843|NCT00758524|9716119|FG006|STARTED|Withdrawal Period (Week 8 to Week 9)||46
8672844|NCT00758524|9716120|FG007|STARTED|Withdrawal Period (Week 8 to Week 9)||38
8672845|NCT00758524|9716121|FG008|STARTED|Withdrawal Period (Week 8 to Week 9)||44
8672846|NCT00758524|9716122|FG009|STARTED|Withdrawal Period (Week 8 to Week 9)|One participant randomized to Placebo arm in Withdrawal Period received LCI699 0.5 mg QD and was counted in LCI699 0.5 mg QD arm in the Randomized Withdrawal Safety Set.|37
8672847|NCT00758524|9716123|FG010|STARTED|Withdrawal Period (Week 8 to Week 9)||41
8672848|NCT00758524|9716124|FG011|STARTED|Withdrawal Period (Week 8 to Week 9)|One participant randomized to LCI699 0.5 mg BID in the core period received LCI699 1.0 mg QD and was considered in the LCI699 1.0 mg QD arm in Randomized Withdrawal Safety Set.|37
8672849|NCT00758524|9716125|FG012|STARTED|Withdrawal Period (Week 8 to Week 9)||45
8576336|NCT00147225|9609133|FG000|NOT COMPLETED|Overall Study||1
8576337|NCT00147225|9609134|FG001|NOT COMPLETED|Overall Study||0
8576338|NCT00147225|9609135|FG002|NOT COMPLETED|Overall Study||2
8576339|NCT00147225|9609136|FG003|NOT COMPLETED|Overall Study||1
8576340|NCT00147225|9609137|FG004|NOT COMPLETED|Overall Study||1
8576341|NCT00147225|9609138|FG005|NOT COMPLETED|Overall Study||2
8576342|NCT00147251|9609154|FG000|STARTED|Recruitment and Enrollment||271
8576343|NCT00147251|9609155|FG001|STARTED|Recruitment and Enrollment||277
8576344|NCT00147251|9609154|FG000|COMPLETED|Recruitment and Enrollment||247
8576345|NCT00147251|9609155|FG001|COMPLETED|Recruitment and Enrollment||252
8576346|NCT00147251|9609154|FG000|NOT COMPLETED|Recruitment and Enrollment||24
8576347|NCT00147251|9609155|FG001|NOT COMPLETED|Recruitment and Enrollment||25
8576348|NCT00147251|9609154|FG000|STARTED|Follow up||247
8576349|NCT00147251|9609155|FG001|STARTED|Follow up||252
8576350|NCT00147251|9609154|FG000|COMPLETED|Follow up||247
8576351|NCT00147251|9609155|FG001|COMPLETED|Follow up||252
8576352|NCT00147251|9609154|FG000|NOT COMPLETED|Follow up||0
8576353|NCT00147251|9609155|FG001|NOT COMPLETED|Follow up||0
8576354|NCT00147316|9609163|FG000|STARTED|Overall Study||103
8576355|NCT00147316|9609163|FG000|COMPLETED|Overall Study||103
8576356|NCT00147316|9609163|FG000|NOT COMPLETED|Overall Study||0
8576357|NCT00147446|9609169|FG000|STARTED|Overall Study||60
8576358|NCT00147446|9609170|FG001|STARTED|Overall Study||61
8576359|NCT00147446|9609169|FG000|COMPLETED|Overall Study||60
8576360|NCT00147446|9609170|FG001|COMPLETED|Overall Study||61
8576361|NCT00147446|9609169|FG000|NOT COMPLETED|Overall Study||0
8576362|NCT00147446|9609170|FG001|NOT COMPLETED|Overall Study||0
8576363|NCT00147498|9609182|FG000|STARTED|Overall Study||61
8576364|NCT00147498|9609183|FG001|STARTED|Overall Study||69
8576365|NCT00147498|9609184|FG002|STARTED|Overall Study||69
8576366|NCT00147498|9609185|FG003|STARTED|Overall Study||65
8576367|NCT00147498|9609182|FG000|COMPLETED|Overall Study||58
8576368|NCT00147498|9609183|FG001|COMPLETED|Overall Study||60
8576369|NCT00147498|9609184|FG002|COMPLETED|Overall Study||52
8576370|NCT00147498|9609185|FG003|COMPLETED|Overall Study||48
8576371|NCT00147498|9609182|FG000|NOT COMPLETED|Overall Study||3
8576372|NCT00147498|9609183|FG001|NOT COMPLETED|Overall Study||9
8576373|NCT00147498|9609184|FG002|NOT COMPLETED|Overall Study||17
8576374|NCT00147498|9609185|FG003|NOT COMPLETED|Overall Study||17
8577672|NCT00160251|9610438|FG006|NOT COMPLETED|Prior to Amendment 2||4
8577673|NCT00160251|9610439|FG007|NOT COMPLETED|Prior to Amendment 2||0
8577674|NCT00160251|9610432|FG000|STARTED|Post-amendment 2||0
8577675|NCT00160251|9610433|FG001|STARTED|Post-amendment 2||0
8577676|NCT00160251|9610434|FG002|STARTED|Post-amendment 2||0
8577677|NCT00160251|9610435|FG003|STARTED|Post-amendment 2||0
8577678|NCT00160251|9610436|FG004|STARTED|Post-amendment 2||0
8577679|NCT00160251|9610437|FG005|STARTED|Post-amendment 2||0
8577680|NCT00160251|9610438|FG006|STARTED|Post-amendment 2||0
8577681|NCT00160251|9610439|FG007|STARTED|Post-amendment 2||143
8577682|NCT00160251|9610432|FG000|COMPLETED|Post-amendment 2||0
8577683|NCT00160251|9610433|FG001|COMPLETED|Post-amendment 2||0
8577684|NCT00160251|9610434|FG002|COMPLETED|Post-amendment 2||0
8577685|NCT00160251|9610435|FG003|COMPLETED|Post-amendment 2||0
8577686|NCT00160251|9610436|FG004|COMPLETED|Post-amendment 2||0
8577687|NCT00160251|9610437|FG005|COMPLETED|Post-amendment 2||0
8577688|NCT00160251|9610438|FG006|COMPLETED|Post-amendment 2||0
8577689|NCT00160251|9610439|FG007|COMPLETED|Post-amendment 2||88
8577690|NCT00160251|9610432|FG000|NOT COMPLETED|Post-amendment 2||0
8577691|NCT00160251|9610433|FG001|NOT COMPLETED|Post-amendment 2||0
8577692|NCT00160251|9610434|FG002|NOT COMPLETED|Post-amendment 2||0
8577693|NCT00160251|9610435|FG003|NOT COMPLETED|Post-amendment 2||0
8577694|NCT00160251|9610436|FG004|NOT COMPLETED|Post-amendment 2||0
8577695|NCT00160251|9610437|FG005|NOT COMPLETED|Post-amendment 2||0
8577696|NCT00160251|9610438|FG006|NOT COMPLETED|Post-amendment 2||0
8577697|NCT00160251|9610439|FG007|NOT COMPLETED|Post-amendment 2||55
8577698|NCT00160524|9610496|FG000|STARTED|Overall Study|One subject was enrolled erroneously and has no data in the database.|595
8577699|NCT00160524|9610496|FG000|COMPLETED|Overall Study||117
8577700|NCT00160524|9610496|FG000|NOT COMPLETED|Overall Study||478
8577701|NCT00160615|9610502|FG000|STARTED|Overall Study||50
8577702|NCT00160615|9610503|FG001|STARTED|Overall Study||101
8577703|NCT00160615|9610502|FG000|COMPLETED|Overall Study||32
8577704|NCT00160615|9610503|FG001|COMPLETED|Overall Study||56
8577705|NCT00160615|9610502|FG000|NOT COMPLETED|Overall Study||18
8577706|NCT00160615|9610503|FG001|NOT COMPLETED|Overall Study||45
8577707|NCT00160641|9610511|FG000|STARTED|Overall Study||567
8577708|NCT00160641|9610511|FG000|COMPLETED|Overall Study||346
8577709|NCT00160641|9610511|FG000|NOT COMPLETED|Overall Study||221
8577710|NCT00160654|9610515|FG000|STARTED|Overall Study||251
8577711|NCT00160654|9610515|FG000|COMPLETED|Overall Study||218
8577712|NCT00160654|9610515|FG000|NOT COMPLETED|Overall Study||33
8577713|NCT00160667|9610522|FG000|STARTED|Overall Study||50
8577714|NCT00160667|9610523|FG001|STARTED|Overall Study||51
8577715|NCT00160667|9610524|FG002|STARTED|Overall Study||51
8577716|NCT00160667|9610522|FG000|COMPLETED|Overall Study||45
8577717|NCT00160667|9610523|FG001|COMPLETED|Overall Study||48
8577718|NCT00160667|9610524|FG002|COMPLETED|Overall Study||45
8577719|NCT00160667|9610522|FG000|NOT COMPLETED|Overall Study||5
8577720|NCT00160667|9610523|FG001|NOT COMPLETED|Overall Study||3
8577721|NCT00160667|9610524|FG002|NOT COMPLETED|Overall Study||6
8577722|NCT00160680|9610535|FG000|STARTED|Overall Study||31
8577723|NCT00160680|9610536|FG001|STARTED|Overall Study||31
8577724|NCT00160680|9610535|FG000|COMPLETED|Overall Study||22
8577725|NCT00160680|9610536|FG001|COMPLETED|Overall Study||18
8577726|NCT00160680|9610535|FG000|NOT COMPLETED|Overall Study||9
8577727|NCT00160680|9610536|FG001|NOT COMPLETED|Overall Study||13
8577728|NCT00160693|9610542|FG000|STARTED|Overall Study||402
8577729|NCT00160693|9610542|FG000|COMPLETED|Overall Study||167
8576375|NCT00147537|9609199|FG000|STARTED|Phase 1b||3
8576376|NCT00147537|9609200|FG001|STARTED|Phase 1b||2
8576377|NCT00147537|9609201|FG002|STARTED|Phase 1b||4
8576378|NCT00147537|9609202|FG003|STARTED|Phase 1b||3
8576379|NCT00147537|9609203|FG004|STARTED|Phase 1b||3
8576380|NCT00147537|9609204|FG005|STARTED|Phase 1b||3
8576381|NCT00147537|9609205|FG006|STARTED|Phase 1b|18 participants randomized; 17 participants treated|18
8576382|NCT00147537|9609206|FG007|STARTED|Phase 1b||7
8576383|NCT00147537|9609207|FG008|STARTED|Phase 1b|18 participants randomized; 17 participants treated|18
8576384|NCT00147537|9609208|FG009|STARTED|Phase 1b||0
8576385|NCT00147537|9609209|FG010|STARTED|Phase 1b||0
8576386|NCT00147537|9609199|FG000|COMPLETED|Phase 1b||1
8576387|NCT00147537|9609200|FG001|COMPLETED|Phase 1b||0
8576388|NCT00147537|9609201|FG002|COMPLETED|Phase 1b||0
8576389|NCT00147537|9609202|FG003|COMPLETED|Phase 1b||1
8576390|NCT00147537|9609203|FG004|COMPLETED|Phase 1b||0
8576391|NCT00147537|9609204|FG005|COMPLETED|Phase 1b||0
8576392|NCT00147537|9609205|FG006|COMPLETED|Phase 1b||0
8576393|NCT00147537|9609206|FG007|COMPLETED|Phase 1b||0
8576394|NCT00147537|9609207|FG008|COMPLETED|Phase 1b||1
8576395|NCT00147537|9609208|FG009|COMPLETED|Phase 1b||0
8576396|NCT00147537|9609209|FG010|COMPLETED|Phase 1b||0
8576397|NCT00147537|9609199|FG000|NOT COMPLETED|Phase 1b||2
8576398|NCT00147537|9609200|FG001|NOT COMPLETED|Phase 1b||2
8576399|NCT00147537|9609201|FG002|NOT COMPLETED|Phase 1b||4
8576400|NCT00147537|9609202|FG003|NOT COMPLETED|Phase 1b||2
8576401|NCT00147537|9609203|FG004|NOT COMPLETED|Phase 1b||3
8576402|NCT00147537|9609204|FG005|NOT COMPLETED|Phase 1b||3
8576403|NCT00147537|9609205|FG006|NOT COMPLETED|Phase 1b||18
8576404|NCT00147537|9609206|FG007|NOT COMPLETED|Phase 1b||7
8576405|NCT00147537|9609207|FG008|NOT COMPLETED|Phase 1b||17
8576406|NCT00147537|9609208|FG009|NOT COMPLETED|Phase 1b||0
8576407|NCT00147537|9609209|FG010|NOT COMPLETED|Phase 1b||0
8576408|NCT00147537|9609199|FG000|STARTED|Phase 2||0
8576409|NCT00147537|9609200|FG001|STARTED|Phase 2||0
8576410|NCT00147537|9609201|FG002|STARTED|Phase 2||0
8576411|NCT00147537|9609202|FG003|STARTED|Phase 2||0
8576412|NCT00147537|9609203|FG004|STARTED|Phase 2||0
8576413|NCT00147537|9609204|FG005|STARTED|Phase 2||0
8576414|NCT00147537|9609205|FG006|STARTED|Phase 2||0
8576415|NCT00147537|9609206|FG007|STARTED|Phase 2||0
8576416|NCT00147537|9609207|FG008|STARTED|Phase 2||0
8576417|NCT00147537|9609208|FG009|STARTED|Phase 2|166 particpants randomized; 163 participants treated|166
8576418|NCT00147537|9609209|FG010|STARTED|Phase 2|55 randomized; 56 treated-1 randomized but not treated, 2 randomized to F+P+C rec'd P+C|55
8576419|NCT00147537|9609199|FG000|COMPLETED|Phase 2||0
8576420|NCT00147537|9609200|FG001|COMPLETED|Phase 2||0
8576421|NCT00147537|9609201|FG002|COMPLETED|Phase 2||0
8576422|NCT00147537|9609202|FG003|COMPLETED|Phase 2||0
8576423|NCT00147537|9609203|FG004|COMPLETED|Phase 2||0
8672850|NCT00758524|9716126|FG013|STARTED|Withdrawal Period (Week 8 to Week 9)||45
8672851|NCT00758524|9716127|FG014|STARTED|Withdrawal Period (Week 8 to Week 9)||39
8672852|NCT00758524|9716128|FG015|STARTED|Withdrawal Period (Week 8 to Week 9)||36
8672853|NCT00758524|9716129|FG016|STARTED|Withdrawal Period (Week 8 to Week 9)||66
8672854|NCT00758524|9716113|FG000|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||0
8672855|NCT00758524|9716114|FG001|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||0
8672856|NCT00758524|9716115|FG002|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||0
8672857|NCT00758524|9716116|FG003|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||0
8672858|NCT00758524|9716117|FG004|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||0
8799495|NCT01437878|9851030|FG001|NOT COMPLETED|Overall Study||0
8576424|NCT00147537|9609204|FG005|COMPLETED|Phase 2||0
8576425|NCT00147537|9609205|FG006|COMPLETED|Phase 2||0
8576426|NCT00147537|9609206|FG007|COMPLETED|Phase 2||0
8576427|NCT00147537|9609207|FG008|COMPLETED|Phase 2||0
8576428|NCT00147537|9609208|FG009|COMPLETED|Phase 2||5
8576429|NCT00147537|9609209|FG010|COMPLETED|Phase 2||3
8576430|NCT00147537|9609199|FG000|NOT COMPLETED|Phase 2||0
8576431|NCT00147537|9609200|FG001|NOT COMPLETED|Phase 2||0
8576432|NCT00147537|9609201|FG002|NOT COMPLETED|Phase 2||0
8576433|NCT00147537|9609202|FG003|NOT COMPLETED|Phase 2||0
8576434|NCT00147537|9609203|FG004|NOT COMPLETED|Phase 2||0
8576435|NCT00147537|9609204|FG005|NOT COMPLETED|Phase 2||0
8576436|NCT00147537|9609205|FG006|NOT COMPLETED|Phase 2||0
8799496|NCT01437943|9851038|FG000|STARTED|Overall Study||7
8799497|NCT01437943|9851039|FG001|STARTED|Overall Study||3
8799498|NCT01437943|9851038|FG000|COMPLETED|Overall Study||0
8799499|NCT01437943|9851039|FG001|COMPLETED|Overall Study||1
8799500|NCT01437943|9851038|FG000|NOT COMPLETED|Overall Study||7
8799501|NCT01437943|9851039|FG001|NOT COMPLETED|Overall Study||2
8799502|NCT01437995|9851048|FG000|STARTED|Overall Study||151
8799503|NCT01437995|9851049|FG001|STARTED|Overall Study||149
8799504|NCT01437995|9851050|FG002|STARTED|Overall Study||155
8799505|NCT01437995|9851048|FG000|Included in Treatment Failure Analysis|Overall Study||150
8799506|NCT01437995|9851049|FG001|Included in Treatment Failure Analysis|Overall Study||146
8799507|NCT01437995|9851050|FG002|Included in Treatment Failure Analysis|Overall Study||151
8799508|NCT01437995|9851048|FG000|COMPLETED|Overall Study||140
8799509|NCT01437995|9851049|FG001|COMPLETED|Overall Study||131
8576437|NCT00147537|9609206|FG007|NOT COMPLETED|Phase 2||0
8576438|NCT00147537|9609207|FG008|NOT COMPLETED|Phase 2||0
8576439|NCT00147537|9609208|FG009|NOT COMPLETED|Phase 2||161
8576440|NCT00147537|9609209|FG010|NOT COMPLETED|Phase 2||52
8576441|NCT00147745|9609257|FG000|STARTED|Overall Study||16
8576442|NCT00147745|9609258|FG001|STARTED|Overall Study||14
8576443|NCT00147745|9609259|FG002|STARTED|Overall Study||6
8576444|NCT00147745|9609257|FG000|COMPLETED|Overall Study||15
8576445|NCT00147745|9609258|FG001|COMPLETED|Overall Study||14
8576446|NCT00147745|9609259|FG002|COMPLETED|Overall Study||6
8576447|NCT00147745|9609257|FG000|NOT COMPLETED|Overall Study||1
8576448|NCT00147745|9609258|FG001|NOT COMPLETED|Overall Study||0
8576449|NCT00147745|9609259|FG002|NOT COMPLETED|Overall Study||0
8576450|NCT00147823|9609269|FG000|STARTED|Overall Study||32
8576451|NCT00147823|9609270|FG001|STARTED|Overall Study||31
8576452|NCT00147823|9609269|FG000|Week 6 Visit|Overall Study||26
8576453|NCT00147823|9609270|FG001|Week 6 Visit|Overall Study||28
8576454|NCT00147823|9609269|FG000|Month 3 Visit|Overall Study||25
8576455|NCT00147823|9609270|FG001|Month 3 Visit|Overall Study||24
8576456|NCT00147823|9609269|FG000|Month 6 Visit|Overall Study||25
8576457|NCT00147823|9609270|FG001|Month 6 Visit|Overall Study||21
8576458|NCT00147823|9609269|FG000|Month 12 Visit|Overall Study||21
8576459|NCT00147823|9609270|FG001|Month 12 Visit|Overall Study|Subjects are counted at each milestone as that is when data is collectec|25
8576460|NCT00147823|9609269|FG000|Month 12 CT Scan|Overall Study||20
8576461|NCT00147823|9609270|FG001|Month 12 CT Scan|Overall Study||25
8576462|NCT00147823|9609269|FG000|Month 18 Visit|Overall Study|As stated previously ea. subject is counted at each milestone, as data is collected at ea. timepoint|21
8576463|NCT00147823|9609270|FG001|Month 18 Visit|Overall Study||20
8576464|NCT00147823|9609269|FG000|Month 24 Visit|Overall Study||21
8576465|NCT00147823|9609270|FG001|Month 24 Visit|Overall Study||18
8576466|NCT00147823|9609269|FG000|COMPLETED|Overall Study||19
8576467|NCT00147823|9609270|FG001|COMPLETED|Overall Study||16
8576468|NCT00147823|9609269|FG000|NOT COMPLETED|Overall Study||13
8576469|NCT00147823|9609270|FG001|NOT COMPLETED|Overall Study||15
8576470|NCT00147966|9609276|FG000|STARTED|Overall Study||24
8576471|NCT00147966|9609276|FG000|COMPLETED|Overall Study||24
8576472|NCT00147966|9609276|FG000|NOT COMPLETED|Overall Study||0
8576473|NCT00148109|9609282|FG000|STARTED|Overall Study||15
8576474|NCT00148109|9609283|FG001|STARTED|Overall Study||21
8576475|NCT00148109|9609282|FG000|COMPLETED|Overall Study||3
8576476|NCT00148109|9609283|FG001|COMPLETED|Overall Study||1
8576477|NCT00148109|9609282|FG000|NOT COMPLETED|Overall Study||12
8576478|NCT00148109|9609283|FG001|NOT COMPLETED|Overall Study||20
8576479|NCT00148122|9609289|FG000|STARTED|Overall Study||40
8576480|NCT00148122|9609289|FG000|COMPLETED|Overall Study||38
8576481|NCT00148122|9609289|FG000|NOT COMPLETED|Overall Study||2
8576482|NCT00148317|9609293|FG000|STARTED|Consolidation (VEL + DEX)||38
8576483|NCT00148317|9609293|FG000|DOXIL Added at Cycle 3|Consolidation (VEL + DEX)||16
8576484|NCT00148317|9609293|FG000|DOXIL Added at Cycle 5|Consolidation (VEL + DEX)||12
8576485|NCT00148317|9609293|FG000|no DOXIL Added|Consolidation (VEL + DEX)||10
8576486|NCT00148317|9609293|FG000|COMPLETED|Consolidation (VEL + DEX)||38
8576487|NCT00148317|9609293|FG000|NOT COMPLETED|Consolidation (VEL + DEX)||0
8576488|NCT00148317|9609293|FG000|STARTED|Mobilization (VEL+CYTOXAN+FILGRASTIM)||38
8576489|NCT00148317|9609293|FG000|COMPLETED|Mobilization (VEL+CYTOXAN+FILGRASTIM)||27
8576490|NCT00148317|9609293|FG000|NOT COMPLETED|Mobilization (VEL+CYTOXAN+FILGRASTIM)||11
8576491|NCT00148343|9609302|FG000|STARTED|Overall Study||54
8576492|NCT00148343|9609303|FG001|STARTED|Overall Study||56
8576493|NCT00148343|9609302|FG000|COMPLETED|Overall Study||39
8576494|NCT00148343|9609303|FG001|COMPLETED|Overall Study||45
8576495|NCT00148343|9609302|FG000|NOT COMPLETED|Overall Study||15
8576496|NCT00148343|9609303|FG001|NOT COMPLETED|Overall Study||11
8576497|NCT00148668|9609311|FG000|STARTED|Overall Study||41
8576498|NCT00148668|9609312|FG001|STARTED|Overall Study||40
8576499|NCT00148668|9609311|FG000|COMPLETED|Overall Study||41
8576500|NCT00148668|9609312|FG001|COMPLETED|Overall Study||40
8576501|NCT00148668|9609311|FG000|NOT COMPLETED|Overall Study||0
8576502|NCT00148668|9609312|FG001|NOT COMPLETED|Overall Study||0
8576503|NCT00148759|9609320|FG000|STARTED|Overall Study||11
8576504|NCT00148759|9609321|FG001|STARTED|Overall Study||12
8576505|NCT00148759|9609320|FG000|24-hr PK Sampling|Overall Study||9
8576506|NCT00148759|9609321|FG001|24-hr PK Sampling|Overall Study||11
8576507|NCT00148759|9609320|FG000|COMPLETED|Overall Study||9
8576508|NCT00148759|9609321|FG001|COMPLETED|Overall Study||11
8576509|NCT00148759|9609320|FG000|NOT COMPLETED|Overall Study||2
8576510|NCT00148759|9609321|FG001|NOT COMPLETED|Overall Study||1
8576511|NCT00148798|9609329|FG000|STARTED|Overall Study|Intent To Treat (ITT) Population|557
8576512|NCT00148798|9609330|FG001|STARTED|Overall Study|ITT Population|568
8576513|NCT00148798|9609329|FG000|COMPLETED|Overall Study||557
8576514|NCT00148798|9609330|FG001|COMPLETED|Overall Study||568
8576515|NCT00148798|9609329|FG000|NOT COMPLETED|Overall Study||0
8576516|NCT00148798|9609330|FG001|NOT COMPLETED|Overall Study||0
8576517|NCT00148941|9609342|FG000|STARTED|Overall Study||1053
8576518|NCT00148941|9609343|FG001|STARTED|Overall Study||1051
8576519|NCT00148941|9609344|FG002|STARTED|Overall Study||1052
8576520|NCT00148941|9609345|FG003|STARTED|Overall Study||1053
8576521|NCT00148941|9609342|FG000|COMPLETED|Overall Study||1035
8576522|NCT00148941|9609343|FG001|COMPLETED|Overall Study||1027
8576523|NCT00148941|9609344|FG002|COMPLETED|Overall Study||1032
8576524|NCT00148941|9609345|FG003|COMPLETED|Overall Study||1029
8576525|NCT00148941|9609342|FG000|NOT COMPLETED|Overall Study||18
8576526|NCT00148941|9609343|FG001|NOT COMPLETED|Overall Study||24
8576527|NCT00148941|9609344|FG002|NOT COMPLETED|Overall Study||20
8576528|NCT00148941|9609345|FG003|NOT COMPLETED|Overall Study||24
8576529|NCT00148954|9609357|FG000|STARTED|Overall Study||985
8576530|NCT00148954|9609358|FG001|STARTED|Overall Study||977
8576531|NCT00148954|9609357|FG000|COMPLETED|Overall Study||678
8576532|NCT00148954|9609358|FG001|COMPLETED|Overall Study||677
8576533|NCT00148954|9609357|FG000|NOT COMPLETED|Overall Study||307
8576534|NCT00148954|9609358|FG001|NOT COMPLETED|Overall Study||300
8576535|NCT00149214|9609366|FG000|STARTED|Overall Study|One patient randomized to Pemetrexed (P) was treated with Cyclophosphamide (C).|135
8576536|NCT00149214|9609367|FG001|STARTED|Overall Study||122
8576537|NCT00149214|9609366|FG000|COMPLETED|Overall Study|The patient treated with Cyclophosphamide (C) was included in that arm (C) for safety analysis.|109
8576538|NCT00149214|9609367|FG001|COMPLETED|Overall Study||105
8576539|NCT00149214|9609366|FG000|NOT COMPLETED|Overall Study||26
8576540|NCT00149214|9609367|FG001|NOT COMPLETED|Overall Study||17
8576541|NCT00149227|9609375|FG000|STARTED|Overall Study||1517
8576542|NCT00149227|9609376|FG001|STARTED|Overall Study||1514
8576543|NCT00149227|9609375|FG000|COMPLETED|Overall Study||1517
8576544|NCT00149227|9609376|FG001|COMPLETED|Overall Study||1514
8576545|NCT00149227|9609375|FG000|NOT COMPLETED|Overall Study||0
8576546|NCT00149227|9609376|FG001|NOT COMPLETED|Overall Study||0
8576547|NCT00149396|9609382|FG000|STARTED|Overall Study||32
8576548|NCT00149396|9609382|FG000|Completed NV1020 Therapy|Overall Study||29
8576549|NCT00149396|9609382|FG000|Completed NV1020 and Chemotherapy|Overall Study||9
8576550|NCT00149396|9609382|FG000|COMPLETED|Overall Study||9
8576551|NCT00149396|9609382|FG000|NOT COMPLETED|Overall Study||23
8576552|NCT00149630|9609395|FG000|STARTED|Overall Study||34
8576553|NCT00149630|9609396|FG001|STARTED|Overall Study||40
8576554|NCT00149630|9609395|FG000|COMPLETED|Overall Study||26
8576555|NCT00149630|9609396|FG001|COMPLETED|Overall Study||35
8576556|NCT00149630|9609395|FG000|NOT COMPLETED|Overall Study||8
8576557|NCT00149630|9609396|FG001|NOT COMPLETED|Overall Study||5
8576558|NCT00149643|9609408|FG000|STARTED|Overall Study||34
8576559|NCT00149643|9609409|FG001|STARTED|Overall Study||36
8576560|NCT00149643|9609408|FG000|COMPLETED|Overall Study||0
8576561|NCT00149643|9609409|FG001|COMPLETED|Overall Study||0
8576562|NCT00149643|9609408|FG000|NOT COMPLETED|Overall Study||34
8576563|NCT00149643|9609409|FG001|NOT COMPLETED|Overall Study||36
8576564|NCT00149669|9609417|FG000|STARTED|Overall Study||32
8672859|NCT00758524|9716118|FG005|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||0
8672860|NCT00758524|9716119|FG006|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||45
8672861|NCT00758524|9716120|FG007|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||38
8672862|NCT00758524|9716121|FG008|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||43
8672863|NCT00758524|9716122|FG009|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||37
8672864|NCT00758524|9716123|FG010|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||41
8672865|NCT00758524|9716124|FG011|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||36
8672866|NCT00758524|9716125|FG012|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||45
8672867|NCT00758524|9716126|FG013|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||44
8672868|NCT00758524|9716127|FG014|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||39
8672869|NCT00758524|9716128|FG015|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||36
8672870|NCT00758524|9716129|FG016|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)|One participant randomized to Placebo arm in Withdrawal Period received LCI699 0.5 mg QD and was counted in LCI699 0.5 mg QD arm in the Randomized Withdrawal Safety Set. However, this participant was counted in the Placebo arm (N=67) in the Randomized Withdrawal Set.|67
8672871|NCT00758524|9716113|FG000|COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
8672872|NCT00758524|9716114|FG001|COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
8672873|NCT00758524|9716115|FG002|COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
8672874|NCT00758524|9716116|FG003|COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
8672875|NCT00758524|9716117|FG004|COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
8672876|NCT00758524|9716118|FG005|COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
8672877|NCT00758524|9716119|FG006|COMPLETED|Withdrawal Period (Week 8 to Week 9)||45
8672878|NCT00758524|9716120|FG007|COMPLETED|Withdrawal Period (Week 8 to Week 9)||38
8672879|NCT00758524|9716121|FG008|COMPLETED|Withdrawal Period (Week 8 to Week 9)||42
8672880|NCT00758524|9716122|FG009|COMPLETED|Withdrawal Period (Week 8 to Week 9)||37
8672881|NCT00758524|9716123|FG010|COMPLETED|Withdrawal Period (Week 8 to Week 9)||41
8672882|NCT00758524|9716124|FG011|COMPLETED|Withdrawal Period (Week 8 to Week 9)||37
8672883|NCT00758524|9716125|FG012|COMPLETED|Withdrawal Period (Week 8 to Week 9)||45
8672884|NCT00758524|9716126|FG013|COMPLETED|Withdrawal Period (Week 8 to Week 9)||45
8672885|NCT00758524|9716127|FG014|COMPLETED|Withdrawal Period (Week 8 to Week 9)||39
8672886|NCT00758524|9716128|FG015|COMPLETED|Withdrawal Period (Week 8 to Week 9)||36
8672887|NCT00758524|9716129|FG016|COMPLETED|Withdrawal Period (Week 8 to Week 9)||66
8672888|NCT00758524|9716113|FG000|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
8672889|NCT00758524|9716114|FG001|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
8672890|NCT00758524|9716115|FG002|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
8672891|NCT00758524|9716116|FG003|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
8672892|NCT00758524|9716117|FG004|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
8672893|NCT00758524|9716118|FG005|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
8672894|NCT00758524|9716119|FG006|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||1
8672895|NCT00758524|9716120|FG007|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
8576565|NCT00149669|9609418|FG001|STARTED|Overall Study||35
8576566|NCT00149669|9609417|FG000|COMPLETED|Overall Study||29
8576567|NCT00149669|9609418|FG001|COMPLETED|Overall Study||30
8576568|NCT00149669|9609417|FG000|NOT COMPLETED|Overall Study||3
8576569|NCT00149669|9609418|FG001|NOT COMPLETED|Overall Study||5
8576570|NCT00149734|9609426|FG000|STARTED|Overall Study||4
8576571|NCT00149734|9609427|FG001|STARTED|Overall Study||4
8576572|NCT00149734|9609426|FG000|Started Intervention 2|Overall Study||4
8576573|NCT00149734|9609427|FG001|Started Intervention 2|Overall Study||4
8576574|NCT00149734|9609426|FG000|COMPLETED|Overall Study||4
8576575|NCT00149734|9609427|FG001|COMPLETED|Overall Study||4
8576576|NCT00149734|9609426|FG000|NOT COMPLETED|Overall Study||0
8576577|NCT00149734|9609427|FG001|NOT COMPLETED|Overall Study||0
8576578|NCT00149747|9609435|FG000|STARTED|Overall Study||36
8576579|NCT00149747|9609436|FG001|STARTED|Overall Study||30
8576580|NCT00149747|9609435|FG000|COMPLETED|Overall Study||32
8576581|NCT00149747|9609436|FG001|COMPLETED|Overall Study||27
8576582|NCT00149747|9609435|FG000|NOT COMPLETED|Overall Study||4
8576583|NCT00149747|9609436|FG001|NOT COMPLETED|Overall Study||3
8576584|NCT00149799|9609444|FG000|STARTED|Open Label Escitalopram (Phase I)||100
8576585|NCT00149799|9609445|FG001|STARTED|Open Label Escitalopram (Phase I)||0
8576586|NCT00149799|9609446|FG002|STARTED|Open Label Escitalopram (Phase I)||0
8576587|NCT00149799|9609444|FG000|COMPLETED|Open Label Escitalopram (Phase I)|14 completers were non-responders and 2 responders terminated the study after completing Phase I|74
8576588|NCT00149799|9609445|FG001|COMPLETED|Open Label Escitalopram (Phase I)||0
8576589|NCT00149799|9609446|FG002|COMPLETED|Open Label Escitalopram (Phase I)||0
8576590|NCT00149799|9609444|FG000|NOT COMPLETED|Open Label Escitalopram (Phase I)||26
8576591|NCT00149799|9609445|FG001|NOT COMPLETED|Open Label Escitalopram (Phase I)||0
8576592|NCT00149799|9609446|FG002|NOT COMPLETED|Open Label Escitalopram (Phase I)||0
8576593|NCT00149799|9609444|FG000|STARTED|Discontinuation (Phase II)||0
8576594|NCT00149799|9609445|FG001|STARTED|Discontinuation (Phase II)|Only responders who completed Phase I and were willing to continue were randomized in Phase II|28
8576595|NCT00149799|9609446|FG002|STARTED|Discontinuation (Phase II)|Only responders who completed Phase I and were willing to continue were randomized in Phase II|30
8576596|NCT00149799|9609444|FG000|COMPLETED|Discontinuation (Phase II)||0
8576597|NCT00149799|9609445|FG001|COMPLETED|Discontinuation (Phase II)||25
8576598|NCT00149799|9609446|FG002|COMPLETED|Discontinuation (Phase II)||21
8576599|NCT00149799|9609444|FG000|NOT COMPLETED|Discontinuation (Phase II)||0
8576600|NCT00149799|9609445|FG001|NOT COMPLETED|Discontinuation (Phase II)||3
8576601|NCT00149799|9609446|FG002|NOT COMPLETED|Discontinuation (Phase II)||9
8576602|NCT00149825|9609456|FG000|STARTED|Overall Study||15
8576603|NCT00149825|9609457|FG001|STARTED|Overall Study||15
8576604|NCT00149825|9609456|FG000|COMPLETED|Overall Study||10
8576605|NCT00149825|9609457|FG001|COMPLETED|Overall Study||12
8576606|NCT00149825|9609456|FG000|NOT COMPLETED|Overall Study||5
8576607|NCT00149825|9609457|FG001|NOT COMPLETED|Overall Study||3
8576608|NCT00149838|9609465|FG000|STARTED|Phase I||92
8576609|NCT00149838|9609466|FG001|STARTED|Phase I||98
8576610|NCT00149838|9609467|FG002|STARTED|Phase I||0
8576611|NCT00149838|9609468|FG003|STARTED|Phase I||0
8576612|NCT00149838|9609465|FG000|COMPLETED|Phase I||72
8576613|NCT00149838|9609466|FG001|COMPLETED|Phase I||82
8576614|NCT00149838|9609467|FG002|COMPLETED|Phase I||0
8576615|NCT00149838|9609468|FG003|COMPLETED|Phase I||0
8576616|NCT00149838|9609465|FG000|NOT COMPLETED|Phase I||20
8576617|NCT00149838|9609466|FG001|NOT COMPLETED|Phase I||16
8576618|NCT00149838|9609467|FG002|NOT COMPLETED|Phase I||0
8576619|NCT00149838|9609468|FG003|NOT COMPLETED|Phase I||0
8576620|NCT00149838|9609465|FG000|STARTED|Phase II||0
8576621|NCT00149838|9609466|FG001|STARTED|Phase II||0
8576622|NCT00149838|9609467|FG002|STARTED|Phase II||144
8576623|NCT00149838|9609468|FG003|STARTED|Phase II||0
8576624|NCT00149838|9609465|FG000|COMPLETED|Phase II||0
8576625|NCT00149838|9609466|FG001|COMPLETED|Phase II||0
8576626|NCT00149838|9609467|FG002|COMPLETED|Phase II||144
8576627|NCT00149838|9609468|FG003|COMPLETED|Phase II||0
8576628|NCT00149838|9609465|FG000|NOT COMPLETED|Phase II||0
8576629|NCT00149838|9609466|FG001|NOT COMPLETED|Phase II||0
8576630|NCT00149838|9609467|FG002|NOT COMPLETED|Phase II||0
8576631|NCT00149838|9609468|FG003|NOT COMPLETED|Phase II||0
8576632|NCT00149838|9609465|FG000|STARTED|Phase III||0
8576633|NCT00149838|9609466|FG001|STARTED|Phase III||0
8576634|NCT00149838|9609467|FG002|STARTED|Phase III||0
8576635|NCT00149838|9609468|FG003|STARTED|Phase III||61
8576636|NCT00149838|9609465|FG000|COMPLETED|Phase III||0
8576637|NCT00149838|9609466|FG001|COMPLETED|Phase III||0
8576638|NCT00149838|9609467|FG002|COMPLETED|Phase III||0
8576639|NCT00149838|9609468|FG003|COMPLETED|Phase III||37
8576640|NCT00149838|9609465|FG000|NOT COMPLETED|Phase III||0
8576641|NCT00149838|9609466|FG001|NOT COMPLETED|Phase III||0
8576642|NCT00149838|9609467|FG002|NOT COMPLETED|Phase III||0
8576643|NCT00149838|9609468|FG003|NOT COMPLETED|Phase III||24
8576644|NCT00149890|9609480|FG000|STARTED|Overall Study|"Started indicates all screened and treated participants."|39
8576645|NCT00149890|9609481|FG001|STARTED|Overall Study||38
8576646|NCT00149890|9609480|FG000|COMPLETED|Overall Study||26
8576647|NCT00149890|9609481|FG001|COMPLETED|Overall Study||20
8576648|NCT00149890|9609480|FG000|NOT COMPLETED|Overall Study||13
8576649|NCT00149890|9609481|FG001|NOT COMPLETED|Overall Study||18
8576650|NCT00149994|9609489|FG000|STARTED|Overall Study|"Started indicates Safety population."|85
8576651|NCT00149994|9609490|FG001|STARTED|Overall Study||86
8576652|NCT00149994|9609489|FG000|COMPLETED|Overall Study|"Completed indicates intention to treat (ITT) population."|84
8576653|NCT00149994|9609490|FG001|COMPLETED|Overall Study||85
8576654|NCT00149994|9609489|FG000|NOT COMPLETED|Overall Study||1
8576655|NCT00149994|9609490|FG001|NOT COMPLETED|Overall Study||1
8576656|NCT00150345|9609498|FG000|STARTED|Overall Study||81
8576657|NCT00150345|9609499|FG001|STARTED|Overall Study||66
8576658|NCT00150345|9609498|FG000|COMPLETED|Overall Study||47
8576659|NCT00150345|9609499|FG001|COMPLETED|Overall Study||34
8576660|NCT00150345|9609498|FG000|NOT COMPLETED|Overall Study||34
8576661|NCT00150345|9609499|FG001|NOT COMPLETED|Overall Study||32
8576662|NCT00150462|9609517|FG000|STARTED|Overall Study||3
8576663|NCT00150462|9609518|FG001|STARTED|Overall Study||3
8576664|NCT00150462|9609519|FG002|STARTED|Overall Study||4
8576665|NCT00150462|9609520|FG003|STARTED|Overall Study||3
8576666|NCT00150462|9609521|FG004|STARTED|Overall Study||3
8576667|NCT00150462|9609522|FG005|STARTED|Overall Study||4
8576668|NCT00150462|9609523|FG006|STARTED|Overall Study||3
8576669|NCT00150462|9609524|FG007|STARTED|Overall Study||8
8576670|NCT00150462|9609525|FG008|STARTED|Overall Study||6
8576671|NCT00150462|9609526|FG009|STARTED|Overall Study||7
8576672|NCT00150462|9609527|FG010|STARTED|Overall Study||4
8576673|NCT00150462|9609517|FG000|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
8576674|NCT00150462|9609518|FG001|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
8576675|NCT00150462|9609519|FG002|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
8576676|NCT00150462|9609520|FG003|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
8576677|NCT00150462|9609521|FG004|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
8576678|NCT00150462|9609522|FG005|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
8576679|NCT00150462|9609523|FG006|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
8576680|NCT00150462|9609524|FG007|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
8576681|NCT00150462|9609525|FG008|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
8576682|NCT00150462|9609526|FG009|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of treatment.|1
8576683|NCT00150462|9609527|FG010|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of treatment.|1
8576684|NCT00150462|9609517|FG000|NOT COMPLETED|Overall Study||3
8576685|NCT00150462|9609518|FG001|NOT COMPLETED|Overall Study||3
8576686|NCT00150462|9609519|FG002|NOT COMPLETED|Overall Study||4
8576687|NCT00150462|9609520|FG003|NOT COMPLETED|Overall Study||3
8576688|NCT00150462|9609521|FG004|NOT COMPLETED|Overall Study||3
8576689|NCT00150462|9609522|FG005|NOT COMPLETED|Overall Study||4
8576690|NCT00150462|9609523|FG006|NOT COMPLETED|Overall Study||3
8576691|NCT00150462|9609524|FG007|NOT COMPLETED|Overall Study||8
8576692|NCT00150462|9609525|FG008|NOT COMPLETED|Overall Study||6
8576693|NCT00150462|9609526|FG009|NOT COMPLETED|Overall Study||6
8576694|NCT00150462|9609527|FG010|NOT COMPLETED|Overall Study||3
8576695|NCT00150592|9609556|FG000|STARTED|Overall Study||121
8576696|NCT00150592|9609557|FG001|STARTED|Overall Study||57
8576697|NCT00150592|9609556|FG000|COMPLETED|Overall Study||114
8576698|NCT00150592|9609557|FG001|COMPLETED|Overall Study||54
8576699|NCT00150592|9609556|FG000|NOT COMPLETED|Overall Study||7
8576700|NCT00150592|9609557|FG001|NOT COMPLETED|Overall Study||3
8576701|NCT00150618|9609568|FG000|STARTED|Overall Study||62
8576702|NCT00150618|9609569|FG001|STARTED|Overall Study||65
8576703|NCT00150618|9609570|FG002|STARTED|Overall Study||65
8576704|NCT00150618|9609571|FG003|STARTED|Overall Study||66
8576705|NCT00150618|9609572|FG004|STARTED|Overall Study||66
8576706|NCT00150618|9609568|FG000|COMPLETED|Overall Study||45
8576707|NCT00150618|9609569|FG001|COMPLETED|Overall Study||47
8576708|NCT00150618|9609570|FG002|COMPLETED|Overall Study||38
8576709|NCT00150618|9609571|FG003|COMPLETED|Overall Study||40
8576710|NCT00150618|9609572|FG004|COMPLETED|Overall Study||41
8576711|NCT00150618|9609568|FG000|NOT COMPLETED|Overall Study||17
8576712|NCT00150618|9609569|FG001|NOT COMPLETED|Overall Study||18
8576713|NCT00150618|9609570|FG002|NOT COMPLETED|Overall Study||27
8576714|NCT00150618|9609571|FG003|NOT COMPLETED|Overall Study||26
8576715|NCT00150618|9609572|FG004|NOT COMPLETED|Overall Study||25
8576716|NCT00150800|9609584|FG000|STARTED|Overall Study||667
8576717|NCT00150800|9609584|FG000|COMPLETED|Overall Study||171
8576718|NCT00150800|9609584|FG000|NOT COMPLETED|Overall Study||496
8576719|NCT00150813|9609589|FG000|STARTED|Overall Study||66
8576720|NCT00150813|9609589|FG000|COMPLETED|Overall Study||48
8576721|NCT00150813|9609589|FG000|NOT COMPLETED|Overall Study||18
8576722|NCT00150969|9609595|FG000|STARTED|24 Month Main Study||217
8576723|NCT00150969|9609596|FG001|STARTED|24 Month Main Study||223
8576724|NCT00150969|9609595|FG000|COMPLETED|24 Month Main Study||198
8576725|NCT00150969|9609596|FG001|COMPLETED|24 Month Main Study||202
8576726|NCT00150969|9609595|FG000|NOT COMPLETED|24 Month Main Study||19
8576727|NCT00150969|9609596|FG001|NOT COMPLETED|24 Month Main Study||21
8576728|NCT00150969|9609595|FG000|STARTED|24-48 Month Extension||121
8576729|NCT00150969|9609596|FG001|STARTED|24-48 Month Extension||140
8576730|NCT00150969|9609595|FG000|COMPLETED|24-48 Month Extension||33
8576731|NCT00150969|9609596|FG001|COMPLETED|24-48 Month Extension||40
8576732|NCT00150969|9609595|FG000|NOT COMPLETED|24-48 Month Extension||88
8576733|NCT00150969|9609596|FG001|NOT COMPLETED|24-48 Month Extension||100
8576734|NCT00151281|9609603|FG000|STARTED|Overall Study||25
8576735|NCT00151281|9609603|FG000|COMPLETED|Overall Study||22
8576736|NCT00151281|9609603|FG000|NOT COMPLETED|Overall Study||3
8576737|NCT00151320|9609610|FG000|STARTED|Overall Study||76
8576738|NCT00151320|9609610|FG000|COMPLETED|Overall Study||76
8576739|NCT00151320|9609610|FG000|NOT COMPLETED|Overall Study||0
8576740|NCT00151372|9609617|FG000|STARTED|Overall Study||67
8576741|NCT00151372|9609618|FG001|STARTED|Overall Study||74
8576742|NCT00151372|9609617|FG000|COMPLETED|Overall Study||38
8576743|NCT00151372|9609618|FG001|COMPLETED|Overall Study||45
8576744|NCT00151372|9609617|FG000|NOT COMPLETED|Overall Study||29
8576745|NCT00151372|9609618|FG001|NOT COMPLETED|Overall Study||29
8576746|NCT00151411|9609626|FG000|STARTED|Overall Study||55
8576747|NCT00151411|9609627|FG001|STARTED|Overall Study||59
8576748|NCT00151411|9609626|FG000|COMPLETED|Overall Study||22
8576749|NCT00151411|9609627|FG001|COMPLETED|Overall Study||16
8576750|NCT00151411|9609626|FG000|NOT COMPLETED|Overall Study||33
8576751|NCT00151411|9609627|FG001|NOT COMPLETED|Overall Study||43
8576752|NCT00151476|9609636|FG000|STARTED|FAP Identified Subjects||13
8576753|NCT00151476|9609637|FG001|STARTED|FAP Identified Subjects||55
8576754|NCT00151476|9609636|FG000|COMPLETED|FAP Identified Subjects||13
8576755|NCT00151476|9609637|FG001|COMPLETED|FAP Identified Subjects||54
8576756|NCT00151476|9609636|FG000|NOT COMPLETED|FAP Identified Subjects||0
8576757|NCT00151476|9609637|FG001|NOT COMPLETED|FAP Identified Subjects||1
8576758|NCT00151476|9609636|FG000|STARTED|FAP Analyzed Subjects||13
8576759|NCT00151476|9609637|FG001|STARTED|FAP Analyzed Subjects||54
8576760|NCT00151476|9609636|FG000|COMPLETED|FAP Analyzed Subjects||13
8576761|NCT00151476|9609637|FG001|COMPLETED|FAP Analyzed Subjects||51
8576762|NCT00151476|9609636|FG000|NOT COMPLETED|FAP Analyzed Subjects||0
8576763|NCT00151476|9609637|FG001|NOT COMPLETED|FAP Analyzed Subjects||3
8576764|NCT00151775|9609649|FG000|STARTED|Period 2 - Double-Blind Dose Response||95
8576765|NCT00151775|9609650|FG001|STARTED|Period 2 - Double-Blind Dose Response||95
8576766|NCT00151775|9609651|FG002|STARTED|Period 2 - Double-Blind Dose Response||0
8576767|NCT00151775|9609652|FG003|STARTED|Period 2 - Double-Blind Dose Response||0
8576768|NCT00151775|9609653|FG004|STARTED|Period 2 - Double-Blind Dose Response||0
8576769|NCT00151775|9609654|FG005|STARTED|Period 2 - Double-Blind Dose Response||56
8576770|NCT00151775|9609655|FG006|STARTED|Period 2 - Double-Blind Dose Response||56
8576771|NCT00151775|9609656|FG007|STARTED|Period 2 - Double-Blind Dose Response||0
8672896|NCT00758524|9716121|FG008|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||2
8672897|NCT00758524|9716122|FG009|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
8672898|NCT00758524|9716123|FG010|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
8672899|NCT00758524|9716124|FG011|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
8672900|NCT00758524|9716125|FG012|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
8672901|NCT00758524|9716126|FG013|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
8672902|NCT00758524|9716127|FG014|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
8672903|NCT00758524|9716128|FG015|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
8672904|NCT00758524|9716129|FG016|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
8672905|NCT00758550|9716169|FG000|STARTED|Overall Study||30
8672906|NCT00758550|9716170|FG001|STARTED|Overall Study||30
8672907|NCT00758550|9716169|FG000|COMPLETED|Overall Study||30
8672908|NCT00758550|9716170|FG001|COMPLETED|Overall Study||30
8672909|NCT00758550|9716169|FG000|NOT COMPLETED|Overall Study||0
8672910|NCT00758550|9716170|FG001|NOT COMPLETED|Overall Study||0
8672911|NCT00758576|9716176|FG000|STARTED|Overall Study||64
8672912|NCT00758576|9716176|FG000|COMPLETED|Overall Study||63
8672913|NCT00758576|9716176|FG000|NOT COMPLETED|Overall Study||1
8672914|NCT00758589|9716184|FG000|STARTED|Overall Study||95
8672915|NCT00758589|9716185|FG001|STARTED|Overall Study||90
8672916|NCT00758589|9716186|FG002|STARTED|Overall Study||92
8672917|NCT00758589|9716187|FG003|STARTED|Overall Study||91
8672918|NCT00758589|9716184|FG000|COMPLETED|Overall Study||92
8672919|NCT00758589|9716185|FG001|COMPLETED|Overall Study||87
8672920|NCT00758589|9716186|FG002|COMPLETED|Overall Study||86
8672921|NCT00758589|9716187|FG003|COMPLETED|Overall Study||85
8672922|NCT00758589|9716184|FG000|NOT COMPLETED|Overall Study||3
8672923|NCT00758589|9716185|FG001|NOT COMPLETED|Overall Study||3
8672924|NCT00758589|9716186|FG002|NOT COMPLETED|Overall Study||6
8672925|NCT00758589|9716187|FG003|NOT COMPLETED|Overall Study||6
8672926|NCT00758602|9716199|FG000|STARTED|Overall Study||104
8672927|NCT00758602|9716200|FG001|STARTED|Overall Study||106
8672928|NCT00758602|9716199|FG000|COMPLETED|Overall Study||85
8672929|NCT00758602|9716200|FG001|COMPLETED|Overall Study||84
8672930|NCT00758602|9716199|FG000|NOT COMPLETED|Overall Study||19
8672931|NCT00758602|9716200|FG001|NOT COMPLETED|Overall Study||22
8672932|NCT00758667|9716209|FG000|STARTED|Overall Study||9
8672933|NCT00758667|9716210|FG001|STARTED|Overall Study||11
8672934|NCT00758667|9716209|FG000|COMPLETED|Overall Study||9
8672935|NCT00758667|9716210|FG001|COMPLETED|Overall Study||11
8672936|NCT00758667|9716209|FG000|NOT COMPLETED|Overall Study||0
8672937|NCT00758667|9716210|FG001|NOT COMPLETED|Overall Study||0
8672938|NCT00758680|9716217|FG000|STARTED|Overall Study||6
8672939|NCT00758680|9716218|FG001|STARTED|Overall Study||6
8672940|NCT00758680|9716219|FG002|STARTED|Overall Study||6
8672941|NCT00758680|9716220|FG003|STARTED|Overall Study||6
8672942|NCT00758680|9716221|FG004|STARTED|Overall Study||6
8672943|NCT00758680|9716222|FG005|STARTED|Overall Study||6
8672944|NCT00758680|9716223|FG006|STARTED|Overall Study||7
8672945|NCT00758680|9716224|FG007|STARTED|Overall Study||20
8576772|NCT00151775|9609657|FG008|STARTED|Period 2 - Double-Blind Dose Response||0
8576773|NCT00151775|9609658|FG009|STARTED|Period 2 - Double-Blind Dose Response||0
8576774|NCT00151775|9609659|FG010|STARTED|Period 2 - Double-Blind Dose Response||60
8576775|NCT00151775|9609660|FG011|STARTED|Period 2 - Double-Blind Dose Response||0
8576776|NCT00151775|9609649|FG000|COMPLETED|Period 2 - Double-Blind Dose Response||93
8576777|NCT00151775|9609650|FG001|COMPLETED|Period 2 - Double-Blind Dose Response||89
8576778|NCT00151775|9609651|FG002|COMPLETED|Period 2 - Double-Blind Dose Response||0
8576779|NCT00151775|9609652|FG003|COMPLETED|Period 2 - Double-Blind Dose Response||0
8576780|NCT00151775|9609653|FG004|COMPLETED|Period 2 - Double-Blind Dose Response||0
8576781|NCT00151775|9609654|FG005|COMPLETED|Period 2 - Double-Blind Dose Response||54
8576782|NCT00151775|9609655|FG006|COMPLETED|Period 2 - Double-Blind Dose Response||53
8576783|NCT00151775|9609656|FG007|COMPLETED|Period 2 - Double-Blind Dose Response||0
8576784|NCT00151775|9609657|FG008|COMPLETED|Period 2 - Double-Blind Dose Response||0
8576785|NCT00151775|9609658|FG009|COMPLETED|Period 2 - Double-Blind Dose Response||0
8576786|NCT00151775|9609659|FG010|COMPLETED|Period 2 - Double-Blind Dose Response||59
8576787|NCT00151775|9609660|FG011|COMPLETED|Period 2 - Double-Blind Dose Response||0
8576788|NCT00151775|9609649|FG000|NOT COMPLETED|Period 2 - Double-Blind Dose Response||2
8576789|NCT00151775|9609650|FG001|NOT COMPLETED|Period 2 - Double-Blind Dose Response||6
8576790|NCT00151775|9609651|FG002|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
8576791|NCT00151775|9609652|FG003|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
8576792|NCT00151775|9609653|FG004|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
8576793|NCT00151775|9609654|FG005|NOT COMPLETED|Period 2 - Double-Blind Dose Response||2
8576794|NCT00151775|9609655|FG006|NOT COMPLETED|Period 2 - Double-Blind Dose Response||3
8576795|NCT00151775|9609656|FG007|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
8576796|NCT00151775|9609657|FG008|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
8576797|NCT00151775|9609658|FG009|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
8576798|NCT00151775|9609659|FG010|NOT COMPLETED|Period 2 - Double-Blind Dose Response||1
8576799|NCT00151775|9609660|FG011|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
8576800|NCT00151775|9609649|FG000|STARTED|Period 3: Double-blind, Withdrawal||48
8576801|NCT00151775|9609650|FG001|STARTED|Period 3: Double-blind, Withdrawal||45
8576802|NCT00151775|9609651|FG002|STARTED|Period 3: Double-blind, Withdrawal||45
8576803|NCT00151775|9609652|FG003|STARTED|Period 3: Double-blind, Withdrawal||44
8576804|NCT00151775|9609653|FG004|STARTED|Period 3: Double-blind, Withdrawal||0
8576805|NCT00151775|9609654|FG005|STARTED|Period 3: Double-blind, Withdrawal||26
8576806|NCT00151775|9609655|FG006|STARTED|Period 3: Double-blind, Withdrawal||27
8576807|NCT00151775|9609656|FG007|STARTED|Period 3: Double-blind, Withdrawal||28
8576808|NCT00151775|9609657|FG008|STARTED|Period 3: Double-blind, Withdrawal||26
8576809|NCT00151775|9609658|FG009|STARTED|Period 3: Double-blind, Withdrawal||0
8576810|NCT00151775|9609659|FG010|STARTED|Period 3: Double-blind, Withdrawal||29
8576811|NCT00151775|9609660|FG011|STARTED|Period 3: Double-blind, Withdrawal||29
8576812|NCT00151775|9609649|FG000|COMPLETED|Period 3: Double-blind, Withdrawal||48
8576813|NCT00151775|9609650|FG001|COMPLETED|Period 3: Double-blind, Withdrawal||45
8576814|NCT00151775|9609651|FG002|COMPLETED|Period 3: Double-blind, Withdrawal||42
8576815|NCT00151775|9609652|FG003|COMPLETED|Period 3: Double-blind, Withdrawal||44
8576816|NCT00151775|9609653|FG004|COMPLETED|Period 3: Double-blind, Withdrawal||0
8576817|NCT00151775|9609654|FG005|COMPLETED|Period 3: Double-blind, Withdrawal||25
8576818|NCT00151775|9609655|FG006|COMPLETED|Period 3: Double-blind, Withdrawal||26
8576819|NCT00151775|9609656|FG007|COMPLETED|Period 3: Double-blind, Withdrawal||27
8576820|NCT00151775|9609657|FG008|COMPLETED|Period 3: Double-blind, Withdrawal||26
8576821|NCT00151775|9609658|FG009|COMPLETED|Period 3: Double-blind, Withdrawal||0
8576822|NCT00151775|9609659|FG010|COMPLETED|Period 3: Double-blind, Withdrawal||29
8576823|NCT00151775|9609660|FG011|COMPLETED|Period 3: Double-blind, Withdrawal||28
8576824|NCT00151775|9609649|FG000|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
8576825|NCT00151775|9609650|FG001|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
8576826|NCT00151775|9609651|FG002|NOT COMPLETED|Period 3: Double-blind, Withdrawal||3
8576827|NCT00151775|9609652|FG003|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
8576828|NCT00151775|9609653|FG004|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
8576829|NCT00151775|9609654|FG005|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
8576830|NCT00151775|9609655|FG006|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
8576831|NCT00151775|9609656|FG007|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
8576832|NCT00151775|9609657|FG008|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
8576833|NCT00151775|9609658|FG009|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
8576834|NCT00151775|9609659|FG010|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
8576835|NCT00151775|9609660|FG011|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
8576836|NCT00151775|9609649|FG000|STARTED|Period 4: Open Label||0
8576837|NCT00151775|9609650|FG001|STARTED|Period 4: Open Label||0
8576838|NCT00151775|9609651|FG002|STARTED|Period 4: Open Label||0
8576839|NCT00151775|9609652|FG003|STARTED|Period 4: Open Label||0
8576840|NCT00151775|9609653|FG004|STARTED|Period 4: Open Label||179
8576841|NCT00151775|9609654|FG005|STARTED|Period 4: Open Label||0
8576842|NCT00151775|9609655|FG006|STARTED|Period 4: Open Label||0
8576843|NCT00151775|9609656|FG007|STARTED|Period 4: Open Label||0
8576844|NCT00151775|9609657|FG008|STARTED|Period 4: Open Label||0
8576845|NCT00151775|9609658|FG009|STARTED|Period 4: Open Label||104
8576846|NCT00151775|9609659|FG010|STARTED|Period 4: Open Label||57
8576847|NCT00151775|9609660|FG011|STARTED|Period 4: Open Label||0
8576848|NCT00151775|9609649|FG000|COMPLETED|Period 4: Open Label||0
8576849|NCT00151775|9609650|FG001|COMPLETED|Period 4: Open Label||0
8576850|NCT00151775|9609651|FG002|COMPLETED|Period 4: Open Label||0
8576851|NCT00151775|9609652|FG003|COMPLETED|Period 4: Open Label||0
8576852|NCT00151775|9609653|FG004|COMPLETED|Period 4: Open Label||149
8576853|NCT00151775|9609654|FG005|COMPLETED|Period 4: Open Label||0
8576854|NCT00151775|9609655|FG006|COMPLETED|Period 4: Open Label||0
8576855|NCT00151775|9609656|FG007|COMPLETED|Period 4: Open Label||0
8576856|NCT00151775|9609657|FG008|COMPLETED|Period 4: Open Label||0
8576857|NCT00151775|9609658|FG009|COMPLETED|Period 4: Open Label||83
8576858|NCT00151775|9609659|FG010|COMPLETED|Period 4: Open Label||57
8576859|NCT00151775|9609660|FG011|COMPLETED|Period 4: Open Label||0
8576860|NCT00151775|9609649|FG000|NOT COMPLETED|Period 4: Open Label||0
8576861|NCT00151775|9609650|FG001|NOT COMPLETED|Period 4: Open Label||0
8576862|NCT00151775|9609651|FG002|NOT COMPLETED|Period 4: Open Label||0
8576863|NCT00151775|9609652|FG003|NOT COMPLETED|Period 4: Open Label||0
8576864|NCT00151775|9609653|FG004|NOT COMPLETED|Period 4: Open Label||30
8576865|NCT00151775|9609654|FG005|NOT COMPLETED|Period 4: Open Label||0
8576866|NCT00151775|9609655|FG006|NOT COMPLETED|Period 4: Open Label||0
8576867|NCT00151775|9609656|FG007|NOT COMPLETED|Period 4: Open Label||0
8576868|NCT00151775|9609657|FG008|NOT COMPLETED|Period 4: Open Label||0
8576869|NCT00151775|9609658|FG009|NOT COMPLETED|Period 4: Open Label||21
8576870|NCT00151775|9609659|FG010|NOT COMPLETED|Period 4: Open Label||0
8576871|NCT00151775|9609660|FG011|NOT COMPLETED|Period 4: Open Label||0
8576872|NCT00151814|9609704|FG000|STARTED|Overall Study||4
8576873|NCT00151814|9609705|FG001|STARTED|Overall Study||10
8576874|NCT00151814|9609706|FG002|STARTED|Overall Study||10
8576875|NCT00151814|9609704|FG000|COMPLETED|Overall Study||4
8576876|NCT00151814|9609705|FG001|COMPLETED|Overall Study||10
8576877|NCT00151814|9609706|FG002|COMPLETED|Overall Study||10
8576878|NCT00151814|9609704|FG000|NOT COMPLETED|Overall Study||0
8576879|NCT00151814|9609705|FG001|NOT COMPLETED|Overall Study||0
8576880|NCT00151814|9609706|FG002|NOT COMPLETED|Overall Study||0
8576881|NCT00151892|9609715|FG000|STARTED|Overall Study||416
8576882|NCT00151892|9609716|FG001|STARTED|Overall Study||413
8576883|NCT00151892|9609715|FG000|COMPLETED|Overall Study||340
8576884|NCT00151892|9609716|FG001|COMPLETED|Overall Study||330
8576885|NCT00151892|9609715|FG000|NOT COMPLETED|Overall Study||76
8576886|NCT00151892|9609716|FG001|NOT COMPLETED|Overall Study||83
8576887|NCT00151996|9609724|FG000|STARTED|Overall Study||42
8576888|NCT00151996|9609725|FG001|STARTED|Overall Study||33
8576889|NCT00151996|9609724|FG000|COMPLETED|Overall Study||37
8576890|NCT00151996|9609725|FG001|COMPLETED|Overall Study||26
8576891|NCT00151996|9609724|FG000|NOT COMPLETED|Overall Study||5
8576892|NCT00151996|9609725|FG001|NOT COMPLETED|Overall Study||7
8576893|NCT00152009|9609735|FG000|STARTED|Overall Study||87
8576894|NCT00152009|9609736|FG001|STARTED|Overall Study||86
8576895|NCT00152009|9609737|FG002|STARTED|Overall Study||86
8576896|NCT00152009|9609738|FG003|STARTED|Overall Study||86
8576897|NCT00152009|9609735|FG000|COMPLETED|Overall Study||58
8576898|NCT00152009|9609736|FG001|COMPLETED|Overall Study||55
8576899|NCT00152009|9609737|FG002|COMPLETED|Overall Study||49
8576900|NCT00152009|9609738|FG003|COMPLETED|Overall Study||53
8576901|NCT00152009|9609735|FG000|NOT COMPLETED|Overall Study||29
8576902|NCT00152009|9609736|FG001|NOT COMPLETED|Overall Study||31
8576903|NCT00152009|9609737|FG002|NOT COMPLETED|Overall Study||37
8576904|NCT00152009|9609738|FG003|NOT COMPLETED|Overall Study||33
8576905|NCT00152464|9609750|FG000|STARTED|Overall Study||255
8576906|NCT00152464|9609751|FG001|STARTED|Overall Study||255
8576907|NCT00152464|9609750|FG000|COMPLETED|Overall Study||215
8576908|NCT00152464|9609751|FG001|COMPLETED|Overall Study||219
8576909|NCT00152464|9609750|FG000|NOT COMPLETED|Overall Study||40
8576910|NCT00152464|9609751|FG001|NOT COMPLETED|Overall Study||36
8576911|NCT00152516|9609757|FG000|STARTED|Overall Study|Subjects that were dispensed at least 1 dose of study medication|255
8576912|NCT00152516|9609757|FG000|COMPLETED|Overall Study|Subjects ongoing until study close-out|180
8576913|NCT00152516|9609757|FG000|NOT COMPLETED|Overall Study||75
8576914|NCT00152763|9609765|FG000|STARTED|Overall Study||77
8576915|NCT00152763|9609766|FG001|STARTED|Overall Study||19
8576916|NCT00152763|9609767|FG002|STARTED|Overall Study||20
8576917|NCT00152763|9609768|FG003|STARTED|Overall Study||77
8576918|NCT00152763|9609765|FG000|COMPLETED|Overall Study||67
8576919|NCT00152763|9609766|FG001|COMPLETED|Overall Study||14
8576920|NCT00152763|9609767|FG002|COMPLETED|Overall Study||16
8576921|NCT00152763|9609768|FG003|COMPLETED|Overall Study||63
8576922|NCT00152763|9609765|FG000|NOT COMPLETED|Overall Study||10
8576923|NCT00152763|9609766|FG001|NOT COMPLETED|Overall Study||5
8576924|NCT00152763|9609767|FG002|NOT COMPLETED|Overall Study||4
8576925|NCT00152763|9609768|FG003|NOT COMPLETED|Overall Study||14
8576926|NCT00152971|9609783|FG000|STARTED|Overall Study||857
8576927|NCT00152971|9609784|FG001|STARTED|Overall Study||871
8576928|NCT00152971|9609785|FG002|STARTED|Overall Study||868
8576929|NCT00152971|9609783|FG000|COMPLETED|Overall Study|Non-completers in 'overall study' table may have completed treatment but not study, and vice versa|806
8576930|NCT00152971|9609784|FG001|COMPLETED|Overall Study|Non-completers in 'overall study' table may have completed treatment but not study, and vice versa|823
8576931|NCT00152971|9609785|FG002|COMPLETED|Overall Study|Non-completers in 'overall study' table may have completed treatment but not study, and vice versa|819
8576932|NCT00152971|9609783|FG000|NOT COMPLETED|Overall Study||51
8576933|NCT00152971|9609784|FG001|NOT COMPLETED|Overall Study||48
8576934|NCT00152971|9609785|FG002|NOT COMPLETED|Overall Study||49
8576935|NCT00152971|9609783|FG000|STARTED|Treatment||857
8576936|NCT00152971|9609784|FG001|STARTED|Treatment||871
8576937|NCT00152971|9609785|FG002|STARTED|Treatment||868
8576938|NCT00152971|9609783|FG000|COMPLETED|Treatment|Non-completers in 'treatment' table may have completed study but not treatment, and vice versa|786
8576939|NCT00152971|9609784|FG001|COMPLETED|Treatment|Non-completers in 'treatment' table may have completed study but not treatment, and vice versa|808
8576940|NCT00152971|9609785|FG002|COMPLETED|Treatment|Non-completers in 'treatment' table may have completed study but not treatment, and vice versa|788
8576941|NCT00152971|9609783|FG000|NOT COMPLETED|Treatment||71
8576942|NCT00152971|9609784|FG001|NOT COMPLETED|Treatment||63
8576943|NCT00152971|9609785|FG002|NOT COMPLETED|Treatment||80
8576944|NCT00153062|9609797|FG000|STARTED|Overall Study||5086
8576945|NCT00153062|9609798|FG001|STARTED|Overall Study||5095
8576946|NCT00153062|9609799|FG002|STARTED|Overall Study||5060
8576947|NCT00153062|9609800|FG003|STARTED|Overall Study||5091
8576948|NCT00153062|9609797|FG000|COMPLETED|Overall Study||4699
8576949|NCT00153062|9609798|FG001|COMPLETED|Overall Study||4689
8576950|NCT00153062|9609799|FG002|COMPLETED|Overall Study||4645
8576951|NCT00153062|9609800|FG003|COMPLETED|Overall Study||4680
8576952|NCT00153062|9609797|FG000|NOT COMPLETED|Overall Study||387
8576953|NCT00153062|9609798|FG001|NOT COMPLETED|Overall Study||406
8576954|NCT00153062|9609799|FG002|NOT COMPLETED|Overall Study||415
8576955|NCT00153062|9609800|FG003|NOT COMPLETED|Overall Study||411
8576956|NCT00153101|9609815|FG000|STARTED|Overall Study||8502
8576957|NCT00153101|9609816|FG001|STARTED|Overall Study||8542
8576958|NCT00153101|9609817|FG002|STARTED|Overall Study||8576
8576959|NCT00153101|9609818|FG003|STARTED|Overall Study||2954
8576960|NCT00153101|9609819|FG004|STARTED|Overall Study||2972
8576961|NCT00153101|9609815|FG000|COMPLETED|Overall Study||8485
8576962|NCT00153101|9609816|FG001|COMPLETED|Overall Study||8524
8576963|NCT00153101|9609817|FG002|COMPLETED|Overall Study||8561
8576964|NCT00153101|9609818|FG003|COMPLETED|Overall Study||2946
8576965|NCT00153101|9609819|FG004|COMPLETED|Overall Study||2962
8576966|NCT00153101|9609815|FG000|NOT COMPLETED|Overall Study||17
8576967|NCT00153101|9609816|FG001|NOT COMPLETED|Overall Study||18
8576968|NCT00153101|9609817|FG002|NOT COMPLETED|Overall Study||15
8576969|NCT00153101|9609818|FG003|NOT COMPLETED|Overall Study||8
8576970|NCT00153101|9609819|FG004|NOT COMPLETED|Overall Study||10
8576971|NCT00153166|9609836|FG000|STARTED|Overall Study||11
8576972|NCT00153166|9609837|FG001|STARTED|Overall Study||37
8576973|NCT00153166|9609838|FG002|STARTED|Overall Study||28
8576974|NCT00153166|9609836|FG000|Received Atorvastatin and Pioglitazone|Overall Study||3
8576975|NCT00153166|9609837|FG001|Received Atorvastatin and Pioglitazone|Overall Study||9
8576976|NCT00153166|9609838|FG002|Received Atorvastatin and Pioglitazone|Overall Study||7
8576977|NCT00153166|9609836|FG000|Received Atorvastatin and Placebo|Overall Study||2
8576978|NCT00153166|9609837|FG001|Received Atorvastatin and Placebo|Overall Study||9
8576979|NCT00153166|9609838|FG002|Received Atorvastatin and Placebo|Overall Study||7
8576980|NCT00153166|9609836|FG000|Received Placebo and Pioglitazone|Overall Study||3
8576981|NCT00153166|9609837|FG001|Received Placebo and Pioglitazone|Overall Study||10
8576982|NCT00153166|9609838|FG002|Received Placebo and Pioglitazone|Overall Study||7
8576983|NCT00153166|9609836|FG000|Received Placebo and Placebo|Overall Study||3
8576984|NCT00153166|9609837|FG001|Received Placebo and Placebo|Overall Study||9
8576985|NCT00153166|9609838|FG002|Received Placebo and Placebo|Overall Study||7
8576986|NCT00153166|9609836|FG000|COMPLETED|Overall Study||11
8576987|NCT00153166|9609837|FG001|COMPLETED|Overall Study||37
8576988|NCT00153166|9609838|FG002|COMPLETED|Overall Study||28
8576989|NCT00153166|9609836|FG000|NOT COMPLETED|Overall Study||0
8576990|NCT00153166|9609837|FG001|NOT COMPLETED|Overall Study||0
8576991|NCT00153166|9609838|FG002|NOT COMPLETED|Overall Study||0
8576992|NCT00153179|9609849|FG000|STARTED|Study Visit Day 1||10
8576993|NCT00153179|9609850|FG001|STARTED|Study Visit Day 1||8
8576994|NCT00153179|9609851|FG002|STARTED|Study Visit Day 1||13
8576995|NCT00153179|9609852|FG003|STARTED|Study Visit Day 1||9
8576996|NCT00153179|9609849|FG000|COMPLETED|Study Visit Day 1||10
8576997|NCT00153179|9609850|FG001|COMPLETED|Study Visit Day 1||8
8576998|NCT00153179|9609851|FG002|COMPLETED|Study Visit Day 1||13
8576999|NCT00153179|9609852|FG003|COMPLETED|Study Visit Day 1||9
8577000|NCT00153179|9609849|FG000|NOT COMPLETED|Study Visit Day 1||0
8577001|NCT00153179|9609850|FG001|NOT COMPLETED|Study Visit Day 1||0
8577002|NCT00153179|9609851|FG002|NOT COMPLETED|Study Visit Day 1||0
8577003|NCT00153179|9609852|FG003|NOT COMPLETED|Study Visit Day 1||0
8577004|NCT00153179|9609849|FG000|STARTED|Study Visit Day 2||10
8577005|NCT00153179|9609850|FG001|STARTED|Study Visit Day 2||8
8577006|NCT00153179|9609851|FG002|STARTED|Study Visit Day 2||13
8577007|NCT00153179|9609852|FG003|STARTED|Study Visit Day 2||9
8577008|NCT00153179|9609849|FG000|COMPLETED|Study Visit Day 2||9
8577009|NCT00153179|9609850|FG001|COMPLETED|Study Visit Day 2||8
8577010|NCT00153179|9609851|FG002|COMPLETED|Study Visit Day 2||11
8577011|NCT00153179|9609852|FG003|COMPLETED|Study Visit Day 2||7
8577012|NCT00153179|9609849|FG000|NOT COMPLETED|Study Visit Day 2||1
8577013|NCT00153179|9609850|FG001|NOT COMPLETED|Study Visit Day 2||0
8577014|NCT00153179|9609851|FG002|NOT COMPLETED|Study Visit Day 2||2
8577015|NCT00153179|9609852|FG003|NOT COMPLETED|Study Visit Day 2||2
8577016|NCT00153803|9609862|FG000|STARTED|Concurrent Chemoradiation||123
8577017|NCT00153803|9609863|FG001|STARTED|Concurrent Chemoradiation||122
8577018|NCT00153803|9609862|FG000|Received Chemoradiation|Concurrent Chemoradiation||118
8577019|NCT00153803|9609863|FG001|Received Chemoradiation|Concurrent Chemoradiation||117
8577020|NCT00153803|9609862|FG000|COMPLETED|Concurrent Chemoradiation||118
8577021|NCT00153803|9609863|FG001|COMPLETED|Concurrent Chemoradiation||117
8577022|NCT00153803|9609862|FG000|NOT COMPLETED|Concurrent Chemoradiation||5
8577023|NCT00153803|9609863|FG001|NOT COMPLETED|Concurrent Chemoradiation||5
8577024|NCT00153803|9609862|FG000|STARTED|Investigational Drug||118
8577025|NCT00153803|9609863|FG001|STARTED|Investigational Drug||117
8577026|NCT00153803|9609862|FG000|Investigational Drug Dispensed|Investigational Drug||77
8577027|NCT00153803|9609863|FG001|Investigational Drug Dispensed|Investigational Drug||75
8577028|NCT00153803|9609862|FG000|COMPLETED|Investigational Drug||77
8577029|NCT00153803|9609863|FG001|COMPLETED|Investigational Drug||75
8577030|NCT00153803|9609862|FG000|NOT COMPLETED|Investigational Drug||41
8577031|NCT00153803|9609863|FG001|NOT COMPLETED|Investigational Drug||42
8577032|NCT00153816|9609878|FG000|STARTED|Overall Study||415
8577033|NCT00153816|9609879|FG001|STARTED|Overall Study||419
8577034|NCT00153816|9609880|FG002|STARTED|Overall Study||420
8577035|NCT00153816|9609881|FG003|STARTED|Overall Study||421
8577036|NCT00153816|9609882|FG004|STARTED|Overall Study||295
8577037|NCT00153816|9609883|FG005|STARTED|Overall Study||289
8577038|NCT00153816|9609878|FG000|COMPLETED|Overall Study||383
8577039|NCT00153816|9609879|FG001|COMPLETED|Overall Study||387
8577040|NCT00153816|9609880|FG002|COMPLETED|Overall Study||388
8577041|NCT00153816|9609881|FG003|COMPLETED|Overall Study||390
8577042|NCT00153816|9609882|FG004|COMPLETED|Overall Study||278
8577043|NCT00153816|9609883|FG005|COMPLETED|Overall Study||262
8577044|NCT00153816|9609878|FG000|NOT COMPLETED|Overall Study||32
8577045|NCT00153816|9609879|FG001|NOT COMPLETED|Overall Study||32
8577046|NCT00153816|9609880|FG002|NOT COMPLETED|Overall Study||32
8577047|NCT00153816|9609881|FG003|NOT COMPLETED|Overall Study||31
8577048|NCT00153816|9609882|FG004|NOT COMPLETED|Overall Study||17
8577049|NCT00153816|9609883|FG005|NOT COMPLETED|Overall Study||27
8577050|NCT00153842|9609899|FG000|STARTED|Overall Study||26
8577051|NCT00153842|9609900|FG001|STARTED|Overall Study||7
8577052|NCT00153842|9609899|FG000|COMPLETED|Overall Study||26
8577053|NCT00153842|9609900|FG001|COMPLETED|Overall Study||7
8577054|NCT00153842|9609899|FG000|NOT COMPLETED|Overall Study||0
8577055|NCT00153842|9609900|FG001|NOT COMPLETED|Overall Study||0
8577056|NCT00153920|9609908|FG000|STARTED|Overall Study||66
8577057|NCT00153920|9609908|FG000|Eligible and Treated|Overall Study||64
8577058|NCT00153920|9609908|FG000|COMPLETED|Overall Study||36
8577059|NCT00153920|9609908|FG000|NOT COMPLETED|Overall Study||30
8577060|NCT00153985|9609912|FG000|STARTED|Overall Study||2
8577061|NCT00153985|9609912|FG000|COMPLETED|Overall Study||2
8577062|NCT00153985|9609912|FG000|NOT COMPLETED|Overall Study||0
8577063|NCT00154063|9609918|FG000|STARTED|Overall Study||104
8577064|NCT00154063|9609919|FG001|STARTED|Overall Study||102
8577065|NCT00154063|9609918|FG000|COMPLETED|Overall Study||92
8577066|NCT00154063|9609919|FG001|COMPLETED|Overall Study||80
8577067|NCT00154063|9609918|FG000|NOT COMPLETED|Overall Study||12
8577068|NCT00154063|9609919|FG001|NOT COMPLETED|Overall Study||22
8577069|NCT00154102|9609931|FG000|STARTED|Overall Study|Randomized and treated subjects; 1 additional subject was treated but not randomised|599
8577070|NCT00154102|9609932|FG001|STARTED|Overall Study|Randomized and treated subjects; 3 additional subjects were treated but not randomised|599
8577071|NCT00154102|9609931|FG000|COMPLETED|Overall Study||592
8577072|NCT00154102|9609932|FG001|COMPLETED|Overall Study||597
8577073|NCT00154102|9609931|FG000|NOT COMPLETED|Overall Study||7
8577074|NCT00154102|9609932|FG001|NOT COMPLETED|Overall Study||2
8577075|NCT00154284|9609940|FG000|STARTED|Overall Study|"Started indicates Safety Population (randomized patients and treated after randomization.)"|59
8577076|NCT00154284|9609941|FG001|STARTED|Overall Study||55
8577077|NCT00154284|9609940|FG000|Intent to Treat (ITT) Population|Overall Study||57
8577078|NCT00154284|9609941|FG001|Intent to Treat (ITT) Population|Overall Study||53
8577079|NCT00154284|9609940|FG000|COMPLETED|Overall Study|"Completed means patients completed on study medication.All patients of both arms completed study."|52
8577080|NCT00154284|9609941|FG001|COMPLETED|Overall Study||42
8577081|NCT00154284|9609940|FG000|NOT COMPLETED|Overall Study||7
8577082|NCT00154284|9609941|FG001|NOT COMPLETED|Overall Study||13
8577083|NCT00154297|9609951|FG000|STARTED|Overall Study|Randomized population.|65
8577084|NCT00154297|9609952|FG001|STARTED|Overall Study|Randomized population.|74
8577085|NCT00154297|9609951|FG000|COMPLETED|Overall Study|Completed study by 12 month.|57
8577086|NCT00154297|9609952|FG001|COMPLETED|Overall Study|Completed study by 12 month.|67
8577087|NCT00154297|9609951|FG000|NOT COMPLETED|Overall Study||8
8577088|NCT00154297|9609952|FG001|NOT COMPLETED|Overall Study||7
8577089|NCT00154310|9609960|FG000|STARTED|Overall Study|"Started indicates enrolled participants. Randomized participants for two arms are 154 and 146."|155
8577090|NCT00154310|9609961|FG001|STARTED|Overall Study||145
8577091|NCT00154310|9609960|FG000|COMPLETED|Overall Study||118
8577092|NCT00154310|9609961|FG001|COMPLETED|Overall Study||117
8577093|NCT00154310|9609960|FG000|NOT COMPLETED|Overall Study||37
8577094|NCT00154310|9609961|FG001|NOT COMPLETED|Overall Study||28
8577095|NCT00154375|9609969|FG000|STARTED|Overall Study||120
8577096|NCT00154375|9609970|FG001|STARTED|Overall Study||120
8577097|NCT00154375|9609969|FG000|Discontinued Study Treatment|Overall Study||111
8577098|NCT00154375|9609970|FG001|Discontinued Study Treatment|Overall Study||104
8577099|NCT00154375|9609969|FG000|Not Exposed to Study Treatment|Overall Study|4 randomized patients didn't receive study treatment were excluded from the safety analyses.|2
8577100|NCT00154375|9609970|FG001|Not Exposed to Study Treatment|Overall Study||2
8577101|NCT00154375|9609969|FG000|COMPLETED|Overall Study||7
8577102|NCT00154375|9609970|FG001|COMPLETED|Overall Study||14
8577103|NCT00154375|9609969|FG000|NOT COMPLETED|Overall Study||113
8577104|NCT00154375|9609970|FG001|NOT COMPLETED|Overall Study||106
8577105|NCT00154466|9609980|FG000|STARTED|Overall Study||20
8577106|NCT00154466|9609981|FG001|STARTED|Overall Study||19
8577107|NCT00154466|9609982|FG002|STARTED|Overall Study|Healthy controls underwent the test of myocardial perfusion only at baseline.|19
8577108|NCT00154466|9609980|FG000|COMPLETED|Overall Study||20
8577109|NCT00154466|9609981|FG001|COMPLETED|Overall Study||19
8577110|NCT00154466|9609982|FG002|COMPLETED|Overall Study||19
8577111|NCT00154466|9609980|FG000|NOT COMPLETED|Overall Study||0
8577112|NCT00154466|9609981|FG001|NOT COMPLETED|Overall Study||0
8577113|NCT00154466|9609982|FG002|NOT COMPLETED|Overall Study||0
8577114|NCT00156013|9609992|FG000|STARTED|Overall Study||33
8672946|NCT00758680|9716225|FG008|STARTED|Overall Study||20
8672947|NCT00758680|9716226|FG009|STARTED|Overall Study||29
8672948|NCT00758680|9716217|FG000|COMPLETED|Overall Study||6
8672949|NCT00758680|9716218|FG001|COMPLETED|Overall Study||6
8672950|NCT00758680|9716219|FG002|COMPLETED|Overall Study||6
8672951|NCT00758680|9716220|FG003|COMPLETED|Overall Study||6
8672952|NCT00758680|9716221|FG004|COMPLETED|Overall Study||6
8672953|NCT00758680|9716222|FG005|COMPLETED|Overall Study||6
8672954|NCT00758680|9716223|FG006|COMPLETED|Overall Study||6
8672955|NCT00758680|9716224|FG007|COMPLETED|Overall Study||19
8672956|NCT00758680|9716225|FG008|COMPLETED|Overall Study||18
8672957|NCT00758680|9716226|FG009|COMPLETED|Overall Study||28
8672958|NCT00758680|9716217|FG000|NOT COMPLETED|Overall Study||0
8672959|NCT00758680|9716218|FG001|NOT COMPLETED|Overall Study||0
8672960|NCT00758680|9716219|FG002|NOT COMPLETED|Overall Study||0
8672961|NCT00758680|9716220|FG003|NOT COMPLETED|Overall Study||0
8672962|NCT00758680|9716221|FG004|NOT COMPLETED|Overall Study||0
8672963|NCT00758680|9716222|FG005|NOT COMPLETED|Overall Study||0
8672964|NCT00758680|9716223|FG006|NOT COMPLETED|Overall Study||1
8672965|NCT00758680|9716224|FG007|NOT COMPLETED|Overall Study||1
8672966|NCT00758680|9716225|FG008|NOT COMPLETED|Overall Study||2
8672967|NCT00758680|9716226|FG009|NOT COMPLETED|Overall Study||1
8672968|NCT00758706|9716251|FG000|STARTED|Overall Study||26
8672969|NCT00758706|9716252|FG001|STARTED|Overall Study||29
8672970|NCT00758706|9716251|FG000|COMPLETED|Overall Study||22
8672971|NCT00758706|9716252|FG001|COMPLETED|Overall Study||25
8672972|NCT00758706|9716251|FG000|NOT COMPLETED|Overall Study||4
8672973|NCT00758706|9716252|FG001|NOT COMPLETED|Overall Study||4
8672974|NCT00758745|9716260|FG000|STARTED|Overall Study||81
8672975|NCT00758745|9716261|FG001|STARTED|Overall Study||81
8672976|NCT00758745|9716260|FG000|COMPLETED|Overall Study||60
8672977|NCT00758745|9716261|FG001|COMPLETED|Overall Study||60
8672978|NCT00758745|9716260|FG000|NOT COMPLETED|Overall Study||21
8672979|NCT00758745|9716261|FG001|NOT COMPLETED|Overall Study||21
8672980|NCT00758758|9716275|FG000|STARTED|Overall Study||14
8672981|NCT00758758|9716276|FG001|STARTED|Overall Study||74
8672982|NCT00758758|9716277|FG002|STARTED|Overall Study||53
8672983|NCT00758758|9716278|FG003|STARTED|Overall Study||6
8672984|NCT00758758|9716279|FG004|STARTED|Overall Study||3
8672985|NCT00758758|9716280|FG005|STARTED|Overall Study||50
8672986|NCT00758758|9716281|FG006|STARTED|Overall Study||31
8672987|NCT00758758|9716282|FG007|STARTED|Overall Study||0
8672988|NCT00758758|9716275|FG000|COMPLETED|Overall Study||11
8672989|NCT00758758|9716276|FG001|COMPLETED|Overall Study||49
8672990|NCT00758758|9716277|FG002|COMPLETED|Overall Study||35
8672991|NCT00758758|9716278|FG003|COMPLETED|Overall Study||4
8799510|NCT01437995|9851050|FG002|COMPLETED|Overall Study||135
8799511|NCT01437995|9851048|FG000|NOT COMPLETED|Overall Study||11
8799512|NCT01437995|9851049|FG001|NOT COMPLETED|Overall Study||18
8799513|NCT01437995|9851050|FG002|NOT COMPLETED|Overall Study||20
8799514|NCT01438008|9851060|FG000|STARTED|Overall Study||4
8799515|NCT01438008|9851061|FG001|STARTED|Overall Study||5
8799516|NCT01438008|9851060|FG000|COMPLETED|Overall Study||4
8799517|NCT01438008|9851061|FG001|COMPLETED|Overall Study||5
8799518|NCT01438008|9851060|FG000|NOT COMPLETED|Overall Study||0
8799519|NCT01438008|9851061|FG001|NOT COMPLETED|Overall Study||0
8799520|NCT01438060|9851069|FG000|STARTED|Acute Phase: Double-blind, 10 Weeks||102
8799521|NCT01438060|9851070|FG001|STARTED|Acute Phase: Double-blind, 10 Weeks||106
8799522|NCT01438060|9851069|FG000|COMPLETED|Acute Phase: Double-blind, 10 Weeks||84
8799523|NCT01438060|9851070|FG001|COMPLETED|Acute Phase: Double-blind, 10 Weeks||88
8799524|NCT01438060|9851069|FG000|NOT COMPLETED|Acute Phase: Double-blind, 10 Weeks||18
8799525|NCT01438060|9851070|FG001|NOT COMPLETED|Acute Phase: Double-blind, 10 Weeks||18
8799526|NCT01438060|9851069|FG000|STARTED|Extension Phase: Week 10 to Week 130|80 out of the 84 participants entered extension phase. All were treated with open-label aripiprazole|80
8918768|NCT02203591|9978795|FG004|COMPLETED|Overall Study||208
8577115|NCT00156013|9609992|FG000|COMPLETED|Overall Study||31
8672992|NCT00758758|9716279|FG004|COMPLETED|Overall Study||1
8672993|NCT00758758|9716280|FG005|COMPLETED|Overall Study||36
8672994|NCT00758758|9716281|FG006|COMPLETED|Overall Study||17
8672995|NCT00758758|9716282|FG007|COMPLETED|Overall Study||0
8672996|NCT00758758|9716275|FG000|NOT COMPLETED|Overall Study||3
8672997|NCT00758758|9716276|FG001|NOT COMPLETED|Overall Study||25
8577116|NCT00156013|9609992|FG000|NOT COMPLETED|Overall Study||2
8577730|NCT00160693|9610542|FG000|NOT COMPLETED|Overall Study||235
8577731|NCT00160706|9610546|FG000|STARTED|Overall Study||310
8577732|NCT00160706|9610546|FG000|COMPLETED|Overall Study||24
8577733|NCT00160706|9610546|FG000|NOT COMPLETED|Overall Study||286
8577734|NCT00161213|9610550|FG000|STARTED|Overall Study||44
8577735|NCT00161213|9610550|FG000|COMPLETED|Overall Study||42
8577736|NCT00161213|9610550|FG000|NOT COMPLETED|Overall Study||2
8577737|NCT00161382|9610556|FG000|STARTED|Overall Study|Number of students allocated to intervention group|598
8577738|NCT00161382|9610557|FG001|STARTED|Overall Study|Number of students allocated to comparison group|847
8577739|NCT00161382|9610556|FG000|COMPLETED|Overall Study|Number of intervention students included in the analyzed cohort (i.e., completed 9th-grade survey)|349
8577740|NCT00161382|9610557|FG001|COMPLETED|Overall Study|Number of control students included in the analyzed cohort (i.e., completed 9th-grade survey)|558
8577741|NCT00161382|9610556|FG000|NOT COMPLETED|Overall Study||249
8577742|NCT00161382|9610557|FG001|NOT COMPLETED|Overall Study||289
8577743|NCT00161473|9610565|FG000|STARTED|Overall Study||12
8577744|NCT00161473|9610566|FG001|STARTED|Overall Study||12
8577745|NCT00161473|9610565|FG000|COMPLETED|Overall Study||7
8577746|NCT00161473|9610566|FG001|COMPLETED|Overall Study||6
8577747|NCT00161473|9610565|FG000|NOT COMPLETED|Overall Study||5
8577748|NCT00161473|9610566|FG001|NOT COMPLETED|Overall Study||6
8577749|NCT00161616|9610574|FG000|STARTED|Overall Study||139
8577750|NCT00161616|9610575|FG001|STARTED|Overall Study||138
8577751|NCT00161616|9610574|FG000|COMPLETED|Overall Study||113
8577752|NCT00161616|9610575|FG001|COMPLETED|Overall Study||119
8577753|NCT00161616|9610574|FG000|NOT COMPLETED|Overall Study||26
8577754|NCT00161616|9610575|FG001|NOT COMPLETED|Overall Study||19
8577755|NCT00162032|9610583|FG000|STARTED|Overall Study||329
8577756|NCT00162032|9610584|FG001|STARTED|Overall Study||116
8577757|NCT00162032|9610583|FG000|COMPLETED|Overall Study|Completed is all subjects who completed 3 yr FU whether or not they were seen in the previous year.|324
8577758|NCT00162032|9610584|FG001|COMPLETED|Overall Study|Completed is all subjects who completed 3 yr FU whether or not they were seen in the previous year.|114
8577759|NCT00162032|9610583|FG000|NOT COMPLETED|Overall Study||5
8577760|NCT00162032|9610584|FG001|NOT COMPLETED|Overall Study||2
8577761|NCT00162097|9610599|FG000|STARTED|Overall Study|Treated on Day 1|6
8577762|NCT00162097|9610600|FG001|STARTED|Overall Study|Treated on Day 1|2
8577763|NCT00162097|9610601|FG002|STARTED|Overall Study|Treated on Day 1|1
8577764|NCT00162097|9610602|FG003|STARTED|Overall Study|Treated on Day 1. One participant enrolled twice in the study and is hence counted twice|7
8577765|NCT00162097|9610599|FG000|COMPLETED|Overall Study||6
8577766|NCT00162097|9610600|FG001|COMPLETED|Overall Study||2
8577767|NCT00162097|9610601|FG002|COMPLETED|Overall Study||1
8577768|NCT00162097|9610602|FG003|COMPLETED|Overall Study||6
8577769|NCT00162097|9610599|FG000|NOT COMPLETED|Overall Study||0
8577770|NCT00162097|9610600|FG001|NOT COMPLETED|Overall Study||0
8577771|NCT00162097|9610601|FG002|NOT COMPLETED|Overall Study||0
8577772|NCT00162097|9610602|FG003|NOT COMPLETED|Overall Study||1
8577773|NCT00162123|9610626|FG000|STARTED|Overall Study|Enrolled|53
8577774|NCT00162123|9610627|FG001|STARTED|Overall Study|Enrolled|34
8577775|NCT00162123|9610628|FG002|STARTED|Overall Study|Enrolled|24
8577776|NCT00162123|9610629|FG003|STARTED|Overall Study|Enrolled|11
8577777|NCT00162123|9610630|FG004|STARTED|Overall Study|Enrolled|45
8577778|NCT00162123|9610631|FG005|STARTED|Overall Study|Enrolled|13
8577779|NCT00162123|9610632|FG006|STARTED|Overall Study|Enrolled|4
8577780|NCT00162123|9610633|FG007|STARTED|Overall Study|Enrolled|58
8577781|NCT00162123|9610626|FG000|Received Treatment|Overall Study||53
8577782|NCT00162123|9610627|FG001|Received Treatment|Overall Study||34
8577783|NCT00162123|9610628|FG002|Received Treatment|Overall Study||24
8577784|NCT00162123|9610629|FG003|Received Treatment|Overall Study||11
8577785|NCT00162123|9610630|FG004|Received Treatment|Overall Study||33
8577786|NCT00162123|9610631|FG005|Received Treatment|Overall Study||12
8577787|NCT00162123|9610632|FG006|Received Treatment|Overall Study||4
8577788|NCT00162123|9610633|FG007|Received Treatment|Overall Study||0
8577789|NCT00162123|9610626|FG000|COMPLETED|Overall Study|Still on treatment|9
8577790|NCT00162123|9610627|FG001|COMPLETED|Overall Study|Still on treatment|5
8577791|NCT00162123|9610628|FG002|COMPLETED|Overall Study|Still on treatment|3
8577792|NCT00162123|9610629|FG003|COMPLETED|Overall Study|Still on treatment|3
8577793|NCT00162123|9610630|FG004|COMPLETED|Overall Study|Still on treatment|14
8577794|NCT00162123|9610631|FG005|COMPLETED|Overall Study|Still on treatment|4
8577795|NCT00162123|9610632|FG006|COMPLETED|Overall Study|Still on treatment|0
8577796|NCT00162123|9610633|FG007|COMPLETED|Overall Study|Still on treatment|0
8577797|NCT00162123|9610626|FG000|NOT COMPLETED|Overall Study||44
8577798|NCT00162123|9610627|FG001|NOT COMPLETED|Overall Study||29
8577799|NCT00162123|9610628|FG002|NOT COMPLETED|Overall Study||21
8577800|NCT00162123|9610629|FG003|NOT COMPLETED|Overall Study||8
8577801|NCT00162123|9610630|FG004|NOT COMPLETED|Overall Study||31
8577802|NCT00162123|9610631|FG005|NOT COMPLETED|Overall Study||9
8577803|NCT00162123|9610632|FG006|NOT COMPLETED|Overall Study||4
8577804|NCT00162123|9610633|FG007|NOT COMPLETED|Overall Study||58
8577805|NCT00162136|9610658|FG000|STARTED|Overall Study||35
8577806|NCT00162136|9610658|FG000|COMPLETED|Overall Study|Number of Participants still on treatment at study termination|0
8577807|NCT00162136|9610658|FG000|NOT COMPLETED|Overall Study||35
8577808|NCT00162266|9610685|FG000|STARTED|Double-Blind Period||115
8577809|NCT00162266|9610686|FG001|STARTED|Double-Blind Period||105
8577117|NCT00156247|9609998|FG000|STARTED|Overall Study||9
8577118|NCT00156247|9609998|FG000|COMPLETED|Overall Study||5
8577119|NCT00156247|9609998|FG000|NOT COMPLETED|Overall Study||4
8577120|NCT00156390|9610004|FG000|STARTED|Overall Study||110
8577121|NCT00156390|9610005|FG001|STARTED|Overall Study||77
8577122|NCT00156390|9610004|FG000|COMPLETED|Overall Study||96
8577123|NCT00156390|9610005|FG001|COMPLETED|Overall Study||69
8577124|NCT00156390|9610004|FG000|NOT COMPLETED|Overall Study||14
8577125|NCT00156390|9610005|FG001|NOT COMPLETED|Overall Study||8
8577126|NCT00156533|9610016|FG000|STARTED|Overall Study||5
8577127|NCT00156533|9610017|FG001|STARTED|Overall Study||5
8577128|NCT00156533|9610018|FG002|STARTED|Overall Study||5
8577129|NCT00156533|9610019|FG003|STARTED|Overall Study||5
8577130|NCT00156533|9610016|FG000|COMPLETED|Overall Study||3
8577131|NCT00156533|9610017|FG001|COMPLETED|Overall Study||3
8577132|NCT00156533|9610018|FG002|COMPLETED|Overall Study||3
8577133|NCT00156533|9610019|FG003|COMPLETED|Overall Study||3
8577134|NCT00156533|9610016|FG000|NOT COMPLETED|Overall Study||2
8577135|NCT00156533|9610017|FG001|NOT COMPLETED|Overall Study||2
8577136|NCT00156533|9610018|FG002|NOT COMPLETED|Overall Study||2
8577137|NCT00156533|9610019|FG003|NOT COMPLETED|Overall Study||2
8577138|NCT00156715|9610031|FG000|STARTED|Overall Study||23
8577139|NCT00156715|9610031|FG000|COMPLETED|Overall Study||16
8577140|NCT00156715|9610031|FG000|NOT COMPLETED|Overall Study||7
8577141|NCT00156819|9610038|FG000|STARTED|Overall Study||169
8577142|NCT00156819|9610039|FG001|STARTED|Overall Study||166
8577143|NCT00156819|9610040|FG002|STARTED|Overall Study||165
8577144|NCT00156819|9610038|FG000|COMPLETED|Overall Study||168
8577145|NCT00156819|9610039|FG001|COMPLETED|Overall Study||165
8577146|NCT00156819|9610040|FG002|COMPLETED|Overall Study||162
8577147|NCT00156819|9610038|FG000|NOT COMPLETED|Overall Study||1
8577148|NCT00156819|9610039|FG001|NOT COMPLETED|Overall Study||1
8577149|NCT00156819|9610040|FG002|NOT COMPLETED|Overall Study||3
8577150|NCT00156910|9610050|FG000|STARTED|Double-Blind Phase (DB)||341
8672998|NCT00758758|9716277|FG002|NOT COMPLETED|Overall Study||18
8672999|NCT00758758|9716278|FG003|NOT COMPLETED|Overall Study||2
8673000|NCT00758758|9716279|FG004|NOT COMPLETED|Overall Study||2
8673001|NCT00758758|9716280|FG005|NOT COMPLETED|Overall Study||14
8673002|NCT00758758|9716281|FG006|NOT COMPLETED|Overall Study||14
8673003|NCT00758758|9716282|FG007|NOT COMPLETED|Overall Study||0
8673004|NCT00758771|9716310|FG000|STARTED|Overall Study||18
8673005|NCT00758771|9716311|FG001|STARTED|Overall Study||20
8673006|NCT00758771|9716310|FG000|COMPLETED|Overall Study||15
8673007|NCT00758771|9716311|FG001|COMPLETED|Overall Study||15
8673008|NCT00758771|9716310|FG000|NOT COMPLETED|Overall Study||3
8673009|NCT00758771|9716311|FG001|NOT COMPLETED|Overall Study||5
8673010|NCT00758784|9716317|FG000|STARTED|Overall Study||38
8673011|NCT00758784|9716317|FG000|COMPLETED|Overall Study||36
8673012|NCT00758784|9716317|FG000|NOT COMPLETED|Overall Study||2
8673013|NCT00758836|9716325|FG000|STARTED|Overall Study||171
8673014|NCT00758836|9716326|FG001|STARTED|Overall Study||171
8673015|NCT00758836|9716327|FG002|STARTED|Overall Study||171
8673016|NCT00758836|9716328|FG003|STARTED|Overall Study||170
8673017|NCT00758836|9716325|FG000|Treated|Overall Study||147
8673018|NCT00758836|9716326|FG001|Treated|Overall Study||145
8673019|NCT00758836|9716327|FG002|Treated|Overall Study||133
8673020|NCT00758836|9716328|FG003|Treated|Overall Study||138
8673021|NCT00758836|9716325|FG000|COMPLETED|Overall Study||147
8673022|NCT00758836|9716326|FG001|COMPLETED|Overall Study||145
8673023|NCT00758836|9716327|FG002|COMPLETED|Overall Study||133
8673024|NCT00758836|9716328|FG003|COMPLETED|Overall Study||138
8673025|NCT00758836|9716325|FG000|NOT COMPLETED|Overall Study||24
8673026|NCT00758836|9716326|FG001|NOT COMPLETED|Overall Study||26
8673027|NCT00758836|9716327|FG002|NOT COMPLETED|Overall Study||38
8673028|NCT00758836|9716328|FG003|NOT COMPLETED|Overall Study||32
8673029|NCT00758862|9716338|FG000|STARTED|Overall Study||20
8673030|NCT00758862|9716338|FG000|COMPLETED|Overall Study||19
8673031|NCT00758862|9716338|FG000|NOT COMPLETED|Overall Study||1
8673032|NCT00759031|9716344|FG000|STARTED|First Intervention (1 Day)||10
8673033|NCT00759031|9716345|FG001|STARTED|First Intervention (1 Day)||9
8673034|NCT00759031|9716344|FG000|COMPLETED|First Intervention (1 Day)||8
8673035|NCT00759031|9716345|FG001|COMPLETED|First Intervention (1 Day)||8
8673036|NCT00759031|9716344|FG000|NOT COMPLETED|First Intervention (1 Day)||2
8673037|NCT00759031|9716345|FG001|NOT COMPLETED|First Intervention (1 Day)||1
8673038|NCT00759031|9716344|FG000|STARTED|Washout After 1st Intervention (1 Week)||8
8673039|NCT00759031|9716345|FG001|STARTED|Washout After 1st Intervention (1 Week)||8
8673040|NCT00759031|9716344|FG000|COMPLETED|Washout After 1st Intervention (1 Week)||8
8673041|NCT00759031|9716345|FG001|COMPLETED|Washout After 1st Intervention (1 Week)||8
8673042|NCT00759031|9716344|FG000|NOT COMPLETED|Washout After 1st Intervention (1 Week)||0
8673043|NCT00759031|9716345|FG001|NOT COMPLETED|Washout After 1st Intervention (1 Week)||0
8673044|NCT00759031|9716344|FG000|STARTED|Second Intervention (1 Day)||8
8673045|NCT00759031|9716345|FG001|STARTED|Second Intervention (1 Day)||8
8673046|NCT00759031|9716344|FG000|COMPLETED|Second Intervention (1 Day)||8
8673047|NCT00759031|9716345|FG001|COMPLETED|Second Intervention (1 Day)||8
8673048|NCT00759031|9716344|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
8673049|NCT00759031|9716345|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
8673050|NCT00759096|9716351|FG000|STARTED|Overall Study||30
8673051|NCT00759096|9716351|FG000|COMPLETED|Overall Study||30
8673052|NCT00759096|9716351|FG000|NOT COMPLETED|Overall Study||0
8673053|NCT00759109|9716357|FG000|STARTED|Overall Study||74
8673054|NCT00759109|9716358|FG001|STARTED|Overall Study||76
8673055|NCT00759109|9716357|FG000|COMPLETED|Overall Study|From both arms combined, 7 discontinued due to death and there were 8 deaths during follow up.|35
8673056|NCT00759109|9716358|FG001|COMPLETED|Overall Study|From both arms combined, 7 discontinued due to death and there were 8 deaths during follow up.|41
8673057|NCT00759109|9716357|FG000|NOT COMPLETED|Overall Study||39
8673058|NCT00759109|9716358|FG001|NOT COMPLETED|Overall Study||35
8673059|NCT00759148|9716366|FG000|STARTED|Overall Study||593
8673060|NCT00759148|9716367|FG001|STARTED|Overall Study||586
8673061|NCT00759148|9716366|FG000|COMPLETED|Overall Study||579
8673062|NCT00759148|9716367|FG001|COMPLETED|Overall Study||554
8673063|NCT00759148|9716366|FG000|NOT COMPLETED|Overall Study||14
8673064|NCT00759148|9716367|FG001|NOT COMPLETED|Overall Study||32
8673065|NCT00759161|9716373|FG000|STARTED|Overall Study||35
8673066|NCT00759161|9716373|FG000|COMPLETED|Overall Study||35
8673067|NCT00759161|9716373|FG000|NOT COMPLETED|Overall Study||0
8673068|NCT00759174|9716382|FG000|STARTED|Overall Study||76
8673069|NCT00759174|9716383|FG001|STARTED|Overall Study||597
8673070|NCT00759174|9716382|FG000|COMPLETED|Overall Study||76
8673071|NCT00759174|9716383|FG001|COMPLETED|Overall Study||595
8673072|NCT00759174|9716382|FG000|NOT COMPLETED|Overall Study||0
8673073|NCT00759174|9716383|FG001|NOT COMPLETED|Overall Study||2
8673074|NCT00759187|9716393|FG000|STARTED|Overall Study||8
8673075|NCT00759187|9716394|FG001|STARTED|Overall Study||8
8673076|NCT00759187|9716395|FG002|STARTED|Overall Study||9
8673077|NCT00759187|9716393|FG000|COMPLETED|Overall Study||8
8673078|NCT00759187|9716394|FG001|COMPLETED|Overall Study||8
8673079|NCT00759187|9716395|FG002|COMPLETED|Overall Study||9
8673080|NCT00759187|9716393|FG000|NOT COMPLETED|Overall Study||0
8673081|NCT00759187|9716394|FG001|NOT COMPLETED|Overall Study||0
8673082|NCT00759187|9716395|FG002|NOT COMPLETED|Overall Study||0
8673083|NCT00759330|9716407|FG000|STARTED|Overall Study||20
8673084|NCT00759330|9716408|FG001|STARTED|Overall Study||42
8673085|NCT00759330|9716409|FG002|STARTED|Overall Study||22
8673086|NCT00759330|9716410|FG003|STARTED|Overall Study||43
8673087|NCT00759330|9716407|FG000|COMPLETED|Overall Study||19
8673088|NCT00759330|9716408|FG001|COMPLETED|Overall Study||41
8673089|NCT00759330|9716409|FG002|COMPLETED|Overall Study||22
8673090|NCT00759330|9716410|FG003|COMPLETED|Overall Study||41
8673091|NCT00759330|9716407|FG000|NOT COMPLETED|Overall Study||1
8673092|NCT00759330|9716408|FG001|NOT COMPLETED|Overall Study||1
8673093|NCT00759330|9716409|FG002|NOT COMPLETED|Overall Study||0
8673094|NCT00759330|9716410|FG003|NOT COMPLETED|Overall Study||2
8673095|NCT00759356|9716423|FG000|STARTED|Overall Study||18
8673096|NCT00759356|9716424|FG001|STARTED|Overall Study||18
8673097|NCT00759356|9716423|FG000|COMPLETED|Overall Study||17
8673098|NCT00759356|9716424|FG001|COMPLETED|Overall Study||15
8673099|NCT00759356|9716423|FG000|NOT COMPLETED|Overall Study||1
8673100|NCT00759356|9716424|FG001|NOT COMPLETED|Overall Study||3
8673101|NCT00759395|9716432|FG000|STARTED|Overall Study||13
8673102|NCT00759395|9716433|FG001|STARTED|Overall Study||9
8673103|NCT00759395|9716432|FG000|COMPLETED|Overall Study||11
8673104|NCT00759395|9716433|FG001|COMPLETED|Overall Study||7
8673105|NCT00759395|9716432|FG000|NOT COMPLETED|Overall Study||2
8673106|NCT00759395|9716433|FG001|NOT COMPLETED|Overall Study||2
8673107|NCT00759408|9716439|FG000|STARTED|Overall Study||38
8673108|NCT00759408|9716439|FG000|COMPLETED|Overall Study||19
8673109|NCT00759408|9716439|FG000|NOT COMPLETED|Overall Study||19
8673110|NCT00759473|9716448|FG000|STARTED|Overall Study||10
8673111|NCT00759473|9716449|FG001|STARTED|Overall Study||10
8673112|NCT00759473|9716450|FG002|STARTED|Overall Study||12
8673113|NCT00759473|9716451|FG003|STARTED|Overall Study||23
8673114|NCT00759473|9716452|FG004|STARTED|Overall Study||24
8673115|NCT00759473|9716448|FG000|COMPLETED|Overall Study||10
8673116|NCT00759473|9716449|FG001|COMPLETED|Overall Study||10
8673117|NCT00759473|9716450|FG002|COMPLETED|Overall Study||12
8673118|NCT00759473|9716451|FG003|COMPLETED|Overall Study||23
8673119|NCT00759473|9716452|FG004|COMPLETED|Overall Study||24
8673120|NCT00759473|9716448|FG000|NOT COMPLETED|Overall Study||0
8673121|NCT00759473|9716449|FG001|NOT COMPLETED|Overall Study||0
8673122|NCT00759473|9716450|FG002|NOT COMPLETED|Overall Study||0
8673123|NCT00759473|9716451|FG003|NOT COMPLETED|Overall Study||0
8673124|NCT00759473|9716452|FG004|NOT COMPLETED|Overall Study||0
8673125|NCT00759525|9716464|FG000|STARTED|First Intervention (14 Days)||7
8673126|NCT00759525|9716465|FG001|STARTED|First Intervention (14 Days)||8
8673127|NCT00759525|9716464|FG000|COMPLETED|First Intervention (14 Days)||7
8673128|NCT00759525|9716465|FG001|COMPLETED|First Intervention (14 Days)||8
8673129|NCT00759525|9716464|FG000|NOT COMPLETED|First Intervention (14 Days)||0
8673130|NCT00759525|9716465|FG001|NOT COMPLETED|First Intervention (14 Days)||0
8673131|NCT00759525|9716464|FG000|STARTED|Washout (14 Days)||7
8673132|NCT00759525|9716465|FG001|STARTED|Washout (14 Days)||8
8673133|NCT00759525|9716464|FG000|COMPLETED|Washout (14 Days)||7
8673134|NCT00759525|9716465|FG001|COMPLETED|Washout (14 Days)||8
8673135|NCT00759525|9716464|FG000|NOT COMPLETED|Washout (14 Days)||0
8673136|NCT00759525|9716465|FG001|NOT COMPLETED|Washout (14 Days)||0
8673137|NCT00759525|9716464|FG000|STARTED|Second Intervention (14 Days)||7
8673138|NCT00759525|9716465|FG001|STARTED|Second Intervention (14 Days)||8
8673139|NCT00759525|9716464|FG000|COMPLETED|Second Intervention (14 Days)||7
8673140|NCT00759525|9716465|FG001|COMPLETED|Second Intervention (14 Days)||8
8673141|NCT00759525|9716464|FG000|NOT COMPLETED|Second Intervention (14 Days)||0
8673142|NCT00759525|9716465|FG001|NOT COMPLETED|Second Intervention (14 Days)||0
8673143|NCT00759564|9716476|FG000|STARTED|First Intervention Period (4 Days)||8
8673144|NCT00759564|9716477|FG001|STARTED|First Intervention Period (4 Days)||8
8673145|NCT00759564|9716478|FG002|STARTED|First Intervention Period (4 Days)||8
8673146|NCT00759564|9716479|FG003|STARTED|First Intervention Period (4 Days)||1
8673147|NCT00759564|9716480|FG004|STARTED|First Intervention Period (4 Days)||4
8673148|NCT00759564|9716476|FG000|COMPLETED|First Intervention Period (4 Days)||8
8673149|NCT00759564|9716477|FG001|COMPLETED|First Intervention Period (4 Days)||8
8673150|NCT00759564|9716478|FG002|COMPLETED|First Intervention Period (4 Days)||8
8673151|NCT00759564|9716479|FG003|COMPLETED|First Intervention Period (4 Days)||1
8673152|NCT00759564|9716480|FG004|COMPLETED|First Intervention Period (4 Days)||4
8673153|NCT00759564|9716476|FG000|NOT COMPLETED|First Intervention Period (4 Days)||0
8673154|NCT00759564|9716477|FG001|NOT COMPLETED|First Intervention Period (4 Days)||0
8673155|NCT00759564|9716478|FG002|NOT COMPLETED|First Intervention Period (4 Days)||0
8673156|NCT00759564|9716479|FG003|NOT COMPLETED|First Intervention Period (4 Days)||0
8673157|NCT00759564|9716480|FG004|NOT COMPLETED|First Intervention Period (4 Days)||0
8673158|NCT00759564|9716476|FG000|STARTED|Washout Period (at Least 14 Days)||8
8673159|NCT00759564|9716477|FG001|STARTED|Washout Period (at Least 14 Days)||8
8673160|NCT00759564|9716478|FG002|STARTED|Washout Period (at Least 14 Days)||8
8673161|NCT00759564|9716479|FG003|STARTED|Washout Period (at Least 14 Days)||1
8673162|NCT00759564|9716480|FG004|STARTED|Washout Period (at Least 14 Days)||4
8673163|NCT00759564|9716476|FG000|COMPLETED|Washout Period (at Least 14 Days)||8
8673164|NCT00759564|9716477|FG001|COMPLETED|Washout Period (at Least 14 Days)||8
8673165|NCT00759564|9716478|FG002|COMPLETED|Washout Period (at Least 14 Days)||8
8673166|NCT00759564|9716479|FG003|COMPLETED|Washout Period (at Least 14 Days)||1
8673167|NCT00759564|9716480|FG004|COMPLETED|Washout Period (at Least 14 Days)||3
8673168|NCT00759564|9716476|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8673169|NCT00759564|9716477|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8673170|NCT00759564|9716478|FG002|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8673171|NCT00759564|9716479|FG003|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8673172|NCT00759564|9716480|FG004|NOT COMPLETED|Washout Period (at Least 14 Days)||1
8673173|NCT00759564|9716476|FG000|STARTED|Second Intervention Period (4 Days)||8
8673174|NCT00759564|9716477|FG001|STARTED|Second Intervention Period (4 Days)||8
8673175|NCT00759564|9716478|FG002|STARTED|Second Intervention Period (4 Days)||8
8673176|NCT00759564|9716479|FG003|STARTED|Second Intervention Period (4 Days)||1
8673177|NCT00759564|9716480|FG004|STARTED|Second Intervention Period (4 Days)||3
8673178|NCT00759564|9716476|FG000|COMPLETED|Second Intervention Period (4 Days)||8
8673179|NCT00759564|9716477|FG001|COMPLETED|Second Intervention Period (4 Days)||8
8673180|NCT00759564|9716478|FG002|COMPLETED|Second Intervention Period (4 Days)||8
8673181|NCT00759564|9716479|FG003|COMPLETED|Second Intervention Period (4 Days)||1
8673182|NCT00759564|9716480|FG004|COMPLETED|Second Intervention Period (4 Days)||3
8673183|NCT00759564|9716476|FG000|NOT COMPLETED|Second Intervention Period (4 Days)||0
8673184|NCT00759564|9716477|FG001|NOT COMPLETED|Second Intervention Period (4 Days)||0
8673185|NCT00759564|9716478|FG002|NOT COMPLETED|Second Intervention Period (4 Days)||0
8673186|NCT00759564|9716479|FG003|NOT COMPLETED|Second Intervention Period (4 Days)||0
8673187|NCT00759564|9716480|FG004|NOT COMPLETED|Second Intervention Period (4 Days)||0
8673188|NCT00759603|9716512|FG000|STARTED|Overall Study||59
8673189|NCT00759603|9716512|FG000|COMPLETED|Overall Study||59
8673190|NCT00759603|9716512|FG000|NOT COMPLETED|Overall Study||0
8673191|NCT00759642|9716516|FG000|STARTED|Overall Study||33
8673192|NCT00759642|9716516|FG000|COMPLETED|Overall Study||33
8673193|NCT00759642|9716516|FG000|NOT COMPLETED|Overall Study||0
8673194|NCT00759655|9716520|FG000|STARTED|Overall Study||1
8673195|NCT00759655|9716520|FG000|COMPLETED|Overall Study||0
8673196|NCT00759655|9716520|FG000|NOT COMPLETED|Overall Study||1
8673197|NCT00759668|9716526|FG000|STARTED|Overall Study||17
8673198|NCT00759668|9716527|FG001|STARTED|Overall Study||18
8673199|NCT00759668|9716526|FG000|COMPLETED|Overall Study||16
8673200|NCT00759668|9716527|FG001|COMPLETED|Overall Study||15
8673201|NCT00759668|9716526|FG000|NOT COMPLETED|Overall Study||1
8673202|NCT00759668|9716527|FG001|NOT COMPLETED|Overall Study||3
8673203|NCT00759681|9716535|FG000|STARTED|Overall Study||107
8673204|NCT00759681|9716536|FG001|STARTED|Overall Study||110
8673205|NCT00759681|9716535|FG000|COMPLETED|Overall Study||97
8673206|NCT00759681|9716536|FG001|COMPLETED|Overall Study||100
8673207|NCT00759681|9716535|FG000|NOT COMPLETED|Overall Study||10
8673208|NCT00759681|9716536|FG001|NOT COMPLETED|Overall Study||10
8673209|NCT00759707|9716543|FG000|STARTED|Overall Study||19
8673210|NCT00759707|9716543|FG000|COMPLETED|Overall Study||19
8673211|NCT00759707|9716543|FG000|NOT COMPLETED|Overall Study||0
8673212|NCT00759759|9716549|FG000|STARTED|Overall Study||18
8673213|NCT00759759|9716550|FG001|STARTED|Overall Study||18
8673214|NCT00759759|9716549|FG000|COMPLETED|Overall Study||14
8673215|NCT00759759|9716550|FG001|COMPLETED|Overall Study||17
8673216|NCT00759759|9716549|FG000|NOT COMPLETED|Overall Study||4
8673217|NCT00759759|9716550|FG001|NOT COMPLETED|Overall Study||1
8673218|NCT00759772|9716558|FG000|STARTED|Overall Study||12
8673219|NCT00759772|9716559|FG001|STARTED|Overall Study||11
8673220|NCT00759772|9716558|FG000|COMPLETED|Overall Study||12
8673221|NCT00759772|9716559|FG001|COMPLETED|Overall Study||11
8673222|NCT00759772|9716558|FG000|NOT COMPLETED|Overall Study||0
8673223|NCT00759772|9716559|FG001|NOT COMPLETED|Overall Study||0
8673224|NCT00759785|9716567|FG000|STARTED|Overall Study||26
8673225|NCT00759785|9716568|FG001|STARTED|Overall Study||22
8673226|NCT00759785|9716567|FG000|Treated|Overall Study||25
8673227|NCT00759785|9716568|FG001|Treated|Overall Study||20
8673228|NCT00759785|9716567|FG000|COMPLETED|Overall Study||14
8673229|NCT00759785|9716568|FG001|COMPLETED|Overall Study||17
8673230|NCT00759785|9716567|FG000|NOT COMPLETED|Overall Study||12
8673231|NCT00759785|9716568|FG001|NOT COMPLETED|Overall Study||5
8673232|NCT00759798|9716574|FG000|STARTED|Overall Study||289
8673233|NCT00759798|9716574|FG000|COMPLETED|Overall Study||289
8673234|NCT00759798|9716574|FG000|NOT COMPLETED|Overall Study||0
8673235|NCT00759811|9716580|FG000|STARTED|Overall Study||25
8673236|NCT00759811|9716581|FG001|STARTED|Overall Study||25
8673237|NCT00759811|9716580|FG000|COMPLETED|Overall Study||23
8673238|NCT00759811|9716581|FG001|COMPLETED|Overall Study||24
8673239|NCT00759811|9716580|FG000|NOT COMPLETED|Overall Study||2
8673240|NCT00759811|9716581|FG001|NOT COMPLETED|Overall Study||1
8673241|NCT00759863|9716589|FG000|STARTED|Overall Study||144
8673242|NCT00759863|9716590|FG001|STARTED|Overall Study||98
8673243|NCT00759863|9716589|FG000|COMPLETED|Overall Study||124
8673244|NCT00759863|9716590|FG001|COMPLETED|Overall Study||80
8673245|NCT00759863|9716589|FG000|NOT COMPLETED|Overall Study||20
8673246|NCT00759863|9716590|FG001|NOT COMPLETED|Overall Study||18
8673247|NCT00759876|9716596|FG000|STARTED|Overall Study||36
8673248|NCT00759876|9716596|FG000|As-Treated Population|Overall Study||36
8673249|NCT00759876|9716596|FG000|Evaluable Population|Overall Study||35
8673250|NCT00759876|9716596|FG000|Ambulatory Evaluable Population|Overall Study||24
8673251|NCT00759876|9716596|FG000|COMPLETED|Overall Study||0
8673252|NCT00759876|9716596|FG000|NOT COMPLETED|Overall Study||36
8673253|NCT00759902|9716602|FG000|STARTED|Overall Study||18
8673254|NCT00759902|9716603|FG001|STARTED|Overall Study||18
8673255|NCT00759902|9716602|FG000|COMPLETED|Overall Study||18
8673256|NCT00759902|9716603|FG001|COMPLETED|Overall Study||17
8673257|NCT00759902|9716602|FG000|NOT COMPLETED|Overall Study||0
8673258|NCT00759902|9716603|FG001|NOT COMPLETED|Overall Study||1
8673259|NCT00759915|9716611|FG000|STARTED|Overall Study||18
8673260|NCT00759915|9716612|FG001|STARTED|Overall Study||18
8673261|NCT00759915|9716611|FG000|COMPLETED|Overall Study||17
8673262|NCT00759915|9716612|FG001|COMPLETED|Overall Study||17
8673263|NCT00759915|9716611|FG000|NOT COMPLETED|Overall Study||1
8673264|NCT00759915|9716612|FG001|NOT COMPLETED|Overall Study||1
8673265|NCT00759941|9716620|FG000|STARTED|Overall Study||42
8673266|NCT00759941|9716621|FG001|STARTED|Overall Study||44
8673267|NCT00759941|9716620|FG000|COMPLETED|Overall Study||39
8673268|NCT00759941|9716621|FG001|COMPLETED|Overall Study||43
8673269|NCT00759941|9716620|FG000|NOT COMPLETED|Overall Study||3
8673270|NCT00759941|9716621|FG001|NOT COMPLETED|Overall Study||1
8673271|NCT00759954|9716629|FG000|STARTED|Overall Study|All assigned participants entered trial|18
8673272|NCT00759954|9716630|FG001|STARTED|Overall Study|All assigned participants entered trial|18
8673273|NCT00759954|9716629|FG000|COMPLETED|Overall Study|One participant(#225) did not enter Period 2 and one participant (#203)dropped out during Period 2|16
8673274|NCT00759954|9716630|FG001|COMPLETED|Overall Study|Two participants (#202 and #228) did not enter Period 2.|16
8673275|NCT00759954|9716629|FG000|NOT COMPLETED|Overall Study||2
8673276|NCT00759954|9716630|FG001|NOT COMPLETED|Overall Study||2
8673277|NCT00759967|9716636|FG000|STARTED|First Intervention||10
8673278|NCT00759967|9716637|FG001|STARTED|First Intervention||9
8673279|NCT00759967|9716636|FG000|COMPLETED|First Intervention||10
8673280|NCT00759967|9716637|FG001|COMPLETED|First Intervention||9
8673281|NCT00759967|9716636|FG000|NOT COMPLETED|First Intervention||0
8673282|NCT00759967|9716637|FG001|NOT COMPLETED|First Intervention||0
8673283|NCT00759967|9716636|FG000|STARTED|Second Intervention||10
8673284|NCT00759967|9716637|FG001|STARTED|Second Intervention||9
8673285|NCT00759967|9716636|FG000|COMPLETED|Second Intervention||8
8673286|NCT00759967|9716637|FG001|COMPLETED|Second Intervention||9
8673287|NCT00759967|9716636|FG000|NOT COMPLETED|Second Intervention||2
8673288|NCT00759967|9716637|FG001|NOT COMPLETED|Second Intervention||0
8673289|NCT00760006|9716649|FG000|STARTED|Overall Study||86
8673290|NCT00760006|9716650|FG001|STARTED|Overall Study||138
8673291|NCT00760006|9716649|FG000|COMPLETED|Overall Study||86
8673292|NCT00760006|9716650|FG001|COMPLETED|Overall Study||138
8673293|NCT00760006|9716649|FG000|NOT COMPLETED|Overall Study||0
8673294|NCT00760006|9716650|FG001|NOT COMPLETED|Overall Study||0
8673295|NCT00760019|9716658|FG000|STARTED|Overall Study||15
8673296|NCT00760019|9716659|FG001|STARTED|Overall Study||15
8673297|NCT00760019|9716660|FG002|STARTED|Overall Study||14
8673298|NCT00760019|9716661|FG003|STARTED|Overall Study||14
8673299|NCT00760019|9716658|FG000|COMPLETED|Overall Study||15
8673300|NCT00760019|9716659|FG001|COMPLETED|Overall Study||15
8673301|NCT00760019|9716660|FG002|COMPLETED|Overall Study||14
8673302|NCT00760019|9716661|FG003|COMPLETED|Overall Study||14
8673303|NCT00760019|9716658|FG000|NOT COMPLETED|Overall Study||0
8673304|NCT00760019|9716659|FG001|NOT COMPLETED|Overall Study||0
8673305|NCT00760019|9716660|FG002|NOT COMPLETED|Overall Study||0
8673306|NCT00760019|9716661|FG003|NOT COMPLETED|Overall Study||0
8673307|NCT00760084|9716667|FG000|STARTED|Overall Study||10
8673308|NCT00760084|9716667|FG000|COMPLETED|Overall Study||0
8673309|NCT00760084|9716667|FG000|NOT COMPLETED|Overall Study||10
8673310|NCT00760214|9716674|FG000|STARTED|Overall Study||295
8673311|NCT00760214|9716675|FG001|STARTED|Overall Study||294
8673312|NCT00760214|9716676|FG002|STARTED|Overall Study||296
8673313|NCT00760214|9716674|FG000|COMPLETED|Overall Study||265
8673314|NCT00760214|9716675|FG001|COMPLETED|Overall Study||264
8673315|NCT00760214|9716676|FG002|COMPLETED|Overall Study||255
8673316|NCT00760214|9716674|FG000|NOT COMPLETED|Overall Study||30
8673317|NCT00760214|9716675|FG001|NOT COMPLETED|Overall Study||30
8673318|NCT00760214|9716676|FG002|NOT COMPLETED|Overall Study||41
8673319|NCT00760266|9716686|FG000|STARTED|Overall Study||228
8673320|NCT00760266|9716687|FG001|STARTED|Overall Study||223
8673321|NCT00760266|9716686|FG000|COMPLETED|Overall Study||204
8673322|NCT00760266|9716687|FG001|COMPLETED|Overall Study||205
8673323|NCT00760266|9716686|FG000|NOT COMPLETED|Overall Study||24
8673324|NCT00760266|9716687|FG001|NOT COMPLETED|Overall Study||18
8673325|NCT00760383|9716695|FG000|STARTED|Overall Study||21
8673326|NCT00760383|9716696|FG001|STARTED|Overall Study||19
8673327|NCT00760383|9716695|FG000|COMPLETED|Overall Study||16
8673328|NCT00760383|9716696|FG001|COMPLETED|Overall Study||12
8673329|NCT00760383|9716695|FG000|NOT COMPLETED|Overall Study||5
8673330|NCT00760383|9716696|FG001|NOT COMPLETED|Overall Study||7
8673331|NCT00760435|9716704|FG000|STARTED|Overall Study||98
8673332|NCT00760435|9716705|FG001|STARTED|Overall Study||98
8673333|NCT00760435|9716704|FG000|COMPLETED|Overall Study||94
8673334|NCT00760435|9716705|FG001|COMPLETED|Overall Study||93
8673335|NCT00760435|9716704|FG000|NOT COMPLETED|Overall Study||4
8673336|NCT00760435|9716705|FG001|NOT COMPLETED|Overall Study||5
8673337|NCT00760474|9716711|FG000|STARTED|Period 1 (P1)||13
8673338|NCT00760474|9716712|FG001|STARTED|Period 1 (P1)||14
8673339|NCT00760474|9716711|FG000|Treated|Period 1 (P1)|1 participant discontinued in P1; re-entered with new identification number and completed P1, P2.|13
8673340|NCT00760474|9716712|FG001|Treated|Period 1 (P1)|1 participant discontinued in P1; re-entered with new identification number and completed P1, P2.|14
8673341|NCT00760474|9716711|FG000|Overall Number of Unique Participants|Period 1 (P1)||12
8673342|NCT00760474|9716712|FG001|Overall Number of Unique Participants|Period 1 (P1)||13
8673343|NCT00760474|9716711|FG000|COMPLETED|Period 1 (P1)||12
8673344|NCT00760474|9716712|FG001|COMPLETED|Period 1 (P1)||13
8673345|NCT00760474|9716711|FG000|NOT COMPLETED|Period 1 (P1)||1
8673346|NCT00760474|9716712|FG001|NOT COMPLETED|Period 1 (P1)||1
8673347|NCT00760474|9716711|FG000|STARTED|Placebo Washout Period||12
8673348|NCT00760474|9716712|FG001|STARTED|Placebo Washout Period||13
8673349|NCT00760474|9716711|FG000|COMPLETED|Placebo Washout Period||12
8673350|NCT00760474|9716712|FG001|COMPLETED|Placebo Washout Period||12
8673351|NCT00760474|9716711|FG000|NOT COMPLETED|Placebo Washout Period||0
8673352|NCT00760474|9716712|FG001|NOT COMPLETED|Placebo Washout Period||1
8673353|NCT00760474|9716711|FG000|STARTED|Period 2 (P2)||12
8673354|NCT00760474|9716712|FG001|STARTED|Period 2 (P2)||12
8673355|NCT00760474|9716711|FG000|COMPLETED|Period 2 (P2)||11
8673356|NCT00760474|9716712|FG001|COMPLETED|Period 2 (P2)||11
8673357|NCT00760474|9716711|FG000|NOT COMPLETED|Period 2 (P2)||1
8673358|NCT00760474|9716712|FG001|NOT COMPLETED|Period 2 (P2)||1
8673359|NCT00760487|9716719|FG000|STARTED|Overall Study||120
8673360|NCT00760487|9716719|FG000|COMPLETED|Overall Study||117
8673361|NCT00760487|9716719|FG000|NOT COMPLETED|Overall Study||3
8673362|NCT00760513|9716725|FG000|STARTED|Overall Study||51
8673363|NCT00760513|9716726|FG001|STARTED|Overall Study||52
8673364|NCT00760513|9716725|FG000|COMPLETED|Overall Study||46
8673365|NCT00760513|9716726|FG001|COMPLETED|Overall Study||45
8673366|NCT00760513|9716725|FG000|NOT COMPLETED|Overall Study||5
8673367|NCT00760513|9716726|FG001|NOT COMPLETED|Overall Study||7
8673368|NCT00760526|9716736|FG000|STARTED|Overall Study||74
8673369|NCT00760526|9716737|FG001|STARTED|Overall Study||72
8673370|NCT00760526|9716736|FG000|COMPLETED|Overall Study||69
8673371|NCT00760526|9716737|FG001|COMPLETED|Overall Study||68
8673372|NCT00760526|9716736|FG000|NOT COMPLETED|Overall Study||5
8673373|NCT00760526|9716737|FG001|NOT COMPLETED|Overall Study||4
8673374|NCT00760552|9716752|FG000|STARTED|Overall Study||61
8673375|NCT00760552|9716753|FG001|STARTED|Overall Study||62
8673376|NCT00760552|9716752|FG000|COMPLETED|Overall Study||48
8673377|NCT00760552|9716753|FG001|COMPLETED|Overall Study||52
8673378|NCT00760552|9716752|FG000|NOT COMPLETED|Overall Study||13
8673379|NCT00760552|9716753|FG001|NOT COMPLETED|Overall Study||10
8673380|NCT00760578|9716763|FG000|STARTED|Overall Study||22
8673381|NCT00760578|9716764|FG001|STARTED|Overall Study||21
8673382|NCT00760578|9716765|FG002|STARTED|Overall Study||21
8673383|NCT00760578|9716766|FG003|STARTED|Overall Study||22
8673384|NCT00760578|9716763|FG000|Entered Drug Treatment Period|Overall Study||21
8673385|NCT00760578|9716764|FG001|Entered Drug Treatment Period|Overall Study||20
8673386|NCT00760578|9716765|FG002|Entered Drug Treatment Period|Overall Study||19
8673387|NCT00760578|9716766|FG003|Entered Drug Treatment Period|Overall Study||22
8673388|NCT00760578|9716763|FG000|COMPLETED|Overall Study||19
8673389|NCT00760578|9716764|FG001|COMPLETED|Overall Study||19
8673390|NCT00760578|9716765|FG002|COMPLETED|Overall Study||16
8673391|NCT00760578|9716766|FG003|COMPLETED|Overall Study||18
8673392|NCT00760578|9716763|FG000|NOT COMPLETED|Overall Study||3
8673393|NCT00760578|9716764|FG001|NOT COMPLETED|Overall Study||2
8673394|NCT00760578|9716765|FG002|NOT COMPLETED|Overall Study||5
8673395|NCT00760578|9716766|FG003|NOT COMPLETED|Overall Study||4
8673396|NCT00760617|9716784|FG000|STARTED|Overall Study||266
8673397|NCT00760617|9716785|FG001|STARTED|Overall Study||144
8673398|NCT00760617|9716786|FG002|STARTED|Overall Study||116
8673399|NCT00760617|9716784|FG000|COMPLETED|Overall Study||261
8673400|NCT00760617|9716785|FG001|COMPLETED|Overall Study||142
8673401|NCT00760617|9716786|FG002|COMPLETED|Overall Study||111
8673402|NCT00760617|9716784|FG000|NOT COMPLETED|Overall Study||5
8673403|NCT00760617|9716785|FG001|NOT COMPLETED|Overall Study||2
8673404|NCT00760617|9716786|FG002|NOT COMPLETED|Overall Study||5
8673405|NCT00760669|9716794|FG000|STARTED|Overall Study||1061
8673406|NCT00760669|9716794|FG000|COMPLETED|Overall Study||1031
8673407|NCT00760669|9716794|FG000|NOT COMPLETED|Overall Study||30
8673408|NCT00760747|9716800|FG000|STARTED|Study Period II||57
8673409|NCT00760747|9716801|FG001|STARTED|Study Period II||55
8673410|NCT00760747|9716800|FG000|Received at Least One Dose of Study Drug|Study Period II||57
8673411|NCT00760747|9716801|FG001|Received at Least One Dose of Study Drug|Study Period II||54
8673412|NCT00760747|9716800|FG000|COMPLETED|Study Period II||44
8673413|NCT00760747|9716801|FG001|COMPLETED|Study Period II||41
8673414|NCT00760747|9716800|FG000|NOT COMPLETED|Study Period II||13
8673415|NCT00760747|9716801|FG001|NOT COMPLETED|Study Period II||14
8673416|NCT00760747|9716800|FG000|STARTED|Study Period III||44
8673417|NCT00760747|9716801|FG001|STARTED|Study Period III||41
8673418|NCT00760747|9716800|FG000|COMPLETED|Study Period III||41
8673419|NCT00760747|9716801|FG001|COMPLETED|Study Period III||38
8673420|NCT00760747|9716800|FG000|NOT COMPLETED|Study Period III||3
8673421|NCT00760747|9716801|FG001|NOT COMPLETED|Study Period III||3
8673422|NCT00760838|9716809|FG000|STARTED|Overall Study||54
8673423|NCT00760838|9716810|FG001|STARTED|Overall Study||55
8673424|NCT00760838|9716809|FG000|COMPLETED|Overall Study||49
8673425|NCT00760838|9716810|FG001|COMPLETED|Overall Study||53
8673426|NCT00760838|9716809|FG000|NOT COMPLETED|Overall Study||5
8673427|NCT00760838|9716810|FG001|NOT COMPLETED|Overall Study||2
8673428|NCT00760877|9716818|FG000|STARTED|Overall Study||104
8673429|NCT00760877|9716819|FG001|STARTED|Overall Study||103
8673430|NCT00760877|9716818|FG000|Cross-over to Nilotinib|Overall Study|Not applicable: cross-over occurred from imatinib to nilotinib only.|0
8673431|NCT00760877|9716819|FG001|Cross-over to Nilotinib|Overall Study||46
8673432|NCT00760877|9716818|FG000|Safety Set|Overall Study||101
8673433|NCT00760877|9716819|FG001|Safety Set|Overall Study||103
8673434|NCT00760877|9716818|FG000|COMPLETED|Overall Study||59
8673435|NCT00760877|9716819|FG001|COMPLETED|Overall Study||77
8673436|NCT00760877|9716818|FG000|NOT COMPLETED|Overall Study||45
8673437|NCT00760877|9716819|FG001|NOT COMPLETED|Overall Study||26
8673438|NCT00760929|9716830|FG000|STARTED|Overall Study||26
8673439|NCT00760929|9716831|FG001|STARTED|Overall Study||29
8673440|NCT00760929|9716832|FG002|STARTED|Overall Study||59
8673441|NCT00760929|9716833|FG003|STARTED|Overall Study||57
8673442|NCT00760929|9716830|FG000|COMPLETED|Overall Study||0
8673443|NCT00760929|9716831|FG001|COMPLETED|Overall Study||1
8673444|NCT00760929|9716832|FG002|COMPLETED|Overall Study||1
8673445|NCT00760929|9716833|FG003|COMPLETED|Overall Study||2
8673446|NCT00760929|9716830|FG000|NOT COMPLETED|Overall Study||26
8673447|NCT00760929|9716831|FG001|NOT COMPLETED|Overall Study||28
8673448|NCT00760929|9716832|FG002|NOT COMPLETED|Overall Study||58
8673449|NCT00760929|9716833|FG003|NOT COMPLETED|Overall Study||55
8673450|NCT00760994|9716845|FG000|STARTED|Overall Study||29
8673451|NCT00760994|9716846|FG001|STARTED|Overall Study||31
8673452|NCT00760994|9716847|FG002|STARTED|Overall Study||20
8673453|NCT00760994|9716845|FG000|COMPLETED|Overall Study||25
8673454|NCT00760994|9716846|FG001|COMPLETED|Overall Study||27
8673455|NCT00760994|9716847|FG002|COMPLETED|Overall Study||17
8673456|NCT00760994|9716845|FG000|NOT COMPLETED|Overall Study||4
8673457|NCT00760994|9716846|FG001|NOT COMPLETED|Overall Study||4
8673458|NCT00760994|9716847|FG002|NOT COMPLETED|Overall Study||3
8673459|NCT00761007|9716861|FG000|STARTED|Overall Study||142
8673460|NCT00761007|9716862|FG001|STARTED|Overall Study||135
8673461|NCT00761007|9716863|FG002|STARTED|Overall Study||139
8673462|NCT00761007|9716864|FG003|STARTED|Overall Study||138
8673463|NCT00761007|9716861|FG000|Safety (>=1 Dose of Study Medication)|Overall Study||140
8673464|NCT00761007|9716862|FG001|Safety (>=1 Dose of Study Medication)|Overall Study||135
8673465|NCT00761007|9716863|FG002|Safety (>=1 Dose of Study Medication)|Overall Study||139
8673466|NCT00761007|9716864|FG003|Safety (>=1 Dose of Study Medication)|Overall Study||137
8673467|NCT00761007|9716861|FG000|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||140
8673468|NCT00761007|9716862|FG001|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||133
8673469|NCT00761007|9716863|FG002|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||135
8673470|NCT00761007|9716864|FG003|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||136
8673471|NCT00761007|9716861|FG000|COMPLETED|Overall Study||129
8673472|NCT00761007|9716862|FG001|COMPLETED|Overall Study||124
8673473|NCT00761007|9716863|FG002|COMPLETED|Overall Study||121
8673474|NCT00761007|9716864|FG003|COMPLETED|Overall Study||131
8673475|NCT00761007|9716861|FG000|NOT COMPLETED|Overall Study||13
8673476|NCT00761007|9716862|FG001|NOT COMPLETED|Overall Study||11
8673477|NCT00761007|9716863|FG002|NOT COMPLETED|Overall Study||18
8673478|NCT00761007|9716864|FG003|NOT COMPLETED|Overall Study||7
8673479|NCT00761085|9716878|FG000|STARTED|Overall Study||12
8673480|NCT00761085|9716879|FG001|STARTED|Overall Study||12
8673481|NCT00761085|9716880|FG002|STARTED|Overall Study||11
8673482|NCT00761085|9716881|FG003|STARTED|Overall Study||12
8673483|NCT00761085|9716878|FG000|COMPLETED|Overall Study||12
8673484|NCT00761085|9716879|FG001|COMPLETED|Overall Study||6
8673485|NCT00761085|9716880|FG002|COMPLETED|Overall Study||11
8673486|NCT00761085|9716881|FG003|COMPLETED|Overall Study||8
8673487|NCT00761085|9716878|FG000|NOT COMPLETED|Overall Study||0
8673488|NCT00761085|9716879|FG001|NOT COMPLETED|Overall Study||6
8673489|NCT00761085|9716880|FG002|NOT COMPLETED|Overall Study||0
8673490|NCT00761085|9716881|FG003|NOT COMPLETED|Overall Study||4
8673491|NCT00761137|9716891|FG000|STARTED|Overall Study||19
8673492|NCT00761137|9716891|FG000|Placebo|Overall Study||19
8673493|NCT00761137|9716891|FG000|0.3 mg Tropicamide|Overall Study||19
8673494|NCT00761137|9716891|FG000|1 mg Tropicamide|Overall Study||19
8673495|NCT00761137|9716891|FG000|3 mg Tropicamide|Overall Study||19
8673496|NCT00761137|9716891|FG000|COMPLETED|Overall Study||19
8673497|NCT00761137|9716891|FG000|NOT COMPLETED|Overall Study||0
8673498|NCT00761150|9716901|FG000|STARTED|Open-label Period||308
8673499|NCT00761150|9716902|FG001|STARTED|Open-label Period||0
8673500|NCT00761150|9716903|FG002|STARTED|Open-label Period||0
8673501|NCT00761150|9716901|FG000|COMPLETED|Open-label Period||238
8673502|NCT00761150|9716902|FG001|COMPLETED|Open-label Period||0
8673503|NCT00761150|9716903|FG002|COMPLETED|Open-label Period||0
8673504|NCT00761150|9716901|FG000|NOT COMPLETED|Open-label Period||70
8673505|NCT00761150|9716902|FG001|NOT COMPLETED|Open-label Period||0
8673506|NCT00761150|9716903|FG002|NOT COMPLETED|Open-label Period||0
8673507|NCT00761150|9716901|FG000|STARTED|Double-blind Period||0
8673508|NCT00761150|9716902|FG001|STARTED|Double-blind Period||120
8673509|NCT00761150|9716903|FG002|STARTED|Double-blind Period||118
8673510|NCT00761150|9716901|FG000|COMPLETED|Double-blind Period||0
8673511|NCT00761150|9716902|FG001|COMPLETED|Double-blind Period||106
8673512|NCT00761150|9716903|FG002|COMPLETED|Double-blind Period||89
8673513|NCT00761150|9716901|FG000|NOT COMPLETED|Double-blind Period||0
8673514|NCT00761150|9716902|FG001|NOT COMPLETED|Double-blind Period||14
8673515|NCT00761150|9716903|FG002|NOT COMPLETED|Double-blind Period||29
8673516|NCT00761189|9716910|FG000|STARTED|Overall Study||491
8673517|NCT00761189|9716910|FG000|COMPLETED|Overall Study||306
8673518|NCT00761189|9716910|FG000|NOT COMPLETED|Overall Study||185
8673519|NCT00761202|9716916|FG000|STARTED|Overall Study||22
8673520|NCT00761202|9716917|FG001|STARTED|Overall Study||28
8673521|NCT00761202|9716916|FG000|COMPLETED|Overall Study||21
8673522|NCT00761202|9716917|FG001|COMPLETED|Overall Study||26
8673523|NCT00761202|9716916|FG000|NOT COMPLETED|Overall Study||1
8673524|NCT00761202|9716917|FG001|NOT COMPLETED|Overall Study||2
8673525|NCT00761215|9716926|FG000|STARTED|Overall Study||64
8673526|NCT00761215|9716927|FG001|STARTED|Overall Study||64
8673527|NCT00761215|9716928|FG002|STARTED|Overall Study||64
8673528|NCT00761215|9716926|FG000|COMPLETED|Overall Study||55
8673529|NCT00761215|9716927|FG001|COMPLETED|Overall Study||60
8673530|NCT00761215|9716928|FG002|COMPLETED|Overall Study||56
8673531|NCT00761215|9716926|FG000|NOT COMPLETED|Overall Study||9
8673532|NCT00761215|9716927|FG001|NOT COMPLETED|Overall Study||4
8673533|NCT00761215|9716928|FG002|NOT COMPLETED|Overall Study||8
8673534|NCT00761267|9716942|FG000|STARTED|Overall Study||20
8673535|NCT00761267|9716943|FG001|STARTED|Overall Study||20
8673536|NCT00761267|9716944|FG002|STARTED|Overall Study||30
8673537|NCT00761267|9716942|FG000|Treated|Overall Study||19
8673538|NCT00761267|9716943|FG001|Treated|Overall Study||19
8673539|NCT00761267|9716944|FG002|Treated|Overall Study||30
8673540|NCT00761267|9716942|FG000|COMPLETED|Overall Study||18
8673541|NCT00761267|9716943|FG001|COMPLETED|Overall Study||16
8673542|NCT00761267|9716944|FG002|COMPLETED|Overall Study||24
8673543|NCT00761267|9716942|FG000|NOT COMPLETED|Overall Study||2
8673544|NCT00761267|9716943|FG001|NOT COMPLETED|Overall Study||4
8673545|NCT00761267|9716944|FG002|NOT COMPLETED|Overall Study||6
8673546|NCT00761280|9716965|FG000|STARTED|Randomization to First Dose||14
8673547|NCT00761280|9716966|FG001|STARTED|Randomization to First Dose||13
8673548|NCT00761280|9716965|FG000|Catheter Surgery|Randomization to First Dose|Safety population|13
8673549|NCT00761280|9716966|FG001|Catheter Surgery|Randomization to First Dose|Not applicable to control group|0
8673550|NCT00761280|9716965|FG000|First Dose of Study Drug / Chemotherapy|Randomization to First Dose||12
8673551|NCT00761280|9716966|FG001|First Dose of Study Drug / Chemotherapy|Randomization to First Dose|Safety population|11
8673552|NCT00761280|9716965|FG000|COMPLETED|Randomization to First Dose||12
8673553|NCT00761280|9716966|FG001|COMPLETED|Randomization to First Dose||11
8673554|NCT00761280|9716965|FG000|NOT COMPLETED|Randomization to First Dose||2
8673555|NCT00761280|9716966|FG001|NOT COMPLETED|Randomization to First Dose||2
8673556|NCT00761280|9716965|FG000|STARTED|First Dose to End of Study||12
8673557|NCT00761280|9716966|FG001|STARTED|First Dose to End of Study||11
8673558|NCT00761280|9716965|FG000|COMPLETED|First Dose to End of Study|Study was discontinued early due to the inability to recruit a sufficient number of participants.|0
8673559|NCT00761280|9716966|FG001|COMPLETED|First Dose to End of Study|Study was discontinued early due to the inability to recruit a sufficient number of participants.|0
8673560|NCT00761280|9716965|FG000|NOT COMPLETED|First Dose to End of Study||12
8673561|NCT00761280|9716966|FG001|NOT COMPLETED|First Dose to End of Study||11
8673562|NCT00761306|9716972|FG000|STARTED|Overall Study||74
8673563|NCT00761306|9716972|FG000|COMPLETED|Overall Study||54
8673564|NCT00761306|9716972|FG000|NOT COMPLETED|Overall Study||20
8673565|NCT00761319|9716978|FG000|STARTED|Overall Study||353
8673566|NCT00761319|9716979|FG001|STARTED|Overall Study||352
8673567|NCT00761319|9716978|FG000|COMPLETED|Overall Study||305
8673568|NCT00761319|9716979|FG001|COMPLETED|Overall Study||318
8673569|NCT00761319|9716978|FG000|NOT COMPLETED|Overall Study||48
8673570|NCT00761319|9716979|FG001|NOT COMPLETED|Overall Study||34
8673571|NCT00761345|9716985|FG000|STARTED|Overall Study||27
8673572|NCT00761345|9716985|FG000|COMPLETED|Overall Study||24
8673573|NCT00761345|9716985|FG000|NOT COMPLETED|Overall Study||3
8673574|NCT00761462|9716991|FG000|STARTED|Treatment|Patients enrolled in study group|510
8673575|NCT00761462|9716992|FG001|STARTED|Treatment|Patients enrolled in study group|519
8673576|NCT00761462|9716991|FG000|COMPLETED|Treatment|Patients with confirmed intake of study drug|487
8673577|NCT00761462|9716992|FG001|COMPLETED|Treatment|Patients with confirmed intake of study drug|507
8673578|NCT00761462|9716991|FG000|NOT COMPLETED|Treatment||23
8673579|NCT00761462|9716992|FG001|NOT COMPLETED|Treatment||12
8673580|NCT00761462|9716991|FG000|STARTED|2 or 5 Years Long-term Safety Follow-up|Patients with confirmed intake of study drug entering long-term safety evaluation|487
8673581|NCT00761462|9716992|FG001|STARTED|2 or 5 Years Long-term Safety Follow-up|Patients with confirmed intake of study drug entering long-term safety evaluation|507
8673582|NCT00761462|9716991|FG000|4-6 Weeks Post Treatment|2 or 5 Years Long-term Safety Follow-up||487
8673583|NCT00761462|9716992|FG001|4-6 Weeks Post Treatment|2 or 5 Years Long-term Safety Follow-up||507
8673584|NCT00761462|9716991|FG000|1 Year Follow-up|2 or 5 Years Long-term Safety Follow-up||485
8673585|NCT00761462|9716992|FG001|1 Year Follow-up|2 or 5 Years Long-term Safety Follow-up||507
8673586|NCT00761462|9716991|FG000|COMPLETED|2 or 5 Years Long-term Safety Follow-up|Patients under safety evaluation at end of 5 year safety Follow-up.|333
8673587|NCT00761462|9716992|FG001|COMPLETED|2 or 5 Years Long-term Safety Follow-up|Patients under safety evaluation at end of 2 year safety Follow-up.|456
8673588|NCT00761462|9716991|FG000|NOT COMPLETED|2 or 5 Years Long-term Safety Follow-up||154
8673589|NCT00761462|9716992|FG001|NOT COMPLETED|2 or 5 Years Long-term Safety Follow-up||51
8673590|NCT00761514|9716998|FG000|STARTED|Overall Study||14
8673591|NCT00761514|9716998|FG000|COMPLETED|Overall Study||7
8673592|NCT00761514|9716998|FG000|NOT COMPLETED|Overall Study||7
8673593|NCT00761579|9717002|FG000|STARTED|Overall Study||190
8673594|NCT00761579|9717002|FG000|COMPLETED|Overall Study||98
8673595|NCT00761579|9717002|FG000|NOT COMPLETED|Overall Study||92
8673596|NCT00761592|9717010|FG000|STARTED|Overall Study||32
8673597|NCT00761592|9717011|FG001|STARTED|Overall Study||33
8673598|NCT00761592|9717010|FG000|COMPLETED|Overall Study||31
8673599|NCT00761592|9717011|FG001|COMPLETED|Overall Study||32
8673600|NCT00761592|9717010|FG000|NOT COMPLETED|Overall Study||1
8673601|NCT00761592|9717011|FG001|NOT COMPLETED|Overall Study||1
8673602|NCT00761605|9717017|FG000|STARTED|Overall Study||387
8673603|NCT00761605|9717017|FG000|COMPLETED|Overall Study||246
8673604|NCT00761605|9717017|FG000|NOT COMPLETED|Overall Study||141
8673605|NCT00761631|9717029|FG000|STARTED|Overall Study||126
8673606|NCT00761631|9717030|FG001|STARTED|Overall Study||181
8673607|NCT00761631|9717031|FG002|STARTED|Overall Study||176
8673608|NCT00761631|9717032|FG003|STARTED|Overall Study||119
8673609|NCT00761631|9717033|FG004|STARTED|Overall Study||299
8673610|NCT00761631|9717034|FG005|STARTED|Overall Study||299
8673611|NCT00761631|9717029|FG000|Vaccinated Dose 1|Overall Study||124
8673612|NCT00761631|9717030|FG001|Vaccinated Dose 1|Overall Study||179
8673613|NCT00761631|9717031|FG002|Vaccinated Dose 1|Overall Study||175
8673614|NCT00761631|9717032|FG003|Vaccinated Dose 1|Overall Study||118
8673615|NCT00761631|9717033|FG004|Vaccinated Dose 1|Overall Study||294
8673616|NCT00761631|9717034|FG005|Vaccinated Dose 1|Overall Study||298
8673617|NCT00761631|9717029|FG000|Vaccinated Dose 2|Overall Study||112
8673618|NCT00761631|9717030|FG001|Vaccinated Dose 2|Overall Study||0
8673619|NCT00761631|9717031|FG002|Vaccinated Dose 2|Overall Study||165
8673620|NCT00761631|9717032|FG003|Vaccinated Dose 2|Overall Study||0
8673621|NCT00761631|9717033|FG004|Vaccinated Dose 2|Overall Study||0
8673622|NCT00761631|9717034|FG005|Vaccinated Dose 2|Overall Study||0
8673623|NCT00761631|9717029|FG000|COMPLETED|Overall Study||111
8673624|NCT00761631|9717030|FG001|COMPLETED|Overall Study||174
8673625|NCT00761631|9717031|FG002|COMPLETED|Overall Study||160
8673626|NCT00761631|9717032|FG003|COMPLETED|Overall Study||116
8673627|NCT00761631|9717033|FG004|COMPLETED|Overall Study||277
8673628|NCT00761631|9717034|FG005|COMPLETED|Overall Study||294
8673629|NCT00761631|9717029|FG000|NOT COMPLETED|Overall Study||15
8673630|NCT00761631|9717030|FG001|NOT COMPLETED|Overall Study||7
8673631|NCT00761631|9717031|FG002|NOT COMPLETED|Overall Study||16
8673632|NCT00761631|9717032|FG003|NOT COMPLETED|Overall Study||3
8673633|NCT00761631|9717033|FG004|NOT COMPLETED|Overall Study||22
8673634|NCT00761631|9717034|FG005|NOT COMPLETED|Overall Study||5
8692662|NCT00862719|9738236|FG003|COMPLETED|Overall Study||0
8692663|NCT00862719|9738233|FG000|NOT COMPLETED|Overall Study||10
8692664|NCT00862719|9738234|FG001|NOT COMPLETED|Overall Study||6
8692665|NCT00862719|9738235|FG002|NOT COMPLETED|Overall Study||4
8692666|NCT00862719|9738236|FG003|NOT COMPLETED|Overall Study||1
8692667|NCT00862745|9738248|FG000|STARTED|Randomized Control Trial||322
8692668|NCT00862745|9738249|FG001|STARTED|Randomized Control Trial||323
8692669|NCT00862745|9738248|FG000|COMPLETED|Randomized Control Trial||284
8692670|NCT00862745|9738249|FG001|COMPLETED|Randomized Control Trial||284
8692671|NCT00862745|9738248|FG000|NOT COMPLETED|Randomized Control Trial||38
8692672|NCT00862745|9738249|FG001|NOT COMPLETED|Randomized Control Trial||39
8692673|NCT00862745|9738248|FG000|STARTED|Open-label Follow-up|19 participants elected not to enter the open-label portion of the study after completing the RCT.|268
8692674|NCT00862745|9738249|FG001|STARTED|Open-label Follow-up|10 participants elected not to enter the open-label portion of the study after completing the RCT.|274
8692675|NCT00862745|9738248|FG000|COMPLETED|Open-label Follow-up||229
8692676|NCT00862745|9738249|FG001|COMPLETED|Open-label Follow-up||225
8692677|NCT00862745|9738248|FG000|NOT COMPLETED|Open-label Follow-up||39
8692678|NCT00862745|9738249|FG001|NOT COMPLETED|Open-label Follow-up||49
8692679|NCT00862784|9738255|FG000|STARTED|Overall Study||48
8692680|NCT00862784|9738255|FG000|Received Any Amount of Study Drug|Overall Study||48
8692681|NCT00862784|9738255|FG000|COMPLETED|Overall Study||48
8692682|NCT00862784|9738255|FG000|NOT COMPLETED|Overall Study||0
8692683|NCT00862810|9738261|FG000|STARTED|Overall Study||33
8692684|NCT00862810|9738262|FG001|STARTED|Overall Study||39
8692685|NCT00862810|9738261|FG000|COMPLETED|Overall Study||29
8673635|NCT00761657|9717066|FG000|STARTED|Part 1 (up to Day 57)||0
8673636|NCT00761657|9717067|FG001|STARTED|Part 1 (up to Day 57)||0
8673637|NCT00761657|9717068|FG002|STARTED|Part 1 (up to Day 57)||12
8673638|NCT00761657|9717069|FG003|STARTED|Part 1 (up to Day 57)||10
8673639|NCT00761657|9717070|FG004|STARTED|Part 1 (up to Day 57)||0
8673640|NCT00761657|9717071|FG005|STARTED|Part 1 (up to Day 57)||0
8673641|NCT00761657|9717072|FG006|STARTED|Part 1 (up to Day 57)||1
8673642|NCT00761657|9717073|FG007|STARTED|Part 1 (up to Day 57)||2
8673643|NCT00761657|9717074|FG008|STARTED|Part 1 (up to Day 57)||10
8673644|NCT00761657|9717066|FG000|Safety Population|Part 1 (up to Day 57)||0
8673645|NCT00761657|9717067|FG001|Safety Population|Part 1 (up to Day 57)||0
8673646|NCT00761657|9717068|FG002|Safety Population|Part 1 (up to Day 57)||12
8673647|NCT00761657|9717069|FG003|Safety Population|Part 1 (up to Day 57)||9
8673648|NCT00761657|9717070|FG004|Safety Population|Part 1 (up to Day 57)||0
8673649|NCT00761657|9717071|FG005|Safety Population|Part 1 (up to Day 57)||0
8673650|NCT00761657|9717072|FG006|Safety Population|Part 1 (up to Day 57)||1
8673651|NCT00761657|9717073|FG007|Safety Population|Part 1 (up to Day 57)||2
8673652|NCT00761657|9717074|FG008|Safety Population|Part 1 (up to Day 57)||10
8673653|NCT00761657|9717066|FG000|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||0
8673654|NCT00761657|9717067|FG001|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||0
8673655|NCT00761657|9717068|FG002|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||5
8673656|NCT00761657|9717069|FG003|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||5
8673657|NCT00761657|9717070|FG004|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||0
8673658|NCT00761657|9717071|FG005|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||0
8673659|NCT00761657|9717072|FG006|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||0
8673660|NCT00761657|9717073|FG007|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||1
8673661|NCT00761657|9717074|FG008|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||6
8673662|NCT00761657|9717066|FG000|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||0
8673663|NCT00761657|9717067|FG001|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||0
8673664|NCT00761657|9717068|FG002|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||5
8673665|NCT00761657|9717069|FG003|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||3
8673666|NCT00761657|9717070|FG004|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||0
8673667|NCT00761657|9717071|FG005|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||0
8673668|NCT00761657|9717072|FG006|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||1
8673669|NCT00761657|9717073|FG007|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||2
8673670|NCT00761657|9717074|FG008|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||0
8673671|NCT00761657|9717066|FG000|COMPLETED|Part 1 (up to Day 57)||0
8673672|NCT00761657|9717067|FG001|COMPLETED|Part 1 (up to Day 57)||0
8673673|NCT00761657|9717068|FG002|COMPLETED|Part 1 (up to Day 57)||8
8673674|NCT00761657|9717069|FG003|COMPLETED|Part 1 (up to Day 57)||4
8673675|NCT00761657|9717070|FG004|COMPLETED|Part 1 (up to Day 57)||0
8673676|NCT00761657|9717071|FG005|COMPLETED|Part 1 (up to Day 57)||0
8673677|NCT00761657|9717072|FG006|COMPLETED|Part 1 (up to Day 57)||0
8673678|NCT00761657|9717073|FG007|COMPLETED|Part 1 (up to Day 57)||1
8673679|NCT00761657|9717074|FG008|COMPLETED|Part 1 (up to Day 57)||9
8673680|NCT00761657|9717066|FG000|NOT COMPLETED|Part 1 (up to Day 57)||0
8673681|NCT00761657|9717067|FG001|NOT COMPLETED|Part 1 (up to Day 57)||0
8673682|NCT00761657|9717068|FG002|NOT COMPLETED|Part 1 (up to Day 57)||4
8673683|NCT00761657|9717069|FG003|NOT COMPLETED|Part 1 (up to Day 57)||6
8673684|NCT00761657|9717070|FG004|NOT COMPLETED|Part 1 (up to Day 57)||0
8673685|NCT00761657|9717071|FG005|NOT COMPLETED|Part 1 (up to Day 57)||0
8673686|NCT00761657|9717072|FG006|NOT COMPLETED|Part 1 (up to Day 57)||1
8673687|NCT00761657|9717073|FG007|NOT COMPLETED|Part 1 (up to Day 57)||1
8673688|NCT00761657|9717074|FG008|NOT COMPLETED|Part 1 (up to Day 57)||1
8673689|NCT00761657|9717066|FG000|STARTED|Part 2 (up to Day 114)||10
8673690|NCT00761657|9717067|FG001|STARTED|Part 2 (up to Day 114)||13
8673691|NCT00761657|9717068|FG002|STARTED|Part 2 (up to Day 114)||0
8673692|NCT00761657|9717069|FG003|STARTED|Part 2 (up to Day 114)||0
8673693|NCT00761657|9717070|FG004|STARTED|Part 2 (up to Day 114)||10
8673694|NCT00761657|9717071|FG005|STARTED|Part 2 (up to Day 114)||11
8673695|NCT00761657|9717072|FG006|STARTED|Part 2 (up to Day 114)||10
8673696|NCT00761657|9717073|FG007|STARTED|Part 2 (up to Day 114)||10
8673697|NCT00761657|9717074|FG008|STARTED|Part 2 (up to Day 114)||18
8673698|NCT00761657|9717066|FG000|Safety Population|Part 2 (up to Day 114)||10
8673699|NCT00761657|9717067|FG001|Safety Population|Part 2 (up to Day 114)||13
8673700|NCT00761657|9717068|FG002|Safety Population|Part 2 (up to Day 114)||0
8673701|NCT00761657|9717069|FG003|Safety Population|Part 2 (up to Day 114)||0
8673702|NCT00761657|9717070|FG004|Safety Population|Part 2 (up to Day 114)||10
8673703|NCT00761657|9717071|FG005|Safety Population|Part 2 (up to Day 114)||11
8673704|NCT00761657|9717072|FG006|Safety Population|Part 2 (up to Day 114)||10
8673705|NCT00761657|9717073|FG007|Safety Population|Part 2 (up to Day 114)||10
8673706|NCT00761657|9717074|FG008|Safety Population|Part 2 (up to Day 114)||18
8673707|NCT00761657|9717066|FG000|EE Population|Part 2 (up to Day 114)||10
8673708|NCT00761657|9717067|FG001|EE Population|Part 2 (up to Day 114)||12
8673709|NCT00761657|9717068|FG002|EE Population|Part 2 (up to Day 114)||0
8673710|NCT00761657|9717069|FG003|EE Population|Part 2 (up to Day 114)||0
8673711|NCT00761657|9717070|FG004|EE Population|Part 2 (up to Day 114)||10
8673712|NCT00761657|9717071|FG005|EE Population|Part 2 (up to Day 114)||11
8673713|NCT00761657|9717072|FG006|EE Population|Part 2 (up to Day 114)||10
8673714|NCT00761657|9717073|FG007|EE Population|Part 2 (up to Day 114)||10
8673715|NCT00761657|9717074|FG008|EE Population|Part 2 (up to Day 114)||11
8673716|NCT00761657|9717066|FG000|PK Population|Part 2 (up to Day 114)||10
8673717|NCT00761657|9717067|FG001|PK Population|Part 2 (up to Day 114)||13
8673718|NCT00761657|9717068|FG002|PK Population|Part 2 (up to Day 114)||0
8673719|NCT00761657|9717069|FG003|PK Population|Part 2 (up to Day 114)||0
8673720|NCT00761657|9717070|FG004|PK Population|Part 2 (up to Day 114)||10
8673721|NCT00761657|9717071|FG005|PK Population|Part 2 (up to Day 114)||11
8673722|NCT00761657|9717072|FG006|PK Population|Part 2 (up to Day 114)||10
8673723|NCT00761657|9717073|FG007|PK Population|Part 2 (up to Day 114)||10
8673724|NCT00761657|9717074|FG008|PK Population|Part 2 (up to Day 114)||0
8673725|NCT00761657|9717066|FG000|COMPLETED|Part 2 (up to Day 114)||10
8673726|NCT00761657|9717067|FG001|COMPLETED|Part 2 (up to Day 114)||13
8673727|NCT00761657|9717068|FG002|COMPLETED|Part 2 (up to Day 114)||0
8673728|NCT00761657|9717069|FG003|COMPLETED|Part 2 (up to Day 114)||0
8673729|NCT00761657|9717070|FG004|COMPLETED|Part 2 (up to Day 114)||10
8673730|NCT00761657|9717071|FG005|COMPLETED|Part 2 (up to Day 114)||11
8673731|NCT00761657|9717072|FG006|COMPLETED|Part 2 (up to Day 114)||10
8673732|NCT00761657|9717073|FG007|COMPLETED|Part 2 (up to Day 114)||10
8673733|NCT00761657|9717074|FG008|COMPLETED|Part 2 (up to Day 114)||17
8673734|NCT00761657|9717066|FG000|NOT COMPLETED|Part 2 (up to Day 114)||0
8673735|NCT00761657|9717067|FG001|NOT COMPLETED|Part 2 (up to Day 114)||0
8673736|NCT00761657|9717068|FG002|NOT COMPLETED|Part 2 (up to Day 114)||0
8673737|NCT00761657|9717069|FG003|NOT COMPLETED|Part 2 (up to Day 114)||0
8673738|NCT00761657|9717070|FG004|NOT COMPLETED|Part 2 (up to Day 114)||0
8673739|NCT00761657|9717071|FG005|NOT COMPLETED|Part 2 (up to Day 114)||0
8673740|NCT00761657|9717072|FG006|NOT COMPLETED|Part 2 (up to Day 114)||0
8673741|NCT00761657|9717073|FG007|NOT COMPLETED|Part 2 (up to Day 114)||0
8673742|NCT00761657|9717074|FG008|NOT COMPLETED|Part 2 (up to Day 114)||1
8673743|NCT00761735|9717104|FG000|STARTED|Overall Study||94
8673744|NCT00761735|9717104|FG000|COMPLETED|Overall Study||80
8673745|NCT00761735|9717104|FG000|NOT COMPLETED|Overall Study||14
8673746|NCT00761748|9717112|FG000|STARTED|First Intervention (21 +/- 3 Days)||20
8673747|NCT00761748|9717113|FG001|STARTED|First Intervention (21 +/- 3 Days)||10
8673748|NCT00761748|9717112|FG000|COMPLETED|First Intervention (21 +/- 3 Days)||17
8673749|NCT00761748|9717113|FG001|COMPLETED|First Intervention (21 +/- 3 Days)||7
8673750|NCT00761748|9717112|FG000|NOT COMPLETED|First Intervention (21 +/- 3 Days)||3
8673751|NCT00761748|9717113|FG001|NOT COMPLETED|First Intervention (21 +/- 3 Days)||3
8673752|NCT00761748|9717112|FG000|STARTED|Second Intervention (21 +/- 3 Days)||17
8673753|NCT00761748|9717113|FG001|STARTED|Second Intervention (21 +/- 3 Days)||7
8673754|NCT00761748|9717112|FG000|COMPLETED|Second Intervention (21 +/- 3 Days)||17
8673755|NCT00761748|9717113|FG001|COMPLETED|Second Intervention (21 +/- 3 Days)||7
8673756|NCT00761748|9717112|FG000|NOT COMPLETED|Second Intervention (21 +/- 3 Days)||0
8673757|NCT00761748|9717113|FG001|NOT COMPLETED|Second Intervention (21 +/- 3 Days)||0
8673758|NCT00761761|9717121|FG000|STARTED|Overall Study||30
8673759|NCT00761761|9717122|FG001|STARTED|Overall Study||30
8673760|NCT00761761|9717121|FG000|COMPLETED|Overall Study||24
8673761|NCT00761761|9717122|FG001|COMPLETED|Overall Study||29
8673762|NCT00761761|9717121|FG000|NOT COMPLETED|Overall Study||6
8673763|NCT00761761|9717122|FG001|NOT COMPLETED|Overall Study||1
8673764|NCT00761774|9717130|FG000|STARTED|Overall Study||108
8673765|NCT00761774|9717130|FG000|COMPLETED|Overall Study||29
8673766|NCT00761774|9717130|FG000|NOT COMPLETED|Overall Study||79
8673767|NCT00761813|9717138|FG000|STARTED|Overall Study||557
8673768|NCT00761813|9717139|FG001|STARTED|Overall Study||551
8673769|NCT00761813|9717138|FG000|COMPLETED|Overall Study||542
8673770|NCT00761813|9717139|FG001|COMPLETED|Overall Study||537
8673771|NCT00761813|9717138|FG000|NOT COMPLETED|Overall Study||15
8673772|NCT00761813|9717139|FG001|NOT COMPLETED|Overall Study||14
8673773|NCT00761865|9717147|FG000|STARTED|Overall Study||16
8673774|NCT00761865|9717148|FG001|STARTED|Overall Study||18
8673775|NCT00761865|9717147|FG000|COMPLETED|Overall Study||8
8673776|NCT00761865|9717148|FG001|COMPLETED|Overall Study||11
8673777|NCT00761865|9717147|FG000|NOT COMPLETED|Overall Study||8
8673778|NCT00761865|9717148|FG001|NOT COMPLETED|Overall Study||7
8673779|NCT00761891|9717154|FG000|STARTED|Overall Study||64
8673780|NCT00761891|9717154|FG000|COMPLETED|Overall Study||54
8673781|NCT00761891|9717154|FG000|NOT COMPLETED|Overall Study||10
8673782|NCT00761930|9717162|FG000|STARTED|Overall Study||34
8673783|NCT00761930|9717163|FG001|STARTED|Overall Study||34
8673784|NCT00761930|9717164|FG002|STARTED|Overall Study||35
8673785|NCT00761930|9717162|FG000|COMPLETED|Overall Study||34
8673786|NCT00761930|9717163|FG001|COMPLETED|Overall Study||34
8673787|NCT00761930|9717164|FG002|COMPLETED|Overall Study||35
8673788|NCT00761930|9717162|FG000|NOT COMPLETED|Overall Study||0
8673789|NCT00761930|9717163|FG001|NOT COMPLETED|Overall Study||0
8673790|NCT00761930|9717164|FG002|NOT COMPLETED|Overall Study||0
8673791|NCT00761956|9717174|FG000|STARTED|Overall Study||87
8673792|NCT00761956|9717175|FG001|STARTED|Overall Study||102
8673793|NCT00761956|9717174|FG000|COMPLETED|Overall Study||52
8673794|NCT00761956|9717175|FG001|COMPLETED|Overall Study||48
8673795|NCT00761956|9717174|FG000|NOT COMPLETED|Overall Study||35
8673796|NCT00761956|9717175|FG001|NOT COMPLETED|Overall Study||54
8673797|NCT00761969|9717183|FG000|STARTED|Overall Study||742
8673798|NCT00761969|9717184|FG001|STARTED|Overall Study||713
8673799|NCT00761969|9717183|FG000|COMPLETED|Overall Study||542
8673800|NCT00761969|9717184|FG001|COMPLETED|Overall Study||573
8673801|NCT00761969|9717183|FG000|NOT COMPLETED|Overall Study||200
8673802|NCT00761969|9717184|FG001|NOT COMPLETED|Overall Study||140
8673803|NCT00762021|9717192|FG000|STARTED|Overall Study||52
8673804|NCT00762021|9717193|FG001|STARTED|Overall Study||52
8673805|NCT00762021|9717192|FG000|COMPLETED|Overall Study||44
8673806|NCT00762021|9717193|FG001|COMPLETED|Overall Study||44
8673807|NCT00762021|9717192|FG000|NOT COMPLETED|Overall Study||8
8673808|NCT00762021|9717193|FG001|NOT COMPLETED|Overall Study||8
8673809|NCT00762034|9717201|FG000|STARTED|Induction Period||472
8673810|NCT00762034|9717202|FG001|STARTED|Induction Period||467
8673811|NCT00762034|9717201|FG000|Received at Least 1 Dose of Study Drug|Induction Period||442
8673812|NCT00762034|9717202|FG001|Received at Least 1 Dose of Study Drug|Induction Period||443
8673813|NCT00762034|9717201|FG000|COMPLETED|Induction Period||294
8673814|NCT00762034|9717202|FG001|COMPLETED|Induction Period||298
8673815|NCT00762034|9717201|FG000|NOT COMPLETED|Induction Period||178
8673816|NCT00762034|9717202|FG001|NOT COMPLETED|Induction Period||169
8673817|NCT00762034|9717201|FG000|STARTED|Maintenance Period||294
8673818|NCT00762034|9717202|FG001|STARTED|Maintenance Period||298
8673819|NCT00762034|9717201|FG000|Received at Least 1 Dose of Study Drug|Maintenance Period||294
8673820|NCT00762034|9717202|FG001|Received at Least 1 Dose of Study Drug|Maintenance Period||298
8673821|NCT00762034|9717201|FG000|COMPLETED|Maintenance Period||0
8673822|NCT00762034|9717202|FG001|COMPLETED|Maintenance Period||0
8673823|NCT00762034|9717201|FG000|NOT COMPLETED|Maintenance Period||294
8673824|NCT00762034|9717202|FG001|NOT COMPLETED|Maintenance Period||298
8673825|NCT00762073|9717220|FG000|STARTED|Overall Study||21
8673826|NCT00762073|9717221|FG001|STARTED|Overall Study||21
8673827|NCT00762073|9717222|FG002|STARTED|Overall Study||20
8673828|NCT00762073|9717223|FG003|STARTED|Overall Study||20
8673829|NCT00762073|9717220|FG000|COMPLETED|Overall Study||17
8673830|NCT00762073|9717221|FG001|COMPLETED|Overall Study||17
8673831|NCT00762073|9717222|FG002|COMPLETED|Overall Study|One participant was enrolled and randomized then withdrew consent and did not receive study drug.|18
8673832|NCT00762073|9717223|FG003|COMPLETED|Overall Study||17
8673833|NCT00762073|9717220|FG000|NOT COMPLETED|Overall Study||4
8673834|NCT00762073|9717221|FG001|NOT COMPLETED|Overall Study||4
8673835|NCT00762073|9717222|FG002|NOT COMPLETED|Overall Study||2
8673836|NCT00762073|9717223|FG003|NOT COMPLETED|Overall Study||3
8673837|NCT00762086|9717242|FG000|STARTED|Overall Study||39
8673838|NCT00762086|9717243|FG001|STARTED|Overall Study||28
8673839|NCT00762086|9717242|FG000|COMPLETED|Overall Study||33
8673840|NCT00762086|9717243|FG001|COMPLETED|Overall Study||24
8673841|NCT00762086|9717242|FG000|NOT COMPLETED|Overall Study||6
8673842|NCT00762086|9717243|FG001|NOT COMPLETED|Overall Study||4
8673843|NCT00762164|9717251|FG000|STARTED|Overall Study||17
8673844|NCT00762164|9717252|FG001|STARTED|Overall Study||17
8673845|NCT00762164|9717251|FG000|COMPLETED|Overall Study||14
8673846|NCT00762164|9717252|FG001|COMPLETED|Overall Study||15
8673847|NCT00762164|9717251|FG000|NOT COMPLETED|Overall Study||3
8673848|NCT00762164|9717252|FG001|NOT COMPLETED|Overall Study||2
8673849|NCT00762177|9717261|FG000|STARTED|1st Treatment Period||8
8673850|NCT00762177|9717262|FG001|STARTED|1st Treatment Period||8
8673851|NCT00762177|9717263|FG002|STARTED|1st Treatment Period||8
8673852|NCT00762177|9717261|FG000|COMPLETED|1st Treatment Period||8
8673853|NCT00762177|9717262|FG001|COMPLETED|1st Treatment Period||8
8673854|NCT00762177|9717263|FG002|COMPLETED|1st Treatment Period||8
8673855|NCT00762177|9717261|FG000|NOT COMPLETED|1st Treatment Period||0
8673856|NCT00762177|9717262|FG001|NOT COMPLETED|1st Treatment Period||0
8673857|NCT00762177|9717263|FG002|NOT COMPLETED|1st Treatment Period||0
8673858|NCT00762177|9717261|FG000|STARTED|Washout After 1st Treatment||8
8673859|NCT00762177|9717262|FG001|STARTED|Washout After 1st Treatment||8
8673860|NCT00762177|9717263|FG002|STARTED|Washout After 1st Treatment||8
8673861|NCT00762177|9717261|FG000|COMPLETED|Washout After 1st Treatment||8
8673862|NCT00762177|9717262|FG001|COMPLETED|Washout After 1st Treatment||8
8673863|NCT00762177|9717263|FG002|COMPLETED|Washout After 1st Treatment||8
8673864|NCT00762177|9717261|FG000|NOT COMPLETED|Washout After 1st Treatment||0
8673865|NCT00762177|9717262|FG001|NOT COMPLETED|Washout After 1st Treatment||0
8673866|NCT00762177|9717263|FG002|NOT COMPLETED|Washout After 1st Treatment||0
8673867|NCT00762177|9717261|FG000|STARTED|2nd Treatment Period||8
8673868|NCT00762177|9717262|FG001|STARTED|2nd Treatment Period||8
8673869|NCT00762177|9717263|FG002|STARTED|2nd Treatment Period||8
8673870|NCT00762177|9717261|FG000|COMPLETED|2nd Treatment Period||8
8673871|NCT00762177|9717262|FG001|COMPLETED|2nd Treatment Period||8
8673872|NCT00762177|9717263|FG002|COMPLETED|2nd Treatment Period||8
8673873|NCT00762177|9717261|FG000|NOT COMPLETED|2nd Treatment Period||0
8673874|NCT00762177|9717262|FG001|NOT COMPLETED|2nd Treatment Period||0
8673875|NCT00762177|9717263|FG002|NOT COMPLETED|2nd Treatment Period||0
8673876|NCT00762177|9717261|FG000|STARTED|Washout After 2nd Treatment||8
8673877|NCT00762177|9717262|FG001|STARTED|Washout After 2nd Treatment||8
8673878|NCT00762177|9717263|FG002|STARTED|Washout After 2nd Treatment||8
8673879|NCT00762177|9717261|FG000|COMPLETED|Washout After 2nd Treatment||8
8673880|NCT00762177|9717262|FG001|COMPLETED|Washout After 2nd Treatment||8
8673881|NCT00762177|9717263|FG002|COMPLETED|Washout After 2nd Treatment||8
8673882|NCT00762177|9717261|FG000|NOT COMPLETED|Washout After 2nd Treatment||0
8673883|NCT00762177|9717262|FG001|NOT COMPLETED|Washout After 2nd Treatment||0
8673884|NCT00762177|9717263|FG002|NOT COMPLETED|Washout After 2nd Treatment||0
8918769|NCT02203591|9978796|FG005|COMPLETED|Overall Study||209
8918770|NCT02203591|9978797|FG006|COMPLETED|Overall Study||219
8673885|NCT00762177|9717261|FG000|STARTED|3rd Treatment Period||8
8673886|NCT00762177|9717262|FG001|STARTED|3rd Treatment Period||8
8673887|NCT00762177|9717263|FG002|STARTED|3rd Treatment Period||8
8673888|NCT00762177|9717261|FG000|COMPLETED|3rd Treatment Period||8
8673889|NCT00762177|9717262|FG001|COMPLETED|3rd Treatment Period||8
8673890|NCT00762177|9717263|FG002|COMPLETED|3rd Treatment Period||8
8673891|NCT00762177|9717261|FG000|NOT COMPLETED|3rd Treatment Period||0
8673892|NCT00762177|9717262|FG001|NOT COMPLETED|3rd Treatment Period||0
8673893|NCT00762177|9717263|FG002|NOT COMPLETED|3rd Treatment Period||0
8673894|NCT00762216|9717274|FG000|STARTED|Overall Study||71
8673895|NCT00762216|9717274|FG000|COMPLETED|Overall Study||71
8673896|NCT00762216|9717274|FG000|NOT COMPLETED|Overall Study||0
8673897|NCT00762229|9717280|FG000|STARTED|Overall Study||15
8673898|NCT00762229|9717281|FG001|STARTED|Overall Study||24
8673899|NCT00762229|9717280|FG000|COMPLETED|Overall Study||14
8673900|NCT00762229|9717281|FG001|COMPLETED|Overall Study||22
8673901|NCT00762229|9717280|FG000|NOT COMPLETED|Overall Study||1
8673902|NCT00762229|9717281|FG001|NOT COMPLETED|Overall Study||2
8673903|NCT00762268|9717289|FG000|STARTED|Overall Study||12
8673904|NCT00762268|9717290|FG001|STARTED|Overall Study||11
8673905|NCT00762268|9717289|FG000|COMPLETED|Overall Study||9
8673906|NCT00762268|9717290|FG001|COMPLETED|Overall Study||8
8673907|NCT00762268|9717289|FG000|NOT COMPLETED|Overall Study||3
8673908|NCT00762268|9717290|FG001|NOT COMPLETED|Overall Study||3
8673909|NCT00762307|9717300|FG000|STARTED|Overall Study||28
8673910|NCT00762307|9717301|FG001|STARTED|Overall Study||11
8673911|NCT00762307|9717302|FG002|STARTED|Overall Study||11
8673912|NCT00762307|9717303|FG003|STARTED|Overall Study||10
8673913|NCT00762307|9717300|FG000|COMPLETED|Overall Study||26
8673914|NCT00762307|9717301|FG001|COMPLETED|Overall Study||11
8673915|NCT00762307|9717302|FG002|COMPLETED|Overall Study||11
8673916|NCT00762307|9717303|FG003|COMPLETED|Overall Study||9
8673917|NCT00762307|9717300|FG000|NOT COMPLETED|Overall Study||2
8673918|NCT00762307|9717301|FG001|NOT COMPLETED|Overall Study||0
8673919|NCT00762307|9717302|FG002|NOT COMPLETED|Overall Study||0
8673920|NCT00762307|9717303|FG003|NOT COMPLETED|Overall Study||1
8673921|NCT00762320|9717324|FG000|STARTED|Overall Study||8
8673922|NCT00762320|9717324|FG000|COMPLETED|Overall Study||8
8673923|NCT00762320|9717324|FG000|NOT COMPLETED|Overall Study||0
8673924|NCT00762359|9717335|FG000|STARTED|Overall Study||226
8673925|NCT00762359|9717336|FG001|STARTED|Overall Study||235
8673926|NCT00762359|9717335|FG000|COMPLETED|Overall Study||167
8673927|NCT00762359|9717336|FG001|COMPLETED|Overall Study||178
8673928|NCT00762359|9717335|FG000|NOT COMPLETED|Overall Study||59
8673929|NCT00762359|9717336|FG001|NOT COMPLETED|Overall Study||57
8673930|NCT00762372|9717345|FG000|STARTED|Overall Study|N=114 enrolled but 3 participant's discontinued before start of study drug administration.|111
8673931|NCT00762372|9717346|FG001|STARTED|Overall Study|N=57 enrolled but 2 participant's discontinued before start of study drug administration.|55
8673932|NCT00762372|9717347|FG002|STARTED|Overall Study|N=53 enrolled but 3 participant's discontinued before start of study drug administration.|50
8673933|NCT00762372|9717345|FG000|COMPLETED|Overall Study||110
8673934|NCT00762372|9717346|FG001|COMPLETED|Overall Study||55
8673935|NCT00762372|9717347|FG002|COMPLETED|Overall Study||50
8673936|NCT00762372|9717345|FG000|NOT COMPLETED|Overall Study||1
8673937|NCT00762372|9717346|FG001|NOT COMPLETED|Overall Study||0
8673938|NCT00762372|9717347|FG002|NOT COMPLETED|Overall Study||0
8673939|NCT00762385|9717361|FG000|STARTED|First Intervention||51
8673940|NCT00762385|9717362|FG001|STARTED|First Intervention||46
8673941|NCT00762385|9717361|FG000|COMPLETED|First Intervention||49
8673942|NCT00762385|9717362|FG001|COMPLETED|First Intervention||42
8673943|NCT00762385|9717361|FG000|NOT COMPLETED|First Intervention||2
8673944|NCT00762385|9717362|FG001|NOT COMPLETED|First Intervention||4
8673945|NCT00762385|9717361|FG000|STARTED|Second Intervention||49
8673946|NCT00762385|9717362|FG001|STARTED|Second Intervention||42
8673947|NCT00762385|9717361|FG000|COMPLETED|Second Intervention||46
8673948|NCT00762385|9717362|FG001|COMPLETED|Second Intervention||39
8673949|NCT00762385|9717361|FG000|NOT COMPLETED|Second Intervention||3
8673950|NCT00762385|9717362|FG001|NOT COMPLETED|Second Intervention||3
8673951|NCT00762411|9717373|FG000|STARTED|Initial Treatment||556
8673952|NCT00762411|9717374|FG001|STARTED|Initial Treatment||555
8673953|NCT00762411|9717373|FG000|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants(pts) who received at least 1 dose of study drug.|555
8673954|NCT00762411|9717374|FG001|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants who received at least 1 dose of study drug.|553
8673955|NCT00762411|9717373|FG000|COMPLETED|Initial Treatment||22
8673956|NCT00762411|9717374|FG001|COMPLETED|Initial Treatment||34
8673957|NCT00762411|9717373|FG000|NOT COMPLETED|Initial Treatment||534
8673958|NCT00762411|9717374|FG001|NOT COMPLETED|Initial Treatment||521
8673959|NCT00762411|9717373|FG000|STARTED|Delayed Start||22
8673960|NCT00762411|9717374|FG001|STARTED|Delayed Start||34
8673961|NCT00762411|9717373|FG000|COMPLETED|Delayed Start||5
8673962|NCT00762411|9717374|FG001|COMPLETED|Delayed Start||8
8673963|NCT00762411|9717373|FG000|NOT COMPLETED|Delayed Start||17
8673964|NCT00762411|9717374|FG001|NOT COMPLETED|Delayed Start||26
8673965|NCT00762411|9717373|FG000|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|312
8673966|NCT00762411|9717374|FG001|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|430
8673967|NCT00762411|9717373|FG000|COMPLETED|Safety Follow Up (SFU)-Optional||228
8673968|NCT00762411|9717374|FG001|COMPLETED|Safety Follow Up (SFU)-Optional||312
8673969|NCT00762411|9717373|FG000|NOT COMPLETED|Safety Follow Up (SFU)-Optional||84
8673970|NCT00762411|9717374|FG001|NOT COMPLETED|Safety Follow Up (SFU)-Optional||118
8673971|NCT00762424|9717386|FG000|STARTED|Overall Study||28
8673972|NCT00762424|9717387|FG001|STARTED|Overall Study||25
8673973|NCT00762424|9717386|FG000|COMPLETED|Overall Study||28
8673974|NCT00762424|9717387|FG001|COMPLETED|Overall Study||25
8673975|NCT00762424|9717386|FG000|NOT COMPLETED|Overall Study||0
8673976|NCT00762424|9717387|FG001|NOT COMPLETED|Overall Study||0
8673977|NCT00762450|9717396|FG000|STARTED|1st Treatment Period||2
8673978|NCT00762450|9717397|FG001|STARTED|1st Treatment Period||2
8673979|NCT00762450|9717398|FG002|STARTED|1st Treatment Period||2
8673980|NCT00762450|9717396|FG000|COMPLETED|1st Treatment Period||2
8673981|NCT00762450|9717397|FG001|COMPLETED|1st Treatment Period||2
8673982|NCT00762450|9717398|FG002|COMPLETED|1st Treatment Period||2
8673983|NCT00762450|9717396|FG000|NOT COMPLETED|1st Treatment Period||0
8673984|NCT00762450|9717397|FG001|NOT COMPLETED|1st Treatment Period||0
8673985|NCT00762450|9717398|FG002|NOT COMPLETED|1st Treatment Period||0
8673986|NCT00762450|9717396|FG000|STARTED|Washout After 1st Treatment Period||2
8673987|NCT00762450|9717397|FG001|STARTED|Washout After 1st Treatment Period||2
8673988|NCT00762450|9717398|FG002|STARTED|Washout After 1st Treatment Period||2
8673989|NCT00762450|9717396|FG000|COMPLETED|Washout After 1st Treatment Period||2
8673990|NCT00762450|9717397|FG001|COMPLETED|Washout After 1st Treatment Period||2
8673991|NCT00762450|9717398|FG002|COMPLETED|Washout After 1st Treatment Period||2
8673992|NCT00762450|9717396|FG000|NOT COMPLETED|Washout After 1st Treatment Period||0
8673993|NCT00762450|9717397|FG001|NOT COMPLETED|Washout After 1st Treatment Period||0
8673994|NCT00762450|9717398|FG002|NOT COMPLETED|Washout After 1st Treatment Period||0
8673995|NCT00762450|9717396|FG000|STARTED|2nd Treatment Period||2
8673996|NCT00762450|9717397|FG001|STARTED|2nd Treatment Period||2
8673997|NCT00762450|9717398|FG002|STARTED|2nd Treatment Period||2
8673998|NCT00762450|9717396|FG000|COMPLETED|2nd Treatment Period||2
8673999|NCT00762450|9717397|FG001|COMPLETED|2nd Treatment Period||2
8674000|NCT00762450|9717398|FG002|COMPLETED|2nd Treatment Period||2
8674001|NCT00762450|9717396|FG000|NOT COMPLETED|2nd Treatment Period||0
8674002|NCT00762450|9717397|FG001|NOT COMPLETED|2nd Treatment Period||0
8674003|NCT00762450|9717398|FG002|NOT COMPLETED|2nd Treatment Period||0
8674004|NCT00762450|9717396|FG000|STARTED|Washout After 2nd Treatment Period||2
8674005|NCT00762450|9717397|FG001|STARTED|Washout After 2nd Treatment Period||2
8674006|NCT00762450|9717398|FG002|STARTED|Washout After 2nd Treatment Period||2
8674007|NCT00762450|9717396|FG000|COMPLETED|Washout After 2nd Treatment Period||2
8674008|NCT00762450|9717397|FG001|COMPLETED|Washout After 2nd Treatment Period||2
8674009|NCT00762450|9717398|FG002|COMPLETED|Washout After 2nd Treatment Period||2
8674010|NCT00762450|9717396|FG000|NOT COMPLETED|Washout After 2nd Treatment Period||0
8674011|NCT00762450|9717397|FG001|NOT COMPLETED|Washout After 2nd Treatment Period||0
8674012|NCT00762450|9717398|FG002|NOT COMPLETED|Washout After 2nd Treatment Period||0
8674013|NCT00762450|9717396|FG000|STARTED|3rd Treatment Period||2
8674014|NCT00762450|9717397|FG001|STARTED|3rd Treatment Period||2
8674015|NCT00762450|9717398|FG002|STARTED|3rd Treatment Period||2
8674016|NCT00762450|9717396|FG000|COMPLETED|3rd Treatment Period||2
8674017|NCT00762450|9717397|FG001|COMPLETED|3rd Treatment Period||2
8674018|NCT00762450|9717398|FG002|COMPLETED|3rd Treatment Period||2
8674019|NCT00762450|9717396|FG000|NOT COMPLETED|3rd Treatment Period||0
8674020|NCT00762450|9717397|FG001|NOT COMPLETED|3rd Treatment Period||0
8674021|NCT00762450|9717398|FG002|NOT COMPLETED|3rd Treatment Period||0
8674022|NCT00762463|9717408|FG000|STARTED|Double-blind Phase (Baseline to Week 6)||120
8674023|NCT00762463|9717409|FG001|STARTED|Double-blind Phase (Baseline to Week 6)||120
8674024|NCT00762463|9717410|FG002|STARTED|Double-blind Phase (Baseline to Week 6)||0
8674025|NCT00762463|9717411|FG003|STARTED|Double-blind Phase (Baseline to Week 6)||0
8674026|NCT00762463|9717408|FG000|COMPLETED|Double-blind Phase (Baseline to Week 6)||113
8674027|NCT00762463|9717409|FG001|COMPLETED|Double-blind Phase (Baseline to Week 6)||110
8674028|NCT00762463|9717410|FG002|COMPLETED|Double-blind Phase (Baseline to Week 6)||0
8674029|NCT00762463|9717411|FG003|COMPLETED|Double-blind Phase (Baseline to Week 6)||0
8674030|NCT00762463|9717408|FG000|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||7
8674031|NCT00762463|9717409|FG001|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||10
8674032|NCT00762463|9717410|FG002|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||0
8674033|NCT00762463|9717411|FG003|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||0
8674034|NCT00762463|9717408|FG000|STARTED|Enrollment in Extension Phase (Week 6)||113
8674035|NCT00762463|9717409|FG001|STARTED|Enrollment in Extension Phase (Week 6)||110
8674036|NCT00762463|9717410|FG002|STARTED|Enrollment in Extension Phase (Week 6)||0
8674037|NCT00762463|9717411|FG003|STARTED|Enrollment in Extension Phase (Week 6)||0
8674038|NCT00762463|9717408|FG000|COMPLETED|Enrollment in Extension Phase (Week 6)||109
8674039|NCT00762463|9717409|FG001|COMPLETED|Enrollment in Extension Phase (Week 6)||109
8674040|NCT00762463|9717410|FG002|COMPLETED|Enrollment in Extension Phase (Week 6)||0
8674041|NCT00762463|9717411|FG003|COMPLETED|Enrollment in Extension Phase (Week 6)||0
8674042|NCT00762463|9717408|FG000|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||4
8674043|NCT00762463|9717409|FG001|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||1
8674044|NCT00762463|9717410|FG002|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||0
8918771|NCT02203591|9978798|FG007|COMPLETED|Overall Study||61
8918772|NCT02203591|9978791|FG000|NOT COMPLETED|Overall Study||147
8918773|NCT02203591|9978792|FG001|NOT COMPLETED|Overall Study||142
8674045|NCT00762463|9717411|FG003|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||0
8674046|NCT00762463|9717408|FG000|STARTED|Extension Phase (Week 6 to Week 12)||55
8674047|NCT00762463|9717409|FG001|STARTED|Extension Phase (Week 6 to Week 12)||55
8674048|NCT00762463|9717410|FG002|STARTED|Extension Phase (Week 6 to Week 12)||54
8674049|NCT00762463|9717411|FG003|STARTED|Extension Phase (Week 6 to Week 12)||54
8674050|NCT00762463|9717408|FG000|COMPLETED|Extension Phase (Week 6 to Week 12)||52
8674051|NCT00762463|9717409|FG001|COMPLETED|Extension Phase (Week 6 to Week 12)||54
8674052|NCT00762463|9717410|FG002|COMPLETED|Extension Phase (Week 6 to Week 12)||50
8674053|NCT00762463|9717411|FG003|COMPLETED|Extension Phase (Week 6 to Week 12)||52
8674054|NCT00762463|9717408|FG000|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||3
8674055|NCT00762463|9717409|FG001|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||1
8674056|NCT00762463|9717410|FG002|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||4
8674057|NCT00762463|9717411|FG003|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||2
8674058|NCT00762476|9717426|FG000|STARTED|Overall Study||206
8674059|NCT00762476|9717427|FG001|STARTED|Overall Study||205
8674060|NCT00762476|9717426|FG000|COMPLETED|Overall Study||183
8674061|NCT00762476|9717427|FG001|COMPLETED|Overall Study||169
8674062|NCT00762476|9717426|FG000|NOT COMPLETED|Overall Study||23
8674063|NCT00762476|9717427|FG001|NOT COMPLETED|Overall Study||36
8674064|NCT00762502|9717437|FG000|STARTED|Baseline to Month 3 (Period 1)||36
8674065|NCT00762502|9717438|FG001|STARTED|Baseline to Month 3 (Period 1)||25
8674066|NCT00762502|9717439|FG002|STARTED|Baseline to Month 3 (Period 1)||51
8674067|NCT00762502|9717437|FG000|COMPLETED|Baseline to Month 3 (Period 1)||26
8674068|NCT00762502|9717438|FG001|COMPLETED|Baseline to Month 3 (Period 1)||19
8674069|NCT00762502|9717439|FG002|COMPLETED|Baseline to Month 3 (Period 1)||32
8674070|NCT00762502|9717437|FG000|NOT COMPLETED|Baseline to Month 3 (Period 1)||10
8674071|NCT00762502|9717438|FG001|NOT COMPLETED|Baseline to Month 3 (Period 1)||6
8674072|NCT00762502|9717439|FG002|NOT COMPLETED|Baseline to Month 3 (Period 1)||19
8674073|NCT00762502|9717437|FG000|STARTED|Month 3 to Month 6 (Period 2)||9
8674074|NCT00762502|9717438|FG001|STARTED|Month 3 to Month 6 (Period 2)||5
8674075|NCT00762502|9717439|FG002|STARTED|Month 3 to Month 6 (Period 2)||23
8674076|NCT00762502|9717437|FG000|COMPLETED|Month 3 to Month 6 (Period 2)||9
8674077|NCT00762502|9717438|FG001|COMPLETED|Month 3 to Month 6 (Period 2)||4
8674078|NCT00762502|9717439|FG002|COMPLETED|Month 3 to Month 6 (Period 2)||23
8674079|NCT00762502|9717437|FG000|NOT COMPLETED|Month 3 to Month 6 (Period 2)||0
8674080|NCT00762502|9717438|FG001|NOT COMPLETED|Month 3 to Month 6 (Period 2)||1
8674081|NCT00762502|9717439|FG002|NOT COMPLETED|Month 3 to Month 6 (Period 2)||0
8674082|NCT00762515|9717447|FG000|STARTED|Overall Study||22
8674083|NCT00762515|9717448|FG001|STARTED|Overall Study||22
8674084|NCT00762515|9717447|FG000|COMPLETED|Overall Study||22
8674085|NCT00762515|9717448|FG001|COMPLETED|Overall Study||22
8674086|NCT00762515|9717447|FG000|NOT COMPLETED|Overall Study||0
8674087|NCT00762515|9717448|FG001|NOT COMPLETED|Overall Study||0
8674088|NCT00762528|9717456|FG000|STARTED|Overall Study||24
8674089|NCT00762528|9717457|FG001|STARTED|Overall Study||25
8674090|NCT00762528|9717456|FG000|COMPLETED|Overall Study||24
8674091|NCT00762528|9717457|FG001|COMPLETED|Overall Study||25
8674092|NCT00762528|9717456|FG000|NOT COMPLETED|Overall Study||0
8674093|NCT00762528|9717457|FG001|NOT COMPLETED|Overall Study||0
8674094|NCT00762606|9717465|FG000|STARTED|Overall Study||55
8674095|NCT00762606|9717466|FG001|STARTED|Overall Study||51
8674096|NCT00762606|9717465|FG000|COMPLETED|Overall Study||37
8674097|NCT00762606|9717466|FG001|COMPLETED|Overall Study||38
8674098|NCT00762606|9717465|FG000|NOT COMPLETED|Overall Study||18
8674099|NCT00762606|9717466|FG001|NOT COMPLETED|Overall Study||13
8674100|NCT00762619|9717474|FG000|STARTED|Overall Study||55
8674101|NCT00762619|9717475|FG001|STARTED|Overall Study||50
8674102|NCT00762619|9717474|FG000|COMPLETED|Overall Study||55
8674103|NCT00762619|9717475|FG001|COMPLETED|Overall Study||50
8674104|NCT00762619|9717474|FG000|NOT COMPLETED|Overall Study||0
8674105|NCT00762619|9717475|FG001|NOT COMPLETED|Overall Study||0
8674106|NCT00762645|9717485|FG000|STARTED|Overall Study||16
8674107|NCT00762645|9717486|FG001|STARTED|Overall Study||14
8674108|NCT00762645|9717485|FG000|COMPLETED|Overall Study||12
8674109|NCT00762645|9717486|FG001|COMPLETED|Overall Study||12
8674110|NCT00762645|9717485|FG000|NOT COMPLETED|Overall Study||4
8674111|NCT00762645|9717486|FG001|NOT COMPLETED|Overall Study||2
8674112|NCT00762710|9717494|FG000|STARTED|Overall Study||48
8674113|NCT00762710|9717495|FG001|STARTED|Overall Study||44
8674114|NCT00762710|9717494|FG000|COMPLETED|Overall Study||27
8674115|NCT00762710|9717495|FG001|COMPLETED|Overall Study||29
8674116|NCT00762710|9717494|FG000|NOT COMPLETED|Overall Study||21
8674117|NCT00762710|9717495|FG001|NOT COMPLETED|Overall Study||15
8674118|NCT00762762|9717503|FG000|STARTED|Overall Study||30
8674119|NCT00762762|9717504|FG001|STARTED|Overall Study||30
8674120|NCT00762762|9717503|FG000|COMPLETED|Overall Study||22
8674121|NCT00762762|9717504|FG001|COMPLETED|Overall Study||20
8674122|NCT00762762|9717503|FG000|NOT COMPLETED|Overall Study||8
8674123|NCT00762762|9717504|FG001|NOT COMPLETED|Overall Study||10
8674124|NCT00762788|9717516|FG000|STARTED|Overall Study||55
8674125|NCT00762788|9717517|FG001|STARTED|Overall Study||58
8674126|NCT00762788|9717518|FG002|STARTED|Overall Study||42
8674127|NCT00762788|9717519|FG003|STARTED|Overall Study||64
8674128|NCT00762788|9717520|FG004|STARTED|Overall Study||43
8674129|NCT00762788|9717521|FG005|STARTED|Overall Study||52
8674130|NCT00762788|9717516|FG000|COMPLETED|Overall Study||29
8674131|NCT00762788|9717517|FG001|COMPLETED|Overall Study||21
8674132|NCT00762788|9717518|FG002|COMPLETED|Overall Study||21
8674133|NCT00762788|9717519|FG003|COMPLETED|Overall Study||38
8674134|NCT00762788|9717520|FG004|COMPLETED|Overall Study||30
8674135|NCT00762788|9717521|FG005|COMPLETED|Overall Study||31
8674136|NCT00762788|9717516|FG000|NOT COMPLETED|Overall Study||26
8674137|NCT00762788|9717517|FG001|NOT COMPLETED|Overall Study||37
8674138|NCT00762788|9717518|FG002|NOT COMPLETED|Overall Study||21
8674139|NCT00762788|9717519|FG003|NOT COMPLETED|Overall Study||26
8674140|NCT00762788|9717520|FG004|NOT COMPLETED|Overall Study||13
8674141|NCT00762788|9717521|FG005|NOT COMPLETED|Overall Study||21
8674142|NCT00762853|9717537|FG000|STARTED|First Treatment Period||10
8674143|NCT00762853|9717538|FG001|STARTED|First Treatment Period||10
8674144|NCT00762853|9717537|FG000|COMPLETED|First Treatment Period||10
8674145|NCT00762853|9717538|FG001|COMPLETED|First Treatment Period||10
8674146|NCT00762853|9717537|FG000|NOT COMPLETED|First Treatment Period||0
8674147|NCT00762853|9717538|FG001|NOT COMPLETED|First Treatment Period||0
8674148|NCT00762853|9717537|FG000|STARTED|1 Week Washout After Treatment 1||10
8674149|NCT00762853|9717538|FG001|STARTED|1 Week Washout After Treatment 1||10
8674150|NCT00762853|9717537|FG000|COMPLETED|1 Week Washout After Treatment 1||10
8674151|NCT00762853|9717538|FG001|COMPLETED|1 Week Washout After Treatment 1||10
8674152|NCT00762853|9717537|FG000|NOT COMPLETED|1 Week Washout After Treatment 1||0
8674153|NCT00762853|9717538|FG001|NOT COMPLETED|1 Week Washout After Treatment 1||0
8674154|NCT00762853|9717537|FG000|STARTED|Second Treatment Period||10
8674155|NCT00762853|9717538|FG001|STARTED|Second Treatment Period||10
8674156|NCT00762853|9717537|FG000|COMPLETED|Second Treatment Period||10
8674157|NCT00762853|9717538|FG001|COMPLETED|Second Treatment Period||10
8674158|NCT00762853|9717537|FG000|NOT COMPLETED|Second Treatment Period||0
8674159|NCT00762853|9717538|FG001|NOT COMPLETED|Second Treatment Period||0
8674160|NCT00762892|9717546|FG000|STARTED|Overall Study||14
8674161|NCT00762892|9717547|FG001|STARTED|Overall Study||14
8674162|NCT00762892|9717546|FG000|COMPLETED|Overall Study||9
8674163|NCT00762892|9717547|FG001|COMPLETED|Overall Study||8
8799527|NCT01438060|9851070|FG001|STARTED|Extension Phase: Week 10 to Week 130|Of the 88 participants, who completed Acute Phase, 81 opted to enter 130-week extension phase|81
8799528|NCT01438060|9851069|FG000|COMPLETED|Extension Phase: Week 10 to Week 130||22
8799529|NCT01438060|9851070|FG001|COMPLETED|Extension Phase: Week 10 to Week 130||25
8799530|NCT01438060|9851069|FG000|NOT COMPLETED|Extension Phase: Week 10 to Week 130||58
8799531|NCT01438060|9851070|FG001|NOT COMPLETED|Extension Phase: Week 10 to Week 130||56
8799532|NCT01438060|9851069|FG000|STARTED|On Study Beyond Week 140||0
8799533|NCT01438060|9851070|FG001|STARTED|On Study Beyond Week 140|9 participants in France who showed improvement at Week 140 continued treatment beyond 140 weeks|9
8799534|NCT01438060|9851069|FG000|COMPLETED|On Study Beyond Week 140||0
8799535|NCT01438060|9851070|FG001|COMPLETED|On Study Beyond Week 140||1
8799536|NCT01438060|9851069|FG000|NOT COMPLETED|On Study Beyond Week 140||0
8799537|NCT01438060|9851070|FG001|NOT COMPLETED|On Study Beyond Week 140||8
8799538|NCT01438151|9851081|FG000|STARTED|Overall Study||11
8799539|NCT01438151|9851081|FG000|COMPLETED|Overall Study||3
8799540|NCT01438151|9851081|FG000|NOT COMPLETED|Overall Study||8
8799541|NCT01438177|9851085|FG000|STARTED|Overall Study||11
8799542|NCT01438177|9851085|FG000|COMPLETED|Overall Study|Patients who were off due to disease progression|9
8799543|NCT01438177|9851085|FG000|NOT COMPLETED|Overall Study||2
8799544|NCT01438229|9851089|FG000|STARTED|Overall Study||47
8799545|NCT01438229|9851089|FG000|Excluded Due to Renal Artery Anatomy|Overall Study||1
8799546|NCT01438229|9851089|FG000|Underwent Procedure|Overall Study||46
8799547|NCT01438229|9851089|FG000|COMPLETED|Overall Study||44
8799548|NCT01438229|9851089|FG000|NOT COMPLETED|Overall Study||3
8799549|NCT01438294|9851095|FG000|STARTED|Overall Study||16
8799550|NCT01438294|9851096|FG001|STARTED|Overall Study||20
8799551|NCT01438294|9851095|FG000|COMPLETED|Overall Study||13
8799552|NCT01438294|9851096|FG001|COMPLETED|Overall Study||13
8799553|NCT01438294|9851095|FG000|NOT COMPLETED|Overall Study||3
8799554|NCT01438294|9851096|FG001|NOT COMPLETED|Overall Study||7
8799555|NCT01438307|9851104|FG000|STARTED|Overall Study||14
8799556|NCT01438307|9851105|FG001|STARTED|Overall Study||14
8799557|NCT01438307|9851104|FG000|COMPLETED|Overall Study||13
8799558|NCT01438307|9851105|FG001|COMPLETED|Overall Study||13
8799559|NCT01438307|9851104|FG000|NOT COMPLETED|Overall Study||1
8799560|NCT01438307|9851105|FG001|NOT COMPLETED|Overall Study||1
8799561|NCT01438411|9851111|FG000|STARTED|Overall Study||53
8799562|NCT01438411|9851111|FG000|COMPLETED|Overall Study||40
8799563|NCT01438411|9851111|FG000|NOT COMPLETED|Overall Study||13
8799564|NCT01438424|9851115|FG000|STARTED|Overall Study|Received treatment|1051
8799565|NCT01438424|9851115|FG000|COMPLETED|Overall Study|Completed treatment|634
8799566|NCT01438424|9851115|FG000|NOT COMPLETED|Overall Study||417
8799567|NCT01438476|9851131|FG000|STARTED|Overall Study||116
8799568|NCT01438476|9851132|FG001|STARTED|Overall Study||45
8799569|NCT01438476|9851131|FG000|COMPLETED|Overall Study||106
8799570|NCT01438476|9851132|FG001|COMPLETED|Overall Study||34
8799571|NCT01438476|9851131|FG000|NOT COMPLETED|Overall Study||10
8799572|NCT01438476|9851132|FG001|NOT COMPLETED|Overall Study||11
8799573|NCT01438489|9851141|FG000|STARTED|Overall Study||103
8799574|NCT01438489|9851142|FG001|STARTED|Overall Study||100
8799575|NCT01438489|9851143|FG002|STARTED|Overall Study||104
8799576|NCT01438489|9851141|FG000|COMPLETED|Overall Study||77
8674164|NCT00762892|9717546|FG000|NOT COMPLETED|Overall Study||5
8674165|NCT00762892|9717547|FG001|NOT COMPLETED|Overall Study||6
8674166|NCT00762931|9717553|FG000|STARTED|Overall Study||25
8674167|NCT00762931|9717553|FG000|COMPLETED|Overall Study||23
8674168|NCT00762931|9717553|FG000|NOT COMPLETED|Overall Study||2
8674169|NCT00762970|9717560|FG000|STARTED|Overall Study||46
8674170|NCT00762970|9717561|FG001|STARTED|Overall Study||44
8674171|NCT00762970|9717562|FG002|STARTED|Overall Study||47
8674172|NCT00762970|9717560|FG000|COMPLETED|Overall Study||34
8674173|NCT00762970|9717561|FG001|COMPLETED|Overall Study||35
8674174|NCT00762970|9717562|FG002|COMPLETED|Overall Study||46
8674175|NCT00762970|9717560|FG000|NOT COMPLETED|Overall Study||12
8674176|NCT00762970|9717561|FG001|NOT COMPLETED|Overall Study||9
8674177|NCT00762970|9717562|FG002|NOT COMPLETED|Overall Study||1
8674178|NCT00762996|9717570|FG000|STARTED|Period One||15
8674179|NCT00762996|9717571|FG001|STARTED|Period One||16
8674180|NCT00762996|9717572|FG002|STARTED|Period One||17
8674181|NCT00762996|9717573|FG003|STARTED|Period One||17
8674182|NCT00762996|9717570|FG000|COMPLETED|Period One||15
8674183|NCT00762996|9717571|FG001|COMPLETED|Period One||16
8674184|NCT00762996|9717572|FG002|COMPLETED|Period One||13
8674185|NCT00762996|9717573|FG003|COMPLETED|Period One||16
8674186|NCT00762996|9717570|FG000|NOT COMPLETED|Period One||0
8674187|NCT00762996|9717571|FG001|NOT COMPLETED|Period One||0
8674188|NCT00762996|9717572|FG002|NOT COMPLETED|Period One||4
8674189|NCT00762996|9717573|FG003|NOT COMPLETED|Period One||1
8674190|NCT00762996|9717570|FG000|STARTED|Period Two||15
8674191|NCT00762996|9717571|FG001|STARTED|Period Two||16
8674192|NCT00762996|9717572|FG002|STARTED|Period Two||13
8674193|NCT00762996|9717573|FG003|STARTED|Period Two||16
8674194|NCT00762996|9717570|FG000|COMPLETED|Period Two||15
8674195|NCT00762996|9717571|FG001|COMPLETED|Period Two||16
8674196|NCT00762996|9717572|FG002|COMPLETED|Period Two||13
8674197|NCT00762996|9717573|FG003|COMPLETED|Period Two||16
8674198|NCT00762996|9717570|FG000|NOT COMPLETED|Period Two||0
8674199|NCT00762996|9717571|FG001|NOT COMPLETED|Period Two||0
8674200|NCT00762996|9717572|FG002|NOT COMPLETED|Period Two||0
8674201|NCT00762996|9717573|FG003|NOT COMPLETED|Period Two||0
8674202|NCT00763035|9717581|FG000|STARTED|First Intervention||10
8674203|NCT00763035|9717582|FG001|STARTED|First Intervention||4
8674204|NCT00763035|9717581|FG000|COMPLETED|First Intervention||9
8674205|NCT00763035|9717582|FG001|COMPLETED|First Intervention||3
9035689|NCT03301649|10097416|FG000|Safety Population|Overall Study||399
9035690|NCT03301649|10097417|FG001|Safety Population|Overall Study||400
9035691|NCT03301649|10097418|FG002|Safety Population|Overall Study||112
9035692|NCT03301649|10097416|FG000|Modified Intent-to-treat(mITT)Population|Overall Study||372
9035693|NCT03301649|10097417|FG001|Modified Intent-to-treat(mITT)Population|Overall Study||380
9035694|NCT03301649|10097418|FG002|Modified Intent-to-treat(mITT)Population|Overall Study||111
9035695|NCT03301649|10097416|FG000|Per-protocol (PP) Population|Overall Study||345
9035696|NCT03301649|10097417|FG001|Per-protocol (PP) Population|Overall Study||354
9035697|NCT03301649|10097418|FG002|Per-protocol (PP) Population|Overall Study||103
9035698|NCT03301649|10097416|FG000|COMPLETED|Overall Study||356
8674206|NCT00763035|9717581|FG000|NOT COMPLETED|First Intervention||1
8674207|NCT00763035|9717582|FG001|NOT COMPLETED|First Intervention||1
8674208|NCT00763035|9717581|FG000|STARTED|Second Intervention||9
8674209|NCT00763035|9717582|FG001|STARTED|Second Intervention||3
8674210|NCT00763035|9717581|FG000|COMPLETED|Second Intervention||6
8674211|NCT00763035|9717582|FG001|COMPLETED|Second Intervention||3
8674212|NCT00763035|9717581|FG000|NOT COMPLETED|Second Intervention||3
8674213|NCT00763035|9717582|FG001|NOT COMPLETED|Second Intervention||0
8674214|NCT00763048|9717590|FG000|STARTED|Overall Study||21
8674215|NCT00763048|9717591|FG001|STARTED|Overall Study||18
8674216|NCT00763048|9717590|FG000|COMPLETED|Overall Study||21
8674217|NCT00763048|9717591|FG001|COMPLETED|Overall Study||18
8674218|NCT00763048|9717590|FG000|NOT COMPLETED|Overall Study||0
8674219|NCT00763048|9717591|FG001|NOT COMPLETED|Overall Study||0
8674220|NCT00763061|9717599|FG000|STARTED|Overall Study||54
8674221|NCT00763061|9717600|FG001|STARTED|Overall Study||57
8674222|NCT00763061|9717599|FG000|COMPLETED|Overall Study||49
8674223|NCT00763061|9717600|FG001|COMPLETED|Overall Study||44
8674224|NCT00763061|9717599|FG000|NOT COMPLETED|Overall Study||5
8674225|NCT00763061|9717600|FG001|NOT COMPLETED|Overall Study||13
8674226|NCT00763139|9717606|FG000|STARTED|Overall Study||17
8674227|NCT00763139|9717607|FG001|STARTED|Overall Study||17
8674228|NCT00763139|9717606|FG000|COMPLETED|Overall Study||12
8674229|NCT00763139|9717607|FG001|COMPLETED|Overall Study||14
8674230|NCT00763139|9717606|FG000|NOT COMPLETED|Overall Study||5
8674231|NCT00763139|9717607|FG001|NOT COMPLETED|Overall Study||3
8674232|NCT00763243|9717618|FG000|STARTED|Waiting Period||9
8674233|NCT00763243|9717618|FG000|COMPLETED|Waiting Period||9
8674234|NCT00763243|9717618|FG000|NOT COMPLETED|Waiting Period||0
8674235|NCT00763243|9717618|FG000|STARTED|Training Period||9
8674236|NCT00763243|9717618|FG000|COMPLETED|Training Period||9
8674237|NCT00763243|9717618|FG000|NOT COMPLETED|Training Period||0
8674238|NCT00763243|9717618|FG000|STARTED|1-Month Follow-Up Period||9
8674239|NCT00763243|9717618|FG000|COMPLETED|1-Month Follow-Up Period||9
8674240|NCT00763243|9717618|FG000|NOT COMPLETED|1-Month Follow-Up Period||0
8674241|NCT00763243|9717618|FG000|STARTED|6-Month Follow-Up Period||9
8674242|NCT00763243|9717618|FG000|COMPLETED|6-Month Follow-Up Period||9
8674243|NCT00763243|9717618|FG000|NOT COMPLETED|6-Month Follow-Up Period||0
8674244|NCT00763256|9717632|FG000|STARTED|Overall Study||15
8674245|NCT00763256|9717633|FG001|STARTED|Overall Study||18
8674246|NCT00763256|9717632|FG000|COMPLETED|Overall Study||8
8674247|NCT00763256|9717633|FG001|COMPLETED|Overall Study||8
8674248|NCT00763256|9717632|FG000|NOT COMPLETED|Overall Study||7
8674249|NCT00763256|9717633|FG001|NOT COMPLETED|Overall Study||10
8674250|NCT00763269|9717641|FG000|STARTED|Overall Study||314
8674251|NCT00763269|9717642|FG001|STARTED|Overall Study||312
8674252|NCT00763269|9717641|FG000|COMPLETED|Overall Study||302
8674253|NCT00763269|9717642|FG001|COMPLETED|Overall Study||299
8674254|NCT00763269|9717641|FG000|NOT COMPLETED|Overall Study||12
8674255|NCT00763269|9717642|FG001|NOT COMPLETED|Overall Study||13
8674256|NCT00763282|9717650|FG000|STARTED|Overall Study||72
8674257|NCT00763282|9717651|FG001|STARTED|Overall Study||72
8674258|NCT00763282|9717650|FG000|COMPLETED|Overall Study||40
8674259|NCT00763282|9717651|FG001|COMPLETED|Overall Study||38
8674260|NCT00763282|9717650|FG000|NOT COMPLETED|Overall Study||32
8674261|NCT00763282|9717651|FG001|NOT COMPLETED|Overall Study||34
8674262|NCT00763321|9717662|FG000|STARTED|Open-label Period||285
8674263|NCT00763321|9717663|FG001|STARTED|Open-label Period||0
8674264|NCT00763321|9717664|FG002|STARTED|Open-label Period||0
8674265|NCT00763321|9717662|FG000|COMPLETED|Open-label Period||222
8674266|NCT00763321|9717663|FG001|COMPLETED|Open-label Period||0
8674267|NCT00763321|9717664|FG002|COMPLETED|Open-label Period||0
8674268|NCT00763321|9717662|FG000|NOT COMPLETED|Open-label Period||63
8674269|NCT00763321|9717663|FG001|NOT COMPLETED|Open-label Period||0
8674270|NCT00763321|9717664|FG002|NOT COMPLETED|Open-label Period||0
8674271|NCT00763321|9717662|FG000|STARTED|Double-blind Period||0
8674272|NCT00763321|9717663|FG001|STARTED|Double-blind Period||109
8674273|NCT00763321|9717664|FG002|STARTED|Double-blind Period||113
8674274|NCT00763321|9717662|FG000|COMPLETED|Double-blind Period||0
8674275|NCT00763321|9717663|FG001|COMPLETED|Double-blind Period||88
8674276|NCT00763321|9717664|FG002|COMPLETED|Double-blind Period||84
8674277|NCT00763321|9717662|FG000|NOT COMPLETED|Double-blind Period||0
8674278|NCT00763321|9717663|FG001|NOT COMPLETED|Double-blind Period||21
8674279|NCT00763321|9717664|FG002|NOT COMPLETED|Double-blind Period||29
8674280|NCT00763360|9717674|FG000|STARTED|Overall Study||61
8674281|NCT00763360|9717675|FG001|STARTED|Overall Study||60
8674282|NCT00763360|9717676|FG002|STARTED|Overall Study||63
8674283|NCT00763360|9717674|FG000|COMPLETED|Overall Study||61
8674284|NCT00763360|9717675|FG001|COMPLETED|Overall Study||58
8674285|NCT00763360|9717676|FG002|COMPLETED|Overall Study||63
8674286|NCT00763360|9717674|FG000|NOT COMPLETED|Overall Study||0
8674287|NCT00763360|9717675|FG001|NOT COMPLETED|Overall Study||2
8674288|NCT00763360|9717676|FG002|NOT COMPLETED|Overall Study||0
8674289|NCT00763386|9717686|FG000|STARTED|Overall Study||164
8674290|NCT00763386|9717687|FG001|STARTED|Overall Study||167
8674291|NCT00763386|9717686|FG000|COMPLETED|Overall Study||116
8674292|NCT00763386|9717687|FG001|COMPLETED|Overall Study||127
8674293|NCT00763386|9717686|FG000|NOT COMPLETED|Overall Study||48
8674294|NCT00763386|9717687|FG001|NOT COMPLETED|Overall Study||40
8674295|NCT00763412|9717695|FG000|STARTED|Overall Study||8
8674296|NCT00763412|9717696|FG001|STARTED|Overall Study||8
8674297|NCT00763412|9717695|FG000|COMPLETED|Overall Study||4
8674298|NCT00763412|9717696|FG001|COMPLETED|Overall Study||4
8674299|NCT00763412|9717695|FG000|NOT COMPLETED|Overall Study||4
8674300|NCT00763412|9717696|FG001|NOT COMPLETED|Overall Study||4
8674301|NCT00763451|9717706|FG000|STARTED|Overall Study|Randomized.|80
8674302|NCT00763451|9717707|FG001|STARTED|Overall Study||82
8674303|NCT00763451|9717708|FG002|STARTED|Overall Study||161
8674304|NCT00763451|9717709|FG003|STARTED|Overall Study||161
8674305|NCT00763451|9717706|FG000|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|79
8674306|NCT00763451|9717707|FG001|Treated/Safety Population|Overall Study||81
8674307|NCT00763451|9717708|FG002|Treated/Safety Population|Overall Study||161
8674308|NCT00763451|9717709|FG003|Treated/Safety Population|Overall Study||161
8674309|NCT00763451|9717706|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|79
8674310|NCT00763451|9717707|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||80
8674311|NCT00763451|9717708|FG002|Modified Intent-to-Treat(mITT)Population|Overall Study||160
8674312|NCT00763451|9717709|FG003|Modified Intent-to-Treat(mITT)Population|Overall Study||160
8674313|NCT00763451|9717706|FG000|COMPLETED|Overall Study||67
8674314|NCT00763451|9717707|FG001|COMPLETED|Overall Study||60
8674315|NCT00763451|9717708|FG002|COMPLETED|Overall Study||121
8674316|NCT00763451|9717709|FG003|COMPLETED|Overall Study||131
8674317|NCT00763451|9717706|FG000|NOT COMPLETED|Overall Study||13
8674318|NCT00763451|9717707|FG001|NOT COMPLETED|Overall Study||22
8674319|NCT00763451|9717708|FG002|NOT COMPLETED|Overall Study||40
8674320|NCT00763451|9717709|FG003|NOT COMPLETED|Overall Study||30
8674321|NCT00763490|9717720|FG000|STARTED|Overall Study||20
8674322|NCT00763490|9717720|FG000|COMPLETED|Overall Study||20
8674323|NCT00763490|9717720|FG000|NOT COMPLETED|Overall Study||0
8674324|NCT00763698|9717724|FG000|STARTED|Overall Study||86
8674325|NCT00763698|9717724|FG000|COMPLETED|Overall Study||76
8674326|NCT00763698|9717724|FG000|NOT COMPLETED|Overall Study||10
8674327|NCT00763750|9717729|FG000|STARTED|Overall Study||25
8674328|NCT00763750|9717729|FG000|COMPLETED|Overall Study||25
8674329|NCT00763750|9717729|FG000|NOT COMPLETED|Overall Study||0
8674330|NCT00763815|9717735|FG000|STARTED|Overall Study|Randomized.|161
8674331|NCT00763815|9717736|FG001|STARTED|Overall Study||323
8674332|NCT00763815|9717735|FG000|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|161
8674333|NCT00763815|9717736|FG001|Treated/Safety Population|Overall Study||323
8674334|NCT00763815|9717735|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|159
8674335|NCT00763815|9717736|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||320
8674336|NCT00763815|9717735|FG000|COMPLETED|Overall Study||109
8674337|NCT00763815|9717736|FG001|COMPLETED|Overall Study||239
8674338|NCT00763815|9717735|FG000|NOT COMPLETED|Overall Study||52
8674339|NCT00763815|9717736|FG001|NOT COMPLETED|Overall Study||84
8674340|NCT00763867|9717744|FG000|STARTED|Overall Study||103
8674341|NCT00763867|9717745|FG001|STARTED|Overall Study||113
8674342|NCT00763867|9717744|FG000|COMPLETED|Overall Study||98
8918774|NCT02203591|9978793|FG002|NOT COMPLETED|Overall Study||151
8918775|NCT02203591|9978794|FG003|NOT COMPLETED|Overall Study||45
8918776|NCT02203591|9978795|FG004|NOT COMPLETED|Overall Study||34
8918777|NCT02203591|9978796|FG005|NOT COMPLETED|Overall Study||35
8918778|NCT02203591|9978797|FG006|NOT COMPLETED|Overall Study||29
8918779|NCT02203591|9978798|FG007|NOT COMPLETED|Overall Study||13
8918780|NCT02203630|9978822|FG000|STARTED|Overall Study||8
8918781|NCT02203630|9978823|FG001|STARTED|Overall Study||9
8918782|NCT02203630|9978822|FG000|COMPLETED|Overall Study||8
8918783|NCT02203630|9978823|FG001|COMPLETED|Overall Study||9
8918784|NCT02203630|9978822|FG000|NOT COMPLETED|Overall Study||0
8918785|NCT02203630|9978823|FG001|NOT COMPLETED|Overall Study||0
8918786|NCT02203721|9978831|FG000|STARTED|Overall Study||148
8918787|NCT02203721|9978832|FG001|STARTED|Overall Study||151
8918788|NCT02203721|9978831|FG000|COMPLETED|Overall Study||147
8918789|NCT02203721|9978832|FG001|COMPLETED|Overall Study||148
8918790|NCT02203721|9978831|FG000|NOT COMPLETED|Overall Study||1
8918791|NCT02203721|9978832|FG001|NOT COMPLETED|Overall Study||3
8918792|NCT02203747|9978840|FG000|STARTED|Overall Study||45
8918793|NCT02203747|9978841|FG001|STARTED|Overall Study||34
8918794|NCT02203747|9978840|FG000|COMPLETED|Overall Study||45
8918795|NCT02203747|9978841|FG001|COMPLETED|Overall Study||34
8918796|NCT02203747|9978840|FG000|NOT COMPLETED|Overall Study||0
8918797|NCT02203747|9978841|FG001|NOT COMPLETED|Overall Study||0
8918798|NCT02203786|9978851|FG000|STARTED|Overall Study||15
8918799|NCT02203786|9978852|FG001|STARTED|Overall Study||15
8918800|NCT02203786|9978853|FG002|STARTED|Overall Study||17
8918801|NCT02203786|9978854|FG003|STARTED|Overall Study||15
8918802|NCT02203786|9978851|FG000|COMPLETED|Overall Study||15
8918803|NCT02203786|9978852|FG001|COMPLETED|Overall Study||15
8918804|NCT02203786|9978853|FG002|COMPLETED|Overall Study||15
8918805|NCT02203786|9978854|FG003|COMPLETED|Overall Study||15
8918806|NCT02203786|9978851|FG000|NOT COMPLETED|Overall Study||0
8918807|NCT02203786|9978852|FG001|NOT COMPLETED|Overall Study||0
8918808|NCT02203786|9978853|FG002|NOT COMPLETED|Overall Study||2
8918809|NCT02203786|9978854|FG003|NOT COMPLETED|Overall Study||0
8918810|NCT02203838|9978870|FG000|STARTED|Overall Study||408
8918811|NCT02203838|9978871|FG001|STARTED|Overall Study||28
8918812|NCT02203838|9978872|FG002|STARTED|Overall Study||31
8918813|NCT02203838|9978873|FG003|STARTED|Overall Study||33
8918814|NCT02203838|9978870|FG000|COMPLETED|Overall Study||198
8918815|NCT02203838|9978871|FG001|COMPLETED|Overall Study||6
8918816|NCT02203838|9978872|FG002|COMPLETED|Overall Study||15
8918817|NCT02203838|9978873|FG003|COMPLETED|Overall Study||15
8918818|NCT02203838|9978870|FG000|NOT COMPLETED|Overall Study||210
8918819|NCT02203838|9978871|FG001|NOT COMPLETED|Overall Study||22
8918820|NCT02203838|9978872|FG002|NOT COMPLETED|Overall Study||16
8918821|NCT02203838|9978873|FG003|NOT COMPLETED|Overall Study||18
8918822|NCT02203851|9978883|FG000|STARTED|Overall Study||110
8918823|NCT02203851|9978883|FG000|COMPLETED|Overall Study||99
8918824|NCT02203851|9978883|FG000|NOT COMPLETED|Overall Study||11
8918825|NCT02203916|9978897|FG000|STARTED|Overall Study||65
8918826|NCT02203916|9978898|FG001|STARTED|Overall Study||132
8918827|NCT02203916|9978899|FG002|STARTED|Overall Study|1 participant was randomized twice and counted only once.|131
8918828|NCT02203916|9978897|FG000|Full Analysis Set (FAS)|Overall Study||65
8918829|NCT02203916|9978898|FG001|Full Analysis Set (FAS)|Overall Study||132
8918830|NCT02203916|9978899|FG002|Full Analysis Set (FAS)|Overall Study|1 participant was randomized twice, counted once in randomized set, and excluded from the FAS.|130
8918831|NCT02203916|9978897|FG000|Safety Analysis Set (SAS)|Overall Study||65
8918832|NCT02203916|9978898|FG001|Safety Analysis Set (SAS)|Overall Study||132
8918833|NCT02203916|9978899|FG002|Safety Analysis Set (SAS)|Overall Study|1 participant was randomized twice, counted once in randomized set, and excluded from the SAS.|130
8918834|NCT02203916|9978897|FG000|COMPLETED|Overall Study||57
8918835|NCT02203916|9978898|FG001|COMPLETED|Overall Study||122
8918836|NCT02203916|9978899|FG002|COMPLETED|Overall Study||120
8918837|NCT02203916|9978897|FG000|NOT COMPLETED|Overall Study||8
8918838|NCT02203916|9978898|FG001|NOT COMPLETED|Overall Study||10
8918839|NCT02203916|9978899|FG002|NOT COMPLETED|Overall Study||11
8918840|NCT02204007|9978909|FG000|STARTED|Overall Study||18
8918841|NCT02204007|9978910|FG001|STARTED|Overall Study||18
8918842|NCT02204007|9978909|FG000|COMPLETED|Overall Study||17
8918843|NCT02204007|9978910|FG001|COMPLETED|Overall Study||17
8918844|NCT02204007|9978909|FG000|NOT COMPLETED|Overall Study||1
8918845|NCT02204007|9978910|FG001|NOT COMPLETED|Overall Study||1
8918846|NCT02204124|9978918|FG000|STARTED|Overall Study||13
8918847|NCT02204124|9978919|FG001|STARTED|Overall Study||19
8918848|NCT02204124|9978918|FG000|COMPLETED|Overall Study||13
8674343|NCT00763867|9717745|FG001|COMPLETED|Overall Study||101
8674344|NCT00763867|9717744|FG000|NOT COMPLETED|Overall Study||5
8674345|NCT00763867|9717745|FG001|NOT COMPLETED|Overall Study||12
8674346|NCT00763919|9717751|FG000|STARTED|Overall Study||43
8674347|NCT00763919|9717751|FG000|COMPLETED|Overall Study||30
8674348|NCT00763919|9717751|FG000|NOT COMPLETED|Overall Study||13
8674349|NCT00763958|9717757|FG000|STARTED|Overall Study||28
8674350|NCT00763958|9717758|FG001|STARTED|Overall Study||16
8674351|NCT00763958|9717757|FG000|COMPLETED|Overall Study||14
8674352|NCT00763958|9717758|FG001|COMPLETED|Overall Study||5
8674353|NCT00763958|9717757|FG000|NOT COMPLETED|Overall Study||14
8674354|NCT00763958|9717758|FG001|NOT COMPLETED|Overall Study||11
8674355|NCT00763971|9717768|FG000|STARTED|Overall Study||113
8674356|NCT00763971|9717769|FG001|STARTED|Overall Study||112
8674357|NCT00763971|9717770|FG002|STARTED|Overall Study||111
8674358|NCT00763971|9717768|FG000|COMPLETED|Overall Study||80
8674359|NCT00763971|9717769|FG001|COMPLETED|Overall Study||74
8674360|NCT00763971|9717770|FG002|COMPLETED|Overall Study||42
8674361|NCT00763971|9717768|FG000|NOT COMPLETED|Overall Study||33
8674362|NCT00763971|9717769|FG001|NOT COMPLETED|Overall Study||38
8674363|NCT00763971|9717770|FG002|NOT COMPLETED|Overall Study||69
8674364|NCT00764309|9717778|FG000|STARTED|Overall Study|Number of participants treated.|31
8674365|NCT00764309|9717778|FG000|COMPLETED|Overall Study|Completed=off study. Major Reasons for off study: AE-13; withdrawn by sponsor-10; Lack of efficacy-3|31
8674366|NCT00764309|9717778|FG000|NOT COMPLETED|Overall Study||0
8674367|NCT00764322|9717784|FG000|STARTED|Overall Study||500
8674368|NCT00764322|9717784|FG000|COMPLETED|Overall Study||480
8674369|NCT00764322|9717784|FG000|NOT COMPLETED|Overall Study||20
8674370|NCT00764361|9717803|FG000|STARTED|Overall Study||8
8674371|NCT00764361|9717804|FG001|STARTED|Overall Study||7
8674372|NCT00764361|9717803|FG000|COMPLETED|Overall Study||6
8674373|NCT00764361|9717804|FG001|COMPLETED|Overall Study||3
8674374|NCT00764361|9717803|FG000|NOT COMPLETED|Overall Study||2
8674375|NCT00764361|9717804|FG001|NOT COMPLETED|Overall Study||4
8674376|NCT00764465|9717816|FG000|STARTED|Overall Study||9
8674377|NCT00764465|9717817|FG001|STARTED|Overall Study||7
8674378|NCT00764465|9717818|FG002|STARTED|Overall Study||7
8674379|NCT00764465|9717819|FG003|STARTED|Overall Study||7
8674380|NCT00764465|9717820|FG004|STARTED|Overall Study||7
8674381|NCT00764465|9717821|FG005|STARTED|Overall Study||8
8674382|NCT00764465|9717816|FG000|COMPLETED|Overall Study||7
8674383|NCT00764465|9717817|FG001|COMPLETED|Overall Study||6
8674384|NCT00764465|9717818|FG002|COMPLETED|Overall Study||6
8674385|NCT00764465|9717819|FG003|COMPLETED|Overall Study||6
8674386|NCT00764465|9717820|FG004|COMPLETED|Overall Study||6
8674387|NCT00764465|9717821|FG005|COMPLETED|Overall Study||7
8674388|NCT00764465|9717816|FG000|NOT COMPLETED|Overall Study||2
8674389|NCT00764465|9717817|FG001|NOT COMPLETED|Overall Study||1
8674390|NCT00764465|9717818|FG002|NOT COMPLETED|Overall Study||1
8674391|NCT00764465|9717819|FG003|NOT COMPLETED|Overall Study||1
8674392|NCT00764465|9717820|FG004|NOT COMPLETED|Overall Study||1
8674393|NCT00764465|9717821|FG005|NOT COMPLETED|Overall Study||1
8674394|NCT00764491|9717840|FG000|STARTED|Overall Study||123
8674395|NCT00764491|9717841|FG001|STARTED|Overall Study||33
8674396|NCT00764491|9717840|FG000|COMPLETED|Overall Study||88
8674397|NCT00764491|9717841|FG001|COMPLETED|Overall Study||16
8674398|NCT00764491|9717840|FG000|NOT COMPLETED|Overall Study||35
8674399|NCT00764491|9717841|FG001|NOT COMPLETED|Overall Study||17
8674400|NCT00764504|9717850|FG000|STARTED|Overall Study||141
8674401|NCT00764504|9717851|FG001|STARTED|Overall Study||141
8674402|NCT00764504|9717852|FG002|STARTED|Overall Study||234
8674403|NCT00764504|9717850|FG000|COMPLETED|Overall Study||75
8674404|NCT00764504|9717851|FG001|COMPLETED|Overall Study||71
8674405|NCT00764504|9717852|FG002|COMPLETED|Overall Study||131
8674406|NCT00764504|9717850|FG000|NOT COMPLETED|Overall Study||66
8674407|NCT00764504|9717851|FG001|NOT COMPLETED|Overall Study||70
8674408|NCT00764504|9717852|FG002|NOT COMPLETED|Overall Study||103
8674409|NCT00764517|9717862|FG000|STARTED|Overall Study||39
8674410|NCT00764517|9717863|FG001|STARTED|Overall Study||18
8674411|NCT00764517|9717862|FG000|COMPLETED|Overall Study||24
8674412|NCT00764517|9717863|FG001|COMPLETED|Overall Study||4
8674413|NCT00764517|9717862|FG000|NOT COMPLETED|Overall Study||15
8674414|NCT00764517|9717863|FG001|NOT COMPLETED|Overall Study||14
8674415|NCT00764660|9717871|FG000|STARTED|Overall Study||75
8674416|NCT00764660|9717872|FG001|STARTED|Overall Study||66
8674417|NCT00764660|9717871|FG000|COMPLETED|Overall Study||53
8674418|NCT00764660|9717872|FG001|COMPLETED|Overall Study||55
8674419|NCT00764660|9717871|FG000|NOT COMPLETED|Overall Study||22
8674420|NCT00764660|9717872|FG001|NOT COMPLETED|Overall Study||11
8674421|NCT00764673|9717878|FG000|STARTED|Overall Study||71
8674422|NCT00764673|9717878|FG000|COMPLETED|Overall Study||59
8674423|NCT00764673|9717878|FG000|NOT COMPLETED|Overall Study||12
8674424|NCT00764738|9717886|FG000|STARTED|Overall Study||24
8674425|NCT00764738|9717887|FG001|STARTED|Overall Study||28
8674426|NCT00764738|9717888|FG002|STARTED|Overall Study||15
8674427|NCT00764738|9717889|FG003|STARTED|Overall Study||24
8674428|NCT00764738|9717886|FG000|COMPLETED|Overall Study||22
8674429|NCT00764738|9717887|FG001|COMPLETED|Overall Study||25
8674430|NCT00764738|9717888|FG002|COMPLETED|Overall Study||12
8674431|NCT00764738|9717889|FG003|COMPLETED|Overall Study||18
8674432|NCT00764738|9717886|FG000|NOT COMPLETED|Overall Study||2
8674433|NCT00764738|9717887|FG001|NOT COMPLETED|Overall Study||3
8674434|NCT00764738|9717888|FG002|NOT COMPLETED|Overall Study||3
8674435|NCT00764738|9717889|FG003|NOT COMPLETED|Overall Study||6
8674436|NCT00764751|9717901|FG000|STARTED|Overall Study||39
8674437|NCT00764751|9717902|FG001|STARTED|Overall Study||12
8674438|NCT00764751|9717901|FG000|COMPLETED|Overall Study||37
8674439|NCT00764751|9717902|FG001|COMPLETED|Overall Study||11
8674440|NCT00764751|9717901|FG000|NOT COMPLETED|Overall Study||2
8674441|NCT00764751|9717902|FG001|NOT COMPLETED|Overall Study||1
8674442|NCT00764790|9717916|FG000|STARTED|Overall Study||1107
8674443|NCT00764790|9717917|FG001|STARTED|Overall Study||1106
8674444|NCT00764790|9717918|FG002|STARTED|Overall Study||1104
8674445|NCT00764790|9717916|FG000|COMPLETED|Overall Study||1069
8674446|NCT00764790|9717917|FG001|COMPLETED|Overall Study||1065
8674447|NCT00764790|9717918|FG002|COMPLETED|Overall Study||1074
8674448|NCT00764790|9717916|FG000|NOT COMPLETED|Overall Study||38
8674449|NCT00764790|9717917|FG001|NOT COMPLETED|Overall Study||41
8674450|NCT00764790|9717918|FG002|NOT COMPLETED|Overall Study||30
8674451|NCT00764868|9717926|FG000|STARTED|Overall Study||269
8674452|NCT00764868|9717926|FG000|COMPLETED|Overall Study||156
8674453|NCT00764868|9717926|FG000|NOT COMPLETED|Overall Study||113
8674454|NCT00764881|9717932|FG000|STARTED|Overall Study||108
8674455|NCT00764881|9717933|FG001|STARTED|Overall Study||109
8674456|NCT00764881|9717932|FG000|Subjects Received Treatment|Overall Study|Full Analysis Set (FAS)|106
8674457|NCT00764881|9717933|FG001|Subjects Received Treatment|Overall Study|Full Analysis Set (FAS)|107
8674458|NCT00764881|9717932|FG000|COMPLETED|Overall Study||92
8674459|NCT00764881|9717933|FG001|COMPLETED|Overall Study||99
8674460|NCT00764881|9717932|FG000|NOT COMPLETED|Overall Study||16
8674461|NCT00764881|9717933|FG001|NOT COMPLETED|Overall Study||10
8674462|NCT00764946|9717942|FG000|STARTED|Overall Study||98
8674463|NCT00764946|9717943|FG001|STARTED|Overall Study||89
8674464|NCT00764946|9717944|FG002|STARTED|Overall Study||22
8674465|NCT00764946|9717942|FG000|TREATED|Overall Study||97
8674466|NCT00764946|9717943|FG001|TREATED|Overall Study||88
8674467|NCT00764946|9717944|FG002|TREATED|Overall Study||21
8674468|NCT00764946|9717942|FG000|COMPLETED|Overall Study||85
8674469|NCT00764946|9717943|FG001|COMPLETED|Overall Study||72
8674470|NCT00764946|9717944|FG002|COMPLETED|Overall Study||18
8674471|NCT00764946|9717942|FG000|NOT COMPLETED|Overall Study||13
8674472|NCT00764946|9717943|FG001|NOT COMPLETED|Overall Study||17
8674473|NCT00764946|9717944|FG002|NOT COMPLETED|Overall Study||4
8674474|NCT00765037|9717958|FG000|STARTED|Overall Study|Original number of eligible subjects who signed a consent form.|19
8674475|NCT00765037|9717958|FG000|COMPLETED|Overall Study|Subjects who came in for 1 year visit.|13
8674476|NCT00765037|9717958|FG000|NOT COMPLETED|Overall Study||6
8674477|NCT00765063|9717962|FG000|STARTED|Overall Study||62
8674478|NCT00765063|9717962|FG000|COMPLETED|Overall Study||30
8674479|NCT00765063|9717962|FG000|NOT COMPLETED|Overall Study||32
8674480|NCT00765076|9717969|FG000|STARTED|Overall Study||69
8674481|NCT00765076|9717970|FG001|STARTED|Overall Study||73
8674482|NCT00765076|9717971|FG002|STARTED|Overall Study||50
8674483|NCT00765076|9717969|FG000|COMPLETED|Overall Study||68
8674484|NCT00765076|9717970|FG001|COMPLETED|Overall Study||73
8674485|NCT00765076|9717971|FG002|COMPLETED|Overall Study||49
8674486|NCT00765076|9717969|FG000|NOT COMPLETED|Overall Study||1
8674487|NCT00765076|9717970|FG001|NOT COMPLETED|Overall Study||0
8674488|NCT00765076|9717971|FG002|NOT COMPLETED|Overall Study||1
8674489|NCT00765102|9717979|FG000|STARTED|Overall Study||32
8674490|NCT00765102|9717979|FG000|COMPLETED|Overall Study|Completed 8 cycles of treatment|1
8674491|NCT00765102|9717979|FG000|NOT COMPLETED|Overall Study||31
8674492|NCT00765128|9717987|FG000|STARTED|Overall Study||8
8674493|NCT00765128|9717988|FG001|STARTED|Overall Study||9
8674494|NCT00765128|9717987|FG000|COMPLETED|Overall Study||8
8674495|NCT00765128|9717988|FG001|COMPLETED|Overall Study||9
8674496|NCT00765128|9717987|FG000|NOT COMPLETED|Overall Study||0
8674497|NCT00765128|9717988|FG001|NOT COMPLETED|Overall Study||0
8674498|NCT00765193|9717994|FG000|STARTED|Problem Area Examination||14381
8674499|NCT00765193|9717994|FG000|COMPLETED|Problem Area Examination||14381
8674500|NCT00765193|9717994|FG000|NOT COMPLETED|Problem Area Examination||0
8674501|NCT00765193|9717994|FG000|STARTED|Full Body Examination||14381
8674502|NCT00765193|9717994|FG000|COMPLETED|Full Body Examination||14381
8674503|NCT00765193|9717994|FG000|NOT COMPLETED|Full Body Examination||0
8674504|NCT00765206|9717999|FG000|STARTED|First Intervention||15
8674505|NCT00765206|9718000|FG001|STARTED|First Intervention||15
8674506|NCT00765206|9718001|FG002|STARTED|First Intervention||15
8674507|NCT00765206|9718002|FG003|STARTED|First Intervention||15
8674508|NCT00765206|9717999|FG000|COMPLETED|First Intervention||15
8674509|NCT00765206|9718000|FG001|COMPLETED|First Intervention||15
8674510|NCT00765206|9718001|FG002|COMPLETED|First Intervention||15
8674511|NCT00765206|9718002|FG003|COMPLETED|First Intervention||15
8674512|NCT00765206|9717999|FG000|NOT COMPLETED|First Intervention||0
8674513|NCT00765206|9718000|FG001|NOT COMPLETED|First Intervention||0
8674514|NCT00765206|9718001|FG002|NOT COMPLETED|First Intervention||0
8674515|NCT00765206|9718002|FG003|NOT COMPLETED|First Intervention||0
8674516|NCT00765206|9717999|FG000|STARTED|Washout Period of 14 Days||15
8674517|NCT00765206|9718000|FG001|STARTED|Washout Period of 14 Days||15
8674518|NCT00765206|9718001|FG002|STARTED|Washout Period of 14 Days||15
8674519|NCT00765206|9718002|FG003|STARTED|Washout Period of 14 Days||15
8674520|NCT00765206|9717999|FG000|COMPLETED|Washout Period of 14 Days||15
8674521|NCT00765206|9718000|FG001|COMPLETED|Washout Period of 14 Days||15
8674522|NCT00765206|9718001|FG002|COMPLETED|Washout Period of 14 Days||15
8674523|NCT00765206|9718002|FG003|COMPLETED|Washout Period of 14 Days||15
8674524|NCT00765206|9717999|FG000|NOT COMPLETED|Washout Period of 14 Days||0
8674525|NCT00765206|9718000|FG001|NOT COMPLETED|Washout Period of 14 Days||0
8674526|NCT00765206|9718001|FG002|NOT COMPLETED|Washout Period of 14 Days||0
8674527|NCT00765206|9718002|FG003|NOT COMPLETED|Washout Period of 14 Days||0
8674528|NCT00765206|9717999|FG000|STARTED|Second Intervention||15
8674529|NCT00765206|9718000|FG001|STARTED|Second Intervention||15
8674530|NCT00765206|9718001|FG002|STARTED|Second Intervention||15
8674531|NCT00765206|9718002|FG003|STARTED|Second Intervention||15
8674532|NCT00765206|9717999|FG000|COMPLETED|Second Intervention||15
8674533|NCT00765206|9718000|FG001|COMPLETED|Second Intervention||15
8674534|NCT00765206|9718001|FG002|COMPLETED|Second Intervention||15
8674535|NCT00765206|9718002|FG003|COMPLETED|Second Intervention||15
8674536|NCT00765206|9717999|FG000|NOT COMPLETED|Second Intervention||0
8674537|NCT00765206|9718000|FG001|NOT COMPLETED|Second Intervention||0
8674538|NCT00765206|9718001|FG002|NOT COMPLETED|Second Intervention||0
8674539|NCT00765206|9718002|FG003|NOT COMPLETED|Second Intervention||0
8674540|NCT00765232|9718010|FG000|STARTED|Overall Study||57
8674541|NCT00765232|9718011|FG001|STARTED|Overall Study||54
8674542|NCT00765232|9718010|FG000|COMPLETED|Overall Study||57
8674543|NCT00765232|9718011|FG001|COMPLETED|Overall Study||54
8674544|NCT00765232|9718010|FG000|NOT COMPLETED|Overall Study||0
8674545|NCT00765232|9718011|FG001|NOT COMPLETED|Overall Study||0
8674546|NCT00765245|9718019|FG000|STARTED|Overall Study||22
8674547|NCT00765245|9718020|FG001|STARTED|Overall Study||22
8674548|NCT00765245|9718019|FG000|COMPLETED|Overall Study||9
8674549|NCT00765245|9718020|FG001|COMPLETED|Overall Study||20
8674550|NCT00765245|9718019|FG000|NOT COMPLETED|Overall Study||13
8674551|NCT00765245|9718020|FG001|NOT COMPLETED|Overall Study||2
8674552|NCT00765336|9718028|FG000|STARTED|Overall Study||91
8674553|NCT00765336|9718029|FG001|STARTED|Overall Study||89
8674554|NCT00765336|9718028|FG000|COMPLETED|Overall Study||72
8674555|NCT00765336|9718029|FG001|COMPLETED|Overall Study||73
8674556|NCT00765336|9718028|FG000|NOT COMPLETED|Overall Study||19
8674557|NCT00765336|9718029|FG001|NOT COMPLETED|Overall Study||16
8674558|NCT00765362|9718035|FG000|STARTED|Overall Study||419
8674559|NCT00765362|9718035|FG000|COMPLETED|Overall Study||282
8674560|NCT00765362|9718035|FG000|NOT COMPLETED|Overall Study||137
8674561|NCT00765375|9718039|FG000|STARTED|Overall Study||5
8674562|NCT00765375|9718039|FG000|COMPLETED|Overall Study||5
8674563|NCT00765375|9718039|FG000|NOT COMPLETED|Overall Study||0
8674564|NCT00765388|9718045|FG000|STARTED|Period 1|A cross-over study|16
8674565|NCT00765388|9718046|FG001|STARTED|Period 1||11
8674566|NCT00765388|9718045|FG000|COMPLETED|Period 1||15
8674567|NCT00765388|9718046|FG001|COMPLETED|Period 1||6
8674568|NCT00765388|9718045|FG000|NOT COMPLETED|Period 1||1
8674569|NCT00765388|9718046|FG001|NOT COMPLETED|Period 1||5
8674570|NCT00765388|9718045|FG000|STARTED|Period 2||15
8674571|NCT00765388|9718046|FG001|STARTED|Period 2||6
8674572|NCT00765388|9718045|FG000|COMPLETED|Period 2||15
8674573|NCT00765388|9718046|FG001|COMPLETED|Period 2||6
8674574|NCT00765388|9718045|FG000|NOT COMPLETED|Period 2||0
8674575|NCT00765388|9718046|FG001|NOT COMPLETED|Period 2||0
8674576|NCT00765570|9718054|FG000|STARTED|Overall Study||9
8674577|NCT00765570|9718055|FG001|STARTED|Overall Study||3
8674578|NCT00765570|9718054|FG000|COMPLETED|Overall Study||7
8674579|NCT00765570|9718055|FG001|COMPLETED|Overall Study||3
8674580|NCT00765570|9718054|FG000|NOT COMPLETED|Overall Study||2
8674581|NCT00765570|9718055|FG001|NOT COMPLETED|Overall Study||0
8674582|NCT00765648|9718063|FG000|STARTED|Overall Study||110
8674583|NCT00765648|9718064|FG001|STARTED|Overall Study||116
8674584|NCT00765648|9718063|FG000|COMPLETED|Overall Study||109
8674585|NCT00765648|9718064|FG001|COMPLETED|Overall Study||114
8674586|NCT00765648|9718063|FG000|NOT COMPLETED|Overall Study||1
8674587|NCT00765648|9718064|FG001|NOT COMPLETED|Overall Study||2
8674588|NCT00765661|9718072|FG000|STARTED|Overall Study||32
8674589|NCT00765661|9718073|FG001|STARTED|Overall Study||31
8674590|NCT00765661|9718072|FG000|COMPLETED|Overall Study||32
8674591|NCT00765661|9718073|FG001|COMPLETED|Overall Study||31
8674592|NCT00765661|9718072|FG000|NOT COMPLETED|Overall Study||0
8674593|NCT00765661|9718073|FG001|NOT COMPLETED|Overall Study||0
8674594|NCT00765674|9718083|FG000|STARTED|Overall Study||287
8674595|NCT00765674|9718084|FG001|STARTED|Overall Study|1 patient was randomized in error and discontinued without taking any double-blind study medication.|298
8674596|NCT00765674|9718085|FG002|STARTED|Overall Study||296
8674597|NCT00765674|9718086|FG003|STARTED|Overall Study|1 patient was randomized in error and discontinued without taking any double-blind study medication.|310
8674598|NCT00765674|9718083|FG000|COMPLETED|Overall Study||266
8674599|NCT00765674|9718084|FG001|COMPLETED|Overall Study||276
8674600|NCT00765674|9718085|FG002|COMPLETED|Overall Study||279
8674601|NCT00765674|9718086|FG003|COMPLETED|Overall Study||285
8674602|NCT00765674|9718083|FG000|NOT COMPLETED|Overall Study||21
8674603|NCT00765674|9718084|FG001|NOT COMPLETED|Overall Study||22
8674604|NCT00765674|9718085|FG002|NOT COMPLETED|Overall Study||17
8674605|NCT00765674|9718086|FG003|NOT COMPLETED|Overall Study||25
8674606|NCT00765726|9718096|FG000|STARTED|Overall Study||12
8674607|NCT00765726|9718096|FG000|COMPLETED|Overall Study||3
8674608|NCT00765726|9718096|FG000|NOT COMPLETED|Overall Study||9
8674609|NCT00765817|9718102|FG000|STARTED|Overall Study|One subject withdrew prior to receiving study medication, not included in analysis set|138
8674610|NCT00765817|9718103|FG001|STARTED|Overall Study|One subject withdrew prior to receiving study medication, not included in analysis set|123
8799577|NCT01438489|9851142|FG001|COMPLETED|Overall Study||84
8674611|NCT00765817|9718102|FG000|COMPLETED|Overall Study||112
8674612|NCT00765817|9718103|FG001|COMPLETED|Overall Study||101
8674613|NCT00765817|9718102|FG000|NOT COMPLETED|Overall Study||26
8674614|NCT00765817|9718103|FG001|NOT COMPLETED|Overall Study||22
8674615|NCT00765843|9718112|FG000|STARTED|Overall Study||26
8674616|NCT00765843|9718113|FG001|STARTED|Overall Study||25
8674617|NCT00765843|9718114|FG002|STARTED|Overall Study||26
8674618|NCT00765843|9718112|FG000|COMPLETED|Overall Study||25
8674619|NCT00765843|9718113|FG001|COMPLETED|Overall Study||21
8674620|NCT00765843|9718114|FG002|COMPLETED|Overall Study||23
8674621|NCT00765843|9718112|FG000|NOT COMPLETED|Overall Study||1
8674622|NCT00765843|9718113|FG001|NOT COMPLETED|Overall Study||4
8674623|NCT00765843|9718114|FG002|NOT COMPLETED|Overall Study||3
8692686|NCT00862810|9738262|FG001|COMPLETED|Overall Study||35
8692687|NCT00862810|9738261|FG000|NOT COMPLETED|Overall Study||4
8692688|NCT00862810|9738262|FG001|NOT COMPLETED|Overall Study||4
8692689|NCT00862823|9738268|FG000|STARTED|First Intervention||6
8692690|NCT00862823|9738269|FG001|STARTED|First Intervention||10
8692691|NCT00862823|9738268|FG000|COMPLETED|First Intervention||5
8692692|NCT00862823|9738269|FG001|COMPLETED|First Intervention||9
8692693|NCT00862823|9738268|FG000|NOT COMPLETED|First Intervention||1
8692694|NCT00862823|9738269|FG001|NOT COMPLETED|First Intervention||1
8692695|NCT00862823|9738268|FG000|STARTED|Washout Period of 2 Weeks||5
8692696|NCT00862823|9738269|FG001|STARTED|Washout Period of 2 Weeks||9
8692697|NCT00862823|9738268|FG000|COMPLETED|Washout Period of 2 Weeks||5
8692698|NCT00862823|9738269|FG001|COMPLETED|Washout Period of 2 Weeks||9
8692699|NCT00862823|9738268|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
8692700|NCT00862823|9738269|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
8692701|NCT00862823|9738268|FG000|STARTED|Second Intervention||5
8692702|NCT00862823|9738269|FG001|STARTED|Second Intervention||9
8692703|NCT00862823|9738268|FG000|COMPLETED|Second Intervention||5
8692704|NCT00862823|9738269|FG001|COMPLETED|Second Intervention||9
8692705|NCT00862823|9738268|FG000|NOT COMPLETED|Second Intervention||0
8692706|NCT00862823|9738269|FG001|NOT COMPLETED|Second Intervention||0
8692707|NCT00862836|9738274|FG000|STARTED|Overall Study||15
8692708|NCT00862836|9738274|FG000|Evaluable for Safety/Toxicity|Overall Study|1 patient withdrew consent before first cycle|14
8692709|NCT00862836|9738274|FG000|Evaluable for Activity (Tumour Response)|Overall Study||10
8692710|NCT00862836|9738274|FG000|COMPLETED|Overall Study||14
8692711|NCT00862836|9738274|FG000|NOT COMPLETED|Overall Study||1
8692712|NCT00862849|9738278|FG000|STARTED|Intervention 1||3
8692713|NCT00862849|9738279|FG001|STARTED|Intervention 1||5
8692714|NCT00862849|9738280|FG002|STARTED|Intervention 1||3
8692715|NCT00862849|9738281|FG003|STARTED|Intervention 1||4
8692716|NCT00862849|9738282|FG004|STARTED|Intervention 1||4
8692717|NCT00862849|9738283|FG005|STARTED|Intervention 1||3
8692718|NCT00862849|9738278|FG000|Received at Least One Dose of Study Drug|Intervention 1||3
8692719|NCT00862849|9738279|FG001|Received at Least One Dose of Study Drug|Intervention 1||5
8692720|NCT00862849|9738280|FG002|Received at Least One Dose of Study Drug|Intervention 1||3
8692721|NCT00862849|9738281|FG003|Received at Least One Dose of Study Drug|Intervention 1||4
8692722|NCT00862849|9738282|FG004|Received at Least One Dose of Study Drug|Intervention 1||4
8692723|NCT00862849|9738283|FG005|Received at Least One Dose of Study Drug|Intervention 1||3
8692724|NCT00862849|9738278|FG000|COMPLETED|Intervention 1||3
8692725|NCT00862849|9738279|FG001|COMPLETED|Intervention 1||5
8692726|NCT00862849|9738280|FG002|COMPLETED|Intervention 1||3
8692727|NCT00862849|9738281|FG003|COMPLETED|Intervention 1||4
8692728|NCT00862849|9738282|FG004|COMPLETED|Intervention 1||4
8692729|NCT00862849|9738283|FG005|COMPLETED|Intervention 1||3
8692730|NCT00862849|9738278|FG000|NOT COMPLETED|Intervention 1||0
8692731|NCT00862849|9738279|FG001|NOT COMPLETED|Intervention 1||0
8692732|NCT00862849|9738280|FG002|NOT COMPLETED|Intervention 1||0
8692733|NCT00862849|9738281|FG003|NOT COMPLETED|Intervention 1||0
8692734|NCT00862849|9738282|FG004|NOT COMPLETED|Intervention 1||0
8692735|NCT00862849|9738283|FG005|NOT COMPLETED|Intervention 1||0
8692736|NCT00862849|9738278|FG000|STARTED|Washout 1 (3 to 14 Days)||3
8692737|NCT00862849|9738279|FG001|STARTED|Washout 1 (3 to 14 Days)||5
8692738|NCT00862849|9738280|FG002|STARTED|Washout 1 (3 to 14 Days)||3
8692739|NCT00862849|9738281|FG003|STARTED|Washout 1 (3 to 14 Days)||4
8692740|NCT00862849|9738282|FG004|STARTED|Washout 1 (3 to 14 Days)||4
8692741|NCT00862849|9738283|FG005|STARTED|Washout 1 (3 to 14 Days)||3
8692742|NCT00862849|9738278|FG000|COMPLETED|Washout 1 (3 to 14 Days)||3
8692743|NCT00862849|9738279|FG001|COMPLETED|Washout 1 (3 to 14 Days)||4
8692744|NCT00862849|9738280|FG002|COMPLETED|Washout 1 (3 to 14 Days)||3
8692745|NCT00862849|9738281|FG003|COMPLETED|Washout 1 (3 to 14 Days)||4
8692746|NCT00862849|9738282|FG004|COMPLETED|Washout 1 (3 to 14 Days)||4
8692747|NCT00862849|9738283|FG005|COMPLETED|Washout 1 (3 to 14 Days)||3
8692748|NCT00862849|9738278|FG000|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
8692749|NCT00862849|9738279|FG001|NOT COMPLETED|Washout 1 (3 to 14 Days)||1
8692750|NCT00862849|9738280|FG002|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
8692751|NCT00862849|9738281|FG003|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
8692752|NCT00862849|9738282|FG004|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
8692753|NCT00862849|9738283|FG005|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
8692754|NCT00862849|9738278|FG000|STARTED|Intervention 2||3
8692755|NCT00862849|9738279|FG001|STARTED|Intervention 2||4
8692756|NCT00862849|9738280|FG002|STARTED|Intervention 2||3
8692757|NCT00862849|9738281|FG003|STARTED|Intervention 2||4
8692758|NCT00862849|9738282|FG004|STARTED|Intervention 2||4
8674624|NCT00765856|9718122|FG000|STARTED|Titration Period||27
8674625|NCT00765856|9718122|FG000|COMPLETED|Titration Period||24
8674626|NCT00765856|9718122|FG000|NOT COMPLETED|Titration Period||3
8674627|NCT00765856|9718122|FG000|STARTED|Maintenance Period||24
8674628|NCT00765856|9718122|FG000|COMPLETED|Maintenance Period||18
8674629|NCT00765856|9718122|FG000|NOT COMPLETED|Maintenance Period||6
8674630|NCT00765882|9718132|FG000|STARTED|Overall Study||215
8674631|NCT00765882|9718133|FG001|STARTED|Overall Study||213
8674632|NCT00765882|9718134|FG002|STARTED|Overall Study||205
8674633|NCT00765882|9718132|FG000|COMPLETED|Overall Study||191
8674634|NCT00765882|9718133|FG001|COMPLETED|Overall Study||173
8674635|NCT00765882|9718134|FG002|COMPLETED|Overall Study||169
8674636|NCT00765882|9718132|FG000|NOT COMPLETED|Overall Study||24
8674637|NCT00765882|9718133|FG001|NOT COMPLETED|Overall Study||40
8674638|NCT00765882|9718134|FG002|NOT COMPLETED|Overall Study||36
8674639|NCT00765895|9718144|FG000|STARTED|Overall Study||65
8674640|NCT00765895|9718145|FG001|STARTED|Overall Study||65
8674641|NCT00765895|9718144|FG000|COMPLETED|Overall Study||65
8674642|NCT00765895|9718145|FG001|COMPLETED|Overall Study||65
8674643|NCT00765895|9718144|FG000|NOT COMPLETED|Overall Study||0
8674644|NCT00765895|9718145|FG001|NOT COMPLETED|Overall Study||0
8674645|NCT00765947|9718151|FG000|STARTED|Overall Study||256
8674646|NCT00765947|9718151|FG000|COMPLETED|Overall Study||232
8674647|NCT00765947|9718151|FG000|NOT COMPLETED|Overall Study||24
8674648|NCT00765999|9718157|FG000|STARTED|Overall Study||1554
8674649|NCT00765999|9718157|FG000|COMPLETED|Overall Study||770
8674650|NCT00765999|9718157|FG000|NOT COMPLETED|Overall Study||784
8674651|NCT00766038|9718165|FG000|STARTED|Overall Study||31
8674652|NCT00766038|9718166|FG001|STARTED|Overall Study||32
8674653|NCT00766038|9718165|FG000|COMPLETED|Overall Study||16
8674654|NCT00766038|9718166|FG001|COMPLETED|Overall Study||18
8674655|NCT00766038|9718165|FG000|NOT COMPLETED|Overall Study||15
8674656|NCT00766038|9718166|FG001|NOT COMPLETED|Overall Study||14
8674657|NCT00766051|9718176|FG000|STARTED|Overall Study||12
8674658|NCT00766051|9718177|FG001|STARTED|Overall Study||10
8674659|NCT00766051|9718176|FG000|COMPLETED|Overall Study||10
8674660|NCT00766051|9718177|FG001|COMPLETED|Overall Study||10
8674661|NCT00766051|9718176|FG000|NOT COMPLETED|Overall Study||2
8674662|NCT00766051|9718177|FG001|NOT COMPLETED|Overall Study||0
8674663|NCT00766090|9718187|FG000|STARTED|Treatment Period 1 (28 Days)||25
8674664|NCT00766090|9718188|FG001|STARTED|Treatment Period 1 (28 Days)||27
8674665|NCT00766090|9718189|FG002|STARTED|Treatment Period 1 (28 Days)||23
8674666|NCT00766090|9718190|FG003|STARTED|Treatment Period 1 (28 Days)||26
8674667|NCT00766090|9718191|FG004|STARTED|Treatment Period 1 (28 Days)||23
8674668|NCT00766090|9718192|FG005|STARTED|Treatment Period 1 (28 Days)||23
8674669|NCT00766090|9718193|FG006|STARTED|Treatment Period 1 (28 Days)||6
8674670|NCT00766090|9718194|FG007|STARTED|Treatment Period 1 (28 Days)||8
8674671|NCT00766090|9718195|FG008|STARTED|Treatment Period 1 (28 Days)||7
8674672|NCT00766090|9718196|FG009|STARTED|Treatment Period 1 (28 Days)||8
8674673|NCT00766090|9718197|FG010|STARTED|Treatment Period 1 (28 Days)||7
8674674|NCT00766090|9718198|FG011|STARTED|Treatment Period 1 (28 Days)||7
8674675|NCT00766090|9718187|FG000|COMPLETED|Treatment Period 1 (28 Days)||22
8674676|NCT00766090|9718188|FG001|COMPLETED|Treatment Period 1 (28 Days)||27
8674677|NCT00766090|9718189|FG002|COMPLETED|Treatment Period 1 (28 Days)||23
8674678|NCT00766090|9718190|FG003|COMPLETED|Treatment Period 1 (28 Days)||25
8674679|NCT00766090|9718191|FG004|COMPLETED|Treatment Period 1 (28 Days)||23
8674680|NCT00766090|9718192|FG005|COMPLETED|Treatment Period 1 (28 Days)||23
8674681|NCT00766090|9718193|FG006|COMPLETED|Treatment Period 1 (28 Days)||6
8674682|NCT00766090|9718194|FG007|COMPLETED|Treatment Period 1 (28 Days)||8
8674683|NCT00766090|9718195|FG008|COMPLETED|Treatment Period 1 (28 Days)||6
8674684|NCT00766090|9718196|FG009|COMPLETED|Treatment Period 1 (28 Days)||8
8674685|NCT00766090|9718197|FG010|COMPLETED|Treatment Period 1 (28 Days)||7
8674686|NCT00766090|9718198|FG011|COMPLETED|Treatment Period 1 (28 Days)||7
8674687|NCT00766090|9718187|FG000|NOT COMPLETED|Treatment Period 1 (28 Days)||3
8674688|NCT00766090|9718188|FG001|NOT COMPLETED|Treatment Period 1 (28 Days)||0
8674689|NCT00766090|9718189|FG002|NOT COMPLETED|Treatment Period 1 (28 Days)||0
8674690|NCT00766090|9718190|FG003|NOT COMPLETED|Treatment Period 1 (28 Days)||1
8674691|NCT00766090|9718191|FG004|NOT COMPLETED|Treatment Period 1 (28 Days)||0
8674692|NCT00766090|9718192|FG005|NOT COMPLETED|Treatment Period 1 (28 Days)||0
8674693|NCT00766090|9718193|FG006|NOT COMPLETED|Treatment Period 1 (28 Days)||0
8674694|NCT00766090|9718194|FG007|NOT COMPLETED|Treatment Period 1 (28 Days)||0
8674695|NCT00766090|9718195|FG008|NOT COMPLETED|Treatment Period 1 (28 Days)||1
8674696|NCT00766090|9718196|FG009|NOT COMPLETED|Treatment Period 1 (28 Days)||0
8674697|NCT00766090|9718197|FG010|NOT COMPLETED|Treatment Period 1 (28 Days)||0
8674698|NCT00766090|9718198|FG011|NOT COMPLETED|Treatment Period 1 (28 Days)||0
8674699|NCT00766090|9718187|FG000|STARTED|Washout Period 1 (14 Days)||22
8674700|NCT00766090|9718188|FG001|STARTED|Washout Period 1 (14 Days)||27
8674701|NCT00766090|9718189|FG002|STARTED|Washout Period 1 (14 Days)||23
8674702|NCT00766090|9718190|FG003|STARTED|Washout Period 1 (14 Days)||25
8674703|NCT00766090|9718191|FG004|STARTED|Washout Period 1 (14 Days)||23
8674704|NCT00766090|9718192|FG005|STARTED|Washout Period 1 (14 Days)||23
8674705|NCT00766090|9718193|FG006|STARTED|Washout Period 1 (14 Days)||6
8674706|NCT00766090|9718194|FG007|STARTED|Washout Period 1 (14 Days)||8
8674707|NCT00766090|9718195|FG008|STARTED|Washout Period 1 (14 Days)||6
8674708|NCT00766090|9718196|FG009|STARTED|Washout Period 1 (14 Days)||8
8674709|NCT00766090|9718197|FG010|STARTED|Washout Period 1 (14 Days)||7
8674710|NCT00766090|9718198|FG011|STARTED|Washout Period 1 (14 Days)||7
8674711|NCT00766090|9718187|FG000|COMPLETED|Washout Period 1 (14 Days)||22
8674712|NCT00766090|9718188|FG001|COMPLETED|Washout Period 1 (14 Days)||27
8674713|NCT00766090|9718189|FG002|COMPLETED|Washout Period 1 (14 Days)||22
8674714|NCT00766090|9718190|FG003|COMPLETED|Washout Period 1 (14 Days)||25
8674715|NCT00766090|9718191|FG004|COMPLETED|Washout Period 1 (14 Days)||23
8674716|NCT00766090|9718192|FG005|COMPLETED|Washout Period 1 (14 Days)||23
8674717|NCT00766090|9718193|FG006|COMPLETED|Washout Period 1 (14 Days)||6
8674718|NCT00766090|9718194|FG007|COMPLETED|Washout Period 1 (14 Days)||8
8674719|NCT00766090|9718195|FG008|COMPLETED|Washout Period 1 (14 Days)||6
8674720|NCT00766090|9718196|FG009|COMPLETED|Washout Period 1 (14 Days)||8
8674721|NCT00766090|9718197|FG010|COMPLETED|Washout Period 1 (14 Days)||7
8674722|NCT00766090|9718198|FG011|COMPLETED|Washout Period 1 (14 Days)||7
8674723|NCT00766090|9718187|FG000|NOT COMPLETED|Washout Period 1 (14 Days)||0
8674724|NCT00766090|9718188|FG001|NOT COMPLETED|Washout Period 1 (14 Days)||0
8674725|NCT00766090|9718189|FG002|NOT COMPLETED|Washout Period 1 (14 Days)||1
8674726|NCT00766090|9718190|FG003|NOT COMPLETED|Washout Period 1 (14 Days)||0
8674727|NCT00766090|9718191|FG004|NOT COMPLETED|Washout Period 1 (14 Days)||0
8674728|NCT00766090|9718192|FG005|NOT COMPLETED|Washout Period 1 (14 Days)||0
8674729|NCT00766090|9718193|FG006|NOT COMPLETED|Washout Period 1 (14 Days)||0
8674730|NCT00766090|9718194|FG007|NOT COMPLETED|Washout Period 1 (14 Days)||0
8674731|NCT00766090|9718195|FG008|NOT COMPLETED|Washout Period 1 (14 Days)||0
8674732|NCT00766090|9718196|FG009|NOT COMPLETED|Washout Period 1 (14 Days)||0
8674733|NCT00766090|9718197|FG010|NOT COMPLETED|Washout Period 1 (14 Days)||0
8674734|NCT00766090|9718198|FG011|NOT COMPLETED|Washout Period 1 (14 Days)||0
8674735|NCT00766090|9718187|FG000|STARTED|Treatment Period 2 (28 Days)||22
8674736|NCT00766090|9718188|FG001|STARTED|Treatment Period 2 (28 Days)||27
8674737|NCT00766090|9718189|FG002|STARTED|Treatment Period 2 (28 Days)||22
8674738|NCT00766090|9718190|FG003|STARTED|Treatment Period 2 (28 Days)||25
8674739|NCT00766090|9718191|FG004|STARTED|Treatment Period 2 (28 Days)||23
8674740|NCT00766090|9718192|FG005|STARTED|Treatment Period 2 (28 Days)||23
8674741|NCT00766090|9718193|FG006|STARTED|Treatment Period 2 (28 Days)||6
8674742|NCT00766090|9718194|FG007|STARTED|Treatment Period 2 (28 Days)||8
8674743|NCT00766090|9718195|FG008|STARTED|Treatment Period 2 (28 Days)||6
8674744|NCT00766090|9718196|FG009|STARTED|Treatment Period 2 (28 Days)||8
8674745|NCT00766090|9718197|FG010|STARTED|Treatment Period 2 (28 Days)||7
8674746|NCT00766090|9718198|FG011|STARTED|Treatment Period 2 (28 Days)||7
8674747|NCT00766090|9718187|FG000|COMPLETED|Treatment Period 2 (28 Days)||22
8674748|NCT00766090|9718188|FG001|COMPLETED|Treatment Period 2 (28 Days)||27
8674749|NCT00766090|9718189|FG002|COMPLETED|Treatment Period 2 (28 Days)||21
8674750|NCT00766090|9718190|FG003|COMPLETED|Treatment Period 2 (28 Days)||25
8674751|NCT00766090|9718191|FG004|COMPLETED|Treatment Period 2 (28 Days)||21
8674752|NCT00766090|9718192|FG005|COMPLETED|Treatment Period 2 (28 Days)||23
8674753|NCT00766090|9718193|FG006|COMPLETED|Treatment Period 2 (28 Days)||6
8674754|NCT00766090|9718194|FG007|COMPLETED|Treatment Period 2 (28 Days)||8
8674755|NCT00766090|9718195|FG008|COMPLETED|Treatment Period 2 (28 Days)||6
8674756|NCT00766090|9718196|FG009|COMPLETED|Treatment Period 2 (28 Days)||8
8674757|NCT00766090|9718197|FG010|COMPLETED|Treatment Period 2 (28 Days)||7
8674758|NCT00766090|9718198|FG011|COMPLETED|Treatment Period 2 (28 Days)||7
8674759|NCT00766090|9718187|FG000|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8674760|NCT00766090|9718188|FG001|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8674761|NCT00766090|9718189|FG002|NOT COMPLETED|Treatment Period 2 (28 Days)||1
8674762|NCT00766090|9718190|FG003|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8674763|NCT00766090|9718191|FG004|NOT COMPLETED|Treatment Period 2 (28 Days)||2
8674764|NCT00766090|9718192|FG005|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8674765|NCT00766090|9718193|FG006|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8674766|NCT00766090|9718194|FG007|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8674767|NCT00766090|9718195|FG008|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8674768|NCT00766090|9718196|FG009|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8674769|NCT00766090|9718197|FG010|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8674770|NCT00766090|9718198|FG011|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8674771|NCT00766090|9718187|FG000|STARTED|Washout Period 2 (14 Days)||22
8674772|NCT00766090|9718188|FG001|STARTED|Washout Period 2 (14 Days)||27
8674773|NCT00766090|9718189|FG002|STARTED|Washout Period 2 (14 Days)||21
8674774|NCT00766090|9718190|FG003|STARTED|Washout Period 2 (14 Days)||25
8674775|NCT00766090|9718191|FG004|STARTED|Washout Period 2 (14 Days)||21
8674776|NCT00766090|9718192|FG005|STARTED|Washout Period 2 (14 Days)||23
8674777|NCT00766090|9718193|FG006|STARTED|Washout Period 2 (14 Days)||6
8674778|NCT00766090|9718194|FG007|STARTED|Washout Period 2 (14 Days)||8
8674779|NCT00766090|9718195|FG008|STARTED|Washout Period 2 (14 Days)||6
8674780|NCT00766090|9718196|FG009|STARTED|Washout Period 2 (14 Days)||8
8674781|NCT00766090|9718197|FG010|STARTED|Washout Period 2 (14 Days)||7
8674782|NCT00766090|9718198|FG011|STARTED|Washout Period 2 (14 Days)||7
8674783|NCT00766090|9718187|FG000|COMPLETED|Washout Period 2 (14 Days)||22
8674784|NCT00766090|9718188|FG001|COMPLETED|Washout Period 2 (14 Days)||27
8674785|NCT00766090|9718189|FG002|COMPLETED|Washout Period 2 (14 Days)||20
8674786|NCT00766090|9718190|FG003|COMPLETED|Washout Period 2 (14 Days)||25
8674787|NCT00766090|9718191|FG004|COMPLETED|Washout Period 2 (14 Days)||21
8674788|NCT00766090|9718192|FG005|COMPLETED|Washout Period 2 (14 Days)||23
8674789|NCT00766090|9718193|FG006|COMPLETED|Washout Period 2 (14 Days)||6
8674790|NCT00766090|9718194|FG007|COMPLETED|Washout Period 2 (14 Days)||8
8674791|NCT00766090|9718195|FG008|COMPLETED|Washout Period 2 (14 Days)||6
8674792|NCT00766090|9718196|FG009|COMPLETED|Washout Period 2 (14 Days)||8
8674793|NCT00766090|9718197|FG010|COMPLETED|Washout Period 2 (14 Days)||7
8674794|NCT00766090|9718198|FG011|COMPLETED|Washout Period 2 (14 Days)||7
8674795|NCT00766090|9718187|FG000|NOT COMPLETED|Washout Period 2 (14 Days)||0
8674796|NCT00766090|9718188|FG001|NOT COMPLETED|Washout Period 2 (14 Days)||0
8674797|NCT00766090|9718189|FG002|NOT COMPLETED|Washout Period 2 (14 Days)||1
8674798|NCT00766090|9718190|FG003|NOT COMPLETED|Washout Period 2 (14 Days)||0
8674799|NCT00766090|9718191|FG004|NOT COMPLETED|Washout Period 2 (14 Days)||0
8674800|NCT00766090|9718192|FG005|NOT COMPLETED|Washout Period 2 (14 Days)||0
8674801|NCT00766090|9718193|FG006|NOT COMPLETED|Washout Period 2 (14 Days)||0
8674802|NCT00766090|9718194|FG007|NOT COMPLETED|Washout Period 2 (14 Days)||0
8674803|NCT00766090|9718195|FG008|NOT COMPLETED|Washout Period 2 (14 Days)||0
8674804|NCT00766090|9718196|FG009|NOT COMPLETED|Washout Period 2 (14 Days)||0
8674805|NCT00766090|9718197|FG010|NOT COMPLETED|Washout Period 2 (14 Days)||0
8674806|NCT00766090|9718198|FG011|NOT COMPLETED|Washout Period 2 (14 Days)||0
8674807|NCT00766090|9718187|FG000|STARTED|Treatment Period 3 (28 Days)||22
8674808|NCT00766090|9718188|FG001|STARTED|Treatment Period 3 (28 Days)||27
8674809|NCT00766090|9718189|FG002|STARTED|Treatment Period 3 (28 Days)||20
8674810|NCT00766090|9718190|FG003|STARTED|Treatment Period 3 (28 Days)||25
8674811|NCT00766090|9718191|FG004|STARTED|Treatment Period 3 (28 Days)||21
8674812|NCT00766090|9718192|FG005|STARTED|Treatment Period 3 (28 Days)||23
8674813|NCT00766090|9718193|FG006|STARTED|Treatment Period 3 (28 Days)||6
8674814|NCT00766090|9718194|FG007|STARTED|Treatment Period 3 (28 Days)||8
8674815|NCT00766090|9718195|FG008|STARTED|Treatment Period 3 (28 Days)||6
8674816|NCT00766090|9718196|FG009|STARTED|Treatment Period 3 (28 Days)||8
8674817|NCT00766090|9718197|FG010|STARTED|Treatment Period 3 (28 Days)||7
8674818|NCT00766090|9718198|FG011|STARTED|Treatment Period 3 (28 Days)||7
8674819|NCT00766090|9718187|FG000|COMPLETED|Treatment Period 3 (28 Days)||22
8674820|NCT00766090|9718188|FG001|COMPLETED|Treatment Period 3 (28 Days)||26
8674821|NCT00766090|9718189|FG002|COMPLETED|Treatment Period 3 (28 Days)||20
8674822|NCT00766090|9718190|FG003|COMPLETED|Treatment Period 3 (28 Days)||24
8674823|NCT00766090|9718191|FG004|COMPLETED|Treatment Period 3 (28 Days)||20
8674824|NCT00766090|9718192|FG005|COMPLETED|Treatment Period 3 (28 Days)||22
8674825|NCT00766090|9718193|FG006|COMPLETED|Treatment Period 3 (28 Days)||6
8674826|NCT00766090|9718194|FG007|COMPLETED|Treatment Period 3 (28 Days)||8
8674827|NCT00766090|9718195|FG008|COMPLETED|Treatment Period 3 (28 Days)||6
8674828|NCT00766090|9718196|FG009|COMPLETED|Treatment Period 3 (28 Days)||8
8674829|NCT00766090|9718197|FG010|COMPLETED|Treatment Period 3 (28 Days)||7
8674830|NCT00766090|9718198|FG011|COMPLETED|Treatment Period 3 (28 Days)||6
8674831|NCT00766090|9718187|FG000|NOT COMPLETED|Treatment Period 3 (28 Days)||0
8674832|NCT00766090|9718188|FG001|NOT COMPLETED|Treatment Period 3 (28 Days)||1
8674833|NCT00766090|9718189|FG002|NOT COMPLETED|Treatment Period 3 (28 Days)||0
8674834|NCT00766090|9718190|FG003|NOT COMPLETED|Treatment Period 3 (28 Days)||1
8674835|NCT00766090|9718191|FG004|NOT COMPLETED|Treatment Period 3 (28 Days)||1
8674836|NCT00766090|9718192|FG005|NOT COMPLETED|Treatment Period 3 (28 Days)||1
8674837|NCT00766090|9718193|FG006|NOT COMPLETED|Treatment Period 3 (28 Days)||0
8674838|NCT00766090|9718194|FG007|NOT COMPLETED|Treatment Period 3 (28 Days)||0
8674839|NCT00766090|9718195|FG008|NOT COMPLETED|Treatment Period 3 (28 Days)||0
8674840|NCT00766090|9718196|FG009|NOT COMPLETED|Treatment Period 3 (28 Days)||0
8674841|NCT00766090|9718197|FG010|NOT COMPLETED|Treatment Period 3 (28 Days)||0
8674842|NCT00766090|9718198|FG011|NOT COMPLETED|Treatment Period 3 (28 Days)||1
8674843|NCT00766116|9718212|FG000|STARTED|Overall Study||50
8674844|NCT00766116|9718212|FG000|COMPLETED|Overall Study||50
8674845|NCT00766116|9718212|FG000|NOT COMPLETED|Overall Study||0
8674846|NCT00766142|9718219|FG000|STARTED|Overall Study||18
8674847|NCT00766142|9718219|FG000|COMPLETED|Overall Study||14
8674848|NCT00766142|9718219|FG000|NOT COMPLETED|Overall Study||4
8674849|NCT00766363|9718227|FG000|STARTED|Overall Study||12
8674850|NCT00766363|9718228|FG001|STARTED|Overall Study||13
8674851|NCT00766363|9718229|FG002|STARTED|Overall Study|Number randomized.|12
8674852|NCT00766363|9718230|FG003|STARTED|Overall Study|Number randomized.|12
8674853|NCT00766363|9718227|FG000|SAFETY POPULATION|Overall Study||12
8674854|NCT00766363|9718228|FG001|SAFETY POPULATION|Overall Study||13
8674855|NCT00766363|9718229|FG002|SAFETY POPULATION|Overall Study|Decreased by one subject who took placebo instead due to treatment assignment error.|11
8674856|NCT00766363|9718230|FG003|SAFETY POPULATION|Overall Study|Increased by one subject who took placebo due to treatment assignment error.|13
8674857|NCT00766363|9718227|FG000|PK POPULATION|Overall Study||12
8674858|NCT00766363|9718228|FG001|PK POPULATION|Overall Study||13
8674859|NCT00766363|9718229|FG002|PK POPULATION|Overall Study||10
8674860|NCT00766363|9718230|FG003|PK POPULATION|Overall Study||13
8674861|NCT00766363|9718227|FG000|COMPLETED|Overall Study||11
8674862|NCT00766363|9718228|FG001|COMPLETED|Overall Study||12
8674863|NCT00766363|9718229|FG002|COMPLETED|Overall Study||12
8674864|NCT00766363|9718230|FG003|COMPLETED|Overall Study||12
8674865|NCT00766363|9718227|FG000|NOT COMPLETED|Overall Study||1
8674866|NCT00766363|9718228|FG001|NOT COMPLETED|Overall Study||1
8674867|NCT00766363|9718229|FG002|NOT COMPLETED|Overall Study||0
8674868|NCT00766363|9718230|FG003|NOT COMPLETED|Overall Study||0
8674869|NCT00766376|9718241|FG000|STARTED|Overall Study||151
8674870|NCT00766376|9718241|FG000|COMPLETED|Overall Study||124
8674871|NCT00766376|9718241|FG000|NOT COMPLETED|Overall Study||27
8674872|NCT00766415|9718247|FG000|STARTED|Overall Study||25
8674873|NCT00766415|9718248|FG001|STARTED|Overall Study||27
8674874|NCT00766415|9718247|FG000|COMPLETED|Overall Study||25
8674875|NCT00766415|9718248|FG001|COMPLETED|Overall Study||26
8674876|NCT00766415|9718247|FG000|NOT COMPLETED|Overall Study||0
8674877|NCT00766415|9718248|FG001|NOT COMPLETED|Overall Study||1
8674878|NCT00766467|9718256|FG000|STARTED|Overall Study||42
8674879|NCT00766467|9718257|FG001|STARTED|Overall Study||39
8674880|NCT00766467|9718256|FG000|Initiated Treatment|Overall Study||39
8674881|NCT00766467|9718257|FG001|Initiated Treatment|Overall Study||38
8674882|NCT00766467|9718256|FG000|COMPLETED|Overall Study||31
8674883|NCT00766467|9718257|FG001|COMPLETED|Overall Study||31
8674884|NCT00766467|9718256|FG000|NOT COMPLETED|Overall Study||11
8674885|NCT00766467|9718257|FG001|NOT COMPLETED|Overall Study||8
8674886|NCT00766493|9718263|FG000|STARTED|Pre-Discharge||250
8674887|NCT00766493|9718263|FG000|COMPLETED|Pre-Discharge||250
8674888|NCT00766493|9718263|FG000|NOT COMPLETED|Pre-Discharge||0
8674889|NCT00766493|9718263|FG000|STARTED|30 Days Post-Procedure||250
8674890|NCT00766493|9718263|FG000|COMPLETED|30 Days Post-Procedure||238
8674891|NCT00766493|9718263|FG000|NOT COMPLETED|30 Days Post-Procedure||12
8674892|NCT00766506|9718269|FG000|STARTED|Overall Study||58
8674893|NCT00766506|9718270|FG001|STARTED|Overall Study||50
8674894|NCT00766506|9718269|FG000|COMPLETED|Overall Study||53
8674895|NCT00766506|9718270|FG001|COMPLETED|Overall Study||48
8674896|NCT00766506|9718269|FG000|NOT COMPLETED|Overall Study||5
8674897|NCT00766506|9718270|FG001|NOT COMPLETED|Overall Study||2
8674898|NCT00766532|9718276|FG000|STARTED|Overall Study||12
8674899|NCT00766532|9718276|FG000|COMPLETED|Overall Study||10
8674900|NCT00766532|9718276|FG000|NOT COMPLETED|Overall Study||2
8674901|NCT00766597|9718280|FG000|STARTED|Overall Study|Screened participants who were evaluated for co-receptor tropism|9
8674902|NCT00766597|9718280|FG000|With CCR5-tropic Virus|Overall Study|Evaluable participants, received the study drug|4
8674903|NCT00766597|9718280|FG000|Without CCR5-tropic Virus|Overall Study|Not evaluable participants, did not receive the study drug|5
8674904|NCT00766597|9718280|FG000|Completed Week 24|Overall Study|Week 24 is the first primary time point of analysis|1
8674905|NCT00766597|9718280|FG000|Completed Week 48|Overall Study|Week 48 is the second primary time point of analysis|0
8674906|NCT00766597|9718280|FG000|COMPLETED|Overall Study|Treatment duration is 48 weeks plus 5 years of follow-up|0
8674907|NCT00766597|9718280|FG000|NOT COMPLETED|Overall Study||9
8674908|NCT00766649|9718286|FG000|STARTED|Overall Study||11
8674909|NCT00766649|9718286|FG000|COMPLETED|Overall Study||1
8674910|NCT00766649|9718286|FG000|NOT COMPLETED|Overall Study||10
8674911|NCT00766675|9718290|FG000|STARTED|Overall Study||80
8674912|NCT00766675|9718290|FG000|COMPLETED|Overall Study||40
8674913|NCT00766675|9718290|FG000|NOT COMPLETED|Overall Study||40
8674914|NCT00766727|9718294|FG000|STARTED|Overall Study||12
8674915|NCT00766727|9718294|FG000|COMPLETED|Overall Study||9
8674916|NCT00766727|9718294|FG000|NOT COMPLETED|Overall Study||3
8674917|NCT00766753|9718302|FG000|STARTED|Overall Study||11
8674918|NCT00766753|9718303|FG001|STARTED|Overall Study||11
8674919|NCT00766753|9718302|FG000|Received at Least One Vaccine|Overall Study||11
8674920|NCT00766753|9718303|FG001|Received at Least One Vaccine|Overall Study||11
8674921|NCT00766753|9718302|FG000|Completed at Least Four Vaccines|Overall Study||10
8674922|NCT00766753|9718303|FG001|Completed at Least Four Vaccines|Overall Study||9
8674923|NCT00766753|9718302|FG000|COMPLETED|Overall Study||11
8674924|NCT00766753|9718303|FG001|COMPLETED|Overall Study||11
8674925|NCT00766753|9718302|FG000|NOT COMPLETED|Overall Study||0
8674926|NCT00766753|9718303|FG001|NOT COMPLETED|Overall Study||0
8674927|NCT00766831|9718310|FG000|STARTED|Overall Study||190
8674928|NCT00766831|9718310|FG000|COMPLETED|Overall Study||75
8674929|NCT00766831|9718310|FG000|NOT COMPLETED|Overall Study||115
8674930|NCT00767000|9718319|FG000|STARTED|54-week Study||119
8674931|NCT00767000|9718320|FG001|STARTED|54-week Study||117
8674932|NCT00767000|9718321|FG002|STARTED|54-week Study||117
8674933|NCT00767000|9718322|FG003|STARTED|54-week Study|Includes additional participants enrolled to enhance evaluation of the safety profile of MK-0941|229
8674934|NCT00767000|9718323|FG004|STARTED|54-week Study|Includes additional participants enrolled to enhance evaluation of the safety profile of MK-0941|231
8674935|NCT00767000|9718319|FG000|COMPLETED|54-week Study||11
8674936|NCT00767000|9718320|FG001|COMPLETED|54-week Study||4
8674937|NCT00767000|9718321|FG002|COMPLETED|54-week Study||8
8674938|NCT00767000|9718322|FG003|COMPLETED|54-week Study||4
8674939|NCT00767000|9718323|FG004|COMPLETED|54-week Study||7
8674940|NCT00767000|9718319|FG000|NOT COMPLETED|54-week Study||108
8674941|NCT00767000|9718320|FG001|NOT COMPLETED|54-week Study||113
8674942|NCT00767000|9718321|FG002|NOT COMPLETED|54-week Study||109
8674943|NCT00767000|9718322|FG003|NOT COMPLETED|54-week Study||225
8674944|NCT00767000|9718323|FG004|NOT COMPLETED|54-week Study||224
8674945|NCT00767000|9718319|FG000|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|7
8674946|NCT00767000|9718320|FG001|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|3
8674947|NCT00767000|9718321|FG002|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|7
8674948|NCT00767000|9718322|FG003|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|2
8674949|NCT00767000|9718323|FG004|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|4
8674950|NCT00767000|9718319|FG000|COMPLETED|Optional 104-week Extension||0
8674951|NCT00767000|9718320|FG001|COMPLETED|Optional 104-week Extension||0
8674952|NCT00767000|9718321|FG002|COMPLETED|Optional 104-week Extension||0
8674953|NCT00767000|9718322|FG003|COMPLETED|Optional 104-week Extension||0
8674954|NCT00767000|9718323|FG004|COMPLETED|Optional 104-week Extension||0
8674955|NCT00767000|9718319|FG000|NOT COMPLETED|Optional 104-week Extension||7
8674956|NCT00767000|9718320|FG001|NOT COMPLETED|Optional 104-week Extension||3
8674957|NCT00767000|9718321|FG002|NOT COMPLETED|Optional 104-week Extension||7
8674958|NCT00767000|9718322|FG003|NOT COMPLETED|Optional 104-week Extension||2
8674959|NCT00767000|9718323|FG004|NOT COMPLETED|Optional 104-week Extension||4
8674960|NCT00767039|9718337|FG000|STARTED|Overall Study|Two early deaths and 3 late deaths occurred in this group|27
8674961|NCT00767039|9718338|FG001|STARTED|Overall Study||25
8674962|NCT00767039|9718337|FG000|COMPLETED|Overall Study||22
8674963|NCT00767039|9718338|FG001|COMPLETED|Overall Study||23
8674964|NCT00767039|9718337|FG000|NOT COMPLETED|Overall Study||5
8674965|NCT00767039|9718338|FG001|NOT COMPLETED|Overall Study||2
8674966|NCT00767104|9718346|FG000|STARTED|Overall Study||20
8674967|NCT00767104|9718347|FG001|STARTED|Overall Study||20
8674968|NCT00767104|9718346|FG000|COMPLETED|Overall Study||19
8674969|NCT00767104|9718347|FG001|COMPLETED|Overall Study||18
8674970|NCT00767104|9718346|FG000|NOT COMPLETED|Overall Study||1
8674971|NCT00767104|9718347|FG001|NOT COMPLETED|Overall Study||2
8674972|NCT00767325|9718355|FG000|STARTED|Overall Study||104
8674973|NCT00767325|9718355|FG000|COMPLETED|Overall Study||89
8674974|NCT00767325|9718355|FG000|NOT COMPLETED|Overall Study||15
8674975|NCT00767338|9718363|FG000|STARTED|Overall Study||1
8674976|NCT00767338|9718364|FG001|STARTED|Overall Study||2
8674977|NCT00767338|9718365|FG002|STARTED|Overall Study||0
8674978|NCT00767338|9718366|FG003|STARTED|Overall Study||0
8674979|NCT00767338|9718363|FG000|COMPLETED|Overall Study||0
8674980|NCT00767338|9718364|FG001|COMPLETED|Overall Study||0
8674981|NCT00767338|9718365|FG002|COMPLETED|Overall Study||0
8674982|NCT00767338|9718366|FG003|COMPLETED|Overall Study||0
8674983|NCT00767338|9718363|FG000|NOT COMPLETED|Overall Study||1
8674984|NCT00767338|9718364|FG001|NOT COMPLETED|Overall Study||2
8674985|NCT00767338|9718365|FG002|NOT COMPLETED|Overall Study||0
8674986|NCT00767338|9718366|FG003|NOT COMPLETED|Overall Study||0
8674987|NCT00767364|9718378|FG000|STARTED|Overall Study||5
8674988|NCT00767364|9718379|FG001|STARTED|Overall Study||3
8674989|NCT00767364|9718378|FG000|COMPLETED|Overall Study||5
8674990|NCT00767364|9718379|FG001|COMPLETED|Overall Study||3
8674991|NCT00767364|9718378|FG000|NOT COMPLETED|Overall Study||0
8674992|NCT00767364|9718379|FG001|NOT COMPLETED|Overall Study||0
8674993|NCT00767455|9718385|FG000|STARTED|Overall Study||59
8674994|NCT00767455|9718385|FG000|COMPLETED|Overall Study||40
8674995|NCT00767455|9718385|FG000|NOT COMPLETED|Overall Study||19
8674996|NCT00767507|9718395|FG000|STARTED|Overall Study||5
8674997|NCT00767507|9718396|FG001|STARTED|Overall Study||6
8674998|NCT00767507|9718397|FG002|STARTED|Overall Study||106
8674999|NCT00767507|9718398|FG003|STARTED|Overall Study||104
8675000|NCT00767507|9718395|FG000|COMPLETED|Overall Study||5
8675001|NCT00767507|9718396|FG001|COMPLETED|Overall Study||6
8675002|NCT00767507|9718397|FG002|COMPLETED|Overall Study||106
8675003|NCT00767507|9718398|FG003|COMPLETED|Overall Study||101
8675004|NCT00767507|9718395|FG000|NOT COMPLETED|Overall Study||0
8675005|NCT00767507|9718396|FG001|NOT COMPLETED|Overall Study||0
8675006|NCT00767507|9718397|FG002|NOT COMPLETED|Overall Study||0
8675007|NCT00767507|9718398|FG003|NOT COMPLETED|Overall Study||3
8675008|NCT00767520|9718417|FG000|STARTED|Overall Study||79
8675009|NCT00767520|9718418|FG001|STARTED|Overall Study||78
8675010|NCT00767520|9718417|FG000|COMPLETED|Overall Study|Completed=Off-treatment; Major reasons: disease progression-50, study drug toxicity-10,AE-3,Death-2|68
8675011|NCT00767520|9718418|FG001|COMPLETED|Overall Study|Completed=Off-treatment; Major reasons: disease progression-56, study drug toxicity-2,AE-1,Death-1|61
8675012|NCT00767520|9718417|FG000|NOT COMPLETED|Overall Study||11
8675013|NCT00767520|9718418|FG001|NOT COMPLETED|Overall Study||17
8675014|NCT00767572|9718424|FG000|STARTED|First Intervention (12 Weeks)||12
8675015|NCT00767572|9718424|FG000|COMPLETED|First Intervention (12 Weeks)||12
8675016|NCT00767572|9718424|FG000|NOT COMPLETED|First Intervention (12 Weeks)||0
8675017|NCT00767572|9718424|FG000|STARTED|Washout (4 Weeks)||12
8675018|NCT00767572|9718424|FG000|COMPLETED|Washout (4 Weeks)||12
8675019|NCT00767572|9718424|FG000|NOT COMPLETED|Washout (4 Weeks)||0
8675020|NCT00767572|9718424|FG000|STARTED|Second Intervention (12 Weeks)||12
8799578|NCT01438489|9851143|FG002|COMPLETED|Overall Study||85
8675021|NCT00767572|9718424|FG000|COMPLETED|Second Intervention (12 Weeks)||12
8675022|NCT00767572|9718424|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||0
8675023|NCT00767624|9718432|FG000|STARTED|Overall Study||75
8675024|NCT00767624|9718433|FG001|STARTED|Overall Study||75
8675025|NCT00767624|9718432|FG000|COMPLETED|Overall Study||51
8675026|NCT00767624|9718433|FG001|COMPLETED|Overall Study||58
8675027|NCT00767624|9718432|FG000|NOT COMPLETED|Overall Study||24
8675028|NCT00767624|9718433|FG001|NOT COMPLETED|Overall Study||17
8675029|NCT00767676|9718439|FG000|STARTED|Overall Study||259
8675030|NCT00767676|9718439|FG000|COMPLETED|Overall Study||205
8675031|NCT00767676|9718439|FG000|NOT COMPLETED|Overall Study||54
8675032|NCT00767767|9718448|FG000|STARTED|Overall Study||21
8675033|NCT00767767|9718449|FG001|STARTED|Overall Study||20
8675034|NCT00767767|9718450|FG002|STARTED|Overall Study||20
8675035|NCT00767767|9718451|FG003|STARTED|Overall Study||3
8675036|NCT00767767|9718452|FG004|STARTED|Overall Study||3
8675037|NCT00767767|9718448|FG000|COMPLETED|Overall Study||21
8675038|NCT00767767|9718449|FG001|COMPLETED|Overall Study||20
8675039|NCT00767767|9718450|FG002|COMPLETED|Overall Study||20
8675040|NCT00767767|9718451|FG003|COMPLETED|Overall Study||3
8675041|NCT00767767|9718452|FG004|COMPLETED|Overall Study||3
8675042|NCT00767767|9718448|FG000|NOT COMPLETED|Overall Study||0
8675043|NCT00767767|9718449|FG001|NOT COMPLETED|Overall Study||0
8675044|NCT00767767|9718450|FG002|NOT COMPLETED|Overall Study||0
8675045|NCT00767767|9718451|FG003|NOT COMPLETED|Overall Study||0
8675046|NCT00767767|9718452|FG004|NOT COMPLETED|Overall Study||0
8675047|NCT00767806|9718466|FG000|STARTED|Overall Study||198
8675048|NCT00767806|9718467|FG001|STARTED|Overall Study||203
8799579|NCT01438489|9851141|FG000|NOT COMPLETED|Overall Study||26
8799580|NCT01438489|9851142|FG001|NOT COMPLETED|Overall Study||16
8799581|NCT01438489|9851143|FG002|NOT COMPLETED|Overall Study||19
8799582|NCT01438541|9851153|FG000|STARTED|Overall Study||29
8799583|NCT01438541|9851153|FG000|COMPLETED|Overall Study||22
8799584|NCT01438541|9851153|FG000|NOT COMPLETED|Overall Study||7
8799585|NCT01438710|9851157|FG000|STARTED|First Week of Treatment|Patients are only treated with Prograf/generic Tacrolimus during the first week.|0
8799586|NCT01438710|9851158|FG001|STARTED|First Week of Treatment||44
8799587|NCT01438710|9851157|FG000|COMPLETED|First Week of Treatment|Patients are only treated with Prograf/generic Tacrolimus during the first week.|0
8799588|NCT01438710|9851158|FG001|COMPLETED|First Week of Treatment||41
8799589|NCT01438710|9851157|FG000|NOT COMPLETED|First Week of Treatment||0
8799590|NCT01438710|9851158|FG001|NOT COMPLETED|First Week of Treatment||3
8799591|NCT01438710|9851157|FG000|STARTED|Second Week of Treatment|Patients completing the first week will continue on LCP-Tacro treatment during the second week.|41
8799592|NCT01438710|9851158|FG001|STARTED|Second Week of Treatment|Patients are only treated with LCP-Tacro during the second week.|0
8799593|NCT01438710|9851157|FG000|COMPLETED|Second Week of Treatment||40
8799594|NCT01438710|9851158|FG001|COMPLETED|Second Week of Treatment|Patients are only treated with LCP-Tacro during the second week.|0
8799595|NCT01438710|9851157|FG000|NOT COMPLETED|Second Week of Treatment||1
8799596|NCT01438710|9851158|FG001|NOT COMPLETED|Second Week of Treatment||0
8799597|NCT01438814|9851165|FG000|STARTED|Overall Study||344
8799598|NCT01438814|9851166|FG001|STARTED|Overall Study||345
8799599|NCT01438814|9851165|FG000|COMPLETED|Overall Study||330
8799600|NCT01438814|9851166|FG001|COMPLETED|Overall Study||331
8799601|NCT01438814|9851165|FG000|NOT COMPLETED|Overall Study||14
8799602|NCT01438814|9851166|FG001|NOT COMPLETED|Overall Study||14
8799603|NCT01438840|9851174|FG000|STARTED|Core Study||17
8799604|NCT01438840|9851175|FG001|STARTED|Core Study||32
8799605|NCT01438840|9851176|FG002|STARTED|Core Study||0
8799606|NCT01438840|9851174|FG000|COMPLETED|Core Study||1
8799607|NCT01438840|9851175|FG001|COMPLETED|Core Study||22
8799608|NCT01438840|9851176|FG002|COMPLETED|Core Study||0
8799609|NCT01438840|9851174|FG000|NOT COMPLETED|Core Study||16
8799610|NCT01438840|9851175|FG001|NOT COMPLETED|Core Study||10
8799611|NCT01438840|9851176|FG002|NOT COMPLETED|Core Study||0
8799612|NCT01438840|9851174|FG000|STARTED|Extension Phase||0
8799613|NCT01438840|9851175|FG001|STARTED|Extension Phase||0
8799614|NCT01438840|9851176|FG002|STARTED|Extension Phase|39 participants met eligibility criteria for the Extension Phase.|39
8799615|NCT01438840|9851174|FG000|COMPLETED|Extension Phase||0
8799616|NCT01438840|9851175|FG001|COMPLETED|Extension Phase||0
8799617|NCT01438840|9851176|FG002|COMPLETED|Extension Phase||29
8799618|NCT01438840|9851174|FG000|NOT COMPLETED|Extension Phase||0
8799619|NCT01438840|9851175|FG001|NOT COMPLETED|Extension Phase||0
8799620|NCT01438840|9851176|FG002|NOT COMPLETED|Extension Phase||10
8799621|NCT01438957|9851188|FG000|STARTED|Overall Study||22
8799622|NCT01438957|9851189|FG001|STARTED|Overall Study||23
8799623|NCT01438957|9851190|FG002|STARTED|Overall Study||24
8799624|NCT01438957|9851191|FG003|STARTED|Overall Study||25
8799625|NCT01438957|9851192|FG004|STARTED|Overall Study||25
8799626|NCT01438957|9851188|FG000|COMPLETED|Overall Study||21
8799627|NCT01438957|9851189|FG001|COMPLETED|Overall Study||22
8799628|NCT01438957|9851190|FG002|COMPLETED|Overall Study||24
8799629|NCT01438957|9851191|FG003|COMPLETED|Overall Study||24
8799630|NCT01438957|9851192|FG004|COMPLETED|Overall Study||25
8799631|NCT01438957|9851188|FG000|NOT COMPLETED|Overall Study||1
8799632|NCT01438957|9851189|FG001|NOT COMPLETED|Overall Study||1
8799633|NCT01438957|9851190|FG002|NOT COMPLETED|Overall Study||0
8799634|NCT01438957|9851191|FG003|NOT COMPLETED|Overall Study||1
8799635|NCT01438957|9851192|FG004|NOT COMPLETED|Overall Study||0
8799636|NCT01438996|9851207|FG000|STARTED|Overall Study||18
8799637|NCT01438996|9851208|FG001|STARTED|Overall Study||13
8799638|NCT01438996|9851209|FG002|STARTED|Overall Study||20
8799639|NCT01438996|9851207|FG000|COMPLETED|Overall Study||14
8799640|NCT01438996|9851208|FG001|COMPLETED|Overall Study||12
8799641|NCT01438996|9851209|FG002|COMPLETED|Overall Study||20
8675049|NCT00767806|9718466|FG000|COMPLETED|Overall Study||147
8675050|NCT00767806|9718467|FG001|COMPLETED|Overall Study||156
8675051|NCT00767806|9718466|FG000|NOT COMPLETED|Overall Study||51
8675052|NCT00767806|9718467|FG001|NOT COMPLETED|Overall Study||47
8675053|NCT00767819|9718476|FG000|STARTED|Overall Study||37
8675054|NCT00767819|9718477|FG001|STARTED|Overall Study||24
8675055|NCT00767819|9718478|FG002|STARTED|Overall Study||10
8675056|NCT00767819|9718476|FG000|Intent to Treat (ITT) Analysis Set|Overall Study||37
8675057|NCT00767819|9718477|FG001|Intent to Treat (ITT) Analysis Set|Overall Study||24
8675058|NCT00767819|9718478|FG002|Intent to Treat (ITT) Analysis Set|Overall Study||10
8675059|NCT00767819|9718476|FG000|Safety Analysis Set (SAF)|Overall Study||37
8675060|NCT00767819|9718477|FG001|Safety Analysis Set (SAF)|Overall Study||24
8675061|NCT00767819|9718478|FG002|Safety Analysis Set (SAF)|Overall Study||10
8675062|NCT00767819|9718476|FG000|COMPLETED|Overall Study||12
8675063|NCT00767819|9718477|FG001|COMPLETED|Overall Study||5
8675064|NCT00767819|9718478|FG002|COMPLETED|Overall Study||10
8675065|NCT00767819|9718476|FG000|NOT COMPLETED|Overall Study||25
8675066|NCT00767819|9718477|FG001|NOT COMPLETED|Overall Study||19
8675067|NCT00767819|9718478|FG002|NOT COMPLETED|Overall Study||0
8675068|NCT00768053|9718486|FG000|STARTED|Overall Study||108
8675069|NCT00768053|9718486|FG000|COMPLETED|Overall Study||97
8675070|NCT00768053|9718486|FG000|NOT COMPLETED|Overall Study||11
8675071|NCT00768066|9718493|FG000|STARTED|Overall Study||22
8675072|NCT00768066|9718494|FG001|STARTED|Overall Study||22
8675073|NCT00768066|9718495|FG002|STARTED|Overall Study||21
8675074|NCT00768066|9718493|FG000|COMPLETED|Overall Study||19
8675075|NCT00768066|9718494|FG001|COMPLETED|Overall Study||19
8675076|NCT00768066|9718495|FG002|COMPLETED|Overall Study||21
8675077|NCT00768066|9718493|FG000|NOT COMPLETED|Overall Study||3
8675078|NCT00768066|9718494|FG001|NOT COMPLETED|Overall Study||3
8675079|NCT00768066|9718495|FG002|NOT COMPLETED|Overall Study||0
8675080|NCT00768079|9718506|FG000|STARTED|Overall Study||38
8675081|NCT00768079|9718507|FG001|STARTED|Overall Study||36
8675082|NCT00768079|9718508|FG002|STARTED|Overall Study||36
8675083|NCT00768079|9718506|FG000|COMPLETED|Overall Study||36
8675084|NCT00768079|9718507|FG001|COMPLETED|Overall Study||35
8675085|NCT00768079|9718508|FG002|COMPLETED|Overall Study||32
8675086|NCT00768079|9718506|FG000|NOT COMPLETED|Overall Study||2
8675087|NCT00768079|9718507|FG001|NOT COMPLETED|Overall Study||1
8675088|NCT00768079|9718508|FG002|NOT COMPLETED|Overall Study||4
8675089|NCT00768118|9718518|FG000|STARTED|Overall Study||11
8675090|NCT00768118|9718518|FG000|COMPLETED|Overall Study||11
8675091|NCT00768118|9718518|FG000|NOT COMPLETED|Overall Study||0
8675092|NCT00768144|9718522|FG000|STARTED|Overall Study||36
8675093|NCT00768144|9718522|FG000|COMPLETED|Overall Study||0
8675094|NCT00768144|9718522|FG000|NOT COMPLETED|Overall Study||36
8675095|NCT00768222|9718528|FG000|STARTED|Overall Study||50
8675096|NCT00768222|9718529|FG001|STARTED|Overall Study||51
8675097|NCT00768222|9718528|FG000|COMPLETED|Overall Study||46
8675098|NCT00768222|9718529|FG001|COMPLETED|Overall Study||47
8675099|NCT00768222|9718528|FG000|NOT COMPLETED|Overall Study||4
8675100|NCT00768222|9718529|FG001|NOT COMPLETED|Overall Study||4
8675101|NCT00768261|9718539|FG000|STARTED|Overall Study||14
8675102|NCT00768261|9718540|FG001|STARTED|Overall Study||18
8675103|NCT00768261|9718541|FG002|STARTED|Overall Study||39
8675104|NCT00768261|9718542|FG003|STARTED|Overall Study||56
8675105|NCT00768261|9718539|FG000|COMPLETED|Overall Study||14
8675106|NCT00768261|9718540|FG001|COMPLETED|Overall Study||18
8675107|NCT00768261|9718541|FG002|COMPLETED|Overall Study||14
8675108|NCT00768261|9718542|FG003|COMPLETED|Overall Study||56
8675109|NCT00768261|9718539|FG000|NOT COMPLETED|Overall Study||0
8675110|NCT00768261|9718540|FG001|NOT COMPLETED|Overall Study||0
8675111|NCT00768261|9718541|FG002|NOT COMPLETED|Overall Study||25
8675112|NCT00768261|9718542|FG003|NOT COMPLETED|Overall Study||0
8675113|NCT00768287|9718555|FG000|STARTED|Pharmacokinetic Study||16
8675114|NCT00768287|9718556|FG001|STARTED|Pharmacokinetic Study||16
8675115|NCT00768287|9718557|FG002|STARTED|Pharmacokinetic Study||0
8675116|NCT00768287|9718558|FG003|STARTED|Pharmacokinetic Study||0
8675117|NCT00768287|9718559|FG004|STARTED|Pharmacokinetic Study||0
8675118|NCT00768287|9718560|FG005|STARTED|Pharmacokinetic Study||0
8675119|NCT00768287|9718555|FG000|COMPLETED|Pharmacokinetic Study||16
8675120|NCT00768287|9718556|FG001|COMPLETED|Pharmacokinetic Study||16
8675121|NCT00768287|9718557|FG002|COMPLETED|Pharmacokinetic Study||0
8675122|NCT00768287|9718558|FG003|COMPLETED|Pharmacokinetic Study||0
8675123|NCT00768287|9718559|FG004|COMPLETED|Pharmacokinetic Study||0
8675124|NCT00768287|9718560|FG005|COMPLETED|Pharmacokinetic Study||0
8675125|NCT00768287|9718555|FG000|NOT COMPLETED|Pharmacokinetic Study||0
8675126|NCT00768287|9718556|FG001|NOT COMPLETED|Pharmacokinetic Study||0
8675127|NCT00768287|9718557|FG002|NOT COMPLETED|Pharmacokinetic Study||0
8675128|NCT00768287|9718558|FG003|NOT COMPLETED|Pharmacokinetic Study||0
8675129|NCT00768287|9718559|FG004|NOT COMPLETED|Pharmacokinetic Study||0
8675130|NCT00768287|9718560|FG005|NOT COMPLETED|Pharmacokinetic Study||0
8675131|NCT00768287|9718555|FG000|STARTED|Repeat Pharmacokinetic Study||0
8675132|NCT00768287|9718556|FG001|STARTED|Repeat Pharmacokinetic Study||0
8675133|NCT00768287|9718557|FG002|STARTED|Repeat Pharmacokinetic Study|Eight subjects were part of the IB1001 first group; 6 were from the nonacog alfa first group.|14
8675134|NCT00768287|9718558|FG003|STARTED|Repeat Pharmacokinetic Study||0
8675135|NCT00768287|9718559|FG004|STARTED|Repeat Pharmacokinetic Study||0
8675136|NCT00768287|9718560|FG005|STARTED|Repeat Pharmacokinetic Study||0
8675137|NCT00768287|9718555|FG000|COMPLETED|Repeat Pharmacokinetic Study||0
8675138|NCT00768287|9718556|FG001|COMPLETED|Repeat Pharmacokinetic Study||0
8675139|NCT00768287|9718557|FG002|COMPLETED|Repeat Pharmacokinetic Study||14
8675140|NCT00768287|9718558|FG003|COMPLETED|Repeat Pharmacokinetic Study||0
8675141|NCT00768287|9718559|FG004|COMPLETED|Repeat Pharmacokinetic Study||0
8675142|NCT00768287|9718560|FG005|COMPLETED|Repeat Pharmacokinetic Study||0
8675143|NCT00768287|9718555|FG000|NOT COMPLETED|Repeat Pharmacokinetic Study||0
8675144|NCT00768287|9718556|FG001|NOT COMPLETED|Repeat Pharmacokinetic Study||0
8675145|NCT00768287|9718557|FG002|NOT COMPLETED|Repeat Pharmacokinetic Study||0
8675146|NCT00768287|9718558|FG003|NOT COMPLETED|Repeat Pharmacokinetic Study||0
8675147|NCT00768287|9718559|FG004|NOT COMPLETED|Repeat Pharmacokinetic Study||0
8675148|NCT00768287|9718560|FG005|NOT COMPLETED|Repeat Pharmacokinetic Study||0
8675149|NCT00768287|9718555|FG000|STARTED|Treatment Study||0
8675150|NCT00768287|9718556|FG001|STARTED|Treatment Study||0
8675151|NCT00768287|9718557|FG002|STARTED|Treatment Study||0
8675152|NCT00768287|9718558|FG003|STARTED|Treatment Study|1 subject was not assigned a regimen at the start of the study.|58
8675153|NCT00768287|9718559|FG004|STARTED|Treatment Study|1 subject was not assigned a regimen at the start of the study.|9
8675154|NCT00768287|9718560|FG005|STARTED|Treatment Study||0
8675155|NCT00768287|9718555|FG000|Treated|Treatment Study||0
8675156|NCT00768287|9718556|FG001|Treated|Treatment Study||0
8675157|NCT00768287|9718557|FG002|Treated|Treatment Study||0
8675158|NCT00768287|9718558|FG003|Treated|Treatment Study|Subjects could switch treatment regimens. 3 subjects switched from On Demand to Prophylaxis.|61
8675159|NCT00768287|9718559|FG004|Treated|Treatment Study|Subjects could switch treatment regimens. 3 subjects switched from Prophylaxis to On Demand.|12
8675160|NCT00768287|9718560|FG005|Treated|Treatment Study||0
8675161|NCT00768287|9718555|FG000|COMPLETED|Treatment Study||0
8675162|NCT00768287|9718556|FG001|COMPLETED|Treatment Study||0
8675163|NCT00768287|9718557|FG002|COMPLETED|Treatment Study||0
8675164|NCT00768287|9718558|FG003|COMPLETED|Treatment Study||58
8675165|NCT00768287|9718559|FG004|COMPLETED|Treatment Study||9
8675166|NCT00768287|9718560|FG005|COMPLETED|Treatment Study||0
8675167|NCT00768287|9718555|FG000|NOT COMPLETED|Treatment Study||0
8675168|NCT00768287|9718556|FG001|NOT COMPLETED|Treatment Study||0
8675169|NCT00768287|9718557|FG002|NOT COMPLETED|Treatment Study||0
8675170|NCT00768287|9718558|FG003|NOT COMPLETED|Treatment Study||0
8675171|NCT00768287|9718559|FG004|NOT COMPLETED|Treatment Study||0
8675172|NCT00768287|9718560|FG005|NOT COMPLETED|Treatment Study||0
8675173|NCT00768287|9718555|FG000|STARTED|Surgical Sub-study||0
8675174|NCT00768287|9718556|FG001|STARTED|Surgical Sub-study||0
8675175|NCT00768287|9718557|FG002|STARTED|Surgical Sub-study||0
8675176|NCT00768287|9718558|FG003|STARTED|Surgical Sub-study||0
8675177|NCT00768287|9718559|FG004|STARTED|Surgical Sub-study||0
8675178|NCT00768287|9718560|FG005|STARTED|Surgical Sub-study|1 female subject was excluded from the efficacy analysis. She was included in the safety population.|17
8675179|NCT00768287|9718555|FG000|COMPLETED|Surgical Sub-study||0
8675180|NCT00768287|9718556|FG001|COMPLETED|Surgical Sub-study||0
8675181|NCT00768287|9718557|FG002|COMPLETED|Surgical Sub-study||0
8675182|NCT00768287|9718558|FG003|COMPLETED|Surgical Sub-study||0
8675183|NCT00768287|9718559|FG004|COMPLETED|Surgical Sub-study||0
8675184|NCT00768287|9718560|FG005|COMPLETED|Surgical Sub-study||17
8675185|NCT00768287|9718555|FG000|NOT COMPLETED|Surgical Sub-study||0
8675186|NCT00768287|9718556|FG001|NOT COMPLETED|Surgical Sub-study||0
8675187|NCT00768287|9718557|FG002|NOT COMPLETED|Surgical Sub-study||0
8675188|NCT00768287|9718558|FG003|NOT COMPLETED|Surgical Sub-study||0
8675189|NCT00768287|9718559|FG004|NOT COMPLETED|Surgical Sub-study||0
8675190|NCT00768287|9718560|FG005|NOT COMPLETED|Surgical Sub-study||0
8675191|NCT00768300|9718574|FG000|STARTED|Overall Study||330
8675192|NCT00768300|9718575|FG001|STARTED|Overall Study||164
8675193|NCT00768300|9718574|FG000|Randomized and Treated|Overall Study||329
8675194|NCT00768300|9718575|FG001|Randomized and Treated|Overall Study||163
8675195|NCT00768300|9718574|FG000|COMPLETED|Overall Study||1
8675196|NCT00768300|9718575|FG001|COMPLETED|Overall Study||1
8675197|NCT00768300|9718574|FG000|NOT COMPLETED|Overall Study||329
8675198|NCT00768300|9718575|FG001|NOT COMPLETED|Overall Study||163
8675199|NCT00768430|9718583|FG000|STARTED|24 Hour Endpoint||48
8675200|NCT00768430|9718584|FG001|STARTED|24 Hour Endpoint||25
8675201|NCT00768430|9718583|FG000|COMPLETED|24 Hour Endpoint||47
8675202|NCT00768430|9718584|FG001|COMPLETED|24 Hour Endpoint||25
8675203|NCT00768430|9718583|FG000|NOT COMPLETED|24 Hour Endpoint||1
8675204|NCT00768430|9718584|FG001|NOT COMPLETED|24 Hour Endpoint||0
8675205|NCT00768430|9718583|FG000|STARTED|7 Day Endpoint||47
8675206|NCT00768430|9718584|FG001|STARTED|7 Day Endpoint||25
8675207|NCT00768430|9718583|FG000|COMPLETED|7 Day Endpoint||45
8675208|NCT00768430|9718584|FG001|COMPLETED|7 Day Endpoint||22
8675209|NCT00768430|9718583|FG000|NOT COMPLETED|7 Day Endpoint||2
8675210|NCT00768430|9718584|FG001|NOT COMPLETED|7 Day Endpoint||3
8675211|NCT00768469|9718592|FG000|STARTED|Overall Study||3
8675212|NCT00768469|9718593|FG001|STARTED|Overall Study||7
8675213|NCT00768469|9718592|FG000|COMPLETED|Overall Study||0
8675214|NCT00768469|9718593|FG001|COMPLETED|Overall Study||0
8675215|NCT00768469|9718592|FG000|NOT COMPLETED|Overall Study||3
8675216|NCT00768469|9718593|FG001|NOT COMPLETED|Overall Study||7
8675217|NCT00768521|9718600|FG000|STARTED|Period 1||9
8675218|NCT00768521|9718601|FG001|STARTED|Period 1||11
8675219|NCT00768521|9718600|FG000|COMPLETED|Period 1||9
8675220|NCT00768521|9718601|FG001|COMPLETED|Period 1||11
8675221|NCT00768521|9718600|FG000|NOT COMPLETED|Period 1||0
8675222|NCT00768521|9718601|FG001|NOT COMPLETED|Period 1||0
8675223|NCT00768521|9718600|FG000|STARTED|Period 2||9
8675224|NCT00768521|9718601|FG001|STARTED|Period 2||11
8675225|NCT00768521|9718600|FG000|COMPLETED|Period 2||9
8675226|NCT00768521|9718601|FG001|COMPLETED|Period 2||11
8675227|NCT00768521|9718600|FG000|NOT COMPLETED|Period 2||0
8675228|NCT00768521|9718601|FG001|NOT COMPLETED|Period 2||0
8675229|NCT00768560|9718613|FG000|STARTED|Intervention Set 1|3-period/treatment crossover|5
8675230|NCT00768560|9718614|FG001|STARTED|Intervention Set 1|3-period/treatment crossover|6
8675231|NCT00768560|9718615|FG002|STARTED|Intervention Set 1|3-period/treatment crossover|6
8675232|NCT00768560|9718616|FG003|STARTED|Intervention Set 1|3-period/treatment crossover|6
8675233|NCT00768560|9718617|FG004|STARTED|Intervention Set 1|3-period/treatment crossover|6
8675234|NCT00768560|9718618|FG005|STARTED|Intervention Set 1|3-period/treatment crossover|6
8675235|NCT00768560|9718613|FG000|Subjects Received Treatment|Intervention Set 1|40 mg OD for 2 weeks|5
8675236|NCT00768560|9718614|FG001|Subjects Received Treatment|Intervention Set 1|40 mg OD for 2 weeks|6
8675237|NCT00768560|9718615|FG002|Subjects Received Treatment|Intervention Set 1|40 mg twice daily (BID) for 2 weeks|6
8675238|NCT00768560|9718616|FG003|Subjects Received Treatment|Intervention Set 1|40 mg BID for 2 weeks|6
8675239|NCT00768560|9718617|FG004|Subjects Received Treatment|Intervention Set 1|80 mg OD for 2 weeks|6
8675240|NCT00768560|9718618|FG005|Subjects Received Treatment|Intervention Set 1|80 mg OD for 2 weeks|6
8675241|NCT00768560|9718613|FG000|COMPLETED|Intervention Set 1||5
8675242|NCT00768560|9718614|FG001|COMPLETED|Intervention Set 1||5
8675243|NCT00768560|9718615|FG002|COMPLETED|Intervention Set 1||6
8675244|NCT00768560|9718616|FG003|COMPLETED|Intervention Set 1||6
8675245|NCT00768560|9718617|FG004|COMPLETED|Intervention Set 1||6
8675246|NCT00768560|9718618|FG005|COMPLETED|Intervention Set 1||6
8675247|NCT00768560|9718613|FG000|NOT COMPLETED|Intervention Set 1||0
8675248|NCT00768560|9718614|FG001|NOT COMPLETED|Intervention Set 1||1
8675249|NCT00768560|9718615|FG002|NOT COMPLETED|Intervention Set 1||0
8675250|NCT00768560|9718616|FG003|NOT COMPLETED|Intervention Set 1||0
8675251|NCT00768560|9718617|FG004|NOT COMPLETED|Intervention Set 1||0
8675252|NCT00768560|9718618|FG005|NOT COMPLETED|Intervention Set 1||0
8675253|NCT00768560|9718613|FG000|STARTED|Intervention Set 2|40 mg BID for 2 weeks|5
8675254|NCT00768560|9718614|FG001|STARTED|Intervention Set 2|80 mg OD for 2 weeks|5
8675255|NCT00768560|9718615|FG002|STARTED|Intervention Set 2|80 mg OD for 2 weeks|6
8675256|NCT00768560|9718616|FG003|STARTED|Intervention Set 2|40 mg OD for 2 weeks|6
8675257|NCT00768560|9718617|FG004|STARTED|Intervention Set 2|40 mg OD for 2 weeks|6
8675258|NCT00768560|9718618|FG005|STARTED|Intervention Set 2|40 mg BID for 2 weeks|6
8675259|NCT00768560|9718613|FG000|COMPLETED|Intervention Set 2||5
8675260|NCT00768560|9718614|FG001|COMPLETED|Intervention Set 2||5
8675261|NCT00768560|9718615|FG002|COMPLETED|Intervention Set 2||6
8675262|NCT00768560|9718616|FG003|COMPLETED|Intervention Set 2||6
8675263|NCT00768560|9718617|FG004|COMPLETED|Intervention Set 2||6
8675264|NCT00768560|9718618|FG005|COMPLETED|Intervention Set 2||6
8675265|NCT00768560|9718613|FG000|NOT COMPLETED|Intervention Set 2||0
8675266|NCT00768560|9718614|FG001|NOT COMPLETED|Intervention Set 2||0
8675267|NCT00768560|9718615|FG002|NOT COMPLETED|Intervention Set 2||0
8675268|NCT00768560|9718616|FG003|NOT COMPLETED|Intervention Set 2||0
8675269|NCT00768560|9718617|FG004|NOT COMPLETED|Intervention Set 2||0
8675270|NCT00768560|9718618|FG005|NOT COMPLETED|Intervention Set 2||0
8675271|NCT00768560|9718613|FG000|STARTED|Intervention Set 3|80 mg OD for 2 weeks|5
8675272|NCT00768560|9718614|FG001|STARTED|Intervention Set 3|40 mg BID for 2 weeks|5
8675273|NCT00768560|9718615|FG002|STARTED|Intervention Set 3|40 mg OD for 2 weeks|6
8675274|NCT00768560|9718616|FG003|STARTED|Intervention Set 3|80 mg OD for 2 weeks|6
8675275|NCT00768560|9718617|FG004|STARTED|Intervention Set 3|40 mg BID for 2 weeks|6
8675276|NCT00768560|9718618|FG005|STARTED|Intervention Set 3|40 mg OD for 2 weeks|6
8675277|NCT00768560|9718613|FG000|COMPLETED|Intervention Set 3||5
8675278|NCT00768560|9718614|FG001|COMPLETED|Intervention Set 3||5
8675279|NCT00768560|9718615|FG002|COMPLETED|Intervention Set 3||6
8675280|NCT00768560|9718616|FG003|COMPLETED|Intervention Set 3||6
8675281|NCT00768560|9718617|FG004|COMPLETED|Intervention Set 3||6
8675282|NCT00768560|9718618|FG005|COMPLETED|Intervention Set 3||6
8675283|NCT00768560|9718613|FG000|NOT COMPLETED|Intervention Set 3||0
8675284|NCT00768560|9718614|FG001|NOT COMPLETED|Intervention Set 3||0
8675285|NCT00768560|9718615|FG002|NOT COMPLETED|Intervention Set 3||0
8675286|NCT00768560|9718616|FG003|NOT COMPLETED|Intervention Set 3||0
8675287|NCT00768560|9718617|FG004|NOT COMPLETED|Intervention Set 3||0
8675288|NCT00768560|9718618|FG005|NOT COMPLETED|Intervention Set 3||0
8675289|NCT00768599|9718629|FG000|STARTED|Overall Study||45
8675290|NCT00768599|9718630|FG001|STARTED|Overall Study||43
8675291|NCT00768599|9718631|FG002|STARTED|Overall Study||47
8675292|NCT00768599|9718629|FG000|COMPLETED|Overall Study||34
8675293|NCT00768599|9718630|FG001|COMPLETED|Overall Study||27
8675294|NCT00768599|9718631|FG002|COMPLETED|Overall Study||35
8675295|NCT00768599|9718629|FG000|NOT COMPLETED|Overall Study||11
8675296|NCT00768599|9718630|FG001|NOT COMPLETED|Overall Study||16
8675297|NCT00768599|9718631|FG002|NOT COMPLETED|Overall Study||12
8675298|NCT00768651|9718639|FG000|STARTED|Overall Study||8
8675299|NCT00768651|9718639|FG000|COMPLETED|Overall Study||7
8675300|NCT00768651|9718639|FG000|NOT COMPLETED|Overall Study||1
8675301|NCT00768664|9718644|FG000|STARTED|Overall Study||69
8675302|NCT00768664|9718644|FG000|COMPLETED|Overall Study||0
8675303|NCT00768664|9718644|FG000|NOT COMPLETED|Overall Study||69
8799642|NCT01438996|9851207|FG000|NOT COMPLETED|Overall Study||4
8675304|NCT00768716|9718650|FG000|STARTED|Overall Study||54
8675305|NCT00768716|9718651|FG001|STARTED|Overall Study||41
8675306|NCT00768716|9718650|FG000|COMPLETED|Overall Study||54
8675307|NCT00768716|9718651|FG001|COMPLETED|Overall Study||41
8675308|NCT00768716|9718650|FG000|NOT COMPLETED|Overall Study||0
8675309|NCT00768716|9718651|FG001|NOT COMPLETED|Overall Study||0
8675310|NCT00768755|9718664|FG000|STARTED|Phase 1||10
8675311|NCT00768755|9718665|FG001|STARTED|Phase 1||0
8675312|NCT00768755|9718666|FG002|STARTED|Phase 1||0
8675313|NCT00768755|9718667|FG003|STARTED|Phase 1||0
8675314|NCT00768755|9718664|FG000|COMPLETED|Phase 1||0
8675315|NCT00768755|9718665|FG001|COMPLETED|Phase 1||0
8675316|NCT00768755|9718666|FG002|COMPLETED|Phase 1||0
8675317|NCT00768755|9718667|FG003|COMPLETED|Phase 1||0
8675318|NCT00768755|9718664|FG000|NOT COMPLETED|Phase 1||10
8675319|NCT00768755|9718665|FG001|NOT COMPLETED|Phase 1||0
8675320|NCT00768755|9718666|FG002|NOT COMPLETED|Phase 1||0
8675321|NCT00768755|9718667|FG003|NOT COMPLETED|Phase 1||0
8675322|NCT00768755|9718664|FG000|STARTED|Phase 2||0
8675323|NCT00768755|9718665|FG001|STARTED|Phase 2||55
8675324|NCT00768755|9718666|FG002|STARTED|Phase 2||58
8675325|NCT00768755|9718667|FG003|STARTED|Phase 2||57
8675326|NCT00768755|9718664|FG000|Treated|Phase 2||0
8675327|NCT00768755|9718665|FG001|Treated|Phase 2||55
8675328|NCT00768755|9718666|FG002|Treated|Phase 2||58
8675329|NCT00768755|9718667|FG003|Treated|Phase 2||55
8675330|NCT00768755|9718664|FG000|COMPLETED|Phase 2||0
8675331|NCT00768755|9718665|FG001|COMPLETED|Phase 2||0
8675332|NCT00768755|9718666|FG002|COMPLETED|Phase 2||0
8675333|NCT00768755|9718667|FG003|COMPLETED|Phase 2||0
8675334|NCT00768755|9718664|FG000|NOT COMPLETED|Phase 2||0
8675335|NCT00768755|9718665|FG001|NOT COMPLETED|Phase 2||55
8675336|NCT00768755|9718666|FG002|NOT COMPLETED|Phase 2||58
8675337|NCT00768755|9718667|FG003|NOT COMPLETED|Phase 2||57
8675338|NCT00768898|9718676|FG000|STARTED|Overall Study||30
8675339|NCT00768898|9718676|FG000|COMPLETED|Overall Study||28
8675340|NCT00768898|9718676|FG000|NOT COMPLETED|Overall Study||2
8675341|NCT00768989|9718687|FG000|STARTED|Prior to Week 24||63
8675342|NCT00768989|9718688|FG001|STARTED|Prior to Week 24||30
8675343|NCT00768989|9718687|FG000|COMPLETED|Prior to Week 24||59
8675344|NCT00768989|9718688|FG001|COMPLETED|Prior to Week 24||27
8675345|NCT00768989|9718687|FG000|NOT COMPLETED|Prior to Week 24||4
8675346|NCT00768989|9718688|FG001|NOT COMPLETED|Prior to Week 24||3
8675347|NCT00768989|9718687|FG000|STARTED|Week 24 to Prior to Week 36||59
8918849|NCT02204124|9978919|FG001|COMPLETED|Overall Study||19
8918850|NCT02204124|9978918|FG000|NOT COMPLETED|Overall Study||0
8918851|NCT02204124|9978919|FG001|NOT COMPLETED|Overall Study||0
8918852|NCT02204150|9978925|FG000|STARTED|Overall Study||56
8918853|NCT02204150|9978925|FG000|COMPLETED|Overall Study||56
8918854|NCT02204150|9978925|FG000|NOT COMPLETED|Overall Study||0
8918855|NCT02204176|9978932|FG000|STARTED|Overall Study||74
8918856|NCT02204176|9978933|FG001|STARTED|Overall Study||73
8918857|NCT02204176|9978934|FG002|STARTED|Overall Study||74
8918858|NCT02204176|9978932|FG000|COMPLETED|Overall Study||64
8918859|NCT02204176|9978933|FG001|COMPLETED|Overall Study||61
8918860|NCT02204176|9978934|FG002|COMPLETED|Overall Study||58
8918861|NCT02204176|9978932|FG000|NOT COMPLETED|Overall Study||10
8918862|NCT02204176|9978933|FG001|NOT COMPLETED|Overall Study||12
8918863|NCT02204176|9978934|FG002|NOT COMPLETED|Overall Study||16
8918864|NCT02204293|9978944|FG000|STARTED|Core Study Part I||19
8918865|NCT02204293|9978945|FG001|STARTED|Core Study Part I||17
8918866|NCT02204293|9978946|FG002|STARTED|Core Study Part I||0
8918867|NCT02204293|9978947|FG003|STARTED|Core Study Part I||0
8918868|NCT02204293|9978948|FG004|STARTED|Core Study Part I||0
8918869|NCT02204293|9978949|FG005|STARTED|Core Study Part I||0
8918870|NCT02204293|9978944|FG000|Intention-to-treat Population|Core Study Part I|One participant left the study before treatment was started.|18
8918871|NCT02204293|9978945|FG001|Intention-to-treat Population|Core Study Part I||17
8918872|NCT02204293|9978946|FG002|Intention-to-treat Population|Core Study Part I||0
8918873|NCT02204293|9978947|FG003|Intention-to-treat Population|Core Study Part I||0
8918874|NCT02204293|9978948|FG004|Intention-to-treat Population|Core Study Part I||0
8918875|NCT02204293|9978949|FG005|Intention-to-treat Population|Core Study Part I||0
8918876|NCT02204293|9978944|FG000|Safety Population|Core Study Part I|2 participants from placebo arm received canakinumab at Week 4, included in Safety population.|20
8918877|NCT02204293|9978945|FG001|Safety Population|Core Study Part I||15
8918878|NCT02204293|9978946|FG002|Safety Population|Core Study Part I||0
8918879|NCT02204293|9978947|FG003|Safety Population|Core Study Part I||0
8918880|NCT02204293|9978948|FG004|Safety Population|Core Study Part I||0
8918881|NCT02204293|9978949|FG005|Safety Population|Core Study Part I||0
8918882|NCT02204293|9978944|FG000|COMPLETED|Core Study Part I||17
8918883|NCT02204293|9978945|FG001|COMPLETED|Core Study Part I||14
8918884|NCT02204293|9978946|FG002|COMPLETED|Core Study Part I||0
8918885|NCT02204293|9978947|FG003|COMPLETED|Core Study Part I||0
8918886|NCT02204293|9978948|FG004|COMPLETED|Core Study Part I||0
8918887|NCT02204293|9978949|FG005|COMPLETED|Core Study Part I||0
8918888|NCT02204293|9978944|FG000|NOT COMPLETED|Core Study Part I||2
8918889|NCT02204293|9978945|FG001|NOT COMPLETED|Core Study Part I||3
8675348|NCT00768989|9718688|FG001|STARTED|Week 24 to Prior to Week 36||27
8675349|NCT00768989|9718687|FG000|COMPLETED|Week 24 to Prior to Week 36||51
8675350|NCT00768989|9718688|FG001|COMPLETED|Week 24 to Prior to Week 36||27
8675351|NCT00768989|9718687|FG000|NOT COMPLETED|Week 24 to Prior to Week 36||8
8675352|NCT00768989|9718688|FG001|NOT COMPLETED|Week 24 to Prior to Week 36||0
8675353|NCT00768989|9718687|FG000|STARTED|On or After Week 36||51
8675354|NCT00768989|9718688|FG001|STARTED|On or After Week 36||27
8675355|NCT00768989|9718687|FG000|COMPLETED|On or After Week 36||0
8675356|NCT00768989|9718688|FG001|COMPLETED|On or After Week 36||0
8675357|NCT00768989|9718687|FG000|NOT COMPLETED|On or After Week 36||51
8675358|NCT00768989|9718688|FG001|NOT COMPLETED|On or After Week 36||27
8675359|NCT00769015|9718698|FG000|STARTED|Overall Study||96
8675360|NCT00769015|9718699|FG001|STARTED|Overall Study||92
8675361|NCT00769015|9718698|FG000|COMPLETED|Overall Study||87
8675362|NCT00769015|9718699|FG001|COMPLETED|Overall Study||76
8675363|NCT00769015|9718698|FG000|NOT COMPLETED|Overall Study||9
8675364|NCT00769015|9718699|FG001|NOT COMPLETED|Overall Study||16
8675365|NCT00769067|9718707|FG000|STARTED|Overall Study||94
8675366|NCT00769067|9718708|FG001|STARTED|Overall Study||94
8675367|NCT00769067|9718707|FG000|Treated|Overall Study||94
8675368|NCT00769067|9718708|FG001|Treated|Overall Study|One participant was not treated: refused treatment for reason other than an adverse event (AE).|93
8675369|NCT00769067|9718707|FG000|COMPLETED|Overall Study||0
8675370|NCT00769067|9718708|FG001|COMPLETED|Overall Study||0
8675371|NCT00769067|9718707|FG000|NOT COMPLETED|Overall Study||94
8675372|NCT00769067|9718708|FG001|NOT COMPLETED|Overall Study||94
8675373|NCT00769119|9718717|FG000|STARTED|Overall Study||22
8675374|NCT00769119|9718718|FG001|STARTED|Overall Study||16
8675375|NCT00769119|9718717|FG000|COMPLETED|Overall Study||20
8675376|NCT00769119|9718718|FG001|COMPLETED|Overall Study||13
8675377|NCT00769119|9718717|FG000|NOT COMPLETED|Overall Study||2
8675378|NCT00769119|9718718|FG001|NOT COMPLETED|Overall Study||3
8675379|NCT00769132|9718724|FG000|STARTED|Period 1||7
8675380|NCT00769132|9718725|FG001|STARTED|Period 1||6
8675381|NCT00769132|9718726|FG002|STARTED|Period 1||6
8675382|NCT00769132|9718727|FG003|STARTED|Period 1||7
8675383|NCT00769132|9718724|FG000|COMPLETED|Period 1||6
8675384|NCT00769132|9718725|FG001|COMPLETED|Period 1||6
8675385|NCT00769132|9718726|FG002|COMPLETED|Period 1||6
8675386|NCT00769132|9718727|FG003|COMPLETED|Period 1||6
8675387|NCT00769132|9718724|FG000|NOT COMPLETED|Period 1||1
8675388|NCT00769132|9718725|FG001|NOT COMPLETED|Period 1||0
8675389|NCT00769132|9718726|FG002|NOT COMPLETED|Period 1||0
8675390|NCT00769132|9718727|FG003|NOT COMPLETED|Period 1||1
8675391|NCT00769132|9718724|FG000|STARTED|Period 2||6
8675392|NCT00769132|9718725|FG001|STARTED|Period 2||6
8675393|NCT00769132|9718726|FG002|STARTED|Period 2||6
8675394|NCT00769132|9718727|FG003|STARTED|Period 2||6
8675395|NCT00769132|9718724|FG000|COMPLETED|Period 2||6
8675396|NCT00769132|9718725|FG001|COMPLETED|Period 2||6
8675397|NCT00769132|9718726|FG002|COMPLETED|Period 2||6
8675398|NCT00769132|9718727|FG003|COMPLETED|Period 2||5
8675399|NCT00769132|9718724|FG000|NOT COMPLETED|Period 2||0
8675400|NCT00769132|9718725|FG001|NOT COMPLETED|Period 2||0
8675401|NCT00769132|9718726|FG002|NOT COMPLETED|Period 2||0
8675402|NCT00769132|9718727|FG003|NOT COMPLETED|Period 2||1
8675403|NCT00769132|9718724|FG000|STARTED|Period 3||6
8675404|NCT00769132|9718725|FG001|STARTED|Period 3||6
8675405|NCT00769132|9718726|FG002|STARTED|Period 3||6
8675406|NCT00769132|9718727|FG003|STARTED|Period 3||5
8675407|NCT00769132|9718724|FG000|COMPLETED|Period 3||5
8675408|NCT00769132|9718725|FG001|COMPLETED|Period 3||6
8675409|NCT00769132|9718726|FG002|COMPLETED|Period 3||6
8675410|NCT00769132|9718727|FG003|COMPLETED|Period 3||5
8675411|NCT00769132|9718724|FG000|NOT COMPLETED|Period 3||1
8675412|NCT00769132|9718725|FG001|NOT COMPLETED|Period 3||0
8675413|NCT00769132|9718726|FG002|NOT COMPLETED|Period 3||0
8675414|NCT00769132|9718727|FG003|NOT COMPLETED|Period 3||0
8675415|NCT00769132|9718724|FG000|STARTED|Period 4||5
8675416|NCT00769132|9718725|FG001|STARTED|Period 4||6
8675417|NCT00769132|9718726|FG002|STARTED|Period 4||6
8675418|NCT00769132|9718727|FG003|STARTED|Period 4||5
8675419|NCT00769132|9718724|FG000|COMPLETED|Period 4||5
8675420|NCT00769132|9718725|FG001|COMPLETED|Period 4||5
8675421|NCT00769132|9718726|FG002|COMPLETED|Period 4||6
8675422|NCT00769132|9718727|FG003|COMPLETED|Period 4||5
8675423|NCT00769132|9718724|FG000|NOT COMPLETED|Period 4||0
8675424|NCT00769132|9718725|FG001|NOT COMPLETED|Period 4||1
8675425|NCT00769132|9718726|FG002|NOT COMPLETED|Period 4||0
8675426|NCT00769132|9718727|FG003|NOT COMPLETED|Period 4||0
8675427|NCT00769184|9718737|FG000|STARTED|Corticosteroid + LCD/ +Placebo (2 Weeks)||7
8675428|NCT00769184|9718738|FG001|STARTED|Corticosteroid + LCD/ +Placebo (2 Weeks)||8
8675429|NCT00769184|9718737|FG000|COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||6
8675430|NCT00769184|9718738|FG001|COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||7
8675431|NCT00769184|9718737|FG000|NOT COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||1
8675432|NCT00769184|9718738|FG001|NOT COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||1
8675433|NCT00769184|9718737|FG000|STARTED|+LCD / +Placebo Only (4 Weeks)||6
8675434|NCT00769184|9718738|FG001|STARTED|+LCD / +Placebo Only (4 Weeks)||7
8675435|NCT00769184|9718737|FG000|COMPLETED|+LCD / +Placebo Only (4 Weeks)||6
8675436|NCT00769184|9718738|FG001|COMPLETED|+LCD / +Placebo Only (4 Weeks)||7
8675437|NCT00769184|9718737|FG000|NOT COMPLETED|+LCD / +Placebo Only (4 Weeks)||0
8675438|NCT00769184|9718738|FG001|NOT COMPLETED|+LCD / +Placebo Only (4 Weeks)||0
8675439|NCT00769184|9718737|FG000|STARTED|No Treatment (6 Weeks)||6
8675440|NCT00769184|9718738|FG001|STARTED|No Treatment (6 Weeks)||7
8675441|NCT00769184|9718737|FG000|COMPLETED|No Treatment (6 Weeks)||5
8675442|NCT00769184|9718738|FG001|COMPLETED|No Treatment (6 Weeks)||6
8675443|NCT00769184|9718737|FG000|NOT COMPLETED|No Treatment (6 Weeks)||1
8675444|NCT00769184|9718738|FG001|NOT COMPLETED|No Treatment (6 Weeks)||1
8675445|NCT00769314|9718748|FG000|STARTED|Overall Study|The number of participants started is defined as those that were randomized and received treatment.|378
8675446|NCT00769314|9718749|FG001|STARTED|Overall Study|The number of participants started is defined as those that were randomized and received treatment.|397
8675447|NCT00769314|9718748|FG000|COMPLETED|Overall Study||361
8675448|NCT00769314|9718749|FG001|COMPLETED|Overall Study||384
8675449|NCT00769314|9718748|FG000|NOT COMPLETED|Overall Study||17
8675450|NCT00769314|9718749|FG001|NOT COMPLETED|Overall Study||13
8675451|NCT00769392|9718755|FG000|STARTED|Overall Study||28
8675452|NCT00769392|9718755|FG000|COMPLETED|Overall Study||24
8675453|NCT00769392|9718755|FG000|NOT COMPLETED|Overall Study||4
8675454|NCT00769483|9718765|FG000|STARTED|Overall Study||9
8675455|NCT00769483|9718766|FG001|STARTED|Overall Study||13
8675456|NCT00769483|9718767|FG002|STARTED|Overall Study||15
8675457|NCT00769483|9718768|FG003|STARTED|Overall Study||15
8675458|NCT00769483|9718769|FG004|STARTED|Overall Study||16
8675459|NCT00769483|9718770|FG005|STARTED|Overall Study||9
8675460|NCT00769483|9718765|FG000|COMPLETED|Overall Study||9
8675461|NCT00769483|9718766|FG001|COMPLETED|Overall Study||12
8675462|NCT00769483|9718767|FG002|COMPLETED|Overall Study||15
8675463|NCT00769483|9718768|FG003|COMPLETED|Overall Study||15
8675464|NCT00769483|9718769|FG004|COMPLETED|Overall Study||15
8675465|NCT00769483|9718770|FG005|COMPLETED|Overall Study||9
8675466|NCT00769483|9718765|FG000|NOT COMPLETED|Overall Study||0
8675467|NCT00769483|9718766|FG001|NOT COMPLETED|Overall Study||1
8675468|NCT00769483|9718767|FG002|NOT COMPLETED|Overall Study||0
8675469|NCT00769483|9718768|FG003|NOT COMPLETED|Overall Study||0
8675470|NCT00769483|9718769|FG004|NOT COMPLETED|Overall Study||1
8675471|NCT00769483|9718770|FG005|NOT COMPLETED|Overall Study||0
8675472|NCT00769561|9718788|FG000|STARTED|Overall Study||29
8675473|NCT00769561|9718789|FG001|STARTED|Overall Study||29
8675474|NCT00769561|9718788|FG000|COMPLETED|Overall Study||26
8675475|NCT00769561|9718789|FG001|COMPLETED|Overall Study||24
8675476|NCT00769561|9718788|FG000|NOT COMPLETED|Overall Study||3
8675477|NCT00769561|9718789|FG001|NOT COMPLETED|Overall Study||5
8675478|NCT00769600|9718797|FG000|STARTED|Overall Study||15
8675479|NCT00769600|9718798|FG001|STARTED|Overall Study||8
8675480|NCT00769600|9718797|FG000|COMPLETED|Overall Study||15
8675481|NCT00769600|9718798|FG001|COMPLETED|Overall Study||8
8675482|NCT00769600|9718797|FG000|NOT COMPLETED|Overall Study||0
8675483|NCT00769600|9718798|FG001|NOT COMPLETED|Overall Study||0
8675484|NCT00769704|9718809|FG000|STARTED|Overall Study||141
8675485|NCT00769704|9718810|FG001|STARTED|Overall Study||296
8675486|NCT00769704|9718809|FG000|Intent-to-treat Population|Overall Study|All participants who were randomized once to study treatment|141
8675487|NCT00769704|9718810|FG001|Intent-to-treat Population|Overall Study|Participants who were randomized once to study treatment; excludes 1 participant randomized 3 times|295
8675488|NCT00769704|9718809|FG000|Received Treatment|Overall Study||127
8675489|NCT00769704|9718810|FG001|Received Treatment|Overall Study||292
8675490|NCT00769704|9718809|FG000|COMPLETED|Overall Study||30
8675491|NCT00769704|9718810|FG001|COMPLETED|Overall Study||97
8675492|NCT00769704|9718809|FG000|NOT COMPLETED|Overall Study||111
8675493|NCT00769704|9718810|FG001|NOT COMPLETED|Overall Study||199
8675494|NCT00769808|9718817|FG000|STARTED|Overall Study||72
8675495|NCT00769808|9718817|FG000|COMPLETED|Overall Study||64
8675496|NCT00769808|9718817|FG000|NOT COMPLETED|Overall Study||8
8675497|NCT00769860|9718823|FG000|STARTED|Overall Study||16
8675498|NCT00769860|9718824|FG001|STARTED|Overall Study||8
8675499|NCT00769860|9718823|FG000|Month 4|Overall Study||16
8675500|NCT00769860|9718824|FG001|Month 4|Overall Study||8
8675501|NCT00769860|9718823|FG000|Month 8|Overall Study||14
8675502|NCT00769860|9718824|FG001|Month 8|Overall Study||8
8675503|NCT00769860|9718823|FG000|COMPLETED|Overall Study||14
8675504|NCT00769860|9718824|FG001|COMPLETED|Overall Study||8
8675505|NCT00769860|9718823|FG000|NOT COMPLETED|Overall Study||2
8675506|NCT00769860|9718824|FG001|NOT COMPLETED|Overall Study||0
8675507|NCT00769886|9718834|FG000|STARTED|Overall Study||36
8675508|NCT00769886|9718835|FG001|STARTED|Overall Study||36
8675509|NCT00769886|9718836|FG002|STARTED|Overall Study||35
8675510|NCT00769886|9718837|FG003|STARTED|Overall Study||37
8675511|NCT00769886|9718834|FG000|COMPLETED|Overall Study||31
8675512|NCT00769886|9718835|FG001|COMPLETED|Overall Study||32
8675513|NCT00769886|9718836|FG002|COMPLETED|Overall Study||34
8675514|NCT00769886|9718837|FG003|COMPLETED|Overall Study||35
8675515|NCT00769886|9718834|FG000|NOT COMPLETED|Overall Study||5
8675516|NCT00769886|9718835|FG001|NOT COMPLETED|Overall Study||4
8675517|NCT00769886|9718836|FG002|NOT COMPLETED|Overall Study||1
8675518|NCT00769886|9718837|FG003|NOT COMPLETED|Overall Study||2
8675519|NCT00770029|9718849|FG000|STARTED|Overall Study||184
8675520|NCT00770029|9718850|FG001|STARTED|Overall Study||92
8675521|NCT00770029|9718849|FG000|COMPLETED|Overall Study||178
8675522|NCT00770029|9718850|FG001|COMPLETED|Overall Study||89
8675523|NCT00770029|9718849|FG000|NOT COMPLETED|Overall Study||6
8675524|NCT00770029|9718850|FG001|NOT COMPLETED|Overall Study||3
8675525|NCT00770120|9718856|FG000|STARTED|Overall Study||61
8675526|NCT00770120|9718856|FG000|Eligible|Overall Study||60
8675527|NCT00770120|9718856|FG000|Not Analyzable|Overall Study||1
8675528|NCT00770120|9718856|FG000|COMPLETED|Overall Study||0
8675529|NCT00770120|9718856|FG000|NOT COMPLETED|Overall Study||61
8675530|NCT00770133|9718865|FG000|STARTED|Overall Study||35
8675531|NCT00770133|9718866|FG001|STARTED|Overall Study||36
8675532|NCT00770133|9718867|FG002|STARTED|Overall Study||35
8675533|NCT00770133|9718868|FG003|STARTED|Overall Study||35
8675534|NCT00770133|9718865|FG000|COMPLETED|Overall Study||32
8675535|NCT00770133|9718866|FG001|COMPLETED|Overall Study||35
8675536|NCT00770133|9718867|FG002|COMPLETED|Overall Study||32
8675537|NCT00770133|9718868|FG003|COMPLETED|Overall Study||32
8675538|NCT00770133|9718865|FG000|NOT COMPLETED|Overall Study||3
8675539|NCT00770133|9718866|FG001|NOT COMPLETED|Overall Study||1
8675540|NCT00770133|9718867|FG002|NOT COMPLETED|Overall Study||3
8675541|NCT00770133|9718868|FG003|NOT COMPLETED|Overall Study||3
8675542|NCT00770146|9718880|FG000|STARTED|Treatment Period||53
8675543|NCT00770146|9718881|FG001|STARTED|Treatment Period||105
8675544|NCT00770146|9718880|FG000|Treated|Treatment Period||52
8675545|NCT00770146|9718881|FG001|Treated|Treatment Period||105
8675546|NCT00770146|9718880|FG000|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement|50
8675547|NCT00770146|9718881|FG001|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement|101
8675548|NCT00770146|9718880|FG000|COMPLETED|Treatment Period||44
8675549|NCT00770146|9718881|FG001|COMPLETED|Treatment Period||60
8675550|NCT00770146|9718880|FG000|NOT COMPLETED|Treatment Period||9
8675551|NCT00770146|9718881|FG001|NOT COMPLETED|Treatment Period||45
8675552|NCT00770146|9718880|FG000|STARTED|Follow-up Period||53
8675553|NCT00770146|9718881|FG001|STARTED|Follow-up Period||105
8675554|NCT00770146|9718880|FG000|COMPLETED|Follow-up Period||42
8675555|NCT00770146|9718881|FG001|COMPLETED|Follow-up Period||85
8675556|NCT00770146|9718880|FG000|NOT COMPLETED|Follow-up Period||11
8675557|NCT00770146|9718881|FG001|NOT COMPLETED|Follow-up Period||20
8675558|NCT00770211|9718889|FG000|STARTED|Overall Study||182
8675559|NCT00770211|9718890|FG001|STARTED|Overall Study||89
8675560|NCT00770211|9718889|FG000|COMPLETED|Overall Study||181
8675561|NCT00770211|9718890|FG001|COMPLETED|Overall Study||87
8675562|NCT00770211|9718889|FG000|NOT COMPLETED|Overall Study||1
8675563|NCT00770211|9718890|FG001|NOT COMPLETED|Overall Study||2
8675564|NCT00770224|9718896|FG000|STARTED|Step 1: Induction||87
8675565|NCT00770224|9718897|FG001|STARTED|Step 1: Induction||0
8675566|NCT00770224|9718896|FG000|Eligible and Evaluable|Step 1: Induction||84
8675567|NCT00770224|9718897|FG001|Eligible and Evaluable|Step 1: Induction||0
8675568|NCT00770224|9718896|FG000|COMPLETED|Step 1: Induction||73
8675569|NCT00770224|9718897|FG001|COMPLETED|Step 1: Induction||0
8675570|NCT00770224|9718896|FG000|NOT COMPLETED|Step 1: Induction||14
8675571|NCT00770224|9718897|FG001|NOT COMPLETED|Step 1: Induction||0
8675572|NCT00770224|9718896|FG000|STARTED|Step 2: Maintenance||0
8675573|NCT00770224|9718897|FG001|STARTED|Step 2: Maintenance||71
8675574|NCT00770224|9718896|FG000|Eligible and Evaluable|Step 2: Maintenance||0
8675575|NCT00770224|9718897|FG001|Eligible and Evaluable|Step 2: Maintenance||69
8675576|NCT00770224|9718896|FG000|COMPLETED|Step 2: Maintenance||0
8675577|NCT00770224|9718897|FG001|COMPLETED|Step 2: Maintenance||41
8675578|NCT00770224|9718896|FG000|NOT COMPLETED|Step 2: Maintenance||0
8675579|NCT00770224|9718897|FG001|NOT COMPLETED|Step 2: Maintenance||30
8675580|NCT00770289|9718904|FG000|STARTED|Overall Study||851
8675581|NCT00770289|9718904|FG000|COMPLETED|Overall Study||845
8675582|NCT00770289|9718904|FG000|NOT COMPLETED|Overall Study||6
8675583|NCT00770315|9718917|FG000|STARTED|Overall Study||197
8675584|NCT00770315|9718918|FG001|STARTED|Overall Study||195
8675585|NCT00770315|9718919|FG002|STARTED|Overall Study||194
8675586|NCT00770315|9718920|FG003|STARTED|Overall Study||198
8675587|NCT00770315|9718917|FG000|COMPLETED|Overall Study||157
8675588|NCT00770315|9718918|FG001|COMPLETED|Overall Study||152
8675589|NCT00770315|9718919|FG002|COMPLETED|Overall Study||137
8675590|NCT00770315|9718920|FG003|COMPLETED|Overall Study||160
8675591|NCT00770315|9718917|FG000|NOT COMPLETED|Overall Study||40
8675592|NCT00770315|9718918|FG001|NOT COMPLETED|Overall Study||43
8675593|NCT00770315|9718919|FG002|NOT COMPLETED|Overall Study||57
8675594|NCT00770315|9718920|FG003|NOT COMPLETED|Overall Study||38
8675595|NCT00770328|9718932|FG000|STARTED|Overall Study||22
8675596|NCT00770328|9718933|FG001|STARTED|Overall Study||15
8675597|NCT00770328|9718932|FG000|COMPLETED|Overall Study||9
8675598|NCT00770328|9718933|FG001|COMPLETED|Overall Study||11
8675599|NCT00770328|9718932|FG000|NOT COMPLETED|Overall Study||13
8675600|NCT00770328|9718933|FG001|NOT COMPLETED|Overall Study||4
8675601|NCT00770341|9718942|FG000|STARTED|Overall Study|Number randomized|89
8918890|NCT02204293|9978946|FG002|NOT COMPLETED|Core Study Part I||0
8918891|NCT02204293|9978947|FG003|NOT COMPLETED|Core Study Part I||0
8918892|NCT02204293|9978948|FG004|NOT COMPLETED|Core Study Part I||0
8918893|NCT02204293|9978949|FG005|NOT COMPLETED|Core Study Part I||0
8918894|NCT02204293|9978944|FG000|STARTED|Core Study Part 2|Participants who achieved response at Week 12, entered Part II.|0
8918895|NCT02204293|9978945|FG001|STARTED|Core Study Part 2||0
8918896|NCT02204293|9978946|FG002|STARTED|Core Study Part 2|Participants who achieved response at Week 12, entered Part II.|12
8918897|NCT02204293|9978947|FG003|STARTED|Core Study Part 2||4
8918898|NCT02204293|9978948|FG004|STARTED|Core Study Part 2||7
8918899|NCT02204293|9978949|FG005|STARTED|Core Study Part 2||0
8918900|NCT02204293|9978944|FG000|Safety Population|Core Study Part 2||0
8918901|NCT02204293|9978945|FG001|Safety Population|Core Study Part 2||0
8918902|NCT02204293|9978946|FG002|Safety Population|Core Study Part 2|Included 2 participants from placebo arm who received canakinumab at Week 4.|14
8918903|NCT02204293|9978947|FG003|Safety Population|Core Study Part 2||2
8918904|NCT02204293|9978948|FG004|Safety Population|Core Study Part 2||7
8918905|NCT02204293|9978949|FG005|Safety Population|Core Study Part 2||0
8918906|NCT02204293|9978944|FG000|COMPLETED|Core Study Part 2||0
8918907|NCT02204293|9978945|FG001|COMPLETED|Core Study Part 2||0
8918908|NCT02204293|9978946|FG002|COMPLETED|Core Study Part 2||12
8675602|NCT00770341|9718943|FG001|STARTED|Overall Study|Number randomized|22
8675603|NCT00770341|9718944|FG002|STARTED|Overall Study|Number randomized|11
8675604|NCT00770341|9718942|FG000|COMPLETED|Overall Study||77
8675605|NCT00770341|9718943|FG001|COMPLETED|Overall Study||17
8675606|NCT00770341|9718944|FG002|COMPLETED|Overall Study||8
8675607|NCT00770341|9718942|FG000|NOT COMPLETED|Overall Study||12
8675608|NCT00770341|9718943|FG001|NOT COMPLETED|Overall Study||5
8675609|NCT00770341|9718944|FG002|NOT COMPLETED|Overall Study||3
8675610|NCT00770367|9718955|FG000|STARTED|First Intervention||18
8675611|NCT00770367|9718956|FG001|STARTED|First Intervention||18
8675612|NCT00770367|9718955|FG000|COMPLETED|First Intervention||18
8675613|NCT00770367|9718956|FG001|COMPLETED|First Intervention||16
8675614|NCT00770367|9718955|FG000|NOT COMPLETED|First Intervention||0
8675615|NCT00770367|9718956|FG001|NOT COMPLETED|First Intervention||2
8675616|NCT00770367|9718955|FG000|STARTED|Washout Period of 4 Weeks||18
8675617|NCT00770367|9718956|FG001|STARTED|Washout Period of 4 Weeks||16
8675618|NCT00770367|9718955|FG000|COMPLETED|Washout Period of 4 Weeks||18
8675619|NCT00770367|9718956|FG001|COMPLETED|Washout Period of 4 Weeks||15
8675620|NCT00770367|9718955|FG000|NOT COMPLETED|Washout Period of 4 Weeks||0
8675621|NCT00770367|9718956|FG001|NOT COMPLETED|Washout Period of 4 Weeks||1
8675622|NCT00770367|9718955|FG000|STARTED|Second Intervention||18
8675623|NCT00770367|9718956|FG001|STARTED|Second Intervention||15
8675624|NCT00770367|9718955|FG000|COMPLETED|Second Intervention||16
8675625|NCT00770367|9718956|FG001|COMPLETED|Second Intervention||15
8675626|NCT00770367|9718955|FG000|NOT COMPLETED|Second Intervention||2
8675627|NCT00770367|9718956|FG001|NOT COMPLETED|Second Intervention||0
8675628|NCT00770432|9718966|FG000|STARTED|Overall Study||102
8675629|NCT00770432|9718967|FG001|STARTED|Overall Study||101
8675630|NCT00770432|9718966|FG000|COMPLETED|Overall Study||98
8675631|NCT00770432|9718967|FG001|COMPLETED|Overall Study||94
8675632|NCT00770432|9718966|FG000|NOT COMPLETED|Overall Study||4
8675633|NCT00770432|9718967|FG001|NOT COMPLETED|Overall Study||7
8675634|NCT00770484|9718975|FG000|STARTED|Overall Study||8
8675635|NCT00770484|9718976|FG001|STARTED|Overall Study||4
8675636|NCT00770484|9718975|FG000|COMPLETED|Overall Study||7
8675637|NCT00770484|9718976|FG001|COMPLETED|Overall Study||4
8675638|NCT00770484|9718975|FG000|NOT COMPLETED|Overall Study||1
8675639|NCT00770484|9718976|FG001|NOT COMPLETED|Overall Study||0
8675640|NCT00770510|9718982|FG000|STARTED|Overall Study||72
8675641|NCT00770510|9718982|FG000|COMPLETED|Overall Study||67
8675642|NCT00770510|9718982|FG000|NOT COMPLETED|Overall Study||5
8675643|NCT00770562|9718996|FG000|STARTED|Overall Study||53
8675644|NCT00770562|9718997|FG001|STARTED|Overall Study||50
8675645|NCT00770562|9718996|FG000|COMPLETED|Overall Study||52
8675646|NCT00770562|9718997|FG001|COMPLETED|Overall Study||49
8675647|NCT00770562|9718996|FG000|NOT COMPLETED|Overall Study||1
8675648|NCT00770562|9718997|FG001|NOT COMPLETED|Overall Study||1
8675649|NCT00770588|9719006|FG000|STARTED|Overall Study||148
8675650|NCT00770588|9719007|FG001|STARTED|Overall Study||148
8675651|NCT00770588|9719006|FG000|COMPLETED|Overall Study||67
8675652|NCT00770588|9719007|FG001|COMPLETED|Overall Study||53
8675653|NCT00770588|9719006|FG000|NOT COMPLETED|Overall Study||81
8675654|NCT00770588|9719007|FG001|NOT COMPLETED|Overall Study||95
8675655|NCT00770601|9719014|FG000|STARTED|Overall Study||7
8675656|NCT00770601|9719014|FG000|COMPLETED|Overall Study||6
8675657|NCT00770601|9719014|FG000|NOT COMPLETED|Overall Study||1
8675658|NCT00770653|9719020|FG000|STARTED|Overall Study||155
8675659|NCT00770653|9719021|FG001|STARTED|Overall Study||150
8675660|NCT00770653|9719020|FG000|COMPLETED|Overall Study||123
8675661|NCT00770653|9719021|FG001|COMPLETED|Overall Study||121
8675662|NCT00770653|9719020|FG000|NOT COMPLETED|Overall Study||32
8675663|NCT00770653|9719021|FG001|NOT COMPLETED|Overall Study||29
8675664|NCT00770679|9719027|FG000|STARTED|Overall Study||16
8675665|NCT00770679|9719027|FG000|COMPLETED|Overall Study||10
8675666|NCT00770679|9719027|FG000|NOT COMPLETED|Overall Study||6
8675667|NCT00770692|9719035|FG000|STARTED|Overall Study|"1 participant whose compliance was unknown, was regarded as a treatment compliance unknown"|81
8675668|NCT00770692|9719036|FG001|STARTED|Overall Study||83
8675669|NCT00770692|9719037|FG002|STARTED|Overall Study||84
8675670|NCT00770692|9719038|FG003|STARTED|Overall Study||77
8675671|NCT00770692|9719035|FG000|COMPLETED|Overall Study||69
8675672|NCT00770692|9719036|FG001|COMPLETED|Overall Study||74
8675673|NCT00770692|9719037|FG002|COMPLETED|Overall Study||70
8675674|NCT00770692|9719038|FG003|COMPLETED|Overall Study||66
8675675|NCT00770692|9719035|FG000|NOT COMPLETED|Overall Study||12
8675676|NCT00770692|9719036|FG001|NOT COMPLETED|Overall Study||9
8675677|NCT00770692|9719037|FG002|NOT COMPLETED|Overall Study||14
8675678|NCT00770692|9719038|FG003|NOT COMPLETED|Overall Study||11
8675679|NCT00770757|9719048|FG000|STARTED|Overall Study||13
8675680|NCT00770757|9719048|FG000|COMPLETED|Overall Study||13
8675681|NCT00770757|9719048|FG000|NOT COMPLETED|Overall Study||0
8675682|NCT00770770|9719054|FG000|STARTED|Overall Study||14
8799643|NCT01438996|9851208|FG001|NOT COMPLETED|Overall Study||1
8799644|NCT01438996|9851209|FG002|NOT COMPLETED|Overall Study||0
8799645|NCT01439009|9851219|FG000|STARTED|Overall Study||50
8799646|NCT01439009|9851220|FG001|STARTED|Overall Study||50
8799647|NCT01439009|9851219|FG000|COMPLETED|Overall Study||42
8799648|NCT01439009|9851220|FG001|COMPLETED|Overall Study||47
8799649|NCT01439009|9851219|FG000|NOT COMPLETED|Overall Study||8
8799650|NCT01439009|9851220|FG001|NOT COMPLETED|Overall Study||3
8799651|NCT01439035|9851226|FG000|STARTED|Overall Study||6
8799652|NCT01439035|9851226|FG000|COMPLETED|Overall Study||6
8799653|NCT01439035|9851226|FG000|NOT COMPLETED|Overall Study||0
8799654|NCT01439074|9851232|FG000|STARTED|Overall Study||75
8799655|NCT01439074|9851233|FG001|STARTED|Overall Study||87
8799656|NCT01439074|9851232|FG000|COMPLETED|Overall Study||66
8675683|NCT00770770|9719055|FG001|STARTED|Overall Study||6
8675684|NCT00770770|9719054|FG000|COMPLETED|Overall Study||4
8675685|NCT00770770|9719055|FG001|COMPLETED|Overall Study||5
8675686|NCT00770770|9719054|FG000|NOT COMPLETED|Overall Study||10
8675687|NCT00770770|9719055|FG001|NOT COMPLETED|Overall Study||1
8675688|NCT00770861|9719063|FG000|STARTED|Overall Study||141
8675689|NCT00770861|9719064|FG001|STARTED|Overall Study||136
8675690|NCT00770861|9719063|FG000|COMPLETED|Overall Study||131
8675691|NCT00770861|9719064|FG001|COMPLETED|Overall Study||120
8675692|NCT00770861|9719063|FG000|NOT COMPLETED|Overall Study||10
8675693|NCT00770861|9719064|FG001|NOT COMPLETED|Overall Study||16
8675694|NCT00770874|9719072|FG000|STARTED|Overall Study||188
8675695|NCT00770874|9719073|FG001|STARTED|Overall Study||176
8675696|NCT00770874|9719072|FG000|COMPLETED|Overall Study||188
8675697|NCT00770874|9719073|FG001|COMPLETED|Overall Study||176
8675698|NCT00770874|9719072|FG000|NOT COMPLETED|Overall Study||0
8675699|NCT00770874|9719073|FG001|NOT COMPLETED|Overall Study||0
8675700|NCT00770913|9719082|FG000|STARTED|Overall Study||113
8675701|NCT00770913|9719083|FG001|STARTED|Overall Study||111
8675702|NCT00770913|9719084|FG002|STARTED|Overall Study||113
8675703|NCT00770913|9719082|FG000|COMPLETED|Overall Study||102
8675704|NCT00770913|9719083|FG001|COMPLETED|Overall Study||103
8675705|NCT00770913|9719084|FG002|COMPLETED|Overall Study||100
8675706|NCT00770913|9719082|FG000|NOT COMPLETED|Overall Study||11
8675707|NCT00770913|9719083|FG001|NOT COMPLETED|Overall Study||8
8675708|NCT00770913|9719084|FG002|NOT COMPLETED|Overall Study||13
8675709|NCT00770991|9719094|FG000|STARTED|Overall Study|34 participants enrolled (signed informed consent). 24 subjects were eligible to be randomized.|12
8675710|NCT00770991|9719095|FG001|STARTED|Overall Study|We anticipated 26-30 subjects with FAP 18 year or olders would need to be enrolled to randomize 18|12
8675711|NCT00770991|9719094|FG000|COMPLETED|Overall Study|7 subjects completed 36 weeks (+/- 10 days)of treatment|7
8675712|NCT00770991|9719095|FG001|COMPLETED|Overall Study|7 subjects completed 36 weeks (+/- 10 days)of treatment|7
8675713|NCT00770991|9719094|FG000|NOT COMPLETED|Overall Study||5
8675714|NCT00770991|9719095|FG001|NOT COMPLETED|Overall Study||5
8675715|NCT00771030|9719113|FG000|STARTED|Overall Study||6
8675716|NCT00771030|9719114|FG001|STARTED|Overall Study||4
8675717|NCT00771030|9719115|FG002|STARTED|Overall Study||6
8675718|NCT00771030|9719116|FG003|STARTED|Overall Study||6
8675719|NCT00771030|9719117|FG004|STARTED|Overall Study||6
8675720|NCT00771030|9719118|FG005|STARTED|Overall Study||6
8675721|NCT00771030|9719119|FG006|STARTED|Overall Study||6
8675722|NCT00771030|9719113|FG000|Received Study Drug|Overall Study||6
8675723|NCT00771030|9719114|FG001|Received Study Drug|Overall Study||4
8675724|NCT00771030|9719115|FG002|Received Study Drug|Overall Study||6
8675725|NCT00771030|9719116|FG003|Received Study Drug|Overall Study||6
8675726|NCT00771030|9719117|FG004|Received Study Drug|Overall Study||6
8675727|NCT00771030|9719118|FG005|Received Study Drug|Overall Study||6
8675728|NCT00771030|9719119|FG006|Received Study Drug|Overall Study||6
8675729|NCT00771030|9719113|FG000|COMPLETED|Overall Study||6
8675730|NCT00771030|9719114|FG001|COMPLETED|Overall Study||3
8675731|NCT00771030|9719115|FG002|COMPLETED|Overall Study||6
8675732|NCT00771030|9719116|FG003|COMPLETED|Overall Study||6
8675733|NCT00771030|9719117|FG004|COMPLETED|Overall Study||6
8675734|NCT00771030|9719118|FG005|COMPLETED|Overall Study||6
8675735|NCT00771030|9719119|FG006|COMPLETED|Overall Study||6
8675736|NCT00771030|9719113|FG000|NOT COMPLETED|Overall Study||0
8675737|NCT00771030|9719114|FG001|NOT COMPLETED|Overall Study||1
8675738|NCT00771030|9719115|FG002|NOT COMPLETED|Overall Study||0
8675739|NCT00771030|9719116|FG003|NOT COMPLETED|Overall Study||0
8675740|NCT00771030|9719117|FG004|NOT COMPLETED|Overall Study||0
8675741|NCT00771030|9719118|FG005|NOT COMPLETED|Overall Study||0
8675742|NCT00771030|9719119|FG006|NOT COMPLETED|Overall Study||0
8675743|NCT00771056|9719140|FG000|STARTED|Overall Study||23
8675744|NCT00771056|9719140|FG000|COMPLETED|Overall Study||18
8675745|NCT00771056|9719140|FG000|NOT COMPLETED|Overall Study||5
8692759|NCT00862849|9738283|FG005|STARTED|Intervention 2||3
8692760|NCT00862849|9738278|FG000|COMPLETED|Intervention 2||3
8692761|NCT00862849|9738279|FG001|COMPLETED|Intervention 2||4
8692762|NCT00862849|9738280|FG002|COMPLETED|Intervention 2||3
8692763|NCT00862849|9738281|FG003|COMPLETED|Intervention 2||4
8692764|NCT00862849|9738282|FG004|COMPLETED|Intervention 2||4
8692765|NCT00862849|9738283|FG005|COMPLETED|Intervention 2||3
8692766|NCT00862849|9738278|FG000|NOT COMPLETED|Intervention 2||0
8692767|NCT00862849|9738279|FG001|NOT COMPLETED|Intervention 2||0
8692768|NCT00862849|9738280|FG002|NOT COMPLETED|Intervention 2||0
8692769|NCT00862849|9738281|FG003|NOT COMPLETED|Intervention 2||0
8692770|NCT00862849|9738282|FG004|NOT COMPLETED|Intervention 2||0
8692771|NCT00862849|9738283|FG005|NOT COMPLETED|Intervention 2||0
8692772|NCT00862849|9738278|FG000|STARTED|Washout 2 (3 to 14 Days)||3
8692773|NCT00862849|9738279|FG001|STARTED|Washout 2 (3 to 14 Days)||4
8692774|NCT00862849|9738280|FG002|STARTED|Washout 2 (3 to 14 Days)||3
8692775|NCT00862849|9738281|FG003|STARTED|Washout 2 (3 to 14 Days)||4
8692776|NCT00862849|9738282|FG004|STARTED|Washout 2 (3 to 14 Days)||4
8692777|NCT00862849|9738283|FG005|STARTED|Washout 2 (3 to 14 Days)||3
8692778|NCT00862849|9738278|FG000|COMPLETED|Washout 2 (3 to 14 Days)||3
8692779|NCT00862849|9738279|FG001|COMPLETED|Washout 2 (3 to 14 Days)||3
8692780|NCT00862849|9738280|FG002|COMPLETED|Washout 2 (3 to 14 Days)||3
8692781|NCT00862849|9738281|FG003|COMPLETED|Washout 2 (3 to 14 Days)||4
8692782|NCT00862849|9738282|FG004|COMPLETED|Washout 2 (3 to 14 Days)||4
8692783|NCT00862849|9738283|FG005|COMPLETED|Washout 2 (3 to 14 Days)||3
8692784|NCT00862849|9738278|FG000|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
8692785|NCT00862849|9738279|FG001|NOT COMPLETED|Washout 2 (3 to 14 Days)||1
8692786|NCT00862849|9738280|FG002|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
8675746|NCT00771173|9719146|FG000|STARTED|Overall Study||129
8675747|NCT00771173|9719147|FG001|STARTED|Overall Study||129
8675748|NCT00771173|9719146|FG000|COMPLETED|Overall Study||107
8675749|NCT00771173|9719147|FG001|COMPLETED|Overall Study||112
8675750|NCT00771173|9719146|FG000|NOT COMPLETED|Overall Study||22
8675751|NCT00771173|9719147|FG001|NOT COMPLETED|Overall Study||17
8675752|NCT00771238|9719155|FG000|STARTED|Overall Study||31
8675753|NCT00771238|9719156|FG001|STARTED|Overall Study||21
8675754|NCT00771238|9719155|FG000|COMPLETED|Overall Study||31
8675755|NCT00771238|9719156|FG001|COMPLETED|Overall Study||21
8675756|NCT00771238|9719155|FG000|NOT COMPLETED|Overall Study||0
8675757|NCT00771238|9719156|FG001|NOT COMPLETED|Overall Study||0
8675758|NCT00771264|9719164|FG000|STARTED|Overall Study||110
8675759|NCT00771264|9719165|FG001|STARTED|Overall Study||110
8675760|NCT00771264|9719164|FG000|COMPLETED|Overall Study||103
8675761|NCT00771264|9719165|FG001|COMPLETED|Overall Study||105
8675762|NCT00771264|9719164|FG000|NOT COMPLETED|Overall Study||7
8675763|NCT00771264|9719165|FG001|NOT COMPLETED|Overall Study||5
8675764|NCT00771277|9719171|FG000|STARTED|Overall Study||6
8675765|NCT00771277|9719171|FG000|COMPLETED|Overall Study||6
8675766|NCT00771277|9719171|FG000|NOT COMPLETED|Overall Study||0
8675767|NCT00771407|9719177|FG000|STARTED|Overall Study||60
8675768|NCT00771407|9719178|FG001|STARTED|Overall Study||60
8675769|NCT00771407|9719177|FG000|COMPLETED|Overall Study||40
8675770|NCT00771407|9719178|FG001|COMPLETED|Overall Study||35
8675771|NCT00771407|9719177|FG000|NOT COMPLETED|Overall Study||20
8675772|NCT00771407|9719178|FG001|NOT COMPLETED|Overall Study||25
8675773|NCT00771472|9719184|FG000|STARTED|Overall Study||6
8675774|NCT00771472|9719185|FG001|STARTED|Overall Study||4
8675775|NCT00771472|9719184|FG000|COMPLETED|Overall Study||0
8675776|NCT00771472|9719185|FG001|COMPLETED|Overall Study||0
8675777|NCT00771472|9719184|FG000|NOT COMPLETED|Overall Study||6
8675778|NCT00771472|9719185|FG001|NOT COMPLETED|Overall Study||4
8675779|NCT00771537|9719206|FG000|STARTED|Overall Study||135
8675780|NCT00771537|9719207|FG001|STARTED|Overall Study||124
8675781|NCT00771537|9719208|FG002|STARTED|Overall Study||151
8675782|NCT00771537|9719209|FG003|STARTED|Overall Study||114
8675783|NCT00771537|9719210|FG004|STARTED|Overall Study||127
8675784|NCT00771537|9719211|FG005|STARTED|Overall Study||118
8675785|NCT00771537|9719212|FG006|STARTED|Overall Study||128
8675786|NCT00771537|9719213|FG007|STARTED|Overall Study||132
8675787|NCT00771537|9719214|FG008|STARTED|Overall Study||115
8675788|NCT00771537|9719215|FG009|STARTED|Overall Study||119
8675789|NCT00771537|9719216|FG010|STARTED|Overall Study||133
8675790|NCT00771537|9719217|FG011|STARTED|Overall Study||137
8675791|NCT00771537|9719218|FG012|STARTED|Overall Study||128
8675792|NCT00771537|9719219|FG013|STARTED|Overall Study||124
8675793|NCT00771537|9719220|FG014|STARTED|Overall Study||124
8675794|NCT00771537|9719221|FG015|STARTED|Overall Study||122
8675795|NCT00771537|9719206|FG000|COMPLETED|Overall Study||135
8675796|NCT00771537|9719207|FG001|COMPLETED|Overall Study||124
8675797|NCT00771537|9719208|FG002|COMPLETED|Overall Study||151
8675798|NCT00771537|9719209|FG003|COMPLETED|Overall Study||114
8675799|NCT00771537|9719210|FG004|COMPLETED|Overall Study||127
8675800|NCT00771537|9719211|FG005|COMPLETED|Overall Study||118
8675801|NCT00771537|9719212|FG006|COMPLETED|Overall Study||128
8675802|NCT00771537|9719213|FG007|COMPLETED|Overall Study||132
8675803|NCT00771537|9719214|FG008|COMPLETED|Overall Study||115
8675804|NCT00771537|9719215|FG009|COMPLETED|Overall Study||119
8675805|NCT00771537|9719216|FG010|COMPLETED|Overall Study||133
8675806|NCT00771537|9719217|FG011|COMPLETED|Overall Study||137
8675807|NCT00771537|9719218|FG012|COMPLETED|Overall Study||128
8675808|NCT00771537|9719219|FG013|COMPLETED|Overall Study||124
8675809|NCT00771537|9719220|FG014|COMPLETED|Overall Study||124
8675810|NCT00771537|9719221|FG015|COMPLETED|Overall Study||122
8675811|NCT00771537|9719206|FG000|NOT COMPLETED|Overall Study||0
8675812|NCT00771537|9719207|FG001|NOT COMPLETED|Overall Study||0
8675813|NCT00771537|9719208|FG002|NOT COMPLETED|Overall Study||0
8675814|NCT00771537|9719209|FG003|NOT COMPLETED|Overall Study||0
8675815|NCT00771537|9719210|FG004|NOT COMPLETED|Overall Study||0
8675816|NCT00771537|9719211|FG005|NOT COMPLETED|Overall Study||0
8675817|NCT00771537|9719212|FG006|NOT COMPLETED|Overall Study||0
8675818|NCT00771537|9719213|FG007|NOT COMPLETED|Overall Study||0
8675819|NCT00771537|9719214|FG008|NOT COMPLETED|Overall Study||0
8675820|NCT00771537|9719215|FG009|NOT COMPLETED|Overall Study||0
8675821|NCT00771537|9719216|FG010|NOT COMPLETED|Overall Study||0
8675822|NCT00771537|9719217|FG011|NOT COMPLETED|Overall Study||0
8675823|NCT00771537|9719218|FG012|NOT COMPLETED|Overall Study||0
8675824|NCT00771537|9719219|FG013|NOT COMPLETED|Overall Study||0
8675825|NCT00771537|9719220|FG014|NOT COMPLETED|Overall Study||0
8675826|NCT00771537|9719221|FG015|NOT COMPLETED|Overall Study||0
8675827|NCT00771615|9719256|FG000|STARTED|Overall Study||49
8675828|NCT00771615|9719257|FG001|STARTED|Overall Study||72
8675829|NCT00771615|9719258|FG002|STARTED|Overall Study||41
8675830|NCT00771615|9719259|FG003|STARTED|Overall Study||60
8675831|NCT00771615|9719260|FG004|STARTED|Overall Study||40
8675832|NCT00771615|9719261|FG005|STARTED|Overall Study||61
8675833|NCT00771615|9719262|FG006|STARTED|Overall Study||46
8675834|NCT00771615|9719263|FG007|STARTED|Overall Study||59
8675835|NCT00771615|9719264|FG008|STARTED|Overall Study||41
8675836|NCT00771615|9719256|FG000|COMPLETED|Overall Study|Up to Day 364|48
8675837|NCT00771615|9719257|FG001|COMPLETED|Overall Study|Up to Day 364|70
8675838|NCT00771615|9719258|FG002|COMPLETED|Overall Study|Up to Day 364|40
8675839|NCT00771615|9719259|FG003|COMPLETED|Overall Study|Up to Day 364|59
8675840|NCT00771615|9719260|FG004|COMPLETED|Overall Study|Up to Day 364|40
8675841|NCT00771615|9719261|FG005|COMPLETED|Overall Study|Up to Day 364|60
8675842|NCT00771615|9719262|FG006|COMPLETED|Overall Study|Up to Day 364|45
8675843|NCT00771615|9719263|FG007|COMPLETED|Overall Study|Up to Day 364|58
8675844|NCT00771615|9719264|FG008|COMPLETED|Overall Study|Up to Day 364|41
8675845|NCT00771615|9719256|FG000|NOT COMPLETED|Overall Study||1
8675846|NCT00771615|9719257|FG001|NOT COMPLETED|Overall Study||2
8675847|NCT00771615|9719258|FG002|NOT COMPLETED|Overall Study||1
8675848|NCT00771615|9719259|FG003|NOT COMPLETED|Overall Study||1
8675849|NCT00771615|9719260|FG004|NOT COMPLETED|Overall Study||0
8675850|NCT00771615|9719261|FG005|NOT COMPLETED|Overall Study||1
8675851|NCT00771615|9719262|FG006|NOT COMPLETED|Overall Study||1
8675852|NCT00771615|9719263|FG007|NOT COMPLETED|Overall Study||1
8675853|NCT00771615|9719264|FG008|NOT COMPLETED|Overall Study||0
8675854|NCT00771667|9719297|FG000|STARTED|Induction Phase||132
8675855|NCT00771667|9719298|FG001|STARTED|Induction Phase||131
8675856|NCT00771667|9719299|FG002|STARTED|Induction Phase||132
8675857|NCT00771667|9719300|FG003|STARTED|Induction Phase||131
8675858|NCT00771667|9719301|FG004|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
8675859|NCT00771667|9719302|FG005|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
8675860|NCT00771667|9719303|FG006|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
8675861|NCT00771667|9719304|FG007|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
8675862|NCT00771667|9719305|FG008|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
8675863|NCT00771667|9719306|FG009|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
8675864|NCT00771667|9719297|FG000|COMPLETED|Induction Phase||113
8675865|NCT00771667|9719298|FG001|COMPLETED|Induction Phase||121
8675866|NCT00771667|9719299|FG002|COMPLETED|Induction Phase||120
8675867|NCT00771667|9719300|FG003|COMPLETED|Induction Phase||123
8675868|NCT00771667|9719301|FG004|COMPLETED|Induction Phase||0
8675869|NCT00771667|9719302|FG005|COMPLETED|Induction Phase||0
8675870|NCT00771667|9719303|FG006|COMPLETED|Induction Phase||0
8675871|NCT00771667|9719304|FG007|COMPLETED|Induction Phase||0
8675872|NCT00771667|9719305|FG008|COMPLETED|Induction Phase||0
8675873|NCT00771667|9719306|FG009|COMPLETED|Induction Phase||0
8675874|NCT00771667|9719297|FG000|NOT COMPLETED|Induction Phase||19
8675875|NCT00771667|9719298|FG001|NOT COMPLETED|Induction Phase||10
8675876|NCT00771667|9719299|FG002|NOT COMPLETED|Induction Phase||12
8675877|NCT00771667|9719300|FG003|NOT COMPLETED|Induction Phase||8
8675878|NCT00771667|9719301|FG004|NOT COMPLETED|Induction Phase||0
8675879|NCT00771667|9719302|FG005|NOT COMPLETED|Induction Phase||0
8675880|NCT00771667|9719303|FG006|NOT COMPLETED|Induction Phase||0
8675881|NCT00771667|9719304|FG007|NOT COMPLETED|Induction Phase||0
8675882|NCT00771667|9719305|FG008|NOT COMPLETED|Induction Phase||0
8675883|NCT00771667|9719306|FG009|NOT COMPLETED|Induction Phase||0
8675884|NCT00771667|9719297|FG000|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
8675885|NCT00771667|9719298|FG001|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
8675886|NCT00771667|9719299|FG002|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
8675887|NCT00771667|9719300|FG003|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
8675888|NCT00771667|9719301|FG004|STARTED|Maintenance Phase||28
8675889|NCT00771667|9719302|FG005|STARTED|Maintenance Phase||85
8675890|NCT00771667|9719303|FG006|STARTED|Maintenance Phase||73
8675891|NCT00771667|9719304|FG007|STARTED|Maintenance Phase||72
8675892|NCT00771667|9719305|FG008|STARTED|Maintenance Phase||110
8675893|NCT00771667|9719306|FG009|STARTED|Maintenance Phase||109
8675894|NCT00771667|9719297|FG000|COMPLETED|Maintenance Phase||0
8675895|NCT00771667|9719298|FG001|COMPLETED|Maintenance Phase||0
8675896|NCT00771667|9719299|FG002|COMPLETED|Maintenance Phase||0
8675897|NCT00771667|9719300|FG003|COMPLETED|Maintenance Phase||0
8675898|NCT00771667|9719301|FG004|COMPLETED|Maintenance Phase||26
8675899|NCT00771667|9719302|FG005|COMPLETED|Maintenance Phase||78
8675900|NCT00771667|9719303|FG006|COMPLETED|Maintenance Phase||63
8675901|NCT00771667|9719304|FG007|COMPLETED|Maintenance Phase||67
8675902|NCT00771667|9719305|FG008|COMPLETED|Maintenance Phase||88
8675903|NCT00771667|9719306|FG009|COMPLETED|Maintenance Phase||92
8675904|NCT00771667|9719297|FG000|NOT COMPLETED|Maintenance Phase||0
8675905|NCT00771667|9719298|FG001|NOT COMPLETED|Maintenance Phase||0
8675906|NCT00771667|9719299|FG002|NOT COMPLETED|Maintenance Phase||0
8675907|NCT00771667|9719300|FG003|NOT COMPLETED|Maintenance Phase||0
8675908|NCT00771667|9719301|FG004|NOT COMPLETED|Maintenance Phase||2
8675909|NCT00771667|9719302|FG005|NOT COMPLETED|Maintenance Phase||7
8675910|NCT00771667|9719303|FG006|NOT COMPLETED|Maintenance Phase||10
8675911|NCT00771667|9719304|FG007|NOT COMPLETED|Maintenance Phase||5
8675912|NCT00771667|9719305|FG008|NOT COMPLETED|Maintenance Phase||22
8675913|NCT00771667|9719306|FG009|NOT COMPLETED|Maintenance Phase||17
8675914|NCT00771745|9719326|FG000|STARTED|Overall Study||6
8675915|NCT00771745|9719327|FG001|STARTED|Overall Study||5
8675916|NCT00771745|9719326|FG000|COMPLETED|Overall Study||6
8675917|NCT00771745|9719327|FG001|COMPLETED|Overall Study||5
8675918|NCT00771745|9719326|FG000|NOT COMPLETED|Overall Study||0
8675919|NCT00771745|9719327|FG001|NOT COMPLETED|Overall Study||0
8675920|NCT00771758|9719336|FG000|STARTED|Overall Study||44
8675921|NCT00771758|9719337|FG001|STARTED|Overall Study||43
8675922|NCT00771758|9719338|FG002|STARTED|Overall Study||21
8675923|NCT00771758|9719336|FG000|COMPLETED|Overall Study||36
8675924|NCT00771758|9719337|FG001|COMPLETED|Overall Study||31
8675925|NCT00771758|9719338|FG002|COMPLETED|Overall Study||19
8675926|NCT00771758|9719336|FG000|NOT COMPLETED|Overall Study||8
8675927|NCT00771758|9719337|FG001|NOT COMPLETED|Overall Study||12
8675928|NCT00771758|9719338|FG002|NOT COMPLETED|Overall Study||2
8675929|NCT00771810|9719366|FG000|STARTED|Overall Study||10
8675930|NCT00771810|9719367|FG001|STARTED|Overall Study||11
8675931|NCT00771810|9719368|FG002|STARTED|Overall Study||13
8675932|NCT00771810|9719366|FG000|COMPLETED|Overall Study||5
8675933|NCT00771810|9719367|FG001|COMPLETED|Overall Study||6
8675934|NCT00771810|9719368|FG002|COMPLETED|Overall Study||6
8675935|NCT00771810|9719366|FG000|NOT COMPLETED|Overall Study||5
8675936|NCT00771810|9719367|FG001|NOT COMPLETED|Overall Study||5
8675937|NCT00771810|9719368|FG002|NOT COMPLETED|Overall Study||7
8675938|NCT00771849|9719379|FG000|STARTED|Overall Study||52
8675939|NCT00771849|9719380|FG001|STARTED|Overall Study|One subject was not vaccinated|51
8675940|NCT00771849|9719379|FG000|COMPLETED|Overall Study||50
8675941|NCT00771849|9719380|FG001|COMPLETED|Overall Study||47
8675942|NCT00771849|9719379|FG000|NOT COMPLETED|Overall Study||2
8675943|NCT00771849|9719380|FG001|NOT COMPLETED|Overall Study||4
8675944|NCT00771875|9719389|FG000|STARTED|Overall Study||10
8675945|NCT00771875|9719390|FG001|STARTED|Overall Study||10
8675946|NCT00771875|9719391|FG002|STARTED|Overall Study||10
8675947|NCT00771875|9719389|FG000|COMPLETED|Overall Study||10
8675948|NCT00771875|9719390|FG001|COMPLETED|Overall Study||9
8675949|NCT00771875|9719391|FG002|COMPLETED|Overall Study||10
8675950|NCT00771875|9719389|FG000|NOT COMPLETED|Overall Study||0
8675951|NCT00771875|9719390|FG001|NOT COMPLETED|Overall Study||1
8675952|NCT00771875|9719391|FG002|NOT COMPLETED|Overall Study||0
8675953|NCT00771901|9719402|FG000|STARTED|Overall Study||10
8675954|NCT00771901|9719403|FG001|STARTED|Overall Study||10
8675955|NCT00771901|9719404|FG002|STARTED|Overall Study||10
8675956|NCT00771901|9719402|FG000|COMPLETED|Overall Study||10
8675957|NCT00771901|9719403|FG001|COMPLETED|Overall Study||10
8675958|NCT00771901|9719404|FG002|COMPLETED|Overall Study||6
8675959|NCT00771901|9719402|FG000|NOT COMPLETED|Overall Study||0
8675960|NCT00771901|9719403|FG001|NOT COMPLETED|Overall Study||0
8675961|NCT00771901|9719404|FG002|NOT COMPLETED|Overall Study||4
8675962|NCT00771914|9719416|FG000|STARTED|Overall Study||7
8675963|NCT00771914|9719417|FG001|STARTED|Overall Study||6
8675964|NCT00771914|9719418|FG002|STARTED|Overall Study||6
8675965|NCT00771914|9719419|FG003|STARTED|Overall Study||8
8675966|NCT00771914|9719416|FG000|COMPLETED|Overall Study||7
8675967|NCT00771914|9719417|FG001|COMPLETED|Overall Study||6
8675968|NCT00771914|9719418|FG002|COMPLETED|Overall Study||6
8675969|NCT00771914|9719419|FG003|COMPLETED|Overall Study||6
8675970|NCT00771914|9719416|FG000|NOT COMPLETED|Overall Study||0
8675971|NCT00771914|9719417|FG001|NOT COMPLETED|Overall Study||0
8675972|NCT00771914|9719418|FG002|NOT COMPLETED|Overall Study||0
8675973|NCT00771914|9719419|FG003|NOT COMPLETED|Overall Study||2
8675974|NCT00771927|9719431|FG000|STARTED|Overall Study|Participant Flow and Baseline Characteristics refer to the Safety Set population.|511
8675975|NCT00771927|9719432|FG001|STARTED|Overall Study|Participant Flow and Baseline Characteristics refer to the Safety Set population.|493
8675976|NCT00771927|9719431|FG000|COMPLETED|Overall Study||256
8675977|NCT00771927|9719432|FG001|COMPLETED|Overall Study||256
8675978|NCT00771927|9719431|FG000|NOT COMPLETED|Overall Study||255
8675979|NCT00771927|9719432|FG001|NOT COMPLETED|Overall Study||237
8675980|NCT00771953|9719440|FG000|STARTED|Overall Study||36
8675981|NCT00771953|9719441|FG001|STARTED|Overall Study||36
8675982|NCT00771953|9719440|FG000|COMPLETED|Overall Study||26
8675983|NCT00771953|9719441|FG001|COMPLETED|Overall Study||26
8675984|NCT00771953|9719440|FG000|NOT COMPLETED|Overall Study||10
8675985|NCT00771953|9719441|FG001|NOT COMPLETED|Overall Study||10
8675986|NCT00772005|9719453|FG000|STARTED|Overall Study||71
8675987|NCT00772005|9719454|FG001|STARTED|Overall Study|One patient withdrew before taking any study drug.|70
8675988|NCT00772005|9719455|FG002|STARTED|Overall Study|One patient withdrew before taking any study drug.|72
8675989|NCT00772005|9719456|FG003|STARTED|Overall Study|Two patients withdrew before taking any study drug.|72
8675990|NCT00772005|9719453|FG000|COMPLETED|Overall Study||46
8675991|NCT00772005|9719454|FG001|COMPLETED|Overall Study||40
8675992|NCT00772005|9719455|FG002|COMPLETED|Overall Study||44
8675993|NCT00772005|9719456|FG003|COMPLETED|Overall Study||46
8675994|NCT00772005|9719453|FG000|NOT COMPLETED|Overall Study||25
8675995|NCT00772005|9719454|FG001|NOT COMPLETED|Overall Study||30
8675996|NCT00772005|9719455|FG002|NOT COMPLETED|Overall Study||28
8675997|NCT00772005|9719456|FG003|NOT COMPLETED|Overall Study||26
8675998|NCT00772031|9719468|FG000|STARTED|Overall Study||96
8675999|NCT00772031|9719469|FG001|STARTED|Overall Study||95
8799657|NCT01439074|9851233|FG001|COMPLETED|Overall Study||74
8676000|NCT00772031|9719468|FG000|COMPLETED|Overall Study||64
8676001|NCT00772031|9719469|FG001|COMPLETED|Overall Study||52
8676002|NCT00772031|9719468|FG000|NOT COMPLETED|Overall Study||32
8676003|NCT00772031|9719469|FG001|NOT COMPLETED|Overall Study||43
8676004|NCT00772070|9719483|FG000|STARTED|Overall Study||102
8676005|NCT00772070|9719484|FG001|STARTED|Overall Study||71
8676006|NCT00772070|9719483|FG000|COMPLETED|Overall Study|Two participants had vaccination errors, they were removed from analysis.|100
8676007|NCT00772070|9719484|FG001|COMPLETED|Overall Study||61
8676008|NCT00772070|9719483|FG000|NOT COMPLETED|Overall Study||2
8676009|NCT00772070|9719484|FG001|NOT COMPLETED|Overall Study||10
8676010|NCT00772109|9719494|FG000|STARTED|Overall Study||956
8676011|NCT00772109|9719495|FG001|STARTED|Overall Study||953
8676012|NCT00772109|9719496|FG002|STARTED|Overall Study||955
8676013|NCT00772109|9719497|FG003|STARTED|Overall Study||1428
8676014|NCT00772109|9719494|FG000|COMPLETED|Overall Study||935
8676015|NCT00772109|9719495|FG001|COMPLETED|Overall Study||934
8676016|NCT00772109|9719496|FG002|COMPLETED|Overall Study||936
8676017|NCT00772109|9719497|FG003|COMPLETED|Overall Study||1397
8676018|NCT00772109|9719494|FG000|NOT COMPLETED|Overall Study||21
8676019|NCT00772109|9719495|FG001|NOT COMPLETED|Overall Study||19
8676020|NCT00772109|9719496|FG002|NOT COMPLETED|Overall Study||19
8676021|NCT00772109|9719497|FG003|NOT COMPLETED|Overall Study||31
8676022|NCT00772148|9719509|FG000|STARTED|Pharmacokinetic Phase (14 Days)||29
8676023|NCT00772148|9719510|FG001|STARTED|Pharmacokinetic Phase (14 Days)||29
8676024|NCT00772148|9719509|FG000|COMPLETED|Pharmacokinetic Phase (14 Days)||21
8676025|NCT00772148|9719510|FG001|COMPLETED|Pharmacokinetic Phase (14 Days)||23
8676026|NCT00772148|9719509|FG000|NOT COMPLETED|Pharmacokinetic Phase (14 Days)||8
8676027|NCT00772148|9719510|FG001|NOT COMPLETED|Pharmacokinetic Phase (14 Days)||6
8676028|NCT00772148|9719509|FG000|STARTED|Maintenance Phase (Week 52)||21
8676029|NCT00772148|9719510|FG001|STARTED|Maintenance Phase (Week 52)||23
8676030|NCT00772148|9719509|FG000|COMPLETED|Maintenance Phase (Week 52)||17
8676031|NCT00772148|9719510|FG001|COMPLETED|Maintenance Phase (Week 52)||18
8676032|NCT00772148|9719509|FG000|NOT COMPLETED|Maintenance Phase (Week 52)||4
8676033|NCT00772148|9719510|FG001|NOT COMPLETED|Maintenance Phase (Week 52)||5
8676034|NCT00772304|9719516|FG000|STARTED|Overall Study||102
8676035|NCT00772304|9719516|FG000|COMPLETED|Overall Study||102
8676036|NCT00772304|9719516|FG000|NOT COMPLETED|Overall Study||0
8676037|NCT00772330|9719520|FG000|STARTED|Overall Study||23
8676038|NCT00772330|9719520|FG000|COMPLETED|Overall Study||20
8676039|NCT00772330|9719520|FG000|NOT COMPLETED|Overall Study||3
8676040|NCT00772369|9719527|FG000|STARTED|Overall Study||3214
8676041|NCT00772369|9719527|FG000|COMPLETED|Overall Study||3213
8676042|NCT00772369|9719527|FG000|NOT COMPLETED|Overall Study||1
8676043|NCT00772382|9719531|FG000|STARTED|Overall Study||116
8676044|NCT00772382|9719531|FG000|COMPLETED|Overall Study||61
8676045|NCT00772382|9719531|FG000|NOT COMPLETED|Overall Study||55
8676046|NCT00772447|9719537|FG000|STARTED|Overall Study||131
8676047|NCT00772447|9719538|FG001|STARTED|Overall Study||134
8676048|NCT00772447|9719537|FG000|COMPLETED|Overall Study||111
8676049|NCT00772447|9719538|FG001|COMPLETED|Overall Study||110
8676050|NCT00772447|9719537|FG000|NOT COMPLETED|Overall Study||20
8676051|NCT00772447|9719538|FG001|NOT COMPLETED|Overall Study||24
8676052|NCT00772538|9719547|FG000|STARTED|Overall Study||222
8676053|NCT00772538|9719548|FG001|STARTED|Overall Study||237
8676054|NCT00772538|9719547|FG000|COMPLETED|Overall Study||202
8676055|NCT00772538|9719548|FG001|COMPLETED|Overall Study||211
8676056|NCT00772538|9719547|FG000|NOT COMPLETED|Overall Study||20
8676057|NCT00772538|9719548|FG001|NOT COMPLETED|Overall Study||26
8676058|NCT00772577|9719556|FG000|STARTED|Overall Study||193
8676059|NCT00772577|9719557|FG001|STARTED|Overall Study||193
8676060|NCT00772577|9719556|FG000|COMPLETED|Overall Study||170
8676061|NCT00772577|9719557|FG001|COMPLETED|Overall Study||170
8676062|NCT00772577|9719556|FG000|NOT COMPLETED|Overall Study||23
8676063|NCT00772577|9719557|FG001|NOT COMPLETED|Overall Study||23
8676064|NCT00772590|9719567|FG000|STARTED|Overall Study||19
8676065|NCT00772590|9719568|FG001|STARTED|Overall Study||19
8676066|NCT00772590|9719569|FG002|STARTED|Overall Study||18
8676067|NCT00772590|9719570|FG003|STARTED|Overall Study||17
8676068|NCT00772590|9719567|FG000|COMPLETED|Overall Study||19
8676069|NCT00772590|9719568|FG001|COMPLETED|Overall Study||19
8676070|NCT00772590|9719569|FG002|COMPLETED|Overall Study||18
8676071|NCT00772590|9719570|FG003|COMPLETED|Overall Study||17
8676072|NCT00772590|9719567|FG000|NOT COMPLETED|Overall Study||0
8676073|NCT00772590|9719568|FG001|NOT COMPLETED|Overall Study||0
8676074|NCT00772590|9719569|FG002|NOT COMPLETED|Overall Study||0
8676075|NCT00772590|9719570|FG003|NOT COMPLETED|Overall Study||0
8676076|NCT00772603|9719583|FG000|STARTED|Overall Study||123
8676077|NCT00772603|9719584|FG001|STARTED|Overall Study||122
8676078|NCT00772603|9719585|FG002|STARTED|Overall Study||121
8676079|NCT00772603|9719583|FG000|COMPLETED|Overall Study||71
8676080|NCT00772603|9719584|FG001|COMPLETED|Overall Study||82
8676081|NCT00772603|9719585|FG002|COMPLETED|Overall Study||95
8676082|NCT00772603|9719583|FG000|NOT COMPLETED|Overall Study||52
8676083|NCT00772603|9719584|FG001|NOT COMPLETED|Overall Study||40
8676084|NCT00772603|9719585|FG002|NOT COMPLETED|Overall Study||26
8676085|NCT00772629|9719598|FG000|STARTED|Overall Study||17
8676086|NCT00772629|9719599|FG001|STARTED|Overall Study||1
8676087|NCT00772629|9719598|FG000|COMPLETED|Overall Study||16
8676088|NCT00772629|9719599|FG001|COMPLETED|Overall Study||1
8676089|NCT00772629|9719598|FG000|NOT COMPLETED|Overall Study||1
8676090|NCT00772629|9719599|FG001|NOT COMPLETED|Overall Study||0
8676091|NCT00772668|9719605|FG000|STARTED|Overall Study||3
8676092|NCT00772668|9719605|FG000|COMPLETED|Overall Study||0
8676093|NCT00772668|9719605|FG000|NOT COMPLETED|Overall Study||3
8676094|NCT00772707|9719610|FG000|STARTED|Overall Study||114
8676095|NCT00772707|9719610|FG000|COMPLETED|Overall Study||111
8676096|NCT00772707|9719610|FG000|NOT COMPLETED|Overall Study||3
8676097|NCT00772772|9719614|FG000|STARTED|Overall Study||12
8676098|NCT00772772|9719614|FG000|COMPLETED|Overall Study||12
8676099|NCT00772772|9719614|FG000|NOT COMPLETED|Overall Study||0
8676100|NCT00772889|9719622|FG000|STARTED|Overall Study||375
8676101|NCT00772889|9719623|FG001|STARTED|Overall Study||393
8676102|NCT00772889|9719624|FG002|STARTED|Overall Study||203
8676103|NCT00772889|9719622|FG000|Completed at Day 21|Overall Study||374
8676104|NCT00772889|9719623|FG001|Completed at Day 21|Overall Study||390
8676105|NCT00772889|9719624|FG002|Completed at Day 21|Overall Study||203
8676106|NCT00772889|9719622|FG000|COMPLETED|Overall Study||353
8676107|NCT00772889|9719623|FG001|COMPLETED|Overall Study||375
8676108|NCT00772889|9719624|FG002|COMPLETED|Overall Study||187
8676109|NCT00772889|9719622|FG000|NOT COMPLETED|Overall Study||22
8676110|NCT00772889|9719623|FG001|NOT COMPLETED|Overall Study||18
8676111|NCT00772889|9719624|FG002|NOT COMPLETED|Overall Study||16
8676112|NCT00772915|9719632|FG000|STARTED|Overall Study||38
8676113|NCT00772915|9719632|FG000|COMPLETED|Overall Study||23
8676114|NCT00772915|9719632|FG000|NOT COMPLETED|Overall Study||15
8676115|NCT00772928|9719638|FG000|STARTED|Overall Study||587
8676116|NCT00772928|9719639|FG001|STARTED|Overall Study||579
8676117|NCT00772928|9719638|FG000|COMPLETED|Overall Study||543
8676118|NCT00772928|9719639|FG001|COMPLETED|Overall Study||538
8676119|NCT00772928|9719638|FG000|NOT COMPLETED|Overall Study||44
8676120|NCT00772928|9719639|FG001|NOT COMPLETED|Overall Study||41
8676121|NCT00772941|9719645|FG000|STARTED|Overall Study||3939
8676122|NCT00772941|9719645|FG000|COMPLETED|Overall Study||3257
8676123|NCT00772941|9719645|FG000|NOT COMPLETED|Overall Study||682
8676124|NCT00772954|9719675|FG000|STARTED|Overall Study||12
8676125|NCT00772954|9719676|FG001|STARTED|Overall Study||12
8676126|NCT00772954|9719677|FG002|STARTED|Overall Study||12
8676127|NCT00772954|9719675|FG000|COMPLETED|Overall Study||12
8676128|NCT00772954|9719676|FG001|COMPLETED|Overall Study||12
8676129|NCT00772954|9719677|FG002|COMPLETED|Overall Study||11
8676130|NCT00772954|9719675|FG000|NOT COMPLETED|Overall Study||0
8676131|NCT00772954|9719676|FG001|NOT COMPLETED|Overall Study||0
8676132|NCT00772954|9719677|FG002|NOT COMPLETED|Overall Study||1
8676133|NCT00772967|9719685|FG000|STARTED|Crossover Treatment 1||3
8676134|NCT00772967|9719686|FG001|STARTED|Crossover Treatment 1||5
8676135|NCT00772967|9719687|FG002|STARTED|Crossover Treatment 1||3
8676136|NCT00772967|9719688|FG003|STARTED|Crossover Treatment 1||4
8676137|NCT00772967|9719689|FG004|STARTED|Crossover Treatment 1||4
8676138|NCT00772967|9719690|FG005|STARTED|Crossover Treatment 1||3
8676139|NCT00772967|9719685|FG000|COMPLETED|Crossover Treatment 1||3
8676140|NCT00772967|9719686|FG001|COMPLETED|Crossover Treatment 1||5
8676141|NCT00772967|9719687|FG002|COMPLETED|Crossover Treatment 1||3
8676142|NCT00772967|9719688|FG003|COMPLETED|Crossover Treatment 1|The withdrawal is not included in any outcomes; but is part of the Adverse Event group for placebo|3
8676143|NCT00772967|9719689|FG004|COMPLETED|Crossover Treatment 1||4
8676144|NCT00772967|9719690|FG005|COMPLETED|Crossover Treatment 1||3
8676145|NCT00772967|9719685|FG000|NOT COMPLETED|Crossover Treatment 1||0
8676146|NCT00772967|9719686|FG001|NOT COMPLETED|Crossover Treatment 1||0
8676147|NCT00772967|9719687|FG002|NOT COMPLETED|Crossover Treatment 1||0
8676148|NCT00772967|9719688|FG003|NOT COMPLETED|Crossover Treatment 1||1
8676149|NCT00772967|9719689|FG004|NOT COMPLETED|Crossover Treatment 1||0
8676150|NCT00772967|9719690|FG005|NOT COMPLETED|Crossover Treatment 1||0
8676151|NCT00772967|9719685|FG000|STARTED|Break 1 (4-7 Days)||3
8676152|NCT00772967|9719686|FG001|STARTED|Break 1 (4-7 Days)||5
8676153|NCT00772967|9719687|FG002|STARTED|Break 1 (4-7 Days)||3
8676154|NCT00772967|9719688|FG003|STARTED|Break 1 (4-7 Days)||3
8676155|NCT00772967|9719689|FG004|STARTED|Break 1 (4-7 Days)||4
8676156|NCT00772967|9719690|FG005|STARTED|Break 1 (4-7 Days)||3
8676157|NCT00772967|9719685|FG000|COMPLETED|Break 1 (4-7 Days)||3
8676158|NCT00772967|9719686|FG001|COMPLETED|Break 1 (4-7 Days)||4
8676159|NCT00772967|9719687|FG002|COMPLETED|Break 1 (4-7 Days)||3
8676160|NCT00772967|9719688|FG003|COMPLETED|Break 1 (4-7 Days)||3
8676161|NCT00772967|9719689|FG004|COMPLETED|Break 1 (4-7 Days)||4
8676162|NCT00772967|9719690|FG005|COMPLETED|Break 1 (4-7 Days)||3
8676163|NCT00772967|9719685|FG000|NOT COMPLETED|Break 1 (4-7 Days)||0
8676164|NCT00772967|9719686|FG001|NOT COMPLETED|Break 1 (4-7 Days)||1
8676165|NCT00772967|9719687|FG002|NOT COMPLETED|Break 1 (4-7 Days)||0
8676166|NCT00772967|9719688|FG003|NOT COMPLETED|Break 1 (4-7 Days)||0
8676167|NCT00772967|9719689|FG004|NOT COMPLETED|Break 1 (4-7 Days)||0
8676168|NCT00772967|9719690|FG005|NOT COMPLETED|Break 1 (4-7 Days)||0
8676169|NCT00772967|9719685|FG000|STARTED|Crossover Treatment 2||3
8676170|NCT00772967|9719686|FG001|STARTED|Crossover Treatment 2||4
8676171|NCT00772967|9719687|FG002|STARTED|Crossover Treatment 2||3
8676172|NCT00772967|9719688|FG003|STARTED|Crossover Treatment 2||3
8676173|NCT00772967|9719689|FG004|STARTED|Crossover Treatment 2||4
8676174|NCT00772967|9719690|FG005|STARTED|Crossover Treatment 2||3
8676175|NCT00772967|9719685|FG000|COMPLETED|Crossover Treatment 2||3
8676176|NCT00772967|9719686|FG001|COMPLETED|Crossover Treatment 2||4
8676177|NCT00772967|9719687|FG002|COMPLETED|Crossover Treatment 2||3
8676178|NCT00772967|9719688|FG003|COMPLETED|Crossover Treatment 2||3
8676179|NCT00772967|9719689|FG004|COMPLETED|Crossover Treatment 2||4
8676180|NCT00772967|9719690|FG005|COMPLETED|Crossover Treatment 2||3
8676181|NCT00772967|9719685|FG000|NOT COMPLETED|Crossover Treatment 2||0
8676182|NCT00772967|9719686|FG001|NOT COMPLETED|Crossover Treatment 2||0
8676183|NCT00772967|9719687|FG002|NOT COMPLETED|Crossover Treatment 2||0
8676184|NCT00772967|9719688|FG003|NOT COMPLETED|Crossover Treatment 2||0
8676185|NCT00772967|9719689|FG004|NOT COMPLETED|Crossover Treatment 2||0
8676186|NCT00772967|9719690|FG005|NOT COMPLETED|Crossover Treatment 2||0
8676187|NCT00772967|9719685|FG000|STARTED|Break 2 (4-7 Days)||3
8676188|NCT00772967|9719686|FG001|STARTED|Break 2 (4-7 Days)||4
8676189|NCT00772967|9719687|FG002|STARTED|Break 2 (4-7 Days)||3
8676190|NCT00772967|9719688|FG003|STARTED|Break 2 (4-7 Days)||3
8676191|NCT00772967|9719689|FG004|STARTED|Break 2 (4-7 Days)||4
8676192|NCT00772967|9719690|FG005|STARTED|Break 2 (4-7 Days)||3
8676193|NCT00772967|9719685|FG000|COMPLETED|Break 2 (4-7 Days)||3
8676194|NCT00772967|9719686|FG001|COMPLETED|Break 2 (4-7 Days)||4
8676195|NCT00772967|9719687|FG002|COMPLETED|Break 2 (4-7 Days)||3
8676196|NCT00772967|9719688|FG003|COMPLETED|Break 2 (4-7 Days)||3
8676197|NCT00772967|9719689|FG004|COMPLETED|Break 2 (4-7 Days)||4
8676198|NCT00772967|9719690|FG005|COMPLETED|Break 2 (4-7 Days)||3
8676199|NCT00772967|9719685|FG000|NOT COMPLETED|Break 2 (4-7 Days)||0
8676200|NCT00772967|9719686|FG001|NOT COMPLETED|Break 2 (4-7 Days)||0
8676201|NCT00772967|9719687|FG002|NOT COMPLETED|Break 2 (4-7 Days)||0
8676202|NCT00772967|9719688|FG003|NOT COMPLETED|Break 2 (4-7 Days)||0
8676203|NCT00772967|9719689|FG004|NOT COMPLETED|Break 2 (4-7 Days)||0
8676204|NCT00772967|9719690|FG005|NOT COMPLETED|Break 2 (4-7 Days)||0
8676205|NCT00772967|9719685|FG000|STARTED|Crossover Treatment 3||3
8676206|NCT00772967|9719686|FG001|STARTED|Crossover Treatment 3||4
8676207|NCT00772967|9719687|FG002|STARTED|Crossover Treatment 3||3
8676208|NCT00772967|9719688|FG003|STARTED|Crossover Treatment 3||3
8676209|NCT00772967|9719689|FG004|STARTED|Crossover Treatment 3||4
8676210|NCT00772967|9719690|FG005|STARTED|Crossover Treatment 3||3
8676211|NCT00772967|9719685|FG000|COMPLETED|Crossover Treatment 3||3
8676212|NCT00772967|9719686|FG001|COMPLETED|Crossover Treatment 3||4
8676213|NCT00772967|9719687|FG002|COMPLETED|Crossover Treatment 3||3
8676214|NCT00772967|9719688|FG003|COMPLETED|Crossover Treatment 3||3
8676215|NCT00772967|9719689|FG004|COMPLETED|Crossover Treatment 3||3
8676216|NCT00772967|9719690|FG005|COMPLETED|Crossover Treatment 3||3
8676217|NCT00772967|9719685|FG000|NOT COMPLETED|Crossover Treatment 3||0
8676218|NCT00772967|9719686|FG001|NOT COMPLETED|Crossover Treatment 3||0
8676219|NCT00772967|9719687|FG002|NOT COMPLETED|Crossover Treatment 3||0
8676220|NCT00772967|9719688|FG003|NOT COMPLETED|Crossover Treatment 3||0
8676221|NCT00772967|9719689|FG004|NOT COMPLETED|Crossover Treatment 3||1
8676222|NCT00772967|9719690|FG005|NOT COMPLETED|Crossover Treatment 3||0
8676223|NCT00773097|9719698|FG000|STARTED|Overall Study||46
8676224|NCT00773097|9719698|FG000|COMPLETED|Overall Study||39
8676225|NCT00773097|9719698|FG000|NOT COMPLETED|Overall Study||7
8676226|NCT00773136|9719702|FG000|STARTED|Overall Study||21
8676227|NCT00773136|9719702|FG000|COMPLETED|Overall Study||19
8676228|NCT00773136|9719702|FG000|NOT COMPLETED|Overall Study||2
8676229|NCT00773175|9719709|FG000|STARTED|Overall Study||73
8676230|NCT00773175|9719710|FG001|STARTED|Overall Study||75
8676231|NCT00773175|9719709|FG000|Initial Fluids Via Randomized Route|Overall Study||73
8676232|NCT00773175|9719710|FG001|Initial Fluids Via Randomized Route|Overall Study||59
8676233|NCT00773175|9719709|FG000|Initial Fluids Via Subcutaneous Rescue|Overall Study||0
8676234|NCT00773175|9719710|FG001|Initial Fluids Via Subcutaneous Rescue|Overall Study||15
8676235|NCT00773175|9719709|FG000|No Fluids Received|Overall Study||0
8676236|NCT00773175|9719710|FG001|No Fluids Received|Overall Study||1
8676237|NCT00773175|9719709|FG000|COMPLETED|Overall Study||71
8676238|NCT00773175|9719710|FG001|COMPLETED|Overall Study||73
8676239|NCT00773175|9719709|FG000|NOT COMPLETED|Overall Study||2
8676240|NCT00773175|9719710|FG001|NOT COMPLETED|Overall Study||2
8676241|NCT00773253|9719723|FG000|STARTED|First Intervention (Week 0-24)||5
8676242|NCT00773253|9719724|FG001|STARTED|First Intervention (Week 0-24)||5
8676243|NCT00773253|9719723|FG000|COMPLETED|First Intervention (Week 0-24)||5
8676244|NCT00773253|9719724|FG001|COMPLETED|First Intervention (Week 0-24)||4
8676245|NCT00773253|9719723|FG000|NOT COMPLETED|First Intervention (Week 0-24)||0
8676246|NCT00773253|9719724|FG001|NOT COMPLETED|First Intervention (Week 0-24)||1
8676247|NCT00773253|9719723|FG000|STARTED|Second Intervention (Week 24-48)||5
8676248|NCT00773253|9719724|FG001|STARTED|Second Intervention (Week 24-48)||4
8676249|NCT00773253|9719723|FG000|COMPLETED|Second Intervention (Week 24-48)||5
8676250|NCT00773253|9719724|FG001|COMPLETED|Second Intervention (Week 24-48)||4
8676251|NCT00773253|9719723|FG000|NOT COMPLETED|Second Intervention (Week 24-48)||0
8676252|NCT00773253|9719724|FG001|NOT COMPLETED|Second Intervention (Week 24-48)||0
8676253|NCT00773279|9719732|FG000|STARTED|Period 1||121
8676254|NCT00773279|9719733|FG001|STARTED|Period 1||121
8676255|NCT00773279|9719732|FG000|COMPLETED|Period 1||114
8676256|NCT00773279|9719733|FG001|COMPLETED|Period 1||117
8676257|NCT00773279|9719732|FG000|NOT COMPLETED|Period 1||7
8676258|NCT00773279|9719733|FG001|NOT COMPLETED|Period 1||4
8676259|NCT00773279|9719732|FG000|STARTED|Period 2||114
8676260|NCT00773279|9719733|FG001|STARTED|Period 2||117
8676261|NCT00773279|9719732|FG000|COMPLETED|Period 2||111
8676262|NCT00773279|9719733|FG001|COMPLETED|Period 2||111
8676263|NCT00773279|9719732|FG000|NOT COMPLETED|Period 2||3
8676264|NCT00773279|9719733|FG001|NOT COMPLETED|Period 2||6
8676265|NCT00773292|9719740|FG000|STARTED|Pre-treatment 4 Weeks||7
8676266|NCT00773292|9719740|FG000|COMPLETED|Pre-treatment 4 Weeks||7
8676267|NCT00773292|9719740|FG000|NOT COMPLETED|Pre-treatment 4 Weeks||0
8676268|NCT00773292|9719740|FG000|STARTED|Treatment 48 Weeks||7
8676269|NCT00773292|9719740|FG000|COMPLETED|Treatment 48 Weeks|Two patients discontinued the treatment but remained on the study|5
8676270|NCT00773292|9719740|FG000|NOT COMPLETED|Treatment 48 Weeks||2
8676271|NCT00773292|9719740|FG000|STARTED|Post Treatment 24 Weeks||7
8676272|NCT00773292|9719740|FG000|COMPLETED|Post Treatment 24 Weeks||7
8676273|NCT00773292|9719740|FG000|NOT COMPLETED|Post Treatment 24 Weeks||0
8676274|NCT00773370|9719746|FG000|STARTED|Overall Study||43
8676275|NCT00773370|9719747|FG001|STARTED|Overall Study||33
8676276|NCT00773370|9719746|FG000|COMPLETED|Overall Study||25
8676277|NCT00773370|9719747|FG001|COMPLETED|Overall Study||23
8676278|NCT00773370|9719746|FG000|NOT COMPLETED|Overall Study||18
8676279|NCT00773370|9719747|FG001|NOT COMPLETED|Overall Study||10
8676280|NCT00773383|9719753|FG000|STARTED|Overall Study||35
8676281|NCT00773383|9719753|FG000|Received Study Drug|Overall Study||34
8676282|NCT00773383|9719753|FG000|COMPLETED|Overall Study|this includes at the time of clinical cut-off (2/23/2010) there were 4 patients ongoing|4
8676283|NCT00773383|9719753|FG000|NOT COMPLETED|Overall Study||31
8676284|NCT00773422|9719764|FG000|STARTED|Overall Study||11
8676285|NCT00773422|9719765|FG001|STARTED|Overall Study||9
8676286|NCT00773422|9719766|FG002|STARTED|Overall Study||10
8676287|NCT00773422|9719764|FG000|COMPLETED|Overall Study||11
8676288|NCT00773422|9719765|FG001|COMPLETED|Overall Study||9
8676289|NCT00773422|9719766|FG002|COMPLETED|Overall Study||10
8676290|NCT00773422|9719764|FG000|NOT COMPLETED|Overall Study||0
8676291|NCT00773422|9719765|FG001|NOT COMPLETED|Overall Study||0
8676292|NCT00773422|9719766|FG002|NOT COMPLETED|Overall Study||0
8676293|NCT00773461|9719776|FG000|STARTED|Overall Study||70
8676294|NCT00773461|9719777|FG001|STARTED|Overall Study||139
8676295|NCT00773461|9719776|FG000|COMPLETED|Overall Study||65
8676296|NCT00773461|9719777|FG001|COMPLETED|Overall Study||135
8676297|NCT00773461|9719776|FG000|NOT COMPLETED|Overall Study||5
8676298|NCT00773461|9719777|FG001|NOT COMPLETED|Overall Study||4
8676299|NCT00773474|9719784|FG000|STARTED|Overall Study||29
8676300|NCT00773474|9719784|FG000|COMPLETED|Overall Study||29
8676301|NCT00773474|9719784|FG000|NOT COMPLETED|Overall Study||0
8676302|NCT00773513|9719790|FG000|STARTED|Overall Study||1413
8676303|NCT00773513|9719791|FG001|STARTED|Overall Study||1412
8676304|NCT00773513|9719790|FG000|Received Study Treatment|Overall Study||1409
8676305|NCT00773513|9719791|FG001|Received Study Treatment|Overall Study||1409
8676306|NCT00773513|9719790|FG000|COMPLETED|Overall Study||312
8676307|NCT00773513|9719791|FG001|COMPLETED|Overall Study||303
8676308|NCT00773513|9719790|FG000|NOT COMPLETED|Overall Study||1101
8676309|NCT00773513|9719791|FG001|NOT COMPLETED|Overall Study||1109
8676310|NCT00773604|9719797|FG000|STARTED|Overall Study||9
8676311|NCT00773604|9719797|FG000|COMPLETED|Overall Study||9
8676312|NCT00773604|9719797|FG000|NOT COMPLETED|Overall Study||0
8676313|NCT00773734|9719805|FG000|STARTED|Core: Placebo Controlled Phase Week 0-16||88
8676314|NCT00773734|9719806|FG001|STARTED|Core: Placebo Controlled Phase Week 0-16||89
8676315|NCT00773734|9719807|FG002|STARTED|Core: Placebo Controlled Phase Week 0-16||87
8676316|NCT00773734|9719808|FG003|STARTED|Core: Placebo Controlled Phase Week 0-16||88
8676317|NCT00773734|9719809|FG004|STARTED|Core: Placebo Controlled Phase Week 0-16||0
8676318|NCT00773734|9719810|FG005|STARTED|Core: Placebo Controlled Phase Week 0-16||0
8676319|NCT00773734|9719805|FG000|COMPLETED|Core: Placebo Controlled Phase Week 0-16|2 participants completed placebo controlled phase but elected not to continue|72
8676320|NCT00773734|9719806|FG001|COMPLETED|Core: Placebo Controlled Phase Week 0-16|2 participants completed placebo controlled phase but elected not to continue|79
8676321|NCT00773734|9719807|FG002|COMPLETED|Core: Placebo Controlled Phase Week 0-16||66
8676322|NCT00773734|9719808|FG003|COMPLETED|Core: Placebo Controlled Phase Week 0-16|3 participants completed placebo controlled phase but elected not to continue|70
8676323|NCT00773734|9719809|FG004|COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
8676324|NCT00773734|9719810|FG005|COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
8676325|NCT00773734|9719805|FG000|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||16
8676326|NCT00773734|9719806|FG001|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||10
8676327|NCT00773734|9719807|FG002|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||21
8676328|NCT00773734|9719808|FG003|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||18
8676329|NCT00773734|9719809|FG004|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
8676330|NCT00773734|9719810|FG005|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
8676331|NCT00773734|9719805|FG000|STARTED|Core: Active Treatment Phase Week 16-24|Placebo participants were re-randomized at Week 16 to receive apremilast 20mg or 30mg PO BID.|0
8676332|NCT00773734|9719806|FG001|STARTED|Core: Active Treatment Phase Week 16-24|2 participants elected not to continue from previous period|77
8676333|NCT00773734|9719807|FG002|STARTED|Core: Active Treatment Phase Week 16-24||66
8676334|NCT00773734|9719808|FG003|STARTED|Core: Active Treatment Phase Week 16-24|3 participants elected not to continue from previous period|67
8676335|NCT00773734|9719809|FG004|STARTED|Core: Active Treatment Phase Week 16-24||34
8676336|NCT00773734|9719810|FG005|STARTED|Core: Active Treatment Phase Week 16-24||36
8676337|NCT00773734|9719805|FG000|COMPLETED|Core: Active Treatment Phase Week 16-24||0
8676338|NCT00773734|9719806|FG001|COMPLETED|Core: Active Treatment Phase Week 16-24||65
8676339|NCT00773734|9719807|FG002|COMPLETED|Core: Active Treatment Phase Week 16-24||59
8676340|NCT00773734|9719808|FG003|COMPLETED|Core: Active Treatment Phase Week 16-24||65
8676341|NCT00773734|9719809|FG004|COMPLETED|Core: Active Treatment Phase Week 16-24||33
8676342|NCT00773734|9719810|FG005|COMPLETED|Core: Active Treatment Phase Week 16-24||31
8676343|NCT00773734|9719805|FG000|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||0
8676344|NCT00773734|9719806|FG001|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||12
8676345|NCT00773734|9719807|FG002|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||7
8676346|NCT00773734|9719808|FG003|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||2
8676347|NCT00773734|9719809|FG004|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||1
8676348|NCT00773734|9719810|FG005|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||5
8676349|NCT00773734|9719805|FG000|STARTED|Extension: Active Treatment Week 24-52||0
8676350|NCT00773734|9719806|FG001|STARTED|Extension: Active Treatment Week 24-52||47
8676351|NCT00773734|9719807|FG002|STARTED|Extension: Active Treatment Week 24-52||50
8676352|NCT00773734|9719808|FG003|STARTED|Extension: Active Treatment Week 24-52||58
8676353|NCT00773734|9719809|FG004|STARTED|Extension: Active Treatment Week 24-52||27
8676354|NCT00773734|9719810|FG005|STARTED|Extension: Active Treatment Week 24-52||27
8676355|NCT00773734|9719805|FG000|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||0
8676356|NCT00773734|9719806|FG001|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||5
8676357|NCT00773734|9719807|FG002|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||10
8676358|NCT00773734|9719808|FG003|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||10
8676359|NCT00773734|9719809|FG004|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||4
8676360|NCT00773734|9719810|FG005|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||4
8676361|NCT00773734|9719805|FG000|COMPLETED|Extension: Active Treatment Week 24-52||0
8676362|NCT00773734|9719806|FG001|COMPLETED|Extension: Active Treatment Week 24-52|Those dosed APR 10 mg BID in extension study were randomly assigned APR 20 mg or 30 mg BID in LTE|34
8676363|NCT00773734|9719807|FG002|COMPLETED|Extension: Active Treatment Week 24-52||33
8676364|NCT00773734|9719808|FG003|COMPLETED|Extension: Active Treatment Week 24-52||48
8676365|NCT00773734|9719809|FG004|COMPLETED|Extension: Active Treatment Week 24-52||22
8676366|NCT00773734|9719810|FG005|COMPLETED|Extension: Active Treatment Week 24-52||19
8676367|NCT00773734|9719805|FG000|NOT COMPLETED|Extension: Active Treatment Week 24-52||0
8676368|NCT00773734|9719806|FG001|NOT COMPLETED|Extension: Active Treatment Week 24-52||13
8676369|NCT00773734|9719807|FG002|NOT COMPLETED|Extension: Active Treatment Week 24-52||17
8676370|NCT00773734|9719808|FG003|NOT COMPLETED|Extension: Active Treatment Week 24-52||10
8676371|NCT00773734|9719809|FG004|NOT COMPLETED|Extension: Active Treatment Week 24-52||5
8676372|NCT00773734|9719810|FG005|NOT COMPLETED|Extension: Active Treatment Week 24-52||8
8676373|NCT00773734|9719805|FG000|STARTED|LTE Period: Week 52 to 6 Years||0
8676374|NCT00773734|9719806|FG001|STARTED|LTE Period: Week 52 to 6 Years||0
8676375|NCT00773734|9719807|FG002|STARTED|LTE Period: Week 52 to 6 Years|Those dosed APR 10 mg BID in extension study were randomly assigned APR 20 mg or 30 mg BID in LTE|16
8676376|NCT00773734|9719808|FG003|STARTED|LTE Period: Week 52 to 6 Years|Those dosed APR 10 mg BID in extension study were randomly assigned APR 20 mg or 30 mg BID in LTE|17
8676377|NCT00773734|9719809|FG004|STARTED|LTE Period: Week 52 to 6 Years||0
8676378|NCT00773734|9719810|FG005|STARTED|LTE Period: Week 52 to 6 Years||0
8676379|NCT00773734|9719805|FG000|COMPLETED|LTE Period: Week 52 to 6 Years||0
8676380|NCT00773734|9719806|FG001|COMPLETED|LTE Period: Week 52 to 6 Years||0
8676381|NCT00773734|9719807|FG002|COMPLETED|LTE Period: Week 52 to 6 Years|Completed = Completed Long Term Extension study|4
8692787|NCT00862849|9738281|FG003|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
8918909|NCT02204293|9978947|FG003|COMPLETED|Core Study Part 2||4
8918910|NCT02204293|9978948|FG004|COMPLETED|Core Study Part 2||7
8918911|NCT02204293|9978949|FG005|COMPLETED|Core Study Part 2||0
8918912|NCT02204293|9978944|FG000|NOT COMPLETED|Core Study Part 2||0
8918913|NCT02204293|9978945|FG001|NOT COMPLETED|Core Study Part 2||0
8918914|NCT02204293|9978946|FG002|NOT COMPLETED|Core Study Part 2||0
8918915|NCT02204293|9978947|FG003|NOT COMPLETED|Core Study Part 2||0
8918916|NCT02204293|9978948|FG004|NOT COMPLETED|Core Study Part 2||0
8918917|NCT02204293|9978949|FG005|NOT COMPLETED|Core Study Part 2||0
8918918|NCT02204293|9978944|FG000|STARTED|LTE Phase||0
8918919|NCT02204293|9978945|FG001|STARTED|LTE Phase||0
8918920|NCT02204293|9978946|FG002|STARTED|LTE Phase||0
8918921|NCT02204293|9978947|FG003|STARTED|LTE Phase||0
8918922|NCT02204293|9978948|FG004|STARTED|LTE Phase||0
8918923|NCT02204293|9978949|FG005|STARTED|LTE Phase||7
8918924|NCT02204293|9978944|FG000|COMPLETED|LTE Phase||0
8918925|NCT02204293|9978945|FG001|COMPLETED|LTE Phase||0
8918926|NCT02204293|9978946|FG002|COMPLETED|LTE Phase||0
8918927|NCT02204293|9978947|FG003|COMPLETED|LTE Phase||0
8918928|NCT02204293|9978948|FG004|COMPLETED|LTE Phase||0
8918929|NCT02204293|9978949|FG005|COMPLETED|LTE Phase||0
8918930|NCT02204293|9978944|FG000|NOT COMPLETED|LTE Phase||0
8918931|NCT02204293|9978945|FG001|NOT COMPLETED|LTE Phase||0
8918932|NCT02204293|9978946|FG002|NOT COMPLETED|LTE Phase||0
8918933|NCT02204293|9978947|FG003|NOT COMPLETED|LTE Phase||0
8918934|NCT02204293|9978948|FG004|NOT COMPLETED|LTE Phase||0
8918935|NCT02204293|9978949|FG005|NOT COMPLETED|LTE Phase||7
8918936|NCT02204319|9978963|FG000|STARTED|Overall Study||10
8918937|NCT02204319|9978963|FG000|COMPLETED|Overall Study|3 did not complete study.|7
8918938|NCT02204319|9978963|FG000|NOT COMPLETED|Overall Study||3
8918939|NCT02204371|9978968|FG000|STARTED|Overall Study||7
8918940|NCT02204371|9978968|FG000|COMPLETED|Overall Study||6
8918941|NCT02204371|9978968|FG000|NOT COMPLETED|Overall Study||1
8918942|NCT02204410|9978972|FG000|STARTED|Overall Study||21
8918943|NCT02204410|9978972|FG000|COMPLETED|Overall Study||10
8918944|NCT02204410|9978972|FG000|NOT COMPLETED|Overall Study||11
8918945|NCT02204449|9978978|FG000|STARTED|Overall Study||46
8918946|NCT02204449|9978979|FG001|STARTED|Overall Study||48
8676382|NCT00773734|9719808|FG003|COMPLETED|LTE Period: Week 52 to 6 Years|Completed = Completed Long Term Extension study|5
8676383|NCT00773734|9719809|FG004|COMPLETED|LTE Period: Week 52 to 6 Years||0
8676384|NCT00773734|9719810|FG005|COMPLETED|LTE Period: Week 52 to 6 Years||0
8676385|NCT00773734|9719805|FG000|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
8676386|NCT00773734|9719806|FG001|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
8676387|NCT00773734|9719807|FG002|NOT COMPLETED|LTE Period: Week 52 to 6 Years||12
8676388|NCT00773734|9719808|FG003|NOT COMPLETED|LTE Period: Week 52 to 6 Years||12
8676389|NCT00773734|9719809|FG004|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
8676390|NCT00773734|9719810|FG005|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
8676391|NCT00773747|9719869|FG000|STARTED|Overall Study||317
8676392|NCT00773747|9719870|FG001|STARTED|Overall Study||320
8676393|NCT00773747|9719869|FG000|Treated|Overall Study||315
8676394|NCT00773747|9719870|FG001|Treated|Overall Study||320
8676395|NCT00773747|9719869|FG000|COMPLETED|Overall Study||20
8676396|NCT00773747|9719870|FG001|COMPLETED|Overall Study||24
8676397|NCT00773747|9719869|FG000|NOT COMPLETED|Overall Study||297
8676398|NCT00773747|9719870|FG001|NOT COMPLETED|Overall Study||296
8676399|NCT00773786|9719876|FG000|STARTED|First Intervention (1 Week)||10
8676400|NCT00773786|9719877|FG001|STARTED|First Intervention (1 Week)||10
8676401|NCT00773786|9719876|FG000|COMPLETED|First Intervention (1 Week)||10
8676402|NCT00773786|9719877|FG001|COMPLETED|First Intervention (1 Week)||10
8676403|NCT00773786|9719876|FG000|NOT COMPLETED|First Intervention (1 Week)||0
8799658|NCT01439074|9851232|FG000|NOT COMPLETED|Overall Study||9
8799659|NCT01439074|9851233|FG001|NOT COMPLETED|Overall Study||13
8799660|NCT01439087|9851239|FG000|STARTED|Overall Study||2
8799661|NCT01439087|9851239|FG000|COMPLETED|Overall Study||2
8799662|NCT01439087|9851239|FG000|NOT COMPLETED|Overall Study||0
8799663|NCT01439126|9851245|FG000|STARTED|Overall Study||68
8799664|NCT01439126|9851246|FG001|STARTED|Overall Study||67
8799665|NCT01439126|9851245|FG000|COMPLETED|Overall Study||37
8799666|NCT01439126|9851246|FG001|COMPLETED|Overall Study||25
8799667|NCT01439126|9851245|FG000|NOT COMPLETED|Overall Study||31
8799668|NCT01439126|9851246|FG001|NOT COMPLETED|Overall Study||42
8799669|NCT01439204|9851254|FG000|STARTED|Overall Study||36
8799670|NCT01439204|9851255|FG001|STARTED|Overall Study||36
8799671|NCT01439204|9851254|FG000|COMPLETED|Overall Study||32
8799672|NCT01439204|9851255|FG001|COMPLETED|Overall Study||33
8799673|NCT01439204|9851254|FG000|NOT COMPLETED|Overall Study||4
8799674|NCT01439204|9851255|FG001|NOT COMPLETED|Overall Study||3
8799675|NCT01439282|9851263|FG000|STARTED|Overall Study||67
8799676|NCT01439282|9851264|FG001|STARTED|Overall Study||10
8799677|NCT01439282|9851263|FG000|COMPLETED|Overall Study||59
8799678|NCT01439282|9851264|FG001|COMPLETED|Overall Study||9
8799679|NCT01439282|9851263|FG000|NOT COMPLETED|Overall Study||8
8799680|NCT01439282|9851264|FG001|NOT COMPLETED|Overall Study||1
8799681|NCT01439360|9851273|FG000|STARTED|Overall Study||6006
8799682|NCT01439360|9851274|FG001|STARTED|Overall Study||6012
8799683|NCT01439360|9851273|FG000|COMPLETED|Overall Study||5808
8799684|NCT01439360|9851274|FG001|COMPLETED|Overall Study||5804
8799685|NCT01439360|9851273|FG000|NOT COMPLETED|Overall Study||198
8799686|NCT01439360|9851274|FG001|NOT COMPLETED|Overall Study||208
8799687|NCT01439373|9851282|FG000|STARTED|Monotherapy (Day 1)||11
8799688|NCT01439373|9851283|FG001|STARTED|Monotherapy (Day 1)||5
8799689|NCT01439373|9851282|FG000|COMPLETED|Monotherapy (Day 1)||11
8799690|NCT01439373|9851283|FG001|COMPLETED|Monotherapy (Day 1)||4
8799691|NCT01439373|9851282|FG000|NOT COMPLETED|Monotherapy (Day 1)||0
8799692|NCT01439373|9851283|FG001|NOT COMPLETED|Monotherapy (Day 1)||1
8799693|NCT01439373|9851282|FG000|STARTED|Combined With PEG and RIBA (Day 2 to 28)||11
8799694|NCT01439373|9851283|FG001|STARTED|Combined With PEG and RIBA (Day 2 to 28)||4
8799695|NCT01439373|9851282|FG000|COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||9
8799696|NCT01439373|9851283|FG001|COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||4
8799697|NCT01439373|9851282|FG000|NOT COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||2
8799698|NCT01439373|9851283|FG001|NOT COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||0
8799699|NCT01439555|9851293|FG000|STARTED|Overall Study||11
8799700|NCT01439555|9851293|FG000|COMPLETED|Overall Study||10
8799701|NCT01439555|9851293|FG000|NOT COMPLETED|Overall Study||1
8799702|NCT01439568|9851299|FG000|STARTED|Overall Study||47
8799703|NCT01439568|9851300|FG001|STARTED|Overall Study||43
8799704|NCT01439568|9851299|FG000|Received at Least One Dose of Study Drug|Overall Study||47
8799705|NCT01439568|9851300|FG001|Received at Least One Dose of Study Drug|Overall Study||43
8799706|NCT01439568|9851299|FG000|COMPLETED|Overall Study||44
8799707|NCT01439568|9851300|FG001|COMPLETED|Overall Study||41
8799708|NCT01439568|9851299|FG000|NOT COMPLETED|Overall Study||3
8799709|NCT01439568|9851300|FG001|NOT COMPLETED|Overall Study||2
8799710|NCT01439581|9851308|FG000|STARTED|Overall Study||216
8799711|NCT01439581|9851309|FG001|STARTED|Overall Study||212
8799712|NCT01439581|9851308|FG000|COMPLETED|Overall Study||216
8799713|NCT01439581|9851309|FG001|COMPLETED|Overall Study||212
8799714|NCT01439581|9851308|FG000|NOT COMPLETED|Overall Study||0
8799715|NCT01439581|9851309|FG001|NOT COMPLETED|Overall Study||0
8799716|NCT01439594|9851315|FG000|STARTED|Overall Study||17
8799717|NCT01439594|9851315|FG000|COMPLETED|Overall Study||17
8799718|NCT01439594|9851315|FG000|NOT COMPLETED|Overall Study||0
8799719|NCT01439620|9851319|FG000|STARTED|Overall Study||7
8799720|NCT01439620|9851319|FG000|COMPLETED|Overall Study||7
8799721|NCT01439620|9851319|FG000|NOT COMPLETED|Overall Study||0
8799722|NCT01439633|9851323|FG000|STARTED|Overall Study||22
8676404|NCT00773786|9719877|FG001|NOT COMPLETED|First Intervention (1 Week)||0
8676405|NCT00773786|9719876|FG000|STARTED|Washout (1 Week)||10
8676406|NCT00773786|9719877|FG001|STARTED|Washout (1 Week)||10
8676407|NCT00773786|9719876|FG000|COMPLETED|Washout (1 Week)||10
8676408|NCT00773786|9719877|FG001|COMPLETED|Washout (1 Week)||10
8676409|NCT00773786|9719876|FG000|NOT COMPLETED|Washout (1 Week)||0
8676410|NCT00773786|9719877|FG001|NOT COMPLETED|Washout (1 Week)||0
8676411|NCT00773786|9719876|FG000|STARTED|Second Intervention (1 Week)||10
8676412|NCT00773786|9719877|FG001|STARTED|Second Intervention (1 Week)||10
8676413|NCT00773786|9719876|FG000|COMPLETED|Second Intervention (1 Week)||10
8676414|NCT00773786|9719877|FG001|COMPLETED|Second Intervention (1 Week)||10
8676415|NCT00773786|9719876|FG000|NOT COMPLETED|Second Intervention (1 Week)||0
8676416|NCT00773786|9719877|FG001|NOT COMPLETED|Second Intervention (1 Week)||0
8676417|NCT00773838|9719884|FG000|STARTED|Overall Study||143
8676418|NCT00773838|9719884|FG000|COMPLETED|Overall Study||0
8676419|NCT00773838|9719884|FG000|NOT COMPLETED|Overall Study||143
8676420|NCT00773955|9719888|FG000|STARTED|Overall Study||15
8676421|NCT00773955|9719888|FG000|COMPLETED|Overall Study||15
8676422|NCT00773955|9719888|FG000|NOT COMPLETED|Overall Study||0
8676423|NCT00773968|9719892|FG000|STARTED|Overall Study||140
8676424|NCT00773968|9719892|FG000|Treated|Overall Study||111
8676425|NCT00773968|9719892|FG000|COMPLETED|Overall Study||95
8676426|NCT00773968|9719892|FG000|NOT COMPLETED|Overall Study||45
8676427|NCT00774046|9719896|FG000|STARTED|Screening||116
8676428|NCT00774046|9719896|FG000|COMPLETED|Screening||60
8676429|NCT00774046|9719896|FG000|NOT COMPLETED|Screening||56
8676430|NCT00774046|9719896|FG000|STARTED|Enrollment||60
8676431|NCT00774046|9719896|FG000|COMPLETED|Enrollment||32
8676432|NCT00774046|9719896|FG000|NOT COMPLETED|Enrollment||28
8676433|NCT00774046|9719896|FG000|STARTED|Induction Therapy||32
8676434|NCT00774046|9719896|FG000|COMPLETED|Induction Therapy||32
8676435|NCT00774046|9719896|FG000|NOT COMPLETED|Induction Therapy||0
8676436|NCT00774046|9719896|FG000|STARTED|Stem Cell Mobilization|For mobilization, the patient must have had a CR and not been a candidate for allogeneic transplant|10
8676437|NCT00774046|9719896|FG000|COMPLETED|Stem Cell Mobilization||7
8676438|NCT00774046|9719896|FG000|NOT COMPLETED|Stem Cell Mobilization||3
8676439|NCT00774046|9719896|FG000|STARTED|Autologous Transplant|2 patients died in remission and 1 relapsed without having received transplant|4
8676440|NCT00774046|9719896|FG000|COMPLETED|Autologous Transplant||4
8676441|NCT00774046|9719896|FG000|NOT COMPLETED|Autologous Transplant||0
8676442|NCT00774163|9719902|FG000|STARTED|Overall Study||30
8676443|NCT00774163|9719903|FG001|STARTED|Overall Study||15
8676444|NCT00774163|9719902|FG000|COMPLETED|Overall Study||30
8676445|NCT00774163|9719903|FG001|COMPLETED|Overall Study||15
8676446|NCT00774163|9719902|FG000|NOT COMPLETED|Overall Study||0
8676447|NCT00774163|9719903|FG001|NOT COMPLETED|Overall Study||0
8676448|NCT00774202|9719911|FG000|STARTED|Overall Study||9
8676449|NCT00774202|9719912|FG001|STARTED|Overall Study||8
8676450|NCT00774202|9719911|FG000|COMPLETED|Overall Study||9
8676451|NCT00774202|9719912|FG001|COMPLETED|Overall Study||8
8676452|NCT00774202|9719911|FG000|NOT COMPLETED|Overall Study||0
8676453|NCT00774202|9719912|FG001|NOT COMPLETED|Overall Study||0
8676454|NCT00774267|9719926|FG000|STARTED|Overall Study||132
8676455|NCT00774267|9719927|FG001|STARTED|Overall Study||111
8676456|NCT00774267|9719928|FG002|STARTED|Overall Study||129
8676457|NCT00774267|9719929|FG003|STARTED|Overall Study||135
8676458|NCT00774267|9719926|FG000|COMPLETED|Overall Study||132
8676459|NCT00774267|9719927|FG001|COMPLETED|Overall Study||111
8676460|NCT00774267|9719928|FG002|COMPLETED|Overall Study||129
8676461|NCT00774267|9719929|FG003|COMPLETED|Overall Study||135
8676462|NCT00774267|9719926|FG000|NOT COMPLETED|Overall Study||0
8676463|NCT00774267|9719927|FG001|NOT COMPLETED|Overall Study||0
8676464|NCT00774267|9719928|FG002|NOT COMPLETED|Overall Study||0
8676465|NCT00774267|9719929|FG003|NOT COMPLETED|Overall Study||0
8676466|NCT00774397|9719946|FG000|STARTED|Overall Study||71
8676467|NCT00774397|9719947|FG001|STARTED|Overall Study||69
8676468|NCT00774397|9719948|FG002|STARTED|Overall Study||143
8676469|NCT00774397|9719949|FG003|STARTED|Overall Study||146
8676470|NCT00774397|9719950|FG004|STARTED|Overall Study||143
8676471|NCT00774397|9719951|FG005|STARTED|Overall Study||76
8676472|NCT00774397|9719952|FG006|STARTED|Overall Study||71
8676473|NCT00774397|9719946|FG000|COMPLETED|Overall Study||57
8676474|NCT00774397|9719947|FG001|COMPLETED|Overall Study||56
8676475|NCT00774397|9719948|FG002|COMPLETED|Overall Study||113
8676476|NCT00774397|9719949|FG003|COMPLETED|Overall Study||129
8676477|NCT00774397|9719950|FG004|COMPLETED|Overall Study||97
8676478|NCT00774397|9719951|FG005|COMPLETED|Overall Study||54
8676479|NCT00774397|9719952|FG006|COMPLETED|Overall Study||41
8676480|NCT00774397|9719946|FG000|NOT COMPLETED|Overall Study||14
8676481|NCT00774397|9719947|FG001|NOT COMPLETED|Overall Study||13
8676482|NCT00774397|9719948|FG002|NOT COMPLETED|Overall Study||30
8676483|NCT00774397|9719949|FG003|NOT COMPLETED|Overall Study||17
8676484|NCT00774397|9719950|FG004|NOT COMPLETED|Overall Study||46
8676485|NCT00774397|9719951|FG005|NOT COMPLETED|Overall Study||22
8676486|NCT00774397|9719952|FG006|NOT COMPLETED|Overall Study||30
8676487|NCT00774566|9719977|FG000|STARTED|Overall Study||159
8676488|NCT00774566|9719978|FG001|STARTED|Overall Study||156
8676489|NCT00774566|9719977|FG000|6 Month Follow up|Overall Study||154
8676490|NCT00774566|9719978|FG001|6 Month Follow up|Overall Study||150
8676491|NCT00774566|9719977|FG000|12 Month Follow up|Overall Study||141
8676492|NCT00774566|9719978|FG001|12 Month Follow up|Overall Study||141
8676493|NCT00774566|9719977|FG000|COMPLETED|Overall Study||141
8676494|NCT00774566|9719978|FG001|COMPLETED|Overall Study||141
8676495|NCT00774566|9719977|FG000|NOT COMPLETED|Overall Study||18
8676496|NCT00774566|9719978|FG001|NOT COMPLETED|Overall Study||15
8676497|NCT00774579|9719986|FG000|STARTED|Overall Study||9
8676498|NCT00774579|9719987|FG001|STARTED|Overall Study||9
8676499|NCT00774579|9719986|FG000|COMPLETED|Overall Study||9
8676500|NCT00774579|9719987|FG001|COMPLETED|Overall Study||9
8676501|NCT00774579|9719986|FG000|NOT COMPLETED|Overall Study||0
8676502|NCT00774579|9719987|FG001|NOT COMPLETED|Overall Study||0
8676503|NCT00774748|9719993|FG000|STARTED|Overall Study||21
8676504|NCT00774748|9719993|FG000|COMPLETED|Overall Study||18
8676505|NCT00774748|9719993|FG000|NOT COMPLETED|Overall Study||3
8676506|NCT00774787|9720001|FG000|STARTED|Overall Study||27
8676507|NCT00774787|9720001|FG000|COMPLETED|Overall Study||26
8676508|NCT00774787|9720001|FG000|NOT COMPLETED|Overall Study||1
8676509|NCT00774800|9720005|FG000|STARTED|Intervention 1||22
8676510|NCT00774800|9720005|FG000|Received at Least One Dose of Study Drug|Intervention 1||22
8676511|NCT00774800|9720005|FG000|COMPLETED|Intervention 1||22
8676512|NCT00774800|9720005|FG000|NOT COMPLETED|Intervention 1||0
8676513|NCT00774800|9720005|FG000|STARTED|Washout (3 to 10 Days)||22
8676514|NCT00774800|9720005|FG000|COMPLETED|Washout (3 to 10 Days)||22
8676515|NCT00774800|9720005|FG000|NOT COMPLETED|Washout (3 to 10 Days)||0
8676516|NCT00774800|9720005|FG000|STARTED|Intervention 2||22
8676517|NCT00774800|9720005|FG000|Received at Least One Dose of Study Drug|Intervention 2||22
8676518|NCT00774800|9720005|FG000|COMPLETED|Intervention 2||22
8676519|NCT00774800|9720005|FG000|NOT COMPLETED|Intervention 2||0
8676520|NCT00774800|9720005|FG000|STARTED|Washout (3 to 10 Days)||22
8676521|NCT00774800|9720005|FG000|COMPLETED|Washout (3 to 10 Days)||22
8676522|NCT00774800|9720005|FG000|NOT COMPLETED|Washout (3 to 10 Days)||0
8676523|NCT00774800|9720005|FG000|STARTED|Intervention 3||22
8676524|NCT00774800|9720005|FG000|Received at Least One Dose of Study Drug|Intervention 3||22
8676525|NCT00774800|9720005|FG000|COMPLETED|Intervention 3||22
8676526|NCT00774800|9720005|FG000|NOT COMPLETED|Intervention 3||0
8676527|NCT00774800|9720005|FG000|STARTED|Washout (3 to 10 Days)||22
8676528|NCT00774800|9720005|FG000|COMPLETED|Washout (3 to 10 Days)||22
8676529|NCT00774800|9720005|FG000|NOT COMPLETED|Washout (3 to 10 Days)||0
8676530|NCT00774800|9720005|FG000|STARTED|Intervention 4||22
8676531|NCT00774800|9720005|FG000|Received at Least One Dose of Study Drug|Intervention 4||21
8676532|NCT00774800|9720005|FG000|COMPLETED|Intervention 4||21
8676533|NCT00774800|9720005|FG000|NOT COMPLETED|Intervention 4||1
8676534|NCT00774852|9720017|FG000|STARTED|Overall Study||69
8676535|NCT00774852|9720018|FG001|STARTED|Overall Study||68
8676536|NCT00774852|9720017|FG000|COMPLETED|Overall Study||24
8676537|NCT00774852|9720018|FG001|COMPLETED|Overall Study||27
8676538|NCT00774852|9720017|FG000|NOT COMPLETED|Overall Study||45
8676539|NCT00774852|9720018|FG001|NOT COMPLETED|Overall Study||41
8676540|NCT00774930|9720036|FG000|STARTED|DB Phase|One subject was randomised to receive lanreotide Autogel, but erroneously received placebo.|59
8676541|NCT00774930|9720037|FG001|STARTED|DB Phase|One subject was randomised to receive lanreotide Autogel, but erroneously received placebo.|56
8676542|NCT00774930|9720036|FG000|COMPLETED|DB Phase|Received 4 DB study injections AND continued to IOL phase OR|45
8676543|NCT00774930|9720037|FG001|COMPLETED|DB Phase|had diary data at least up to day 21 after 4th dose, regardless of missing diary data before day 21.|34
8676544|NCT00774930|9720036|FG000|NOT COMPLETED|DB Phase||14
8676545|NCT00774930|9720037|FG001|NOT COMPLETED|DB Phase||22
8676546|NCT00774930|9720036|FG000|STARTED|IOL Phase||56
8676547|NCT00774930|9720037|FG001|STARTED|IOL Phase|Includes 1 subject listed as completing and withdrawing from the DB phase due to brain radiation|46
8676548|NCT00774930|9720036|FG000|COMPLETED|IOL Phase||43
8676549|NCT00774930|9720037|FG001|COMPLETED|IOL Phase||37
8676550|NCT00774930|9720036|FG000|NOT COMPLETED|IOL Phase||13
8676551|NCT00774930|9720037|FG001|NOT COMPLETED|IOL Phase||9
8676552|NCT00774930|9720036|FG000|STARTED|LTOLE Phase|24 subjects from IOL did not enter LTOLE (11 completed IOL, 13 did not complete IOL).|32
8676553|NCT00774930|9720037|FG001|STARTED|LTOLE Phase|20 subjects from IOL did not enter LTOLE (12 completed IOL, 8 did not complete IOL).|25
8676554|NCT00774930|9720036|FG000|COMPLETED|LTOLE Phase||17
8676555|NCT00774930|9720037|FG001|COMPLETED|LTOLE Phase||8
8676556|NCT00774930|9720036|FG000|NOT COMPLETED|LTOLE Phase||15
8676557|NCT00774930|9720037|FG001|NOT COMPLETED|LTOLE Phase||17
8676558|NCT00774995|9720049|FG000|STARTED|Overall Study||9
8676559|NCT00774995|9720050|FG001|STARTED|Overall Study||16
8676560|NCT00774995|9720051|FG002|STARTED|Overall Study||8
8676561|NCT00774995|9720052|FG003|STARTED|Overall Study||16
8676562|NCT00774995|9720049|FG000|COMPLETED|Overall Study||9
8676563|NCT00774995|9720050|FG001|COMPLETED|Overall Study||16
8676564|NCT00774995|9720051|FG002|COMPLETED|Overall Study||7
8676565|NCT00774995|9720052|FG003|COMPLETED|Overall Study||16
8676566|NCT00774995|9720049|FG000|NOT COMPLETED|Overall Study||0
8676567|NCT00774995|9720050|FG001|NOT COMPLETED|Overall Study||0
8676568|NCT00774995|9720051|FG002|NOT COMPLETED|Overall Study||1
8676569|NCT00774995|9720052|FG003|NOT COMPLETED|Overall Study||0
8676570|NCT00775021|9720062|FG000|STARTED|First Intervention||63
8676571|NCT00775021|9720063|FG001|STARTED|First Intervention||60
8676572|NCT00775021|9720062|FG000|COMPLETED|First Intervention||62
8676573|NCT00775021|9720063|FG001|COMPLETED|First Intervention||60
8676574|NCT00775021|9720062|FG000|NOT COMPLETED|First Intervention||1
8676575|NCT00775021|9720063|FG001|NOT COMPLETED|First Intervention||0
8676576|NCT00775021|9720062|FG000|STARTED|Second Intervention||62
8676577|NCT00775021|9720063|FG001|STARTED|Second Intervention||60
8676578|NCT00775021|9720062|FG000|COMPLETED|Second Intervention||62
8676579|NCT00775021|9720063|FG001|COMPLETED|Second Intervention||59
8676580|NCT00775021|9720062|FG000|NOT COMPLETED|Second Intervention||0
8676581|NCT00775021|9720063|FG001|NOT COMPLETED|Second Intervention||1
8676582|NCT00775138|9720073|FG000|STARTED|Overall Study||24
8676583|NCT00775138|9720074|FG001|STARTED|Overall Study||10
8676584|NCT00775138|9720075|FG002|STARTED|Overall Study||20
8676585|NCT00775138|9720076|FG003|STARTED|Overall Study||10
8676586|NCT00775138|9720073|FG000|COMPLETED|Overall Study||24
8676587|NCT00775138|9720074|FG001|COMPLETED|Overall Study||10
8676588|NCT00775138|9720075|FG002|COMPLETED|Overall Study||17
8676589|NCT00775138|9720076|FG003|COMPLETED|Overall Study||8
8676590|NCT00775138|9720073|FG000|NOT COMPLETED|Overall Study||0
8676591|NCT00775138|9720074|FG001|NOT COMPLETED|Overall Study||0
8676592|NCT00775138|9720075|FG002|NOT COMPLETED|Overall Study||3
8676593|NCT00775138|9720076|FG003|NOT COMPLETED|Overall Study||2
8676594|NCT00775203|9720090|FG000|STARTED|Overall Study||206
8676595|NCT00775203|9720091|FG001|STARTED|Overall Study||206
8676596|NCT00775203|9720090|FG000|Received Study Medication|Overall Study||202
8676597|NCT00775203|9720091|FG001|Received Study Medication|Overall Study||204
8676598|NCT00775203|9720090|FG000|COMPLETED|Overall Study||144
8676599|NCT00775203|9720091|FG001|COMPLETED|Overall Study||163
8676600|NCT00775203|9720090|FG000|NOT COMPLETED|Overall Study||62
8676601|NCT00775203|9720091|FG001|NOT COMPLETED|Overall Study||43
8676602|NCT00775229|9720099|FG000|STARTED|Overall Study||25
8676603|NCT00775229|9720100|FG001|STARTED|Overall Study||26
8676604|NCT00775229|9720099|FG000|COMPLETED|Overall Study||20
8676605|NCT00775229|9720100|FG001|COMPLETED|Overall Study||24
8676606|NCT00775229|9720099|FG000|NOT COMPLETED|Overall Study||5
8676607|NCT00775229|9720100|FG001|NOT COMPLETED|Overall Study||2
8676608|NCT00775268|9720108|FG000|STARTED|Baseline||9
8676609|NCT00775268|9720109|FG001|STARTED|Baseline||22
8676610|NCT00775268|9720108|FG000|COMPLETED|Baseline||8
8676611|NCT00775268|9720109|FG001|COMPLETED|Baseline||21
8676612|NCT00775268|9720108|FG000|NOT COMPLETED|Baseline||1
8676613|NCT00775268|9720109|FG001|NOT COMPLETED|Baseline||1
8676614|NCT00775268|9720108|FG000|STARTED|After 2 Cycles||8
8676615|NCT00775268|9720109|FG001|STARTED|After 2 Cycles|These 21 patients were not scanned after 2-cycles in this Arm. They were only scanned at baseline.|0
8676616|NCT00775268|9720108|FG000|COMPLETED|After 2 Cycles||7
8676617|NCT00775268|9720109|FG001|COMPLETED|After 2 Cycles||0
8676618|NCT00775268|9720108|FG000|NOT COMPLETED|After 2 Cycles||1
8676619|NCT00775268|9720109|FG001|NOT COMPLETED|After 2 Cycles||0
8676620|NCT00775268|9720108|FG000|STARTED|After Completion||7
8676621|NCT00775268|9720109|FG001|STARTED|After Completion||0
8676622|NCT00775268|9720108|FG000|COMPLETED|After Completion||6
8676623|NCT00775268|9720109|FG001|COMPLETED|After Completion||0
8676624|NCT00775268|9720108|FG000|NOT COMPLETED|After Completion||1
8676625|NCT00775268|9720109|FG001|NOT COMPLETED|After Completion||0
8676626|NCT00775346|9720126|FG000|STARTED|Overall Study||92
8676627|NCT00775346|9720126|FG000|COMPLETED|Overall Study||92
8676628|NCT00775346|9720126|FG000|NOT COMPLETED|Overall Study||0
8676629|NCT00775411|9720130|FG000|STARTED|Overall Study||44
8676630|NCT00775411|9720130|FG000|COMPLETED|Overall Study||43
8676631|NCT00775411|9720130|FG000|NOT COMPLETED|Overall Study||1
8676632|NCT00775437|9720134|FG000|STARTED|Overall Study||32
8676633|NCT00775437|9720134|FG000|COMPLETED|Overall Study||26
8676634|NCT00775437|9720134|FG000|NOT COMPLETED|Overall Study||6
8676635|NCT00775450|9720143|FG000|STARTED|Overall Study||295
8676636|NCT00775450|9720144|FG001|STARTED|Overall Study||98
8676637|NCT00775450|9720145|FG002|STARTED|Overall Study||105
8676638|NCT00775450|9720146|FG003|STARTED|Overall Study||108
8676639|NCT00775450|9720147|FG004|STARTED|Overall Study||201
8676640|NCT00775450|9720143|FG000|COMPLETED|Overall Study||292
8676641|NCT00775450|9720144|FG001|COMPLETED|Overall Study||98
8676642|NCT00775450|9720145|FG002|COMPLETED|Overall Study||105
8676643|NCT00775450|9720146|FG003|COMPLETED|Overall Study||108
8676644|NCT00775450|9720147|FG004|COMPLETED|Overall Study||199
8676645|NCT00775450|9720143|FG000|NOT COMPLETED|Overall Study||3
8676646|NCT00775450|9720144|FG001|NOT COMPLETED|Overall Study||0
8676647|NCT00775450|9720145|FG002|NOT COMPLETED|Overall Study||0
8676648|NCT00775450|9720146|FG003|NOT COMPLETED|Overall Study||0
8676649|NCT00775450|9720147|FG004|NOT COMPLETED|Overall Study||2
8676650|NCT00775463|9720161|FG000|STARTED|Overall Study||76
8676651|NCT00775463|9720162|FG001|STARTED|Overall Study||72
8676652|NCT00775463|9720161|FG000|COMPLETED|Overall Study||65
8676653|NCT00775463|9720162|FG001|COMPLETED|Overall Study||59
8676654|NCT00775463|9720161|FG000|NOT COMPLETED|Overall Study||11
8676655|NCT00775463|9720162|FG001|NOT COMPLETED|Overall Study||13
8676656|NCT00775528|9720175|FG000|STARTED|Overall Study|Started means number of patients who consented|19
8676657|NCT00775528|9720175|FG000|COMPLETED|Overall Study||18
8676658|NCT00775528|9720175|FG000|NOT COMPLETED|Overall Study||1
8676659|NCT00775593|9720179|FG000|STARTED|Overall Study||60
8676660|NCT00775593|9720179|FG000|COMPLETED|Overall Study||53
8799723|NCT01439633|9851323|FG000|COMPLETED|Overall Study||22
8676661|NCT00775593|9720179|FG000|NOT COMPLETED|Overall Study||7
8676662|NCT00775606|9720185|FG000|STARTED|Overall Study||8
8676663|NCT00775606|9720186|FG001|STARTED|Overall Study||5
8676664|NCT00775606|9720185|FG000|COMPLETED|Overall Study||5
8676665|NCT00775606|9720186|FG001|COMPLETED|Overall Study||5
8676666|NCT00775606|9720185|FG000|NOT COMPLETED|Overall Study||3
8676667|NCT00775606|9720186|FG001|NOT COMPLETED|Overall Study||0
8676668|NCT00775645|9720196|FG000|STARTED|Overall Study||208
8676669|NCT00775645|9720197|FG001|STARTED|Overall Study||201
8676670|NCT00775645|9720196|FG000|COMPLETED|Overall Study||191
8676671|NCT00775645|9720197|FG001|COMPLETED|Overall Study||181
8676672|NCT00775645|9720196|FG000|NOT COMPLETED|Overall Study||17
8676673|NCT00775645|9720197|FG001|NOT COMPLETED|Overall Study||20
8676674|NCT00775658|9720203|FG000|STARTED|First Intervention||10
8676675|NCT00775658|9720204|FG001|STARTED|First Intervention||11
8676676|NCT00775658|9720203|FG000|COMPLETED|First Intervention||10
8676677|NCT00775658|9720204|FG001|COMPLETED|First Intervention||11
8676678|NCT00775658|9720203|FG000|NOT COMPLETED|First Intervention||0
8676679|NCT00775658|9720204|FG001|NOT COMPLETED|First Intervention||0
8676680|NCT00775658|9720203|FG000|STARTED|Second Intervention||10
8676681|NCT00775658|9720204|FG001|STARTED|Second Intervention||11
8676682|NCT00775658|9720203|FG000|COMPLETED|Second Intervention||10
8676683|NCT00775658|9720204|FG001|COMPLETED|Second Intervention||11
8676684|NCT00775658|9720203|FG000|NOT COMPLETED|Second Intervention||0
8676685|NCT00775658|9720204|FG001|NOT COMPLETED|Second Intervention||0
8676686|NCT00775671|9720212|FG000|STARTED|Overall Study||23
8676687|NCT00775671|9720213|FG001|STARTED|Overall Study||23
8676688|NCT00775671|9720212|FG000|COMPLETED|Overall Study||23
8676689|NCT00775671|9720213|FG001|COMPLETED|Overall Study||23
8676690|NCT00775671|9720212|FG000|NOT COMPLETED|Overall Study||0
8676691|NCT00775671|9720213|FG001|NOT COMPLETED|Overall Study||0
8676692|NCT00775684|9720222|FG000|STARTED|Overall Study||17
8676693|NCT00775684|9720223|FG001|STARTED|Overall Study||13
8676694|NCT00775684|9720224|FG002|STARTED|Overall Study||17
8676695|NCT00775684|9720222|FG000|COMPLETED|Overall Study||14
8676696|NCT00775684|9720223|FG001|COMPLETED|Overall Study||12
8676697|NCT00775684|9720224|FG002|COMPLETED|Overall Study||14
8676698|NCT00775684|9720222|FG000|NOT COMPLETED|Overall Study||3
8676699|NCT00775684|9720223|FG001|NOT COMPLETED|Overall Study||1
8676700|NCT00775684|9720224|FG002|NOT COMPLETED|Overall Study||3
8676701|NCT00775931|9720243|FG000|STARTED|Overall Study||6
8676702|NCT00775931|9720244|FG001|STARTED|Overall Study||1
8676703|NCT00775931|9720243|FG000|COMPLETED|Overall Study||6
8676704|NCT00775931|9720244|FG001|COMPLETED|Overall Study||1
8676705|NCT00775931|9720243|FG000|NOT COMPLETED|Overall Study||0
8676706|NCT00775931|9720244|FG001|NOT COMPLETED|Overall Study||0
8676707|NCT00775944|9720254|FG000|STARTED|Overall Study||648
8676708|NCT00775944|9720255|FG001|STARTED|Overall Study||647
8676709|NCT00775944|9720256|FG002|STARTED|Overall Study||648
8676710|NCT00775944|9720257|FG003|STARTED|Overall Study||648
8676711|NCT00775944|9720254|FG000|COMPLETED|Overall Study|15 participants withdrew consent|633
8676712|NCT00775944|9720255|FG001|COMPLETED|Overall Study|9 participants withdrew consent|638
8676713|NCT00775944|9720256|FG002|COMPLETED|Overall Study|16 participants withdrew consent|632
8676714|NCT00775944|9720257|FG003|COMPLETED|Overall Study|16 participants withdrew consent|632
8676715|NCT00775944|9720254|FG000|NOT COMPLETED|Overall Study||15
8676716|NCT00775944|9720255|FG001|NOT COMPLETED|Overall Study||9
8676717|NCT00775944|9720256|FG002|NOT COMPLETED|Overall Study||16
8676718|NCT00775944|9720257|FG003|NOT COMPLETED|Overall Study||16
8676719|NCT00775983|9720269|FG000|STARTED|Overall Study||36
8676720|NCT00775983|9720270|FG001|STARTED|Overall Study||36
8676721|NCT00775983|9720269|FG000|COMPLETED|Overall Study||35
8676722|NCT00775983|9720270|FG001|COMPLETED|Overall Study||34
8676723|NCT00775983|9720269|FG000|NOT COMPLETED|Overall Study||1
8676724|NCT00775983|9720270|FG001|NOT COMPLETED|Overall Study||2
8676725|NCT00776009|9720282|FG000|STARTED|Period 1: First Intervention||26
8676726|NCT00776009|9720283|FG001|STARTED|Period 1: First Intervention||28
8799724|NCT01439633|9851323|FG000|NOT COMPLETED|Overall Study||0
8799725|NCT01439672|9851327|FG000|STARTED|Overall Study||35
8799726|NCT01439672|9851327|FG000|COMPLETED|Overall Study||11
8799727|NCT01439672|9851327|FG000|NOT COMPLETED|Overall Study||24
8799728|NCT01439711|9851331|FG000|STARTED|Overall Study||108
8799729|NCT01439711|9851331|FG000|COMPLETED|Overall Study||68
8799730|NCT01439711|9851331|FG000|NOT COMPLETED|Overall Study||40
8799731|NCT01439724|9851337|FG000|STARTED|Overall Study||47
8799732|NCT01439724|9851338|FG001|STARTED|Overall Study||47
8799733|NCT01439724|9851337|FG000|COMPLETED|Overall Study||38
8799734|NCT01439724|9851338|FG001|COMPLETED|Overall Study||39
8799735|NCT01439724|9851337|FG000|NOT COMPLETED|Overall Study||9
8799736|NCT01439724|9851338|FG001|NOT COMPLETED|Overall Study||8
8799737|NCT01439815|9851346|FG000|STARTED|Overall Study||11
8799738|NCT01439815|9851347|FG001|STARTED|Overall Study||11
8799739|NCT01439815|9851346|FG000|All Randomized Participant Population|Overall Study||11
8799740|NCT01439815|9851347|FG001|All Randomized Participant Population|Overall Study||11
8799741|NCT01439815|9851346|FG000|COMPLETED|Overall Study||11
8799742|NCT01439815|9851347|FG001|COMPLETED|Overall Study||9
8799743|NCT01439815|9851346|FG000|NOT COMPLETED|Overall Study||0
8799744|NCT01439815|9851347|FG001|NOT COMPLETED|Overall Study||2
8799745|NCT01439854|9851355|FG000|STARTED|Overall Study||8
8799746|NCT01439854|9851356|FG001|STARTED|Overall Study||10
8799747|NCT01439854|9851355|FG000|COMPLETED|Overall Study||8
8799748|NCT01439854|9851356|FG001|COMPLETED|Overall Study||10
8799749|NCT01439854|9851355|FG000|NOT COMPLETED|Overall Study||0
8799750|NCT01439854|9851356|FG001|NOT COMPLETED|Overall Study||0
8676727|NCT00776009|9720284|FG002|STARTED|Period 1: First Intervention||29
8799751|NCT01439867|9851364|FG000|STARTED|Overall Study||8
8799752|NCT01439867|9851365|FG001|STARTED|Overall Study||10
8676728|NCT00776009|9720285|FG003|STARTED|Period 1: First Intervention||27
8676729|NCT00776009|9720286|FG004|STARTED|Period 1: First Intervention||28
8676730|NCT00776009|9720287|FG005|STARTED|Period 1: First Intervention||27
8676731|NCT00776009|9720282|FG000|COMPLETED|Period 1: First Intervention||26
8676732|NCT00776009|9720283|FG001|COMPLETED|Period 1: First Intervention||27
8676733|NCT00776009|9720284|FG002|COMPLETED|Period 1: First Intervention||28
8676734|NCT00776009|9720285|FG003|COMPLETED|Period 1: First Intervention||27
8676735|NCT00776009|9720286|FG004|COMPLETED|Period 1: First Intervention||26
8676736|NCT00776009|9720287|FG005|COMPLETED|Period 1: First Intervention||27
8676737|NCT00776009|9720282|FG000|NOT COMPLETED|Period 1: First Intervention||0
8676738|NCT00776009|9720283|FG001|NOT COMPLETED|Period 1: First Intervention||1
8676739|NCT00776009|9720284|FG002|NOT COMPLETED|Period 1: First Intervention||1
8676740|NCT00776009|9720285|FG003|NOT COMPLETED|Period 1: First Intervention||0
8676741|NCT00776009|9720286|FG004|NOT COMPLETED|Period 1: First Intervention||2
8676742|NCT00776009|9720287|FG005|NOT COMPLETED|Period 1: First Intervention||0
8676743|NCT00776009|9720282|FG000|STARTED|Period 2: Second Intervention||26
8676744|NCT00776009|9720283|FG001|STARTED|Period 2: Second Intervention||27
8676745|NCT00776009|9720284|FG002|STARTED|Period 2: Second Intervention||28
8676746|NCT00776009|9720285|FG003|STARTED|Period 2: Second Intervention||27
8676747|NCT00776009|9720286|FG004|STARTED|Period 2: Second Intervention||26
8676748|NCT00776009|9720287|FG005|STARTED|Period 2: Second Intervention||27
8676749|NCT00776009|9720282|FG000|COMPLETED|Period 2: Second Intervention||25
8676750|NCT00776009|9720283|FG001|COMPLETED|Period 2: Second Intervention||27
8676751|NCT00776009|9720284|FG002|COMPLETED|Period 2: Second Intervention||27
8676752|NCT00776009|9720285|FG003|COMPLETED|Period 2: Second Intervention||27
8676753|NCT00776009|9720286|FG004|COMPLETED|Period 2: Second Intervention||26
8676754|NCT00776009|9720287|FG005|COMPLETED|Period 2: Second Intervention||26
8676755|NCT00776009|9720282|FG000|NOT COMPLETED|Period 2: Second Intervention||1
8676756|NCT00776009|9720283|FG001|NOT COMPLETED|Period 2: Second Intervention||0
8676757|NCT00776009|9720284|FG002|NOT COMPLETED|Period 2: Second Intervention||1
8676758|NCT00776009|9720285|FG003|NOT COMPLETED|Period 2: Second Intervention||0
8676759|NCT00776009|9720286|FG004|NOT COMPLETED|Period 2: Second Intervention||0
8676760|NCT00776009|9720287|FG005|NOT COMPLETED|Period 2: Second Intervention||1
8676761|NCT00776009|9720282|FG000|STARTED|Period 3: Third Intervention||25
8676762|NCT00776009|9720283|FG001|STARTED|Period 3: Third Intervention||27
8676763|NCT00776009|9720284|FG002|STARTED|Period 3: Third Intervention||27
8676764|NCT00776009|9720285|FG003|STARTED|Period 3: Third Intervention||27
8676765|NCT00776009|9720286|FG004|STARTED|Period 3: Third Intervention||26
8676766|NCT00776009|9720287|FG005|STARTED|Period 3: Third Intervention||26
8676767|NCT00776009|9720282|FG000|COMPLETED|Period 3: Third Intervention||24
8676768|NCT00776009|9720283|FG001|COMPLETED|Period 3: Third Intervention||27
8676769|NCT00776009|9720284|FG002|COMPLETED|Period 3: Third Intervention||27
8676770|NCT00776009|9720285|FG003|COMPLETED|Period 3: Third Intervention||27
8676771|NCT00776009|9720286|FG004|COMPLETED|Period 3: Third Intervention||26
8676772|NCT00776009|9720287|FG005|COMPLETED|Period 3: Third Intervention||26
8676773|NCT00776009|9720282|FG000|NOT COMPLETED|Period 3: Third Intervention||1
8676774|NCT00776009|9720283|FG001|NOT COMPLETED|Period 3: Third Intervention||0
8676775|NCT00776009|9720284|FG002|NOT COMPLETED|Period 3: Third Intervention||0
8676776|NCT00776009|9720285|FG003|NOT COMPLETED|Period 3: Third Intervention||0
8676777|NCT00776009|9720286|FG004|NOT COMPLETED|Period 3: Third Intervention||0
8676778|NCT00776009|9720287|FG005|NOT COMPLETED|Period 3: Third Intervention||0
8676779|NCT00776230|9720298|FG000|STARTED|Overall Study||99
8676780|NCT00776230|9720299|FG001|STARTED|Overall Study||103
8676781|NCT00776230|9720300|FG002|STARTED|Overall Study||102
8676782|NCT00776230|9720298|FG000|Enrolled and Vaccinated at Day 0|Overall Study||98
8676783|NCT00776230|9720299|FG001|Enrolled and Vaccinated at Day 0|Overall Study||103
8676784|NCT00776230|9720300|FG002|Enrolled and Vaccinated at Day 0|Overall Study||102
8676785|NCT00776230|9720298|FG000|COMPLETED|Overall Study||96
8676786|NCT00776230|9720299|FG001|COMPLETED|Overall Study||100
8676787|NCT00776230|9720300|FG002|COMPLETED|Overall Study||97
8676788|NCT00776230|9720298|FG000|NOT COMPLETED|Overall Study||3
8676789|NCT00776230|9720299|FG001|NOT COMPLETED|Overall Study||3
8676790|NCT00776230|9720300|FG002|NOT COMPLETED|Overall Study||5
8676791|NCT00776295|9720308|FG000|STARTED|Overall Study||2
8676792|NCT00776295|9720308|FG000|COMPLETED|Overall Study||2
8676793|NCT00776295|9720308|FG000|NOT COMPLETED|Overall Study||0
8676794|NCT00776594|9720314|FG000|STARTED|Overall Study||66
8676795|NCT00776594|9720315|FG001|STARTED|Overall Study||36
8676796|NCT00776594|9720314|FG000|COMPLETED|Overall Study||62
8676797|NCT00776594|9720315|FG001|COMPLETED|Overall Study||34
8676798|NCT00776594|9720314|FG000|NOT COMPLETED|Overall Study||4
8676799|NCT00776594|9720315|FG001|NOT COMPLETED|Overall Study||2
8676800|NCT00776659|9720323|FG000|STARTED|Overall Study||39
8676801|NCT00776659|9720323|FG000|COMPLETED|Overall Study||13
8676802|NCT00776659|9720323|FG000|NOT COMPLETED|Overall Study||26
8676803|NCT00776789|9720329|FG000|STARTED|Overall Study||20
8676804|NCT00776789|9720330|FG001|STARTED|Overall Study||21
8676805|NCT00776789|9720329|FG000|COMPLETED|Overall Study||17
8676806|NCT00776789|9720330|FG001|COMPLETED|Overall Study||18
8676807|NCT00776789|9720329|FG000|NOT COMPLETED|Overall Study||3
8676808|NCT00776789|9720330|FG001|NOT COMPLETED|Overall Study||3
8692788|NCT00862849|9738282|FG004|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
8692789|NCT00862849|9738283|FG005|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
8676809|NCT00776919|9720342|FG000|STARTED|Overall Study||327
8676810|NCT00776919|9720343|FG001|STARTED|Overall Study||328
8676811|NCT00776919|9720344|FG002|STARTED|Overall Study||328
8676812|NCT00776919|9720345|FG003|STARTED|Overall Study||332
8676813|NCT00776919|9720342|FG000|COMPLETED|Overall Study||300
8676814|NCT00776919|9720343|FG001|COMPLETED|Overall Study||295
8676815|NCT00776919|9720344|FG002|COMPLETED|Overall Study||296
8676816|NCT00776919|9720345|FG003|COMPLETED|Overall Study||293
8676817|NCT00776919|9720342|FG000|NOT COMPLETED|Overall Study||27
8676818|NCT00776919|9720343|FG001|NOT COMPLETED|Overall Study||33
8676819|NCT00776919|9720344|FG002|NOT COMPLETED|Overall Study||32
8676820|NCT00776919|9720345|FG003|NOT COMPLETED|Overall Study||39
8676821|NCT00776984|9720357|FG000|STARTED|Overall Study||234
8676822|NCT00776984|9720358|FG001|STARTED|Overall Study||219
8676823|NCT00776984|9720357|FG000|COMPLETED|Overall Study||203
8676824|NCT00776984|9720358|FG001|COMPLETED|Overall Study||198
8676825|NCT00776984|9720357|FG000|NOT COMPLETED|Overall Study||31
8676826|NCT00776984|9720358|FG001|NOT COMPLETED|Overall Study||21
8676827|NCT00776997|9720364|FG000|STARTED|Overall Study||100
8676828|NCT00776997|9720364|FG000|COMPLETED|Overall Study|98 subjects evaluated at 12-months. Endpoint analysis based on all subjects treated (n=100)|98
8676829|NCT00776997|9720364|FG000|NOT COMPLETED|Overall Study||2
8676830|NCT00777023|9720371|FG000|STARTED|Overall Study|192 patients were randomized, but only 186 received study treatment.|186
8676831|NCT00777023|9720372|FG001|STARTED|Overall Study|190 patients were randomized, and 190 received study treatment.|190
8676832|NCT00777023|9720373|FG002|STARTED|Overall Study|183 patients were randomized, and 183 received study treatment.|183
8676833|NCT00777023|9720371|FG000|COMPLETED|Overall Study||151
8676834|NCT00777023|9720372|FG001|COMPLETED|Overall Study||149
8676835|NCT00777023|9720373|FG002|COMPLETED|Overall Study||146
8676836|NCT00777023|9720371|FG000|NOT COMPLETED|Overall Study||35
8676837|NCT00777023|9720372|FG001|NOT COMPLETED|Overall Study||41
8676838|NCT00777023|9720373|FG002|NOT COMPLETED|Overall Study||37
8676839|NCT00777049|9720383|FG000|STARTED|Overall Study||33
8676840|NCT00777049|9720384|FG001|STARTED|Overall Study||21
8676841|NCT00777049|9720383|FG000|COMPLETED|Overall Study||32
8676842|NCT00777049|9720384|FG001|COMPLETED|Overall Study||20
8676843|NCT00777049|9720383|FG000|NOT COMPLETED|Overall Study||1
8676844|NCT00777049|9720384|FG001|NOT COMPLETED|Overall Study||1
8676845|NCT00777062|9720392|FG000|STARTED|Overall Study||39
8676846|NCT00777062|9720393|FG001|STARTED|Overall Study||41
8676847|NCT00777062|9720392|FG000|COMPLETED|Overall Study||36
8676848|NCT00777062|9720393|FG001|COMPLETED|Overall Study||36
8676849|NCT00777062|9720392|FG000|NOT COMPLETED|Overall Study||3
8676850|NCT00777062|9720393|FG001|NOT COMPLETED|Overall Study||5
8676851|NCT00777088|9720399|FG000|STARTED|Overall Study||108
8676852|NCT00777088|9720399|FG000|COMPLETED|Overall Study||107
8676853|NCT00777088|9720399|FG000|NOT COMPLETED|Overall Study||1
8676854|NCT00777101|9720406|FG000|STARTED|Overall Study||117
8676855|NCT00777101|9720407|FG001|STARTED|Overall Study||116
8676856|NCT00777101|9720406|FG000|Treated|Overall Study||116
8676857|NCT00777101|9720407|FG001|Treated|Overall Study||115
8676858|NCT00777101|9720406|FG000|COMPLETED|Overall Study||55
8676859|NCT00777101|9720407|FG001|COMPLETED|Overall Study||65
8676860|NCT00777101|9720406|FG000|NOT COMPLETED|Overall Study||62
8676861|NCT00777101|9720407|FG001|NOT COMPLETED|Overall Study||51
8676862|NCT00777153|9720417|FG000|STARTED|Overall Study||131
8676863|NCT00777153|9720418|FG001|STARTED|Overall Study||129
8676864|NCT00777153|9720419|FG002|STARTED|Overall Study||65
8676865|NCT00777153|9720417|FG000|COMPLETED|Overall Study||41
8676866|NCT00777153|9720418|FG001|COMPLETED|Overall Study||46
8676867|NCT00777153|9720419|FG002|COMPLETED|Overall Study||28
8676868|NCT00777153|9720417|FG000|NOT COMPLETED|Overall Study||90
8676869|NCT00777153|9720418|FG001|NOT COMPLETED|Overall Study||83
8676870|NCT00777153|9720419|FG002|NOT COMPLETED|Overall Study||37
8676871|NCT00777179|9720433|FG000|STARTED|Overall Study|Number of participants for intent-to-treat (ITT) set population|75
8676872|NCT00777179|9720434|FG001|STARTED|Overall Study|Number of participants for intent-to-treat (ITT) set population|42
8676873|NCT00777179|9720433|FG000|COMPLETED|Overall Study|All participants' data within ITT set were included for final result.|75
8676874|NCT00777179|9720434|FG001|COMPLETED|Overall Study|All participants' data within ITT set were included for final result.|42
8676875|NCT00777179|9720433|FG000|NOT COMPLETED|Overall Study||0
8676876|NCT00777179|9720434|FG001|NOT COMPLETED|Overall Study||0
8676877|NCT00777205|9720442|FG000|STARTED|Overall Study||243
8676878|NCT00777205|9720443|FG001|STARTED|Overall Study||200
8676879|NCT00777205|9720442|FG000|Intervention Interruption|Overall Study||0
8676880|NCT00777205|9720443|FG001|Intervention Interruption|Overall Study|56 participants excluded from main analyses due to 2 mos interruption in study intervention|56
8676881|NCT00777205|9720442|FG000|COMPLETED|Overall Study||212
8676882|NCT00777205|9720443|FG001|COMPLETED|Overall Study||129
8676883|NCT00777205|9720442|FG000|NOT COMPLETED|Overall Study||31
8676884|NCT00777205|9720443|FG001|NOT COMPLETED|Overall Study||71
8676885|NCT00777257|9720454|FG000|STARTED|Overall Study||444
8676886|NCT00777257|9720455|FG001|STARTED|Overall Study||450
8676887|NCT00777257|9720456|FG002|STARTED|Overall Study||451
8676888|NCT00777257|9720454|FG000|COMPLETED|Overall Study||433
8676889|NCT00777257|9720455|FG001|COMPLETED|Overall Study||438
8676890|NCT00777257|9720456|FG002|COMPLETED|Overall Study||442
8676891|NCT00777257|9720454|FG000|NOT COMPLETED|Overall Study||11
8676892|NCT00777257|9720455|FG001|NOT COMPLETED|Overall Study||12
8676893|NCT00777257|9720456|FG002|NOT COMPLETED|Overall Study||9
8676894|NCT00777296|9720468|FG000|STARTED|Overall Study||21
8676895|NCT00777296|9720469|FG001|STARTED|Overall Study||11
8676896|NCT00777296|9720470|FG002|STARTED|Overall Study||23
8676897|NCT00777296|9720471|FG003|STARTED|Overall Study||11
8676898|NCT00777296|9720468|FG000|COMPLETED|Overall Study||20
8676899|NCT00777296|9720469|FG001|COMPLETED|Overall Study||10
8676900|NCT00777296|9720470|FG002|COMPLETED|Overall Study||21
8676901|NCT00777296|9720471|FG003|COMPLETED|Overall Study||10
8676902|NCT00777296|9720468|FG000|NOT COMPLETED|Overall Study||1
8676903|NCT00777296|9720469|FG001|NOT COMPLETED|Overall Study||1
8676904|NCT00777296|9720470|FG002|NOT COMPLETED|Overall Study||2
8676905|NCT00777296|9720471|FG003|NOT COMPLETED|Overall Study||1
8676906|NCT00777335|9720495|FG000|STARTED|Overall Study||2
8676907|NCT00777335|9720496|FG001|STARTED|Overall Study||2
8676908|NCT00777335|9720495|FG000|COMPLETED|Overall Study||2
8676909|NCT00777335|9720496|FG001|COMPLETED|Overall Study||2
8676910|NCT00777335|9720495|FG000|NOT COMPLETED|Overall Study||0
8676911|NCT00777335|9720496|FG001|NOT COMPLETED|Overall Study||0
8676912|NCT00777491|9720504|FG000|STARTED|Overall Study||35
8676913|NCT00777491|9720505|FG001|STARTED|Overall Study||35
8676914|NCT00777491|9720504|FG000|Eligible|Overall Study||33
8676915|NCT00777491|9720505|FG001|Eligible|Overall Study||33
8676916|NCT00777491|9720504|FG000|Has 3-year Efficacy Data|Overall Study||27
8676917|NCT00777491|9720505|FG001|Has 3-year Efficacy Data|Overall Study||25
8676918|NCT00777491|9720504|FG000|Started Induction Therapy|Overall Study||33
8676919|NCT00777491|9720505|FG001|Started Induction Therapy|Overall Study||33
8676920|NCT00777491|9720504|FG000|Started Consolidation Therapy|Overall Study||29
8676921|NCT00777491|9720505|FG001|Started Consolidation Therapy|Overall Study||25
8676922|NCT00777491|9720504|FG000|Started Adjuvant Therapy|Overall Study||32
8676923|NCT00777491|9720505|FG001|Started Adjuvant Therapy|Overall Study||31
8676924|NCT00777491|9720504|FG000|Has Adverse Event Data (Treatment)|Overall Study||33
8676925|NCT00777491|9720505|FG001|Has Adverse Event Data (Treatment)|Overall Study||33
8676926|NCT00777491|9720504|FG000|Has Adverse Event Data (Late)|Overall Study||32
8676927|NCT00777491|9720505|FG001|Has Adverse Event Data (Late)|Overall Study||31
8676928|NCT00777491|9720504|FG000|Has 3 Year AUASI Data|Overall Study||6
8676929|NCT00777491|9720505|FG001|Has 3 Year AUASI Data|Overall Study||6
8676930|NCT00777491|9720504|FG000|COMPLETED|Overall Study||33
8676931|NCT00777491|9720505|FG001|COMPLETED|Overall Study||33
8676932|NCT00777491|9720504|FG000|NOT COMPLETED|Overall Study||2
8676933|NCT00777491|9720505|FG001|NOT COMPLETED|Overall Study||2
8676934|NCT00777556|9720511|FG000|STARTED|Overall Study|Enrolled; signed informed consent|343
8676935|NCT00777556|9720511|FG000|Dispensed Product|Overall Study||307
8676936|NCT00777556|9720511|FG000|Safety Population|Overall Study|Participants who used the product; two were given product in error (inappropriately self-selected)|299
8676937|NCT00777556|9720511|FG000|Used Product|Overall Study||297
8676938|NCT00777556|9720511|FG000|COMPLETED|Overall Study|Completed all 3 follow-up visits|277
8676939|NCT00777556|9720511|FG000|NOT COMPLETED|Overall Study||66
8676940|NCT00777608|9720517|FG000|STARTED|Overall Study||53
8676941|NCT00777608|9720518|FG001|STARTED|Overall Study||53
8676942|NCT00777608|9720517|FG000|COMPLETED|Overall Study||49
8676943|NCT00777608|9720518|FG001|COMPLETED|Overall Study||47
8676944|NCT00777608|9720517|FG000|NOT COMPLETED|Overall Study||4
8676945|NCT00777608|9720518|FG001|NOT COMPLETED|Overall Study||6
8676946|NCT00777634|9720526|FG000|STARTED|Overall Study||134
8676947|NCT00777634|9720527|FG001|STARTED|Overall Study||134
8676948|NCT00777634|9720526|FG000|COMPLETED|Overall Study||129
8676949|NCT00777634|9720527|FG001|COMPLETED|Overall Study||133
8676950|NCT00777634|9720526|FG000|NOT COMPLETED|Overall Study||5
8676951|NCT00777634|9720527|FG001|NOT COMPLETED|Overall Study||1
8676952|NCT00777764|9720535|FG000|STARTED|Overall Study||30
8676953|NCT00777764|9720536|FG001|STARTED|Overall Study||30
8676954|NCT00777764|9720535|FG000|COMPLETED|Overall Study||30
8676955|NCT00777764|9720536|FG001|COMPLETED|Overall Study||29
8676956|NCT00777764|9720535|FG000|NOT COMPLETED|Overall Study||0
8676957|NCT00777764|9720536|FG001|NOT COMPLETED|Overall Study||1
8676958|NCT00777790|9720547|FG000|STARTED|Overall Study||76
8676959|NCT00777790|9720548|FG001|STARTED|Overall Study||77
8676960|NCT00777790|9720549|FG002|STARTED|Overall Study||88
8676961|NCT00777790|9720547|FG000|COMPLETED|Overall Study||76
8676962|NCT00777790|9720548|FG001|COMPLETED|Overall Study||77
8676963|NCT00777790|9720549|FG002|COMPLETED|Overall Study||88
8676964|NCT00777790|9720547|FG000|NOT COMPLETED|Overall Study||0
8676965|NCT00777790|9720548|FG001|NOT COMPLETED|Overall Study||0
8676966|NCT00777790|9720549|FG002|NOT COMPLETED|Overall Study||0
8676967|NCT00777803|9720559|FG000|STARTED|Overall Study||284
8676968|NCT00777803|9720560|FG001|STARTED|Overall Study||97
8676969|NCT00777803|9720559|FG000|COMPLETED|Overall Study||269
8676970|NCT00777803|9720560|FG001|COMPLETED|Overall Study||90
8676971|NCT00777803|9720559|FG000|NOT COMPLETED|Overall Study||15
8676972|NCT00777803|9720560|FG001|NOT COMPLETED|Overall Study||7
8676973|NCT00777829|9720566|FG000|STARTED|Overall Study||15
8676974|NCT00777829|9720567|FG001|STARTED|Overall Study||15
8676975|NCT00777829|9720566|FG000|Study Orientation|Overall Study||15
8676976|NCT00777829|9720567|FG001|Study Orientation|Overall Study||13
8676977|NCT00777829|9720566|FG000|COMPLETED|Overall Study||15
8676978|NCT00777829|9720567|FG001|COMPLETED|Overall Study||13
8676979|NCT00777829|9720566|FG000|NOT COMPLETED|Overall Study||0
8676980|NCT00777829|9720567|FG001|NOT COMPLETED|Overall Study||2
8676981|NCT00777855|9720575|FG000|STARTED|First Intervention||5
8676982|NCT00777855|9720576|FG001|STARTED|First Intervention||5
8676983|NCT00777855|9720575|FG000|COMPLETED|First Intervention||5
8676984|NCT00777855|9720576|FG001|COMPLETED|First Intervention||5
8676985|NCT00777855|9720575|FG000|NOT COMPLETED|First Intervention||0
8676986|NCT00777855|9720576|FG001|NOT COMPLETED|First Intervention||0
8676987|NCT00777855|9720575|FG000|STARTED|Washout Period (>= 14 Days)||5
8676988|NCT00777855|9720576|FG001|STARTED|Washout Period (>= 14 Days)||5
8676989|NCT00777855|9720575|FG000|COMPLETED|Washout Period (>= 14 Days)||5
8676990|NCT00777855|9720576|FG001|COMPLETED|Washout Period (>= 14 Days)||5
8676991|NCT00777855|9720575|FG000|NOT COMPLETED|Washout Period (>= 14 Days)||0
8676992|NCT00777855|9720576|FG001|NOT COMPLETED|Washout Period (>= 14 Days)||0
8676993|NCT00777855|9720575|FG000|STARTED|Second Intervention||5
8676994|NCT00777855|9720576|FG001|STARTED|Second Intervention||5
8676995|NCT00777855|9720575|FG000|COMPLETED|Second Intervention||5
8676996|NCT00777855|9720576|FG001|COMPLETED|Second Intervention||5
8676997|NCT00777855|9720575|FG000|NOT COMPLETED|Second Intervention||0
8676998|NCT00777855|9720576|FG001|NOT COMPLETED|Second Intervention||0
8676999|NCT00777920|9720581|FG000|STARTED|Overall Study||140
8677000|NCT00777920|9720581|FG000|COMPLETED|Overall Study||90
8677001|NCT00777920|9720581|FG000|NOT COMPLETED|Overall Study||50
8677002|NCT00777946|9720588|FG000|STARTED|Overall Study|1 patient in the Aliskiren 300 mg/Amlodipine 10 mg group was randomized in error.|283
8677003|NCT00777946|9720589|FG001|STARTED|Overall Study|1 patient in the Aliskiren 300 mg/Amlodipine 5 mg group was randomized in error.|277
8677004|NCT00777946|9720590|FG002|STARTED|Overall Study||260
8677005|NCT00777946|9720588|FG000|Safety & Full Analysis Sets|Overall Study||282
8677006|NCT00777946|9720589|FG001|Safety & Full Analysis Sets|Overall Study||276
8677007|NCT00777946|9720590|FG002|Safety & Full Analysis Sets|Overall Study||260
8677008|NCT00777946|9720588|FG000|COMPLETED|Overall Study||262
8677009|NCT00777946|9720589|FG001|COMPLETED|Overall Study||271
8677010|NCT00777946|9720590|FG002|COMPLETED|Overall Study||244
8677011|NCT00777946|9720588|FG000|NOT COMPLETED|Overall Study||21
8677012|NCT00777946|9720589|FG001|NOT COMPLETED|Overall Study||6
8677013|NCT00777946|9720590|FG002|NOT COMPLETED|Overall Study||16
8677014|NCT00778102|9720600|FG000|STARTED|Overall Study||39
8677015|NCT00778102|9720601|FG001|STARTED|Overall Study||41
8677016|NCT00778102|9720600|FG000|COMPLETED|Overall Study||18
8677017|NCT00778102|9720601|FG001|COMPLETED|Overall Study||19
8677018|NCT00778102|9720600|FG000|NOT COMPLETED|Overall Study||21
8677019|NCT00778102|9720601|FG001|NOT COMPLETED|Overall Study||22
8677020|NCT00778167|9720610|FG000|STARTED|Overall Study||6
8677021|NCT00778167|9720611|FG001|STARTED|Overall Study||8
8677022|NCT00778167|9720612|FG002|STARTED|Overall Study||4
8677023|NCT00778167|9720610|FG000|COMPLETED|Overall Study||6
8677024|NCT00778167|9720611|FG001|COMPLETED|Overall Study||8
8677025|NCT00778167|9720612|FG002|COMPLETED|Overall Study||4
8677026|NCT00778167|9720610|FG000|NOT COMPLETED|Overall Study||0
8677027|NCT00778167|9720611|FG001|NOT COMPLETED|Overall Study||0
8677028|NCT00778167|9720612|FG002|NOT COMPLETED|Overall Study||0
8677029|NCT00778258|9720629|FG000|STARTED|Overall Study||16
8677030|NCT00778258|9720630|FG001|STARTED|Overall Study||5
8677031|NCT00778258|9720631|FG002|STARTED|Overall Study||20
8677032|NCT00778258|9720632|FG003|STARTED|Overall Study||15
8677033|NCT00778258|9720633|FG004|STARTED|Overall Study||6
8677034|NCT00778258|9720634|FG005|STARTED|Overall Study||23
8677035|NCT00778258|9720635|FG006|STARTED|Overall Study||34
8677036|NCT00778258|9720636|FG007|STARTED|Overall Study||41
8677037|NCT00778258|9720637|FG008|STARTED|Overall Study||10
8677038|NCT00778258|9720629|FG000|COMPLETED|Overall Study||9
8677039|NCT00778258|9720630|FG001|COMPLETED|Overall Study||3
8677040|NCT00778258|9720631|FG002|COMPLETED|Overall Study||10
8677041|NCT00778258|9720632|FG003|COMPLETED|Overall Study||12
8677042|NCT00778258|9720633|FG004|COMPLETED|Overall Study||6
8677043|NCT00778258|9720634|FG005|COMPLETED|Overall Study||13
8677044|NCT00778258|9720635|FG006|COMPLETED|Overall Study||19
8677045|NCT00778258|9720636|FG007|COMPLETED|Overall Study||26
8677046|NCT00778258|9720637|FG008|COMPLETED|Overall Study||6
8677047|NCT00778258|9720629|FG000|NOT COMPLETED|Overall Study||7
8677048|NCT00778258|9720630|FG001|NOT COMPLETED|Overall Study||2
8677049|NCT00778258|9720631|FG002|NOT COMPLETED|Overall Study||10
8677050|NCT00778258|9720632|FG003|NOT COMPLETED|Overall Study||3
8677051|NCT00778258|9720633|FG004|NOT COMPLETED|Overall Study||0
8677052|NCT00778258|9720634|FG005|NOT COMPLETED|Overall Study||10
8677053|NCT00778258|9720635|FG006|NOT COMPLETED|Overall Study||15
8677054|NCT00778258|9720636|FG007|NOT COMPLETED|Overall Study||15
8677055|NCT00778258|9720637|FG008|NOT COMPLETED|Overall Study||4
8677056|NCT00778310|9720665|FG000|STARTED|Overall Study||17
8677057|NCT00778310|9720666|FG001|STARTED|Overall Study||26
8677058|NCT00778310|9720665|FG000|Usable Data|Overall Study||14
8677059|NCT00778310|9720666|FG001|Usable Data|Overall Study||21
8677060|NCT00778310|9720665|FG000|COMPLETED|Overall Study||17
8677061|NCT00778310|9720666|FG001|COMPLETED|Overall Study||26
8677062|NCT00778310|9720665|FG000|NOT COMPLETED|Overall Study||0
8677063|NCT00778310|9720666|FG001|NOT COMPLETED|Overall Study||0
8677064|NCT00778336|9720678|FG000|STARTED|Index Procedure-Discharge||198
8677065|NCT00778336|9720679|FG001|STARTED|Index Procedure-Discharge||170
8677066|NCT00778336|9720680|FG002|STARTED|Index Procedure-Discharge||72
8677067|NCT00778336|9720681|FG003|STARTED|Index Procedure-Discharge||12
8677068|NCT00778336|9720678|FG000|COMPLETED|Index Procedure-Discharge||192
8677069|NCT00778336|9720679|FG001|COMPLETED|Index Procedure-Discharge||167
8677070|NCT00778336|9720680|FG002|COMPLETED|Index Procedure-Discharge||70
8677071|NCT00778336|9720681|FG003|COMPLETED|Index Procedure-Discharge||12
8677072|NCT00778336|9720678|FG000|NOT COMPLETED|Index Procedure-Discharge||6
8677073|NCT00778336|9720679|FG001|NOT COMPLETED|Index Procedure-Discharge||3
8677074|NCT00778336|9720680|FG002|NOT COMPLETED|Index Procedure-Discharge||2
8677075|NCT00778336|9720681|FG003|NOT COMPLETED|Index Procedure-Discharge||0
8677076|NCT00778336|9720678|FG000|STARTED|3 Month Follow Up||192
8677077|NCT00778336|9720679|FG001|STARTED|3 Month Follow Up||167
8677078|NCT00778336|9720680|FG002|STARTED|3 Month Follow Up||70
8677079|NCT00778336|9720681|FG003|STARTED|3 Month Follow Up||12
8677080|NCT00778336|9720678|FG000|COMPLETED|3 Month Follow Up||169
8677081|NCT00778336|9720679|FG001|COMPLETED|3 Month Follow Up||144
8677082|NCT00778336|9720680|FG002|COMPLETED|3 Month Follow Up||65
8677083|NCT00778336|9720681|FG003|COMPLETED|3 Month Follow Up||12
8677084|NCT00778336|9720678|FG000|NOT COMPLETED|3 Month Follow Up||23
8677085|NCT00778336|9720679|FG001|NOT COMPLETED|3 Month Follow Up||23
8677086|NCT00778336|9720680|FG002|NOT COMPLETED|3 Month Follow Up||5
8677087|NCT00778336|9720681|FG003|NOT COMPLETED|3 Month Follow Up||0
8677088|NCT00778375|9720691|FG000|STARTED|Overall Study||122
8677089|NCT00778375|9720691|FG000|COMPLETED|Overall Study||119
8677090|NCT00778375|9720691|FG000|NOT COMPLETED|Overall Study||3
8677091|NCT00778622|9720700|FG000|STARTED|Overall Study||125
8677092|NCT00778622|9720701|FG001|STARTED|Overall Study||122
8677093|NCT00778622|9720702|FG002|STARTED|Overall Study||124
8677094|NCT00778622|9720700|FG000|COMPLETED|Overall Study||109
8677095|NCT00778622|9720701|FG001|COMPLETED|Overall Study||107
8677096|NCT00778622|9720702|FG002|COMPLETED|Overall Study||109
8677097|NCT00778622|9720700|FG000|NOT COMPLETED|Overall Study||16
8677098|NCT00778622|9720701|FG001|NOT COMPLETED|Overall Study||15
8677099|NCT00778622|9720702|FG002|NOT COMPLETED|Overall Study||15
8677100|NCT00778648|9720716|FG000|STARTED|Overall Study||272
8677101|NCT00778648|9720717|FG001|STARTED|Overall Study||271
8677102|NCT00778648|9720716|FG000|COMPLETED|Overall Study||263
8677103|NCT00778648|9720717|FG001|COMPLETED|Overall Study||266
8677104|NCT00778648|9720716|FG000|NOT COMPLETED|Overall Study||9
8677105|NCT00778648|9720717|FG001|NOT COMPLETED|Overall Study||5
8677106|NCT00778817|9720723|FG000|STARTED|Overall Study||20
8677107|NCT00778817|9720723|FG000|COMPLETED|Overall Study||16
8677108|NCT00778817|9720723|FG000|NOT COMPLETED|Overall Study||4
8677109|NCT00778830|9720729|FG000|STARTED|Overall Study||101
8677110|NCT00778830|9720730|FG001|STARTED|Overall Study||188
8677111|NCT00778830|9720729|FG000|COMPLETED|Overall Study||101
8677112|NCT00778830|9720730|FG001|COMPLETED|Overall Study||187
8677113|NCT00778830|9720729|FG000|NOT COMPLETED|Overall Study||0
8677114|NCT00778830|9720730|FG001|NOT COMPLETED|Overall Study||1
8677115|NCT00778869|9720736|FG000|STARTED|Overall Study||10
8677116|NCT00778869|9720736|FG000|COMPLETED|Overall Study||10
8677117|NCT00778869|9720736|FG000|NOT COMPLETED|Overall Study||0
8677118|NCT00778895|9720743|FG000|STARTED|Active Phase||164
8677119|NCT00778895|9720744|FG001|STARTED|Active Phase||167
8677120|NCT00778895|9720745|FG002|STARTED|Active Phase||43
8677121|NCT00778895|9720743|FG000|COMPLETED|Active Phase||157
8677122|NCT00778895|9720744|FG001|COMPLETED|Active Phase||161
8677123|NCT00778895|9720745|FG002|COMPLETED|Active Phase||43
8677124|NCT00778895|9720743|FG000|NOT COMPLETED|Active Phase||7
8677125|NCT00778895|9720744|FG001|NOT COMPLETED|Active Phase||6
8677126|NCT00778895|9720745|FG002|NOT COMPLETED|Active Phase||0
8677127|NCT00778895|9720743|FG000|STARTED|ESFU Phase||164
8677128|NCT00778895|9720744|FG001|STARTED|ESFU Phase||167
8677129|NCT00778895|9720745|FG002|STARTED|ESFU Phase||43
8677130|NCT00778895|9720743|FG000|COMPLETED|ESFU Phase||153
8677131|NCT00778895|9720744|FG001|COMPLETED|ESFU Phase||155
8677132|NCT00778895|9720745|FG002|COMPLETED|ESFU Phase||41
8677133|NCT00778895|9720743|FG000|NOT COMPLETED|ESFU Phase||11
8677134|NCT00778895|9720744|FG001|NOT COMPLETED|ESFU Phase||12
8677135|NCT00778895|9720745|FG002|NOT COMPLETED|ESFU Phase||2
8677136|NCT00778921|9720757|FG000|STARTED|Overall Study||279
8677137|NCT00778921|9720758|FG001|STARTED|Overall Study||285
8677138|NCT00778921|9720759|FG002|STARTED|Overall Study||283
8677139|NCT00778921|9720757|FG000|COMPLETED|Overall Study||261
8677140|NCT00778921|9720758|FG001|COMPLETED|Overall Study||266
8677141|NCT00778921|9720759|FG002|COMPLETED|Overall Study||255
8677142|NCT00778921|9720757|FG000|NOT COMPLETED|Overall Study||18
8677143|NCT00778921|9720758|FG001|NOT COMPLETED|Overall Study||19
8677144|NCT00778921|9720759|FG002|NOT COMPLETED|Overall Study||28
8677145|NCT00779025|9720767|FG000|STARTED|Overall Study||82
8677146|NCT00779025|9720767|FG000|COMPLETED|Overall Study||81
8677147|NCT00779025|9720767|FG000|NOT COMPLETED|Overall Study||1
8677148|NCT00779103|9720772|FG000|STARTED|Overall Study|Initial Phase (First Implant) - 36 Completed|36
8677149|NCT00779103|9720772|FG000|Second & Third Implant|Overall Study|Initial Extension Phase/Extended Access Phase (Second and Third Implant) - 22 Completed|31
8677150|NCT00779103|9720772|FG000|Fourth Implant|Overall Study|Second Extension Phase (4th Implant with Yearly Implantations till no longer required): 11 Completed|13
8677151|NCT00779103|9720772|FG000|No Treatment|Overall Study|Optional Long Term Follow-up Phase (No Treatment)|9
8677152|NCT00779103|9720772|FG000|COMPLETED|Overall Study|Initial Phase (First Implant)|36
8677153|NCT00779103|9720772|FG000|NOT COMPLETED|Overall Study||0
8677154|NCT00779142|9720780|FG000|STARTED|Overall Study|5 patients signed consent and were screened.|5
8677155|NCT00779142|9720780|FG000|COMPLETED|Overall Study|Only 2 patients were actually enrolled.|2
8677156|NCT00779142|9720780|FG000|NOT COMPLETED|Overall Study||3
8677157|NCT00779155|9720787|FG000|STARTED|Overall Study||6
8677158|NCT00779155|9720788|FG001|STARTED|Overall Study||6
8677159|NCT00779155|9720787|FG000|COMPLETED|Overall Study||6
8677160|NCT00779155|9720788|FG001|COMPLETED|Overall Study||6
8677161|NCT00779155|9720787|FG000|NOT COMPLETED|Overall Study||0
8677162|NCT00779155|9720788|FG001|NOT COMPLETED|Overall Study||0
8677163|NCT00779246|9720796|FG000|STARTED|Overall Study||750
8677164|NCT00779246|9720797|FG001|STARTED|Overall Study||768
8677165|NCT00779246|9720796|FG000|COMPLETED|Overall Study||717
8677166|NCT00779246|9720797|FG001|COMPLETED|Overall Study||715
8677167|NCT00779246|9720796|FG000|NOT COMPLETED|Overall Study||33
8677168|NCT00779246|9720797|FG001|NOT COMPLETED|Overall Study||53
8677169|NCT00779259|9720803|FG000|STARTED|Theophylline Alone||24
8677170|NCT00779259|9720803|FG000|COMPLETED|Theophylline Alone||24
8677171|NCT00779259|9720803|FG000|NOT COMPLETED|Theophylline Alone||0
8677172|NCT00779259|9720803|FG000|STARTED|4 Day Washout Period||24
8677173|NCT00779259|9720803|FG000|COMPLETED|4 Day Washout Period||24
8677174|NCT00779259|9720803|FG000|NOT COMPLETED|4 Day Washout Period||0
8677175|NCT00779259|9720803|FG000|STARTED|Quinine Alone||24
8677176|NCT00779259|9720803|FG000|COMPLETED|Quinine Alone||22
8677177|NCT00779259|9720803|FG000|NOT COMPLETED|Quinine Alone||2
8677178|NCT00779259|9720803|FG000|STARTED|Theophylline With Quinine||22
8677179|NCT00779259|9720803|FG000|COMPLETED|Theophylline With Quinine||22
8677180|NCT00779259|9720803|FG000|NOT COMPLETED|Theophylline With Quinine||0
8677181|NCT00779285|9720821|FG000|STARTED|Overall Study||1
8677182|NCT00779285|9720821|FG000|COMPLETED|Overall Study||1
8677183|NCT00779285|9720821|FG000|NOT COMPLETED|Overall Study||0
8677184|NCT00779311|9720830|FG000|STARTED|Overall Study|2 of 6 patients were not evaluable for DLT assessment and were replaced for a total of 8 enrolled.|8
8677185|NCT00779311|9720831|FG001|STARTED|Overall Study||0
8677186|NCT00779311|9720832|FG002|STARTED|Overall Study||0
8677187|NCT00779311|9720833|FG003|STARTED|Overall Study||0
8677188|NCT00779311|9720834|FG004|STARTED|Overall Study||0
8677189|NCT00779311|9720830|FG000|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||6
8677190|NCT00779311|9720831|FG001|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
8677191|NCT00779311|9720832|FG002|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
8677192|NCT00779311|9720833|FG003|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
8677193|NCT00779311|9720834|FG004|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
8677194|NCT00779311|9720830|FG000|COMPLETED|Overall Study||8
8677195|NCT00779311|9720831|FG001|COMPLETED|Overall Study||0
8677196|NCT00779311|9720832|FG002|COMPLETED|Overall Study||0
8677197|NCT00779311|9720833|FG003|COMPLETED|Overall Study||0
8677198|NCT00779311|9720834|FG004|COMPLETED|Overall Study||0
8677199|NCT00779311|9720830|FG000|NOT COMPLETED|Overall Study||0
8677200|NCT00779311|9720831|FG001|NOT COMPLETED|Overall Study||0
8677201|NCT00779311|9720832|FG002|NOT COMPLETED|Overall Study||0
8677202|NCT00779311|9720833|FG003|NOT COMPLETED|Overall Study||0
8677203|NCT00779311|9720834|FG004|NOT COMPLETED|Overall Study||0
8677204|NCT00779324|9720848|FG000|STARTED|Overall Study||82
8677205|NCT00779324|9720849|FG001|STARTED|Overall Study||86
8677206|NCT00779324|9720848|FG000|Completed 28-day Mid-point|Overall Study||80
8677207|NCT00779324|9720849|FG001|Completed 28-day Mid-point|Overall Study||81
8677208|NCT00779324|9720848|FG000|COMPLETED|Overall Study||75
8677209|NCT00779324|9720849|FG001|COMPLETED|Overall Study||82
8677210|NCT00779324|9720848|FG000|NOT COMPLETED|Overall Study||7
8677211|NCT00779324|9720849|FG001|NOT COMPLETED|Overall Study||4
8677212|NCT00779402|9720857|FG000|STARTED|Treatment Phase 1||117
8918947|NCT02204449|9978978|FG000|COMPLETED|Overall Study||39
8918948|NCT02204449|9978979|FG001|COMPLETED|Overall Study||37
8918949|NCT02204449|9978978|FG000|NOT COMPLETED|Overall Study||7
8918950|NCT02204449|9978979|FG001|NOT COMPLETED|Overall Study||11
8918951|NCT02204566|9978985|FG000|STARTED|Overall Study||5
8918952|NCT02204566|9978985|FG000|COMPLETED|Overall Study||1
8918953|NCT02204566|9978985|FG000|NOT COMPLETED|Overall Study||4
8918954|NCT02204579|9978989|FG000|STARTED|Overall Study||7
8918955|NCT02204579|9978989|FG000|Participants Started in Pre-Amendment|Overall Study|Two participants completed treatment in pre-amendment and were re-enrolled in post-amendment.|2
8918956|NCT02204579|9978989|FG000|Participants Started in Post-Amendment|Overall Study|Two participants from pre-amendment were re-enrolled with different identification numbers.|5
8918957|NCT02204579|9978989|FG000|Treated|Overall Study||5
8918958|NCT02204579|9978989|FG000|COMPLETED|Overall Study||5
8918959|NCT02204579|9978989|FG000|NOT COMPLETED|Overall Study||2
8918960|NCT02204657|9979000|FG000|STARTED|Overall Study||32
8918961|NCT02204657|9979001|FG001|STARTED|Overall Study||25
8918962|NCT02204657|9979000|FG000|COMPLETED|Overall Study||25
8918963|NCT02204657|9979001|FG001|COMPLETED|Overall Study||25
8918964|NCT02204657|9979000|FG000|NOT COMPLETED|Overall Study||7
8918965|NCT02204657|9979001|FG001|NOT COMPLETED|Overall Study||0
8918966|NCT02204748|9979007|FG000|STARTED|Overall Study||5
8918967|NCT02204748|9979007|FG000|COMPLETED|Overall Study||5
8918968|NCT02204748|9979007|FG000|NOT COMPLETED|Overall Study||0
8918969|NCT02204761|9979011|FG000|STARTED|Overall Study||6
8677213|NCT00779402|9720858|FG001|STARTED|Treatment Phase 1||59
8677214|NCT00779402|9720857|FG000|Received ≥1 Leukapherisis (Safety Set)|Treatment Phase 1||116
8918970|NCT02204761|9979011|FG000|COMPLETED|Overall Study||6
8918971|NCT02204761|9979011|FG000|NOT COMPLETED|Overall Study||0
8918972|NCT02204917|9979015|FG000|STARTED|Overall Study||31
8677215|NCT00779402|9720858|FG001|Received ≥1 Leukapherisis (Safety Set)|Treatment Phase 1||59
8677216|NCT00779402|9720857|FG000|Received ≥1 Study Product (Exposure Set)|Treatment Phase 1||113
8677217|NCT00779402|9720858|FG001|Received ≥1 Study Product (Exposure Set)|Treatment Phase 1||59
8677218|NCT00779402|9720857|FG000|Received Booster Infusion|Treatment Phase 1||50
8677219|NCT00779402|9720858|FG001|Received Booster Infusion|Treatment Phase 1||30
8677220|NCT00779402|9720857|FG000|COMPLETED|Treatment Phase 1||84
8677221|NCT00779402|9720858|FG001|COMPLETED|Treatment Phase 1||44
8677222|NCT00779402|9720857|FG000|NOT COMPLETED|Treatment Phase 1||33
8677223|NCT00779402|9720858|FG001|NOT COMPLETED|Treatment Phase 1||15
8677224|NCT00779402|9720857|FG000|STARTED|Surveillance Phase||84
8677225|NCT00779402|9720858|FG001|STARTED|Surveillance Phase||44
8677226|NCT00779402|9720857|FG000|COMPLETED|Surveillance Phase||41
8677227|NCT00779402|9720858|FG001|COMPLETED|Surveillance Phase||13
8677228|NCT00779402|9720857|FG000|NOT COMPLETED|Surveillance Phase||43
8677229|NCT00779402|9720858|FG001|NOT COMPLETED|Surveillance Phase||31
8677230|NCT00779402|9720857|FG000|STARTED|Long-term Follow-up||41
8677231|NCT00779402|9720858|FG001|STARTED|Long-term Follow-up||13
8677232|NCT00779402|9720857|FG000|COMPLETED|Long-term Follow-up||20
8677233|NCT00779402|9720858|FG001|COMPLETED|Long-term Follow-up||7
8677234|NCT00779402|9720857|FG000|NOT COMPLETED|Long-term Follow-up||21
8677235|NCT00779402|9720858|FG001|NOT COMPLETED|Long-term Follow-up||6
8677236|NCT00779467|9720868|FG000|STARTED|Overall Study||53
8677237|NCT00779467|9720869|FG001|STARTED|Overall Study||45
8677238|NCT00779467|9720870|FG002|STARTED|Overall Study||48
8677239|NCT00779467|9720871|FG003|STARTED|Overall Study||54
8677240|NCT00779467|9720868|FG000|COMPLETED|Overall Study||38
8677241|NCT00779467|9720869|FG001|COMPLETED|Overall Study||40
8677242|NCT00779467|9720870|FG002|COMPLETED|Overall Study||38
8677243|NCT00779467|9720871|FG003|COMPLETED|Overall Study||35
8677244|NCT00779467|9720868|FG000|NOT COMPLETED|Overall Study||15
8677245|NCT00779467|9720869|FG001|NOT COMPLETED|Overall Study||5
8677246|NCT00779467|9720870|FG002|NOT COMPLETED|Overall Study||10
8677247|NCT00779467|9720871|FG003|NOT COMPLETED|Overall Study||19
8677248|NCT00779506|9720881|FG000|STARTED|Overall Study||96
8677249|NCT00779506|9720881|FG000|Enrolled|Overall Study||96
8677250|NCT00779506|9720881|FG000|Screen Failed|Overall Study||2
8677251|NCT00779506|9720881|FG000|Assigned|Overall Study||94
8677252|NCT00779506|9720881|FG000|MITT|Overall Study||89
8677253|NCT00779506|9720881|FG000|Treatment Complete|Overall Study||67
8677254|NCT00779506|9720881|FG000|Withdrawal Treatment|Overall Study||27
8677255|NCT00779506|9720881|FG000|COMPLETED|Overall Study||67
8677256|NCT00779506|9720881|FG000|NOT COMPLETED|Overall Study||29
8677257|NCT00779558|9720887|FG000|STARTED|Overall Study||57
8677258|NCT00779558|9720888|FG001|STARTED|Overall Study||44
8677259|NCT00779558|9720887|FG000|COMPLETED|Overall Study||53
8677260|NCT00779558|9720888|FG001|COMPLETED|Overall Study||37
8677261|NCT00779558|9720887|FG000|NOT COMPLETED|Overall Study||4
8677262|NCT00779558|9720888|FG001|NOT COMPLETED|Overall Study||7
8677263|NCT00779584|9720903|FG000|STARTED|Overall Study||3
8677264|NCT00779584|9720904|FG001|STARTED|Overall Study||3
8677265|NCT00779584|9720905|FG002|STARTED|Overall Study||7
8677266|NCT00779584|9720906|FG003|STARTED|Overall Study||6
8677267|NCT00779584|9720907|FG004|STARTED|Overall Study||7
8677268|NCT00779584|9720908|FG005|STARTED|Overall Study||6
8677269|NCT00779584|9720909|FG006|STARTED|Overall Study||8
8677270|NCT00779584|9720910|FG007|STARTED|Overall Study||3
8677271|NCT00779584|9720911|FG008|STARTED|Overall Study||2
8677272|NCT00779584|9720903|FG000|Treated|Overall Study||3
8677273|NCT00779584|9720904|FG001|Treated|Overall Study||3
8677274|NCT00779584|9720905|FG002|Treated|Overall Study||7
8677275|NCT00779584|9720906|FG003|Treated|Overall Study||6
8677276|NCT00779584|9720907|FG004|Treated|Overall Study||7
8677277|NCT00779584|9720908|FG005|Treated|Overall Study||4
8677278|NCT00779584|9720909|FG006|Treated|Overall Study||8
8677279|NCT00779584|9720910|FG007|Treated|Overall Study||3
8677280|NCT00779584|9720911|FG008|Treated|Overall Study||2
8677281|NCT00779584|9720903|FG000|COMPLETED|Overall Study||0
8677282|NCT00779584|9720904|FG001|COMPLETED|Overall Study||0
8677283|NCT00779584|9720905|FG002|COMPLETED|Overall Study||0
8677284|NCT00779584|9720906|FG003|COMPLETED|Overall Study||0
8677285|NCT00779584|9720907|FG004|COMPLETED|Overall Study||0
8677286|NCT00779584|9720908|FG005|COMPLETED|Overall Study||0
8677287|NCT00779584|9720909|FG006|COMPLETED|Overall Study||0
8677288|NCT00779584|9720910|FG007|COMPLETED|Overall Study||0
8677289|NCT00779584|9720911|FG008|COMPLETED|Overall Study||0
8677290|NCT00779584|9720903|FG000|NOT COMPLETED|Overall Study||3
8677291|NCT00779584|9720904|FG001|NOT COMPLETED|Overall Study||3
8677292|NCT00779584|9720905|FG002|NOT COMPLETED|Overall Study||7
8677293|NCT00779584|9720906|FG003|NOT COMPLETED|Overall Study||6
8677294|NCT00779584|9720907|FG004|NOT COMPLETED|Overall Study||7
8677295|NCT00779584|9720908|FG005|NOT COMPLETED|Overall Study||6
8677296|NCT00779584|9720909|FG006|NOT COMPLETED|Overall Study||8
8677297|NCT00779584|9720910|FG007|NOT COMPLETED|Overall Study||3
8677298|NCT00779584|9720911|FG008|NOT COMPLETED|Overall Study||2
8677299|NCT00779675|9720931|FG000|STARTED|Treatment Period|One of the 660 participants did not receive study treatment.|660
8677300|NCT00779675|9720931|FG000|COMPLETED|Treatment Period||328
8677301|NCT00779675|9720931|FG000|NOT COMPLETED|Treatment Period||332
8677302|NCT00779675|9720931|FG000|STARTED|Extended Treatment Period|Clinical responders during the treatment period could enter the extended treatment period.|193
8677303|NCT00779675|9720931|FG000|COMPLETED|Extended Treatment Period||147
8677304|NCT00779675|9720931|FG000|NOT COMPLETED|Extended Treatment Period||46
8677305|NCT00779701|9720939|FG000|STARTED|Overall Study||27
8677306|NCT00779701|9720939|FG000|COMPLETED|Overall Study||27
8677307|NCT00779701|9720939|FG000|NOT COMPLETED|Overall Study||0
8677308|NCT00779766|9720945|FG000|STARTED|Month 24||3026
8677309|NCT00779766|9720946|FG001|STARTED|Month 24||3025
8677310|NCT00779766|9720945|FG000|COMPLETED|Month 24||2694
8677311|NCT00779766|9720946|FG001|COMPLETED|Month 24||2693
8677312|NCT00779766|9720945|FG000|NOT COMPLETED|Month 24||332
8677313|NCT00779766|9720946|FG001|NOT COMPLETED|Month 24||332
8677314|NCT00779766|9720945|FG000|STARTED|Month 48||2703
8677315|NCT00779766|9720946|FG001|STARTED|Month 48||2727
8677316|NCT00779766|9720945|FG000|COMPLETED|Month 48||2529
8677317|NCT00779766|9720946|FG001|COMPLETED|Month 48||2559
8677318|NCT00779766|9720945|FG000|NOT COMPLETED|Month 48||174
8677319|NCT00779766|9720946|FG001|NOT COMPLETED|Month 48||168
8677320|NCT00779766|9720945|FG000|STARTED|Month 72||2319
8677321|NCT00779766|9720946|FG001|STARTED|Month 72||2347
8677322|NCT00779766|9720945|FG000|COMPLETED|Month 72||2134
8677323|NCT00779766|9720946|FG001|COMPLETED|Month 72||2158
8677324|NCT00779766|9720945|FG000|NOT COMPLETED|Month 72||185
8677325|NCT00779766|9720946|FG001|NOT COMPLETED|Month 72||189
8677326|NCT00779779|9720953|FG000|STARTED|Overall Study||522
8677327|NCT00779779|9720953|FG000|COMPLETED|Overall Study||498
8677328|NCT00779779|9720953|FG000|NOT COMPLETED|Overall Study||24
8677329|NCT00779857|9720957|FG000|STARTED|Overall Study|70 patients treated|70
8677330|NCT00779857|9720957|FG000|30 Day Post Procedure|Overall Study|2 missed Visit|68
8677331|NCT00779857|9720957|FG000|3 Month Post Procedure|Overall Study|3 month follow-up, 65 of the subjects were available for evaluation.|65
8677332|NCT00779857|9720957|FG000|COMPLETED|Overall Study|12 Month Post procedure, 64 subjects available for evaluation|64
8677333|NCT00779857|9720957|FG000|NOT COMPLETED|Overall Study||6
8677334|NCT00779870|9720964|FG000|STARTED|Overall Study||5
8677335|NCT00779870|9720965|FG001|STARTED|Overall Study||6
8677336|NCT00779870|9720966|FG002|STARTED|Overall Study||7
8677337|NCT00779870|9720964|FG000|COMPLETED|Overall Study||5
8677338|NCT00779870|9720965|FG001|COMPLETED|Overall Study||6
8677339|NCT00779870|9720966|FG002|COMPLETED|Overall Study||7
8677340|NCT00779870|9720964|FG000|NOT COMPLETED|Overall Study||0
8677341|NCT00779870|9720965|FG001|NOT COMPLETED|Overall Study||0
8677342|NCT00779870|9720966|FG002|NOT COMPLETED|Overall Study||0
8677343|NCT00779909|9720978|FG000|STARTED|Overall Study||10
8677344|NCT00779909|9720979|FG001|STARTED|Overall Study||9
8677345|NCT00779909|9720980|FG002|STARTED|Overall Study||8
8677346|NCT00779909|9720981|FG003|STARTED|Overall Study||8
8677347|NCT00779909|9720978|FG000|COMPLETED|Overall Study||9
8677348|NCT00779909|9720979|FG001|COMPLETED|Overall Study||8
8677349|NCT00779909|9720980|FG002|COMPLETED|Overall Study||8
8677350|NCT00779909|9720981|FG003|COMPLETED|Overall Study||7
8677351|NCT00779909|9720978|FG000|NOT COMPLETED|Overall Study||1
8677352|NCT00779909|9720979|FG001|NOT COMPLETED|Overall Study||1
8677353|NCT00779909|9720980|FG002|NOT COMPLETED|Overall Study||0
8677354|NCT00779909|9720981|FG003|NOT COMPLETED|Overall Study||1
8677355|NCT00780026|9721000|FG000|STARTED|Overall Study||50
8677356|NCT00780026|9721001|FG001|STARTED|Overall Study||50
8677357|NCT00780026|9721000|FG000|COMPLETED|Overall Study||50
8677358|NCT00780026|9721001|FG001|COMPLETED|Overall Study||50
8677359|NCT00780026|9721000|FG000|NOT COMPLETED|Overall Study||0
8677360|NCT00780026|9721001|FG001|NOT COMPLETED|Overall Study||0
8677361|NCT00780143|9721007|FG000|STARTED|Overall Study||3
8677362|NCT00780143|9721007|FG000|COMPLETED|Overall Study||0
8677363|NCT00780143|9721007|FG000|NOT COMPLETED|Overall Study||3
8677364|NCT00780208|9721011|FG000|STARTED|Overall Study||14
8677365|NCT00780208|9721011|FG000|COMPLETED|Overall Study||8
8677366|NCT00780208|9721011|FG000|NOT COMPLETED|Overall Study||6
8677367|NCT00780234|9721017|FG000|STARTED|Overall Study||47
8677368|NCT00780234|9721018|FG001|STARTED|Overall Study||45
8677369|NCT00780234|9721017|FG000|COMPLETED|Overall Study||39
8677370|NCT00780234|9721018|FG001|COMPLETED|Overall Study||37
8677371|NCT00780234|9721017|FG000|NOT COMPLETED|Overall Study||8
8677372|NCT00780234|9721018|FG001|NOT COMPLETED|Overall Study||8
8677373|NCT00780273|9721024|FG000|STARTED|Overall Study||19
8677374|NCT00780273|9721024|FG000|COMPLETED|Overall Study||17
8677375|NCT00780273|9721024|FG000|NOT COMPLETED|Overall Study||2
8677376|NCT00780338|9721031|FG000|STARTED|Baseline to Mid (1 Year)||174
8677377|NCT00780338|9721032|FG001|STARTED|Baseline to Mid (1 Year)||202
8677378|NCT00780338|9721031|FG000|COMPLETED|Baseline to Mid (1 Year)||169
8677379|NCT00780338|9721032|FG001|COMPLETED|Baseline to Mid (1 Year)||164
8677380|NCT00780338|9721031|FG000|NOT COMPLETED|Baseline to Mid (1 Year)||5
8677381|NCT00780338|9721032|FG001|NOT COMPLETED|Baseline to Mid (1 Year)||38
8677382|NCT00780338|9721031|FG000|STARTED|Mid to Post (1 Year; 2 Years in Total)||169
8677383|NCT00780338|9721032|FG001|STARTED|Mid to Post (1 Year; 2 Years in Total)||164
8677384|NCT00780338|9721031|FG000|COMPLETED|Mid to Post (1 Year; 2 Years in Total)||156
8677385|NCT00780338|9721032|FG001|COMPLETED|Mid to Post (1 Year; 2 Years in Total)||159
8677386|NCT00780338|9721031|FG000|NOT COMPLETED|Mid to Post (1 Year; 2 Years in Total)||13
8677387|NCT00780338|9721032|FG001|NOT COMPLETED|Mid to Post (1 Year; 2 Years in Total)||5
8677388|NCT00780416|9721044|FG000|STARTED|Overall Study||126
8677389|NCT00780416|9721045|FG001|STARTED|Overall Study||63
8677390|NCT00780416|9721044|FG000|COMPLETED|Overall Study||114
8677391|NCT00780416|9721045|FG001|COMPLETED|Overall Study||54
8677392|NCT00780416|9721044|FG000|NOT COMPLETED|Overall Study||12
8677393|NCT00780416|9721045|FG001|NOT COMPLETED|Overall Study||9
8677394|NCT00780442|9721053|FG000|STARTED|Overall Study||12
8677395|NCT00780442|9721054|FG001|STARTED|Overall Study||15
8677396|NCT00780442|9721053|FG000|COMPLETED|Overall Study||12
8677397|NCT00780442|9721054|FG001|COMPLETED|Overall Study||15
8677398|NCT00780442|9721053|FG000|NOT COMPLETED|Overall Study||0
8677399|NCT00780442|9721054|FG001|NOT COMPLETED|Overall Study||0
8677400|NCT00780494|9721060|FG000|STARTED|Overall Study||35
8677401|NCT00780494|9721060|FG000|COMPLETED|Overall Study||35
8677402|NCT00780494|9721060|FG000|NOT COMPLETED|Overall Study||0
8677403|NCT00780559|9721066|FG000|STARTED|Overall Study||32
8677404|NCT00780559|9721067|FG001|STARTED|Overall Study||40
8677405|NCT00780559|9721066|FG000|COMPLETED|Overall Study||29
8677406|NCT00780559|9721067|FG001|COMPLETED|Overall Study||33
8677407|NCT00780559|9721066|FG000|NOT COMPLETED|Overall Study||3
8677408|NCT00780559|9721067|FG001|NOT COMPLETED|Overall Study||7
8677409|NCT00780572|9721077|FG000|STARTED|Overall Study||297
8677410|NCT00780572|9721078|FG001|STARTED|Overall Study||298
8677411|NCT00780572|9721077|FG000|COMPLETED|Overall Study||297
8677412|NCT00780572|9721078|FG001|COMPLETED|Overall Study||298
8677413|NCT00780572|9721077|FG000|NOT COMPLETED|Overall Study||0
8677414|NCT00780572|9721078|FG001|NOT COMPLETED|Overall Study||0
8677415|NCT00780676|9721089|FG000|STARTED|Overall Study||9
8677416|NCT00780676|9721090|FG001|STARTED|Overall Study||8
8677417|NCT00780676|9721091|FG002|STARTED|Overall Study||13
8677418|NCT00780676|9721092|FG003|STARTED|Overall Study||0
8677419|NCT00780676|9721093|FG004|STARTED|Overall Study||0
8677420|NCT00780676|9721089|FG000|COMPLETED|Overall Study||9
8677421|NCT00780676|9721090|FG001|COMPLETED|Overall Study||8
8677422|NCT00780676|9721091|FG002|COMPLETED|Overall Study||13
8677423|NCT00780676|9721092|FG003|COMPLETED|Overall Study||0
8677424|NCT00780676|9721093|FG004|COMPLETED|Overall Study||0
8677425|NCT00780676|9721089|FG000|NOT COMPLETED|Overall Study||0
8677426|NCT00780676|9721090|FG001|NOT COMPLETED|Overall Study||0
8677427|NCT00780676|9721091|FG002|NOT COMPLETED|Overall Study||0
8677428|NCT00780676|9721092|FG003|NOT COMPLETED|Overall Study||0
8677429|NCT00780676|9721093|FG004|NOT COMPLETED|Overall Study||0
8677430|NCT00780715|9721103|FG000|STARTED|Overall Study||6
8677431|NCT00780715|9721104|FG001|STARTED|Overall Study||6
8677432|NCT00780715|9721105|FG002|STARTED|Overall Study||6
8677433|NCT00780715|9721106|FG003|STARTED|Overall Study||11
8677434|NCT00780715|9721103|FG000|COMPLETED|Overall Study||6
8677435|NCT00780715|9721104|FG001|COMPLETED|Overall Study||6
8677436|NCT00780715|9721105|FG002|COMPLETED|Overall Study||6
8677437|NCT00780715|9721106|FG003|COMPLETED|Overall Study||11
8677438|NCT00780715|9721103|FG000|NOT COMPLETED|Overall Study||0
8677439|NCT00780715|9721104|FG001|NOT COMPLETED|Overall Study||0
8677440|NCT00780715|9721105|FG002|NOT COMPLETED|Overall Study||0
8677441|NCT00780715|9721106|FG003|NOT COMPLETED|Overall Study||0
8677442|NCT00780741|9721118|FG000|STARTED|Overall Study|randomized|82
8677443|NCT00780741|9721119|FG001|STARTED|Overall Study|randomized|81
8677444|NCT00780741|9721118|FG000|6-Month Visit|Overall Study|6 months (±2 weeks) timed from randomization|73
8677445|NCT00780741|9721119|FG001|6-Month Visit|Overall Study|6 months (±2 weeks) timed from randomization|67
8677446|NCT00780741|9721118|FG000|COMPLETED|Overall Study|18 months of age (±4 weeks)|75
8677447|NCT00780741|9721119|FG001|COMPLETED|Overall Study|18 months of age (±4 weeks)|71
8677448|NCT00780741|9721118|FG000|NOT COMPLETED|Overall Study||7
8677449|NCT00780741|9721119|FG001|NOT COMPLETED|Overall Study||10
8677450|NCT00780910|9721126|FG000|STARTED|Overall Study||109
8677451|NCT00780910|9721126|FG000|COMPLETED|Overall Study||107
8677452|NCT00780910|9721126|FG000|NOT COMPLETED|Overall Study||2
8677453|NCT00780962|9721132|FG000|STARTED|Overall Study||200
8677454|NCT00780962|9721133|FG001|STARTED|Overall Study||199
8677455|NCT00780962|9721132|FG000|Second Blood Draw (Outcome Measurement)|Overall Study||185
8677456|NCT00780962|9721133|FG001|Second Blood Draw (Outcome Measurement)|Overall Study||172
8677457|NCT00780962|9721132|FG000|COMPLETED|Overall Study||185
8677458|NCT00780962|9721133|FG001|COMPLETED|Overall Study||172
8677459|NCT00780962|9721132|FG000|NOT COMPLETED|Overall Study||15
8677460|NCT00780962|9721133|FG001|NOT COMPLETED|Overall Study||27
8677461|NCT00780975|9721139|FG000|STARTED|Overall Study||8
8677462|NCT00780975|9721139|FG000|COMPLETED|Overall Study||0
8677463|NCT00780975|9721139|FG000|NOT COMPLETED|Overall Study||8
8677464|NCT00781079|9721145|FG000|STARTED|Overall Study||149
8677465|NCT00781079|9721146|FG001|STARTED|Overall Study||133
8677466|NCT00781079|9721145|FG000|COMPLETED|Overall Study||122
8677467|NCT00781079|9721146|FG001|COMPLETED|Overall Study||116
8677468|NCT00781079|9721145|FG000|NOT COMPLETED|Overall Study||27
8677469|NCT00781079|9721146|FG001|NOT COMPLETED|Overall Study||17
8677470|NCT00781274|9721152|FG000|STARTED|Overall Study||32
8677471|NCT00781274|9721152|FG000|COMPLETED|Overall Study||30
8677472|NCT00781274|9721152|FG000|NOT COMPLETED|Overall Study||2
8677473|NCT00781326|9721156|FG000|STARTED|Phase I|Nine subjects consented; 3 did not meet eligibility criteria. 6 started antidepressant treatment.|6
8677474|NCT00781326|9721156|FG000|COMPLETED|Phase I||2
8677475|NCT00781326|9721156|FG000|NOT COMPLETED|Phase I||4
8677476|NCT00781326|9721156|FG000|STARTED|Phase 2|Study terminated prior to enrollment into Phase II|0
8677477|NCT00781326|9721156|FG000|COMPLETED|Phase 2||0
8677478|NCT00781326|9721156|FG000|NOT COMPLETED|Phase 2||0
8677479|NCT00781365|9721162|FG000|STARTED|Overall Study||228
8677480|NCT00781365|9721163|FG001|STARTED|Overall Study||222
8677481|NCT00781365|9721162|FG000|COMPLETED|Overall Study|completed both 6 and 12 month follow up|194
8677482|NCT00781365|9721163|FG001|COMPLETED|Overall Study|completed both 6 and 12 month follow up|186
8677483|NCT00781365|9721162|FG000|NOT COMPLETED|Overall Study||34
8677484|NCT00781365|9721163|FG001|NOT COMPLETED|Overall Study||36
8677485|NCT00781391|9721172|FG000|STARTED|Overall Study||7036
8677486|NCT00781391|9721173|FG001|STARTED|Overall Study||7035
8677487|NCT00781391|9721174|FG002|STARTED|Overall Study||7034
8677488|NCT00781391|9721172|FG000|Safety Analysis Set (Received Drug)|Overall Study||7012
8677489|NCT00781391|9721173|FG001|Safety Analysis Set (Received Drug)|Overall Study||7012
8677490|NCT00781391|9721174|FG002|Safety Analysis Set (Received Drug)|Overall Study||7002
8677491|NCT00781391|9721172|FG000|mITT Analysis Set (Received Drug)|Overall Study||7012
8677492|NCT00781391|9721173|FG001|mITT Analysis Set (Received Drug)|Overall Study||7012
8677493|NCT00781391|9721174|FG002|mITT Analysis Set (Received Drug)|Overall Study||7002
8677494|NCT00781391|9721172|FG000|Per Protocol Analysis Set|Overall Study||6993
8677495|NCT00781391|9721173|FG001|Per Protocol Analysis Set|Overall Study||6995
8677496|NCT00781391|9721174|FG002|Per Protocol Analysis Set|Overall Study||6982
8677497|NCT00781391|9721172|FG000|COMPLETED|Overall Study||6157
8677498|NCT00781391|9721173|FG001|COMPLETED|Overall Study||6228
8677499|NCT00781391|9721174|FG002|COMPLETED|Overall Study||6250
8677500|NCT00781391|9721172|FG000|NOT COMPLETED|Overall Study||879
8677501|NCT00781391|9721173|FG001|NOT COMPLETED|Overall Study||807
8677502|NCT00781391|9721174|FG002|NOT COMPLETED|Overall Study||784
8677503|NCT00781456|9721184|FG000|STARTED|Overall Study||58
8677504|NCT00781456|9721185|FG001|STARTED|Overall Study||51
8677505|NCT00781456|9721184|FG000|Received Study Drug|Overall Study||57
8677506|NCT00781456|9721185|FG001|Received Study Drug|Overall Study||49
8677507|NCT00781456|9721184|FG000|COMPLETED|Overall Study||37
8677508|NCT00781456|9721185|FG001|COMPLETED|Overall Study||35
8677509|NCT00781456|9721184|FG000|NOT COMPLETED|Overall Study||21
8677510|NCT00781456|9721185|FG001|NOT COMPLETED|Overall Study||16
8677511|NCT00781508|9721193|FG000|STARTED|Overall Study|"First Intervention (1 day), Washout (48 hours), Second Intervention (1 day)"|5
8677512|NCT00781508|9721194|FG001|STARTED|Overall Study|"First Intervention (1 day), Washout (48 hours), Second Intervention (1 day)"|5
8677513|NCT00781508|9721193|FG000|COMPLETED|Overall Study||5
8677514|NCT00781508|9721194|FG001|COMPLETED|Overall Study||5
8677515|NCT00781508|9721193|FG000|NOT COMPLETED|Overall Study||0
8677516|NCT00781508|9721194|FG001|NOT COMPLETED|Overall Study||0
8677517|NCT00781599|9721204|FG000|STARTED|Overall Study||36
8677518|NCT00781599|9721205|FG001|STARTED|Overall Study||36
8677519|NCT00781599|9721204|FG000|COMPLETED|Overall Study||29
8677520|NCT00781599|9721205|FG001|COMPLETED|Overall Study||32
8677521|NCT00781599|9721204|FG000|NOT COMPLETED|Overall Study||7
8677522|NCT00781599|9721205|FG001|NOT COMPLETED|Overall Study||4
8677523|NCT00781768|9721213|FG000|STARTED|Overall Study||89
8677524|NCT00781768|9721214|FG001|STARTED|Overall Study||92
8677525|NCT00781768|9721213|FG000|COMPLETED|Overall Study||89
8677526|NCT00781768|9721214|FG001|COMPLETED|Overall Study||90
8677527|NCT00781768|9721213|FG000|NOT COMPLETED|Overall Study||0
8677528|NCT00781768|9721214|FG001|NOT COMPLETED|Overall Study||2
8677529|NCT00781859|9721222|FG000|STARTED|Overall Study||219
8677530|NCT00781859|9721223|FG001|STARTED|Overall Study||107
8677531|NCT00781859|9721222|FG000|COMPLETED|Overall Study||200
8677532|NCT00781859|9721223|FG001|COMPLETED|Overall Study||98
8677533|NCT00781859|9721222|FG000|NOT COMPLETED|Overall Study||19
8677534|NCT00781859|9721223|FG001|NOT COMPLETED|Overall Study||9
8677535|NCT00781885|9721229|FG000|STARTED|Overall Study||19
8677536|NCT00781885|9721229|FG000|Received at Least 1 Dose of Study Drug|Overall Study||19
8677537|NCT00781885|9721229|FG000|COMPLETED|Overall Study||18
8677538|NCT00781885|9721229|FG000|NOT COMPLETED|Overall Study||1
8677539|NCT00781898|9721235|FG000|STARTED|Overall Study||153
8677540|NCT00781898|9721236|FG001|STARTED|Overall Study||155
8677541|NCT00781898|9721235|FG000|COMPLETED|Overall Study||119
8677542|NCT00781898|9721236|FG001|COMPLETED|Overall Study||126
8677543|NCT00781898|9721235|FG000|NOT COMPLETED|Overall Study||34
8677544|NCT00781898|9721236|FG001|NOT COMPLETED|Overall Study||29
8677545|NCT00781911|9721244|FG000|STARTED|Overall Study||31
8677546|NCT00781911|9721245|FG001|STARTED|Overall Study||12
8677547|NCT00781911|9721244|FG000|Received at Least 1 Dose of Study Drug|Overall Study||31
8677548|NCT00781911|9721245|FG001|Received at Least 1 Dose of Study Drug|Overall Study||12
8677549|NCT00781911|9721244|FG000|COMPLETED|Overall Study||25
8677550|NCT00781911|9721245|FG001|COMPLETED|Overall Study||4
8677551|NCT00781911|9721244|FG000|NOT COMPLETED|Overall Study||6
8677552|NCT00781911|9721245|FG001|NOT COMPLETED|Overall Study||8
8677553|NCT00781937|9721255|FG000|STARTED|Main Trial Period Through Week 56||212
8677554|NCT00781937|9721256|FG001|STARTED|Main Trial Period Through Week 56||210
8677555|NCT00781937|9721255|FG000|COMPLETED|Main Trial Period Through Week 56||159
8677556|NCT00781937|9721256|FG001|COMPLETED|Main Trial Period Through Week 56||146
8677557|NCT00781937|9721255|FG000|NOT COMPLETED|Main Trial Period Through Week 56||53
8677558|NCT00781937|9721256|FG001|NOT COMPLETED|Main Trial Period Through Week 56||64
8677559|NCT00781937|9721255|FG000|STARTED|Follow up Period (Week 56-68)||159
8677560|NCT00781937|9721256|FG001|STARTED|Follow up Period (Week 56-68)||146
8677561|NCT00781937|9721255|FG000|COMPLETED|Follow up Period (Week 56-68)||153
8677562|NCT00781937|9721256|FG001|COMPLETED|Follow up Period (Week 56-68)||141
8677563|NCT00781937|9721255|FG000|NOT COMPLETED|Follow up Period (Week 56-68)||6
8677564|NCT00781937|9721256|FG001|NOT COMPLETED|Follow up Period (Week 56-68)||5
8677565|NCT00781950|9721264|FG000|STARTED|Overall Study||52
8677566|NCT00781950|9721265|FG001|STARTED|Overall Study||58
8677567|NCT00781950|9721264|FG000|COMPLETED|Overall Study||41
8677568|NCT00781950|9721265|FG001|COMPLETED|Overall Study||45
8677569|NCT00781950|9721264|FG000|NOT COMPLETED|Overall Study||11
8677570|NCT00781950|9721265|FG001|NOT COMPLETED|Overall Study||13
8677571|NCT00781963|9721274|FG000|STARTED|Overall Study||106
8677572|NCT00781963|9721275|FG001|STARTED|Overall Study||53
8677573|NCT00781963|9721274|FG000|COMPLETED|Overall Study||89
8799753|NCT01439867|9851364|FG000|Received Treatment|Overall Study||7
8799754|NCT01439867|9851365|FG001|Received Treatment|Overall Study||10
8799755|NCT01439867|9851364|FG000|COMPLETED|Overall Study||2
8799756|NCT01439867|9851365|FG001|COMPLETED|Overall Study||2
8799757|NCT01439867|9851364|FG000|NOT COMPLETED|Overall Study||6
8799758|NCT01439867|9851365|FG001|NOT COMPLETED|Overall Study||8
8799759|NCT01439880|9851375|FG000|STARTED|SOC-controlled Period (Year 1)||442
8799760|NCT01439880|9851376|FG001|STARTED|SOC-controlled Period (Year 1)||882
8799761|NCT01439880|9851375|FG000|Received Evolocumab|SOC-controlled Period (Year 1)||0
8799762|NCT01439880|9851376|FG001|Received Evolocumab|SOC-controlled Period (Year 1)||881
8799763|NCT01439880|9851375|FG000|COMPLETED|SOC-controlled Period (Year 1)||398
8799764|NCT01439880|9851376|FG001|COMPLETED|SOC-controlled Period (Year 1)||822
8799765|NCT01439880|9851375|FG000|NOT COMPLETED|SOC-controlled Period (Year 1)||44
8799766|NCT01439880|9851376|FG001|NOT COMPLETED|SOC-controlled Period (Year 1)||60
8799767|NCT01439880|9851375|FG000|STARTED|All-IP Period (Years 2 to 5)||398
8799768|NCT01439880|9851376|FG001|STARTED|All-IP Period (Years 2 to 5)||822
8799769|NCT01439880|9851375|FG000|Received Evolocumab|All-IP Period (Years 2 to 5)||374
8799770|NCT01439880|9851376|FG001|Received Evolocumab|All-IP Period (Years 2 to 5)||777
8799771|NCT01439880|9851375|FG000|COMPLETED|All-IP Period (Years 2 to 5)||328
8799772|NCT01439880|9851376|FG001|COMPLETED|All-IP Period (Years 2 to 5)||682
8799773|NCT01439880|9851375|FG000|NOT COMPLETED|All-IP Period (Years 2 to 5)||70
8799774|NCT01439880|9851376|FG001|NOT COMPLETED|All-IP Period (Years 2 to 5)||140
8799775|NCT01439945|9851396|FG000|STARTED|Double-Blind Treatment Phase||97
8799776|NCT01439945|9851397|FG001|STARTED|Double-Blind Treatment Phase||96
8799777|NCT01439945|9851398|FG002|STARTED|Double-Blind Treatment Phase||48
8799778|NCT01439945|9851399|FG003|STARTED|Double-Blind Treatment Phase||48
8799779|NCT01439945|9851396|FG000|COMPLETED|Double-Blind Treatment Phase||93
8799780|NCT01439945|9851397|FG001|COMPLETED|Double-Blind Treatment Phase||91
8799781|NCT01439945|9851398|FG002|COMPLETED|Double-Blind Treatment Phase||45
8799782|NCT01439945|9851399|FG003|COMPLETED|Double-Blind Treatment Phase||46
8799783|NCT01439945|9851396|FG000|NOT COMPLETED|Double-Blind Treatment Phase||4
8799784|NCT01439945|9851397|FG001|NOT COMPLETED|Double-Blind Treatment Phase||5
8799785|NCT01439945|9851398|FG002|NOT COMPLETED|Double-Blind Treatment Phase||3
8799786|NCT01439945|9851399|FG003|NOT COMPLETED|Double-Blind Treatment Phase||2
8799787|NCT01439945|9851396|FG000|STARTED|Optional Continuation Phase||72
8799788|NCT01439945|9851397|FG001|STARTED|Optional Continuation Phase||44
8799789|NCT01439945|9851398|FG002|STARTED|Optional Continuation Phase||0
8799790|NCT01439945|9851399|FG003|STARTED|Optional Continuation Phase||0
8799791|NCT01439945|9851396|FG000|COMPLETED|Optional Continuation Phase||72
8799792|NCT01439945|9851397|FG001|COMPLETED|Optional Continuation Phase||44
8799793|NCT01439945|9851398|FG002|COMPLETED|Optional Continuation Phase||0
8799794|NCT01439945|9851399|FG003|COMPLETED|Optional Continuation Phase||0
8799795|NCT01439945|9851396|FG000|NOT COMPLETED|Optional Continuation Phase||0
8799796|NCT01439945|9851397|FG001|NOT COMPLETED|Optional Continuation Phase||0
8799797|NCT01439945|9851398|FG002|NOT COMPLETED|Optional Continuation Phase||0
8799798|NCT01439945|9851399|FG003|NOT COMPLETED|Optional Continuation Phase||0
8799799|NCT01439971|9851415|FG000|STARTED|Overall Study||1
8799800|NCT01439971|9851416|FG001|STARTED|Overall Study||7
8799801|NCT01439971|9851417|FG002|STARTED|Overall Study||8
8799802|NCT01439971|9851418|FG003|STARTED|Overall Study||6
8799803|NCT01439971|9851419|FG004|STARTED|Overall Study||7
8799804|NCT01439971|9851415|FG000|Received Treatment|Overall Study||1
8799805|NCT01439971|9851416|FG001|Received Treatment|Overall Study||6
8799806|NCT01439971|9851417|FG002|Received Treatment|Overall Study||6
8799807|NCT01439971|9851418|FG003|Received Treatment|Overall Study||6
8799808|NCT01439971|9851419|FG004|Received Treatment|Overall Study||6
8799809|NCT01439971|9851415|FG000|COMPLETED|Overall Study||1
8799810|NCT01439971|9851416|FG001|COMPLETED|Overall Study||6
8799811|NCT01439971|9851417|FG002|COMPLETED|Overall Study||6
8799812|NCT01439971|9851418|FG003|COMPLETED|Overall Study||6
8799813|NCT01439971|9851419|FG004|COMPLETED|Overall Study||6
8799814|NCT01439971|9851415|FG000|NOT COMPLETED|Overall Study||0
8799815|NCT01439971|9851416|FG001|NOT COMPLETED|Overall Study||1
8799816|NCT01439971|9851417|FG002|NOT COMPLETED|Overall Study||2
8799817|NCT01439971|9851418|FG003|NOT COMPLETED|Overall Study||0
8799818|NCT01439971|9851419|FG004|NOT COMPLETED|Overall Study||1
8799819|NCT01440049|9851431|FG000|STARTED|Overall Study||160
8799820|NCT01440049|9851431|FG000|COMPLETED|Overall Study||155
8799821|NCT01440049|9851431|FG000|NOT COMPLETED|Overall Study||5
8799822|NCT01440101|9851438|FG000|STARTED|Overall Study||12
8799823|NCT01440101|9851439|FG001|STARTED|Overall Study||47
8799824|NCT01440101|9851440|FG002|STARTED|Overall Study||47
8799825|NCT01440101|9851438|FG000|COMPLETED|Overall Study||10
8799826|NCT01440101|9851439|FG001|COMPLETED|Overall Study||43
8799827|NCT01440101|9851440|FG002|COMPLETED|Overall Study||46
8799828|NCT01440101|9851438|FG000|NOT COMPLETED|Overall Study||2
8799829|NCT01440101|9851439|FG001|NOT COMPLETED|Overall Study||4
8918973|NCT02204917|9979015|FG000|COMPLETED|Overall Study||30
8918974|NCT02204917|9979015|FG000|NOT COMPLETED|Overall Study||1
8677574|NCT00781963|9721275|FG001|COMPLETED|Overall Study||51
8677575|NCT00781963|9721274|FG000|NOT COMPLETED|Overall Study||17
8677576|NCT00781963|9721275|FG001|NOT COMPLETED|Overall Study||2
8677577|NCT00782067|9721281|FG000|STARTED|Overall Study||116
8677578|NCT00782067|9721281|FG000|Safety Set (SS)|Overall Study||116
8677579|NCT00782067|9721281|FG000|Primary Efficacy Population (PEP)|Overall Study||89
8677580|NCT00782067|9721281|FG000|COMPLETED|Overall Study||0
8677581|NCT00782067|9721281|FG000|NOT COMPLETED|Overall Study||116
8677582|NCT00782171|9721287|FG000|STARTED|Overall Study||146
8677583|NCT00782171|9721288|FG001|STARTED|Overall Study||134
8677584|NCT00782171|9721287|FG000|20-23 Weeks|Overall Study||135
8677585|NCT00782171|9721288|FG001|20-23 Weeks|Overall Study||124
8677586|NCT00782171|9721287|FG000|1 Year|Overall Study||131
8677587|NCT00782171|9721288|FG001|1 Year|Overall Study||120
8677588|NCT00782171|9721287|FG000|Surgery (Baseline)|Overall Study||138
8677589|NCT00782171|9721288|FG001|Surgery (Baseline)|Overall Study||128
8677590|NCT00782171|9721287|FG000|COMPLETED|Overall Study||124
8677591|NCT00782171|9721288|FG001|COMPLETED|Overall Study||115
8677592|NCT00782171|9721287|FG000|NOT COMPLETED|Overall Study||22
8677593|NCT00782171|9721288|FG001|NOT COMPLETED|Overall Study||19
8677594|NCT00782210|9721297|FG000|STARTED|Overall Study||209
8677595|NCT00782210|9721298|FG001|STARTED|Overall Study||208
8677596|NCT00782210|9721299|FG002|STARTED|Overall Study||207
8677597|NCT00782210|9721297|FG000|COMPLETED|Overall Study||159
8677598|NCT00782210|9721298|FG001|COMPLETED|Overall Study||173
8677599|NCT00782210|9721299|FG002|COMPLETED|Overall Study||172
8677600|NCT00782210|9721297|FG000|NOT COMPLETED|Overall Study||50
8677601|NCT00782210|9721298|FG001|NOT COMPLETED|Overall Study||35
8677602|NCT00782210|9721299|FG002|NOT COMPLETED|Overall Study||35
8677603|NCT00782275|9721316|FG000|STARTED|Overall Study||41
8677604|NCT00782275|9721316|FG000|Treated|Overall Study||40
8677605|NCT00782275|9721316|FG000|Prior VEGFR Response Evaluable|Overall Study|One patient was unevaluable and therefore excluded from related subgroup analyses.|39
8677606|NCT00782275|9721316|FG000|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
8677607|NCT00782275|9721316|FG000|NOT COMPLETED|Overall Study||41
8677608|NCT00782340|9721323|FG000|STARTED|Open Label Titration||263
8677609|NCT00782340|9721324|FG001|STARTED|Open Label Titration||0
8677610|NCT00782340|9721325|FG002|STARTED|Open Label Titration||0
8677611|NCT00782340|9721323|FG000|COMPLETED|Open Label Titration||162
8677612|NCT00782340|9721324|FG001|COMPLETED|Open Label Titration||0
8677613|NCT00782340|9721325|FG002|COMPLETED|Open Label Titration||0
8677614|NCT00782340|9721323|FG000|NOT COMPLETED|Open Label Titration||101
8677615|NCT00782340|9721324|FG001|NOT COMPLETED|Open Label Titration||0
8677616|NCT00782340|9721325|FG002|NOT COMPLETED|Open Label Titration||0
8677617|NCT00782340|9721323|FG000|STARTED|Randomized Double Blind||0
8677618|NCT00782340|9721324|FG001|STARTED|Randomized Double Blind||82
8677619|NCT00782340|9721325|FG002|STARTED|Randomized Double Blind||80
8677620|NCT00782340|9721323|FG000|COMPLETED|Randomized Double Blind||0
8677621|NCT00782340|9721324|FG001|COMPLETED|Randomized Double Blind||82
8677622|NCT00782340|9721325|FG002|COMPLETED|Randomized Double Blind||80
8677623|NCT00782340|9721323|FG000|NOT COMPLETED|Randomized Double Blind||0
8677624|NCT00782340|9721324|FG001|NOT COMPLETED|Randomized Double Blind||0
8677625|NCT00782340|9721325|FG002|NOT COMPLETED|Randomized Double Blind||0
8677626|NCT00782379|9721332|FG000|STARTED|Overall Study||20
8677627|NCT00782379|9721332|FG000|COMPLETED|Overall Study||20
8677628|NCT00782379|9721332|FG000|NOT COMPLETED|Overall Study||0
8677629|NCT00782418|9721336|FG000|STARTED|Period 1 Procedure/Treatment Groups||3
8677630|NCT00782418|9721337|FG001|STARTED|Period 1 Procedure/Treatment Groups||4
8677631|NCT00782418|9721338|FG002|STARTED|Period 1 Procedure/Treatment Groups||4
8677632|NCT00782418|9721339|FG003|STARTED|Period 1 Procedure/Treatment Groups||2
8677633|NCT00782418|9721340|FG004|STARTED|Period 1 Procedure/Treatment Groups||5
8677634|NCT00782418|9721341|FG005|STARTED|Period 1 Procedure/Treatment Groups||5
8677635|NCT00782418|9721342|FG006|STARTED|Period 1 Procedure/Treatment Groups||4
8677636|NCT00782418|9721336|FG000|COMPLETED|Period 1 Procedure/Treatment Groups||1
8677637|NCT00782418|9721337|FG001|COMPLETED|Period 1 Procedure/Treatment Groups||4
8677638|NCT00782418|9721338|FG002|COMPLETED|Period 1 Procedure/Treatment Groups||4
8677639|NCT00782418|9721339|FG003|COMPLETED|Period 1 Procedure/Treatment Groups||2
8677640|NCT00782418|9721340|FG004|COMPLETED|Period 1 Procedure/Treatment Groups||4
8677641|NCT00782418|9721341|FG005|COMPLETED|Period 1 Procedure/Treatment Groups||4
8677642|NCT00782418|9721342|FG006|COMPLETED|Period 1 Procedure/Treatment Groups||4
8677643|NCT00782418|9721336|FG000|NOT COMPLETED|Period 1 Procedure/Treatment Groups||2
8677644|NCT00782418|9721337|FG001|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
8677645|NCT00782418|9721338|FG002|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
8677646|NCT00782418|9721339|FG003|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
8677647|NCT00782418|9721340|FG004|NOT COMPLETED|Period 1 Procedure/Treatment Groups||1
8677648|NCT00782418|9721341|FG005|NOT COMPLETED|Period 1 Procedure/Treatment Groups||1
8677649|NCT00782418|9721342|FG006|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
8677650|NCT00782418|9721336|FG000|STARTED|Period 2 Procedure/Treatment Groups||3
8677651|NCT00782418|9721337|FG001|STARTED|Period 2 Procedure/Treatment Groups||4
8677652|NCT00782418|9721338|FG002|STARTED|Period 2 Procedure/Treatment Groups||4
8677653|NCT00782418|9721339|FG003|STARTED|Period 2 Procedure/Treatment Groups||1
8677654|NCT00782418|9721340|FG004|STARTED|Period 2 Procedure/Treatment Groups||3
8677655|NCT00782418|9721341|FG005|STARTED|Period 2 Procedure/Treatment Groups||4
8677656|NCT00782418|9721342|FG006|STARTED|Period 2 Procedure/Treatment Groups||4
8677657|NCT00782418|9721336|FG000|COMPLETED|Period 2 Procedure/Treatment Groups||3
8677658|NCT00782418|9721337|FG001|COMPLETED|Period 2 Procedure/Treatment Groups||4
8677659|NCT00782418|9721338|FG002|COMPLETED|Period 2 Procedure/Treatment Groups||4
8677660|NCT00782418|9721339|FG003|COMPLETED|Period 2 Procedure/Treatment Groups||1
8677661|NCT00782418|9721340|FG004|COMPLETED|Period 2 Procedure/Treatment Groups||3
8677662|NCT00782418|9721341|FG005|COMPLETED|Period 2 Procedure/Treatment Groups||4
8677663|NCT00782418|9721342|FG006|COMPLETED|Period 2 Procedure/Treatment Groups||4
8677664|NCT00782418|9721336|FG000|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
8677665|NCT00782418|9721337|FG001|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
8677666|NCT00782418|9721338|FG002|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
8677667|NCT00782418|9721339|FG003|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
8677668|NCT00782418|9721340|FG004|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
8677669|NCT00782418|9721341|FG005|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
8677670|NCT00782418|9721342|FG006|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
8677671|NCT00782496|9721358|FG000|STARTED|Overall Study||106
8677672|NCT00782496|9721359|FG001|STARTED|Overall Study||105
8677673|NCT00782496|9721358|FG000|COMPLETED|Overall Study||92
8677674|NCT00782496|9721359|FG001|COMPLETED|Overall Study||90
8677675|NCT00782496|9721358|FG000|NOT COMPLETED|Overall Study||14
8677676|NCT00782496|9721359|FG001|NOT COMPLETED|Overall Study||15
8692790|NCT00862849|9738278|FG000|STARTED|Intervention 3||3
8692791|NCT00862849|9738279|FG001|STARTED|Intervention 3||3
8692792|NCT00862849|9738280|FG002|STARTED|Intervention 3||3
8692793|NCT00862849|9738281|FG003|STARTED|Intervention 3||4
8692794|NCT00862849|9738282|FG004|STARTED|Intervention 3||4
8692795|NCT00862849|9738283|FG005|STARTED|Intervention 3||3
8692796|NCT00862849|9738278|FG000|COMPLETED|Intervention 3||3
8692797|NCT00862849|9738279|FG001|COMPLETED|Intervention 3||3
8692798|NCT00862849|9738280|FG002|COMPLETED|Intervention 3||3
8692799|NCT00862849|9738281|FG003|COMPLETED|Intervention 3||4
8692800|NCT00862849|9738282|FG004|COMPLETED|Intervention 3||4
8692801|NCT00862849|9738283|FG005|COMPLETED|Intervention 3||3
8692802|NCT00862849|9738278|FG000|NOT COMPLETED|Intervention 3||0
8692803|NCT00862849|9738279|FG001|NOT COMPLETED|Intervention 3||0
8692804|NCT00862849|9738280|FG002|NOT COMPLETED|Intervention 3||0
8692805|NCT00862849|9738281|FG003|NOT COMPLETED|Intervention 3||0
8692806|NCT00862849|9738282|FG004|NOT COMPLETED|Intervention 3||0
8692807|NCT00862849|9738283|FG005|NOT COMPLETED|Intervention 3||0
8692808|NCT00862849|9738278|FG000|STARTED|Washout 3 (3 to 14 Days)||3
8692809|NCT00862849|9738279|FG001|STARTED|Washout 3 (3 to 14 Days)||3
8692810|NCT00862849|9738280|FG002|STARTED|Washout 3 (3 to 14 Days)||3
8692811|NCT00862849|9738281|FG003|STARTED|Washout 3 (3 to 14 Days)||4
8692812|NCT00862849|9738282|FG004|STARTED|Washout 3 (3 to 14 Days)||4
8692813|NCT00862849|9738283|FG005|STARTED|Washout 3 (3 to 14 Days)||3
8692814|NCT00862849|9738278|FG000|COMPLETED|Washout 3 (3 to 14 Days)||3
8692815|NCT00862849|9738279|FG001|COMPLETED|Washout 3 (3 to 14 Days)||3
8692816|NCT00862849|9738280|FG002|COMPLETED|Washout 3 (3 to 14 Days)||3
8692817|NCT00862849|9738281|FG003|COMPLETED|Washout 3 (3 to 14 Days)||4
8692818|NCT00862849|9738282|FG004|COMPLETED|Washout 3 (3 to 14 Days)||4
8692819|NCT00862849|9738283|FG005|COMPLETED|Washout 3 (3 to 14 Days)||3
8692820|NCT00862849|9738278|FG000|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
8692821|NCT00862849|9738279|FG001|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
8692822|NCT00862849|9738280|FG002|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
8692823|NCT00862849|9738281|FG003|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
8692824|NCT00862849|9738282|FG004|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
8692825|NCT00862849|9738283|FG005|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
8692826|NCT00862849|9738278|FG000|STARTED|Intervention 4||3
8692827|NCT00862849|9738279|FG001|STARTED|Intervention 4||3
8692828|NCT00862849|9738280|FG002|STARTED|Intervention 4||3
8692829|NCT00862849|9738281|FG003|STARTED|Intervention 4||4
8692830|NCT00862849|9738282|FG004|STARTED|Intervention 4||4
8692831|NCT00862849|9738283|FG005|STARTED|Intervention 4||3
8692832|NCT00862849|9738278|FG000|COMPLETED|Intervention 4||3
8692833|NCT00862849|9738279|FG001|COMPLETED|Intervention 4||3
8692834|NCT00862849|9738280|FG002|COMPLETED|Intervention 4||3
8692835|NCT00862849|9738281|FG003|COMPLETED|Intervention 4||4
8692836|NCT00862849|9738282|FG004|COMPLETED|Intervention 4||4
8692837|NCT00862849|9738283|FG005|COMPLETED|Intervention 4||3
8692838|NCT00862849|9738278|FG000|NOT COMPLETED|Intervention 4||0
8692839|NCT00862849|9738279|FG001|NOT COMPLETED|Intervention 4||0
8692840|NCT00862849|9738280|FG002|NOT COMPLETED|Intervention 4||0
8692841|NCT00862849|9738281|FG003|NOT COMPLETED|Intervention 4||0
8692842|NCT00862849|9738282|FG004|NOT COMPLETED|Intervention 4||0
8692843|NCT00862849|9738283|FG005|NOT COMPLETED|Intervention 4||0
8692844|NCT00862849|9738278|FG000|STARTED|Washout 4 (3 to 14 Days)||3
8692845|NCT00862849|9738279|FG001|STARTED|Washout 4 (3 to 14 Days)||3
8692846|NCT00862849|9738280|FG002|STARTED|Washout 4 (3 to 14 Days)||3
8692847|NCT00862849|9738281|FG003|STARTED|Washout 4 (3 to 14 Days)||4
8692848|NCT00862849|9738282|FG004|STARTED|Washout 4 (3 to 14 Days)||4
8692849|NCT00862849|9738283|FG005|STARTED|Washout 4 (3 to 14 Days)||3
8677677|NCT00782509|9721369|FG000|STARTED|Overall Study||216
8677678|NCT00782509|9721370|FG001|STARTED|Overall Study||209
8677679|NCT00782509|9721371|FG002|STARTED|Overall Study||217
8677680|NCT00782509|9721369|FG000|COMPLETED|Overall Study||175
8677681|NCT00782509|9721370|FG001|COMPLETED|Overall Study||185
8677682|NCT00782509|9721371|FG002|COMPLETED|Overall Study||181
8677683|NCT00782509|9721369|FG000|NOT COMPLETED|Overall Study||41
8677684|NCT00782509|9721370|FG001|NOT COMPLETED|Overall Study||24
8677685|NCT00782509|9721371|FG002|NOT COMPLETED|Overall Study||36
8677686|NCT00782626|9721386|FG000|STARTED|Overall Study||23
8677687|NCT00782626|9721386|FG000|COMPLETED|Overall Study||16
8677688|NCT00782626|9721386|FG000|NOT COMPLETED|Overall Study||7
8677689|NCT00782639|9721392|FG000|STARTED|Overall Study||12
8677690|NCT00782639|9721393|FG001|STARTED|Overall Study||11
8677691|NCT00782639|9721392|FG000|COMPLETED|Overall Study|This study was terminated due to low enrollment.|12
8677692|NCT00782639|9721393|FG001|COMPLETED|Overall Study|This study was terminated due to low enrollment.|11
8677693|NCT00782639|9721392|FG000|NOT COMPLETED|Overall Study||0
8677694|NCT00782639|9721393|FG001|NOT COMPLETED|Overall Study||0
8677695|NCT00782717|9721403|FG000|STARTED|Overall Study||133
8677696|NCT00782717|9721404|FG001|STARTED|Overall Study||130
8677697|NCT00782717|9721403|FG000|COMPLETED|Overall Study||118
8677698|NCT00782717|9721404|FG001|COMPLETED|Overall Study||102
8677699|NCT00782717|9721403|FG000|NOT COMPLETED|Overall Study||15
8677700|NCT00782717|9721404|FG001|NOT COMPLETED|Overall Study||28
8677701|NCT00782756|9721410|FG000|STARTED|Overall Study||40
8677702|NCT00782756|9721410|FG000|COMPLETED|Overall Study||40
8677703|NCT00782756|9721410|FG000|NOT COMPLETED|Overall Study||0
8677704|NCT00782795|9721416|FG000|STARTED|Overall Study||17
8677705|NCT00782795|9721417|FG001|STARTED|Overall Study||8
8677706|NCT00782795|9721416|FG000|6 Weeks (1st Apptment)|Overall Study||16
8677707|NCT00782795|9721417|FG001|6 Weeks (1st Apptment)|Overall Study||7
8677708|NCT00782795|9721416|FG000|24 Week Appointment|Overall Study||16
8677709|NCT00782795|9721417|FG001|24 Week Appointment|Overall Study||7
8677710|NCT00782795|9721416|FG000|COMPLETED|Overall Study||16
8677711|NCT00782795|9721417|FG001|COMPLETED|Overall Study||6
8677712|NCT00782795|9721416|FG000|NOT COMPLETED|Overall Study||1
8677713|NCT00782795|9721417|FG001|NOT COMPLETED|Overall Study||2
8677714|NCT00782821|9721427|FG000|STARTED|Overall Study||10
8677715|NCT00782821|9721428|FG001|STARTED|Overall Study||10
8677716|NCT00782821|9721429|FG002|STARTED|Overall Study||10
8677717|NCT00782821|9721430|FG003|STARTED|Overall Study||10
8677718|NCT00782821|9721427|FG000|COMPLETED|Overall Study||10
8677719|NCT00782821|9721428|FG001|COMPLETED|Overall Study||10
8677720|NCT00782821|9721429|FG002|COMPLETED|Overall Study||9
8677721|NCT00782821|9721430|FG003|COMPLETED|Overall Study||8
8677722|NCT00782821|9721427|FG000|NOT COMPLETED|Overall Study||0
8677723|NCT00782821|9721428|FG001|NOT COMPLETED|Overall Study||0
8677724|NCT00782821|9721429|FG002|NOT COMPLETED|Overall Study||1
8677725|NCT00782821|9721430|FG003|NOT COMPLETED|Overall Study||2
8677726|NCT00782834|9721447|FG000|STARTED|Screened Patients||15
8677727|NCT00782834|9721447|FG000|COMPLETED|Screened Patients|1 pt ineligible d/t arrhythmia|14
8677728|NCT00782834|9721447|FG000|NOT COMPLETED|Screened Patients||1
8677729|NCT00782834|9721447|FG000|STARTED|Treatment Phase||14
8677730|NCT00782834|9721447|FG000|COMPLETED|Treatment Phase||13
8677731|NCT00782834|9721447|FG000|NOT COMPLETED|Treatment Phase||1
8677732|NCT00783094|9721454|FG000|STARTED|Randomized Double-Blind Treatment Period||142
8677733|NCT00783094|9721455|FG001|STARTED|Randomized Double-Blind Treatment Period||140
8677734|NCT00783094|9721456|FG002|STARTED|Randomized Double-Blind Treatment Period||140
8677735|NCT00783094|9721454|FG000|COMPLETED|Randomized Double-Blind Treatment Period||135
8677736|NCT00783094|9721455|FG001|COMPLETED|Randomized Double-Blind Treatment Period||128
8677737|NCT00783094|9721456|FG002|COMPLETED|Randomized Double-Blind Treatment Period||131
8677738|NCT00783094|9721454|FG000|NOT COMPLETED|Randomized Double-Blind Treatment Period||7
8677739|NCT00783094|9721455|FG001|NOT COMPLETED|Randomized Double-Blind Treatment Period||12
8677740|NCT00783094|9721456|FG002|NOT COMPLETED|Randomized Double-Blind Treatment Period||9
8677741|NCT00783094|9721454|FG000|STARTED|Open-Label Extension Period||135
8677742|NCT00783094|9721455|FG001|STARTED|Open-Label Extension Period||128
8677743|NCT00783094|9721456|FG002|STARTED|Open-Label Extension Period||131
8677744|NCT00783094|9721454|FG000|COMPLETED|Open-Label Extension Period||113
8677745|NCT00783094|9721455|FG001|COMPLETED|Open-Label Extension Period||109
8677746|NCT00783094|9721456|FG002|COMPLETED|Open-Label Extension Period||101
8677747|NCT00783094|9721454|FG000|NOT COMPLETED|Open-Label Extension Period||22
8677748|NCT00783094|9721455|FG001|NOT COMPLETED|Open-Label Extension Period||19
8677749|NCT00783094|9721456|FG002|NOT COMPLETED|Open-Label Extension Period||30
8677750|NCT00783198|9721470|FG000|STARTED|Overall Study||190
8677751|NCT00783198|9721471|FG001|STARTED|Overall Study||187
8677752|NCT00783198|9721472|FG002|STARTED|Overall Study||188
8677753|NCT00783198|9721470|FG000|COMPLETED|Overall Study||133
8677754|NCT00783198|9721471|FG001|COMPLETED|Overall Study||144
8677755|NCT00783198|9721472|FG002|COMPLETED|Overall Study||146
8677756|NCT00783198|9721470|FG000|NOT COMPLETED|Overall Study||57
8677757|NCT00783198|9721471|FG001|NOT COMPLETED|Overall Study||43
8677758|NCT00783198|9721472|FG002|NOT COMPLETED|Overall Study||42
8677759|NCT00783289|9721484|FG000|STARTED|Overall Study||6
8677760|NCT00783289|9721485|FG001|STARTED|Overall Study||7
8677761|NCT00783289|9721486|FG002|STARTED|Overall Study||6
8677762|NCT00783289|9721487|FG003|STARTED|Overall Study||6
8677763|NCT00783289|9721484|FG000|COMPLETED|Overall Study||6
8677764|NCT00783289|9721485|FG001|COMPLETED|Overall Study||6
8677765|NCT00783289|9721486|FG002|COMPLETED|Overall Study||6
8677766|NCT00783289|9721487|FG003|COMPLETED|Overall Study||6
8677767|NCT00783289|9721484|FG000|NOT COMPLETED|Overall Study||0
8677768|NCT00783289|9721485|FG001|NOT COMPLETED|Overall Study||1
8677769|NCT00783289|9721486|FG002|NOT COMPLETED|Overall Study||0
8677770|NCT00783289|9721487|FG003|NOT COMPLETED|Overall Study||0
8677771|NCT00783302|9721500|FG000|STARTED|Overall Study||885
8677772|NCT00783302|9721500|FG000|COMPLETED|Overall Study||850
8677773|NCT00783302|9721500|FG000|NOT COMPLETED|Overall Study||35
8677774|NCT00783367|9721520|FG000|STARTED|Overall Study||27
8677775|NCT00783367|9721521|FG001|STARTED|Overall Study||23
8677776|NCT00783367|9721520|FG000|COMPLETED|Overall Study||27
8677777|NCT00783367|9721521|FG001|COMPLETED|Overall Study||23
8677778|NCT00783367|9721520|FG000|NOT COMPLETED|Overall Study||0
8677779|NCT00783367|9721521|FG001|NOT COMPLETED|Overall Study||0
8677780|NCT00783432|9721529|FG000|STARTED|Overall Study|This includes 2 subjects that received a randomization number but did not receive study drug|430
8677781|NCT00783432|9721530|FG001|STARTED|Overall Study|This includes 2 subjects that received a randomization number but did not receive study drug|432
8677782|NCT00783432|9721529|FG000|COMPLETED|Overall Study||345
8677783|NCT00783432|9721530|FG001|COMPLETED|Overall Study||354
8677784|NCT00783432|9721529|FG000|NOT COMPLETED|Overall Study||85
8677785|NCT00783432|9721530|FG001|NOT COMPLETED|Overall Study||78
8677786|NCT00783614|9721540|FG000|STARTED|Overall Study||6
8677787|NCT00783614|9721541|FG001|STARTED|Overall Study||6
8677788|NCT00783614|9721542|FG002|STARTED|Overall Study||5
8677789|NCT00783614|9721543|FG003|STARTED|Overall Study||5
8677790|NCT00783614|9721540|FG000|COMPLETED|Overall Study||6
8677791|NCT00783614|9721541|FG001|COMPLETED|Overall Study||6
8677792|NCT00783614|9721542|FG002|COMPLETED|Overall Study||5
8677793|NCT00783614|9721543|FG003|COMPLETED|Overall Study||5
8677794|NCT00783614|9721540|FG000|NOT COMPLETED|Overall Study||0
8677795|NCT00783614|9721541|FG001|NOT COMPLETED|Overall Study||0
8677796|NCT00783614|9721542|FG002|NOT COMPLETED|Overall Study||0
8677797|NCT00783614|9721543|FG003|NOT COMPLETED|Overall Study||0
8677798|NCT00783692|9721556|FG000|STARTED|Induction Phase||148
8677799|NCT00783692|9721557|FG001|STARTED|Induction Phase||220
8677800|NCT00783692|9721558|FG002|STARTED|Induction Phase||748
8677801|NCT00783692|9721559|FG003|STARTED|Induction Phase||0
8677802|NCT00783692|9721560|FG004|STARTED|Induction Phase||0
8677803|NCT00783692|9721561|FG005|STARTED|Induction Phase||0
8677804|NCT00783692|9721562|FG006|STARTED|Induction Phase||0
8677805|NCT00783692|9721556|FG000|Treated|Induction Phase||148
8677806|NCT00783692|9721557|FG001|Treated|Induction Phase||220
8677807|NCT00783692|9721558|FG002|Treated|Induction Phase||747
8677808|NCT00783692|9721559|FG003|Treated|Induction Phase||0
8677809|NCT00783692|9721560|FG004|Treated|Induction Phase||0
8677810|NCT00783692|9721561|FG005|Treated|Induction Phase||0
8677811|NCT00783692|9721562|FG006|Treated|Induction Phase||0
8677812|NCT00783692|9721556|FG000|COMPLETED|Induction Phase||137
8677813|NCT00783692|9721557|FG001|COMPLETED|Induction Phase||199
8677814|NCT00783692|9721558|FG002|COMPLETED|Induction Phase||674
8677815|NCT00783692|9721559|FG003|COMPLETED|Induction Phase||0
8677816|NCT00783692|9721560|FG004|COMPLETED|Induction Phase||0
8677817|NCT00783692|9721561|FG005|COMPLETED|Induction Phase||0
8677818|NCT00783692|9721562|FG006|COMPLETED|Induction Phase||0
8677819|NCT00783692|9721556|FG000|NOT COMPLETED|Induction Phase||11
8677820|NCT00783692|9721557|FG001|NOT COMPLETED|Induction Phase||21
8677821|NCT00783692|9721558|FG002|NOT COMPLETED|Induction Phase||74
8677822|NCT00783692|9721559|FG003|NOT COMPLETED|Induction Phase||0
8677823|NCT00783692|9721560|FG004|NOT COMPLETED|Induction Phase||0
8677824|NCT00783692|9721561|FG005|NOT COMPLETED|Induction Phase||0
8677825|NCT00783692|9721562|FG006|NOT COMPLETED|Induction Phase||0
8677826|NCT00783692|9721556|FG000|STARTED|Maintenance Phase||137
8677827|NCT00783692|9721557|FG001|STARTED|Maintenance Phase||0
8677828|NCT00783692|9721558|FG002|STARTED|Maintenance Phase||0
8677829|NCT00783692|9721559|FG003|STARTED|Maintenance Phase||153
8677830|NCT00783692|9721560|FG004|STARTED|Maintenance Phase||154
8677831|NCT00783692|9721561|FG005|STARTED|Maintenance Phase||154
8677832|NCT00783692|9721562|FG006|STARTED|Maintenance Phase||412
8677833|NCT00783692|9721556|FG000|COMPLETED|Maintenance Phase||42
8677834|NCT00783692|9721557|FG001|COMPLETED|Maintenance Phase||0
8677835|NCT00783692|9721558|FG002|COMPLETED|Maintenance Phase||0
8677836|NCT00783692|9721559|FG003|COMPLETED|Maintenance Phase||64
8677837|NCT00783692|9721560|FG004|COMPLETED|Maintenance Phase||73
8677838|NCT00783692|9721561|FG005|COMPLETED|Maintenance Phase||82
8677839|NCT00783692|9721562|FG006|COMPLETED|Maintenance Phase||163
8677840|NCT00783692|9721556|FG000|NOT COMPLETED|Maintenance Phase||95
8677841|NCT00783692|9721557|FG001|NOT COMPLETED|Maintenance Phase||0
8677842|NCT00783692|9721558|FG002|NOT COMPLETED|Maintenance Phase||0
8677843|NCT00783692|9721559|FG003|NOT COMPLETED|Maintenance Phase||89
8677844|NCT00783692|9721560|FG004|NOT COMPLETED|Maintenance Phase||81
8677845|NCT00783692|9721561|FG005|NOT COMPLETED|Maintenance Phase||72
8677846|NCT00783692|9721562|FG006|NOT COMPLETED|Maintenance Phase||249
8677847|NCT00783705|9721577|FG000|STARTED|Overall Study||44
8677848|NCT00783705|9721578|FG001|STARTED|Overall Study||41
8677849|NCT00783705|9721577|FG000|COMPLETED|Overall Study||38
8677850|NCT00783705|9721578|FG001|COMPLETED|Overall Study||36
8677851|NCT00783705|9721577|FG000|NOT COMPLETED|Overall Study||6
8677852|NCT00783705|9721578|FG001|NOT COMPLETED|Overall Study||5
8677853|NCT00783718|9721587|FG000|STARTED|Induction Phase||149
8677854|NCT00783718|9721588|FG001|STARTED|Induction Phase||225
8677855|NCT00783718|9721589|FG002|STARTED|Induction Phase||521
8677856|NCT00783718|9721590|FG003|STARTED|Induction Phase||0
8677857|NCT00783718|9721591|FG004|STARTED|Induction Phase||0
8677858|NCT00783718|9721592|FG005|STARTED|Induction Phase||0
8677859|NCT00783718|9721593|FG006|STARTED|Induction Phase||0
8677860|NCT00783718|9721587|FG000|COMPLETED|Induction Phase||135
8677861|NCT00783718|9721588|FG001|COMPLETED|Induction Phase||218
8677862|NCT00783718|9721589|FG002|COMPLETED|Induction Phase||485
8677863|NCT00783718|9721590|FG003|COMPLETED|Induction Phase||0
8677864|NCT00783718|9721591|FG004|COMPLETED|Induction Phase||0
8677865|NCT00783718|9721592|FG005|COMPLETED|Induction Phase||0
8677866|NCT00783718|9721593|FG006|COMPLETED|Induction Phase||0
8677867|NCT00783718|9721587|FG000|NOT COMPLETED|Induction Phase||14
8677868|NCT00783718|9721588|FG001|NOT COMPLETED|Induction Phase||7
8677869|NCT00783718|9721589|FG002|NOT COMPLETED|Induction Phase||36
8677870|NCT00783718|9721590|FG003|NOT COMPLETED|Induction Phase||0
8677871|NCT00783718|9721591|FG004|NOT COMPLETED|Induction Phase||0
8677872|NCT00783718|9721592|FG005|NOT COMPLETED|Induction Phase||0
8677873|NCT00783718|9721593|FG006|NOT COMPLETED|Induction Phase||0
8677874|NCT00783718|9721587|FG000|STARTED|Maintenance Phase||135
8677875|NCT00783718|9721588|FG001|STARTED|Maintenance Phase||0
8677876|NCT00783718|9721589|FG002|STARTED|Maintenance Phase||0
8677877|NCT00783718|9721590|FG003|STARTED|Maintenance Phase||126
8677878|NCT00783718|9721591|FG004|STARTED|Maintenance Phase||122
8677879|NCT00783718|9721592|FG005|STARTED|Maintenance Phase||125
8677880|NCT00783718|9721593|FG006|STARTED|Maintenance Phase||330
8677881|NCT00783718|9721587|FG000|COMPLETED|Maintenance Phase||30
8677882|NCT00783718|9721588|FG001|COMPLETED|Maintenance Phase||0
8677883|NCT00783718|9721589|FG002|COMPLETED|Maintenance Phase||0
8677884|NCT00783718|9721590|FG003|COMPLETED|Maintenance Phase||48
8677885|NCT00783718|9721591|FG004|COMPLETED|Maintenance Phase||77
8677886|NCT00783718|9721592|FG005|COMPLETED|Maintenance Phase||84
8677887|NCT00783718|9721593|FG006|COMPLETED|Maintenance Phase||135
8677888|NCT00783718|9721587|FG000|NOT COMPLETED|Maintenance Phase||105
8677889|NCT00783718|9721588|FG001|NOT COMPLETED|Maintenance Phase||0
8677890|NCT00783718|9721589|FG002|NOT COMPLETED|Maintenance Phase||0
8677891|NCT00783718|9721590|FG003|NOT COMPLETED|Maintenance Phase||78
8677892|NCT00783718|9721591|FG004|NOT COMPLETED|Maintenance Phase||45
8677893|NCT00783718|9721592|FG005|NOT COMPLETED|Maintenance Phase||41
8677894|NCT00783718|9721593|FG006|NOT COMPLETED|Maintenance Phase||195
8677895|NCT00783796|9721603|FG000|STARTED|Overall Study||150
8677896|NCT00783796|9721603|FG000|COMPLETED|Overall Study||144
8677897|NCT00783796|9721603|FG000|NOT COMPLETED|Overall Study||6
8677898|NCT00783835|9721609|FG000|STARTED|Overall Study||60
8677899|NCT00783835|9721609|FG000|COMPLETED|Overall Study||50
8677900|NCT00783835|9721609|FG000|NOT COMPLETED|Overall Study||10
8677901|NCT00783952|9721613|FG000|STARTED|Overall Study||8
8677902|NCT00783952|9721613|FG000|COMPLETED|Overall Study||8
8677903|NCT00783952|9721613|FG000|NOT COMPLETED|Overall Study||0
8677904|NCT00783965|9721620|FG000|STARTED|First Intervention (12 Months)||5
8677905|NCT00783965|9721621|FG001|STARTED|First Intervention (12 Months)||29
8677906|NCT00783965|9721620|FG000|COMPLETED|First Intervention (12 Months)||2
8677907|NCT00783965|9721621|FG001|COMPLETED|First Intervention (12 Months)||25
8677908|NCT00783965|9721620|FG000|NOT COMPLETED|First Intervention (12 Months)||3
8677909|NCT00783965|9721621|FG001|NOT COMPLETED|First Intervention (12 Months)||4
8677910|NCT00783965|9721620|FG000|STARTED|Second Intervention (24 Months)||2
8677911|NCT00783965|9721621|FG001|STARTED|Second Intervention (24 Months)||25
8677912|NCT00783965|9721620|FG000|COMPLETED|Second Intervention (24 Months)||2
8677913|NCT00783965|9721621|FG001|COMPLETED|Second Intervention (24 Months)||16
8677914|NCT00783965|9721620|FG000|NOT COMPLETED|Second Intervention (24 Months)||0
8799830|NCT01440101|9851440|FG002|NOT COMPLETED|Overall Study||1
8799831|NCT01440283|9851449|FG000|STARTED|Overall Study||14
8799832|NCT01440283|9851449|FG000|COMPLETED|Overall Study||4
8799833|NCT01440283|9851449|FG000|NOT COMPLETED|Overall Study||10
8799834|NCT01440322|9851461|FG000|STARTED|Overall Study||97
8799835|NCT01440322|9851462|FG001|STARTED|Overall Study||50
8799836|NCT01440322|9851461|FG000|COMPLETED|Overall Study||90
8799837|NCT01440322|9851462|FG001|COMPLETED|Overall Study||49
8799838|NCT01440322|9851461|FG000|NOT COMPLETED|Overall Study||7
8799839|NCT01440322|9851462|FG001|NOT COMPLETED|Overall Study||1
8799840|NCT01440374|9851471|FG000|STARTED|Part 1: Open-label Phase||17
8799841|NCT01440374|9851472|FG001|STARTED|Part 1: Open-label Phase||0
8799842|NCT01440374|9851473|FG002|STARTED|Part 1: Open-label Phase||0
8799843|NCT01440374|9851474|FG003|STARTED|Part 1: Open-label Phase||0
8799844|NCT01440374|9851471|FG000|COMPLETED|Part 1: Open-label Phase||11
8677915|NCT00783965|9721621|FG001|NOT COMPLETED|Second Intervention (24 Months)||9
8677916|NCT00784030|9721629|FG000|STARTED|Overall Study||13
8677917|NCT00784030|9721630|FG001|STARTED|Overall Study||10
8677918|NCT00784030|9721629|FG000|COMPLETED|Overall Study||13
8677919|NCT00784030|9721630|FG001|COMPLETED|Overall Study||10
8677920|NCT00784030|9721629|FG000|NOT COMPLETED|Overall Study||0
8677921|NCT00784030|9721630|FG001|NOT COMPLETED|Overall Study||0
8677922|NCT00784095|9721639|FG000|STARTED|Overall Study||12
8677923|NCT00784095|9721640|FG001|STARTED|Overall Study||12
8677924|NCT00784095|9721641|FG002|STARTED|Overall Study||12
8677925|NCT00784095|9721639|FG000|COMPLETED|Overall Study||12
8677926|NCT00784095|9721640|FG001|COMPLETED|Overall Study||11
8677927|NCT00784095|9721641|FG002|COMPLETED|Overall Study||11
8677928|NCT00784095|9721639|FG000|NOT COMPLETED|Overall Study||0
8677929|NCT00784095|9721640|FG001|NOT COMPLETED|Overall Study||1
8677930|NCT00784095|9721641|FG002|NOT COMPLETED|Overall Study||1
8677931|NCT00784134|9721654|FG000|STARTED|Overall Study||249
8677932|NCT00784134|9721655|FG001|STARTED|Overall Study||251
8677933|NCT00784134|9721654|FG000|COMPLETED|Overall Study||246
8677934|NCT00784134|9721655|FG001|COMPLETED|Overall Study||245
8677935|NCT00784134|9721654|FG000|NOT COMPLETED|Overall Study||3
8677936|NCT00784134|9721655|FG001|NOT COMPLETED|Overall Study||6
8677937|NCT00784147|9721663|FG000|STARTED|Overall Study||59
8677938|NCT00784147|9721664|FG001|STARTED|Overall Study||54
8677939|NCT00784147|9721663|FG000|COMPLETED|Overall Study||51
8677940|NCT00784147|9721664|FG001|COMPLETED|Overall Study||45
8677941|NCT00784147|9721663|FG000|NOT COMPLETED|Overall Study||8
8677942|NCT00784147|9721664|FG001|NOT COMPLETED|Overall Study||9
8677943|NCT00784225|9721674|FG000|STARTED|Overall Study||3375
8677944|NCT00784225|9721675|FG001|STARTED|Overall Study||3357
8677945|NCT00784225|9721676|FG002|STARTED|Overall Study||3369
8677946|NCT00784225|9721677|FG003|STARTED|Overall Study||3374
8677947|NCT00784225|9721674|FG000|COMPLETED|Overall Study||3375
8677948|NCT00784225|9721675|FG001|COMPLETED|Overall Study||3357
8677949|NCT00784225|9721676|FG002|COMPLETED|Overall Study||3369
8677950|NCT00784225|9721677|FG003|COMPLETED|Overall Study||3374
8677951|NCT00784225|9721674|FG000|NOT COMPLETED|Overall Study||0
8677952|NCT00784225|9721675|FG001|NOT COMPLETED|Overall Study||0
8677953|NCT00784225|9721676|FG002|NOT COMPLETED|Overall Study||0
8677954|NCT00784225|9721677|FG003|NOT COMPLETED|Overall Study||0
8677955|NCT00784238|9721691|FG000|STARTED|Overall Study||289
8677956|NCT00784238|9721691|FG000|COMPLETED|Overall Study||170
8677957|NCT00784238|9721691|FG000|NOT COMPLETED|Overall Study||119
8677958|NCT00784277|9721702|FG000|STARTED|IR Treatment||148
8677959|NCT00784277|9721703|FG001|STARTED|IR Treatment||151
8677960|NCT00784277|9721704|FG002|STARTED|IR Treatment||154
8677961|NCT00784277|9721705|FG003|STARTED|IR Treatment||143
8677962|NCT00784277|9721706|FG004|STARTED|IR Treatment|"0 in ER column indicates this reporting group is not relevant to IR phase."|0
8677963|NCT00784277|9721707|FG005|STARTED|IR Treatment|"0 in ER column indicates this reporting group is not relevant to IR phase."|0
8677964|NCT00784277|9721708|FG006|STARTED|IR Treatment|"0 in ER column indicates this reporting group is not relevant to IR phase."|0
8677965|NCT00784277|9721702|FG000|COMPLETED|IR Treatment||132
8677966|NCT00784277|9721703|FG001|COMPLETED|IR Treatment||134
8677967|NCT00784277|9721704|FG002|COMPLETED|IR Treatment||126
8677968|NCT00784277|9721705|FG003|COMPLETED|IR Treatment||100
8677969|NCT00784277|9721706|FG004|COMPLETED|IR Treatment||0
8677970|NCT00784277|9721707|FG005|COMPLETED|IR Treatment||0
8677971|NCT00784277|9721708|FG006|COMPLETED|IR Treatment||0
8677972|NCT00784277|9721702|FG000|NOT COMPLETED|IR Treatment||16
8677973|NCT00784277|9721703|FG001|NOT COMPLETED|IR Treatment||17
8677974|NCT00784277|9721704|FG002|NOT COMPLETED|IR Treatment||28
8677975|NCT00784277|9721705|FG003|NOT COMPLETED|IR Treatment||43
8677976|NCT00784277|9721706|FG004|NOT COMPLETED|IR Treatment||0
8677977|NCT00784277|9721707|FG005|NOT COMPLETED|IR Treatment||0
8677978|NCT00784277|9721708|FG006|NOT COMPLETED|IR Treatment||0
8677979|NCT00784277|9721702|FG000|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
8677980|NCT00784277|9721703|FG001|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
8677981|NCT00784277|9721704|FG002|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
8677982|NCT00784277|9721705|FG003|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
8677983|NCT00784277|9721706|FG004|STARTED|ER Treatment|10 participants who had completed IR treatment have not taken any ER treatment.|122
8677984|NCT00784277|9721707|FG005|STARTED|ER Treatment|10 participants who had completed IR treatment have not taken any ER treatment.|250
8677985|NCT00784277|9721708|FG006|STARTED|ER Treatment|9 participants who had completed IR treatment have not taken any ER treatment.|91
8677986|NCT00784277|9721702|FG000|COMPLETED|ER Treatment||0
8677987|NCT00784277|9721703|FG001|COMPLETED|ER Treatment||0
8677988|NCT00784277|9721704|FG002|COMPLETED|ER Treatment||0
8677989|NCT00784277|9721705|FG003|COMPLETED|ER Treatment||0
8677990|NCT00784277|9721706|FG004|COMPLETED|ER Treatment||113
8677991|NCT00784277|9721707|FG005|COMPLETED|ER Treatment||226
8677992|NCT00784277|9721708|FG006|COMPLETED|ER Treatment||76
8677993|NCT00784277|9721702|FG000|NOT COMPLETED|ER Treatment||0
8677994|NCT00784277|9721703|FG001|NOT COMPLETED|ER Treatment||0
8677995|NCT00784277|9721704|FG002|NOT COMPLETED|ER Treatment||0
8677996|NCT00784277|9721705|FG003|NOT COMPLETED|ER Treatment||0
8677997|NCT00784277|9721706|FG004|NOT COMPLETED|ER Treatment||9
8677998|NCT00784277|9721707|FG005|NOT COMPLETED|ER Treatment||24
8677999|NCT00784277|9721708|FG006|NOT COMPLETED|ER Treatment||15
8678000|NCT00784303|9721723|FG000|STARTED|Overall Study||58
8678001|NCT00784303|9721724|FG001|STARTED|Overall Study||59
8678002|NCT00784303|9721723|FG000|COMPLETED|Overall Study||58
8678003|NCT00784303|9721724|FG001|COMPLETED|Overall Study||59
8678004|NCT00784303|9721723|FG000|NOT COMPLETED|Overall Study||0
8678005|NCT00784303|9721724|FG001|NOT COMPLETED|Overall Study||0
8678006|NCT00784368|9721734|FG000|STARTED|Overall Study||16
8678007|NCT00784368|9721735|FG001|STARTED|Overall Study||16
8678008|NCT00784368|9721736|FG002|STARTED|Overall Study||23
8678009|NCT00784368|9721734|FG000|COMPLETED|Overall Study||8
8678010|NCT00784368|9721735|FG001|COMPLETED|Overall Study||5
8678011|NCT00784368|9721736|FG002|COMPLETED|Overall Study||12
8678012|NCT00784368|9721734|FG000|NOT COMPLETED|Overall Study||8
8678013|NCT00784368|9721735|FG001|NOT COMPLETED|Overall Study||11
8678014|NCT00784368|9721736|FG002|NOT COMPLETED|Overall Study||11
8678015|NCT00784459|9721749|FG000|STARTED|Overall Study||11
8678016|NCT00784459|9721750|FG001|STARTED|Overall Study||13
8678017|NCT00784459|9721749|FG000|COMPLETED|Overall Study||11
8678018|NCT00784459|9721750|FG001|COMPLETED|Overall Study||11
8678019|NCT00784459|9721749|FG000|NOT COMPLETED|Overall Study||0
8678020|NCT00784459|9721750|FG001|NOT COMPLETED|Overall Study||2
8678021|NCT00784524|9721756|FG000|STARTED|Overall Study||14
8678022|NCT00784524|9721756|FG000|COMPLETED|Overall Study||14
8678023|NCT00784524|9721756|FG000|NOT COMPLETED|Overall Study||0
8678024|NCT00784550|9721762|FG000|STARTED|Overall Study||173
8678025|NCT00784550|9721763|FG001|STARTED|Overall Study||169
8678026|NCT00784550|9721762|FG000|COMPLETED|Overall Study||137
8678027|NCT00784550|9721763|FG001|COMPLETED|Overall Study||127
8678028|NCT00784550|9721762|FG000|NOT COMPLETED|Overall Study||36
8678029|NCT00784550|9721763|FG001|NOT COMPLETED|Overall Study||42
8678030|NCT00784563|9721772|FG000|STARTED|Years 1 & 2||21
8678031|NCT00784563|9721773|FG001|STARTED|Years 1 & 2||22
8678032|NCT00784563|9721774|FG002|STARTED|Years 1 & 2||0
8678033|NCT00784563|9721772|FG000|COMPLETED|Years 1 & 2||18
8678034|NCT00784563|9721773|FG001|COMPLETED|Years 1 & 2||17
8678035|NCT00784563|9721774|FG002|COMPLETED|Years 1 & 2||0
8678036|NCT00784563|9721772|FG000|NOT COMPLETED|Years 1 & 2||3
8678037|NCT00784563|9721773|FG001|NOT COMPLETED|Years 1 & 2||5
8678038|NCT00784563|9721774|FG002|NOT COMPLETED|Years 1 & 2||0
8678039|NCT00784563|9721772|FG000|STARTED|Year 3||0
8678040|NCT00784563|9721773|FG001|STARTED|Year 3||0
8678041|NCT00784563|9721774|FG002|STARTED|Year 3||17
8678042|NCT00784563|9721772|FG000|COMPLETED|Year 3||0
8678043|NCT00784563|9721773|FG001|COMPLETED|Year 3||0
8678044|NCT00784563|9721774|FG002|COMPLETED|Year 3||14
8678045|NCT00784563|9721772|FG000|NOT COMPLETED|Year 3||0
8678046|NCT00784563|9721773|FG001|NOT COMPLETED|Year 3||0
8678047|NCT00784563|9721774|FG002|NOT COMPLETED|Year 3||3
8678048|NCT00784641|9721783|FG000|STARTED|Overall Study||189
8678049|NCT00784641|9721784|FG001|STARTED|Overall Study||189
8678050|NCT00784641|9721785|FG002|STARTED|Overall Study||189
8678051|NCT00784641|9721783|FG000|COMPLETED|Overall Study||183
8678052|NCT00784641|9721784|FG001|COMPLETED|Overall Study||186
8678053|NCT00784641|9721785|FG002|COMPLETED|Overall Study||187
8678054|NCT00784641|9721783|FG000|NOT COMPLETED|Overall Study||6
8678055|NCT00784641|9721784|FG001|NOT COMPLETED|Overall Study||3
8678056|NCT00784641|9721785|FG002|NOT COMPLETED|Overall Study||2
8678057|NCT00784654|9721793|FG000|STARTED|Open-Label Period (Non-Randomized)||276
8678058|NCT00784654|9721794|FG001|STARTED|Open-Label Period (Non-Randomized)||0
8678059|NCT00784654|9721795|FG002|STARTED|Open-Label Period (Non-Randomized)||0
8678060|NCT00784654|9721793|FG000|COMPLETED|Open-Label Period (Non-Randomized)||165
8678061|NCT00784654|9721794|FG001|COMPLETED|Open-Label Period (Non-Randomized)||0
8678062|NCT00784654|9721795|FG002|COMPLETED|Open-Label Period (Non-Randomized)||0
8678063|NCT00784654|9721793|FG000|NOT COMPLETED|Open-Label Period (Non-Randomized)||111
8678064|NCT00784654|9721794|FG001|NOT COMPLETED|Open-Label Period (Non-Randomized)||0
8678065|NCT00784654|9721795|FG002|NOT COMPLETED|Open-Label Period (Non-Randomized)||0
8678066|NCT00784654|9721793|FG000|STARTED|Randomized Withdrawal Period||0
8678067|NCT00784654|9721794|FG001|STARTED|Randomized Withdrawal Period||78
8678068|NCT00784654|9721795|FG002|STARTED|Randomized Withdrawal Period||79
8678069|NCT00784654|9721793|FG000|COMPLETED|Randomized Withdrawal Period||0
8678070|NCT00784654|9721794|FG001|COMPLETED|Randomized Withdrawal Period||60
8678071|NCT00784654|9721795|FG002|COMPLETED|Randomized Withdrawal Period||16
8678072|NCT00784654|9721793|FG000|NOT COMPLETED|Randomized Withdrawal Period||0
8678073|NCT00784654|9721794|FG001|NOT COMPLETED|Randomized Withdrawal Period||18
8678074|NCT00784654|9721795|FG002|NOT COMPLETED|Randomized Withdrawal Period||63
8678075|NCT00784693|9721808|FG000|STARTED|Overall Study||23
8678076|NCT00784693|9721809|FG001|STARTED|Overall Study||25
8678077|NCT00784693|9721808|FG000|Treated|Overall Study||22
8678078|NCT00784693|9721809|FG001|Treated|Overall Study||25
8678079|NCT00784693|9721808|FG000|COMPLETED|Overall Study||20
8678080|NCT00784693|9721809|FG001|COMPLETED|Overall Study||19
8678081|NCT00784693|9721808|FG000|NOT COMPLETED|Overall Study||3
8678082|NCT00784693|9721809|FG001|NOT COMPLETED|Overall Study||6
8678083|NCT00784719|9721822|FG000|STARTED|Overall Study||47
8678084|NCT00784719|9721823|FG001|STARTED|Overall Study||46
8678085|NCT00784719|9721824|FG002|STARTED|Overall Study||47
8678086|NCT00784719|9721825|FG003|STARTED|Overall Study||48
8678087|NCT00784719|9721826|FG004|STARTED|Overall Study||48
8678088|NCT00784719|9721827|FG005|STARTED|Overall Study||44
8678089|NCT00784719|9721828|FG006|STARTED|Overall Study||47
8678090|NCT00784719|9721822|FG000|COMPLETED|Overall Study||44
8678091|NCT00784719|9721823|FG001|COMPLETED|Overall Study||43
8678092|NCT00784719|9721824|FG002|COMPLETED|Overall Study||46
8678093|NCT00784719|9721825|FG003|COMPLETED|Overall Study||48
8678094|NCT00784719|9721826|FG004|COMPLETED|Overall Study||42
8678095|NCT00784719|9721827|FG005|COMPLETED|Overall Study||41
8678096|NCT00784719|9721828|FG006|COMPLETED|Overall Study||42
8678097|NCT00784719|9721822|FG000|NOT COMPLETED|Overall Study||3
8678098|NCT00784719|9721823|FG001|NOT COMPLETED|Overall Study||3
8678099|NCT00784719|9721824|FG002|NOT COMPLETED|Overall Study||1
8678100|NCT00784719|9721825|FG003|NOT COMPLETED|Overall Study||0
8678101|NCT00784719|9721826|FG004|NOT COMPLETED|Overall Study||6
8678102|NCT00784719|9721827|FG005|NOT COMPLETED|Overall Study||3
8678103|NCT00784719|9721828|FG006|NOT COMPLETED|Overall Study||5
8678104|NCT00784758|9721846|FG000|STARTED|Overall Study||42
8678105|NCT00784758|9721847|FG001|STARTED|Overall Study||39
8678106|NCT00784758|9721846|FG000|Began Treatment|Overall Study||41
8678107|NCT00784758|9721847|FG001|Began Treatment|Overall Study||39
8678108|NCT00784758|9721846|FG000|Completed Treatment|Overall Study||40
8678109|NCT00784758|9721847|FG001|Completed Treatment|Overall Study||39
8678110|NCT00784758|9721846|FG000|COMPLETED|Overall Study||38
8678111|NCT00784758|9721847|FG001|COMPLETED|Overall Study||39
8678112|NCT00784758|9721846|FG000|NOT COMPLETED|Overall Study||4
8678113|NCT00784758|9721847|FG001|NOT COMPLETED|Overall Study||0
8678114|NCT00784784|9721857|FG000|STARTED|Overall Study||22
8678115|NCT00784784|9721858|FG001|STARTED|Overall Study||42
8678116|NCT00784784|9721857|FG000|COMPLETED|Overall Study||20
8678117|NCT00784784|9721858|FG001|COMPLETED|Overall Study||40
8678118|NCT00784784|9721857|FG000|NOT COMPLETED|Overall Study||2
8678119|NCT00784784|9721858|FG001|NOT COMPLETED|Overall Study||2
8678120|NCT00784810|9721866|FG000|STARTED|Overall Study||124
8678121|NCT00784810|9721867|FG001|STARTED|Overall Study||123
8678122|NCT00784810|9721866|FG000|COMPLETED|Overall Study||61
8678123|NCT00784810|9721867|FG001|COMPLETED|Overall Study||74
8678124|NCT00784810|9721866|FG000|NOT COMPLETED|Overall Study||63
8678125|NCT00784810|9721867|FG001|NOT COMPLETED|Overall Study||49
8678126|NCT00784836|9721873|FG000|STARTED|Overall Study||3
8678127|NCT00784836|9721873|FG000|COMPLETED|Overall Study|The study was terminated early by the Sponsor for business reason not related to safety.|0
8678128|NCT00784836|9721873|FG000|NOT COMPLETED|Overall Study||3
8678129|NCT00784849|9721877|FG000|STARTED|Overall Study||62
8678130|NCT00784849|9721877|FG000|COMPLETED|Overall Study||62
8678131|NCT00784849|9721877|FG000|NOT COMPLETED|Overall Study||0
8678132|NCT00784875|9721885|FG000|STARTED|Period A - Baseline||0
8678133|NCT00784875|9721886|FG001|STARTED|Period A - Baseline||0
8678134|NCT00784875|9721887|FG002|STARTED|Period A - Baseline||0
8678135|NCT00784875|9721888|FG003|STARTED|Period A - Baseline||643
8678136|NCT00784875|9721885|FG000|COMPLETED|Period A - Baseline||0
8678137|NCT00784875|9721886|FG001|COMPLETED|Period A - Baseline||0
8678138|NCT00784875|9721887|FG002|COMPLETED|Period A - Baseline||0
8678139|NCT00784875|9721888|FG003|COMPLETED|Period A - Baseline||461
8678140|NCT00784875|9721885|FG000|NOT COMPLETED|Period A - Baseline||0
8678141|NCT00784875|9721886|FG001|NOT COMPLETED|Period A - Baseline||0
8678142|NCT00784875|9721887|FG002|NOT COMPLETED|Period A - Baseline||0
8678143|NCT00784875|9721888|FG003|NOT COMPLETED|Period A - Baseline||182
8678144|NCT00784875|9721885|FG000|STARTED|Period B - Efficacy Endpoint||114
8678145|NCT00784875|9721886|FG001|STARTED|Period B - Efficacy Endpoint||113
8678146|NCT00784875|9721887|FG002|STARTED|Period B - Efficacy Endpoint||117
8678147|NCT00784875|9721888|FG003|STARTED|Period B - Efficacy Endpoint||117
8678148|NCT00784875|9721885|FG000|Cohort 2|Period B - Efficacy Endpoint||102
8678149|NCT00784875|9721886|FG001|Cohort 2|Period B - Efficacy Endpoint||102
8678150|NCT00784875|9721887|FG002|Cohort 2|Period B - Efficacy Endpoint||102
8678151|NCT00784875|9721888|FG003|Cohort 2|Period B - Efficacy Endpoint||101
8678152|NCT00784875|9721885|FG000|COMPLETED|Period B - Efficacy Endpoint||100
8678153|NCT00784875|9721886|FG001|COMPLETED|Period B - Efficacy Endpoint||101
8678154|NCT00784875|9721887|FG002|COMPLETED|Period B - Efficacy Endpoint||96
8678155|NCT00784875|9721888|FG003|COMPLETED|Period B - Efficacy Endpoint||98
8678156|NCT00784875|9721885|FG000|NOT COMPLETED|Period B - Efficacy Endpoint||14
8678157|NCT00784875|9721886|FG001|NOT COMPLETED|Period B - Efficacy Endpoint||12
8678158|NCT00784875|9721887|FG002|NOT COMPLETED|Period B - Efficacy Endpoint||21
8678159|NCT00784875|9721888|FG003|NOT COMPLETED|Period B - Efficacy Endpoint||19
8678160|NCT00784875|9721885|FG000|STARTED|Period C||103
8678161|NCT00784875|9721886|FG001|STARTED|Period C||97
8678162|NCT00784875|9721887|FG002|STARTED|Period C||97
8678163|NCT00784875|9721888|FG003|STARTED|Period C||98
8678164|NCT00784875|9721885|FG000|COMPLETED|Period C||96
8678165|NCT00784875|9721886|FG001|COMPLETED|Period C||91
8678166|NCT00784875|9721887|FG002|COMPLETED|Period C||84
8678167|NCT00784875|9721888|FG003|COMPLETED|Period C||91
8678168|NCT00784875|9721885|FG000|NOT COMPLETED|Period C||7
8678169|NCT00784875|9721886|FG001|NOT COMPLETED|Period C||6
8678170|NCT00784875|9721887|FG002|NOT COMPLETED|Period C||13
8678171|NCT00784875|9721888|FG003|NOT COMPLETED|Period C||7
8678172|NCT00784875|9721885|FG000|STARTED|Period D||91
8678173|NCT00784875|9721886|FG001|STARTED|Period D||89
8678174|NCT00784875|9721887|FG002|STARTED|Period D||94
8678175|NCT00784875|9721888|FG003|STARTED|Period D||88
8678176|NCT00784875|9721885|FG000|COMPLETED|Period D||86
8678177|NCT00784875|9721886|FG001|COMPLETED|Period D||85
8678178|NCT00784875|9721887|FG002|COMPLETED|Period D||88
8678179|NCT00784875|9721888|FG003|COMPLETED|Period D||87
8678180|NCT00784875|9721885|FG000|NOT COMPLETED|Period D||5
8678181|NCT00784875|9721886|FG001|NOT COMPLETED|Period D||4
8678182|NCT00784875|9721887|FG002|NOT COMPLETED|Period D||6
8678183|NCT00784875|9721888|FG003|NOT COMPLETED|Period D||1
8678184|NCT00784927|9721911|FG000|STARTED|Overall Study||36
8678185|NCT00784927|9721911|FG000|COMPLETED|Overall Study||33
8678186|NCT00784927|9721911|FG000|NOT COMPLETED|Overall Study||3
8678187|NCT00784979|9721916|FG000|STARTED|Overall Study||26
8678188|NCT00784979|9721916|FG000|COMPLETED|Overall Study||20
8918975|NCT02204982|9979024|FG000|STARTED|Overall Study||6
8918976|NCT02204982|9979025|FG001|STARTED|Overall Study||7
8918977|NCT02204982|9979024|FG000|COMPLETED|Overall Study||2
8918978|NCT02204982|9979025|FG001|COMPLETED|Overall Study||0
8918979|NCT02204982|9979024|FG000|NOT COMPLETED|Overall Study||4
8918980|NCT02204982|9979025|FG001|NOT COMPLETED|Overall Study||7
8918981|NCT02205177|9979033|FG000|STARTED|Overall Study||8
8918982|NCT02205177|9979034|FG001|STARTED|Overall Study||2
8918983|NCT02205177|9979033|FG000|COMPLETED|Overall Study||6
8918984|NCT02205177|9979034|FG001|COMPLETED|Overall Study||2
8918985|NCT02205177|9979033|FG000|NOT COMPLETED|Overall Study||2
8918986|NCT02205177|9979034|FG001|NOT COMPLETED|Overall Study||0
8918987|NCT02205307|9979042|FG000|STARTED|Overall Study||178
8918988|NCT02205307|9979043|FG001|STARTED|Overall Study||169
8918989|NCT02205307|9979042|FG000|COMPLETED|Overall Study||161
8918990|NCT02205307|9979043|FG001|COMPLETED|Overall Study||163
8918991|NCT02205307|9979042|FG000|NOT COMPLETED|Overall Study||17
8918992|NCT02205307|9979043|FG001|NOT COMPLETED|Overall Study||6
8918993|NCT02205333|9979059|FG000|STARTED|Overall Study||8
8918994|NCT02205333|9979060|FG001|STARTED|Overall Study||6
8918995|NCT02205333|9979061|FG002|STARTED|Overall Study||3
8918996|NCT02205333|9979062|FG003|STARTED|Overall Study||7
8918997|NCT02205333|9979063|FG004|STARTED|Overall Study||6
8918998|NCT02205333|9979064|FG005|STARTED|Overall Study||7
8918999|NCT02205333|9979065|FG006|STARTED|Overall Study||7
8919000|NCT02205333|9979066|FG007|STARTED|Overall Study||3
8919001|NCT02205333|9979067|FG008|STARTED|Overall Study||1
8919002|NCT02205333|9979059|FG000|COMPLETED|Overall Study||2
8919003|NCT02205333|9979060|FG001|COMPLETED|Overall Study||0
8919004|NCT02205333|9979061|FG002|COMPLETED|Overall Study||1
8919005|NCT02205333|9979062|FG003|COMPLETED|Overall Study||0
8919006|NCT02205333|9979063|FG004|COMPLETED|Overall Study||1
8919007|NCT02205333|9979064|FG005|COMPLETED|Overall Study||4
8919008|NCT02205333|9979065|FG006|COMPLETED|Overall Study||2
8919009|NCT02205333|9979066|FG007|COMPLETED|Overall Study||1
8919010|NCT02205333|9979067|FG008|COMPLETED|Overall Study||1
8919011|NCT02205333|9979059|FG000|NOT COMPLETED|Overall Study||6
8919012|NCT02205333|9979060|FG001|NOT COMPLETED|Overall Study||6
8919013|NCT02205333|9979061|FG002|NOT COMPLETED|Overall Study||2
8919014|NCT02205333|9979062|FG003|NOT COMPLETED|Overall Study||7
8919015|NCT02205333|9979063|FG004|NOT COMPLETED|Overall Study||5
8919016|NCT02205333|9979064|FG005|NOT COMPLETED|Overall Study||3
8919017|NCT02205333|9979065|FG006|NOT COMPLETED|Overall Study||5
8919018|NCT02205333|9979066|FG007|NOT COMPLETED|Overall Study||2
8919019|NCT02205333|9979067|FG008|NOT COMPLETED|Overall Study||0
8919020|NCT02205476|9979089|FG000|STARTED|Overall Study||7
8919021|NCT02205476|9979090|FG001|STARTED|Overall Study||3
8919022|NCT02205476|9979089|FG000|COMPLETED|Overall Study||0
8919023|NCT02205476|9979090|FG001|COMPLETED|Overall Study||0
8919024|NCT02205476|9979089|FG000|NOT COMPLETED|Overall Study||7
8919025|NCT02205476|9979090|FG001|NOT COMPLETED|Overall Study||3
8919026|NCT02205801|9979106|FG000|STARTED|Overall Study||11
8919027|NCT02205801|9979107|FG001|STARTED|Overall Study||8
8919028|NCT02205801|9979108|FG002|STARTED|Overall Study||9
8919029|NCT02205801|9979109|FG003|STARTED|Overall Study||8
8919030|NCT02205801|9979106|FG000|COMPLETED|Overall Study||11
8919031|NCT02205801|9979107|FG001|COMPLETED|Overall Study||8
8919032|NCT02205801|9979108|FG002|COMPLETED|Overall Study||9
8919033|NCT02205801|9979109|FG003|COMPLETED|Overall Study||8
8919034|NCT02205801|9979106|FG000|NOT COMPLETED|Overall Study||0
8919035|NCT02205801|9979107|FG001|NOT COMPLETED|Overall Study||0
8919036|NCT02205801|9979108|FG002|NOT COMPLETED|Overall Study||0
8919037|NCT02205801|9979109|FG003|NOT COMPLETED|Overall Study||0
8919038|NCT02205814|9979123|FG000|STARTED|Overall Study||110
8919039|NCT02205814|9979124|FG001|STARTED|Overall Study||110
8919040|NCT02205814|9979125|FG002|STARTED|Overall Study||108
8919041|NCT02205814|9979126|FG003|STARTED|Overall Study||108
8919042|NCT02205814|9979123|FG000|COMPLETED|Overall Study||108
8919043|NCT02205814|9979124|FG001|COMPLETED|Overall Study||109
8919044|NCT02205814|9979125|FG002|COMPLETED|Overall Study||103
8919045|NCT02205814|9979126|FG003|COMPLETED|Overall Study||104
8919046|NCT02205814|9979123|FG000|NOT COMPLETED|Overall Study||2
8919047|NCT02205814|9979124|FG001|NOT COMPLETED|Overall Study||1
8919048|NCT02205814|9979125|FG002|NOT COMPLETED|Overall Study||5
8919049|NCT02205814|9979126|FG003|NOT COMPLETED|Overall Study||4
8919050|NCT02205983|9979140|FG000|STARTED|Overall Study||12
8919051|NCT02205983|9979141|FG001|STARTED|Overall Study||12
8919052|NCT02205983|9979142|FG002|STARTED|Overall Study||13
8919053|NCT02205983|9979143|FG003|STARTED|Overall Study||13
8678189|NCT00784979|9721916|FG000|NOT COMPLETED|Overall Study||6
8678190|NCT00785044|9721920|FG000|STARTED|Overall Study|Eligible to participate in MBG313|964
8919054|NCT02205983|9979140|FG000|COMPLETED|Overall Study||12
8919055|NCT02205983|9979141|FG001|COMPLETED|Overall Study||12
8919056|NCT02205983|9979142|FG002|COMPLETED|Overall Study||13
8678191|NCT00785044|9721920|FG000|Enrolled Participants|Overall Study|Out of 964 from MBG311 and MBG312 HF participants, 471 enrolled into the extension MBG313 study.|471
8678192|NCT00785044|9721920|FG000|COMPLETED|Overall Study|Data for 471 participants (MBG313) combined with data from MBG311 and MBG312 for efficacy analysis|468
8678193|NCT00785044|9721920|FG000|NOT COMPLETED|Overall Study||496
8678194|NCT00785213|9721925|FG000|STARTED|Rosiglitazone Alone||23
8678195|NCT00785213|9721925|FG000|COMPLETED|Rosiglitazone Alone||23
8678196|NCT00785213|9721925|FG000|NOT COMPLETED|Rosiglitazone Alone||0
8678197|NCT00785213|9721925|FG000|STARTED|2 Day Washout Period||23
8678198|NCT00785213|9721925|FG000|COMPLETED|2 Day Washout Period||23
8678199|NCT00785213|9721925|FG000|NOT COMPLETED|2 Day Washout Period||0
8678200|NCT00785213|9721925|FG000|STARTED|Quinine Sulfate Alone||23
8678201|NCT00785213|9721925|FG000|COMPLETED|Quinine Sulfate Alone||19
8678202|NCT00785213|9721925|FG000|NOT COMPLETED|Quinine Sulfate Alone||4
8678203|NCT00785213|9721925|FG000|STARTED|Rosiglitazone With Quinine Sulfate||19
8678204|NCT00785213|9721925|FG000|COMPLETED|Rosiglitazone With Quinine Sulfate||18
8678205|NCT00785213|9721925|FG000|NOT COMPLETED|Rosiglitazone With Quinine Sulfate||1
8678206|NCT00785486|9721932|FG000|STARTED|Midazolam Alone||24
8678207|NCT00785486|9721932|FG000|COMPLETED|Midazolam Alone|one participant withdrew for personal reasons after first midazolam dose|23
8678208|NCT00785486|9721932|FG000|NOT COMPLETED|Midazolam Alone||1
8678209|NCT00785486|9721932|FG000|STARTED|3 Day Washout||23
8678210|NCT00785486|9721932|FG000|COMPLETED|3 Day Washout||23
8678211|NCT00785486|9721932|FG000|NOT COMPLETED|3 Day Washout||0
8678212|NCT00785486|9721932|FG000|STARTED|Qualaquin Alone at Steady State||23
8678213|NCT00785486|9721932|FG000|COMPLETED|Qualaquin Alone at Steady State||23
8678214|NCT00785486|9721932|FG000|NOT COMPLETED|Qualaquin Alone at Steady State||0
8678215|NCT00785486|9721932|FG000|STARTED|Midazolam With Qualaquin at Steady State||23
8678216|NCT00785486|9721932|FG000|COMPLETED|Midazolam With Qualaquin at Steady State||23
8678217|NCT00785486|9721932|FG000|NOT COMPLETED|Midazolam With Qualaquin at Steady State||0
8678218|NCT00785512|9721955|FG000|STARTED|Overall Study||102
8678219|NCT00785512|9721956|FG001|STARTED|Overall Study||105
8678220|NCT00785512|9721955|FG000|COMPLETED|Overall Study||99
8678221|NCT00785512|9721956|FG001|COMPLETED|Overall Study||101
8678222|NCT00785512|9721955|FG000|NOT COMPLETED|Overall Study||3
8678223|NCT00785512|9721956|FG001|NOT COMPLETED|Overall Study||4
8678224|NCT00785538|9721967|FG000|STARTED|PK Period||7
8678225|NCT00785538|9721968|FG001|STARTED|PK Period||1
8678226|NCT00785538|9721969|FG002|STARTED|PK Period||1
8678227|NCT00785538|9721970|FG003|STARTED|PK Period||0
8678228|NCT00785538|9721967|FG000|COMPLETED|PK Period||7
8678229|NCT00785538|9721968|FG001|COMPLETED|PK Period||1
8678230|NCT00785538|9721969|FG002|COMPLETED|PK Period||1
8678231|NCT00785538|9721970|FG003|COMPLETED|PK Period||0
8678232|NCT00785538|9721967|FG000|NOT COMPLETED|PK Period||0
8678233|NCT00785538|9721968|FG001|NOT COMPLETED|PK Period||0
8678234|NCT00785538|9721969|FG002|NOT COMPLETED|PK Period||0
8678235|NCT00785538|9721970|FG003|NOT COMPLETED|PK Period||0
8678236|NCT00785538|9721967|FG000|STARTED|Treatment Period||7
8678237|NCT00785538|9721968|FG001|STARTED|Treatment Period||9
8678238|NCT00785538|9721969|FG002|STARTED|Treatment Period||6
8678239|NCT00785538|9721970|FG003|STARTED|Treatment Period||2
8678240|NCT00785538|9721967|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||7
8678241|NCT00785538|9721968|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||9
8678242|NCT00785538|9721969|FG002|Received at Least 1 Dose of Study Drug|Treatment Period||6
8678243|NCT00785538|9721970|FG003|Received at Least 1 Dose of Study Drug|Treatment Period||2
8678244|NCT00785538|9721967|FG000|COMPLETED|Treatment Period||6
8678245|NCT00785538|9721968|FG001|COMPLETED|Treatment Period||7
8678246|NCT00785538|9721969|FG002|COMPLETED|Treatment Period||4
8678247|NCT00785538|9721970|FG003|COMPLETED|Treatment Period||1
8678248|NCT00785538|9721967|FG000|NOT COMPLETED|Treatment Period||1
8678249|NCT00785538|9721968|FG001|NOT COMPLETED|Treatment Period||2
8678250|NCT00785538|9721969|FG002|NOT COMPLETED|Treatment Period||2
8678251|NCT00785538|9721970|FG003|NOT COMPLETED|Treatment Period||1
8678252|NCT00785577|9721986|FG000|STARTED|Study Period 2: Therapy Phase||89
8678253|NCT00785577|9721987|FG001|STARTED|Study Period 2: Therapy Phase||45
8678254|NCT00785577|9721988|FG002|STARTED|Study Period 2: Therapy Phase||43
8678255|NCT00785577|9721989|FG003|STARTED|Study Period 2: Therapy Phase||49
8678256|NCT00785577|9721990|FG004|STARTED|Study Period 2: Therapy Phase||47
8678257|NCT00785577|9721986|FG000|COMPLETED|Study Period 2: Therapy Phase||78
8678258|NCT00785577|9721987|FG001|COMPLETED|Study Period 2: Therapy Phase||36
8678259|NCT00785577|9721988|FG002|COMPLETED|Study Period 2: Therapy Phase||25
8678260|NCT00785577|9721989|FG003|COMPLETED|Study Period 2: Therapy Phase||36
8678261|NCT00785577|9721990|FG004|COMPLETED|Study Period 2: Therapy Phase||27
8678262|NCT00785577|9721986|FG000|NOT COMPLETED|Study Period 2: Therapy Phase||11
8678263|NCT00785577|9721987|FG001|NOT COMPLETED|Study Period 2: Therapy Phase||9
8678264|NCT00785577|9721988|FG002|NOT COMPLETED|Study Period 2: Therapy Phase||18
8678265|NCT00785577|9721989|FG003|NOT COMPLETED|Study Period 2: Therapy Phase||13
8678266|NCT00785577|9721990|FG004|NOT COMPLETED|Study Period 2: Therapy Phase||20
8678267|NCT00785577|9721986|FG000|STARTED|Study Period 3: 1-Week Washout Phase||78
8678268|NCT00785577|9721987|FG001|STARTED|Study Period 3: 1-Week Washout Phase||36
8678269|NCT00785577|9721988|FG002|STARTED|Study Period 3: 1-Week Washout Phase||25
8678270|NCT00785577|9721989|FG003|STARTED|Study Period 3: 1-Week Washout Phase||36
8678271|NCT00785577|9721990|FG004|STARTED|Study Period 3: 1-Week Washout Phase||27
8678272|NCT00785577|9721986|FG000|COMPLETED|Study Period 3: 1-Week Washout Phase||78
8678273|NCT00785577|9721987|FG001|COMPLETED|Study Period 3: 1-Week Washout Phase||36
8678274|NCT00785577|9721988|FG002|COMPLETED|Study Period 3: 1-Week Washout Phase||25
8678275|NCT00785577|9721989|FG003|COMPLETED|Study Period 3: 1-Week Washout Phase||35
8678276|NCT00785577|9721990|FG004|COMPLETED|Study Period 3: 1-Week Washout Phase||26
8678277|NCT00785577|9721986|FG000|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
8678278|NCT00785577|9721987|FG001|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
8678279|NCT00785577|9721988|FG002|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
8678280|NCT00785577|9721989|FG003|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
8678281|NCT00785577|9721990|FG004|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
8678282|NCT00785629|9722016|FG000|STARTED|Overall Study||30
8678283|NCT00785629|9722017|FG001|STARTED|Overall Study||30
8678284|NCT00785629|9722018|FG002|STARTED|Overall Study||28
8678285|NCT00785629|9722019|FG003|STARTED|Overall Study||57
8678286|NCT00785629|9722016|FG000|COMPLETED|Overall Study|8 not completed|22
8678287|NCT00785629|9722017|FG001|COMPLETED|Overall Study|5 not completed|25
8678288|NCT00785629|9722018|FG002|COMPLETED|Overall Study|10 not completed|18
8678289|NCT00785629|9722019|FG003|COMPLETED|Overall Study|16 not completed|41
8678290|NCT00785629|9722016|FG000|NOT COMPLETED|Overall Study||8
8678291|NCT00785629|9722017|FG001|NOT COMPLETED|Overall Study||5
8678292|NCT00785629|9722018|FG002|NOT COMPLETED|Overall Study||10
8678293|NCT00785629|9722019|FG003|NOT COMPLETED|Overall Study||16
8678294|NCT00785707|9722027|FG000|STARTED|Overall Study||31
8678295|NCT00785707|9722027|FG000|COMPLETED|Overall Study||24
8678296|NCT00785707|9722027|FG000|NOT COMPLETED|Overall Study||7
8678297|NCT00785772|9722031|FG000|STARTED|Overall Study||1
8678298|NCT00785772|9722031|FG000|COMPLETED|Overall Study||1
8678299|NCT00785772|9722031|FG000|NOT COMPLETED|Overall Study||0
8678300|NCT00785785|9722037|FG000|STARTED|Core Phase up to 36 Months||324
8678301|NCT00785785|9722038|FG001|STARTED|Core Phase up to 36 Months||320
8678302|NCT00785785|9722037|FG000|COMPLETED|Core Phase up to 36 Months||0
8678303|NCT00785785|9722038|FG001|COMPLETED|Core Phase up to 36 Months||0
8678304|NCT00785785|9722037|FG000|NOT COMPLETED|Core Phase up to 36 Months||324
8678305|NCT00785785|9722038|FG001|NOT COMPLETED|Core Phase up to 36 Months||320
8678306|NCT00785785|9722037|FG000|STARTED|Optional Extension Phase|crossover extension phase was optional|39
8678307|NCT00785785|9722038|FG001|STARTED|Optional Extension Phase|crossover extension phase was optional|125
8678308|NCT00785785|9722037|FG000|COMPLETED|Optional Extension Phase||0
8678309|NCT00785785|9722038|FG001|COMPLETED|Optional Extension Phase||0
8678310|NCT00785785|9722037|FG000|NOT COMPLETED|Optional Extension Phase||39
8678311|NCT00785785|9722038|FG001|NOT COMPLETED|Optional Extension Phase||125
8678312|NCT00785928|9722053|FG000|STARTED|Treatment Phase||36
8678313|NCT00785928|9722054|FG001|STARTED|Treatment Phase||30
8678314|NCT00785928|9722055|FG002|STARTED|Treatment Phase||20
8678315|NCT00785928|9722056|FG003|STARTED|Treatment Phase||15
8678316|NCT00785928|9722057|FG004|STARTED|Treatment Phase||18
8678317|NCT00785928|9722058|FG005|STARTED|Treatment Phase||13
8799845|NCT01440374|9851472|FG001|COMPLETED|Part 1: Open-label Phase||0
8799846|NCT01440374|9851473|FG002|COMPLETED|Part 1: Open-label Phase||0
8799847|NCT01440374|9851474|FG003|COMPLETED|Part 1: Open-label Phase||0
8799848|NCT01440374|9851471|FG000|NOT COMPLETED|Part 1: Open-label Phase||6
8799849|NCT01440374|9851472|FG001|NOT COMPLETED|Part 1: Open-label Phase||0
8799850|NCT01440374|9851473|FG002|NOT COMPLETED|Part 1: Open-label Phase||0
8799851|NCT01440374|9851474|FG003|NOT COMPLETED|Part 1: Open-label Phase||0
8799852|NCT01440374|9851471|FG000|STARTED|Part 2; Double-blind Phase||0
8799853|NCT01440374|9851472|FG001|STARTED|Part 2; Double-blind Phase||47
8799854|NCT01440374|9851473|FG002|STARTED|Part 2; Double-blind Phase||98
8799855|NCT01440374|9851474|FG003|STARTED|Part 2; Double-blind Phase||0
8799856|NCT01440374|9851471|FG000|COMPLETED|Part 2; Double-blind Phase||0
8799857|NCT01440374|9851472|FG001|COMPLETED|Part 2; Double-blind Phase||27
8799858|NCT01440374|9851473|FG002|COMPLETED|Part 2; Double-blind Phase||43
8799859|NCT01440374|9851474|FG003|COMPLETED|Part 2; Double-blind Phase||0
8799860|NCT01440374|9851471|FG000|NOT COMPLETED|Part 2; Double-blind Phase||0
8799861|NCT01440374|9851472|FG001|NOT COMPLETED|Part 2; Double-blind Phase||20
8799862|NCT01440374|9851473|FG002|NOT COMPLETED|Part 2; Double-blind Phase||55
8799863|NCT01440374|9851474|FG003|NOT COMPLETED|Part 2; Double-blind Phase||0
8799864|NCT01440374|9851471|FG000|STARTED|Part 3: Extension||0
8799865|NCT01440374|9851472|FG001|STARTED|Part 3: Extension||0
8799866|NCT01440374|9851473|FG002|STARTED|Part 3: Extension||0
8799867|NCT01440374|9851474|FG003|STARTED|Part 3: Extension||59
8799868|NCT01440374|9851471|FG000|COMPLETED|Part 3: Extension||0
8799869|NCT01440374|9851472|FG001|COMPLETED|Part 3: Extension||0
8799870|NCT01440374|9851473|FG002|COMPLETED|Part 3: Extension||0
8799871|NCT01440374|9851474|FG003|COMPLETED|Part 3: Extension||27
8799872|NCT01440374|9851471|FG000|NOT COMPLETED|Part 3: Extension||0
8799873|NCT01440374|9851472|FG001|NOT COMPLETED|Part 3: Extension||0
8678318|NCT00785928|9722059|FG006|STARTED|Treatment Phase||26
8678319|NCT00785928|9722053|FG000|COMPLETED|Treatment Phase||33
8678320|NCT00785928|9722054|FG001|COMPLETED|Treatment Phase||25
8678321|NCT00785928|9722055|FG002|COMPLETED|Treatment Phase||17
8678322|NCT00785928|9722056|FG003|COMPLETED|Treatment Phase||15
8678323|NCT00785928|9722057|FG004|COMPLETED|Treatment Phase||16
8678324|NCT00785928|9722058|FG005|COMPLETED|Treatment Phase||13
8678325|NCT00785928|9722059|FG006|COMPLETED|Treatment Phase||23
8678326|NCT00785928|9722053|FG000|NOT COMPLETED|Treatment Phase||3
8678327|NCT00785928|9722054|FG001|NOT COMPLETED|Treatment Phase||5
8678328|NCT00785928|9722055|FG002|NOT COMPLETED|Treatment Phase||3
8678329|NCT00785928|9722056|FG003|NOT COMPLETED|Treatment Phase||0
8678330|NCT00785928|9722057|FG004|NOT COMPLETED|Treatment Phase||2
8678331|NCT00785928|9722058|FG005|NOT COMPLETED|Treatment Phase||0
8678332|NCT00785928|9722059|FG006|NOT COMPLETED|Treatment Phase||3
8678333|NCT00785928|9722053|FG000|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|8
8678334|NCT00785928|9722054|FG001|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|8
8678335|NCT00785928|9722055|FG002|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|6
8678336|NCT00785928|9722056|FG003|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|4
8678337|NCT00785928|9722057|FG004|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|6
8678338|NCT00785928|9722058|FG005|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|0
8678339|NCT00785928|9722059|FG006|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|14
8678340|NCT00785928|9722053|FG000|COMPLETED|Follow-up Phases (Weeks 24-72)||7
8678341|NCT00785928|9722054|FG001|COMPLETED|Follow-up Phases (Weeks 24-72)||5
8678342|NCT00785928|9722055|FG002|COMPLETED|Follow-up Phases (Weeks 24-72)||4
8678343|NCT00785928|9722056|FG003|COMPLETED|Follow-up Phases (Weeks 24-72)||4
8678344|NCT00785928|9722057|FG004|COMPLETED|Follow-up Phases (Weeks 24-72)||4
8678345|NCT00785928|9722058|FG005|COMPLETED|Follow-up Phases (Weeks 24-72)||0
8678346|NCT00785928|9722059|FG006|COMPLETED|Follow-up Phases (Weeks 24-72)||9
8678347|NCT00785928|9722053|FG000|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||1
8678348|NCT00785928|9722054|FG001|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||3
8678349|NCT00785928|9722055|FG002|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||2
8678350|NCT00785928|9722056|FG003|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||0
8678351|NCT00785928|9722057|FG004|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||2
8678352|NCT00785928|9722058|FG005|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||0
8678353|NCT00785928|9722059|FG006|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||5
8678354|NCT00785980|9722097|FG000|STARTED|Quinine Sulfate Alone||24
8678355|NCT00785980|9722097|FG000|COMPLETED|Quinine Sulfate Alone||24
8678356|NCT00785980|9722097|FG000|NOT COMPLETED|Quinine Sulfate Alone||0
8678357|NCT00785980|9722097|FG000|STARTED|7 Day Washout Period||24
8678358|NCT00785980|9722097|FG000|COMPLETED|7 Day Washout Period||21
8678359|NCT00785980|9722097|FG000|NOT COMPLETED|7 Day Washout Period||3
8678360|NCT00785980|9722097|FG000|STARTED|Ciprofloxacin Alone||21
8678361|NCT00785980|9722097|FG000|COMPLETED|Ciprofloxacin Alone||21
8678362|NCT00785980|9722097|FG000|NOT COMPLETED|Ciprofloxacin Alone||0
8678363|NCT00785980|9722097|FG000|STARTED|Quinine Sulfate With Ciprofloxacin||21
8678364|NCT00785980|9722097|FG000|COMPLETED|Quinine Sulfate With Ciprofloxacin||21
8678365|NCT00785980|9722097|FG000|NOT COMPLETED|Quinine Sulfate With Ciprofloxacin||0
8678366|NCT00786019|9722106|FG000|STARTED|Overall Study||20
8678367|NCT00786019|9722107|FG001|STARTED|Overall Study||27
8678368|NCT00786019|9722106|FG000|COMPLETED|Overall Study||15
8678369|NCT00786019|9722107|FG001|COMPLETED|Overall Study||17
8678370|NCT00786019|9722106|FG000|NOT COMPLETED|Overall Study||5
8678371|NCT00786019|9722107|FG001|NOT COMPLETED|Overall Study||10
8678372|NCT00786032|9722115|FG000|STARTED|Overall Study||27
8678373|NCT00786032|9722115|FG000|Independent Users|Overall Study|All data analyses were based on the 14 independent users.|14
8678374|NCT00786032|9722115|FG000|COMPLETED|Overall Study||3
8678375|NCT00786032|9722115|FG000|NOT COMPLETED|Overall Study||24
8678376|NCT00786188|9722123|FG000|STARTED|Overall Study||50
8678377|NCT00786188|9722124|FG001|STARTED|Overall Study||52
8678378|NCT00786188|9722123|FG000|COMPLETED|Overall Study||45
8678379|NCT00786188|9722124|FG001|COMPLETED|Overall Study||51
8678380|NCT00786188|9722123|FG000|NOT COMPLETED|Overall Study||5
8678381|NCT00786188|9722124|FG001|NOT COMPLETED|Overall Study||1
8678382|NCT00786409|9722132|FG000|STARTED|Overall Study||27
8678383|NCT00786409|9722132|FG000|COMPLETED|Overall Study||20
8678384|NCT00786409|9722132|FG000|NOT COMPLETED|Overall Study||7
8678385|NCT00786422|9722136|FG000|STARTED|Rivaroxaban Treatment||25
8678386|NCT00786422|9722136|FG000|COMPLETED|Rivaroxaban Treatment||14
8678387|NCT00786422|9722136|FG000|NOT COMPLETED|Rivaroxaban Treatment||11
8678388|NCT00786422|9722136|FG000|STARTED|Follow-up Period|Participants entered follow-up period. No reason documents for those not entering this period|20
8678389|NCT00786422|9722136|FG000|COMPLETED|Follow-up Period||17
8678390|NCT00786422|9722136|FG000|NOT COMPLETED|Follow-up Period||3
8678391|NCT00786474|9722144|FG000|STARTED|Overall Study||950
8678392|NCT00786474|9722145|FG001|STARTED|Overall Study||934
8678393|NCT00786474|9722144|FG000|COMPLETED|Overall Study||913
8678394|NCT00786474|9722145|FG001|COMPLETED|Overall Study||891
8678395|NCT00786474|9722144|FG000|NOT COMPLETED|Overall Study||37
8678396|NCT00786474|9722145|FG001|NOT COMPLETED|Overall Study||43
8678397|NCT00786487|9722155|FG000|STARTED|Overall Study||10
8678398|NCT00786487|9722156|FG001|STARTED|Overall Study||7
8678399|NCT00786487|9722157|FG002|STARTED|Overall Study||9
8678400|NCT00786487|9722158|FG003|STARTED|Overall Study||7
8678401|NCT00786487|9722155|FG000|COMPLETED|Overall Study||10
8678402|NCT00786487|9722156|FG001|COMPLETED|Overall Study||7
8678403|NCT00786487|9722157|FG002|COMPLETED|Overall Study||9
8678404|NCT00786487|9722158|FG003|COMPLETED|Overall Study||7
8678405|NCT00786487|9722155|FG000|NOT COMPLETED|Overall Study||0
8678406|NCT00786487|9722156|FG001|NOT COMPLETED|Overall Study||0
8678407|NCT00786487|9722157|FG002|NOT COMPLETED|Overall Study||0
8678408|NCT00786487|9722158|FG003|NOT COMPLETED|Overall Study||0
8678409|NCT00786565|9722168|FG000|STARTED|Enrollment Prior to Surgery||75
8678410|NCT00786565|9722168|FG000|COMPLETED|Enrollment Prior to Surgery|69 participants - Akreos Advanced Optic Lens in one eye and Akreos Adapt Lens in the fellow eye.|69
8678411|NCT00786565|9722168|FG000|NOT COMPLETED|Enrollment Prior to Surgery||6
8678412|NCT00786565|9722168|FG000|STARTED|Post Surgery||69
8678413|NCT00786565|9722168|FG000|COMPLETED|Post Surgery|67 Participants (134 eyes) completed the study.|67
8678414|NCT00786565|9722168|FG000|NOT COMPLETED|Post Surgery||2
8678415|NCT00786643|9722176|FG000|STARTED|Overall Study||20
8678416|NCT00786643|9722177|FG001|STARTED|Overall Study||28
8678417|NCT00786643|9722176|FG000|COMPLETED|Overall Study||20
8678418|NCT00786643|9722177|FG001|COMPLETED|Overall Study||28
8678419|NCT00786643|9722176|FG000|NOT COMPLETED|Overall Study||0
8678420|NCT00786643|9722177|FG001|NOT COMPLETED|Overall Study||0
8678421|NCT00786799|9722185|FG000|STARTED|Overall Study||14
8678422|NCT00786799|9722186|FG001|STARTED|Overall Study||13
8678423|NCT00786799|9722185|FG000|COMPLETED|Overall Study||13
8678424|NCT00786799|9722186|FG001|COMPLETED|Overall Study||12
8678425|NCT00786799|9722185|FG000|NOT COMPLETED|Overall Study||1
8678426|NCT00786799|9722186|FG001|NOT COMPLETED|Overall Study||1
8678427|NCT00786825|9722199|FG000|STARTED|Overall Study||5
8678428|NCT00786825|9722200|FG001|STARTED|Overall Study||5
8678429|NCT00786825|9722199|FG000|COMPLETED|Overall Study||5
8678430|NCT00786825|9722200|FG001|COMPLETED|Overall Study||5
8678431|NCT00786825|9722199|FG000|NOT COMPLETED|Overall Study||0
8678432|NCT00786825|9722200|FG001|NOT COMPLETED|Overall Study||0
8678433|NCT00786838|9722206|FG000|STARTED|Overall Study||75
8678434|NCT00786838|9722206|FG000|COMPLETED|Overall Study||26
8678435|NCT00786838|9722206|FG000|NOT COMPLETED|Overall Study||49
8678436|NCT00786864|9722217|FG000|STARTED|Overall Study||39
8678437|NCT00786864|9722218|FG001|STARTED|Overall Study||33
8678438|NCT00786864|9722217|FG000|COMPLETED|Overall Study|1 child excluded at the 3 month follow-up, as he sustained a serious back injury|38
8678439|NCT00786864|9722218|FG001|COMPLETED|Overall Study|1 child lost to study immediately post-intervention as she left the school|32
8678440|NCT00786864|9722217|FG000|NOT COMPLETED|Overall Study||1
8678441|NCT00786864|9722218|FG001|NOT COMPLETED|Overall Study||1
8678442|NCT00786916|9722227|FG000|STARTED|Overall Study||39
8678443|NCT00786916|9722228|FG001|STARTED|Overall Study||36
8678444|NCT00786916|9722229|FG002|STARTED|Overall Study||34
8678445|NCT00786916|9722227|FG000|COMPLETED|Overall Study||39
8678446|NCT00786916|9722228|FG001|COMPLETED|Overall Study||36
8678447|NCT00786916|9722229|FG002|COMPLETED|Overall Study||34
8678448|NCT00786916|9722227|FG000|NOT COMPLETED|Overall Study||0
8678449|NCT00786916|9722228|FG001|NOT COMPLETED|Overall Study||0
8678450|NCT00786916|9722229|FG002|NOT COMPLETED|Overall Study||0
8678451|NCT00786994|9722241|FG000|STARTED|Overall Study||57
8678452|NCT00786994|9722242|FG001|STARTED|Overall Study||54
8678453|NCT00786994|9722243|FG002|STARTED|Overall Study||26
8678454|NCT00786994|9722244|FG003|STARTED|Overall Study||28
8678455|NCT00786994|9722241|FG000|ITT|Overall Study||53
8678456|NCT00786994|9722242|FG001|ITT|Overall Study||51
8678457|NCT00786994|9722243|FG002|ITT|Overall Study||25
8678458|NCT00786994|9722244|FG003|ITT|Overall Study||28
8678459|NCT00786994|9722241|FG000|COMPLETED|Overall Study||47
8678460|NCT00786994|9722242|FG001|COMPLETED|Overall Study||39
8678461|NCT00786994|9722243|FG002|COMPLETED|Overall Study||24
8678462|NCT00786994|9722244|FG003|COMPLETED|Overall Study||22
8678463|NCT00786994|9722241|FG000|NOT COMPLETED|Overall Study||10
8678464|NCT00786994|9722242|FG001|NOT COMPLETED|Overall Study||15
8678465|NCT00786994|9722243|FG002|NOT COMPLETED|Overall Study||2
8678466|NCT00786994|9722244|FG003|NOT COMPLETED|Overall Study||6
8678467|NCT00787020|9722255|FG000|STARTED|Overall Study||24
8678468|NCT00787020|9722256|FG001|STARTED|Overall Study||13
8678469|NCT00787020|9722255|FG000|COMPLETED|Overall Study||24
8678470|NCT00787020|9722256|FG001|COMPLETED|Overall Study||13
8678471|NCT00787020|9722255|FG000|NOT COMPLETED|Overall Study||0
8678472|NCT00787020|9722256|FG001|NOT COMPLETED|Overall Study||0
8678473|NCT00787137|9722265|FG000|STARTED|Overall Study||6
8678474|NCT00787137|9722266|FG001|STARTED|Overall Study||6
8678475|NCT00787137|9722267|FG002|STARTED|Overall Study||5
8678476|NCT00787137|9722265|FG000|COMPLETED|Overall Study||6
8678477|NCT00787137|9722266|FG001|COMPLETED|Overall Study||6
8678478|NCT00787137|9722267|FG002|COMPLETED|Overall Study||4
8678479|NCT00787137|9722265|FG000|NOT COMPLETED|Overall Study||0
8678480|NCT00787137|9722266|FG001|NOT COMPLETED|Overall Study||0
8678481|NCT00787137|9722267|FG002|NOT COMPLETED|Overall Study||1
8678482|NCT00787150|9722278|FG000|STARTED|Overall Study|Of 222 participants enrolled 4 discontinued before dosing, made a total of 218 participants started.|75
8678483|NCT00787150|9722279|FG001|STARTED|Overall Study|Of 222 participants enrolled 4 discontinued before dosing, made a total of 218 participants started.|72
8678484|NCT00787150|9722280|FG002|STARTED|Overall Study|Of 222 participants enrolled 4 discontinued before dosing, made a total of 218 participants started.|71
8678485|NCT00787150|9722278|FG000|COMPLETED|Overall Study||66
8678486|NCT00787150|9722279|FG001|COMPLETED|Overall Study||65
8678487|NCT00787150|9722280|FG002|COMPLETED|Overall Study||66
8678488|NCT00787150|9722278|FG000|NOT COMPLETED|Overall Study||9
8678489|NCT00787150|9722279|FG001|NOT COMPLETED|Overall Study||7
8678490|NCT00787150|9722280|FG002|NOT COMPLETED|Overall Study||5
8678491|NCT00787189|9722292|FG000|STARTED|Overall Study||32
8678492|NCT00787189|9722293|FG001|STARTED|Overall Study||32
8678493|NCT00787189|9722292|FG000|COMPLETED|Overall Study|To study end point.|30
8678494|NCT00787189|9722293|FG001|COMPLETED|Overall Study|To study end point.|30
8678495|NCT00787189|9722292|FG000|NOT COMPLETED|Overall Study||2
8678496|NCT00787189|9722293|FG001|NOT COMPLETED|Overall Study||2
8678497|NCT00787202|9722304|FG000|STARTED|Overall Study||49
8678498|NCT00787202|9722305|FG001|STARTED|Overall Study||31
8678499|NCT00787202|9722306|FG002|STARTED|Overall Study||33
8678500|NCT00787202|9722307|FG003|STARTED|Overall Study||33
8678501|NCT00787202|9722308|FG004|STARTED|Overall Study||49
8678502|NCT00787202|9722304|FG000|Treated|Overall Study||48
8678503|NCT00787202|9722305|FG001|Treated|Overall Study||31
8799874|NCT01440374|9851473|FG002|NOT COMPLETED|Part 3: Extension||0
8799875|NCT01440374|9851474|FG003|NOT COMPLETED|Part 3: Extension||32
8799876|NCT01440387|9851488|FG000|STARTED|Overall Study||56
8799877|NCT01440387|9851489|FG001|STARTED|Overall Study||56
8799878|NCT01440387|9851488|FG000|COMPLETED|Overall Study||56
8799879|NCT01440387|9851489|FG001|COMPLETED|Overall Study||56
8799880|NCT01440387|9851488|FG000|NOT COMPLETED|Overall Study||0
8799881|NCT01440387|9851489|FG001|NOT COMPLETED|Overall Study||0
8799882|NCT01440543|9851499|FG000|STARTED|Overall Study||106
8799883|NCT01440543|9851500|FG001|STARTED|Overall Study||105
8799884|NCT01440543|9851501|FG002|STARTED|Overall Study||102
8799885|NCT01440543|9851502|FG003|STARTED|Overall Study||107
8799886|NCT01440543|9851499|FG000|COMPLETED|Overall Study||102
8799887|NCT01440543|9851500|FG001|COMPLETED|Overall Study||101
8799888|NCT01440543|9851501|FG002|COMPLETED|Overall Study||100
8799889|NCT01440543|9851502|FG003|COMPLETED|Overall Study||101
8799890|NCT01440543|9851499|FG000|NOT COMPLETED|Overall Study||4
8799891|NCT01440543|9851500|FG001|NOT COMPLETED|Overall Study||4
8799892|NCT01440543|9851501|FG002|NOT COMPLETED|Overall Study||2
8799893|NCT01440543|9851502|FG003|NOT COMPLETED|Overall Study||6
8799894|NCT01440569|9851514|FG000|STARTED|Main Study||296
8799895|NCT01440569|9851515|FG001|STARTED|Main Study||18
8799896|NCT01440569|9851514|FG000|Enrolled and Treated|Main Study||295
8799897|NCT01440569|9851515|FG001|Enrolled and Treated|Main Study||18
8799898|NCT01440569|9851514|FG000|COMPLETED|Main Study||260
8799899|NCT01440569|9851515|FG001|COMPLETED|Main Study||14
8799900|NCT01440569|9851514|FG000|NOT COMPLETED|Main Study||36
8799901|NCT01440569|9851515|FG001|NOT COMPLETED|Main Study||4
8799902|NCT01440569|9851514|FG000|STARTED|Open-Label Rollover Phase|9 participants who completed the Main Study did not enroll into the Rollover Phase.|251
8799903|NCT01440569|9851515|FG001|STARTED|Open-Label Rollover Phase|1 participant who completed the Main Study did not enroll into the Rollover Phase.|13
8799904|NCT01440569|9851514|FG000|COMPLETED|Open-Label Rollover Phase||204
8799905|NCT01440569|9851515|FG001|COMPLETED|Open-Label Rollover Phase||7
8799906|NCT01440569|9851514|FG000|NOT COMPLETED|Open-Label Rollover Phase||47
8799907|NCT01440569|9851515|FG001|NOT COMPLETED|Open-Label Rollover Phase||6
8799908|NCT01440634|9851523|FG000|STARTED|Cross Sectional Phase||0
8799909|NCT01440634|9851524|FG001|STARTED|Cross Sectional Phase||347
8799910|NCT01440634|9851523|FG000|COMPLETED|Cross Sectional Phase||0
8799911|NCT01440634|9851524|FG001|COMPLETED|Cross Sectional Phase||347
8799912|NCT01440634|9851523|FG000|NOT COMPLETED|Cross Sectional Phase||0
8799913|NCT01440634|9851524|FG001|NOT COMPLETED|Cross Sectional Phase||0
8799914|NCT01440634|9851523|FG000|STARTED|Randomization Phase||30
8799915|NCT01440634|9851524|FG001|STARTED|Randomization Phase||24
8799916|NCT01440634|9851523|FG000|COMPLETED|Randomization Phase||24
8799917|NCT01440634|9851524|FG001|COMPLETED|Randomization Phase||14
8799918|NCT01440634|9851523|FG000|NOT COMPLETED|Randomization Phase||6
8799919|NCT01440634|9851524|FG001|NOT COMPLETED|Randomization Phase||10
8799920|NCT01440647|9851532|FG000|STARTED|Overall Study||16
8799921|NCT01440647|9851533|FG001|STARTED|Overall Study||18
8799922|NCT01440647|9851532|FG000|COMPLETED|Overall Study||14
8799923|NCT01440647|9851533|FG001|COMPLETED|Overall Study||15
8799924|NCT01440647|9851532|FG000|NOT COMPLETED|Overall Study||2
8799925|NCT01440647|9851533|FG001|NOT COMPLETED|Overall Study||3
8799926|NCT01440764|9851541|FG000|STARTED|Test Day 1||4
8799927|NCT01440764|9851542|FG001|STARTED|Test Day 1||2
8799928|NCT01440764|9851543|FG002|STARTED|Test Day 1||6
8678504|NCT00787202|9722306|FG002|Treated|Overall Study||33
8678505|NCT00787202|9722307|FG003|Treated|Overall Study||33
8678506|NCT00787202|9722308|FG004|Treated|Overall Study||49
8678507|NCT00787202|9722304|FG000|COMPLETED|Overall Study||35
8799929|NCT01440764|9851544|FG003|STARTED|Test Day 1||1
8799930|NCT01440764|9851545|FG004|STARTED|Test Day 1||3
8678508|NCT00787202|9722305|FG001|COMPLETED|Overall Study||20
8678509|NCT00787202|9722306|FG002|COMPLETED|Overall Study||26
8678510|NCT00787202|9722307|FG003|COMPLETED|Overall Study||31
8678511|NCT00787202|9722308|FG004|COMPLETED|Overall Study||45
8678512|NCT00787202|9722304|FG000|NOT COMPLETED|Overall Study||14
8678513|NCT00787202|9722305|FG001|NOT COMPLETED|Overall Study||11
8678514|NCT00787202|9722306|FG002|NOT COMPLETED|Overall Study||7
8678515|NCT00787202|9722307|FG003|NOT COMPLETED|Overall Study||2
8678516|NCT00787202|9722308|FG004|NOT COMPLETED|Overall Study||4
8678517|NCT00787241|9722327|FG000|STARTED|Overall Study||261
8678518|NCT00787241|9722328|FG001|STARTED|Overall Study||143
8678519|NCT00787241|9722329|FG002|STARTED|Overall Study||41
8678520|NCT00787241|9722327|FG000|COMPLETED|Overall Study||261
8678521|NCT00787241|9722328|FG001|COMPLETED|Overall Study||143
8678522|NCT00787241|9722329|FG002|COMPLETED|Overall Study||41
8678523|NCT00787241|9722327|FG000|NOT COMPLETED|Overall Study||0
8678524|NCT00787241|9722328|FG001|NOT COMPLETED|Overall Study||0
8678525|NCT00787241|9722329|FG002|NOT COMPLETED|Overall Study||0
8678526|NCT00787254|9722339|FG000|STARTED|Overall Study||185
8678527|NCT00787254|9722340|FG001|STARTED|Overall Study||181
8678528|NCT00787254|9722339|FG000|COMPLETED|Overall Study||109
8678529|NCT00787254|9722340|FG001|COMPLETED|Overall Study||99
8678530|NCT00787254|9722339|FG000|NOT COMPLETED|Overall Study||76
8678531|NCT00787254|9722340|FG001|NOT COMPLETED|Overall Study||82
8678532|NCT00787267|9722346|FG000|STARTED|Overall Study|Signed a consent form|37
8678533|NCT00787267|9722346|FG000|COMPLETED|Overall Study|Received at least one dose of study drug|25
8678534|NCT00787267|9722346|FG000|NOT COMPLETED|Overall Study||12
8678535|NCT00787319|9722350|FG000|STARTED|Overall Study||108
8678536|NCT00787319|9722350|FG000|COMPLETED|Overall Study||45
8678537|NCT00787319|9722350|FG000|NOT COMPLETED|Overall Study||63
8678538|NCT00787332|9722356|FG000|STARTED|Overall Study||8
8678539|NCT00787332|9722357|FG001|STARTED|Overall Study||8
8678540|NCT00787332|9722356|FG000|COMPLETED|Overall Study||8
8678541|NCT00787332|9722357|FG001|COMPLETED|Overall Study||8
8678542|NCT00787332|9722356|FG000|NOT COMPLETED|Overall Study||0
8678543|NCT00787332|9722357|FG001|NOT COMPLETED|Overall Study||0
8678544|NCT00787527|9722363|FG000|STARTED|Overall Study||14
8678545|NCT00787527|9722363|FG000|COMPLETED|Overall Study||11
8678546|NCT00787527|9722363|FG000|NOT COMPLETED|Overall Study||3
8678547|NCT00787566|9722374|FG000|STARTED|Overall Study||21
8678548|NCT00787566|9722375|FG001|STARTED|Overall Study||25
8678549|NCT00787566|9722376|FG002|STARTED|Overall Study||22
8678550|NCT00787566|9722374|FG000|COMPLETED|Overall Study||21
8678551|NCT00787566|9722375|FG001|COMPLETED|Overall Study|1 patient withdrew from the study due to an AE related to chemotherapy agent administration.|24
8678552|NCT00787566|9722376|FG002|COMPLETED|Overall Study||22
8678553|NCT00787566|9722374|FG000|NOT COMPLETED|Overall Study||0
8678554|NCT00787566|9722375|FG001|NOT COMPLETED|Overall Study||1
8678555|NCT00787566|9722376|FG002|NOT COMPLETED|Overall Study||0
8678556|NCT00787605|9722386|FG000|STARTED|Overall Study||428
8678557|NCT00787605|9722387|FG001|STARTED|Overall Study||432
8678558|NCT00787605|9722386|FG000|COMPLETED|Overall Study||382
8678559|NCT00787605|9722387|FG001|COMPLETED|Overall Study||376
8678560|NCT00787605|9722386|FG000|NOT COMPLETED|Overall Study||46
8678561|NCT00787605|9722387|FG001|NOT COMPLETED|Overall Study||56
8678562|NCT00787644|9722395|FG000|STARTED|Overall Study||12
8678563|NCT00787644|9722396|FG001|STARTED|Overall Study||11
8678564|NCT00787644|9722395|FG000|COMPLETED|Overall Study||10
8678565|NCT00787644|9722396|FG001|COMPLETED|Overall Study||9
8678566|NCT00787644|9722395|FG000|NOT COMPLETED|Overall Study||2
8678567|NCT00787644|9722396|FG001|NOT COMPLETED|Overall Study||2
8678568|NCT00787722|9722402|FG000|STARTED|Overall Study||13
8678569|NCT00787722|9722402|FG000|COMPLETED|Overall Study||12
8678570|NCT00787722|9722402|FG000|NOT COMPLETED|Overall Study||1
8678571|NCT00787761|9722407|FG000|STARTED|Overall Study||24
8678572|NCT00787761|9722407|FG000|COMPLETED|Overall Study||24
8678573|NCT00787761|9722407|FG000|NOT COMPLETED|Overall Study||0
8678574|NCT00787787|9722413|FG000|STARTED|Overall Study||7
8678575|NCT00787787|9722413|FG000|COMPLETED|Overall Study||0
8678576|NCT00787787|9722413|FG000|NOT COMPLETED|Overall Study||7
8678577|NCT00787800|9722419|FG000|STARTED|Overall Study||50
8678578|NCT00787800|9722420|FG001|STARTED|Overall Study||50
8678579|NCT00787800|9722419|FG000|COMPLETED|Overall Study||47
8678580|NCT00787800|9722420|FG001|COMPLETED|Overall Study||43
8678581|NCT00787800|9722419|FG000|NOT COMPLETED|Overall Study||3
8678582|NCT00787800|9722420|FG001|NOT COMPLETED|Overall Study||7
8678583|NCT00787839|9722427|FG000|STARTED|Overall Study||1939
8678584|NCT00787839|9722427|FG000|Consented|Overall Study|consented|1939
8678585|NCT00787839|9722427|FG000|Completed GCT Screening|Overall Study||1876
8678586|NCT00787839|9722427|FG000|Complete GCT, OGTT, A1c, Demographics|Overall Study||1535
8678587|NCT00787839|9722427|FG000|COMPLETED|Overall Study||1535
8678588|NCT00787839|9722427|FG000|NOT COMPLETED|Overall Study||404
8678589|NCT00787852|9722450|FG000|STARTED|Overall Study||6
8678590|NCT00787852|9722451|FG001|STARTED|Overall Study|The study was terminated prior to enrolled to group 2|5
8678591|NCT00787852|9722450|FG000|COMPLETED|Overall Study|1 patient withdrew consent prior to starting|5
8678592|NCT00787852|9722451|FG001|COMPLETED|Overall Study||5
8678593|NCT00787852|9722450|FG000|NOT COMPLETED|Overall Study||1
8678594|NCT00787852|9722451|FG001|NOT COMPLETED|Overall Study||0
8678595|NCT00787891|9722459|FG000|STARTED|Short-term Double-blind Phase (Part 1)||65
8678596|NCT00787891|9722460|FG001|STARTED|Short-term Double-blind Phase (Part 1)||62
8678597|NCT00787891|9722459|FG000|COMPLETED|Short-term Double-blind Phase (Part 1)||55
8678598|NCT00787891|9722460|FG001|COMPLETED|Short-term Double-blind Phase (Part 1)||53
8678599|NCT00787891|9722459|FG000|NOT COMPLETED|Short-term Double-blind Phase (Part 1)||10
8678600|NCT00787891|9722460|FG001|NOT COMPLETED|Short-term Double-blind Phase (Part 1)||9
8678601|NCT00787891|9722459|FG000|STARTED|Maintenance Double-blind Phase (Part 2)||33
8678602|NCT00787891|9722460|FG001|STARTED|Maintenance Double-blind Phase (Part 2)||31
8678603|NCT00787891|9722459|FG000|COMPLETED|Maintenance Double-blind Phase (Part 2)||26
8678604|NCT00787891|9722460|FG001|COMPLETED|Maintenance Double-blind Phase (Part 2)||24
8678605|NCT00787891|9722459|FG000|NOT COMPLETED|Maintenance Double-blind Phase (Part 2)||7
8678606|NCT00787891|9722460|FG001|NOT COMPLETED|Maintenance Double-blind Phase (Part 2)||7
8678607|NCT00787904|9722470|FG000|STARTED|Overall Study||6
8678608|NCT00787904|9722471|FG001|STARTED|Overall Study||13
8678609|NCT00787904|9722470|FG000|COMPLETED|Overall Study||6
8678610|NCT00787904|9722471|FG001|COMPLETED|Overall Study||13
8678611|NCT00787904|9722470|FG000|NOT COMPLETED|Overall Study||0
8678612|NCT00787904|9722471|FG001|NOT COMPLETED|Overall Study||0
8678613|NCT00787930|9722477|FG000|STARTED|Acute Treatment -- 3 Weeks||19
8678614|NCT00787930|9722477|FG000|COMPLETED|Acute Treatment -- 3 Weeks||19
8678615|NCT00787930|9722477|FG000|NOT COMPLETED|Acute Treatment -- 3 Weeks||0
8678616|NCT00787930|9722477|FG000|STARTED|Continuation Treatment -- up to 12 Month||19
8678617|NCT00787930|9722477|FG000|COMPLETED|Continuation Treatment -- up to 12 Month||16
8678618|NCT00787930|9722477|FG000|NOT COMPLETED|Continuation Treatment -- up to 12 Month||3
8678619|NCT00787943|9722487|FG000|STARTED|Overall Study||10
8678620|NCT00787943|9722487|FG000|COMPLETED|Overall Study||10
8678621|NCT00787943|9722487|FG000|NOT COMPLETED|Overall Study||0
8678622|NCT00788008|9722497|FG000|STARTED|Overall Study||98
8678623|NCT00788008|9722498|FG001|STARTED|Overall Study||101
8678624|NCT00788008|9722497|FG000|COMPLETED|Overall Study||98
8678625|NCT00788008|9722498|FG001|COMPLETED|Overall Study||101
8678626|NCT00788008|9722497|FG000|NOT COMPLETED|Overall Study||0
8678627|NCT00788008|9722498|FG001|NOT COMPLETED|Overall Study||0
8678628|NCT00788073|9722506|FG000|STARTED|STX209 Then Placebo||30
8678629|NCT00788073|9722507|FG001|STARTED|STX209 Then Placebo||33
8678630|NCT00788073|9722506|FG000|COMPLETED|STX209 Then Placebo||29
8678631|NCT00788073|9722507|FG001|COMPLETED|STX209 Then Placebo||30
8678632|NCT00788073|9722506|FG000|NOT COMPLETED|STX209 Then Placebo||1
8678633|NCT00788073|9722507|FG001|NOT COMPLETED|STX209 Then Placebo||3
8678634|NCT00788073|9722506|FG000|STARTED|Placebo Then STX209||29
8678635|NCT00788073|9722507|FG001|STARTED|Placebo Then STX209||30
8678636|NCT00788073|9722506|FG000|COMPLETED|Placebo Then STX209||27
8678637|NCT00788073|9722507|FG001|COMPLETED|Placebo Then STX209||29
8678638|NCT00788073|9722506|FG000|NOT COMPLETED|Placebo Then STX209||2
8678639|NCT00788073|9722507|FG001|NOT COMPLETED|Placebo Then STX209||1
8692850|NCT00862849|9738278|FG000|COMPLETED|Washout 4 (3 to 14 Days)||3
8799931|NCT01440764|9851546|FG005|STARTED|Test Day 1||5
8799932|NCT01440764|9851547|FG006|STARTED|Test Day 1||3
8799933|NCT01440764|9851541|FG000|COMPLETED|Test Day 1||4
8799934|NCT01440764|9851542|FG001|COMPLETED|Test Day 1||2
8799935|NCT01440764|9851543|FG002|COMPLETED|Test Day 1||6
8799936|NCT01440764|9851544|FG003|COMPLETED|Test Day 1||1
8799937|NCT01440764|9851545|FG004|COMPLETED|Test Day 1||3
8799938|NCT01440764|9851546|FG005|COMPLETED|Test Day 1||5
8799939|NCT01440764|9851547|FG006|COMPLETED|Test Day 1||3
8799940|NCT01440764|9851541|FG000|NOT COMPLETED|Test Day 1||0
8799941|NCT01440764|9851542|FG001|NOT COMPLETED|Test Day 1||0
8799942|NCT01440764|9851543|FG002|NOT COMPLETED|Test Day 1||0
8799943|NCT01440764|9851544|FG003|NOT COMPLETED|Test Day 1||0
8799944|NCT01440764|9851545|FG004|NOT COMPLETED|Test Day 1||0
8799945|NCT01440764|9851546|FG005|NOT COMPLETED|Test Day 1||0
8799946|NCT01440764|9851547|FG006|NOT COMPLETED|Test Day 1||0
8799947|NCT01440764|9851541|FG000|STARTED|Test Day 2|Following Test Day 1, 1 subject withdrew from the study before beginning Test Day 2.|3
8799948|NCT01440764|9851542|FG001|STARTED|Test Day 2||2
8799949|NCT01440764|9851543|FG002|STARTED|Test Day 2||6
8799950|NCT01440764|9851544|FG003|STARTED|Test Day 2||1
8799951|NCT01440764|9851545|FG004|STARTED|Test Day 2||3
8799952|NCT01440764|9851546|FG005|STARTED|Test Day 2||5
8799953|NCT01440764|9851547|FG006|STARTED|Test Day 2||3
8799954|NCT01440764|9851541|FG000|COMPLETED|Test Day 2||3
8799955|NCT01440764|9851542|FG001|COMPLETED|Test Day 2||2
8692851|NCT00862849|9738279|FG001|COMPLETED|Washout 4 (3 to 14 Days)||3
8692852|NCT00862849|9738280|FG002|COMPLETED|Washout 4 (3 to 14 Days)||3
8692853|NCT00862849|9738281|FG003|COMPLETED|Washout 4 (3 to 14 Days)||4
8692854|NCT00862849|9738282|FG004|COMPLETED|Washout 4 (3 to 14 Days)||4
8692855|NCT00862849|9738283|FG005|COMPLETED|Washout 4 (3 to 14 Days)||3
8692856|NCT00862849|9738278|FG000|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
8692857|NCT00862849|9738279|FG001|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
8692858|NCT00862849|9738280|FG002|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
8692859|NCT00862849|9738281|FG003|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
8692860|NCT00862849|9738282|FG004|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
8678640|NCT00788255|9722513|FG000|STARTED|Overall Study||25
8678641|NCT00788255|9722513|FG000|Oxytocin Infusion 1: 22.5 μU/mL|Overall Study||25
8678642|NCT00788255|9722513|FG000|Oxytocin Infusion 2: 30.1μU/mL|Overall Study||25
8678643|NCT00788255|9722513|FG000|Oxytocin Infusion 3: 32.9μU/mL|Overall Study||25
8678644|NCT00788255|9722513|FG000|Oxytocin: 0 μU/mL|Overall Study||25
8678645|NCT00788255|9722513|FG000|COMPLETED|Overall Study||25
8678646|NCT00788255|9722513|FG000|NOT COMPLETED|Overall Study||0
8678647|NCT00788372|9722520|FG000|STARTED|Period 1 (up to 4 Weeks)||142
8678648|NCT00788372|9722520|FG000|COMPLETED|Period 1 (up to 4 Weeks)||111
8678649|NCT00788372|9722520|FG000|NOT COMPLETED|Period 1 (up to 4 Weeks)||31
8678650|NCT00788372|9722520|FG000|STARTED|Period 2 (Week 4 to Week 52)||111
8678651|NCT00788372|9722520|FG000|COMPLETED|Period 2 (Week 4 to Week 52)||79
8678652|NCT00788372|9722520|FG000|NOT COMPLETED|Period 2 (Week 4 to Week 52)||32
8678653|NCT00788593|9722524|FG000|STARTED|Placebo Run-in Phase||82
8678654|NCT00788593|9722525|FG001|STARTED|Placebo Run-in Phase||0
8678655|NCT00788593|9722526|FG002|STARTED|Placebo Run-in Phase||0
8678656|NCT00788593|9722524|FG000|COMPLETED|Placebo Run-in Phase||76
8678657|NCT00788593|9722525|FG001|COMPLETED|Placebo Run-in Phase||0
8678658|NCT00788593|9722526|FG002|COMPLETED|Placebo Run-in Phase||0
8678659|NCT00788593|9722524|FG000|NOT COMPLETED|Placebo Run-in Phase||6
8678660|NCT00788593|9722525|FG001|NOT COMPLETED|Placebo Run-in Phase||0
8678661|NCT00788593|9722526|FG002|NOT COMPLETED|Placebo Run-in Phase||0
8678662|NCT00788593|9722524|FG000|STARTED|First Intervention Period||0
8678663|NCT00788593|9722525|FG001|STARTED|First Intervention Period||39
8678664|NCT00788593|9722526|FG002|STARTED|First Intervention Period||37
8678665|NCT00788593|9722524|FG000|COMPLETED|First Intervention Period||0
8678666|NCT00788593|9722525|FG001|COMPLETED|First Intervention Period||38
8678667|NCT00788593|9722526|FG002|COMPLETED|First Intervention Period||37
8678668|NCT00788593|9722524|FG000|NOT COMPLETED|First Intervention Period||0
8678669|NCT00788593|9722525|FG001|NOT COMPLETED|First Intervention Period||1
8678670|NCT00788593|9722526|FG002|NOT COMPLETED|First Intervention Period||0
8678671|NCT00788593|9722524|FG000|STARTED|Second Intervention Period||0
8678672|NCT00788593|9722525|FG001|STARTED|Second Intervention Period||38
8678673|NCT00788593|9722526|FG002|STARTED|Second Intervention Period||37
8678674|NCT00788593|9722524|FG000|COMPLETED|Second Intervention Period||0
8678675|NCT00788593|9722525|FG001|COMPLETED|Second Intervention Period||37
8678676|NCT00788593|9722526|FG002|COMPLETED|Second Intervention Period||36
8678677|NCT00788593|9722524|FG000|NOT COMPLETED|Second Intervention Period||0
8678678|NCT00788593|9722525|FG001|NOT COMPLETED|Second Intervention Period||1
8678679|NCT00788593|9722526|FG002|NOT COMPLETED|Second Intervention Period||1
8678680|NCT00788697|9722536|FG000|STARTED|Overall Study||349
8678681|NCT00788697|9722536|FG000|COMPLETED|Overall Study||240
8678682|NCT00788697|9722536|FG000|NOT COMPLETED|Overall Study||109
8678683|NCT00788775|9722550|FG000|STARTED|Overall Study||11
8678684|NCT00788775|9722551|FG001|STARTED|Overall Study||9
8678685|NCT00788775|9722550|FG000|Treated|Overall Study||11
8678686|NCT00788775|9722551|FG001|Treated|Overall Study||8
8678687|NCT00788775|9722550|FG000|COMPLETED|Overall Study||1
8678688|NCT00788775|9722551|FG001|COMPLETED|Overall Study||1
8678689|NCT00788775|9722550|FG000|NOT COMPLETED|Overall Study||10
8678690|NCT00788775|9722551|FG001|NOT COMPLETED|Overall Study||8
8678691|NCT00788827|9722557|FG000|STARTED|Overall Study||7
8678692|NCT00788827|9722557|FG000|COMPLETED|Overall Study||5
8678693|NCT00788827|9722557|FG000|NOT COMPLETED|Overall Study||2
8678694|NCT00788892|9722565|FG000|STARTED|Overall Study||85
8678695|NCT00788892|9722566|FG001|STARTED|Overall Study||41
8678696|NCT00788892|9722565|FG000|COMPLETED|Overall Study||36
8678697|NCT00788892|9722566|FG001|COMPLETED|Overall Study||18
8678698|NCT00788892|9722565|FG000|NOT COMPLETED|Overall Study||49
8678699|NCT00788892|9722566|FG001|NOT COMPLETED|Overall Study||23
8678700|NCT00788957|9722576|FG000|STARTED|Part 1||11
8678701|NCT00788957|9722577|FG001|STARTED|Part 1||0
8678702|NCT00788957|9722578|FG002|STARTED|Part 1||0
8678703|NCT00788957|9722579|FG003|STARTED|Part 1||0
8678704|NCT00788957|9722580|FG004|STARTED|Part 1||0
8678705|NCT00788957|9722581|FG005|STARTED|Part 1||0
8678706|NCT00788957|9722576|FG000|COMPLETED|Part 1|Completed the safety follow-up visit|2
8678707|NCT00788957|9722577|FG001|COMPLETED|Part 1||0
8678708|NCT00788957|9722578|FG002|COMPLETED|Part 1||0
8919057|NCT02205983|9979143|FG003|COMPLETED|Overall Study||13
8919058|NCT02205983|9979140|FG000|NOT COMPLETED|Overall Study||0
8678709|NCT00788957|9722579|FG003|COMPLETED|Part 1||0
8678710|NCT00788957|9722580|FG004|COMPLETED|Part 1||0
8678711|NCT00788957|9722581|FG005|COMPLETED|Part 1||0
8678712|NCT00788957|9722576|FG000|NOT COMPLETED|Part 1||9
8678713|NCT00788957|9722577|FG001|NOT COMPLETED|Part 1||0
8678714|NCT00788957|9722578|FG002|NOT COMPLETED|Part 1||0
8678715|NCT00788957|9722579|FG003|NOT COMPLETED|Part 1||0
8678716|NCT00788957|9722580|FG004|NOT COMPLETED|Part 1||0
8678717|NCT00788957|9722581|FG005|NOT COMPLETED|Part 1||0
8678718|NCT00788957|9722576|FG000|STARTED|Part 2||0
8678719|NCT00788957|9722577|FG001|STARTED|Part 2||48
8678720|NCT00788957|9722578|FG002|STARTED|Part 2||48
8678721|NCT00788957|9722579|FG003|STARTED|Part 2||46
8678722|NCT00788957|9722580|FG004|STARTED|Part 2||0
8678723|NCT00788957|9722581|FG005|STARTED|Part 2||0
8678724|NCT00788957|9722576|FG000|COMPLETED|Part 2||0
8678725|NCT00788957|9722577|FG001|COMPLETED|Part 2|Completed the safety follow-up visit at the end of the study|6
8678726|NCT00788957|9722578|FG002|COMPLETED|Part 2|Completed the safety follow-up visit|4
8678727|NCT00788957|9722579|FG003|COMPLETED|Part 2|Completed the safety follow-up visit|5
8678728|NCT00788957|9722580|FG004|COMPLETED|Part 2||0
8678729|NCT00788957|9722581|FG005|COMPLETED|Part 2||0
8678730|NCT00788957|9722576|FG000|NOT COMPLETED|Part 2||0
8678731|NCT00788957|9722577|FG001|NOT COMPLETED|Part 2||42
8678732|NCT00788957|9722578|FG002|NOT COMPLETED|Part 2||44
8678733|NCT00788957|9722579|FG003|NOT COMPLETED|Part 2||41
8678734|NCT00788957|9722580|FG004|NOT COMPLETED|Part 2||0
8678735|NCT00788957|9722581|FG005|NOT COMPLETED|Part 2||0
8678736|NCT00788957|9722576|FG000|STARTED|Part 3||0
8678737|NCT00788957|9722577|FG001|STARTED|Part 3||0
8678738|NCT00788957|9722578|FG002|STARTED|Part 3||0
8678739|NCT00788957|9722579|FG003|STARTED|Part 3||0
8678740|NCT00788957|9722580|FG004|STARTED|Part 3||13
8678741|NCT00788957|9722581|FG005|STARTED|Part 3||12
8678742|NCT00788957|9722576|FG000|COMPLETED|Part 3||0
8678743|NCT00788957|9722577|FG001|COMPLETED|Part 3||0
8678744|NCT00788957|9722578|FG002|COMPLETED|Part 3||0
8678745|NCT00788957|9722579|FG003|COMPLETED|Part 3||0
8678746|NCT00788957|9722580|FG004|COMPLETED|Part 3|Completed the safety follow-up visit|4
8678747|NCT00788957|9722581|FG005|COMPLETED|Part 3|Completed the safety follow-up visit|1
8678748|NCT00788957|9722576|FG000|NOT COMPLETED|Part 3||0
8678749|NCT00788957|9722577|FG001|NOT COMPLETED|Part 3||0
8678750|NCT00788957|9722578|FG002|NOT COMPLETED|Part 3||0
8678751|NCT00788957|9722579|FG003|NOT COMPLETED|Part 3||0
8678752|NCT00788957|9722580|FG004|NOT COMPLETED|Part 3||9
8678753|NCT00788957|9722581|FG005|NOT COMPLETED|Part 3||11
8678754|NCT00789035|9722603|FG000|STARTED|Overall Study||82
8678755|NCT00789035|9722604|FG001|STARTED|Overall Study||81
8678756|NCT00789035|9722605|FG002|STARTED|Overall Study||81
8678757|NCT00789035|9722606|FG003|STARTED|Overall Study||82
8678758|NCT00789035|9722607|FG004|STARTED|Overall Study||80
8678759|NCT00789035|9722603|FG000|COMPLETED|Overall Study||76
8678760|NCT00789035|9722604|FG001|COMPLETED|Overall Study||74
8678761|NCT00789035|9722605|FG002|COMPLETED|Overall Study||80
8678762|NCT00789035|9722606|FG003|COMPLETED|Overall Study||81
8678763|NCT00789035|9722607|FG004|COMPLETED|Overall Study||74
8678764|NCT00789035|9722603|FG000|NOT COMPLETED|Overall Study||6
8678765|NCT00789035|9722604|FG001|NOT COMPLETED|Overall Study||7
8678766|NCT00789035|9722605|FG002|NOT COMPLETED|Overall Study||1
8678767|NCT00789035|9722606|FG003|NOT COMPLETED|Overall Study||1
8678768|NCT00789035|9722607|FG004|NOT COMPLETED|Overall Study||6
8678769|NCT00789074|9722624|FG000|STARTED|Overall Study||53
8678770|NCT00789074|9722625|FG001|STARTED|Overall Study||48
8678771|NCT00789074|9722624|FG000|COMPLETED|Overall Study||42
8678772|NCT00789074|9722625|FG001|COMPLETED|Overall Study||35
8678773|NCT00789074|9722624|FG000|NOT COMPLETED|Overall Study||11
8678774|NCT00789074|9722625|FG001|NOT COMPLETED|Overall Study||13
8678775|NCT00789113|9722634|FG000|STARTED|Overall Study||12
8678776|NCT00789113|9722634|FG000|COMPLETED|Overall Study||12
8678777|NCT00789113|9722634|FG000|NOT COMPLETED|Overall Study||0
8678778|NCT00789191|9722641|FG000|STARTED|Overall Study||111
8678779|NCT00789191|9722642|FG001|STARTED|Overall Study||111
8678780|NCT00789191|9722641|FG000|Exposed|Overall Study|2 withdrew informed consent. 1 randomised by mistake. 1 non-compliance|107
8678781|NCT00789191|9722642|FG001|Exposed|Overall Study|1 non-compliance|110
8678782|NCT00789191|9722641|FG000|COMPLETED|Overall Study||97
8678783|NCT00789191|9722642|FG001|COMPLETED|Overall Study||92
8678784|NCT00789191|9722641|FG000|NOT COMPLETED|Overall Study||14
8678785|NCT00789191|9722642|FG001|NOT COMPLETED|Overall Study||19
8678786|NCT00789256|9722650|FG000|STARTED|Overall Study||14
8678787|NCT00789256|9722651|FG001|STARTED|Overall Study||12
8678788|NCT00789256|9722650|FG000|COMPLETED|Overall Study|Strata 1 had 5 responders and continued accrual, but the study was closed due to low accrual.|14
8678789|NCT00789256|9722651|FG001|COMPLETED|Overall Study||12
8678790|NCT00789256|9722650|FG000|NOT COMPLETED|Overall Study||0
8678791|NCT00789256|9722651|FG001|NOT COMPLETED|Overall Study||0
8678792|NCT00789321|9722662|FG000|STARTED|Overall Study||24
8678793|NCT00789321|9722663|FG001|STARTED|Overall Study||23
8678794|NCT00789321|9722662|FG000|COMPLETED|Overall Study||24
8678795|NCT00789321|9722663|FG001|COMPLETED|Overall Study||22
8678796|NCT00789321|9722662|FG000|NOT COMPLETED|Overall Study||0
8678797|NCT00789321|9722663|FG001|NOT COMPLETED|Overall Study||1
8678798|NCT00789360|9722671|FG000|STARTED|Overall Study||15
8678799|NCT00789360|9722672|FG001|STARTED|Overall Study||15
8678800|NCT00789360|9722671|FG000|COMPLETED|Overall Study||12
8678801|NCT00789360|9722672|FG001|COMPLETED|Overall Study||14
8678802|NCT00789360|9722671|FG000|NOT COMPLETED|Overall Study||3
8678803|NCT00789360|9722672|FG001|NOT COMPLETED|Overall Study||1
8678804|NCT00789373|9722679|FG000|STARTED|Induction||939
8678805|NCT00789373|9722680|FG001|STARTED|Induction||0
8678806|NCT00789373|9722681|FG002|STARTED|Induction||0
8678807|NCT00789373|9722679|FG000|COMPLETED|Induction|1 patient received maintenance therapy post-induction but was never randomized.|540
8678808|NCT00789373|9722680|FG001|COMPLETED|Induction||0
8678809|NCT00789373|9722681|FG002|COMPLETED|Induction||0
8678810|NCT00789373|9722679|FG000|NOT COMPLETED|Induction||399
8678811|NCT00789373|9722680|FG001|NOT COMPLETED|Induction||0
8678812|NCT00789373|9722681|FG002|NOT COMPLETED|Induction||0
8678813|NCT00789373|9722679|FG000|STARTED|Maintenance||0
8678814|NCT00789373|9722680|FG001|STARTED|Maintenance||359
8678815|NCT00789373|9722681|FG002|STARTED|Maintenance||180
8678816|NCT00789373|9722679|FG000|COMPLETED|Maintenance||0
8678817|NCT00789373|9722680|FG001|COMPLETED|Maintenance||0
8678818|NCT00789373|9722681|FG002|COMPLETED|Maintenance||0
8678819|NCT00789373|9722679|FG000|NOT COMPLETED|Maintenance||0
8678820|NCT00789373|9722680|FG001|NOT COMPLETED|Maintenance||359
8678821|NCT00789373|9722681|FG002|NOT COMPLETED|Maintenance||180
8678822|NCT00789438|9722695|FG000|STARTED|Overall Study||21
8678823|NCT00789438|9722696|FG001|STARTED|Overall Study||20
8678824|NCT00789438|9722697|FG002|STARTED|Overall Study||28
8678825|NCT00789438|9722695|FG000|COMPLETED|Overall Study||21
8678826|NCT00789438|9722696|FG001|COMPLETED|Overall Study||20
8678827|NCT00789438|9722697|FG002|COMPLETED|Overall Study||28
8678828|NCT00789438|9722695|FG000|NOT COMPLETED|Overall Study||0
8678829|NCT00789438|9722696|FG001|NOT COMPLETED|Overall Study||0
8678830|NCT00789438|9722697|FG002|NOT COMPLETED|Overall Study||0
8678831|NCT00789477|9722710|FG000|STARTED|Overall Study|randomized|44
8678832|NCT00789477|9722711|FG001|STARTED|Overall Study|randomized|44
8678833|NCT00789477|9722712|FG002|STARTED|Overall Study|randomized|44
8678834|NCT00789477|9722713|FG003|STARTED|Overall Study|randomized|44
8678835|NCT00789477|9722714|FG004|STARTED|Overall Study|randomized|45
8678836|NCT00789477|9722710|FG000|Participants Received Treatment|Overall Study|safety analysis set (SAF)|44
8678837|NCT00789477|9722711|FG001|Participants Received Treatment|Overall Study|SAF|44
8678838|NCT00789477|9722712|FG002|Participants Received Treatment|Overall Study|SAF|44
8678839|NCT00789477|9722713|FG003|Participants Received Treatment|Overall Study|SAF|42
8678840|NCT00789477|9722714|FG004|Participants Received Treatment|Overall Study|SAF|45
8678841|NCT00789477|9722710|FG000|COMPLETED|Overall Study||33
8678842|NCT00789477|9722711|FG001|COMPLETED|Overall Study||38
8678843|NCT00789477|9722712|FG002|COMPLETED|Overall Study||33
8678844|NCT00789477|9722713|FG003|COMPLETED|Overall Study||34
8678845|NCT00789477|9722714|FG004|COMPLETED|Overall Study||38
8678846|NCT00789477|9722710|FG000|NOT COMPLETED|Overall Study||11
8678847|NCT00789477|9722711|FG001|NOT COMPLETED|Overall Study||6
8678848|NCT00789477|9722712|FG002|NOT COMPLETED|Overall Study||11
8678849|NCT00789477|9722713|FG003|NOT COMPLETED|Overall Study||10
8678850|NCT00789477|9722714|FG004|NOT COMPLETED|Overall Study||7
8678851|NCT00789529|9722730|FG000|STARTED|Overall Study||16
8678852|NCT00789529|9722731|FG001|STARTED|Overall Study||16
8678853|NCT00789529|9722730|FG000|COMPLETED|Overall Study||15
8678854|NCT00789529|9722731|FG001|COMPLETED|Overall Study||15
8678855|NCT00789529|9722730|FG000|NOT COMPLETED|Overall Study||1
8678856|NCT00789529|9722731|FG001|NOT COMPLETED|Overall Study||1
8678857|NCT00789555|9722740|FG000|STARTED|Overall Study||421
8678858|NCT00789555|9722741|FG001|STARTED|Overall Study||417
8678859|NCT00789555|9722742|FG002|STARTED|Overall Study||422
8678860|NCT00789555|9722740|FG000|COMPLETED|Overall Study||262
8678861|NCT00789555|9722741|FG001|COMPLETED|Overall Study||278
8678862|NCT00789555|9722742|FG002|COMPLETED|Overall Study||263
8678863|NCT00789555|9722740|FG000|NOT COMPLETED|Overall Study||159
8678864|NCT00789555|9722741|FG001|NOT COMPLETED|Overall Study||139
8678865|NCT00789555|9722742|FG002|NOT COMPLETED|Overall Study||159
8678866|NCT00789581|9722752|FG000|STARTED|AC Therapy||306
8678867|NCT00789581|9722753|FG001|STARTED|AC Therapy||308
8678868|NCT00789581|9722752|FG000|COMPLETED|AC Therapy||295
8678869|NCT00789581|9722753|FG001|COMPLETED|AC Therapy||291
8678870|NCT00789581|9722752|FG000|NOT COMPLETED|AC Therapy||11
8678871|NCT00789581|9722753|FG001|NOT COMPLETED|AC Therapy||17
8678872|NCT00789581|9722752|FG000|STARTED|Adjuvant Therapy||295
8678873|NCT00789581|9722753|FG001|STARTED|Adjuvant Therapy||291
8678874|NCT00789581|9722752|FG000|COMPLETED|Adjuvant Therapy||255
8678875|NCT00789581|9722753|FG001|COMPLETED|Adjuvant Therapy||234
8678876|NCT00789581|9722752|FG000|NOT COMPLETED|Adjuvant Therapy||40
8678877|NCT00789581|9722753|FG001|NOT COMPLETED|Adjuvant Therapy||57
8678878|NCT00789672|9722762|FG000|STARTED|Overall Study||16
8678879|NCT00789672|9722763|FG001|STARTED|Overall Study||17
8678880|NCT00789672|9722762|FG000|COMPLETED|Overall Study||16
8678881|NCT00789672|9722763|FG001|COMPLETED|Overall Study||17
8678882|NCT00789672|9722762|FG000|NOT COMPLETED|Overall Study||0
8678883|NCT00789672|9722763|FG001|NOT COMPLETED|Overall Study||0
8678884|NCT00789685|9722769|FG000|STARTED|Overall Study||37
8678885|NCT00789685|9722769|FG000|COMPLETED|Overall Study|Completed the study to Day 28|25
8678886|NCT00789685|9722769|FG000|NOT COMPLETED|Overall Study||12
8678887|NCT00789698|9722777|FG000|STARTED|Overall Study||72
8678888|NCT00789698|9722778|FG001|STARTED|Overall Study||79
8678889|NCT00789698|9722779|FG002|STARTED|Overall Study||56
8678890|NCT00789698|9722780|FG003|STARTED|Overall Study||85
8678891|NCT00789698|9722777|FG000|COMPLETED|Overall Study||32
8678892|NCT00789698|9722778|FG001|COMPLETED|Overall Study||46
8678893|NCT00789698|9722779|FG002|COMPLETED|Overall Study||29
8678894|NCT00789698|9722780|FG003|COMPLETED|Overall Study||33
8678895|NCT00789698|9722777|FG000|NOT COMPLETED|Overall Study||40
8678896|NCT00789698|9722778|FG001|NOT COMPLETED|Overall Study||33
8678897|NCT00789698|9722779|FG002|NOT COMPLETED|Overall Study||27
8678898|NCT00789698|9722780|FG003|NOT COMPLETED|Overall Study||52
8678899|NCT00789724|9722791|FG000|STARTED|Overall Study||5
8678900|NCT00789724|9722792|FG001|STARTED|Overall Study||5
8678901|NCT00789724|9722791|FG000|COMPLETED|Overall Study||5
8678902|NCT00789724|9722792|FG001|COMPLETED|Overall Study||5
8678903|NCT00789724|9722791|FG000|NOT COMPLETED|Overall Study||0
8678904|NCT00789724|9722792|FG001|NOT COMPLETED|Overall Study||0
8678905|NCT00789737|9722800|FG000|STARTED|Overall Study||176
8678906|NCT00789737|9722801|FG001|STARTED|Overall Study||181
8678907|NCT00789737|9722800|FG000|COMPLETED|Overall Study||128
8678908|NCT00789737|9722801|FG001|COMPLETED|Overall Study||126
8678909|NCT00789737|9722800|FG000|NOT COMPLETED|Overall Study||48
8678910|NCT00789737|9722801|FG001|NOT COMPLETED|Overall Study||55
8678911|NCT00789750|9722809|FG000|STARTED|Overall Study||280
8678912|NCT00789750|9722810|FG001|STARTED|Overall Study||282
8678913|NCT00789750|9722809|FG000|Dropped During run-in Period|Overall Study||6
8678914|NCT00789750|9722810|FG001|Dropped During run-in Period|Overall Study||5
8678915|NCT00789750|9722809|FG000|Safety Set|Overall Study||274
8678916|NCT00789750|9722810|FG001|Safety Set|Overall Study||277
8678917|NCT00789750|9722809|FG000|Intent to Treat Set|Overall Study||271
8678918|NCT00789750|9722810|FG001|Intent to Treat Set|Overall Study||276
8678919|NCT00789750|9722809|FG000|COMPLETED|Overall Study||221
8678920|NCT00789750|9722810|FG001|COMPLETED|Overall Study||222
8678921|NCT00789750|9722809|FG000|NOT COMPLETED|Overall Study||59
8678922|NCT00789750|9722810|FG001|NOT COMPLETED|Overall Study||60
8678923|NCT00789776|9722818|FG000|STARTED|Overall Study||5
8678924|NCT00789776|9722819|FG001|STARTED|Overall Study||36
8678925|NCT00789776|9722818|FG000|COMPLETED|Overall Study||5
8678926|NCT00789776|9722819|FG001|COMPLETED|Overall Study||35
8678927|NCT00789776|9722818|FG000|NOT COMPLETED|Overall Study||0
8678928|NCT00789776|9722819|FG001|NOT COMPLETED|Overall Study||1
8678929|NCT00789802|9722828|FG000|STARTED|Overall Study||44
8678930|NCT00789802|9722829|FG001|STARTED|Overall Study||42
8678931|NCT00789802|9722830|FG002|STARTED|Overall Study||43
8678932|NCT00789802|9722828|FG000|COMPLETED|Overall Study||34
8678933|NCT00789802|9722829|FG001|COMPLETED|Overall Study||35
8678934|NCT00789802|9722830|FG002|COMPLETED|Overall Study||37
8678935|NCT00789802|9722828|FG000|NOT COMPLETED|Overall Study||10
8678936|NCT00789802|9722829|FG001|NOT COMPLETED|Overall Study||7
8678937|NCT00789802|9722830|FG002|NOT COMPLETED|Overall Study||6
8678938|NCT00789815|9722843|FG000|STARTED|Overall Study||250
8678939|NCT00789815|9722844|FG001|STARTED|Overall Study||250
8678940|NCT00789815|9722843|FG000|COMPLETED|Overall Study||243
8678941|NCT00789815|9722844|FG001|COMPLETED|Overall Study||249
8678942|NCT00789815|9722843|FG000|NOT COMPLETED|Overall Study||7
8678943|NCT00789815|9722844|FG001|NOT COMPLETED|Overall Study||1
8678944|NCT00789828|9722852|FG000|STARTED|Core Period (48 Weeks)||78
8678945|NCT00789828|9722853|FG001|STARTED|Core Period (48 Weeks)||39
8678946|NCT00789828|9722852|FG000|COMPLETED|Core Period (48 Weeks)||78
8678947|NCT00789828|9722853|FG001|COMPLETED|Core Period (48 Weeks)||33
8678948|NCT00789828|9722852|FG000|NOT COMPLETED|Core Period (48 Weeks)||0
8678949|NCT00789828|9722853|FG001|NOT COMPLETED|Core Period (48 Weeks)||6
8678950|NCT00789828|9722852|FG000|STARTED|Open-label Extension Period (4 Years)|Of 117 participants only 111 completed the core period and continued in the extension period|111
8678951|NCT00789828|9722853|FG001|STARTED|Open-label Extension Period (4 Years)|No participant received placebo.|0
8678952|NCT00789828|9722852|FG000|COMPLETED|Open-label Extension Period (4 Years)||82
8678953|NCT00789828|9722853|FG001|COMPLETED|Open-label Extension Period (4 Years)||0
8678954|NCT00789828|9722852|FG000|NOT COMPLETED|Open-label Extension Period (4 Years)||29
8678955|NCT00789828|9722853|FG001|NOT COMPLETED|Open-label Extension Period (4 Years)||0
8678956|NCT00789854|9722865|FG000|STARTED|Overall Study||228
8678957|NCT00789854|9722866|FG001|STARTED|Overall Study||231
8678958|NCT00789854|9722867|FG002|STARTED|Overall Study||229
8678959|NCT00789854|9722865|FG000|COMPLETED|Overall Study||179
8678960|NCT00789854|9722866|FG001|COMPLETED|Overall Study||196
8678961|NCT00789854|9722867|FG002|COMPLETED|Overall Study||182
8678962|NCT00789854|9722865|FG000|NOT COMPLETED|Overall Study||49
8678963|NCT00789854|9722866|FG001|NOT COMPLETED|Overall Study||35
8678964|NCT00789854|9722867|FG002|NOT COMPLETED|Overall Study||47
8678965|NCT00789867|9722878|FG000|STARTED|Overall Study||17
8678966|NCT00789867|9722879|FG001|STARTED|Overall Study||10
8678967|NCT00789867|9722880|FG002|STARTED|Overall Study||8
8678968|NCT00789867|9722878|FG000|COMPLETED|Overall Study||17
8678969|NCT00789867|9722879|FG001|COMPLETED|Overall Study||10
8678970|NCT00789867|9722880|FG002|COMPLETED|Overall Study||8
8678971|NCT00789867|9722878|FG000|NOT COMPLETED|Overall Study||0
8678972|NCT00789867|9722879|FG001|NOT COMPLETED|Overall Study||0
8678973|NCT00789867|9722880|FG002|NOT COMPLETED|Overall Study||0
8678974|NCT00789880|9722895|FG000|STARTED|Overall Study||16
8678975|NCT00789880|9722896|FG001|STARTED|Overall Study||16
8678976|NCT00789880|9722897|FG002|STARTED|Overall Study||8
8678977|NCT00789880|9722898|FG003|STARTED|Overall Study||16
8678978|NCT00789880|9722899|FG004|STARTED|Overall Study||18
8678979|NCT00789880|9722900|FG005|STARTED|Overall Study||8
8678980|NCT00789880|9722895|FG000|COMPLETED|Overall Study||15
8678981|NCT00789880|9722896|FG001|COMPLETED|Overall Study||15
8678982|NCT00789880|9722897|FG002|COMPLETED|Overall Study||8
8678983|NCT00789880|9722898|FG003|COMPLETED|Overall Study||15
8678984|NCT00789880|9722899|FG004|COMPLETED|Overall Study||15
8678985|NCT00789880|9722900|FG005|COMPLETED|Overall Study||8
8678986|NCT00789880|9722895|FG000|NOT COMPLETED|Overall Study||1
8678987|NCT00789880|9722896|FG001|NOT COMPLETED|Overall Study||1
8678988|NCT00789880|9722897|FG002|NOT COMPLETED|Overall Study||0
8678989|NCT00789880|9722898|FG003|NOT COMPLETED|Overall Study||1
8678990|NCT00789880|9722899|FG004|NOT COMPLETED|Overall Study||3
8678991|NCT00789880|9722900|FG005|NOT COMPLETED|Overall Study||0
8678992|NCT00789958|9722914|FG000|STARTED|Overall Study||105
8678993|NCT00789958|9722914|FG000|Eligible and Analyzable|Overall Study||79
8678994|NCT00789958|9722914|FG000|COMPLETED|Overall Study||68
8678995|NCT00789958|9722914|FG000|NOT COMPLETED|Overall Study||37
8678996|NCT00789997|9722922|FG000|STARTED|Overall Study||41
8678997|NCT00789997|9722923|FG001|STARTED|Overall Study||40
8678998|NCT00789997|9722922|FG000|COMPLETED|Overall Study||40
8678999|NCT00789997|9722923|FG001|COMPLETED|Overall Study||38
8679000|NCT00789997|9722922|FG000|NOT COMPLETED|Overall Study||1
8679001|NCT00789997|9722923|FG001|NOT COMPLETED|Overall Study||2
8679002|NCT00790023|9722932|FG000|STARTED|Overall Study||237
8679003|NCT00790023|9722933|FG001|STARTED|Overall Study||235
8679004|NCT00790023|9722934|FG002|STARTED|Overall Study||235
8679005|NCT00790023|9722932|FG000|COMPLETED|Overall Study||226
8679006|NCT00790023|9722933|FG001|COMPLETED|Overall Study||225
8679007|NCT00790023|9722934|FG002|COMPLETED|Overall Study||214
8679008|NCT00790023|9722932|FG000|NOT COMPLETED|Overall Study||11
8679009|NCT00790023|9722933|FG001|NOT COMPLETED|Overall Study||10
8679010|NCT00790023|9722934|FG002|NOT COMPLETED|Overall Study||21
8679011|NCT00790036|9722945|FG000|STARTED|Overall Study||372
8679012|NCT00790036|9722946|FG001|STARTED|Overall Study||370
8679013|NCT00790036|9722945|FG000|Untreated Participants|Overall Study|not treated due to administrative problems, protocol deviation, and subject withdrawal of consent.|4
8679014|NCT00790036|9722946|FG001|Untreated Participants|Overall Study|not treated due to administrative problems and subject withdrawal of consent.|6
8679015|NCT00790036|9722945|FG000|COMPLETED|Overall Study|completed = treatment duration completed as per protocol|177
8919059|NCT02205983|9979141|FG001|NOT COMPLETED|Overall Study||0
8919060|NCT02205983|9979142|FG002|NOT COMPLETED|Overall Study||0
8919061|NCT02205983|9979143|FG003|NOT COMPLETED|Overall Study||0
8919062|NCT02206061|9979156|FG000|STARTED|Overall Study||149
8919063|NCT02206061|9979157|FG001|STARTED|Overall Study||142
8919064|NCT02206061|9979158|FG002|STARTED|Overall Study||139
8919065|NCT02206061|9979156|FG000|COMPLETED|Overall Study||131
8919066|NCT02206061|9979157|FG001|COMPLETED|Overall Study||128
8919067|NCT02206061|9979158|FG002|COMPLETED|Overall Study||118
8919068|NCT02206061|9979156|FG000|NOT COMPLETED|Overall Study||18
8919069|NCT02206061|9979157|FG001|NOT COMPLETED|Overall Study||14
8919070|NCT02206061|9979158|FG002|NOT COMPLETED|Overall Study||21
8919071|NCT02206152|9979166|FG000|STARTED|Pre-Randomization||22
8919072|NCT02206152|9979166|FG000|COMPLETED|Pre-Randomization||20
8919073|NCT02206152|9979166|FG000|NOT COMPLETED|Pre-Randomization||2
8919074|NCT02206152|9979166|FG000|STARTED|Placebo, Then NAC||10
8919075|NCT02206152|9979166|FG000|COMPLETED|Placebo, Then NAC||10
8919076|NCT02206152|9979166|FG000|NOT COMPLETED|Placebo, Then NAC||0
8919077|NCT02206152|9979166|FG000|STARTED|NAC, Then Placebo||10
8919078|NCT02206152|9979166|FG000|COMPLETED|NAC, Then Placebo||10
8919079|NCT02206152|9979166|FG000|NOT COMPLETED|NAC, Then Placebo||0
8919080|NCT02206217|9979174|FG000|STARTED|Overall Study||90
8919081|NCT02206217|9979175|FG001|STARTED|Overall Study||93
8919082|NCT02206217|9979174|FG000|COMPLETED|Overall Study||81
8919083|NCT02206217|9979175|FG001|COMPLETED|Overall Study||79
8919084|NCT02206217|9979174|FG000|NOT COMPLETED|Overall Study||9
8919085|NCT02206217|9979175|FG001|NOT COMPLETED|Overall Study||14
8919086|NCT02206607|9979181|FG000|STARTED|Open-Label Run-In||42
8919087|NCT02206607|9979182|FG001|STARTED|Open-Label Run-In||0
8919088|NCT02206607|9979183|FG002|STARTED|Open-Label Run-In||0
8919089|NCT02206607|9979184|FG003|STARTED|Open-Label Run-In||0
8919090|NCT02206607|9979185|FG004|STARTED|Open-Label Run-In||0
8919091|NCT02206607|9979181|FG000|COMPLETED|Open-Label Run-In||39
8919092|NCT02206607|9979182|FG001|COMPLETED|Open-Label Run-In||0
8919093|NCT02206607|9979183|FG002|COMPLETED|Open-Label Run-In||0
8919094|NCT02206607|9979184|FG003|COMPLETED|Open-Label Run-In||0
8919095|NCT02206607|9979185|FG004|COMPLETED|Open-Label Run-In||0
8919096|NCT02206607|9979181|FG000|NOT COMPLETED|Open-Label Run-In||3
8919097|NCT02206607|9979182|FG001|NOT COMPLETED|Open-Label Run-In||0
8919098|NCT02206607|9979183|FG002|NOT COMPLETED|Open-Label Run-In||0
8919099|NCT02206607|9979184|FG003|NOT COMPLETED|Open-Label Run-In||0
8919100|NCT02206607|9979185|FG004|NOT COMPLETED|Open-Label Run-In||0
8919101|NCT02206607|9979181|FG000|STARTED|First Intervention Period||0
8919102|NCT02206607|9979182|FG001|STARTED|First Intervention Period||9
8919103|NCT02206607|9979183|FG002|STARTED|First Intervention Period||9
8919104|NCT02206607|9979184|FG003|STARTED|First Intervention Period||11
8919105|NCT02206607|9979185|FG004|STARTED|First Intervention Period||10
8919106|NCT02206607|9979181|FG000|COMPLETED|First Intervention Period||0
8919107|NCT02206607|9979182|FG001|COMPLETED|First Intervention Period||9
8919108|NCT02206607|9979183|FG002|COMPLETED|First Intervention Period||9
8919109|NCT02206607|9979184|FG003|COMPLETED|First Intervention Period||11
8679016|NCT00790036|9722946|FG001|COMPLETED|Overall Study|completed = treatment duration completed as per protocol|249
8679017|NCT00790036|9722945|FG000|NOT COMPLETED|Overall Study||195
8919110|NCT02206607|9979185|FG004|COMPLETED|First Intervention Period||10
8919111|NCT02206607|9979181|FG000|NOT COMPLETED|First Intervention Period||0
8919112|NCT02206607|9979182|FG001|NOT COMPLETED|First Intervention Period||0
8919113|NCT02206607|9979183|FG002|NOT COMPLETED|First Intervention Period||0
8919114|NCT02206607|9979184|FG003|NOT COMPLETED|First Intervention Period||0
8919115|NCT02206607|9979185|FG004|NOT COMPLETED|First Intervention Period||0
8679018|NCT00790036|9722946|FG001|NOT COMPLETED|Overall Study||121
8679019|NCT00790062|9722956|FG000|STARTED|Overall Study||659
8679020|NCT00790062|9722957|FG001|STARTED|Overall Study||481
8679021|NCT00790062|9722958|FG002|STARTED|Overall Study||658
8679022|NCT00790062|9722956|FG000|COMPLETED|Overall Study||659
8679023|NCT00790062|9722957|FG001|COMPLETED|Overall Study||481
8679024|NCT00790062|9722958|FG002|COMPLETED|Overall Study||658
8679025|NCT00790062|9722956|FG000|NOT COMPLETED|Overall Study||0
8679026|NCT00790062|9722957|FG001|NOT COMPLETED|Overall Study||0
8679027|NCT00790062|9722958|FG002|NOT COMPLETED|Overall Study||0
8679028|NCT00790088|9722975|FG000|STARTED|Overall Study||274
8679029|NCT00790088|9722975|FG000|Eligible for Data Analysis|Overall Study|Number of participants minus 11 protocol violation|263
8679030|NCT00790088|9722975|FG000|COMPLETED|Overall Study||235
8679031|NCT00790088|9722975|FG000|NOT COMPLETED|Overall Study||39
8679032|NCT00790192|9722985|FG000|STARTED|Overall Study||125
8679033|NCT00790192|9722986|FG001|STARTED|Overall Study||121
8679034|NCT00790192|9722987|FG002|STARTED|Overall Study||120
8679035|NCT00790192|9722988|FG003|STARTED|Overall Study||122
8679036|NCT00790192|9722985|FG000|COMPLETED|Overall Study||89
8679037|NCT00790192|9722986|FG001|COMPLETED|Overall Study||93
8679038|NCT00790192|9722987|FG002|COMPLETED|Overall Study||97
8679039|NCT00790192|9722988|FG003|COMPLETED|Overall Study||74
8679040|NCT00790192|9722985|FG000|NOT COMPLETED|Overall Study||36
8679041|NCT00790192|9722986|FG001|NOT COMPLETED|Overall Study||28
8679042|NCT00790192|9722987|FG002|NOT COMPLETED|Overall Study||23
8679043|NCT00790192|9722988|FG003|NOT COMPLETED|Overall Study||48
8679044|NCT00790205|9723000|FG000|STARTED|Overall Study||7332
8679045|NCT00790205|9723001|FG001|STARTED|Overall Study||7339
8679046|NCT00790205|9723000|FG000|Treated|Overall Study||7266
8679047|NCT00790205|9723001|FG001|Treated|Overall Study||7274
8679048|NCT00790205|9723000|FG000|COMPLETED|Overall Study||6972
8679049|NCT00790205|9723001|FG001|COMPLETED|Overall Study||6905
8679050|NCT00790205|9723000|FG000|NOT COMPLETED|Overall Study||360
8679051|NCT00790205|9723001|FG001|NOT COMPLETED|Overall Study||434
8679052|NCT00790270|9723010|FG000|STARTED|Overall Study||21
8679053|NCT00790270|9723011|FG001|STARTED|Overall Study||20
8679054|NCT00790270|9723012|FG002|STARTED|Overall Study||20
8679055|NCT00790270|9723010|FG000|COMPLETED|Overall Study||21
8679056|NCT00790270|9723011|FG001|COMPLETED|Overall Study||20
8679057|NCT00790270|9723012|FG002|COMPLETED|Overall Study||20
8679058|NCT00790270|9723010|FG000|NOT COMPLETED|Overall Study||0
8679059|NCT00790270|9723011|FG001|NOT COMPLETED|Overall Study||0
8679060|NCT00790270|9723012|FG002|NOT COMPLETED|Overall Study||0
8679061|NCT00790296|9723022|FG000|STARTED|Overall Study||5
8679062|NCT00790296|9723023|FG001|STARTED|Overall Study||6
8679063|NCT00790296|9723022|FG000|COMPLETED|Overall Study||4
8679064|NCT00790296|9723023|FG001|COMPLETED|Overall Study||4
8679065|NCT00790296|9723022|FG000|NOT COMPLETED|Overall Study||1
8679066|NCT00790296|9723023|FG001|NOT COMPLETED|Overall Study||2
8679067|NCT00790335|9723031|FG000|STARTED|Overall Study||337
8679068|NCT00790335|9723032|FG001|STARTED|Overall Study||355
8679069|NCT00790335|9723031|FG000|COMPLETED|Overall Study||257
8679070|NCT00790335|9723032|FG001|COMPLETED|Overall Study||243
8679071|NCT00790335|9723031|FG000|NOT COMPLETED|Overall Study||80
8679072|NCT00790335|9723032|FG001|NOT COMPLETED|Overall Study||112
8679073|NCT00790400|9723040|FG000|STARTED|Double-blind Period (Core Phase)||79
8679074|NCT00790400|9723041|FG001|STARTED|Double-blind Period (Core Phase)||39
8679075|NCT00790400|9723040|FG000|COMPLETED|Double-blind Period (Core Phase)|Completed = Completed the Core phase & moved to Extension phase|72
8679076|NCT00790400|9723041|FG001|COMPLETED|Double-blind Period (Core Phase)|Completed = 1st received Placebo in the Core phase, switched to Everolimus in Extension phase|26
8679077|NCT00790400|9723040|FG000|NOT COMPLETED|Double-blind Period (Core Phase)||7
8679078|NCT00790400|9723041|FG001|NOT COMPLETED|Double-blind Period (Core Phase)||13
8679079|NCT00790400|9723040|FG000|STARTED|Everolimus Period (Core or Extension)|112 pts had Everolimus during core and/or extension (6 from placebo did not switch to Eve. in ext.)|112
8679080|NCT00790400|9723041|FG001|STARTED|Everolimus Period (Core or Extension)|"Placebo randomized patients who switched to Everolimus are reported in Everolimus arm."|0
8679081|NCT00790400|9723040|FG000|COMPLETED|Everolimus Period (Core or Extension)|Treatment duration completed as per protocol|83
8679082|NCT00790400|9723041|FG001|COMPLETED|Everolimus Period (Core or Extension)||0
8679083|NCT00790400|9723040|FG000|NOT COMPLETED|Everolimus Period (Core or Extension)||29
8679084|NCT00790400|9723041|FG001|NOT COMPLETED|Everolimus Period (Core or Extension)||0
8679085|NCT00790556|9723050|FG000|STARTED|Treatment Period 1||8
8679086|NCT00790556|9723051|FG001|STARTED|Treatment Period 1||6
8679087|NCT00790556|9723050|FG000|COMPLETED|Treatment Period 1||6
8679088|NCT00790556|9723051|FG001|COMPLETED|Treatment Period 1||6
8679089|NCT00790556|9723050|FG000|NOT COMPLETED|Treatment Period 1||2
8679090|NCT00790556|9723051|FG001|NOT COMPLETED|Treatment Period 1||0
8679091|NCT00790556|9723050|FG000|STARTED|Washout After Period 1||6
8679092|NCT00790556|9723051|FG001|STARTED|Washout After Period 1||6
8679093|NCT00790556|9723050|FG000|COMPLETED|Washout After Period 1||6
8679094|NCT00790556|9723051|FG001|COMPLETED|Washout After Period 1||6
8679095|NCT00790556|9723050|FG000|NOT COMPLETED|Washout After Period 1||0
8679096|NCT00790556|9723051|FG001|NOT COMPLETED|Washout After Period 1||0
8679097|NCT00790556|9723050|FG000|STARTED|Treatment Period 2||6
8679098|NCT00790556|9723051|FG001|STARTED|Treatment Period 2||6
8919116|NCT02206607|9979181|FG000|STARTED|First Washout Period 5 to 10 Days||0
8679099|NCT00790556|9723050|FG000|COMPLETED|Treatment Period 2||6
8679100|NCT00790556|9723051|FG001|COMPLETED|Treatment Period 2||6
8679101|NCT00790556|9723050|FG000|NOT COMPLETED|Treatment Period 2||0
8679102|NCT00790556|9723051|FG001|NOT COMPLETED|Treatment Period 2||0
8679103|NCT00790569|9723060|FG000|STARTED|End of Treatment (6 Month Interview)||137
8679104|NCT00790569|9723061|FG001|STARTED|End of Treatment (6 Month Interview)||45
8679105|NCT00790569|9723062|FG002|STARTED|End of Treatment (6 Month Interview)||133
8679106|NCT00790569|9723060|FG000|COMPLETED|End of Treatment (6 Month Interview)||115
8679107|NCT00790569|9723061|FG001|COMPLETED|End of Treatment (6 Month Interview)||35
8679108|NCT00790569|9723062|FG002|COMPLETED|End of Treatment (6 Month Interview)||107
8679109|NCT00790569|9723060|FG000|NOT COMPLETED|End of Treatment (6 Month Interview)||22
8679110|NCT00790569|9723061|FG001|NOT COMPLETED|End of Treatment (6 Month Interview)||10
8679111|NCT00790569|9723062|FG002|NOT COMPLETED|End of Treatment (6 Month Interview)||26
8679112|NCT00790569|9723060|FG000|STARTED|End of Study (12 Month Interview)||137
8679113|NCT00790569|9723061|FG001|STARTED|End of Study (12 Month Interview)||45
8679114|NCT00790569|9723062|FG002|STARTED|End of Study (12 Month Interview)||133
8679115|NCT00790569|9723060|FG000|COMPLETED|End of Study (12 Month Interview)||71
8679116|NCT00790569|9723061|FG001|COMPLETED|End of Study (12 Month Interview)||26
8679117|NCT00790569|9723062|FG002|COMPLETED|End of Study (12 Month Interview)||83
8679118|NCT00790569|9723060|FG000|NOT COMPLETED|End of Study (12 Month Interview)||66
8679119|NCT00790569|9723061|FG001|NOT COMPLETED|End of Study (12 Month Interview)||19
8679120|NCT00790569|9723062|FG002|NOT COMPLETED|End of Study (12 Month Interview)||50
8679121|NCT00790582|9723072|FG000|STARTED|Overall Study||109
8679122|NCT00790582|9723073|FG001|STARTED|Overall Study||249
8679123|NCT00790582|9723072|FG000|COMPLETED|Overall Study||78
8679124|NCT00790582|9723073|FG001|COMPLETED|Overall Study||162
8679125|NCT00790582|9723072|FG000|NOT COMPLETED|Overall Study||31
8679126|NCT00790582|9723073|FG001|NOT COMPLETED|Overall Study||87
8679127|NCT00790647|9723081|FG000|STARTED|Overall Study||10
8679128|NCT00790647|9723081|FG000|COMPLETED|Overall Study||9
8679129|NCT00790647|9723081|FG000|NOT COMPLETED|Overall Study||1
8679130|NCT00790673|9723091|FG000|STARTED|Overall Study||6
8679131|NCT00790673|9723092|FG001|STARTED|Overall Study||6
8679132|NCT00790673|9723093|FG002|STARTED|Overall Study||12
8679133|NCT00790673|9723094|FG003|STARTED|Overall Study||8
8679134|NCT00790673|9723091|FG000|COMPLETED|Overall Study||6
8679135|NCT00790673|9723092|FG001|COMPLETED|Overall Study||6
8679136|NCT00790673|9723093|FG002|COMPLETED|Overall Study||12
8679137|NCT00790673|9723094|FG003|COMPLETED|Overall Study||8
8679138|NCT00790673|9723091|FG000|NOT COMPLETED|Overall Study||0
8679139|NCT00790673|9723092|FG001|NOT COMPLETED|Overall Study||0
8679140|NCT00790673|9723093|FG002|NOT COMPLETED|Overall Study||0
8679141|NCT00790673|9723094|FG003|NOT COMPLETED|Overall Study||0
8679142|NCT00790699|9723106|FG000|STARTED|Overall Study||17
8679143|NCT00790699|9723107|FG001|STARTED|Overall Study||14
8679144|NCT00790699|9723106|FG000|COMPLETED|Overall Study||16
8679145|NCT00790699|9723107|FG001|COMPLETED|Overall Study||14
8679146|NCT00790699|9723106|FG000|NOT COMPLETED|Overall Study||1
8679147|NCT00790699|9723107|FG001|NOT COMPLETED|Overall Study||0
8679148|NCT00790738|9723117|FG000|STARTED|Overall Study||5
8679149|NCT00790738|9723118|FG001|STARTED|Overall Study||6
8679150|NCT00790738|9723117|FG000|COMPLETED|Overall Study||3
8679151|NCT00790738|9723118|FG001|COMPLETED|Overall Study||3
8679152|NCT00790738|9723117|FG000|NOT COMPLETED|Overall Study||2
8679153|NCT00790738|9723118|FG001|NOT COMPLETED|Overall Study||3
8679154|NCT00790751|9723128|FG000|STARTED|Overall Study||162
8679155|NCT00790751|9723129|FG001|STARTED|Overall Study||161
8679156|NCT00790751|9723130|FG002|STARTED|Overall Study||161
8679157|NCT00790751|9723131|FG003|STARTED|Overall Study||162
8679158|NCT00790751|9723128|FG000|COMPLETED|Overall Study||137
8679159|NCT00790751|9723129|FG001|COMPLETED|Overall Study||131
8679160|NCT00790751|9723130|FG002|COMPLETED|Overall Study||141
8679161|NCT00790751|9723131|FG003|COMPLETED|Overall Study||141
8679162|NCT00790751|9723128|FG000|NOT COMPLETED|Overall Study||25
8679163|NCT00790751|9723129|FG001|NOT COMPLETED|Overall Study||30
8679164|NCT00790751|9723130|FG002|NOT COMPLETED|Overall Study||20
8679165|NCT00790751|9723131|FG003|NOT COMPLETED|Overall Study||21
8679166|NCT00790790|9723144|FG000|STARTED|Study Period 2: Therapy Phase||49
8679167|NCT00790790|9723145|FG001|STARTED|Study Period 2: Therapy Phase||50
8679168|NCT00790790|9723146|FG002|STARTED|Study Period 2: Therapy Phase||48
8679169|NCT00790790|9723144|FG000|COMPLETED|Study Period 2: Therapy Phase||37
8679170|NCT00790790|9723145|FG001|COMPLETED|Study Period 2: Therapy Phase||32
8679171|NCT00790790|9723146|FG002|COMPLETED|Study Period 2: Therapy Phase||27
8679172|NCT00790790|9723144|FG000|NOT COMPLETED|Study Period 2: Therapy Phase||12
8679173|NCT00790790|9723145|FG001|NOT COMPLETED|Study Period 2: Therapy Phase||18
8679174|NCT00790790|9723146|FG002|NOT COMPLETED|Study Period 2: Therapy Phase||21
8679175|NCT00790790|9723144|FG000|STARTED|Study Period 3: 1-Week Washout Phase||37
8679176|NCT00790790|9723145|FG001|STARTED|Study Period 3: 1-Week Washout Phase||32
8679177|NCT00790790|9723146|FG002|STARTED|Study Period 3: 1-Week Washout Phase||27
8679178|NCT00790790|9723144|FG000|COMPLETED|Study Period 3: 1-Week Washout Phase||37
8679179|NCT00790790|9723145|FG001|COMPLETED|Study Period 3: 1-Week Washout Phase||31
8679180|NCT00790790|9723146|FG002|COMPLETED|Study Period 3: 1-Week Washout Phase||26
8679181|NCT00790790|9723144|FG000|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
8679182|NCT00790790|9723145|FG001|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
8679183|NCT00790790|9723146|FG002|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
8679184|NCT00790842|9723162|FG000|STARTED|Dose Level 1||6
8679185|NCT00790842|9723163|FG001|STARTED|Dose Level 1||0
8679186|NCT00790842|9723164|FG002|STARTED|Dose Level 1||0
8679187|NCT00790842|9723165|FG003|STARTED|Dose Level 1||3
8679188|NCT00790842|9723166|FG004|STARTED|Dose Level 1||0
8679189|NCT00790842|9723167|FG005|STARTED|Dose Level 1||0
8679190|NCT00790842|9723168|FG006|STARTED|Dose Level 1||0
8679191|NCT00790842|9723169|FG007|STARTED|Dose Level 1||3
8679192|NCT00790842|9723170|FG008|STARTED|Dose Level 1||0
8679193|NCT00790842|9723171|FG009|STARTED|Dose Level 1||0
8679194|NCT00790842|9723172|FG010|STARTED|Dose Level 1||0
8679195|NCT00790842|9723162|FG000|Began Treatment|Dose Level 1||6
8679196|NCT00790842|9723163|FG001|Began Treatment|Dose Level 1||0
8679197|NCT00790842|9723164|FG002|Began Treatment|Dose Level 1||0
8679198|NCT00790842|9723165|FG003|Began Treatment|Dose Level 1||3
8679199|NCT00790842|9723166|FG004|Began Treatment|Dose Level 1||0
8679200|NCT00790842|9723167|FG005|Began Treatment|Dose Level 1||0
8679201|NCT00790842|9723168|FG006|Began Treatment|Dose Level 1||0
8679202|NCT00790842|9723169|FG007|Began Treatment|Dose Level 1||3
8679203|NCT00790842|9723170|FG008|Began Treatment|Dose Level 1||0
8679204|NCT00790842|9723171|FG009|Began Treatment|Dose Level 1||0
8679205|NCT00790842|9723172|FG010|Began Treatment|Dose Level 1||0
8679206|NCT00790842|9723162|FG000|COMPLETED|Dose Level 1||3
8679207|NCT00790842|9723163|FG001|COMPLETED|Dose Level 1||0
8679208|NCT00790842|9723164|FG002|COMPLETED|Dose Level 1||0
8679209|NCT00790842|9723165|FG003|COMPLETED|Dose Level 1||1
8679210|NCT00790842|9723166|FG004|COMPLETED|Dose Level 1||0
8679211|NCT00790842|9723167|FG005|COMPLETED|Dose Level 1||0
8679212|NCT00790842|9723168|FG006|COMPLETED|Dose Level 1||0
8679213|NCT00790842|9723169|FG007|COMPLETED|Dose Level 1||1
8679214|NCT00790842|9723170|FG008|COMPLETED|Dose Level 1||0
8679215|NCT00790842|9723171|FG009|COMPLETED|Dose Level 1||0
8679216|NCT00790842|9723172|FG010|COMPLETED|Dose Level 1||0
8679217|NCT00790842|9723162|FG000|NOT COMPLETED|Dose Level 1||3
8679218|NCT00790842|9723163|FG001|NOT COMPLETED|Dose Level 1||0
8679219|NCT00790842|9723164|FG002|NOT COMPLETED|Dose Level 1||0
8679220|NCT00790842|9723165|FG003|NOT COMPLETED|Dose Level 1||2
8679221|NCT00790842|9723166|FG004|NOT COMPLETED|Dose Level 1||0
8679222|NCT00790842|9723167|FG005|NOT COMPLETED|Dose Level 1||0
8679223|NCT00790842|9723168|FG006|NOT COMPLETED|Dose Level 1||0
8679224|NCT00790842|9723169|FG007|NOT COMPLETED|Dose Level 1||2
8679225|NCT00790842|9723170|FG008|NOT COMPLETED|Dose Level 1||0
8679226|NCT00790842|9723171|FG009|NOT COMPLETED|Dose Level 1||0
8679227|NCT00790842|9723172|FG010|NOT COMPLETED|Dose Level 1||0
8679228|NCT00790842|9723162|FG000|STARTED|Dose Level 2||0
8679229|NCT00790842|9723163|FG001|STARTED|Dose Level 2||3
8679230|NCT00790842|9723164|FG002|STARTED|Dose Level 2||0
8679231|NCT00790842|9723165|FG003|STARTED|Dose Level 2||0
8679232|NCT00790842|9723166|FG004|STARTED|Dose Level 2||3
8679233|NCT00790842|9723167|FG005|STARTED|Dose Level 2||0
8679234|NCT00790842|9723168|FG006|STARTED|Dose Level 2||0
8679235|NCT00790842|9723169|FG007|STARTED|Dose Level 2||0
8679236|NCT00790842|9723170|FG008|STARTED|Dose Level 2||3
8679237|NCT00790842|9723171|FG009|STARTED|Dose Level 2||0
8679238|NCT00790842|9723172|FG010|STARTED|Dose Level 2||0
8679239|NCT00790842|9723162|FG000|Began Treatment|Dose Level 2||0
8679240|NCT00790842|9723163|FG001|Began Treatment|Dose Level 2||3
8679241|NCT00790842|9723164|FG002|Began Treatment|Dose Level 2||0
8679242|NCT00790842|9723165|FG003|Began Treatment|Dose Level 2||0
8679243|NCT00790842|9723166|FG004|Began Treatment|Dose Level 2||3
8679244|NCT00790842|9723167|FG005|Began Treatment|Dose Level 2||0
8679245|NCT00790842|9723168|FG006|Began Treatment|Dose Level 2||0
8679246|NCT00790842|9723169|FG007|Began Treatment|Dose Level 2||0
8679247|NCT00790842|9723170|FG008|Began Treatment|Dose Level 2||3
8679248|NCT00790842|9723171|FG009|Began Treatment|Dose Level 2||0
8679249|NCT00790842|9723172|FG010|Began Treatment|Dose Level 2||0
8679250|NCT00790842|9723162|FG000|COMPLETED|Dose Level 2||0
8679251|NCT00790842|9723163|FG001|COMPLETED|Dose Level 2||0
8679252|NCT00790842|9723164|FG002|COMPLETED|Dose Level 2||0
8679253|NCT00790842|9723165|FG003|COMPLETED|Dose Level 2||0
8679254|NCT00790842|9723166|FG004|COMPLETED|Dose Level 2||2
8679255|NCT00790842|9723167|FG005|COMPLETED|Dose Level 2||0
8679256|NCT00790842|9723168|FG006|COMPLETED|Dose Level 2||0
8679257|NCT00790842|9723169|FG007|COMPLETED|Dose Level 2||0
8679258|NCT00790842|9723170|FG008|COMPLETED|Dose Level 2||1
8679259|NCT00790842|9723171|FG009|COMPLETED|Dose Level 2||0
8679260|NCT00790842|9723172|FG010|COMPLETED|Dose Level 2||0
8679261|NCT00790842|9723162|FG000|NOT COMPLETED|Dose Level 2||0
8679262|NCT00790842|9723163|FG001|NOT COMPLETED|Dose Level 2||3
8679263|NCT00790842|9723164|FG002|NOT COMPLETED|Dose Level 2||0
8679264|NCT00790842|9723165|FG003|NOT COMPLETED|Dose Level 2||0
8679265|NCT00790842|9723166|FG004|NOT COMPLETED|Dose Level 2||1
8679266|NCT00790842|9723167|FG005|NOT COMPLETED|Dose Level 2||0
8679267|NCT00790842|9723168|FG006|NOT COMPLETED|Dose Level 2||0
8679268|NCT00790842|9723169|FG007|NOT COMPLETED|Dose Level 2||0
8679269|NCT00790842|9723170|FG008|NOT COMPLETED|Dose Level 2||2
8679270|NCT00790842|9723171|FG009|NOT COMPLETED|Dose Level 2||0
8679271|NCT00790842|9723172|FG010|NOT COMPLETED|Dose Level 2||0
8679272|NCT00790842|9723162|FG000|STARTED|Dose Level 3||0
8679273|NCT00790842|9723163|FG001|STARTED|Dose Level 3||0
8679274|NCT00790842|9723164|FG002|STARTED|Dose Level 3||7
8679275|NCT00790842|9723165|FG003|STARTED|Dose Level 3||0
8679276|NCT00790842|9723166|FG004|STARTED|Dose Level 3||0
8679277|NCT00790842|9723167|FG005|STARTED|Dose Level 3||3
8679278|NCT00790842|9723168|FG006|STARTED|Dose Level 3||0
8679279|NCT00790842|9723169|FG007|STARTED|Dose Level 3||0
8679280|NCT00790842|9723170|FG008|STARTED|Dose Level 3||0
8679281|NCT00790842|9723171|FG009|STARTED|Dose Level 3||3
8679282|NCT00790842|9723172|FG010|STARTED|Dose Level 3||0
8679283|NCT00790842|9723162|FG000|Began Treatment|Dose Level 3||0
8679284|NCT00790842|9723163|FG001|Began Treatment|Dose Level 3||0
8679285|NCT00790842|9723164|FG002|Began Treatment|Dose Level 3||6
8679286|NCT00790842|9723165|FG003|Began Treatment|Dose Level 3||0
8679287|NCT00790842|9723166|FG004|Began Treatment|Dose Level 3||0
8679288|NCT00790842|9723167|FG005|Began Treatment|Dose Level 3||3
8679289|NCT00790842|9723168|FG006|Began Treatment|Dose Level 3||0
8679290|NCT00790842|9723169|FG007|Began Treatment|Dose Level 3||0
8679291|NCT00790842|9723170|FG008|Began Treatment|Dose Level 3||0
8679292|NCT00790842|9723171|FG009|Began Treatment|Dose Level 3||3
8679293|NCT00790842|9723172|FG010|Began Treatment|Dose Level 3||0
8679294|NCT00790842|9723162|FG000|COMPLETED|Dose Level 3||0
8679295|NCT00790842|9723163|FG001|COMPLETED|Dose Level 3||0
8679296|NCT00790842|9723164|FG002|COMPLETED|Dose Level 3||2
8679297|NCT00790842|9723165|FG003|COMPLETED|Dose Level 3||0
8679298|NCT00790842|9723166|FG004|COMPLETED|Dose Level 3||0
8679299|NCT00790842|9723167|FG005|COMPLETED|Dose Level 3||2
8679300|NCT00790842|9723168|FG006|COMPLETED|Dose Level 3||0
8679301|NCT00790842|9723169|FG007|COMPLETED|Dose Level 3||0
8679302|NCT00790842|9723170|FG008|COMPLETED|Dose Level 3||0
8679303|NCT00790842|9723171|FG009|COMPLETED|Dose Level 3||1
8679304|NCT00790842|9723172|FG010|COMPLETED|Dose Level 3||0
8679305|NCT00790842|9723162|FG000|NOT COMPLETED|Dose Level 3||0
8679306|NCT00790842|9723163|FG001|NOT COMPLETED|Dose Level 3||0
8679307|NCT00790842|9723164|FG002|NOT COMPLETED|Dose Level 3||5
8679308|NCT00790842|9723165|FG003|NOT COMPLETED|Dose Level 3||0
8679309|NCT00790842|9723166|FG004|NOT COMPLETED|Dose Level 3||0
8679310|NCT00790842|9723167|FG005|NOT COMPLETED|Dose Level 3||1
8679311|NCT00790842|9723168|FG006|NOT COMPLETED|Dose Level 3||0
8679312|NCT00790842|9723169|FG007|NOT COMPLETED|Dose Level 3||0
8679313|NCT00790842|9723170|FG008|NOT COMPLETED|Dose Level 3||0
8679314|NCT00790842|9723171|FG009|NOT COMPLETED|Dose Level 3||2
8679315|NCT00790842|9723172|FG010|NOT COMPLETED|Dose Level 3||0
8679316|NCT00790842|9723162|FG000|STARTED|Dose Level 4||0
8679317|NCT00790842|9723163|FG001|STARTED|Dose Level 4||0
8679318|NCT00790842|9723164|FG002|STARTED|Dose Level 4||0
8679319|NCT00790842|9723165|FG003|STARTED|Dose Level 4||0
8679320|NCT00790842|9723166|FG004|STARTED|Dose Level 4||0
8679321|NCT00790842|9723167|FG005|STARTED|Dose Level 4||0
8679322|NCT00790842|9723168|FG006|STARTED|Dose Level 4||8
8679323|NCT00790842|9723169|FG007|STARTED|Dose Level 4||0
8679324|NCT00790842|9723170|FG008|STARTED|Dose Level 4||0
8679325|NCT00790842|9723171|FG009|STARTED|Dose Level 4||0
8679326|NCT00790842|9723172|FG010|STARTED|Dose Level 4||5
8679327|NCT00790842|9723162|FG000|Began Treatment|Dose Level 4||0
8679328|NCT00790842|9723163|FG001|Began Treatment|Dose Level 4||0
8679329|NCT00790842|9723164|FG002|Began Treatment|Dose Level 4||0
8679330|NCT00790842|9723165|FG003|Began Treatment|Dose Level 4||0
8679331|NCT00790842|9723166|FG004|Began Treatment|Dose Level 4||0
8679332|NCT00790842|9723167|FG005|Began Treatment|Dose Level 4||0
8679333|NCT00790842|9723168|FG006|Began Treatment|Dose Level 4||8
8679334|NCT00790842|9723169|FG007|Began Treatment|Dose Level 4||0
8679335|NCT00790842|9723170|FG008|Began Treatment|Dose Level 4||0
8679336|NCT00790842|9723171|FG009|Began Treatment|Dose Level 4||0
8679337|NCT00790842|9723172|FG010|Began Treatment|Dose Level 4||5
8679338|NCT00790842|9723162|FG000|COMPLETED|Dose Level 4||0
8679339|NCT00790842|9723163|FG001|COMPLETED|Dose Level 4||0
8679340|NCT00790842|9723164|FG002|COMPLETED|Dose Level 4||0
8679341|NCT00790842|9723165|FG003|COMPLETED|Dose Level 4||0
8679342|NCT00790842|9723166|FG004|COMPLETED|Dose Level 4||0
8679343|NCT00790842|9723167|FG005|COMPLETED|Dose Level 4||0
8679344|NCT00790842|9723168|FG006|COMPLETED|Dose Level 4||6
8679345|NCT00790842|9723169|FG007|COMPLETED|Dose Level 4||0
8679346|NCT00790842|9723170|FG008|COMPLETED|Dose Level 4||0
8679347|NCT00790842|9723171|FG009|COMPLETED|Dose Level 4||0
8679348|NCT00790842|9723172|FG010|COMPLETED|Dose Level 4||3
8679349|NCT00790842|9723162|FG000|NOT COMPLETED|Dose Level 4||0
8679350|NCT00790842|9723163|FG001|NOT COMPLETED|Dose Level 4||0
8679351|NCT00790842|9723164|FG002|NOT COMPLETED|Dose Level 4||0
8679352|NCT00790842|9723165|FG003|NOT COMPLETED|Dose Level 4||0
8679353|NCT00790842|9723166|FG004|NOT COMPLETED|Dose Level 4||0
8679354|NCT00790842|9723167|FG005|NOT COMPLETED|Dose Level 4||0
8679355|NCT00790842|9723168|FG006|NOT COMPLETED|Dose Level 4||2
8679356|NCT00790842|9723169|FG007|NOT COMPLETED|Dose Level 4||0
8679357|NCT00790842|9723170|FG008|NOT COMPLETED|Dose Level 4||0
8679358|NCT00790842|9723171|FG009|NOT COMPLETED|Dose Level 4||0
8679359|NCT00790842|9723172|FG010|NOT COMPLETED|Dose Level 4||2
8679360|NCT00790842|9723162|FG000|STARTED|Expansion Cohort||0
8679361|NCT00790842|9723163|FG001|STARTED|Expansion Cohort||0
8679362|NCT00790842|9723164|FG002|STARTED|Expansion Cohort||14
8679363|NCT00790842|9723165|FG003|STARTED|Expansion Cohort||0
8679364|NCT00790842|9723166|FG004|STARTED|Expansion Cohort||0
8679365|NCT00790842|9723167|FG005|STARTED|Expansion Cohort||0
8679366|NCT00790842|9723168|FG006|STARTED|Expansion Cohort||2
8679367|NCT00790842|9723169|FG007|STARTED|Expansion Cohort||0
8679368|NCT00790842|9723170|FG008|STARTED|Expansion Cohort||0
8679369|NCT00790842|9723171|FG009|STARTED|Expansion Cohort||0
8679370|NCT00790842|9723172|FG010|STARTED|Expansion Cohort||0
8679371|NCT00790842|9723162|FG000|Began Treatment|Expansion Cohort||0
8679372|NCT00790842|9723163|FG001|Began Treatment|Expansion Cohort||0
8679373|NCT00790842|9723164|FG002|Began Treatment|Expansion Cohort||14
8679374|NCT00790842|9723165|FG003|Began Treatment|Expansion Cohort||0
8679375|NCT00790842|9723166|FG004|Began Treatment|Expansion Cohort||0
8679376|NCT00790842|9723167|FG005|Began Treatment|Expansion Cohort||0
8679377|NCT00790842|9723168|FG006|Began Treatment|Expansion Cohort||2
8679378|NCT00790842|9723169|FG007|Began Treatment|Expansion Cohort||0
8679379|NCT00790842|9723170|FG008|Began Treatment|Expansion Cohort||0
8799956|NCT01440764|9851543|FG002|COMPLETED|Test Day 2||6
8799957|NCT01440764|9851544|FG003|COMPLETED|Test Day 2||1
8799958|NCT01440764|9851545|FG004|COMPLETED|Test Day 2||3
8799959|NCT01440764|9851546|FG005|COMPLETED|Test Day 2||5
8799960|NCT01440764|9851547|FG006|COMPLETED|Test Day 2||3
8799961|NCT01440764|9851541|FG000|NOT COMPLETED|Test Day 2||0
8799962|NCT01440764|9851542|FG001|NOT COMPLETED|Test Day 2||0
8799963|NCT01440764|9851543|FG002|NOT COMPLETED|Test Day 2||0
8799964|NCT01440764|9851544|FG003|NOT COMPLETED|Test Day 2||0
8799965|NCT01440764|9851545|FG004|NOT COMPLETED|Test Day 2||0
8799966|NCT01440764|9851546|FG005|NOT COMPLETED|Test Day 2||0
8799967|NCT01440764|9851547|FG006|NOT COMPLETED|Test Day 2||0
8799968|NCT01440764|9851541|FG000|STARTED|Test Day 3||3
8799969|NCT01440764|9851542|FG001|STARTED|Test Day 3||2
8799970|NCT01440764|9851543|FG002|STARTED|Test Day 3||6
8799971|NCT01440764|9851544|FG003|STARTED|Test Day 3||1
8799972|NCT01440764|9851545|FG004|STARTED|Test Day 3||3
8799973|NCT01440764|9851546|FG005|STARTED|Test Day 3||5
8799974|NCT01440764|9851547|FG006|STARTED|Test Day 3||3
8799975|NCT01440764|9851541|FG000|COMPLETED|Test Day 3||3
8799976|NCT01440764|9851542|FG001|COMPLETED|Test Day 3||2
8799977|NCT01440764|9851543|FG002|COMPLETED|Test Day 3||6
8799978|NCT01440764|9851544|FG003|COMPLETED|Test Day 3||1
8799979|NCT01440764|9851545|FG004|COMPLETED|Test Day 3||3
8799980|NCT01440764|9851546|FG005|COMPLETED|Test Day 3||5
8799981|NCT01440764|9851547|FG006|COMPLETED|Test Day 3||3
8799982|NCT01440764|9851541|FG000|NOT COMPLETED|Test Day 3||0
8799983|NCT01440764|9851542|FG001|NOT COMPLETED|Test Day 3||0
8799984|NCT01440764|9851543|FG002|NOT COMPLETED|Test Day 3||0
8799985|NCT01440764|9851544|FG003|NOT COMPLETED|Test Day 3||0
8799986|NCT01440764|9851545|FG004|NOT COMPLETED|Test Day 3||0
8799987|NCT01440764|9851546|FG005|NOT COMPLETED|Test Day 3||0
8799988|NCT01440764|9851547|FG006|NOT COMPLETED|Test Day 3||0
8799989|NCT01440803|9851567|FG000|STARTED|Overall Study||13
8799990|NCT01440803|9851568|FG001|STARTED|Overall Study||28
8799991|NCT01440803|9851567|FG000|Period 1 - Forteo/Placebo|Overall Study||13
8799992|NCT01440803|9851568|FG001|Period 1 - Forteo/Placebo|Overall Study||28
8799993|NCT01440803|9851567|FG000|Period 2 - Forteo/Forteo|Overall Study||13
8799994|NCT01440803|9851568|FG001|Period 2 - Forteo/Forteo|Overall Study||28
8799995|NCT01440803|9851567|FG000|Period 3 - Forteo Open Label|Overall Study||13
8799996|NCT01440803|9851568|FG001|Period 3 - Forteo Open Label|Overall Study||27
8799997|NCT01440803|9851567|FG000|COMPLETED|Overall Study||11
8799998|NCT01440803|9851568|FG001|COMPLETED|Overall Study||24
8799999|NCT01440803|9851567|FG000|NOT COMPLETED|Overall Study||2
8800000|NCT01440803|9851568|FG001|NOT COMPLETED|Overall Study||4
8800001|NCT01440816|9851577|FG000|STARTED|Overall Study||3
8800002|NCT01440816|9851578|FG001|STARTED|Overall Study||12
8800003|NCT01440816|9851577|FG000|COMPLETED|Overall Study||2
8800004|NCT01440816|9851578|FG001|COMPLETED|Overall Study||1
8800005|NCT01440816|9851577|FG000|NOT COMPLETED|Overall Study||1
8800006|NCT01440816|9851578|FG001|NOT COMPLETED|Overall Study||11
8800007|NCT01440881|9851588|FG000|STARTED|Overall Study||14
8800008|NCT01440881|9851589|FG001|STARTED|Overall Study||15
8800009|NCT01440881|9851588|FG000|COMPLETED|Overall Study||14
8800010|NCT01440881|9851589|FG001|COMPLETED|Overall Study||14
8800011|NCT01440881|9851588|FG000|NOT COMPLETED|Overall Study||0
8800012|NCT01440881|9851589|FG001|NOT COMPLETED|Overall Study||1
8800013|NCT01440920|9851599|FG000|STARTED|Overall Study||3
8800014|NCT01440920|9851600|FG001|STARTED|Overall Study||3
8800015|NCT01440920|9851601|FG002|STARTED|Overall Study||3
8800016|NCT01440920|9851599|FG000|COMPLETED|Overall Study||3
8800017|NCT01440920|9851600|FG001|COMPLETED|Overall Study||3
8800018|NCT01440920|9851601|FG002|COMPLETED|Overall Study||3
8800019|NCT01440920|9851599|FG000|NOT COMPLETED|Overall Study||0
8800020|NCT01440920|9851600|FG001|NOT COMPLETED|Overall Study||0
8679380|NCT00790842|9723171|FG009|Began Treatment|Expansion Cohort||0
8679381|NCT00790842|9723172|FG010|Began Treatment|Expansion Cohort||0
8679382|NCT00790842|9723162|FG000|COMPLETED|Expansion Cohort||0
8800021|NCT01440920|9851601|FG002|NOT COMPLETED|Overall Study||0
8800022|NCT01440946|9851611|FG000|STARTED|Overall Study||15
8800023|NCT01440946|9851612|FG001|STARTED|Overall Study||15
8800024|NCT01440946|9851611|FG000|COMPLETED|Overall Study||13
8800025|NCT01440946|9851612|FG001|COMPLETED|Overall Study||14
8800026|NCT01440946|9851611|FG000|NOT COMPLETED|Overall Study||2
8800027|NCT01440946|9851612|FG001|NOT COMPLETED|Overall Study||1
8800028|NCT01440959|9851619|FG000|STARTED|Overall Study||30
8800029|NCT01440959|9851619|FG000|COMPLETED|Overall Study||30
8800030|NCT01440959|9851619|FG000|NOT COMPLETED|Overall Study||0
8800031|NCT01440972|9851625|FG000|STARTED|Overall Study||24
8800032|NCT01440972|9851626|FG001|STARTED|Overall Study||21
8679383|NCT00790842|9723163|FG001|COMPLETED|Expansion Cohort||0
8679384|NCT00790842|9723164|FG002|COMPLETED|Expansion Cohort||7
8679385|NCT00790842|9723165|FG003|COMPLETED|Expansion Cohort||0
8679386|NCT00790842|9723166|FG004|COMPLETED|Expansion Cohort||0
8679387|NCT00790842|9723167|FG005|COMPLETED|Expansion Cohort||0
8679388|NCT00790842|9723168|FG006|COMPLETED|Expansion Cohort||1
8679389|NCT00790842|9723169|FG007|COMPLETED|Expansion Cohort||0
8679390|NCT00790842|9723170|FG008|COMPLETED|Expansion Cohort||0
8679391|NCT00790842|9723171|FG009|COMPLETED|Expansion Cohort||0
8679392|NCT00790842|9723172|FG010|COMPLETED|Expansion Cohort||0
8679393|NCT00790842|9723162|FG000|NOT COMPLETED|Expansion Cohort||0
8679394|NCT00790842|9723163|FG001|NOT COMPLETED|Expansion Cohort||0
8679395|NCT00790842|9723164|FG002|NOT COMPLETED|Expansion Cohort||7
8679396|NCT00790842|9723165|FG003|NOT COMPLETED|Expansion Cohort||0
8679397|NCT00790842|9723166|FG004|NOT COMPLETED|Expansion Cohort||0
8679398|NCT00790842|9723167|FG005|NOT COMPLETED|Expansion Cohort||0
8679399|NCT00790842|9723168|FG006|NOT COMPLETED|Expansion Cohort||1
8679400|NCT00790842|9723169|FG007|NOT COMPLETED|Expansion Cohort||0
8679401|NCT00790842|9723170|FG008|NOT COMPLETED|Expansion Cohort||0
8679402|NCT00790842|9723171|FG009|NOT COMPLETED|Expansion Cohort||0
8679403|NCT00790842|9723172|FG010|NOT COMPLETED|Expansion Cohort||0
8679404|NCT00790855|9723220|FG000|STARTED|Overall Study||25
8679405|NCT00790855|9723220|FG000|COMPLETED|Overall Study||25
8679406|NCT00790855|9723220|FG000|NOT COMPLETED|Overall Study||0
8679407|NCT00790868|9723227|FG000|STARTED|Overall Study||88
8679408|NCT00790868|9723228|FG001|STARTED|Overall Study||92
8679409|NCT00790868|9723227|FG000|COMPLETED|Overall Study||82
8679410|NCT00790868|9723228|FG001|COMPLETED|Overall Study||75
8679411|NCT00790868|9723227|FG000|NOT COMPLETED|Overall Study||6
8679412|NCT00790868|9723228|FG001|NOT COMPLETED|Overall Study||17
8679413|NCT00790907|9723239|FG000|STARTED|Overall Study||1209
8679414|NCT00790907|9723240|FG001|STARTED|Overall Study||1024
8679415|NCT00790907|9723241|FG002|STARTED|Overall Study||1002
8679416|NCT00790907|9723239|FG000|COMPLETED|Overall Study||754
8679417|NCT00790907|9723240|FG001|COMPLETED|Overall Study||684
8679418|NCT00790907|9723241|FG002|COMPLETED|Overall Study||663
8679419|NCT00790907|9723239|FG000|NOT COMPLETED|Overall Study||455
8679420|NCT00790907|9723240|FG001|NOT COMPLETED|Overall Study||340
8679421|NCT00790907|9723241|FG002|NOT COMPLETED|Overall Study||339
8679422|NCT00791037|9723248|FG000|STARTED|Overall Study||23
8679423|NCT00791037|9723248|FG000|Primary Outcome|Overall Study||19
8679424|NCT00791037|9723248|FG000|Skeletal or Bone-only Disease by FDG-PET|Overall Study||1
8679425|NCT00791037|9723248|FG000|COMPLETED|Overall Study||23
8679426|NCT00791037|9723248|FG000|NOT COMPLETED|Overall Study||0
8679427|NCT00791089|9723256|FG000|STARTED|Overall Study||6
8679428|NCT00791089|9723257|FG001|STARTED|Overall Study||6
8679429|NCT00791089|9723256|FG000|Began Actually Taking Fish Oil or Placeb|Overall Study||6
8679430|NCT00791089|9723257|FG001|Began Actually Taking Fish Oil or Placeb|Overall Study||5
8679431|NCT00791089|9723256|FG000|Six-month Data Collected|Overall Study||6
8679432|NCT00791089|9723257|FG001|Six-month Data Collected|Overall Study||5
8679433|NCT00791089|9723256|FG000|COMPLETED|Overall Study||0
8679434|NCT00791089|9723257|FG001|COMPLETED|Overall Study||0
8679435|NCT00791089|9723256|FG000|NOT COMPLETED|Overall Study||6
8679436|NCT00791089|9723257|FG001|NOT COMPLETED|Overall Study||6
8679437|NCT00791102|9723263|FG000|STARTED|Period 1||10
8679438|NCT00791102|9723264|FG001|STARTED|Period 1||10
8679439|NCT00791102|9723263|FG000|COMPLETED|Period 1||10
8679440|NCT00791102|9723264|FG001|COMPLETED|Period 1||10
8679441|NCT00791102|9723263|FG000|NOT COMPLETED|Period 1||0
8679442|NCT00791102|9723264|FG001|NOT COMPLETED|Period 1||0
8679443|NCT00791102|9723263|FG000|STARTED|Washout Period of 2 Weeks||10
8679444|NCT00791102|9723264|FG001|STARTED|Washout Period of 2 Weeks||10
8679445|NCT00791102|9723263|FG000|COMPLETED|Washout Period of 2 Weeks||10
8679446|NCT00791102|9723264|FG001|COMPLETED|Washout Period of 2 Weeks||10
8679447|NCT00791102|9723263|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
8679448|NCT00791102|9723264|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
8679449|NCT00791102|9723263|FG000|STARTED|Period 2||10
8679450|NCT00791102|9723264|FG001|STARTED|Period 2||10
8679451|NCT00791102|9723263|FG000|COMPLETED|Period 2||10
8679452|NCT00791102|9723264|FG001|COMPLETED|Period 2||10
8679453|NCT00791102|9723263|FG000|NOT COMPLETED|Period 2||0
8679454|NCT00791102|9723264|FG001|NOT COMPLETED|Period 2||0
8679455|NCT00791128|9723270|FG000|STARTED|Overall Study||22
8679456|NCT00791128|9723270|FG000|COMPLETED|Overall Study||13
8679457|NCT00791128|9723270|FG000|NOT COMPLETED|Overall Study||9
8679458|NCT00791219|9723277|FG000|STARTED|Overall Study||24
8679459|NCT00791219|9723278|FG001|STARTED|Overall Study||76
8679460|NCT00791219|9723279|FG002|STARTED|Overall Study||75
8679461|NCT00791219|9723277|FG000|COMPLETED|Overall Study||19
8679462|NCT00791219|9723278|FG001|COMPLETED|Overall Study||60
8679463|NCT00791219|9723279|FG002|COMPLETED|Overall Study||61
8679464|NCT00791219|9723277|FG000|NOT COMPLETED|Overall Study||5
8679465|NCT00791219|9723278|FG001|NOT COMPLETED|Overall Study||16
8679466|NCT00791219|9723279|FG002|NOT COMPLETED|Overall Study||14
8679467|NCT00791258|9723287|FG000|STARTED|Overall Study||999
8679468|NCT00791258|9723287|FG000|COMPLETED|Overall Study||736
8679469|NCT00791258|9723287|FG000|NOT COMPLETED|Overall Study||263
8679470|NCT00791323|9723293|FG000|STARTED|Overall Study||6
8679471|NCT00791323|9723294|FG001|STARTED|Overall Study||3
8679472|NCT00791323|9723293|FG000|COMPLETED|Overall Study||6
8679473|NCT00791323|9723294|FG001|COMPLETED|Overall Study||3
8679474|NCT00791323|9723293|FG000|NOT COMPLETED|Overall Study||0
8679475|NCT00791323|9723294|FG001|NOT COMPLETED|Overall Study||0
8679476|NCT00791388|9723305|FG000|STARTED|Period 1 - 50 mg Dose Group||3
8679477|NCT00791388|9723306|FG001|STARTED|Period 1 - 50 mg Dose Group||8
8679478|NCT00791388|9723307|FG002|STARTED|Period 1 - 50 mg Dose Group||0
8679479|NCT00791388|9723308|FG003|STARTED|Period 1 - 50 mg Dose Group||0
8679480|NCT00791388|9723309|FG004|STARTED|Period 1 - 50 mg Dose Group||0
8679481|NCT00791388|9723305|FG000|COMPLETED|Period 1 - 50 mg Dose Group||3
8679482|NCT00791388|9723306|FG001|COMPLETED|Period 1 - 50 mg Dose Group||7
8679483|NCT00791388|9723307|FG002|COMPLETED|Period 1 - 50 mg Dose Group||0
8679484|NCT00791388|9723308|FG003|COMPLETED|Period 1 - 50 mg Dose Group||0
8679485|NCT00791388|9723309|FG004|COMPLETED|Period 1 - 50 mg Dose Group||0
8679486|NCT00791388|9723305|FG000|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
8679487|NCT00791388|9723306|FG001|NOT COMPLETED|Period 1 - 50 mg Dose Group||1
8679488|NCT00791388|9723307|FG002|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
8679489|NCT00791388|9723308|FG003|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
8679490|NCT00791388|9723309|FG004|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
8679491|NCT00791388|9723305|FG000|STARTED|Period 2 - 100 mg Dose Group||3
8679492|NCT00791388|9723306|FG001|STARTED|Period 2 - 100 mg Dose Group||0
8679493|NCT00791388|9723307|FG002|STARTED|Period 2 - 100 mg Dose Group||8
8679494|NCT00791388|9723308|FG003|STARTED|Period 2 - 100 mg Dose Group||0
8679495|NCT00791388|9723309|FG004|STARTED|Period 2 - 100 mg Dose Group||0
8679496|NCT00791388|9723305|FG000|COMPLETED|Period 2 - 100 mg Dose Group||2
8679497|NCT00791388|9723306|FG001|COMPLETED|Period 2 - 100 mg Dose Group||0
8679498|NCT00791388|9723307|FG002|COMPLETED|Period 2 - 100 mg Dose Group||8
8679499|NCT00791388|9723308|FG003|COMPLETED|Period 2 - 100 mg Dose Group||0
8679500|NCT00791388|9723309|FG004|COMPLETED|Period 2 - 100 mg Dose Group||0
8679501|NCT00791388|9723305|FG000|NOT COMPLETED|Period 2 - 100 mg Dose Group||1
8679502|NCT00791388|9723306|FG001|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
8800033|NCT01440972|9851625|FG000|COMPLETED|Overall Study||21
8800034|NCT01440972|9851626|FG001|COMPLETED|Overall Study||19
8800035|NCT01440972|9851625|FG000|NOT COMPLETED|Overall Study||3
8800036|NCT01440972|9851626|FG001|NOT COMPLETED|Overall Study||2
8800037|NCT01441037|9851632|FG000|STARTED|Overall Study||27
8800038|NCT01441037|9851632|FG000|COMPLETED|Overall Study||27
8800039|NCT01441037|9851632|FG000|NOT COMPLETED|Overall Study||0
8800040|NCT01441063|9851636|FG000|STARTED|Tocilizumab Alone||8
8800041|NCT01441063|9851636|FG000|COMPLETED|Tocilizumab Alone||5
8800042|NCT01441063|9851636|FG000|NOT COMPLETED|Tocilizumab Alone||3
8800043|NCT01441063|9851636|FG000|STARTED|Tocilizumab + Zidovudine /Valganciclovir||3
8800044|NCT01441063|9851636|FG000|COMPLETED|Tocilizumab + Zidovudine /Valganciclovir||2
8800045|NCT01441063|9851636|FG000|NOT COMPLETED|Tocilizumab + Zidovudine /Valganciclovir||1
8800046|NCT01441076|9851643|FG000|STARTED|Overall Study||6
8800047|NCT01441076|9851643|FG000|COMPLETED|Overall Study||4
8800048|NCT01441076|9851643|FG000|NOT COMPLETED|Overall Study||2
8800049|NCT01441102|9851647|FG000|STARTED|Overall Study|Two participants withdrew prior to Month 6; therefore, two additional participants were enrolled.|7
8800050|NCT01441102|9851647|FG000|COMPLETED|Overall Study||4
8800051|NCT01441102|9851647|FG000|NOT COMPLETED|Overall Study||3
8800052|NCT01441180|9851654|FG000|STARTED|Overall Study||10
8800053|NCT01441180|9851655|FG001|STARTED|Overall Study||25
8800054|NCT01441180|9851656|FG002|STARTED|Overall Study||25
8800055|NCT01441180|9851654|FG000|COMPLETED|Overall Study||9
8800056|NCT01441180|9851655|FG001|COMPLETED|Overall Study||24
8800057|NCT01441180|9851656|FG002|COMPLETED|Overall Study||22
8800058|NCT01441180|9851654|FG000|NOT COMPLETED|Overall Study||1
8800059|NCT01441180|9851655|FG001|NOT COMPLETED|Overall Study||1
8800060|NCT01441180|9851656|FG002|NOT COMPLETED|Overall Study||3
8800061|NCT01441245|9851669|FG000|STARTED|Overall Study||30
8800062|NCT01441245|9851670|FG001|STARTED|Overall Study||27
8800063|NCT01441245|9851669|FG000|COMPLETED|Overall Study||30
8800064|NCT01441245|9851670|FG001|COMPLETED|Overall Study||27
8800065|NCT01441245|9851669|FG000|NOT COMPLETED|Overall Study||0
8800066|NCT01441245|9851670|FG001|NOT COMPLETED|Overall Study||0
8800067|NCT01441401|9851692|FG000|STARTED|Overall Study||82
8800068|NCT01441401|9851692|FG000|COMPLETED|Overall Study|Number of participants whose survey form was collected was presented.|82
8800069|NCT01441401|9851692|FG000|NOT COMPLETED|Overall Study||0
8800070|NCT01441414|9851710|FG000|STARTED|Overall Study||18
8800071|NCT01441414|9851710|FG000|COMPLETED|Overall Study||3
8800072|NCT01441414|9851710|FG000|NOT COMPLETED|Overall Study||15
8800073|NCT01441440|9851729|FG000|STARTED|Overall Study|Safety analysis set|183
8800074|NCT01441440|9851730|FG001|STARTED|Overall Study|Safety analysis set|174
8800075|NCT01441440|9851731|FG002|STARTED|Overall Study|Safety analysis set|180
8800076|NCT01441440|9851729|FG000|COMPLETED|Overall Study||166
8800077|NCT01441440|9851730|FG001|COMPLETED|Overall Study||151
8800078|NCT01441440|9851731|FG002|COMPLETED|Overall Study||158
8800079|NCT01441440|9851729|FG000|NOT COMPLETED|Overall Study||17
8800080|NCT01441440|9851730|FG001|NOT COMPLETED|Overall Study||23
8800081|NCT01441440|9851731|FG002|NOT COMPLETED|Overall Study||22
8800082|NCT01441466|9851741|FG000|STARTED|Overall Study||37
8800083|NCT01441466|9851742|FG001|STARTED|Overall Study||11
8800084|NCT01441466|9851741|FG000|COMPLETED|Overall Study||37
8800085|NCT01441466|9851742|FG001|COMPLETED|Overall Study||11
8800086|NCT01441466|9851741|FG000|NOT COMPLETED|Overall Study||0
8800087|NCT01441466|9851742|FG001|NOT COMPLETED|Overall Study||0
8800088|NCT01441492|9851751|FG000|STARTED|Overall Study||197
8679503|NCT00791388|9723307|FG002|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
8679504|NCT00791388|9723308|FG003|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
8679505|NCT00791388|9723309|FG004|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
8679506|NCT00791388|9723305|FG000|STARTED|Period 3 - 200 mg Dose Group||3
8679507|NCT00791388|9723306|FG001|STARTED|Period 3 - 200 mg Dose Group||0
8679508|NCT00791388|9723307|FG002|STARTED|Period 3 - 200 mg Dose Group||0
8679509|NCT00791388|9723308|FG003|STARTED|Period 3 - 200 mg Dose Group||8
8679510|NCT00791388|9723309|FG004|STARTED|Period 3 - 200 mg Dose Group||0
8679511|NCT00791388|9723305|FG000|COMPLETED|Period 3 - 200 mg Dose Group||3
8679512|NCT00791388|9723306|FG001|COMPLETED|Period 3 - 200 mg Dose Group||0
8679513|NCT00791388|9723307|FG002|COMPLETED|Period 3 - 200 mg Dose Group||0
8679514|NCT00791388|9723308|FG003|COMPLETED|Period 3 - 200 mg Dose Group||8
8679515|NCT00791388|9723309|FG004|COMPLETED|Period 3 - 200 mg Dose Group||0
8679516|NCT00791388|9723305|FG000|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
8679517|NCT00791388|9723306|FG001|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
8679518|NCT00791388|9723307|FG002|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
8679519|NCT00791388|9723308|FG003|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
8679520|NCT00791388|9723309|FG004|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
8679521|NCT00791388|9723305|FG000|STARTED|Period 4 - 400 mg Dose Group||4
8679522|NCT00791388|9723306|FG001|STARTED|Period 4 - 400 mg Dose Group||0
8679523|NCT00791388|9723307|FG002|STARTED|Period 4 - 400 mg Dose Group||0
8679524|NCT00791388|9723308|FG003|STARTED|Period 4 - 400 mg Dose Group||0
8679525|NCT00791388|9723309|FG004|STARTED|Period 4 - 400 mg Dose Group||8
8679526|NCT00791388|9723305|FG000|COMPLETED|Period 4 - 400 mg Dose Group||4
8679527|NCT00791388|9723306|FG001|COMPLETED|Period 4 - 400 mg Dose Group||0
8679528|NCT00791388|9723307|FG002|COMPLETED|Period 4 - 400 mg Dose Group||0
8679529|NCT00791388|9723308|FG003|COMPLETED|Period 4 - 400 mg Dose Group||0
8679530|NCT00791388|9723309|FG004|COMPLETED|Period 4 - 400 mg Dose Group||4
8679531|NCT00791388|9723305|FG000|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
8679532|NCT00791388|9723306|FG001|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
8679533|NCT00791388|9723307|FG002|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
8679534|NCT00791388|9723308|FG003|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
8679535|NCT00791388|9723309|FG004|NOT COMPLETED|Period 4 - 400 mg Dose Group||4
8679536|NCT00791479|9723327|FG000|STARTED|Overall Study||35
8679537|NCT00791479|9723328|FG001|STARTED|Overall Study||34
8679538|NCT00791479|9723329|FG002|STARTED|Overall Study||34
8679539|NCT00791479|9723330|FG003|STARTED|Overall Study||29
8679540|NCT00791479|9723331|FG004|STARTED|Overall Study|3mg LY2189265 discont. Replaced with 1.5mg dose based on dose finding Study H9X-MC-GBCF; NCT00734474|3
8679541|NCT00791479|9723332|FG005|STARTED|Overall Study||32
8679542|NCT00791479|9723327|FG000|Received at Least One Dose of Study Drug|Overall Study||35
8679543|NCT00791479|9723328|FG001|Received at Least One Dose of Study Drug|Overall Study||34
8679544|NCT00791479|9723329|FG002|Received at Least One Dose of Study Drug|Overall Study||34
8679545|NCT00791479|9723330|FG003|Received at Least One Dose of Study Drug|Overall Study||29
8679546|NCT00791479|9723331|FG004|Received at Least One Dose of Study Drug|Overall Study||3
8679547|NCT00791479|9723332|FG005|Received at Least One Dose of Study Drug|Overall Study||32
8679548|NCT00791479|9723327|FG000|COMPLETED|Overall Study||33
8679549|NCT00791479|9723328|FG001|COMPLETED|Overall Study||31
8679550|NCT00791479|9723329|FG002|COMPLETED|Overall Study||34
8679551|NCT00791479|9723330|FG003|COMPLETED|Overall Study||25
8679552|NCT00791479|9723331|FG004|COMPLETED|Overall Study||0
8679553|NCT00791479|9723332|FG005|COMPLETED|Overall Study||29
8679554|NCT00791479|9723327|FG000|NOT COMPLETED|Overall Study||2
8679555|NCT00791479|9723328|FG001|NOT COMPLETED|Overall Study||3
8679556|NCT00791479|9723329|FG002|NOT COMPLETED|Overall Study||0
8679557|NCT00791479|9723330|FG003|NOT COMPLETED|Overall Study||4
8679558|NCT00791479|9723331|FG004|NOT COMPLETED|Overall Study||3
8679559|NCT00791479|9723332|FG005|NOT COMPLETED|Overall Study||3
8679560|NCT00791492|9723355|FG000|STARTED|Overall Study||45
8679561|NCT00791492|9723356|FG001|STARTED|Overall Study||41
8679562|NCT00791492|9723355|FG000|TREATED|Overall Study||44
8679563|NCT00791492|9723356|FG001|TREATED|Overall Study||41
8679564|NCT00791492|9723355|FG000|COMPLETED|Overall Study||39
8679565|NCT00791492|9723356|FG001|COMPLETED|Overall Study||38
8679566|NCT00791492|9723355|FG000|NOT COMPLETED|Overall Study||6
8679567|NCT00791492|9723356|FG001|NOT COMPLETED|Overall Study||3
8679568|NCT00791518|9723362|FG000|STARTED|Overall Study||1084
8679569|NCT00791518|9723362|FG000|COMPLETED|Overall Study||991
8679570|NCT00791518|9723362|FG000|NOT COMPLETED|Overall Study||93
8679571|NCT00791557|9723381|FG000|STARTED|Overall Study||2
8679572|NCT00791557|9723381|FG000|COMPLETED|Overall Study||1
8679573|NCT00791557|9723381|FG000|NOT COMPLETED|Overall Study||1
8679574|NCT00791648|9723387|FG000|STARTED|Overall Study||308
8800089|NCT01441492|9851752|FG001|STARTED|Overall Study||202
8800090|NCT01441492|9851751|FG000|COMPLETED|Overall Study||170
8679575|NCT00791648|9723388|FG001|STARTED|Overall Study||309
8679576|NCT00791648|9723387|FG000|COMPLETED|Overall Study||308
8800091|NCT01441492|9851752|FG001|COMPLETED|Overall Study||174
8800092|NCT01441492|9851751|FG000|NOT COMPLETED|Overall Study||27
8800093|NCT01441492|9851752|FG001|NOT COMPLETED|Overall Study||28
8800094|NCT01441570|9851762|FG000|STARTED|Overall Study||6
8800095|NCT01441570|9851763|FG001|STARTED|Overall Study||5
8800096|NCT01441570|9851762|FG000|COMPLETED|Overall Study||6
8800097|NCT01441570|9851763|FG001|COMPLETED|Overall Study||5
8800098|NCT01441570|9851762|FG000|NOT COMPLETED|Overall Study||0
8679577|NCT00791648|9723388|FG001|COMPLETED|Overall Study||307
8679578|NCT00791648|9723387|FG000|NOT COMPLETED|Overall Study||0
8679579|NCT00791648|9723388|FG001|NOT COMPLETED|Overall Study||2
8679580|NCT00791661|9723397|FG000|STARTED|Period 1||8
8679581|NCT00791661|9723398|FG001|STARTED|Period 1||8
8679582|NCT00791661|9723399|FG002|STARTED|Period 1||8
8679583|NCT00791661|9723397|FG000|Received MK-1006|Period 1||6
8679584|NCT00791661|9723398|FG001|Received MK-1006|Period 1||6
8679585|NCT00791661|9723399|FG002|Received MK-1006|Period 1||6
8679586|NCT00791661|9723397|FG000|Received Matching Placebo to MK-1006|Period 1||2
8679587|NCT00791661|9723398|FG001|Received Matching Placebo to MK-1006|Period 1||2
8679588|NCT00791661|9723399|FG002|Received Matching Placebo to MK-1006|Period 1||2
8679589|NCT00791661|9723397|FG000|COMPLETED|Period 1||8
8679590|NCT00791661|9723398|FG001|COMPLETED|Period 1||8
8679591|NCT00791661|9723399|FG002|COMPLETED|Period 1||8
8679592|NCT00791661|9723397|FG000|NOT COMPLETED|Period 1||0
8679593|NCT00791661|9723398|FG001|NOT COMPLETED|Period 1||0
8679594|NCT00791661|9723399|FG002|NOT COMPLETED|Period 1||0
8679595|NCT00791661|9723397|FG000|STARTED|7 Day Wash-out||8
8679596|NCT00791661|9723398|FG001|STARTED|7 Day Wash-out||8
8679597|NCT00791661|9723399|FG002|STARTED|7 Day Wash-out||8
8679598|NCT00791661|9723397|FG000|COMPLETED|7 Day Wash-out||8
8679599|NCT00791661|9723398|FG001|COMPLETED|7 Day Wash-out||8
8679600|NCT00791661|9723399|FG002|COMPLETED|7 Day Wash-out||6
8679601|NCT00791661|9723397|FG000|NOT COMPLETED|7 Day Wash-out||0
8679602|NCT00791661|9723398|FG001|NOT COMPLETED|7 Day Wash-out||0
8679603|NCT00791661|9723399|FG002|NOT COMPLETED|7 Day Wash-out||2
8679604|NCT00791661|9723397|FG000|STARTED|Period 2||8
8679605|NCT00791661|9723398|FG001|STARTED|Period 2||8
8679606|NCT00791661|9723399|FG002|STARTED|Period 2||6
8679607|NCT00791661|9723397|FG000|Received MK-1006|Period 2||6
8679608|NCT00791661|9723398|FG001|Received MK-1006|Period 2||6
8679609|NCT00791661|9723399|FG002|Received MK-1006|Period 2||4
8679610|NCT00791661|9723397|FG000|Received Matching Placebo to MK-1006|Period 2||2
8679611|NCT00791661|9723398|FG001|Received Matching Placebo to MK-1006|Period 2||2
8679612|NCT00791661|9723399|FG002|Received Matching Placebo to MK-1006|Period 2||2
8679613|NCT00791661|9723397|FG000|COMPLETED|Period 2||8
8679614|NCT00791661|9723398|FG001|COMPLETED|Period 2||8
8679615|NCT00791661|9723399|FG002|COMPLETED|Period 2||6
8679616|NCT00791661|9723397|FG000|NOT COMPLETED|Period 2||0
8679617|NCT00791661|9723398|FG001|NOT COMPLETED|Period 2||0
8679618|NCT00791661|9723399|FG002|NOT COMPLETED|Period 2||0
8679619|NCT00791661|9723397|FG000|STARTED|7 Day Wash-out||8
8679620|NCT00791661|9723398|FG001|STARTED|7 Day Wash-out||8
8679621|NCT00791661|9723399|FG002|STARTED|7 Day Wash-out||6
8679622|NCT00791661|9723397|FG000|COMPLETED|7 Day Wash-out||8
8679623|NCT00791661|9723398|FG001|COMPLETED|7 Day Wash-out||8
8679624|NCT00791661|9723399|FG002|COMPLETED|7 Day Wash-out||6
8679625|NCT00791661|9723397|FG000|NOT COMPLETED|7 Day Wash-out||0
8679626|NCT00791661|9723398|FG001|NOT COMPLETED|7 Day Wash-out||0
8679627|NCT00791661|9723399|FG002|NOT COMPLETED|7 Day Wash-out||0
8679628|NCT00791661|9723397|FG000|STARTED|Period 3||8
8679629|NCT00791661|9723398|FG001|STARTED|Period 3||8
8679630|NCT00791661|9723399|FG002|STARTED|Period 3||6
8679631|NCT00791661|9723397|FG000|Received MK-1006|Period 3||6
8679632|NCT00791661|9723398|FG001|Received MK-1006|Period 3||6
8679633|NCT00791661|9723399|FG002|Received MK-1006|Period 3||5
8679634|NCT00791661|9723397|FG000|Received Matching Placebo to MK-1006|Period 3||2
8679635|NCT00791661|9723398|FG001|Received Matching Placebo to MK-1006|Period 3||2
8679636|NCT00791661|9723399|FG002|Received Matching Placebo to MK-1006|Period 3||1
8679637|NCT00791661|9723397|FG000|COMPLETED|Period 3||8
8679638|NCT00791661|9723398|FG001|COMPLETED|Period 3||8
8679639|NCT00791661|9723399|FG002|COMPLETED|Period 3||6
8679640|NCT00791661|9723397|FG000|NOT COMPLETED|Period 3||0
8679641|NCT00791661|9723398|FG001|NOT COMPLETED|Period 3||0
8679642|NCT00791661|9723399|FG002|NOT COMPLETED|Period 3||0
8679643|NCT00791700|9723427|FG000|STARTED|Overall Study||16
8679644|NCT00791700|9723428|FG001|STARTED|Overall Study||31
8679645|NCT00791700|9723429|FG002|STARTED|Overall Study||13
8679646|NCT00791700|9723430|FG003|STARTED|Overall Study||43
8679647|NCT00791700|9723427|FG000|COMPLETED|Overall Study||10
8679648|NCT00791700|9723428|FG001|COMPLETED|Overall Study||20
8679649|NCT00791700|9723429|FG002|COMPLETED|Overall Study||7
8679650|NCT00791700|9723430|FG003|COMPLETED|Overall Study||13
8679651|NCT00791700|9723427|FG000|NOT COMPLETED|Overall Study||6
8679652|NCT00791700|9723428|FG001|NOT COMPLETED|Overall Study||11
8679653|NCT00791700|9723429|FG002|NOT COMPLETED|Overall Study||6
8679654|NCT00791700|9723430|FG003|NOT COMPLETED|Overall Study||30
8679655|NCT00791765|9723453|FG000|STARTED|Weeks 1 to 12||62
8679656|NCT00791765|9723454|FG001|STARTED|Weeks 1 to 12||62
8679657|NCT00791765|9723453|FG000|Treated|Weeks 1 to 12||62
8679658|NCT00791765|9723454|FG001|Treated|Weeks 1 to 12||59
8679659|NCT00791765|9723453|FG000|COMPLETED|Weeks 1 to 12||54
8679660|NCT00791765|9723454|FG001|COMPLETED|Weeks 1 to 12||58
8679661|NCT00791765|9723453|FG000|NOT COMPLETED|Weeks 1 to 12||8
8679662|NCT00791765|9723454|FG001|NOT COMPLETED|Weeks 1 to 12||4
8679663|NCT00791765|9723453|FG000|STARTED|Weeks 13 to 24||54
8679664|NCT00791765|9723454|FG001|STARTED|Weeks 13 to 24|1 participant discontinued due to an adverse event after completing 12 weeks.|57
8679665|NCT00791765|9723453|FG000|COMPLETED|Weeks 13 to 24||49
8679666|NCT00791765|9723454|FG001|COMPLETED|Weeks 13 to 24||49
8679667|NCT00791765|9723453|FG000|NOT COMPLETED|Weeks 13 to 24||5
8679668|NCT00791765|9723454|FG001|NOT COMPLETED|Weeks 13 to 24||8
8679669|NCT00791778|9723462|FG000|STARTED|Double-blind Treatment||123
8679670|NCT00791778|9723463|FG001|STARTED|Double-blind Treatment||123
8679671|NCT00791778|9723462|FG000|COMPLETED|Double-blind Treatment|includes: 42 subjects with progression, 4 subjects transferred to a continuation study|46
8679672|NCT00791778|9723463|FG001|COMPLETED|Double-blind Treatment|includes: 75 subjects with progression|75
8679673|NCT00791778|9723462|FG000|NOT COMPLETED|Double-blind Treatment||77
8679674|NCT00791778|9723463|FG001|NOT COMPLETED|Double-blind Treatment||48
8679675|NCT00791778|9723462|FG000|STARTED|Follow-up||100
8679676|NCT00791778|9723463|FG001|STARTED|Follow-up||91
8679677|NCT00791778|9723462|FG000|COMPLETED|Follow-up|Includes 79 participants with study follow-up terminated by sponsor and 16 deaths|95
8679678|NCT00791778|9723463|FG001|COMPLETED|Follow-up|Includes 78 participants with study follow-up terminated by sponsor and 12 deaths|90
8679679|NCT00791778|9723462|FG000|NOT COMPLETED|Follow-up||5
8679680|NCT00791778|9723463|FG001|NOT COMPLETED|Follow-up||1
8679681|NCT00791817|9723471|FG000|STARTED|1: Single Dose Followed by Week Washout||5
8679682|NCT00791817|9723472|FG001|STARTED|1: Single Dose Followed by Week Washout||5
8679683|NCT00791817|9723471|FG000|COMPLETED|1: Single Dose Followed by Week Washout||5
8679684|NCT00791817|9723472|FG001|COMPLETED|1: Single Dose Followed by Week Washout||5
8679685|NCT00791817|9723471|FG000|NOT COMPLETED|1: Single Dose Followed by Week Washout||0
8679686|NCT00791817|9723472|FG001|NOT COMPLETED|1: Single Dose Followed by Week Washout||0
8679687|NCT00791817|9723471|FG000|STARTED|2: Single Dose||5
8679688|NCT00791817|9723472|FG001|STARTED|2: Single Dose||5
8679689|NCT00791817|9723471|FG000|COMPLETED|2: Single Dose||5
8679690|NCT00791817|9723472|FG001|COMPLETED|2: Single Dose||5
8679691|NCT00791817|9723471|FG000|NOT COMPLETED|2: Single Dose||0
8679692|NCT00791817|9723472|FG001|NOT COMPLETED|2: Single Dose||0
8679693|NCT00791908|9723478|FG000|STARTED|Overall Study||15
8679694|NCT00791908|9723478|FG000|COMPLETED|Overall Study||15
8679695|NCT00791908|9723478|FG000|NOT COMPLETED|Overall Study||0
8679696|NCT00791921|9723488|FG000|STARTED|Overall Study||116
8679697|NCT00791921|9723489|FG001|STARTED|Overall Study||114
8679698|NCT00791921|9723488|FG000|COMPLETED|Overall Study||82
8679699|NCT00791921|9723489|FG001|COMPLETED|Overall Study||18
8679700|NCT00791921|9723488|FG000|NOT COMPLETED|Overall Study||34
8679701|NCT00791921|9723489|FG001|NOT COMPLETED|Overall Study||96
8679702|NCT00791934|9723495|FG000|STARTED|Overall Study||63
8679703|NCT00791934|9723495|FG000|COMPLETED|Overall Study|Follow-up extended to 1 yr. 13 subjects chose not to participate in the extension.|48
8679704|NCT00791934|9723495|FG000|NOT COMPLETED|Overall Study||15
8679705|NCT00791973|9723501|FG000|STARTED|First Intervention (1 Week)||8
8679706|NCT00791973|9723502|FG001|STARTED|First Intervention (1 Week)||7
8679707|NCT00791973|9723501|FG000|COMPLETED|First Intervention (1 Week)||8
8679708|NCT00791973|9723502|FG001|COMPLETED|First Intervention (1 Week)||7
8679709|NCT00791973|9723501|FG000|NOT COMPLETED|First Intervention (1 Week)||0
8679710|NCT00791973|9723502|FG001|NOT COMPLETED|First Intervention (1 Week)||0
8679711|NCT00791973|9723501|FG000|STARTED|Washout (1 Week)||8
8679712|NCT00791973|9723502|FG001|STARTED|Washout (1 Week)||7
8679713|NCT00791973|9723501|FG000|COMPLETED|Washout (1 Week)||8
8679714|NCT00791973|9723502|FG001|COMPLETED|Washout (1 Week)||7
8679715|NCT00791973|9723501|FG000|NOT COMPLETED|Washout (1 Week)||0
8679716|NCT00791973|9723502|FG001|NOT COMPLETED|Washout (1 Week)||0
8679717|NCT00791973|9723501|FG000|STARTED|Second Intervention (1 Week)||8
8679718|NCT00791973|9723502|FG001|STARTED|Second Intervention (1 Week)||7
8679719|NCT00791973|9723501|FG000|COMPLETED|Second Intervention (1 Week)||8
8679720|NCT00791973|9723502|FG001|COMPLETED|Second Intervention (1 Week)||7
8679721|NCT00791973|9723501|FG000|NOT COMPLETED|Second Intervention (1 Week)||0
8679722|NCT00791973|9723502|FG001|NOT COMPLETED|Second Intervention (1 Week)||0
8679723|NCT00791999|9723512|FG000|STARTED|Overall Study||72
8679724|NCT00791999|9723513|FG001|STARTED|Overall Study||82
8679725|NCT00791999|9723514|FG002|STARTED|Overall Study||85
8679726|NCT00791999|9723515|FG003|STARTED|Overall Study||77
8679727|NCT00791999|9723512|FG000|COMPLETED|Overall Study||51
8679728|NCT00791999|9723513|FG001|COMPLETED|Overall Study||66
8679729|NCT00791999|9723514|FG002|COMPLETED|Overall Study||65
8679730|NCT00791999|9723515|FG003|COMPLETED|Overall Study||25
8679731|NCT00791999|9723512|FG000|NOT COMPLETED|Overall Study||21
8679732|NCT00791999|9723513|FG001|NOT COMPLETED|Overall Study||16
8679733|NCT00791999|9723514|FG002|NOT COMPLETED|Overall Study||20
8679734|NCT00791999|9723515|FG003|NOT COMPLETED|Overall Study||52
8679735|NCT00792077|9723525|FG000|STARTED|Overall Study||6
8679736|NCT00792077|9723525|FG000|Day 15+/- 3 Days|Overall Study||6
8679737|NCT00792077|9723525|FG000|Day 29+/-3 Days|Overall Study||6
8679738|NCT00792077|9723525|FG000|Day 43+/-3 Days|Overall Study||6
8679739|NCT00792077|9723525|FG000|Day 57+/-3 Days|Overall Study||6
8679740|NCT00792077|9723525|FG000|COMPLETED|Overall Study||6
8679741|NCT00792077|9723525|FG000|NOT COMPLETED|Overall Study||0
8679742|NCT00792103|9723529|FG000|STARTED|Overall Study|15 subjects were enrolled but did not treat for a total of 183 subjects in the safety population|198
8679743|NCT00792103|9723529|FG000|COMPLETED|Overall Study||65
8679744|NCT00792103|9723529|FG000|NOT COMPLETED|Overall Study||133
8679745|NCT00792142|9723533|FG000|STARTED|Overall Study||45
8679746|NCT00792142|9723533|FG000|COMPLETED|Overall Study||45
8679747|NCT00792142|9723533|FG000|NOT COMPLETED|Overall Study||0
8679748|NCT00792298|9723537|FG000|STARTED|Treatment Period 1||31
8679749|NCT00792298|9723538|FG001|STARTED|Treatment Period 1||32
8679750|NCT00792298|9723539|FG002|STARTED|Treatment Period 1||33
8679751|NCT00792298|9723540|FG003|STARTED|Treatment Period 1||32
8679752|NCT00792298|9723541|FG004|STARTED|Treatment Period 1||32
8679753|NCT00792298|9723542|FG005|STARTED|Treatment Period 1||32
8679754|NCT00792298|9723543|FG006|STARTED|Treatment Period 1||31
8679755|NCT00792298|9723544|FG007|STARTED|Treatment Period 1||31
8679756|NCT00792298|9723537|FG000|COMPLETED|Treatment Period 1||30
8679757|NCT00792298|9723538|FG001|COMPLETED|Treatment Period 1||31
8679758|NCT00792298|9723539|FG002|COMPLETED|Treatment Period 1||31
8679759|NCT00792298|9723540|FG003|COMPLETED|Treatment Period 1||28
8679760|NCT00792298|9723541|FG004|COMPLETED|Treatment Period 1||32
8679761|NCT00792298|9723542|FG005|COMPLETED|Treatment Period 1||29
8679762|NCT00792298|9723543|FG006|COMPLETED|Treatment Period 1||27
8679763|NCT00792298|9723544|FG007|COMPLETED|Treatment Period 1||30
8679764|NCT00792298|9723537|FG000|NOT COMPLETED|Treatment Period 1||1
8679765|NCT00792298|9723538|FG001|NOT COMPLETED|Treatment Period 1||1
8679766|NCT00792298|9723539|FG002|NOT COMPLETED|Treatment Period 1||2
8679767|NCT00792298|9723540|FG003|NOT COMPLETED|Treatment Period 1||4
8679768|NCT00792298|9723541|FG004|NOT COMPLETED|Treatment Period 1||0
8679769|NCT00792298|9723542|FG005|NOT COMPLETED|Treatment Period 1||3
8679770|NCT00792298|9723543|FG006|NOT COMPLETED|Treatment Period 1||4
8679771|NCT00792298|9723544|FG007|NOT COMPLETED|Treatment Period 1||1
8679772|NCT00792298|9723537|FG000|STARTED|Washout||30
8679773|NCT00792298|9723538|FG001|STARTED|Washout||31
8679774|NCT00792298|9723539|FG002|STARTED|Washout|1 participant discontinued therapy during Period 1 but entered the Washout as allowed per protocol|32
8679775|NCT00792298|9723540|FG003|STARTED|Washout||28
8679776|NCT00792298|9723541|FG004|STARTED|Washout||32
8679777|NCT00792298|9723542|FG005|STARTED|Washout||29
8679778|NCT00792298|9723543|FG006|STARTED|Washout|2 participants discontinued therapy during Period 1 but entered the Washout as allowed per protocol|29
8679779|NCT00792298|9723544|FG007|STARTED|Washout||30
8679780|NCT00792298|9723537|FG000|COMPLETED|Washout||30
8679781|NCT00792298|9723538|FG001|COMPLETED|Washout||31
8679782|NCT00792298|9723539|FG002|COMPLETED|Washout||31
8679783|NCT00792298|9723540|FG003|COMPLETED|Washout||28
8679784|NCT00792298|9723541|FG004|COMPLETED|Washout||32
8800099|NCT01441570|9851763|FG001|NOT COMPLETED|Overall Study||0
8800100|NCT01441596|9851772|FG000|STARTED|Overall Study||40
8800101|NCT01441596|9851773|FG001|STARTED|Overall Study||38
8800102|NCT01441596|9851774|FG002|STARTED|Overall Study||43
8800103|NCT01441596|9851772|FG000|COMPLETED|Overall Study||36
8800104|NCT01441596|9851773|FG001|COMPLETED|Overall Study||35
8800105|NCT01441596|9851774|FG002|COMPLETED|Overall Study||39
8800106|NCT01441596|9851772|FG000|NOT COMPLETED|Overall Study||4
8800107|NCT01441596|9851773|FG001|NOT COMPLETED|Overall Study||3
8800108|NCT01441596|9851774|FG002|NOT COMPLETED|Overall Study||4
8800109|NCT01441635|9851792|FG000|STARTED|Overall Study||32
8919117|NCT02206607|9979182|FG001|STARTED|First Washout Period 5 to 10 Days||9
8919118|NCT02206607|9979183|FG002|STARTED|First Washout Period 5 to 10 Days||9
8919119|NCT02206607|9979184|FG003|STARTED|First Washout Period 5 to 10 Days||11
8919120|NCT02206607|9979185|FG004|STARTED|First Washout Period 5 to 10 Days||10
8919121|NCT02206607|9979181|FG000|COMPLETED|First Washout Period 5 to 10 Days||0
8919122|NCT02206607|9979182|FG001|COMPLETED|First Washout Period 5 to 10 Days||9
8919123|NCT02206607|9979183|FG002|COMPLETED|First Washout Period 5 to 10 Days||9
8919124|NCT02206607|9979184|FG003|COMPLETED|First Washout Period 5 to 10 Days||11
8919125|NCT02206607|9979185|FG004|COMPLETED|First Washout Period 5 to 10 Days||10
8919126|NCT02206607|9979181|FG000|NOT COMPLETED|First Washout Period 5 to 10 Days||0
8919127|NCT02206607|9979182|FG001|NOT COMPLETED|First Washout Period 5 to 10 Days||0
8919128|NCT02206607|9979183|FG002|NOT COMPLETED|First Washout Period 5 to 10 Days||0
8919129|NCT02206607|9979184|FG003|NOT COMPLETED|First Washout Period 5 to 10 Days||0
8919130|NCT02206607|9979185|FG004|NOT COMPLETED|First Washout Period 5 to 10 Days||0
8919131|NCT02206607|9979181|FG000|STARTED|Second Intervention Period||0
8919132|NCT02206607|9979182|FG001|STARTED|Second Intervention Period||9
8919133|NCT02206607|9979183|FG002|STARTED|Second Intervention Period||9
8919134|NCT02206607|9979184|FG003|STARTED|Second Intervention Period||11
8919135|NCT02206607|9979185|FG004|STARTED|Second Intervention Period||10
8919136|NCT02206607|9979181|FG000|COMPLETED|Second Intervention Period||0
8919137|NCT02206607|9979182|FG001|COMPLETED|Second Intervention Period||9
8919138|NCT02206607|9979183|FG002|COMPLETED|Second Intervention Period||9
8919139|NCT02206607|9979184|FG003|COMPLETED|Second Intervention Period||10
8919140|NCT02206607|9979185|FG004|COMPLETED|Second Intervention Period||10
8919141|NCT02206607|9979181|FG000|NOT COMPLETED|Second Intervention Period||0
8919142|NCT02206607|9979182|FG001|NOT COMPLETED|Second Intervention Period||0
8919143|NCT02206607|9979183|FG002|NOT COMPLETED|Second Intervention Period||0
8919144|NCT02206607|9979184|FG003|NOT COMPLETED|Second Intervention Period||1
8919145|NCT02206607|9979185|FG004|NOT COMPLETED|Second Intervention Period||0
8919146|NCT02206607|9979181|FG000|STARTED|Second Washout Period 5 to 10 Days||0
8919147|NCT02206607|9979182|FG001|STARTED|Second Washout Period 5 to 10 Days||9
8800110|NCT01441635|9851793|FG001|STARTED|Overall Study||33
8919148|NCT02206607|9979183|FG002|STARTED|Second Washout Period 5 to 10 Days||9
8919149|NCT02206607|9979184|FG003|STARTED|Second Washout Period 5 to 10 Days||10
8919150|NCT02206607|9979185|FG004|STARTED|Second Washout Period 5 to 10 Days||10
8679785|NCT00792298|9723542|FG005|COMPLETED|Washout||27
8679786|NCT00792298|9723543|FG006|COMPLETED|Washout||29
8679787|NCT00792298|9723544|FG007|COMPLETED|Washout||30
8679788|NCT00792298|9723537|FG000|NOT COMPLETED|Washout||0
8679789|NCT00792298|9723538|FG001|NOT COMPLETED|Washout||0
8679790|NCT00792298|9723539|FG002|NOT COMPLETED|Washout||1
8679791|NCT00792298|9723540|FG003|NOT COMPLETED|Washout||0
8679792|NCT00792298|9723541|FG004|NOT COMPLETED|Washout||0
8919151|NCT02206607|9979181|FG000|COMPLETED|Second Washout Period 5 to 10 Days||0
8919152|NCT02206607|9979182|FG001|COMPLETED|Second Washout Period 5 to 10 Days||9
8919153|NCT02206607|9979183|FG002|COMPLETED|Second Washout Period 5 to 10 Days||9
8919154|NCT02206607|9979184|FG003|COMPLETED|Second Washout Period 5 to 10 Days||10
8919155|NCT02206607|9979185|FG004|COMPLETED|Second Washout Period 5 to 10 Days||10
8919156|NCT02206607|9979181|FG000|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
8919157|NCT02206607|9979182|FG001|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
8919158|NCT02206607|9979183|FG002|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
8919159|NCT02206607|9979184|FG003|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
8919160|NCT02206607|9979185|FG004|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
8919161|NCT02206607|9979181|FG000|STARTED|Third Intervention Period||0
8919162|NCT02206607|9979182|FG001|STARTED|Third Intervention Period||9
8919163|NCT02206607|9979183|FG002|STARTED|Third Intervention Period||9
8919164|NCT02206607|9979184|FG003|STARTED|Third Intervention Period||10
8919165|NCT02206607|9979185|FG004|STARTED|Third Intervention Period||10
8919166|NCT02206607|9979181|FG000|COMPLETED|Third Intervention Period||0
8919167|NCT02206607|9979182|FG001|COMPLETED|Third Intervention Period||9
8919168|NCT02206607|9979183|FG002|COMPLETED|Third Intervention Period||9
8919169|NCT02206607|9979184|FG003|COMPLETED|Third Intervention Period||10
8919170|NCT02206607|9979185|FG004|COMPLETED|Third Intervention Period||10
8919171|NCT02206607|9979181|FG000|NOT COMPLETED|Third Intervention Period||0
8919172|NCT02206607|9979182|FG001|NOT COMPLETED|Third Intervention Period||0
8919173|NCT02206607|9979183|FG002|NOT COMPLETED|Third Intervention Period||0
8919174|NCT02206607|9979184|FG003|NOT COMPLETED|Third Intervention Period||0
8919175|NCT02206607|9979185|FG004|NOT COMPLETED|Third Intervention Period||0
8919176|NCT02206607|9979181|FG000|STARTED|Third Washout Period 5 to 10 Days||0
8919177|NCT02206607|9979182|FG001|STARTED|Third Washout Period 5 to 10 Days||9
8919178|NCT02206607|9979183|FG002|STARTED|Third Washout Period 5 to 10 Days||9
8919179|NCT02206607|9979184|FG003|STARTED|Third Washout Period 5 to 10 Days||10
8919180|NCT02206607|9979185|FG004|STARTED|Third Washout Period 5 to 10 Days||10
8919181|NCT02206607|9979181|FG000|COMPLETED|Third Washout Period 5 to 10 Days||0
8919182|NCT02206607|9979182|FG001|COMPLETED|Third Washout Period 5 to 10 Days||9
8919183|NCT02206607|9979183|FG002|COMPLETED|Third Washout Period 5 to 10 Days||9
8919184|NCT02206607|9979184|FG003|COMPLETED|Third Washout Period 5 to 10 Days||10
8919185|NCT02206607|9979185|FG004|COMPLETED|Third Washout Period 5 to 10 Days||10
8919186|NCT02206607|9979181|FG000|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
8919187|NCT02206607|9979182|FG001|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
8919188|NCT02206607|9979183|FG002|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
8919189|NCT02206607|9979184|FG003|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
8919190|NCT02206607|9979185|FG004|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
8919191|NCT02206607|9979181|FG000|STARTED|Fourth Intervention Period||0
8919192|NCT02206607|9979182|FG001|STARTED|Fourth Intervention Period||9
8919193|NCT02206607|9979183|FG002|STARTED|Fourth Intervention Period||9
8919194|NCT02206607|9979184|FG003|STARTED|Fourth Intervention Period||10
8919195|NCT02206607|9979185|FG004|STARTED|Fourth Intervention Period||10
8919196|NCT02206607|9979181|FG000|COMPLETED|Fourth Intervention Period||0
8919197|NCT02206607|9979182|FG001|COMPLETED|Fourth Intervention Period||9
8919198|NCT02206607|9979183|FG002|COMPLETED|Fourth Intervention Period||9
8919199|NCT02206607|9979184|FG003|COMPLETED|Fourth Intervention Period||10
8919200|NCT02206607|9979185|FG004|COMPLETED|Fourth Intervention Period||10
8919201|NCT02206607|9979181|FG000|NOT COMPLETED|Fourth Intervention Period||0
8919202|NCT02206607|9979182|FG001|NOT COMPLETED|Fourth Intervention Period||0
8919203|NCT02206607|9979183|FG002|NOT COMPLETED|Fourth Intervention Period||0
8919204|NCT02206607|9979184|FG003|NOT COMPLETED|Fourth Intervention Period||0
8919205|NCT02206607|9979185|FG004|NOT COMPLETED|Fourth Intervention Period||0
8919206|NCT02206620|9979201|FG000|STARTED|Phase I - First Intervention (6 Weeks)||22
8919207|NCT02206620|9979202|FG001|STARTED|Phase I - First Intervention (6 Weeks)||27
8919208|NCT02206620|9979201|FG000|COMPLETED|Phase I - First Intervention (6 Weeks)||21
8919209|NCT02206620|9979202|FG001|COMPLETED|Phase I - First Intervention (6 Weeks)||26
8919210|NCT02206620|9979201|FG000|NOT COMPLETED|Phase I - First Intervention (6 Weeks)||1
8919211|NCT02206620|9979202|FG001|NOT COMPLETED|Phase I - First Intervention (6 Weeks)||1
8919212|NCT02206620|9979201|FG000|STARTED|Washout (6 Weeks)||21
8919213|NCT02206620|9979202|FG001|STARTED|Washout (6 Weeks)||26
8919214|NCT02206620|9979201|FG000|COMPLETED|Washout (6 Weeks)||21
8919215|NCT02206620|9979202|FG001|COMPLETED|Washout (6 Weeks)||26
8919216|NCT02206620|9979201|FG000|NOT COMPLETED|Washout (6 Weeks)||0
8919217|NCT02206620|9979202|FG001|NOT COMPLETED|Washout (6 Weeks)||0
8919218|NCT02206620|9979201|FG000|STARTED|Phase II - Second Intervention (6 Weeks)||21
8919219|NCT02206620|9979202|FG001|STARTED|Phase II - Second Intervention (6 Weeks)||26
9035699|NCT03301649|10097417|FG001|COMPLETED|Overall Study||356
9035700|NCT03301649|10097418|FG002|COMPLETED|Overall Study||27
9035701|NCT03301649|10097416|FG000|NOT COMPLETED|Overall Study||43
8679793|NCT00792298|9723542|FG005|NOT COMPLETED|Washout||2
8679794|NCT00792298|9723543|FG006|NOT COMPLETED|Washout||0
8679795|NCT00792298|9723544|FG007|NOT COMPLETED|Washout||0
8679796|NCT00792298|9723537|FG000|STARTED|Treatment Period 2||30
8679797|NCT00792298|9723538|FG001|STARTED|Treatment Period 2||31
8679798|NCT00792298|9723539|FG002|STARTED|Treatment Period 2||31
8679799|NCT00792298|9723540|FG003|STARTED|Treatment Period 2||28
8679800|NCT00792298|9723541|FG004|STARTED|Treatment Period 2||32
8679801|NCT00792298|9723542|FG005|STARTED|Treatment Period 2||27
8679802|NCT00792298|9723543|FG006|STARTED|Treatment Period 2||29
8679803|NCT00792298|9723544|FG007|STARTED|Treatment Period 2||30
8679804|NCT00792298|9723537|FG000|COMPLETED|Treatment Period 2||29
8679805|NCT00792298|9723538|FG001|COMPLETED|Treatment Period 2||30
8679806|NCT00792298|9723539|FG002|COMPLETED|Treatment Period 2||30
8679807|NCT00792298|9723540|FG003|COMPLETED|Treatment Period 2||26
8679808|NCT00792298|9723541|FG004|COMPLETED|Treatment Period 2||30
8679809|NCT00792298|9723542|FG005|COMPLETED|Treatment Period 2||27
8679810|NCT00792298|9723543|FG006|COMPLETED|Treatment Period 2||28
8800111|NCT01441635|9851794|FG002|STARTED|Overall Study||16
8800112|NCT01441635|9851795|FG003|STARTED|Overall Study||35
8800113|NCT01441635|9851796|FG004|STARTED|Overall Study||18
8800114|NCT01441635|9851797|FG005|STARTED|Overall Study||34
8800115|NCT01441635|9851798|FG006|STARTED|Overall Study||30
8800116|NCT01441635|9851799|FG007|STARTED|Overall Study||30
8800117|NCT01441635|9851800|FG008|STARTED|Overall Study||16
8800118|NCT01441635|9851801|FG009|STARTED|Overall Study||27
8800119|NCT01441635|9851792|FG000|COMPLETED|Overall Study||26
8800120|NCT01441635|9851793|FG001|COMPLETED|Overall Study||27
8800121|NCT01441635|9851794|FG002|COMPLETED|Overall Study||13
8800122|NCT01441635|9851795|FG003|COMPLETED|Overall Study||28
8800123|NCT01441635|9851796|FG004|COMPLETED|Overall Study||16
8800124|NCT01441635|9851797|FG005|COMPLETED|Overall Study||29
8800125|NCT01441635|9851798|FG006|COMPLETED|Overall Study||24
8800126|NCT01441635|9851799|FG007|COMPLETED|Overall Study||26
8800127|NCT01441635|9851800|FG008|COMPLETED|Overall Study||14
8800128|NCT01441635|9851801|FG009|COMPLETED|Overall Study||25
8800129|NCT01441635|9851792|FG000|NOT COMPLETED|Overall Study||6
8800130|NCT01441635|9851793|FG001|NOT COMPLETED|Overall Study||6
8800131|NCT01441635|9851794|FG002|NOT COMPLETED|Overall Study||3
8800132|NCT01441635|9851795|FG003|NOT COMPLETED|Overall Study||7
8800133|NCT01441635|9851796|FG004|NOT COMPLETED|Overall Study||2
8800134|NCT01441635|9851797|FG005|NOT COMPLETED|Overall Study||5
8800135|NCT01441635|9851798|FG006|NOT COMPLETED|Overall Study||6
8800136|NCT01441635|9851799|FG007|NOT COMPLETED|Overall Study||4
8800137|NCT01441635|9851800|FG008|NOT COMPLETED|Overall Study||2
8800138|NCT01441635|9851801|FG009|NOT COMPLETED|Overall Study||2
8800139|NCT01441765|9851825|FG000|STARTED|Overall Study||11
8800140|NCT01441765|9851826|FG001|STARTED|Overall Study|not opened|0
8800141|NCT01441765|9851825|FG000|COMPLETED|Overall Study||10
8800142|NCT01441765|9851826|FG001|COMPLETED|Overall Study|not opened|0
8800143|NCT01441765|9851825|FG000|NOT COMPLETED|Overall Study||1
8800144|NCT01441765|9851826|FG001|NOT COMPLETED|Overall Study||0
8800145|NCT01441843|9851834|FG000|STARTED|Overall Study||200
8800146|NCT01441843|9851835|FG001|STARTED|Overall Study||200
8800147|NCT01441843|9851834|FG000|COMPLETED|Overall Study||188
8800148|NCT01441843|9851835|FG001|COMPLETED|Overall Study||195
8800149|NCT01441843|9851834|FG000|NOT COMPLETED|Overall Study||12
8800150|NCT01441843|9851835|FG001|NOT COMPLETED|Overall Study||5
8800151|NCT01441882|9851841|FG000|STARTED|Overall Study||19
8800152|NCT01441882|9851841|FG000|COMPLETED|Overall Study||13
8800153|NCT01441882|9851841|FG000|NOT COMPLETED|Overall Study||6
8800154|NCT01441960|9851845|FG000|STARTED|First Neuromuscular Blocking Agent:||26
8800155|NCT01441960|9851846|FG001|STARTED|First Neuromuscular Blocking Agent:||19
8800156|NCT01441960|9851845|FG000|COMPLETED|First Neuromuscular Blocking Agent:||18
8800157|NCT01441960|9851846|FG001|COMPLETED|First Neuromuscular Blocking Agent:||13
8800158|NCT01441960|9851845|FG000|NOT COMPLETED|First Neuromuscular Blocking Agent:||8
8800159|NCT01441960|9851846|FG001|NOT COMPLETED|First Neuromuscular Blocking Agent:||6
8800160|NCT01441960|9851845|FG000|STARTED|Second Neuromuscular Blocking Agent||18
8800161|NCT01441960|9851846|FG001|STARTED|Second Neuromuscular Blocking Agent||13
8800162|NCT01441960|9851845|FG000|COMPLETED|Second Neuromuscular Blocking Agent||18
8800163|NCT01441960|9851846|FG001|COMPLETED|Second Neuromuscular Blocking Agent||13
8800164|NCT01441960|9851845|FG000|NOT COMPLETED|Second Neuromuscular Blocking Agent||0
8800165|NCT01441960|9851846|FG001|NOT COMPLETED|Second Neuromuscular Blocking Agent||0
8800166|NCT01441973|9851858|FG000|STARTED|Overall Study||15
8800167|NCT01441973|9851859|FG001|STARTED|Overall Study||16
8800168|NCT01441973|9851858|FG000|COMPLETED|Overall Study|Still receiving treatment|0
8800169|NCT01441973|9851859|FG001|COMPLETED|Overall Study|Still receiving treatment|0
8800170|NCT01441973|9851858|FG000|NOT COMPLETED|Overall Study||15
8800171|NCT01441973|9851859|FG001|NOT COMPLETED|Overall Study||16
8800172|NCT01442038|9851868|FG000|STARTED|Overall Study||1332
8800173|NCT01442038|9851869|FG001|STARTED|Overall Study||1319
8800174|NCT01442038|9851868|FG000|COMPLETED|Overall Study||1029
8800175|NCT01442038|9851869|FG001|COMPLETED|Overall Study||1040
8800176|NCT01442038|9851868|FG000|NOT COMPLETED|Overall Study||303
8800177|NCT01442038|9851869|FG001|NOT COMPLETED|Overall Study||279
8800178|NCT01442064|9851881|FG000|STARTED|Overall Study||97
8800179|NCT01442064|9851882|FG001|STARTED|Overall Study||103
8800180|NCT01442064|9851883|FG002|STARTED|Overall Study||104
8800181|NCT01442064|9851884|FG003|STARTED|Overall Study||98
8800182|NCT01442064|9851885|FG004|STARTED|Overall Study||107
8679811|NCT00792298|9723544|FG007|COMPLETED|Treatment Period 2||28
8679812|NCT00792298|9723537|FG000|NOT COMPLETED|Treatment Period 2||1
8679813|NCT00792298|9723538|FG001|NOT COMPLETED|Treatment Period 2||1
8679814|NCT00792298|9723539|FG002|NOT COMPLETED|Treatment Period 2||1
8679815|NCT00792298|9723540|FG003|NOT COMPLETED|Treatment Period 2||2
8679816|NCT00792298|9723541|FG004|NOT COMPLETED|Treatment Period 2||2
8679817|NCT00792298|9723542|FG005|NOT COMPLETED|Treatment Period 2||0
8679818|NCT00792298|9723543|FG006|NOT COMPLETED|Treatment Period 2||1
8679819|NCT00792298|9723544|FG007|NOT COMPLETED|Treatment Period 2||2
8679820|NCT00792428|9723563|FG000|STARTED|Overall Study||10
8679821|NCT00792428|9723564|FG001|STARTED|Overall Study||10
8679822|NCT00792428|9723563|FG000|COMPLETED|Overall Study||10
8679823|NCT00792428|9723564|FG001|COMPLETED|Overall Study||10
8679824|NCT00792428|9723563|FG000|NOT COMPLETED|Overall Study||0
8679825|NCT00792428|9723564|FG001|NOT COMPLETED|Overall Study||0
8679826|NCT00792467|9723570|FG000|STARTED|Overall Study||24
8679827|NCT00792467|9723570|FG000|COMPLETED|Overall Study||2
8679828|NCT00792467|9723570|FG000|NOT COMPLETED|Overall Study||22
8679829|NCT00792571|9723575|FG000|STARTED|Overall Study||18
8679830|NCT00792571|9723575|FG000|COMPLETED|Overall Study||8
8679831|NCT00792571|9723575|FG000|NOT COMPLETED|Overall Study||10
8679832|NCT00792610|9723579|FG000|STARTED|Overall Study||127
8679833|NCT00792610|9723579|FG000|Youths|Overall Study||127
8679834|NCT00792610|9723579|FG000|COMPLETED|Overall Study||127
8679835|NCT00792610|9723579|FG000|NOT COMPLETED|Overall Study||0
8679836|NCT00792623|9723583|FG000|STARTED|Overall Study||29
8679837|NCT00792623|9723583|FG000|COMPLETED|Overall Study||22
8679838|NCT00792623|9723583|FG000|NOT COMPLETED|Overall Study||7
8679839|NCT00792636|9723591|FG000|STARTED|Overall Study||135
8679840|NCT00792636|9723592|FG001|STARTED|Overall Study||136
8679841|NCT00792636|9723593|FG002|STARTED|Overall Study||136
8679842|NCT00792636|9723591|FG000|COMPLETED|Overall Study||67
8679843|NCT00792636|9723592|FG001|COMPLETED|Overall Study||55
8679844|NCT00792636|9723593|FG002|COMPLETED|Overall Study||55
8679845|NCT00792636|9723591|FG000|NOT COMPLETED|Overall Study||68
8679846|NCT00792636|9723592|FG001|NOT COMPLETED|Overall Study||81
8679847|NCT00792636|9723593|FG002|NOT COMPLETED|Overall Study||81
8679848|NCT00792688|9723606|FG000|STARTED|Overall Study||9
8679849|NCT00792688|9723607|FG001|STARTED|Overall Study||8
8679850|NCT00792688|9723608|FG002|STARTED|Overall Study||9
8679851|NCT00792688|9723606|FG000|COMPLETED|Overall Study||9
8679852|NCT00792688|9723607|FG001|COMPLETED|Overall Study||8
8679853|NCT00792688|9723608|FG002|COMPLETED|Overall Study||9
8679854|NCT00792688|9723606|FG000|NOT COMPLETED|Overall Study||0
8679855|NCT00792688|9723607|FG001|NOT COMPLETED|Overall Study||0
8679856|NCT00792688|9723608|FG002|NOT COMPLETED|Overall Study||0
8679857|NCT00792701|9723618|FG000|STARTED|Overall Study||19
8679858|NCT00792701|9723619|FG001|STARTED|Overall Study||66
8679859|NCT00792701|9723618|FG000|Eligible|Overall Study||18
8679860|NCT00792701|9723619|FG001|Eligible|Overall Study||63
8679861|NCT00792701|9723618|FG000|Eligible and Analyzable|Overall Study||17
8679862|NCT00792701|9723619|FG001|Eligible and Analyzable|Overall Study||44
8679863|NCT00792701|9723618|FG000|COMPLETED|Overall Study||0
8679864|NCT00792701|9723619|FG001|COMPLETED|Overall Study||22
8679865|NCT00792701|9723618|FG000|NOT COMPLETED|Overall Study||19
8679866|NCT00792701|9723619|FG001|NOT COMPLETED|Overall Study||44
8679867|NCT00792805|9723630|FG000|STARTED|Overall Study||188
8679868|NCT00792805|9723631|FG001|STARTED|Overall Study||188
8679869|NCT00792805|9723632|FG002|STARTED|Overall Study||187
8679870|NCT00792805|9723630|FG000|Exposed to Study Medication or Placebo|Overall Study|One patient in this group did not receive any study treatment.|187
8679871|NCT00792805|9723631|FG001|Exposed to Study Medication or Placebo|Overall Study||188
8679872|NCT00792805|9723632|FG002|Exposed to Study Medication or Placebo|Overall Study|One patient in this group did not receive any study treatment.|186
8679873|NCT00792805|9723630|FG000|COMPLETED|Overall Study||166
8679874|NCT00792805|9723631|FG001|COMPLETED|Overall Study||162
8679875|NCT00792805|9723632|FG002|COMPLETED|Overall Study||154
8679876|NCT00792805|9723630|FG000|NOT COMPLETED|Overall Study||22
8679877|NCT00792805|9723631|FG001|NOT COMPLETED|Overall Study||26
8679878|NCT00792805|9723632|FG002|NOT COMPLETED|Overall Study||33
8679879|NCT00792909|9723643|FG000|STARTED|Overall Study||51
8679880|NCT00792909|9723644|FG001|STARTED|Overall Study||59
8679881|NCT00792909|9723645|FG002|STARTED|Overall Study||62
8679882|NCT00792909|9723643|FG000|COMPLETED|Overall Study||51
8679883|NCT00792909|9723644|FG001|COMPLETED|Overall Study||58
8679884|NCT00792909|9723645|FG002|COMPLETED|Overall Study||62
8679885|NCT00792909|9723643|FG000|NOT COMPLETED|Overall Study||0
8679886|NCT00792909|9723644|FG001|NOT COMPLETED|Overall Study||1
8679887|NCT00792909|9723645|FG002|NOT COMPLETED|Overall Study||0
8679888|NCT00792922|9723660|FG000|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|
8679889|NCT00792922|9723661|FG001|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|
8679890|NCT00792922|9723662|FG002|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|
8679891|NCT00792922|9723663|FG003|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|
8679892|NCT00792922|9723660|FG000|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|
8679893|NCT00792922|9723661|FG001|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|
8679894|NCT00792922|9723662|FG002|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|
8679895|NCT00792922|9723663|FG003|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|
8679896|NCT00792922|9723660|FG000|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|
8679897|NCT00792922|9723661|FG001|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|
8679898|NCT00792922|9723662|FG002|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|
8679899|NCT00792922|9723663|FG003|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|
8679900|NCT00792922|9723660|FG000|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|
8679901|NCT00792922|9723661|FG001|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|
8679902|NCT00792922|9723662|FG002|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|
8679903|NCT00792922|9723663|FG003|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|
8679904|NCT00792922|9723660|FG000|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|
8679905|NCT00792922|9723661|FG001|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|
8679906|NCT00792922|9723662|FG002|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|
8679907|NCT00792922|9723663|FG003|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|
8679908|NCT00792922|9723660|FG000|NOT COMPLETED|At Baseline||
8679909|NCT00792922|9723661|FG001|NOT COMPLETED|At Baseline||
8679910|NCT00792922|9723662|FG002|NOT COMPLETED|At Baseline||
8679911|NCT00792922|9723663|FG003|NOT COMPLETED|At Baseline||
8679912|NCT00792922|9723660|FG000|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months~the trial was conducted at community level and data reported per community basis"|
8679913|NCT00792922|9723661|FG001|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months~the trial was conducted at community level and data reported per community basis"|
8679914|NCT00792922|9723662|FG002|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months~the trial was conducted at community level and data reported per community basis"|
8679915|NCT00792922|9723663|FG003|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months~the trial was conducted at community level and data reported per community basis"|
8679916|NCT00792922|9723660|FG000|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|
8679917|NCT00792922|9723661|FG001|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|
8679918|NCT00792922|9723662|FG002|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|
8679919|NCT00792922|9723663|FG003|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|
8679920|NCT00792922|9723660|FG000|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|
8679921|NCT00792922|9723661|FG001|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|
8679922|NCT00792922|9723662|FG002|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|
8679923|NCT00792922|9723663|FG003|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|
8679924|NCT00792922|9723660|FG000|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|
8679925|NCT00792922|9723661|FG001|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|
8679926|NCT00792922|9723662|FG002|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|
8679927|NCT00792922|9723663|FG003|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|
8679928|NCT00792922|9723660|FG000|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|
8679929|NCT00792922|9723661|FG001|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|
8679930|NCT00792922|9723662|FG002|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|
8679931|NCT00792922|9723663|FG003|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|
8679932|NCT00792922|9723660|FG000|NOT COMPLETED|At 3 Years||
8679933|NCT00792922|9723661|FG001|NOT COMPLETED|At 3 Years||
8679934|NCT00792922|9723662|FG002|NOT COMPLETED|At 3 Years||
8679935|NCT00792922|9723663|FG003|NOT COMPLETED|At 3 Years||
8679936|NCT00792935|9723677|FG000|STARTED|Overall Study||72
8679937|NCT00792935|9723678|FG001|STARTED|Overall Study||71
8679938|NCT00792935|9723677|FG000|COMPLETED|Overall Study||68
8679939|NCT00792935|9723678|FG001|COMPLETED|Overall Study||68
8679940|NCT00792935|9723677|FG000|NOT COMPLETED|Overall Study||4
8679941|NCT00792935|9723678|FG001|NOT COMPLETED|Overall Study||3
8679942|NCT00793104|9723684|FG000|STARTED|Overall Study||10
8679943|NCT00793104|9723684|FG000|COMPLETED|Overall Study||9
8679944|NCT00793104|9723684|FG000|NOT COMPLETED|Overall Study||1
8679945|NCT00793182|9723690|FG000|STARTED|Overall Study||2
8679946|NCT00793182|9723691|FG001|STARTED|Overall Study||4
8679947|NCT00793182|9723690|FG000|COMPLETED|Overall Study||2
8679948|NCT00793182|9723691|FG001|COMPLETED|Overall Study||3
8679949|NCT00793182|9723690|FG000|NOT COMPLETED|Overall Study||0
8679950|NCT00793182|9723691|FG001|NOT COMPLETED|Overall Study||1
8692861|NCT00862849|9738283|FG005|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
8692862|NCT00862849|9738278|FG000|STARTED|Intervention 5||3
8692863|NCT00862849|9738279|FG001|STARTED|Intervention 5||3
8692864|NCT00862849|9738280|FG002|STARTED|Intervention 5||3
8679951|NCT00793325|9723697|FG000|STARTED|Overall Study||909
8679952|NCT00793325|9723697|FG000|COMPLETED|Overall Study||890
8679953|NCT00793325|9723697|FG000|NOT COMPLETED|Overall Study||19
8679954|NCT00793403|9723720|FG000|STARTED|Overall Study||293
8679955|NCT00793403|9723720|FG000|COMPLETED|Overall Study||220
8679956|NCT00793403|9723720|FG000|NOT COMPLETED|Overall Study||73
8679957|NCT00793455|9723726|FG000|STARTED|Overall Study||314
8679958|NCT00793455|9723727|FG001|STARTED|Overall Study||314
8679959|NCT00793455|9723726|FG000|COMPLETED|Overall Study||314
8679960|NCT00793455|9723727|FG001|COMPLETED|Overall Study||314
8679961|NCT00793455|9723726|FG000|NOT COMPLETED|Overall Study||0
8679962|NCT00793455|9723727|FG001|NOT COMPLETED|Overall Study||0
8679963|NCT00793546|9723736|FG000|STARTED|Overall Study||14
8679964|NCT00793546|9723737|FG001|STARTED|Overall Study||28
8679965|NCT00793546|9723736|FG000|COMPLETED|Overall Study||0
8679966|NCT00793546|9723737|FG001|COMPLETED|Overall Study||0
8679967|NCT00793546|9723736|FG000|NOT COMPLETED|Overall Study||14
8679968|NCT00793546|9723737|FG001|NOT COMPLETED|Overall Study||28
8679969|NCT00793572|9723745|FG000|STARTED|Overall Study||32
8679970|NCT00793572|9723745|FG000|COMPLETED|Overall Study||32
8679971|NCT00793572|9723745|FG000|NOT COMPLETED|Overall Study||0
8679972|NCT00793585|9723751|FG000|STARTED|Overall Study||19
8679973|NCT00793585|9723752|FG001|STARTED|Overall Study||21
8679974|NCT00793585|9723751|FG000|COMPLETED|Overall Study||17
8679975|NCT00793585|9723752|FG001|COMPLETED|Overall Study||18
8679976|NCT00793585|9723751|FG000|NOT COMPLETED|Overall Study||2
8679977|NCT00793585|9723752|FG001|NOT COMPLETED|Overall Study||3
8679978|NCT00793598|9723763|FG000|STARTED|Overall Study||1
8679979|NCT00793598|9723764|FG001|STARTED|Overall Study||1
8679980|NCT00793598|9723765|FG002|STARTED|Overall Study||1
8679981|NCT00793598|9723766|FG003|STARTED|Overall Study||2
8679982|NCT00793598|9723767|FG004|STARTED|Overall Study||8
8679983|NCT00793598|9723768|FG005|STARTED|Overall Study||8
8679984|NCT00793598|9723769|FG006|STARTED|Overall Study||4
8679985|NCT00793598|9723770|FG007|STARTED|Overall Study||4
8679986|NCT00793598|9723763|FG000|COMPLETED|Overall Study||1
8679987|NCT00793598|9723764|FG001|COMPLETED|Overall Study||0
8679988|NCT00793598|9723765|FG002|COMPLETED|Overall Study||1
8679989|NCT00793598|9723766|FG003|COMPLETED|Overall Study||2
8679990|NCT00793598|9723767|FG004|COMPLETED|Overall Study||8
8679991|NCT00793598|9723768|FG005|COMPLETED|Overall Study||7
8679992|NCT00793598|9723769|FG006|COMPLETED|Overall Study||4
8679993|NCT00793598|9723770|FG007|COMPLETED|Overall Study||3
8679994|NCT00793598|9723763|FG000|NOT COMPLETED|Overall Study||0
8679995|NCT00793598|9723764|FG001|NOT COMPLETED|Overall Study||1
8679996|NCT00793598|9723765|FG002|NOT COMPLETED|Overall Study||0
8679997|NCT00793598|9723766|FG003|NOT COMPLETED|Overall Study||0
8679998|NCT00793598|9723767|FG004|NOT COMPLETED|Overall Study||0
8679999|NCT00793598|9723768|FG005|NOT COMPLETED|Overall Study||1
8680000|NCT00793598|9723769|FG006|NOT COMPLETED|Overall Study||0
8680001|NCT00793598|9723770|FG007|NOT COMPLETED|Overall Study||1
8680002|NCT00793611|9723794|FG000|STARTED|Overall Study||10
8680003|NCT00793611|9723795|FG001|STARTED|Overall Study||10
8680004|NCT00793611|9723794|FG000|COMPLETED|Overall Study||10
8680005|NCT00793611|9723795|FG001|COMPLETED|Overall Study||10
8680006|NCT00793611|9723794|FG000|NOT COMPLETED|Overall Study||0
8680007|NCT00793611|9723795|FG001|NOT COMPLETED|Overall Study||0
8680008|NCT00793624|9723805|FG000|STARTED|Overall Study||225
8680009|NCT00793624|9723806|FG001|STARTED|Overall Study||227
8680010|NCT00793624|9723807|FG002|STARTED|Overall Study||225
8680011|NCT00793624|9723808|FG003|STARTED|Overall Study||227
8680012|NCT00793624|9723805|FG000|COMPLETED|Overall Study||168
8680013|NCT00793624|9723806|FG001|COMPLETED|Overall Study||191
8680014|NCT00793624|9723807|FG002|COMPLETED|Overall Study||186
8680015|NCT00793624|9723808|FG003|COMPLETED|Overall Study||184
8680016|NCT00793624|9723805|FG000|NOT COMPLETED|Overall Study||57
8680017|NCT00793624|9723806|FG001|NOT COMPLETED|Overall Study||36
8680018|NCT00793624|9723807|FG002|NOT COMPLETED|Overall Study||39
8680019|NCT00793624|9723808|FG003|NOT COMPLETED|Overall Study||43
8680020|NCT00793650|9723828|FG000|STARTED|Overall Study||19
8680021|NCT00793650|9723829|FG001|STARTED|Overall Study||20
8680022|NCT00793650|9723828|FG000|COMPLETED|Overall Study||19
8680023|NCT00793650|9723829|FG001|COMPLETED|Overall Study||20
8680024|NCT00793650|9723828|FG000|NOT COMPLETED|Overall Study||0
8680025|NCT00793650|9723829|FG001|NOT COMPLETED|Overall Study||0
8680026|NCT00793780|9723839|FG000|STARTED|Overall Study||12
8680027|NCT00793780|9723840|FG001|STARTED|Overall Study||12
8680028|NCT00793780|9723839|FG000|Randomization|Overall Study||12
8680029|NCT00793780|9723840|FG001|Randomization|Overall Study||12
8680030|NCT00793780|9723839|FG000|Collected Baseline Data|Overall Study||11
8680031|NCT00793780|9723840|FG001|Collected Baseline Data|Overall Study||12
8680032|NCT00793780|9723839|FG000|COMPLETED|Overall Study||10
8680033|NCT00793780|9723840|FG001|COMPLETED|Overall Study||11
8680034|NCT00793780|9723839|FG000|NOT COMPLETED|Overall Study||2
8680035|NCT00793780|9723840|FG001|NOT COMPLETED|Overall Study||1
8680036|NCT00793793|9723858|FG000|STARTED|Overall Study||8
8680037|NCT00793793|9723859|FG001|STARTED|Overall Study||6
8680038|NCT00793793|9723860|FG002|STARTED|Overall Study||7
8680039|NCT00793793|9723861|FG003|STARTED|Overall Study||7
8680040|NCT00793793|9723862|FG004|STARTED|Overall Study||6
8680041|NCT00793793|9723863|FG005|STARTED|Overall Study||6
8680042|NCT00793793|9723864|FG006|STARTED|Overall Study||7
8680043|NCT00793793|9723865|FG007|STARTED|Overall Study||6
8680044|NCT00793793|9723866|FG008|STARTED|Overall Study||15
8680045|NCT00793793|9723867|FG009|STARTED|Overall Study||15
8680046|NCT00793793|9723868|FG010|STARTED|Overall Study||6
8680047|NCT00793793|9723869|FG011|STARTED|Overall Study||7
8680048|NCT00793793|9723858|FG000|COMPLETED|Overall Study||8
8680049|NCT00793793|9723859|FG001|COMPLETED|Overall Study||5
8680050|NCT00793793|9723860|FG002|COMPLETED|Overall Study||5
8680051|NCT00793793|9723861|FG003|COMPLETED|Overall Study||4
8680052|NCT00793793|9723862|FG004|COMPLETED|Overall Study||4
8680053|NCT00793793|9723863|FG005|COMPLETED|Overall Study||4
8680054|NCT00793793|9723864|FG006|COMPLETED|Overall Study||3
8680055|NCT00793793|9723865|FG007|COMPLETED|Overall Study||6
8680056|NCT00793793|9723866|FG008|COMPLETED|Overall Study||6
8680057|NCT00793793|9723867|FG009|COMPLETED|Overall Study||6
8680058|NCT00793793|9723868|FG010|COMPLETED|Overall Study||3
8680059|NCT00793793|9723869|FG011|COMPLETED|Overall Study||1
8680060|NCT00793793|9723858|FG000|NOT COMPLETED|Overall Study||0
8680061|NCT00793793|9723859|FG001|NOT COMPLETED|Overall Study||1
8680062|NCT00793793|9723860|FG002|NOT COMPLETED|Overall Study||2
8680063|NCT00793793|9723861|FG003|NOT COMPLETED|Overall Study||3
8680064|NCT00793793|9723862|FG004|NOT COMPLETED|Overall Study||2
8680065|NCT00793793|9723863|FG005|NOT COMPLETED|Overall Study||2
8680066|NCT00793793|9723864|FG006|NOT COMPLETED|Overall Study||4
8680067|NCT00793793|9723865|FG007|NOT COMPLETED|Overall Study||0
8680068|NCT00793793|9723866|FG008|NOT COMPLETED|Overall Study||9
8680069|NCT00793793|9723867|FG009|NOT COMPLETED|Overall Study||9
8680070|NCT00793793|9723868|FG010|NOT COMPLETED|Overall Study||3
8680071|NCT00793793|9723869|FG011|NOT COMPLETED|Overall Study||6
8680072|NCT00793819|9723917|FG000|STARTED|Overall Study||111
8680073|NCT00793819|9723918|FG001|STARTED|Overall Study||98
8680074|NCT00793819|9723917|FG000|COMPLETED|Overall Study||97
8680075|NCT00793819|9723918|FG001|COMPLETED|Overall Study||89
8680076|NCT00793819|9723917|FG000|NOT COMPLETED|Overall Study||14
8680077|NCT00793819|9723918|FG001|NOT COMPLETED|Overall Study||9
8680078|NCT00793871|9723924|FG000|STARTED|Overall Study||60
8680079|NCT00793871|9723924|FG000|Received Treatment|Overall Study||59
8680080|NCT00793871|9723924|FG000|COMPLETED|Overall Study||0
8680081|NCT00793871|9723924|FG000|NOT COMPLETED|Overall Study||60
8680082|NCT00793910|9723930|FG000|STARTED|Overall Study||53
8680083|NCT00793910|9723931|FG001|STARTED|Overall Study||53
8680084|NCT00793910|9723930|FG000|COMPLETED|Overall Study||48
8680085|NCT00793910|9723931|FG001|COMPLETED|Overall Study||46
8680086|NCT00793910|9723930|FG000|NOT COMPLETED|Overall Study||5
8680087|NCT00793910|9723931|FG001|NOT COMPLETED|Overall Study||7
8680088|NCT00794040|9723939|FG000|STARTED|Overall Study||25
8800183|NCT01442064|9851886|FG005|STARTED|Overall Study||99
8800184|NCT01442064|9851881|FG000|Ranibizumab-Treated Subjects|Overall Study|Includes participants who received Ranibizumab in either the initial studies or the extension study.|93
8800185|NCT01442064|9851882|FG001|Ranibizumab-Treated Subjects|Overall Study||103
8800186|NCT01442064|9851883|FG002|Ranibizumab-Treated Subjects|Overall Study||104
8800187|NCT01442064|9851884|FG003|Ranibizumab-Treated Subjects|Overall Study||96
8800188|NCT01442064|9851885|FG004|Ranibizumab-Treated Subjects|Overall Study||107
8800189|NCT01442064|9851886|FG005|Ranibizumab-Treated Subjects|Overall Study||99
8800190|NCT01442064|9851881|FG000|Received Study Drug in Extension Study|Overall Study||61
8800191|NCT01442064|9851882|FG001|Received Study Drug in Extension Study|Overall Study||70
8800192|NCT01442064|9851883|FG002|Received Study Drug in Extension Study|Overall Study||60
8800193|NCT01442064|9851884|FG003|Received Study Drug in Extension Study|Overall Study||70
8800194|NCT01442064|9851885|FG004|Received Study Drug in Extension Study|Overall Study||89
8800195|NCT01442064|9851886|FG005|Received Study Drug in Extension Study|Overall Study||81
8800196|NCT01442064|9851881|FG000|COMPLETED|Overall Study||0
8800197|NCT01442064|9851882|FG001|COMPLETED|Overall Study||2
8800198|NCT01442064|9851883|FG002|COMPLETED|Overall Study||0
8800199|NCT01442064|9851884|FG003|COMPLETED|Overall Study||0
8800200|NCT01442064|9851885|FG004|COMPLETED|Overall Study||1
8800201|NCT01442064|9851886|FG005|COMPLETED|Overall Study||0
8800202|NCT01442064|9851881|FG000|NOT COMPLETED|Overall Study||97
8800203|NCT01442064|9851882|FG001|NOT COMPLETED|Overall Study||101
8800204|NCT01442064|9851883|FG002|NOT COMPLETED|Overall Study||104
8800205|NCT01442064|9851884|FG003|NOT COMPLETED|Overall Study||98
8800206|NCT01442064|9851885|FG004|NOT COMPLETED|Overall Study||106
8800207|NCT01442064|9851886|FG005|NOT COMPLETED|Overall Study||99
8800208|NCT01442103|9851903|FG000|STARTED|Overall Study||10
8800209|NCT01442103|9851903|FG000|COMPLETED|Overall Study||8
8800210|NCT01442103|9851903|FG000|NOT COMPLETED|Overall Study||2
8800211|NCT01442129|9851909|FG000|STARTED|Overall Study||20
8800212|NCT01442129|9851910|FG001|STARTED|Overall Study||10
8800213|NCT01442129|9851909|FG000|COMPLETED|Overall Study|Treatment withheld from 1 patient randomized before results of screening PRA known|20
8800214|NCT01442129|9851910|FG001|COMPLETED|Overall Study||10
8800215|NCT01442129|9851909|FG000|NOT COMPLETED|Overall Study||0
8800216|NCT01442129|9851910|FG001|NOT COMPLETED|Overall Study||0
8800217|NCT01442155|9851916|FG000|STARTED|Overall Study||74
8680089|NCT00794040|9723940|FG001|STARTED|Overall Study||28
8680090|NCT00794040|9723939|FG000|COMPLETED|Overall Study||22
8680091|NCT00794040|9723940|FG001|COMPLETED|Overall Study||23
8680092|NCT00794040|9723939|FG000|NOT COMPLETED|Overall Study||3
8680093|NCT00794040|9723940|FG001|NOT COMPLETED|Overall Study||5
8680094|NCT00794118|9723946|FG000|STARTED|Overall Study||299
8680095|NCT00794118|9723946|FG000|COMPLETED|Overall Study||272
8680096|NCT00794118|9723946|FG000|NOT COMPLETED|Overall Study||27
8680097|NCT00794144|9723952|FG000|STARTED|Overall Study||66
8680098|NCT00794144|9723953|FG001|STARTED|Overall Study||66
8680099|NCT00794144|9723952|FG000|COMPLETED|Overall Study||63
8680100|NCT00794144|9723953|FG001|COMPLETED|Overall Study||63
8680101|NCT00794144|9723952|FG000|NOT COMPLETED|Overall Study||3
8680102|NCT00794144|9723953|FG001|NOT COMPLETED|Overall Study||3
8680103|NCT00794157|9723962|FG000|STARTED|Overall Study||114
8680104|NCT00794157|9723963|FG001|STARTED|Overall Study||116
8680105|NCT00794157|9723964|FG002|STARTED|Overall Study||117
8680106|NCT00794157|9723962|FG000|COMPLETED|Overall Study||104
8680107|NCT00794157|9723963|FG001|COMPLETED|Overall Study||106
8680108|NCT00794157|9723964|FG002|COMPLETED|Overall Study||98
8680109|NCT00794157|9723962|FG000|NOT COMPLETED|Overall Study||10
8680110|NCT00794157|9723963|FG001|NOT COMPLETED|Overall Study||10
8680111|NCT00794157|9723964|FG002|NOT COMPLETED|Overall Study||19
8680112|NCT00794170|9723974|FG000|STARTED|Overall Study||157
8680113|NCT00794170|9723975|FG001|STARTED|Overall Study||155
8680114|NCT00794170|9723974|FG000|COMPLETED|Overall Study||150
8680115|NCT00794170|9723975|FG001|COMPLETED|Overall Study||152
8680116|NCT00794170|9723974|FG000|NOT COMPLETED|Overall Study||7
8680117|NCT00794170|9723975|FG001|NOT COMPLETED|Overall Study||3
8680118|NCT00794196|9723983|FG000|STARTED|Overall Study||92
8680119|NCT00794196|9723984|FG001|STARTED|Overall Study||87
8680120|NCT00794196|9723983|FG000|COMPLETED|Overall Study||87
8680121|NCT00794196|9723984|FG001|COMPLETED|Overall Study||64
8680122|NCT00794196|9723983|FG000|NOT COMPLETED|Overall Study||5
8680123|NCT00794196|9723984|FG001|NOT COMPLETED|Overall Study||23
8680124|NCT00794313|9723990|FG000|STARTED|Overall Study||1
8680125|NCT00794313|9723991|FG001|STARTED|Overall Study||1
8680126|NCT00794313|9723992|FG002|STARTED|Overall Study||1
8680127|NCT00794313|9723990|FG000|COMPLETED|Overall Study||1
8680128|NCT00794313|9723991|FG001|COMPLETED|Overall Study||1
8680129|NCT00794313|9723992|FG002|COMPLETED|Overall Study||1
8680130|NCT00794313|9723990|FG000|NOT COMPLETED|Overall Study||0
8680131|NCT00794313|9723991|FG001|NOT COMPLETED|Overall Study||0
8680132|NCT00794313|9723992|FG002|NOT COMPLETED|Overall Study||0
8680133|NCT00794339|9724003|FG000|STARTED|Overall Study||73
8680134|NCT00794339|9724003|FG000|Eligible|Overall Study||69
8680135|NCT00794339|9724003|FG000|Evaluable|Overall Study||59
8680136|NCT00794339|9724003|FG000|COMPLETED|Overall Study||59
8680137|NCT00794339|9724003|FG000|NOT COMPLETED|Overall Study||14
8680138|NCT00794365|9724024|FG000|STARTED|Overall Study||330
8680139|NCT00794365|9724024|FG000|COMPLETED|Overall Study||251
8680140|NCT00794365|9724024|FG000|NOT COMPLETED|Overall Study||79
8680141|NCT00794417|9724032|FG000|STARTED|Phase 1: Baseline (Day 1) up to Day 751||4
8680142|NCT00794417|9724033|FG001|STARTED|Phase 1: Baseline (Day 1) up to Day 751||7
8680143|NCT00794417|9724034|FG002|STARTED|Phase 1: Baseline (Day 1) up to Day 751||7
8680144|NCT00794417|9724035|FG003|STARTED|Phase 1: Baseline (Day 1) up to Day 751||0
8680145|NCT00794417|9724032|FG000|COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||1
8680146|NCT00794417|9724033|FG001|COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||4
8680147|NCT00794417|9724034|FG002|COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||4
8680148|NCT00794417|9724035|FG003|COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||0
8680149|NCT00794417|9724032|FG000|NOT COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||3
8680150|NCT00794417|9724033|FG001|NOT COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||3
8680151|NCT00794417|9724034|FG002|NOT COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||3
8680152|NCT00794417|9724035|FG003|NOT COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||0
8680153|NCT00794417|9724032|FG000|STARTED|Phase 2: Baseline (Day 421) to Day 972|Participants enrolled in phase 1 were not eligible for enrollment in phase 2.|0
8680154|NCT00794417|9724033|FG001|STARTED|Phase 2: Baseline (Day 421) to Day 972|Participants enrolled in phase 1 were not eligible for enrollment in phase 2.|0
8680155|NCT00794417|9724034|FG002|STARTED|Phase 2: Baseline (Day 421) to Day 972|Participants enrolled in phase 1 were not eligible for enrollment in phase 2.|0
8680156|NCT00794417|9724035|FG003|STARTED|Phase 2: Baseline (Day 421) to Day 972||42
8680157|NCT00794417|9724032|FG000|COMPLETED|Phase 2: Baseline (Day 421) to Day 972||0
8680158|NCT00794417|9724033|FG001|COMPLETED|Phase 2: Baseline (Day 421) to Day 972||0
8680159|NCT00794417|9724034|FG002|COMPLETED|Phase 2: Baseline (Day 421) to Day 972||0
8680160|NCT00794417|9724035|FG003|COMPLETED|Phase 2: Baseline (Day 421) to Day 972||7
8680161|NCT00794417|9724032|FG000|NOT COMPLETED|Phase 2: Baseline (Day 421) to Day 972||0
8680162|NCT00794417|9724033|FG001|NOT COMPLETED|Phase 2: Baseline (Day 421) to Day 972||0
8680163|NCT00794417|9724034|FG002|NOT COMPLETED|Phase 2: Baseline (Day 421) to Day 972||0
8680164|NCT00794417|9724035|FG003|NOT COMPLETED|Phase 2: Baseline (Day 421) to Day 972||35
8680165|NCT00794469|9724047|FG000|STARTED|Overall Study||21
8680166|NCT00794469|9724047|FG000|COMPLETED|Overall Study||21
8680167|NCT00794469|9724047|FG000|NOT COMPLETED|Overall Study||0
8680168|NCT00794508|9724051|FG000|STARTED|Overall Study||10
8680169|NCT00794508|9724051|FG000|COMPLETED|Overall Study||10
8680170|NCT00794508|9724051|FG000|NOT COMPLETED|Overall Study||0
8680171|NCT00794547|9724055|FG000|STARTED|Overall Study||18
8680172|NCT00794547|9724056|FG001|STARTED|Overall Study||16
8680173|NCT00794547|9724055|FG000|COMPLETED|Overall Study||18
8680174|NCT00794547|9724056|FG001|COMPLETED|Overall Study||16
8680175|NCT00794547|9724055|FG000|NOT COMPLETED|Overall Study||0
8680176|NCT00794547|9724056|FG001|NOT COMPLETED|Overall Study||0
8680177|NCT00794560|9724064|FG000|STARTED|Overall Study||36
8680178|NCT00794560|9724065|FG001|STARTED|Overall Study||36
8800218|NCT01442155|9851916|FG000|COMPLETED|Overall Study||9
8800219|NCT01442155|9851916|FG000|NOT COMPLETED|Overall Study||65
8680179|NCT00794560|9724066|FG002|STARTED|Overall Study||44
8680180|NCT00794560|9724067|FG003|STARTED|Overall Study||38
8680181|NCT00794560|9724064|FG000|COMPLETED|Overall Study||33
8680182|NCT00794560|9724065|FG001|COMPLETED|Overall Study||32
8680183|NCT00794560|9724066|FG002|COMPLETED|Overall Study||40
8680184|NCT00794560|9724067|FG003|COMPLETED|Overall Study||34
8680185|NCT00794560|9724064|FG000|NOT COMPLETED|Overall Study||3
8680186|NCT00794560|9724065|FG001|NOT COMPLETED|Overall Study||4
8680187|NCT00794560|9724066|FG002|NOT COMPLETED|Overall Study||4
8680188|NCT00794560|9724067|FG003|NOT COMPLETED|Overall Study||4
8680189|NCT00794573|9724079|FG000|STARTED|Overall Study||151
8680190|NCT00794573|9724080|FG001|STARTED|Overall Study||151
8680191|NCT00794573|9724079|FG000|COMPLETED|Overall Study||113
8680192|NCT00794573|9724080|FG001|COMPLETED|Overall Study||106
8680193|NCT00794573|9724079|FG000|NOT COMPLETED|Overall Study||38
8680194|NCT00794573|9724080|FG001|NOT COMPLETED|Overall Study||45
8680195|NCT00794664|9724088|FG000|STARTED|Treatment Period||19
8680196|NCT00794664|9724089|FG001|STARTED|Treatment Period||39
8680197|NCT00794664|9724088|FG000|COMPLETED|Treatment Period|3 participants enrolled in open-label extension study NCT00694109|18
8680198|NCT00794664|9724089|FG001|COMPLETED|Treatment Period|6 participants enrolled in open-label extension study NCT00694109|27
8680199|NCT00794664|9724088|FG000|NOT COMPLETED|Treatment Period||1
8680200|NCT00794664|9724089|FG001|NOT COMPLETED|Treatment Period||12
8680201|NCT00794664|9724088|FG000|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|16
8680202|NCT00794664|9724089|FG001|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|33
8680203|NCT00794664|9724088|FG000|COMPLETED|Follow-up Period||15
8680204|NCT00794664|9724089|FG001|COMPLETED|Follow-up Period||28
8680205|NCT00794664|9724088|FG000|NOT COMPLETED|Follow-up Period||1
8680206|NCT00794664|9724089|FG001|NOT COMPLETED|Follow-up Period||5
8680207|NCT00794820|9724095|FG000|STARTED|Overall Study||66
8680208|NCT00794820|9724095|FG000|COMPLETED|Overall Study||50
8680209|NCT00794820|9724095|FG000|NOT COMPLETED|Overall Study||16
8680210|NCT00794950|9724099|FG000|STARTED|BCG Induction||43
8680211|NCT00794950|9724099|FG000|COMPLETED|BCG Induction||36
8680212|NCT00794950|9724099|FG000|NOT COMPLETED|BCG Induction||7
8680213|NCT00794950|9724099|FG000|STARTED|Beginning Sunitinib Treatment||36
8680214|NCT00794950|9724099|FG000|COMPLETED|Beginning Sunitinib Treatment||24
8680215|NCT00794950|9724099|FG000|NOT COMPLETED|Beginning Sunitinib Treatment||12
8680216|NCT00794963|9724106|FG000|STARTED|Overall Study||4
8680217|NCT00794963|9724107|FG001|STARTED|Overall Study||4
8680218|NCT00794963|9724106|FG000|COMPLETED|Overall Study||3
8680219|NCT00794963|9724107|FG001|COMPLETED|Overall Study||0
8680220|NCT00794963|9724106|FG000|NOT COMPLETED|Overall Study||1
8680221|NCT00794963|9724107|FG001|NOT COMPLETED|Overall Study||4
8800220|NCT01442181|9851922|FG000|STARTED|Overall Study||14
8800221|NCT01442181|9851923|FG001|STARTED|Overall Study||11
8800222|NCT01442181|9851922|FG000|COMPLETED|Overall Study||10
8800223|NCT01442181|9851923|FG001|COMPLETED|Overall Study||8
8800224|NCT01442181|9851922|FG000|NOT COMPLETED|Overall Study||4
8800225|NCT01442181|9851923|FG001|NOT COMPLETED|Overall Study||3
8800226|NCT01442376|9851933|FG000|STARTED|Overall Study|Randomized patients|169
8800227|NCT01442376|9851934|FG001|STARTED|Overall Study|Randomized patients|169
8800228|NCT01442376|9851935|FG002|STARTED|Overall Study|Randomized patients|164
8800229|NCT01442376|9851933|FG000|COMPLETED|Overall Study||166
8800230|NCT01442376|9851934|FG001|COMPLETED|Overall Study||160
8800231|NCT01442376|9851935|FG002|COMPLETED|Overall Study||159
8800232|NCT01442376|9851933|FG000|NOT COMPLETED|Overall Study||3
8800233|NCT01442376|9851934|FG001|NOT COMPLETED|Overall Study||9
8800234|NCT01442376|9851935|FG002|NOT COMPLETED|Overall Study||5
8800235|NCT01442493|9851945|FG000|STARTED|Overall Study||149
8800236|NCT01442493|9851946|FG001|STARTED|Overall Study||151
8800237|NCT01442493|9851945|FG000|COMPLETED|Overall Study||146
8800238|NCT01442493|9851946|FG001|COMPLETED|Overall Study||149
8800239|NCT01442493|9851945|FG000|NOT COMPLETED|Overall Study||3
8800240|NCT01442493|9851946|FG001|NOT COMPLETED|Overall Study||2
8800241|NCT01442675|9851952|FG000|STARTED|Overall Study||834
8800242|NCT01442675|9851952|FG000|Safety Analysis Set|Overall Study|Safety Analysis Set are subjects who received study vaccine and for whom safety data were available.|831
8800243|NCT01442675|9851952|FG000|Per-Protocol Analysis Set|Overall Study|The Per-Protocol Analysis Set are subjects with no pre-defined protocol deviations.|781
8800244|NCT01442675|9851952|FG000|COMPLETED|Overall Study||822
8800245|NCT01442675|9851952|FG000|NOT COMPLETED|Overall Study||12
8800246|NCT01442688|9851959|FG000|STARTED|First Intervention||31
8800247|NCT01442688|9851960|FG001|STARTED|First Intervention||31
8800248|NCT01442688|9851959|FG000|COMPLETED|First Intervention||29
8800249|NCT01442688|9851960|FG001|COMPLETED|First Intervention||31
8800250|NCT01442688|9851959|FG000|NOT COMPLETED|First Intervention||2
8800251|NCT01442688|9851960|FG001|NOT COMPLETED|First Intervention||0
8800252|NCT01442688|9851959|FG000|STARTED|Second Intervention||29
8800253|NCT01442688|9851960|FG001|STARTED|Second Intervention||31
8800254|NCT01442688|9851959|FG000|COMPLETED|Second Intervention||28
8800255|NCT01442688|9851960|FG001|COMPLETED|Second Intervention||31
8800256|NCT01442688|9851959|FG000|NOT COMPLETED|Second Intervention||1
8800257|NCT01442688|9851960|FG001|NOT COMPLETED|Second Intervention||0
8800258|NCT01442714|9851966|FG000|STARTED|Overall Study||33
8800259|NCT01442714|9851966|FG000|COMPLETED|Overall Study||21
9035702|NCT03301649|10097417|FG001|NOT COMPLETED|Overall Study||44
8680222|NCT00795002|9724115|FG000|STARTED|Overall Study||37
8680223|NCT00795002|9724116|FG001|STARTED|Overall Study||37
8680224|NCT00795002|9724115|FG000|COMPLETED|Overall Study||37
8680225|NCT00795002|9724116|FG001|COMPLETED|Overall Study||37
8680226|NCT00795002|9724115|FG000|NOT COMPLETED|Overall Study||0
8680227|NCT00795002|9724116|FG001|NOT COMPLETED|Overall Study||0
8680228|NCT00795132|9724122|FG000|STARTED|Overall Study||47
8680229|NCT00795132|9724122|FG000|COMPLETED|Overall Study||44
8680230|NCT00795132|9724122|FG000|NOT COMPLETED|Overall Study||3
8680231|NCT00795145|9724136|FG000|STARTED|Cohort 1||3
8680232|NCT00795145|9724137|FG001|STARTED|Cohort 1||3
8680233|NCT00795145|9724138|FG002|STARTED|Cohort 1||3
8680234|NCT00795145|9724139|FG003|STARTED|Cohort 1||0
8680235|NCT00795145|9724140|FG004|STARTED|Cohort 1||0
8680236|NCT00795145|9724141|FG005|STARTED|Cohort 1||0
8680237|NCT00795145|9724142|FG006|STARTED|Cohort 1||0
8680238|NCT00795145|9724136|FG000|COMPLETED|Cohort 1||3
8680239|NCT00795145|9724137|FG001|COMPLETED|Cohort 1||3
8680240|NCT00795145|9724138|FG002|COMPLETED|Cohort 1||3
8680241|NCT00795145|9724139|FG003|COMPLETED|Cohort 1||0
8680242|NCT00795145|9724140|FG004|COMPLETED|Cohort 1||0
8680243|NCT00795145|9724141|FG005|COMPLETED|Cohort 1||0
8680244|NCT00795145|9724142|FG006|COMPLETED|Cohort 1||0
8680245|NCT00795145|9724136|FG000|NOT COMPLETED|Cohort 1||0
8680246|NCT00795145|9724137|FG001|NOT COMPLETED|Cohort 1||0
8680247|NCT00795145|9724138|FG002|NOT COMPLETED|Cohort 1||0
8680248|NCT00795145|9724139|FG003|NOT COMPLETED|Cohort 1||0
8680249|NCT00795145|9724140|FG004|NOT COMPLETED|Cohort 1||0
8680250|NCT00795145|9724141|FG005|NOT COMPLETED|Cohort 1||0
8680251|NCT00795145|9724142|FG006|NOT COMPLETED|Cohort 1||0
8680252|NCT00795145|9724136|FG000|STARTED|Cohort 2||0
8680253|NCT00795145|9724137|FG001|STARTED|Cohort 2||0
8680254|NCT00795145|9724138|FG002|STARTED|Cohort 2||0
8680255|NCT00795145|9724139|FG003|STARTED|Cohort 2||10
8680256|NCT00795145|9724140|FG004|STARTED|Cohort 2||10
8680257|NCT00795145|9724141|FG005|STARTED|Cohort 2||10
8680258|NCT00795145|9724142|FG006|STARTED|Cohort 2||10
8680259|NCT00795145|9724136|FG000|COMPLETED|Cohort 2||0
8680260|NCT00795145|9724137|FG001|COMPLETED|Cohort 2||0
8680261|NCT00795145|9724138|FG002|COMPLETED|Cohort 2||0
8680262|NCT00795145|9724139|FG003|COMPLETED|Cohort 2||10
8680263|NCT00795145|9724140|FG004|COMPLETED|Cohort 2||10
8680264|NCT00795145|9724141|FG005|COMPLETED|Cohort 2||10
8680265|NCT00795145|9724142|FG006|COMPLETED|Cohort 2||10
8680266|NCT00795145|9724136|FG000|NOT COMPLETED|Cohort 2||0
8680267|NCT00795145|9724137|FG001|NOT COMPLETED|Cohort 2||0
8680268|NCT00795145|9724138|FG002|NOT COMPLETED|Cohort 2||0
8680269|NCT00795145|9724139|FG003|NOT COMPLETED|Cohort 2||0
8680270|NCT00795145|9724140|FG004|NOT COMPLETED|Cohort 2||0
8680271|NCT00795145|9724141|FG005|NOT COMPLETED|Cohort 2||0
8680272|NCT00795145|9724142|FG006|NOT COMPLETED|Cohort 2||0
8680273|NCT00795184|9724169|FG000|STARTED|Overall Study||65
8680274|NCT00795184|9724170|FG001|STARTED|Overall Study||57
8680275|NCT00795184|9724169|FG000|COMPLETED|Overall Study|57 patients analysable, completed all 3 imaging procedures|57
8680276|NCT00795184|9724170|FG001|COMPLETED|Overall Study|44 patients analysable, completed all 3 imaging procedures|44
8680277|NCT00795184|9724169|FG000|NOT COMPLETED|Overall Study||8
8680278|NCT00795184|9724170|FG001|NOT COMPLETED|Overall Study||13
8680279|NCT00795210|9724182|FG000|STARTED|Overall Study||8
8680280|NCT00795210|9724183|FG001|STARTED|Overall Study||12
8680281|NCT00795210|9724184|FG002|STARTED|Overall Study||5
8680282|NCT00795210|9724182|FG000|COMPLETED|Overall Study||8
8680283|NCT00795210|9724183|FG001|COMPLETED|Overall Study||11
8680284|NCT00795210|9724184|FG002|COMPLETED|Overall Study||3
8680285|NCT00795210|9724182|FG000|NOT COMPLETED|Overall Study||0
8680286|NCT00795210|9724183|FG001|NOT COMPLETED|Overall Study||1
8680287|NCT00795210|9724184|FG002|NOT COMPLETED|Overall Study||2
8680288|NCT00795275|9724194|FG000|STARTED|Overall Study||11
8680289|NCT00795275|9724195|FG001|STARTED|Overall Study||15
8680290|NCT00795275|9724194|FG000|COMPLETED|Overall Study||10
8680291|NCT00795275|9724195|FG001|COMPLETED|Overall Study||13
8680292|NCT00795275|9724194|FG000|NOT COMPLETED|Overall Study||1
8680293|NCT00795275|9724195|FG001|NOT COMPLETED|Overall Study||2
8680294|NCT00795288|9724205|FG000|STARTED|Overall Study||21
8680295|NCT00795288|9724206|FG001|STARTED|Overall Study||21
8680296|NCT00795288|9724205|FG000|COMPLETED|Overall Study||21
8680297|NCT00795288|9724206|FG001|COMPLETED|Overall Study||21
8680298|NCT00795288|9724205|FG000|NOT COMPLETED|Overall Study||0
8680299|NCT00795288|9724206|FG001|NOT COMPLETED|Overall Study||0
8680300|NCT00795340|9724216|FG000|STARTED|Overall Study||153
8680301|NCT00795340|9724217|FG001|STARTED|Overall Study||153
8680302|NCT00795340|9724216|FG000|COMPLETED|Overall Study||146
8680303|NCT00795340|9724217|FG001|COMPLETED|Overall Study||153
8680304|NCT00795340|9724216|FG000|NOT COMPLETED|Overall Study||7
8680305|NCT00795340|9724217|FG001|NOT COMPLETED|Overall Study||0
8680306|NCT00795366|9724225|FG000|STARTED|Overall Study||42
8680307|NCT00795366|9724226|FG001|STARTED|Overall Study||54
8680308|NCT00795366|9724225|FG000|COMPLETED|Overall Study||42
8680309|NCT00795366|9724226|FG001|COMPLETED|Overall Study||54
8680310|NCT00795366|9724225|FG000|NOT COMPLETED|Overall Study||0
8680311|NCT00795366|9724226|FG001|NOT COMPLETED|Overall Study||0
8680312|NCT00795509|9724232|FG000|STARTED|Overall Study||374
8680313|NCT00795509|9724232|FG000|COMPLETED|Overall Study||343
8680314|NCT00795509|9724232|FG000|NOT COMPLETED|Overall Study||31
8680315|NCT00795535|9724236|FG000|STARTED|Overall Study||95
8680316|NCT00795535|9724236|FG000|COMPLETED|Overall Study||75
8680317|NCT00795535|9724236|FG000|NOT COMPLETED|Overall Study||20
8680318|NCT00795600|9724242|FG000|STARTED|Overall Study||25
8680319|NCT00795600|9724243|FG001|STARTED|Overall Study||35
8680320|NCT00795600|9724242|FG000|Exposed to Drug|Overall Study|1 patient did not take study medication because the patient withdrew consent|24
8680321|NCT00795600|9724243|FG001|Exposed to Drug|Overall Study||35
8680322|NCT00795600|9724242|FG000|COMPLETED|Overall Study||21
8680323|NCT00795600|9724243|FG001|COMPLETED|Overall Study||31
8680324|NCT00795600|9724242|FG000|NOT COMPLETED|Overall Study||4
8680325|NCT00795600|9724243|FG001|NOT COMPLETED|Overall Study||4
8680326|NCT00795639|9724251|FG000|STARTED|Overall Study||91
8680327|NCT00795639|9724252|FG001|STARTED|Overall Study||92
8680328|NCT00795639|9724251|FG000|Randomized and Not Treated|Overall Study||0
8680329|NCT00795639|9724252|FG001|Randomized and Not Treated|Overall Study||1
8680330|NCT00795639|9724251|FG000|COMPLETED|Overall Study||70
8680331|NCT00795639|9724252|FG001|COMPLETED|Overall Study||66
8680332|NCT00795639|9724251|FG000|NOT COMPLETED|Overall Study||21
8680333|NCT00795639|9724252|FG001|NOT COMPLETED|Overall Study||26
8680334|NCT00795704|9724260|FG000|STARTED|Overall Study||12
8680335|NCT00795704|9724261|FG001|STARTED|Overall Study||12
8680336|NCT00795704|9724260|FG000|COMPLETED|Overall Study||8
8680337|NCT00795704|9724261|FG001|COMPLETED|Overall Study||9
8680338|NCT00795704|9724260|FG000|NOT COMPLETED|Overall Study||4
8680339|NCT00795704|9724261|FG001|NOT COMPLETED|Overall Study||3
8680340|NCT00795717|9724269|FG000|STARTED|Phase I Followed by Wash Out x 4 Weeks|Randomized to treatment first|20
8680341|NCT00795717|9724270|FG001|STARTED|Phase I Followed by Wash Out x 4 Weeks|Randomized to placebo first|21
8680342|NCT00795717|9724269|FG000|COMPLETED|Phase I Followed by Wash Out x 4 Weeks||18
8680343|NCT00795717|9724270|FG001|COMPLETED|Phase I Followed by Wash Out x 4 Weeks||19
8680344|NCT00795717|9724269|FG000|NOT COMPLETED|Phase I Followed by Wash Out x 4 Weeks||2
8680345|NCT00795717|9724270|FG001|NOT COMPLETED|Phase I Followed by Wash Out x 4 Weeks||2
8680346|NCT00795717|9724269|FG000|STARTED|Phase II||18
8680347|NCT00795717|9724270|FG001|STARTED|Phase II||19
8680348|NCT00795717|9724269|FG000|COMPLETED|Phase II||18
8680349|NCT00795717|9724270|FG001|COMPLETED|Phase II||18
8680350|NCT00795717|9724269|FG000|NOT COMPLETED|Phase II||0
8680351|NCT00795717|9724270|FG001|NOT COMPLETED|Phase II||1
8680352|NCT00795769|9724277|FG000|STARTED|Overall Study||49
8680353|NCT00795769|9724277|FG000|COMPLETED|Overall Study||49
8680354|NCT00795769|9724277|FG000|NOT COMPLETED|Overall Study||0
8680355|NCT00795821|9724283|FG000|STARTED|Acute Treatment Phase||250
8680356|NCT00795821|9724284|FG001|STARTED|Acute Treatment Phase||245
8680357|NCT00795821|9724283|FG000|COMPLETED|Acute Treatment Phase|4 LY-treated participants in the Acute Phase chose not to enter the Long-term Extension Phase.|194
8680358|NCT00795821|9724284|FG001|COMPLETED|Acute Treatment Phase|7 placebo-treated participants in the Acute Phase chose not to enter the Long-term Extension Phase.|214
8680359|NCT00795821|9724283|FG000|NOT COMPLETED|Acute Treatment Phase||56
8680360|NCT00795821|9724284|FG001|NOT COMPLETED|Acute Treatment Phase||31
8680361|NCT00795821|9724283|FG000|STARTED|Long-term Extension Phase||190
8680362|NCT00795821|9724284|FG001|STARTED|Long-term Extension Phase|All placebo-treated participants received LY2216684 in the Long-term Extension Phase.|207
8680363|NCT00795821|9724283|FG000|COMPLETED|Long-term Extension Phase||100
8680364|NCT00795821|9724284|FG001|COMPLETED|Long-term Extension Phase||115
8680365|NCT00795821|9724283|FG000|NOT COMPLETED|Long-term Extension Phase||90
8680366|NCT00795821|9724284|FG001|NOT COMPLETED|Long-term Extension Phase||92
8680367|NCT00795821|9724283|FG000|STARTED|Taper Phase|N=240 participants entered Taper Phases: N=4 from Acute Phase; N=236 from Extension Phase.|240
8680368|NCT00795821|9724284|FG001|STARTED|Taper Phase|N=6 participants entered only Acute Taper Phase.|6
8680369|NCT00795821|9724283|FG000|COMPLETED|Taper Phase|N=231 participants completed Taper Phases: N=3 from Acute Phase; N=228 from Extension Phase.|231
8680370|NCT00795821|9724284|FG001|COMPLETED|Taper Phase|N=6 participants completed only Acute Taper Phase; N=0 participants entered Extension Taper Phase.|6
8680371|NCT00795821|9724283|FG000|NOT COMPLETED|Taper Phase||9
8680372|NCT00795821|9724284|FG001|NOT COMPLETED|Taper Phase||0
8680373|NCT00795886|9724300|FG000|STARTED|Overall Study||63
8680374|NCT00795886|9724300|FG000|COMPLETED|Overall Study||53
8680375|NCT00795886|9724300|FG000|NOT COMPLETED|Overall Study||10
8680376|NCT00795951|9724305|FG000|STARTED|Overall Study||102
8680377|NCT00795951|9724305|FG000|COMPLETED|Overall Study||100
8680378|NCT00795951|9724305|FG000|NOT COMPLETED|Overall Study||2
8680379|NCT00796003|9724312|FG000|STARTED|Overall Study|Number of participants enrolled|3
8680380|NCT00796003|9724313|FG001|STARTED|Overall Study|Number of participants enrolled. Includes 6 participants from Phase I (20 mg/m2) group|36
8680381|NCT00796003|9724312|FG000|Treated|Overall Study|Number of participants treated|3
8680382|NCT00796003|9724313|FG001|Treated|Overall Study|Number of participants treated|34
8680383|NCT00796003|9724312|FG000|COMPLETED|Overall Study||0
8680384|NCT00796003|9724313|FG001|COMPLETED|Overall Study|Includes 2 participants from Phase I (20 mg/m2) group|7
8680385|NCT00796003|9724312|FG000|NOT COMPLETED|Overall Study||3
8680386|NCT00796003|9724313|FG001|NOT COMPLETED|Overall Study||29
8680387|NCT00796120|9724324|FG000|STARTED|Overall Study||61
8680388|NCT00796120|9724325|FG001|STARTED|Overall Study||60
8680389|NCT00796120|9724324|FG000|Treated|Overall Study||61
8680390|NCT00796120|9724325|FG001|Treated|Overall Study||57
8680391|NCT00796120|9724324|FG000|COMPLETED|Overall Study||0
8680392|NCT00796120|9724325|FG001|COMPLETED|Overall Study||0
8680393|NCT00796120|9724324|FG000|NOT COMPLETED|Overall Study||61
8680394|NCT00796120|9724325|FG001|NOT COMPLETED|Overall Study||60
8680395|NCT00796224|9724333|FG000|STARTED|Overall Study||19
8680396|NCT00796224|9724334|FG001|STARTED|Overall Study||19
8680397|NCT00796224|9724333|FG000|COMPLETED|Overall Study||18
8680398|NCT00796224|9724334|FG001|COMPLETED|Overall Study||18
8680399|NCT00796224|9724333|FG000|NOT COMPLETED|Overall Study||1
8680400|NCT00796224|9724334|FG001|NOT COMPLETED|Overall Study||1
8680401|NCT00796302|9724344|FG000|STARTED|Overall Study||84
8680402|NCT00796302|9724345|FG001|STARTED|Overall Study||84
8680403|NCT00796302|9724344|FG000|COMPLETED|Overall Study||71
8680404|NCT00796302|9724345|FG001|COMPLETED|Overall Study||66
8680405|NCT00796302|9724344|FG000|NOT COMPLETED|Overall Study||13
8680406|NCT00796302|9724345|FG001|NOT COMPLETED|Overall Study||18
8680407|NCT00796315|9724352|FG000|STARTED|Overall Study||9
8680408|NCT00796315|9724353|FG001|STARTED|Overall Study||17
8680409|NCT00796315|9724354|FG002|STARTED|Overall Study||15
8680410|NCT00796315|9724352|FG000|COMPLETED|Overall Study||9
8680411|NCT00796315|9724353|FG001|COMPLETED|Overall Study||16
8680412|NCT00796315|9724354|FG002|COMPLETED|Overall Study||15
8680413|NCT00796315|9724352|FG000|NOT COMPLETED|Overall Study||0
8680414|NCT00796315|9724353|FG001|NOT COMPLETED|Overall Study||1
8680415|NCT00796315|9724354|FG002|NOT COMPLETED|Overall Study||0
8680416|NCT00796328|9724365|FG000|STARTED|Overall Study||46
8680417|NCT00796328|9724365|FG000|COMPLETED|Overall Study||40
8680418|NCT00796328|9724365|FG000|NOT COMPLETED|Overall Study||6
8680419|NCT00796367|9724372|FG000|STARTED|Overall Study||227
8680420|NCT00796367|9724373|FG001|STARTED|Overall Study|one participant signed ICF but withdrew from study prior to first dosing in OB-305|154
8680421|NCT00796367|9724374|FG002|STARTED|Overall Study||295
8680422|NCT00796367|9724372|FG000|COMPLETED|Overall Study||197
8680423|NCT00796367|9724373|FG001|COMPLETED|Overall Study||129
8680424|NCT00796367|9724374|FG002|COMPLETED|Overall Study||248
8680425|NCT00796367|9724372|FG000|NOT COMPLETED|Overall Study||30
8680426|NCT00796367|9724373|FG001|NOT COMPLETED|Overall Study||25
8680427|NCT00796367|9724374|FG002|NOT COMPLETED|Overall Study||47
8680428|NCT00796419|9724384|FG000|STARTED|Overall Study||13
8680429|NCT00796419|9724385|FG001|STARTED|Overall Study||14
8680430|NCT00796419|9724384|FG000|COMPLETED|Overall Study||13
8680431|NCT00796419|9724385|FG001|COMPLETED|Overall Study||13
8680432|NCT00796419|9724384|FG000|NOT COMPLETED|Overall Study||0
8680433|NCT00796419|9724385|FG001|NOT COMPLETED|Overall Study||1
8680434|NCT00796445|9724393|FG000|STARTED|Overall Study||895
8680435|NCT00796445|9724394|FG001|STARTED|Overall Study||450
8680436|NCT00796445|9724393|FG000|COMPLETED|Overall Study||310
8680437|NCT00796445|9724394|FG001|COMPLETED|Overall Study||158
8680438|NCT00796445|9724393|FG000|NOT COMPLETED|Overall Study||585
8680439|NCT00796445|9724394|FG001|NOT COMPLETED|Overall Study||292
8680440|NCT00796549|9724408|FG000|STARTED|Overall Study|Excluding duplicate records for 5 patients who were screened twice|218
8680441|NCT00796549|9724408|FG000|Entered|Overall Study|entered and treated|69
8680442|NCT00796549|9724408|FG000|COMPLETED|Overall Study||0
8680443|NCT00796549|9724408|FG000|NOT COMPLETED|Overall Study||218
8680444|NCT00796562|9724414|FG000|STARTED|Overall Study||96
8680445|NCT00796562|9724414|FG000|COMPLETED|Overall Study||47
8680446|NCT00796562|9724414|FG000|NOT COMPLETED|Overall Study||49
8680447|NCT00796614|9724422|FG000|STARTED|Overall Study||41
8680448|NCT00796614|9724423|FG001|STARTED|Overall Study||40
8680449|NCT00796614|9724424|FG002|STARTED|Overall Study||39
8680450|NCT00796614|9724425|FG003|STARTED|Overall Study||41
8680451|NCT00796614|9724422|FG000|Not Treated|Overall Study||0
8680452|NCT00796614|9724423|FG001|Not Treated|Overall Study||0
8680453|NCT00796614|9724424|FG002|Not Treated|Overall Study||1
8680454|NCT00796614|9724425|FG003|Not Treated|Overall Study||0
8680455|NCT00796614|9724422|FG000|COMPLETED|Overall Study||36
8680456|NCT00796614|9724423|FG001|COMPLETED|Overall Study||36
8680457|NCT00796614|9724424|FG002|COMPLETED|Overall Study||36
8680458|NCT00796614|9724425|FG003|COMPLETED|Overall Study||40
8680459|NCT00796614|9724422|FG000|NOT COMPLETED|Overall Study||5
8680460|NCT00796614|9724423|FG001|NOT COMPLETED|Overall Study||4
8680461|NCT00796614|9724424|FG002|NOT COMPLETED|Overall Study||3
8680462|NCT00796614|9724425|FG003|NOT COMPLETED|Overall Study||1
8680463|NCT00796627|9724437|FG000|STARTED|Overall Study||10
8680464|NCT00796627|9724438|FG001|STARTED|Overall Study||31
8680465|NCT00796627|9724437|FG000|COMPLETED|Overall Study||10
8680466|NCT00796627|9724438|FG001|COMPLETED|Overall Study||31
8680467|NCT00796627|9724437|FG000|NOT COMPLETED|Overall Study||0
8680468|NCT00796627|9724438|FG001|NOT COMPLETED|Overall Study||0
8680469|NCT00796653|9724448|FG000|STARTED|Overall Study||235
8680470|NCT00796653|9724449|FG001|STARTED|Overall Study||232
8680471|NCT00796653|9724450|FG002|STARTED|Overall Study||234
8680472|NCT00796653|9724451|FG003|STARTED|Overall Study||233
8680473|NCT00796653|9724448|FG000|COMPLETED|Overall Study||184
8680474|NCT00796653|9724449|FG001|COMPLETED|Overall Study||195
8680475|NCT00796653|9724450|FG002|COMPLETED|Overall Study||198
8680476|NCT00796653|9724451|FG003|COMPLETED|Overall Study||193
8680477|NCT00796653|9724448|FG000|NOT COMPLETED|Overall Study||51
8680478|NCT00796653|9724449|FG001|NOT COMPLETED|Overall Study||37
8680479|NCT00796653|9724450|FG002|NOT COMPLETED|Overall Study||36
8680480|NCT00796653|9724451|FG003|NOT COMPLETED|Overall Study||40
8680481|NCT00796666|9724471|FG000|STARTED|Overall Study||67
8680482|NCT00796666|9724472|FG001|STARTED|Overall Study||64
8680483|NCT00796666|9724471|FG000|Treated|Overall Study||66
8680484|NCT00796666|9724472|FG001|Treated|Overall Study||64
8680485|NCT00796666|9724471|FG000|Randomized and Not Treated|Overall Study||1
8680486|NCT00796666|9724472|FG001|Randomized and Not Treated|Overall Study||0
8680487|NCT00796666|9724471|FG000|COMPLETED|Overall Study||0
8680488|NCT00796666|9724472|FG001|COMPLETED|Overall Study||0
8680489|NCT00796666|9724471|FG000|NOT COMPLETED|Overall Study||67
8680490|NCT00796666|9724472|FG001|NOT COMPLETED|Overall Study||64
8680491|NCT00796705|9724482|FG000|STARTED|Overall Study||3
8680492|NCT00796705|9724483|FG001|STARTED|Overall Study||4
8800260|NCT01442714|9851966|FG000|NOT COMPLETED|Overall Study||12
8800261|NCT01442779|9851972|FG000|STARTED|Overall Study||18
8800262|NCT01442779|9851972|FG000|COMPLETED|Overall Study||11
8800263|NCT01442779|9851972|FG000|NOT COMPLETED|Overall Study||7
8800264|NCT01442844|9851978|FG000|STARTED|Overall Study||1
8800265|NCT01442844|9851979|FG001|STARTED|Overall Study||2
8800266|NCT01442844|9851978|FG000|COMPLETED|Overall Study||1
8800267|NCT01442844|9851979|FG001|COMPLETED|Overall Study||2
8800268|NCT01442844|9851978|FG000|NOT COMPLETED|Overall Study||0
8800269|NCT01442844|9851979|FG001|NOT COMPLETED|Overall Study||0
8800270|NCT01443026|9851987|FG000|STARTED|Overall Study||29
8800271|NCT01443026|9851988|FG001|STARTED|Overall Study||37
8800272|NCT01443026|9851987|FG000|COMPLETED|Overall Study||26
8800273|NCT01443026|9851988|FG001|COMPLETED|Overall Study||32
8800274|NCT01443026|9851987|FG000|NOT COMPLETED|Overall Study||3
8800275|NCT01443026|9851988|FG001|NOT COMPLETED|Overall Study||5
8800276|NCT01443078|9851994|FG000|STARTED|Overall Study||42
8800277|NCT01443078|9851994|FG000|COMPLETED|Overall Study||13
8800278|NCT01443078|9851994|FG000|NOT COMPLETED|Overall Study||29
8800279|NCT01443130|9852004|FG000|STARTED|Overall Study||300
8800280|NCT01443130|9852005|FG001|STARTED|Overall Study||300
8800281|NCT01443130|9852006|FG002|STARTED|Overall Study||300
8800282|NCT01443130|9852007|FG003|STARTED|Overall Study||270
8800283|NCT01443130|9852008|FG004|STARTED|Overall Study||274
8800284|NCT01443130|9852009|FG005|STARTED|Overall Study||259
8800285|NCT01443130|9852004|FG000|COMPLETED|Overall Study||232
8800286|NCT01443130|9852005|FG001|COMPLETED|Overall Study||231
8800287|NCT01443130|9852006|FG002|COMPLETED|Overall Study||223
8800288|NCT01443130|9852007|FG003|COMPLETED|Overall Study||231
8800289|NCT01443130|9852008|FG004|COMPLETED|Overall Study||230
8800290|NCT01443130|9852009|FG005|COMPLETED|Overall Study||225
8800291|NCT01443130|9852004|FG000|NOT COMPLETED|Overall Study||68
8800292|NCT01443130|9852005|FG001|NOT COMPLETED|Overall Study||69
8800293|NCT01443130|9852006|FG002|NOT COMPLETED|Overall Study||77
8800294|NCT01443130|9852007|FG003|NOT COMPLETED|Overall Study||39
8800295|NCT01443130|9852008|FG004|NOT COMPLETED|Overall Study||44
8800296|NCT01443130|9852009|FG005|NOT COMPLETED|Overall Study||34
8800297|NCT01443364|9852023|FG000|STARTED|Overall Study||132
8800298|NCT01443364|9852023|FG000|COMPLETED|Overall Study||91
8800299|NCT01443364|9852023|FG000|NOT COMPLETED|Overall Study||41
8800300|NCT01443403|9852031|FG000|STARTED|Overall Study||61
8800301|NCT01443403|9852032|FG001|STARTED|Overall Study||61
8800302|NCT01443403|9852033|FG002|STARTED|Overall Study||61
8800303|NCT01443403|9852034|FG003|STARTED|Overall Study||61
8919220|NCT02206620|9979201|FG000|COMPLETED|Phase II - Second Intervention (6 Weeks)||21
8919221|NCT02206620|9979202|FG001|COMPLETED|Phase II - Second Intervention (6 Weeks)||24
8919222|NCT02206620|9979201|FG000|NOT COMPLETED|Phase II - Second Intervention (6 Weeks)||0
8919223|NCT02206620|9979202|FG001|NOT COMPLETED|Phase II - Second Intervention (6 Weeks)||2
8919224|NCT02206685|9979216|FG000|STARTED|Overall Study||37
8919225|NCT02206685|9979217|FG001|STARTED|Overall Study||37
8919226|NCT02206685|9979216|FG000|COMPLETED|Overall Study||32
8919227|NCT02206685|9979217|FG001|COMPLETED|Overall Study||30
8919228|NCT02206685|9979216|FG000|NOT COMPLETED|Overall Study||5
8919229|NCT02206685|9979217|FG001|NOT COMPLETED|Overall Study||7
8919230|NCT02206776|9979225|FG000|STARTED|Overall Study||1
8919231|NCT02206776|9979226|FG001|STARTED|Overall Study||1
8919232|NCT02206776|9979225|FG000|COMPLETED|Overall Study||1
8919233|NCT02206776|9979226|FG001|COMPLETED|Overall Study||1
8919234|NCT02206776|9979225|FG000|NOT COMPLETED|Overall Study||0
8919235|NCT02206776|9979226|FG001|NOT COMPLETED|Overall Study||0
8919236|NCT02206828|9979232|FG000|STARTED|Overall Study||100
8919237|NCT02206828|9979232|FG000|COMPLETED|Overall Study||93
8919238|NCT02206828|9979232|FG000|NOT COMPLETED|Overall Study||7
8919239|NCT02207088|9979259|FG000|STARTED|Overall Study||68
8919240|NCT02207088|9979259|FG000|COMPLETED|Overall Study||66
8919241|NCT02207088|9979259|FG000|NOT COMPLETED|Overall Study||2
8919242|NCT02207231|9979266|FG000|STARTED|Placebo Controlled Period: Week 0 - 16||174
8919243|NCT02207231|9979267|FG001|STARTED|Placebo Controlled Period: Week 0 - 16||329
8919244|NCT02207231|9979268|FG002|STARTED|Placebo Controlled Period: Week 0 - 16||334
8800304|NCT01443403|9852031|FG000|Received Treatment|Overall Study||61
8800305|NCT01443403|9852032|FG001|Received Treatment|Overall Study||61
8800306|NCT01443403|9852033|FG002|Received Treatment|Overall Study||60
8800307|NCT01443403|9852034|FG003|Received Treatment|Overall Study||61
8800308|NCT01443403|9852031|FG000|COMPLETED|Overall Study||55
8800309|NCT01443403|9852032|FG001|COMPLETED|Overall Study||55
8919245|NCT02207231|9979269|FG003|STARTED|Placebo Controlled Period: Week 0 - 16||0
8919246|NCT02207231|9979266|FG000|Treated|Placebo Controlled Period: Week 0 - 16||174
8919247|NCT02207231|9979267|FG001|Treated|Placebo Controlled Period: Week 0 - 16||329
8919248|NCT02207231|9979268|FG002|Treated|Placebo Controlled Period: Week 0 - 16||333
8919249|NCT02207231|9979269|FG003|Treated|Placebo Controlled Period: Week 0 - 16||0
8800310|NCT01443403|9852033|FG002|COMPLETED|Overall Study||54
8800311|NCT01443403|9852034|FG003|COMPLETED|Overall Study||52
8800312|NCT01443403|9852031|FG000|NOT COMPLETED|Overall Study||6
8800313|NCT01443403|9852032|FG001|NOT COMPLETED|Overall Study||6
8680493|NCT00796705|9724484|FG002|STARTED|Overall Study||4
8680494|NCT00796705|9724485|FG003|STARTED|Overall Study||2
8680495|NCT00796705|9724482|FG000|COMPLETED|Overall Study||3
8680496|NCT00796705|9724483|FG001|COMPLETED|Overall Study||4
8680497|NCT00796705|9724484|FG002|COMPLETED|Overall Study||4
8680498|NCT00796705|9724485|FG003|COMPLETED|Overall Study||2
8680499|NCT00796705|9724482|FG000|NOT COMPLETED|Overall Study||0
8680500|NCT00796705|9724483|FG001|NOT COMPLETED|Overall Study||0
8680501|NCT00796705|9724484|FG002|NOT COMPLETED|Overall Study||0
8680502|NCT00796705|9724485|FG003|NOT COMPLETED|Overall Study||0
8680503|NCT00796718|9724497|FG000|STARTED|Overall Study||62
8680504|NCT00796718|9724497|FG000|COMPLETED|Overall Study||53
8680505|NCT00796718|9724497|FG000|NOT COMPLETED|Overall Study||9
8680506|NCT00796744|9724504|FG000|STARTED|Overall Study||24
8680507|NCT00796744|9724505|FG001|STARTED|Overall Study||26
8680508|NCT00796744|9724506|FG002|STARTED|Overall Study||28
8680509|NCT00796744|9724504|FG000|COMPLETED|Overall Study||24
8680510|NCT00796744|9724505|FG001|COMPLETED|Overall Study||26
8680511|NCT00796744|9724506|FG002|COMPLETED|Overall Study||27
8680512|NCT00796744|9724504|FG000|NOT COMPLETED|Overall Study||0
8680513|NCT00796744|9724505|FG001|NOT COMPLETED|Overall Study||0
8680514|NCT00796744|9724506|FG002|NOT COMPLETED|Overall Study||1
8680515|NCT00796757|9724516|FG000|STARTED|Overall Study||146
8680516|NCT00796757|9724516|FG000|COMPLETED|Overall Study||60
8680517|NCT00796757|9724516|FG000|NOT COMPLETED|Overall Study||86
8680518|NCT00796822|9724522|FG000|STARTED|Overall Study||13
8680519|NCT00796822|9724523|FG001|STARTED|Overall Study||13
8680520|NCT00796822|9724522|FG000|COMPLETED|Overall Study||10
8680521|NCT00796822|9724523|FG001|COMPLETED|Overall Study||13
8680522|NCT00796822|9724522|FG000|NOT COMPLETED|Overall Study||3
8680523|NCT00796822|9724523|FG001|NOT COMPLETED|Overall Study||0
8680524|NCT00796926|9724531|FG000|STARTED|Overall Study||15
8680525|NCT00796926|9724532|FG001|STARTED|Overall Study||15
8680526|NCT00796926|9724531|FG000|COMPLETED|Overall Study||14
8680527|NCT00796926|9724532|FG001|COMPLETED|Overall Study||15
8680528|NCT00796926|9724531|FG000|NOT COMPLETED|Overall Study||1
8680529|NCT00796926|9724532|FG001|NOT COMPLETED|Overall Study||0
8680530|NCT00796978|9724538|FG000|STARTED|Overall Study||56
8680531|NCT00796978|9724538|FG000|COMPLETED|Overall Study||44
8680532|NCT00796978|9724538|FG000|NOT COMPLETED|Overall Study||12
8680533|NCT00796991|9724545|FG000|STARTED|Overall Study||20
8680534|NCT00796991|9724546|FG001|STARTED|Overall Study||19
8680535|NCT00796991|9724547|FG002|STARTED|Overall Study||20
8680536|NCT00796991|9724545|FG000|COMPLETED|Overall Study|Participants continued treatment into maintenance phase.|5
8680537|NCT00796991|9724546|FG001|COMPLETED|Overall Study|Participants continued treatment into maintenance phase.|7
8680538|NCT00796991|9724547|FG002|COMPLETED|Overall Study|Participants continued treatment into maintenance phase.|6
8680539|NCT00796991|9724545|FG000|NOT COMPLETED|Overall Study||15
8680540|NCT00796991|9724546|FG001|NOT COMPLETED|Overall Study||12
8680541|NCT00796991|9724547|FG002|NOT COMPLETED|Overall Study||14
8680542|NCT00797108|9724558|FG000|STARTED|Overall Study||12
8680543|NCT00797108|9724559|FG001|STARTED|Overall Study||11
8680544|NCT00797108|9724560|FG002|STARTED|Overall Study||12
8680545|NCT00797108|9724558|FG000|Treated|Overall Study||10
8680546|NCT00797108|9724559|FG001|Treated|Overall Study||11
8680547|NCT00797108|9724560|FG002|Treated|Overall Study||12
8680548|NCT00797108|9724558|FG000|COMPLETED|Overall Study||8
8680549|NCT00797108|9724559|FG001|COMPLETED|Overall Study||9
8680550|NCT00797108|9724560|FG002|COMPLETED|Overall Study||6
8680551|NCT00797108|9724558|FG000|NOT COMPLETED|Overall Study||4
8680552|NCT00797108|9724559|FG001|NOT COMPLETED|Overall Study||2
8680553|NCT00797108|9724560|FG002|NOT COMPLETED|Overall Study||6
8680554|NCT00797212|9724568|FG000|STARTED|Overall Study||50
8680555|NCT00797212|9724568|FG000|COMPLETED|Overall Study||50
8680556|NCT00797212|9724568|FG000|NOT COMPLETED|Overall Study||0
8680557|NCT00797225|9724576|FG000|STARTED|Weeks 1 to 12||43
8680558|NCT00797225|9724577|FG001|STARTED|Weeks 1 to 12||43
8680559|NCT00797225|9724578|FG002|STARTED|Weeks 1 to 12||44
8680560|NCT00797225|9724579|FG003|STARTED|Weeks 1 to 12||44
8680561|NCT00797225|9724580|FG004|STARTED|Weeks 1 to 12||0
8680562|NCT00797225|9724581|FG005|STARTED|Weeks 1 to 12||0
8680563|NCT00797225|9724582|FG006|STARTED|Weeks 1 to 12||0
8680564|NCT00797225|9724583|FG007|STARTED|Weeks 1 to 12||0
8680565|NCT00797225|9724576|FG000|Received Study Drug|Weeks 1 to 12||43
8680566|NCT00797225|9724577|FG001|Received Study Drug|Weeks 1 to 12||43
8680567|NCT00797225|9724578|FG002|Received Study Drug|Weeks 1 to 12||44
8680568|NCT00797225|9724579|FG003|Received Study Drug|Weeks 1 to 12||44
8680569|NCT00797225|9724580|FG004|Received Study Drug|Weeks 1 to 12||0
8680570|NCT00797225|9724581|FG005|Received Study Drug|Weeks 1 to 12||0
8680571|NCT00797225|9724582|FG006|Received Study Drug|Weeks 1 to 12||0
8680572|NCT00797225|9724583|FG007|Received Study Drug|Weeks 1 to 12||0
8680573|NCT00797225|9724576|FG000|COMPLETED|Weeks 1 to 12||41
8680574|NCT00797225|9724577|FG001|COMPLETED|Weeks 1 to 12||42
8680575|NCT00797225|9724578|FG002|COMPLETED|Weeks 1 to 12||43
8680576|NCT00797225|9724579|FG003|COMPLETED|Weeks 1 to 12||44
8680577|NCT00797225|9724580|FG004|COMPLETED|Weeks 1 to 12||0
8680578|NCT00797225|9724581|FG005|COMPLETED|Weeks 1 to 12||0
8680579|NCT00797225|9724582|FG006|COMPLETED|Weeks 1 to 12||0
8680580|NCT00797225|9724583|FG007|COMPLETED|Weeks 1 to 12||0
8680581|NCT00797225|9724576|FG000|NOT COMPLETED|Weeks 1 to 12||2
8680582|NCT00797225|9724577|FG001|NOT COMPLETED|Weeks 1 to 12||1
8680583|NCT00797225|9724578|FG002|NOT COMPLETED|Weeks 1 to 12||1
8680584|NCT00797225|9724579|FG003|NOT COMPLETED|Weeks 1 to 12||0
8680585|NCT00797225|9724580|FG004|NOT COMPLETED|Weeks 1 to 12||0
8680586|NCT00797225|9724581|FG005|NOT COMPLETED|Weeks 1 to 12||0
8680587|NCT00797225|9724582|FG006|NOT COMPLETED|Weeks 1 to 12||0
8680588|NCT00797225|9724583|FG007|NOT COMPLETED|Weeks 1 to 12||0
8680589|NCT00797225|9724576|FG000|STARTED|Weeks 13 to 24||0
8680590|NCT00797225|9724577|FG001|STARTED|Weeks 13 to 24||42
8680591|NCT00797225|9724578|FG002|STARTED|Weeks 13 to 24||43
8680592|NCT00797225|9724579|FG003|STARTED|Weeks 13 to 24||0
8680593|NCT00797225|9724580|FG004|STARTED|Weeks 13 to 24||20
8680594|NCT00797225|9724581|FG005|STARTED|Weeks 13 to 24||21
8680595|NCT00797225|9724582|FG006|STARTED|Weeks 13 to 24||22
8680596|NCT00797225|9724583|FG007|STARTED|Weeks 13 to 24||22
8680597|NCT00797225|9724576|FG000|COMPLETED|Weeks 13 to 24||0
8680598|NCT00797225|9724577|FG001|COMPLETED|Weeks 13 to 24||38
8800314|NCT01443403|9852033|FG002|NOT COMPLETED|Overall Study||7
8800315|NCT01443403|9852034|FG003|NOT COMPLETED|Overall Study||9
8800316|NCT01443442|9852049|FG000|STARTED|Overall Study||12
8800317|NCT01443442|9852050|FG001|STARTED|Overall Study||11
8800318|NCT01443442|9852049|FG000|COMPLETED|Overall Study||12
8800319|NCT01443442|9852050|FG001|COMPLETED|Overall Study||11
8800320|NCT01443442|9852049|FG000|NOT COMPLETED|Overall Study||0
8800321|NCT01443442|9852050|FG001|NOT COMPLETED|Overall Study||0
8800322|NCT01443494|9852056|FG000|STARTED|Overall Study||19
8800323|NCT01443494|9852056|FG000|COMPLETED|Overall Study||19
8800324|NCT01443494|9852056|FG000|NOT COMPLETED|Overall Study||0
8800325|NCT01443546|9852063|FG000|STARTED|Overall Study||9
8800326|NCT01443546|9852064|FG001|STARTED|Overall Study||9
8800327|NCT01443546|9852065|FG002|STARTED|Overall Study||8
8800328|NCT01443546|9852063|FG000|COMPLETED|Overall Study||9
8800329|NCT01443546|9852064|FG001|COMPLETED|Overall Study||9
8800330|NCT01443546|9852065|FG002|COMPLETED|Overall Study||8
8800331|NCT01443546|9852063|FG000|NOT COMPLETED|Overall Study||0
8800332|NCT01443546|9852064|FG001|NOT COMPLETED|Overall Study||0
8800333|NCT01443546|9852065|FG002|NOT COMPLETED|Overall Study||0
8800334|NCT01443845|9852077|FG000|STARTED|Overall Study||1176
8800335|NCT01443845|9852078|FG001|STARTED|Overall Study||1178
8800336|NCT01443845|9852077|FG000|COMPLETED|Overall Study||922
8800337|NCT01443845|9852078|FG001|COMPLETED|Overall Study||841
8800338|NCT01443845|9852077|FG000|NOT COMPLETED|Overall Study||254
8800339|NCT01443845|9852078|FG001|NOT COMPLETED|Overall Study||337
8800340|NCT01443858|9852087|FG000|STARTED|Overall Study||25
8800341|NCT01443858|9852088|FG001|STARTED|Overall Study||25
8800342|NCT01443858|9852089|FG002|STARTED|Overall Study||25
8800343|NCT01443858|9852087|FG000|COMPLETED|Overall Study||10
8800344|NCT01443858|9852088|FG001|COMPLETED|Overall Study||12
8800345|NCT01443858|9852089|FG002|COMPLETED|Overall Study||18
8800346|NCT01443858|9852087|FG000|NOT COMPLETED|Overall Study||15
8800347|NCT01443858|9852088|FG001|NOT COMPLETED|Overall Study||13
8800348|NCT01443858|9852089|FG002|NOT COMPLETED|Overall Study||7
8800349|NCT01444027|9852100|FG000|STARTED|Overall Study||172
8800350|NCT01444027|9852101|FG001|STARTED|Overall Study||171
8800351|NCT01444027|9852102|FG002|STARTED|Overall Study||171
8800352|NCT01444027|9852100|FG000|Received Intervention as Assigned|Overall Study||168
8800353|NCT01444027|9852101|FG001|Received Intervention as Assigned|Overall Study||161
8800354|NCT01444027|9852102|FG002|Received Intervention as Assigned|Overall Study||147
8800355|NCT01444027|9852100|FG000|1 Month Follow-up|Overall Study||160
8800356|NCT01444027|9852101|FG001|1 Month Follow-up|Overall Study||159
8800357|NCT01444027|9852102|FG002|1 Month Follow-up|Overall Study||141
8800358|NCT01444027|9852100|FG000|3 Month Follow-up|Overall Study||142
8800359|NCT01444027|9852101|FG001|3 Month Follow-up|Overall Study||141
8800360|NCT01444027|9852102|FG002|3 Month Follow-up|Overall Study||133
8800361|NCT01444027|9852100|FG000|COMPLETED|Overall Study||142
8800362|NCT01444027|9852101|FG001|COMPLETED|Overall Study||141
8800363|NCT01444027|9852102|FG002|COMPLETED|Overall Study||133
8800364|NCT01444027|9852100|FG000|NOT COMPLETED|Overall Study||30
8800365|NCT01444027|9852101|FG001|NOT COMPLETED|Overall Study||30
8800366|NCT01444027|9852102|FG002|NOT COMPLETED|Overall Study||38
8800367|NCT01444287|9852110|FG000|STARTED|Period 1||22
8800368|NCT01444287|9852110|FG000|COMPLETED|Period 1||22
8800369|NCT01444287|9852110|FG000|NOT COMPLETED|Period 1||0
8800370|NCT01444287|9852110|FG000|STARTED|Period 2||22
8800371|NCT01444287|9852110|FG000|COMPLETED|Period 2||22
8800372|NCT01444287|9852110|FG000|NOT COMPLETED|Period 2||0
8800373|NCT01444287|9852110|FG000|STARTED|Period 3||22
8800374|NCT01444287|9852110|FG000|COMPLETED|Period 3||22
8800375|NCT01444287|9852110|FG000|NOT COMPLETED|Period 3||0
8800376|NCT01444287|9852110|FG000|STARTED|Period 4||22
8800377|NCT01444287|9852110|FG000|COMPLETED|Period 4||22
8800378|NCT01444287|9852110|FG000|NOT COMPLETED|Period 4||0
8800379|NCT01444300|9852126|FG000|STARTED|Overall Study||12
8800380|NCT01444300|9852127|FG001|STARTED|Overall Study||12
8800381|NCT01444300|9852126|FG000|COMPLETED|Overall Study||8
8800382|NCT01444300|9852127|FG001|COMPLETED|Overall Study||12
8800383|NCT01444300|9852126|FG000|NOT COMPLETED|Overall Study||4
8800384|NCT01444300|9852127|FG001|NOT COMPLETED|Overall Study||0
8800385|NCT01444378|9852134|FG000|STARTED|Overall Study|A total of 141 patients were enrolled into MOMENTUM|141
8800386|NCT01444378|9852134|FG000|COMPLETED|Overall Study||124
8800387|NCT01444378|9852134|FG000|NOT COMPLETED|Overall Study||17
8800388|NCT01444391|9852141|FG000|STARTED|Overall Study||42
8800389|NCT01444391|9852141|FG000|COMPLETED|Overall Study||41
8800390|NCT01444391|9852141|FG000|NOT COMPLETED|Overall Study||1
8800391|NCT01444417|9852147|FG000|STARTED|Overall Study||20
8680599|NCT00797225|9724578|FG002|COMPLETED|Weeks 13 to 24||41
8680600|NCT00797225|9724579|FG003|COMPLETED|Weeks 13 to 24||0
8680601|NCT00797225|9724580|FG004|COMPLETED|Weeks 13 to 24||19
8680602|NCT00797225|9724581|FG005|COMPLETED|Weeks 13 to 24||21
8680603|NCT00797225|9724582|FG006|COMPLETED|Weeks 13 to 24||20
8680604|NCT00797225|9724583|FG007|COMPLETED|Weeks 13 to 24||22
8680605|NCT00797225|9724576|FG000|NOT COMPLETED|Weeks 13 to 24||0
8680606|NCT00797225|9724577|FG001|NOT COMPLETED|Weeks 13 to 24||4
8680607|NCT00797225|9724578|FG002|NOT COMPLETED|Weeks 13 to 24||2
8680608|NCT00797225|9724579|FG003|NOT COMPLETED|Weeks 13 to 24||0
8680609|NCT00797225|9724580|FG004|NOT COMPLETED|Weeks 13 to 24||1
8680610|NCT00797225|9724581|FG005|NOT COMPLETED|Weeks 13 to 24||0
8680611|NCT00797225|9724582|FG006|NOT COMPLETED|Weeks 13 to 24||2
8680612|NCT00797225|9724583|FG007|NOT COMPLETED|Weeks 13 to 24||0
8680613|NCT00797277|9724601|FG000|STARTED|Overall Study||37
8680614|NCT00797277|9724602|FG001|STARTED|Overall Study||30
8680615|NCT00797277|9724601|FG000|COMPLETED|Overall Study||37
8680616|NCT00797277|9724602|FG001|COMPLETED|Overall Study||30
8680617|NCT00797277|9724601|FG000|NOT COMPLETED|Overall Study||0
8680618|NCT00797277|9724602|FG001|NOT COMPLETED|Overall Study||0
8680619|NCT00797316|9724611|FG000|STARTED|Overall Study||267
8680620|NCT00797316|9724612|FG001|STARTED|Overall Study||265
8680621|NCT00797316|9724611|FG000|COMPLETED|Overall Study||244
8680622|NCT00797316|9724612|FG001|COMPLETED|Overall Study||233
8680623|NCT00797316|9724611|FG000|NOT COMPLETED|Overall Study||23
8680624|NCT00797316|9724612|FG001|NOT COMPLETED|Overall Study||32
8680625|NCT00797459|9724618|FG000|STARTED|Overall Study||60
8680626|NCT00797459|9724618|FG000|COMPLETED|Overall Study||60
8680627|NCT00797459|9724618|FG000|NOT COMPLETED|Overall Study||0
8680628|NCT00797511|9724626|FG000|STARTED|Overall Study||132
8680629|NCT00797511|9724626|FG000|COMPLETED|Overall Study||131
8680630|NCT00797511|9724626|FG000|NOT COMPLETED|Overall Study||1
8680631|NCT00797563|9724631|FG000|STARTED|Overall Study|number of subjects|102
8680632|NCT00797563|9724631|FG000|COMPLETED|Overall Study||101
8680633|NCT00797563|9724631|FG000|NOT COMPLETED|Overall Study||1
8680634|NCT00797667|9724638|FG000|STARTED|Overall Study||265
8680635|NCT00797667|9724639|FG001|STARTED|Overall Study||264
8680636|NCT00797667|9724640|FG002|STARTED|Overall Study||131
8680637|NCT00797667|9724638|FG000|Treated|Overall Study||263
8680638|NCT00797667|9724639|FG001|Treated|Overall Study||263
8680639|NCT00797667|9724640|FG002|Treated|Overall Study||130
8680640|NCT00797667|9724638|FG000|COMPLETED|Overall Study||5
8680641|NCT00797667|9724639|FG001|COMPLETED|Overall Study||5
8680642|NCT00797667|9724640|FG002|COMPLETED|Overall Study||4
8680643|NCT00797667|9724638|FG000|NOT COMPLETED|Overall Study||260
8680644|NCT00797667|9724639|FG001|NOT COMPLETED|Overall Study||259
8680645|NCT00797667|9724640|FG002|NOT COMPLETED|Overall Study||127
8680646|NCT00797732|9724650|FG000|STARTED|Overall Study||21
8680647|NCT00797732|9724651|FG001|STARTED|Overall Study||21
8680648|NCT00797732|9724652|FG002|STARTED|Overall Study||154
8680649|NCT00797732|9724650|FG000|Evaluable at Baseline|Overall Study||18
8680650|NCT00797732|9724651|FG001|Evaluable at Baseline|Overall Study||18
8680651|NCT00797732|9724652|FG002|Evaluable at Baseline|Overall Study||0
8680652|NCT00797732|9724650|FG000|Evaluable at 20 Weeks|Overall Study||17
8680653|NCT00797732|9724651|FG001|Evaluable at 20 Weeks|Overall Study||18
8680654|NCT00797732|9724652|FG002|Evaluable at 20 Weeks|Overall Study||0
8680655|NCT00797732|9724650|FG000|Evaluable at 12 Months|Overall Study||17
8680656|NCT00797732|9724651|FG001|Evaluable at 12 Months|Overall Study||18
8680657|NCT00797732|9724652|FG002|Evaluable at 12 Months|Overall Study||0
8680658|NCT00797732|9724650|FG000|COMPLETED|Overall Study||16
8680659|NCT00797732|9724651|FG001|COMPLETED|Overall Study||18
8680660|NCT00797732|9724652|FG002|COMPLETED|Overall Study||0
8680661|NCT00797732|9724650|FG000|NOT COMPLETED|Overall Study||5
8680662|NCT00797732|9724651|FG001|NOT COMPLETED|Overall Study||3
8680663|NCT00797732|9724652|FG002|NOT COMPLETED|Overall Study||154
8680664|NCT00797797|9724660|FG000|STARTED|Overall Study|Two patients took no background stable dose of pregabalin after randomization and are not included.|178
8680665|NCT00797797|9724661|FG001|STARTED|Overall Study||184
8680666|NCT00797797|9724660|FG000|COMPLETED|Overall Study||123
8680667|NCT00797797|9724661|FG001|COMPLETED|Overall Study||141
8680668|NCT00797797|9724660|FG000|NOT COMPLETED|Overall Study||55
8680669|NCT00797797|9724661|FG001|NOT COMPLETED|Overall Study||43
8680670|NCT00797823|9724670|FG000|STARTED|Pilot Studies|Not involved in pilot studies|0
8680671|NCT00797823|9724671|FG001|STARTED|Pilot Studies|Not involved in pilot studies|0
8680672|NCT00797823|9724672|FG002|STARTED|Pilot Studies||6
8680673|NCT00797823|9724670|FG000|COMPLETED|Pilot Studies||0
8680674|NCT00797823|9724671|FG001|COMPLETED|Pilot Studies||0
8680675|NCT00797823|9724672|FG002|COMPLETED|Pilot Studies||6
8680676|NCT00797823|9724670|FG000|NOT COMPLETED|Pilot Studies||0
8680677|NCT00797823|9724671|FG001|NOT COMPLETED|Pilot Studies||0
8680678|NCT00797823|9724672|FG002|NOT COMPLETED|Pilot Studies||0
8680679|NCT00797823|9724670|FG000|STARTED|First Period (Initial Randomization)||4
8680680|NCT00797823|9724671|FG001|STARTED|First Period (Initial Randomization)||4
8680681|NCT00797823|9724672|FG002|STARTED|First Period (Initial Randomization)|Pilot studies only performed during initial period.|0
8680682|NCT00797823|9724670|FG000|COMPLETED|First Period (Initial Randomization)||3
8680683|NCT00797823|9724671|FG001|COMPLETED|First Period (Initial Randomization)||4
8680684|NCT00797823|9724672|FG002|COMPLETED|First Period (Initial Randomization)||0
8680685|NCT00797823|9724670|FG000|NOT COMPLETED|First Period (Initial Randomization)||1
8680686|NCT00797823|9724671|FG001|NOT COMPLETED|First Period (Initial Randomization)||0
8680687|NCT00797823|9724672|FG002|NOT COMPLETED|First Period (Initial Randomization)||0
8680688|NCT00797823|9724670|FG000|STARTED|Second Period (Crossover)||3
8680689|NCT00797823|9724671|FG001|STARTED|Second Period (Crossover)||4
8680690|NCT00797823|9724672|FG002|STARTED|Second Period (Crossover)||0
8680691|NCT00797823|9724670|FG000|COMPLETED|Second Period (Crossover)||3
8680692|NCT00797823|9724671|FG001|COMPLETED|Second Period (Crossover)||4
8680693|NCT00797823|9724672|FG002|COMPLETED|Second Period (Crossover)||0
8680694|NCT00797823|9724670|FG000|NOT COMPLETED|Second Period (Crossover)||0
8680695|NCT00797823|9724671|FG001|NOT COMPLETED|Second Period (Crossover)||0
8680696|NCT00797823|9724672|FG002|NOT COMPLETED|Second Period (Crossover)||0
8680697|NCT00797862|9724682|FG000|STARTED|Overall Study|3 participants were mis-randomized and discontinued. Only 617 participants received study drug.|620
8680698|NCT00797862|9724683|FG001|STARTED|Overall Study|3 participants were mis-randomized and discontinued. Only 315 participants received study drug.|318
8680699|NCT00797862|9724684|FG002|STARTED|Overall Study|1 participant was mis-randomized and discontinued. Only 315 participants received study drug.|316
8680700|NCT00797862|9724682|FG000|Entered Double-Blind Treatment (FAS)|Overall Study||617
8680701|NCT00797862|9724683|FG001|Entered Double-Blind Treatment (FAS)|Overall Study||315
8680702|NCT00797862|9724684|FG002|Entered Double-Blind Treatment (FAS)|Overall Study||315
8680703|NCT00797862|9724682|FG000|COMPLETED|Overall Study||496
8680704|NCT00797862|9724683|FG001|COMPLETED|Overall Study||250
8680705|NCT00797862|9724684|FG002|COMPLETED|Overall Study||230
8680706|NCT00797862|9724682|FG000|NOT COMPLETED|Overall Study||124
8680707|NCT00797862|9724683|FG001|NOT COMPLETED|Overall Study||68
8680708|NCT00797862|9724684|FG002|NOT COMPLETED|Overall Study||86
8680709|NCT00797966|9724696|FG000|STARTED|Phase A||0
8680710|NCT00797966|9724697|FG001|STARTED|Phase A||0
8680711|NCT00797966|9724698|FG002|STARTED|Phase A||0
8680712|NCT00797966|9724699|FG003|STARTED|Phase A||0
8680713|NCT00797966|9724700|FG004|STARTED|Phase A|850 participants entered Phase A; 849 participants were treated.|849
8680714|NCT00797966|9724701|FG005|STARTED|Phase A||0
8680715|NCT00797966|9724696|FG000|COMPLETED|Phase A||0
8680716|NCT00797966|9724697|FG001|COMPLETED|Phase A||0
8680717|NCT00797966|9724698|FG002|COMPLETED|Phase A||0
8680718|NCT00797966|9724699|FG003|COMPLETED|Phase A||0
8680719|NCT00797966|9724700|FG004|COMPLETED|Phase A||664
8680720|NCT00797966|9724701|FG005|COMPLETED|Phase A||0
8680721|NCT00797966|9724696|FG000|NOT COMPLETED|Phase A||0
8680722|NCT00797966|9724697|FG001|NOT COMPLETED|Phase A||0
8680723|NCT00797966|9724698|FG002|NOT COMPLETED|Phase A||0
8680724|NCT00797966|9724699|FG003|NOT COMPLETED|Phase A||0
8680725|NCT00797966|9724700|FG004|NOT COMPLETED|Phase A||185
8680726|NCT00797966|9724701|FG005|NOT COMPLETED|Phase A||0
8680727|NCT00797966|9724696|FG000|STARTED|Phase B|Randomized participants.|62
8680728|NCT00797966|9724697|FG001|STARTED|Phase B|Randomized participants.|120
8680729|NCT00797966|9724698|FG002|STARTED|Phase B|Randomized participants.|121
8680730|NCT00797966|9724699|FG003|STARTED|Phase B|Randomized participants.|126
8680731|NCT00797966|9724700|FG004|STARTED|Phase B||0
8680732|NCT00797966|9724701|FG005|STARTED|Phase B||0
8680733|NCT00797966|9724696|FG000|COMPLETED|Phase B||51
8680734|NCT00797966|9724697|FG001|COMPLETED|Phase B||102
8680735|NCT00797966|9724698|FG002|COMPLETED|Phase B||100
8680736|NCT00797966|9724699|FG003|COMPLETED|Phase B||110
8680737|NCT00797966|9724700|FG004|COMPLETED|Phase B||0
8680738|NCT00797966|9724701|FG005|COMPLETED|Phase B||0
8680739|NCT00797966|9724696|FG000|NOT COMPLETED|Phase B||11
8680740|NCT00797966|9724697|FG001|NOT COMPLETED|Phase B||18
8680741|NCT00797966|9724698|FG002|NOT COMPLETED|Phase B||21
8680742|NCT00797966|9724699|FG003|NOT COMPLETED|Phase B||16
8680743|NCT00797966|9724700|FG004|NOT COMPLETED|Phase B||0
8680744|NCT00797966|9724701|FG005|NOT COMPLETED|Phase B||0
8680745|NCT00797966|9724696|FG000|STARTED|Phase A+||0
8680746|NCT00797966|9724697|FG001|STARTED|Phase A+||0
8680747|NCT00797966|9724698|FG002|STARTED|Phase A+||0
8680748|NCT00797966|9724699|FG003|STARTED|Phase A+||0
8680749|NCT00797966|9724700|FG004|STARTED|Phase A+||0
8680750|NCT00797966|9724701|FG005|STARTED|Phase A+||235
8680751|NCT00797966|9724696|FG000|COMPLETED|Phase A+||0
8680752|NCT00797966|9724697|FG001|COMPLETED|Phase A+||0
8680753|NCT00797966|9724698|FG002|COMPLETED|Phase A+||0
8680754|NCT00797966|9724699|FG003|COMPLETED|Phase A+||0
8680755|NCT00797966|9724700|FG004|COMPLETED|Phase A+||0
8680756|NCT00797966|9724701|FG005|COMPLETED|Phase A+||207
8680757|NCT00797966|9724696|FG000|NOT COMPLETED|Phase A+||0
8680758|NCT00797966|9724697|FG001|NOT COMPLETED|Phase A+||0
8680759|NCT00797966|9724698|FG002|NOT COMPLETED|Phase A+||0
8680760|NCT00797966|9724699|FG003|NOT COMPLETED|Phase A+||0
8680761|NCT00797966|9724700|FG004|NOT COMPLETED|Phase A+||0
8680762|NCT00797966|9724701|FG005|NOT COMPLETED|Phase A+||28
8680763|NCT00798018|9724717|FG000|STARTED|Overall Study||25
8680764|NCT00798018|9724718|FG001|STARTED|Overall Study||25
8680765|NCT00798018|9724719|FG002|STARTED|Overall Study||25
8680766|NCT00798018|9724720|FG003|STARTED|Overall Study||25
8680767|NCT00798018|9724717|FG000|COMPLETED|Overall Study||25
8680768|NCT00798018|9724718|FG001|COMPLETED|Overall Study||25
8680769|NCT00798018|9724719|FG002|COMPLETED|Overall Study||25
8680770|NCT00798018|9724720|FG003|COMPLETED|Overall Study||25
8680771|NCT00798018|9724717|FG000|NOT COMPLETED|Overall Study||0
8680772|NCT00798018|9724718|FG001|NOT COMPLETED|Overall Study||0
8680773|NCT00798018|9724719|FG002|NOT COMPLETED|Overall Study||0
8680774|NCT00798018|9724720|FG003|NOT COMPLETED|Overall Study||0
8680775|NCT00798096|9724730|FG000|STARTED|Overall Study|Treatment with 200 mg bid, oral Fostamatanib until disease progression, toxicity or withdrawal|18
8680776|NCT00798096|9724730|FG000|COMPLETED|Overall Study|Completion of Study is defined as a minimum of 8 weeks of treatment or early disease progression|16
8680777|NCT00798096|9724730|FG000|NOT COMPLETED|Overall Study||2
8680778|NCT00798135|9724734|FG000|STARTED|Overall Study||13
8680779|NCT00798135|9724734|FG000|COMPLETED|Overall Study||0
8680780|NCT00798135|9724734|FG000|NOT COMPLETED|Overall Study||13
8680781|NCT00798161|9724745|FG000|STARTED|Overall Study||72
8680782|NCT00798161|9724746|FG001|STARTED|Overall Study||144
8680783|NCT00798161|9724747|FG002|STARTED|Overall Study||147
8680784|NCT00798161|9724748|FG003|STARTED|Overall Study||142
8680785|NCT00798161|9724749|FG004|STARTED|Overall Study||143
8680786|NCT00798161|9724750|FG005|STARTED|Overall Study||143
8680787|NCT00798161|9724751|FG006|STARTED|Overall Study||66
8680788|NCT00798161|9724745|FG000|COMPLETED|Overall Study||54
8680789|NCT00798161|9724746|FG001|COMPLETED|Overall Study||127
8680790|NCT00798161|9724747|FG002|COMPLETED|Overall Study||126
8680791|NCT00798161|9724748|FG003|COMPLETED|Overall Study||121
8680792|NCT00798161|9724749|FG004|COMPLETED|Overall Study||127
8800392|NCT01444417|9852148|FG001|STARTED|Overall Study||42
8800393|NCT01444417|9852147|FG000|Received Treatment|Overall Study||19
8800394|NCT01444417|9852148|FG001|Received Treatment|Overall Study||42
8800395|NCT01444417|9852147|FG000|COMPLETED|Overall Study||18
8800396|NCT01444417|9852148|FG001|COMPLETED|Overall Study||41
8800397|NCT01444417|9852147|FG000|NOT COMPLETED|Overall Study||2
8800398|NCT01444417|9852148|FG001|NOT COMPLETED|Overall Study||1
8800399|NCT01444430|9852156|FG000|STARTED|Overall Study||5846
8800400|NCT01444430|9852157|FG001|STARTED|Overall Study||5847
8800401|NCT01444430|9852156|FG000|COMPLETED|Overall Study||5785
8800402|NCT01444430|9852157|FG001|COMPLETED|Overall Study||5766
8800403|NCT01444430|9852156|FG000|NOT COMPLETED|Overall Study||61
8800404|NCT01444430|9852157|FG001|NOT COMPLETED|Overall Study||81
8800405|NCT01444456|9852163|FG000|STARTED|Overall Study||1262
8800406|NCT01444456|9852163|FG000|Received Darbepoetin Alfa or Other ESA|Overall Study||1158
8800407|NCT01444456|9852163|FG000|Received Darbepoetin Alfa|Overall Study||1134
8800408|NCT01444456|9852163|FG000|COMPLETED|Overall Study|Defined as 4 weeks after last dose of ESA or chemotherapy or 13 weeks after enrolment|977
8800409|NCT01444456|9852163|FG000|NOT COMPLETED|Overall Study||285
8800410|NCT01444651|9852169|FG000|STARTED|Overall Study||36
8800411|NCT01444651|9852170|FG001|STARTED|Overall Study||37
8800412|NCT01444651|9852169|FG000|COMPLETED|Overall Study||25
8800413|NCT01444651|9852170|FG001|COMPLETED|Overall Study||28
8800414|NCT01444651|9852169|FG000|NOT COMPLETED|Overall Study||11
8800415|NCT01444651|9852170|FG001|NOT COMPLETED|Overall Study||9
8800416|NCT01444716|9852176|FG000|STARTED|Overall Study||34
8800417|NCT01444716|9852176|FG000|COMPLETED|Overall Study||34
8800418|NCT01444716|9852176|FG000|NOT COMPLETED|Overall Study||0
8800419|NCT01444742|9852180|FG000|STARTED|Overall Study||81
8800420|NCT01444742|9852180|FG000|COMPLETED|Overall Study||80
8800421|NCT01444742|9852180|FG000|NOT COMPLETED|Overall Study||1
8800422|NCT01444781|9852187|FG000|STARTED|Overall Study||416
8800423|NCT01444781|9852188|FG001|STARTED|Overall Study||415
8800424|NCT01444781|9852189|FG002|STARTED|Overall Study||275
8800425|NCT01444781|9852187|FG000|COMPLETED|Overall Study||413
8800426|NCT01444781|9852188|FG001|COMPLETED|Overall Study||411
8800427|NCT01444781|9852189|FG002|COMPLETED|Overall Study||272
8800428|NCT01444781|9852187|FG000|NOT COMPLETED|Overall Study||3
8800429|NCT01444781|9852188|FG001|NOT COMPLETED|Overall Study||4
8800430|NCT01444781|9852189|FG002|NOT COMPLETED|Overall Study||3
8800431|NCT01444898|9852204|FG000|STARTED|Overall Study||10
8800432|NCT01444898|9852204|FG000|COMPLETED|Overall Study||9
8800433|NCT01444898|9852204|FG000|NOT COMPLETED|Overall Study||1
8800434|NCT01444911|9852210|FG000|STARTED|Overall Study||16
8800435|NCT01444911|9852211|FG001|STARTED|Overall Study||13
8800436|NCT01444911|9852210|FG000|COMPLETED|Overall Study||8
8800437|NCT01444911|9852211|FG001|COMPLETED|Overall Study||13
8800438|NCT01444911|9852210|FG000|NOT COMPLETED|Overall Study||8
8800439|NCT01444911|9852211|FG001|NOT COMPLETED|Overall Study||0
8800440|NCT01444924|9852219|FG000|STARTED|Overall Study||31
8800441|NCT01444924|9852220|FG001|STARTED|Overall Study||33
8800442|NCT01444924|9852219|FG000|COMPLETED|Overall Study||31
8800443|NCT01444924|9852220|FG001|COMPLETED|Overall Study||33
8800444|NCT01444924|9852219|FG000|NOT COMPLETED|Overall Study||0
8800445|NCT01444924|9852220|FG001|NOT COMPLETED|Overall Study||0
8800446|NCT01445028|9852228|FG000|STARTED|Overall Study||58
8800447|NCT01445028|9852229|FG001|STARTED|Overall Study||54
8800448|NCT01445028|9852228|FG000|COMPLETED|Overall Study||58
8800449|NCT01445028|9852229|FG001|COMPLETED|Overall Study||51
8800450|NCT01445028|9852228|FG000|NOT COMPLETED|Overall Study||0
8800451|NCT01445028|9852229|FG001|NOT COMPLETED|Overall Study||3
8800452|NCT01445080|9852244|FG000|STARTED|Overall Study||7
8800453|NCT01445080|9852245|FG001|STARTED|Overall Study||5
8800454|NCT01445080|9852246|FG002|STARTED|Overall Study||12
8800455|NCT01445080|9852247|FG003|STARTED|Overall Study||8
8800456|NCT01445080|9852248|FG004|STARTED|Overall Study||4
8680793|NCT00798161|9724750|FG005|COMPLETED|Overall Study||132
8800457|NCT01445080|9852249|FG005|STARTED|Overall Study||9
8800458|NCT01445080|9852250|FG006|STARTED|Overall Study||2
8800459|NCT01445080|9852251|FG007|STARTED|Overall Study||5
8800460|NCT01445080|9852252|FG008|STARTED|Overall Study||18
8800461|NCT01445080|9852244|FG000|COMPLETED|Overall Study||0
8680794|NCT00798161|9724751|FG006|COMPLETED|Overall Study||56
8680795|NCT00798161|9724745|FG000|NOT COMPLETED|Overall Study||18
8680796|NCT00798161|9724746|FG001|NOT COMPLETED|Overall Study||17
8680797|NCT00798161|9724747|FG002|NOT COMPLETED|Overall Study||21
8680798|NCT00798161|9724748|FG003|NOT COMPLETED|Overall Study||21
8680799|NCT00798161|9724749|FG004|NOT COMPLETED|Overall Study||16
8680800|NCT00798161|9724750|FG005|NOT COMPLETED|Overall Study||11
8680801|NCT00798161|9724751|FG006|NOT COMPLETED|Overall Study||10
8680802|NCT00798174|9724767|FG000|STARTED|Overall Study||16
8680803|NCT00798174|9724768|FG001|STARTED|Overall Study||16
8680804|NCT00798174|9724767|FG000|COMPLETED|Overall Study||12
8680805|NCT00798174|9724768|FG001|COMPLETED|Overall Study||13
8680806|NCT00798174|9724767|FG000|NOT COMPLETED|Overall Study||4
8680807|NCT00798174|9724768|FG001|NOT COMPLETED|Overall Study||3
8680808|NCT00798304|9724775|FG000|STARTED|Overall Study||14
8680809|NCT00798304|9724776|FG001|STARTED|Overall Study||22
8680810|NCT00798304|9724777|FG002|STARTED|Overall Study||10
8680811|NCT00798304|9724775|FG000|COMPLETED|Overall Study||0
8680812|NCT00798304|9724776|FG001|COMPLETED|Overall Study||0
8680813|NCT00798304|9724777|FG002|COMPLETED|Overall Study||0
8680814|NCT00798304|9724775|FG000|NOT COMPLETED|Overall Study||14
8680815|NCT00798304|9724776|FG001|NOT COMPLETED|Overall Study||22
8680816|NCT00798304|9724777|FG002|NOT COMPLETED|Overall Study||10
8680817|NCT00798317|9724787|FG000|STARTED|Overall Study||245
8680818|NCT00798317|9724788|FG001|STARTED|Overall Study||81
8680819|NCT00798317|9724787|FG000|COMPLETED|Overall Study||235
8680820|NCT00798317|9724788|FG001|COMPLETED|Overall Study||74
8680821|NCT00798317|9724787|FG000|NOT COMPLETED|Overall Study||10
8680822|NCT00798317|9724788|FG001|NOT COMPLETED|Overall Study||7
8680823|NCT00798369|9724800|FG000|STARTED|Overall Study||28
8680824|NCT00798369|9724801|FG001|STARTED|Overall Study||29
8680825|NCT00798369|9724802|FG002|STARTED|Overall Study||29
8680826|NCT00798369|9724803|FG003|STARTED|Overall Study||29
8680827|NCT00798369|9724804|FG004|STARTED|Overall Study||28
8680828|NCT00798369|9724805|FG005|STARTED|Overall Study||57
8680829|NCT00798369|9724800|FG000|COMPLETED|Overall Study||27
8680830|NCT00798369|9724801|FG001|COMPLETED|Overall Study||28
8680831|NCT00798369|9724802|FG002|COMPLETED|Overall Study||27
8680832|NCT00798369|9724803|FG003|COMPLETED|Overall Study||28
8680833|NCT00798369|9724804|FG004|COMPLETED|Overall Study||27
8680834|NCT00798369|9724805|FG005|COMPLETED|Overall Study||54
8680835|NCT00798369|9724800|FG000|NOT COMPLETED|Overall Study||1
8680836|NCT00798369|9724801|FG001|NOT COMPLETED|Overall Study||1
8680837|NCT00798369|9724802|FG002|NOT COMPLETED|Overall Study||2
8680838|NCT00798369|9724803|FG003|NOT COMPLETED|Overall Study||1
8680839|NCT00798369|9724804|FG004|NOT COMPLETED|Overall Study||1
8680840|NCT00798369|9724805|FG005|NOT COMPLETED|Overall Study||3
8680841|NCT00798434|9724822|FG000|STARTED|Double-Blind||396
8680842|NCT00798434|9724823|FG001|STARTED|Double-Blind||398
8680843|NCT00798434|9724822|FG000|Received Treatment|Double-Blind||393
8680844|NCT00798434|9724823|FG001|Received Treatment|Double-Blind||392
8680845|NCT00798434|9724822|FG000|COMPLETED|Double-Blind||341
8680846|NCT00798434|9724823|FG001|COMPLETED|Double-Blind||314
8680847|NCT00798434|9724822|FG000|NOT COMPLETED|Double-Blind||55
8680848|NCT00798434|9724823|FG001|NOT COMPLETED|Double-Blind||84
8680849|NCT00798434|9724822|FG000|STARTED|Open-Label||341
8680850|NCT00798434|9724823|FG001|STARTED|Open-Label||314
8680851|NCT00798434|9724822|FG000|Received Treatment|Open-Label||341
8680852|NCT00798434|9724823|FG001|Received Treatment|Open-Label||313
8680853|NCT00798434|9724822|FG000|COMPLETED|Open-Label||299
8680854|NCT00798434|9724823|FG001|COMPLETED|Open-Label||282
8680855|NCT00798434|9724822|FG000|NOT COMPLETED|Open-Label||42
8680856|NCT00798434|9724823|FG001|NOT COMPLETED|Open-Label||32
8680857|NCT00798486|9724834|FG000|STARTED|Overall Study||110
8680858|NCT00798486|9724834|FG000|COMPLETED|Overall Study||110
8680859|NCT00798486|9724834|FG000|NOT COMPLETED|Overall Study||0
8692865|NCT00862849|9738281|FG003|STARTED|Intervention 5||4
8692866|NCT00862849|9738282|FG004|STARTED|Intervention 5||4
8692867|NCT00862849|9738283|FG005|STARTED|Intervention 5||3
8692868|NCT00862849|9738278|FG000|COMPLETED|Intervention 5||3
8692869|NCT00862849|9738279|FG001|COMPLETED|Intervention 5||3
8800462|NCT01445080|9852245|FG001|COMPLETED|Overall Study||0
8800463|NCT01445080|9852246|FG002|COMPLETED|Overall Study||0
8800464|NCT01445080|9852247|FG003|COMPLETED|Overall Study||0
8800465|NCT01445080|9852248|FG004|COMPLETED|Overall Study||0
8800466|NCT01445080|9852249|FG005|COMPLETED|Overall Study||0
8800467|NCT01445080|9852250|FG006|COMPLETED|Overall Study||0
8800468|NCT01445080|9852251|FG007|COMPLETED|Overall Study||0
8800469|NCT01445080|9852252|FG008|COMPLETED|Overall Study||0
8800470|NCT01445080|9852244|FG000|NOT COMPLETED|Overall Study||7
8800471|NCT01445080|9852245|FG001|NOT COMPLETED|Overall Study||5
8800472|NCT01445080|9852246|FG002|NOT COMPLETED|Overall Study||12
8800473|NCT01445080|9852247|FG003|NOT COMPLETED|Overall Study||8
8692870|NCT00862849|9738280|FG002|COMPLETED|Intervention 5||3
8692871|NCT00862849|9738281|FG003|COMPLETED|Intervention 5||4
8692872|NCT00862849|9738282|FG004|COMPLETED|Intervention 5||4
8692873|NCT00862849|9738283|FG005|COMPLETED|Intervention 5||3
8692874|NCT00862849|9738278|FG000|NOT COMPLETED|Intervention 5||0
8692875|NCT00862849|9738279|FG001|NOT COMPLETED|Intervention 5||0
8692876|NCT00862849|9738280|FG002|NOT COMPLETED|Intervention 5||0
8692877|NCT00862849|9738281|FG003|NOT COMPLETED|Intervention 5||0
8692878|NCT00862849|9738282|FG004|NOT COMPLETED|Intervention 5||0
8800474|NCT01445080|9852248|FG004|NOT COMPLETED|Overall Study||4
8680860|NCT00798577|9724840|FG000|STARTED|Overall Study||17
8680861|NCT00798577|9724841|FG001|STARTED|Overall Study||7
8680862|NCT00798577|9724840|FG000|COMPLETED|Overall Study||17
8680863|NCT00798577|9724841|FG001|COMPLETED|Overall Study||7
8680864|NCT00798577|9724840|FG000|NOT COMPLETED|Overall Study||0
8680865|NCT00798577|9724841|FG001|NOT COMPLETED|Overall Study||0
8680866|NCT00798603|9724847|FG000|STARTED|Overall Study||62
8680867|NCT00798603|9724847|FG000|COMPLETED|Overall Study||27
8680868|NCT00798603|9724847|FG000|NOT COMPLETED|Overall Study||35
8680869|NCT00798655|9724851|FG000|STARTED|Overall Study||46
8680870|NCT00798655|9724851|FG000|COMPLETED|Overall Study||44
8680871|NCT00798655|9724851|FG000|NOT COMPLETED|Overall Study||2
8680872|NCT00798694|9724857|FG000|STARTED|Overall Study||30
8680873|NCT00798694|9724858|FG001|STARTED|Overall Study||28
8680874|NCT00798694|9724857|FG000|COMPLETED|Overall Study||28
8680875|NCT00798694|9724858|FG001|COMPLETED|Overall Study||27
8680876|NCT00798694|9724857|FG000|NOT COMPLETED|Overall Study||2
8680877|NCT00798694|9724858|FG001|NOT COMPLETED|Overall Study||1
8680878|NCT00798707|9724873|FG000|STARTED|Overall Study||235
8680879|NCT00798707|9724874|FG001|STARTED|Overall Study||237
8680880|NCT00798707|9724875|FG002|STARTED|Overall Study||237
8680881|NCT00798707|9724873|FG000|Treated|Overall Study||231
8680882|NCT00798707|9724874|FG001|Treated|Overall Study||232
8680883|NCT00798707|9724875|FG002|Treated|Overall Study||236
8680884|NCT00798707|9724873|FG000|COMPLETED|Overall Study||209
8680885|NCT00798707|9724874|FG001|COMPLETED|Overall Study||204
8680886|NCT00798707|9724875|FG002|COMPLETED|Overall Study||215
8680887|NCT00798707|9724873|FG000|NOT COMPLETED|Overall Study||26
8680888|NCT00798707|9724874|FG001|NOT COMPLETED|Overall Study||33
8680889|NCT00798707|9724875|FG002|NOT COMPLETED|Overall Study||22
8680890|NCT00798720|9724883|FG000|STARTED|Overall Study||18
8680891|NCT00798720|9724883|FG000|COMPLETED|Overall Study||18
8680892|NCT00798720|9724883|FG000|NOT COMPLETED|Overall Study||0
8680893|NCT00798759|9724889|FG000|STARTED|Overall Study||117
8680894|NCT00798759|9724890|FG001|STARTED|Overall Study||119
8680895|NCT00798759|9724889|FG000|COMPLETED|Overall Study||109
8680896|NCT00798759|9724890|FG001|COMPLETED|Overall Study||106
8680897|NCT00798759|9724889|FG000|NOT COMPLETED|Overall Study||8
8680898|NCT00798759|9724890|FG001|NOT COMPLETED|Overall Study||13
8680899|NCT00798889|9724896|FG000|STARTED|Overall Study||314
8680900|NCT00798889|9724896|FG000|Treated|Overall Study||311
8680901|NCT00798889|9724896|FG000|COMPLETED|Overall Study||0
8680902|NCT00798889|9724896|FG000|NOT COMPLETED|Overall Study||314
8680903|NCT00798967|9724902|FG000|STARTED|Overall Study||43
8680904|NCT00798967|9724903|FG001|STARTED|Overall Study||43
8680905|NCT00798967|9724902|FG000|Discontinued During Dosing Period|Overall Study||4
8680906|NCT00798967|9724903|FG001|Discontinued During Dosing Period|Overall Study||4
8680907|NCT00798967|9724902|FG000|COMPLETED|Overall Study||39
8680908|NCT00798967|9724903|FG001|COMPLETED|Overall Study||39
8680909|NCT00798967|9724902|FG000|NOT COMPLETED|Overall Study||4
8680910|NCT00798967|9724903|FG001|NOT COMPLETED|Overall Study||4
8680911|NCT00799227|9724910|FG000|STARTED|Overall Study||56
8680912|NCT00799227|9724910|FG000|COMPLETED|Overall Study||53
8680913|NCT00799227|9724910|FG000|NOT COMPLETED|Overall Study||3
8680914|NCT00799383|9724916|FG000|STARTED|Overall Study||23
8680915|NCT00799383|9724917|FG001|STARTED|Overall Study||24
8680916|NCT00799383|9724916|FG000|COMPLETED|Overall Study||20
8680917|NCT00799383|9724917|FG001|COMPLETED|Overall Study||18
8680918|NCT00799383|9724916|FG000|NOT COMPLETED|Overall Study||3
8680919|NCT00799383|9724917|FG001|NOT COMPLETED|Overall Study||6
8680920|NCT00799409|9724926|FG000|STARTED|Overall Study||7
8680921|NCT00799409|9724927|FG001|STARTED|Overall Study||36
8680922|NCT00799409|9724928|FG002|STARTED|Overall Study||35
8680923|NCT00799409|9724926|FG000|COMPLETED|Overall Study||0
8680924|NCT00799409|9724927|FG001|COMPLETED|Overall Study||36
8680925|NCT00799409|9724928|FG002|COMPLETED|Overall Study||35
8680926|NCT00799409|9724926|FG000|NOT COMPLETED|Overall Study||7
8680927|NCT00799409|9724927|FG001|NOT COMPLETED|Overall Study||0
8680928|NCT00799409|9724928|FG002|NOT COMPLETED|Overall Study||0
8680929|NCT00799422|9724936|FG000|STARTED|First Week of Wear||4
8680930|NCT00799422|9724937|FG001|STARTED|First Week of Wear||4
8680931|NCT00799422|9724938|FG002|STARTED|First Week of Wear||4
8680932|NCT00799422|9724939|FG003|STARTED|First Week of Wear||5
8680933|NCT00799422|9724940|FG004|STARTED|First Week of Wear||4
8680934|NCT00799422|9724941|FG005|STARTED|First Week of Wear||5
8680935|NCT00799422|9724936|FG000|COMPLETED|First Week of Wear||4
8680936|NCT00799422|9724937|FG001|COMPLETED|First Week of Wear||4
8680937|NCT00799422|9724938|FG002|COMPLETED|First Week of Wear||3
8680938|NCT00799422|9724939|FG003|COMPLETED|First Week of Wear||4
8680939|NCT00799422|9724940|FG004|COMPLETED|First Week of Wear||4
8680940|NCT00799422|9724941|FG005|COMPLETED|First Week of Wear||5
8680941|NCT00799422|9724936|FG000|NOT COMPLETED|First Week of Wear||0
8680942|NCT00799422|9724937|FG001|NOT COMPLETED|First Week of Wear||0
8680943|NCT00799422|9724938|FG002|NOT COMPLETED|First Week of Wear||1
8680944|NCT00799422|9724939|FG003|NOT COMPLETED|First Week of Wear||1
8680945|NCT00799422|9724940|FG004|NOT COMPLETED|First Week of Wear||0
8680946|NCT00799422|9724941|FG005|NOT COMPLETED|First Week of Wear||0
8680947|NCT00799422|9724936|FG000|STARTED|Second Week of Wear||4
8680948|NCT00799422|9724937|FG001|STARTED|Second Week of Wear||4
8680949|NCT00799422|9724938|FG002|STARTED|Second Week of Wear||3
8692879|NCT00862849|9738283|FG005|NOT COMPLETED|Intervention 5||0
8680950|NCT00799422|9724939|FG003|STARTED|Second Week of Wear|One subject discontinued between First and Second 3 weeks (adverse event)|3
8680951|NCT00799422|9724940|FG004|STARTED|Second Week of Wear||4
8680952|NCT00799422|9724941|FG005|STARTED|Second Week of Wear|One subject discontinued between First and Second 3 weeks (adverse event)|4
8680953|NCT00799422|9724936|FG000|COMPLETED|Second Week of Wear||4
8680954|NCT00799422|9724937|FG001|COMPLETED|Second Week of Wear||4
8680955|NCT00799422|9724938|FG002|COMPLETED|Second Week of Wear||3
8680956|NCT00799422|9724939|FG003|COMPLETED|Second Week of Wear||3
8680957|NCT00799422|9724940|FG004|COMPLETED|Second Week of Wear||4
8680958|NCT00799422|9724941|FG005|COMPLETED|Second Week of Wear||4
8680959|NCT00799422|9724936|FG000|NOT COMPLETED|Second Week of Wear||0
8680960|NCT00799422|9724937|FG001|NOT COMPLETED|Second Week of Wear||0
8680961|NCT00799422|9724938|FG002|NOT COMPLETED|Second Week of Wear||0
8680962|NCT00799422|9724939|FG003|NOT COMPLETED|Second Week of Wear||0
8680963|NCT00799422|9724940|FG004|NOT COMPLETED|Second Week of Wear||0
8680964|NCT00799422|9724941|FG005|NOT COMPLETED|Second Week of Wear||0
8680965|NCT00799422|9724936|FG000|STARTED|Third Week of Wear||4
8680966|NCT00799422|9724937|FG001|STARTED|Third Week of Wear||4
8680967|NCT00799422|9724938|FG002|STARTED|Third Week of Wear||3
8680968|NCT00799422|9724939|FG003|STARTED|Third Week of Wear||3
8680969|NCT00799422|9724940|FG004|STARTED|Third Week of Wear||4
8680970|NCT00799422|9724941|FG005|STARTED|Third Week of Wear||4
8680971|NCT00799422|9724936|FG000|COMPLETED|Third Week of Wear||4
8680972|NCT00799422|9724937|FG001|COMPLETED|Third Week of Wear||4
8680973|NCT00799422|9724938|FG002|COMPLETED|Third Week of Wear||3
8680974|NCT00799422|9724939|FG003|COMPLETED|Third Week of Wear||3
8680975|NCT00799422|9724940|FG004|COMPLETED|Third Week of Wear||4
8680976|NCT00799422|9724941|FG005|COMPLETED|Third Week of Wear||4
8680977|NCT00799422|9724936|FG000|NOT COMPLETED|Third Week of Wear||0
8680978|NCT00799422|9724937|FG001|NOT COMPLETED|Third Week of Wear||0
8680979|NCT00799422|9724938|FG002|NOT COMPLETED|Third Week of Wear||0
8680980|NCT00799422|9724939|FG003|NOT COMPLETED|Third Week of Wear||0
8680981|NCT00799422|9724940|FG004|NOT COMPLETED|Third Week of Wear||0
8680982|NCT00799422|9724941|FG005|NOT COMPLETED|Third Week of Wear||0
8680983|NCT00799435|9724951|FG000|STARTED|Overall Study||1
8680984|NCT00799435|9724952|FG001|STARTED|Overall Study||1
8680985|NCT00799435|9724951|FG000|COMPLETED|Overall Study||1
8680986|NCT00799435|9724952|FG001|COMPLETED|Overall Study||1
8680987|NCT00799435|9724951|FG000|NOT COMPLETED|Overall Study||0
8680988|NCT00799435|9724952|FG001|NOT COMPLETED|Overall Study||0
8680989|NCT00799474|9724958|FG000|STARTED|Overall Study||609
8680990|NCT00799474|9724958|FG000|COMPLETED|Overall Study||609
8680991|NCT00799474|9724958|FG000|NOT COMPLETED|Overall Study||0
8680992|NCT00799487|9724965|FG000|STARTED|Dose Adjustment Period||21
8680993|NCT00799487|9724966|FG001|STARTED|Dose Adjustment Period||34
8680994|NCT00799487|9724967|FG002|STARTED|Dose Adjustment Period||34
8680995|NCT00799487|9724965|FG000|COMPLETED|Dose Adjustment Period||0
8680996|NCT00799487|9724966|FG001|COMPLETED|Dose Adjustment Period||34
8680997|NCT00799487|9724967|FG002|COMPLETED|Dose Adjustment Period||34
8680998|NCT00799487|9724965|FG000|NOT COMPLETED|Dose Adjustment Period||21
8680999|NCT00799487|9724966|FG001|NOT COMPLETED|Dose Adjustment Period||0
8681000|NCT00799487|9724967|FG002|NOT COMPLETED|Dose Adjustment Period||0
8681001|NCT00799487|9724965|FG000|STARTED|Double-Blind Assessment Period||0
8681002|NCT00799487|9724966|FG001|STARTED|Double-Blind Assessment Period||34
8681003|NCT00799487|9724967|FG002|STARTED|Double-Blind Assessment Period||34
8681004|NCT00799487|9724965|FG000|COMPLETED|Double-Blind Assessment Period||0
8681005|NCT00799487|9724966|FG001|COMPLETED|Double-Blind Assessment Period||33
8681006|NCT00799487|9724967|FG002|COMPLETED|Double-Blind Assessment Period||32
8681007|NCT00799487|9724965|FG000|NOT COMPLETED|Double-Blind Assessment Period||0
8681008|NCT00799487|9724966|FG001|NOT COMPLETED|Double-Blind Assessment Period||1
8681009|NCT00799487|9724967|FG002|NOT COMPLETED|Double-Blind Assessment Period||2
8681010|NCT00799578|9724978|FG000|STARTED|Overall Study||13
8681011|NCT00799578|9724978|FG000|COMPLETED|Overall Study||11
8681012|NCT00799578|9724978|FG000|NOT COMPLETED|Overall Study||2
8681013|NCT00799591|9724982|FG000|STARTED|Overall Study||156
8681014|NCT00799591|9724982|FG000|COMPLETED|Overall Study||90
8681015|NCT00799591|9724982|FG000|NOT COMPLETED|Overall Study||66
8681016|NCT00799604|9724989|FG000|STARTED|Bolus 1 (Pre-anesthesia)||10
8681017|NCT00799604|9724990|FG001|STARTED|Bolus 1 (Pre-anesthesia)||10
8681018|NCT00799604|9724991|FG002|STARTED|Bolus 1 (Pre-anesthesia)||10
8681019|NCT00799604|9724989|FG000|COMPLETED|Bolus 1 (Pre-anesthesia)||10
8681020|NCT00799604|9724990|FG001|COMPLETED|Bolus 1 (Pre-anesthesia)||10
8681021|NCT00799604|9724991|FG002|COMPLETED|Bolus 1 (Pre-anesthesia)||10
8681022|NCT00799604|9724989|FG000|NOT COMPLETED|Bolus 1 (Pre-anesthesia)||0
8681023|NCT00799604|9724990|FG001|NOT COMPLETED|Bolus 1 (Pre-anesthesia)||0
8681024|NCT00799604|9724991|FG002|NOT COMPLETED|Bolus 1 (Pre-anesthesia)||0
8681025|NCT00799604|9724989|FG000|STARTED|Bolus 2 (With Anesthesia)|Dose determined per discretion of investigator at 250, 500 or 125μg, based on response to Bolus 1.|6
8681026|NCT00799604|9724990|FG001|STARTED|Bolus 2 (With Anesthesia)|Dose determined per discretion of investigator at 250, 500 or 125μg, based on response to Bolus 1.|12
8681027|NCT00799604|9724991|FG002|STARTED|Bolus 2 (With Anesthesia)|Dose determined per discretion of investigator at 250, 500 or 125μg, based on response to Bolus 1.|3
8681028|NCT00799604|9724989|FG000|COMPLETED|Bolus 2 (With Anesthesia)||6
8681029|NCT00799604|9724990|FG001|COMPLETED|Bolus 2 (With Anesthesia)||12
8681030|NCT00799604|9724991|FG002|COMPLETED|Bolus 2 (With Anesthesia)||3
8681031|NCT00799604|9724989|FG000|NOT COMPLETED|Bolus 2 (With Anesthesia)||0
8681032|NCT00799604|9724990|FG001|NOT COMPLETED|Bolus 2 (With Anesthesia)||0
8681033|NCT00799604|9724991|FG002|NOT COMPLETED|Bolus 2 (With Anesthesia)||0
8681034|NCT00799617|9725001|FG000|STARTED|Main Testosterone Trial||395
8681035|NCT00799617|9725002|FG001|STARTED|Main Testosterone Trial||395
8681036|NCT00799617|9725001|FG000|COMPLETED|Main Testosterone Trial|Participants qualified for 1 of the 3 main trials (sexual function, physical function, vitality).|376
8681037|NCT00799617|9725002|FG001|COMPLETED|Main Testosterone Trial||374
8681038|NCT00799617|9725001|FG000|NOT COMPLETED|Main Testosterone Trial||19
8681039|NCT00799617|9725002|FG001|NOT COMPLETED|Main Testosterone Trial||21
8681040|NCT00799617|9725001|FG000|STARTED|Sexual Funtion Trial||234
8681041|NCT00799617|9725002|FG001|STARTED|Sexual Funtion Trial||236
8681042|NCT00799617|9725001|FG000|COMPLETED|Sexual Funtion Trial||218
8681043|NCT00799617|9725002|FG001|COMPLETED|Sexual Funtion Trial||215
8681044|NCT00799617|9725001|FG000|NOT COMPLETED|Sexual Funtion Trial||16
8681045|NCT00799617|9725002|FG001|NOT COMPLETED|Sexual Funtion Trial||21
8681046|NCT00799617|9725001|FG000|STARTED|Physical Function Trial||191
8681047|NCT00799617|9725002|FG001|STARTED|Physical Function Trial||196
8681048|NCT00799617|9725001|FG000|COMPLETED|Physical Function Trial||185
8681049|NCT00799617|9725002|FG001|COMPLETED|Physical Function Trial||185
8681050|NCT00799617|9725001|FG000|NOT COMPLETED|Physical Function Trial||6
8681051|NCT00799617|9725002|FG001|NOT COMPLETED|Physical Function Trial||11
8681052|NCT00799617|9725001|FG000|STARTED|Vitality Trial||236
8681053|NCT00799617|9725002|FG001|STARTED|Vitality Trial||238
8681054|NCT00799617|9725001|FG000|COMPLETED|Vitality Trial||229
8681055|NCT00799617|9725002|FG001|COMPLETED|Vitality Trial||216
8681056|NCT00799617|9725001|FG000|NOT COMPLETED|Vitality Trial||7
8681057|NCT00799617|9725002|FG001|NOT COMPLETED|Vitality Trial||22
8681058|NCT00799617|9725001|FG000|STARTED|Cardiovascular Trial||88
8681059|NCT00799617|9725002|FG001|STARTED|Cardiovascular Trial||82
8681060|NCT00799617|9725001|FG000|COMPLETED|Cardiovascular Trial||73
8681061|NCT00799617|9725002|FG001|COMPLETED|Cardiovascular Trial||65
8681062|NCT00799617|9725001|FG000|NOT COMPLETED|Cardiovascular Trial||15
8681063|NCT00799617|9725002|FG001|NOT COMPLETED|Cardiovascular Trial||17
8681064|NCT00799617|9725001|FG000|STARTED|Bone Trial||110
8681065|NCT00799617|9725002|FG001|STARTED|Bone Trial||101
8681066|NCT00799617|9725001|FG000|COMPLETED|Bone Trial||104
8681067|NCT00799617|9725002|FG001|COMPLETED|Bone Trial||85
8681068|NCT00799617|9725001|FG000|NOT COMPLETED|Bone Trial||6
8681069|NCT00799617|9725002|FG001|NOT COMPLETED|Bone Trial||16
8681070|NCT00799617|9725001|FG000|STARTED|Cognitive Function Trial||247
8681071|NCT00799617|9725002|FG001|STARTED|Cognitive Function Trial||246
8681072|NCT00799617|9725001|FG000|COMPLETED|Cognitive Function Trial||247
8681073|NCT00799617|9725002|FG001|COMPLETED|Cognitive Function Trial||245
8681074|NCT00799617|9725001|FG000|NOT COMPLETED|Cognitive Function Trial||0
8681075|NCT00799617|9725002|FG001|NOT COMPLETED|Cognitive Function Trial||1
8681076|NCT00799617|9725001|FG000|STARTED|Anemia Trial||27
8681077|NCT00799617|9725002|FG001|STARTED|Anemia Trial||35
8681078|NCT00799617|9725001|FG000|COMPLETED|Anemia Trial||24
8681079|NCT00799617|9725002|FG001|COMPLETED|Anemia Trial||32
8681080|NCT00799617|9725001|FG000|NOT COMPLETED|Anemia Trial||3
8681081|NCT00799617|9725002|FG001|NOT COMPLETED|Anemia Trial||3
8681082|NCT00799643|9725010|FG000|STARTED|Overall Study||140
8681083|NCT00799643|9725011|FG001|STARTED|Overall Study||146
8681084|NCT00799643|9725010|FG000|COMPLETED|Overall Study||115
8681085|NCT00799643|9725011|FG001|COMPLETED|Overall Study||119
8681086|NCT00799643|9725010|FG000|NOT COMPLETED|Overall Study||25
8681087|NCT00799643|9725011|FG001|NOT COMPLETED|Overall Study||27
8681088|NCT00799708|9725021|FG000|STARTED|Overall Study||10
8681089|NCT00799708|9725022|FG001|STARTED|Overall Study||6
8681090|NCT00799708|9725023|FG002|STARTED|Overall Study||11
8681091|NCT00799708|9725021|FG000|COMPLETED|Overall Study||9
8681092|NCT00799708|9725022|FG001|COMPLETED|Overall Study||6
8681093|NCT00799708|9725023|FG002|COMPLETED|Overall Study||11
8681094|NCT00799708|9725021|FG000|NOT COMPLETED|Overall Study||1
8681095|NCT00799708|9725022|FG001|NOT COMPLETED|Overall Study||0
8681096|NCT00799708|9725023|FG002|NOT COMPLETED|Overall Study||0
8681097|NCT00799812|9725033|FG000|STARTED|Overall Study||335
8681098|NCT00799812|9725033|FG000|CHG Swabstick (3 @ Once)|Overall Study||139
8681099|NCT00799812|9725033|FG000|CHG Swabstick Sequential|Overall Study||138
8681100|NCT00799812|9725033|FG000|Hibiclens|Overall Study||133
8681101|NCT00799812|9725033|FG000|Sterile Water Swab (3 @ Once)|Overall Study||132
8681102|NCT00799812|9725033|FG000|Sterile Water Swabstick (Sequential)|Overall Study||126
8681103|NCT00799812|9725033|FG000|COMPLETED|Overall Study||335
8681104|NCT00799812|9725033|FG000|NOT COMPLETED|Overall Study||0
8681105|NCT00799825|9725045|FG000|STARTED|Overall Study||344
8681106|NCT00799825|9725045|FG000|COMPLETED|Overall Study||296
8681107|NCT00799825|9725045|FG000|NOT COMPLETED|Overall Study||48
8681108|NCT00799903|9725051|FG000|STARTED|Overall Study||7904
8681109|NCT00799903|9725052|FG001|STARTED|Overall Study||7924
8681110|NCT00799903|9725051|FG000|COMPLETED|Overall Study||7631
8681111|NCT00799903|9725052|FG001|COMPLETED|Overall Study||7646
8681112|NCT00799903|9725051|FG000|NOT COMPLETED|Overall Study||273
8681113|NCT00799903|9725052|FG001|NOT COMPLETED|Overall Study||278
8681114|NCT00799981|9725058|FG000|STARTED|Overall Study||10
8681115|NCT00799981|9725059|FG001|STARTED|Overall Study||9
8681116|NCT00799981|9725060|FG002|STARTED|Overall Study||10
8681117|NCT00799981|9725061|FG003|STARTED|Overall Study||10
8681118|NCT00799981|9725062|FG004|STARTED|Overall Study||11
8681119|NCT00799981|9725063|FG005|STARTED|Overall Study||10
8681120|NCT00799981|9725058|FG000|COMPLETED|Overall Study||10
8681121|NCT00799981|9725059|FG001|COMPLETED|Overall Study||9
8800475|NCT01445080|9852249|FG005|NOT COMPLETED|Overall Study||9
8800476|NCT01445080|9852250|FG006|NOT COMPLETED|Overall Study||2
8800477|NCT01445080|9852251|FG007|NOT COMPLETED|Overall Study||5
8800478|NCT01445080|9852252|FG008|NOT COMPLETED|Overall Study||18
8800479|NCT01445171|9852287|FG000|STARTED|Overall Study||295
8800480|NCT01445171|9852287|FG000|Implanted With Study Device|Overall Study||287
8800481|NCT01445171|9852287|FG000|COMPLETED|Overall Study||200
8800482|NCT01445171|9852287|FG000|NOT COMPLETED|Overall Study||95
8800483|NCT01445301|9852296|FG000|STARTED|Overall Study||204
8800484|NCT01445301|9852297|FG001|STARTED|Overall Study||297
8800485|NCT01445301|9852298|FG002|STARTED|Overall Study||299
8800486|NCT01445301|9852296|FG000|COMPLETED|Overall Study||183
8800487|NCT01445301|9852297|FG001|COMPLETED|Overall Study||262
8800488|NCT01445301|9852298|FG002|COMPLETED|Overall Study||290
8800489|NCT01445301|9852296|FG000|NOT COMPLETED|Overall Study||21
8800490|NCT01445301|9852297|FG001|NOT COMPLETED|Overall Study||35
8800491|NCT01445301|9852298|FG002|NOT COMPLETED|Overall Study||9
8800492|NCT01445535|9852310|FG000|STARTED|Overall Study||3
8800493|NCT01445535|9852311|FG001|STARTED|Overall Study||3
8800494|NCT01445535|9852312|FG002|STARTED|Overall Study||3
8800495|NCT01445535|9852313|FG003|STARTED|Overall Study||6
8800496|NCT01445535|9852310|FG000|COMPLETED|Overall Study||2
8800497|NCT01445535|9852311|FG001|COMPLETED|Overall Study||3
8800498|NCT01445535|9852312|FG002|COMPLETED|Overall Study||2
8800499|NCT01445535|9852313|FG003|COMPLETED|Overall Study||4
8800500|NCT01445535|9852310|FG000|NOT COMPLETED|Overall Study||1
8800501|NCT01445535|9852311|FG001|NOT COMPLETED|Overall Study||0
8800502|NCT01445535|9852312|FG002|NOT COMPLETED|Overall Study||1
8800503|NCT01445535|9852313|FG003|NOT COMPLETED|Overall Study||2
8800504|NCT01445548|9852324|FG000|STARTED|Overall Study||6
8800505|NCT01445548|9852324|FG000|COMPLETED|Overall Study||5
8800506|NCT01445548|9852324|FG000|NOT COMPLETED|Overall Study||1
8800507|NCT01445613|9852328|FG000|STARTED|30-day Follow-up||1200
8800508|NCT01445613|9852328|FG000|COMPLETED|30-day Follow-up||1165
8800509|NCT01445613|9852328|FG000|NOT COMPLETED|30-day Follow-up||35
8800510|NCT01445613|9852328|FG000|STARTED|1-year Follow-up||1165
8800511|NCT01445613|9852328|FG000|COMPLETED|1-year Follow-up||1088
8800512|NCT01445613|9852328|FG000|NOT COMPLETED|1-year Follow-up||77
8800513|NCT01445626|9852338|FG000|STARTED|Overall Study||87
8800514|NCT01445626|9852338|FG000|COMPLETED|Overall Study||87
8800515|NCT01445626|9852338|FG000|NOT COMPLETED|Overall Study||0
8800516|NCT01445652|9852344|FG000|STARTED|Overall Study||57
8800517|NCT01445652|9852345|FG001|STARTED|Overall Study||53
8800518|NCT01445652|9852344|FG000|COMPLETED|Overall Study||47
8800519|NCT01445652|9852345|FG001|COMPLETED|Overall Study||50
8800520|NCT01445652|9852344|FG000|NOT COMPLETED|Overall Study||10
8800521|NCT01445652|9852345|FG001|NOT COMPLETED|Overall Study||3
8800522|NCT01445678|9852353|FG000|STARTED|Overall Study||482
8800523|NCT01445678|9852354|FG001|STARTED|Overall Study||497
8800524|NCT01445678|9852353|FG000|COMPLETED|Overall Study||452
8800525|NCT01445678|9852354|FG001|COMPLETED|Overall Study||476
8800526|NCT01445678|9852353|FG000|NOT COMPLETED|Overall Study||30
8800527|NCT01445678|9852354|FG001|NOT COMPLETED|Overall Study||21
8800528|NCT01445730|9852360|FG000|STARTED|Overall Study||82
8800529|NCT01445730|9852360|FG000|COMPLETED|Overall Study||71
8800530|NCT01445730|9852360|FG000|NOT COMPLETED|Overall Study||11
8800531|NCT01445769|9852364|FG000|STARTED|Overall Study||45
8800532|NCT01445769|9852364|FG000|COMPLETED|Overall Study||37
8800533|NCT01445769|9852364|FG000|NOT COMPLETED|Overall Study||8
8800534|NCT01445821|9852372|FG000|STARTED|Overall Study||22
8800535|NCT01445821|9852373|FG001|STARTED|Overall Study||22
8800536|NCT01445821|9852372|FG000|COMPLETED|Overall Study||22
8800537|NCT01445821|9852373|FG001|COMPLETED|Overall Study||22
8800538|NCT01445821|9852372|FG000|NOT COMPLETED|Overall Study||0
8800539|NCT01445821|9852373|FG001|NOT COMPLETED|Overall Study||0
8800540|NCT01445847|9852381|FG000|STARTED|Overall Study||50
8800541|NCT01445847|9852382|FG001|STARTED|Overall Study||50
8800542|NCT01445847|9852381|FG000|COMPLETED|Overall Study||36
8800543|NCT01445847|9852382|FG001|COMPLETED|Overall Study||36
8800544|NCT01445847|9852381|FG000|NOT COMPLETED|Overall Study||14
8800545|NCT01445847|9852382|FG001|NOT COMPLETED|Overall Study||14
8800546|NCT01445873|9852388|FG000|STARTED|Overall Study||36
8800547|NCT01445873|9852388|FG000|COMPLETED|Overall Study||36
8800548|NCT01445873|9852388|FG000|NOT COMPLETED|Overall Study||0
8800549|NCT01445886|9852392|FG000|STARTED|Overall Study||33
8800550|NCT01445886|9852392|FG000|COMPLETED|Overall Study||28
8800551|NCT01445886|9852392|FG000|NOT COMPLETED|Overall Study||5
8800552|NCT01445951|9852401|FG000|STARTED|Overall Study||174
8800553|NCT01445951|9852402|FG001|STARTED|Overall Study||174
8800554|NCT01445951|9852403|FG002|STARTED|Overall Study||170
8800555|NCT01445951|9852401|FG000|COMPLETED|Overall Study||130
8800556|NCT01445951|9852402|FG001|COMPLETED|Overall Study||138
8800557|NCT01445951|9852403|FG002|COMPLETED|Overall Study||151
8800558|NCT01445951|9852401|FG000|NOT COMPLETED|Overall Study||44
8800559|NCT01445951|9852402|FG001|NOT COMPLETED|Overall Study||36
8681122|NCT00799981|9725060|FG002|COMPLETED|Overall Study||10
8681123|NCT00799981|9725061|FG003|COMPLETED|Overall Study||10
8681124|NCT00799981|9725062|FG004|COMPLETED|Overall Study||11
8681125|NCT00799981|9725063|FG005|COMPLETED|Overall Study||10
8681126|NCT00799981|9725058|FG000|NOT COMPLETED|Overall Study||0
8681127|NCT00799981|9725059|FG001|NOT COMPLETED|Overall Study||0
8681128|NCT00799981|9725060|FG002|NOT COMPLETED|Overall Study||0
8681129|NCT00799981|9725061|FG003|NOT COMPLETED|Overall Study||0
8681130|NCT00799981|9725062|FG004|NOT COMPLETED|Overall Study||0
8681131|NCT00799981|9725063|FG005|NOT COMPLETED|Overall Study||0
8681132|NCT00800176|9725078|FG000|STARTED|Overall Study||66
8681133|NCT00800176|9725079|FG001|STARTED|Overall Study||66
8681134|NCT00800176|9725080|FG002|STARTED|Overall Study||65
8681135|NCT00800176|9725081|FG003|STARTED|Overall Study||66
8681136|NCT00800176|9725082|FG004|STARTED|Overall Study||64
8681137|NCT00800176|9725083|FG005|STARTED|Overall Study||67
8681138|NCT00800176|9725078|FG000|COMPLETED|Overall Study||57
8681139|NCT00800176|9725079|FG001|COMPLETED|Overall Study||60
8681140|NCT00800176|9725080|FG002|COMPLETED|Overall Study||65
8681141|NCT00800176|9725081|FG003|COMPLETED|Overall Study||62
8681142|NCT00800176|9725082|FG004|COMPLETED|Overall Study||60
8681143|NCT00800176|9725083|FG005|COMPLETED|Overall Study||62
8681144|NCT00800176|9725078|FG000|NOT COMPLETED|Overall Study||9
8681145|NCT00800176|9725079|FG001|NOT COMPLETED|Overall Study||6
8681146|NCT00800176|9725080|FG002|NOT COMPLETED|Overall Study||0
8681147|NCT00800176|9725081|FG003|NOT COMPLETED|Overall Study||4
8681148|NCT00800176|9725082|FG004|NOT COMPLETED|Overall Study||4
8681149|NCT00800176|9725083|FG005|NOT COMPLETED|Overall Study||5
8681150|NCT00800202|9725099|FG000|STARTED|Overall Study||67
8681151|NCT00800202|9725100|FG001|STARTED|Overall Study||24
8681152|NCT00800202|9725099|FG000|COMPLETED|Overall Study||0
8681153|NCT00800202|9725100|FG001|COMPLETED|Overall Study||0
8681154|NCT00800202|9725099|FG000|NOT COMPLETED|Overall Study||67
8681155|NCT00800202|9725100|FG001|NOT COMPLETED|Overall Study||24
8681156|NCT00800254|9725108|FG000|STARTED|Overall Study||35
8681157|NCT00800254|9725109|FG001|STARTED|Overall Study||31
8681158|NCT00800254|9725108|FG000|3.5 Weeks Post-operatively|Overall Study||31
8681159|NCT00800254|9725109|FG001|3.5 Weeks Post-operatively|Overall Study||31
8681160|NCT00800254|9725108|FG000|COMPLETED|Overall Study||30
8681161|NCT00800254|9725109|FG001|COMPLETED|Overall Study||25
8681162|NCT00800254|9725108|FG000|NOT COMPLETED|Overall Study||5
8681163|NCT00800254|9725109|FG001|NOT COMPLETED|Overall Study||6
8681164|NCT00800345|9725115|FG000|STARTED|Overall Study||33
8681165|NCT00800345|9725115|FG000|COMPLETED|Overall Study||33
8681166|NCT00800345|9725115|FG000|NOT COMPLETED|Overall Study||0
8681167|NCT00800384|9725121|FG000|STARTED|Overall Study||1247
8681168|NCT00800384|9725122|FG001|STARTED|Overall Study||1253
8681169|NCT00800384|9725121|FG000|COMPLETED|Overall Study||1206
8681170|NCT00800384|9725122|FG001|COMPLETED|Overall Study||1210
8681171|NCT00800384|9725121|FG000|NOT COMPLETED|Overall Study||41
8681172|NCT00800384|9725122|FG001|NOT COMPLETED|Overall Study||43
8681173|NCT00800436|9725136|FG000|STARTED|Overall Study||6
8681174|NCT00800436|9725137|FG001|STARTED|Overall Study||6
8681175|NCT00800436|9725138|FG002|STARTED|Overall Study||6
8681176|NCT00800436|9725139|FG003|STARTED|Overall Study||6
8681177|NCT00800436|9725140|FG004|STARTED|Overall Study||6
8681178|NCT00800436|9725141|FG005|STARTED|Overall Study||20
8681179|NCT00800436|9725142|FG006|STARTED|Overall Study||20
8681180|NCT00800436|9725136|FG000|COMPLETED|Overall Study||6
8681181|NCT00800436|9725137|FG001|COMPLETED|Overall Study||6
8681182|NCT00800436|9725138|FG002|COMPLETED|Overall Study||5
8681183|NCT00800436|9725139|FG003|COMPLETED|Overall Study||5
8681184|NCT00800436|9725140|FG004|COMPLETED|Overall Study||6
8681185|NCT00800436|9725141|FG005|COMPLETED|Overall Study||20
8681186|NCT00800436|9725142|FG006|COMPLETED|Overall Study||20
8681187|NCT00800436|9725136|FG000|NOT COMPLETED|Overall Study||0
8681188|NCT00800436|9725137|FG001|NOT COMPLETED|Overall Study||0
8681189|NCT00800436|9725138|FG002|NOT COMPLETED|Overall Study||1
8681190|NCT00800436|9725139|FG003|NOT COMPLETED|Overall Study||1
8681191|NCT00800436|9725140|FG004|NOT COMPLETED|Overall Study||0
8681192|NCT00800436|9725141|FG005|NOT COMPLETED|Overall Study||0
8681193|NCT00800436|9725142|FG006|NOT COMPLETED|Overall Study||0
8681194|NCT00800540|9725158|FG000|STARTED|Period One: 6 Weeks||17
8681195|NCT00800540|9725159|FG001|STARTED|Period One: 6 Weeks||18
8681196|NCT00800540|9725158|FG000|COMPLETED|Period One: 6 Weeks||16
8681197|NCT00800540|9725159|FG001|COMPLETED|Period One: 6 Weeks||17
8681198|NCT00800540|9725158|FG000|NOT COMPLETED|Period One: 6 Weeks||1
8681199|NCT00800540|9725159|FG001|NOT COMPLETED|Period One: 6 Weeks||1
8681200|NCT00800540|9725158|FG000|STARTED|Washout: 4 Weeks||16
8681201|NCT00800540|9725159|FG001|STARTED|Washout: 4 Weeks||17
8681202|NCT00800540|9725158|FG000|COMPLETED|Washout: 4 Weeks||16
8681203|NCT00800540|9725159|FG001|COMPLETED|Washout: 4 Weeks||17
8681204|NCT00800540|9725158|FG000|NOT COMPLETED|Washout: 4 Weeks||0
8681205|NCT00800540|9725159|FG001|NOT COMPLETED|Washout: 4 Weeks||0
8681206|NCT00800540|9725158|FG000|STARTED|Period 2: 6 Weeks||16
8681207|NCT00800540|9725159|FG001|STARTED|Period 2: 6 Weeks||17
8681208|NCT00800540|9725158|FG000|COMPLETED|Period 2: 6 Weeks||16
8681209|NCT00800540|9725159|FG001|COMPLETED|Period 2: 6 Weeks||16
8681210|NCT00800540|9725158|FG000|NOT COMPLETED|Period 2: 6 Weeks||0
8681211|NCT00800540|9725159|FG001|NOT COMPLETED|Period 2: 6 Weeks||1
8681212|NCT00800683|9725167|FG000|STARTED|Overall Study|Number who started treatment|65
8692880|NCT00862849|9738278|FG000|STARTED|Washout 5 (3 to 14 Days)||3
8681213|NCT00800683|9725168|FG001|STARTED|Overall Study|Number who started treatment|68
8681214|NCT00800683|9725167|FG000|COMPLETED|Overall Study|Number who completed treatment|48
8681215|NCT00800683|9725168|FG001|COMPLETED|Overall Study|Number who completed treatment|49
8681216|NCT00800683|9725167|FG000|NOT COMPLETED|Overall Study||17
8681217|NCT00800683|9725168|FG001|NOT COMPLETED|Overall Study||19
8681218|NCT00800735|9725174|FG000|STARTED|Overall Study||30
8681219|NCT00800735|9725174|FG000|COMPLETED|Overall Study||16
8681220|NCT00800735|9725174|FG000|NOT COMPLETED|Overall Study||14
8681221|NCT00800839|9725178|FG000|STARTED|Overall Study||56
8681222|NCT00800839|9725178|FG000|COMPLETED|Overall Study||49
8681223|NCT00800839|9725178|FG000|NOT COMPLETED|Overall Study||7
8681224|NCT00800865|9725184|FG000|STARTED|Overall Study||15
8681225|NCT00800865|9725185|FG001|STARTED|Overall Study||16
8681226|NCT00800865|9725184|FG000|COMPLETED|Overall Study||15
8681227|NCT00800865|9725185|FG001|COMPLETED|Overall Study||16
8681228|NCT00800865|9725184|FG000|NOT COMPLETED|Overall Study||0
8681229|NCT00800865|9725185|FG001|NOT COMPLETED|Overall Study||0
8681230|NCT00800982|9725193|FG000|STARTED|Overall Study||15
8681231|NCT00800982|9725194|FG001|STARTED|Overall Study||15
8681232|NCT00800982|9725193|FG000|COMPLETED|Overall Study||13
8681233|NCT00800982|9725194|FG001|COMPLETED|Overall Study||12
8681234|NCT00800982|9725193|FG000|NOT COMPLETED|Overall Study||2
8681235|NCT00800982|9725194|FG001|NOT COMPLETED|Overall Study||3
8681236|NCT00801099|9725200|FG000|STARTED|Overall Study||276
8681237|NCT00801099|9725200|FG000|COMPLETED|Overall Study||175
8681238|NCT00801099|9725200|FG000|NOT COMPLETED|Overall Study||101
8681239|NCT00801138|9725208|FG000|STARTED|Overall Study||54
8681240|NCT00801138|9725209|FG001|STARTED|Overall Study||56
8681241|NCT00801138|9725210|FG002|STARTED|Overall Study||54
8681242|NCT00801138|9725211|FG003|STARTED|Overall Study||54
8681243|NCT00801138|9725208|FG000|COMPLETED|Overall Study||54
8681244|NCT00801138|9725209|FG001|COMPLETED|Overall Study||56
8681245|NCT00801138|9725210|FG002|COMPLETED|Overall Study||54
8681246|NCT00801138|9725211|FG003|COMPLETED|Overall Study||54
8681247|NCT00801138|9725208|FG000|NOT COMPLETED|Overall Study||0
8681248|NCT00801138|9725209|FG001|NOT COMPLETED|Overall Study||0
8681249|NCT00801138|9725210|FG002|NOT COMPLETED|Overall Study||0
8681250|NCT00801138|9725211|FG003|NOT COMPLETED|Overall Study||0
8681251|NCT00801229|9725223|FG000|STARTED|Signed Consent||38
8681252|NCT00801229|9725224|FG001|STARTED|Signed Consent||37
8681253|NCT00801229|9725223|FG000|COMPLETED|Signed Consent||35
8681254|NCT00801229|9725224|FG001|COMPLETED|Signed Consent||34
8681255|NCT00801229|9725223|FG000|NOT COMPLETED|Signed Consent||3
8681256|NCT00801229|9725224|FG001|NOT COMPLETED|Signed Consent||3
8681257|NCT00801229|9725223|FG000|STARTED|Received Study Drug/Placebo||35
8681258|NCT00801229|9725224|FG001|STARTED|Received Study Drug/Placebo||34
8681259|NCT00801229|9725223|FG000|COMPLETED|Received Study Drug/Placebo||31
8681260|NCT00801229|9725224|FG001|COMPLETED|Received Study Drug/Placebo||30
8800560|NCT01445951|9852403|FG002|NOT COMPLETED|Overall Study||19
8800561|NCT01446003|9852411|FG000|STARTED|Period 1||16
8800562|NCT01446003|9852412|FG001|STARTED|Period 1||15
8800563|NCT01446003|9852411|FG000|COMPLETED|Period 1||14
8800564|NCT01446003|9852412|FG001|COMPLETED|Period 1||15
8800565|NCT01446003|9852411|FG000|NOT COMPLETED|Period 1||2
8800566|NCT01446003|9852412|FG001|NOT COMPLETED|Period 1||0
8800567|NCT01446003|9852411|FG000|STARTED|Period 2||14
8800568|NCT01446003|9852412|FG001|STARTED|Period 2||15
8800569|NCT01446003|9852411|FG000|COMPLETED|Period 2||13
8800570|NCT01446003|9852412|FG001|COMPLETED|Period 2||15
8800571|NCT01446003|9852411|FG000|NOT COMPLETED|Period 2||1
8800572|NCT01446003|9852412|FG001|NOT COMPLETED|Period 2||0
8800573|NCT01446042|9852421|FG000|STARTED|Overall Study||142
8800574|NCT01446042|9852422|FG001|STARTED|Overall Study||86
8800575|NCT01446042|9852423|FG002|STARTED|Overall Study||78
8800576|NCT01446042|9852421|FG000|COMPLETED|Overall Study||122
8800577|NCT01446042|9852422|FG001|COMPLETED|Overall Study||83
8800578|NCT01446042|9852423|FG002|COMPLETED|Overall Study||69
8800579|NCT01446042|9852421|FG000|NOT COMPLETED|Overall Study||20
8800580|NCT01446042|9852422|FG001|NOT COMPLETED|Overall Study||3
8800581|NCT01446042|9852423|FG002|NOT COMPLETED|Overall Study||9
8800582|NCT01446159|9852435|FG000|STARTED|Overall Study||3
8800583|NCT01446159|9852436|FG001|STARTED|Overall Study||3
8800584|NCT01446159|9852437|FG002|STARTED|Overall Study||92
8800585|NCT01446159|9852438|FG003|STARTED|Overall Study||85
8800586|NCT01446159|9852435|FG000|COMPLETED|Overall Study||0
8800587|NCT01446159|9852436|FG001|COMPLETED|Overall Study||0
8681261|NCT00801229|9725223|FG000|NOT COMPLETED|Received Study Drug/Placebo||4
8681262|NCT00801229|9725224|FG001|NOT COMPLETED|Received Study Drug/Placebo||4
8681263|NCT00801242|9725230|FG000|STARTED|Overall Study|Randomized participants.|220
8681264|NCT00801242|9725230|FG000|Safety Analysis Set|Overall Study|Randomized participants who received ≥1 dose of degarelix.|216
8681265|NCT00801242|9725230|FG000|Full Analysis Set (FAS), Cycle 1|Overall Study|Randomized participants who received ≥1 dose and had ≥1 efficacy assessment.|213
8681266|NCT00801242|9725230|FG000|FAS, Off-treatment Cycle 1|Overall Study|Completed 7 months induction period and were enrolled in the off-treatment period of cycle 1.|191
8681267|NCT00801242|9725230|FG000|Started Cycle 2|Overall Study||35
8681268|NCT00801242|9725230|FG000|Started Cycle 3|Overall Study||2
8681269|NCT00801242|9725230|FG000|COMPLETED|Overall Study|42, 10, and 0 participants withdrew during Cycles 1, 2, and 3 (i.e. 168 completed the trial).|168
8800588|NCT01446159|9852437|FG002|COMPLETED|Overall Study||21
8800589|NCT01446159|9852438|FG003|COMPLETED|Overall Study||23
8681270|NCT00801242|9725230|FG000|NOT COMPLETED|Overall Study||52
8681271|NCT00801398|9725240|FG000|STARTED|Overall Study||13
8681272|NCT00801398|9725241|FG001|STARTED|Overall Study||9
8681273|NCT00801398|9725242|FG002|STARTED|Overall Study||11
8681274|NCT00801398|9725243|FG003|STARTED|Overall Study||9
8681275|NCT00801398|9725244|FG004|STARTED|Overall Study||8
8681276|NCT00801398|9725245|FG005|STARTED|Overall Study||8
8681277|NCT00801398|9725240|FG000|COMPLETED|Overall Study||7
8681278|NCT00801398|9725241|FG001|COMPLETED|Overall Study||0
8681279|NCT00801398|9725242|FG002|COMPLETED|Overall Study||4
8681280|NCT00801398|9725243|FG003|COMPLETED|Overall Study||3
8681281|NCT00801398|9725244|FG004|COMPLETED|Overall Study||1
8681282|NCT00801398|9725245|FG005|COMPLETED|Overall Study||5
8681283|NCT00801398|9725240|FG000|NOT COMPLETED|Overall Study||6
8681284|NCT00801398|9725241|FG001|NOT COMPLETED|Overall Study||9
8681285|NCT00801398|9725242|FG002|NOT COMPLETED|Overall Study||7
8681286|NCT00801398|9725243|FG003|NOT COMPLETED|Overall Study||6
8681287|NCT00801398|9725244|FG004|NOT COMPLETED|Overall Study||7
8681288|NCT00801398|9725245|FG005|NOT COMPLETED|Overall Study||3
8800590|NCT01446159|9852435|FG000|NOT COMPLETED|Overall Study||3
8800591|NCT01446159|9852436|FG001|NOT COMPLETED|Overall Study||3
8800592|NCT01446159|9852437|FG002|NOT COMPLETED|Overall Study||71
8800593|NCT01446159|9852438|FG003|NOT COMPLETED|Overall Study||62
8800594|NCT01446237|9852450|FG000|STARTED|Overall Study||125
8800595|NCT01446237|9852450|FG000|COMPLETED|Overall Study||115
8800596|NCT01446237|9852450|FG000|NOT COMPLETED|Overall Study||10
8800597|NCT01446289|9852458|FG000|STARTED|Overall Study||51
8800598|NCT01446289|9852459|FG001|STARTED|Overall Study||35
8800599|NCT01446289|9852460|FG002|STARTED|Overall Study||51
8800600|NCT01446289|9852461|FG003|STARTED|Overall Study||35
8800601|NCT01446289|9852458|FG000|COMPLETED|Overall Study||50
8800602|NCT01446289|9852459|FG001|COMPLETED|Overall Study||35
8800603|NCT01446289|9852460|FG002|COMPLETED|Overall Study||50
8800604|NCT01446289|9852461|FG003|COMPLETED|Overall Study||35
8800605|NCT01446289|9852458|FG000|NOT COMPLETED|Overall Study||1
8800606|NCT01446289|9852459|FG001|NOT COMPLETED|Overall Study||0
8800607|NCT01446289|9852460|FG002|NOT COMPLETED|Overall Study||1
8800608|NCT01446289|9852461|FG003|NOT COMPLETED|Overall Study||0
8800609|NCT01446419|9852475|FG000|STARTED|Overall Study||147
8800610|NCT01446419|9852476|FG001|STARTED|Overall Study||78
8800611|NCT01446419|9852475|FG000|3 Month Follow-up|Overall Study||146
8800612|NCT01446419|9852476|FG001|3 Month Follow-up|Overall Study||77
8800613|NCT01446419|9852475|FG000|6 Month Follow-up|Overall Study||144
8800614|NCT01446419|9852476|FG001|6 Month Follow-up|Overall Study||77
8800615|NCT01446419|9852475|FG000|12 Month Follow-up|Overall Study||142
8800616|NCT01446419|9852476|FG001|12 Month Follow-up|Overall Study||77
8800617|NCT01446419|9852475|FG000|COMPLETED|Overall Study||142
8800618|NCT01446419|9852476|FG001|COMPLETED|Overall Study||77
8800619|NCT01446419|9852475|FG000|NOT COMPLETED|Overall Study||5
8800620|NCT01446419|9852476|FG001|NOT COMPLETED|Overall Study||1
8800621|NCT01446666|9852482|FG000|STARTED|Overall Study|Among the 423 participants who consented, 15 withdrew the consent and one died.|407
8800622|NCT01446666|9852482|FG000|COMPLETED|Overall Study||326
8800623|NCT01446666|9852482|FG000|NOT COMPLETED|Overall Study||81
8800624|NCT01446705|9852489|FG000|STARTED|Overall Study||50446
8800625|NCT01446705|9852490|FG001|STARTED|Overall Study||6627
8800626|NCT01446705|9852489|FG000|COMPLETED|Overall Study||50446
8800627|NCT01446705|9852490|FG001|COMPLETED|Overall Study||6627
8800628|NCT01446705|9852489|FG000|NOT COMPLETED|Overall Study||0
8800629|NCT01446705|9852490|FG001|NOT COMPLETED|Overall Study||0
8800630|NCT01446809|9852508|FG000|STARTED|Overall Study||14
8800631|NCT01446809|9852509|FG001|STARTED|Overall Study||7
8800632|NCT01446809|9852510|FG002|STARTED|Overall Study||2
8800633|NCT01446809|9852508|FG000|COMPLETED|Overall Study||14
8800634|NCT01446809|9852509|FG001|COMPLETED|Overall Study||7
8800635|NCT01446809|9852510|FG002|COMPLETED|Overall Study||0
8800636|NCT01446809|9852508|FG000|NOT COMPLETED|Overall Study||0
8800637|NCT01446809|9852509|FG001|NOT COMPLETED|Overall Study||0
8800638|NCT01446809|9852510|FG002|NOT COMPLETED|Overall Study||2
8800639|NCT01446874|9852522|FG000|STARTED|Overall Study||20
9035703|NCT03301649|10097418|FG002|NOT COMPLETED|Overall Study||85
8800640|NCT01446874|9852523|FG001|STARTED|Overall Study||50
8800641|NCT01446874|9852524|FG002|STARTED|Overall Study||80
8800642|NCT01446874|9852522|FG000|COMPLETED|Overall Study||18
8800643|NCT01446874|9852523|FG001|COMPLETED|Overall Study||46
8800644|NCT01446874|9852524|FG002|COMPLETED|Overall Study||62
8800645|NCT01446874|9852522|FG000|NOT COMPLETED|Overall Study||2
8800646|NCT01446874|9852523|FG001|NOT COMPLETED|Overall Study||4
8800647|NCT01446874|9852524|FG002|NOT COMPLETED|Overall Study||18
8800648|NCT01446913|9852535|FG000|STARTED|Overall Study||86
8800649|NCT01446913|9852536|FG001|STARTED|Overall Study||82
8800650|NCT01446913|9852537|FG002|STARTED|Overall Study||84
8800651|NCT01446913|9852535|FG000|Patients With Sleep Study|Overall Study||53
8800652|NCT01446913|9852536|FG001|Patients With Sleep Study|Overall Study||56
8800653|NCT01446913|9852537|FG002|Patients With Sleep Study|Overall Study||29
8800654|NCT01446913|9852535|FG000|Patients With Sleep Apnea|Overall Study||39
8800655|NCT01446913|9852536|FG001|Patients With Sleep Apnea|Overall Study||45
8800656|NCT01446913|9852537|FG002|Patients With Sleep Apnea|Overall Study||21
8800657|NCT01446913|9852535|FG000|COMPLETED|Overall Study||77
8681289|NCT00801632|9725273|FG000|STARTED|Overall Study||5
8681290|NCT00801632|9725273|FG000|COMPLETED|Overall Study||4
8681291|NCT00801632|9725273|FG000|NOT COMPLETED|Overall Study||1
8681292|NCT00801684|9725277|FG000|STARTED|Overall Study||24
8681293|NCT00801684|9725277|FG000|COMPLETED|Overall Study||24
8681294|NCT00801684|9725277|FG000|NOT COMPLETED|Overall Study||0
8681295|NCT00801723|9725296|FG000|STARTED|Overall Study||61
8681296|NCT00801723|9725297|FG001|STARTED|Overall Study||62
8681297|NCT00801723|9725296|FG000|COMPLETED|Overall Study||25
8681298|NCT00801723|9725297|FG001|COMPLETED|Overall Study||27
8681299|NCT00801723|9725296|FG000|NOT COMPLETED|Overall Study||36
8681300|NCT00801723|9725297|FG001|NOT COMPLETED|Overall Study||35
8681301|NCT00801801|9725303|FG000|STARTED|Overall Study||5
8681302|NCT00801801|9725303|FG000|COMPLETED|Overall Study||5
8681303|NCT00801801|9725303|FG000|NOT COMPLETED|Overall Study||0
8681304|NCT00801827|9725308|FG000|STARTED|Overall Study|2 others consented but due to scheduling did not complete|5
8681305|NCT00801827|9725308|FG000|COMPLETED|Overall Study||5
8681306|NCT00801827|9725308|FG000|NOT COMPLETED|Overall Study||0
8681307|NCT00801892|9725314|FG000|STARTED|Main Study Period||12
8681308|NCT00801892|9725315|FG001|STARTED|Main Study Period||11
8681309|NCT00801892|9725314|FG000|COMPLETED|Main Study Period||12
8681310|NCT00801892|9725315|FG001|COMPLETED|Main Study Period||10
8681311|NCT00801892|9725314|FG000|NOT COMPLETED|Main Study Period||0
8681312|NCT00801892|9725315|FG001|NOT COMPLETED|Main Study Period||1
8681313|NCT00801892|9725314|FG000|STARTED|Sham Crossover Period||0
8681314|NCT00801892|9725315|FG001|STARTED|Sham Crossover Period||7
8681315|NCT00801892|9725314|FG000|COMPLETED|Sham Crossover Period||0
8681316|NCT00801892|9725315|FG001|COMPLETED|Sham Crossover Period||5
8681317|NCT00801892|9725314|FG000|NOT COMPLETED|Sham Crossover Period||0
8681318|NCT00801892|9725315|FG001|NOT COMPLETED|Sham Crossover Period||2
8681319|NCT00801983|9725325|FG000|STARTED|Period 1||44
8681320|NCT00801983|9725326|FG001|STARTED|Period 1||41
8681321|NCT00801983|9725325|FG000|COMPLETED|Period 1||40
8681322|NCT00801983|9725326|FG001|COMPLETED|Period 1||33
8681323|NCT00801983|9725325|FG000|NOT COMPLETED|Period 1||4
8681324|NCT00801983|9725326|FG001|NOT COMPLETED|Period 1||8
8681325|NCT00801983|9725325|FG000|STARTED|Period 2||40
8681326|NCT00801983|9725326|FG001|STARTED|Period 2||33
8681327|NCT00801983|9725325|FG000|COMPLETED|Period 2||38
8681328|NCT00801983|9725326|FG001|COMPLETED|Period 2||32
8681329|NCT00801983|9725325|FG000|NOT COMPLETED|Period 2||2
8681330|NCT00801983|9725326|FG001|NOT COMPLETED|Period 2||1
8681331|NCT00802074|9725338|FG000|STARTED|Overall Study||9
8681332|NCT00802074|9725339|FG001|STARTED|Overall Study||8
8681333|NCT00802074|9725340|FG002|STARTED|Overall Study||7
8681334|NCT00802074|9725341|FG003|STARTED|Overall Study||7
8681335|NCT00802074|9725342|FG004|STARTED|Overall Study||7
8681336|NCT00802074|9725343|FG005|STARTED|Overall Study||7
8681337|NCT00802074|9725338|FG000|COMPLETED|Overall Study||7
8681338|NCT00802074|9725339|FG001|COMPLETED|Overall Study||7
8681339|NCT00802074|9725340|FG002|COMPLETED|Overall Study||6
8681340|NCT00802074|9725341|FG003|COMPLETED|Overall Study||7
8681341|NCT00802074|9725342|FG004|COMPLETED|Overall Study||7
8681342|NCT00802074|9725343|FG005|COMPLETED|Overall Study||7
8681343|NCT00802074|9725338|FG000|NOT COMPLETED|Overall Study||2
8681344|NCT00802074|9725339|FG001|NOT COMPLETED|Overall Study||1
8681345|NCT00802074|9725340|FG002|NOT COMPLETED|Overall Study||1
8681346|NCT00802074|9725341|FG003|NOT COMPLETED|Overall Study||0
8681347|NCT00802074|9725342|FG004|NOT COMPLETED|Overall Study||0
8681348|NCT00802074|9725343|FG005|NOT COMPLETED|Overall Study||0
8681349|NCT00802100|9725363|FG000|STARTED|Overall Study||6
8681350|NCT00802100|9725364|FG001|STARTED|Overall Study||9
8681351|NCT00802100|9725365|FG002|STARTED|Overall Study||6
8681352|NCT00802100|9725363|FG000|COMPLETED|Overall Study||0
8681353|NCT00802100|9725364|FG001|COMPLETED|Overall Study||2
8681354|NCT00802100|9725365|FG002|COMPLETED|Overall Study||2
8681355|NCT00802100|9725363|FG000|NOT COMPLETED|Overall Study||6
8681356|NCT00802100|9725364|FG001|NOT COMPLETED|Overall Study||7
8681357|NCT00802100|9725365|FG002|NOT COMPLETED|Overall Study||4
8681358|NCT00802113|9725376|FG000|STARTED|Overall Study||6
8681359|NCT00802113|9725377|FG001|STARTED|Overall Study||17
8681360|NCT00802113|9725376|FG000|COMPLETED|Overall Study||6
8681361|NCT00802113|9725377|FG001|COMPLETED|Overall Study||17
8681362|NCT00802113|9725376|FG000|NOT COMPLETED|Overall Study||0
8681363|NCT00802113|9725377|FG001|NOT COMPLETED|Overall Study||0
8681364|NCT00802178|9725383|FG000|STARTED|Overall Study||2448
8681365|NCT00802178|9725383|FG000|COMPLETED|Overall Study||2335
8681366|NCT00802178|9725383|FG000|NOT COMPLETED|Overall Study||113
8681367|NCT00802204|9725389|FG000|STARTED|Overall Study||9
8681368|NCT00802204|9725390|FG001|STARTED|Overall Study||19
8681369|NCT00802204|9725389|FG000|COMPLETED|Overall Study||8
8681370|NCT00802204|9725390|FG001|COMPLETED|Overall Study||18
8681371|NCT00802204|9725389|FG000|NOT COMPLETED|Overall Study||1
8681372|NCT00802204|9725390|FG001|NOT COMPLETED|Overall Study||1
8681373|NCT00802360|9725403|FG000|STARTED|Overall Study||42
8681374|NCT00802360|9725404|FG001|STARTED|Overall Study||42
8681375|NCT00802360|9725405|FG002|STARTED|Overall Study||42
8681376|NCT00802360|9725406|FG003|STARTED|Overall Study||39
8681377|NCT00802360|9725403|FG000|COMPLETED|Overall Study||18
8681378|NCT00802360|9725404|FG001|COMPLETED|Overall Study||16
8681379|NCT00802360|9725405|FG002|COMPLETED|Overall Study||17
8681380|NCT00802360|9725406|FG003|COMPLETED|Overall Study||17
8681381|NCT00802360|9725403|FG000|NOT COMPLETED|Overall Study||24
8681382|NCT00802360|9725404|FG001|NOT COMPLETED|Overall Study||26
8681383|NCT00802360|9725405|FG002|NOT COMPLETED|Overall Study||25
8681384|NCT00802360|9725406|FG003|NOT COMPLETED|Overall Study||22
8681385|NCT00802412|9725420|FG000|STARTED|Overall Study||65
8681386|NCT00802412|9725421|FG001|STARTED|Overall Study||67
8681387|NCT00802412|9725420|FG000|COMPLETED|Overall Study||63
8681388|NCT00802412|9725421|FG001|COMPLETED|Overall Study||66
8681389|NCT00802412|9725420|FG000|NOT COMPLETED|Overall Study||2
8681390|NCT00802412|9725421|FG001|NOT COMPLETED|Overall Study||1
8681391|NCT00802438|9725427|FG000|STARTED|Overall Study||38
8681392|NCT00802438|9725427|FG000|COMPLETED|Overall Study||10
8681393|NCT00802438|9725427|FG000|NOT COMPLETED|Overall Study||28
8681394|NCT00802464|9725435|FG000|STARTED|Month 0 - Month 8||38
8681395|NCT00802464|9725436|FG001|STARTED|Month 0 - Month 8||73
8681396|NCT00802464|9725437|FG002|STARTED|Month 0 - Month 8||149
8681397|NCT00802464|9725438|FG003|STARTED|Month 0 - Month 8||150
8681398|NCT00802464|9725435|FG000|COMPLETED|Month 0 - Month 8||38
8681399|NCT00802464|9725436|FG001|COMPLETED|Month 0 - Month 8||70
8681400|NCT00802464|9725437|FG002|COMPLETED|Month 0 - Month 8||142
8681401|NCT00802464|9725438|FG003|COMPLETED|Month 0 - Month 8||141
8681402|NCT00802464|9725435|FG000|NOT COMPLETED|Month 0 - Month 8||0
8681403|NCT00802464|9725436|FG001|NOT COMPLETED|Month 0 - Month 8||3
8681404|NCT00802464|9725437|FG002|NOT COMPLETED|Month 0 - Month 8||7
8681405|NCT00802464|9725438|FG003|NOT COMPLETED|Month 0 - Month 8||9
8681406|NCT00802464|9725435|FG000|STARTED|Month 8 - Month 14||34
8681407|NCT00802464|9725436|FG001|STARTED|Month 8 - Month 14||65
8681408|NCT00802464|9725437|FG002|STARTED|Month 8 - Month 14||130
8681409|NCT00802464|9725438|FG003|STARTED|Month 8 - Month 14||126
8681410|NCT00802464|9725435|FG000|COMPLETED|Month 8 - Month 14||33
8681411|NCT00802464|9725436|FG001|COMPLETED|Month 8 - Month 14||63
8681412|NCT00802464|9725437|FG002|COMPLETED|Month 8 - Month 14||129
8681413|NCT00802464|9725438|FG003|COMPLETED|Month 8 - Month 14||126
8681414|NCT00802464|9725435|FG000|NOT COMPLETED|Month 8 - Month 14||1
8681415|NCT00802464|9725436|FG001|NOT COMPLETED|Month 8 - Month 14||2
8681416|NCT00802464|9725437|FG002|NOT COMPLETED|Month 8 - Month 14||1
8681417|NCT00802464|9725438|FG003|NOT COMPLETED|Month 8 - Month 14||0
8681418|NCT00802503|9725452|FG000|STARTED|Overall Study||152
8681419|NCT00802503|9725453|FG001|STARTED|Overall Study||153
8681420|NCT00802503|9725452|FG000|COMPLETED|Overall Study||142
8681421|NCT00802503|9725453|FG001|COMPLETED|Overall Study||133
8681422|NCT00802503|9725452|FG000|NOT COMPLETED|Overall Study||10
8681423|NCT00802503|9725453|FG001|NOT COMPLETED|Overall Study||20
8681424|NCT00802529|9725465|FG000|STARTED|Overall Study||30
8681425|NCT00802529|9725466|FG001|STARTED|Overall Study||30
8681426|NCT00802529|9725465|FG000|COMPLETED|Overall Study|2 patients crossed-over to gentamicin after steroids failed to control vertigo (as per protocol).|30
8681427|NCT00802529|9725466|FG001|COMPLETED|Overall Study||29
8681428|NCT00802529|9725465|FG000|NOT COMPLETED|Overall Study||0
8681429|NCT00802529|9725466|FG001|NOT COMPLETED|Overall Study||1
8681430|NCT00802633|9725474|FG000|STARTED|Overall Study||40
8681431|NCT00802633|9725475|FG001|STARTED|Overall Study||40
8681432|NCT00802633|9725474|FG000|COMPLETED|Overall Study||40
8681433|NCT00802633|9725475|FG001|COMPLETED|Overall Study||40
8681434|NCT00802633|9725474|FG000|NOT COMPLETED|Overall Study||0
8681435|NCT00802633|9725475|FG001|NOT COMPLETED|Overall Study||0
8681436|NCT00802672|9725484|FG000|STARTED|Overall Study||224
8681437|NCT00802672|9725485|FG001|STARTED|Overall Study||226
8681438|NCT00802672|9725486|FG002|STARTED|Overall Study||111
8681439|NCT00802672|9725484|FG000|COMPLETED|Overall Study||156
8681440|NCT00802672|9725485|FG001|COMPLETED|Overall Study||174
8681441|NCT00802672|9725486|FG002|COMPLETED|Overall Study||77
8919250|NCT02207231|9979266|FG000|COMPLETED|Placebo Controlled Period: Week 0 - 16||167
8919251|NCT02207231|9979267|FG001|COMPLETED|Placebo Controlled Period: Week 0 - 16||322
8919252|NCT02207231|9979268|FG002|COMPLETED|Placebo Controlled Period: Week 0 - 16||324
8919253|NCT02207231|9979269|FG003|COMPLETED|Placebo Controlled Period: Week 0 - 16||0
8919254|NCT02207231|9979266|FG000|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||7
8919255|NCT02207231|9979267|FG001|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||7
8919256|NCT02207231|9979268|FG002|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||10
8919257|NCT02207231|9979269|FG003|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||0
8681442|NCT00802672|9725484|FG000|NOT COMPLETED|Overall Study||68
8681443|NCT00802672|9725485|FG001|NOT COMPLETED|Overall Study||52
8681444|NCT00802672|9725486|FG002|NOT COMPLETED|Overall Study||34
8681445|NCT00802685|9725496|FG000|STARTED|Overall Study||54
8681446|NCT00802685|9725497|FG001|STARTED|Overall Study||51
8681447|NCT00802685|9725496|FG000|COMPLETED|Overall Study||54
8681448|NCT00802685|9725497|FG001|COMPLETED|Overall Study||51
8681449|NCT00802685|9725496|FG000|NOT COMPLETED|Overall Study||0
8681450|NCT00802685|9725497|FG001|NOT COMPLETED|Overall Study||0
8681451|NCT00802737|9725506|FG000|STARTED|Overall Study||17
8681452|NCT00802737|9725507|FG001|STARTED|Overall Study||11
8681453|NCT00802737|9725508|FG002|STARTED|Overall Study||1
8681454|NCT00802737|9725506|FG000|COMPLETED|Overall Study||0
8681455|NCT00802737|9725507|FG001|COMPLETED|Overall Study||0
8681456|NCT00802737|9725508|FG002|COMPLETED|Overall Study||0
8681457|NCT00802737|9725506|FG000|NOT COMPLETED|Overall Study||17
8681458|NCT00802737|9725507|FG001|NOT COMPLETED|Overall Study||11
8681459|NCT00802737|9725508|FG002|NOT COMPLETED|Overall Study||1
8681460|NCT00802841|9725519|FG000|STARTED|Overall Study||96
8681461|NCT00802841|9725520|FG001|STARTED|Overall Study||95
8681462|NCT00802841|9725519|FG000|Full Analysis Set|Overall Study||96
8681463|NCT00802841|9725520|FG001|Full Analysis Set|Overall Study||95
8681464|NCT00802841|9725519|FG000|Safety Set|Overall Study||96
8681465|NCT00802841|9725520|FG001|Safety Set|Overall Study||93
8681466|NCT00802841|9725519|FG000|Cross-over Set|Overall Study||13
8681467|NCT00802841|9725520|FG001|Cross-over Set|Overall Study||56
8681468|NCT00802841|9725519|FG000|COMPLETED|Overall Study||0
8681469|NCT00802841|9725520|FG001|COMPLETED|Overall Study||0
8681470|NCT00802841|9725519|FG000|NOT COMPLETED|Overall Study||96
8681471|NCT00802841|9725520|FG001|NOT COMPLETED|Overall Study||95
8681472|NCT00802854|9725528|FG000|STARTED|Overall Study||244
8681473|NCT00802854|9725528|FG000|COMPLETED|Overall Study||244
8681474|NCT00802854|9725528|FG000|NOT COMPLETED|Overall Study||0
8681475|NCT00802867|9725532|FG000|STARTED|Overall Study||989
8681476|NCT00802867|9725532|FG000|COMPLETED|Overall Study||976
8681477|NCT00802867|9725532|FG000|NOT COMPLETED|Overall Study||13
8681478|NCT00802880|9725536|FG000|STARTED|Overall Study||80
8681479|NCT00802880|9725536|FG000|COMPLETED|Overall Study||80
8681480|NCT00802880|9725536|FG000|NOT COMPLETED|Overall Study||0
8681481|NCT00802919|9725546|FG000|STARTED|Overall Study||45
8681482|NCT00802919|9725547|FG001|STARTED|Overall Study||46
8681483|NCT00802919|9725546|FG000|COMPLETED|Overall Study||42
8681484|NCT00802919|9725547|FG001|COMPLETED|Overall Study||45
8681485|NCT00802919|9725546|FG000|NOT COMPLETED|Overall Study||3
8681486|NCT00802919|9725547|FG001|NOT COMPLETED|Overall Study||1
8681487|NCT00802945|9725556|FG000|STARTED|Overall Study||35
8681488|NCT00802945|9725557|FG001|STARTED|Overall Study||35
8681489|NCT00802945|9725556|FG000|COMPLETED|Overall Study||0
8681490|NCT00802945|9725557|FG001|COMPLETED|Overall Study||0
8681491|NCT00802945|9725556|FG000|NOT COMPLETED|Overall Study||35
8681492|NCT00802945|9725557|FG001|NOT COMPLETED|Overall Study||35
8681493|NCT00802997|9725567|FG000|STARTED|Baseline to 3 Months||34
8681494|NCT00802997|9725568|FG001|STARTED|Baseline to 3 Months||17
8681495|NCT00802997|9725567|FG000|COMPLETED|Baseline to 3 Months||34
8681496|NCT00802997|9725568|FG001|COMPLETED|Baseline to 3 Months||17
8681497|NCT00802997|9725567|FG000|NOT COMPLETED|Baseline to 3 Months||0
8681498|NCT00802997|9725568|FG001|NOT COMPLETED|Baseline to 3 Months||0
8681499|NCT00802997|9725567|FG000|STARTED|3 Months to 6 Months||34
8681500|NCT00802997|9725568|FG001|STARTED|3 Months to 6 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
8681501|NCT00802997|9725567|FG000|COMPLETED|3 Months to 6 Months||27
8681502|NCT00802997|9725568|FG001|COMPLETED|3 Months to 6 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
8681503|NCT00802997|9725567|FG000|NOT COMPLETED|3 Months to 6 Months||7
8681504|NCT00802997|9725568|FG001|NOT COMPLETED|3 Months to 6 Months||0
8681505|NCT00802997|9725567|FG000|STARTED|6 Month to 9 Months||27
8681506|NCT00802997|9725568|FG001|STARTED|6 Month to 9 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
8681507|NCT00802997|9725567|FG000|COMPLETED|6 Month to 9 Months||25
8681508|NCT00802997|9725568|FG001|COMPLETED|6 Month to 9 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
8681509|NCT00802997|9725567|FG000|NOT COMPLETED|6 Month to 9 Months||2
8681510|NCT00802997|9725568|FG001|NOT COMPLETED|6 Month to 9 Months||0
8681511|NCT00803010|9725576|FG000|STARTED|Overall Study||37
8681512|NCT00803010|9725577|FG001|STARTED|Overall Study||37
8681513|NCT00803010|9725576|FG000|COMPLETED|Overall Study||37
8681514|NCT00803010|9725577|FG001|COMPLETED|Overall Study||37
8681515|NCT00803010|9725576|FG000|NOT COMPLETED|Overall Study||0
8681516|NCT00803010|9725577|FG001|NOT COMPLETED|Overall Study||0
8681517|NCT00803023|9725587|FG000|STARTED|Overall Study||32
8681518|NCT00803023|9725588|FG001|STARTED|Overall Study||33
8681519|NCT00803023|9725589|FG002|STARTED|Overall Study||31
8681520|NCT00803023|9725590|FG003|STARTED|Overall Study||33
8681521|NCT00803023|9725587|FG000|COMPLETED|Overall Study||27
8681522|NCT00803023|9725588|FG001|COMPLETED|Overall Study||25
8681523|NCT00803023|9725589|FG002|COMPLETED|Overall Study||20
8681524|NCT00803023|9725590|FG003|COMPLETED|Overall Study||25
8681525|NCT00803023|9725587|FG000|NOT COMPLETED|Overall Study||5
8681526|NCT00803023|9725588|FG001|NOT COMPLETED|Overall Study||8
8681527|NCT00803023|9725589|FG002|NOT COMPLETED|Overall Study||11
8681528|NCT00803023|9725590|FG003|NOT COMPLETED|Overall Study||8
8681529|NCT00803049|9725604|FG000|STARTED|Overall Study|Randomized in extension study|129
8919258|NCT02207231|9979266|FG000|STARTED|Active Controlled Period: Week 16 - 48|2 participants did not cross-over.|165
8681530|NCT00803049|9725605|FG001|STARTED|Overall Study|Randomized in extension study|252
8681531|NCT00803049|9725606|FG002|STARTED|Overall Study|Randomized in extension study|108
8681532|NCT00803049|9725607|FG003|STARTED|Overall Study|Randomized in extension study|253
8681533|NCT00803049|9725604|FG000|Treated|Overall Study||129
8681534|NCT00803049|9725605|FG001|Treated|Overall Study||252
8681535|NCT00803049|9725606|FG002|Treated|Overall Study||108
8681536|NCT00803049|9725607|FG003|Treated|Overall Study||251
8681537|NCT00803049|9725604|FG000|Safety Population|Overall Study||129
8681538|NCT00803049|9725605|FG001|Safety Population|Overall Study|Included 1 participant from Placebo/Teriflunomide 14 mg and 1 from Teriflunomide14 mg/14 mg arm|254
8681539|NCT00803049|9725606|FG002|Safety Population|Overall Study|1 participant received Teriflunomide 7 mg and analysed in Teriflunomide 7 mg/7 mg arm|107
8692881|NCT00862849|9738279|FG001|STARTED|Washout 5 (3 to 14 Days)||3
8800658|NCT01446913|9852536|FG001|COMPLETED|Overall Study||73
8681540|NCT00803049|9725607|FG003|Safety Population|Overall Study|1 participant received Teriflunomide 7 mg and analysed in Teriflunomide 7 mg/7 mg arm|250
8681541|NCT00803049|9725604|FG000|COMPLETED|Overall Study||68
8681542|NCT00803049|9725605|FG001|COMPLETED|Overall Study||134
8681543|NCT00803049|9725606|FG002|COMPLETED|Overall Study||64
8681544|NCT00803049|9725607|FG003|COMPLETED|Overall Study||151
8681545|NCT00803049|9725604|FG000|NOT COMPLETED|Overall Study||61
8681546|NCT00803049|9725605|FG001|NOT COMPLETED|Overall Study||118
8681547|NCT00803049|9725606|FG002|NOT COMPLETED|Overall Study||44
8681548|NCT00803049|9725607|FG003|NOT COMPLETED|Overall Study||102
8681549|NCT00803062|9725621|FG000|STARTED|Overall Study||114
8681550|NCT00803062|9725622|FG001|STARTED|Overall Study||115
8681551|NCT00803062|9725623|FG002|STARTED|Overall Study||111
8681552|NCT00803062|9725624|FG003|STARTED|Overall Study||112
8681553|NCT00803062|9725621|FG000|COMPLETED|Overall Study||114
8681554|NCT00803062|9725622|FG001|COMPLETED|Overall Study||115
8681555|NCT00803062|9725623|FG002|COMPLETED|Overall Study||111
8681556|NCT00803062|9725624|FG003|COMPLETED|Overall Study||112
8681557|NCT00803062|9725621|FG000|NOT COMPLETED|Overall Study||0
8681558|NCT00803062|9725622|FG001|NOT COMPLETED|Overall Study||0
8681559|NCT00803062|9725623|FG002|NOT COMPLETED|Overall Study||0
8681560|NCT00803062|9725624|FG003|NOT COMPLETED|Overall Study||0
8681561|NCT00803101|9725636|FG000|STARTED|Overall Study||88
8681562|NCT00803101|9725637|FG001|STARTED|Overall Study||88
8681563|NCT00803101|9725636|FG000|COMPLETED|Overall Study||70
8681564|NCT00803101|9725637|FG001|COMPLETED|Overall Study||66
8681565|NCT00803101|9725636|FG000|NOT COMPLETED|Overall Study||18
8681566|NCT00803101|9725637|FG001|NOT COMPLETED|Overall Study||22
8681567|NCT00803205|9725645|FG000|STARTED|Overall Study||120
8681568|NCT00803205|9725646|FG001|STARTED|Overall Study||118
8681569|NCT00803205|9725645|FG000|Completed Week 16|Overall Study||107
8681570|NCT00803205|9725646|FG001|Completed Week 16|Overall Study||113
8681571|NCT00803205|9725645|FG000|Completed Week 24|Overall Study||103
8681572|NCT00803205|9725646|FG001|Completed Week 24|Overall Study||110
8681573|NCT00803205|9725645|FG000|As-Treated Population*|Overall Study||120
8681574|NCT00803205|9725646|FG001|As-Treated Population*|Overall Study||118
8681575|NCT00803205|9725645|FG000|ITT Population|Overall Study||116
8681576|NCT00803205|9725646|FG001|ITT Population|Overall Study||116
8681577|NCT00803205|9725645|FG000|Per Protocol Population|Overall Study||100
8681578|NCT00803205|9725646|FG001|Per Protocol Population|Overall Study||103
8681579|NCT00803205|9725645|FG000|COMPLETED|Overall Study||100
8681580|NCT00803205|9725646|FG001|COMPLETED|Overall Study||104
8681581|NCT00803205|9725645|FG000|NOT COMPLETED|Overall Study||20
8681582|NCT00803205|9725646|FG001|NOT COMPLETED|Overall Study||14
8681583|NCT00803244|9725654|FG000|STARTED|Overall Study||188
8681584|NCT00803244|9725655|FG001|STARTED|Overall Study||193
8681585|NCT00803244|9725654|FG000|COMPLETED|Overall Study||181
8681586|NCT00803244|9725655|FG001|COMPLETED|Overall Study||178
8681587|NCT00803244|9725654|FG000|NOT COMPLETED|Overall Study||7
8681588|NCT00803244|9725655|FG001|NOT COMPLETED|Overall Study||15
8681589|NCT00803270|9725663|FG000|STARTED|Overall Study||13
8681590|NCT00803270|9725664|FG001|STARTED|Overall Study||14
8681591|NCT00803270|9725663|FG000|COMPLETED|Overall Study||12
8681592|NCT00803270|9725664|FG001|COMPLETED|Overall Study||12
8681593|NCT00803270|9725663|FG000|NOT COMPLETED|Overall Study||1
8681594|NCT00803270|9725664|FG001|NOT COMPLETED|Overall Study||2
8681595|NCT00803361|9725672|FG000|STARTED|Overall Study||108
8681596|NCT00803361|9725673|FG001|STARTED|Overall Study||102
8681597|NCT00803361|9725672|FG000|COMPLETED|Overall Study||82
8681598|NCT00803361|9725673|FG001|COMPLETED|Overall Study||74
8681599|NCT00803361|9725672|FG000|NOT COMPLETED|Overall Study||26
8681600|NCT00803361|9725673|FG001|NOT COMPLETED|Overall Study||28
8681601|NCT00803400|9725681|FG000|STARTED|Overall Study||75
8681602|NCT00803400|9725682|FG001|STARTED|Overall Study||75
8681603|NCT00803400|9725681|FG000|COMPLETED|Overall Study||55
8681604|NCT00803400|9725682|FG001|COMPLETED|Overall Study||51
8681605|NCT00803400|9725681|FG000|NOT COMPLETED|Overall Study||20
8681606|NCT00803400|9725682|FG001|NOT COMPLETED|Overall Study||24
8681607|NCT00803452|9725691|FG000|STARTED|Overall Study||9
8681608|NCT00803452|9725692|FG001|STARTED|Overall Study||22
8681609|NCT00803452|9725691|FG000|COMPLETED|Overall Study||9
8681610|NCT00803452|9725692|FG001|COMPLETED|Overall Study||17
8681611|NCT00803452|9725691|FG000|NOT COMPLETED|Overall Study||0
8681612|NCT00803452|9725692|FG001|NOT COMPLETED|Overall Study||5
8681613|NCT00803543|9725700|FG000|STARTED|Overall Study||69
8681614|NCT00803543|9725701|FG001|STARTED|Overall Study||34
8681615|NCT00803543|9725700|FG000|COMPLETED|Overall Study||45
8681616|NCT00803543|9725701|FG001|COMPLETED|Overall Study||22
8681617|NCT00803543|9725700|FG000|NOT COMPLETED|Overall Study||24
8681618|NCT00803543|9725701|FG001|NOT COMPLETED|Overall Study||12
8681619|NCT00803569|9725707|FG000|STARTED|Overall Study||13
8681620|NCT00803569|9725707|FG000|COMPLETED|Overall Study||9
8681621|NCT00803569|9725707|FG000|NOT COMPLETED|Overall Study||4
8681622|NCT00803595|9725714|FG000|STARTED|Overall Study||337
8681623|NCT00803595|9725715|FG001|STARTED|Overall Study||327
8681624|NCT00803595|9725716|FG002|STARTED|Overall Study||338
8681625|NCT00803595|9725714|FG000|COMPLETED|Overall Study||322
8681626|NCT00803595|9725715|FG001|COMPLETED|Overall Study||319
8681627|NCT00803595|9725716|FG002|COMPLETED|Overall Study||322
8681628|NCT00803595|9725714|FG000|NOT COMPLETED|Overall Study||15
8681629|NCT00803595|9725715|FG001|NOT COMPLETED|Overall Study||8
8681630|NCT00803595|9725716|FG002|NOT COMPLETED|Overall Study||16
8681631|NCT00803634|9725726|FG000|STARTED|Overall Study|All patients dosed with clevidipine [Safety population]|51
8681632|NCT00803634|9725727|FG001|STARTED|Overall Study|All patients dosed with SOC antihypertensive therapy [Safety population]|53
8681633|NCT00803634|9725726|FG000|mITT (Dosed & Have Confirmed AHF)|Overall Study|All patients dosed with clevidipine and confirmed to have AHF [mITT population]|44
8681634|NCT00803634|9725727|FG001|mITT (Dosed & Have Confirmed AHF)|Overall Study|All patients dosed with SOC antihypertensive therapy and confirmed to have AHF [mITT population]|41
8681635|NCT00803634|9725726|FG000|COMPLETED|Overall Study|All patients dosed with clevidipine [Safety population]|45
8681636|NCT00803634|9725727|FG001|COMPLETED|Overall Study|All patients dosed with SOC antihypertensive therapy [Safety population]|48
8681637|NCT00803634|9725726|FG000|NOT COMPLETED|Overall Study||6
8681638|NCT00803634|9725727|FG001|NOT COMPLETED|Overall Study||5
8681639|NCT00803647|9725734|FG000|STARTED|Overall Study||20
8681640|NCT00803647|9725734|FG000|COMPLETED|Overall Study||20
8681641|NCT00803647|9725734|FG000|NOT COMPLETED|Overall Study||0
8681642|NCT00803686|9725742|FG000|STARTED|Part 1, Period 1||6
8681643|NCT00803686|9725743|FG001|STARTED|Part 1, Period 1||6
8681644|NCT00803686|9725744|FG002|STARTED|Part 1, Period 1||0
8681645|NCT00803686|9725745|FG003|STARTED|Part 1, Period 1||0
8681646|NCT00803686|9725742|FG000|COMPLETED|Part 1, Period 1||6
8681647|NCT00803686|9725743|FG001|COMPLETED|Part 1, Period 1||6
8681648|NCT00803686|9725744|FG002|COMPLETED|Part 1, Period 1||0
8681649|NCT00803686|9725745|FG003|COMPLETED|Part 1, Period 1||0
8681650|NCT00803686|9725742|FG000|NOT COMPLETED|Part 1, Period 1||0
8681651|NCT00803686|9725743|FG001|NOT COMPLETED|Part 1, Period 1||0
8681652|NCT00803686|9725744|FG002|NOT COMPLETED|Part 1, Period 1||0
8681653|NCT00803686|9725745|FG003|NOT COMPLETED|Part 1, Period 1||0
8681654|NCT00803686|9725742|FG000|STARTED|Part 1, Period 2||6
8681655|NCT00803686|9725743|FG001|STARTED|Part 1, Period 2||6
8681656|NCT00803686|9725744|FG002|STARTED|Part 1, Period 2|No subjects were to be treated until after Periods 1 and 2.|0
8681657|NCT00803686|9725745|FG003|STARTED|Part 1, Period 2|No subjects were to be treated until after Periods 1 and 2.|0
8681658|NCT00803686|9725742|FG000|COMPLETED|Part 1, Period 2||6
8681659|NCT00803686|9725743|FG001|COMPLETED|Part 1, Period 2||6
8681660|NCT00803686|9725744|FG002|COMPLETED|Part 1, Period 2|No subjects treated.|0
8681661|NCT00803686|9725745|FG003|COMPLETED|Part 1, Period 2|No subjects treated.|0
8681662|NCT00803686|9725742|FG000|NOT COMPLETED|Part 1, Period 2||0
8681663|NCT00803686|9725743|FG001|NOT COMPLETED|Part 1, Period 2||0
8681664|NCT00803686|9725744|FG002|NOT COMPLETED|Part 1, Period 2||0
8681665|NCT00803686|9725745|FG003|NOT COMPLETED|Part 1, Period 2||0
8681666|NCT00803686|9725742|FG000|STARTED|Part 2, Period 3|No subjects were treated in this period|0
8681667|NCT00803686|9725743|FG001|STARTED|Part 2, Period 3|No subjects were treated in this period.|0
8681668|NCT00803686|9725744|FG002|STARTED|Part 2, Period 3|Of the 6 eligible, 1 elected not to continue into Period 3.|5
8681669|NCT00803686|9725745|FG003|STARTED|Part 2, Period 3|Of the 6 eligible, 2 elected not to continue into Period 3.|4
8681670|NCT00803686|9725742|FG000|COMPLETED|Part 2, Period 3|No subjects were treated in this period|0
8681671|NCT00803686|9725743|FG001|COMPLETED|Part 2, Period 3|No subjects were treated in this period.|0
8681672|NCT00803686|9725744|FG002|COMPLETED|Part 2, Period 3|All who started this period completed|5
8681673|NCT00803686|9725745|FG003|COMPLETED|Part 2, Period 3|All who started this period completed|4
8681674|NCT00803686|9725742|FG000|NOT COMPLETED|Part 2, Period 3||0
8681675|NCT00803686|9725743|FG001|NOT COMPLETED|Part 2, Period 3||0
8681676|NCT00803686|9725744|FG002|NOT COMPLETED|Part 2, Period 3||0
8681677|NCT00803686|9725745|FG003|NOT COMPLETED|Part 2, Period 3||0
8681678|NCT00803712|9725759|FG000|STARTED|Overall Study|154 participants were randomized to the cinacalcet group|154
8681679|NCT00803712|9725760|FG001|STARTED|Overall Study|155 participants were randomized to the control group|155
8681680|NCT00803712|9725759|FG000|Full Analysis Set|Overall Study|153 participants randomized and had at least one PTH concentration available after study day 1.|153
8681681|NCT00803712|9725760|FG001|Full Analysis Set|Overall Study|151 participants randomized and had at least one PTH concentration available after study day 1.|151
8681682|NCT00803712|9725759|FG000|Safety Analysis Set|Overall Study|Rz'ed to cinacalcet and received at least 1 dose, or to control but received cinacalcet throughout|155
8681683|NCT00803712|9725760|FG001|Safety Analysis Set|Overall Study|Randomized to the control group|154
8681684|NCT00803712|9725759|FG000|COMPLETED|Overall Study|118 participants randomized to the cinacalcet group completed the study|118
8681685|NCT00803712|9725760|FG001|COMPLETED|Overall Study|128 participants randomized to the control group completed the study|128
8681686|NCT00803712|9725759|FG000|NOT COMPLETED|Overall Study||36
8681687|NCT00803712|9725760|FG001|NOT COMPLETED|Overall Study||27
8681688|NCT00803738|9725768|FG000|STARTED|Overall Study||286
8681689|NCT00803738|9725769|FG001|STARTED|Overall Study||286
8681690|NCT00803738|9725768|FG000|COMPLETED|Overall Study||192
8681691|NCT00803738|9725769|FG001|COMPLETED|Overall Study||176
8681692|NCT00803738|9725768|FG000|NOT COMPLETED|Overall Study||94
8681693|NCT00803738|9725769|FG001|NOT COMPLETED|Overall Study||110
8681694|NCT00803751|9725777|FG000|STARTED|Overall Study||26
8681695|NCT00803751|9725778|FG001|STARTED|Overall Study||23
8681696|NCT00803751|9725777|FG000|COMPLETED|Overall Study||26
8681697|NCT00803751|9725778|FG001|COMPLETED|Overall Study||23
8681698|NCT00803751|9725777|FG000|NOT COMPLETED|Overall Study||0
8681699|NCT00803751|9725778|FG001|NOT COMPLETED|Overall Study||0
8681700|NCT00803777|9725784|FG000|STARTED|Overall Study||147
8681701|NCT00803777|9725784|FG000|COMPLETED|Overall Study||147
8681702|NCT00803777|9725784|FG000|NOT COMPLETED|Overall Study||0
8681703|NCT00803959|9725790|FG000|STARTED|Overall Study||315
8681704|NCT00803959|9725791|FG001|STARTED|Overall Study||315
8681705|NCT00803959|9725790|FG000|ITT Analysis With Primary Outcome Data|Overall Study||266
8681706|NCT00803959|9725791|FG001|ITT Analysis With Primary Outcome Data|Overall Study||272
8681707|NCT00803959|9725790|FG000|COMPLETED|Overall Study|Because it is a non-inferiority trial, the PP analysis was the main analysis (n=259).|259
8681708|NCT00803959|9725791|FG001|COMPLETED|Overall Study|Because it is a non-inferiority trial, the PP analysis was the main analysis (n=264).|264
8681709|NCT00803959|9725790|FG000|NOT COMPLETED|Overall Study||56
8681710|NCT00803959|9725791|FG001|NOT COMPLETED|Overall Study||51
8681711|NCT00804141|9725797|FG000|STARTED|Overall Study||1040
8681712|NCT00804141|9725797|FG000|Received at Least 1 Dose of Study Drug|Overall Study||1034
8681713|NCT00804141|9725797|FG000|COMPLETED|Overall Study||477
8681714|NCT00804141|9725797|FG000|NOT COMPLETED|Overall Study||563
8681715|NCT00804193|9725804|FG000|STARTED|Overall Study||220
8681716|NCT00804193|9725805|FG001|STARTED|Overall Study||224
8681717|NCT00804193|9725806|FG002|STARTED|Overall Study||109
8681718|NCT00804193|9725804|FG000|COMPLETED|Overall Study||181
8681719|NCT00804193|9725805|FG001|COMPLETED|Overall Study||180
8681720|NCT00804193|9725806|FG002|COMPLETED|Overall Study||77
8681721|NCT00804193|9725804|FG000|NOT COMPLETED|Overall Study||39
8681722|NCT00804193|9725805|FG001|NOT COMPLETED|Overall Study||44
8681723|NCT00804193|9725806|FG002|NOT COMPLETED|Overall Study||32
8681724|NCT00804570|9725816|FG000|STARTED|Overall Study||187
8681725|NCT00804570|9725817|FG001|STARTED|Overall Study||188
8681726|NCT00804570|9725816|FG000|COMPLETED|Overall Study||115
8681727|NCT00804570|9725817|FG001|COMPLETED|Overall Study||94
8681728|NCT00804570|9725816|FG000|NOT COMPLETED|Overall Study||72
8681729|NCT00804570|9725817|FG001|NOT COMPLETED|Overall Study||94
8681730|NCT00804596|9725824|FG000|STARTED|Overall Study||74
8681731|NCT00804596|9725824|FG000|COMPLETED|Overall Study||74
8681732|NCT00804596|9725824|FG000|NOT COMPLETED|Overall Study||0
8681733|NCT00804609|9725830|FG000|STARTED|Overall Study||15
8681734|NCT00804609|9725831|FG001|STARTED|Overall Study||15
8681735|NCT00804609|9725830|FG000|COMPLETED|Overall Study||15
8681736|NCT00804609|9725831|FG001|COMPLETED|Overall Study||14
8681737|NCT00804609|9725830|FG000|NOT COMPLETED|Overall Study||0
8681738|NCT00804609|9725831|FG001|NOT COMPLETED|Overall Study||1
8681739|NCT00804648|9725837|FG000|STARTED|First Intervention||3
8681740|NCT00804648|9725838|FG001|STARTED|First Intervention||5
8681741|NCT00804648|9725839|FG002|STARTED|First Intervention||6
8681742|NCT00804648|9725840|FG003|STARTED|First Intervention||4
8681743|NCT00804648|9725841|FG004|STARTED|First Intervention||4
8681744|NCT00804648|9725842|FG005|STARTED|First Intervention||8
8681745|NCT00804648|9725837|FG000|COMPLETED|First Intervention||3
8681746|NCT00804648|9725838|FG001|COMPLETED|First Intervention||5
8681747|NCT00804648|9725839|FG002|COMPLETED|First Intervention||6
8681748|NCT00804648|9725840|FG003|COMPLETED|First Intervention||4
8681749|NCT00804648|9725841|FG004|COMPLETED|First Intervention||4
8681750|NCT00804648|9725842|FG005|COMPLETED|First Intervention||8
8681751|NCT00804648|9725837|FG000|NOT COMPLETED|First Intervention||0
8681752|NCT00804648|9725838|FG001|NOT COMPLETED|First Intervention||0
8681753|NCT00804648|9725839|FG002|NOT COMPLETED|First Intervention||0
8681754|NCT00804648|9725840|FG003|NOT COMPLETED|First Intervention||0
8681755|NCT00804648|9725841|FG004|NOT COMPLETED|First Intervention||0
8681756|NCT00804648|9725842|FG005|NOT COMPLETED|First Intervention||0
8681757|NCT00804648|9725837|FG000|STARTED|Second Intervention||3
8681758|NCT00804648|9725838|FG001|STARTED|Second Intervention||5
8681759|NCT00804648|9725839|FG002|STARTED|Second Intervention||6
8681760|NCT00804648|9725840|FG003|STARTED|Second Intervention||4
8681761|NCT00804648|9725841|FG004|STARTED|Second Intervention||4
8681762|NCT00804648|9725842|FG005|STARTED|Second Intervention||8
8681763|NCT00804648|9725837|FG000|COMPLETED|Second Intervention||3
8681764|NCT00804648|9725838|FG001|COMPLETED|Second Intervention||5
8681765|NCT00804648|9725839|FG002|COMPLETED|Second Intervention||6
8681766|NCT00804648|9725840|FG003|COMPLETED|Second Intervention||4
8681767|NCT00804648|9725841|FG004|COMPLETED|Second Intervention||4
8681768|NCT00804648|9725842|FG005|COMPLETED|Second Intervention||8
8681769|NCT00804648|9725837|FG000|NOT COMPLETED|Second Intervention||0
8681770|NCT00804648|9725838|FG001|NOT COMPLETED|Second Intervention||0
8681771|NCT00804648|9725839|FG002|NOT COMPLETED|Second Intervention||0
8681772|NCT00804648|9725840|FG003|NOT COMPLETED|Second Intervention||0
8681773|NCT00804648|9725841|FG004|NOT COMPLETED|Second Intervention||0
8681774|NCT00804648|9725842|FG005|NOT COMPLETED|Second Intervention||0
8681775|NCT00804648|9725837|FG000|STARTED|Third Invervention||3
8681776|NCT00804648|9725838|FG001|STARTED|Third Invervention||5
8681777|NCT00804648|9725839|FG002|STARTED|Third Invervention||6
8681778|NCT00804648|9725840|FG003|STARTED|Third Invervention||4
8681779|NCT00804648|9725841|FG004|STARTED|Third Invervention||4
8681780|NCT00804648|9725842|FG005|STARTED|Third Invervention||8
8681781|NCT00804648|9725837|FG000|COMPLETED|Third Invervention||3
8681782|NCT00804648|9725838|FG001|COMPLETED|Third Invervention||5
8681783|NCT00804648|9725839|FG002|COMPLETED|Third Invervention||6
8681784|NCT00804648|9725840|FG003|COMPLETED|Third Invervention||4
8681785|NCT00804648|9725841|FG004|COMPLETED|Third Invervention||4
8681786|NCT00804648|9725842|FG005|COMPLETED|Third Invervention||8
8681787|NCT00804648|9725837|FG000|NOT COMPLETED|Third Invervention||0
8681788|NCT00804648|9725838|FG001|NOT COMPLETED|Third Invervention||0
8681789|NCT00804648|9725839|FG002|NOT COMPLETED|Third Invervention||0
8681790|NCT00804648|9725840|FG003|NOT COMPLETED|Third Invervention||0
8681791|NCT00804648|9725841|FG004|NOT COMPLETED|Third Invervention||0
8681792|NCT00804648|9725842|FG005|NOT COMPLETED|Third Invervention||0
8692882|NCT00862849|9738280|FG002|STARTED|Washout 5 (3 to 14 Days)||3
8692883|NCT00862849|9738281|FG003|STARTED|Washout 5 (3 to 14 Days)||4
8692884|NCT00862849|9738282|FG004|STARTED|Washout 5 (3 to 14 Days)||4
8692885|NCT00862849|9738283|FG005|STARTED|Washout 5 (3 to 14 Days)||3
8692886|NCT00862849|9738278|FG000|COMPLETED|Washout 5 (3 to 14 Days)||3
8692887|NCT00862849|9738279|FG001|COMPLETED|Washout 5 (3 to 14 Days)||3
8692888|NCT00862849|9738280|FG002|COMPLETED|Washout 5 (3 to 14 Days)||3
8692889|NCT00862849|9738281|FG003|COMPLETED|Washout 5 (3 to 14 Days)||4
8692890|NCT00862849|9738282|FG004|COMPLETED|Washout 5 (3 to 14 Days)||4
8692891|NCT00862849|9738283|FG005|COMPLETED|Washout 5 (3 to 14 Days)||3
8692892|NCT00862849|9738278|FG000|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
8692893|NCT00862849|9738279|FG001|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
8692894|NCT00862849|9738280|FG002|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
8692895|NCT00862849|9738281|FG003|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
8692896|NCT00862849|9738282|FG004|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
8692897|NCT00862849|9738283|FG005|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
8692898|NCT00862849|9738278|FG000|STARTED|Intervention 6||3
8692899|NCT00862849|9738279|FG001|STARTED|Intervention 6||3
8692900|NCT00862849|9738280|FG002|STARTED|Intervention 6||3
8692901|NCT00862849|9738281|FG003|STARTED|Intervention 6||4
8692902|NCT00862849|9738282|FG004|STARTED|Intervention 6||4
8692903|NCT00862849|9738283|FG005|STARTED|Intervention 6||3
8692904|NCT00862849|9738278|FG000|COMPLETED|Intervention 6||3
8692905|NCT00862849|9738279|FG001|COMPLETED|Intervention 6||3
8692906|NCT00862849|9738280|FG002|COMPLETED|Intervention 6||3
8692907|NCT00862849|9738281|FG003|COMPLETED|Intervention 6||4
8692908|NCT00862849|9738282|FG004|COMPLETED|Intervention 6||4
8692909|NCT00862849|9738283|FG005|COMPLETED|Intervention 6||3
8692910|NCT00862849|9738278|FG000|NOT COMPLETED|Intervention 6||0
8692911|NCT00862849|9738279|FG001|NOT COMPLETED|Intervention 6||0
8692912|NCT00862849|9738280|FG002|NOT COMPLETED|Intervention 6||0
8692913|NCT00862849|9738281|FG003|NOT COMPLETED|Intervention 6||0
8692914|NCT00862849|9738282|FG004|NOT COMPLETED|Intervention 6||0
8692915|NCT00862849|9738283|FG005|NOT COMPLETED|Intervention 6||0
8692916|NCT00862940|9738293|FG000|STARTED|Overall Study||133
8692917|NCT00862940|9738294|FG001|STARTED|Overall Study||144
8692918|NCT00862940|9738293|FG000|COMPLETED|Overall Study||103
8692919|NCT00862940|9738294|FG001|COMPLETED|Overall Study||114
8692920|NCT00862940|9738293|FG000|NOT COMPLETED|Overall Study||30
8692921|NCT00862940|9738294|FG001|NOT COMPLETED|Overall Study||30
8692922|NCT00862979|9738302|FG000|STARTED|Overall Study||84
8692923|NCT00862979|9738303|FG001|STARTED|Overall Study||78
8692924|NCT00862979|9738302|FG000|Full Analysis Set (FAS)|Overall Study||74
8692925|NCT00862979|9738303|FG001|Full Analysis Set (FAS)|Overall Study||71
8692926|NCT00862979|9738302|FG000|COMPLETED|Overall Study||76
8692927|NCT00862979|9738303|FG001|COMPLETED|Overall Study||71
8692928|NCT00862979|9738302|FG000|NOT COMPLETED|Overall Study||8
8692929|NCT00862979|9738303|FG001|NOT COMPLETED|Overall Study||7
8692930|NCT00862992|9738312|FG000|STARTED|Overall Study||12
8692931|NCT00862992|9738313|FG001|STARTED|Overall Study||10
8692932|NCT00862992|9738314|FG002|STARTED|Overall Study||12
8692933|NCT00862992|9738312|FG000|COMPLETED|Overall Study||9
8692934|NCT00862992|9738313|FG001|COMPLETED|Overall Study||9
8692935|NCT00862992|9738314|FG002|COMPLETED|Overall Study||9
8692936|NCT00862992|9738312|FG000|NOT COMPLETED|Overall Study||3
8692937|NCT00862992|9738313|FG001|NOT COMPLETED|Overall Study||1
8692938|NCT00862992|9738314|FG002|NOT COMPLETED|Overall Study||3
8692939|NCT00863057|9738326|FG000|STARTED|Milestones Period 1 (Weeks 0-5)||4
8692940|NCT00863057|9738327|FG001|STARTED|Milestones Period 1 (Weeks 0-5)||4
8692941|NCT00863057|9738328|FG002|STARTED|Milestones Period 1 (Weeks 0-5)||3
8692942|NCT00863057|9738329|FG003|STARTED|Milestones Period 1 (Weeks 0-5)||4
8692943|NCT00863057|9738326|FG000|COMPLETED|Milestones Period 1 (Weeks 0-5)||3
8692944|NCT00863057|9738327|FG001|COMPLETED|Milestones Period 1 (Weeks 0-5)||2
8692945|NCT00863057|9738328|FG002|COMPLETED|Milestones Period 1 (Weeks 0-5)||3
8692946|NCT00863057|9738329|FG003|COMPLETED|Milestones Period 1 (Weeks 0-5)||3
8800659|NCT01446913|9852537|FG002|COMPLETED|Overall Study||73
8692947|NCT00863057|9738326|FG000|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||1
8692948|NCT00863057|9738327|FG001|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||2
8692949|NCT00863057|9738328|FG002|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||0
8692950|NCT00863057|9738329|FG003|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||1
8692951|NCT00863057|9738326|FG000|STARTED|Period 2 (Weeks 6-10)||3
8692952|NCT00863057|9738327|FG001|STARTED|Period 2 (Weeks 6-10)||2
8692953|NCT00863057|9738328|FG002|STARTED|Period 2 (Weeks 6-10)||3
8692954|NCT00863057|9738329|FG003|STARTED|Period 2 (Weeks 6-10)||3
8692955|NCT00863057|9738326|FG000|COMPLETED|Period 2 (Weeks 6-10)||3
8692956|NCT00863057|9738327|FG001|COMPLETED|Period 2 (Weeks 6-10)||1
8692957|NCT00863057|9738328|FG002|COMPLETED|Period 2 (Weeks 6-10)||2
8692958|NCT00863057|9738329|FG003|COMPLETED|Period 2 (Weeks 6-10)||2
8692959|NCT00863057|9738326|FG000|NOT COMPLETED|Period 2 (Weeks 6-10)||0
8692960|NCT00863057|9738327|FG001|NOT COMPLETED|Period 2 (Weeks 6-10)||1
8692961|NCT00863057|9738328|FG002|NOT COMPLETED|Period 2 (Weeks 6-10)||1
8692962|NCT00863057|9738329|FG003|NOT COMPLETED|Period 2 (Weeks 6-10)||1
8692963|NCT00863057|9738326|FG000|STARTED|Period 3 (Weeks 11-15)||3
8692964|NCT00863057|9738327|FG001|STARTED|Period 3 (Weeks 11-15)||1
8692965|NCT00863057|9738328|FG002|STARTED|Period 3 (Weeks 11-15)||2
8681793|NCT00804687|9725850|FG000|STARTED|Period 1: Treatment Period||9
8681794|NCT00804687|9725851|FG001|STARTED|Period 1: Treatment Period||9
8681795|NCT00804687|9725852|FG002|STARTED|Period 1: Treatment Period||9
8681796|NCT00804687|9725853|FG003|STARTED|Period 1: Treatment Period||9
8681797|NCT00804687|9725854|FG004|STARTED|Period 1: Treatment Period||9
8681798|NCT00804687|9725855|FG005|STARTED|Period 1: Treatment Period||8
8681799|NCT00804687|9725850|FG000|COMPLETED|Period 1: Treatment Period||9
8681800|NCT00804687|9725851|FG001|COMPLETED|Period 1: Treatment Period||9
8681801|NCT00804687|9725852|FG002|COMPLETED|Period 1: Treatment Period||9
8681802|NCT00804687|9725853|FG003|COMPLETED|Period 1: Treatment Period||9
8681803|NCT00804687|9725854|FG004|COMPLETED|Period 1: Treatment Period||9
8681804|NCT00804687|9725855|FG005|COMPLETED|Period 1: Treatment Period||8
8681805|NCT00804687|9725850|FG000|NOT COMPLETED|Period 1: Treatment Period||0
8681806|NCT00804687|9725851|FG001|NOT COMPLETED|Period 1: Treatment Period||0
8681807|NCT00804687|9725852|FG002|NOT COMPLETED|Period 1: Treatment Period||0
8681808|NCT00804687|9725853|FG003|NOT COMPLETED|Period 1: Treatment Period||0
8681809|NCT00804687|9725854|FG004|NOT COMPLETED|Period 1: Treatment Period||0
8681810|NCT00804687|9725855|FG005|NOT COMPLETED|Period 1: Treatment Period||0
8681811|NCT00804687|9725850|FG000|STARTED|Period 2: Washout Period||9
8681812|NCT00804687|9725851|FG001|STARTED|Period 2: Washout Period||9
8681813|NCT00804687|9725852|FG002|STARTED|Period 2: Washout Period||9
8681814|NCT00804687|9725853|FG003|STARTED|Period 2: Washout Period||9
8681815|NCT00804687|9725854|FG004|STARTED|Period 2: Washout Period||9
8681816|NCT00804687|9725855|FG005|STARTED|Period 2: Washout Period||8
8681817|NCT00804687|9725850|FG000|COMPLETED|Period 2: Washout Period||9
8681818|NCT00804687|9725851|FG001|COMPLETED|Period 2: Washout Period||9
8681819|NCT00804687|9725852|FG002|COMPLETED|Period 2: Washout Period||9
8681820|NCT00804687|9725853|FG003|COMPLETED|Period 2: Washout Period||9
8681821|NCT00804687|9725854|FG004|COMPLETED|Period 2: Washout Period||9
8681822|NCT00804687|9725855|FG005|COMPLETED|Period 2: Washout Period||8
8681823|NCT00804687|9725850|FG000|NOT COMPLETED|Period 2: Washout Period||0
8681824|NCT00804687|9725851|FG001|NOT COMPLETED|Period 2: Washout Period||0
8681825|NCT00804687|9725852|FG002|NOT COMPLETED|Period 2: Washout Period||0
8681826|NCT00804687|9725853|FG003|NOT COMPLETED|Period 2: Washout Period||0
8681827|NCT00804687|9725854|FG004|NOT COMPLETED|Period 2: Washout Period||0
8681828|NCT00804687|9725855|FG005|NOT COMPLETED|Period 2: Washout Period||0
8681829|NCT00804687|9725850|FG000|STARTED|Period 3: Treatment Period||9
8681830|NCT00804687|9725851|FG001|STARTED|Period 3: Treatment Period||9
8681831|NCT00804687|9725852|FG002|STARTED|Period 3: Treatment Period||9
8681832|NCT00804687|9725853|FG003|STARTED|Period 3: Treatment Period||9
8681833|NCT00804687|9725854|FG004|STARTED|Period 3: Treatment Period||9
8681834|NCT00804687|9725855|FG005|STARTED|Period 3: Treatment Period||8
8681835|NCT00804687|9725850|FG000|COMPLETED|Period 3: Treatment Period||9
8681836|NCT00804687|9725851|FG001|COMPLETED|Period 3: Treatment Period||9
8681837|NCT00804687|9725852|FG002|COMPLETED|Period 3: Treatment Period||9
8681838|NCT00804687|9725853|FG003|COMPLETED|Period 3: Treatment Period||8
8681839|NCT00804687|9725854|FG004|COMPLETED|Period 3: Treatment Period||9
8681840|NCT00804687|9725855|FG005|COMPLETED|Period 3: Treatment Period||8
8681841|NCT00804687|9725850|FG000|NOT COMPLETED|Period 3: Treatment Period||0
8681842|NCT00804687|9725851|FG001|NOT COMPLETED|Period 3: Treatment Period||0
8681843|NCT00804687|9725852|FG002|NOT COMPLETED|Period 3: Treatment Period||0
8681844|NCT00804687|9725853|FG003|NOT COMPLETED|Period 3: Treatment Period||1
8681845|NCT00804687|9725854|FG004|NOT COMPLETED|Period 3: Treatment Period||0
8681846|NCT00804687|9725855|FG005|NOT COMPLETED|Period 3: Treatment Period||0
8681847|NCT00804687|9725850|FG000|STARTED|Period 4: Washout Period||9
8681848|NCT00804687|9725851|FG001|STARTED|Period 4: Washout Period||9
8681849|NCT00804687|9725852|FG002|STARTED|Period 4: Washout Period||9
8681850|NCT00804687|9725853|FG003|STARTED|Period 4: Washout Period||8
8681851|NCT00804687|9725854|FG004|STARTED|Period 4: Washout Period||9
8681852|NCT00804687|9725855|FG005|STARTED|Period 4: Washout Period||8
8681853|NCT00804687|9725850|FG000|COMPLETED|Period 4: Washout Period||9
8681854|NCT00804687|9725851|FG001|COMPLETED|Period 4: Washout Period||9
8681855|NCT00804687|9725852|FG002|COMPLETED|Period 4: Washout Period||9
8681856|NCT00804687|9725853|FG003|COMPLETED|Period 4: Washout Period||8
8681857|NCT00804687|9725854|FG004|COMPLETED|Period 4: Washout Period||9
8681858|NCT00804687|9725855|FG005|COMPLETED|Period 4: Washout Period||8
8681859|NCT00804687|9725850|FG000|NOT COMPLETED|Period 4: Washout Period||0
8681860|NCT00804687|9725851|FG001|NOT COMPLETED|Period 4: Washout Period||0
8681861|NCT00804687|9725852|FG002|NOT COMPLETED|Period 4: Washout Period||0
8681862|NCT00804687|9725853|FG003|NOT COMPLETED|Period 4: Washout Period||0
8681863|NCT00804687|9725854|FG004|NOT COMPLETED|Period 4: Washout Period||0
8681864|NCT00804687|9725855|FG005|NOT COMPLETED|Period 4: Washout Period||0
8681865|NCT00804687|9725850|FG000|STARTED|Period 5: Treatment Period||9
8681866|NCT00804687|9725851|FG001|STARTED|Period 5: Treatment Period||9
8681867|NCT00804687|9725852|FG002|STARTED|Period 5: Treatment Period||9
8681868|NCT00804687|9725853|FG003|STARTED|Period 5: Treatment Period||8
8681869|NCT00804687|9725854|FG004|STARTED|Period 5: Treatment Period||9
8681870|NCT00804687|9725855|FG005|STARTED|Period 5: Treatment Period||8
8681871|NCT00804687|9725850|FG000|COMPLETED|Period 5: Treatment Period||8
8681872|NCT00804687|9725851|FG001|COMPLETED|Period 5: Treatment Period||9
8681873|NCT00804687|9725852|FG002|COMPLETED|Period 5: Treatment Period||8
8681874|NCT00804687|9725853|FG003|COMPLETED|Period 5: Treatment Period||8
8681875|NCT00804687|9725854|FG004|COMPLETED|Period 5: Treatment Period||8
8681876|NCT00804687|9725855|FG005|COMPLETED|Period 5: Treatment Period||8
8681877|NCT00804687|9725850|FG000|NOT COMPLETED|Period 5: Treatment Period||1
8681878|NCT00804687|9725851|FG001|NOT COMPLETED|Period 5: Treatment Period||0
8681879|NCT00804687|9725852|FG002|NOT COMPLETED|Period 5: Treatment Period||1
8681880|NCT00804687|9725853|FG003|NOT COMPLETED|Period 5: Treatment Period||0
8681881|NCT00804687|9725854|FG004|NOT COMPLETED|Period 5: Treatment Period||1
8681882|NCT00804687|9725855|FG005|NOT COMPLETED|Period 5: Treatment Period||0
8681883|NCT00804843|9725865|FG000|STARTED|Overall Study||50
8681884|NCT00804843|9725866|FG001|STARTED|Overall Study||50
8681885|NCT00804843|9725865|FG000|COMPLETED|Overall Study||40
8681886|NCT00804843|9725866|FG001|COMPLETED|Overall Study||43
8681887|NCT00804843|9725865|FG000|NOT COMPLETED|Overall Study||10
8681888|NCT00804843|9725866|FG001|NOT COMPLETED|Overall Study||7
8681889|NCT00804908|9725876|FG000|STARTED|Overall Study||115
8681890|NCT00804908|9725877|FG001|STARTED|Overall Study||116
8681891|NCT00804908|9725878|FG002|STARTED|Overall Study||115
8681892|NCT00804908|9725876|FG000|COMPLETED|Overall Study||0
8681893|NCT00804908|9725877|FG001|COMPLETED|Overall Study||0
8681894|NCT00804908|9725878|FG002|COMPLETED|Overall Study||1
8681895|NCT00804908|9725876|FG000|NOT COMPLETED|Overall Study||115
8800660|NCT01446913|9852535|FG000|NOT COMPLETED|Overall Study||9
8800661|NCT01446913|9852536|FG001|NOT COMPLETED|Overall Study||9
8800662|NCT01446913|9852537|FG002|NOT COMPLETED|Overall Study||11
8800663|NCT01446965|9852553|FG000|STARTED|Randominization||1554
8800664|NCT01446965|9852554|FG001|STARTED|Randominization||794
8800665|NCT01446965|9852553|FG000|COMPLETED|Randominization||1524
8800666|NCT01446965|9852554|FG001|COMPLETED|Randominization||778
8800667|NCT01446965|9852553|FG000|NOT COMPLETED|Randominization||30
8800668|NCT01446965|9852554|FG001|NOT COMPLETED|Randominization||16
8800669|NCT01446965|9852553|FG000|STARTED|Participants Followed and Analyzed||1524
8800670|NCT01446965|9852554|FG001|STARTED|Participants Followed and Analyzed||778
8800671|NCT01446965|9852553|FG000|Received WCD|Participants Followed and Analyzed||1481
8800672|NCT01446965|9852554|FG001|Received WCD|Participants Followed and Analyzed||0
8800673|NCT01446965|9852553|FG000|Never Wore WCD|Participants Followed and Analyzed||43
8800674|NCT01446965|9852554|FG001|Never Wore WCD|Participants Followed and Analyzed||0
8800675|NCT01446965|9852553|FG000|Never Given WCD|Participants Followed and Analyzed||0
8800676|NCT01446965|9852554|FG001|Never Given WCD|Participants Followed and Analyzed||758
8800677|NCT01446965|9852553|FG000|Given WCD Out of Protocol|Participants Followed and Analyzed||0
8800678|NCT01446965|9852554|FG001|Given WCD Out of Protocol|Participants Followed and Analyzed||20
8800679|NCT01446965|9852553|FG000|COMPLETED|Participants Followed and Analyzed||1514
8800680|NCT01446965|9852554|FG001|COMPLETED|Participants Followed and Analyzed||766
8800681|NCT01446965|9852553|FG000|NOT COMPLETED|Participants Followed and Analyzed||10
8800682|NCT01446965|9852554|FG001|NOT COMPLETED|Participants Followed and Analyzed||12
8800683|NCT01447017|9852562|FG000|STARTED|Overall Study||45
8800684|NCT01447017|9852563|FG001|STARTED|Overall Study||24
8800685|NCT01447017|9852562|FG000|Performed Visit 2|Overall Study||43
8800686|NCT01447017|9852563|FG001|Performed Visit 2|Overall Study||24
8800687|NCT01447017|9852562|FG000|COMPLETED|Overall Study|In safety analysis: 42. In efficacy analyses: 40 in full analysis set, and 39 in per-protocol set.|35
8800688|NCT01447017|9852563|FG001|COMPLETED|Overall Study|In safety analysis: 24. In efficacy analyses: 24 in full analysis set, and 22 in per-protocol set.|14
8800689|NCT01447017|9852562|FG000|NOT COMPLETED|Overall Study||10
8800690|NCT01447017|9852563|FG001|NOT COMPLETED|Overall Study||10
8800691|NCT01447121|9852569|FG000|STARTED|Overall Study||118
8800692|NCT01447121|9852569|FG000|COMPLETED|Overall Study||118
8800693|NCT01447121|9852569|FG000|NOT COMPLETED|Overall Study||0
8800694|NCT01447225|9852578|FG000|STARTED|Overall Study||3
8800695|NCT01447225|9852579|FG001|STARTED|Overall Study||8
8800696|NCT01447225|9852580|FG002|STARTED|Overall Study||5
8800697|NCT01447225|9852581|FG003|STARTED|Overall Study||3
8800698|NCT01447225|9852582|FG004|STARTED|Overall Study||3
8800699|NCT01447225|9852583|FG005|STARTED|Overall Study||3
8800700|NCT01447225|9852584|FG006|STARTED|Overall Study||7
8800701|NCT01447225|9852585|FG007|STARTED|Overall Study||4
8800702|NCT01447225|9852586|FG008|STARTED|Overall Study||3
8800703|NCT01447225|9852587|FG009|STARTED|Overall Study||4
8800704|NCT01447225|9852578|FG000|COMPLETED|Overall Study||3
8800705|NCT01447225|9852579|FG001|COMPLETED|Overall Study||8
8800706|NCT01447225|9852580|FG002|COMPLETED|Overall Study||5
8800707|NCT01447225|9852581|FG003|COMPLETED|Overall Study||3
8800708|NCT01447225|9852582|FG004|COMPLETED|Overall Study||3
8800709|NCT01447225|9852583|FG005|COMPLETED|Overall Study||3
8800710|NCT01447225|9852584|FG006|COMPLETED|Overall Study||7
8800711|NCT01447225|9852585|FG007|COMPLETED|Overall Study||4
8800712|NCT01447225|9852586|FG008|COMPLETED|Overall Study||3
8681896|NCT00804908|9725877|FG001|NOT COMPLETED|Overall Study||116
8681897|NCT00804908|9725878|FG002|NOT COMPLETED|Overall Study||114
8681898|NCT00804973|9725889|FG000|STARTED|Overall Study||40
8681899|NCT00804973|9725890|FG001|STARTED|Overall Study||40
8681900|NCT00804973|9725891|FG002|STARTED|Overall Study||40
8800713|NCT01447225|9852587|FG009|COMPLETED|Overall Study||4
8800714|NCT01447225|9852578|FG000|NOT COMPLETED|Overall Study||0
8800715|NCT01447225|9852579|FG001|NOT COMPLETED|Overall Study||0
8800716|NCT01447225|9852580|FG002|NOT COMPLETED|Overall Study||0
8800717|NCT01447225|9852581|FG003|NOT COMPLETED|Overall Study||0
8800718|NCT01447225|9852582|FG004|NOT COMPLETED|Overall Study||0
8800719|NCT01447225|9852583|FG005|NOT COMPLETED|Overall Study||0
8681901|NCT00804973|9725889|FG000|Received at Least 1 Dose of Study Drug|Overall Study||40
8681902|NCT00804973|9725890|FG001|Received at Least 1 Dose of Study Drug|Overall Study||40
8681903|NCT00804973|9725891|FG002|Received at Least 1 Dose of Study Drug|Overall Study||40
8681904|NCT00804973|9725889|FG000|COMPLETED|Overall Study||40
8681905|NCT00804973|9725890|FG001|COMPLETED|Overall Study||40
8681906|NCT00804973|9725891|FG002|COMPLETED|Overall Study||40
8681907|NCT00804973|9725889|FG000|NOT COMPLETED|Overall Study||0
8681908|NCT00804973|9725890|FG001|NOT COMPLETED|Overall Study||0
8681909|NCT00804973|9725891|FG002|NOT COMPLETED|Overall Study||0
8681910|NCT00804986|9725905|FG000|STARTED|Overall Study||36
8681911|NCT00804986|9725906|FG001|STARTED|Overall Study||43
8681912|NCT00804986|9725907|FG002|STARTED|Overall Study||42
8681913|NCT00804986|9725908|FG003|STARTED|Overall Study||42
8681914|NCT00804986|9725909|FG004|STARTED|Overall Study||43
8681915|NCT00804986|9725910|FG005|STARTED|Overall Study||41
8681916|NCT00804986|9725905|FG000|COMPLETED|Overall Study||35
8681917|NCT00804986|9725906|FG001|COMPLETED|Overall Study||35
8681918|NCT00804986|9725907|FG002|COMPLETED|Overall Study||40
8681919|NCT00804986|9725908|FG003|COMPLETED|Overall Study||34
8681920|NCT00804986|9725909|FG004|COMPLETED|Overall Study||34
8681921|NCT00804986|9725910|FG005|COMPLETED|Overall Study||31
8681922|NCT00804986|9725905|FG000|NOT COMPLETED|Overall Study||1
8681923|NCT00804986|9725906|FG001|NOT COMPLETED|Overall Study||8
8681924|NCT00804986|9725907|FG002|NOT COMPLETED|Overall Study||2
8681925|NCT00804986|9725908|FG003|NOT COMPLETED|Overall Study||8
8681926|NCT00804986|9725909|FG004|NOT COMPLETED|Overall Study||9
8681927|NCT00804986|9725910|FG005|NOT COMPLETED|Overall Study||10
8681928|NCT00804999|9725928|FG000|STARTED|Overall Study||15
8681929|NCT00804999|9725929|FG001|STARTED|Overall Study||12
8681930|NCT00804999|9725930|FG002|STARTED|Overall Study||14
8681931|NCT00804999|9725931|FG003|STARTED|Overall Study||10
8681932|NCT00804999|9725928|FG000|COMPLETED|Overall Study||15
8681933|NCT00804999|9725929|FG001|COMPLETED|Overall Study||12
8681934|NCT00804999|9725930|FG002|COMPLETED|Overall Study||14
8681935|NCT00804999|9725931|FG003|COMPLETED|Overall Study||10
8681936|NCT00804999|9725928|FG000|NOT COMPLETED|Overall Study||0
8681937|NCT00804999|9725929|FG001|NOT COMPLETED|Overall Study||0
8681938|NCT00804999|9725930|FG002|NOT COMPLETED|Overall Study||0
8681939|NCT00804999|9725931|FG003|NOT COMPLETED|Overall Study||0
8681940|NCT00805025|9725941|FG000|STARTED|Overall Study||131
8681941|NCT00805025|9725941|FG000|Enrolled and Treated|Overall Study||89
8681942|NCT00805025|9725941|FG000|COMPLETED|Overall Study||82
8681943|NCT00805025|9725941|FG000|NOT COMPLETED|Overall Study||49
8681944|NCT00805038|9725947|FG000|STARTED|Overall Study||75
8681945|NCT00805038|9725948|FG001|STARTED|Overall Study||92
8681946|NCT00805038|9725947|FG000|COMPLETED|Overall Study||75
8681947|NCT00805038|9725948|FG001|COMPLETED|Overall Study||92
8681948|NCT00805038|9725947|FG000|NOT COMPLETED|Overall Study||0
8681949|NCT00805038|9725948|FG001|NOT COMPLETED|Overall Study||0
8681950|NCT00805142|9725956|FG000|STARTED|Titration Period||36
8681951|NCT00805142|9725957|FG001|STARTED|Titration Period||42
8681952|NCT00805142|9725956|FG000|COMPLETED|Titration Period||30
8681953|NCT00805142|9725957|FG001|COMPLETED|Titration Period||32
8681954|NCT00805142|9725956|FG000|NOT COMPLETED|Titration Period||6
8681955|NCT00805142|9725957|FG001|NOT COMPLETED|Titration Period||10
8681956|NCT00805142|9725956|FG000|STARTED|Maintenance Period||30
8681957|NCT00805142|9725957|FG001|STARTED|Maintenance Period||32
8681958|NCT00805142|9725956|FG000|COMPLETED|Maintenance Period||30
8681959|NCT00805142|9725957|FG001|COMPLETED|Maintenance Period||30
8681960|NCT00805142|9725956|FG000|NOT COMPLETED|Maintenance Period||0
8681961|NCT00805142|9725957|FG001|NOT COMPLETED|Maintenance Period||2
8681962|NCT00805194|9725972|FG000|STARTED|Overall Study|randomised patients|655
8681963|NCT00805194|9725973|FG001|STARTED|Overall Study|randomised patients|659
8681964|NCT00805194|9725972|FG000|COMPLETED|Overall Study||6
8681965|NCT00805194|9725973|FG001|COMPLETED|Overall Study||5
8681966|NCT00805194|9725972|FG000|NOT COMPLETED|Overall Study||649
8681967|NCT00805194|9725973|FG001|NOT COMPLETED|Overall Study||654
8681968|NCT00805207|9725993|FG000|STARTED|Overall Study||1
8681969|NCT00805207|9725994|FG001|STARTED|Overall Study||9
8681970|NCT00805207|9725995|FG002|STARTED|Overall Study||12
8681971|NCT00805207|9725996|FG003|STARTED|Overall Study||6
8681972|NCT00805207|9725997|FG004|STARTED|Overall Study||3
8681973|NCT00805207|9725998|FG005|STARTED|Overall Study||12
8681974|NCT00805207|9725999|FG006|STARTED|Overall Study||6
8681975|NCT00805207|9726000|FG007|STARTED|Overall Study||6
8681976|NCT00805207|9726001|FG008|STARTED|Overall Study||6
8681977|NCT00805207|9725993|FG000|COMPLETED|Overall Study||1
8681978|NCT00805207|9725994|FG001|COMPLETED|Overall Study||7
8681979|NCT00805207|9725995|FG002|COMPLETED|Overall Study||11
8681980|NCT00805207|9725996|FG003|COMPLETED|Overall Study||6
8681981|NCT00805207|9725997|FG004|COMPLETED|Overall Study||2
8681982|NCT00805207|9725998|FG005|COMPLETED|Overall Study||9
8681983|NCT00805207|9725999|FG006|COMPLETED|Overall Study||6
8681984|NCT00805207|9726000|FG007|COMPLETED|Overall Study||6
8681985|NCT00805207|9726001|FG008|COMPLETED|Overall Study||6
8681986|NCT00805207|9725993|FG000|NOT COMPLETED|Overall Study||0
8681987|NCT00805207|9725994|FG001|NOT COMPLETED|Overall Study||2
8681988|NCT00805207|9725995|FG002|NOT COMPLETED|Overall Study||1
8681989|NCT00805207|9725996|FG003|NOT COMPLETED|Overall Study||0
8681990|NCT00805207|9725997|FG004|NOT COMPLETED|Overall Study||1
8681991|NCT00805207|9725998|FG005|NOT COMPLETED|Overall Study||3
8681992|NCT00805207|9725999|FG006|NOT COMPLETED|Overall Study||0
8681993|NCT00805207|9726000|FG007|NOT COMPLETED|Overall Study||0
8681994|NCT00805207|9726001|FG008|NOT COMPLETED|Overall Study||0
8681995|NCT00805285|9726025|FG000|STARTED|Overall Study||1
8681996|NCT00805285|9726025|FG000|COMPLETED|Overall Study||0
8681997|NCT00805285|9726025|FG000|NOT COMPLETED|Overall Study||1
8681998|NCT00805389|9726034|FG000|STARTED|Overall Study||143
8681999|NCT00805389|9726035|FG001|STARTED|Overall Study||142
8682000|NCT00805389|9726036|FG002|STARTED|Overall Study||141
8682001|NCT00805389|9726037|FG003|STARTED|Overall Study||145
8682002|NCT00805389|9726038|FG004|STARTED|Overall Study||142
8682003|NCT00805389|9726034|FG000|COMPLETED|Overall Study||136
8682004|NCT00805389|9726035|FG001|COMPLETED|Overall Study||137
8682005|NCT00805389|9726036|FG002|COMPLETED|Overall Study||129
8682006|NCT00805389|9726037|FG003|COMPLETED|Overall Study||128
8682007|NCT00805389|9726038|FG004|COMPLETED|Overall Study||129
8682008|NCT00805389|9726034|FG000|NOT COMPLETED|Overall Study||7
8682009|NCT00805389|9726035|FG001|NOT COMPLETED|Overall Study||5
8682010|NCT00805389|9726036|FG002|NOT COMPLETED|Overall Study||12
8682011|NCT00805389|9726037|FG003|NOT COMPLETED|Overall Study||17
8682012|NCT00805389|9726038|FG004|NOT COMPLETED|Overall Study||13
8682013|NCT00805441|9726062|FG000|STARTED|Overall Study||94
8682014|NCT00805441|9726063|FG001|STARTED|Overall Study||96
8682015|NCT00805441|9726062|FG000|Full Analysis Set (FAS)|Overall Study|All randomized participants who received ≥1 dose study drug and contributed to post-baseline data.|92
8682016|NCT00805441|9726063|FG001|Full Analysis Set (FAS)|Overall Study|All randomized participants who received ≥1 dose study drug and contributed to post-baseline data.|91
8682017|NCT00805441|9726062|FG000|COMPLETED|Overall Study||60
8682018|NCT00805441|9726063|FG001|COMPLETED|Overall Study||60
8682019|NCT00805441|9726062|FG000|NOT COMPLETED|Overall Study||34
8682020|NCT00805441|9726063|FG001|NOT COMPLETED|Overall Study||36
8682021|NCT00805467|9726073|FG000|STARTED|Overall Study|Patients who received treatment|1
8682022|NCT00805467|9726074|FG001|STARTED|Overall Study|Patients who received treatment|59
8682023|NCT00805467|9726075|FG002|STARTED|Overall Study|Patients who received treatment|183
8682024|NCT00805467|9726076|FG003|STARTED|Overall Study|Patients who received treatment|381
8682025|NCT00805467|9726073|FG000|Enrolled But Did Not Receive Treatment|Overall Study||0
8682026|NCT00805467|9726074|FG001|Enrolled But Did Not Receive Treatment|Overall Study||0
8682027|NCT00805467|9726075|FG002|Enrolled But Did Not Receive Treatment|Overall Study||0
8682028|NCT00805467|9726076|FG003|Enrolled But Did Not Receive Treatment|Overall Study||0
8682029|NCT00805467|9726073|FG000|COMPLETED|Overall Study|Ongoing when study terminated|1
8682030|NCT00805467|9726074|FG001|COMPLETED|Overall Study|Ongoing when study terminated|25
8682031|NCT00805467|9726075|FG002|COMPLETED|Overall Study|Ongoing when study terminated|80
8682032|NCT00805467|9726076|FG003|COMPLETED|Overall Study|Ongoing when study terminated|144
8682033|NCT00805467|9726073|FG000|NOT COMPLETED|Overall Study||0
8682034|NCT00805467|9726074|FG001|NOT COMPLETED|Overall Study||34
8682035|NCT00805467|9726075|FG002|NOT COMPLETED|Overall Study||103
8682036|NCT00805467|9726076|FG003|NOT COMPLETED|Overall Study||237
8682037|NCT00805480|9726090|FG000|STARTED|Overall Study||30
8682038|NCT00805480|9726091|FG001|STARTED|Overall Study||29
8682039|NCT00805480|9726092|FG002|STARTED|Overall Study||31
8682040|NCT00805480|9726093|FG003|STARTED|Overall Study||10
8682041|NCT00805480|9726090|FG000|Pharmacodynamic Analysis Set|Overall Study||30
8682042|NCT00805480|9726091|FG001|Pharmacodynamic Analysis Set|Overall Study||25
8682043|NCT00805480|9726092|FG002|Pharmacodynamic Analysis Set|Overall Study||29
8682044|NCT00805480|9726093|FG003|Pharmacodynamic Analysis Set|Overall Study||10
8682045|NCT00805480|9726090|FG000|COMPLETED|Overall Study||16
8682046|NCT00805480|9726091|FG001|COMPLETED|Overall Study||22
8682047|NCT00805480|9726092|FG002|COMPLETED|Overall Study||19
8682048|NCT00805480|9726093|FG003|COMPLETED|Overall Study||5
8682049|NCT00805480|9726090|FG000|NOT COMPLETED|Overall Study||14
8800720|NCT01447225|9852584|FG006|NOT COMPLETED|Overall Study||0
8800721|NCT01447225|9852585|FG007|NOT COMPLETED|Overall Study||0
8800722|NCT01447225|9852586|FG008|NOT COMPLETED|Overall Study||0
8800723|NCT01447225|9852587|FG009|NOT COMPLETED|Overall Study||0
8800724|NCT01447407|9852623|FG000|STARTED|Overall Study||41
8800725|NCT01447407|9852624|FG001|STARTED|Overall Study||40
8800726|NCT01447407|9852625|FG002|STARTED|Overall Study||41
8800727|NCT01447407|9852626|FG003|STARTED|Overall Study||42
8800728|NCT01447407|9852623|FG000|COMPLETED|Overall Study||39
8800729|NCT01447407|9852624|FG001|COMPLETED|Overall Study||40
8800730|NCT01447407|9852625|FG002|COMPLETED|Overall Study||40
8800731|NCT01447407|9852626|FG003|COMPLETED|Overall Study||40
8800732|NCT01447407|9852623|FG000|NOT COMPLETED|Overall Study||2
8800733|NCT01447407|9852624|FG001|NOT COMPLETED|Overall Study||0
8800734|NCT01447407|9852625|FG002|NOT COMPLETED|Overall Study||1
8800735|NCT01447407|9852626|FG003|NOT COMPLETED|Overall Study||2
8800736|NCT01447420|9852639|FG000|STARTED|Overall Study||39
8800737|NCT01447420|9852640|FG001|STARTED|Overall Study||72
8800738|NCT01447420|9852641|FG002|STARTED|Overall Study||18
8800739|NCT01447420|9852639|FG000|COMPLETED|Overall Study||29
8800740|NCT01447420|9852640|FG001|COMPLETED|Overall Study||45
8800741|NCT01447420|9852641|FG002|COMPLETED|Overall Study||8
8800742|NCT01447420|9852639|FG000|NOT COMPLETED|Overall Study||10
8800743|NCT01447420|9852640|FG001|NOT COMPLETED|Overall Study||27
8800744|NCT01447420|9852641|FG002|NOT COMPLETED|Overall Study||10
8800745|NCT01447433|9852650|FG000|STARTED|Overall Study||26
8800746|NCT01447433|9852651|FG001|STARTED|Overall Study||27
8800747|NCT01447433|9852650|FG000|COMPLETED|Overall Study||22
8682050|NCT00805480|9726091|FG001|NOT COMPLETED|Overall Study||7
8682051|NCT00805480|9726092|FG002|NOT COMPLETED|Overall Study||12
8682052|NCT00805480|9726093|FG003|NOT COMPLETED|Overall Study||5
8682053|NCT00805493|9726106|FG000|STARTED|Overall Study||3
8682054|NCT00805493|9726107|FG001|STARTED|Overall Study||2
8682055|NCT00805493|9726108|FG002|STARTED|Overall Study||1
8682056|NCT00805493|9726106|FG000|COMPLETED|Overall Study||1
8682057|NCT00805493|9726107|FG001|COMPLETED|Overall Study||2
8682058|NCT00805493|9726108|FG002|COMPLETED|Overall Study||0
8682059|NCT00805493|9726106|FG000|NOT COMPLETED|Overall Study||2
8682060|NCT00805493|9726107|FG001|NOT COMPLETED|Overall Study||0
8682061|NCT00805493|9726108|FG002|NOT COMPLETED|Overall Study||1
8682062|NCT00805532|9726121|FG000|STARTED|Overall Study||42
8682063|NCT00805532|9726122|FG001|STARTED|Overall Study||39
8682064|NCT00805532|9726121|FG000|COMPLETED|Overall Study|We did intent-to-treat analyses so 42 participants' data were analyzed.|42
8682065|NCT00805532|9726122|FG001|COMPLETED|Overall Study||38
8682066|NCT00805532|9726121|FG000|NOT COMPLETED|Overall Study||0
8682067|NCT00805532|9726122|FG001|NOT COMPLETED|Overall Study||1
8682068|NCT00805545|9726132|FG000|STARTED|Overall Study||200
8682069|NCT00805545|9726133|FG001|STARTED|Overall Study||200
8682070|NCT00805545|9726132|FG000|COMPLETED|Overall Study||194
8682071|NCT00805545|9726133|FG001|COMPLETED|Overall Study||197
8682072|NCT00805545|9726132|FG000|NOT COMPLETED|Overall Study||6
8682073|NCT00805545|9726133|FG001|NOT COMPLETED|Overall Study||3
8682074|NCT00805675|9726142|FG000|STARTED|Overall Study||16
8682075|NCT00805675|9726143|FG001|STARTED|Overall Study||14
8682076|NCT00805675|9726144|FG002|STARTED|Overall Study||16
8682077|NCT00805675|9726142|FG000|COMPLETED|Overall Study||16
8682078|NCT00805675|9726143|FG001|COMPLETED|Overall Study||14
8682079|NCT00805675|9726144|FG002|COMPLETED|Overall Study||15
8682080|NCT00805675|9726142|FG000|NOT COMPLETED|Overall Study||0
8682081|NCT00805675|9726143|FG001|NOT COMPLETED|Overall Study||0
8682082|NCT00805675|9726144|FG002|NOT COMPLETED|Overall Study||1
8682083|NCT00805740|9726154|FG000|STARTED|Overall Study||28
8682084|NCT00805740|9726155|FG001|STARTED|Overall Study||13
8682085|NCT00805740|9726154|FG000|Treated|Overall Study||26
8682086|NCT00805740|9726155|FG001|Treated|Overall Study||13
8682087|NCT00805740|9726154|FG000|COMPLETED|Overall Study||17
8682088|NCT00805740|9726155|FG001|COMPLETED|Overall Study||9
8682089|NCT00805740|9726154|FG000|NOT COMPLETED|Overall Study||11
8682090|NCT00805740|9726155|FG001|NOT COMPLETED|Overall Study||4
8682091|NCT00805766|9726161|FG000|STARTED|Screening Period||45
8682092|NCT00805766|9726161|FG000|COMPLETED|Screening Period||39
8682093|NCT00805766|9726161|FG000|NOT COMPLETED|Screening Period||6
8682094|NCT00805766|9726161|FG000|STARTED|Increased Dose Period||39
8682095|NCT00805766|9726161|FG000|COMPLETED|Increased Dose Period||26
8682096|NCT00805766|9726161|FG000|NOT COMPLETED|Increased Dose Period||13
8682097|NCT00805792|9726169|FG000|STARTED|Overall Study||33
8682098|NCT00805792|9726169|FG000|COMPLETED|Overall Study||28
8682099|NCT00805792|9726169|FG000|NOT COMPLETED|Overall Study||5
8682100|NCT00805870|9726175|FG000|STARTED|Overall Study||10
8682101|NCT00805870|9726176|FG001|STARTED|Overall Study||10
8682102|NCT00805870|9726175|FG000|COMPLETED|Overall Study||10
8682103|NCT00805870|9726176|FG001|COMPLETED|Overall Study||10
8682104|NCT00805870|9726175|FG000|NOT COMPLETED|Overall Study||0
8682105|NCT00805870|9726176|FG001|NOT COMPLETED|Overall Study||0
8682106|NCT00805935|9726186|FG000|STARTED|Overall Study||25
8682107|NCT00805935|9726187|FG001|STARTED|Overall Study||27
8682108|NCT00805935|9726188|FG002|STARTED|Overall Study||28
8682109|NCT00805935|9726189|FG003|STARTED|Overall Study||30
8682110|NCT00805935|9726186|FG000|COMPLETED|Overall Study||12
8682111|NCT00805935|9726187|FG001|COMPLETED|Overall Study||8
8682112|NCT00805935|9726188|FG002|COMPLETED|Overall Study||13
8682113|NCT00805935|9726189|FG003|COMPLETED|Overall Study||19
8682114|NCT00805935|9726186|FG000|NOT COMPLETED|Overall Study||13
8682115|NCT00805935|9726187|FG001|NOT COMPLETED|Overall Study||19
8682116|NCT00805935|9726188|FG002|NOT COMPLETED|Overall Study||15
8682117|NCT00805935|9726189|FG003|NOT COMPLETED|Overall Study||11
8682118|NCT00805948|9726203|FG000|STARTED|Overall Study||154
8682119|NCT00805948|9726204|FG001|STARTED|Overall Study||195
8682120|NCT00805948|9726203|FG000|COMPLETED|Overall Study||86
8682121|NCT00805948|9726204|FG001|COMPLETED|Overall Study||99
8682122|NCT00805948|9726203|FG000|NOT COMPLETED|Overall Study||68
8682123|NCT00805948|9726204|FG001|NOT COMPLETED|Overall Study||96
8682124|NCT00806026|9726217|FG000|STARTED|Overall Study||185
8682125|NCT00806026|9726218|FG001|STARTED|Overall Study||183
8682126|NCT00806026|9726219|FG002|STARTED|Overall Study||182
8682127|NCT00806026|9726220|FG003|STARTED|Overall Study||61
8682128|NCT00806026|9726221|FG004|STARTED|Overall Study||59
8682129|NCT00806026|9726222|FG005|STARTED|Overall Study||61
8682130|NCT00806026|9726217|FG000|Treated|Overall Study||182
8682131|NCT00806026|9726218|FG001|Treated|Overall Study||178
8682132|NCT00806026|9726219|FG002|Treated|Overall Study||180
8682133|NCT00806026|9726220|FG003|Treated|Overall Study||59
8682134|NCT00806026|9726221|FG004|Treated|Overall Study||59
8682135|NCT00806026|9726222|FG005|Treated|Overall Study||61
8682136|NCT00806026|9726217|FG000|COMPLETED|Overall Study||93
8682137|NCT00806026|9726218|FG001|COMPLETED|Overall Study||82
8682138|NCT00806026|9726219|FG002|COMPLETED|Overall Study||89
8682139|NCT00806026|9726220|FG003|COMPLETED|Overall Study||32
8682140|NCT00806026|9726221|FG004|COMPLETED|Overall Study||29
8682141|NCT00806026|9726222|FG005|COMPLETED|Overall Study||29
8682142|NCT00806026|9726217|FG000|NOT COMPLETED|Overall Study||92
8682143|NCT00806026|9726218|FG001|NOT COMPLETED|Overall Study||101
8682144|NCT00806026|9726219|FG002|NOT COMPLETED|Overall Study||93
8682145|NCT00806026|9726220|FG003|NOT COMPLETED|Overall Study||29
8682146|NCT00806026|9726221|FG004|NOT COMPLETED|Overall Study||30
8682147|NCT00806026|9726222|FG005|NOT COMPLETED|Overall Study||32
8682148|NCT00806078|9726236|FG000|STARTED|First Intervention||9
8682149|NCT00806078|9726237|FG001|STARTED|First Intervention||9
8682150|NCT00806078|9726236|FG000|COMPLETED|First Intervention||9
8682151|NCT00806078|9726237|FG001|COMPLETED|First Intervention||9
8682152|NCT00806078|9726236|FG000|NOT COMPLETED|First Intervention||0
8682153|NCT00806078|9726237|FG001|NOT COMPLETED|First Intervention||0
8682154|NCT00806078|9726236|FG000|STARTED|7 Day Washout Period||9
8682155|NCT00806078|9726237|FG001|STARTED|7 Day Washout Period||9
8682156|NCT00806078|9726236|FG000|COMPLETED|7 Day Washout Period||9
8682157|NCT00806078|9726237|FG001|COMPLETED|7 Day Washout Period||9
8682158|NCT00806078|9726236|FG000|NOT COMPLETED|7 Day Washout Period||0
8682159|NCT00806078|9726237|FG001|NOT COMPLETED|7 Day Washout Period||0
8682160|NCT00806078|9726236|FG000|STARTED|Second Intervention||9
8682161|NCT00806078|9726237|FG001|STARTED|Second Intervention||9
8682162|NCT00806078|9726236|FG000|COMPLETED|Second Intervention||9
8800748|NCT01447433|9852651|FG001|COMPLETED|Overall Study||21
8800749|NCT01447433|9852650|FG000|NOT COMPLETED|Overall Study||4
8800750|NCT01447433|9852651|FG001|NOT COMPLETED|Overall Study||6
8800751|NCT01447446|9852663|FG000|STARTED|Overall Study|Started means participants who started treatment and included in core population.|2312
8800752|NCT01447446|9852664|FG001|STARTED|Overall Study||496
8800753|NCT01447446|9852665|FG002|STARTED|Overall Study||292
8800754|NCT01447446|9852666|FG003|STARTED|Overall Study||93
8800755|NCT01447446|9852667|FG004|STARTED|Overall Study||821
8800756|NCT01447446|9852668|FG005|STARTED|Overall Study||86
8800757|NCT01447446|9852663|FG000|COMPLETED|Overall Study|Completed means the participants who completed the 24- weeks of follow-up period.|1590
8800758|NCT01447446|9852664|FG001|COMPLETED|Overall Study|Insuff.=Insufficient VR= Virological response TRT.=Treatment SVR= Sustained Virological Response|331
8800759|NCT01447446|9852665|FG002|COMPLETED|Overall Study||192
8800760|NCT01447446|9852666|FG003|COMPLETED|Overall Study||60
8800761|NCT01447446|9852667|FG004|COMPLETED|Overall Study||610
8800762|NCT01447446|9852668|FG005|COMPLETED|Overall Study||54
8800763|NCT01447446|9852663|FG000|NOT COMPLETED|Overall Study||722
8800764|NCT01447446|9852664|FG001|NOT COMPLETED|Overall Study||165
8800765|NCT01447446|9852665|FG002|NOT COMPLETED|Overall Study||100
8800766|NCT01447446|9852666|FG003|NOT COMPLETED|Overall Study||33
8800767|NCT01447446|9852667|FG004|NOT COMPLETED|Overall Study||211
8800768|NCT01447446|9852668|FG005|NOT COMPLETED|Overall Study||32
8800769|NCT01447511|9852693|FG000|STARTED|Control Period||8
8800770|NCT01447511|9852694|FG001|STARTED|Control Period||5
8800771|NCT01447511|9852695|FG002|STARTED|Control Period||9
8800772|NCT01447511|9852696|FG003|STARTED|Control Period||3
8800773|NCT01447511|9852697|FG004|STARTED|Control Period||4
8800774|NCT01447511|9852693|FG000|COMPLETED|Control Period||8
8800775|NCT01447511|9852694|FG001|COMPLETED|Control Period||5
8800776|NCT01447511|9852695|FG002|COMPLETED|Control Period||9
8800777|NCT01447511|9852696|FG003|COMPLETED|Control Period||3
8800778|NCT01447511|9852697|FG004|COMPLETED|Control Period||4
8800779|NCT01447511|9852693|FG000|NOT COMPLETED|Control Period||0
8800780|NCT01447511|9852694|FG001|NOT COMPLETED|Control Period||0
8800781|NCT01447511|9852695|FG002|NOT COMPLETED|Control Period||0
8800782|NCT01447511|9852696|FG003|NOT COMPLETED|Control Period||0
8800783|NCT01447511|9852697|FG004|NOT COMPLETED|Control Period||0
8800784|NCT01447511|9852693|FG000|STARTED|Fluconazole Period||8
8800785|NCT01447511|9852694|FG001|STARTED|Fluconazole Period||0
8800786|NCT01447511|9852695|FG002|STARTED|Fluconazole Period||9
8800787|NCT01447511|9852696|FG003|STARTED|Fluconazole Period||3
8919259|NCT02207231|9979267|FG001|STARTED|Active Controlled Period: Week 16 - 48||322
8919260|NCT02207231|9979268|FG002|STARTED|Active Controlled Period: Week 16 - 48||324
8919261|NCT02207231|9979269|FG003|STARTED|Active Controlled Period: Week 16 - 48||0
8919262|NCT02207231|9979266|FG000|COMPLETED|Active Controlled Period: Week 16 - 48||162
8919263|NCT02207231|9979267|FG001|COMPLETED|Active Controlled Period: Week 16 - 48||301
8919264|NCT02207231|9979268|FG002|COMPLETED|Active Controlled Period: Week 16 - 48||281
8919265|NCT02207231|9979269|FG003|COMPLETED|Active Controlled Period: Week 16 - 48||0
8919266|NCT02207231|9979266|FG000|NOT COMPLETED|Active Controlled Period: Week 16 - 48||3
8919267|NCT02207231|9979267|FG001|NOT COMPLETED|Active Controlled Period: Week 16 - 48||21
8919268|NCT02207231|9979268|FG002|NOT COMPLETED|Active Controlled Period: Week 16 - 48||43
8919269|NCT02207231|9979269|FG003|NOT COMPLETED|Active Controlled Period: Week 16 - 48||0
8919270|NCT02207231|9979266|FG000|STARTED|Open-label Guselkumab: Week 48 - 264||0
8919271|NCT02207231|9979267|FG001|STARTED|Open-label Guselkumab: Week 48 - 264||0
8919272|NCT02207231|9979268|FG002|STARTED|Open-label Guselkumab: Week 48 - 264|One participant did not crossover at Week 52 due to adverse event.|280
8919273|NCT02207231|9979269|FG003|STARTED|Open-label Guselkumab: Week 48 - 264|162 + 301= 463|463
8919274|NCT02207231|9979266|FG000|COMPLETED|Open-label Guselkumab: Week 48 - 264||0
8919275|NCT02207231|9979267|FG001|COMPLETED|Open-label Guselkumab: Week 48 - 264||0
8682163|NCT00806078|9726237|FG001|COMPLETED|Second Intervention||9
8682164|NCT00806078|9726236|FG000|NOT COMPLETED|Second Intervention||0
8800788|NCT01447511|9852697|FG004|STARTED|Fluconazole Period||4
8800789|NCT01447511|9852693|FG000|COMPLETED|Fluconazole Period||8
8800790|NCT01447511|9852694|FG001|COMPLETED|Fluconazole Period||0
8682165|NCT00806078|9726237|FG001|NOT COMPLETED|Second Intervention||0
8682166|NCT00806156|9726245|FG000|STARTED|Overall Study||39
8682167|NCT00806156|9726246|FG001|STARTED|Overall Study||139
8682168|NCT00806156|9726245|FG000|COMPLETED|Overall Study||0
8682169|NCT00806156|9726246|FG001|COMPLETED|Overall Study||0
8682170|NCT00806156|9726245|FG000|NOT COMPLETED|Overall Study||39
8682171|NCT00806156|9726246|FG001|NOT COMPLETED|Overall Study||139
8682172|NCT00806195|9726268|FG000|STARTED|Overall Study||4363
8682173|NCT00806195|9726269|FG001|STARTED|Overall Study||1483
8682174|NCT00806195|9726270|FG002|STARTED|Overall Study||1409
8682175|NCT00806195|9726271|FG003|STARTED|Overall Study||489
8682176|NCT00806195|9726268|FG000|COMPLETED|Overall Study||3849
8682177|NCT00806195|9726269|FG001|COMPLETED|Overall Study||1321
8682178|NCT00806195|9726270|FG002|COMPLETED|Overall Study||1139
8682179|NCT00806195|9726271|FG003|COMPLETED|Overall Study||383
8682180|NCT00806195|9726268|FG000|NOT COMPLETED|Overall Study||514
8682181|NCT00806195|9726269|FG001|NOT COMPLETED|Overall Study||162
8682182|NCT00806195|9726270|FG002|NOT COMPLETED|Overall Study||270
8682183|NCT00806195|9726271|FG003|NOT COMPLETED|Overall Study||106
8682184|NCT00806221|9726283|FG000|STARTED|Overall Study||22
8682185|NCT00806221|9726283|FG000|COMPLETED|Overall Study||20
8682186|NCT00806221|9726283|FG000|NOT COMPLETED|Overall Study||2
8682187|NCT00806234|9726290|FG000|STARTED|Overall Study||47
8682188|NCT00806234|9726291|FG001|STARTED|Overall Study||31
8682189|NCT00806234|9726292|FG002|STARTED|Overall Study||49
8682190|NCT00806234|9726290|FG000|COMPLETED|Overall Study||34
8682191|NCT00806234|9726291|FG001|COMPLETED|Overall Study||19
8682192|NCT00806234|9726292|FG002|COMPLETED|Overall Study||37
8682193|NCT00806234|9726290|FG000|NOT COMPLETED|Overall Study||13
8682194|NCT00806234|9726291|FG001|NOT COMPLETED|Overall Study||12
8682195|NCT00806234|9726292|FG002|NOT COMPLETED|Overall Study||12
8682196|NCT00806260|9726306|FG000|STARTED|Period 1 (1 Day)||15
8682197|NCT00806260|9726307|FG001|STARTED|Period 1 (1 Day)||8
8682198|NCT00806260|9726308|FG002|STARTED|Period 1 (1 Day)||8
8682199|NCT00806260|9726309|FG003|STARTED|Period 1 (1 Day)||14
8682200|NCT00806260|9726310|FG004|STARTED|Period 1 (1 Day)||18
8682201|NCT00806260|9726311|FG005|STARTED|Period 1 (1 Day)||17
8682202|NCT00806260|9726306|FG000|COMPLETED|Period 1 (1 Day)||15
8682203|NCT00806260|9726307|FG001|COMPLETED|Period 1 (1 Day)||8
8682204|NCT00806260|9726308|FG002|COMPLETED|Period 1 (1 Day)||8
8682205|NCT00806260|9726309|FG003|COMPLETED|Period 1 (1 Day)||14
8682206|NCT00806260|9726310|FG004|COMPLETED|Period 1 (1 Day)|did not move onto Periods 2 and 3 due to adjusted design of study|15
8682207|NCT00806260|9726311|FG005|COMPLETED|Period 1 (1 Day)|did not move onto Periods 2 and 3 due to adjusted design of study|17
8682208|NCT00806260|9726306|FG000|NOT COMPLETED|Period 1 (1 Day)||0
8682209|NCT00806260|9726307|FG001|NOT COMPLETED|Period 1 (1 Day)||0
8682210|NCT00806260|9726308|FG002|NOT COMPLETED|Period 1 (1 Day)||0
8682211|NCT00806260|9726309|FG003|NOT COMPLETED|Period 1 (1 Day)||0
8682212|NCT00806260|9726310|FG004|NOT COMPLETED|Period 1 (1 Day)||3
8682213|NCT00806260|9726311|FG005|NOT COMPLETED|Period 1 (1 Day)||0
8682214|NCT00806260|9726306|FG000|STARTED|Period 2||15
8682215|NCT00806260|9726307|FG001|STARTED|Period 2||8
8682216|NCT00806260|9726308|FG002|STARTED|Period 2||8
8682217|NCT00806260|9726309|FG003|STARTED|Period 2||14
8682218|NCT00806260|9726310|FG004|STARTED|Period 2||0
8682219|NCT00806260|9726311|FG005|STARTED|Period 2||0
8682220|NCT00806260|9726306|FG000|COMPLETED|Period 2||13
8682221|NCT00806260|9726307|FG001|COMPLETED|Period 2||8
8682222|NCT00806260|9726308|FG002|COMPLETED|Period 2||6
8682223|NCT00806260|9726309|FG003|COMPLETED|Period 2||12
8682224|NCT00806260|9726310|FG004|COMPLETED|Period 2||0
8682225|NCT00806260|9726311|FG005|COMPLETED|Period 2||0
8682226|NCT00806260|9726306|FG000|NOT COMPLETED|Period 2||2
8682227|NCT00806260|9726307|FG001|NOT COMPLETED|Period 2||0
8682228|NCT00806260|9726308|FG002|NOT COMPLETED|Period 2||2
8682229|NCT00806260|9726309|FG003|NOT COMPLETED|Period 2||2
8682230|NCT00806260|9726310|FG004|NOT COMPLETED|Period 2||0
8682231|NCT00806260|9726311|FG005|NOT COMPLETED|Period 2||0
8682232|NCT00806260|9726306|FG000|STARTED|Period 3||13
8682233|NCT00806260|9726307|FG001|STARTED|Period 3||8
8682234|NCT00806260|9726308|FG002|STARTED|Period 3||6
8682235|NCT00806260|9726309|FG003|STARTED|Period 3||12
8682236|NCT00806260|9726310|FG004|STARTED|Period 3||0
8682237|NCT00806260|9726311|FG005|STARTED|Period 3||0
8682238|NCT00806260|9726306|FG000|COMPLETED|Period 3||12
8682239|NCT00806260|9726307|FG001|COMPLETED|Period 3||7
8682240|NCT00806260|9726308|FG002|COMPLETED|Period 3||5
8682241|NCT00806260|9726309|FG003|COMPLETED|Period 3||12
8682242|NCT00806260|9726310|FG004|COMPLETED|Period 3||0
8682243|NCT00806260|9726311|FG005|COMPLETED|Period 3||0
8682244|NCT00806260|9726306|FG000|NOT COMPLETED|Period 3||1
8682245|NCT00806260|9726307|FG001|NOT COMPLETED|Period 3||1
8682246|NCT00806260|9726308|FG002|NOT COMPLETED|Period 3||1
8682247|NCT00806260|9726309|FG003|NOT COMPLETED|Period 3||0
8682248|NCT00806260|9726310|FG004|NOT COMPLETED|Period 3||0
8682249|NCT00806260|9726311|FG005|NOT COMPLETED|Period 3||0
8682250|NCT00806286|9726326|FG000|STARTED|Overall Study||54
8682251|NCT00806286|9726327|FG001|STARTED|Overall Study||54
8682252|NCT00806286|9726328|FG002|STARTED|Overall Study||3
8682253|NCT00806286|9726326|FG000|COMPLETED|Overall Study||0
8682254|NCT00806286|9726327|FG001|COMPLETED|Overall Study||0
8682255|NCT00806286|9726328|FG002|COMPLETED|Overall Study||0
8682256|NCT00806286|9726326|FG000|NOT COMPLETED|Overall Study||54
8682257|NCT00806286|9726327|FG001|NOT COMPLETED|Overall Study||54
8682258|NCT00806286|9726328|FG002|NOT COMPLETED|Overall Study||3
8682259|NCT00806351|9726338|FG000|STARTED|Overall Study||15
8682260|NCT00806351|9726339|FG001|STARTED|Overall Study||6
8682261|NCT00806351|9726338|FG000|COMPLETED|Overall Study||10
8682262|NCT00806351|9726339|FG001|COMPLETED|Overall Study||2
8682263|NCT00806351|9726338|FG000|NOT COMPLETED|Overall Study||5
8682264|NCT00806351|9726339|FG001|NOT COMPLETED|Overall Study||4
8682265|NCT00806442|9726345|FG000|STARTED|Overall Study||18
8682266|NCT00806442|9726346|FG001|STARTED|Overall Study||21
8682267|NCT00806442|9726345|FG000|First Intervention (3 Wks)|Overall Study||18
8682268|NCT00806442|9726346|FG001|First Intervention (3 Wks)|Overall Study||21
8682269|NCT00806442|9726345|FG000|Washout (3 Wks)|Overall Study||15
8682270|NCT00806442|9726346|FG001|Washout (3 Wks)|Overall Study||14
8682271|NCT00806442|9726345|FG000|Second Intervention (3 Wks)|Overall Study||15
8682272|NCT00806442|9726346|FG001|Second Intervention (3 Wks)|Overall Study||14
8682273|NCT00806442|9726345|FG000|COMPLETED|Overall Study||14
8682274|NCT00806442|9726346|FG001|COMPLETED|Overall Study||14
8682275|NCT00806442|9726345|FG000|NOT COMPLETED|Overall Study||4
8682276|NCT00806442|9726346|FG001|NOT COMPLETED|Overall Study||7
8682277|NCT00806494|9726354|FG000|STARTED|Overall Study||331
8682278|NCT00806494|9726354|FG000|COMPLETED|Overall Study||251
8682279|NCT00806494|9726354|FG000|NOT COMPLETED|Overall Study||80
8682280|NCT00806546|9726359|FG000|STARTED|Overall Study|35 subjects were enrolled but did not treat for a total of 479 subjects in the safety population|514
8682281|NCT00806546|9726359|FG000|COMPLETED|Overall Study||207
8682282|NCT00806546|9726359|FG000|NOT COMPLETED|Overall Study||307
8682283|NCT00806585|9726368|FG000|STARTED|Overall Study||137
8682284|NCT00806585|9726369|FG001|STARTED|Overall Study||134
8682285|NCT00806585|9726370|FG002|STARTED|Overall Study||141
8682286|NCT00806585|9726371|FG003|STARTED|Overall Study||71
8682287|NCT00806585|9726372|FG004|STARTED|Overall Study||137
8682288|NCT00806585|9726368|FG000|COMPLETED|Overall Study||105
8682289|NCT00806585|9726369|FG001|COMPLETED|Overall Study||103
8682290|NCT00806585|9726370|FG002|COMPLETED|Overall Study||109
8682291|NCT00806585|9726371|FG003|COMPLETED|Overall Study||56
8682292|NCT00806585|9726372|FG004|COMPLETED|Overall Study||106
8682293|NCT00806585|9726368|FG000|NOT COMPLETED|Overall Study||32
8682294|NCT00806585|9726369|FG001|NOT COMPLETED|Overall Study||31
8682295|NCT00806585|9726370|FG002|NOT COMPLETED|Overall Study||32
8682296|NCT00806585|9726371|FG003|NOT COMPLETED|Overall Study||15
8682297|NCT00806585|9726372|FG004|NOT COMPLETED|Overall Study||31
8682298|NCT00806598|9726384|FG000|STARTED|Overall Study||48
8682299|NCT00806598|9726384|FG000|COMPLETED|Overall Study||48
8682300|NCT00806598|9726384|FG000|NOT COMPLETED|Overall Study||0
8682301|NCT00806624|9726391|FG000|STARTED|Overall Study||79
8682302|NCT00806624|9726392|FG001|STARTED|Overall Study||80
8682303|NCT00806624|9726393|FG002|STARTED|Overall Study||75
8682304|NCT00806624|9726391|FG000|COMPLETED|Overall Study||70
8682305|NCT00806624|9726392|FG001|COMPLETED|Overall Study||68
8682306|NCT00806624|9726393|FG002|COMPLETED|Overall Study||69
8682307|NCT00806624|9726391|FG000|NOT COMPLETED|Overall Study||9
8682308|NCT00806624|9726392|FG001|NOT COMPLETED|Overall Study||12
8682309|NCT00806624|9726393|FG002|NOT COMPLETED|Overall Study||6
8682310|NCT00806676|9726404|FG000|STARTED|Overall Study||29
8682311|NCT00806676|9726405|FG001|STARTED|Overall Study||9
8682312|NCT00806676|9726406|FG002|STARTED|Overall Study||29
8682313|NCT00806676|9726404|FG000|COMPLETED|Overall Study||25
8682314|NCT00806676|9726405|FG001|COMPLETED|Overall Study||9
8682315|NCT00806676|9726406|FG002|COMPLETED|Overall Study||23
8682316|NCT00806676|9726404|FG000|NOT COMPLETED|Overall Study||4
8682317|NCT00806676|9726405|FG001|NOT COMPLETED|Overall Study||0
8682318|NCT00806676|9726406|FG002|NOT COMPLETED|Overall Study||6
8682319|NCT00806819|9726417|FG000|STARTED|Overall Study|randomised patients|353
8682320|NCT00806819|9726418|FG001|STARTED|Overall Study|randomised patients|360
8682321|NCT00806819|9726417|FG000|COMPLETED|Overall Study|On-treatment at analysis DBL date (15 February 2013)|7
8682322|NCT00806819|9726418|FG001|COMPLETED|Overall Study|On-treatment at analysis DBL date (15 February 2013)|2
8682323|NCT00806819|9726417|FG000|NOT COMPLETED|Overall Study||346
8682324|NCT00806819|9726418|FG001|NOT COMPLETED|Overall Study||358
8682325|NCT00806988|9726427|FG000|STARTED|Overall Study||150
8682326|NCT00806988|9726428|FG001|STARTED|Overall Study||151
8682327|NCT00806988|9726427|FG000|COMPLETED|Overall Study||123
8682328|NCT00806988|9726428|FG001|COMPLETED|Overall Study||108
8682329|NCT00806988|9726427|FG000|NOT COMPLETED|Overall Study||27
8682330|NCT00806988|9726428|FG001|NOT COMPLETED|Overall Study||43
8682331|NCT00807001|9726439|FG000|STARTED|Overall Study|For all groups, number of subjects who received at least one dose of study drug.|8
8682332|NCT00807001|9726440|FG001|STARTED|Overall Study||8
8682333|NCT00807001|9726441|FG002|STARTED|Overall Study||8
8682334|NCT00807001|9726442|FG003|STARTED|Overall Study||8
8682335|NCT00807001|9726443|FG004|STARTED|Overall Study||9
8682336|NCT00807001|9726439|FG000|COMPLETED|Overall Study||8
8682337|NCT00807001|9726440|FG001|COMPLETED|Overall Study||7
8682338|NCT00807001|9726441|FG002|COMPLETED|Overall Study||8
8682339|NCT00807001|9726442|FG003|COMPLETED|Overall Study||8
8682340|NCT00807001|9726443|FG004|COMPLETED|Overall Study||9
8682341|NCT00807001|9726439|FG000|NOT COMPLETED|Overall Study||0
8682342|NCT00807001|9726440|FG001|NOT COMPLETED|Overall Study||1
8682343|NCT00807001|9726441|FG002|NOT COMPLETED|Overall Study||0
8682344|NCT00807001|9726442|FG003|NOT COMPLETED|Overall Study||0
8682345|NCT00807001|9726443|FG004|NOT COMPLETED|Overall Study||0
8682346|NCT00807014|9726457|FG000|STARTED|Overall Study||83
8682347|NCT00807014|9726458|FG001|STARTED|Overall Study||85
8682348|NCT00807014|9726457|FG000|COMPLETED|Overall Study||56
8682349|NCT00807014|9726458|FG001|COMPLETED|Overall Study||58
8682350|NCT00807014|9726457|FG000|NOT COMPLETED|Overall Study||27
8682351|NCT00807014|9726458|FG001|NOT COMPLETED|Overall Study||27
8682352|NCT00807040|9726466|FG000|STARTED|Overall Study||126
8682353|NCT00807040|9726467|FG001|STARTED|Overall Study||125
8682354|NCT00807040|9726466|FG000|COMPLETED|Overall Study||90
8682355|NCT00807040|9726467|FG001|COMPLETED|Overall Study||84
8682356|NCT00807040|9726466|FG000|NOT COMPLETED|Overall Study||36
8682357|NCT00807040|9726467|FG001|NOT COMPLETED|Overall Study||41
8682358|NCT00807092|9726475|FG000|STARTED|Overall Study||72
8682359|NCT00807092|9726476|FG001|STARTED|Overall Study||73
8682360|NCT00807092|9726475|FG000|Exposed to Drug|Overall Study|Subject was randomised, but not exposed to any trial drug|71
8682361|NCT00807092|9726476|FG001|Exposed to Drug|Overall Study||73
8682362|NCT00807092|9726475|FG000|COMPLETED|Overall Study||71
8682363|NCT00807092|9726476|FG001|COMPLETED|Overall Study||69
8682364|NCT00807092|9726475|FG000|NOT COMPLETED|Overall Study||1
8682365|NCT00807092|9726476|FG001|NOT COMPLETED|Overall Study||4
8682366|NCT00807144|9726484|FG000|STARTED|Overall Study||52
8682367|NCT00807144|9726485|FG001|STARTED|Overall Study||50
8682368|NCT00807144|9726484|FG000|COMPLETED|Overall Study||52
8682369|NCT00807144|9726485|FG001|COMPLETED|Overall Study||49
8682370|NCT00807144|9726484|FG000|NOT COMPLETED|Overall Study||0
8682371|NCT00807144|9726485|FG001|NOT COMPLETED|Overall Study||1
8682372|NCT00807209|9726494|FG000|STARTED|Overall Study||1
8682373|NCT00807209|9726495|FG001|STARTED|Overall Study||1
8682374|NCT00807209|9726496|FG002|STARTED|Overall Study||1
8682375|NCT00807209|9726494|FG000|COMPLETED|Overall Study||1
8682376|NCT00807209|9726495|FG001|COMPLETED|Overall Study||1
8682377|NCT00807209|9726496|FG002|COMPLETED|Overall Study||1
8682378|NCT00807209|9726494|FG000|NOT COMPLETED|Overall Study||0
8682379|NCT00807209|9726495|FG001|NOT COMPLETED|Overall Study||0
8682380|NCT00807209|9726496|FG002|NOT COMPLETED|Overall Study||0
8682381|NCT00807235|9726506|FG000|STARTED|Overall Study||11
8682382|NCT00807235|9726507|FG001|STARTED|Overall Study||6
8682383|NCT00807235|9726506|FG000|COMPLETED|Overall Study||10
8682384|NCT00807235|9726507|FG001|COMPLETED|Overall Study||6
8682385|NCT00807235|9726506|FG000|NOT COMPLETED|Overall Study||1
8682386|NCT00807235|9726507|FG001|NOT COMPLETED|Overall Study||0
8682387|NCT00807248|9726517|FG000|STARTED|Overall Study||71
8682388|NCT00807248|9726518|FG001|STARTED|Overall Study||140
8682389|NCT00807248|9726519|FG002|STARTED|Overall Study||139
8682390|NCT00807248|9726520|FG003|STARTED|Overall Study||140
8682391|NCT00807248|9726517|FG000|COMPLETED|Overall Study||50
8682392|NCT00807248|9726518|FG001|COMPLETED|Overall Study||128
8682393|NCT00807248|9726519|FG002|COMPLETED|Overall Study||121
8682394|NCT00807248|9726520|FG003|COMPLETED|Overall Study||126
8682395|NCT00807248|9726517|FG000|NOT COMPLETED|Overall Study||21
8682396|NCT00807248|9726518|FG001|NOT COMPLETED|Overall Study||12
8682397|NCT00807248|9726519|FG002|NOT COMPLETED|Overall Study||18
8682398|NCT00807248|9726520|FG003|NOT COMPLETED|Overall Study||14
8682399|NCT00807456|9726530|FG000|STARTED|Overall Study||65
8682400|NCT00807456|9726530|FG000|COMPLETED|Overall Study||65
8682401|NCT00807456|9726530|FG000|NOT COMPLETED|Overall Study||0
8682402|NCT00807495|9726539|FG000|STARTED|Overall Study||22
8682403|NCT00807495|9726540|FG001|STARTED|Overall Study||13
8682404|NCT00807495|9726541|FG002|STARTED|Overall Study||5
8682405|NCT00807495|9726542|FG003|STARTED|Overall Study||1
8682406|NCT00807495|9726543|FG004|STARTED|Overall Study|An ATL participant had late on-study biopsy and was in DLBL, reducing ATL participants from 8 to 7.|7
8682407|NCT00807495|9726539|FG000|COMPLETED|Overall Study|Completed = participants who completed the study treatment to PD or symptomatic deterioration.|14
8682408|NCT00807495|9726540|FG001|COMPLETED|Overall Study||7
8682409|NCT00807495|9726541|FG002|COMPLETED|Overall Study||1
8682410|NCT00807495|9726542|FG003|COMPLETED|Overall Study||0
8682411|NCT00807495|9726543|FG004|COMPLETED|Overall Study||2
8682412|NCT00807495|9726539|FG000|NOT COMPLETED|Overall Study||8
8682413|NCT00807495|9726540|FG001|NOT COMPLETED|Overall Study||6
8682414|NCT00807495|9726541|FG002|NOT COMPLETED|Overall Study||4
8682415|NCT00807495|9726542|FG003|NOT COMPLETED|Overall Study||1
8682416|NCT00807495|9726543|FG004|NOT COMPLETED|Overall Study||5
8682417|NCT00807560|9726557|FG000|STARTED|Overall Study||38
8682418|NCT00807560|9726558|FG001|STARTED|Overall Study||39
8682419|NCT00807560|9726557|FG000|COMPLETED|Overall Study||38
8682420|NCT00807560|9726558|FG001|COMPLETED|Overall Study||39
8682421|NCT00807560|9726557|FG000|NOT COMPLETED|Overall Study||0
8682422|NCT00807560|9726558|FG001|NOT COMPLETED|Overall Study||0
8682423|NCT00807573|9726564|FG000|STARTED|Overall Study||44
8682424|NCT00807573|9726564|FG000|COMPLETED|Overall Study||42
8682425|NCT00807573|9726564|FG000|NOT COMPLETED|Overall Study||2
8682426|NCT00807586|9726570|FG000|STARTED|Overall Study||60
8682427|NCT00807586|9726571|FG001|STARTED|Overall Study||59
8682428|NCT00807586|9726570|FG000|COMPLETED|Overall Study||54
8682429|NCT00807586|9726571|FG001|COMPLETED|Overall Study||58
8682430|NCT00807586|9726570|FG000|NOT COMPLETED|Overall Study||6
8682431|NCT00807586|9726571|FG001|NOT COMPLETED|Overall Study||1
8682432|NCT00807599|9726579|FG000|STARTED|Overall Study||26
8682433|NCT00807599|9726580|FG001|STARTED|Overall Study||24
8682434|NCT00807599|9726581|FG002|STARTED|Overall Study||17
8682435|NCT00807599|9726579|FG000|COMPLETED|Overall Study||26
8682436|NCT00807599|9726580|FG001|COMPLETED|Overall Study||24
8682437|NCT00807599|9726581|FG002|COMPLETED|Overall Study||0
8682438|NCT00807599|9726579|FG000|NOT COMPLETED|Overall Study||0
8682439|NCT00807599|9726580|FG001|NOT COMPLETED|Overall Study||0
8682440|NCT00807599|9726581|FG002|NOT COMPLETED|Overall Study||17
8682441|NCT00807664|9726589|FG000|STARTED|Overall Study||88
8682442|NCT00807664|9726590|FG001|STARTED|Overall Study||94
8682443|NCT00807664|9726589|FG000|COMPLETED|Overall Study||77
8682444|NCT00807664|9726590|FG001|COMPLETED|Overall Study||75
8682445|NCT00807664|9726589|FG000|NOT COMPLETED|Overall Study||11
8682446|NCT00807664|9726590|FG001|NOT COMPLETED|Overall Study||19
8682447|NCT00807742|9726599|FG000|STARTED|Overall Study||172
8682448|NCT00807742|9726600|FG001|STARTED|Overall Study||168
8682449|NCT00807742|9726599|FG000|COMPLETED|Overall Study||126
8682450|NCT00807742|9726600|FG001|COMPLETED|Overall Study||114
8682451|NCT00807742|9726599|FG000|NOT COMPLETED|Overall Study||46
8682452|NCT00807742|9726600|FG001|NOT COMPLETED|Overall Study||54
8682453|NCT00807768|9726608|FG000|STARTED|Overall Study||301
8682454|NCT00807768|9726609|FG001|STARTED|Overall Study||300
8682455|NCT00807768|9726608|FG000|COMPLETED|Overall Study||301
8682456|NCT00807768|9726609|FG001|COMPLETED|Overall Study||300
8682457|NCT00807768|9726608|FG000|NOT COMPLETED|Overall Study||0
8682458|NCT00807768|9726609|FG001|NOT COMPLETED|Overall Study||0
8682459|NCT00807846|9726617|FG000|STARTED|Overall Study||100
8682460|NCT00807846|9726618|FG001|STARTED|Overall Study||98
8682461|NCT00807846|9726617|FG000|COMPLETED|Overall Study||88
8682462|NCT00807846|9726618|FG001|COMPLETED|Overall Study||94
8682463|NCT00807846|9726617|FG000|NOT COMPLETED|Overall Study||12
8682464|NCT00807846|9726618|FG001|NOT COMPLETED|Overall Study||4
8682465|NCT00807885|9726633|FG000|STARTED|Overall Study||10
8682466|NCT00807885|9726634|FG001|STARTED|Overall Study||11
8682467|NCT00807885|9726635|FG002|STARTED|Overall Study||11
8682468|NCT00807885|9726636|FG003|STARTED|Overall Study||10
8682469|NCT00807885|9726637|FG004|STARTED|Overall Study||12
8682470|NCT00807885|9726638|FG005|STARTED|Overall Study||12
8682471|NCT00807885|9726639|FG006|STARTED|Overall Study||12
8682472|NCT00807885|9726640|FG007|STARTED|Overall Study||11
8682473|NCT00807885|9726641|FG008|STARTED|Overall Study||11
8682474|NCT00807885|9726633|FG000|COMPLETED|Overall Study||10
8682475|NCT00807885|9726634|FG001|COMPLETED|Overall Study||11
8682476|NCT00807885|9726635|FG002|COMPLETED|Overall Study||11
8682477|NCT00807885|9726636|FG003|COMPLETED|Overall Study||10
8682478|NCT00807885|9726637|FG004|COMPLETED|Overall Study||12
8682479|NCT00807885|9726638|FG005|COMPLETED|Overall Study|Subject completed treatment, but lost to follow-up|11
8682480|NCT00807885|9726639|FG006|COMPLETED|Overall Study||12
8682481|NCT00807885|9726640|FG007|COMPLETED|Overall Study||11
8682482|NCT00807885|9726641|FG008|COMPLETED|Overall Study||11
8682483|NCT00807885|9726633|FG000|NOT COMPLETED|Overall Study||0
8682484|NCT00807885|9726634|FG001|NOT COMPLETED|Overall Study||0
8682485|NCT00807885|9726635|FG002|NOT COMPLETED|Overall Study||0
8682486|NCT00807885|9726636|FG003|NOT COMPLETED|Overall Study||0
8682487|NCT00807885|9726637|FG004|NOT COMPLETED|Overall Study||0
8682488|NCT00807885|9726638|FG005|NOT COMPLETED|Overall Study||1
8682489|NCT00807885|9726639|FG006|NOT COMPLETED|Overall Study||0
8682490|NCT00807885|9726640|FG007|NOT COMPLETED|Overall Study||0
8682491|NCT00807885|9726641|FG008|NOT COMPLETED|Overall Study||0
8682492|NCT00807937|9726665|FG000|STARTED|Overall Study||93
8682493|NCT00807937|9726666|FG001|STARTED|Overall Study||92
8682494|NCT00807937|9726667|FG002|STARTED|Overall Study||92
8682495|NCT00807937|9726668|FG003|STARTED|Overall Study||92
8682496|NCT00807937|9726665|FG000|COMPLETED|Overall Study||66
8682497|NCT00807937|9726666|FG001|COMPLETED|Overall Study||67
8682498|NCT00807937|9726667|FG002|COMPLETED|Overall Study||78
8682499|NCT00807937|9726668|FG003|COMPLETED|Overall Study||77
8682500|NCT00807937|9726665|FG000|NOT COMPLETED|Overall Study||27
8682501|NCT00807937|9726666|FG001|NOT COMPLETED|Overall Study||25
8682502|NCT00807937|9726667|FG002|NOT COMPLETED|Overall Study||14
8682503|NCT00807937|9726668|FG003|NOT COMPLETED|Overall Study||15
8682504|NCT00807989|9726680|FG000|STARTED|Overall Study||107
8682505|NCT00807989|9726681|FG001|STARTED|Overall Study||100
8682506|NCT00807989|9726680|FG000|COMPLETED|Overall Study||104
8682507|NCT00807989|9726681|FG001|COMPLETED|Overall Study||98
8682508|NCT00807989|9726680|FG000|NOT COMPLETED|Overall Study||3
8682509|NCT00807989|9726681|FG001|NOT COMPLETED|Overall Study||2
8682510|NCT00808015|9726687|FG000|STARTED|Overall Study||1377
8682511|NCT00808015|9726687|FG000|Treated|Overall Study||1373
8682512|NCT00808015|9726687|FG000|COMPLETED|Overall Study||1033
8682513|NCT00808015|9726687|FG000|NOT COMPLETED|Overall Study||344
8682514|NCT00808028|9726695|FG000|STARTED|Stage 1 (6 Months)||121
8682515|NCT00808028|9726696|FG001|STARTED|Stage 1 (6 Months)|Participants in rLP2086 60 mcg group participated only in Stage 1 and were not eligible for Stage 2|22
8682516|NCT00808028|9726697|FG002|STARTED|Stage 1 (6 Months)||198
8682517|NCT00808028|9726698|FG003|STARTED|Stage 1 (6 Months)||198
8682518|NCT00808028|9726695|FG000|COMPLETED|Stage 1 (6 Months)||116
8682519|NCT00808028|9726696|FG001|COMPLETED|Stage 1 (6 Months)|Participants in rLP2086 60 mcg group participated only in Stage 1 and were not eligible for Stage 2|21
8682520|NCT00808028|9726697|FG002|COMPLETED|Stage 1 (6 Months)||191
8682521|NCT00808028|9726698|FG003|COMPLETED|Stage 1 (6 Months)||183
8682522|NCT00808028|9726695|FG000|NOT COMPLETED|Stage 1 (6 Months)||5
8682523|NCT00808028|9726696|FG001|NOT COMPLETED|Stage 1 (6 Months)||1
8682524|NCT00808028|9726697|FG002|NOT COMPLETED|Stage 1 (6 Months)||7
8682525|NCT00808028|9726698|FG003|NOT COMPLETED|Stage 1 (6 Months)||15
8682526|NCT00808028|9726695|FG000|STARTED|Stage 2 (Followed up to 48 Months )|Out of 511 completed participants in Stage 1, 89 did not enter Stage 2|80
8682527|NCT00808028|9726696|FG001|STARTED|Stage 2 (Followed up to 48 Months )||0
8682528|NCT00808028|9726697|FG002|STARTED|Stage 2 (Followed up to 48 Months )||170
8682529|NCT00808028|9726698|FG003|STARTED|Stage 2 (Followed up to 48 Months )||151
8682530|NCT00808028|9726695|FG000|COMPLETED|Stage 2 (Followed up to 48 Months )|Out of 511 completed participants in Stage 1, 89 did not enter Stage 2|69
8682531|NCT00808028|9726696|FG001|COMPLETED|Stage 2 (Followed up to 48 Months )||0
8682532|NCT00808028|9726697|FG002|COMPLETED|Stage 2 (Followed up to 48 Months )||141
8682533|NCT00808028|9726698|FG003|COMPLETED|Stage 2 (Followed up to 48 Months )||128
8682534|NCT00808028|9726695|FG000|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||11
8682535|NCT00808028|9726696|FG001|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||0
8682536|NCT00808028|9726697|FG002|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||29
8682537|NCT00808028|9726698|FG003|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||23
8682538|NCT00808067|9726720|FG000|STARTED|Overall Study|Number of patients which are treated.|2927
8682539|NCT00808067|9726721|FG001|STARTED|Overall Study|Number of patients which are treated.|2956
8682540|NCT00808067|9726720|FG000|COMPLETED|Overall Study||2446
8682541|NCT00808067|9726721|FG001|COMPLETED|Overall Study||2438
8682542|NCT00808067|9726720|FG000|NOT COMPLETED|Overall Study||481
8682543|NCT00808067|9726721|FG001|NOT COMPLETED|Overall Study||518
8682544|NCT00808132|9726732|FG000|STARTED|Overall Study||455
8682545|NCT00808132|9726733|FG001|STARTED|Overall Study||481
8682546|NCT00808132|9726734|FG002|STARTED|Overall Study||239
8682547|NCT00808132|9726735|FG003|STARTED|Overall Study||228
8682548|NCT00808132|9726736|FG004|STARTED|Overall Study||483
8682549|NCT00808132|9726732|FG000|Treated|Overall Study||445
8682550|NCT00808132|9726733|FG001|Treated|Overall Study||474
8682551|NCT00808132|9726734|FG002|Treated|Overall Study||230
8682552|NCT00808132|9726735|FG003|Treated|Overall Study||220
8682553|NCT00808132|9726736|FG004|Treated|Overall Study||474
8682554|NCT00808132|9726732|FG000|COMPLETED|Overall Study||357
8682555|NCT00808132|9726733|FG001|COMPLETED|Overall Study||393
8682556|NCT00808132|9726734|FG002|COMPLETED|Overall Study||185
8682557|NCT00808132|9726735|FG003|COMPLETED|Overall Study||159
8682558|NCT00808132|9726736|FG004|COMPLETED|Overall Study||383
8682559|NCT00808132|9726732|FG000|NOT COMPLETED|Overall Study||98
8682560|NCT00808132|9726733|FG001|NOT COMPLETED|Overall Study||88
8682561|NCT00808132|9726734|FG002|NOT COMPLETED|Overall Study||54
8682562|NCT00808132|9726735|FG003|NOT COMPLETED|Overall Study||69
8682563|NCT00808132|9726736|FG004|NOT COMPLETED|Overall Study||100
8682564|NCT00808210|9726750|FG000|STARTED|Study Period + 48 Weeks of Follow-up||15
8682565|NCT00808210|9726751|FG001|STARTED|Study Period + 48 Weeks of Follow-up||13
8682566|NCT00808210|9726750|FG000|COMPLETED|Study Period + 48 Weeks of Follow-up||6
8682567|NCT00808210|9726751|FG001|COMPLETED|Study Period + 48 Weeks of Follow-up||4
8682568|NCT00808210|9726750|FG000|NOT COMPLETED|Study Period + 48 Weeks of Follow-up||9
8682569|NCT00808210|9726751|FG001|NOT COMPLETED|Study Period + 48 Weeks of Follow-up||9
8682570|NCT00808210|9726750|FG000|STARTED|Double-Blind TX Period||15
8682571|NCT00808210|9726751|FG001|STARTED|Double-Blind TX Period||13
8682572|NCT00808210|9726750|FG000|COMPLETED|Double-Blind TX Period||13
8682573|NCT00808210|9726751|FG001|COMPLETED|Double-Blind TX Period||10
8682574|NCT00808210|9726750|FG000|NOT COMPLETED|Double-Blind TX Period||2
8682575|NCT00808210|9726751|FG001|NOT COMPLETED|Double-Blind TX Period||3
8682576|NCT00808210|9726750|FG000|STARTED|Open Label Ocrelizumab Treatment Period||9
8682577|NCT00808210|9726751|FG001|STARTED|Open Label Ocrelizumab Treatment Period||4
8682578|NCT00808210|9726750|FG000|COMPLETED|Open Label Ocrelizumab Treatment Period||0
8682579|NCT00808210|9726751|FG001|COMPLETED|Open Label Ocrelizumab Treatment Period||0
8682580|NCT00808210|9726750|FG000|NOT COMPLETED|Open Label Ocrelizumab Treatment Period||9
8682581|NCT00808210|9726751|FG001|NOT COMPLETED|Open Label Ocrelizumab Treatment Period||4
8682582|NCT00808236|9726759|FG000|STARTED|Overall Study||96
8682583|NCT00808236|9726760|FG001|STARTED|Overall Study||104
8682584|NCT00808236|9726759|FG000|Met Eligibility Criteria|Overall Study|Pre-defined exclusions: DNAR(4); had pulse(2); CVA(2); Drug OD(2); On home oxygen(1); Unwitnessed(1)|84
8682585|NCT00808236|9726760|FG001|Met Eligibility Criteria|Overall Study|Pre-defined exclusions: Terminal(1); Asphyxia(1), In-hospital(1)|101
8682586|NCT00808236|9726759|FG000|Included in Analysis|Overall Study|Lost to Follow-Up: taken to non-participating hospital (1)|83
8682587|NCT00808236|9726760|FG001|Included in Analysis|Overall Study|Crossed over & withdrawn (1); Lost to Follow-Up: taken to non-participating hospital (1)|99
8682588|NCT00808236|9726759|FG000|Achieved ROSC|Overall Study||33
8682589|NCT00808236|9726760|FG001|Achieved ROSC|Overall Study||43
8682590|NCT00808236|9726759|FG000|Admitted to Hospital|Overall Study|Died during transport to hospital(2); DNAR determination was made at hospital(1)|30
8682591|NCT00808236|9726760|FG001|Admitted to Hospital|Overall Study|Died during transport to hospital(1)|42
8682592|NCT00808236|9726759|FG000|COMPLETED|Overall Study||14
8682593|NCT00808236|9726760|FG001|COMPLETED|Overall Study||13
8682594|NCT00808236|9726759|FG000|NOT COMPLETED|Overall Study||82
8682595|NCT00808236|9726760|FG001|NOT COMPLETED|Overall Study||91
8682596|NCT00808249|9726770|FG000|STARTED|Overall Study||107
8682597|NCT00808249|9726771|FG001|STARTED|Overall Study||106
8682598|NCT00808249|9726772|FG002|STARTED|Overall Study||105
8682599|NCT00808249|9726773|FG003|STARTED|Overall Study||106
8682600|NCT00808249|9726770|FG000|COMPLETED|Overall Study||90
8682601|NCT00808249|9726771|FG001|COMPLETED|Overall Study||91
8682602|NCT00808249|9726772|FG002|COMPLETED|Overall Study||83
8682603|NCT00808249|9726773|FG003|COMPLETED|Overall Study||90
8682604|NCT00808249|9726770|FG000|NOT COMPLETED|Overall Study||17
8682605|NCT00808249|9726771|FG001|NOT COMPLETED|Overall Study||15
8682606|NCT00808249|9726772|FG002|NOT COMPLETED|Overall Study||22
8682607|NCT00808249|9726773|FG003|NOT COMPLETED|Overall Study||16
8682608|NCT00808340|9726783|FG000|STARTED|First Intervention||4
8682609|NCT00808340|9726784|FG001|STARTED|First Intervention||9
8682610|NCT00808340|9726785|FG002|STARTED|First Intervention||7
8682611|NCT00808340|9726786|FG003|STARTED|First Intervention||3
8682612|NCT00808340|9726787|FG004|STARTED|First Intervention||5
8682613|NCT00808340|9726788|FG005|STARTED|First Intervention||6
8682614|NCT00808340|9726783|FG000|COMPLETED|First Intervention||4
8682615|NCT00808340|9726784|FG001|COMPLETED|First Intervention||9
8682616|NCT00808340|9726785|FG002|COMPLETED|First Intervention||7
8682617|NCT00808340|9726786|FG003|COMPLETED|First Intervention||3
8682618|NCT00808340|9726787|FG004|COMPLETED|First Intervention||5
8682619|NCT00808340|9726788|FG005|COMPLETED|First Intervention||6
8682620|NCT00808340|9726783|FG000|NOT COMPLETED|First Intervention||0
8682621|NCT00808340|9726784|FG001|NOT COMPLETED|First Intervention||0
8682622|NCT00808340|9726785|FG002|NOT COMPLETED|First Intervention||0
8682623|NCT00808340|9726786|FG003|NOT COMPLETED|First Intervention||0
8682624|NCT00808340|9726787|FG004|NOT COMPLETED|First Intervention||0
8682625|NCT00808340|9726788|FG005|NOT COMPLETED|First Intervention||0
8682626|NCT00808340|9726783|FG000|STARTED|Second Intervention||4
8682627|NCT00808340|9726784|FG001|STARTED|Second Intervention||9
8682628|NCT00808340|9726785|FG002|STARTED|Second Intervention||7
8682629|NCT00808340|9726786|FG003|STARTED|Second Intervention||3
8682630|NCT00808340|9726787|FG004|STARTED|Second Intervention||5
8682631|NCT00808340|9726788|FG005|STARTED|Second Intervention||6
8682632|NCT00808340|9726783|FG000|COMPLETED|Second Intervention||4
8682633|NCT00808340|9726784|FG001|COMPLETED|Second Intervention||9
8682634|NCT00808340|9726785|FG002|COMPLETED|Second Intervention||7
8682635|NCT00808340|9726786|FG003|COMPLETED|Second Intervention||3
8682636|NCT00808340|9726787|FG004|COMPLETED|Second Intervention||5
8682637|NCT00808340|9726788|FG005|COMPLETED|Second Intervention||6
8682638|NCT00808340|9726783|FG000|NOT COMPLETED|Second Intervention||0
8682639|NCT00808340|9726784|FG001|NOT COMPLETED|Second Intervention||0
8682640|NCT00808340|9726785|FG002|NOT COMPLETED|Second Intervention||0
8682641|NCT00808340|9726786|FG003|NOT COMPLETED|Second Intervention||0
8682642|NCT00808340|9726787|FG004|NOT COMPLETED|Second Intervention||0
8682643|NCT00808340|9726788|FG005|NOT COMPLETED|Second Intervention||0
8682644|NCT00808340|9726783|FG000|STARTED|Third Intervention||4
8682645|NCT00808340|9726784|FG001|STARTED|Third Intervention||9
8682646|NCT00808340|9726785|FG002|STARTED|Third Intervention||7
8682647|NCT00808340|9726786|FG003|STARTED|Third Intervention||3
8682648|NCT00808340|9726787|FG004|STARTED|Third Intervention||5
8682649|NCT00808340|9726788|FG005|STARTED|Third Intervention||6
8682650|NCT00808340|9726783|FG000|COMPLETED|Third Intervention||4
8682651|NCT00808340|9726784|FG001|COMPLETED|Third Intervention||9
8682652|NCT00808340|9726785|FG002|COMPLETED|Third Intervention||7
8682653|NCT00808340|9726786|FG003|COMPLETED|Third Intervention||3
8682654|NCT00808340|9726787|FG004|COMPLETED|Third Intervention||5
8682655|NCT00808340|9726788|FG005|COMPLETED|Third Intervention||6
8682656|NCT00808340|9726783|FG000|NOT COMPLETED|Third Intervention||0
8682657|NCT00808340|9726784|FG001|NOT COMPLETED|Third Intervention||0
8682658|NCT00808340|9726785|FG002|NOT COMPLETED|Third Intervention||0
8682659|NCT00808340|9726786|FG003|NOT COMPLETED|Third Intervention||0
8682660|NCT00808340|9726787|FG004|NOT COMPLETED|Third Intervention||0
8682661|NCT00808340|9726788|FG005|NOT COMPLETED|Third Intervention||0
8682662|NCT00808405|9726798|FG000|STARTED|Overall Study||61
8682663|NCT00808405|9726799|FG001|STARTED|Overall Study||27
8682664|NCT00808405|9726798|FG000|COMPLETED|Overall Study||61
8682665|NCT00808405|9726799|FG001|COMPLETED|Overall Study||27
8682666|NCT00808405|9726798|FG000|NOT COMPLETED|Overall Study||0
8682667|NCT00808405|9726799|FG001|NOT COMPLETED|Overall Study||0
8682668|NCT00808444|9726807|FG000|STARTED|Overall Study||233
8682669|NCT00808444|9726808|FG001|STARTED|Overall Study||233
8682670|NCT00808444|9726807|FG000|COMPLETED|Overall Study||232
8682671|NCT00808444|9726808|FG001|COMPLETED|Overall Study||232
8682672|NCT00808444|9726807|FG000|NOT COMPLETED|Overall Study||1
8682673|NCT00808444|9726808|FG001|NOT COMPLETED|Overall Study||1
8682674|NCT00808470|9726816|FG000|STARTED|Overall Study||37
8682675|NCT00808470|9726817|FG001|STARTED|Overall Study||35
8682676|NCT00808470|9726816|FG000|COMPLETED|Overall Study||35
8682677|NCT00808470|9726817|FG001|COMPLETED|Overall Study||35
8682678|NCT00808470|9726816|FG000|NOT COMPLETED|Overall Study||2
8682679|NCT00808470|9726817|FG001|NOT COMPLETED|Overall Study||0
8682680|NCT00808483|9726829|FG000|STARTED|From 3 to 5 Months After Surgery||35
8682681|NCT00808483|9726830|FG001|STARTED|From 3 to 5 Months After Surgery||33
8682682|NCT00808483|9726829|FG000|COMPLETED|From 3 to 5 Months After Surgery||33
8682683|NCT00808483|9726830|FG001|COMPLETED|From 3 to 5 Months After Surgery||32
8682684|NCT00808483|9726829|FG000|NOT COMPLETED|From 3 to 5 Months After Surgery||2
8682685|NCT00808483|9726830|FG001|NOT COMPLETED|From 3 to 5 Months After Surgery||1
8682686|NCT00808483|9726829|FG000|STARTED|From 5 Months to 12 Months||33
8682687|NCT00808483|9726830|FG001|STARTED|From 5 Months to 12 Months||32
8682688|NCT00808483|9726829|FG000|COMPLETED|From 5 Months to 12 Months||32
8682689|NCT00808483|9726830|FG001|COMPLETED|From 5 Months to 12 Months||32
8682690|NCT00808483|9726829|FG000|NOT COMPLETED|From 5 Months to 12 Months||1
8682691|NCT00808483|9726830|FG001|NOT COMPLETED|From 5 Months to 12 Months||0
8682692|NCT00808509|9726845|FG000|STARTED|Randomized Phase||17
8682693|NCT00808509|9726846|FG001|STARTED|Randomized Phase||16
8682694|NCT00808509|9726845|FG000|Received Rescue Therapy|Randomized Phase||0
8682695|NCT00808509|9726846|FG001|Received Rescue Therapy|Randomized Phase||9
8682696|NCT00808509|9726845|FG000|COMPLETED|Randomized Phase||15
8682697|NCT00808509|9726846|FG001|COMPLETED|Randomized Phase|Includes participants who received rescue therapy & follow-up for 12 weeks|11
8682698|NCT00808509|9726845|FG000|NOT COMPLETED|Randomized Phase||2
8682699|NCT00808509|9726846|FG001|NOT COMPLETED|Randomized Phase||5
8682700|NCT00808509|9726845|FG000|STARTED|Observation Phase|The observation phase was open to all participants|16
8682701|NCT00808509|9726846|FG001|STARTED|Observation Phase|The observation phase was open to all participants|15
8682702|NCT00808509|9726845|FG000|COMPLETED|Observation Phase||16
8682703|NCT00808509|9726846|FG001|COMPLETED|Observation Phase||15
8682704|NCT00808509|9726845|FG000|NOT COMPLETED|Observation Phase||0
8682705|NCT00808509|9726846|FG001|NOT COMPLETED|Observation Phase||0
8682706|NCT00808639|9726854|FG000|STARTED|Overall Study||39
8682707|NCT00808639|9726854|FG000|COMPLETED|Overall Study|One patient went off treatment due to disease progression before surgery.|38
8682708|NCT00808639|9726854|FG000|NOT COMPLETED|Overall Study||1
8682709|NCT00808665|9726860|FG000|STARTED|Overall Study||31
8682710|NCT00808665|9726861|FG001|STARTED|Overall Study||32
8682711|NCT00808665|9726860|FG000|Medication Started|Overall Study||30
8682712|NCT00808665|9726861|FG001|Medication Started|Overall Study||32
8682713|NCT00808665|9726860|FG000|Completed Intra-operative Dose|Overall Study||26
8682714|NCT00808665|9726861|FG001|Completed Intra-operative Dose|Overall Study||32
8682715|NCT00808665|9726860|FG000|Completed Post Operative Doses|Overall Study||25
8682716|NCT00808665|9726861|FG001|Completed Post Operative Doses|Overall Study||29
8682717|NCT00808665|9726860|FG000|COMPLETED|Overall Study||25
8682718|NCT00808665|9726861|FG001|COMPLETED|Overall Study||29
8682719|NCT00808665|9726860|FG000|NOT COMPLETED|Overall Study||6
8682720|NCT00808665|9726861|FG001|NOT COMPLETED|Overall Study||3
8682721|NCT00808808|9726870|FG000|STARTED|Overall Study|Started includes all employees at participating sites.|4078
8682722|NCT00808808|9726871|FG001|STARTED|Overall Study|Started includes all employees at participating sites|3757
8800791|NCT01447511|9852695|FG002|COMPLETED|Fluconazole Period||8
8800792|NCT01447511|9852696|FG003|COMPLETED|Fluconazole Period||3
8800793|NCT01447511|9852697|FG004|COMPLETED|Fluconazole Period||4
8800794|NCT01447511|9852693|FG000|NOT COMPLETED|Fluconazole Period||0
8800795|NCT01447511|9852694|FG001|NOT COMPLETED|Fluconazole Period||0
8800796|NCT01447511|9852695|FG002|NOT COMPLETED|Fluconazole Period||1
8800797|NCT01447511|9852696|FG003|NOT COMPLETED|Fluconazole Period||0
8800798|NCT01447511|9852697|FG004|NOT COMPLETED|Fluconazole Period||0
8800799|NCT01447511|9852693|FG000|STARTED|Rifampin Period||8
8800800|NCT01447511|9852694|FG001|STARTED|Rifampin Period||5
8800801|NCT01447511|9852695|FG002|STARTED|Rifampin Period||8
8800802|NCT01447511|9852696|FG003|STARTED|Rifampin Period||3
8800803|NCT01447511|9852697|FG004|STARTED|Rifampin Period||4
8800804|NCT01447511|9852693|FG000|COMPLETED|Rifampin Period||8
8800805|NCT01447511|9852694|FG001|COMPLETED|Rifampin Period||5
8800806|NCT01447511|9852695|FG002|COMPLETED|Rifampin Period||8
8800807|NCT01447511|9852696|FG003|COMPLETED|Rifampin Period||2
8800808|NCT01447511|9852697|FG004|COMPLETED|Rifampin Period||4
8800809|NCT01447511|9852693|FG000|NOT COMPLETED|Rifampin Period||0
8800810|NCT01447511|9852694|FG001|NOT COMPLETED|Rifampin Period||0
8800811|NCT01447511|9852695|FG002|NOT COMPLETED|Rifampin Period||0
8800812|NCT01447511|9852696|FG003|NOT COMPLETED|Rifampin Period||1
8800813|NCT01447511|9852697|FG004|NOT COMPLETED|Rifampin Period||0
8800814|NCT01447576|9852709|FG000|STARTED|Overall Study||1036
8800815|NCT01447576|9852709|FG000|COMPLETED|Overall Study||560
8800816|NCT01447576|9852709|FG000|NOT COMPLETED|Overall Study||476
8800817|NCT01447706|9852715|FG000|STARTED|Overall Study||140
8800818|NCT01447706|9852716|FG001|STARTED|Overall Study|3 patients enrolled but not dosed|83
8800819|NCT01447706|9852715|FG000|COMPLETED|Overall Study||140
8800820|NCT01447706|9852716|FG001|COMPLETED|Overall Study||80
8800821|NCT01447706|9852715|FG000|NOT COMPLETED|Overall Study||0
8800822|NCT01447706|9852716|FG001|NOT COMPLETED|Overall Study||3
8800823|NCT01447719|9852726|FG000|STARTED|Overall Study||152
8800824|NCT01447719|9852726|FG000|Valid AV-45 Scan Acquired|Overall Study||147
8800825|NCT01447719|9852726|FG000|Deceased <2 Years After AV-45 Scan|Overall Study||66
8800826|NCT01447719|9852726|FG000|COMPLETED|Overall Study||59
8800827|NCT01447719|9852726|FG000|NOT COMPLETED|Overall Study||93
8800828|NCT01447849|9852739|FG000|STARTED|First Intervention||10
8800829|NCT01447849|9852740|FG001|STARTED|First Intervention||10
8800830|NCT01447849|9852741|FG002|STARTED|First Intervention||10
8800831|NCT01447849|9852742|FG003|STARTED|First Intervention||10
8800832|NCT01447849|9852739|FG000|COMPLETED|First Intervention||10
8800833|NCT01447849|9852740|FG001|COMPLETED|First Intervention||10
8800834|NCT01447849|9852741|FG002|COMPLETED|First Intervention||10
8800835|NCT01447849|9852742|FG003|COMPLETED|First Intervention||10
8800836|NCT01447849|9852739|FG000|NOT COMPLETED|First Intervention||0
8800837|NCT01447849|9852740|FG001|NOT COMPLETED|First Intervention||0
8800838|NCT01447849|9852741|FG002|NOT COMPLETED|First Intervention||0
8800839|NCT01447849|9852742|FG003|NOT COMPLETED|First Intervention||0
8800840|NCT01447849|9852739|FG000|STARTED|Washout Period for 1 Week||10
8800841|NCT01447849|9852740|FG001|STARTED|Washout Period for 1 Week||10
8800842|NCT01447849|9852741|FG002|STARTED|Washout Period for 1 Week||10
8800843|NCT01447849|9852742|FG003|STARTED|Washout Period for 1 Week||10
8800844|NCT01447849|9852739|FG000|COMPLETED|Washout Period for 1 Week||10
8682723|NCT00808808|9726872|FG002|STARTED|Overall Study|Started includes all employees at participating sites.|4387
8682724|NCT00808808|9726870|FG000|Vaccinated|Overall Study|Vaccinated includes all employees who were vaccinated at the employee vaccination clinics.|1392
8682725|NCT00808808|9726871|FG001|Vaccinated|Overall Study|Vaccinated includes all employees who were vaccinated at the employee vaccination clinics.|1489
8682726|NCT00808808|9726872|FG002|Vaccinated|Overall Study|Vaccinated includes all employees who were vaccinated at the employee vaccination clinics.|2132
8682727|NCT00808808|9726870|FG000|COMPLETED|Overall Study|Completed includes vaccinated employees who completed surveys.|1261
8682728|NCT00808808|9726871|FG001|COMPLETED|Overall Study|Completed includes vaccinated employees who completed surveys.|1320
8682729|NCT00808808|9726872|FG002|COMPLETED|Overall Study|Completed includes vaccinated employees who completed surveys.|1830
8682730|NCT00808808|9726870|FG000|NOT COMPLETED|Overall Study||2817
8682731|NCT00808808|9726871|FG001|NOT COMPLETED|Overall Study||2437
8682732|NCT00808808|9726872|FG002|NOT COMPLETED|Overall Study||2557
8682733|NCT00808834|9726886|FG000|STARTED|Period 1||97
8682734|NCT00808834|9726887|FG001|STARTED|Period 1||99
8682735|NCT00808834|9726886|FG000|COMPLETED|Period 1||97
8682736|NCT00808834|9726887|FG001|COMPLETED|Period 1||99
8682737|NCT00808834|9726886|FG000|NOT COMPLETED|Period 1||0
8682738|NCT00808834|9726887|FG001|NOT COMPLETED|Period 1||0
8682739|NCT00808834|9726886|FG000|STARTED|Period 2||97
8682740|NCT00808834|9726887|FG001|STARTED|Period 2||99
8682741|NCT00808834|9726886|FG000|COMPLETED|Period 2||97
8682742|NCT00808834|9726887|FG001|COMPLETED|Period 2||99
8682743|NCT00808834|9726886|FG000|NOT COMPLETED|Period 2||0
8682744|NCT00808834|9726887|FG001|NOT COMPLETED|Period 2||0
8682745|NCT00809055|9726895|FG000|STARTED|Overall Study||37
8682746|NCT00809055|9726896|FG001|STARTED|Overall Study||37
8682747|NCT00809055|9726895|FG000|COMPLETED|Overall Study||28
8682748|NCT00809055|9726896|FG001|COMPLETED|Overall Study||30
8682749|NCT00809055|9726895|FG000|NOT COMPLETED|Overall Study||9
8682750|NCT00809055|9726896|FG001|NOT COMPLETED|Overall Study||7
8682751|NCT00809094|9726904|FG000|STARTED|Overall Study||36
8682752|NCT00809094|9726905|FG001|STARTED|Overall Study||34
8682753|NCT00809094|9726904|FG000|COMPLETED|Overall Study||36
8682754|NCT00809094|9726905|FG001|COMPLETED|Overall Study||33
8682755|NCT00809094|9726904|FG000|NOT COMPLETED|Overall Study||0
8682756|NCT00809094|9726905|FG001|NOT COMPLETED|Overall Study||1
8682757|NCT00809133|9726925|FG000|STARTED|Overall Study||3
8682758|NCT00809133|9726926|FG001|STARTED|Overall Study||7
8682759|NCT00809133|9726927|FG002|STARTED|Overall Study||6
8682760|NCT00809133|9726928|FG003|STARTED|Overall Study||3
8682761|NCT00809133|9726929|FG004|STARTED|Overall Study||5
8682762|NCT00809133|9726930|FG005|STARTED|Overall Study||7
8682763|NCT00809133|9726931|FG006|STARTED|Overall Study||6
8682764|NCT00809133|9726932|FG007|STARTED|Overall Study||8
8682765|NCT00809133|9726933|FG008|STARTED|Overall Study||3
8682766|NCT00809133|9726934|FG009|STARTED|Overall Study||9
8682767|NCT00809133|9726935|FG010|STARTED|Overall Study||6
8682768|NCT00809133|9726936|FG011|STARTED|Overall Study||8
8682769|NCT00809133|9726937|FG012|STARTED|Overall Study||5
8682770|NCT00809133|9726938|FG013|STARTED|Overall Study||7
8682771|NCT00809133|9726925|FG000|COMPLETED|Overall Study||0
8682772|NCT00809133|9726926|FG001|COMPLETED|Overall Study||0
8682773|NCT00809133|9726927|FG002|COMPLETED|Overall Study||0
8682774|NCT00809133|9726928|FG003|COMPLETED|Overall Study||0
8682775|NCT00809133|9726929|FG004|COMPLETED|Overall Study||0
8682776|NCT00809133|9726930|FG005|COMPLETED|Overall Study||0
8682777|NCT00809133|9726931|FG006|COMPLETED|Overall Study||0
8682778|NCT00809133|9726932|FG007|COMPLETED|Overall Study||0
8682779|NCT00809133|9726933|FG008|COMPLETED|Overall Study||0
8682780|NCT00809133|9726934|FG009|COMPLETED|Overall Study||0
8682781|NCT00809133|9726935|FG010|COMPLETED|Overall Study||0
8682782|NCT00809133|9726936|FG011|COMPLETED|Overall Study||0
8682783|NCT00809133|9726937|FG012|COMPLETED|Overall Study||0
8682784|NCT00809133|9726938|FG013|COMPLETED|Overall Study||0
8682785|NCT00809133|9726925|FG000|NOT COMPLETED|Overall Study||3
8682786|NCT00809133|9726926|FG001|NOT COMPLETED|Overall Study||7
8682787|NCT00809133|9726927|FG002|NOT COMPLETED|Overall Study||6
8682788|NCT00809133|9726928|FG003|NOT COMPLETED|Overall Study||3
8682789|NCT00809133|9726929|FG004|NOT COMPLETED|Overall Study||5
8682790|NCT00809133|9726930|FG005|NOT COMPLETED|Overall Study||7
8682791|NCT00809133|9726931|FG006|NOT COMPLETED|Overall Study||6
8682792|NCT00809133|9726932|FG007|NOT COMPLETED|Overall Study||8
8682793|NCT00809133|9726933|FG008|NOT COMPLETED|Overall Study||3
8682794|NCT00809133|9726934|FG009|NOT COMPLETED|Overall Study||9
8682795|NCT00809133|9726935|FG010|NOT COMPLETED|Overall Study||6
8682796|NCT00809133|9726936|FG011|NOT COMPLETED|Overall Study||8
8682797|NCT00809133|9726937|FG012|NOT COMPLETED|Overall Study||5
8682798|NCT00809133|9726938|FG013|NOT COMPLETED|Overall Study||7
8682799|NCT00809146|9726983|FG000|STARTED|Overall Study||448
8682800|NCT00809146|9726984|FG001|STARTED|Overall Study||445
8682801|NCT00809146|9726983|FG000|COMPLETED|Overall Study||448
8682802|NCT00809146|9726984|FG001|COMPLETED|Overall Study||445
8682803|NCT00809146|9726983|FG000|NOT COMPLETED|Overall Study||0
8682804|NCT00809146|9726984|FG001|NOT COMPLETED|Overall Study||0
8682805|NCT00809159|9726994|FG000|STARTED|Part 1||24
8682806|NCT00809159|9726995|FG001|STARTED|Part 1||6
8682807|NCT00809159|9726996|FG002|STARTED|Part 1||0
8682808|NCT00809159|9726997|FG003|STARTED|Part 1||0
8682809|NCT00809159|9726998|FG004|STARTED|Part 1||0
8682810|NCT00809159|9726999|FG005|STARTED|Part 1||0
8682811|NCT00809159|9726994|FG000|PK Analysis Set|Part 1||24
8682812|NCT00809159|9726995|FG001|PK Analysis Set|Part 1||6
8682813|NCT00809159|9726996|FG002|PK Analysis Set|Part 1||0
8682814|NCT00809159|9726997|FG003|PK Analysis Set|Part 1||0
8682815|NCT00809159|9726998|FG004|PK Analysis Set|Part 1||0
8682816|NCT00809159|9726999|FG005|PK Analysis Set|Part 1||0
8682817|NCT00809159|9726994|FG000|PD Analysis Set|Part 1||23
8682818|NCT00809159|9726995|FG001|PD Analysis Set|Part 1||6
8682819|NCT00809159|9726996|FG002|PD Analysis Set|Part 1||0
8682820|NCT00809159|9726997|FG003|PD Analysis Set|Part 1||0
8682821|NCT00809159|9726998|FG004|PD Analysis Set|Part 1||0
8682822|NCT00809159|9726999|FG005|PD Analysis Set|Part 1||0
8682823|NCT00809159|9726994|FG000|COMPLETED|Part 1||16
8682824|NCT00809159|9726995|FG001|COMPLETED|Part 1||3
8682825|NCT00809159|9726996|FG002|COMPLETED|Part 1||0
8682826|NCT00809159|9726997|FG003|COMPLETED|Part 1||0
8682827|NCT00809159|9726998|FG004|COMPLETED|Part 1||0
8682828|NCT00809159|9726999|FG005|COMPLETED|Part 1||0
8682829|NCT00809159|9726994|FG000|NOT COMPLETED|Part 1||8
8682830|NCT00809159|9726995|FG001|NOT COMPLETED|Part 1||3
8682831|NCT00809159|9726996|FG002|NOT COMPLETED|Part 1||0
8682832|NCT00809159|9726997|FG003|NOT COMPLETED|Part 1||0
8682833|NCT00809159|9726998|FG004|NOT COMPLETED|Part 1||0
8682834|NCT00809159|9726999|FG005|NOT COMPLETED|Part 1||0
8682835|NCT00809159|9726994|FG000|STARTED|Part 1 and 2||0
8682836|NCT00809159|9726995|FG001|STARTED|Part 1 and 2||0
8682837|NCT00809159|9726996|FG002|STARTED|Part 1 and 2||30
8682838|NCT00809159|9726997|FG003|STARTED|Part 1 and 2||12
8682839|NCT00809159|9726998|FG004|STARTED|Part 1 and 2||12
8682840|NCT00809159|9726999|FG005|STARTED|Part 1 and 2||6
8682841|NCT00809159|9726994|FG000|PK Analysis Set|Part 1 and 2||0
8682842|NCT00809159|9726995|FG001|PK Analysis Set|Part 1 and 2||0
8682843|NCT00809159|9726996|FG002|PK Analysis Set|Part 1 and 2||30
8682844|NCT00809159|9726997|FG003|PK Analysis Set|Part 1 and 2||12
8682845|NCT00809159|9726998|FG004|PK Analysis Set|Part 1 and 2||12
8682846|NCT00809159|9726999|FG005|PK Analysis Set|Part 1 and 2||6
8682847|NCT00809159|9726994|FG000|PD Analysis Set|Part 1 and 2||0
8682848|NCT00809159|9726995|FG001|PD Analysis Set|Part 1 and 2||0
8682849|NCT00809159|9726996|FG002|PD Analysis Set|Part 1 and 2||28
8682850|NCT00809159|9726997|FG003|PD Analysis Set|Part 1 and 2||12
8682851|NCT00809159|9726998|FG004|PD Analysis Set|Part 1 and 2||12
8682852|NCT00809159|9726999|FG005|PD Analysis Set|Part 1 and 2||6
8682853|NCT00809159|9726994|FG000|COMPLETED|Part 1 and 2||0
8682854|NCT00809159|9726995|FG001|COMPLETED|Part 1 and 2||0
8682855|NCT00809159|9726996|FG002|COMPLETED|Part 1 and 2||20
8682856|NCT00809159|9726997|FG003|COMPLETED|Part 1 and 2||7
8682857|NCT00809159|9726998|FG004|COMPLETED|Part 1 and 2||6
8682858|NCT00809159|9726999|FG005|COMPLETED|Part 1 and 2||3
8682859|NCT00809159|9726994|FG000|NOT COMPLETED|Part 1 and 2||0
8682860|NCT00809159|9726995|FG001|NOT COMPLETED|Part 1 and 2||0
8682861|NCT00809159|9726996|FG002|NOT COMPLETED|Part 1 and 2||10
8682862|NCT00809159|9726997|FG003|NOT COMPLETED|Part 1 and 2||5
8682863|NCT00809159|9726998|FG004|NOT COMPLETED|Part 1 and 2||6
8682864|NCT00809159|9726999|FG005|NOT COMPLETED|Part 1 and 2||3
8682865|NCT00809185|9727013|FG000|STARTED|Overall Study||7
8682866|NCT00809185|9727013|FG000|COMPLETED|Overall Study||7
8682867|NCT00809185|9727013|FG000|NOT COMPLETED|Overall Study||0
8682868|NCT00809276|9727018|FG000|STARTED|Overall Study||92
8682869|NCT00809276|9727018|FG000|COMPLETED|Overall Study||92
8682870|NCT00809276|9727018|FG000|NOT COMPLETED|Overall Study||0
8682871|NCT00809328|9727022|FG000|STARTED|Overall Study||102
8682872|NCT00809328|9727022|FG000|COMPLETED|Overall Study||73
8682873|NCT00809328|9727022|FG000|NOT COMPLETED|Overall Study||29
8682874|NCT00809354|9727036|FG000|STARTED|Overall Study||288
8682875|NCT00809354|9727037|FG001|STARTED|Overall Study||289
8682876|NCT00809354|9727038|FG002|STARTED|Overall Study||286
8682877|NCT00809354|9727039|FG003|STARTED|Overall Study||288
8682878|NCT00809354|9727040|FG004|STARTED|Overall Study||288
8682879|NCT00809354|9727041|FG005|STARTED|Overall Study||256
8682880|NCT00809354|9727042|FG006|STARTED|Overall Study||255
8682881|NCT00809354|9727043|FG007|STARTED|Overall Study||257
8682882|NCT00809354|9727044|FG008|STARTED|Overall Study||256
8682883|NCT00809354|9727045|FG009|STARTED|Overall Study||257
8682884|NCT00809354|9727036|FG000|Treated|Overall Study||285
8682885|NCT00809354|9727037|FG001|Treated|Overall Study||288
8682886|NCT00809354|9727038|FG002|Treated|Overall Study||280
8682887|NCT00809354|9727039|FG003|Treated|Overall Study||288
8682888|NCT00809354|9727040|FG004|Treated|Overall Study||283
8682889|NCT00809354|9727041|FG005|Treated|Overall Study||256
8682890|NCT00809354|9727042|FG006|Treated|Overall Study||254
8682891|NCT00809354|9727043|FG007|Treated|Overall Study||256
8682892|NCT00809354|9727044|FG008|Treated|Overall Study||254
8682893|NCT00809354|9727045|FG009|Treated|Overall Study||256
8682894|NCT00809354|9727036|FG000|COMPLETED|Overall Study||33
8682895|NCT00809354|9727037|FG001|COMPLETED|Overall Study||31
8682896|NCT00809354|9727038|FG002|COMPLETED|Overall Study||32
8682897|NCT00809354|9727039|FG003|COMPLETED|Overall Study||32
8682898|NCT00809354|9727040|FG004|COMPLETED|Overall Study||32
8682899|NCT00809354|9727041|FG005|COMPLETED|Overall Study||31
8682900|NCT00809354|9727042|FG006|COMPLETED|Overall Study||32
8682901|NCT00809354|9727043|FG007|COMPLETED|Overall Study||19
8682902|NCT00809354|9727044|FG008|COMPLETED|Overall Study||28
8682903|NCT00809354|9727045|FG009|COMPLETED|Overall Study||31
8682904|NCT00809354|9727036|FG000|NOT COMPLETED|Overall Study||255
8682905|NCT00809354|9727037|FG001|NOT COMPLETED|Overall Study||258
8682906|NCT00809354|9727038|FG002|NOT COMPLETED|Overall Study||254
8682907|NCT00809354|9727039|FG003|NOT COMPLETED|Overall Study||256
8682908|NCT00809354|9727040|FG004|NOT COMPLETED|Overall Study||256
8682909|NCT00809354|9727041|FG005|NOT COMPLETED|Overall Study||225
8682910|NCT00809354|9727042|FG006|NOT COMPLETED|Overall Study||223
8682911|NCT00809354|9727043|FG007|NOT COMPLETED|Overall Study||238
8682912|NCT00809354|9727044|FG008|NOT COMPLETED|Overall Study||228
8682913|NCT00809354|9727045|FG009|NOT COMPLETED|Overall Study||226
8682914|NCT00809445|9727075|FG000|STARTED|1 Month Follow-up||429
8682915|NCT00809445|9727076|FG001|STARTED|1 Month Follow-up||433
8682916|NCT00809445|9727077|FG002|STARTED|1 Month Follow-up||419
8682917|NCT00809445|9727075|FG000|COMPLETED|1 Month Follow-up||427
8682918|NCT00809445|9727076|FG001|COMPLETED|1 Month Follow-up||429
8682919|NCT00809445|9727077|FG002|COMPLETED|1 Month Follow-up||415
8682920|NCT00809445|9727075|FG000|NOT COMPLETED|1 Month Follow-up||2
8682921|NCT00809445|9727076|FG001|NOT COMPLETED|1 Month Follow-up||4
8682922|NCT00809445|9727077|FG002|NOT COMPLETED|1 Month Follow-up||4
8682923|NCT00809445|9727075|FG000|STARTED|6 Month Follow-up||429
8682924|NCT00809445|9727076|FG001|STARTED|6 Month Follow-up||433
8682925|NCT00809445|9727077|FG002|STARTED|6 Month Follow-up||419
8682926|NCT00809445|9727075|FG000|COMPLETED|6 Month Follow-up||405
8682927|NCT00809445|9727076|FG001|COMPLETED|6 Month Follow-up||410
8682928|NCT00809445|9727077|FG002|COMPLETED|6 Month Follow-up||395
8682929|NCT00809445|9727075|FG000|NOT COMPLETED|6 Month Follow-up||24
8682930|NCT00809445|9727076|FG001|NOT COMPLETED|6 Month Follow-up||23
8682931|NCT00809445|9727077|FG002|NOT COMPLETED|6 Month Follow-up||24
8682932|NCT00809471|9727088|FG000|STARTED|Overall Study||130
8682933|NCT00809471|9727089|FG001|STARTED|Overall Study||129
8682934|NCT00809471|9727090|FG002|STARTED|Overall Study||131
8682935|NCT00809471|9727088|FG000|COMPLETED|Overall Study||110
8682936|NCT00809471|9727089|FG001|COMPLETED|Overall Study||109
8682937|NCT00809471|9727090|FG002|COMPLETED|Overall Study||114
8682938|NCT00809471|9727088|FG000|NOT COMPLETED|Overall Study||20
8682939|NCT00809471|9727089|FG001|NOT COMPLETED|Overall Study||20
8682940|NCT00809471|9727090|FG002|NOT COMPLETED|Overall Study||17
8682941|NCT00809523|9727100|FG000|STARTED|Overall Study||54
8682942|NCT00809523|9727101|FG001|STARTED|Overall Study||52
8682943|NCT00809523|9727100|FG000|COMPLETED|Overall Study||47
8682944|NCT00809523|9727101|FG001|COMPLETED|Overall Study||48
8682945|NCT00809523|9727100|FG000|NOT COMPLETED|Overall Study||7
8682946|NCT00809523|9727101|FG001|NOT COMPLETED|Overall Study||4
8682947|NCT00809614|9727109|FG000|STARTED|Overall Study||28
8682948|NCT00809614|9727110|FG001|STARTED|Overall Study||14
8682949|NCT00809614|9727109|FG000|Pharmacokinetic Safety Set|Overall Study||27
8682950|NCT00809614|9727110|FG001|Pharmacokinetic Safety Set|Overall Study||14
8682951|NCT00809614|9727109|FG000|Pharmacodynamic (PD) Set|Overall Study||24
8682952|NCT00809614|9727110|FG001|Pharmacodynamic (PD) Set|Overall Study||13
8682953|NCT00809614|9727109|FG000|COMPLETED|Overall Study||25
8682954|NCT00809614|9727110|FG001|COMPLETED|Overall Study||10
8682955|NCT00809614|9727109|FG000|NOT COMPLETED|Overall Study||3
8682956|NCT00809614|9727110|FG001|NOT COMPLETED|Overall Study||4
8682957|NCT00809757|9727119|FG000|STARTED|Overall Study||68
8682958|NCT00809757|9727120|FG001|STARTED|Overall Study||65
8682959|NCT00809757|9727121|FG002|STARTED|Overall Study||64
8682960|NCT00809757|9727119|FG000|COMPLETED|Overall Study||62
8682961|NCT00809757|9727120|FG001|COMPLETED|Overall Study||60
8682962|NCT00809757|9727121|FG002|COMPLETED|Overall Study||53
8682963|NCT00809757|9727119|FG000|NOT COMPLETED|Overall Study||6
8682964|NCT00809757|9727120|FG001|NOT COMPLETED|Overall Study||5
8682965|NCT00809757|9727121|FG002|NOT COMPLETED|Overall Study||11
8682966|NCT00809783|9727138|FG000|STARTED|Overall Study||525
8682967|NCT00809783|9727139|FG001|STARTED|Overall Study||832
8682968|NCT00809783|9727140|FG002|STARTED|Overall Study||790
8682969|NCT00809783|9727138|FG000|Treated|Overall Study||522
8682970|NCT00809783|9727139|FG001|Treated|Overall Study||832
8682971|NCT00809783|9727140|FG002|Treated|Overall Study||788
8682972|NCT00809783|9727138|FG000|COMPLETED|Overall Study||0
8682973|NCT00809783|9727139|FG001|COMPLETED|Overall Study||0
8682974|NCT00809783|9727140|FG002|COMPLETED|Overall Study||0
8682975|NCT00809783|9727138|FG000|NOT COMPLETED|Overall Study||525
8682976|NCT00809783|9727139|FG001|NOT COMPLETED|Overall Study||832
8682977|NCT00809783|9727140|FG002|NOT COMPLETED|Overall Study||790
8682978|NCT00809809|9727150|FG000|STARTED|Overall Study||78
8682979|NCT00809809|9727151|FG001|STARTED|Overall Study||79
8682980|NCT00809809|9727150|FG000|COMPLETED|Overall Study|3 dropped from the study when it was discovered they met the exclusion criteria|75
8682981|NCT00809809|9727151|FG001|COMPLETED|Overall Study|2 dropped from the study when it was discovered they met the exclusion criteria|77
8682982|NCT00809809|9727150|FG000|NOT COMPLETED|Overall Study||3
8682983|NCT00809809|9727151|FG001|NOT COMPLETED|Overall Study||2
8682984|NCT00809835|9727161|FG000|STARTED|Overall Study||28
8682985|NCT00809835|9727162|FG001|STARTED|Overall Study||27
8682986|NCT00809835|9727163|FG002|STARTED|Overall Study||38
8682987|NCT00809835|9727164|FG003|STARTED|Overall Study||27
8682988|NCT00809835|9727161|FG000|COMPLETED|Overall Study||20
8682989|NCT00809835|9727162|FG001|COMPLETED|Overall Study||20
8682990|NCT00809835|9727163|FG002|COMPLETED|Overall Study||27
8682991|NCT00809835|9727164|FG003|COMPLETED|Overall Study||25
8682992|NCT00809835|9727161|FG000|NOT COMPLETED|Overall Study||8
8682993|NCT00809835|9727162|FG001|NOT COMPLETED|Overall Study||7
8682994|NCT00809835|9727163|FG002|NOT COMPLETED|Overall Study||11
8682995|NCT00809835|9727164|FG003|NOT COMPLETED|Overall Study||2
8682996|NCT00809848|9727179|FG000|STARTED|Overall Study||36
8682997|NCT00809848|9727180|FG001|STARTED|Overall Study||34
8682998|NCT00809848|9727181|FG002|STARTED|Overall Study||34
8682999|NCT00809848|9727182|FG003|STARTED|Overall Study||31
8683000|NCT00809848|9727183|FG004|STARTED|Overall Study||37
8683001|NCT00809848|9727179|FG000|COMPLETED|Overall Study||36
8683002|NCT00809848|9727180|FG001|COMPLETED|Overall Study||34
8683003|NCT00809848|9727181|FG002|COMPLETED|Overall Study||34
8683004|NCT00809848|9727182|FG003|COMPLETED|Overall Study||30
8683005|NCT00809848|9727183|FG004|COMPLETED|Overall Study||34
8683006|NCT00809848|9727179|FG000|NOT COMPLETED|Overall Study||0
8683007|NCT00809848|9727180|FG001|NOT COMPLETED|Overall Study||0
8683008|NCT00809848|9727181|FG002|NOT COMPLETED|Overall Study||0
8683009|NCT00809848|9727182|FG003|NOT COMPLETED|Overall Study||1
8683010|NCT00809848|9727183|FG004|NOT COMPLETED|Overall Study||3
8692966|NCT00863057|9738329|FG003|STARTED|Period 3 (Weeks 11-15)||2
8692967|NCT00863057|9738326|FG000|COMPLETED|Period 3 (Weeks 11-15)||3
8692968|NCT00863057|9738327|FG001|COMPLETED|Period 3 (Weeks 11-15)||1
8692969|NCT00863057|9738328|FG002|COMPLETED|Period 3 (Weeks 11-15)||2
8692970|NCT00863057|9738329|FG003|COMPLETED|Period 3 (Weeks 11-15)||2
8692971|NCT00863057|9738326|FG000|NOT COMPLETED|Period 3 (Weeks 11-15)||0
8692972|NCT00863057|9738327|FG001|NOT COMPLETED|Period 3 (Weeks 11-15)||0
8692973|NCT00863057|9738328|FG002|NOT COMPLETED|Period 3 (Weeks 11-15)||0
8692974|NCT00863057|9738329|FG003|NOT COMPLETED|Period 3 (Weeks 11-15)||0
8692975|NCT00863057|9738326|FG000|STARTED|Period 4 (Weeks 16-20)||3
8692976|NCT00863057|9738327|FG001|STARTED|Period 4 (Weeks 16-20)||1
8692977|NCT00863057|9738328|FG002|STARTED|Period 4 (Weeks 16-20)||2
8692978|NCT00863057|9738329|FG003|STARTED|Period 4 (Weeks 16-20)||2
8692979|NCT00863057|9738326|FG000|COMPLETED|Period 4 (Weeks 16-20)||3
8692980|NCT00863057|9738327|FG001|COMPLETED|Period 4 (Weeks 16-20)||1
8692981|NCT00863057|9738328|FG002|COMPLETED|Period 4 (Weeks 16-20)||2
8692982|NCT00863057|9738329|FG003|COMPLETED|Period 4 (Weeks 16-20)||2
8692983|NCT00863057|9738326|FG000|NOT COMPLETED|Period 4 (Weeks 16-20)||0
8692984|NCT00863057|9738327|FG001|NOT COMPLETED|Period 4 (Weeks 16-20)||0
8692985|NCT00863057|9738328|FG002|NOT COMPLETED|Period 4 (Weeks 16-20)||0
8692986|NCT00863057|9738329|FG003|NOT COMPLETED|Period 4 (Weeks 16-20)||0
8692987|NCT00863109|9738345|FG000|STARTED|Treatment Period||130
8692988|NCT00863109|9738345|FG000|COMPLETED|Treatment Period||53
8692989|NCT00863109|9738345|FG000|NOT COMPLETED|Treatment Period||77
8692990|NCT00863109|9738345|FG000|STARTED|Follow-up Period|Follow-up performed on 53 who completed Treatment Period plus 6 who discontinued treatment|59
8692991|NCT00863109|9738345|FG000|COMPLETED|Follow-up Period||48
8692992|NCT00863109|9738345|FG000|NOT COMPLETED|Follow-up Period||11
8692993|NCT00863122|9738353|FG000|STARTED|Overall Study||19
8692994|NCT00863122|9738354|FG001|STARTED|Overall Study||7
8692995|NCT00863122|9738353|FG000|COMPLETED|Overall Study||19
8692996|NCT00863122|9738354|FG001|COMPLETED|Overall Study||7
8692997|NCT00863122|9738353|FG000|NOT COMPLETED|Overall Study||0
8692998|NCT00863122|9738354|FG001|NOT COMPLETED|Overall Study||0
8692999|NCT00863265|9738364|FG000|STARTED|Overall Study||4
8693000|NCT00863265|9738365|FG001|STARTED|Overall Study||3
8693001|NCT00863265|9738366|FG002|STARTED|Overall Study||4
8693002|NCT00863265|9738367|FG003|STARTED|Overall Study||4
8693003|NCT00863265|9738368|FG004|STARTED|Overall Study||4
8693004|NCT00863265|9738369|FG005|STARTED|Overall Study||3
8693005|NCT00863265|9738364|FG000|COMPLETED|Overall Study||4
8693006|NCT00863265|9738365|FG001|COMPLETED|Overall Study||3
8693007|NCT00863265|9738366|FG002|COMPLETED|Overall Study||4
8693008|NCT00863265|9738367|FG003|COMPLETED|Overall Study||4
8693009|NCT00863265|9738368|FG004|COMPLETED|Overall Study||3
8693010|NCT00863265|9738369|FG005|COMPLETED|Overall Study||3
8693011|NCT00863265|9738364|FG000|NOT COMPLETED|Overall Study||0
8693012|NCT00863265|9738365|FG001|NOT COMPLETED|Overall Study||0
8693013|NCT00863265|9738366|FG002|NOT COMPLETED|Overall Study||0
8693014|NCT00863265|9738367|FG003|NOT COMPLETED|Overall Study||0
8693015|NCT00863265|9738368|FG004|NOT COMPLETED|Overall Study||1
8693016|NCT00863265|9738369|FG005|NOT COMPLETED|Overall Study||0
8693017|NCT00863304|9738387|FG000|STARTED|Overall Study||212
8693018|NCT00863304|9738388|FG001|STARTED|Overall Study||212
8693019|NCT00863304|9738389|FG002|STARTED|Overall Study||213
8693020|NCT00863304|9738390|FG003|STARTED|Overall Study||212
8693021|NCT00863304|9738387|FG000|Treated|Overall Study||209
8693022|NCT00863304|9738388|FG001|Treated|Overall Study||211
8693023|NCT00863304|9738389|FG002|Treated|Overall Study||209
8693024|NCT00863304|9738390|FG003|Treated|Overall Study||211
8693025|NCT00863304|9738387|FG000|COMPLETED|Overall Study||18
8693026|NCT00863304|9738388|FG001|COMPLETED|Overall Study||27
8693027|NCT00863304|9738389|FG002|COMPLETED|Overall Study||26
8693028|NCT00863304|9738390|FG003|COMPLETED|Overall Study||21
8693029|NCT00863304|9738387|FG000|NOT COMPLETED|Overall Study||194
8693030|NCT00863304|9738388|FG001|NOT COMPLETED|Overall Study||185
8693031|NCT00863304|9738389|FG002|NOT COMPLETED|Overall Study||187
8693032|NCT00863304|9738390|FG003|NOT COMPLETED|Overall Study||191
8693033|NCT00863317|9738404|FG000|STARTED|Overall Study||68
8693034|NCT00863317|9738405|FG001|STARTED|Overall Study||73
8693035|NCT00863317|9738404|FG000|COMPLETED|Overall Study||60
8693036|NCT00863317|9738405|FG001|COMPLETED|Overall Study||64
8693037|NCT00863317|9738404|FG000|NOT COMPLETED|Overall Study||8
8693038|NCT00863317|9738405|FG001|NOT COMPLETED|Overall Study||9
8693039|NCT00863343|9738413|FG000|STARTED|Overall Study||17
8693040|NCT00863343|9738414|FG001|STARTED|Overall Study||374
8683011|NCT00809926|9727198|FG000|STARTED|Overall Study||232
8683012|NCT00809926|9727199|FG001|STARTED|Overall Study||219
8683013|NCT00809926|9727198|FG000|COMPLETED|Overall Study||201
8683014|NCT00809926|9727199|FG001|COMPLETED|Overall Study||196
8683015|NCT00809926|9727198|FG000|NOT COMPLETED|Overall Study||31
8683016|NCT00809926|9727199|FG001|NOT COMPLETED|Overall Study||23
8683017|NCT00809965|9727208|FG000|STARTED|Overall Study||5176
8683018|NCT00809965|9727209|FG001|STARTED|Overall Study||5174
8683019|NCT00809965|9727210|FG002|STARTED|Overall Study||5176
8683020|NCT00809965|9727208|FG000|Treated/Safety Population|Overall Study|All randomized participants who received at least one dose of study drug|5125
8683021|NCT00809965|9727209|FG001|Treated/Safety Population|Overall Study|All randomized participants who received at least one dose of study drug|5115
8683022|NCT00809965|9727210|FG002|Treated/Safety Population|Overall Study|All randomized participants who received at least one dose of study drug|5110
8683023|NCT00809965|9727208|FG000|Modified Intent-to-Treat Population|Overall Study|All randomized participants excluding 3 sites without regard to treatment exposure|5113
8683024|NCT00809965|9727209|FG001|Modified Intent-to-Treat Population|Overall Study|All randomized participants excluding 3 sites without regard to treatment exposure|5114
8683025|NCT00809965|9727210|FG002|Modified Intent-to-Treat Population|Overall Study|All randomized participants excluding 3 sites without regard to treatment exposure|5115
8683026|NCT00809965|9727208|FG000|COMPLETED|Overall Study||4393
8683027|NCT00809965|9727209|FG001|COMPLETED|Overall Study||4399
8683028|NCT00809965|9727210|FG002|COMPLETED|Overall Study||4332
8683029|NCT00809965|9727208|FG000|NOT COMPLETED|Overall Study||783
8683030|NCT00809965|9727209|FG001|NOT COMPLETED|Overall Study||775
8683031|NCT00809965|9727210|FG002|NOT COMPLETED|Overall Study||844
8683032|NCT00810043|9727220|FG000|STARTED|Overall Study||57
8683033|NCT00810043|9727221|FG001|STARTED|Overall Study||55
8683034|NCT00810043|9727222|FG002|STARTED|Overall Study||8
8683035|NCT00810043|9727220|FG000|COMPLETED|Overall Study||53
8683036|NCT00810043|9727221|FG001|COMPLETED|Overall Study||54
8683037|NCT00810043|9727222|FG002|COMPLETED|Overall Study||0
8683038|NCT00810043|9727220|FG000|NOT COMPLETED|Overall Study||4
8683039|NCT00810043|9727221|FG001|NOT COMPLETED|Overall Study||1
8683040|NCT00810043|9727222|FG002|NOT COMPLETED|Overall Study||8
8683041|NCT00810069|9727233|FG000|STARTED|Lead-in Period I||840
8683042|NCT00810069|9727234|FG001|STARTED|Lead-in Period I||0
8683043|NCT00810069|9727235|FG002|STARTED|Lead-in Period I||0
8683044|NCT00810069|9727233|FG000|COMPLETED|Lead-in Period I||566
8683045|NCT00810069|9727234|FG001|COMPLETED|Lead-in Period I||0
8683046|NCT00810069|9727235|FG002|COMPLETED|Lead-in Period I||0
8683047|NCT00810069|9727233|FG000|NOT COMPLETED|Lead-in Period I||274
8683048|NCT00810069|9727234|FG001|NOT COMPLETED|Lead-in Period I||0
8683049|NCT00810069|9727235|FG002|NOT COMPLETED|Lead-in Period I||0
8683050|NCT00810069|9727233|FG000|STARTED|Double-Blind Period II||0
8683051|NCT00810069|9727234|FG001|STARTED|Double-Blind Period II||282
8683052|NCT00810069|9727235|FG002|STARTED|Double-Blind Period II|At Week 8 - delayed intervention divided by response to treatment (nonresponders or responders).|284
8683053|NCT00810069|9727233|FG000|COMPLETED|Double-Blind Period II||0
8800845|NCT01447849|9852740|FG001|COMPLETED|Washout Period for 1 Week||10
8800846|NCT01447849|9852741|FG002|COMPLETED|Washout Period for 1 Week||10
8800847|NCT01447849|9852742|FG003|COMPLETED|Washout Period for 1 Week||10
8800848|NCT01447849|9852739|FG000|NOT COMPLETED|Washout Period for 1 Week||0
8800849|NCT01447849|9852740|FG001|NOT COMPLETED|Washout Period for 1 Week||0
8800850|NCT01447849|9852741|FG002|NOT COMPLETED|Washout Period for 1 Week||0
8800851|NCT01447849|9852742|FG003|NOT COMPLETED|Washout Period for 1 Week||0
8800852|NCT01447849|9852739|FG000|STARTED|Second Intervention||10
8800853|NCT01447849|9852740|FG001|STARTED|Second Intervention||10
8800854|NCT01447849|9852741|FG002|STARTED|Second Intervention||10
8800855|NCT01447849|9852742|FG003|STARTED|Second Intervention||10
8800856|NCT01447849|9852739|FG000|COMPLETED|Second Intervention||10
8800857|NCT01447849|9852740|FG001|COMPLETED|Second Intervention||10
8800858|NCT01447849|9852741|FG002|COMPLETED|Second Intervention||10
8800859|NCT01447849|9852742|FG003|COMPLETED|Second Intervention||10
8800860|NCT01447849|9852739|FG000|NOT COMPLETED|Second Intervention||0
8800861|NCT01447849|9852740|FG001|NOT COMPLETED|Second Intervention||0
8800862|NCT01447849|9852741|FG002|NOT COMPLETED|Second Intervention||0
8800863|NCT01447849|9852742|FG003|NOT COMPLETED|Second Intervention||0
8800864|NCT01447888|9852754|FG000|STARTED|Overall Study||45
8800865|NCT01447888|9852755|FG001|STARTED|Overall Study||55
8800866|NCT01447888|9852754|FG000|COMPLETED|Overall Study||45
8800867|NCT01447888|9852755|FG001|COMPLETED|Overall Study||55
8800868|NCT01447888|9852754|FG000|NOT COMPLETED|Overall Study||0
8800869|NCT01447888|9852755|FG001|NOT COMPLETED|Overall Study||0
8800870|NCT01447914|9852761|FG000|STARTED|Overall Study||16
8800871|NCT01447914|9852761|FG000|COMPLETED|Overall Study||16
8800872|NCT01447914|9852761|FG000|NOT COMPLETED|Overall Study||0
8800873|NCT01447927|9852767|FG000|STARTED|Overall Study||38
8800874|NCT01447927|9852768|FG001|STARTED|Overall Study||36
8800875|NCT01447927|9852767|FG000|COMPLETED|Overall Study||33
8800876|NCT01447927|9852768|FG001|COMPLETED|Overall Study||33
8800877|NCT01447927|9852767|FG000|NOT COMPLETED|Overall Study||5
8800878|NCT01447927|9852768|FG001|NOT COMPLETED|Overall Study||3
8800879|NCT01448044|9852776|FG000|STARTED|Treatment Period||82
8800880|NCT01448044|9852777|FG001|STARTED|Treatment Period||42
8800881|NCT01448044|9852776|FG000|COMPLETED|Treatment Period||59
8800882|NCT01448044|9852777|FG001|COMPLETED|Treatment Period||26
8800883|NCT01448044|9852776|FG000|NOT COMPLETED|Treatment Period||23
8800884|NCT01448044|9852777|FG001|NOT COMPLETED|Treatment Period||16
8683054|NCT00810069|9727234|FG001|COMPLETED|Double-Blind Period II||226
8683055|NCT00810069|9727235|FG002|COMPLETED|Double-Blind Period II||212
8683056|NCT00810069|9727233|FG000|NOT COMPLETED|Double-Blind Period II||0
8683057|NCT00810069|9727234|FG001|NOT COMPLETED|Double-Blind Period II||56
8683058|NCT00810069|9727235|FG002|NOT COMPLETED|Double-Blind Period II||72
8683059|NCT00810082|9727246|FG000|STARTED|Overall Study||34
8683060|NCT00810082|9727247|FG001|STARTED|Overall Study||31
8683061|NCT00810082|9727246|FG000|COMPLETED|Overall Study||34
8683062|NCT00810082|9727247|FG001|COMPLETED|Overall Study||27
8683063|NCT00810082|9727246|FG000|NOT COMPLETED|Overall Study||0
8919276|NCT02207231|9979268|FG002|COMPLETED|Open-label Guselkumab: Week 48 - 264||242
8919277|NCT02207231|9979269|FG003|COMPLETED|Open-label Guselkumab: Week 48 - 264||380
8919278|NCT02207231|9979266|FG000|NOT COMPLETED|Open-label Guselkumab: Week 48 - 264||0
8919279|NCT02207231|9979267|FG001|NOT COMPLETED|Open-label Guselkumab: Week 48 - 264||0
8919280|NCT02207231|9979268|FG002|NOT COMPLETED|Open-label Guselkumab: Week 48 - 264||38
8919281|NCT02207231|9979269|FG003|NOT COMPLETED|Open-label Guselkumab: Week 48 - 264||83
8919282|NCT02207244|9979290|FG000|STARTED|Placebo Controlled Period: Week 0-16||248
8919283|NCT02207244|9979291|FG001|STARTED|Placebo Controlled Period: Week 0-16||496
8919284|NCT02207244|9979292|FG002|STARTED|Placebo Controlled Period: Week 0-16||248
8919285|NCT02207244|9979293|FG003|STARTED|Placebo Controlled Period: Week 0-16||0
8919286|NCT02207244|9979294|FG004|STARTED|Placebo Controlled Period: Week 0-16||0
8919287|NCT02207244|9979295|FG005|STARTED|Placebo Controlled Period: Week 0-16||0
8919288|NCT02207244|9979296|FG006|STARTED|Placebo Controlled Period: Week 0-16||0
8919289|NCT02207244|9979297|FG007|STARTED|Placebo Controlled Period: Week 0-16||0
8919290|NCT02207244|9979298|FG008|STARTED|Placebo Controlled Period: Week 0-16||0
8919291|NCT02207244|9979299|FG009|STARTED|Placebo Controlled Period: Week 0-16||0
8919292|NCT02207244|9979300|FG010|STARTED|Placebo Controlled Period: Week 0-16||0
8919293|NCT02207244|9979290|FG000|Treated|Placebo Controlled Period: Week 0-16||248
8919294|NCT02207244|9979291|FG001|Treated|Placebo Controlled Period: Week 0-16||494
8919295|NCT02207244|9979292|FG002|Treated|Placebo Controlled Period: Week 0-16||248
8919296|NCT02207244|9979293|FG003|Treated|Placebo Controlled Period: Week 0-16||0
8919297|NCT02207244|9979294|FG004|Treated|Placebo Controlled Period: Week 0-16||0
8919298|NCT02207244|9979295|FG005|Treated|Placebo Controlled Period: Week 0-16||0
8919299|NCT02207244|9979296|FG006|Treated|Placebo Controlled Period: Week 0-16||0
8919300|NCT02207244|9979297|FG007|Treated|Placebo Controlled Period: Week 0-16||0
8919301|NCT02207244|9979298|FG008|Treated|Placebo Controlled Period: Week 0-16||0
8919302|NCT02207244|9979299|FG009|Treated|Placebo Controlled Period: Week 0-16||0
8919303|NCT02207244|9979300|FG010|Treated|Placebo Controlled Period: Week 0-16||0
8919304|NCT02207244|9979290|FG000|COMPLETED|Placebo Controlled Period: Week 0-16||233
8919305|NCT02207244|9979291|FG001|COMPLETED|Placebo Controlled Period: Week 0-16||478
8919306|NCT02207244|9979292|FG002|COMPLETED|Placebo Controlled Period: Week 0-16||237
8919307|NCT02207244|9979293|FG003|COMPLETED|Placebo Controlled Period: Week 0-16||0
8919308|NCT02207244|9979294|FG004|COMPLETED|Placebo Controlled Period: Week 0-16||0
8919309|NCT02207244|9979295|FG005|COMPLETED|Placebo Controlled Period: Week 0-16||0
8919310|NCT02207244|9979296|FG006|COMPLETED|Placebo Controlled Period: Week 0-16||0
8919311|NCT02207244|9979297|FG007|COMPLETED|Placebo Controlled Period: Week 0-16||0
8683064|NCT00810082|9727247|FG001|NOT COMPLETED|Overall Study||4
8683065|NCT00810095|9727253|FG000|STARTED|Overall Study||40
8683066|NCT00810095|9727253|FG000|COMPLETED|Overall Study||40
8683067|NCT00810095|9727253|FG000|NOT COMPLETED|Overall Study||0
8683068|NCT00810108|9727259|FG000|STARTED|Overall Study||6
8683069|NCT00810108|9727260|FG001|STARTED|Overall Study||7
8683070|NCT00810108|9727259|FG000|COMPLETED|Overall Study||5
8683071|NCT00810108|9727260|FG001|COMPLETED|Overall Study||7
8683072|NCT00810108|9727259|FG000|NOT COMPLETED|Overall Study||1
8683073|NCT00810108|9727260|FG001|NOT COMPLETED|Overall Study||0
8683074|NCT00810199|9727267|FG000|STARTED|Overall Study||279
8683075|NCT00810199|9727268|FG001|STARTED|Overall Study||277
8683076|NCT00810199|9727267|FG000|Received Study Drug|Overall Study||277
8683077|NCT00810199|9727268|FG001|Received Study Drug|Overall Study||276
8683078|NCT00810199|9727267|FG000|Completed Week 24|Overall Study||259
8683079|NCT00810199|9727268|FG001|Completed Week 24|Overall Study||250
8683080|NCT00810199|9727267|FG000|Completed Week 52|Overall Study||243
8683081|NCT00810199|9727268|FG001|Completed Week 52|Overall Study||229
8683082|NCT00810199|9727267|FG000|Completed Week 104|Overall Study||222
8683083|NCT00810199|9727268|FG001|Completed Week 104|Overall Study||201
8683084|NCT00810199|9727267|FG000|COMPLETED|Overall Study||220
8683085|NCT00810199|9727268|FG001|COMPLETED|Overall Study|Completed=Completed Treatment|195
8683086|NCT00810199|9727267|FG000|NOT COMPLETED|Overall Study||59
8683087|NCT00810199|9727268|FG001|NOT COMPLETED|Overall Study||82
8683088|NCT00810264|9727280|FG000|STARTED|Overall Study||2499
8683089|NCT00810264|9727280|FG000|COMPLETED|Overall Study||946
8683090|NCT00810264|9727280|FG000|NOT COMPLETED|Overall Study||1553
8683091|NCT00810277|9727288|FG000|STARTED|Overall Study||14
8683092|NCT00810277|9727288|FG000|COMPLETED|Overall Study||13
8683093|NCT00810277|9727288|FG000|NOT COMPLETED|Overall Study||1
8683094|NCT00810303|9727292|FG000|STARTED|Efavirenz Alone - Day 1-5||12
8683095|NCT00810303|9727292|FG000|COMPLETED|Efavirenz Alone - Day 1-5||12
8683096|NCT00810303|9727292|FG000|NOT COMPLETED|Efavirenz Alone - Day 1-5||0
8683097|NCT00810303|9727292|FG000|STARTED|Ezetimibe Alone - Day 6-15||12
8683098|NCT00810303|9727292|FG000|COMPLETED|Ezetimibe Alone - Day 6-15||12
8683099|NCT00810303|9727292|FG000|NOT COMPLETED|Ezetimibe Alone - Day 6-15||0
8683100|NCT00810303|9727292|FG000|STARTED|Ezetimibe and Efavirenz - Day 16-20||12
8683101|NCT00810303|9727292|FG000|COMPLETED|Ezetimibe and Efavirenz - Day 16-20||12
8683102|NCT00810303|9727292|FG000|NOT COMPLETED|Ezetimibe and Efavirenz - Day 16-20||0
8683103|NCT00810303|9727292|FG000|STARTED|Ezetimibe and Efavirenz - Day 21-30||12
8683104|NCT00810303|9727292|FG000|COMPLETED|Ezetimibe and Efavirenz - Day 21-30||12
8683105|NCT00810303|9727292|FG000|NOT COMPLETED|Ezetimibe and Efavirenz - Day 21-30||0
8683106|NCT00810342|9727302|FG000|STARTED|Month 1 Follow-up||154
8683107|NCT00810342|9727303|FG001|STARTED|Month 1 Follow-up||157
8683108|NCT00810342|9727302|FG000|COMPLETED|Month 1 Follow-up||149
8683109|NCT00810342|9727303|FG001|COMPLETED|Month 1 Follow-up||155
8683110|NCT00810342|9727302|FG000|NOT COMPLETED|Month 1 Follow-up||5
8683111|NCT00810342|9727303|FG001|NOT COMPLETED|Month 1 Follow-up||2
8683112|NCT00810342|9727302|FG000|STARTED|6-month Follow-up||149
8683113|NCT00810342|9727303|FG001|STARTED|6-month Follow-up||155
8683114|NCT00810342|9727302|FG000|COMPLETED|6-month Follow-up||125
8683115|NCT00810342|9727303|FG001|COMPLETED|6-month Follow-up||147
8683116|NCT00810342|9727302|FG000|NOT COMPLETED|6-month Follow-up||24
8683117|NCT00810342|9727303|FG001|NOT COMPLETED|6-month Follow-up||8
8683118|NCT00810342|9727302|FG000|STARTED|12-month Followup||125
8683119|NCT00810342|9727303|FG001|STARTED|12-month Followup||147
8683120|NCT00810342|9727302|FG000|COMPLETED|12-month Followup||113
8683121|NCT00810342|9727303|FG001|COMPLETED|12-month Followup||136
8683122|NCT00810342|9727302|FG000|NOT COMPLETED|12-month Followup||12
8683123|NCT00810342|9727303|FG001|NOT COMPLETED|12-month Followup||11
8683124|NCT00810355|9727314|FG000|STARTED|Overall Study||25
8683125|NCT00810355|9727315|FG001|STARTED|Overall Study||25
8683126|NCT00810355|9727316|FG002|STARTED|Overall Study||25
8683127|NCT00810355|9727314|FG000|COMPLETED|Overall Study||11
8683128|NCT00810355|9727315|FG001|COMPLETED|Overall Study||8
8683129|NCT00810355|9727316|FG002|COMPLETED|Overall Study||14
8683130|NCT00810355|9727314|FG000|NOT COMPLETED|Overall Study||14
8683131|NCT00810355|9727315|FG001|NOT COMPLETED|Overall Study||17
8683132|NCT00810355|9727316|FG002|NOT COMPLETED|Overall Study||11
8683133|NCT00810368|9727326|FG000|STARTED|Overall Study||18
8683134|NCT00810368|9727327|FG001|STARTED|Overall Study||15
8683135|NCT00810368|9727326|FG000|COMPLETED|Overall Study||12
8800885|NCT01448044|9852776|FG000|STARTED|Follow Up Period|Out of 82 participants who entered the treatment period, 77 continued in the follow-up period.|77
8800886|NCT01448044|9852777|FG001|STARTED|Follow Up Period|Out of 42 participants who entered the treatment period, 40 continued in the follow-up period.|40
8800887|NCT01448044|9852776|FG000|COMPLETED|Follow Up Period||65
8800888|NCT01448044|9852777|FG001|COMPLETED|Follow Up Period||26
8800889|NCT01448044|9852776|FG000|NOT COMPLETED|Follow Up Period||12
8800890|NCT01448044|9852777|FG001|NOT COMPLETED|Follow Up Period||14
8800891|NCT01448057|9852785|FG000|STARTED|Overall Study||170
8800892|NCT01448057|9852786|FG001|STARTED|Overall Study||171
8800893|NCT01448057|9852785|FG000|COMPLETED|Overall Study||162
8800894|NCT01448057|9852786|FG001|COMPLETED|Overall Study||167
8800895|NCT01448057|9852785|FG000|NOT COMPLETED|Overall Study||8
8800896|NCT01448057|9852786|FG001|NOT COMPLETED|Overall Study||4
8800897|NCT01448213|9852794|FG000|STARTED|Overall Study||130
8800898|NCT01448213|9852795|FG001|STARTED|Overall Study||134
8800899|NCT01448213|9852794|FG000|COMPLETED|Overall Study||113
8800900|NCT01448213|9852795|FG001|COMPLETED|Overall Study||112
8800901|NCT01448213|9852794|FG000|NOT COMPLETED|Overall Study||17
8800902|NCT01448213|9852795|FG001|NOT COMPLETED|Overall Study||22
8800903|NCT01448356|9852801|FG000|STARTED|Overall Study||10
8800904|NCT01448356|9852801|FG000|COMPLETED|Overall Study|cross-over|10
8800905|NCT01448356|9852801|FG000|NOT COMPLETED|Overall Study||0
8800906|NCT01448421|9852806|FG000|STARTED|Overall Study||37
8800907|NCT01448421|9852806|FG000|COMPLETED|Overall Study||37
8800908|NCT01448421|9852806|FG000|NOT COMPLETED|Overall Study||0
8800909|NCT01448447|9852812|FG000|STARTED|Overall Study||20
8800910|NCT01448447|9852813|FG001|STARTED|Overall Study||0
8800911|NCT01448447|9852812|FG000|COMPLETED|Overall Study||20
8800912|NCT01448447|9852813|FG001|COMPLETED|Overall Study||0
8800913|NCT01448447|9852812|FG000|NOT COMPLETED|Overall Study||0
8800914|NCT01448447|9852813|FG001|NOT COMPLETED|Overall Study||0
8800915|NCT01448486|9852821|FG000|STARTED|Overall Study||3
8800916|NCT01448486|9852822|FG001|STARTED|Overall Study||3
8800917|NCT01448486|9852821|FG000|COMPLETED|Overall Study||3
8800918|NCT01448486|9852822|FG001|COMPLETED|Overall Study||3
8800919|NCT01448486|9852821|FG000|NOT COMPLETED|Overall Study||0
8800920|NCT01448486|9852822|FG001|NOT COMPLETED|Overall Study||0
8800921|NCT01448525|9852830|FG000|STARTED|Overall Study||44
8800922|NCT01448525|9852831|FG001|STARTED|Overall Study||44
8800923|NCT01448525|9852830|FG000|COMPLETED|Overall Study||43
8800924|NCT01448525|9852831|FG001|COMPLETED|Overall Study||42
8800925|NCT01448525|9852830|FG000|NOT COMPLETED|Overall Study||1
8800926|NCT01448525|9852831|FG001|NOT COMPLETED|Overall Study||2
8800927|NCT01448616|9852840|FG000|STARTED|Lead-In (Observational Phase)||73
8800928|NCT01448616|9852841|FG001|STARTED|Lead-In (Observational Phase)|N/A during observational phase as participants randomized subsequently|0
8800929|NCT01448616|9852842|FG002|STARTED|Lead-In (Observational Phase)|N/A during observational phase as participants randomized subsequently|0
8800930|NCT01448616|9852843|FG003|STARTED|Lead-In (Observational Phase)|N/A during observational phase as participants randomized subsequently|0
8800931|NCT01448616|9852840|FG000|COMPLETED|Lead-In (Observational Phase)|Participants who swabbed >90% completed this phase and were randomized to treatment 2:2:1.|64
8919312|NCT02207244|9979298|FG008|COMPLETED|Placebo Controlled Period: Week 0-16||0
8683136|NCT00810368|9727327|FG001|COMPLETED|Overall Study||13
8683137|NCT00810368|9727326|FG000|NOT COMPLETED|Overall Study||6
8683138|NCT00810368|9727327|FG001|NOT COMPLETED|Overall Study||2
8683139|NCT00810394|9727335|FG000|STARTED|Overall Study||50
8683140|NCT00810394|9727335|FG000|Cycle 2 600mg Twice Daily|Overall Study||13
8683141|NCT00810394|9727335|FG000|Cycle 2 400mg Once Daily|Overall Study||22
8683142|NCT00810394|9727335|FG000|Cycle 3 800 mg Twice Daily|Overall Study||4
8683143|NCT00810394|9727335|FG000|Cycle 3 400mg Twice Daily|Overall Study||5
8683144|NCT00810394|9727335|FG000|COMPLETED|Overall Study||47
8683145|NCT00810394|9727335|FG000|NOT COMPLETED|Overall Study||3
8683146|NCT00810407|9727339|FG000|STARTED|Overall Study||594
8683147|NCT00810407|9727339|FG000|COMPLETED|Overall Study||588
8683148|NCT00810407|9727339|FG000|NOT COMPLETED|Overall Study||6
8683149|NCT00810459|9727343|FG000|STARTED|Overall Study||4
8683150|NCT00810459|9727344|FG001|STARTED|Overall Study||2
8683151|NCT00810459|9727343|FG000|COMPLETED|Overall Study||4
8683152|NCT00810459|9727344|FG001|COMPLETED|Overall Study||2
8683153|NCT00810459|9727343|FG000|NOT COMPLETED|Overall Study||0
8683154|NCT00810459|9727344|FG001|NOT COMPLETED|Overall Study||0
8683155|NCT00810498|9727351|FG000|STARTED|Overall Study||6
8683156|NCT00810498|9727352|FG001|STARTED|Overall Study||5
8683157|NCT00810498|9727351|FG000|COMPLETED|Overall Study||6
8683158|NCT00810498|9727352|FG001|COMPLETED|Overall Study||5
8683159|NCT00810498|9727351|FG000|NOT COMPLETED|Overall Study||0
8683160|NCT00810498|9727352|FG001|NOT COMPLETED|Overall Study||0
8683161|NCT00810511|9727360|FG000|STARTED|Overall Study||107
8683162|NCT00810511|9727361|FG001|STARTED|Overall Study||106
8683163|NCT00810511|9727360|FG000|COMPLETED|Overall Study||97
8683164|NCT00810511|9727361|FG001|COMPLETED|Overall Study||102
8683165|NCT00810511|9727360|FG000|NOT COMPLETED|Overall Study||10
8683166|NCT00810511|9727361|FG001|NOT COMPLETED|Overall Study||4
8683167|NCT00810576|9727367|FG000|STARTED|Overall Study||1
8683168|NCT00810576|9727367|FG000|COMPLETED|Overall Study||1
8683169|NCT00810576|9727367|FG000|NOT COMPLETED|Overall Study||0
8683170|NCT00810602|9727371|FG000|STARTED|Overall Study||27
8683171|NCT00810602|9727372|FG001|STARTED|Overall Study||34
8683172|NCT00810602|9727371|FG000|COMPLETED|Overall Study||19
8683173|NCT00810602|9727372|FG001|COMPLETED|Overall Study||31
8683174|NCT00810602|9727371|FG000|NOT COMPLETED|Overall Study||8
8683175|NCT00810602|9727372|FG001|NOT COMPLETED|Overall Study||3
8683176|NCT00810615|9727378|FG000|STARTED|Overall Study||25
8683177|NCT00810615|9727379|FG001|STARTED|Overall Study||25
8683178|NCT00810615|9727378|FG000|COMPLETED|Overall Study|One male withdrawal due to personal reasons.|24
8683179|NCT00810615|9727379|FG001|COMPLETED|Overall Study|One male withdrawal due to personal reasons.|24
8683180|NCT00810615|9727378|FG000|NOT COMPLETED|Overall Study||1
8683181|NCT00810615|9727379|FG001|NOT COMPLETED|Overall Study||1
8683182|NCT00810641|9727400|FG000|STARTED|Overall Study||52
8683183|NCT00810641|9727401|FG001|STARTED|Overall Study||54
8683184|NCT00810641|9727402|FG002|STARTED|Overall Study||51
8683185|NCT00810641|9727400|FG000|COMPLETED|Overall Study||52
8683186|NCT00810641|9727401|FG001|COMPLETED|Overall Study||53
8683187|NCT00810641|9727402|FG002|COMPLETED|Overall Study||49
8683188|NCT00810641|9727400|FG000|NOT COMPLETED|Overall Study||0
8683189|NCT00810641|9727401|FG001|NOT COMPLETED|Overall Study||1
8683190|NCT00810641|9727402|FG002|NOT COMPLETED|Overall Study||2
8683191|NCT00810693|9727413|FG000|STARTED|Treatment Period||254
8683192|NCT00810693|9727414|FG001|STARTED|Treatment Period|1 randomized but not treated|64
8683193|NCT00810693|9727415|FG002|STARTED|Treatment Period|1 randomized but not treated|127
8683194|NCT00810693|9727413|FG000|Participants Received Treatment|Treatment Period||254
8683195|NCT00810693|9727414|FG001|Participants Received Treatment|Treatment Period||63
8683196|NCT00810693|9727415|FG002|Participants Received Treatment|Treatment Period||126
8683197|NCT00810693|9727413|FG000|COMPLETED|Treatment Period||237
8683198|NCT00810693|9727414|FG001|COMPLETED|Treatment Period||57
8683199|NCT00810693|9727415|FG002|COMPLETED|Treatment Period||111
8683200|NCT00810693|9727413|FG000|NOT COMPLETED|Treatment Period||17
8683201|NCT00810693|9727414|FG001|NOT COMPLETED|Treatment Period||7
8683202|NCT00810693|9727415|FG002|NOT COMPLETED|Treatment Period||16
8683203|NCT00810693|9727413|FG000|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|23
8683204|NCT00810693|9727414|FG001|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|7
8683205|NCT00810693|9727415|FG002|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|16
8683206|NCT00810693|9727413|FG000|COMPLETED|Follow-up Period (FUP)||15
8683207|NCT00810693|9727414|FG001|COMPLETED|Follow-up Period (FUP)||4
8683208|NCT00810693|9727415|FG002|COMPLETED|Follow-up Period (FUP)||12
8683209|NCT00810693|9727413|FG000|NOT COMPLETED|Follow-up Period (FUP)||8
8683210|NCT00810693|9727414|FG001|NOT COMPLETED|Follow-up Period (FUP)||3
8683211|NCT00810693|9727415|FG002|NOT COMPLETED|Follow-up Period (FUP)||4
8683212|NCT00810719|9727423|FG000|STARTED|Overall Study||30
8683213|NCT00810719|9727423|FG000|COMPLETED|Overall Study||30
8683214|NCT00810719|9727423|FG000|NOT COMPLETED|Overall Study||0
8683215|NCT00810771|9727430|FG000|STARTED|Overall Study||232
8683216|NCT00810771|9727431|FG001|STARTED|Overall Study||234
9035704|NCT03301714|10097429|FG000|STARTED|Overall Study||60
8683217|NCT00810771|9727432|FG002|STARTED|Overall Study||84
8683218|NCT00810771|9727430|FG000|COMPLETED|Overall Study||232
8683219|NCT00810771|9727431|FG001|COMPLETED|Overall Study||234
8683220|NCT00810771|9727432|FG002|COMPLETED|Overall Study||84
8683221|NCT00810771|9727430|FG000|NOT COMPLETED|Overall Study||0
8683222|NCT00810771|9727431|FG001|NOT COMPLETED|Overall Study||0
8683223|NCT00810771|9727432|FG002|NOT COMPLETED|Overall Study||0
8683224|NCT00810797|9727442|FG000|STARTED|Overall Study||36
8683225|NCT00810797|9727442|FG000|COMPLETED|Overall Study||36
8683226|NCT00810797|9727442|FG000|NOT COMPLETED|Overall Study||0
8683227|NCT00810810|9727450|FG000|STARTED|Overall Study||124
8683228|NCT00810810|9727451|FG001|STARTED|Overall Study||49
8683229|NCT00810810|9727452|FG002|STARTED|Overall Study||56
8683230|NCT00810810|9727453|FG003|STARTED|Overall Study||51
8683231|NCT00810810|9727450|FG000|COMPLETED|Overall Study||124
8683232|NCT00810810|9727451|FG001|COMPLETED|Overall Study||38
8683233|NCT00810810|9727452|FG002|COMPLETED|Overall Study||45
8683234|NCT00810810|9727453|FG003|COMPLETED|Overall Study||38
8683235|NCT00810810|9727450|FG000|NOT COMPLETED|Overall Study||0
8683236|NCT00810810|9727451|FG001|NOT COMPLETED|Overall Study||11
8683237|NCT00810810|9727452|FG002|NOT COMPLETED|Overall Study||11
8683238|NCT00810810|9727453|FG003|NOT COMPLETED|Overall Study||13
8683239|NCT00810888|9727466|FG000|STARTED|Overall Study||10
8683240|NCT00810888|9727467|FG001|STARTED|Overall Study||9
8683241|NCT00810888|9727468|FG002|STARTED|Overall Study||73
8683242|NCT00810888|9727466|FG000|COMPLETED|Overall Study||10
8683243|NCT00810888|9727467|FG001|COMPLETED|Overall Study||9
8683244|NCT00810888|9727468|FG002|COMPLETED|Overall Study||73
8683245|NCT00810888|9727466|FG000|NOT COMPLETED|Overall Study||0
8683246|NCT00810888|9727467|FG001|NOT COMPLETED|Overall Study||0
8683247|NCT00810888|9727468|FG002|NOT COMPLETED|Overall Study||0
8683248|NCT00810901|9727478|FG000|STARTED|Overall Study||253
8683249|NCT00810901|9727479|FG001|STARTED|Overall Study||176
8683250|NCT00810901|9727478|FG000|1-month Follow up|Overall Study||242
8683251|NCT00810901|9727479|FG001|1-month Follow up|Overall Study||146
8683252|NCT00810901|9727478|FG000|6-month Follow-up|Overall Study||181
8683253|NCT00810901|9727479|FG001|6-month Follow-up|Overall Study||122
8683254|NCT00810901|9727478|FG000|COMPLETED|Overall Study||165
8683255|NCT00810901|9727479|FG001|COMPLETED|Overall Study||118
8683256|NCT00810901|9727478|FG000|NOT COMPLETED|Overall Study||88
8683257|NCT00810901|9727479|FG001|NOT COMPLETED|Overall Study||58
8683258|NCT00811018|9727485|FG000|STARTED|Overall Study||1192
8683259|NCT00811018|9727485|FG000|COMPLETED|Overall Study||224
8683260|NCT00811018|9727485|FG000|NOT COMPLETED|Overall Study||968
8683261|NCT00811057|9727492|FG000|STARTED|Overall Study||90
8683262|NCT00811057|9727493|FG001|STARTED|Overall Study||114
8683263|NCT00811057|9727494|FG002|STARTED|Overall Study||97
8683264|NCT00811057|9727492|FG000|COMPLETED|Overall Study||85
8683265|NCT00811057|9727493|FG001|COMPLETED|Overall Study||104
8683266|NCT00811057|9727494|FG002|COMPLETED|Overall Study||87
8683267|NCT00811057|9727492|FG000|NOT COMPLETED|Overall Study||5
8683268|NCT00811057|9727493|FG001|NOT COMPLETED|Overall Study||10
8683269|NCT00811057|9727494|FG002|NOT COMPLETED|Overall Study||10
8683270|NCT00811070|9727508|FG000|STARTED|Overall Study||7
8683271|NCT00811070|9727509|FG001|STARTED|Overall Study||7
8683272|NCT00811070|9727510|FG002|STARTED|Overall Study||3
8683273|NCT00811070|9727511|FG003|STARTED|Overall Study||28
8683274|NCT00811070|9727512|FG004|STARTED|Overall Study||7
8683275|NCT00811070|9727513|FG005|STARTED|Overall Study||11
8683276|NCT00811070|9727508|FG000|COMPLETED|Overall Study||6
8683277|NCT00811070|9727509|FG001|COMPLETED|Overall Study||6
8683278|NCT00811070|9727510|FG002|COMPLETED|Overall Study||3
8683279|NCT00811070|9727511|FG003|COMPLETED|Overall Study||26
8683280|NCT00811070|9727512|FG004|COMPLETED|Overall Study||2
8683281|NCT00811070|9727513|FG005|COMPLETED|Overall Study||10
8683282|NCT00811070|9727508|FG000|NOT COMPLETED|Overall Study||1
8683283|NCT00811070|9727509|FG001|NOT COMPLETED|Overall Study||1
8683284|NCT00811070|9727510|FG002|NOT COMPLETED|Overall Study||0
8683285|NCT00811070|9727511|FG003|NOT COMPLETED|Overall Study||2
8683286|NCT00811070|9727512|FG004|NOT COMPLETED|Overall Study||5
8683287|NCT00811070|9727513|FG005|NOT COMPLETED|Overall Study||1
8683288|NCT00811135|9727529|FG000|STARTED|Overall Study||88
8683289|NCT00811135|9727529|FG000|COMPLETED|Overall Study||0
8683290|NCT00811135|9727529|FG000|NOT COMPLETED|Overall Study||88
8683291|NCT00811174|9727533|FG000|STARTED|Overall Study||5
8683292|NCT00811174|9727533|FG000|COMPLETED|Overall Study||2
8683293|NCT00811174|9727533|FG000|NOT COMPLETED|Overall Study||3
8683294|NCT00811187|9727539|FG000|STARTED|Overall Study||40
8683295|NCT00811187|9727540|FG001|STARTED|Overall Study||40
8683296|NCT00811187|9727539|FG000|COMPLETED|Overall Study||37
8683297|NCT00811187|9727540|FG001|COMPLETED|Overall Study||37
8683298|NCT00811187|9727539|FG000|NOT COMPLETED|Overall Study||3
8683299|NCT00811187|9727540|FG001|NOT COMPLETED|Overall Study||3
8683300|NCT00811252|9727549|FG000|STARTED|Overall Study||145
8683301|NCT00811252|9727550|FG001|STARTED|Overall Study||156
8683302|NCT00811252|9727551|FG002|STARTED|Overall Study||151
8683303|NCT00811252|9727549|FG000|COMPLETED|Overall Study||128
8683304|NCT00811252|9727550|FG001|COMPLETED|Overall Study||136
8683305|NCT00811252|9727551|FG002|COMPLETED|Overall Study||128
8683306|NCT00811252|9727549|FG000|NOT COMPLETED|Overall Study||17
8683307|NCT00811252|9727550|FG001|NOT COMPLETED|Overall Study||20
8683308|NCT00811252|9727551|FG002|NOT COMPLETED|Overall Study||23
8683309|NCT00811317|9727559|FG000|STARTED|Overall Study||11
8683310|NCT00811317|9727559|FG000|COMPLETED|Overall Study||11
8683311|NCT00811317|9727559|FG000|NOT COMPLETED|Overall Study||0
8683312|NCT00811382|9727565|FG000|STARTED|Overall Study||88
8683313|NCT00811382|9727566|FG001|STARTED|Overall Study||75
8683314|NCT00811382|9727565|FG000|COMPLETED|Overall Study||88
8683315|NCT00811382|9727566|FG001|COMPLETED|Overall Study||75
8683316|NCT00811382|9727565|FG000|NOT COMPLETED|Overall Study||0
8683317|NCT00811382|9727566|FG001|NOT COMPLETED|Overall Study||0
8683318|NCT00811395|9727580|FG000|STARTED|Initial Treatment (PDY6045 or PDY6046)||41
8683319|NCT00811395|9727581|FG001|STARTED|Initial Treatment (PDY6045 or PDY6046)|One participant received 7 mg instead of 14 mg as per randomization|37
8683320|NCT00811395|9727582|FG002|STARTED|Initial Treatment (PDY6045 or PDY6046)||38
8683321|NCT00811395|9727583|FG003|STARTED|Initial Treatment (PDY6045 or PDY6046)||40
8683322|NCT00811395|9727584|FG004|STARTED|Initial Treatment (PDY6045 or PDY6046)||42
8683323|NCT00811395|9727585|FG005|STARTED|Initial Treatment (PDY6045 or PDY6046)||41
8683324|NCT00811395|9727580|FG000|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6045/NCT00489489 record)|38
8683325|NCT00811395|9727581|FG001|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6045/NCT00489489 record)|33
8683326|NCT00811395|9727582|FG002|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6045/NCT00489489 record)|36
8683327|NCT00811395|9727583|FG003|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6046/NCT00475865 record)|38
8683328|NCT00811395|9727584|FG004|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6046/NCT00475865 record)|37
8683329|NCT00811395|9727585|FG005|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6046/NCT00475865 record)|35
8683330|NCT00811395|9727580|FG000|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||3
8683331|NCT00811395|9727581|FG001|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||4
8683332|NCT00811395|9727582|FG002|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||2
8683333|NCT00811395|9727583|FG003|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||2
8683334|NCT00811395|9727584|FG004|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||5
8683335|NCT00811395|9727585|FG005|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||6
8683336|NCT00811395|9727580|FG000|STARTED|Extension Treatment|continued initial treatment|31
8683337|NCT00811395|9727581|FG001|STARTED|Extension Treatment|continued initial treatment|28
8683338|NCT00811395|9727582|FG002|STARTED|Extension Treatment|continued initial treatment|27
8683339|NCT00811395|9727583|FG003|STARTED|Extension Treatment|continued initial treatment|37
8683340|NCT00811395|9727584|FG004|STARTED|Extension Treatment|continued initial treatment|30
8683341|NCT00811395|9727585|FG005|STARTED|Extension Treatment|continued initial treatment|29
8683342|NCT00811395|9727580|FG000|COMPLETED|Extension Treatment|completed 48-week treatment|29
8683343|NCT00811395|9727581|FG001|COMPLETED|Extension Treatment|completed 48-week treatment|22
8683344|NCT00811395|9727582|FG002|COMPLETED|Extension Treatment|completed 48-week treatment|24
8683345|NCT00811395|9727583|FG003|COMPLETED|Extension Treatment|completed 48-week treatment|34
8683346|NCT00811395|9727584|FG004|COMPLETED|Extension Treatment|completed 48-week treatment|30
8683347|NCT00811395|9727585|FG005|COMPLETED|Extension Treatment|completed 48-week treatment|27
8683348|NCT00811395|9727580|FG000|NOT COMPLETED|Extension Treatment||2
8683349|NCT00811395|9727581|FG001|NOT COMPLETED|Extension Treatment||6
8683350|NCT00811395|9727582|FG002|NOT COMPLETED|Extension Treatment||3
8683351|NCT00811395|9727583|FG003|NOT COMPLETED|Extension Treatment||3
8683352|NCT00811395|9727584|FG004|NOT COMPLETED|Extension Treatment||0
8683353|NCT00811395|9727585|FG005|NOT COMPLETED|Extension Treatment||2
8683354|NCT00811434|9727602|FG000|STARTED|First Intervention||7
8683355|NCT00811434|9727603|FG001|STARTED|First Intervention||5
8683356|NCT00811434|9727602|FG000|COMPLETED|First Intervention||4
8683357|NCT00811434|9727603|FG001|COMPLETED|First Intervention||5
8683358|NCT00811434|9727602|FG000|NOT COMPLETED|First Intervention||3
8683359|NCT00811434|9727603|FG001|NOT COMPLETED|First Intervention||0
8683360|NCT00811434|9727602|FG000|STARTED|Washout (1 Month)||4
8683361|NCT00811434|9727603|FG001|STARTED|Washout (1 Month)||5
8683362|NCT00811434|9727602|FG000|COMPLETED|Washout (1 Month)||4
8683363|NCT00811434|9727603|FG001|COMPLETED|Washout (1 Month)||5
8683364|NCT00811434|9727602|FG000|NOT COMPLETED|Washout (1 Month)||0
8683365|NCT00811434|9727603|FG001|NOT COMPLETED|Washout (1 Month)||0
8683366|NCT00811434|9727602|FG000|STARTED|Second Intervention||4
8683367|NCT00811434|9727603|FG001|STARTED|Second Intervention||5
8683368|NCT00811434|9727602|FG000|COMPLETED|Second Intervention||4
8683369|NCT00811434|9727603|FG001|COMPLETED|Second Intervention||5
8683370|NCT00811434|9727602|FG000|NOT COMPLETED|Second Intervention||0
8683371|NCT00811434|9727603|FG001|NOT COMPLETED|Second Intervention||0
8683372|NCT00811473|9727612|FG000|STARTED|Overall Study||93
8683373|NCT00811473|9727613|FG001|STARTED|Overall Study||100
8683374|NCT00811473|9727612|FG000|COMPLETED|Overall Study||70
8683375|NCT00811473|9727613|FG001|COMPLETED|Overall Study||74
8683376|NCT00811473|9727612|FG000|NOT COMPLETED|Overall Study||23
8683377|NCT00811473|9727613|FG001|NOT COMPLETED|Overall Study||26
8683378|NCT00811564|9727621|FG000|STARTED|Overall Study||73
8683379|NCT00811564|9727622|FG001|STARTED|Overall Study||75
8683380|NCT00811564|9727621|FG000|COMPLETED|Overall Study||64
8683381|NCT00811564|9727622|FG001|COMPLETED|Overall Study||73
8683382|NCT00811564|9727621|FG000|NOT COMPLETED|Overall Study||9
8683383|NCT00811564|9727622|FG001|NOT COMPLETED|Overall Study||2
8683384|NCT00811577|9727630|FG000|STARTED|Overall Study||126
8683385|NCT00811577|9727631|FG001|STARTED|Overall Study||24
8800932|NCT01448616|9852841|FG001|COMPLETED|Lead-In (Observational Phase)|completed >90% of sample collection to qualify for randomization for next phase|0
8800933|NCT01448616|9852842|FG002|COMPLETED|Lead-In (Observational Phase)||0
8683386|NCT00811577|9727630|FG000|COMPLETED|Overall Study||116
8683387|NCT00811577|9727631|FG001|COMPLETED|Overall Study||23
8683388|NCT00811577|9727630|FG000|NOT COMPLETED|Overall Study||10
8683389|NCT00811577|9727631|FG001|NOT COMPLETED|Overall Study||1
8683390|NCT00811642|9727680|FG000|STARTED|Overall Study|63 participants were screened and enrolled; 62 participants from Safety Set (SS) started study drug.|62
8683391|NCT00811642|9727680|FG000|COMPLETED|Overall Study|The Per Protocol Set (PPS) includes the 47 participants who completed the study per protocol.|47
8683392|NCT00811642|9727680|FG000|NOT COMPLETED|Overall Study||15
8683393|NCT00811655|9727684|FG000|STARTED|Overall Study||6
8683394|NCT00811655|9727684|FG000|COMPLETED|Overall Study||5
8683395|NCT00811655|9727684|FG000|NOT COMPLETED|Overall Study||1
8683396|NCT00811720|9727690|FG000|STARTED|All Randomised Patients||298
8683397|NCT00811720|9727691|FG001|STARTED|All Randomised Patients||306
8683398|NCT00811720|9727690|FG000|COMPLETED|All Randomised Patients||296
8683399|NCT00811720|9727691|FG001|COMPLETED|All Randomised Patients||302
8683400|NCT00811720|9727690|FG000|NOT COMPLETED|All Randomised Patients||2
8683401|NCT00811720|9727691|FG001|NOT COMPLETED|All Randomised Patients||4
8683402|NCT00811720|9727690|FG000|STARTED|All Treated Patients||296
8683403|NCT00811720|9727691|FG001|STARTED|All Treated Patients||302
8683404|NCT00811720|9727690|FG000|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|200
8683405|NCT00811720|9727691|FG001|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|138
8683406|NCT00811720|9727690|FG000|NOT COMPLETED|All Treated Patients||96
8683407|NCT00811720|9727691|FG001|NOT COMPLETED|All Treated Patients||164
8683408|NCT00811733|9727699|FG000|STARTED|Overall Study||15
8683409|NCT00811733|9727700|FG001|STARTED|Overall Study||22
8683410|NCT00811733|9727699|FG000|COMPLETED|Overall Study||4
8683411|NCT00811733|9727700|FG001|COMPLETED|Overall Study||12
8683412|NCT00811733|9727699|FG000|NOT COMPLETED|Overall Study||11
8683413|NCT00811733|9727700|FG001|NOT COMPLETED|Overall Study||10
8683414|NCT00811798|9727706|FG000|STARTED|Overall Study||92
8683415|NCT00811798|9727706|FG000|COMPLETED|Overall Study||92
8683416|NCT00811798|9727706|FG000|NOT COMPLETED|Overall Study||0
8683417|NCT00811850|9727710|FG000|STARTED|Treatment Period 1: Combigan® or Cosopt®||15
8683418|NCT00811850|9727710|FG000|COMPLETED|Treatment Period 1: Combigan® or Cosopt®||15
8683419|NCT00811850|9727710|FG000|NOT COMPLETED|Treatment Period 1: Combigan® or Cosopt®||0
8683420|NCT00811850|9727710|FG000|STARTED|Treatment Period 2: Wash Out||15
8683421|NCT00811850|9727710|FG000|COMPLETED|Treatment Period 2: Wash Out||15
8683422|NCT00811850|9727710|FG000|NOT COMPLETED|Treatment Period 2: Wash Out||0
8683423|NCT00811850|9727710|FG000|STARTED|Treatment Period 3: Combigan® or Cosopt®||15
8683424|NCT00811850|9727710|FG000|COMPLETED|Treatment Period 3: Combigan® or Cosopt®||15
8683425|NCT00811850|9727710|FG000|NOT COMPLETED|Treatment Period 3: Combigan® or Cosopt®||0
8683426|NCT00811928|9727718|FG000|STARTED|Overall Study||129
8683427|NCT00811928|9727719|FG001|STARTED|Overall Study||123
8683428|NCT00811928|9727718|FG000|COMPLETED|Overall Study||90
8683429|NCT00811928|9727719|FG001|COMPLETED|Overall Study||90
8683430|NCT00811928|9727718|FG000|NOT COMPLETED|Overall Study||39
8683431|NCT00811928|9727719|FG001|NOT COMPLETED|Overall Study||33
8683432|NCT00811941|9727727|FG000|STARTED|All Randomised Patients||166
8683433|NCT00811941|9727728|FG001|STARTED|All Randomised Patients||509
8683434|NCT00811941|9727727|FG000|COMPLETED|All Randomised Patients||164
8683435|NCT00811941|9727728|FG001|COMPLETED|All Randomised Patients||501
8683436|NCT00811941|9727727|FG000|NOT COMPLETED|All Randomised Patients||2
8683437|NCT00811941|9727728|FG001|NOT COMPLETED|All Randomised Patients||8
8683438|NCT00811941|9727727|FG000|STARTED|All Treated Patients||164
8683439|NCT00811941|9727728|FG001|STARTED|All Treated Patients||501
8683440|NCT00811941|9727727|FG000|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|112
8683441|NCT00811941|9727728|FG001|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|310
8683442|NCT00811941|9727727|FG000|NOT COMPLETED|All Treated Patients||52
8683443|NCT00811941|9727728|FG001|NOT COMPLETED|All Treated Patients||191
8683444|NCT00811954|9727737|FG000|STARTED|Overall Study||605
8683445|NCT00811954|9727738|FG001|STARTED|Overall Study||603
8683446|NCT00811954|9727739|FG002|STARTED|Overall Study||601
8683447|NCT00811954|9727737|FG000|COMPLETED|Overall Study||516
8683448|NCT00811954|9727738|FG001|COMPLETED|Overall Study||531
8683449|NCT00811954|9727739|FG002|COMPLETED|Overall Study||500
8683450|NCT00811954|9727737|FG000|NOT COMPLETED|Overall Study||89
8683451|NCT00811954|9727738|FG001|NOT COMPLETED|Overall Study||72
8683452|NCT00811954|9727739|FG002|NOT COMPLETED|Overall Study||101
8683453|NCT00812097|9727751|FG000|STARTED|Overall Study||572
8683454|NCT00812097|9727752|FG001|STARTED|Overall Study||190
8683455|NCT00812097|9727753|FG002|STARTED|Overall Study||124
8683456|NCT00812097|9727754|FG003|STARTED|Overall Study||69
8683457|NCT00812097|9727751|FG000|COMPLETED|Overall Study||327
8683458|NCT00812097|9727752|FG001|COMPLETED|Overall Study||101
8683459|NCT00812097|9727753|FG002|COMPLETED|Overall Study||67
8683460|NCT00812097|9727754|FG003|COMPLETED|Overall Study||34
8683461|NCT00812097|9727751|FG000|NOT COMPLETED|Overall Study||245
8683462|NCT00812097|9727752|FG001|NOT COMPLETED|Overall Study||89
8683463|NCT00812097|9727753|FG002|NOT COMPLETED|Overall Study||57
8919313|NCT02207244|9979299|FG009|COMPLETED|Placebo Controlled Period: Week 0-16||0
8683464|NCT00812097|9727754|FG003|NOT COMPLETED|Overall Study||35
8683465|NCT00812110|9727764|FG000|STARTED|Overall Study||292
8683466|NCT00812110|9727764|FG000|COMPLETED|Overall Study||292
8683467|NCT00812110|9727764|FG000|NOT COMPLETED|Overall Study||0
8683468|NCT00812253|9727770|FG000|STARTED|Overall Study||32
8683469|NCT00812253|9727771|FG001|STARTED|Overall Study||42
8683470|NCT00812253|9727770|FG000|COMPLETED|Overall Study||26
8683471|NCT00812253|9727771|FG001|COMPLETED|Overall Study||39
8683472|NCT00812253|9727770|FG000|NOT COMPLETED|Overall Study||6
8683473|NCT00812253|9727771|FG001|NOT COMPLETED|Overall Study||3
8683474|NCT00812331|9727782|FG000|STARTED|Overall Study||6
8683475|NCT00812331|9727783|FG001|STARTED|Overall Study||8
8683476|NCT00812331|9727784|FG002|STARTED|Overall Study||8
8683477|NCT00812331|9727785|FG003|STARTED|Overall Study||7
8683478|NCT00812331|9727786|FG004|STARTED|Overall Study||8
8683479|NCT00812331|9727782|FG000|COMPLETED|Overall Study||5
8683480|NCT00812331|9727783|FG001|COMPLETED|Overall Study||8
8683481|NCT00812331|9727784|FG002|COMPLETED|Overall Study||8
8683482|NCT00812331|9727785|FG003|COMPLETED|Overall Study||7
8683483|NCT00812331|9727786|FG004|COMPLETED|Overall Study||8
8683484|NCT00812331|9727782|FG000|NOT COMPLETED|Overall Study||1
8683485|NCT00812331|9727783|FG001|NOT COMPLETED|Overall Study||0
8683486|NCT00812331|9727784|FG002|NOT COMPLETED|Overall Study||0
8683487|NCT00812331|9727785|FG003|NOT COMPLETED|Overall Study||0
8683488|NCT00812331|9727786|FG004|NOT COMPLETED|Overall Study||0
8683489|NCT00812461|9727796|FG000|STARTED|All Randomised Patients||360
8683490|NCT00812461|9727797|FG001|STARTED|All Randomised Patients||358
8683491|NCT00812461|9727796|FG000|COMPLETED|All Randomised Patients||337
8683492|NCT00812461|9727797|FG001|COMPLETED|All Randomised Patients||341
8683493|NCT00812461|9727796|FG000|NOT COMPLETED|All Randomised Patients||23
8683494|NCT00812461|9727797|FG001|NOT COMPLETED|All Randomised Patients||17
8683495|NCT00812461|9727796|FG000|STARTED|All Treated Patients||337
8683496|NCT00812461|9727797|FG001|STARTED|All Treated Patients||341
8683497|NCT00812461|9727796|FG000|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|205
8683498|NCT00812461|9727797|FG001|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|194
8683499|NCT00812461|9727796|FG000|NOT COMPLETED|All Treated Patients||132
8683500|NCT00812461|9727797|FG001|NOT COMPLETED|All Treated Patients||147
8683501|NCT00812487|9727805|FG000|STARTED|Overall Study||32
8683502|NCT00812487|9727806|FG001|STARTED|Overall Study||42
8683503|NCT00812487|9727805|FG000|COMPLETED|Overall Study||26
8683504|NCT00812487|9727806|FG001|COMPLETED|Overall Study||39
8683505|NCT00812487|9727805|FG000|NOT COMPLETED|Overall Study||6
8683506|NCT00812487|9727806|FG001|NOT COMPLETED|Overall Study||3
8683507|NCT00812565|9727820|FG000|STARTED|Overall Study||8
8683508|NCT00812565|9727821|FG001|STARTED|Overall Study||7
8683509|NCT00812565|9727822|FG002|STARTED|Overall Study||7
8683510|NCT00812565|9727823|FG003|STARTED|Overall Study||7
8683511|NCT00812565|9727824|FG004|STARTED|Overall Study||7
8683512|NCT00812565|9727825|FG005|STARTED|Overall Study||7
8683513|NCT00812565|9727826|FG006|STARTED|Overall Study||8
8683514|NCT00812565|9727827|FG007|STARTED|Overall Study||7
8683515|NCT00812565|9727820|FG000|COMPLETED|Overall Study||5
8683516|NCT00812565|9727821|FG001|COMPLETED|Overall Study||6
8683517|NCT00812565|9727822|FG002|COMPLETED|Overall Study||7
8683518|NCT00812565|9727823|FG003|COMPLETED|Overall Study||5
8683519|NCT00812565|9727824|FG004|COMPLETED|Overall Study||6
8683520|NCT00812565|9727825|FG005|COMPLETED|Overall Study||6
8683521|NCT00812565|9727826|FG006|COMPLETED|Overall Study||8
8683522|NCT00812565|9727827|FG007|COMPLETED|Overall Study||6
8683523|NCT00812565|9727820|FG000|NOT COMPLETED|Overall Study||3
8683524|NCT00812565|9727821|FG001|NOT COMPLETED|Overall Study||1
8683525|NCT00812565|9727822|FG002|NOT COMPLETED|Overall Study||0
8683526|NCT00812565|9727823|FG003|NOT COMPLETED|Overall Study||2
8683527|NCT00812565|9727824|FG004|NOT COMPLETED|Overall Study||1
8683528|NCT00812565|9727825|FG005|NOT COMPLETED|Overall Study||1
8683529|NCT00812565|9727826|FG006|NOT COMPLETED|Overall Study||0
8683530|NCT00812565|9727827|FG007|NOT COMPLETED|Overall Study||1
8683531|NCT00812604|9727847|FG000|STARTED|Overall Study||28
8683532|NCT00812604|9727848|FG001|STARTED|Overall Study||27
8683533|NCT00812604|9727847|FG000|COMPLETED|Overall Study||23
8683534|NCT00812604|9727848|FG001|COMPLETED|Overall Study||22
8683535|NCT00812604|9727847|FG000|NOT COMPLETED|Overall Study||5
8683536|NCT00812604|9727848|FG001|NOT COMPLETED|Overall Study||5
8683537|NCT00812812|9727856|FG000|STARTED|Overall Study||27
8683538|NCT00812812|9727857|FG001|STARTED|Overall Study||29
8683539|NCT00812812|9727856|FG000|COMPLETED|Overall Study||24
8683540|NCT00812812|9727857|FG001|COMPLETED|Overall Study||25
8683541|NCT00812812|9727856|FG000|NOT COMPLETED|Overall Study||3
8683542|NCT00812812|9727857|FG001|NOT COMPLETED|Overall Study||4
8683543|NCT00812838|9727867|FG000|STARTED|Treatment Period of 16 Weeks||6
8683544|NCT00812838|9727868|FG001|STARTED|Treatment Period of 16 Weeks||6
8683545|NCT00812838|9727867|FG000|COMPLETED|Treatment Period of 16 Weeks||6
8683546|NCT00812838|9727868|FG001|COMPLETED|Treatment Period of 16 Weeks||6
8683547|NCT00812838|9727867|FG000|NOT COMPLETED|Treatment Period of 16 Weeks||0
8683548|NCT00812838|9727868|FG001|NOT COMPLETED|Treatment Period of 16 Weeks||0
8683549|NCT00812838|9727867|FG000|STARTED|Optional Crossover of 16 Weeks||0
8683550|NCT00812838|9727868|FG001|STARTED|Optional Crossover of 16 Weeks||4
8683551|NCT00812838|9727867|FG000|COMPLETED|Optional Crossover of 16 Weeks||0
8683552|NCT00812838|9727868|FG001|COMPLETED|Optional Crossover of 16 Weeks||4
8683553|NCT00812838|9727867|FG000|NOT COMPLETED|Optional Crossover of 16 Weeks||0
8683554|NCT00812838|9727868|FG001|NOT COMPLETED|Optional Crossover of 16 Weeks||0
8683555|NCT00812877|9727878|FG000|STARTED|Overall Study||195
8683556|NCT00812877|9727879|FG001|STARTED|Overall Study||181
8683557|NCT00812877|9727878|FG000|COMPLETED|Overall Study||158
8683558|NCT00812877|9727879|FG001|COMPLETED|Overall Study||130
8683559|NCT00812877|9727878|FG000|NOT COMPLETED|Overall Study||37
8683560|NCT00812877|9727879|FG001|NOT COMPLETED|Overall Study||51
8683561|NCT00812916|9727885|FG000|STARTED|Overall Study|206 enrolled (consented)|206
8683562|NCT00812916|9727885|FG000|Data Available|Overall Study||205
8683563|NCT00812916|9727885|FG000|CFAE - Guided Ablation|Overall Study||203
8683564|NCT00812916|9727885|FG000|COMPLETED|Overall Study||203
8683565|NCT00812916|9727885|FG000|NOT COMPLETED|Overall Study||3
8683566|NCT00812929|9727891|FG000|STARTED|Treatment Period 1||5
8683567|NCT00812929|9727892|FG001|STARTED|Treatment Period 1||4
8683568|NCT00812929|9727893|FG002|STARTED|Treatment Period 1||5
8683569|NCT00812929|9727894|FG003|STARTED|Treatment Period 1||4
8683570|NCT00812929|9727895|FG004|STARTED|Treatment Period 1||5
8683571|NCT00812929|9727896|FG005|STARTED|Treatment Period 1||5
8683572|NCT00812929|9727897|FG006|STARTED|Treatment Period 1||5
8683573|NCT00812929|9727898|FG007|STARTED|Treatment Period 1||5
8683574|NCT00812929|9727899|FG008|STARTED|Treatment Period 1||4
8683575|NCT00812929|9727900|FG009|STARTED|Treatment Period 1||5
8683576|NCT00812929|9727891|FG000|COMPLETED|Treatment Period 1||5
8683577|NCT00812929|9727892|FG001|COMPLETED|Treatment Period 1||4
8683578|NCT00812929|9727893|FG002|COMPLETED|Treatment Period 1||5
8683579|NCT00812929|9727894|FG003|COMPLETED|Treatment Period 1||4
8683580|NCT00812929|9727895|FG004|COMPLETED|Treatment Period 1||5
8683581|NCT00812929|9727896|FG005|COMPLETED|Treatment Period 1||5
8683582|NCT00812929|9727897|FG006|COMPLETED|Treatment Period 1||5
8683583|NCT00812929|9727898|FG007|COMPLETED|Treatment Period 1||5
8683584|NCT00812929|9727899|FG008|COMPLETED|Treatment Period 1||4
8683585|NCT00812929|9727900|FG009|COMPLETED|Treatment Period 1||5
8683586|NCT00812929|9727891|FG000|NOT COMPLETED|Treatment Period 1||0
8683587|NCT00812929|9727892|FG001|NOT COMPLETED|Treatment Period 1||0
8683588|NCT00812929|9727893|FG002|NOT COMPLETED|Treatment Period 1||0
8683589|NCT00812929|9727894|FG003|NOT COMPLETED|Treatment Period 1||0
8683590|NCT00812929|9727895|FG004|NOT COMPLETED|Treatment Period 1||0
8683591|NCT00812929|9727896|FG005|NOT COMPLETED|Treatment Period 1||0
8683592|NCT00812929|9727897|FG006|NOT COMPLETED|Treatment Period 1||0
8683593|NCT00812929|9727898|FG007|NOT COMPLETED|Treatment Period 1||0
8683594|NCT00812929|9727899|FG008|NOT COMPLETED|Treatment Period 1||0
8683595|NCT00812929|9727900|FG009|NOT COMPLETED|Treatment Period 1||0
8683596|NCT00812929|9727891|FG000|STARTED|Washout Period 1 (7 Days)||5
8683597|NCT00812929|9727892|FG001|STARTED|Washout Period 1 (7 Days)||4
8683598|NCT00812929|9727893|FG002|STARTED|Washout Period 1 (7 Days)||5
8683599|NCT00812929|9727894|FG003|STARTED|Washout Period 1 (7 Days)||4
8683600|NCT00812929|9727895|FG004|STARTED|Washout Period 1 (7 Days)||5
8683601|NCT00812929|9727896|FG005|STARTED|Washout Period 1 (7 Days)||5
8683602|NCT00812929|9727897|FG006|STARTED|Washout Period 1 (7 Days)||5
8683603|NCT00812929|9727898|FG007|STARTED|Washout Period 1 (7 Days)||5
8683604|NCT00812929|9727899|FG008|STARTED|Washout Period 1 (7 Days)||4
8683605|NCT00812929|9727900|FG009|STARTED|Washout Period 1 (7 Days)||5
8683606|NCT00812929|9727891|FG000|COMPLETED|Washout Period 1 (7 Days)||5
8683607|NCT00812929|9727892|FG001|COMPLETED|Washout Period 1 (7 Days)||4
8683608|NCT00812929|9727893|FG002|COMPLETED|Washout Period 1 (7 Days)||4
8683609|NCT00812929|9727894|FG003|COMPLETED|Washout Period 1 (7 Days)||4
8683610|NCT00812929|9727895|FG004|COMPLETED|Washout Period 1 (7 Days)||5
8683611|NCT00812929|9727896|FG005|COMPLETED|Washout Period 1 (7 Days)||5
8683612|NCT00812929|9727897|FG006|COMPLETED|Washout Period 1 (7 Days)||5
8683613|NCT00812929|9727898|FG007|COMPLETED|Washout Period 1 (7 Days)||5
8683614|NCT00812929|9727899|FG008|COMPLETED|Washout Period 1 (7 Days)||4
8683615|NCT00812929|9727900|FG009|COMPLETED|Washout Period 1 (7 Days)||5
8683616|NCT00812929|9727891|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
8683617|NCT00812929|9727892|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
8683618|NCT00812929|9727893|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||1
8683619|NCT00812929|9727894|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
8683620|NCT00812929|9727895|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||0
8683621|NCT00812929|9727896|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||0
8683622|NCT00812929|9727897|FG006|NOT COMPLETED|Washout Period 1 (7 Days)||0
8683623|NCT00812929|9727898|FG007|NOT COMPLETED|Washout Period 1 (7 Days)||0
8683624|NCT00812929|9727899|FG008|NOT COMPLETED|Washout Period 1 (7 Days)||0
8683625|NCT00812929|9727900|FG009|NOT COMPLETED|Washout Period 1 (7 Days)||0
8683626|NCT00812929|9727891|FG000|STARTED|Treatment Period 2||5
8683627|NCT00812929|9727892|FG001|STARTED|Treatment Period 2||4
8683628|NCT00812929|9727893|FG002|STARTED|Treatment Period 2||4
8683629|NCT00812929|9727894|FG003|STARTED|Treatment Period 2||4
8683630|NCT00812929|9727895|FG004|STARTED|Treatment Period 2||5
8683631|NCT00812929|9727896|FG005|STARTED|Treatment Period 2||5
8683632|NCT00812929|9727897|FG006|STARTED|Treatment Period 2||5
8683633|NCT00812929|9727898|FG007|STARTED|Treatment Period 2||5
8683634|NCT00812929|9727899|FG008|STARTED|Treatment Period 2||4
8683635|NCT00812929|9727900|FG009|STARTED|Treatment Period 2||5
8683636|NCT00812929|9727891|FG000|COMPLETED|Treatment Period 2||5
8683637|NCT00812929|9727892|FG001|COMPLETED|Treatment Period 2||4
8683638|NCT00812929|9727893|FG002|COMPLETED|Treatment Period 2||4
8683639|NCT00812929|9727894|FG003|COMPLETED|Treatment Period 2||4
8683640|NCT00812929|9727895|FG004|COMPLETED|Treatment Period 2||5
8683641|NCT00812929|9727896|FG005|COMPLETED|Treatment Period 2||5
8683642|NCT00812929|9727897|FG006|COMPLETED|Treatment Period 2||5
8683643|NCT00812929|9727898|FG007|COMPLETED|Treatment Period 2||5
8683644|NCT00812929|9727899|FG008|COMPLETED|Treatment Period 2||4
8683645|NCT00812929|9727900|FG009|COMPLETED|Treatment Period 2||5
8683646|NCT00812929|9727891|FG000|NOT COMPLETED|Treatment Period 2||0
8683647|NCT00812929|9727892|FG001|NOT COMPLETED|Treatment Period 2||0
8683648|NCT00812929|9727893|FG002|NOT COMPLETED|Treatment Period 2||0
8683649|NCT00812929|9727894|FG003|NOT COMPLETED|Treatment Period 2||0
8683650|NCT00812929|9727895|FG004|NOT COMPLETED|Treatment Period 2||0
8683651|NCT00812929|9727896|FG005|NOT COMPLETED|Treatment Period 2||0
8683652|NCT00812929|9727897|FG006|NOT COMPLETED|Treatment Period 2||0
8683653|NCT00812929|9727898|FG007|NOT COMPLETED|Treatment Period 2||0
8683654|NCT00812929|9727899|FG008|NOT COMPLETED|Treatment Period 2||0
8683655|NCT00812929|9727900|FG009|NOT COMPLETED|Treatment Period 2||0
8683656|NCT00812929|9727891|FG000|STARTED|Washout Period 2 (7 Days)||5
8683657|NCT00812929|9727892|FG001|STARTED|Washout Period 2 (7 Days)||4
8683658|NCT00812929|9727893|FG002|STARTED|Washout Period 2 (7 Days)||4
8683659|NCT00812929|9727894|FG003|STARTED|Washout Period 2 (7 Days)||4
8683660|NCT00812929|9727895|FG004|STARTED|Washout Period 2 (7 Days)||5
8683661|NCT00812929|9727896|FG005|STARTED|Washout Period 2 (7 Days)||5
8683662|NCT00812929|9727897|FG006|STARTED|Washout Period 2 (7 Days)||5
8683663|NCT00812929|9727898|FG007|STARTED|Washout Period 2 (7 Days)||5
8683664|NCT00812929|9727899|FG008|STARTED|Washout Period 2 (7 Days)||4
8683665|NCT00812929|9727900|FG009|STARTED|Washout Period 2 (7 Days)||5
8683666|NCT00812929|9727891|FG000|COMPLETED|Washout Period 2 (7 Days)||5
8683667|NCT00812929|9727892|FG001|COMPLETED|Washout Period 2 (7 Days)||4
8683668|NCT00812929|9727893|FG002|COMPLETED|Washout Period 2 (7 Days)||4
8683669|NCT00812929|9727894|FG003|COMPLETED|Washout Period 2 (7 Days)||4
8683670|NCT00812929|9727895|FG004|COMPLETED|Washout Period 2 (7 Days)||5
8683671|NCT00812929|9727896|FG005|COMPLETED|Washout Period 2 (7 Days)||5
8683672|NCT00812929|9727897|FG006|COMPLETED|Washout Period 2 (7 Days)||5
8683673|NCT00812929|9727898|FG007|COMPLETED|Washout Period 2 (7 Days)||5
8683674|NCT00812929|9727899|FG008|COMPLETED|Washout Period 2 (7 Days)||4
8683675|NCT00812929|9727900|FG009|COMPLETED|Washout Period 2 (7 Days)||4
8683676|NCT00812929|9727891|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
8683677|NCT00812929|9727892|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
8683678|NCT00812929|9727893|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
8683679|NCT00812929|9727894|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
8683680|NCT00812929|9727895|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0
8683681|NCT00812929|9727896|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0
8683682|NCT00812929|9727897|FG006|NOT COMPLETED|Washout Period 2 (7 Days)||0
8683683|NCT00812929|9727898|FG007|NOT COMPLETED|Washout Period 2 (7 Days)||0
8683684|NCT00812929|9727899|FG008|NOT COMPLETED|Washout Period 2 (7 Days)||0
8683685|NCT00812929|9727900|FG009|NOT COMPLETED|Washout Period 2 (7 Days)||1
8683686|NCT00812929|9727891|FG000|STARTED|Treatment Period 3||5
8683687|NCT00812929|9727892|FG001|STARTED|Treatment Period 3||4
8683688|NCT00812929|9727893|FG002|STARTED|Treatment Period 3||4
8683689|NCT00812929|9727894|FG003|STARTED|Treatment Period 3||4
8683690|NCT00812929|9727895|FG004|STARTED|Treatment Period 3||5
8683691|NCT00812929|9727896|FG005|STARTED|Treatment Period 3||5
8683692|NCT00812929|9727897|FG006|STARTED|Treatment Period 3||5
8683693|NCT00812929|9727898|FG007|STARTED|Treatment Period 3||5
8683694|NCT00812929|9727899|FG008|STARTED|Treatment Period 3||4
8683695|NCT00812929|9727900|FG009|STARTED|Treatment Period 3||4
8683696|NCT00812929|9727891|FG000|COMPLETED|Treatment Period 3||5
8683697|NCT00812929|9727892|FG001|COMPLETED|Treatment Period 3||4
8683698|NCT00812929|9727893|FG002|COMPLETED|Treatment Period 3||4
8683699|NCT00812929|9727894|FG003|COMPLETED|Treatment Period 3||4
8683700|NCT00812929|9727895|FG004|COMPLETED|Treatment Period 3||5
8683701|NCT00812929|9727896|FG005|COMPLETED|Treatment Period 3||5
8683702|NCT00812929|9727897|FG006|COMPLETED|Treatment Period 3||5
8683703|NCT00812929|9727898|FG007|COMPLETED|Treatment Period 3||5
8683704|NCT00812929|9727899|FG008|COMPLETED|Treatment Period 3||4
8683705|NCT00812929|9727900|FG009|COMPLETED|Treatment Period 3||4
8683706|NCT00812929|9727891|FG000|NOT COMPLETED|Treatment Period 3||0
8683707|NCT00812929|9727892|FG001|NOT COMPLETED|Treatment Period 3||0
8683708|NCT00812929|9727893|FG002|NOT COMPLETED|Treatment Period 3||0
8683709|NCT00812929|9727894|FG003|NOT COMPLETED|Treatment Period 3||0
8683710|NCT00812929|9727895|FG004|NOT COMPLETED|Treatment Period 3||0
8683711|NCT00812929|9727896|FG005|NOT COMPLETED|Treatment Period 3||0
8683712|NCT00812929|9727897|FG006|NOT COMPLETED|Treatment Period 3||0
8683713|NCT00812929|9727898|FG007|NOT COMPLETED|Treatment Period 3||0
8683714|NCT00812929|9727899|FG008|NOT COMPLETED|Treatment Period 3||0
8683715|NCT00812929|9727900|FG009|NOT COMPLETED|Treatment Period 3||0
8683716|NCT00812929|9727891|FG000|STARTED|Washout Period 3 (7 Days)||5
8683717|NCT00812929|9727892|FG001|STARTED|Washout Period 3 (7 Days)||4
8683718|NCT00812929|9727893|FG002|STARTED|Washout Period 3 (7 Days)||4
8683719|NCT00812929|9727894|FG003|STARTED|Washout Period 3 (7 Days)||4
8683720|NCT00812929|9727895|FG004|STARTED|Washout Period 3 (7 Days)||5
8683721|NCT00812929|9727896|FG005|STARTED|Washout Period 3 (7 Days)||5
8683722|NCT00812929|9727897|FG006|STARTED|Washout Period 3 (7 Days)||5
8683723|NCT00812929|9727898|FG007|STARTED|Washout Period 3 (7 Days)||5
8683724|NCT00812929|9727899|FG008|STARTED|Washout Period 3 (7 Days)||4
8683725|NCT00812929|9727900|FG009|STARTED|Washout Period 3 (7 Days)||4
8683726|NCT00812929|9727891|FG000|COMPLETED|Washout Period 3 (7 Days)||5
8683727|NCT00812929|9727892|FG001|COMPLETED|Washout Period 3 (7 Days)||4
8683728|NCT00812929|9727893|FG002|COMPLETED|Washout Period 3 (7 Days)||4
8683729|NCT00812929|9727894|FG003|COMPLETED|Washout Period 3 (7 Days)||4
8683730|NCT00812929|9727895|FG004|COMPLETED|Washout Period 3 (7 Days)||5
8683731|NCT00812929|9727896|FG005|COMPLETED|Washout Period 3 (7 Days)||4
8683732|NCT00812929|9727897|FG006|COMPLETED|Washout Period 3 (7 Days)||5
8683733|NCT00812929|9727898|FG007|COMPLETED|Washout Period 3 (7 Days)||5
8683734|NCT00812929|9727899|FG008|COMPLETED|Washout Period 3 (7 Days)||4
8683735|NCT00812929|9727900|FG009|COMPLETED|Washout Period 3 (7 Days)||4
8683736|NCT00812929|9727891|FG000|NOT COMPLETED|Washout Period 3 (7 Days)||0
8683737|NCT00812929|9727892|FG001|NOT COMPLETED|Washout Period 3 (7 Days)||0
8683738|NCT00812929|9727893|FG002|NOT COMPLETED|Washout Period 3 (7 Days)||0
8683739|NCT00812929|9727894|FG003|NOT COMPLETED|Washout Period 3 (7 Days)||0
8683740|NCT00812929|9727895|FG004|NOT COMPLETED|Washout Period 3 (7 Days)||0
8683741|NCT00812929|9727896|FG005|NOT COMPLETED|Washout Period 3 (7 Days)||1
8683742|NCT00812929|9727897|FG006|NOT COMPLETED|Washout Period 3 (7 Days)||0
8683743|NCT00812929|9727898|FG007|NOT COMPLETED|Washout Period 3 (7 Days)||0
8683744|NCT00812929|9727899|FG008|NOT COMPLETED|Washout Period 3 (7 Days)||0
8683745|NCT00812929|9727900|FG009|NOT COMPLETED|Washout Period 3 (7 Days)||0
8683746|NCT00812929|9727891|FG000|STARTED|Treatment Period 4||5
8683747|NCT00812929|9727892|FG001|STARTED|Treatment Period 4||4
8683748|NCT00812929|9727893|FG002|STARTED|Treatment Period 4||4
8683749|NCT00812929|9727894|FG003|STARTED|Treatment Period 4||4
8683750|NCT00812929|9727895|FG004|STARTED|Treatment Period 4||5
8683751|NCT00812929|9727896|FG005|STARTED|Treatment Period 4||4
8683752|NCT00812929|9727897|FG006|STARTED|Treatment Period 4||5
8683753|NCT00812929|9727898|FG007|STARTED|Treatment Period 4||5
8683754|NCT00812929|9727899|FG008|STARTED|Treatment Period 4||4
8683755|NCT00812929|9727900|FG009|STARTED|Treatment Period 4||4
8683756|NCT00812929|9727891|FG000|COMPLETED|Treatment Period 4||5
8683757|NCT00812929|9727892|FG001|COMPLETED|Treatment Period 4||4
8683758|NCT00812929|9727893|FG002|COMPLETED|Treatment Period 4||4
8683759|NCT00812929|9727894|FG003|COMPLETED|Treatment Period 4||4
8683760|NCT00812929|9727895|FG004|COMPLETED|Treatment Period 4||5
8683761|NCT00812929|9727896|FG005|COMPLETED|Treatment Period 4||4
8683762|NCT00812929|9727897|FG006|COMPLETED|Treatment Period 4||5
8683763|NCT00812929|9727898|FG007|COMPLETED|Treatment Period 4||5
8683764|NCT00812929|9727899|FG008|COMPLETED|Treatment Period 4||4
8683765|NCT00812929|9727900|FG009|COMPLETED|Treatment Period 4||4
8683766|NCT00812929|9727891|FG000|NOT COMPLETED|Treatment Period 4||0
8683767|NCT00812929|9727892|FG001|NOT COMPLETED|Treatment Period 4||0
8683768|NCT00812929|9727893|FG002|NOT COMPLETED|Treatment Period 4||0
8683769|NCT00812929|9727894|FG003|NOT COMPLETED|Treatment Period 4||0
8683770|NCT00812929|9727895|FG004|NOT COMPLETED|Treatment Period 4||0
8683771|NCT00812929|9727896|FG005|NOT COMPLETED|Treatment Period 4||0
8683772|NCT00812929|9727897|FG006|NOT COMPLETED|Treatment Period 4||0
8683773|NCT00812929|9727898|FG007|NOT COMPLETED|Treatment Period 4||0
8683774|NCT00812929|9727899|FG008|NOT COMPLETED|Treatment Period 4||0
8683775|NCT00812929|9727900|FG009|NOT COMPLETED|Treatment Period 4||0
8683776|NCT00812929|9727891|FG000|STARTED|Washout Period 4 (7 Days)||5
8683777|NCT00812929|9727892|FG001|STARTED|Washout Period 4 (7 Days)||4
8683778|NCT00812929|9727893|FG002|STARTED|Washout Period 4 (7 Days)||4
8683779|NCT00812929|9727894|FG003|STARTED|Washout Period 4 (7 Days)||4
8683780|NCT00812929|9727895|FG004|STARTED|Washout Period 4 (7 Days)||5
8683781|NCT00812929|9727896|FG005|STARTED|Washout Period 4 (7 Days)||4
8683782|NCT00812929|9727897|FG006|STARTED|Washout Period 4 (7 Days)||5
8683783|NCT00812929|9727898|FG007|STARTED|Washout Period 4 (7 Days)||5
8683784|NCT00812929|9727899|FG008|STARTED|Washout Period 4 (7 Days)||4
8683785|NCT00812929|9727900|FG009|STARTED|Washout Period 4 (7 Days)||4
8683786|NCT00812929|9727891|FG000|COMPLETED|Washout Period 4 (7 Days)||5
8683787|NCT00812929|9727892|FG001|COMPLETED|Washout Period 4 (7 Days)||4
8683788|NCT00812929|9727893|FG002|COMPLETED|Washout Period 4 (7 Days)||4
8683789|NCT00812929|9727894|FG003|COMPLETED|Washout Period 4 (7 Days)||4
8683790|NCT00812929|9727895|FG004|COMPLETED|Washout Period 4 (7 Days)||5
8683791|NCT00812929|9727896|FG005|COMPLETED|Washout Period 4 (7 Days)||4
8683792|NCT00812929|9727897|FG006|COMPLETED|Washout Period 4 (7 Days)||5
8683793|NCT00812929|9727898|FG007|COMPLETED|Washout Period 4 (7 Days)||5
8683794|NCT00812929|9727899|FG008|COMPLETED|Washout Period 4 (7 Days)||4
8683795|NCT00812929|9727900|FG009|COMPLETED|Washout Period 4 (7 Days)||4
8683796|NCT00812929|9727891|FG000|NOT COMPLETED|Washout Period 4 (7 Days)||0
8683797|NCT00812929|9727892|FG001|NOT COMPLETED|Washout Period 4 (7 Days)||0
8683798|NCT00812929|9727893|FG002|NOT COMPLETED|Washout Period 4 (7 Days)||0
8683799|NCT00812929|9727894|FG003|NOT COMPLETED|Washout Period 4 (7 Days)||0
8683800|NCT00812929|9727895|FG004|NOT COMPLETED|Washout Period 4 (7 Days)||0
8683801|NCT00812929|9727896|FG005|NOT COMPLETED|Washout Period 4 (7 Days)||0
8683802|NCT00812929|9727897|FG006|NOT COMPLETED|Washout Period 4 (7 Days)||0
8683803|NCT00812929|9727898|FG007|NOT COMPLETED|Washout Period 4 (7 Days)||0
8683804|NCT00812929|9727899|FG008|NOT COMPLETED|Washout Period 4 (7 Days)||0
8683805|NCT00812929|9727900|FG009|NOT COMPLETED|Washout Period 4 (7 Days)||0
8683806|NCT00812929|9727891|FG000|STARTED|Treatment Period 5||5
8683807|NCT00812929|9727892|FG001|STARTED|Treatment Period 5||4
8683808|NCT00812929|9727893|FG002|STARTED|Treatment Period 5||4
8800934|NCT01448616|9852843|FG003|COMPLETED|Lead-In (Observational Phase)||0
8800935|NCT01448616|9852840|FG000|NOT COMPLETED|Lead-In (Observational Phase)||9
8800936|NCT01448616|9852841|FG001|NOT COMPLETED|Lead-In (Observational Phase)||0
8800937|NCT01448616|9852842|FG002|NOT COMPLETED|Lead-In (Observational Phase)||0
8683809|NCT00812929|9727894|FG003|STARTED|Treatment Period 5||4
8683810|NCT00812929|9727895|FG004|STARTED|Treatment Period 5||5
8683811|NCT00812929|9727896|FG005|STARTED|Treatment Period 5||4
8683812|NCT00812929|9727897|FG006|STARTED|Treatment Period 5||5
8683813|NCT00812929|9727898|FG007|STARTED|Treatment Period 5||5
8683814|NCT00812929|9727899|FG008|STARTED|Treatment Period 5||4
8683815|NCT00812929|9727900|FG009|STARTED|Treatment Period 5||4
8683816|NCT00812929|9727891|FG000|COMPLETED|Treatment Period 5||5
8683817|NCT00812929|9727892|FG001|COMPLETED|Treatment Period 5||4
8683818|NCT00812929|9727893|FG002|COMPLETED|Treatment Period 5||4
8683819|NCT00812929|9727894|FG003|COMPLETED|Treatment Period 5||4
8683820|NCT00812929|9727895|FG004|COMPLETED|Treatment Period 5||5
8683821|NCT00812929|9727896|FG005|COMPLETED|Treatment Period 5||4
8683822|NCT00812929|9727897|FG006|COMPLETED|Treatment Period 5||5
8683823|NCT00812929|9727898|FG007|COMPLETED|Treatment Period 5||5
8683824|NCT00812929|9727899|FG008|COMPLETED|Treatment Period 5||4
8683825|NCT00812929|9727900|FG009|COMPLETED|Treatment Period 5||4
8683826|NCT00812929|9727891|FG000|NOT COMPLETED|Treatment Period 5||0
8683827|NCT00812929|9727892|FG001|NOT COMPLETED|Treatment Period 5||0
8683828|NCT00812929|9727893|FG002|NOT COMPLETED|Treatment Period 5||0
8683829|NCT00812929|9727894|FG003|NOT COMPLETED|Treatment Period 5||0
8683830|NCT00812929|9727895|FG004|NOT COMPLETED|Treatment Period 5||0
8683831|NCT00812929|9727896|FG005|NOT COMPLETED|Treatment Period 5||0
8683832|NCT00812929|9727897|FG006|NOT COMPLETED|Treatment Period 5||0
8683833|NCT00812929|9727898|FG007|NOT COMPLETED|Treatment Period 5||0
8683834|NCT00812929|9727899|FG008|NOT COMPLETED|Treatment Period 5||0
8683835|NCT00812929|9727900|FG009|NOT COMPLETED|Treatment Period 5||0
8683836|NCT00812955|9727921|FG000|STARTED|Overall Study||119
8683837|NCT00812955|9727922|FG001|STARTED|Overall Study||118
8683838|NCT00812955|9727923|FG002|STARTED|Overall Study||119
8683839|NCT00812955|9727924|FG003|STARTED|Overall Study||118
8683840|NCT00812955|9727921|FG000|COMPLETED|Overall Study||109
8683841|NCT00812955|9727922|FG001|COMPLETED|Overall Study||111
8683842|NCT00812955|9727923|FG002|COMPLETED|Overall Study||113
8683843|NCT00812955|9727924|FG003|COMPLETED|Overall Study||110
8683844|NCT00812955|9727921|FG000|NOT COMPLETED|Overall Study||10
8683845|NCT00812955|9727922|FG001|NOT COMPLETED|Overall Study||7
8683846|NCT00812955|9727923|FG002|NOT COMPLETED|Overall Study||6
8683847|NCT00812955|9727924|FG003|NOT COMPLETED|Overall Study||8
8683848|NCT00812968|9727938|FG000|STARTED|Overall Study||11
8683849|NCT00812968|9727938|FG000|COMPLETED|Overall Study||0
8683850|NCT00812968|9727938|FG000|NOT COMPLETED|Overall Study||11
8683851|NCT00812981|9727946|FG000|STARTED|Overall Study||160
8683852|NCT00812981|9727947|FG001|STARTED|Overall Study||160
8683853|NCT00812981|9727946|FG000|COMPLETED|Overall Study||160
8683854|NCT00812981|9727947|FG001|COMPLETED|Overall Study||159
8683855|NCT00812981|9727946|FG000|NOT COMPLETED|Overall Study||0
8683856|NCT00812981|9727947|FG001|NOT COMPLETED|Overall Study||1
8683857|NCT00813098|9727956|FG000|STARTED|Overall Study||49
8683858|NCT00813098|9727957|FG001|STARTED|Overall Study||54
8683859|NCT00813098|9727958|FG002|STARTED|Overall Study||52
8683860|NCT00813098|9727956|FG000|COMPLETED|Overall Study||46
8683861|NCT00813098|9727957|FG001|COMPLETED|Overall Study||46
8683862|NCT00813098|9727958|FG002|COMPLETED|Overall Study||50
8683863|NCT00813098|9727956|FG000|NOT COMPLETED|Overall Study||3
8683864|NCT00813098|9727957|FG001|NOT COMPLETED|Overall Study||8
8683865|NCT00813098|9727958|FG002|NOT COMPLETED|Overall Study||2
8683866|NCT00813111|9727968|FG000|STARTED|Overall Study||66
8683867|NCT00813111|9727969|FG001|STARTED|Overall Study||70
8683868|NCT00813111|9727968|FG000|COMPLETED|Overall Study||64
8683869|NCT00813111|9727969|FG001|COMPLETED|Overall Study||70
8683870|NCT00813111|9727968|FG000|NOT COMPLETED|Overall Study||2
8683871|NCT00813111|9727969|FG001|NOT COMPLETED|Overall Study||0
8683872|NCT00813124|9727975|FG000|STARTED|Overall Study||24
8683873|NCT00813124|9727975|FG000|COMPLETED|Overall Study||12
8683874|NCT00813124|9727975|FG000|NOT COMPLETED|Overall Study||12
8683875|NCT00813150|9727981|FG000|STARTED|Treatment Period|Number of randomized and treated participants|46
8683876|NCT00813150|9727982|FG001|STARTED|Treatment Period|Number of randomized and treated participants|47
8683877|NCT00813150|9727981|FG000|Intent-to-treat Participants|Treatment Period||43
8683878|NCT00813150|9727982|FG001|Intent-to-treat Participants|Treatment Period||47
8683879|NCT00813150|9727981|FG000|COMPLETED|Treatment Period|Participants who completed 8 cycles of treatment|14
8683880|NCT00813150|9727982|FG001|COMPLETED|Treatment Period|Participants who completed 8 cycles of treatment|15
8683881|NCT00813150|9727981|FG000|NOT COMPLETED|Treatment Period||32
8683882|NCT00813150|9727982|FG001|NOT COMPLETED|Treatment Period||32
8683883|NCT00813150|9727981|FG000|STARTED|Long Term Follow-up|Number of participants who entered follow-up phase|26
8683884|NCT00813150|9727982|FG001|STARTED|Long Term Follow-up|Number of participants who entered follow-up phase|31
8683885|NCT00813150|9727981|FG000|COMPLETED|Long Term Follow-up|Number of participants who completed follow-up phase|2
8683886|NCT00813150|9727982|FG001|COMPLETED|Long Term Follow-up|Number of participants who completed follow-up phase|0
8683887|NCT00813150|9727981|FG000|NOT COMPLETED|Long Term Follow-up||24
8683888|NCT00813150|9727982|FG001|NOT COMPLETED|Long Term Follow-up||31
8683889|NCT00813176|9727990|FG000|STARTED|Overall Study||25
8683890|NCT00813176|9727991|FG001|STARTED|Overall Study||25
8683891|NCT00813176|9727990|FG000|COMPLETED|Overall Study||25
8683892|NCT00813176|9727991|FG001|COMPLETED|Overall Study||25
8683893|NCT00813176|9727990|FG000|NOT COMPLETED|Overall Study||0
8683894|NCT00813176|9727991|FG001|NOT COMPLETED|Overall Study||0
8683895|NCT00813293|9728001|FG000|STARTED|Overall Study||10
8683896|NCT00813293|9728002|FG001|STARTED|Overall Study||10
8683897|NCT00813293|9728001|FG000|Started Treatment|Overall Study||9
8683898|NCT00813293|9728002|FG001|Started Treatment|Overall Study||10
8683899|NCT00813293|9728001|FG000|Evaluable RFA|Overall Study||7
8683900|NCT00813293|9728002|FG001|Evaluable RFA|Overall Study||8
8683901|NCT00813293|9728001|FG000|COMPLETED|Overall Study||9
8683902|NCT00813293|9728002|FG001|COMPLETED|Overall Study||9
8683903|NCT00813293|9728001|FG000|NOT COMPLETED|Overall Study||1
8683904|NCT00813293|9728002|FG001|NOT COMPLETED|Overall Study||1
8683905|NCT00813319|9728010|FG000|STARTED|Overall Study||108
8683906|NCT00813319|9728011|FG001|STARTED|Overall Study||108
8683907|NCT00813319|9728010|FG000|COMPLETED|Overall Study|100 out of 108 have complete follow-up data, there were 8 missing charts 7 months post-randomization|108
8683908|NCT00813319|9728011|FG001|COMPLETED|Overall Study|104 out of 108 have complete follow-up data, there were 4 missing charts 7 months post-randomization|108
8683909|NCT00813319|9728010|FG000|NOT COMPLETED|Overall Study||0
8683910|NCT00813319|9728011|FG001|NOT COMPLETED|Overall Study||0
8683911|NCT00813358|9728017|FG000|STARTED|Overall Study||115
8683912|NCT00813358|9728017|FG000|COMPLETED|Overall Study||46
8800938|NCT01448616|9852843|FG003|NOT COMPLETED|Lead-In (Observational Phase)||0
8919314|NCT02207244|9979300|FG010|COMPLETED|Placebo Controlled Period: Week 0-16||0
8919315|NCT02207244|9979290|FG000|NOT COMPLETED|Placebo Controlled Period: Week 0-16||15
8919316|NCT02207244|9979291|FG001|NOT COMPLETED|Placebo Controlled Period: Week 0-16||18
8919317|NCT02207244|9979292|FG002|NOT COMPLETED|Placebo Controlled Period: Week 0-16||11
8919318|NCT02207244|9979293|FG003|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0
8919319|NCT02207244|9979294|FG004|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0
8919320|NCT02207244|9979295|FG005|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0
8919321|NCT02207244|9979296|FG006|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0
8919322|NCT02207244|9979297|FG007|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0
8919323|NCT02207244|9979298|FG008|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0
8919324|NCT02207244|9979299|FG009|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0
8919325|NCT02207244|9979300|FG010|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0
8919326|NCT02207244|9979290|FG000|STARTED|Placebo Crossover and ACP: Week 16-28||0
8919327|NCT02207244|9979291|FG001|STARTED|Placebo Crossover and ACP: Week 16-28||0
8919328|NCT02207244|9979292|FG002|STARTED|Placebo Crossover and ACP: Week 16-28||0
8919329|NCT02207244|9979293|FG003|STARTED|Placebo Crossover and ACP: Week 16-28||233
8919330|NCT02207244|9979294|FG004|STARTED|Placebo Crossover and ACP: Week 16-28||478
8919331|NCT02207244|9979295|FG005|STARTED|Placebo Crossover and ACP: Week 16-28||237
8919332|NCT02207244|9979296|FG006|STARTED|Placebo Crossover and ACP: Week 16-28||0
8919333|NCT02207244|9979297|FG007|STARTED|Placebo Crossover and ACP: Week 16-28||0
8919334|NCT02207244|9979298|FG008|STARTED|Placebo Crossover and ACP: Week 16-28||0
8919335|NCT02207244|9979299|FG009|STARTED|Placebo Crossover and ACP: Week 16-28||0
8919336|NCT02207244|9979300|FG010|STARTED|Placebo Crossover and ACP: Week 16-28||0
8919337|NCT02207244|9979290|FG000|COMPLETED|Placebo Crossover and ACP: Week 16-28||0
8919338|NCT02207244|9979291|FG001|COMPLETED|Placebo Crossover and ACP: Week 16-28||0
8919339|NCT02207244|9979292|FG002|COMPLETED|Placebo Crossover and ACP: Week 16-28||0
8919340|NCT02207244|9979293|FG003|COMPLETED|Placebo Crossover and ACP: Week 16-28||227
8919341|NCT02207244|9979294|FG004|COMPLETED|Placebo Crossover and ACP: Week 16-28||470
8919342|NCT02207244|9979295|FG005|COMPLETED|Placebo Crossover and ACP: Week 16-28||228
8919343|NCT02207244|9979296|FG006|COMPLETED|Placebo Crossover and ACP: Week 16-28||0
8919344|NCT02207244|9979297|FG007|COMPLETED|Placebo Crossover and ACP: Week 16-28||0
8919345|NCT02207244|9979298|FG008|COMPLETED|Placebo Crossover and ACP: Week 16-28||0
8919346|NCT02207244|9979299|FG009|COMPLETED|Placebo Crossover and ACP: Week 16-28||0
8919347|NCT02207244|9979300|FG010|COMPLETED|Placebo Crossover and ACP: Week 16-28||0
8919348|NCT02207244|9979290|FG000|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0
8919349|NCT02207244|9979291|FG001|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0
9035705|NCT03301714|10097430|FG001|STARTED|Overall Study||60
8683913|NCT00813358|9728017|FG000|NOT COMPLETED|Overall Study||69
8800939|NCT01448616|9852840|FG000|STARTED|Study Drug (Treatment Phase)|All qualifying participants from this group moved to treatment group.|0
8800940|NCT01448616|9852841|FG001|STARTED|Study Drug (Treatment Phase)||24
8800941|NCT01448616|9852842|FG002|STARTED|Study Drug (Treatment Phase)||27
8800942|NCT01448616|9852843|FG003|STARTED|Study Drug (Treatment Phase)||13
8800943|NCT01448616|9852840|FG000|COMPLETED|Study Drug (Treatment Phase)||0
8800944|NCT01448616|9852841|FG001|COMPLETED|Study Drug (Treatment Phase)||22
8800945|NCT01448616|9852842|FG002|COMPLETED|Study Drug (Treatment Phase)||23
8800946|NCT01448616|9852843|FG003|COMPLETED|Study Drug (Treatment Phase)||9
8800947|NCT01448616|9852840|FG000|NOT COMPLETED|Study Drug (Treatment Phase)||0
8800948|NCT01448616|9852841|FG001|NOT COMPLETED|Study Drug (Treatment Phase)||2
8800949|NCT01448616|9852842|FG002|NOT COMPLETED|Study Drug (Treatment Phase)||4
8800950|NCT01448616|9852843|FG003|NOT COMPLETED|Study Drug (Treatment Phase)||4
8800951|NCT01448707|9852858|FG000|STARTED|Overall Study||137
8800952|NCT01448707|9852859|FG001|STARTED|Overall Study||136
8800953|NCT01448707|9852858|FG000|COMPLETED|Overall Study||119
8800954|NCT01448707|9852859|FG001|COMPLETED|Overall Study||118
8800955|NCT01448707|9852858|FG000|NOT COMPLETED|Overall Study||18
8800956|NCT01448707|9852859|FG001|NOT COMPLETED|Overall Study||18
8800957|NCT01448824|9852873|FG000|STARTED|Part 1 Period 1: Multiple Ascending Dose||12
8683914|NCT00813488|9728021|FG000|STARTED|Titration Period 1||107
8683915|NCT00813488|9728022|FG001|STARTED|Titration Period 1||106
8683916|NCT00813488|9728021|FG000|COMPLETED|Titration Period 1||80
8683917|NCT00813488|9728022|FG001|COMPLETED|Titration Period 1||89
8683918|NCT00813488|9728021|FG000|NOT COMPLETED|Titration Period 1||27
8683919|NCT00813488|9728022|FG001|NOT COMPLETED|Titration Period 1||17
8683920|NCT00813488|9728021|FG000|STARTED|Titration Period 2||80
8683921|NCT00813488|9728022|FG001|STARTED|Titration Period 2||89
8683922|NCT00813488|9728021|FG000|COMPLETED|Titration Period 2||64
8683923|NCT00813488|9728022|FG001|COMPLETED|Titration Period 2||79
8683924|NCT00813488|9728021|FG000|NOT COMPLETED|Titration Period 2||16
8683925|NCT00813488|9728022|FG001|NOT COMPLETED|Titration Period 2||10
8683926|NCT00813488|9728021|FG000|STARTED|Double-blind Treatment Period 1|After titration subjects were re-randomized to these two treatment arms|72
8800958|NCT01448824|9852874|FG001|STARTED|Part 1 Period 1: Multiple Ascending Dose||4
8800959|NCT01448824|9852875|FG002|STARTED|Part 1 Period 1: Multiple Ascending Dose||4
8800960|NCT01448824|9852876|FG003|STARTED|Part 1 Period 1: Multiple Ascending Dose||10
8800961|NCT01448824|9852877|FG004|STARTED|Part 1 Period 1: Multiple Ascending Dose||16
8800962|NCT01448824|9852878|FG005|STARTED|Part 1 Period 1: Multiple Ascending Dose||12
8800963|NCT01448824|9852879|FG006|STARTED|Part 1 Period 1: Multiple Ascending Dose||12
8800964|NCT01448824|9852880|FG007|STARTED|Part 1 Period 1: Multiple Ascending Dose||0
8800965|NCT01448824|9852873|FG000|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||12
8800966|NCT01448824|9852874|FG001|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||4
8800967|NCT01448824|9852875|FG002|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||4
8800968|NCT01448824|9852876|FG003|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||10
8800969|NCT01448824|9852877|FG004|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||16
8800970|NCT01448824|9852878|FG005|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||12
8800971|NCT01448824|9852879|FG006|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||12
8800972|NCT01448824|9852880|FG007|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||0
8800973|NCT01448824|9852873|FG000|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||12
8800974|NCT01448824|9852874|FG001|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||4
8800975|NCT01448824|9852875|FG002|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||4
8800976|NCT01448824|9852876|FG003|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||9
8800977|NCT01448824|9852877|FG004|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||14
8800978|NCT01448824|9852878|FG005|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||10
8800979|NCT01448824|9852879|FG006|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||11
8800980|NCT01448824|9852880|FG007|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0
8800981|NCT01448824|9852873|FG000|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0
8800982|NCT01448824|9852874|FG001|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0
8800983|NCT01448824|9852875|FG002|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0
8800984|NCT01448824|9852876|FG003|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||1
8800985|NCT01448824|9852877|FG004|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||2
8800986|NCT01448824|9852878|FG005|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||2
8800987|NCT01448824|9852879|FG006|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||1
8800988|NCT01448824|9852880|FG007|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0
8800989|NCT01448824|9852873|FG000|STARTED|Part 1: Washout Period||12
8800990|NCT01448824|9852874|FG001|STARTED|Part 1: Washout Period||4
8800991|NCT01448824|9852875|FG002|STARTED|Part 1: Washout Period||4
8800992|NCT01448824|9852876|FG003|STARTED|Part 1: Washout Period|Participants in Part 1 Cohorts B through D participated in Period 1 only.|0
8919350|NCT02207244|9979292|FG002|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0
8919351|NCT02207244|9979293|FG003|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||6
8919352|NCT02207244|9979294|FG004|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||8
8919353|NCT02207244|9979295|FG005|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||9
8919354|NCT02207244|9979296|FG006|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0
8919355|NCT02207244|9979297|FG007|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0
8919356|NCT02207244|9979298|FG008|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0
8919357|NCT02207244|9979299|FG009|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0
8919358|NCT02207244|9979300|FG010|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0
8919359|NCT02207244|9979290|FG000|STARTED|Withdrawal and Re-treatment: Week 28-72||0
8919360|NCT02207244|9979291|FG001|STARTED|Withdrawal and Re-treatment: Week 28-72||0
8919361|NCT02207244|9979292|FG002|STARTED|Withdrawal and Re-treatment: Week 28-72||0
8919362|NCT02207244|9979293|FG003|STARTED|Withdrawal and Re-treatment: Week 28-72||0
8919363|NCT02207244|9979294|FG004|STARTED|Withdrawal and Re-treatment: Week 28-72||0
8919364|NCT02207244|9979295|FG005|STARTED|Withdrawal and Re-treatment: Week 28-72||0
8919365|NCT02207244|9979296|FG006|STARTED|Withdrawal and Re-treatment: Week 28-72||227
8919366|NCT02207244|9979297|FG007|STARTED|Withdrawal and Re-treatment: Week 28-72||470
8683927|NCT00813488|9728022|FG001|STARTED|Double-blind Treatment Period 1|After titration subjects were re-randomized to these two treatment arms|71
8800993|NCT01448824|9852877|FG004|STARTED|Part 1: Washout Period|Participants in Part 1 Cohort B participated in Period 1 only.|0
8800994|NCT01448824|9852878|FG005|STARTED|Part 1: Washout Period|Participants in Part 1 Cohort C participated in Period 1 only.|0
8800995|NCT01448824|9852879|FG006|STARTED|Part 1: Washout Period|Participants in Part 1 Cohort D participated in Period 1 only.|0
8683928|NCT00813488|9728021|FG000|COMPLETED|Double-blind Treatment Period 1||71
8683929|NCT00813488|9728022|FG001|COMPLETED|Double-blind Treatment Period 1||66
8683930|NCT00813488|9728021|FG000|NOT COMPLETED|Double-blind Treatment Period 1||1
8683931|NCT00813488|9728022|FG001|NOT COMPLETED|Double-blind Treatment Period 1||5
8683932|NCT00813488|9728021|FG000|STARTED|Double-blind Treatment Period 2||71
8683933|NCT00813488|9728022|FG001|STARTED|Double-blind Treatment Period 2||66
8683934|NCT00813488|9728021|FG000|COMPLETED|Double-blind Treatment Period 2||66
8683935|NCT00813488|9728022|FG001|COMPLETED|Double-blind Treatment Period 2||65
8683936|NCT00813488|9728021|FG000|NOT COMPLETED|Double-blind Treatment Period 2||5
8683937|NCT00813488|9728022|FG001|NOT COMPLETED|Double-blind Treatment Period 2||1
8683938|NCT00813488|9728021|FG000|STARTED|Open-label Extension|Patients completing double-blind periods were randomized to FBT or standard of care for open-label|65
8683939|NCT00813488|9728022|FG001|STARTED|Open-label Extension|Patients completing double-blind periods were randomized to FBT or standard of care for open-label|66
8683940|NCT00813488|9728021|FG000|COMPLETED|Open-label Extension|This group received FBT open--label|53
8683941|NCT00813488|9728022|FG001|COMPLETED|Open-label Extension|This group received standard of care (including immediate-release oxycodone)|59
8683942|NCT00813488|9728021|FG000|NOT COMPLETED|Open-label Extension||12
8683943|NCT00813488|9728022|FG001|NOT COMPLETED|Open-label Extension||7
8683944|NCT00813592|9728032|FG000|STARTED|Overall Study||2
8683945|NCT00813592|9728032|FG000|Treated|Overall Study|Two patients were treated.|2
8683946|NCT00813592|9728032|FG000|Response Assessment|Overall Study|One patient met the response assessment.|1
8683947|NCT00813592|9728032|FG000|COMPLETED|Overall Study||0
8683948|NCT00813592|9728032|FG000|NOT COMPLETED|Overall Study||2
8683949|NCT00813709|9728040|FG000|STARTED|Double Blind Period||84
8683950|NCT00813709|9728041|FG001|STARTED|Double Blind Period||117
8683951|NCT00813709|9728042|FG002|STARTED|Double Blind Period||99
8683952|NCT00813709|9728043|FG003|STARTED|Double Blind Period||0
8683953|NCT00813709|9728044|FG004|STARTED|Double Blind Period||0
8683954|NCT00813709|9728045|FG005|STARTED|Double Blind Period||0
8683955|NCT00813709|9728040|FG000|Treated|Double Blind Period||83
8683956|NCT00813709|9728041|FG001|Treated|Double Blind Period||114
8683957|NCT00813709|9728042|FG002|Treated|Double Blind Period||98
8683958|NCT00813709|9728043|FG003|Treated|Double Blind Period||0
8683959|NCT00813709|9728044|FG004|Treated|Double Blind Period||0
8683960|NCT00813709|9728045|FG005|Treated|Double Blind Period||0
8683961|NCT00813709|9728040|FG000|COMPLETED|Double Blind Period||53
8683962|NCT00813709|9728041|FG001|COMPLETED|Double Blind Period||76
8683963|NCT00813709|9728042|FG002|COMPLETED|Double Blind Period||68
8683964|NCT00813709|9728043|FG003|COMPLETED|Double Blind Period||0
8683965|NCT00813709|9728044|FG004|COMPLETED|Double Blind Period||0
8683966|NCT00813709|9728045|FG005|COMPLETED|Double Blind Period||0
8683967|NCT00813709|9728040|FG000|NOT COMPLETED|Double Blind Period||31
8683968|NCT00813709|9728041|FG001|NOT COMPLETED|Double Blind Period||41
8683969|NCT00813709|9728042|FG002|NOT COMPLETED|Double Blind Period||31
8683970|NCT00813709|9728043|FG003|NOT COMPLETED|Double Blind Period||0
8683971|NCT00813709|9728044|FG004|NOT COMPLETED|Double Blind Period||0
8683972|NCT00813709|9728045|FG005|NOT COMPLETED|Double Blind Period||0
8683973|NCT00813709|9728040|FG000|STARTED|Open Label Period||0
8683974|NCT00813709|9728041|FG001|STARTED|Open Label Period||0
8683975|NCT00813709|9728042|FG002|STARTED|Open Label Period||0
8683976|NCT00813709|9728043|FG003|STARTED|Open Label Period|49 participants in OL period initially + 9 participants from DB converted to CDMS during the study|58
8683977|NCT00813709|9728044|FG004|STARTED|Open Label Period|25 participants in OL period initially + 26 participants from DB converted to CDMS during the study|51
8683978|NCT00813709|9728045|FG005|STARTED|Open Label Period|28 participants in OL period initially + 18 participants from DB converted to CDMS during the study|46
8683979|NCT00813709|9728040|FG000|Treated|Open Label Period||0
8683980|NCT00813709|9728041|FG001|Treated|Open Label Period||0
8683981|NCT00813709|9728042|FG002|Treated|Open Label Period||0
8683982|NCT00813709|9728043|FG003|Treated|Open Label Period||57
8683983|NCT00813709|9728044|FG004|Treated|Open Label Period||51
8683984|NCT00813709|9728045|FG005|Treated|Open Label Period||45
8683985|NCT00813709|9728040|FG000|COMPLETED|Open Label Period||0
8683986|NCT00813709|9728041|FG001|COMPLETED|Open Label Period||0
8800996|NCT01448824|9852880|FG007|STARTED|Part 1: Washout Period||0
8800997|NCT01448824|9852873|FG000|COMPLETED|Part 1: Washout Period||11
8800998|NCT01448824|9852874|FG001|COMPLETED|Part 1: Washout Period||4
8800999|NCT01448824|9852875|FG002|COMPLETED|Part 1: Washout Period||4
8801000|NCT01448824|9852876|FG003|COMPLETED|Part 1: Washout Period||0
8801001|NCT01448824|9852877|FG004|COMPLETED|Part 1: Washout Period||0
8801002|NCT01448824|9852878|FG005|COMPLETED|Part 1: Washout Period||0
8801003|NCT01448824|9852879|FG006|COMPLETED|Part 1: Washout Period||0
8801004|NCT01448824|9852880|FG007|COMPLETED|Part 1: Washout Period||0
8801005|NCT01448824|9852873|FG000|NOT COMPLETED|Part 1: Washout Period||1
8801006|NCT01448824|9852874|FG001|NOT COMPLETED|Part 1: Washout Period||0
8801007|NCT01448824|9852875|FG002|NOT COMPLETED|Part 1: Washout Period||0
8801008|NCT01448824|9852876|FG003|NOT COMPLETED|Part 1: Washout Period||0
8801009|NCT01448824|9852877|FG004|NOT COMPLETED|Part 1: Washout Period||0
9035706|NCT03301714|10097431|FG002|STARTED|Overall Study||60
8801010|NCT01448824|9852878|FG005|NOT COMPLETED|Part 1: Washout Period||0
8801011|NCT01448824|9852879|FG006|NOT COMPLETED|Part 1: Washout Period||0
8801012|NCT01448824|9852880|FG007|NOT COMPLETED|Part 1: Washout Period||0
8801013|NCT01448824|9852873|FG000|STARTED|Part 1 Period 2: Multiple Ascending Dose||11
8801014|NCT01448824|9852874|FG001|STARTED|Part 1 Period 2: Multiple Ascending Dose||4
8683987|NCT00813709|9728042|FG002|COMPLETED|Open Label Period||0
8683988|NCT00813709|9728043|FG003|COMPLETED|Open Label Period||38
8683989|NCT00813709|9728044|FG004|COMPLETED|Open Label Period||41
8683990|NCT00813709|9728045|FG005|COMPLETED|Open Label Period||35
8683991|NCT00813709|9728040|FG000|NOT COMPLETED|Open Label Period||0
8683992|NCT00813709|9728041|FG001|NOT COMPLETED|Open Label Period||0
8683993|NCT00813709|9728042|FG002|NOT COMPLETED|Open Label Period||0
8683994|NCT00813709|9728043|FG003|NOT COMPLETED|Open Label Period||20
8683995|NCT00813709|9728044|FG004|NOT COMPLETED|Open Label Period||10
8683996|NCT00813709|9728045|FG005|NOT COMPLETED|Open Label Period||11
8683997|NCT00813748|9728076|FG000|STARTED|Main Observational Study||30
8683998|NCT00813748|9728077|FG001|STARTED|Main Observational Study||88
8683999|NCT00813748|9728076|FG000|COMPLETED|Main Observational Study||30
8684000|NCT00813748|9728077|FG001|COMPLETED|Main Observational Study||88
8684001|NCT00813748|9728076|FG000|NOT COMPLETED|Main Observational Study||0
8684002|NCT00813748|9728077|FG001|NOT COMPLETED|Main Observational Study||0
8684003|NCT00813748|9728076|FG000|STARTED|Skin Test Substudy|Included participants who discontinued omalizumab for at least 16 weeks but not more than 18 months.|3
8684004|NCT00813748|9728077|FG001|STARTED|Skin Test Substudy|Included participants who discontinued omalizumab for at least 16 weeks but not more than 18 months.|8
8684005|NCT00813748|9728076|FG000|COMPLETED|Skin Test Substudy||3
8684006|NCT00813748|9728077|FG001|COMPLETED|Skin Test Substudy||7
8684007|NCT00813748|9728076|FG000|NOT COMPLETED|Skin Test Substudy||0
8684008|NCT00813748|9728077|FG001|NOT COMPLETED|Skin Test Substudy||1
8684009|NCT00813761|9728087|FG000|STARTED|Phase 1 (Baseline to 4 Weeks)||121
8684010|NCT00813761|9728088|FG001|STARTED|Phase 1 (Baseline to 4 Weeks)||103
8684011|NCT00813761|9728089|FG002|STARTED|Phase 1 (Baseline to 4 Weeks)||115
8684012|NCT00813761|9728090|FG003|STARTED|Phase 1 (Baseline to 4 Weeks)||107
8684013|NCT00813761|9728087|FG000|COMPLETED|Phase 1 (Baseline to 4 Weeks)||117
8684014|NCT00813761|9728088|FG001|COMPLETED|Phase 1 (Baseline to 4 Weeks)||100
8684015|NCT00813761|9728089|FG002|COMPLETED|Phase 1 (Baseline to 4 Weeks)||103
8684016|NCT00813761|9728090|FG003|COMPLETED|Phase 1 (Baseline to 4 Weeks)||105
8684017|NCT00813761|9728087|FG000|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||4
8684018|NCT00813761|9728088|FG001|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||3
8684019|NCT00813761|9728089|FG002|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||12
8684020|NCT00813761|9728090|FG003|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||2
8684021|NCT00813761|9728087|FG000|STARTED|Phase 2 (4 Weeks to 24 Weeks)||117
8684022|NCT00813761|9728088|FG001|STARTED|Phase 2 (4 Weeks to 24 Weeks)||100
8684023|NCT00813761|9728089|FG002|STARTED|Phase 2 (4 Weeks to 24 Weeks)||103
8684024|NCT00813761|9728090|FG003|STARTED|Phase 2 (4 Weeks to 24 Weeks)||105
8684025|NCT00813761|9728087|FG000|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||101
8684026|NCT00813761|9728088|FG001|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||91
8684027|NCT00813761|9728089|FG002|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||94
8684028|NCT00813761|9728090|FG003|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||100
8684029|NCT00813761|9728087|FG000|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||16
8684030|NCT00813761|9728088|FG001|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||9
8684031|NCT00813761|9728089|FG002|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||9
8684032|NCT00813761|9728090|FG003|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||5
8684033|NCT00813800|9728106|FG000|STARTED|Overall Study||11
8684034|NCT00813800|9728106|FG000|COMPLETED|Overall Study||5
8684035|NCT00813800|9728106|FG000|NOT COMPLETED|Overall Study||6
8684036|NCT00813813|9728112|FG000|STARTED|Overall Study||7
8684037|NCT00813813|9728113|FG001|STARTED|Overall Study||25
8684038|NCT00813813|9728112|FG000|COMPLETED|Overall Study||4
8684039|NCT00813813|9728113|FG001|COMPLETED|Overall Study||16
8684040|NCT00813813|9728112|FG000|NOT COMPLETED|Overall Study||3
8684041|NCT00813813|9728113|FG001|NOT COMPLETED|Overall Study||9
8684042|NCT00813865|9728119|FG000|STARTED|Overall Study||8
8684043|NCT00813865|9728119|FG000|Safety Population|Overall Study||8
8684044|NCT00813865|9728119|FG000|Pharmacodynamic (PD) Population|Overall Study||8
8684045|NCT00813865|9728119|FG000|COMPLETED|Overall Study||1
8684046|NCT00813865|9728119|FG000|NOT COMPLETED|Overall Study||7
8684047|NCT00813904|9728123|FG000|STARTED|Overall Study||31
8684048|NCT00813904|9728123|FG000|COMPLETED|Overall Study||30
8684049|NCT00813904|9728123|FG000|NOT COMPLETED|Overall Study||1
8684050|NCT00813917|9728129|FG000|STARTED|Overall Study||38
8684051|NCT00813917|9728130|FG001|STARTED|Overall Study||38
8684052|NCT00813917|9728129|FG000|COMPLETED|Overall Study||32
8684053|NCT00813917|9728130|FG001|COMPLETED|Overall Study||32
8684054|NCT00813917|9728129|FG000|NOT COMPLETED|Overall Study||6
8684055|NCT00813917|9728130|FG001|NOT COMPLETED|Overall Study||6
8684056|NCT00813943|9728139|FG000|STARTED|Overall Study||88
8684057|NCT00813943|9728140|FG001|STARTED|Overall Study||88
8684058|NCT00813943|9728141|FG002|STARTED|Overall Study||89
8684059|NCT00813943|9728139|FG000|COMPLETED|Overall Study||83
8684060|NCT00813943|9728140|FG001|COMPLETED|Overall Study||83
8684061|NCT00813943|9728141|FG002|COMPLETED|Overall Study||86
8684062|NCT00813943|9728139|FG000|NOT COMPLETED|Overall Study||5
8684063|NCT00813943|9728140|FG001|NOT COMPLETED|Overall Study||5
8684064|NCT00813943|9728141|FG002|NOT COMPLETED|Overall Study||3
8684065|NCT00813982|9728150|FG000|STARTED|Overall Study||59
8684066|NCT00813982|9728150|FG000|COMPLETED|Overall Study||59
8684067|NCT00813982|9728150|FG000|NOT COMPLETED|Overall Study||0
8684068|NCT00813995|9728158|FG000|STARTED|Overall Study||197
8684069|NCT00813995|9728159|FG001|STARTED|Overall Study||198
8684070|NCT00813995|9728158|FG000|COMPLETED|Overall Study||174
8684071|NCT00813995|9728159|FG001|COMPLETED|Overall Study||182
8684072|NCT00813995|9728158|FG000|NOT COMPLETED|Overall Study||23
8684073|NCT00813995|9728159|FG001|NOT COMPLETED|Overall Study||16
8684074|NCT00814138|9728171|FG000|STARTED|Overall Study||25
8684075|NCT00814138|9728172|FG001|STARTED|Overall Study||25
8684076|NCT00814138|9728171|FG000|COMPLETED|Overall Study||24
8684077|NCT00814138|9728172|FG001|COMPLETED|Overall Study||18
8684078|NCT00814138|9728171|FG000|NOT COMPLETED|Overall Study||1
8684079|NCT00814138|9728172|FG001|NOT COMPLETED|Overall Study||7
8684080|NCT00814164|9728180|FG000|STARTED|Overall Study||21
8684081|NCT00814164|9728180|FG000|COMPLETED|Overall Study||2
8684082|NCT00814164|9728180|FG000|NOT COMPLETED|Overall Study||19
8684083|NCT00814177|9728186|FG000|STARTED|Overall Study||80
8684084|NCT00814177|9728187|FG001|STARTED|Overall Study||80
8684085|NCT00814177|9728186|FG000|COMPLETED|Overall Study||80
8684086|NCT00814177|9728187|FG001|COMPLETED|Overall Study||80
8684087|NCT00814177|9728186|FG000|NOT COMPLETED|Overall Study||0
8684088|NCT00814177|9728187|FG001|NOT COMPLETED|Overall Study||0
8684089|NCT00814255|9728196|FG000|STARTED|Overall Study||8
8684090|NCT00814255|9728197|FG001|STARTED|Overall Study||7
8684091|NCT00814255|9728198|FG002|STARTED|Overall Study||8
8684092|NCT00814255|9728196|FG000|COMPLETED|Overall Study||7
8684093|NCT00814255|9728197|FG001|COMPLETED|Overall Study||7
8684094|NCT00814255|9728198|FG002|COMPLETED|Overall Study||7
8684095|NCT00814255|9728196|FG000|NOT COMPLETED|Overall Study||1
8684096|NCT00814255|9728197|FG001|NOT COMPLETED|Overall Study||0
8684097|NCT00814255|9728198|FG002|NOT COMPLETED|Overall Study||1
8684098|NCT00814307|9728213|FG000|STARTED|Overall Study||244
8684099|NCT00814307|9728214|FG001|STARTED|Overall Study||245
8684100|NCT00814307|9728215|FG002|STARTED|Overall Study||61
8684101|NCT00814307|9728216|FG003|STARTED|Overall Study||61
8684102|NCT00814307|9728213|FG000|Treated|Overall Study||243
8684103|NCT00814307|9728214|FG001|Treated|Overall Study||245
8684104|NCT00814307|9728215|FG002|Treated|Overall Study||61
8684105|NCT00814307|9728216|FG003|Treated|Overall Study||61
8684106|NCT00814307|9728213|FG000|COMPLETED|Overall Study||232
8684107|NCT00814307|9728214|FG001|COMPLETED|Overall Study||218
8684108|NCT00814307|9728215|FG002|COMPLETED|Overall Study||54
8684109|NCT00814307|9728216|FG003|COMPLETED|Overall Study||51
8684110|NCT00814307|9728213|FG000|NOT COMPLETED|Overall Study||12
8684111|NCT00814307|9728214|FG001|NOT COMPLETED|Overall Study||27
8684112|NCT00814307|9728215|FG002|NOT COMPLETED|Overall Study||7
8684113|NCT00814307|9728216|FG003|NOT COMPLETED|Overall Study||10
8684114|NCT00814320|9728230|FG000|STARTED|Epoch 1 (IV Treatment)||14
8684115|NCT00814320|9728231|FG001|STARTED|Epoch 1 (IV Treatment)||73
8684116|NCT00814320|9728230|FG000|COMPLETED|Epoch 1 (IV Treatment)||13
8684117|NCT00814320|9728231|FG001|COMPLETED|Epoch 1 (IV Treatment)||71
8684118|NCT00814320|9728230|FG000|NOT COMPLETED|Epoch 1 (IV Treatment)||1
8684119|NCT00814320|9728231|FG001|NOT COMPLETED|Epoch 1 (IV Treatment)||2
8684120|NCT00814320|9728230|FG000|STARTED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||13
8684121|NCT00814320|9728231|FG001|STARTED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||71
8684122|NCT00814320|9728230|FG000|COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||13
8684123|NCT00814320|9728231|FG001|COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||70
8684124|NCT00814320|9728230|FG000|NOT COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||0
8684125|NCT00814320|9728231|FG001|NOT COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||1
8684126|NCT00814320|9728230|FG000|STARTED|"Epoch 2 Ramp-up (Ramp-up)"||13
8684127|NCT00814320|9728231|FG001|STARTED|"Epoch 2 Ramp-up (Ramp-up)"||70
8684128|NCT00814320|9728230|FG000|COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||11
8684129|NCT00814320|9728231|FG001|COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||70
8684130|NCT00814320|9728230|FG000|NOT COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||2
8684131|NCT00814320|9728231|FG001|NOT COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||0
8684132|NCT00814320|9728230|FG000|STARTED|Epoch 2 After Ramp-up (SC/rHuPH20)||11
8684133|NCT00814320|9728231|FG001|STARTED|Epoch 2 After Ramp-up (SC/rHuPH20)||70
8684134|NCT00814320|9728230|FG000|COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)||8
8684135|NCT00814320|9728231|FG001|COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)|Three participants who switched to safety follow-up remained in the study.|60
8684136|NCT00814320|9728230|FG000|NOT COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)||3
8684137|NCT00814320|9728231|FG001|NOT COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)||10
8684138|NCT00814346|9728256|FG000|STARTED|Double-blind Phase (4 Weeks)||23
8684139|NCT00814346|9728257|FG001|STARTED|Double-blind Phase (4 Weeks)||26
8684140|NCT00814346|9728256|FG000|CNE|Double-blind Phase (4 Weeks)||10
8684141|NCT00814346|9728257|FG001|CNE|Double-blind Phase (4 Weeks)||13
8684142|NCT00814346|9728256|FG000|MC|Double-blind Phase (4 Weeks)||10
8684143|NCT00814346|9728257|FG001|MC|Double-blind Phase (4 Weeks)||11
8684144|NCT00814346|9728256|FG000|AD|Double-blind Phase (4 Weeks)||3
8684145|NCT00814346|9728257|FG001|AD|Double-blind Phase (4 Weeks)||2
8684146|NCT00814346|9728256|FG000|COMPLETED|Double-blind Phase (4 Weeks)||23
8684147|NCT00814346|9728257|FG001|COMPLETED|Double-blind Phase (4 Weeks)||23
8684148|NCT00814346|9728256|FG000|NOT COMPLETED|Double-blind Phase (4 Weeks)||0
8684149|NCT00814346|9728257|FG001|NOT COMPLETED|Double-blind Phase (4 Weeks)||3
8684150|NCT00814346|9728256|FG000|STARTED|Open Phase (17 Months)|Open period was treated with EGB761®. 41 subjects accepted follow-up open period(21 in CNE,20 in MC)|41
8684151|NCT00814346|9728257|FG001|STARTED|Open Phase (17 Months)|This was an open period, without placebo arm, the number of subject on placebo is 0.|0
8684152|NCT00814346|9728256|FG000|CNE|Open Phase (17 Months)||21
8684153|NCT00814346|9728257|FG001|CNE|Open Phase (17 Months)||0
8684154|NCT00814346|9728256|FG000|MC|Open Phase (17 Months)||20
8684155|NCT00814346|9728257|FG001|MC|Open Phase (17 Months)||0
8684156|NCT00814346|9728256|FG000|AD|Open Phase (17 Months)|Open period was not proposed to AD subjects.|0
8684157|NCT00814346|9728257|FG001|AD|Open Phase (17 Months)||0
8684158|NCT00814346|9728256|FG000|COMPLETED|Open Phase (17 Months)||31
8684159|NCT00814346|9728257|FG001|COMPLETED|Open Phase (17 Months)||0
8684160|NCT00814346|9728256|FG000|NOT COMPLETED|Open Phase (17 Months)||10
8684161|NCT00814346|9728257|FG001|NOT COMPLETED|Open Phase (17 Months)||0
8684162|NCT00814463|9728276|FG000|STARTED|Overall Study||1
8684163|NCT00814463|9728276|FG000|COMPLETED|Overall Study||0
8684164|NCT00814463|9728276|FG000|NOT COMPLETED|Overall Study||1
8684165|NCT00814489|9728284|FG000|STARTED|Overall Study||15
8684166|NCT00814489|9728285|FG001|STARTED|Overall Study||17
8684167|NCT00814489|9728286|FG002|STARTED|Overall Study||8
8684168|NCT00814489|9728284|FG000|COMPLETED|Overall Study||13
8684169|NCT00814489|9728285|FG001|COMPLETED|Overall Study||17
8684170|NCT00814489|9728286|FG002|COMPLETED|Overall Study||7
8684171|NCT00814489|9728284|FG000|NOT COMPLETED|Overall Study||2
8684172|NCT00814489|9728285|FG001|NOT COMPLETED|Overall Study||0
8684173|NCT00814489|9728286|FG002|NOT COMPLETED|Overall Study||1
8684174|NCT00814502|9728298|FG000|STARTED|Overall Study||8
8684175|NCT00814502|9728299|FG001|STARTED|Overall Study||9
8801015|NCT01448824|9852875|FG002|STARTED|Part 1 Period 2: Multiple Ascending Dose||4
8801016|NCT01448824|9852876|FG003|STARTED|Part 1 Period 2: Multiple Ascending Dose|Participants in Part 1 Cohorts B through D participated in Period 1 only.|0
8801017|NCT01448824|9852877|FG004|STARTED|Part 1 Period 2: Multiple Ascending Dose|Participants in Part 1 Cohort B participated in Period 1 only.|0
8801018|NCT01448824|9852878|FG005|STARTED|Part 1 Period 2: Multiple Ascending Dose|Participants in Part 1 Cohort C participated in Period 1 only.|0
8801019|NCT01448824|9852879|FG006|STARTED|Part 1 Period 2: Multiple Ascending Dose|Participants in Part 1 Cohort D participated in Period 1 only.|0
8801020|NCT01448824|9852880|FG007|STARTED|Part 1 Period 2: Multiple Ascending Dose||0
8801021|NCT01448824|9852873|FG000|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||11
8801022|NCT01448824|9852874|FG001|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||4
8801023|NCT01448824|9852875|FG002|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||4
8801024|NCT01448824|9852876|FG003|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0
8801025|NCT01448824|9852877|FG004|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0
8801026|NCT01448824|9852878|FG005|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0
8801027|NCT01448824|9852879|FG006|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0
8801028|NCT01448824|9852880|FG007|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0
8801029|NCT01448824|9852873|FG000|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||11
8801030|NCT01448824|9852874|FG001|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||4
8801031|NCT01448824|9852875|FG002|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||4
8801032|NCT01448824|9852876|FG003|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
8801033|NCT01448824|9852877|FG004|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
8801034|NCT01448824|9852878|FG005|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
8801035|NCT01448824|9852879|FG006|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
8801036|NCT01448824|9852880|FG007|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
8801037|NCT01448824|9852873|FG000|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
8801038|NCT01448824|9852874|FG001|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
8801039|NCT01448824|9852875|FG002|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
8801040|NCT01448824|9852876|FG003|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
8801041|NCT01448824|9852877|FG004|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
8801042|NCT01448824|9852878|FG005|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
8801043|NCT01448824|9852879|FG006|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
8801044|NCT01448824|9852880|FG007|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
8801045|NCT01448824|9852873|FG000|STARTED|Part 2 Period 1: Drug-drug Interaction||0
8801046|NCT01448824|9852874|FG001|STARTED|Part 2 Period 1: Drug-drug Interaction||0
8801047|NCT01448824|9852875|FG002|STARTED|Part 2 Period 1: Drug-drug Interaction||0
8801048|NCT01448824|9852876|FG003|STARTED|Part 2 Period 1: Drug-drug Interaction||0
8801049|NCT01448824|9852877|FG004|STARTED|Part 2 Period 1: Drug-drug Interaction||0
8801050|NCT01448824|9852878|FG005|STARTED|Part 2 Period 1: Drug-drug Interaction||0
8801051|NCT01448824|9852879|FG006|STARTED|Part 2 Period 1: Drug-drug Interaction||0
8801052|NCT01448824|9852880|FG007|STARTED|Part 2 Period 1: Drug-drug Interaction||12
8801053|NCT01448824|9852873|FG000|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
8801054|NCT01448824|9852874|FG001|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
8801055|NCT01448824|9852875|FG002|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
8801056|NCT01448824|9852876|FG003|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
8801057|NCT01448824|9852877|FG004|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
8801058|NCT01448824|9852878|FG005|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
8801059|NCT01448824|9852879|FG006|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
8801060|NCT01448824|9852880|FG007|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||12
8801061|NCT01448824|9852873|FG000|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
8801062|NCT01448824|9852874|FG001|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
8801063|NCT01448824|9852875|FG002|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
8684176|NCT00814502|9728298|FG000|COMPLETED|Overall Study||7
8684177|NCT00814502|9728299|FG001|COMPLETED|Overall Study||7
8684178|NCT00814502|9728298|FG000|NOT COMPLETED|Overall Study||1
8684179|NCT00814502|9728299|FG001|NOT COMPLETED|Overall Study||2
8693041|NCT00863343|9738413|FG000|COMPLETED|Overall Study||17
8693042|NCT00863343|9738414|FG001|COMPLETED|Overall Study||374
8693043|NCT00863343|9738413|FG000|NOT COMPLETED|Overall Study||0
8693044|NCT00863343|9738414|FG001|NOT COMPLETED|Overall Study||0
8693045|NCT00863356|9738422|FG000|STARTED|Overall Study||20
8693046|NCT00863356|9738422|FG000|COMPLETED|Overall Study||20
8693047|NCT00863356|9738422|FG000|NOT COMPLETED|Overall Study||0
8693048|NCT00863434|9738426|FG000|STARTED|Overall Study||2
8693049|NCT00863434|9738426|FG000|COMPLETED|Overall Study||2
8693050|NCT00863434|9738426|FG000|NOT COMPLETED|Overall Study||0
8693051|NCT00863551|9738430|FG000|STARTED|Overall Study||12
8693052|NCT00863551|9738430|FG000|COMPLETED|Overall Study||12
8693053|NCT00863551|9738430|FG000|NOT COMPLETED|Overall Study||0
8693054|NCT00863655|9738436|FG000|STARTED|Overall Study||485
8693055|NCT00863655|9738437|FG001|STARTED|Overall Study||239
8693056|NCT00863655|9738436|FG000|COMPLETED|Overall Study|Completed means discontinued the treatment period.|0
8693057|NCT00863655|9738437|FG001|COMPLETED|Overall Study|Completed means discontinued the treatment period.|0
8693058|NCT00863655|9738436|FG000|NOT COMPLETED|Overall Study||485
8693059|NCT00863655|9738437|FG001|NOT COMPLETED|Overall Study||239
8693060|NCT00863681|9738446|FG000|STARTED|Overall Study||231
8693061|NCT00863681|9738447|FG001|STARTED|Overall Study||109
8693062|NCT00863681|9738448|FG002|STARTED|Overall Study||56
8693063|NCT00863681|9738446|FG000|COMPLETED|Overall Study|Completed treatment|140
8693064|NCT00863681|9738447|FG001|COMPLETED|Overall Study|Completed treatment|66
8693065|NCT00863681|9738448|FG002|COMPLETED|Overall Study|Completed treatment|38
8693066|NCT00863681|9738446|FG000|NOT COMPLETED|Overall Study||91
8693067|NCT00863681|9738447|FG001|NOT COMPLETED|Overall Study||43
8693068|NCT00863681|9738448|FG002|NOT COMPLETED|Overall Study||18
8693069|NCT00863707|9738458|FG000|STARTED|Overall Study||174
8693070|NCT00863707|9738459|FG001|STARTED|Overall Study||337
8693071|NCT00863707|9738458|FG000|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|170
8693072|NCT00863707|9738459|FG001|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|334
8693073|NCT00863707|9738458|FG000|NOT COMPLETED|Overall Study||4
8693074|NCT00863707|9738459|FG001|NOT COMPLETED|Overall Study||3
8693075|NCT00863746|9738467|FG000|STARTED|Treatment||350
8693076|NCT00863746|9738468|FG001|STARTED|Treatment||353
8693077|NCT00863746|9738467|FG000|Participants Received Treatment|Treatment|Safety population|346
8693078|NCT00863746|9738468|FG001|Participants Received Treatment|Treatment|Safety population|351
8693079|NCT00863746|9738467|FG000|COMPLETED|Treatment||279
8693080|NCT00863746|9738468|FG001|COMPLETED|Treatment||318
8693081|NCT00863746|9738467|FG000|NOT COMPLETED|Treatment||71
8693082|NCT00863746|9738468|FG001|NOT COMPLETED|Treatment||35
8693083|NCT00863746|9738467|FG000|STARTED|Survival Follow up|298 patients of 317 patients (= 346 randomized - 29 deaths) entered the survival follow-up|298
8693084|NCT00863746|9738468|FG001|STARTED|Survival Follow up|331 patients of 339 patients (=353 randomized - 14 death) entered the survival follow-up.|331
8693085|NCT00863746|9738467|FG000|COMPLETED|Survival Follow up||45
8693086|NCT00863746|9738468|FG001|COMPLETED|Survival Follow up||51
8693087|NCT00863746|9738467|FG000|NOT COMPLETED|Survival Follow up||253
8693088|NCT00863746|9738468|FG001|NOT COMPLETED|Survival Follow up||280
8693089|NCT00863772|9738477|FG000|STARTED|Overall Study||74
8693090|NCT00863772|9738478|FG001|STARTED|Overall Study||74
8693091|NCT00863772|9738479|FG002|STARTED|Overall Study||72
8693092|NCT00863772|9738477|FG000|Treated|Overall Study||73
8693093|NCT00863772|9738478|FG001|Treated|Overall Study||74
8693094|NCT00863772|9738479|FG002|Treated|Overall Study||72
8693095|NCT00863772|9738477|FG000|COMPLETED|Overall Study||6
8693096|NCT00863772|9738478|FG001|COMPLETED|Overall Study||9
8693097|NCT00863772|9738479|FG002|COMPLETED|Overall Study||11
8693098|NCT00863772|9738477|FG000|NOT COMPLETED|Overall Study||68
8693099|NCT00863772|9738478|FG001|NOT COMPLETED|Overall Study||65
8693100|NCT00863772|9738479|FG002|NOT COMPLETED|Overall Study||61
8693101|NCT00863798|9738490|FG000|STARTED|Overall Study||227
8693102|NCT00863798|9738491|FG001|STARTED|Overall Study||228
8693103|NCT00863798|9738492|FG002|STARTED|Overall Study||227
8693104|NCT00863798|9738490|FG000|Treated|Overall Study||223
8693105|NCT00863798|9738491|FG001|Treated|Overall Study||226
8693106|NCT00863798|9738492|FG002|Treated|Overall Study||224
8693107|NCT00863798|9738490|FG000|COMPLETED|Overall Study||195
8693108|NCT00863798|9738491|FG001|COMPLETED|Overall Study||198
8693109|NCT00863798|9738492|FG002|COMPLETED|Overall Study||202
8693110|NCT00863798|9738490|FG000|NOT COMPLETED|Overall Study||32
8693111|NCT00863798|9738491|FG001|NOT COMPLETED|Overall Study||30
8693112|NCT00863798|9738492|FG002|NOT COMPLETED|Overall Study||25
8693113|NCT00863928|9738502|FG000|STARTED|Overall Study||94
8693114|NCT00863928|9738503|FG001|STARTED|Overall Study||41
8693115|NCT00863928|9738502|FG000|COMPLETED|Overall Study||58
8693116|NCT00863928|9738503|FG001|COMPLETED|Overall Study||41
8693117|NCT00863928|9738502|FG000|NOT COMPLETED|Overall Study||36
8693118|NCT00863928|9738503|FG001|NOT COMPLETED|Overall Study||0
8693119|NCT00864032|9738509|FG000|STARTED|Overall Study||3
8693120|NCT00864032|9738510|FG001|STARTED|Overall Study||5
8693121|NCT00864032|9738511|FG002|STARTED|Overall Study||0
8693122|NCT00864032|9738509|FG000|COMPLETED|Overall Study||3
8693123|NCT00864032|9738510|FG001|COMPLETED|Overall Study||5
8693124|NCT00864032|9738511|FG002|COMPLETED|Overall Study||0
8693125|NCT00864032|9738509|FG000|NOT COMPLETED|Overall Study||0
8684180|NCT00814580|9728309|FG000|STARTED|Overall Study||194
8684181|NCT00814580|9728310|FG001|STARTED|Overall Study||188
8684182|NCT00814580|9728309|FG000|COMPLETED|Overall Study||163
8684183|NCT00814580|9728310|FG001|COMPLETED|Overall Study||141
8684184|NCT00814580|9728309|FG000|NOT COMPLETED|Overall Study||31
8684185|NCT00814580|9728310|FG001|NOT COMPLETED|Overall Study||47
8684186|NCT00814632|9728328|FG000|STARTED|Overall Study|Ten were allocated to treatment intervention however one was not treated due to lactose allergy.|9
8684187|NCT00814632|9728328|FG000|COMPLETED|Overall Study|Two subjects withdrew early due to lack of efficacy.|7
8684188|NCT00814632|9728328|FG000|NOT COMPLETED|Overall Study||2
8684189|NCT00814658|9728334|FG000|STARTED|Overall Study||9
8684190|NCT00814658|9728335|FG001|STARTED|Overall Study||12
8684191|NCT00814658|9728334|FG000|COMPLETED|Overall Study||5
8684192|NCT00814658|9728335|FG001|COMPLETED|Overall Study||8
8684193|NCT00814658|9728334|FG000|NOT COMPLETED|Overall Study||4
8684194|NCT00814658|9728335|FG001|NOT COMPLETED|Overall Study||4
8684195|NCT00814671|9728354|FG000|STARTED|Overall Study||54
8684196|NCT00814671|9728355|FG001|STARTED|Overall Study||48
8684197|NCT00814671|9728356|FG002|STARTED|Overall Study||51
8684198|NCT00814671|9728354|FG000|COMPLETED|Overall Study||47
8684199|NCT00814671|9728355|FG001|COMPLETED|Overall Study||44
8684200|NCT00814671|9728356|FG002|COMPLETED|Overall Study||49
8684201|NCT00814671|9728354|FG000|NOT COMPLETED|Overall Study||7
8684202|NCT00814671|9728355|FG001|NOT COMPLETED|Overall Study||4
8684203|NCT00814671|9728356|FG002|NOT COMPLETED|Overall Study||2
8684204|NCT00814697|9728368|FG000|STARTED|Overall Study||12
8684205|NCT00814697|9728368|FG000|COMPLETED|Overall Study||12
8684206|NCT00814697|9728368|FG000|NOT COMPLETED|Overall Study||0
8684207|NCT00814710|9728374|FG000|STARTED|Overall Study||240
8684208|NCT00814710|9728375|FG001|STARTED|Overall Study||120
8684209|NCT00814710|9728374|FG000|COMPLETED|Overall Study||232
8684210|NCT00814710|9728375|FG001|COMPLETED|Overall Study||117
8684211|NCT00814710|9728374|FG000|NOT COMPLETED|Overall Study||8
8684212|NCT00814710|9728375|FG001|NOT COMPLETED|Overall Study||3
8684213|NCT00814775|9728383|FG000|STARTED|Overall Study||23
8684214|NCT00814775|9728384|FG001|STARTED|Overall Study||20
8684215|NCT00814775|9728383|FG000|COMPLETED|Overall Study||23
8684216|NCT00814775|9728384|FG001|COMPLETED|Overall Study||20
8684217|NCT00814775|9728383|FG000|NOT COMPLETED|Overall Study||0
8684218|NCT00814775|9728384|FG001|NOT COMPLETED|Overall Study||0
8684219|NCT00814788|9728390|FG000|STARTED|Overall Study||24
8684220|NCT00814788|9728390|FG000|COMPLETED|Overall Study||24
8684221|NCT00814788|9728390|FG000|NOT COMPLETED|Overall Study||0
8684222|NCT00814801|9728399|FG000|STARTED|Overall Study||194
8684223|NCT00814801|9728400|FG001|STARTED|Overall Study||192
8684224|NCT00814801|9728401|FG002|STARTED|Overall Study||194
8684225|NCT00814801|9728399|FG000|COMPLETED|Overall Study||160
8684226|NCT00814801|9728400|FG001|COMPLETED|Overall Study||154
8801064|NCT01448824|9852876|FG003|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
8801065|NCT01448824|9852877|FG004|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
8801066|NCT01448824|9852878|FG005|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
8801067|NCT01448824|9852879|FG006|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
8801068|NCT01448824|9852880|FG007|COMPLETED|Part 2 Period 1: Drug-drug Interaction||11
8801069|NCT01448824|9852873|FG000|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
8801070|NCT01448824|9852874|FG001|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
8801071|NCT01448824|9852875|FG002|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
8801072|NCT01448824|9852876|FG003|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
8801073|NCT01448824|9852877|FG004|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
8801074|NCT01448824|9852878|FG005|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
8801075|NCT01448824|9852879|FG006|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
8801076|NCT01448824|9852880|FG007|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||1
8801077|NCT01448824|9852873|FG000|STARTED|Part 2: Washout Period||0
8801078|NCT01448824|9852874|FG001|STARTED|Part 2: Washout Period||0
8801079|NCT01448824|9852875|FG002|STARTED|Part 2: Washout Period||0
8801080|NCT01448824|9852876|FG003|STARTED|Part 2: Washout Period||0
8801081|NCT01448824|9852877|FG004|STARTED|Part 2: Washout Period||0
8801082|NCT01448824|9852878|FG005|STARTED|Part 2: Washout Period||0
8801083|NCT01448824|9852879|FG006|STARTED|Part 2: Washout Period||0
8801084|NCT01448824|9852880|FG007|STARTED|Part 2: Washout Period||11
8801085|NCT01448824|9852873|FG000|COMPLETED|Part 2: Washout Period||0
8801086|NCT01448824|9852874|FG001|COMPLETED|Part 2: Washout Period||0
8801087|NCT01448824|9852875|FG002|COMPLETED|Part 2: Washout Period||0
8801088|NCT01448824|9852876|FG003|COMPLETED|Part 2: Washout Period||0
8801089|NCT01448824|9852877|FG004|COMPLETED|Part 2: Washout Period||0
8801090|NCT01448824|9852878|FG005|COMPLETED|Part 2: Washout Period||0
8801091|NCT01448824|9852879|FG006|COMPLETED|Part 2: Washout Period||0
8801092|NCT01448824|9852880|FG007|COMPLETED|Part 2: Washout Period||11
8801093|NCT01448824|9852873|FG000|NOT COMPLETED|Part 2: Washout Period||0
8801094|NCT01448824|9852874|FG001|NOT COMPLETED|Part 2: Washout Period||0
8801095|NCT01448824|9852875|FG002|NOT COMPLETED|Part 2: Washout Period||0
8801096|NCT01448824|9852876|FG003|NOT COMPLETED|Part 2: Washout Period||0
8801097|NCT01448824|9852877|FG004|NOT COMPLETED|Part 2: Washout Period||0
8801098|NCT01448824|9852878|FG005|NOT COMPLETED|Part 2: Washout Period||0
8801099|NCT01448824|9852879|FG006|NOT COMPLETED|Part 2: Washout Period||0
8801100|NCT01448824|9852880|FG007|NOT COMPLETED|Part 2: Washout Period||0
8801101|NCT01448824|9852873|FG000|STARTED|Part 2 Period 2: Drug-drug Interaction||0
8684227|NCT00814801|9728401|FG002|COMPLETED|Overall Study||151
8684228|NCT00814801|9728399|FG000|NOT COMPLETED|Overall Study||34
8684229|NCT00814801|9728400|FG001|NOT COMPLETED|Overall Study||38
8684230|NCT00814801|9728401|FG002|NOT COMPLETED|Overall Study||43
8684231|NCT00814879|9728411|FG000|STARTED|By Week 24||28
8684232|NCT00814879|9728412|FG001|STARTED|By Week 24||30
8684233|NCT00814879|9728411|FG000|COMPLETED|By Week 24||27
8684234|NCT00814879|9728412|FG001|COMPLETED|By Week 24||29
8684235|NCT00814879|9728411|FG000|NOT COMPLETED|By Week 24||1
8684236|NCT00814879|9728412|FG001|NOT COMPLETED|By Week 24||1
8684237|NCT00814879|9728411|FG000|STARTED|By Week 48||27
8684238|NCT00814879|9728412|FG001|STARTED|By Week 48||29
8684239|NCT00814879|9728411|FG000|COMPLETED|By Week 48||25
8684240|NCT00814879|9728412|FG001|COMPLETED|By Week 48||26
8684241|NCT00814879|9728411|FG000|NOT COMPLETED|By Week 48||2
8684242|NCT00814879|9728412|FG001|NOT COMPLETED|By Week 48||3
8684243|NCT00814970|9728419|FG000|STARTED|Overall Study||196
8684244|NCT00814970|9728419|FG000|COMPLETED|Overall Study||146
8684245|NCT00814970|9728419|FG000|NOT COMPLETED|Overall Study||50
8684246|NCT00815035|9728427|FG000|STARTED|Blinded Phase||10
8684247|NCT00815035|9728428|FG001|STARTED|Blinded Phase||6
8684248|NCT00815035|9728429|FG002|STARTED|Blinded Phase||0
8684249|NCT00815035|9728427|FG000|COMPLETED|Blinded Phase||9
8684250|NCT00815035|9728428|FG001|COMPLETED|Blinded Phase||6
8684251|NCT00815035|9728429|FG002|COMPLETED|Blinded Phase||0
8684252|NCT00815035|9728427|FG000|NOT COMPLETED|Blinded Phase||1
8684253|NCT00815035|9728428|FG001|NOT COMPLETED|Blinded Phase||0
8684254|NCT00815035|9728429|FG002|NOT COMPLETED|Blinded Phase||0
8684255|NCT00815035|9728427|FG000|STARTED|Open Label Extension Phase|After unblinding, subjects completing the blinded phase moved to the open-label phase of the study|0
8684256|NCT00815035|9728428|FG001|STARTED|Open Label Extension Phase|After unblinding, subjects completing the blinded phase moved to the open-label phase of the study|0
8684257|NCT00815035|9728429|FG002|STARTED|Open Label Extension Phase|After unblinding, subjects completing the blinded phase moved to the open-label phase of the study|15
8684258|NCT00815035|9728427|FG000|COMPLETED|Open Label Extension Phase||0
8684259|NCT00815035|9728428|FG001|COMPLETED|Open Label Extension Phase||0
8684260|NCT00815035|9728429|FG002|COMPLETED|Open Label Extension Phase||9
8684261|NCT00815035|9728427|FG000|NOT COMPLETED|Open Label Extension Phase||0
8684262|NCT00815035|9728428|FG001|NOT COMPLETED|Open Label Extension Phase||0
8684263|NCT00815035|9728429|FG002|NOT COMPLETED|Open Label Extension Phase||6
8684264|NCT00815087|9728440|FG000|STARTED|Overall Study||10
8684265|NCT00815087|9728441|FG001|STARTED|Overall Study||10
8684266|NCT00815087|9728440|FG000|COMPLETED|Overall Study||10
8684267|NCT00815087|9728441|FG001|COMPLETED|Overall Study||10
8684268|NCT00815087|9728440|FG000|NOT COMPLETED|Overall Study||0
8684269|NCT00815087|9728441|FG001|NOT COMPLETED|Overall Study||0
8684270|NCT00815191|9728449|FG000|STARTED|Overall Study||38
8684271|NCT00815191|9728450|FG001|STARTED|Overall Study||35
8684272|NCT00815191|9728449|FG000|COMPLETED|Overall Study||37
8684273|NCT00815191|9728450|FG001|COMPLETED|Overall Study||34
8684274|NCT00815191|9728449|FG000|NOT COMPLETED|Overall Study||1
8684275|NCT00815191|9728450|FG001|NOT COMPLETED|Overall Study||1
8684276|NCT00815295|9728459|FG000|STARTED|Overall Study||8
8684277|NCT00815295|9728460|FG001|STARTED|Overall Study||8
8684278|NCT00815295|9728461|FG002|STARTED|Overall Study||12
8684279|NCT00815295|9728459|FG000|COMPLETED|Overall Study||8
8684280|NCT00815295|9728460|FG001|COMPLETED|Overall Study||7
8684281|NCT00815295|9728461|FG002|COMPLETED|Overall Study||9
8684282|NCT00815295|9728459|FG000|NOT COMPLETED|Overall Study||0
8684283|NCT00815295|9728460|FG001|NOT COMPLETED|Overall Study||1
8684284|NCT00815295|9728461|FG002|NOT COMPLETED|Overall Study||3
8684285|NCT00815308|9728469|FG000|STARTED|Overall Study||55
8684286|NCT00815308|9728469|FG000|COMPLETED|Overall Study||45
8684287|NCT00815308|9728469|FG000|NOT COMPLETED|Overall Study||10
8684288|NCT00815347|9728473|FG000|STARTED|Overall Study||11
8684289|NCT00815347|9728473|FG000|COMPLETED|Overall Study||7
8684290|NCT00815347|9728473|FG000|NOT COMPLETED|Overall Study||4
8684291|NCT00815360|9728481|FG000|STARTED|Overall Study||11
8684292|NCT00815360|9728482|FG001|STARTED|Overall Study||11
8684293|NCT00815360|9728481|FG000|COMPLETED|Overall Study||11
8684294|NCT00815360|9728482|FG001|COMPLETED|Overall Study||11
8684295|NCT00815360|9728481|FG000|NOT COMPLETED|Overall Study||0
8684296|NCT00815360|9728482|FG001|NOT COMPLETED|Overall Study||0
8684297|NCT00815490|9728490|FG000|STARTED|Overall Study||9
8684298|NCT00815490|9728491|FG001|STARTED|Overall Study||9
8684299|NCT00815490|9728490|FG000|COMPLETED|Overall Study||9
8684300|NCT00815490|9728491|FG001|COMPLETED|Overall Study||9
8684301|NCT00815490|9728490|FG000|NOT COMPLETED|Overall Study||0
8684302|NCT00815490|9728491|FG001|NOT COMPLETED|Overall Study||0
8684303|NCT00815516|9728499|FG000|STARTED|Overall Study||20
8684304|NCT00815516|9728500|FG001|STARTED|Overall Study||10
8684305|NCT00815516|9728499|FG000|COMPLETED|Overall Study||16
8684306|NCT00815516|9728500|FG001|COMPLETED|Overall Study||9
8684307|NCT00815516|9728499|FG000|NOT COMPLETED|Overall Study||4
8684308|NCT00815516|9728500|FG001|NOT COMPLETED|Overall Study||1
8684309|NCT00815659|9728506|FG000|STARTED|Overall Study||97
8684310|NCT00815659|9728506|FG000|COMPLETED|Overall Study||74
8684311|NCT00815659|9728506|FG000|NOT COMPLETED|Overall Study||23
8684312|NCT00815685|9728510|FG000|STARTED|Overall Study||36
8684313|NCT00815685|9728510|FG000|COMPLETED|Overall Study|Complete pre and post-treatment serum samples were available for 14 participants.|14
8684314|NCT00815685|9728510|FG000|NOT COMPLETED|Overall Study||22
8684315|NCT00815698|9728516|FG000|STARTED|Overall Study||163
8684316|NCT00815698|9728517|FG001|STARTED|Overall Study||171
8684317|NCT00815698|9728516|FG000|COMPLETED|Overall Study||163
8684318|NCT00815698|9728517|FG001|COMPLETED|Overall Study||171
8684319|NCT00815698|9728516|FG000|NOT COMPLETED|Overall Study||0
8684320|NCT00815698|9728517|FG001|NOT COMPLETED|Overall Study||0
8684321|NCT00815776|9728526|FG000|STARTED|Overall Study||60
8684322|NCT00815776|9728527|FG001|STARTED|Overall Study||64
8684323|NCT00815776|9728528|FG002|STARTED|Overall Study||28
8684324|NCT00815776|9728526|FG000|COMPLETED|Overall Study||52
8684325|NCT00815776|9728527|FG001|COMPLETED|Overall Study||56
8684326|NCT00815776|9728528|FG002|COMPLETED|Overall Study||22
8684327|NCT00815776|9728526|FG000|NOT COMPLETED|Overall Study||8
8684328|NCT00815776|9728527|FG001|NOT COMPLETED|Overall Study||8
8684329|NCT00815776|9728528|FG002|NOT COMPLETED|Overall Study||6
8684330|NCT00815919|9728539|FG000|STARTED|Overall Study||22
8684331|NCT00815919|9728539|FG000|COMPLETED|Overall Study||18
8684332|NCT00815919|9728539|FG000|NOT COMPLETED|Overall Study||4
8684333|NCT00815997|9728545|FG000|STARTED|Overall Study||80
8684334|NCT00815997|9728546|FG001|STARTED|Overall Study||80
8684335|NCT00815997|9728545|FG000|COMPLETED|Overall Study||80
8684336|NCT00815997|9728546|FG001|COMPLETED|Overall Study||80
8684337|NCT00815997|9728545|FG000|NOT COMPLETED|Overall Study||0
8684338|NCT00815997|9728546|FG001|NOT COMPLETED|Overall Study||0
8684339|NCT00816023|9728558|FG000|STARTED|Overall Study||71
8684340|NCT00816023|9728559|FG001|STARTED|Overall Study||62
8684341|NCT00816023|9728560|FG002|STARTED|Overall Study||69
8684342|NCT00816023|9728561|FG003|STARTED|Overall Study||74
8684343|NCT00816023|9728558|FG000|Completed Therapy|Overall Study||65
8684344|NCT00816023|9728559|FG001|Completed Therapy|Overall Study||59
8684345|NCT00816023|9728560|FG002|Completed Therapy|Overall Study||61
8684346|NCT00816023|9728561|FG003|Completed Therapy|Overall Study||63
8684347|NCT00816023|9728558|FG000|COMPLETED|Overall Study||62
8684348|NCT00816023|9728559|FG001|COMPLETED|Overall Study||56
8684349|NCT00816023|9728560|FG002|COMPLETED|Overall Study||60
8684350|NCT00816023|9728561|FG003|COMPLETED|Overall Study||62
8684351|NCT00816023|9728558|FG000|NOT COMPLETED|Overall Study||9
8684352|NCT00816023|9728559|FG001|NOT COMPLETED|Overall Study||6
8684353|NCT00816023|9728560|FG002|NOT COMPLETED|Overall Study||9
8684354|NCT00816023|9728561|FG003|NOT COMPLETED|Overall Study||12
8684355|NCT00816036|9728573|FG000|STARTED|Overall Study||503
8684356|NCT00816036|9728574|FG001|STARTED|Overall Study||395
8684357|NCT00816036|9728573|FG000|COMPLETED|Overall Study||327
8684358|NCT00816036|9728574|FG001|COMPLETED|Overall Study||287
8684359|NCT00816036|9728573|FG000|NOT COMPLETED|Overall Study||176
8684360|NCT00816036|9728574|FG001|NOT COMPLETED|Overall Study||108
8684361|NCT00816062|9728580|FG000|STARTED|Overall Study||260
8684362|NCT00816062|9728580|FG000|COMPLETED|Overall Study||133
8684363|NCT00816062|9728580|FG000|NOT COMPLETED|Overall Study||127
8684364|NCT00816101|9728588|FG000|STARTED|Overall Study||13
8684365|NCT00816101|9728589|FG001|STARTED|Overall Study||8
8684366|NCT00816101|9728590|FG002|STARTED|Overall Study||5
8684367|NCT00816101|9728588|FG000|COMPLETED|Overall Study||13
8684368|NCT00816101|9728589|FG001|COMPLETED|Overall Study||8
8684369|NCT00816101|9728590|FG002|COMPLETED|Overall Study||5
8684370|NCT00816101|9728588|FG000|NOT COMPLETED|Overall Study||0
8684371|NCT00816101|9728589|FG001|NOT COMPLETED|Overall Study||0
8684372|NCT00816101|9728590|FG002|NOT COMPLETED|Overall Study||0
8684373|NCT00816166|9728600|FG000|STARTED|Overall Study|Of 59 randomized to Stent Arm, 4 were treated with Medical Therapy Only|59
8684374|NCT00816166|9728601|FG001|STARTED|Overall Study|Of 53 randomized to Medical Therapy Arm, 9 were treated with Stent+Medical Therapy|53
8801102|NCT01448824|9852874|FG001|STARTED|Part 2 Period 2: Drug-drug Interaction||0
8801103|NCT01448824|9852875|FG002|STARTED|Part 2 Period 2: Drug-drug Interaction||0
8801104|NCT01448824|9852876|FG003|STARTED|Part 2 Period 2: Drug-drug Interaction||0
8801105|NCT01448824|9852877|FG004|STARTED|Part 2 Period 2: Drug-drug Interaction||0
8801106|NCT01448824|9852878|FG005|STARTED|Part 2 Period 2: Drug-drug Interaction||0
8801107|NCT01448824|9852879|FG006|STARTED|Part 2 Period 2: Drug-drug Interaction||0
8801108|NCT01448824|9852880|FG007|STARTED|Part 2 Period 2: Drug-drug Interaction||11
8801109|NCT01448824|9852873|FG000|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
8801110|NCT01448824|9852874|FG001|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
8801111|NCT01448824|9852875|FG002|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
8801112|NCT01448824|9852876|FG003|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
8919367|NCT02207244|9979298|FG008|STARTED|Withdrawal and Re-treatment: Week 28-72||220
8919368|NCT02207244|9979299|FG009|STARTED|Withdrawal and Re-treatment: Week 28-72||8
8919369|NCT02207244|9979300|FG010|STARTED|Withdrawal and Re-treatment: Week 28-72||0
8919370|NCT02207244|9979290|FG000|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0
8919371|NCT02207244|9979291|FG001|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0
8919372|NCT02207244|9979292|FG002|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0
9035707|NCT03301714|10097429|FG000|COMPLETED|Overall Study||50
8684375|NCT00816166|9728600|FG000|ITT Population (Met Eligibility)|Overall Study|Of 59 randomized to Stent Arm, 1 subject failed to meet eligibility and was excluded from the ITT|58
8684376|NCT00816166|9728601|FG001|ITT Population (Met Eligibility)|Overall Study||53
8684377|NCT00816166|9728600|FG000|COMPLETED|Overall Study||49
8684378|NCT00816166|9728601|FG001|COMPLETED|Overall Study||41
8684379|NCT00816166|9728600|FG000|NOT COMPLETED|Overall Study||10
8684380|NCT00816166|9728601|FG001|NOT COMPLETED|Overall Study||12
8684381|NCT00816348|9728607|FG000|STARTED|Overall Study||15
8684382|NCT00816348|9728607|FG000|COMPLETED|Overall Study||15
8684383|NCT00816348|9728607|FG000|NOT COMPLETED|Overall Study||0
8684384|NCT00816361|9728618|FG000|STARTED|Overall Study||4
8684385|NCT00816361|9728619|FG001|STARTED|Overall Study||3
8684386|NCT00816361|9728620|FG002|STARTED|Overall Study||4
8684387|NCT00816361|9728621|FG003|STARTED|Overall Study||3
8684388|NCT00816361|9728622|FG004|STARTED|Overall Study||3
8684389|NCT00816361|9728623|FG005|STARTED|Overall Study||3
8684390|NCT00816361|9728624|FG006|STARTED|Overall Study||3
8684391|NCT00816361|9728625|FG007|STARTED|Overall Study||10
8684392|NCT00816361|9728626|FG008|STARTED|Overall Study||10
8684393|NCT00816361|9728618|FG000|COMPLETED|Overall Study||0
8684394|NCT00816361|9728619|FG001|COMPLETED|Overall Study||0
8684395|NCT00816361|9728620|FG002|COMPLETED|Overall Study||1
8684396|NCT00816361|9728621|FG003|COMPLETED|Overall Study||0
8684397|NCT00816361|9728622|FG004|COMPLETED|Overall Study||1
8684398|NCT00816361|9728623|FG005|COMPLETED|Overall Study||0
8684399|NCT00816361|9728624|FG006|COMPLETED|Overall Study||0
8684400|NCT00816361|9728625|FG007|COMPLETED|Overall Study||1
8684401|NCT00816361|9728626|FG008|COMPLETED|Overall Study||0
8684402|NCT00816361|9728618|FG000|NOT COMPLETED|Overall Study||4
8684403|NCT00816361|9728619|FG001|NOT COMPLETED|Overall Study||3
8684404|NCT00816361|9728620|FG002|NOT COMPLETED|Overall Study||3
8684405|NCT00816361|9728621|FG003|NOT COMPLETED|Overall Study||3
8684406|NCT00816361|9728622|FG004|NOT COMPLETED|Overall Study||2
8684407|NCT00816361|9728623|FG005|NOT COMPLETED|Overall Study||3
8684408|NCT00816361|9728624|FG006|NOT COMPLETED|Overall Study||3
8684409|NCT00816361|9728625|FG007|NOT COMPLETED|Overall Study||9
8684410|NCT00816361|9728626|FG008|NOT COMPLETED|Overall Study||10
8684411|NCT00816400|9728656|FG000|STARTED|Overall Study||3
8684412|NCT00816400|9728657|FG001|STARTED|Overall Study||3
8684413|NCT00816400|9728658|FG002|STARTED|Overall Study||5
8684414|NCT00816400|9728659|FG003|STARTED|Overall Study||3
8684415|NCT00816400|9728660|FG004|STARTED|Overall Study||3
8684416|NCT00816400|9728661|FG005|STARTED|Overall Study||3
8684417|NCT00816400|9728662|FG006|STARTED|Overall Study||3
8684418|NCT00816400|9728663|FG007|STARTED|Overall Study||6
8684419|NCT00816400|9728664|FG008|STARTED|Overall Study||6
8684420|NCT00816400|9728656|FG000|COMPLETED|Overall Study||1
8684421|NCT00816400|9728657|FG001|COMPLETED|Overall Study||0
8684422|NCT00816400|9728658|FG002|COMPLETED|Overall Study||0
8684423|NCT00816400|9728659|FG003|COMPLETED|Overall Study||0
8684424|NCT00816400|9728660|FG004|COMPLETED|Overall Study||1
8684425|NCT00816400|9728661|FG005|COMPLETED|Overall Study||0
8684426|NCT00816400|9728662|FG006|COMPLETED|Overall Study||1
8684427|NCT00816400|9728663|FG007|COMPLETED|Overall Study||1
8684428|NCT00816400|9728664|FG008|COMPLETED|Overall Study||0
8684429|NCT00816400|9728656|FG000|NOT COMPLETED|Overall Study||2
8684430|NCT00816400|9728657|FG001|NOT COMPLETED|Overall Study||3
8684431|NCT00816400|9728658|FG002|NOT COMPLETED|Overall Study||5
8684432|NCT00816400|9728659|FG003|NOT COMPLETED|Overall Study||3
8684433|NCT00816400|9728660|FG004|NOT COMPLETED|Overall Study||2
8684434|NCT00816400|9728661|FG005|NOT COMPLETED|Overall Study||3
8684435|NCT00816400|9728662|FG006|NOT COMPLETED|Overall Study||2
8684436|NCT00816400|9728663|FG007|NOT COMPLETED|Overall Study||5
8684437|NCT00816400|9728664|FG008|NOT COMPLETED|Overall Study||6
8684438|NCT00816556|9728688|FG000|STARTED|Overall Study||20
8684439|NCT00816556|9728689|FG001|STARTED|Overall Study||21
8684440|NCT00816556|9728690|FG002|STARTED|Overall Study||22
8684441|NCT00816556|9728688|FG000|COMPLETED|Overall Study||18
8684442|NCT00816556|9728689|FG001|COMPLETED|Overall Study||19
8684443|NCT00816556|9728690|FG002|COMPLETED|Overall Study||19
8684444|NCT00816556|9728688|FG000|NOT COMPLETED|Overall Study||2
8684445|NCT00816556|9728689|FG001|NOT COMPLETED|Overall Study||2
8684446|NCT00816556|9728690|FG002|NOT COMPLETED|Overall Study||3
8684447|NCT00816595|9728700|FG000|STARTED|Overall Study||35
8684448|NCT00816595|9728701|FG001|STARTED|Overall Study||33
8684449|NCT00816595|9728700|FG000|COMPLETED|Overall Study||33
8684450|NCT00816595|9728701|FG001|COMPLETED|Overall Study||33
8684451|NCT00816595|9728700|FG000|NOT COMPLETED|Overall Study||2
8684452|NCT00816595|9728701|FG001|NOT COMPLETED|Overall Study||0
8684453|NCT00816751|9728711|FG000|STARTED|Overall Study||45
8684454|NCT00816751|9728712|FG001|STARTED|Overall Study||44
8684455|NCT00816751|9728711|FG000|COMPLETED|Overall Study||45
8684456|NCT00816751|9728712|FG001|COMPLETED|Overall Study||44
8684457|NCT00816751|9728711|FG000|NOT COMPLETED|Overall Study||0
8684458|NCT00816751|9728712|FG001|NOT COMPLETED|Overall Study||0
8684459|NCT00816829|9728720|FG000|STARTED|Overall Study||16
8684460|NCT00816829|9728721|FG001|STARTED|Overall Study||18
8684461|NCT00816829|9728720|FG000|COMPLETED|Overall Study||16
8684462|NCT00816829|9728721|FG001|COMPLETED|Overall Study||18
8684463|NCT00816829|9728720|FG000|NOT COMPLETED|Overall Study||0
8684464|NCT00816829|9728721|FG001|NOT COMPLETED|Overall Study||0
8684465|NCT00816907|9728729|FG000|STARTED|Overall Study||71
8684466|NCT00816907|9728730|FG001|STARTED|Overall Study||75
8684467|NCT00816907|9728729|FG000|COMPLETED|Overall Study||58
8684468|NCT00816907|9728730|FG001|COMPLETED|Overall Study||58
8684469|NCT00816907|9728729|FG000|NOT COMPLETED|Overall Study||13
8684470|NCT00816907|9728730|FG001|NOT COMPLETED|Overall Study||17
8684471|NCT00817063|9728740|FG000|STARTED|Overall Study||298
8684472|NCT00817063|9728741|FG001|STARTED|Overall Study||298
8684473|NCT00817063|9728740|FG000|COMPLETED|Overall Study||161
8684474|NCT00817063|9728741|FG001|COMPLETED|Overall Study||128
8684475|NCT00817063|9728740|FG000|NOT COMPLETED|Overall Study||137
8684476|NCT00817063|9728741|FG001|NOT COMPLETED|Overall Study||170
8684477|NCT00817089|9728751|FG000|STARTED|First Alcohol Challenge||6
8684478|NCT00817089|9728752|FG001|STARTED|First Alcohol Challenge||8
8684479|NCT00817089|9728753|FG002|STARTED|First Alcohol Challenge||4
8684480|NCT00817089|9728754|FG003|STARTED|First Alcohol Challenge||6
8684481|NCT00817089|9728751|FG000|COMPLETED|First Alcohol Challenge||6
8684482|NCT00817089|9728752|FG001|COMPLETED|First Alcohol Challenge||8
8684483|NCT00817089|9728753|FG002|COMPLETED|First Alcohol Challenge||4
8684484|NCT00817089|9728754|FG003|COMPLETED|First Alcohol Challenge||5
8684485|NCT00817089|9728751|FG000|NOT COMPLETED|First Alcohol Challenge||0
8684486|NCT00817089|9728752|FG001|NOT COMPLETED|First Alcohol Challenge||0
8684487|NCT00817089|9728753|FG002|NOT COMPLETED|First Alcohol Challenge||0
8684488|NCT00817089|9728754|FG003|NOT COMPLETED|First Alcohol Challenge||1
8684489|NCT00817089|9728751|FG000|STARTED|Second Alcohol Challenge||6
8684490|NCT00817089|9728752|FG001|STARTED|Second Alcohol Challenge||8
8684491|NCT00817089|9728753|FG002|STARTED|Second Alcohol Challenge||4
8684492|NCT00817089|9728754|FG003|STARTED|Second Alcohol Challenge||5
8684493|NCT00817089|9728751|FG000|COMPLETED|Second Alcohol Challenge||6
8684494|NCT00817089|9728752|FG001|COMPLETED|Second Alcohol Challenge||7
8684495|NCT00817089|9728753|FG002|COMPLETED|Second Alcohol Challenge||4
8684496|NCT00817089|9728754|FG003|COMPLETED|Second Alcohol Challenge||5
8684497|NCT00817089|9728751|FG000|NOT COMPLETED|Second Alcohol Challenge||0
8684498|NCT00817089|9728752|FG001|NOT COMPLETED|Second Alcohol Challenge||1
8684499|NCT00817089|9728753|FG002|NOT COMPLETED|Second Alcohol Challenge||0
8684500|NCT00817089|9728754|FG003|NOT COMPLETED|Second Alcohol Challenge||0
8684501|NCT00817206|9728770|FG000|STARTED|Overall Study||163
8684502|NCT00817206|9728771|FG001|STARTED|Overall Study||163
8684503|NCT00817206|9728770|FG000|COMPLETED|Overall Study||142
8684504|NCT00817206|9728771|FG001|COMPLETED|Overall Study||154
8684505|NCT00817206|9728770|FG000|NOT COMPLETED|Overall Study||21
8684506|NCT00817206|9728771|FG001|NOT COMPLETED|Overall Study||9
8684507|NCT00817219|9728777|FG000|STARTED|Overall Study||33
8684508|NCT00817219|9728777|FG000|COMPLETED|Overall Study||33
8684509|NCT00817219|9728777|FG000|NOT COMPLETED|Overall Study||0
8684510|NCT00817336|9728783|FG000|STARTED|Overall Study||8
8684511|NCT00817336|9728784|FG001|STARTED|Overall Study||8
8684512|NCT00817336|9728783|FG000|COMPLETED|Overall Study||7
8684513|NCT00817336|9728784|FG001|COMPLETED|Overall Study||7
8684514|NCT00817336|9728783|FG000|NOT COMPLETED|Overall Study||1
8684515|NCT00817336|9728784|FG001|NOT COMPLETED|Overall Study||1
8684516|NCT00817414|9728794|FG000|STARTED|Overall Study||12
8684517|NCT00817414|9728795|FG001|STARTED|Overall Study||12
8684518|NCT00817414|9728796|FG002|STARTED|Overall Study||13
8684519|NCT00817414|9728797|FG003|STARTED|Overall Study||13
8684520|NCT00817414|9728798|FG004|STARTED|Overall Study||13
8684521|NCT00817414|9728794|FG000|COMPLETED|Overall Study||10
8684522|NCT00817414|9728795|FG001|COMPLETED|Overall Study||9
8684523|NCT00817414|9728796|FG002|COMPLETED|Overall Study||9
8684524|NCT00817414|9728797|FG003|COMPLETED|Overall Study||1
8684525|NCT00817414|9728798|FG004|COMPLETED|Overall Study||11
8684526|NCT00817414|9728794|FG000|NOT COMPLETED|Overall Study||2
8684527|NCT00817414|9728795|FG001|NOT COMPLETED|Overall Study||3
8684528|NCT00817414|9728796|FG002|NOT COMPLETED|Overall Study||4
8684529|NCT00817414|9728797|FG003|NOT COMPLETED|Overall Study||12
8684530|NCT00817414|9728798|FG004|NOT COMPLETED|Overall Study||2
8684531|NCT00817479|9728817|FG000|STARTED|Overall Study||6
8684532|NCT00817479|9728818|FG001|STARTED|Overall Study||14
8684533|NCT00817479|9728817|FG000|COMPLETED|Overall Study||5
8684534|NCT00817479|9728818|FG001|COMPLETED|Overall Study||13
8684535|NCT00817479|9728817|FG000|NOT COMPLETED|Overall Study||1
8684536|NCT00817479|9728818|FG001|NOT COMPLETED|Overall Study||1
8684537|NCT00817531|9728824|FG000|STARTED|Overall Study|22 patients were eligible for this study and started the treatment.|22
8684538|NCT00817531|9728824|FG000|COMPLETED|Overall Study|20 out of 22 patients finished study treatment. 2 patients stopped the treatment after the 1st week.|20
8684539|NCT00817531|9728824|FG000|NOT COMPLETED|Overall Study||2
8684540|NCT00817596|9728828|FG000|STARTED|Overall Study||110
8684541|NCT00817596|9728828|FG000|COMPLETED|Overall Study||62
8684542|NCT00817596|9728828|FG000|NOT COMPLETED|Overall Study||48
8684543|NCT00817635|9728837|FG000|STARTED|Overall Study||32
8684544|NCT00817635|9728838|FG001|STARTED|Overall Study||26
8684545|NCT00817635|9728839|FG002|STARTED|Overall Study||31
8684546|NCT00817635|9728840|FG003|STARTED|Overall Study||33
8684547|NCT00817635|9728841|FG004|STARTED|Overall Study||33
8684548|NCT00817635|9728837|FG000|COMPLETED|Overall Study||23
8684549|NCT00817635|9728838|FG001|COMPLETED|Overall Study||22
8684550|NCT00817635|9728839|FG002|COMPLETED|Overall Study||28
8684551|NCT00817635|9728840|FG003|COMPLETED|Overall Study||28
8684552|NCT00817635|9728841|FG004|COMPLETED|Overall Study||25
8684553|NCT00817635|9728837|FG000|NOT COMPLETED|Overall Study||9
8684554|NCT00817635|9728838|FG001|NOT COMPLETED|Overall Study||4
8684555|NCT00817635|9728839|FG002|NOT COMPLETED|Overall Study||3
8684556|NCT00817635|9728840|FG003|NOT COMPLETED|Overall Study||5
8684557|NCT00817635|9728841|FG004|NOT COMPLETED|Overall Study||8
8684558|NCT00817778|9728862|FG000|STARTED|Overall Study||19
8684559|NCT00817778|9728863|FG001|STARTED|Overall Study||8
8684560|NCT00817778|9728862|FG000|COMPLETED|Overall Study||16
8684561|NCT00817778|9728863|FG001|COMPLETED|Overall Study||5
8684562|NCT00817778|9728862|FG000|NOT COMPLETED|Overall Study||3
8684563|NCT00817778|9728863|FG001|NOT COMPLETED|Overall Study||3
8684564|NCT00817804|9728871|FG000|STARTED|Overall Study||1
8684565|NCT00817804|9728872|FG001|STARTED|Overall Study||2
8684566|NCT00817804|9728871|FG000|COMPLETED|Overall Study||1
8684567|NCT00817804|9728872|FG001|COMPLETED|Overall Study||2
8684568|NCT00817804|9728871|FG000|NOT COMPLETED|Overall Study||0
8684569|NCT00817804|9728872|FG001|NOT COMPLETED|Overall Study||0
8684570|NCT00817843|9728878|FG000|STARTED|First Period (6 Weeks)||50
8684571|NCT00817843|9728879|FG001|STARTED|First Period (6 Weeks)||50
8801113|NCT01448824|9852877|FG004|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
8801114|NCT01448824|9852878|FG005|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
8801115|NCT01448824|9852879|FG006|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
8801116|NCT01448824|9852880|FG007|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||11
8801117|NCT01448824|9852873|FG000|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
8801118|NCT01448824|9852874|FG001|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
8801119|NCT01448824|9852875|FG002|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
8801120|NCT01448824|9852876|FG003|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
8801121|NCT01448824|9852877|FG004|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
8801122|NCT01448824|9852878|FG005|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
8801123|NCT01448824|9852879|FG006|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
8801124|NCT01448824|9852880|FG007|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||10
8801125|NCT01448824|9852873|FG000|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
8801126|NCT01448824|9852874|FG001|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
8801127|NCT01448824|9852875|FG002|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
8801128|NCT01448824|9852876|FG003|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
8801129|NCT01448824|9852877|FG004|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
8801130|NCT01448824|9852878|FG005|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
8801131|NCT01448824|9852879|FG006|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
8801132|NCT01448824|9852880|FG007|COMPLETED|Part 2 Period 2: Drug-drug Interaction||8
8801133|NCT01448824|9852873|FG000|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
8801134|NCT01448824|9852874|FG001|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
8801135|NCT01448824|9852875|FG002|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
8801136|NCT01448824|9852876|FG003|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
8801137|NCT01448824|9852877|FG004|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
8801138|NCT01448824|9852878|FG005|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
8801139|NCT01448824|9852879|FG006|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
8801140|NCT01448824|9852880|FG007|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||3
8801141|NCT01448850|9852910|FG000|STARTED|Overall Study||164
8801142|NCT01448850|9852911|FG001|STARTED|Overall Study||160
8801143|NCT01448850|9852910|FG000|COMPLETED|Overall Study||130
8801144|NCT01448850|9852911|FG001|COMPLETED|Overall Study||120
8801145|NCT01448850|9852910|FG000|NOT COMPLETED|Overall Study||34
8801146|NCT01448850|9852911|FG001|NOT COMPLETED|Overall Study||40
8801147|NCT01449006|9852920|FG000|STARTED|Overall Study||8
8801148|NCT01449006|9852921|FG001|STARTED|Overall Study||9
8801149|NCT01449006|9852920|FG000|COMPLETED|Overall Study||5
8801150|NCT01449006|9852921|FG001|COMPLETED|Overall Study||9
8801151|NCT01449006|9852920|FG000|NOT COMPLETED|Overall Study||3
8801152|NCT01449006|9852921|FG001|NOT COMPLETED|Overall Study||0
8801153|NCT01449240|9852927|FG000|STARTED|Overall Study||10
8801154|NCT01449240|9852927|FG000|COMPLETED|Overall Study||10
8801155|NCT01449240|9852927|FG000|NOT COMPLETED|Overall Study||0
8801156|NCT01449266|9852931|FG000|STARTED|Overall Study||10
8801157|NCT01449266|9852931|FG000|COMPLETED|Overall Study||10
8801158|NCT01449266|9852931|FG000|NOT COMPLETED|Overall Study||0
8801159|NCT01449279|9852935|FG000|STARTED|Overall Study||22
8801160|NCT01449279|9852935|FG000|COMPLETED|Overall Study||15
8801161|NCT01449279|9852935|FG000|NOT COMPLETED|Overall Study||7
8801162|NCT01449305|9852939|FG000|STARTED|Overall Study||44
8801163|NCT01449305|9852939|FG000|COMPLETED|Overall Study||42
8801164|NCT01449305|9852939|FG000|NOT COMPLETED|Overall Study||2
8801165|NCT01449370|9852968|FG000|STARTED|Overall Study||6
8801166|NCT01449370|9852969|FG001|STARTED|Overall Study||6
8801167|NCT01449370|9852970|FG002|STARTED|Overall Study||8
8801168|NCT01449370|9852971|FG003|STARTED|Overall Study||4
8801169|NCT01449370|9852972|FG004|STARTED|Overall Study||3
8801170|NCT01449370|9852973|FG005|STARTED|Overall Study||3
8801171|NCT01449370|9852974|FG006|STARTED|Overall Study||3
8801172|NCT01449370|9852975|FG007|STARTED|Overall Study||3
8801173|NCT01449370|9852976|FG008|STARTED|Overall Study||12
8801174|NCT01449370|9852977|FG009|STARTED|Overall Study||3
8801175|NCT01449370|9852978|FG010|STARTED|Overall Study||3
8801176|NCT01449370|9852979|FG011|STARTED|Overall Study||3
8801177|NCT01449370|9852980|FG012|STARTED|Overall Study||3
8801178|NCT01449370|9852981|FG013|STARTED|Overall Study||11
8801179|NCT01449370|9852982|FG014|STARTED|Overall Study||3
8801180|NCT01449370|9852983|FG015|STARTED|Overall Study||3
8801181|NCT01449370|9852984|FG016|STARTED|Overall Study||7
8801182|NCT01449370|9852985|FG017|STARTED|Overall Study||3
8801183|NCT01449370|9852986|FG018|STARTED|Overall Study||3
8801184|NCT01449370|9852987|FG019|STARTED|Overall Study||3
8801185|NCT01449370|9852988|FG020|STARTED|Overall Study||6
8684572|NCT00817843|9728878|FG000|COMPLETED|First Period (6 Weeks)|All patients with >=1 postrandomization dose and measurement were analyzed|42
8684573|NCT00817843|9728879|FG001|COMPLETED|First Period (6 Weeks)||46
8684574|NCT00817843|9728878|FG000|NOT COMPLETED|First Period (6 Weeks)||8
8684575|NCT00817843|9728879|FG001|NOT COMPLETED|First Period (6 Weeks)||4
8684576|NCT00817843|9728878|FG000|STARTED|Washout Period (6 Weeks)||42
8684577|NCT00817843|9728879|FG001|STARTED|Washout Period (6 Weeks)||46
8684578|NCT00817843|9728878|FG000|COMPLETED|Washout Period (6 Weeks)||41
8684579|NCT00817843|9728879|FG001|COMPLETED|Washout Period (6 Weeks)||45
8684580|NCT00817843|9728878|FG000|NOT COMPLETED|Washout Period (6 Weeks)||1
8684581|NCT00817843|9728879|FG001|NOT COMPLETED|Washout Period (6 Weeks)||1
8684582|NCT00817843|9728878|FG000|STARTED|Second Period (6 Weeks)||41
8684583|NCT00817843|9728879|FG001|STARTED|Second Period (6 Weeks)||45
8684584|NCT00817843|9728878|FG000|COMPLETED|Second Period (6 Weeks)|All patients with >=1 postrandomization dose and measurement were analyzed|41
8684585|NCT00817843|9728879|FG001|COMPLETED|Second Period (6 Weeks)||44
8684586|NCT00817843|9728878|FG000|NOT COMPLETED|Second Period (6 Weeks)||0
8684587|NCT00817843|9728879|FG001|NOT COMPLETED|Second Period (6 Weeks)||1
8684588|NCT00817999|9728886|FG000|STARTED|Grapefruit Juice||15
8684589|NCT00817999|9728887|FG001|STARTED|Grapefruit Juice||17
8684590|NCT00817999|9728886|FG000|COMPLETED|Grapefruit Juice||15
8684591|NCT00817999|9728887|FG001|COMPLETED|Grapefruit Juice||17
8684592|NCT00817999|9728886|FG000|NOT COMPLETED|Grapefruit Juice||0
8684593|NCT00817999|9728887|FG001|NOT COMPLETED|Grapefruit Juice||0
8684594|NCT00817999|9728886|FG000|STARTED|No Grapefruit Juice||15
8684595|NCT00817999|9728887|FG001|STARTED|No Grapefruit Juice||17
8684596|NCT00817999|9728886|FG000|COMPLETED|No Grapefruit Juice||15
8684597|NCT00817999|9728887|FG001|COMPLETED|No Grapefruit Juice||17
8684598|NCT00817999|9728886|FG000|NOT COMPLETED|No Grapefruit Juice||0
8684599|NCT00817999|9728887|FG001|NOT COMPLETED|No Grapefruit Juice||0
8684600|NCT00818116|9728895|FG000|STARTED|Overall Study||34
8684601|NCT00818116|9728895|FG000|COMPLETED|Overall Study||34
8684602|NCT00818116|9728895|FG000|NOT COMPLETED|Overall Study||0
8684603|NCT00818168|9728899|FG000|STARTED|Overall Study||320
8684604|NCT00818168|9728899|FG000|COMPLETED|Overall Study|Includes 78 participants whose completer/non-completer status was not reported (missing)|250
8684605|NCT00818168|9728899|FG000|NOT COMPLETED|Overall Study||70
8684606|NCT00818207|9728905|FG000|STARTED|Overall Study||696
8684607|NCT00818207|9728906|FG001|STARTED|Overall Study||684
8684608|NCT00818207|9728905|FG000|COMPLETED|Overall Study||474
8684609|NCT00818207|9728906|FG001|COMPLETED|Overall Study||417
8684610|NCT00818207|9728905|FG000|NOT COMPLETED|Overall Study||222
8684611|NCT00818207|9728906|FG001|NOT COMPLETED|Overall Study||267
8684612|NCT00818246|9728912|FG000|STARTED|Overall Study||40
8684613|NCT00818246|9728912|FG000|COMPLETED|Overall Study|split-face study|35
8684614|NCT00818246|9728912|FG000|NOT COMPLETED|Overall Study||5
8684615|NCT00818259|9728923|FG000|STARTED|Randomization||12
8684616|NCT00818259|9728924|FG001|STARTED|Randomization||11
8684617|NCT00818259|9728925|FG002|STARTED|Randomization||19
8684618|NCT00818259|9728926|FG003|STARTED|Randomization||20
8684619|NCT00818259|9728927|FG004|STARTED|Randomization||19
8684620|NCT00818259|9728928|FG005|STARTED|Randomization||0
8684621|NCT00818259|9728929|FG006|STARTED|Randomization||5
8684622|NCT00818259|9728930|FG007|STARTED|Randomization||0
8684623|NCT00818259|9728931|FG008|STARTED|Randomization||6
8684624|NCT00818259|9728923|FG000|COMPLETED|Randomization||12
8684625|NCT00818259|9728924|FG001|COMPLETED|Randomization||11
8684626|NCT00818259|9728925|FG002|COMPLETED|Randomization||19
8684627|NCT00818259|9728926|FG003|COMPLETED|Randomization||20
8684628|NCT00818259|9728927|FG004|COMPLETED|Randomization||19
8684629|NCT00818259|9728928|FG005|COMPLETED|Randomization||0
8684630|NCT00818259|9728929|FG006|COMPLETED|Randomization||5
8684631|NCT00818259|9728930|FG007|COMPLETED|Randomization||0
8684632|NCT00818259|9728931|FG008|COMPLETED|Randomization||6
8684633|NCT00818259|9728923|FG000|NOT COMPLETED|Randomization||0
8684634|NCT00818259|9728924|FG001|NOT COMPLETED|Randomization||0
8684635|NCT00818259|9728925|FG002|NOT COMPLETED|Randomization||0
8684636|NCT00818259|9728926|FG003|NOT COMPLETED|Randomization||0
8684637|NCT00818259|9728927|FG004|NOT COMPLETED|Randomization||0
8684638|NCT00818259|9728928|FG005|NOT COMPLETED|Randomization||0
8684639|NCT00818259|9728929|FG006|NOT COMPLETED|Randomization||0
8684640|NCT00818259|9728930|FG007|NOT COMPLETED|Randomization||0
8684641|NCT00818259|9728931|FG008|NOT COMPLETED|Randomization||0
8684642|NCT00818259|9728923|FG000|STARTED|Part I|Newly enrolled participants|12
8684643|NCT00818259|9728924|FG001|STARTED|Part I|Newly enrolled participants|11
8684644|NCT00818259|9728925|FG002|STARTED|Part I||0
8684645|NCT00818259|9728926|FG003|STARTED|Part I||0
8684646|NCT00818259|9728927|FG004|STARTED|Part I||0
8684647|NCT00818259|9728928|FG005|STARTED|Part I||0
8684648|NCT00818259|9728929|FG006|STARTED|Part I||0
8684649|NCT00818259|9728930|FG007|STARTED|Part I||0
8684650|NCT00818259|9728931|FG008|STARTED|Part I||0
8684651|NCT00818259|9728923|FG000|COMPLETED|Part I||11
8684652|NCT00818259|9728924|FG001|COMPLETED|Part I||11
8684653|NCT00818259|9728925|FG002|COMPLETED|Part I||0
8684654|NCT00818259|9728926|FG003|COMPLETED|Part I||0
8684655|NCT00818259|9728927|FG004|COMPLETED|Part I||0
8684656|NCT00818259|9728928|FG005|COMPLETED|Part I||0
8684657|NCT00818259|9728929|FG006|COMPLETED|Part I||0
8684658|NCT00818259|9728930|FG007|COMPLETED|Part I||0
8684659|NCT00818259|9728931|FG008|COMPLETED|Part I||0
8684660|NCT00818259|9728923|FG000|NOT COMPLETED|Part I||1
8684661|NCT00818259|9728924|FG001|NOT COMPLETED|Part I||0
8684662|NCT00818259|9728925|FG002|NOT COMPLETED|Part I||0
8684663|NCT00818259|9728926|FG003|NOT COMPLETED|Part I||0
8684664|NCT00818259|9728927|FG004|NOT COMPLETED|Part I||0
8684665|NCT00818259|9728928|FG005|NOT COMPLETED|Part I||0
8684666|NCT00818259|9728929|FG006|NOT COMPLETED|Part I||0
8684667|NCT00818259|9728930|FG007|NOT COMPLETED|Part I||0
8684668|NCT00818259|9728931|FG008|NOT COMPLETED|Part I||0
8684669|NCT00818259|9728923|FG000|STARTED|Part II||0
8684670|NCT00818259|9728924|FG001|STARTED|Part II||0
8684671|NCT00818259|9728925|FG002|STARTED|Part II|Newly enrolled participants|19
8684672|NCT00818259|9728926|FG003|STARTED|Part II|Newly enrolled participants|20
8684673|NCT00818259|9728927|FG004|STARTED|Part II||0
8684674|NCT00818259|9728928|FG005|STARTED|Part II||0
8684675|NCT00818259|9728929|FG006|STARTED|Part II||0
8684676|NCT00818259|9728930|FG007|STARTED|Part II||0
8684677|NCT00818259|9728931|FG008|STARTED|Part II||0
8684678|NCT00818259|9728923|FG000|Treated|Part II||0
8684679|NCT00818259|9728924|FG001|Treated|Part II||0
8684680|NCT00818259|9728925|FG002|Treated|Part II||19
8684681|NCT00818259|9728926|FG003|Treated|Part II||19
8684682|NCT00818259|9728927|FG004|Treated|Part II||0
8684683|NCT00818259|9728928|FG005|Treated|Part II||0
8684684|NCT00818259|9728929|FG006|Treated|Part II||0
8684685|NCT00818259|9728930|FG007|Treated|Part II||0
8684686|NCT00818259|9728931|FG008|Treated|Part II||0
8684687|NCT00818259|9728923|FG000|COMPLETED|Part II||0
8684688|NCT00818259|9728924|FG001|COMPLETED|Part II||0
8684689|NCT00818259|9728925|FG002|COMPLETED|Part II||18
8684690|NCT00818259|9728926|FG003|COMPLETED|Part II||18
8684691|NCT00818259|9728927|FG004|COMPLETED|Part II||0
8684692|NCT00818259|9728928|FG005|COMPLETED|Part II||0
8684693|NCT00818259|9728929|FG006|COMPLETED|Part II||0
8684694|NCT00818259|9728930|FG007|COMPLETED|Part II||0
8684695|NCT00818259|9728931|FG008|COMPLETED|Part II||0
8684696|NCT00818259|9728923|FG000|NOT COMPLETED|Part II||0
8684697|NCT00818259|9728924|FG001|NOT COMPLETED|Part II||0
8684698|NCT00818259|9728925|FG002|NOT COMPLETED|Part II||1
8684699|NCT00818259|9728926|FG003|NOT COMPLETED|Part II||2
8684700|NCT00818259|9728927|FG004|NOT COMPLETED|Part II||0
8684701|NCT00818259|9728928|FG005|NOT COMPLETED|Part II||0
8684702|NCT00818259|9728929|FG006|NOT COMPLETED|Part II||0
8684703|NCT00818259|9728930|FG007|NOT COMPLETED|Part II||0
8684704|NCT00818259|9728931|FG008|NOT COMPLETED|Part II||0
8684705|NCT00818259|9728923|FG000|STARTED|Part III||0
8684706|NCT00818259|9728924|FG001|STARTED|Part III||0
8684707|NCT00818259|9728925|FG002|STARTED|Part III||0
8684708|NCT00818259|9728926|FG003|STARTED|Part III||0
8684709|NCT00818259|9728927|FG004|STARTED|Part III|Newly enrolled participants|19
8684710|NCT00818259|9728928|FG005|STARTED|Part III||0
8684711|NCT00818259|9728929|FG006|STARTED|Part III||0
8684712|NCT00818259|9728930|FG007|STARTED|Part III||0
8684713|NCT00818259|9728931|FG008|STARTED|Part III||0
8684714|NCT00818259|9728923|FG000|COMPLETED|Part III||0
8684715|NCT00818259|9728924|FG001|COMPLETED|Part III||0
8684716|NCT00818259|9728925|FG002|COMPLETED|Part III||0
8684717|NCT00818259|9728926|FG003|COMPLETED|Part III||0
8684718|NCT00818259|9728927|FG004|COMPLETED|Part III||19
8684719|NCT00818259|9728928|FG005|COMPLETED|Part III||0
8684720|NCT00818259|9728929|FG006|COMPLETED|Part III||0
8684721|NCT00818259|9728930|FG007|COMPLETED|Part III||0
8684722|NCT00818259|9728931|FG008|COMPLETED|Part III||0
8684723|NCT00818259|9728923|FG000|NOT COMPLETED|Part III||0
8684724|NCT00818259|9728924|FG001|NOT COMPLETED|Part III||0
8684725|NCT00818259|9728925|FG002|NOT COMPLETED|Part III||0
8684726|NCT00818259|9728926|FG003|NOT COMPLETED|Part III||0
8684727|NCT00818259|9728927|FG004|NOT COMPLETED|Part III||0
8684728|NCT00818259|9728928|FG005|NOT COMPLETED|Part III||0
8684729|NCT00818259|9728929|FG006|NOT COMPLETED|Part III||0
8684730|NCT00818259|9728930|FG007|NOT COMPLETED|Part III||0
8684731|NCT00818259|9728931|FG008|NOT COMPLETED|Part III||0
8684732|NCT00818259|9728923|FG000|STARTED|Part IV||0
8684733|NCT00818259|9728924|FG001|STARTED|Part IV||0
8684734|NCT00818259|9728925|FG002|STARTED|Part IV||0
8684735|NCT00818259|9728926|FG003|STARTED|Part IV||0
8684736|NCT00818259|9728927|FG004|STARTED|Part IV||0
8684737|NCT00818259|9728928|FG005|STARTED|Part IV|Participants continuing from Part III|15
8684738|NCT00818259|9728929|FG006|STARTED|Part IV|Newly enrolled participants|5
8684739|NCT00818259|9728930|FG007|STARTED|Part IV||0
8684740|NCT00818259|9728931|FG008|STARTED|Part IV||0
8684741|NCT00818259|9728923|FG000|COMPLETED|Part IV||0
8684742|NCT00818259|9728924|FG001|COMPLETED|Part IV||0
8684743|NCT00818259|9728925|FG002|COMPLETED|Part IV||0
8684744|NCT00818259|9728926|FG003|COMPLETED|Part IV||0
8684745|NCT00818259|9728927|FG004|COMPLETED|Part IV||0
8684746|NCT00818259|9728928|FG005|COMPLETED|Part IV||14
8684747|NCT00818259|9728929|FG006|COMPLETED|Part IV||5
8684748|NCT00818259|9728930|FG007|COMPLETED|Part IV||0
8684749|NCT00818259|9728931|FG008|COMPLETED|Part IV||0
8684750|NCT00818259|9728923|FG000|NOT COMPLETED|Part IV||0
8684751|NCT00818259|9728924|FG001|NOT COMPLETED|Part IV||0
8684752|NCT00818259|9728925|FG002|NOT COMPLETED|Part IV||0
8684753|NCT00818259|9728926|FG003|NOT COMPLETED|Part IV||0
8684754|NCT00818259|9728927|FG004|NOT COMPLETED|Part IV||0
8684755|NCT00818259|9728928|FG005|NOT COMPLETED|Part IV||1
8684756|NCT00818259|9728929|FG006|NOT COMPLETED|Part IV||0
8684757|NCT00818259|9728930|FG007|NOT COMPLETED|Part IV||0
8684758|NCT00818259|9728931|FG008|NOT COMPLETED|Part IV||0
8684759|NCT00818259|9728923|FG000|STARTED|Part V||0
8684760|NCT00818259|9728924|FG001|STARTED|Part V||0
8684761|NCT00818259|9728925|FG002|STARTED|Part V||0
8684762|NCT00818259|9728926|FG003|STARTED|Part V||0
8684763|NCT00818259|9728927|FG004|STARTED|Part V||0
8684764|NCT00818259|9728928|FG005|STARTED|Part V||0
8684765|NCT00818259|9728929|FG006|STARTED|Part V||0
8684766|NCT00818259|9728930|FG007|STARTED|Part V|Participants continuing from Part IV|17
8684767|NCT00818259|9728931|FG008|STARTED|Part V|Newly enrolled participants|6
8684768|NCT00818259|9728923|FG000|COMPLETED|Part V||0
8684769|NCT00818259|9728924|FG001|COMPLETED|Part V||0
8684770|NCT00818259|9728925|FG002|COMPLETED|Part V||0
8684771|NCT00818259|9728926|FG003|COMPLETED|Part V||0
8684772|NCT00818259|9728927|FG004|COMPLETED|Part V||0
8684773|NCT00818259|9728928|FG005|COMPLETED|Part V||0
8684774|NCT00818259|9728929|FG006|COMPLETED|Part V||0
8684775|NCT00818259|9728930|FG007|COMPLETED|Part V||16
8684776|NCT00818259|9728931|FG008|COMPLETED|Part V||6
8684777|NCT00818259|9728923|FG000|NOT COMPLETED|Part V||0
8684778|NCT00818259|9728924|FG001|NOT COMPLETED|Part V||0
8684779|NCT00818259|9728925|FG002|NOT COMPLETED|Part V||0
8684780|NCT00818259|9728926|FG003|NOT COMPLETED|Part V||0
8684781|NCT00818259|9728927|FG004|NOT COMPLETED|Part V||0
8684782|NCT00818259|9728928|FG005|NOT COMPLETED|Part V||0
8684783|NCT00818259|9728929|FG006|NOT COMPLETED|Part V||0
8801186|NCT01449370|9852989|FG021|STARTED|Overall Study||4
8801187|NCT01449370|9852990|FG022|STARTED|Overall Study||4
8801188|NCT01449370|9852991|FG023|STARTED|Overall Study||10
8801189|NCT01449370|9852992|FG024|STARTED|Overall Study||8
8801190|NCT01449370|9852968|FG000|COMPLETED|Overall Study||0
8801191|NCT01449370|9852969|FG001|COMPLETED|Overall Study||0
8801192|NCT01449370|9852970|FG002|COMPLETED|Overall Study||0
8801193|NCT01449370|9852971|FG003|COMPLETED|Overall Study||0
8801194|NCT01449370|9852972|FG004|COMPLETED|Overall Study||0
8801195|NCT01449370|9852973|FG005|COMPLETED|Overall Study||0
8801196|NCT01449370|9852974|FG006|COMPLETED|Overall Study||0
8801197|NCT01449370|9852975|FG007|COMPLETED|Overall Study||0
8801198|NCT01449370|9852976|FG008|COMPLETED|Overall Study||0
8801199|NCT01449370|9852977|FG009|COMPLETED|Overall Study||0
8801200|NCT01449370|9852978|FG010|COMPLETED|Overall Study||0
8801201|NCT01449370|9852979|FG011|COMPLETED|Overall Study||0
8801202|NCT01449370|9852980|FG012|COMPLETED|Overall Study||0
8801203|NCT01449370|9852981|FG013|COMPLETED|Overall Study||0
8801204|NCT01449370|9852982|FG014|COMPLETED|Overall Study||0
8801205|NCT01449370|9852983|FG015|COMPLETED|Overall Study||0
8801206|NCT01449370|9852984|FG016|COMPLETED|Overall Study||0
8801207|NCT01449370|9852985|FG017|COMPLETED|Overall Study||0
8919373|NCT02207244|9979293|FG003|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0
8919374|NCT02207244|9979294|FG004|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0
8919375|NCT02207244|9979295|FG005|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0
8919376|NCT02207244|9979296|FG006|Nonresponders|Withdrawal and Re-treatment: Week 28-72||80
8919377|NCT02207244|9979297|FG007|Nonresponders|Withdrawal and Re-treatment: Week 28-72||95
8919378|NCT02207244|9979298|FG008|Nonresponders|Withdrawal and Re-treatment: Week 28-72||112
8919379|NCT02207244|9979299|FG009|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0
8919380|NCT02207244|9979300|FG010|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0
8919381|NCT02207244|9979290|FG000|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
8919382|NCT02207244|9979291|FG001|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
8919383|NCT02207244|9979292|FG002|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
8919384|NCT02207244|9979293|FG003|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
8919385|NCT02207244|9979294|FG004|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
8919386|NCT02207244|9979295|FG005|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
8919387|NCT02207244|9979296|FG006|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
8919388|NCT02207244|9979297|FG007|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72|Participants randomized to withdrawal=182 and maintenance= 193|375
8919389|NCT02207244|9979298|FG008|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
8919390|NCT02207244|9979299|FG009|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
8919391|NCT02207244|9979300|FG010|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
8919392|NCT02207244|9979290|FG000|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0
8919393|NCT02207244|9979291|FG001|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0
8919394|NCT02207244|9979292|FG002|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0
8919395|NCT02207244|9979293|FG003|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0
8919396|NCT02207244|9979294|FG004|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0
8919397|NCT02207244|9979295|FG005|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0
8919398|NCT02207244|9979296|FG006|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||147
8919399|NCT02207244|9979297|FG007|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0
8919400|NCT02207244|9979298|FG008|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||108
8684784|NCT00818259|9728930|FG007|NOT COMPLETED|Part V||1
8684785|NCT00818259|9728931|FG008|NOT COMPLETED|Part V||0
8684786|NCT00818272|9728947|FG000|STARTED|Overall Study||148
8684787|NCT00818272|9728947|FG000|COMPLETED|Overall Study||74
8684788|NCT00818272|9728947|FG000|NOT COMPLETED|Overall Study||74
8684789|NCT00818324|9728951|FG000|STARTED|Overall Study||154
8684790|NCT00818324|9728951|FG000|COMPLETED|Overall Study||127
8801208|NCT01449370|9852986|FG018|COMPLETED|Overall Study||0
8801209|NCT01449370|9852987|FG019|COMPLETED|Overall Study||0
8801210|NCT01449370|9852988|FG020|COMPLETED|Overall Study||0
8684791|NCT00818324|9728951|FG000|NOT COMPLETED|Overall Study||27
8684792|NCT00818337|9728955|FG000|STARTED|Overall Study||36
8684793|NCT00818337|9728955|FG000|COMPLETED|Overall Study||36
8684794|NCT00818337|9728955|FG000|NOT COMPLETED|Overall Study||0
8684795|NCT00818363|9728962|FG000|STARTED|Overall Study||40
8684796|NCT00818363|9728963|FG001|STARTED|Overall Study||20
8684797|NCT00818363|9728962|FG000|COMPLETED|Overall Study||40
8684798|NCT00818363|9728963|FG001|COMPLETED|Overall Study||19
8684799|NCT00818363|9728962|FG000|NOT COMPLETED|Overall Study||0
8684800|NCT00818363|9728963|FG001|NOT COMPLETED|Overall Study||1
8684801|NCT00818389|9728971|FG000|STARTED|Overall Study||40
8684802|NCT00818389|9728972|FG001|STARTED|Overall Study||44
8684803|NCT00818389|9728971|FG000|COMPLETED|Overall Study|4 subjects terminated study early before 1st interim analysis. Study terminated early for futility.|36
8684804|NCT00818389|9728972|FG001|COMPLETED|Overall Study|6 subjects terminated study early before 1st interim analysis. Study terminated early for futility.|38
8684805|NCT00818389|9728971|FG000|NOT COMPLETED|Overall Study||4
8684806|NCT00818389|9728972|FG001|NOT COMPLETED|Overall Study||6
8684807|NCT00818441|9728980|FG000|STARTED|Overall Study||89
8684808|NCT00818441|9728981|FG001|STARTED|Overall Study||30
8684809|NCT00818441|9728980|FG000|COMPLETED|Overall Study||0
8684810|NCT00818441|9728981|FG001|COMPLETED|Overall Study||0
8684811|NCT00818441|9728980|FG000|NOT COMPLETED|Overall Study||89
8684812|NCT00818441|9728981|FG001|NOT COMPLETED|Overall Study||30
8684813|NCT00818454|9728988|FG000|STARTED|Treatment Period 1||115
8684814|NCT00818454|9728989|FG001|STARTED|Treatment Period 1||111
8684815|NCT00818454|9728990|FG002|STARTED|Treatment Period 1||0
8684816|NCT00818454|9728991|FG003|STARTED|Treatment Period 1||0
8684817|NCT00818454|9728988|FG000|COMPLETED|Treatment Period 1||112
8684818|NCT00818454|9728989|FG001|COMPLETED|Treatment Period 1||110
8684819|NCT00818454|9728990|FG002|COMPLETED|Treatment Period 1||0
8684820|NCT00818454|9728991|FG003|COMPLETED|Treatment Period 1||0
8684821|NCT00818454|9728988|FG000|NOT COMPLETED|Treatment Period 1||3
8684822|NCT00818454|9728989|FG001|NOT COMPLETED|Treatment Period 1||1
8684823|NCT00818454|9728990|FG002|NOT COMPLETED|Treatment Period 1||0
8684824|NCT00818454|9728991|FG003|NOT COMPLETED|Treatment Period 1||0
8684825|NCT00818454|9728988|FG000|STARTED|Washout Period of 1 Week||112
8684826|NCT00818454|9728989|FG001|STARTED|Washout Period of 1 Week||110
8684827|NCT00818454|9728990|FG002|STARTED|Washout Period of 1 Week||0
8684828|NCT00818454|9728991|FG003|STARTED|Washout Period of 1 Week||0
8684829|NCT00818454|9728988|FG000|COMPLETED|Washout Period of 1 Week||108
8684830|NCT00818454|9728989|FG001|COMPLETED|Washout Period of 1 Week||107
8684831|NCT00818454|9728990|FG002|COMPLETED|Washout Period of 1 Week||0
8684832|NCT00818454|9728991|FG003|COMPLETED|Washout Period of 1 Week||0
8684833|NCT00818454|9728988|FG000|NOT COMPLETED|Washout Period of 1 Week||4
8684834|NCT00818454|9728989|FG001|NOT COMPLETED|Washout Period of 1 Week||3
8684835|NCT00818454|9728990|FG002|NOT COMPLETED|Washout Period of 1 Week||0
8684836|NCT00818454|9728991|FG003|NOT COMPLETED|Washout Period of 1 Week||0
8684837|NCT00818454|9728988|FG000|STARTED|Treatment Period 2||108
8684838|NCT00818454|9728989|FG001|STARTED|Treatment Period 2||107
8684839|NCT00818454|9728990|FG002|STARTED|Treatment Period 2||0
8684840|NCT00818454|9728991|FG003|STARTED|Treatment Period 2||0
8684841|NCT00818454|9728988|FG000|COMPLETED|Treatment Period 2||106
8684842|NCT00818454|9728989|FG001|COMPLETED|Treatment Period 2||106
8684843|NCT00818454|9728990|FG002|COMPLETED|Treatment Period 2||0
8684844|NCT00818454|9728991|FG003|COMPLETED|Treatment Period 2||0
8684845|NCT00818454|9728988|FG000|NOT COMPLETED|Treatment Period 2||2
8684846|NCT00818454|9728989|FG001|NOT COMPLETED|Treatment Period 2||1
8684847|NCT00818454|9728990|FG002|NOT COMPLETED|Treatment Period 2||0
8684848|NCT00818454|9728991|FG003|NOT COMPLETED|Treatment Period 2||0
8684849|NCT00818454|9728988|FG000|STARTED|Treatment Period 3||0
8684850|NCT00818454|9728989|FG001|STARTED|Treatment Period 3||0
8684851|NCT00818454|9728990|FG002|STARTED|Treatment Period 3||26
8684852|NCT00818454|9728991|FG003|STARTED|Treatment Period 3||139
8684853|NCT00818454|9728988|FG000|COMPLETED|Treatment Period 3||0
8684854|NCT00818454|9728989|FG001|COMPLETED|Treatment Period 3||0
8684855|NCT00818454|9728990|FG002|COMPLETED|Treatment Period 3||26
8684856|NCT00818454|9728991|FG003|COMPLETED|Treatment Period 3||138
8684857|NCT00818454|9728988|FG000|NOT COMPLETED|Treatment Period 3||0
8684858|NCT00818454|9728989|FG001|NOT COMPLETED|Treatment Period 3||0
8684859|NCT00818454|9728990|FG002|NOT COMPLETED|Treatment Period 3||0
8684860|NCT00818454|9728991|FG003|NOT COMPLETED|Treatment Period 3||1
8684861|NCT00818519|9729003|FG000|STARTED|Overall Study|2 excluded from FAS because study drug intake unknown or never administered|89
8684862|NCT00818519|9729004|FG001|STARTED|Overall Study|4 excluded from FAS because study drug intake unknown or never administered|90
8684863|NCT00818519|9729003|FG000|Participants Received Treatment|Overall Study|= Baseline|87
8684864|NCT00818519|9729004|FG001|Participants Received Treatment|Overall Study|= Baseline|86
8684865|NCT00818519|9729003|FG000|COMPLETED|Overall Study||75
8684866|NCT00818519|9729004|FG001|COMPLETED|Overall Study||71
8684867|NCT00818519|9729003|FG000|NOT COMPLETED|Overall Study||14
8684868|NCT00818519|9729004|FG001|NOT COMPLETED|Overall Study||19
8684869|NCT00818623|9729018|FG000|STARTED|Overall Study||26
8684870|NCT00818623|9729019|FG001|STARTED|Overall Study||12
8684871|NCT00818623|9729020|FG002|STARTED|Overall Study||13
8684872|NCT00818623|9729021|FG003|STARTED|Overall Study||24
8684873|NCT00818623|9729022|FG004|STARTED|Overall Study||27
8684874|NCT00818623|9729023|FG005|STARTED|Overall Study||24
8684875|NCT00818623|9729024|FG006|STARTED|Overall Study||27
8684876|NCT00818623|9729025|FG007|STARTED|Overall Study||27
8684877|NCT00818623|9729018|FG000|Intent-to-treat (ITT) Population|Overall Study|One participant in this group was randomized but never received any treatment.|25
8684878|NCT00818623|9729019|FG001|Intent-to-treat (ITT) Population|Overall Study||12
8684879|NCT00818623|9729020|FG002|Intent-to-treat (ITT) Population|Overall Study|One participant in this group was randomized but never received any treatment.|12
8684880|NCT00818623|9729021|FG003|Intent-to-treat (ITT) Population|Overall Study||24
8684881|NCT00818623|9729022|FG004|Intent-to-treat (ITT) Population|Overall Study|Three participants in this group were randomized but never received any treatment.|24
8684882|NCT00818623|9729023|FG005|Intent-to-treat (ITT) Population|Overall Study||24
8684883|NCT00818623|9729024|FG006|Intent-to-treat (ITT) Population|Overall Study|Three participants in this group were randomized but never received any treatment.|24
8684884|NCT00818623|9729025|FG007|Intent-to-treat (ITT) Population|Overall Study||27
8684885|NCT00818623|9729018|FG000|COMPLETED|Overall Study||24
8684886|NCT00818623|9729019|FG001|COMPLETED|Overall Study||8
8684887|NCT00818623|9729020|FG002|COMPLETED|Overall Study||9
8684888|NCT00818623|9729021|FG003|COMPLETED|Overall Study||19
8684889|NCT00818623|9729022|FG004|COMPLETED|Overall Study||23
8684890|NCT00818623|9729023|FG005|COMPLETED|Overall Study||21
8684891|NCT00818623|9729024|FG006|COMPLETED|Overall Study||23
8684892|NCT00818623|9729025|FG007|COMPLETED|Overall Study||26
8684893|NCT00818623|9729018|FG000|NOT COMPLETED|Overall Study||2
8684894|NCT00818623|9729019|FG001|NOT COMPLETED|Overall Study||4
8684895|NCT00818623|9729020|FG002|NOT COMPLETED|Overall Study||4
8684896|NCT00818623|9729021|FG003|NOT COMPLETED|Overall Study||5
8684897|NCT00818623|9729022|FG004|NOT COMPLETED|Overall Study||4
8684898|NCT00818623|9729023|FG005|NOT COMPLETED|Overall Study||3
8684899|NCT00818623|9729024|FG006|NOT COMPLETED|Overall Study||4
8684900|NCT00818623|9729025|FG007|NOT COMPLETED|Overall Study||1
8684901|NCT00818649|9729043|FG000|STARTED|Overall Study||16
8684902|NCT00818649|9729043|FG000|COMPLETED|Overall Study||12
8684903|NCT00818649|9729043|FG000|NOT COMPLETED|Overall Study||4
8684904|NCT00818662|9729052|FG000|STARTED|Overall Study||127
8684905|NCT00818662|9729053|FG001|STARTED|Overall Study||135
8684906|NCT00818662|9729054|FG002|STARTED|Overall Study||58
8684907|NCT00818662|9729055|FG003|STARTED|Overall Study||63
8684908|NCT00818662|9729052|FG000|COMPLETED|Overall Study||104
8684909|NCT00818662|9729053|FG001|COMPLETED|Overall Study||102
8684910|NCT00818662|9729054|FG002|COMPLETED|Overall Study||49
8684911|NCT00818662|9729055|FG003|COMPLETED|Overall Study||47
8684912|NCT00818662|9729052|FG000|NOT COMPLETED|Overall Study||23
8684913|NCT00818662|9729053|FG001|NOT COMPLETED|Overall Study||33
8684914|NCT00818662|9729054|FG002|NOT COMPLETED|Overall Study||9
8684915|NCT00818662|9729055|FG003|NOT COMPLETED|Overall Study||16
8684916|NCT00818753|9729069|FG000|STARTED|Overall Study|There were 53 participants randomised, but only 51 were treated.|22
8684917|NCT00818753|9729070|FG001|STARTED|Overall Study|There were 53 participants randomised, but only 51 were treated.|21
8684918|NCT00818753|9729071|FG002|STARTED|Overall Study|There were 53 participants randomised, but only 51 were treated.|10
8684919|NCT00818753|9729069|FG000|COMPLETED|Overall Study||19
8684920|NCT00818753|9729070|FG001|COMPLETED|Overall Study||21
8684921|NCT00818753|9729071|FG002|COMPLETED|Overall Study||9
8684922|NCT00818753|9729069|FG000|NOT COMPLETED|Overall Study||3
8684923|NCT00818753|9729070|FG001|NOT COMPLETED|Overall Study||0
8684924|NCT00818753|9729071|FG002|NOT COMPLETED|Overall Study||1
8684925|NCT00818766|9729081|FG000|STARTED|Overall Study||125
8684926|NCT00818766|9729082|FG001|STARTED|Overall Study||126
8684927|NCT00818766|9729081|FG000|Received Allocated Intervention|Overall Study|1 withdrew consent, 1 had active infection and 1 was given open-label antibiotic after surgery.|122
8684928|NCT00818766|9729082|FG001|Received Allocated Intervention|Overall Study||126
8684929|NCT00818766|9729081|FG000|Intent-to-Treat Population|Overall Study|1 participant was randomized twice but only counted once (per first randomization).|121
8684930|NCT00818766|9729082|FG001|Intent-to-Treat Population|Overall Study|2 participants were randomized twice but only counted once (per first randomization).|124
8684931|NCT00818766|9729081|FG000|COMPLETED|Overall Study||110
8684932|NCT00818766|9729082|FG001|COMPLETED|Overall Study||116
8684933|NCT00818766|9729081|FG000|NOT COMPLETED|Overall Study||15
8684934|NCT00818766|9729082|FG001|NOT COMPLETED|Overall Study||10
8684935|NCT00818779|9729090|FG000|STARTED|Overall Study||22
8684936|NCT00818779|9729091|FG001|STARTED|Overall Study||16
8684937|NCT00818779|9729090|FG000|COMPLETED|Overall Study||16
8684938|NCT00818779|9729091|FG001|COMPLETED|Overall Study||15
8684939|NCT00818779|9729090|FG000|NOT COMPLETED|Overall Study||6
8684940|NCT00818779|9729091|FG001|NOT COMPLETED|Overall Study||1
8684941|NCT00818805|9729097|FG000|STARTED|First Intervention||25
8684942|NCT00818805|9729098|FG001|STARTED|First Intervention||25
8684943|NCT00818805|9729097|FG000|COMPLETED|First Intervention||25
8684944|NCT00818805|9729098|FG001|COMPLETED|First Intervention||25
8684945|NCT00818805|9729097|FG000|NOT COMPLETED|First Intervention||0
8684946|NCT00818805|9729098|FG001|NOT COMPLETED|First Intervention||0
8684947|NCT00818805|9729097|FG000|STARTED|Second Intervention||25
8684948|NCT00818805|9729098|FG001|STARTED|Second Intervention||25
8684949|NCT00818805|9729097|FG000|COMPLETED|Second Intervention||25
8684950|NCT00818805|9729098|FG001|COMPLETED|Second Intervention||25
8684951|NCT00818805|9729097|FG000|NOT COMPLETED|Second Intervention||0
8684952|NCT00818805|9729098|FG001|NOT COMPLETED|Second Intervention||0
8684953|NCT00818883|9729110|FG000|STARTED|Overall Study||303
8684954|NCT00818883|9729111|FG001|STARTED|Overall Study||306
8684955|NCT00818883|9729110|FG000|COMPLETED|Overall Study||252
8684956|NCT00818883|9729111|FG001|COMPLETED|Overall Study||260
8684957|NCT00818883|9729110|FG000|NOT COMPLETED|Overall Study||51
8684958|NCT00818883|9729111|FG001|NOT COMPLETED|Overall Study||46
8684959|NCT00818961|9729117|FG000|STARTED|Overall Study||36
8684960|NCT00818961|9729117|FG000|COMPLETED|Overall Study||36
8684961|NCT00818961|9729117|FG000|NOT COMPLETED|Overall Study||0
8684962|NCT00819013|9729125|FG000|STARTED|Overall Study||22
8684963|NCT00819013|9729126|FG001|STARTED|Overall Study||23
8684964|NCT00819013|9729127|FG002|STARTED|Overall Study||21
8684965|NCT00819013|9729128|FG003|STARTED|Overall Study||21
8684966|NCT00819013|9729125|FG000|COMPLETED|Overall Study||19
8684967|NCT00819013|9729126|FG001|COMPLETED|Overall Study||22
8684968|NCT00819013|9729127|FG002|COMPLETED|Overall Study||16
8684969|NCT00819013|9729128|FG003|COMPLETED|Overall Study||17
8684970|NCT00819013|9729125|FG000|NOT COMPLETED|Overall Study||3
8684971|NCT00819013|9729126|FG001|NOT COMPLETED|Overall Study||1
8684972|NCT00819013|9729127|FG002|NOT COMPLETED|Overall Study||5
8684973|NCT00819013|9729128|FG003|NOT COMPLETED|Overall Study||4
8684974|NCT00819039|9729141|FG000|STARTED|Overall Study||46
8684975|NCT00819039|9729142|FG001|STARTED|Overall Study||27
8684976|NCT00819039|9729143|FG002|STARTED|Overall Study||25
8684977|NCT00819039|9729141|FG000|COMPLETED|Overall Study||44
8684978|NCT00819039|9729142|FG001|COMPLETED|Overall Study||27
8684979|NCT00819039|9729143|FG002|COMPLETED|Overall Study||24
8684980|NCT00819039|9729141|FG000|NOT COMPLETED|Overall Study||2
8684981|NCT00819039|9729142|FG001|NOT COMPLETED|Overall Study||0
8684982|NCT00819039|9729143|FG002|NOT COMPLETED|Overall Study||1
8684983|NCT00819052|9729155|FG000|STARTED|Overall Study||148
8684984|NCT00819052|9729156|FG001|STARTED|Overall Study||295
8684985|NCT00819052|9729155|FG000|COMPLETED|Overall Study||142
8684986|NCT00819052|9729156|FG001|COMPLETED|Overall Study||281
8684987|NCT00819052|9729155|FG000|NOT COMPLETED|Overall Study||6
8684988|NCT00819052|9729156|FG001|NOT COMPLETED|Overall Study||14
8684989|NCT00819091|9729167|FG000|STARTED|Overall Study||84
8684990|NCT00819091|9729168|FG001|STARTED|Overall Study||161
8684991|NCT00819091|9729167|FG000|COMPLETED|Overall Study||77
8684992|NCT00819091|9729168|FG001|COMPLETED|Overall Study||151
8684993|NCT00819091|9729167|FG000|NOT COMPLETED|Overall Study||7
8684994|NCT00819091|9729168|FG001|NOT COMPLETED|Overall Study||10
8684995|NCT00819156|9729180|FG000|STARTED|Overall Study||30
8684996|NCT00819156|9729181|FG001|STARTED|Overall Study||33
8684997|NCT00819156|9729182|FG002|STARTED|Overall Study||32
8684998|NCT00819156|9729183|FG003|STARTED|Overall Study||30
8684999|NCT00819156|9729184|FG004|STARTED|Overall Study||33
8685000|NCT00819156|9729185|FG005|STARTED|Overall Study||31
8685001|NCT00819156|9729180|FG000|Randomised and Treated (ITT Population)|Overall Study||30
8685002|NCT00819156|9729181|FG001|Randomised and Treated (ITT Population)|Overall Study||32
8685003|NCT00819156|9729182|FG002|Randomised and Treated (ITT Population)|Overall Study||32
8685004|NCT00819156|9729183|FG003|Randomised and Treated (ITT Population)|Overall Study||30
8685005|NCT00819156|9729184|FG004|Randomised and Treated (ITT Population)|Overall Study||33
8685006|NCT00819156|9729185|FG005|Randomised and Treated (ITT Population)|Overall Study||30
8685007|NCT00819156|9729180|FG000|COMPLETED|Overall Study||20
8685008|NCT00819156|9729181|FG001|COMPLETED|Overall Study||23
8685009|NCT00819156|9729182|FG002|COMPLETED|Overall Study||26
8685010|NCT00819156|9729183|FG003|COMPLETED|Overall Study||28
8685011|NCT00819156|9729184|FG004|COMPLETED|Overall Study||27
8685012|NCT00819156|9729185|FG005|COMPLETED|Overall Study||23
8685013|NCT00819156|9729180|FG000|NOT COMPLETED|Overall Study||10
8685014|NCT00819156|9729181|FG001|NOT COMPLETED|Overall Study||10
8685015|NCT00819156|9729182|FG002|NOT COMPLETED|Overall Study||6
8685016|NCT00819156|9729183|FG003|NOT COMPLETED|Overall Study||2
8685017|NCT00819156|9729184|FG004|NOT COMPLETED|Overall Study||6
8685018|NCT00819156|9729185|FG005|NOT COMPLETED|Overall Study||8
8685019|NCT00819182|9729210|FG000|STARTED|Overall Study|Consented participants allocated to this arm.|88
8685020|NCT00819182|9729211|FG001|STARTED|Overall Study|Consented participants allocated to this arm.|86
8685021|NCT00819182|9729212|FG002|STARTED|Overall Study|Consented participants allocated to this arm.|44
8685022|NCT00819182|9729210|FG000|Week 16 Visit|Overall Study||75
8685023|NCT00819182|9729211|FG001|Week 16 Visit|Overall Study||78
8685024|NCT00819182|9729212|FG002|Week 16 Visit|Overall Study||43
8685025|NCT00819182|9729210|FG000|COMPLETED|Overall Study||75
8685026|NCT00819182|9729211|FG001|COMPLETED|Overall Study||78
8685027|NCT00819182|9729212|FG002|COMPLETED|Overall Study||43
8685028|NCT00819182|9729210|FG000|NOT COMPLETED|Overall Study||13
8685029|NCT00819182|9729211|FG001|NOT COMPLETED|Overall Study||8
8685030|NCT00819182|9729212|FG002|NOT COMPLETED|Overall Study||1
8685031|NCT00819234|9729220|FG000|STARTED|Overall Study||31
8685032|NCT00819234|9729221|FG001|STARTED|Overall Study||35
8685033|NCT00819234|9729222|FG002|STARTED|Overall Study||36
8685034|NCT00819234|9729223|FG003|STARTED|Overall Study||28
8685035|NCT00819234|9729224|FG004|STARTED|Overall Study||13
8685036|NCT00819234|9729225|FG005|STARTED|Overall Study||14
8685037|NCT00819234|9729226|FG006|STARTED|Overall Study||13
8685038|NCT00819234|9729227|FG007|STARTED|Overall Study||29
8685039|NCT00819234|9729228|FG008|STARTED|Overall Study||37
8685040|NCT00819234|9729229|FG009|STARTED|Overall Study||37
8685041|NCT00819234|9729220|FG000|COMPLETED|Overall Study||21
8685042|NCT00819234|9729221|FG001|COMPLETED|Overall Study||20
8685043|NCT00819234|9729222|FG002|COMPLETED|Overall Study||28
8685044|NCT00819234|9729223|FG003|COMPLETED|Overall Study||22
8685045|NCT00819234|9729224|FG004|COMPLETED|Overall Study||12
8685046|NCT00819234|9729225|FG005|COMPLETED|Overall Study||7
8685047|NCT00819234|9729226|FG006|COMPLETED|Overall Study||8
8685048|NCT00819234|9729227|FG007|COMPLETED|Overall Study||20
8685049|NCT00819234|9729228|FG008|COMPLETED|Overall Study||31
8685050|NCT00819234|9729229|FG009|COMPLETED|Overall Study||30
8685051|NCT00819234|9729220|FG000|NOT COMPLETED|Overall Study||10
8685052|NCT00819234|9729221|FG001|NOT COMPLETED|Overall Study||15
8685053|NCT00819234|9729222|FG002|NOT COMPLETED|Overall Study||8
8685054|NCT00819234|9729223|FG003|NOT COMPLETED|Overall Study||6
8685055|NCT00819234|9729224|FG004|NOT COMPLETED|Overall Study||1
8685056|NCT00819234|9729225|FG005|NOT COMPLETED|Overall Study||7
8685057|NCT00819234|9729226|FG006|NOT COMPLETED|Overall Study||5
8685058|NCT00819234|9729227|FG007|NOT COMPLETED|Overall Study||9
8685059|NCT00819234|9729228|FG008|NOT COMPLETED|Overall Study||6
8685060|NCT00819234|9729229|FG009|NOT COMPLETED|Overall Study||7
8685061|NCT00819247|9729287|FG000|STARTED|Overall Study||43
8685062|NCT00819247|9729288|FG001|STARTED|Overall Study||46
8685063|NCT00819247|9729289|FG002|STARTED|Overall Study||40
8685064|NCT00819247|9729287|FG000|Randomized|Overall Study||43
8685065|NCT00819247|9729288|FG001|Randomized|Overall Study||46
8685066|NCT00819247|9729289|FG002|Randomized|Overall Study||40
8685067|NCT00819247|9729287|FG000|Intent-to-treat Population|Overall Study|One randomised participant withdrew at Day 1.|42
8685068|NCT00819247|9729288|FG001|Intent-to-treat Population|Overall Study||46
8685069|NCT00819247|9729289|FG002|Intent-to-treat Population|Overall Study|One randomised participant withdrew at Day 1.|39
8685070|NCT00819247|9729287|FG000|Per Protocol Population|Overall Study|One participant- baseline testosterone outside normal range. Three participants- prohibited drugs.|38
8685071|NCT00819247|9729288|FG001|Per Protocol Population|Overall Study|Two participants - prohibited drugs|44
8685072|NCT00819247|9729289|FG002|Per Protocol Population|Overall Study|One participant - baseline testosterone outside normal range.|38
8685073|NCT00819247|9729287|FG000|COMPLETED|Overall Study||32
8685074|NCT00819247|9729288|FG001|COMPLETED|Overall Study||30
8685075|NCT00819247|9729289|FG002|COMPLETED|Overall Study||26
8685076|NCT00819247|9729287|FG000|NOT COMPLETED|Overall Study||11
8685077|NCT00819247|9729288|FG001|NOT COMPLETED|Overall Study||16
8685078|NCT00819247|9729289|FG002|NOT COMPLETED|Overall Study||14
8685079|NCT00819260|9729297|FG000|STARTED|Overall Study||31
8685080|NCT00819260|9729297|FG000|COMPLETED|Overall Study||31
8685081|NCT00819260|9729297|FG000|NOT COMPLETED|Overall Study||0
8685082|NCT00819286|9729305|FG000|STARTED|Overall Study||70
8685083|NCT00819286|9729306|FG001|STARTED|Overall Study||70
8685084|NCT00819286|9729305|FG000|COMPLETED|Overall Study||56
8685085|NCT00819286|9729306|FG001|COMPLETED|Overall Study||45
8685086|NCT00819286|9729305|FG000|NOT COMPLETED|Overall Study||14
8685087|NCT00819286|9729306|FG001|NOT COMPLETED|Overall Study||25
8685088|NCT00819390|9729316|FG000|STARTED|Overall Study||16
8685089|NCT00819390|9729317|FG001|STARTED|Overall Study||17
8685090|NCT00819390|9729318|FG002|STARTED|Overall Study||18
8685091|NCT00819390|9729319|FG003|STARTED|Overall Study||19
8685092|NCT00819390|9729316|FG000|COMPLETED|Overall Study||13
8685093|NCT00819390|9729317|FG001|COMPLETED|Overall Study||16
8685094|NCT00819390|9729318|FG002|COMPLETED|Overall Study||17
8685095|NCT00819390|9729319|FG003|COMPLETED|Overall Study||19
8685096|NCT00819390|9729316|FG000|NOT COMPLETED|Overall Study||3
8685097|NCT00819390|9729317|FG001|NOT COMPLETED|Overall Study||1
8685098|NCT00819390|9729318|FG002|NOT COMPLETED|Overall Study||1
8685099|NCT00819390|9729319|FG003|NOT COMPLETED|Overall Study||0
8685100|NCT00819403|9729334|FG000|STARTED|First Intervention (6 Weeks)||7
8685101|NCT00819403|9729335|FG001|STARTED|First Intervention (6 Weeks)||8
8685102|NCT00819403|9729334|FG000|COMPLETED|First Intervention (6 Weeks)||7
8685103|NCT00819403|9729335|FG001|COMPLETED|First Intervention (6 Weeks)||8
8685104|NCT00819403|9729334|FG000|NOT COMPLETED|First Intervention (6 Weeks)||0
8685105|NCT00819403|9729335|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0
8685106|NCT00819403|9729334|FG000|STARTED|Washout (14 Days)||7
8685107|NCT00819403|9729335|FG001|STARTED|Washout (14 Days)||8
8685108|NCT00819403|9729334|FG000|COMPLETED|Washout (14 Days)||7
8685109|NCT00819403|9729335|FG001|COMPLETED|Washout (14 Days)||8
8685110|NCT00819403|9729334|FG000|NOT COMPLETED|Washout (14 Days)||0
8685111|NCT00819403|9729335|FG001|NOT COMPLETED|Washout (14 Days)||0
8685112|NCT00819403|9729334|FG000|STARTED|Second Intervention (6 Weeks)||7
8801211|NCT01449370|9852989|FG021|COMPLETED|Overall Study||0
8801212|NCT01449370|9852990|FG022|COMPLETED|Overall Study||0
8801213|NCT01449370|9852991|FG023|COMPLETED|Overall Study||0
8801214|NCT01449370|9852992|FG024|COMPLETED|Overall Study||0
8801215|NCT01449370|9852968|FG000|NOT COMPLETED|Overall Study||6
8801216|NCT01449370|9852969|FG001|NOT COMPLETED|Overall Study||6
8801217|NCT01449370|9852970|FG002|NOT COMPLETED|Overall Study||8
8801218|NCT01449370|9852971|FG003|NOT COMPLETED|Overall Study||4
8801219|NCT01449370|9852972|FG004|NOT COMPLETED|Overall Study||3
8801220|NCT01449370|9852973|FG005|NOT COMPLETED|Overall Study||3
8801221|NCT01449370|9852974|FG006|NOT COMPLETED|Overall Study||3
8801222|NCT01449370|9852975|FG007|NOT COMPLETED|Overall Study||3
8801223|NCT01449370|9852976|FG008|NOT COMPLETED|Overall Study||12
8801224|NCT01449370|9852977|FG009|NOT COMPLETED|Overall Study||3
8801225|NCT01449370|9852978|FG010|NOT COMPLETED|Overall Study||3
8801226|NCT01449370|9852979|FG011|NOT COMPLETED|Overall Study||3
8801227|NCT01449370|9852980|FG012|NOT COMPLETED|Overall Study||3
8801228|NCT01449370|9852981|FG013|NOT COMPLETED|Overall Study||11
8801229|NCT01449370|9852982|FG014|NOT COMPLETED|Overall Study||3
8685113|NCT00819403|9729335|FG001|STARTED|Second Intervention (6 Weeks)||8
8685114|NCT00819403|9729334|FG000|COMPLETED|Second Intervention (6 Weeks)||7
8685115|NCT00819403|9729335|FG001|COMPLETED|Second Intervention (6 Weeks)||8
8685116|NCT00819403|9729334|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
8685117|NCT00819403|9729335|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0
8685118|NCT00819507|9729342|FG000|STARTED|Overall Study||25
8685119|NCT00819507|9729342|FG000|COMPLETED|Overall Study||25
8685120|NCT00819507|9729342|FG000|NOT COMPLETED|Overall Study||0
8685121|NCT00819585|9729353|FG000|STARTED|Core Study|Participants who started the core study are included in the randomized and full analysis sets.|55
8685122|NCT00819585|9729354|FG001|STARTED|Core Study||54
8685123|NCT00819585|9729355|FG002|STARTED|Core Study||54
8685124|NCT00819585|9729356|FG003|STARTED|Core Study||54
8685125|NCT00819585|9729357|FG004|STARTED|Core Study||53
8685126|NCT00819585|9729358|FG005|STARTED|Core Study||54
8685127|NCT00819585|9729359|FG006|STARTED|Core Study||108
8685128|NCT00819585|9729360|FG007|STARTED|Core Study|There were no participants in this arm during the core study.|0
8685129|NCT00819585|9729361|FG008|STARTED|Core Study|There were no participants in this arm during the core study.|0
8685130|NCT00819585|9729362|FG009|STARTED|Core Study|There were no participants in this arm during the core study.|0
8685131|NCT00819585|9729363|FG010|STARTED|Core Study|There were no participants in this arm during the core study.|0
8685132|NCT00819585|9729353|FG000|Received Study Medication|Core Study|Participants who received study medication are included in the safety population.|55
8685133|NCT00819585|9729354|FG001|Received Study Medication|Core Study||54
8685134|NCT00819585|9729355|FG002|Received Study Medication|Core Study||54
8685135|NCT00819585|9729356|FG003|Received Study Medication|Core Study||54
8685136|NCT00819585|9729357|FG004|Received Study Medication|Core Study||53
8685137|NCT00819585|9729358|FG005|Received Study Medication|Core Study|One participant in this treatment arm was HIV+ve and did not receive any study medication.|53
8685138|NCT00819585|9729359|FG006|Received Study Medication|Core Study||108
8685139|NCT00819585|9729360|FG007|Received Study Medication|Core Study||0
8685140|NCT00819585|9729361|FG008|Received Study Medication|Core Study||0
8685141|NCT00819585|9729362|FG009|Received Study Medication|Core Study||0
8685142|NCT00819585|9729363|FG010|Received Study Medication|Core Study||0
8685143|NCT00819585|9729353|FG000|COMPLETED|Core Study||49
8685144|NCT00819585|9729354|FG001|COMPLETED|Core Study||48
8685145|NCT00819585|9729355|FG002|COMPLETED|Core Study||48
8685146|NCT00819585|9729356|FG003|COMPLETED|Core Study||49
8685147|NCT00819585|9729357|FG004|COMPLETED|Core Study||50
8685148|NCT00819585|9729358|FG005|COMPLETED|Core Study||52
8685149|NCT00819585|9729359|FG006|COMPLETED|Core Study||95
8685150|NCT00819585|9729360|FG007|COMPLETED|Core Study||0
8685151|NCT00819585|9729361|FG008|COMPLETED|Core Study||0
8685152|NCT00819585|9729362|FG009|COMPLETED|Core Study||0
8685153|NCT00819585|9729363|FG010|COMPLETED|Core Study||0
8685154|NCT00819585|9729353|FG000|NOT COMPLETED|Core Study||6
8685155|NCT00819585|9729354|FG001|NOT COMPLETED|Core Study||6
8685156|NCT00819585|9729355|FG002|NOT COMPLETED|Core Study||6
8685157|NCT00819585|9729356|FG003|NOT COMPLETED|Core Study||5
8685158|NCT00819585|9729357|FG004|NOT COMPLETED|Core Study||3
8685159|NCT00819585|9729358|FG005|NOT COMPLETED|Core Study||2
8685160|NCT00819585|9729359|FG006|NOT COMPLETED|Core Study||13
8685161|NCT00819585|9729360|FG007|NOT COMPLETED|Core Study||0
8685162|NCT00819585|9729361|FG008|NOT COMPLETED|Core Study||0
8685163|NCT00819585|9729362|FG009|NOT COMPLETED|Core Study||0
8685164|NCT00819585|9729363|FG010|NOT COMPLETED|Core Study||0
8685165|NCT00819585|9729353|FG000|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
8685166|NCT00819585|9729354|FG001|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
8685167|NCT00819585|9729355|FG002|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
8685168|NCT00819585|9729356|FG003|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
8685169|NCT00819585|9729357|FG004|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
8685170|NCT00819585|9729358|FG005|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
8685171|NCT00819585|9729359|FG006|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
8685172|NCT00819585|9729360|FG007|STARTED|Extension Study||75
8685173|NCT00819585|9729361|FG008|STARTED|Extension Study||181
8685174|NCT00819585|9729362|FG009|STARTED|Extension Study||25
8685175|NCT00819585|9729363|FG010|STARTED|Extension Study||60
8685176|NCT00819585|9729353|FG000|COMPLETED|Extension Study||0
8685177|NCT00819585|9729354|FG001|COMPLETED|Extension Study||0
8685178|NCT00819585|9729355|FG002|COMPLETED|Extension Study||0
8685179|NCT00819585|9729356|FG003|COMPLETED|Extension Study||0
8685180|NCT00819585|9729357|FG004|COMPLETED|Extension Study||0
8685181|NCT00819585|9729358|FG005|COMPLETED|Extension Study||0
8685182|NCT00819585|9729359|FG006|COMPLETED|Extension Study||0
8685183|NCT00819585|9729360|FG007|COMPLETED|Extension Study||75
8685184|NCT00819585|9729361|FG008|COMPLETED|Extension Study||173
8685185|NCT00819585|9729362|FG009|COMPLETED|Extension Study||24
8685186|NCT00819585|9729363|FG010|COMPLETED|Extension Study||58
8685187|NCT00819585|9729353|FG000|NOT COMPLETED|Extension Study||0
8685188|NCT00819585|9729354|FG001|NOT COMPLETED|Extension Study||0
8685189|NCT00819585|9729355|FG002|NOT COMPLETED|Extension Study||0
8685190|NCT00819585|9729356|FG003|NOT COMPLETED|Extension Study||0
8685191|NCT00819585|9729357|FG004|NOT COMPLETED|Extension Study||0
8685192|NCT00819585|9729358|FG005|NOT COMPLETED|Extension Study||0
8685193|NCT00819585|9729359|FG006|NOT COMPLETED|Extension Study||0
8685194|NCT00819585|9729360|FG007|NOT COMPLETED|Extension Study||0
8685195|NCT00819585|9729361|FG008|NOT COMPLETED|Extension Study||8
8685196|NCT00819585|9729362|FG009|NOT COMPLETED|Extension Study||1
8685197|NCT00819585|9729363|FG010|NOT COMPLETED|Extension Study||2
8685198|NCT00819637|9729394|FG000|STARTED|Overall Study||2
8685199|NCT00819637|9729395|FG001|STARTED|Overall Study||0
8685200|NCT00819637|9729396|FG002|STARTED|Overall Study||0
8685201|NCT00819637|9729394|FG000|COMPLETED|Overall Study||2
8685202|NCT00819637|9729395|FG001|COMPLETED|Overall Study||0
8685203|NCT00819637|9729396|FG002|COMPLETED|Overall Study||0
8685204|NCT00819637|9729394|FG000|NOT COMPLETED|Overall Study||0
8685205|NCT00819637|9729395|FG001|NOT COMPLETED|Overall Study||0
8685206|NCT00819637|9729396|FG002|NOT COMPLETED|Overall Study||0
8685207|NCT00819741|9729406|FG000|STARTED|Overall Study||218
8685208|NCT00819741|9729407|FG001|STARTED|Overall Study||215
8685209|NCT00819741|9729406|FG000|Exposed to Drug|Overall Study||218
8685210|NCT00819741|9729407|FG001|Exposed to Drug|Overall Study|One subject after randomisation was not exposed to the treatment due to non-compliance|214
8685211|NCT00819741|9729406|FG000|COMPLETED|Overall Study||196
8685212|NCT00819741|9729407|FG001|COMPLETED|Overall Study||201
8685213|NCT00819741|9729406|FG000|NOT COMPLETED|Overall Study||22
8685214|NCT00819741|9729407|FG001|NOT COMPLETED|Overall Study||14
8685215|NCT00819767|9729415|FG000|STARTED|Overall Study||33
8685216|NCT00819767|9729416|FG001|STARTED|Overall Study||35
8685217|NCT00819767|9729415|FG000|COMPLETED|Overall Study||32
8685218|NCT00819767|9729416|FG001|COMPLETED|Overall Study||33
8685219|NCT00819767|9729415|FG000|NOT COMPLETED|Overall Study||1
8685220|NCT00819767|9729416|FG001|NOT COMPLETED|Overall Study||2
8685221|NCT00819780|9729424|FG000|STARTED|Overall Study||142
8685222|NCT00819780|9729425|FG001|STARTED|Overall Study||143
8685223|NCT00819780|9729424|FG000|Received Study Treatment|Overall Study||139
8685224|NCT00819780|9729425|FG001|Received Study Treatment|Overall Study||139
8685225|NCT00819780|9729424|FG000|COMPLETED|Overall Study|Indicates participants who ended study treatment|114
8685226|NCT00819780|9729425|FG001|COMPLETED|Overall Study|Indicates participants who ended study treatment|122
8685227|NCT00819780|9729424|FG000|NOT COMPLETED|Overall Study||28
8685228|NCT00819780|9729425|FG001|NOT COMPLETED|Overall Study||21
8685229|NCT00819793|9729431|FG000|STARTED|Overall Study||32
8685230|NCT00819793|9729431|FG000|COMPLETED|Overall Study||32
8685231|NCT00819793|9729431|FG000|NOT COMPLETED|Overall Study||0
8685232|NCT00819910|9729440|FG000|STARTED|Overall Study||10
8685233|NCT00819910|9729441|FG001|STARTED|Overall Study||10
8685234|NCT00819910|9729442|FG002|STARTED|Overall Study||10
8685235|NCT00819910|9729443|FG003|STARTED|Overall Study||11
8685236|NCT00819910|9729440|FG000|COMPLETED|Overall Study||8
8685237|NCT00819910|9729441|FG001|COMPLETED|Overall Study||9
8685238|NCT00819910|9729442|FG002|COMPLETED|Overall Study||7
8685239|NCT00819910|9729443|FG003|COMPLETED|Overall Study||10
8685240|NCT00819910|9729440|FG000|NOT COMPLETED|Overall Study||2
8685241|NCT00819910|9729441|FG001|NOT COMPLETED|Overall Study||1
8685242|NCT00819910|9729442|FG002|NOT COMPLETED|Overall Study||3
8685243|NCT00819910|9729443|FG003|NOT COMPLETED|Overall Study||1
8685244|NCT00820040|9729455|FG000|STARTED|Overall Study||10
8685245|NCT00820040|9729455|FG000|Safety Evaluable Population|Overall Study||8
8685246|NCT00820040|9729455|FG000|Full Analysis Set|Overall Study||8
8685247|NCT00820040|9729455|FG000|COMPLETED|Overall Study||7
8685248|NCT00820040|9729455|FG000|NOT COMPLETED|Overall Study||3
8685249|NCT00820170|9729464|FG000|STARTED|Overall Study||3
8685250|NCT00820170|9729465|FG001|STARTED|Overall Study||5
8685251|NCT00820170|9729466|FG002|STARTED|Overall Study||3
8685252|NCT00820170|9729467|FG003|STARTED|Overall Study||40
8685253|NCT00820170|9729468|FG004|STARTED|Overall Study||4
8685254|NCT00820170|9729464|FG000|COMPLETED|Overall Study||3
8685255|NCT00820170|9729465|FG001|COMPLETED|Overall Study||5
8685256|NCT00820170|9729466|FG002|COMPLETED|Overall Study||3
8685257|NCT00820170|9729467|FG003|COMPLETED|Overall Study||40
8685258|NCT00820170|9729468|FG004|COMPLETED|Overall Study||0
8685259|NCT00820170|9729464|FG000|NOT COMPLETED|Overall Study||0
8685260|NCT00820170|9729465|FG001|NOT COMPLETED|Overall Study||0
8685261|NCT00820170|9729466|FG002|NOT COMPLETED|Overall Study||0
8685262|NCT00820170|9729467|FG003|NOT COMPLETED|Overall Study||0
8685263|NCT00820170|9729468|FG004|NOT COMPLETED|Overall Study||4
8685264|NCT00820222|9729487|FG000|STARTED|Overall Study||271
8685265|NCT00820222|9729488|FG001|STARTED|Overall Study||269
8685266|NCT00820222|9729487|FG000|COMPLETED|Overall Study||95
8685267|NCT00820222|9729488|FG001|COMPLETED|Overall Study||79
8685268|NCT00820222|9729487|FG000|NOT COMPLETED|Overall Study||176
8685269|NCT00820222|9729488|FG001|NOT COMPLETED|Overall Study||190
8685270|NCT00820235|9729497|FG000|STARTED|Overall Study||48
8685271|NCT00820235|9729498|FG001|STARTED|Overall Study||49
8685272|NCT00820235|9729499|FG002|STARTED|Overall Study||44
8685273|NCT00820235|9729497|FG000|COMPLETED|Overall Study||33
8685274|NCT00820235|9729498|FG001|COMPLETED|Overall Study||28
8685275|NCT00820235|9729499|FG002|COMPLETED|Overall Study||27
8685276|NCT00820235|9729497|FG000|NOT COMPLETED|Overall Study||15
8685277|NCT00820235|9729498|FG001|NOT COMPLETED|Overall Study||21
8685278|NCT00820235|9729499|FG002|NOT COMPLETED|Overall Study||17
8685279|NCT00820248|9729509|FG000|STARTED|Overall Study||160
8685280|NCT00820248|9729510|FG001|STARTED|Overall Study||160
8685281|NCT00820248|9729509|FG000|Received Protocol Treatment|Overall Study||156
8685282|NCT00820248|9729510|FG001|Received Protocol Treatment|Overall Study||159
8685283|NCT00820248|9729509|FG000|COMPLETED|Overall Study||156
8685284|NCT00820248|9729510|FG001|COMPLETED|Overall Study||159
8685285|NCT00820248|9729509|FG000|NOT COMPLETED|Overall Study||4
8685286|NCT00820248|9729510|FG001|NOT COMPLETED|Overall Study||1
8693126|NCT00864032|9738510|FG001|NOT COMPLETED|Overall Study||0
8693127|NCT00864032|9738511|FG002|NOT COMPLETED|Overall Study||0
8693128|NCT00864084|9738517|FG000|STARTED|Overall Study||14
8693129|NCT00864084|9738517|FG000|COMPLETED|Overall Study||11
8693130|NCT00864084|9738517|FG000|NOT COMPLETED|Overall Study||3
8693131|NCT00864097|9738530|FG000|STARTED|Overall Study||154
8693132|NCT00864097|9738531|FG001|STARTED|Overall Study||157
8693133|NCT00864097|9738532|FG002|STARTED|Overall Study||151
8693134|NCT00864097|9738533|FG003|STARTED|Overall Study||145
8693135|NCT00864097|9738530|FG000|Treated|Overall Study||152
8693136|NCT00864097|9738531|FG001|Treated|Overall Study||157
8693137|NCT00864097|9738532|FG002|Treated|Overall Study||150
8693138|NCT00864097|9738533|FG003|Treated|Overall Study||145
8693139|NCT00864097|9738530|FG000|COMPLETED|Overall Study||15
8693140|NCT00864097|9738531|FG001|COMPLETED|Overall Study||20
8693141|NCT00864097|9738532|FG002|COMPLETED|Overall Study||19
8693142|NCT00864097|9738533|FG003|COMPLETED|Overall Study||20
8693143|NCT00864097|9738530|FG000|NOT COMPLETED|Overall Study||139
8693144|NCT00864097|9738531|FG001|NOT COMPLETED|Overall Study||137
8693145|NCT00864097|9738532|FG002|NOT COMPLETED|Overall Study||132
8693146|NCT00864097|9738533|FG003|NOT COMPLETED|Overall Study||125
8693147|NCT00864123|9738545|FG000|STARTED|Overall Study||15
8693148|NCT00864123|9738546|FG001|STARTED|Overall Study||15
8693149|NCT00864123|9738545|FG000|COMPLETED|Overall Study||15
8693150|NCT00864123|9738546|FG001|COMPLETED|Overall Study||15
8693151|NCT00864123|9738545|FG000|NOT COMPLETED|Overall Study||0
8693152|NCT00864123|9738546|FG001|NOT COMPLETED|Overall Study||0
8693153|NCT00864253|9738554|FG000|STARTED|Overall Study||264
8693154|NCT00864253|9738555|FG001|STARTED|Overall Study||265
8693155|NCT00864253|9738554|FG000|Treated|Overall Study||257
8693156|NCT00864253|9738555|FG001|Treated|Overall Study||258
8693157|NCT00864253|9738554|FG000|COMPLETED|Overall Study|Completed = defined as discontinuation due to progressive disease|165
8693158|NCT00864253|9738555|FG001|COMPLETED|Overall Study|Completed = defined as discontinuation due to progressive disease|207
8693159|NCT00864253|9738554|FG000|NOT COMPLETED|Overall Study||99
8693160|NCT00864253|9738555|FG001|NOT COMPLETED|Overall Study||58
8693161|NCT00864383|9738566|FG000|STARTED|Per- Protocol||640
8693162|NCT00864383|9738567|FG001|STARTED|Per- Protocol||655
8693163|NCT00864383|9738568|FG002|STARTED|Per- Protocol||636
8693164|NCT00864383|9738566|FG000|COMPLETED|Per- Protocol||510
8693165|NCT00864383|9738567|FG001|COMPLETED|Per- Protocol||514
8693166|NCT00864383|9738568|FG002|COMPLETED|Per- Protocol||524
8693167|NCT00864383|9738566|FG000|NOT COMPLETED|Per- Protocol||130
8693168|NCT00864383|9738567|FG001|NOT COMPLETED|Per- Protocol||141
8693169|NCT00864383|9738568|FG002|NOT COMPLETED|Per- Protocol||112
8693170|NCT00864383|9738566|FG000|STARTED|Modified Intent to Treat||640
8693171|NCT00864383|9738567|FG001|STARTED|Modified Intent to Treat||655
8693172|NCT00864383|9738568|FG002|STARTED|Modified Intent to Treat||636
8693173|NCT00864383|9738566|FG000|COMPLETED|Modified Intent to Treat||555
8693174|NCT00864383|9738567|FG001|COMPLETED|Modified Intent to Treat||568
8693175|NCT00864383|9738568|FG002|COMPLETED|Modified Intent to Treat||551
8693176|NCT00864383|9738566|FG000|NOT COMPLETED|Modified Intent to Treat||85
8693177|NCT00864383|9738567|FG001|NOT COMPLETED|Modified Intent to Treat||87
8693178|NCT00864383|9738568|FG002|NOT COMPLETED|Modified Intent to Treat||85
8693179|NCT00864513|9738576|FG000|STARTED|Overall Study||15
8693180|NCT00864513|9738576|FG000|COMPLETED|Overall Study||12
8693181|NCT00864513|9738576|FG000|NOT COMPLETED|Overall Study||3
8693182|NCT00864539|9738586|FG000|STARTED|Overall Study||104
8693183|NCT00864539|9738587|FG001|STARTED|Overall Study||95
8693184|NCT00864539|9738588|FG002|STARTED|Overall Study||102
8693185|NCT00864539|9738589|FG003|STARTED|Overall Study||96
8693186|NCT00864539|9738590|FG004|STARTED|Overall Study||103
8693187|NCT00864539|9738591|FG005|STARTED|Overall Study||85
8693188|NCT00864539|9738586|FG000|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|95
8693189|NCT00864539|9738587|FG001|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|72
8693190|NCT00864539|9738588|FG002|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|92
8693191|NCT00864539|9738589|FG003|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|89
8693192|NCT00864539|9738590|FG004|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|81
8693193|NCT00864539|9738591|FG005|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|71
8693194|NCT00864539|9738586|FG000|NOT COMPLETED|Overall Study||9
8693195|NCT00864539|9738587|FG001|NOT COMPLETED|Overall Study||23
8693196|NCT00864539|9738588|FG002|NOT COMPLETED|Overall Study||10
8693197|NCT00864539|9738589|FG003|NOT COMPLETED|Overall Study||7
8693198|NCT00864539|9738590|FG004|NOT COMPLETED|Overall Study||22
8693199|NCT00864539|9738591|FG005|NOT COMPLETED|Overall Study||14
8693200|NCT00864682|9738608|FG000|STARTED|Overall Study||52
8693201|NCT00864682|9738609|FG001|STARTED|Overall Study||51
8693202|NCT00864682|9738610|FG002|STARTED|Overall Study||53
8693203|NCT00864682|9738608|FG000|COMPLETED|Overall Study||50
8693204|NCT00864682|9738609|FG001|COMPLETED|Overall Study||50
8693205|NCT00864682|9738610|FG002|COMPLETED|Overall Study||51
8693206|NCT00864682|9738608|FG000|NOT COMPLETED|Overall Study||2
8693207|NCT00864682|9738609|FG001|NOT COMPLETED|Overall Study||1
8685287|NCT00820443|9729516|FG000|STARTED|Pre-Op||253
8801230|NCT01449370|9852983|FG015|NOT COMPLETED|Overall Study||3
8801231|NCT01449370|9852984|FG016|NOT COMPLETED|Overall Study||7
8801232|NCT01449370|9852985|FG017|NOT COMPLETED|Overall Study||3
8801233|NCT01449370|9852986|FG018|NOT COMPLETED|Overall Study||3
8801234|NCT01449370|9852987|FG019|NOT COMPLETED|Overall Study||3
8801235|NCT01449370|9852988|FG020|NOT COMPLETED|Overall Study||6
8801236|NCT01449370|9852989|FG021|NOT COMPLETED|Overall Study||4
8801237|NCT01449370|9852990|FG022|NOT COMPLETED|Overall Study||4
8801238|NCT01449370|9852991|FG023|NOT COMPLETED|Overall Study||10
8801239|NCT01449370|9852992|FG024|NOT COMPLETED|Overall Study||8
8801240|NCT01449461|9853071|FG000|STARTED|Overall Study||6
8801241|NCT01449461|9853072|FG001|STARTED|Overall Study||18
8801242|NCT01449461|9853073|FG002|STARTED|Overall Study||18
8801243|NCT01449461|9853074|FG003|STARTED|Overall Study||32
8801244|NCT01449461|9853075|FG004|STARTED|Overall Study||48
8801245|NCT01449461|9853076|FG005|STARTED|Overall Study||15
8801246|NCT01449461|9853071|FG000|COMPLETED|Overall Study||0
8801247|NCT01449461|9853072|FG001|COMPLETED|Overall Study||0
8801248|NCT01449461|9853073|FG002|COMPLETED|Overall Study||0
8801249|NCT01449461|9853074|FG003|COMPLETED|Overall Study||0
8801250|NCT01449461|9853075|FG004|COMPLETED|Overall Study||0
8801251|NCT01449461|9853076|FG005|COMPLETED|Overall Study||0
8801252|NCT01449461|9853071|FG000|NOT COMPLETED|Overall Study||6
8801253|NCT01449461|9853072|FG001|NOT COMPLETED|Overall Study||18
8801254|NCT01449461|9853073|FG002|NOT COMPLETED|Overall Study||18
8801255|NCT01449461|9853074|FG003|NOT COMPLETED|Overall Study||32
8801256|NCT01449461|9853075|FG004|NOT COMPLETED|Overall Study||48
8801257|NCT01449461|9853076|FG005|NOT COMPLETED|Overall Study||15
8801258|NCT01449513|9853101|FG000|STARTED|Overall Study||16
8801259|NCT01449513|9853102|FG001|STARTED|Overall Study||8
8801260|NCT01449513|9853101|FG000|COMPLETED|Overall Study||16
8801261|NCT01449513|9853102|FG001|COMPLETED|Overall Study||8
8801262|NCT01449513|9853101|FG000|NOT COMPLETED|Overall Study||0
8801263|NCT01449513|9853102|FG001|NOT COMPLETED|Overall Study||0
8801264|NCT01449526|9853110|FG000|STARTED|Overall Study||83
8801265|NCT01449526|9853111|FG001|STARTED|Overall Study||83
8801266|NCT01449526|9853110|FG000|COMPLETED|Overall Study||81
8801267|NCT01449526|9853111|FG001|COMPLETED|Overall Study||77
8801268|NCT01449526|9853110|FG000|NOT COMPLETED|Overall Study||2
8801269|NCT01449526|9853111|FG001|NOT COMPLETED|Overall Study||6
8801270|NCT01449539|9853117|FG000|STARTED|Overall Study||8
8801271|NCT01449539|9853117|FG000|COMPLETED|Overall Study||4
8801272|NCT01449539|9853117|FG000|NOT COMPLETED|Overall Study||4
8801273|NCT01449630|9853130|FG000|STARTED|Period 1||2
8685288|NCT00820443|9729516|FG000|COMPLETED|Pre-Op||253
8685289|NCT00820443|9729516|FG000|NOT COMPLETED|Pre-Op||0
8685290|NCT00820443|9729516|FG000|STARTED|Op||253
8685291|NCT00820443|9729516|FG000|COMPLETED|Op||253
8685292|NCT00820443|9729516|FG000|NOT COMPLETED|Op||0
8685293|NCT00820443|9729516|FG000|STARTED|Immediately||253
8685294|NCT00820443|9729516|FG000|COMPLETED|Immediately||248
8685295|NCT00820443|9729516|FG000|NOT COMPLETED|Immediately||5
8685296|NCT00820443|9729516|FG000|STARTED|3 Month||253
8685297|NCT00820443|9729516|FG000|COMPLETED|3 Month||244
8685298|NCT00820443|9729516|FG000|NOT COMPLETED|3 Month||9
8685299|NCT00820443|9729516|FG000|STARTED|6 Month||253
8685300|NCT00820443|9729516|FG000|COMPLETED|6 Month||233
8685301|NCT00820443|9729516|FG000|NOT COMPLETED|6 Month||20
8685302|NCT00820443|9729516|FG000|STARTED|12 Month||250
8685303|NCT00820443|9729516|FG000|COMPLETED|12 Month||226
8685304|NCT00820443|9729516|FG000|NOT COMPLETED|12 Month||24
8685305|NCT00820443|9729516|FG000|STARTED|24 Month||245
8685306|NCT00820443|9729516|FG000|COMPLETED|24 Month||202
8685307|NCT00820443|9729516|FG000|NOT COMPLETED|24 Month||43
8685308|NCT00820534|9729523|FG000|STARTED|Overall Study||64
8685309|NCT00820534|9729524|FG001|STARTED|Overall Study||62
8685310|NCT00820534|9729523|FG000|COMPLETED|Overall Study||64
8685311|NCT00820534|9729524|FG001|COMPLETED|Overall Study||62
8685312|NCT00820534|9729523|FG000|NOT COMPLETED|Overall Study||0
8685313|NCT00820534|9729524|FG001|NOT COMPLETED|Overall Study||0
8685314|NCT00820573|9729534|FG000|STARTED|Overall Study||4
8685315|NCT00820573|9729535|FG001|STARTED|Overall Study||4
8685316|NCT00820573|9729536|FG002|STARTED|Overall Study||4
8685317|NCT00820573|9729537|FG003|STARTED|Overall Study||4
8685318|NCT00820573|9729534|FG000|COMPLETED|Overall Study||4
8685319|NCT00820573|9729535|FG001|COMPLETED|Overall Study||4
8685320|NCT00820573|9729536|FG002|COMPLETED|Overall Study||4
8685321|NCT00820573|9729537|FG003|COMPLETED|Overall Study||4
8685322|NCT00820573|9729534|FG000|NOT COMPLETED|Overall Study||0
8685323|NCT00820573|9729535|FG001|NOT COMPLETED|Overall Study||0
8685324|NCT00820573|9729536|FG002|NOT COMPLETED|Overall Study||0
8685325|NCT00820573|9729537|FG003|NOT COMPLETED|Overall Study||0
8685326|NCT00820599|9729556|FG000|STARTED|Overall Study||211
8685327|NCT00820599|9729556|FG000|COMPLETED|Overall Study||80
8685328|NCT00820599|9729556|FG000|NOT COMPLETED|Overall Study||131
8685329|NCT00820612|9729562|FG000|STARTED|Overall Study||307
8685330|NCT00820612|9729563|FG001|STARTED|Overall Study||295
8685331|NCT00820612|9729562|FG000|COMPLETED|Overall Study||307
8685332|NCT00820612|9729563|FG001|COMPLETED|Overall Study||295
8685333|NCT00820612|9729562|FG000|NOT COMPLETED|Overall Study||0
8685334|NCT00820612|9729563|FG001|NOT COMPLETED|Overall Study||0
8801274|NCT01449630|9853131|FG001|STARTED|Period 1||6
8801275|NCT01449630|9853132|FG002|STARTED|Period 1||2
8685335|NCT00820664|9729572|FG000|STARTED|Overall Study||9
8685336|NCT00820664|9729573|FG001|STARTED|Overall Study||11
8685337|NCT00820664|9729574|FG002|STARTED|Overall Study||9
8685338|NCT00820664|9729572|FG000|COMPLETED|Overall Study||9
8685339|NCT00820664|9729573|FG001|COMPLETED|Overall Study||11
8685340|NCT00820664|9729574|FG002|COMPLETED|Overall Study||9
8685341|NCT00820664|9729572|FG000|NOT COMPLETED|Overall Study||0
8685342|NCT00820664|9729573|FG001|NOT COMPLETED|Overall Study||0
8685343|NCT00820664|9729574|FG002|NOT COMPLETED|Overall Study||0
8685344|NCT00820755|9729582|FG000|STARTED|Period 1: Combination Therapy Phase||583
8685345|NCT00820755|9729583|FG001|STARTED|Period 1: Combination Therapy Phase||0
8685346|NCT00820755|9729584|FG002|STARTED|Period 1: Combination Therapy Phase||0
8685347|NCT00820755|9729582|FG000|COMPLETED|Period 1: Combination Therapy Phase|2 of 313 participants excluded from maintenance phase analysis (reason: not eligible)|313
8685348|NCT00820755|9729583|FG001|COMPLETED|Period 1: Combination Therapy Phase||0
8685349|NCT00820755|9729584|FG002|COMPLETED|Period 1: Combination Therapy Phase||0
8685350|NCT00820755|9729582|FG000|NOT COMPLETED|Period 1: Combination Therapy Phase||270
8685351|NCT00820755|9729583|FG001|NOT COMPLETED|Period 1: Combination Therapy Phase||0
8685352|NCT00820755|9729584|FG002|NOT COMPLETED|Period 1: Combination Therapy Phase||0
8801276|NCT01449630|9853133|FG003|STARTED|Period 1||2
8801277|NCT01449630|9853134|FG004|STARTED|Period 1||5
8801278|NCT01449630|9853135|FG005|STARTED|Period 1||2
8801279|NCT01449630|9853136|FG006|STARTED|Period 1||2
8801280|NCT01449630|9853137|FG007|STARTED|Period 1||6
8801281|NCT01449630|9853138|FG008|STARTED|Period 1||2
8801282|NCT01449630|9853130|FG000|Received at Least 1 Dose|Period 1||2
8801283|NCT01449630|9853131|FG001|Received at Least 1 Dose|Period 1||6
8801284|NCT01449630|9853132|FG002|Received at Least 1 Dose|Period 1||2
8801285|NCT01449630|9853133|FG003|Received at Least 1 Dose|Period 1||2
8801286|NCT01449630|9853134|FG004|Received at Least 1 Dose|Period 1||5
8801287|NCT01449630|9853135|FG005|Received at Least 1 Dose|Period 1||1
8801288|NCT01449630|9853136|FG006|Received at Least 1 Dose|Period 1||2
8801289|NCT01449630|9853137|FG007|Received at Least 1 Dose|Period 1||6
8801290|NCT01449630|9853138|FG008|Received at Least 1 Dose|Period 1||2
8801291|NCT01449630|9853130|FG000|COMPLETED|Period 1||1
8801292|NCT01449630|9853131|FG001|COMPLETED|Period 1||6
8801293|NCT01449630|9853132|FG002|COMPLETED|Period 1||2
8801294|NCT01449630|9853133|FG003|COMPLETED|Period 1||1
8801295|NCT01449630|9853134|FG004|COMPLETED|Period 1||5
8801296|NCT01449630|9853135|FG005|COMPLETED|Period 1||1
8801297|NCT01449630|9853136|FG006|COMPLETED|Period 1||2
8801298|NCT01449630|9853137|FG007|COMPLETED|Period 1||6
8801299|NCT01449630|9853138|FG008|COMPLETED|Period 1||2
8801300|NCT01449630|9853130|FG000|NOT COMPLETED|Period 1||1
8919401|NCT02207244|9979299|FG009|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0
8919402|NCT02207244|9979300|FG010|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0
8919403|NCT02207244|9979290|FG000|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
8919404|NCT02207244|9979291|FG001|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
8919405|NCT02207244|9979292|FG002|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
8919406|NCT02207244|9979293|FG003|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
8919407|NCT02207244|9979294|FG004|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
8919408|NCT02207244|9979295|FG005|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
8919409|NCT02207244|9979296|FG006|COMPLETED|Withdrawal and Re-treatment: Week 28-72||213
8919410|NCT02207244|9979297|FG007|COMPLETED|Withdrawal and Re-treatment: Week 28-72||443
8919411|NCT02207244|9979298|FG008|COMPLETED|Withdrawal and Re-treatment: Week 28-72||211
8919412|NCT02207244|9979299|FG009|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
8919413|NCT02207244|9979300|FG010|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
8919414|NCT02207244|9979290|FG000|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
8919415|NCT02207244|9979291|FG001|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
8919416|NCT02207244|9979292|FG002|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
8919417|NCT02207244|9979293|FG003|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
8919418|NCT02207244|9979294|FG004|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
8919419|NCT02207244|9979295|FG005|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
8919420|NCT02207244|9979296|FG006|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||14
8919421|NCT02207244|9979297|FG007|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||27
8919422|NCT02207244|9979298|FG008|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||9
8919423|NCT02207244|9979299|FG009|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||8
8919424|NCT02207244|9979300|FG010|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
8919425|NCT02207244|9979290|FG000|STARTED|Open-label Guselkumab: Week 72-264||0
8919426|NCT02207244|9979291|FG001|STARTED|Open-label Guselkumab: Week 72-264||0
8919427|NCT02207244|9979292|FG002|STARTED|Open-label Guselkumab: Week 72-264||0
8919428|NCT02207244|9979293|FG003|STARTED|Open-label Guselkumab: Week 72-264||0
8919429|NCT02207244|9979294|FG004|STARTED|Open-label Guselkumab: Week 72-264||0
8919430|NCT02207244|9979295|FG005|STARTED|Open-label Guselkumab: Week 72-264||0
8685353|NCT00820755|9729582|FG000|STARTED|Period 2: Maintenance Therapy Phase||0
8685354|NCT00820755|9729583|FG001|STARTED|Period 2: Maintenance Therapy Phase||157
8685355|NCT00820755|9729584|FG002|STARTED|Period 2: Maintenance Therapy Phase||154
8801301|NCT01449630|9853131|FG001|NOT COMPLETED|Period 1||0
8801302|NCT01449630|9853132|FG002|NOT COMPLETED|Period 1||0
8801303|NCT01449630|9853133|FG003|NOT COMPLETED|Period 1||1
8801304|NCT01449630|9853134|FG004|NOT COMPLETED|Period 1||0
8685356|NCT00820755|9729582|FG000|COMPLETED|Period 2: Maintenance Therapy Phase||0
8685357|NCT00820755|9729583|FG001|COMPLETED|Period 2: Maintenance Therapy Phase||112
8685358|NCT00820755|9729584|FG002|COMPLETED|Period 2: Maintenance Therapy Phase||109
8685359|NCT00820755|9729582|FG000|NOT COMPLETED|Period 2: Maintenance Therapy Phase||0
8685360|NCT00820755|9729583|FG001|NOT COMPLETED|Period 2: Maintenance Therapy Phase||45
8685361|NCT00820755|9729584|FG002|NOT COMPLETED|Period 2: Maintenance Therapy Phase||45
8685362|NCT00820872|9729592|FG000|STARTED|Overall Study||30
8685363|NCT00820872|9729592|FG000|COMPLETED|Overall Study||30
8685364|NCT00820872|9729592|FG000|NOT COMPLETED|Overall Study||0
8685365|NCT00820898|9729596|FG000|STARTED|Overall Study||24
8685366|NCT00820898|9729596|FG000|COMPLETED|Overall Study||23
8685367|NCT00820898|9729596|FG000|NOT COMPLETED|Overall Study||1
8685368|NCT00821015|9729606|FG000|STARTED|Overall Study||27
8685369|NCT00821015|9729606|FG000|COMPLETED|Overall Study||15
8685370|NCT00821015|9729606|FG000|NOT COMPLETED|Overall Study||12
8685371|NCT00821041|9729612|FG000|STARTED|Overall Study||59
8685372|NCT00821041|9729613|FG001|STARTED|Overall Study||59
8685373|NCT00821041|9729612|FG000|COMPLETED|Overall Study||59
8685374|NCT00821041|9729613|FG001|COMPLETED|Overall Study||59
8685375|NCT00821041|9729612|FG000|NOT COMPLETED|Overall Study||0
8685376|NCT00821041|9729613|FG001|NOT COMPLETED|Overall Study||0
8685377|NCT00821093|9729621|FG000|STARTED|Overall Study||560
8685378|NCT00821093|9729622|FG001|STARTED|Overall Study||563
8685379|NCT00821093|9729621|FG000|Exposed to Drug|Overall Study||559
8685380|NCT00821093|9729622|FG001|Exposed to Drug|Overall Study||562
8685381|NCT00821093|9729621|FG000|COMPLETED|Overall Study||511
8685382|NCT00821093|9729622|FG001|COMPLETED|Overall Study||523
8685383|NCT00821093|9729621|FG000|NOT COMPLETED|Overall Study||49
8685384|NCT00821093|9729622|FG001|NOT COMPLETED|Overall Study||40
8685385|NCT00821119|9729630|FG000|STARTED|Overall Study||100
8685386|NCT00821119|9729631|FG001|STARTED|Overall Study||100
8685387|NCT00821119|9729630|FG000|COMPLETED|Overall Study||100
8685388|NCT00821119|9729631|FG001|COMPLETED|Overall Study||100
8685389|NCT00821119|9729630|FG000|NOT COMPLETED|Overall Study||0
8685390|NCT00821119|9729631|FG001|NOT COMPLETED|Overall Study||0
8685391|NCT00821184|9729641|FG000|STARTED|Overall Study||6
8685392|NCT00821184|9729642|FG001|STARTED|Overall Study||6
8685393|NCT00821184|9729641|FG000|COMPLETED|Overall Study||6
8685394|NCT00821184|9729642|FG001|COMPLETED|Overall Study||6
8685395|NCT00821184|9729641|FG000|NOT COMPLETED|Overall Study||0
8685396|NCT00821184|9729642|FG001|NOT COMPLETED|Overall Study||0
8693208|NCT00864682|9738610|FG002|NOT COMPLETED|Overall Study||2
8693209|NCT00864708|9738618|FG000|STARTED|Overall Study||1
8693210|NCT00864708|9738618|FG000|COMPLETED|Overall Study||1
8693211|NCT00864708|9738618|FG000|NOT COMPLETED|Overall Study||0
8693212|NCT00864721|9738624|FG000|STARTED|Overall Study||63
8693213|NCT00864721|9738624|FG000|COMPLETED|Overall Study||29
8693214|NCT00864721|9738624|FG000|NOT COMPLETED|Overall Study||34
8693215|NCT00864851|9738631|FG000|STARTED|Overall Study||20
8693216|NCT00864851|9738632|FG001|STARTED|Overall Study||19
8693217|NCT00864851|9738633|FG002|STARTED|Overall Study||5
8693218|NCT00864851|9738631|FG000|COMPLETED|Overall Study||17
8693219|NCT00864851|9738632|FG001|COMPLETED|Overall Study||18
8693220|NCT00864851|9738633|FG002|COMPLETED|Overall Study||5
8693221|NCT00864851|9738631|FG000|NOT COMPLETED|Overall Study||3
8693222|NCT00864851|9738632|FG001|NOT COMPLETED|Overall Study||1
8693223|NCT00864851|9738633|FG002|NOT COMPLETED|Overall Study||0
8693224|NCT00864916|9738645|FG000|STARTED|Overall Study||10
8693225|NCT00864916|9738646|FG001|STARTED|Overall Study||9
8693226|NCT00864916|9738645|FG000|COMPLETED|Overall Study||4
8693227|NCT00864916|9738646|FG001|COMPLETED|Overall Study||5
8693228|NCT00864916|9738645|FG000|NOT COMPLETED|Overall Study||6
8693229|NCT00864916|9738646|FG001|NOT COMPLETED|Overall Study||4
8693230|NCT00865020|9738654|FG000|STARTED|Overall Study||414
8693231|NCT00865020|9738655|FG001|STARTED|Overall Study||408
8801305|NCT01449630|9853135|FG005|NOT COMPLETED|Period 1||1
8801306|NCT01449630|9853136|FG006|NOT COMPLETED|Period 1||0
8801307|NCT01449630|9853137|FG007|NOT COMPLETED|Period 1||0
8801308|NCT01449630|9853138|FG008|NOT COMPLETED|Period 1||0
8801309|NCT01449630|9853130|FG000|STARTED|Period 2||1
8801310|NCT01449630|9853131|FG001|STARTED|Period 2||6
8801311|NCT01449630|9853132|FG002|STARTED|Period 2||2
8801312|NCT01449630|9853133|FG003|STARTED|Period 2||1
8801313|NCT01449630|9853134|FG004|STARTED|Period 2||5
8801314|NCT01449630|9853135|FG005|STARTED|Period 2||1
8801315|NCT01449630|9853136|FG006|STARTED|Period 2||2
8801316|NCT01449630|9853137|FG007|STARTED|Period 2||6
8693232|NCT00865020|9738654|FG000|COMPLETED|Overall Study||365
8693233|NCT00865020|9738655|FG001|COMPLETED|Overall Study||357
8693234|NCT00865020|9738654|FG000|NOT COMPLETED|Overall Study||49
8693235|NCT00865020|9738655|FG001|NOT COMPLETED|Overall Study||51
8693236|NCT00865046|9738664|FG000|STARTED|Overall Study||63
8693237|NCT00865046|9738665|FG001|STARTED|Overall Study||64
8693238|NCT00865046|9738666|FG002|STARTED|Overall Study||63
8693239|NCT00865046|9738664|FG000|COMPLETED|Overall Study||57
8693240|NCT00865046|9738665|FG001|COMPLETED|Overall Study||59
8693241|NCT00865046|9738666|FG002|COMPLETED|Overall Study||62
8693242|NCT00865046|9738664|FG000|NOT COMPLETED|Overall Study||6
8693243|NCT00865046|9738665|FG001|NOT COMPLETED|Overall Study||5
8693244|NCT00865046|9738666|FG002|NOT COMPLETED|Overall Study||1
8693245|NCT00865098|9738674|FG000|STARTED|Overall Study||22
8801317|NCT01449630|9853138|FG008|STARTED|Period 2||2
8801318|NCT01449630|9853130|FG000|COMPLETED|Period 2||1
8685397|NCT04187989|9729652|FG000|STARTED|Overall Study - 3-Month Follow-Up||76
8685398|NCT04187989|9729653|FG001|STARTED|Overall Study - 3-Month Follow-Up||73
8685399|NCT04187989|9729652|FG000|COMPLETED|Overall Study - 3-Month Follow-Up||70
8685400|NCT04187989|9729653|FG001|COMPLETED|Overall Study - 3-Month Follow-Up||65
8685401|NCT04187989|9729652|FG000|NOT COMPLETED|Overall Study - 3-Month Follow-Up||6
8685402|NCT04187989|9729653|FG001|NOT COMPLETED|Overall Study - 3-Month Follow-Up||8
8685403|NCT04187989|9729652|FG000|STARTED|Overall Study - 6-Month Follow-Up||76
8685404|NCT04187989|9729653|FG001|STARTED|Overall Study - 6-Month Follow-Up||73
8685405|NCT04187989|9729652|FG000|COMPLETED|Overall Study - 6-Month Follow-Up||68
8685406|NCT04187989|9729653|FG001|COMPLETED|Overall Study - 6-Month Follow-Up||65
8685407|NCT04187989|9729652|FG000|NOT COMPLETED|Overall Study - 6-Month Follow-Up||8
8685408|NCT04187989|9729653|FG001|NOT COMPLETED|Overall Study - 6-Month Follow-Up||8
8685409|NCT04109118|9729659|FG000|STARTED|Overall Study||4
8685410|NCT04109118|9729659|FG000|COMPLETED|Overall Study||1
8685411|NCT04109118|9729659|FG000|NOT COMPLETED|Overall Study||3
8685412|NCT04045132|9729666|FG000|STARTED|Overall Study||37
8685413|NCT04045132|9729667|FG001|STARTED|Overall Study||38
8685414|NCT04045132|9729666|FG000|COMPLETED|Overall Study||34
8685415|NCT04045132|9729667|FG001|COMPLETED|Overall Study||31
8685416|NCT04045132|9729666|FG000|NOT COMPLETED|Overall Study||3
8685417|NCT04045132|9729667|FG001|NOT COMPLETED|Overall Study||7
8685418|NCT03846219|9729678|FG000|STARTED|Overall Study||72
8685419|NCT03846219|9729679|FG001|STARTED|Overall Study||69
8685420|NCT03846219|9729680|FG002|STARTED|Overall Study||69
8685421|NCT03846219|9729678|FG000|Patients Treated|Overall Study||71
8685422|NCT03846219|9729679|FG001|Patients Treated|Overall Study||69
8685423|NCT03846219|9729680|FG002|Patients Treated|Overall Study||69
8685424|NCT03846219|9729678|FG000|COMPLETED|Overall Study||69
8685425|NCT03846219|9729679|FG001|COMPLETED|Overall Study||65
8685426|NCT03846219|9729680|FG002|COMPLETED|Overall Study||64
8685427|NCT03846219|9729678|FG000|NOT COMPLETED|Overall Study||3
8685428|NCT03846219|9729679|FG001|NOT COMPLETED|Overall Study||4
8685429|NCT03846219|9729680|FG002|NOT COMPLETED|Overall Study||5
8685430|NCT03758404|9729699|FG000|STARTED|Overall Study||3
8685431|NCT03758404|9729700|FG001|STARTED|Overall Study||3
8685432|NCT03758404|9729701|FG002|STARTED|Overall Study||5
8685433|NCT03758404|9729699|FG000|COMPLETED|Overall Study||3
8685434|NCT03758404|9729700|FG001|COMPLETED|Overall Study||3
8919431|NCT02207244|9979296|FG006|STARTED|Open-label Guselkumab: Week 72-264||0
8919432|NCT02207244|9979297|FG007|STARTED|Open-label Guselkumab: Week 72-264||0
8919433|NCT02207244|9979298|FG008|STARTED|Open-label Guselkumab: Week 72-264||211
8919434|NCT02207244|9979299|FG009|STARTED|Open-label Guselkumab: Week 72-264||0
8919435|NCT02207244|9979300|FG010|STARTED|Open-label Guselkumab: Week 72-264||656
8919436|NCT02207244|9979290|FG000|COMPLETED|Open-label Guselkumab: Week 72-264||0
8919437|NCT02207244|9979291|FG001|COMPLETED|Open-label Guselkumab: Week 72-264||0
8919438|NCT02207244|9979292|FG002|COMPLETED|Open-label Guselkumab: Week 72-264||0
8919439|NCT02207244|9979293|FG003|COMPLETED|Open-label Guselkumab: Week 72-264||0
8919440|NCT02207244|9979294|FG004|COMPLETED|Open-label Guselkumab: Week 72-264||0
8919441|NCT02207244|9979295|FG005|COMPLETED|Open-label Guselkumab: Week 72-264||0
8919442|NCT02207244|9979296|FG006|COMPLETED|Open-label Guselkumab: Week 72-264||0
8919443|NCT02207244|9979297|FG007|COMPLETED|Open-label Guselkumab: Week 72-264||0
8919444|NCT02207244|9979298|FG008|COMPLETED|Open-label Guselkumab: Week 72-264||173
8919445|NCT02207244|9979299|FG009|COMPLETED|Open-label Guselkumab: Week 72-264||0
8919446|NCT02207244|9979300|FG010|COMPLETED|Open-label Guselkumab: Week 72-264||554
8919447|NCT02207244|9979290|FG000|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0
8919448|NCT02207244|9979291|FG001|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0
8919449|NCT02207244|9979292|FG002|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0
8919450|NCT02207244|9979293|FG003|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0
8919451|NCT02207244|9979294|FG004|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0
8919452|NCT02207244|9979295|FG005|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0
8919453|NCT02207244|9979296|FG006|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0
8919454|NCT02207244|9979297|FG007|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0
8919455|NCT02207244|9979298|FG008|NOT COMPLETED|Open-label Guselkumab: Week 72-264||38
8919456|NCT02207244|9979299|FG009|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0
8919457|NCT02207244|9979300|FG010|NOT COMPLETED|Open-label Guselkumab: Week 72-264||102
8919458|NCT02207322|9979331|FG000|STARTED|Overall Study||79
8919459|NCT02207322|9979332|FG001|STARTED|Overall Study||81
8919460|NCT02207322|9979331|FG000|Week-2|Overall Study||77
8919461|NCT02207322|9979332|FG001|Week-2|Overall Study||80
8919462|NCT02207322|9979331|FG000|3-month|Overall Study||74
8919463|NCT02207322|9979332|FG001|3-month|Overall Study||75
8919464|NCT02207322|9979331|FG000|COMPLETED|Overall Study|6-month|70
8919465|NCT02207322|9979332|FG001|COMPLETED|Overall Study|6-month|71
8919466|NCT02207322|9979331|FG000|NOT COMPLETED|Overall Study||9
8919467|NCT02207322|9979332|FG001|NOT COMPLETED|Overall Study||10
8919468|NCT02207374|9979341|FG000|STARTED|Overall Study||239
8919469|NCT02207374|9979342|FG001|STARTED|Overall Study||241
8919470|NCT02207374|9979343|FG002|STARTED|Overall Study||121
8919471|NCT02207374|9979341|FG000|Exposed|Overall Study||239
8919472|NCT02207374|9979342|FG001|Exposed|Overall Study||241
8919473|NCT02207374|9979343|FG002|Exposed|Overall Study||120
8919474|NCT02207374|9979341|FG000|COMPLETED|Overall Study||233
8919475|NCT02207374|9979342|FG001|COMPLETED|Overall Study||231
8919476|NCT02207374|9979343|FG002|COMPLETED|Overall Study||115
8685435|NCT03758404|9729701|FG002|COMPLETED|Overall Study||5
8685436|NCT03758404|9729699|FG000|NOT COMPLETED|Overall Study||0
8685437|NCT03758404|9729700|FG001|NOT COMPLETED|Overall Study||0
8685438|NCT03758404|9729701|FG002|NOT COMPLETED|Overall Study||0
8685439|NCT03698708|9729711|FG000|STARTED|Overall Study||17
8685440|NCT03698708|9729712|FG001|STARTED|Overall Study||20
8685441|NCT03698708|9729711|FG000|COMPLETED|Overall Study||13
8685442|NCT03698708|9729712|FG001|COMPLETED|Overall Study||16
8685443|NCT03698708|9729711|FG000|NOT COMPLETED|Overall Study||4
8685444|NCT03698708|9729712|FG001|NOT COMPLETED|Overall Study||4
8693246|NCT00865098|9738674|FG000|COMPLETED|Overall Study|Discontinued from the study due to progressive disease, after completing planned treatment schedule|21
8693247|NCT00865098|9738674|FG000|NOT COMPLETED|Overall Study||1
8693248|NCT00865124|9738681|FG000|STARTED|Overall Study||27
8693249|NCT00865124|9738682|FG001|STARTED|Overall Study||25
8693250|NCT00865124|9738683|FG002|STARTED|Overall Study||17
8693251|NCT00865124|9738681|FG000|COMPLETED|Overall Study||23
8919477|NCT02207374|9979341|FG000|NOT COMPLETED|Overall Study||6
8919478|NCT02207374|9979342|FG001|NOT COMPLETED|Overall Study||10
8919479|NCT02207374|9979343|FG002|NOT COMPLETED|Overall Study||6
8919480|NCT02207400|9979353|FG000|STARTED|Overall Study||123
8919481|NCT02207400|9979354|FG001|STARTED|Overall Study||123
8919482|NCT02207400|9979353|FG000|COMPLETED|Overall Study||107
8919483|NCT02207400|9979354|FG001|COMPLETED|Overall Study||109
8919484|NCT02207400|9979353|FG000|NOT COMPLETED|Overall Study||16
8919485|NCT02207400|9979354|FG001|NOT COMPLETED|Overall Study||14
8919486|NCT02207413|9979369|FG000|STARTED|Overall Study||60
8919487|NCT02207413|9979370|FG001|STARTED|Overall Study||60
8919488|NCT02207413|9979371|FG002|STARTED|Overall Study||410
8919489|NCT02207413|9979372|FG003|STARTED|Overall Study||411
8919490|NCT02207413|9979373|FG004|STARTED|Overall Study||466
8919491|NCT02207413|9979374|FG005|STARTED|Overall Study||474
8919492|NCT02207413|9979369|FG000|COMPLETED|Overall Study||59
8919493|NCT02207413|9979370|FG001|COMPLETED|Overall Study||60
8919494|NCT02207413|9979371|FG002|COMPLETED|Overall Study|Primed subjects: 309; Unprimed subjects: 101|410
8919495|NCT02207413|9979372|FG003|COMPLETED|Overall Study|Primed subjects: 312; Unprimed subjects: 98|410
8919496|NCT02207413|9979373|FG004|COMPLETED|Overall Study|Primed subjects: 40; Unprimed subjects: 419|459
8919497|NCT02207413|9979374|FG005|COMPLETED|Overall Study|Primed subjects: 41; Unprimed subjects: 420|461
8919498|NCT02207413|9979369|FG000|NOT COMPLETED|Overall Study||1
8919499|NCT02207413|9979370|FG001|NOT COMPLETED|Overall Study||0
8919500|NCT02207413|9979371|FG002|NOT COMPLETED|Overall Study||0
8919501|NCT02207413|9979372|FG003|NOT COMPLETED|Overall Study||1
8919502|NCT02207413|9979373|FG004|NOT COMPLETED|Overall Study||7
8919503|NCT02207413|9979374|FG005|NOT COMPLETED|Overall Study||13
8919504|NCT02207478|9979396|FG000|STARTED|Overall Study||40
8919505|NCT02207478|9979397|FG001|STARTED|Overall Study||46
8919506|NCT02207478|9979396|FG000|COMPLETED|Overall Study||40
8919507|NCT02207478|9979397|FG001|COMPLETED|Overall Study||46
8919508|NCT02207478|9979396|FG000|NOT COMPLETED|Overall Study||0
8919509|NCT02207478|9979397|FG001|NOT COMPLETED|Overall Study||0
8919510|NCT02207491|9979405|FG000|STARTED|Overall Study||202
8919511|NCT02207491|9979406|FG001|STARTED|Overall Study||209
8919512|NCT02207491|9979405|FG000|COMPLETED|Overall Study||171
8919513|NCT02207491|9979406|FG001|COMPLETED|Overall Study||196
8919514|NCT02207491|9979405|FG000|NOT COMPLETED|Overall Study||31
8919515|NCT02207491|9979406|FG001|NOT COMPLETED|Overall Study||13
8919516|NCT02207530|9979412|FG000|STARTED|Overall Study||112
8919517|NCT02207530|9979412|FG000|COMPLETED|Overall Study||21
8919518|NCT02207530|9979412|FG000|NOT COMPLETED|Overall Study||91
8919519|NCT02207556|9979418|FG000|STARTED|Overall Study||7
8919520|NCT02207556|9979419|FG001|STARTED|Overall Study||25
8919521|NCT02207556|9979418|FG000|COMPLETED|Overall Study||5
8919522|NCT02207556|9979419|FG001|COMPLETED|Overall Study||20
8919523|NCT02207556|9979418|FG000|NOT COMPLETED|Overall Study||2
8919524|NCT02207556|9979419|FG001|NOT COMPLETED|Overall Study||5
8919525|NCT02207569|9979428|FG000|STARTED|Enrolled to Implant|241 Attempted Implant|241
8919526|NCT02207569|9979428|FG000|COMPLETED|Enrolled to Implant|237 Implanted|237
8919527|NCT02207569|9979428|FG000|NOT COMPLETED|Enrolled to Implant||4
8919528|NCT02207569|9979428|FG000|STARTED|Implant to 1-Month|241 Attempted Implant|241
8919529|NCT02207569|9979428|FG000|COMPLETED|Implant to 1-Month||232
8919530|NCT02207569|9979428|FG000|NOT COMPLETED|Implant to 1-Month||9
8919531|NCT02207569|9979428|FG000|STARTED|1-Month to 6-Month||232
8919532|NCT02207569|9979428|FG000|COMPLETED|1-Month to 6-Month||222
8919533|NCT02207569|9979428|FG000|NOT COMPLETED|1-Month to 6-Month||10
8919534|NCT02207569|9979428|FG000|STARTED|12-Month||222
8919535|NCT02207569|9979428|FG000|COMPLETED|12-Month||213
8919536|NCT02207569|9979428|FG000|NOT COMPLETED|12-Month||9
8919537|NCT02207569|9979428|FG000|STARTED|6-Month to 12-Month||213
8919538|NCT02207569|9979428|FG000|COMPLETED|6-Month to 12-Month||197
8919539|NCT02207569|9979428|FG000|NOT COMPLETED|6-Month to 12-Month||16
8919540|NCT02207569|9979428|FG000|STARTED|12-Month to 24 Month||197
8919541|NCT02207569|9979428|FG000|COMPLETED|12-Month to 24 Month||171
8919542|NCT02207569|9979428|FG000|NOT COMPLETED|12-Month to 24 Month||26
8919543|NCT02207569|9979428|FG000|STARTED|24-Month to 36-Month||171
8919544|NCT02207569|9979428|FG000|COMPLETED|24-Month to 36-Month||144
8919545|NCT02207569|9979428|FG000|NOT COMPLETED|24-Month to 36-Month||27
8919546|NCT02207569|9979428|FG000|STARTED|36-Month to 48-Month||144
8919547|NCT02207569|9979428|FG000|COMPLETED|36-Month to 48-Month||113
8693252|NCT00865124|9738682|FG001|COMPLETED|Overall Study||24
8685445|NCT03608696|9729718|FG000|STARTED|Overall Study||10
8685446|NCT03608696|9729718|FG000|COMPLETED|Overall Study||10
8685447|NCT03608696|9729718|FG000|NOT COMPLETED|Overall Study||0
8685448|NCT03606668|9729722|FG000|STARTED|Overall Study||20
8685449|NCT03606668|9729722|FG000|COMPLETED|Overall Study||18
8685450|NCT03606668|9729722|FG000|NOT COMPLETED|Overall Study||2
8685451|NCT03575897|9729728|FG000|STARTED|Overall Study||25
8685452|NCT03575897|9729729|FG001|STARTED|Overall Study||25
8685453|NCT03575897|9729728|FG000|COMPLETED|Overall Study||13
8685454|NCT03575897|9729729|FG001|COMPLETED|Overall Study||12
8685455|NCT03575897|9729728|FG000|NOT COMPLETED|Overall Study||12
8685456|NCT03575897|9729729|FG001|NOT COMPLETED|Overall Study||13
8685457|NCT03343626|9729743|FG000|STARTED|Overall Study||31
8685458|NCT03343626|9729744|FG001|STARTED|Overall Study||31
8685459|NCT03343626|9729745|FG002|STARTED|Overall Study||31
8685460|NCT03343626|9729746|FG003|STARTED|Overall Study||32
8685461|NCT03343626|9729747|FG004|STARTED|Overall Study||36
8685462|NCT03343626|9729748|FG005|STARTED|Overall Study||37
8685463|NCT03343626|9729749|FG006|STARTED|Overall Study||37
8685464|NCT03343626|9729750|FG007|STARTED|Overall Study||36
8685465|NCT03343626|9729743|FG000|Safety Analysis Set|Overall Study||31
8685466|NCT03343626|9729744|FG001|Safety Analysis Set|Overall Study||31
8685467|NCT03343626|9729745|FG002|Safety Analysis Set|Overall Study||31
8685468|NCT03343626|9729746|FG003|Safety Analysis Set|Overall Study||32
8685469|NCT03343626|9729747|FG004|Safety Analysis Set|Overall Study||36
8685470|NCT03343626|9729748|FG005|Safety Analysis Set|Overall Study||37
8685471|NCT03343626|9729749|FG006|Safety Analysis Set|Overall Study||37
8685472|NCT03343626|9729750|FG007|Safety Analysis Set|Overall Study||36
8685473|NCT03343626|9729743|FG000|Full Analysis Set|Overall Study||30
8685474|NCT03343626|9729744|FG001|Full Analysis Set|Overall Study||28
8685475|NCT03343626|9729745|FG002|Full Analysis Set|Overall Study||31
8685476|NCT03343626|9729746|FG003|Full Analysis Set|Overall Study||30
8685477|NCT03343626|9729747|FG004|Full Analysis Set|Overall Study||34
8685478|NCT03343626|9729748|FG005|Full Analysis Set|Overall Study||34
8685479|NCT03343626|9729749|FG006|Full Analysis Set|Overall Study||34
8685480|NCT03343626|9729750|FG007|Full Analysis Set|Overall Study||34
8685481|NCT03343626|9729743|FG000|Per Protocol Set|Overall Study||28
8685482|NCT03343626|9729744|FG001|Per Protocol Set|Overall Study||25
8685483|NCT03343626|9729745|FG002|Per Protocol Set|Overall Study||29
8685484|NCT03343626|9729746|FG003|Per Protocol Set|Overall Study||30
8685485|NCT03343626|9729747|FG004|Per Protocol Set|Overall Study||34
8685486|NCT03343626|9729748|FG005|Per Protocol Set|Overall Study||33
8685487|NCT03343626|9729749|FG006|Per Protocol Set|Overall Study||34
8685488|NCT03343626|9729750|FG007|Per Protocol Set|Overall Study||33
8685489|NCT03343626|9729743|FG000|COMPLETED|Overall Study||25
8685490|NCT03343626|9729744|FG001|COMPLETED|Overall Study||26
8685491|NCT03343626|9729745|FG002|COMPLETED|Overall Study||29
8685492|NCT03343626|9729746|FG003|COMPLETED|Overall Study||24
8685493|NCT03343626|9729747|FG004|COMPLETED|Overall Study||29
8685494|NCT03343626|9729748|FG005|COMPLETED|Overall Study||32
8685495|NCT03343626|9729749|FG006|COMPLETED|Overall Study||32
8685496|NCT03343626|9729750|FG007|COMPLETED|Overall Study||25
8685497|NCT03343626|9729743|FG000|NOT COMPLETED|Overall Study||6
8685498|NCT03343626|9729744|FG001|NOT COMPLETED|Overall Study||5
8685499|NCT03343626|9729745|FG002|NOT COMPLETED|Overall Study||2
8685500|NCT03343626|9729746|FG003|NOT COMPLETED|Overall Study||8
8685501|NCT03343626|9729747|FG004|NOT COMPLETED|Overall Study||7
8685502|NCT03343626|9729748|FG005|NOT COMPLETED|Overall Study||5
8685503|NCT03343626|9729749|FG006|NOT COMPLETED|Overall Study||5
8685504|NCT03343626|9729750|FG007|NOT COMPLETED|Overall Study||11
8685505|NCT03088930|9729771|FG000|STARTED|Overall Study||3
8685506|NCT03088930|9729771|FG000|COMPLETED|Overall Study||3
8685507|NCT03088930|9729771|FG000|NOT COMPLETED|Overall Study||0
8685508|NCT02960204|9729779|FG000|STARTED|Overall Study||65
8685509|NCT02960204|9729780|FG001|STARTED|Overall Study||65
8685510|NCT02960204|9729781|FG002|STARTED|Overall Study||66
8685511|NCT02960204|9729782|FG003|STARTED|Overall Study||67
8685512|NCT02960204|9729779|FG000|Randomized|Overall Study||65
8685513|NCT02960204|9729780|FG001|Randomized|Overall Study||65
8685514|NCT02960204|9729781|FG002|Randomized|Overall Study||66
8685515|NCT02960204|9729782|FG003|Randomized|Overall Study||67
8685516|NCT02960204|9729779|FG000|Completed Week 24 of Study|Overall Study||62
8685517|NCT02960204|9729780|FG001|Completed Week 24 of Study|Overall Study||62
8685518|NCT02960204|9729781|FG002|Completed Week 24 of Study|Overall Study||60
8685519|NCT02960204|9729782|FG003|Completed Week 24 of Study|Overall Study||66
8685520|NCT02960204|9729779|FG000|Completed Week 48 of Study|Overall Study||55
8685521|NCT02960204|9729780|FG001|Completed Week 48 of Study|Overall Study||55
8685522|NCT02960204|9729781|FG002|Completed Week 48 of Study|Overall Study||50
8685523|NCT02960204|9729782|FG003|Completed Week 48 of Study|Overall Study||59
8685524|NCT02960204|9729779|FG000|COMPLETED|Overall Study||36
8685525|NCT02960204|9729780|FG001|COMPLETED|Overall Study||44
8685526|NCT02960204|9729781|FG002|COMPLETED|Overall Study||37
8685527|NCT02960204|9729782|FG003|COMPLETED|Overall Study||38
8685528|NCT02960204|9729779|FG000|NOT COMPLETED|Overall Study||29
8685529|NCT02960204|9729780|FG001|NOT COMPLETED|Overall Study||21
8685530|NCT02960204|9729781|FG002|NOT COMPLETED|Overall Study||29
8685531|NCT02960204|9729782|FG003|NOT COMPLETED|Overall Study||29
8685532|NCT02856269|9729794|FG000|STARTED|Overall Study||25
8685533|NCT02856269|9729795|FG001|STARTED|Overall Study||27
8685534|NCT02856269|9729794|FG000|COMPLETED|Overall Study||24
8685535|NCT02856269|9729795|FG001|COMPLETED|Overall Study||24
8685536|NCT02856269|9729794|FG000|NOT COMPLETED|Overall Study||1
8685537|NCT02856269|9729795|FG001|NOT COMPLETED|Overall Study||3
8685538|NCT02807363|9729805|FG000|STARTED|Dosing Period||9
8685539|NCT02807363|9729806|FG001|STARTED|Dosing Period||9
8685540|NCT02807363|9729807|FG002|STARTED|Dosing Period||5
8685541|NCT02807363|9729808|FG003|STARTED|Dosing Period||12
8685542|NCT02807363|9729805|FG000|COMPLETED|Dosing Period||9
8685543|NCT02807363|9729806|FG001|COMPLETED|Dosing Period||8
8685544|NCT02807363|9729807|FG002|COMPLETED|Dosing Period||5
8685545|NCT02807363|9729808|FG003|COMPLETED|Dosing Period||12
8685546|NCT02807363|9729805|FG000|NOT COMPLETED|Dosing Period||0
8685547|NCT02807363|9729806|FG001|NOT COMPLETED|Dosing Period||1
8685548|NCT02807363|9729807|FG002|NOT COMPLETED|Dosing Period||0
8685549|NCT02807363|9729808|FG003|NOT COMPLETED|Dosing Period||0
8685550|NCT02807363|9729805|FG000|STARTED|Post- Dosing Period||9
8685551|NCT02807363|9729806|FG001|STARTED|Post- Dosing Period||8
8685552|NCT02807363|9729807|FG002|STARTED|Post- Dosing Period||5
8685553|NCT02807363|9729808|FG003|STARTED|Post- Dosing Period||12
8685554|NCT02807363|9729805|FG000|COMPLETED|Post- Dosing Period||9
8685555|NCT02807363|9729806|FG001|COMPLETED|Post- Dosing Period||8
8685556|NCT02807363|9729807|FG002|COMPLETED|Post- Dosing Period||5
8685557|NCT02807363|9729808|FG003|COMPLETED|Post- Dosing Period||12
8685558|NCT02807363|9729805|FG000|NOT COMPLETED|Post- Dosing Period||0
8685559|NCT02807363|9729806|FG001|NOT COMPLETED|Post- Dosing Period||0
8685560|NCT02807363|9729807|FG002|NOT COMPLETED|Post- Dosing Period||0
8685561|NCT02807363|9729808|FG003|NOT COMPLETED|Post- Dosing Period||0
8685562|NCT02756403|9729824|FG000|STARTED|Overall Study||46
8685563|NCT02756403|9729825|FG001|STARTED|Overall Study||45
8685564|NCT02756403|9729826|FG002|STARTED|Overall Study||43
8685565|NCT02756403|9729827|FG003|STARTED|Overall Study||47
8685566|NCT02756403|9729824|FG000|COMPLETED|Overall Study||46
8685567|NCT02756403|9729825|FG001|COMPLETED|Overall Study||42
8685568|NCT02756403|9729826|FG002|COMPLETED|Overall Study||41
8685569|NCT02756403|9729827|FG003|COMPLETED|Overall Study||45
8685570|NCT02756403|9729824|FG000|NOT COMPLETED|Overall Study||0
8685571|NCT02756403|9729825|FG001|NOT COMPLETED|Overall Study||3
8685572|NCT02756403|9729826|FG002|NOT COMPLETED|Overall Study||2
8685573|NCT02756403|9729827|FG003|NOT COMPLETED|Overall Study||2
8685574|NCT02751502|9729837|FG000|STARTED|Overall Study||4
8685575|NCT02751502|9729837|FG000|COMPLETED|Overall Study||0
8685576|NCT02751502|9729837|FG000|NOT COMPLETED|Overall Study||4
8685577|NCT02487797|9729843|FG000|STARTED|Overall Study||502
8685578|NCT02487797|9729844|FG001|STARTED|Overall Study||501
8685579|NCT02487797|9729843|FG000|COMPLETED|Overall Study||502
8685580|NCT02487797|9729844|FG001|COMPLETED|Overall Study||501
8685581|NCT02487797|9729843|FG000|NOT COMPLETED|Overall Study||0
8685582|NCT02487797|9729844|FG001|NOT COMPLETED|Overall Study||0
8693253|NCT00865124|9738683|FG002|COMPLETED|Overall Study||17
8693254|NCT00865124|9738681|FG000|NOT COMPLETED|Overall Study||4
8693255|NCT00865124|9738682|FG001|NOT COMPLETED|Overall Study||1
8693256|NCT00865124|9738683|FG002|NOT COMPLETED|Overall Study||0
8693257|NCT00865189|9738693|FG000|STARTED|Overall Study||46
8693258|NCT00865189|9738694|FG001|STARTED|Overall Study||45
8693259|NCT00865189|9738693|FG000|COMPLETED|Overall Study||34
8693260|NCT00865189|9738694|FG001|COMPLETED|Overall Study||26
8693261|NCT00865189|9738693|FG000|NOT COMPLETED|Overall Study||12
8693262|NCT00865189|9738694|FG001|NOT COMPLETED|Overall Study||19
8693263|NCT00865202|9738702|FG000|STARTED|Overall Study||152
8693264|NCT00865202|9738703|FG001|STARTED|Overall Study||149
8693265|NCT00865202|9738702|FG000|COMPLETED|Overall Study||152
8693266|NCT00865202|9738703|FG001|COMPLETED|Overall Study||149
8693267|NCT00865202|9738702|FG000|NOT COMPLETED|Overall Study||0
8693268|NCT00865202|9738703|FG001|NOT COMPLETED|Overall Study||0
8693269|NCT00865280|9738712|FG000|STARTED|Overall Study||70
8693270|NCT00865280|9738713|FG001|STARTED|Overall Study||73
8693271|NCT00865280|9738712|FG000|COMPLETED|Overall Study||64
8693272|NCT00865280|9738713|FG001|COMPLETED|Overall Study||70
8693273|NCT00865280|9738712|FG000|NOT COMPLETED|Overall Study||6
8693274|NCT00865280|9738713|FG001|NOT COMPLETED|Overall Study||3
8693275|NCT00865306|9738721|FG000|STARTED|Controlled Trial|35 assigned to CBT. One child in trial had 0 anxiety disorders, so we excluded her from analysis.|34
8693276|NCT00865306|9738722|FG001|STARTED|Controlled Trial||30
8693277|NCT00865306|9738721|FG000|COMPLETED|Controlled Trial||29
8693278|NCT00865306|9738722|FG001|COMPLETED|Controlled Trial||28
8693279|NCT00865306|9738721|FG000|NOT COMPLETED|Controlled Trial||5
8693280|NCT00865306|9738722|FG001|NOT COMPLETED|Controlled Trial||2
8693281|NCT00865306|9738721|FG000|STARTED|One-Year Follow-Up||29
8693282|NCT00865306|9738722|FG001|STARTED|One-Year Follow-Up|Only controls who opted for CBT after the waitlist (n=17) were included. 2 were lost (15 included).|15
8693283|NCT00865306|9738721|FG000|COMPLETED|One-Year Follow-Up||29
8693284|NCT00865306|9738722|FG001|COMPLETED|One-Year Follow-Up||15
8693285|NCT00865306|9738721|FG000|NOT COMPLETED|One-Year Follow-Up||0
8693286|NCT00865306|9738722|FG001|NOT COMPLETED|One-Year Follow-Up||0
8693287|NCT00865345|9738728|FG000|STARTED|Overall Study||63
8693288|NCT00865345|9738728|FG000|COMPLETED|Overall Study||61
8693289|NCT00865345|9738728|FG000|NOT COMPLETED|Overall Study||2
8693290|NCT00865566|9738734|FG000|STARTED|Overall Study||1253
8693291|NCT00865566|9738735|FG001|STARTED|Overall Study||1251
8693292|NCT00865566|9738734|FG000|Modified Intent-to-Treat Population|Overall Study||1251
8693293|NCT00865566|9738735|FG001|Modified Intent-to-Treat Population|Overall Study||1245
8693294|NCT00865566|9738734|FG000|COMPLETED|Overall Study||629
8685583|NCT02348359|9729854|FG000|STARTED|Overall Study||40
8685584|NCT02348359|9729855|FG001|STARTED|Overall Study||39
8685585|NCT02348359|9729856|FG002|STARTED|Overall Study||39
8685586|NCT02348359|9729857|FG003|STARTED|Overall Study||39
8685587|NCT02348359|9729854|FG000|COMPLETED|Overall Study||29
8685588|NCT02348359|9729855|FG001|COMPLETED|Overall Study||22
8685589|NCT02348359|9729856|FG002|COMPLETED|Overall Study||25
8685590|NCT02348359|9729857|FG003|COMPLETED|Overall Study||27
8685591|NCT02348359|9729854|FG000|NOT COMPLETED|Overall Study||11
8685592|NCT02348359|9729855|FG001|NOT COMPLETED|Overall Study||17
8685593|NCT02348359|9729856|FG002|NOT COMPLETED|Overall Study||14
8685594|NCT02348359|9729857|FG003|NOT COMPLETED|Overall Study||12
8685595|NCT02285062|9729869|FG000|STARTED|Overall Study||285
8685596|NCT02285062|9729870|FG001|STARTED|Overall Study||285
8685597|NCT02285062|9729869|FG000|Received Study Treatment|Overall Study||283
8685598|NCT02285062|9729870|FG001|Received Study Treatment|Overall Study||284
8685599|NCT02285062|9729869|FG000|Ongoing Study Treatment|Overall Study||0
8685600|NCT02285062|9729870|FG001|Ongoing Study Treatment|Overall Study||0
8685601|NCT02285062|9729869|FG000|COMPLETED|Overall Study||207
8685602|NCT02285062|9729870|FG001|COMPLETED|Overall Study||201
8685603|NCT02285062|9729869|FG000|NOT COMPLETED|Overall Study||78
8685604|NCT02285062|9729870|FG001|NOT COMPLETED|Overall Study||84
8685605|NCT02264977|9729876|FG000|STARTED|Overall Study||9
8685606|NCT02264977|9729876|FG000|COMPLETED|Overall Study||4
8685607|NCT02264977|9729876|FG000|NOT COMPLETED|Overall Study||5
8685608|NCT01981096|9729882|FG000|STARTED|Overall Study||20
8685609|NCT01981096|9729883|FG001|STARTED|Overall Study||20
8685610|NCT01981096|9729882|FG000|Post-treatment|Overall Study||17
8685611|NCT01981096|9729883|FG001|Post-treatment|Overall Study||19
8685612|NCT01981096|9729882|FG000|COMPLETED|Overall Study||17
8685613|NCT01981096|9729883|FG001|COMPLETED|Overall Study||19
8685614|NCT01981096|9729882|FG000|NOT COMPLETED|Overall Study||3
8685615|NCT01981096|9729883|FG001|NOT COMPLETED|Overall Study||1
8685616|NCT01935336|9729893|FG000|STARTED|Overall Study|Only one subject was treated due to the black box warning RE: ponatinib-associated vascular issues. The protocol was modified with additional inclusion and exclusion criteria, which severely limited the number of cases treated with the drug|6
8685617|NCT01935336|9729894|FG001|STARTED|Overall Study|no subjects were treated in this arm|3
8685618|NCT01935336|9729895|FG002|STARTED|Overall Study|Only three subjects were treated due to the black box warning RE: ponatinib-associated vascular issues. The protocol was modified with additional inclusion and exclusion criteria, which severely limited the number of cases treated with the drug|47
8685619|NCT01935336|9729896|FG003|STARTED|Overall Study|No subjects were treated in this arm|66
8685620|NCT01935336|9729893|FG000|Started Treatment|Overall Study||1
8919548|NCT02207569|9979428|FG000|NOT COMPLETED|36-Month to 48-Month||31
8919549|NCT02207569|9979428|FG000|STARTED|48-Month to 60-Month||113
8919550|NCT02207569|9979428|FG000|COMPLETED|48-Month to 60-Month||109
8919551|NCT02207569|9979428|FG000|NOT COMPLETED|48-Month to 60-Month||4
8919552|NCT02207608|9979434|FG000|STARTED|Overall Study||15
8919553|NCT02207608|9979435|FG001|STARTED|Overall Study||15
8919554|NCT02207608|9979434|FG000|COMPLETED|Overall Study||14
8919555|NCT02207608|9979435|FG001|COMPLETED|Overall Study||15
8919556|NCT02207608|9979434|FG000|NOT COMPLETED|Overall Study||1
8919557|NCT02207608|9979435|FG001|NOT COMPLETED|Overall Study||0
8919558|NCT02207621|9979444|FG000|STARTED|Overall Study||251
8919559|NCT02207621|9979445|FG001|STARTED|Overall Study||251
8919560|NCT02207621|9979446|FG002|STARTED|Overall Study||254
8919561|NCT02207621|9979444|FG000|COMPLETED|Overall Study||146
8919562|NCT02207621|9979445|FG001|COMPLETED|Overall Study||204
8919563|NCT02207621|9979446|FG002|COMPLETED|Overall Study||86
8919564|NCT02207621|9979444|FG000|NOT COMPLETED|Overall Study||105
8919565|NCT02207621|9979445|FG001|NOT COMPLETED|Overall Study||47
8919566|NCT02207621|9979446|FG002|NOT COMPLETED|Overall Study||168
8919567|NCT02207634|9979457|FG000|STARTED|Overall Study||990
8919568|NCT02207634|9979458|FG001|STARTED|Overall Study||984
8919569|NCT02207634|9979457|FG000|Received Treatment|Overall Study||990
8919570|NCT02207634|9979458|FG001|Received Treatment|Overall Study||983
8919571|NCT02207634|9979457|FG000|COMPLETED|Overall Study||968
8919572|NCT02207634|9979458|FG001|COMPLETED|Overall Study||953
8919573|NCT02207634|9979457|FG000|NOT COMPLETED|Overall Study||22
8919574|NCT02207634|9979458|FG001|NOT COMPLETED|Overall Study||31
8919575|NCT02207725|9979468|FG000|STARTED|Overall Study||9
8919576|NCT02207725|9979469|FG001|STARTED|Overall Study||25
8919577|NCT02207725|9979470|FG002|STARTED|Overall Study||9
8919578|NCT02207725|9979471|FG003|STARTED|Overall Study||25
8919579|NCT02207725|9979468|FG000|COMPLETED|Overall Study||9
8919580|NCT02207725|9979469|FG001|COMPLETED|Overall Study||24
8919581|NCT02207725|9979470|FG002|COMPLETED|Overall Study||8
8919582|NCT02207725|9979471|FG003|COMPLETED|Overall Study||24
8919583|NCT02207725|9979468|FG000|NOT COMPLETED|Overall Study||0
8919584|NCT02207725|9979469|FG001|NOT COMPLETED|Overall Study||1
8919585|NCT02207725|9979470|FG002|NOT COMPLETED|Overall Study||1
8919586|NCT02207725|9979471|FG003|NOT COMPLETED|Overall Study||1
8919587|NCT02207803|9979485|FG000|STARTED|Overall Study||125
8919588|NCT02207803|9979486|FG001|STARTED|Overall Study||125
8919589|NCT02207803|9979485|FG000|COMPLETED|Overall Study||110
8685621|NCT01935336|9729894|FG001|Started Treatment|Overall Study||0
8685622|NCT01935336|9729895|FG002|Started Treatment|Overall Study||3
8919590|NCT02207803|9979486|FG001|COMPLETED|Overall Study||108
8919591|NCT02207803|9979485|FG000|NOT COMPLETED|Overall Study||15
8919592|NCT02207803|9979486|FG001|NOT COMPLETED|Overall Study||17
8685623|NCT01935336|9729896|FG003|Started Treatment|Overall Study||0
8685624|NCT01935336|9729893|FG000|COMPLETED|Overall Study||0
8685625|NCT01935336|9729894|FG001|COMPLETED|Overall Study||0
8685626|NCT01935336|9729895|FG002|COMPLETED|Overall Study||0
8685627|NCT01935336|9729896|FG003|COMPLETED|Overall Study||0
8685628|NCT01935336|9729893|FG000|NOT COMPLETED|Overall Study||6
8685629|NCT01935336|9729894|FG001|NOT COMPLETED|Overall Study||3
8685630|NCT01935336|9729895|FG002|NOT COMPLETED|Overall Study||47
8685631|NCT01935336|9729896|FG003|NOT COMPLETED|Overall Study||66
8685632|NCT01712490|9729914|FG000|STARTED|Overall Study||664
8685633|NCT01712490|9729915|FG001|STARTED|Overall Study||670
8685634|NCT01712490|9729914|FG000|Treated|Overall Study||662
8685635|NCT01712490|9729915|FG001|Treated|Overall Study||659
8685636|NCT01712490|9729914|FG000|COMPLETED|Overall Study||0
8685637|NCT01712490|9729915|FG001|COMPLETED|Overall Study||0
8685638|NCT01712490|9729914|FG000|NOT COMPLETED|Overall Study||664
8685639|NCT01712490|9729915|FG001|NOT COMPLETED|Overall Study||670
8685640|NCT01702805|9729923|FG000|STARTED|Overall Study||911
8685641|NCT01702805|9729924|FG001|STARTED|Overall Study||913
8685642|NCT01702805|9729923|FG000|Completed Assessment for Neurodevelopmental Impairment|Overall Study||699
8685643|NCT01702805|9729924|FG001|Completed Assessment for Neurodevelopmental Impairment|Overall Study||712
8685644|NCT01702805|9729923|FG000|Died After Discharge|Overall Study||19
8685645|NCT01702805|9729924|FG001|Died After Discharge|Overall Study||10
8685646|NCT01702805|9729923|FG000|Died Before Discharge|Overall Study||127
8685647|NCT01702805|9729924|FG001|Died Before Discharge|Overall Study||125
8685648|NCT01702805|9729923|FG000|Survived to Discharge|Overall Study||781
8685649|NCT01702805|9729924|FG001|Survived to Discharge|Overall Study||781
8685650|NCT01702805|9729923|FG000|COMPLETED|Overall Study||845
8685651|NCT01702805|9729924|FG001|COMPLETED|Overall Study||847
8685652|NCT01702805|9729923|FG000|NOT COMPLETED|Overall Study||66
8685653|NCT01702805|9729924|FG001|NOT COMPLETED|Overall Study||66
8685654|NCT01499160|9729930|FG000|STARTED|Overall Study||7
8685655|NCT01499160|9729930|FG000|COMPLETED|Overall Study|"1 pt-withdrew consent~1pt-had cardiac toxicity"|5
8685656|NCT01499160|9729930|FG000|NOT COMPLETED|Overall Study||2
8685657|NCT01333436|9729937|FG000|STARTED|Overall Study||43
8685658|NCT01333436|9729938|FG001|STARTED|Overall Study||50
8685659|NCT01333436|9729937|FG000|COMPLETED|Overall Study||43
8685660|NCT01333436|9729938|FG001|COMPLETED|Overall Study||50
8685661|NCT01333436|9729937|FG000|NOT COMPLETED|Overall Study||0
8685662|NCT01333436|9729938|FG001|NOT COMPLETED|Overall Study||0
8685663|NCT01307631|9729944|FG000|STARTED|Overall Study||9
8685664|NCT01307631|9729945|FG001|STARTED|Overall Study||28
8685665|NCT01307631|9729944|FG000|COMPLETED|Overall Study||9
8685666|NCT01307631|9729945|FG001|COMPLETED|Overall Study||28
8685667|NCT01307631|9729944|FG000|NOT COMPLETED|Overall Study||0
8685668|NCT01307631|9729945|FG001|NOT COMPLETED|Overall Study||0
8685669|NCT01256086|9729955|FG000|STARTED|Treatment Day 1||11
8685670|NCT01256086|9729956|FG001|STARTED|Treatment Day 1||11
8685671|NCT01256086|9729957|FG002|STARTED|Treatment Day 1||11
8685672|NCT01256086|9729958|FG003|STARTED|Treatment Day 1||11
8685673|NCT01256086|9729955|FG000|COMPLETED|Treatment Day 1||11
8685674|NCT01256086|9729956|FG001|COMPLETED|Treatment Day 1||11
8685675|NCT01256086|9729957|FG002|COMPLETED|Treatment Day 1||11
8685676|NCT01256086|9729958|FG003|COMPLETED|Treatment Day 1||11
8685677|NCT01256086|9729955|FG000|NOT COMPLETED|Treatment Day 1||0
8685678|NCT01256086|9729956|FG001|NOT COMPLETED|Treatment Day 1||0
8685679|NCT01256086|9729957|FG002|NOT COMPLETED|Treatment Day 1||0
8685680|NCT01256086|9729958|FG003|NOT COMPLETED|Treatment Day 1||0
8685681|NCT01256086|9729955|FG000|STARTED|Treatment Day 2||11
8685682|NCT01256086|9729956|FG001|STARTED|Treatment Day 2||10
8685683|NCT01256086|9729957|FG002|STARTED|Treatment Day 2||9
8685684|NCT01256086|9729958|FG003|STARTED|Treatment Day 2||11
8685685|NCT01256086|9729955|FG000|COMPLETED|Treatment Day 2||11
8685686|NCT01256086|9729956|FG001|COMPLETED|Treatment Day 2||10
8685687|NCT01256086|9729957|FG002|COMPLETED|Treatment Day 2||9
8685688|NCT01256086|9729958|FG003|COMPLETED|Treatment Day 2||11
8685689|NCT01256086|9729955|FG000|NOT COMPLETED|Treatment Day 2||0
8685690|NCT01256086|9729956|FG001|NOT COMPLETED|Treatment Day 2||0
8685691|NCT01256086|9729957|FG002|NOT COMPLETED|Treatment Day 2||0
8685692|NCT01256086|9729958|FG003|NOT COMPLETED|Treatment Day 2||0
8685693|NCT01256086|9729955|FG000|STARTED|Treatment Day 3||11
8685694|NCT01256086|9729956|FG001|STARTED|Treatment Day 3||10
8685695|NCT01256086|9729957|FG002|STARTED|Treatment Day 3||9
8685696|NCT01256086|9729958|FG003|STARTED|Treatment Day 3||11
8685697|NCT01256086|9729955|FG000|COMPLETED|Treatment Day 3||11
8685698|NCT01256086|9729956|FG001|COMPLETED|Treatment Day 3||10
8685699|NCT01256086|9729957|FG002|COMPLETED|Treatment Day 3||9
8685700|NCT01256086|9729958|FG003|COMPLETED|Treatment Day 3||11
8685701|NCT01256086|9729955|FG000|NOT COMPLETED|Treatment Day 3||0
8685702|NCT01256086|9729956|FG001|NOT COMPLETED|Treatment Day 3||0
8685703|NCT01256086|9729957|FG002|NOT COMPLETED|Treatment Day 3||0
8685704|NCT01256086|9729958|FG003|NOT COMPLETED|Treatment Day 3||0
8685705|NCT01256086|9729955|FG000|STARTED|Treatment Day 4||11
8685706|NCT01256086|9729956|FG001|STARTED|Treatment Day 4||10
8685707|NCT01256086|9729957|FG002|STARTED|Treatment Day 4||9
8685708|NCT01256086|9729958|FG003|STARTED|Treatment Day 4||11
8685709|NCT01256086|9729955|FG000|COMPLETED|Treatment Day 4||11
8685710|NCT01256086|9729956|FG001|COMPLETED|Treatment Day 4||10
8685711|NCT01256086|9729957|FG002|COMPLETED|Treatment Day 4||9
8685712|NCT01256086|9729958|FG003|COMPLETED|Treatment Day 4||11
8685713|NCT01256086|9729955|FG000|NOT COMPLETED|Treatment Day 4||0
8685714|NCT01256086|9729956|FG001|NOT COMPLETED|Treatment Day 4||0
8685715|NCT01256086|9729957|FG002|NOT COMPLETED|Treatment Day 4||0
8685716|NCT01256086|9729958|FG003|NOT COMPLETED|Treatment Day 4||0
8685717|NCT01061151|9729972|FG000|STARTED|Protocol Version 2.0: 04/2011-09/2012||855
8685718|NCT01061151|9729973|FG001|STARTED|Protocol Version 2.0: 04/2011-09/2012||861
8685719|NCT01061151|9729974|FG002|STARTED|Protocol Version 2.0: 04/2011-09/2012||25
8685720|NCT01061151|9729975|FG003|STARTED|Protocol Version 2.0: 04/2011-09/2012||129
8685721|NCT01061151|9729972|FG000|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||853
8685722|NCT01061151|9729973|FG001|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||861
8685723|NCT01061151|9729974|FG002|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||24
8685724|NCT01061151|9729975|FG003|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||129
8685725|NCT01061151|9729972|FG000|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||623
8685726|NCT01061151|9729973|FG001|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||620
8685727|NCT01061151|9729974|FG002|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||16
8685728|NCT01061151|9729975|FG003|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||101
8685729|NCT01061151|9729972|FG000|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||232
8685730|NCT01061151|9729973|FG001|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||241
8685731|NCT01061151|9729974|FG002|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||9
8685732|NCT01061151|9729975|FG003|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||28
8685733|NCT01061151|9729972|FG000|STARTED|Protocol Version 3.0: 10/2012-10/2014||694
8685734|NCT01061151|9729973|FG001|STARTED|Protocol Version 3.0: 10/2012-10/2014||686
8685735|NCT01061151|9729974|FG002|STARTED|Protocol Version 3.0: 10/2012-10/2014||422
8685736|NCT01061151|9729975|FG003|STARTED|Protocol Version 3.0: 10/2012-10/2014||75
8685737|NCT01061151|9729972|FG000|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||694
8685738|NCT01061151|9729973|FG001|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||684
8685739|NCT01061151|9729974|FG002|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||421
8685740|NCT01061151|9729975|FG003|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||75
8685741|NCT01061151|9729972|FG000|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||542
8685742|NCT01061151|9729973|FG001|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||548
8685743|NCT01061151|9729974|FG002|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||345
8685744|NCT01061151|9729975|FG003|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||55
8685745|NCT01061151|9729972|FG000|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||152
8685746|NCT01061151|9729973|FG001|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||138
8685747|NCT01061151|9729974|FG002|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||77
8685748|NCT01061151|9729975|FG003|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||20
8685749|NCT00981058|9729997|FG000|STARTED|Overall Study||545
8685750|NCT00981058|9729998|FG001|STARTED|Overall Study||548
8685751|NCT00981058|9729997|FG000|Received at Least 1 Dose of Study Drug|Overall Study||538
8685752|NCT00981058|9729998|FG001|Received at Least 1 Dose of Study Drug|Overall Study||541
8685753|NCT00981058|9729997|FG000|Death Due to Any Cause|Overall Study||418
8685754|NCT00981058|9729998|FG001|Death Due to Any Cause|Overall Study||442
8685755|NCT00981058|9729997|FG000|COMPLETED|Overall Study||425
8685756|NCT00981058|9729998|FG001|COMPLETED|Overall Study||451
8685757|NCT00981058|9729997|FG000|NOT COMPLETED|Overall Study||120
8685758|NCT00981058|9729998|FG001|NOT COMPLETED|Overall Study||97
8685759|NCT00885495|9730006|FG000|STARTED|Overall Study||8
8685760|NCT00885495|9730007|FG001|STARTED|Overall Study||9
8685761|NCT00885495|9730006|FG000|COMPLETED|Overall Study||6
8685762|NCT00885495|9730007|FG001|COMPLETED|Overall Study||6
8685763|NCT00885495|9730006|FG000|NOT COMPLETED|Overall Study||2
8685764|NCT00885495|9730007|FG001|NOT COMPLETED|Overall Study||3
8685765|NCT00084799|9730020|FG000|STARTED|Overall Study||5
8685766|NCT00084799|9730021|FG001|STARTED|Overall Study||5
8685767|NCT00084799|9730020|FG000|COMPLETED|Overall Study||4
8685768|NCT00084799|9730021|FG001|COMPLETED|Overall Study||5
8685769|NCT00084799|9730020|FG000|NOT COMPLETED|Overall Study||1
8685770|NCT00084799|9730021|FG001|NOT COMPLETED|Overall Study||0
8685771|NCT00821236|9730030|FG000|STARTED|Overall Study||40
8685772|NCT00821236|9730030|FG000|COMPLETED|Overall Study||37
8685773|NCT00821236|9730030|FG000|NOT COMPLETED|Overall Study||3
8685774|NCT00821327|9730038|FG000|STARTED|Overall Study||36
8685775|NCT00821327|9730038|FG000|COMPLETED|Overall Study||1
8685776|NCT00821327|9730038|FG000|NOT COMPLETED|Overall Study||35
8685777|NCT00821431|9730044|FG000|STARTED|Overall Study||38
8685778|NCT00821431|9730045|FG001|STARTED|Overall Study||52
8685779|NCT00821431|9730044|FG000|COMPLETED|Overall Study||23
8685780|NCT00821431|9730045|FG001|COMPLETED|Overall Study||47
8685781|NCT00821431|9730044|FG000|NOT COMPLETED|Overall Study||15
8685782|NCT00821431|9730045|FG001|NOT COMPLETED|Overall Study||5
8685783|NCT00821509|9730054|FG000|STARTED|Overall Study||257
8685784|NCT00821509|9730055|FG001|STARTED|Overall Study||202
8685785|NCT00821509|9730056|FG002|STARTED|Overall Study||224
8685786|NCT00821509|9730054|FG000|COMPLETED|Overall Study|This is a result of 56 lost-to-follow-up and 44 new recruits|245
8685787|NCT00821509|9730055|FG001|COMPLETED|Overall Study|This is a result of 57 lost-to-follow-up and 46 new recruits|191
8685788|NCT00821509|9730056|FG002|COMPLETED|Overall Study|This is a result of 50 lost-to-follow-up and 16 new recruits|190
8685789|NCT00821509|9730054|FG000|NOT COMPLETED|Overall Study||12
8685790|NCT00821509|9730055|FG001|NOT COMPLETED|Overall Study||11
8801319|NCT01449630|9853131|FG001|COMPLETED|Period 2||6
8685791|NCT00821509|9730056|FG002|NOT COMPLETED|Overall Study||34
8685792|NCT00821626|9730066|FG000|STARTED|Overall Study||60
8685793|NCT00821626|9730067|FG001|STARTED|Overall Study||33
8685794|NCT00821626|9730066|FG000|COMPLETED|Overall Study||60
8685795|NCT00821626|9730067|FG001|COMPLETED|Overall Study||33
8685796|NCT00821626|9730066|FG000|NOT COMPLETED|Overall Study||0
8685797|NCT00821626|9730067|FG001|NOT COMPLETED|Overall Study||0
8685798|NCT00821678|9730077|FG000|STARTED|Overall Study||133
8685799|NCT00821678|9730078|FG001|STARTED|Overall Study||132
8685800|NCT00821678|9730077|FG000|COMPLETED|Overall Study||112
8685801|NCT00821678|9730078|FG001|COMPLETED|Overall Study||118
8685802|NCT00821678|9730077|FG000|NOT COMPLETED|Overall Study||21
8685803|NCT00821678|9730078|FG001|NOT COMPLETED|Overall Study||14
8685804|NCT00821795|9730088|FG000|STARTED|Overall Study||50
8685805|NCT00821795|9730089|FG001|STARTED|Overall Study||64
8685806|NCT00821795|9730088|FG000|COMPLETED|Overall Study||44
8685807|NCT00821795|9730089|FG001|COMPLETED|Overall Study||60
8685808|NCT00821795|9730088|FG000|NOT COMPLETED|Overall Study||6
8685809|NCT00821795|9730089|FG001|NOT COMPLETED|Overall Study||4
8685810|NCT00821821|9730098|FG000|STARTED|Overall Study||12
8685811|NCT00821821|9730099|FG001|STARTED|Overall Study||13
8685812|NCT00821821|9730100|FG002|STARTED|Overall Study||11
8685813|NCT00821821|9730098|FG000|COMPLETED|Overall Study||12
8685814|NCT00821821|9730099|FG001|COMPLETED|Overall Study||13
8685815|NCT00821821|9730100|FG002|COMPLETED|Overall Study||11
8685816|NCT00821821|9730098|FG000|NOT COMPLETED|Overall Study||0
8685817|NCT00821821|9730099|FG001|NOT COMPLETED|Overall Study||0
8685818|NCT00821821|9730100|FG002|NOT COMPLETED|Overall Study||0
8685819|NCT00821873|9730110|FG000|STARTED|Overall Study||9
8685820|NCT00821873|9730110|FG000|COMPLETED|Overall Study||5
8685821|NCT00821873|9730110|FG000|NOT COMPLETED|Overall Study||4
8685822|NCT00821886|9730114|FG000|STARTED|Overall Study|Two patients were enrolled, but subsequently found to be ineligible|58
8685823|NCT00821886|9730114|FG000|COMPLETED|Overall Study||49
8685824|NCT00821886|9730114|FG000|NOT COMPLETED|Overall Study||9
8685825|NCT00821951|9730118|FG000|STARTED|Overall Study||17
8685826|NCT00821951|9730118|FG000|COMPLETED|Overall Study||12
8685827|NCT00821951|9730118|FG000|NOT COMPLETED|Overall Study||5
8685828|NCT00821964|9730122|FG000|STARTED|Overall Study||15
8685829|NCT00821964|9730122|FG000|Evaluable for Clinical Response|Overall Study||14
8685830|NCT00821964|9730122|FG000|Evaluable for Pathologic Response|Overall Study||7
8685831|NCT00821964|9730122|FG000|COMPLETED|Overall Study||9
8685832|NCT00821964|9730122|FG000|NOT COMPLETED|Overall Study||6
8685833|NCT00822094|9730131|FG000|STARTED|Overall Study||81
8685834|NCT00822094|9730132|FG001|STARTED|Overall Study||45
8685835|NCT00822094|9730131|FG000|COMPLETED|Overall Study||37
8685836|NCT00822094|9730132|FG001|COMPLETED|Overall Study||20
8685837|NCT00822094|9730131|FG000|NOT COMPLETED|Overall Study||44
8685838|NCT00822094|9730132|FG001|NOT COMPLETED|Overall Study||25
8685839|NCT00822107|9730138|FG000|STARTED|Overall Study||5
8685840|NCT00822107|9730138|FG000|COMPLETED|Overall Study||5
8685841|NCT00822107|9730138|FG000|NOT COMPLETED|Overall Study||0
8685842|NCT00822172|9730144|FG000|STARTED|Overall Study||80
8685843|NCT00822172|9730145|FG001|STARTED|Overall Study||83
8685844|NCT00822172|9730144|FG000|COMPLETED|Overall Study||65
8685845|NCT00822172|9730145|FG001|COMPLETED|Overall Study||64
8685846|NCT00822172|9730144|FG000|NOT COMPLETED|Overall Study||15
8685847|NCT00822172|9730145|FG001|NOT COMPLETED|Overall Study||19
8685848|NCT00822185|9730156|FG000|STARTED|Overall Study||6
8685849|NCT00822185|9730157|FG001|STARTED|Overall Study||6
8685850|NCT00822185|9730158|FG002|STARTED|Overall Study||6
8685851|NCT00822185|9730159|FG003|STARTED|Overall Study||6
8685852|NCT00822185|9730160|FG004|STARTED|Overall Study||8
8685853|NCT00822185|9730156|FG000|COMPLETED|Overall Study||6
8685854|NCT00822185|9730157|FG001|COMPLETED|Overall Study||6
8685855|NCT00822185|9730158|FG002|COMPLETED|Overall Study||6
8685856|NCT00822185|9730159|FG003|COMPLETED|Overall Study||6
8685857|NCT00822185|9730160|FG004|COMPLETED|Overall Study||8
8685858|NCT00822185|9730156|FG000|NOT COMPLETED|Overall Study||0
8685859|NCT00822185|9730157|FG001|NOT COMPLETED|Overall Study||0
8685860|NCT00822185|9730158|FG002|NOT COMPLETED|Overall Study||0
8685861|NCT00822185|9730159|FG003|NOT COMPLETED|Overall Study||0
8685862|NCT00822185|9730160|FG004|NOT COMPLETED|Overall Study||0
8685863|NCT00822237|9730174|FG000|STARTED|Dose 1 Vaccination|Number randomized|299
8685864|NCT00822237|9730175|FG001|STARTED|Dose 1 Vaccination|Number randomized|299
8685865|NCT00822237|9730174|FG000|COMPLETED|Dose 1 Vaccination||274
8685866|NCT00822237|9730175|FG001|COMPLETED|Dose 1 Vaccination||273
8685867|NCT00822237|9730174|FG000|NOT COMPLETED|Dose 1 Vaccination||25
8685868|NCT00822237|9730175|FG001|NOT COMPLETED|Dose 1 Vaccination||26
8685869|NCT00822237|9730174|FG000|STARTED|Dose 2 Vaccination|Number who received second dose|274
8685870|NCT00822237|9730175|FG001|STARTED|Dose 2 Vaccination|Number who received second dose|273
8685871|NCT00822237|9730174|FG000|COMPLETED|Dose 2 Vaccination||270
8685872|NCT00822237|9730175|FG001|COMPLETED|Dose 2 Vaccination||262
8685873|NCT00822237|9730174|FG000|NOT COMPLETED|Dose 2 Vaccination||4
8685874|NCT00822237|9730175|FG001|NOT COMPLETED|Dose 2 Vaccination||11
8685875|NCT00822328|9730182|FG000|STARTED|Overall Study||12
8685876|NCT00822328|9730183|FG001|STARTED|Overall Study||12
8685877|NCT00822328|9730182|FG000|COMPLETED|Overall Study||12
8685878|NCT00822328|9730183|FG001|COMPLETED|Overall Study||12
8685879|NCT00822328|9730182|FG000|NOT COMPLETED|Overall Study||0
8685880|NCT00822328|9730183|FG001|NOT COMPLETED|Overall Study||0
8685881|NCT00822354|9730191|FG000|STARTED|First Intervention (28 Days)||5
8685882|NCT00822354|9730192|FG001|STARTED|First Intervention (28 Days)||5
8685883|NCT00822354|9730191|FG000|COMPLETED|First Intervention (28 Days)||4
8685884|NCT00822354|9730192|FG001|COMPLETED|First Intervention (28 Days)||5
8685885|NCT00822354|9730191|FG000|NOT COMPLETED|First Intervention (28 Days)||1
8685886|NCT00822354|9730192|FG001|NOT COMPLETED|First Intervention (28 Days)||0
8685887|NCT00822354|9730191|FG000|STARTED|Washout (7 Days)||4
8685888|NCT00822354|9730192|FG001|STARTED|Washout (7 Days)||5
8685889|NCT00822354|9730191|FG000|COMPLETED|Washout (7 Days)||4
8685890|NCT00822354|9730192|FG001|COMPLETED|Washout (7 Days)||5
8685891|NCT00822354|9730191|FG000|NOT COMPLETED|Washout (7 Days)||0
8685892|NCT00822354|9730192|FG001|NOT COMPLETED|Washout (7 Days)||0
8685893|NCT00822354|9730191|FG000|STARTED|Second Intervention (28 Days)||4
8685894|NCT00822354|9730192|FG001|STARTED|Second Intervention (28 Days)||5
8685895|NCT00822354|9730191|FG000|COMPLETED|Second Intervention (28 Days)||3
8685896|NCT00822354|9730192|FG001|COMPLETED|Second Intervention (28 Days)||5
8685897|NCT00822354|9730191|FG000|NOT COMPLETED|Second Intervention (28 Days)||1
8685898|NCT00822354|9730192|FG001|NOT COMPLETED|Second Intervention (28 Days)||0
8685899|NCT00822510|9730202|FG000|STARTED|Overall Study||38
8685900|NCT00822510|9730203|FG001|STARTED|Overall Study||41
8685901|NCT00822510|9730202|FG000|COMPLETED|Overall Study||35
8685902|NCT00822510|9730203|FG001|COMPLETED|Overall Study||36
8685903|NCT00822510|9730202|FG000|NOT COMPLETED|Overall Study||3
8685904|NCT00822510|9730203|FG001|NOT COMPLETED|Overall Study||5
8685905|NCT00822523|9730214|FG000|STARTED|Overall Study||5
8685906|NCT00822523|9730215|FG001|STARTED|Overall Study||4
8685907|NCT00822523|9730216|FG002|STARTED|Overall Study||4
8685908|NCT00822523|9730214|FG000|COMPLETED|Overall Study||5
8685909|NCT00822523|9730215|FG001|COMPLETED|Overall Study||4
8685910|NCT00822523|9730216|FG002|COMPLETED|Overall Study||4
8685911|NCT00822523|9730214|FG000|NOT COMPLETED|Overall Study||0
8685912|NCT00822523|9730215|FG001|NOT COMPLETED|Overall Study||0
8685913|NCT00822523|9730216|FG002|NOT COMPLETED|Overall Study||0
8685914|NCT00822588|9730234|FG000|STARTED|Overall Study|7 participants excluded before surgery. No baseline data available|113
8685915|NCT00822588|9730235|FG001|STARTED|Overall Study|4 participants excluded before surgery. No baseline data available|114
8685916|NCT00822588|9730234|FG000|COMPLETED|Overall Study|APT/ITT analysis set|106
8685917|NCT00822588|9730235|FG001|COMPLETED|Overall Study|APT/ITT analysis set|110
8685918|NCT00822588|9730234|FG000|NOT COMPLETED|Overall Study||7
8685919|NCT00822588|9730235|FG001|NOT COMPLETED|Overall Study||4
8685920|NCT00822692|9730243|FG000|STARTED|Overall Study|July 1, 2008|63
8685921|NCT00822692|9730244|FG001|STARTED|Overall Study|July 1, 2008|76
8685922|NCT00822692|9730243|FG000|COMPLETED|Overall Study|June 1, 2009|46
8685923|NCT00822692|9730244|FG001|COMPLETED|Overall Study|June 1 , 2009|51
8685924|NCT00822692|9730243|FG000|NOT COMPLETED|Overall Study||17
8685925|NCT00822692|9730244|FG001|NOT COMPLETED|Overall Study||25
8685926|NCT00822757|9730252|FG000|STARTED|Overall Study||41
8685927|NCT00822757|9730253|FG001|STARTED|Overall Study||10
8685928|NCT00822757|9730252|FG000|COMPLETED|Overall Study||41
8685929|NCT00822757|9730253|FG001|COMPLETED|Overall Study||10
8685930|NCT00822757|9730252|FG000|NOT COMPLETED|Overall Study||0
8685931|NCT00822757|9730253|FG001|NOT COMPLETED|Overall Study||0
8685932|NCT00822770|9730261|FG000|STARTED|Overall Study||18
8685933|NCT00822770|9730262|FG001|STARTED|Overall Study||29
8685934|NCT00822770|9730261|FG000|COMPLETED|Overall Study||15
8685935|NCT00822770|9730262|FG001|COMPLETED|Overall Study||28
8685936|NCT00822770|9730261|FG000|NOT COMPLETED|Overall Study||3
8685937|NCT00822770|9730262|FG001|NOT COMPLETED|Overall Study||1
8685938|NCT00822900|9730270|FG000|STARTED|Overall Study||442
8685939|NCT00822900|9730271|FG001|STARTED|Overall Study||440
8685940|NCT00822900|9730270|FG000|COMPLETED|Overall Study||334
8685941|NCT00822900|9730271|FG001|COMPLETED|Overall Study||347
8685942|NCT00822900|9730270|FG000|NOT COMPLETED|Overall Study||108
8685943|NCT00822900|9730271|FG001|NOT COMPLETED|Overall Study||93
8685944|NCT00822926|9730279|FG000|STARTED|First Injection Visit||2
8685945|NCT00822926|9730280|FG001|STARTED|First Injection Visit||3
8685946|NCT00822926|9730279|FG000|COMPLETED|First Injection Visit||2
8685947|NCT00822926|9730280|FG001|COMPLETED|First Injection Visit||3
8685948|NCT00822926|9730279|FG000|NOT COMPLETED|First Injection Visit||0
8685949|NCT00822926|9730280|FG001|NOT COMPLETED|First Injection Visit||0
8685950|NCT00822926|9730279|FG000|STARTED|Washout (Varies Based on Scheduling)||2
8685951|NCT00822926|9730280|FG001|STARTED|Washout (Varies Based on Scheduling)||3
8685952|NCT00822926|9730279|FG000|COMPLETED|Washout (Varies Based on Scheduling)||2
8685953|NCT00822926|9730280|FG001|COMPLETED|Washout (Varies Based on Scheduling)||3
8685954|NCT00822926|9730279|FG000|NOT COMPLETED|Washout (Varies Based on Scheduling)||0
8685955|NCT00822926|9730280|FG001|NOT COMPLETED|Washout (Varies Based on Scheduling)||0
8685956|NCT00822926|9730279|FG000|STARTED|Second Injection Visit||2
8685957|NCT00822926|9730280|FG001|STARTED|Second Injection Visit||3
8685958|NCT00822926|9730279|FG000|COMPLETED|Second Injection Visit||1
8685959|NCT00822926|9730280|FG001|COMPLETED|Second Injection Visit||2
8685960|NCT00822926|9730279|FG000|NOT COMPLETED|Second Injection Visit||1
8685961|NCT00822926|9730280|FG001|NOT COMPLETED|Second Injection Visit||1
8685962|NCT00823043|9730289|FG000|STARTED|Overall Study||64
8685963|NCT00823043|9730290|FG001|STARTED|Overall Study||39
8685964|NCT00823043|9730289|FG000|COMPLETED|Overall Study||64
8685965|NCT00823043|9730290|FG001|COMPLETED|Overall Study||39
8685966|NCT00823043|9730289|FG000|NOT COMPLETED|Overall Study||0
8685967|NCT00823043|9730290|FG001|NOT COMPLETED|Overall Study||0
8685968|NCT00823069|9730295|FG000|STARTED|Overall Study||60
8685969|NCT00823069|9730295|FG000|COMPLETED|Overall Study||60
8685970|NCT00823069|9730295|FG000|NOT COMPLETED|Overall Study||0
8685971|NCT00823082|9730304|FG000|STARTED|Overall Study||100
8685972|NCT00823082|9730305|FG001|STARTED|Overall Study||100
8685973|NCT00823082|9730304|FG000|Safety Population|Overall Study||100
8685974|NCT00823082|9730305|FG001|Safety Population|Overall Study||99
8685975|NCT00823082|9730304|FG000|Intent-to-Treat/Per Protocol Populations|Overall Study||100
8685976|NCT00823082|9730305|FG001|Intent-to-Treat/Per Protocol Populations|Overall Study||94
8685977|NCT00823082|9730304|FG000|COMPLETED|Overall Study||100
8685978|NCT00823082|9730305|FG001|COMPLETED|Overall Study||99
8685979|NCT00823082|9730304|FG000|NOT COMPLETED|Overall Study||0
8685980|NCT00823082|9730305|FG001|NOT COMPLETED|Overall Study||1
8685981|NCT00823134|9730311|FG000|STARTED|Overall Study||23
8685982|NCT00823134|9730311|FG000|COMPLETED|Overall Study||22
8685983|NCT00823134|9730311|FG000|NOT COMPLETED|Overall Study||1
8685984|NCT00823199|9730316|FG000|STARTED|Overall Study||10
8685985|NCT00823199|9730316|FG000|COMPLETED|Overall Study||8
8685986|NCT00823199|9730316|FG000|NOT COMPLETED|Overall Study||2
8685987|NCT00823212|9730323|FG000|STARTED|Overall Study||762
8685988|NCT00823212|9730324|FG001|STARTED|Overall Study||768
8685989|NCT00823212|9730323|FG000|COMPLETED|Overall Study|12-month follow-up|727
8685990|NCT00823212|9730324|FG001|COMPLETED|Overall Study|12-month follow-up|735
8685991|NCT00823212|9730323|FG000|NOT COMPLETED|Overall Study||35
8685992|NCT00823212|9730324|FG001|NOT COMPLETED|Overall Study||33
8685993|NCT00823264|9730334|FG000|STARTED|Overall Study||10
8685994|NCT00823264|9730335|FG001|STARTED|Overall Study||7
8685995|NCT00823264|9730334|FG000|COMPLETED|Overall Study||8
8685996|NCT00823264|9730335|FG001|COMPLETED|Overall Study||7
8685997|NCT00823264|9730334|FG000|NOT COMPLETED|Overall Study||2
8685998|NCT00823264|9730335|FG001|NOT COMPLETED|Overall Study||0
8685999|NCT00823303|9730343|FG000|STARTED|Overall Study||54
8686000|NCT00823303|9730344|FG001|STARTED|Overall Study||56
8686001|NCT00823303|9730343|FG000|COMPLETED|Overall Study||45
8686002|NCT00823303|9730344|FG001|COMPLETED|Overall Study||45
8686003|NCT00823303|9730343|FG000|NOT COMPLETED|Overall Study||9
8686004|NCT00823303|9730344|FG001|NOT COMPLETED|Overall Study||11
8686005|NCT00823459|9730350|FG000|STARTED|Overall Study||58
8686006|NCT00823459|9730350|FG000|COMPLETED|Overall Study||58
8686007|NCT00823459|9730350|FG000|NOT COMPLETED|Overall Study||0
8686008|NCT00823472|9730357|FG000|STARTED|Overall Study||80
8686009|NCT00823472|9730358|FG001|STARTED|Overall Study||67
8686010|NCT00823472|9730357|FG000|COMPLETED|Overall Study||56
8686011|NCT00823472|9730358|FG001|COMPLETED|Overall Study||39
8686012|NCT00823472|9730357|FG000|NOT COMPLETED|Overall Study||24
8686013|NCT00823472|9730358|FG001|NOT COMPLETED|Overall Study||28
8686014|NCT00823615|9730364|FG000|STARTED|Period 1||19
8686015|NCT00823615|9730365|FG001|STARTED|Period 1||19
8686016|NCT00823615|9730364|FG000|COMPLETED|Period 1||19
8686017|NCT00823615|9730365|FG001|COMPLETED|Period 1||19
8686018|NCT00823615|9730364|FG000|NOT COMPLETED|Period 1||0
8686019|NCT00823615|9730365|FG001|NOT COMPLETED|Period 1||0
8686020|NCT00823615|9730364|FG000|STARTED|Period 2||19
8686021|NCT00823615|9730365|FG001|STARTED|Period 2||19
8686022|NCT00823615|9730364|FG000|COMPLETED|Period 2||16
8686023|NCT00823615|9730365|FG001|COMPLETED|Period 2||17
8686024|NCT00823615|9730364|FG000|NOT COMPLETED|Period 2||3
8686025|NCT00823615|9730365|FG001|NOT COMPLETED|Period 2||2
8686026|NCT00823719|9730373|FG000|STARTED|Overall Study||26
8686027|NCT00823719|9730374|FG001|STARTED|Overall Study||35
8686028|NCT00823719|9730373|FG000|COMPLETED|Overall Study||20
8686029|NCT00823719|9730374|FG001|COMPLETED|Overall Study||24
8686030|NCT00823719|9730373|FG000|NOT COMPLETED|Overall Study||6
8686031|NCT00823719|9730374|FG001|NOT COMPLETED|Overall Study||11
8686032|NCT00823797|9730384|FG000|STARTED|Overall Study||29
8686033|NCT00823797|9730385|FG001|STARTED|Overall Study||16
8686034|NCT00823797|9730384|FG000|COMPLETED|Overall Study||29
8686035|NCT00823797|9730385|FG001|COMPLETED|Overall Study||16
8686036|NCT00823797|9730384|FG000|NOT COMPLETED|Overall Study||0
8686037|NCT00823797|9730385|FG001|NOT COMPLETED|Overall Study||0
8686038|NCT00823823|9730392|FG000|STARTED|Overall Study||109
8686039|NCT00823823|9730393|FG001|STARTED|Overall Study||107
8686040|NCT00823823|9730392|FG000|COMPLETED|Overall Study||101
8686041|NCT00823823|9730393|FG001|COMPLETED|Overall Study||101
8686042|NCT00823823|9730392|FG000|NOT COMPLETED|Overall Study||8
8686043|NCT00823823|9730393|FG001|NOT COMPLETED|Overall Study||6
8686044|NCT00823836|9730401|FG000|STARTED|NV and PR/XR Switching Phases||156
8686045|NCT00823836|9730402|FG001|STARTED|NV and PR/XR Switching Phases||146
8686046|NCT00823836|9730401|FG000|COMPLETED|NV and PR/XR Switching Phases||124
8686047|NCT00823836|9730402|FG001|COMPLETED|NV and PR/XR Switching Phases||117
8686048|NCT00823836|9730401|FG000|NOT COMPLETED|NV and PR/XR Switching Phases||32
8686049|NCT00823836|9730402|FG001|NOT COMPLETED|NV and PR/XR Switching Phases||29
8686050|NCT00823836|9730401|FG000|STARTED|Long-term Phase||73
8686051|NCT00823836|9730402|FG001|STARTED|Long-term Phase||84
8686052|NCT00823836|9730401|FG000|COMPLETED|Long-term Phase||68
8686053|NCT00823836|9730402|FG001|COMPLETED|Long-term Phase||79
8686054|NCT00823836|9730401|FG000|NOT COMPLETED|Long-term Phase||5
8686055|NCT00823836|9730402|FG001|NOT COMPLETED|Long-term Phase||5
8693295|NCT00865566|9738735|FG001|COMPLETED|Overall Study||564
8693296|NCT00865566|9738734|FG000|NOT COMPLETED|Overall Study||624
8686056|NCT00823901|9730413|FG000|STARTED|Overall Study|Randomized to clindamycin/tretinoin gel|43
8686057|NCT00823901|9730414|FG001|STARTED|Overall Study|Randomized to placebo gel|40
8686058|NCT00823901|9730413|FG000|COMPLETED|Overall Study|Discontinued intervention (n=2) Only baseline completed (n=2)|39
8686059|NCT00823901|9730414|FG001|COMPLETED|Overall Study|Discontinued intervention (n=1) Only baseline completed (n=1)|38
8686060|NCT00823901|9730413|FG000|NOT COMPLETED|Overall Study||4
8801320|NCT01449630|9853132|FG002|COMPLETED|Period 2||2
8801321|NCT01449630|9853133|FG003|COMPLETED|Period 2||1
8801322|NCT01449630|9853134|FG004|COMPLETED|Period 2||5
8801323|NCT01449630|9853135|FG005|COMPLETED|Period 2||1
8801324|NCT01449630|9853136|FG006|COMPLETED|Period 2||1
8801325|NCT01449630|9853137|FG007|COMPLETED|Period 2||6
8801326|NCT01449630|9853138|FG008|COMPLETED|Period 2||2
8801327|NCT01449630|9853130|FG000|NOT COMPLETED|Period 2||0
8801328|NCT01449630|9853131|FG001|NOT COMPLETED|Period 2||0
8801329|NCT01449630|9853132|FG002|NOT COMPLETED|Period 2||0
8801330|NCT01449630|9853133|FG003|NOT COMPLETED|Period 2||0
8801331|NCT01449630|9853134|FG004|NOT COMPLETED|Period 2||0
8801332|NCT01449630|9853135|FG005|NOT COMPLETED|Period 2||0
8801333|NCT01449630|9853136|FG006|NOT COMPLETED|Period 2||1
8801334|NCT01449630|9853137|FG007|NOT COMPLETED|Period 2||0
8801335|NCT01449630|9853138|FG008|NOT COMPLETED|Period 2||0
8801336|NCT01449630|9853130|FG000|STARTED|Period 3||1
8801337|NCT01449630|9853131|FG001|STARTED|Period 3||6
8801338|NCT01449630|9853132|FG002|STARTED|Period 3||2
8801339|NCT01449630|9853133|FG003|STARTED|Period 3||1
8801340|NCT01449630|9853134|FG004|STARTED|Period 3||5
8801341|NCT01449630|9853135|FG005|STARTED|Period 3||1
8801342|NCT01449630|9853136|FG006|STARTED|Period 3||1
8801343|NCT01449630|9853137|FG007|STARTED|Period 3||6
8801344|NCT01449630|9853138|FG008|STARTED|Period 3||2
8801345|NCT01449630|9853130|FG000|COMPLETED|Period 3||1
8801346|NCT01449630|9853131|FG001|COMPLETED|Period 3||6
8801347|NCT01449630|9853132|FG002|COMPLETED|Period 3||2
8801348|NCT01449630|9853133|FG003|COMPLETED|Period 3||1
8801349|NCT01449630|9853134|FG004|COMPLETED|Period 3||5
8801350|NCT01449630|9853135|FG005|COMPLETED|Period 3||1
8801351|NCT01449630|9853136|FG006|COMPLETED|Period 3||1
8801352|NCT01449630|9853137|FG007|COMPLETED|Period 3||6
8801353|NCT01449630|9853138|FG008|COMPLETED|Period 3||2
8801354|NCT01449630|9853130|FG000|NOT COMPLETED|Period 3||0
8801355|NCT01449630|9853131|FG001|NOT COMPLETED|Period 3||0
8801356|NCT01449630|9853132|FG002|NOT COMPLETED|Period 3||0
8801357|NCT01449630|9853133|FG003|NOT COMPLETED|Period 3||0
8801358|NCT01449630|9853134|FG004|NOT COMPLETED|Period 3||0
8801359|NCT01449630|9853135|FG005|NOT COMPLETED|Period 3||0
8801360|NCT01449630|9853136|FG006|NOT COMPLETED|Period 3||0
8801361|NCT01449630|9853137|FG007|NOT COMPLETED|Period 3||0
8801362|NCT01449630|9853138|FG008|NOT COMPLETED|Period 3||0
8919593|NCT02207816|9979495|FG000|STARTED|Overall Study||1046
8919594|NCT02207816|9979496|FG001|STARTED|Overall Study||1010
8919595|NCT02207816|9979497|FG002|STARTED|Overall Study||1028
8919596|NCT02207816|9979495|FG000|COMPLETED|Overall Study||995
8919597|NCT02207816|9979496|FG001|COMPLETED|Overall Study||924
8919598|NCT02207816|9979497|FG002|COMPLETED|Overall Study||961
8919599|NCT02207816|9979495|FG000|NOT COMPLETED|Overall Study||51
8919600|NCT02207816|9979496|FG001|NOT COMPLETED|Overall Study||86
8919601|NCT02207816|9979497|FG002|NOT COMPLETED|Overall Study||67
8919602|NCT02207829|9979510|FG000|STARTED|Overall Study||509
8919603|NCT02207829|9979511|FG001|STARTED|Overall Study||508
8919604|NCT02207829|9979510|FG000|COMPLETED|Overall Study||467
8919605|NCT02207829|9979511|FG001|COMPLETED|Overall Study||474
8919606|NCT02207829|9979510|FG000|NOT COMPLETED|Overall Study||42
8919607|NCT02207829|9979511|FG001|NOT COMPLETED|Overall Study||34
8919608|NCT02207907|9979519|FG000|STARTED|Overall Study||124
8919609|NCT02207907|9979520|FG001|STARTED|Overall Study||123
8919610|NCT02207907|9979519|FG000|COMPLETED|Overall Study||113
8919611|NCT02207907|9979520|FG001|COMPLETED|Overall Study||115
8919612|NCT02207907|9979519|FG000|NOT COMPLETED|Overall Study||11
8919613|NCT02207907|9979520|FG001|NOT COMPLETED|Overall Study||8
8919614|NCT02207946|9979529|FG000|STARTED|Overall Study||19
8919615|NCT02207946|9979530|FG001|STARTED|Overall Study||11
8919616|NCT02207946|9979529|FG000|COMPLETED|Overall Study||18
8919617|NCT02207946|9979530|FG001|COMPLETED|Overall Study||10
8919618|NCT02207946|9979529|FG000|NOT COMPLETED|Overall Study||1
8919619|NCT02207946|9979530|FG001|NOT COMPLETED|Overall Study||1
8919620|NCT02207972|9979539|FG000|STARTED|Overall Study||22
8919621|NCT02207972|9979540|FG001|STARTED|Overall Study||24
8919622|NCT02207972|9979539|FG000|COMPLETED|Overall Study||22
8919623|NCT02207972|9979540|FG001|COMPLETED|Overall Study||24
8919624|NCT02207972|9979539|FG000|NOT COMPLETED|Overall Study||0
8919625|NCT02207972|9979540|FG001|NOT COMPLETED|Overall Study||0
8919626|NCT02208037|9979550|FG000|STARTED|Overall Study||93
8919627|NCT02208037|9979551|FG001|STARTED|Overall Study||93
8686061|NCT00823901|9730414|FG001|NOT COMPLETED|Overall Study||2
8686062|NCT00823966|9730420|FG000|STARTED|Overall Study||3
8686063|NCT00823966|9730420|FG000|COMPLETED|Overall Study||3
8686064|NCT00823966|9730420|FG000|NOT COMPLETED|Overall Study||0
8686065|NCT00823979|9730427|FG000|STARTED|Overall Study||35
8919628|NCT02208037|9979552|FG002|STARTED|Overall Study||93
8919629|NCT02208037|9979550|FG000|COMPLETED|Overall Study||89
8919630|NCT02208037|9979551|FG001|COMPLETED|Overall Study||92
8919631|NCT02208037|9979552|FG002|COMPLETED|Overall Study||92
8686066|NCT00823979|9730428|FG001|STARTED|Overall Study||35
8686067|NCT00823979|9730429|FG002|STARTED|Overall Study||35
8686068|NCT00823979|9730427|FG000|Treated|Overall Study||31
8686069|NCT00823979|9730428|FG001|Treated|Overall Study||32
8686070|NCT00823979|9730429|FG002|Treated|Overall Study||34
8686071|NCT00823979|9730427|FG000|COMPLETED|Overall Study||6
8686072|NCT00823979|9730428|FG001|COMPLETED|Overall Study||3
8686073|NCT00823979|9730429|FG002|COMPLETED|Overall Study||11
8686074|NCT00823979|9730427|FG000|NOT COMPLETED|Overall Study||29
8686075|NCT00823979|9730428|FG001|NOT COMPLETED|Overall Study||32
8686076|NCT00823979|9730429|FG002|NOT COMPLETED|Overall Study||24
8686077|NCT00824005|9730439|FG000|STARTED|Overall Study||31
8686078|NCT00824005|9730440|FG001|STARTED|Overall Study||61
8686079|NCT00824005|9730439|FG000|COMPLETED|Overall Study||31
8686080|NCT00824005|9730440|FG001|COMPLETED|Overall Study||59
8686081|NCT00824005|9730439|FG000|NOT COMPLETED|Overall Study||0
8686082|NCT00824005|9730440|FG001|NOT COMPLETED|Overall Study||2
8686083|NCT00824044|9730448|FG000|STARTED|Overall Study||23
8686084|NCT00824044|9730449|FG001|STARTED|Overall Study||16
8686085|NCT00824044|9730448|FG000|COMPLETED|Overall Study||14
8686086|NCT00824044|9730449|FG001|COMPLETED|Overall Study||10
8686087|NCT00824044|9730448|FG000|NOT COMPLETED|Overall Study||9
8686088|NCT00824044|9730449|FG001|NOT COMPLETED|Overall Study||6
8686089|NCT00824070|9730462|FG000|STARTED|Overall Study||34
8686090|NCT00824070|9730463|FG001|STARTED|Overall Study||35
8686091|NCT00824070|9730464|FG002|STARTED|Overall Study||36
8686092|NCT00824070|9730462|FG000|COMPLETED|Overall Study||34
8686093|NCT00824070|9730463|FG001|COMPLETED|Overall Study||35
8686094|NCT00824070|9730464|FG002|COMPLETED|Overall Study||36
8686095|NCT00824070|9730462|FG000|NOT COMPLETED|Overall Study||0
8686096|NCT00824070|9730463|FG001|NOT COMPLETED|Overall Study||0
8686097|NCT00824070|9730464|FG002|NOT COMPLETED|Overall Study||0
8686098|NCT00824161|9730472|FG000|STARTED|Overall Study||28
8686099|NCT00824161|9730472|FG000|COMPLETED|Overall Study||26
8686100|NCT00824161|9730472|FG000|NOT COMPLETED|Overall Study||2
8686101|NCT00824265|9730479|FG000|STARTED|Treatment Phase||183
8686102|NCT00824265|9730480|FG001|STARTED|Treatment Phase||182
8686103|NCT00824265|9730479|FG000|COMPLETED|Treatment Phase||119
8686104|NCT00824265|9730480|FG001|COMPLETED|Treatment Phase||102
8686105|NCT00824265|9730479|FG000|NOT COMPLETED|Treatment Phase||64
8686106|NCT00824265|9730480|FG001|NOT COMPLETED|Treatment Phase||80
8686107|NCT00824265|9730479|FG000|STARTED|Follow-up Phase||172
8686108|NCT00824265|9730480|FG001|STARTED|Follow-up Phase||160
8686109|NCT00824265|9730479|FG000|COMPLETED|Follow-up Phase||154
8686110|NCT00824265|9730480|FG001|COMPLETED|Follow-up Phase||129
8686111|NCT00824265|9730479|FG000|NOT COMPLETED|Follow-up Phase||18
8686112|NCT00824265|9730480|FG001|NOT COMPLETED|Follow-up Phase||31
8686113|NCT00824265|9730479|FG000|STARTED|Survival Follow-up Phase||96
8686114|NCT00824265|9730480|FG001|STARTED|Survival Follow-up Phase||89
8686115|NCT00824265|9730479|FG000|COMPLETED|Survival Follow-up Phase||87
8686116|NCT00824265|9730480|FG001|COMPLETED|Survival Follow-up Phase||73
8686117|NCT00824265|9730479|FG000|NOT COMPLETED|Survival Follow-up Phase||9
8686118|NCT00824265|9730480|FG001|NOT COMPLETED|Survival Follow-up Phase||16
8686119|NCT00824291|9730492|FG000|STARTED|Overall Study||285
8686120|NCT00824291|9730493|FG001|STARTED|Overall Study||142
8686121|NCT00824291|9730492|FG000|COMPLETED|Overall Study||231
8686122|NCT00824291|9730493|FG001|COMPLETED|Overall Study||107
8686123|NCT00824291|9730492|FG000|NOT COMPLETED|Overall Study||54
8686124|NCT00824291|9730493|FG001|NOT COMPLETED|Overall Study||35
8686125|NCT00824369|9730505|FG000|STARTED|Overall Study||5
8686126|NCT00824369|9730506|FG001|STARTED|Overall Study||4
8686127|NCT00824369|9730507|FG002|STARTED|Overall Study||3
8686128|NCT00824369|9730508|FG003|STARTED|Overall Study||11
8686129|NCT00824369|9730509|FG004|STARTED|Overall Study||12
8686130|NCT00824369|9730510|FG005|STARTED|Overall Study||17
8686131|NCT00824369|9730505|FG000|COMPLETED|Overall Study||4
8686132|NCT00824369|9730506|FG001|COMPLETED|Overall Study||4
8686133|NCT00824369|9730507|FG002|COMPLETED|Overall Study||2
8686134|NCT00824369|9730508|FG003|COMPLETED|Overall Study||9
8686135|NCT00824369|9730509|FG004|COMPLETED|Overall Study||11
8686136|NCT00824369|9730510|FG005|COMPLETED|Overall Study||16
8686137|NCT00824369|9730505|FG000|NOT COMPLETED|Overall Study||1
8686138|NCT00824369|9730506|FG001|NOT COMPLETED|Overall Study||0
8686139|NCT00824369|9730507|FG002|NOT COMPLETED|Overall Study||1
8686140|NCT00824369|9730508|FG003|NOT COMPLETED|Overall Study||2
8686141|NCT00824369|9730509|FG004|NOT COMPLETED|Overall Study||1
8686142|NCT00824369|9730510|FG005|NOT COMPLETED|Overall Study||1
8686143|NCT00824382|9730528|FG000|STARTED|Overall Study||79
8686144|NCT00824382|9730529|FG001|STARTED|Overall Study||84
8686145|NCT00824382|9730530|FG002|STARTED|Overall Study||79
8686146|NCT00824382|9730531|FG003|STARTED|Overall Study||86
8686147|NCT00824382|9730528|FG000|COMPLETED|Overall Study||74
8686148|NCT00824382|9730529|FG001|COMPLETED|Overall Study||82
8686149|NCT00824382|9730530|FG002|COMPLETED|Overall Study||76
8686150|NCT00824382|9730531|FG003|COMPLETED|Overall Study||81
8686151|NCT00824382|9730528|FG000|NOT COMPLETED|Overall Study||5
8686152|NCT00824382|9730529|FG001|NOT COMPLETED|Overall Study||2
8686153|NCT00824382|9730530|FG002|NOT COMPLETED|Overall Study||3
8686154|NCT00824382|9730531|FG003|NOT COMPLETED|Overall Study||5
8686155|NCT00824408|9730548|FG000|STARTED|Run-in Phase||6
8686156|NCT00824408|9730549|FG001|STARTED|Run-in Phase||6
8686157|NCT00824408|9730550|FG002|STARTED|Run-in Phase||0
8686158|NCT00824408|9730551|FG003|STARTED|Run-in Phase||0
8686159|NCT00824408|9730552|FG004|STARTED|Run-in Phase||0
8686160|NCT00824408|9730548|FG000|COMPLETED|Run-in Phase||0
8686161|NCT00824408|9730549|FG001|COMPLETED|Run-in Phase||0
8686162|NCT00824408|9730550|FG002|COMPLETED|Run-in Phase||0
8686163|NCT00824408|9730551|FG003|COMPLETED|Run-in Phase||0
8686164|NCT00824408|9730552|FG004|COMPLETED|Run-in Phase||0
8686165|NCT00824408|9730548|FG000|NOT COMPLETED|Run-in Phase||6
8686166|NCT00824408|9730549|FG001|NOT COMPLETED|Run-in Phase||6
8686167|NCT00824408|9730550|FG002|NOT COMPLETED|Run-in Phase||0
8686168|NCT00824408|9730551|FG003|NOT COMPLETED|Run-in Phase||0
8686169|NCT00824408|9730552|FG004|NOT COMPLETED|Run-in Phase||0
8686170|NCT00824408|9730548|FG000|STARTED|Randomized Phase||0
8686171|NCT00824408|9730549|FG001|STARTED|Randomized Phase||0
8686172|NCT00824408|9730550|FG002|STARTED|Randomized Phase||37
8686173|NCT00824408|9730551|FG003|STARTED|Randomized Phase||47
8686174|NCT00824408|9730552|FG004|STARTED|Randomized Phase||47
8686175|NCT00824408|9730548|FG000|COMPLETED|Randomized Phase||0
8686176|NCT00824408|9730549|FG001|COMPLETED|Randomized Phase||0
8686177|NCT00824408|9730550|FG002|COMPLETED|Randomized Phase|On-treatment at data cutoff (21Dec2012)|1
8686178|NCT00824408|9730551|FG003|COMPLETED|Randomized Phase|On-treatment at data cutoff (21Dec2012)|1
8686179|NCT00824408|9730552|FG004|COMPLETED|Randomized Phase|On-treatment at data cutoff (21Dec2012)|1
8686180|NCT00824408|9730548|FG000|NOT COMPLETED|Randomized Phase||0
8686181|NCT00824408|9730549|FG001|NOT COMPLETED|Randomized Phase||0
8686182|NCT00824408|9730550|FG002|NOT COMPLETED|Randomized Phase||36
8686183|NCT00824408|9730551|FG003|NOT COMPLETED|Randomized Phase||46
8686184|NCT00824408|9730552|FG004|NOT COMPLETED|Randomized Phase||46
8686185|NCT00824421|9730573|FG000|STARTED|Overall Study||66
8686186|NCT00824421|9730574|FG001|STARTED|Overall Study||66
8686187|NCT00824421|9730575|FG002|STARTED|Overall Study||63
8686188|NCT00824421|9730573|FG000|Treated|Overall Study||65
8686189|NCT00824421|9730574|FG001|Treated|Overall Study||65
8919632|NCT02208037|9979550|FG000|NOT COMPLETED|Overall Study||4
8919633|NCT02208037|9979551|FG001|NOT COMPLETED|Overall Study||1
8919634|NCT02208037|9979552|FG002|NOT COMPLETED|Overall Study||1
8919635|NCT02208050|9979562|FG000|STARTED|Baseline Assessment Period: 2 Weeks||36
8919636|NCT02208050|9979563|FG001|STARTED|Baseline Assessment Period: 2 Weeks||28
8919637|NCT02208050|9979562|FG000|COMPLETED|Baseline Assessment Period: 2 Weeks||36
8919638|NCT02208050|9979563|FG001|COMPLETED|Baseline Assessment Period: 2 Weeks||28
8919639|NCT02208050|9979562|FG000|NOT COMPLETED|Baseline Assessment Period: 2 Weeks||0
8919640|NCT02208050|9979563|FG001|NOT COMPLETED|Baseline Assessment Period: 2 Weeks||0
8919641|NCT02208050|9979562|FG000|STARTED|Treatment Period 1: 8 Weeks Treatment||36
8919642|NCT02208050|9979563|FG001|STARTED|Treatment Period 1: 8 Weeks Treatment||28
8919643|NCT02208050|9979562|FG000|COMPLETED|Treatment Period 1: 8 Weeks Treatment||36
8919644|NCT02208050|9979563|FG001|COMPLETED|Treatment Period 1: 8 Weeks Treatment||28
8919645|NCT02208050|9979562|FG000|NOT COMPLETED|Treatment Period 1: 8 Weeks Treatment||0
8919646|NCT02208050|9979563|FG001|NOT COMPLETED|Treatment Period 1: 8 Weeks Treatment||0
8919647|NCT02208050|9979562|FG000|STARTED|Washout Period 1: 2 Weeks||36
8919648|NCT02208050|9979563|FG001|STARTED|Washout Period 1: 2 Weeks||28
8919649|NCT02208050|9979562|FG000|COMPLETED|Washout Period 1: 2 Weeks||35
8919650|NCT02208050|9979563|FG001|COMPLETED|Washout Period 1: 2 Weeks||28
8919651|NCT02208050|9979562|FG000|NOT COMPLETED|Washout Period 1: 2 Weeks||1
8919652|NCT02208050|9979563|FG001|NOT COMPLETED|Washout Period 1: 2 Weeks||0
8919653|NCT02208050|9979562|FG000|STARTED|Treatment Period 2: 8 Weeks Treatment||35
8919654|NCT02208050|9979563|FG001|STARTED|Treatment Period 2: 8 Weeks Treatment||28
8919655|NCT02208050|9979562|FG000|COMPLETED|Treatment Period 2: 8 Weeks Treatment||33
8919656|NCT02208050|9979563|FG001|COMPLETED|Treatment Period 2: 8 Weeks Treatment||28
8919657|NCT02208050|9979562|FG000|NOT COMPLETED|Treatment Period 2: 8 Weeks Treatment||2
8919658|NCT02208050|9979563|FG001|NOT COMPLETED|Treatment Period 2: 8 Weeks Treatment||0
8919659|NCT02208050|9979562|FG000|STARTED|Washout Period 2: 2 Weeks Washout.||33
8919660|NCT02208050|9979563|FG001|STARTED|Washout Period 2: 2 Weeks Washout.||28
8919661|NCT02208050|9979562|FG000|COMPLETED|Washout Period 2: 2 Weeks Washout.||33
8919662|NCT02208050|9979563|FG001|COMPLETED|Washout Period 2: 2 Weeks Washout.||28
8919663|NCT02208050|9979562|FG000|NOT COMPLETED|Washout Period 2: 2 Weeks Washout.||0
8919664|NCT02208050|9979563|FG001|NOT COMPLETED|Washout Period 2: 2 Weeks Washout.||0
8919665|NCT02208063|9979585|FG000|STARTED|Overall Study||60
8919666|NCT02208063|9979586|FG001|STARTED|Overall Study||61
8919667|NCT02208063|9979585|FG000|Randomized and Treated|Overall Study||58
8919668|NCT02208063|9979586|FG001|Randomized and Treated|Overall Study||60
8919669|NCT02208063|9979585|FG000|Microbiological All Treated|Overall Study||47
8919670|NCT02208063|9979586|FG001|Microbiological All Treated|Overall Study||52
8919671|NCT02208063|9979585|FG000|COMPLETED|Overall Study||48
8919672|NCT02208063|9979586|FG001|COMPLETED|Overall Study||50
8919673|NCT02208063|9979585|FG000|NOT COMPLETED|Overall Study||12
8919674|NCT02208063|9979586|FG001|NOT COMPLETED|Overall Study||11
8919675|NCT02208089|9979594|FG000|STARTED|Overall Study||47
8919676|NCT02208089|9979595|FG001|STARTED|Overall Study||47
8919677|NCT02208089|9979594|FG000|COMPLETED|Overall Study||40
8919678|NCT02208089|9979595|FG001|COMPLETED|Overall Study||47
8919679|NCT02208089|9979594|FG000|NOT COMPLETED|Overall Study||7
8919680|NCT02208089|9979595|FG001|NOT COMPLETED|Overall Study||0
8919681|NCT02208297|9979604|FG000|STARTED|Overall Study||163
8919682|NCT02208297|9979605|FG001|STARTED|Overall Study||163
8919683|NCT02208297|9979604|FG000|COMPLETED|Overall Study||141
8686190|NCT00824421|9730575|FG002|Treated|Overall Study||63
8686191|NCT00824421|9730573|FG000|COMPLETED|Overall Study||49
8686192|NCT00824421|9730574|FG001|COMPLETED|Overall Study||44
8686193|NCT00824421|9730575|FG002|COMPLETED|Overall Study||49
8686194|NCT00824421|9730573|FG000|NOT COMPLETED|Overall Study||17
8686195|NCT00824421|9730574|FG001|NOT COMPLETED|Overall Study||22
8686196|NCT00824421|9730575|FG002|NOT COMPLETED|Overall Study||14
8686197|NCT00824434|9730585|FG000|STARTED|Overall Study||100
8686198|NCT00824434|9730585|FG000|COMPLETED|Overall Study||100
8686199|NCT00824434|9730585|FG000|NOT COMPLETED|Overall Study||0
8686200|NCT00824460|9730595|FG000|STARTED|Overall Study||26
8686201|NCT00824460|9730596|FG001|STARTED|Overall Study||26
8686202|NCT00824460|9730597|FG002|STARTED|Overall Study||25
8686203|NCT00824460|9730598|FG003|STARTED|Overall Study||27
8686204|NCT00824460|9730599|FG004|STARTED|Overall Study||24
8686205|NCT00824460|9730600|FG005|STARTED|Overall Study||26
8686206|NCT00824460|9730595|FG000|COMPLETED|Overall Study||18
8686207|NCT00824460|9730596|FG001|COMPLETED|Overall Study||17
8686208|NCT00824460|9730597|FG002|COMPLETED|Overall Study||20
8686209|NCT00824460|9730598|FG003|COMPLETED|Overall Study||15
8686210|NCT00824460|9730599|FG004|COMPLETED|Overall Study||15
8686211|NCT00824460|9730600|FG005|COMPLETED|Overall Study||18
8686212|NCT00824460|9730595|FG000|NOT COMPLETED|Overall Study||8
8686213|NCT00824460|9730596|FG001|NOT COMPLETED|Overall Study||9
8686214|NCT00824460|9730597|FG002|NOT COMPLETED|Overall Study||5
8686215|NCT00824460|9730598|FG003|NOT COMPLETED|Overall Study||12
8686216|NCT00824460|9730599|FG004|NOT COMPLETED|Overall Study||9
8686217|NCT00824460|9730600|FG005|NOT COMPLETED|Overall Study||8
8686218|NCT00824473|9730624|FG000|STARTED|Overall Study|1 subject was randomized in error|255
8686219|NCT00824473|9730625|FG001|STARTED|Overall Study||251
8686220|NCT00824473|9730624|FG000|COMPLETED|Overall Study||240
8686221|NCT00824473|9730625|FG001|COMPLETED|Overall Study||238
8686222|NCT00824473|9730624|FG000|NOT COMPLETED|Overall Study||15
8686223|NCT00824473|9730625|FG001|NOT COMPLETED|Overall Study||13
8686224|NCT00824512|9730633|FG000|STARTED|Overall Study||11
8686225|NCT00824512|9730634|FG001|STARTED|Overall Study||11
8686226|NCT00824512|9730633|FG000|COMPLETED|Overall Study||11
8686227|NCT00824512|9730634|FG001|COMPLETED|Overall Study||11
8686228|NCT00824512|9730633|FG000|NOT COMPLETED|Overall Study||0
8686229|NCT00824512|9730634|FG001|NOT COMPLETED|Overall Study||0
8686230|NCT00824538|9730640|FG000|STARTED|Overall Study|13 patients entered the study|13
8686231|NCT00824538|9730640|FG000|COMPLETED|Overall Study||11
8686232|NCT00824538|9730640|FG000|NOT COMPLETED|Overall Study||2
8686233|NCT00824564|9730647|FG000|STARTED|Overall Study||42
8686234|NCT00824564|9730648|FG001|STARTED|Overall Study||40
8686235|NCT00824564|9730647|FG000|Treated|Overall Study||41
8686236|NCT00824564|9730648|FG001|Treated|Overall Study||40
8686237|NCT00824564|9730647|FG000|COMPLETED|Overall Study||34
8686238|NCT00824564|9730648|FG001|COMPLETED|Overall Study||30
8686239|NCT00824564|9730647|FG000|NOT COMPLETED|Overall Study||8
8686240|NCT00824564|9730648|FG001|NOT COMPLETED|Overall Study||10
8686241|NCT00824616|9730656|FG000|STARTED|Overall Study||34
8686242|NCT00824616|9730657|FG001|STARTED|Overall Study||34
8686243|NCT00824616|9730656|FG000|COMPLETED|Overall Study||28
8686244|NCT00824616|9730657|FG001|COMPLETED|Overall Study||27
8686245|NCT00824616|9730656|FG000|NOT COMPLETED|Overall Study||6
8686246|NCT00824616|9730657|FG001|NOT COMPLETED|Overall Study||7
8686247|NCT00824655|9730665|FG000|STARTED|Infant Series (5 Months of Age)||118
8686248|NCT00824655|9730666|FG001|STARTED|Infant Series (5 Months of Age)||0
8686249|NCT00824655|9730665|FG000|COMPLETED|Infant Series (5 Months of Age)||118
8686250|NCT00824655|9730666|FG001|COMPLETED|Infant Series (5 Months of Age)||0
8686251|NCT00824655|9730665|FG000|NOT COMPLETED|Infant Series (5 Months of Age)||0
8801363|NCT01449682|9853162|FG000|STARTED|Overall Study||5
8801364|NCT01449682|9853163|FG001|STARTED|Overall Study||5
8801365|NCT01449682|9853162|FG000|COMPLETED|Overall Study||4
8801366|NCT01449682|9853163|FG001|COMPLETED|Overall Study||4
8801367|NCT01449682|9853162|FG000|NOT COMPLETED|Overall Study||1
8801368|NCT01449682|9853163|FG001|NOT COMPLETED|Overall Study||1
8801369|NCT01449708|9853171|FG000|STARTED|Overall Study||61
8801370|NCT01449708|9853172|FG001|STARTED|Overall Study||63
8801371|NCT01449708|9853171|FG000|COMPLETED|Overall Study||59
8801372|NCT01449708|9853172|FG001|COMPLETED|Overall Study||60
8801373|NCT01449708|9853171|FG000|NOT COMPLETED|Overall Study||2
8801374|NCT01449708|9853172|FG001|NOT COMPLETED|Overall Study||3
8801375|NCT01449721|9853183|FG000|STARTED|Overall Study||112
8801376|NCT01449721|9853184|FG001|STARTED|Overall Study||30
8801377|NCT01449721|9853183|FG000|COMPLETED|Overall Study||112
8801378|NCT01449721|9853184|FG001|COMPLETED|Overall Study||28
8801379|NCT01449721|9853183|FG000|NOT COMPLETED|Overall Study||0
8801380|NCT01449721|9853184|FG001|NOT COMPLETED|Overall Study||2
8801381|NCT01449734|9853190|FG000|STARTED|Overall Study||215
8801382|NCT01449734|9853190|FG000|COMPLETED|Overall Study||215
8801383|NCT01449734|9853190|FG000|NOT COMPLETED|Overall Study||0
8686252|NCT00824655|9730666|FG001|NOT COMPLETED|Infant Series (5 Months of Age)||0
8686253|NCT00824655|9730665|FG000|STARTED|After Infant Dose (6 Months of Age)||118
8686254|NCT00824655|9730666|FG001|STARTED|After Infant Dose (6 Months of Age)||0
8686255|NCT00824655|9730665|FG000|COMPLETED|After Infant Dose (6 Months of Age)||118
8686256|NCT00824655|9730666|FG001|COMPLETED|After Infant Dose (6 Months of Age)||0
8686257|NCT00824655|9730665|FG000|NOT COMPLETED|After Infant Dose (6 Months of Age)||0
8686258|NCT00824655|9730666|FG001|NOT COMPLETED|After Infant Dose (6 Months of Age)||0
8686259|NCT00824655|9730665|FG000|STARTED|Toddler Dose (12 Months of Age)||118
8686260|NCT00824655|9730666|FG001|STARTED|Toddler Dose (12 Months of Age)||116
8686261|NCT00824655|9730665|FG000|COMPLETED|Toddler Dose (12 Months of Age)||116
8686262|NCT00824655|9730666|FG001|COMPLETED|Toddler Dose (12 Months of Age)||116
8686263|NCT00824655|9730665|FG000|NOT COMPLETED|Toddler Dose (12 Months of Age)||2
8686264|NCT00824655|9730666|FG001|NOT COMPLETED|Toddler Dose (12 Months of Age)||0
8686265|NCT00824720|9730677|FG000|STARTED|Overall Study|3 subjects in the high dose group did not receive device - unable to insert.|19
8686266|NCT00824720|9730678|FG001|STARTED|Overall Study|1 subject in the low dose group did not receive device - unable to insert.|16
8686267|NCT00824720|9730679|FG002|STARTED|Overall Study||20
8686268|NCT00824720|9730677|FG000|COMPLETED|Overall Study||16
8686269|NCT00824720|9730678|FG001|COMPLETED|Overall Study||15
8686270|NCT00824720|9730679|FG002|COMPLETED|Overall Study||19
8686271|NCT00824720|9730677|FG000|NOT COMPLETED|Overall Study||3
8686272|NCT00824720|9730678|FG001|NOT COMPLETED|Overall Study||1
8686273|NCT00824720|9730679|FG002|NOT COMPLETED|Overall Study||1
8686274|NCT00824733|9730687|FG000|STARTED|Overall Study||6
8686275|NCT00824733|9730687|FG000|COMPLETED|Overall Study||6
8686276|NCT00824733|9730687|FG000|NOT COMPLETED|Overall Study||0
8686277|NCT00824746|9730691|FG000|STARTED|Overall Study||23
8686278|NCT00824746|9730691|FG000|COMPLETED|Overall Study||23
8686279|NCT00824746|9730691|FG000|NOT COMPLETED|Overall Study||0
8686280|NCT00824772|9730697|FG000|STARTED|Overall Study||204
8686281|NCT00824772|9730697|FG000|COMPLETED|Overall Study||196
8686282|NCT00824772|9730697|FG000|NOT COMPLETED|Overall Study||8
8686283|NCT00824824|9730703|FG000|STARTED|Overall Study||4
8686284|NCT00824824|9730704|FG001|STARTED|Overall Study||3
8686285|NCT00824824|9730703|FG000|COMPLETED|Overall Study||4
8686286|NCT00824824|9730704|FG001|COMPLETED|Overall Study||3
8686287|NCT00824824|9730703|FG000|NOT COMPLETED|Overall Study||0
8686288|NCT00824824|9730704|FG001|NOT COMPLETED|Overall Study||0
8686289|NCT00824850|9730712|FG000|STARTED|Overall Study||38
8686290|NCT00824850|9730713|FG001|STARTED|Overall Study||37
8686291|NCT00824850|9730712|FG000|Received Vaccination 13vPnC|Overall Study||38
8686292|NCT00824850|9730713|FG001|Received Vaccination 13vPnC|Overall Study||36
8686293|NCT00824850|9730712|FG000|COMPLETED|Overall Study||38
8686294|NCT00824850|9730713|FG001|COMPLETED|Overall Study||36
8686295|NCT00824850|9730712|FG000|NOT COMPLETED|Overall Study||0
8686296|NCT00824850|9730713|FG001|NOT COMPLETED|Overall Study||1
8686297|NCT00824993|9730727|FG000|STARTED|Overall Study||39
8686298|NCT00824993|9730728|FG001|STARTED|Overall Study||39
8686299|NCT00824993|9730727|FG000|6 Month Follow up|Overall Study||33
8686300|NCT00824993|9730728|FG001|6 Month Follow up|Overall Study||27
8686301|NCT00824993|9730727|FG000|COMPLETED|Overall Study||25
8686302|NCT00824993|9730728|FG001|COMPLETED|Overall Study||22
8686303|NCT00824993|9730727|FG000|NOT COMPLETED|Overall Study||14
8686304|NCT00824993|9730728|FG001|NOT COMPLETED|Overall Study||17
8801384|NCT01449747|9853196|FG000|STARTED|Overall Study||12
8801385|NCT01449747|9853197|FG001|STARTED|Overall Study||12
8801386|NCT01449747|9853196|FG000|COMPLETED|Overall Study||12
8801387|NCT01449747|9853197|FG001|COMPLETED|Overall Study||12
8801388|NCT01449747|9853196|FG000|NOT COMPLETED|Overall Study||0
8801389|NCT01449747|9853197|FG001|NOT COMPLETED|Overall Study||0
8801390|NCT01449812|9853206|FG000|STARTED|Overall Study||272
8801391|NCT01449812|9853207|FG001|STARTED|Overall Study||273
8801392|NCT01449812|9853208|FG002|STARTED|Overall Study||280
8801393|NCT01449812|9853206|FG000|COMPLETED|Overall Study||270
8801394|NCT01449812|9853207|FG001|COMPLETED|Overall Study||273
8801395|NCT01449812|9853208|FG002|COMPLETED|Overall Study||279
8801396|NCT01449812|9853206|FG000|NOT COMPLETED|Overall Study||2
8801397|NCT01449812|9853207|FG001|NOT COMPLETED|Overall Study||0
8801398|NCT01449812|9853208|FG002|NOT COMPLETED|Overall Study||1
8801399|NCT01449864|9853216|FG000|STARTED|Overall Study||22
8801400|NCT01449864|9853216|FG000|COMPLETED|Overall Study||17
8801401|NCT01449864|9853216|FG000|NOT COMPLETED|Overall Study||5
8801402|NCT01449929|9853222|FG000|STARTED|Randomization Phase 96 Week||242
8801403|NCT01449929|9853223|FG001|STARTED|Randomization Phase 96 Week||242
8801404|NCT01449929|9853224|FG002|STARTED|Randomization Phase 96 Week||0
8801405|NCT01449929|9853222|FG000|COMPLETED|Randomization Phase 96 Week||209
8801406|NCT01449929|9853223|FG001|COMPLETED|Randomization Phase 96 Week||189
8801407|NCT01449929|9853224|FG002|COMPLETED|Randomization Phase 96 Week||0
8801408|NCT01449929|9853222|FG000|NOT COMPLETED|Randomization Phase 96 Week||33
8801409|NCT01449929|9853223|FG001|NOT COMPLETED|Randomization Phase 96 Week||53
8801410|NCT01449929|9853224|FG002|NOT COMPLETED|Randomization Phase 96 Week||0
8801411|NCT01449929|9853222|FG000|STARTED|Extension Phase Approximately 3 Years||0
8801412|NCT01449929|9853223|FG001|STARTED|Extension Phase Approximately 3 Years||0
8801413|NCT01449929|9853224|FG002|STARTED|Extension Phase Approximately 3 Years||123
8801414|NCT01449929|9853222|FG000|COMPLETED|Extension Phase Approximately 3 Years||0
8801415|NCT01449929|9853223|FG001|COMPLETED|Extension Phase Approximately 3 Years||0
8801416|NCT01449929|9853224|FG002|COMPLETED|Extension Phase Approximately 3 Years||115
8801417|NCT01449929|9853222|FG000|NOT COMPLETED|Extension Phase Approximately 3 Years||0
8801418|NCT01449929|9853223|FG001|NOT COMPLETED|Extension Phase Approximately 3 Years||0
8801419|NCT01449929|9853224|FG002|NOT COMPLETED|Extension Phase Approximately 3 Years||8
8801420|NCT01449955|9853236|FG000|STARTED|Overall Study||28
8801421|NCT01449955|9853237|FG001|STARTED|Overall Study||26
8801422|NCT01449955|9853236|FG000|COMPLETED|Overall Study||27
8801423|NCT01449955|9853237|FG001|COMPLETED|Overall Study||24
8801424|NCT01449955|9853236|FG000|NOT COMPLETED|Overall Study||1
8801425|NCT01449955|9853237|FG001|NOT COMPLETED|Overall Study||2
8801426|NCT01450007|9853253|FG000|STARTED|Overall Study||44
8801427|NCT01450007|9853254|FG001|STARTED|Overall Study||42
8686305|NCT00825162|9730737|FG000|STARTED|Overall Study||710
8686306|NCT00825162|9730738|FG001|STARTED|Overall Study||880
8686307|NCT00825162|9730739|FG002|STARTED|Overall Study||402
8686308|NCT00825162|9730737|FG000|COMPLETED|Overall Study||682
8686309|NCT00825162|9730738|FG001|COMPLETED|Overall Study||859
8686310|NCT00825162|9730739|FG002|COMPLETED|Overall Study||396
8686311|NCT00825162|9730737|FG000|NOT COMPLETED|Overall Study||28
8686312|NCT00825162|9730738|FG001|NOT COMPLETED|Overall Study||21
8686313|NCT00825162|9730739|FG002|NOT COMPLETED|Overall Study||6
8686314|NCT00825175|9730754|FG000|STARTED|Overall Study||10
8686315|NCT00825175|9730755|FG001|STARTED|Overall Study||12
8686316|NCT00825175|9730754|FG000|COMPLETED|Overall Study||10
8686317|NCT00825175|9730755|FG001|COMPLETED|Overall Study||7
8686318|NCT00825175|9730754|FG000|NOT COMPLETED|Overall Study||0
8686319|NCT00825175|9730755|FG001|NOT COMPLETED|Overall Study||5
8686320|NCT00825266|9730763|FG000|STARTED|Overall Study||1
8686321|NCT00825266|9730764|FG001|STARTED|Overall Study||1
8686322|NCT00825266|9730763|FG000|COMPLETED|Overall Study||1
8686323|NCT00825266|9730764|FG001|COMPLETED|Overall Study||1
8686324|NCT00825266|9730763|FG000|NOT COMPLETED|Overall Study||0
8686325|NCT00825266|9730764|FG001|NOT COMPLETED|Overall Study||0
8686326|NCT00825305|9730772|FG000|STARTED|Overall Study||550
8686327|NCT00825305|9730773|FG001|STARTED|Overall Study||275
8686328|NCT00825305|9730772|FG000|COMPLETED|Overall Study||533
8686329|NCT00825305|9730773|FG001|COMPLETED|Overall Study||252
8686330|NCT00825305|9730772|FG000|NOT COMPLETED|Overall Study||17
8686331|NCT00825305|9730773|FG001|NOT COMPLETED|Overall Study||23
8686332|NCT00825318|9730779|FG000|STARTED|Overall Study||13
8686333|NCT00825318|9730779|FG000|COMPLETED|Overall Study||12
8686334|NCT00825318|9730779|FG000|NOT COMPLETED|Overall Study||1
8686335|NCT00825344|9730789|FG000|STARTED|Overall Study||34
8686336|NCT00825344|9730790|FG001|STARTED|Overall Study||43
8686337|NCT00825344|9730789|FG000|COMPLETED|Overall Study||33
8686338|NCT00825344|9730790|FG001|COMPLETED|Overall Study||42
8686339|NCT00825344|9730789|FG000|NOT COMPLETED|Overall Study||1
8686340|NCT00825344|9730790|FG001|NOT COMPLETED|Overall Study||1
8686341|NCT00825370|9730798|FG000|STARTED|Overall Study||175
8686342|NCT00825370|9730799|FG001|STARTED|Overall Study||175
8686343|NCT00825370|9730798|FG000|COMPLETED|Overall Study||175
8686344|NCT00825370|9730799|FG001|COMPLETED|Overall Study||175
8686345|NCT00825370|9730798|FG000|NOT COMPLETED|Overall Study||0
8686346|NCT00825370|9730799|FG001|NOT COMPLETED|Overall Study||0
8686347|NCT00825500|9730808|FG000|STARTED|Overall Study||125
8686348|NCT00825500|9730809|FG001|STARTED|Overall Study||121
8686349|NCT00825500|9730810|FG002|STARTED|Overall Study||120
8686350|NCT00825500|9730808|FG000|COMPLETED|Overall Study||125
8686351|NCT00825500|9730809|FG001|COMPLETED|Overall Study||121
8686352|NCT00825500|9730810|FG002|COMPLETED|Overall Study||120
8686353|NCT00825500|9730808|FG000|NOT COMPLETED|Overall Study||0
8686354|NCT00825500|9730809|FG001|NOT COMPLETED|Overall Study||0
8686355|NCT00825500|9730810|FG002|NOT COMPLETED|Overall Study||0
8686356|NCT00825565|9730818|FG000|STARTED|Overall Study||8
8686357|NCT00825565|9730818|FG000|COMPLETED|Overall Study||8
8686358|NCT00825565|9730818|FG000|NOT COMPLETED|Overall Study||0
8686359|NCT00825630|9730832|FG000|STARTED|Overall Study||29
8686360|NCT00825630|9730833|FG001|STARTED|Overall Study||62
8686361|NCT00825630|9730834|FG002|STARTED|Overall Study||19
8686362|NCT00825630|9730835|FG003|STARTED|Overall Study||13
8686363|NCT00825630|9730832|FG000|COMPLETED|Overall Study||29
8686364|NCT00825630|9730833|FG001|COMPLETED|Overall Study||62
8686365|NCT00825630|9730834|FG002|COMPLETED|Overall Study||19
8686366|NCT00825630|9730835|FG003|COMPLETED|Overall Study||13
8686367|NCT00825630|9730832|FG000|NOT COMPLETED|Overall Study||0
8686368|NCT00825630|9730833|FG001|NOT COMPLETED|Overall Study||0
8686369|NCT00825630|9730834|FG002|NOT COMPLETED|Overall Study||0
8686370|NCT00825630|9730835|FG003|NOT COMPLETED|Overall Study||0
8686371|NCT00825682|9730847|FG000|STARTED|Overall Study||47
8686372|NCT00825682|9730848|FG001|STARTED|Overall Study||25
8686373|NCT00825682|9730847|FG000|COMPLETED|Overall Study||34
8686374|NCT00825682|9730848|FG001|COMPLETED|Overall Study||20
8686375|NCT00825682|9730847|FG000|NOT COMPLETED|Overall Study||13
8686376|NCT00825682|9730848|FG001|NOT COMPLETED|Overall Study||5
8686377|NCT00825734|9730855|FG000|STARTED|Phase I||4
8686378|NCT00825734|9730856|FG001|STARTED|Phase I||3
8686379|NCT00825734|9730857|FG002|STARTED|Phase I||3
8686380|NCT00825734|9730855|FG000|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
8686381|NCT00825734|9730856|FG001|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
8686382|NCT00825734|9730857|FG002|COMPLETED|Phase I||3
8686383|NCT00825734|9730855|FG000|NOT COMPLETED|Phase I||4
8686384|NCT00825734|9730856|FG001|NOT COMPLETED|Phase I||3
8686385|NCT00825734|9730857|FG002|NOT COMPLETED|Phase I||0
8686386|NCT00825734|9730855|FG000|STARTED|Phase II||0
8686387|NCT00825734|9730856|FG001|STARTED|Phase II||0
8686388|NCT00825734|9730857|FG002|STARTED|Phase II|Includes patients treated at MTD during Phase I and 73 additional patients enrolled for Phase II|76
8686389|NCT00825734|9730855|FG000|COMPLETED|Phase II||0
8686390|NCT00825734|9730856|FG001|COMPLETED|Phase II||0
8686391|NCT00825734|9730857|FG002|COMPLETED|Phase II||0
8686392|NCT00825734|9730855|FG000|NOT COMPLETED|Phase II||0
8686393|NCT00825734|9730856|FG001|NOT COMPLETED|Phase II||0
8686394|NCT00825734|9730857|FG002|NOT COMPLETED|Phase II||76
8686395|NCT00825786|9730864|FG000|STARTED|Overall Study||52
8686396|NCT00825786|9730865|FG001|STARTED|Overall Study||51
8686397|NCT00825786|9730864|FG000|COMPLETED|Overall Study||52
8686398|NCT00825786|9730865|FG001|COMPLETED|Overall Study||51
8686399|NCT00825786|9730864|FG000|NOT COMPLETED|Overall Study||0
8686400|NCT00825786|9730865|FG001|NOT COMPLETED|Overall Study||0
8686401|NCT00825812|9730875|FG000|STARTED|Overall Study||29
8686402|NCT00825812|9730876|FG001|STARTED|Overall Study||32
8686403|NCT00825812|9730877|FG002|STARTED|Overall Study||126
8686404|NCT00825812|9730878|FG003|STARTED|Overall Study||121
8686405|NCT00825812|9730875|FG000|TREATED|Overall Study||29
8686406|NCT00825812|9730876|FG001|TREATED|Overall Study||31
8686407|NCT00825812|9730877|FG002|TREATED|Overall Study||120
8686408|NCT00825812|9730878|FG003|TREATED|Overall Study||111
8686409|NCT00825812|9730875|FG000|COMPLETED|Overall Study||29
8686410|NCT00825812|9730876|FG001|COMPLETED|Overall Study||31
8686411|NCT00825812|9730877|FG002|COMPLETED|Overall Study||120
8686412|NCT00825812|9730878|FG003|COMPLETED|Overall Study||111
8686413|NCT00825812|9730875|FG000|NOT COMPLETED|Overall Study||0
8686414|NCT00825812|9730876|FG001|NOT COMPLETED|Overall Study||1
8686415|NCT00825812|9730877|FG002|NOT COMPLETED|Overall Study||6
8686416|NCT00825812|9730878|FG003|NOT COMPLETED|Overall Study||10
8686417|NCT00825825|9730888|FG000|STARTED|First Medication Period (14 Days)||6
8686418|NCT00825825|9730889|FG001|STARTED|First Medication Period (14 Days)||4
8686419|NCT00825825|9730890|FG002|STARTED|First Medication Period (14 Days)||3
8686420|NCT00825825|9730891|FG003|STARTED|First Medication Period (14 Days)||5
8686421|NCT00825825|9730892|FG004|STARTED|First Medication Period (14 Days)||4
8686422|NCT00825825|9730893|FG005|STARTED|First Medication Period (14 Days)||5
8686423|NCT00825825|9730888|FG000|COMPLETED|First Medication Period (14 Days)||3
8686424|NCT00825825|9730889|FG001|COMPLETED|First Medication Period (14 Days)||4
8686425|NCT00825825|9730890|FG002|COMPLETED|First Medication Period (14 Days)||2
8686426|NCT00825825|9730891|FG003|COMPLETED|First Medication Period (14 Days)||5
8686427|NCT00825825|9730892|FG004|COMPLETED|First Medication Period (14 Days)||4
8686428|NCT00825825|9730893|FG005|COMPLETED|First Medication Period (14 Days)||3
8686429|NCT00825825|9730888|FG000|NOT COMPLETED|First Medication Period (14 Days)||3
8686430|NCT00825825|9730889|FG001|NOT COMPLETED|First Medication Period (14 Days)||0
8686431|NCT00825825|9730890|FG002|NOT COMPLETED|First Medication Period (14 Days)||1
8801428|NCT01450007|9853255|FG002|STARTED|Overall Study||44
8801429|NCT01450007|9853253|FG000|COMPLETED|Overall Study||42
8801430|NCT01450007|9853254|FG001|COMPLETED|Overall Study||37
8801431|NCT01450007|9853255|FG002|COMPLETED|Overall Study||41
8801432|NCT01450007|9853253|FG000|NOT COMPLETED|Overall Study||2
8801433|NCT01450007|9853254|FG001|NOT COMPLETED|Overall Study||5
8801434|NCT01450007|9853255|FG002|NOT COMPLETED|Overall Study||3
8801435|NCT01450098|9853265|FG000|STARTED|Period 1||8
8801436|NCT01450098|9853266|FG001|STARTED|Period 1||31
8801437|NCT01450098|9853265|FG000|Received at Least 1 Dose of Study Drug|Period 1||8
8801438|NCT01450098|9853266|FG001|Received at Least 1 Dose of Study Drug|Period 1||31
8801439|NCT01450098|9853265|FG000|COMPLETED|Period 1||8
8801440|NCT01450098|9853266|FG001|COMPLETED|Period 1||31
8801441|NCT01450098|9853265|FG000|NOT COMPLETED|Period 1||0
8801442|NCT01450098|9853266|FG001|NOT COMPLETED|Period 1||0
8801443|NCT01450098|9853265|FG000|STARTED|Washout Period of at Least 14 Days||8
8801444|NCT01450098|9853266|FG001|STARTED|Washout Period of at Least 14 Days||31
8801445|NCT01450098|9853265|FG000|COMPLETED|Washout Period of at Least 14 Days||8
8801446|NCT01450098|9853266|FG001|COMPLETED|Washout Period of at Least 14 Days||31
8801447|NCT01450098|9853265|FG000|NOT COMPLETED|Washout Period of at Least 14 Days||0
8801448|NCT01450098|9853266|FG001|NOT COMPLETED|Washout Period of at Least 14 Days||0
8801449|NCT01450098|9853265|FG000|STARTED|Period 2||8
8801450|NCT01450098|9853266|FG001|STARTED|Period 2||31
8801451|NCT01450098|9853265|FG000|Received at Least 1 Dose of Study Drug|Period 2||8
8801452|NCT01450098|9853266|FG001|Received at Least 1 Dose of Study Drug|Period 2||31
8801453|NCT01450098|9853265|FG000|COMPLETED|Period 2||8
8801454|NCT01450098|9853266|FG001|COMPLETED|Period 2||31
8801455|NCT01450098|9853265|FG000|NOT COMPLETED|Period 2||0
8801456|NCT01450098|9853266|FG001|NOT COMPLETED|Period 2||0
8801457|NCT01450098|9853265|FG000|STARTED|Washout of at Least 14 Days||8
8801458|NCT01450098|9853266|FG001|STARTED|Washout of at Least 14 Days||31
8801459|NCT01450098|9853265|FG000|COMPLETED|Washout of at Least 14 Days||8
8801460|NCT01450098|9853266|FG001|COMPLETED|Washout of at Least 14 Days||31
8801461|NCT01450098|9853265|FG000|NOT COMPLETED|Washout of at Least 14 Days||0
8801462|NCT01450098|9853266|FG001|NOT COMPLETED|Washout of at Least 14 Days||0
8801463|NCT01450098|9853265|FG000|STARTED|Period 3||8
8801464|NCT01450098|9853266|FG001|STARTED|Period 3||31
8801465|NCT01450098|9853265|FG000|Received at Least 1 Dose of Study Drug|Period 3||8
8801466|NCT01450098|9853266|FG001|Received at Least 1 Dose of Study Drug|Period 3||30
8801467|NCT01450098|9853265|FG000|COMPLETED|Period 3||8
8801468|NCT01450098|9853266|FG001|COMPLETED|Period 3||28
8801469|NCT01450098|9853265|FG000|NOT COMPLETED|Period 3||0
8801470|NCT01450098|9853266|FG001|NOT COMPLETED|Period 3||3
8801471|NCT01450137|9853281|FG000|STARTED|Up to Week 12||20
8801472|NCT01450137|9853282|FG001|STARTED|Up to Week 12||10
8801473|NCT01450137|9853281|FG000|COMPLETED|Up to Week 12||18
8801474|NCT01450137|9853282|FG001|COMPLETED|Up to Week 12||7
8801475|NCT01450137|9853281|FG000|NOT COMPLETED|Up to Week 12||2
8801476|NCT01450137|9853282|FG001|NOT COMPLETED|Up to Week 12||3
8686432|NCT00825825|9730891|FG003|NOT COMPLETED|First Medication Period (14 Days)||0
8686433|NCT00825825|9730892|FG004|NOT COMPLETED|First Medication Period (14 Days)||0
8686434|NCT00825825|9730893|FG005|NOT COMPLETED|First Medication Period (14 Days)||2
8686435|NCT00825825|9730888|FG000|STARTED|First Washout Period (14 Days)||3
8686436|NCT00825825|9730889|FG001|STARTED|First Washout Period (14 Days)||4
8686437|NCT00825825|9730890|FG002|STARTED|First Washout Period (14 Days)||2
8686438|NCT00825825|9730891|FG003|STARTED|First Washout Period (14 Days)||5
8686439|NCT00825825|9730892|FG004|STARTED|First Washout Period (14 Days)||4
8686440|NCT00825825|9730893|FG005|STARTED|First Washout Period (14 Days)||3
8686441|NCT00825825|9730888|FG000|COMPLETED|First Washout Period (14 Days)||3
8686442|NCT00825825|9730889|FG001|COMPLETED|First Washout Period (14 Days)||4
8686443|NCT00825825|9730890|FG002|COMPLETED|First Washout Period (14 Days)||2
8686444|NCT00825825|9730891|FG003|COMPLETED|First Washout Period (14 Days)||5
8686445|NCT00825825|9730892|FG004|COMPLETED|First Washout Period (14 Days)||4
8686446|NCT00825825|9730893|FG005|COMPLETED|First Washout Period (14 Days)||3
8686447|NCT00825825|9730888|FG000|NOT COMPLETED|First Washout Period (14 Days)||0
8686448|NCT00825825|9730889|FG001|NOT COMPLETED|First Washout Period (14 Days)||0
8686449|NCT00825825|9730890|FG002|NOT COMPLETED|First Washout Period (14 Days)||0
8686450|NCT00825825|9730891|FG003|NOT COMPLETED|First Washout Period (14 Days)||0
8686451|NCT00825825|9730892|FG004|NOT COMPLETED|First Washout Period (14 Days)||0
8686452|NCT00825825|9730893|FG005|NOT COMPLETED|First Washout Period (14 Days)||0
8686453|NCT00825825|9730888|FG000|STARTED|Second Medication Period (14 Days)||3
8686454|NCT00825825|9730889|FG001|STARTED|Second Medication Period (14 Days)||4
8686455|NCT00825825|9730890|FG002|STARTED|Second Medication Period (14 Days)||2
8686456|NCT00825825|9730891|FG003|STARTED|Second Medication Period (14 Days)||5
8686457|NCT00825825|9730892|FG004|STARTED|Second Medication Period (14 Days)||4
8686458|NCT00825825|9730893|FG005|STARTED|Second Medication Period (14 Days)||3
8686459|NCT00825825|9730888|FG000|COMPLETED|Second Medication Period (14 Days)||1
8686460|NCT00825825|9730889|FG001|COMPLETED|Second Medication Period (14 Days)||4
8686461|NCT00825825|9730890|FG002|COMPLETED|Second Medication Period (14 Days)||2
8686462|NCT00825825|9730891|FG003|COMPLETED|Second Medication Period (14 Days)||3
8686463|NCT00825825|9730892|FG004|COMPLETED|Second Medication Period (14 Days)||3
8686464|NCT00825825|9730893|FG005|COMPLETED|Second Medication Period (14 Days)||3
8686465|NCT00825825|9730888|FG000|NOT COMPLETED|Second Medication Period (14 Days)||2
8686466|NCT00825825|9730889|FG001|NOT COMPLETED|Second Medication Period (14 Days)||0
8686467|NCT00825825|9730890|FG002|NOT COMPLETED|Second Medication Period (14 Days)||0
8686468|NCT00825825|9730891|FG003|NOT COMPLETED|Second Medication Period (14 Days)||2
8686469|NCT00825825|9730892|FG004|NOT COMPLETED|Second Medication Period (14 Days)||1
8686470|NCT00825825|9730893|FG005|NOT COMPLETED|Second Medication Period (14 Days)||0
8686471|NCT00825825|9730888|FG000|STARTED|Second Washout Period (14 Days)||1
8686472|NCT00825825|9730889|FG001|STARTED|Second Washout Period (14 Days)||4
8686473|NCT00825825|9730890|FG002|STARTED|Second Washout Period (14 Days)||2
8686474|NCT00825825|9730891|FG003|STARTED|Second Washout Period (14 Days)||3
8686475|NCT00825825|9730892|FG004|STARTED|Second Washout Period (14 Days)||3
8686476|NCT00825825|9730893|FG005|STARTED|Second Washout Period (14 Days)||3
8686477|NCT00825825|9730888|FG000|COMPLETED|Second Washout Period (14 Days)||1
8686478|NCT00825825|9730889|FG001|COMPLETED|Second Washout Period (14 Days)||4
8686479|NCT00825825|9730890|FG002|COMPLETED|Second Washout Period (14 Days)||2
8686480|NCT00825825|9730891|FG003|COMPLETED|Second Washout Period (14 Days)||3
8686481|NCT00825825|9730892|FG004|COMPLETED|Second Washout Period (14 Days)||3
8686482|NCT00825825|9730893|FG005|COMPLETED|Second Washout Period (14 Days)||3
8686483|NCT00825825|9730888|FG000|NOT COMPLETED|Second Washout Period (14 Days)||0
8686484|NCT00825825|9730889|FG001|NOT COMPLETED|Second Washout Period (14 Days)||0
8686485|NCT00825825|9730890|FG002|NOT COMPLETED|Second Washout Period (14 Days)||0
8686486|NCT00825825|9730891|FG003|NOT COMPLETED|Second Washout Period (14 Days)||0
8686487|NCT00825825|9730892|FG004|NOT COMPLETED|Second Washout Period (14 Days)||0
8686488|NCT00825825|9730893|FG005|NOT COMPLETED|Second Washout Period (14 Days)||0
8686489|NCT00825825|9730888|FG000|STARTED|Third Medication Period (14 Days)||1
8686490|NCT00825825|9730889|FG001|STARTED|Third Medication Period (14 Days)||4
8686491|NCT00825825|9730890|FG002|STARTED|Third Medication Period (14 Days)||2
8686492|NCT00825825|9730891|FG003|STARTED|Third Medication Period (14 Days)||3
8686493|NCT00825825|9730892|FG004|STARTED|Third Medication Period (14 Days)||3
8686494|NCT00825825|9730893|FG005|STARTED|Third Medication Period (14 Days)||3
8686495|NCT00825825|9730888|FG000|COMPLETED|Third Medication Period (14 Days)||1
8686496|NCT00825825|9730889|FG001|COMPLETED|Third Medication Period (14 Days)||2
8686497|NCT00825825|9730890|FG002|COMPLETED|Third Medication Period (14 Days)||2
8686498|NCT00825825|9730891|FG003|COMPLETED|Third Medication Period (14 Days)||3
8686499|NCT00825825|9730892|FG004|COMPLETED|Third Medication Period (14 Days)||3
8686500|NCT00825825|9730893|FG005|COMPLETED|Third Medication Period (14 Days)||1
8686501|NCT00825825|9730888|FG000|NOT COMPLETED|Third Medication Period (14 Days)||0
8686502|NCT00825825|9730889|FG001|NOT COMPLETED|Third Medication Period (14 Days)||2
8686503|NCT00825825|9730890|FG002|NOT COMPLETED|Third Medication Period (14 Days)||0
8686504|NCT00825825|9730891|FG003|NOT COMPLETED|Third Medication Period (14 Days)||0
8686505|NCT00825825|9730892|FG004|NOT COMPLETED|Third Medication Period (14 Days)||0
8686506|NCT00825825|9730893|FG005|NOT COMPLETED|Third Medication Period (14 Days)||2
8686507|NCT00825916|9730903|FG000|STARTED|Overall Study||19
8686508|NCT00825916|9730904|FG001|STARTED|Overall Study||20
8686509|NCT00825916|9730905|FG002|STARTED|Overall Study||20
8686510|NCT00825916|9730903|FG000|COMPLETED|Overall Study||15
8686511|NCT00825916|9730904|FG001|COMPLETED|Overall Study||18
8686512|NCT00825916|9730905|FG002|COMPLETED|Overall Study||19
8686513|NCT00825916|9730903|FG000|NOT COMPLETED|Overall Study||4
8686514|NCT00825916|9730904|FG001|NOT COMPLETED|Overall Study||2
8686515|NCT00825916|9730905|FG002|NOT COMPLETED|Overall Study||1
8686516|NCT00825994|9730946|FG000|STARTED|Overall Study||24
8686517|NCT00825994|9730946|FG000|COMPLETED|Overall Study||19
8686518|NCT00825994|9730946|FG000|NOT COMPLETED|Overall Study||5
8686519|NCT00826007|9730952|FG000|STARTED|Overall Study|Retrospective review|308
8686520|NCT00826007|9730953|FG001|STARTED|Overall Study||279
8686521|NCT00826007|9730952|FG000|COMPLETED|Overall Study|Retrospective review|308
8686522|NCT00826007|9730953|FG001|COMPLETED|Overall Study||279
8686523|NCT00826007|9730952|FG000|NOT COMPLETED|Overall Study||0
8686524|NCT00826007|9730953|FG001|NOT COMPLETED|Overall Study||0
8686525|NCT00826020|9730958|FG000|STARTED|Overall Study||72
8686526|NCT00826020|9730958|FG000|COMPLETED|Overall Study||72
8686527|NCT00826020|9730958|FG000|NOT COMPLETED|Overall Study||0
8686528|NCT00826111|9730964|FG000|STARTED|Overall Study||14
8686529|NCT00826111|9730965|FG001|STARTED|Overall Study||5
8686530|NCT00826111|9730964|FG000|COMPLETED|Overall Study||7
8686531|NCT00826111|9730965|FG001|COMPLETED|Overall Study||3
8686532|NCT00826111|9730964|FG000|NOT COMPLETED|Overall Study||7
8686533|NCT00826111|9730965|FG001|NOT COMPLETED|Overall Study||2
8686534|NCT00826150|9730977|FG000|STARTED|Overall Study||8
8686535|NCT00826150|9730978|FG001|STARTED|Overall Study||3
8686536|NCT00826150|9730979|FG002|STARTED|Overall Study||3
8686537|NCT00826150|9730977|FG000|COMPLETED|Overall Study||2
8686538|NCT00826150|9730978|FG001|COMPLETED|Overall Study||1
8686539|NCT00826150|9730979|FG002|COMPLETED|Overall Study||0
8686540|NCT00826150|9730977|FG000|NOT COMPLETED|Overall Study||6
8686541|NCT00826150|9730978|FG001|NOT COMPLETED|Overall Study||2
8686542|NCT00826150|9730979|FG002|NOT COMPLETED|Overall Study||3
8686543|NCT00826176|9730991|FG000|STARTED|Overall Study|enrolled|128
8686544|NCT00826176|9730992|FG001|STARTED|Overall Study|enrolled|36
8686545|NCT00826176|9730991|FG000|COMPLETED|Overall Study|treated and completed|115
8686546|NCT00826176|9730992|FG001|COMPLETED|Overall Study|treated and completed|36
8686547|NCT00826176|9730991|FG000|NOT COMPLETED|Overall Study||13
8686548|NCT00826176|9730992|FG001|NOT COMPLETED|Overall Study||0
8686549|NCT00826202|9731000|FG000|STARTED|Overall Study||20
8686550|NCT00826202|9731001|FG001|STARTED|Overall Study||24
8686551|NCT00826202|9731000|FG000|Completed Visit 4 (1st Efficacy Visit)|Overall Study||15
8686552|NCT00826202|9731001|FG001|Completed Visit 4 (1st Efficacy Visit)|Overall Study||20
8686553|NCT00826202|9731000|FG000|COMPLETED|Overall Study||10
8686554|NCT00826202|9731001|FG001|COMPLETED|Overall Study||11
8686555|NCT00826202|9731000|FG000|NOT COMPLETED|Overall Study||10
8686556|NCT00826202|9731001|FG001|NOT COMPLETED|Overall Study||13
8686557|NCT00826228|9731007|FG000|STARTED|Overall Study||12
8686558|NCT00826228|9731007|FG000|COMPLETED|Overall Study||11
8686559|NCT00826228|9731007|FG000|NOT COMPLETED|Overall Study||1
8686560|NCT00826241|9731012|FG000|STARTED|Overall Study||58
8686561|NCT00826241|9731012|FG000|COMPLETED|Overall Study||31
8686562|NCT00826241|9731012|FG000|NOT COMPLETED|Overall Study||27
8686563|NCT00826267|9731019|FG000|STARTED|Overall Study||10
8686564|NCT00826267|9731020|FG001|STARTED|Overall Study||8
8686565|NCT00826267|9731021|FG002|STARTED|Overall Study||11
8686566|NCT00826267|9731019|FG000|COMPLETED|Overall Study||9
8686567|NCT00826267|9731020|FG001|COMPLETED|Overall Study||8
8686568|NCT00826267|9731021|FG002|COMPLETED|Overall Study||11
8686569|NCT00826267|9731019|FG000|NOT COMPLETED|Overall Study||1
8686570|NCT00826267|9731020|FG001|NOT COMPLETED|Overall Study||0
8686571|NCT00826267|9731021|FG002|NOT COMPLETED|Overall Study||0
8686572|NCT00826280|9731033|FG000|STARTED|Overall Study||114
8686573|NCT00826280|9731034|FG001|STARTED|Overall Study||116
8686574|NCT00826280|9731035|FG002|STARTED|Overall Study||117
8686575|NCT00826280|9731033|FG000|Safety Analysis Set|Overall Study|Safety Analysis Set (SAF) was all randomized subjects who received at least one dose of regadenoson|113
8686576|NCT00826280|9731034|FG001|Safety Analysis Set|Overall Study|SAF was all randomized subjects who received at least one dose of regadenoson|116
8686577|NCT00826280|9731035|FG002|Safety Analysis Set|Overall Study|SAF was all randomized subjects who received at least one dose of regadenoson|116
8686578|NCT00826280|9731033|FG000|Completed Treatment|Overall Study|Subjects who completed treatment but had ≥ 1 non-interpretable scan were not included in FAS|66
8686579|NCT00826280|9731034|FG001|Completed Treatment|Overall Study|Subjects who completed treatment but had ≥ 1 non-interpretable scan were not included in FAS|71
8686580|NCT00826280|9731035|FG002|Completed Treatment|Overall Study|Subjects who completed treatment but had ≥ 1 non-interpretable scan were not included in FAS|72
8686581|NCT00826280|9731033|FG000|COMPLETED|Overall Study|Ending Population equals FAS, all randomized subjects with interpretable MPI scans|66
8686582|NCT00826280|9731034|FG001|COMPLETED|Overall Study|Ending Population equals FAS, all randomized subjects with interpretable MPI scans|70
8686583|NCT00826280|9731035|FG002|COMPLETED|Overall Study|Ending Population equals FAS, all randomized subjects with interpretable MPI scans|71
8686584|NCT00826280|9731033|FG000|NOT COMPLETED|Overall Study||48
8686585|NCT00826280|9731034|FG001|NOT COMPLETED|Overall Study||46
8686586|NCT00826280|9731035|FG002|NOT COMPLETED|Overall Study||46
8686587|NCT00826449|9731045|FG000|STARTED|Overall Study||47
8686588|NCT00826449|9731045|FG000|Phase I|Overall Study||12
8686589|NCT00826449|9731045|FG000|Phase II|Overall Study||35
8686590|NCT00826449|9731045|FG000|COMPLETED|Overall Study||42
8686591|NCT00826449|9731045|FG000|NOT COMPLETED|Overall Study||5
8686592|NCT00826514|9731052|FG000|STARTED|Overall Study||30
8686593|NCT00826514|9731053|FG001|STARTED|Overall Study||32
8686594|NCT00826514|9731052|FG000|COMPLETED|Overall Study||27
8686595|NCT00826514|9731053|FG001|COMPLETED|Overall Study||27
8686596|NCT00826514|9731052|FG000|NOT COMPLETED|Overall Study||3
8686597|NCT00826514|9731053|FG001|NOT COMPLETED|Overall Study||5
8686598|NCT00826540|9731059|FG000|STARTED|Overall Study||83
8686599|NCT00826540|9731059|FG000|COMPLETED|Overall Study||79
8686600|NCT00826540|9731059|FG000|NOT COMPLETED|Overall Study||4
8686601|NCT00826618|9731063|FG000|STARTED|Overall Study||6
8686602|NCT00826618|9731063|FG000|COMPLETED|Overall Study||5
8686603|NCT00826618|9731063|FG000|NOT COMPLETED|Overall Study||1
8686604|NCT00826748|9731070|FG000|STARTED|Overall Study||6
8686605|NCT00826748|9731071|FG001|STARTED|Overall Study||4
8686606|NCT00826748|9731072|FG002|STARTED|Overall Study||12
8686607|NCT00826748|9731070|FG000|COMPLETED|Overall Study||6
8686608|NCT00826748|9731071|FG001|COMPLETED|Overall Study||4
8686609|NCT00826748|9731072|FG002|COMPLETED|Overall Study||8
8686610|NCT00826748|9731070|FG000|NOT COMPLETED|Overall Study||0
8686611|NCT00826748|9731071|FG001|NOT COMPLETED|Overall Study||0
8686612|NCT00826748|9731072|FG002|NOT COMPLETED|Overall Study||4
8686613|NCT00826800|9731080|FG000|STARTED|Overall Study||2
8686614|NCT00826800|9731080|FG000|COMPLETED|Overall Study||2
8686615|NCT00826800|9731080|FG000|NOT COMPLETED|Overall Study||0
8686616|NCT00826943|9731084|FG000|STARTED|Overall Study||6
8686617|NCT00826943|9731085|FG001|STARTED|Overall Study||6
8686618|NCT00826943|9731086|FG002|STARTED|Overall Study||4
8686619|NCT00826943|9731087|FG003|STARTED|Overall Study||5
8686620|NCT00826943|9731088|FG004|STARTED|Overall Study||7
8686621|NCT00826943|9731089|FG005|STARTED|Overall Study||2
8686622|NCT00826943|9731084|FG000|COMPLETED|Overall Study||6
8686623|NCT00826943|9731085|FG001|COMPLETED|Overall Study||6
8686624|NCT00826943|9731086|FG002|COMPLETED|Overall Study||4
8686625|NCT00826943|9731087|FG003|COMPLETED|Overall Study||5
8686626|NCT00826943|9731088|FG004|COMPLETED|Overall Study||6
8686627|NCT00826943|9731089|FG005|COMPLETED|Overall Study||2
8686628|NCT00826943|9731084|FG000|NOT COMPLETED|Overall Study||0
8686629|NCT00826943|9731085|FG001|NOT COMPLETED|Overall Study||0
8686630|NCT00826943|9731086|FG002|NOT COMPLETED|Overall Study||0
8686631|NCT00826943|9731087|FG003|NOT COMPLETED|Overall Study||0
8686632|NCT00826943|9731088|FG004|NOT COMPLETED|Overall Study||1
8686633|NCT00826943|9731089|FG005|NOT COMPLETED|Overall Study||0
8686634|NCT00827073|9731099|FG000|STARTED|Overall Study||20
8686635|NCT00827073|9731100|FG001|STARTED|Overall Study||20
8686636|NCT00827073|9731099|FG000|COMPLETED|Overall Study||20
8686637|NCT00827073|9731100|FG001|COMPLETED|Overall Study||20
8686638|NCT00827073|9731099|FG000|NOT COMPLETED|Overall Study||0
8686639|NCT00827073|9731100|FG001|NOT COMPLETED|Overall Study||0
8686640|NCT00827099|9731106|FG000|STARTED|Overall Study||5
8686641|NCT00827099|9731106|FG000|COMPLETED|Overall Study||5
8686642|NCT00827099|9731106|FG000|NOT COMPLETED|Overall Study||0
8686643|NCT00827112|9731112|FG000|STARTED|Overall Study||65
8686644|NCT00827112|9731113|FG001|STARTED|Overall Study||64
8686645|NCT00827112|9731112|FG000|Treated|Overall Study||60
8686646|NCT00827112|9731113|FG001|Treated|Overall Study||61
8686647|NCT00827112|9731112|FG000|COMPLETED|Overall Study||50
8686648|NCT00827112|9731113|FG001|COMPLETED|Overall Study||52
8686649|NCT00827112|9731112|FG000|NOT COMPLETED|Overall Study||15
8686650|NCT00827112|9731113|FG001|NOT COMPLETED|Overall Study||12
8686651|NCT00827242|9731121|FG000|STARTED|Overall Study||161
8686652|NCT00827242|9731122|FG001|STARTED|Overall Study||164
8686653|NCT00827242|9731121|FG000|COMPLETED|Overall Study||148
8686654|NCT00827242|9731122|FG001|COMPLETED|Overall Study||152
8686655|NCT00827242|9731121|FG000|NOT COMPLETED|Overall Study||13
8686656|NCT00827242|9731122|FG001|NOT COMPLETED|Overall Study||12
8686657|NCT00827255|9731128|FG000|STARTED|Overall Study||35
8686658|NCT00827255|9731128|FG000|COMPLETED|Overall Study||35
8686659|NCT00827255|9731128|FG000|NOT COMPLETED|Overall Study||0
8686660|NCT00827359|9731132|FG000|STARTED|Overall Study||25
8686661|NCT00827359|9731132|FG000|Treated|Overall Study||24
8686662|NCT00827359|9731132|FG000|COMPLETED|Overall Study||0
8686663|NCT00827359|9731132|FG000|NOT COMPLETED|Overall Study||25
8686664|NCT00827372|9731136|FG000|STARTED|Overall Study||10
8686665|NCT00827372|9731136|FG000|COMPLETED|Overall Study||2
8686666|NCT00827372|9731136|FG000|NOT COMPLETED|Overall Study||8
8686667|NCT00827502|9731141|FG000|STARTED|Overall Study||421
8686668|NCT00827502|9731141|FG000|Received Treatment (Number Treated)|Overall Study||410
8686669|NCT00827502|9731141|FG000|COMPLETED|Overall Study||400
8686670|NCT00827502|9731141|FG000|NOT COMPLETED|Overall Study||21
8686671|NCT00827541|9731147|FG000|STARTED|Overall Study||19
8686672|NCT00827541|9731148|FG001|STARTED|Overall Study||96
8686673|NCT00827541|9731147|FG000|COMPLETED|Overall Study||15
8686674|NCT00827541|9731148|FG001|COMPLETED|Overall Study||85
8686675|NCT00827541|9731147|FG000|NOT COMPLETED|Overall Study||4
8686676|NCT00827541|9731148|FG001|NOT COMPLETED|Overall Study||11
8686677|NCT00827606|9731156|FG000|STARTED|Overall Study||139
8686678|NCT00827606|9731157|FG001|STARTED|Overall Study||132
8686679|NCT00827606|9731156|FG000|COMPLETED|Overall Study||112
8686680|NCT00827606|9731157|FG001|COMPLETED|Overall Study||94
8686681|NCT00827606|9731156|FG000|NOT COMPLETED|Overall Study||27
8686682|NCT00827606|9731157|FG001|NOT COMPLETED|Overall Study||38
8686683|NCT00827632|9731171|FG000|STARTED|Overall Study||128
8686684|NCT00827632|9731172|FG001|STARTED|Overall Study||98
8686685|NCT00827632|9731171|FG000|COMPLETED|Overall Study||106
8686686|NCT00827632|9731172|FG001|COMPLETED|Overall Study||75
8686687|NCT00827632|9731171|FG000|NOT COMPLETED|Overall Study||22
8686688|NCT00827632|9731172|FG001|NOT COMPLETED|Overall Study||23
8686689|NCT00827775|9731180|FG000|STARTED|Overall Study||25
8686690|NCT00827775|9731181|FG001|STARTED|Overall Study||30
8686691|NCT00827775|9731180|FG000|COMPLETED|Overall Study||25
8686692|NCT00827775|9731181|FG001|COMPLETED|Overall Study||25
8686693|NCT00827775|9731180|FG000|NOT COMPLETED|Overall Study||0
8686694|NCT00827775|9731181|FG001|NOT COMPLETED|Overall Study||5
8686695|NCT00827827|9731189|FG000|STARTED|Overall Study||22
8686696|NCT00827827|9731190|FG001|STARTED|Overall Study||16
8686697|NCT00827827|9731189|FG000|COMPLETED|Overall Study||14
8686698|NCT00827827|9731190|FG001|COMPLETED|Overall Study||16
8686699|NCT00827827|9731189|FG000|NOT COMPLETED|Overall Study||8
8686700|NCT00827827|9731190|FG001|NOT COMPLETED|Overall Study||0
8686701|NCT00827918|9731200|FG000|STARTED|Overall Study||86
8686702|NCT00827918|9731201|FG001|STARTED|Overall Study||47
8686703|NCT00827918|9731202|FG002|STARTED|Overall Study||83
8686704|NCT00827918|9731200|FG000|COMPLETED|Overall Study||58
8686705|NCT00827918|9731201|FG001|COMPLETED|Overall Study||38
8686706|NCT00827918|9731202|FG002|COMPLETED|Overall Study||62
8686707|NCT00827918|9731200|FG000|NOT COMPLETED|Overall Study||28
8686708|NCT00827918|9731201|FG001|NOT COMPLETED|Overall Study||9
8686709|NCT00827918|9731202|FG002|NOT COMPLETED|Overall Study||21
8686710|NCT00827931|9731212|FG000|STARTED|Overall Study||49
8686711|NCT00827931|9731213|FG001|STARTED|Overall Study||45
8686712|NCT00827931|9731212|FG000|COMPLETED|Overall Study||43
8686713|NCT00827931|9731213|FG001|COMPLETED|Overall Study||39
8686714|NCT00827931|9731212|FG000|NOT COMPLETED|Overall Study||6
8686715|NCT00827931|9731213|FG001|NOT COMPLETED|Overall Study||6
8686716|NCT00827944|9731221|FG000|STARTED|Overall Study||304
8686717|NCT00827944|9731222|FG001|STARTED|Overall Study||299
8686718|NCT00827944|9731221|FG000|COMPLETED|Overall Study||241
8686719|NCT00827944|9731222|FG001|COMPLETED|Overall Study||240
8686720|NCT00827944|9731221|FG000|NOT COMPLETED|Overall Study||63
8686721|NCT00827944|9731222|FG001|NOT COMPLETED|Overall Study||59
8686722|NCT00827983|9731230|FG000|STARTED|Overall Study|All randomised patients|339
8686723|NCT00827983|9731231|FG001|STARTED|Overall Study|all randomised patients|344
8686724|NCT00827983|9731230|FG000|COMPLETED|Overall Study|patients who performed the pregnancy test|321
8686725|NCT00827983|9731231|FG001|COMPLETED|Overall Study|patients who performed the pregnancy test|328
8686726|NCT00827983|9731230|FG000|NOT COMPLETED|Overall Study||18
8686727|NCT00827983|9731231|FG001|NOT COMPLETED|Overall Study||16
8686728|NCT00828009|9731237|FG000|STARTED|Step 1 - Chemo RT/Consolidation Chemo||70
8686729|NCT00828009|9731237|FG000|Started Treatment|Step 1 - Chemo RT/Consolidation Chemo||68
8686730|NCT00828009|9731237|FG000|COMPLETED|Step 1 - Chemo RT/Consolidation Chemo||39
8686731|NCT00828009|9731237|FG000|NOT COMPLETED|Step 1 - Chemo RT/Consolidation Chemo||31
8686732|NCT00828009|9731237|FG000|STARTED|Step 2 - Maintenance Therapy|Among 39 pts with tx completion, 4 did not register to step 2 and 2 had PD at the end of step 1.|33
8686733|NCT00828009|9731237|FG000|COMPLETED|Step 2 - Maintenance Therapy|Max maintenance therapy was 34 cycles. No patients were off treatment due to completion of 34 cycles|0
8686734|NCT00828009|9731237|FG000|NOT COMPLETED|Step 2 - Maintenance Therapy||33
8686735|NCT00828061|9731242|FG000|STARTED|Period 1||4
8686736|NCT00828061|9731243|FG001|STARTED|Period 1||3
8686737|NCT00828061|9731244|FG002|STARTED|Period 1||3
8686738|NCT00828061|9731245|FG003|STARTED|Period 1||3
8686739|NCT00828061|9731246|FG004|STARTED|Period 1||3
8686740|NCT00828061|9731247|FG005|STARTED|Period 1||3
8686741|NCT00828061|9731242|FG000|COMPLETED|Period 1||4
8686742|NCT00828061|9731243|FG001|COMPLETED|Period 1||3
8686743|NCT00828061|9731244|FG002|COMPLETED|Period 1||3
8686744|NCT00828061|9731245|FG003|COMPLETED|Period 1||3
8686745|NCT00828061|9731246|FG004|COMPLETED|Period 1||3
8686746|NCT00828061|9731247|FG005|COMPLETED|Period 1||3
8686747|NCT00828061|9731242|FG000|NOT COMPLETED|Period 1||0
8686748|NCT00828061|9731243|FG001|NOT COMPLETED|Period 1||0
8686749|NCT00828061|9731244|FG002|NOT COMPLETED|Period 1||0
8686750|NCT00828061|9731245|FG003|NOT COMPLETED|Period 1||0
8686751|NCT00828061|9731246|FG004|NOT COMPLETED|Period 1||0
8686752|NCT00828061|9731247|FG005|NOT COMPLETED|Period 1||0
8686753|NCT00828061|9731242|FG000|STARTED|Period 2||4
8686754|NCT00828061|9731243|FG001|STARTED|Period 2||3
8686755|NCT00828061|9731244|FG002|STARTED|Period 2||3
8686756|NCT00828061|9731245|FG003|STARTED|Period 2||3
8686757|NCT00828061|9731246|FG004|STARTED|Period 2||3
8686758|NCT00828061|9731247|FG005|STARTED|Period 2||3
8686759|NCT00828061|9731242|FG000|COMPLETED|Period 2||4
8686760|NCT00828061|9731243|FG001|COMPLETED|Period 2||3
8686761|NCT00828061|9731244|FG002|COMPLETED|Period 2||3
8686762|NCT00828061|9731245|FG003|COMPLETED|Period 2||3
8686763|NCT00828061|9731246|FG004|COMPLETED|Period 2||3
8686764|NCT00828061|9731247|FG005|COMPLETED|Period 2||3
8686765|NCT00828061|9731242|FG000|NOT COMPLETED|Period 2||0
8686766|NCT00828061|9731243|FG001|NOT COMPLETED|Period 2||0
8686767|NCT00828061|9731244|FG002|NOT COMPLETED|Period 2||0
8686768|NCT00828061|9731245|FG003|NOT COMPLETED|Period 2||0
8686769|NCT00828061|9731246|FG004|NOT COMPLETED|Period 2||0
8686770|NCT00828061|9731247|FG005|NOT COMPLETED|Period 2||0
8686771|NCT00828061|9731242|FG000|STARTED|Period 3||4
8686772|NCT00828061|9731243|FG001|STARTED|Period 3||3
8686773|NCT00828061|9731244|FG002|STARTED|Period 3||3
8686774|NCT00828061|9731245|FG003|STARTED|Period 3||3
8686775|NCT00828061|9731246|FG004|STARTED|Period 3||3
8686776|NCT00828061|9731247|FG005|STARTED|Period 3||3
8686777|NCT00828061|9731242|FG000|COMPLETED|Period 3||4
8686778|NCT00828061|9731243|FG001|COMPLETED|Period 3||3
8686779|NCT00828061|9731244|FG002|COMPLETED|Period 3||3
8686780|NCT00828061|9731245|FG003|COMPLETED|Period 3||3
8686781|NCT00828061|9731246|FG004|COMPLETED|Period 3||3
8686782|NCT00828061|9731247|FG005|COMPLETED|Period 3||3
8686783|NCT00828061|9731242|FG000|NOT COMPLETED|Period 3||0
8686784|NCT00828061|9731243|FG001|NOT COMPLETED|Period 3||0
8686785|NCT00828061|9731244|FG002|NOT COMPLETED|Period 3||0
8686786|NCT00828061|9731245|FG003|NOT COMPLETED|Period 3||0
8686787|NCT00828061|9731246|FG004|NOT COMPLETED|Period 3||0
8686788|NCT00828061|9731247|FG005|NOT COMPLETED|Period 3||0
8686789|NCT00828074|9731257|FG000|STARTED|Overall Study||6
8686790|NCT00828074|9731258|FG001|STARTED|Overall Study||5
8686791|NCT00828074|9731259|FG002|STARTED|Overall Study||35
8686792|NCT00828074|9731257|FG000|COMPLETED|Overall Study||6
8686793|NCT00828074|9731258|FG001|COMPLETED|Overall Study||5
8686794|NCT00828074|9731259|FG002|COMPLETED|Overall Study||35
8686795|NCT00828074|9731257|FG000|NOT COMPLETED|Overall Study||0
8686796|NCT00828074|9731258|FG001|NOT COMPLETED|Overall Study||0
8686797|NCT00828074|9731259|FG002|NOT COMPLETED|Overall Study||0
8686798|NCT00828113|9731271|FG000|STARTED|Overall Study||50
8686799|NCT00828113|9731272|FG001|STARTED|Overall Study||51
8686800|NCT00828113|9731271|FG000|COMPLETED|Overall Study||20
8686801|NCT00828113|9731272|FG001|COMPLETED|Overall Study||20
8686802|NCT00828113|9731271|FG000|NOT COMPLETED|Overall Study||30
8686803|NCT00828113|9731272|FG001|NOT COMPLETED|Overall Study||31
8686804|NCT00828139|9731282|FG000|STARTED|Overall Study||42
8686805|NCT00828139|9731283|FG001|STARTED|Overall Study||41
8686806|NCT00828139|9731284|FG002|STARTED|Overall Study||55
8686807|NCT00828139|9731285|FG003|STARTED|Overall Study||51
8686808|NCT00828139|9731282|FG000|COMPLETED|Overall Study||1
8686809|NCT00828139|9731283|FG001|COMPLETED|Overall Study||0
8686810|NCT00828139|9731284|FG002|COMPLETED|Overall Study||0
8686811|NCT00828139|9731285|FG003|COMPLETED|Overall Study||0
8686812|NCT00828139|9731282|FG000|NOT COMPLETED|Overall Study||41
8686813|NCT00828139|9731283|FG001|NOT COMPLETED|Overall Study||41
8686814|NCT00828139|9731284|FG002|NOT COMPLETED|Overall Study||55
8686815|NCT00828139|9731285|FG003|NOT COMPLETED|Overall Study||51
8686816|NCT00828178|9731297|FG000|STARTED|Overall Study||42
8686817|NCT00828178|9731298|FG001|STARTED|Overall Study|Eighty seven participants were randomized.|45
8686818|NCT00828178|9731297|FG000|COMPLETED|Overall Study||42
8686819|NCT00828178|9731298|FG001|COMPLETED|Overall Study|Two patients did not complete the study.|43
8686820|NCT00828178|9731297|FG000|NOT COMPLETED|Overall Study||0
8686821|NCT00828178|9731298|FG001|NOT COMPLETED|Overall Study||2
8686822|NCT00828191|9731308|FG000|STARTED|Overall Study|Randomized patients|400
8686823|NCT00828191|9731309|FG001|STARTED|Overall Study|Randomized patients|400
8686824|NCT00828191|9731308|FG000|COMPLETED|Overall Study|Patients with at least one embryo transferred.|392
8686825|NCT00828191|9731309|FG001|COMPLETED|Overall Study|Patients with at least one embryo transferred.|390
8686826|NCT00828191|9731308|FG000|NOT COMPLETED|Overall Study||8
8686827|NCT00828191|9731309|FG001|NOT COMPLETED|Overall Study||10
8686828|NCT00828204|9731317|FG000|STARTED|Main Study: Prior to Study Suspension||21
8686829|NCT00828204|9731318|FG001|STARTED|Main Study: Prior to Study Suspension|Main Subset was not enrolled until after study suspension (period 2, below).|0
8686830|NCT00828204|9731317|FG000|Completed Manual Injection|Main Study: Prior to Study Suspension||21
8686831|NCT00828204|9731318|FG001|Completed Manual Injection|Main Study: Prior to Study Suspension||0
8686832|NCT00828204|9731317|FG000|Continued With Autoinjector Injections|Main Study: Prior to Study Suspension||19
8686833|NCT00828204|9731318|FG001|Continued With Autoinjector Injections|Main Study: Prior to Study Suspension||0
8686834|NCT00828204|9731317|FG000|COMPLETED|Main Study: Prior to Study Suspension||7
8686835|NCT00828204|9731318|FG001|COMPLETED|Main Study: Prior to Study Suspension||0
8686836|NCT00828204|9731317|FG000|NOT COMPLETED|Main Study: Prior to Study Suspension||14
8686837|NCT00828204|9731318|FG001|NOT COMPLETED|Main Study: Prior to Study Suspension||0
8686838|NCT00828204|9731317|FG000|STARTED|Main Study: After Study Restart|Initial Subset participants did not continue after the study was suspended.|0
8686839|NCT00828204|9731318|FG001|STARTED|Main Study: After Study Restart|After a protocol amendment, the Main Subset participants were enrolled.|74
8686840|NCT00828204|9731317|FG000|Completed Manual Injection|Main Study: After Study Restart||0
8686841|NCT00828204|9731318|FG001|Completed Manual Injection|Main Study: After Study Restart||74
8686842|NCT00828204|9731317|FG000|Continued With Autoinjector Injections|Main Study: After Study Restart||0
8686843|NCT00828204|9731318|FG001|Continued With Autoinjector Injections|Main Study: After Study Restart||72
8686844|NCT00828204|9731317|FG000|COMPLETED|Main Study: After Study Restart||0
8686845|NCT00828204|9731318|FG001|COMPLETED|Main Study: After Study Restart||71
8686846|NCT00828204|9731317|FG000|NOT COMPLETED|Main Study: After Study Restart||0
8686847|NCT00828204|9731318|FG001|NOT COMPLETED|Main Study: After Study Restart||3
8686848|NCT00828204|9731317|FG000|STARTED|Extension Study|Participation in the Extension Study was not offered to Initial Subset after completing Main Study.|0
8686849|NCT00828204|9731318|FG001|STARTED|Extension Study|Participation in Extension Study was optional for Main Subset participants completing Main Study.|64
8686850|NCT00828204|9731317|FG000|COMPLETED|Extension Study||0
8686851|NCT00828204|9731318|FG001|COMPLETED|Extension Study||61
8686852|NCT00828204|9731317|FG000|NOT COMPLETED|Extension Study||0
8686853|NCT00828204|9731318|FG001|NOT COMPLETED|Extension Study||3
8686854|NCT00828295|9731327|FG000|STARTED|Overall Study||75
8686855|NCT00828295|9731328|FG001|STARTED|Overall Study||75
8686856|NCT00828295|9731327|FG000|COMPLETED|Overall Study||75
8686857|NCT00828295|9731328|FG001|COMPLETED|Overall Study||75
8686858|NCT00828295|9731327|FG000|NOT COMPLETED|Overall Study||0
8686859|NCT00828295|9731328|FG001|NOT COMPLETED|Overall Study||0
8686860|NCT00828347|9731336|FG000|STARTED|Overall Study||12
8686861|NCT00828347|9731337|FG001|STARTED|Overall Study||11
8686862|NCT00828347|9731336|FG000|COMPLETED|Overall Study||12
8686863|NCT00828347|9731337|FG001|COMPLETED|Overall Study||11
8686864|NCT00828347|9731336|FG000|NOT COMPLETED|Overall Study||0
8686865|NCT00828347|9731337|FG001|NOT COMPLETED|Overall Study||0
8686866|NCT00828412|9731345|FG000|STARTED|Overall Study||50
8686867|NCT00828412|9731346|FG001|STARTED|Overall Study||50
8686868|NCT00828412|9731345|FG000|COMPLETED|Overall Study||41
8686869|NCT00828412|9731346|FG001|COMPLETED|Overall Study||48
8686870|NCT00828412|9731345|FG000|NOT COMPLETED|Overall Study||9
8686871|NCT00828412|9731346|FG001|NOT COMPLETED|Overall Study||2
8686872|NCT00828451|9731352|FG000|STARTED|Overall Study||29
8686873|NCT00828451|9731352|FG000|COMPLETED|Overall Study||18
8686874|NCT00828451|9731352|FG000|NOT COMPLETED|Overall Study||11
8686875|NCT00828464|9731356|FG000|STARTED|Overall Study||30
8686876|NCT00828464|9731356|FG000|COMPLETED|Overall Study||29
8686877|NCT00828464|9731356|FG000|NOT COMPLETED|Overall Study||1
8686878|NCT00828516|9731360|FG000|STARTED|Clinical Phase: Series 1||35
8686879|NCT00828516|9731360|FG000|COMPLETED|Clinical Phase: Series 1||33
8686880|NCT00828516|9731360|FG000|NOT COMPLETED|Clinical Phase: Series 1||2
8686881|NCT00828516|9731360|FG000|STARTED|Clinical Phase: Series 2||30
8686882|NCT00828516|9731360|FG000|COMPLETED|Clinical Phase: Series 2||30
8686883|NCT00828516|9731360|FG000|NOT COMPLETED|Clinical Phase: Series 2||0
8686884|NCT00828542|9731366|FG000|STARTED|Overall Study||23
8686885|NCT00828542|9731367|FG001|STARTED|Overall Study||23
8686886|NCT00828542|9731366|FG000|COMPLETED|Overall Study||20
8686887|NCT00828542|9731367|FG001|COMPLETED|Overall Study||20
8686888|NCT00828542|9731366|FG000|NOT COMPLETED|Overall Study||3
8686889|NCT00828542|9731367|FG001|NOT COMPLETED|Overall Study||3
8686890|NCT00828568|9731376|FG000|STARTED|Randomized||184
8686891|NCT00828568|9731377|FG001|STARTED|Randomized||179
8686892|NCT00828568|9731378|FG002|STARTED|Randomized||62
8686893|NCT00828568|9731376|FG000|COMPLETED|Randomized||183
8686894|NCT00828568|9731377|FG001|COMPLETED|Randomized||179
8686895|NCT00828568|9731378|FG002|COMPLETED|Randomized||60
8686896|NCT00828568|9731376|FG000|NOT COMPLETED|Randomized||1
8686897|NCT00828568|9731377|FG001|NOT COMPLETED|Randomized||0
8686898|NCT00828568|9731378|FG002|NOT COMPLETED|Randomized||2
8686899|NCT00828568|9731376|FG000|STARTED|Treated - Received at Least One Dose||183
8686900|NCT00828568|9731377|FG001|STARTED|Treated - Received at Least One Dose||179
8686901|NCT00828568|9731378|FG002|STARTED|Treated - Received at Least One Dose||60
8686902|NCT00828568|9731376|FG000|COMPLETED|Treated - Received at Least One Dose||153
8686903|NCT00828568|9731377|FG001|COMPLETED|Treated - Received at Least One Dose||150
8686904|NCT00828568|9731378|FG002|COMPLETED|Treated - Received at Least One Dose||55
8686905|NCT00828568|9731376|FG000|NOT COMPLETED|Treated - Received at Least One Dose||30
8686906|NCT00828568|9731377|FG001|NOT COMPLETED|Treated - Received at Least One Dose||29
8686907|NCT00828568|9731378|FG002|NOT COMPLETED|Treated - Received at Least One Dose||5
8686908|NCT00828672|9731389|FG000|STARTED|Pre-treatment (Baseline)||43
8686909|NCT00828672|9731390|FG001|STARTED|Pre-treatment (Baseline)||41
8686910|NCT00828672|9731389|FG000|COMPLETED|Pre-treatment (Baseline)||43
8686911|NCT00828672|9731390|FG001|COMPLETED|Pre-treatment (Baseline)||41
8686912|NCT00828672|9731389|FG000|NOT COMPLETED|Pre-treatment (Baseline)||0
8686913|NCT00828672|9731390|FG001|NOT COMPLETED|Pre-treatment (Baseline)||0
8686914|NCT00828672|9731389|FG000|STARTED|Study Treatment||43
8686915|NCT00828672|9731390|FG001|STARTED|Study Treatment||41
8686916|NCT00828672|9731389|FG000|COMPLETED|Study Treatment||41
8686917|NCT00828672|9731390|FG001|COMPLETED|Study Treatment||39
8686918|NCT00828672|9731389|FG000|NOT COMPLETED|Study Treatment||2
8686919|NCT00828672|9731390|FG001|NOT COMPLETED|Study Treatment||2
8686920|NCT00828672|9731389|FG000|STARTED|Post-surgery (<30 Days)||41
8686921|NCT00828672|9731390|FG001|STARTED|Post-surgery (<30 Days)||39
8686922|NCT00828672|9731389|FG000|COMPLETED|Post-surgery (<30 Days)||41
8686923|NCT00828672|9731390|FG001|COMPLETED|Post-surgery (<30 Days)||38
8686924|NCT00828672|9731389|FG000|NOT COMPLETED|Post-surgery (<30 Days)||0
8686925|NCT00828672|9731390|FG001|NOT COMPLETED|Post-surgery (<30 Days)||1
8686926|NCT00828672|9731389|FG000|STARTED|Follow-up|Patient in Arm 1 with clinical complete response and no surgery is in follow up (joined this period)|42
8686927|NCT00828672|9731390|FG001|STARTED|Follow-up|Patients with no central review material and with adverse event are in followup (joined this period)|41
8686928|NCT00828672|9731389|FG000|COMPLETED|Follow-up||42
8686929|NCT00828672|9731390|FG001|COMPLETED|Follow-up||41
8686930|NCT00828672|9731389|FG000|NOT COMPLETED|Follow-up||0
8686931|NCT00828672|9731390|FG001|NOT COMPLETED|Follow-up||0
8686932|NCT00828711|9731399|FG000|STARTED|Overall Study||118
8686933|NCT00828711|9731400|FG001|STARTED|Overall Study||125
8686934|NCT00828711|9731401|FG002|STARTED|Overall Study||131
8686935|NCT00828711|9731399|FG000|COMPLETED|Overall Study||117
8686936|NCT00828711|9731400|FG001|COMPLETED|Overall Study||125
8686937|NCT00828711|9731401|FG002|COMPLETED|Overall Study||131
8686938|NCT00828711|9731399|FG000|NOT COMPLETED|Overall Study||1
8686939|NCT00828711|9731400|FG001|NOT COMPLETED|Overall Study||0
8686940|NCT00828711|9731401|FG002|NOT COMPLETED|Overall Study||0
8686941|NCT00828750|9731409|FG000|STARTED|Overall Study||19
8686942|NCT00828750|9731409|FG000|COMPLETED|Overall Study||15
8686943|NCT00828750|9731409|FG000|NOT COMPLETED|Overall Study||4
8686944|NCT00828841|9731417|FG000|STARTED|Overall Study||235
8686945|NCT00828841|9731418|FG001|STARTED|Overall Study||236
8686946|NCT00828841|9731419|FG002|STARTED|Overall Study||130
8686947|NCT00828841|9731417|FG000|COMPLETED|Overall Study||231
8686948|NCT00828841|9731418|FG001|COMPLETED|Overall Study||232
8686949|NCT00828841|9731419|FG002|COMPLETED|Overall Study||126
8686950|NCT00828841|9731417|FG000|NOT COMPLETED|Overall Study||4
8686951|NCT00828841|9731418|FG001|NOT COMPLETED|Overall Study||4
8686952|NCT00828841|9731419|FG002|NOT COMPLETED|Overall Study||4
8686953|NCT00828945|9731429|FG000|STARTED|Overall Study||257
8686954|NCT00828945|9731429|FG000|COMPLETED|Overall Study||216
8686955|NCT00828945|9731429|FG000|NOT COMPLETED|Overall Study||41
8693297|NCT00865566|9738735|FG001|NOT COMPLETED|Overall Study||687
8693298|NCT00865709|9738743|FG000|STARTED|Treatment||97
8693299|NCT00865709|9738744|FG001|STARTED|Treatment||101
8693300|NCT00865709|9738743|FG000|Received Treatment|Treatment|Safety population|97
8693301|NCT00865709|9738744|FG001|Received Treatment|Treatment|Safety population|101
8693302|NCT00865709|9738743|FG000|COMPLETED|Treatment|Patients who continued treatment at data cut-off or discontinued treatment due to PD or death|67
8693303|NCT00865709|9738744|FG001|COMPLETED|Treatment|Patients who continued treatment at data cut-off or discontinued treatment due to PD or death|83
8693304|NCT00865709|9738743|FG000|NOT COMPLETED|Treatment||30
8693305|NCT00865709|9738744|FG001|NOT COMPLETED|Treatment||18
8693306|NCT00865709|9738743|FG000|STARTED|Active Follow-up||25
8693307|NCT00865709|9738744|FG001|STARTED|Active Follow-up||16
8693308|NCT00865709|9738743|FG000|COMPLETED|Active Follow-up||17
8693309|NCT00865709|9738744|FG001|COMPLETED|Active Follow-up||15
8693310|NCT00865709|9738743|FG000|NOT COMPLETED|Active Follow-up||8
8693311|NCT00865709|9738744|FG001|NOT COMPLETED|Active Follow-up||1
8693312|NCT00865709|9738743|FG000|STARTED|Long Term Follow-up||70
8693313|NCT00865709|9738744|FG001|STARTED|Long Term Follow-up||82
8693314|NCT00865709|9738743|FG000|COMPLETED|Long Term Follow-up||24
8693315|NCT00865709|9738744|FG001|COMPLETED|Long Term Follow-up||33
8693316|NCT00865709|9738743|FG000|NOT COMPLETED|Long Term Follow-up||46
8693317|NCT00865709|9738744|FG001|NOT COMPLETED|Long Term Follow-up||49
8693318|NCT00865904|9738757|FG000|STARTED|Overall Study|Randomized.|19
8693319|NCT00865904|9738758|FG001|STARTED|Overall Study|Randomized.|18
8693320|NCT00865904|9738759|FG002|STARTED|Overall Study|Randomized.|18
8693321|NCT00865904|9738760|FG003|STARTED|Overall Study|Randomized.|18
8693322|NCT00865904|9738761|FG004|STARTED|Overall Study|Randomized.|20
8693323|NCT00865904|9738757|FG000|COMPLETED|Overall Study|Completed 14-day follow-up.|17
8693324|NCT00865904|9738758|FG001|COMPLETED|Overall Study|Completed 14-day follow-up.|18
8693325|NCT00865904|9738759|FG002|COMPLETED|Overall Study|Completed 14-day follow-up.|18
8693326|NCT00865904|9738760|FG003|COMPLETED|Overall Study|Completed 14-day follow-up.|17
8693327|NCT00865904|9738761|FG004|COMPLETED|Overall Study|Completed 14-day follow-up.|19
8693328|NCT00865904|9738757|FG000|NOT COMPLETED|Overall Study||2
8693329|NCT00865904|9738758|FG001|NOT COMPLETED|Overall Study||0
8693330|NCT00865904|9738759|FG002|NOT COMPLETED|Overall Study||0
8693331|NCT00865904|9738760|FG003|NOT COMPLETED|Overall Study||1
8693332|NCT00865904|9738761|FG004|NOT COMPLETED|Overall Study||1
8693333|NCT00865969|9738777|FG000|STARTED|Overall Study||129
8693334|NCT00865969|9738777|FG000|COMPLETED|Overall Study||129
8693335|NCT00865969|9738777|FG000|NOT COMPLETED|Overall Study||0
8693336|NCT00866034|9738783|FG000|STARTED|Overall Study||308
8693337|NCT00866034|9738784|FG001|STARTED|Overall Study||309
8693338|NCT00866034|9738783|FG000|COMPLETED|Overall Study||292
8693339|NCT00866034|9738784|FG001|COMPLETED|Overall Study||301
8693340|NCT00866034|9738783|FG000|NOT COMPLETED|Overall Study||16
8693341|NCT00866034|9738784|FG001|NOT COMPLETED|Overall Study||8
8693342|NCT00866047|9738790|FG000|STARTED|Treatment Period||58
8693343|NCT00866047|9738790|FG000|COMPLETED|Treatment Period|Number who completed 16 cycles of treatment|10
8693344|NCT00866047|9738790|FG000|NOT COMPLETED|Treatment Period||48
8693345|NCT00866047|9738790|FG000|STARTED|Follow-up Period|All participants were to be followed after treatment|58
8693346|NCT00866047|9738790|FG000|COMPLETED|Follow-up Period|Completed survival follow-up due to death [25] or study completion [28]|53
8693347|NCT00866047|9738790|FG000|NOT COMPLETED|Follow-up Period||5
8693348|NCT00866177|9738794|FG000|STARTED|Overall Study||167
8693349|NCT00866177|9738794|FG000|COMPLETED|Overall Study||15
8693350|NCT00866177|9738794|FG000|NOT COMPLETED|Overall Study||152
8693351|NCT00866281|9738800|FG000|STARTED|Overall Study||7
8693352|NCT00866281|9738801|FG001|STARTED|Overall Study||15
8693353|NCT00866281|9738800|FG000|COMPLETED|Overall Study||0
8693354|NCT00866281|9738801|FG001|COMPLETED|Overall Study||0
8693355|NCT00866281|9738800|FG000|NOT COMPLETED|Overall Study||7
8693356|NCT00866281|9738801|FG001|NOT COMPLETED|Overall Study||15
8693769|NCT00868439|9739307|FG000|NOT COMPLETED|Overall Study||8
8693770|NCT00868439|9739308|FG001|NOT COMPLETED|Overall Study||9
8693771|NCT00868452|9739316|FG000|STARTED|Overall Study||183
8693772|NCT00868452|9739317|FG001|STARTED|Overall Study||165
8693773|NCT00868452|9739316|FG000|COMPLETED|Overall Study||143
8693774|NCT00868452|9739317|FG001|COMPLETED|Overall Study||136
8693775|NCT00868452|9739316|FG000|NOT COMPLETED|Overall Study||40
8693776|NCT00868452|9739317|FG001|NOT COMPLETED|Overall Study||29
8693777|NCT00868517|9739327|FG000|STARTED|Overall Study||12
8693778|NCT00868517|9739328|FG001|STARTED|Overall Study||12
8693779|NCT00868517|9739329|FG002|STARTED|Overall Study||11
8693780|NCT00868517|9739327|FG000|COMPLETED|Overall Study||8
8693781|NCT00868517|9739328|FG001|COMPLETED|Overall Study||8
8693782|NCT00868517|9739329|FG002|COMPLETED|Overall Study||9
8686956|NCT00828984|9731436|FG000|STARTED|Overall Study||28
8686957|NCT00828984|9731437|FG001|STARTED|Overall Study||31
8686958|NCT00828984|9731438|FG002|STARTED|Overall Study||28
8686959|NCT00828984|9731436|FG000|Randomization|Overall Study||28
8686960|NCT00828984|9731437|FG001|Randomization|Overall Study||31
8686961|NCT00828984|9731438|FG002|Randomization|Overall Study||28
8686962|NCT00828984|9731436|FG000|Treatment|Overall Study||24
8686963|NCT00828984|9731437|FG001|Treatment|Overall Study||26
8686964|NCT00828984|9731438|FG002|Treatment|Overall Study||24
8686965|NCT00828984|9731436|FG000|Flexible Sigmoidoscopy|Overall Study||20
8686966|NCT00828984|9731437|FG001|Flexible Sigmoidoscopy|Overall Study||19
8686967|NCT00828984|9731438|FG002|Flexible Sigmoidoscopy|Overall Study||19
8686968|NCT00828984|9731436|FG000|Post Intervention Follow-Up|Overall Study||15
8686969|NCT00828984|9731437|FG001|Post Intervention Follow-Up|Overall Study||16
8686970|NCT00828984|9731438|FG002|Post Intervention Follow-Up|Overall Study||19
8686971|NCT00828984|9731436|FG000|COMPLETED|Overall Study||14
8686972|NCT00828984|9731437|FG001|COMPLETED|Overall Study||15
8686973|NCT00828984|9731438|FG002|COMPLETED|Overall Study||19
8686974|NCT00828984|9731436|FG000|NOT COMPLETED|Overall Study||14
8686975|NCT00828984|9731437|FG001|NOT COMPLETED|Overall Study||16
8686976|NCT00828984|9731438|FG002|NOT COMPLETED|Overall Study||9
8686977|NCT00829010|9731451|FG000|STARTED|Overall Study||83
8686978|NCT00829010|9731452|FG001|STARTED|Overall Study||101
8686979|NCT00829010|9731453|FG002|STARTED|Overall Study||100
8686980|NCT00829010|9731454|FG003|STARTED|Overall Study||100
8686981|NCT00829010|9731455|FG004|STARTED|Overall Study||100
8686982|NCT00829010|9731451|FG000|COMPLETED|Overall Study||73
8686983|NCT00829010|9731452|FG001|COMPLETED|Overall Study||92
8686984|NCT00829010|9731453|FG002|COMPLETED|Overall Study||97
8686985|NCT00829010|9731454|FG003|COMPLETED|Overall Study||92
8686986|NCT00829010|9731455|FG004|COMPLETED|Overall Study||98
8686987|NCT00829010|9731451|FG000|NOT COMPLETED|Overall Study||10
8686988|NCT00829010|9731452|FG001|NOT COMPLETED|Overall Study||9
8686989|NCT00829010|9731453|FG002|NOT COMPLETED|Overall Study||3
8686990|NCT00829010|9731454|FG003|NOT COMPLETED|Overall Study||8
8686991|NCT00829010|9731455|FG004|NOT COMPLETED|Overall Study||2
8686992|NCT00829036|9731467|FG000|STARTED|Overall Study||24
8801477|NCT01450137|9853281|FG000|STARTED|Week 12 to Study End||18
8801478|NCT01450137|9853282|FG001|STARTED|Week 12 to Study End||7
8801479|NCT01450137|9853281|FG000|COMPLETED|Week 12 to Study End||18
8801480|NCT01450137|9853282|FG001|COMPLETED|Week 12 to Study End||5
8801481|NCT01450137|9853281|FG000|NOT COMPLETED|Week 12 to Study End||0
8801482|NCT01450137|9853282|FG001|NOT COMPLETED|Week 12 to Study End||2
8801483|NCT01450189|9853291|FG000|STARTED|Overall Study||9
8801484|NCT01450189|9853292|FG001|STARTED|Overall Study||18
8801485|NCT01450189|9853293|FG002|STARTED|Overall Study||19
8801486|NCT01450189|9853291|FG000|COMPLETED|Overall Study||9
8801487|NCT01450189|9853292|FG001|COMPLETED|Overall Study||18
8801488|NCT01450189|9853293|FG002|COMPLETED|Overall Study||19
8801489|NCT01450189|9853291|FG000|NOT COMPLETED|Overall Study||0
8801490|NCT01450189|9853292|FG001|NOT COMPLETED|Overall Study||0
8801491|NCT01450189|9853293|FG002|NOT COMPLETED|Overall Study||0
8801492|NCT01450306|9853310|FG000|STARTED|Overall Study||10
8801493|NCT01450306|9853311|FG001|STARTED|Overall Study||10
8801494|NCT01450306|9853310|FG000|COMPLETED|Overall Study||10
8801495|NCT01450306|9853311|FG001|COMPLETED|Overall Study||10
8801496|NCT01450306|9853310|FG000|NOT COMPLETED|Overall Study||0
8801497|NCT01450306|9853311|FG001|NOT COMPLETED|Overall Study||0
8801498|NCT01450319|9853317|FG000|STARTED|Overall Study||70
8801499|NCT01450319|9853317|FG000|COMPLETED|Overall Study||70
8801500|NCT01450319|9853317|FG000|NOT COMPLETED|Overall Study||0
8801501|NCT01450397|9853321|FG000|STARTED|Overall Study||5
8801502|NCT01450397|9853321|FG000|COMPLETED|Overall Study||5
8801503|NCT01450397|9853321|FG000|NOT COMPLETED|Overall Study||0
8801504|NCT01450540|9853327|FG000|STARTED|Overall Study||123
8801505|NCT01450540|9853328|FG001|STARTED|Overall Study||118
8801506|NCT01450540|9853327|FG000|COMPLETED|Overall Study||101
8801507|NCT01450540|9853328|FG001|COMPLETED|Overall Study||82
8801508|NCT01450540|9853327|FG000|NOT COMPLETED|Overall Study||22
8801509|NCT01450540|9853328|FG001|NOT COMPLETED|Overall Study||36
8801510|NCT01450631|9853338|FG000|STARTED|Overall Study||46
8801511|NCT01450631|9853339|FG001|STARTED|Overall Study||46
8801512|NCT01450631|9853338|FG000|COMPLETED|Overall Study||43
8801513|NCT01450631|9853339|FG001|COMPLETED|Overall Study||42
8801514|NCT01450631|9853338|FG000|NOT COMPLETED|Overall Study||3
8801515|NCT01450631|9853339|FG001|NOT COMPLETED|Overall Study||4
8801516|NCT01450683|9853345|FG000|STARTED|Overall Study||4
8801517|NCT01450683|9853345|FG000|COMPLETED|Overall Study||2
8801518|NCT01450683|9853345|FG000|NOT COMPLETED|Overall Study||2
8801519|NCT01450696|9853351|FG000|STARTED|Overall Study||148
8801520|NCT01450696|9853352|FG001|STARTED|Overall Study||148
8801521|NCT01450696|9853351|FG000|Treated (Safety Population)|Overall Study||147
8801522|NCT01450696|9853352|FG001|Treated (Safety Population)|Overall Study||147
8801523|NCT01450696|9853351|FG000|COMPLETED|Overall Study||0
8801524|NCT01450696|9853352|FG001|COMPLETED|Overall Study||0
8801525|NCT01450696|9853351|FG000|NOT COMPLETED|Overall Study||148
8801526|NCT01450696|9853352|FG001|NOT COMPLETED|Overall Study||148
8801527|NCT01450761|9853360|FG000|STARTED|Randomization||566
8801528|NCT01450761|9853361|FG001|STARTED|Randomization||566
8801529|NCT01450761|9853360|FG000|COMPLETED|Randomization||562
8801530|NCT01450761|9853361|FG001|COMPLETED|Randomization||561
8801531|NCT01450761|9853360|FG000|NOT COMPLETED|Randomization||4
8686993|NCT00829036|9731467|FG000|COMPLETED|Overall Study||24
8686994|NCT00829036|9731467|FG000|NOT COMPLETED|Overall Study||0
8686995|NCT00829049|9731473|FG000|STARTED|Overall Study||77
8686996|NCT00829049|9731474|FG001|STARTED|Overall Study||88
8686997|NCT00829049|9731473|FG000|COMPLETED|Overall Study||60
8686998|NCT00829049|9731474|FG001|COMPLETED|Overall Study||68
8686999|NCT00829049|9731473|FG000|NOT COMPLETED|Overall Study||17
8687000|NCT00829049|9731474|FG001|NOT COMPLETED|Overall Study||20
8687001|NCT00829166|9731482|FG000|STARTED|Overall Study||495
8687002|NCT00829166|9731483|FG001|STARTED|Overall Study||496
8687003|NCT00829166|9731482|FG000|Treated|Overall Study||490
8687004|NCT00829166|9731483|FG001|Treated|Overall Study||488
8687005|NCT00829166|9731482|FG000|COMPLETED|Overall Study||0
8801532|NCT01450761|9853361|FG001|NOT COMPLETED|Randomization||5
8801533|NCT01450761|9853360|FG000|STARTED|Lead-in Chemotherapy||562
8801534|NCT01450761|9853361|FG001|STARTED|Lead-in Chemotherapy||561
8801535|NCT01450761|9853360|FG000|COMPLETED|Lead-in Chemotherapy||478
8801536|NCT01450761|9853361|FG001|COMPLETED|Lead-in Chemotherapy||476
8801537|NCT01450761|9853360|FG000|NOT COMPLETED|Lead-in Chemotherapy||84
8801538|NCT01450761|9853361|FG001|NOT COMPLETED|Lead-in Chemotherapy||85
8801539|NCT01450761|9853360|FG000|STARTED|Treatment With Blinded Study Therapy||478
8801540|NCT01450761|9853361|FG001|STARTED|Treatment With Blinded Study Therapy||476
8801541|NCT01450761|9853360|FG000|COMPLETED|Treatment With Blinded Study Therapy||0
8801542|NCT01450761|9853361|FG001|COMPLETED|Treatment With Blinded Study Therapy||0
8801543|NCT01450761|9853360|FG000|NOT COMPLETED|Treatment With Blinded Study Therapy||478
8801544|NCT01450761|9853361|FG001|NOT COMPLETED|Treatment With Blinded Study Therapy||476
8801545|NCT01450787|9853369|FG000|STARTED|Overall Study||38
8801546|NCT01450787|9853370|FG001|STARTED|Overall Study||25
8801547|NCT01450787|9853369|FG000|COMPLETED|Overall Study||38
8801548|NCT01450787|9853370|FG001|COMPLETED|Overall Study||25
8801549|NCT01450787|9853369|FG000|NOT COMPLETED|Overall Study||0
8801550|NCT01450787|9853370|FG001|NOT COMPLETED|Overall Study||0
8801551|NCT01450800|9853378|FG000|STARTED|Overall Study|82 participants were randomized to nitrofurantoin|82
8801552|NCT01450800|9853379|FG001|STARTED|Overall Study|81 participants were randomized to placebo|81
8801553|NCT01450800|9853378|FG000|COMPLETED|Overall Study||81
8801554|NCT01450800|9853379|FG001|COMPLETED|Overall Study||78
8801555|NCT01450800|9853378|FG000|NOT COMPLETED|Overall Study||1
8801556|NCT01450800|9853379|FG001|NOT COMPLETED|Overall Study||3
8801557|NCT01450813|9853391|FG000|STARTED|Overall Study||20
8801558|NCT01450813|9853392|FG001|STARTED|Overall Study||20
8801559|NCT01450813|9853393|FG002|STARTED|Overall Study||20
8801560|NCT01450813|9853394|FG003|STARTED|Overall Study||20
8801561|NCT01450813|9853391|FG000|COMPLETED|Overall Study||19
8801562|NCT01450813|9853392|FG001|COMPLETED|Overall Study||19
8801563|NCT01450813|9853393|FG002|COMPLETED|Overall Study||20
8801564|NCT01450813|9853394|FG003|COMPLETED|Overall Study||17
8801565|NCT01450813|9853391|FG000|NOT COMPLETED|Overall Study||1
8801566|NCT01450813|9853392|FG001|NOT COMPLETED|Overall Study||1
8801567|NCT01450813|9853393|FG002|NOT COMPLETED|Overall Study||0
8801568|NCT01450813|9853394|FG003|NOT COMPLETED|Overall Study||3
8801569|NCT01450826|9853408|FG000|STARTED|Overall Study||70
8801570|NCT01450826|9853409|FG001|STARTED|Overall Study||66
8801571|NCT01450826|9853408|FG000|COMPLETED|Overall Study||70
8801572|NCT01450826|9853409|FG001|COMPLETED|Overall Study||66
8801573|NCT01450826|9853408|FG000|NOT COMPLETED|Overall Study||0
8801574|NCT01450826|9853409|FG001|NOT COMPLETED|Overall Study||0
8801575|NCT01450943|9853418|FG000|STARTED|Overall Study||28
8801576|NCT01450943|9853419|FG001|STARTED|Overall Study||42
8801577|NCT01450943|9853420|FG002|STARTED|Overall Study||48
8801578|NCT01450943|9853418|FG000|COMPLETED|Overall Study||26
8801579|NCT01450943|9853419|FG001|COMPLETED|Overall Study||35
8801580|NCT01450943|9853420|FG002|COMPLETED|Overall Study||42
8801581|NCT01450943|9853418|FG000|NOT COMPLETED|Overall Study||2
8801582|NCT01450943|9853419|FG001|NOT COMPLETED|Overall Study||7
8801583|NCT01450943|9853420|FG002|NOT COMPLETED|Overall Study||6
8801584|NCT01451164|9853436|FG000|STARTED|Overall Study||115
8801585|NCT01451164|9853437|FG001|STARTED|Overall Study||115
8801586|NCT01451164|9853438|FG002|STARTED|Overall Study||113
8801587|NCT01451164|9853439|FG003|STARTED|Overall Study||116
8801588|NCT01451164|9853436|FG000|COMPLETED|Overall Study||72
8801589|NCT01451164|9853437|FG001|COMPLETED|Overall Study||81
8801590|NCT01451164|9853438|FG002|COMPLETED|Overall Study||68
8801591|NCT01451164|9853439|FG003|COMPLETED|Overall Study||70
8801592|NCT01451164|9853436|FG000|NOT COMPLETED|Overall Study||43
8801593|NCT01451164|9853437|FG001|NOT COMPLETED|Overall Study||34
8801594|NCT01451164|9853438|FG002|NOT COMPLETED|Overall Study||45
8801595|NCT01451164|9853439|FG003|NOT COMPLETED|Overall Study||46
8801596|NCT01451203|9853451|FG000|STARTED|Double-blind Treatment Period||158
8801597|NCT01451203|9853452|FG001|STARTED|Double-blind Treatment Period||161
8801598|NCT01451203|9853451|FG000|Received Treatment|Double-blind Treatment Period||157
8801599|NCT01451203|9853452|FG001|Received Treatment|Double-blind Treatment Period||159
8687006|NCT00829166|9731483|FG001|COMPLETED|Overall Study||0
8687007|NCT00829166|9731482|FG000|NOT COMPLETED|Overall Study||495
8801600|NCT01451203|9853451|FG000|Received Rescue Treatment|Double-blind Treatment Period|Participants who did not achieve improvement at & after Week 24 were dropped out of study schedule.|70
8801601|NCT01451203|9853452|FG001|Received Rescue Treatment|Double-blind Treatment Period|Participants who did not achieve improvement at & after Week 24 were dropped out of study schedule.|36
8801602|NCT01451203|9853451|FG000|COMPLETED|Double-blind Treatment Period||73
8687008|NCT00829166|9731483|FG001|NOT COMPLETED|Overall Study||496
8687009|NCT00829179|9731490|FG000|STARTED|Overall Study||20
8687010|NCT00829179|9731490|FG000|COMPLETED|Overall Study||19
8687011|NCT00829179|9731490|FG000|NOT COMPLETED|Overall Study||1
8687012|NCT00829244|9731496|FG000|STARTED|Overall Study||96
8687013|NCT00829244|9731497|FG001|STARTED|Overall Study||104
8687014|NCT00829244|9731496|FG000|COMPLETED|Overall Study||82
8687015|NCT00829244|9731497|FG001|COMPLETED|Overall Study||83
8687016|NCT00829244|9731496|FG000|NOT COMPLETED|Overall Study||14
8687017|NCT00829244|9731497|FG001|NOT COMPLETED|Overall Study||21
8687018|NCT00829283|9731505|FG000|STARTED|Overall Study||39
8687019|NCT00829283|9731506|FG001|STARTED|Overall Study||152
8687020|NCT00829283|9731505|FG000|COMPLETED|Overall Study||32
8687021|NCT00829283|9731506|FG001|COMPLETED|Overall Study||127
8687022|NCT00829283|9731505|FG000|NOT COMPLETED|Overall Study||7
8687023|NCT00829283|9731506|FG001|NOT COMPLETED|Overall Study||25
8687024|NCT00829296|9731514|FG000|STARTED|Overall Study||34
8687025|NCT00829296|9731515|FG001|STARTED|Overall Study||36
8687026|NCT00829296|9731514|FG000|COMPLETED|Overall Study||29
8687027|NCT00829296|9731515|FG001|COMPLETED|Overall Study||32
8687028|NCT00829296|9731514|FG000|NOT COMPLETED|Overall Study||5
8687029|NCT00829296|9731515|FG001|NOT COMPLETED|Overall Study||4
8687030|NCT00829387|9731523|FG000|STARTED|Overall Study||23
8687031|NCT00829387|9731524|FG001|STARTED|Overall Study||24
8687032|NCT00829387|9731523|FG000|COMPLETED|Overall Study||20
8687033|NCT00829387|9731524|FG001|COMPLETED|Overall Study||21
8687034|NCT00829387|9731523|FG000|NOT COMPLETED|Overall Study||3
8687035|NCT00829387|9731524|FG001|NOT COMPLETED|Overall Study||3
8687036|NCT00829413|9731530|FG000|STARTED|Overall Study||353
8687037|NCT00829413|9731530|FG000|COMPLETED|Overall Study||259
8687038|NCT00829413|9731530|FG000|NOT COMPLETED|Overall Study||94
8687039|NCT00829439|9731541|FG000|STARTED|Overall Study||3
8687040|NCT00829439|9731542|FG001|STARTED|Overall Study||3
8687041|NCT00829439|9731543|FG002|STARTED|Overall Study||6
8687042|NCT00829439|9731544|FG003|STARTED|Overall Study||4
8687043|NCT00829439|9731541|FG000|COMPLETED|Overall Study||3
8687044|NCT00829439|9731542|FG001|COMPLETED|Overall Study||3
8687045|NCT00829439|9731543|FG002|COMPLETED|Overall Study||5
8687046|NCT00829439|9731544|FG003|COMPLETED|Overall Study||4
8687047|NCT00829439|9731541|FG000|NOT COMPLETED|Overall Study||0
8687048|NCT00829439|9731542|FG001|NOT COMPLETED|Overall Study||0
8687049|NCT00829439|9731543|FG002|NOT COMPLETED|Overall Study||1
8687050|NCT00829439|9731544|FG003|NOT COMPLETED|Overall Study||0
8687051|NCT00829621|9731550|FG000|STARTED|Overall Study||8
8687052|NCT00829621|9731551|FG001|STARTED|Overall Study||12
8687053|NCT00829621|9731550|FG000|COMPLETED|Overall Study||4
8687054|NCT00829621|9731551|FG001|COMPLETED|Overall Study||8
8687055|NCT00829621|9731550|FG000|NOT COMPLETED|Overall Study||4
8687056|NCT00829621|9731551|FG001|NOT COMPLETED|Overall Study||4
8687057|NCT00829738|9731557|FG000|STARTED|Overall Study||4188
8687058|NCT00829738|9731557|FG000|COMPLETED|Overall Study||4180
8687059|NCT00829738|9731557|FG000|NOT COMPLETED|Overall Study||8
8687060|NCT00829829|9731565|FG000|STARTED|Overall Study||80
8687061|NCT00829829|9731566|FG001|STARTED|Overall Study||80
8687062|NCT00829829|9731567|FG002|STARTED|Overall Study||81
8687063|NCT00829829|9731565|FG000|Treated|Overall Study||79
8687064|NCT00829829|9731566|FG001|Treated|Overall Study||80
8687065|NCT00829829|9731567|FG002|Treated|Overall Study||81
8687066|NCT00829829|9731565|FG000|COMPLETED|Overall Study||58
8687067|NCT00829829|9731566|FG001|COMPLETED|Overall Study||64
8687068|NCT00829829|9731567|FG002|COMPLETED|Overall Study||70
8687069|NCT00829829|9731565|FG000|NOT COMPLETED|Overall Study||22
8687070|NCT00829829|9731566|FG001|NOT COMPLETED|Overall Study||16
8687071|NCT00829829|9731567|FG002|NOT COMPLETED|Overall Study||11
8687072|NCT00829933|9731580|FG000|STARTED|Overall Study||135
8687073|NCT00829933|9731581|FG001|STARTED|Overall Study||135
8687074|NCT00829933|9731582|FG002|STARTED|Overall Study||132
8687075|NCT00829933|9731583|FG003|STARTED|Overall Study||134
8687076|NCT00829933|9731580|FG000|Baseline Analysis Population|Overall Study||131
8687077|NCT00829933|9731581|FG001|Baseline Analysis Population|Overall Study||134
8687078|NCT00829933|9731582|FG002|Baseline Analysis Population|Overall Study||131
8687079|NCT00829933|9731583|FG003|Baseline Analysis Population|Overall Study||129
8687080|NCT00829933|9731580|FG000|COMPLETED|Overall Study||121
8687081|NCT00829933|9731581|FG001|COMPLETED|Overall Study||122
8687082|NCT00829933|9731582|FG002|COMPLETED|Overall Study||119
8687083|NCT00829933|9731583|FG003|COMPLETED|Overall Study||120
8687084|NCT00829933|9731580|FG000|NOT COMPLETED|Overall Study||14
8687085|NCT00829933|9731581|FG001|NOT COMPLETED|Overall Study||13
8687086|NCT00829933|9731582|FG002|NOT COMPLETED|Overall Study||13
8687087|NCT00829933|9731583|FG003|NOT COMPLETED|Overall Study||14
8687088|NCT00829985|9731595|FG000|STARTED|Overall Study||28
8687089|NCT00829985|9731596|FG001|STARTED|Overall Study||26
8687090|NCT00829985|9731595|FG000|COMPLETED|Overall Study||19
8687091|NCT00829985|9731596|FG001|COMPLETED|Overall Study||22
8687092|NCT00829985|9731595|FG000|NOT COMPLETED|Overall Study||9
8687093|NCT00829985|9731596|FG001|NOT COMPLETED|Overall Study||4
8687094|NCT00830037|9731604|FG000|STARTED|Overall Study||67
8687095|NCT00830037|9731605|FG001|STARTED|Overall Study||69
8687096|NCT00830037|9731604|FG000|COMPLETED|Overall Study||49
8687097|NCT00830037|9731605|FG001|COMPLETED|Overall Study||50
8687098|NCT00830037|9731604|FG000|NOT COMPLETED|Overall Study||18
8687099|NCT00830037|9731605|FG001|NOT COMPLETED|Overall Study||19
8687100|NCT00830063|9731615|FG000|STARTED|Overall Study||208
8687101|NCT00830063|9731616|FG001|STARTED|Overall Study||208
8687102|NCT00830063|9731617|FG002|STARTED|Overall Study||208
8687103|NCT00830063|9731618|FG003|STARTED|Overall Study||208
8687104|NCT00830063|9731615|FG000|Treated|Overall Study||208
8687105|NCT00830063|9731616|FG001|Treated|Overall Study||206
8687106|NCT00830063|9731617|FG002|Treated|Overall Study||208
8687107|NCT00830063|9731618|FG003|Treated|Overall Study||206
8687108|NCT00830063|9731615|FG000|COMPLETED|Overall Study||8
8687109|NCT00830063|9731616|FG001|COMPLETED|Overall Study||16
8687110|NCT00830063|9731617|FG002|COMPLETED|Overall Study||10
8687111|NCT00830063|9731618|FG003|COMPLETED|Overall Study||13
8687112|NCT00830063|9731615|FG000|NOT COMPLETED|Overall Study||200
8687113|NCT00830063|9731616|FG001|NOT COMPLETED|Overall Study||192
8687114|NCT00830063|9731617|FG002|NOT COMPLETED|Overall Study||198
8687115|NCT00830063|9731618|FG003|NOT COMPLETED|Overall Study||195
8687116|NCT00830076|9731630|FG000|STARTED|Sitagliptin + Placebo Metformin||18
8687117|NCT00830076|9731630|FG000|COMPLETED|Sitagliptin + Placebo Metformin||18
8687118|NCT00830076|9731630|FG000|NOT COMPLETED|Sitagliptin + Placebo Metformin||0
8687119|NCT00830076|9731630|FG000|STARTED|7-day Washout||18
8687120|NCT00830076|9731630|FG000|COMPLETED|7-day Washout||18
8687121|NCT00830076|9731630|FG000|NOT COMPLETED|7-day Washout||0
8687122|NCT00830076|9731630|FG000|STARTED|Metformin + Placebo Sitagliptin||18
8687123|NCT00830076|9731630|FG000|COMPLETED|Metformin + Placebo Sitagliptin||18
8687124|NCT00830076|9731630|FG000|NOT COMPLETED|Metformin + Placebo Sitagliptin||0
8687125|NCT00830076|9731630|FG000|STARTED|7-day Washout||18
8687126|NCT00830076|9731630|FG000|COMPLETED|7-day Washout||18
8687127|NCT00830076|9731630|FG000|NOT COMPLETED|7-day Washout||0
8687128|NCT00830076|9731630|FG000|STARTED|Sitagliptin + Metformin||18
8687129|NCT00830076|9731630|FG000|COMPLETED|Sitagliptin + Metformin||18
8687130|NCT00830076|9731630|FG000|NOT COMPLETED|Sitagliptin + Metformin||0
8687131|NCT00830076|9731630|FG000|STARTED|7-day Washout||18
8687132|NCT00830076|9731630|FG000|COMPLETED|7-day Washout||18
8687133|NCT00830076|9731630|FG000|NOT COMPLETED|7-day Washout||0
8687134|NCT00830076|9731630|FG000|STARTED|Placebo Sitagliptin + Placebo Metformin||18
8687135|NCT00830076|9731630|FG000|COMPLETED|Placebo Sitagliptin + Placebo Metformin||18
8687136|NCT00830076|9731630|FG000|NOT COMPLETED|Placebo Sitagliptin + Placebo Metformin||0
8687137|NCT00830115|9731637|FG000|STARTED|Overall Study||1045
8687138|NCT00830115|9731637|FG000|COMPLETED|Overall Study||1042
8687139|NCT00830115|9731637|FG000|NOT COMPLETED|Overall Study||3
8687140|NCT00830128|9731643|FG000|STARTED|Overall Study||106
8687141|NCT00830128|9731643|FG000|COMPLETED|Overall Study||87
8687142|NCT00830128|9731643|FG000|NOT COMPLETED|Overall Study||19
8687143|NCT00830167|9731649|FG000|STARTED|Overall Study|Treated|248
8687144|NCT00830167|9731650|FG001|STARTED|Overall Study|Treated|250
8687145|NCT00830167|9731649|FG000|COMPLETED|Overall Study||208
8687146|NCT00830167|9731650|FG001|COMPLETED|Overall Study||207
8687147|NCT00830167|9731649|FG000|NOT COMPLETED|Overall Study||40
8687148|NCT00830167|9731650|FG001|NOT COMPLETED|Overall Study||43
8687149|NCT00830180|9731656|FG000|STARTED|Overall Study||41
8687150|NCT00830180|9731656|FG000|Received Tanezumab in Parent Study A4091003|Overall Study||19
8687151|NCT00830180|9731656|FG000|Received Placebo in Parent Study A4091003|Overall Study||22
8687152|NCT00830180|9731656|FG000|COMPLETED|Overall Study||15
8687153|NCT00830180|9731656|FG000|NOT COMPLETED|Overall Study||26
8687154|NCT00830232|9731664|FG000|STARTED|Overall Study||20
8687155|NCT00830232|9731665|FG001|STARTED|Overall Study||20
8687156|NCT00830232|9731664|FG000|COMPLETED|Overall Study||20
8687157|NCT00830232|9731665|FG001|COMPLETED|Overall Study||20
8687158|NCT00830232|9731664|FG000|NOT COMPLETED|Overall Study||0
8687159|NCT00830232|9731665|FG001|NOT COMPLETED|Overall Study||0
8687160|NCT00830284|9731671|FG000|STARTED|Overall Study|The study was started in our Medical Surgical ICU October of 2008.|12
8687161|NCT00830284|9731671|FG000|COMPLETED|Overall Study||10
8687162|NCT00830284|9731671|FG000|NOT COMPLETED|Overall Study||2
8687163|NCT00830310|9731675|FG000|STARTED|Overall Study||43
8687164|NCT00830310|9731675|FG000|COMPLETED|Overall Study||30
8687165|NCT00830310|9731675|FG000|NOT COMPLETED|Overall Study||13
8687166|NCT00830362|9731681|FG000|STARTED|Overall Study|They received Propranolol and completed Test Session (Session 1). One subject left after day 1.|27
8687167|NCT00830362|9731682|FG001|STARTED|Overall Study|They received Propranolol and completed Test Session (Session 1). One subject left after day 1.|24
8687168|NCT00830362|9731681|FG000|Completed Sessions 1 and 2|Overall Study|Received propranolol and completed both Test and Retrieval sessions (Session 1 and 2).|26
8687169|NCT00830362|9731682|FG001|Completed Sessions 1 and 2|Overall Study|Received palcebo and completed both Test and Retrieval sessions (Session 1 and 2).|24
8687170|NCT00830362|9731681|FG000|COMPLETED|Overall Study|The enrolled subjects that completed all 3 testing sessions (were not lost to follow-up).|23
8687171|NCT00830362|9731682|FG001|COMPLETED|Overall Study|The enrolled subjects that completed all 3 testing sessions (were not lost to follow-up).|20
8687172|NCT00830362|9731681|FG000|NOT COMPLETED|Overall Study||4
8687173|NCT00830362|9731682|FG001|NOT COMPLETED|Overall Study||4
8687174|NCT00830375|9731688|FG000|STARTED|Overall Study||10
8687175|NCT00830375|9731688|FG000|COMPLETED|Overall Study||9
8687176|NCT00830375|9731688|FG000|NOT COMPLETED|Overall Study||1
8687177|NCT00830388|9731692|FG000|STARTED|Overall Study||11
8687178|NCT00830388|9731692|FG000|COMPLETED|Overall Study||11
8687179|NCT00830388|9731692|FG000|NOT COMPLETED|Overall Study||0
8687180|NCT00830440|9731698|FG000|STARTED|Overall Study||32
8687181|NCT00830440|9731699|FG001|STARTED|Overall Study||11
8687182|NCT00830440|9731698|FG000|Received Device|Overall Study||26
8687183|NCT00830440|9731699|FG001|Received Device|Overall Study||0
8687184|NCT00830440|9731698|FG000|Completed 12 Week Follow up|Overall Study||24
8687185|NCT00830440|9731699|FG001|Completed 12 Week Follow up|Overall Study||11
8687186|NCT00830440|9731698|FG000|Completed 16 Week Follow up|Overall Study||4
8687187|NCT00830440|9731699|FG001|Completed 16 Week Follow up|Overall Study||0
8687188|NCT00830440|9731698|FG000|Completed 24 Week Follow up|Overall Study||3
8687189|NCT00830440|9731699|FG001|Completed 24 Week Follow up|Overall Study||0
8687190|NCT00830440|9731698|FG000|COMPLETED|Overall Study||24
8687191|NCT00830440|9731699|FG001|COMPLETED|Overall Study||11
8687192|NCT00830440|9731698|FG000|NOT COMPLETED|Overall Study||8
8687193|NCT00830440|9731699|FG001|NOT COMPLETED|Overall Study||0
8687194|NCT00830518|9731708|FG000|STARTED|Overall Study||46
8687195|NCT00830518|9731709|FG001|STARTED|Overall Study||11
8687196|NCT00830518|9731708|FG000|COMPLETED|Overall Study|Completed = participants who completed study treatment.|0
8687197|NCT00830518|9731709|FG001|COMPLETED|Overall Study||0
8687198|NCT00830518|9731708|FG000|NOT COMPLETED|Overall Study||46
8687199|NCT00830518|9731709|FG001|NOT COMPLETED|Overall Study||11
8687200|NCT00830596|9731719|FG000|STARTED|Overall Study||74
8687201|NCT00830596|9731720|FG001|STARTED|Overall Study||74
8687202|NCT00830596|9731721|FG002|STARTED|Overall Study||73
8687203|NCT00830596|9731719|FG000|COMPLETED|Overall Study||72
8687204|NCT00830596|9731720|FG001|COMPLETED|Overall Study||72
8687205|NCT00830596|9731721|FG002|COMPLETED|Overall Study||67
8687206|NCT00830596|9731719|FG000|NOT COMPLETED|Overall Study||2
8687207|NCT00830596|9731720|FG001|NOT COMPLETED|Overall Study||2
8687208|NCT00830596|9731721|FG002|NOT COMPLETED|Overall Study||6
8687209|NCT00830765|9731731|FG000|STARTED|Overall Study||73
8687210|NCT00830765|9731732|FG001|STARTED|Overall Study||71
8687211|NCT00830765|9731731|FG000|COMPLETED|Overall Study||70
8687212|NCT00830765|9731732|FG001|COMPLETED|Overall Study||69
8687213|NCT00830765|9731731|FG000|NOT COMPLETED|Overall Study||3
8687214|NCT00830765|9731732|FG001|NOT COMPLETED|Overall Study||2
8687215|NCT00830791|9731744|FG000|STARTED|Overall Study||8
8687216|NCT00830791|9731745|FG001|STARTED|Overall Study||8
8687217|NCT00830791|9731746|FG002|STARTED|Overall Study||8
8687218|NCT00830791|9731747|FG003|STARTED|Overall Study||8
8687219|NCT00830791|9731748|FG004|STARTED|Overall Study||0
8687220|NCT00830791|9731749|FG005|STARTED|Overall Study||0
8687221|NCT00830791|9731744|FG000|COMPLETED|Overall Study||8
8687222|NCT00830791|9731745|FG001|COMPLETED|Overall Study||8
8687223|NCT00830791|9731746|FG002|COMPLETED|Overall Study||8
8687224|NCT00830791|9731747|FG003|COMPLETED|Overall Study||8
8687225|NCT00830791|9731748|FG004|COMPLETED|Overall Study||0
8687226|NCT00830791|9731749|FG005|COMPLETED|Overall Study||0
8687227|NCT00830791|9731744|FG000|NOT COMPLETED|Overall Study||0
8687228|NCT00830791|9731745|FG001|NOT COMPLETED|Overall Study||0
8687229|NCT00830791|9731746|FG002|NOT COMPLETED|Overall Study||0
8687230|NCT00830791|9731747|FG003|NOT COMPLETED|Overall Study||0
8687231|NCT00830791|9731748|FG004|NOT COMPLETED|Overall Study||0
8687232|NCT00830791|9731749|FG005|NOT COMPLETED|Overall Study||0
8687233|NCT00830804|9731762|FG000|STARTED|Overall Study|113 subjects enrolled. One subject never started study treatment and was excluded in all analysis.|112
8687234|NCT00830804|9731762|FG000|COMPLETED|Overall Study||97
8687235|NCT00830804|9731762|FG000|NOT COMPLETED|Overall Study||15
8687236|NCT00830869|9731779|FG000|STARTED|Period 1: Part 1||1
8687237|NCT00830869|9731780|FG001|STARTED|Period 1: Part 1||1
8687238|NCT00830869|9731781|FG002|STARTED|Period 1: Part 1||1
8687239|NCT00830869|9731782|FG003|STARTED|Period 1: Part 1||7
8687240|NCT00830869|9731783|FG004|STARTED|Period 1: Part 1||4
8687241|NCT00830869|9731784|FG005|STARTED|Period 1: Part 1||6
8687242|NCT00830869|9731785|FG006|STARTED|Period 1: Part 1||3
8687243|NCT00830869|9731786|FG007|STARTED|Period 1: Part 1||0
8687244|NCT00830869|9731787|FG008|STARTED|Period 1: Part 1||0
8687245|NCT00830869|9731788|FG009|STARTED|Period 1: Part 1||0
8687246|NCT00830869|9731789|FG010|STARTED|Period 1: Part 1||0
8687247|NCT00830869|9731790|FG011|STARTED|Period 1: Part 1||0
8687248|NCT00830869|9731779|FG000|COMPLETED|Period 1: Part 1||0
8687249|NCT00830869|9731780|FG001|COMPLETED|Period 1: Part 1||0
8687250|NCT00830869|9731781|FG002|COMPLETED|Period 1: Part 1||0
8687251|NCT00830869|9731782|FG003|COMPLETED|Period 1: Part 1||0
8687252|NCT00830869|9731783|FG004|COMPLETED|Period 1: Part 1||0
8687253|NCT00830869|9731784|FG005|COMPLETED|Period 1: Part 1||0
8687254|NCT00830869|9731785|FG006|COMPLETED|Period 1: Part 1||0
8687255|NCT00830869|9731786|FG007|COMPLETED|Period 1: Part 1||0
8687256|NCT00830869|9731787|FG008|COMPLETED|Period 1: Part 1||0
8687257|NCT00830869|9731788|FG009|COMPLETED|Period 1: Part 1||0
8687258|NCT00830869|9731789|FG010|COMPLETED|Period 1: Part 1||0
8687259|NCT00830869|9731790|FG011|COMPLETED|Period 1: Part 1||0
8687260|NCT00830869|9731779|FG000|NOT COMPLETED|Period 1: Part 1||1
8687261|NCT00830869|9731780|FG001|NOT COMPLETED|Period 1: Part 1||1
8687262|NCT00830869|9731781|FG002|NOT COMPLETED|Period 1: Part 1||1
8687263|NCT00830869|9731782|FG003|NOT COMPLETED|Period 1: Part 1||7
8687264|NCT00830869|9731783|FG004|NOT COMPLETED|Period 1: Part 1||4
8687265|NCT00830869|9731784|FG005|NOT COMPLETED|Period 1: Part 1||6
8687266|NCT00830869|9731785|FG006|NOT COMPLETED|Period 1: Part 1||3
8687267|NCT00830869|9731786|FG007|NOT COMPLETED|Period 1: Part 1||0
8687268|NCT00830869|9731787|FG008|NOT COMPLETED|Period 1: Part 1||0
8687269|NCT00830869|9731788|FG009|NOT COMPLETED|Period 1: Part 1||0
8687270|NCT00830869|9731789|FG010|NOT COMPLETED|Period 1: Part 1||0
8687271|NCT00830869|9731790|FG011|NOT COMPLETED|Period 1: Part 1||0
8687272|NCT00830869|9731779|FG000|STARTED|Period 2: Part 2||0
8687273|NCT00830869|9731780|FG001|STARTED|Period 2: Part 2||0
8687274|NCT00830869|9731781|FG002|STARTED|Period 2: Part 2||0
8687275|NCT00830869|9731782|FG003|STARTED|Period 2: Part 2||0
8687276|NCT00830869|9731783|FG004|STARTED|Period 2: Part 2||0
8687277|NCT00830869|9731784|FG005|STARTED|Period 2: Part 2||0
8687278|NCT00830869|9731785|FG006|STARTED|Period 2: Part 2||0
8687279|NCT00830869|9731786|FG007|STARTED|Period 2: Part 2||20
8687280|NCT00830869|9731787|FG008|STARTED|Period 2: Part 2||22
8687281|NCT00830869|9731788|FG009|STARTED|Period 2: Part 2||20
8687282|NCT00830869|9731789|FG010|STARTED|Period 2: Part 2||11
8687283|NCT00830869|9731790|FG011|STARTED|Period 2: Part 2||20
8687284|NCT00830869|9731779|FG000|COMPLETED|Period 2: Part 2||0
8687285|NCT00830869|9731780|FG001|COMPLETED|Period 2: Part 2||0
8687286|NCT00830869|9731781|FG002|COMPLETED|Period 2: Part 2||0
8687287|NCT00830869|9731782|FG003|COMPLETED|Period 2: Part 2||0
8687288|NCT00830869|9731783|FG004|COMPLETED|Period 2: Part 2||0
8687289|NCT00830869|9731784|FG005|COMPLETED|Period 2: Part 2||0
8687290|NCT00830869|9731785|FG006|COMPLETED|Period 2: Part 2||0
8687291|NCT00830869|9731786|FG007|COMPLETED|Period 2: Part 2||0
8687292|NCT00830869|9731787|FG008|COMPLETED|Period 2: Part 2||0
8687293|NCT00830869|9731788|FG009|COMPLETED|Period 2: Part 2||0
8687294|NCT00830869|9731789|FG010|COMPLETED|Period 2: Part 2||0
8687295|NCT00830869|9731790|FG011|COMPLETED|Period 2: Part 2||0
8687296|NCT00830869|9731779|FG000|NOT COMPLETED|Period 2: Part 2||0
8687297|NCT00830869|9731780|FG001|NOT COMPLETED|Period 2: Part 2||0
8687298|NCT00830869|9731781|FG002|NOT COMPLETED|Period 2: Part 2||0
8687299|NCT00830869|9731782|FG003|NOT COMPLETED|Period 2: Part 2||0
8687300|NCT00830869|9731783|FG004|NOT COMPLETED|Period 2: Part 2||0
8687301|NCT00830869|9731784|FG005|NOT COMPLETED|Period 2: Part 2||0
8687302|NCT00830869|9731785|FG006|NOT COMPLETED|Period 2: Part 2||0
8687303|NCT00830869|9731786|FG007|NOT COMPLETED|Period 2: Part 2||20
8687304|NCT00830869|9731787|FG008|NOT COMPLETED|Period 2: Part 2||22
8687305|NCT00830869|9731788|FG009|NOT COMPLETED|Period 2: Part 2||20
8687306|NCT00830869|9731789|FG010|NOT COMPLETED|Period 2: Part 2||11
8687307|NCT00830869|9731790|FG011|NOT COMPLETED|Period 2: Part 2||20
8687308|NCT00830947|9731819|FG000|STARTED|Overall Study||23
8687309|NCT00830947|9731820|FG001|STARTED|Overall Study||22
8687310|NCT00830947|9731819|FG000|COMPLETED|Overall Study||19
8687311|NCT00830947|9731820|FG001|COMPLETED|Overall Study||18
8687312|NCT00830947|9731819|FG000|NOT COMPLETED|Overall Study||4
8687313|NCT00830947|9731820|FG001|NOT COMPLETED|Overall Study||4
8687314|NCT00830960|9731832|FG000|STARTED|Overall Study|"Number of participants STARTED equals the number of participants randomized."|124
8687315|NCT00830960|9731833|FG001|STARTED|Overall Study||124
8687316|NCT00830960|9731834|FG002|STARTED|Overall Study||137
8687317|NCT00830960|9731835|FG003|STARTED|Overall Study||138
8687318|NCT00830960|9731836|FG004|STARTED|Overall Study||96
8687319|NCT00830960|9731837|FG005|STARTED|Overall Study|Total 720 participants were randomized; 1 was not included in a cohort as baseline weight missing.|100
8687320|NCT00830960|9731832|FG000|Received at Least 1 Dose of Study Drug|Overall Study|Baseline Characteristics (below) include those who received ≥1 dose study drug, not all who STARTED.|117
8687321|NCT00830960|9731833|FG001|Received at Least 1 Dose of Study Drug|Overall Study||122
8687322|NCT00830960|9731834|FG002|Received at Least 1 Dose of Study Drug|Overall Study||133
8687323|NCT00830960|9731835|FG003|Received at Least 1 Dose of Study Drug|Overall Study||135
8687324|NCT00830960|9731836|FG004|Received at Least 1 Dose of Study Drug|Overall Study||91
8687325|NCT00830960|9731837|FG005|Received at Least 1 Dose of Study Drug|Overall Study||93
8687326|NCT00830960|9731832|FG000|COMPLETED|Overall Study||91
8687327|NCT00830960|9731833|FG001|COMPLETED|Overall Study||96
9035708|NCT03301714|10097430|FG001|COMPLETED|Overall Study||54
9035709|NCT03301714|10097431|FG002|COMPLETED|Overall Study||53
9035710|NCT03301714|10097429|FG000|NOT COMPLETED|Overall Study||10
8577151|NCT00156910|9610051|FG001|STARTED|Double-Blind Phase (DB)||338
8687328|NCT00830960|9731834|FG002|COMPLETED|Overall Study||108
8687329|NCT00830960|9731835|FG003|COMPLETED|Overall Study||106
8687330|NCT00830960|9731836|FG004|COMPLETED|Overall Study|6 participants not completed due to death; 1 additional death occurred after study discontinuation.|64
8687331|NCT00830960|9731837|FG005|COMPLETED|Overall Study||63
8687332|NCT00830960|9731832|FG000|NOT COMPLETED|Overall Study||33
8687333|NCT00830960|9731833|FG001|NOT COMPLETED|Overall Study||28
8687334|NCT00830960|9731834|FG002|NOT COMPLETED|Overall Study||29
8687335|NCT00830960|9731835|FG003|NOT COMPLETED|Overall Study||32
8687336|NCT00830960|9731836|FG004|NOT COMPLETED|Overall Study||32
8687337|NCT00830960|9731837|FG005|NOT COMPLETED|Overall Study||37
8687338|NCT00831129|9731876|FG000|STARTED|Overall Study||20
8687339|NCT00831129|9731877|FG001|STARTED|Overall Study||33
8687340|NCT00831129|9731876|FG000|COMPLETED|Overall Study||20
8687341|NCT00831129|9731877|FG001|COMPLETED|Overall Study||23
8687342|NCT00831129|9731876|FG000|NOT COMPLETED|Overall Study||0
8687343|NCT00831129|9731877|FG001|NOT COMPLETED|Overall Study||10
8687344|NCT00831181|9731883|FG000|STARTED|Overall Study||27
8577152|NCT00156910|9610050|FG000|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|296
8577153|NCT00156910|9610051|FG001|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|295
8577154|NCT00156910|9610050|FG000|NOT COMPLETED|Double-Blind Phase (DB)||45
8577155|NCT00156910|9610051|FG001|NOT COMPLETED|Double-Blind Phase (DB)||43
8577156|NCT00156910|9610050|FG000|STARTED|Open-Label Phase (OL)|Number of DB Botulinum toxin type A patients who rolled into OL phase|285
8577157|NCT00156910|9610051|FG001|STARTED|Open-Label Phase (OL)|Number of DB Placebo patients who rolled into OL Phase|286
8577158|NCT00156910|9610050|FG000|COMPLETED|Open-Label Phase (OL)||252
8687345|NCT00831181|9731883|FG000|COMPLETED|Overall Study||15
8687346|NCT00831181|9731883|FG000|NOT COMPLETED|Overall Study||12
8687347|NCT00831233|9731890|FG000|STARTED|Overall Study|Intention-to-treat (ITT) population.|29
8687348|NCT00831233|9731891|FG001|STARTED|Overall Study|ITT population.|13
8687349|NCT00831233|9731890|FG000|Full Analysis Set (FAS)|Overall Study|2 participants were randomised but never treated.|27
8687350|NCT00831233|9731891|FG001|Full Analysis Set (FAS)|Overall Study||13
8687351|NCT00831233|9731890|FG000|Per Protocol (PP) Analysis Set|Overall Study||26
8687352|NCT00831233|9731891|FG001|Per Protocol (PP) Analysis Set|Overall Study||11
8687353|NCT00831233|9731890|FG000|COMPLETED|Overall Study||26
8687354|NCT00831233|9731891|FG001|COMPLETED|Overall Study||12
8687355|NCT00831233|9731890|FG000|NOT COMPLETED|Overall Study||3
8687356|NCT00831233|9731891|FG001|NOT COMPLETED|Overall Study||1
8687357|NCT00831272|9731901|FG000|STARTED|Overall Study||38
8687358|NCT00831272|9731902|FG001|STARTED|Overall Study||44
8801603|NCT01451203|9853452|FG001|COMPLETED|Double-blind Treatment Period||111
8801604|NCT01451203|9853451|FG000|NOT COMPLETED|Double-blind Treatment Period||85
8801605|NCT01451203|9853452|FG001|NOT COMPLETED|Double-blind Treatment Period||50
8801606|NCT01451203|9853451|FG000|STARTED|Post-treatment Period|Two participants received rescue treatment and did not enter this period.|71
8801607|NCT01451203|9853452|FG001|STARTED|Post-treatment Period|Three participants received rescue treatment and did not enter this period.|108
8801608|NCT01451203|9853451|FG000|Received Rescue Treatment|Post-treatment Period|Participants who presented with flares at any time were dropped out of study schedule.|12
8801609|NCT01451203|9853452|FG001|Received Rescue Treatment|Post-treatment Period|Participants who presented with flares at any time were dropped out of study schedule.|28
8801610|NCT01451203|9853451|FG000|COMPLETED|Post-treatment Period||57
8801611|NCT01451203|9853452|FG001|COMPLETED|Post-treatment Period||74
8801612|NCT01451203|9853451|FG000|NOT COMPLETED|Post-treatment Period||14
8801613|NCT01451203|9853452|FG001|NOT COMPLETED|Post-treatment Period||34
8801614|NCT01451372|9853458|FG000|STARTED|Overall Study||69
8801615|NCT01451372|9853458|FG000|COMPLETED|Overall Study||69
8801616|NCT01451372|9853458|FG000|NOT COMPLETED|Overall Study||0
8801617|NCT01451385|9853462|FG000|STARTED|Overall Study||376
8801618|NCT01451385|9853462|FG000|COMPLETED|Overall Study||285
8801619|NCT01451385|9853462|FG000|NOT COMPLETED|Overall Study||91
8801620|NCT01451398|9853468|FG000|STARTED|Overall Study||177
8801621|NCT01451398|9853469|FG001|STARTED|Overall Study||176
8801622|NCT01451398|9853468|FG000|COMPLETED|Overall Study||150
8801623|NCT01451398|9853469|FG001|COMPLETED|Overall Study||139
8801624|NCT01451398|9853468|FG000|NOT COMPLETED|Overall Study||27
8801625|NCT01451398|9853469|FG001|NOT COMPLETED|Overall Study||37
8801626|NCT01451411|9853477|FG000|STARTED|Overall Study||3
8801627|NCT01451411|9853478|FG001|STARTED|Overall Study||1
8801628|NCT01451411|9853477|FG000|COMPLETED|Overall Study||3
8801629|NCT01451411|9853478|FG001|COMPLETED|Overall Study||1
8801630|NCT01451411|9853477|FG000|NOT COMPLETED|Overall Study||0
8801631|NCT01451411|9853478|FG001|NOT COMPLETED|Overall Study||0
8801632|NCT01451424|9853488|FG000|STARTED|Overall Study||9
8801633|NCT01451424|9853489|FG001|STARTED|Overall Study||9
8801634|NCT01451424|9853490|FG002|STARTED|Overall Study||12
8801635|NCT01451424|9853491|FG003|STARTED|Overall Study||10
8801636|NCT01451424|9853488|FG000|COMPLETED|Overall Study||8
8801637|NCT01451424|9853489|FG001|COMPLETED|Overall Study||7
8801638|NCT01451424|9853490|FG002|COMPLETED|Overall Study||11
8801639|NCT01451424|9853491|FG003|COMPLETED|Overall Study||5
8801640|NCT01451424|9853488|FG000|NOT COMPLETED|Overall Study||1
8801641|NCT01451424|9853489|FG001|NOT COMPLETED|Overall Study||2
8801642|NCT01451424|9853490|FG002|NOT COMPLETED|Overall Study||1
8801643|NCT01451424|9853491|FG003|NOT COMPLETED|Overall Study||5
8801644|NCT01451437|9853515|FG000|STARTED|Overall Study||1
8801645|NCT01451437|9853516|FG001|STARTED|Overall Study||1
8801646|NCT01451437|9853517|FG002|STARTED|Overall Study||3
8801647|NCT01451437|9853518|FG003|STARTED|Overall Study||1
8801648|NCT01451437|9853519|FG004|STARTED|Overall Study||4
8801649|NCT01451437|9853520|FG005|STARTED|Overall Study||3
8801650|NCT01451437|9853521|FG006|STARTED|Overall Study||6
8801651|NCT01451437|9853522|FG007|STARTED|Overall Study||3
8801652|NCT01451437|9853523|FG008|STARTED|Overall Study||4
8801653|NCT01451437|9853515|FG000|COMPLETED|Overall Study||0
8801654|NCT01451437|9853516|FG001|COMPLETED|Overall Study||0
8801655|NCT01451437|9853517|FG002|COMPLETED|Overall Study||0
8801656|NCT01451437|9853518|FG003|COMPLETED|Overall Study||0
8801657|NCT01451437|9853519|FG004|COMPLETED|Overall Study||0
8801658|NCT01451437|9853520|FG005|COMPLETED|Overall Study||0
8801659|NCT01451437|9853521|FG006|COMPLETED|Overall Study||0
8801660|NCT01451437|9853522|FG007|COMPLETED|Overall Study||0
8801661|NCT01451437|9853523|FG008|COMPLETED|Overall Study||0
8801662|NCT01451437|9853515|FG000|NOT COMPLETED|Overall Study||1
8801663|NCT01451437|9853516|FG001|NOT COMPLETED|Overall Study||1
8801664|NCT01451437|9853517|FG002|NOT COMPLETED|Overall Study||3
8801665|NCT01451437|9853518|FG003|NOT COMPLETED|Overall Study||1
8687359|NCT00831272|9731903|FG002|STARTED|Overall Study||73
8687360|NCT00831272|9731904|FG003|STARTED|Overall Study||66
8687361|NCT00831272|9731901|FG000|COMPLETED|Overall Study||30
8801666|NCT01451437|9853519|FG004|NOT COMPLETED|Overall Study||4
8801667|NCT01451437|9853520|FG005|NOT COMPLETED|Overall Study||3
8801668|NCT01451437|9853521|FG006|NOT COMPLETED|Overall Study||6
8801669|NCT01451437|9853522|FG007|NOT COMPLETED|Overall Study||3
8801670|NCT01451437|9853523|FG008|NOT COMPLETED|Overall Study||4
8801671|NCT01451463|9853552|FG000|STARTED|Overall Study||11
8687362|NCT00831272|9731902|FG001|COMPLETED|Overall Study||37
8687363|NCT00831272|9731903|FG002|COMPLETED|Overall Study||63
8687364|NCT00831272|9731904|FG003|COMPLETED|Overall Study||56
8687365|NCT00831272|9731901|FG000|NOT COMPLETED|Overall Study||8
8687366|NCT00831272|9731902|FG001|NOT COMPLETED|Overall Study||7
8687367|NCT00831272|9731903|FG002|NOT COMPLETED|Overall Study||10
8687368|NCT00831272|9731904|FG003|NOT COMPLETED|Overall Study||10
8687369|NCT00831311|9731916|FG000|STARTED|Overall Study||312
8687370|NCT00831311|9731917|FG001|STARTED|Overall Study||312
8687371|NCT00831311|9731916|FG000|COMPLETED|Overall Study||300
8687372|NCT00831311|9731917|FG001|COMPLETED|Overall Study||304
8687373|NCT00831311|9731916|FG000|NOT COMPLETED|Overall Study||12
8687374|NCT00831311|9731917|FG001|NOT COMPLETED|Overall Study||8
8687375|NCT00831389|9731926|FG000|STARTED|Overall Study||6
8687376|NCT00831389|9731927|FG001|STARTED|Overall Study||7
8687377|NCT00831389|9731926|FG000|COMPLETED|Overall Study||6
8687378|NCT00831389|9731927|FG001|COMPLETED|Overall Study||6
8687379|NCT00831389|9731926|FG000|NOT COMPLETED|Overall Study||0
8687380|NCT00831389|9731927|FG001|NOT COMPLETED|Overall Study||1
8687381|NCT00831415|9731933|FG000|STARTED|Overall Study||304
8687382|NCT00831415|9731933|FG000|"Completers for Exposure"|Overall Study|Participants with ≥ 301 days of exposure to study drug and completed study day 308 evaluations.|227
8687383|NCT00831415|9731933|FG000|"Study Completers"|Overall Study|"Defined as participants whose conclusion of study participation status was study completed."|227
8687384|NCT00831415|9731933|FG000|COMPLETED|Overall Study|In addition to Completers for Study includes 2 participants who discontinued after on-therapy period|229
8687385|NCT00831415|9731933|FG000|NOT COMPLETED|Overall Study||75
8687386|NCT00831428|9731937|FG000|STARTED|Overall Study||97
8687387|NCT00831428|9731937|FG000|COMPLETED|Overall Study||97
8687388|NCT00831428|9731937|FG000|NOT COMPLETED|Overall Study||0
8687389|NCT00831441|9731943|FG000|STARTED|Randomized||3687
8687390|NCT00831441|9731944|FG001|STARTED|Randomized||3705
8687391|NCT00831441|9731943|FG000|Treated|Randomized||3643
8687392|NCT00831441|9731944|FG001|Treated|Randomized||3672
8687393|NCT00831441|9731943|FG000|COMPLETED|Randomized||0
8687394|NCT00831441|9731944|FG001|COMPLETED|Randomized||0
8687395|NCT00831441|9731943|FG000|NOT COMPLETED|Randomized||3687
8687396|NCT00831441|9731944|FG001|NOT COMPLETED|Randomized||3705
8687397|NCT00831441|9731943|FG000|STARTED|Follow Up (30 Days)|3508 participants entered the follow up period.|3508
8687398|NCT00831441|9731944|FG001|STARTED|Follow Up (30 Days)|3529 participants entered the follow up period.|3529
8687399|NCT00831441|9731943|FG000|COMPLETED|Follow Up (30 Days)||3375
8687400|NCT00831441|9731944|FG001|COMPLETED|Follow Up (30 Days)||3355
8687401|NCT00831441|9731943|FG000|NOT COMPLETED|Follow Up (30 Days)||133
8687402|NCT00831441|9731944|FG001|NOT COMPLETED|Follow Up (30 Days)||174
8687403|NCT00831480|9731951|FG000|STARTED|Overall Study||9
8687404|NCT00831480|9731951|FG000|COMPLETED|Overall Study||7
8687405|NCT00831480|9731951|FG000|NOT COMPLETED|Overall Study||2
8687406|NCT00831493|9731955|FG000|STARTED|Overall Study||3
8687407|NCT00831493|9731955|FG000|COMPLETED|Overall Study||2
8687408|NCT00831493|9731955|FG000|NOT COMPLETED|Overall Study||1
8687409|NCT00831675|9731961|FG000|STARTED|Overall Study||12
8687410|NCT00831675|9731962|FG001|STARTED|Overall Study||18
8687411|NCT00831675|9731961|FG000|COMPLETED|Overall Study||12
8687412|NCT00831675|9731962|FG001|COMPLETED|Overall Study||18
8687413|NCT00831675|9731961|FG000|NOT COMPLETED|Overall Study||0
8687414|NCT00831675|9731962|FG001|NOT COMPLETED|Overall Study||0
8687415|NCT00831701|9731970|FG000|STARTED|Overall Study||50
8687416|NCT00831701|9731971|FG001|STARTED|Overall Study||50
8687417|NCT00831701|9731970|FG000|COMPLETED|Overall Study||45
8687418|NCT00831701|9731971|FG001|COMPLETED|Overall Study||45
8687419|NCT00831701|9731970|FG000|NOT COMPLETED|Overall Study||5
8687420|NCT00831701|9731971|FG001|NOT COMPLETED|Overall Study||5
8687421|NCT00831753|9731979|FG000|STARTED|Overall Study||132
8687422|NCT00831753|9731980|FG001|STARTED|Overall Study||131
8687423|NCT00831753|9731979|FG000|COMPLETED|Overall Study||132
8687424|NCT00831753|9731980|FG001|COMPLETED|Overall Study||131
8687425|NCT00831753|9731979|FG000|NOT COMPLETED|Overall Study||0
8687426|NCT00831753|9731980|FG001|NOT COMPLETED|Overall Study||0
8687427|NCT00831766|9731988|FG000|STARTED|Overall Study||23
8687428|NCT00831766|9731989|FG001|STARTED|Overall Study||28
8687429|NCT00831766|9731988|FG000|COMPLETED|Overall Study||23
8687430|NCT00831766|9731989|FG001|COMPLETED|Overall Study||28
8687431|NCT00831766|9731988|FG000|NOT COMPLETED|Overall Study||0
8687432|NCT00831766|9731989|FG001|NOT COMPLETED|Overall Study||0
8687433|NCT00831779|9731998|FG000|STARTED|Overall Study||21
8687434|NCT00831779|9731999|FG001|STARTED|Overall Study||23
8687435|NCT00831779|9731998|FG000|COMPLETED|Overall Study||20
8687436|NCT00831779|9731999|FG001|COMPLETED|Overall Study||22
8687437|NCT00831779|9731998|FG000|NOT COMPLETED|Overall Study||1
8687438|NCT00831779|9731999|FG001|NOT COMPLETED|Overall Study||1
8687439|NCT00831792|9732005|FG000|STARTED|Overall Study||46
8687440|NCT00831792|9732005|FG000|COMPLETED|Overall Study||40
8687441|NCT00831792|9732005|FG000|NOT COMPLETED|Overall Study||6
8687442|NCT00831844|9732019|FG000|STARTED|Overall Study||10
8687443|NCT00831844|9732020|FG001|STARTED|Overall Study||12
8687444|NCT00831844|9732021|FG002|STARTED|Overall Study||21
8687445|NCT00831844|9732022|FG003|STARTED|Overall Study||10
8687446|NCT00831844|9732023|FG004|STARTED|Overall Study||14
8687447|NCT00831844|9732024|FG005|STARTED|Overall Study||20
8687448|NCT00831844|9732025|FG006|STARTED|Overall Study||10
8687449|NCT00831844|9732026|FG007|STARTED|Overall Study||10
8687450|NCT00831844|9732027|FG008|STARTED|Overall Study||9
8687451|NCT00831844|9732028|FG009|STARTED|Overall Study||0
8687452|NCT00831844|9732019|FG000|COMPLETED|Overall Study||0
8687453|NCT00831844|9732020|FG001|COMPLETED|Overall Study||0
8687454|NCT00831844|9732021|FG002|COMPLETED|Overall Study||1
8687455|NCT00831844|9732022|FG003|COMPLETED|Overall Study||0
8687456|NCT00831844|9732023|FG004|COMPLETED|Overall Study||0
8687457|NCT00831844|9732024|FG005|COMPLETED|Overall Study||1
8687458|NCT00831844|9732025|FG006|COMPLETED|Overall Study||0
8687459|NCT00831844|9732026|FG007|COMPLETED|Overall Study||0
8687460|NCT00831844|9732027|FG008|COMPLETED|Overall Study||0
8687461|NCT00831844|9732028|FG009|COMPLETED|Overall Study||0
8687462|NCT00831844|9732019|FG000|NOT COMPLETED|Overall Study||10
8687463|NCT00831844|9732020|FG001|NOT COMPLETED|Overall Study||12
8687464|NCT00831844|9732021|FG002|NOT COMPLETED|Overall Study||20
8687465|NCT00831844|9732022|FG003|NOT COMPLETED|Overall Study||10
8687466|NCT00831844|9732023|FG004|NOT COMPLETED|Overall Study||14
8687467|NCT00831844|9732024|FG005|NOT COMPLETED|Overall Study||19
8687468|NCT00831844|9732025|FG006|NOT COMPLETED|Overall Study||10
8687469|NCT00831844|9732026|FG007|NOT COMPLETED|Overall Study||10
8687470|NCT00831844|9732027|FG008|NOT COMPLETED|Overall Study||9
8687471|NCT00831844|9732028|FG009|NOT COMPLETED|Overall Study||0
8687472|NCT00831987|9732052|FG000|STARTED|Overall Study||60
8687473|NCT00831987|9732053|FG001|STARTED|Overall Study||60
8687474|NCT00831987|9732052|FG000|COMPLETED|Overall Study||60
8687475|NCT00831987|9732053|FG001|COMPLETED|Overall Study||60
8687476|NCT00831987|9732052|FG000|NOT COMPLETED|Overall Study||0
8687477|NCT00831987|9732053|FG001|NOT COMPLETED|Overall Study||0
8687478|NCT00832000|9732059|FG000|STARTED|Overall Study|Mexiletine 200 mg orally three times daily|29
8687479|NCT00832000|9732060|FG001|STARTED|Overall Study|Placebo|30
8687480|NCT00832000|9732059|FG000|Crossed Over to Opposite Intervention|Overall Study|Placebo|25
8687481|NCT00832000|9732060|FG001|Crossed Over to Opposite Intervention|Overall Study|Mexiletine 200 mg orally three times daily|29
8687482|NCT00832000|9732059|FG000|COMPLETED|Overall Study||23
8687483|NCT00832000|9732060|FG001|COMPLETED|Overall Study||29
8687484|NCT00832000|9732059|FG000|NOT COMPLETED|Overall Study||6
8687485|NCT00832000|9732060|FG001|NOT COMPLETED|Overall Study||1
8687486|NCT00832078|9732095|FG000|STARTED|Test Day 1- 1 Period||13
8687487|NCT00832078|9732096|FG001|STARTED|Test Day 1- 1 Period||12
8687488|NCT00832078|9732095|FG000|COMPLETED|Test Day 1- 1 Period||13
8687489|NCT00832078|9732096|FG001|COMPLETED|Test Day 1- 1 Period||12
8687490|NCT00832078|9732095|FG000|NOT COMPLETED|Test Day 1- 1 Period||0
8687491|NCT00832078|9732096|FG001|NOT COMPLETED|Test Day 1- 1 Period||0
8687492|NCT00832078|9732095|FG000|STARTED|Test Day 1-2 Period||13
8687493|NCT00832078|9732096|FG001|STARTED|Test Day 1-2 Period||12
8687494|NCT00832078|9732095|FG000|COMPLETED|Test Day 1-2 Period||13
8687495|NCT00832078|9732096|FG001|COMPLETED|Test Day 1-2 Period||10
8687496|NCT00832078|9732095|FG000|NOT COMPLETED|Test Day 1-2 Period||0
8687497|NCT00832078|9732096|FG001|NOT COMPLETED|Test Day 1-2 Period||2
8687498|NCT00832078|9732095|FG000|STARTED|Test Day 2 - 1 Period||13
8687499|NCT00832078|9732096|FG001|STARTED|Test Day 2 - 1 Period||10
8687500|NCT00832078|9732095|FG000|COMPLETED|Test Day 2 - 1 Period||13
8687501|NCT00832078|9732096|FG001|COMPLETED|Test Day 2 - 1 Period||10
8687502|NCT00832078|9732095|FG000|NOT COMPLETED|Test Day 2 - 1 Period||0
8687503|NCT00832078|9732096|FG001|NOT COMPLETED|Test Day 2 - 1 Period||0
8687504|NCT00832078|9732095|FG000|STARTED|Test Day 2 - 2 Period||13
8687505|NCT00832078|9732096|FG001|STARTED|Test Day 2 - 2 Period||10
8687506|NCT00832078|9732095|FG000|COMPLETED|Test Day 2 - 2 Period||12
8687507|NCT00832078|9732096|FG001|COMPLETED|Test Day 2 - 2 Period||10
8687508|NCT00832078|9732095|FG000|NOT COMPLETED|Test Day 2 - 2 Period||1
8687509|NCT00832078|9732096|FG001|NOT COMPLETED|Test Day 2 - 2 Period||0
8687510|NCT00832091|9732104|FG000|STARTED|Overall Study||17
8687511|NCT00832091|9732105|FG001|STARTED|Overall Study||55
8687512|NCT00832091|9732104|FG000|COMPLETED|Overall Study||12
8687513|NCT00832091|9732105|FG001|COMPLETED|Overall Study||53
8687514|NCT00832091|9732104|FG000|NOT COMPLETED|Overall Study||5
8687515|NCT00832091|9732105|FG001|NOT COMPLETED|Overall Study||2
8687516|NCT00832117|9732113|FG000|STARTED|Overall Study||29
8687517|NCT00832117|9732113|FG000|COMPLETED|Overall Study||17
8687518|NCT00832117|9732113|FG000|NOT COMPLETED|Overall Study||12
8687519|NCT00832130|9732122|FG000|STARTED|Overall Study||69
8687520|NCT00832130|9732123|FG001|STARTED|Overall Study||70
8687521|NCT00832130|9732122|FG000|COMPLETED|Overall Study||69
8687522|NCT00832130|9732123|FG001|COMPLETED|Overall Study||70
8687523|NCT00832130|9732122|FG000|NOT COMPLETED|Overall Study||0
8687524|NCT00832130|9732123|FG001|NOT COMPLETED|Overall Study||0
8687525|NCT00832260|9732129|FG000|STARTED|Overall Study||70
8687526|NCT00832260|9732129|FG000|COMPLETED|Overall Study||70
8687527|NCT00832260|9732129|FG000|NOT COMPLETED|Overall Study||0
8687528|NCT00832338|9732133|FG000|STARTED|Overall Study||23
8687529|NCT00832338|9732133|FG000|COMPLETED|Overall Study||23
8687530|NCT00832338|9732133|FG000|NOT COMPLETED|Overall Study||0
8687531|NCT00832377|9732137|FG000|STARTED|Overall Study||37
8687532|NCT00832377|9732137|FG000|COMPLETED|Overall Study||36
8687533|NCT00832377|9732137|FG000|NOT COMPLETED|Overall Study||1
8687534|NCT00832390|9732144|FG000|STARTED|Overall Study||12
8687535|NCT00832390|9732145|FG001|STARTED|Overall Study||16
8687536|NCT00832390|9732146|FG002|STARTED|Overall Study||1
8687537|NCT00832390|9732144|FG000|COMPLETED|Overall Study||12
8687538|NCT00832390|9732145|FG001|COMPLETED|Overall Study||16
8687539|NCT00832390|9732146|FG002|COMPLETED|Overall Study||1
8687540|NCT00832390|9732144|FG000|NOT COMPLETED|Overall Study||0
8687541|NCT00832390|9732145|FG001|NOT COMPLETED|Overall Study||0
8687542|NCT00832390|9732146|FG002|NOT COMPLETED|Overall Study||0
8687543|NCT00832416|9732158|FG000|STARTED|Overall Study||110
8687544|NCT00832416|9732159|FG001|STARTED|Overall Study||113
8687545|NCT00832416|9732160|FG002|STARTED|Overall Study||115
8687546|NCT00832416|9732161|FG003|STARTED|Overall Study||227
8687547|NCT00832416|9732158|FG000|COMPLETED|Overall Study||64
8687548|NCT00832416|9732159|FG001|COMPLETED|Overall Study||60
8687549|NCT00832416|9732160|FG002|COMPLETED|Overall Study||54
8687550|NCT00832416|9732161|FG003|COMPLETED|Overall Study||144
8687551|NCT00832416|9732158|FG000|NOT COMPLETED|Overall Study||46
8687552|NCT00832416|9732159|FG001|NOT COMPLETED|Overall Study||53
8687553|NCT00832416|9732160|FG002|NOT COMPLETED|Overall Study||61
8687554|NCT00832416|9732161|FG003|NOT COMPLETED|Overall Study||83
8687555|NCT00832585|9732171|FG000|STARTED|Overall Study|Eight subjects were screened but only 5 started the study and received study drug.|5
8687556|NCT00832585|9732171|FG000|COMPLETED|Overall Study|Only three subjects completed all of the visits for the study as per protocol.|3
8687557|NCT00832585|9732171|FG000|NOT COMPLETED|Overall Study||2
8687558|NCT00832637|9732175|FG000|STARTED|Overall Study||33
8687559|NCT00832637|9732175|FG000|COMPLETED|Overall Study||33
8687560|NCT00832637|9732175|FG000|NOT COMPLETED|Overall Study||0
8687561|NCT00832650|9732182|FG000|STARTED|Overall Study||25
8687562|NCT00832650|9732183|FG001|STARTED|Overall Study||12
8687563|NCT00832650|9732184|FG002|STARTED|Overall Study||23
8687564|NCT00832650|9732182|FG000|Treated|Overall Study||25
8687565|NCT00832650|9732183|FG001|Treated|Overall Study||12
8687566|NCT00832650|9732184|FG002|Treated|Overall Study||22
8687567|NCT00832650|9732182|FG000|COMPLETED|Overall Study||25
8687568|NCT00832650|9732183|FG001|COMPLETED|Overall Study||12
8687569|NCT00832650|9732184|FG002|COMPLETED|Overall Study||22
8687570|NCT00832650|9732182|FG000|NOT COMPLETED|Overall Study||0
8687571|NCT00832650|9732183|FG001|NOT COMPLETED|Overall Study||0
8687572|NCT00832650|9732184|FG002|NOT COMPLETED|Overall Study||1
8687573|NCT00832767|9732194|FG000|STARTED|Overall Study||121
8687574|NCT00832767|9732195|FG001|STARTED|Overall Study||81
8687575|NCT00832767|9732194|FG000|COMPLETED|Overall Study||99
8687576|NCT00832767|9732195|FG001|COMPLETED|Overall Study||63
8687577|NCT00832767|9732194|FG000|NOT COMPLETED|Overall Study||22
8687578|NCT00832767|9732195|FG001|NOT COMPLETED|Overall Study||18
8687579|NCT00832780|9732203|FG000|STARTED|Overall Study||44
8687580|NCT00832780|9732203|FG000|COMPLETED|Overall Study||19
8687581|NCT00832780|9732203|FG000|NOT COMPLETED|Overall Study||25
8687582|NCT00832819|9732210|FG000|STARTED|Overall Study||6
8687583|NCT00832819|9732211|FG001|STARTED|Overall Study||6
8687584|NCT00832819|9732212|FG002|STARTED|Overall Study||16
8687585|NCT00832819|9732210|FG000|COMPLETED|Overall Study||6
8687586|NCT00832819|9732211|FG001|COMPLETED|Overall Study||5
8687587|NCT00832819|9732212|FG002|COMPLETED|Overall Study||15
8687588|NCT00832819|9732210|FG000|NOT COMPLETED|Overall Study||0
8687589|NCT00832819|9732211|FG001|NOT COMPLETED|Overall Study||1
8687590|NCT00832819|9732212|FG002|NOT COMPLETED|Overall Study||1
8687591|NCT00832871|9732218|FG000|STARTED|Overall Study||4
8687592|NCT00832871|9732218|FG000|COMPLETED|Overall Study||4
8687593|NCT00832871|9732218|FG000|NOT COMPLETED|Overall Study||0
8687594|NCT00832975|9732222|FG000|STARTED|Overall Study||157
8687595|NCT00832975|9732222|FG000|COMPLETED|Overall Study||118
8687596|NCT00832975|9732222|FG000|NOT COMPLETED|Overall Study||39
8687597|NCT00833027|9732226|FG000|STARTED|Overall Study||608
8687598|NCT00833027|9732226|FG000|COMPLETED|Overall Study||397
8687599|NCT00833027|9732226|FG000|NOT COMPLETED|Overall Study||211
8687600|NCT00833040|9732230|FG000|STARTED|Overall Study||6
8687601|NCT00833040|9732231|FG001|STARTED|Overall Study||6
8687602|NCT00833040|9732232|FG002|STARTED|Overall Study||6
8687603|NCT00833040|9732233|FG003|STARTED|Overall Study||6
8687604|NCT00833040|9732234|FG004|STARTED|Overall Study||5
8687605|NCT00833040|9732235|FG005|STARTED|Overall Study||5
8687606|NCT00833040|9732230|FG000|COMPLETED|Overall Study||6
8687607|NCT00833040|9732231|FG001|COMPLETED|Overall Study||6
8687608|NCT00833040|9732232|FG002|COMPLETED|Overall Study||6
8687609|NCT00833040|9732233|FG003|COMPLETED|Overall Study||6
8687610|NCT00833040|9732234|FG004|COMPLETED|Overall Study||5
8687611|NCT00833040|9732235|FG005|COMPLETED|Overall Study||4
8687612|NCT00833040|9732230|FG000|NOT COMPLETED|Overall Study||0
8687613|NCT00833040|9732231|FG001|NOT COMPLETED|Overall Study||0
8687614|NCT00833040|9732232|FG002|NOT COMPLETED|Overall Study||0
8687615|NCT00833040|9732233|FG003|NOT COMPLETED|Overall Study||0
8687616|NCT00833040|9732234|FG004|NOT COMPLETED|Overall Study||0
8687617|NCT00833040|9732235|FG005|NOT COMPLETED|Overall Study||1
8687618|NCT00833053|9732242|FG000|STARTED|Overall Study||19
8687619|NCT00833053|9732243|FG001|STARTED|Overall Study||20
8687620|NCT00833053|9732242|FG000|COMPLETED|Overall Study||10
8687621|NCT00833053|9732243|FG001|COMPLETED|Overall Study||17
8687622|NCT00833053|9732242|FG000|NOT COMPLETED|Overall Study||9
8687623|NCT00833053|9732243|FG001|NOT COMPLETED|Overall Study||3
8687624|NCT00833092|9732251|FG000|STARTED|Overall Study||54
8687625|NCT00833092|9732252|FG001|STARTED|Overall Study||57
8687626|NCT00833092|9732251|FG000|COMPLETED|Overall Study||50
8687627|NCT00833092|9732252|FG001|COMPLETED|Overall Study||50
8687628|NCT00833092|9732251|FG000|NOT COMPLETED|Overall Study||4
8687629|NCT00833092|9732252|FG001|NOT COMPLETED|Overall Study||7
8687630|NCT00833105|9732258|FG000|STARTED|Overall Study||13
8687631|NCT00833105|9732258|FG000|COMPLETED|Overall Study||10
8687632|NCT00833105|9732258|FG000|NOT COMPLETED|Overall Study||3
8687633|NCT00833248|9732266|FG000|STARTED|Overall Study||181
8687634|NCT00833248|9732267|FG001|STARTED|Overall Study||65
8687635|NCT00833248|9732266|FG000|Full Analysis Set (FAS)|Overall Study||180
8687636|NCT00833248|9732267|FG001|Full Analysis Set (FAS)|Overall Study||64
8801672|NCT01451463|9853552|FG000|COMPLETED|Overall Study||11
8801673|NCT01451463|9853552|FG000|NOT COMPLETED|Overall Study||0
8801674|NCT01451541|9853564|FG000|STARTED|Overall Study||283
8801675|NCT01451541|9853565|FG001|STARTED|Overall Study||282
8801676|NCT01451541|9853566|FG002|STARTED|Overall Study|283 randomized. ITT = 281 (2 subjects discontinued prior to study medication).|281
8801677|NCT01451541|9853564|FG000|COMPLETED|Overall Study||247
8801678|NCT01451541|9853565|FG001|COMPLETED|Overall Study||257
8801679|NCT01451541|9853566|FG002|COMPLETED|Overall Study||254
8801680|NCT01451541|9853564|FG000|NOT COMPLETED|Overall Study||36
8801681|NCT01451541|9853565|FG001|NOT COMPLETED|Overall Study||25
8801682|NCT01451541|9853566|FG002|NOT COMPLETED|Overall Study||27
8801683|NCT01451554|9853578|FG000|STARTED|Overall Study||33
8801684|NCT01451554|9853579|FG001|STARTED|Overall Study||32
8801685|NCT01451554|9853578|FG000|COMPLETED|Overall Study||19
8801686|NCT01451554|9853579|FG001|COMPLETED|Overall Study||23
8801687|NCT01451554|9853578|FG000|NOT COMPLETED|Overall Study||14
8801688|NCT01451554|9853579|FG001|NOT COMPLETED|Overall Study||9
8801689|NCT01451606|9853587|FG000|STARTED|Overall Study||16
8801690|NCT01451606|9853588|FG001|STARTED|Overall Study||18
8801691|NCT01451606|9853587|FG000|COMPLETED|Overall Study||12
8801692|NCT01451606|9853588|FG001|COMPLETED|Overall Study||15
8801693|NCT01451606|9853587|FG000|NOT COMPLETED|Overall Study||4
8801694|NCT01451606|9853588|FG001|NOT COMPLETED|Overall Study||3
8801695|NCT01451632|9853596|FG000|STARTED|Overall Study||8
8801696|NCT01451632|9853597|FG001|STARTED|Overall Study||4
8801697|NCT01451632|9853598|FG002|STARTED|Overall Study||3
8801698|NCT01451632|9853599|FG003|STARTED|Overall Study||3
8801699|NCT01451632|9853600|FG004|STARTED|Overall Study||4
8801700|NCT01451632|9853601|FG005|STARTED|Overall Study||4
8801701|NCT01451632|9853602|FG006|STARTED|Overall Study||8
8801702|NCT01451632|9853603|FG007|STARTED|Overall Study||6
8801703|NCT01451632|9853604|FG008|STARTED|Overall Study||4
8801704|NCT01451632|9853605|FG009|STARTED|Overall Study||4
8801705|NCT01451632|9853596|FG000|COMPLETED|Overall Study||8
8801706|NCT01451632|9853597|FG001|COMPLETED|Overall Study||4
8801707|NCT01451632|9853598|FG002|COMPLETED|Overall Study||3
8801708|NCT01451632|9853599|FG003|COMPLETED|Overall Study||3
8801709|NCT01451632|9853600|FG004|COMPLETED|Overall Study||4
8801710|NCT01451632|9853601|FG005|COMPLETED|Overall Study||4
8801711|NCT01451632|9853602|FG006|COMPLETED|Overall Study||8
8801712|NCT01451632|9853603|FG007|COMPLETED|Overall Study||6
8801713|NCT01451632|9853604|FG008|COMPLETED|Overall Study||4
8801714|NCT01451632|9853605|FG009|COMPLETED|Overall Study||4
8801715|NCT01451632|9853596|FG000|NOT COMPLETED|Overall Study||0
8801716|NCT01451632|9853597|FG001|NOT COMPLETED|Overall Study||0
8801717|NCT01451632|9853598|FG002|NOT COMPLETED|Overall Study||0
8801718|NCT01451632|9853599|FG003|NOT COMPLETED|Overall Study||0
8801719|NCT01451632|9853600|FG004|NOT COMPLETED|Overall Study||0
8801720|NCT01451632|9853601|FG005|NOT COMPLETED|Overall Study||0
8801721|NCT01451632|9853602|FG006|NOT COMPLETED|Overall Study||0
8801722|NCT01451632|9853603|FG007|NOT COMPLETED|Overall Study||0
8801723|NCT01451632|9853604|FG008|NOT COMPLETED|Overall Study||0
8801724|NCT01451632|9853605|FG009|NOT COMPLETED|Overall Study||0
8801725|NCT01451645|9853632|FG000|STARTED|Overall Study||41
8801726|NCT01451645|9853633|FG001|STARTED|Overall Study||41
8801727|NCT01451645|9853632|FG000|COMPLETED|Overall Study||32
8801728|NCT01451645|9853633|FG001|COMPLETED|Overall Study||33
8801729|NCT01451645|9853632|FG000|NOT COMPLETED|Overall Study||9
8801730|NCT01451645|9853633|FG001|NOT COMPLETED|Overall Study||8
8801731|NCT01451749|9853641|FG000|STARTED|Overall Study||216
8801732|NCT01451749|9853642|FG001|STARTED|Overall Study||108
8801733|NCT01451749|9853641|FG000|COMPLETED|Overall Study||184
8801734|NCT01451749|9853642|FG001|COMPLETED|Overall Study||94
8801735|NCT01451749|9853641|FG000|NOT COMPLETED|Overall Study||32
8801736|NCT01451749|9853642|FG001|NOT COMPLETED|Overall Study||14
8801737|NCT01451762|9853653|FG000|STARTED|Overall Study||30
8801738|NCT01451762|9853654|FG001|STARTED|Overall Study||30
8801739|NCT01451762|9853655|FG002|STARTED|Overall Study||30
8801740|NCT01451762|9853653|FG000|COMPLETED|Overall Study||27
8801741|NCT01451762|9853654|FG001|COMPLETED|Overall Study||24
8801742|NCT01451762|9853655|FG002|COMPLETED|Overall Study||24
8801743|NCT01451762|9853653|FG000|NOT COMPLETED|Overall Study||3
8801744|NCT01451762|9853654|FG001|NOT COMPLETED|Overall Study||6
8801745|NCT01451762|9853655|FG002|NOT COMPLETED|Overall Study||6
8801746|NCT01451775|9853663|FG000|STARTED|Overall Study||3
8801747|NCT01451775|9853664|FG001|STARTED|Overall Study||3
8801748|NCT01451775|9853665|FG002|STARTED|Overall Study||3
8801749|NCT01451775|9853666|FG003|STARTED|Overall Study||3
8801750|NCT01451775|9853667|FG004|STARTED|Overall Study||3
8801751|NCT01451775|9853668|FG005|STARTED|Overall Study||3
8801752|NCT01451775|9853663|FG000|COMPLETED|Overall Study||3
8687637|NCT00833248|9732266|FG000|Per Protocol (PP) Analysis Set|Overall Study||164
8687638|NCT00833248|9732267|FG001|Per Protocol (PP) Analysis Set|Overall Study||57
8687639|NCT00833248|9732266|FG000|Safety Analysis Set|Overall Study||181
8687640|NCT00833248|9732267|FG001|Safety Analysis Set|Overall Study||64
8687641|NCT00833248|9732266|FG000|COMPLETED|Overall Study||177
8801753|NCT01451775|9853664|FG001|COMPLETED|Overall Study||3
8801754|NCT01451775|9853665|FG002|COMPLETED|Overall Study||3
8687642|NCT00833248|9732267|FG001|COMPLETED|Overall Study||62
8687643|NCT00833248|9732266|FG000|NOT COMPLETED|Overall Study||4
8687644|NCT00833248|9732267|FG001|NOT COMPLETED|Overall Study||3
8687645|NCT00833261|9732273|FG000|STARTED|Overall Study||37
8687646|NCT00833261|9732273|FG000|COMPLETED|Overall Study|3 patients withdrew from the study prior to treatment & 1 receiving it did not complete the course.|33
8687647|NCT00833261|9732273|FG000|NOT COMPLETED|Overall Study||4
8687648|NCT00833365|9732279|FG000|STARTED|Overall Study||9
8687649|NCT00833365|9732280|FG001|STARTED|Overall Study||6
8687650|NCT00833365|9732279|FG000|COMPLETED|Overall Study||9
8687651|NCT00833365|9732280|FG001|COMPLETED|Overall Study||6
8687652|NCT00833365|9732279|FG000|NOT COMPLETED|Overall Study||0
8687653|NCT00833365|9732280|FG001|NOT COMPLETED|Overall Study||0
8687654|NCT00833417|9732288|FG000|STARTED|Overall Study||33
8687655|NCT00833417|9732289|FG001|STARTED|Overall Study||71
8687656|NCT00833417|9732288|FG000|COMPLETED|Overall Study||0
8687657|NCT00833417|9732289|FG001|COMPLETED|Overall Study||0
8687658|NCT00833417|9732288|FG000|NOT COMPLETED|Overall Study||33
8687659|NCT00833417|9732289|FG001|NOT COMPLETED|Overall Study||71
8687660|NCT00833443|9732298|FG000|STARTED|Overall Study||41
8687661|NCT00833443|9732299|FG001|STARTED|Overall Study||43
8687662|NCT00833443|9732298|FG000|COMPLETED|Overall Study||21
8687663|NCT00833443|9732299|FG001|COMPLETED|Overall Study||15
8687664|NCT00833443|9732298|FG000|NOT COMPLETED|Overall Study||20
8687665|NCT00833443|9732299|FG001|NOT COMPLETED|Overall Study||28
8687666|NCT00833469|9732307|FG000|STARTED|Overall Study||5
8687667|NCT00833469|9732307|FG000|COMPLETED|Overall Study||3
8687668|NCT00833469|9732307|FG000|NOT COMPLETED|Overall Study||2
8687669|NCT00833482|9732313|FG000|STARTED|Days 1-3|Participants who received treatment|24
8687670|NCT00833482|9732314|FG001|STARTED|Days 1-3|Participants who received treatment|0
8687671|NCT00833482|9732315|FG002|STARTED|Days 1-3||0
8687672|NCT00833482|9732316|FG003|STARTED|Days 1-3||8
8687673|NCT00833482|9732317|FG004|STARTED|Days 1-3||0
8687674|NCT00833482|9732318|FG005|STARTED|Days 1-3||0
8687675|NCT00833482|9732313|FG000|COMPLETED|Days 1-3||24
8687676|NCT00833482|9732314|FG001|COMPLETED|Days 1-3||0
8687677|NCT00833482|9732315|FG002|COMPLETED|Days 1-3||0
8687678|NCT00833482|9732316|FG003|COMPLETED|Days 1-3||8
8687679|NCT00833482|9732317|FG004|COMPLETED|Days 1-3||0
8687680|NCT00833482|9732318|FG005|COMPLETED|Days 1-3||0
8687681|NCT00833482|9732313|FG000|NOT COMPLETED|Days 1-3||0
8687682|NCT00833482|9732314|FG001|NOT COMPLETED|Days 1-3||0
8687683|NCT00833482|9732315|FG002|NOT COMPLETED|Days 1-3||0
8687684|NCT00833482|9732316|FG003|NOT COMPLETED|Days 1-3||0
8687685|NCT00833482|9732317|FG004|NOT COMPLETED|Days 1-3||0
8687686|NCT00833482|9732318|FG005|NOT COMPLETED|Days 1-3||0
8687687|NCT00833482|9732313|FG000|STARTED|Days 11-20||0
8687688|NCT00833482|9732314|FG001|STARTED|Days 11-20|Participants who received treatment.|24
8687689|NCT00833482|9732315|FG002|STARTED|Days 11-20||0
8687690|NCT00833482|9732316|FG003|STARTED|Days 11-20||0
8687691|NCT00833482|9732317|FG004|STARTED|Days 11-20||0
8687692|NCT00833482|9732318|FG005|STARTED|Days 11-20|Participants who received treatment.|8
8687693|NCT00833482|9732313|FG000|COMPLETED|Days 11-20||0
8687694|NCT00833482|9732314|FG001|COMPLETED|Days 11-20||21
8687695|NCT00833482|9732315|FG002|COMPLETED|Days 11-20||0
8687696|NCT00833482|9732316|FG003|COMPLETED|Days 11-20||0
8687697|NCT00833482|9732317|FG004|COMPLETED|Days 11-20||0
8687698|NCT00833482|9732318|FG005|COMPLETED|Days 11-20||8
8687699|NCT00833482|9732313|FG000|NOT COMPLETED|Days 11-20||0
8687700|NCT00833482|9732314|FG001|NOT COMPLETED|Days 11-20||3
8687701|NCT00833482|9732315|FG002|NOT COMPLETED|Days 11-20||0
8687702|NCT00833482|9732316|FG003|NOT COMPLETED|Days 11-20||0
8687703|NCT00833482|9732317|FG004|NOT COMPLETED|Days 11-20||0
8687704|NCT00833482|9732318|FG005|NOT COMPLETED|Days 11-20||0
8687705|NCT00833482|9732313|FG000|STARTED|Days 21-30||0
8687706|NCT00833482|9732314|FG001|STARTED|Days 21-30||0
8687707|NCT00833482|9732315|FG002|STARTED|Days 21-30||21
8687708|NCT00833482|9732316|FG003|STARTED|Days 21-30||0
8687709|NCT00833482|9732317|FG004|STARTED|Days 21-30||8
8687710|NCT00833482|9732318|FG005|STARTED|Days 21-30||0
8687711|NCT00833482|9732313|FG000|COMPLETED|Days 21-30||0
8687712|NCT00833482|9732314|FG001|COMPLETED|Days 21-30||0
8687713|NCT00833482|9732315|FG002|COMPLETED|Days 21-30||20
8687714|NCT00833482|9732316|FG003|COMPLETED|Days 21-30||0
8687715|NCT00833482|9732317|FG004|COMPLETED|Days 21-30||7
8687716|NCT00833482|9732318|FG005|COMPLETED|Days 21-30||0
8687717|NCT00833482|9732313|FG000|NOT COMPLETED|Days 21-30||0
8687718|NCT00833482|9732314|FG001|NOT COMPLETED|Days 21-30||0
8687719|NCT00833482|9732315|FG002|NOT COMPLETED|Days 21-30||1
8687720|NCT00833482|9732316|FG003|NOT COMPLETED|Days 21-30||0
8687721|NCT00833482|9732317|FG004|NOT COMPLETED|Days 21-30||1
8687722|NCT00833482|9732318|FG005|NOT COMPLETED|Days 21-30||0
8687723|NCT00833547|9732342|FG000|STARTED|Overall Study||13
8687724|NCT00833547|9732343|FG001|STARTED|Overall Study||12
8687725|NCT00833547|9732342|FG000|COMPLETED|Overall Study||11
8687726|NCT00833547|9732343|FG001|COMPLETED|Overall Study||10
8687727|NCT00833547|9732342|FG000|NOT COMPLETED|Overall Study||2
8687728|NCT00833547|9732343|FG001|NOT COMPLETED|Overall Study||2
8687729|NCT00833560|9732349|FG000|STARTED|Overall Study||395
8687730|NCT00833560|9732349|FG000|COMPLETED|Overall Study||353
8687731|NCT00833560|9732349|FG000|NOT COMPLETED|Overall Study||42
8687732|NCT00833638|9732356|FG000|STARTED|Phase 2: Double-blind Treatment Phase||121
8687733|NCT00833638|9732357|FG001|STARTED|Phase 2: Double-blind Treatment Phase||118
8687734|NCT00833638|9732358|FG002|STARTED|Phase 2: Double-blind Treatment Phase||133
8687735|NCT00833638|9732356|FG000|COMPLETED|Phase 2: Double-blind Treatment Phase||111
8687736|NCT00833638|9732357|FG001|COMPLETED|Phase 2: Double-blind Treatment Phase||108
8687737|NCT00833638|9732358|FG002|COMPLETED|Phase 2: Double-blind Treatment Phase||124
8687738|NCT00833638|9732356|FG000|NOT COMPLETED|Phase 2: Double-blind Treatment Phase||10
8687739|NCT00833638|9732357|FG001|NOT COMPLETED|Phase 2: Double-blind Treatment Phase||10
8687740|NCT00833638|9732358|FG002|NOT COMPLETED|Phase 2: Double-blind Treatment Phase||9
8687741|NCT00833638|9732356|FG000|STARTED|Phase 3: Open-label Extension Phase||111
8687742|NCT00833638|9732357|FG001|STARTED|Phase 3: Open-label Extension Phase||108
8687743|NCT00833638|9732358|FG002|STARTED|Phase 3: Open-label Extension Phase||124
8687744|NCT00833638|9732356|FG000|COMPLETED|Phase 3: Open-label Extension Phase||110
8687745|NCT00833638|9732357|FG001|COMPLETED|Phase 3: Open-label Extension Phase||105
8687746|NCT00833638|9732358|FG002|COMPLETED|Phase 3: Open-label Extension Phase||122
8687747|NCT00833638|9732356|FG000|NOT COMPLETED|Phase 3: Open-label Extension Phase||1
8687748|NCT00833638|9732357|FG001|NOT COMPLETED|Phase 3: Open-label Extension Phase||3
8687749|NCT00833638|9732358|FG002|NOT COMPLETED|Phase 3: Open-label Extension Phase||2
8687750|NCT00833690|9732377|FG000|STARTED|Overall Study||25
8687751|NCT00833690|9732378|FG001|STARTED|Overall Study||24
8687752|NCT00833690|9732379|FG002|STARTED|Overall Study||26
8687753|NCT00833690|9732377|FG000|COMPLETED|Overall Study||21
8687754|NCT00833690|9732378|FG001|COMPLETED|Overall Study||22
8687755|NCT00833690|9732379|FG002|COMPLETED|Overall Study||26
8687756|NCT00833690|9732377|FG000|NOT COMPLETED|Overall Study||4
8687757|NCT00833690|9732378|FG001|NOT COMPLETED|Overall Study||2
8687758|NCT00833690|9732379|FG002|NOT COMPLETED|Overall Study||0
8687759|NCT00833703|9732389|FG000|STARTED|Overall Study|Included|23
8687760|NCT00833703|9732390|FG001|STARTED|Overall Study|Included|26
8687761|NCT00833703|9732389|FG000|Treated|Overall Study||23
8687762|NCT00833703|9732390|FG001|Treated|Overall Study||26
8687763|NCT00833703|9732389|FG000|Completed Treatment|Overall Study||22
8687764|NCT00833703|9732390|FG001|Completed Treatment|Overall Study||24
8687765|NCT00833703|9732389|FG000|COMPLETED|Overall Study|Completed follow-up|23
8687766|NCT00833703|9732390|FG001|COMPLETED|Overall Study|Completed follow-up|25
8687767|NCT00833703|9732389|FG000|NOT COMPLETED|Overall Study||0
8687768|NCT00833703|9732390|FG001|NOT COMPLETED|Overall Study||1
8687769|NCT00833755|9732400|FG000|STARTED|Overall Study||16
8687770|NCT00833755|9732401|FG001|STARTED|Overall Study||18
8687771|NCT00833755|9732402|FG002|STARTED|Overall Study||22
8687772|NCT00833755|9732403|FG003|STARTED|Overall Study||23
8687773|NCT00833755|9732400|FG000|COMPLETED|Overall Study||12
8687774|NCT00833755|9732401|FG001|COMPLETED|Overall Study||13
8687775|NCT00833755|9732402|FG002|COMPLETED|Overall Study||20
8687776|NCT00833755|9732403|FG003|COMPLETED|Overall Study||17
8687777|NCT00833755|9732400|FG000|NOT COMPLETED|Overall Study||4
8687778|NCT00833755|9732401|FG001|NOT COMPLETED|Overall Study||5
8687779|NCT00833755|9732402|FG002|NOT COMPLETED|Overall Study||2
8687780|NCT00833755|9732403|FG003|NOT COMPLETED|Overall Study||6
8687781|NCT00833781|9732416|FG000|STARTED|Overall Study||10
8687782|NCT00833781|9732417|FG001|STARTED|Overall Study||5
8687783|NCT00833781|9732416|FG000|COMPLETED|Overall Study||10
8687784|NCT00833781|9732417|FG001|COMPLETED|Overall Study||5
8687785|NCT00833781|9732416|FG000|NOT COMPLETED|Overall Study||0
8687786|NCT00833781|9732417|FG001|NOT COMPLETED|Overall Study||0
8687787|NCT00833794|9732424|FG000|STARTED|Open-label Phase|Enrolled. Population described in the baseline characteristics is 1023 patients (Open-Label safety).|1028
8687788|NCT00833794|9732425|FG001|STARTED|Open-label Phase|No Placebo arm during open-label phase.|0
8687789|NCT00833794|9732424|FG000|Entered run-in Period|Open-label Phase||1027
8687790|NCT00833794|9732425|FG001|Entered run-in Period|Open-label Phase||0
8687791|NCT00833794|9732424|FG000|Received Open-Label Treatment|Open-label Phase||1023
8687792|NCT00833794|9732425|FG001|Received Open-Label Treatment|Open-label Phase||0
8687793|NCT00833794|9732424|FG000|COMPLETED|Open-label Phase|Randomized in double-blind phase|646
8687794|NCT00833794|9732425|FG001|COMPLETED|Open-label Phase||0
8687795|NCT00833794|9732424|FG000|NOT COMPLETED|Open-label Phase||382
8687796|NCT00833794|9732425|FG001|NOT COMPLETED|Open-label Phase||0
8687797|NCT00833794|9732424|FG000|STARTED|Double-blind Phase|Of the 646 patients who completed the Open-Label phase, 432 were randomized to Tramadol Once A Day|432
8687798|NCT00833794|9732425|FG001|STARTED|Double-blind Phase|Of the 646 patients who completed the Open-Label phase, 214 were randomized to Placebo|214
8687799|NCT00833794|9732424|FG000|COMPLETED|Double-blind Phase||326
8687800|NCT00833794|9732425|FG001|COMPLETED|Double-blind Phase||165
8687801|NCT00833794|9732424|FG000|NOT COMPLETED|Double-blind Phase||106
8687802|NCT00833794|9732425|FG001|NOT COMPLETED|Double-blind Phase||49
8687803|NCT00833833|9732439|FG000|STARTED|Phase 1 (as of 01 April 2011)||6
8687804|NCT00833833|9732440|FG001|STARTED|Phase 1 (as of 01 April 2011)||8
8687805|NCT00833833|9732441|FG002|STARTED|Phase 1 (as of 01 April 2011)||14
8687806|NCT00833833|9732442|FG003|STARTED|Phase 1 (as of 01 April 2011)||10
8687807|NCT00833833|9732443|FG004|STARTED|Phase 1 (as of 01 April 2011)||0
8801755|NCT01451775|9853666|FG003|COMPLETED|Overall Study||3
8801756|NCT01451775|9853667|FG004|COMPLETED|Overall Study||3
8801757|NCT01451775|9853668|FG005|COMPLETED|Overall Study||3
8801758|NCT01451775|9853663|FG000|NOT COMPLETED|Overall Study||0
8801759|NCT01451775|9853664|FG001|NOT COMPLETED|Overall Study||0
8801760|NCT01451775|9853665|FG002|NOT COMPLETED|Overall Study||0
8801761|NCT01451775|9853666|FG003|NOT COMPLETED|Overall Study||0
8801762|NCT01451775|9853667|FG004|NOT COMPLETED|Overall Study||0
8687808|NCT00833833|9732444|FG005|STARTED|Phase 1 (as of 01 April 2011)||0
8687809|NCT00833833|9732439|FG000|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|2
8687810|NCT00833833|9732440|FG001|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|3
8687811|NCT00833833|9732441|FG002|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|5
8687812|NCT00833833|9732442|FG003|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|4
8687813|NCT00833833|9732443|FG004|COMPLETED|Phase 1 (as of 01 April 2011)||0
8687814|NCT00833833|9732444|FG005|COMPLETED|Phase 1 (as of 01 April 2011)||0
8687815|NCT00833833|9732439|FG000|NOT COMPLETED|Phase 1 (as of 01 April 2011)||4
8687816|NCT00833833|9732440|FG001|NOT COMPLETED|Phase 1 (as of 01 April 2011)||5
8687817|NCT00833833|9732441|FG002|NOT COMPLETED|Phase 1 (as of 01 April 2011)||9
8687818|NCT00833833|9732442|FG003|NOT COMPLETED|Phase 1 (as of 01 April 2011)||6
8687819|NCT00833833|9732443|FG004|NOT COMPLETED|Phase 1 (as of 01 April 2011)||0
8687820|NCT00833833|9732444|FG005|NOT COMPLETED|Phase 1 (as of 01 April 2011)||0
8687821|NCT00833833|9732439|FG000|STARTED|Phase 2 (as of 01 April 2011)||0
8687822|NCT00833833|9732440|FG001|STARTED|Phase 2 (as of 01 April 2011)||0
8687823|NCT00833833|9732441|FG002|STARTED|Phase 2 (as of 01 April 2011)||0
8687824|NCT00833833|9732442|FG003|STARTED|Phase 2 (as of 01 April 2011)||0
8687825|NCT00833833|9732443|FG004|STARTED|Phase 2 (as of 01 April 2011)||113
8687826|NCT00833833|9732444|FG005|STARTED|Phase 2 (as of 01 April 2011)||108
8687827|NCT00833833|9732439|FG000|Safety Population|Phase 2 (as of 01 April 2011)||0
8687828|NCT00833833|9732440|FG001|Safety Population|Phase 2 (as of 01 April 2011)||0
8687829|NCT00833833|9732441|FG002|Safety Population|Phase 2 (as of 01 April 2011)||0
8687830|NCT00833833|9732442|FG003|Safety Population|Phase 2 (as of 01 April 2011)||0
8687831|NCT00833833|9732443|FG004|Safety Population|Phase 2 (as of 01 April 2011)||112
8687832|NCT00833833|9732444|FG005|Safety Population|Phase 2 (as of 01 April 2011)||107
8687833|NCT00833833|9732439|FG000|COMPLETED|Phase 2 (as of 01 April 2011)||0
8687834|NCT00833833|9732440|FG001|COMPLETED|Phase 2 (as of 01 April 2011)||0
8687835|NCT00833833|9732441|FG002|COMPLETED|Phase 2 (as of 01 April 2011)||0
8687836|NCT00833833|9732442|FG003|COMPLETED|Phase 2 (as of 01 April 2011)||0
8687837|NCT00833833|9732443|FG004|COMPLETED|Phase 2 (as of 01 April 2011)|Confirmed progressive disease|58
8687838|NCT00833833|9732444|FG005|COMPLETED|Phase 2 (as of 01 April 2011)|Confirmed progressive disease|47
8687839|NCT00833833|9732439|FG000|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
8687840|NCT00833833|9732440|FG001|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
8687841|NCT00833833|9732441|FG002|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
8687842|NCT00833833|9732442|FG003|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
8687843|NCT00833833|9732443|FG004|NOT COMPLETED|Phase 2 (as of 01 April 2011)||55
8687844|NCT00833833|9732444|FG005|NOT COMPLETED|Phase 2 (as of 01 April 2011)||61
8687845|NCT00833898|9732466|FG000|STARTED|Overall Study||74
8687846|NCT00833898|9732467|FG001|STARTED|Overall Study||74
8687847|NCT00833898|9732466|FG000|Month 1 (Post Transplantation)|Overall Study||72
8687848|NCT00833898|9732467|FG001|Month 1 (Post Transplantation)|Overall Study||74
8687849|NCT00833898|9732466|FG000|Month 3 (Post Transplantation)|Overall Study||66
8687850|NCT00833898|9732467|FG001|Month 3 (Post Transplantation)|Overall Study||64
8687851|NCT00833898|9732466|FG000|Month 6 (Post Transplantation)|Overall Study||59
8687852|NCT00833898|9732467|FG001|Month 6 (Post Transplantation)|Overall Study||54
8687853|NCT00833898|9732466|FG000|Month 12 (Post Transplantation)|Overall Study||50
8687854|NCT00833898|9732467|FG001|Month 12 (Post Transplantation)|Overall Study||50
8687855|NCT00833898|9732466|FG000|COMPLETED|Overall Study||34
8687856|NCT00833898|9732467|FG001|COMPLETED|Overall Study||38
8687857|NCT00833898|9732466|FG000|NOT COMPLETED|Overall Study||40
8687858|NCT00833898|9732467|FG001|NOT COMPLETED|Overall Study||36
8687859|NCT00833911|9732473|FG000|STARTED|Titration||392
8687860|NCT00833911|9732473|FG000|COMPLETED|Titration||371
8687861|NCT00833911|9732473|FG000|NOT COMPLETED|Titration||21
8687862|NCT00833911|9732473|FG000|STARTED|Maintenance Phase I||371
8687863|NCT00833911|9732473|FG000|COMPLETED|Maintenance Phase I||273
8687864|NCT00833911|9732473|FG000|NOT COMPLETED|Maintenance Phase I||98
8687865|NCT00833911|9732473|FG000|STARTED|Maintenance Phase II|97 patients chose not to continue into Maintenance Phase II|176
8687866|NCT00833911|9732473|FG000|COMPLETED|Maintenance Phase II||166
8687867|NCT00833911|9732473|FG000|NOT COMPLETED|Maintenance Phase II||10
8687868|NCT00833924|9732481|FG000|STARTED|Overall Study||120
8687869|NCT00833924|9732481|FG000|30-day|Overall Study||120
8687870|NCT00833924|9732481|FG000|12-month|Overall Study||113
8687871|NCT00833924|9732481|FG000|COMPLETED|Overall Study||11
8687872|NCT00833924|9732481|FG000|NOT COMPLETED|Overall Study||109
8693357|NCT00866294|9738813|FG000|STARTED|Overall Study||172
8693358|NCT00866294|9738814|FG001|STARTED|Overall Study||161
8693359|NCT00866294|9738815|FG002|STARTED|Overall Study||83
8693360|NCT00866294|9738813|FG000|COMPLETED|Overall Study||139
8693361|NCT00866294|9738814|FG001|COMPLETED|Overall Study||141
8693362|NCT00866294|9738815|FG002|COMPLETED|Overall Study||72
8693363|NCT00866294|9738813|FG000|NOT COMPLETED|Overall Study||33
8693364|NCT00866294|9738814|FG001|NOT COMPLETED|Overall Study||20
8801763|NCT01451775|9853668|FG005|NOT COMPLETED|Overall Study||0
8693365|NCT00866294|9738815|FG002|NOT COMPLETED|Overall Study||11
8693366|NCT00866307|9738831|FG000|STARTED|Induction||104
8693367|NCT00866307|9738832|FG001|STARTED|Induction||0
8693368|NCT00866307|9738833|FG002|STARTED|Induction||0
8693369|NCT00866307|9738831|FG000|COMPLETED|Induction||84
8693370|NCT00866307|9738832|FG001|COMPLETED|Induction||0
8693371|NCT00866307|9738833|FG002|COMPLETED|Induction||0
8687873|NCT00833976|9732485|FG000|STARTED|Overall Study||65
8687874|NCT00833976|9732485|FG000|COMPLETED|Overall Study||14
8687875|NCT00833976|9732485|FG000|NOT COMPLETED|Overall Study||51
8687876|NCT00833989|9732493|FG000|STARTED|Overall Study||17
8687877|NCT00833989|9732494|FG001|STARTED|Overall Study||8
8687878|NCT00833989|9732495|FG002|STARTED|Overall Study||9
8687879|NCT00833989|9732496|FG003|STARTED|Overall Study||8
8687880|NCT00833989|9732493|FG000|COMPLETED|Overall Study||14
8687881|NCT00833989|9732494|FG001|COMPLETED|Overall Study||8
8687882|NCT00833989|9732495|FG002|COMPLETED|Overall Study||8
8687883|NCT00833989|9732496|FG003|COMPLETED|Overall Study||6
8687884|NCT00833989|9732493|FG000|NOT COMPLETED|Overall Study||3
8687885|NCT00833989|9732494|FG001|NOT COMPLETED|Overall Study||0
8687886|NCT00833989|9732495|FG002|NOT COMPLETED|Overall Study||1
8687887|NCT00833989|9732496|FG003|NOT COMPLETED|Overall Study||2
8687888|NCT00834041|9732511|FG000|STARTED|Overall Study||19
8687889|NCT00834041|9732512|FG001|STARTED|Overall Study||20
8687890|NCT00834041|9732511|FG000|COMPLETED|Overall Study||18
8687891|NCT00834041|9732512|FG001|COMPLETED|Overall Study||19
8687892|NCT00834041|9732511|FG000|NOT COMPLETED|Overall Study||1
8687893|NCT00834041|9732512|FG001|NOT COMPLETED|Overall Study||1
8687894|NCT00834080|9732518|FG000|STARTED|Overall Study||38
8687895|NCT00834080|9732518|FG000|COMPLETED|Overall Study||15
8687896|NCT00834080|9732518|FG000|NOT COMPLETED|Overall Study||23
8687897|NCT00834106|9732524|FG000|STARTED|Base Study (Day 1 to Month 30)|Randomized participants|1503
8687898|NCT00834106|9732525|FG001|STARTED|Base Study (Day 1 to Month 30)|Randomized participants|1503
8687899|NCT00834106|9732524|FG000|Vaccinated|Base Study (Day 1 to Month 30)||1503
8687900|NCT00834106|9732525|FG001|Vaccinated|Base Study (Day 1 to Month 30)||1503
8687901|NCT00834106|9732524|FG000|Completed Vaccinations|Base Study (Day 1 to Month 30)||1473
8687902|NCT00834106|9732525|FG001|Completed Vaccinations|Base Study (Day 1 to Month 30)||1463
8687903|NCT00834106|9732524|FG000|COMPLETED|Base Study (Day 1 to Month 30)|Completed Month 30 follow-up|1401
8687904|NCT00834106|9732525|FG001|COMPLETED|Base Study (Day 1 to Month 30)|Completed Month 30 follow-up|1358
8687905|NCT00834106|9732524|FG000|NOT COMPLETED|Base Study (Day 1 to Month 30)||102
8687906|NCT00834106|9732525|FG001|NOT COMPLETED|Base Study (Day 1 to Month 30)||145
8687907|NCT00834106|9732524|FG000|STARTED|Extension Study (Month 42 to Month 90)|Some participants missed the Month 30 visit but returned for the Month 42 visit|1404
8687908|NCT00834106|9732525|FG001|STARTED|Extension Study (Month 42 to Month 90)|Some participants missed the Month 30 visit but returned for the Month 42 visit|1368
8687909|NCT00834106|9732524|FG000|COMPLETED|Extension Study (Month 42 to Month 90)||1308
8687910|NCT00834106|9732525|FG001|COMPLETED|Extension Study (Month 42 to Month 90)||1294
8687911|NCT00834106|9732524|FG000|NOT COMPLETED|Extension Study (Month 42 to Month 90)||96
8687912|NCT00834106|9732525|FG001|NOT COMPLETED|Extension Study (Month 42 to Month 90)||74
8687913|NCT00834171|9732533|FG000|STARTED|Overall Study||43
8687914|NCT00834171|9732534|FG001|STARTED|Overall Study||7
8687915|NCT00834171|9732533|FG000|COMPLETED|Overall Study||43
8687916|NCT00834171|9732534|FG001|COMPLETED|Overall Study||7
8687917|NCT00834171|9732533|FG000|NOT COMPLETED|Overall Study||0
8687918|NCT00834171|9732534|FG001|NOT COMPLETED|Overall Study||0
8687919|NCT00834210|9732542|FG000|STARTED|Overall Study||86
8687920|NCT00834210|9732543|FG001|STARTED|Overall Study||85
8687921|NCT00834210|9732542|FG000|COMPLETED|Overall Study||83
8687922|NCT00834210|9732543|FG001|COMPLETED|Overall Study||77
8687923|NCT00834210|9732542|FG000|NOT COMPLETED|Overall Study||3
8687924|NCT00834210|9732543|FG001|NOT COMPLETED|Overall Study||8
8687925|NCT00834236|9732551|FG000|STARTED|Overall Study||29
8687926|NCT00834236|9732552|FG001|STARTED|Overall Study||47
8687927|NCT00834236|9732551|FG000|COMPLETED|Overall Study||29
8687928|NCT00834236|9732552|FG001|COMPLETED|Overall Study||47
8687929|NCT00834236|9732551|FG000|NOT COMPLETED|Overall Study||0
8687930|NCT00834236|9732552|FG001|NOT COMPLETED|Overall Study||0
8687931|NCT00834288|9732560|FG000|STARTED|Treatment Phase I||13
8687932|NCT00834288|9732561|FG001|STARTED|Treatment Phase I||13
8687933|NCT00834288|9732560|FG000|COMPLETED|Treatment Phase I||13
8687934|NCT00834288|9732561|FG001|COMPLETED|Treatment Phase I||13
8687935|NCT00834288|9732560|FG000|NOT COMPLETED|Treatment Phase I||0
8687936|NCT00834288|9732561|FG001|NOT COMPLETED|Treatment Phase I||0
8687937|NCT00834288|9732560|FG000|STARTED|Treatment Phase II||13
8687938|NCT00834288|9732561|FG001|STARTED|Treatment Phase II||13
8687939|NCT00834288|9732560|FG000|COMPLETED|Treatment Phase II||13
8687940|NCT00834288|9732561|FG001|COMPLETED|Treatment Phase II||13
8687941|NCT00834288|9732560|FG000|NOT COMPLETED|Treatment Phase II||0
8687942|NCT00834288|9732561|FG001|NOT COMPLETED|Treatment Phase II||0
8687943|NCT00834366|9732569|FG000|STARTED|Treatment Period 1||13
8687944|NCT00834366|9732570|FG001|STARTED|Treatment Period 1||13
8687945|NCT00834366|9732569|FG000|COMPLETED|Treatment Period 1||12
8687946|NCT00834366|9732570|FG001|COMPLETED|Treatment Period 1||12
8687947|NCT00834366|9732569|FG000|NOT COMPLETED|Treatment Period 1||1
8687948|NCT00834366|9732570|FG001|NOT COMPLETED|Treatment Period 1||1
8687949|NCT00834366|9732569|FG000|STARTED|Treatment Period 2||12
8687950|NCT00834366|9732570|FG001|STARTED|Treatment Period 2||12
8687951|NCT00834366|9732569|FG000|COMPLETED|Treatment Period 2||12
8687952|NCT00834366|9732570|FG001|COMPLETED|Treatment Period 2||12
8687953|NCT00834366|9732569|FG000|NOT COMPLETED|Treatment Period 2||0
8687954|NCT00834366|9732570|FG001|NOT COMPLETED|Treatment Period 2||0
8687955|NCT00834483|9732578|FG000|STARTED|Overall Study||31
8687956|NCT00834483|9732579|FG001|STARTED|Overall Study||29
8687957|NCT00834483|9732578|FG000|COMPLETED|Overall Study||31
8687958|NCT00834483|9732579|FG001|COMPLETED|Overall Study||29
8687959|NCT00834483|9732578|FG000|NOT COMPLETED|Overall Study||0
8687960|NCT00834483|9732579|FG001|NOT COMPLETED|Overall Study||0
8687961|NCT00834626|9732585|FG000|STARTED|Overall Study||30
8687962|NCT00834626|9732585|FG000|1 Year Follow-up|Overall Study||30
8687963|NCT00834626|9732585|FG000|COMPLETED|Overall Study||30
8687964|NCT00834626|9732585|FG000|NOT COMPLETED|Overall Study||0
8687965|NCT00834652|9732592|FG000|STARTED|Overall Study||104
8687966|NCT00834652|9732593|FG001|STARTED|Overall Study||102
8687967|NCT00834652|9732592|FG000|COMPLETED|Overall Study||66
8687968|NCT00834652|9732593|FG001|COMPLETED|Overall Study||62
8687969|NCT00834652|9732592|FG000|NOT COMPLETED|Overall Study||38
8687970|NCT00834652|9732593|FG001|NOT COMPLETED|Overall Study||40
8687971|NCT00834678|9732599|FG000|STARTED|Overall Study||11
8687972|NCT00834678|9732599|FG000|COMPLETED|Overall Study||11
8687973|NCT00834678|9732599|FG000|NOT COMPLETED|Overall Study||0
8687974|NCT00834808|9732608|FG000|STARTED|Treatment Period 1 (Day 1)||9
8687975|NCT00834808|9732609|FG001|STARTED|Treatment Period 1 (Day 1)||9
8687976|NCT00834808|9732610|FG002|STARTED|Treatment Period 1 (Day 1)||9
8687977|NCT00834808|9732608|FG000|COMPLETED|Treatment Period 1 (Day 1)||9
8687978|NCT00834808|9732609|FG001|COMPLETED|Treatment Period 1 (Day 1)||9
8687979|NCT00834808|9732610|FG002|COMPLETED|Treatment Period 1 (Day 1)||9
8687980|NCT00834808|9732608|FG000|NOT COMPLETED|Treatment Period 1 (Day 1)||0
8687981|NCT00834808|9732609|FG001|NOT COMPLETED|Treatment Period 1 (Day 1)||0
8687982|NCT00834808|9732610|FG002|NOT COMPLETED|Treatment Period 1 (Day 1)||0
8687983|NCT00834808|9732608|FG000|STARTED|Treatment Period 2 (Day 8)||9
8687984|NCT00834808|9732609|FG001|STARTED|Treatment Period 2 (Day 8)||9
8687985|NCT00834808|9732610|FG002|STARTED|Treatment Period 2 (Day 8)||9
8687986|NCT00834808|9732608|FG000|COMPLETED|Treatment Period 2 (Day 8)||9
8687987|NCT00834808|9732609|FG001|COMPLETED|Treatment Period 2 (Day 8)||9
8687988|NCT00834808|9732610|FG002|COMPLETED|Treatment Period 2 (Day 8)||9
8687989|NCT00834808|9732608|FG000|NOT COMPLETED|Treatment Period 2 (Day 8)||0
9035711|NCT03301714|10097430|FG001|NOT COMPLETED|Overall Study||6
9035712|NCT03301714|10097431|FG002|NOT COMPLETED|Overall Study||7
9035713|NCT03301740|10097444|FG000|STARTED|Phase 1 Intervention (3 Weeks)||18
9035714|NCT03301740|10097445|FG001|STARTED|Phase 1 Intervention (3 Weeks)||16
9035715|NCT03301740|10097444|FG000|COMPLETED|Phase 1 Intervention (3 Weeks)||18
9035716|NCT03301740|10097445|FG001|COMPLETED|Phase 1 Intervention (3 Weeks)||16
9035717|NCT03301740|10097444|FG000|NOT COMPLETED|Phase 1 Intervention (3 Weeks)||0
9035718|NCT03301740|10097445|FG001|NOT COMPLETED|Phase 1 Intervention (3 Weeks)||0
9035719|NCT03301740|10097444|FG000|STARTED|First Washout (1 Week)||18
9035720|NCT03301740|10097445|FG001|STARTED|First Washout (1 Week)||16
8687990|NCT00834808|9732609|FG001|NOT COMPLETED|Treatment Period 2 (Day 8)||0
8687991|NCT00834808|9732610|FG002|NOT COMPLETED|Treatment Period 2 (Day 8)||0
8687992|NCT00834808|9732608|FG000|STARTED|Treatment Period 3 (Day 15)||9
8687993|NCT00834808|9732609|FG001|STARTED|Treatment Period 3 (Day 15)||9
8687994|NCT00834808|9732610|FG002|STARTED|Treatment Period 3 (Day 15)||9
8687995|NCT00834808|9732608|FG000|COMPLETED|Treatment Period 3 (Day 15)||9
8687996|NCT00834808|9732609|FG001|COMPLETED|Treatment Period 3 (Day 15)||9
8687997|NCT00834808|9732610|FG002|COMPLETED|Treatment Period 3 (Day 15)||9
8687998|NCT00834808|9732608|FG000|NOT COMPLETED|Treatment Period 3 (Day 15)||0
8687999|NCT00834808|9732609|FG001|NOT COMPLETED|Treatment Period 3 (Day 15)||0
8688000|NCT00834808|9732610|FG002|NOT COMPLETED|Treatment Period 3 (Day 15)||0
8688001|NCT00834834|9732620|FG000|STARTED|Overall Study||42
8688002|NCT00834834|9732621|FG001|STARTED|Overall Study||42
8688003|NCT00834834|9732620|FG000|COMPLETED|Overall Study||38
8688004|NCT00834834|9732621|FG001|COMPLETED|Overall Study||39
8688005|NCT00834834|9732620|FG000|NOT COMPLETED|Overall Study||4
8688006|NCT00834834|9732621|FG001|NOT COMPLETED|Overall Study||3
8688007|NCT00834886|9732631|FG000|STARTED|Overall Study||10
8688008|NCT00834886|9732632|FG001|STARTED|Overall Study||10
8688009|NCT00834886|9732633|FG002|STARTED|Overall Study||10
8688010|NCT00834886|9732634|FG003|STARTED|Overall Study||10
8688011|NCT00834886|9732631|FG000|COMPLETED|Overall Study||10
8688012|NCT00834886|9732632|FG001|COMPLETED|Overall Study||9
8688013|NCT00834886|9732633|FG002|COMPLETED|Overall Study||9
8688014|NCT00834886|9732634|FG003|COMPLETED|Overall Study||10
8688015|NCT00834886|9732631|FG000|NOT COMPLETED|Overall Study||0
8688016|NCT00834886|9732632|FG001|NOT COMPLETED|Overall Study||1
8688017|NCT00834886|9732633|FG002|NOT COMPLETED|Overall Study||1
8688018|NCT00834886|9732634|FG003|NOT COMPLETED|Overall Study||0
8688019|NCT00834899|9732646|FG000|STARTED|Overall Study||9
8688020|NCT00834899|9732647|FG001|STARTED|Overall Study||4
8688021|NCT00834899|9732646|FG000|COMPLETED|Overall Study|One patient withdrew consent following completion of the study drug infusion.|8
8688022|NCT00834899|9732647|FG001|COMPLETED|Overall Study|One patient was withdrawn early because she did not meet eligibility criteria.|3
8688023|NCT00834899|9732646|FG000|NOT COMPLETED|Overall Study||1
8801764|NCT01451814|9853678|FG000|STARTED|Overall Study||35
8688024|NCT00834899|9732647|FG001|NOT COMPLETED|Overall Study||1
8688025|NCT00834912|9732659|FG000|STARTED|Treatment Period 1||6
8688026|NCT00834912|9732660|FG001|STARTED|Treatment Period 1||6
8688027|NCT00834912|9732661|FG002|STARTED|Treatment Period 1||6
8688028|NCT00834912|9732662|FG003|STARTED|Treatment Period 1||6
8688029|NCT00834912|9732663|FG004|STARTED|Treatment Period 1||6
8688030|NCT00834912|9732664|FG005|STARTED|Treatment Period 1||6
9035721|NCT03301740|10097444|FG000|COMPLETED|First Washout (1 Week)||18
8688031|NCT00834912|9732659|FG000|COMPLETED|Treatment Period 1||6
8688032|NCT00834912|9732660|FG001|COMPLETED|Treatment Period 1|One subject completed all of treatment period 1 assessments but did not enter treatment period 2|5
8688033|NCT00834912|9732661|FG002|COMPLETED|Treatment Period 1||6
8688034|NCT00834912|9732662|FG003|COMPLETED|Treatment Period 1|One subject completed all of treatment period 1 assessments but did not enter treatment period 2|5
8688035|NCT00834912|9732663|FG004|COMPLETED|Treatment Period 1||6
8688036|NCT00834912|9732664|FG005|COMPLETED|Treatment Period 1||6
8688037|NCT00834912|9732659|FG000|NOT COMPLETED|Treatment Period 1||0
8688038|NCT00834912|9732660|FG001|NOT COMPLETED|Treatment Period 1||1
8688039|NCT00834912|9732661|FG002|NOT COMPLETED|Treatment Period 1||0
8688040|NCT00834912|9732662|FG003|NOT COMPLETED|Treatment Period 1||1
8688041|NCT00834912|9732663|FG004|NOT COMPLETED|Treatment Period 1||0
8688042|NCT00834912|9732664|FG005|NOT COMPLETED|Treatment Period 1||0
8688043|NCT00834912|9732659|FG000|STARTED|Treatment Period 2||6
8688044|NCT00834912|9732660|FG001|STARTED|Treatment Period 2||5
8688045|NCT00834912|9732661|FG002|STARTED|Treatment Period 2||6
8688046|NCT00834912|9732662|FG003|STARTED|Treatment Period 2||5
8688047|NCT00834912|9732663|FG004|STARTED|Treatment Period 2||6
8688048|NCT00834912|9732664|FG005|STARTED|Treatment Period 2||6
8688049|NCT00834912|9732659|FG000|COMPLETED|Treatment Period 2||6
8688050|NCT00834912|9732660|FG001|COMPLETED|Treatment Period 2||5
8688051|NCT00834912|9732661|FG002|COMPLETED|Treatment Period 2|One subject completed treatment period 2 but did not enter treatment period 3|5
8688052|NCT00834912|9732662|FG003|COMPLETED|Treatment Period 2||5
8688053|NCT00834912|9732663|FG004|COMPLETED|Treatment Period 2|One subject completed treatment period 2 but did not enter treatment period 3|5
8688054|NCT00834912|9732664|FG005|COMPLETED|Treatment Period 2||6
8688055|NCT00834912|9732659|FG000|NOT COMPLETED|Treatment Period 2||0
8688056|NCT00834912|9732660|FG001|NOT COMPLETED|Treatment Period 2||0
8688057|NCT00834912|9732661|FG002|NOT COMPLETED|Treatment Period 2||1
8688058|NCT00834912|9732662|FG003|NOT COMPLETED|Treatment Period 2||0
8688059|NCT00834912|9732663|FG004|NOT COMPLETED|Treatment Period 2||1
8688060|NCT00834912|9732664|FG005|NOT COMPLETED|Treatment Period 2||0
8688061|NCT00834912|9732659|FG000|STARTED|Treatment Period 3||6
8688062|NCT00834912|9732660|FG001|STARTED|Treatment Period 3||5
8688063|NCT00834912|9732661|FG002|STARTED|Treatment Period 3||5
8688064|NCT00834912|9732662|FG003|STARTED|Treatment Period 3||5
8688065|NCT00834912|9732663|FG004|STARTED|Treatment Period 3||5
8688066|NCT00834912|9732664|FG005|STARTED|Treatment Period 3||6
8688067|NCT00834912|9732659|FG000|COMPLETED|Treatment Period 3||6
8688068|NCT00834912|9732660|FG001|COMPLETED|Treatment Period 3||5
8688069|NCT00834912|9732661|FG002|COMPLETED|Treatment Period 3||5
8688070|NCT00834912|9732662|FG003|COMPLETED|Treatment Period 3||5
8688071|NCT00834912|9732663|FG004|COMPLETED|Treatment Period 3||5
8688072|NCT00834912|9732664|FG005|COMPLETED|Treatment Period 3||6
8688073|NCT00834912|9732659|FG000|NOT COMPLETED|Treatment Period 3||0
8688074|NCT00834912|9732660|FG001|NOT COMPLETED|Treatment Period 3||0
8688075|NCT00834912|9732661|FG002|NOT COMPLETED|Treatment Period 3||0
8688076|NCT00834912|9732662|FG003|NOT COMPLETED|Treatment Period 3||0
8688077|NCT00834912|9732663|FG004|NOT COMPLETED|Treatment Period 3||0
8688078|NCT00834912|9732664|FG005|NOT COMPLETED|Treatment Period 3||0
8688079|NCT00835003|9732674|FG000|STARTED|Overall Study||636
8688080|NCT00835003|9732675|FG001|STARTED|Overall Study||638
8688081|NCT00835003|9732674|FG000|COMPLETED|Overall Study||636
8688082|NCT00835003|9732675|FG001|COMPLETED|Overall Study||638
8688083|NCT00835003|9732674|FG000|NOT COMPLETED|Overall Study||0
8688084|NCT00835003|9732675|FG001|NOT COMPLETED|Overall Study||0
8688085|NCT00835068|9732683|FG000|STARTED|Overall Study||57
8688086|NCT00835068|9732684|FG001|STARTED|Overall Study||1
8688087|NCT00835068|9732683|FG000|COMPLETED|Overall Study||47
8688088|NCT00835068|9732684|FG001|COMPLETED|Overall Study||0
8688089|NCT00835068|9732683|FG000|NOT COMPLETED|Overall Study||10
8688090|NCT00835068|9732684|FG001|NOT COMPLETED|Overall Study||1
8688091|NCT00835120|9732690|FG000|STARTED|Overall Study||34
8688092|NCT00835120|9732690|FG000|COMPLETED|Overall Study||26
8688093|NCT00835120|9732690|FG000|NOT COMPLETED|Overall Study||8
8688094|NCT00835159|9732696|FG000|STARTED|Overall Study||11
8688095|NCT00835159|9732697|FG001|STARTED|Overall Study||17
8688096|NCT00835159|9732696|FG000|COMPLETED|Overall Study||11
8688097|NCT00835159|9732697|FG001|COMPLETED|Overall Study||17
8688098|NCT00835159|9732696|FG000|NOT COMPLETED|Overall Study||0
8688099|NCT00835159|9732697|FG001|NOT COMPLETED|Overall Study||0
8688100|NCT00835185|9732703|FG000|STARTED|Overall Study||44
8688101|NCT00835185|9732703|FG000|Received at Least 1 Dose of Study Drug|Overall Study||44
8688102|NCT00835185|9732703|FG000|COMPLETED|Overall Study||44
8688103|NCT00835185|9732703|FG000|NOT COMPLETED|Overall Study||0
8688104|NCT00835198|9732710|FG000|STARTED|Overall Study||82
8688105|NCT00835198|9732711|FG001|STARTED|Overall Study||81
8688106|NCT00835198|9732710|FG000|COMPLETED|Overall Study||74
8688107|NCT00835198|9732711|FG001|COMPLETED|Overall Study||74
8688108|NCT00835198|9732710|FG000|NOT COMPLETED|Overall Study||8
8688109|NCT00835198|9732711|FG001|NOT COMPLETED|Overall Study||7
8688110|NCT00835224|9732717|FG000|STARTED|Overall Study||34
8688111|NCT00835224|9732717|FG000|COMPLETED|Overall Study||24
8688112|NCT00835224|9732717|FG000|NOT COMPLETED|Overall Study||10
8688113|NCT00835237|9732733|FG000|STARTED|Overall Study||887
8688114|NCT00835237|9732734|FG001|STARTED|Overall Study||445
8688115|NCT00835237|9732733|FG000|COMPLETED|Overall Study||881
8688116|NCT00835237|9732734|FG001|COMPLETED|Overall Study||445
8688117|NCT00835237|9732733|FG000|NOT COMPLETED|Overall Study||6
8688118|NCT00835237|9732734|FG001|NOT COMPLETED|Overall Study||0
8688119|NCT00835341|9732742|FG000|STARTED|Overall Study||35
8688120|NCT00835341|9732743|FG001|STARTED|Overall Study||58
8688121|NCT00835341|9732742|FG000|COMPLETED|Overall Study||32
8688122|NCT00835341|9732743|FG001|COMPLETED|Overall Study||46
8688123|NCT00835341|9732742|FG000|NOT COMPLETED|Overall Study||3
8688124|NCT00835341|9732743|FG001|NOT COMPLETED|Overall Study||12
8688125|NCT00835380|9732749|FG000|STARTED|Overall Study||80
8688126|NCT00835380|9732749|FG000|COMPLETED|Overall Study||78
8688127|NCT00835380|9732749|FG000|NOT COMPLETED|Overall Study||2
8688128|NCT00835510|9732756|FG000|STARTED|Overall Study||219
8688129|NCT00835510|9732757|FG001|STARTED|Overall Study||221
8688130|NCT00835510|9732758|FG002|STARTED|Overall Study||108
8688131|NCT00835510|9732756|FG000|Positive Fungal Culture|Overall Study||149
8688132|NCT00835510|9732757|FG001|Positive Fungal Culture|Overall Study||155
8688133|NCT00835510|9732758|FG002|Positive Fungal Culture|Overall Study||71
8688134|NCT00835510|9732756|FG000|COMPLETED|Overall Study||143
8688135|NCT00835510|9732757|FG001|COMPLETED|Overall Study||152
8688136|NCT00835510|9732758|FG002|COMPLETED|Overall Study||70
8688137|NCT00835510|9732756|FG000|NOT COMPLETED|Overall Study||76
8688138|NCT00835510|9732757|FG001|NOT COMPLETED|Overall Study||69
8688139|NCT00835510|9732758|FG002|NOT COMPLETED|Overall Study||38
8688140|NCT00835731|9732768|FG000|STARTED|Overall Study||64
8688141|NCT00835731|9732769|FG001|STARTED|Overall Study||61
8688142|NCT00835731|9732768|FG000|COMPLETED|Overall Study||62
8688143|NCT00835731|9732769|FG001|COMPLETED|Overall Study||60
8688144|NCT00835731|9732768|FG000|NOT COMPLETED|Overall Study||2
8688145|NCT00835731|9732769|FG001|NOT COMPLETED|Overall Study||1
8688146|NCT00835770|9732777|FG000|STARTED|Overall Study||868
8688147|NCT00835770|9732778|FG001|STARTED|Overall Study||868
8688148|NCT00835770|9732777|FG000|COMPLETED|Overall Study||384
8688149|NCT00835770|9732778|FG001|COMPLETED|Overall Study||375
8688150|NCT00835770|9732777|FG000|NOT COMPLETED|Overall Study||484
8688151|NCT00835770|9732778|FG001|NOT COMPLETED|Overall Study||493
8688152|NCT00835861|9732792|FG000|STARTED|Overall Study||15
8688153|NCT00835861|9732793|FG001|STARTED|Overall Study||16
8688154|NCT00835861|9732792|FG000|COMPLETED|Overall Study||14
8688155|NCT00835861|9732793|FG001|COMPLETED|Overall Study||14
8688156|NCT00835861|9732792|FG000|NOT COMPLETED|Overall Study||1
8688157|NCT00835861|9732793|FG001|NOT COMPLETED|Overall Study||2
8688158|NCT00835900|9732801|FG000|STARTED|Overall Study||32
8688159|NCT00835900|9732802|FG001|STARTED|Overall Study||28
8688160|NCT00835900|9732801|FG000|COMPLETED|Overall Study||27
8688161|NCT00835900|9732802|FG001|COMPLETED|Overall Study||22
8688162|NCT00835900|9732801|FG000|NOT COMPLETED|Overall Study||5
8688163|NCT00835900|9732802|FG001|NOT COMPLETED|Overall Study||6
8688164|NCT00835926|9732810|FG000|STARTED|Overall Study||61
8688165|NCT00835926|9732811|FG001|STARTED|Overall Study||60
8688166|NCT00835926|9732810|FG000|COMPLETED|Overall Study||61
8688167|NCT00835926|9732811|FG001|COMPLETED|Overall Study||60
8688168|NCT00835926|9732810|FG000|NOT COMPLETED|Overall Study||0
8688169|NCT00835926|9732811|FG001|NOT COMPLETED|Overall Study||0
8688170|NCT00835978|9732821|FG000|STARTED|Overall Study||56
8688171|NCT00835978|9732822|FG001|STARTED|Overall Study||56
8688172|NCT00835978|9732823|FG002|STARTED|Overall Study||91
8688173|NCT00835978|9732824|FG003|STARTED|Overall Study||10
8688174|NCT00835978|9732821|FG000|Treated|Overall Study||56
8688175|NCT00835978|9732822|FG001|Treated|Overall Study||56
8688176|NCT00835978|9732823|FG002|Treated|Overall Study||91
8688177|NCT00835978|9732824|FG003|Treated|Overall Study||10
8688178|NCT00835978|9732821|FG000|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
8688179|NCT00835978|9732822|FG001|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
8688180|NCT00835978|9732823|FG002|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
8801765|NCT01451814|9853679|FG001|STARTED|Overall Study||31
8801766|NCT01451814|9853678|FG000|Attended a Session|Overall Study||35
8801767|NCT01451814|9853679|FG001|Attended a Session|Overall Study||31
8801768|NCT01451814|9853678|FG000|COMPLETED|Overall Study||29
8801769|NCT01451814|9853679|FG001|COMPLETED|Overall Study||26
8801770|NCT01451814|9853678|FG000|NOT COMPLETED|Overall Study||6
8801771|NCT01451814|9853679|FG001|NOT COMPLETED|Overall Study||5
8801772|NCT01451827|9853689|FG000|STARTED|Overall Study||45
8801773|NCT01451827|9853690|FG001|STARTED|Overall Study||45
8801774|NCT01451827|9853691|FG002|STARTED|Overall Study||44
8801775|NCT01451827|9853692|FG003|STARTED|Overall Study||43
8801776|NCT01451827|9853689|FG000|COMPLETED|Overall Study||42
8801777|NCT01451827|9853690|FG001|COMPLETED|Overall Study||40
8801778|NCT01451827|9853691|FG002|COMPLETED|Overall Study||42
8801779|NCT01451827|9853692|FG003|COMPLETED|Overall Study||39
8801780|NCT01451827|9853689|FG000|NOT COMPLETED|Overall Study||3
8801781|NCT01451827|9853690|FG001|NOT COMPLETED|Overall Study||5
8801782|NCT01451827|9853691|FG002|NOT COMPLETED|Overall Study||2
8801783|NCT01451827|9853692|FG003|NOT COMPLETED|Overall Study||4
8801784|NCT01451931|9853705|FG000|STARTED|Overall Study||909
8801785|NCT01451931|9853706|FG001|STARTED|Overall Study||901
8801786|NCT01451931|9853707|FG002|STARTED|Overall Study||966
8688181|NCT00835978|9732824|FG003|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
8688182|NCT00835978|9732821|FG000|NOT COMPLETED|Overall Study||56
8688183|NCT00835978|9732822|FG001|NOT COMPLETED|Overall Study||56
8688184|NCT00835978|9732823|FG002|NOT COMPLETED|Overall Study||91
8688185|NCT00835978|9732824|FG003|NOT COMPLETED|Overall Study||10
8688186|NCT00836017|9732839|FG000|STARTED|Overall Study||1046
8688187|NCT00836017|9732839|FG000|COMPLETED|Overall Study||502
8688188|NCT00836017|9732839|FG000|NOT COMPLETED|Overall Study||544
8688189|NCT00836095|9732845|FG000|STARTED|Overall Study||22
8688190|NCT00836095|9732846|FG001|STARTED|Overall Study||30
8688191|NCT00836095|9732845|FG000|COMPLETED|Overall Study||22
8688192|NCT00836095|9732846|FG001|COMPLETED|Overall Study||27
8688193|NCT00836095|9732845|FG000|NOT COMPLETED|Overall Study||0
8688194|NCT00836095|9732846|FG001|NOT COMPLETED|Overall Study||3
8688195|NCT00836186|9732852|FG000|STARTED|Overall Study||82
8688196|NCT00836186|9732852|FG000|COMPLETED|Overall Study||81
8688197|NCT00836186|9732852|FG000|NOT COMPLETED|Overall Study||1
8688198|NCT00836277|9732857|FG000|STARTED|Overall Study||24
8688199|NCT00836277|9732857|FG000|COMPLETED|Overall Study||18
8688200|NCT00836277|9732857|FG000|NOT COMPLETED|Overall Study||6
8688201|NCT00836342|9732864|FG000|STARTED|Overall Study||22
8688202|NCT00836342|9732865|FG001|STARTED|Overall Study||23
8688203|NCT00836342|9732866|FG002|STARTED|Overall Study||36
8688204|NCT00836342|9732864|FG000|COMPLETED|Overall Study||22
8688205|NCT00836342|9732865|FG001|COMPLETED|Overall Study||23
8688206|NCT00836342|9732866|FG002|COMPLETED|Overall Study||36
8688207|NCT00836342|9732864|FG000|NOT COMPLETED|Overall Study||0
8688208|NCT00836342|9732865|FG001|NOT COMPLETED|Overall Study||0
8688209|NCT00836342|9732866|FG002|NOT COMPLETED|Overall Study||0
8688210|NCT00836407|9732878|FG000|STARTED|Overall Study||15
8688211|NCT00836407|9732879|FG001|STARTED|Overall Study||15
8688212|NCT00836407|9732878|FG000|COMPLETED|Overall Study||4
8688213|NCT00836407|9732879|FG001|COMPLETED|Overall Study||7
8688214|NCT00836407|9732878|FG000|NOT COMPLETED|Overall Study||11
8688215|NCT00836407|9732879|FG001|NOT COMPLETED|Overall Study||8
8688216|NCT00836433|9732887|FG000|STARTED|Overall Study||361
8688217|NCT00836433|9732888|FG001|STARTED|Overall Study||328
8688218|NCT00836433|9732887|FG000|COMPLETED|Overall Study||349
8688219|NCT00836433|9732888|FG001|COMPLETED|Overall Study||321
8688220|NCT00836433|9732887|FG000|NOT COMPLETED|Overall Study||12
8688221|NCT00836433|9732888|FG001|NOT COMPLETED|Overall Study||7
8688222|NCT00836498|9732898|FG000|STARTED|Overall Study||44
8688223|NCT00836498|9732899|FG001|STARTED|Overall Study||22
8688224|NCT00836498|9732898|FG000|COMPLETED|Overall Study|Participant who discontinued the study vaccination due to AE completed the 180-day safety follow-up.|40
8688225|NCT00836498|9732899|FG001|COMPLETED|Overall Study||21
8801787|NCT01451931|9853705|FG000|Baseline Data Collection|Overall Study||908
8801788|NCT01451931|9853706|FG001|Baseline Data Collection|Overall Study||893
8801789|NCT01451931|9853707|FG002|Baseline Data Collection|Overall Study||958
8801790|NCT01451931|9853705|FG000|6-month Follow up|Overall Study||876
8801791|NCT01451931|9853706|FG001|6-month Follow up|Overall Study||843
8801792|NCT01451931|9853707|FG002|6-month Follow up|Overall Study||923
8801793|NCT01451931|9853705|FG000|COMPLETED|Overall Study||876
8801794|NCT01451931|9853706|FG001|COMPLETED|Overall Study||843
8801795|NCT01451931|9853707|FG002|COMPLETED|Overall Study||923
8801796|NCT01451931|9853705|FG000|NOT COMPLETED|Overall Study||33
8801797|NCT01451931|9853706|FG001|NOT COMPLETED|Overall Study||58
8801798|NCT01451931|9853707|FG002|NOT COMPLETED|Overall Study||43
8801799|NCT01451983|9853720|FG000|STARTED|Overall Study||26
8801800|NCT01451983|9853721|FG001|STARTED|Overall Study||27
8801801|NCT01451983|9853722|FG002|STARTED|Overall Study||61
8919684|NCT02208297|9979605|FG001|COMPLETED|Overall Study||107
8919685|NCT02208297|9979604|FG000|NOT COMPLETED|Overall Study||22
8919686|NCT02208297|9979605|FG001|NOT COMPLETED|Overall Study||56
8919687|NCT02208310|9979613|FG000|STARTED|Overall Study||6
8919688|NCT02208310|9979614|FG001|STARTED|Overall Study||5
8919689|NCT02208310|9979613|FG000|Day 180|Overall Study||0
8919690|NCT02208310|9979614|FG001|Day 180|Overall Study||1
8919691|NCT02208310|9979613|FG000|COMPLETED|Overall Study||0
8919692|NCT02208310|9979614|FG001|COMPLETED|Overall Study||0
8919693|NCT02208310|9979613|FG000|NOT COMPLETED|Overall Study||6
8919694|NCT02208310|9979614|FG001|NOT COMPLETED|Overall Study||5
8919695|NCT02208349|9979622|FG000|STARTED|Initial 6 Months||16
8919696|NCT02208349|9979623|FG001|STARTED|Initial 6 Months||9
8919697|NCT02208349|9979622|FG000|COMPLETED|Initial 6 Months||16
8919698|NCT02208349|9979623|FG001|COMPLETED|Initial 6 Months||9
8919699|NCT02208349|9979622|FG000|NOT COMPLETED|Initial 6 Months||0
8919700|NCT02208349|9979623|FG001|NOT COMPLETED|Initial 6 Months||0
8919701|NCT02208349|9979622|FG000|STARTED|Second 6 Months||11
8919702|NCT02208349|9979623|FG001|STARTED|Second 6 Months||7
8919703|NCT02208349|9979622|FG000|COMPLETED|Second 6 Months||11
8919704|NCT02208349|9979623|FG001|COMPLETED|Second 6 Months||7
8919705|NCT02208349|9979622|FG000|NOT COMPLETED|Second 6 Months||0
8919706|NCT02208349|9979623|FG001|NOT COMPLETED|Second 6 Months||0
8688226|NCT00836498|9732898|FG000|NOT COMPLETED|Overall Study||4
8688227|NCT00836498|9732899|FG001|NOT COMPLETED|Overall Study||1
8688228|NCT00836589|9732906|FG000|STARTED|Overall Study||1997
8688229|NCT00836589|9732906|FG000|COMPLETED|Overall Study||731
8801802|NCT01451983|9853723|FG003|STARTED|Overall Study||24
8919707|NCT02208349|9979622|FG000|STARTED|Third 6 Month||6
8919708|NCT02208349|9979623|FG001|STARTED|Third 6 Month||3
8919709|NCT02208349|9979622|FG000|COMPLETED|Third 6 Month||6
8919710|NCT02208349|9979623|FG001|COMPLETED|Third 6 Month||3
8688230|NCT00836589|9732906|FG000|NOT COMPLETED|Overall Study||1266
8688231|NCT00836641|9732920|FG000|STARTED|Overall Study||36
8688232|NCT00836641|9732921|FG001|STARTED|Overall Study||34
8688233|NCT00836641|9732920|FG000|COMPLETED|Overall Study||36
8688234|NCT00836641|9732921|FG001|COMPLETED|Overall Study||34
8688235|NCT00836641|9732920|FG000|NOT COMPLETED|Overall Study||0
8688236|NCT00836641|9732921|FG001|NOT COMPLETED|Overall Study||0
8688237|NCT00836693|9732928|FG000|STARTED|Overall Study||147
8688238|NCT00836693|9732929|FG001|STARTED|Overall Study||70
8688239|NCT00836693|9732928|FG000|COMPLETED|Overall Study||130
8688240|NCT00836693|9732929|FG001|COMPLETED|Overall Study||64
8688241|NCT00836693|9732928|FG000|NOT COMPLETED|Overall Study||17
8688242|NCT00836693|9732929|FG001|NOT COMPLETED|Overall Study||6
8688243|NCT00836719|9732935|FG000|STARTED|Overall Study||10
8688244|NCT00836719|9732935|FG000|COMPLETED|Overall Study||10
8688245|NCT00836719|9732935|FG000|NOT COMPLETED|Overall Study||0
8688246|NCT00836745|9732939|FG000|STARTED|Overall Study||36
8688247|NCT00836745|9732939|FG000|COMPLETED|Overall Study||15
8688248|NCT00836745|9732939|FG000|NOT COMPLETED|Overall Study||21
8688249|NCT00836758|9732943|FG000|STARTED|Overall Study||115
8688250|NCT00836758|9732943|FG000|COMPLETED|Overall Study||115
8688251|NCT00836758|9732943|FG000|NOT COMPLETED|Overall Study||0
8688252|NCT00836810|9732951|FG000|STARTED|Overall Study||5
8688253|NCT00836810|9732952|FG001|STARTED|Overall Study||6
8688254|NCT00836810|9732951|FG000|COMPLETED|Overall Study|1 patient was subsequently diagnosed with SLE and, per protocol, was not included.|4
8688255|NCT00836810|9732952|FG001|COMPLETED|Overall Study||6
8688256|NCT00836810|9732951|FG000|NOT COMPLETED|Overall Study||1
8688257|NCT00836810|9732952|FG001|NOT COMPLETED|Overall Study||0
8688258|NCT00836875|9732960|FG000|STARTED|Overall Study||11
8688259|NCT00836875|9732961|FG001|STARTED|Overall Study||20
8688260|NCT00836875|9732960|FG000|COMPLETED|Overall Study||8
8688261|NCT00836875|9732961|FG001|COMPLETED|Overall Study||17
8688262|NCT00836875|9732960|FG000|NOT COMPLETED|Overall Study||3
8688263|NCT00836875|9732961|FG001|NOT COMPLETED|Overall Study||3
8688264|NCT00836888|9732971|FG000|STARTED|Overall Study||3
8688265|NCT00836888|9732972|FG001|STARTED|Overall Study||5
8688266|NCT00836888|9732973|FG002|STARTED|Overall Study||6
8688267|NCT00836888|9732974|FG003|STARTED|Overall Study||3
8688268|NCT00836888|9732971|FG000|COMPLETED|Overall Study||0
8688269|NCT00836888|9732972|FG001|COMPLETED|Overall Study||2
8688270|NCT00836888|9732973|FG002|COMPLETED|Overall Study||0
8688271|NCT00836888|9732974|FG003|COMPLETED|Overall Study||0
8688272|NCT00836888|9732971|FG000|NOT COMPLETED|Overall Study||3
8688273|NCT00836888|9732972|FG001|NOT COMPLETED|Overall Study||3
8688274|NCT00836888|9732973|FG002|NOT COMPLETED|Overall Study||6
8688275|NCT00836888|9732974|FG003|NOT COMPLETED|Overall Study||3
8688276|NCT00836927|9732989|FG000|STARTED|Overall Study||3
8688277|NCT00836927|9732990|FG001|STARTED|Overall Study||1
8688278|NCT00836927|9732991|FG002|STARTED|Overall Study|One participant received ridaforolimus 3 mg IV infusion before being switched to the oral tablet.|1
8688279|NCT00836927|9732992|FG003|STARTED|Overall Study||1
8688280|NCT00836927|9732993|FG004|STARTED|Overall Study||1
8688281|NCT00836927|9732989|FG000|Completed Dosing Through 03 Apr 2017|Overall Study||0
8688282|NCT00836927|9732990|FG001|Completed Dosing Through 03 Apr 2017|Overall Study|Participant continued to receive study drug past the data cut-off date of 03 Apr 2017|1
8688283|NCT00836927|9732991|FG002|Completed Dosing Through 03 Apr 2017|Overall Study|Participant continued to receive study drug past the data cut-off date of 03 Apr 2017|1
8688284|NCT00836927|9732992|FG003|Completed Dosing Through 03 Apr 2017|Overall Study||0
8688285|NCT00836927|9732993|FG004|Completed Dosing Through 03 Apr 2017|Overall Study||0
8688286|NCT00836927|9732989|FG000|COMPLETED|Overall Study||0
8688287|NCT00836927|9732990|FG001|COMPLETED|Overall Study|Participant completed treatment by 04 Feb 2018|1
8688288|NCT00836927|9732991|FG002|COMPLETED|Overall Study|Participant completed treatment by 04 Feb 2018|1
8688289|NCT00836927|9732992|FG003|COMPLETED|Overall Study||0
8688290|NCT00836927|9732993|FG004|COMPLETED|Overall Study||0
8688291|NCT00836927|9732989|FG000|NOT COMPLETED|Overall Study||3
8688292|NCT00836927|9732990|FG001|NOT COMPLETED|Overall Study||0
8688293|NCT00836927|9732991|FG002|NOT COMPLETED|Overall Study||0
8688294|NCT00836927|9732992|FG003|NOT COMPLETED|Overall Study||1
8688295|NCT00836927|9732993|FG004|NOT COMPLETED|Overall Study||1
8688296|NCT00836953|9733007|FG000|STARTED|Overall Study||33
8688297|NCT00836953|9733007|FG000|COMPLETED|Overall Study||31
8688298|NCT00836953|9733007|FG000|NOT COMPLETED|Overall Study||2
8688299|NCT00837031|9733011|FG000|STARTED|Overall Study||72
8688300|NCT00837031|9733011|FG000|COMPLETED|Overall Study||72
8688301|NCT00837031|9733011|FG000|NOT COMPLETED|Overall Study||0
8688302|NCT00837096|9733017|FG000|STARTED|Overall Study||10
8688303|NCT00837096|9733018|FG001|STARTED|Overall Study||9
8688304|NCT00837096|9733017|FG000|COMPLETED|Overall Study||0
8688305|NCT00837096|9733018|FG001|COMPLETED|Overall Study||0
8688306|NCT00837096|9733017|FG000|NOT COMPLETED|Overall Study||10
8688307|NCT00837096|9733018|FG001|NOT COMPLETED|Overall Study||9
8688308|NCT00837148|9733024|FG000|STARTED|Overall Study||37
8688309|NCT00837148|9733024|FG000|COMPLETED|Overall Study||35
8688310|NCT00837148|9733024|FG000|NOT COMPLETED|Overall Study||2
8688311|NCT00837161|9733028|FG000|STARTED|Overall Study||11
8688312|NCT00837161|9733028|FG000|COMPLETED|Overall Study||9
8688313|NCT00837161|9733028|FG000|NOT COMPLETED|Overall Study||2
8688314|NCT00837200|9733032|FG000|STARTED|Overall Study||13
8688315|NCT00837200|9733032|FG000|COMPLETED|Overall Study||13
8688316|NCT00837200|9733032|FG000|NOT COMPLETED|Overall Study||0
8688317|NCT00837213|9733038|FG000|STARTED|Overall Study||16
8688318|NCT00837213|9733039|FG001|STARTED|Overall Study||17
8688319|NCT00837213|9733038|FG000|COMPLETED|Overall Study||10
8688320|NCT00837213|9733039|FG001|COMPLETED|Overall Study||12
8688321|NCT00837213|9733038|FG000|NOT COMPLETED|Overall Study||6
8688322|NCT00837213|9733039|FG001|NOT COMPLETED|Overall Study||5
8688323|NCT00837252|9733045|FG000|STARTED|Overall Study||5
8688324|NCT00837252|9733045|FG000|COMPLETED|Overall Study||5
8688325|NCT00837252|9733045|FG000|NOT COMPLETED|Overall Study||0
8688326|NCT00837330|9733051|FG000|STARTED|Overall Study||10
8688327|NCT00837330|9733052|FG001|STARTED|Overall Study||10
8688328|NCT00837330|9733051|FG000|COMPLETED|Overall Study||9
8688329|NCT00837330|9733052|FG001|COMPLETED|Overall Study||7
8688330|NCT00837330|9733051|FG000|NOT COMPLETED|Overall Study||1
8688331|NCT00837330|9733052|FG001|NOT COMPLETED|Overall Study||3
8688332|NCT00837434|9733060|FG000|STARTED|Overall Study||43
8688333|NCT00837434|9733061|FG001|STARTED|Overall Study||20
8688334|NCT00837434|9733060|FG000|COMPLETED|Overall Study||34
8688335|NCT00837434|9733061|FG001|COMPLETED|Overall Study||19
8688336|NCT00837434|9733060|FG000|NOT COMPLETED|Overall Study||9
8688337|NCT00837434|9733061|FG001|NOT COMPLETED|Overall Study||1
8919711|NCT02208349|9979622|FG000|NOT COMPLETED|Third 6 Month||0
8919712|NCT02208349|9979623|FG001|NOT COMPLETED|Third 6 Month||0
8919713|NCT02208349|9979622|FG000|STARTED|Fourth 6 Month||14
8919714|NCT02208349|9979623|FG001|STARTED|Fourth 6 Month||2
8919715|NCT02208349|9979622|FG000|COMPLETED|Fourth 6 Month||14
8919716|NCT02208349|9979623|FG001|COMPLETED|Fourth 6 Month||2
8919717|NCT02208349|9979622|FG000|NOT COMPLETED|Fourth 6 Month||0
8919718|NCT02208349|9979623|FG001|NOT COMPLETED|Fourth 6 Month||0
8919719|NCT02208349|9979622|FG000|STARTED|Fifth 6 Month||7
8919720|NCT02208349|9979623|FG001|STARTED|Fifth 6 Month||2
8919721|NCT02208349|9979622|FG000|COMPLETED|Fifth 6 Month||7
8919722|NCT02208349|9979623|FG001|COMPLETED|Fifth 6 Month||2
8919723|NCT02208349|9979622|FG000|NOT COMPLETED|Fifth 6 Month||0
8919724|NCT02208349|9979623|FG001|NOT COMPLETED|Fifth 6 Month||0
8919725|NCT02208349|9979622|FG000|STARTED|Sixth 6 Month||3
8919726|NCT02208349|9979623|FG001|STARTED|Sixth 6 Month||2
8919727|NCT02208349|9979622|FG000|COMPLETED|Sixth 6 Month||3
8919728|NCT02208349|9979623|FG001|COMPLETED|Sixth 6 Month||2
8919729|NCT02208349|9979622|FG000|NOT COMPLETED|Sixth 6 Month||0
8919730|NCT02208349|9979623|FG001|NOT COMPLETED|Sixth 6 Month||0
8919731|NCT02208466|9979634|FG000|STARTED|Overall Study||9
8919732|NCT02208466|9979635|FG001|STARTED|Overall Study||10
8919733|NCT02208466|9979636|FG002|STARTED|Overall Study||8
8919734|NCT02208466|9979634|FG000|COMPLETED|Overall Study||9
8919735|NCT02208466|9979635|FG001|COMPLETED|Overall Study||10
8919736|NCT02208466|9979636|FG002|COMPLETED|Overall Study||8
8919737|NCT02208466|9979634|FG000|NOT COMPLETED|Overall Study||0
8919738|NCT02208466|9979635|FG001|NOT COMPLETED|Overall Study||0
8919739|NCT02208466|9979636|FG002|NOT COMPLETED|Overall Study||0
8919740|NCT02208843|9979644|FG000|STARTED|Overall Study||60
8919741|NCT02208843|9979644|FG000|COMPLETED|Overall Study||0
8919742|NCT02208843|9979644|FG000|NOT COMPLETED|Overall Study||60
8919743|NCT02208999|9979650|FG000|STARTED|Overall Study||106
8919744|NCT02208999|9979650|FG000|COMPLETED|Overall Study||105
8919745|NCT02208999|9979650|FG000|NOT COMPLETED|Overall Study||1
8919746|NCT02209064|9979669|FG000|STARTED|Overall Study||25
9035722|NCT03301740|10097445|FG001|COMPLETED|First Washout (1 Week)||16
9035723|NCT03301740|10097444|FG000|NOT COMPLETED|First Washout (1 Week)||0
9035724|NCT03301740|10097445|FG001|NOT COMPLETED|First Washout (1 Week)||0
9035725|NCT03301740|10097444|FG000|STARTED|Phase 2 Intervention (3 Weeks)||18
9035726|NCT03301740|10097445|FG001|STARTED|Phase 2 Intervention (3 Weeks)||16
9035727|NCT03301740|10097444|FG000|COMPLETED|Phase 2 Intervention (3 Weeks)||17
9035728|NCT03301740|10097445|FG001|COMPLETED|Phase 2 Intervention (3 Weeks)||16
9035729|NCT03301740|10097444|FG000|NOT COMPLETED|Phase 2 Intervention (3 Weeks)||1
9035730|NCT03301740|10097445|FG001|NOT COMPLETED|Phase 2 Intervention (3 Weeks)||0
9035731|NCT03301740|10097444|FG000|STARTED|Second Washout (1 Week)||17
9035732|NCT03301740|10097445|FG001|STARTED|Second Washout (1 Week)||16
9035733|NCT03301740|10097444|FG000|COMPLETED|Second Washout (1 Week)||17
9035734|NCT03301740|10097445|FG001|COMPLETED|Second Washout (1 Week)||16
9035735|NCT03301740|10097444|FG000|NOT COMPLETED|Second Washout (1 Week)||0
9035736|NCT03301740|10097445|FG001|NOT COMPLETED|Second Washout (1 Week)||0
9035737|NCT03301740|10097444|FG000|STARTED|Phase 3 Intervention (3 Weeks)||17
9035738|NCT03301740|10097445|FG001|STARTED|Phase 3 Intervention (3 Weeks)||16
9035739|NCT03301740|10097444|FG000|COMPLETED|Phase 3 Intervention (3 Weeks)||17
9035740|NCT03301740|10097445|FG001|COMPLETED|Phase 3 Intervention (3 Weeks)||16
9035741|NCT03301740|10097444|FG000|NOT COMPLETED|Phase 3 Intervention (3 Weeks)||0
8688338|NCT00837447|9733067|FG000|STARTED|Overall Study|Each of the 54 pts received a Nexgen CR on one side and a Nexgen CR-Flex on the contralateral side.|54
8688339|NCT00837447|9733067|FG000|COMPLETED|Overall Study|Each of the 54 pts received a Nexgen CR on one side and a Nexgen CR-Flex on the contralateral side.|54
8688340|NCT00837447|9733067|FG000|NOT COMPLETED|Overall Study||0
8919747|NCT02209064|9979669|FG000|COMPLETED|Overall Study||25
8919748|NCT02209064|9979669|FG000|NOT COMPLETED|Overall Study||0
8688341|NCT00837473|9733072|FG000|STARTED|Overall Study||15
8688342|NCT00837473|9733072|FG000|COMPLETED|Overall Study||12
8688343|NCT00837473|9733072|FG000|NOT COMPLETED|Overall Study||3
8919749|NCT02209181|9979678|FG000|STARTED|Overall Study||67
9035742|NCT03301740|10097445|FG001|NOT COMPLETED|Phase 3 Intervention (3 Weeks)||0
9035743|NCT03301740|10097444|FG000|STARTED|Third Washout (1 Week)||17
9035744|NCT03301740|10097445|FG001|STARTED|Third Washout (1 Week)||16
9035745|NCT03301740|10097444|FG000|COMPLETED|Third Washout (1 Week)||17
8688344|NCT00837486|9733078|FG000|STARTED|Blinded-treatment Phase||16
8688345|NCT00837486|9733079|FG001|STARTED|Blinded-treatment Phase||14
8688346|NCT00837486|9733078|FG000|COMPLETED|Blinded-treatment Phase|One subject did not receive the allocated intervention.|15
8688347|NCT00837486|9733079|FG001|COMPLETED|Blinded-treatment Phase||14
8688348|NCT00837486|9733078|FG000|NOT COMPLETED|Blinded-treatment Phase||1
8688349|NCT00837486|9733079|FG001|NOT COMPLETED|Blinded-treatment Phase||0
8688350|NCT00837486|9733078|FG000|STARTED|Long-term Follow-up Phase - Open Label|All subjects received open-label stimulation during this phase.|29
8688351|NCT00837486|9733079|FG001|STARTED|Long-term Follow-up Phase - Open Label||0
8688352|NCT00837486|9733078|FG000|COMPLETED|Long-term Follow-up Phase - Open Label||24
8688353|NCT00837486|9733079|FG001|COMPLETED|Long-term Follow-up Phase - Open Label||0
8688354|NCT00837486|9733078|FG000|NOT COMPLETED|Long-term Follow-up Phase - Open Label||5
8688355|NCT00837486|9733079|FG001|NOT COMPLETED|Long-term Follow-up Phase - Open Label||0
8688356|NCT00837512|9733087|FG000|STARTED|First Intervention (6hrs) - RANDOMIZED||8
8688357|NCT00837512|9733088|FG001|STARTED|First Intervention (6hrs) - RANDOMIZED||8
8688358|NCT00837512|9733087|FG000|COMPLETED|First Intervention (6hrs) - RANDOMIZED||8
8688359|NCT00837512|9733088|FG001|COMPLETED|First Intervention (6hrs) - RANDOMIZED||8
8688360|NCT00837512|9733087|FG000|NOT COMPLETED|First Intervention (6hrs) - RANDOMIZED||0
8688361|NCT00837512|9733088|FG001|NOT COMPLETED|First Intervention (6hrs) - RANDOMIZED||0
8688362|NCT00837512|9733087|FG000|STARTED|Both Arms: Washout (7-28 Days)||8
8688363|NCT00837512|9733088|FG001|STARTED|Both Arms: Washout (7-28 Days)||8
8688364|NCT00837512|9733087|FG000|COMPLETED|Both Arms: Washout (7-28 Days)||8
8688365|NCT00837512|9733088|FG001|COMPLETED|Both Arms: Washout (7-28 Days)||8
8688366|NCT00837512|9733087|FG000|NOT COMPLETED|Both Arms: Washout (7-28 Days)||0
8688367|NCT00837512|9733088|FG001|NOT COMPLETED|Both Arms: Washout (7-28 Days)||0
8688368|NCT00837512|9733087|FG000|STARTED|2nd Intervention (6 Hrs) - RANDOMIZED||8
8688369|NCT00837512|9733088|FG001|STARTED|2nd Intervention (6 Hrs) - RANDOMIZED||8
8688370|NCT00837512|9733087|FG000|COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||8
8688371|NCT00837512|9733088|FG001|COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||8
8688372|NCT00837512|9733087|FG000|NOT COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||0
8688373|NCT00837512|9733088|FG001|NOT COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||0
8688374|NCT00837577|9733096|FG000|STARTED|Double-blind Period||70
8688375|NCT00837577|9733097|FG001|STARTED|Double-blind Period||63
8688376|NCT00837577|9733096|FG000|COMPLETED|Double-blind Period||68
8688377|NCT00837577|9733097|FG001|COMPLETED|Double-blind Period||63
8688378|NCT00837577|9733096|FG000|NOT COMPLETED|Double-blind Period||2
8688379|NCT00837577|9733097|FG001|NOT COMPLETED|Double-blind Period||0
8688380|NCT00837577|9733096|FG000|STARTED|Open-label Period||68
8688381|NCT00837577|9733097|FG001|STARTED|Open-label Period||63
8688382|NCT00837577|9733096|FG000|COMPLETED|Open-label Period||60
8688383|NCT00837577|9733097|FG001|COMPLETED|Open-label Period||54
8688384|NCT00837577|9733096|FG000|NOT COMPLETED|Open-label Period||8
8688385|NCT00837577|9733097|FG001|NOT COMPLETED|Open-label Period||9
8688386|NCT00837590|9733107|FG000|STARTED|Overall Study||6
8688387|NCT00837590|9733108|FG001|STARTED|Overall Study||5
8688388|NCT00837590|9733109|FG002|STARTED|Overall Study||5
8688389|NCT00837590|9733107|FG000|COMPLETED|Overall Study||6
8688390|NCT00837590|9733108|FG001|COMPLETED|Overall Study||4
8688391|NCT00837590|9733109|FG002|COMPLETED|Overall Study||4
8688392|NCT00837590|9733107|FG000|NOT COMPLETED|Overall Study||0
8688393|NCT00837590|9733108|FG001|NOT COMPLETED|Overall Study||1
8688394|NCT00837590|9733109|FG002|NOT COMPLETED|Overall Study||1
8688395|NCT00837616|9733119|FG000|STARTED|Overall Study||20
8688396|NCT00837616|9733120|FG001|STARTED|Overall Study||21
8688397|NCT00837616|9733119|FG000|COMPLETED|Overall Study||20
8688398|NCT00837616|9733120|FG001|COMPLETED|Overall Study||20
8688399|NCT00837616|9733119|FG000|NOT COMPLETED|Overall Study||0
8688400|NCT00837616|9733120|FG001|NOT COMPLETED|Overall Study||1
8688401|NCT00837694|9733132|FG000|STARTED|Overall Study||10
8688402|NCT00837694|9733133|FG001|STARTED|Overall Study||11
8688403|NCT00837694|9733134|FG002|STARTED|Overall Study||10
8688404|NCT00837694|9733135|FG003|STARTED|Overall Study||11
8688405|NCT00837694|9733136|FG004|STARTED|Overall Study||12
8688406|NCT00837694|9733137|FG005|STARTED|Overall Study||11
8688407|NCT00837694|9733132|FG000|COMPLETED|Overall Study||8
8688408|NCT00837694|9733133|FG001|COMPLETED|Overall Study||11
8688409|NCT00837694|9733134|FG002|COMPLETED|Overall Study||8
8688410|NCT00837694|9733135|FG003|COMPLETED|Overall Study||10
8688411|NCT00837694|9733136|FG004|COMPLETED|Overall Study||11
8688412|NCT00837694|9733137|FG005|COMPLETED|Overall Study||10
8688413|NCT00837694|9733132|FG000|NOT COMPLETED|Overall Study||2
8688414|NCT00837694|9733133|FG001|NOT COMPLETED|Overall Study||0
8688415|NCT00837694|9733134|FG002|NOT COMPLETED|Overall Study||2
8688416|NCT00837694|9733135|FG003|NOT COMPLETED|Overall Study||1
8688417|NCT00837694|9733136|FG004|NOT COMPLETED|Overall Study||1
8688418|NCT00837694|9733137|FG005|NOT COMPLETED|Overall Study||1
8688419|NCT00837759|9733151|FG000|STARTED|Overall Study||7
8688420|NCT00837759|9733151|FG000|COMPLETED|Overall Study||3
8688421|NCT00837759|9733151|FG000|NOT COMPLETED|Overall Study||4
8688422|NCT00837811|9733158|FG000|STARTED|Overall Study||60
8688423|NCT00837811|9733159|FG001|STARTED|Overall Study||121
8688424|NCT00837811|9733160|FG002|STARTED|Overall Study||1
8688425|NCT00837811|9733158|FG000|Received Any Amount of Study Drug|Overall Study||60
8688426|NCT00837811|9733159|FG001|Received Any Amount of Study Drug|Overall Study||121
8688427|NCT00837811|9733160|FG002|Received Any Amount of Study Drug|Overall Study||1
8688428|NCT00837811|9733158|FG000|Had at Least 1 Efficacy Assessment|Overall Study||59
8688429|NCT00837811|9733159|FG001|Had at Least 1 Efficacy Assessment|Overall Study||121
8688430|NCT00837811|9733160|FG002|Had at Least 1 Efficacy Assessment|Overall Study||1
8688431|NCT00837811|9733158|FG000|Included in Efficacy Analyses|Overall Study||59
8688432|NCT00837811|9733159|FG001|Included in Efficacy Analyses|Overall Study|Excludes participant from site with Good Clinical Practice (GCP) violations.|120
8688433|NCT00837811|9733160|FG002|Included in Efficacy Analyses|Overall Study||1
8688434|NCT00837811|9733158|FG000|COMPLETED|Overall Study||53
8688435|NCT00837811|9733159|FG001|COMPLETED|Overall Study||87
8688436|NCT00837811|9733160|FG002|COMPLETED|Overall Study||0
8688437|NCT00837811|9733158|FG000|NOT COMPLETED|Overall Study||7
8688438|NCT00837811|9733159|FG001|NOT COMPLETED|Overall Study||34
8688439|NCT00837811|9733160|FG002|NOT COMPLETED|Overall Study||1
8688440|NCT00837824|9733179|FG000|STARTED|Overall Study||11
8688441|NCT00837824|9733180|FG001|STARTED|Overall Study||9
8688442|NCT00837824|9733179|FG000|COMPLETED|Overall Study||11
8688443|NCT00837824|9733180|FG001|COMPLETED|Overall Study||9
8688444|NCT00837824|9733179|FG000|NOT COMPLETED|Overall Study||0
8688445|NCT00837824|9733180|FG001|NOT COMPLETED|Overall Study||0
8688446|NCT00837876|9733187|FG000|STARTED|Overall Study||37
8688447|NCT00837876|9733187|FG000|COMPLETED|Overall Study||0
8688448|NCT00837876|9733187|FG000|NOT COMPLETED|Overall Study||37
8688449|NCT00837902|9733193|FG000|STARTED|Overall Study||85
8688450|NCT00837902|9733194|FG001|STARTED|Overall Study||69
8688451|NCT00837902|9733193|FG000|COMPLETED|Overall Study||85
8688452|NCT00837902|9733194|FG001|COMPLETED|Overall Study||69
8688453|NCT00837902|9733193|FG000|NOT COMPLETED|Overall Study||0
8688454|NCT00837902|9733194|FG001|NOT COMPLETED|Overall Study||0
8688455|NCT00837967|9733201|FG000|STARTED|First Intervention||13
8688456|NCT00837967|9733202|FG001|STARTED|First Intervention||12
8688457|NCT00837967|9733201|FG000|COMPLETED|First Intervention||13
8688458|NCT00837967|9733202|FG001|COMPLETED|First Intervention||12
8688459|NCT00837967|9733201|FG000|NOT COMPLETED|First Intervention||0
8688460|NCT00837967|9733202|FG001|NOT COMPLETED|First Intervention||0
8688461|NCT00837967|9733201|FG000|STARTED|Washout Period of 7 - 14 Days||13
8688462|NCT00837967|9733202|FG001|STARTED|Washout Period of 7 - 14 Days||12
8688463|NCT00837967|9733201|FG000|COMPLETED|Washout Period of 7 - 14 Days||11
8688464|NCT00837967|9733202|FG001|COMPLETED|Washout Period of 7 - 14 Days||12
8688465|NCT00837967|9733201|FG000|NOT COMPLETED|Washout Period of 7 - 14 Days||2
8688466|NCT00837967|9733202|FG001|NOT COMPLETED|Washout Period of 7 - 14 Days||0
8688467|NCT00837967|9733201|FG000|STARTED|Second Intervention||11
8688468|NCT00837967|9733202|FG001|STARTED|Second Intervention||12
8688469|NCT00837967|9733201|FG000|COMPLETED|Second Intervention||11
8688470|NCT00837967|9733202|FG001|COMPLETED|Second Intervention||12
8688471|NCT00837967|9733201|FG000|NOT COMPLETED|Second Intervention||0
8688472|NCT00837967|9733202|FG001|NOT COMPLETED|Second Intervention||0
8688473|NCT00838006|9733211|FG000|STARTED|Overall Study||102
8688474|NCT00838006|9733212|FG001|STARTED|Overall Study||98
8688475|NCT00838006|9733213|FG002|STARTED|Overall Study||142
8688476|NCT00838006|9733211|FG000|3-month Post-deployment Follow-up|Overall Study||92
8688477|NCT00838006|9733212|FG001|3-month Post-deployment Follow-up|Overall Study||80
8688478|NCT00838006|9733213|FG002|3-month Post-deployment Follow-up|Overall Study||135
8688479|NCT00838006|9733211|FG000|COMPLETED|Overall Study||68
8688480|NCT00838006|9733212|FG001|COMPLETED|Overall Study||72
8688481|NCT00838006|9733213|FG002|COMPLETED|Overall Study||94
8688482|NCT00838006|9733211|FG000|NOT COMPLETED|Overall Study||34
8688483|NCT00838006|9733212|FG001|NOT COMPLETED|Overall Study||26
8688484|NCT00838006|9733213|FG002|NOT COMPLETED|Overall Study||48
8688485|NCT00838097|9733223|FG000|STARTED|Overall Study||321
8688486|NCT00838097|9733223|FG000|Received Darbepoetin Alfa|Overall Study||319
8688487|NCT00838097|9733223|FG000|COMPLETED|Overall Study||145
8688488|NCT00838097|9733223|FG000|NOT COMPLETED|Overall Study||176
8688489|NCT00838110|9733229|FG000|STARTED|Overall Study||127
8688490|NCT00838110|9733230|FG001|STARTED|Overall Study||128
8688491|NCT00838110|9733231|FG002|STARTED|Overall Study||243
8688492|NCT00838110|9733232|FG003|STARTED|Overall Study||244
8688493|NCT00838110|9733229|FG000|Treated|Overall Study||127
8688494|NCT00838110|9733230|FG001|Treated|Overall Study||127
8688495|NCT00838110|9733231|FG002|Treated|Overall Study||243
8688496|NCT00838110|9733232|FG003|Treated|Overall Study||244
8688497|NCT00838110|9733229|FG000|COMPLETED|Overall Study||105
8688498|NCT00838110|9733230|FG001|COMPLETED|Overall Study||106
8688499|NCT00838110|9733231|FG002|COMPLETED|Overall Study||226
8688500|NCT00838110|9733232|FG003|COMPLETED|Overall Study||226
8688501|NCT00838110|9733229|FG000|NOT COMPLETED|Overall Study||22
8688502|NCT00838110|9733230|FG001|NOT COMPLETED|Overall Study||22
8688503|NCT00838110|9733231|FG002|NOT COMPLETED|Overall Study||17
8688504|NCT00838110|9733232|FG003|NOT COMPLETED|Overall Study||18
8688505|NCT00838162|9733246|FG000|STARTED|Overall Study||9
8688506|NCT00838162|9733247|FG001|STARTED|Overall Study||8
8688507|NCT00838162|9733248|FG002|STARTED|Overall Study||8
8688508|NCT00838162|9733249|FG003|STARTED|Overall Study||8
8688509|NCT00838162|9733246|FG000|COMPLETED|Overall Study||9
8688510|NCT00838162|9733247|FG001|COMPLETED|Overall Study||8
8688511|NCT00838162|9733248|FG002|COMPLETED|Overall Study||8
8688512|NCT00838162|9733249|FG003|COMPLETED|Overall Study||8
8688513|NCT00838162|9733246|FG000|NOT COMPLETED|Overall Study||0
8688514|NCT00838162|9733247|FG001|NOT COMPLETED|Overall Study||0
8688515|NCT00838162|9733248|FG002|NOT COMPLETED|Overall Study||0
8688516|NCT00838162|9733249|FG003|NOT COMPLETED|Overall Study||0
8688517|NCT00838201|9733261|FG000|STARTED|Overall Study||186
8688518|NCT00838201|9733262|FG001|STARTED|Overall Study||198
8688519|NCT00838201|9733261|FG000|COMPLETED|Overall Study||144
8688520|NCT00838201|9733262|FG001|COMPLETED|Overall Study||145
8688521|NCT00838201|9733261|FG000|NOT COMPLETED|Overall Study||42
8688522|NCT00838201|9733262|FG001|NOT COMPLETED|Overall Study||53
8688523|NCT00838331|9733268|FG000|STARTED|Fresh Blood Transfusion||17
8688524|NCT00838331|9733268|FG000|COMPLETED|Fresh Blood Transfusion||17
8688525|NCT00838331|9733268|FG000|NOT COMPLETED|Fresh Blood Transfusion||0
8688526|NCT00838331|9733268|FG000|STARTED|Aged Blood Transfusion||17
8688527|NCT00838331|9733268|FG000|COMPLETED|Aged Blood Transfusion||8
8688528|NCT00838331|9733268|FG000|NOT COMPLETED|Aged Blood Transfusion||9
8688529|NCT00838435|9733272|FG000|STARTED|Part 1 (4 Weeks)||95
8688530|NCT00838435|9733272|FG000|COMPLETED|Part 1 (4 Weeks)||95
8688531|NCT00838435|9733272|FG000|NOT COMPLETED|Part 1 (4 Weeks)||0
8688532|NCT00838435|9733272|FG000|STARTED|PK Sub-Study 2 (4 Weeks)|1 subject declined participation in the PK Sub-Study.|94
8688533|NCT00838435|9733272|FG000|COMPLETED|PK Sub-Study 2 (4 Weeks)||93
8688534|NCT00838435|9733272|FG000|NOT COMPLETED|PK Sub-Study 2 (4 Weeks)||1
8688535|NCT00838435|9733272|FG000|STARTED|Safety/Efficacy Sub-Study 1 (6 Months)|65 of 95 subjects in Part 1 were determined responders & eligible for the Safety/Efficacy Sub-study.|65
8688536|NCT00838435|9733272|FG000|COMPLETED|Safety/Efficacy Sub-Study 1 (6 Months)||63
8688537|NCT00838435|9733272|FG000|NOT COMPLETED|Safety/Efficacy Sub-Study 1 (6 Months)||2
8688538|NCT00838435|9733272|FG000|STARTED|Part 2 (7 Years)|65 of 95 subjects in Part 1 were determined responders & eligible for the Part 2 of the study.|65
8688539|NCT00838435|9733272|FG000|COMPLETED|Part 2 (7 Years)||49
8688540|NCT00838435|9733272|FG000|NOT COMPLETED|Part 2 (7 Years)||16
8688541|NCT00838513|9733279|FG000|STARTED|Screening Period||23
8688542|NCT00838513|9733279|FG000|COMPLETED|Screening Period||20
8688543|NCT00838513|9733279|FG000|NOT COMPLETED|Screening Period||3
8688544|NCT00838513|9733279|FG000|STARTED|Observation Period (8 Weeks)||20
8688545|NCT00838513|9733279|FG000|COMPLETED|Observation Period (8 Weeks)||20
8688546|NCT00838513|9733279|FG000|NOT COMPLETED|Observation Period (8 Weeks)||0
8688547|NCT00838513|9733279|FG000|STARTED|Treatment Period (26 Weeks)||20
8688548|NCT00838513|9733279|FG000|COMPLETED|Treatment Period (26 Weeks)||20
8801803|NCT01451983|9853720|FG000|COMPLETED|Overall Study||26
8801804|NCT01451983|9853721|FG001|COMPLETED|Overall Study||27
8801805|NCT01451983|9853722|FG002|COMPLETED|Overall Study||61
8801806|NCT01451983|9853723|FG003|COMPLETED|Overall Study||24
8801807|NCT01451983|9853720|FG000|NOT COMPLETED|Overall Study||0
8801808|NCT01451983|9853721|FG001|NOT COMPLETED|Overall Study||0
8801809|NCT01451983|9853722|FG002|NOT COMPLETED|Overall Study||0
8801810|NCT01451983|9853723|FG003|NOT COMPLETED|Overall Study||0
8801811|NCT01451996|9853737|FG000|STARTED|Overall Study||83
8801812|NCT01451996|9853738|FG001|STARTED|Overall Study||87
8801813|NCT01451996|9853739|FG002|STARTED|Overall Study||85
8801814|NCT01451996|9853740|FG003|STARTED|Overall Study||85
8801815|NCT01451996|9853737|FG000|COMPLETED|Overall Study||83
8801816|NCT01451996|9853738|FG001|COMPLETED|Overall Study||87
8801817|NCT01451996|9853739|FG002|COMPLETED|Overall Study||85
8801818|NCT01451996|9853740|FG003|COMPLETED|Overall Study||85
8801819|NCT01451996|9853737|FG000|NOT COMPLETED|Overall Study||0
8801820|NCT01451996|9853738|FG001|NOT COMPLETED|Overall Study||0
8801821|NCT01451996|9853739|FG002|NOT COMPLETED|Overall Study||0
8801822|NCT01451996|9853740|FG003|NOT COMPLETED|Overall Study||0
8801823|NCT01452126|9853750|FG000|STARTED|Overall Study||49
8801824|NCT01452126|9853750|FG000|COMPLETED|Overall Study||49
8801825|NCT01452126|9853750|FG000|NOT COMPLETED|Overall Study||0
8801826|NCT01452191|9853761|FG000|STARTED|Overall Study||373
8801827|NCT01452191|9853762|FG001|STARTED|Overall Study||369
8801828|NCT01452191|9853763|FG002|STARTED|Overall Study||370
8801829|NCT01452191|9853761|FG000|COMPLETED|Overall Study||241
8801830|NCT01452191|9853762|FG001|COMPLETED|Overall Study||252
8801831|NCT01452191|9853763|FG002|COMPLETED|Overall Study||258
8801832|NCT01452191|9853761|FG000|NOT COMPLETED|Overall Study||132
8801833|NCT01452191|9853762|FG001|NOT COMPLETED|Overall Study||117
8801834|NCT01452191|9853763|FG002|NOT COMPLETED|Overall Study||112
8801835|NCT01452269|9853773|FG000|STARTED|Overall Study||48
8801836|NCT01452269|9853774|FG001|STARTED|Overall Study||56
8801837|NCT01452269|9853773|FG000|COMPLETED|Overall Study||47
8801838|NCT01452269|9853774|FG001|COMPLETED|Overall Study||51
8801839|NCT01452269|9853773|FG000|NOT COMPLETED|Overall Study||1
8801840|NCT01452269|9853774|FG001|NOT COMPLETED|Overall Study||5
8801841|NCT01452347|9853782|FG000|STARTED|Overall Study||168
8801842|NCT01452347|9853783|FG001|STARTED|Overall Study||84
8801843|NCT01452347|9853782|FG000|COMPLETED|Overall Study||151
8801844|NCT01452347|9853783|FG001|COMPLETED|Overall Study||77
8801845|NCT01452347|9853782|FG000|NOT COMPLETED|Overall Study||17
8801846|NCT01452347|9853783|FG001|NOT COMPLETED|Overall Study||7
8801847|NCT01452412|9853793|FG000|STARTED|Overall Study||74
8801848|NCT01452412|9853794|FG001|STARTED|Overall Study||75
8801849|NCT01452412|9853793|FG000|COMPLETED|Overall Study||46
8801850|NCT01452412|9853794|FG001|COMPLETED|Overall Study||58
8801851|NCT01452412|9853793|FG000|NOT COMPLETED|Overall Study||28
8801852|NCT01452412|9853794|FG001|NOT COMPLETED|Overall Study||17
8801853|NCT01452425|9853800|FG000|STARTED|Overall Study||10
8801854|NCT01452425|9853800|FG000|COMPLETED|Overall Study||10
8801855|NCT01452425|9853800|FG000|NOT COMPLETED|Overall Study||0
8801856|NCT01452529|9853807|FG000|STARTED|Run-in Period||905
8801857|NCT01452529|9853808|FG001|STARTED|Run-in Period||0
8801858|NCT01452529|9853809|FG002|STARTED|Run-in Period||0
8688549|NCT00838513|9733279|FG000|NOT COMPLETED|Treatment Period (26 Weeks)||0
8688550|NCT00838513|9733279|FG000|STARTED|Extension Treatment Period||19
8688551|NCT00838513|9733279|FG000|COMPLETED|Extension Treatment Period||18
8688552|NCT00838513|9733279|FG000|NOT COMPLETED|Extension Treatment Period||1
8688553|NCT00838513|9733279|FG000|STARTED|Post Treatment Period (Patients Who Disc||5
8688554|NCT00838513|9733279|FG000|COMPLETED|Post Treatment Period (Patients Who Disc||4
8688555|NCT00838513|9733279|FG000|NOT COMPLETED|Post Treatment Period (Patients Who Disc||1
8688556|NCT00838539|9733295|FG000|STARTED|Overall Study||3
8688557|NCT00838539|9733296|FG001|STARTED|Overall Study||6
8688558|NCT00838539|9733297|FG002|STARTED|Overall Study||5
8688559|NCT00838539|9733298|FG003|STARTED|Overall Study||4
8688560|NCT00838539|9733299|FG004|STARTED|Overall Study||6
8688561|NCT00838539|9733300|FG005|STARTED|Overall Study||4
8688562|NCT00838539|9733301|FG006|STARTED|Overall Study||7
8688563|NCT00838539|9733302|FG007|STARTED|Overall Study||6
8688564|NCT00838539|9733303|FG008|STARTED|Overall Study||5
8688565|NCT00838539|9733304|FG009|STARTED|Overall Study||8
8688566|NCT00838539|9733305|FG010|STARTED|Overall Study||5
8688567|NCT00838539|9733306|FG011|STARTED|Overall Study||4
8688568|NCT00838539|9733295|FG000|Received Treatment|Overall Study||3
8688569|NCT00838539|9733296|FG001|Received Treatment|Overall Study||5
8688570|NCT00838539|9733297|FG002|Received Treatment|Overall Study||5
8688571|NCT00838539|9733298|FG003|Received Treatment|Overall Study||4
8688572|NCT00838539|9733299|FG004|Received Treatment|Overall Study||4
8688573|NCT00838539|9733300|FG005|Received Treatment|Overall Study||4
8688574|NCT00838539|9733301|FG006|Received Treatment|Overall Study||7
8688575|NCT00838539|9733302|FG007|Received Treatment|Overall Study||6
8688576|NCT00838539|9733303|FG008|Received Treatment|Overall Study||5
8688577|NCT00838539|9733304|FG009|Received Treatment|Overall Study||8
8688578|NCT00838539|9733305|FG010|Received Treatment|Overall Study||5
8688579|NCT00838539|9733306|FG011|Received Treatment|Overall Study||4
8688580|NCT00838539|9733295|FG000|COMPLETED|Overall Study||0
8688581|NCT00838539|9733296|FG001|COMPLETED|Overall Study||0
8688582|NCT00838539|9733297|FG002|COMPLETED|Overall Study||0
8688583|NCT00838539|9733298|FG003|COMPLETED|Overall Study||0
8688584|NCT00838539|9733299|FG004|COMPLETED|Overall Study||0
8688585|NCT00838539|9733300|FG005|COMPLETED|Overall Study||0
8688586|NCT00838539|9733301|FG006|COMPLETED|Overall Study||2
8688587|NCT00838539|9733302|FG007|COMPLETED|Overall Study||0
8688588|NCT00838539|9733303|FG008|COMPLETED|Overall Study||0
8688589|NCT00838539|9733304|FG009|COMPLETED|Overall Study||0
8688590|NCT00838539|9733305|FG010|COMPLETED|Overall Study||0
8688591|NCT00838539|9733306|FG011|COMPLETED|Overall Study||0
8688592|NCT00838539|9733295|FG000|NOT COMPLETED|Overall Study||3
8688593|NCT00838539|9733296|FG001|NOT COMPLETED|Overall Study||6
8688594|NCT00838539|9733297|FG002|NOT COMPLETED|Overall Study||5
8688595|NCT00838539|9733298|FG003|NOT COMPLETED|Overall Study||4
8688596|NCT00838539|9733299|FG004|NOT COMPLETED|Overall Study||6
8688597|NCT00838539|9733300|FG005|NOT COMPLETED|Overall Study||4
8688598|NCT00838539|9733301|FG006|NOT COMPLETED|Overall Study||5
8688599|NCT00838539|9733302|FG007|NOT COMPLETED|Overall Study||6
8688600|NCT00838539|9733303|FG008|NOT COMPLETED|Overall Study||5
8688601|NCT00838539|9733304|FG009|NOT COMPLETED|Overall Study||8
8688602|NCT00838539|9733305|FG010|NOT COMPLETED|Overall Study||5
8688603|NCT00838539|9733306|FG011|NOT COMPLETED|Overall Study||4
8688604|NCT00838565|9733352|FG000|STARTED|Overall Study||9
8688605|NCT00838565|9733353|FG001|STARTED|Overall Study||7
8688606|NCT00838565|9733354|FG002|STARTED|Overall Study||6
8688607|NCT00838565|9733355|FG003|STARTED|Overall Study||6
8688608|NCT00838565|9733356|FG004|STARTED|Overall Study||6
8688609|NCT00838565|9733357|FG005|STARTED|Overall Study||7
8688610|NCT00838565|9733352|FG000|Treated|Overall Study||9
8688611|NCT00838565|9733353|FG001|Treated|Overall Study||6
8688612|NCT00838565|9733354|FG002|Treated|Overall Study||6
8688613|NCT00838565|9733355|FG003|Treated|Overall Study||6
8688614|NCT00838565|9733356|FG004|Treated|Overall Study||6
8688615|NCT00838565|9733357|FG005|Treated|Overall Study||7
8688616|NCT00838565|9733352|FG000|COMPLETED|Overall Study||9
8688617|NCT00838565|9733353|FG001|COMPLETED|Overall Study||4
8688618|NCT00838565|9733354|FG002|COMPLETED|Overall Study||5
8688619|NCT00838565|9733355|FG003|COMPLETED|Overall Study||6
8688620|NCT00838565|9733356|FG004|COMPLETED|Overall Study||6
8688621|NCT00838565|9733357|FG005|COMPLETED|Overall Study||5
8688622|NCT00838565|9733352|FG000|NOT COMPLETED|Overall Study||0
8688623|NCT00838565|9733353|FG001|NOT COMPLETED|Overall Study||3
8688624|NCT00838565|9733354|FG002|NOT COMPLETED|Overall Study||1
8688625|NCT00838565|9733355|FG003|NOT COMPLETED|Overall Study||0
8688626|NCT00838565|9733356|FG004|NOT COMPLETED|Overall Study||0
8688627|NCT00838565|9733357|FG005|NOT COMPLETED|Overall Study||2
8688628|NCT00838578|9733376|FG000|STARTED|Overall Study|In this Ph 1/2 study, 65 subjects were enrolled; 2 were protocol violators, so only 63 treated.|65
8688629|NCT00838578|9733376|FG000|COMPLETED|Overall Study||63
8688630|NCT00838578|9733376|FG000|NOT COMPLETED|Overall Study||2
8688631|NCT00838682|9733386|FG000|STARTED|Overall Study||54
8688632|NCT00838682|9733387|FG001|STARTED|Overall Study||52
8688633|NCT00838682|9733386|FG000|COMPLETED|Overall Study||29
8688634|NCT00838682|9733387|FG001|COMPLETED|Overall Study||33
8688635|NCT00838682|9733386|FG000|NOT COMPLETED|Overall Study||25
8688636|NCT00838682|9733387|FG001|NOT COMPLETED|Overall Study||19
8688637|NCT00838695|9733395|FG000|STARTED|Overall Study||42
8688638|NCT00838695|9733396|FG001|STARTED|Overall Study||64
8688639|NCT00838695|9733395|FG000|COMPLETED|Overall Study||42
8688640|NCT00838695|9733396|FG001|COMPLETED|Overall Study||64
8688641|NCT00838695|9733395|FG000|NOT COMPLETED|Overall Study||0
8688642|NCT00838695|9733396|FG001|NOT COMPLETED|Overall Study||0
8688643|NCT00838903|9733406|FG000|STARTED|Treatment Period (156 Weeks)||101
8688644|NCT00838903|9733407|FG001|STARTED|Treatment Period (156 Weeks)||302
8688645|NCT00838903|9733408|FG002|STARTED|Treatment Period (156 Weeks)||307
8688646|NCT00838903|9733409|FG003|STARTED|Treatment Period (156 Weeks)||302
8688647|NCT00838903|9733406|FG000|Missing Active Treatment Status|Treatment Period (156 Weeks)||1
8688648|NCT00838903|9733407|FG001|Missing Active Treatment Status|Treatment Period (156 Weeks)||0
8688649|NCT00838903|9733408|FG002|Missing Active Treatment Status|Treatment Period (156 Weeks)||0
8688650|NCT00838903|9733409|FG003|Missing Active Treatment Status|Treatment Period (156 Weeks)||0
8688651|NCT00838903|9733406|FG000|COMPLETED|Treatment Period (156 Weeks)||55
8688652|NCT00838903|9733407|FG001|COMPLETED|Treatment Period (156 Weeks)||190
8688653|NCT00838903|9733408|FG002|COMPLETED|Treatment Period (156 Weeks)||191
8688654|NCT00838903|9733409|FG003|COMPLETED|Treatment Period (156 Weeks)||192
8688655|NCT00838903|9733406|FG000|NOT COMPLETED|Treatment Period (156 Weeks)||46
8688656|NCT00838903|9733407|FG001|NOT COMPLETED|Treatment Period (156 Weeks)||112
8688657|NCT00838903|9733408|FG002|NOT COMPLETED|Treatment Period (156 Weeks)||116
8688658|NCT00838903|9733409|FG003|NOT COMPLETED|Treatment Period (156 Weeks)||110
8688659|NCT00838903|9733406|FG000|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|101
8688660|NCT00838903|9733407|FG001|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|302
8688661|NCT00838903|9733408|FG002|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|307
8688662|NCT00838903|9733409|FG003|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|302
8688663|NCT00838903|9733406|FG000|COMPLETED|Follow-up Period (8 Weeks)||75
8688664|NCT00838903|9733407|FG001|COMPLETED|Follow-up Period (8 Weeks)||237
8688665|NCT00838903|9733408|FG002|COMPLETED|Follow-up Period (8 Weeks)||243
8688666|NCT00838903|9733409|FG003|COMPLETED|Follow-up Period (8 Weeks)||244
8688667|NCT00838903|9733406|FG000|NOT COMPLETED|Follow-up Period (8 Weeks)||26
8688668|NCT00838903|9733407|FG001|NOT COMPLETED|Follow-up Period (8 Weeks)||65
8688669|NCT00838903|9733408|FG002|NOT COMPLETED|Follow-up Period (8 Weeks)||64
8688670|NCT00838903|9733409|FG003|NOT COMPLETED|Follow-up Period (8 Weeks)||58
8688671|NCT00838916|9733421|FG000|STARTED|Treatment Period (156 Weeks)||504
8688672|NCT00838916|9733422|FG001|STARTED|Treatment Period (156 Weeks)||241
8688673|NCT00838916|9733421|FG000|COMPLETED|Treatment Period (156 Weeks)||308
8688674|NCT00838916|9733422|FG001|COMPLETED|Treatment Period (156 Weeks)||164
8688675|NCT00838916|9733421|FG000|NOT COMPLETED|Treatment Period (156 Weeks)||196
8688676|NCT00838916|9733422|FG001|NOT COMPLETED|Treatment Period (156 Weeks)||77
8688677|NCT00838916|9733421|FG000|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|504
8688678|NCT00838916|9733422|FG001|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|241
8688679|NCT00838916|9733421|FG000|COMPLETED|Follow-up Period (8 Weeks)||408
8688680|NCT00838916|9733422|FG001|COMPLETED|Follow-up Period (8 Weeks)||190
8688681|NCT00838916|9733421|FG000|NOT COMPLETED|Follow-up Period (8 Weeks)||96
8688682|NCT00838916|9733422|FG001|NOT COMPLETED|Follow-up Period (8 Weeks)||51
8688683|NCT00838929|9733431|FG000|STARTED|Overall Study||3
8688684|NCT00838929|9733432|FG001|STARTED|Overall Study||8
8688685|NCT00838929|9733433|FG002|STARTED|Overall Study||6
8688686|NCT00838929|9733431|FG000|COMPLETED|Overall Study||3
8688687|NCT00838929|9733432|FG001|COMPLETED|Overall Study||5
8688688|NCT00838929|9733433|FG002|COMPLETED|Overall Study||5
8688689|NCT00838929|9733431|FG000|NOT COMPLETED|Overall Study||0
8688690|NCT00838929|9733432|FG001|NOT COMPLETED|Overall Study||3
8688691|NCT00838929|9733433|FG002|NOT COMPLETED|Overall Study||1
8688692|NCT00839072|9733439|FG000|STARTED|First Intervention Period||12
8688693|NCT00839072|9733440|FG001|STARTED|First Intervention Period||12
8688694|NCT00839072|9733439|FG000|COMPLETED|First Intervention Period||10
8688695|NCT00839072|9733440|FG001|COMPLETED|First Intervention Period||11
8688696|NCT00839072|9733439|FG000|NOT COMPLETED|First Intervention Period||2
8688697|NCT00839072|9733440|FG001|NOT COMPLETED|First Intervention Period||1
8688698|NCT00839072|9733439|FG000|STARTED|Washout Period of 7 Days||10
8688699|NCT00839072|9733440|FG001|STARTED|Washout Period of 7 Days||11
8688700|NCT00839072|9733439|FG000|COMPLETED|Washout Period of 7 Days||10
8688701|NCT00839072|9733440|FG001|COMPLETED|Washout Period of 7 Days||11
8688702|NCT00839072|9733439|FG000|NOT COMPLETED|Washout Period of 7 Days||0
8688703|NCT00839072|9733440|FG001|NOT COMPLETED|Washout Period of 7 Days||0
8688704|NCT00839072|9733439|FG000|STARTED|Second Intervention Period||10
8688705|NCT00839072|9733440|FG001|STARTED|Second Intervention Period||11
8688706|NCT00839072|9733439|FG000|COMPLETED|Second Intervention Period||9
8688707|NCT00839072|9733440|FG001|COMPLETED|Second Intervention Period||11
8688708|NCT00839072|9733439|FG000|NOT COMPLETED|Second Intervention Period||1
8688709|NCT00839072|9733440|FG001|NOT COMPLETED|Second Intervention Period||0
8688710|NCT00839098|9733449|FG000|STARTED|Overall Study||3
8688711|NCT00839098|9733450|FG001|STARTED|Overall Study||12
8688712|NCT00839098|9733451|FG002|STARTED|Overall Study||13
8688713|NCT00839098|9733449|FG000|COMPLETED|Overall Study||1
8688714|NCT00839098|9733450|FG001|COMPLETED|Overall Study||11
8688715|NCT00839098|9733451|FG002|COMPLETED|Overall Study||6
8688716|NCT00839098|9733449|FG000|NOT COMPLETED|Overall Study||2
8688717|NCT00839098|9733450|FG001|NOT COMPLETED|Overall Study||1
8688718|NCT00839098|9733451|FG002|NOT COMPLETED|Overall Study||7
8688719|NCT00839241|9733461|FG000|STARTED|Overall Study||20
8688720|NCT00839241|9733462|FG001|STARTED|Overall Study||25
8688721|NCT00839241|9733461|FG000|COMPLETED|Overall Study||15
8688722|NCT00839241|9733462|FG001|COMPLETED|Overall Study||8
8688723|NCT00839241|9733461|FG000|NOT COMPLETED|Overall Study||5
8688724|NCT00839241|9733462|FG001|NOT COMPLETED|Overall Study||17
8688725|NCT00839254|9733476|FG000|STARTED|Overall Study||1849
8688726|NCT00839254|9733477|FG001|STARTED|Overall Study||1316
8688727|NCT00839254|9733478|FG002|STARTED|Overall Study||1069
8688728|NCT00839254|9733479|FG003|STARTED|Overall Study||859
8688729|NCT00839254|9733480|FG004|STARTED|Overall Study||241
8688730|NCT00839254|9733481|FG005|STARTED|Overall Study||204
8688731|NCT00839254|9733482|FG006|STARTED|Overall Study||368
8688732|NCT00839254|9733483|FG007|STARTED|Overall Study||271
8688733|NCT00839254|9733476|FG000|COMPLETED|Overall Study||1696
8688734|NCT00839254|9733477|FG001|COMPLETED|Overall Study||1224
8688735|NCT00839254|9733478|FG002|COMPLETED|Overall Study||979
8688736|NCT00839254|9733479|FG003|COMPLETED|Overall Study||797
8688737|NCT00839254|9733480|FG004|COMPLETED|Overall Study||204
8688738|NCT00839254|9733481|FG005|COMPLETED|Overall Study||178
8688739|NCT00839254|9733482|FG006|COMPLETED|Overall Study||340
8688740|NCT00839254|9733483|FG007|COMPLETED|Overall Study||256
8688741|NCT00839254|9733476|FG000|NOT COMPLETED|Overall Study||153
8688742|NCT00839254|9733477|FG001|NOT COMPLETED|Overall Study||92
8688743|NCT00839254|9733478|FG002|NOT COMPLETED|Overall Study||90
8688744|NCT00839254|9733479|FG003|NOT COMPLETED|Overall Study||62
8688745|NCT00839254|9733480|FG004|NOT COMPLETED|Overall Study||37
8688746|NCT00839254|9733481|FG005|NOT COMPLETED|Overall Study||26
8688747|NCT00839254|9733482|FG006|NOT COMPLETED|Overall Study||28
8688748|NCT00839254|9733483|FG007|NOT COMPLETED|Overall Study||15
8688749|NCT00839306|9733534|FG000|STARTED|Overall Study|Treated|60
8688750|NCT00839306|9733535|FG001|STARTED|Overall Study|Treated|177
8688751|NCT00839306|9733534|FG000|COMPLETED|Overall Study||35
8688752|NCT00839306|9733535|FG001|COMPLETED|Overall Study||134
8688753|NCT00839306|9733534|FG000|NOT COMPLETED|Overall Study||25
8688754|NCT00839306|9733535|FG001|NOT COMPLETED|Overall Study||43
8688755|NCT00839319|9733547|FG000|STARTED|Overall Study||8
8688756|NCT00839319|9733548|FG001|STARTED|Overall Study||8
8688757|NCT00839319|9733549|FG002|STARTED|Overall Study||8
8688758|NCT00839319|9733550|FG003|STARTED|Overall Study||8
8688759|NCT00839319|9733551|FG004|STARTED|Overall Study||8
8688760|NCT00839319|9733547|FG000|COMPLETED|Overall Study|1 withdrew consent prior to procedures; 1 excluded from analysis (low serum LH)|6
8688761|NCT00839319|9733548|FG001|COMPLETED|Overall Study|1 excluded from analysis (low serum LH)|7
8688762|NCT00839319|9733549|FG002|COMPLETED|Overall Study|1 dropped out after Day 1 visit, 2 excluded from analysis (low serum LH)|5
8688763|NCT00839319|9733550|FG003|COMPLETED|Overall Study|1 withdrawn by investigator for syncopal reaction , 2 excluded from analysis (low serum LH)|5
8688764|NCT00839319|9733551|FG004|COMPLETED|Overall Study||8
8688765|NCT00839319|9733547|FG000|NOT COMPLETED|Overall Study||2
8688766|NCT00839319|9733548|FG001|NOT COMPLETED|Overall Study||1
8688767|NCT00839319|9733549|FG002|NOT COMPLETED|Overall Study||3
8688768|NCT00839319|9733550|FG003|NOT COMPLETED|Overall Study||3
8801859|NCT01452529|9853807|FG000|COMPLETED|Run-in Period||592
8801860|NCT01452529|9853808|FG001|COMPLETED|Run-in Period||0
8801861|NCT01452529|9853809|FG002|COMPLETED|Run-in Period||0
8801862|NCT01452529|9853807|FG000|NOT COMPLETED|Run-in Period||313
8801863|NCT01452529|9853808|FG001|NOT COMPLETED|Run-in Period||0
8801864|NCT01452529|9853809|FG002|NOT COMPLETED|Run-in Period||0
8801865|NCT01452529|9853807|FG000|STARTED|Double-blind (DB) Period||0
8801866|NCT01452529|9853808|FG001|STARTED|Double-blind (DB) Period|Four subjects were randomized but did not receive DB medication|296
8801867|NCT01452529|9853809|FG002|STARTED|Double-blind (DB) Period||292
8801868|NCT01452529|9853807|FG000|COMPLETED|Double-blind (DB) Period||0
8801869|NCT01452529|9853808|FG001|COMPLETED|Double-blind (DB) Period|4 subjects who did not receive DB medication were still counted as discontinued in the DB period|229
8801870|NCT01452529|9853809|FG002|COMPLETED|Double-blind (DB) Period||210
8801871|NCT01452529|9853807|FG000|NOT COMPLETED|Double-blind (DB) Period||0
8801872|NCT01452529|9853808|FG001|NOT COMPLETED|Double-blind (DB) Period||67
8801873|NCT01452529|9853809|FG002|NOT COMPLETED|Double-blind (DB) Period||82
8801874|NCT01452789|9853818|FG000|STARTED|Overall Study||33
8801875|NCT01452789|9853819|FG001|STARTED|Overall Study||30
8801876|NCT01452789|9853818|FG000|COMPLETED|Overall Study||30
8801877|NCT01452789|9853819|FG001|COMPLETED|Overall Study||28
8801878|NCT01452789|9853818|FG000|NOT COMPLETED|Overall Study||3
8801879|NCT01452789|9853819|FG001|NOT COMPLETED|Overall Study||2
8801880|NCT01452919|9853825|FG000|STARTED|Open-Label Treatment||123
8801881|NCT01452919|9853826|FG001|STARTED|Open-Label Treatment||0
8801882|NCT01452919|9853827|FG002|STARTED|Open-Label Treatment||0
8801883|NCT01452919|9853825|FG000|Received at Least 1 Dose of Study Drug|Open-Label Treatment||123
8801884|NCT01452919|9853826|FG001|Received at Least 1 Dose of Study Drug|Open-Label Treatment||0
8688769|NCT00839319|9733551|FG004|NOT COMPLETED|Overall Study||0
8693372|NCT00866307|9738831|FG000|NOT COMPLETED|Induction||20
8693373|NCT00866307|9738832|FG001|NOT COMPLETED|Induction||0
8693374|NCT00866307|9738833|FG002|NOT COMPLETED|Induction||0
8693375|NCT00866307|9738831|FG000|STARTED|Consolidation/Maintenance||0
8693376|NCT00866307|9738832|FG001|STARTED|Consolidation/Maintenance||54
8801885|NCT01452919|9853827|FG002|Received at Least 1 Dose of Study Drug|Open-Label Treatment||0
8688770|NCT00839332|9733566|FG000|STARTED|Phase 1||50
8688771|NCT00839332|9733567|FG001|STARTED|Phase 1|Participants in Phase 2 did not participate in Phase 1.|0
8688772|NCT00839332|9733568|FG002|STARTED|Phase 1|Participants in Phase 2 did not participate in Phase 1.|0
8688773|NCT00839332|9733566|FG000|Received at Least 1 Dose of Study Drug|Phase 1||50
8688774|NCT00839332|9733567|FG001|Received at Least 1 Dose of Study Drug|Phase 1||0
8688775|NCT00839332|9733568|FG002|Received at Least 1 Dose of Study Drug|Phase 1||0
8688776|NCT00839332|9733566|FG000|COMPLETED|Phase 1||0
8688777|NCT00839332|9733567|FG001|COMPLETED|Phase 1||0
8688778|NCT00839332|9733568|FG002|COMPLETED|Phase 1||0
8688779|NCT00839332|9733566|FG000|NOT COMPLETED|Phase 1||50
8688780|NCT00839332|9733567|FG001|NOT COMPLETED|Phase 1||0
8688781|NCT00839332|9733568|FG002|NOT COMPLETED|Phase 1||0
8688782|NCT00839332|9733566|FG000|STARTED|Phase 2|Participants in Phase 1 did not participate in Phase 2.|0
8688783|NCT00839332|9733567|FG001|STARTED|Phase 2||68
8688784|NCT00839332|9733568|FG002|STARTED|Phase 2||39
8688785|NCT00839332|9733566|FG000|Received at Least 1 Dose of Study Drug|Phase 2||0
8688786|NCT00839332|9733567|FG001|Received at Least 1 Dose of Study Drug|Phase 2||65
8688787|NCT00839332|9733568|FG002|Received at Least 1 Dose of Study Drug|Phase 2||34
8688788|NCT00839332|9733566|FG000|COMPLETED|Phase 2||0
8688789|NCT00839332|9733567|FG001|COMPLETED|Phase 2||0
8688790|NCT00839332|9733568|FG002|COMPLETED|Phase 2||0
8688791|NCT00839332|9733566|FG000|NOT COMPLETED|Phase 2||0
8688792|NCT00839332|9733567|FG001|NOT COMPLETED|Phase 2||68
8688793|NCT00839332|9733568|FG002|NOT COMPLETED|Phase 2||39
8688794|NCT00839423|9733581|FG000|STARTED|Overall Study||105
8688795|NCT00839423|9733582|FG001|STARTED|Overall Study||108
8688796|NCT00839423|9733583|FG002|STARTED|Overall Study||100
8688797|NCT00839423|9733584|FG003|STARTED|Overall Study||113
8688798|NCT00839423|9733581|FG000|COMPLETED|Overall Study||87
8688799|NCT00839423|9733582|FG001|COMPLETED|Overall Study||98
8688800|NCT00839423|9733583|FG002|COMPLETED|Overall Study||82
8688801|NCT00839423|9733584|FG003|COMPLETED|Overall Study||93
8688802|NCT00839423|9733581|FG000|NOT COMPLETED|Overall Study||18
8688803|NCT00839423|9733582|FG001|NOT COMPLETED|Overall Study||10
8688804|NCT00839423|9733583|FG002|NOT COMPLETED|Overall Study||18
8688805|NCT00839423|9733584|FG003|NOT COMPLETED|Overall Study||20
8688806|NCT00839436|9733597|FG000|STARTED|Overall Study||3
8688807|NCT00839436|9733598|FG001|STARTED|Overall Study||5
8688808|NCT00839436|9733599|FG002|STARTED|Overall Study||1
8688809|NCT00839436|9733597|FG000|COMPLETED|Overall Study||2
8688810|NCT00839436|9733598|FG001|COMPLETED|Overall Study||4
8688811|NCT00839436|9733599|FG002|COMPLETED|Overall Study||0
8688812|NCT00839436|9733597|FG000|NOT COMPLETED|Overall Study||1
8688813|NCT00839436|9733598|FG001|NOT COMPLETED|Overall Study||1
8688814|NCT00839436|9733599|FG002|NOT COMPLETED|Overall Study||1
8688815|NCT00839527|9733610|FG000|STARTED|Treatment Period (TP) (156 Weeks)||115
8688816|NCT00839527|9733611|FG001|STARTED|Treatment Period (TP) (156 Weeks)||277
8688817|NCT00839527|9733612|FG002|STARTED|Treatment Period (TP) (156 Weeks)||271
8688818|NCT00839527|9733610|FG000|COMPLETED|Treatment Period (TP) (156 Weeks)||55
8688819|NCT00839527|9733611|FG001|COMPLETED|Treatment Period (TP) (156 Weeks)||159
8688820|NCT00839527|9733612|FG002|COMPLETED|Treatment Period (TP) (156 Weeks)||152
8688821|NCT00839527|9733610|FG000|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||60
8688822|NCT00839527|9733611|FG001|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||118
8688823|NCT00839527|9733612|FG002|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||119
8688824|NCT00839527|9733610|FG000|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. One par. did not participate in the FUP.|114
8688825|NCT00839527|9733611|FG001|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. Four par. did not participate in the FUP.|273
8688826|NCT00839527|9733612|FG002|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. Five par. did not participate in the FUP.|266
8688827|NCT00839527|9733610|FG000|COMPLETED|Follow-up Period (FUP) (8 Weeks)||86
8688828|NCT00839527|9733611|FG001|COMPLETED|Follow-up Period (FUP) (8 Weeks)||217
8688829|NCT00839527|9733612|FG002|COMPLETED|Follow-up Period (FUP) (8 Weeks)||204
8688830|NCT00839527|9733610|FG000|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||28
8688831|NCT00839527|9733611|FG001|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||56
8688832|NCT00839527|9733612|FG002|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||62
8688833|NCT00839540|9733625|FG000|STARTED|Overall Study||8
8688834|NCT00839540|9733626|FG001|STARTED|Overall Study||8
8688835|NCT00839540|9733627|FG002|STARTED|Overall Study||5
8688836|NCT00839540|9733625|FG000|COMPLETED|Overall Study||8
8688837|NCT00839540|9733626|FG001|COMPLETED|Overall Study||8
8688838|NCT00839540|9733627|FG002|COMPLETED|Overall Study||5
8688839|NCT00839540|9733625|FG000|NOT COMPLETED|Overall Study||0
8688840|NCT00839540|9733626|FG001|NOT COMPLETED|Overall Study||0
8688841|NCT00839540|9733627|FG002|NOT COMPLETED|Overall Study||0
8688842|NCT00839800|9733637|FG000|STARTED|Overall Study||1049
8688843|NCT00839800|9733638|FG001|STARTED|Overall Study||1042
8688844|NCT00839800|9733637|FG000|COMPLETED|Overall Study||956
8688845|NCT00839800|9733638|FG001|COMPLETED|Overall Study||932
8688846|NCT00839800|9733637|FG000|NOT COMPLETED|Overall Study||93
8688847|NCT00839800|9733638|FG001|NOT COMPLETED|Overall Study||110
8688848|NCT00839852|9733644|FG000|STARTED|Overall Study||93
8688849|NCT00839852|9733644|FG000|COMPLETED|Overall Study||46
8688850|NCT00839852|9733644|FG000|NOT COMPLETED|Overall Study||47
8688851|NCT00839917|9733650|FG000|STARTED|Overall Study||13
8688852|NCT00839917|9733651|FG001|STARTED|Overall Study||17
8693377|NCT00866307|9738833|FG002|STARTED|Consolidation/Maintenance||30
8688853|NCT00839917|9733650|FG000|COMPLETED|Overall Study|Study completers were randomized participants who received study vaccination and had follow-up data|12
8688854|NCT00839917|9733651|FG001|COMPLETED|Overall Study|Study completers were randomized participants who received study vaccination and had follow-up data|16
8688855|NCT00839917|9733650|FG000|NOT COMPLETED|Overall Study||1
8688856|NCT00839917|9733651|FG001|NOT COMPLETED|Overall Study||1
8688857|NCT00839956|9733657|FG000|STARTED|Overall Study||31
8688858|NCT00839956|9733657|FG000|COMPLETED|Overall Study||19
8688859|NCT00839956|9733657|FG000|NOT COMPLETED|Overall Study||12
8688860|NCT00839982|9733661|FG000|STARTED|Overall Study||4
8688861|NCT00839982|9733662|FG001|STARTED|Overall Study||26
8688862|NCT00839982|9733663|FG002|STARTED|Overall Study||2
8688863|NCT00839982|9733664|FG003|STARTED|Overall Study||3
8688864|NCT00839982|9733661|FG000|COMPLETED|Overall Study||4
8688865|NCT00839982|9733662|FG001|COMPLETED|Overall Study||26
8688866|NCT00839982|9733663|FG002|COMPLETED|Overall Study||2
8688867|NCT00839982|9733664|FG003|COMPLETED|Overall Study||3
8688868|NCT00839982|9733661|FG000|NOT COMPLETED|Overall Study||0
8688869|NCT00839982|9733662|FG001|NOT COMPLETED|Overall Study||0
8688870|NCT00839982|9733663|FG002|NOT COMPLETED|Overall Study||0
8688871|NCT00839982|9733664|FG003|NOT COMPLETED|Overall Study||0
8688872|NCT00840034|9733674|FG000|STARTED|Acute Treatment Phase||111
8688873|NCT00840034|9733675|FG001|STARTED|Acute Treatment Phase||116
8688874|NCT00840034|9733674|FG000|COMPLETED|Acute Treatment Phase||90
8688875|NCT00840034|9733675|FG001|COMPLETED|Acute Treatment Phase||80
8688876|NCT00840034|9733674|FG000|NOT COMPLETED|Acute Treatment Phase||21
8688877|NCT00840034|9733675|FG001|NOT COMPLETED|Acute Treatment Phase||36
8688878|NCT00840034|9733674|FG000|STARTED|Taper Phase|Completed Acute Treatment (AT) or discontinued ≥4 weeks of AT and chose to participate in Taper.|90
8688879|NCT00840034|9733675|FG001|STARTED|Taper Phase|Completed Acute Treatment (AT) or discontinued ≥4 weeks of AT and chose to participate in Taper.|82
8688880|NCT00840034|9733674|FG000|COMPLETED|Taper Phase||87
8688881|NCT00840034|9733675|FG001|COMPLETED|Taper Phase||80
8688882|NCT00840034|9733674|FG000|NOT COMPLETED|Taper Phase||3
8688883|NCT00840034|9733675|FG001|NOT COMPLETED|Taper Phase||2
8688884|NCT00840060|9733685|FG000|STARTED|Overall Study||20
8688885|NCT00840060|9733686|FG001|STARTED|Overall Study||20
8688886|NCT00840060|9733685|FG000|COMPLETED|Overall Study||19
8688887|NCT00840060|9733686|FG001|COMPLETED|Overall Study||19
8688888|NCT00840060|9733685|FG000|NOT COMPLETED|Overall Study||1
8688889|NCT00840060|9733686|FG001|NOT COMPLETED|Overall Study||1
8688890|NCT00840086|9733692|FG000|STARTED|Overall Study||150
8688891|NCT00840086|9733692|FG000|COMPLETED|Overall Study||146
8688892|NCT00840086|9733692|FG000|NOT COMPLETED|Overall Study||4
8688893|NCT00840294|9733701|FG000|STARTED|Overall Study||42
8688894|NCT00840294|9733702|FG001|STARTED|Overall Study||43
8688895|NCT00840294|9733701|FG000|COMPLETED|Overall Study|These are the subjects included in the baseline, outcomes, and adverse events tables|39
8688896|NCT00840294|9733702|FG001|COMPLETED|Overall Study|These are the subjects included in the baseline, outcomes, and adverse events tables|38
8688897|NCT00840294|9733701|FG000|NOT COMPLETED|Overall Study||3
8688898|NCT00840294|9733702|FG001|NOT COMPLETED|Overall Study||5
8688899|NCT00840307|9733708|FG000|STARTED|Overall Study||20
8688900|NCT00840307|9733708|FG000|COMPLETED|Overall Study||16
8688901|NCT00840307|9733708|FG000|NOT COMPLETED|Overall Study||4
8688902|NCT00840450|9733712|FG000|STARTED|Overall Study||12
8688903|NCT00840450|9733712|FG000|COMPLETED|Overall Study||9
8688904|NCT00840450|9733712|FG000|NOT COMPLETED|Overall Study||3
8688905|NCT00840463|9733718|FG000|STARTED|Overall Study||3
8688906|NCT00840463|9733719|FG001|STARTED|Overall Study||1
8688907|NCT00840463|9733718|FG000|COMPLETED|Overall Study||2
8688908|NCT00840463|9733719|FG001|COMPLETED|Overall Study||1
8688909|NCT00840463|9733718|FG000|NOT COMPLETED|Overall Study||1
8688910|NCT00840463|9733719|FG001|NOT COMPLETED|Overall Study||0
8688911|NCT00840658|9733729|FG000|STARTED|Overall Study||144
8688912|NCT00840658|9733730|FG001|STARTED|Overall Study||146
8688913|NCT00840658|9733731|FG002|STARTED|Overall Study||148
8688914|NCT00840658|9733732|FG003|STARTED|Overall Study||146
8688915|NCT00840658|9733729|FG000|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|139
8688916|NCT00840658|9733730|FG001|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|143
8688917|NCT00840658|9733731|FG002|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|143
8688918|NCT00840658|9733732|FG003|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|142
8688919|NCT00840658|9733729|FG000|NOT COMPLETED|Overall Study||5
8688920|NCT00840658|9733730|FG001|NOT COMPLETED|Overall Study||3
8688921|NCT00840658|9733731|FG002|NOT COMPLETED|Overall Study||5
8688922|NCT00840658|9733732|FG003|NOT COMPLETED|Overall Study||4
8688923|NCT00840749|9733748|FG000|STARTED|Overall Study|includes patients who were screened but did not end up treated on protocol|31
8688924|NCT00840749|9733749|FG001|STARTED|Overall Study|includes patients who were screened but did not end up treated on protocol|27
8688925|NCT00840749|9733748|FG000|Treatment|Overall Study||20
8688926|NCT00840749|9733749|FG001|Treatment|Overall Study||16
8688927|NCT00840749|9733748|FG000|1 Month Post tx|Overall Study||19
8688928|NCT00840749|9733749|FG001|1 Month Post tx|Overall Study||15
8688929|NCT00840749|9733748|FG000|6 Months Post tx|Overall Study||16
8688930|NCT00840749|9733749|FG001|6 Months Post tx|Overall Study||10
8688931|NCT00840749|9733748|FG000|12 Months Post tx|Overall Study||14
8688932|NCT00840749|9733749|FG001|12 Months Post tx|Overall Study||7
8688933|NCT00840749|9733748|FG000|18 Months Post tx|Overall Study||12
8688934|NCT00840749|9733749|FG001|18 Months Post tx|Overall Study||6
8688935|NCT00840749|9733748|FG000|24 Months Post tx|Overall Study||9
8688936|NCT00840749|9733749|FG001|24 Months Post tx|Overall Study||3
8688937|NCT00840749|9733748|FG000|36 Months Post tx|Overall Study||1
8688938|NCT00840749|9733749|FG001|36 Months Post tx|Overall Study||0
8688939|NCT00840749|9733748|FG000|COMPLETED|Overall Study||0
8688940|NCT00840749|9733749|FG001|COMPLETED|Overall Study||0
8688941|NCT00840749|9733748|FG000|NOT COMPLETED|Overall Study||31
8688942|NCT00840749|9733749|FG001|NOT COMPLETED|Overall Study||27
8688943|NCT00840970|9733755|FG000|STARTED|Overall Study||7
8688944|NCT00840970|9733756|FG001|STARTED|Overall Study||38
8688945|NCT00840970|9733757|FG002|STARTED|Overall Study||5
8688946|NCT00840970|9733755|FG000|COMPLETED|Overall Study||7
8688947|NCT00840970|9733756|FG001|COMPLETED|Overall Study||38
8688948|NCT00840970|9733757|FG002|COMPLETED|Overall Study||4
8688949|NCT00840970|9733755|FG000|NOT COMPLETED|Overall Study||0
8688950|NCT00840970|9733756|FG001|NOT COMPLETED|Overall Study||0
8688951|NCT00840970|9733757|FG002|NOT COMPLETED|Overall Study||1
8688952|NCT00840996|9733769|FG000|STARTED|Overall Study||58
8688953|NCT00840996|9733770|FG001|STARTED|Overall Study||58
8688954|NCT00840996|9733769|FG000|COMPLETED|Overall Study||57
8688955|NCT00840996|9733770|FG001|COMPLETED|Overall Study||58
8688956|NCT00840996|9733769|FG000|NOT COMPLETED|Overall Study||1
8688957|NCT00840996|9733770|FG001|NOT COMPLETED|Overall Study||0
8688958|NCT00841087|9733778|FG000|STARTED|Overall Study||33
8688959|NCT00841087|9733779|FG001|STARTED|Overall Study||32
8688960|NCT00841087|9733778|FG000|COMPLETED|Overall Study||33
8688961|NCT00841087|9733779|FG001|COMPLETED|Overall Study||32
8688962|NCT00841087|9733778|FG000|NOT COMPLETED|Overall Study||0
8688963|NCT00841087|9733779|FG001|NOT COMPLETED|Overall Study||0
8688964|NCT00841100|9733785|FG000|STARTED|Acute Component (24 Hours)||21
8688965|NCT00841100|9733785|FG000|COMPLETED|Acute Component (24 Hours)||21
8688966|NCT00841100|9733785|FG000|NOT COMPLETED|Acute Component (24 Hours)||0
8688967|NCT00841100|9733785|FG000|STARTED|Phase 1 (28 Days)|3 participants from the acute phase elected not to continue to the Phase 1 component of the study.|18
8688968|NCT00841100|9733785|FG000|COMPLETED|Phase 1 (28 Days)||15
8688969|NCT00841100|9733785|FG000|NOT COMPLETED|Phase 1 (28 Days)||3
8688970|NCT00841100|9733785|FG000|STARTED|Phase 2 (2 Weeks)|Participants who were non-responsive on the Phase 1 component of the study continued on to Phase 2.|5
8688971|NCT00841100|9733785|FG000|COMPLETED|Phase 2 (2 Weeks)||5
8688972|NCT00841100|9733785|FG000|NOT COMPLETED|Phase 2 (2 Weeks)||0
8688973|NCT00841100|9733785|FG000|STARTED|Phase 3 (28 Days)|Participants who achieved a fasting blood phenylalanine of <600 umol/l can continue to Phase 3.|4
8688974|NCT00841100|9733785|FG000|COMPLETED|Phase 3 (28 Days)||4
8688975|NCT00841100|9733785|FG000|NOT COMPLETED|Phase 3 (28 Days)||0
8688976|NCT00841204|9733791|FG000|STARTED|Overall Study||25
8688977|NCT00841204|9733792|FG001|STARTED|Overall Study||25
8688978|NCT00841204|9733791|FG000|COMPLETED|Overall Study||25
8688979|NCT00841204|9733792|FG001|COMPLETED|Overall Study||25
8688980|NCT00841204|9733791|FG000|NOT COMPLETED|Overall Study||0
8688981|NCT00841204|9733792|FG001|NOT COMPLETED|Overall Study||0
8688982|NCT00841269|9733802|FG000|STARTED|Overall Study||20
8688983|NCT00841269|9733803|FG001|STARTED|Overall Study||22
8688984|NCT00841269|9733802|FG000|COMPLETED|Overall Study||12
8688985|NCT00841269|9733803|FG001|COMPLETED|Overall Study||13
8688986|NCT00841269|9733802|FG000|NOT COMPLETED|Overall Study||8
8688987|NCT00841269|9733803|FG001|NOT COMPLETED|Overall Study||9
8688988|NCT00841321|9733810|FG000|STARTED|Overall Study||59
8688989|NCT00841321|9733811|FG001|STARTED|Overall Study||61
8688990|NCT00841321|9733810|FG000|COMPLETED|Overall Study||58
8688991|NCT00841321|9733811|FG001|COMPLETED|Overall Study||58
8688992|NCT00841321|9733810|FG000|NOT COMPLETED|Overall Study||1
8688993|NCT00841321|9733811|FG001|NOT COMPLETED|Overall Study||3
8688994|NCT00841412|9733819|FG000|STARTED|Overall Study|200 of 222 consented residents completed baseline assessments across both groups.|120
8688995|NCT00841412|9733820|FG001|STARTED|Overall Study|80 residents were in the delayed intervention group, but all residents received intervention.|80
8688996|NCT00841412|9733819|FG000|COMPLETED|Overall Study|130 residents completed all study phases across both groups, including follow-up.|80
8688997|NCT00841412|9733820|FG001|COMPLETED|Overall Study||50
8688998|NCT00841412|9733819|FG000|NOT COMPLETED|Overall Study||40
8688999|NCT00841412|9733820|FG001|NOT COMPLETED|Overall Study||30
8689000|NCT00841555|9733827|FG000|STARTED|Overall Study||3
8689001|NCT00841555|9733828|FG001|STARTED|Overall Study||3
8689002|NCT00841555|9733829|FG002|STARTED|Overall Study||3
8689003|NCT00841555|9733827|FG000|COMPLETED|Overall Study||3
8689004|NCT00841555|9733828|FG001|COMPLETED|Overall Study||3
8689005|NCT00841555|9733829|FG002|COMPLETED|Overall Study||3
8689006|NCT00841555|9733827|FG000|NOT COMPLETED|Overall Study||0
8689007|NCT00841555|9733828|FG001|NOT COMPLETED|Overall Study||0
8689008|NCT00841555|9733829|FG002|NOT COMPLETED|Overall Study||0
8689009|NCT00841568|9733835|FG000|STARTED|Overall Study||17
8689010|NCT00841568|9733835|FG000|COMPLETED|Overall Study||12
8689011|NCT00841568|9733835|FG000|NOT COMPLETED|Overall Study||5
8689012|NCT00841672|9733845|FG000|STARTED|Overall Study|One patient was mis-randomized and was not treated in the double-blind treatment period.|244
8689013|NCT00841672|9733846|FG001|STARTED|Overall Study||241
8689014|NCT00841672|9733845|FG000|COMPLETED|Overall Study||224
8689015|NCT00841672|9733846|FG001|COMPLETED|Overall Study||209
8689016|NCT00841672|9733845|FG000|NOT COMPLETED|Overall Study||20
8689017|NCT00841672|9733846|FG001|NOT COMPLETED|Overall Study||32
8689018|NCT00841763|9733854|FG000|STARTED|Overall Study||2691
8689019|NCT00841763|9733855|FG001|STARTED|Overall Study||681
8689020|NCT00841763|9733856|FG002|STARTED|Overall Study||219
8689021|NCT00841763|9733857|FG003|STARTED|Overall Study||56
8689022|NCT00841763|9733854|FG000|COMPLETED|Overall Study||2529
8689023|NCT00841763|9733855|FG001|COMPLETED|Overall Study||624
8689024|NCT00841763|9733856|FG002|COMPLETED|Overall Study||211
8689025|NCT00841763|9733857|FG003|COMPLETED|Overall Study||53
8689026|NCT00841763|9733854|FG000|NOT COMPLETED|Overall Study||162
8689027|NCT00841763|9733855|FG001|NOT COMPLETED|Overall Study||57
8689028|NCT00841763|9733856|FG002|NOT COMPLETED|Overall Study||8
8689029|NCT00841763|9733857|FG003|NOT COMPLETED|Overall Study||3
8689030|NCT00841776|9733904|FG000|STARTED|Overall Study||27
8689031|NCT00841776|9733905|FG001|STARTED|Overall Study||27
8689032|NCT00841776|9733904|FG000|COMPLETED|Overall Study||25
8689033|NCT00841776|9733905|FG001|COMPLETED|Overall Study||24
8689034|NCT00841776|9733904|FG000|NOT COMPLETED|Overall Study||2
8689035|NCT00841776|9733905|FG001|NOT COMPLETED|Overall Study||3
8689036|NCT00841828|9733913|FG000|STARTED|Overall Study||52
8689037|NCT00841828|9733914|FG001|STARTED|Overall Study||50
8689038|NCT00841828|9733913|FG000|COMPLETED|Overall Study||42
8689039|NCT00841828|9733914|FG001|COMPLETED|Overall Study||48
8801886|NCT01452919|9853825|FG000|COMPLETED|Open-Label Treatment||103
8801887|NCT01452919|9853826|FG001|COMPLETED|Open-Label Treatment||0
8801888|NCT01452919|9853827|FG002|COMPLETED|Open-Label Treatment||0
8801889|NCT01452919|9853825|FG000|NOT COMPLETED|Open-Label Treatment||20
8801890|NCT01452919|9853826|FG001|NOT COMPLETED|Open-Label Treatment||0
8801891|NCT01452919|9853827|FG002|NOT COMPLETED|Open-Label Treatment||0
8801892|NCT01452919|9853825|FG000|STARTED|Randomization Treatment||0
8801893|NCT01452919|9853826|FG001|STARTED|Randomization Treatment||50
8801894|NCT01452919|9853827|FG002|STARTED|Randomization Treatment||53
8801895|NCT01452919|9853825|FG000|Received at Least 1 Dose of Study Drug|Randomization Treatment||0
8801896|NCT01452919|9853826|FG001|Received at Least 1 Dose of Study Drug|Randomization Treatment||50
8801897|NCT01452919|9853827|FG002|Received at Least 1 Dose of Study Drug|Randomization Treatment||53
8801898|NCT01452919|9853825|FG000|COMPLETED|Randomization Treatment||0
8801899|NCT01452919|9853826|FG001|COMPLETED|Randomization Treatment||47
8801900|NCT01452919|9853827|FG002|COMPLETED|Randomization Treatment||51
8801901|NCT01452919|9853825|FG000|NOT COMPLETED|Randomization Treatment||0
8801902|NCT01452919|9853826|FG001|NOT COMPLETED|Randomization Treatment||3
8801903|NCT01452919|9853827|FG002|NOT COMPLETED|Randomization Treatment||2
8801904|NCT01453023|9853837|FG000|STARTED|Treatment Period (TP) 1||13
8801905|NCT01453023|9853838|FG001|STARTED|Treatment Period (TP) 1||13
8801906|NCT01453023|9853837|FG000|COMPLETED|Treatment Period (TP) 1||12
8801907|NCT01453023|9853838|FG001|COMPLETED|Treatment Period (TP) 1||12
8801908|NCT01453023|9853837|FG000|NOT COMPLETED|Treatment Period (TP) 1||1
8801909|NCT01453023|9853838|FG001|NOT COMPLETED|Treatment Period (TP) 1||1
8801910|NCT01453023|9853837|FG000|STARTED|Washout Period||12
8801911|NCT01453023|9853838|FG001|STARTED|Washout Period||12
8801912|NCT01453023|9853837|FG000|COMPLETED|Washout Period||12
8801913|NCT01453023|9853838|FG001|COMPLETED|Washout Period||12
8801914|NCT01453023|9853837|FG000|NOT COMPLETED|Washout Period||0
8801915|NCT01453023|9853838|FG001|NOT COMPLETED|Washout Period||0
8801916|NCT01453023|9853837|FG000|STARTED|Treatment Period 2||12
8801917|NCT01453023|9853838|FG001|STARTED|Treatment Period 2||12
8801918|NCT01453023|9853837|FG000|COMPLETED|Treatment Period 2||12
8801919|NCT01453023|9853838|FG001|COMPLETED|Treatment Period 2||11
8801920|NCT01453023|9853837|FG000|NOT COMPLETED|Treatment Period 2||0
8801921|NCT01453023|9853838|FG001|NOT COMPLETED|Treatment Period 2||1
8801922|NCT01453036|9853847|FG000|STARTED|Overall Study||308
8801923|NCT01453036|9853848|FG001|STARTED|Overall Study||308
8801924|NCT01453036|9853849|FG002|STARTED|Overall Study||308
8801925|NCT01453036|9853847|FG000|COMPLETED|Overall Study||282
8801926|NCT01453036|9853848|FG001|COMPLETED|Overall Study||193
8801927|NCT01453036|9853849|FG002|COMPLETED|Overall Study||277
8801928|NCT01453036|9853847|FG000|NOT COMPLETED|Overall Study||26
8801929|NCT01453036|9853848|FG001|NOT COMPLETED|Overall Study||115
8801930|NCT01453036|9853849|FG002|NOT COMPLETED|Overall Study||31
8801931|NCT01453049|9853859|FG000|STARTED|Overall Study||42
8801932|NCT01453049|9853860|FG001|STARTED|Overall Study||44
8801933|NCT01453049|9853859|FG000|COMPLETED|Overall Study||1
8801934|NCT01453049|9853860|FG001|COMPLETED|Overall Study||2
8801935|NCT01453049|9853859|FG000|NOT COMPLETED|Overall Study||41
8801936|NCT01453049|9853860|FG001|NOT COMPLETED|Overall Study||42
8801937|NCT01453075|9853868|FG000|STARTED|Overall Study||16
8801938|NCT01453075|9853869|FG001|STARTED|Overall Study||15
8801939|NCT01453075|9853868|FG000|COMPLETED|Overall Study||11
8801940|NCT01453075|9853869|FG001|COMPLETED|Overall Study||14
8801941|NCT01453075|9853868|FG000|NOT COMPLETED|Overall Study||5
8801942|NCT01453075|9853869|FG001|NOT COMPLETED|Overall Study||1
8801943|NCT01453153|9853878|FG000|STARTED|Overall Study||4
8801944|NCT01453153|9853879|FG001|STARTED|Overall Study||4
8801945|NCT01453153|9853880|FG002|STARTED|Overall Study||20
8801946|NCT01453153|9853878|FG000|COMPLETED|Overall Study||0
8801947|NCT01453153|9853879|FG001|COMPLETED|Overall Study||0
8801948|NCT01453153|9853880|FG002|COMPLETED|Overall Study||0
8801949|NCT01453153|9853878|FG000|NOT COMPLETED|Overall Study||4
8801950|NCT01453153|9853879|FG001|NOT COMPLETED|Overall Study||4
8801951|NCT01453153|9853880|FG002|NOT COMPLETED|Overall Study||20
8801952|NCT01453166|9853895|FG000|STARTED|Overall Study||42
8801953|NCT01453166|9853896|FG001|STARTED|Overall Study||41
8801954|NCT01453166|9853897|FG002|STARTED|Overall Study||39
8689040|NCT00841828|9733913|FG000|NOT COMPLETED|Overall Study||10
8689041|NCT00841828|9733914|FG001|NOT COMPLETED|Overall Study||2
8689042|NCT00841906|9733924|FG000|STARTED|Overall Study||18
8689043|NCT00841906|9733925|FG001|STARTED|Overall Study||14
8689044|NCT00841906|9733924|FG000|COMPLETED|Overall Study||16
8689045|NCT00841906|9733925|FG001|COMPLETED|Overall Study||14
8689046|NCT00841906|9733924|FG000|NOT COMPLETED|Overall Study||2
8689047|NCT00841906|9733925|FG001|NOT COMPLETED|Overall Study||0
8689048|NCT00841971|9733935|FG000|STARTED|Overall Study||100
8689049|NCT00841971|9733936|FG001|STARTED|Overall Study||100
8689050|NCT00841971|9733935|FG000|COMPLETED|Overall Study||98
8689051|NCT00841971|9733936|FG001|COMPLETED|Overall Study||99
8689052|NCT00841971|9733935|FG000|NOT COMPLETED|Overall Study||2
8689053|NCT00841971|9733936|FG001|NOT COMPLETED|Overall Study||1
8689054|NCT00842023|9733944|FG000|STARTED|Overall Study||45
8689055|NCT00842023|9733945|FG001|STARTED|Overall Study||44
8689056|NCT00842023|9733944|FG000|COMPLETED|Overall Study||45
8689057|NCT00842023|9733945|FG001|COMPLETED|Overall Study||44
8689058|NCT00842023|9733944|FG000|NOT COMPLETED|Overall Study||0
8689059|NCT00842023|9733945|FG001|NOT COMPLETED|Overall Study||0
8689060|NCT00842075|9733956|FG000|STARTED|Overall Study||5
8689061|NCT00842075|9733957|FG001|STARTED|Overall Study||5
8689062|NCT00842075|9733956|FG000|COMPLETED|Overall Study||5
8689063|NCT00842075|9733957|FG001|COMPLETED|Overall Study||5
8689064|NCT00842075|9733956|FG000|NOT COMPLETED|Overall Study||0
8689065|NCT00842075|9733957|FG001|NOT COMPLETED|Overall Study||0
8689066|NCT00842153|9733965|FG000|STARTED|Overall Study||28
8689067|NCT00842153|9733966|FG001|STARTED|Overall Study||30
8689068|NCT00842153|9733965|FG000|COMPLETED|Overall Study||27
8689069|NCT00842153|9733966|FG001|COMPLETED|Overall Study||27
8689070|NCT00842153|9733965|FG000|NOT COMPLETED|Overall Study||1
8689071|NCT00842153|9733966|FG001|NOT COMPLETED|Overall Study||3
8689072|NCT00842231|9733972|FG000|STARTED|Overall Study||40
8689073|NCT00842231|9733972|FG000|COMPLETED|Overall Study||40
8689074|NCT00842231|9733972|FG000|NOT COMPLETED|Overall Study||0
8689075|NCT00842244|9733976|FG000|STARTED|Overall Study||22
8689076|NCT00842244|9733976|FG000|COMPLETED|Overall Study||1
8689077|NCT00842244|9733976|FG000|NOT COMPLETED|Overall Study||21
8689078|NCT00842257|9733983|FG000|STARTED|Overall Study||20
8689079|NCT00842257|9733983|FG000|COMPLETED|Overall Study||19
8689080|NCT00842257|9733983|FG000|NOT COMPLETED|Overall Study||1
8689081|NCT00842296|9733987|FG000|STARTED|Overall Study||326
8689082|NCT00842296|9733987|FG000|COMPLETED|Overall Study||326
8689083|NCT00842296|9733987|FG000|NOT COMPLETED|Overall Study||0
8689084|NCT00842309|9733993|FG000|STARTED|Overall Study|14 randomized. 2 withdrew prior to initiating DCS-not included in modified intent-to-treat analyses.|14
8689085|NCT00842309|9733994|FG001|STARTED|Overall Study||14
8689086|NCT00842309|9733993|FG000|COMPLETED|Overall Study||11
8689087|NCT00842309|9733994|FG001|COMPLETED|Overall Study||13
8689088|NCT00842309|9733993|FG000|NOT COMPLETED|Overall Study||3
8689089|NCT00842309|9733994|FG001|NOT COMPLETED|Overall Study||1
8689090|NCT00842335|9734000|FG000|STARTED|Overall Study||18
8689091|NCT00842335|9734000|FG000|COMPLETED|Overall Study||18
8689092|NCT00842335|9734000|FG000|NOT COMPLETED|Overall Study||0
8689093|NCT00842348|9734008|FG000|STARTED|Patients Randomised in Study 726||101
8689094|NCT00842348|9734009|FG001|STARTED|Patients Randomised in Study 726||103
8919750|NCT02209181|9979679|FG001|STARTED|Overall Study||67
8919751|NCT02209181|9979680|FG002|STARTED|Overall Study||69
8919752|NCT02209181|9979681|FG003|STARTED|Overall Study||66
8919753|NCT02209181|9979678|FG000|COMPLETED|Overall Study||66
8919754|NCT02209181|9979679|FG001|COMPLETED|Overall Study||66
8919755|NCT02209181|9979680|FG002|COMPLETED|Overall Study||68
8919756|NCT02209181|9979681|FG003|COMPLETED|Overall Study||66
8919757|NCT02209181|9979678|FG000|NOT COMPLETED|Overall Study||1
8919758|NCT02209181|9979679|FG001|NOT COMPLETED|Overall Study||1
8919759|NCT02209181|9979680|FG002|NOT COMPLETED|Overall Study||1
8919760|NCT02209181|9979681|FG003|NOT COMPLETED|Overall Study||0
8919761|NCT02209259|9979694|FG000|STARTED|Overall Study||56
8919762|NCT02209259|9979695|FG001|STARTED|Overall Study||56
8919763|NCT02209259|9979696|FG002|STARTED|Overall Study||56
8919764|NCT02209259|9979694|FG000|COMPLETED|Overall Study||56
8919765|NCT02209259|9979695|FG001|COMPLETED|Overall Study||56
8919766|NCT02209259|9979696|FG002|COMPLETED|Overall Study||56
8919767|NCT02209259|9979694|FG000|NOT COMPLETED|Overall Study||0
8919768|NCT02209259|9979695|FG001|NOT COMPLETED|Overall Study||0
8919769|NCT02209259|9979696|FG002|NOT COMPLETED|Overall Study||0
8919770|NCT02209272|9979706|FG000|STARTED|Overall Study||32
8919771|NCT02209272|9979707|FG001|STARTED|Overall Study||36
8919772|NCT02209272|9979706|FG000|COMPLETED|Overall Study||32
8919773|NCT02209272|9979707|FG001|COMPLETED|Overall Study||36
8919774|NCT02209272|9979706|FG000|NOT COMPLETED|Overall Study||0
8919775|NCT02209272|9979707|FG001|NOT COMPLETED|Overall Study||0
8919776|NCT02209454|9979713|FG000|STARTED|First Period||13
8919777|NCT02209454|9979714|FG001|STARTED|First Period||13
8919778|NCT02209454|9979713|FG000|COMPLETED|First Period||13
8919779|NCT02209454|9979714|FG001|COMPLETED|First Period||13
8689095|NCT00842348|9734008|FG000|COMPLETED|Patients Randomised in Study 726|41 patients had stable disease and 1 patient had progressive disease.|42
8689096|NCT00842348|9734009|FG001|COMPLETED|Patients Randomised in Study 726|15 patients had stable disease and 32 patients had progressive disease.|47
8689097|NCT00842348|9734008|FG000|NOT COMPLETED|Patients Randomised in Study 726||59
8919780|NCT02209454|9979713|FG000|NOT COMPLETED|First Period||0
8919781|NCT02209454|9979714|FG001|NOT COMPLETED|First Period||0
8689098|NCT00842348|9734009|FG001|NOT COMPLETED|Patients Randomised in Study 726||56
8689099|NCT00842348|9734008|FG000|STARTED|Study 729||42
8689100|NCT00842348|9734009|FG001|STARTED|Study 729||47
8689101|NCT00842348|9734008|FG000|COMPLETED|Study 729|Enrolled in Study 729 and received at least one dose of open label lanreotide Autogel.|16
8689102|NCT00842348|9734009|FG001|COMPLETED|Study 729|Enrolled in Study 729 and received at least one dose of open label lanreotide Autogel.|9
8689103|NCT00842348|9734008|FG000|NOT COMPLETED|Study 729||26
8689104|NCT00842348|9734009|FG001|NOT COMPLETED|Study 729||38
8689105|NCT00842361|9734021|FG000|STARTED|Overall Study||33
8689106|NCT00842361|9734022|FG001|STARTED|Overall Study||33
8689107|NCT00842361|9734021|FG000|Exposed|Overall Study||33
8689108|NCT00842361|9734022|FG001|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|32
8689109|NCT00842361|9734021|FG000|COMPLETED|Overall Study||32
8801955|NCT01453166|9853895|FG000|COMPLETED|Overall Study||40
8801956|NCT01453166|9853896|FG001|COMPLETED|Overall Study||39
8801957|NCT01453166|9853897|FG002|COMPLETED|Overall Study||38
8801958|NCT01453166|9853895|FG000|NOT COMPLETED|Overall Study||2
8801959|NCT01453166|9853896|FG001|NOT COMPLETED|Overall Study||2
8801960|NCT01453166|9853897|FG002|NOT COMPLETED|Overall Study||1
8801961|NCT01453205|9853908|FG000|STARTED|Overall Study||80
8801962|NCT01453205|9853909|FG001|STARTED|Overall Study||52
8801963|NCT01453205|9853910|FG002|STARTED|Overall Study||55
8801964|NCT01453205|9853908|FG000|COMPLETED|Overall Study||0
8801965|NCT01453205|9853909|FG001|COMPLETED|Overall Study||0
8801966|NCT01453205|9853910|FG002|COMPLETED|Overall Study||1
8801967|NCT01453205|9853908|FG000|NOT COMPLETED|Overall Study||80
8801968|NCT01453205|9853909|FG001|NOT COMPLETED|Overall Study||52
8801969|NCT01453205|9853910|FG002|NOT COMPLETED|Overall Study||54
8801970|NCT01453296|9853921|FG000|STARTED|Treatment Period 1||14
8801971|NCT01453296|9853922|FG001|STARTED|Treatment Period 1||14
8801972|NCT01453296|9853921|FG000|COMPLETED|Treatment Period 1||13
8801973|NCT01453296|9853922|FG001|COMPLETED|Treatment Period 1||13
8801974|NCT01453296|9853921|FG000|NOT COMPLETED|Treatment Period 1||1
8801975|NCT01453296|9853922|FG001|NOT COMPLETED|Treatment Period 1||1
8801976|NCT01453296|9853921|FG000|STARTED|Washout Period||13
8801977|NCT01453296|9853922|FG001|STARTED|Washout Period||13
8801978|NCT01453296|9853921|FG000|COMPLETED|Washout Period||13
8801979|NCT01453296|9853922|FG001|COMPLETED|Washout Period||13
8801980|NCT01453296|9853921|FG000|NOT COMPLETED|Washout Period||0
8801981|NCT01453296|9853922|FG001|NOT COMPLETED|Washout Period||0
8801982|NCT01453296|9853921|FG000|STARTED|Treatment Period 2||13
8801983|NCT01453296|9853922|FG001|STARTED|Treatment Period 2||13
8801984|NCT01453296|9853921|FG000|COMPLETED|Treatment Period 2||11
8801985|NCT01453296|9853922|FG001|COMPLETED|Treatment Period 2||13
8801986|NCT01453296|9853921|FG000|NOT COMPLETED|Treatment Period 2||2
8801987|NCT01453296|9853922|FG001|NOT COMPLETED|Treatment Period 2||0
8801988|NCT01453348|9853931|FG000|STARTED|Overall Study||84
8801989|NCT01453348|9853932|FG001|STARTED|Overall Study||84
8801990|NCT01453348|9853933|FG002|STARTED|Overall Study||84
8801991|NCT01453348|9853931|FG000|COMPLETED|Overall Study||83
8801992|NCT01453348|9853932|FG001|COMPLETED|Overall Study||83
8801993|NCT01453348|9853933|FG002|COMPLETED|Overall Study||83
8801994|NCT01453348|9853931|FG000|NOT COMPLETED|Overall Study||1
8801995|NCT01453348|9853932|FG001|NOT COMPLETED|Overall Study||1
8801996|NCT01453348|9853933|FG002|NOT COMPLETED|Overall Study||1
8801997|NCT01453361|9853944|FG000|STARTED|Overall Study||18
8801998|NCT01453361|9853944|FG000|COMPLETED|Overall Study||2
8801999|NCT01453361|9853944|FG000|NOT COMPLETED|Overall Study||16
8802000|NCT01453374|9853948|FG000|STARTED|Overall Study||27
8802001|NCT01453374|9853948|FG000|COMPLETED|Overall Study|Defined as receiving 7 injections and 2 follow-up visits.|9
8802002|NCT01453374|9853948|FG000|NOT COMPLETED|Overall Study||18
8802003|NCT01453387|9853956|FG000|STARTED|Overall Study||21
8802004|NCT01453387|9853957|FG001|STARTED|Overall Study||7
8802005|NCT01453387|9853956|FG000|COMPLETED|Overall Study||21
8802006|NCT01453387|9853957|FG001|COMPLETED|Overall Study||7
8802007|NCT01453387|9853956|FG000|NOT COMPLETED|Overall Study||0
8802008|NCT01453387|9853957|FG001|NOT COMPLETED|Overall Study||0
8802009|NCT01453413|9853980|FG000|STARTED|Overall Study||297
8802010|NCT01453413|9853980|FG000|COMPLETED|Overall Study||297
8802011|NCT01453413|9853980|FG000|NOT COMPLETED|Overall Study||0
8802012|NCT01453439|9853986|FG000|STARTED|Treatment Phase||61
8802013|NCT01453439|9853987|FG001|STARTED|Treatment Phase||59
8802014|NCT01453439|9853986|FG000|COMPLETED|Treatment Phase||44
8802015|NCT01453439|9853987|FG001|COMPLETED|Treatment Phase||48
8802016|NCT01453439|9853986|FG000|NOT COMPLETED|Treatment Phase||17
8802017|NCT01453439|9853987|FG001|NOT COMPLETED|Treatment Phase||11
8802018|NCT01453439|9853986|FG000|STARTED|Follow-up||44
8802019|NCT01453439|9853987|FG001|STARTED|Follow-up||48
8802020|NCT01453439|9853986|FG000|COMPLETED|Follow-up||39
8802021|NCT01453439|9853987|FG001|COMPLETED|Follow-up||37
8802022|NCT01453439|9853986|FG000|NOT COMPLETED|Follow-up||5
8802023|NCT01453439|9853987|FG001|NOT COMPLETED|Follow-up||11
8802024|NCT01453569|9853996|FG000|STARTED|Overall Study||86
8802025|NCT01453569|9853997|FG001|STARTED|Overall Study||84
8802026|NCT01453569|9853998|FG002|STARTED|Overall Study||85
8802027|NCT01453569|9853996|FG000|COMPLETED|Overall Study||75
8802028|NCT01453569|9853997|FG001|COMPLETED|Overall Study||70
8802029|NCT01453569|9853998|FG002|COMPLETED|Overall Study||78
9035746|NCT03301740|10097445|FG001|COMPLETED|Third Washout (1 Week)||16
8802030|NCT01453569|9853996|FG000|NOT COMPLETED|Overall Study||11
8802031|NCT01453569|9853997|FG001|NOT COMPLETED|Overall Study||14
8689110|NCT00842361|9734022|FG001|COMPLETED|Overall Study||31
8689111|NCT00842361|9734021|FG000|NOT COMPLETED|Overall Study||1
8689112|NCT00842361|9734022|FG001|NOT COMPLETED|Overall Study||2
8689113|NCT00842543|9734032|FG000|STARTED|Overall Study||13
8689114|NCT00842543|9734033|FG001|STARTED|Overall Study||5
8689115|NCT00842543|9734034|FG002|STARTED|Overall Study||13
8689116|NCT00842543|9734035|FG003|STARTED|Overall Study||8
8689117|NCT00842543|9734032|FG000|COMPLETED|Overall Study||11
8689118|NCT00842543|9734033|FG001|COMPLETED|Overall Study||5
8689119|NCT00842543|9734034|FG002|COMPLETED|Overall Study||10
8689120|NCT00842543|9734035|FG003|COMPLETED|Overall Study||4
8689121|NCT00842543|9734032|FG000|NOT COMPLETED|Overall Study||2
8689122|NCT00842543|9734033|FG001|NOT COMPLETED|Overall Study||0
8689123|NCT00842543|9734034|FG002|NOT COMPLETED|Overall Study||3
8689124|NCT00842543|9734035|FG003|NOT COMPLETED|Overall Study||4
8689125|NCT00842608|9734051|FG000|STARTED|Overall Study||174
8689126|NCT00842608|9734052|FG001|STARTED|Overall Study||177
8689127|NCT00842608|9734053|FG002|STARTED|Overall Study||99
8689128|NCT00842608|9734054|FG003|STARTED|Overall Study||101
8689129|NCT00842608|9734051|FG000|COMPLETED|Overall Study||170
8689130|NCT00842608|9734052|FG001|COMPLETED|Overall Study||176
8689131|NCT00842608|9734053|FG002|COMPLETED|Overall Study||99
8689132|NCT00842608|9734054|FG003|COMPLETED|Overall Study||100
8689133|NCT00842608|9734051|FG000|NOT COMPLETED|Overall Study||4
8689134|NCT00842608|9734052|FG001|NOT COMPLETED|Overall Study||1
8689135|NCT00842608|9734053|FG002|NOT COMPLETED|Overall Study||0
8689136|NCT00842608|9734054|FG003|NOT COMPLETED|Overall Study||1
8689137|NCT00842712|9734071|FG000|STARTED|Safety Run-in Part||3
8689138|NCT00842712|9734072|FG001|STARTED|Safety Run-in Part||3
8689139|NCT00842712|9734073|FG002|STARTED|Safety Run-in Part||3
8689140|NCT00842712|9734074|FG003|STARTED|Safety Run-in Part||3
8689141|NCT00842712|9734075|FG004|STARTED|Safety Run-in Part||0
8689142|NCT00842712|9734076|FG005|STARTED|Safety Run-in Part||0
8689143|NCT00842712|9734077|FG006|STARTED|Safety Run-in Part||0
8689144|NCT00842712|9734071|FG000|COMPLETED|Safety Run-in Part||0
8689145|NCT00842712|9734072|FG001|COMPLETED|Safety Run-in Part||1
8689146|NCT00842712|9734073|FG002|COMPLETED|Safety Run-in Part||3
8689147|NCT00842712|9734074|FG003|COMPLETED|Safety Run-in Part||2
8689148|NCT00842712|9734075|FG004|COMPLETED|Safety Run-in Part||0
8689149|NCT00842712|9734076|FG005|COMPLETED|Safety Run-in Part||0
8689150|NCT00842712|9734077|FG006|COMPLETED|Safety Run-in Part||0
8689151|NCT00842712|9734071|FG000|NOT COMPLETED|Safety Run-in Part||3
8689152|NCT00842712|9734072|FG001|NOT COMPLETED|Safety Run-in Part||2
8689153|NCT00842712|9734073|FG002|NOT COMPLETED|Safety Run-in Part||0
8689154|NCT00842712|9734074|FG003|NOT COMPLETED|Safety Run-in Part||1
8689155|NCT00842712|9734075|FG004|NOT COMPLETED|Safety Run-in Part||0
8689156|NCT00842712|9734076|FG005|NOT COMPLETED|Safety Run-in Part||0
8689157|NCT00842712|9734077|FG006|NOT COMPLETED|Safety Run-in Part||0
8689158|NCT00842712|9734071|FG000|STARTED|Randomized Part||0
8689159|NCT00842712|9734072|FG001|STARTED|Randomized Part||0
8689160|NCT00842712|9734073|FG002|STARTED|Randomized Part||0
8689161|NCT00842712|9734074|FG003|STARTED|Randomized Part||0
8689162|NCT00842712|9734075|FG004|STARTED|Randomized Part||85
8689163|NCT00842712|9734076|FG005|STARTED|Randomized Part||51
8689164|NCT00842712|9734077|FG006|STARTED|Randomized Part||84
8689165|NCT00842712|9734071|FG000|Treated|Randomized Part||0
8689166|NCT00842712|9734072|FG001|Treated|Randomized Part||0
8689167|NCT00842712|9734073|FG002|Treated|Randomized Part||0
8689168|NCT00842712|9734074|FG003|Treated|Randomized Part||0
8689169|NCT00842712|9734075|FG004|Treated|Randomized Part||85
8689170|NCT00842712|9734076|FG005|Treated|Randomized Part||50
8689171|NCT00842712|9734077|FG006|Treated|Randomized Part||80
8689172|NCT00842712|9734071|FG000|COMPLETED|Randomized Part||0
8689173|NCT00842712|9734072|FG001|COMPLETED|Randomized Part||0
8689174|NCT00842712|9734073|FG002|COMPLETED|Randomized Part||0
8689175|NCT00842712|9734074|FG003|COMPLETED|Randomized Part||0
8689176|NCT00842712|9734075|FG004|COMPLETED|Randomized Part||85
8689177|NCT00842712|9734076|FG005|COMPLETED|Randomized Part||50
8689178|NCT00842712|9734077|FG006|COMPLETED|Randomized Part||78
8689179|NCT00842712|9734071|FG000|NOT COMPLETED|Randomized Part||0
8689180|NCT00842712|9734072|FG001|NOT COMPLETED|Randomized Part||0
8919782|NCT02209454|9979713|FG000|STARTED|Washout Period a Minimum of a 7 Day||13
8919783|NCT02209454|9979714|FG001|STARTED|Washout Period a Minimum of a 7 Day||13
8919784|NCT02209454|9979713|FG000|COMPLETED|Washout Period a Minimum of a 7 Day||13
8919785|NCT02209454|9979714|FG001|COMPLETED|Washout Period a Minimum of a 7 Day||13
8689181|NCT00842712|9734073|FG002|NOT COMPLETED|Randomized Part||0
8689182|NCT00842712|9734074|FG003|NOT COMPLETED|Randomized Part||0
8689183|NCT00842712|9734075|FG004|NOT COMPLETED|Randomized Part||0
8689184|NCT00842712|9734076|FG005|NOT COMPLETED|Randomized Part||1
8689185|NCT00842712|9734077|FG006|NOT COMPLETED|Randomized Part||6
8689186|NCT00842751|9734093|FG000|STARTED|Overall Study||11
8689187|NCT00842751|9734093|FG000|COMPLETED|Overall Study||11
8689188|NCT00842751|9734093|FG000|NOT COMPLETED|Overall Study||0
8689189|NCT00842764|9734106|FG000|STARTED|Overall Study||7
8689190|NCT00842764|9734106|FG000|COMPLETED|Overall Study||5
8689191|NCT00842764|9734106|FG000|NOT COMPLETED|Overall Study||2
8689192|NCT00842829|9734112|FG000|STARTED|Dose Titration Period||156
8689193|NCT00842829|9734113|FG001|STARTED|Dose Titration Period||174
8689194|NCT00842829|9734114|FG002|STARTED|Dose Titration Period||0
8689195|NCT00842829|9734112|FG000|Titration Safety Analysis Set|Dose Titration Period|Received at least one dose of study drug|145
8689196|NCT00842829|9734113|FG001|Titration Safety Analysis Set|Dose Titration Period|Received at least one dose of study drug|167
8689197|NCT00842829|9734114|FG002|Titration Safety Analysis Set|Dose Titration Period||0
8689198|NCT00842829|9734112|FG000|COMPLETED|Dose Titration Period||130
8689199|NCT00842829|9734113|FG001|COMPLETED|Dose Titration Period||151
8689200|NCT00842829|9734114|FG002|COMPLETED|Dose Titration Period||0
8689201|NCT00842829|9734112|FG000|NOT COMPLETED|Dose Titration Period||26
8689202|NCT00842829|9734113|FG001|NOT COMPLETED|Dose Titration Period||23
8689203|NCT00842829|9734114|FG002|NOT COMPLETED|Dose Titration Period||0
8689204|NCT00842829|9734112|FG000|STARTED|Treatment Period||0
8689205|NCT00842829|9734113|FG001|STARTED|Treatment Period||0
8689206|NCT00842829|9734114|FG002|STARTED|Treatment Period||281
8689207|NCT00842829|9734112|FG000|Safety Analysis Set|Treatment Period||0
8689208|NCT00842829|9734113|FG001|Safety Analysis Set|Treatment Period||0
8689209|NCT00842829|9734114|FG002|Safety Analysis Set|Treatment Period|Received at least one dose of study drug|223
8689210|NCT00842829|9734112|FG000|COMPLETED|Treatment Period||0
8689211|NCT00842829|9734113|FG001|COMPLETED|Treatment Period||0
8689212|NCT00842829|9734114|FG002|COMPLETED|Treatment Period||218
8689213|NCT00842829|9734112|FG000|NOT COMPLETED|Treatment Period||0
8689214|NCT00842829|9734113|FG001|NOT COMPLETED|Treatment Period||0
8689215|NCT00842829|9734114|FG002|NOT COMPLETED|Treatment Period||63
8689216|NCT00842829|9734112|FG000|STARTED|Continuation Period||0
8689217|NCT00842829|9734113|FG001|STARTED|Continuation Period||0
8689218|NCT00842829|9734114|FG002|STARTED|Continuation Period|Eligible for Continuation Period|88
8689219|NCT00842829|9734112|FG000|Continuation Safety Analysis Set|Continuation Period||0
8689220|NCT00842829|9734113|FG001|Continuation Safety Analysis Set|Continuation Period||0
8689221|NCT00842829|9734114|FG002|Continuation Safety Analysis Set|Continuation Period|Received at least one dose of study drug|87
8689222|NCT00842829|9734112|FG000|COMPLETED|Continuation Period||0
8689223|NCT00842829|9734113|FG001|COMPLETED|Continuation Period||0
8689224|NCT00842829|9734114|FG002|COMPLETED|Continuation Period||27
8689225|NCT00842829|9734112|FG000|NOT COMPLETED|Continuation Period||0
8689226|NCT00842829|9734113|FG001|NOT COMPLETED|Continuation Period||0
8689227|NCT00842829|9734114|FG002|NOT COMPLETED|Continuation Period||61
8689228|NCT00842946|9734128|FG000|STARTED|Overall Study||21
8689229|NCT00842946|9734129|FG001|STARTED|Overall Study||24
8689230|NCT00842946|9734128|FG000|COMPLETED|Overall Study||16
8689231|NCT00842946|9734129|FG001|COMPLETED|Overall Study||19
8689232|NCT00842946|9734128|FG000|NOT COMPLETED|Overall Study||5
8689233|NCT00842946|9734129|FG001|NOT COMPLETED|Overall Study||5
8689234|NCT00842985|9734135|FG000|STARTED|Screening||53
8689235|NCT00842985|9734135|FG000|COMPLETED|Screening||26
8689236|NCT00842985|9734135|FG000|NOT COMPLETED|Screening||27
8689237|NCT00842985|9734135|FG000|STARTED|First Intervention|Signed Consent|26
8689238|NCT00842985|9734135|FG000|COMPLETED|First Intervention|Completed 1st Intervention|20
8689239|NCT00842985|9734135|FG000|NOT COMPLETED|First Intervention||6
8689240|NCT00842985|9734135|FG000|STARTED|Washout Period of GE 4 Days||20
8689241|NCT00842985|9734135|FG000|COMPLETED|Washout Period of GE 4 Days||18
8689242|NCT00842985|9734135|FG000|NOT COMPLETED|Washout Period of GE 4 Days||2
8689243|NCT00842985|9734135|FG000|STARTED|Second Intervention||18
8689244|NCT00842985|9734135|FG000|COMPLETED|Second Intervention||17
8689245|NCT00842985|9734135|FG000|NOT COMPLETED|Second Intervention||1
8689246|NCT00842985|9734135|FG000|STARTED|Washout Period of GE 4 Days||17
8689247|NCT00842985|9734135|FG000|COMPLETED|Washout Period of GE 4 Days||15
8689248|NCT00842985|9734135|FG000|NOT COMPLETED|Washout Period of GE 4 Days||2
8689249|NCT00842985|9734135|FG000|STARTED|Third Intervention||15
8689250|NCT00842985|9734135|FG000|COMPLETED|Third Intervention||15
8689251|NCT00842985|9734135|FG000|NOT COMPLETED|Third Intervention||0
8689252|NCT00842985|9734135|FG000|STARTED|Washout Period of GE 4 Days||15
8689253|NCT00842985|9734135|FG000|COMPLETED|Washout Period of GE 4 Days||15
8689254|NCT00842985|9734135|FG000|NOT COMPLETED|Washout Period of GE 4 Days||0
8689255|NCT00842985|9734135|FG000|STARTED|Fourth Intervention||15
8689256|NCT00842985|9734135|FG000|COMPLETED|Fourth Intervention||15
8689257|NCT00842985|9734135|FG000|NOT COMPLETED|Fourth Intervention||0
8689258|NCT00843024|9734146|FG000|STARTED|Single-blind Placebo Run-In Phase||408
8689259|NCT00843024|9734147|FG001|STARTED|Single-blind Placebo Run-In Phase||457
8689260|NCT00843024|9734148|FG002|STARTED|Single-blind Placebo Run-In Phase||0
8689261|NCT00843024|9734149|FG003|STARTED|Single-blind Placebo Run-In Phase||0
8689262|NCT00843024|9734150|FG004|STARTED|Single-blind Placebo Run-In Phase||0
8689263|NCT00843024|9734151|FG005|STARTED|Single-blind Placebo Run-In Phase||0
8689264|NCT00843024|9734146|FG000|COMPLETED|Single-blind Placebo Run-In Phase||268
8689265|NCT00843024|9734147|FG001|COMPLETED|Single-blind Placebo Run-In Phase||321
8689266|NCT00843024|9734148|FG002|COMPLETED|Single-blind Placebo Run-In Phase||0
8689267|NCT00843024|9734149|FG003|COMPLETED|Single-blind Placebo Run-In Phase||0
8689268|NCT00843024|9734150|FG004|COMPLETED|Single-blind Placebo Run-In Phase||0
8689269|NCT00843024|9734151|FG005|COMPLETED|Single-blind Placebo Run-In Phase||0
8689270|NCT00843024|9734146|FG000|NOT COMPLETED|Single-blind Placebo Run-In Phase||140
8689271|NCT00843024|9734147|FG001|NOT COMPLETED|Single-blind Placebo Run-In Phase||136
8689272|NCT00843024|9734148|FG002|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
8689273|NCT00843024|9734149|FG003|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
8689274|NCT00843024|9734150|FG004|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
8689275|NCT00843024|9734151|FG005|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
8689276|NCT00843024|9734146|FG000|STARTED|Double-blind Treatment Phase||0
8689277|NCT00843024|9734147|FG001|STARTED|Double-blind Treatment Phase||0
8689278|NCT00843024|9734148|FG002|STARTED|Double-blind Treatment Phase||176
8689279|NCT00843024|9734149|FG003|STARTED|Double-blind Treatment Phase||119
8689280|NCT00843024|9734150|FG004|STARTED|Double-blind Treatment Phase||117
8689281|NCT00843024|9734151|FG005|STARTED|Double-blind Treatment Phase||177
8689282|NCT00843024|9734146|FG000|COMPLETED|Double-blind Treatment Phase||0
8689283|NCT00843024|9734147|FG001|COMPLETED|Double-blind Treatment Phase||0
8689284|NCT00843024|9734148|FG002|COMPLETED|Double-blind Treatment Phase||145
8689285|NCT00843024|9734149|FG003|COMPLETED|Double-blind Treatment Phase||96
8689286|NCT00843024|9734150|FG004|COMPLETED|Double-blind Treatment Phase||97
8689287|NCT00843024|9734151|FG005|COMPLETED|Double-blind Treatment Phase||152
8689288|NCT00843024|9734146|FG000|NOT COMPLETED|Double-blind Treatment Phase||0
8689289|NCT00843024|9734147|FG001|NOT COMPLETED|Double-blind Treatment Phase||0
8689290|NCT00843024|9734148|FG002|NOT COMPLETED|Double-blind Treatment Phase||31
8689291|NCT00843024|9734149|FG003|NOT COMPLETED|Double-blind Treatment Phase||23
8689292|NCT00843024|9734150|FG004|NOT COMPLETED|Double-blind Treatment Phase||20
8689293|NCT00843024|9734151|FG005|NOT COMPLETED|Double-blind Treatment Phase||25
8689294|NCT00843115|9734164|FG000|STARTED|Overall Study||370
8689295|NCT00843115|9734164|FG000|COMPLETED|Overall Study||304
8689296|NCT00843115|9734164|FG000|NOT COMPLETED|Overall Study||66
8689297|NCT00843167|9734170|FG000|STARTED|Treatment Period||27
8689298|NCT00843167|9734171|FG001|STARTED|Treatment Period||27
8689299|NCT00843167|9734170|FG000|COMPLETED|Treatment Period||24
8689300|NCT00843167|9734171|FG001|COMPLETED|Treatment Period||19
8689301|NCT00843167|9734170|FG000|NOT COMPLETED|Treatment Period||3
8689302|NCT00843167|9734171|FG001|NOT COMPLETED|Treatment Period||8
8689303|NCT00843167|9734170|FG000|STARTED|Follow-up||24
8689304|NCT00843167|9734171|FG001|STARTED|Follow-up||24
8689305|NCT00843167|9734170|FG000|Completed Final Visit|Follow-up||24
8689306|NCT00843167|9734171|FG001|Completed Final Visit|Follow-up||24
8689307|NCT00843167|9734170|FG000|COMPLETED|Follow-up||24
8689308|NCT00843167|9734171|FG001|COMPLETED|Follow-up||24
8689309|NCT00843167|9734170|FG000|NOT COMPLETED|Follow-up||0
8689310|NCT00843167|9734171|FG001|NOT COMPLETED|Follow-up||0
8689311|NCT00843180|9734183|FG000|STARTED|Overall Study||16
8689312|NCT00843180|9734184|FG001|STARTED|Overall Study||7
8689313|NCT00843180|9734183|FG000|COMPLETED|Overall Study||16
8689314|NCT00843180|9734184|FG001|COMPLETED|Overall Study||7
8689315|NCT00843180|9734183|FG000|NOT COMPLETED|Overall Study||0
8689316|NCT00843180|9734184|FG001|NOT COMPLETED|Overall Study||0
8689317|NCT00843193|9734192|FG000|STARTED|Overall Study||99
8689318|NCT00843193|9734193|FG001|STARTED|Overall Study||99
8689319|NCT00843193|9734192|FG000|COMPLETED|Overall Study||91
8689320|NCT00843193|9734193|FG001|COMPLETED|Overall Study||88
8689321|NCT00843193|9734192|FG000|NOT COMPLETED|Overall Study||8
8689322|NCT00843193|9734193|FG001|NOT COMPLETED|Overall Study||11
8689323|NCT00843284|9734200|FG000|STARTED|Overall Study||691
8689324|NCT00843284|9734200|FG000|COMPLETED|Overall Study||619
8689325|NCT00843284|9734200|FG000|NOT COMPLETED|Overall Study||72
8689326|NCT00843349|9734208|FG000|STARTED|Overall Study||11
8689327|NCT00843349|9734209|FG001|STARTED|Overall Study||11
8689328|NCT00843349|9734210|FG002|STARTED|Overall Study||10
8689329|NCT00843349|9734211|FG003|STARTED|Overall Study||11
8689330|NCT00843349|9734208|FG000|COMPLETED|Overall Study||8
8689331|NCT00843349|9734209|FG001|COMPLETED|Overall Study||11
8689332|NCT00843349|9734210|FG002|COMPLETED|Overall Study||10
8689333|NCT00843349|9734211|FG003|COMPLETED|Overall Study||10
8689334|NCT00843349|9734208|FG000|NOT COMPLETED|Overall Study||3
8689335|NCT00843349|9734209|FG001|NOT COMPLETED|Overall Study||0
8689336|NCT00843349|9734210|FG002|NOT COMPLETED|Overall Study||0
8689337|NCT00843349|9734211|FG003|NOT COMPLETED|Overall Study||1
8689338|NCT00843466|9734223|FG000|STARTED|Overall Study||24
8689339|NCT00843466|9734224|FG001|STARTED|Overall Study||18
8689340|NCT00843466|9734223|FG000|COMPLETED|Overall Study||24
8689341|NCT00843466|9734224|FG001|COMPLETED|Overall Study||18
8689342|NCT00843466|9734223|FG000|NOT COMPLETED|Overall Study||0
8689343|NCT00843466|9734224|FG001|NOT COMPLETED|Overall Study||0
8689344|NCT00843479|9734232|FG000|STARTED|Overall Study||12
8689345|NCT00843479|9734233|FG001|STARTED|Overall Study||12
8689346|NCT00843479|9734232|FG000|COMPLETED|Overall Study||12
8689347|NCT00843479|9734233|FG001|COMPLETED|Overall Study||12
8689348|NCT00843479|9734232|FG000|NOT COMPLETED|Overall Study||0
8689349|NCT00843479|9734233|FG001|NOT COMPLETED|Overall Study||0
8689350|NCT00843492|9734243|FG000|STARTED|Overall Study||622
8689351|NCT00843492|9734244|FG001|STARTED|Overall Study||621
8689352|NCT00843492|9734243|FG000|COMPLETED|Overall Study||614
8689353|NCT00843492|9734244|FG001|COMPLETED|Overall Study||607
8689354|NCT00843492|9734243|FG000|NOT COMPLETED|Overall Study||8
8689355|NCT00843492|9734244|FG001|NOT COMPLETED|Overall Study||14
8689356|NCT00843518|9734252|FG000|STARTED|Period 2 (Double-blind Treatment)||63
8689357|NCT00843518|9734253|FG001|STARTED|Period 2 (Double-blind Treatment)||69
8689358|NCT00843518|9734252|FG000|COMPLETED|Period 2 (Double-blind Treatment)||43
8689359|NCT00843518|9734253|FG001|COMPLETED|Period 2 (Double-blind Treatment)||49
8689360|NCT00843518|9734252|FG000|NOT COMPLETED|Period 2 (Double-blind Treatment)||20
8689361|NCT00843518|9734253|FG001|NOT COMPLETED|Period 2 (Double-blind Treatment)||20
8689362|NCT00843518|9734252|FG000|STARTED|Period 3 (Single-blind Washout)|1 LY451395 participant completed double-blind treatment, but did not enter washout period.|42
8689363|NCT00843518|9734253|FG001|STARTED|Period 3 (Single-blind Washout)||49
8689364|NCT00843518|9734252|FG000|COMPLETED|Period 3 (Single-blind Washout)||42
8689365|NCT00843518|9734253|FG001|COMPLETED|Period 3 (Single-blind Washout)||49
8689366|NCT00843518|9734252|FG000|NOT COMPLETED|Period 3 (Single-blind Washout)||0
8689367|NCT00843518|9734253|FG001|NOT COMPLETED|Period 3 (Single-blind Washout)||0
8689368|NCT00843531|9734263|FG000|STARTED|Overall Study||17
8689369|NCT00843531|9734263|FG000|COMPLETED|Overall Study||17
8689370|NCT00843531|9734263|FG000|NOT COMPLETED|Overall Study||0
8689371|NCT00843622|9734273|FG000|STARTED|Overall Study||125
8689372|NCT00843622|9734274|FG001|STARTED|Overall Study||125
8689373|NCT00843622|9734273|FG000|COMPLETED|Overall Study||82
8689374|NCT00843622|9734274|FG001|COMPLETED|Overall Study||70
8689375|NCT00843622|9734273|FG000|NOT COMPLETED|Overall Study||43
8689376|NCT00843622|9734274|FG001|NOT COMPLETED|Overall Study||55
8689377|NCT00843635|9734283|FG000|STARTED|Overall Study||15
8689378|NCT00843635|9734284|FG001|STARTED|Overall Study||15
8689379|NCT00843635|9734285|FG002|STARTED|Overall Study||5
8689380|NCT00843635|9734283|FG000|COMPLETED|Overall Study||13
8689381|NCT00843635|9734284|FG001|COMPLETED|Overall Study||13
8689382|NCT00843635|9734285|FG002|COMPLETED|Overall Study||5
8689383|NCT00843635|9734283|FG000|NOT COMPLETED|Overall Study||2
8689384|NCT00843635|9734284|FG001|NOT COMPLETED|Overall Study||2
8689385|NCT00843635|9734285|FG002|NOT COMPLETED|Overall Study||0
8689386|NCT00843713|9734299|FG000|STARTED|Overall Study||30
8689387|NCT00843713|9734300|FG001|STARTED|Overall Study||26
8689388|NCT00843713|9734299|FG000|COMPLETED|Overall Study||30
8689389|NCT00843713|9734300|FG001|COMPLETED|Overall Study||26
8689390|NCT00843713|9734299|FG000|NOT COMPLETED|Overall Study||0
8689391|NCT00843713|9734300|FG001|NOT COMPLETED|Overall Study||0
8689392|NCT00843726|9734308|FG000|STARTED|Overall Study||49
8689393|NCT00843726|9734309|FG001|STARTED|Overall Study||49
8689394|NCT00843726|9734308|FG000|COMPLETED|Overall Study||48
8689395|NCT00843726|9734309|FG001|COMPLETED|Overall Study||48
8689396|NCT00843726|9734308|FG000|NOT COMPLETED|Overall Study||1
8689397|NCT00843726|9734309|FG001|NOT COMPLETED|Overall Study||1
8689398|NCT00843778|9734316|FG000|STARTED|Overall Study||131
8689399|NCT00843778|9734316|FG000|COMPLETED|Overall Study||96
8689400|NCT00843778|9734316|FG000|NOT COMPLETED|Overall Study||35
8689401|NCT00843843|9734322|FG000|STARTED|Overall Study||8
8689402|NCT00843843|9734323|FG001|STARTED|Overall Study||8
8689403|NCT00843843|9734322|FG000|COMPLETED|Overall Study||6
8689404|NCT00843843|9734323|FG001|COMPLETED|Overall Study||6
8689405|NCT00843843|9734322|FG000|NOT COMPLETED|Overall Study||2
8689406|NCT00843843|9734323|FG001|NOT COMPLETED|Overall Study||2
8689407|NCT00843856|9734331|FG000|STARTED|Overall Study||20
8689408|NCT00843856|9734332|FG001|STARTED|Overall Study||20
8689409|NCT00843856|9734331|FG000|COMPLETED|Overall Study||19
8689410|NCT00843856|9734332|FG001|COMPLETED|Overall Study||18
8689411|NCT00843856|9734331|FG000|NOT COMPLETED|Overall Study||1
8689412|NCT00843856|9734332|FG001|NOT COMPLETED|Overall Study||2
8689413|NCT00844051|9734340|FG000|STARTED|Overall Study||2087
8689414|NCT00844051|9734341|FG001|STARTED|Overall Study||2368
8689415|NCT00844051|9734340|FG000|COMPLETED|Overall Study||2087
8689416|NCT00844051|9734341|FG001|COMPLETED|Overall Study||2368
8689417|NCT00844051|9734340|FG000|NOT COMPLETED|Overall Study||0
8689418|NCT00844051|9734341|FG001|NOT COMPLETED|Overall Study||0
8689419|NCT00844090|9734349|FG000|STARTED|Overall Study||52
8689420|NCT00844090|9734350|FG001|STARTED|Overall Study||54
8689421|NCT00844090|9734349|FG000|COMPLETED|Overall Study||46
8689422|NCT00844090|9734350|FG001|COMPLETED|Overall Study||46
8689423|NCT00844090|9734349|FG000|NOT COMPLETED|Overall Study||6
8689424|NCT00844090|9734350|FG001|NOT COMPLETED|Overall Study||8
8689425|NCT00844194|9734358|FG000|STARTED|Overall Study||78
8689426|NCT00844194|9734359|FG001|STARTED|Overall Study||30
8689427|NCT00844194|9734358|FG000|COMPLETED|Overall Study||53
8689428|NCT00844194|9734359|FG001|COMPLETED|Overall Study||22
8689429|NCT00844194|9734358|FG000|NOT COMPLETED|Overall Study||25
8689430|NCT00844194|9734359|FG001|NOT COMPLETED|Overall Study||8
8689431|NCT00844298|9734369|FG000|STARTED|Overall Study||91
8689432|NCT00844298|9734369|FG000|COMPLETED|Overall Study||91
8689433|NCT00844298|9734369|FG000|NOT COMPLETED|Overall Study||0
8689434|NCT00844376|9734373|FG000|STARTED|Period 1: First Intervention||6
8689435|NCT00844376|9734374|FG001|STARTED|Period 1: First Intervention||6
8689436|NCT00844376|9734373|FG000|COMPLETED|Period 1: First Intervention||5
8689437|NCT00844376|9734374|FG001|COMPLETED|Period 1: First Intervention||6
8689438|NCT00844376|9734373|FG000|NOT COMPLETED|Period 1: First Intervention||1
8689439|NCT00844376|9734374|FG001|NOT COMPLETED|Period 1: First Intervention||0
8689440|NCT00844376|9734373|FG000|STARTED|Period 2: Second Intervention||5
8689441|NCT00844376|9734374|FG001|STARTED|Period 2: Second Intervention||6
8689442|NCT00844376|9734373|FG000|COMPLETED|Period 2: Second Intervention|Total subjects administered Test drug = 12; total subjects administered Reference drug = 11.|5
8689443|NCT00844376|9734374|FG001|COMPLETED|Period 2: Second Intervention||6
8802032|NCT01453569|9853998|FG002|NOT COMPLETED|Overall Study||7
8689444|NCT00844376|9734373|FG000|NOT COMPLETED|Period 2: Second Intervention||0
8689445|NCT00844376|9734374|FG001|NOT COMPLETED|Period 2: Second Intervention||0
8689446|NCT00844415|9734380|FG000|STARTED|Overall Study|Entered and treated.|9
8689447|NCT00844415|9734380|FG000|Pat. Received 75mg Followed by 100mg|Overall Study||3
8689448|NCT00844415|9734380|FG000|Pat. Received 100mg Followed by 125mg|Overall Study||3
8689449|NCT00844415|9734380|FG000|Pat. Received 125mg Followed by 150mg|Overall Study||2
8689450|NCT00844415|9734380|FG000|Pat. Received Single Dose 75mg|Overall Study||1
8689451|NCT00844415|9734380|FG000|COMPLETED|Overall Study|Completed.|8
8689452|NCT00844415|9734380|FG000|NOT COMPLETED|Overall Study||1
8689453|NCT00844428|9734385|FG000|STARTED|Screening Period||23
8689454|NCT00844428|9734385|FG000|COMPLETED|Screening Period||20
8689455|NCT00844428|9734385|FG000|NOT COMPLETED|Screening Period||3
8689456|NCT00844428|9734385|FG000|STARTED|Observation Period (8 Weeks)||20
8689457|NCT00844428|9734385|FG000|COMPLETED|Observation Period (8 Weeks)||20
8689458|NCT00844428|9734385|FG000|NOT COMPLETED|Observation Period (8 Weeks)||0
8689459|NCT00844428|9734385|FG000|STARTED|Treatment Period (26 Weeks)||20
8689460|NCT00844428|9734385|FG000|COMPLETED|Treatment Period (26 Weeks)||20
8689461|NCT00844428|9734385|FG000|NOT COMPLETED|Treatment Period (26 Weeks)||0
8689462|NCT00844428|9734385|FG000|STARTED|Extension Treatment Period||19
8689463|NCT00844428|9734385|FG000|COMPLETED|Extension Treatment Period||18
8689464|NCT00844428|9734385|FG000|NOT COMPLETED|Extension Treatment Period||1
8689465|NCT00844428|9734385|FG000|STARTED|Post Treatment Period (Patients Who Disc||5
8689466|NCT00844428|9734385|FG000|COMPLETED|Post Treatment Period (Patients Who Disc||4
8689467|NCT00844428|9734385|FG000|NOT COMPLETED|Post Treatment Period (Patients Who Disc||1
8689468|NCT00844519|9734391|FG000|STARTED|Overall Study||26
8689469|NCT00844519|9734392|FG001|STARTED|Overall Study||26
8689470|NCT00844519|9734391|FG000|COMPLETED|Overall Study||24
8689471|NCT00844519|9734392|FG001|COMPLETED|Overall Study||25
8689472|NCT00844519|9734391|FG000|NOT COMPLETED|Overall Study||2
8689473|NCT00844519|9734392|FG001|NOT COMPLETED|Overall Study||1
8689474|NCT00844532|9734398|FG000|STARTED|Overall Study||151
8689475|NCT00844532|9734398|FG000|COMPLETED|Overall Study||112
8689476|NCT00844532|9734398|FG000|NOT COMPLETED|Overall Study||39
8689477|NCT00844545|9734402|FG000|STARTED|Screening Period||17
8689478|NCT00844545|9734402|FG000|COMPLETED|Screening Period||17
8689479|NCT00844545|9734402|FG000|NOT COMPLETED|Screening Period||0
8689480|NCT00844545|9734402|FG000|STARTED|Treatment Period (26 Weeks)||17
8689481|NCT00844545|9734402|FG000|COMPLETED|Treatment Period (26 Weeks)||15
8689482|NCT00844545|9734402|FG000|NOT COMPLETED|Treatment Period (26 Weeks)||2
8689483|NCT00844545|9734402|FG000|STARTED|Extension Treatment Period||13
8689484|NCT00844545|9734402|FG000|COMPLETED|Extension Treatment Period||11
8689485|NCT00844545|9734402|FG000|NOT COMPLETED|Extension Treatment Period||2
8689486|NCT00844545|9734402|FG000|STARTED|Post Treatment Period||6
8689487|NCT00844545|9734402|FG000|COMPLETED|Post Treatment Period||5
8689488|NCT00844545|9734402|FG000|NOT COMPLETED|Post Treatment Period||1
8689489|NCT00844558|9734409|FG000|STARTED|Overall Study|"Received allocated intervention (n=33)~Did not receive allocated intervention (n=3)"|36
8689490|NCT00844558|9734410|FG001|STARTED|Overall Study|"Received allocated intervention (n=21)~Did not receive allocated intervention (n=1)"|22
8689491|NCT00844558|9734409|FG000|Received Allocated Intervention|Overall Study||33
8689492|NCT00844558|9734410|FG001|Received Allocated Intervention|Overall Study||21
8689493|NCT00844558|9734409|FG000|3 Month Visit|Overall Study|Discontinued intervention (n=4)|29
8689494|NCT00844558|9734410|FG001|3 Month Visit|Overall Study|"Lost to follow-up (n=1)~Discontinued Intervention (n=1)"|19
8689495|NCT00844558|9734409|FG000|6 Month Visit|Overall Study|Discontinued intervention (n=1)|28
8689496|NCT00844558|9734410|FG001|6 Month Visit|Overall Study|-Discontinued intervention (n=1)|18
8689497|NCT00844558|9734409|FG000|12 Month Visit|Overall Study|Discontinued intervention (n=4)|24
8689498|NCT00844558|9734410|FG001|12 Month Visit|Overall Study|-Discontinued intervention (n=0)|18
8689499|NCT00844558|9734409|FG000|COMPLETED|Overall Study||24
8689500|NCT00844558|9734410|FG001|COMPLETED|Overall Study||18
8689501|NCT00844558|9734409|FG000|NOT COMPLETED|Overall Study||12
8689502|NCT00844558|9734410|FG001|NOT COMPLETED|Overall Study||4
8689503|NCT00844597|9734427|FG000|STARTED|Overall Study||4
8689504|NCT00844597|9734428|FG001|STARTED|Overall Study||2
8689505|NCT00844597|9734429|FG002|STARTED|Overall Study||2
8689506|NCT00844597|9734430|FG003|STARTED|Overall Study||3
8689507|NCT00844597|9734431|FG004|STARTED|Overall Study||4
8689508|NCT00844597|9734432|FG005|STARTED|Overall Study||4
8689509|NCT00844597|9734427|FG000|COMPLETED|Overall Study||4
8689510|NCT00844597|9734428|FG001|COMPLETED|Overall Study||2
8689511|NCT00844597|9734429|FG002|COMPLETED|Overall Study||2
8689512|NCT00844597|9734430|FG003|COMPLETED|Overall Study||2
8689513|NCT00844597|9734431|FG004|COMPLETED|Overall Study||4
8689514|NCT00844597|9734432|FG005|COMPLETED|Overall Study||4
8689515|NCT00844597|9734427|FG000|NOT COMPLETED|Overall Study||0
8689516|NCT00844597|9734428|FG001|NOT COMPLETED|Overall Study||0
8689517|NCT00844597|9734429|FG002|NOT COMPLETED|Overall Study||0
8689518|NCT00844597|9734430|FG003|NOT COMPLETED|Overall Study||1
8689519|NCT00844597|9734431|FG004|NOT COMPLETED|Overall Study||0
8689520|NCT00844597|9734432|FG005|NOT COMPLETED|Overall Study||0
8689521|NCT00844649|9734450|FG000|STARTED|Overall Study|Started = Intent to Treat Population and includes all randomized participants|431
8689522|NCT00844649|9734451|FG001|STARTED|Overall Study|Started = Intent to Treat Population and includes all randomized participants|430
8689523|NCT00844649|9734450|FG000|Treated Population|Overall Study|Treated population = all randomized patients who received at least one dose of study drug|421
8689524|NCT00844649|9734451|FG001|Treated Population|Overall Study|Treated population = all randomized patients who received at least one dose of study drug|402
8689525|NCT00844649|9734450|FG000|COMPLETED|Overall Study|Completed = participants remaining on treatment at the time of the data cut off 17 Sept 2012|26
8689526|NCT00844649|9734451|FG001|COMPLETED|Overall Study|Completed = participants remaining on treatment at the time of the data cut off 17 Sept 2012|12
8689527|NCT00844649|9734450|FG000|NOT COMPLETED|Overall Study||405
8689528|NCT00844649|9734451|FG001|NOT COMPLETED|Overall Study||418
8689529|NCT00844714|9734459|FG000|STARTED|Overall Study||20
8689530|NCT00844714|9734459|FG000|COMPLETED|Overall Study||20
8689531|NCT00844714|9734459|FG000|NOT COMPLETED|Overall Study||0
8689532|NCT00844753|9734467|FG000|STARTED|Overall Study||32
8689533|NCT00844753|9734468|FG001|STARTED|Overall Study||32
8689534|NCT00844753|9734469|FG002|STARTED|Overall Study||32
8689535|NCT00844753|9734470|FG003|STARTED|Overall Study||32
8689536|NCT00844753|9734467|FG000|COMPLETED|Overall Study||24
8689537|NCT00844753|9734468|FG001|COMPLETED|Overall Study||29
8689538|NCT00844753|9734469|FG002|COMPLETED|Overall Study||25
8689539|NCT00844753|9734470|FG003|COMPLETED|Overall Study||21
8689540|NCT00844753|9734467|FG000|NOT COMPLETED|Overall Study||8
8689541|NCT00844753|9734468|FG001|NOT COMPLETED|Overall Study||3
8689542|NCT00844753|9734469|FG002|NOT COMPLETED|Overall Study||7
8689543|NCT00844753|9734470|FG003|NOT COMPLETED|Overall Study||11
8689544|NCT00844805|9734480|FG000|STARTED|Treatment Phase||106
8689545|NCT00844805|9734481|FG001|STARTED|Treatment Phase||52
8689546|NCT00844805|9734482|FG002|STARTED|Treatment Phase||0
8689547|NCT00844805|9734483|FG003|STARTED|Treatment Phase||0
8689548|NCT00844805|9734480|FG000|COMPLETED|Treatment Phase||96
8689549|NCT00844805|9734481|FG001|COMPLETED|Treatment Phase||45
8689550|NCT00844805|9734482|FG002|COMPLETED|Treatment Phase||0
8689551|NCT00844805|9734483|FG003|COMPLETED|Treatment Phase||0
8689552|NCT00844805|9734480|FG000|NOT COMPLETED|Treatment Phase||10
8689553|NCT00844805|9734481|FG001|NOT COMPLETED|Treatment Phase||7
8689554|NCT00844805|9734482|FG002|NOT COMPLETED|Treatment Phase||0
8689555|NCT00844805|9734483|FG003|NOT COMPLETED|Treatment Phase||0
8689556|NCT00844805|9734480|FG000|STARTED|Follow-Up Phase||0
8689557|NCT00844805|9734481|FG001|STARTED|Follow-Up Phase||0
8689558|NCT00844805|9734482|FG002|STARTED|Follow-Up Phase|Participants who met partial remission criteria at the end of treatment entered the Follow-Up Phase.|41
8689559|NCT00844805|9734483|FG003|STARTED|Follow-Up Phase|Participants who met partial remission criteria at the end of treatment entered the Follow-Up Phase.|41
8689560|NCT00844805|9734480|FG000|COMPLETED|Follow-Up Phase||0
8689561|NCT00844805|9734481|FG001|COMPLETED|Follow-Up Phase||0
8689562|NCT00844805|9734482|FG002|COMPLETED|Follow-Up Phase||32
8689563|NCT00844805|9734483|FG003|COMPLETED|Follow-Up Phase||32
8689564|NCT00844805|9734480|FG000|NOT COMPLETED|Follow-Up Phase||0
8689565|NCT00844805|9734481|FG001|NOT COMPLETED|Follow-Up Phase||0
8689566|NCT00844805|9734482|FG002|NOT COMPLETED|Follow-Up Phase||9
8689567|NCT00844805|9734483|FG003|NOT COMPLETED|Follow-Up Phase||9
8689568|NCT00844831|9734494|FG000|STARTED|Overall Study||25
8689569|NCT00844831|9734494|FG000|COMPLETED|Overall Study||19
8689570|NCT00844831|9734494|FG000|NOT COMPLETED|Overall Study||6
8689571|NCT00844844|9734502|FG000|STARTED|Screening Period||17
8689572|NCT00844844|9734502|FG000|COMPLETED|Screening Period||17
8689573|NCT00844844|9734502|FG000|NOT COMPLETED|Screening Period||0
8689574|NCT00844844|9734502|FG000|STARTED|Treatment Period (26 Weeks)||17
8689575|NCT00844844|9734502|FG000|COMPLETED|Treatment Period (26 Weeks)||15
8689576|NCT00844844|9734502|FG000|NOT COMPLETED|Treatment Period (26 Weeks)||2
8689577|NCT00844844|9734502|FG000|STARTED|Extension Treatment Period||13
8689578|NCT00844844|9734502|FG000|COMPLETED|Extension Treatment Period||11
8689579|NCT00844844|9734502|FG000|NOT COMPLETED|Extension Treatment Period||2
8689580|NCT00844844|9734502|FG000|STARTED|Post Treatment Period||6
8689581|NCT00844844|9734502|FG000|COMPLETED|Post Treatment Period||5
8802033|NCT01453595|9854009|FG000|STARTED|Overall Study||2
8802034|NCT01453595|9854010|FG001|STARTED|Overall Study||6
8802035|NCT01453595|9854011|FG002|STARTED|Overall Study||2
8802036|NCT01453595|9854009|FG000|COMPLETED|Overall Study||0
8802037|NCT01453595|9854010|FG001|COMPLETED|Overall Study||5
8802038|NCT01453595|9854011|FG002|COMPLETED|Overall Study||0
8802039|NCT01453595|9854009|FG000|NOT COMPLETED|Overall Study||2
8802040|NCT01453595|9854010|FG001|NOT COMPLETED|Overall Study||1
8802041|NCT01453595|9854011|FG002|NOT COMPLETED|Overall Study||2
8802042|NCT01453725|9854019|FG000|STARTED|Overall Study||98
8802043|NCT01453725|9854020|FG001|STARTED|Overall Study||100
8802044|NCT01453725|9854019|FG000|COMPLETED|Overall Study||85
8802045|NCT01453725|9854020|FG001|COMPLETED|Overall Study||89
8802046|NCT01453725|9854019|FG000|NOT COMPLETED|Overall Study||13
8802047|NCT01453725|9854020|FG001|NOT COMPLETED|Overall Study||11
8802048|NCT01453855|9854030|FG000|STARTED|Overall Study||442
8802049|NCT01453855|9854031|FG001|STARTED|Overall Study||422
8802050|NCT01453855|9854030|FG000|COMPLETED|Overall Study||432
8802051|NCT01453855|9854031|FG001|COMPLETED|Overall Study||408
8802052|NCT01453855|9854030|FG000|NOT COMPLETED|Overall Study||10
8802053|NCT01453855|9854031|FG001|NOT COMPLETED|Overall Study||14
8802054|NCT01453894|9854039|FG000|STARTED|Overall Study||225
8802055|NCT01453894|9854040|FG001|STARTED|Overall Study||225
8802056|NCT01453894|9854039|FG000|COMPLETED|Overall Study||225
8802057|NCT01453894|9854040|FG001|COMPLETED|Overall Study||225
8802058|NCT01453894|9854039|FG000|NOT COMPLETED|Overall Study||0
8802059|NCT01453894|9854040|FG001|NOT COMPLETED|Overall Study||0
8802060|NCT01453998|9854049|FG000|STARTED|Before Protocol Amendment 2||85
8802061|NCT01453998|9854050|FG001|STARTED|Before Protocol Amendment 2||88
8802062|NCT01453998|9854051|FG002|STARTED|Before Protocol Amendment 2||99
8802063|NCT01453998|9854049|FG000|COMPLETED|Before Protocol Amendment 2||85
8802064|NCT01453998|9854050|FG001|COMPLETED|Before Protocol Amendment 2||88
8802065|NCT01453998|9854051|FG002|COMPLETED|Before Protocol Amendment 2||99
8802066|NCT01453998|9854049|FG000|NOT COMPLETED|Before Protocol Amendment 2||0
8689582|NCT00844844|9734502|FG000|NOT COMPLETED|Post Treatment Period||1
8689583|NCT00844857|9734508|FG000|STARTED|Overall Study||194
8689584|NCT00844857|9734509|FG001|STARTED|Overall Study||97
8689585|NCT00844857|9734508|FG000|Population Analyzed|Overall Study|Randomized participants who took at least 1 dose of study drug excluding 2 GCP noncompliant sites.|170
8689586|NCT00844857|9734509|FG001|Population Analyzed|Overall Study|randomized participants who took at least 1 dose of study drug excluding 2 GCP noncompliant sites.|85
8689587|NCT00844857|9734508|FG000|COMPLETED|Overall Study||116
8689588|NCT00844857|9734509|FG001|COMPLETED|Overall Study||60
8689589|NCT00844857|9734508|FG000|NOT COMPLETED|Overall Study||78
8689590|NCT00844857|9734509|FG001|NOT COMPLETED|Overall Study||37
8689591|NCT00844883|9734518|FG000|STARTED|Overall Study||50
8689592|NCT00844883|9734518|FG000|Patients Who Received TACE|Overall Study|2 patients withdrawn at Week 1 prior to TACE for intolerance to sorafenib|48
8689593|NCT00844883|9734518|FG000|COMPLETED|Overall Study||46
8689594|NCT00844883|9734518|FG000|NOT COMPLETED|Overall Study||4
8689595|NCT00844896|9734524|FG000|STARTED|Overall Study||29
8689596|NCT00844896|9734525|FG001|STARTED|Overall Study||28
8689597|NCT00844896|9734524|FG000|COMPLETED|Overall Study||17
8689598|NCT00844896|9734525|FG001|COMPLETED|Overall Study||11
8689599|NCT00844896|9734524|FG000|NOT COMPLETED|Overall Study||12
8689600|NCT00844896|9734525|FG001|NOT COMPLETED|Overall Study||17
8689601|NCT00845000|9734538|FG000|STARTED|Period 1||2
8689602|NCT00845000|9734539|FG001|STARTED|Period 1||2
8689603|NCT00845000|9734540|FG002|STARTED|Period 1||2
8689604|NCT00845000|9734541|FG003|STARTED|Period 1||2
8689605|NCT00845000|9734542|FG004|STARTED|Period 1||2
8689606|NCT00845000|9734543|FG005|STARTED|Period 1||2
8689607|NCT00845000|9734538|FG000|COMPLETED|Period 1||2
8689608|NCT00845000|9734539|FG001|COMPLETED|Period 1||2
8689609|NCT00845000|9734540|FG002|COMPLETED|Period 1||2
8689610|NCT00845000|9734541|FG003|COMPLETED|Period 1||2
8689611|NCT00845000|9734542|FG004|COMPLETED|Period 1||2
8689612|NCT00845000|9734543|FG005|COMPLETED|Period 1||2
8689613|NCT00845000|9734538|FG000|NOT COMPLETED|Period 1||0
8689614|NCT00845000|9734539|FG001|NOT COMPLETED|Period 1||0
8689615|NCT00845000|9734540|FG002|NOT COMPLETED|Period 1||0
8689616|NCT00845000|9734541|FG003|NOT COMPLETED|Period 1||0
8689617|NCT00845000|9734542|FG004|NOT COMPLETED|Period 1||0
8689618|NCT00845000|9734543|FG005|NOT COMPLETED|Period 1||0
8689619|NCT00845000|9734538|FG000|STARTED|Period 2||2
8689620|NCT00845000|9734539|FG001|STARTED|Period 2||2
8689621|NCT00845000|9734540|FG002|STARTED|Period 2||2
8689622|NCT00845000|9734541|FG003|STARTED|Period 2||2
8689623|NCT00845000|9734542|FG004|STARTED|Period 2||2
8689624|NCT00845000|9734543|FG005|STARTED|Period 2||2
8689625|NCT00845000|9734538|FG000|COMPLETED|Period 2||2
8689626|NCT00845000|9734539|FG001|COMPLETED|Period 2||2
8689627|NCT00845000|9734540|FG002|COMPLETED|Period 2||2
8689628|NCT00845000|9734541|FG003|COMPLETED|Period 2||2
8689629|NCT00845000|9734542|FG004|COMPLETED|Period 2||2
8689630|NCT00845000|9734543|FG005|COMPLETED|Period 2||2
8689631|NCT00845000|9734538|FG000|NOT COMPLETED|Period 2||0
8689632|NCT00845000|9734539|FG001|NOT COMPLETED|Period 2||0
8689633|NCT00845000|9734540|FG002|NOT COMPLETED|Period 2||0
8802067|NCT01453998|9854050|FG001|NOT COMPLETED|Before Protocol Amendment 2||0
8802068|NCT01453998|9854051|FG002|NOT COMPLETED|Before Protocol Amendment 2||0
8802069|NCT01453998|9854049|FG000|STARTED|After Protocol Amendment 2.||131
8802070|NCT01453998|9854050|FG001|STARTED|After Protocol Amendment 2.||130
8802071|NCT01453998|9854051|FG002|STARTED|After Protocol Amendment 2.||124
8802072|NCT01453998|9854049|FG000|COMPLETED|After Protocol Amendment 2.||130
8802073|NCT01453998|9854050|FG001|COMPLETED|After Protocol Amendment 2.||130
8802074|NCT01453998|9854051|FG002|COMPLETED|After Protocol Amendment 2.||124
8802075|NCT01453998|9854049|FG000|NOT COMPLETED|After Protocol Amendment 2.||1
8802076|NCT01453998|9854050|FG001|NOT COMPLETED|After Protocol Amendment 2.||0
8802077|NCT01453998|9854051|FG002|NOT COMPLETED|After Protocol Amendment 2.||0
8802078|NCT01454063|9854064|FG000|STARTED|Randomized||202
8802079|NCT01454063|9854065|FG001|STARTED|Randomized||203
8802080|NCT01454063|9854064|FG000|COMPLETED|Randomized||201
8802081|NCT01454063|9854065|FG001|COMPLETED|Randomized||201
8802082|NCT01454063|9854064|FG000|NOT COMPLETED|Randomized||1
8802083|NCT01454063|9854065|FG001|NOT COMPLETED|Randomized||2
8802084|NCT01454063|9854064|FG000|STARTED|Treated||201
8802085|NCT01454063|9854065|FG001|STARTED|Treated||201
8802086|NCT01454063|9854064|FG000|COMPLETED|Treated||199
8802087|NCT01454063|9854065|FG001|COMPLETED|Treated||201
8802088|NCT01454063|9854064|FG000|NOT COMPLETED|Treated||2
8802089|NCT01454063|9854065|FG001|NOT COMPLETED|Treated||0
8802090|NCT01454076|9854076|FG000|STARTED|Overall Study||29
8802091|NCT01454076|9854077|FG001|STARTED|Overall Study||20
8802092|NCT01454076|9854078|FG002|STARTED|Overall Study||24
8802093|NCT01454076|9854079|FG003|STARTED|Overall Study||18
8802094|NCT01454076|9854080|FG004|STARTED|Overall Study||21
8802095|NCT01454076|9854076|FG000|COMPLETED|Overall Study||16
8802096|NCT01454076|9854077|FG001|COMPLETED|Overall Study||14
8802097|NCT01454076|9854078|FG002|COMPLETED|Overall Study||15
8689634|NCT00845000|9734541|FG003|NOT COMPLETED|Period 2||0
8689635|NCT00845000|9734542|FG004|NOT COMPLETED|Period 2||0
8689636|NCT00845000|9734543|FG005|NOT COMPLETED|Period 2||0
8689637|NCT00845000|9734538|FG000|STARTED|Period 3||2
8689638|NCT00845000|9734539|FG001|STARTED|Period 3||2
8689639|NCT00845000|9734540|FG002|STARTED|Period 3||2
8689640|NCT00845000|9734541|FG003|STARTED|Period 3||2
8689641|NCT00845000|9734542|FG004|STARTED|Period 3||2
8689642|NCT00845000|9734543|FG005|STARTED|Period 3||2
8689643|NCT00845000|9734538|FG000|COMPLETED|Period 3||2
8689644|NCT00845000|9734539|FG001|COMPLETED|Period 3||2
8689645|NCT00845000|9734540|FG002|COMPLETED|Period 3||2
8689646|NCT00845000|9734541|FG003|COMPLETED|Period 3||2
8689647|NCT00845000|9734542|FG004|COMPLETED|Period 3||2
8689648|NCT00845000|9734543|FG005|COMPLETED|Period 3||2
8689649|NCT00845000|9734538|FG000|NOT COMPLETED|Period 3||0
8689650|NCT00845000|9734539|FG001|NOT COMPLETED|Period 3||0
8689651|NCT00845000|9734540|FG002|NOT COMPLETED|Period 3||0
8689652|NCT00845000|9734541|FG003|NOT COMPLETED|Period 3||0
8689653|NCT00845000|9734542|FG004|NOT COMPLETED|Period 3||0
8689654|NCT00845000|9734543|FG005|NOT COMPLETED|Period 3||0
8689655|NCT00845039|9734553|FG000|STARTED|Overall Study||2
8689656|NCT00845039|9734554|FG001|STARTED|Overall Study||2
8689657|NCT00845039|9734553|FG000|Received at Least 1 Dose of Study Drug|Overall Study||2
8689658|NCT00845039|9734554|FG001|Received at Least 1 Dose of Study Drug|Overall Study||2
8689659|NCT00845039|9734553|FG000|COMPLETED|Overall Study||2
8689660|NCT00845039|9734554|FG001|COMPLETED|Overall Study||2
8689661|NCT00845039|9734553|FG000|NOT COMPLETED|Overall Study||0
8689662|NCT00845039|9734554|FG001|NOT COMPLETED|Overall Study||0
8689663|NCT00845065|9734564|FG000|STARTED|Overall Study||67
8689664|NCT00845065|9734565|FG001|STARTED|Overall Study||134
8689665|NCT00845065|9734564|FG000|COMPLETED|Overall Study||20
8689666|NCT00845065|9734565|FG001|COMPLETED|Overall Study||79
8689667|NCT00845065|9734564|FG000|NOT COMPLETED|Overall Study||47
8689668|NCT00845065|9734565|FG001|NOT COMPLETED|Overall Study||55
8689669|NCT00845130|9734573|FG000|STARTED|Overall Study||20
8689670|NCT00845130|9734574|FG001|STARTED|Overall Study||22
8689671|NCT00845130|9734573|FG000|COMPLETED|Overall Study||16
8689672|NCT00845130|9734574|FG001|COMPLETED|Overall Study||19
8689673|NCT00845130|9734573|FG000|NOT COMPLETED|Overall Study||4
8689674|NCT00845130|9734574|FG001|NOT COMPLETED|Overall Study||3
8689675|NCT00845182|9734585|FG000|STARTED|Overall Study||13
8689676|NCT00845182|9734586|FG001|STARTED|Overall Study||15
8689677|NCT00845182|9734587|FG002|STARTED|Overall Study||15
8689678|NCT00845182|9734585|FG000|COMPLETED|Overall Study||10
8689679|NCT00845182|9734586|FG001|COMPLETED|Overall Study||11
8689680|NCT00845182|9734587|FG002|COMPLETED|Overall Study||9
8689681|NCT00845182|9734585|FG000|NOT COMPLETED|Overall Study||3
8689682|NCT00845182|9734586|FG001|NOT COMPLETED|Overall Study||4
8689683|NCT00845182|9734587|FG002|NOT COMPLETED|Overall Study||6
8689684|NCT00845195|9734601|FG000|STARTED|Overall Study||75
8689685|NCT00845195|9734602|FG001|STARTED|Overall Study||75
8689686|NCT00845195|9734601|FG000|COMPLETED|Overall Study||75
8689687|NCT00845195|9734602|FG001|COMPLETED|Overall Study||75
8689688|NCT00845195|9734601|FG000|NOT COMPLETED|Overall Study||0
8689689|NCT00845195|9734602|FG001|NOT COMPLETED|Overall Study||0
8693378|NCT00866307|9738831|FG000|COMPLETED|Consolidation/Maintenance||0
8693379|NCT00866307|9738832|FG001|COMPLETED|Consolidation/Maintenance||45
8693380|NCT00866307|9738833|FG002|COMPLETED|Consolidation/Maintenance||14
8693381|NCT00866307|9738831|FG000|NOT COMPLETED|Consolidation/Maintenance||0
8693382|NCT00866307|9738832|FG001|NOT COMPLETED|Consolidation/Maintenance||9
8693383|NCT00866307|9738833|FG002|NOT COMPLETED|Consolidation/Maintenance||16
8693384|NCT00866320|9738839|FG000|STARTED|Overall Study||49
8693385|NCT00866320|9738839|FG000|COMPLETED|Overall Study|All patients that received treatment were analyzed.|43
8693386|NCT00866320|9738839|FG000|NOT COMPLETED|Overall Study||6
8693387|NCT00866333|9738848|FG000|STARTED|Overall Study||16
8693388|NCT00866333|9738849|FG001|STARTED|Overall Study||17
8693389|NCT00866333|9738850|FG002|STARTED|Overall Study||16
8693390|NCT00866333|9738848|FG000|COMPLETED|Overall Study||11
8693391|NCT00866333|9738849|FG001|COMPLETED|Overall Study||10
8693392|NCT00866333|9738850|FG002|COMPLETED|Overall Study||4
8693393|NCT00866333|9738848|FG000|NOT COMPLETED|Overall Study||5
8693394|NCT00866333|9738849|FG001|NOT COMPLETED|Overall Study||7
8693395|NCT00866333|9738850|FG002|NOT COMPLETED|Overall Study||12
8693396|NCT00866359|9738860|FG000|STARTED|Treatment Phase (Days 1 to 85)||56
8693397|NCT00866359|9738861|FG001|STARTED|Treatment Phase (Days 1 to 85)||55
8693398|NCT00866359|9738862|FG002|STARTED|Treatment Phase (Days 1 to 85)||0
8693399|NCT00866359|9738863|FG003|STARTED|Treatment Phase (Days 1 to 85)||0
8693400|NCT00866359|9738860|FG000|COMPLETED|Treatment Phase (Days 1 to 85)||45
8693401|NCT00866359|9738861|FG001|COMPLETED|Treatment Phase (Days 1 to 85)||50
8693402|NCT00866359|9738862|FG002|COMPLETED|Treatment Phase (Days 1 to 85)||0
8693403|NCT00866359|9738863|FG003|COMPLETED|Treatment Phase (Days 1 to 85)||0
8693404|NCT00866359|9738860|FG000|NOT COMPLETED|Treatment Phase (Days 1 to 85)||11
8693405|NCT00866359|9738861|FG001|NOT COMPLETED|Treatment Phase (Days 1 to 85)||5
8693406|NCT00866359|9738862|FG002|NOT COMPLETED|Treatment Phase (Days 1 to 85)||0
8693407|NCT00866359|9738863|FG003|NOT COMPLETED|Treatment Phase (Days 1 to 85)||0
8693408|NCT00866359|9738860|FG000|STARTED|Extension Phase (Day 86 to 169)||0
8693409|NCT00866359|9738861|FG001|STARTED|Extension Phase (Day 86 to 169)||0
8693410|NCT00866359|9738862|FG002|STARTED|Extension Phase (Day 86 to 169)||45
8693411|NCT00866359|9738863|FG003|STARTED|Extension Phase (Day 86 to 169)||50
8693412|NCT00866359|9738860|FG000|COMPLETED|Extension Phase (Day 86 to 169)||0
8693413|NCT00866359|9738861|FG001|COMPLETED|Extension Phase (Day 86 to 169)||0
8693414|NCT00866359|9738862|FG002|COMPLETED|Extension Phase (Day 86 to 169)||44
8693415|NCT00866359|9738863|FG003|COMPLETED|Extension Phase (Day 86 to 169)||47
8693416|NCT00866359|9738860|FG000|NOT COMPLETED|Extension Phase (Day 86 to 169)||0
8693417|NCT00866359|9738861|FG001|NOT COMPLETED|Extension Phase (Day 86 to 169)||0
8693418|NCT00866359|9738862|FG002|NOT COMPLETED|Extension Phase (Day 86 to 169)||1
8689690|NCT00845429|9734611|FG000|STARTED|Overall Study||244
8689691|NCT00845429|9734612|FG001|STARTED|Overall Study||241
8689692|NCT00845429|9734613|FG002|STARTED|Overall Study||244
8689693|NCT00845429|9734611|FG000|COMPLETED|Overall Study||230
8689694|NCT00845429|9734612|FG001|COMPLETED|Overall Study||226
8689695|NCT00845429|9734613|FG002|COMPLETED|Overall Study||224
8689696|NCT00845429|9734611|FG000|NOT COMPLETED|Overall Study||14
8689697|NCT00845429|9734612|FG001|NOT COMPLETED|Overall Study||15
8689698|NCT00845429|9734613|FG002|NOT COMPLETED|Overall Study||20
8689699|NCT00845481|9734621|FG000|STARTED|Overall Study||24
8689700|NCT00845481|9734621|FG000|COMPLETED|Overall Study||24
8689701|NCT00845481|9734621|FG000|NOT COMPLETED|Overall Study||0
8689702|NCT00845507|9734632|FG000|STARTED|Overall Study||24
8689703|NCT00845507|9734633|FG001|STARTED|Overall Study||30
8689704|NCT00845507|9734632|FG000|COMPLETED|Overall Study||22
8689705|NCT00845507|9734633|FG001|COMPLETED|Overall Study||29
8689706|NCT00845507|9734632|FG000|NOT COMPLETED|Overall Study||2
8689707|NCT00845507|9734633|FG001|NOT COMPLETED|Overall Study||1
8689708|NCT00845520|9734642|FG000|STARTED|Overall Study||25
8689709|NCT00845520|9734643|FG001|STARTED|Overall Study||25
8689710|NCT00845520|9734644|FG002|STARTED|Overall Study||24
8689711|NCT00845520|9734642|FG000|COMPLETED|Overall Study||23
8689712|NCT00845520|9734643|FG001|COMPLETED|Overall Study||23
8689713|NCT00845520|9734644|FG002|COMPLETED|Overall Study||23
8689714|NCT00845520|9734642|FG000|NOT COMPLETED|Overall Study||2
8689715|NCT00845520|9734643|FG001|NOT COMPLETED|Overall Study||2
8689716|NCT00845520|9734644|FG002|NOT COMPLETED|Overall Study||1
8689717|NCT00845650|9734664|FG000|STARTED|Overall Study|1 subject not dosed|31
8689718|NCT00845650|9734665|FG001|STARTED|Overall Study||5
8689719|NCT00845650|9734666|FG002|STARTED|Overall Study||31
8689720|NCT00845650|9734667|FG003|STARTED|Overall Study||14
8689721|NCT00845650|9734668|FG004|STARTED|Overall Study|2 subjects not dosed|31
8689722|NCT00845650|9734669|FG005|STARTED|Overall Study|1 subject not dosed|17
8689723|NCT00845650|9734664|FG000|COMPLETED|Overall Study||30
8689724|NCT00845650|9734665|FG001|COMPLETED|Overall Study||5
8689725|NCT00845650|9734666|FG002|COMPLETED|Overall Study||28
8689726|NCT00845650|9734667|FG003|COMPLETED|Overall Study||13
8689727|NCT00845650|9734668|FG004|COMPLETED|Overall Study||28
8689728|NCT00845650|9734669|FG005|COMPLETED|Overall Study||15
8689729|NCT00845650|9734664|FG000|NOT COMPLETED|Overall Study||1
8689730|NCT00845650|9734665|FG001|NOT COMPLETED|Overall Study||0
8689731|NCT00845650|9734666|FG002|NOT COMPLETED|Overall Study||3
8689732|NCT00845650|9734667|FG003|NOT COMPLETED|Overall Study||1
8689733|NCT00845650|9734668|FG004|NOT COMPLETED|Overall Study||3
8689734|NCT00845650|9734669|FG005|NOT COMPLETED|Overall Study||2
8689735|NCT00845663|9734687|FG000|STARTED|Overall Study||49
8689736|NCT00845663|9734688|FG001|STARTED|Overall Study||49
8689737|NCT00845663|9734687|FG000|COMPLETED|Overall Study||49
8689738|NCT00845663|9734688|FG001|COMPLETED|Overall Study||49
8689739|NCT00845663|9734687|FG000|NOT COMPLETED|Overall Study||0
8689740|NCT00845663|9734688|FG001|NOT COMPLETED|Overall Study||0
8689741|NCT00845676|9734694|FG000|STARTED|Overall Study||21
8689742|NCT00845676|9734694|FG000|COMPLETED|Overall Study||19
8689743|NCT00845676|9734694|FG000|NOT COMPLETED|Overall Study||2
8689744|NCT00845728|9734701|FG000|STARTED|Overall Study||1723
8689745|NCT00845728|9734702|FG001|STARTED|Overall Study||1721
8689746|NCT00845728|9734701|FG000|Exposed|Overall Study||1721
8689747|NCT00845728|9734702|FG001|Exposed|Overall Study||1718
8689748|NCT00845728|9734701|FG000|COMPLETED|Overall Study||1337
8689749|NCT00845728|9734702|FG001|COMPLETED|Overall Study||1379
8689750|NCT00845728|9734701|FG000|NOT COMPLETED|Overall Study||386
8689751|NCT00845728|9734702|FG001|NOT COMPLETED|Overall Study||342
8689752|NCT00845832|9734711|FG000|STARTED|Treatment Period||4
8689753|NCT00845832|9734712|FG001|STARTED|Treatment Period||10
8689754|NCT00845832|9734713|FG002|STARTED|Treatment Period||10
8689755|NCT00845832|9734711|FG000|COMPLETED|Treatment Period||3
8689756|NCT00845832|9734712|FG001|COMPLETED|Treatment Period||7
8689757|NCT00845832|9734713|FG002|COMPLETED|Treatment Period||10
8689758|NCT00845832|9734711|FG000|NOT COMPLETED|Treatment Period||1
8689759|NCT00845832|9734712|FG001|NOT COMPLETED|Treatment Period||3
8689760|NCT00845832|9734713|FG002|NOT COMPLETED|Treatment Period||0
8689761|NCT00845832|9734711|FG000|STARTED|Safety Follow-Up|One participant from this group was re-assigned to TCZ (4 mg/kg) group.|3
8689762|NCT00845832|9734712|FG001|STARTED|Safety Follow-Up|All participants who withdrew from study were asked to return for safety follow-up.|9
8689763|NCT00845832|9734713|FG002|STARTED|Safety Follow-Up|One participant each from the placebo and TCZ (2 mg/kg) groups were re-assigned to this group.|12
8689764|NCT00845832|9734711|FG000|COMPLETED|Safety Follow-Up||2
8689765|NCT00845832|9734712|FG001|COMPLETED|Safety Follow-Up|One participant from this group was re-assigned to TCZ (4 mg/kg) group.|9
8689766|NCT00845832|9734713|FG002|COMPLETED|Safety Follow-Up||12
8689767|NCT00845832|9734711|FG000|NOT COMPLETED|Safety Follow-Up||1
8689768|NCT00845832|9734712|FG001|NOT COMPLETED|Safety Follow-Up||0
8689769|NCT00845832|9734713|FG002|NOT COMPLETED|Safety Follow-Up||0
8689770|NCT00845832|9734711|FG000|STARTED|Extended Safety Follow-Up||2
8689771|NCT00845832|9734712|FG001|STARTED|Extended Safety Follow-Up|Only participants who remained B cell depleted required extended safety follow-up.|5
8689772|NCT00845832|9734713|FG002|STARTED|Extended Safety Follow-Up|Only participants who remained B cell depleted required extended safety follow-up.|7
8689773|NCT00845832|9734711|FG000|COMPLETED|Extended Safety Follow-Up||2
8689774|NCT00845832|9734712|FG001|COMPLETED|Extended Safety Follow-Up||5
8689775|NCT00845832|9734713|FG002|COMPLETED|Extended Safety Follow-Up||0
8689776|NCT00845832|9734711|FG000|NOT COMPLETED|Extended Safety Follow-Up||0
8689777|NCT00845832|9734712|FG001|NOT COMPLETED|Extended Safety Follow-Up||0
8689778|NCT00845832|9734713|FG002|NOT COMPLETED|Extended Safety Follow-Up||7
8689779|NCT00845858|9734724|FG000|STARTED|Overall Study|"95 subjects received allocated intervention.~1 subject withdrew consent and was not dosed."|96
8689780|NCT00845858|9734725|FG001|STARTED|Overall Study|"95 subjects received allocated intervention.~1 subject was not eligible and was not dosed."|96
8689781|NCT00845858|9734726|FG002|STARTED|Overall Study||95
8689782|NCT00845858|9734724|FG000|COMPLETED|Overall Study||88
8689783|NCT00845858|9734725|FG001|COMPLETED|Overall Study||84
8689784|NCT00845858|9734726|FG002|COMPLETED|Overall Study||87
8689785|NCT00845858|9734724|FG000|NOT COMPLETED|Overall Study||8
8689786|NCT00845858|9734725|FG001|NOT COMPLETED|Overall Study||12
8689787|NCT00845858|9734726|FG002|NOT COMPLETED|Overall Study||8
8689788|NCT00845871|9734737|FG000|STARTED|Run-in Period||65
8689789|NCT00845871|9734737|FG000|COMPLETED|Run-in Period||65
8689790|NCT00845871|9734737|FG000|NOT COMPLETED|Run-in Period||0
8689791|NCT00845871|9734737|FG000|STARTED|Assessment Period||65
8689792|NCT00845871|9734737|FG000|COMPLETED|Assessment Period||58
8689793|NCT00845871|9734737|FG000|NOT COMPLETED|Assessment Period||7
8689794|NCT00845897|9734764|FG000|STARTED|Overall Study||5
8689795|NCT00845897|9734765|FG001|STARTED|Overall Study||7
8689796|NCT00845897|9734766|FG002|STARTED|Overall Study||5
8689797|NCT00845897|9734764|FG000|COMPLETED|Overall Study||3
8689798|NCT00845897|9734765|FG001|COMPLETED|Overall Study||2
8689799|NCT00845897|9734766|FG002|COMPLETED|Overall Study||2
8689800|NCT00845897|9734764|FG000|NOT COMPLETED|Overall Study||2
8689801|NCT00845897|9734765|FG001|NOT COMPLETED|Overall Study||5
8689802|NCT00845897|9734766|FG002|NOT COMPLETED|Overall Study||3
8689803|NCT00845975|9734776|FG000|STARTED|Overall Study||9
8689804|NCT00845975|9734777|FG001|STARTED|Overall Study||9
8689805|NCT00845975|9734776|FG000|COMPLETED|Overall Study||9
8689806|NCT00845975|9734777|FG001|COMPLETED|Overall Study||9
8689807|NCT00845975|9734776|FG000|NOT COMPLETED|Overall Study||0
8689808|NCT00845975|9734777|FG001|NOT COMPLETED|Overall Study||0
8689809|NCT00846027|9734783|FG000|STARTED|Overall Study||90
8689810|NCT00846027|9734783|FG000|Received Treatment|Overall Study||83
8689811|NCT00846027|9734783|FG000|COMPLETED|Overall Study||0
8689812|NCT00846027|9734783|FG000|NOT COMPLETED|Overall Study||90
8689813|NCT00846040|9734790|FG000|STARTED|Baseline: Days 1-5||10
8689814|NCT00846040|9734791|FG001|STARTED|Baseline: Days 1-5||10
8689815|NCT00846040|9734792|FG002|STARTED|Baseline: Days 1-5||23
8689816|NCT00846040|9734790|FG000|COMPLETED|Baseline: Days 1-5||9
8689817|NCT00846040|9734791|FG001|COMPLETED|Baseline: Days 1-5||10
8689818|NCT00846040|9734792|FG002|COMPLETED|Baseline: Days 1-5||23
8689819|NCT00846040|9734790|FG000|NOT COMPLETED|Baseline: Days 1-5||1
8689820|NCT00846040|9734791|FG001|NOT COMPLETED|Baseline: Days 1-5||0
8689821|NCT00846040|9734792|FG002|NOT COMPLETED|Baseline: Days 1-5||0
8689822|NCT00846040|9734790|FG000|STARTED|First Treatment Period: Days 6-14||9
8689823|NCT00846040|9734791|FG001|STARTED|First Treatment Period: Days 6-14||10
8689824|NCT00846040|9734792|FG002|STARTED|First Treatment Period: Days 6-14|This group participated in only the baseline period|0
8919786|NCT02209454|9979713|FG000|NOT COMPLETED|Washout Period a Minimum of a 7 Day||0
8919787|NCT02209454|9979714|FG001|NOT COMPLETED|Washout Period a Minimum of a 7 Day||0
8919788|NCT02209454|9979713|FG000|STARTED|Second Period||13
8919789|NCT02209454|9979714|FG001|STARTED|Second Period||13
8919790|NCT02209454|9979713|FG000|COMPLETED|Second Period||12
8919791|NCT02209454|9979714|FG001|COMPLETED|Second Period||13
8919792|NCT02209454|9979713|FG000|NOT COMPLETED|Second Period||1
8919793|NCT02209454|9979714|FG001|NOT COMPLETED|Second Period||0
8919794|NCT02209506|9979725|FG000|STARTED|Overall Study||3
8919795|NCT02209506|9979726|FG001|STARTED|Overall Study||6
8919796|NCT02209506|9979727|FG002|STARTED|Overall Study||6
8919797|NCT02209506|9979728|FG003|STARTED|Overall Study||2
8919798|NCT02209506|9979729|FG004|STARTED|Overall Study||6
8919799|NCT02209506|9979725|FG000|COMPLETED|Overall Study||3
8919800|NCT02209506|9979726|FG001|COMPLETED|Overall Study||6
8919801|NCT02209506|9979727|FG002|COMPLETED|Overall Study||6
8919802|NCT02209506|9979728|FG003|COMPLETED|Overall Study||2
8919803|NCT02209506|9979729|FG004|COMPLETED|Overall Study||5
8919804|NCT02209506|9979725|FG000|NOT COMPLETED|Overall Study||0
8919805|NCT02209506|9979726|FG001|NOT COMPLETED|Overall Study||0
8919806|NCT02209506|9979727|FG002|NOT COMPLETED|Overall Study||0
8919807|NCT02209506|9979728|FG003|NOT COMPLETED|Overall Study||0
8919808|NCT02209506|9979729|FG004|NOT COMPLETED|Overall Study||1
8919809|NCT02209519|9979746|FG000|STARTED|Overall Study||107
8919810|NCT02209519|9979747|FG001|STARTED|Overall Study||107
8919811|NCT02209519|9979746|FG000|COMPLETED|Overall Study||107
8919812|NCT02209519|9979747|FG001|COMPLETED|Overall Study||107
8689825|NCT00846040|9734790|FG000|COMPLETED|First Treatment Period: Days 6-14||9
8689826|NCT00846040|9734791|FG001|COMPLETED|First Treatment Period: Days 6-14||10
8919813|NCT02209519|9979746|FG000|NOT COMPLETED|Overall Study||0
8919814|NCT02209519|9979747|FG001|NOT COMPLETED|Overall Study||0
8919815|NCT02209532|9979756|FG000|STARTED|Overall Study||90
8919816|NCT02209532|9979757|FG001|STARTED|Overall Study||90
8919817|NCT02209532|9979756|FG000|COMPLETED|Overall Study||87
8919818|NCT02209532|9979757|FG001|COMPLETED|Overall Study||89
8689827|NCT00846040|9734792|FG002|COMPLETED|First Treatment Period: Days 6-14||0
8689828|NCT00846040|9734790|FG000|NOT COMPLETED|First Treatment Period: Days 6-14||0
8689829|NCT00846040|9734791|FG001|NOT COMPLETED|First Treatment Period: Days 6-14||0
8689830|NCT00846040|9734792|FG002|NOT COMPLETED|First Treatment Period: Days 6-14||0
8689831|NCT00846040|9734790|FG000|STARTED|Washout: 2 Weeks to 10 Weeks||9
8689832|NCT00846040|9734791|FG001|STARTED|Washout: 2 Weeks to 10 Weeks||10
8689833|NCT00846040|9734792|FG002|STARTED|Washout: 2 Weeks to 10 Weeks||0
8689834|NCT00846040|9734790|FG000|COMPLETED|Washout: 2 Weeks to 10 Weeks||9
8689835|NCT00846040|9734791|FG001|COMPLETED|Washout: 2 Weeks to 10 Weeks||8
8689836|NCT00846040|9734792|FG002|COMPLETED|Washout: 2 Weeks to 10 Weeks||0
8689837|NCT00846040|9734790|FG000|NOT COMPLETED|Washout: 2 Weeks to 10 Weeks||0
8689838|NCT00846040|9734791|FG001|NOT COMPLETED|Washout: 2 Weeks to 10 Weeks||2
8689839|NCT00846040|9734792|FG002|NOT COMPLETED|Washout: 2 Weeks to 10 Weeks||0
8689840|NCT00846040|9734790|FG000|STARTED|Second Treatment: After Washout, 14 Day||9
8689841|NCT00846040|9734791|FG001|STARTED|Second Treatment: After Washout, 14 Day||8
8689842|NCT00846040|9734792|FG002|STARTED|Second Treatment: After Washout, 14 Day||0
8689843|NCT00846040|9734790|FG000|COMPLETED|Second Treatment: After Washout, 14 Day||9
8689844|NCT00846040|9734791|FG001|COMPLETED|Second Treatment: After Washout, 14 Day||8
8689845|NCT00846040|9734792|FG002|COMPLETED|Second Treatment: After Washout, 14 Day||0
8689846|NCT00846040|9734790|FG000|NOT COMPLETED|Second Treatment: After Washout, 14 Day||0
8689847|NCT00846040|9734791|FG001|NOT COMPLETED|Second Treatment: After Washout, 14 Day||0
8689848|NCT00846040|9734792|FG002|NOT COMPLETED|Second Treatment: After Washout, 14 Day||0
8689849|NCT00846053|9734803|FG000|STARTED|Overall Study|No milestones. Enrollment continued until end of study.|13
8689850|NCT00846053|9734804|FG001|STARTED|Overall Study||8
8689851|NCT00846053|9734803|FG000|COMPLETED|Overall Study|No milestones. Enrollment continued until end of study. 21 subjects enrolled.|10
8689852|NCT00846053|9734804|FG001|COMPLETED|Overall Study||8
8689853|NCT00846053|9734803|FG000|NOT COMPLETED|Overall Study||3
8689854|NCT00846053|9734804|FG001|NOT COMPLETED|Overall Study||0
8689855|NCT00846066|9734814|FG000|STARTED|Overall Study||27
8689856|NCT00846066|9734815|FG001|STARTED|Overall Study||29
8689857|NCT00846066|9734814|FG000|COMPLETED|Overall Study||27
8689858|NCT00846066|9734815|FG001|COMPLETED|Overall Study||29
8689859|NCT00846066|9734814|FG000|NOT COMPLETED|Overall Study||0
8689860|NCT00846066|9734815|FG001|NOT COMPLETED|Overall Study||0
8689861|NCT00846287|9734824|FG000|STARTED|Overall Study||16
8689862|NCT00846287|9734825|FG001|STARTED|Overall Study||15
8689863|NCT00846287|9734824|FG000|COMPLETED|Overall Study||6
8689864|NCT00846287|9734825|FG001|COMPLETED|Overall Study||10
8689865|NCT00846287|9734824|FG000|NOT COMPLETED|Overall Study||10
8689866|NCT00846287|9734825|FG001|NOT COMPLETED|Overall Study||5
8689867|NCT00846365|9734834|FG000|STARTED|Overall Study||372
8689868|NCT00846365|9734835|FG001|STARTED|Overall Study||357
8689869|NCT00846365|9734836|FG002|STARTED|Overall Study||356
8689870|NCT00846365|9734834|FG000|COMPLETED|Overall Study||317
8689871|NCT00846365|9734835|FG001|COMPLETED|Overall Study||308
8689872|NCT00846365|9734836|FG002|COMPLETED|Overall Study||323
8689873|NCT00846365|9734834|FG000|NOT COMPLETED|Overall Study||55
8689874|NCT00846365|9734835|FG001|NOT COMPLETED|Overall Study||49
8689875|NCT00846365|9734836|FG002|NOT COMPLETED|Overall Study||33
8689876|NCT00846391|9734847|FG000|STARTED|Overall Study||4
8689877|NCT00846391|9734848|FG001|STARTED|Overall Study||4
8689878|NCT00846391|9734849|FG002|STARTED|Overall Study||6
8689879|NCT00846391|9734847|FG000|COMPLETED|Overall Study||3
8689880|NCT00846391|9734848|FG001|COMPLETED|Overall Study||2
8689881|NCT00846391|9734849|FG002|COMPLETED|Overall Study||3
8689882|NCT00846391|9734847|FG000|NOT COMPLETED|Overall Study||1
8689883|NCT00846391|9734848|FG001|NOT COMPLETED|Overall Study||2
8689884|NCT00846391|9734849|FG002|NOT COMPLETED|Overall Study||3
8689885|NCT00846482|9734857|FG000|STARTED|Overall Study||64
8689886|NCT00846482|9734857|FG000|COMPLETED|Overall Study||54
8689887|NCT00846482|9734857|FG000|NOT COMPLETED|Overall Study||10
8689888|NCT00846495|9734864|FG000|STARTED|Overall Study||28
8689889|NCT00846495|9734865|FG001|STARTED|Overall Study||27
8689890|NCT00846495|9734864|FG000|COMPLETED|Overall Study||20
8689891|NCT00846495|9734865|FG001|COMPLETED|Overall Study||24
8689892|NCT00846495|9734864|FG000|NOT COMPLETED|Overall Study||8
8689893|NCT00846495|9734865|FG001|NOT COMPLETED|Overall Study||3
8689894|NCT00846521|9734871|FG000|STARTED|Overall Study||23
8689895|NCT00846521|9734871|FG000|COMPLETED|Overall Study||12
8802098|NCT01454076|9854079|FG003|COMPLETED|Overall Study||16
8802099|NCT01454076|9854080|FG004|COMPLETED|Overall Study||15
8802100|NCT01454076|9854076|FG000|NOT COMPLETED|Overall Study||13
8802101|NCT01454076|9854077|FG001|NOT COMPLETED|Overall Study||6
8802102|NCT01454076|9854078|FG002|NOT COMPLETED|Overall Study||9
8802103|NCT01454076|9854079|FG003|NOT COMPLETED|Overall Study||2
8802104|NCT01454076|9854080|FG004|NOT COMPLETED|Overall Study||6
8802105|NCT01454102|9854117|FG000|STARTED|Overall Study||12
8802106|NCT01454102|9854118|FG001|STARTED|Overall Study||15
8802107|NCT01454102|9854119|FG002|STARTED|Overall Study||15
8802108|NCT01454102|9854120|FG003|STARTED|Overall Study||12
8802109|NCT01454102|9854121|FG004|STARTED|Overall Study||21
8802110|NCT01454102|9854122|FG005|STARTED|Overall Study||52
8802111|NCT01454102|9854123|FG006|STARTED|Overall Study||24
8802112|NCT01454102|9854124|FG007|STARTED|Overall Study||25
8802113|NCT01454102|9854125|FG008|STARTED|Overall Study||13
8802114|NCT01454102|9854126|FG009|STARTED|Overall Study||13
8802115|NCT01454102|9854127|FG010|STARTED|Overall Study||12
8802116|NCT01454102|9854128|FG011|STARTED|Overall Study||31
8802117|NCT01454102|9854129|FG012|STARTED|Overall Study||40
8802118|NCT01454102|9854130|FG013|STARTED|Overall Study||38
8802119|NCT01454102|9854131|FG014|STARTED|Overall Study||39
8689896|NCT00846521|9734871|FG000|NOT COMPLETED|Overall Study||11
8689897|NCT00846547|9734875|FG000|STARTED|Overall Study||32
8689898|NCT00846547|9734875|FG000|COMPLETED|Overall Study||25
8689899|NCT00846547|9734875|FG000|NOT COMPLETED|Overall Study||7
8689900|NCT00846573|9734882|FG000|STARTED|Overall Study||5
8689901|NCT00846573|9734883|FG001|STARTED|Overall Study||2
8689902|NCT00846573|9734884|FG002|STARTED|Overall Study||7
8689903|NCT00846573|9734885|FG003|STARTED|Overall Study||0
8689904|NCT00846573|9734882|FG000|COMPLETED|Overall Study||5
8689905|NCT00846573|9734883|FG001|COMPLETED|Overall Study||2
8689906|NCT00846573|9734884|FG002|COMPLETED|Overall Study||7
8689907|NCT00846573|9734885|FG003|COMPLETED|Overall Study||0
8689908|NCT00846573|9734882|FG000|NOT COMPLETED|Overall Study||0
8689909|NCT00846573|9734883|FG001|NOT COMPLETED|Overall Study||0
8689910|NCT00846573|9734884|FG002|NOT COMPLETED|Overall Study||0
8689911|NCT00846573|9734885|FG003|NOT COMPLETED|Overall Study||0
8802120|NCT01454102|9854132|FG015|STARTED|Overall Study||14
8802121|NCT01454102|9854117|FG000|COMPLETED|Overall Study||12
8802122|NCT01454102|9854118|FG001|COMPLETED|Overall Study||15
8802123|NCT01454102|9854119|FG002|COMPLETED|Overall Study||15
8802124|NCT01454102|9854120|FG003|COMPLETED|Overall Study||12
8802125|NCT01454102|9854121|FG004|COMPLETED|Overall Study||18
8802126|NCT01454102|9854122|FG005|COMPLETED|Overall Study||49
8802127|NCT01454102|9854123|FG006|COMPLETED|Overall Study||22
8802128|NCT01454102|9854124|FG007|COMPLETED|Overall Study||25
8802129|NCT01454102|9854125|FG008|COMPLETED|Overall Study||12
8802130|NCT01454102|9854126|FG009|COMPLETED|Overall Study||13
8802131|NCT01454102|9854127|FG010|COMPLETED|Overall Study||12
8802132|NCT01454102|9854128|FG011|COMPLETED|Overall Study||27
8802133|NCT01454102|9854129|FG012|COMPLETED|Overall Study||33
8802134|NCT01454102|9854130|FG013|COMPLETED|Overall Study||34
8802135|NCT01454102|9854131|FG014|COMPLETED|Overall Study||36
8802136|NCT01454102|9854132|FG015|COMPLETED|Overall Study||13
8802137|NCT01454102|9854117|FG000|NOT COMPLETED|Overall Study||0
8802138|NCT01454102|9854118|FG001|NOT COMPLETED|Overall Study||0
8802139|NCT01454102|9854119|FG002|NOT COMPLETED|Overall Study||0
8802140|NCT01454102|9854120|FG003|NOT COMPLETED|Overall Study||0
8802141|NCT01454102|9854121|FG004|NOT COMPLETED|Overall Study||3
8802142|NCT01454102|9854122|FG005|NOT COMPLETED|Overall Study||3
8802143|NCT01454102|9854123|FG006|NOT COMPLETED|Overall Study||2
8802144|NCT01454102|9854124|FG007|NOT COMPLETED|Overall Study||0
8802145|NCT01454102|9854125|FG008|NOT COMPLETED|Overall Study||1
8802146|NCT01454102|9854126|FG009|NOT COMPLETED|Overall Study||0
8802147|NCT01454102|9854127|FG010|NOT COMPLETED|Overall Study||0
8802148|NCT01454102|9854128|FG011|NOT COMPLETED|Overall Study||4
8802149|NCT01454102|9854129|FG012|NOT COMPLETED|Overall Study||7
8802150|NCT01454102|9854130|FG013|NOT COMPLETED|Overall Study||4
8802151|NCT01454102|9854131|FG014|NOT COMPLETED|Overall Study||3
8802152|NCT01454102|9854132|FG015|NOT COMPLETED|Overall Study||1
8802153|NCT01454258|9854167|FG000|STARTED|Overall Study||10100
8802154|NCT01454258|9854167|FG000|COMPLETED|Overall Study||9103
8802155|NCT01454258|9854167|FG000|NOT COMPLETED|Overall Study||997
8802156|NCT01454284|9854175|FG000|STARTED|Overall Study||664
8802157|NCT01454284|9854176|FG001|STARTED|Overall Study||450
8802158|NCT01454284|9854175|FG000|Received at Least 1 Dose of Study Drug|Overall Study||663
8802159|NCT01454284|9854176|FG001|Received at Least 1 Dose of Study Drug|Overall Study||449
8802160|NCT01454284|9854175|FG000|COMPLETED|Overall Study||548
8802161|NCT01454284|9854176|FG001|COMPLETED|Overall Study||377
8802162|NCT01454284|9854175|FG000|NOT COMPLETED|Overall Study||116
8802163|NCT01454284|9854176|FG001|NOT COMPLETED|Overall Study||73
8802164|NCT01454362|9854184|FG000|STARTED|Overall Study||28
8802165|NCT01454362|9854185|FG001|STARTED|Overall Study||23
8802166|NCT01454362|9854184|FG000|COMPLETED|Overall Study||28
8802167|NCT01454362|9854185|FG001|COMPLETED|Overall Study||23
8802168|NCT01454362|9854184|FG000|NOT COMPLETED|Overall Study||0
8802169|NCT01454362|9854185|FG001|NOT COMPLETED|Overall Study||0
8802170|NCT01454401|9854193|FG000|STARTED|Overall Study|ITT|44
8802171|NCT01454401|9854193|FG000|COMPLETED|Overall Study|Per Protocol (PP)|39
8802172|NCT01454401|9854193|FG000|NOT COMPLETED|Overall Study||5
8802173|NCT01454414|9854199|FG000|STARTED|Overall Study||79
8802174|NCT01454414|9854200|FG001|STARTED|Overall Study||80
8802175|NCT01454414|9854199|FG000|Baseline: Subjects That Sent Uniforms|Overall Study||67
8802176|NCT01454414|9854200|FG001|Baseline: Subjects That Sent Uniforms|Overall Study||66
8802177|NCT01454414|9854199|FG000|COMPLETED|Overall Study||66
8802178|NCT01454414|9854200|FG001|COMPLETED|Overall Study||64
8802179|NCT01454414|9854199|FG000|NOT COMPLETED|Overall Study||13
8802180|NCT01454414|9854200|FG001|NOT COMPLETED|Overall Study||16
8802181|NCT01454505|9854209|FG000|STARTED|Overall Study||35
8802182|NCT01454505|9854210|FG001|STARTED|Overall Study||15
8802183|NCT01454505|9854211|FG002|STARTED|Overall Study||40
8802184|NCT01454505|9854212|FG003|STARTED|Overall Study||20
8802185|NCT01454505|9854209|FG000|COMPLETED|Overall Study||35
8802186|NCT01454505|9854210|FG001|COMPLETED|Overall Study||15
8802187|NCT01454505|9854211|FG002|COMPLETED|Overall Study||40
8802188|NCT01454505|9854212|FG003|COMPLETED|Overall Study||20
8802189|NCT01454505|9854209|FG000|NOT COMPLETED|Overall Study||0
8802190|NCT01454505|9854210|FG001|NOT COMPLETED|Overall Study||0
8689912|NCT00846586|9734895|FG000|STARTED|Overall Study||570
8802191|NCT01454505|9854211|FG002|NOT COMPLETED|Overall Study||0
8802192|NCT01454505|9854212|FG003|NOT COMPLETED|Overall Study||0
8802193|NCT01454531|9854222|FG000|STARTED|Overall Study||196
8802194|NCT01454531|9854222|FG000|Subjects Treated|Overall Study||192
8689913|NCT00846586|9734896|FG001|STARTED|Overall Study||564
8689914|NCT00846586|9734895|FG000|Received Study Drug|Overall Study||570
8689915|NCT00846586|9734896|FG001|Received Study Drug|Overall Study|Three patients were not exposed to study treatment in this group.|561
8689916|NCT00846586|9734895|FG000|COMPLETED|Overall Study||531
8689917|NCT00846586|9734896|FG001|COMPLETED|Overall Study||529
8689918|NCT00846586|9734895|FG000|NOT COMPLETED|Overall Study||39
8689919|NCT00846586|9734896|FG001|NOT COMPLETED|Overall Study||35
8689920|NCT00846651|9734904|FG000|STARTED|Overall Study||41
8689921|NCT00846651|9734905|FG001|STARTED|Overall Study||41
8689922|NCT00846651|9734904|FG000|COMPLETED|Overall Study||37
8689923|NCT00846651|9734905|FG001|COMPLETED|Overall Study||37
8689924|NCT00846651|9734904|FG000|NOT COMPLETED|Overall Study||4
8689925|NCT00846651|9734905|FG001|NOT COMPLETED|Overall Study||4
8689926|NCT00846742|9734913|FG000|STARTED|Overall Study||85
8689927|NCT00846742|9734913|FG000|With Radiation Therapy (RT)|Overall Study||17
8689928|NCT00846742|9734913|FG000|Without Radiation Therapy (RT)|Overall Study||68
8689929|NCT00846742|9734913|FG000|COMPLETED|Overall Study||84
8689930|NCT00846742|9734913|FG000|NOT COMPLETED|Overall Study||1
8689931|NCT00846768|9734918|FG000|STARTED|Overall Study||11
8689932|NCT00846768|9734919|FG001|STARTED|Overall Study||12
8689933|NCT00846768|9734920|FG002|STARTED|Overall Study||12
8689934|NCT00846768|9734921|FG003|STARTED|Overall Study||12
8689935|NCT00846768|9734918|FG000|COMPLETED|Overall Study||11
8689936|NCT00846768|9734919|FG001|COMPLETED|Overall Study||11
8689937|NCT00846768|9734920|FG002|COMPLETED|Overall Study||12
8689938|NCT00846768|9734921|FG003|COMPLETED|Overall Study||12
8689939|NCT00846768|9734918|FG000|NOT COMPLETED|Overall Study||0
8689940|NCT00846768|9734919|FG001|NOT COMPLETED|Overall Study||1
8689941|NCT00846768|9734920|FG002|NOT COMPLETED|Overall Study||0
8689942|NCT00846768|9734921|FG003|NOT COMPLETED|Overall Study||0
8689943|NCT00846807|9734931|FG000|STARTED|Overall Study|Entered and treated.|5292
8689944|NCT00846807|9734931|FG000|COMPLETED|Overall Study|Completed treatment.|4660
8689945|NCT00846807|9734931|FG000|NOT COMPLETED|Overall Study||632
8689946|NCT00846846|9734935|FG000|STARTED|Overall Study||1018
8689947|NCT00846846|9734935|FG000|COMPLETED|Overall Study|Study ongoing but not recruiting participants.|943
8689948|NCT00846846|9734935|FG000|NOT COMPLETED|Overall Study||75
8689949|NCT00847015|9734939|FG000|STARTED|Overall Study||18
8689950|NCT00847015|9734939|FG000|COMPLETED|Overall Study||15
8689951|NCT00847015|9734939|FG000|NOT COMPLETED|Overall Study||3
8689952|NCT00847132|9734945|FG000|STARTED|Overall Study||90
8689953|NCT00847132|9734946|FG001|STARTED|Overall Study||85
8689954|NCT00847132|9734945|FG000|COMPLETED|Overall Study||89
8689955|NCT00847132|9734946|FG001|COMPLETED|Overall Study||84
8689956|NCT00847132|9734945|FG000|NOT COMPLETED|Overall Study||1
8689957|NCT00847132|9734946|FG001|NOT COMPLETED|Overall Study||1
8689958|NCT00847145|9734960|FG000|STARTED|Overall Study||629
8689959|NCT00847145|9734961|FG001|STARTED|Overall Study||633
8689960|NCT00847145|9734962|FG002|STARTED|Overall Study||285
8689961|NCT00847145|9734963|FG003|STARTED|Overall Study||117
8689962|NCT00847145|9734964|FG004|STARTED|Overall Study||137
8689963|NCT00847145|9734965|FG005|STARTED|Overall Study||156
8689964|NCT00847145|9734966|FG006|STARTED|Overall Study||152
8689965|NCT00847145|9734967|FG007|STARTED|Overall Study||140
8689966|NCT00847145|9734960|FG000|COMPLETED|Overall Study||623
8689967|NCT00847145|9734961|FG001|COMPLETED|Overall Study||627
8689968|NCT00847145|9734962|FG002|COMPLETED|Overall Study||274
8689969|NCT00847145|9734963|FG003|COMPLETED|Overall Study||116
8689970|NCT00847145|9734964|FG004|COMPLETED|Overall Study||131
8689971|NCT00847145|9734965|FG005|COMPLETED|Overall Study||152
8689972|NCT00847145|9734966|FG006|COMPLETED|Overall Study||143
8689973|NCT00847145|9734967|FG007|COMPLETED|Overall Study||136
8689974|NCT00847145|9734960|FG000|NOT COMPLETED|Overall Study||6
8689975|NCT00847145|9734961|FG001|NOT COMPLETED|Overall Study||6
8689976|NCT00847145|9734962|FG002|NOT COMPLETED|Overall Study||11
8689977|NCT00847145|9734963|FG003|NOT COMPLETED|Overall Study||1
8689978|NCT00847145|9734964|FG004|NOT COMPLETED|Overall Study||6
8689979|NCT00847145|9734965|FG005|NOT COMPLETED|Overall Study||4
8689980|NCT00847145|9734966|FG006|NOT COMPLETED|Overall Study||9
8689981|NCT00847145|9734967|FG007|NOT COMPLETED|Overall Study||4
8689982|NCT00847171|9734994|FG000|STARTED|Overall Study||20
8689983|NCT00847171|9734994|FG000|COMPLETED|Overall Study||20
8689984|NCT00847171|9734994|FG000|NOT COMPLETED|Overall Study||0
8689985|NCT00847197|9735001|FG000|STARTED|Overall Study||116
8689986|NCT00847197|9735002|FG001|STARTED|Overall Study||75
8689987|NCT00847197|9735001|FG000|COMPLETED|Overall Study||92
8689988|NCT00847197|9735002|FG001|COMPLETED|Overall Study||70
8689989|NCT00847197|9735001|FG000|NOT COMPLETED|Overall Study||24
8689990|NCT00847197|9735002|FG001|NOT COMPLETED|Overall Study||5
8689991|NCT00847210|9735010|FG000|STARTED|Overall Study||18
8689992|NCT00847210|9735011|FG001|STARTED|Overall Study||18
8689993|NCT00847210|9735010|FG000|COMPLETED|Overall Study||18
8689994|NCT00847210|9735011|FG001|COMPLETED|Overall Study||18
8689995|NCT00847210|9735010|FG000|NOT COMPLETED|Overall Study||0
8689996|NCT00847210|9735011|FG001|NOT COMPLETED|Overall Study||0
8689997|NCT00847288|9735019|FG000|STARTED|Overall Study||841
8689998|NCT00847288|9735020|FG001|STARTED|Overall Study||827
8689999|NCT00847288|9735019|FG000|COMPLETED|Overall Study||811
8690000|NCT00847288|9735020|FG001|COMPLETED|Overall Study||780
8690001|NCT00847288|9735019|FG000|NOT COMPLETED|Overall Study||30
8690002|NCT00847288|9735020|FG001|NOT COMPLETED|Overall Study||47
8690003|NCT00847301|9735026|FG000|STARTED|Overall Study||428
8690004|NCT00847301|9735026|FG000|COMPLETED|Overall Study||374
8690005|NCT00847301|9735026|FG000|NOT COMPLETED|Overall Study||54
8690006|NCT00847379|9735033|FG000|STARTED|Overall Study||59
8690007|NCT00847379|9735034|FG001|STARTED|Overall Study||57
8690008|NCT00847379|9735035|FG002|STARTED|Overall Study||57
8690009|NCT00847379|9735033|FG000|As-treated Population|Overall Study||59
8690010|NCT00847379|9735034|FG001|As-treated Population|Overall Study||57
8690011|NCT00847379|9735035|FG002|As-treated Population|Overall Study||57
8690012|NCT00847379|9735033|FG000|COMPLETED|Overall Study||0
8690013|NCT00847379|9735034|FG001|COMPLETED|Overall Study||0
8690014|NCT00847379|9735035|FG002|COMPLETED|Overall Study||0
8690015|NCT00847379|9735033|FG000|NOT COMPLETED|Overall Study||59
8690016|NCT00847379|9735034|FG001|NOT COMPLETED|Overall Study||57
8690017|NCT00847379|9735035|FG002|NOT COMPLETED|Overall Study||57
8690018|NCT00847522|9735045|FG000|STARTED|Overall Study||90
8690019|NCT00847522|9735045|FG000|Phase I|Overall Study||10
8690020|NCT00847522|9735045|FG000|Phase II|Overall Study||80
8690021|NCT00847522|9735045|FG000|COMPLETED|Overall Study||90
8690022|NCT00847522|9735045|FG000|NOT COMPLETED|Overall Study||0
8690023|NCT00847535|9735049|FG000|STARTED|Overall Study||24
8690024|NCT00847535|9735050|FG001|STARTED|Overall Study||24
8690025|NCT00847535|9735051|FG002|STARTED|Overall Study||16
8690026|NCT00847535|9735049|FG000|10 Million AMDC|Overall Study||8
8690027|NCT00847535|9735050|FG001|10 Million AMDC|Overall Study||8
8690028|NCT00847535|9735051|FG002|10 Million AMDC|Overall Study||0
8690029|NCT00847535|9735049|FG000|50 Million AMDC|Overall Study||8
8690030|NCT00847535|9735050|FG001|50 Million AMDC|Overall Study||8
8690031|NCT00847535|9735051|FG002|50 Million AMDC|Overall Study||0
8690032|NCT00847535|9735049|FG000|100 Million AMDC|Overall Study||8
8690033|NCT00847535|9735050|FG001|100 Million AMDC|Overall Study||8
8690034|NCT00847535|9735051|FG002|100 Million AMDC|Overall Study||8
8690035|NCT00847535|9735049|FG000|200 Million AMDC|Overall Study||0
8690036|NCT00847535|9735050|FG001|200 Million AMDC|Overall Study||0
8690037|NCT00847535|9735051|FG002|200 Million AMDC|Overall Study||8
8690038|NCT00847535|9735049|FG000|COMPLETED|Overall Study||22
8690039|NCT00847535|9735050|FG001|COMPLETED|Overall Study||22
8690040|NCT00847535|9735051|FG002|COMPLETED|Overall Study||15
8690041|NCT00847535|9735049|FG000|NOT COMPLETED|Overall Study||2
8690042|NCT00847535|9735050|FG001|NOT COMPLETED|Overall Study||2
8690043|NCT00847535|9735051|FG002|NOT COMPLETED|Overall Study||1
8690044|NCT00847561|9735058|FG000|STARTED|Overall Study||70
8690045|NCT00847561|9735059|FG001|STARTED|Overall Study||66
8690046|NCT00847561|9735058|FG000|COMPLETED|Overall Study||57
8690047|NCT00847561|9735059|FG001|COMPLETED|Overall Study||62
8690048|NCT00847561|9735058|FG000|NOT COMPLETED|Overall Study||13
8690049|NCT00847561|9735059|FG001|NOT COMPLETED|Overall Study||4
8690050|NCT00847587|9735067|FG000|STARTED|Overall Study||35
8690051|NCT00847587|9735068|FG001|STARTED|Overall Study||34
8690052|NCT00847587|9735067|FG000|COMPLETED|Overall Study|Patient declined study after randomization.|34
8690053|NCT00847587|9735068|FG001|COMPLETED|Overall Study||34
8690054|NCT00847587|9735067|FG000|NOT COMPLETED|Overall Study||1
8690055|NCT00847587|9735068|FG001|NOT COMPLETED|Overall Study||0
8690056|NCT00847613|9735078|FG000|STARTED|Overall Study||321
8690057|NCT00847613|9735079|FG001|STARTED|Overall Study||319
8690058|NCT00847613|9735080|FG002|STARTED|Overall Study||81
8690059|NCT00847613|9735081|FG003|STARTED|Overall Study||79
8690060|NCT00847613|9735078|FG000|Treated|Overall Study||321
8690061|NCT00847613|9735079|FG001|Treated|Overall Study||316
8690062|NCT00847613|9735080|FG002|Treated|Overall Study||81
8690063|NCT00847613|9735081|FG003|Treated|Overall Study||79
8690064|NCT00847613|9735078|FG000|COMPLETED|Overall Study||0
8690065|NCT00847613|9735079|FG001|COMPLETED|Overall Study||0
8690066|NCT00847613|9735080|FG002|COMPLETED|Overall Study||0
8690067|NCT00847613|9735081|FG003|COMPLETED|Overall Study||0
8690068|NCT00847613|9735078|FG000|NOT COMPLETED|Overall Study||321
8690069|NCT00847613|9735079|FG001|NOT COMPLETED|Overall Study||319
8690070|NCT00847613|9735080|FG002|NOT COMPLETED|Overall Study||81
8690071|NCT00847613|9735081|FG003|NOT COMPLETED|Overall Study||79
8690072|NCT00847626|9735109|FG000|STARTED|Overall Study||156
8690073|NCT00847626|9735110|FG001|STARTED|Overall Study||154
8690074|NCT00847626|9735111|FG002|STARTED|Overall Study|Includes participant who was randomized but did not receive study medication.|147
8690075|NCT00847626|9735112|FG003|STARTED|Overall Study||156
8690076|NCT00847626|9735113|FG004|STARTED|Overall Study||153
8690077|NCT00847626|9735114|FG005|STARTED|Overall Study|Includes participant who was randomized but did not receive study medication.|162
8690078|NCT00847626|9735115|FG006|STARTED|Overall Study|Includes participant who was randomized but did not receive study medication.|157
8690079|NCT00847626|9735116|FG007|STARTED|Overall Study|Includes participant who was treated with double-blind study medication but not randomized.|160
8690080|NCT00847626|9735117|FG008|STARTED|Overall Study||155
8690081|NCT00847626|9735118|FG009|STARTED|Overall Study||153
8690082|NCT00847626|9735119|FG010|STARTED|Overall Study||162
8690083|NCT00847626|9735109|FG000|COMPLETED|Overall Study||135
8690084|NCT00847626|9735110|FG001|COMPLETED|Overall Study||131
8690085|NCT00847626|9735111|FG002|COMPLETED|Overall Study||131
8690086|NCT00847626|9735112|FG003|COMPLETED|Overall Study||125
8690087|NCT00847626|9735113|FG004|COMPLETED|Overall Study||125
8690088|NCT00847626|9735114|FG005|COMPLETED|Overall Study||125
8690089|NCT00847626|9735115|FG006|COMPLETED|Overall Study||135
8690090|NCT00847626|9735116|FG007|COMPLETED|Overall Study||141
8690091|NCT00847626|9735117|FG008|COMPLETED|Overall Study||141
8690092|NCT00847626|9735118|FG009|COMPLETED|Overall Study||139
8690093|NCT00847626|9735119|FG010|COMPLETED|Overall Study||142
8690094|NCT00847626|9735109|FG000|NOT COMPLETED|Overall Study||21
8690095|NCT00847626|9735110|FG001|NOT COMPLETED|Overall Study||23
8690096|NCT00847626|9735111|FG002|NOT COMPLETED|Overall Study||16
8690097|NCT00847626|9735112|FG003|NOT COMPLETED|Overall Study||31
8690098|NCT00847626|9735113|FG004|NOT COMPLETED|Overall Study||28
8690099|NCT00847626|9735114|FG005|NOT COMPLETED|Overall Study||37
8690100|NCT00847626|9735115|FG006|NOT COMPLETED|Overall Study||22
8690101|NCT00847626|9735116|FG007|NOT COMPLETED|Overall Study||19
8690102|NCT00847626|9735117|FG008|NOT COMPLETED|Overall Study||14
8690103|NCT00847626|9735118|FG009|NOT COMPLETED|Overall Study||14
8690104|NCT00847626|9735119|FG010|NOT COMPLETED|Overall Study||20
8690105|NCT00847665|9735148|FG000|STARTED|Overall Study||165
8690106|NCT00847665|9735149|FG001|STARTED|Overall Study||165
8690107|NCT00847665|9735148|FG000|COMPLETED|Overall Study||164
8690108|NCT00847665|9735149|FG001|COMPLETED|Overall Study||165
8690109|NCT00847665|9735148|FG000|NOT COMPLETED|Overall Study||1
8690110|NCT00847665|9735149|FG001|NOT COMPLETED|Overall Study||0
8690111|NCT00847704|9735155|FG000|STARTED|Overall Study||3
8690112|NCT00847704|9735155|FG000|COMPLETED|Overall Study||2
8690113|NCT00847704|9735155|FG000|NOT COMPLETED|Overall Study||1
8690114|NCT00847730|9735159|FG000|STARTED|Overall Study||33
8690115|NCT00847730|9735159|FG000|COMPLETED|Overall Study||25
8690116|NCT00847730|9735159|FG000|NOT COMPLETED|Overall Study||8
8690117|NCT00847808|9735163|FG000|STARTED|Overall Study||178
8690118|NCT00847808|9735163|FG000|COMPLETED|Overall Study||163
8690119|NCT00847808|9735163|FG000|NOT COMPLETED|Overall Study||15
8690120|NCT00847886|9735169|FG000|STARTED|Overall Study||12
8690121|NCT00847886|9735170|FG001|STARTED|Overall Study||4
8690122|NCT00847886|9735169|FG000|COMPLETED|Overall Study||12
8690123|NCT00847886|9735170|FG001|COMPLETED|Overall Study||3
8690124|NCT00847886|9735169|FG000|NOT COMPLETED|Overall Study||0
8690125|NCT00847886|9735170|FG001|NOT COMPLETED|Overall Study||1
8690126|NCT00847912|9735178|FG000|STARTED|Overall Study||477
8690127|NCT00847912|9735179|FG001|STARTED|Overall Study||477
8690128|NCT00847912|9735178|FG000|COMPLETED|Overall Study||468
8690129|NCT00847912|9735179|FG001|COMPLETED|Overall Study||464
8690130|NCT00847912|9735178|FG000|NOT COMPLETED|Overall Study||9
8690131|NCT00847912|9735179|FG001|NOT COMPLETED|Overall Study||13
8690132|NCT00847938|9735190|FG000|STARTED|Overall Study||16
8690133|NCT00847938|9735191|FG001|STARTED|Overall Study||15
8690134|NCT00847938|9735192|FG002|STARTED|Overall Study||16
8690135|NCT00847938|9735193|FG003|STARTED|Overall Study||15
8690136|NCT00847938|9735190|FG000|COMPLETED|Overall Study||16
8690137|NCT00847938|9735191|FG001|COMPLETED|Overall Study||14
8690138|NCT00847938|9735192|FG002|COMPLETED|Overall Study||15
8690139|NCT00847938|9735193|FG003|COMPLETED|Overall Study||15
8690140|NCT00847938|9735190|FG000|NOT COMPLETED|Overall Study||0
8690141|NCT00847938|9735191|FG001|NOT COMPLETED|Overall Study||1
8690142|NCT00847938|9735192|FG002|NOT COMPLETED|Overall Study||1
8690143|NCT00847938|9735193|FG003|NOT COMPLETED|Overall Study||0
8690144|NCT00848016|9735203|FG000|STARTED|Overall Study||29
8690145|NCT00848016|9735203|FG000|COMPLETED|Overall Study||29
8690146|NCT00848016|9735203|FG000|NOT COMPLETED|Overall Study||0
8690147|NCT00848042|9735210|FG000|STARTED|Overall Study||5
8690148|NCT00848042|9735211|FG001|STARTED|Overall Study||5
8690149|NCT00848042|9735212|FG002|STARTED|Overall Study||1
8690150|NCT00848042|9735210|FG000|Day 1|Overall Study||5
8690151|NCT00848042|9735211|FG001|Day 1|Overall Study||5
8690152|NCT00848042|9735212|FG002|Day 1|Overall Study||1
8690153|NCT00848042|9735210|FG000|Day 2|Overall Study||5
8690154|NCT00848042|9735211|FG001|Day 2|Overall Study||5
8690155|NCT00848042|9735212|FG002|Day 2|Overall Study||1
8690156|NCT00848042|9735210|FG000|Day 3|Overall Study||5
8690157|NCT00848042|9735211|FG001|Day 3|Overall Study||5
8690158|NCT00848042|9735212|FG002|Day 3|Overall Study||1
8577159|NCT00156910|9610051|FG001|COMPLETED|Open-Label Phase (OL)||231
8690159|NCT00848042|9735210|FG000|Day 8|Overall Study||5
8690160|NCT00848042|9735211|FG001|Day 8|Overall Study||5
8690161|NCT00848042|9735212|FG002|Day 8|Overall Study||1
8690162|NCT00848042|9735210|FG000|Day 15|Overall Study||4
8690163|NCT00848042|9735211|FG001|Day 15|Overall Study||5
8690164|NCT00848042|9735212|FG002|Day 15|Overall Study||1
8690165|NCT00848042|9735210|FG000|Month 1|Overall Study||4
8690166|NCT00848042|9735211|FG001|Month 1|Overall Study||5
8690167|NCT00848042|9735212|FG002|Month 1|Overall Study||1
8690168|NCT00848042|9735210|FG000|Month 2|Overall Study||1
8690169|NCT00848042|9735211|FG001|Month 2|Overall Study||5
8690170|NCT00848042|9735212|FG002|Month 2|Overall Study||1
8690171|NCT00848042|9735210|FG000|Month 3|Overall Study||1
8690172|NCT00848042|9735211|FG001|Month 3|Overall Study||4
8690173|NCT00848042|9735212|FG002|Month 3|Overall Study||1
8690174|NCT00848042|9735210|FG000|Month 4|Overall Study||1
8690175|NCT00848042|9735211|FG001|Month 4|Overall Study||4
8690176|NCT00848042|9735212|FG002|Month 4|Overall Study||1
8577160|NCT00156910|9610050|FG000|NOT COMPLETED|Open-Label Phase (OL)||33
8577161|NCT00156910|9610051|FG001|NOT COMPLETED|Open-Label Phase (OL)||55
8577162|NCT00156923|9610059|FG000|STARTED|Overall Study||56
8577163|NCT00156923|9610060|FG001|STARTED|Overall Study||52
8577164|NCT00156923|9610059|FG000|COMPLETED|Overall Study||22
8577165|NCT00156923|9610060|FG001|COMPLETED|Overall Study||20
8577166|NCT00156923|9610059|FG000|NOT COMPLETED|Overall Study||34
8577167|NCT00156923|9610060|FG001|NOT COMPLETED|Overall Study||32
8690177|NCT00848042|9735210|FG000|Month 5|Overall Study||1
8690178|NCT00848042|9735211|FG001|Month 5|Overall Study||3
8690179|NCT00848042|9735212|FG002|Month 5|Overall Study||1
8690180|NCT00848042|9735210|FG000|Month 6|Overall Study||1
8690181|NCT00848042|9735211|FG001|Month 6|Overall Study||3
8690182|NCT00848042|9735212|FG002|Month 6|Overall Study||1
8690183|NCT00848042|9735210|FG000|COMPLETED|Overall Study||1
8690184|NCT00848042|9735211|FG001|COMPLETED|Overall Study||3
8690185|NCT00848042|9735212|FG002|COMPLETED|Overall Study||1
8690186|NCT00848042|9735210|FG000|NOT COMPLETED|Overall Study||4
8690187|NCT00848042|9735211|FG001|NOT COMPLETED|Overall Study||2
8690188|NCT00848042|9735212|FG002|NOT COMPLETED|Overall Study||0
8690189|NCT00848081|9735222|FG000|STARTED|Overall Study||160
8690190|NCT00848081|9735223|FG001|STARTED|Overall Study||158
8690191|NCT00848081|9735222|FG000|COMPLETED|Overall Study||140
8690192|NCT00848081|9735223|FG001|COMPLETED|Overall Study||140
8690193|NCT00848081|9735222|FG000|NOT COMPLETED|Overall Study||20
8690194|NCT00848081|9735223|FG001|NOT COMPLETED|Overall Study||18
8690195|NCT00848107|9735229|FG000|STARTED|Overall Study||115
8690196|NCT00848107|9735229|FG000|COMPLETED|Overall Study||94
8690197|NCT00848107|9735229|FG000|NOT COMPLETED|Overall Study||21
8690198|NCT00848120|9735233|FG000|STARTED|Overall Study||29
8690199|NCT00848120|9735233|FG000|COMPLETED|Overall Study||28
8690200|NCT00848120|9735233|FG000|NOT COMPLETED|Overall Study||1
8690201|NCT00848172|9735239|FG000|STARTED|Visit 2 - Drug Administration||10
8690202|NCT00848172|9735240|FG001|STARTED|Visit 2 - Drug Administration||9
8690203|NCT00848172|9735239|FG000|COMPLETED|Visit 2 - Drug Administration||10
8690204|NCT00848172|9735240|FG001|COMPLETED|Visit 2 - Drug Administration||8
8690205|NCT00848172|9735239|FG000|NOT COMPLETED|Visit 2 - Drug Administration||0
8690206|NCT00848172|9735240|FG001|NOT COMPLETED|Visit 2 - Drug Administration||1
8690207|NCT00848172|9735239|FG000|STARTED|Visit 3 - Follow Up||10
8690208|NCT00848172|9735240|FG001|STARTED|Visit 3 - Follow Up||8
8690209|NCT00848172|9735239|FG000|COMPLETED|Visit 3 - Follow Up||10
8690210|NCT00848172|9735240|FG001|COMPLETED|Visit 3 - Follow Up||8
8690211|NCT00848172|9735239|FG000|NOT COMPLETED|Visit 3 - Follow Up||0
8690212|NCT00848172|9735240|FG001|NOT COMPLETED|Visit 3 - Follow Up||0
8690213|NCT00848185|9735252|FG000|STARTED|Overall Study||32
8690214|NCT00848185|9735253|FG001|STARTED|Overall Study||32
8690215|NCT00848185|9735254|FG002|STARTED|Overall Study||32
8690216|NCT00848185|9735252|FG000|COMPLETED|Overall Study||32
8690217|NCT00848185|9735253|FG001|COMPLETED|Overall Study||32
8802195|NCT01454531|9854222|FG000|COMPLETED|Overall Study||173
8802196|NCT01454531|9854222|FG000|NOT COMPLETED|Overall Study||23
8802197|NCT01454570|9854226|FG000|STARTED|Overall Study||19
8802198|NCT01454570|9854226|FG000|COMPLETED|Overall Study||10
8802199|NCT01454570|9854226|FG000|NOT COMPLETED|Overall Study||9
8802200|NCT01454583|9854233|FG000|STARTED|1st Year|From initially 15337 pat. 351 withdrawed from the registry, 14986 pat. were assigned to the groups.|10177
8802201|NCT01454583|9854234|FG001|STARTED|1st Year||2696
8802202|NCT01454583|9854235|FG002|STARTED|1st Year||2113
8802203|NCT01454583|9854233|FG000|COMPLETED|1st Year||9120
8802204|NCT01454583|9854234|FG001|COMPLETED|1st Year||2378
8802205|NCT01454583|9854235|FG002|COMPLETED|1st Year||1933
8802206|NCT01454583|9854233|FG000|NOT COMPLETED|1st Year||1057
8802207|NCT01454583|9854234|FG001|NOT COMPLETED|1st Year||318
8802208|NCT01454583|9854235|FG002|NOT COMPLETED|1st Year||180
8802209|NCT01454583|9854233|FG000|STARTED|2nd Year||10177
8802210|NCT01454583|9854234|FG001|STARTED|2nd Year||2696
8802211|NCT01454583|9854235|FG002|STARTED|2nd Year||2113
8802212|NCT01454583|9854233|FG000|COMPLETED|2nd Year||6212
8802213|NCT01454583|9854234|FG001|COMPLETED|2nd Year||1647
8802214|NCT01454583|9854235|FG002|COMPLETED|2nd Year||1376
8802215|NCT01454583|9854233|FG000|NOT COMPLETED|2nd Year||3965
8802216|NCT01454583|9854234|FG001|NOT COMPLETED|2nd Year||1049
8802217|NCT01454583|9854235|FG002|NOT COMPLETED|2nd Year||737
8802218|NCT01454583|9854233|FG000|STARTED|3rd Year||3791
8802219|NCT01454583|9854234|FG001|STARTED|3rd Year||982
8802220|NCT01454583|9854235|FG002|STARTED|3rd Year||582
8802221|NCT01454583|9854233|FG000|COMPLETED|3rd Year||1832
8802222|NCT01454583|9854234|FG001|COMPLETED|3rd Year||470
8802223|NCT01454583|9854235|FG002|COMPLETED|3rd Year||285
8802224|NCT01454583|9854233|FG000|NOT COMPLETED|3rd Year||1959
8802225|NCT01454583|9854234|FG001|NOT COMPLETED|3rd Year||512
8802226|NCT01454583|9854235|FG002|NOT COMPLETED|3rd Year||297
8802227|NCT01454596|9854255|FG000|STARTED|Overall Study||1
8802228|NCT01454596|9854256|FG001|STARTED|Overall Study||1
8802229|NCT01454596|9854257|FG002|STARTED|Overall Study||1
8802230|NCT01454596|9854258|FG003|STARTED|Overall Study||1
8802231|NCT01454596|9854259|FG004|STARTED|Overall Study||1
8802232|NCT01454596|9854260|FG005|STARTED|Overall Study||1
8802233|NCT01454596|9854261|FG006|STARTED|Overall Study||1
8802234|NCT01454596|9854262|FG007|STARTED|Overall Study||3
8802235|NCT01454596|9854263|FG008|STARTED|Overall Study||3
8802236|NCT01454596|9854264|FG009|STARTED|Overall Study||3
8802237|NCT01454596|9854265|FG010|STARTED|Overall Study||1
8802238|NCT01454596|9854266|FG011|STARTED|Overall Study||1
8690218|NCT00848185|9735254|FG002|COMPLETED|Overall Study||32
8690219|NCT00848185|9735252|FG000|NOT COMPLETED|Overall Study||0
8690220|NCT00848185|9735253|FG001|NOT COMPLETED|Overall Study||0
8690221|NCT00848185|9735254|FG002|NOT COMPLETED|Overall Study||0
8690222|NCT00848198|9735262|FG000|STARTED|Overall Study||314
8802239|NCT01454596|9854255|FG000|COMPLETED|Overall Study||1
8802240|NCT01454596|9854256|FG001|COMPLETED|Overall Study||1
8802241|NCT01454596|9854257|FG002|COMPLETED|Overall Study||1
8690223|NCT00848198|9735262|FG000|COMPLETED|Overall Study||299
8690224|NCT00848198|9735262|FG000|NOT COMPLETED|Overall Study||15
8690225|NCT00848211|9735274|FG000|STARTED|Overall Study||6
8690226|NCT00848211|9735275|FG001|STARTED|Overall Study||7
8690227|NCT00848211|9735276|FG002|STARTED|Overall Study||6
8690228|NCT00848211|9735277|FG003|STARTED|Overall Study||5
8690229|NCT00848211|9735274|FG000|COMPLETED|Overall Study||6
8690230|NCT00848211|9735275|FG001|COMPLETED|Overall Study||6
8690231|NCT00848211|9735276|FG002|COMPLETED|Overall Study||5
8690232|NCT00848211|9735277|FG003|COMPLETED|Overall Study||5
8690233|NCT00848211|9735274|FG000|NOT COMPLETED|Overall Study||0
8690234|NCT00848211|9735275|FG001|NOT COMPLETED|Overall Study||1
8690235|NCT00848211|9735276|FG002|NOT COMPLETED|Overall Study||1
8690236|NCT00848211|9735277|FG003|NOT COMPLETED|Overall Study||0
8690237|NCT00848237|9735287|FG000|STARTED|Overall Study||5521
8690238|NCT00848237|9735287|FG000|COMPLETED|Overall Study||4982
8690239|NCT00848237|9735287|FG000|NOT COMPLETED|Overall Study||539
8690240|NCT00848250|9735293|FG000|STARTED|Overall Study||11
8690241|NCT00848250|9735294|FG001|STARTED|Overall Study||10
8690242|NCT00848250|9735293|FG000|COMPLETED|Overall Study||11
8690243|NCT00848250|9735294|FG001|COMPLETED|Overall Study||9
8690244|NCT00848250|9735293|FG000|NOT COMPLETED|Overall Study||0
8690245|NCT00848250|9735294|FG001|NOT COMPLETED|Overall Study||1
8690246|NCT00848354|9735303|FG000|STARTED|Phase 1|One participant was randomized to the Etanercept + Methotrexate group but received SSZ in error.|281
8690247|NCT00848354|9735304|FG001|STARTED|Phase 1||143
8690248|NCT00848354|9735303|FG000|COMPLETED|Phase 1||269
8690249|NCT00848354|9735304|FG001|COMPLETED|Phase 1||129
8690250|NCT00848354|9735303|FG000|NOT COMPLETED|Phase 1||12
8690251|NCT00848354|9735304|FG001|NOT COMPLETED|Phase 1||14
8690252|NCT00848354|9735303|FG000|STARTED|Phase 2 Year 1|Randomized Phase 1 treatment assignment. 9 participants discontinued between Phase 1 and Phase 2.|260
8690253|NCT00848354|9735304|FG001|STARTED|Phase 2 Year 1|Randomized Phase 1 treatment assignment. 3 participants discontinued between Phase 1 and Phase 2.|126
8690254|NCT00848354|9735303|FG000|COMPLETED|Phase 2 Year 1||242
8690255|NCT00848354|9735304|FG001|COMPLETED|Phase 2 Year 1||120
8690256|NCT00848354|9735303|FG000|NOT COMPLETED|Phase 2 Year 1||18
8690257|NCT00848354|9735304|FG001|NOT COMPLETED|Phase 2 Year 1||6
8690258|NCT00848354|9735303|FG000|STARTED|Phase 2 Year 2|"Randomized Phase 1 treatment assignment.~1 participant discontinued between Year 1 and Year 2."|241
8690259|NCT00848354|9735304|FG001|STARTED|Phase 2 Year 2|Randomized Phase 1 treatment assignment.|120
8690260|NCT00848354|9735303|FG000|COMPLETED|Phase 2 Year 2||218
8690261|NCT00848354|9735304|FG001|COMPLETED|Phase 2 Year 2||113
8690262|NCT00848354|9735303|FG000|NOT COMPLETED|Phase 2 Year 2||23
8690263|NCT00848354|9735304|FG001|NOT COMPLETED|Phase 2 Year 2||7
8690264|NCT00848367|9735316|FG000|STARTED|Overall Study||52
8690265|NCT00848367|9735317|FG001|STARTED|Overall Study||50
8690266|NCT00848367|9735316|FG000|COMPLETED|Overall Study||43
8690267|NCT00848367|9735317|FG001|COMPLETED|Overall Study||41
8690268|NCT00848367|9735316|FG000|NOT COMPLETED|Overall Study||9
8690269|NCT00848367|9735317|FG001|NOT COMPLETED|Overall Study||9
8690270|NCT00848393|9735328|FG000|STARTED|Overall Study||17
8690271|NCT00848393|9735329|FG001|STARTED|Overall Study||16
8690272|NCT00848393|9735330|FG002|STARTED|Overall Study||18
8690273|NCT00848393|9735328|FG000|COMPLETED|Overall Study||17
8690274|NCT00848393|9735329|FG001|COMPLETED|Overall Study||16
8690275|NCT00848393|9735330|FG002|COMPLETED|Overall Study||15
8690276|NCT00848393|9735328|FG000|NOT COMPLETED|Overall Study||0
8690277|NCT00848393|9735329|FG001|NOT COMPLETED|Overall Study||0
8690278|NCT00848393|9735330|FG002|NOT COMPLETED|Overall Study||3
8690279|NCT00848484|9735344|FG000|STARTED|First Intervention (Treatment Period 1)||27
8690280|NCT00848484|9735345|FG001|STARTED|First Intervention (Treatment Period 1)||27
8690281|NCT00848484|9735344|FG000|With Reduced Dose at Treatment Period 1|First Intervention (Treatment Period 1)||2
8690282|NCT00848484|9735345|FG001|With Reduced Dose at Treatment Period 1|First Intervention (Treatment Period 1)||1
8690283|NCT00848484|9735344|FG000|COMPLETED|First Intervention (Treatment Period 1)||25
8690284|NCT00848484|9735345|FG001|COMPLETED|First Intervention (Treatment Period 1)||24
8690285|NCT00848484|9735344|FG000|NOT COMPLETED|First Intervention (Treatment Period 1)||2
8690286|NCT00848484|9735345|FG001|NOT COMPLETED|First Intervention (Treatment Period 1)||3
8690287|NCT00848484|9735344|FG000|STARTED|Washout Period of Two Weeks||25
8690288|NCT00848484|9735345|FG001|STARTED|Washout Period of Two Weeks||24
8690289|NCT00848484|9735344|FG000|COMPLETED|Washout Period of Two Weeks||25
8690290|NCT00848484|9735345|FG001|COMPLETED|Washout Period of Two Weeks||21
8690291|NCT00848484|9735344|FG000|NOT COMPLETED|Washout Period of Two Weeks||0
8690292|NCT00848484|9735345|FG001|NOT COMPLETED|Washout Period of Two Weeks||3
8690293|NCT00848484|9735344|FG000|STARTED|Second Intervention (Treatment Period 2)||25
8690294|NCT00848484|9735345|FG001|STARTED|Second Intervention (Treatment Period 2)||21
8690295|NCT00848484|9735344|FG000|With Reduced Dose at Treatment Period 2|Second Intervention (Treatment Period 2)||0
8690296|NCT00848484|9735345|FG001|With Reduced Dose at Treatment Period 2|Second Intervention (Treatment Period 2)||0
8690297|NCT00848484|9735344|FG000|COMPLETED|Second Intervention (Treatment Period 2)||25
8690298|NCT00848484|9735345|FG001|COMPLETED|Second Intervention (Treatment Period 2)||20
8690299|NCT00848484|9735344|FG000|NOT COMPLETED|Second Intervention (Treatment Period 2)||0
8690300|NCT00848484|9735345|FG001|NOT COMPLETED|Second Intervention (Treatment Period 2)||1
8690301|NCT00848497|9735353|FG000|STARTED|Overall Study||2
8690302|NCT00848497|9735354|FG001|STARTED|Overall Study|Completed Visit 4|1
8690303|NCT00848497|9735353|FG000|COMPLETED|Overall Study||0
8690304|NCT00848497|9735354|FG001|COMPLETED|Overall Study||0
8690305|NCT00848497|9735353|FG000|NOT COMPLETED|Overall Study||2
8690306|NCT00848497|9735354|FG001|NOT COMPLETED|Overall Study||1
8690307|NCT00848510|9735366|FG000|STARTED|Overall Study||10
8690308|NCT00848510|9735367|FG001|STARTED|Overall Study||13
8690309|NCT00848510|9735368|FG002|STARTED|Overall Study||8
8690310|NCT00848510|9735369|FG003|STARTED|Overall Study||10
8690311|NCT00848510|9735366|FG000|COMPLETED|Overall Study||10
8690312|NCT00848510|9735367|FG001|COMPLETED|Overall Study||13
8690313|NCT00848510|9735368|FG002|COMPLETED|Overall Study||8
8690314|NCT00848510|9735369|FG003|COMPLETED|Overall Study||10
8690315|NCT00848510|9735366|FG000|NOT COMPLETED|Overall Study||0
8690316|NCT00848510|9735367|FG001|NOT COMPLETED|Overall Study||0
8690317|NCT00848510|9735368|FG002|NOT COMPLETED|Overall Study||0
8690318|NCT00848510|9735369|FG003|NOT COMPLETED|Overall Study||0
8690319|NCT00848536|9735381|FG000|STARTED|Overall Study||185
8690320|NCT00848536|9735382|FG001|STARTED|Overall Study||186
8690321|NCT00848536|9735381|FG000|COMPLETED|Overall Study||181
8690322|NCT00848536|9735382|FG001|COMPLETED|Overall Study||179
8690323|NCT00848536|9735381|FG000|NOT COMPLETED|Overall Study||4
8690324|NCT00848536|9735382|FG001|NOT COMPLETED|Overall Study||7
8690325|NCT00848549|9735390|FG000|STARTED|E2090-E044-310 (Base Study) Disposition||282
8690326|NCT00848549|9735391|FG001|STARTED|E2090-E044-310 (Base Study) Disposition||301
8690327|NCT00848549|9735390|FG000|COMPLETED|E2090-E044-310 (Base Study) Disposition||161
8690328|NCT00848549|9735391|FG001|COMPLETED|E2090-E044-310 (Base Study) Disposition||192
8690329|NCT00848549|9735390|FG000|NOT COMPLETED|E2090-E044-310 (Base Study) Disposition||121
8690330|NCT00848549|9735391|FG001|NOT COMPLETED|E2090-E044-310 (Base Study) Disposition||109
8690331|NCT00848549|9735390|FG000|STARTED|E2090-E044-310 (Base Study) Transition||161
8690332|NCT00848549|9735391|FG001|STARTED|E2090-E044-310 (Base Study) Transition||192
8690333|NCT00848549|9735390|FG000|COMPLETED|E2090-E044-310 (Base Study) Transition||137
8690334|NCT00848549|9735391|FG001|COMPLETED|E2090-E044-310 (Base Study) Transition||158
8690335|NCT00848549|9735390|FG000|NOT COMPLETED|E2090-E044-310 (Base Study) Transition||24
8690336|NCT00848549|9735391|FG001|NOT COMPLETED|E2090-E044-310 (Base Study) Transition||34
8690337|NCT00848549|9735390|FG000|STARTED|E2090-E044-314 (Extension Study)||137
8690338|NCT00848549|9735391|FG001|STARTED|E2090-E044-314 (Extension Study)||158
8690339|NCT00848549|9735390|FG000|COMPLETED|E2090-E044-314 (Extension Study)||120
8690340|NCT00848549|9735391|FG001|COMPLETED|E2090-E044-314 (Extension Study)||134
8690341|NCT00848549|9735390|FG000|NOT COMPLETED|E2090-E044-314 (Extension Study)||17
8690342|NCT00848549|9735391|FG001|NOT COMPLETED|E2090-E044-314 (Extension Study)||24
8690343|NCT00848718|9735412|FG000|STARTED|Overall Study||7
8690344|NCT00848718|9735413|FG001|STARTED|Overall Study||9
8690345|NCT00848718|9735414|FG002|STARTED|Overall Study||6
8690346|NCT00848718|9735415|FG003|STARTED|Overall Study||5
8690347|NCT00848718|9735416|FG004|STARTED|Overall Study||6
8690348|NCT00848718|9735417|FG005|STARTED|Overall Study||5
8690349|NCT00848718|9735418|FG006|STARTED|Overall Study||3
8690350|NCT00848718|9735419|FG007|STARTED|Overall Study||5
8690351|NCT00848718|9735420|FG008|STARTED|Overall Study||4
8690352|NCT00848718|9735421|FG009|STARTED|Overall Study||9
8690353|NCT00848718|9735422|FG010|STARTED|Overall Study||4
8690354|NCT00848718|9735423|FG011|STARTED|Overall Study||6
8690355|NCT00848718|9735424|FG012|STARTED|Overall Study||8
8690356|NCT00848718|9735412|FG000|Treated|Overall Study|1 participant was allocated but did not receive treatment due to progression of disease|6
8690357|NCT00848718|9735413|FG001|Treated|Overall Study||9
8690358|NCT00848718|9735414|FG002|Treated|Overall Study|1 participant was allocated but did not receive treatment due to progression of disease|5
8690359|NCT00848718|9735415|FG003|Treated|Overall Study||5
8690360|NCT00848718|9735416|FG004|Treated|Overall Study||6
8690361|NCT00848718|9735417|FG005|Treated|Overall Study||5
8690362|NCT00848718|9735418|FG006|Treated|Overall Study||3
8690363|NCT00848718|9735419|FG007|Treated|Overall Study|1 participant was allocated but did not receive treatment due to progression of disease|4
8690364|NCT00848718|9735420|FG008|Treated|Overall Study||4
8690365|NCT00848718|9735421|FG009|Treated|Overall Study||9
8690366|NCT00848718|9735422|FG010|Treated|Overall Study||4
8690367|NCT00848718|9735423|FG011|Treated|Overall Study||6
8690368|NCT00848718|9735424|FG012|Treated|Overall Study|2 participants were allocated but did not receive treatment due to progression of disease|6
8690369|NCT00848718|9735412|FG000|COMPLETED|Overall Study||0
8690370|NCT00848718|9735413|FG001|COMPLETED|Overall Study||0
8690371|NCT00848718|9735414|FG002|COMPLETED|Overall Study||0
8690372|NCT00848718|9735415|FG003|COMPLETED|Overall Study||0
8690373|NCT00848718|9735416|FG004|COMPLETED|Overall Study||0
8690374|NCT00848718|9735417|FG005|COMPLETED|Overall Study||0
8690375|NCT00848718|9735418|FG006|COMPLETED|Overall Study||0
8690376|NCT00848718|9735419|FG007|COMPLETED|Overall Study||0
8690377|NCT00848718|9735420|FG008|COMPLETED|Overall Study||0
8690378|NCT00848718|9735421|FG009|COMPLETED|Overall Study||0
8690379|NCT00848718|9735422|FG010|COMPLETED|Overall Study||0
8690380|NCT00848718|9735423|FG011|COMPLETED|Overall Study||0
8690381|NCT00848718|9735424|FG012|COMPLETED|Overall Study||0
8690382|NCT00848718|9735412|FG000|NOT COMPLETED|Overall Study||7
8690383|NCT00848718|9735413|FG001|NOT COMPLETED|Overall Study||9
8690384|NCT00848718|9735414|FG002|NOT COMPLETED|Overall Study||6
8690385|NCT00848718|9735415|FG003|NOT COMPLETED|Overall Study||5
8690386|NCT00848718|9735416|FG004|NOT COMPLETED|Overall Study||6
8690387|NCT00848718|9735417|FG005|NOT COMPLETED|Overall Study||5
8690388|NCT00848718|9735418|FG006|NOT COMPLETED|Overall Study||3
8690389|NCT00848718|9735419|FG007|NOT COMPLETED|Overall Study||5
8690390|NCT00848718|9735420|FG008|NOT COMPLETED|Overall Study||4
8690391|NCT00848718|9735421|FG009|NOT COMPLETED|Overall Study||9
8690392|NCT00848718|9735422|FG010|NOT COMPLETED|Overall Study||4
8690393|NCT00848718|9735423|FG011|NOT COMPLETED|Overall Study||6
8690394|NCT00848718|9735424|FG012|NOT COMPLETED|Overall Study||8
8690395|NCT00848744|9735458|FG000|STARTED|Overall Study||10
8690396|NCT00848744|9735458|FG000|COMPLETED|Overall Study||10
8690397|NCT00848744|9735458|FG000|NOT COMPLETED|Overall Study||0
8690398|NCT00848783|9735466|FG000|STARTED|Overall Study||4
8690399|NCT00848783|9735467|FG001|STARTED|Overall Study||3
8690400|NCT00848783|9735468|FG002|STARTED|Overall Study||1
8690401|NCT00848783|9735466|FG000|COMPLETED|Overall Study||1
8690402|NCT00848783|9735467|FG001|COMPLETED|Overall Study||1
8690403|NCT00848783|9735468|FG002|COMPLETED|Overall Study||1
8690404|NCT00848783|9735466|FG000|NOT COMPLETED|Overall Study||3
8690405|NCT00848783|9735467|FG001|NOT COMPLETED|Overall Study||2
8690406|NCT00848783|9735468|FG002|NOT COMPLETED|Overall Study||0
8690407|NCT00848926|9735475|FG000|STARTED|Treatment Period||102
8690408|NCT00848926|9735475|FG000|COMPLETED|Treatment Period|Number who completed 16 cycles of treatment|18
8690409|NCT00848926|9735475|FG000|NOT COMPLETED|Treatment Period||84
8690410|NCT00848926|9735475|FG000|STARTED|Follow-up Period|All participants were to be followed after treatment|102
8690411|NCT00848926|9735475|FG000|COMPLETED|Follow-up Period|Completed survival follow-up due to death [57] or study termination by sponsor [33]|90
8690412|NCT00848926|9735475|FG000|NOT COMPLETED|Follow-up Period||12
8690413|NCT00848965|9735479|FG000|STARTED|Overall Study||59
8690414|NCT00848965|9735479|FG000|COMPLETED|Overall Study||57
8690415|NCT00848965|9735479|FG000|NOT COMPLETED|Overall Study||2
8690416|NCT00849017|9735494|FG000|STARTED|Treatment Period (156 Weeks)||101
8690417|NCT00849017|9735495|FG001|STARTED|Treatment Period (156 Weeks)||101
8690418|NCT00849017|9735496|FG002|STARTED|Treatment Period (156 Weeks)||99
8690419|NCT00849017|9735494|FG000|COMPLETED|Treatment Period (156 Weeks)||58
8690420|NCT00849017|9735495|FG001|COMPLETED|Treatment Period (156 Weeks)||68
8690421|NCT00849017|9735496|FG002|COMPLETED|Treatment Period (156 Weeks)||57
8690422|NCT00849017|9735494|FG000|NOT COMPLETED|Treatment Period (156 Weeks)||43
8690423|NCT00849017|9735495|FG001|NOT COMPLETED|Treatment Period (156 Weeks)||33
8690424|NCT00849017|9735496|FG002|NOT COMPLETED|Treatment Period (156 Weeks)||42
8690425|NCT00849017|9735494|FG000|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|101
8690426|NCT00849017|9735495|FG001|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|101
8690427|NCT00849017|9735496|FG002|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|99
8690428|NCT00849017|9735494|FG000|COMPLETED|Follow-up Period (8 Weeks)||76
8690429|NCT00849017|9735495|FG001|COMPLETED|Follow-up Period (8 Weeks)||83
8690430|NCT00849017|9735496|FG002|COMPLETED|Follow-up Period (8 Weeks)||74
8690431|NCT00849017|9735494|FG000|NOT COMPLETED|Follow-up Period (8 Weeks)||25
8690432|NCT00849017|9735495|FG001|NOT COMPLETED|Follow-up Period (8 Weeks)||18
8690433|NCT00849017|9735496|FG002|NOT COMPLETED|Follow-up Period (8 Weeks)||25
8690434|NCT00849056|9735510|FG000|STARTED|Treatment Period (TP) (156 Weeks)||151
8690435|NCT00849056|9735511|FG001|STARTED|Treatment Period (TP) (156 Weeks)||150
8690436|NCT00849056|9735510|FG000|COMPLETED|Treatment Period (TP) (156 Weeks)||88
8690437|NCT00849056|9735511|FG001|COMPLETED|Treatment Period (TP) (156 Weeks)||100
8690438|NCT00849056|9735510|FG000|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||63
8690439|NCT00849056|9735511|FG001|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||50
8690440|NCT00849056|9735510|FG000|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. Two par. did not participate in the FUP.|149
8690441|NCT00849056|9735511|FG001|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. One par. did not participate in the FUP.|149
8690442|NCT00849056|9735510|FG000|COMPLETED|Follow-up Period (FUP) (8 Weeks)||122
8690443|NCT00849056|9735511|FG001|COMPLETED|Follow-up Period (FUP) (8 Weeks)||124
8690444|NCT00849056|9735510|FG000|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||27
8690445|NCT00849056|9735511|FG001|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||25
8690446|NCT00849108|9735520|FG000|STARTED|Cohort 1 Dose Ranging and Dose Interval||33
8690447|NCT00849108|9735521|FG001|STARTED|Cohort 1 Dose Ranging and Dose Interval|Cohort 2(Pharm Stress) subjects did not participate in dose range, dose frequency|0
8690448|NCT00849108|9735520|FG000|COMPLETED|Cohort 1 Dose Ranging and Dose Interval||32
8690449|NCT00849108|9735521|FG001|COMPLETED|Cohort 1 Dose Ranging and Dose Interval||0
8690450|NCT00849108|9735520|FG000|NOT COMPLETED|Cohort 1 Dose Ranging and Dose Interval||1
8690451|NCT00849108|9735521|FG001|NOT COMPLETED|Cohort 1 Dose Ranging and Dose Interval||0
8690452|NCT00849108|9735520|FG000|STARTED|Cohort 2 Efficacy|Cohort 1 subjects did not participate in period 2: efficacy|0
8690453|NCT00849108|9735521|FG001|STARTED|Cohort 2 Efficacy||143
8690454|NCT00849108|9735520|FG000|COMPLETED|Cohort 2 Efficacy||0
8690455|NCT00849108|9735521|FG001|COMPLETED|Cohort 2 Efficacy||133
8690456|NCT00849108|9735520|FG000|NOT COMPLETED|Cohort 2 Efficacy||0
8690457|NCT00849108|9735521|FG001|NOT COMPLETED|Cohort 2 Efficacy||10
8690458|NCT00849121|9735531|FG000|STARTED|Overall Study||8
8690459|NCT00849121|9735532|FG001|STARTED|Overall Study||9
8690460|NCT00849121|9735531|FG000|COMPLETED|Overall Study||8
8690461|NCT00849121|9735532|FG001|COMPLETED|Overall Study||9
8690462|NCT00849121|9735531|FG000|NOT COMPLETED|Overall Study||0
8690463|NCT00849121|9735532|FG001|NOT COMPLETED|Overall Study||0
8690464|NCT00849147|9735538|FG000|STARTED|Overall Study||55
8690465|NCT00849147|9735538|FG000|COMPLETED|Overall Study||50
8690466|NCT00849147|9735538|FG000|NOT COMPLETED|Overall Study||5
8690467|NCT00849186|9735542|FG000|STARTED|Overall Study||26
8690468|NCT00849186|9735542|FG000|COMPLETED|Overall Study||16
8690469|NCT00849186|9735542|FG000|NOT COMPLETED|Overall Study||10
8690470|NCT00849212|9735547|FG000|STARTED|Overall Study||30
8690471|NCT00849212|9735547|FG000|COMPLETED|Overall Study||23
8690472|NCT00849212|9735547|FG000|NOT COMPLETED|Overall Study||7
8690473|NCT00849251|9735551|FG000|STARTED|Overall Study||6
8690474|NCT00849251|9735552|FG001|STARTED|Overall Study||25
8690475|NCT00849251|9735551|FG000|COMPLETED|Overall Study||5
8690476|NCT00849251|9735552|FG001|COMPLETED|Overall Study||24
8690477|NCT00849251|9735551|FG000|NOT COMPLETED|Overall Study||1
8690478|NCT00849251|9735552|FG001|NOT COMPLETED|Overall Study||1
8690479|NCT00849290|9735558|FG000|STARTED|Overall Study||113
8690480|NCT00849290|9735558|FG000|COMPLETED|Overall Study||58
8690481|NCT00849290|9735558|FG000|NOT COMPLETED|Overall Study||55
8690482|NCT00849381|9735562|FG000|STARTED|Overall Study|Out of the subjects who started, 243 were enrolled at the center having compliance issues.|1237
8690483|NCT00849381|9735562|FG000|COMPLETED|Overall Study|Out of the subjects who completed, 167 were enrolled at the center having compliance issues.|1092
8690484|NCT00849381|9735562|FG000|NOT COMPLETED|Overall Study||145
8690485|NCT00849472|9735566|FG000|STARTED|Doxorubicin and Cyclophosphamide (AC)||101
8690486|NCT00849472|9735566|FG000|COMPLETED|Doxorubicin and Cyclophosphamide (AC)||95
8690487|NCT00849472|9735566|FG000|NOT COMPLETED|Doxorubicin and Cyclophosphamide (AC)||6
8690488|NCT00849472|9735566|FG000|STARTED|Weekly Paclitaxel|One par. was deemed ineligible after completing AC therapy and did not start paclitaxel+pazopanib.|94
8690489|NCT00849472|9735566|FG000|COMPLETED|Weekly Paclitaxel||78
8690490|NCT00849472|9735566|FG000|NOT COMPLETED|Weekly Paclitaxel||16
8690491|NCT00849472|9735566|FG000|STARTED|Pazopanib Presurgery Treatment (PPT)||94
8690492|NCT00849472|9735566|FG000|COMPLETED|Pazopanib Presurgery Treatment (PPT)||36
8690493|NCT00849472|9735566|FG000|NOT COMPLETED|Pazopanib Presurgery Treatment (PPT)||58
8690494|NCT00849472|9735566|FG000|STARTED|Pazopanib Postsurgery Treatment|36 participants completed PPT; 7 participants who discontinued PPT resumed treatment postsurgery.|42
8690495|NCT00849472|9735566|FG000|COMPLETED|Pazopanib Postsurgery Treatment||16
8690496|NCT00849472|9735566|FG000|NOT COMPLETED|Pazopanib Postsurgery Treatment||26
8690497|NCT00849680|9735579|FG000|STARTED|Overall Study||27
8690498|NCT00849680|9735580|FG001|STARTED|Overall Study||13
8690499|NCT00849680|9735581|FG002|STARTED|Overall Study||42
8690500|NCT00849680|9735582|FG003|STARTED|Overall Study||42
8690501|NCT00849680|9735583|FG004|STARTED|Overall Study||42
8690502|NCT00849680|9735584|FG005|STARTED|Overall Study||42
8690503|NCT00849680|9735585|FG006|STARTED|Overall Study||78
8690504|NCT00849680|9735586|FG007|STARTED|Overall Study||31
8690505|NCT00849680|9735579|FG000|COMPLETED|Overall Study||16
8690506|NCT00849680|9735580|FG001|COMPLETED|Overall Study||10
8690507|NCT00849680|9735581|FG002|COMPLETED|Overall Study||27
8690508|NCT00849680|9735582|FG003|COMPLETED|Overall Study||28
8690509|NCT00849680|9735583|FG004|COMPLETED|Overall Study||32
8690510|NCT00849680|9735584|FG005|COMPLETED|Overall Study||27
8690511|NCT00849680|9735585|FG006|COMPLETED|Overall Study||61
8690512|NCT00849680|9735586|FG007|COMPLETED|Overall Study||23
8690513|NCT00849680|9735579|FG000|NOT COMPLETED|Overall Study||11
8690514|NCT00849680|9735580|FG001|NOT COMPLETED|Overall Study||3
8690515|NCT00849680|9735581|FG002|NOT COMPLETED|Overall Study||15
8690516|NCT00849680|9735582|FG003|NOT COMPLETED|Overall Study||14
8690517|NCT00849680|9735583|FG004|NOT COMPLETED|Overall Study||10
8690518|NCT00849680|9735584|FG005|NOT COMPLETED|Overall Study||15
8690519|NCT00849680|9735585|FG006|NOT COMPLETED|Overall Study||17
8690520|NCT00849680|9735586|FG007|NOT COMPLETED|Overall Study||8
8690521|NCT00849693|9735608|FG000|STARTED|Acute Treatment Phase||108
8690522|NCT00849693|9735609|FG001|STARTED|Acute Treatment Phase||116
8690523|NCT00849693|9735610|FG002|STARTED|Acute Treatment Phase||117
8690524|NCT00849693|9735611|FG003|STARTED|Acute Treatment Phase||122
8690525|NCT00849693|9735608|FG000|COMPLETED|Acute Treatment Phase|2 didn't enter extension phase.|75
8690526|NCT00849693|9735609|FG001|COMPLETED|Acute Treatment Phase|1 didn't enter extension phase|81
8690527|NCT00849693|9735610|FG002|COMPLETED|Acute Treatment Phase||84
8690528|NCT00849693|9735611|FG003|COMPLETED|Acute Treatment Phase|3 didn't enter extension phase|85
8690529|NCT00849693|9735608|FG000|NOT COMPLETED|Acute Treatment Phase||33
8690530|NCT00849693|9735609|FG001|NOT COMPLETED|Acute Treatment Phase||35
8690531|NCT00849693|9735610|FG002|NOT COMPLETED|Acute Treatment Phase||33
8690532|NCT00849693|9735611|FG003|NOT COMPLETED|Acute Treatment Phase||37
8690533|NCT00849693|9735608|FG000|STARTED|Extension Phase||73
8690534|NCT00849693|9735609|FG001|STARTED|Extension Phase||80
8690535|NCT00849693|9735610|FG002|STARTED|Extension Phase||84
8690536|NCT00849693|9735611|FG003|STARTED|Extension Phase||82
8690537|NCT00849693|9735608|FG000|COMPLETED|Extension Phase||43
8690538|NCT00849693|9735609|FG001|COMPLETED|Extension Phase||50
8690539|NCT00849693|9735610|FG002|COMPLETED|Extension Phase||49
8690540|NCT00849693|9735611|FG003|COMPLETED|Extension Phase||44
8690541|NCT00849693|9735608|FG000|NOT COMPLETED|Extension Phase||30
8690542|NCT00849693|9735609|FG001|NOT COMPLETED|Extension Phase||30
8690543|NCT00849693|9735610|FG002|NOT COMPLETED|Extension Phase||35
8690544|NCT00849693|9735611|FG003|NOT COMPLETED|Extension Phase||38
8690545|NCT00849810|9735633|FG000|STARTED|Overall Study||1
8690546|NCT00849810|9735633|FG000|COMPLETED|Overall Study||1
8690547|NCT00849810|9735633|FG000|NOT COMPLETED|Overall Study||0
8690548|NCT00849875|9735640|FG000|STARTED|Overall Study||48
8690549|NCT00849875|9735640|FG000|COMPLETED|Overall Study||1
8690550|NCT00849875|9735640|FG000|NOT COMPLETED|Overall Study||47
8690551|NCT00849901|9735654|FG000|STARTED|Acute Treatment Phase||117
8690552|NCT00849901|9735655|FG001|STARTED|Acute Treatment Phase||117
8690553|NCT00849901|9735656|FG002|STARTED|Acute Treatment Phase||103
8690554|NCT00849901|9735654|FG000|COMPLETED|Acute Treatment Phase|4 didn't enter extension phase.|87
8690555|NCT00849901|9735655|FG001|COMPLETED|Acute Treatment Phase||91
8690556|NCT00849901|9735656|FG002|COMPLETED|Acute Treatment Phase|1 didn't enter extension phase.|87
8690557|NCT00849901|9735654|FG000|NOT COMPLETED|Acute Treatment Phase||30
8690558|NCT00849901|9735655|FG001|NOT COMPLETED|Acute Treatment Phase||26
8690559|NCT00849901|9735656|FG002|NOT COMPLETED|Acute Treatment Phase||16
8690560|NCT00849901|9735654|FG000|STARTED|Extension Phase||83
8690561|NCT00849901|9735655|FG001|STARTED|Extension Phase||91
8690562|NCT00849901|9735656|FG002|STARTED|Extension Phase||86
8690563|NCT00849901|9735654|FG000|COMPLETED|Extension Phase||56
8690564|NCT00849901|9735655|FG001|COMPLETED|Extension Phase||65
8690565|NCT00849901|9735656|FG002|COMPLETED|Extension Phase||69
8690566|NCT00849901|9735654|FG000|NOT COMPLETED|Extension Phase||27
8690567|NCT00849901|9735655|FG001|NOT COMPLETED|Extension Phase||26
8690568|NCT00849901|9735656|FG002|NOT COMPLETED|Extension Phase||17
8690569|NCT00849940|9735670|FG000|STARTED|Overall Study||72
8690570|NCT00849940|9735670|FG000|COMPLETED|Overall Study||68
8690571|NCT00849940|9735670|FG000|NOT COMPLETED|Overall Study||4
8690572|NCT00850031|9735674|FG000|STARTED|Overall Study||118
8690573|NCT00850031|9735674|FG000|COMPLETED|Overall Study||101
8690574|NCT00850031|9735674|FG000|NOT COMPLETED|Overall Study||17
8690575|NCT00850070|9735680|FG000|STARTED|Overall Study||23
8690576|NCT00850070|9735681|FG001|STARTED|Overall Study||23
8690577|NCT00850070|9735680|FG000|COMPLETED|Overall Study||20
8690578|NCT00850070|9735681|FG001|COMPLETED|Overall Study||22
8690579|NCT00850070|9735680|FG000|NOT COMPLETED|Overall Study||3
8690580|NCT00850070|9735681|FG001|NOT COMPLETED|Overall Study||1
8690581|NCT00850096|9735694|FG000|STARTED|Overall Study||47
8690582|NCT00850096|9735695|FG001|STARTED|Overall Study||47
8690583|NCT00850096|9735694|FG000|COMPLETED|Overall Study||44
8690584|NCT00850096|9735695|FG001|COMPLETED|Overall Study||45
8690585|NCT00850096|9735694|FG000|NOT COMPLETED|Overall Study||3
8690586|NCT00850096|9735695|FG001|NOT COMPLETED|Overall Study||2
8690587|NCT00850135|9735701|FG000|STARTED|Overall Study||57
8690588|NCT00850135|9735701|FG000|COMPLETED|Overall Study||56
8690589|NCT00850135|9735701|FG000|NOT COMPLETED|Overall Study||1
8690590|NCT00850200|9735707|FG000|STARTED|Overall Study||20
8690591|NCT00850200|9735707|FG000|COMPLETED|Overall Study||15
8690592|NCT00850200|9735707|FG000|NOT COMPLETED|Overall Study||5
8690593|NCT00850343|9735718|FG000|STARTED|Overall Study||110
8690594|NCT00850343|9735719|FG001|STARTED|Overall Study||12
8690595|NCT00850343|9735720|FG002|STARTED|Overall Study||43
8690596|NCT00850343|9735721|FG003|STARTED|Overall Study||43
8919819|NCT02209532|9979756|FG000|NOT COMPLETED|Overall Study||3
8919820|NCT02209532|9979757|FG001|NOT COMPLETED|Overall Study||1
8919821|NCT02209597|9979764|FG000|STARTED|Phase 1 Current Tx (Non-randomized)||74
8919822|NCT02209597|9979764|FG000|COMPLETED|Phase 1 Current Tx (Non-randomized)||71
8919823|NCT02209597|9979764|FG000|NOT COMPLETED|Phase 1 Current Tx (Non-randomized)||3
8919824|NCT02209597|9979764|FG000|STARTED|Phase 2 (Randomized: 1 Brand, 3 Generic)||71
8919825|NCT02209597|9979764|FG000|COMPLETED|Phase 2 (Randomized: 1 Brand, 3 Generic)||67
8919826|NCT02209597|9979764|FG000|NOT COMPLETED|Phase 2 (Randomized: 1 Brand, 3 Generic)||4
8919827|NCT02209597|9979764|FG000|STARTED|Phase 3 (Randomized: 1 Brand, 3 Generic)||67
8919828|NCT02209597|9979764|FG000|COMPLETED|Phase 3 (Randomized: 1 Brand, 3 Generic)||67
8919829|NCT02209597|9979764|FG000|NOT COMPLETED|Phase 3 (Randomized: 1 Brand, 3 Generic)||0
8919830|NCT02209597|9979764|FG000|STARTED|Phase 4 (Randomized: 1 Brand, 3 Generic)||67
8919831|NCT02209597|9979764|FG000|COMPLETED|Phase 4 (Randomized: 1 Brand, 3 Generic)||67
8919832|NCT02209597|9979764|FG000|NOT COMPLETED|Phase 4 (Randomized: 1 Brand, 3 Generic)||0
8919833|NCT02209610|9979776|FG000|STARTED|Overall Study||16
8919834|NCT02209610|9979777|FG001|STARTED|Overall Study||16
8919835|NCT02209610|9979776|FG000|COMPLETED|Overall Study||16
8919836|NCT02209610|9979777|FG001|COMPLETED|Overall Study||16
8919837|NCT02209610|9979776|FG000|NOT COMPLETED|Overall Study||0
8919838|NCT02209610|9979777|FG001|NOT COMPLETED|Overall Study||0
8919839|NCT02209766|9979788|FG000|STARTED|Overall Study||6
8919840|NCT02209766|9979789|FG001|STARTED|Overall Study||3
8919841|NCT02209766|9979790|FG002|STARTED|Overall Study||6
8919842|NCT02209766|9979791|FG003|STARTED|Overall Study||3
8919843|NCT02209766|9979792|FG004|STARTED|Overall Study||6
8919844|NCT02209766|9979788|FG000|COMPLETED|Overall Study||6
8919845|NCT02209766|9979789|FG001|COMPLETED|Overall Study||3
8919846|NCT02209766|9979790|FG002|COMPLETED|Overall Study||6
8919847|NCT02209766|9979791|FG003|COMPLETED|Overall Study||2
8919848|NCT02209766|9979792|FG004|COMPLETED|Overall Study||6
8919849|NCT02209766|9979788|FG000|NOT COMPLETED|Overall Study||0
8919850|NCT02209766|9979789|FG001|NOT COMPLETED|Overall Study||0
8919851|NCT02209766|9979790|FG002|NOT COMPLETED|Overall Study||0
8919852|NCT02209766|9979791|FG003|NOT COMPLETED|Overall Study||1
8919853|NCT02209766|9979792|FG004|NOT COMPLETED|Overall Study||0
9035747|NCT03301740|10097444|FG000|NOT COMPLETED|Third Washout (1 Week)||0
8690597|NCT00850343|9735718|FG000|Completed Week 24|Overall Study||94
8690598|NCT00850343|9735719|FG001|Completed Week 24|Overall Study||12
8690599|NCT00850343|9735720|FG002|Completed Week 24|Overall Study||39
8690600|NCT00850343|9735721|FG003|Completed Week 24|Overall Study||39
8690601|NCT00850343|9735718|FG000|Completed Week 52|Overall Study||88
8690602|NCT00850343|9735719|FG001|Completed Week 52|Overall Study||11
8690603|NCT00850343|9735720|FG002|Completed Week 52|Overall Study||37
8690604|NCT00850343|9735721|FG003|Completed Week 52|Overall Study||37
8690605|NCT00850343|9735718|FG000|COMPLETED|Overall Study||64
8690606|NCT00850343|9735719|FG001|COMPLETED|Overall Study||9
8690607|NCT00850343|9735720|FG002|COMPLETED|Overall Study||29
8690608|NCT00850343|9735721|FG003|COMPLETED|Overall Study||30
8690609|NCT00850343|9735718|FG000|NOT COMPLETED|Overall Study||46
8690610|NCT00850343|9735719|FG001|NOT COMPLETED|Overall Study||3
8690611|NCT00850343|9735720|FG002|NOT COMPLETED|Overall Study||14
8690612|NCT00850343|9735721|FG003|NOT COMPLETED|Overall Study||13
8693419|NCT00866359|9738863|FG003|NOT COMPLETED|Extension Phase (Day 86 to 169)||3
8693420|NCT00866359|9738860|FG000|STARTED|Observational Follow-Up Phase||0
8693421|NCT00866359|9738861|FG001|STARTED|Observational Follow-Up Phase||0
8693422|NCT00866359|9738862|FG002|STARTED|Observational Follow-Up Phase|Includes those who entered the follow-up phase from both the placebo controlled or extension phase.|54
8693423|NCT00866359|9738863|FG003|STARTED|Observational Follow-Up Phase|Includes those who entered the follow-up phase from both the placebo controlled or extension phase.|54
8693424|NCT00866359|9738860|FG000|COMPLETED|Observational Follow-Up Phase||0
8693425|NCT00866359|9738861|FG001|COMPLETED|Observational Follow-Up Phase||0
8693426|NCT00866359|9738862|FG002|COMPLETED|Observational Follow-Up Phase||54
8693427|NCT00866359|9738863|FG003|COMPLETED|Observational Follow-Up Phase||54
8693428|NCT00866359|9738860|FG000|NOT COMPLETED|Observational Follow-Up Phase||0
8693429|NCT00866359|9738861|FG001|NOT COMPLETED|Observational Follow-Up Phase||0
8693430|NCT00866359|9738862|FG002|NOT COMPLETED|Observational Follow-Up Phase||0
8693431|NCT00866359|9738863|FG003|NOT COMPLETED|Observational Follow-Up Phase||0
8693432|NCT00866606|9738890|FG000|STARTED|Overall Study||35
8693433|NCT00866606|9738890|FG000|COMPLETED|Overall Study||31
8693434|NCT00866606|9738890|FG000|NOT COMPLETED|Overall Study||4
8693435|NCT00866619|9738898|FG000|STARTED|Overall Study||5948
8693436|NCT00866619|9738899|FG001|STARTED|Overall Study||4358
8693437|NCT00866619|9738900|FG002|STARTED|Overall Study||2974
8693438|NCT00866619|9738901|FG003|STARTED|Overall Study||2179
8693439|NCT00866619|9738898|FG000|COMPLETED|Overall Study||4102
8693440|NCT00866619|9738899|FG001|COMPLETED|Overall Study||3088
8693441|NCT00866619|9738900|FG002|COMPLETED|Overall Study||2085
8693442|NCT00866619|9738901|FG003|COMPLETED|Overall Study||1549
8693443|NCT00866619|9738898|FG000|NOT COMPLETED|Overall Study||1846
8693444|NCT00866619|9738899|FG001|NOT COMPLETED|Overall Study||1270
8693445|NCT00866619|9738900|FG002|NOT COMPLETED|Overall Study||889
8693446|NCT00866619|9738901|FG003|NOT COMPLETED|Overall Study||630
8693447|NCT00866658|9738938|FG000|STARTED|Overall Study|Randomized.|157
8693448|NCT00866658|9738939|FG001|STARTED|Overall Study||154
8693449|NCT00866658|9738938|FG000|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|157
8693450|NCT00866658|9738939|FG001|Safety Population|Overall Study||154
8693451|NCT00866658|9738938|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|157
8693452|NCT00866658|9738939|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||154
8693453|NCT00866658|9738938|FG000|COMPLETED|Overall Study||144
8693454|NCT00866658|9738939|FG001|COMPLETED|Overall Study||133
8693455|NCT00866658|9738938|FG000|NOT COMPLETED|Overall Study||13
8693456|NCT00866658|9738939|FG001|NOT COMPLETED|Overall Study||21
8693457|NCT00866697|9738947|FG000|STARTED|Overall Study||468
8693458|NCT00866697|9738948|FG001|STARTED|Overall Study||472
8693459|NCT00866697|9738947|FG000|COMPLETED|Overall Study||254
8693460|NCT00866697|9738948|FG001|COMPLETED|Overall Study||244
8693461|NCT00866697|9738947|FG000|NOT COMPLETED|Overall Study||214
8693462|NCT00866697|9738948|FG001|NOT COMPLETED|Overall Study||228
8693463|NCT00866723|9738954|FG000|STARTED|Overall Study||5
8693464|NCT00866723|9738954|FG000|COMPLETED|Overall Study||0
8693465|NCT00866723|9738954|FG000|NOT COMPLETED|Overall Study||5
8693466|NCT00866749|9738958|FG000|STARTED|Overall Study||120
8693467|NCT00866749|9738958|FG000|COMPLETED|Overall Study||120
8693468|NCT00866749|9738958|FG000|NOT COMPLETED|Overall Study||0
8693469|NCT00866775|9738964|FG000|STARTED|Overall Study||65
8693470|NCT00866775|9738965|FG001|STARTED|Overall Study||128
8693471|NCT00866775|9738964|FG000|COMPLETED|Overall Study||29
8693472|NCT00866775|9738965|FG001|COMPLETED|Overall Study||76
8693473|NCT00866775|9738964|FG000|NOT COMPLETED|Overall Study||36
8693474|NCT00866775|9738965|FG001|NOT COMPLETED|Overall Study||52
8693475|NCT00866788|9738977|FG000|STARTED|Overall Study||21
8693476|NCT00866788|9738978|FG001|STARTED|Overall Study||23
8693477|NCT00866788|9738979|FG002|STARTED|Overall Study||25
8693478|NCT00866788|9738980|FG003|STARTED|Overall Study||21
8693479|NCT00866788|9738977|FG000|COMPLETED|Overall Study||15
8693480|NCT00866788|9738978|FG001|COMPLETED|Overall Study||17
8693481|NCT00866788|9738979|FG002|COMPLETED|Overall Study||23
8693482|NCT00866788|9738980|FG003|COMPLETED|Overall Study||16
8693483|NCT00866788|9738977|FG000|NOT COMPLETED|Overall Study||6
8693484|NCT00866788|9738978|FG001|NOT COMPLETED|Overall Study||6
8693485|NCT00866788|9738979|FG002|NOT COMPLETED|Overall Study||2
8693486|NCT00866788|9738980|FG003|NOT COMPLETED|Overall Study||5
8693487|NCT00866814|9738993|FG000|STARTED|Overall Study||119
8693488|NCT00866814|9738993|FG000|COMPLETED|Overall Study||99
8693489|NCT00866814|9738993|FG000|NOT COMPLETED|Overall Study||20
8693490|NCT00866879|9738999|FG000|STARTED|Overall Study||90
8693491|NCT00866879|9739000|FG001|STARTED|Overall Study||185
8693492|NCT00866879|9738999|FG000|COMPLETED|Overall Study||90
8690613|NCT00850395|9735731|FG000|STARTED|Overall Study||79
8690614|NCT00850395|9735731|FG000|COMPLETED|Overall Study||69
8690615|NCT00850395|9735731|FG000|NOT COMPLETED|Overall Study||10
8690616|NCT00850460|9735737|FG000|STARTED|Overall Study||7
8690617|NCT00850460|9735738|FG001|STARTED|Overall Study||7
8690618|NCT00850460|9735737|FG000|Started - Week 0|Overall Study||7
8690619|NCT00850460|9735738|FG001|Started - Week 0|Overall Study||7
8690620|NCT00850460|9735737|FG000|Completion - Week 8|Overall Study||3
8690621|NCT00850460|9735738|FG001|Completion - Week 8|Overall Study||3
8690622|NCT00850460|9735737|FG000|COMPLETED|Overall Study||3
8690623|NCT00850460|9735738|FG001|COMPLETED|Overall Study||3
8690624|NCT00850460|9735737|FG000|NOT COMPLETED|Overall Study||4
8690625|NCT00850460|9735738|FG001|NOT COMPLETED|Overall Study||4
8690626|NCT00850473|9735744|FG000|STARTED|Overall Study||3
8690627|NCT00850473|9735744|FG000|COMPLETED|Overall Study||3
8690628|NCT00850473|9735744|FG000|NOT COMPLETED|Overall Study||0
8690629|NCT00850499|9735750|FG000|STARTED|Overall Study||4
8690630|NCT00850499|9735751|FG001|STARTED|Overall Study||8
8690631|NCT00850499|9735750|FG000|COMPLETED|Overall Study||1
8690632|NCT00850499|9735751|FG001|COMPLETED|Overall Study||6
8690633|NCT00850499|9735750|FG000|NOT COMPLETED|Overall Study||3
8690634|NCT00850499|9735751|FG001|NOT COMPLETED|Overall Study||2
8690635|NCT00850538|9735757|FG000|STARTED|Overall Study||101
8690636|NCT00850538|9735757|FG000|COMPLETED|Overall Study||60
8690637|NCT00850538|9735757|FG000|NOT COMPLETED|Overall Study||41
8690638|NCT00850564|9735761|FG000|STARTED|Overall Study||15
8690639|NCT00850564|9735761|FG000|COMPLETED|Overall Study||13
8690640|NCT00850564|9735761|FG000|NOT COMPLETED|Overall Study||2
8690641|NCT00850603|9735770|FG000|STARTED|Overall Study||34
8690642|NCT00850603|9735771|FG001|STARTED|Overall Study||34
8690643|NCT00850603|9735772|FG002|STARTED|Overall Study||34
8690644|NCT00850603|9735773|FG003|STARTED|Overall Study||34
8690645|NCT00850603|9735774|FG004|STARTED|Overall Study||34
8690646|NCT00850603|9735770|FG000|COMPLETED|Overall Study||34
8690647|NCT00850603|9735771|FG001|COMPLETED|Overall Study||34
8690648|NCT00850603|9735772|FG002|COMPLETED|Overall Study||34
8690649|NCT00850603|9735773|FG003|COMPLETED|Overall Study||34
8690650|NCT00850603|9735774|FG004|COMPLETED|Overall Study||34
8690651|NCT00850603|9735770|FG000|NOT COMPLETED|Overall Study||0
8690652|NCT00850603|9735771|FG001|NOT COMPLETED|Overall Study||0
8690653|NCT00850603|9735772|FG002|NOT COMPLETED|Overall Study||0
8690654|NCT00850603|9735773|FG003|NOT COMPLETED|Overall Study||0
8690655|NCT00850603|9735774|FG004|NOT COMPLETED|Overall Study||0
8690656|NCT00850642|9735788|FG000|STARTED|Overall Study||3
8690657|NCT00850642|9735789|FG001|STARTED|Overall Study||4
8690658|NCT00850642|9735788|FG000|COMPLETED|Overall Study||3
8690659|NCT00850642|9735789|FG001|COMPLETED|Overall Study||4
8690660|NCT00850642|9735788|FG000|NOT COMPLETED|Overall Study||0
8690661|NCT00850642|9735789|FG001|NOT COMPLETED|Overall Study||0
8690662|NCT00850759|9735804|FG000|STARTED|Overall Study||59
8690663|NCT00850759|9735805|FG001|STARTED|Overall Study||57
8690664|NCT00850759|9735806|FG002|STARTED|Overall Study||57
8690665|NCT00850759|9735807|FG003|STARTED|Overall Study||58
8690666|NCT00850759|9735804|FG000|COMPLETED|Overall Study||52
8690667|NCT00850759|9735805|FG001|COMPLETED|Overall Study||52
8690668|NCT00850759|9735806|FG002|COMPLETED|Overall Study||52
8690669|NCT00850759|9735807|FG003|COMPLETED|Overall Study||55
8690670|NCT00850759|9735804|FG000|NOT COMPLETED|Overall Study||7
8690671|NCT00850759|9735805|FG001|NOT COMPLETED|Overall Study||5
8690672|NCT00850759|9735806|FG002|NOT COMPLETED|Overall Study||5
8690673|NCT00850759|9735807|FG003|NOT COMPLETED|Overall Study||3
8690674|NCT00850889|9735817|FG000|STARTED|Overall Study||32
8690675|NCT00850889|9735817|FG000|COMPLETED|Overall Study||32
8690676|NCT00850889|9735817|FG000|NOT COMPLETED|Overall Study||0
8690677|NCT00850993|9735828|FG000|STARTED|Overall Study||17
8690678|NCT00850993|9735829|FG001|STARTED|Overall Study||18
8690679|NCT00850993|9735830|FG002|STARTED|Overall Study||8
8690680|NCT00850993|9735831|FG003|STARTED|Overall Study||15
8690681|NCT00850993|9735828|FG000|Safety|Overall Study||17
8690682|NCT00850993|9735829|FG001|Safety|Overall Study||18
8690683|NCT00850993|9735830|FG002|Safety|Overall Study||8
8690684|NCT00850993|9735831|FG003|Safety|Overall Study||15
8690685|NCT00850993|9735828|FG000|Intent-to-treat|Overall Study||17
8690686|NCT00850993|9735829|FG001|Intent-to-treat|Overall Study||18
8690687|NCT00850993|9735830|FG002|Intent-to-treat|Overall Study||8
8690688|NCT00850993|9735831|FG003|Intent-to-treat|Overall Study||15
8690689|NCT00850993|9735828|FG000|Received Phototherapy|Overall Study||3
8690690|NCT00850993|9735829|FG001|Received Phototherapy|Overall Study||6
8690691|NCT00850993|9735830|FG002|Received Phototherapy|Overall Study||2
8690692|NCT00850993|9735831|FG003|Received Phototherapy|Overall Study||8
8690693|NCT00850993|9735828|FG000|Per Protocol|Overall Study||10
8690694|NCT00850993|9735829|FG001|Per Protocol|Overall Study||13
8690695|NCT00850993|9735830|FG002|Per Protocol|Overall Study||5
8690696|NCT00850993|9735831|FG003|Per Protocol|Overall Study||13
8690697|NCT00850993|9735828|FG000|COMPLETED|Overall Study||16
8690698|NCT00850993|9735829|FG001|COMPLETED|Overall Study||18
8690699|NCT00850993|9735830|FG002|COMPLETED|Overall Study||8
8690700|NCT00850993|9735831|FG003|COMPLETED|Overall Study||14
8690701|NCT00850993|9735828|FG000|NOT COMPLETED|Overall Study||1
8690702|NCT00850993|9735829|FG001|NOT COMPLETED|Overall Study||0
8690703|NCT00850993|9735830|FG002|NOT COMPLETED|Overall Study||0
8690704|NCT00850993|9735831|FG003|NOT COMPLETED|Overall Study||1
8690705|NCT00851006|9735841|FG000|STARTED|Overall Study||7
8690706|NCT00851006|9735842|FG001|STARTED|Overall Study||6
8690707|NCT00851006|9735841|FG000|COMPLETED|Overall Study||7
8690708|NCT00851006|9735842|FG001|COMPLETED|Overall Study||6
8690709|NCT00851006|9735841|FG000|NOT COMPLETED|Overall Study||0
8690710|NCT00851006|9735842|FG001|NOT COMPLETED|Overall Study||0
8690711|NCT00851084|9735851|FG000|STARTED|Overall Study||117
8690712|NCT00851084|9735852|FG001|STARTED|Overall Study||119
8690713|NCT00851084|9735851|FG000|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria.|0
8690714|NCT00851084|9735852|FG001|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria.|0
8690715|NCT00851084|9735851|FG000|NOT COMPLETED|Overall Study||117
8690716|NCT00851084|9735852|FG001|NOT COMPLETED|Overall Study||119
8690717|NCT00851253|9735862|FG000|STARTED|Overall Study||2
8690718|NCT00851253|9735863|FG001|STARTED|Overall Study||10
8690719|NCT00851253|9735862|FG000|COMPLETED|Overall Study||1
8690720|NCT00851253|9735863|FG001|COMPLETED|Overall Study||10
8690721|NCT00851253|9735862|FG000|NOT COMPLETED|Overall Study||1
8690722|NCT00851253|9735863|FG001|NOT COMPLETED|Overall Study||0
8690723|NCT00851279|9735869|FG000|STARTED|Overall Study||53
8690724|NCT00851279|9735869|FG000|COMPLETED|Overall Study||53
8690725|NCT00851279|9735869|FG000|NOT COMPLETED|Overall Study||0
8690726|NCT00851318|9735877|FG000|STARTED|Overall Study||81
8690727|NCT00851318|9735878|FG001|STARTED|Overall Study||19
8802242|NCT01454596|9854258|FG003|COMPLETED|Overall Study||1
8802243|NCT01454596|9854259|FG004|COMPLETED|Overall Study||1
8802244|NCT01454596|9854260|FG005|COMPLETED|Overall Study||1
8802245|NCT01454596|9854261|FG006|COMPLETED|Overall Study||1
8802246|NCT01454596|9854262|FG007|COMPLETED|Overall Study||3
8802247|NCT01454596|9854263|FG008|COMPLETED|Overall Study||3
8802248|NCT01454596|9854264|FG009|COMPLETED|Overall Study||2
8802249|NCT01454596|9854265|FG010|COMPLETED|Overall Study||0
8802250|NCT01454596|9854266|FG011|COMPLETED|Overall Study||1
8802251|NCT01454596|9854255|FG000|NOT COMPLETED|Overall Study||0
8802252|NCT01454596|9854256|FG001|NOT COMPLETED|Overall Study||0
8802253|NCT01454596|9854257|FG002|NOT COMPLETED|Overall Study||0
8802254|NCT01454596|9854258|FG003|NOT COMPLETED|Overall Study||0
8802255|NCT01454596|9854259|FG004|NOT COMPLETED|Overall Study||0
8802256|NCT01454596|9854260|FG005|NOT COMPLETED|Overall Study||0
8802257|NCT01454596|9854261|FG006|NOT COMPLETED|Overall Study||0
8802258|NCT01454596|9854262|FG007|NOT COMPLETED|Overall Study||0
8802259|NCT01454596|9854263|FG008|NOT COMPLETED|Overall Study||0
8802260|NCT01454596|9854264|FG009|NOT COMPLETED|Overall Study||1
8802261|NCT01454596|9854265|FG010|NOT COMPLETED|Overall Study||1
8802262|NCT01454596|9854266|FG011|NOT COMPLETED|Overall Study||0
8802263|NCT01454726|9854294|FG000|STARTED|Overall Study||16
8802264|NCT01454726|9854295|FG001|STARTED|Overall Study||11
8802265|NCT01454726|9854294|FG000|COMPLETED|Overall Study||16
8802266|NCT01454726|9854295|FG001|COMPLETED|Overall Study||10
8802267|NCT01454726|9854294|FG000|NOT COMPLETED|Overall Study||0
8802268|NCT01454726|9854295|FG001|NOT COMPLETED|Overall Study||1
8802269|NCT01454739|9854303|FG000|STARTED|Overall Study|30 participants in <6 Years Old Age Cohort and 31 participants in 6 to <12 Years Old Age Cohort.|61
8802270|NCT01454739|9854304|FG001|STARTED|Overall Study||179
8802271|NCT01454739|9854303|FG000|Tailored Prophylaxis|Overall Study||59
8802272|NCT01454739|9854304|FG001|Tailored Prophylaxis|Overall Study||131
8802273|NCT01454739|9854303|FG000|Weekly Prophylaxis|Overall Study||0
8802274|NCT01454739|9854304|FG001|Weekly Prophylaxis|Overall Study||34
8802275|NCT01454739|9854303|FG000|Personalized Prophylaxis|Overall Study||3
8802276|NCT01454739|9854304|FG001|Personalized Prophylaxis|Overall Study||23
8802277|NCT01454739|9854303|FG000|Episodic|Overall Study||0
8802278|NCT01454739|9854304|FG001|Episodic|Overall Study||13
8802279|NCT01454739|9854303|FG000|Surgery Subgroup|Overall Study||2
8802280|NCT01454739|9854304|FG001|Surgery Subgroup|Overall Study||26
8802281|NCT01454739|9854303|FG000|COMPLETED|Overall Study||54
8802282|NCT01454739|9854304|FG001|COMPLETED|Overall Study||158
8802283|NCT01454739|9854303|FG000|NOT COMPLETED|Overall Study||7
8802284|NCT01454739|9854304|FG001|NOT COMPLETED|Overall Study||21
8802285|NCT01454778|9854317|FG000|STARTED|Overall Study||50
8802286|NCT01454778|9854317|FG000|COMPLETED|Overall Study||47
8802287|NCT01454778|9854317|FG000|NOT COMPLETED|Overall Study||3
8802288|NCT01454791|9854323|FG000|STARTED|Overall Study||20
8802289|NCT01454791|9854324|FG001|STARTED|Overall Study||20
8802290|NCT01454791|9854323|FG000|COMPLETED|Overall Study|20 subjects started with Diclofenac, then switched to placebo|20
8802291|NCT01454791|9854324|FG001|COMPLETED|Overall Study|20 subjects started with placebo, then switched to Diclofenac|20
8802292|NCT01454791|9854323|FG000|NOT COMPLETED|Overall Study||0
8802293|NCT01454791|9854324|FG001|NOT COMPLETED|Overall Study||0
8802294|NCT01454830|9854334|FG000|STARTED|Overall Study||61
8802295|NCT01454830|9854335|FG001|STARTED|Overall Study||57
8802296|NCT01454830|9854334|FG000|COMPLETED|Overall Study||30
8802297|NCT01454830|9854335|FG001|COMPLETED|Overall Study||30
8802298|NCT01454830|9854334|FG000|NOT COMPLETED|Overall Study||31
8802299|NCT01454830|9854335|FG001|NOT COMPLETED|Overall Study||27
8802300|NCT01454934|9854343|FG000|STARTED|Overall Study||270
8802301|NCT01454934|9854344|FG001|STARTED|Overall Study||270
8802302|NCT01454934|9854343|FG000|COMPLETED|Overall Study||0
8690728|NCT00851318|9735879|FG002|STARTED|Overall Study||93
8690729|NCT00851318|9735880|FG003|STARTED|Overall Study||92
8690730|NCT00851318|9735877|FG000|Completed Week 24|Overall Study||69
8690731|NCT00851318|9735878|FG001|Completed Week 24|Overall Study||17
8802303|NCT01454934|9854344|FG001|COMPLETED|Overall Study||0
8690732|NCT00851318|9735879|FG002|Completed Week 24|Overall Study||90
8690733|NCT00851318|9735880|FG003|Completed Week 24|Overall Study||87
8690734|NCT00851318|9735877|FG000|Completed Week 52|Overall Study||64
8690735|NCT00851318|9735878|FG001|Completed Week 52|Overall Study||16
8690736|NCT00851318|9735879|FG002|Completed Week 52|Overall Study||87
8690737|NCT00851318|9735880|FG003|Completed Week 52|Overall Study||85
8690738|NCT00851318|9735877|FG000|COMPLETED|Overall Study||51
8690739|NCT00851318|9735878|FG001|COMPLETED|Overall Study||14
8690740|NCT00851318|9735879|FG002|COMPLETED|Overall Study||72
8690741|NCT00851318|9735880|FG003|COMPLETED|Overall Study||73
8690742|NCT00851318|9735877|FG000|NOT COMPLETED|Overall Study||30
8690743|NCT00851318|9735878|FG001|NOT COMPLETED|Overall Study||5
8690744|NCT00851318|9735879|FG002|NOT COMPLETED|Overall Study||21
8690745|NCT00851318|9735880|FG003|NOT COMPLETED|Overall Study||19
8690746|NCT00851357|9735893|FG000|STARTED|Overall Study||1200
8690747|NCT00851357|9735894|FG001|STARTED|Overall Study||1201
8690748|NCT00851357|9735895|FG002|STARTED|Overall Study||1799
8690749|NCT00851357|9735893|FG000|COMPLETED|Overall Study||1200
8690750|NCT00851357|9735894|FG001|COMPLETED|Overall Study||1201
8690751|NCT00851357|9735895|FG002|COMPLETED|Overall Study||1799
8690752|NCT00851357|9735893|FG000|NOT COMPLETED|Overall Study||0
8690753|NCT00851357|9735894|FG001|NOT COMPLETED|Overall Study||0
8690754|NCT00851357|9735895|FG002|NOT COMPLETED|Overall Study||0
8690755|NCT00851409|9735903|FG000|STARTED|Overall Study||25
8690756|NCT00851409|9735903|FG000|COMPLETED|Overall Study||25
8690757|NCT00851409|9735903|FG000|NOT COMPLETED|Overall Study||0
8690758|NCT00851630|9735910|FG000|STARTED|Overall Study||35
8690759|NCT00851630|9735911|FG001|STARTED|Overall Study||35
8690760|NCT00851630|9735910|FG000|COMPLETED|Overall Study||33
8690761|NCT00851630|9735911|FG001|COMPLETED|Overall Study||33
8690762|NCT00851630|9735910|FG000|NOT COMPLETED|Overall Study||2
8690763|NCT00851630|9735911|FG001|NOT COMPLETED|Overall Study||2
8690764|NCT00851643|9735923|FG000|STARTED|Base Study (Up to 12 Months)||15
8690765|NCT00851643|9735924|FG001|STARTED|Base Study (Up to 12 Months)||30
8690766|NCT00851643|9735925|FG002|STARTED|Base Study (Up to 12 Months)||30
8690767|NCT00851643|9735926|FG003|STARTED|Base Study (Up to 12 Months)||15
8690768|NCT00851643|9735927|FG004|STARTED|Base Study (Up to 12 Months)||30
8690769|NCT00851643|9735928|FG005|STARTED|Base Study (Up to 12 Months)||30
8690770|NCT00851643|9735923|FG000|COMPLETED|Base Study (Up to 12 Months)||14
8690771|NCT00851643|9735924|FG001|COMPLETED|Base Study (Up to 12 Months)||30
8690772|NCT00851643|9735925|FG002|COMPLETED|Base Study (Up to 12 Months)||30
8690773|NCT00851643|9735926|FG003|COMPLETED|Base Study (Up to 12 Months)||15
8690774|NCT00851643|9735927|FG004|COMPLETED|Base Study (Up to 12 Months)||30
8690775|NCT00851643|9735928|FG005|COMPLETED|Base Study (Up to 12 Months)||29
8690776|NCT00851643|9735923|FG000|NOT COMPLETED|Base Study (Up to 12 Months)||1
8690777|NCT00851643|9735924|FG001|NOT COMPLETED|Base Study (Up to 12 Months)||0
8690778|NCT00851643|9735925|FG002|NOT COMPLETED|Base Study (Up to 12 Months)||0
8690779|NCT00851643|9735926|FG003|NOT COMPLETED|Base Study (Up to 12 Months)||0
8690780|NCT00851643|9735927|FG004|NOT COMPLETED|Base Study (Up to 12 Months)||0
8690781|NCT00851643|9735928|FG005|NOT COMPLETED|Base Study (Up to 12 Months)||1
8690782|NCT00851643|9735923|FG000|STARTED|Extension Study (Up to 36 Months)||10
8690783|NCT00851643|9735924|FG001|STARTED|Extension Study (Up to 36 Months)||19
8690784|NCT00851643|9735925|FG002|STARTED|Extension Study (Up to 36 Months)||19
8690785|NCT00851643|9735926|FG003|STARTED|Extension Study (Up to 36 Months)||7
8690786|NCT00851643|9735927|FG004|STARTED|Extension Study (Up to 36 Months)||21
8690787|NCT00851643|9735928|FG005|STARTED|Extension Study (Up to 36 Months)||15
8690788|NCT00851643|9735923|FG000|COMPLETED|Extension Study (Up to 36 Months)||6
8690789|NCT00851643|9735924|FG001|COMPLETED|Extension Study (Up to 36 Months)||15
8690790|NCT00851643|9735925|FG002|COMPLETED|Extension Study (Up to 36 Months)||14
8690791|NCT00851643|9735926|FG003|COMPLETED|Extension Study (Up to 36 Months)||5
8690792|NCT00851643|9735927|FG004|COMPLETED|Extension Study (Up to 36 Months)||19
8690793|NCT00851643|9735928|FG005|COMPLETED|Extension Study (Up to 36 Months)||14
8690794|NCT00851643|9735923|FG000|NOT COMPLETED|Extension Study (Up to 36 Months)||4
8690795|NCT00851643|9735924|FG001|NOT COMPLETED|Extension Study (Up to 36 Months)||4
8690796|NCT00851643|9735925|FG002|NOT COMPLETED|Extension Study (Up to 36 Months)||5
8690797|NCT00851643|9735926|FG003|NOT COMPLETED|Extension Study (Up to 36 Months)||2
8690798|NCT00851643|9735927|FG004|NOT COMPLETED|Extension Study (Up to 36 Months)||2
8690799|NCT00851643|9735928|FG005|NOT COMPLETED|Extension Study (Up to 36 Months)||1
8690800|NCT00851721|9735943|FG000|STARTED|Overall Study||19
8690801|NCT00851721|9735944|FG001|STARTED|Overall Study||17
8690802|NCT00851721|9735943|FG000|COMPLETED|Overall Study||17
8690803|NCT00851721|9735944|FG001|COMPLETED|Overall Study||16
8690804|NCT00851721|9735943|FG000|NOT COMPLETED|Overall Study||2
8690805|NCT00851721|9735944|FG001|NOT COMPLETED|Overall Study||1
8690806|NCT00851786|9735958|FG000|STARTED|Overall Study|One subject cannot adhere to protocol requirement and was off study with no vaccine.|296
8690807|NCT00851786|9735959|FG001|STARTED|Overall Study|Two subjects (one found ineligible and one withdrew consent) were off study with no vaccine.|99
8690808|NCT00851786|9735958|FG000|COMPLETED|Overall Study||291
8690809|NCT00851786|9735959|FG001|COMPLETED|Overall Study||97
8690810|NCT00851786|9735958|FG000|NOT COMPLETED|Overall Study||5
8690811|NCT00851786|9735959|FG001|NOT COMPLETED|Overall Study||2
8690812|NCT00851799|9735968|FG000|STARTED|Overall Study||109
8690813|NCT00851799|9735969|FG001|STARTED|Overall Study||106
8690814|NCT00851799|9735970|FG002|STARTED|Overall Study||113
8690815|NCT00851799|9735968|FG000|COMPLETED|Overall Study||93
8690816|NCT00851799|9735969|FG001|COMPLETED|Overall Study||93
8690817|NCT00851799|9735970|FG002|COMPLETED|Overall Study||89
8690818|NCT00851799|9735968|FG000|NOT COMPLETED|Overall Study||16
8690819|NCT00851799|9735969|FG001|NOT COMPLETED|Overall Study||13
8690820|NCT00851799|9735970|FG002|NOT COMPLETED|Overall Study||24
8690821|NCT00851877|9735978|FG000|STARTED|Phase I-1||7
8690822|NCT00851877|9735979|FG001|STARTED|Phase I-1||0
8690823|NCT00851877|9735980|FG002|STARTED|Phase I-1||0
8690824|NCT00851877|9735978|FG000|COMPLETED|Phase I-1||6
8690825|NCT00851877|9735979|FG001|COMPLETED|Phase I-1||0
8690826|NCT00851877|9735980|FG002|COMPLETED|Phase I-1||0
8690827|NCT00851877|9735978|FG000|NOT COMPLETED|Phase I-1||1
8690828|NCT00851877|9735979|FG001|NOT COMPLETED|Phase I-1||0
8690829|NCT00851877|9735980|FG002|NOT COMPLETED|Phase I-1||0
8690830|NCT00851877|9735978|FG000|STARTED|Phase I-2||0
8690831|NCT00851877|9735979|FG001|STARTED|Phase I-2||5
8690832|NCT00851877|9735980|FG002|STARTED|Phase I-2||0
8690833|NCT00851877|9735978|FG000|COMPLETED|Phase I-2||0
8690834|NCT00851877|9735979|FG001|COMPLETED|Phase I-2||5
8690835|NCT00851877|9735980|FG002|COMPLETED|Phase I-2||0
8690836|NCT00851877|9735978|FG000|NOT COMPLETED|Phase I-2||0
8690837|NCT00851877|9735979|FG001|NOT COMPLETED|Phase I-2||0
8690838|NCT00851877|9735980|FG002|NOT COMPLETED|Phase I-2||0
8690839|NCT00851877|9735978|FG000|STARTED|Phase II||0
8690840|NCT00851877|9735979|FG001|STARTED|Phase II||0
8690841|NCT00851877|9735980|FG002|STARTED|Phase II||25
8690842|NCT00851877|9735978|FG000|COMPLETED|Phase II||0
8690843|NCT00851877|9735979|FG001|COMPLETED|Phase II||0
8690844|NCT00851877|9735980|FG002|COMPLETED|Phase II||22
8690845|NCT00851877|9735978|FG000|NOT COMPLETED|Phase II||0
8690846|NCT00851877|9735979|FG001|NOT COMPLETED|Phase II||0
8690847|NCT00851877|9735980|FG002|NOT COMPLETED|Phase II||3
8690848|NCT00851890|9735990|FG000|STARTED|Overall Study||8
8690849|NCT00851890|9735991|FG001|STARTED|Overall Study||8
8690850|NCT00851890|9735992|FG002|STARTED|Overall Study||8
8690851|NCT00851890|9735993|FG003|STARTED|Overall Study||6
8690852|NCT00851890|9735990|FG000|COMPLETED|Overall Study||8
8690853|NCT00851890|9735991|FG001|COMPLETED|Overall Study||7
8690854|NCT00851890|9735992|FG002|COMPLETED|Overall Study||8
8690855|NCT00851890|9735993|FG003|COMPLETED|Overall Study||5
8690856|NCT00851890|9735990|FG000|NOT COMPLETED|Overall Study||0
8690857|NCT00851890|9735991|FG001|NOT COMPLETED|Overall Study||1
8690858|NCT00851890|9735992|FG002|NOT COMPLETED|Overall Study||0
8690859|NCT00851890|9735993|FG003|NOT COMPLETED|Overall Study||1
8690860|NCT00851903|9736003|FG000|STARTED|Overall Study||112
8690861|NCT00851903|9736003|FG000|Safety Population|Overall Study|patients treated with at least one dose of insulin glargine OR one dose of sitagliptin|112
8690862|NCT00851903|9736003|FG000|Treated by Combination|Overall Study|patients treated with at least one dose of insulin glargine AND one dose of sitagliptin|111
8690863|NCT00851903|9736003|FG000|Modified Intent-To-Treat Population|Overall Study|mITT population: patients treated by combination with at least 1 on-treatment efficacy measure|111
8690864|NCT00851903|9736003|FG000|COMPLETED|Overall Study||110
8690865|NCT00851903|9736003|FG000|NOT COMPLETED|Overall Study||2
8690866|NCT00852137|9736009|FG000|STARTED|Overall Study||13
8690867|NCT00852137|9736010|FG001|STARTED|Overall Study||3
8690868|NCT00852137|9736009|FG000|COMPLETED|Overall Study||13
8690869|NCT00852137|9736010|FG001|COMPLETED|Overall Study||3
8690870|NCT00852137|9736009|FG000|NOT COMPLETED|Overall Study||0
8690871|NCT00852137|9736010|FG001|NOT COMPLETED|Overall Study||0
8690872|NCT00852202|9736019|FG000|STARTED|Overall Study||77
8690873|NCT00852202|9736020|FG001|STARTED|Overall Study||75
8690874|NCT00852202|9736021|FG002|STARTED|Overall Study||75
8690875|NCT00852202|9736019|FG000|COMPLETED|Overall Study||60
8690876|NCT00852202|9736020|FG001|COMPLETED|Overall Study||63
8690877|NCT00852202|9736021|FG002|COMPLETED|Overall Study||49
8690878|NCT00852202|9736019|FG000|NOT COMPLETED|Overall Study||17
8690879|NCT00852202|9736020|FG001|NOT COMPLETED|Overall Study||12
8690880|NCT00852202|9736021|FG002|NOT COMPLETED|Overall Study||26
8690881|NCT00852397|9736033|FG000|STARTED|Overall Study||52
8690882|NCT00852397|9736034|FG001|STARTED|Overall Study||49
8690883|NCT00852397|9736035|FG002|STARTED|Overall Study||50
8690884|NCT00852397|9736033|FG000|Treated Participants|Overall Study||51
8690885|NCT00852397|9736034|FG001|Treated Participants|Overall Study||49
8690886|NCT00852397|9736035|FG002|Treated Participants|Overall Study||49
8690887|NCT00852397|9736033|FG000|COMPLETED|Overall Study||41
8690888|NCT00852397|9736034|FG001|COMPLETED|Overall Study||41
8690889|NCT00852397|9736035|FG002|COMPLETED|Overall Study||36
8690890|NCT00852397|9736033|FG000|NOT COMPLETED|Overall Study||11
8690891|NCT00852397|9736034|FG001|NOT COMPLETED|Overall Study||8
8690892|NCT00852397|9736035|FG002|NOT COMPLETED|Overall Study||14
8690893|NCT00852475|9736045|FG000|STARTED|Overall Study||26
8690894|NCT00852475|9736046|FG001|STARTED|Overall Study||20
8690895|NCT00852475|9736045|FG000|COMPLETED|Overall Study||23
8690896|NCT00852475|9736046|FG001|COMPLETED|Overall Study||16
8690897|NCT00852475|9736045|FG000|NOT COMPLETED|Overall Study||3
8690898|NCT00852475|9736046|FG001|NOT COMPLETED|Overall Study||4
8690899|NCT00852527|9736054|FG000|STARTED|Overall Study||196
8690900|NCT00852527|9736055|FG001|STARTED|Overall Study||242
8690901|NCT00852527|9736054|FG000|COMPLETED|Overall Study||196
8690902|NCT00852527|9736055|FG001|COMPLETED|Overall Study||242
8690903|NCT00852527|9736054|FG000|NOT COMPLETED|Overall Study||0
8690904|NCT00852527|9736055|FG001|NOT COMPLETED|Overall Study||0
8690905|NCT00852540|9736062|FG000|STARTED|Overall Study||270
8690906|NCT00852540|9736063|FG001|STARTED|Overall Study||140
8690907|NCT00852540|9736062|FG000|COMPLETED|Overall Study||234
8690908|NCT00852540|9736063|FG001|COMPLETED|Overall Study||122
8690909|NCT00852540|9736062|FG000|NOT COMPLETED|Overall Study||36
8690910|NCT00852540|9736063|FG001|NOT COMPLETED|Overall Study||18
8690911|NCT00852592|9736072|FG000|STARTED|Overall Study||23
8690912|NCT00852592|9736073|FG001|STARTED|Overall Study||23
8690913|NCT00852592|9736072|FG000|COMPLETED|Overall Study||20
8690914|NCT00852592|9736073|FG001|COMPLETED|Overall Study||19
8690915|NCT00852592|9736072|FG000|NOT COMPLETED|Overall Study||3
8690916|NCT00852592|9736073|FG001|NOT COMPLETED|Overall Study||4
8690917|NCT00852631|9736079|FG000|STARTED|Overall Study||28
8690918|NCT00852631|9736079|FG000|COMPLETED|Overall Study||17
8690919|NCT00852631|9736079|FG000|NOT COMPLETED|Overall Study||11
8690920|NCT00852644|9736083|FG000|STARTED|Overall Study||3
8690921|NCT00852644|9736084|FG001|STARTED|Overall Study||3
8690922|NCT00852644|9736085|FG002|STARTED|Overall Study||0
8690923|NCT00852644|9736086|FG003|STARTED|Overall Study||3
8690924|NCT00852644|9736087|FG004|STARTED|Overall Study||0
8690925|NCT00852644|9736088|FG005|STARTED|Overall Study||0
8690926|NCT00852644|9736083|FG000|COMPLETED|Overall Study||3
8690927|NCT00852644|9736084|FG001|COMPLETED|Overall Study||3
8690928|NCT00852644|9736085|FG002|COMPLETED|Overall Study||0
8690929|NCT00852644|9736086|FG003|COMPLETED|Overall Study||3
8690930|NCT00852644|9736087|FG004|COMPLETED|Overall Study||0
8690931|NCT00852644|9736088|FG005|COMPLETED|Overall Study||0
8690932|NCT00852644|9736083|FG000|NOT COMPLETED|Overall Study||0
8690933|NCT00852644|9736084|FG001|NOT COMPLETED|Overall Study||0
8690934|NCT00852644|9736085|FG002|NOT COMPLETED|Overall Study||0
8690935|NCT00852644|9736086|FG003|NOT COMPLETED|Overall Study||0
8690936|NCT00852644|9736087|FG004|NOT COMPLETED|Overall Study||0
8690937|NCT00852644|9736088|FG005|NOT COMPLETED|Overall Study||0
8690938|NCT00852761|9736105|FG000|STARTED|Overall Study||17
8690939|NCT00852761|9736106|FG001|STARTED|Overall Study||17
8690940|NCT00852761|9736105|FG000|COMPLETED|Overall Study||17
8802304|NCT01454934|9854343|FG000|NOT COMPLETED|Overall Study||270
8802305|NCT01454934|9854344|FG001|NOT COMPLETED|Overall Study||270
8802306|NCT01454947|9854358|FG000|STARTED|Overall Study||27
8802307|NCT01454947|9854359|FG001|STARTED|Overall Study||42
8802308|NCT01454947|9854360|FG002|STARTED|Overall Study||35
8802309|NCT01454947|9854361|FG003|STARTED|Overall Study||20
8802310|NCT01454947|9854362|FG004|STARTED|Overall Study||34
8802311|NCT01454947|9854363|FG005|STARTED|Overall Study||35
8802312|NCT01454947|9854364|FG006|STARTED|Overall Study||27
8802313|NCT01454947|9854365|FG007|STARTED|Overall Study||28
8802314|NCT01454947|9854358|FG000|COMPLETED|Overall Study||24
8802315|NCT01454947|9854359|FG001|COMPLETED|Overall Study||38
8802316|NCT01454947|9854360|FG002|COMPLETED|Overall Study||32
8802317|NCT01454947|9854361|FG003|COMPLETED|Overall Study||19
8802318|NCT01454947|9854362|FG004|COMPLETED|Overall Study||33
8802319|NCT01454947|9854363|FG005|COMPLETED|Overall Study||32
8802320|NCT01454947|9854364|FG006|COMPLETED|Overall Study||26
8802321|NCT01454947|9854365|FG007|COMPLETED|Overall Study||23
8802322|NCT01454947|9854358|FG000|NOT COMPLETED|Overall Study||3
8802323|NCT01454947|9854359|FG001|NOT COMPLETED|Overall Study||4
8802324|NCT01454947|9854360|FG002|NOT COMPLETED|Overall Study||3
8802325|NCT01454947|9854361|FG003|NOT COMPLETED|Overall Study||1
8802326|NCT01454947|9854362|FG004|NOT COMPLETED|Overall Study||1
8802327|NCT01454947|9854363|FG005|NOT COMPLETED|Overall Study||3
8802328|NCT01454947|9854364|FG006|NOT COMPLETED|Overall Study||1
8802329|NCT01454947|9854365|FG007|NOT COMPLETED|Overall Study||5
8802330|NCT01455012|9854385|FG000|STARTED|Overall Study||41
8802331|NCT01455012|9854386|FG001|STARTED|Overall Study||40
8802332|NCT01455012|9854385|FG000|COMPLETED|Overall Study||30
8802333|NCT01455012|9854386|FG001|COMPLETED|Overall Study||36
8802334|NCT01455012|9854385|FG000|NOT COMPLETED|Overall Study||11
8802335|NCT01455012|9854386|FG001|NOT COMPLETED|Overall Study||4
8802336|NCT01455064|9854392|FG000|STARTED|Overall Study||31
8802337|NCT01455064|9854392|FG000|COMPLETED|Overall Study||30
8802338|NCT01455064|9854392|FG000|NOT COMPLETED|Overall Study||1
8802339|NCT01455181|9854396|FG000|STARTED|Overall Study||24
8802340|NCT01455181|9854396|FG000|COMPLETED|Overall Study||24
8802341|NCT01455181|9854396|FG000|NOT COMPLETED|Overall Study||0
8919854|NCT02209948|9979804|FG000|STARTED|Overall Study||80
8919855|NCT02209948|9979805|FG001|STARTED|Overall Study||79
8919856|NCT02209948|9979804|FG000|Recieved Alocated Intervention|Overall Study||80
8919857|NCT02209948|9979805|FG001|Recieved Alocated Intervention|Overall Study||79
8919858|NCT02209948|9979804|FG000|Lost to Follow up|Overall Study||0
8919859|NCT02209948|9979805|FG001|Lost to Follow up|Overall Study||1
8919860|NCT02209948|9979804|FG000|Discontinued Due to Progression|Overall Study||31
8919861|NCT02209948|9979805|FG001|Discontinued Due to Progression|Overall Study||39
8919862|NCT02209948|9979804|FG000|COMPLETED|Overall Study||80
8919863|NCT02209948|9979805|FG001|COMPLETED|Overall Study||79
8690941|NCT00852761|9736106|FG001|COMPLETED|Overall Study||17
8690942|NCT00852761|9736105|FG000|NOT COMPLETED|Overall Study||0
8690943|NCT00852761|9736106|FG001|NOT COMPLETED|Overall Study||0
8690944|NCT00852917|9736116|FG000|STARTED|Overall Study||106
8690945|NCT00852917|9736117|FG001|STARTED|Overall Study||111
8690946|NCT00852917|9736118|FG002|STARTED|Overall Study||108
8690947|NCT00852917|9736119|FG003|STARTED|Overall Study||227
8690948|NCT00852917|9736116|FG000|COMPLETED|Overall Study||62
8690949|NCT00852917|9736117|FG001|COMPLETED|Overall Study||65
8690950|NCT00852917|9736118|FG002|COMPLETED|Overall Study||50
8919864|NCT02209948|9979804|FG000|NOT COMPLETED|Overall Study||0
8690951|NCT00852917|9736119|FG003|COMPLETED|Overall Study||134
8690952|NCT00852917|9736116|FG000|NOT COMPLETED|Overall Study||44
8690953|NCT00852917|9736117|FG001|NOT COMPLETED|Overall Study||46
8690954|NCT00852917|9736118|FG002|NOT COMPLETED|Overall Study||58
8690955|NCT00852917|9736119|FG003|NOT COMPLETED|Overall Study||93
8690956|NCT00852930|9736132|FG000|STARTED|Overall Study||16
8690957|NCT00852930|9736133|FG001|STARTED|Overall Study||17
8690958|NCT00852930|9736134|FG002|STARTED|Overall Study||17
8690959|NCT00852930|9736132|FG000|COMPLETED|Overall Study||15
8690960|NCT00852930|9736133|FG001|COMPLETED|Overall Study||16
8690961|NCT00852930|9736134|FG002|COMPLETED|Overall Study||15
8690962|NCT00852930|9736132|FG000|NOT COMPLETED|Overall Study||1
8690963|NCT00852930|9736133|FG001|NOT COMPLETED|Overall Study||1
8690964|NCT00852930|9736134|FG002|NOT COMPLETED|Overall Study||2
8690965|NCT00852969|9736145|FG000|STARTED|Overall Study||15
8690966|NCT00852969|9736146|FG001|STARTED|Overall Study||15
8690967|NCT00852969|9736145|FG000|COMPLETED|Overall Study||15
8690968|NCT00852969|9736146|FG001|COMPLETED|Overall Study||13
8690969|NCT00852969|9736145|FG000|NOT COMPLETED|Overall Study||0
8690970|NCT00852969|9736146|FG001|NOT COMPLETED|Overall Study||2
8690971|NCT00852995|9736157|FG000|STARTED|Overall Study||46
8690972|NCT00852995|9736158|FG001|STARTED|Overall Study||43
8802342|NCT01455194|9854403|FG000|STARTED|Overall Study||153
8802343|NCT01455194|9854404|FG001|STARTED|Overall Study||120
8802344|NCT01455194|9854405|FG002|STARTED|Overall Study||122
8802345|NCT01455194|9854406|FG003|STARTED|Overall Study||125
8802346|NCT01455194|9854403|FG000|COMPLETED|Overall Study||0
8802347|NCT01455194|9854404|FG001|COMPLETED|Overall Study||89
8802348|NCT01455194|9854405|FG002|COMPLETED|Overall Study||92
8802349|NCT01455194|9854406|FG003|COMPLETED|Overall Study||97
8802350|NCT01455194|9854403|FG000|NOT COMPLETED|Overall Study||153
8802351|NCT01455194|9854404|FG001|NOT COMPLETED|Overall Study||31
8802352|NCT01455194|9854405|FG002|NOT COMPLETED|Overall Study||30
8802353|NCT01455194|9854406|FG003|NOT COMPLETED|Overall Study||28
8802354|NCT01455220|9854419|FG000|STARTED|Overall Study||45
8802355|NCT01455220|9854419|FG000|COMPLETED|Overall Study||15
8802356|NCT01455220|9854419|FG000|NOT COMPLETED|Overall Study||30
8802357|NCT01455415|9854428|FG000|STARTED|Period 1|Started=Treated|154
8802358|NCT01455415|9854429|FG001|STARTED|Period 1|Started=Treated|147
8802359|NCT01455415|9854428|FG000|COMPLETED|Period 1||135
8802360|NCT01455415|9854429|FG001|COMPLETED|Period 1||123
8802361|NCT01455415|9854428|FG000|NOT COMPLETED|Period 1||19
8802362|NCT01455415|9854429|FG001|NOT COMPLETED|Period 1||24
8802363|NCT01455415|9854428|FG000|STARTED|Washout||135
8802364|NCT01455415|9854429|FG001|STARTED|Washout||123
8802365|NCT01455415|9854428|FG000|COMPLETED|Washout||127
8802366|NCT01455415|9854429|FG001|COMPLETED|Washout||116
8802367|NCT01455415|9854428|FG000|NOT COMPLETED|Washout||8
8802368|NCT01455415|9854429|FG001|NOT COMPLETED|Washout||7
8802369|NCT01455415|9854428|FG000|STARTED|Period 2||127
8802370|NCT01455415|9854429|FG001|STARTED|Period 2||116
8802371|NCT01455415|9854428|FG000|COMPLETED|Period 2||114
8802372|NCT01455415|9854429|FG001|COMPLETED|Period 2||106
8802373|NCT01455415|9854428|FG000|NOT COMPLETED|Period 2||13
8802374|NCT01455415|9854429|FG001|NOT COMPLETED|Period 2||10
8802375|NCT01455415|9854428|FG000|STARTED|Follow-up||114
8802376|NCT01455415|9854429|FG001|STARTED|Follow-up||106
8802377|NCT01455415|9854428|FG000|COMPLETED|Follow-up||111
8802378|NCT01455415|9854429|FG001|COMPLETED|Follow-up||104
8802379|NCT01455415|9854428|FG000|NOT COMPLETED|Follow-up||3
8802380|NCT01455415|9854429|FG001|NOT COMPLETED|Follow-up||2
8802381|NCT01455428|9854437|FG000|STARTED|Overall Study||112
8802382|NCT01455428|9854438|FG001|STARTED|Overall Study||110
8802383|NCT01455428|9854437|FG000|Treated|Overall Study||111
8802384|NCT01455428|9854438|FG001|Treated|Overall Study||109
8802385|NCT01455428|9854437|FG000|COMPLETED|Overall Study||98
8802386|NCT01455428|9854438|FG001|COMPLETED|Overall Study||92
8802387|NCT01455428|9854437|FG000|NOT COMPLETED|Overall Study||14
8802388|NCT01455428|9854438|FG001|NOT COMPLETED|Overall Study||18
8802389|NCT01455519|9854446|FG000|STARTED|Overall Study||12
8802390|NCT01455519|9854447|FG001|STARTED|Overall Study||23
8802391|NCT01455519|9854446|FG000|COMPLETED|Overall Study||8
8802392|NCT01455519|9854447|FG001|COMPLETED|Overall Study||18
8802393|NCT01455519|9854446|FG000|NOT COMPLETED|Overall Study||4
8802394|NCT01455519|9854447|FG001|NOT COMPLETED|Overall Study||5
8802395|NCT01455545|9854453|FG000|STARTED|Overall Study||55
8802396|NCT01455545|9854454|FG001|STARTED|Overall Study||45
8802397|NCT01455545|9854453|FG000|COMPLETED|Overall Study||55
8802398|NCT01455545|9854454|FG001|COMPLETED|Overall Study||45
8802399|NCT01455545|9854453|FG000|NOT COMPLETED|Overall Study||0
8802400|NCT01455545|9854454|FG001|NOT COMPLETED|Overall Study||0
8802401|NCT01456000|9854471|FG000|STARTED|Overall Study||178
8690973|NCT00852995|9736159|FG002|STARTED|Overall Study||44
8802402|NCT01456000|9854472|FG001|STARTED|Overall Study||175
8802403|NCT01456000|9854471|FG000|COMPLETED|Overall Study||170
8802404|NCT01456000|9854472|FG001|COMPLETED|Overall Study||172
8802405|NCT01456000|9854471|FG000|NOT COMPLETED|Overall Study||8
8802406|NCT01456000|9854472|FG001|NOT COMPLETED|Overall Study||3
8690974|NCT00852995|9736160|FG003|STARTED|Overall Study||45
8802407|NCT01456039|9854481|FG000|STARTED|Phase 1 (First Step)||3
8802408|NCT01456039|9854482|FG001|STARTED|Phase 1 (First Step)||8
8802409|NCT01456039|9854483|FG002|STARTED|Phase 1 (First Step)||0
8802410|NCT01456039|9854481|FG000|COMPLETED|Phase 1 (First Step)|Completed = on treatment|1
8802411|NCT01456039|9854482|FG001|COMPLETED|Phase 1 (First Step)|Completed = on treatment|1
8802412|NCT01456039|9854483|FG002|COMPLETED|Phase 1 (First Step)||0
8802413|NCT01456039|9854481|FG000|NOT COMPLETED|Phase 1 (First Step)||2
8802414|NCT01456039|9854482|FG001|NOT COMPLETED|Phase 1 (First Step)||7
8802415|NCT01456039|9854483|FG002|NOT COMPLETED|Phase 1 (First Step)||0
8802416|NCT01456039|9854481|FG000|STARTED|Phase 2 (Second Step)||0
8802417|NCT01456039|9854482|FG001|STARTED|Phase 2 (Second Step)||0
8802418|NCT01456039|9854483|FG002|STARTED|Phase 2 (Second Step)||40
8802419|NCT01456039|9854481|FG000|COMPLETED|Phase 2 (Second Step)||0
8802420|NCT01456039|9854482|FG001|COMPLETED|Phase 2 (Second Step)||0
8802421|NCT01456039|9854483|FG002|COMPLETED|Phase 2 (Second Step)||7
8802422|NCT01456039|9854481|FG000|NOT COMPLETED|Phase 2 (Second Step)||0
8802423|NCT01456039|9854482|FG001|NOT COMPLETED|Phase 2 (Second Step)||0
8802424|NCT01456039|9854483|FG002|NOT COMPLETED|Phase 2 (Second Step)||33
8802425|NCT01456052|9854502|FG000|STARTED|Overall Study||10
8802426|NCT01456052|9854503|FG001|STARTED|Overall Study|One subject did not receive any study drug. That subject is not included in the safety population.|25
8802427|NCT01456052|9854504|FG002|STARTED|Overall Study||24
8802428|NCT01456052|9854502|FG000|COMPLETED|Overall Study||8
8802429|NCT01456052|9854503|FG001|COMPLETED|Overall Study||20
8802430|NCT01456052|9854504|FG002|COMPLETED|Overall Study||19
8802431|NCT01456052|9854502|FG000|NOT COMPLETED|Overall Study||2
8802432|NCT01456052|9854503|FG001|NOT COMPLETED|Overall Study||5
8802433|NCT01456052|9854504|FG002|NOT COMPLETED|Overall Study||5
8802434|NCT01456130|9854513|FG000|STARTED|Overall Study||67
8802435|NCT01456130|9854513|FG000|COMPLETED|Overall Study||57
8802436|NCT01456130|9854513|FG000|NOT COMPLETED|Overall Study||10
8802437|NCT01456143|9854517|FG000|STARTED|Overall Study||33
8802438|NCT01456143|9854517|FG000|COMPLETED|Overall Study||33
8802439|NCT01456143|9854517|FG000|NOT COMPLETED|Overall Study||0
8802440|NCT01456169|9854524|FG000|STARTED|Overall Study|Indicates participants who were randomized into the double-blind treatment period|133
8802441|NCT01456169|9854525|FG001|STARTED|Overall Study|Indicates participants who were randomized into the double-blind treatment period|127
8802442|NCT01456169|9854526|FG002|STARTED|Overall Study|Indicates participants who were randomized into the double-blind treatment period|135
8802443|NCT01456169|9854524|FG000|COMPLETED|Overall Study||123
8802444|NCT01456169|9854525|FG001|COMPLETED|Overall Study||122
8802445|NCT01456169|9854526|FG002|COMPLETED|Overall Study||123
8802446|NCT01456169|9854524|FG000|NOT COMPLETED|Overall Study||10
8802447|NCT01456169|9854525|FG001|NOT COMPLETED|Overall Study||5
8802448|NCT01456169|9854526|FG002|NOT COMPLETED|Overall Study||12
8802449|NCT01456195|9854538|FG000|STARTED|Overall Study||143
8802450|NCT01456195|9854539|FG001|STARTED|Overall Study||137
8802451|NCT01456195|9854540|FG002|STARTED|Overall Study||141
8802452|NCT01456195|9854538|FG000|COMPLETED|Overall Study||132
8802453|NCT01456195|9854539|FG001|COMPLETED|Overall Study||127
8802454|NCT01456195|9854540|FG002|COMPLETED|Overall Study||127
8802455|NCT01456195|9854538|FG000|NOT COMPLETED|Overall Study||11
8802456|NCT01456195|9854539|FG001|NOT COMPLETED|Overall Study||10
8802457|NCT01456195|9854540|FG002|NOT COMPLETED|Overall Study||14
8802458|NCT01456221|9854550|FG000|STARTED|Overall Study||183
8802459|NCT01456221|9854551|FG001|STARTED|Overall Study||183
8802460|NCT01456221|9854550|FG000|COMPLETED|Overall Study||119
8802461|NCT01456221|9854551|FG001|COMPLETED|Overall Study||126
8802462|NCT01456221|9854550|FG000|NOT COMPLETED|Overall Study||64
8802463|NCT01456221|9854551|FG001|NOT COMPLETED|Overall Study||57
8802464|NCT01456299|9854560|FG000|STARTED|Overall Study||34
8802465|NCT01456299|9854561|FG001|STARTED|Overall Study||34
8802466|NCT01456299|9854562|FG002|STARTED|Overall Study||34
8802467|NCT01456299|9854560|FG000|COMPLETED|Overall Study||34
8802468|NCT01456299|9854561|FG001|COMPLETED|Overall Study||33
8802469|NCT01456299|9854562|FG002|COMPLETED|Overall Study||33
8802470|NCT01456299|9854560|FG000|NOT COMPLETED|Overall Study||0
8802471|NCT01456299|9854561|FG001|NOT COMPLETED|Overall Study||1
8802472|NCT01456299|9854562|FG002|NOT COMPLETED|Overall Study||1
8802473|NCT01456494|9854572|FG000|STARTED|Initial Inpatient Visit||24
8802474|NCT01456494|9854573|FG001|STARTED|Initial Inpatient Visit||26
8802475|NCT01456494|9854572|FG000|COMPLETED|Initial Inpatient Visit||24
8802476|NCT01456494|9854573|FG001|COMPLETED|Initial Inpatient Visit||26
8802477|NCT01456494|9854572|FG000|NOT COMPLETED|Initial Inpatient Visit||0
8802478|NCT01456494|9854573|FG001|NOT COMPLETED|Initial Inpatient Visit||0
8802479|NCT01456494|9854572|FG000|STARTED|Follow-Up Visit (Post 30-day Discharge)||24
8802480|NCT01456494|9854573|FG001|STARTED|Follow-Up Visit (Post 30-day Discharge)||26
8802481|NCT01456494|9854572|FG000|COMPLETED|Follow-Up Visit (Post 30-day Discharge)||19
8802482|NCT01456494|9854573|FG001|COMPLETED|Follow-Up Visit (Post 30-day Discharge)||20
8802483|NCT01456494|9854572|FG000|NOT COMPLETED|Follow-Up Visit (Post 30-day Discharge)||5
8802484|NCT01456494|9854573|FG001|NOT COMPLETED|Follow-Up Visit (Post 30-day Discharge)||6
8802485|NCT01456780|9854582|FG000|STARTED|Overall Study||20
8802486|NCT01456780|9854583|FG001|STARTED|Overall Study||20
8802487|NCT01456780|9854584|FG002|STARTED|Overall Study||20
8802488|NCT01456780|9854582|FG000|COMPLETED|Overall Study||17
8802489|NCT01456780|9854583|FG001|COMPLETED|Overall Study||17
8802490|NCT01456780|9854584|FG002|COMPLETED|Overall Study||20
8802491|NCT01456780|9854582|FG000|NOT COMPLETED|Overall Study||3
8802492|NCT01456780|9854583|FG001|NOT COMPLETED|Overall Study||3
8802493|NCT01456780|9854584|FG002|NOT COMPLETED|Overall Study||0
8802494|NCT01456897|9854594|FG000|STARTED|Overall Study||184
8802495|NCT01456897|9854595|FG001|STARTED|Overall Study||98
8802496|NCT01456897|9854594|FG000|COMPLETED|Overall Study||109
8802497|NCT01456897|9854595|FG001|COMPLETED|Overall Study||41
8802498|NCT01456897|9854594|FG000|NOT COMPLETED|Overall Study||75
8802499|NCT01456897|9854595|FG001|NOT COMPLETED|Overall Study||57
8802500|NCT01456936|9854605|FG000|STARTED|Overall Study||2037
8802501|NCT01456936|9854606|FG001|STARTED|Overall Study||2034
8802502|NCT01456936|9854607|FG002|STARTED|Overall Study||2038
8802503|NCT01456936|9854608|FG003|STARTED|Overall Study||2035
8802504|NCT01456936|9854605|FG000|Randomized and Treated|Overall Study||2016
8802505|NCT01456936|9854606|FG001|Randomized and Treated|Overall Study||2006
8802506|NCT01456936|9854607|FG002|Randomized and Treated|Overall Study||2022
8802507|NCT01456936|9854608|FG003|Randomized and Treated|Overall Study||2014
8802508|NCT01456936|9854605|FG000|COMPLETED|Overall Study||1598
8802509|NCT01456936|9854606|FG001|COMPLETED|Overall Study||1586
8802510|NCT01456936|9854607|FG002|COMPLETED|Overall Study||1557
8802511|NCT01456936|9854608|FG003|COMPLETED|Overall Study||1552
8802512|NCT01456936|9854605|FG000|NOT COMPLETED|Overall Study||439
8802513|NCT01456936|9854606|FG001|NOT COMPLETED|Overall Study||448
8802514|NCT01456936|9854607|FG002|NOT COMPLETED|Overall Study||481
8802515|NCT01456936|9854608|FG003|NOT COMPLETED|Overall Study||483
8802516|NCT01456949|9854618|FG000|STARTED|Enrollment||402
8802517|NCT01456949|9854618|FG000|Treated|Enrollment||359
8802518|NCT01456949|9854618|FG000|Modified Intent to Treat Group (mITT)|Enrollment||354
8802519|NCT01456949|9854618|FG000|COMPLETED|Enrollment|6 rollover subjects not included in final analysis. 359 treated; 354 treated & met all I/E criteria.|365
8802520|NCT01456949|9854618|FG000|NOT COMPLETED|Enrollment||37
8802521|NCT01456949|9854618|FG000|STARTED|Study Cryoablation Procedure & Follow-up||365
8802522|NCT01456949|9854618|FG000|3-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of 354 subjects who were treated and met all I/E criteria (mITT group).|344
8802523|NCT01456949|9854618|FG000|6-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of mITT group.|342
8802524|NCT01456949|9854618|FG000|12-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of mITT group.|325
8802525|NCT01456949|9854618|FG000|24-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of mITT group.|309
8802526|NCT01456949|9854618|FG000|36-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of mITT group.|298
8802527|NCT01456949|9854618|FG000|COMPLETED|Study Cryoablation Procedure & Follow-up|5 subjects completed at least 36 months of follow-up but did not complete a 36 month follow-up visit|303
8802528|NCT01456949|9854618|FG000|NOT COMPLETED|Study Cryoablation Procedure & Follow-up||62
8802529|NCT01456962|9854624|FG000|STARTED|Overall Study||16
8802530|NCT01456962|9854625|FG001|STARTED|Overall Study||20
8802531|NCT01456962|9854624|FG000|COMPLETED|Overall Study||14
8802532|NCT01456962|9854625|FG001|COMPLETED|Overall Study||19
8802533|NCT01456962|9854624|FG000|NOT COMPLETED|Overall Study||2
8802534|NCT01456962|9854625|FG001|NOT COMPLETED|Overall Study||1
8802535|NCT01457014|9854631|FG000|STARTED|First Night||74
8802536|NCT01457014|9854632|FG001|STARTED|First Night||0
8802537|NCT01457014|9854633|FG002|STARTED|First Night||0
8802538|NCT01457014|9854634|FG003|STARTED|First Night||0
8802539|NCT01457014|9854631|FG000|COMPLETED|First Night||34
8802540|NCT01457014|9854632|FG001|COMPLETED|First Night||0
8802541|NCT01457014|9854633|FG002|COMPLETED|First Night||0
8919865|NCT02209948|9979805|FG001|NOT COMPLETED|Overall Study||0
8919866|NCT02210000|9979813|FG000|STARTED|Overall Study||57
8919867|NCT02210000|9979814|FG001|STARTED|Overall Study||57
8919868|NCT02210000|9979813|FG000|COMPLETED|Overall Study||38
8919869|NCT02210000|9979814|FG001|COMPLETED|Overall Study||36
8919870|NCT02210000|9979813|FG000|NOT COMPLETED|Overall Study||19
8919871|NCT02210000|9979814|FG001|NOT COMPLETED|Overall Study||21
8919872|NCT02210039|9979820|FG000|STARTED|Overall Study||6
8919873|NCT02210039|9979820|FG000|COMPLETED|Overall Study||6
8919874|NCT02210039|9979820|FG000|NOT COMPLETED|Overall Study||0
8919875|NCT02210052|9979824|FG000|STARTED|Overall Study||6
8919876|NCT02210052|9979824|FG000|COMPLETED|Overall Study||6
8919877|NCT02210052|9979824|FG000|NOT COMPLETED|Overall Study||0
8919878|NCT02210065|9979828|FG000|STARTED|Overall Study||1
8919879|NCT02210065|9979828|FG000|COMPLETED|Overall Study||1
8919880|NCT02210065|9979828|FG000|NOT COMPLETED|Overall Study||0
8919881|NCT02210091|9979834|FG000|STARTED|Overall Study||32
8919882|NCT02210091|9979835|FG001|STARTED|Overall Study||34
8919883|NCT02210091|9979834|FG000|COMPLETED|Overall Study||32
8919884|NCT02210091|9979835|FG001|COMPLETED|Overall Study||32
8919885|NCT02210091|9979834|FG000|NOT COMPLETED|Overall Study||0
8919886|NCT02210091|9979835|FG001|NOT COMPLETED|Overall Study||2
8919887|NCT02210195|9979859|FG000|STARTED|Overall Study||10
8919888|NCT02210195|9979860|FG001|STARTED|Overall Study||10
8919889|NCT02210195|9979859|FG000|COMPLETED|Overall Study||6
8919890|NCT02210195|9979860|FG001|COMPLETED|Overall Study||10
8919891|NCT02210195|9979859|FG000|NOT COMPLETED|Overall Study||4
8919892|NCT02210195|9979860|FG001|NOT COMPLETED|Overall Study||0
8919893|NCT02210208|9979866|FG000|STARTED|Period A (Graft Site)||25
8919894|NCT02210208|9979866|FG000|COMPLETED|Period A (Graft Site)||23
8919895|NCT02210208|9979866|FG000|NOT COMPLETED|Period A (Graft Site)||2
8919896|NCT02210208|9979866|FG000|STARTED|Period B (Donor Site)|6 subjects was decided by the Physician not to be included in the Part B.|19
8919897|NCT02210208|9979866|FG000|COMPLETED|Period B (Donor Site)||12
8919898|NCT02210208|9979866|FG000|NOT COMPLETED|Period B (Donor Site)||7
8919899|NCT02210221|9979872|FG000|STARTED|Overall Study||4559
8919900|NCT02210221|9979872|FG000|COMPLETED|Overall Study||4509
8802542|NCT01457014|9854634|FG003|COMPLETED|First Night||0
8802543|NCT01457014|9854631|FG000|NOT COMPLETED|First Night||40
8802544|NCT01457014|9854632|FG001|NOT COMPLETED|First Night||0
8802545|NCT01457014|9854633|FG002|NOT COMPLETED|First Night||0
8802546|NCT01457014|9854634|FG003|NOT COMPLETED|First Night||0
8802547|NCT01457014|9854631|FG000|STARTED|Second Night|The Diagnostic PSG was only completed on the First night|0
8802548|NCT01457014|9854632|FG001|STARTED|Second Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|12
8802549|NCT01457014|9854633|FG002|STARTED|Second Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
8802550|NCT01457014|9854634|FG003|STARTED|Second Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
8802551|NCT01457014|9854631|FG000|COMPLETED|Second Night|The Diagnostic PSG was only completed on the First night|0
8802552|NCT01457014|9854632|FG001|COMPLETED|Second Night||12
8802553|NCT01457014|9854633|FG002|COMPLETED|Second Night||11
8802554|NCT01457014|9854634|FG003|COMPLETED|Second Night||11
8802555|NCT01457014|9854631|FG000|NOT COMPLETED|Second Night||0
8802556|NCT01457014|9854632|FG001|NOT COMPLETED|Second Night||0
8802557|NCT01457014|9854633|FG002|NOT COMPLETED|Second Night||0
8802558|NCT01457014|9854634|FG003|NOT COMPLETED|Second Night||0
8802559|NCT01457014|9854631|FG000|STARTED|Third Night|The Diagnostic PSG was only completed on the First night|0
8802560|NCT01457014|9854632|FG001|STARTED|Third Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
8802561|NCT01457014|9854633|FG002|STARTED|Third Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
8802562|NCT01457014|9854634|FG003|STARTED|Third Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|12
8802563|NCT01457014|9854631|FG000|COMPLETED|Third Night|The Diagnostic PSG was only completed on the First night|0
8802564|NCT01457014|9854632|FG001|COMPLETED|Third Night||11
8802565|NCT01457014|9854633|FG002|COMPLETED|Third Night||11
8802566|NCT01457014|9854634|FG003|COMPLETED|Third Night||12
8802567|NCT01457014|9854631|FG000|NOT COMPLETED|Third Night||0
8802568|NCT01457014|9854632|FG001|NOT COMPLETED|Third Night||0
8802569|NCT01457014|9854633|FG002|NOT COMPLETED|Third Night||0
8802570|NCT01457014|9854634|FG003|NOT COMPLETED|Third Night||0
8802571|NCT01457014|9854631|FG000|STARTED|Fourth Night|The Diagnostic PSG was only completed on the First night|0
8802572|NCT01457014|9854632|FG001|STARTED|Fourth Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
8802573|NCT01457014|9854633|FG002|STARTED|Fourth Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|12
8802574|NCT01457014|9854634|FG003|STARTED|Fourth Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
8802575|NCT01457014|9854631|FG000|COMPLETED|Fourth Night|The Diagnostic PSG was only completed on the First night|0
8802576|NCT01457014|9854632|FG001|COMPLETED|Fourth Night||11
8802577|NCT01457014|9854633|FG002|COMPLETED|Fourth Night||12
8802578|NCT01457014|9854634|FG003|COMPLETED|Fourth Night||11
8802579|NCT01457014|9854631|FG000|NOT COMPLETED|Fourth Night||0
8802580|NCT01457014|9854632|FG001|NOT COMPLETED|Fourth Night||0
8802581|NCT01457014|9854633|FG002|NOT COMPLETED|Fourth Night||0
8802582|NCT01457014|9854634|FG003|NOT COMPLETED|Fourth Night||0
8802583|NCT01457118|9854646|FG000|STARTED|Overall Study||20
8802584|NCT01457118|9854647|FG001|STARTED|Overall Study||4
8802585|NCT01457118|9854648|FG002|STARTED|Overall Study||1
8802586|NCT01457118|9854649|FG003|STARTED|Overall Study||2
8802587|NCT01457118|9854646|FG000|COMPLETED|Overall Study||0
8802588|NCT01457118|9854647|FG001|COMPLETED|Overall Study||0
8802589|NCT01457118|9854648|FG002|COMPLETED|Overall Study||0
8802590|NCT01457118|9854649|FG003|COMPLETED|Overall Study||0
8802591|NCT01457118|9854646|FG000|NOT COMPLETED|Overall Study||20
8802592|NCT01457118|9854647|FG001|NOT COMPLETED|Overall Study||4
8802593|NCT01457118|9854648|FG002|NOT COMPLETED|Overall Study||1
8802594|NCT01457118|9854649|FG003|NOT COMPLETED|Overall Study||2
8802595|NCT01457196|9854659|FG000|STARTED|Overall Study||2074
8802596|NCT01457196|9854659|FG000|COMPLETED|Overall Study||2074
8802597|NCT01457196|9854659|FG000|NOT COMPLETED|Overall Study||0
8802598|NCT01457339|9854667|FG000|STARTED|Period 1 (50 mg)||7
8802599|NCT01457339|9854668|FG001|STARTED|Period 1 (50 mg)||24
8802600|NCT01457339|9854667|FG000|COMPLETED|Period 1 (50 mg)||7
8802601|NCT01457339|9854668|FG001|COMPLETED|Period 1 (50 mg)||24
8802602|NCT01457339|9854667|FG000|NOT COMPLETED|Period 1 (50 mg)||0
8802603|NCT01457339|9854668|FG001|NOT COMPLETED|Period 1 (50 mg)||0
8802604|NCT01457339|9854667|FG000|STARTED|Period 2 (70 mg)||7
8802605|NCT01457339|9854668|FG001|STARTED|Period 2 (70 mg)||24
8802606|NCT01457339|9854667|FG000|COMPLETED|Period 2 (70 mg)||7
8802607|NCT01457339|9854668|FG001|COMPLETED|Period 2 (70 mg)||24
8802608|NCT01457339|9854667|FG000|NOT COMPLETED|Period 2 (70 mg)||0
8802609|NCT01457339|9854668|FG001|NOT COMPLETED|Period 2 (70 mg)||0
8802610|NCT01457339|9854667|FG000|STARTED|Period 3 (100 mg)||7
8802611|NCT01457339|9854668|FG001|STARTED|Period 3 (100 mg)||24
8802612|NCT01457339|9854667|FG000|COMPLETED|Period 3 (100 mg)||7
8802613|NCT01457339|9854668|FG001|COMPLETED|Period 3 (100 mg)||23
8802614|NCT01457339|9854667|FG000|NOT COMPLETED|Period 3 (100 mg)||0
8802615|NCT01457339|9854668|FG001|NOT COMPLETED|Period 3 (100 mg)||1
8802616|NCT01457339|9854667|FG000|STARTED|Period 4 (150 mg)||7
8802617|NCT01457339|9854668|FG001|STARTED|Period 4 (150 mg)||23
8802618|NCT01457339|9854667|FG000|COMPLETED|Period 4 (150 mg)||7
8802619|NCT01457339|9854668|FG001|COMPLETED|Period 4 (150 mg)||23
8802620|NCT01457339|9854667|FG000|NOT COMPLETED|Period 4 (150 mg)||0
8802621|NCT01457339|9854668|FG001|NOT COMPLETED|Period 4 (150 mg)||0
8802622|NCT01457339|9854667|FG000|STARTED|Period 5 (200 mg)||7
8802623|NCT01457339|9854668|FG001|STARTED|Period 5 (200 mg)||23
8802624|NCT01457339|9854667|FG000|COMPLETED|Period 5 (200 mg)||7
8802625|NCT01457339|9854668|FG001|COMPLETED|Period 5 (200 mg)||22
8802626|NCT01457339|9854667|FG000|NOT COMPLETED|Period 5 (200 mg)||0
8802627|NCT01457339|9854668|FG001|NOT COMPLETED|Period 5 (200 mg)||1
8802628|NCT01457339|9854667|FG000|STARTED|Period 6 (250 mg)||7
8802629|NCT01457339|9854668|FG001|STARTED|Period 6 (250 mg)||22
8802630|NCT01457339|9854667|FG000|COMPLETED|Period 6 (250 mg)||6
8802631|NCT01457339|9854668|FG001|COMPLETED|Period 6 (250 mg)||21
8802632|NCT01457339|9854667|FG000|NOT COMPLETED|Period 6 (250 mg)||1
8802633|NCT01457339|9854668|FG001|NOT COMPLETED|Period 6 (250 mg)||1
8802634|NCT01457352|9854693|FG000|STARTED|Period 1||392
8802635|NCT01457352|9854694|FG001|STARTED|Period 1||0
8802636|NCT01457352|9854693|FG000|COMPLETED|Period 1||376
8802637|NCT01457352|9854694|FG001|COMPLETED|Period 1||0
8802638|NCT01457352|9854693|FG000|NOT COMPLETED|Period 1||16
8802639|NCT01457352|9854694|FG001|NOT COMPLETED|Period 1||0
8802640|NCT01457352|9854693|FG000|STARTED|Period 2||376
8802641|NCT01457352|9854694|FG001|STARTED|Period 2||0
8802642|NCT01457352|9854693|FG000|COMPLETED|Period 2||296
8802643|NCT01457352|9854694|FG001|COMPLETED|Period 2||0
8802644|NCT01457352|9854693|FG000|NOT COMPLETED|Period 2||80
8802645|NCT01457352|9854694|FG001|NOT COMPLETED|Period 2||0
8802646|NCT01457352|9854693|FG000|STARTED|Period 3||147
8802647|NCT01457352|9854694|FG001|STARTED|Period 3||149
8802648|NCT01457352|9854693|FG000|Randomization|Period 3||147
8802649|NCT01457352|9854694|FG001|Randomization|Period 3||149
8802650|NCT01457352|9854693|FG000|COMPLETED|Period 3||146
8802651|NCT01457352|9854694|FG001|COMPLETED|Period 3||144
8802652|NCT01457352|9854693|FG000|NOT COMPLETED|Period 3||1
8802653|NCT01457352|9854694|FG001|NOT COMPLETED|Period 3||5
8802654|NCT01457417|9854709|FG000|STARTED|Overall Study||3
8802655|NCT01457417|9854710|FG001|STARTED|Overall Study||3
8802656|NCT01457417|9854711|FG002|STARTED|Overall Study||4
8802657|NCT01457417|9854712|FG003|STARTED|Overall Study||3
8802658|NCT01457417|9854713|FG004|STARTED|Overall Study||19
8802659|NCT01457417|9854709|FG000|COMPLETED|Overall Study||3
8802660|NCT01457417|9854710|FG001|COMPLETED|Overall Study||3
8802661|NCT01457417|9854711|FG002|COMPLETED|Overall Study||4
8802662|NCT01457417|9854712|FG003|COMPLETED|Overall Study||3
8802663|NCT01457417|9854713|FG004|COMPLETED|Overall Study||19
8802664|NCT01457417|9854709|FG000|NOT COMPLETED|Overall Study||0
8802665|NCT01457417|9854710|FG001|NOT COMPLETED|Overall Study||0
8802666|NCT01457417|9854711|FG002|NOT COMPLETED|Overall Study||0
8802667|NCT01457417|9854712|FG003|NOT COMPLETED|Overall Study||0
8802668|NCT01457417|9854713|FG004|NOT COMPLETED|Overall Study||0
8802669|NCT01457430|9854727|FG000|STARTED|Overall Study||19
8802670|NCT01457430|9854727|FG000|COMPLETED|Overall Study||19
8802671|NCT01457430|9854727|FG000|NOT COMPLETED|Overall Study||0
8802672|NCT01457521|9854734|FG000|STARTED|Overall Study||123
8802673|NCT01457521|9854735|FG001|STARTED|Overall Study||127
8802674|NCT01457521|9854734|FG000|COMPLETED|Overall Study||111
8802675|NCT01457521|9854735|FG001|COMPLETED|Overall Study||117
8802676|NCT01457521|9854734|FG000|NOT COMPLETED|Overall Study||12
8802677|NCT01457521|9854735|FG001|NOT COMPLETED|Overall Study||10
8802678|NCT01457573|9854741|FG000|STARTED|Overall Study||10
8802679|NCT01457573|9854741|FG000|COMPLETED|Overall Study||10
8802680|NCT01457573|9854741|FG000|NOT COMPLETED|Overall Study||0
8802681|NCT01457703|9854748|FG000|STARTED|Overall Study||29
8802682|NCT01457703|9854749|FG001|STARTED|Overall Study||33
8802683|NCT01457703|9854748|FG000|COMPLETED|Overall Study||23
8802684|NCT01457703|9854749|FG001|COMPLETED|Overall Study||22
8802685|NCT01457703|9854748|FG000|NOT COMPLETED|Overall Study||6
8802686|NCT01457703|9854749|FG001|NOT COMPLETED|Overall Study||11
8802687|NCT01457846|9854759|FG000|STARTED|Overall Study||41
8802688|NCT01457846|9854760|FG001|STARTED|Overall Study||30
8802689|NCT01457846|9854759|FG000|Received Treatment|Overall Study||40
8802690|NCT01457846|9854760|FG001|Received Treatment|Overall Study||27
8802691|NCT01457846|9854759|FG000|Did Not Receive Treatment|Overall Study||1
8802692|NCT01457846|9854760|FG001|Did Not Receive Treatment|Overall Study||3
8802693|NCT01457846|9854759|FG000|Ongoing Treatment at Data Cut-off|Overall Study||1
8802694|NCT01457846|9854760|FG001|Ongoing Treatment at Data Cut-off|Overall Study||1
8802695|NCT01457846|9854759|FG000|COMPLETED|Overall Study||0
8802696|NCT01457846|9854760|FG001|COMPLETED|Overall Study||0
8802697|NCT01457846|9854759|FG000|NOT COMPLETED|Overall Study||41
8802698|NCT01457846|9854760|FG001|NOT COMPLETED|Overall Study||30
8802699|NCT01457885|9854766|FG000|STARTED|Overall Study||74
8802700|NCT01457885|9854766|FG000|COMPLETED|Overall Study||74
8802701|NCT01457885|9854766|FG000|NOT COMPLETED|Overall Study||0
8802702|NCT01457924|9854775|FG000|STARTED|Treatment Phase (Weeks 0-24)||67
8802703|NCT01457924|9854776|FG001|STARTED|Treatment Phase (Weeks 0-24)||34
8802704|NCT01457924|9854777|FG002|STARTED|Treatment Phase (Weeks 0-24)||32
8802705|NCT01457924|9854778|FG003|STARTED|Treatment Phase (Weeks 0-24)||34
8802706|NCT01457924|9854779|FG004|STARTED|Treatment Phase (Weeks 0-24)||64
8802707|NCT01457924|9854775|FG000|Completed to Week 12|Treatment Phase (Weeks 0-24)||65
8802708|NCT01457924|9854776|FG001|Completed to Week 12|Treatment Phase (Weeks 0-24)||31
8802709|NCT01457924|9854777|FG002|Completed to Week 12|Treatment Phase (Weeks 0-24)||30
8802710|NCT01457924|9854778|FG003|Completed to Week 12|Treatment Phase (Weeks 0-24)||33
8802711|NCT01457924|9854779|FG004|Completed to Week 12|Treatment Phase (Weeks 0-24)||60
8802712|NCT01457924|9854775|FG000|COMPLETED|Treatment Phase (Weeks 0-24)||64
8802713|NCT01457924|9854776|FG001|COMPLETED|Treatment Phase (Weeks 0-24)||29
8802714|NCT01457924|9854777|FG002|COMPLETED|Treatment Phase (Weeks 0-24)||30
8802715|NCT01457924|9854778|FG003|COMPLETED|Treatment Phase (Weeks 0-24)||33
8802716|NCT01457924|9854779|FG004|COMPLETED|Treatment Phase (Weeks 0-24)||58
8802717|NCT01457924|9854775|FG000|NOT COMPLETED|Treatment Phase (Weeks 0-24)||3
8802718|NCT01457924|9854776|FG001|NOT COMPLETED|Treatment Phase (Weeks 0-24)||5
8802719|NCT01457924|9854777|FG002|NOT COMPLETED|Treatment Phase (Weeks 0-24)||2
8802720|NCT01457924|9854778|FG003|NOT COMPLETED|Treatment Phase (Weeks 0-24)||1
8802721|NCT01457924|9854779|FG004|NOT COMPLETED|Treatment Phase (Weeks 0-24)||6
8802722|NCT01457924|9854775|FG000|STARTED|FUP (Weeks 24-48)||66
8802723|NCT01457924|9854776|FG001|STARTED|FUP (Weeks 24-48)||31
8802724|NCT01457924|9854777|FG002|STARTED|FUP (Weeks 24-48)||32
8802725|NCT01457924|9854778|FG003|STARTED|FUP (Weeks 24-48)||33
8802726|NCT01457924|9854779|FG004|STARTED|FUP (Weeks 24-48)||59
8802727|NCT01457924|9854775|FG000|COMPLETED|FUP (Weeks 24-48)||63
8802728|NCT01457924|9854776|FG001|COMPLETED|FUP (Weeks 24-48)||30
8802729|NCT01457924|9854777|FG002|COMPLETED|FUP (Weeks 24-48)||30
8802730|NCT01457924|9854778|FG003|COMPLETED|FUP (Weeks 24-48)||32
8802731|NCT01457924|9854779|FG004|COMPLETED|FUP (Weeks 24-48)||57
8802732|NCT01457924|9854775|FG000|NOT COMPLETED|FUP (Weeks 24-48)||3
8802733|NCT01457924|9854776|FG001|NOT COMPLETED|FUP (Weeks 24-48)||1
8802734|NCT01457924|9854777|FG002|NOT COMPLETED|FUP (Weeks 24-48)||2
8802735|NCT01457924|9854778|FG003|NOT COMPLETED|FUP (Weeks 24-48)||1
8802736|NCT01457924|9854779|FG004|NOT COMPLETED|FUP (Weeks 24-48)||2
8802737|NCT01457924|9854775|FG000|STARTED|Individualized FUP (Weeks 48+)||16
8802738|NCT01457924|9854776|FG001|STARTED|Individualized FUP (Weeks 48+)||18
8802739|NCT01457924|9854777|FG002|STARTED|Individualized FUP (Weeks 48+)||16
8802740|NCT01457924|9854778|FG003|STARTED|Individualized FUP (Weeks 48+)||20
8802741|NCT01457924|9854779|FG004|STARTED|Individualized FUP (Weeks 48+)||42
8919901|NCT02210221|9979872|FG000|NOT COMPLETED|Overall Study||50
8919902|NCT02210247|9979886|FG000|STARTED|Overall Study||12
8919903|NCT02210247|9979887|FG001|STARTED|Overall Study||12
8919904|NCT02210247|9979888|FG002|STARTED|Overall Study||12
8919905|NCT02210247|9979889|FG003|STARTED|Overall Study||12
8919906|NCT02210247|9979890|FG004|STARTED|Overall Study||12
8919907|NCT02210247|9979886|FG000|COMPLETED|Overall Study||12
8919908|NCT02210247|9979887|FG001|COMPLETED|Overall Study||12
8919909|NCT02210247|9979888|FG002|COMPLETED|Overall Study||12
8919910|NCT02210247|9979889|FG003|COMPLETED|Overall Study||12
8919911|NCT02210247|9979890|FG004|COMPLETED|Overall Study||12
8919912|NCT02210247|9979886|FG000|NOT COMPLETED|Overall Study||0
8919913|NCT02210247|9979887|FG001|NOT COMPLETED|Overall Study||0
8919914|NCT02210247|9979888|FG002|NOT COMPLETED|Overall Study||0
8919915|NCT02210247|9979889|FG003|NOT COMPLETED|Overall Study||0
8919916|NCT02210247|9979890|FG004|NOT COMPLETED|Overall Study||0
8919917|NCT02210286|9979907|FG000|STARTED|Overall Study||17
8919918|NCT02210286|9979907|FG000|COMPLETED|Overall Study||15
8919919|NCT02210286|9979907|FG000|NOT COMPLETED|Overall Study||2
8919920|NCT02210689|9979918|FG000|STARTED|Overall Study||242
8919921|NCT02210689|9979919|FG001|STARTED|Overall Study||240
8919922|NCT02210689|9979920|FG002|STARTED|Overall Study||122
8919923|NCT02210689|9979918|FG000|Safety Population|Overall Study||233
8919924|NCT02210689|9979919|FG001|Safety Population|Overall Study||236
8919925|NCT02210689|9979920|FG002|Safety Population|Overall Study||122
8919926|NCT02210689|9979918|FG000|mITT Population|Overall Study||199
8919927|NCT02210689|9979919|FG001|mITT Population|Overall Study||207
8919928|NCT02210689|9979920|FG002|mITT Population|Overall Study||107
8919929|NCT02210689|9979918|FG000|PP Population|Overall Study||164
8919930|NCT02210689|9979919|FG001|PP Population|Overall Study||169
8919931|NCT02210689|9979920|FG002|PP Population|Overall Study||84
8919932|NCT02210689|9979918|FG000|COMPLETED|Overall Study||190
8919933|NCT02210689|9979919|FG001|COMPLETED|Overall Study||193
8919934|NCT02210689|9979920|FG002|COMPLETED|Overall Study||99
8919935|NCT02210689|9979918|FG000|NOT COMPLETED|Overall Study||52
8919936|NCT02210689|9979919|FG001|NOT COMPLETED|Overall Study||47
8919937|NCT02210689|9979920|FG002|NOT COMPLETED|Overall Study||23
8919938|NCT02210780|9979930|FG000|STARTED|Overall Study||97
8919939|NCT02210780|9979931|FG001|STARTED|Overall Study||97
8919940|NCT02210780|9979930|FG000|COMPLETED|Overall Study||92
8919941|NCT02210780|9979931|FG001|COMPLETED|Overall Study||89
8919942|NCT02210780|9979930|FG000|NOT COMPLETED|Overall Study||5
8919943|NCT02210780|9979931|FG001|NOT COMPLETED|Overall Study||8
8919944|NCT02211014|9979939|FG000|STARTED|Overall Study||13
8919945|NCT02211014|9979940|FG001|STARTED|Overall Study||14
8919946|NCT02211014|9979939|FG000|COMPLETED|Overall Study||11
8919947|NCT02211014|9979940|FG001|COMPLETED|Overall Study||8
8919948|NCT02211014|9979939|FG000|NOT COMPLETED|Overall Study||2
8919949|NCT02211014|9979940|FG001|NOT COMPLETED|Overall Study||6
8919950|NCT02211261|9979973|FG000|STARTED|Overall Study||9
8919951|NCT02211261|9979974|FG001|STARTED|Overall Study||6
8919952|NCT02211261|9979975|FG002|STARTED|Overall Study||6
8919953|NCT02211261|9979976|FG003|STARTED|Overall Study||6
8919954|NCT02211261|9979977|FG004|STARTED|Overall Study||9
8919955|NCT02211261|9979978|FG005|STARTED|Overall Study||2
8919956|NCT02211261|9979979|FG006|STARTED|Overall Study||6
8919957|NCT02211261|9979980|FG007|STARTED|Overall Study||8
8919958|NCT02211261|9979981|FG008|STARTED|Overall Study||8
8919959|NCT02211261|9979982|FG009|STARTED|Overall Study||16
8919960|NCT02211261|9979983|FG010|STARTED|Overall Study||8
8919961|NCT02211261|9979973|FG000|COMPLETED|Overall Study||9
8919962|NCT02211261|9979974|FG001|COMPLETED|Overall Study||6
8919963|NCT02211261|9979975|FG002|COMPLETED|Overall Study||5
8919964|NCT02211261|9979976|FG003|COMPLETED|Overall Study||6
8919965|NCT02211261|9979977|FG004|COMPLETED|Overall Study||7
8802742|NCT01457924|9854775|FG000|COMPLETED|Individualized FUP (Weeks 48+)||11
8802743|NCT01457924|9854776|FG001|COMPLETED|Individualized FUP (Weeks 48+)||14
8802744|NCT01457924|9854777|FG002|COMPLETED|Individualized FUP (Weeks 48+)||12
8802745|NCT01457924|9854778|FG003|COMPLETED|Individualized FUP (Weeks 48+)||15
8802746|NCT01457924|9854779|FG004|COMPLETED|Individualized FUP (Weeks 48+)||36
8802747|NCT01457924|9854775|FG000|NOT COMPLETED|Individualized FUP (Weeks 48+)||5
8802748|NCT01457924|9854776|FG001|NOT COMPLETED|Individualized FUP (Weeks 48+)||4
8802749|NCT01457924|9854777|FG002|NOT COMPLETED|Individualized FUP (Weeks 48+)||4
8802750|NCT01457924|9854778|FG003|NOT COMPLETED|Individualized FUP (Weeks 48+)||5
8802751|NCT01457924|9854779|FG004|NOT COMPLETED|Individualized FUP (Weeks 48+)||6
8802752|NCT01457950|9854793|FG000|STARTED|Double-Blind Phase||69
8802753|NCT01457950|9854794|FG001|STARTED|Double-Blind Phase||66
8802754|NCT01457950|9854795|FG002|STARTED|Double-Blind Phase||0
8802755|NCT01457950|9854796|FG003|STARTED|Double-Blind Phase||0
8802756|NCT01457950|9854793|FG000|Completed the 6 Month Assessment|Double-Blind Phase|"Completed 6 month assessment refers to par. that completed at least one 6 month assessment."|62
8802757|NCT01457950|9854794|FG001|Completed the 6 Month Assessment|Double-Blind Phase|"Completed 6 month assessment refers to par. that completed at least one 6 month assessment."|64
8802758|NCT01457950|9854795|FG002|Completed the 6 Month Assessment|Double-Blind Phase||0
8802759|NCT01457950|9854796|FG003|Completed the 6 Month Assessment|Double-Blind Phase||0
8802760|NCT01457950|9854793|FG000|COMPLETED|Double-Blind Phase|"Completed refers to par. that did not have a withdraw reason at the 6 month visit."|60
8802761|NCT01457950|9854794|FG001|COMPLETED|Double-Blind Phase|"Completed refers to par. that did not have a withdraw reason at the 6 month visit."|63
8802762|NCT01457950|9854795|FG002|COMPLETED|Double-Blind Phase||0
8802763|NCT01457950|9854796|FG003|COMPLETED|Double-Blind Phase||0
8802764|NCT01457950|9854793|FG000|NOT COMPLETED|Double-Blind Phase||9
8802765|NCT01457950|9854794|FG001|NOT COMPLETED|Double-Blind Phase||3
8802766|NCT01457950|9854795|FG002|NOT COMPLETED|Double-Blind Phase||0
8802767|NCT01457950|9854796|FG003|NOT COMPLETED|Double-Blind Phase||0
8802768|NCT01457950|9854793|FG000|STARTED|Open-Label Phase||0
8802769|NCT01457950|9854794|FG001|STARTED|Open-Label Phase||0
8802770|NCT01457950|9854795|FG002|STARTED|Open-Label Phase||60
8802771|NCT01457950|9854796|FG003|STARTED|Open-Label Phase||63
8802772|NCT01457950|9854793|FG000|COMPLETED|Open-Label Phase||0
8802773|NCT01457950|9854794|FG001|COMPLETED|Open-Label Phase||0
8802774|NCT01457950|9854795|FG002|COMPLETED|Open-Label Phase||58
8802775|NCT01457950|9854796|FG003|COMPLETED|Open-Label Phase||61
8802776|NCT01457950|9854793|FG000|NOT COMPLETED|Open-Label Phase||0
8802777|NCT01457950|9854794|FG001|NOT COMPLETED|Open-Label Phase||0
8802778|NCT01457950|9854795|FG002|NOT COMPLETED|Open-Label Phase||2
8802779|NCT01457950|9854796|FG003|NOT COMPLETED|Open-Label Phase||2
8802780|NCT01458106|9854809|FG000|STARTED|Overall Study||36
8802781|NCT01458106|9854810|FG001|STARTED|Overall Study||35
8802782|NCT01458106|9854809|FG000|PK Subgroup|Overall Study||25
8802783|NCT01458106|9854810|FG001|PK Subgroup|Overall Study||35
8802784|NCT01458106|9854809|FG000|Non-PK Subgroup|Overall Study||11
8802785|NCT01458106|9854810|FG001|Non-PK Subgroup|Overall Study||0
8802786|NCT01458106|9854809|FG000|COMPLETED|Overall Study||33
8802787|NCT01458106|9854810|FG001|COMPLETED|Overall Study||34
8802788|NCT01458106|9854809|FG000|NOT COMPLETED|Overall Study||3
8802789|NCT01458106|9854810|FG001|NOT COMPLETED|Overall Study||1
8802790|NCT01458119|9854819|FG000|STARTED|Overall Study||85
8802791|NCT01458119|9854819|FG000|Received at Least 1 Dose of Study Drug|Overall Study||85
8802792|NCT01458119|9854819|FG000|Safety Population|Overall Study||85
8802793|NCT01458119|9854819|FG000|Intent to Treat (ITT) Population|Overall Study||85
8802794|NCT01458119|9854819|FG000|ITT-Amenable Population|Overall Study||68
8802795|NCT01458119|9854819|FG000|COMPLETED|Overall Study||65
8802796|NCT01458119|9854819|FG000|NOT COMPLETED|Overall Study||20
8802797|NCT01458132|9854826|FG000|STARTED|Overall Study||15
8802798|NCT01458132|9854827|FG001|STARTED|Overall Study||4
8802799|NCT01458132|9854826|FG000|COMPLETED|Overall Study||0
8802800|NCT01458132|9854827|FG001|COMPLETED|Overall Study||1
8802801|NCT01458132|9854826|FG000|NOT COMPLETED|Overall Study||15
8802802|NCT01458132|9854827|FG001|NOT COMPLETED|Overall Study||3
8802803|NCT01458171|9854833|FG000|STARTED|Overall Study||23
8802804|NCT01458171|9854833|FG000|COMPLETED|Overall Study||22
8802805|NCT01458171|9854833|FG000|NOT COMPLETED|Overall Study||1
8802806|NCT01458210|9854839|FG000|STARTED|Lead-in (1st Course of Ortho-Cyclen)||22
8802807|NCT01458210|9854839|FG000|Received at Least One Dose of Study Drug|Lead-in (1st Course of Ortho-Cyclen)||22
8802808|NCT01458210|9854839|FG000|COMPLETED|Lead-in (1st Course of Ortho-Cyclen)||22
8802809|NCT01458210|9854839|FG000|NOT COMPLETED|Lead-in (1st Course of Ortho-Cyclen)||0
8802810|NCT01458210|9854839|FG000|STARTED|Ortho-Cyclen Alone (Period 1)||22
8802811|NCT01458210|9854839|FG000|COMPLETED|Ortho-Cyclen Alone (Period 1)||18
8802812|NCT01458210|9854839|FG000|NOT COMPLETED|Ortho-Cyclen Alone (Period 1)||4
8802813|NCT01458210|9854839|FG000|STARTED|Ortho-Cyclen + Dulaglutide (Period 2)|1 participant received Ortho-Cyclen, discontinued due to Adverse Event before receiving Dulaglutide.|18
8802814|NCT01458210|9854839|FG000|COMPLETED|Ortho-Cyclen + Dulaglutide (Period 2)||15
8802815|NCT01458210|9854839|FG000|NOT COMPLETED|Ortho-Cyclen + Dulaglutide (Period 2)||3
8802816|NCT01458249|9854848|FG000|STARTED|Overall Study||52
8802817|NCT01458249|9854848|FG000|Participants Treated|Overall Study||51
8802818|NCT01458249|9854848|FG000|COMPLETED|Overall Study||44
8802819|NCT01458249|9854848|FG000|NOT COMPLETED|Overall Study||8
8802820|NCT01458275|9854856|FG000|STARTED|Overall Study||283
8802821|NCT01458275|9854857|FG001|STARTED|Overall Study||282
8802822|NCT01458275|9854858|FG002|STARTED|Overall Study||282
8802823|NCT01458275|9854856|FG000|COMPLETED|Overall Study||269
8802824|NCT01458275|9854857|FG001|COMPLETED|Overall Study||269
8802825|NCT01458275|9854858|FG002|COMPLETED|Overall Study||273
8802826|NCT01458275|9854856|FG000|NOT COMPLETED|Overall Study||14
8802827|NCT01458275|9854857|FG001|NOT COMPLETED|Overall Study||13
8802828|NCT01458275|9854858|FG002|NOT COMPLETED|Overall Study||9
8802829|NCT01458288|9854868|FG000|STARTED|Overall Study||12
8802830|NCT01458288|9854868|FG000|COMPLETED|Overall Study||12
8802831|NCT01458288|9854868|FG000|NOT COMPLETED|Overall Study||0
8802832|NCT01458327|9854873|FG000|STARTED|Overall Study||3
8802833|NCT01458327|9854873|FG000|COMPLETED|Overall Study||3
8802834|NCT01458327|9854873|FG000|NOT COMPLETED|Overall Study||0
8802835|NCT01458366|9854883|FG000|STARTED|Period 1: 70mg/m^2||5
8802836|NCT01458366|9854884|FG001|STARTED|Period 1: 70mg/m^2||0
8802837|NCT01458366|9854885|FG002|STARTED|Period 1: 70mg/m^2||0
8802838|NCT01458366|9854886|FG003|STARTED|Period 1: 70mg/m^2||0
8802839|NCT01458366|9854887|FG004|STARTED|Period 1: 70mg/m^2||0
8802840|NCT01458366|9854883|FG000|COMPLETED|Period 1: 70mg/m^2||3
8802841|NCT01458366|9854884|FG001|COMPLETED|Period 1: 70mg/m^2||0
8802842|NCT01458366|9854885|FG002|COMPLETED|Period 1: 70mg/m^2||0
8802843|NCT01458366|9854886|FG003|COMPLETED|Period 1: 70mg/m^2||0
8802844|NCT01458366|9854887|FG004|COMPLETED|Period 1: 70mg/m^2||0
8802845|NCT01458366|9854883|FG000|NOT COMPLETED|Period 1: 70mg/m^2||2
8802846|NCT01458366|9854884|FG001|NOT COMPLETED|Period 1: 70mg/m^2||0
8802847|NCT01458366|9854885|FG002|NOT COMPLETED|Period 1: 70mg/m^2||0
8802848|NCT01458366|9854886|FG003|NOT COMPLETED|Period 1: 70mg/m^2||0
8802849|NCT01458366|9854887|FG004|NOT COMPLETED|Period 1: 70mg/m^2||0
8802850|NCT01458366|9854883|FG000|STARTED|Period 2: 50mg/m^2||0
8802851|NCT01458366|9854884|FG001|STARTED|Period 2: 50mg/m^2||0
8802852|NCT01458366|9854885|FG002|STARTED|Period 2: 50mg/m^2||0
8802853|NCT01458366|9854886|FG003|STARTED|Period 2: 50mg/m^2||0
8802854|NCT01458366|9854887|FG004|STARTED|Period 2: 50mg/m^2||0
8802855|NCT01458366|9854883|FG000|COMPLETED|Period 2: 50mg/m^2||0
8802856|NCT01458366|9854884|FG001|COMPLETED|Period 2: 50mg/m^2||0
8802857|NCT01458366|9854885|FG002|COMPLETED|Period 2: 50mg/m^2||0
8802858|NCT01458366|9854886|FG003|COMPLETED|Period 2: 50mg/m^2||0
8802859|NCT01458366|9854887|FG004|COMPLETED|Period 2: 50mg/m^2||0
8802860|NCT01458366|9854883|FG000|NOT COMPLETED|Period 2: 50mg/m^2||0
8802861|NCT01458366|9854884|FG001|NOT COMPLETED|Period 2: 50mg/m^2||0
8802862|NCT01458366|9854885|FG002|NOT COMPLETED|Period 2: 50mg/m^2||0
8802863|NCT01458366|9854886|FG003|NOT COMPLETED|Period 2: 50mg/m^2||0
8802864|NCT01458366|9854887|FG004|NOT COMPLETED|Period 2: 50mg/m^2||0
8802865|NCT01458366|9854883|FG000|STARTED|Period 3: 90mg/m^2||0
8802866|NCT01458366|9854884|FG001|STARTED|Period 3: 90mg/m^2||0
8802867|NCT01458366|9854885|FG002|STARTED|Period 3: 90mg/m^2||3
8802868|NCT01458366|9854886|FG003|STARTED|Period 3: 90mg/m^2||0
8802869|NCT01458366|9854887|FG004|STARTED|Period 3: 90mg/m^2||0
8802870|NCT01458366|9854883|FG000|COMPLETED|Period 3: 90mg/m^2||0
8802871|NCT01458366|9854884|FG001|COMPLETED|Period 3: 90mg/m^2||0
8802872|NCT01458366|9854885|FG002|COMPLETED|Period 3: 90mg/m^2||3
8802873|NCT01458366|9854886|FG003|COMPLETED|Period 3: 90mg/m^2||0
8802874|NCT01458366|9854887|FG004|COMPLETED|Period 3: 90mg/m^2||0
8802875|NCT01458366|9854883|FG000|NOT COMPLETED|Period 3: 90mg/m^2||0
8802876|NCT01458366|9854884|FG001|NOT COMPLETED|Period 3: 90mg/m^2||0
8802877|NCT01458366|9854885|FG002|NOT COMPLETED|Period 3: 90mg/m^2||0
8802878|NCT01458366|9854886|FG003|NOT COMPLETED|Period 3: 90mg/m^2||0
8802879|NCT01458366|9854887|FG004|NOT COMPLETED|Period 3: 90mg/m^2||0
8802880|NCT01458366|9854883|FG000|STARTED|Period 4: 120mg/m^2||0
8802881|NCT01458366|9854884|FG001|STARTED|Period 4: 120mg/m^2||0
8802882|NCT01458366|9854885|FG002|STARTED|Period 4: 120mg/m^2||0
8802883|NCT01458366|9854886|FG003|STARTED|Period 4: 120mg/m^2||3
8802884|NCT01458366|9854887|FG004|STARTED|Period 4: 120mg/m^2||0
8802885|NCT01458366|9854883|FG000|COMPLETED|Period 4: 120mg/m^2||0
8802886|NCT01458366|9854884|FG001|COMPLETED|Period 4: 120mg/m^2||0
8802887|NCT01458366|9854885|FG002|COMPLETED|Period 4: 120mg/m^2||0
8802888|NCT01458366|9854886|FG003|COMPLETED|Period 4: 120mg/m^2||3
8802889|NCT01458366|9854887|FG004|COMPLETED|Period 4: 120mg/m^2||0
8802890|NCT01458366|9854883|FG000|NOT COMPLETED|Period 4: 120mg/m^2||0
8802891|NCT01458366|9854884|FG001|NOT COMPLETED|Period 4: 120mg/m^2||0
8802892|NCT01458366|9854885|FG002|NOT COMPLETED|Period 4: 120mg/m^2||0
8802893|NCT01458366|9854886|FG003|NOT COMPLETED|Period 4: 120mg/m^2||0
8802894|NCT01458366|9854887|FG004|NOT COMPLETED|Period 4: 120mg/m^2||0
8802895|NCT01458366|9854883|FG000|STARTED|Period 5: Maximum Tolerated Dose (MTD)||0
8802896|NCT01458366|9854884|FG001|STARTED|Period 5: Maximum Tolerated Dose (MTD)||0
8802897|NCT01458366|9854885|FG002|STARTED|Period 5: Maximum Tolerated Dose (MTD)||0
8802898|NCT01458366|9854886|FG003|STARTED|Period 5: Maximum Tolerated Dose (MTD)||0
8802899|NCT01458366|9854887|FG004|STARTED|Period 5: Maximum Tolerated Dose (MTD)||27
8802900|NCT01458366|9854883|FG000|COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
8802901|NCT01458366|9854884|FG001|COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
8802902|NCT01458366|9854885|FG002|COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
8802903|NCT01458366|9854886|FG003|COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
8802904|NCT01458366|9854887|FG004|COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||26
8802905|NCT01458366|9854883|FG000|NOT COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
8802906|NCT01458366|9854884|FG001|NOT COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
8802907|NCT01458366|9854885|FG002|NOT COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
8802908|NCT01458366|9854886|FG003|NOT COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
8802909|NCT01458366|9854887|FG004|NOT COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||1
8802910|NCT01458392|9854898|FG000|STARTED|Overall Study||2
8802911|NCT01458392|9854899|FG001|STARTED|Overall Study||13
8802912|NCT01458392|9854900|FG002|STARTED|Overall Study||31
8802913|NCT01458392|9854898|FG000|COMPLETED|Overall Study||0
8802914|NCT01458392|9854899|FG001|COMPLETED|Overall Study||0
8802915|NCT01458392|9854900|FG002|COMPLETED|Overall Study||0
8802916|NCT01458392|9854898|FG000|NOT COMPLETED|Overall Study||2
8802917|NCT01458392|9854899|FG001|NOT COMPLETED|Overall Study||13
8802918|NCT01458392|9854900|FG002|NOT COMPLETED|Overall Study||31
8802919|NCT01458418|9854916|FG000|STARTED|Overall Study||0
8802920|NCT01458418|9854917|FG001|STARTED|Overall Study||0
8802921|NCT01458418|9854918|FG002|STARTED|Overall Study||0
8802922|NCT01458418|9854919|FG003|STARTED|Overall Study||4
8802923|NCT01458418|9854916|FG000|COMPLETED|Overall Study||0
8802924|NCT01458418|9854917|FG001|COMPLETED|Overall Study||0
8802925|NCT01458418|9854918|FG002|COMPLETED|Overall Study||0
8802926|NCT01458418|9854919|FG003|COMPLETED|Overall Study||4
8802927|NCT01458418|9854916|FG000|NOT COMPLETED|Overall Study||0
8802928|NCT01458418|9854917|FG001|NOT COMPLETED|Overall Study||0
8802929|NCT01458418|9854918|FG002|NOT COMPLETED|Overall Study||0
8802930|NCT01458418|9854919|FG003|NOT COMPLETED|Overall Study||0
8802931|NCT01458522|9854931|FG000|STARTED|Overall Study||37
8802932|NCT01458522|9854932|FG001|STARTED|Overall Study||37
8802933|NCT01458522|9854931|FG000|Received First Drug|Overall Study||35
8802934|NCT01458522|9854932|FG001|Received First Drug|Overall Study||35
8802935|NCT01458522|9854931|FG000|Crossover to Second Drug|Overall Study||15
8802936|NCT01458522|9854932|FG001|Crossover to Second Drug|Overall Study||10
8802937|NCT01458522|9854931|FG000|COMPLETED|Overall Study||34
8802938|NCT01458522|9854932|FG001|COMPLETED|Overall Study||26
8802939|NCT01458522|9854931|FG000|NOT COMPLETED|Overall Study||3
8802940|NCT01458522|9854932|FG001|NOT COMPLETED|Overall Study||11
8802941|NCT01458535|9854950|FG000|STARTED|Overall Study||10
8802942|NCT01458535|9854951|FG001|STARTED|Overall Study||10
8802943|NCT01458535|9854952|FG002|STARTED|Overall Study||10
8802944|NCT01458535|9854953|FG003|STARTED|Overall Study||10
8802945|NCT01458535|9854954|FG004|STARTED|Overall Study||10
8802946|NCT01458535|9854955|FG005|STARTED|Overall Study||11
8802947|NCT01458535|9854950|FG000|COMPLETED|Overall Study||10
8802948|NCT01458535|9854951|FG001|COMPLETED|Overall Study||8
8802949|NCT01458535|9854952|FG002|COMPLETED|Overall Study||8
8802950|NCT01458535|9854953|FG003|COMPLETED|Overall Study||6
8802951|NCT01458535|9854954|FG004|COMPLETED|Overall Study||6
8802952|NCT01458535|9854955|FG005|COMPLETED|Overall Study||7
8802953|NCT01458535|9854950|FG000|NOT COMPLETED|Overall Study||0
8802954|NCT01458535|9854951|FG001|NOT COMPLETED|Overall Study||2
8802955|NCT01458535|9854952|FG002|NOT COMPLETED|Overall Study||2
8802956|NCT01458535|9854953|FG003|NOT COMPLETED|Overall Study||4
8802957|NCT01458535|9854954|FG004|NOT COMPLETED|Overall Study||4
8802958|NCT01458535|9854955|FG005|NOT COMPLETED|Overall Study||4
8802959|NCT01458561|9854971|FG000|STARTED|Overall Study||0
8802960|NCT01458561|9854972|FG001|STARTED|Overall Study||1
8802961|NCT01458561|9854971|FG000|COMPLETED|Overall Study||0
8802962|NCT01458561|9854972|FG001|COMPLETED|Overall Study||1
8802963|NCT01458561|9854971|FG000|NOT COMPLETED|Overall Study||0
8802964|NCT01458561|9854972|FG001|NOT COMPLETED|Overall Study||0
8802965|NCT01458574|9855011|FG000|STARTED|Overall Study||198
8802966|NCT01458574|9855012|FG001|STARTED|Overall Study||197
8802967|NCT01458574|9855013|FG002|STARTED|Overall Study||198
8802968|NCT01458574|9855011|FG000|Treated|Overall Study||198
8802969|NCT01458574|9855012|FG001|Treated|Overall Study||196
8802970|NCT01458574|9855013|FG002|Treated|Overall Study||198
8802971|NCT01458574|9855011|FG000|COMPLETED|Overall Study||111
8802972|NCT01458574|9855012|FG001|COMPLETED|Overall Study||126
8802973|NCT01458574|9855013|FG002|COMPLETED|Overall Study||53
8802974|NCT01458574|9855011|FG000|NOT COMPLETED|Overall Study||87
8802975|NCT01458574|9855012|FG001|NOT COMPLETED|Overall Study||71
8802976|NCT01458574|9855013|FG002|NOT COMPLETED|Overall Study||145
8802977|NCT01458587|9855023|FG000|STARTED|Overall Study||35
8802978|NCT01458587|9855024|FG001|STARTED|Overall Study||35
8802979|NCT01458587|9855023|FG000|COMPLETED|Overall Study||34
8802980|NCT01458587|9855024|FG001|COMPLETED|Overall Study||35
8802981|NCT01458587|9855023|FG000|NOT COMPLETED|Overall Study||1
8802982|NCT01458587|9855024|FG001|NOT COMPLETED|Overall Study||0
8802983|NCT01458639|9855032|FG000|STARTED|Overall Study||18
8802984|NCT01458639|9855032|FG000|COMPLETED|Overall Study||12
8802985|NCT01458639|9855032|FG000|NOT COMPLETED|Overall Study||6
8802986|NCT01458951|9855039|FG000|STARTED|Overall Study||429
8802987|NCT01458951|9855040|FG001|STARTED|Overall Study||6
8802988|NCT01458951|9855041|FG002|STARTED|Overall Study||112
8802989|NCT01458951|9855039|FG000|COMPLETED|Overall Study||397
8802990|NCT01458951|9855040|FG001|COMPLETED|Overall Study||5
8802991|NCT01458951|9855041|FG002|COMPLETED|Overall Study||97
8802992|NCT01458951|9855039|FG000|NOT COMPLETED|Overall Study||32
8802993|NCT01458951|9855040|FG001|NOT COMPLETED|Overall Study||1
8802994|NCT01458951|9855041|FG002|NOT COMPLETED|Overall Study||15
8802995|NCT01458990|9855050|FG000|STARTED|Overall Study||45
8802996|NCT01458990|9855051|FG001|STARTED|Overall Study||15
8802997|NCT01458990|9855050|FG000|COMPLETED|Overall Study||45
8802998|NCT01458990|9855051|FG001|COMPLETED|Overall Study||15
8802999|NCT01458990|9855050|FG000|NOT COMPLETED|Overall Study||0
8803000|NCT01458990|9855051|FG001|NOT COMPLETED|Overall Study||0
8803001|NCT01459016|9855059|FG000|STARTED|Overall Study||56
8803002|NCT01459016|9855059|FG000|COMPLETED|Overall Study||41
8803003|NCT01459016|9855059|FG000|NOT COMPLETED|Overall Study||15
8803004|NCT01459068|9855065|FG000|STARTED|Overall Study||165
8803005|NCT01459068|9855066|FG001|STARTED|Overall Study||182
8803006|NCT01459068|9855065|FG000|COMPLETED|Overall Study||126
8803007|NCT01459068|9855066|FG001|COMPLETED|Overall Study||148
8803008|NCT01459068|9855065|FG000|NOT COMPLETED|Overall Study||39
8803009|NCT01459068|9855066|FG001|NOT COMPLETED|Overall Study||34
8803010|NCT01459588|9855076|FG000|STARTED|Overall Study||105
8803011|NCT01459588|9855077|FG001|STARTED|Overall Study||51
8803012|NCT01459588|9855078|FG002|STARTED|Overall Study||103
8803013|NCT01459588|9855079|FG003|STARTED|Overall Study||56
8803014|NCT01459588|9855076|FG000|COMPLETED|Overall Study||104
8803015|NCT01459588|9855077|FG001|COMPLETED|Overall Study||49
8803016|NCT01459588|9855078|FG002|COMPLETED|Overall Study||102
8803017|NCT01459588|9855079|FG003|COMPLETED|Overall Study||55
8803018|NCT01459588|9855076|FG000|NOT COMPLETED|Overall Study||1
8803019|NCT01459588|9855077|FG001|NOT COMPLETED|Overall Study||2
8803020|NCT01459588|9855078|FG002|NOT COMPLETED|Overall Study||1
8803021|NCT01459588|9855079|FG003|NOT COMPLETED|Overall Study||1
8803022|NCT01459614|9855091|FG000|STARTED|Overall Study||29
8803023|NCT01459614|9855092|FG001|STARTED|Overall Study||10
8803024|NCT01459614|9855091|FG000|COMPLETED|Overall Study||28
8803025|NCT01459614|9855092|FG001|COMPLETED|Overall Study||10
8803026|NCT01459614|9855091|FG000|NOT COMPLETED|Overall Study||1
8803027|NCT01459614|9855092|FG001|NOT COMPLETED|Overall Study||0
8803028|NCT01459653|9855098|FG000|STARTED|Overall Study||1496
8803029|NCT01459653|9855098|FG000|COMPLETED|Overall Study||828
8803030|NCT01459653|9855098|FG000|NOT COMPLETED|Overall Study||668
8803031|NCT01459705|9855172|FG000|STARTED|Overall Study||54
8803032|NCT01459705|9855173|FG001|STARTED|Overall Study||54
8803033|NCT01459705|9855174|FG002|STARTED|Overall Study||54
8803034|NCT01459705|9855172|FG000|COMPLETED|Overall Study||32
8803035|NCT01459705|9855173|FG001|COMPLETED|Overall Study||30
8803036|NCT01459705|9855174|FG002|COMPLETED|Overall Study||47
8803037|NCT01459705|9855172|FG000|NOT COMPLETED|Overall Study||22
8803038|NCT01459705|9855173|FG001|NOT COMPLETED|Overall Study||24
8803039|NCT01459705|9855174|FG002|NOT COMPLETED|Overall Study||7
8803040|NCT01459718|9855182|FG000|STARTED|Overall Study||13
8803041|NCT01459718|9855182|FG000|Safety Analysis Set|Overall Study||13
8803042|NCT01459718|9855182|FG000|COMPLETED|Overall Study||10
8803043|NCT01459718|9855182|FG000|NOT COMPLETED|Overall Study||3
8803044|NCT01459783|9855188|FG000|STARTED|Baseline to 6 Months||71
8803045|NCT01459783|9855189|FG001|STARTED|Baseline to 6 Months||73
8803046|NCT01459783|9855188|FG000|COMPLETED|Baseline to 6 Months||39
8803047|NCT01459783|9855189|FG001|COMPLETED|Baseline to 6 Months||53
8803048|NCT01459783|9855188|FG000|NOT COMPLETED|Baseline to 6 Months||32
8803049|NCT01459783|9855189|FG001|NOT COMPLETED|Baseline to 6 Months||20
8803050|NCT01459783|9855188|FG000|STARTED|6 Months to 12 Months||39
8803051|NCT01459783|9855189|FG001|STARTED|6 Months to 12 Months||53
8803052|NCT01459783|9855188|FG000|COMPLETED|6 Months to 12 Months||20
8803053|NCT01459783|9855189|FG001|COMPLETED|6 Months to 12 Months||23
8803054|NCT01459783|9855188|FG000|NOT COMPLETED|6 Months to 12 Months||19
8803055|NCT01459783|9855189|FG001|NOT COMPLETED|6 Months to 12 Months||30
8803056|NCT01459796|9855197|FG000|STARTED|Overall Study||94
8803057|NCT01459796|9855198|FG001|STARTED|Overall Study||126
8803058|NCT01459796|9855197|FG000|COMPLETED|Overall Study||0
8803059|NCT01459796|9855198|FG001|COMPLETED|Overall Study||0
8803060|NCT01459796|9855197|FG000|NOT COMPLETED|Overall Study||94
8803061|NCT01459796|9855198|FG001|NOT COMPLETED|Overall Study||126
8803062|NCT01459913|9855208|FG000|STARTED|Overall Study||106
8803063|NCT01459913|9855209|FG001|STARTED|Overall Study||52
8803064|NCT01459913|9855210|FG002|STARTED|Overall Study||19
8803065|NCT01459913|9855211|FG003|STARTED|Overall Study||62
8803066|NCT01459913|9855208|FG000|COMPLETED|Overall Study||65
8803067|NCT01459913|9855209|FG001|COMPLETED|Overall Study||32
8803068|NCT01459913|9855210|FG002|COMPLETED|Overall Study||6
8803069|NCT01459913|9855211|FG003|COMPLETED|Overall Study||29
8803070|NCT01459913|9855208|FG000|NOT COMPLETED|Overall Study||41
8803071|NCT01459913|9855209|FG001|NOT COMPLETED|Overall Study||20
8803072|NCT01459913|9855210|FG002|NOT COMPLETED|Overall Study||13
8803073|NCT01459913|9855211|FG003|NOT COMPLETED|Overall Study||33
8803074|NCT01460225|9855223|FG000|STARTED|Overall Study|January 2009.|19
8803075|NCT01460225|9855223|FG000|COMPLETED|Overall Study|November 2010|19
8803076|NCT01460225|9855223|FG000|NOT COMPLETED|Overall Study||0
8803077|NCT01460290|9855228|FG000|STARTED|Overall Study||15
8803078|NCT01460290|9855228|FG000|COMPLETED|Overall Study||11
8803079|NCT01460290|9855228|FG000|NOT COMPLETED|Overall Study||4
8803080|NCT01460303|9855235|FG000|STARTED|Overall Study||25
8803081|NCT01460303|9855236|FG001|STARTED|Overall Study||24
8803082|NCT01460303|9855235|FG000|COMPLETED|Overall Study||25
8803083|NCT01460303|9855236|FG001|COMPLETED|Overall Study||24
8803084|NCT01460303|9855235|FG000|NOT COMPLETED|Overall Study||0
8803085|NCT01460303|9855236|FG001|NOT COMPLETED|Overall Study||0
8803086|NCT01460342|9855244|FG000|STARTED|Overall Study||304
8803087|NCT01460342|9855245|FG001|STARTED|Overall Study||306
8803088|NCT01460342|9855244|FG000|Received at Least 1 Dose of Study Drug|Overall Study||304
8803089|NCT01460342|9855245|FG001|Received at Least 1 Dose of Study Drug|Overall Study||306
8803090|NCT01460342|9855244|FG000|COMPLETED|Overall Study||293
8803091|NCT01460342|9855245|FG001|COMPLETED|Overall Study||292
8803092|NCT01460342|9855244|FG000|NOT COMPLETED|Overall Study||11
8803093|NCT01460342|9855245|FG001|NOT COMPLETED|Overall Study||14
8803094|NCT01460368|9855253|FG000|STARTED|Part A||7
8803095|NCT01460368|9855254|FG001|STARTED|Part A||0
8803096|NCT01460368|9855255|FG002|STARTED|Part A||0
8803097|NCT01460368|9855256|FG003|STARTED|Part A||0
8803098|NCT01460368|9855257|FG004|STARTED|Part A||0
8803099|NCT01460368|9855258|FG005|STARTED|Part A||0
8803100|NCT01460368|9855259|FG006|STARTED|Part A||0
8803101|NCT01460368|9855253|FG000|Received at Least One Dose of Study Drug|Part A||7
8803102|NCT01460368|9855254|FG001|Received at Least One Dose of Study Drug|Part A||0
8803103|NCT01460368|9855255|FG002|Received at Least One Dose of Study Drug|Part A||0
8803104|NCT01460368|9855256|FG003|Received at Least One Dose of Study Drug|Part A||0
8803105|NCT01460368|9855257|FG004|Received at Least One Dose of Study Drug|Part A||0
8803106|NCT01460368|9855258|FG005|Received at Least One Dose of Study Drug|Part A||0
8803107|NCT01460368|9855259|FG006|Received at Least One Dose of Study Drug|Part A||0
8803108|NCT01460368|9855253|FG000|COMPLETED|Part A||7
8803109|NCT01460368|9855254|FG001|COMPLETED|Part A||0
8803110|NCT01460368|9855255|FG002|COMPLETED|Part A||0
8803111|NCT01460368|9855256|FG003|COMPLETED|Part A||0
8803112|NCT01460368|9855257|FG004|COMPLETED|Part A||0
8803113|NCT01460368|9855258|FG005|COMPLETED|Part A||0
8803114|NCT01460368|9855259|FG006|COMPLETED|Part A||0
8803115|NCT01460368|9855253|FG000|NOT COMPLETED|Part A||0
8803116|NCT01460368|9855254|FG001|NOT COMPLETED|Part A||0
8803117|NCT01460368|9855255|FG002|NOT COMPLETED|Part A||0
8803118|NCT01460368|9855256|FG003|NOT COMPLETED|Part A||0
8803119|NCT01460368|9855257|FG004|NOT COMPLETED|Part A||0
8803120|NCT01460368|9855258|FG005|NOT COMPLETED|Part A||0
8803121|NCT01460368|9855259|FG006|NOT COMPLETED|Part A||0
8803122|NCT01460368|9855253|FG000|STARTED|Part B: First Intervention (Period 1)||0
8803123|NCT01460368|9855254|FG001|STARTED|Part B: First Intervention (Period 1)||10
8803124|NCT01460368|9855255|FG002|STARTED|Part B: First Intervention (Period 1)||10
8803125|NCT01460368|9855256|FG003|STARTED|Part B: First Intervention (Period 1)||10
8803126|NCT01460368|9855257|FG004|STARTED|Part B: First Intervention (Period 1)||10
8803127|NCT01460368|9855258|FG005|STARTED|Part B: First Intervention (Period 1)||10
8803128|NCT01460368|9855259|FG006|STARTED|Part B: First Intervention (Period 1)||10
8803129|NCT01460368|9855253|FG000|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||0
8803130|NCT01460368|9855254|FG001|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
8803131|NCT01460368|9855255|FG002|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
8803132|NCT01460368|9855256|FG003|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
8803133|NCT01460368|9855257|FG004|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
8803134|NCT01460368|9855258|FG005|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
8803135|NCT01460368|9855259|FG006|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
8803136|NCT01460368|9855253|FG000|COMPLETED|Part B: First Intervention (Period 1)||0
8803137|NCT01460368|9855254|FG001|COMPLETED|Part B: First Intervention (Period 1)||10
8803138|NCT01460368|9855255|FG002|COMPLETED|Part B: First Intervention (Period 1)||10
8803139|NCT01460368|9855256|FG003|COMPLETED|Part B: First Intervention (Period 1)||10
8803140|NCT01460368|9855257|FG004|COMPLETED|Part B: First Intervention (Period 1)||9
8803141|NCT01460368|9855258|FG005|COMPLETED|Part B: First Intervention (Period 1)||10
8803142|NCT01460368|9855259|FG006|COMPLETED|Part B: First Intervention (Period 1)||10
8803143|NCT01460368|9855253|FG000|NOT COMPLETED|Part B: First Intervention (Period 1)||0
8803144|NCT01460368|9855254|FG001|NOT COMPLETED|Part B: First Intervention (Period 1)||0
8803145|NCT01460368|9855255|FG002|NOT COMPLETED|Part B: First Intervention (Period 1)||0
8803146|NCT01460368|9855256|FG003|NOT COMPLETED|Part B: First Intervention (Period 1)||0
8803147|NCT01460368|9855257|FG004|NOT COMPLETED|Part B: First Intervention (Period 1)||1
8803148|NCT01460368|9855258|FG005|NOT COMPLETED|Part B: First Intervention (Period 1)||0
8803149|NCT01460368|9855259|FG006|NOT COMPLETED|Part B: First Intervention (Period 1)||0
8803150|NCT01460368|9855253|FG000|STARTED|Part B: Washout (up to 15 Days)||0
8803151|NCT01460368|9855254|FG001|STARTED|Part B: Washout (up to 15 Days)||10
8803152|NCT01460368|9855255|FG002|STARTED|Part B: Washout (up to 15 Days)||10
8803153|NCT01460368|9855256|FG003|STARTED|Part B: Washout (up to 15 Days)||10
8803154|NCT01460368|9855257|FG004|STARTED|Part B: Washout (up to 15 Days)||9
8803155|NCT01460368|9855258|FG005|STARTED|Part B: Washout (up to 15 Days)||10
8803156|NCT01460368|9855259|FG006|STARTED|Part B: Washout (up to 15 Days)||10
8803157|NCT01460368|9855253|FG000|COMPLETED|Part B: Washout (up to 15 Days)||0
8803158|NCT01460368|9855254|FG001|COMPLETED|Part B: Washout (up to 15 Days)||10
8803159|NCT01460368|9855255|FG002|COMPLETED|Part B: Washout (up to 15 Days)||10
8803160|NCT01460368|9855256|FG003|COMPLETED|Part B: Washout (up to 15 Days)||10
8803161|NCT01460368|9855257|FG004|COMPLETED|Part B: Washout (up to 15 Days)||9
8803162|NCT01460368|9855258|FG005|COMPLETED|Part B: Washout (up to 15 Days)||10
8803163|NCT01460368|9855259|FG006|COMPLETED|Part B: Washout (up to 15 Days)||10
8803164|NCT01460368|9855253|FG000|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
8803165|NCT01460368|9855254|FG001|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
8803166|NCT01460368|9855255|FG002|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
8803167|NCT01460368|9855256|FG003|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
8803168|NCT01460368|9855257|FG004|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
8803169|NCT01460368|9855258|FG005|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
8803170|NCT01460368|9855259|FG006|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
8803171|NCT01460368|9855253|FG000|STARTED|Part B: Second Intervention (Period 2)||0
8803172|NCT01460368|9855254|FG001|STARTED|Part B: Second Intervention (Period 2)||10
8803173|NCT01460368|9855255|FG002|STARTED|Part B: Second Intervention (Period 2)||10
8803174|NCT01460368|9855256|FG003|STARTED|Part B: Second Intervention (Period 2)||10
8803175|NCT01460368|9855257|FG004|STARTED|Part B: Second Intervention (Period 2)||9
8803176|NCT01460368|9855258|FG005|STARTED|Part B: Second Intervention (Period 2)||10
8803177|NCT01460368|9855259|FG006|STARTED|Part B: Second Intervention (Period 2)||10
8803178|NCT01460368|9855253|FG000|COMPLETED|Part B: Second Intervention (Period 2)||0
8803179|NCT01460368|9855254|FG001|COMPLETED|Part B: Second Intervention (Period 2)||8
8803180|NCT01460368|9855255|FG002|COMPLETED|Part B: Second Intervention (Period 2)||10
8803181|NCT01460368|9855256|FG003|COMPLETED|Part B: Second Intervention (Period 2)||10
8803182|NCT01460368|9855257|FG004|COMPLETED|Part B: Second Intervention (Period 2)||9
8803183|NCT01460368|9855258|FG005|COMPLETED|Part B: Second Intervention (Period 2)||10
8803184|NCT01460368|9855259|FG006|COMPLETED|Part B: Second Intervention (Period 2)||9
8803185|NCT01460368|9855253|FG000|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
8803186|NCT01460368|9855254|FG001|NOT COMPLETED|Part B: Second Intervention (Period 2)||2
8803187|NCT01460368|9855255|FG002|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
8803188|NCT01460368|9855256|FG003|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
8803189|NCT01460368|9855257|FG004|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
8803190|NCT01460368|9855258|FG005|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
8803191|NCT01460368|9855259|FG006|NOT COMPLETED|Part B: Second Intervention (Period 2)||1
8803192|NCT01460368|9855253|FG000|STARTED|Part B: Washout (up to 15 Days)||0
8803193|NCT01460368|9855254|FG001|STARTED|Part B: Washout (up to 15 Days)||8
8803194|NCT01460368|9855255|FG002|STARTED|Part B: Washout (up to 15 Days)||10
8803195|NCT01460368|9855256|FG003|STARTED|Part B: Washout (up to 15 Days)||10
8803196|NCT01460368|9855257|FG004|STARTED|Part B: Washout (up to 15 Days)||9
8803197|NCT01460368|9855258|FG005|STARTED|Part B: Washout (up to 15 Days)||10
8803198|NCT01460368|9855259|FG006|STARTED|Part B: Washout (up to 15 Days)||9
8803199|NCT01460368|9855253|FG000|COMPLETED|Part B: Washout (up to 15 Days)||0
8803200|NCT01460368|9855254|FG001|COMPLETED|Part B: Washout (up to 15 Days)||8
8803201|NCT01460368|9855255|FG002|COMPLETED|Part B: Washout (up to 15 Days)||9
8803202|NCT01460368|9855256|FG003|COMPLETED|Part B: Washout (up to 15 Days)||10
8803203|NCT01460368|9855257|FG004|COMPLETED|Part B: Washout (up to 15 Days)||9
8803204|NCT01460368|9855258|FG005|COMPLETED|Part B: Washout (up to 15 Days)||10
8803205|NCT01460368|9855259|FG006|COMPLETED|Part B: Washout (up to 15 Days)||9
8803206|NCT01460368|9855253|FG000|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
8803207|NCT01460368|9855254|FG001|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
8803208|NCT01460368|9855255|FG002|NOT COMPLETED|Part B: Washout (up to 15 Days)||1
8803209|NCT01460368|9855256|FG003|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
8803210|NCT01460368|9855257|FG004|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
8803211|NCT01460368|9855258|FG005|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
8803212|NCT01460368|9855259|FG006|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
8803213|NCT01460368|9855253|FG000|STARTED|Part B: Third Interventions (Period 3)||0
8803214|NCT01460368|9855254|FG001|STARTED|Part B: Third Interventions (Period 3)||8
8803215|NCT01460368|9855255|FG002|STARTED|Part B: Third Interventions (Period 3)||9
8803216|NCT01460368|9855256|FG003|STARTED|Part B: Third Interventions (Period 3)||10
8803217|NCT01460368|9855257|FG004|STARTED|Part B: Third Interventions (Period 3)||9
8803218|NCT01460368|9855258|FG005|STARTED|Part B: Third Interventions (Period 3)||10
8803219|NCT01460368|9855259|FG006|STARTED|Part B: Third Interventions (Period 3)||9
8803220|NCT01460368|9855253|FG000|COMPLETED|Part B: Third Interventions (Period 3)||0
8803221|NCT01460368|9855254|FG001|COMPLETED|Part B: Third Interventions (Period 3)||8
8803222|NCT01460368|9855255|FG002|COMPLETED|Part B: Third Interventions (Period 3)||8
8803223|NCT01460368|9855256|FG003|COMPLETED|Part B: Third Interventions (Period 3)||9
8803224|NCT01460368|9855257|FG004|COMPLETED|Part B: Third Interventions (Period 3)||9
8803225|NCT01460368|9855258|FG005|COMPLETED|Part B: Third Interventions (Period 3)||9
8803226|NCT01460368|9855259|FG006|COMPLETED|Part B: Third Interventions (Period 3)||9
8803227|NCT01460368|9855253|FG000|NOT COMPLETED|Part B: Third Interventions (Period 3)||0
8803228|NCT01460368|9855254|FG001|NOT COMPLETED|Part B: Third Interventions (Period 3)||0
8803229|NCT01460368|9855255|FG002|NOT COMPLETED|Part B: Third Interventions (Period 3)||1
8803230|NCT01460368|9855256|FG003|NOT COMPLETED|Part B: Third Interventions (Period 3)||1
8803231|NCT01460368|9855257|FG004|NOT COMPLETED|Part B: Third Interventions (Period 3)||0
8803232|NCT01460368|9855258|FG005|NOT COMPLETED|Part B: Third Interventions (Period 3)||1
8803233|NCT01460368|9855259|FG006|NOT COMPLETED|Part B: Third Interventions (Period 3)||0
8803234|NCT01460381|9855270|FG000|STARTED|Period 1 (Days 1-7)||7
8803235|NCT01460381|9855271|FG001|STARTED|Period 1 (Days 1-7)||11
8803236|NCT01460381|9855270|FG000|Received at Least 1 Dose of Study Drug|Period 1 (Days 1-7)||7
8803237|NCT01460381|9855271|FG001|Received at Least 1 Dose of Study Drug|Period 1 (Days 1-7)||11
8803238|NCT01460381|9855270|FG000|COMPLETED|Period 1 (Days 1-7)||7
8803239|NCT01460381|9855271|FG001|COMPLETED|Period 1 (Days 1-7)||11
8803240|NCT01460381|9855270|FG000|NOT COMPLETED|Period 1 (Days 1-7)||0
8803241|NCT01460381|9855271|FG001|NOT COMPLETED|Period 1 (Days 1-7)||0
8803242|NCT01460381|9855270|FG000|STARTED|Period 2 (Days 8-15)||7
8803243|NCT01460381|9855271|FG001|STARTED|Period 2 (Days 8-15)|CYP2C19 extensive metabolizers did not participate in Period 2.|0
8803244|NCT01460381|9855270|FG000|COMPLETED|Period 2 (Days 8-15)|One participant was lost to follow-up after completing Period 2 and did not complete the study.|6
8803245|NCT01460381|9855271|FG001|COMPLETED|Period 2 (Days 8-15)|CYP2C19 extensive metabolizers did not participate in Period 2|0
8803246|NCT01460381|9855270|FG000|NOT COMPLETED|Period 2 (Days 8-15)||1
8803247|NCT01460381|9855271|FG001|NOT COMPLETED|Period 2 (Days 8-15)||0
8803248|NCT01460407|9855279|FG000|STARTED|Period 1: Day 1 to Day 5||14
8803249|NCT01460407|9855280|FG001|STARTED|Period 1: Day 1 to Day 5||0
8803250|NCT01460407|9855279|FG000|COMPLETED|Period 1: Day 1 to Day 5||14
8803251|NCT01460407|9855280|FG001|COMPLETED|Period 1: Day 1 to Day 5||0
8803252|NCT01460407|9855279|FG000|NOT COMPLETED|Period 1: Day 1 to Day 5||0
8803253|NCT01460407|9855280|FG001|NOT COMPLETED|Period 1: Day 1 to Day 5||0
8803254|NCT01460407|9855279|FG000|STARTED|Period 2: Day 6 to Day 14||0
8803255|NCT01460407|9855280|FG001|STARTED|Period 2: Day 6 to Day 14||14
8803256|NCT01460407|9855279|FG000|COMPLETED|Period 2: Day 6 to Day 14||0
8803257|NCT01460407|9855280|FG001|COMPLETED|Period 2: Day 6 to Day 14||13
8803258|NCT01460407|9855279|FG000|NOT COMPLETED|Period 2: Day 6 to Day 14||0
8803259|NCT01460407|9855280|FG001|NOT COMPLETED|Period 2: Day 6 to Day 14||1
8803260|NCT01460446|9855289|FG000|STARTED|Overall Study||105
8803261|NCT01460446|9855290|FG001|STARTED|Overall Study||113
8803262|NCT01460446|9855289|FG000|COMPLETED|Overall Study||100
8803263|NCT01460446|9855290|FG001|COMPLETED|Overall Study||93
8803264|NCT01460446|9855289|FG000|NOT COMPLETED|Overall Study||5
8803265|NCT01460446|9855290|FG001|NOT COMPLETED|Overall Study||20
8803266|NCT01460628|9855297|FG000|STARTED|Overall Study||25
8803267|NCT01460628|9855297|FG000|COMPLETED|Overall Study||20
8803268|NCT01460628|9855297|FG000|NOT COMPLETED|Overall Study||5
8803269|NCT01460719|9855301|FG000|STARTED|Overall Study||80
8803270|NCT01460719|9855301|FG000|Vaccination 1 (Day 1)|Overall Study||80
8690975|NCT00852995|9736161|FG004|STARTED|Overall Study||50
8690976|NCT00852995|9736157|FG000|COMPLETED|Overall Study||38
8690977|NCT00852995|9736158|FG001|COMPLETED|Overall Study||42
8803271|NCT01460719|9855301|FG000|Vaccination 2 (~Day 30)|Overall Study||78
8803272|NCT01460719|9855301|FG000|Vaccination 3 (~Day 60)|Overall Study||78
8803273|NCT01460719|9855301|FG000|Vaccination 4 (~Day 90)|Overall Study||78
8803274|NCT01460719|9855301|FG000|COMPLETED|Overall Study||78
8803275|NCT01460719|9855301|FG000|NOT COMPLETED|Overall Study||2
8803276|NCT01460732|9855305|FG000|STARTED|Overall Study||81
8803277|NCT01460732|9855305|FG000|COMPLETED|Overall Study||81
8803278|NCT01460732|9855305|FG000|NOT COMPLETED|Overall Study||0
8803279|NCT01460875|9855311|FG000|STARTED|Overall Study||34
8803280|NCT01460875|9855311|FG000|COMPLETED|Overall Study||34
8803281|NCT01460875|9855311|FG000|NOT COMPLETED|Overall Study||0
8803282|NCT01460901|9855315|FG000|STARTED|Overall Study|First enrollment|5
8803283|NCT01460901|9855315|FG000|tV-CTL Infusion|Overall Study||3
8803284|NCT01460901|9855315|FG000|COMPLETED|Overall Study|Follow-up completed|3
8803285|NCT01460901|9855315|FG000|NOT COMPLETED|Overall Study||2
8803286|NCT01460927|9855322|FG000|STARTED|Overall Study||25
8803287|NCT01460927|9855322|FG000|COMPLETED|Overall Study||25
8803288|NCT01460927|9855322|FG000|NOT COMPLETED|Overall Study||0
8803289|NCT01460940|9855330|FG000|STARTED|Overall Study||24
8803290|NCT01460940|9855330|FG000|COMPLETED|Overall Study||24
8803291|NCT01460940|9855330|FG000|NOT COMPLETED|Overall Study||0
8803292|NCT01461005|9855334|FG000|STARTED|Overall Study||1
8803293|NCT01461005|9855334|FG000|COMPLETED|Overall Study||0
8803294|NCT01461005|9855334|FG000|NOT COMPLETED|Overall Study||1
8803295|NCT01461044|9855341|FG000|STARTED|Overall Study||150
8803296|NCT01461044|9855342|FG001|STARTED|Overall Study||77
8803297|NCT01461044|9855341|FG000|Participants Alive at Inclusion|Overall Study||127
8803298|NCT01461044|9855342|FG001|Participants Alive at Inclusion|Overall Study||58
8803299|NCT01461044|9855341|FG000|COMPLETED|Overall Study||80
8803300|NCT01461044|9855342|FG001|COMPLETED|Overall Study||37
8803301|NCT01461044|9855341|FG000|NOT COMPLETED|Overall Study||70
8803302|NCT01461044|9855342|FG001|NOT COMPLETED|Overall Study||40
8803303|NCT01461057|9855353|FG000|STARTED|Overall Study||15
8803304|NCT01461057|9855354|FG001|STARTED|Overall Study||15
8803305|NCT01461057|9855353|FG000|COMPLETED|Overall Study||0
8803306|NCT01461057|9855354|FG001|COMPLETED|Overall Study||0
8803307|NCT01461057|9855353|FG000|NOT COMPLETED|Overall Study||15
8803308|NCT01461057|9855354|FG001|NOT COMPLETED|Overall Study||15
8803309|NCT01461096|9855362|FG000|STARTED|Overall Study||288
8803310|NCT01461096|9855363|FG001|STARTED|Overall Study||287
8803311|NCT01461096|9855362|FG000|Did Not Start Treatment|Overall Study||0
8803312|NCT01461096|9855363|FG001|Did Not Start Treatment|Overall Study|Randomized but never started treatment and was discontinued from the study|1
8803313|NCT01461096|9855362|FG000|COMPLETED|Overall Study||226
8803314|NCT01461096|9855363|FG001|COMPLETED|Overall Study||226
8690978|NCT00852995|9736159|FG002|COMPLETED|Overall Study||39
8803315|NCT01461096|9855362|FG000|NOT COMPLETED|Overall Study||62
8803316|NCT01461096|9855363|FG001|NOT COMPLETED|Overall Study||61
8803317|NCT01461369|9855373|FG000|STARTED|Overall Study||104
8803318|NCT01461369|9855374|FG001|STARTED|Overall Study||98
8803319|NCT01461369|9855375|FG002|STARTED|Overall Study||103
8803320|NCT01461369|9855373|FG000|COMPLETED|Overall Study||91
8803321|NCT01461369|9855374|FG001|COMPLETED|Overall Study||81
8803322|NCT01461369|9855375|FG002|COMPLETED|Overall Study||86
8803323|NCT01461369|9855373|FG000|NOT COMPLETED|Overall Study||13
8803324|NCT01461369|9855374|FG001|NOT COMPLETED|Overall Study||17
8803325|NCT01461369|9855375|FG002|NOT COMPLETED|Overall Study||17
8803326|NCT01461473|9855385|FG000|STARTED|Overall Study||72
8803327|NCT01461473|9855386|FG001|STARTED|Overall Study||59
8803328|NCT01461473|9855385|FG000|COMPLETED|Overall Study||67
8803329|NCT01461473|9855386|FG001|COMPLETED|Overall Study||55
8803330|NCT01461473|9855385|FG000|NOT COMPLETED|Overall Study||5
8803331|NCT01461473|9855386|FG001|NOT COMPLETED|Overall Study||4
8803332|NCT01461499|9855394|FG000|STARTED|Overall Study||119
8803333|NCT01461499|9855395|FG001|STARTED|Overall Study||118
8803334|NCT01461499|9855394|FG000|COMPLETED|Overall Study||111
8803335|NCT01461499|9855395|FG001|COMPLETED|Overall Study||114
8803336|NCT01461499|9855394|FG000|NOT COMPLETED|Overall Study||8
8803337|NCT01461499|9855395|FG001|NOT COMPLETED|Overall Study||4
8803338|NCT01461538|9855406|FG000|STARTED|Overall Study||46
8803339|NCT01461538|9855407|FG001|STARTED|Overall Study||28
8803340|NCT01461538|9855408|FG002|STARTED|Overall Study||9
8803341|NCT01461538|9855406|FG000|COMPLETED|Overall Study||28
8803342|NCT01461538|9855407|FG001|COMPLETED|Overall Study||20
8803343|NCT01461538|9855408|FG002|COMPLETED|Overall Study||7
8803344|NCT01461538|9855406|FG000|NOT COMPLETED|Overall Study||18
8803345|NCT01461538|9855407|FG001|NOT COMPLETED|Overall Study||8
8803346|NCT01461538|9855408|FG002|NOT COMPLETED|Overall Study||2
8803347|NCT01461551|9855421|FG000|STARTED|Overall Study||35
8803348|NCT01461551|9855422|FG001|STARTED|Overall Study||35
8803349|NCT01461551|9855423|FG002|STARTED|Overall Study||35
8803350|NCT01461551|9855421|FG000|COMPLETED|Overall Study||33
8803351|NCT01461551|9855422|FG001|COMPLETED|Overall Study||34
8803352|NCT01461551|9855423|FG002|COMPLETED|Overall Study||33
8803353|NCT01461551|9855421|FG000|NOT COMPLETED|Overall Study||2
8803354|NCT01461551|9855422|FG001|NOT COMPLETED|Overall Study||1
8803355|NCT01461551|9855423|FG002|NOT COMPLETED|Overall Study||2
8803356|NCT01461655|9855431|FG000|STARTED|Overall Study||40
8803357|NCT01461655|9855431|FG000|COMPLETED|Overall Study||40
8803358|NCT01461655|9855431|FG000|NOT COMPLETED|Overall Study||0
8803359|NCT01461668|9855438|FG000|STARTED|Overall Study||27
8803360|NCT01461668|9855439|FG001|STARTED|Overall Study||26
8803361|NCT01461668|9855438|FG000|COMPLETED|Overall Study||25
8803362|NCT01461668|9855439|FG001|COMPLETED|Overall Study||25
8803363|NCT01461668|9855438|FG000|NOT COMPLETED|Overall Study||2
8803364|NCT01461668|9855439|FG001|NOT COMPLETED|Overall Study||1
8803365|NCT01461707|9855447|FG000|STARTED|Overall Study||15
8803366|NCT01461707|9855448|FG001|STARTED|Overall Study||15
8803367|NCT01461707|9855447|FG000|COMPLETED|Overall Study||14
8803368|NCT01461707|9855448|FG001|COMPLETED|Overall Study||15
8803369|NCT01461707|9855447|FG000|NOT COMPLETED|Overall Study||1
8803370|NCT01461707|9855448|FG001|NOT COMPLETED|Overall Study||0
8803371|NCT01461733|9855456|FG000|STARTED|Overall Study||12
8803372|NCT01461733|9855457|FG001|STARTED|Overall Study||12
8803373|NCT01461733|9855456|FG000|COMPLETED|Overall Study||8
8803374|NCT01461733|9855457|FG001|COMPLETED|Overall Study||8
8803375|NCT01461733|9855456|FG000|NOT COMPLETED|Overall Study||4
8803376|NCT01461733|9855457|FG001|NOT COMPLETED|Overall Study||4
8803377|NCT01461811|9855465|FG000|STARTED|Overall Study||95
8803378|NCT01461811|9855466|FG001|STARTED|Overall Study||49
8803379|NCT01461811|9855465|FG000|COMPLETED|Overall Study||91
8803380|NCT01461811|9855466|FG001|COMPLETED|Overall Study||46
8803381|NCT01461811|9855465|FG000|NOT COMPLETED|Overall Study||4
8803382|NCT01461811|9855466|FG001|NOT COMPLETED|Overall Study||3
8803383|NCT01461824|9855475|FG000|STARTED|Overall Study||12
8803384|NCT01461824|9855476|FG001|STARTED|Overall Study||11
8803385|NCT01461824|9855477|FG002|STARTED|Overall Study||11
8803386|NCT01461824|9855475|FG000|COMPLETED|Overall Study||10
8803387|NCT01461824|9855476|FG001|COMPLETED|Overall Study||7
8803388|NCT01461824|9855477|FG002|COMPLETED|Overall Study||8
8803389|NCT01461824|9855475|FG000|NOT COMPLETED|Overall Study||2
8803390|NCT01461824|9855476|FG001|NOT COMPLETED|Overall Study||4
8803391|NCT01461824|9855477|FG002|NOT COMPLETED|Overall Study||3
8803392|NCT01461863|9855487|FG000|STARTED|Overall Study||48
8803393|NCT01461863|9855488|FG001|STARTED|Overall Study||48
8803394|NCT01461863|9855487|FG000|COMPLETED|Overall Study||48
8803395|NCT01461863|9855488|FG001|COMPLETED|Overall Study||48
8803396|NCT01461863|9855487|FG000|NOT COMPLETED|Overall Study||0
8803397|NCT01461863|9855488|FG001|NOT COMPLETED|Overall Study||0
8803398|NCT01461928|9855496|FG000|STARTED|Induction (up to 8 Months)||692
8803399|NCT01461928|9855497|FG001|STARTED|Induction (up to 8 Months)||0
8803400|NCT01461928|9855498|FG002|STARTED|Induction (up to 8 Months)||0
8803401|NCT01461928|9855496|FG000|COMPLETED|Induction (up to 8 Months)||494
8803402|NCT01461928|9855497|FG001|COMPLETED|Induction (up to 8 Months)||0
8803403|NCT01461928|9855498|FG002|COMPLETED|Induction (up to 8 Months)||0
8803404|NCT01461928|9855496|FG000|NOT COMPLETED|Induction (up to 8 Months)||198
8803405|NCT01461928|9855497|FG001|NOT COMPLETED|Induction (up to 8 Months)||0
8803406|NCT01461928|9855498|FG002|NOT COMPLETED|Induction (up to 8 Months)||0
8919966|NCT02211261|9979978|FG005|COMPLETED|Overall Study||1
8803407|NCT01461928|9855496|FG000|STARTED|Maintenance I (24 Months)||494
8803408|NCT01461928|9855497|FG001|STARTED|Maintenance I (24 Months)||0
8803409|NCT01461928|9855498|FG002|STARTED|Maintenance I (24 Months)||0
8803410|NCT01461928|9855496|FG000|COMPLETED|Maintenance I (24 Months)|Responders during 2 yrs Maint I treatment|276
8803411|NCT01461928|9855497|FG001|COMPLETED|Maintenance I (24 Months)||0
8803412|NCT01461928|9855498|FG002|COMPLETED|Maintenance I (24 Months)||0
8803413|NCT01461928|9855496|FG000|NOT COMPLETED|Maintenance I (24 Months)||218
8803414|NCT01461928|9855497|FG001|NOT COMPLETED|Maintenance I (24 Months)||0
8919967|NCT02211261|9979979|FG006|COMPLETED|Overall Study||6
8803415|NCT01461928|9855498|FG002|NOT COMPLETED|Maintenance I (24 Months)||0
8803416|NCT01461928|9855496|FG000|STARTED|Maintenance II (15 Months)||0
8803417|NCT01461928|9855497|FG001|STARTED|Maintenance II (15 Months)||138
8803418|NCT01461928|9855498|FG002|STARTED|Maintenance II (15 Months)||138
8803419|NCT01461928|9855496|FG000|COMPLETED|Maintenance II (15 Months)||0
8803420|NCT01461928|9855497|FG001|COMPLETED|Maintenance II (15 Months)|6 participants did not receive treatment|115
8803421|NCT01461928|9855498|FG002|COMPLETED|Maintenance II (15 Months)||111
8803422|NCT01461928|9855496|FG000|NOT COMPLETED|Maintenance II (15 Months)||0
8803423|NCT01461928|9855497|FG001|NOT COMPLETED|Maintenance II (15 Months)||23
8803424|NCT01461928|9855498|FG002|NOT COMPLETED|Maintenance II (15 Months)||27
8803425|NCT01461980|9855512|FG000|STARTED|Overall Study||888
8803426|NCT01461980|9855513|FG001|STARTED|Overall Study||878
8803427|NCT01461980|9855514|FG002|STARTED|Overall Study||882
8803428|NCT01461980|9855512|FG000|Vaccination 1|Overall Study||884
8803429|NCT01461980|9855513|FG001|Vaccination 1|Overall Study||870
8803430|NCT01461980|9855514|FG002|Vaccination 1|Overall Study||875
8803431|NCT01461980|9855512|FG000|Vaccination 2|Overall Study||802
8803432|NCT01461980|9855513|FG001|Vaccination 2|Overall Study||819
8803433|NCT01461980|9855514|FG002|Vaccination 2|Overall Study||799
8803434|NCT01461980|9855512|FG000|Vaccination 3|Overall Study||757
8803435|NCT01461980|9855513|FG001|Vaccination 3|Overall Study||777
8803436|NCT01461980|9855514|FG002|Vaccination 3|Overall Study||748
8803437|NCT01461980|9855512|FG000|COMPLETED|Overall Study||722
8803438|NCT01461980|9855513|FG001|COMPLETED|Overall Study||733
8803439|NCT01461980|9855514|FG002|COMPLETED|Overall Study||717
8803440|NCT01461980|9855512|FG000|NOT COMPLETED|Overall Study||166
8803441|NCT01461980|9855513|FG001|NOT COMPLETED|Overall Study||145
8803442|NCT01461980|9855514|FG002|NOT COMPLETED|Overall Study||165
8803443|NCT01461993|9855526|FG000|STARTED|Overall Study||999
8803444|NCT01461993|9855527|FG001|STARTED|Overall Study||998
8803445|NCT01461993|9855528|FG002|STARTED|Overall Study||502
8803446|NCT01461993|9855526|FG000|COMPLETED|Overall Study||848
8803447|NCT01461993|9855527|FG001|COMPLETED|Overall Study||841
8803448|NCT01461993|9855528|FG002|COMPLETED|Overall Study||438
8803449|NCT01461993|9855526|FG000|NOT COMPLETED|Overall Study||151
8803450|NCT01461993|9855527|FG001|NOT COMPLETED|Overall Study||157
8803451|NCT01461993|9855528|FG002|NOT COMPLETED|Overall Study||64
8803452|NCT01462045|9855540|FG000|STARTED|Overall Study||11
8803453|NCT01462045|9855541|FG001|STARTED|Overall Study||11
8803454|NCT01462045|9855542|FG002|STARTED|Overall Study||7
8803455|NCT01462045|9855540|FG000|COMPLETED|Overall Study||11
8803456|NCT01462045|9855541|FG001|COMPLETED|Overall Study||10
8803457|NCT01462045|9855542|FG002|COMPLETED|Overall Study||7
8803458|NCT01462045|9855540|FG000|NOT COMPLETED|Overall Study||0
8803459|NCT01462045|9855541|FG001|NOT COMPLETED|Overall Study||1
8803460|NCT01462045|9855542|FG002|NOT COMPLETED|Overall Study||0
8919968|NCT02211261|9979980|FG007|COMPLETED|Overall Study||7
8919969|NCT02211261|9979981|FG008|COMPLETED|Overall Study||8
8919970|NCT02211261|9979982|FG009|COMPLETED|Overall Study||14
8919971|NCT02211261|9979983|FG010|COMPLETED|Overall Study||8
8919972|NCT02211261|9979973|FG000|NOT COMPLETED|Overall Study||0
8919973|NCT02211261|9979974|FG001|NOT COMPLETED|Overall Study||0
8919974|NCT02211261|9979975|FG002|NOT COMPLETED|Overall Study||1
8919975|NCT02211261|9979976|FG003|NOT COMPLETED|Overall Study||0
8919976|NCT02211261|9979977|FG004|NOT COMPLETED|Overall Study||2
8919977|NCT02211261|9979978|FG005|NOT COMPLETED|Overall Study||1
8919978|NCT02211261|9979979|FG006|NOT COMPLETED|Overall Study||0
8919979|NCT02211261|9979980|FG007|NOT COMPLETED|Overall Study||1
8919980|NCT02211261|9979981|FG008|NOT COMPLETED|Overall Study||0
8919981|NCT02211261|9979982|FG009|NOT COMPLETED|Overall Study||2
8919982|NCT02211261|9979983|FG010|NOT COMPLETED|Overall Study||0
8919983|NCT02211313|9980018|FG000|STARTED|Overall Study||18
8919984|NCT02211313|9980019|FG001|STARTED|Overall Study||23
8919985|NCT02211313|9980018|FG000|COMPLETED|Overall Study||12
8919986|NCT02211313|9980019|FG001|COMPLETED|Overall Study||20
8919987|NCT02211313|9980018|FG000|NOT COMPLETED|Overall Study||6
8919988|NCT02211313|9980019|FG001|NOT COMPLETED|Overall Study||3
8919989|NCT02211456|9980025|FG000|STARTED|Overall Study||15
8919990|NCT02211456|9980025|FG000|COMPLETED|Overall Study||15
8919991|NCT02211456|9980025|FG000|NOT COMPLETED|Overall Study||0
8919992|NCT02211495|9980031|FG000|STARTED|Overall Study||4
8919993|NCT02211495|9980032|FG001|STARTED|Overall Study||4
8919994|NCT02211495|9980031|FG000|COMPLETED|Overall Study||4
8919995|NCT02211495|9980032|FG001|COMPLETED|Overall Study||4
8919996|NCT02211495|9980031|FG000|NOT COMPLETED|Overall Study||0
8919997|NCT02211495|9980032|FG001|NOT COMPLETED|Overall Study||0
8919998|NCT02211534|9980044|FG000|STARTED|Overall Study||24
8919999|NCT02211534|9980045|FG001|STARTED|Overall Study||11
8920000|NCT02211534|9980044|FG000|COMPLETED|Overall Study||11
8920001|NCT02211534|9980045|FG001|COMPLETED|Overall Study||6
8920002|NCT02211534|9980044|FG000|NOT COMPLETED|Overall Study||13
8920003|NCT02211534|9980045|FG001|NOT COMPLETED|Overall Study||5
8920004|NCT02211638|9980051|FG000|STARTED|Overall Study||18113
8920005|NCT02211638|9980051|FG000|COMPLETED|Overall Study||17130
8920006|NCT02211638|9980051|FG000|NOT COMPLETED|Overall Study||983
8920007|NCT02212028|9980057|FG000|STARTED|Overall Study||26
8920008|NCT02212028|9980058|FG001|STARTED|Overall Study||26
8920009|NCT02212028|9980057|FG000|COMPLETED|Overall Study||26
8920010|NCT02212028|9980058|FG001|COMPLETED|Overall Study||26
8920011|NCT02212028|9980057|FG000|NOT COMPLETED|Overall Study||0
8920012|NCT02212028|9980058|FG001|NOT COMPLETED|Overall Study||0
8920013|NCT02212106|9980066|FG000|STARTED|Overall Study||302
8920014|NCT02212106|9980067|FG001|STARTED|Overall Study||100
8920015|NCT02212106|9980066|FG000|COMPLETED|Overall Study||292
8920016|NCT02212106|9980067|FG001|COMPLETED|Overall Study||96
8803461|NCT01462084|9855550|FG000|STARTED|Overall Study||11
8803462|NCT01462084|9855551|FG001|STARTED|Overall Study||10
8803463|NCT01462084|9855550|FG000|Included for Analysis|Overall Study||9
8803464|NCT01462084|9855551|FG001|Included for Analysis|Overall Study||9
8803465|NCT01462084|9855550|FG000|COMPLETED|Overall Study||9
8803466|NCT01462084|9855551|FG001|COMPLETED|Overall Study||9
8803467|NCT01462084|9855550|FG000|NOT COMPLETED|Overall Study||2
8803468|NCT01462084|9855551|FG001|NOT COMPLETED|Overall Study||1
8803469|NCT01462110|9855560|FG000|STARTED|Overall Study||44
8803470|NCT01462110|9855561|FG001|STARTED|Overall Study||43
8803471|NCT01462110|9855560|FG000|COMPLETED|Overall Study||43
8803472|NCT01462110|9855561|FG001|COMPLETED|Overall Study||43
8803473|NCT01462110|9855560|FG000|NOT COMPLETED|Overall Study||1
8803474|NCT01462110|9855561|FG001|NOT COMPLETED|Overall Study||0
8803475|NCT01462162|9855567|FG000|STARTED|Overall Study||120
8803476|NCT01462162|9855567|FG000|COMPLETED|Overall Study||108
8803477|NCT01462162|9855567|FG000|NOT COMPLETED|Overall Study||12
8803478|NCT01462227|9855574|FG000|STARTED|First Assignment||4
8803479|NCT01462227|9855575|FG001|STARTED|First Assignment||2
8803480|NCT01462227|9855576|FG002|STARTED|First Assignment||6
8803481|NCT01462227|9855577|FG003|STARTED|First Assignment||5
8803482|NCT01462227|9855574|FG000|COMPLETED|First Assignment||4
8803483|NCT01462227|9855575|FG001|COMPLETED|First Assignment||2
8803484|NCT01462227|9855576|FG002|COMPLETED|First Assignment||6
8803485|NCT01462227|9855577|FG003|COMPLETED|First Assignment||5
8803486|NCT01462227|9855574|FG000|NOT COMPLETED|First Assignment||0
8803487|NCT01462227|9855575|FG001|NOT COMPLETED|First Assignment||0
8803488|NCT01462227|9855576|FG002|NOT COMPLETED|First Assignment||0
8803489|NCT01462227|9855577|FG003|NOT COMPLETED|First Assignment||0
8803490|NCT01462227|9855574|FG000|STARTED|Second Assignment||4
8803491|NCT01462227|9855575|FG001|STARTED|Second Assignment||2
8803492|NCT01462227|9855576|FG002|STARTED|Second Assignment||6
8803493|NCT01462227|9855577|FG003|STARTED|Second Assignment||5
8803494|NCT01462227|9855574|FG000|COMPLETED|Second Assignment||3
8803495|NCT01462227|9855575|FG001|COMPLETED|Second Assignment||1
8803496|NCT01462227|9855576|FG002|COMPLETED|Second Assignment||5
8803497|NCT01462227|9855577|FG003|COMPLETED|Second Assignment||5
8803498|NCT01462227|9855574|FG000|NOT COMPLETED|Second Assignment||1
8803499|NCT01462227|9855575|FG001|NOT COMPLETED|Second Assignment||1
8803500|NCT01462227|9855576|FG002|NOT COMPLETED|Second Assignment||1
8803501|NCT01462227|9855577|FG003|NOT COMPLETED|Second Assignment||0
8803502|NCT01462253|9855585|FG000|STARTED|Overall Study||35
8803503|NCT01462253|9855585|FG000|COMPLETED|Overall Study||27
8803504|NCT01462253|9855585|FG000|NOT COMPLETED|Overall Study||8
8803505|NCT01462266|9855591|FG000|STARTED|Overall Study||330
8803506|NCT01462266|9855592|FG001|STARTED|Overall Study||330
8803507|NCT01462266|9855591|FG000|Treated|Overall Study|One participant was randomized in error and did not receive study medication.|329
8803508|NCT01462266|9855592|FG001|Treated|Overall Study|One participant was randomized in error and did not receive study medication.|329
8803509|NCT01462266|9855591|FG000|COMPLETED|Overall Study||295
8803510|NCT01462266|9855592|FG001|COMPLETED|Overall Study||303
8803511|NCT01462266|9855591|FG000|NOT COMPLETED|Overall Study||35
8803512|NCT01462266|9855592|FG001|NOT COMPLETED|Overall Study||27
8803513|NCT01462279|9855598|FG000|STARTED|Overall Study||20
8920017|NCT02212106|9980066|FG000|NOT COMPLETED|Overall Study||10
8920018|NCT02212106|9980067|FG001|NOT COMPLETED|Overall Study||4
8920019|NCT02212197|9980077|FG000|STARTED|Overall Study||19
8920020|NCT02212197|9980078|FG001|STARTED|Overall Study||15
8920021|NCT02212197|9980079|FG002|STARTED|Overall Study||17
8920022|NCT02212197|9980077|FG000|COMPLETED|Overall Study||18
8920023|NCT02212197|9980078|FG001|COMPLETED|Overall Study||15
8920024|NCT02212197|9980079|FG002|COMPLETED|Overall Study||17
8920025|NCT02212197|9980077|FG000|NOT COMPLETED|Overall Study||1
8920026|NCT02212197|9980078|FG001|NOT COMPLETED|Overall Study||0
8920027|NCT02212197|9980079|FG002|NOT COMPLETED|Overall Study||0
8920028|NCT02212301|9980087|FG000|STARTED|Period 1||21
8920029|NCT02212301|9980088|FG001|STARTED|Period 1||22
8920030|NCT02212301|9980087|FG000|COMPLETED|Period 1||21
8920031|NCT02212301|9980088|FG001|COMPLETED|Period 1||21
8920032|NCT02212301|9980087|FG000|NOT COMPLETED|Period 1||0
8920033|NCT02212301|9980088|FG001|NOT COMPLETED|Period 1||1
8920034|NCT02212301|9980087|FG000|STARTED|Period 2||21
8920035|NCT02212301|9980088|FG001|STARTED|Period 2||21
8920036|NCT02212301|9980087|FG000|COMPLETED|Period 2||21
8920037|NCT02212301|9980088|FG001|COMPLETED|Period 2||21
8920038|NCT02212301|9980087|FG000|NOT COMPLETED|Period 2||0
8920039|NCT02212301|9980088|FG001|NOT COMPLETED|Period 2||0
8920040|NCT02212379|9980095|FG000|STARTED|From Baseline to Week 48||165
8920041|NCT02212379|9980095|FG000|COMPLETED|From Baseline to Week 48||156
8920042|NCT02212379|9980095|FG000|NOT COMPLETED|From Baseline to Week 48||9
8920043|NCT02212379|9980095|FG000|STARTED|From Week 48 to Week 96||156
8920044|NCT02212379|9980095|FG000|COMPLETED|From Week 48 to Week 96||152
8920045|NCT02212379|9980095|FG000|NOT COMPLETED|From Week 48 to Week 96||4
8920046|NCT02212457|9980108|FG000|STARTED|Overall Study||228
8803514|NCT01462279|9855598|FG000|COMPLETED|Overall Study||17
8920047|NCT02212457|9980109|FG001|STARTED|Overall Study||232
8920048|NCT02212457|9980110|FG002|STARTED|Overall Study||157
8920049|NCT02212457|9980111|FG003|STARTED|Overall Study||134
8920050|NCT02212457|9980112|FG004|STARTED|Overall Study||152
8920051|NCT02212457|9980113|FG005|STARTED|Overall Study||160
8920052|NCT02212457|9980108|FG000|COMPLETED|Overall Study||209
8920053|NCT02212457|9980109|FG001|COMPLETED|Overall Study||211
8803515|NCT01462279|9855598|FG000|NOT COMPLETED|Overall Study||3
8803516|NCT01462292|9855605|FG000|STARTED|Overall Study||16
8803517|NCT01462292|9855606|FG001|STARTED|Overall Study||17
8803518|NCT01462292|9855607|FG002|STARTED|Overall Study||18
8803519|NCT01462292|9855605|FG000|COMPLETED|Overall Study||16
8803520|NCT01462292|9855606|FG001|COMPLETED|Overall Study||17
8803521|NCT01462292|9855607|FG002|COMPLETED|Overall Study||18
8803522|NCT01462292|9855605|FG000|NOT COMPLETED|Overall Study||0
8803523|NCT01462292|9855606|FG001|NOT COMPLETED|Overall Study||0
8803524|NCT01462292|9855607|FG002|NOT COMPLETED|Overall Study||0
8803525|NCT01462305|9855620|FG000|STARTED|Overall Study||18
8803526|NCT01462305|9855621|FG001|STARTED|Overall Study||17
8803527|NCT01462305|9855620|FG000|COMPLETED|Overall Study||16
8803528|NCT01462305|9855621|FG001|COMPLETED|Overall Study||13
8803529|NCT01462305|9855620|FG000|NOT COMPLETED|Overall Study||2
8803530|NCT01462305|9855621|FG001|NOT COMPLETED|Overall Study||4
8803531|NCT01462318|9855629|FG000|STARTED|Main Study / TP-DI Study||113
8803532|NCT01462318|9855630|FG001|STARTED|Main Study / TP-DI Study||20
8803533|NCT01462318|9855631|FG002|STARTED|Main Study / TP-DI Study||0
8803534|NCT01462318|9855629|FG000|Enrolled in Intensive PK Substudy|Main Study / TP-DI Study||26
8803535|NCT01462318|9855630|FG001|Enrolled in Intensive PK Substudy|Main Study / TP-DI Study||0
8803536|NCT01462318|9855631|FG002|Enrolled in Intensive PK Substudy|Main Study / TP-DI Study||0
8803537|NCT01462318|9855629|FG000|COMPLETED|Main Study / TP-DI Study||105
8803538|NCT01462318|9855630|FG001|COMPLETED|Main Study / TP-DI Study||20
8803539|NCT01462318|9855631|FG002|COMPLETED|Main Study / TP-DI Study||0
8803540|NCT01462318|9855629|FG000|NOT COMPLETED|Main Study / TP-DI Study||8
8803541|NCT01462318|9855630|FG001|NOT COMPLETED|Main Study / TP-DI Study||0
8803542|NCT01462318|9855631|FG002|NOT COMPLETED|Main Study / TP-DI Study||0
8803543|NCT01462318|9855629|FG000|STARTED|Extension Phase|95 participants from the Main Study entered the Extension Phase|0
8803544|NCT01462318|9855630|FG001|STARTED|Extension Phase|20 participants from the TP-DI Study entered the Extension Phase|0
8803545|NCT01462318|9855631|FG002|STARTED|Extension Phase|10 participants from the Main Study did not enter the Extension Phase.|115
8803546|NCT01462318|9855629|FG000|COMPLETED|Extension Phase||0
8803547|NCT01462318|9855630|FG001|COMPLETED|Extension Phase||0
8803548|NCT01462318|9855631|FG002|COMPLETED|Extension Phase||70
8803549|NCT01462318|9855629|FG000|NOT COMPLETED|Extension Phase||0
8803550|NCT01462318|9855630|FG001|NOT COMPLETED|Extension Phase||0
8803551|NCT01462318|9855631|FG002|NOT COMPLETED|Extension Phase||45
8803552|NCT01462344|9855638|FG000|STARTED|Overall Study||3107
8803553|NCT01462344|9855639|FG001|STARTED|Overall Study||3101
8803554|NCT01462344|9855638|FG000|COMPLETED|Overall Study||2724
8803555|NCT01462344|9855639|FG001|COMPLETED|Overall Study||2751
8803556|NCT01462344|9855638|FG000|NOT COMPLETED|Overall Study||383
8803557|NCT01462344|9855639|FG001|NOT COMPLETED|Overall Study||350
8803558|NCT01462357|9855648|FG000|STARTED|Overall Study||359
8803559|NCT01462357|9855649|FG001|STARTED|Overall Study||358
8803560|NCT01462357|9855650|FG002|STARTED|Overall Study||358
8803561|NCT01462357|9855648|FG000|COMPLETED|Overall Study||351
8803562|NCT01462357|9855649|FG001|COMPLETED|Overall Study||339
8803563|NCT01462357|9855650|FG002|COMPLETED|Overall Study||346
8803564|NCT01462357|9855648|FG000|NOT COMPLETED|Overall Study||8
8803565|NCT01462357|9855649|FG001|NOT COMPLETED|Overall Study||19
8803566|NCT01462357|9855650|FG002|NOT COMPLETED|Overall Study||12
8803567|NCT01462435|9855662|FG000|STARTED|Overall Study||106
8803568|NCT01462435|9855663|FG001|STARTED|Overall Study||109
8803569|NCT01462435|9855664|FG002|STARTED|Overall Study||107
8803570|NCT01462435|9855665|FG003|STARTED|Overall Study||106
8803571|NCT01462435|9855662|FG000|COMPLETED|Overall Study||105
8803572|NCT01462435|9855663|FG001|COMPLETED|Overall Study||109
8803573|NCT01462435|9855664|FG002|COMPLETED|Overall Study||106
8803574|NCT01462435|9855665|FG003|COMPLETED|Overall Study||101
8803575|NCT01462435|9855662|FG000|NOT COMPLETED|Overall Study||1
8803576|NCT01462435|9855663|FG001|NOT COMPLETED|Overall Study||0
8803577|NCT01462435|9855664|FG002|NOT COMPLETED|Overall Study||1
8803578|NCT01462435|9855665|FG003|NOT COMPLETED|Overall Study||5
8803579|NCT01462565|9855675|FG000|STARTED|Overall Study||16
8803580|NCT01462565|9855675|FG000|COMPLETED|Overall Study||16
8803581|NCT01462565|9855675|FG000|NOT COMPLETED|Overall Study||0
8803582|NCT01462695|9855681|FG000|STARTED|Overall Study||17
8803583|NCT01462695|9855682|FG001|STARTED|Overall Study||13
8803584|NCT01462695|9855681|FG000|COMPLETED|Overall Study||0
8803585|NCT01462695|9855682|FG001|COMPLETED|Overall Study||0
8803586|NCT01462695|9855681|FG000|NOT COMPLETED|Overall Study||17
8803587|NCT01462695|9855682|FG001|NOT COMPLETED|Overall Study||13
8803588|NCT01462773|9855688|FG000|STARTED|Overall Study||16
8803589|NCT01462773|9855688|FG000|COMPLETED|Overall Study||16
8803590|NCT01462773|9855688|FG000|NOT COMPLETED|Overall Study||0
8803591|NCT01462812|9855695|FG000|STARTED|Overall Study||111
8803592|NCT01462812|9855696|FG001|STARTED|Overall Study||112
8803593|NCT01462812|9855695|FG000|COMPLETED|Overall Study||111
8803594|NCT01462812|9855696|FG001|COMPLETED|Overall Study||111
8803595|NCT01462812|9855695|FG000|NOT COMPLETED|Overall Study||0
8803596|NCT01462812|9855696|FG001|NOT COMPLETED|Overall Study||1
8803597|NCT01462877|9855702|FG000|STARTED|Overall Study||506
8803598|NCT01462877|9855702|FG000|Safety Set|Overall Study||492
8803599|NCT01462877|9855702|FG000|Full Analysis Set|Overall Study||468
8803600|NCT01462877|9855702|FG000|Per-protocol Set|Overall Study||364
8803601|NCT01462877|9855702|FG000|COMPLETED|Overall Study||435
8803602|NCT01462877|9855702|FG000|NOT COMPLETED|Overall Study||71
8803603|NCT01462929|9855709|FG000|STARTED|Overall Study||171
8803604|NCT01462929|9855710|FG001|STARTED|Overall Study||158
8803605|NCT01462929|9855711|FG002|STARTED|Overall Study||85
8803606|NCT01462929|9855709|FG000|COMPLETED|Overall Study||166
8803607|NCT01462929|9855710|FG001|COMPLETED|Overall Study||154
8803608|NCT01462929|9855711|FG002|COMPLETED|Overall Study||80
8803609|NCT01462929|9855709|FG000|NOT COMPLETED|Overall Study||5
8803610|NCT01462929|9855710|FG001|NOT COMPLETED|Overall Study||4
8803611|NCT01462929|9855711|FG002|NOT COMPLETED|Overall Study||5
8803612|NCT01462942|9855724|FG000|STARTED|Overall Study||194
8803613|NCT01462942|9855725|FG001|STARTED|Overall Study||385
8803614|NCT01462942|9855726|FG002|STARTED|Overall Study||381
8803615|NCT01462942|9855727|FG003|STARTED|Overall Study||385
8803616|NCT01462942|9855728|FG004|STARTED|Overall Study||384
8803617|NCT01462942|9855724|FG000|COMPLETED|Overall Study||160
8803618|NCT01462942|9855725|FG001|COMPLETED|Overall Study||351
8803619|NCT01462942|9855726|FG002|COMPLETED|Overall Study||341
8803620|NCT01462942|9855727|FG003|COMPLETED|Overall Study||335
8803621|NCT01462942|9855728|FG004|COMPLETED|Overall Study||339
8803622|NCT01462942|9855724|FG000|NOT COMPLETED|Overall Study||34
8803623|NCT01462942|9855725|FG001|NOT COMPLETED|Overall Study||34
8803624|NCT01462942|9855726|FG002|NOT COMPLETED|Overall Study||40
8803625|NCT01462942|9855727|FG003|NOT COMPLETED|Overall Study||50
8803626|NCT01462942|9855728|FG004|NOT COMPLETED|Overall Study||45
8803627|NCT01463007|9855740|FG000|STARTED|Overall Study||41
8803628|NCT01463007|9855740|FG000|COMPLETED|Overall Study||40
8803629|NCT01463007|9855740|FG000|NOT COMPLETED|Overall Study||1
8803630|NCT01463033|9855747|FG000|STARTED|Overall Study||66
8803631|NCT01463033|9855748|FG001|STARTED|Overall Study||60
8803632|NCT01463033|9855747|FG000|COMPLETED|Overall Study|3 deaths, 4 lost to follow up|59
8803633|NCT01463033|9855748|FG001|COMPLETED|Overall Study|2 deaths, 4 lost to follow up|54
8803634|NCT01463033|9855747|FG000|NOT COMPLETED|Overall Study||7
8803635|NCT01463033|9855748|FG001|NOT COMPLETED|Overall Study||6
8803636|NCT01463098|9855769|FG000|STARTED|Part A (11 Days)||16
8803637|NCT01463098|9855770|FG001|STARTED|Part A (11 Days)||6
8803638|NCT01463098|9855771|FG002|STARTED|Part A (11 Days)||6
8803639|NCT01463098|9855772|FG003|STARTED|Part A (11 Days)||6
8803640|NCT01463098|9855773|FG004|STARTED|Part A (11 Days)||6
8803641|NCT01463098|9855774|FG005|STARTED|Part A (11 Days)||6
8803642|NCT01463098|9855775|FG006|STARTED|Part A (11 Days)||6
8803643|NCT01463098|9855776|FG007|STARTED|Part A (11 Days)||6
8803644|NCT01463098|9855777|FG008|STARTED|Part A (11 Days)||6
8803645|NCT01463098|9855778|FG009|STARTED|Part A (11 Days)||0
8803646|NCT01463098|9855779|FG010|STARTED|Part A (11 Days)||0
8803647|NCT01463098|9855780|FG011|STARTED|Part A (11 Days)||0
8803648|NCT01463098|9855781|FG012|STARTED|Part A (11 Days)||0
8803649|NCT01463098|9855782|FG013|STARTED|Part A (11 Days)||0
8803650|NCT01463098|9855769|FG000|COMPLETED|Part A (11 Days)||14
8803651|NCT01463098|9855770|FG001|COMPLETED|Part A (11 Days)||6
8803652|NCT01463098|9855771|FG002|COMPLETED|Part A (11 Days)||6
8803653|NCT01463098|9855772|FG003|COMPLETED|Part A (11 Days)||6
8803654|NCT01463098|9855773|FG004|COMPLETED|Part A (11 Days)||5
8803655|NCT01463098|9855774|FG005|COMPLETED|Part A (11 Days)||6
8803656|NCT01463098|9855775|FG006|COMPLETED|Part A (11 Days)||6
8803657|NCT01463098|9855776|FG007|COMPLETED|Part A (11 Days)||6
8803658|NCT01463098|9855777|FG008|COMPLETED|Part A (11 Days)||5
8803659|NCT01463098|9855778|FG009|COMPLETED|Part A (11 Days)||0
8803660|NCT01463098|9855779|FG010|COMPLETED|Part A (11 Days)||0
8803661|NCT01463098|9855780|FG011|COMPLETED|Part A (11 Days)||0
8803662|NCT01463098|9855781|FG012|COMPLETED|Part A (11 Days)||0
8803663|NCT01463098|9855782|FG013|COMPLETED|Part A (11 Days)||0
8803664|NCT01463098|9855769|FG000|NOT COMPLETED|Part A (11 Days)||2
8803665|NCT01463098|9855770|FG001|NOT COMPLETED|Part A (11 Days)||0
8803666|NCT01463098|9855771|FG002|NOT COMPLETED|Part A (11 Days)||0
8803667|NCT01463098|9855772|FG003|NOT COMPLETED|Part A (11 Days)||0
8803668|NCT01463098|9855773|FG004|NOT COMPLETED|Part A (11 Days)||1
8803669|NCT01463098|9855774|FG005|NOT COMPLETED|Part A (11 Days)||0
8803670|NCT01463098|9855775|FG006|NOT COMPLETED|Part A (11 Days)||0
8803671|NCT01463098|9855776|FG007|NOT COMPLETED|Part A (11 Days)||0
8803672|NCT01463098|9855777|FG008|NOT COMPLETED|Part A (11 Days)||1
8803673|NCT01463098|9855778|FG009|NOT COMPLETED|Part A (11 Days)||0
8803674|NCT01463098|9855779|FG010|NOT COMPLETED|Part A (11 Days)||0
8803675|NCT01463098|9855780|FG011|NOT COMPLETED|Part A (11 Days)||0
8803676|NCT01463098|9855781|FG012|NOT COMPLETED|Part A (11 Days)||0
8803677|NCT01463098|9855782|FG013|NOT COMPLETED|Part A (11 Days)||0
8803678|NCT01463098|9855769|FG000|STARTED|Part B (11 Days)||0
8803679|NCT01463098|9855770|FG001|STARTED|Part B (11 Days)||0
8803680|NCT01463098|9855771|FG002|STARTED|Part B (11 Days)||0
8803681|NCT01463098|9855772|FG003|STARTED|Part B (11 Days)||0
8803682|NCT01463098|9855773|FG004|STARTED|Part B (11 Days)||0
8803683|NCT01463098|9855774|FG005|STARTED|Part B (11 Days)||0
8803684|NCT01463098|9855775|FG006|STARTED|Part B (11 Days)||0
8803685|NCT01463098|9855776|FG007|STARTED|Part B (11 Days)||0
8803686|NCT01463098|9855777|FG008|STARTED|Part B (11 Days)||0
8803687|NCT01463098|9855778|FG009|STARTED|Part B (11 Days)||12
8803688|NCT01463098|9855779|FG010|STARTED|Part B (11 Days)||11
8803689|NCT01463098|9855780|FG011|STARTED|Part B (11 Days)||13
8803690|NCT01463098|9855781|FG012|STARTED|Part B (11 Days)||10
8803691|NCT01463098|9855782|FG013|STARTED|Part B (11 Days)||12
8803692|NCT01463098|9855769|FG000|COMPLETED|Part B (11 Days)||0
8803693|NCT01463098|9855770|FG001|COMPLETED|Part B (11 Days)||0
8803694|NCT01463098|9855771|FG002|COMPLETED|Part B (11 Days)||0
8803695|NCT01463098|9855772|FG003|COMPLETED|Part B (11 Days)||0
8803696|NCT01463098|9855773|FG004|COMPLETED|Part B (11 Days)||0
8803697|NCT01463098|9855774|FG005|COMPLETED|Part B (11 Days)||0
8803698|NCT01463098|9855775|FG006|COMPLETED|Part B (11 Days)||0
8803699|NCT01463098|9855776|FG007|COMPLETED|Part B (11 Days)||0
8803700|NCT01463098|9855777|FG008|COMPLETED|Part B (11 Days)||0
8803701|NCT01463098|9855778|FG009|COMPLETED|Part B (11 Days)||12
8803702|NCT01463098|9855779|FG010|COMPLETED|Part B (11 Days)||11
8803703|NCT01463098|9855780|FG011|COMPLETED|Part B (11 Days)||12
8803704|NCT01463098|9855781|FG012|COMPLETED|Part B (11 Days)||10
8803705|NCT01463098|9855782|FG013|COMPLETED|Part B (11 Days)||12
8803706|NCT01463098|9855769|FG000|NOT COMPLETED|Part B (11 Days)||0
8803707|NCT01463098|9855770|FG001|NOT COMPLETED|Part B (11 Days)||0
8803708|NCT01463098|9855771|FG002|NOT COMPLETED|Part B (11 Days)||0
8803709|NCT01463098|9855772|FG003|NOT COMPLETED|Part B (11 Days)||0
8803710|NCT01463098|9855773|FG004|NOT COMPLETED|Part B (11 Days)||0
8803711|NCT01463098|9855774|FG005|NOT COMPLETED|Part B (11 Days)||0
8803712|NCT01463098|9855775|FG006|NOT COMPLETED|Part B (11 Days)||0
8803713|NCT01463098|9855776|FG007|NOT COMPLETED|Part B (11 Days)||0
8803714|NCT01463098|9855777|FG008|NOT COMPLETED|Part B (11 Days)||0
8803715|NCT01463098|9855778|FG009|NOT COMPLETED|Part B (11 Days)||0
8803716|NCT01463098|9855779|FG010|NOT COMPLETED|Part B (11 Days)||0
8803717|NCT01463098|9855780|FG011|NOT COMPLETED|Part B (11 Days)||1
8803718|NCT01463098|9855781|FG012|NOT COMPLETED|Part B (11 Days)||0
8803719|NCT01463098|9855782|FG013|NOT COMPLETED|Part B (11 Days)||0
8803720|NCT01463111|9855831|FG000|STARTED|Overall Study||26
8803721|NCT01463111|9855831|FG000|COMPLETED|Overall Study||17
8803722|NCT01463111|9855831|FG000|NOT COMPLETED|Overall Study||9
8803723|NCT01463202|9855837|FG000|STARTED|Overall Study||79
8803724|NCT01463202|9855838|FG001|STARTED|Overall Study||78
8803725|NCT01463202|9855837|FG000|COMPLETED|Overall Study||79
8803726|NCT01463202|9855838|FG001|COMPLETED|Overall Study||78
8803727|NCT01463202|9855837|FG000|NOT COMPLETED|Overall Study||0
8803728|NCT01463202|9855838|FG001|NOT COMPLETED|Overall Study||0
8803729|NCT01463267|9855848|FG000|STARTED|Overall Study||15
8803730|NCT01463267|9855849|FG001|STARTED|Overall Study||15
8803731|NCT01463267|9855850|FG002|STARTED|Overall Study||15
8803732|NCT01463267|9855851|FG003|STARTED|Overall Study||15
8803733|NCT01463267|9855848|FG000|COMPLETED|Overall Study||14
8803734|NCT01463267|9855849|FG001|COMPLETED|Overall Study||15
8803735|NCT01463267|9855850|FG002|COMPLETED|Overall Study||13
8803736|NCT01463267|9855851|FG003|COMPLETED|Overall Study||13
8803737|NCT01463267|9855848|FG000|NOT COMPLETED|Overall Study||1
8803738|NCT01463267|9855849|FG001|NOT COMPLETED|Overall Study||0
8803739|NCT01463267|9855850|FG002|NOT COMPLETED|Overall Study||2
8803740|NCT01463267|9855851|FG003|NOT COMPLETED|Overall Study||2
8803741|NCT01463306|9855864|FG000|STARTED|Overall Study||384
8803742|NCT01463306|9855865|FG001|STARTED|Overall Study||210
8803743|NCT01463306|9855866|FG002|STARTED|Overall Study||11
8803744|NCT01463306|9855864|FG000|COMPLETED|Overall Study||298
8803745|NCT01463306|9855865|FG001|COMPLETED|Overall Study||158
8803746|NCT01463306|9855866|FG002|COMPLETED|Overall Study||6
8803747|NCT01463306|9855864|FG000|NOT COMPLETED|Overall Study||86
8803748|NCT01463306|9855865|FG001|NOT COMPLETED|Overall Study||52
8803749|NCT01463306|9855866|FG002|NOT COMPLETED|Overall Study||5
8803750|NCT01463358|9855876|FG000|STARTED|Overall Study||49
8803751|NCT01463358|9855877|FG001|STARTED|Overall Study||52
8803752|NCT01463358|9855876|FG000|COMPLETED|Overall Study||46
8803753|NCT01463358|9855877|FG001|COMPLETED|Overall Study||47
8803754|NCT01463358|9855876|FG000|NOT COMPLETED|Overall Study||3
8803755|NCT01463358|9855877|FG001|NOT COMPLETED|Overall Study||5
8803756|NCT01463384|9855883|FG000|STARTED|Overall Study||13
8803757|NCT01463384|9855883|FG000|COMPLETED|Overall Study||13
8803758|NCT01463384|9855883|FG000|NOT COMPLETED|Overall Study||0
8803759|NCT01463527|9855891|FG000|STARTED|Overall Study||83
8803760|NCT01463527|9855892|FG001|STARTED|Overall Study||84
8803761|NCT01463527|9855891|FG000|COMPLETED|Overall Study||77
8803762|NCT01463527|9855892|FG001|COMPLETED|Overall Study||77
8803763|NCT01463527|9855891|FG000|NOT COMPLETED|Overall Study||6
8803764|NCT01463527|9855892|FG001|NOT COMPLETED|Overall Study||7
8803765|NCT01463631|9855902|FG000|STARTED|Overall Study||3
8803766|NCT01463631|9855903|FG001|STARTED|Overall Study||4
8803767|NCT01463631|9855904|FG002|STARTED|Overall Study||5
8803768|NCT01463631|9855905|FG003|STARTED|Overall Study||15
8803769|NCT01463631|9855902|FG000|Received at Least One Dose of Study Drug|Overall Study||3
8803770|NCT01463631|9855903|FG001|Received at Least One Dose of Study Drug|Overall Study||4
8803771|NCT01463631|9855904|FG002|Received at Least One Dose of Study Drug|Overall Study||5
8803772|NCT01463631|9855905|FG003|Received at Least One Dose of Study Drug|Overall Study||15
8803773|NCT01463631|9855902|FG000|COMPLETED|Overall Study||3
8803774|NCT01463631|9855903|FG001|COMPLETED|Overall Study||4
8803775|NCT01463631|9855904|FG002|COMPLETED|Overall Study||4
8803776|NCT01463631|9855905|FG003|COMPLETED|Overall Study||9
8803777|NCT01463631|9855902|FG000|NOT COMPLETED|Overall Study||0
8803778|NCT01463631|9855903|FG001|NOT COMPLETED|Overall Study||0
8803779|NCT01463631|9855904|FG002|NOT COMPLETED|Overall Study||1
8803780|NCT01463631|9855905|FG003|NOT COMPLETED|Overall Study||6
8803781|NCT01463683|9855920|FG000|STARTED|Overall Study||309
8803782|NCT01463683|9855921|FG001|STARTED|Overall Study||309
8803783|NCT01463683|9855922|FG002|STARTED|Overall Study||104
8803784|NCT01463683|9855920|FG000|Received Vaccination 1 (Day 1)|Overall Study||309
8803785|NCT01463683|9855921|FG001|Received Vaccination 1 (Day 1)|Overall Study||308
8803786|NCT01463683|9855922|FG002|Received Vaccination 1 (Day 1)|Overall Study||104
8803787|NCT01463683|9855920|FG000|Received Vaccination 2 (Month 1)|Overall Study||302
8803788|NCT01463683|9855921|FG001|Received Vaccination 2 (Month 1)|Overall Study||300
8803789|NCT01463683|9855922|FG002|Received Vaccination 2 (Month 1)|Overall Study||103
8803790|NCT01463683|9855920|FG000|Received Vaccination 3 (Month 6)|Overall Study||290
8803791|NCT01463683|9855921|FG001|Received Vaccination 3 (Month 6)|Overall Study||281
8803792|NCT01463683|9855922|FG002|Received Vaccination 3 (Month 6)|Overall Study||93
8803793|NCT01463683|9855920|FG000|COMPLETED|Overall Study||290
8803794|NCT01463683|9855921|FG001|COMPLETED|Overall Study||278
8803795|NCT01463683|9855922|FG002|COMPLETED|Overall Study||93
8803796|NCT01463683|9855920|FG000|NOT COMPLETED|Overall Study||19
8803797|NCT01463683|9855921|FG001|NOT COMPLETED|Overall Study||31
8803798|NCT01463683|9855922|FG002|NOT COMPLETED|Overall Study||11
8803799|NCT01463696|9855938|FG000|STARTED|Overall Study||1
8803800|NCT01463696|9855939|FG001|STARTED|Overall Study||6
8803801|NCT01463696|9855940|FG002|STARTED|Overall Study||3
8803802|NCT01463696|9855941|FG003|STARTED|Overall Study||7
8803803|NCT01463696|9855942|FG004|STARTED|Overall Study||3
8803804|NCT01463696|9855943|FG005|STARTED|Overall Study||6
8803805|NCT01463696|9855944|FG006|STARTED|Overall Study||16
8803806|NCT01463696|9855945|FG007|STARTED|Overall Study||6
8803807|NCT01463696|9855938|FG000|Treated|Overall Study||1
8803808|NCT01463696|9855939|FG001|Treated|Overall Study||6
8803809|NCT01463696|9855940|FG002|Treated|Overall Study||3
8803810|NCT01463696|9855941|FG003|Treated|Overall Study||7
8803811|NCT01463696|9855942|FG004|Treated|Overall Study||3
8803812|NCT01463696|9855943|FG005|Treated|Overall Study||6
8803813|NCT01463696|9855944|FG006|Treated|Overall Study||15
8803814|NCT01463696|9855945|FG007|Treated|Overall Study||6
8803815|NCT01463696|9855938|FG000|COMPLETED|Overall Study||1
8803816|NCT01463696|9855939|FG001|COMPLETED|Overall Study||4
8803817|NCT01463696|9855940|FG002|COMPLETED|Overall Study||2
8803818|NCT01463696|9855941|FG003|COMPLETED|Overall Study||3
8803819|NCT01463696|9855942|FG004|COMPLETED|Overall Study||2
8803820|NCT01463696|9855943|FG005|COMPLETED|Overall Study||3
8803821|NCT01463696|9855944|FG006|COMPLETED|Overall Study||6
8803822|NCT01463696|9855945|FG007|COMPLETED|Overall Study||2
8803823|NCT01463696|9855938|FG000|NOT COMPLETED|Overall Study||0
8803824|NCT01463696|9855939|FG001|NOT COMPLETED|Overall Study||2
8803825|NCT01463696|9855940|FG002|NOT COMPLETED|Overall Study||1
8803826|NCT01463696|9855941|FG003|NOT COMPLETED|Overall Study||4
8803827|NCT01463696|9855942|FG004|NOT COMPLETED|Overall Study||1
8803828|NCT01463696|9855943|FG005|NOT COMPLETED|Overall Study||3
8803829|NCT01463696|9855944|FG006|NOT COMPLETED|Overall Study||10
8803830|NCT01463696|9855945|FG007|NOT COMPLETED|Overall Study||4
8803831|NCT01463878|9855965|FG000|STARTED|Overall Study||9
8803832|NCT01463878|9855966|FG001|STARTED|Overall Study||9
8803833|NCT01463878|9855965|FG000|COMPLETED|Overall Study||7
8803834|NCT01463878|9855966|FG001|COMPLETED|Overall Study||7
8803835|NCT01463878|9855965|FG000|NOT COMPLETED|Overall Study||2
8803836|NCT01463878|9855966|FG001|NOT COMPLETED|Overall Study||2
8803837|NCT01463982|9855976|FG000|STARTED|Overall Study||3
8803838|NCT01463982|9855977|FG001|STARTED|Overall Study||8
8803839|NCT01463982|9855978|FG002|STARTED|Overall Study||4
8803840|NCT01463982|9855979|FG003|STARTED|Overall Study||6
8803841|NCT01463982|9855976|FG000|COMPLETED|Overall Study||3
8803842|NCT01463982|9855977|FG001|COMPLETED|Overall Study||7
8803843|NCT01463982|9855978|FG002|COMPLETED|Overall Study||2
8803844|NCT01463982|9855979|FG003|COMPLETED|Overall Study||6
8803845|NCT01463982|9855976|FG000|NOT COMPLETED|Overall Study||0
8803846|NCT01463982|9855977|FG001|NOT COMPLETED|Overall Study||1
8803847|NCT01463982|9855978|FG002|NOT COMPLETED|Overall Study||2
8803848|NCT01463982|9855979|FG003|NOT COMPLETED|Overall Study||0
8803849|NCT01464021|9855989|FG000|STARTED|Overall Study||26
8803850|NCT01464021|9855989|FG000|COMPLETED|Overall Study||0
8803851|NCT01464021|9855989|FG000|NOT COMPLETED|Overall Study||26
8803852|NCT01464190|9855995|FG000|STARTED|Overall Study||391
8803853|NCT01464190|9855996|FG001|STARTED|Overall Study||268
8803854|NCT01464190|9855995|FG000|COMPLETED|Overall Study||322
8803855|NCT01464190|9855996|FG001|COMPLETED|Overall Study||227
8803856|NCT01464190|9855995|FG000|NOT COMPLETED|Overall Study||69
8803857|NCT01464190|9855996|FG001|NOT COMPLETED|Overall Study||41
8803858|NCT01464229|9856004|FG000|STARTED|Overall Study||10
8803859|NCT01464229|9856005|FG001|STARTED|Overall Study||10
8803860|NCT01464229|9856004|FG000|COMPLETED|Overall Study||5
8803861|NCT01464229|9856005|FG001|COMPLETED|Overall Study||8
8803862|NCT01464229|9856004|FG000|NOT COMPLETED|Overall Study||5
8803863|NCT01464229|9856005|FG001|NOT COMPLETED|Overall Study||2
8803864|NCT01464255|9856013|FG000|STARTED|Overall Study||25
8803865|NCT01464255|9856014|FG001|STARTED|Overall Study||25
8803866|NCT01464255|9856013|FG000|COMPLETED|Overall Study||25
8803867|NCT01464255|9856014|FG001|COMPLETED|Overall Study||24
8803868|NCT01464255|9856013|FG000|NOT COMPLETED|Overall Study||0
8803869|NCT01464255|9856014|FG001|NOT COMPLETED|Overall Study||1
8803870|NCT01464307|9856023|FG000|STARTED|Main Period||144
8803871|NCT01464307|9856024|FG001|STARTED|Main Period||145
8803872|NCT01464307|9856023|FG000|Treated|Main Period||144
8803873|NCT01464307|9856024|FG001|Treated|Main Period||145
8803874|NCT01464307|9856023|FG000|COMPLETED|Main Period||129
8803875|NCT01464307|9856024|FG001|COMPLETED|Main Period||140
8803876|NCT01464307|9856023|FG000|NOT COMPLETED|Main Period||15
8803877|NCT01464307|9856024|FG001|NOT COMPLETED|Main Period||5
8803878|NCT01464307|9856023|FG000|STARTED|Open-Label Extension Period||269
8803879|NCT01464307|9856024|FG001|STARTED|Open-Label Extension Period||0
8803880|NCT01464307|9856023|FG000|Treated|Open-Label Extension Period||269
8803881|NCT01464307|9856024|FG001|Treated|Open-Label Extension Period||0
8803882|NCT01464307|9856023|FG000|COMPLETED|Open-Label Extension Period||218
8803883|NCT01464307|9856024|FG001|COMPLETED|Open-Label Extension Period||0
8803884|NCT01464307|9856023|FG000|NOT COMPLETED|Open-Label Extension Period||51
8803885|NCT01464307|9856024|FG001|NOT COMPLETED|Open-Label Extension Period||0
8803886|NCT01464333|9856031|FG000|STARTED|Overall Study||389
8803887|NCT01464333|9856031|FG000|COMPLETED|Overall Study||226
8803888|NCT01464333|9856031|FG000|NOT COMPLETED|Overall Study||163
8803889|NCT01464346|9856035|FG000|STARTED|Overall Study||29
8803890|NCT01464346|9856036|FG001|STARTED|Overall Study||32
8803891|NCT01464346|9856037|FG002|STARTED|Overall Study||29
8803892|NCT01464346|9856035|FG000|COMPLETED|Overall Study||29
8803893|NCT01464346|9856036|FG001|COMPLETED|Overall Study||32
8803894|NCT01464346|9856037|FG002|COMPLETED|Overall Study||28
8803895|NCT01464346|9856035|FG000|NOT COMPLETED|Overall Study||0
8803896|NCT01464346|9856036|FG001|NOT COMPLETED|Overall Study||0
8803897|NCT01464346|9856037|FG002|NOT COMPLETED|Overall Study||1
8803898|NCT01464359|9856045|FG000|STARTED|Overall Study||3
8803899|NCT01464359|9856045|FG000|COMPLETED|Overall Study||3
8803900|NCT01464359|9856045|FG000|NOT COMPLETED|Overall Study||0
8803901|NCT01464424|9856049|FG000|STARTED|Period 1, First 6 Weeks||42
8803902|NCT01464424|9856050|FG001|STARTED|Period 1, First 6 Weeks||42
8803903|NCT01464424|9856049|FG000|COMPLETED|Period 1, First 6 Weeks||42
8803904|NCT01464424|9856050|FG001|COMPLETED|Period 1, First 6 Weeks||41
8803905|NCT01464424|9856049|FG000|NOT COMPLETED|Period 1, First 6 Weeks||0
8803906|NCT01464424|9856050|FG001|NOT COMPLETED|Period 1, First 6 Weeks||1
8803907|NCT01464424|9856049|FG000|STARTED|Period 2, Second 6 Weeks||42
8803908|NCT01464424|9856050|FG001|STARTED|Period 2, Second 6 Weeks||41
8803909|NCT01464424|9856049|FG000|COMPLETED|Period 2, Second 6 Weeks||42
8803910|NCT01464424|9856050|FG001|COMPLETED|Period 2, Second 6 Weeks||41
8803911|NCT01464424|9856049|FG000|NOT COMPLETED|Period 2, Second 6 Weeks||0
8803912|NCT01464424|9856050|FG001|NOT COMPLETED|Period 2, Second 6 Weeks||0
8803913|NCT01464619|9856058|FG000|STARTED|Overall Study||32
8803914|NCT01464619|9856059|FG001|STARTED|Overall Study||29
8803915|NCT01464619|9856058|FG000|COMPLETED|Overall Study||29
8803916|NCT01464619|9856059|FG001|COMPLETED|Overall Study||25
8803917|NCT01464619|9856058|FG000|NOT COMPLETED|Overall Study||3
8803918|NCT01464619|9856059|FG001|NOT COMPLETED|Overall Study||4
8803919|NCT01464697|9856069|FG000|STARTED|Overall Study||93
8803920|NCT01464697|9856070|FG001|STARTED|Overall Study||96
8803921|NCT01464697|9856069|FG000|COMPLETED|Overall Study||90
8803922|NCT01464697|9856070|FG001|COMPLETED|Overall Study||86
8803923|NCT01464697|9856069|FG000|NOT COMPLETED|Overall Study||3
8803924|NCT01464697|9856070|FG001|NOT COMPLETED|Overall Study||10
8803925|NCT01464775|9856078|FG000|STARTED|Overall Study||123
8803926|NCT01464775|9856079|FG001|STARTED|Overall Study||44
8803927|NCT01464775|9856078|FG000|COMPLETED|Overall Study||112
8803928|NCT01464775|9856079|FG001|COMPLETED|Overall Study||38
8803929|NCT01464775|9856078|FG000|NOT COMPLETED|Overall Study||11
8803930|NCT01464775|9856079|FG001|NOT COMPLETED|Overall Study||6
8803931|NCT01464788|9856090|FG000|STARTED|Overall Study||30
8803932|NCT01464788|9856091|FG001|STARTED|Overall Study||31
8803933|NCT01464788|9856092|FG002|STARTED|Overall Study||29
8803934|NCT01464788|9856090|FG000|COMPLETED|Overall Study||30
8803935|NCT01464788|9856091|FG001|COMPLETED|Overall Study||29
8803936|NCT01464788|9856092|FG002|COMPLETED|Overall Study||29
8803937|NCT01464788|9856090|FG000|NOT COMPLETED|Overall Study||0
8803938|NCT01464788|9856091|FG001|NOT COMPLETED|Overall Study||2
8803939|NCT01464788|9856092|FG002|NOT COMPLETED|Overall Study||0
8803940|NCT01464827|9856116|FG000|STARTED|Overall Study||80
8803941|NCT01464827|9856117|FG001|STARTED|Overall Study||43
8803942|NCT01464827|9856118|FG002|STARTED|Overall Study||39
8803943|NCT01464827|9856119|FG003|STARTED|Overall Study||40
8803944|NCT01464827|9856120|FG004|STARTED|Overall Study||80
8803945|NCT01464827|9856121|FG005|STARTED|Overall Study||39
8803946|NCT01464827|9856122|FG006|STARTED|Overall Study||41
8803947|NCT01464827|9856123|FG007|STARTED|Overall Study||40
8803948|NCT01464827|9856124|FG008|STARTED|Overall Study||40
8803949|NCT01464827|9856125|FG009|STARTED|Overall Study||47
8803950|NCT01464827|9856126|FG010|STARTED|Overall Study||23
8803951|NCT01464827|9856127|FG011|STARTED|Overall Study||23
8803952|NCT01464827|9856128|FG012|STARTED|Overall Study||23
8803953|NCT01464827|9856129|FG013|STARTED|Overall Study||22
8803954|NCT01464827|9856116|FG000|Treated|Overall Study||80
8803955|NCT01464827|9856117|FG001|Treated|Overall Study||41
8803956|NCT01464827|9856118|FG002|Treated|Overall Study||39
8803957|NCT01464827|9856119|FG003|Treated|Overall Study||40
8803958|NCT01464827|9856120|FG004|Treated|Overall Study||79
8803959|NCT01464827|9856121|FG005|Treated|Overall Study||39
8803960|NCT01464827|9856122|FG006|Treated|Overall Study||40
8803961|NCT01464827|9856123|FG007|Treated|Overall Study||40
8803962|NCT01464827|9856124|FG008|Treated|Overall Study||40
8803963|NCT01464827|9856125|FG009|Treated|Overall Study||45
8803964|NCT01464827|9856126|FG010|Treated|Overall Study||23
8803965|NCT01464827|9856127|FG011|Treated|Overall Study||22
8803966|NCT01464827|9856128|FG012|Treated|Overall Study||23
8803967|NCT01464827|9856129|FG013|Treated|Overall Study||20
8803968|NCT01464827|9856116|FG000|COMPLETED|Overall Study||77
8803969|NCT01464827|9856117|FG001|COMPLETED|Overall Study||36
8803970|NCT01464827|9856118|FG002|COMPLETED|Overall Study||39
8803971|NCT01464827|9856119|FG003|COMPLETED|Overall Study||36
8803972|NCT01464827|9856120|FG004|COMPLETED|Overall Study||72
8803973|NCT01464827|9856121|FG005|COMPLETED|Overall Study||38
8803974|NCT01464827|9856122|FG006|COMPLETED|Overall Study||37
8803975|NCT01464827|9856123|FG007|COMPLETED|Overall Study||37
8803976|NCT01464827|9856124|FG008|COMPLETED|Overall Study||37
8803977|NCT01464827|9856125|FG009|COMPLETED|Overall Study||44
8803978|NCT01464827|9856126|FG010|COMPLETED|Overall Study||21
8803979|NCT01464827|9856127|FG011|COMPLETED|Overall Study||21
8803980|NCT01464827|9856128|FG012|COMPLETED|Overall Study||21
8803981|NCT01464827|9856129|FG013|COMPLETED|Overall Study||19
8803982|NCT01464827|9856116|FG000|NOT COMPLETED|Overall Study||3
8803983|NCT01464827|9856117|FG001|NOT COMPLETED|Overall Study||7
8803984|NCT01464827|9856118|FG002|NOT COMPLETED|Overall Study||0
8803985|NCT01464827|9856119|FG003|NOT COMPLETED|Overall Study||4
8803986|NCT01464827|9856120|FG004|NOT COMPLETED|Overall Study||8
8803987|NCT01464827|9856121|FG005|NOT COMPLETED|Overall Study||1
8803988|NCT01464827|9856122|FG006|NOT COMPLETED|Overall Study||4
8803989|NCT01464827|9856123|FG007|NOT COMPLETED|Overall Study||3
8803990|NCT01464827|9856124|FG008|NOT COMPLETED|Overall Study||3
8803991|NCT01464827|9856125|FG009|NOT COMPLETED|Overall Study||3
8803992|NCT01464827|9856126|FG010|NOT COMPLETED|Overall Study||2
8803993|NCT01464827|9856127|FG011|NOT COMPLETED|Overall Study||2
8803994|NCT01464827|9856128|FG012|NOT COMPLETED|Overall Study||2
8803995|NCT01464827|9856129|FG013|NOT COMPLETED|Overall Study||3
8803996|NCT01464840|9856173|FG000|STARTED|Overall Study||10
8803997|NCT01464840|9856174|FG001|STARTED|Overall Study||10
8803998|NCT01464840|9856175|FG002|STARTED|Overall Study||10
8803999|NCT01464840|9856173|FG000|COMPLETED|Overall Study||10
8804000|NCT01464840|9856174|FG001|COMPLETED|Overall Study||10
8804001|NCT01464840|9856175|FG002|COMPLETED|Overall Study||10
8804002|NCT01464840|9856173|FG000|NOT COMPLETED|Overall Study||0
8804003|NCT01464840|9856174|FG001|NOT COMPLETED|Overall Study||0
8804004|NCT01464840|9856175|FG002|NOT COMPLETED|Overall Study||0
8804005|NCT01464879|9856183|FG000|STARTED|Overall Study||20
8804006|NCT01464879|9856183|FG000|Hand Application (2.50 mL)|Overall Study||20
8804007|NCT01464879|9856183|FG000|Washout Period|Overall Study||20
8804008|NCT01464879|9856183|FG000|Applicator Application (1.25 mL)|Overall Study|One subject discontinued due to non-compliance.|19
8804009|NCT01464879|9856183|FG000|Applicator Application (2.50 mL)|Overall Study|One subject discontinued due to physician's decision.|18
8804010|NCT01464879|9856183|FG000|Applicator Application (3.75 mL)|Overall Study||18
8804011|NCT01464879|9856183|FG000|COMPLETED|Overall Study||18
8804012|NCT01464879|9856183|FG000|NOT COMPLETED|Overall Study||2
8804013|NCT01464931|9856195|FG000|STARTED|Overall Study||16
8804014|NCT01464931|9856196|FG001|STARTED|Overall Study||16
8804015|NCT01464931|9856195|FG000|COMPLETED|Overall Study||15
8804016|NCT01464931|9856196|FG001|COMPLETED|Overall Study||16
8804017|NCT01464931|9856195|FG000|NOT COMPLETED|Overall Study||1
8804018|NCT01464931|9856196|FG001|NOT COMPLETED|Overall Study||0
8804019|NCT01464996|9856209|FG000|STARTED|Overall Study||24
8804020|NCT01464996|9856209|FG000|OptiBond XTR|Overall Study||23
8804021|NCT01464996|9856209|FG000|OptiBond FL|Overall Study||24
8804022|NCT01464996|9856209|FG000|COMPLETED|Overall Study||24
8804023|NCT01464996|9856209|FG000|NOT COMPLETED|Overall Study||0
8804024|NCT01465022|9856218|FG000|STARTED|Overall Study||64
8804025|NCT01465022|9856219|FG001|STARTED|Overall Study||63
8804026|NCT01465022|9856220|FG002|STARTED|Overall Study||70
8804027|NCT01465022|9856218|FG000|COMPLETED|Overall Study||41
8804028|NCT01465022|9856219|FG001|COMPLETED|Overall Study||40
8804029|NCT01465022|9856220|FG002|COMPLETED|Overall Study||0
8804030|NCT01465022|9856218|FG000|NOT COMPLETED|Overall Study||23
8804031|NCT01465022|9856219|FG001|NOT COMPLETED|Overall Study||23
8804032|NCT01465022|9856220|FG002|NOT COMPLETED|Overall Study||70
8804033|NCT01465048|9856229|FG000|STARTED|Overall Study||6
8804034|NCT01465048|9856230|FG001|STARTED|Overall Study||6
8804035|NCT01465048|9856231|FG002|STARTED|Overall Study||6
8804036|NCT01465048|9856229|FG000|COMPLETED|Overall Study||6
8804037|NCT01465048|9856230|FG001|COMPLETED|Overall Study||6
8804038|NCT01465048|9856231|FG002|COMPLETED|Overall Study||6
8804039|NCT01465048|9856229|FG000|NOT COMPLETED|Overall Study||0
8804040|NCT01465048|9856230|FG001|NOT COMPLETED|Overall Study||0
8804041|NCT01465048|9856231|FG002|NOT COMPLETED|Overall Study||0
8804042|NCT01465178|9856241|FG000|STARTED|Overall Study||31
8804043|NCT01465178|9856242|FG001|STARTED|Overall Study||31
8804044|NCT01465178|9856241|FG000|COMPLETED|Overall Study||30
8804045|NCT01465178|9856242|FG001|COMPLETED|Overall Study||31
8804046|NCT01465178|9856241|FG000|NOT COMPLETED|Overall Study||1
8804047|NCT01465178|9856242|FG001|NOT COMPLETED|Overall Study||0
8804048|NCT01465191|9856251|FG000|STARTED|Overall Study||56
8804049|NCT01465191|9856252|FG001|STARTED|Overall Study||63
8804050|NCT01465191|9856253|FG002|STARTED|Overall Study||50
8804051|NCT01465191|9856251|FG000|COMPLETED|Overall Study||47
8804052|NCT01465191|9856252|FG001|COMPLETED|Overall Study||54
8804053|NCT01465191|9856253|FG002|COMPLETED|Overall Study||43
8804054|NCT01465191|9856251|FG000|NOT COMPLETED|Overall Study||9
8804055|NCT01465191|9856252|FG001|NOT COMPLETED|Overall Study||9
8804056|NCT01465191|9856253|FG002|NOT COMPLETED|Overall Study||7
8804057|NCT01465334|9856266|FG000|STARTED|Overall Study||15
8804058|NCT01465334|9856267|FG001|STARTED|Overall Study||15
8804059|NCT01465334|9856266|FG000|Complete Part A Induction|Overall Study||12
8804060|NCT01465334|9856267|FG001|Complete Part A Induction|Overall Study||15
8804061|NCT01465334|9856266|FG000|Complete Part B Induction|Overall Study||7
8804062|NCT01465334|9856267|FG001|Complete Part B Induction|Overall Study||15
8804063|NCT01465334|9856266|FG000|Eligible for Allogeneic Transplant|Overall Study||9
8804064|NCT01465334|9856267|FG001|Eligible for Allogeneic Transplant|Overall Study||9
8804065|NCT01465334|9856266|FG000|COMPLETED|Overall Study||13
8804066|NCT01465334|9856267|FG001|COMPLETED|Overall Study||9
8804067|NCT01465334|9856266|FG000|NOT COMPLETED|Overall Study||2
8804068|NCT01465334|9856267|FG001|NOT COMPLETED|Overall Study||6
8804069|NCT01465347|9856273|FG000|STARTED|Overall Study||3
8804070|NCT01465347|9856274|FG001|STARTED|Overall Study||56
8804071|NCT01465347|9856273|FG000|COMPLETED|Overall Study||2
8804072|NCT01465347|9856274|FG001|COMPLETED|Overall Study||53
8804073|NCT01465347|9856273|FG000|NOT COMPLETED|Overall Study||1
8804074|NCT01465347|9856274|FG001|NOT COMPLETED|Overall Study||3
8804075|NCT01465386|9856283|FG000|STARTED|Overall Study||6
8804076|NCT01465386|9856283|FG000|COMPLETED|Overall Study||2
8804077|NCT01465386|9856283|FG000|NOT COMPLETED|Overall Study||4
8804078|NCT01465412|9856291|FG000|STARTED|Overall Study||12
8804079|NCT01465412|9856292|FG001|STARTED|Overall Study||12
8920054|NCT02212457|9980110|FG002|COMPLETED|Overall Study||141
8920055|NCT02212457|9980111|FG003|COMPLETED|Overall Study||123
8920056|NCT02212457|9980112|FG004|COMPLETED|Overall Study||137
8920057|NCT02212457|9980113|FG005|COMPLETED|Overall Study||147
8920058|NCT02212457|9980108|FG000|NOT COMPLETED|Overall Study||19
8920059|NCT02212457|9980109|FG001|NOT COMPLETED|Overall Study||21
8920060|NCT02212457|9980110|FG002|NOT COMPLETED|Overall Study||16
8920061|NCT02212457|9980111|FG003|NOT COMPLETED|Overall Study||11
8920062|NCT02212457|9980112|FG004|NOT COMPLETED|Overall Study||15
8920063|NCT02212457|9980113|FG005|NOT COMPLETED|Overall Study||13
8920064|NCT02212587|9980134|FG000|STARTED|Overall Study||10
8920065|NCT02212587|9980134|FG000|COMPLETED|Overall Study||9
8920066|NCT02212587|9980134|FG000|NOT COMPLETED|Overall Study||1
8920067|NCT02212678|9980138|FG000|STARTED|Overall Study||8
8920068|NCT02212678|9980138|FG000|COMPLETED|Overall Study||7
8920069|NCT02212678|9980138|FG000|NOT COMPLETED|Overall Study||1
8920070|NCT02212730|9980144|FG000|STARTED|Overall Study||6
8920071|NCT02212730|9980145|FG001|STARTED|Overall Study||4
8920072|NCT02212730|9980144|FG000|Received Neoadjuvant Pembrolizumab|Overall Study||4
8920073|NCT02212730|9980145|FG001|Received Neoadjuvant Pembrolizumab|Overall Study||0
8920074|NCT02212730|9980144|FG000|Underwent RCC|Overall Study||4
8920075|NCT02212730|9980145|FG001|Underwent RCC|Overall Study||3
8920076|NCT02212730|9980144|FG000|Received Post-RCC Pembrolizumab|Overall Study||1
8920077|NCT02212730|9980145|FG001|Received Post-RCC Pembrolizumab|Overall Study||1
8920078|NCT02212730|9980144|FG000|COMPLETED|Overall Study||4
8920079|NCT02212730|9980145|FG001|COMPLETED|Overall Study||3
8920080|NCT02212730|9980144|FG000|NOT COMPLETED|Overall Study||2
8920081|NCT02212730|9980145|FG001|NOT COMPLETED|Overall Study||1
8920082|NCT02212834|9980155|FG000|STARTED|Overall Study||33938
8920083|NCT02212834|9980156|FG001|STARTED|Overall Study||2506
8920084|NCT02212834|9980155|FG000|COMPLETED|Overall Study||33938
8920085|NCT02212834|9980156|FG001|COMPLETED|Overall Study||2506
8920086|NCT02212834|9980155|FG000|NOT COMPLETED|Overall Study||0
8920087|NCT02212834|9980156|FG001|NOT COMPLETED|Overall Study||0
8920088|NCT02212977|9980164|FG000|STARTED|Overall Study||55
8920089|NCT02212977|9980165|FG001|STARTED|Overall Study||54
8920090|NCT02212977|9980164|FG000|COMPLETED|Overall Study||50
8920091|NCT02212977|9980165|FG001|COMPLETED|Overall Study||48
8920092|NCT02212977|9980164|FG000|NOT COMPLETED|Overall Study||5
8920093|NCT02212977|9980165|FG001|NOT COMPLETED|Overall Study||6
8920094|NCT02213042|9980174|FG000|STARTED|Overall Study||17
8920095|NCT02213042|9980175|FG001|STARTED|Overall Study||15
8920096|NCT02213042|9980176|FG002|STARTED|Overall Study||10
8920097|NCT02213042|9980174|FG000|Total Deaths|Overall Study||11
8920098|NCT02213042|9980175|FG001|Total Deaths|Overall Study||9
8920099|NCT02213042|9980176|FG002|Total Deaths|Overall Study||6
8920100|NCT02213042|9980174|FG000|COMPLETED|Overall Study||0
8920101|NCT02213042|9980175|FG001|COMPLETED|Overall Study||0
8920102|NCT02213042|9980176|FG002|COMPLETED|Overall Study||0
8920103|NCT02213042|9980174|FG000|NOT COMPLETED|Overall Study||17
8920104|NCT02213042|9980175|FG001|NOT COMPLETED|Overall Study||15
8920105|NCT02213042|9980176|FG002|NOT COMPLETED|Overall Study||10
8920106|NCT02213055|9980188|FG000|STARTED|Overall Study||97
8920107|NCT02213055|9980189|FG001|STARTED|Overall Study||0
8920108|NCT02213055|9980188|FG000|COMPLETED|Overall Study||58
8920109|NCT02213055|9980189|FG001|COMPLETED|Overall Study||0
8920110|NCT02213055|9980188|FG000|NOT COMPLETED|Overall Study||39
8804080|NCT01465412|9856293|FG002|STARTED|Overall Study||9
8920111|NCT02213055|9980189|FG001|NOT COMPLETED|Overall Study||0
8920112|NCT02213068|9980198|FG000|STARTED|Overall Study||9
8920113|NCT02213068|9980199|FG001|STARTED|Overall Study||8
8920114|NCT02213068|9980200|FG002|STARTED|Overall Study||10
8920115|NCT02213068|9980198|FG000|COMPLETED|Overall Study||9
8920116|NCT02213068|9980199|FG001|COMPLETED|Overall Study||8
8920117|NCT02213068|9980200|FG002|COMPLETED|Overall Study||10
8920118|NCT02213068|9980198|FG000|NOT COMPLETED|Overall Study||0
8920119|NCT02213068|9980199|FG001|NOT COMPLETED|Overall Study||0
8920120|NCT02213068|9980200|FG002|NOT COMPLETED|Overall Study||0
8920121|NCT02213094|9980210|FG000|STARTED|Overall Study||5
8920122|NCT02213094|9980211|FG001|STARTED|Overall Study||5
8804081|NCT01465412|9856294|FG003|STARTED|Overall Study||9
8804082|NCT01465412|9856291|FG000|COMPLETED|Overall Study||12
8804083|NCT01465412|9856292|FG001|COMPLETED|Overall Study||12
8804084|NCT01465412|9856293|FG002|COMPLETED|Overall Study||9
8804085|NCT01465412|9856294|FG003|COMPLETED|Overall Study||9
8804086|NCT01465412|9856291|FG000|NOT COMPLETED|Overall Study||0
8804087|NCT01465412|9856292|FG001|NOT COMPLETED|Overall Study||0
8804088|NCT01465412|9856293|FG002|NOT COMPLETED|Overall Study||0
8804089|NCT01465412|9856294|FG003|NOT COMPLETED|Overall Study||0
8804090|NCT01465464|9856306|FG000|STARTED|Overall Study||444
8804091|NCT01465464|9856307|FG001|STARTED|Overall Study||444
8804092|NCT01465464|9856306|FG000|COMPLETED|Overall Study||0
8804093|NCT01465464|9856307|FG001|COMPLETED|Overall Study||0
8804094|NCT01465464|9856306|FG000|NOT COMPLETED|Overall Study||444
8804095|NCT01465464|9856307|FG001|NOT COMPLETED|Overall Study||444
8804096|NCT01465659|9856317|FG000|STARTED|Completed 1 Cycle of Treatment||7
8804097|NCT01465659|9856318|FG001|STARTED|Completed 1 Cycle of Treatment||5
8804098|NCT01465659|9856319|FG002|STARTED|Completed 1 Cycle of Treatment||6
8804099|NCT01465659|9856320|FG003|STARTED|Completed 1 Cycle of Treatment||11
8804100|NCT01465659|9856317|FG000|Completed 1 Cycle of Treatment|Completed 1 Cycle of Treatment||7
8804101|NCT01465659|9856318|FG001|Completed 1 Cycle of Treatment|Completed 1 Cycle of Treatment||4
8804102|NCT01465659|9856319|FG002|Completed 1 Cycle of Treatment|Completed 1 Cycle of Treatment||6
8804103|NCT01465659|9856320|FG003|Completed 1 Cycle of Treatment|Completed 1 Cycle of Treatment||11
8804104|NCT01465659|9856317|FG000|COMPLETED|Completed 1 Cycle of Treatment||7
8804105|NCT01465659|9856318|FG001|COMPLETED|Completed 1 Cycle of Treatment||4
8804106|NCT01465659|9856319|FG002|COMPLETED|Completed 1 Cycle of Treatment||6
8804107|NCT01465659|9856320|FG003|COMPLETED|Completed 1 Cycle of Treatment||10
8804108|NCT01465659|9856317|FG000|NOT COMPLETED|Completed 1 Cycle of Treatment||0
8804109|NCT01465659|9856318|FG001|NOT COMPLETED|Completed 1 Cycle of Treatment||1
8804110|NCT01465659|9856319|FG002|NOT COMPLETED|Completed 1 Cycle of Treatment||0
8804111|NCT01465659|9856320|FG003|NOT COMPLETED|Completed 1 Cycle of Treatment||1
8804112|NCT01465659|9856317|FG000|STARTED|Completed 2 Cycles/Reached 1st Response||7
8804113|NCT01465659|9856318|FG001|STARTED|Completed 2 Cycles/Reached 1st Response||4
8804114|NCT01465659|9856319|FG002|STARTED|Completed 2 Cycles/Reached 1st Response||6
8804115|NCT01465659|9856320|FG003|STARTED|Completed 2 Cycles/Reached 1st Response||10
8804116|NCT01465659|9856317|FG000|Attempted 2 Cycles of Treatment|Completed 2 Cycles/Reached 1st Response||7
8804117|NCT01465659|9856318|FG001|Attempted 2 Cycles of Treatment|Completed 2 Cycles/Reached 1st Response||4
8804118|NCT01465659|9856319|FG002|Attempted 2 Cycles of Treatment|Completed 2 Cycles/Reached 1st Response||6
8804119|NCT01465659|9856320|FG003|Attempted 2 Cycles of Treatment|Completed 2 Cycles/Reached 1st Response||10
8804120|NCT01465659|9856317|FG000|Reached 1st Response|Completed 2 Cycles/Reached 1st Response||7
8804121|NCT01465659|9856318|FG001|Reached 1st Response|Completed 2 Cycles/Reached 1st Response||4
8804122|NCT01465659|9856319|FG002|Reached 1st Response|Completed 2 Cycles/Reached 1st Response||6
8804123|NCT01465659|9856320|FG003|Reached 1st Response|Completed 2 Cycles/Reached 1st Response||10
8804124|NCT01465659|9856317|FG000|Assessed to Move on to Next Cycle|Completed 2 Cycles/Reached 1st Response||7
8804125|NCT01465659|9856318|FG001|Assessed to Move on to Next Cycle|Completed 2 Cycles/Reached 1st Response||4
8804126|NCT01465659|9856319|FG002|Assessed to Move on to Next Cycle|Completed 2 Cycles/Reached 1st Response||4
8804127|NCT01465659|9856320|FG003|Assessed to Move on to Next Cycle|Completed 2 Cycles/Reached 1st Response||10
8804128|NCT01465659|9856317|FG000|COMPLETED|Completed 2 Cycles/Reached 1st Response||5
8804129|NCT01465659|9856318|FG001|COMPLETED|Completed 2 Cycles/Reached 1st Response||4
8804130|NCT01465659|9856319|FG002|COMPLETED|Completed 2 Cycles/Reached 1st Response||4
8804131|NCT01465659|9856320|FG003|COMPLETED|Completed 2 Cycles/Reached 1st Response||9
8804132|NCT01465659|9856317|FG000|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||2
8804133|NCT01465659|9856318|FG001|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
8804134|NCT01465659|9856319|FG002|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||2
8804135|NCT01465659|9856320|FG003|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||1
8804136|NCT01465659|9856317|FG000|STARTED|Went on to Cycle 3 and Beyond||5
8804137|NCT01465659|9856318|FG001|STARTED|Went on to Cycle 3 and Beyond||4
8804138|NCT01465659|9856319|FG002|STARTED|Went on to Cycle 3 and Beyond||4
8804139|NCT01465659|9856320|FG003|STARTED|Went on to Cycle 3 and Beyond||9
8804140|NCT01465659|9856317|FG000|COMPLETED|Went on to Cycle 3 and Beyond||5
8804141|NCT01465659|9856318|FG001|COMPLETED|Went on to Cycle 3 and Beyond||4
8804142|NCT01465659|9856319|FG002|COMPLETED|Went on to Cycle 3 and Beyond||4
8804143|NCT01465659|9856320|FG003|COMPLETED|Went on to Cycle 3 and Beyond||9
8804144|NCT01465659|9856317|FG000|NOT COMPLETED|Went on to Cycle 3 and Beyond||0
8804145|NCT01465659|9856318|FG001|NOT COMPLETED|Went on to Cycle 3 and Beyond||0
8804146|NCT01465659|9856319|FG002|NOT COMPLETED|Went on to Cycle 3 and Beyond||0
8804147|NCT01465659|9856320|FG003|NOT COMPLETED|Went on to Cycle 3 and Beyond||0
8804148|NCT01465659|9856317|FG000|STARTED|Completed Follow for 1 Year||7
8804149|NCT01465659|9856318|FG001|STARTED|Completed Follow for 1 Year||4
8804150|NCT01465659|9856319|FG002|STARTED|Completed Follow for 1 Year||6
8804151|NCT01465659|9856320|FG003|STARTED|Completed Follow for 1 Year||11
8804152|NCT01465659|9856317|FG000|COMPLETED|Completed Follow for 1 Year||1
8804153|NCT01465659|9856318|FG001|COMPLETED|Completed Follow for 1 Year||1
8804154|NCT01465659|9856319|FG002|COMPLETED|Completed Follow for 1 Year||4
8804155|NCT01465659|9856320|FG003|COMPLETED|Completed Follow for 1 Year||7
8804156|NCT01465659|9856317|FG000|NOT COMPLETED|Completed Follow for 1 Year||6
8804157|NCT01465659|9856318|FG001|NOT COMPLETED|Completed Follow for 1 Year||3
8804158|NCT01465659|9856319|FG002|NOT COMPLETED|Completed Follow for 1 Year||2
8804159|NCT01465659|9856320|FG003|NOT COMPLETED|Completed Follow for 1 Year||4
8804160|NCT01465763|9856336|FG000|STARTED|Overall Study||476
8804161|NCT01465763|9856337|FG001|STARTED|Overall Study||16
8804162|NCT01465763|9856338|FG002|STARTED|Overall Study||122
8804163|NCT01465763|9856336|FG000|COMPLETED|Overall Study||445
8804164|NCT01465763|9856337|FG001|COMPLETED|Overall Study||15
8804165|NCT01465763|9856338|FG002|COMPLETED|Overall Study||118
8804166|NCT01465763|9856336|FG000|NOT COMPLETED|Overall Study||31
8804167|NCT01465763|9856337|FG001|NOT COMPLETED|Overall Study||1
8804168|NCT01465763|9856338|FG002|NOT COMPLETED|Overall Study||4
8804169|NCT01465802|9856350|FG000|STARTED|Overall Study||66
8804170|NCT01465802|9856351|FG001|STARTED|Overall Study||66
8804171|NCT01465802|9856352|FG002|STARTED|Overall Study||7
8804172|NCT01465802|9856353|FG003|STARTED|Overall Study|An additional 5 participants were enrolled in Cohort II but not treated.|67
8804173|NCT01465802|9856354|FG004|STARTED|Overall Study||25
8804174|NCT01465802|9856350|FG000|COMPLETED|Overall Study||33
8804175|NCT01465802|9856351|FG001|COMPLETED|Overall Study||42
8804176|NCT01465802|9856352|FG002|COMPLETED|Overall Study||7
8804177|NCT01465802|9856353|FG003|COMPLETED|Overall Study||38
8804178|NCT01465802|9856354|FG004|COMPLETED|Overall Study||13
8804179|NCT01465802|9856350|FG000|NOT COMPLETED|Overall Study||33
8804180|NCT01465802|9856351|FG001|NOT COMPLETED|Overall Study||24
8804181|NCT01465802|9856352|FG002|NOT COMPLETED|Overall Study||0
8804182|NCT01465802|9856353|FG003|NOT COMPLETED|Overall Study||29
8804183|NCT01465802|9856354|FG004|NOT COMPLETED|Overall Study||12
8804184|NCT01465841|9856368|FG000|STARTED|Overall Study||517
8804185|NCT01465841|9856368|FG000|COMPLETED|Overall Study||449
8804186|NCT01465841|9856368|FG000|NOT COMPLETED|Overall Study||68
8804187|NCT01465958|9856372|FG000|STARTED|Run-in Phase||11
8804188|NCT01465958|9856373|FG001|STARTED|Run-in Phase||0
8804189|NCT01465958|9856372|FG000|COMPLETED|Run-in Phase||10
8804190|NCT01465958|9856373|FG001|COMPLETED|Run-in Phase||0
8804191|NCT01465958|9856372|FG000|NOT COMPLETED|Run-in Phase||1
8804192|NCT01465958|9856373|FG001|NOT COMPLETED|Run-in Phase||0
8804193|NCT01465958|9856372|FG000|STARTED|Intravenous (IV) Phase|One subject entered the IV phase directly.|11
8804194|NCT01465958|9856373|FG001|STARTED|Intravenous (IV) Phase||0
8804195|NCT01465958|9856372|FG000|COMPLETED|Intravenous (IV) Phase||11
8804196|NCT01465958|9856373|FG001|COMPLETED|Intravenous (IV) Phase||0
8804197|NCT01465958|9856372|FG000|NOT COMPLETED|Intravenous (IV) Phase||0
8804198|NCT01465958|9856373|FG001|NOT COMPLETED|Intravenous (IV) Phase||0
8804199|NCT01465958|9856372|FG000|STARTED|Subcutaneous (SC) Phase|After completing the intravenous (IV) phase, subjects entered the subcutaneous (SC) phase.|0
8804200|NCT01465958|9856373|FG001|STARTED|Subcutaneous (SC) Phase|Eleven subjects completed the IV phase and entered the SC phase.|11
8804201|NCT01465958|9856372|FG000|COMPLETED|Subcutaneous (SC) Phase||0
8804202|NCT01465958|9856373|FG001|COMPLETED|Subcutaneous (SC) Phase||10
8804203|NCT01465958|9856372|FG000|NOT COMPLETED|Subcutaneous (SC) Phase||0
8804204|NCT01465958|9856373|FG001|NOT COMPLETED|Subcutaneous (SC) Phase||1
8804205|NCT01465997|9856382|FG000|STARTED|Overall Study||279
8804206|NCT01465997|9856383|FG001|STARTED|Overall Study||269
8804207|NCT01465997|9856382|FG000|COMPLETED|Overall Study||211
8804208|NCT01465997|9856383|FG001|COMPLETED|Overall Study||180
8804209|NCT01465997|9856382|FG000|NOT COMPLETED|Overall Study||68
8804210|NCT01465997|9856383|FG001|NOT COMPLETED|Overall Study||89
8804211|NCT01466062|9856391|FG000|STARTED|Overall Study||28
8804212|NCT01466062|9856391|FG000|COMPLETED|Overall Study||26
8804213|NCT01466062|9856391|FG000|NOT COMPLETED|Overall Study||2
8804214|NCT01466075|9856395|FG000|STARTED|Overall Study||207
8804215|NCT01466075|9856395|FG000|COMPLETED|Overall Study||207
8804216|NCT01466075|9856395|FG000|NOT COMPLETED|Overall Study||0
8804217|NCT01466127|9856401|FG000|STARTED|Overall Study||30
8804218|NCT01466127|9856402|FG001|STARTED|Overall Study||30
8804219|NCT01466127|9856401|FG000|COMPLETED|Overall Study||16
8804220|NCT01466127|9856402|FG001|COMPLETED|Overall Study||14
8804221|NCT01466127|9856401|FG000|NOT COMPLETED|Overall Study||14
8804222|NCT01466127|9856402|FG001|NOT COMPLETED|Overall Study||16
8804223|NCT01466153|9856411|FG000|STARTED|Overall Study||62
8804224|NCT01466153|9856412|FG001|STARTED|Overall Study||36
8804225|NCT01466153|9856413|FG002|STARTED|Overall Study||61
8804226|NCT01466153|9856411|FG000|COMPLETED|Overall Study||33
8804227|NCT01466153|9856412|FG001|COMPLETED|Overall Study||12
8804228|NCT01466153|9856413|FG002|COMPLETED|Overall Study||36
8804229|NCT01466153|9856411|FG000|NOT COMPLETED|Overall Study||29
8804230|NCT01466153|9856412|FG001|NOT COMPLETED|Overall Study||24
8804231|NCT01466153|9856413|FG002|NOT COMPLETED|Overall Study||25
8804232|NCT01466166|9856423|FG000|STARTED|Overall Study||188
8804233|NCT01466166|9856423|FG000|Received Treatment|Overall Study||188
8804234|NCT01466166|9856423|FG000|Completed 24 Weeks of Treatment|Overall Study||55
8804235|NCT01466166|9856423|FG000|COMPLETED|Overall Study||25
8804236|NCT01466166|9856423|FG000|NOT COMPLETED|Overall Study||163
8804237|NCT01466179|9856427|FG000|STARTED|Overall Study|Participants enrolled during the first 3 stages of the study|189
8804238|NCT01466179|9856427|FG000|COMPLETED|Overall Study|Completed 5 cycles of treatment; Data as of the time of the data cut-off date (10 October 2013).|10
8804239|NCT01466179|9856427|FG000|NOT COMPLETED|Overall Study||179
8804240|NCT01466192|9856434|FG000|STARTED|Overall Study||108
8804241|NCT01466192|9856434|FG000|COMPLETED|Overall Study||104
8804242|NCT01466192|9856434|FG000|NOT COMPLETED|Overall Study||4
8804243|NCT01466270|9856440|FG000|STARTED|Overall Study||31
8804244|NCT01466270|9856441|FG001|STARTED|Overall Study||31
8804245|NCT01466270|9856440|FG000|COMPLETED|Overall Study||19
8804246|NCT01466270|9856441|FG001|COMPLETED|Overall Study||25
8804247|NCT01466270|9856440|FG000|NOT COMPLETED|Overall Study||12
8804248|NCT01466270|9856441|FG001|NOT COMPLETED|Overall Study||6
8804249|NCT01466348|9856449|FG000|STARTED|Period I - First Intervention||36
8804250|NCT01466348|9856450|FG001|STARTED|Period I - First Intervention||36
8804251|NCT01466348|9856449|FG000|Intent To Treat (ITT) Population|Period I - First Intervention||36
8804252|NCT01466348|9856450|FG001|Intent To Treat (ITT) Population|Period I - First Intervention|1 participant withdrew prior receiving the treatment|35
8804253|NCT01466348|9856449|FG000|COMPLETED|Period I - First Intervention||36
8804254|NCT01466348|9856450|FG001|COMPLETED|Period I - First Intervention||35
8804255|NCT01466348|9856449|FG000|NOT COMPLETED|Period I - First Intervention||0
8804256|NCT01466348|9856450|FG001|NOT COMPLETED|Period I - First Intervention||1
8804257|NCT01466348|9856449|FG000|STARTED|Period II - Second Intervention||35
8804258|NCT01466348|9856450|FG001|STARTED|Period II - Second Intervention||36
8804259|NCT01466348|9856449|FG000|COMPLETED|Period II - Second Intervention||35
8804260|NCT01466348|9856450|FG001|COMPLETED|Period II - Second Intervention||36
8804261|NCT01466348|9856449|FG000|NOT COMPLETED|Period II - Second Intervention||0
8804262|NCT01466348|9856450|FG001|NOT COMPLETED|Period II - Second Intervention||0
8804263|NCT01466361|9856462|FG000|STARTED|Overall Study||52
8804264|NCT01466361|9856463|FG001|STARTED|Overall Study||34
8804265|NCT01466361|9856464|FG002|STARTED|Overall Study||60
8804266|NCT01466361|9856465|FG003|STARTED|Overall Study||41
8804267|NCT01466361|9856462|FG000|COMPLETED|Overall Study||52
8804268|NCT01466361|9856463|FG001|COMPLETED|Overall Study||34
8804269|NCT01466361|9856464|FG002|COMPLETED|Overall Study||60
8804270|NCT01466361|9856465|FG003|COMPLETED|Overall Study||41
8804271|NCT01466361|9856462|FG000|NOT COMPLETED|Overall Study||0
8804272|NCT01466361|9856463|FG001|NOT COMPLETED|Overall Study||0
8804273|NCT01466361|9856464|FG002|NOT COMPLETED|Overall Study||0
8804274|NCT01466361|9856465|FG003|NOT COMPLETED|Overall Study||0
8804275|NCT01466387|9856486|FG000|STARTED|Overall Study||101
8804276|NCT01466387|9856487|FG001|STARTED|Overall Study||100
8804277|NCT01466387|9856488|FG002|STARTED|Overall Study||99
8804278|NCT01466387|9856489|FG003|STARTED|Overall Study||101
8804279|NCT01466387|9856490|FG004|STARTED|Overall Study||51
8804280|NCT01466387|9856491|FG005|STARTED|Overall Study||100
8804281|NCT01466387|9856486|FG000|COMPLETED|Overall Study||100
8804282|NCT01466387|9856487|FG001|COMPLETED|Overall Study||100
8804283|NCT01466387|9856488|FG002|COMPLETED|Overall Study||98
8804284|NCT01466387|9856489|FG003|COMPLETED|Overall Study||99
8804285|NCT01466387|9856490|FG004|COMPLETED|Overall Study||51
8804286|NCT01466387|9856491|FG005|COMPLETED|Overall Study||99
8804287|NCT01466387|9856486|FG000|NOT COMPLETED|Overall Study||1
8804288|NCT01466387|9856487|FG001|NOT COMPLETED|Overall Study||0
8804289|NCT01466387|9856488|FG002|NOT COMPLETED|Overall Study||1
8804290|NCT01466387|9856489|FG003|NOT COMPLETED|Overall Study||2
8804291|NCT01466387|9856490|FG004|NOT COMPLETED|Overall Study||0
8804292|NCT01466387|9856491|FG005|NOT COMPLETED|Overall Study||1
8804293|NCT01466491|9856518|FG000|STARTED|Overall Study||83
8804294|NCT01466491|9856519|FG001|STARTED|Overall Study||83
8804295|NCT01466491|9856520|FG002|STARTED|Overall Study||83
8804296|NCT01466491|9856521|FG003|STARTED|Overall Study||83
8804297|NCT01466491|9856518|FG000|COMPLETED|Overall Study||83
8804298|NCT01466491|9856519|FG001|COMPLETED|Overall Study||80
8804299|NCT01466491|9856520|FG002|COMPLETED|Overall Study||80
8804300|NCT01466491|9856521|FG003|COMPLETED|Overall Study||83
8804301|NCT01466491|9856518|FG000|NOT COMPLETED|Overall Study||0
8804302|NCT01466491|9856519|FG001|NOT COMPLETED|Overall Study||3
8804303|NCT01466491|9856520|FG002|NOT COMPLETED|Overall Study||3
8804304|NCT01466491|9856521|FG003|NOT COMPLETED|Overall Study||0
8804305|NCT01466595|9856533|FG000|STARTED|Overall Study||49
8804306|NCT01466595|9856534|FG001|STARTED|Overall Study||24
8804307|NCT01466595|9856533|FG000|COMPLETED|Overall Study||49
8804308|NCT01466595|9856534|FG001|COMPLETED|Overall Study||23
8804309|NCT01466595|9856533|FG000|NOT COMPLETED|Overall Study||0
8804310|NCT01466595|9856534|FG001|NOT COMPLETED|Overall Study||1
8804311|NCT01466660|9856542|FG000|STARTED|Overall Study||160
8804312|NCT01466660|9856543|FG001|STARTED|Overall Study||159
8804313|NCT01466660|9856542|FG000|COMPLETED|Overall Study|On treatment at analysis cut-off date, 12 April 2019|0
8804314|NCT01466660|9856543|FG001|COMPLETED|Overall Study|On treatment at analysis cut-off date, 12 April 2019|0
8804315|NCT01466660|9856542|FG000|NOT COMPLETED|Overall Study||160
8804316|NCT01466660|9856543|FG001|NOT COMPLETED|Overall Study||159
8804317|NCT01466673|9856551|FG000|STARTED|Overall Study||100
8804318|NCT01466673|9856552|FG001|STARTED|Overall Study||101
8804319|NCT01466673|9856551|FG000|COMPLETED|Overall Study||93
8804320|NCT01466673|9856552|FG001|COMPLETED|Overall Study||95
8804321|NCT01466673|9856551|FG000|NOT COMPLETED|Overall Study||7
8804322|NCT01466673|9856552|FG001|NOT COMPLETED|Overall Study||6
8804323|NCT01466751|9856560|FG000|STARTED|Overall Study||14
8804324|NCT01466751|9856561|FG001|STARTED|Overall Study||14
8804325|NCT01466751|9856560|FG000|COMPLETED|Overall Study||13
8804326|NCT01466751|9856561|FG001|COMPLETED|Overall Study||14
8804327|NCT01466751|9856560|FG000|NOT COMPLETED|Overall Study||1
8804328|NCT01466751|9856561|FG001|NOT COMPLETED|Overall Study||0
8804329|NCT01466764|9856571|FG000|STARTED|Overall Study||5
8804330|NCT01466764|9856572|FG001|STARTED|Overall Study||5
8804331|NCT01466764|9856571|FG000|COMPLETED|Overall Study||5
8804332|NCT01466764|9856572|FG001|COMPLETED|Overall Study||5
8804333|NCT01466764|9856571|FG000|NOT COMPLETED|Overall Study||0
8804334|NCT01466764|9856572|FG001|NOT COMPLETED|Overall Study||0
8804335|NCT01466790|9856586|FG000|STARTED|Overall Study|Not including 1 participant who was randomized to this group, but never received treatment.|24
8804336|NCT01466790|9856587|FG001|STARTED|Overall Study||15
8804337|NCT01466790|9856588|FG002|STARTED|Overall Study||27
8804338|NCT01466790|9856589|FG003|STARTED|Overall Study||14
8804339|NCT01466790|9856590|FG004|STARTED|Overall Study||30
8804340|NCT01466790|9856591|FG005|STARTED|Overall Study||16
8804341|NCT01466790|9856592|FG006|STARTED|Overall Study||27
8804342|NCT01466790|9856593|FG007|STARTED|Overall Study||14
8804343|NCT01466790|9856586|FG000|COMPLETED|Overall Study||20
8804344|NCT01466790|9856587|FG001|COMPLETED|Overall Study||14
8804345|NCT01466790|9856588|FG002|COMPLETED|Overall Study||27
8804346|NCT01466790|9856589|FG003|COMPLETED|Overall Study||14
8804347|NCT01466790|9856590|FG004|COMPLETED|Overall Study||27
8804348|NCT01466790|9856591|FG005|COMPLETED|Overall Study||16
8804349|NCT01466790|9856592|FG006|COMPLETED|Overall Study||26
8804350|NCT01466790|9856593|FG007|COMPLETED|Overall Study||13
8804351|NCT01466790|9856586|FG000|NOT COMPLETED|Overall Study||4
8804352|NCT01466790|9856587|FG001|NOT COMPLETED|Overall Study||1
8804353|NCT01466790|9856588|FG002|NOT COMPLETED|Overall Study||0
8804354|NCT01466790|9856589|FG003|NOT COMPLETED|Overall Study||0
8804355|NCT01466790|9856590|FG004|NOT COMPLETED|Overall Study||3
8804356|NCT01466790|9856591|FG005|NOT COMPLETED|Overall Study||0
8804357|NCT01466790|9856592|FG006|NOT COMPLETED|Overall Study||1
8804358|NCT01466790|9856593|FG007|NOT COMPLETED|Overall Study||1
8804359|NCT01466881|9856607|FG000|STARTED|Overall Study||42
8804360|NCT01466881|9856607|FG000|Eligible and Treated|Overall Study||37
8804361|NCT01466881|9856607|FG000|COMPLETED|Overall Study||2
8804362|NCT01466881|9856607|FG000|NOT COMPLETED|Overall Study||40
8804363|NCT01466972|9856613|FG000|STARTED|Overall Study||30
8804364|NCT01466972|9856613|FG000|COMPLETED|Overall Study||30
8804365|NCT01466972|9856613|FG000|NOT COMPLETED|Overall Study||0
8804366|NCT01466985|9856620|FG000|STARTED|Overall Study||6
8804367|NCT01466985|9856621|FG001|STARTED|Overall Study||6
8804368|NCT01466985|9856622|FG002|STARTED|Overall Study||6
8804369|NCT01466985|9856620|FG000|COMPLETED|Overall Study||6
8804370|NCT01466985|9856621|FG001|COMPLETED|Overall Study||6
8804371|NCT01466985|9856622|FG002|COMPLETED|Overall Study||6
8804372|NCT01466985|9856620|FG000|NOT COMPLETED|Overall Study||0
8804373|NCT01466985|9856621|FG001|NOT COMPLETED|Overall Study||0
8804374|NCT01466985|9856622|FG002|NOT COMPLETED|Overall Study||0
8804375|NCT01467037|9856633|FG000|STARTED|Overall Study||374
8804376|NCT01467037|9856633|FG000|COMPLETED|Overall Study||374
8804377|NCT01467037|9856633|FG000|NOT COMPLETED|Overall Study||0
8804378|NCT01467063|9856640|FG000|STARTED|Overall Study||6
8804379|NCT01467063|9856641|FG001|STARTED|Overall Study||7
8804380|NCT01467063|9856640|FG000|COMPLETED|Overall Study||5
8804381|NCT01467063|9856641|FG001|COMPLETED|Overall Study||7
8804382|NCT01467063|9856640|FG000|NOT COMPLETED|Overall Study||1
8804383|NCT01467063|9856641|FG001|NOT COMPLETED|Overall Study||0
8804384|NCT01467076|9856650|FG000|STARTED|Overall Study||3
8804385|NCT01467076|9856651|FG001|STARTED|Overall Study||2
8804386|NCT01467076|9856652|FG002|STARTED|Overall Study||2
8804387|NCT01467076|9856650|FG000|COMPLETED|Overall Study||2
8804388|NCT01467076|9856651|FG001|COMPLETED|Overall Study||2
8804389|NCT01467076|9856652|FG002|COMPLETED|Overall Study||2
8804390|NCT01467076|9856650|FG000|NOT COMPLETED|Overall Study||1
8804391|NCT01467076|9856651|FG001|NOT COMPLETED|Overall Study||0
8804392|NCT01467076|9856652|FG002|NOT COMPLETED|Overall Study||0
8920123|NCT02213094|9980210|FG000|COMPLETED|Overall Study|One subject stopped study agent early because of elevation in LFTs > 3x ULN|4
8920124|NCT02213094|9980211|FG001|COMPLETED|Overall Study||5
8920125|NCT02213094|9980210|FG000|NOT COMPLETED|Overall Study||1
8920126|NCT02213094|9980211|FG001|NOT COMPLETED|Overall Study||0
8920127|NCT02213133|9980220|FG000|STARTED|Overall Study||37
8920128|NCT02213133|9980221|FG001|STARTED|Overall Study||5
8920129|NCT02213133|9980222|FG002|STARTED|Overall Study||3
8920130|NCT02213133|9980220|FG000|Treated|Overall Study||33
8920131|NCT02213133|9980221|FG001|Treated|Overall Study||4
8920132|NCT02213133|9980222|FG002|Treated|Overall Study||1
8920133|NCT02213133|9980220|FG000|COMPLETED|Overall Study||0
8920134|NCT02213133|9980221|FG001|COMPLETED|Overall Study||0
8920135|NCT02213133|9980222|FG002|COMPLETED|Overall Study||0
8920136|NCT02213133|9980220|FG000|NOT COMPLETED|Overall Study||37
9035748|NCT03301740|10097445|FG001|NOT COMPLETED|Third Washout (1 Week)||0
8804393|NCT01467271|9856660|FG000|STARTED|Overall Study||540
8804394|NCT01467271|9856660|FG000|COMPLETED|Overall Study||338
8804395|NCT01467271|9856660|FG000|NOT COMPLETED|Overall Study||202
8804396|NCT01467427|9856666|FG000|STARTED|Overall Study||12
8804397|NCT01467427|9856667|FG001|STARTED|Overall Study||13
8804398|NCT01467427|9856666|FG000|Completed Main Phase|Overall Study||11
8804399|NCT01467427|9856667|FG001|Completed Main Phase|Overall Study||13
8804400|NCT01467427|9856666|FG000|COMPLETED|Overall Study||0
8804401|NCT01467427|9856667|FG001|COMPLETED|Overall Study||0
8804402|NCT01467427|9856666|FG000|NOT COMPLETED|Overall Study||12
8920137|NCT02213133|9980221|FG001|NOT COMPLETED|Overall Study||5
8920138|NCT02213133|9980222|FG002|NOT COMPLETED|Overall Study||3
8920139|NCT02213198|9980233|FG000|STARTED|Baseline||306
8920140|NCT02213198|9980234|FG001|STARTED|Baseline||159
8920141|NCT02213198|9980233|FG000|COMPLETED|Baseline||218
8920142|NCT02213198|9980234|FG001|COMPLETED|Baseline||108
8804403|NCT01467427|9856667|FG001|NOT COMPLETED|Overall Study||13
8804404|NCT01467466|9856677|FG000|STARTED|Overall Study||1300
8804405|NCT01467466|9856678|FG001|STARTED|Overall Study||1292
8804406|NCT01467466|9856679|FG002|STARTED|Overall Study||1294
8804407|NCT01467466|9856680|FG003|STARTED|Overall Study||1291
8804408|NCT01467466|9856677|FG000|COMPLETED|Overall Study||1191
8804409|NCT01467466|9856678|FG001|COMPLETED|Overall Study||1188
8804410|NCT01467466|9856679|FG002|COMPLETED|Overall Study||1190
8804411|NCT01467466|9856680|FG003|COMPLETED|Overall Study||1203
8804412|NCT01467466|9856677|FG000|NOT COMPLETED|Overall Study||109
8804413|NCT01467466|9856678|FG001|NOT COMPLETED|Overall Study||104
8804414|NCT01467466|9856679|FG002|NOT COMPLETED|Overall Study||104
8804415|NCT01467466|9856680|FG003|NOT COMPLETED|Overall Study||88
8804416|NCT01467479|9856693|FG000|STARTED|Overall Study||55
8804417|NCT01467479|9856694|FG001|STARTED|Overall Study||69
8804418|NCT01467479|9856695|FG002|STARTED|Overall Study||61
8804419|NCT01467479|9856693|FG000|Treated|Overall Study||54
8804420|NCT01467479|9856694|FG001|Treated|Overall Study||69
8804421|NCT01467479|9856695|FG002|Treated|Overall Study||59
8804422|NCT01467479|9856693|FG000|COMPLETED|Overall Study||46
8804423|NCT01467479|9856694|FG001|COMPLETED|Overall Study||52
8804424|NCT01467479|9856695|FG002|COMPLETED|Overall Study||45
8804425|NCT01467479|9856693|FG000|NOT COMPLETED|Overall Study||9
8804426|NCT01467479|9856694|FG001|NOT COMPLETED|Overall Study||17
8804427|NCT01467479|9856695|FG002|NOT COMPLETED|Overall Study||16
8804428|NCT01467492|9856706|FG000|STARTED|Overall Study||83
8804429|NCT01467492|9856707|FG001|STARTED|Overall Study||38
8804430|NCT01467492|9856706|FG000|COMPLETED|Overall Study||61
8804431|NCT01467492|9856707|FG001|COMPLETED|Overall Study||25
8804432|NCT01467492|9856706|FG000|NOT COMPLETED|Overall Study||22
8804433|NCT01467492|9856707|FG001|NOT COMPLETED|Overall Study||13
8804434|NCT01467505|9856716|FG000|STARTED|Overall Study||51
8804435|NCT01467505|9856717|FG001|STARTED|Overall Study||10
8804436|NCT01467505|9856716|FG000|COMPLETED|Overall Study||18
8804437|NCT01467505|9856717|FG001|COMPLETED|Overall Study||7
8804438|NCT01467505|9856716|FG000|NOT COMPLETED|Overall Study||33
8804439|NCT01467505|9856717|FG001|NOT COMPLETED|Overall Study||3
8804440|NCT01467557|9856725|FG000|STARTED|Overall Study||601
8804441|NCT01467557|9856726|FG001|STARTED|Overall Study||570
8804442|NCT01467557|9856725|FG000|2 Week Survey Completed|Overall Study||551
8804443|NCT01467557|9856726|FG001|2 Week Survey Completed|Overall Study||522
8804444|NCT01467557|9856725|FG000|4 Month Survey Completed|Overall Study||533
8804445|NCT01467557|9856726|FG001|4 Month Survey Completed|Overall Study||493
8804446|NCT01467557|9856725|FG000|12 Month Survey Completed|Overall Study||502
8804447|NCT01467557|9856726|FG001|12 Month Survey Completed|Overall Study||463
8804448|NCT01467557|9856725|FG000|COMPLETED|Overall Study||502
8804449|NCT01467557|9856726|FG001|COMPLETED|Overall Study||463
8804450|NCT01467557|9856725|FG000|NOT COMPLETED|Overall Study||99
8804451|NCT01467557|9856726|FG001|NOT COMPLETED|Overall Study||107
8804452|NCT01467570|9856734|FG000|STARTED|Overall Study||75
8804453|NCT01467570|9856735|FG001|STARTED|Overall Study||72
8804454|NCT01467570|9856734|FG000|COMPLETED|Overall Study||67
8804455|NCT01467570|9856735|FG001|COMPLETED|Overall Study||63
8804456|NCT01467570|9856734|FG000|NOT COMPLETED|Overall Study||8
8804457|NCT01467570|9856735|FG001|NOT COMPLETED|Overall Study||9
8920143|NCT02213198|9980233|FG000|NOT COMPLETED|Baseline||88
8920144|NCT02213198|9980234|FG001|NOT COMPLETED|Baseline||51
8920145|NCT02213198|9980233|FG000|STARTED|Follow up 1 3 Mos Post BL End of TCC tx||218
8920146|NCT02213198|9980234|FG001|STARTED|Follow up 1 3 Mos Post BL End of TCC tx||108
8920147|NCT02213198|9980233|FG000|COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||125
8920148|NCT02213198|9980234|FG001|COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||67
8920149|NCT02213198|9980233|FG000|NOT COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||93
8920150|NCT02213198|9980234|FG001|NOT COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||41
8920151|NCT02213198|9980233|FG000|STARTED|Follow up 2 6 Months Post TCC Treatment||125
8920152|NCT02213198|9980234|FG001|STARTED|Follow up 2 6 Months Post TCC Treatment||67
8920153|NCT02213198|9980233|FG000|COMPLETED|Follow up 2 6 Months Post TCC Treatment||102
8920154|NCT02213198|9980234|FG001|COMPLETED|Follow up 2 6 Months Post TCC Treatment||60
8920155|NCT02213198|9980233|FG000|NOT COMPLETED|Follow up 2 6 Months Post TCC Treatment||23
8920156|NCT02213198|9980234|FG001|NOT COMPLETED|Follow up 2 6 Months Post TCC Treatment||7
8920157|NCT02213250|9980240|FG000|STARTED|Overall Study||4
8920158|NCT02213250|9980241|FG001|STARTED|Overall Study||8
8920159|NCT02213250|9980240|FG000|COMPLETED|Overall Study||4
8920160|NCT02213250|9980241|FG001|COMPLETED|Overall Study||8
8920161|NCT02213250|9980240|FG000|NOT COMPLETED|Overall Study||0
8920162|NCT02213250|9980241|FG001|NOT COMPLETED|Overall Study||0
8920163|NCT02213263|9980250|FG000|STARTED|Overall Study||198
8920164|NCT02213263|9980251|FG001|STARTED|Overall Study||196
8920165|NCT02213263|9980250|FG000|Treated|Overall Study||197
8920166|NCT02213263|9980251|FG001|Treated|Overall Study||196
8920167|NCT02213263|9980250|FG000|COMPLETED|Overall Study||170
8920168|NCT02213263|9980251|FG001|COMPLETED|Overall Study||170
8920169|NCT02213263|9980250|FG000|NOT COMPLETED|Overall Study||28
8920170|NCT02213263|9980251|FG001|NOT COMPLETED|Overall Study||26
8920171|NCT02213289|9980259|FG000|STARTED|Overall Study||68
8920172|NCT02213289|9980260|FG001|STARTED|Overall Study||12
8920173|NCT02213289|9980259|FG000|Immuno-oncology|Overall Study||5
8920174|NCT02213289|9980260|FG001|Immuno-oncology|Overall Study||0
8920175|NCT02213289|9980259|FG000|HER2 Amplified|Overall Study||16
8920176|NCT02213289|9980260|FG001|HER2 Amplified|Overall Study||0
8804458|NCT01467583|9856746|FG000|STARTED|Overall Study||16
8804459|NCT01467583|9856747|FG001|STARTED|Overall Study||4
8804460|NCT01467583|9856748|FG002|STARTED|Overall Study||12
8804461|NCT01467583|9856746|FG000|COMPLETED|Overall Study|Both patients completed > 1 dose and so their data was included in the results.|14
8804462|NCT01467583|9856747|FG001|COMPLETED|Overall Study|Death unrelated to study drug on day #3. Data to that point is included in the results|3
8804463|NCT01467583|9856748|FG002|COMPLETED|Overall Study||10
8804464|NCT01467583|9856746|FG000|NOT COMPLETED|Overall Study||2
8804465|NCT01467583|9856747|FG001|NOT COMPLETED|Overall Study||1
8804466|NCT01467583|9856748|FG002|NOT COMPLETED|Overall Study||2
8804467|NCT01467661|9856759|FG000|STARTED|Overall Study||53
8804468|NCT01467661|9856759|FG000|Completed SPD422-308 (NCT01214915)|Overall Study||42
8804469|NCT01467661|9856759|FG000|Started SPD422-309 (NCT01467661)|Overall Study||41
8804470|NCT01467661|9856759|FG000|Started Post Marketing Trial|Overall Study||33
8920177|NCT02213289|9980259|FG000|EGFR Amplified|Overall Study||8
8920178|NCT02213289|9980260|FG001|EGFR Amplified|Overall Study||0
8920179|NCT02213289|9980259|FG000|FGFR2 Amplified|Overall Study||1
8920180|NCT02213289|9980260|FG001|FGFR2 Amplified|Overall Study||0
8920181|NCT02213289|9980259|FG000|MAPK/PIK3CA Aberrant|Overall Study||20
8920182|NCT02213289|9980260|FG001|MAPK/PIK3CA Aberrant|Overall Study||0
8920183|NCT02213289|9980259|FG000|EGFR Expressing|Overall Study||9
8920184|NCT02213289|9980260|FG001|EGFR Expressing|Overall Study||0
8920185|NCT02213289|9980259|FG000|All Negative|Overall Study||9
8920186|NCT02213289|9980260|FG001|All Negative|Overall Study||0
8920187|NCT02213289|9980259|FG000|Other (Non-ITT)|Overall Study||0
8920188|NCT02213289|9980260|FG001|Other (Non-ITT)|Overall Study||12
8920189|NCT02213289|9980259|FG000|COMPLETED|Overall Study||68
8920190|NCT02213289|9980260|FG001|COMPLETED|Overall Study||12
8920191|NCT02213289|9980259|FG000|NOT COMPLETED|Overall Study||0
8920192|NCT02213289|9980260|FG001|NOT COMPLETED|Overall Study||0
8920193|NCT02213458|9980272|FG000|STARTED|Overall Study||1024
8920194|NCT02213458|9980273|FG001|STARTED|Overall Study||536
8920195|NCT02213458|9980272|FG000|COMPLETED|Overall Study||970
8920196|NCT02213458|9980273|FG001|COMPLETED|Overall Study||526
8920197|NCT02213458|9980272|FG000|NOT COMPLETED|Overall Study||54
8920198|NCT02213458|9980273|FG001|NOT COMPLETED|Overall Study||10
8920199|NCT02213510|9980281|FG000|STARTED|Overall Study||21
8920200|NCT02213510|9980282|FG001|STARTED|Overall Study||19
8920201|NCT02213510|9980281|FG000|COMPLETED|Overall Study||20
8920202|NCT02213510|9980282|FG001|COMPLETED|Overall Study||18
8920203|NCT02213510|9980281|FG000|NOT COMPLETED|Overall Study||1
8920204|NCT02213510|9980282|FG001|NOT COMPLETED|Overall Study||1
8920205|NCT02213666|9980288|FG000|STARTED|Overall Study||72
8920206|NCT02213666|9980288|FG000|COMPLETED|Overall Study||71
8920207|NCT02213666|9980288|FG000|NOT COMPLETED|Overall Study||1
8920208|NCT02213900|9980294|FG000|STARTED|Overall Study||68
8920209|NCT02213900|9980295|FG001|STARTED|Overall Study||67
8920210|NCT02213900|9980294|FG000|COMPLETED|Overall Study||68
8920211|NCT02213900|9980295|FG001|COMPLETED|Overall Study||67
8920212|NCT02213900|9980294|FG000|NOT COMPLETED|Overall Study||0
8920213|NCT02213900|9980295|FG001|NOT COMPLETED|Overall Study||0
9035749|NCT03301740|10097444|FG000|STARTED|Phase 4 Intervention (3 Weeks)||17
9035750|NCT03301740|10097445|FG001|STARTED|Phase 4 Intervention (3 Weeks)||16
9035751|NCT03301740|10097444|FG000|COMPLETED|Phase 4 Intervention (3 Weeks)||16
9035752|NCT03301740|10097445|FG001|COMPLETED|Phase 4 Intervention (3 Weeks)||16
9035753|NCT03301740|10097444|FG000|NOT COMPLETED|Phase 4 Intervention (3 Weeks)||1
9035754|NCT03301740|10097445|FG001|NOT COMPLETED|Phase 4 Intervention (3 Weeks)||0
9035755|NCT03301779|10097451|FG000|STARTED|Overall Study||48
9035756|NCT03301779|10097452|FG001|STARTED|Overall Study||52
9035757|NCT03301779|10097451|FG000|COMPLETED|Overall Study||40
9035758|NCT03301779|10097452|FG001|COMPLETED|Overall Study||45
9035759|NCT03301779|10097451|FG000|NOT COMPLETED|Overall Study||8
9035760|NCT03301779|10097452|FG001|NOT COMPLETED|Overall Study||7
9035761|NCT03301831|10097460|FG000|STARTED|Overall Study||46
9035762|NCT03301831|10097461|FG001|STARTED|Overall Study||47
9035763|NCT03301831|10097460|FG000|COMPLETED|Overall Study||26
9035764|NCT03301831|10097461|FG001|COMPLETED|Overall Study||44
9035765|NCT03301831|10097460|FG000|NOT COMPLETED|Overall Study||20
9035766|NCT03301831|10097461|FG001|NOT COMPLETED|Overall Study||3
9035767|NCT03301844|10097469|FG000|STARTED|Overall Study|Each patient apply the Blephapad Combo wipes to one eye and standard treatment to the other eye.|19
9035768|NCT03301844|10097470|FG001|STARTED|Overall Study|Each patient apply the Blephapad Combo wipes to one eye and standard treatment to the other eye.|19
9035769|NCT03301844|10097469|FG000|COMPLETED|Overall Study||18
9035770|NCT03301844|10097470|FG001|COMPLETED|Overall Study||18
9035771|NCT03301844|10097469|FG000|NOT COMPLETED|Overall Study||1
9035772|NCT03301844|10097470|FG001|NOT COMPLETED|Overall Study||1
9035773|NCT03302091|10097478|FG000|STARTED|Overall Study||10
9035774|NCT03302091|10097479|FG001|STARTED|Overall Study||10
9035775|NCT03302091|10097478|FG000|COMPLETED|Overall Study||10
9035776|NCT03302091|10097479|FG001|COMPLETED|Overall Study||10
9035777|NCT03302091|10097478|FG000|NOT COMPLETED|Overall Study||0
8804471|NCT01467661|9856759|FG000|COMPLETED|Overall Study||32
8804472|NCT01467661|9856759|FG000|NOT COMPLETED|Overall Study||21
8920214|NCT02214017|9980303|FG000|STARTED|Overall Study||22
9035778|NCT03302091|10097479|FG001|NOT COMPLETED|Overall Study||0
9035779|NCT03302416|10097485|FG000|STARTED|Overall Study||19
9035780|NCT03302416|10097485|FG000|COMPLETED|Overall Study||19
9035781|NCT03302416|10097485|FG000|NOT COMPLETED|Overall Study||0
8804473|NCT01467700|9856769|FG000|STARTED|Overall Study||115
8804474|NCT01467700|9856770|FG001|STARTED|Overall Study||128
8804475|NCT01467700|9856771|FG002|STARTED|Overall Study||124
8804476|NCT01467700|9856772|FG003|STARTED|Overall Study||123
8804477|NCT01467700|9856769|FG000|Safety Set - Received Treatment|Overall Study||115
8804478|NCT01467700|9856770|FG001|Safety Set - Received Treatment|Overall Study||127
8804479|NCT01467700|9856771|FG002|Safety Set - Received Treatment|Overall Study||124
8804480|NCT01467700|9856772|FG003|Safety Set - Received Treatment|Overall Study||123
8804481|NCT01467700|9856769|FG000|COMPLETED|Overall Study||86
8804482|NCT01467700|9856770|FG001|COMPLETED|Overall Study||100
8804483|NCT01467700|9856771|FG002|COMPLETED|Overall Study||97
8804484|NCT01467700|9856772|FG003|COMPLETED|Overall Study||96
8804485|NCT01467700|9856769|FG000|NOT COMPLETED|Overall Study||29
8804486|NCT01467700|9856770|FG001|NOT COMPLETED|Overall Study||28
8804487|NCT01467700|9856771|FG002|NOT COMPLETED|Overall Study||27
8804488|NCT01467700|9856772|FG003|NOT COMPLETED|Overall Study||27
8804489|NCT01467713|9856786|FG000|STARTED|Overall Study||164
8804490|NCT01467713|9856787|FG001|STARTED|Overall Study||164
8804491|NCT01467713|9856788|FG002|STARTED|Overall Study||160
8804492|NCT01467713|9856789|FG003|STARTED|Overall Study||154
8804493|NCT01467713|9856786|FG000|Safety Analysis Set: Received Treatment|Overall Study||163
8804494|NCT01467713|9856787|FG001|Safety Analysis Set: Received Treatment|Overall Study||164
8804495|NCT01467713|9856788|FG002|Safety Analysis Set: Received Treatment|Overall Study||159
8804496|NCT01467713|9856789|FG003|Safety Analysis Set: Received Treatment|Overall Study||154
8804497|NCT01467713|9856786|FG000|COMPLETED|Overall Study||62
8804498|NCT01467713|9856787|FG001|COMPLETED|Overall Study||60
8804499|NCT01467713|9856788|FG002|COMPLETED|Overall Study||58
8804500|NCT01467713|9856789|FG003|COMPLETED|Overall Study||45
8804501|NCT01467713|9856786|FG000|NOT COMPLETED|Overall Study||102
8804502|NCT01467713|9856787|FG001|NOT COMPLETED|Overall Study||104
8804503|NCT01467713|9856788|FG002|NOT COMPLETED|Overall Study||102
8804504|NCT01467713|9856789|FG003|NOT COMPLETED|Overall Study||109
8804505|NCT01467882|9856799|FG000|STARTED|Overall Study||44
8804506|NCT01467882|9856799|FG000|COMPLETED|Overall Study||44
8804507|NCT01467882|9856799|FG000|NOT COMPLETED|Overall Study||0
8804508|NCT01467934|9856813|FG000|STARTED|Overall Study||208
8804509|NCT01467934|9856814|FG001|STARTED|Overall Study||212
8804510|NCT01467934|9856815|FG002|STARTED|Overall Study||110
8804511|NCT01467934|9856813|FG000|COMPLETED|Overall Study||208
8804512|NCT01467934|9856814|FG001|COMPLETED|Overall Study||212
8804513|NCT01467934|9856815|FG002|COMPLETED|Overall Study||110
8804514|NCT01467934|9856813|FG000|NOT COMPLETED|Overall Study||0
8804515|NCT01467934|9856814|FG001|NOT COMPLETED|Overall Study||0
8804516|NCT01467934|9856815|FG002|NOT COMPLETED|Overall Study||0
8804517|NCT01467947|9856823|FG000|STARTED|Overall Study||46
8804518|NCT01467947|9856823|FG000|COMPLETED|Overall Study||46
8804519|NCT01467947|9856823|FG000|NOT COMPLETED|Overall Study||0
8804520|NCT01467960|9856833|FG000|STARTED|Overall Study||30
8804521|NCT01467960|9856834|FG001|STARTED|Overall Study||30
8804522|NCT01467960|9856835|FG002|STARTED|Overall Study||30
8804523|NCT01467960|9856836|FG003|STARTED|Overall Study||30
8804524|NCT01467960|9856837|FG004|STARTED|Overall Study||30
8804525|NCT01467960|9856838|FG005|STARTED|Overall Study||30
8804526|NCT01467960|9856833|FG000|COMPLETED|Overall Study||30
8804527|NCT01467960|9856834|FG001|COMPLETED|Overall Study||30
8804528|NCT01467960|9856835|FG002|COMPLETED|Overall Study||30
8804529|NCT01467960|9856836|FG003|COMPLETED|Overall Study||0
8804530|NCT01467960|9856837|FG004|COMPLETED|Overall Study||0
8804531|NCT01467960|9856838|FG005|COMPLETED|Overall Study||0
8804532|NCT01467960|9856833|FG000|NOT COMPLETED|Overall Study||0
8804533|NCT01467960|9856834|FG001|NOT COMPLETED|Overall Study||0
8804534|NCT01467960|9856835|FG002|NOT COMPLETED|Overall Study||0
8804535|NCT01467960|9856836|FG003|NOT COMPLETED|Overall Study||30
8804536|NCT01467960|9856837|FG004|NOT COMPLETED|Overall Study||30
8804537|NCT01467960|9856838|FG005|NOT COMPLETED|Overall Study||30
8804538|NCT01467999|9856852|FG000|STARTED|Overall Study||22
8804539|NCT01467999|9856852|FG000|COMPLETED|Overall Study||9
8804540|NCT01467999|9856852|FG000|NOT COMPLETED|Overall Study||13
8804541|NCT01468012|9856859|FG000|STARTED|Overall Study||9
8804542|NCT01468012|9856860|FG001|STARTED|Overall Study||10
8804543|NCT01468012|9856861|FG002|STARTED|Overall Study||4
8804544|NCT01468012|9856859|FG000|COMPLETED|Overall Study||7
8804545|NCT01468012|9856860|FG001|COMPLETED|Overall Study||9
8804546|NCT01468012|9856861|FG002|COMPLETED|Overall Study||0
8804547|NCT01468012|9856859|FG000|NOT COMPLETED|Overall Study||2
8804548|NCT01468012|9856860|FG001|NOT COMPLETED|Overall Study||1
8804549|NCT01468012|9856861|FG002|NOT COMPLETED|Overall Study||4
8804550|NCT01468077|9856872|FG000|STARTED|Overall Study||22
8804551|NCT01468077|9856873|FG001|STARTED|Overall Study||25
8804552|NCT01468077|9856872|FG000|COMPLETED|Overall Study||18
8804553|NCT01468077|9856873|FG001|COMPLETED|Overall Study||22
8804554|NCT01468077|9856872|FG000|NOT COMPLETED|Overall Study||4
8804555|NCT01468077|9856873|FG001|NOT COMPLETED|Overall Study||3
8804556|NCT01468181|9856884|FG000|STARTED|Overall Study||131
8804557|NCT01468181|9856885|FG001|STARTED|Overall Study||61
8804558|NCT01468181|9856886|FG002|STARTED|Overall Study||65
8804559|NCT01468181|9856887|FG003|STARTED|Overall Study||66
8804560|NCT01468181|9856888|FG004|STARTED|Overall Study||71
8804561|NCT01468181|9856884|FG000|Received at Least 1 Dose of Study Drug|Overall Study||131
8804562|NCT01468181|9856885|FG001|Received at Least 1 Dose of Study Drug|Overall Study||61
8920215|NCT02214017|9980304|FG001|STARTED|Overall Study||18
8804563|NCT01468181|9856886|FG002|Received at Least 1 Dose of Study Drug|Overall Study||65
8804564|NCT01468181|9856887|FG003|Received at Least 1 Dose of Study Drug|Overall Study||66
8804565|NCT01468181|9856888|FG004|Received at Least 1 Dose of Study Drug|Overall Study||71
8804566|NCT01468181|9856884|FG000|COMPLETED|Overall Study||121
8804567|NCT01468181|9856885|FG001|COMPLETED|Overall Study||59
8804568|NCT01468181|9856886|FG002|COMPLETED|Overall Study||57
8804569|NCT01468181|9856887|FG003|COMPLETED|Overall Study||63
8804570|NCT01468181|9856888|FG004|COMPLETED|Overall Study||66
8804571|NCT01468181|9856884|FG000|NOT COMPLETED|Overall Study||10
8804572|NCT01468181|9856885|FG001|NOT COMPLETED|Overall Study||2
8804573|NCT01468181|9856886|FG002|NOT COMPLETED|Overall Study||8
8804574|NCT01468181|9856887|FG003|NOT COMPLETED|Overall Study||3
8804575|NCT01468181|9856888|FG004|NOT COMPLETED|Overall Study||5
8804576|NCT01468207|9856902|FG000|STARTED|Treatment Period 1||154
8804577|NCT01468207|9856903|FG001|STARTED|Treatment Period 1||153
8804578|NCT01468207|9856904|FG002|STARTED|Treatment Period 1||0
8804579|NCT01468207|9856905|FG003|STARTED|Treatment Period 1||0
8804580|NCT01468207|9856906|FG004|STARTED|Treatment Period 1||0
8804581|NCT01468207|9856907|FG005|STARTED|Treatment Period 1||0
8804582|NCT01468207|9856902|FG000|Received Study Drug|Treatment Period 1||152
8804583|NCT01468207|9856903|FG001|Received Study Drug|Treatment Period 1||153
8804584|NCT01468207|9856904|FG002|Received Study Drug|Treatment Period 1||0
8804585|NCT01468207|9856905|FG003|Received Study Drug|Treatment Period 1||0
8804586|NCT01468207|9856906|FG004|Received Study Drug|Treatment Period 1||0
8804587|NCT01468207|9856907|FG005|Received Study Drug|Treatment Period 1||0
8804588|NCT01468207|9856902|FG000|COMPLETED|Treatment Period 1||145
8804589|NCT01468207|9856903|FG001|COMPLETED|Treatment Period 1||145
8804590|NCT01468207|9856904|FG002|COMPLETED|Treatment Period 1||0
8804591|NCT01468207|9856905|FG003|COMPLETED|Treatment Period 1||0
8804592|NCT01468207|9856906|FG004|COMPLETED|Treatment Period 1||0
8804593|NCT01468207|9856907|FG005|COMPLETED|Treatment Period 1||0
8804594|NCT01468207|9856902|FG000|NOT COMPLETED|Treatment Period 1||9
8804595|NCT01468207|9856903|FG001|NOT COMPLETED|Treatment Period 1||8
8804596|NCT01468207|9856904|FG002|NOT COMPLETED|Treatment Period 1||0
8804597|NCT01468207|9856905|FG003|NOT COMPLETED|Treatment Period 1||0
8804598|NCT01468207|9856906|FG004|NOT COMPLETED|Treatment Period 1||0
8804599|NCT01468207|9856907|FG005|NOT COMPLETED|Treatment Period 1||0
8804600|NCT01468207|9856902|FG000|STARTED|Treatment Period 2||0
8804601|NCT01468207|9856903|FG001|STARTED|Treatment Period 2||0
8804602|NCT01468207|9856904|FG002|STARTED|Treatment Period 2||145
8804603|NCT01468207|9856905|FG003|STARTED|Treatment Period 2||49
8804604|NCT01468207|9856906|FG004|STARTED|Treatment Period 2||48
8804605|NCT01468207|9856907|FG005|STARTED|Treatment Period 2||48
8804606|NCT01468207|9856902|FG000|COMPLETED|Treatment Period 2||0
8804607|NCT01468207|9856903|FG001|COMPLETED|Treatment Period 2||0
8804608|NCT01468207|9856904|FG002|COMPLETED|Treatment Period 2||93
8804609|NCT01468207|9856905|FG003|COMPLETED|Treatment Period 2||22
8804610|NCT01468207|9856906|FG004|COMPLETED|Treatment Period 2||27
8804611|NCT01468207|9856907|FG005|COMPLETED|Treatment Period 2||28
8804612|NCT01468207|9856902|FG000|NOT COMPLETED|Treatment Period 2||0
8804613|NCT01468207|9856903|FG001|NOT COMPLETED|Treatment Period 2||0
8804614|NCT01468207|9856904|FG002|NOT COMPLETED|Treatment Period 2||52
8804615|NCT01468207|9856905|FG003|NOT COMPLETED|Treatment Period 2||27
8804616|NCT01468207|9856906|FG004|NOT COMPLETED|Treatment Period 2||21
8804617|NCT01468207|9856907|FG005|NOT COMPLETED|Treatment Period 2||20
8804618|NCT01468233|9856927|FG000|STARTED|Treatment Period 1||163
8804619|NCT01468233|9856928|FG001|STARTED|Treatment Period 1||163
8804620|NCT01468233|9856929|FG002|STARTED|Treatment Period 1||0
8804621|NCT01468233|9856930|FG003|STARTED|Treatment Period 1||0
8804622|NCT01468233|9856931|FG004|STARTED|Treatment Period 1||0
8804623|NCT01468233|9856932|FG005|STARTED|Treatment Period 1||0
8804624|NCT01468233|9856927|FG000|COMPLETED|Treatment Period 1||151
8804625|NCT01468233|9856928|FG001|COMPLETED|Treatment Period 1||155
8804626|NCT01468233|9856929|FG002|COMPLETED|Treatment Period 1||0
8804627|NCT01468233|9856930|FG003|COMPLETED|Treatment Period 1||0
8804628|NCT01468233|9856931|FG004|COMPLETED|Treatment Period 1||0
8804629|NCT01468233|9856932|FG005|COMPLETED|Treatment Period 1||0
8804630|NCT01468233|9856927|FG000|NOT COMPLETED|Treatment Period 1||12
8804631|NCT01468233|9856928|FG001|NOT COMPLETED|Treatment Period 1||8
8804632|NCT01468233|9856929|FG002|NOT COMPLETED|Treatment Period 1||0
8804633|NCT01468233|9856930|FG003|NOT COMPLETED|Treatment Period 1||0
8804634|NCT01468233|9856931|FG004|NOT COMPLETED|Treatment Period 1||0
8804635|NCT01468233|9856932|FG005|NOT COMPLETED|Treatment Period 1||0
8804636|NCT01468233|9856927|FG000|STARTED|Treatment Period 2||0
8804637|NCT01468233|9856928|FG001|STARTED|Treatment Period 2||0
8804638|NCT01468233|9856929|FG002|STARTED|Treatment Period 2||151
8804639|NCT01468233|9856930|FG003|STARTED|Treatment Period 2||51
8804640|NCT01468233|9856931|FG004|STARTED|Treatment Period 2||53
8804641|NCT01468233|9856932|FG005|STARTED|Treatment Period 2||51
8804642|NCT01468233|9856927|FG000|COMPLETED|Treatment Period 2||0
8804643|NCT01468233|9856928|FG001|COMPLETED|Treatment Period 2||0
8804644|NCT01468233|9856929|FG002|COMPLETED|Treatment Period 2||40
8804645|NCT01468233|9856930|FG003|COMPLETED|Treatment Period 2||23
8804646|NCT01468233|9856931|FG004|COMPLETED|Treatment Period 2||25
8804647|NCT01468233|9856932|FG005|COMPLETED|Treatment Period 2||28
8804648|NCT01468233|9856927|FG000|NOT COMPLETED|Treatment Period 2||0
8804649|NCT01468233|9856928|FG001|NOT COMPLETED|Treatment Period 2||0
8804650|NCT01468233|9856929|FG002|NOT COMPLETED|Treatment Period 2||111
8804651|NCT01468233|9856930|FG003|NOT COMPLETED|Treatment Period 2||28
8804652|NCT01468233|9856931|FG004|NOT COMPLETED|Treatment Period 2||28
8804653|NCT01468233|9856932|FG005|NOT COMPLETED|Treatment Period 2||23
8804654|NCT01468311|9856950|FG000|STARTED|Overall Study||6
8804655|NCT01468311|9856950|FG000|COMPLETED|Overall Study||4
8804656|NCT01468311|9856950|FG000|NOT COMPLETED|Overall Study||2
8804657|NCT01468337|9856954|FG000|STARTED|Overall Study||5
8804658|NCT01468337|9856954|FG000|Week 2|Overall Study||5
8804659|NCT01468337|9856954|FG000|Received Interferon Gamma-1b at Week 4|Overall Study|One participant received additional Interferon gamma-1b dosing at Week 4 and after Week 8|2
8804660|NCT01468337|9856954|FG000|Received Interferon Gamma-1b After Wk 8|Overall Study|Two participants had 2 Interferon gamma-1b dosing cycles after Wk 8|4
8804661|NCT01468337|9856954|FG000|Week 48|Overall Study|Two participants did not have a Week 48 visit but completed the study.|3
8804662|NCT01468337|9856954|FG000|COMPLETED|Overall Study||5
8804663|NCT01468337|9856954|FG000|NOT COMPLETED|Overall Study||0
8804664|NCT01468350|9856962|FG000|STARTED|(PART A) Day 1, Day 3||6
8804665|NCT01468350|9856963|FG001|STARTED|(PART A) Day 1, Day 3||5
8804666|NCT01468350|9856964|FG002|STARTED|(PART A) Day 1, Day 3||0
8804667|NCT01468350|9856965|FG003|STARTED|(PART A) Day 1, Day 3||0
8804668|NCT01468350|9856962|FG000|COMPLETED|(PART A) Day 1, Day 3||6
8804669|NCT01468350|9856963|FG001|COMPLETED|(PART A) Day 1, Day 3||5
8804670|NCT01468350|9856964|FG002|COMPLETED|(PART A) Day 1, Day 3||0
8804671|NCT01468350|9856965|FG003|COMPLETED|(PART A) Day 1, Day 3||0
8804672|NCT01468350|9856962|FG000|NOT COMPLETED|(PART A) Day 1, Day 3||0
8804673|NCT01468350|9856963|FG001|NOT COMPLETED|(PART A) Day 1, Day 3||0
8804674|NCT01468350|9856964|FG002|NOT COMPLETED|(PART A) Day 1, Day 3||0
8804675|NCT01468350|9856965|FG003|NOT COMPLETED|(PART A) Day 1, Day 3||0
8804676|NCT01468350|9856962|FG000|STARTED|(PART B) Day 1, Day 15||0
8804677|NCT01468350|9856963|FG001|STARTED|(PART B) Day 1, Day 15||0
8804678|NCT01468350|9856964|FG002|STARTED|(PART B) Day 1, Day 15||12
8804679|NCT01468350|9856965|FG003|STARTED|(PART B) Day 1, Day 15||12
8804680|NCT01468350|9856962|FG000|COMPLETED|(PART B) Day 1, Day 15||0
8804681|NCT01468350|9856963|FG001|COMPLETED|(PART B) Day 1, Day 15||0
8804682|NCT01468350|9856964|FG002|COMPLETED|(PART B) Day 1, Day 15||12
8804683|NCT01468350|9856965|FG003|COMPLETED|(PART B) Day 1, Day 15||12
8804684|NCT01468350|9856962|FG000|NOT COMPLETED|(PART B) Day 1, Day 15||0
8804685|NCT01468350|9856963|FG001|NOT COMPLETED|(PART B) Day 1, Day 15||0
8804686|NCT01468350|9856964|FG002|NOT COMPLETED|(PART B) Day 1, Day 15||0
8804687|NCT01468350|9856965|FG003|NOT COMPLETED|(PART B) Day 1, Day 15||0
8804688|NCT01468454|9856975|FG000|STARTED|Overall Study||128
8804689|NCT01468454|9856975|FG000|PETs Completed|Overall Study||128
8804690|NCT01468454|9856975|FG000|Had Both PET and Surgery|Overall Study||119
8804691|NCT01468454|9856975|FG000|COMPLETED|Overall Study||119
8804692|NCT01468454|9856975|FG000|NOT COMPLETED|Overall Study||9
8804693|NCT01468532|9856980|FG000|STARTED|Overall Study||18
8804694|NCT01468532|9856980|FG000|COMPLETED|Overall Study||18
8804695|NCT01468532|9856980|FG000|NOT COMPLETED|Overall Study||0
8804696|NCT01468558|9856984|FG000|STARTED|Overall Study||24
8804697|NCT01468558|9856984|FG000|COMPLETED|Overall Study||22
8804698|NCT01468558|9856984|FG000|NOT COMPLETED|Overall Study||2
8804699|NCT01468584|9856992|FG000|STARTED|Overall Study||10
8804700|NCT01468584|9856992|FG000|COMPLETED|Overall Study||10
8804701|NCT01468584|9856992|FG000|NOT COMPLETED|Overall Study||0
8804702|NCT01468597|9856996|FG000|STARTED|Overall Study||184
8804703|NCT01468597|9856996|FG000|COMPLETED|Overall Study||149
8804704|NCT01468597|9856996|FG000|NOT COMPLETED|Overall Study||35
8804705|NCT01468675|9857002|FG000|STARTED|Overall Study||2699
8804706|NCT01468675|9857003|FG001|STARTED|Overall Study||3376
8804707|NCT01468675|9857002|FG000|COMPLETED|Overall Study||1699
8804708|NCT01468675|9857003|FG001|COMPLETED|Overall Study||2004
8804709|NCT01468675|9857002|FG000|NOT COMPLETED|Overall Study||1000
8804710|NCT01468675|9857003|FG001|NOT COMPLETED|Overall Study||1372
8804711|NCT01468701|9857026|FG000|STARTED|Overall Study||4964
8804712|NCT01468701|9857027|FG001|STARTED|Overall Study||5103
8804713|NCT01468701|9857028|FG002|STARTED|Overall Study||1784
8804714|NCT01468701|9857029|FG003|STARTED|Overall Study||715
8804715|NCT01468701|9857030|FG004|STARTED|Overall Study||1736
8804716|NCT01468701|9857031|FG005|STARTED|Overall Study||128
8804717|NCT01468701|9857032|FG006|STARTED|Overall Study||1209
8804718|NCT01468701|9857033|FG007|STARTED|Overall Study||5
8804719|NCT01468701|9857034|FG008|STARTED|Overall Study||3879
8804720|NCT01468701|9857035|FG009|STARTED|Overall Study||4962
8804721|NCT01468701|9857036|FG010|STARTED|Overall Study||4054
8804722|NCT01468701|9857037|FG011|STARTED|Overall Study||4538
8804723|NCT01468701|9857038|FG012|STARTED|Overall Study||333
8804724|NCT01468701|9857039|FG013|STARTED|Overall Study||2182
8804725|NCT01468701|9857040|FG014|STARTED|Overall Study||214
8804726|NCT01468701|9857041|FG015|STARTED|Overall Study||1418
8804727|NCT01468701|9857042|FG016|STARTED|Overall Study||11
8804728|NCT01468701|9857026|FG000|All Eligible Patient|Overall Study||4873
8804729|NCT01468701|9857027|FG001|All Eligible Patient|Overall Study||4963
8804730|NCT01468701|9857028|FG002|All Eligible Patient|Overall Study||1755
8804731|NCT01468701|9857029|FG003|All Eligible Patient|Overall Study||703
8804732|NCT01468701|9857030|FG004|All Eligible Patient|Overall Study||1714
8804733|NCT01468701|9857031|FG005|All Eligible Patient|Overall Study||126
8804734|NCT01468701|9857032|FG006|All Eligible Patient|Overall Study||1170
8804735|NCT01468701|9857033|FG007|All Eligible Patient|Overall Study||4
8804736|NCT01468701|9857034|FG008|All Eligible Patient|Overall Study||3839
8804737|NCT01468701|9857035|FG009|All Eligible Patient|Overall Study||4836
8804738|NCT01468701|9857036|FG010|All Eligible Patient|Overall Study||4015
8804739|NCT01468701|9857037|FG011|All Eligible Patient|Overall Study||4505
8804740|NCT01468701|9857038|FG012|All Eligible Patient|Overall Study||332
8804741|NCT01468701|9857039|FG013|All Eligible Patient|Overall Study||2163
8804742|NCT01468701|9857040|FG014|All Eligible Patient|Overall Study||213
8804743|NCT01468701|9857041|FG015|All Eligible Patient|Overall Study||1386
8804744|NCT01468701|9857042|FG016|All Eligible Patient|Overall Study||11
8804745|NCT01468701|9857026|FG000|COMPLETED|Overall Study||3965
8804746|NCT01468701|9857027|FG001|COMPLETED|Overall Study||0
8804747|NCT01468701|9857028|FG002|COMPLETED|Overall Study||0
8804748|NCT01468701|9857029|FG003|COMPLETED|Overall Study||0
8804749|NCT01468701|9857030|FG004|COMPLETED|Overall Study||0
8804750|NCT01468701|9857031|FG005|COMPLETED|Overall Study||0
8804751|NCT01468701|9857032|FG006|COMPLETED|Overall Study||0
8804752|NCT01468701|9857033|FG007|COMPLETED|Overall Study||0
8804753|NCT01468701|9857034|FG008|COMPLETED|Overall Study||3219
8804754|NCT01468701|9857035|FG009|COMPLETED|Overall Study||3780
8804755|NCT01468701|9857036|FG010|COMPLETED|Overall Study||3256
8804756|NCT01468701|9857037|FG011|COMPLETED|Overall Study||3672
8804757|NCT01468701|9857038|FG012|COMPLETED|Overall Study||284
8804758|NCT01468701|9857039|FG013|COMPLETED|Overall Study||1712
8804759|NCT01468701|9857040|FG014|COMPLETED|Overall Study||151
8804760|NCT01468701|9857041|FG015|COMPLETED|Overall Study||1056
8804761|NCT01468701|9857042|FG016|COMPLETED|Overall Study||10
8804762|NCT01468701|9857026|FG000|NOT COMPLETED|Overall Study||999
8804763|NCT01468701|9857027|FG001|NOT COMPLETED|Overall Study||5103
8804764|NCT01468701|9857028|FG002|NOT COMPLETED|Overall Study||1784
8804765|NCT01468701|9857029|FG003|NOT COMPLETED|Overall Study||715
8804766|NCT01468701|9857030|FG004|NOT COMPLETED|Overall Study||1736
8804767|NCT01468701|9857031|FG005|NOT COMPLETED|Overall Study||128
8804768|NCT01468701|9857032|FG006|NOT COMPLETED|Overall Study||1209
8804769|NCT01468701|9857033|FG007|NOT COMPLETED|Overall Study||5
8804770|NCT01468701|9857034|FG008|NOT COMPLETED|Overall Study||660
8804771|NCT01468701|9857035|FG009|NOT COMPLETED|Overall Study||1182
8804772|NCT01468701|9857036|FG010|NOT COMPLETED|Overall Study||798
8804773|NCT01468701|9857037|FG011|NOT COMPLETED|Overall Study||866
8804774|NCT01468701|9857038|FG012|NOT COMPLETED|Overall Study||49
8804775|NCT01468701|9857039|FG013|NOT COMPLETED|Overall Study||470
8804776|NCT01468701|9857040|FG014|NOT COMPLETED|Overall Study||63
8804777|NCT01468701|9857041|FG015|NOT COMPLETED|Overall Study||362
8804778|NCT01468701|9857042|FG016|NOT COMPLETED|Overall Study||1
8804779|NCT01468818|9857055|FG000|STARTED|Overall Study||18
8804780|NCT01468818|9857055|FG000|COMPLETED|Overall Study||16
8804781|NCT01468818|9857055|FG000|NOT COMPLETED|Overall Study||2
8804782|NCT01468844|9857061|FG000|STARTED|Overall Study||4
8804783|NCT01468844|9857062|FG001|STARTED|Overall Study||2
8804784|NCT01468844|9857061|FG000|COMPLETED|Overall Study||2
8804785|NCT01468844|9857062|FG001|COMPLETED|Overall Study||2
8804786|NCT01468844|9857061|FG000|NOT COMPLETED|Overall Study||2
8804787|NCT01468844|9857062|FG001|NOT COMPLETED|Overall Study||0
8804788|NCT01468909|9857073|FG000|STARTED|Overall Study||52
8804789|NCT01468909|9857074|FG001|STARTED|Overall Study||54
8804790|NCT01468909|9857073|FG000|COMPLETED|Overall Study||50
8804791|NCT01468909|9857074|FG001|COMPLETED|Overall Study||52
8804792|NCT01468909|9857073|FG000|NOT COMPLETED|Overall Study||2
8804793|NCT01468909|9857074|FG001|NOT COMPLETED|Overall Study||2
8804794|NCT01468974|9857080|FG000|STARTED|1 Month Follow-up|Intent-to-treat (ITT) population|35
8804795|NCT01468974|9857080|FG000|COMPLETED|1 Month Follow-up||34
8804796|NCT01468974|9857080|FG000|NOT COMPLETED|1 Month Follow-up||1
8804797|NCT01468974|9857080|FG000|STARTED|6 Months Follow-up||34
8804798|NCT01468974|9857080|FG000|COMPLETED|6 Months Follow-up||34
8804799|NCT01468974|9857080|FG000|NOT COMPLETED|6 Months Follow-up||0
8804800|NCT01468974|9857080|FG000|STARTED|1 Year Follow-up||34
8804801|NCT01468974|9857080|FG000|COMPLETED|1 Year Follow-up||34
8804802|NCT01468974|9857080|FG000|NOT COMPLETED|1 Year Follow-up||0
8804803|NCT01468974|9857080|FG000|STARTED|2 Years Follow-up||34
8804804|NCT01468974|9857080|FG000|COMPLETED|2 Years Follow-up||32
8804805|NCT01468974|9857080|FG000|NOT COMPLETED|2 Years Follow-up||2
8804806|NCT01468974|9857080|FG000|STARTED|3 Years Follow-up||32
8804807|NCT01468974|9857080|FG000|COMPLETED|3 Years Follow-up||26
8804808|NCT01468974|9857080|FG000|NOT COMPLETED|3 Years Follow-up||6
8804809|NCT01468987|9857086|FG000|STARTED|Overall Study||691
8804810|NCT01468987|9857087|FG001|STARTED|Overall Study||678
8804811|NCT01468987|9857086|FG000|Received at Least 1 Dose of Study Drug|Overall Study||691
8804812|NCT01468987|9857087|FG001|Received at Least 1 Dose of Study Drug|Overall Study||677
8804813|NCT01468987|9857086|FG000|COMPLETED|Overall Study||620
8804814|NCT01468987|9857087|FG001|COMPLETED|Overall Study||618
8804815|NCT01468987|9857086|FG000|NOT COMPLETED|Overall Study||71
8804816|NCT01468987|9857087|FG001|NOT COMPLETED|Overall Study||60
8804817|NCT01469000|9857097|FG000|STARTED|Overall Study||129
8804818|NCT01469000|9857098|FG001|STARTED|Overall Study||66
8804819|NCT01469000|9857097|FG000|Received at Least 1 Dose of Study Drug|Overall Study||126
8804820|NCT01469000|9857098|FG001|Received at Least 1 Dose of Study Drug|Overall Study||65
8804821|NCT01469000|9857097|FG000|COMPLETED|Overall Study||109
8804822|NCT01469000|9857098|FG001|COMPLETED|Overall Study||62
8804823|NCT01469000|9857097|FG000|NOT COMPLETED|Overall Study||20
8804824|NCT01469000|9857098|FG001|NOT COMPLETED|Overall Study||4
8804825|NCT01469013|9857109|FG000|STARTED|Part A (Treatment Period)||24
8804826|NCT01469013|9857110|FG001|STARTED|Part A (Treatment Period)||24
8804827|NCT01469013|9857111|FG002|STARTED|Part A (Treatment Period)||24
8804828|NCT01469013|9857112|FG003|STARTED|Part A (Treatment Period)||24
8804829|NCT01469013|9857113|FG004|STARTED|Part A (Treatment Period)||49
8804830|NCT01469013|9857114|FG005|STARTED|Part A (Treatment Period)||0
8804831|NCT01469013|9857115|FG006|STARTED|Part A (Treatment Period)||0
8804832|NCT01469013|9857116|FG007|STARTED|Part A (Treatment Period)||0
8804833|NCT01469013|9857117|FG008|STARTED|Part A (Treatment Period)||0
8804834|NCT01469013|9857118|FG009|STARTED|Part A (Treatment Period)||0
8804835|NCT01469013|9857119|FG010|STARTED|Part A (Treatment Period)||0
8804836|NCT01469013|9857120|FG011|STARTED|Part A (Treatment Period)||0
8804837|NCT01469013|9857121|FG012|STARTED|Part A (Treatment Period)||0
8804838|NCT01469013|9857109|FG000|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||24
8804839|NCT01469013|9857110|FG001|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||24
8804840|NCT01469013|9857111|FG002|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||24
8804841|NCT01469013|9857112|FG003|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||24
8804842|NCT01469013|9857113|FG004|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||49
8804843|NCT01469013|9857114|FG005|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
8804844|NCT01469013|9857115|FG006|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
8804845|NCT01469013|9857116|FG007|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
8804846|NCT01469013|9857117|FG008|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
8804847|NCT01469013|9857118|FG009|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
8804848|NCT01469013|9857119|FG010|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
8804849|NCT01469013|9857120|FG011|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
8804850|NCT01469013|9857121|FG012|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
8804851|NCT01469013|9857109|FG000|COMPLETED|Part A (Treatment Period)||23
8804852|NCT01469013|9857110|FG001|COMPLETED|Part A (Treatment Period)||24
8804853|NCT01469013|9857111|FG002|COMPLETED|Part A (Treatment Period)||23
8804854|NCT01469013|9857112|FG003|COMPLETED|Part A (Treatment Period)||24
8804855|NCT01469013|9857113|FG004|COMPLETED|Part A (Treatment Period)||48
8804856|NCT01469013|9857114|FG005|COMPLETED|Part A (Treatment Period)||0
8804857|NCT01469013|9857115|FG006|COMPLETED|Part A (Treatment Period)||0
8804858|NCT01469013|9857116|FG007|COMPLETED|Part A (Treatment Period)||0
8804859|NCT01469013|9857117|FG008|COMPLETED|Part A (Treatment Period)||0
8804860|NCT01469013|9857118|FG009|COMPLETED|Part A (Treatment Period)||0
8804861|NCT01469013|9857119|FG010|COMPLETED|Part A (Treatment Period)||0
8804862|NCT01469013|9857120|FG011|COMPLETED|Part A (Treatment Period)||0
8804863|NCT01469013|9857121|FG012|COMPLETED|Part A (Treatment Period)||0
8804864|NCT01469013|9857109|FG000|NOT COMPLETED|Part A (Treatment Period)||1
8804865|NCT01469013|9857110|FG001|NOT COMPLETED|Part A (Treatment Period)||0
8804866|NCT01469013|9857111|FG002|NOT COMPLETED|Part A (Treatment Period)||1
8804867|NCT01469013|9857112|FG003|NOT COMPLETED|Part A (Treatment Period)||0
8804868|NCT01469013|9857113|FG004|NOT COMPLETED|Part A (Treatment Period)||1
8804869|NCT01469013|9857114|FG005|NOT COMPLETED|Part A (Treatment Period)||0
8804870|NCT01469013|9857115|FG006|NOT COMPLETED|Part A (Treatment Period)||0
8804871|NCT01469013|9857116|FG007|NOT COMPLETED|Part A (Treatment Period)||0
8804872|NCT01469013|9857117|FG008|NOT COMPLETED|Part A (Treatment Period)||0
8804873|NCT01469013|9857118|FG009|NOT COMPLETED|Part A (Treatment Period)||0
8804874|NCT01469013|9857119|FG010|NOT COMPLETED|Part A (Treatment Period)||0
8804875|NCT01469013|9857120|FG011|NOT COMPLETED|Part A (Treatment Period)||0
8804876|NCT01469013|9857121|FG012|NOT COMPLETED|Part A (Treatment Period)||0
8804877|NCT01469013|9857109|FG000|STARTED|Part B (Extension Period)||0
8804878|NCT01469013|9857110|FG001|STARTED|Part B (Extension Period)||0
8804879|NCT01469013|9857111|FG002|STARTED|Part B (Extension Period)||0
8804880|NCT01469013|9857112|FG003|STARTED|Part B (Extension Period)||0
8804881|NCT01469013|9857113|FG004|STARTED|Part B (Extension Period)||0
8804882|NCT01469013|9857114|FG005|STARTED|Part B (Extension Period)||12
8804883|NCT01469013|9857115|FG006|STARTED|Part B (Extension Period)||12
8804884|NCT01469013|9857116|FG007|STARTED|Part B (Extension Period)||23
8804885|NCT01469013|9857117|FG008|STARTED|Part B (Extension Period)||24
8804886|NCT01469013|9857118|FG009|STARTED|Part B (Extension Period)||11
8804887|NCT01469013|9857119|FG010|STARTED|Part B (Extension Period)||12
8804888|NCT01469013|9857120|FG011|STARTED|Part B (Extension Period)||24
8804889|NCT01469013|9857121|FG012|STARTED|Part B (Extension Period)||24
8804890|NCT01469013|9857109|FG000|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
8804891|NCT01469013|9857110|FG001|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
8804892|NCT01469013|9857111|FG002|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
8804893|NCT01469013|9857112|FG003|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
8804894|NCT01469013|9857113|FG004|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
8804895|NCT01469013|9857114|FG005|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||12
8804896|NCT01469013|9857115|FG006|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||12
8804897|NCT01469013|9857116|FG007|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||23
8804898|NCT01469013|9857117|FG008|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||24
8804899|NCT01469013|9857118|FG009|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||11
8804900|NCT01469013|9857119|FG010|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||12
8920216|NCT02214017|9980303|FG000|COMPLETED|Overall Study||22
8920217|NCT02214017|9980304|FG001|COMPLETED|Overall Study||18
8804901|NCT01469013|9857120|FG011|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||24
8804902|NCT01469013|9857121|FG012|Received at Least 1 Dose of Study Drug|Part B (Extension Period)|1 participant discontinued prior to receiving study drug|23
8804903|NCT01469013|9857109|FG000|COMPLETED|Part B (Extension Period)||0
8804904|NCT01469013|9857110|FG001|COMPLETED|Part B (Extension Period)||0
8804905|NCT01469013|9857111|FG002|COMPLETED|Part B (Extension Period)||0
8804906|NCT01469013|9857112|FG003|COMPLETED|Part B (Extension Period)||0
8804907|NCT01469013|9857113|FG004|COMPLETED|Part B (Extension Period)||0
8804908|NCT01469013|9857114|FG005|COMPLETED|Part B (Extension Period)||10
8804909|NCT01469013|9857115|FG006|COMPLETED|Part B (Extension Period)||7
8804910|NCT01469013|9857116|FG007|COMPLETED|Part B (Extension Period)||18
8804911|NCT01469013|9857117|FG008|COMPLETED|Part B (Extension Period)||20
8804912|NCT01469013|9857118|FG009|COMPLETED|Part B (Extension Period)||8
8804913|NCT01469013|9857119|FG010|COMPLETED|Part B (Extension Period)||10
8804914|NCT01469013|9857120|FG011|COMPLETED|Part B (Extension Period)||18
8804915|NCT01469013|9857121|FG012|COMPLETED|Part B (Extension Period)||18
8804916|NCT01469013|9857109|FG000|NOT COMPLETED|Part B (Extension Period)||0
8804917|NCT01469013|9857110|FG001|NOT COMPLETED|Part B (Extension Period)||0
8804918|NCT01469013|9857111|FG002|NOT COMPLETED|Part B (Extension Period)||0
8804919|NCT01469013|9857112|FG003|NOT COMPLETED|Part B (Extension Period)||0
8804920|NCT01469013|9857113|FG004|NOT COMPLETED|Part B (Extension Period)||0
8804921|NCT01469013|9857114|FG005|NOT COMPLETED|Part B (Extension Period)||2
8804922|NCT01469013|9857115|FG006|NOT COMPLETED|Part B (Extension Period)||5
8804923|NCT01469013|9857116|FG007|NOT COMPLETED|Part B (Extension Period)||5
8804924|NCT01469013|9857117|FG008|NOT COMPLETED|Part B (Extension Period)||4
8804925|NCT01469013|9857118|FG009|NOT COMPLETED|Part B (Extension Period)||3
8804926|NCT01469013|9857119|FG010|NOT COMPLETED|Part B (Extension Period)||2
8804927|NCT01469013|9857120|FG011|NOT COMPLETED|Part B (Extension Period)||6
8804928|NCT01469013|9857121|FG012|NOT COMPLETED|Part B (Extension Period)||6
8804929|NCT01469039|9857151|FG000|STARTED|Overall Study||207
8804930|NCT01469039|9857152|FG001|STARTED|Overall Study||208
8804931|NCT01469039|9857153|FG002|STARTED|Overall Study||208
8804932|NCT01469039|9857151|FG000|COMPLETED|Overall Study||130
8804933|NCT01469039|9857152|FG001|COMPLETED|Overall Study||135
8804934|NCT01469039|9857153|FG002|COMPLETED|Overall Study||95
8804935|NCT01469039|9857151|FG000|NOT COMPLETED|Overall Study||77
8804936|NCT01469039|9857152|FG001|NOT COMPLETED|Overall Study||73
8804937|NCT01469039|9857153|FG002|NOT COMPLETED|Overall Study||113
8804938|NCT01469052|9857167|FG000|STARTED|Overall Study||6
8804939|NCT01469052|9857168|FG001|STARTED|Overall Study||4
8804940|NCT01469052|9857169|FG002|STARTED|Overall Study||6
8804941|NCT01469052|9857170|FG003|STARTED|Overall Study||6
8804942|NCT01469052|9857171|FG004|STARTED|Overall Study||8
8804943|NCT01469052|9857172|FG005|STARTED|Overall Study||6
8804944|NCT01469052|9857167|FG000|COMPLETED|Overall Study||0
8804945|NCT01469052|9857168|FG001|COMPLETED|Overall Study||0
8804946|NCT01469052|9857169|FG002|COMPLETED|Overall Study||0
8804947|NCT01469052|9857170|FG003|COMPLETED|Overall Study||1
8804948|NCT01469052|9857171|FG004|COMPLETED|Overall Study||0
8804949|NCT01469052|9857172|FG005|COMPLETED|Overall Study||0
8920218|NCT02214017|9980303|FG000|NOT COMPLETED|Overall Study||0
8920219|NCT02214017|9980304|FG001|NOT COMPLETED|Overall Study||0
8920220|NCT02214121|9980313|FG000|STARTED|Part A||46
8920221|NCT02214121|9980314|FG001|STARTED|Part A||0
8920222|NCT02214121|9980315|FG002|STARTED|Part A||0
8920223|NCT02214121|9980313|FG000|COMPLETED|Part A||39
8920224|NCT02214121|9980314|FG001|COMPLETED|Part A||0
8920225|NCT02214121|9980315|FG002|COMPLETED|Part A||0
8920226|NCT02214121|9980313|FG000|NOT COMPLETED|Part A||7
8920227|NCT02214121|9980314|FG001|NOT COMPLETED|Part A||0
8920228|NCT02214121|9980315|FG002|NOT COMPLETED|Part A||0
8920229|NCT02214121|9980313|FG000|STARTED|Part B||0
8920230|NCT02214121|9980314|FG001|STARTED|Part B||17
8920231|NCT02214121|9980315|FG002|STARTED|Part B||8
8920232|NCT02214121|9980313|FG000|COMPLETED|Part B||0
8920233|NCT02214121|9980314|FG001|COMPLETED|Part B||14
8920234|NCT02214121|9980315|FG002|COMPLETED|Part B||7
8920235|NCT02214121|9980313|FG000|NOT COMPLETED|Part B||0
8920236|NCT02214121|9980314|FG001|NOT COMPLETED|Part B||3
8920237|NCT02214121|9980315|FG002|NOT COMPLETED|Part B||1
8920238|NCT02214147|9980338|FG000|STARTED|Overall Study||16
8920239|NCT02214147|9980339|FG001|STARTED|Overall Study||12
8920240|NCT02214147|9980340|FG002|STARTED|Overall Study||8
8920241|NCT02214147|9980338|FG000|COMPLETED|Overall Study||16
8920242|NCT02214147|9980339|FG001|COMPLETED|Overall Study||12
8920243|NCT02214147|9980340|FG002|COMPLETED|Overall Study||8
8920244|NCT02214147|9980338|FG000|NOT COMPLETED|Overall Study||0
8920245|NCT02214147|9980339|FG001|NOT COMPLETED|Overall Study||0
8920246|NCT02214147|9980340|FG002|NOT COMPLETED|Overall Study||0
8920247|NCT02214186|9980350|FG000|STARTED|Overall Study||23
8920248|NCT02214186|9980351|FG001|STARTED|Overall Study||23
8920249|NCT02214186|9980350|FG000|COMPLETED|Overall Study||21
8920250|NCT02214186|9980351|FG001|COMPLETED|Overall Study||21
8920251|NCT02214186|9980350|FG000|NOT COMPLETED|Overall Study||2
8920252|NCT02214186|9980351|FG001|NOT COMPLETED|Overall Study||2
8920253|NCT02214212|9980359|FG000|STARTED|Overall Study||66
8920254|NCT02214212|9980360|FG001|STARTED|Overall Study||65
8920255|NCT02214212|9980359|FG000|COMPLETED|Overall Study||57
8920256|NCT02214212|9980360|FG001|COMPLETED|Overall Study||59
8920257|NCT02214212|9980359|FG000|NOT COMPLETED|Overall Study||9
8920258|NCT02214212|9980360|FG001|NOT COMPLETED|Overall Study||6
8804950|NCT01469052|9857167|FG000|NOT COMPLETED|Overall Study||6
8804951|NCT01469052|9857168|FG001|NOT COMPLETED|Overall Study||4
8804952|NCT01469052|9857169|FG002|NOT COMPLETED|Overall Study||6
8804953|NCT01469052|9857170|FG003|NOT COMPLETED|Overall Study||5
8804954|NCT01469052|9857171|FG004|NOT COMPLETED|Overall Study||8
8804955|NCT01469052|9857172|FG005|NOT COMPLETED|Overall Study||6
8804956|NCT01469065|9857189|FG000|STARTED|Overall Study||16
8804957|NCT01469065|9857190|FG001|STARTED|Overall Study||17
8804958|NCT01469065|9857191|FG002|STARTED|Overall Study||16
8804959|NCT01469065|9857192|FG003|STARTED|Overall Study||16
8804960|NCT01469065|9857193|FG004|STARTED|Overall Study||17
8804961|NCT01469065|9857189|FG000|COMPLETED|Overall Study||16
8804962|NCT01469065|9857190|FG001|COMPLETED|Overall Study||16
8804963|NCT01469065|9857191|FG002|COMPLETED|Overall Study||16
8804964|NCT01469065|9857192|FG003|COMPLETED|Overall Study||16
8804965|NCT01469065|9857193|FG004|COMPLETED|Overall Study||16
8804966|NCT01469065|9857189|FG000|NOT COMPLETED|Overall Study||0
8804967|NCT01469065|9857190|FG001|NOT COMPLETED|Overall Study||1
8804968|NCT01469065|9857191|FG002|NOT COMPLETED|Overall Study||0
8804969|NCT01469065|9857192|FG003|NOT COMPLETED|Overall Study||0
8804970|NCT01469065|9857193|FG004|NOT COMPLETED|Overall Study||1
8804971|NCT01469182|9857211|FG000|STARTED|Overall Study||610
8804972|NCT01469182|9857212|FG001|STARTED|Overall Study||304
8804973|NCT01469182|9857211|FG000|Treated|Overall Study||609
8804974|NCT01469182|9857212|FG001|Treated|Overall Study||304
8804975|NCT01469182|9857211|FG000|COMPLETED|Overall Study||575
8804976|NCT01469182|9857212|FG001|COMPLETED|Overall Study||298
8804977|NCT01469182|9857211|FG000|NOT COMPLETED|Overall Study||35
8804978|NCT01469182|9857212|FG001|NOT COMPLETED|Overall Study||6
8804979|NCT01469221|9857220|FG000|STARTED|Open Label Phase||0
8804980|NCT01469221|9857221|FG001|STARTED|Open Label Phase||0
8804981|NCT01469221|9857222|FG002|STARTED|Open Label Phase||47
8804982|NCT01469221|9857220|FG000|COMPLETED|Open Label Phase||0
8804983|NCT01469221|9857221|FG001|COMPLETED|Open Label Phase||0
8804984|NCT01469221|9857222|FG002|COMPLETED|Open Label Phase||44
8804985|NCT01469221|9857220|FG000|NOT COMPLETED|Open Label Phase||0
8804986|NCT01469221|9857221|FG001|NOT COMPLETED|Open Label Phase||0
8804987|NCT01469221|9857222|FG002|NOT COMPLETED|Open Label Phase||3
8804988|NCT01469221|9857220|FG000|STARTED|Double Blind Phase||14
8804989|NCT01469221|9857221|FG001|STARTED|Double Blind Phase||17
8804990|NCT01469221|9857222|FG002|STARTED|Double Blind Phase||0
8804991|NCT01469221|9857220|FG000|COMPLETED|Double Blind Phase||0
8804992|NCT01469221|9857221|FG001|COMPLETED|Double Blind Phase||0
8804993|NCT01469221|9857222|FG002|COMPLETED|Double Blind Phase||0
8804994|NCT01469221|9857220|FG000|NOT COMPLETED|Double Blind Phase||14
8804995|NCT01469221|9857221|FG001|NOT COMPLETED|Double Blind Phase||17
8804996|NCT01469221|9857222|FG002|NOT COMPLETED|Double Blind Phase||0
8804997|NCT01469234|9857232|FG000|STARTED|Overall Study||85
8804998|NCT01469234|9857233|FG001|STARTED|Overall Study||85
8804999|NCT01469234|9857234|FG002|STARTED|Overall Study||85
8805000|NCT01469234|9857232|FG000|COMPLETED|Overall Study||85
8805001|NCT01469234|9857233|FG001|COMPLETED|Overall Study||85
8805002|NCT01469234|9857234|FG002|COMPLETED|Overall Study||85
8805003|NCT01469234|9857232|FG000|NOT COMPLETED|Overall Study||0
8805004|NCT01469234|9857233|FG001|NOT COMPLETED|Overall Study||0
8805005|NCT01469234|9857234|FG002|NOT COMPLETED|Overall Study||0
8805006|NCT01469364|9857242|FG000|STARTED|Overall Study||30
8805007|NCT01469364|9857242|FG000|COMPLETED|Overall Study||28
8805008|NCT01469364|9857242|FG000|NOT COMPLETED|Overall Study||2
8805009|NCT01469377|9857249|FG000|STARTED|Overall Study||269
8805010|NCT01469377|9857250|FG001|STARTED|Overall Study||274
8805011|NCT01469377|9857251|FG002|STARTED|Overall Study||276
8805012|NCT01469377|9857249|FG000|COMPLETED|Overall Study||234
8805013|NCT01469377|9857250|FG001|COMPLETED|Overall Study||226
8805014|NCT01469377|9857251|FG002|COMPLETED|Overall Study||210
8805015|NCT01469377|9857249|FG000|NOT COMPLETED|Overall Study||35
8805016|NCT01469377|9857250|FG001|NOT COMPLETED|Overall Study||48
8805017|NCT01469377|9857251|FG002|NOT COMPLETED|Overall Study||66
8805018|NCT01469546|9857259|FG000|STARTED|Received 5 mg Dose||42
8805019|NCT01469546|9857259|FG000|Completed First Cycle|Received 5 mg Dose||30
8805020|NCT01469546|9857259|FG000|COMPLETED|Received 5 mg Dose||19
8805021|NCT01469546|9857259|FG000|NOT COMPLETED|Received 5 mg Dose||23
8805022|NCT01469546|9857259|FG000|STARTED|Dose Escalation to 10 mg||19
8805023|NCT01469546|9857259|FG000|COMPLETED|Dose Escalation to 10 mg||19
8805024|NCT01469546|9857259|FG000|NOT COMPLETED|Dose Escalation to 10 mg||0
8805025|NCT01469585|9857265|FG000|STARTED|Overall Study||11
8805026|NCT01469585|9857266|FG001|STARTED|Overall Study||9
8805027|NCT01469585|9857265|FG000|COMPLETED|Overall Study||4
8805028|NCT01469585|9857266|FG001|COMPLETED|Overall Study||6
8805029|NCT01469585|9857265|FG000|NOT COMPLETED|Overall Study||7
8805030|NCT01469585|9857266|FG001|NOT COMPLETED|Overall Study||3
8805031|NCT01469637|9857276|FG000|STARTED|First Intervention||22
8805032|NCT01469637|9857277|FG001|STARTED|First Intervention||22
8805033|NCT01469637|9857276|FG000|COMPLETED|First Intervention||22
8805034|NCT01469637|9857277|FG001|COMPLETED|First Intervention||21
8805035|NCT01469637|9857276|FG000|NOT COMPLETED|First Intervention||0
8805036|NCT01469637|9857277|FG001|NOT COMPLETED|First Intervention||1
8805037|NCT01469637|9857276|FG000|STARTED|Second Intervention||22
8805038|NCT01469637|9857277|FG001|STARTED|Second Intervention||21
8805039|NCT01469637|9857276|FG000|COMPLETED|Second Intervention||21
8805040|NCT01469637|9857277|FG001|COMPLETED|Second Intervention||21
8805041|NCT01469637|9857276|FG000|NOT COMPLETED|Second Intervention||1
8805042|NCT01469637|9857277|FG001|NOT COMPLETED|Second Intervention||0
8805043|NCT01469715|9857283|FG000|STARTED|Overall Study||16
8805044|NCT01469715|9857283|FG000|COMPLETED|Overall Study||16
8805045|NCT01469715|9857283|FG000|NOT COMPLETED|Overall Study||0
8805046|NCT01469767|9857287|FG000|STARTED|Overall Study||10
8805047|NCT01469767|9857287|FG000|COMPLETED|Overall Study||10
8805048|NCT01469767|9857287|FG000|NOT COMPLETED|Overall Study||0
8805049|NCT01469819|9857291|FG000|STARTED|Overall Study||37
8805050|NCT01469819|9857291|FG000|COMPLETED|Overall Study||29
8805051|NCT01469819|9857291|FG000|NOT COMPLETED|Overall Study||8
8805052|NCT01470001|9857303|FG000|STARTED|Overall Study||58
8805053|NCT01470001|9857304|FG001|STARTED|Overall Study||60
8805054|NCT01470001|9857303|FG000|COMPLETED|Overall Study||53
8805055|NCT01470001|9857304|FG001|COMPLETED|Overall Study||58
8805056|NCT01470001|9857303|FG000|NOT COMPLETED|Overall Study||5
8805057|NCT01470001|9857304|FG001|NOT COMPLETED|Overall Study||2
8805058|NCT01470027|9857316|FG000|STARTED|Overall Study||16
8805059|NCT01470027|9857317|FG001|STARTED|Overall Study||15
8805060|NCT01470027|9857318|FG002|STARTED|Overall Study||16
8805061|NCT01470027|9857316|FG000|COMPLETED|Overall Study||15
8805062|NCT01470027|9857317|FG001|COMPLETED|Overall Study||14
8805063|NCT01470027|9857318|FG002|COMPLETED|Overall Study||15
8805064|NCT01470027|9857316|FG000|NOT COMPLETED|Overall Study||1
8805065|NCT01470027|9857317|FG001|NOT COMPLETED|Overall Study||1
8805066|NCT01470027|9857318|FG002|NOT COMPLETED|Overall Study||1
8805067|NCT01470118|9857335|FG000|STARTED|Overall Study||43
8805068|NCT01470118|9857336|FG001|STARTED|Overall Study||43
8805069|NCT01470118|9857337|FG002|STARTED|Overall Study||41
8805070|NCT01470118|9857335|FG000|COMPLETED|Overall Study||38
8805071|NCT01470118|9857336|FG001|COMPLETED|Overall Study||38
8805072|NCT01470118|9857337|FG002|COMPLETED|Overall Study||39
8805073|NCT01470118|9857335|FG000|NOT COMPLETED|Overall Study||5
8805074|NCT01470118|9857336|FG001|NOT COMPLETED|Overall Study||5
8805075|NCT01470118|9857337|FG002|NOT COMPLETED|Overall Study||2
8805076|NCT01470144|9857345|FG000|STARTED|Overall Study||41
8805077|NCT01470144|9857345|FG000|COMPLETED|Overall Study|"Completed corresponds to subjects switching to commercial EFI upon market approval/reimbursement"|31
8805078|NCT01470144|9857345|FG000|NOT COMPLETED|Overall Study||10
8805079|NCT01470170|9857354|FG000|STARTED|Overall Study||34
8805080|NCT01470170|9857355|FG001|STARTED|Overall Study||35
8805081|NCT01470170|9857356|FG002|STARTED|Overall Study||34
8805082|NCT01470170|9857357|FG003|STARTED|Overall Study||36
8805083|NCT01470170|9857358|FG004|STARTED|Overall Study||34
8805084|NCT01470170|9857354|FG000|COMPLETED|Overall Study||34
8805085|NCT01470170|9857355|FG001|COMPLETED|Overall Study||35
8805086|NCT01470170|9857356|FG002|COMPLETED|Overall Study||34
8805087|NCT01470170|9857357|FG003|COMPLETED|Overall Study||36
8805088|NCT01470170|9857358|FG004|COMPLETED|Overall Study||34
8805089|NCT01470170|9857354|FG000|NOT COMPLETED|Overall Study||0
8805090|NCT01470170|9857355|FG001|NOT COMPLETED|Overall Study||0
8805091|NCT01470170|9857356|FG002|NOT COMPLETED|Overall Study||0
8805092|NCT01470170|9857357|FG003|NOT COMPLETED|Overall Study||0
8805093|NCT01470170|9857358|FG004|NOT COMPLETED|Overall Study||0
8805094|NCT01470196|9857370|FG000|STARTED|Overall Study||31
8805095|NCT01470196|9857370|FG000|COMPLETED|Overall Study||31
8805096|NCT01470196|9857370|FG000|NOT COMPLETED|Overall Study||0
8805097|NCT01470248|9857374|FG000|STARTED|Overall Study||20
8805098|NCT01470248|9857374|FG000|COMPLETED|Overall Study||19
8805099|NCT01470248|9857374|FG000|NOT COMPLETED|Overall Study||1
8805100|NCT01470417|9857380|FG000|STARTED|Overall Study||3
8805101|NCT01470417|9857381|FG001|STARTED|Overall Study||7
8805102|NCT01470417|9857380|FG000|COMPLETED|Overall Study||3
8805103|NCT01470417|9857381|FG001|COMPLETED|Overall Study||5
8805104|NCT01470417|9857380|FG000|NOT COMPLETED|Overall Study||0
8805105|NCT01470417|9857381|FG001|NOT COMPLETED|Overall Study||2
8805106|NCT01470469|9857389|FG000|STARTED|Overall Study||21
8805107|NCT01470469|9857390|FG001|STARTED|Overall Study||62
8805108|NCT01470469|9857389|FG000|COMPLETED|Overall Study||11
8805109|NCT01470469|9857390|FG001|COMPLETED|Overall Study||38
8805110|NCT01470469|9857389|FG000|NOT COMPLETED|Overall Study||10
8805111|NCT01470469|9857390|FG001|NOT COMPLETED|Overall Study||24
8805112|NCT01470599|9857398|FG000|STARTED|Overall Study||62
8805113|NCT01470599|9857399|FG001|STARTED|Overall Study||88
8805114|NCT01470599|9857398|FG000|COMPLETED|Overall Study||43
8805115|NCT01470599|9857399|FG001|COMPLETED|Overall Study||45
8805116|NCT01470599|9857398|FG000|NOT COMPLETED|Overall Study||19
8805117|NCT01470599|9857399|FG001|NOT COMPLETED|Overall Study||43
8805118|NCT01470612|9857407|FG000|STARTED|Overall Study||175
8805119|NCT01470612|9857408|FG001|STARTED|Overall Study||769
8805120|NCT01470612|9857407|FG000|COMPLETED|Overall Study||91
8805121|NCT01470612|9857408|FG001|COMPLETED|Overall Study||104
8805122|NCT01470612|9857407|FG000|NOT COMPLETED|Overall Study||84
8805123|NCT01470612|9857408|FG001|NOT COMPLETED|Overall Study||665
8805124|NCT01470651|9857416|FG000|STARTED|Overall Study||13
8805125|NCT01470651|9857417|FG001|STARTED|Overall Study||13
8805126|NCT01470651|9857416|FG000|COMPLETED|Overall Study||6
8805127|NCT01470651|9857417|FG001|COMPLETED|Overall Study||10
8805128|NCT01470651|9857416|FG000|NOT COMPLETED|Overall Study||7
8805129|NCT01470651|9857417|FG001|NOT COMPLETED|Overall Study||3
8805130|NCT01470781|9857425|FG000|STARTED|Overall Study||39
8805131|NCT01470781|9857426|FG001|STARTED|Overall Study||33
8805132|NCT01470781|9857425|FG000|Midpoint Assessment|Overall Study||30
8805133|NCT01470781|9857426|FG001|Midpoint Assessment|Overall Study||30
8805134|NCT01470781|9857425|FG000|Post-Treatment Assessment|Overall Study||22
8805135|NCT01470781|9857426|FG001|Post-Treatment Assessment|Overall Study||23
8805136|NCT01470781|9857425|FG000|COMPLETED|Overall Study||21
8805137|NCT01470781|9857426|FG001|COMPLETED|Overall Study||21
8805138|NCT01470781|9857425|FG000|NOT COMPLETED|Overall Study||18
8805139|NCT01470781|9857426|FG001|NOT COMPLETED|Overall Study||12
8805140|NCT01470859|9857435|FG000|STARTED|Overall Study||15
8805141|NCT01470859|9857436|FG001|STARTED|Overall Study||15
8805142|NCT01470859|9857435|FG000|COMPLETED|Overall Study||14
8805143|NCT01470859|9857436|FG001|COMPLETED|Overall Study||15
8805144|NCT01470859|9857435|FG000|NOT COMPLETED|Overall Study||1
8805145|NCT01470859|9857436|FG001|NOT COMPLETED|Overall Study||0
8805146|NCT01470989|9857444|FG000|STARTED|Overall Study||227
8805147|NCT01470989|9857445|FG001|STARTED|Overall Study||229
8805148|NCT01470989|9857444|FG000|Completed Core Study|Overall Study||208
8805149|NCT01470989|9857445|FG001|Completed Core Study|Overall Study||208
8805150|NCT01470989|9857444|FG000|Entered Extension 1 Study|Overall Study||174
8805151|NCT01470989|9857445|FG001|Entered Extension 1 Study|Overall Study||161
8805152|NCT01470989|9857444|FG000|Completed Extension 1 Study|Overall Study||165
8805153|NCT01470989|9857445|FG001|Completed Extension 1 Study|Overall Study||152
8805154|NCT01470989|9857444|FG000|Entered Extension 2 Study|Overall Study||141
8805155|NCT01470989|9857445|FG001|Entered Extension 2 Study|Overall Study||131
8805156|NCT01470989|9857444|FG000|Completed Extension 2 Study|Overall Study||132
8805157|NCT01470989|9857445|FG001|Completed Extension 2 Study|Overall Study||117
8805158|NCT01470989|9857444|FG000|Entered Extension 3|Overall Study||87
8805159|NCT01470989|9857445|FG001|Entered Extension 3|Overall Study||49
8805160|NCT01470989|9857444|FG000|COMPLETED|Overall Study||79
8805161|NCT01470989|9857445|FG001|COMPLETED|Overall Study||43
8805162|NCT01470989|9857444|FG000|NOT COMPLETED|Overall Study||148
8805163|NCT01470989|9857445|FG001|NOT COMPLETED|Overall Study||186
8805164|NCT01471015|9857456|FG000|STARTED|Overall Study||10
8805165|NCT01471015|9857457|FG001|STARTED|Overall Study||10
8805166|NCT01471015|9857458|FG002|STARTED|Overall Study||10
8805167|NCT01471015|9857456|FG000|COMPLETED|Overall Study||10
8805168|NCT01471015|9857457|FG001|COMPLETED|Overall Study||9
8805169|NCT01471015|9857458|FG002|COMPLETED|Overall Study||9
8805170|NCT01471015|9857456|FG000|NOT COMPLETED|Overall Study||0
8805171|NCT01471015|9857457|FG001|NOT COMPLETED|Overall Study||1
8805172|NCT01471015|9857458|FG002|NOT COMPLETED|Overall Study||1
8805173|NCT01471028|9857468|FG000|STARTED|VTI-208||96
8805174|NCT01471028|9857469|FG001|STARTED|VTI-208||107
8805175|NCT01471028|9857468|FG000|COMPLETED|VTI-208||56
8805176|NCT01471028|9857469|FG001|COMPLETED|VTI-208||63
8805177|NCT01471028|9857468|FG000|NOT COMPLETED|VTI-208||40
8805178|NCT01471028|9857469|FG001|NOT COMPLETED|VTI-208||44
8805179|NCT01471028|9857468|FG000|STARTED|VTI-208E||56
8805180|NCT01471028|9857469|FG001|STARTED|VTI-208E||63
8805181|NCT01471028|9857468|FG000|Database Lock, 31 July 2015|VTI-208E||56
8805182|NCT01471028|9857469|FG001|Database Lock, 31 July 2015|VTI-208E||63
8805183|NCT01471028|9857468|FG000|COMPLETED|VTI-208E||48
8805184|NCT01471028|9857469|FG001|COMPLETED|VTI-208E||51
8805185|NCT01471028|9857468|FG000|NOT COMPLETED|VTI-208E||8
8805186|NCT01471028|9857469|FG001|NOT COMPLETED|VTI-208E||12
8805187|NCT01471041|9857478|FG000|STARTED|Overall Study||54
8805188|NCT01471041|9857478|FG000|COMPLETED|Overall Study||47
8805189|NCT01471041|9857478|FG000|NOT COMPLETED|Overall Study||7
8805190|NCT01471054|9857484|FG000|STARTED|Overall Study||5
8805191|NCT01471054|9857485|FG001|STARTED|Overall Study||1
8805192|NCT01471054|9857484|FG000|COMPLETED|Overall Study||1
8805193|NCT01471054|9857485|FG001|COMPLETED|Overall Study||1
8805194|NCT01471054|9857484|FG000|NOT COMPLETED|Overall Study||4
8805195|NCT01471054|9857485|FG001|NOT COMPLETED|Overall Study||0
8805196|NCT01471093|9857503|FG000|STARTED|Overall Study||25
8805197|NCT01471093|9857504|FG001|STARTED|Overall Study||25
8805198|NCT01471093|9857505|FG002|STARTED|Overall Study||25
8805199|NCT01471093|9857506|FG003|STARTED|Overall Study||25
8805200|NCT01471093|9857503|FG000|COMPLETED|Overall Study||24
8805201|NCT01471093|9857504|FG001|COMPLETED|Overall Study||25
8805202|NCT01471093|9857505|FG002|COMPLETED|Overall Study||25
8805203|NCT01471093|9857506|FG003|COMPLETED|Overall Study||25
8805204|NCT01471093|9857503|FG000|NOT COMPLETED|Overall Study||1
8805205|NCT01471093|9857504|FG001|NOT COMPLETED|Overall Study||0
8805206|NCT01471093|9857505|FG002|NOT COMPLETED|Overall Study||0
8805207|NCT01471093|9857506|FG003|NOT COMPLETED|Overall Study||0
8805208|NCT01471171|9857512|FG000|STARTED|Treatment Period 1||57
8805209|NCT01471171|9857513|FG001|STARTED|Treatment Period 1||55
8805210|NCT01471171|9857512|FG000|COMPLETED|Treatment Period 1||53
8805211|NCT01471171|9857513|FG001|COMPLETED|Treatment Period 1||54
8805212|NCT01471171|9857512|FG000|NOT COMPLETED|Treatment Period 1||4
8805213|NCT01471171|9857513|FG001|NOT COMPLETED|Treatment Period 1||1
8805214|NCT01471171|9857512|FG000|STARTED|Treatment Period 2||53
8805215|NCT01471171|9857513|FG001|STARTED|Treatment Period 2||54
8805216|NCT01471171|9857512|FG000|COMPLETED|Treatment Period 2||52
8805217|NCT01471171|9857513|FG001|COMPLETED|Treatment Period 2||54
8805218|NCT01471171|9857512|FG000|NOT COMPLETED|Treatment Period 2||1
8805219|NCT01471171|9857513|FG001|NOT COMPLETED|Treatment Period 2||0
8805220|NCT01471197|9857521|FG000|STARTED|Overall Study||6
8805221|NCT01471197|9857522|FG001|STARTED|Overall Study||2
8805222|NCT01471197|9857521|FG000|COMPLETED|Overall Study||0
8805223|NCT01471197|9857522|FG001|COMPLETED|Overall Study||0
8805224|NCT01471197|9857521|FG000|NOT COMPLETED|Overall Study||6
8805225|NCT01471197|9857522|FG001|NOT COMPLETED|Overall Study||2
8805226|NCT01471353|9857528|FG000|STARTED|Overall Study||42
8805227|NCT01471353|9857528|FG000|COMPLETED|Overall Study||39
8805228|NCT01471353|9857528|FG000|NOT COMPLETED|Overall Study||3
8805229|NCT01471379|9857535|FG000|STARTED|Overall Study||1
8805230|NCT01471379|9857536|FG001|STARTED|Overall Study||1
8805231|NCT01471379|9857537|FG002|STARTED|Overall Study||0
8805232|NCT01471379|9857535|FG000|COMPLETED|Overall Study||0
8805233|NCT01471379|9857536|FG001|COMPLETED|Overall Study||0
8805234|NCT01471379|9857537|FG002|COMPLETED|Overall Study||0
8805235|NCT01471379|9857535|FG000|NOT COMPLETED|Overall Study||1
8805236|NCT01471379|9857536|FG001|NOT COMPLETED|Overall Study||1
8805237|NCT01471379|9857537|FG002|NOT COMPLETED|Overall Study||0
8805238|NCT01471457|9857548|FG000|STARTED|Overall Study||92
8805239|NCT01471457|9857549|FG001|STARTED|Overall Study||92
8805240|NCT01471457|9857548|FG000|COMPLETED|Overall Study||73
8805241|NCT01471457|9857549|FG001|COMPLETED|Overall Study||74
8805242|NCT01471457|9857548|FG000|NOT COMPLETED|Overall Study||19
8805243|NCT01471457|9857549|FG001|NOT COMPLETED|Overall Study||18
8805244|NCT01471522|9857557|FG000|STARTED|Overall Study||2588
8805245|NCT01471522|9857558|FG001|STARTED|Overall Study||2591
8805246|NCT01471522|9857557|FG000|COMPLETED|Overall Study||2524
8805247|NCT01471522|9857558|FG001|COMPLETED|Overall Study||2543
8805248|NCT01471522|9857557|FG000|NOT COMPLETED|Overall Study||64
8805249|NCT01471522|9857558|FG001|NOT COMPLETED|Overall Study||48
8805250|NCT01471574|9857569|FG000|STARTED|Treatment Period||132
8805251|NCT01471574|9857570|FG001|STARTED|Treatment Period||39
8805252|NCT01471574|9857571|FG002|STARTED|Treatment Period||106
8805253|NCT01471574|9857572|FG003|STARTED|Treatment Period||24
8805254|NCT01471574|9857569|FG000|COMPLETED|Treatment Period||101
8805255|NCT01471574|9857570|FG001|COMPLETED|Treatment Period||29
8805256|NCT01471574|9857571|FG002|COMPLETED|Treatment Period||82
8805257|NCT01471574|9857572|FG003|COMPLETED|Treatment Period||21
8805258|NCT01471574|9857569|FG000|NOT COMPLETED|Treatment Period||31
8805259|NCT01471574|9857570|FG001|NOT COMPLETED|Treatment Period||10
8805260|NCT01471574|9857571|FG002|NOT COMPLETED|Treatment Period||24
8805261|NCT01471574|9857572|FG003|NOT COMPLETED|Treatment Period||3
8805262|NCT01471574|9857569|FG000|STARTED|Follow-up Period||121
8805263|NCT01471574|9857570|FG001|STARTED|Follow-up Period||34
8805264|NCT01471574|9857571|FG002|STARTED|Follow-up Period||102
8805265|NCT01471574|9857572|FG003|STARTED|Follow-up Period||24
8805266|NCT01471574|9857569|FG000|COMPLETED|Follow-up Period||114
8805267|NCT01471574|9857570|FG001|COMPLETED|Follow-up Period||32
8805268|NCT01471574|9857571|FG002|COMPLETED|Follow-up Period||95
8805269|NCT01471574|9857572|FG003|COMPLETED|Follow-up Period||21
8805270|NCT01471574|9857569|FG000|NOT COMPLETED|Follow-up Period||7
8805271|NCT01471574|9857570|FG001|NOT COMPLETED|Follow-up Period||2
8805272|NCT01471574|9857571|FG002|NOT COMPLETED|Follow-up Period||7
8805273|NCT01471574|9857572|FG003|NOT COMPLETED|Follow-up Period||3
8805274|NCT01471626|9857588|FG000|STARTED|Overall Study||21
8805275|NCT01471626|9857588|FG000|COMPLETED|Overall Study||21
8805276|NCT01471626|9857588|FG000|NOT COMPLETED|Overall Study||0
8805277|NCT01471639|9857592|FG000|STARTED|Overall Study||37
8805278|NCT01471639|9857592|FG000|COMPLETED|Overall Study||37
8805279|NCT01471639|9857592|FG000|NOT COMPLETED|Overall Study||0
8805280|NCT01471691|9857598|FG000|STARTED|Overall Study||8
8805281|NCT01471691|9857599|FG001|STARTED|Overall Study||6
8805282|NCT01471691|9857598|FG000|COMPLETED|Overall Study||8
8805283|NCT01471691|9857599|FG001|COMPLETED|Overall Study||5
8805284|NCT01471691|9857598|FG000|NOT COMPLETED|Overall Study||0
8805285|NCT01471691|9857599|FG001|NOT COMPLETED|Overall Study||1
8805286|NCT01471782|9857611|FG000|STARTED|Overall Study||5
8805287|NCT01471782|9857612|FG001|STARTED|Overall Study||7
8805288|NCT01471782|9857613|FG002|STARTED|Overall Study||5
8805289|NCT01471782|9857614|FG003|STARTED|Overall Study||6
8805290|NCT01471782|9857615|FG004|STARTED|Overall Study||26
8805291|NCT01471782|9857616|FG005|STARTED|Overall Study||44
8805292|NCT01471782|9857611|FG000|COMPLETED|Overall Study|Completed 5 cycles|0
8805293|NCT01471782|9857612|FG001|COMPLETED|Overall Study|Completed 5 cycles|1
8805294|NCT01471782|9857613|FG002|COMPLETED|Overall Study|Completed 5 cycles|0
8805295|NCT01471782|9857614|FG003|COMPLETED|Overall Study|Completed 5 cycles|1
8805296|NCT01471782|9857615|FG004|COMPLETED|Overall Study|Completed 5 cycles|0
8805297|NCT01471782|9857616|FG005|COMPLETED|Overall Study|Completed 5 cycles|3
8805298|NCT01471782|9857611|FG000|NOT COMPLETED|Overall Study||5
8805299|NCT01471782|9857612|FG001|NOT COMPLETED|Overall Study||6
8805300|NCT01471782|9857613|FG002|NOT COMPLETED|Overall Study||5
8805301|NCT01471782|9857614|FG003|NOT COMPLETED|Overall Study||5
8805302|NCT01471782|9857615|FG004|NOT COMPLETED|Overall Study||26
8805303|NCT01471782|9857616|FG005|NOT COMPLETED|Overall Study||41
8805304|NCT01472185|9857643|FG000|STARTED|Overall Study||232
8805305|NCT01472185|9857644|FG001|STARTED|Overall Study||233
8805306|NCT01472185|9857643|FG000|COMPLETED|Overall Study||198
8805307|NCT01472185|9857644|FG001|COMPLETED|Overall Study||199
8805308|NCT01472185|9857643|FG000|NOT COMPLETED|Overall Study||34
8805309|NCT01472185|9857644|FG001|NOT COMPLETED|Overall Study||34
8805310|NCT01472289|9857650|FG000|STARTED|Overall Study||17
8805311|NCT01472289|9857650|FG000|COMPLETED|Overall Study||15
8805312|NCT01472289|9857650|FG000|NOT COMPLETED|Overall Study||2
8805313|NCT01472341|9857654|FG000|STARTED|Overall Study||507
8805314|NCT01472341|9857654|FG000|COMPLETED|Overall Study||235
8805315|NCT01472341|9857654|FG000|NOT COMPLETED|Overall Study||272
8805316|NCT01472380|9857658|FG000|STARTED|Efavirenz Alone||30
8805317|NCT01472380|9857658|FG000|COMPLETED|Efavirenz Alone||29
8805318|NCT01472380|9857658|FG000|NOT COMPLETED|Efavirenz Alone||1
8805319|NCT01472380|9857658|FG000|STARTED|Fenofibric Acid (FFA) Alone||29
8805320|NCT01472380|9857658|FG000|COMPLETED|Fenofibric Acid (FFA) Alone||29
8805321|NCT01472380|9857658|FG000|NOT COMPLETED|Fenofibric Acid (FFA) Alone||0
8805322|NCT01472380|9857658|FG000|STARTED|1 Day Period Between Dosing||29
8805323|NCT01472380|9857658|FG000|COMPLETED|1 Day Period Between Dosing||28
8805324|NCT01472380|9857658|FG000|NOT COMPLETED|1 Day Period Between Dosing||1
8805325|NCT01472380|9857658|FG000|STARTED|Efavirenz and FFA||28
8805326|NCT01472380|9857658|FG000|COMPLETED|Efavirenz and FFA||28
8805327|NCT01472380|9857658|FG000|NOT COMPLETED|Efavirenz and FFA||0
8805328|NCT01472432|9857667|FG000|STARTED|Overall Study||53
8805329|NCT01472432|9857668|FG001|STARTED|Overall Study||53
8805330|NCT01472432|9857667|FG000|Ulcer Reduction|Overall Study||13
8805331|NCT01472432|9857668|FG001|Ulcer Reduction|Overall Study||33
8805332|NCT01472432|9857667|FG000|COMPLETED|Overall Study||53
8805333|NCT01472432|9857668|FG001|COMPLETED|Overall Study||53
8805334|NCT01472432|9857667|FG000|NOT COMPLETED|Overall Study||0
8805335|NCT01472432|9857668|FG001|NOT COMPLETED|Overall Study||0
8805336|NCT01472445|9857678|FG000|STARTED|Overall Study||25
8805337|NCT01472445|9857679|FG001|STARTED|Overall Study||16
8805338|NCT01472445|9857678|FG000|COMPLETED|Overall Study||25
8805339|NCT01472445|9857679|FG001|COMPLETED|Overall Study||16
8805340|NCT01472445|9857678|FG000|NOT COMPLETED|Overall Study||0
8805341|NCT01472445|9857679|FG001|NOT COMPLETED|Overall Study||0
8805342|NCT01472549|9857689|FG000|STARTED|Overall Study||572
8805343|NCT01472549|9857690|FG001|STARTED|Overall Study||575
8805344|NCT01472549|9857689|FG000|COMPLETED|Overall Study||572
8805345|NCT01472549|9857690|FG001|COMPLETED|Overall Study||575
8805346|NCT01472549|9857689|FG000|NOT COMPLETED|Overall Study||0
8805347|NCT01472549|9857690|FG001|NOT COMPLETED|Overall Study||0
8805348|NCT01472718|9857698|FG000|STARTED|Overall Study||104
8805349|NCT01472718|9857699|FG001|STARTED|Overall Study||104
8805350|NCT01472718|9857698|FG000|COMPLETED|Overall Study||98
8805351|NCT01472718|9857699|FG001|COMPLETED|Overall Study||97
8805352|NCT01472718|9857698|FG000|NOT COMPLETED|Overall Study||6
8805353|NCT01472718|9857699|FG001|NOT COMPLETED|Overall Study||7
8805354|NCT01472757|9857709|FG000|STARTED|Overall Study||91
8805355|NCT01472757|9857710|FG001|STARTED|Overall Study||93
8805356|NCT01472757|9857711|FG002|STARTED|Overall Study||95
8805357|NCT01472757|9857712|FG003|STARTED|Overall Study||94
8805358|NCT01472757|9857709|FG000|Full Analysis Set|Overall Study||91
8805359|NCT01472757|9857710|FG001|Full Analysis Set|Overall Study||93
8805360|NCT01472757|9857711|FG002|Full Analysis Set|Overall Study||92
8805361|NCT01472757|9857712|FG003|Full Analysis Set|Overall Study||92
8805362|NCT01472757|9857709|FG000|COMPLETED|Overall Study||61
8805363|NCT01472757|9857710|FG001|COMPLETED|Overall Study||80
8805364|NCT01472757|9857711|FG002|COMPLETED|Overall Study||76
8805365|NCT01472757|9857712|FG003|COMPLETED|Overall Study||75
8805366|NCT01472757|9857709|FG000|NOT COMPLETED|Overall Study||30
8805367|NCT01472757|9857710|FG001|NOT COMPLETED|Overall Study||13
8805368|NCT01472757|9857711|FG002|NOT COMPLETED|Overall Study||19
8805369|NCT01472757|9857712|FG003|NOT COMPLETED|Overall Study||19
8805370|NCT01472822|9857724|FG000|STARTED|Overall Study||30
8805371|NCT01472822|9857725|FG001|STARTED|Overall Study||30
8805372|NCT01472822|9857724|FG000|COMPLETED|Overall Study||28
8805373|NCT01472822|9857725|FG001|COMPLETED|Overall Study||28
8805374|NCT01472822|9857724|FG000|NOT COMPLETED|Overall Study||2
8805375|NCT01472822|9857725|FG001|NOT COMPLETED|Overall Study||2
8805376|NCT01472835|9857733|FG000|STARTED|Overall Study||37
8805377|NCT01472835|9857734|FG001|STARTED|Overall Study||36
8805378|NCT01472835|9857733|FG000|COMPLETED|Overall Study||35
8805379|NCT01472835|9857734|FG001|COMPLETED|Overall Study||36
8805380|NCT01472835|9857733|FG000|NOT COMPLETED|Overall Study||2
8805381|NCT01472835|9857734|FG001|NOT COMPLETED|Overall Study||0
8805382|NCT01472874|9857743|FG000|STARTED|Overall Study||8
8805383|NCT01472874|9857743|FG000|COMPLETED|Overall Study||8
8805384|NCT01472874|9857743|FG000|NOT COMPLETED|Overall Study||0
8805385|NCT01472939|9857751|FG000|STARTED|Overall Study||123
8805386|NCT01472939|9857752|FG001|STARTED|Overall Study||119
8805387|NCT01472939|9857753|FG002|STARTED|Overall Study||119
8805388|NCT01472939|9857754|FG003|STARTED|Overall Study||119
8805389|NCT01472939|9857751|FG000|COMPLETED|Overall Study||103
8805390|NCT01472939|9857752|FG001|COMPLETED|Overall Study||105
8805391|NCT01472939|9857753|FG002|COMPLETED|Overall Study||108
8805392|NCT01472939|9857754|FG003|COMPLETED|Overall Study||99
8805393|NCT01472939|9857751|FG000|NOT COMPLETED|Overall Study||20
8805394|NCT01472939|9857752|FG001|NOT COMPLETED|Overall Study||14
8805395|NCT01472939|9857753|FG002|NOT COMPLETED|Overall Study||11
8805396|NCT01472939|9857754|FG003|NOT COMPLETED|Overall Study||20
8805397|NCT01472965|9857769|FG000|STARTED|Overall Study||49
8805398|NCT01472965|9857770|FG001|STARTED|Overall Study||46
8805399|NCT01472965|9857769|FG000|COMPLETED|Overall Study||48
8805400|NCT01472965|9857770|FG001|COMPLETED|Overall Study||46
8805401|NCT01472965|9857769|FG000|NOT COMPLETED|Overall Study||1
8805402|NCT01472965|9857770|FG001|NOT COMPLETED|Overall Study||0
8805403|NCT01473160|9857776|FG000|STARTED|Overall Study||9
8805404|NCT01473160|9857776|FG000|COMPLETED|Overall Study||9
8805405|NCT01473160|9857776|FG000|NOT COMPLETED|Overall Study||0
8805406|NCT01473355|9857782|FG000|STARTED|Overall Study||45
8805407|NCT01473355|9857782|FG000|COMPLETED|Overall Study||39
8805408|NCT01473355|9857782|FG000|NOT COMPLETED|Overall Study||6
8805409|NCT01473368|9857790|FG000|STARTED|Overall Study||14
8805410|NCT01473368|9857791|FG001|STARTED|Overall Study||12
8805411|NCT01473368|9857792|FG002|STARTED|Overall Study||15
8805412|NCT01473368|9857793|FG003|STARTED|Overall Study||12
8805413|NCT01473368|9857790|FG000|COMPLETED|Overall Study||13
8805414|NCT01473368|9857791|FG001|COMPLETED|Overall Study||12
8805415|NCT01473368|9857792|FG002|COMPLETED|Overall Study||12
8805416|NCT01473368|9857793|FG003|COMPLETED|Overall Study||12
8805417|NCT01473368|9857790|FG000|NOT COMPLETED|Overall Study||1
8805418|NCT01473368|9857791|FG001|NOT COMPLETED|Overall Study||0
8805419|NCT01473368|9857792|FG002|NOT COMPLETED|Overall Study||3
8805420|NCT01473368|9857793|FG003|NOT COMPLETED|Overall Study||0
8805421|NCT01473381|9857823|FG000|STARTED|Overall Study||290
8805422|NCT01473381|9857824|FG001|STARTED|Overall Study||292
8805423|NCT01473381|9857825|FG002|STARTED|Overall Study||291
8805424|NCT01473381|9857826|FG003|STARTED|Overall Study||289
8805425|NCT01473381|9857823|FG000|Safety Population|Overall Study||281
8805426|NCT01473381|9857824|FG001|Safety Population|Overall Study||288
8805427|NCT01473381|9857825|FG002|Safety Population|Overall Study||287
9035782|NCT03302559|10097489|FG000|STARTED|Overall Study||29
9035783|NCT03302559|10097489|FG000|COMPLETED|Overall Study||23
9035784|NCT03302559|10097489|FG000|NOT COMPLETED|Overall Study||6
9035785|NCT03302741|10097495|FG000|STARTED|Overall Study||8
9035786|NCT03302741|10097496|FG001|STARTED|Overall Study||9
9035787|NCT03302741|10097495|FG000|COMPLETED|Overall Study||7
9035788|NCT03302741|10097496|FG001|COMPLETED|Overall Study||8
9035789|NCT03302741|10097495|FG000|NOT COMPLETED|Overall Study||1
9035790|NCT03302741|10097496|FG001|NOT COMPLETED|Overall Study||1
9035791|NCT03302767|10097502|FG000|STARTED|Overall Study||29
9035792|NCT03302767|10097502|FG000|COMPLETED|Overall Study||29
9035793|NCT03302767|10097502|FG000|NOT COMPLETED|Overall Study||0
8805428|NCT01473381|9857826|FG003|Safety Population|Overall Study||282
8805429|NCT01473381|9857823|FG000|COMPLETED|Overall Study||210
8805430|NCT01473381|9857824|FG001|COMPLETED|Overall Study||199
8805431|NCT01473381|9857825|FG002|COMPLETED|Overall Study||189
8805432|NCT01473381|9857826|FG003|COMPLETED|Overall Study||200
8805433|NCT01473381|9857823|FG000|NOT COMPLETED|Overall Study||80
8805434|NCT01473381|9857824|FG001|NOT COMPLETED|Overall Study||93
8805435|NCT01473381|9857825|FG002|NOT COMPLETED|Overall Study||102
8805436|NCT01473381|9857826|FG003|NOT COMPLETED|Overall Study||89
8805437|NCT01473394|9857839|FG000|STARTED|Overall Study||253
8805438|NCT01473394|9857840|FG001|STARTED|Overall Study||255
8805439|NCT01473394|9857839|FG000|COMPLETED|Overall Study||208
8805440|NCT01473394|9857840|FG001|COMPLETED|Overall Study||212
8805441|NCT01473394|9857839|FG000|NOT COMPLETED|Overall Study||45
8805442|NCT01473394|9857840|FG001|NOT COMPLETED|Overall Study||43
8805443|NCT01473407|9857848|FG000|STARTED|Overall Study||306
8805444|NCT01473407|9857849|FG001|STARTED|Overall Study||306
8805445|NCT01473407|9857848|FG000|COMPLETED|Overall Study||252
8805446|NCT01473407|9857849|FG001|COMPLETED|Overall Study||259
8805447|NCT01473407|9857848|FG000|NOT COMPLETED|Overall Study||54
8805448|NCT01473407|9857849|FG001|NOT COMPLETED|Overall Study||47
8805449|NCT01473420|9857857|FG000|STARTED|Titration Period (18 Weeks)||160
8805450|NCT01473420|9857858|FG001|STARTED|Titration Period (18 Weeks)||160
8805451|NCT01473420|9857857|FG000|Treated|Titration Period (18 Weeks)||80
8805452|NCT01473420|9857858|FG001|Treated|Titration Period (18 Weeks)||86
8805453|NCT01473420|9857857|FG000|COMPLETED|Titration Period (18 Weeks)||124
8805454|NCT01473420|9857858|FG001|COMPLETED|Titration Period (18 Weeks)||122
8805455|NCT01473420|9857857|FG000|NOT COMPLETED|Titration Period (18 Weeks)||36
8805456|NCT01473420|9857858|FG001|NOT COMPLETED|Titration Period (18 Weeks)||38
8805457|NCT01473420|9857857|FG000|STARTED|Maintenance Period (16 Weeks)||124
8805458|NCT01473420|9857858|FG001|STARTED|Maintenance Period (16 Weeks)||122
8805459|NCT01473420|9857857|FG000|COMPLETED|Maintenance Period (16 Weeks)||106
8805460|NCT01473420|9857858|FG001|COMPLETED|Maintenance Period (16 Weeks)||105
8805461|NCT01473420|9857857|FG000|NOT COMPLETED|Maintenance Period (16 Weeks)||18
8805462|NCT01473420|9857858|FG001|NOT COMPLETED|Maintenance Period (16 Weeks)||17
8805463|NCT01473524|9857873|FG000|STARTED|DB Phase||71
8805464|NCT01473524|9857874|FG001|STARTED|DB Phase||73
8805465|NCT01473524|9857875|FG002|STARTED|DB Phase||73
8805466|NCT01473524|9857876|FG003|STARTED|DB Phase||0
8805467|NCT01473524|9857877|FG004|STARTED|DB Phase||0
8805468|NCT01473524|9857878|FG005|STARTED|DB Phase||0
8805469|NCT01473524|9857873|FG000|Received at Least 1 Dose of Study Drug|DB Phase||70
8805470|NCT01473524|9857874|FG001|Received at Least 1 Dose of Study Drug|DB Phase||73
8805471|NCT01473524|9857875|FG002|Received at Least 1 Dose of Study Drug|DB Phase||73
8805472|NCT01473524|9857876|FG003|Received at Least 1 Dose of Study Drug|DB Phase||0
8805473|NCT01473524|9857877|FG004|Received at Least 1 Dose of Study Drug|DB Phase||0
8805474|NCT01473524|9857878|FG005|Received at Least 1 Dose of Study Drug|DB Phase||0
8805475|NCT01473524|9857873|FG000|COMPLETED|DB Phase||64
8805476|NCT01473524|9857874|FG001|COMPLETED|DB Phase||64
8805477|NCT01473524|9857875|FG002|COMPLETED|DB Phase||70
8805478|NCT01473524|9857876|FG003|COMPLETED|DB Phase||0
8805479|NCT01473524|9857877|FG004|COMPLETED|DB Phase||0
9035794|NCT03302780|10097506|FG000|STARTED|Overall Study||3
9035795|NCT03302780|10097507|FG001|STARTED|Overall Study||3
9035796|NCT03302780|10097506|FG000|COMPLETED|Overall Study||3
9035797|NCT03302780|10097507|FG001|COMPLETED|Overall Study||3
8805480|NCT01473524|9857878|FG005|COMPLETED|DB Phase||0
8805481|NCT01473524|9857873|FG000|NOT COMPLETED|DB Phase||7
8805482|NCT01473524|9857874|FG001|NOT COMPLETED|DB Phase||9
8805483|NCT01473524|9857875|FG002|NOT COMPLETED|DB Phase||3
8805484|NCT01473524|9857876|FG003|NOT COMPLETED|DB Phase||0
8805485|NCT01473524|9857877|FG004|NOT COMPLETED|DB Phase||0
8805486|NCT01473524|9857878|FG005|NOT COMPLETED|DB Phase||0
8805487|NCT01473524|9857873|FG000|STARTED|LTSE Phase||0
8805488|NCT01473524|9857874|FG001|STARTED|LTSE Phase||0
8805489|NCT01473524|9857875|FG002|STARTED|LTSE Phase||0
8805490|NCT01473524|9857876|FG003|STARTED|LTSE Phase|One participant in the double-blind OCA 5-10 mg group did not enroll in the LTSE phase.|63
8805491|NCT01473524|9857877|FG004|STARTED|LTSE Phase||64
8805492|NCT01473524|9857878|FG005|STARTED|LTSE Phase|Four participants in the double-blind placebo group did not enroll in the LTSE phase.|66
8805493|NCT01473524|9857873|FG000|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||0
8805494|NCT01473524|9857874|FG001|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||0
8805495|NCT01473524|9857875|FG002|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||0
8805496|NCT01473524|9857876|FG003|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||63
8805497|NCT01473524|9857877|FG004|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||64
8805498|NCT01473524|9857878|FG005|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||66
8805499|NCT01473524|9857873|FG000|COMPLETED|LTSE Phase||0
8805500|NCT01473524|9857874|FG001|COMPLETED|LTSE Phase||0
8805501|NCT01473524|9857875|FG002|COMPLETED|LTSE Phase||0
8805502|NCT01473524|9857876|FG003|COMPLETED|LTSE Phase||54
8805503|NCT01473524|9857877|FG004|COMPLETED|LTSE Phase||47
8805504|NCT01473524|9857878|FG005|COMPLETED|LTSE Phase||45
8805505|NCT01473524|9857873|FG000|NOT COMPLETED|LTSE Phase||0
8805506|NCT01473524|9857874|FG001|NOT COMPLETED|LTSE Phase||0
8805507|NCT01473524|9857875|FG002|NOT COMPLETED|LTSE Phase||0
8805508|NCT01473524|9857876|FG003|NOT COMPLETED|LTSE Phase||9
8805509|NCT01473524|9857877|FG004|NOT COMPLETED|LTSE Phase||17
8805510|NCT01473524|9857878|FG005|NOT COMPLETED|LTSE Phase||21
8805511|NCT01473563|9857900|FG000|STARTED|Overall Study||52
8805512|NCT01473563|9857900|FG000|Received at Least 1 Dose of Study Drug|Overall Study||52
8805513|NCT01473563|9857900|FG000|COMPLETED|Overall Study||51
8805514|NCT01473563|9857900|FG000|NOT COMPLETED|Overall Study||1
8805515|NCT01473589|9857906|FG000|STARTED|Overall Study||60
8805516|NCT01473589|9857907|FG001|STARTED|Overall Study||62
8805517|NCT01473589|9857906|FG000|Received at Least 1 Dose of Study Drug|Overall Study|Randomized participants who received at least 1 dose of study drug.|60
8805518|NCT01473589|9857907|FG001|Received at Least 1 Dose of Study Drug|Overall Study|Randomized participants who received at least 1 dose of study drug.|61
8805519|NCT01473589|9857906|FG000|Completed 6 Months|Overall Study||51
8805520|NCT01473589|9857907|FG001|Completed 6 Months|Overall Study||54
8805521|NCT01473589|9857906|FG000|Completed 12 Months|Overall Study||49
8805522|NCT01473589|9857907|FG001|Completed 12 Months|Overall Study||48
8805523|NCT01473589|9857906|FG000|COMPLETED|Overall Study||49
8805524|NCT01473589|9857907|FG001|COMPLETED|Overall Study||46
8805525|NCT01473589|9857906|FG000|NOT COMPLETED|Overall Study||11
8805526|NCT01473589|9857907|FG001|NOT COMPLETED|Overall Study||16
8920259|NCT02214225|9980374|FG000|STARTED|Overall Study||1741
8920260|NCT02214225|9980375|FG001|STARTED|Overall Study||871
8920261|NCT02214225|9980376|FG002|STARTED|Overall Study||872
8920262|NCT02214225|9980374|FG000|COMPLETED|Overall Study||1686
8920263|NCT02214225|9980375|FG001|COMPLETED|Overall Study||852
8920264|NCT02214225|9980376|FG002|COMPLETED|Overall Study||850
8920265|NCT02214225|9980374|FG000|NOT COMPLETED|Overall Study||55
8920266|NCT02214225|9980375|FG001|NOT COMPLETED|Overall Study||19
8920267|NCT02214225|9980376|FG002|NOT COMPLETED|Overall Study||22
8920268|NCT02214238|9980409|FG000|STARTED|Overall Study||26
8920269|NCT02214238|9980410|FG001|STARTED|Overall Study||23
8920270|NCT02214238|9980409|FG000|COMPLETED|Overall Study||20
8920271|NCT02214238|9980410|FG001|COMPLETED|Overall Study||17
8920272|NCT02214238|9980409|FG000|NOT COMPLETED|Overall Study||6
8920273|NCT02214238|9980410|FG001|NOT COMPLETED|Overall Study||6
8920274|NCT02214277|9980419|FG000|STARTED|Overall Study||123
8920275|NCT02214277|9980420|FG001|STARTED|Overall Study||121
8920276|NCT02214277|9980421|FG002|STARTED|Overall Study||119
8920277|NCT02214277|9980419|FG000|COMPLETED|Overall Study||104
8920278|NCT02214277|9980420|FG001|COMPLETED|Overall Study||96
8920279|NCT02214277|9980421|FG002|COMPLETED|Overall Study||85
8920280|NCT02214277|9980419|FG000|NOT COMPLETED|Overall Study||19
8920281|NCT02214277|9980420|FG001|NOT COMPLETED|Overall Study||25
8920282|NCT02214277|9980421|FG002|NOT COMPLETED|Overall Study||34
8920283|NCT02214290|9980428|FG000|STARTED|First Intervention (7 Days)||8
8920284|NCT02214290|9980429|FG001|STARTED|First Intervention (7 Days)||8
8920285|NCT02214290|9980428|FG000|COMPLETED|First Intervention (7 Days)||8
8920286|NCT02214290|9980429|FG001|COMPLETED|First Intervention (7 Days)||8
8920287|NCT02214290|9980428|FG000|NOT COMPLETED|First Intervention (7 Days)||0
8920288|NCT02214290|9980429|FG001|NOT COMPLETED|First Intervention (7 Days)||0
8920289|NCT02214290|9980428|FG000|STARTED|Washout (14 Days)||8
8920290|NCT02214290|9980429|FG001|STARTED|Washout (14 Days)||8
8920291|NCT02214290|9980428|FG000|COMPLETED|Washout (14 Days)||8
8920292|NCT02214290|9980429|FG001|COMPLETED|Washout (14 Days)||8
8920293|NCT02214290|9980428|FG000|NOT COMPLETED|Washout (14 Days)||0
8920294|NCT02214290|9980429|FG001|NOT COMPLETED|Washout (14 Days)||0
8920295|NCT02214290|9980428|FG000|STARTED|Second Intervention (7 Days)||8
8920296|NCT02214290|9980429|FG001|STARTED|Second Intervention (7 Days)||8
8920297|NCT02214290|9980428|FG000|COMPLETED|Second Intervention (7 Days)||8
8805527|NCT01473602|9857917|FG000|STARTED|Overall Study||18
8805528|NCT01473602|9857918|FG001|STARTED|Overall Study||21
8805529|NCT01473602|9857917|FG000|Received at Least 1 Dose of Study Drug|Overall Study||18
8805530|NCT01473602|9857918|FG001|Received at Least 1 Dose of Study Drug|Overall Study||20
8805531|NCT01473602|9857917|FG000|Completed 6 Months|Overall Study||12
8805532|NCT01473602|9857918|FG001|Completed 6 Months|Overall Study||15
8805533|NCT01473602|9857917|FG000|Completed 12 Months|Overall Study||10
8805534|NCT01473602|9857918|FG001|Completed 12 Months|Overall Study||13
8805535|NCT01473602|9857917|FG000|COMPLETED|Overall Study||10
8805536|NCT01473602|9857918|FG001|COMPLETED|Overall Study||13
8805537|NCT01473602|9857917|FG000|NOT COMPLETED|Overall Study||8
8805538|NCT01473602|9857918|FG001|NOT COMPLETED|Overall Study||8
8805539|NCT01473745|9857928|FG000|STARTED|Overall Study||24
8805540|NCT01473745|9857929|FG001|STARTED|Overall Study||24
8805541|NCT01473745|9857928|FG000|COMPLETED|Overall Study||24
8805542|NCT01473745|9857929|FG001|COMPLETED|Overall Study||24
8805543|NCT01473745|9857928|FG000|NOT COMPLETED|Overall Study||0
8805544|NCT01473745|9857929|FG001|NOT COMPLETED|Overall Study||0
8805545|NCT01473758|9857937|FG000|STARTED|Cycle 1||38
8805546|NCT01473758|9857938|FG001|STARTED|Cycle 1||43
8805547|NCT01473758|9857939|FG002|STARTED|Cycle 1||0
8805548|NCT01473758|9857940|FG003|STARTED|Cycle 1||0
8805549|NCT01473758|9857937|FG000|COMPLETED|Cycle 1||27
8805550|NCT01473758|9857938|FG001|COMPLETED|Cycle 1||40
8805551|NCT01473758|9857939|FG002|COMPLETED|Cycle 1||0
8805552|NCT01473758|9857940|FG003|COMPLETED|Cycle 1||0
8805553|NCT01473758|9857937|FG000|NOT COMPLETED|Cycle 1||11
8920298|NCT02214290|9980429|FG001|COMPLETED|Second Intervention (7 Days)||8
8920299|NCT02214290|9980428|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
8920300|NCT02214290|9980429|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
8920301|NCT02214420|9980440|FG000|STARTED|Overall Study||14
8920302|NCT02214420|9980441|FG001|STARTED|Overall Study||10
8920303|NCT02214420|9980440|FG000|COMPLETED|Overall Study||13
8920304|NCT02214420|9980441|FG001|COMPLETED|Overall Study||10
8920305|NCT02214420|9980440|FG000|NOT COMPLETED|Overall Study||1
8920306|NCT02214420|9980441|FG001|NOT COMPLETED|Overall Study||0
8920307|NCT02214615|9980449|FG000|STARTED|First Intervention||1
8920308|NCT02214615|9980450|FG001|STARTED|First Intervention||1
8920309|NCT02214615|9980449|FG000|COMPLETED|First Intervention||1
8920310|NCT02214615|9980450|FG001|COMPLETED|First Intervention||1
8920311|NCT02214615|9980449|FG000|NOT COMPLETED|First Intervention||0
8920312|NCT02214615|9980450|FG001|NOT COMPLETED|First Intervention||0
8920313|NCT02214615|9980449|FG000|STARTED|Washout||1
8920314|NCT02214615|9980450|FG001|STARTED|Washout||1
8920315|NCT02214615|9980449|FG000|COMPLETED|Washout||1
8920316|NCT02214615|9980450|FG001|COMPLETED|Washout||1
8920317|NCT02214615|9980449|FG000|NOT COMPLETED|Washout||0
8920318|NCT02214615|9980450|FG001|NOT COMPLETED|Washout||0
8920319|NCT02214615|9980449|FG000|STARTED|Second Intervention||1
8920320|NCT02214615|9980450|FG001|STARTED|Second Intervention||1
8920321|NCT02214615|9980449|FG000|COMPLETED|Second Intervention||1
8920322|NCT02214615|9980450|FG001|COMPLETED|Second Intervention||1
8920323|NCT02214615|9980449|FG000|NOT COMPLETED|Second Intervention||0
8920324|NCT02214615|9980450|FG001|NOT COMPLETED|Second Intervention||0
8920325|NCT02214628|9980458|FG000|STARTED|Overall Study||63
8920326|NCT02214628|9980459|FG001|STARTED|Overall Study||38
8920327|NCT02214628|9980458|FG000|COMPLETED|Overall Study||36
8920328|NCT02214628|9980459|FG001|COMPLETED|Overall Study||9
8920329|NCT02214628|9980458|FG000|NOT COMPLETED|Overall Study||27
8920330|NCT02214628|9980459|FG001|NOT COMPLETED|Overall Study||29
8920331|NCT02215070|9980469|FG000|STARTED|Overall Study||26
8920332|NCT02215070|9980470|FG001|STARTED|Overall Study||52
8920333|NCT02215070|9980469|FG000|COMPLETED|Overall Study||20
8920334|NCT02215070|9980470|FG001|COMPLETED|Overall Study||52
8920335|NCT02215070|9980469|FG000|NOT COMPLETED|Overall Study||6
8920336|NCT02215070|9980470|FG001|NOT COMPLETED|Overall Study||0
8920337|NCT02215161|9980476|FG000|STARTED|Overall Study||14
8920338|NCT02215161|9980476|FG000|COMPLETED|Overall Study||14
8920339|NCT02215161|9980476|FG000|NOT COMPLETED|Overall Study||0
8920340|NCT02215200|9980491|FG000|STARTED|Overall Study||29
8920341|NCT02215200|9980492|FG001|STARTED|Overall Study||29
8920342|NCT02215200|9980493|FG002|STARTED|Overall Study||31
8920343|NCT02215200|9980491|FG000|COMPLETED|Overall Study||29
8920344|NCT02215200|9980492|FG001|COMPLETED|Overall Study||28
8920345|NCT02215200|9980493|FG002|COMPLETED|Overall Study||30
8920346|NCT02215200|9980491|FG000|NOT COMPLETED|Overall Study||0
8920347|NCT02215200|9980492|FG001|NOT COMPLETED|Overall Study||1
8920348|NCT02215200|9980493|FG002|NOT COMPLETED|Overall Study||1
8920349|NCT02215252|9980504|FG000|STARTED|Overall Study||44
8920350|NCT02215252|9980505|FG001|STARTED|Overall Study||46
8920351|NCT02215252|9980506|FG002|STARTED|Overall Study||45
8920352|NCT02215252|9980504|FG000|COMPLETED|Overall Study||42
8920353|NCT02215252|9980505|FG001|COMPLETED|Overall Study||38
8920354|NCT02215252|9980506|FG002|COMPLETED|Overall Study||41
8920355|NCT02215252|9980504|FG000|NOT COMPLETED|Overall Study||2
8805554|NCT01473758|9857938|FG001|NOT COMPLETED|Cycle 1||3
8805555|NCT01473758|9857939|FG002|NOT COMPLETED|Cycle 1||0
8805556|NCT01473758|9857940|FG003|NOT COMPLETED|Cycle 1||0
8805557|NCT01473758|9857937|FG000|STARTED|Cycle 2||0
8805558|NCT01473758|9857938|FG001|STARTED|Cycle 2||0
8805559|NCT01473758|9857939|FG002|STARTED|Cycle 2||10
8805560|NCT01473758|9857940|FG003|STARTED|Cycle 2||4
8920356|NCT02215252|9980505|FG001|NOT COMPLETED|Overall Study||8
8920357|NCT02215252|9980506|FG002|NOT COMPLETED|Overall Study||4
8805561|NCT01473758|9857937|FG000|COMPLETED|Cycle 2||0
8805562|NCT01473758|9857938|FG001|COMPLETED|Cycle 2||0
8805563|NCT01473758|9857939|FG002|COMPLETED|Cycle 2||5
8805564|NCT01473758|9857940|FG003|COMPLETED|Cycle 2||4
8805565|NCT01473758|9857937|FG000|NOT COMPLETED|Cycle 2||0
8805566|NCT01473758|9857938|FG001|NOT COMPLETED|Cycle 2||0
8805567|NCT01473758|9857939|FG002|NOT COMPLETED|Cycle 2||5
8805568|NCT01473758|9857940|FG003|NOT COMPLETED|Cycle 2||0
8805569|NCT01473836|9857948|FG000|STARTED|Overall Study||38
8805570|NCT01473836|9857948|FG000|COMPLETED|Overall Study||32
8805571|NCT01473836|9857948|FG000|NOT COMPLETED|Overall Study||6
8805572|NCT01473940|9857956|FG000|STARTED|Induction Therapy||3
8805573|NCT01473940|9857957|FG001|STARTED|Induction Therapy||4
8805574|NCT01473940|9857958|FG002|STARTED|Induction Therapy||6
8805575|NCT01473940|9857959|FG003|STARTED|Induction Therapy||8
8805576|NCT01473940|9857956|FG000|Started Treatment|Induction Therapy||3
8805577|NCT01473940|9857957|FG001|Started Treatment|Induction Therapy||4
8805578|NCT01473940|9857958|FG002|Started Treatment|Induction Therapy||6
8805579|NCT01473940|9857959|FG003|Started Treatment|Induction Therapy||8
8805580|NCT01473940|9857956|FG000|Completed Induction- 12 Weeks|Induction Therapy||3
8805581|NCT01473940|9857957|FG001|Completed Induction- 12 Weeks|Induction Therapy||3
8805582|NCT01473940|9857958|FG002|Completed Induction- 12 Weeks|Induction Therapy||4
8805583|NCT01473940|9857959|FG003|Completed Induction- 12 Weeks|Induction Therapy||7
8805584|NCT01473940|9857956|FG000|COMPLETED|Induction Therapy||3
8805585|NCT01473940|9857957|FG001|COMPLETED|Induction Therapy||3
8805586|NCT01473940|9857958|FG002|COMPLETED|Induction Therapy||4
8805587|NCT01473940|9857959|FG003|COMPLETED|Induction Therapy||7
8805588|NCT01473940|9857956|FG000|NOT COMPLETED|Induction Therapy||0
8805589|NCT01473940|9857957|FG001|NOT COMPLETED|Induction Therapy||1
8805590|NCT01473940|9857958|FG002|NOT COMPLETED|Induction Therapy||2
8805591|NCT01473940|9857959|FG003|NOT COMPLETED|Induction Therapy||1
8805592|NCT01473940|9857956|FG000|STARTED|Maintenance Therapy||3
8805593|NCT01473940|9857957|FG001|STARTED|Maintenance Therapy||3
8805594|NCT01473940|9857958|FG002|STARTED|Maintenance Therapy||4
8805595|NCT01473940|9857959|FG003|STARTED|Maintenance Therapy||7
8805596|NCT01473940|9857956|FG000|Evaluated for Response|Maintenance Therapy||3
8805597|NCT01473940|9857957|FG001|Evaluated for Response|Maintenance Therapy||3
8805598|NCT01473940|9857958|FG002|Evaluated for Response|Maintenance Therapy||4
8805599|NCT01473940|9857959|FG003|Evaluated for Response|Maintenance Therapy||7
8805600|NCT01473940|9857956|FG000|Went on to Start Maintenance Therapy|Maintenance Therapy||2
8805601|NCT01473940|9857957|FG001|Went on to Start Maintenance Therapy|Maintenance Therapy||1
8805602|NCT01473940|9857958|FG002|Went on to Start Maintenance Therapy|Maintenance Therapy||3
8805603|NCT01473940|9857959|FG003|Went on to Start Maintenance Therapy|Maintenance Therapy||3
8805604|NCT01473940|9857956|FG000|COMPLETED|Maintenance Therapy||2
8805605|NCT01473940|9857957|FG001|COMPLETED|Maintenance Therapy||1
8805606|NCT01473940|9857958|FG002|COMPLETED|Maintenance Therapy||3
8805607|NCT01473940|9857959|FG003|COMPLETED|Maintenance Therapy||3
8805608|NCT01473940|9857956|FG000|NOT COMPLETED|Maintenance Therapy||1
8805609|NCT01473940|9857957|FG001|NOT COMPLETED|Maintenance Therapy||2
8805610|NCT01473940|9857958|FG002|NOT COMPLETED|Maintenance Therapy||1
8805611|NCT01473940|9857959|FG003|NOT COMPLETED|Maintenance Therapy||4
8805612|NCT01473940|9857956|FG000|STARTED|Follow-up Until Death||3
8805613|NCT01473940|9857957|FG001|STARTED|Follow-up Until Death||4
8805614|NCT01473940|9857958|FG002|STARTED|Follow-up Until Death||5
8805615|NCT01473940|9857959|FG003|STARTED|Follow-up Until Death||7
8805616|NCT01473940|9857956|FG000|COMPLETED|Follow-up Until Death||3
8805617|NCT01473940|9857957|FG001|COMPLETED|Follow-up Until Death||4
8805618|NCT01473940|9857958|FG002|COMPLETED|Follow-up Until Death||5
8805619|NCT01473940|9857959|FG003|COMPLETED|Follow-up Until Death||7
8805620|NCT01473940|9857956|FG000|NOT COMPLETED|Follow-up Until Death||0
8805621|NCT01473940|9857957|FG001|NOT COMPLETED|Follow-up Until Death||0
8805622|NCT01473940|9857958|FG002|NOT COMPLETED|Follow-up Until Death||0
8805623|NCT01473940|9857959|FG003|NOT COMPLETED|Follow-up Until Death||0
8805624|NCT01473953|9857977|FG000|STARTED|Overall Study||6
8805625|NCT01473953|9857978|FG001|STARTED|Overall Study||6
8805626|NCT01473953|9857979|FG002|STARTED|Overall Study||6
8805627|NCT01473953|9857980|FG003|STARTED|Overall Study||5
8805628|NCT01473953|9857981|FG004|STARTED|Overall Study||8
8805629|NCT01473953|9857977|FG000|COMPLETED|Overall Study||5
8805630|NCT01473953|9857978|FG001|COMPLETED|Overall Study||6
8805631|NCT01473953|9857979|FG002|COMPLETED|Overall Study||6
8805632|NCT01473953|9857980|FG003|COMPLETED|Overall Study||5
8920358|NCT02215369|9980514|FG000|STARTED|Overall Study||112
8920359|NCT02215369|9980514|FG000|COMPLETED|Overall Study||70
8805633|NCT01473953|9857981|FG004|COMPLETED|Overall Study||8
8805634|NCT01473953|9857977|FG000|NOT COMPLETED|Overall Study||1
8805635|NCT01473953|9857978|FG001|NOT COMPLETED|Overall Study||0
8805636|NCT01473953|9857979|FG002|NOT COMPLETED|Overall Study||0
8805637|NCT01473953|9857980|FG003|NOT COMPLETED|Overall Study||0
8805638|NCT01473953|9857981|FG004|NOT COMPLETED|Overall Study||0
8805639|NCT01473992|9857995|FG000|STARTED|Overall Study||10
8805640|NCT01473992|9857996|FG001|STARTED|Overall Study||10
8805641|NCT01473992|9857997|FG002|STARTED|Overall Study||5
8805642|NCT01473992|9857995|FG000|COMPLETED|Overall Study||10
8805643|NCT01473992|9857996|FG001|COMPLETED|Overall Study||10
8805644|NCT01473992|9857997|FG002|COMPLETED|Overall Study||5
8805645|NCT01473992|9857995|FG000|NOT COMPLETED|Overall Study||0
8805646|NCT01473992|9857996|FG001|NOT COMPLETED|Overall Study||0
8805647|NCT01473992|9857997|FG002|NOT COMPLETED|Overall Study||0
8805648|NCT01474018|9858007|FG000|STARTED|Overall Study||5
8805649|NCT01474018|9858008|FG001|STARTED|Overall Study||10
8805650|NCT01474018|9858007|FG000|COMPLETED|Overall Study|Writing paper|5
8805651|NCT01474018|9858008|FG001|COMPLETED|Overall Study||7
8805652|NCT01474018|9858007|FG000|NOT COMPLETED|Overall Study||0
8805653|NCT01474018|9858008|FG001|NOT COMPLETED|Overall Study||3
8805654|NCT01474109|9858017|FG000|STARTED|Period 1: Baseline to Week 16||95
8805655|NCT01474109|9858018|FG001|STARTED|Period 1: Baseline to Week 16||97
8805656|NCT01474109|9858019|FG002|STARTED|Period 1: Baseline to Week 16||97
8805657|NCT01474109|9858017|FG000|COMPLETED|Period 1: Baseline to Week 16||88
8805658|NCT01474109|9858018|FG001|COMPLETED|Period 1: Baseline to Week 16||91
8805659|NCT01474109|9858019|FG002|COMPLETED|Period 1: Baseline to Week 16||95
8805660|NCT01474109|9858017|FG000|NOT COMPLETED|Period 1: Baseline to Week 16||7
8805661|NCT01474109|9858018|FG001|NOT COMPLETED|Period 1: Baseline to Week 16||6
8805662|NCT01474109|9858019|FG002|NOT COMPLETED|Period 1: Baseline to Week 16||2
8805663|NCT01474109|9858017|FG000|STARTED|Period 2: Week 16 to End of Study||88
8805664|NCT01474109|9858018|FG001|STARTED|Period 2: Week 16 to End of Study||91
8805665|NCT01474109|9858019|FG002|STARTED|Period 2: Week 16 to End of Study||95
8805666|NCT01474109|9858017|FG000|COMPLETED|Period 2: Week 16 to End of Study||70
8805667|NCT01474109|9858018|FG001|COMPLETED|Period 2: Week 16 to End of Study||73
8805668|NCT01474109|9858019|FG002|COMPLETED|Period 2: Week 16 to End of Study||83
8805669|NCT01474109|9858017|FG000|NOT COMPLETED|Period 2: Week 16 to End of Study||18
8805670|NCT01474109|9858018|FG001|NOT COMPLETED|Period 2: Week 16 to End of Study||18
8805671|NCT01474109|9858019|FG002|NOT COMPLETED|Period 2: Week 16 to End of Study||12
8805672|NCT01474122|9858030|FG000|STARTED|Period 1: Baseline to Week 16||88
8805673|NCT01474122|9858031|FG001|STARTED|Period 1: Baseline to Week 16|One patient was randomised but did not receive study treatment|88
8805674|NCT01474122|9858032|FG002|STARTED|Period 1: Baseline to Week 16||89
8805675|NCT01474122|9858030|FG000|COMPLETED|Period 1: Baseline to Week 16||87
8805676|NCT01474122|9858031|FG001|COMPLETED|Period 1: Baseline to Week 16||86
8805677|NCT01474122|9858032|FG002|COMPLETED|Period 1: Baseline to Week 16||88
8805678|NCT01474122|9858030|FG000|NOT COMPLETED|Period 1: Baseline to Week 16||1
8805679|NCT01474122|9858031|FG001|NOT COMPLETED|Period 1: Baseline to Week 16||2
8805680|NCT01474122|9858032|FG002|NOT COMPLETED|Period 1: Baseline to Week 16||1
8805681|NCT01474122|9858030|FG000|STARTED|Period 2: Week 16 to End of Study||87
8805682|NCT01474122|9858031|FG001|STARTED|Period 2: Week 16 to End of Study||86
8805683|NCT01474122|9858032|FG002|STARTED|Period 2: Week 16 to End of Study||88
8805684|NCT01474122|9858030|FG000|COMPLETED|Period 2: Week 16 to End of Study|Patients on treatment at the time of study termination|70
8805685|NCT01474122|9858031|FG001|COMPLETED|Period 2: Week 16 to End of Study|Patients on treatment at the time of study termination|73
8805686|NCT01474122|9858032|FG002|COMPLETED|Period 2: Week 16 to End of Study|Patients on treatment at the time of study termination|73
8805687|NCT01474122|9858030|FG000|NOT COMPLETED|Period 2: Week 16 to End of Study||17
8805688|NCT01474122|9858031|FG001|NOT COMPLETED|Period 2: Week 16 to End of Study||13
8805689|NCT01474122|9858032|FG002|NOT COMPLETED|Period 2: Week 16 to End of Study||15
8805690|NCT01474200|9858044|FG000|STARTED|Overall Study||110
8805691|NCT01474200|9858045|FG001|STARTED|Overall Study||114
8805692|NCT01474200|9858044|FG000|COMPLETED|Overall Study||81
8805693|NCT01474200|9858045|FG001|COMPLETED|Overall Study||84
8805694|NCT01474200|9858044|FG000|NOT COMPLETED|Overall Study||29
8805695|NCT01474200|9858045|FG001|NOT COMPLETED|Overall Study||30
8805696|NCT01474213|9858053|FG000|STARTED|Overall Study||20
8805697|NCT01474213|9858054|FG001|STARTED|Overall Study||20
8805698|NCT01474213|9858053|FG000|COMPLETED|Overall Study||20
8805699|NCT01474213|9858054|FG001|COMPLETED|Overall Study||20
8805700|NCT01474213|9858053|FG000|NOT COMPLETED|Overall Study||0
8805701|NCT01474213|9858054|FG001|NOT COMPLETED|Overall Study||0
8805702|NCT01474239|9858066|FG000|STARTED|Overall Study||59
8805703|NCT01474239|9858067|FG001|STARTED|Overall Study||32
8805704|NCT01474239|9858066|FG000|COMPLETED|Overall Study||0
8805705|NCT01474239|9858067|FG001|COMPLETED|Overall Study||0
8805706|NCT01474239|9858066|FG000|NOT COMPLETED|Overall Study||59
8805707|NCT01474239|9858067|FG001|NOT COMPLETED|Overall Study||32
8805708|NCT01474291|9858075|FG000|STARTED|Overall Study||603
8805709|NCT01474291|9858075|FG000|Evaluable for Efficacy|Overall Study|Received tocilizumab infusion and met all inclusion/exclusion criteria|577
8805710|NCT01474291|9858075|FG000|COMPLETED|Overall Study||383
8805711|NCT01474291|9858075|FG000|NOT COMPLETED|Overall Study||220
8805712|NCT01474317|9858082|FG000|STARTED|Overall Study||226
8805713|NCT01474317|9858082|FG000|COMPLETED|Overall Study||224
8805714|NCT01474317|9858082|FG000|NOT COMPLETED|Overall Study||2
8805715|NCT01474434|9858090|FG000|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||8
8805716|NCT01474434|9858091|FG001|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||9
8805717|NCT01474434|9858092|FG002|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||11
8805718|NCT01474434|9858093|FG003|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||13
8805719|NCT01474434|9858090|FG000|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||7
8805720|NCT01474434|9858091|FG001|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||9
8805721|NCT01474434|9858092|FG002|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||10
8805722|NCT01474434|9858093|FG003|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||11
8805723|NCT01474434|9858090|FG000|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||1
8805724|NCT01474434|9858091|FG001|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||0
8805725|NCT01474434|9858092|FG002|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||1
8805726|NCT01474434|9858093|FG003|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||2
8805727|NCT01474434|9858090|FG000|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||7
8805728|NCT01474434|9858091|FG001|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||9
8805729|NCT01474434|9858092|FG002|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||10
8805730|NCT01474434|9858093|FG003|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||11
8805731|NCT01474434|9858090|FG000|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||7
8805732|NCT01474434|9858091|FG001|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||9
8805733|NCT01474434|9858092|FG002|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||10
8805734|NCT01474434|9858093|FG003|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||11
8805735|NCT01474434|9858090|FG000|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
8805736|NCT01474434|9858091|FG001|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
8805737|NCT01474434|9858092|FG002|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
8805738|NCT01474434|9858093|FG003|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
8805739|NCT01474486|9858107|FG000|STARTED|Overall Study||28
8805740|NCT01474486|9858107|FG000|Treated|Overall Study||22
8805741|NCT01474486|9858107|FG000|COMPLETED|Overall Study||20
8805742|NCT01474486|9858107|FG000|NOT COMPLETED|Overall Study||8
8805743|NCT01474512|9858118|FG000|STARTED|Induction Period||431
8805744|NCT01474512|9858119|FG001|STARTED|Induction Period||432
8805745|NCT01474512|9858120|FG002|STARTED|Induction Period||433
8805746|NCT01474512|9858121|FG003|STARTED|Induction Period||0
8805747|NCT01474512|9858122|FG004|STARTED|Induction Period||0
8805748|NCT01474512|9858123|FG005|STARTED|Induction Period||0
8805749|NCT01474512|9858124|FG006|STARTED|Induction Period||0
8805750|NCT01474512|9858125|FG007|STARTED|Induction Period||0
8805751|NCT01474512|9858126|FG008|STARTED|Induction Period||0
8805752|NCT01474512|9858127|FG009|STARTED|Induction Period||0
8920360|NCT02215369|9980514|FG000|NOT COMPLETED|Overall Study||42
8920361|NCT02215616|9980522|FG000|STARTED|Overall Study||108
8920362|NCT02215616|9980523|FG001|STARTED|Overall Study||107
8920363|NCT02215616|9980524|FG002|STARTED|Overall Study||107
8920364|NCT02215616|9980525|FG003|STARTED|Overall Study||30
8920365|NCT02215616|9980522|FG000|Received at Least 1 Dose of Study Drug|Overall Study||108
8920366|NCT02215616|9980523|FG001|Received at Least 1 Dose of Study Drug|Overall Study||107
8920367|NCT02215616|9980524|FG002|Received at Least 1 Dose of Study Drug|Overall Study||106
8920368|NCT02215616|9980525|FG003|Received at Least 1 Dose of Study Drug|Overall Study||29
8920369|NCT02215616|9980522|FG000|COMPLETED|Overall Study||97
8920370|NCT02215616|9980523|FG001|COMPLETED|Overall Study||90
8920371|NCT02215616|9980524|FG002|COMPLETED|Overall Study||93
8920372|NCT02215616|9980525|FG003|COMPLETED|Overall Study||17
8920373|NCT02215616|9980522|FG000|NOT COMPLETED|Overall Study||11
8920374|NCT02215616|9980523|FG001|NOT COMPLETED|Overall Study||17
8920375|NCT02215616|9980524|FG002|NOT COMPLETED|Overall Study||14
8920376|NCT02215616|9980525|FG003|NOT COMPLETED|Overall Study||13
8920377|NCT02215954|9980538|FG000|STARTED|Overall Study||214
8920378|NCT02215954|9980539|FG001|STARTED|Overall Study||212
8920379|NCT02215954|9980540|FG002|STARTED|Overall Study||211
8920380|NCT02215954|9980538|FG000|Intention-To-Treat (ITT) Analysis Set|Overall Study||214
8920381|NCT02215954|9980539|FG001|Intention-To-Treat (ITT) Analysis Set|Overall Study||212
8920382|NCT02215954|9980540|FG002|Intention-To-Treat (ITT) Analysis Set|Overall Study||211
8920383|NCT02215954|9980538|FG000|Per Protocol (PP) Analysis Set|Overall Study||212
8920384|NCT02215954|9980539|FG001|Per Protocol (PP) Analysis Set|Overall Study||208
8920385|NCT02215954|9980540|FG002|Per Protocol (PP) Analysis Set|Overall Study||205
8920386|NCT02215954|9980538|FG000|Safety Analysis Set|Overall Study||213
8920387|NCT02215954|9980539|FG001|Safety Analysis Set|Overall Study||211
8920388|NCT02215954|9980540|FG002|Safety Analysis Set|Overall Study||208
8920389|NCT02215954|9980538|FG000|COMPLETED|Overall Study||213
8920390|NCT02215954|9980539|FG001|COMPLETED|Overall Study||211
8920391|NCT02215954|9980540|FG002|COMPLETED|Overall Study||205
8920392|NCT02215954|9980538|FG000|NOT COMPLETED|Overall Study||1
8920393|NCT02215954|9980539|FG001|NOT COMPLETED|Overall Study||1
8920394|NCT02215954|9980540|FG002|NOT COMPLETED|Overall Study||6
8920395|NCT02215967|9980553|FG000|STARTED|Overall Study||3
8920396|NCT02215967|9980554|FG001|STARTED|Overall Study||3
8920397|NCT02215967|9980555|FG002|STARTED|Overall Study||5
8920398|NCT02215967|9980556|FG003|STARTED|Overall Study||19
8920399|NCT02215967|9980553|FG000|COMPLETED|Overall Study||3
8920400|NCT02215967|9980554|FG001|COMPLETED|Overall Study||3
8920401|NCT02215967|9980555|FG002|COMPLETED|Overall Study||4
8920402|NCT02215967|9980556|FG003|COMPLETED|Overall Study||16
8920403|NCT02215967|9980553|FG000|NOT COMPLETED|Overall Study||0
8920404|NCT02215967|9980554|FG001|NOT COMPLETED|Overall Study||0
8920405|NCT02215967|9980555|FG002|NOT COMPLETED|Overall Study||1
8920406|NCT02215967|9980556|FG003|NOT COMPLETED|Overall Study||3
8920407|NCT02216071|9980568|FG000|STARTED|Overall Study||254
8920408|NCT02216071|9980569|FG001|STARTED|Overall Study||245
8920409|NCT02216071|9980568|FG000|COMPLETED|Overall Study||239
8920410|NCT02216071|9980569|FG001|COMPLETED|Overall Study||233
8805753|NCT01474512|9858128|FG010|STARTED|Induction Period||0
8920411|NCT02216071|9980568|FG000|NOT COMPLETED|Overall Study||15
8920412|NCT02216071|9980569|FG001|NOT COMPLETED|Overall Study||12
8920413|NCT02216097|9980577|FG000|STARTED|Overall Study||8
8920414|NCT02216097|9980578|FG001|STARTED|Overall Study||6
8920415|NCT02216097|9980577|FG000|COMPLETED|Overall Study||8
8920416|NCT02216097|9980578|FG001|COMPLETED|Overall Study||6
8920417|NCT02216097|9980577|FG000|NOT COMPLETED|Overall Study||0
8920418|NCT02216097|9980578|FG001|NOT COMPLETED|Overall Study||0
8920419|NCT02216123|9980586|FG000|STARTED|Overall Study||166
8920420|NCT02216123|9980587|FG001|STARTED|Overall Study||85
8920421|NCT02216123|9980586|FG000|COMPLETED|Overall Study||160
8920422|NCT02216123|9980587|FG001|COMPLETED|Overall Study||83
8920423|NCT02216123|9980586|FG000|NOT COMPLETED|Overall Study||6
8920424|NCT02216123|9980587|FG001|NOT COMPLETED|Overall Study||2
8920425|NCT02216136|9980600|FG000|STARTED|Overall Study||72
8920426|NCT02216136|9980601|FG001|STARTED|Overall Study||90
8920427|NCT02216136|9980602|FG002|STARTED|Overall Study||0
8920428|NCT02216136|9980600|FG000|COMPLETED|Overall Study||72
8920429|NCT02216136|9980601|FG001|COMPLETED|Overall Study||90
8920430|NCT02216136|9980602|FG002|COMPLETED|Overall Study||0
8920431|NCT02216136|9980600|FG000|NOT COMPLETED|Overall Study||0
8920432|NCT02216136|9980601|FG001|NOT COMPLETED|Overall Study||0
8920433|NCT02216136|9980602|FG002|NOT COMPLETED|Overall Study||0
8920434|NCT02216214|9980612|FG000|STARTED|Overall Study||443
8920435|NCT02216214|9980613|FG001|STARTED|Overall Study||445
8920436|NCT02216214|9980612|FG000|Treated|Overall Study||442
8920437|NCT02216214|9980613|FG001|Treated|Overall Study||445
8920438|NCT02216214|9980612|FG000|COMPLETED|Overall Study||400
8920439|NCT02216214|9980613|FG001|COMPLETED|Overall Study||409
8920440|NCT02216214|9980612|FG000|NOT COMPLETED|Overall Study||43
8920441|NCT02216214|9980613|FG001|NOT COMPLETED|Overall Study||36
8920442|NCT02216357|9980621|FG000|STARTED|Overall Study||14
8920443|NCT02216357|9980622|FG001|STARTED|Overall Study||5
8920444|NCT02216357|9980621|FG000|COMPLETED|Overall Study||12
8920445|NCT02216357|9980622|FG001|COMPLETED|Overall Study||4
8920446|NCT02216357|9980621|FG000|NOT COMPLETED|Overall Study||2
8920447|NCT02216357|9980622|FG001|NOT COMPLETED|Overall Study||1
8920448|NCT02216422|9980628|FG000|STARTED|Overall Study||36
8920449|NCT02216422|9980628|FG000|COMPLETED|Overall Study||36
8920450|NCT02216422|9980628|FG000|NOT COMPLETED|Overall Study||0
8920451|NCT02216526|9980635|FG000|STARTED|Overall Study||45
8920452|NCT02216526|9980636|FG001|STARTED|Overall Study||44
8920453|NCT02216526|9980637|FG002|STARTED|Overall Study||44
8920454|NCT02216526|9980635|FG000|COMPLETED|Overall Study||40
8920455|NCT02216526|9980636|FG001|COMPLETED|Overall Study||41
8920456|NCT02216526|9980637|FG002|COMPLETED|Overall Study||36
8920457|NCT02216526|9980635|FG000|NOT COMPLETED|Overall Study||5
9035798|NCT03302780|10097506|FG000|NOT COMPLETED|Overall Study||0
9035799|NCT03302780|10097507|FG001|NOT COMPLETED|Overall Study||0
9035800|NCT03302793|10097513|FG000|STARTED|Overall Study||6
9035801|NCT03302793|10097514|FG001|STARTED|Overall Study||6
9035802|NCT03302793|10097513|FG000|COMPLETED|Overall Study||6
9035803|NCT03302793|10097514|FG001|COMPLETED|Overall Study||4
9035804|NCT03302793|10097513|FG000|NOT COMPLETED|Overall Study||0
9035805|NCT03302793|10097514|FG001|NOT COMPLETED|Overall Study||2
9035806|NCT03302936|10097522|FG000|STARTED|Overall Study||49
9035807|NCT03302936|10097523|FG001|STARTED|Overall Study||49
9035808|NCT03302936|10097522|FG000|COMPLETED|Overall Study||46
9035809|NCT03302936|10097523|FG001|COMPLETED|Overall Study||45
9035810|NCT03302936|10097522|FG000|NOT COMPLETED|Overall Study||3
9035811|NCT03302936|10097523|FG001|NOT COMPLETED|Overall Study||4
9035812|NCT03302975|10097533|FG000|STARTED|Overall Study||16
9035813|NCT03302975|10097533|FG000|COMPLETED|Overall Study||12
9035814|NCT03302975|10097533|FG000|NOT COMPLETED|Overall Study||4
9035815|NCT03303079|10097540|FG000|STARTED|Overall Study||189
9035816|NCT03303079|10097541|FG001|STARTED|Overall Study||191
9035817|NCT03303079|10097542|FG002|STARTED|Overall Study||191
9035818|NCT03303079|10097540|FG000|COMPLETED|Overall Study||182
9035819|NCT03303079|10097541|FG001|COMPLETED|Overall Study||180
9035820|NCT03303079|10097542|FG002|COMPLETED|Overall Study||179
9035821|NCT03303079|10097540|FG000|NOT COMPLETED|Overall Study||7
9035822|NCT03303079|10097541|FG001|NOT COMPLETED|Overall Study||11
9035823|NCT03303079|10097542|FG002|NOT COMPLETED|Overall Study||12
9035824|NCT03303092|10097553|FG000|STARTED|Overall Study||121
9035825|NCT03303092|10097554|FG001|STARTED|Overall Study||119
9035826|NCT03303092|10097555|FG002|STARTED|Overall Study||117
9035827|NCT03303092|10097553|FG000|COMPLETED|Overall Study||118
9035828|NCT03303092|10097554|FG001|COMPLETED|Overall Study||113
9035829|NCT03303092|10097555|FG002|COMPLETED|Overall Study||112
9035830|NCT03303092|10097553|FG000|NOT COMPLETED|Overall Study||3
9035831|NCT03303092|10097554|FG001|NOT COMPLETED|Overall Study||6
9035832|NCT03303092|10097555|FG002|NOT COMPLETED|Overall Study||5
9035833|NCT03303105|10097565|FG000|STARTED|Overall Study||25
9035834|NCT03303105|10097566|FG001|STARTED|Overall Study||25
9035835|NCT03303105|10097565|FG000|COMPLETED|Overall Study||23
9035836|NCT03303105|10097566|FG001|COMPLETED|Overall Study||21
9035837|NCT03303105|10097565|FG000|NOT COMPLETED|Overall Study||2
9035838|NCT03303105|10097566|FG001|NOT COMPLETED|Overall Study||4
8920458|NCT02216526|9980636|FG001|NOT COMPLETED|Overall Study||3
9035839|NCT03303144|10097572|FG000|STARTED|Triferic Via Hemodialysate (Day 3)||26
9035840|NCT03303144|10097573|FG001|STARTED|Triferic Via Hemodialysate (Day 3)||0
9035841|NCT03303144|10097574|FG002|STARTED|Triferic Via Hemodialysate (Day 3)||0
9035842|NCT03303144|10097572|FG000|COMPLETED|Triferic Via Hemodialysate (Day 3)||26
9035843|NCT03303144|10097573|FG001|COMPLETED|Triferic Via Hemodialysate (Day 3)||0
9035844|NCT03303144|10097574|FG002|COMPLETED|Triferic Via Hemodialysate (Day 3)||0
9035845|NCT03303144|10097572|FG000|NOT COMPLETED|Triferic Via Hemodialysate (Day 3)||0
9035846|NCT03303144|10097573|FG001|NOT COMPLETED|Triferic Via Hemodialysate (Day 3)||0
9035847|NCT03303144|10097574|FG002|NOT COMPLETED|Triferic Via Hemodialysate (Day 3)||0
9035848|NCT03303144|10097572|FG000|STARTED|Triferic Via IV Infusion (Day 8)||0
8920459|NCT02216526|9980637|FG002|NOT COMPLETED|Overall Study||8
8920460|NCT02216591|9980647|FG000|STARTED|Overall Study||11
8920461|NCT02216591|9980648|FG001|STARTED|Overall Study||10
8920462|NCT02216591|9980647|FG000|COMPLETED|Overall Study||11
8920463|NCT02216591|9980648|FG001|COMPLETED|Overall Study||9
8920464|NCT02216591|9980647|FG000|NOT COMPLETED|Overall Study||0
8920465|NCT02216591|9980648|FG001|NOT COMPLETED|Overall Study||1
8920466|NCT02216695|9980654|FG000|STARTED|Overall Study||64882
8920467|NCT02216695|9980654|FG000|COMPLETED|Overall Study|This is a database study and hence, 64882 patients were finally included|64882
8920468|NCT02216695|9980654|FG000|NOT COMPLETED|Overall Study||0
8920469|NCT02216773|9980665|FG000|STARTED|Overall Study||28
8920470|NCT02216773|9980666|FG001|STARTED|Overall Study||29
8920471|NCT02216773|9980665|FG000|Underwent Procedure (PVE/RALPPS)|Overall Study||24
8920472|NCT02216773|9980666|FG001|Underwent Procedure (PVE/RALPPS)|Overall Study||26
8920473|NCT02216773|9980665|FG000|COMPLETED|Overall Study||16
8920474|NCT02216773|9980666|FG001|COMPLETED|Overall Study||24
8920475|NCT02216773|9980665|FG000|NOT COMPLETED|Overall Study||12
8920476|NCT02216773|9980666|FG001|NOT COMPLETED|Overall Study||5
8920477|NCT02216812|9980674|FG000|STARTED|Overall Study||67
8920478|NCT02216812|9980675|FG001|STARTED|Overall Study||67
8920479|NCT02216812|9980674|FG000|COMPLETED|Overall Study||57
8920480|NCT02216812|9980675|FG001|COMPLETED|Overall Study||62
8920481|NCT02216812|9980674|FG000|NOT COMPLETED|Overall Study||10
8920482|NCT02216812|9980675|FG001|NOT COMPLETED|Overall Study||5
8920483|NCT02216851|9980683|FG000|STARTED|Overall Study||98
8920484|NCT02216851|9980684|FG001|STARTED|Overall Study||33
8920485|NCT02216851|9980683|FG000|COMPLETED|Overall Study||96
8920486|NCT02216851|9980684|FG001|COMPLETED|Overall Study||32
8920487|NCT02216851|9980683|FG000|NOT COMPLETED|Overall Study||2
8920488|NCT02216851|9980684|FG001|NOT COMPLETED|Overall Study||1
8920489|NCT02217280|9980690|FG000|STARTED|Overall Study||20
8920490|NCT02217280|9980690|FG000|COMPLETED|Overall Study||16
8920491|NCT02217280|9980690|FG000|NOT COMPLETED|Overall Study||4
8920492|NCT02217332|9980695|FG000|STARTED|Overall Study|Safety Population|20
8920493|NCT02217332|9980695|FG000|COMPLETED|Overall Study|Subjects who continued to optional open-label treatment|13
8920494|NCT02217332|9980695|FG000|NOT COMPLETED|Overall Study||7
8920495|NCT02217410|9980702|FG000|STARTED|Overall Study||7
8920496|NCT02217410|9980703|FG001|STARTED|Overall Study||34
8920497|NCT02217410|9980704|FG002|STARTED|Overall Study||18
8920498|NCT02217410|9980702|FG000|COMPLETED|Overall Study||6
8920499|NCT02217410|9980703|FG001|COMPLETED|Overall Study||30
8920500|NCT02217410|9980704|FG002|COMPLETED|Overall Study||13
8920501|NCT02217410|9980702|FG000|NOT COMPLETED|Overall Study||1
8920502|NCT02217410|9980703|FG001|NOT COMPLETED|Overall Study||4
8920503|NCT02217410|9980704|FG002|NOT COMPLETED|Overall Study||5
8920504|NCT02217436|9980719|FG000|STARTED|Overall Study||40
8920505|NCT02217436|9980720|FG001|STARTED|Overall Study||40
8920506|NCT02217436|9980719|FG000|COMPLETED|Overall Study||39
8920507|NCT02217436|9980720|FG001|COMPLETED|Overall Study||38
8920508|NCT02217436|9980719|FG000|NOT COMPLETED|Overall Study||1
8920509|NCT02217436|9980720|FG001|NOT COMPLETED|Overall Study||2
8920510|NCT02217475|9980729|FG000|STARTED|Treatment Period 1 (Year 1)||72
8920511|NCT02217475|9980730|FG001|STARTED|Treatment Period 1 (Year 1)||72
8920512|NCT02217475|9980731|FG002|STARTED|Treatment Period 1 (Year 1)||145
8920513|NCT02217475|9980729|FG000|Safety Analysis Set|Treatment Period 1 (Year 1)||72
8920514|NCT02217475|9980730|FG001|Safety Analysis Set|Treatment Period 1 (Year 1)||72
8920515|NCT02217475|9980731|FG002|Safety Analysis Set|Treatment Period 1 (Year 1)||144
8920516|NCT02217475|9980729|FG000|COMPLETED|Treatment Period 1 (Year 1)||62
8920517|NCT02217475|9980730|FG001|COMPLETED|Treatment Period 1 (Year 1)||64
8920518|NCT02217475|9980731|FG002|COMPLETED|Treatment Period 1 (Year 1)||124
8920519|NCT02217475|9980729|FG000|NOT COMPLETED|Treatment Period 1 (Year 1)||10
8920520|NCT02217475|9980730|FG001|NOT COMPLETED|Treatment Period 1 (Year 1)||8
8920521|NCT02217475|9980731|FG002|NOT COMPLETED|Treatment Period 1 (Year 1)||21
8920522|NCT02217475|9980729|FG000|STARTED|Discontinued After Period 1||62
8920523|NCT02217475|9980730|FG001|STARTED|Discontinued After Period 1||64
8920524|NCT02217475|9980731|FG002|STARTED|Discontinued After Period 1||124
8920525|NCT02217475|9980729|FG000|COMPLETED|Discontinued After Period 1||60
8920526|NCT02217475|9980730|FG001|COMPLETED|Discontinued After Period 1||61
8920527|NCT02217475|9980731|FG002|COMPLETED|Discontinued After Period 1||121
8920528|NCT02217475|9980729|FG000|NOT COMPLETED|Discontinued After Period 1||2
8920529|NCT02217475|9980730|FG001|NOT COMPLETED|Discontinued After Period 1||3
8920530|NCT02217475|9980731|FG002|NOT COMPLETED|Discontinued After Period 1||3
8920531|NCT02217475|9980729|FG000|STARTED|Treatment Period 2 (Year 2)||60
8920532|NCT02217475|9980730|FG001|STARTED|Treatment Period 2 (Year 2)||61
8920533|NCT02217475|9980731|FG002|STARTED|Treatment Period 2 (Year 2)||121
8920534|NCT02217475|9980729|FG000|COMPLETED|Treatment Period 2 (Year 2)||58
8920535|NCT02217475|9980730|FG001|COMPLETED|Treatment Period 2 (Year 2)||59
8920536|NCT02217475|9980731|FG002|COMPLETED|Treatment Period 2 (Year 2)||109
8920537|NCT02217475|9980729|FG000|NOT COMPLETED|Treatment Period 2 (Year 2)||2
8920538|NCT02217475|9980730|FG001|NOT COMPLETED|Treatment Period 2 (Year 2)||2
8920539|NCT02217475|9980731|FG002|NOT COMPLETED|Treatment Period 2 (Year 2)||12
8920540|NCT02217501|9980750|FG000|STARTED|Overall Study||77
8920541|NCT02217501|9980751|FG001|STARTED|Overall Study||82
8920542|NCT02217501|9980750|FG000|COMPLETED|Overall Study||74
8920543|NCT02217501|9980751|FG001|COMPLETED|Overall Study||78
8920544|NCT02217501|9980750|FG000|NOT COMPLETED|Overall Study||3
8920545|NCT02217501|9980751|FG001|NOT COMPLETED|Overall Study||4
8920546|NCT02217527|9980759|FG000|STARTED|Drug Condition 1: First Study Phase||18
8920547|NCT02217527|9980760|FG001|STARTED|Drug Condition 1: First Study Phase||18
8920548|NCT02217527|9980759|FG000|COMPLETED|Drug Condition 1: First Study Phase||17
8920549|NCT02217527|9980760|FG001|COMPLETED|Drug Condition 1: First Study Phase||15
8920550|NCT02217527|9980759|FG000|NOT COMPLETED|Drug Condition 1: First Study Phase||1
8920551|NCT02217527|9980760|FG001|NOT COMPLETED|Drug Condition 1: First Study Phase||3
8920552|NCT02217527|9980759|FG000|STARTED|Drug Condition 2: Second Study Phase||17
8920553|NCT02217527|9980760|FG001|STARTED|Drug Condition 2: Second Study Phase||15
8920554|NCT02217527|9980759|FG000|COMPLETED|Drug Condition 2: Second Study Phase||17
8920555|NCT02217527|9980760|FG001|COMPLETED|Drug Condition 2: Second Study Phase||14
8920556|NCT02217527|9980759|FG000|NOT COMPLETED|Drug Condition 2: Second Study Phase||0
8920557|NCT02217527|9980760|FG001|NOT COMPLETED|Drug Condition 2: Second Study Phase||1
8920558|NCT02217566|9980766|FG000|STARTED|Overall Study||46
8920559|NCT02217566|9980766|FG000|COMPLETED|Overall Study||35
8920560|NCT02217566|9980766|FG000|NOT COMPLETED|Overall Study||11
8920561|NCT02217618|9980770|FG000|STARTED|Overall Study||16
8920562|NCT02217618|9980770|FG000|Received Study Drug|Overall Study||16
8920563|NCT02217618|9980770|FG000|COMPLETED|Overall Study||16
8920564|NCT02217618|9980770|FG000|NOT COMPLETED|Overall Study||0
8920565|NCT02217800|9980774|FG000|STARTED|Overall Study||8
8920566|NCT02217800|9980774|FG000|COMPLETED|Overall Study||8
8920567|NCT02217800|9980774|FG000|NOT COMPLETED|Overall Study||0
8920568|NCT02217878|9980788|FG000|STARTED|Overall Study||37
8920569|NCT02217878|9980789|FG001|STARTED|Overall Study||37
8920570|NCT02217878|9980788|FG000|COMPLETED|Overall Study||35
8920571|NCT02217878|9980789|FG001|COMPLETED|Overall Study||35
8920572|NCT02217878|9980788|FG000|NOT COMPLETED|Overall Study||2
8920573|NCT02217878|9980789|FG001|NOT COMPLETED|Overall Study||2
8920574|NCT02217904|9980800|FG000|STARTED|Overall Study||6
8920575|NCT02217904|9980801|FG001|STARTED|Overall Study||6
8920576|NCT02217904|9980802|FG002|STARTED|Overall Study||6
8920577|NCT02217904|9980803|FG003|STARTED|Overall Study||6
8920578|NCT02217904|9980804|FG004|STARTED|Overall Study||6
8920579|NCT02217904|9980805|FG005|STARTED|Overall Study||0
8920580|NCT02217904|9980806|FG006|STARTED|Overall Study||0
8920581|NCT02217904|9980800|FG000|COMPLETED|Overall Study||6
8920582|NCT02217904|9980801|FG001|COMPLETED|Overall Study||6
8920583|NCT02217904|9980802|FG002|COMPLETED|Overall Study||6
8920584|NCT02217904|9980803|FG003|COMPLETED|Overall Study||6
8920585|NCT02217904|9980804|FG004|COMPLETED|Overall Study||6
8920586|NCT02217904|9980805|FG005|COMPLETED|Overall Study||0
8920587|NCT02217904|9980806|FG006|COMPLETED|Overall Study||0
8920588|NCT02217904|9980800|FG000|NOT COMPLETED|Overall Study||0
8920589|NCT02217904|9980801|FG001|NOT COMPLETED|Overall Study||0
8920590|NCT02217904|9980802|FG002|NOT COMPLETED|Overall Study||0
8920591|NCT02217904|9980803|FG003|NOT COMPLETED|Overall Study||0
8920592|NCT02217904|9980804|FG004|NOT COMPLETED|Overall Study||0
8920593|NCT02217904|9980805|FG005|NOT COMPLETED|Overall Study||0
8920594|NCT02217904|9980806|FG006|NOT COMPLETED|Overall Study||0
8920595|NCT02217982|9980820|FG000|STARTED|Overall Study||1
8920596|NCT02217982|9980821|FG001|STARTED|Overall Study||4
8920597|NCT02217982|9980820|FG000|COMPLETED|Overall Study|Trial closed before patient finished|0
8920598|NCT02217982|9980821|FG001|COMPLETED|Overall Study||3
8920599|NCT02217982|9980820|FG000|NOT COMPLETED|Overall Study||1
8920600|NCT02217982|9980821|FG001|NOT COMPLETED|Overall Study||1
8920601|NCT02218008|9980830|FG000|STARTED|Stage 1 (S1)||280
8920602|NCT02218008|9980831|FG001|STARTED|Stage 1 (S1)||63
8920603|NCT02218008|9980832|FG002|STARTED|Stage 1 (S1)||63
8920604|NCT02218008|9980833|FG003|STARTED|Stage 1 (S1)||0
8920605|NCT02218008|9980834|FG004|STARTED|Stage 1 (S1)||0
8920606|NCT02218008|9980835|FG005|STARTED|Stage 1 (S1)||0
8920607|NCT02218008|9980830|FG000|COMPLETED|Stage 1 (S1)||258
8920608|NCT02218008|9980831|FG001|COMPLETED|Stage 1 (S1)||56
8920609|NCT02218008|9980832|FG002|COMPLETED|Stage 1 (S1)||48
8920610|NCT02218008|9980833|FG003|COMPLETED|Stage 1 (S1)||0
8920611|NCT02218008|9980834|FG004|COMPLETED|Stage 1 (S1)||0
8920612|NCT02218008|9980835|FG005|COMPLETED|Stage 1 (S1)||0
8920613|NCT02218008|9980830|FG000|NOT COMPLETED|Stage 1 (S1)||22
8920614|NCT02218008|9980831|FG001|NOT COMPLETED|Stage 1 (S1)||7
8920615|NCT02218008|9980832|FG002|NOT COMPLETED|Stage 1 (S1)||15
8920616|NCT02218008|9980833|FG003|NOT COMPLETED|Stage 1 (S1)||0
8920617|NCT02218008|9980834|FG004|NOT COMPLETED|Stage 1 (S1)||0
8920618|NCT02218008|9980835|FG005|NOT COMPLETED|Stage 1 (S1)||0
8920619|NCT02218008|9980830|FG000|STARTED|Stage 2 (S2)||0
8920620|NCT02218008|9980831|FG001|STARTED|Stage 2 (S2)||0
8920621|NCT02218008|9980832|FG002|STARTED|Stage 2 (S2)||0
8920622|NCT02218008|9980833|FG003|STARTED|Stage 2 (S2)||62
8920623|NCT02218008|9980834|FG004|STARTED|Stage 2 (S2)||62
8920624|NCT02218008|9980835|FG005|STARTED|Stage 2 (S2)||63
8920625|NCT02218008|9980830|FG000|COMPLETED|Stage 2 (S2)||0
8920626|NCT02218008|9980831|FG001|COMPLETED|Stage 2 (S2)||0
8920627|NCT02218008|9980832|FG002|COMPLETED|Stage 2 (S2)||0
8920628|NCT02218008|9980833|FG003|COMPLETED|Stage 2 (S2)||58
8920629|NCT02218008|9980834|FG004|COMPLETED|Stage 2 (S2)||58
8920630|NCT02218008|9980835|FG005|COMPLETED|Stage 2 (S2)||57
8920631|NCT02218008|9980830|FG000|NOT COMPLETED|Stage 2 (S2)||0
8920632|NCT02218008|9980831|FG001|NOT COMPLETED|Stage 2 (S2)||0
8920633|NCT02218008|9980832|FG002|NOT COMPLETED|Stage 2 (S2)||0
8920634|NCT02218008|9980833|FG003|NOT COMPLETED|Stage 2 (S2)||4
8920635|NCT02218008|9980834|FG004|NOT COMPLETED|Stage 2 (S2)||4
8920636|NCT02218008|9980835|FG005|NOT COMPLETED|Stage 2 (S2)||6
8920637|NCT02218190|9980851|FG000|STARTED|Overall Study||13
8920638|NCT02218190|9980852|FG001|STARTED|Overall Study||13
8920639|NCT02218190|9980851|FG000|COMPLETED|Overall Study||13
8920640|NCT02218190|9980852|FG001|COMPLETED|Overall Study||13
8920641|NCT02218190|9980851|FG000|NOT COMPLETED|Overall Study||0
8920642|NCT02218190|9980852|FG001|NOT COMPLETED|Overall Study||0
8920643|NCT02218203|9980858|FG000|STARTED|Overall Study||26
8920644|NCT02218203|9980858|FG000|Placebo Dex v. 0mg/km LBM Lidocaine|Overall Study||24
8920645|NCT02218203|9980858|FG000|Placebo Dex v. 1mg/km LBM Lidocaine|Overall Study||24
8920646|NCT02218203|9980858|FG000|Placebo Dex v. 2mg/km LBM Lidocaine|Overall Study||24
8920647|NCT02218203|9980858|FG000|Placebo Dex v. 4mg/km LBM Lidocaine|Overall Study||24
8805754|NCT01474512|9858129|FG011|STARTED|Induction Period||0
8805755|NCT01474512|9858130|FG012|STARTED|Induction Period||0
8805756|NCT01474512|9858131|FG013|STARTED|Induction Period||0
8805757|NCT01474512|9858132|FG014|STARTED|Induction Period||0
8805758|NCT01474512|9858133|FG015|STARTED|Induction Period||0
8805759|NCT01474512|9858134|FG016|STARTED|Induction Period||0
8805760|NCT01474512|9858135|FG017|STARTED|Induction Period||0
8805761|NCT01474512|9858118|FG000|Received Study Drug|Induction Period||431
8805762|NCT01474512|9858119|FG001|Received Study Drug|Induction Period||432
8805763|NCT01474512|9858120|FG002|Received Study Drug|Induction Period||433
8805764|NCT01474512|9858121|FG003|Received Study Drug|Induction Period||0
8805765|NCT01474512|9858122|FG004|Received Study Drug|Induction Period||0
8805766|NCT01474512|9858123|FG005|Received Study Drug|Induction Period||0
8805767|NCT01474512|9858124|FG006|Received Study Drug|Induction Period||0
8805768|NCT01474512|9858125|FG007|Received Study Drug|Induction Period||0
8805769|NCT01474512|9858126|FG008|Received Study Drug|Induction Period||0
8805770|NCT01474512|9858127|FG009|Received Study Drug|Induction Period||0
8805771|NCT01474512|9858128|FG010|Received Study Drug|Induction Period||0
8805772|NCT01474512|9858129|FG011|Received Study Drug|Induction Period||0
8805773|NCT01474512|9858130|FG012|Received Study Drug|Induction Period||0
8805774|NCT01474512|9858131|FG013|Received Study Drug|Induction Period||0
8805775|NCT01474512|9858132|FG014|Received Study Drug|Induction Period||0
8805776|NCT01474512|9858133|FG015|Received Study Drug|Induction Period||0
8805777|NCT01474512|9858134|FG016|Received Study Drug|Induction Period||0
8805778|NCT01474512|9858135|FG017|Received Study Drug|Induction Period||0
8805779|NCT01474512|9858118|FG000|COMPLETED|Induction Period||407
8805780|NCT01474512|9858119|FG001|COMPLETED|Induction Period||408
8805781|NCT01474512|9858120|FG002|COMPLETED|Induction Period||415
8805782|NCT01474512|9858121|FG003|COMPLETED|Induction Period||0
8805783|NCT01474512|9858122|FG004|COMPLETED|Induction Period||0
8805784|NCT01474512|9858123|FG005|COMPLETED|Induction Period||0
8805785|NCT01474512|9858124|FG006|COMPLETED|Induction Period||0
8805786|NCT01474512|9858125|FG007|COMPLETED|Induction Period||0
8805787|NCT01474512|9858126|FG008|COMPLETED|Induction Period||0
8805788|NCT01474512|9858127|FG009|COMPLETED|Induction Period||0
8805789|NCT01474512|9858128|FG010|COMPLETED|Induction Period||0
8805790|NCT01474512|9858129|FG011|COMPLETED|Induction Period||0
8805791|NCT01474512|9858130|FG012|COMPLETED|Induction Period||0
8805792|NCT01474512|9858131|FG013|COMPLETED|Induction Period||0
8805793|NCT01474512|9858132|FG014|COMPLETED|Induction Period||0
8805794|NCT01474512|9858133|FG015|COMPLETED|Induction Period||0
8805795|NCT01474512|9858134|FG016|COMPLETED|Induction Period||0
8805796|NCT01474512|9858135|FG017|COMPLETED|Induction Period||0
8805797|NCT01474512|9858118|FG000|NOT COMPLETED|Induction Period||24
8805798|NCT01474512|9858119|FG001|NOT COMPLETED|Induction Period||24
8805799|NCT01474512|9858120|FG002|NOT COMPLETED|Induction Period||18
8805800|NCT01474512|9858121|FG003|NOT COMPLETED|Induction Period||0
8805801|NCT01474512|9858122|FG004|NOT COMPLETED|Induction Period||0
8805802|NCT01474512|9858123|FG005|NOT COMPLETED|Induction Period||0
8805803|NCT01474512|9858124|FG006|NOT COMPLETED|Induction Period||0
8805804|NCT01474512|9858125|FG007|NOT COMPLETED|Induction Period||0
8805805|NCT01474512|9858126|FG008|NOT COMPLETED|Induction Period||0
8805806|NCT01474512|9858127|FG009|NOT COMPLETED|Induction Period||0
8805807|NCT01474512|9858128|FG010|NOT COMPLETED|Induction Period||0
8805808|NCT01474512|9858129|FG011|NOT COMPLETED|Induction Period||0
8805809|NCT01474512|9858130|FG012|NOT COMPLETED|Induction Period||0
8805810|NCT01474512|9858131|FG013|NOT COMPLETED|Induction Period||0
8805811|NCT01474512|9858132|FG014|NOT COMPLETED|Induction Period||0
8920648|NCT02218203|9980858|FG000|Low Dose Dex v. 0mg/km LBM Lidocaine|Overall Study||26
9035849|NCT03303144|10097573|FG001|STARTED|Triferic Via IV Infusion (Day 8)||26
8805812|NCT01474512|9858133|FG015|NOT COMPLETED|Induction Period||0
8805813|NCT01474512|9858134|FG016|NOT COMPLETED|Induction Period||0
8805814|NCT01474512|9858135|FG017|NOT COMPLETED|Induction Period||0
8805815|NCT01474512|9858118|FG000|STARTED|Maintenance Period||0
8805816|NCT01474512|9858119|FG001|STARTED|Maintenance Period||0
8805817|NCT01474512|9858120|FG002|STARTED|Maintenance Period||0
8805818|NCT01474512|9858121|FG003|STARTED|Maintenance Period||226
8805819|NCT01474512|9858122|FG004|STARTED|Maintenance Period|One participant withdrew end of Induction but re-randomized and treated with maintenance dose ixe.|227
8805820|NCT01474512|9858123|FG005|STARTED|Maintenance Period||229
8805821|NCT01474512|9858124|FG006|STARTED|Maintenance Period||16
8805822|NCT01474512|9858125|FG007|STARTED|Maintenance Period||391
8805823|NCT01474512|9858126|FG008|STARTED|Maintenance Period||78
8805824|NCT01474512|9858127|FG009|STARTED|Maintenance Period||62
8920649|NCT02218203|9980858|FG000|Low Dose Dex v. 1mg/km LBM Lidocaine|Overall Study||26
8920650|NCT02218203|9980858|FG000|Low Dose Dex v. 2mg/km LBM Lidocaine|Overall Study||26
8920651|NCT02218203|9980858|FG000|Low Dose Dex v. 4mg/km LBM Lidocaine|Overall Study||26
8920652|NCT02218203|9980858|FG000|Medium Dose Dex v. 0mg/km LBM Lidocaine|Overall Study||24
8920653|NCT02218203|9980858|FG000|Medium Dose Dex v. 1mg/km LBM Lidocaine|Overall Study||24
8920654|NCT02218203|9980858|FG000|Medium Dose Dex v. 2mg/km LBM Lidocaine|Overall Study||24
8920655|NCT02218203|9980858|FG000|Medium Dose Dex v. 4mg/km LBM Lidocaine|Overall Study||24
8920656|NCT02218203|9980858|FG000|High Dose Dex v. 0mg/km LBM Lidocaine|Overall Study||24
8920657|NCT02218203|9980858|FG000|High Dose Dex v. 1mg/km LBM Lidocaine|Overall Study||24
8920658|NCT02218203|9980858|FG000|High Dose Dex v. 2mg/km LBM Lidocaine|Overall Study||24
8920659|NCT02218203|9980858|FG000|High Dose Dex v. 4mg/km LBM Lidocaine|Overall Study||24
8920660|NCT02218203|9980858|FG000|COMPLETED|Overall Study|2 subjects did not complete the placebo, medium dose, and high dose dex/lido combination arms.|26
8920661|NCT02218203|9980858|FG000|NOT COMPLETED|Overall Study||0
8920662|NCT02218216|9980882|FG000|STARTED|Overall Study||14
8920663|NCT02218216|9980883|FG001|STARTED|Overall Study||2
8920664|NCT02218216|9980884|FG002|STARTED|Overall Study||3
8920665|NCT02218216|9980882|FG000|COMPLETED|Overall Study||8
8920666|NCT02218216|9980883|FG001|COMPLETED|Overall Study||2
8920667|NCT02218216|9980884|FG002|COMPLETED|Overall Study||3
8920668|NCT02218216|9980882|FG000|NOT COMPLETED|Overall Study||6
8920669|NCT02218216|9980883|FG001|NOT COMPLETED|Overall Study||0
8920670|NCT02218216|9980884|FG002|NOT COMPLETED|Overall Study||0
8920671|NCT02218242|9980892|FG000|STARTED|Overall Study||9
8920672|NCT02218242|9980892|FG000|COMPLETED|Overall Study||9
8920673|NCT02218242|9980892|FG000|NOT COMPLETED|Overall Study||0
8920674|NCT02218268|9980896|FG000|STARTED|First Phase (2 Hours)||30
8920675|NCT02218268|9980897|FG001|STARTED|First Phase (2 Hours)||30
8920676|NCT02218268|9980896|FG000|COMPLETED|First Phase (2 Hours)||30
8920677|NCT02218268|9980897|FG001|COMPLETED|First Phase (2 Hours)||30
8920678|NCT02218268|9980896|FG000|NOT COMPLETED|First Phase (2 Hours)||0
8920679|NCT02218268|9980897|FG001|NOT COMPLETED|First Phase (2 Hours)||0
8920680|NCT02218268|9980896|FG000|STARTED|24 Hour Washout||30
8920681|NCT02218268|9980897|FG001|STARTED|24 Hour Washout||30
8920682|NCT02218268|9980896|FG000|COMPLETED|24 Hour Washout||19
8920683|NCT02218268|9980897|FG001|COMPLETED|24 Hour Washout||21
8920684|NCT02218268|9980896|FG000|NOT COMPLETED|24 Hour Washout||11
8920685|NCT02218268|9980897|FG001|NOT COMPLETED|24 Hour Washout||9
8920686|NCT02218268|9980896|FG000|STARTED|Final Phase (2 Hours)||19
8920687|NCT02218268|9980897|FG001|STARTED|Final Phase (2 Hours)||21
8920688|NCT02218268|9980896|FG000|COMPLETED|Final Phase (2 Hours)||19
8920689|NCT02218268|9980897|FG001|COMPLETED|Final Phase (2 Hours)||21
8920690|NCT02218268|9980896|FG000|NOT COMPLETED|Final Phase (2 Hours)||0
8920691|NCT02218268|9980897|FG001|NOT COMPLETED|Final Phase (2 Hours)||0
8920692|NCT02218307|9980905|FG000|STARTED|Overall Study||34
8920693|NCT02218307|9980906|FG001|STARTED|Overall Study||34
8920694|NCT02218307|9980905|FG000|COMPLETED|Overall Study||25
8920695|NCT02218307|9980906|FG001|COMPLETED|Overall Study||33
8920696|NCT02218307|9980905|FG000|NOT COMPLETED|Overall Study||9
8920697|NCT02218307|9980906|FG001|NOT COMPLETED|Overall Study||1
8920698|NCT02218320|9980914|FG000|STARTED|Overall Study|First participant visit on this arm Dec 2014|10
8920699|NCT02218320|9980915|FG001|STARTED|Overall Study|First participant contact on this arm was December 2014|10
8920700|NCT02218320|9980914|FG000|COMPLETED|Overall Study|Last participant contact on this arm was June 2015|10
8920701|NCT02218320|9980915|FG001|COMPLETED|Overall Study|Last participant contact on this arm was October 2015|10
8920702|NCT02218320|9980914|FG000|NOT COMPLETED|Overall Study||0
8920703|NCT02218320|9980915|FG001|NOT COMPLETED|Overall Study||0
8920704|NCT02218372|9980923|FG000|STARTED|Overall Study||100
8920705|NCT02218372|9980924|FG001|STARTED|Overall Study||48
8920706|NCT02218372|9980923|FG000|Treated|Overall Study||98
8920707|NCT02218372|9980924|FG001|Treated|Overall Study||44
8920708|NCT02218372|9980923|FG000|COMPLETED|Overall Study||95
8920709|NCT02218372|9980924|FG001|COMPLETED|Overall Study||42
8920710|NCT02218372|9980923|FG000|NOT COMPLETED|Overall Study||5
8920711|NCT02218372|9980924|FG001|NOT COMPLETED|Overall Study||6
8920712|NCT02218424|9980937|FG000|STARTED|Overall Study||30
8920713|NCT02218424|9980938|FG001|STARTED|Overall Study||30
8920714|NCT02218424|9980937|FG000|COMPLETED|Overall Study||30
8920715|NCT02218424|9980938|FG001|COMPLETED|Overall Study||30
8920716|NCT02218424|9980937|FG000|NOT COMPLETED|Overall Study||0
8920717|NCT02218424|9980938|FG001|NOT COMPLETED|Overall Study||0
9035850|NCT03303144|10097574|FG002|STARTED|Triferic Via IV Infusion (Day 8)||0
9035851|NCT03303144|10097572|FG000|COMPLETED|Triferic Via IV Infusion (Day 8)||0
9035852|NCT03303144|10097573|FG001|COMPLETED|Triferic Via IV Infusion (Day 8)||25
9035853|NCT03303144|10097574|FG002|COMPLETED|Triferic Via IV Infusion (Day 8)||0
9035854|NCT03303144|10097572|FG000|NOT COMPLETED|Triferic Via IV Infusion (Day 8)||0
9035855|NCT03303144|10097573|FG001|NOT COMPLETED|Triferic Via IV Infusion (Day 8)||1
9035856|NCT03303144|10097574|FG002|NOT COMPLETED|Triferic Via IV Infusion (Day 8)||0
9035857|NCT03303144|10097572|FG000|STARTED|Triferic Via IV Infusion (Day 10)||0
9035858|NCT03303144|10097573|FG001|STARTED|Triferic Via IV Infusion (Day 10)||0
9035859|NCT03303144|10097574|FG002|STARTED|Triferic Via IV Infusion (Day 10)||26
9035860|NCT03303144|10097572|FG000|COMPLETED|Triferic Via IV Infusion (Day 10)||0
9035861|NCT03303144|10097573|FG001|COMPLETED|Triferic Via IV Infusion (Day 10)||0
9035862|NCT03303144|10097574|FG002|COMPLETED|Triferic Via IV Infusion (Day 10)||25
8920718|NCT02218463|9980946|FG000|STARTED|Overall Study||21
8920719|NCT02218463|9980947|FG001|STARTED|Overall Study||22
8920720|NCT02218463|9980946|FG000|COMPLETED|Overall Study||18
8920721|NCT02218463|9980947|FG001|COMPLETED|Overall Study||19
8920722|NCT02218463|9980946|FG000|NOT COMPLETED|Overall Study||3
8920723|NCT02218463|9980947|FG001|NOT COMPLETED|Overall Study||3
8920724|NCT02218489|9980955|FG000|STARTED|Overall Study||101
8920725|NCT02218489|9980956|FG001|STARTED|Overall Study||104
8920726|NCT02218489|9980955|FG000|COMPLETED|Overall Study||96
8920727|NCT02218489|9980956|FG001|COMPLETED|Overall Study||101
8920728|NCT02218489|9980955|FG000|NOT COMPLETED|Overall Study||5
8920729|NCT02218489|9980956|FG001|NOT COMPLETED|Overall Study||3
8920730|NCT02218541|9980965|FG000|STARTED|Overall Study||11
8920731|NCT02218541|9980966|FG001|STARTED|Overall Study||11
8920732|NCT02218541|9980965|FG000|COMPLETED|Overall Study||5
8920733|NCT02218541|9980966|FG001|COMPLETED|Overall Study||9
8920734|NCT02218541|9980965|FG000|NOT COMPLETED|Overall Study||6
8920735|NCT02218541|9980966|FG001|NOT COMPLETED|Overall Study||2
8920736|NCT02218736|9980975|FG000|STARTED|Overall Study||45
8920737|NCT02218736|9980976|FG001|STARTED|Overall Study||44
8920738|NCT02218736|9980975|FG000|COMPLETED|Overall Study||33
8920739|NCT02218736|9980976|FG001|COMPLETED|Overall Study||35
8920740|NCT02218736|9980975|FG000|NOT COMPLETED|Overall Study||12
8920741|NCT02218736|9980976|FG001|NOT COMPLETED|Overall Study||9
8920742|NCT02219009|9980984|FG000|STARTED|Overall Study||37
8920743|NCT02219009|9980985|FG001|STARTED|Overall Study||30
8920744|NCT02219009|9980984|FG000|COMPLETED|Overall Study||27
8920745|NCT02219009|9980985|FG001|COMPLETED|Overall Study||22
8920746|NCT02219009|9980984|FG000|NOT COMPLETED|Overall Study||10
8920747|NCT02219009|9980985|FG001|NOT COMPLETED|Overall Study||8
8920748|NCT02219048|9980993|FG000|STARTED|Overall Study||26
8920749|NCT02219048|9980994|FG001|STARTED|Overall Study||25
8920750|NCT02219048|9980993|FG000|COMPLETED|Overall Study||5
8920751|NCT02219048|9980994|FG001|COMPLETED|Overall Study||4
8920752|NCT02219048|9980993|FG000|NOT COMPLETED|Overall Study||21
8920753|NCT02219048|9980994|FG001|NOT COMPLETED|Overall Study||21
8920754|NCT02219087|9981002|FG000|STARTED|Overall Study||30
8920755|NCT02219087|9981003|FG001|STARTED|Overall Study||30
8920756|NCT02219087|9981002|FG000|COMPLETED|Overall Study||30
8920757|NCT02219087|9981003|FG001|COMPLETED|Overall Study|Randomization envelope pulled out of sequence for consented patient. Excluded by request of IRB|29
8920758|NCT02219087|9981002|FG000|NOT COMPLETED|Overall Study||0
8920759|NCT02219087|9981003|FG001|NOT COMPLETED|Overall Study||1
8920760|NCT02219256|9981021|FG000|STARTED|Overall Study||12
8920761|NCT02219256|9981022|FG001|STARTED|Overall Study||4
8920762|NCT02219256|9981023|FG002|STARTED|Overall Study||4
8920763|NCT02219256|9981024|FG003|STARTED|Overall Study||4
8920764|NCT02219256|9981025|FG004|STARTED|Overall Study||6
8920765|NCT02219256|9981026|FG005|STARTED|Overall Study||6
8920766|NCT02219256|9981027|FG006|STARTED|Overall Study||6
8920767|NCT02219256|9981028|FG007|STARTED|Overall Study||8
8920768|NCT02219256|9981029|FG008|STARTED|Overall Study||6
8920769|NCT02219256|9981030|FG009|STARTED|Overall Study||6
8920770|NCT02219256|9981031|FG010|STARTED|Overall Study||6
8920771|NCT02219256|9981032|FG011|STARTED|Overall Study||6
8920772|NCT02219256|9981021|FG000|COMPLETED|Overall Study||12
8920773|NCT02219256|9981022|FG001|COMPLETED|Overall Study||4
8920774|NCT02219256|9981023|FG002|COMPLETED|Overall Study||4
8920775|NCT02219256|9981024|FG003|COMPLETED|Overall Study||4
8920776|NCT02219256|9981025|FG004|COMPLETED|Overall Study||6
8920777|NCT02219256|9981026|FG005|COMPLETED|Overall Study||6
8920778|NCT02219256|9981027|FG006|COMPLETED|Overall Study||6
8920779|NCT02219256|9981028|FG007|COMPLETED|Overall Study||8
8920780|NCT02219256|9981029|FG008|COMPLETED|Overall Study||6
8920781|NCT02219256|9981030|FG009|COMPLETED|Overall Study||6
8920782|NCT02219256|9981031|FG010|COMPLETED|Overall Study||6
8920783|NCT02219256|9981032|FG011|COMPLETED|Overall Study||6
8920784|NCT02219256|9981021|FG000|NOT COMPLETED|Overall Study||0
8920785|NCT02219256|9981022|FG001|NOT COMPLETED|Overall Study||0
8920786|NCT02219256|9981023|FG002|NOT COMPLETED|Overall Study||0
8920787|NCT02219256|9981024|FG003|NOT COMPLETED|Overall Study||0
8920788|NCT02219256|9981025|FG004|NOT COMPLETED|Overall Study||0
8920789|NCT02219256|9981026|FG005|NOT COMPLETED|Overall Study||0
8920790|NCT02219256|9981027|FG006|NOT COMPLETED|Overall Study||0
8920791|NCT02219256|9981028|FG007|NOT COMPLETED|Overall Study||0
8920792|NCT02219256|9981029|FG008|NOT COMPLETED|Overall Study||0
8920793|NCT02219256|9981030|FG009|NOT COMPLETED|Overall Study||0
8920794|NCT02219256|9981031|FG010|NOT COMPLETED|Overall Study||0
8920795|NCT02219256|9981032|FG011|NOT COMPLETED|Overall Study||0
8920796|NCT02219282|9981060|FG000|STARTED|Overall Study||33
8920797|NCT02219282|9981061|FG001|STARTED|Overall Study||33
8920798|NCT02219282|9981060|FG000|COMPLETED|Overall Study||32
8920799|NCT02219282|9981061|FG001|COMPLETED|Overall Study||32
8920800|NCT02219282|9981060|FG000|NOT COMPLETED|Overall Study||1
8920801|NCT02219282|9981061|FG001|NOT COMPLETED|Overall Study||1
8920802|NCT02219308|9981073|FG000|STARTED|Overall Study||32
8920803|NCT02219308|9981074|FG001|STARTED|Overall Study||35
8920804|NCT02219308|9981073|FG000|COMPLETED|Overall Study||31
8920805|NCT02219308|9981074|FG001|COMPLETED|Overall Study||33
8920806|NCT02219308|9981073|FG000|NOT COMPLETED|Overall Study||1
8920807|NCT02219308|9981074|FG001|NOT COMPLETED|Overall Study||2
8920808|NCT02219321|9981082|FG000|STARTED|Overall Study||1
8920809|NCT02219321|9981083|FG001|STARTED|Overall Study||2
8920810|NCT02219321|9981082|FG000|COMPLETED|Overall Study||1
8920811|NCT02219321|9981083|FG001|COMPLETED|Overall Study||2
8920812|NCT02219321|9981082|FG000|NOT COMPLETED|Overall Study||0
8920813|NCT02219321|9981083|FG001|NOT COMPLETED|Overall Study||0
8920814|NCT02219334|9981091|FG000|STARTED|Overall Study||32
8920815|NCT02219334|9981092|FG001|STARTED|Overall Study||23
8920816|NCT02219334|9981091|FG000|COMPLETED|Overall Study||24
8920817|NCT02219334|9981092|FG001|COMPLETED|Overall Study||20
8920818|NCT02219334|9981091|FG000|NOT COMPLETED|Overall Study||8
8920819|NCT02219334|9981092|FG001|NOT COMPLETED|Overall Study||3
8920820|NCT02219438|9981100|FG000|STARTED|Overall Study||13
8920821|NCT02219438|9981101|FG001|STARTED|Overall Study||11
8920822|NCT02219438|9981100|FG000|COMPLETED|Overall Study||13
8920823|NCT02219438|9981101|FG001|COMPLETED|Overall Study||11
8920824|NCT02219438|9981100|FG000|NOT COMPLETED|Overall Study||0
8920825|NCT02219438|9981101|FG001|NOT COMPLETED|Overall Study||0
8920826|NCT02219464|9981111|FG000|STARTED|Overall Study||30
8920827|NCT02219464|9981112|FG001|STARTED|Overall Study||30
8920828|NCT02219464|9981111|FG000|COMPLETED|Overall Study||27
8920829|NCT02219464|9981112|FG001|COMPLETED|Overall Study||30
8920830|NCT02219464|9981111|FG000|NOT COMPLETED|Overall Study||3
8920831|NCT02219464|9981112|FG001|NOT COMPLETED|Overall Study||0
8920832|NCT02219477|9981121|FG000|STARTED|Overall Study||9
8920833|NCT02219477|9981122|FG001|STARTED|Overall Study||24
8920834|NCT02219477|9981123|FG002|STARTED|Overall Study||3
8920835|NCT02219477|9981121|FG000|COMPLETED|Overall Study||9
8920836|NCT02219477|9981122|FG001|COMPLETED|Overall Study||22
8920837|NCT02219477|9981123|FG002|COMPLETED|Overall Study||2
8920838|NCT02219477|9981121|FG000|NOT COMPLETED|Overall Study||0
8920839|NCT02219477|9981122|FG001|NOT COMPLETED|Overall Study||2
8920840|NCT02219477|9981123|FG002|NOT COMPLETED|Overall Study||1
8920841|NCT02219503|9981132|FG000|STARTED|Overall Study||60
8920842|NCT02219503|9981132|FG000|COMPLETED|Overall Study||60
8920843|NCT02219503|9981132|FG000|NOT COMPLETED|Overall Study||0
8920844|NCT02219516|9981140|FG000|STARTED|Overall Study||8
8920845|NCT02219516|9981141|FG001|STARTED|Overall Study||8
8920846|NCT02219516|9981142|FG002|STARTED|Overall Study||7
8920847|NCT02219516|9981143|FG003|STARTED|Overall Study||8
8920848|NCT02219516|9981140|FG000|COMPLETED|Overall Study||8
8920849|NCT02219516|9981141|FG001|COMPLETED|Overall Study||8
8920850|NCT02219516|9981142|FG002|COMPLETED|Overall Study||7
8920851|NCT02219516|9981143|FG003|COMPLETED|Overall Study||8
8920852|NCT02219516|9981140|FG000|NOT COMPLETED|Overall Study||0
8920853|NCT02219516|9981141|FG001|NOT COMPLETED|Overall Study||0
8920854|NCT02219516|9981142|FG002|NOT COMPLETED|Overall Study||0
8920855|NCT02219516|9981143|FG003|NOT COMPLETED|Overall Study||0
8920856|NCT02219685|9981155|FG000|STARTED|Blinded Treatment Phase||26
8920857|NCT02219685|9981156|FG001|STARTED|Blinded Treatment Phase||14
8920858|NCT02219685|9981155|FG000|COMPLETED|Blinded Treatment Phase||24
8920859|NCT02219685|9981156|FG001|COMPLETED|Blinded Treatment Phase||14
8920860|NCT02219685|9981155|FG000|NOT COMPLETED|Blinded Treatment Phase||2
8920861|NCT02219685|9981156|FG001|NOT COMPLETED|Blinded Treatment Phase||0
8920862|NCT02219685|9981155|FG000|STARTED|Open-Label (After Posttreatment Week 4)|Only participants from the Placebo arm were eligible to enroll in the Open-Label Phase.|0
8920863|NCT02219685|9981156|FG001|STARTED|Open-Label (After Posttreatment Week 4)||14
8920864|NCT02219685|9981155|FG000|COMPLETED|Open-Label (After Posttreatment Week 4)||0
8920865|NCT02219685|9981156|FG001|COMPLETED|Open-Label (After Posttreatment Week 4)||14
8920866|NCT02219685|9981155|FG000|NOT COMPLETED|Open-Label (After Posttreatment Week 4)||0
8920867|NCT02219685|9981156|FG001|NOT COMPLETED|Open-Label (After Posttreatment Week 4)||0
8920868|NCT02219815|9981166|FG000|STARTED|Overall Study||44
8920869|NCT02219815|9981167|FG001|STARTED|Overall Study||45
8920870|NCT02219815|9981166|FG000|Post Hospital Discharge Analysis|Overall Study||42
8920871|NCT02219815|9981167|FG001|Post Hospital Discharge Analysis|Overall Study||39
8920872|NCT02219815|9981166|FG000|3 Month Post Surgery|Overall Study||34
8920873|NCT02219815|9981167|FG001|3 Month Post Surgery|Overall Study||31
8920874|NCT02219815|9981166|FG000|COMPLETED|Overall Study||22
8920875|NCT02219815|9981167|FG001|COMPLETED|Overall Study||21
8920876|NCT02219815|9981166|FG000|NOT COMPLETED|Overall Study||22
8920877|NCT02219815|9981167|FG001|NOT COMPLETED|Overall Study||24
8920878|NCT02219932|9981175|FG000|STARTED|Overall Study||319
8920879|NCT02219932|9981176|FG001|STARTED|Overall Study||317
8920880|NCT02219932|9981175|FG000|Randomized, Not Treated|Overall Study||0
8920881|NCT02219932|9981176|FG001|Randomized, Not Treated|Overall Study||1
8920882|NCT02219932|9981175|FG000|COMPLETED|Overall Study||254
8920883|NCT02219932|9981176|FG001|COMPLETED|Overall Study||266
8920884|NCT02219932|9981175|FG000|NOT COMPLETED|Overall Study||65
8920885|NCT02219932|9981176|FG001|NOT COMPLETED|Overall Study||51
8920886|NCT02219997|9981184|FG000|STARTED|First Filter||33
8920887|NCT02219997|9981185|FG001|STARTED|First Filter||17
8920888|NCT02219997|9981186|FG002|STARTED|First Filter||18
8920889|NCT02219997|9981184|FG000|COMPLETED|First Filter||33
8920890|NCT02219997|9981185|FG001|COMPLETED|First Filter||17
8920891|NCT02219997|9981186|FG002|COMPLETED|First Filter||18
8920892|NCT02219997|9981184|FG000|NOT COMPLETED|First Filter||0
8920893|NCT02219997|9981185|FG001|NOT COMPLETED|First Filter||0
8920894|NCT02219997|9981186|FG002|NOT COMPLETED|First Filter||0
8920895|NCT02219997|9981184|FG000|STARTED|Second Filter||0
8920896|NCT02219997|9981185|FG001|STARTED|Second Filter||17
8920897|NCT02219997|9981186|FG002|STARTED|Second Filter||18
8920898|NCT02219997|9981184|FG000|COMPLETED|Second Filter||0
8920899|NCT02219997|9981185|FG001|COMPLETED|Second Filter||17
8920900|NCT02219997|9981186|FG002|COMPLETED|Second Filter||18
8920901|NCT02219997|9981184|FG000|NOT COMPLETED|Second Filter||0
8920902|NCT02219997|9981185|FG001|NOT COMPLETED|Second Filter||0
8920903|NCT02219997|9981186|FG002|NOT COMPLETED|Second Filter||0
8920904|NCT02220205|9981199|FG000|STARTED|Overall Study||30
8920905|NCT02220205|9981200|FG001|STARTED|Overall Study||30
8920906|NCT02220205|9981199|FG000|COMPLETED|Overall Study||29
8920907|NCT02220205|9981200|FG001|COMPLETED|Overall Study||30
8920908|NCT02220205|9981199|FG000|NOT COMPLETED|Overall Study||1
8920909|NCT02220205|9981200|FG001|NOT COMPLETED|Overall Study||0
8920910|NCT02220712|9981206|FG000|STARTED|Overall Study||17
8920911|NCT02220712|9981206|FG000|COMPLETED|Overall Study||13
8920912|NCT02220712|9981206|FG000|NOT COMPLETED|Overall Study||4
8920913|NCT02220725|9981218|FG000|STARTED|Overall Study||14
8920914|NCT02220725|9981219|FG001|STARTED|Overall Study||27
8920915|NCT02220725|9981220|FG002|STARTED|Overall Study||13
8920916|NCT02220725|9981221|FG003|STARTED|Overall Study||26
8920917|NCT02220725|9981218|FG000|COMPLETED|Overall Study||14
8920918|NCT02220725|9981219|FG001|COMPLETED|Overall Study||27
8920919|NCT02220725|9981220|FG002|COMPLETED|Overall Study||13
8920920|NCT02220725|9981221|FG003|COMPLETED|Overall Study||24
8920921|NCT02220725|9981218|FG000|NOT COMPLETED|Overall Study||0
8920922|NCT02220725|9981219|FG001|NOT COMPLETED|Overall Study||0
8920923|NCT02220725|9981220|FG002|NOT COMPLETED|Overall Study||0
8920924|NCT02220725|9981221|FG003|NOT COMPLETED|Overall Study||2
8920925|NCT02220764|9981236|FG000|STARTED|Overall Study||24
8920926|NCT02220764|9981237|FG001|STARTED|Overall Study||8
8920927|NCT02220764|9981236|FG000|COMPLETED|Overall Study||20
8920928|NCT02220764|9981237|FG001|COMPLETED|Overall Study||7
8920929|NCT02220764|9981236|FG000|NOT COMPLETED|Overall Study||4
8920930|NCT02220764|9981237|FG001|NOT COMPLETED|Overall Study||1
8920931|NCT02220907|9981243|FG000|STARTED|Overall Study||153
8920932|NCT02220907|9981243|FG000|COMPLETED|Overall Study||142
8920933|NCT02220907|9981243|FG000|NOT COMPLETED|Overall Study||11
8920934|NCT02220920|9981249|FG000|STARTED|Overall Study||76
8920935|NCT02220920|9981250|FG001|STARTED|Overall Study||70
8920936|NCT02220920|9981249|FG000|COMPLETED|Overall Study||73
8920937|NCT02220920|9981250|FG001|COMPLETED|Overall Study||67
8920938|NCT02220920|9981249|FG000|NOT COMPLETED|Overall Study||3
8920939|NCT02220920|9981250|FG001|NOT COMPLETED|Overall Study||3
8920940|NCT02220998|9981258|FG000|STARTED|Overall Study||135
8920941|NCT02220998|9981259|FG001|STARTED|Overall Study||134
8920942|NCT02220998|9981258|FG000|COMPLETED|Overall Study||128
8920943|NCT02220998|9981259|FG001|COMPLETED|Overall Study||123
8920944|NCT02220998|9981258|FG000|NOT COMPLETED|Overall Study||7
8920945|NCT02220998|9981259|FG001|NOT COMPLETED|Overall Study||11
8920946|NCT02221219|9981269|FG000|STARTED|Overall Study||36
8920947|NCT02221219|9981270|FG001|STARTED|Overall Study||87
8920948|NCT02221219|9981271|FG002|STARTED|Overall Study||41
8920949|NCT02221219|9981272|FG003|STARTED|Overall Study||92
8920950|NCT02221219|9981269|FG000|COMPLETED|Overall Study||36
8920951|NCT02221219|9981270|FG001|COMPLETED|Overall Study||87
8920952|NCT02221219|9981271|FG002|COMPLETED|Overall Study||41
8920953|NCT02221219|9981272|FG003|COMPLETED|Overall Study||92
8920954|NCT02221219|9981269|FG000|NOT COMPLETED|Overall Study||0
8920955|NCT02221219|9981270|FG001|NOT COMPLETED|Overall Study||0
8920956|NCT02221219|9981271|FG002|NOT COMPLETED|Overall Study||0
8920957|NCT02221219|9981272|FG003|NOT COMPLETED|Overall Study||0
8920958|NCT02221284|9981286|FG000|STARTED|Overall Study||964
8920959|NCT02221284|9981286|FG000|COMPLETED|Overall Study||903
8920960|NCT02221284|9981286|FG000|NOT COMPLETED|Overall Study||61
8920961|NCT02221349|9981298|FG000|STARTED|Overall Study||15
8920962|NCT02221349|9981299|FG001|STARTED|Overall Study||15
8920963|NCT02221349|9981298|FG000|COMPLETED|Overall Study||14
8920964|NCT02221349|9981299|FG001|COMPLETED|Overall Study||15
8920965|NCT02221349|9981298|FG000|NOT COMPLETED|Overall Study||1
8920966|NCT02221349|9981299|FG001|NOT COMPLETED|Overall Study||0
8920967|NCT02221557|9981305|FG000|STARTED|Overall Study||8
8920968|NCT02221557|9981305|FG000|COMPLETED|Overall Study||5
8920969|NCT02221557|9981305|FG000|NOT COMPLETED|Overall Study||3
8920970|NCT02221648|9981311|FG000|STARTED|Overall Study||22
8920971|NCT02221648|9981312|FG001|STARTED|Overall Study||21
8920972|NCT02221648|9981311|FG000|COMPLETED|Overall Study||19
8920973|NCT02221648|9981312|FG001|COMPLETED|Overall Study||18
8920974|NCT02221648|9981311|FG000|NOT COMPLETED|Overall Study||3
8920975|NCT02221648|9981312|FG001|NOT COMPLETED|Overall Study||3
8920976|NCT02221674|9981325|FG000|STARTED|Overall Study||8
8920977|NCT02221674|9981326|FG001|STARTED|Overall Study||6
8920978|NCT02221674|9981327|FG002|STARTED|Overall Study||5
8920979|NCT02221674|9981325|FG000|COMPLETED|Overall Study||7
8920980|NCT02221674|9981326|FG001|COMPLETED|Overall Study||6
8920981|NCT02221674|9981327|FG002|COMPLETED|Overall Study||5
8920982|NCT02221674|9981325|FG000|NOT COMPLETED|Overall Study||1
8920983|NCT02221674|9981326|FG001|NOT COMPLETED|Overall Study||0
8920984|NCT02221674|9981327|FG002|NOT COMPLETED|Overall Study||0
8920985|NCT02221739|9981338|FG000|STARTED|Overall Study||39
8920986|NCT02221739|9981338|FG000|COMPLETED|Overall Study||21
8920987|NCT02221739|9981338|FG000|NOT COMPLETED|Overall Study||18
8920988|NCT02221869|9981345|FG000|STARTED|Overall Study||31
8920989|NCT02221869|9981346|FG001|STARTED|Overall Study||32
8920990|NCT02221869|9981347|FG002|STARTED|Overall Study||43
8920991|NCT02221869|9981345|FG000|COMPLETED|Overall Study||30
8920992|NCT02221869|9981346|FG001|COMPLETED|Overall Study||32
8920993|NCT02221869|9981347|FG002|COMPLETED|Overall Study||33
8920994|NCT02221869|9981345|FG000|NOT COMPLETED|Overall Study||1
8920995|NCT02221869|9981346|FG001|NOT COMPLETED|Overall Study||0
8920996|NCT02221869|9981347|FG002|NOT COMPLETED|Overall Study||10
8920997|NCT02221882|9981359|FG000|STARTED|Overall Study||3
8920998|NCT02221882|9981360|FG001|STARTED|Overall Study||3
8920999|NCT02221882|9981361|FG002|STARTED|Overall Study||11
8921000|NCT02221882|9981362|FG003|STARTED|Overall Study||3
8921001|NCT02221882|9981363|FG004|STARTED|Overall Study||5
8921002|NCT02221882|9981364|FG005|STARTED|Overall Study||4
8921003|NCT02221882|9981359|FG000|Received at Least One Dose of Study Drug|Overall Study||3
8921004|NCT02221882|9981360|FG001|Received at Least One Dose of Study Drug|Overall Study||3
8921005|NCT02221882|9981361|FG002|Received at Least One Dose of Study Drug|Overall Study||11
8921006|NCT02221882|9981362|FG003|Received at Least One Dose of Study Drug|Overall Study||3
8921007|NCT02221882|9981363|FG004|Received at Least One Dose of Study Drug|Overall Study||5
8921008|NCT02221882|9981364|FG005|Received at Least One Dose of Study Drug|Overall Study||4
8921009|NCT02221882|9981359|FG000|COMPLETED|Overall Study||3
8921010|NCT02221882|9981360|FG001|COMPLETED|Overall Study||2
9035863|NCT03303144|10097572|FG000|NOT COMPLETED|Triferic Via IV Infusion (Day 10)||0
9035864|NCT03303144|10097573|FG001|NOT COMPLETED|Triferic Via IV Infusion (Day 10)||0
9035865|NCT03303144|10097574|FG002|NOT COMPLETED|Triferic Via IV Infusion (Day 10)||1
9035866|NCT03303196|10097585|FG000|STARTED|Overall Study|Individuals who were assigned to BHBP admission then SC admission.|5
9035867|NCT03303196|10097586|FG001|STARTED|Overall Study|Individuals who were assigned to SC admission then BHBP admission.|5
9035868|NCT03303196|10097585|FG000|Washout|Overall Study||5
9035869|NCT03303196|10097586|FG001|Washout|Overall Study||5
9035870|NCT03303196|10097585|FG000|COMPLETED|Overall Study||5
9035871|NCT03303196|10097586|FG001|COMPLETED|Overall Study||5
9035872|NCT03303196|10097585|FG000|NOT COMPLETED|Overall Study||0
9035873|NCT03303196|10097586|FG001|NOT COMPLETED|Overall Study||0
9035874|NCT03303404|10097591|FG000|STARTED|Overall Study||22
9035875|NCT03303404|10097591|FG000|COMPLETED|Overall Study||22
9035876|NCT03303404|10097591|FG000|NOT COMPLETED|Overall Study||0
9035877|NCT03303417|10097595|FG000|STARTED|Overall Study||8
9035878|NCT03303417|10097596|FG001|STARTED|Overall Study||8
9035879|NCT03303417|10097595|FG000|COMPLETED|Overall Study||7
9035880|NCT03303417|10097596|FG001|COMPLETED|Overall Study||7
9035881|NCT03303417|10097595|FG000|NOT COMPLETED|Overall Study||1
9035882|NCT03303417|10097596|FG001|NOT COMPLETED|Overall Study||1
9035883|NCT03303521|10097604|FG000|STARTED|Overall Study||97
9035884|NCT03303521|10097605|FG001|STARTED|Overall Study||99
9035885|NCT03303521|10097604|FG000|COMPLETED|Overall Study||92
9035886|NCT03303521|10097605|FG001|COMPLETED|Overall Study||96
9035887|NCT03303521|10097604|FG000|NOT COMPLETED|Overall Study||5
9035888|NCT03303521|10097605|FG001|NOT COMPLETED|Overall Study||3
9035889|NCT03303794|10097613|FG000|STARTED|Overall Study||13
9035890|NCT03303794|10097614|FG001|STARTED|Overall Study||12
9035891|NCT03303794|10097613|FG000|COMPLETED|Overall Study||13
9035892|NCT03303794|10097614|FG001|COMPLETED|Overall Study||12
9035893|NCT03303794|10097613|FG000|NOT COMPLETED|Overall Study||0
9035894|NCT03303794|10097614|FG001|NOT COMPLETED|Overall Study||0
9035895|NCT03303911|10097622|FG000|STARTED|Overall Study||13
9035896|NCT03303911|10097623|FG001|STARTED|Overall Study||13
9035897|NCT03303911|10097622|FG000|COMPLETED|Overall Study||13
9035898|NCT03303911|10097623|FG001|COMPLETED|Overall Study||13
9035899|NCT03303911|10097622|FG000|NOT COMPLETED|Overall Study||0
9035900|NCT03303911|10097623|FG001|NOT COMPLETED|Overall Study||0
9035901|NCT03304054|10097632|FG000|STARTED|Overall Study||27
9035902|NCT03304054|10097633|FG001|STARTED|Overall Study||7
9035903|NCT03304054|10097634|FG002|STARTED|Overall Study||28
9035904|NCT03304054|10097635|FG003|STARTED|Overall Study||8
9035905|NCT03304054|10097636|FG004|STARTED|Overall Study||17
9035906|NCT03304054|10097637|FG005|STARTED|Overall Study||6
9035907|NCT03304054|10097632|FG000|COMPLETED|Overall Study||27
9035908|NCT03304054|10097633|FG001|COMPLETED|Overall Study||7
9035909|NCT03304054|10097634|FG002|COMPLETED|Overall Study||27
9035910|NCT03304054|10097635|FG003|COMPLETED|Overall Study||8
9035911|NCT03304054|10097636|FG004|COMPLETED|Overall Study||0
9035912|NCT03304054|10097637|FG005|COMPLETED|Overall Study||0
9035913|NCT03304054|10097632|FG000|NOT COMPLETED|Overall Study||0
9035914|NCT03304054|10097633|FG001|NOT COMPLETED|Overall Study||0
9035915|NCT03304054|10097634|FG002|NOT COMPLETED|Overall Study||1
9035916|NCT03304054|10097635|FG003|NOT COMPLETED|Overall Study||0
9035917|NCT03304054|10097636|FG004|NOT COMPLETED|Overall Study||17
9035918|NCT03304054|10097637|FG005|NOT COMPLETED|Overall Study||6
9035919|NCT03304106|10097648|FG000|STARTED|Overall Study||44
9035920|NCT03304106|10097649|FG001|STARTED|Overall Study||58
9035921|NCT03304106|10097648|FG000|COMPLETED|Overall Study||31
9035922|NCT03304106|10097649|FG001|COMPLETED|Overall Study||56
9035923|NCT03304106|10097648|FG000|NOT COMPLETED|Overall Study||13
9035924|NCT03304106|10097649|FG001|NOT COMPLETED|Overall Study||2
9035925|NCT03304119|10097657|FG000|STARTED|Overall Study||37
9035926|NCT03304119|10097658|FG001|STARTED|Overall Study||55
9035927|NCT03304119|10097657|FG000|COMPLETED|Overall Study||37
9035928|NCT03304119|10097658|FG001|COMPLETED|Overall Study||55
9035929|NCT03304119|10097657|FG000|NOT COMPLETED|Overall Study||0
9035930|NCT03304119|10097658|FG001|NOT COMPLETED|Overall Study||0
9035931|NCT03304184|10097666|FG000|STARTED|Overall Study||15
9035932|NCT03304184|10097667|FG001|STARTED|Overall Study||9
9035933|NCT03304184|10097666|FG000|COMPLETED|Overall Study||14
9035934|NCT03304184|10097667|FG001|COMPLETED|Overall Study||7
9035935|NCT03304184|10097666|FG000|NOT COMPLETED|Overall Study||1
8921011|NCT02221882|9981361|FG002|COMPLETED|Overall Study||7
8921012|NCT02221882|9981362|FG003|COMPLETED|Overall Study||1
8921013|NCT02221882|9981363|FG004|COMPLETED|Overall Study||3
8921014|NCT02221882|9981364|FG005|COMPLETED|Overall Study||2
8921015|NCT02221882|9981359|FG000|NOT COMPLETED|Overall Study||0
8921016|NCT02221882|9981360|FG001|NOT COMPLETED|Overall Study||1
8921017|NCT02221882|9981361|FG002|NOT COMPLETED|Overall Study||4
8921018|NCT02221882|9981362|FG003|NOT COMPLETED|Overall Study||2
8921019|NCT02221882|9981363|FG004|NOT COMPLETED|Overall Study||2
8921020|NCT02221882|9981364|FG005|NOT COMPLETED|Overall Study||2
8921021|NCT02221947|9981385|FG000|STARTED|Overall Study||6
8921022|NCT02221947|9981386|FG001|STARTED|Overall Study||3
8921023|NCT02221947|9981385|FG000|COMPLETED|Overall Study||6
8921024|NCT02221947|9981386|FG001|COMPLETED|Overall Study||3
8921025|NCT02221947|9981385|FG000|NOT COMPLETED|Overall Study||0
8921026|NCT02221947|9981386|FG001|NOT COMPLETED|Overall Study||0
8921027|NCT02222129|9981397|FG000|STARTED|Overall Study||100
8921028|NCT02222129|9981398|FG001|STARTED|Overall Study||106
8921029|NCT02222129|9981397|FG000|COMPLETED|Overall Study||100
8921030|NCT02222129|9981398|FG001|COMPLETED|Overall Study||106
8921031|NCT02222129|9981397|FG000|NOT COMPLETED|Overall Study||0
8921032|NCT02222129|9981398|FG001|NOT COMPLETED|Overall Study||0
8921033|NCT02222181|9981404|FG000|STARTED|Overall Study||163
8921034|NCT02222181|9981404|FG000|COMPLETED|Overall Study||55
8921035|NCT02222181|9981404|FG000|NOT COMPLETED|Overall Study||108
8921036|NCT02222207|9981408|FG000|STARTED|Overall Study||52
8921037|NCT02222207|9981408|FG000|Treated and Valid for Full Analysis Set|Overall Study||51
8921038|NCT02222207|9981408|FG000|COMPLETED|Overall Study||48
8921039|NCT02222207|9981408|FG000|NOT COMPLETED|Overall Study||4
8921040|NCT02222246|9981414|FG000|STARTED|Overall Study||53
8921041|NCT02222246|9981415|FG001|STARTED|Overall Study||53
8921042|NCT02222246|9981414|FG000|COMPLETED|Overall Study||26
8921043|NCT02222246|9981415|FG001|COMPLETED|Overall Study||26
8921044|NCT02222246|9981414|FG000|NOT COMPLETED|Overall Study||27
8921045|NCT02222246|9981415|FG001|NOT COMPLETED|Overall Study||27
8921046|NCT02222337|9981425|FG000|STARTED|Overall Study||140
8921047|NCT02222337|9981426|FG001|STARTED|Overall Study|132 participants were enrolled but 2 withdrew and never provided any data.|132
8921048|NCT02222337|9981425|FG000|COMPLETED|Overall Study||114
8921049|NCT02222337|9981426|FG001|COMPLETED|Overall Study||108
8921050|NCT02222337|9981425|FG000|NOT COMPLETED|Overall Study||26
8921051|NCT02222337|9981426|FG001|NOT COMPLETED|Overall Study||24
8921052|NCT02222493|9981438|FG000|STARTED|Period 1: First Dose-Week 30 (Pre-dose)||324
8921053|NCT02222493|9981439|FG001|STARTED|Period 1: First Dose-Week 30 (Pre-dose)||326
8921054|NCT02222493|9981438|FG000|Received Treatment|Period 1: First Dose-Week 30 (Pre-dose)||323
8921055|NCT02222493|9981439|FG001|Received Treatment|Period 1: First Dose-Week 30 (Pre-dose)||326
8921056|NCT02222493|9981438|FG000|COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||280
8921057|NCT02222493|9981439|FG001|COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||286
8921058|NCT02222493|9981438|FG000|NOT COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||44
8921059|NCT02222493|9981439|FG001|NOT COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||40
8921060|NCT02222493|9981438|FG000|STARTED|Period 2: Week30 Dosing-Week54(Pre-dose)||423
8921061|NCT02222493|9981439|FG001|STARTED|Period 2: Week30 Dosing-Week54(Pre-dose)||143
8921062|NCT02222493|9981438|FG000|COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||380
8921063|NCT02222493|9981439|FG001|COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||126
8921064|NCT02222493|9981438|FG000|NOT COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||43
8921065|NCT02222493|9981439|FG001|NOT COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||17
8921066|NCT02222493|9981438|FG000|STARTED|Period 3: Week 54 Dosing-Week 78 Visit||505
8921067|NCT02222493|9981439|FG001|STARTED|Period 3: Week 54 Dosing-Week 78 Visit||0
8921068|NCT02222493|9981438|FG000|COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||474
8921069|NCT02222493|9981439|FG001|COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||0
8921070|NCT02222493|9981438|FG000|NOT COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||31
8921071|NCT02222493|9981439|FG001|NOT COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||0
8921072|NCT02222558|9981458|FG000|STARTED|Period 1: Single Dose||25
8921073|NCT02222558|9981459|FG001|STARTED|Period 1: Single Dose||0
8921074|NCT02222558|9981460|FG002|STARTED|Period 1: Single Dose||0
8921075|NCT02222558|9981461|FG003|STARTED|Period 1: Single Dose||0
8921076|NCT02222558|9981462|FG004|STARTED|Period 1: Single Dose||0
8921077|NCT02222558|9981463|FG005|STARTED|Period 1: Single Dose||0
8921078|NCT02222558|9981458|FG000|COMPLETED|Period 1: Single Dose||21
8921079|NCT02222558|9981459|FG001|COMPLETED|Period 1: Single Dose||0
8921080|NCT02222558|9981460|FG002|COMPLETED|Period 1: Single Dose||0
8921081|NCT02222558|9981461|FG003|COMPLETED|Period 1: Single Dose||0
8921082|NCT02222558|9981462|FG004|COMPLETED|Period 1: Single Dose||0
8921083|NCT02222558|9981463|FG005|COMPLETED|Period 1: Single Dose||0
8921084|NCT02222558|9981458|FG000|NOT COMPLETED|Period 1: Single Dose||4
8921085|NCT02222558|9981459|FG001|NOT COMPLETED|Period 1: Single Dose||0
8921086|NCT02222558|9981460|FG002|NOT COMPLETED|Period 1: Single Dose||0
8921087|NCT02222558|9981461|FG003|NOT COMPLETED|Period 1: Single Dose||0
8921088|NCT02222558|9981462|FG004|NOT COMPLETED|Period 1: Single Dose||0
8921089|NCT02222558|9981463|FG005|NOT COMPLETED|Period 1: Single Dose||0
8921090|NCT02222558|9981458|FG000|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
8921091|NCT02222558|9981459|FG001|STARTED|Period 2: Two Times Daily Dosing 90 mg||21
8921092|NCT02222558|9981460|FG002|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
8921093|NCT02222558|9981461|FG003|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
8921094|NCT02222558|9981462|FG004|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
8921095|NCT02222558|9981463|FG005|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
8921096|NCT02222558|9981458|FG000|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
8921097|NCT02222558|9981459|FG001|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||21
8921098|NCT02222558|9981460|FG002|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
8921099|NCT02222558|9981461|FG003|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
8921100|NCT02222558|9981462|FG004|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
8921101|NCT02222558|9981463|FG005|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
8921102|NCT02222558|9981458|FG000|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
8921103|NCT02222558|9981459|FG001|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
8921104|NCT02222558|9981460|FG002|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
8921105|NCT02222558|9981461|FG003|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
8921106|NCT02222558|9981462|FG004|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
8921107|NCT02222558|9981463|FG005|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
8921108|NCT02222558|9981458|FG000|STARTED|Period 3||0
8921109|NCT02222558|9981459|FG001|STARTED|Period 3||0
8921110|NCT02222558|9981460|FG002|STARTED|Period 3||4
8921111|NCT02222558|9981461|FG003|STARTED|Period 3||1
8921112|NCT02222558|9981462|FG004|STARTED|Period 3||8
8921113|NCT02222558|9981463|FG005|STARTED|Period 3||8
8921114|NCT02222558|9981458|FG000|COMPLETED|Period 3||0
8921115|NCT02222558|9981459|FG001|COMPLETED|Period 3||0
8921116|NCT02222558|9981460|FG002|COMPLETED|Period 3||4
8921117|NCT02222558|9981461|FG003|COMPLETED|Period 3||1
8921118|NCT02222558|9981462|FG004|COMPLETED|Period 3||8
8921119|NCT02222558|9981463|FG005|COMPLETED|Period 3||7
8921120|NCT02222558|9981458|FG000|NOT COMPLETED|Period 3||0
8921121|NCT02222558|9981459|FG001|NOT COMPLETED|Period 3||0
8921122|NCT02222558|9981460|FG002|NOT COMPLETED|Period 3||0
8921123|NCT02222558|9981461|FG003|NOT COMPLETED|Period 3||0
8921124|NCT02222558|9981462|FG004|NOT COMPLETED|Period 3||0
8921125|NCT02222558|9981463|FG005|NOT COMPLETED|Period 3||1
8921126|NCT02222610|9981480|FG000|STARTED|Baseline to W48||8
8921127|NCT02222610|9981481|FG001|STARTED|Baseline to W48||16
8921128|NCT02222610|9981482|FG002|STARTED|Baseline to W48||16
8921129|NCT02222610|9981480|FG000|COMPLETED|Baseline to W48||8
8921130|NCT02222610|9981481|FG001|COMPLETED|Baseline to W48||14
8921131|NCT02222610|9981482|FG002|COMPLETED|Baseline to W48||15
8921132|NCT02222610|9981480|FG000|NOT COMPLETED|Baseline to W48||0
8921133|NCT02222610|9981481|FG001|NOT COMPLETED|Baseline to W48||2
8921134|NCT02222610|9981482|FG002|NOT COMPLETED|Baseline to W48||1
8921135|NCT02222610|9981480|FG000|STARTED|Baseline to W104||8
8921136|NCT02222610|9981481|FG001|STARTED|Baseline to W104||16
8921137|NCT02222610|9981482|FG002|STARTED|Baseline to W104||16
8921138|NCT02222610|9981480|FG000|COMPLETED|Baseline to W104||8
8921139|NCT02222610|9981481|FG001|COMPLETED|Baseline to W104||11
8921140|NCT02222610|9981482|FG002|COMPLETED|Baseline to W104||10
8921141|NCT02222610|9981480|FG000|NOT COMPLETED|Baseline to W104||0
8921142|NCT02222610|9981481|FG001|NOT COMPLETED|Baseline to W104||5
8921143|NCT02222610|9981482|FG002|NOT COMPLETED|Baseline to W104||6
8921144|NCT02222688|9981497|FG000|STARTED|Overall Study||4
8921145|NCT02222688|9981498|FG001|STARTED|Overall Study||3
8921146|NCT02222688|9981499|FG002|STARTED|Overall Study||3
8921147|NCT02222688|9981500|FG003|STARTED|Overall Study||5
8921148|NCT02222688|9981501|FG004|STARTED|Overall Study||3
8921149|NCT02222688|9981502|FG005|STARTED|Overall Study||3
8921150|NCT02222688|9981503|FG006|STARTED|Overall Study||6
8921151|NCT02222688|9981497|FG000|COMPLETED|Overall Study||3
8921152|NCT02222688|9981498|FG001|COMPLETED|Overall Study||3
8921153|NCT02222688|9981499|FG002|COMPLETED|Overall Study||3
8921154|NCT02222688|9981500|FG003|COMPLETED|Overall Study||3
8921155|NCT02222688|9981501|FG004|COMPLETED|Overall Study||2
8921156|NCT02222688|9981502|FG005|COMPLETED|Overall Study||3
8921157|NCT02222688|9981503|FG006|COMPLETED|Overall Study||5
8921158|NCT02222688|9981497|FG000|NOT COMPLETED|Overall Study||1
8921159|NCT02222688|9981498|FG001|NOT COMPLETED|Overall Study||0
8921160|NCT02222688|9981499|FG002|NOT COMPLETED|Overall Study||0
8921161|NCT02222688|9981500|FG003|NOT COMPLETED|Overall Study||2
8921162|NCT02222688|9981501|FG004|NOT COMPLETED|Overall Study||1
8921163|NCT02222688|9981502|FG005|NOT COMPLETED|Overall Study||0
8921164|NCT02222688|9981503|FG006|NOT COMPLETED|Overall Study||1
8921165|NCT02222714|9981526|FG000|STARTED|Overall Study||15
8921166|NCT02222714|9981527|FG001|STARTED|Overall Study||24
8921167|NCT02222714|9981528|FG002|STARTED|Overall Study||12
8921168|NCT02222714|9981529|FG003|STARTED|Overall Study||15
8921169|NCT02222714|9981530|FG004|STARTED|Overall Study||44
8921170|NCT02222714|9981526|FG000|COMPLETED|Overall Study||15
8921171|NCT02222714|9981527|FG001|COMPLETED|Overall Study||22
8921172|NCT02222714|9981528|FG002|COMPLETED|Overall Study||8
8921173|NCT02222714|9981529|FG003|COMPLETED|Overall Study||11
8921174|NCT02222714|9981530|FG004|COMPLETED|Overall Study||37
8921175|NCT02222714|9981526|FG000|NOT COMPLETED|Overall Study||0
8921176|NCT02222714|9981527|FG001|NOT COMPLETED|Overall Study||2
8921177|NCT02222714|9981528|FG002|NOT COMPLETED|Overall Study||4
8921178|NCT02222714|9981529|FG003|NOT COMPLETED|Overall Study||4
8921179|NCT02222714|9981530|FG004|NOT COMPLETED|Overall Study||7
8921180|NCT02222818|9981547|FG000|STARTED|Period 1|Start of CAFR evaluation period|33
8921181|NCT02222818|9981548|FG001|STARTED|Period 1|Start of CAFRPlus evaluation period|33
8921182|NCT02222818|9981547|FG000|COMPLETED|Period 1|End of CAFR evaluation period|33
8921183|NCT02222818|9981548|FG001|COMPLETED|Period 1|End of CAFRPlus evaluation period|30
8921184|NCT02222818|9981547|FG000|NOT COMPLETED|Period 1||0
8921185|NCT02222818|9981548|FG001|NOT COMPLETED|Period 1||3
8921186|NCT02222818|9981547|FG000|STARTED|Period 2|Start of CAFRPlus evaluation period|33
8921187|NCT02222818|9981548|FG001|STARTED|Period 2|Start of CAFR evaluation period|30
8921188|NCT02222818|9981547|FG000|COMPLETED|Period 2|End of CAFRPlus evaluation period|33
8921189|NCT02222818|9981548|FG001|COMPLETED|Period 2|End of CAFR evaluation period|30
8921190|NCT02222818|9981547|FG000|NOT COMPLETED|Period 2||0
8921191|NCT02222818|9981548|FG001|NOT COMPLETED|Period 2||0
8921192|NCT02222870|9981555|FG000|STARTED|Overall Study||30
8921193|NCT02222870|9981556|FG001|STARTED|Overall Study||30
8921194|NCT02222870|9981555|FG000|COMPLETED|Overall Study||30
8921195|NCT02222870|9981556|FG001|COMPLETED|Overall Study||30
8921196|NCT02222870|9981555|FG000|NOT COMPLETED|Overall Study||0
8921197|NCT02222870|9981556|FG001|NOT COMPLETED|Overall Study||0
8921198|NCT02222896|9981562|FG000|STARTED|Abdomen||253
8921199|NCT02222896|9981563|FG001|STARTED|Abdomen||48
8921200|NCT02222896|9981564|FG002|STARTED|Abdomen||253
8921201|NCT02222896|9981562|FG000|COMPLETED|Abdomen||219
8921202|NCT02222896|9981563|FG001|COMPLETED|Abdomen||38
8921203|NCT02222896|9981564|FG002|COMPLETED|Abdomen||221
8921204|NCT02222896|9981562|FG000|NOT COMPLETED|Abdomen||34
8921205|NCT02222896|9981563|FG001|NOT COMPLETED|Abdomen||10
8921206|NCT02222896|9981564|FG002|NOT COMPLETED|Abdomen||32
8921207|NCT02222896|9981562|FG000|STARTED|Groin||254
8921208|NCT02222896|9981563|FG001|STARTED|Groin||48
8921209|NCT02222896|9981564|FG002|STARTED|Groin||250
8921210|NCT02222896|9981562|FG000|COMPLETED|Groin||211
8921211|NCT02222896|9981563|FG001|COMPLETED|Groin||39
8921212|NCT02222896|9981564|FG002|COMPLETED|Groin||210
8921213|NCT02222896|9981562|FG000|NOT COMPLETED|Groin||43
8921214|NCT02222896|9981563|FG001|NOT COMPLETED|Groin||9
8921215|NCT02222896|9981564|FG002|NOT COMPLETED|Groin||40
8921216|NCT02222922|9981584|FG000|STARTED|Overall Study||2
8921217|NCT02222922|9981585|FG001|STARTED|Overall Study||2
8921218|NCT02222922|9981586|FG002|STARTED|Overall Study||2
8921219|NCT02222922|9981587|FG003|STARTED|Overall Study||5
8921220|NCT02222922|9981588|FG004|STARTED|Overall Study||96
8921221|NCT02222922|9981589|FG005|STARTED|Overall Study||6
8921222|NCT02222922|9981590|FG006|STARTED|Overall Study||3
8921223|NCT02222922|9981591|FG007|STARTED|Overall Study||10
8921224|NCT02222922|9981592|FG008|STARTED|Overall Study||12
8921225|NCT02222922|9981584|FG000|Received Treatment|Overall Study||2
8921226|NCT02222922|9981585|FG001|Received Treatment|Overall Study||2
8921227|NCT02222922|9981586|FG002|Received Treatment|Overall Study||2
8921228|NCT02222922|9981587|FG003|Received Treatment|Overall Study||4
8921229|NCT02222922|9981588|FG004|Received Treatment|Overall Study||96
8921230|NCT02222922|9981589|FG005|Received Treatment|Overall Study||6
8921231|NCT02222922|9981590|FG006|Received Treatment|Overall Study||3
8921232|NCT02222922|9981591|FG007|Received Treatment|Overall Study||10
8921233|NCT02222922|9981592|FG008|Received Treatment|Overall Study||12
8921234|NCT02222922|9981584|FG000|COMPLETED|Overall Study||1
8921235|NCT02222922|9981585|FG001|COMPLETED|Overall Study||2
8921236|NCT02222922|9981586|FG002|COMPLETED|Overall Study||1
8921237|NCT02222922|9981587|FG003|COMPLETED|Overall Study||2
8921238|NCT02222922|9981588|FG004|COMPLETED|Overall Study||58
8921239|NCT02222922|9981589|FG005|COMPLETED|Overall Study||3
8921240|NCT02222922|9981590|FG006|COMPLETED|Overall Study||1
8921241|NCT02222922|9981591|FG007|COMPLETED|Overall Study||6
8921242|NCT02222922|9981592|FG008|COMPLETED|Overall Study||6
8921243|NCT02222922|9981584|FG000|NOT COMPLETED|Overall Study||1
8921244|NCT02222922|9981585|FG001|NOT COMPLETED|Overall Study||0
8921245|NCT02222922|9981586|FG002|NOT COMPLETED|Overall Study||1
8921246|NCT02222922|9981587|FG003|NOT COMPLETED|Overall Study||3
8921247|NCT02222922|9981588|FG004|NOT COMPLETED|Overall Study||38
8921248|NCT02222922|9981589|FG005|NOT COMPLETED|Overall Study||3
8921249|NCT02222922|9981590|FG006|NOT COMPLETED|Overall Study||2
8921250|NCT02222922|9981591|FG007|NOT COMPLETED|Overall Study||4
8921251|NCT02222922|9981592|FG008|NOT COMPLETED|Overall Study||6
8921252|NCT02223065|9981628|FG000|STARTED|Overall Study||18
8921253|NCT02223065|9981629|FG001|STARTED|Overall Study||18
8921254|NCT02223065|9981628|FG000|COMPLETED|Overall Study||18
8921255|NCT02223065|9981629|FG001|COMPLETED|Overall Study||18
8921256|NCT02223065|9981628|FG000|NOT COMPLETED|Overall Study||0
8921257|NCT02223065|9981629|FG001|NOT COMPLETED|Overall Study||0
8921258|NCT02223260|9981635|FG000|STARTED|Overall Study||8
8921259|NCT02223260|9981635|FG000|COMPLETED|Overall Study||8
8921260|NCT02223260|9981635|FG000|NOT COMPLETED|Overall Study||0
8921261|NCT02223338|9981641|FG000|STARTED|Overall Study||60
8921262|NCT02223338|9981642|FG001|STARTED|Overall Study||60
8921263|NCT02223338|9981641|FG000|COMPLETED|Overall Study||60
8921264|NCT02223338|9981642|FG001|COMPLETED|Overall Study||60
8921265|NCT02223338|9981641|FG000|NOT COMPLETED|Overall Study||0
8921266|NCT02223338|9981642|FG001|NOT COMPLETED|Overall Study||0
8921267|NCT02223351|9981650|FG000|STARTED|Overall Study||24
8921268|NCT02223351|9981651|FG001|STARTED|Overall Study||24
8921269|NCT02223351|9981650|FG000|First Intervention (8 Days)|Overall Study||24
8921270|NCT02223351|9981651|FG001|First Intervention (8 Days)|Overall Study||24
8921271|NCT02223351|9981650|FG000|Wasout (2weeks)|Overall Study||24
8921272|NCT02223351|9981651|FG001|Wasout (2weeks)|Overall Study||24
8921273|NCT02223351|9981650|FG000|Second Intervention (8 Days)|Overall Study||24
8921274|NCT02223351|9981651|FG001|Second Intervention (8 Days)|Overall Study||24
8921275|NCT02223351|9981650|FG000|COMPLETED|Overall Study||24
8921276|NCT02223351|9981651|FG001|COMPLETED|Overall Study||24
8921277|NCT02223351|9981650|FG000|NOT COMPLETED|Overall Study||0
8921278|NCT02223351|9981651|FG001|NOT COMPLETED|Overall Study||0
8921279|NCT02223364|9981668|FG000|STARTED|Overall Study||55
8921280|NCT02223364|9981669|FG001|STARTED|Overall Study||55
8921281|NCT02223364|9981670|FG002|STARTED|Overall Study||55
8921282|NCT02223364|9981668|FG000|COMPLETED|Overall Study||50
8921283|NCT02223364|9981669|FG001|COMPLETED|Overall Study||55
8921284|NCT02223364|9981670|FG002|COMPLETED|Overall Study||52
8921285|NCT02223364|9981668|FG000|NOT COMPLETED|Overall Study||5
8921286|NCT02223364|9981669|FG001|NOT COMPLETED|Overall Study||0
8921287|NCT02223364|9981670|FG002|NOT COMPLETED|Overall Study||3
8921288|NCT02223390|9981680|FG000|STARTED|Overall Study||32
8921289|NCT02223390|9981681|FG001|STARTED|Overall Study||32
8921290|NCT02223390|9981680|FG000|COMPLETED|Overall Study||23
8921291|NCT02223390|9981681|FG001|COMPLETED|Overall Study||28
8921292|NCT02223390|9981680|FG000|NOT COMPLETED|Overall Study||9
8921293|NCT02223390|9981681|FG001|NOT COMPLETED|Overall Study||4
8921294|NCT02223429|9981691|FG000|STARTED|Overall Study||8
8921295|NCT02223429|9981692|FG001|STARTED|Overall Study||8
8921296|NCT02223429|9981693|FG002|STARTED|Overall Study||8
8921297|NCT02223429|9981694|FG003|STARTED|Overall Study||8
8921298|NCT02223429|9981691|FG000|COMPLETED|Overall Study||7
8921299|NCT02223429|9981692|FG001|COMPLETED|Overall Study||8
8921300|NCT02223429|9981693|FG002|COMPLETED|Overall Study||8
8921301|NCT02223429|9981694|FG003|COMPLETED|Overall Study||8
8921302|NCT02223429|9981691|FG000|NOT COMPLETED|Overall Study||1
8921303|NCT02223429|9981692|FG001|NOT COMPLETED|Overall Study||0
8921304|NCT02223429|9981693|FG002|NOT COMPLETED|Overall Study||0
8921305|NCT02223429|9981694|FG003|NOT COMPLETED|Overall Study||0
8921306|NCT02223455|9981712|FG000|STARTED|Overall Study|Participant level data not collected.|
8921307|NCT02223455|9981713|FG001|STARTED|Overall Study|Participant level data not collected.|
8921308|NCT02223455|9981714|FG002|STARTED|Overall Study|Participant level data not collected.|
8921309|NCT02223455|9981712|FG000|COMPLETED|Overall Study|Participant level data not collected.|
8921310|NCT02223455|9981713|FG001|COMPLETED|Overall Study|Participant level data not collected.|
8921311|NCT02223455|9981714|FG002|COMPLETED|Overall Study|Participant level data not collected.|
8921312|NCT02223455|9981712|FG000|NOT COMPLETED|Overall Study||
8921313|NCT02223455|9981713|FG001|NOT COMPLETED|Overall Study||
8921314|NCT02223455|9981714|FG002|NOT COMPLETED|Overall Study||
8921315|NCT02223546|9981722|FG000|STARTED|Overall Study||15
8921316|NCT02223546|9981722|FG000|COMPLETED|Overall Study||15
8921317|NCT02223546|9981722|FG000|NOT COMPLETED|Overall Study||0
8921318|NCT02223637|9981726|FG000|STARTED|Overall Study||82
8921319|NCT02223637|9981726|FG000|COMPLETED|Overall Study||82
8921320|NCT02223637|9981726|FG000|NOT COMPLETED|Overall Study||0
8921321|NCT02223650|9981733|FG000|STARTED|Overall Study||27
8921322|NCT02223650|9981734|FG001|STARTED|Overall Study||31
8921323|NCT02223650|9981733|FG000|COMPLETED|Overall Study||27
8921324|NCT02223650|9981734|FG001|COMPLETED|Overall Study||31
8921325|NCT02223650|9981733|FG000|NOT COMPLETED|Overall Study||0
8921326|NCT02223650|9981734|FG001|NOT COMPLETED|Overall Study||0
8921327|NCT02223689|9981742|FG000|STARTED|Overall Study||35
8921328|NCT02223689|9981742|FG000|COMPLETED|Overall Study||35
8921329|NCT02223689|9981742|FG000|NOT COMPLETED|Overall Study||0
8921330|NCT02223702|9981749|FG000|STARTED|Overall Study||20
8921331|NCT02223702|9981750|FG001|STARTED|Overall Study||19
8921332|NCT02223702|9981749|FG000|COMPLETED|Overall Study||19
8921333|NCT02223702|9981750|FG001|COMPLETED|Overall Study||15
8921334|NCT02223702|9981749|FG000|NOT COMPLETED|Overall Study||1
8921335|NCT02223702|9981750|FG001|NOT COMPLETED|Overall Study||4
8921336|NCT02223715|9981756|FG000|STARTED|Overall Study||600
8921337|NCT02223715|9981756|FG000|COMPLETED|Overall Study||496
8921338|NCT02223715|9981756|FG000|NOT COMPLETED|Overall Study||104
8921339|NCT02223754|9981765|FG000|STARTED|Period 1||163
8921340|NCT02223754|9981766|FG001|STARTED|Period 1||159
8921341|NCT02223754|9981765|FG000|COMPLETED|Period 1||159
8921342|NCT02223754|9981766|FG001|COMPLETED|Period 1||144
8921343|NCT02223754|9981765|FG000|NOT COMPLETED|Period 1||4
8921344|NCT02223754|9981766|FG001|NOT COMPLETED|Period 1||15
8921345|NCT02223754|9981765|FG000|STARTED|Period 2||159
8921346|NCT02223754|9981766|FG001|STARTED|Period 2||144
8921347|NCT02223754|9981765|FG000|COMPLETED|Period 2||156
8921348|NCT02223754|9981766|FG001|COMPLETED|Period 2||141
8921349|NCT02223754|9981765|FG000|NOT COMPLETED|Period 2||3
8921350|NCT02223754|9981766|FG001|NOT COMPLETED|Period 2||3
8921351|NCT02223793|9981776|FG000|STARTED|Overall Study||185
8921352|NCT02223793|9981777|FG001|STARTED|Overall Study||199
8921353|NCT02223793|9981778|FG002|STARTED|Overall Study||198
8921354|NCT02223793|9981776|FG000|COMPLETED|Overall Study||168
8921355|NCT02223793|9981777|FG001|COMPLETED|Overall Study||190
8921356|NCT02223793|9981778|FG002|COMPLETED|Overall Study||185
8921357|NCT02223793|9981776|FG000|NOT COMPLETED|Overall Study||17
8921358|NCT02223793|9981777|FG001|NOT COMPLETED|Overall Study||9
8921359|NCT02223793|9981778|FG002|NOT COMPLETED|Overall Study||13
8921360|NCT02223858|9981788|FG000|STARTED|Overall Study||180
8921361|NCT02223858|9981789|FG001|STARTED|Overall Study||180
8921362|NCT02223858|9981788|FG000|1-month Follow-up|Overall Study||156
8921363|NCT02223858|9981789|FG001|1-month Follow-up|Overall Study||150
8921364|NCT02223858|9981788|FG000|3-month Follow-up|Overall Study||155
8921365|NCT02223858|9981789|FG001|3-month Follow-up|Overall Study||154
8921366|NCT02223858|9981788|FG000|6-month Follow-up|Overall Study||156
8921367|NCT02223858|9981789|FG001|6-month Follow-up|Overall Study||154
8921368|NCT02223858|9981788|FG000|COMPLETED|Overall Study||156
8921369|NCT02223858|9981789|FG001|COMPLETED|Overall Study||154
8921370|NCT02223858|9981788|FG000|NOT COMPLETED|Overall Study||24
8921371|NCT02223858|9981789|FG001|NOT COMPLETED|Overall Study||26
8921372|NCT02223871|9981795|FG000|STARTED|Overall Study||8
8921373|NCT02223871|9981795|FG000|COMPLETED|Overall Study||8
8921374|NCT02223871|9981795|FG000|NOT COMPLETED|Overall Study||0
8921375|NCT02224053|9981799|FG000|STARTED|AZD9291 and Omeprazole Co-administration||68
8921376|NCT02224053|9981799|FG000|COMPLETED|AZD9291 and Omeprazole Co-administration||47
8921377|NCT02224053|9981799|FG000|NOT COMPLETED|AZD9291 and Omeprazole Co-administration||21
8921378|NCT02224053|9981799|FG000|STARTED|AZD9291 Alone||47
8921379|NCT02224053|9981799|FG000|COMPLETED|AZD9291 Alone||47
8921380|NCT02224053|9981799|FG000|NOT COMPLETED|AZD9291 Alone||0
8921381|NCT02224157|9981807|FG000|STARTED|Overall Study||2095
8921382|NCT02224157|9981808|FG001|STARTED|Overall Study||2094
8921383|NCT02224157|9981807|FG000|Patients Who Completed Treatment|Overall Study||1924
8921384|NCT02224157|9981808|FG001|Patients Who Completed Treatment|Overall Study||1903
8921385|NCT02224157|9981807|FG000|COMPLETED|Overall Study||1985
8921386|NCT02224157|9981808|FG001|COMPLETED|Overall Study||1983
8921387|NCT02224157|9981807|FG000|NOT COMPLETED|Overall Study||110
8921388|NCT02224157|9981808|FG001|NOT COMPLETED|Overall Study||111
8921389|NCT02224274|9981816|FG000|STARTED|Overall Study||17
8921390|NCT02224274|9981817|FG001|STARTED|Overall Study||20
8921391|NCT02224274|9981816|FG000|COMPLETED|Overall Study||16
8921392|NCT02224274|9981817|FG001|COMPLETED|Overall Study||20
8921393|NCT02224274|9981816|FG000|NOT COMPLETED|Overall Study||1
8921394|NCT02224274|9981817|FG001|NOT COMPLETED|Overall Study||0
8921395|NCT02224313|9981825|FG000|STARTED|Overall Study||10
8921396|NCT02224313|9981826|FG001|STARTED|Overall Study||10
8921397|NCT02224313|9981825|FG000|COMPLETED|Overall Study||7
8921398|NCT02224313|9981826|FG001|COMPLETED|Overall Study||9
8921399|NCT02224313|9981825|FG000|NOT COMPLETED|Overall Study||3
8921400|NCT02224313|9981826|FG001|NOT COMPLETED|Overall Study||1
8921401|NCT02224404|9981832|FG000|STARTED|Overall Study||21
8921402|NCT02224404|9981832|FG000|COMPLETED|Overall Study||21
8921403|NCT02224404|9981832|FG000|NOT COMPLETED|Overall Study||0
8921404|NCT02224482|9981838|FG000|STARTED|Overall Study||214
8921405|NCT02224482|9981839|FG001|STARTED|Overall Study||217
8921406|NCT02224482|9981838|FG000|COMPLETED|Overall Study||63
8921407|NCT02224482|9981839|FG001|COMPLETED|Overall Study||57
8921408|NCT02224482|9981838|FG000|NOT COMPLETED|Overall Study||151
8921409|NCT02224482|9981839|FG001|NOT COMPLETED|Overall Study||160
8921410|NCT02224508|9981847|FG000|STARTED|Overall Study|Number of patients surveyed in intervention segment of the health plan (group practice).|935
8921411|NCT02224508|9981848|FG001|STARTED|Overall Study|Number of patients surveyed in the control segment of the health plan (contracted care).|653
8921412|NCT02224508|9981847|FG000|COMPLETED|Overall Study||935
8921413|NCT02224508|9981848|FG001|COMPLETED|Overall Study||653
8921414|NCT02224508|9981847|FG000|NOT COMPLETED|Overall Study||0
8921415|NCT02224508|9981848|FG001|NOT COMPLETED|Overall Study||0
8921416|NCT02224560|9981858|FG000|STARTED|Overall Study||76
8921417|NCT02224560|9981859|FG001|STARTED|Overall Study||73
8921418|NCT02224560|9981860|FG002|STARTED|Overall Study||76
8921419|NCT02224560|9981858|FG000|Safety Analysis Set|Overall Study|Six participants assigned to the 10 mg/kg/day dose were included in the 20 mg/kg/day group.|82
8921420|NCT02224560|9981859|FG001|Safety Analysis Set|Overall Study|Six participants assigned to the 10 mg/kg/day dose were included in the 20 mg/kg/day group.|67
8921421|NCT02224560|9981860|FG002|Safety Analysis Set|Overall Study||76
8921422|NCT02224560|9981858|FG000|Intent to Treat (ITT) Analysis Set|Overall Study||76
8921423|NCT02224560|9981859|FG001|Intent to Treat (ITT) Analysis Set|Overall Study||73
8921424|NCT02224560|9981860|FG002|Intent to Treat (ITT) Analysis Set|Overall Study||76
8921425|NCT02224560|9981858|FG000|COMPLETED|Overall Study||67
8921426|NCT02224560|9981859|FG001|COMPLETED|Overall Study||71
8921427|NCT02224560|9981860|FG002|COMPLETED|Overall Study||74
8921428|NCT02224560|9981858|FG000|NOT COMPLETED|Overall Study||9
8921429|NCT02224560|9981859|FG001|NOT COMPLETED|Overall Study||2
8921430|NCT02224560|9981860|FG002|NOT COMPLETED|Overall Study||2
8921431|NCT02224612|9981868|FG000|STARTED|Overall Study||48
8921432|NCT02224612|9981869|FG001|STARTED|Overall Study||48
8921433|NCT02224612|9981868|FG000|COMPLETED|Overall Study||48
8921434|NCT02224612|9981869|FG001|COMPLETED|Overall Study||48
8921435|NCT02224612|9981868|FG000|NOT COMPLETED|Overall Study||0
8921436|NCT02224612|9981869|FG001|NOT COMPLETED|Overall Study||0
8921437|NCT02224625|9981877|FG000|STARTED|Irritation||39
8921438|NCT02224625|9981877|FG000|COMPLETED|Irritation||33
8921439|NCT02224625|9981877|FG000|NOT COMPLETED|Irritation||6
8921440|NCT02224625|9981877|FG000|STARTED|Sensitization|Subjects from Irritation study also participated in Sensitization Study|249
8921441|NCT02224625|9981877|FG000|COMPLETED|Sensitization||194
8921442|NCT02224625|9981877|FG000|NOT COMPLETED|Sensitization||55
8921443|NCT02224638|9981891|FG000|STARTED|Overall Study||11
8921444|NCT02224638|9981892|FG001|STARTED|Overall Study||10
8921445|NCT02224638|9981891|FG000|COMPLETED|Overall Study||10
8921446|NCT02224638|9981892|FG001|COMPLETED|Overall Study||9
8921447|NCT02224638|9981891|FG000|NOT COMPLETED|Overall Study||1
8921448|NCT02224638|9981892|FG001|NOT COMPLETED|Overall Study||1
8921449|NCT02224664|9981900|FG000|STARTED|Lead-in Period (3 Days)||50
8921450|NCT02224664|9981901|FG001|STARTED|Lead-in Period (3 Days)||0
8921451|NCT02224664|9981902|FG002|STARTED|Lead-in Period (3 Days)||0
8921452|NCT02224664|9981903|FG003|STARTED|Lead-in Period (3 Days)||0
8921453|NCT02224664|9981904|FG004|STARTED|Lead-in Period (3 Days)||0
8921454|NCT02224664|9981900|FG000|COMPLETED|Lead-in Period (3 Days)||45
8921455|NCT02224664|9981901|FG001|COMPLETED|Lead-in Period (3 Days)||0
8921456|NCT02224664|9981902|FG002|COMPLETED|Lead-in Period (3 Days)||0
8921457|NCT02224664|9981903|FG003|COMPLETED|Lead-in Period (3 Days)||0
8921458|NCT02224664|9981904|FG004|COMPLETED|Lead-in Period (3 Days)||0
8921459|NCT02224664|9981900|FG000|NOT COMPLETED|Lead-in Period (3 Days)||5
8921460|NCT02224664|9981901|FG001|NOT COMPLETED|Lead-in Period (3 Days)||0
8921461|NCT02224664|9981902|FG002|NOT COMPLETED|Lead-in Period (3 Days)||0
8921462|NCT02224664|9981903|FG003|NOT COMPLETED|Lead-in Period (3 Days)||0
8921463|NCT02224664|9981904|FG004|NOT COMPLETED|Lead-in Period (3 Days)||0
8921464|NCT02224664|9981900|FG000|STARTED|Dose Escalation Period (21 Days)||0
8921465|NCT02224664|9981901|FG001|STARTED|Dose Escalation Period (21 Days)||9
8921466|NCT02224664|9981902|FG002|STARTED|Dose Escalation Period (21 Days)||11
8921467|NCT02224664|9981903|FG003|STARTED|Dose Escalation Period (21 Days)||6
8921468|NCT02224664|9981904|FG004|STARTED|Dose Escalation Period (21 Days)||19
8921469|NCT02224664|9981900|FG000|COMPLETED|Dose Escalation Period (21 Days)||0
8921470|NCT02224664|9981901|FG001|COMPLETED|Dose Escalation Period (21 Days)||9
8921471|NCT02224664|9981902|FG002|COMPLETED|Dose Escalation Period (21 Days)||9
8921472|NCT02224664|9981903|FG003|COMPLETED|Dose Escalation Period (21 Days)||3
8921473|NCT02224664|9981904|FG004|COMPLETED|Dose Escalation Period (21 Days)||8
8921474|NCT02224664|9981900|FG000|NOT COMPLETED|Dose Escalation Period (21 Days)||0
8921475|NCT02224664|9981901|FG001|NOT COMPLETED|Dose Escalation Period (21 Days)||0
8921476|NCT02224664|9981902|FG002|NOT COMPLETED|Dose Escalation Period (21 Days)||2
8921477|NCT02224664|9981903|FG003|NOT COMPLETED|Dose Escalation Period (21 Days)||3
8921478|NCT02224664|9981904|FG004|NOT COMPLETED|Dose Escalation Period (21 Days)||11
8921479|NCT02224690|9981922|FG000|STARTED|Overall Study||86
8921480|NCT02224690|9981923|FG001|STARTED|Overall Study||85
8921481|NCT02224690|9981922|FG000|Safety Analysis Set|Overall Study||86
8921482|NCT02224690|9981923|FG001|Safety Analysis Set|Overall Study||85
8921483|NCT02224690|9981922|FG000|Intent to Treat (ITT) Analysis Set|Overall Study||86
9035936|NCT03304184|10097667|FG001|NOT COMPLETED|Overall Study||2
9035937|NCT03304522|10097676|FG000|STARTED|Overall Study||46
9035938|NCT03304522|10097677|FG001|STARTED|Overall Study||43
9035939|NCT03304522|10097676|FG000|COMPLETED|Overall Study||45
9035940|NCT03304522|10097677|FG001|COMPLETED|Overall Study||35
9035941|NCT03304522|10097676|FG000|NOT COMPLETED|Overall Study||1
9035942|NCT03304522|10097677|FG001|NOT COMPLETED|Overall Study||8
9035943|NCT03304626|10097685|FG000|STARTED|Overall Study||20
9035944|NCT03304626|10097686|FG001|STARTED|Overall Study||20
9035945|NCT03304626|10097685|FG000|COMPLETED|Overall Study||18
9035946|NCT03304626|10097686|FG001|COMPLETED|Overall Study||19
9035947|NCT03304626|10097685|FG000|NOT COMPLETED|Overall Study||2
9035948|NCT03304626|10097686|FG001|NOT COMPLETED|Overall Study||1
9035949|NCT03304873|10097695|FG000|STARTED|Overall Study||23
9035950|NCT03304873|10097696|FG001|STARTED|Overall Study||24
9035951|NCT03304873|10097695|FG000|COMPLETED|Overall Study||22
9035952|NCT03304873|10097696|FG001|COMPLETED|Overall Study||16
9035953|NCT03304873|10097695|FG000|NOT COMPLETED|Overall Study||1
9035954|NCT03304873|10097696|FG001|NOT COMPLETED|Overall Study||8
9035955|NCT03305081|10097704|FG000|STARTED|Overall Study||25
9035956|NCT03305081|10097705|FG001|STARTED|Overall Study||20
9035957|NCT03305081|10097704|FG000|COMPLETED|Overall Study||15
9035958|NCT03305081|10097705|FG001|COMPLETED|Overall Study||5
9035959|NCT03305081|10097704|FG000|NOT COMPLETED|Overall Study||10
9035960|NCT03305081|10097705|FG001|NOT COMPLETED|Overall Study||15
9035961|NCT03305159|10097713|FG000|STARTED|Overall Study||66
9035962|NCT03305159|10097714|FG001|STARTED|Overall Study||68
9035963|NCT03305159|10097713|FG000|COMPLETED|Overall Study||63
9035964|NCT03305159|10097714|FG001|COMPLETED|Overall Study||60
9035965|NCT03305159|10097713|FG000|NOT COMPLETED|Overall Study||3
9035966|NCT03305159|10097714|FG001|NOT COMPLETED|Overall Study||8
9035967|NCT03305419|10097728|FG000|STARTED|Part A Period 1 (1Day) + Washout (7days)||3
9035968|NCT03305419|10097729|FG001|STARTED|Part A Period 1 (1Day) + Washout (7days)||3
9035969|NCT03305419|10097730|FG002|STARTED|Part A Period 1 (1Day) + Washout (7days)||3
9035970|NCT03305419|10097731|FG003|STARTED|Part A Period 1 (1Day) + Washout (7days)||3
9035971|NCT03305419|10097732|FG004|STARTED|Part A Period 1 (1Day) + Washout (7days)||0
9035972|NCT03305419|10097733|FG005|STARTED|Part A Period 1 (1Day) + Washout (7days)||0
9035973|NCT03305419|10097734|FG006|STARTED|Part A Period 1 (1Day) + Washout (7days)||0
9035974|NCT03305419|10097735|FG007|STARTED|Part A Period 1 (1Day) + Washout (7days)||0
9035975|NCT03305419|10097728|FG000|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||3
9035976|NCT03305419|10097729|FG001|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||2
9035977|NCT03305419|10097730|FG002|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||3
9035978|NCT03305419|10097731|FG003|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||3
9035979|NCT03305419|10097732|FG004|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
9035980|NCT03305419|10097733|FG005|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
9035981|NCT03305419|10097734|FG006|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
9035982|NCT03305419|10097735|FG007|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
9035983|NCT03305419|10097728|FG000|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
9035984|NCT03305419|10097729|FG001|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||1
9035985|NCT03305419|10097730|FG002|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
9035986|NCT03305419|10097731|FG003|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
9035987|NCT03305419|10097732|FG004|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
8805825|NCT01474512|9858128|FG010|STARTED|Maintenance Period||0
8805826|NCT01474512|9858129|FG011|STARTED|Maintenance Period||0
8805827|NCT01474512|9858130|FG012|STARTED|Maintenance Period||0
8805828|NCT01474512|9858131|FG013|STARTED|Maintenance Period||0
8805829|NCT01474512|9858132|FG014|STARTED|Maintenance Period||0
8805830|NCT01474512|9858133|FG015|STARTED|Maintenance Period||0
8805831|NCT01474512|9858134|FG016|STARTED|Maintenance Period||0
8805832|NCT01474512|9858135|FG017|STARTED|Maintenance Period||0
8805833|NCT01474512|9858118|FG000|Received Study Drug|Maintenance Period||0
8805834|NCT01474512|9858119|FG001|Received Study Drug|Maintenance Period||0
8805835|NCT01474512|9858120|FG002|Received Study Drug|Maintenance Period||0
8805836|NCT01474512|9858121|FG003|Received Study Drug|Maintenance Period||226
8805837|NCT01474512|9858122|FG004|Received Study Drug|Maintenance Period||227
8805838|NCT01474512|9858123|FG005|Received Study Drug|Maintenance Period||229
8805839|NCT01474512|9858124|FG006|Received Study Drug|Maintenance Period||16
8805840|NCT01474512|9858125|FG007|Received Study Drug|Maintenance Period||391
8805841|NCT01474512|9858126|FG008|Received Study Drug|Maintenance Period||78
8805842|NCT01474512|9858127|FG009|Received Study Drug|Maintenance Period||62
8805843|NCT01474512|9858128|FG010|Received Study Drug|Maintenance Period||0
8805844|NCT01474512|9858129|FG011|Received Study Drug|Maintenance Period||0
8805845|NCT01474512|9858130|FG012|Received Study Drug|Maintenance Period||0
8805846|NCT01474512|9858131|FG013|Received Study Drug|Maintenance Period||0
8805847|NCT01474512|9858132|FG014|Received Study Drug|Maintenance Period||0
8805848|NCT01474512|9858133|FG015|Received Study Drug|Maintenance Period||0
8805849|NCT01474512|9858134|FG016|Received Study Drug|Maintenance Period||0
8805850|NCT01474512|9858135|FG017|Received Study Drug|Maintenance Period||0
8805851|NCT01474512|9858118|FG000|Relapsed Population Received Drug|Maintenance Period||0
8805852|NCT01474512|9858119|FG001|Relapsed Population Received Drug|Maintenance Period||0
8805853|NCT01474512|9858120|FG002|Relapsed Population Received Drug|Maintenance Period||0
8805854|NCT01474512|9858121|FG003|Relapsed Population Received Drug|Maintenance Period||0
8805855|NCT01474512|9858122|FG004|Relapsed Population Received Drug|Maintenance Period||0
8805856|NCT01474512|9858123|FG005|Relapsed Population Received Drug|Maintenance Period||0
8805857|NCT01474512|9858124|FG006|Relapsed Population Received Drug|Maintenance Period||0
8805858|NCT01474512|9858125|FG007|Relapsed Population Received Drug|Maintenance Period||0
8805859|NCT01474512|9858126|FG008|Relapsed Population Received Drug|Maintenance Period||0
8805860|NCT01474512|9858127|FG009|Relapsed Population Received Drug|Maintenance Period||0
8805861|NCT01474512|9858128|FG010|Relapsed Population Received Drug|Maintenance Period||348
8805862|NCT01474512|9858129|FG011|Relapsed Population Received Drug|Maintenance Period||0
8805863|NCT01474512|9858130|FG012|Relapsed Population Received Drug|Maintenance Period||0
8805864|NCT01474512|9858131|FG013|Relapsed Population Received Drug|Maintenance Period||0
8805865|NCT01474512|9858132|FG014|Relapsed Population Received Drug|Maintenance Period||0
8805866|NCT01474512|9858133|FG015|Relapsed Population Received Drug|Maintenance Period||0
8805867|NCT01474512|9858134|FG016|Relapsed Population Received Drug|Maintenance Period||0
8805868|NCT01474512|9858135|FG017|Relapsed Population Received Drug|Maintenance Period||0
8805869|NCT01474512|9858118|FG000|Relapsed Population Completers|Maintenance Period||0
8805870|NCT01474512|9858119|FG001|Relapsed Population Completers|Maintenance Period||0
8805871|NCT01474512|9858120|FG002|Relapsed Population Completers|Maintenance Period||0
8805872|NCT01474512|9858121|FG003|Relapsed Population Completers|Maintenance Period||0
8805873|NCT01474512|9858122|FG004|Relapsed Population Completers|Maintenance Period||0
8805874|NCT01474512|9858123|FG005|Relapsed Population Completers|Maintenance Period||0
8805875|NCT01474512|9858124|FG006|Relapsed Population Completers|Maintenance Period||0
8805876|NCT01474512|9858125|FG007|Relapsed Population Completers|Maintenance Period||0
8805877|NCT01474512|9858126|FG008|Relapsed Population Completers|Maintenance Period||0
8805878|NCT01474512|9858127|FG009|Relapsed Population Completers|Maintenance Period||0
8805879|NCT01474512|9858128|FG010|Relapsed Population Completers|Maintenance Period||321
8805880|NCT01474512|9858129|FG011|Relapsed Population Completers|Maintenance Period||0
8805881|NCT01474512|9858130|FG012|Relapsed Population Completers|Maintenance Period||0
8805882|NCT01474512|9858131|FG013|Relapsed Population Completers|Maintenance Period||0
8805883|NCT01474512|9858132|FG014|Relapsed Population Completers|Maintenance Period||0
8805884|NCT01474512|9858133|FG015|Relapsed Population Completers|Maintenance Period||0
8805885|NCT01474512|9858134|FG016|Relapsed Population Completers|Maintenance Period||0
8805886|NCT01474512|9858135|FG017|Relapsed Population Completers|Maintenance Period||0
8805887|NCT01474512|9858118|FG000|COMPLETED|Maintenance Period||0
8805888|NCT01474512|9858119|FG001|COMPLETED|Maintenance Period||0
8805889|NCT01474512|9858120|FG002|COMPLETED|Maintenance Period||0
8805890|NCT01474512|9858121|FG003|COMPLETED|Maintenance Period||24
8805891|NCT01474512|9858122|FG004|COMPLETED|Maintenance Period||108
8805892|NCT01474512|9858123|FG005|COMPLETED|Maintenance Period||177
8805893|NCT01474512|9858124|FG006|COMPLETED|Maintenance Period||6
8805894|NCT01474512|9858125|FG007|COMPLETED|Maintenance Period||350
8805895|NCT01474512|9858126|FG008|COMPLETED|Maintenance Period||62
8805896|NCT01474512|9858127|FG009|COMPLETED|Maintenance Period||44
8805897|NCT01474512|9858128|FG010|COMPLETED|Maintenance Period||0
8805898|NCT01474512|9858129|FG011|COMPLETED|Maintenance Period||0
8805899|NCT01474512|9858130|FG012|COMPLETED|Maintenance Period||0
8921484|NCT02224690|9981923|FG001|Intent to Treat (ITT) Analysis Set|Overall Study||85
8921485|NCT02224690|9981922|FG000|COMPLETED|Overall Study||72
8921486|NCT02224690|9981923|FG001|COMPLETED|Overall Study||84
8921487|NCT02224690|9981922|FG000|NOT COMPLETED|Overall Study||14
8921488|NCT02224690|9981923|FG001|NOT COMPLETED|Overall Study||1
8921489|NCT02224703|9981932|FG000|STARTED|Overall Study||67
8921490|NCT02224703|9981933|FG001|STARTED|Overall Study||67
8921491|NCT02224703|9981934|FG002|STARTED|Overall Study||65
8921492|NCT02224703|9981932|FG000|Received at Least 1 Dose of Study Drug|Overall Study||66
8921493|NCT02224703|9981933|FG001|Received at Least 1 Dose of Study Drug|Overall Study||67
8921494|NCT02224703|9981934|FG002|Received at Least 1 Dose of Study Drug|Overall Study||65
8921495|NCT02224703|9981932|FG000|Safety Analysis Set|Overall Study|Two participants assigned to the 10 mg/kg/day dose were included in the 20 mg/kg/day group|64
8921496|NCT02224703|9981933|FG001|Safety Analysis Set|Overall Study|Two participants assigned to the 10 mg/kg/day dose were included in the 20 mg/kg/day group|69
8921497|NCT02224703|9981934|FG002|Safety Analysis Set|Overall Study||65
8921498|NCT02224703|9981932|FG000|Intent to Treat (ITT) Analysis Set|Overall Study||66
8921499|NCT02224703|9981933|FG001|Intent to Treat (ITT) Analysis Set|Overall Study||67
8921500|NCT02224703|9981934|FG002|Intent to Treat (ITT) Analysis Set|Overall Study||65
8921501|NCT02224703|9981932|FG000|COMPLETED|Overall Study||64
8921502|NCT02224703|9981933|FG001|COMPLETED|Overall Study||61
8921503|NCT02224703|9981934|FG002|COMPLETED|Overall Study||65
8921504|NCT02224703|9981932|FG000|NOT COMPLETED|Overall Study||3
8921505|NCT02224703|9981933|FG001|NOT COMPLETED|Overall Study||6
8921506|NCT02224703|9981934|FG002|NOT COMPLETED|Overall Study||0
8921507|NCT02224729|9981943|FG000|STARTED|Overall Study||24
8921508|NCT02224729|9981943|FG000|COMPLETED|Overall Study||24
8921509|NCT02224729|9981943|FG000|NOT COMPLETED|Overall Study||0
8921510|NCT02224755|9981949|FG000|STARTED|Randomization to Device Implant|Patients in the Full Study Cohort (n=1028) who were randomized to HeartMate II|512
8921511|NCT02224755|9981950|FG001|STARTED|Randomization to Device Implant|Patients in the Full Study Cohort (n=1028) who were randomized to HeartMate 3|516
9035988|NCT03305419|10097733|FG005|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
9035989|NCT03305419|10097734|FG006|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
9035990|NCT03305419|10097735|FG007|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
9035991|NCT03305419|10097728|FG000|STARTED|Part A Period 2 (1Day) + Washout (7days)||3
9035992|NCT03305419|10097729|FG001|STARTED|Part A Period 2 (1Day) + Washout (7days)|1 participant was added to GSK2982772 120 mg TID/240 mg TID/Placebo arm|3
9035993|NCT03305419|10097730|FG002|STARTED|Part A Period 2 (1Day) + Washout (7days)||3
9035994|NCT03305419|10097731|FG003|STARTED|Part A Period 2 (1Day) + Washout (7days)||3
9035995|NCT03305419|10097732|FG004|STARTED|Part A Period 2 (1Day) + Washout (7days)||0
9035996|NCT03305419|10097733|FG005|STARTED|Part A Period 2 (1Day) + Washout (7days)||0
9035997|NCT03305419|10097734|FG006|STARTED|Part A Period 2 (1Day) + Washout (7days)||0
9035998|NCT03305419|10097735|FG007|STARTED|Part A Period 2 (1Day) + Washout (7days)||0
9035999|NCT03305419|10097728|FG000|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||1
9036000|NCT03305419|10097729|FG001|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||3
9036001|NCT03305419|10097730|FG002|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||3
9036002|NCT03305419|10097731|FG003|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||3
9036003|NCT03305419|10097732|FG004|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
9036004|NCT03305419|10097733|FG005|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
9036005|NCT03305419|10097734|FG006|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
9036006|NCT03305419|10097735|FG007|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
9036007|NCT03305419|10097728|FG000|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||2
9036008|NCT03305419|10097729|FG001|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
9036009|NCT03305419|10097730|FG002|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
9036010|NCT03305419|10097731|FG003|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
9036011|NCT03305419|10097732|FG004|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
9036012|NCT03305419|10097733|FG005|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
9036013|NCT03305419|10097734|FG006|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
9036014|NCT03305419|10097735|FG007|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
9036015|NCT03305419|10097728|FG000|STARTED|Part A Period 3 (1Day) + Washout (7days)|2 participants were added to GSK2982772 120 mg TID/240 mg TID/360 mg BID arm after Washout Period.|3
9036016|NCT03305419|10097729|FG001|STARTED|Part A Period 3 (1Day) + Washout (7days)||3
9036017|NCT03305419|10097730|FG002|STARTED|Part A Period 3 (1Day) + Washout (7days)||3
9036018|NCT03305419|10097731|FG003|STARTED|Part A Period 3 (1Day) + Washout (7days)||3
9036019|NCT03305419|10097732|FG004|STARTED|Part A Period 3 (1Day) + Washout (7days)||0
9036020|NCT03305419|10097733|FG005|STARTED|Part A Period 3 (1Day) + Washout (7days)||0
9036021|NCT03305419|10097734|FG006|STARTED|Part A Period 3 (1Day) + Washout (7days)||0
9036022|NCT03305419|10097735|FG007|STARTED|Part A Period 3 (1Day) + Washout (7days)||0
9036023|NCT03305419|10097728|FG000|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||3
9036024|NCT03305419|10097729|FG001|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||3
9036025|NCT03305419|10097730|FG002|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||3
9036026|NCT03305419|10097731|FG003|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||3
9036027|NCT03305419|10097732|FG004|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
9036028|NCT03305419|10097733|FG005|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
9036029|NCT03305419|10097734|FG006|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
9036030|NCT03305419|10097735|FG007|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
8921512|NCT02224755|9981949|FG000|COMPLETED|Randomization to Device Implant|Patients who underwent HeartMate II LVAS implant|505
8921513|NCT02224755|9981950|FG001|COMPLETED|Randomization to Device Implant|Patients who underwent HeartMate 3 LVAS implant|515
8921514|NCT02224755|9981949|FG000|NOT COMPLETED|Randomization to Device Implant||7
8921515|NCT02224755|9981950|FG001|NOT COMPLETED|Randomization to Device Implant||1
8921516|NCT02224755|9981949|FG000|STARTED|Two Year Follow up Post-implant||505
8921517|NCT02224755|9981950|FG001|STARTED|Two Year Follow up Post-implant||515
8921518|NCT02224755|9981949|FG000|COMPLETED|Two Year Follow up Post-implant||247
8921519|NCT02224755|9981950|FG001|COMPLETED|Two Year Follow up Post-implant||289
8921520|NCT02224755|9981949|FG000|NOT COMPLETED|Two Year Follow up Post-implant||258
8921521|NCT02224755|9981950|FG001|NOT COMPLETED|Two Year Follow up Post-implant||226
8921522|NCT02224820|9981960|FG000|STARTED|Overall Study||8
8921523|NCT02224820|9981960|FG000|COMPLETED|Overall Study|One patient did not receive full dose|8
8921524|NCT02224820|9981960|FG000|NOT COMPLETED|Overall Study||0
8921525|NCT02224846|9981966|FG000|STARTED|Period 1 (Month 3)||211
8921526|NCT02224846|9981967|FG001|STARTED|Period 1 (Month 3)||424
8921527|NCT02224846|9981966|FG000|Received at Least One Dose of Study Drug|Period 1 (Month 3)||210
8921528|NCT02224846|9981967|FG001|Received at Least One Dose of Study Drug|Period 1 (Month 3)||421
8921529|NCT02224846|9981966|FG000|COMPLETED|Period 1 (Month 3)||192
8921530|NCT02224846|9981967|FG001|COMPLETED|Period 1 (Month 3)||388
8921531|NCT02224846|9981966|FG000|NOT COMPLETED|Period 1 (Month 3)||19
8921532|NCT02224846|9981967|FG001|NOT COMPLETED|Period 1 (Month 3)||36
8921533|NCT02224846|9981966|FG000|STARTED|Period 2 (Month 3 to Month 12)||192
8921534|NCT02224846|9981967|FG001|STARTED|Period 2 (Month 3 to Month 12)||388
8921535|NCT02224846|9981966|FG000|COMPLETED|Period 2 (Month 3 to Month 12)||173
8921536|NCT02224846|9981967|FG001|COMPLETED|Period 2 (Month 3 to Month 12)||357
8921537|NCT02224846|9981966|FG000|NOT COMPLETED|Period 2 (Month 3 to Month 12)||19
8921538|NCT02224846|9981967|FG001|NOT COMPLETED|Period 2 (Month 3 to Month 12)||31
8921539|NCT02224846|9981966|FG000|STARTED|Period 2 (Month 12 to Month 24)||173
8921540|NCT02224846|9981967|FG001|STARTED|Period 2 (Month 12 to Month 24)||357
8921541|NCT02224846|9981966|FG000|COMPLETED|Period 2 (Month 12 to Month 24)||131
8921542|NCT02224846|9981967|FG001|COMPLETED|Period 2 (Month 12 to Month 24)||283
8921543|NCT02224846|9981966|FG000|NOT COMPLETED|Period 2 (Month 12 to Month 24)||42
8921544|NCT02224846|9981967|FG001|NOT COMPLETED|Period 2 (Month 12 to Month 24)||74
8921545|NCT02225080|9981973|FG000|STARTED|Overall Study||100
8921546|NCT02225080|9981973|FG000|COMPLETED|Overall Study||100
8921547|NCT02225080|9981973|FG000|NOT COMPLETED|Overall Study||0
8921548|NCT02225106|9981977|FG000|STARTED|Overall Study||11
8921549|NCT02225106|9981977|FG000|COMPLETED|Overall Study||11
8921550|NCT02225106|9981977|FG000|NOT COMPLETED|Overall Study||0
8921551|NCT02225132|9981981|FG000|STARTED|Overall Study||10
8921552|NCT02225132|9981981|FG000|COMPLETED|Overall Study||10
8921553|NCT02225132|9981981|FG000|NOT COMPLETED|Overall Study||0
8921554|NCT02225223|9981987|FG000|STARTED|Overall Study||27
8921555|NCT02225223|9981988|FG001|STARTED|Overall Study||8
8921556|NCT02225223|9981987|FG000|COMPLETED|Overall Study||8
8921557|NCT02225223|9981988|FG001|COMPLETED|Overall Study||3
8921558|NCT02225223|9981987|FG000|NOT COMPLETED|Overall Study||19
8921559|NCT02225223|9981988|FG001|NOT COMPLETED|Overall Study||5
8921560|NCT02225353|9981997|FG000|STARTED|Overall Study||91
8921561|NCT02225353|9981998|FG001|STARTED|Overall Study||90
8921562|NCT02225353|9981999|FG002|STARTED|Overall Study||90
8921563|NCT02225353|9981997|FG000|COMPLETED|Overall Study||87
8921564|NCT02225353|9981998|FG001|COMPLETED|Overall Study||84
8921565|NCT02225353|9981999|FG002|COMPLETED|Overall Study||75
8921566|NCT02225353|9981997|FG000|NOT COMPLETED|Overall Study||4
8921567|NCT02225353|9981998|FG001|NOT COMPLETED|Overall Study||6
8921568|NCT02225353|9981999|FG002|NOT COMPLETED|Overall Study||15
8921569|NCT02225587|9982012|FG000|STARTED|Overall Study||200
8921570|NCT02225587|9982013|FG001|STARTED|Overall Study||200
8921571|NCT02225587|9982012|FG000|Vaccination 2|Overall Study||188
8921572|NCT02225587|9982013|FG001|Vaccination 2|Overall Study||185
8921573|NCT02225587|9982012|FG000|Vaccination 3|Overall Study||172
8921574|NCT02225587|9982013|FG001|Vaccination 3|Overall Study||164
8921575|NCT02225587|9982012|FG000|COMPLETED|Overall Study||172
8921576|NCT02225587|9982013|FG001|COMPLETED|Overall Study||162
8921577|NCT02225587|9982012|FG000|NOT COMPLETED|Overall Study||28
8921578|NCT02225587|9982013|FG001|NOT COMPLETED|Overall Study||38
8921579|NCT02225665|9982021|FG000|STARTED|Overall Study||3
8921580|NCT02225665|9982022|FG001|STARTED|Overall Study||5
8921581|NCT02225665|9982021|FG000|COMPLETED|Overall Study||2
8921582|NCT02225665|9982022|FG001|COMPLETED|Overall Study||4
8921583|NCT02225665|9982021|FG000|NOT COMPLETED|Overall Study||1
8921584|NCT02225665|9982022|FG001|NOT COMPLETED|Overall Study||1
8921585|NCT02225743|9982028|FG000|STARTED|Overall Study||120
8921586|NCT02225743|9982028|FG000|COMPLETED|Overall Study|18 patients chose not to participate on the day of surgery.|102
8921587|NCT02225743|9982028|FG000|NOT COMPLETED|Overall Study||18
8921588|NCT02225860|9982034|FG000|STARTED|Overall Study||17
8921589|NCT02225860|9982035|FG001|STARTED|Overall Study||17
8921590|NCT02225860|9982034|FG000|COMPLETED|Overall Study||16
8921591|NCT02225860|9982035|FG001|COMPLETED|Overall Study||17
8921592|NCT02225860|9982034|FG000|NOT COMPLETED|Overall Study||1
8921593|NCT02225860|9982035|FG001|NOT COMPLETED|Overall Study||0
8921594|NCT02225925|9982042|FG000|STARTED|Overall Study||45
8921595|NCT02225925|9982042|FG000|COMPLETED|Overall Study||45
8921596|NCT02225925|9982042|FG000|NOT COMPLETED|Overall Study||0
8921597|NCT02226003|9982049|FG000|STARTED|Overall Study||98
8921598|NCT02226003|9982050|FG001|STARTED|Overall Study||96
8921599|NCT02226003|9982051|FG002|STARTED|Overall Study||97
8921600|NCT02226003|9982049|FG000|COMPLETED|Overall Study||96
8921601|NCT02226003|9982050|FG001|COMPLETED|Overall Study||95
8921602|NCT02226003|9982051|FG002|COMPLETED|Overall Study||91
8921603|NCT02226003|9982049|FG000|NOT COMPLETED|Overall Study||2
8921604|NCT02226003|9982050|FG001|NOT COMPLETED|Overall Study||1
8921605|NCT02226003|9982051|FG002|NOT COMPLETED|Overall Study||6
8921606|NCT02226120|9982059|FG000|STARTED|Overall Study||1980
8921607|NCT02226120|9982059|FG000|COMPLETED|Overall Study||1660
8921608|NCT02226120|9982059|FG000|NOT COMPLETED|Overall Study||320
9036031|NCT03305419|10097728|FG000|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
9036032|NCT03305419|10097729|FG001|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
9036033|NCT03305419|10097730|FG002|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
9036034|NCT03305419|10097731|FG003|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
9036035|NCT03305419|10097732|FG004|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
9036036|NCT03305419|10097733|FG005|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
9036037|NCT03305419|10097734|FG006|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
9036038|NCT03305419|10097735|FG007|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
9036039|NCT03305419|10097728|FG000|STARTED|Part B (14 Days)||0
9036040|NCT03305419|10097729|FG001|STARTED|Part B (14 Days)||0
9036041|NCT03305419|10097730|FG002|STARTED|Part B (14 Days)||0
9036042|NCT03305419|10097731|FG003|STARTED|Part B (14 Days)||0
9036043|NCT03305419|10097732|FG004|STARTED|Part B (14 Days)||14
9036044|NCT03305419|10097733|FG005|STARTED|Part B (14 Days)||20
9036045|NCT03305419|10097734|FG006|STARTED|Part B (14 Days)||13
9036046|NCT03305419|10097735|FG007|STARTED|Part B (14 Days)||0
9036047|NCT03305419|10097728|FG000|COMPLETED|Part B (14 Days)||0
9036048|NCT03305419|10097729|FG001|COMPLETED|Part B (14 Days)||0
9036049|NCT03305419|10097730|FG002|COMPLETED|Part B (14 Days)||0
9036050|NCT03305419|10097731|FG003|COMPLETED|Part B (14 Days)||0
9036051|NCT03305419|10097732|FG004|COMPLETED|Part B (14 Days)||11
9036052|NCT03305419|10097733|FG005|COMPLETED|Part B (14 Days)||10
9036053|NCT03305419|10097734|FG006|COMPLETED|Part B (14 Days)||8
9036054|NCT03305419|10097735|FG007|COMPLETED|Part B (14 Days)||0
9036055|NCT03305419|10097728|FG000|NOT COMPLETED|Part B (14 Days)||0
9036056|NCT03305419|10097729|FG001|NOT COMPLETED|Part B (14 Days)||0
9036057|NCT03305419|10097730|FG002|NOT COMPLETED|Part B (14 Days)||0
9036058|NCT03305419|10097731|FG003|NOT COMPLETED|Part B (14 Days)||0
9036059|NCT03305419|10097732|FG004|NOT COMPLETED|Part B (14 Days)||3
9036060|NCT03305419|10097733|FG005|NOT COMPLETED|Part B (14 Days)||10
9036061|NCT03305419|10097734|FG006|NOT COMPLETED|Part B (14 Days)||5
9036062|NCT03305419|10097735|FG007|NOT COMPLETED|Part B (14 Days)||0
9036063|NCT03305575|10097760|FG000|STARTED|Overall Study||5
9036064|NCT03305575|10097761|FG001|STARTED|Overall Study||5
9036065|NCT03305575|10097760|FG000|COMPLETED|Overall Study||4
9036066|NCT03305575|10097761|FG001|COMPLETED|Overall Study||5
9036067|NCT03305575|10097760|FG000|NOT COMPLETED|Overall Study||1
9036068|NCT03305575|10097761|FG001|NOT COMPLETED|Overall Study||0
9036069|NCT03305653|10097767|FG000|STARTED|Overall Study||21
9036070|NCT03305653|10097767|FG000|COMPLETED|Overall Study||21
9036071|NCT03305653|10097767|FG000|NOT COMPLETED|Overall Study||0
9036072|NCT03305666|10097773|FG000|STARTED|Overall Study||18
9036073|NCT03305666|10097774|FG001|STARTED|Overall Study||18
9036074|NCT03305666|10097773|FG000|COMPLETED|Overall Study||16
9036075|NCT03305666|10097774|FG001|COMPLETED|Overall Study||18
9036076|NCT03305666|10097773|FG000|NOT COMPLETED|Overall Study||2
9036077|NCT03305666|10097774|FG001|NOT COMPLETED|Overall Study||0
9036078|NCT03305731|10097780|FG000|STARTED|Overall Study||21
9036079|NCT03305731|10097780|FG000|Week 6|Overall Study||20
9036080|NCT03305731|10097780|FG000|Week 11|Overall Study||20
9036081|NCT03305731|10097780|FG000|COMPLETED|Overall Study||20
9036082|NCT03305731|10097780|FG000|NOT COMPLETED|Overall Study||1
9036083|NCT03305770|10097786|FG000|STARTED|Overall Study||70
9036084|NCT03305770|10097787|FG001|STARTED|Overall Study||37
9036085|NCT03305770|10097786|FG000|Enrolled Dispensed Analysis Set|Overall Study||70
9036086|NCT03305770|10097787|FG001|Enrolled Dispensed Analysis Set|Overall Study||36
9036087|NCT03305770|10097786|FG000|Completed Analysis Set|Overall Study||69
9036088|NCT03305770|10097787|FG001|Completed Analysis Set|Overall Study||36
9036089|NCT03305770|10097786|FG000|COMPLETED|Overall Study||69
9036090|NCT03305770|10097787|FG001|COMPLETED|Overall Study||36
9036091|NCT03305770|10097786|FG000|NOT COMPLETED|Overall Study||1
9036092|NCT03305770|10097787|FG001|NOT COMPLETED|Overall Study||1
9036093|NCT03305809|10097799|FG000|STARTED|Overall Study||86
9036094|NCT03305809|10097800|FG001|STARTED|Overall Study||86
9036095|NCT03305809|10097801|FG002|STARTED|Overall Study||85
9036096|NCT03305809|10097802|FG003|STARTED|Overall Study||87
9036097|NCT03305809|10097799|FG000|Received at Least One Dose of Study Drug|Overall Study||86
9036098|NCT03305809|10097800|FG001|Received at Least One Dose of Study Drug|Overall Study||86
9036099|NCT03305809|10097801|FG002|Received at Least One Dose of Study Drug|Overall Study||85
9036100|NCT03305809|10097802|FG003|Received at Least One Dose of Study Drug|Overall Study||87
9036101|NCT03305809|10097799|FG000|COMPLETED|Overall Study||79
9036102|NCT03305809|10097800|FG001|COMPLETED|Overall Study||78
9036103|NCT03305809|10097801|FG002|COMPLETED|Overall Study||66
9036104|NCT03305809|10097802|FG003|COMPLETED|Overall Study||60
9036105|NCT03305809|10097799|FG000|NOT COMPLETED|Overall Study||7
9036106|NCT03305809|10097800|FG001|NOT COMPLETED|Overall Study||8
8921609|NCT02226159|9982065|FG000|STARTED|Overall Study||33
8921610|NCT02226159|9982066|FG001|STARTED|Overall Study||32
8921611|NCT02226159|9982065|FG000|COMPLETED|Overall Study||27
8921612|NCT02226159|9982066|FG001|COMPLETED|Overall Study||26
8921613|NCT02226159|9982065|FG000|NOT COMPLETED|Overall Study||6
8921614|NCT02226159|9982066|FG001|NOT COMPLETED|Overall Study||6
8921615|NCT02226172|9982072|FG000|STARTED|Overall Study||21
8921616|NCT02226172|9982072|FG000|COMPLETED|Overall Study||4
8921617|NCT02226172|9982072|FG000|NOT COMPLETED|Overall Study||17
8921618|NCT02226198|9982076|FG000|STARTED|Lead-in Phase||11
8921619|NCT02226198|9982077|FG001|STARTED|Lead-in Phase||0
8921620|NCT02226198|9982078|FG002|STARTED|Lead-in Phase||0
8921621|NCT02226198|9982076|FG000|COMPLETED|Lead-in Phase||10
8921622|NCT02226198|9982077|FG001|COMPLETED|Lead-in Phase||0
8921623|NCT02226198|9982078|FG002|COMPLETED|Lead-in Phase||0
8921624|NCT02226198|9982076|FG000|NOT COMPLETED|Lead-in Phase||1
8921625|NCT02226198|9982077|FG001|NOT COMPLETED|Lead-in Phase||0
8921626|NCT02226198|9982078|FG002|NOT COMPLETED|Lead-in Phase||0
8921627|NCT02226198|9982076|FG000|STARTED|Cross-Over: First Intervention (6 Weeks)||0
8921628|NCT02226198|9982077|FG001|STARTED|Cross-Over: First Intervention (6 Weeks)||7
8921629|NCT02226198|9982078|FG002|STARTED|Cross-Over: First Intervention (6 Weeks)||7
8921630|NCT02226198|9982076|FG000|COMPLETED|Cross-Over: First Intervention (6 Weeks)||0
8921631|NCT02226198|9982077|FG001|COMPLETED|Cross-Over: First Intervention (6 Weeks)||6
8921632|NCT02226198|9982078|FG002|COMPLETED|Cross-Over: First Intervention (6 Weeks)||7
8805900|NCT01474512|9858131|FG013|COMPLETED|Maintenance Period||0
8805901|NCT01474512|9858132|FG014|COMPLETED|Maintenance Period||0
8805902|NCT01474512|9858133|FG015|COMPLETED|Maintenance Period||0
8805903|NCT01474512|9858134|FG016|COMPLETED|Maintenance Period||0
8805904|NCT01474512|9858135|FG017|COMPLETED|Maintenance Period||0
8805905|NCT01474512|9858118|FG000|NOT COMPLETED|Maintenance Period||0
8805906|NCT01474512|9858119|FG001|NOT COMPLETED|Maintenance Period||0
8805907|NCT01474512|9858120|FG002|NOT COMPLETED|Maintenance Period||0
8805908|NCT01474512|9858121|FG003|NOT COMPLETED|Maintenance Period||202
8805909|NCT01474512|9858122|FG004|NOT COMPLETED|Maintenance Period||119
8805910|NCT01474512|9858123|FG005|NOT COMPLETED|Maintenance Period||52
8805911|NCT01474512|9858124|FG006|NOT COMPLETED|Maintenance Period||10
8805912|NCT01474512|9858125|FG007|NOT COMPLETED|Maintenance Period||41
8805913|NCT01474512|9858126|FG008|NOT COMPLETED|Maintenance Period||16
8805914|NCT01474512|9858127|FG009|NOT COMPLETED|Maintenance Period||18
8805915|NCT01474512|9858128|FG010|NOT COMPLETED|Maintenance Period||0
8805916|NCT01474512|9858129|FG011|NOT COMPLETED|Maintenance Period||0
8805917|NCT01474512|9858130|FG012|NOT COMPLETED|Maintenance Period||0
8805918|NCT01474512|9858131|FG013|NOT COMPLETED|Maintenance Period||0
8805919|NCT01474512|9858132|FG014|NOT COMPLETED|Maintenance Period||0
8805920|NCT01474512|9858133|FG015|NOT COMPLETED|Maintenance Period||0
8805921|NCT01474512|9858134|FG016|NOT COMPLETED|Maintenance Period||0
8805922|NCT01474512|9858135|FG017|NOT COMPLETED|Maintenance Period||0
8805923|NCT01474512|9858118|FG000|STARTED|Long-Term Extension Period||0
8805924|NCT01474512|9858119|FG001|STARTED|Long-Term Extension Period||0
8805925|NCT01474512|9858120|FG002|STARTED|Long-Term Extension Period||0
8805926|NCT01474512|9858121|FG003|STARTED|Long-Term Extension Period||0
8805927|NCT01474512|9858122|FG004|STARTED|Long-Term Extension Period||0
8805928|NCT01474512|9858123|FG005|STARTED|Long-Term Extension Period||0
8805929|NCT01474512|9858124|FG006|STARTED|Long-Term Extension Period||0
8805930|NCT01474512|9858125|FG007|STARTED|Long-Term Extension Period||0
8805931|NCT01474512|9858126|FG008|STARTED|Long-Term Extension Period||0
8805932|NCT01474512|9858127|FG009|STARTED|Long-Term Extension Period||0
8805933|NCT01474512|9858128|FG010|STARTED|Long-Term Extension Period||0
8805934|NCT01474512|9858129|FG011|STARTED|Long-Term Extension Period|9 participants did not start the long-term extension period.|26
8805935|NCT01474512|9858130|FG012|STARTED|Long-Term Extension Period|Participants received Ixe alone at the start of long-term extension.|1054
8805936|NCT01474512|9858131|FG013|STARTED|Long-Term Extension Period|Participants received Ixe in all dosing regimens, including participants who switched PBO to Ixe.|1075
8805937|NCT01474512|9858132|FG014|STARTED|Long-Term Extension Period||0
8805938|NCT01474512|9858133|FG015|STARTED|Long-Term Extension Period||0
8805939|NCT01474512|9858134|FG016|STARTED|Long-Term Extension Period||0
8805940|NCT01474512|9858135|FG017|STARTED|Long-Term Extension Period||0
8805941|NCT01474512|9858118|FG000|COMPLETED|Long-Term Extension Period||0
8805942|NCT01474512|9858119|FG001|COMPLETED|Long-Term Extension Period||0
8805943|NCT01474512|9858120|FG002|COMPLETED|Long-Term Extension Period||0
8805944|NCT01474512|9858121|FG003|COMPLETED|Long-Term Extension Period||0
8805945|NCT01474512|9858122|FG004|COMPLETED|Long-Term Extension Period||0
8805946|NCT01474512|9858123|FG005|COMPLETED|Long-Term Extension Period||0
8805947|NCT01474512|9858124|FG006|COMPLETED|Long-Term Extension Period||0
8805948|NCT01474512|9858125|FG007|COMPLETED|Long-Term Extension Period||0
8921633|NCT02226198|9982076|FG000|NOT COMPLETED|Cross-Over: First Intervention (6 Weeks)||0
8921634|NCT02226198|9982077|FG001|NOT COMPLETED|Cross-Over: First Intervention (6 Weeks)||1
8921635|NCT02226198|9982078|FG002|NOT COMPLETED|Cross-Over: First Intervention (6 Weeks)||0
8921636|NCT02226198|9982076|FG000|STARTED|Cross-Over: Second Interv. (6 Weeks)||0
8921637|NCT02226198|9982077|FG001|STARTED|Cross-Over: Second Interv. (6 Weeks)||6
8921638|NCT02226198|9982078|FG002|STARTED|Cross-Over: Second Interv. (6 Weeks)||7
8805949|NCT01474512|9858126|FG008|COMPLETED|Long-Term Extension Period||0
8805950|NCT01474512|9858127|FG009|COMPLETED|Long-Term Extension Period||0
8921639|NCT02226198|9982076|FG000|COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
8921640|NCT02226198|9982077|FG001|COMPLETED|Cross-Over: Second Interv. (6 Weeks)||6
8921641|NCT02226198|9982078|FG002|COMPLETED|Cross-Over: Second Interv. (6 Weeks)||7
8921642|NCT02226198|9982076|FG000|NOT COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
8921643|NCT02226198|9982077|FG001|NOT COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
8921644|NCT02226198|9982078|FG002|NOT COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
8921645|NCT02226198|9982076|FG000|STARTED|Maintenance Phase (12 Weeks)||13
8921646|NCT02226198|9982077|FG001|STARTED|Maintenance Phase (12 Weeks)||0
9036107|NCT03305809|10097801|FG002|NOT COMPLETED|Overall Study||19
9036108|NCT03305809|10097802|FG003|NOT COMPLETED|Overall Study||27
9036109|NCT03305822|10097815|FG000|STARTED|Period 1||20
9036110|NCT03305822|10097816|FG001|STARTED|Period 1||18
9036111|NCT03305822|10097815|FG000|Received at Least 1 Dose of Study Drug|Period 1||20
9036112|NCT03305822|10097816|FG001|Received at Least 1 Dose of Study Drug|Period 1||18
9036113|NCT03305822|10097815|FG000|COMPLETED|Period 1||20
9036114|NCT03305822|10097816|FG001|COMPLETED|Period 1||18
9036115|NCT03305822|10097815|FG000|NOT COMPLETED|Period 1||0
8921647|NCT02226198|9982078|FG002|STARTED|Maintenance Phase (12 Weeks)||0
9036116|NCT03305822|10097816|FG001|NOT COMPLETED|Period 1||0
9036117|NCT03305822|10097815|FG000|STARTED|Washout|Cross-over study. All participants from Period 1 went on to Washout and Period 2.|20
9036118|NCT03305822|10097816|FG001|STARTED|Washout|Cross-over study. All participants from Period 1 went on to Washout and Period 2.|18
9036119|NCT03305822|10097815|FG000|COMPLETED|Washout||20
9036120|NCT03305822|10097816|FG001|COMPLETED|Washout||18
9036121|NCT03305822|10097815|FG000|NOT COMPLETED|Washout||0
9036122|NCT03305822|10097816|FG001|NOT COMPLETED|Washout||0
9036123|NCT03305822|10097815|FG000|STARTED|Period 2||20
9036124|NCT03305822|10097816|FG001|STARTED|Period 2||18
9036125|NCT03305822|10097815|FG000|Received at Least 1 Dose of Study Drug|Period 2||20
9036126|NCT03305822|10097816|FG001|Received at Least 1 Dose of Study Drug|Period 2||18
9036127|NCT03305822|10097815|FG000|COMPLETED|Period 2||20
9036128|NCT03305822|10097816|FG001|COMPLETED|Period 2||18
9036129|NCT03305822|10097815|FG000|NOT COMPLETED|Period 2||0
9036130|NCT03305822|10097816|FG001|NOT COMPLETED|Period 2||0
9036131|NCT03305887|10097824|FG000|STARTED|Overall Study||91
9036132|NCT03305887|10097825|FG001|STARTED|Overall Study||93
9036133|NCT03305887|10097824|FG000|COMPLETED|Overall Study||80
9036134|NCT03305887|10097825|FG001|COMPLETED|Overall Study||83
9036135|NCT03305887|10097824|FG000|NOT COMPLETED|Overall Study||11
9036136|NCT03305887|10097825|FG001|NOT COMPLETED|Overall Study||10
9036137|NCT03306043|10097831|FG000|STARTED|Overall Study||102
9036138|NCT03306043|10097831|FG000|COMPLETED|Overall Study||98
9036139|NCT03306043|10097831|FG000|NOT COMPLETED|Overall Study||4
9036140|NCT03306199|10097835|FG000|STARTED|Overall Study||82
9036141|NCT03306199|10097835|FG000|COMPLETED|Overall Study||67
9036142|NCT03306199|10097835|FG000|NOT COMPLETED|Overall Study||15
9036143|NCT03306277|10097839|FG000|STARTED|Overall Study||22
9036144|NCT03306277|10097839|FG000|COMPLETED|Overall Study||19
9036145|NCT03306277|10097839|FG000|NOT COMPLETED|Overall Study||3
9036146|NCT03306420|10097848|FG000|STARTED|Overall Study||3
9036147|NCT03306420|10097849|FG001|STARTED|Overall Study||3
9036148|NCT03306420|10097850|FG002|STARTED|Overall Study||3
9036149|NCT03306420|10097851|FG003|STARTED|Overall Study||3
9036150|NCT03306420|10097852|FG004|STARTED|Overall Study||3
9036151|NCT03306420|10097848|FG000|COMPLETED|Overall Study||3
9036152|NCT03306420|10097849|FG001|COMPLETED|Overall Study||3
9036153|NCT03306420|10097850|FG002|COMPLETED|Overall Study||3
9036154|NCT03306420|10097851|FG003|COMPLETED|Overall Study||3
9036155|NCT03306420|10097852|FG004|COMPLETED|Overall Study||3
9036156|NCT03306420|10097848|FG000|NOT COMPLETED|Overall Study||0
9036157|NCT03306420|10097849|FG001|NOT COMPLETED|Overall Study||0
9036158|NCT03306420|10097850|FG002|NOT COMPLETED|Overall Study||0
9036159|NCT03306420|10097851|FG003|NOT COMPLETED|Overall Study||0
9036160|NCT03306420|10097852|FG004|NOT COMPLETED|Overall Study||0
9036161|NCT03306433|10097864|FG000|STARTED|Overall Study||16
9036162|NCT03306433|10097864|FG000|UDMA-K18|Overall Study||12
9036163|NCT03306433|10097864|FG000|Adhesive Control|Overall Study||12
9036164|NCT03306433|10097864|FG000|UDMA-control|Overall Study||9
9036165|NCT03306433|10097864|FG000|COMPLETED|Overall Study||9
9036166|NCT03306433|10097864|FG000|NOT COMPLETED|Overall Study||7
9036167|NCT03306589|10097878|FG000|STARTED|Part 1 (69 Days)||2
9036168|NCT03306589|10097879|FG001|STARTED|Part 1 (69 Days)||4
9036169|NCT03306589|10097880|FG002|STARTED|Part 1 (69 Days)||2
9036170|NCT03306589|10097881|FG003|STARTED|Part 1 (69 Days)||4
9036171|NCT03306589|10097882|FG004|STARTED|Part 1 (69 Days)||0
9036172|NCT03306589|10097883|FG005|STARTED|Part 1 (69 Days)||0
9036173|NCT03306589|10097878|FG000|COMPLETED|Part 1 (69 Days)||2
9036174|NCT03306589|10097879|FG001|COMPLETED|Part 1 (69 Days)||4
9036175|NCT03306589|10097880|FG002|COMPLETED|Part 1 (69 Days)||2
9036176|NCT03306589|10097881|FG003|COMPLETED|Part 1 (69 Days)||4
9036177|NCT03306589|10097882|FG004|COMPLETED|Part 1 (69 Days)||0
9036178|NCT03306589|10097883|FG005|COMPLETED|Part 1 (69 Days)||0
9036179|NCT03306589|10097878|FG000|NOT COMPLETED|Part 1 (69 Days)||0
9036180|NCT03306589|10097879|FG001|NOT COMPLETED|Part 1 (69 Days)||0
9036181|NCT03306589|10097880|FG002|NOT COMPLETED|Part 1 (69 Days)||0
9036182|NCT03306589|10097881|FG003|NOT COMPLETED|Part 1 (69 Days)||0
9036183|NCT03306589|10097882|FG004|NOT COMPLETED|Part 1 (69 Days)||0
9036184|NCT03306589|10097883|FG005|NOT COMPLETED|Part 1 (69 Days)||0
9036185|NCT03306589|10097878|FG000|STARTED|Part 2 (69 Days)||0
9036186|NCT03306589|10097879|FG001|STARTED|Part 2 (69 Days)||0
9036187|NCT03306589|10097880|FG002|STARTED|Part 2 (69 Days)||0
9036188|NCT03306589|10097881|FG003|STARTED|Part 2 (69 Days)||0
9036189|NCT03306589|10097882|FG004|STARTED|Part 2 (69 Days)||0
9036190|NCT03306589|10097883|FG005|STARTED|Part 2 (69 Days)||0
9036191|NCT03306589|10097878|FG000|COMPLETED|Part 2 (69 Days)||0
9036192|NCT03306589|10097879|FG001|COMPLETED|Part 2 (69 Days)||0
9036193|NCT03306589|10097880|FG002|COMPLETED|Part 2 (69 Days)||0
9036194|NCT03306589|10097881|FG003|COMPLETED|Part 2 (69 Days)||0
9036195|NCT03306589|10097882|FG004|COMPLETED|Part 2 (69 Days)||0
9036196|NCT03306589|10097883|FG005|COMPLETED|Part 2 (69 Days)||0
9036197|NCT03306589|10097878|FG000|NOT COMPLETED|Part 2 (69 Days)||0
9036198|NCT03306589|10097879|FG001|NOT COMPLETED|Part 2 (69 Days)||0
9036199|NCT03306589|10097880|FG002|NOT COMPLETED|Part 2 (69 Days)||0
9036200|NCT03306589|10097881|FG003|NOT COMPLETED|Part 2 (69 Days)||0
9036201|NCT03306589|10097882|FG004|NOT COMPLETED|Part 2 (69 Days)||0
9036202|NCT03306589|10097883|FG005|NOT COMPLETED|Part 2 (69 Days)||0
9036203|NCT03306641|10097899|FG000|STARTED|First Intervention||23
9036204|NCT03306641|10097900|FG001|STARTED|First Intervention||22
9036205|NCT03306641|10097899|FG000|COMPLETED|First Intervention||23
9036206|NCT03306641|10097900|FG001|COMPLETED|First Intervention||22
9036207|NCT03306641|10097899|FG000|NOT COMPLETED|First Intervention||0
9036208|NCT03306641|10097900|FG001|NOT COMPLETED|First Intervention||0
9036209|NCT03306641|10097899|FG000|STARTED|Second Intervention||23
9036210|NCT03306641|10097900|FG001|STARTED|Second Intervention||22
9036211|NCT03306641|10097899|FG000|COMPLETED|Second Intervention||23
9036212|NCT03306641|10097900|FG001|COMPLETED|Second Intervention||22
9036213|NCT03306641|10097899|FG000|NOT COMPLETED|Second Intervention||0
9036214|NCT03306641|10097900|FG001|NOT COMPLETED|Second Intervention||0
9036215|NCT03307005|10097908|FG000|STARTED|Overall Study||3
9036216|NCT03307005|10097909|FG001|STARTED|Overall Study||2
9036217|NCT03307005|10097908|FG000|COMPLETED|Overall Study||3
9036218|NCT03307005|10097909|FG001|COMPLETED|Overall Study||2
9036219|NCT03307005|10097908|FG000|NOT COMPLETED|Overall Study||0
9036220|NCT03307005|10097909|FG001|NOT COMPLETED|Overall Study||0
9036221|NCT03307174|10097919|FG000|STARTED|Overall Study||60
9036222|NCT03307174|10097920|FG001|STARTED|Overall Study||60
9036223|NCT03307174|10097919|FG000|COMPLETED|Overall Study||46
9036224|NCT03307174|10097920|FG001|COMPLETED|Overall Study||53
9036225|NCT03307174|10097919|FG000|NOT COMPLETED|Overall Study||14
9036226|NCT03307174|10097920|FG001|NOT COMPLETED|Overall Study||7
9036227|NCT03307252|10097937|FG000|STARTED|Part 1, Period 1|Participants randomised in Part 1|4
9036228|NCT03307252|10097938|FG001|STARTED|Part 1, Period 1|Participants randomised in Part 1|4
9036229|NCT03307252|10097939|FG002|STARTED|Part 1, Period 1|Participants randomised in Part 1|4
9036230|NCT03307252|10097940|FG003|STARTED|Part 1, Period 1||0
9036231|NCT03307252|10097941|FG004|STARTED|Part 1, Period 1||0
9036232|NCT03307252|10097942|FG005|STARTED|Part 1, Period 1||0
9036233|NCT03307252|10097943|FG006|STARTED|Part 1, Period 1||0
9036234|NCT03307252|10097944|FG007|STARTED|Part 1, Period 1||0
9036235|NCT03307252|10097945|FG008|STARTED|Part 1, Period 1||0
9036236|NCT03307252|10097946|FG009|STARTED|Part 1, Period 1||0
9036237|NCT03307252|10097947|FG010|STARTED|Part 1, Period 1||0
9036238|NCT03307252|10097937|FG000|COMPLETED|Part 1, Period 1||4
9036239|NCT03307252|10097938|FG001|COMPLETED|Part 1, Period 1||4
9036240|NCT03307252|10097939|FG002|COMPLETED|Part 1, Period 1||4
9036241|NCT03307252|10097940|FG003|COMPLETED|Part 1, Period 1||0
9036242|NCT03307252|10097941|FG004|COMPLETED|Part 1, Period 1||0
9036243|NCT03307252|10097942|FG005|COMPLETED|Part 1, Period 1||0
9036244|NCT03307252|10097943|FG006|COMPLETED|Part 1, Period 1||0
9036245|NCT03307252|10097944|FG007|COMPLETED|Part 1, Period 1||0
9036246|NCT03307252|10097945|FG008|COMPLETED|Part 1, Period 1||0
9036247|NCT03307252|10097946|FG009|COMPLETED|Part 1, Period 1||0
9036248|NCT03307252|10097947|FG010|COMPLETED|Part 1, Period 1||0
9036249|NCT03307252|10097937|FG000|NOT COMPLETED|Part 1, Period 1||0
9036250|NCT03307252|10097938|FG001|NOT COMPLETED|Part 1, Period 1||0
9036251|NCT03307252|10097939|FG002|NOT COMPLETED|Part 1, Period 1||0
9036252|NCT03307252|10097940|FG003|NOT COMPLETED|Part 1, Period 1||0
9036253|NCT03307252|10097941|FG004|NOT COMPLETED|Part 1, Period 1||0
9036254|NCT03307252|10097942|FG005|NOT COMPLETED|Part 1, Period 1||0
9036255|NCT03307252|10097943|FG006|NOT COMPLETED|Part 1, Period 1||0
9036256|NCT03307252|10097944|FG007|NOT COMPLETED|Part 1, Period 1||0
9036257|NCT03307252|10097945|FG008|NOT COMPLETED|Part 1, Period 1||0
9036258|NCT03307252|10097946|FG009|NOT COMPLETED|Part 1, Period 1||0
9036259|NCT03307252|10097947|FG010|NOT COMPLETED|Part 1, Period 1||0
9036260|NCT03307252|10097937|FG000|STARTED|Part 1, Washout Period 1 (13 Days)||4
9036261|NCT03307252|10097938|FG001|STARTED|Part 1, Washout Period 1 (13 Days)||4
9036262|NCT03307252|10097939|FG002|STARTED|Part 1, Washout Period 1 (13 Days)||4
9036263|NCT03307252|10097940|FG003|STARTED|Part 1, Washout Period 1 (13 Days)||0
9036264|NCT03307252|10097941|FG004|STARTED|Part 1, Washout Period 1 (13 Days)||0
9036265|NCT03307252|10097942|FG005|STARTED|Part 1, Washout Period 1 (13 Days)||0
9036266|NCT03307252|10097943|FG006|STARTED|Part 1, Washout Period 1 (13 Days)||0
9036267|NCT03307252|10097944|FG007|STARTED|Part 1, Washout Period 1 (13 Days)||0
9036268|NCT03307252|10097945|FG008|STARTED|Part 1, Washout Period 1 (13 Days)||0
9036269|NCT03307252|10097946|FG009|STARTED|Part 1, Washout Period 1 (13 Days)||0
9036270|NCT03307252|10097947|FG010|STARTED|Part 1, Washout Period 1 (13 Days)||0
9036271|NCT03307252|10097937|FG000|COMPLETED|Part 1, Washout Period 1 (13 Days)||4
9036272|NCT03307252|10097938|FG001|COMPLETED|Part 1, Washout Period 1 (13 Days)||4
9036273|NCT03307252|10097939|FG002|COMPLETED|Part 1, Washout Period 1 (13 Days)||4
9036274|NCT03307252|10097940|FG003|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
9036275|NCT03307252|10097941|FG004|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
9036276|NCT03307252|10097942|FG005|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
9036277|NCT03307252|10097943|FG006|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
9036278|NCT03307252|10097944|FG007|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
9036279|NCT03307252|10097945|FG008|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
9036280|NCT03307252|10097946|FG009|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
9036281|NCT03307252|10097947|FG010|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
9036282|NCT03307252|10097937|FG000|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
9036283|NCT03307252|10097938|FG001|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
9036284|NCT03307252|10097939|FG002|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
9036285|NCT03307252|10097940|FG003|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
9036286|NCT03307252|10097941|FG004|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
9036287|NCT03307252|10097942|FG005|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
9036288|NCT03307252|10097943|FG006|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
9036289|NCT03307252|10097944|FG007|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
9036290|NCT03307252|10097945|FG008|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
9036291|NCT03307252|10097946|FG009|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
9036292|NCT03307252|10097947|FG010|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
9036293|NCT03307252|10097937|FG000|STARTED|Part 1, Period 2|Participants randomised in Part 1|4
9036294|NCT03307252|10097938|FG001|STARTED|Part 1, Period 2|Participants randomised in Part 1|4
9036295|NCT03307252|10097939|FG002|STARTED|Part 1, Period 2|Participants randomised in Part 1|4
9036296|NCT03307252|10097940|FG003|STARTED|Part 1, Period 2||0
9036297|NCT03307252|10097941|FG004|STARTED|Part 1, Period 2||0
9036298|NCT03307252|10097942|FG005|STARTED|Part 1, Period 2||0
9036299|NCT03307252|10097943|FG006|STARTED|Part 1, Period 2||0
9036300|NCT03307252|10097944|FG007|STARTED|Part 1, Period 2||0
9036301|NCT03307252|10097945|FG008|STARTED|Part 1, Period 2||0
9036302|NCT03307252|10097946|FG009|STARTED|Part 1, Period 2||0
9036303|NCT03307252|10097947|FG010|STARTED|Part 1, Period 2||0
9036304|NCT03307252|10097937|FG000|COMPLETED|Part 1, Period 2||4
9036305|NCT03307252|10097938|FG001|COMPLETED|Part 1, Period 2||4
9036306|NCT03307252|10097939|FG002|COMPLETED|Part 1, Period 2||4
9036307|NCT03307252|10097940|FG003|COMPLETED|Part 1, Period 2||0
9036308|NCT03307252|10097941|FG004|COMPLETED|Part 1, Period 2||0
9036309|NCT03307252|10097942|FG005|COMPLETED|Part 1, Period 2||0
9036310|NCT03307252|10097943|FG006|COMPLETED|Part 1, Period 2||0
9036311|NCT03307252|10097944|FG007|COMPLETED|Part 1, Period 2||0
9036312|NCT03307252|10097945|FG008|COMPLETED|Part 1, Period 2||0
9036313|NCT03307252|10097946|FG009|COMPLETED|Part 1, Period 2||0
9036314|NCT03307252|10097947|FG010|COMPLETED|Part 1, Period 2||0
9036315|NCT03307252|10097937|FG000|NOT COMPLETED|Part 1, Period 2||0
9036316|NCT03307252|10097938|FG001|NOT COMPLETED|Part 1, Period 2||0
9036317|NCT03307252|10097939|FG002|NOT COMPLETED|Part 1, Period 2||0
9036318|NCT03307252|10097940|FG003|NOT COMPLETED|Part 1, Period 2||0
9036319|NCT03307252|10097941|FG004|NOT COMPLETED|Part 1, Period 2||0
9036320|NCT03307252|10097942|FG005|NOT COMPLETED|Part 1, Period 2||0
9036321|NCT03307252|10097943|FG006|NOT COMPLETED|Part 1, Period 2||0
9036322|NCT03307252|10097944|FG007|NOT COMPLETED|Part 1, Period 2||0
9036323|NCT03307252|10097945|FG008|NOT COMPLETED|Part 1, Period 2||0
9036324|NCT03307252|10097946|FG009|NOT COMPLETED|Part 1, Period 2||0
9036325|NCT03307252|10097947|FG010|NOT COMPLETED|Part 1, Period 2||0
9036326|NCT03307252|10097937|FG000|STARTED|Part 1, Washout Period 2 (13 Days)||4
9036327|NCT03307252|10097938|FG001|STARTED|Part 1, Washout Period 2 (13 Days)||4
9036328|NCT03307252|10097939|FG002|STARTED|Part 1, Washout Period 2 (13 Days)||4
9036329|NCT03307252|10097940|FG003|STARTED|Part 1, Washout Period 2 (13 Days)||0
9036330|NCT03307252|10097941|FG004|STARTED|Part 1, Washout Period 2 (13 Days)||0
9036331|NCT03307252|10097942|FG005|STARTED|Part 1, Washout Period 2 (13 Days)||0
9036332|NCT03307252|10097943|FG006|STARTED|Part 1, Washout Period 2 (13 Days)||0
9036333|NCT03307252|10097944|FG007|STARTED|Part 1, Washout Period 2 (13 Days)||0
9036334|NCT03307252|10097945|FG008|STARTED|Part 1, Washout Period 2 (13 Days)||0
9036335|NCT03307252|10097946|FG009|STARTED|Part 1, Washout Period 2 (13 Days)||0
9036336|NCT03307252|10097947|FG010|STARTED|Part 1, Washout Period 2 (13 Days)||0
9036337|NCT03307252|10097937|FG000|COMPLETED|Part 1, Washout Period 2 (13 Days)||4
9036338|NCT03307252|10097938|FG001|COMPLETED|Part 1, Washout Period 2 (13 Days)||4
9036339|NCT03307252|10097939|FG002|COMPLETED|Part 1, Washout Period 2 (13 Days)||4
9036340|NCT03307252|10097940|FG003|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
9036341|NCT03307252|10097941|FG004|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
9036342|NCT03307252|10097942|FG005|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
9036343|NCT03307252|10097943|FG006|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
9036344|NCT03307252|10097944|FG007|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
9036345|NCT03307252|10097945|FG008|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
9036346|NCT03307252|10097946|FG009|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
9036347|NCT03307252|10097947|FG010|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
9036348|NCT03307252|10097937|FG000|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
9036349|NCT03307252|10097938|FG001|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
9036350|NCT03307252|10097939|FG002|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
9036351|NCT03307252|10097940|FG003|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
9036352|NCT03307252|10097941|FG004|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
9036353|NCT03307252|10097942|FG005|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
9036354|NCT03307252|10097943|FG006|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
9036355|NCT03307252|10097944|FG007|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
9036356|NCT03307252|10097945|FG008|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
9036357|NCT03307252|10097946|FG009|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
9036358|NCT03307252|10097947|FG010|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
9036359|NCT03307252|10097937|FG000|STARTED|Part 1, Period 3|Participants randomised in Part 1|4
9036360|NCT03307252|10097938|FG001|STARTED|Part 1, Period 3|Participants randomised in Part 1|4
9036361|NCT03307252|10097939|FG002|STARTED|Part 1, Period 3|Participants randomised in Part 1|4
9036362|NCT03307252|10097940|FG003|STARTED|Part 1, Period 3||0
9036363|NCT03307252|10097941|FG004|STARTED|Part 1, Period 3||0
9036364|NCT03307252|10097942|FG005|STARTED|Part 1, Period 3||0
9036365|NCT03307252|10097943|FG006|STARTED|Part 1, Period 3||0
9036366|NCT03307252|10097944|FG007|STARTED|Part 1, Period 3||0
9036367|NCT03307252|10097945|FG008|STARTED|Part 1, Period 3||0
9036368|NCT03307252|10097946|FG009|STARTED|Part 1, Period 3||0
9036369|NCT03307252|10097947|FG010|STARTED|Part 1, Period 3||0
9036370|NCT03307252|10097937|FG000|COMPLETED|Part 1, Period 3||4
9036371|NCT03307252|10097938|FG001|COMPLETED|Part 1, Period 3||4
9036372|NCT03307252|10097939|FG002|COMPLETED|Part 1, Period 3||4
9036373|NCT03307252|10097940|FG003|COMPLETED|Part 1, Period 3||0
9036374|NCT03307252|10097941|FG004|COMPLETED|Part 1, Period 3||0
9036375|NCT03307252|10097942|FG005|COMPLETED|Part 1, Period 3||0
9036376|NCT03307252|10097943|FG006|COMPLETED|Part 1, Period 3||0
9036377|NCT03307252|10097944|FG007|COMPLETED|Part 1, Period 3||0
9036378|NCT03307252|10097945|FG008|COMPLETED|Part 1, Period 3||0
9036379|NCT03307252|10097946|FG009|COMPLETED|Part 1, Period 3||0
9036380|NCT03307252|10097947|FG010|COMPLETED|Part 1, Period 3||0
9036381|NCT03307252|10097937|FG000|NOT COMPLETED|Part 1, Period 3||0
9036382|NCT03307252|10097938|FG001|NOT COMPLETED|Part 1, Period 3||0
9036383|NCT03307252|10097939|FG002|NOT COMPLETED|Part 1, Period 3||0
9036384|NCT03307252|10097940|FG003|NOT COMPLETED|Part 1, Period 3||0
9036385|NCT03307252|10097941|FG004|NOT COMPLETED|Part 1, Period 3||0
9036386|NCT03307252|10097942|FG005|NOT COMPLETED|Part 1, Period 3||0
9036387|NCT03307252|10097943|FG006|NOT COMPLETED|Part 1, Period 3||0
9036388|NCT03307252|10097944|FG007|NOT COMPLETED|Part 1, Period 3||0
9036389|NCT03307252|10097945|FG008|NOT COMPLETED|Part 1, Period 3||0
9036390|NCT03307252|10097946|FG009|NOT COMPLETED|Part 1, Period 3||0
9036391|NCT03307252|10097947|FG010|NOT COMPLETED|Part 1, Period 3||0
9036392|NCT03307252|10097937|FG000|STARTED|Part 2, Period 1||0
9036393|NCT03307252|10097938|FG001|STARTED|Part 2, Period 1||0
9036394|NCT03307252|10097939|FG002|STARTED|Part 2, Period 1||0
9036395|NCT03307252|10097940|FG003|STARTED|Part 2, Period 1|Participants randomized in Part 2|4
9036396|NCT03307252|10097941|FG004|STARTED|Part 2, Period 1|Participants randomized in Part 2|4
9036397|NCT03307252|10097942|FG005|STARTED|Part 2, Period 1|Participants randomized in Part 2|4
9036398|NCT03307252|10097943|FG006|STARTED|Part 2, Period 1|Participants randomized in Part 2|5
9036399|NCT03307252|10097944|FG007|STARTED|Part 2, Period 1||0
9036400|NCT03307252|10097945|FG008|STARTED|Part 2, Period 1||0
9036401|NCT03307252|10097946|FG009|STARTED|Part 2, Period 1||0
9036402|NCT03307252|10097947|FG010|STARTED|Part 2, Period 1||0
9036403|NCT03307252|10097937|FG000|COMPLETED|Part 2, Period 1||0
9036404|NCT03307252|10097938|FG001|COMPLETED|Part 2, Period 1||0
9036405|NCT03307252|10097939|FG002|COMPLETED|Part 2, Period 1||0
9036406|NCT03307252|10097940|FG003|COMPLETED|Part 2, Period 1||4
9036407|NCT03307252|10097941|FG004|COMPLETED|Part 2, Period 1||4
9036408|NCT03307252|10097942|FG005|COMPLETED|Part 2, Period 1||3
9036409|NCT03307252|10097943|FG006|COMPLETED|Part 2, Period 1||5
9036410|NCT03307252|10097944|FG007|COMPLETED|Part 2, Period 1||0
9036411|NCT03307252|10097945|FG008|COMPLETED|Part 2, Period 1||0
9036412|NCT03307252|10097946|FG009|COMPLETED|Part 2, Period 1||0
9036413|NCT03307252|10097947|FG010|COMPLETED|Part 2, Period 1||0
9036414|NCT03307252|10097937|FG000|NOT COMPLETED|Part 2, Period 1||0
9036415|NCT03307252|10097938|FG001|NOT COMPLETED|Part 2, Period 1||0
9036416|NCT03307252|10097939|FG002|NOT COMPLETED|Part 2, Period 1||0
9036417|NCT03307252|10097940|FG003|NOT COMPLETED|Part 2, Period 1||0
9036418|NCT03307252|10097941|FG004|NOT COMPLETED|Part 2, Period 1||0
9036419|NCT03307252|10097942|FG005|NOT COMPLETED|Part 2, Period 1||1
9036420|NCT03307252|10097943|FG006|NOT COMPLETED|Part 2, Period 1||0
9036421|NCT03307252|10097944|FG007|NOT COMPLETED|Part 2, Period 1||0
9036422|NCT03307252|10097945|FG008|NOT COMPLETED|Part 2, Period 1||0
9036423|NCT03307252|10097946|FG009|NOT COMPLETED|Part 2, Period 1||0
9036424|NCT03307252|10097947|FG010|NOT COMPLETED|Part 2, Period 1||0
9036425|NCT03307252|10097937|FG000|STARTED|Part 2, Washout Period 1 (7 Days)||0
9036426|NCT03307252|10097938|FG001|STARTED|Part 2, Washout Period 1 (7 Days)||0
9036427|NCT03307252|10097939|FG002|STARTED|Part 2, Washout Period 1 (7 Days)||0
9036428|NCT03307252|10097940|FG003|STARTED|Part 2, Washout Period 1 (7 Days)||4
9036429|NCT03307252|10097941|FG004|STARTED|Part 2, Washout Period 1 (7 Days)||4
9036430|NCT03307252|10097942|FG005|STARTED|Part 2, Washout Period 1 (7 Days)||3
9036431|NCT03307252|10097943|FG006|STARTED|Part 2, Washout Period 1 (7 Days)||5
9036432|NCT03307252|10097944|FG007|STARTED|Part 2, Washout Period 1 (7 Days)||0
9036433|NCT03307252|10097945|FG008|STARTED|Part 2, Washout Period 1 (7 Days)||0
9036434|NCT03307252|10097946|FG009|STARTED|Part 2, Washout Period 1 (7 Days)||0
9036435|NCT03307252|10097947|FG010|STARTED|Part 2, Washout Period 1 (7 Days)||0
9036436|NCT03307252|10097937|FG000|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
9036437|NCT03307252|10097938|FG001|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
9036438|NCT03307252|10097939|FG002|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
9036439|NCT03307252|10097940|FG003|COMPLETED|Part 2, Washout Period 1 (7 Days)||4
9036440|NCT03307252|10097941|FG004|COMPLETED|Part 2, Washout Period 1 (7 Days)||4
9036441|NCT03307252|10097942|FG005|COMPLETED|Part 2, Washout Period 1 (7 Days)||3
9036442|NCT03307252|10097943|FG006|COMPLETED|Part 2, Washout Period 1 (7 Days)||5
9036443|NCT03307252|10097944|FG007|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
9036444|NCT03307252|10097945|FG008|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
9036445|NCT03307252|10097946|FG009|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
9036446|NCT03307252|10097947|FG010|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
9036447|NCT03307252|10097937|FG000|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
9036448|NCT03307252|10097938|FG001|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
9036449|NCT03307252|10097939|FG002|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
9036450|NCT03307252|10097940|FG003|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
9036451|NCT03307252|10097941|FG004|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
9036452|NCT03307252|10097942|FG005|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
9036453|NCT03307252|10097943|FG006|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
9036454|NCT03307252|10097944|FG007|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
9036455|NCT03307252|10097945|FG008|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
9036456|NCT03307252|10097946|FG009|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
9036457|NCT03307252|10097947|FG010|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
9036458|NCT03307252|10097937|FG000|STARTED|Part 2, Period 2||0
9036459|NCT03307252|10097938|FG001|STARTED|Part 2, Period 2||0
9036460|NCT03307252|10097939|FG002|STARTED|Part 2, Period 2||0
9036461|NCT03307252|10097940|FG003|STARTED|Part 2, Period 2||4
9036462|NCT03307252|10097941|FG004|STARTED|Part 2, Period 2||4
9036463|NCT03307252|10097942|FG005|STARTED|Part 2, Period 2||3
9036464|NCT03307252|10097943|FG006|STARTED|Part 2, Period 2||5
9036465|NCT03307252|10097944|FG007|STARTED|Part 2, Period 2||0
9036466|NCT03307252|10097945|FG008|STARTED|Part 2, Period 2||0
9036467|NCT03307252|10097946|FG009|STARTED|Part 2, Period 2||0
9036468|NCT03307252|10097947|FG010|STARTED|Part 2, Period 2||0
9036469|NCT03307252|10097937|FG000|COMPLETED|Part 2, Period 2||0
9036470|NCT03307252|10097938|FG001|COMPLETED|Part 2, Period 2||0
9036471|NCT03307252|10097939|FG002|COMPLETED|Part 2, Period 2||0
9036472|NCT03307252|10097940|FG003|COMPLETED|Part 2, Period 2||4
9036473|NCT03307252|10097941|FG004|COMPLETED|Part 2, Period 2||4
9036474|NCT03307252|10097942|FG005|COMPLETED|Part 2, Period 2||3
9036475|NCT03307252|10097943|FG006|COMPLETED|Part 2, Period 2||5
9036476|NCT03307252|10097944|FG007|COMPLETED|Part 2, Period 2||0
9036477|NCT03307252|10097945|FG008|COMPLETED|Part 2, Period 2||0
9036478|NCT03307252|10097946|FG009|COMPLETED|Part 2, Period 2||0
9036479|NCT03307252|10097947|FG010|COMPLETED|Part 2, Period 2||0
9036480|NCT03307252|10097937|FG000|NOT COMPLETED|Part 2, Period 2||0
9036481|NCT03307252|10097938|FG001|NOT COMPLETED|Part 2, Period 2||0
9036482|NCT03307252|10097939|FG002|NOT COMPLETED|Part 2, Period 2||0
9036483|NCT03307252|10097940|FG003|NOT COMPLETED|Part 2, Period 2||0
9036484|NCT03307252|10097941|FG004|NOT COMPLETED|Part 2, Period 2||0
9036485|NCT03307252|10097942|FG005|NOT COMPLETED|Part 2, Period 2||0
9036486|NCT03307252|10097943|FG006|NOT COMPLETED|Part 2, Period 2||0
9036487|NCT03307252|10097944|FG007|NOT COMPLETED|Part 2, Period 2||0
9036488|NCT03307252|10097945|FG008|NOT COMPLETED|Part 2, Period 2||0
9036489|NCT03307252|10097946|FG009|NOT COMPLETED|Part 2, Period 2||0
9036490|NCT03307252|10097947|FG010|NOT COMPLETED|Part 2, Period 2||0
9036491|NCT03307252|10097937|FG000|STARTED|Part 2, Washout Period 2 (7 Days)||0
9036492|NCT03307252|10097938|FG001|STARTED|Part 2, Washout Period 2 (7 Days)||0
9036493|NCT03307252|10097939|FG002|STARTED|Part 2, Washout Period 2 (7 Days)||0
9036494|NCT03307252|10097940|FG003|STARTED|Part 2, Washout Period 2 (7 Days)||4
9036495|NCT03307252|10097941|FG004|STARTED|Part 2, Washout Period 2 (7 Days)||4
9036496|NCT03307252|10097942|FG005|STARTED|Part 2, Washout Period 2 (7 Days)||3
9036497|NCT03307252|10097943|FG006|STARTED|Part 2, Washout Period 2 (7 Days)||5
9036498|NCT03307252|10097944|FG007|STARTED|Part 2, Washout Period 2 (7 Days)||0
9036499|NCT03307252|10097945|FG008|STARTED|Part 2, Washout Period 2 (7 Days)||0
9036500|NCT03307252|10097946|FG009|STARTED|Part 2, Washout Period 2 (7 Days)||0
9036501|NCT03307252|10097947|FG010|STARTED|Part 2, Washout Period 2 (7 Days)||0
9036502|NCT03307252|10097937|FG000|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
9036503|NCT03307252|10097938|FG001|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
9036504|NCT03307252|10097939|FG002|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
9036505|NCT03307252|10097940|FG003|COMPLETED|Part 2, Washout Period 2 (7 Days)||4
9036506|NCT03307252|10097941|FG004|COMPLETED|Part 2, Washout Period 2 (7 Days)||4
9036507|NCT03307252|10097942|FG005|COMPLETED|Part 2, Washout Period 2 (7 Days)||3
9036508|NCT03307252|10097943|FG006|COMPLETED|Part 2, Washout Period 2 (7 Days)||5
9036509|NCT03307252|10097944|FG007|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
9036510|NCT03307252|10097945|FG008|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
9036511|NCT03307252|10097946|FG009|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
9036512|NCT03307252|10097947|FG010|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
9036513|NCT03307252|10097937|FG000|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
9036514|NCT03307252|10097938|FG001|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
9036515|NCT03307252|10097939|FG002|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
9036516|NCT03307252|10097940|FG003|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
9036517|NCT03307252|10097941|FG004|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
9036518|NCT03307252|10097942|FG005|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
9036519|NCT03307252|10097943|FG006|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
9036520|NCT03307252|10097944|FG007|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
9036521|NCT03307252|10097945|FG008|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
9036522|NCT03307252|10097946|FG009|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
9036523|NCT03307252|10097947|FG010|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
9036524|NCT03307252|10097937|FG000|STARTED|Part 2, Period 3||0
9036525|NCT03307252|10097938|FG001|STARTED|Part 2, Period 3||0
9036526|NCT03307252|10097939|FG002|STARTED|Part 2, Period 3||0
9036527|NCT03307252|10097940|FG003|STARTED|Part 2, Period 3||4
9036528|NCT03307252|10097941|FG004|STARTED|Part 2, Period 3||4
9036529|NCT03307252|10097942|FG005|STARTED|Part 2, Period 3||3
9036530|NCT03307252|10097943|FG006|STARTED|Part 2, Period 3||5
9036531|NCT03307252|10097944|FG007|STARTED|Part 2, Period 3||0
9036532|NCT03307252|10097945|FG008|STARTED|Part 2, Period 3||0
9036533|NCT03307252|10097946|FG009|STARTED|Part 2, Period 3||0
9036534|NCT03307252|10097947|FG010|STARTED|Part 2, Period 3||0
9036535|NCT03307252|10097937|FG000|COMPLETED|Part 2, Period 3||0
9036536|NCT03307252|10097938|FG001|COMPLETED|Part 2, Period 3||0
9036537|NCT03307252|10097939|FG002|COMPLETED|Part 2, Period 3||0
9036538|NCT03307252|10097940|FG003|COMPLETED|Part 2, Period 3||4
9036539|NCT03307252|10097941|FG004|COMPLETED|Part 2, Period 3||3
9036540|NCT03307252|10097942|FG005|COMPLETED|Part 2, Period 3||3
9036541|NCT03307252|10097943|FG006|COMPLETED|Part 2, Period 3||5
9036542|NCT03307252|10097944|FG007|COMPLETED|Part 2, Period 3||0
9036543|NCT03307252|10097945|FG008|COMPLETED|Part 2, Period 3||0
9036544|NCT03307252|10097946|FG009|COMPLETED|Part 2, Period 3||0
9036545|NCT03307252|10097947|FG010|COMPLETED|Part 2, Period 3||0
9036546|NCT03307252|10097937|FG000|NOT COMPLETED|Part 2, Period 3||0
9036547|NCT03307252|10097938|FG001|NOT COMPLETED|Part 2, Period 3||0
9036548|NCT03307252|10097939|FG002|NOT COMPLETED|Part 2, Period 3||0
9036549|NCT03307252|10097940|FG003|NOT COMPLETED|Part 2, Period 3||0
9036550|NCT03307252|10097941|FG004|NOT COMPLETED|Part 2, Period 3||1
9036551|NCT03307252|10097942|FG005|NOT COMPLETED|Part 2, Period 3||0
9036552|NCT03307252|10097943|FG006|NOT COMPLETED|Part 2, Period 3||0
9036553|NCT03307252|10097944|FG007|NOT COMPLETED|Part 2, Period 3||0
9036554|NCT03307252|10097945|FG008|NOT COMPLETED|Part 2, Period 3||0
9036555|NCT03307252|10097946|FG009|NOT COMPLETED|Part 2, Period 3||0
9036556|NCT03307252|10097947|FG010|NOT COMPLETED|Part 2, Period 3||0
9036557|NCT03307252|10097937|FG000|STARTED|Part 2, Washout Period 3 (7 Days)||0
9036558|NCT03307252|10097938|FG001|STARTED|Part 2, Washout Period 3 (7 Days)||0
9036559|NCT03307252|10097939|FG002|STARTED|Part 2, Washout Period 3 (7 Days)||0
9036560|NCT03307252|10097940|FG003|STARTED|Part 2, Washout Period 3 (7 Days)||4
9036561|NCT03307252|10097941|FG004|STARTED|Part 2, Washout Period 3 (7 Days)||3
9036562|NCT03307252|10097942|FG005|STARTED|Part 2, Washout Period 3 (7 Days)||3
9036563|NCT03307252|10097943|FG006|STARTED|Part 2, Washout Period 3 (7 Days)||5
9036564|NCT03307252|10097944|FG007|STARTED|Part 2, Washout Period 3 (7 Days)||0
9036565|NCT03307252|10097945|FG008|STARTED|Part 2, Washout Period 3 (7 Days)||0
9036566|NCT03307252|10097946|FG009|STARTED|Part 2, Washout Period 3 (7 Days)||0
9036567|NCT03307252|10097947|FG010|STARTED|Part 2, Washout Period 3 (7 Days)||0
9036568|NCT03307252|10097937|FG000|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
9036569|NCT03307252|10097938|FG001|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
9036570|NCT03307252|10097939|FG002|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
9036571|NCT03307252|10097940|FG003|COMPLETED|Part 2, Washout Period 3 (7 Days)||4
9036572|NCT03307252|10097941|FG004|COMPLETED|Part 2, Washout Period 3 (7 Days)||3
9036573|NCT03307252|10097942|FG005|COMPLETED|Part 2, Washout Period 3 (7 Days)||3
9036574|NCT03307252|10097943|FG006|COMPLETED|Part 2, Washout Period 3 (7 Days)||4
9036575|NCT03307252|10097944|FG007|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
9036576|NCT03307252|10097945|FG008|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
9036577|NCT03307252|10097946|FG009|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
9036578|NCT03307252|10097947|FG010|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
9036579|NCT03307252|10097937|FG000|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
9036580|NCT03307252|10097938|FG001|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
9036581|NCT03307252|10097939|FG002|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
9036582|NCT03307252|10097940|FG003|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
9036583|NCT03307252|10097941|FG004|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
9036584|NCT03307252|10097942|FG005|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
9036585|NCT03307252|10097943|FG006|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||1
8805951|NCT01474512|9858128|FG010|COMPLETED|Long-Term Extension Period||0
8805952|NCT01474512|9858129|FG011|COMPLETED|Long-Term Extension Period||0
8805953|NCT01474512|9858130|FG012|COMPLETED|Long-Term Extension Period||836
8805954|NCT01474512|9858131|FG013|COMPLETED|Long-Term Extension Period||855
8805955|NCT01474512|9858132|FG014|COMPLETED|Long-Term Extension Period||0
8805956|NCT01474512|9858133|FG015|COMPLETED|Long-Term Extension Period||0
8805957|NCT01474512|9858134|FG016|COMPLETED|Long-Term Extension Period||0
8805958|NCT01474512|9858135|FG017|COMPLETED|Long-Term Extension Period||0
8805959|NCT01474512|9858118|FG000|NOT COMPLETED|Long-Term Extension Period||0
8805960|NCT01474512|9858119|FG001|NOT COMPLETED|Long-Term Extension Period||0
8805961|NCT01474512|9858120|FG002|NOT COMPLETED|Long-Term Extension Period||0
8805962|NCT01474512|9858121|FG003|NOT COMPLETED|Long-Term Extension Period||0
8805963|NCT01474512|9858122|FG004|NOT COMPLETED|Long-Term Extension Period||0
8805964|NCT01474512|9858123|FG005|NOT COMPLETED|Long-Term Extension Period||0
8805965|NCT01474512|9858124|FG006|NOT COMPLETED|Long-Term Extension Period||0
8805966|NCT01474512|9858125|FG007|NOT COMPLETED|Long-Term Extension Period||0
8805967|NCT01474512|9858126|FG008|NOT COMPLETED|Long-Term Extension Period||0
8805968|NCT01474512|9858127|FG009|NOT COMPLETED|Long-Term Extension Period||0
8805969|NCT01474512|9858128|FG010|NOT COMPLETED|Long-Term Extension Period||0
8805970|NCT01474512|9858129|FG011|NOT COMPLETED|Long-Term Extension Period||26
8805971|NCT01474512|9858130|FG012|NOT COMPLETED|Long-Term Extension Period||218
8805972|NCT01474512|9858131|FG013|NOT COMPLETED|Long-Term Extension Period||220
8805973|NCT01474512|9858132|FG014|NOT COMPLETED|Long-Term Extension Period||0
8805974|NCT01474512|9858133|FG015|NOT COMPLETED|Long-Term Extension Period||0
8805975|NCT01474512|9858134|FG016|NOT COMPLETED|Long-Term Extension Period||0
9036586|NCT03307252|10097944|FG007|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
9036587|NCT03307252|10097945|FG008|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
9036588|NCT03307252|10097946|FG009|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
9036589|NCT03307252|10097947|FG010|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
9036590|NCT03307252|10097937|FG000|STARTED|Part 2, Period 4||0
9036591|NCT03307252|10097938|FG001|STARTED|Part 2, Period 4||0
9036592|NCT03307252|10097939|FG002|STARTED|Part 2, Period 4||0
9036593|NCT03307252|10097940|FG003|STARTED|Part 2, Period 4||4
9036594|NCT03307252|10097941|FG004|STARTED|Part 2, Period 4||3
9036595|NCT03307252|10097942|FG005|STARTED|Part 2, Period 4||3
9036596|NCT03307252|10097943|FG006|STARTED|Part 2, Period 4||5
9036597|NCT03307252|10097944|FG007|STARTED|Part 2, Period 4||0
9036598|NCT03307252|10097945|FG008|STARTED|Part 2, Period 4||0
9036599|NCT03307252|10097946|FG009|STARTED|Part 2, Period 4||0
9036600|NCT03307252|10097947|FG010|STARTED|Part 2, Period 4||0
9036601|NCT03307252|10097937|FG000|COMPLETED|Part 2, Period 4||0
9036602|NCT03307252|10097938|FG001|COMPLETED|Part 2, Period 4||0
9036603|NCT03307252|10097939|FG002|COMPLETED|Part 2, Period 4||0
9036604|NCT03307252|10097940|FG003|COMPLETED|Part 2, Period 4||4
9036605|NCT03307252|10097941|FG004|COMPLETED|Part 2, Period 4||3
9036606|NCT03307252|10097942|FG005|COMPLETED|Part 2, Period 4||3
9036607|NCT03307252|10097943|FG006|COMPLETED|Part 2, Period 4||4
9036608|NCT03307252|10097944|FG007|COMPLETED|Part 2, Period 4||0
9036609|NCT03307252|10097945|FG008|COMPLETED|Part 2, Period 4||0
9036610|NCT03307252|10097946|FG009|COMPLETED|Part 2, Period 4||0
9036611|NCT03307252|10097947|FG010|COMPLETED|Part 2, Period 4||0
9036612|NCT03307252|10097937|FG000|NOT COMPLETED|Part 2, Period 4||0
9036613|NCT03307252|10097938|FG001|NOT COMPLETED|Part 2, Period 4||0
9036614|NCT03307252|10097939|FG002|NOT COMPLETED|Part 2, Period 4||0
9036615|NCT03307252|10097940|FG003|NOT COMPLETED|Part 2, Period 4||0
9036616|NCT03307252|10097941|FG004|NOT COMPLETED|Part 2, Period 4||0
9036617|NCT03307252|10097942|FG005|NOT COMPLETED|Part 2, Period 4||0
9036618|NCT03307252|10097943|FG006|NOT COMPLETED|Part 2, Period 4||1
9036619|NCT03307252|10097944|FG007|NOT COMPLETED|Part 2, Period 4||0
9036620|NCT03307252|10097945|FG008|NOT COMPLETED|Part 2, Period 4||0
9036621|NCT03307252|10097946|FG009|NOT COMPLETED|Part 2, Period 4||0
9036622|NCT03307252|10097947|FG010|NOT COMPLETED|Part 2, Period 4||0
9036623|NCT03307252|10097937|FG000|STARTED|Part 3, Period 1||0
9036624|NCT03307252|10097938|FG001|STARTED|Part 3, Period 1||0
9036625|NCT03307252|10097939|FG002|STARTED|Part 3, Period 1||0
9036626|NCT03307252|10097940|FG003|STARTED|Part 3, Period 1||0
9036627|NCT03307252|10097941|FG004|STARTED|Part 3, Period 1||0
9036628|NCT03307252|10097942|FG005|STARTED|Part 3, Period 1||0
9036629|NCT03307252|10097943|FG006|STARTED|Part 3, Period 1||0
9036630|NCT03307252|10097944|FG007|STARTED|Part 3, Period 1||4
9036631|NCT03307252|10097945|FG008|STARTED|Part 3, Period 1||4
9036632|NCT03307252|10097946|FG009|STARTED|Part 3, Period 1||4
9036633|NCT03307252|10097947|FG010|STARTED|Part 3, Period 1||4
9036634|NCT03307252|10097937|FG000|COMPLETED|Part 3, Period 1||0
9036635|NCT03307252|10097938|FG001|COMPLETED|Part 3, Period 1||0
9036636|NCT03307252|10097939|FG002|COMPLETED|Part 3, Period 1||0
9036637|NCT03307252|10097940|FG003|COMPLETED|Part 3, Period 1||0
9036638|NCT03307252|10097941|FG004|COMPLETED|Part 3, Period 1||0
9036639|NCT03307252|10097942|FG005|COMPLETED|Part 3, Period 1||0
9036640|NCT03307252|10097943|FG006|COMPLETED|Part 3, Period 1||0
9036641|NCT03307252|10097944|FG007|COMPLETED|Part 3, Period 1|Participants randomized in Part 3|4
9036642|NCT03307252|10097945|FG008|COMPLETED|Part 3, Period 1|Participants randomized in Part 3|4
9036643|NCT03307252|10097946|FG009|COMPLETED|Part 3, Period 1|Participants randomized in Part 3|4
9036644|NCT03307252|10097947|FG010|COMPLETED|Part 3, Period 1|Participants randomized in Part 3|4
9036645|NCT03307252|10097937|FG000|NOT COMPLETED|Part 3, Period 1||0
9036646|NCT03307252|10097938|FG001|NOT COMPLETED|Part 3, Period 1||0
9036647|NCT03307252|10097939|FG002|NOT COMPLETED|Part 3, Period 1||0
9036648|NCT03307252|10097940|FG003|NOT COMPLETED|Part 3, Period 1||0
9036649|NCT03307252|10097941|FG004|NOT COMPLETED|Part 3, Period 1||0
9036650|NCT03307252|10097942|FG005|NOT COMPLETED|Part 3, Period 1||0
9036651|NCT03307252|10097943|FG006|NOT COMPLETED|Part 3, Period 1||0
9036652|NCT03307252|10097944|FG007|NOT COMPLETED|Part 3, Period 1||0
9036653|NCT03307252|10097945|FG008|NOT COMPLETED|Part 3, Period 1||0
9036654|NCT03307252|10097946|FG009|NOT COMPLETED|Part 3, Period 1||0
9036655|NCT03307252|10097947|FG010|NOT COMPLETED|Part 3, Period 1||0
9036656|NCT03307252|10097937|FG000|STARTED|Part 3, Washout Period 1 (7 Days)||0
9036657|NCT03307252|10097938|FG001|STARTED|Part 3, Washout Period 1 (7 Days)||0
9036658|NCT03307252|10097939|FG002|STARTED|Part 3, Washout Period 1 (7 Days)||0
9036659|NCT03307252|10097940|FG003|STARTED|Part 3, Washout Period 1 (7 Days)||0
9036660|NCT03307252|10097941|FG004|STARTED|Part 3, Washout Period 1 (7 Days)||0
9036661|NCT03307252|10097942|FG005|STARTED|Part 3, Washout Period 1 (7 Days)||0
9036662|NCT03307252|10097943|FG006|STARTED|Part 3, Washout Period 1 (7 Days)||0
9036663|NCT03307252|10097944|FG007|STARTED|Part 3, Washout Period 1 (7 Days)||4
9036664|NCT03307252|10097945|FG008|STARTED|Part 3, Washout Period 1 (7 Days)||4
9036665|NCT03307252|10097946|FG009|STARTED|Part 3, Washout Period 1 (7 Days)||4
9036666|NCT03307252|10097947|FG010|STARTED|Part 3, Washout Period 1 (7 Days)||4
9036667|NCT03307252|10097937|FG000|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
9036668|NCT03307252|10097938|FG001|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
9036669|NCT03307252|10097939|FG002|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
9036670|NCT03307252|10097940|FG003|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
9036671|NCT03307252|10097941|FG004|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
9036672|NCT03307252|10097942|FG005|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
9036673|NCT03307252|10097943|FG006|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
9036674|NCT03307252|10097944|FG007|COMPLETED|Part 3, Washout Period 1 (7 Days)||4
9036675|NCT03307252|10097945|FG008|COMPLETED|Part 3, Washout Period 1 (7 Days)||4
9036676|NCT03307252|10097946|FG009|COMPLETED|Part 3, Washout Period 1 (7 Days)||4
9036677|NCT03307252|10097947|FG010|COMPLETED|Part 3, Washout Period 1 (7 Days)||4
9036678|NCT03307252|10097937|FG000|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
9036679|NCT03307252|10097938|FG001|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
9036680|NCT03307252|10097939|FG002|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
9036681|NCT03307252|10097940|FG003|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
9036682|NCT03307252|10097941|FG004|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
9036683|NCT03307252|10097942|FG005|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
9036684|NCT03307252|10097943|FG006|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
9036685|NCT03307252|10097944|FG007|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
9036686|NCT03307252|10097945|FG008|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
9036687|NCT03307252|10097946|FG009|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
9036688|NCT03307252|10097947|FG010|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
9036689|NCT03307252|10097937|FG000|STARTED|Part 3, Period 2||0
9036690|NCT03307252|10097938|FG001|STARTED|Part 3, Period 2||0
9036691|NCT03307252|10097939|FG002|STARTED|Part 3, Period 2||0
9036692|NCT03307252|10097940|FG003|STARTED|Part 3, Period 2||0
9036693|NCT03307252|10097941|FG004|STARTED|Part 3, Period 2||0
9036694|NCT03307252|10097942|FG005|STARTED|Part 3, Period 2||0
9036695|NCT03307252|10097943|FG006|STARTED|Part 3, Period 2||0
9036696|NCT03307252|10097944|FG007|STARTED|Part 3, Period 2||4
9036697|NCT03307252|10097945|FG008|STARTED|Part 3, Period 2||4
9036698|NCT03307252|10097946|FG009|STARTED|Part 3, Period 2||4
9036699|NCT03307252|10097947|FG010|STARTED|Part 3, Period 2||4
9036700|NCT03307252|10097937|FG000|COMPLETED|Part 3, Period 2||0
9036701|NCT03307252|10097938|FG001|COMPLETED|Part 3, Period 2||0
9036702|NCT03307252|10097939|FG002|COMPLETED|Part 3, Period 2||0
9036703|NCT03307252|10097940|FG003|COMPLETED|Part 3, Period 2||0
9036704|NCT03307252|10097941|FG004|COMPLETED|Part 3, Period 2||0
9036705|NCT03307252|10097942|FG005|COMPLETED|Part 3, Period 2||0
9036706|NCT03307252|10097943|FG006|COMPLETED|Part 3, Period 2||0
9036707|NCT03307252|10097944|FG007|COMPLETED|Part 3, Period 2||4
9036708|NCT03307252|10097945|FG008|COMPLETED|Part 3, Period 2||4
9036709|NCT03307252|10097946|FG009|COMPLETED|Part 3, Period 2||4
9036710|NCT03307252|10097947|FG010|COMPLETED|Part 3, Period 2||4
9036711|NCT03307252|10097937|FG000|NOT COMPLETED|Part 3, Period 2||0
9036712|NCT03307252|10097938|FG001|NOT COMPLETED|Part 3, Period 2||0
9036713|NCT03307252|10097939|FG002|NOT COMPLETED|Part 3, Period 2||0
9036714|NCT03307252|10097940|FG003|NOT COMPLETED|Part 3, Period 2||0
9036715|NCT03307252|10097941|FG004|NOT COMPLETED|Part 3, Period 2||0
9036716|NCT03307252|10097942|FG005|NOT COMPLETED|Part 3, Period 2||0
9036717|NCT03307252|10097943|FG006|NOT COMPLETED|Part 3, Period 2||0
9036718|NCT03307252|10097944|FG007|NOT COMPLETED|Part 3, Period 2||0
9036719|NCT03307252|10097945|FG008|NOT COMPLETED|Part 3, Period 2||0
9036720|NCT03307252|10097946|FG009|NOT COMPLETED|Part 3, Period 2||0
9036721|NCT03307252|10097947|FG010|NOT COMPLETED|Part 3, Period 2||0
9036722|NCT03307252|10097937|FG000|STARTED|Part 3, Washout Period 2 (7 Days)||0
9036723|NCT03307252|10097938|FG001|STARTED|Part 3, Washout Period 2 (7 Days)||0
9036724|NCT03307252|10097939|FG002|STARTED|Part 3, Washout Period 2 (7 Days)||0
9036725|NCT03307252|10097940|FG003|STARTED|Part 3, Washout Period 2 (7 Days)||0
9036726|NCT03307252|10097941|FG004|STARTED|Part 3, Washout Period 2 (7 Days)||0
9036727|NCT03307252|10097942|FG005|STARTED|Part 3, Washout Period 2 (7 Days)||0
9036728|NCT03307252|10097943|FG006|STARTED|Part 3, Washout Period 2 (7 Days)||0
9036729|NCT03307252|10097944|FG007|STARTED|Part 3, Washout Period 2 (7 Days)||4
9036730|NCT03307252|10097945|FG008|STARTED|Part 3, Washout Period 2 (7 Days)||4
9036731|NCT03307252|10097946|FG009|STARTED|Part 3, Washout Period 2 (7 Days)||4
9036732|NCT03307252|10097947|FG010|STARTED|Part 3, Washout Period 2 (7 Days)||4
9036733|NCT03307252|10097937|FG000|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
9036734|NCT03307252|10097938|FG001|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
9036735|NCT03307252|10097939|FG002|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
9036736|NCT03307252|10097940|FG003|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
9036737|NCT03307252|10097941|FG004|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
9036738|NCT03307252|10097942|FG005|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
9036739|NCT03307252|10097943|FG006|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
9036740|NCT03307252|10097944|FG007|COMPLETED|Part 3, Washout Period 2 (7 Days)||4
9036741|NCT03307252|10097945|FG008|COMPLETED|Part 3, Washout Period 2 (7 Days)||4
9036742|NCT03307252|10097946|FG009|COMPLETED|Part 3, Washout Period 2 (7 Days)||4
9036743|NCT03307252|10097947|FG010|COMPLETED|Part 3, Washout Period 2 (7 Days)||4
9036744|NCT03307252|10097937|FG000|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
9036745|NCT03307252|10097938|FG001|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
9036746|NCT03307252|10097939|FG002|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
9036747|NCT03307252|10097940|FG003|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
9036748|NCT03307252|10097941|FG004|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
9036749|NCT03307252|10097942|FG005|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
9036750|NCT03307252|10097943|FG006|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
9036751|NCT03307252|10097944|FG007|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
9036752|NCT03307252|10097945|FG008|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
9036753|NCT03307252|10097946|FG009|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
9036754|NCT03307252|10097947|FG010|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
8690979|NCT00852995|9736160|FG003|COMPLETED|Overall Study||40
8690980|NCT00852995|9736161|FG004|COMPLETED|Overall Study||46
8690981|NCT00852995|9736157|FG000|NOT COMPLETED|Overall Study||8
8690982|NCT00852995|9736158|FG001|NOT COMPLETED|Overall Study||1
8690983|NCT00852995|9736159|FG002|NOT COMPLETED|Overall Study||5
8690984|NCT00852995|9736160|FG003|NOT COMPLETED|Overall Study||5
8690985|NCT00852995|9736161|FG004|NOT COMPLETED|Overall Study||4
8690986|NCT00853021|9736178|FG000|STARTED|Overall Study||26
8690987|NCT00853021|9736178|FG000|COMPLETED|Overall Study||21
8690988|NCT00853021|9736178|FG000|NOT COMPLETED|Overall Study||5
8690989|NCT00853047|9736187|FG000|STARTED|Core Phase||5
8690990|NCT00853047|9736188|FG001|STARTED|Core Phase||3
8690991|NCT00853047|9736189|FG002|STARTED|Core Phase||3
8690992|NCT00853047|9736190|FG003|STARTED|Core Phase||3
8690993|NCT00853047|9736191|FG004|STARTED|Core Phase||9
8690994|NCT00853047|9736192|FG005|STARTED|Core Phase||0
8690995|NCT00853047|9736187|FG000|COMPLETED|Core Phase||5
8690996|NCT00853047|9736188|FG001|COMPLETED|Core Phase||3
8690997|NCT00853047|9736189|FG002|COMPLETED|Core Phase||3
8690998|NCT00853047|9736190|FG003|COMPLETED|Core Phase||2
8690999|NCT00853047|9736191|FG004|COMPLETED|Core Phase||9
8691000|NCT00853047|9736192|FG005|COMPLETED|Core Phase||0
8691001|NCT00853047|9736187|FG000|NOT COMPLETED|Core Phase||0
8691002|NCT00853047|9736188|FG001|NOT COMPLETED|Core Phase||0
8691003|NCT00853047|9736189|FG002|NOT COMPLETED|Core Phase||0
8691004|NCT00853047|9736190|FG003|NOT COMPLETED|Core Phase||1
8691005|NCT00853047|9736191|FG004|NOT COMPLETED|Core Phase||0
8691006|NCT00853047|9736192|FG005|NOT COMPLETED|Core Phase||0
8691007|NCT00853047|9736187|FG000|STARTED|Open-Label Extension Phase||0
8691008|NCT00853047|9736188|FG001|STARTED|Open-Label Extension Phase||0
8691009|NCT00853047|9736189|FG002|STARTED|Open-Label Extension Phase||0
8691010|NCT00853047|9736190|FG003|STARTED|Open-Label Extension Phase||0
8691011|NCT00853047|9736191|FG004|STARTED|Open-Label Extension Phase||0
8691012|NCT00853047|9736192|FG005|STARTED|Open-Label Extension Phase|19 of the 22 participants who completed the Core Phase entered the optional Open-Label Extension.|19
8691013|NCT00853047|9736187|FG000|Completed 8-week Extension Period|Open-Label Extension Phase||0
8691014|NCT00853047|9736188|FG001|Completed 8-week Extension Period|Open-Label Extension Phase||0
8691015|NCT00853047|9736189|FG002|Completed 8-week Extension Period|Open-Label Extension Phase||0
8691016|NCT00853047|9736190|FG003|Completed 8-week Extension Period|Open-Label Extension Phase||0
8691017|NCT00853047|9736191|FG004|Completed 8-week Extension Period|Open-Label Extension Phase||0
8693493|NCT00866879|9739000|FG001|COMPLETED|Overall Study||185
8693494|NCT00866879|9738999|FG000|NOT COMPLETED|Overall Study||0
8693495|NCT00866879|9739000|FG001|NOT COMPLETED|Overall Study||0
8693496|NCT00866905|9739006|FG000|STARTED|Overall Study||168
8693497|NCT00866905|9739006|FG000|COMPLETED|Overall Study||135
8693498|NCT00866905|9739006|FG000|NOT COMPLETED|Overall Study||33
8693499|NCT00867009|9739012|FG000|STARTED|Induction Period|Participants with Stage IIIB/IV non-squamous (NS) non-small cell lung cancer (NSCLC)|113
8693500|NCT00867009|9739012|FG000|Received at Least 1 Dose of Study Drug|Induction Period||113
8693501|NCT00867009|9739012|FG000|Protocol Qualified (PQ) Population|Induction Period|Stage IIIB/IV NS-NSCLC, no concurrent chemotherapy, measurable disease, ≥1 dose study drug.|109
8693502|NCT00867009|9739012|FG000|COMPLETED|Induction Period|Participants continued on the study in the Maintenance Period.|51
8693503|NCT00867009|9739012|FG000|NOT COMPLETED|Induction Period||62
8693504|NCT00867009|9739012|FG000|STARTED|Maintenance Period||51
8693505|NCT00867009|9739012|FG000|COMPLETED|Maintenance Period|Participant was considered completed if they had PD, death, or stopped receiving study drug.|47
8693506|NCT00867009|9739012|FG000|NOT COMPLETED|Maintenance Period||4
8693507|NCT00867035|9739018|FG000|STARTED|Baseline to 1 Hour||13
8693508|NCT00867035|9739019|FG001|STARTED|Baseline to 1 Hour||9
8693509|NCT00867035|9739018|FG000|COMPLETED|Baseline to 1 Hour||12
8693510|NCT00867035|9739019|FG001|COMPLETED|Baseline to 1 Hour||8
8693511|NCT00867035|9739018|FG000|NOT COMPLETED|Baseline to 1 Hour||1
8693512|NCT00867035|9739019|FG001|NOT COMPLETED|Baseline to 1 Hour||1
8693513|NCT00867035|9739018|FG000|STARTED|Baseline to 2 Hours||12
8693514|NCT00867035|9739019|FG001|STARTED|Baseline to 2 Hours||8
8693515|NCT00867035|9739018|FG000|COMPLETED|Baseline to 2 Hours||12
8693516|NCT00867035|9739019|FG001|COMPLETED|Baseline to 2 Hours||8
8693517|NCT00867035|9739018|FG000|NOT COMPLETED|Baseline to 2 Hours||0
8693518|NCT00867035|9739019|FG001|NOT COMPLETED|Baseline to 2 Hours||0
8693519|NCT00867035|9739018|FG000|STARTED|Baseline to 4 Hours||12
8693520|NCT00867035|9739019|FG001|STARTED|Baseline to 4 Hours||8
8693521|NCT00867035|9739018|FG000|COMPLETED|Baseline to 4 Hours||12
8693522|NCT00867035|9739019|FG001|COMPLETED|Baseline to 4 Hours||8
8693523|NCT00867035|9739018|FG000|NOT COMPLETED|Baseline to 4 Hours||0
8693524|NCT00867035|9739019|FG001|NOT COMPLETED|Baseline to 4 Hours||0
8693525|NCT00867035|9739018|FG000|STARTED|Baseline to 1 Week||12
8693526|NCT00867035|9739019|FG001|STARTED|Baseline to 1 Week||8
8693527|NCT00867035|9739018|FG000|COMPLETED|Baseline to 1 Week||11
8693528|NCT00867035|9739019|FG001|COMPLETED|Baseline to 1 Week||8
8693529|NCT00867035|9739018|FG000|NOT COMPLETED|Baseline to 1 Week||1
8693530|NCT00867035|9739019|FG001|NOT COMPLETED|Baseline to 1 Week||0
8693531|NCT00867087|9739025|FG000|STARTED|Overall Study||63
8693532|NCT00867087|9739025|FG000|COMPLETED|Overall Study||21
8693533|NCT00867087|9739025|FG000|NOT COMPLETED|Overall Study||42
8693534|NCT00867100|9739042|FG000|STARTED|Overall Study||5
8693535|NCT00867100|9739043|FG001|STARTED|Overall Study||5
8693536|NCT00867100|9739044|FG002|STARTED|Overall Study||8
8693537|NCT00867100|9739045|FG003|STARTED|Overall Study||8
8693538|NCT00867100|9739046|FG004|STARTED|Overall Study||14
8693539|NCT00867100|9739047|FG005|STARTED|Overall Study||6
8693540|NCT00867100|9739048|FG006|STARTED|Overall Study||7
8691018|NCT00853047|9736192|FG005|Completed 8-week Extension Period|Open-Label Extension Phase||16
8691019|NCT00853047|9736187|FG000|COMPLETED|Open-Label Extension Phase||0
8691020|NCT00853047|9736188|FG001|COMPLETED|Open-Label Extension Phase||0
8691021|NCT00853047|9736189|FG002|COMPLETED|Open-Label Extension Phase||0
8691022|NCT00853047|9736190|FG003|COMPLETED|Open-Label Extension Phase||0
8691023|NCT00853047|9736191|FG004|COMPLETED|Open-Label Extension Phase||0
8691024|NCT00853047|9736192|FG005|COMPLETED|Open-Label Extension Phase||2
8691025|NCT00853047|9736187|FG000|NOT COMPLETED|Open-Label Extension Phase||0
8691026|NCT00853047|9736188|FG001|NOT COMPLETED|Open-Label Extension Phase||0
8691027|NCT00853047|9736189|FG002|NOT COMPLETED|Open-Label Extension Phase||0
8691028|NCT00853047|9736190|FG003|NOT COMPLETED|Open-Label Extension Phase||0
8691029|NCT00853047|9736191|FG004|NOT COMPLETED|Open-Label Extension Phase||0
8691030|NCT00853047|9736192|FG005|NOT COMPLETED|Open-Label Extension Phase||17
8691031|NCT00853073|9736209|FG000|STARTED|Overall Study||32
8691032|NCT00853073|9736210|FG001|STARTED|Overall Study||31
8691033|NCT00853073|9736209|FG000|COMPLETED|Overall Study||29
8691034|NCT00853073|9736210|FG001|COMPLETED|Overall Study||29
8691035|NCT00853073|9736209|FG000|NOT COMPLETED|Overall Study||3
8691036|NCT00853073|9736210|FG001|NOT COMPLETED|Overall Study||2
8691037|NCT00853099|9736219|FG000|STARTED|Double-blind Period||96
8691038|NCT00853099|9736220|FG001|STARTED|Double-blind Period||87
8691039|NCT00853099|9736221|FG002|STARTED|Double-blind Period||91
8691040|NCT00853099|9736222|FG003|STARTED|Double-blind Period||0
8691041|NCT00853099|9736219|FG000|Treated|Double-blind Period||96
8691042|NCT00853099|9736220|FG001|Treated|Double-blind Period||87
8691043|NCT00853099|9736221|FG002|Treated|Double-blind Period|1 participant, incorrectly treated with open-label (rescue) study drug at Week 0, was excluded.|90
8691044|NCT00853099|9736222|FG003|Treated|Double-blind Period||0
8691045|NCT00853099|9736219|FG000|Completed Week 8|Double-blind Period||92
8691046|NCT00853099|9736220|FG001|Completed Week 8|Double-blind Period||85
8691047|NCT00853099|9736221|FG002|Completed Week 8|Double-blind Period||86
8691048|NCT00853099|9736222|FG003|Completed Week 8|Double-blind Period||0
8691049|NCT00853099|9736219|FG000|COMPLETED|Double-blind Period|Participants who completed Week 52.|73
8691050|NCT00853099|9736220|FG001|COMPLETED|Double-blind Period|Participants who completed Week 52.|58
8691051|NCT00853099|9736221|FG002|COMPLETED|Double-blind Period|Participants who completed Week 52.|60
8691052|NCT00853099|9736222|FG003|COMPLETED|Double-blind Period||0
8691053|NCT00853099|9736219|FG000|NOT COMPLETED|Double-blind Period||23
8691054|NCT00853099|9736220|FG001|NOT COMPLETED|Double-blind Period||29
8691055|NCT00853099|9736221|FG002|NOT COMPLETED|Double-blind Period||31
8691056|NCT00853099|9736222|FG003|NOT COMPLETED|Double-blind Period||0
8691057|NCT00853099|9736219|FG000|STARTED|Double-blind + Open-label Periods||0
8691058|NCT00853099|9736220|FG001|STARTED|Double-blind + Open-label Periods||0
8691059|NCT00853099|9736221|FG002|STARTED|Double-blind + Open-label Periods||0
8691060|NCT00853099|9736222|FG003|STARTED|Double-blind + Open-label Periods|7 participants randomized to placebo did not receive any adalimumab; 1 participant was excluded.|266
8691061|NCT00853099|9736219|FG000|COMPLETED|Double-blind + Open-label Periods||0
8691062|NCT00853099|9736220|FG001|COMPLETED|Double-blind + Open-label Periods||0
8691063|NCT00853099|9736221|FG002|COMPLETED|Double-blind + Open-label Periods||0
8691064|NCT00853099|9736222|FG003|COMPLETED|Double-blind + Open-label Periods||119
8691065|NCT00853099|9736219|FG000|NOT COMPLETED|Double-blind + Open-label Periods||0
8691066|NCT00853099|9736220|FG001|NOT COMPLETED|Double-blind + Open-label Periods||0
8691067|NCT00853099|9736221|FG002|NOT COMPLETED|Double-blind + Open-label Periods||0
8691068|NCT00853099|9736222|FG003|NOT COMPLETED|Double-blind + Open-label Periods||147
8691069|NCT00853112|9736239|FG000|STARTED|Overall Study||6
8691070|NCT00853112|9736240|FG001|STARTED|Overall Study||7
8691071|NCT00853112|9736241|FG002|STARTED|Overall Study||7
8691072|NCT00853112|9736242|FG003|STARTED|Overall Study||8
8691073|NCT00853112|9736243|FG004|STARTED|Overall Study||6
8691074|NCT00853112|9736244|FG005|STARTED|Overall Study||7
8691075|NCT00853112|9736245|FG006|STARTED|Overall Study||7
8691076|NCT00853112|9736239|FG000|Treated|Overall Study||6
8691077|NCT00853112|9736240|FG001|Treated|Overall Study||6
8691078|NCT00853112|9736241|FG002|Treated|Overall Study||7
8691079|NCT00853112|9736242|FG003|Treated|Overall Study||6
8805976|NCT01474512|9858135|FG017|NOT COMPLETED|Long-Term Extension Period||0
8691080|NCT00853112|9736243|FG004|Treated|Overall Study||6
8691081|NCT00853112|9736244|FG005|Treated|Overall Study||7
8691082|NCT00853112|9736245|FG006|Treated|Overall Study||6
8691083|NCT00853112|9736239|FG000|COMPLETED|Overall Study||6
8691084|NCT00853112|9736240|FG001|COMPLETED|Overall Study||6
8691085|NCT00853112|9736241|FG002|COMPLETED|Overall Study||7
8691086|NCT00853112|9736242|FG003|COMPLETED|Overall Study||6
8691087|NCT00853112|9736243|FG004|COMPLETED|Overall Study||6
8691088|NCT00853112|9736244|FG005|COMPLETED|Overall Study||7
8691089|NCT00853112|9736245|FG006|COMPLETED|Overall Study||6
8691090|NCT00853112|9736239|FG000|NOT COMPLETED|Overall Study||0
8691091|NCT00853112|9736240|FG001|NOT COMPLETED|Overall Study||1
8691092|NCT00853112|9736241|FG002|NOT COMPLETED|Overall Study||0
8691093|NCT00853112|9736242|FG003|NOT COMPLETED|Overall Study||2
8691094|NCT00853112|9736243|FG004|NOT COMPLETED|Overall Study||0
8691095|NCT00853112|9736244|FG005|NOT COMPLETED|Overall Study||0
8691096|NCT00853112|9736245|FG006|NOT COMPLETED|Overall Study||1
8691097|NCT00853125|9736261|FG000|STARTED|Overall Study||10
8691098|NCT00853125|9736261|FG000|COMPLETED|Overall Study||9
8691099|NCT00853125|9736261|FG000|NOT COMPLETED|Overall Study||1
8691100|NCT00853151|9736270|FG000|STARTED|Overall Study||38
8691101|NCT00853151|9736271|FG001|STARTED|Overall Study||37
8691102|NCT00853151|9736272|FG002|STARTED|Overall Study||38
8691103|NCT00853151|9736273|FG003|STARTED|Overall Study||18
8691104|NCT00853151|9736270|FG000|COMPLETED|Overall Study||28
8691105|NCT00853151|9736271|FG001|COMPLETED|Overall Study||24
8691106|NCT00853151|9736272|FG002|COMPLETED|Overall Study||30
8691107|NCT00853151|9736273|FG003|COMPLETED|Overall Study||15
8691108|NCT00853151|9736270|FG000|NOT COMPLETED|Overall Study||10
8691109|NCT00853151|9736271|FG001|NOT COMPLETED|Overall Study||13
8691110|NCT00853151|9736272|FG002|NOT COMPLETED|Overall Study||8
8691111|NCT00853151|9736273|FG003|NOT COMPLETED|Overall Study||3
8691112|NCT00853242|9736293|FG000|STARTED|Overall Study||50
8691113|NCT00853242|9736294|FG001|STARTED|Overall Study||50
8691114|NCT00853242|9736295|FG002|STARTED|Overall Study||49
8691115|NCT00853242|9736296|FG003|STARTED|Overall Study||50
8691116|NCT00853242|9736297|FG004|STARTED|Overall Study||50
8691117|NCT00853242|9736298|FG005|STARTED|Overall Study||51
8691118|NCT00853242|9736299|FG006|STARTED|Overall Study||49
8691119|NCT00853242|9736293|FG000|Treated|Overall Study||50
8691120|NCT00853242|9736294|FG001|Treated|Overall Study||49
8691121|NCT00853242|9736295|FG002|Treated|Overall Study||48
8691122|NCT00853242|9736296|FG003|Treated|Overall Study||50
8691123|NCT00853242|9736297|FG004|Treated|Overall Study||50
8691124|NCT00853242|9736298|FG005|Treated|Overall Study||51
8691125|NCT00853242|9736299|FG006|Treated|Overall Study||48
8691126|NCT00853242|9736293|FG000|COMPLETED|Overall Study||47
8691127|NCT00853242|9736294|FG001|COMPLETED|Overall Study||47
8691128|NCT00853242|9736295|FG002|COMPLETED|Overall Study||46
8691129|NCT00853242|9736296|FG003|COMPLETED|Overall Study||46
8691130|NCT00853242|9736297|FG004|COMPLETED|Overall Study||46
8691131|NCT00853242|9736298|FG005|COMPLETED|Overall Study||49
8691132|NCT00853242|9736299|FG006|COMPLETED|Overall Study||44
8691133|NCT00853242|9736293|FG000|NOT COMPLETED|Overall Study||3
8691134|NCT00853242|9736294|FG001|NOT COMPLETED|Overall Study||3
8691135|NCT00853242|9736295|FG002|NOT COMPLETED|Overall Study||3
8691136|NCT00853242|9736296|FG003|NOT COMPLETED|Overall Study||4
8691137|NCT00853242|9736297|FG004|NOT COMPLETED|Overall Study||4
8691138|NCT00853242|9736298|FG005|NOT COMPLETED|Overall Study||2
8691139|NCT00853242|9736299|FG006|NOT COMPLETED|Overall Study||5
8691140|NCT00853333|9736324|FG000|STARTED|Overall Study||28
8691141|NCT00853333|9736325|FG001|STARTED|Overall Study||27
8691142|NCT00853333|9736326|FG002|STARTED|Overall Study||31
8691143|NCT00853333|9736324|FG000|COMPLETED|Overall Study||28
8691144|NCT00853333|9736325|FG001|COMPLETED|Overall Study||27
8691145|NCT00853333|9736326|FG002|COMPLETED|Overall Study||31
8691146|NCT00853333|9736324|FG000|NOT COMPLETED|Overall Study||0
8691147|NCT00853333|9736325|FG001|NOT COMPLETED|Overall Study||0
8691148|NCT00853333|9736326|FG002|NOT COMPLETED|Overall Study||0
8691149|NCT00853372|9736336|FG000|STARTED|Overall Study||43
8691150|NCT00853372|9736337|FG001|STARTED|Overall Study||42
8691151|NCT00853372|9736336|FG000|COMPLETED|Overall Study||11
8691152|NCT00853372|9736337|FG001|COMPLETED|Overall Study||13
8691153|NCT00853372|9736336|FG000|NOT COMPLETED|Overall Study||32
8691154|NCT00853372|9736337|FG001|NOT COMPLETED|Overall Study||29
8691155|NCT00853385|9736348|FG000|STARTED|Overall Study||204
8691156|NCT00853385|9736349|FG001|STARTED|Overall Study||201
8691157|NCT00853385|9736350|FG002|STARTED|Overall Study||56
8691158|NCT00853385|9736351|FG003|STARTED|Overall Study||52
8691159|NCT00853385|9736352|FG004|STARTED|Overall Study||204
8691160|NCT00853385|9736348|FG000|COMPLETED|Overall Study||150
8691161|NCT00853385|9736349|FG001|COMPLETED|Overall Study||158
8691162|NCT00853385|9736350|FG002|COMPLETED|Overall Study||47
8691163|NCT00853385|9736351|FG003|COMPLETED|Overall Study||39
8691164|NCT00853385|9736352|FG004|COMPLETED|Overall Study||162
8691165|NCT00853385|9736348|FG000|NOT COMPLETED|Overall Study||54
8691166|NCT00853385|9736349|FG001|NOT COMPLETED|Overall Study||43
8691167|NCT00853385|9736350|FG002|NOT COMPLETED|Overall Study||9
8691168|NCT00853385|9736351|FG003|NOT COMPLETED|Overall Study||13
8691169|NCT00853385|9736352|FG004|NOT COMPLETED|Overall Study||42
8691170|NCT00853489|9736376|FG000|STARTED|Overall Study||16
8691171|NCT00853489|9736377|FG001|STARTED|Overall Study||14
8691172|NCT00853489|9736376|FG000|COMPLETED|Overall Study||11
8691173|NCT00853489|9736377|FG001|COMPLETED|Overall Study||12
8691174|NCT00853489|9736376|FG000|NOT COMPLETED|Overall Study||5
8691175|NCT00853489|9736377|FG001|NOT COMPLETED|Overall Study||2
8691176|NCT00853580|9736385|FG000|STARTED|Overall Study||74
8691177|NCT00853580|9736386|FG001|STARTED|Overall Study||72
8691178|NCT00853580|9736385|FG000|COMPLETED|Overall Study||67
8691179|NCT00853580|9736386|FG001|COMPLETED|Overall Study||56
8691180|NCT00853580|9736385|FG000|NOT COMPLETED|Overall Study||7
8691181|NCT00853580|9736386|FG001|NOT COMPLETED|Overall Study||16
8691182|NCT00853593|9736392|FG000|STARTED|Overall Study||197
8691183|NCT00853593|9736392|FG000|Implant Attempted|Overall Study||193
8691184|NCT00853593|9736392|FG000|Model 4396 Lead Attempted|Overall Study||164
8691185|NCT00853593|9736392|FG000|COMPLETED|Overall Study||152
8691186|NCT00853593|9736392|FG000|NOT COMPLETED|Overall Study||45
8691187|NCT00853606|9736413|FG000|STARTED|Overall Study||712
8691188|NCT00853606|9736413|FG000|COMPLETED|Overall Study||492
8691189|NCT00853606|9736413|FG000|NOT COMPLETED|Overall Study||220
8691190|NCT00853645|9736417|FG000|STARTED|Overall Study||6
8691191|NCT00853645|9736417|FG000|COMPLETED|Overall Study||6
8691192|NCT00853645|9736417|FG000|NOT COMPLETED|Overall Study||0
8691193|NCT00853658|9736424|FG000|STARTED|Overall Study||2354
8691194|NCT00853658|9736425|FG001|STARTED|Overall Study||2356
8921648|NCT02226198|9982076|FG000|COMPLETED|Maintenance Phase (12 Weeks)||13
8921649|NCT02226198|9982077|FG001|COMPLETED|Maintenance Phase (12 Weeks)||0
8921650|NCT02226198|9982078|FG002|COMPLETED|Maintenance Phase (12 Weeks)||0
8921651|NCT02226198|9982076|FG000|NOT COMPLETED|Maintenance Phase (12 Weeks)||0
8921652|NCT02226198|9982077|FG001|NOT COMPLETED|Maintenance Phase (12 Weeks)||0
8921653|NCT02226198|9982078|FG002|NOT COMPLETED|Maintenance Phase (12 Weeks)||0
8921654|NCT02226549|9982106|FG000|STARTED|Overall Study||23
8921655|NCT02226549|9982107|FG001|STARTED|Overall Study||24
8921656|NCT02226549|9982106|FG000|COMPLETED|Overall Study||22
8921657|NCT02226549|9982107|FG001|COMPLETED|Overall Study||23
8921658|NCT02226549|9982106|FG000|NOT COMPLETED|Overall Study||1
8921659|NCT02226549|9982107|FG001|NOT COMPLETED|Overall Study||1
8921660|NCT02226562|9982115|FG000|STARTED|Overall Study||95
8921661|NCT02226562|9982116|FG001|STARTED|Overall Study||96
8921662|NCT02226562|9982115|FG000|COMPLETED|Overall Study||95
8921663|NCT02226562|9982116|FG001|COMPLETED|Overall Study|Lost to follow up|95
8921664|NCT02226562|9982115|FG000|NOT COMPLETED|Overall Study||0
8921665|NCT02226562|9982116|FG001|NOT COMPLETED|Overall Study||1
8921666|NCT02226653|9982124|FG000|STARTED|Treatment Period 1 Fasted State||24
8921667|NCT02226653|9982125|FG001|STARTED|Treatment Period 1 Fasted State||24
8921668|NCT02226653|9982124|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1 Fasted State||24
8921669|NCT02226653|9982125|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1 Fasted State||24
8921670|NCT02226653|9982124|FG000|COMPLETED|Treatment Period 1 Fasted State||24
8921671|NCT02226653|9982125|FG001|COMPLETED|Treatment Period 1 Fasted State||24
8921672|NCT02226653|9982124|FG000|NOT COMPLETED|Treatment Period 1 Fasted State||0
8921673|NCT02226653|9982125|FG001|NOT COMPLETED|Treatment Period 1 Fasted State||0
8921674|NCT02226653|9982124|FG000|STARTED|Washout Period 1 (at Least 21 Days)||24
8921675|NCT02226653|9982125|FG001|STARTED|Washout Period 1 (at Least 21 Days)||24
8921676|NCT02226653|9982124|FG000|COMPLETED|Washout Period 1 (at Least 21 Days)||24
8921677|NCT02226653|9982125|FG001|COMPLETED|Washout Period 1 (at Least 21 Days)||24
8921678|NCT02226653|9982124|FG000|NOT COMPLETED|Washout Period 1 (at Least 21 Days)||0
8921679|NCT02226653|9982125|FG001|NOT COMPLETED|Washout Period 1 (at Least 21 Days)||0
8921680|NCT02226653|9982124|FG000|STARTED|Treatment Period 2 Fasted State||24
8921681|NCT02226653|9982125|FG001|STARTED|Treatment Period 2 Fasted State||24
8921682|NCT02226653|9982124|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 2 Fasted State||24
8921683|NCT02226653|9982125|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 2 Fasted State||24
8921684|NCT02226653|9982124|FG000|COMPLETED|Treatment Period 2 Fasted State||23
8921685|NCT02226653|9982125|FG001|COMPLETED|Treatment Period 2 Fasted State||24
8921686|NCT02226653|9982124|FG000|NOT COMPLETED|Treatment Period 2 Fasted State||1
8921687|NCT02226653|9982125|FG001|NOT COMPLETED|Treatment Period 2 Fasted State||0
8921688|NCT02226653|9982124|FG000|STARTED|Washout Period 2 (at Least 21 Days)||23
8921689|NCT02226653|9982125|FG001|STARTED|Washout Period 2 (at Least 21 Days)||24
8921690|NCT02226653|9982124|FG000|COMPLETED|Washout Period 2 (at Least 21 Days)||23
8921691|NCT02226653|9982125|FG001|COMPLETED|Washout Period 2 (at Least 21 Days)||24
8921692|NCT02226653|9982124|FG000|NOT COMPLETED|Washout Period 2 (at Least 21 Days)||0
8921693|NCT02226653|9982125|FG001|NOT COMPLETED|Washout Period 2 (at Least 21 Days)||0
8921694|NCT02226653|9982124|FG000|STARTED|Treatment Period 3 Fasted State||23
8921695|NCT02226653|9982125|FG001|STARTED|Treatment Period 3 Fasted State||24
8921696|NCT02226653|9982124|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 3 Fasted State||23
8921697|NCT02226653|9982125|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 3 Fasted State||24
8921698|NCT02226653|9982124|FG000|COMPLETED|Treatment Period 3 Fasted State||23
8921699|NCT02226653|9982125|FG001|COMPLETED|Treatment Period 3 Fasted State||24
8921700|NCT02226653|9982124|FG000|NOT COMPLETED|Treatment Period 3 Fasted State||0
8921701|NCT02226653|9982125|FG001|NOT COMPLETED|Treatment Period 3 Fasted State||0
8921702|NCT02226653|9982124|FG000|STARTED|Washout Period 3 (at Least 21 Days)||23
8921703|NCT02226653|9982125|FG001|STARTED|Washout Period 3 (at Least 21 Days)||24
8921704|NCT02226653|9982124|FG000|COMPLETED|Washout Period 3 (at Least 21 Days)||23
8921705|NCT02226653|9982125|FG001|COMPLETED|Washout Period 3 (at Least 21 Days)||24
8921706|NCT02226653|9982124|FG000|NOT COMPLETED|Washout Period 3 (at Least 21 Days)||0
8921707|NCT02226653|9982125|FG001|NOT COMPLETED|Washout Period 3 (at Least 21 Days)||0
8921708|NCT02226653|9982124|FG000|STARTED|Treatment Period 4 Fasted State||23
8921709|NCT02226653|9982125|FG001|STARTED|Treatment Period 4 Fasted State||24
8921710|NCT02226653|9982124|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 4 Fasted State||23
8921711|NCT02226653|9982125|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 4 Fasted State||24
8921712|NCT02226653|9982124|FG000|COMPLETED|Treatment Period 4 Fasted State||23
8921713|NCT02226653|9982125|FG001|COMPLETED|Treatment Period 4 Fasted State||24
8921714|NCT02226653|9982124|FG000|NOT COMPLETED|Treatment Period 4 Fasted State||0
8921715|NCT02226653|9982125|FG001|NOT COMPLETED|Treatment Period 4 Fasted State||0
8921716|NCT02226653|9982124|FG000|STARTED|Washout Period 4 (at Least 21 Days)||23
8921717|NCT02226653|9982125|FG001|STARTED|Washout Period 4 (at Least 21 Days)||24
8921718|NCT02226653|9982124|FG000|COMPLETED|Washout Period 4 (at Least 21 Days)||23
8921719|NCT02226653|9982125|FG001|COMPLETED|Washout Period 4 (at Least 21 Days)||24
8921720|NCT02226653|9982124|FG000|NOT COMPLETED|Washout Period 4 (at Least 21 Days)||0
8921721|NCT02226653|9982125|FG001|NOT COMPLETED|Washout Period 4 (at Least 21 Days)||0
8921722|NCT02226653|9982124|FG000|STARTED|Treatment Period 5 Fed State||23
8921723|NCT02226653|9982125|FG001|STARTED|Treatment Period 5 Fed State||24
9036755|NCT03307252|10097937|FG000|STARTED|Part 3, Period 3||0
8921724|NCT02226653|9982124|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 5 Fed State||23
8921725|NCT02226653|9982125|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 5 Fed State||24
8921726|NCT02226653|9982124|FG000|COMPLETED|Treatment Period 5 Fed State||23
8921727|NCT02226653|9982125|FG001|COMPLETED|Treatment Period 5 Fed State||23
8921728|NCT02226653|9982124|FG000|NOT COMPLETED|Treatment Period 5 Fed State||0
8921729|NCT02226653|9982125|FG001|NOT COMPLETED|Treatment Period 5 Fed State||1
8921730|NCT02226653|9982124|FG000|STARTED|Washout Period 5 (at Least 21 Days)||23
8921731|NCT02226653|9982125|FG001|STARTED|Washout Period 5 (at Least 21 Days)||23
8921732|NCT02226653|9982124|FG000|COMPLETED|Washout Period 5 (at Least 21 Days)||23
8921733|NCT02226653|9982125|FG001|COMPLETED|Washout Period 5 (at Least 21 Days)||23
8921734|NCT02226653|9982124|FG000|NOT COMPLETED|Washout Period 5 (at Least 21 Days)||0
8921735|NCT02226653|9982125|FG001|NOT COMPLETED|Washout Period 5 (at Least 21 Days)||0
8921736|NCT02226796|9982138|FG000|STARTED|First Intervention Phase (Week 1)||2
8921737|NCT02226796|9982139|FG001|STARTED|First Intervention Phase (Week 1)||1
8921738|NCT02226796|9982138|FG000|Baseline Assessment|First Intervention Phase (Week 1)||2
8921739|NCT02226796|9982139|FG001|Baseline Assessment|First Intervention Phase (Week 1)||1
8921740|NCT02226796|9982138|FG000|Follow Up Assessment|First Intervention Phase (Week 1)||2
8921741|NCT02226796|9982139|FG001|Follow Up Assessment|First Intervention Phase (Week 1)||1
8921742|NCT02226796|9982138|FG000|COMPLETED|First Intervention Phase (Week 1)||2
8921743|NCT02226796|9982139|FG001|COMPLETED|First Intervention Phase (Week 1)||1
8921744|NCT02226796|9982138|FG000|NOT COMPLETED|First Intervention Phase (Week 1)||0
8921745|NCT02226796|9982139|FG001|NOT COMPLETED|First Intervention Phase (Week 1)||0
8921746|NCT02226796|9982138|FG000|STARTED|Washout (Weeks 2-5)||2
8921747|NCT02226796|9982139|FG001|STARTED|Washout (Weeks 2-5)||1
8921748|NCT02226796|9982138|FG000|COMPLETED|Washout (Weeks 2-5)||2
8921749|NCT02226796|9982139|FG001|COMPLETED|Washout (Weeks 2-5)||1
8921750|NCT02226796|9982138|FG000|NOT COMPLETED|Washout (Weeks 2-5)||0
8921751|NCT02226796|9982139|FG001|NOT COMPLETED|Washout (Weeks 2-5)||0
8921752|NCT02226796|9982138|FG000|STARTED|Second Intervention Phase (Week 6)||2
8921753|NCT02226796|9982139|FG001|STARTED|Second Intervention Phase (Week 6)||1
8921754|NCT02226796|9982138|FG000|Baseline Assessment|Second Intervention Phase (Week 6)||2
8921755|NCT02226796|9982139|FG001|Baseline Assessment|Second Intervention Phase (Week 6)||1
8921756|NCT02226796|9982138|FG000|Follow Up Assessment|Second Intervention Phase (Week 6)||2
8921757|NCT02226796|9982139|FG001|Follow Up Assessment|Second Intervention Phase (Week 6)||1
8921758|NCT02226796|9982138|FG000|COMPLETED|Second Intervention Phase (Week 6)||2
8921759|NCT02226796|9982139|FG001|COMPLETED|Second Intervention Phase (Week 6)||1
8921760|NCT02226796|9982138|FG000|NOT COMPLETED|Second Intervention Phase (Week 6)||0
8921761|NCT02226796|9982139|FG001|NOT COMPLETED|Second Intervention Phase (Week 6)||0
8921762|NCT02226965|9982145|FG000|STARTED|Overall Study||45
8921763|NCT02226965|9982145|FG000|COMPLETED|Overall Study||4
8921764|NCT02226965|9982145|FG000|NOT COMPLETED|Overall Study||41
8921765|NCT02227108|9982149|FG000|STARTED|Overall Study||32
8921766|NCT02227108|9982149|FG000|Treated|Overall Study||30
8921767|NCT02227108|9982149|FG000|COMPLETED|Overall Study||1
8921768|NCT02227108|9982149|FG000|NOT COMPLETED|Overall Study||31
8921769|NCT02227121|9982153|FG000|STARTED|Overall Study||16
8921770|NCT02227121|9982153|FG000|COMPLETED|Overall Study||16
8921771|NCT02227121|9982153|FG000|NOT COMPLETED|Overall Study||0
8921772|NCT02227316|9982161|FG000|STARTED|Overall Study||4
8921773|NCT02227316|9982162|FG001|STARTED|Overall Study||4
8921774|NCT02227316|9982163|FG002|STARTED|Overall Study||16
8921775|NCT02227316|9982164|FG003|STARTED|Overall Study||16
8921776|NCT02227316|9982161|FG000|COMPLETED|Overall Study||4
8921777|NCT02227316|9982162|FG001|COMPLETED|Overall Study||4
8921778|NCT02227316|9982163|FG002|COMPLETED|Overall Study||16
8921779|NCT02227316|9982164|FG003|COMPLETED|Overall Study||16
8921780|NCT02227316|9982161|FG000|NOT COMPLETED|Overall Study||0
8921781|NCT02227316|9982162|FG001|NOT COMPLETED|Overall Study||0
8921782|NCT02227316|9982163|FG002|NOT COMPLETED|Overall Study||0
8921783|NCT02227316|9982164|FG003|NOT COMPLETED|Overall Study||0
8921784|NCT02227329|9982176|FG000|STARTED|Overall Study||18
8921785|NCT02227329|9982177|FG001|STARTED|Overall Study||20
8921786|NCT02227329|9982176|FG000|COMPLETED|Overall Study||18
8921787|NCT02227329|9982177|FG001|COMPLETED|Overall Study||20
8921788|NCT02227329|9982176|FG000|NOT COMPLETED|Overall Study||0
8921789|NCT02227329|9982177|FG001|NOT COMPLETED|Overall Study||0
8921790|NCT02227368|9982185|FG000|STARTED|Overall Study||16
8921791|NCT02227368|9982186|FG001|STARTED|Overall Study||24
8921792|NCT02227368|9982185|FG000|Sujects Who Received Treatment|Overall Study||16
8921793|NCT02227368|9982186|FG001|Sujects Who Received Treatment|Overall Study||24
8921794|NCT02227368|9982185|FG000|Sujects Who Completed Treatment|Overall Study||10
8921795|NCT02227368|9982186|FG001|Sujects Who Completed Treatment|Overall Study||17
8921796|NCT02227368|9982185|FG000|COMPLETED|Overall Study|Subjects who discontinued treatment were encouraged to remain in the study.|14
8921797|NCT02227368|9982186|FG001|COMPLETED|Overall Study|Subjects who discontinued treatment were encouraged to remain in the study.|20
8921798|NCT02227368|9982185|FG000|NOT COMPLETED|Overall Study||2
8921799|NCT02227368|9982186|FG001|NOT COMPLETED|Overall Study||4
8921800|NCT02227446|9982194|FG000|STARTED|Overall Study||521
8921801|NCT02227446|9982195|FG001|STARTED|Overall Study||515
8921802|NCT02227446|9982194|FG000|COMPLETED|Overall Study||499
8921803|NCT02227446|9982195|FG001|COMPLETED|Overall Study||481
8921804|NCT02227446|9982194|FG000|NOT COMPLETED|Overall Study||22
8921805|NCT02227446|9982195|FG001|NOT COMPLETED|Overall Study||34
8921806|NCT02227485|9982203|FG000|STARTED|First Follow-up||40
8921807|NCT02227485|9982204|FG001|STARTED|First Follow-up||40
8921808|NCT02227485|9982203|FG000|COMPLETED|First Follow-up|At the first follow-up we lost 4 patients.|36
8921809|NCT02227485|9982204|FG001|COMPLETED|First Follow-up|After 2 weeks, 2 patients had withdrew the study.|38
8921810|NCT02227485|9982203|FG000|NOT COMPLETED|First Follow-up||4
8921811|NCT02227485|9982204|FG001|NOT COMPLETED|First Follow-up||2
8921812|NCT02227485|9982203|FG000|STARTED|Second Follow-up||36
8921813|NCT02227485|9982204|FG001|STARTED|Second Follow-up||38
8921814|NCT02227485|9982203|FG000|COMPLETED|Second Follow-up|At the second follow-up we lost 2 patients.|34
8921815|NCT02227485|9982204|FG001|COMPLETED|Second Follow-up|At the second follow-up we lost 2 patients.|36
8921816|NCT02227485|9982203|FG000|NOT COMPLETED|Second Follow-up||2
8921817|NCT02227485|9982204|FG001|NOT COMPLETED|Second Follow-up||2
8921818|NCT02227667|9982211|FG000|STARTED|Overall Study||16
8921819|NCT02227667|9982211|FG000|COMPLETED|Overall Study||16
8921820|NCT02227667|9982211|FG000|NOT COMPLETED|Overall Study||0
8921821|NCT02227693|9982219|FG000|STARTED|Overall Study||11
8921822|NCT02227693|9982220|FG001|STARTED|Overall Study||7
8921823|NCT02227693|9982221|FG002|STARTED|Overall Study||11
8921824|NCT02227693|9982222|FG003|STARTED|Overall Study||10
8921825|NCT02227693|9982219|FG000|COMPLETED|Overall Study||11
8921826|NCT02227693|9982220|FG001|COMPLETED|Overall Study||7
8921827|NCT02227693|9982221|FG002|COMPLETED|Overall Study||11
8921828|NCT02227693|9982222|FG003|COMPLETED|Overall Study||10
8921829|NCT02227693|9982219|FG000|NOT COMPLETED|Overall Study||0
8921830|NCT02227693|9982220|FG001|NOT COMPLETED|Overall Study||0
8921831|NCT02227693|9982221|FG002|NOT COMPLETED|Overall Study||0
8921832|NCT02227693|9982222|FG003|NOT COMPLETED|Overall Study||0
8921833|NCT02227706|9982238|FG000|STARTED|Overall Study||20
8921834|NCT02227706|9982239|FG001|STARTED|Overall Study||20
8921835|NCT02227706|9982238|FG000|COMPLETED|Overall Study||20
8921836|NCT02227706|9982239|FG001|COMPLETED|Overall Study||20
8921837|NCT02227706|9982238|FG000|NOT COMPLETED|Overall Study||0
8921838|NCT02227706|9982239|FG001|NOT COMPLETED|Overall Study||0
8921839|NCT02227758|9982245|FG000|STARTED|Overall Study||112
8921840|NCT02227758|9982245|FG000|COMPLETED|Overall Study||45
8921841|NCT02227758|9982245|FG000|NOT COMPLETED|Overall Study||67
8921842|NCT02227784|9982255|FG000|STARTED|Double-Blind Phase||123
8921843|NCT02227784|9982256|FG001|STARTED|Double-Blind Phase||54
8921844|NCT02227784|9982257|FG002|STARTED|Double-Blind Phase||62
8921845|NCT02227784|9982258|FG003|STARTED|Double-Blind Phase||127
8921846|NCT02227784|9982259|FG004|STARTED|Double-Blind Phase||0
8921847|NCT02227784|9982255|FG000|COMPLETED|Double-Blind Phase||83
8921848|NCT02227784|9982256|FG001|COMPLETED|Double-Blind Phase||36
8921849|NCT02227784|9982257|FG002|COMPLETED|Double-Blind Phase||41
8921850|NCT02227784|9982258|FG003|COMPLETED|Double-Blind Phase||88
8921851|NCT02227784|9982259|FG004|COMPLETED|Double-Blind Phase||0
8921852|NCT02227784|9982255|FG000|NOT COMPLETED|Double-Blind Phase||40
8921853|NCT02227784|9982256|FG001|NOT COMPLETED|Double-Blind Phase||18
8921854|NCT02227784|9982257|FG002|NOT COMPLETED|Double-Blind Phase||21
8921855|NCT02227784|9982258|FG003|NOT COMPLETED|Double-Blind Phase||39
8921856|NCT02227784|9982259|FG004|NOT COMPLETED|Double-Blind Phase||0
9036756|NCT03307252|10097938|FG001|STARTED|Part 3, Period 3||0
9036757|NCT03307252|10097939|FG002|STARTED|Part 3, Period 3||0
9036758|NCT03307252|10097940|FG003|STARTED|Part 3, Period 3||0
9036759|NCT03307252|10097941|FG004|STARTED|Part 3, Period 3||0
9036760|NCT03307252|10097942|FG005|STARTED|Part 3, Period 3||0
9036761|NCT03307252|10097943|FG006|STARTED|Part 3, Period 3||0
9036762|NCT03307252|10097944|FG007|STARTED|Part 3, Period 3||4
9036763|NCT03307252|10097945|FG008|STARTED|Part 3, Period 3||4
9036764|NCT03307252|10097946|FG009|STARTED|Part 3, Period 3||4
9036765|NCT03307252|10097947|FG010|STARTED|Part 3, Period 3||4
9036766|NCT03307252|10097937|FG000|COMPLETED|Part 3, Period 3||0
9036767|NCT03307252|10097938|FG001|COMPLETED|Part 3, Period 3||0
9036768|NCT03307252|10097939|FG002|COMPLETED|Part 3, Period 3||0
9036769|NCT03307252|10097940|FG003|COMPLETED|Part 3, Period 3||0
9036770|NCT03307252|10097941|FG004|COMPLETED|Part 3, Period 3||0
9036771|NCT03307252|10097942|FG005|COMPLETED|Part 3, Period 3||0
9036772|NCT03307252|10097943|FG006|COMPLETED|Part 3, Period 3||0
9036773|NCT03307252|10097944|FG007|COMPLETED|Part 3, Period 3||4
9036774|NCT03307252|10097945|FG008|COMPLETED|Part 3, Period 3||4
9036775|NCT03307252|10097946|FG009|COMPLETED|Part 3, Period 3||4
9036776|NCT03307252|10097947|FG010|COMPLETED|Part 3, Period 3||4
9036777|NCT03307252|10097937|FG000|NOT COMPLETED|Part 3, Period 3||0
9036778|NCT03307252|10097938|FG001|NOT COMPLETED|Part 3, Period 3||0
9036779|NCT03307252|10097939|FG002|NOT COMPLETED|Part 3, Period 3||0
9036780|NCT03307252|10097940|FG003|NOT COMPLETED|Part 3, Period 3||0
9036781|NCT03307252|10097941|FG004|NOT COMPLETED|Part 3, Period 3||0
9036782|NCT03307252|10097942|FG005|NOT COMPLETED|Part 3, Period 3||0
9036783|NCT03307252|10097943|FG006|NOT COMPLETED|Part 3, Period 3||0
9036784|NCT03307252|10097944|FG007|NOT COMPLETED|Part 3, Period 3||0
9036785|NCT03307252|10097945|FG008|NOT COMPLETED|Part 3, Period 3||0
9036786|NCT03307252|10097946|FG009|NOT COMPLETED|Part 3, Period 3||0
9036787|NCT03307252|10097947|FG010|NOT COMPLETED|Part 3, Period 3||0
9036788|NCT03307252|10097937|FG000|STARTED|Part 3, Washout Period 3 (7 Days)||0
9036789|NCT03307252|10097938|FG001|STARTED|Part 3, Washout Period 3 (7 Days)||0
9036790|NCT03307252|10097939|FG002|STARTED|Part 3, Washout Period 3 (7 Days)||0
8921857|NCT02227784|9982255|FG000|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|0
8921858|NCT02227784|9982256|FG001|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|0
8921859|NCT02227784|9982257|FG002|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|0
8921860|NCT02227784|9982258|FG003|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|0
8921861|NCT02227784|9982259|FG004|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|248
8921862|NCT02227784|9982255|FG000|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0
8921863|NCT02227784|9982256|FG001|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0
8921864|NCT02227784|9982257|FG002|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0
8921865|NCT02227784|9982258|FG003|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0
8921866|NCT02227784|9982259|FG004|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||247
8921867|NCT02227784|9982255|FG000|COMPLETED|Open-Label Extension Phase (OLE)||0
8921868|NCT02227784|9982256|FG001|COMPLETED|Open-Label Extension Phase (OLE)||0
8921869|NCT02227784|9982257|FG002|COMPLETED|Open-Label Extension Phase (OLE)||0
8921870|NCT02227784|9982258|FG003|COMPLETED|Open-Label Extension Phase (OLE)||0
8921871|NCT02227784|9982259|FG004|COMPLETED|Open-Label Extension Phase (OLE)||0
8921872|NCT02227784|9982255|FG000|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
8921873|NCT02227784|9982256|FG001|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
8921874|NCT02227784|9982257|FG002|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
8921875|NCT02227784|9982258|FG003|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
8921876|NCT02227784|9982259|FG004|NOT COMPLETED|Open-Label Extension Phase (OLE)||248
8921877|NCT02227810|9982274|FG000|STARTED|Overall Study||19
8921878|NCT02227810|9982275|FG001|STARTED|Overall Study||34
8921879|NCT02227810|9982274|FG000|COMPLETED|Overall Study||17
8921880|NCT02227810|9982275|FG001|COMPLETED|Overall Study||29
8921881|NCT02227810|9982274|FG000|NOT COMPLETED|Overall Study||2
8921882|NCT02227810|9982275|FG001|NOT COMPLETED|Overall Study||5
8921883|NCT02227836|9982283|FG000|STARTED|Overall Study||8
8921884|NCT02227836|9982283|FG000|COMPLETED|Overall Study||8
8921885|NCT02227836|9982283|FG000|NOT COMPLETED|Overall Study||0
8921886|NCT02227849|9982287|FG000|STARTED|Overall Study||71
8921887|NCT02227849|9982287|FG000|COMPLETED|Overall Study||63
8921888|NCT02227849|9982287|FG000|NOT COMPLETED|Overall Study||8
8921889|NCT02228096|9982293|FG000|STARTED|Overall Study||75
8921890|NCT02228096|9982293|FG000|Enrolled Into Long-term f/u Protocol|Overall Study||31
8921891|NCT02228096|9982293|FG000|Enrolled But Not Infused|Overall Study||11
8921892|NCT02228096|9982293|FG000|Enrolled and Infused|Overall Study||64
8921893|NCT02228096|9982293|FG000|COMPLETED|Overall Study|Completed = study follow-up completed|4
8921894|NCT02228096|9982293|FG000|NOT COMPLETED|Overall Study||71
8921895|NCT02228174|9982311|FG000|STARTED|Overall Study||147
8921896|NCT02228174|9982311|FG000|Full Analysis Population|Overall Study|Subjects who didn't become pregnant or diagnosed with an interfering medical condition at 12-months|143
8921897|NCT02228174|9982311|FG000|COMPLETED|Overall Study||142
8921898|NCT02228174|9982311|FG000|NOT COMPLETED|Overall Study||5
8921899|NCT02228395|9982315|FG000|STARTED|First Intervention Period||3
8921900|NCT02228395|9982316|FG001|STARTED|First Intervention Period||3
8921901|NCT02228395|9982317|FG002|STARTED|First Intervention Period||3
8921902|NCT02228395|9982315|FG000|COMPLETED|First Intervention Period||2
8921903|NCT02228395|9982316|FG001|COMPLETED|First Intervention Period||2
8921904|NCT02228395|9982317|FG002|COMPLETED|First Intervention Period||2
8921905|NCT02228395|9982315|FG000|NOT COMPLETED|First Intervention Period||1
8921906|NCT02228395|9982316|FG001|NOT COMPLETED|First Intervention Period||1
8921907|NCT02228395|9982317|FG002|NOT COMPLETED|First Intervention Period||1
8921908|NCT02228395|9982315|FG000|STARTED|Washout Period (at Least 10 Days)|One participant discontinued in the First Intervention Period and was replaced.|3
8921909|NCT02228395|9982316|FG001|STARTED|Washout Period (at Least 10 Days)|One participant discontinued in the First Intervention Period and was replaced.|3
8921910|NCT02228395|9982317|FG002|STARTED|Washout Period (at Least 10 Days)|One participant discontinued in the First Intervention Period and was replaced.|3
8921911|NCT02228395|9982315|FG000|COMPLETED|Washout Period (at Least 10 Days)||3
8921912|NCT02228395|9982316|FG001|COMPLETED|Washout Period (at Least 10 Days)||3
8921913|NCT02228395|9982317|FG002|COMPLETED|Washout Period (at Least 10 Days)||3
8921914|NCT02228395|9982315|FG000|NOT COMPLETED|Washout Period (at Least 10 Days)||0
8921915|NCT02228395|9982316|FG001|NOT COMPLETED|Washout Period (at Least 10 Days)||0
8921916|NCT02228395|9982317|FG002|NOT COMPLETED|Washout Period (at Least 10 Days)||0
8921917|NCT02228395|9982315|FG000|STARTED|Second Intervention Period||3
8921918|NCT02228395|9982316|FG001|STARTED|Second Intervention Period||3
8921919|NCT02228395|9982317|FG002|STARTED|Second Intervention Period||3
8921920|NCT02228395|9982315|FG000|COMPLETED|Second Intervention Period||3
8921921|NCT02228395|9982316|FG001|COMPLETED|Second Intervention Period||3
8921922|NCT02228395|9982317|FG002|COMPLETED|Second Intervention Period||3
8921923|NCT02228395|9982315|FG000|NOT COMPLETED|Second Intervention Period||0
8921924|NCT02228395|9982316|FG001|NOT COMPLETED|Second Intervention Period||0
8921925|NCT02228395|9982317|FG002|NOT COMPLETED|Second Intervention Period||0
8921926|NCT02228395|9982315|FG000|STARTED|Washout Period (at Least 10 Days)||3
8921927|NCT02228395|9982316|FG001|STARTED|Washout Period (at Least 10 Days)||3
8921928|NCT02228395|9982317|FG002|STARTED|Washout Period (at Least 10 Days)||3
8921929|NCT02228395|9982315|FG000|COMPLETED|Washout Period (at Least 10 Days)||3
8921930|NCT02228395|9982316|FG001|COMPLETED|Washout Period (at Least 10 Days)||3
8921931|NCT02228395|9982317|FG002|COMPLETED|Washout Period (at Least 10 Days)||3
8921932|NCT02228395|9982315|FG000|NOT COMPLETED|Washout Period (at Least 10 Days)||0
8921933|NCT02228395|9982316|FG001|NOT COMPLETED|Washout Period (at Least 10 Days)||0
8921934|NCT02228395|9982317|FG002|NOT COMPLETED|Washout Period (at Least 10 Days)||0
8921935|NCT02228395|9982315|FG000|STARTED|Third Intervention Period||3
8921936|NCT02228395|9982316|FG001|STARTED|Third Intervention Period||3
8921937|NCT02228395|9982317|FG002|STARTED|Third Intervention Period||3
8921938|NCT02228395|9982315|FG000|COMPLETED|Third Intervention Period||3
8921939|NCT02228395|9982316|FG001|COMPLETED|Third Intervention Period||3
8921940|NCT02228395|9982317|FG002|COMPLETED|Third Intervention Period||3
8921941|NCT02228395|9982315|FG000|NOT COMPLETED|Third Intervention Period||0
8921942|NCT02228395|9982316|FG001|NOT COMPLETED|Third Intervention Period||0
8921943|NCT02228395|9982317|FG002|NOT COMPLETED|Third Intervention Period||0
8921944|NCT02228408|9982329|FG000|STARTED|Overall Study||7
8921945|NCT02228408|9982330|FG001|STARTED|Overall Study||10
8921946|NCT02228408|9982329|FG000|COMPLETED|Overall Study||7
8921947|NCT02228408|9982330|FG001|COMPLETED|Overall Study||10
8921948|NCT02228408|9982329|FG000|NOT COMPLETED|Overall Study||0
8921949|NCT02228408|9982330|FG001|NOT COMPLETED|Overall Study||0
8921950|NCT02228460|9982336|FG000|STARTED|Overall Study||11
8921951|NCT02228460|9982336|FG000|COMPLETED|Overall Study||9
8921952|NCT02228460|9982336|FG000|NOT COMPLETED|Overall Study||2
8921953|NCT02228499|9982343|FG000|STARTED|Overall Study||30
8921954|NCT02228499|9982344|FG001|STARTED|Overall Study||36
8921955|NCT02228499|9982343|FG000|COMPLETED|Overall Study||7
8921956|NCT02228499|9982344|FG001|COMPLETED|Overall Study||10
8921957|NCT02228499|9982343|FG000|NOT COMPLETED|Overall Study||23
8921958|NCT02228499|9982344|FG001|NOT COMPLETED|Overall Study||26
8921959|NCT02228564|9982350|FG000|STARTED|Overall Study||155
8921960|NCT02228564|9982350|FG000|COMPLETED|Overall Study||106
8921961|NCT02228564|9982350|FG000|NOT COMPLETED|Overall Study||49
8921962|NCT02228590|9982354|FG000|STARTED|Overall Study||20
8921963|NCT02228590|9982354|FG000|COMPLETED|Overall Study||19
8921964|NCT02228590|9982354|FG000|NOT COMPLETED|Overall Study||1
8921965|NCT02228681|9982361|FG000|STARTED|Overall Study||37
8921966|NCT02228681|9982362|FG001|STARTED|Overall Study||37
8921967|NCT02228681|9982361|FG000|COMPLETED|Overall Study||37
8921968|NCT02228681|9982362|FG001|COMPLETED|Overall Study||37
8921969|NCT02228681|9982361|FG000|NOT COMPLETED|Overall Study||0
8921970|NCT02228681|9982362|FG001|NOT COMPLETED|Overall Study||0
8921971|NCT02228720|9982368|FG000|STARTED|Open Label - Baseline||15
8921972|NCT02228720|9982368|FG000|COMPLETED|Open Label - Baseline||15
8921973|NCT02228720|9982368|FG000|NOT COMPLETED|Open Label - Baseline||0
8921974|NCT02228720|9982368|FG000|STARTED|Open Label - Day 30||15
8921975|NCT02228720|9982368|FG000|COMPLETED|Open Label - Day 30||14
8921976|NCT02228720|9982368|FG000|NOT COMPLETED|Open Label - Day 30||1
8921977|NCT02228720|9982368|FG000|STARTED|Open Label - Day 90||14
8921978|NCT02228720|9982368|FG000|COMPLETED|Open Label - Day 90||14
8921979|NCT02228720|9982368|FG000|NOT COMPLETED|Open Label - Day 90||0
8921980|NCT02228824|9982374|FG000|STARTED|Overall Study||118
8921981|NCT02228824|9982375|FG001|STARTED|Overall Study||120
8921982|NCT02228824|9982374|FG000|COMPLETED|Overall Study||89
8921983|NCT02228824|9982375|FG001|COMPLETED|Overall Study||98
8921984|NCT02228824|9982374|FG000|NOT COMPLETED|Overall Study||29
8921985|NCT02228824|9982375|FG001|NOT COMPLETED|Overall Study||22
8921986|NCT02228967|9982383|FG000|STARTED|Overall Study||403
8921987|NCT02228967|9982384|FG001|STARTED|Overall Study||388
8921988|NCT02228967|9982383|FG000|COMPLETED|Overall Study||244
8921989|NCT02228967|9982384|FG001|COMPLETED|Overall Study||228
8921990|NCT02228967|9982383|FG000|NOT COMPLETED|Overall Study||159
8921991|NCT02228967|9982384|FG001|NOT COMPLETED|Overall Study||160
8921992|NCT02228980|9982394|FG000|STARTED|Overall Study||150
8921993|NCT02228980|9982395|FG001|STARTED|Overall Study||150
8921994|NCT02228980|9982396|FG002|STARTED|Overall Study||151
8921995|NCT02228980|9982397|FG003|STARTED|Overall Study||151
8921996|NCT02228980|9982394|FG000|COMPLETED|Overall Study||126
8921997|NCT02228980|9982395|FG001|COMPLETED|Overall Study||147
8921998|NCT02228980|9982396|FG002|COMPLETED|Overall Study||149
8921999|NCT02228980|9982397|FG003|COMPLETED|Overall Study||148
8922000|NCT02228980|9982394|FG000|NOT COMPLETED|Overall Study||24
8922001|NCT02228980|9982395|FG001|NOT COMPLETED|Overall Study||3
8922002|NCT02228980|9982396|FG002|NOT COMPLETED|Overall Study||2
8922003|NCT02228980|9982397|FG003|NOT COMPLETED|Overall Study||3
8922004|NCT02229214|9982413|FG000|STARTED|Overall Study||41
8922005|NCT02229214|9982414|FG001|STARTED|Overall Study||10
8922006|NCT02229214|9982413|FG000|COMPLETED|Overall Study||35
8922007|NCT02229214|9982414|FG001|COMPLETED|Overall Study||10
8922008|NCT02229214|9982413|FG000|NOT COMPLETED|Overall Study||6
8922009|NCT02229214|9982414|FG001|NOT COMPLETED|Overall Study||0
8922010|NCT02229227|9982424|FG000|STARTED|Overall Study||402
8922011|NCT02229227|9982425|FG001|STARTED|Overall Study||412
8922012|NCT02229227|9982424|FG000|COMPLETED|Overall Study||351
8922013|NCT02229227|9982425|FG001|COMPLETED|Overall Study||350
8922014|NCT02229227|9982424|FG000|NOT COMPLETED|Overall Study||51
8922015|NCT02229227|9982425|FG001|NOT COMPLETED|Overall Study||62
8922016|NCT02229318|9982431|FG000|STARTED|Overall Study|September 6th 2014 11 enrolled|11
8922017|NCT02229318|9982431|FG000|COMPLETED|Overall Study|September 15th 2014 11 completed|11
8922018|NCT02229318|9982431|FG000|NOT COMPLETED|Overall Study||0
8922019|NCT02229383|9982438|FG000|STARTED|Overall Study||232
8922020|NCT02229383|9982439|FG001|STARTED|Overall Study||229
8922021|NCT02229383|9982438|FG000|Received Treatment|Overall Study||231
8922022|NCT02229383|9982439|FG001|Received Treatment|Overall Study||229
8922023|NCT02229383|9982438|FG000|Safety Analysis Set|Overall Study||231
8922024|NCT02229383|9982439|FG001|Safety Analysis Set|Overall Study||229
8922025|NCT02229383|9982438|FG000|Intent-to-treat (ITT) Analysis Set|Overall Study||230
8922026|NCT02229383|9982439|FG001|Intent-to-treat (ITT) Analysis Set|Overall Study||228
8922027|NCT02229383|9982438|FG000|COMPLETED|Overall Study||212
8922028|NCT02229383|9982439|FG001|COMPLETED|Overall Study||207
8922029|NCT02229383|9982438|FG000|NOT COMPLETED|Overall Study||20
8922030|NCT02229383|9982439|FG001|NOT COMPLETED|Overall Study||22
8922031|NCT02229396|9982448|FG000|STARTED|Overall Study||233
8922032|NCT02229396|9982449|FG001|STARTED|Overall Study||231
8922033|NCT02229396|9982450|FG002|STARTED|Overall Study||231
8922034|NCT02229396|9982448|FG000|Randomization Code Allocated|Overall Study||233
8922035|NCT02229396|9982449|FG001|Randomization Code Allocated|Overall Study||231
8922036|NCT02229396|9982450|FG002|Randomization Code Allocated|Overall Study||231
8922037|NCT02229396|9982448|FG000|Safety Analysis Set|Overall Study||233
8922038|NCT02229396|9982449|FG001|Safety Analysis Set|Overall Study||231
8922039|NCT02229396|9982450|FG002|Safety Analysis Set|Overall Study||230
8922040|NCT02229396|9982448|FG000|Intent-to-Treat (ITT) Analysis Set|Overall Study||230
8922041|NCT02229396|9982449|FG001|Intent-to-Treat (ITT) Analysis Set|Overall Study||228
8922042|NCT02229396|9982450|FG002|Intent-to-Treat (ITT) Analysis Set|Overall Study||227
8922043|NCT02229396|9982448|FG000|Completed 28-Week Study Period|Overall Study||208
8922044|NCT02229396|9982449|FG001|Completed 28-Week Study Period|Overall Study||202
8922045|NCT02229396|9982450|FG002|Completed 28-Week Study Period|Overall Study||193
8922046|NCT02229396|9982448|FG000|Completed 52-Week Study Period|Overall Study||194
8922047|NCT02229396|9982449|FG001|Completed 52-Week Study Period|Overall Study||193
8922048|NCT02229396|9982450|FG002|Completed 52-Week Study Period|Overall Study||177
8922049|NCT02229396|9982448|FG000|COMPLETED|Overall Study||155
8922050|NCT02229396|9982449|FG001|COMPLETED|Overall Study||154
8922051|NCT02229396|9982450|FG002|COMPLETED|Overall Study||136
8922052|NCT02229396|9982448|FG000|NOT COMPLETED|Overall Study||78
8922053|NCT02229396|9982449|FG001|NOT COMPLETED|Overall Study||77
8922054|NCT02229396|9982450|FG002|NOT COMPLETED|Overall Study||95
8922055|NCT02229461|9982465|FG000|STARTED|Overall Study|Randomized and received treatment|17
8922056|NCT02229461|9982466|FG001|STARTED|Overall Study|Randomized and received treatment|17
8922057|NCT02229461|9982467|FG002|STARTED|Overall Study|Randomized and received treatment|17
8922058|NCT02229461|9982468|FG003|STARTED|Overall Study|Randomized and received treatment|17
8922059|NCT02229461|9982469|FG004|STARTED|Overall Study|Randomized and received treatment|17
8922060|NCT02229461|9982470|FG005|STARTED|Overall Study|Randomized and received treatment|17
8922061|NCT02229461|9982465|FG000|COMPLETED|Overall Study||17
8922062|NCT02229461|9982466|FG001|COMPLETED|Overall Study||17
8922063|NCT02229461|9982467|FG002|COMPLETED|Overall Study||17
8922064|NCT02229461|9982468|FG003|COMPLETED|Overall Study||17
8922065|NCT02229461|9982469|FG004|COMPLETED|Overall Study||17
8922066|NCT02229461|9982470|FG005|COMPLETED|Overall Study||17
8922067|NCT02229461|9982465|FG000|NOT COMPLETED|Overall Study||0
8922068|NCT02229461|9982466|FG001|NOT COMPLETED|Overall Study||0
8922069|NCT02229461|9982467|FG002|NOT COMPLETED|Overall Study||0
8922070|NCT02229461|9982468|FG003|NOT COMPLETED|Overall Study||0
8922071|NCT02229461|9982469|FG004|NOT COMPLETED|Overall Study||0
8922072|NCT02229461|9982470|FG005|NOT COMPLETED|Overall Study||0
8922073|NCT02229474|9982487|FG000|STARTED|Overall Study||16
8922074|NCT02229474|9982488|FG001|STARTED|Overall Study||18
8922075|NCT02229474|9982487|FG000|COMPLETED|Overall Study||16
8922076|NCT02229474|9982488|FG001|COMPLETED|Overall Study||15
8922077|NCT02229474|9982487|FG000|NOT COMPLETED|Overall Study||0
8922078|NCT02229474|9982488|FG001|NOT COMPLETED|Overall Study||3
8922079|NCT02229487|9982497|FG000|STARTED|Overall Study||24
8922080|NCT02229487|9982498|FG001|STARTED|Overall Study||27
8922081|NCT02229487|9982497|FG000|COMPLETED|Overall Study||24
8922082|NCT02229487|9982498|FG001|COMPLETED|Overall Study||27
8922083|NCT02229487|9982497|FG000|NOT COMPLETED|Overall Study||0
8922084|NCT02229487|9982498|FG001|NOT COMPLETED|Overall Study||0
8922085|NCT02229513|9982506|FG000|STARTED|Overall Study||100
8922086|NCT02229513|9982507|FG001|STARTED|Overall Study||100
8922087|NCT02229513|9982506|FG000|COMPLETED|Overall Study||100
8922088|NCT02229513|9982507|FG001|COMPLETED|Overall Study||100
8922089|NCT02229513|9982506|FG000|NOT COMPLETED|Overall Study||0
8922090|NCT02229513|9982507|FG001|NOT COMPLETED|Overall Study||0
8922091|NCT02229539|9982516|FG000|STARTED|Cycle 1 (Treatment Per Protocol)||77
8922092|NCT02229539|9982517|FG001|STARTED|Cycle 1 (Treatment Per Protocol)||76
8922093|NCT02229539|9982518|FG002|STARTED|Cycle 1 (Treatment Per Protocol)||75
8922094|NCT02229539|9982516|FG000|COMPLETED|Cycle 1 (Treatment Per Protocol)||74
8922095|NCT02229539|9982517|FG001|COMPLETED|Cycle 1 (Treatment Per Protocol)||71
8922096|NCT02229539|9982518|FG002|COMPLETED|Cycle 1 (Treatment Per Protocol)||72
8922097|NCT02229539|9982516|FG000|NOT COMPLETED|Cycle 1 (Treatment Per Protocol)||3
8922098|NCT02229539|9982517|FG001|NOT COMPLETED|Cycle 1 (Treatment Per Protocol)||5
8922099|NCT02229539|9982518|FG002|NOT COMPLETED|Cycle 1 (Treatment Per Protocol)||3
8922100|NCT02229539|9982516|FG000|STARTED|Cycle 2 (Optional Continuation Phase)||35
8922101|NCT02229539|9982517|FG001|STARTED|Cycle 2 (Optional Continuation Phase)||36
8922102|NCT02229539|9982518|FG002|STARTED|Cycle 2 (Optional Continuation Phase)||32
8922103|NCT02229539|9982516|FG000|COMPLETED|Cycle 2 (Optional Continuation Phase)||26
8922104|NCT02229539|9982517|FG001|COMPLETED|Cycle 2 (Optional Continuation Phase)||29
8922105|NCT02229539|9982518|FG002|COMPLETED|Cycle 2 (Optional Continuation Phase)||22
8922106|NCT02229539|9982516|FG000|NOT COMPLETED|Cycle 2 (Optional Continuation Phase)||9
8922107|NCT02229539|9982517|FG001|NOT COMPLETED|Cycle 2 (Optional Continuation Phase)||7
8922108|NCT02229539|9982518|FG002|NOT COMPLETED|Cycle 2 (Optional Continuation Phase)||10
8922109|NCT02229552|9982526|FG000|STARTED|Baseline||237
8922110|NCT02229552|9982526|FG000|COMPLETED|Baseline||231
8922111|NCT02229552|9982526|FG000|NOT COMPLETED|Baseline||6
8922112|NCT02229552|9982526|FG000|STARTED|1-year Follow up||231
8922113|NCT02229552|9982526|FG000|COMPLETED|1-year Follow up||206
8922114|NCT02229552|9982526|FG000|NOT COMPLETED|1-year Follow up||25
8922115|NCT02229552|9982526|FG000|STARTED|2-Year Follow up|All baseline participants were eligible for year 2 follow up, regardless of completion of year 1.|231
8922116|NCT02229552|9982526|FG000|COMPLETED|2-Year Follow up||205
8922117|NCT02229552|9982526|FG000|NOT COMPLETED|2-Year Follow up||26
8922118|NCT02229851|9982533|FG000|STARTED|Main Phase (Double-blind Phase)||61
8922119|NCT02229851|9982534|FG001|STARTED|Main Phase (Double-blind Phase)||119
8922120|NCT02229851|9982535|FG002|STARTED|Main Phase (Double-blind Phase)||120
8922121|NCT02229851|9982536|FG003|STARTED|Main Phase (Double-blind Phase)|This arm is not applicable for the Main phase.|0
8922122|NCT02229851|9982537|FG004|STARTED|Main Phase (Double-blind Phase)|This arm is not applicable for the Main phase.|0
8922123|NCT02229851|9982538|FG005|STARTED|Main Phase (Double-blind Phase)|This arm is not applicable for the Main phase.|0
8922124|NCT02229851|9982539|FG006|STARTED|Main Phase (Double-blind Phase)|This arm is not applicable for the Main phase.|0
8922125|NCT02229851|9982533|FG000|Full Analysis Set|Main Phase (Double-blind Phase)||61
8922126|NCT02229851|9982534|FG001|Full Analysis Set|Main Phase (Double-blind Phase)||119
8922127|NCT02229851|9982535|FG002|Full Analysis Set|Main Phase (Double-blind Phase)||120
8922128|NCT02229851|9982536|FG003|Full Analysis Set|Main Phase (Double-blind Phase)||0
8922129|NCT02229851|9982537|FG004|Full Analysis Set|Main Phase (Double-blind Phase)||0
8922130|NCT02229851|9982538|FG005|Full Analysis Set|Main Phase (Double-blind Phase)||0
8922131|NCT02229851|9982539|FG006|Full Analysis Set|Main Phase (Double-blind Phase)||0
8922132|NCT02229851|9982533|FG000|Safety Analysis Set|Main Phase (Double-blind Phase)||61
8922133|NCT02229851|9982534|FG001|Safety Analysis Set|Main Phase (Double-blind Phase)||119
8922134|NCT02229851|9982535|FG002|Safety Analysis Set|Main Phase (Double-blind Phase)||120
8922135|NCT02229851|9982536|FG003|Safety Analysis Set|Main Phase (Double-blind Phase)||0
8922136|NCT02229851|9982537|FG004|Safety Analysis Set|Main Phase (Double-blind Phase)||0
8922137|NCT02229851|9982538|FG005|Safety Analysis Set|Main Phase (Double-blind Phase)||0
8922138|NCT02229851|9982539|FG006|Safety Analysis Set|Main Phase (Double-blind Phase)||0
8922139|NCT02229851|9982533|FG000|COMPLETED|Main Phase (Double-blind Phase)||55
8922140|NCT02229851|9982534|FG001|COMPLETED|Main Phase (Double-blind Phase)||103
8922141|NCT02229851|9982535|FG002|COMPLETED|Main Phase (Double-blind Phase)||114
8922142|NCT02229851|9982536|FG003|COMPLETED|Main Phase (Double-blind Phase)||0
8922143|NCT02229851|9982537|FG004|COMPLETED|Main Phase (Double-blind Phase)||0
8922144|NCT02229851|9982538|FG005|COMPLETED|Main Phase (Double-blind Phase)||0
8922145|NCT02229851|9982539|FG006|COMPLETED|Main Phase (Double-blind Phase)||0
8922146|NCT02229851|9982533|FG000|NOT COMPLETED|Main Phase (Double-blind Phase)||6
8922147|NCT02229851|9982534|FG001|NOT COMPLETED|Main Phase (Double-blind Phase)||16
8922148|NCT02229851|9982535|FG002|NOT COMPLETED|Main Phase (Double-blind Phase)||6
8922149|NCT02229851|9982536|FG003|NOT COMPLETED|Main Phase (Double-blind Phase)||0
8922150|NCT02229851|9982537|FG004|NOT COMPLETED|Main Phase (Double-blind Phase)||0
8922151|NCT02229851|9982538|FG005|NOT COMPLETED|Main Phase (Double-blind Phase)||0
8922152|NCT02229851|9982539|FG006|NOT COMPLETED|Main Phase (Double-blind Phase)||0
8922153|NCT02229851|9982533|FG000|STARTED|Extension Phase (Open-label Phase)|This arm is not applicable for the Extension phase.|0
8922154|NCT02229851|9982534|FG001|STARTED|Extension Phase (Open-label Phase)|This arm is not applicable for the Extension phase.|0
8922155|NCT02229851|9982535|FG002|STARTED|Extension Phase (Open-label Phase)|This arm is not applicable for the Extension phase.|0
8922156|NCT02229851|9982536|FG003|STARTED|Extension Phase (Open-label Phase)||55
8922157|NCT02229851|9982537|FG004|STARTED|Extension Phase (Open-label Phase)||114
8922158|NCT02229851|9982538|FG005|STARTED|Extension Phase (Open-label Phase)||52
8922159|NCT02229851|9982539|FG006|STARTED|Extension Phase (Open-label Phase)||51
8922160|NCT02229851|9982533|FG000|COMPLETED|Extension Phase (Open-label Phase)||0
8922161|NCT02229851|9982534|FG001|COMPLETED|Extension Phase (Open-label Phase)||0
8922162|NCT02229851|9982535|FG002|COMPLETED|Extension Phase (Open-label Phase)||0
8922163|NCT02229851|9982536|FG003|COMPLETED|Extension Phase (Open-label Phase)||53
8922164|NCT02229851|9982537|FG004|COMPLETED|Extension Phase (Open-label Phase)||109
8922165|NCT02229851|9982538|FG005|COMPLETED|Extension Phase (Open-label Phase)||47
8922166|NCT02229851|9982539|FG006|COMPLETED|Extension Phase (Open-label Phase)||48
8922167|NCT02229851|9982533|FG000|NOT COMPLETED|Extension Phase (Open-label Phase)||0
8922168|NCT02229851|9982534|FG001|NOT COMPLETED|Extension Phase (Open-label Phase)||0
8922169|NCT02229851|9982535|FG002|NOT COMPLETED|Extension Phase (Open-label Phase)||0
8922170|NCT02229851|9982536|FG003|NOT COMPLETED|Extension Phase (Open-label Phase)||2
8922171|NCT02229851|9982537|FG004|NOT COMPLETED|Extension Phase (Open-label Phase)||5
8922172|NCT02229851|9982538|FG005|NOT COMPLETED|Extension Phase (Open-label Phase)||5
8922173|NCT02229851|9982539|FG006|NOT COMPLETED|Extension Phase (Open-label Phase)||3
8922174|NCT02229864|9982554|FG000|STARTED|Overall Study||12
8922175|NCT02229864|9982554|FG000|COMPLETED|Overall Study||9
8922176|NCT02229864|9982554|FG000|NOT COMPLETED|Overall Study||3
8922177|NCT02230085|9982558|FG000|STARTED|Overall Study||110
8922178|NCT02230085|9982558|FG000|COMPLETED|Overall Study||106
8922179|NCT02230085|9982558|FG000|NOT COMPLETED|Overall Study||4
8922180|NCT02230306|9982562|FG000|STARTED|Overall Study||5
8922181|NCT02230306|9982562|FG000|COMPLETED|Overall Study||4
8922182|NCT02230306|9982562|FG000|NOT COMPLETED|Overall Study||1
8922183|NCT02230332|9982568|FG000|STARTED|Overall Study||38
8922184|NCT02230332|9982569|FG001|STARTED|Overall Study||40
8922185|NCT02230332|9982568|FG000|COMPLETED|Overall Study||34
8922186|NCT02230332|9982569|FG001|COMPLETED|Overall Study||39
8922187|NCT02230332|9982568|FG000|NOT COMPLETED|Overall Study||4
8922188|NCT02230332|9982569|FG001|NOT COMPLETED|Overall Study||1
8922189|NCT02230384|9982577|FG000|STARTED|Phase 1||30
8922190|NCT02230384|9982578|FG001|STARTED|Phase 1||32
8922191|NCT02230384|9982577|FG000|COMPLETED|Phase 1||29
8922192|NCT02230384|9982578|FG001|COMPLETED|Phase 1||31
8922193|NCT02230384|9982577|FG000|NOT COMPLETED|Phase 1||1
8922194|NCT02230384|9982578|FG001|NOT COMPLETED|Phase 1||1
8922195|NCT02230384|9982577|FG000|STARTED|Phase 1 Wash Out||29
8922196|NCT02230384|9982578|FG001|STARTED|Phase 1 Wash Out||31
8922197|NCT02230384|9982577|FG000|COMPLETED|Phase 1 Wash Out||29
8922198|NCT02230384|9982578|FG001|COMPLETED|Phase 1 Wash Out||31
8922199|NCT02230384|9982577|FG000|NOT COMPLETED|Phase 1 Wash Out||0
8922200|NCT02230384|9982578|FG001|NOT COMPLETED|Phase 1 Wash Out||0
8922201|NCT02230384|9982577|FG000|STARTED|Phase 2 - Switch||29
8922202|NCT02230384|9982578|FG001|STARTED|Phase 2 - Switch||31
8922203|NCT02230384|9982577|FG000|COMPLETED|Phase 2 - Switch||26
8922204|NCT02230384|9982578|FG001|COMPLETED|Phase 2 - Switch||30
8922205|NCT02230384|9982577|FG000|NOT COMPLETED|Phase 2 - Switch||3
8922206|NCT02230384|9982578|FG001|NOT COMPLETED|Phase 2 - Switch||1
8922207|NCT02230384|9982577|FG000|STARTED|Phase 2 Wash Out||26
8922208|NCT02230384|9982578|FG001|STARTED|Phase 2 Wash Out||30
8922209|NCT02230384|9982577|FG000|COMPLETED|Phase 2 Wash Out||26
8922210|NCT02230384|9982578|FG001|COMPLETED|Phase 2 Wash Out||30
8922211|NCT02230384|9982577|FG000|NOT COMPLETED|Phase 2 Wash Out||0
8922212|NCT02230384|9982578|FG001|NOT COMPLETED|Phase 2 Wash Out||0
8922213|NCT02230527|9982594|FG000|STARTED|Overall Study||23
8922214|NCT02230527|9982595|FG001|STARTED|Overall Study||23
8922215|NCT02230527|9982594|FG000|COMPLETED|Overall Study||18
8922216|NCT02230527|9982595|FG001|COMPLETED|Overall Study||21
8922217|NCT02230527|9982594|FG000|NOT COMPLETED|Overall Study||5
8922218|NCT02230527|9982595|FG001|NOT COMPLETED|Overall Study||2
8922219|NCT02230540|9982601|FG000|STARTED|Overall Study||8
8922220|NCT02230540|9982602|FG001|STARTED|Overall Study|The study was terminated before initiation of sequence B. Sequence B was therefore not initiated.|0
8922221|NCT02230540|9982601|FG000|COMPLETED|Overall Study||8
8922222|NCT02230540|9982602|FG001|COMPLETED|Overall Study||0
8922223|NCT02230540|9982601|FG000|NOT COMPLETED|Overall Study||0
8922224|NCT02230540|9982602|FG001|NOT COMPLETED|Overall Study||0
8922225|NCT02230566|9982610|FG000|STARTED|Overall Study||3
8922226|NCT02230566|9982611|FG001|STARTED|Overall Study||3
8922227|NCT02230566|9982612|FG002|STARTED|Overall Study||3
8922228|NCT02230566|9982613|FG003|STARTED|Overall Study||3
8922229|NCT02230566|9982610|FG000|COMPLETED|Overall Study||3
8922230|NCT02230566|9982611|FG001|COMPLETED|Overall Study||3
8922231|NCT02230566|9982612|FG002|COMPLETED|Overall Study||3
8922232|NCT02230566|9982613|FG003|COMPLETED|Overall Study||3
8922233|NCT02230566|9982610|FG000|NOT COMPLETED|Overall Study||0
8922234|NCT02230566|9982611|FG001|NOT COMPLETED|Overall Study||0
8922235|NCT02230566|9982612|FG002|NOT COMPLETED|Overall Study||0
8922236|NCT02230566|9982613|FG003|NOT COMPLETED|Overall Study||0
8922237|NCT02230579|9982625|FG000|STARTED|Overall Study||6
8922238|NCT02230579|9982626|FG001|STARTED|Overall Study||6
8922239|NCT02230579|9982627|FG002|STARTED|Overall Study||6
8922240|NCT02230579|9982628|FG003|STARTED|Overall Study||6
8922241|NCT02230579|9982629|FG004|STARTED|Overall Study||6
8922242|NCT02230579|9982630|FG005|STARTED|Overall Study||6
8922243|NCT02230579|9982631|FG006|STARTED|Overall Study||12
8922244|NCT02230579|9982625|FG000|COMPLETED|Overall Study||6
8922245|NCT02230579|9982626|FG001|COMPLETED|Overall Study||6
8922246|NCT02230579|9982627|FG002|COMPLETED|Overall Study||6
8922247|NCT02230579|9982628|FG003|COMPLETED|Overall Study||6
8922248|NCT02230579|9982629|FG004|COMPLETED|Overall Study||6
8922249|NCT02230579|9982630|FG005|COMPLETED|Overall Study||6
8922250|NCT02230579|9982631|FG006|COMPLETED|Overall Study||12
8922251|NCT02230579|9982625|FG000|NOT COMPLETED|Overall Study||0
8922252|NCT02230579|9982626|FG001|NOT COMPLETED|Overall Study||0
8922253|NCT02230579|9982627|FG002|NOT COMPLETED|Overall Study||0
8922254|NCT02230579|9982628|FG003|NOT COMPLETED|Overall Study||0
8922255|NCT02230579|9982629|FG004|NOT COMPLETED|Overall Study||0
8922256|NCT02230579|9982630|FG005|NOT COMPLETED|Overall Study||0
8922257|NCT02230579|9982631|FG006|NOT COMPLETED|Overall Study||0
8922258|NCT02230670|9982649|FG000|STARTED|Overall Study||44
8922259|NCT02230670|9982650|FG001|STARTED|Overall Study|One subject randomized to placebo withdrew from the study before receiving any study treatment.|42
8922260|NCT02230670|9982649|FG000|COMPLETED|Overall Study||40
8922261|NCT02230670|9982650|FG001|COMPLETED|Overall Study||34
8922262|NCT02230670|9982649|FG000|NOT COMPLETED|Overall Study||4
8922263|NCT02230670|9982650|FG001|NOT COMPLETED|Overall Study||8
8922264|NCT02230683|9982656|FG000|STARTED|Overall Study||23
8922265|NCT02230683|9982656|FG000|COMPLETED|Overall Study||22
8922266|NCT02230683|9982656|FG000|NOT COMPLETED|Overall Study||1
8922267|NCT02230696|9982669|FG000|STARTED|Overall Study||381
8922268|NCT02230696|9982670|FG001|STARTED|Overall Study||376
8922269|NCT02230696|9982671|FG002|STARTED|Overall Study||194
8922270|NCT02230696|9982669|FG000|COMPLETED|Overall Study||366
8922271|NCT02230696|9982670|FG001|COMPLETED|Overall Study||365
8922272|NCT02230696|9982671|FG002|COMPLETED|Overall Study||190
8922273|NCT02230696|9982669|FG000|NOT COMPLETED|Overall Study||15
8922274|NCT02230696|9982670|FG001|NOT COMPLETED|Overall Study||11
8922275|NCT02230696|9982671|FG002|NOT COMPLETED|Overall Study||4
8922276|NCT02230761|9982681|FG000|STARTED|Overall Study||60
8922277|NCT02230761|9982682|FG001|STARTED|Overall Study||30
8922278|NCT02230761|9982681|FG000|COMPLETED|Overall Study||60
8922279|NCT02230761|9982682|FG001|COMPLETED|Overall Study||29
8922280|NCT02230761|9982681|FG000|NOT COMPLETED|Overall Study||0
8922281|NCT02230761|9982682|FG001|NOT COMPLETED|Overall Study||1
8922282|NCT02230904|9982690|FG000|STARTED|Overall Study||29
8922283|NCT02230904|9982691|FG001|STARTED|Overall Study||28
8922284|NCT02230904|9982690|FG000|COMPLETED|Overall Study||29
8922285|NCT02230904|9982691|FG001|COMPLETED|Overall Study||27
8922286|NCT02230904|9982690|FG000|NOT COMPLETED|Overall Study||0
8922287|NCT02230904|9982691|FG001|NOT COMPLETED|Overall Study||1
8922288|NCT02230956|9982702|FG000|STARTED|Overall Study||44
8922289|NCT02230956|9982703|FG001|STARTED|Overall Study||43
8922290|NCT02230956|9982704|FG002|STARTED|Overall Study||89
8922291|NCT02230956|9982702|FG000|COMPLETED|Overall Study||39
8922292|NCT02230956|9982703|FG001|COMPLETED|Overall Study||37
8922293|NCT02230956|9982704|FG002|COMPLETED|Overall Study||82
8922294|NCT02230956|9982702|FG000|NOT COMPLETED|Overall Study||5
8922295|NCT02230956|9982703|FG001|NOT COMPLETED|Overall Study||6
8922296|NCT02230956|9982704|FG002|NOT COMPLETED|Overall Study||7
8922297|NCT02230995|9982714|FG000|STARTED|Period 1 + Washout||15
8922298|NCT02230995|9982715|FG001|STARTED|Period 1 + Washout||15
8922299|NCT02230995|9982714|FG000|COMPLETED|Period 1 + Washout||15
8922300|NCT02230995|9982715|FG001|COMPLETED|Period 1 + Washout||15
8922301|NCT02230995|9982714|FG000|NOT COMPLETED|Period 1 + Washout||0
8922302|NCT02230995|9982715|FG001|NOT COMPLETED|Period 1 + Washout||0
8922303|NCT02230995|9982714|FG000|STARTED|Period 2 + Washout||15
8922304|NCT02230995|9982715|FG001|STARTED|Period 2 + Washout||15
8922305|NCT02230995|9982714|FG000|COMPLETED|Period 2 + Washout||15
8922306|NCT02230995|9982715|FG001|COMPLETED|Period 2 + Washout||15
8922307|NCT02230995|9982714|FG000|NOT COMPLETED|Period 2 + Washout||0
8922308|NCT02230995|9982715|FG001|NOT COMPLETED|Period 2 + Washout||0
8922309|NCT02231086|9982723|FG000|STARTED|Overall Study||102
8922310|NCT02231086|9982724|FG001|STARTED|Overall Study||102
8922311|NCT02231086|9982723|FG000|COMPLETED|Overall Study||63
8922312|NCT02231086|9982724|FG001|COMPLETED|Overall Study||65
8922313|NCT02231086|9982723|FG000|NOT COMPLETED|Overall Study||39
8922314|NCT02231086|9982724|FG001|NOT COMPLETED|Overall Study||37
8922315|NCT02231164|9982732|FG000|STARTED|Overall Study||6
8922316|NCT02231164|9982733|FG001|STARTED|Overall Study||6
8922317|NCT02231164|9982732|FG000|COMPLETED|Overall Study||0
8922318|NCT02231164|9982733|FG001|COMPLETED|Overall Study||0
8922319|NCT02231164|9982732|FG000|NOT COMPLETED|Overall Study||6
8922320|NCT02231164|9982733|FG001|NOT COMPLETED|Overall Study||6
8922321|NCT02231177|9982739|FG000|STARTED|Treatment Period 1 (21 Days)||8
8922322|NCT02231177|9982740|FG001|STARTED|Treatment Period 1 (21 Days)||7
8922323|NCT02231177|9982741|FG002|STARTED|Treatment Period 1 (21 Days)||8
8922324|NCT02231177|9982742|FG003|STARTED|Treatment Period 1 (21 Days)||7
8922325|NCT02231177|9982743|FG004|STARTED|Treatment Period 1 (21 Days)||8
8922326|NCT02231177|9982744|FG005|STARTED|Treatment Period 1 (21 Days)||9
8922327|NCT02231177|9982739|FG000|COMPLETED|Treatment Period 1 (21 Days)||8
8922328|NCT02231177|9982740|FG001|COMPLETED|Treatment Period 1 (21 Days)||7
8922329|NCT02231177|9982741|FG002|COMPLETED|Treatment Period 1 (21 Days)||8
8922330|NCT02231177|9982742|FG003|COMPLETED|Treatment Period 1 (21 Days)||7
8922331|NCT02231177|9982743|FG004|COMPLETED|Treatment Period 1 (21 Days)||8
8922332|NCT02231177|9982744|FG005|COMPLETED|Treatment Period 1 (21 Days)||9
8922333|NCT02231177|9982739|FG000|NOT COMPLETED|Treatment Period 1 (21 Days)||0
8922334|NCT02231177|9982740|FG001|NOT COMPLETED|Treatment Period 1 (21 Days)||0
8922335|NCT02231177|9982741|FG002|NOT COMPLETED|Treatment Period 1 (21 Days)||0
8922336|NCT02231177|9982742|FG003|NOT COMPLETED|Treatment Period 1 (21 Days)||0
8922337|NCT02231177|9982743|FG004|NOT COMPLETED|Treatment Period 1 (21 Days)||0
8922338|NCT02231177|9982744|FG005|NOT COMPLETED|Treatment Period 1 (21 Days)||0
8922339|NCT02231177|9982739|FG000|STARTED|Treatment Period 2 (21 Days)||8
8922340|NCT02231177|9982740|FG001|STARTED|Treatment Period 2 (21 Days)||7
8922341|NCT02231177|9982741|FG002|STARTED|Treatment Period 2 (21 Days)||8
8922342|NCT02231177|9982742|FG003|STARTED|Treatment Period 2 (21 Days)||7
8922343|NCT02231177|9982743|FG004|STARTED|Treatment Period 2 (21 Days)||8
8922344|NCT02231177|9982744|FG005|STARTED|Treatment Period 2 (21 Days)||9
8922345|NCT02231177|9982739|FG000|COMPLETED|Treatment Period 2 (21 Days)||8
8922346|NCT02231177|9982740|FG001|COMPLETED|Treatment Period 2 (21 Days)||7
8922347|NCT02231177|9982741|FG002|COMPLETED|Treatment Period 2 (21 Days)||8
8922348|NCT02231177|9982742|FG003|COMPLETED|Treatment Period 2 (21 Days)||7
8922349|NCT02231177|9982743|FG004|COMPLETED|Treatment Period 2 (21 Days)||8
8922350|NCT02231177|9982744|FG005|COMPLETED|Treatment Period 2 (21 Days)||9
8922351|NCT02231177|9982739|FG000|NOT COMPLETED|Treatment Period 2 (21 Days)||0
8922352|NCT02231177|9982740|FG001|NOT COMPLETED|Treatment Period 2 (21 Days)||0
8922353|NCT02231177|9982741|FG002|NOT COMPLETED|Treatment Period 2 (21 Days)||0
8922354|NCT02231177|9982742|FG003|NOT COMPLETED|Treatment Period 2 (21 Days)||0
9036791|NCT03307252|10097940|FG003|STARTED|Part 3, Washout Period 3 (7 Days)||0
8922355|NCT02231177|9982743|FG004|NOT COMPLETED|Treatment Period 2 (21 Days)||0
8922356|NCT02231177|9982744|FG005|NOT COMPLETED|Treatment Period 2 (21 Days)||0
8922357|NCT02231177|9982739|FG000|STARTED|Treatment Period 3 (21 Days)||8
8922358|NCT02231177|9982740|FG001|STARTED|Treatment Period 3 (21 Days)||7
8922359|NCT02231177|9982741|FG002|STARTED|Treatment Period 3 (21 Days)||8
8922360|NCT02231177|9982742|FG003|STARTED|Treatment Period 3 (21 Days)||7
8922361|NCT02231177|9982743|FG004|STARTED|Treatment Period 3 (21 Days)||8
8922362|NCT02231177|9982744|FG005|STARTED|Treatment Period 3 (21 Days)||9
8922363|NCT02231177|9982739|FG000|COMPLETED|Treatment Period 3 (21 Days)||8
8922364|NCT02231177|9982740|FG001|COMPLETED|Treatment Period 3 (21 Days)||7
8922365|NCT02231177|9982741|FG002|COMPLETED|Treatment Period 3 (21 Days)||8
8922366|NCT02231177|9982742|FG003|COMPLETED|Treatment Period 3 (21 Days)||7
8922367|NCT02231177|9982743|FG004|COMPLETED|Treatment Period 3 (21 Days)||8
8922368|NCT02231177|9982744|FG005|COMPLETED|Treatment Period 3 (21 Days)||9
8922369|NCT02231177|9982739|FG000|NOT COMPLETED|Treatment Period 3 (21 Days)||0
8922370|NCT02231177|9982740|FG001|NOT COMPLETED|Treatment Period 3 (21 Days)||0
8922371|NCT02231177|9982741|FG002|NOT COMPLETED|Treatment Period 3 (21 Days)||0
8922372|NCT02231177|9982742|FG003|NOT COMPLETED|Treatment Period 3 (21 Days)||0
8922373|NCT02231177|9982743|FG004|NOT COMPLETED|Treatment Period 3 (21 Days)||0
8922374|NCT02231177|9982744|FG005|NOT COMPLETED|Treatment Period 3 (21 Days)||0
8922375|NCT02231580|9982755|FG000|STARTED|Overall Study||14
8922376|NCT02231580|9982756|FG001|STARTED|Overall Study||3
8922377|NCT02231580|9982755|FG000|Cohort 1|Overall Study||8
8922378|NCT02231580|9982756|FG001|Cohort 1|Overall Study||2
8922379|NCT02231580|9982755|FG000|Cohort 2|Overall Study||6
8922380|NCT02231580|9982756|FG001|Cohort 2|Overall Study||1
8922381|NCT02231580|9982755|FG000|COMPLETED|Overall Study||9
8922382|NCT02231580|9982756|FG001|COMPLETED|Overall Study||3
8922383|NCT02231580|9982755|FG000|NOT COMPLETED|Overall Study||5
8922384|NCT02231580|9982756|FG001|NOT COMPLETED|Overall Study||0
8922385|NCT02231918|9982767|FG000|STARTED|Overall Study||9
8922386|NCT02231918|9982768|FG001|STARTED|Overall Study||15
8922387|NCT02231918|9982769|FG002|STARTED|Overall Study||2
8922388|NCT02231918|9982767|FG000|COMPLETED|Overall Study||9
8922389|NCT02231918|9982768|FG001|COMPLETED|Overall Study||14
8922390|NCT02231918|9982769|FG002|COMPLETED|Overall Study||1
8922391|NCT02231918|9982767|FG000|NOT COMPLETED|Overall Study||0
8922392|NCT02231918|9982768|FG001|NOT COMPLETED|Overall Study||1
8922393|NCT02231918|9982769|FG002|NOT COMPLETED|Overall Study||1
8922394|NCT02232009|9982777|FG000|STARTED|Overall Study||9
8922395|NCT02232009|9982777|FG000|COMPLETED|Overall Study||9
8922396|NCT02232009|9982777|FG000|NOT COMPLETED|Overall Study||0
8922397|NCT02232022|9982781|FG000|STARTED|Overall Study||53
8922398|NCT02232022|9982781|FG000|COMPLETED|Overall Study||51
8922399|NCT02232022|9982781|FG000|NOT COMPLETED|Overall Study||2
8922400|NCT02232061|9982787|FG000|STARTED|Overall Study||6
8922401|NCT02232061|9982787|FG000|COMPLETED|Overall Study||4
8922402|NCT02232061|9982787|FG000|NOT COMPLETED|Overall Study||2
8922403|NCT02232074|9982793|FG000|STARTED|Overall Study||154
8922404|NCT02232074|9982794|FG001|STARTED|Overall Study||152
8922405|NCT02232074|9982793|FG000|COMPLETED|Overall Study||113
8922406|NCT02232074|9982794|FG001|COMPLETED|Overall Study||107
8922407|NCT02232074|9982793|FG000|NOT COMPLETED|Overall Study||41
8922408|NCT02232074|9982794|FG001|NOT COMPLETED|Overall Study||45
8922409|NCT02232087|9982806|FG000|STARTED|Overall Study||9
8922410|NCT02232087|9982807|FG001|STARTED|Overall Study||10
8922411|NCT02232087|9982808|FG002|STARTED|Overall Study||8
8922412|NCT02232087|9982809|FG003|STARTED|Overall Study||8
8922413|NCT02232087|9982810|FG004|STARTED|Overall Study||8
8922414|NCT02232087|9982811|FG005|STARTED|Overall Study||9
8922415|NCT02232087|9982806|FG000|COMPLETED|Overall Study||7
8922416|NCT02232087|9982807|FG001|COMPLETED|Overall Study||8
8922417|NCT02232087|9982808|FG002|COMPLETED|Overall Study||8
8922418|NCT02232087|9982809|FG003|COMPLETED|Overall Study||7
8922419|NCT02232087|9982810|FG004|COMPLETED|Overall Study||7
8922420|NCT02232087|9982811|FG005|COMPLETED|Overall Study||6
8922421|NCT02232087|9982806|FG000|NOT COMPLETED|Overall Study||2
8922422|NCT02232087|9982807|FG001|NOT COMPLETED|Overall Study||2
8922423|NCT02232087|9982808|FG002|NOT COMPLETED|Overall Study||0
8922424|NCT02232087|9982809|FG003|NOT COMPLETED|Overall Study||1
8922425|NCT02232087|9982810|FG004|NOT COMPLETED|Overall Study||1
8922426|NCT02232087|9982811|FG005|NOT COMPLETED|Overall Study||3
8922427|NCT02232126|9982832|FG000|STARTED|Overall Study||91
8922428|NCT02232126|9982833|FG001|STARTED|Overall Study||90
8922429|NCT02232126|9982832|FG000|COMPLETED|Overall Study||91
8922430|NCT02232126|9982833|FG001|COMPLETED|Overall Study||90
8922431|NCT02232126|9982832|FG000|NOT COMPLETED|Overall Study||0
8922432|NCT02232126|9982833|FG001|NOT COMPLETED|Overall Study||0
8922433|NCT02232178|9982844|FG000|STARTED|Overall Study||26
8922434|NCT02232178|9982845|FG001|STARTED|Overall Study||25
8922435|NCT02232178|9982846|FG002|STARTED|Overall Study||13
8922436|NCT02232178|9982844|FG000|Per Protocol PK Population|Overall Study||26
8922437|NCT02232178|9982845|FG001|Per Protocol PK Population|Overall Study||24
8922438|NCT02232178|9982846|FG002|Per Protocol PK Population|Overall Study||11
8922439|NCT02232178|9982844|FG000|Safety Population|Overall Study||26
8922440|NCT02232178|9982845|FG001|Safety Population|Overall Study||24
8922441|NCT02232178|9982846|FG002|Safety Population|Overall Study||12
8922442|NCT02232178|9982844|FG000|COMPLETED|Overall Study||25
8922443|NCT02232178|9982845|FG001|COMPLETED|Overall Study||24
8922444|NCT02232178|9982846|FG002|COMPLETED|Overall Study||12
8922445|NCT02232178|9982844|FG000|NOT COMPLETED|Overall Study||1
8922446|NCT02232178|9982845|FG001|NOT COMPLETED|Overall Study||1
8922447|NCT02232178|9982846|FG002|NOT COMPLETED|Overall Study||1
8922448|NCT02232243|9982857|FG000|STARTED|First Dose (200mg HCQ Twice Daily)||3
8922449|NCT02232243|9982858|FG001|STARTED|First Dose (200mg HCQ Twice Daily)||0
8922450|NCT02232243|9982859|FG002|STARTED|First Dose (200mg HCQ Twice Daily)||0
8922451|NCT02232243|9982857|FG000|COMPLETED|First Dose (200mg HCQ Twice Daily)||3
8922452|NCT02232243|9982858|FG001|COMPLETED|First Dose (200mg HCQ Twice Daily)||0
8922453|NCT02232243|9982859|FG002|COMPLETED|First Dose (200mg HCQ Twice Daily)||0
8922454|NCT02232243|9982857|FG000|NOT COMPLETED|First Dose (200mg HCQ Twice Daily)||0
8922455|NCT02232243|9982858|FG001|NOT COMPLETED|First Dose (200mg HCQ Twice Daily)||0
8922456|NCT02232243|9982859|FG002|NOT COMPLETED|First Dose (200mg HCQ Twice Daily)||0
8922457|NCT02232243|9982857|FG000|STARTED|Second Dose (400mg HCQ Twice Daily)||0
8922458|NCT02232243|9982858|FG001|STARTED|Second Dose (400mg HCQ Twice Daily)||4
8922459|NCT02232243|9982859|FG002|STARTED|Second Dose (400mg HCQ Twice Daily)||0
8922460|NCT02232243|9982857|FG000|COMPLETED|Second Dose (400mg HCQ Twice Daily)||0
8922461|NCT02232243|9982858|FG001|COMPLETED|Second Dose (400mg HCQ Twice Daily)||3
8922462|NCT02232243|9982859|FG002|COMPLETED|Second Dose (400mg HCQ Twice Daily)||0
8922463|NCT02232243|9982857|FG000|NOT COMPLETED|Second Dose (400mg HCQ Twice Daily)||0
8922464|NCT02232243|9982858|FG001|NOT COMPLETED|Second Dose (400mg HCQ Twice Daily)||1
8922465|NCT02232243|9982859|FG002|NOT COMPLETED|Second Dose (400mg HCQ Twice Daily)||0
8922466|NCT02232243|9982857|FG000|STARTED|Third Dose(200mg HCQ Twice Daily)||0
8922467|NCT02232243|9982858|FG001|STARTED|Third Dose(200mg HCQ Twice Daily)||0
8922468|NCT02232243|9982859|FG002|STARTED|Third Dose(200mg HCQ Twice Daily)||3
8922469|NCT02232243|9982857|FG000|COMPLETED|Third Dose(200mg HCQ Twice Daily)||0
8922470|NCT02232243|9982858|FG001|COMPLETED|Third Dose(200mg HCQ Twice Daily)||0
8922471|NCT02232243|9982859|FG002|COMPLETED|Third Dose(200mg HCQ Twice Daily)||3
8922472|NCT02232243|9982857|FG000|NOT COMPLETED|Third Dose(200mg HCQ Twice Daily)||0
8922473|NCT02232243|9982858|FG001|NOT COMPLETED|Third Dose(200mg HCQ Twice Daily)||0
8922474|NCT02232243|9982859|FG002|NOT COMPLETED|Third Dose(200mg HCQ Twice Daily)||0
8922475|NCT02232425|9982870|FG000|STARTED|Overall Study||58
8922476|NCT02232425|9982871|FG001|STARTED|Overall Study||30
8922477|NCT02232425|9982870|FG000|COMPLETED|Overall Study||44
8922478|NCT02232425|9982871|FG001|COMPLETED|Overall Study||22
8922479|NCT02232425|9982870|FG000|NOT COMPLETED|Overall Study||14
8922480|NCT02232425|9982871|FG001|NOT COMPLETED|Overall Study||8
8922481|NCT02232698|9982879|FG000|STARTED|Overall Study||120
8922482|NCT02232698|9982880|FG001|STARTED|Overall Study||121
8922483|NCT02232698|9982879|FG000|COMPLETED|Overall Study||110
8922484|NCT02232698|9982880|FG001|COMPLETED|Overall Study||101
8922485|NCT02232698|9982879|FG000|NOT COMPLETED|Overall Study||10
8922486|NCT02232698|9982880|FG001|NOT COMPLETED|Overall Study||20
8922487|NCT02232802|9982888|FG000|STARTED|Period 1||24
8922488|NCT02232802|9982889|FG001|STARTED|Period 1||23
8922489|NCT02232802|9982888|FG000|COMPLETED|Period 1||22
8922490|NCT02232802|9982889|FG001|COMPLETED|Period 1||22
8922491|NCT02232802|9982888|FG000|NOT COMPLETED|Period 1||2
8922492|NCT02232802|9982889|FG001|NOT COMPLETED|Period 1||1
8922493|NCT02232802|9982888|FG000|STARTED|Washout||22
8922494|NCT02232802|9982889|FG001|STARTED|Washout||22
8922495|NCT02232802|9982888|FG000|COMPLETED|Washout||22
8922496|NCT02232802|9982889|FG001|COMPLETED|Washout||22
8922497|NCT02232802|9982888|FG000|NOT COMPLETED|Washout||0
8922498|NCT02232802|9982889|FG001|NOT COMPLETED|Washout||0
8922499|NCT02232802|9982888|FG000|STARTED|Period 2||22
8922500|NCT02232802|9982889|FG001|STARTED|Period 2||22
8922501|NCT02232802|9982888|FG000|COMPLETED|Period 2||22
8922502|NCT02232802|9982889|FG001|COMPLETED|Period 2||22
8922503|NCT02232802|9982888|FG000|NOT COMPLETED|Period 2||0
8922504|NCT02232802|9982889|FG001|NOT COMPLETED|Period 2||0
8922505|NCT02232802|9982888|FG000|STARTED|Washout||22
8922506|NCT02232802|9982889|FG001|STARTED|Washout||22
8922507|NCT02232802|9982888|FG000|COMPLETED|Washout||22
8922508|NCT02232802|9982889|FG001|COMPLETED|Washout||22
8922509|NCT02232802|9982888|FG000|NOT COMPLETED|Washout||0
8922510|NCT02232802|9982889|FG001|NOT COMPLETED|Washout||0
8922511|NCT02232893|9982897|FG000|STARTED|Overall Study||35
8922512|NCT02232893|9982898|FG001|STARTED|Overall Study||34
8922513|NCT02232893|9982897|FG000|Safety Population|Overall Study|Pts who rec'd at least 1 dose of study drug. All safety analyses performed using this population.|34
8922514|NCT02232893|9982898|FG001|Safety Population|Overall Study|Pts who rec'd at least 1 dose of study drug. All safety analyses performed using this population.|32
8922515|NCT02232893|9982897|FG000|Primary Endpoint Population|Overall Study|Patients who provided GIQLI scores both at baseline and Visit 4 were analyzed for primary endpoint|24
8922516|NCT02232893|9982898|FG001|Primary Endpoint Population|Overall Study|Patients who provided GIQLI scores both at baseline and Visit 4 were analyzed for primary endpoint|19
8922517|NCT02232893|9982897|FG000|COMPLETED|Overall Study||31
8922518|NCT02232893|9982898|FG001|COMPLETED|Overall Study||27
8922519|NCT02232893|9982897|FG000|NOT COMPLETED|Overall Study||4
8922520|NCT02232893|9982898|FG001|NOT COMPLETED|Overall Study||7
8922521|NCT02232984|9982904|FG000|STARTED|Overall Study|Enrolled subjects|749
8922522|NCT02232984|9982904|FG000|Successfully Implanted|Overall Study|Successfully implanted subjects|675
8922523|NCT02232984|9982904|FG000|COMPLETED|Overall Study|Total number of subjects who completed study|672
8922524|NCT02232984|9982904|FG000|NOT COMPLETED|Overall Study||77
8922525|NCT02233101|9982913|FG000|STARTED|Overall Study||86
9036792|NCT03307252|10097941|FG004|STARTED|Part 3, Washout Period 3 (7 Days)||0
9036793|NCT03307252|10097942|FG005|STARTED|Part 3, Washout Period 3 (7 Days)||0
9036794|NCT03307252|10097943|FG006|STARTED|Part 3, Washout Period 3 (7 Days)||0
9036795|NCT03307252|10097944|FG007|STARTED|Part 3, Washout Period 3 (7 Days)||4
9036796|NCT03307252|10097945|FG008|STARTED|Part 3, Washout Period 3 (7 Days)||4
9036797|NCT03307252|10097946|FG009|STARTED|Part 3, Washout Period 3 (7 Days)||4
9036798|NCT03307252|10097947|FG010|STARTED|Part 3, Washout Period 3 (7 Days)||4
9036799|NCT03307252|10097937|FG000|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
9036800|NCT03307252|10097938|FG001|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
9036801|NCT03307252|10097939|FG002|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
9036802|NCT03307252|10097940|FG003|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
9036803|NCT03307252|10097941|FG004|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
9036804|NCT03307252|10097942|FG005|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
9036805|NCT03307252|10097943|FG006|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
9036806|NCT03307252|10097944|FG007|COMPLETED|Part 3, Washout Period 3 (7 Days)||4
9036807|NCT03307252|10097945|FG008|COMPLETED|Part 3, Washout Period 3 (7 Days)||4
9036808|NCT03307252|10097946|FG009|COMPLETED|Part 3, Washout Period 3 (7 Days)||4
9036809|NCT03307252|10097947|FG010|COMPLETED|Part 3, Washout Period 3 (7 Days)||3
9036810|NCT03307252|10097937|FG000|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
9036811|NCT03307252|10097938|FG001|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
9036812|NCT03307252|10097939|FG002|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
9036813|NCT03307252|10097940|FG003|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
9036814|NCT03307252|10097941|FG004|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
9036815|NCT03307252|10097942|FG005|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
9036816|NCT03307252|10097943|FG006|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
9036817|NCT03307252|10097944|FG007|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
9036818|NCT03307252|10097945|FG008|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
9036819|NCT03307252|10097946|FG009|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
9036820|NCT03307252|10097947|FG010|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||1
9036821|NCT03307252|10097937|FG000|STARTED|Part 3, Period 4||0
9036822|NCT03307252|10097938|FG001|STARTED|Part 3, Period 4||0
9036823|NCT03307252|10097939|FG002|STARTED|Part 3, Period 4||0
9036824|NCT03307252|10097940|FG003|STARTED|Part 3, Period 4||0
9036825|NCT03307252|10097941|FG004|STARTED|Part 3, Period 4||0
9036826|NCT03307252|10097942|FG005|STARTED|Part 3, Period 4||0
9036827|NCT03307252|10097943|FG006|STARTED|Part 3, Period 4||0
9036828|NCT03307252|10097944|FG007|STARTED|Part 3, Period 4||4
9036829|NCT03307252|10097945|FG008|STARTED|Part 3, Period 4||4
9036830|NCT03307252|10097946|FG009|STARTED|Part 3, Period 4||4
9036831|NCT03307252|10097947|FG010|STARTED|Part 3, Period 4||3
9036832|NCT03307252|10097937|FG000|COMPLETED|Part 3, Period 4||0
9036833|NCT03307252|10097938|FG001|COMPLETED|Part 3, Period 4||0
9036834|NCT03307252|10097939|FG002|COMPLETED|Part 3, Period 4||0
9036835|NCT03307252|10097940|FG003|COMPLETED|Part 3, Period 4||0
9036836|NCT03307252|10097941|FG004|COMPLETED|Part 3, Period 4||0
9036837|NCT03307252|10097942|FG005|COMPLETED|Part 3, Period 4||0
9036838|NCT03307252|10097943|FG006|COMPLETED|Part 3, Period 4||0
9036839|NCT03307252|10097944|FG007|COMPLETED|Part 3, Period 4||4
9036840|NCT03307252|10097945|FG008|COMPLETED|Part 3, Period 4||4
9036841|NCT03307252|10097946|FG009|COMPLETED|Part 3, Period 4||4
9036842|NCT03307252|10097947|FG010|COMPLETED|Part 3, Period 4||3
9036843|NCT03307252|10097937|FG000|NOT COMPLETED|Part 3, Period 4||0
9036844|NCT03307252|10097938|FG001|NOT COMPLETED|Part 3, Period 4||0
9036845|NCT03307252|10097939|FG002|NOT COMPLETED|Part 3, Period 4||0
9036846|NCT03307252|10097940|FG003|NOT COMPLETED|Part 3, Period 4||0
9036847|NCT03307252|10097941|FG004|NOT COMPLETED|Part 3, Period 4||0
9036848|NCT03307252|10097942|FG005|NOT COMPLETED|Part 3, Period 4||0
9036849|NCT03307252|10097943|FG006|NOT COMPLETED|Part 3, Period 4||0
9036850|NCT03307252|10097944|FG007|NOT COMPLETED|Part 3, Period 4||0
9036851|NCT03307252|10097945|FG008|NOT COMPLETED|Part 3, Period 4||0
9036852|NCT03307252|10097946|FG009|NOT COMPLETED|Part 3, Period 4||0
9036853|NCT03307252|10097947|FG010|NOT COMPLETED|Part 3, Period 4||0
9036854|NCT03307837|10097969|FG000|STARTED|Overall Study||6
9036855|NCT03307837|10097970|FG001|STARTED|Overall Study||6
9036856|NCT03307837|10097971|FG002|STARTED|Overall Study||6
9036857|NCT03307837|10097972|FG003|STARTED|Overall Study||6
9036858|NCT03307837|10097973|FG004|STARTED|Overall Study||6
9036859|NCT03307837|10097974|FG005|STARTED|Overall Study||10
9036860|NCT03307837|10097969|FG000|COMPLETED|Overall Study||5
9036861|NCT03307837|10097970|FG001|COMPLETED|Overall Study||5
9036862|NCT03307837|10097971|FG002|COMPLETED|Overall Study||5
9036863|NCT03307837|10097972|FG003|COMPLETED|Overall Study||6
9036864|NCT03307837|10097973|FG004|COMPLETED|Overall Study||6
9036865|NCT03307837|10097974|FG005|COMPLETED|Overall Study||8
9036866|NCT03307837|10097969|FG000|NOT COMPLETED|Overall Study||1
9036867|NCT03307837|10097970|FG001|NOT COMPLETED|Overall Study||1
9036868|NCT03307837|10097971|FG002|NOT COMPLETED|Overall Study||1
9036869|NCT03307837|10097972|FG003|NOT COMPLETED|Overall Study||0
9036870|NCT03307837|10097973|FG004|NOT COMPLETED|Overall Study||0
9036871|NCT03307837|10097974|FG005|NOT COMPLETED|Overall Study||2
9036872|NCT03308058|10097995|FG000|STARTED|Overall Study||23
9036873|NCT03308058|10097996|FG001|STARTED|Overall Study||23
9036874|NCT03308058|10097995|FG000|COMPLETED|Overall Study||23
9036875|NCT03308058|10097996|FG001|COMPLETED|Overall Study||23
9036876|NCT03308058|10097995|FG000|NOT COMPLETED|Overall Study||0
9036877|NCT03308058|10097996|FG001|NOT COMPLETED|Overall Study||0
9036878|NCT03308097|10098004|FG000|STARTED|Overall Study||33
9036879|NCT03308097|10098005|FG001|STARTED|Overall Study||32
9036880|NCT03308097|10098004|FG000|COMPLETED|Overall Study||31
9036881|NCT03308097|10098005|FG001|COMPLETED|Overall Study||31
9036882|NCT03308097|10098004|FG000|NOT COMPLETED|Overall Study||2
9036883|NCT03308097|10098005|FG001|NOT COMPLETED|Overall Study||1
9036884|NCT03308669|10098013|FG000|STARTED|Overall Study||10
9036885|NCT03308669|10098014|FG001|STARTED|Overall Study||20
9036886|NCT03308669|10098013|FG000|Received at Least One Dose of Study Drug|Overall Study||10
9036887|NCT03308669|10098014|FG001|Received at Least One Dose of Study Drug|Overall Study||20
9036888|NCT03308669|10098013|FG000|COMPLETED|Overall Study||10
9036889|NCT03308669|10098014|FG001|COMPLETED|Overall Study||20
9036890|NCT03308669|10098013|FG000|NOT COMPLETED|Overall Study||0
9036891|NCT03308669|10098014|FG001|NOT COMPLETED|Overall Study||0
9036892|NCT03308799|10098035|FG000|STARTED|Overall Study||342
9036893|NCT03308799|10098036|FG001|STARTED|Overall Study||337
9036894|NCT03308799|10098037|FG002|STARTED|Overall Study||115
9036895|NCT03308799|10098035|FG000|COMPLETED|Overall Study||320
9036896|NCT03308799|10098036|FG001|COMPLETED|Overall Study||309
9036897|NCT03308799|10098037|FG002|COMPLETED|Overall Study||94
9036898|NCT03308799|10098035|FG000|NOT COMPLETED|Overall Study||22
9036899|NCT03308799|10098036|FG001|NOT COMPLETED|Overall Study||28
9036900|NCT03308799|10098037|FG002|NOT COMPLETED|Overall Study||21
9036901|NCT03308942|10098050|FG000|STARTED|Stage 1 (up to a Maximum of 29 Months)||17
9036902|NCT03308942|10098051|FG001|STARTED|Stage 1 (up to a Maximum of 29 Months)||21
9036903|NCT03308942|10098052|FG002|STARTED|Stage 1 (up to a Maximum of 29 Months)||3
9036904|NCT03308942|10098053|FG003|STARTED|Stage 1 (up to a Maximum of 29 Months)||0
9036905|NCT03308942|10098054|FG004|STARTED|Stage 1 (up to a Maximum of 29 Months)||0
9036906|NCT03308942|10098050|FG000|COMPLETED|Stage 1 (up to a Maximum of 29 Months)||0
9036907|NCT03308942|10098051|FG001|COMPLETED|Stage 1 (up to a Maximum of 29 Months)||0
9036908|NCT03308942|10098052|FG002|COMPLETED|Stage 1 (up to a Maximum of 29 Months)||0
9036909|NCT03308942|10098053|FG003|COMPLETED|Stage 1 (up to a Maximum of 29 Months)||0
9036910|NCT03308942|10098054|FG004|COMPLETED|Stage 1 (up to a Maximum of 29 Months)||0
9036911|NCT03308942|10098050|FG000|NOT COMPLETED|Stage 1 (up to a Maximum of 29 Months)||17
9036912|NCT03308942|10098051|FG001|NOT COMPLETED|Stage 1 (up to a Maximum of 29 Months)||21
9036913|NCT03308942|10098052|FG002|NOT COMPLETED|Stage 1 (up to a Maximum of 29 Months)||3
9036914|NCT03308942|10098053|FG003|NOT COMPLETED|Stage 1 (up to a Maximum of 29 Months)||0
9036915|NCT03308942|10098054|FG004|NOT COMPLETED|Stage 1 (up to a Maximum of 29 Months)||0
9036916|NCT03308942|10098050|FG000|STARTED|Stage 2 (up to a Maximum of 17 Months)||0
9036917|NCT03308942|10098051|FG001|STARTED|Stage 2 (up to a Maximum of 17 Months)||0
9036918|NCT03308942|10098052|FG002|STARTED|Stage 2 (up to a Maximum of 17 Months)||0
9036919|NCT03308942|10098053|FG003|STARTED|Stage 2 (up to a Maximum of 17 Months)||12
9036920|NCT03308942|10098054|FG004|STARTED|Stage 2 (up to a Maximum of 17 Months)||0
9036921|NCT03308942|10098050|FG000|COMPLETED|Stage 2 (up to a Maximum of 17 Months)||0
9036922|NCT03308942|10098051|FG001|COMPLETED|Stage 2 (up to a Maximum of 17 Months)||0
9036923|NCT03308942|10098052|FG002|COMPLETED|Stage 2 (up to a Maximum of 17 Months)||0
9036924|NCT03308942|10098053|FG003|COMPLETED|Stage 2 (up to a Maximum of 17 Months)||0
9036925|NCT03308942|10098054|FG004|COMPLETED|Stage 2 (up to a Maximum of 17 Months)||0
9036926|NCT03308942|10098050|FG000|NOT COMPLETED|Stage 2 (up to a Maximum of 17 Months)||0
9036927|NCT03308942|10098051|FG001|NOT COMPLETED|Stage 2 (up to a Maximum of 17 Months)||0
9036928|NCT03308942|10098052|FG002|NOT COMPLETED|Stage 2 (up to a Maximum of 17 Months)||0
9036929|NCT03308942|10098053|FG003|NOT COMPLETED|Stage 2 (up to a Maximum of 17 Months)||12
9036930|NCT03308942|10098054|FG004|NOT COMPLETED|Stage 2 (up to a Maximum of 17 Months)||0
9036931|NCT03308968|10098070|FG000|STARTED|Double-Blind Period (12 Weeks)||279
9036932|NCT03308968|10098071|FG001|STARTED|Double-Blind Period (12 Weeks)||276
9036933|NCT03308968|10098072|FG002|STARTED|Double-Blind Period (12 Weeks)||283
9036934|NCT03308968|10098070|FG000|DB Safety Analysis Set|Double-Blind Period (12 Weeks)|2 participants (1 with CM and 1 with EM) randomized to placebo but received Fremanezumab monthly.|277
9036935|NCT03308968|10098071|FG001|DB Safety Analysis Set|Double-Blind Period (12 Weeks)||276
9036936|NCT03308968|10098072|FG002|DB Safety Analysis Set|Double-Blind Period (12 Weeks)|2 participants (1 with CM and 1 with EM) randomized to placebo but received Fremanezumab monthly.|285
9036937|NCT03308968|10098070|FG000|DB Modified ITT (mITT) Analysis Set|Double-Blind Period (12 Weeks)||278
9036938|NCT03308968|10098071|FG001|DB Modified ITT (mITT) Analysis Set|Double-Blind Period (12 Weeks)||276
9036939|NCT03308968|10098072|FG002|DB Modified ITT (mITT) Analysis Set|Double-Blind Period (12 Weeks)||283
9036940|NCT03308968|10098070|FG000|COMPLETED|Double-Blind Period (12 Weeks)||264
9036941|NCT03308968|10098071|FG001|COMPLETED|Double-Blind Period (12 Weeks)||271
9036942|NCT03308968|10098072|FG002|COMPLETED|Double-Blind Period (12 Weeks)||272
9036943|NCT03308968|10098070|FG000|NOT COMPLETED|Double-Blind Period (12 Weeks)||15
9036944|NCT03308968|10098071|FG001|NOT COMPLETED|Double-Blind Period (12 Weeks)||5
9036945|NCT03308968|10098072|FG002|NOT COMPLETED|Double-Blind Period (12 Weeks)||11
9036946|NCT03308968|10098070|FG000|STARTED|Open-Label Period (12 Weeks)||264
9036947|NCT03308968|10098071|FG001|STARTED|Open-Label Period (12 Weeks)||271
9036948|NCT03308968|10098072|FG002|STARTED|Open-Label Period (12 Weeks)||272
9036949|NCT03308968|10098070|FG000|OL mITT Analysis Set|Open-Label Period (12 Weeks)||263
9036950|NCT03308968|10098071|FG001|OL mITT Analysis Set|Open-Label Period (12 Weeks)||271
9036951|NCT03308968|10098072|FG002|OL mITT Analysis Set|Open-Label Period (12 Weeks)||272
9036952|NCT03308968|10098070|FG000|COMPLETED|Open-Label Period (12 Weeks)||253
9036953|NCT03308968|10098071|FG001|COMPLETED|Open-Label Period (12 Weeks)||259
9036954|NCT03308968|10098072|FG002|COMPLETED|Open-Label Period (12 Weeks)||260
9036955|NCT03308968|10098070|FG000|NOT COMPLETED|Open-Label Period (12 Weeks)||11
9036956|NCT03308968|10098071|FG001|NOT COMPLETED|Open-Label Period (12 Weeks)||12
9036957|NCT03308968|10098072|FG002|NOT COMPLETED|Open-Label Period (12 Weeks)||12
9036958|NCT03309020|10098085|FG000|STARTED|Overall Study||12
9036959|NCT03309020|10098086|FG001|STARTED|Overall Study||25
9036960|NCT03309020|10098085|FG000|Underwent Cataract Surgery|Overall Study||10
9036961|NCT03309020|10098086|FG001|Underwent Cataract Surgery|Overall Study||24
9036962|NCT03309020|10098085|FG000|COMPLETED|Overall Study||9
9036963|NCT03309020|10098086|FG001|COMPLETED|Overall Study||24
9036964|NCT03309020|10098085|FG000|NOT COMPLETED|Overall Study||3
9036965|NCT03309020|10098086|FG001|NOT COMPLETED|Overall Study||1
9036966|NCT03309202|10098098|FG000|STARTED|Overall Study||6
9036967|NCT03309202|10098099|FG001|STARTED|Overall Study||6
9036968|NCT03309202|10098100|FG002|STARTED|Overall Study||6
9036969|NCT03309202|10098101|FG003|STARTED|Overall Study||6
9036970|NCT03309202|10098098|FG000|COMPLETED|Overall Study||5
9036971|NCT03309202|10098099|FG001|COMPLETED|Overall Study||6
9036972|NCT03309202|10098100|FG002|COMPLETED|Overall Study||6
9036973|NCT03309202|10098101|FG003|COMPLETED|Overall Study||6
9036974|NCT03309202|10098098|FG000|NOT COMPLETED|Overall Study||1
9036975|NCT03309202|10098099|FG001|NOT COMPLETED|Overall Study||0
9036976|NCT03309202|10098100|FG002|NOT COMPLETED|Overall Study||0
9036977|NCT03309202|10098101|FG003|NOT COMPLETED|Overall Study||0
9036978|NCT03309449|10098114|FG000|STARTED|Overall Study||46
9036979|NCT03309449|10098115|FG001|STARTED|Overall Study||46
9036980|NCT03309449|10098116|FG002|STARTED|Overall Study||46
9036981|NCT03309449|10098114|FG000|COMPLETED|Overall Study||46
9036982|NCT03309449|10098115|FG001|COMPLETED|Overall Study||46
9036983|NCT03309449|10098116|FG002|COMPLETED|Overall Study||46
9036984|NCT03309449|10098114|FG000|NOT COMPLETED|Overall Study||0
9036985|NCT03309449|10098115|FG001|NOT COMPLETED|Overall Study||0
9036986|NCT03309449|10098116|FG002|NOT COMPLETED|Overall Study||0
9036987|NCT03309605|10098132|FG000|STARTED|Overall Study||6
9036988|NCT03309605|10098133|FG001|STARTED|Overall Study||5
9036989|NCT03309605|10098134|FG002|STARTED|Overall Study||6
9036990|NCT03309605|10098135|FG003|STARTED|Overall Study||6
9036991|NCT03309605|10098136|FG004|STARTED|Overall Study||6
9036992|NCT03309605|10098137|FG005|STARTED|Overall Study||6
9036993|NCT03309605|10098138|FG006|STARTED|Overall Study||6
9036994|NCT03309605|10098139|FG007|STARTED|Overall Study||21
9036995|NCT03309605|10098132|FG000|COMPLETED|Overall Study||6
9036996|NCT03309605|10098133|FG001|COMPLETED|Overall Study||5
9036997|NCT03309605|10098134|FG002|COMPLETED|Overall Study||6
9036998|NCT03309605|10098135|FG003|COMPLETED|Overall Study||5
9036999|NCT03309605|10098136|FG004|COMPLETED|Overall Study||5
9037000|NCT03309605|10098137|FG005|COMPLETED|Overall Study||6
9037001|NCT03309605|10098138|FG006|COMPLETED|Overall Study||3
9037002|NCT03309605|10098139|FG007|COMPLETED|Overall Study||19
9037003|NCT03309605|10098132|FG000|NOT COMPLETED|Overall Study||0
9037004|NCT03309605|10098133|FG001|NOT COMPLETED|Overall Study||0
9037005|NCT03309605|10098134|FG002|NOT COMPLETED|Overall Study||0
9037006|NCT03309605|10098135|FG003|NOT COMPLETED|Overall Study||1
9037007|NCT03309605|10098136|FG004|NOT COMPLETED|Overall Study||1
9037008|NCT03309605|10098137|FG005|NOT COMPLETED|Overall Study||0
9037009|NCT03309605|10098138|FG006|NOT COMPLETED|Overall Study||3
9037010|NCT03309605|10098139|FG007|NOT COMPLETED|Overall Study||2
9037011|NCT03309657|10098153|FG000|STARTED|Overall Study||10
9037012|NCT03309657|10098153|FG000|COMPLETED|Overall Study||10
9037013|NCT03309657|10098153|FG000|NOT COMPLETED|Overall Study||0
9037014|NCT03309696|10098159|FG000|STARTED|Overall Study|All five subjects in this arm were randomize to all sham and active tDCS and rTMS interventions.|5
9037015|NCT03309696|10098160|FG001|STARTED|Overall Study|All five subjects in this arm were randomize to all sham and active tDCS and rTMS interventions.|5
9037016|NCT03309696|10098161|FG002|STARTED|Overall Study||0
9037017|NCT03309696|10098162|FG003|STARTED|Overall Study||0
9037018|NCT03309696|10098159|FG000|COMPLETED|Overall Study||5
9037019|NCT03309696|10098160|FG001|COMPLETED|Overall Study||0
9037020|NCT03309696|10098161|FG002|COMPLETED|Overall Study||0
9037021|NCT03309696|10098162|FG003|COMPLETED|Overall Study||0
9037022|NCT03309696|10098159|FG000|NOT COMPLETED|Overall Study||0
9037023|NCT03309696|10098160|FG001|NOT COMPLETED|Overall Study||5
9037024|NCT03309696|10098161|FG002|NOT COMPLETED|Overall Study||0
9037025|NCT03309696|10098162|FG003|NOT COMPLETED|Overall Study||0
9037026|NCT03309787|10098173|FG000|STARTED|Overall Study||8
9037027|NCT03309787|10098174|FG001|STARTED|Overall Study||20
9037028|NCT03309787|10098175|FG002|STARTED|Overall Study||9
9037029|NCT03309787|10098173|FG000|COMPLETED|Overall Study||6
9037030|NCT03309787|10098174|FG001|COMPLETED|Overall Study||14
9037031|NCT03309787|10098175|FG002|COMPLETED|Overall Study||7
9037032|NCT03309787|10098173|FG000|NOT COMPLETED|Overall Study||2
9037033|NCT03309787|10098174|FG001|NOT COMPLETED|Overall Study||6
9037034|NCT03309787|10098175|FG002|NOT COMPLETED|Overall Study||2
9037035|NCT03309943|10098191|FG000|STARTED|Overall Study||22
9037036|NCT03309943|10098192|FG001|STARTED|Overall Study||22
9037037|NCT03309943|10098191|FG000|COMPLETED|Overall Study||22
9037038|NCT03309943|10098192|FG001|COMPLETED|Overall Study||20
9037039|NCT03309943|10098191|FG000|NOT COMPLETED|Overall Study||0
9037040|NCT03309943|10098192|FG001|NOT COMPLETED|Overall Study||2
9037041|NCT03310021|10098218|FG000|STARTED|Overall Study||6
9037042|NCT03310021|10098219|FG001|STARTED|Overall Study||3
9037043|NCT03310021|10098220|FG002|STARTED|Overall Study||6
9037044|NCT03310021|10098221|FG003|STARTED|Overall Study||3
9037045|NCT03310021|10098222|FG004|STARTED|Overall Study||8
9037046|NCT03310021|10098223|FG005|STARTED|Overall Study||4
9037047|NCT03310021|10098224|FG006|STARTED|Overall Study||8
9037048|NCT03310021|10098225|FG007|STARTED|Overall Study||4
9037049|NCT03310021|10098226|FG008|STARTED|Overall Study||6
9037050|NCT03310021|10098227|FG009|STARTED|Overall Study||3
9037051|NCT03310021|10098228|FG010|STARTED|Overall Study||6
9037052|NCT03310021|10098229|FG011|STARTED|Overall Study||3
9037053|NCT03310021|10098230|FG012|STARTED|Overall Study||8
9037054|NCT03310021|10098231|FG013|STARTED|Overall Study||4
9037055|NCT03310021|10098232|FG014|STARTED|Overall Study||6
9037056|NCT03310021|10098233|FG015|STARTED|Overall Study||3
9037057|NCT03310021|10098234|FG016|STARTED|Overall Study||10
9037058|NCT03310021|10098235|FG017|STARTED|Overall Study||5
9037059|NCT03310021|10098236|FG018|STARTED|Overall Study||8
9037060|NCT03310021|10098237|FG019|STARTED|Overall Study||3
9037061|NCT03310021|10098218|FG000|COMPLETED|Overall Study||6
9037062|NCT03310021|10098219|FG001|COMPLETED|Overall Study||3
9037063|NCT03310021|10098220|FG002|COMPLETED|Overall Study||6
9037064|NCT03310021|10098221|FG003|COMPLETED|Overall Study||3
9037065|NCT03310021|10098222|FG004|COMPLETED|Overall Study||8
9037066|NCT03310021|10098223|FG005|COMPLETED|Overall Study||4
9037067|NCT03310021|10098224|FG006|COMPLETED|Overall Study||7
9037068|NCT03310021|10098225|FG007|COMPLETED|Overall Study||4
9037069|NCT03310021|10098226|FG008|COMPLETED|Overall Study||6
9037070|NCT03310021|10098227|FG009|COMPLETED|Overall Study||3
9037071|NCT03310021|10098228|FG010|COMPLETED|Overall Study||5
9037072|NCT03310021|10098229|FG011|COMPLETED|Overall Study||3
9037073|NCT03310021|10098230|FG012|COMPLETED|Overall Study||8
9037074|NCT03310021|10098231|FG013|COMPLETED|Overall Study||4
9037075|NCT03310021|10098232|FG014|COMPLETED|Overall Study||6
9037076|NCT03310021|10098233|FG015|COMPLETED|Overall Study||3
9037077|NCT03310021|10098234|FG016|COMPLETED|Overall Study||10
9037078|NCT03310021|10098235|FG017|COMPLETED|Overall Study||5
9037079|NCT03310021|10098236|FG018|COMPLETED|Overall Study||8
9037080|NCT03310021|10098237|FG019|COMPLETED|Overall Study||3
9037081|NCT03310021|10098218|FG000|NOT COMPLETED|Overall Study||0
9037082|NCT03310021|10098219|FG001|NOT COMPLETED|Overall Study||0
9037083|NCT03310021|10098220|FG002|NOT COMPLETED|Overall Study||0
9037084|NCT03310021|10098221|FG003|NOT COMPLETED|Overall Study||0
9037085|NCT03310021|10098222|FG004|NOT COMPLETED|Overall Study||0
9037086|NCT03310021|10098223|FG005|NOT COMPLETED|Overall Study||0
9037087|NCT03310021|10098224|FG006|NOT COMPLETED|Overall Study||1
9037088|NCT03310021|10098225|FG007|NOT COMPLETED|Overall Study||0
9037089|NCT03310021|10098226|FG008|NOT COMPLETED|Overall Study||0
9037090|NCT03310021|10098227|FG009|NOT COMPLETED|Overall Study||0
9037091|NCT03310021|10098228|FG010|NOT COMPLETED|Overall Study||1
9037092|NCT03310021|10098229|FG011|NOT COMPLETED|Overall Study||0
9037093|NCT03310021|10098230|FG012|NOT COMPLETED|Overall Study||0
9037094|NCT03310021|10098231|FG013|NOT COMPLETED|Overall Study||0
9037095|NCT03310021|10098232|FG014|NOT COMPLETED|Overall Study||0
9037096|NCT03310021|10098233|FG015|NOT COMPLETED|Overall Study||0
9037097|NCT03310021|10098234|FG016|NOT COMPLETED|Overall Study||0
9037098|NCT03310021|10098235|FG017|NOT COMPLETED|Overall Study||0
9037099|NCT03310021|10098236|FG018|NOT COMPLETED|Overall Study||0
9037100|NCT03310021|10098237|FG019|NOT COMPLETED|Overall Study||0
9037101|NCT03310268|10098282|FG000|STARTED|Overall Study||62
9037102|NCT03310268|10098283|FG001|STARTED|Overall Study||62
9037103|NCT03310268|10098284|FG002|STARTED|Overall Study||61
9037104|NCT03310268|10098282|FG000|COMPLETED|Overall Study||61
9037105|NCT03310268|10098283|FG001|COMPLETED|Overall Study||57
9037106|NCT03310268|10098284|FG002|COMPLETED|Overall Study||61
9037107|NCT03310268|10098282|FG000|NOT COMPLETED|Overall Study||1
9037108|NCT03310268|10098283|FG001|NOT COMPLETED|Overall Study||5
9037109|NCT03310268|10098284|FG002|NOT COMPLETED|Overall Study||0
9037110|NCT03310411|10098292|FG000|STARTED|Period 1||10
9037111|NCT03310411|10098293|FG001|STARTED|Period 1||10
9037112|NCT03310411|10098294|FG002|STARTED|Period 1||10
9037113|NCT03310411|10098295|FG003|STARTED|Period 1||10
9037114|NCT03310411|10098292|FG000|Received at Least 1 Dose of Study Drug|Period 1||10
9037115|NCT03310411|10098293|FG001|Received at Least 1 Dose of Study Drug|Period 1||10
9037116|NCT03310411|10098294|FG002|Received at Least 1 Dose of Study Drug|Period 1||10
9037117|NCT03310411|10098295|FG003|Received at Least 1 Dose of Study Drug|Period 1||10
9037118|NCT03310411|10098292|FG000|COMPLETED|Period 1||10
9037119|NCT03310411|10098293|FG001|COMPLETED|Period 1||10
9037120|NCT03310411|10098294|FG002|COMPLETED|Period 1||10
9037121|NCT03310411|10098295|FG003|COMPLETED|Period 1||9
9037122|NCT03310411|10098292|FG000|NOT COMPLETED|Period 1||0
9037123|NCT03310411|10098293|FG001|NOT COMPLETED|Period 1||0
9037124|NCT03310411|10098294|FG002|NOT COMPLETED|Period 1||0
9037125|NCT03310411|10098295|FG003|NOT COMPLETED|Period 1||1
9037126|NCT03310411|10098292|FG000|STARTED|Period 2||10
9037127|NCT03310411|10098293|FG001|STARTED|Period 2||10
9037128|NCT03310411|10098294|FG002|STARTED|Period 2||10
9037129|NCT03310411|10098295|FG003|STARTED|Period 2||9
9037130|NCT03310411|10098292|FG000|COMPLETED|Period 2||10
9037131|NCT03310411|10098293|FG001|COMPLETED|Period 2||10
9037132|NCT03310411|10098294|FG002|COMPLETED|Period 2||10
9037133|NCT03310411|10098295|FG003|COMPLETED|Period 2||9
9037134|NCT03310411|10098292|FG000|NOT COMPLETED|Period 2||0
9037135|NCT03310411|10098293|FG001|NOT COMPLETED|Period 2||0
9037136|NCT03310411|10098294|FG002|NOT COMPLETED|Period 2||0
9037137|NCT03310411|10098295|FG003|NOT COMPLETED|Period 2||0
9037138|NCT03310411|10098292|FG000|STARTED|Period 3||10
9037139|NCT03310411|10098293|FG001|STARTED|Period 3||10
9037140|NCT03310411|10098294|FG002|STARTED|Period 3||10
9037141|NCT03310411|10098295|FG003|STARTED|Period 3||9
9037142|NCT03310411|10098292|FG000|COMPLETED|Period 3||10
9037143|NCT03310411|10098293|FG001|COMPLETED|Period 3||10
9037144|NCT03310411|10098294|FG002|COMPLETED|Period 3||10
9037145|NCT03310411|10098295|FG003|COMPLETED|Period 3||9
9037146|NCT03310411|10098292|FG000|NOT COMPLETED|Period 3||0
9037147|NCT03310411|10098293|FG001|NOT COMPLETED|Period 3||0
9037148|NCT03310411|10098294|FG002|NOT COMPLETED|Period 3||0
9037149|NCT03310411|10098295|FG003|NOT COMPLETED|Period 3||0
9037150|NCT03310411|10098292|FG000|STARTED|Period Title: Period 4||10
9037151|NCT03310411|10098293|FG001|STARTED|Period Title: Period 4||10
9037152|NCT03310411|10098294|FG002|STARTED|Period Title: Period 4||10
9037153|NCT03310411|10098295|FG003|STARTED|Period Title: Period 4||9
9037154|NCT03310411|10098292|FG000|COMPLETED|Period Title: Period 4||10
9037155|NCT03310411|10098293|FG001|COMPLETED|Period Title: Period 4||10
9037156|NCT03310411|10098294|FG002|COMPLETED|Period Title: Period 4||10
9037157|NCT03310411|10098295|FG003|COMPLETED|Period Title: Period 4||9
9037158|NCT03310411|10098292|FG000|NOT COMPLETED|Period Title: Period 4||0
9037159|NCT03310411|10098293|FG001|NOT COMPLETED|Period Title: Period 4||0
9037160|NCT03310411|10098294|FG002|NOT COMPLETED|Period Title: Period 4||0
9037161|NCT03310411|10098295|FG003|NOT COMPLETED|Period Title: Period 4||0
9037162|NCT03310450|10098314|FG000|STARTED|Overall Study||32
9037163|NCT03310450|10098315|FG001|STARTED|Overall Study||34
9037164|NCT03310450|10098316|FG002|STARTED|Overall Study||28
9037165|NCT03310450|10098314|FG000|COMPLETED|Overall Study||30
9037166|NCT03310450|10098315|FG001|COMPLETED|Overall Study||30
9037167|NCT03310450|10098316|FG002|COMPLETED|Overall Study||28
9037168|NCT03310450|10098314|FG000|NOT COMPLETED|Overall Study||2
9037169|NCT03310450|10098315|FG001|NOT COMPLETED|Overall Study||4
9037170|NCT03310450|10098316|FG002|NOT COMPLETED|Overall Study||0
9037171|NCT03310580|10098330|FG000|STARTED|Overall Study||15
9037172|NCT03310580|10098331|FG001|STARTED|Overall Study||15
9037173|NCT03310580|10098332|FG002|STARTED|Overall Study||12
9037174|NCT03310580|10098330|FG000|COMPLETED|Overall Study||15
9037175|NCT03310580|10098331|FG001|COMPLETED|Overall Study||14
9037176|NCT03310580|10098332|FG002|COMPLETED|Overall Study||12
9037177|NCT03310580|10098330|FG000|NOT COMPLETED|Overall Study||0
9037178|NCT03310580|10098331|FG001|NOT COMPLETED|Overall Study||1
9037179|NCT03310580|10098332|FG002|NOT COMPLETED|Overall Study||0
9037180|NCT03310723|10098343|FG000|STARTED|Overall Study||20
9037181|NCT03310723|10098344|FG001|STARTED|Overall Study||20
9037182|NCT03310723|10098343|FG000|COMPLETED|Overall Study||20
9037183|NCT03310723|10098344|FG001|COMPLETED|Overall Study||17
9037184|NCT03310723|10098343|FG000|NOT COMPLETED|Overall Study||0
9037185|NCT03310723|10098344|FG001|NOT COMPLETED|Overall Study||3
9037186|NCT03310775|10098352|FG000|STARTED|Overall Study||19
9037187|NCT03310775|10098353|FG001|STARTED|Overall Study||18
9037188|NCT03310775|10098352|FG000|COMPLETED|Overall Study||17
9037189|NCT03310775|10098353|FG001|COMPLETED|Overall Study||14
9037190|NCT03310775|10098352|FG000|NOT COMPLETED|Overall Study||2
9037191|NCT03310775|10098353|FG001|NOT COMPLETED|Overall Study||4
9037192|NCT03310970|10098359|FG000|STARTED|Overall Study||11
9037193|NCT03310970|10098360|FG001|STARTED|Overall Study||12
9037194|NCT03310970|10098359|FG000|COMPLETED|Overall Study||11
9037195|NCT03310970|10098360|FG001|COMPLETED|Overall Study||11
9037196|NCT03310970|10098359|FG000|NOT COMPLETED|Overall Study||0
9037197|NCT03310970|10098360|FG001|NOT COMPLETED|Overall Study||1
9037198|NCT03311230|10098371|FG000|STARTED|Overall Study||151
9037199|NCT03311230|10098372|FG001|STARTED|Overall Study||151
9037200|NCT03311230|10098373|FG002|STARTED|Overall Study||150
9037201|NCT03311230|10098374|FG003|STARTED|Overall Study||150
9037202|NCT03311230|10098371|FG000|COMPLETED|Overall Study||150
9037203|NCT03311230|10098372|FG001|COMPLETED|Overall Study||146
9037204|NCT03311230|10098373|FG002|COMPLETED|Overall Study||148
9037205|NCT03311230|10098374|FG003|COMPLETED|Overall Study||143
9037206|NCT03311230|10098371|FG000|NOT COMPLETED|Overall Study||1
9037207|NCT03311230|10098372|FG001|NOT COMPLETED|Overall Study||5
9037208|NCT03311230|10098373|FG002|NOT COMPLETED|Overall Study||2
9037209|NCT03311230|10098374|FG003|NOT COMPLETED|Overall Study||7
9037210|NCT03311373|10098384|FG000|STARTED|Overall Study||56
9037211|NCT03311373|10098384|FG000|COMPLETED|Overall Study||47
9037212|NCT03311373|10098384|FG000|NOT COMPLETED|Overall Study||9
9037213|NCT03311646|10098394|FG000|STARTED|Overall Study|Number who were eligible and consented.|31
9037214|NCT03311646|10098394|FG000|COMPLETED|Overall Study|Completed VLNC Condition|16
9037215|NCT03311646|10098394|FG000|NOT COMPLETED|Overall Study||15
9037216|NCT03311659|10098399|FG000|STARTED|Overall Study||447
9037217|NCT03311659|10098399|FG000|COMPLETED|Overall Study||446
9037218|NCT03311659|10098399|FG000|NOT COMPLETED|Overall Study||1
9037219|NCT03311724|10098407|FG000|STARTED|Overall Study||26
9037220|NCT03311724|10098408|FG001|STARTED|Overall Study||29
9037221|NCT03311724|10098409|FG002|STARTED|Overall Study||28
9037222|NCT03311724|10098410|FG003|STARTED|Overall Study||28
9037223|NCT03311724|10098407|FG000|Received At Least One Dose of Study Drug|Overall Study||26
9037224|NCT03311724|10098408|FG001|Received At Least One Dose of Study Drug|Overall Study||29
9037225|NCT03311724|10098409|FG002|Received At Least One Dose of Study Drug|Overall Study||28
9037226|NCT03311724|10098410|FG003|Received At Least One Dose of Study Drug|Overall Study||28
9037227|NCT03311724|10098407|FG000|Completed Treatment|Overall Study||20
9037228|NCT03311724|10098408|FG001|Completed Treatment|Overall Study||27
9037229|NCT03311724|10098409|FG002|Completed Treatment|Overall Study||22
9037230|NCT03311724|10098410|FG003|Completed Treatment|Overall Study||26
9037231|NCT03311724|10098407|FG000|COMPLETED|Overall Study||23
9037232|NCT03311724|10098408|FG001|COMPLETED|Overall Study||28
9037233|NCT03311724|10098409|FG002|COMPLETED|Overall Study||26
9037234|NCT03311724|10098410|FG003|COMPLETED|Overall Study||27
9037235|NCT03311724|10098407|FG000|NOT COMPLETED|Overall Study||3
9037236|NCT03311724|10098408|FG001|NOT COMPLETED|Overall Study||1
9037237|NCT03311724|10098409|FG002|NOT COMPLETED|Overall Study||2
9037238|NCT03311724|10098410|FG003|NOT COMPLETED|Overall Study||1
9037239|NCT03311841|10098428|FG000|STARTED|Period 1||6
9037240|NCT03311841|10098429|FG001|STARTED|Period 1||7
9037241|NCT03311841|10098430|FG002|STARTED|Period 1||6
9037242|NCT03311841|10098431|FG003|STARTED|Period 1||7
9037243|NCT03311841|10098432|FG004|STARTED|Period 1||6
9037244|NCT03311841|10098428|FG000|COMPLETED|Period 1||6
9037245|NCT03311841|10098429|FG001|COMPLETED|Period 1||7
9037246|NCT03311841|10098430|FG002|COMPLETED|Period 1||6
9037247|NCT03311841|10098431|FG003|COMPLETED|Period 1||7
9037248|NCT03311841|10098432|FG004|COMPLETED|Period 1||6
9037249|NCT03311841|10098428|FG000|NOT COMPLETED|Period 1||0
9037250|NCT03311841|10098429|FG001|NOT COMPLETED|Period 1||0
9037251|NCT03311841|10098430|FG002|NOT COMPLETED|Period 1||0
9037252|NCT03311841|10098431|FG003|NOT COMPLETED|Period 1||0
9037253|NCT03311841|10098432|FG004|NOT COMPLETED|Period 1||0
9037254|NCT03311841|10098428|FG000|STARTED|14-day Wash-out||6
9037255|NCT03311841|10098429|FG001|STARTED|14-day Wash-out||7
9037256|NCT03311841|10098430|FG002|STARTED|14-day Wash-out||6
9037257|NCT03311841|10098431|FG003|STARTED|14-day Wash-out||7
9037258|NCT03311841|10098432|FG004|STARTED|14-day Wash-out||6
9037259|NCT03311841|10098428|FG000|COMPLETED|14-day Wash-out||6
9037260|NCT03311841|10098429|FG001|COMPLETED|14-day Wash-out||6
9037261|NCT03311841|10098430|FG002|COMPLETED|14-day Wash-out||6
9037262|NCT03311841|10098431|FG003|COMPLETED|14-day Wash-out||6
9037263|NCT03311841|10098432|FG004|COMPLETED|14-day Wash-out||6
9037264|NCT03311841|10098428|FG000|NOT COMPLETED|14-day Wash-out||0
9037265|NCT03311841|10098429|FG001|NOT COMPLETED|14-day Wash-out||1
9037266|NCT03311841|10098430|FG002|NOT COMPLETED|14-day Wash-out||0
9037267|NCT03311841|10098431|FG003|NOT COMPLETED|14-day Wash-out||1
8577168|NCT00156936|9610068|FG000|STARTED|Overall Study||92
8577169|NCT00156936|9610069|FG001|STARTED|Overall Study||16
8577170|NCT00156936|9610068|FG000|COMPLETED|Overall Study||20
8577171|NCT00156936|9610069|FG001|COMPLETED|Overall Study||5
8577172|NCT00156936|9610068|FG000|NOT COMPLETED|Overall Study||72
8577173|NCT00156936|9610069|FG001|NOT COMPLETED|Overall Study||11
8577174|NCT00157014|9610079|FG000|STARTED|Overall Study||52
8577175|NCT00157014|9610080|FG001|STARTED|Overall Study||46
8577176|NCT00157014|9610081|FG002|STARTED|Overall Study||5
8577177|NCT00157014|9610082|FG003|STARTED|Overall Study||6
8577178|NCT00157014|9610079|FG000|COMPLETED|Overall Study||45
8577179|NCT00157014|9610080|FG001|COMPLETED|Overall Study||41
8577180|NCT00157014|9610081|FG002|COMPLETED|Overall Study||4
8577181|NCT00157014|9610082|FG003|COMPLETED|Overall Study||5
9037268|NCT03311841|10098432|FG004|NOT COMPLETED|14-day Wash-out||0
9037269|NCT03311841|10098428|FG000|STARTED|Period 2||6
9037270|NCT03311841|10098429|FG001|STARTED|Period 2||6
9037271|NCT03311841|10098430|FG002|STARTED|Period 2||6
9037272|NCT03311841|10098431|FG003|STARTED|Period 2||6
8577182|NCT00157014|9610079|FG000|NOT COMPLETED|Overall Study||7
8577183|NCT00157014|9610080|FG001|NOT COMPLETED|Overall Study||5
8922526|NCT02233101|9982914|FG001|STARTED|Overall Study||81
8922527|NCT02233101|9982913|FG000|COMPLETED|Overall Study||74
8922528|NCT02233101|9982914|FG001|COMPLETED|Overall Study||80
9037273|NCT03311841|10098432|FG004|STARTED|Period 2||6
9037274|NCT03311841|10098428|FG000|COMPLETED|Period 2||6
9037275|NCT03311841|10098429|FG001|COMPLETED|Period 2||6
9037276|NCT03311841|10098430|FG002|COMPLETED|Period 2||6
9037277|NCT03311841|10098431|FG003|COMPLETED|Period 2||6
9037278|NCT03311841|10098432|FG004|COMPLETED|Period 2||6
9037279|NCT03311841|10098428|FG000|NOT COMPLETED|Period 2||0
9037280|NCT03311841|10098429|FG001|NOT COMPLETED|Period 2||0
9037281|NCT03311841|10098430|FG002|NOT COMPLETED|Period 2||0
9037282|NCT03311841|10098431|FG003|NOT COMPLETED|Period 2||0
9037283|NCT03311841|10098432|FG004|NOT COMPLETED|Period 2||0
9037284|NCT03312023|10098457|FG000|STARTED|Overall Study||8
9037285|NCT03312023|10098458|FG001|STARTED|Overall Study||5
9037286|NCT03312023|10098459|FG002|STARTED|Overall Study||4
9037287|NCT03312023|10098460|FG003|STARTED|Overall Study||4
9037288|NCT03312023|10098457|FG000|Completed Week 12|Overall Study||8
9037289|NCT03312023|10098458|FG001|Completed Week 12|Overall Study||5
9037290|NCT03312023|10098459|FG002|Completed Week 12|Overall Study||4
9037291|NCT03312023|10098460|FG003|Completed Week 12|Overall Study||4
9037292|NCT03312023|10098457|FG000|COMPLETED|Overall Study||8
9037293|NCT03312023|10098458|FG001|COMPLETED|Overall Study||5
9037294|NCT03312023|10098459|FG002|COMPLETED|Overall Study||4
9037295|NCT03312023|10098460|FG003|COMPLETED|Overall Study||4
9037296|NCT03312023|10098457|FG000|NOT COMPLETED|Overall Study||0
9037297|NCT03312023|10098458|FG001|NOT COMPLETED|Overall Study||0
9037298|NCT03312023|10098459|FG002|NOT COMPLETED|Overall Study||0
9037299|NCT03312023|10098460|FG003|NOT COMPLETED|Overall Study||0
9037300|NCT03312114|10098471|FG000|STARTED|Overall Study||5
9037301|NCT03312114|10098471|FG000|COMPLETED|Overall Study||0
9037302|NCT03312114|10098471|FG000|NOT COMPLETED|Overall Study||5
9037303|NCT03312218|10098478|FG000|STARTED|Overall Study||335
9037304|NCT03312218|10098479|FG001|STARTED|Overall Study||299
9037305|NCT03312218|10098478|FG000|COMPLETED|Overall Study||281
9037306|NCT03312218|10098479|FG001|COMPLETED|Overall Study||241
9037307|NCT03312218|10098478|FG000|NOT COMPLETED|Overall Study||54
9037308|NCT03312218|10098479|FG001|NOT COMPLETED|Overall Study||58
9037309|NCT03312231|10098490|FG000|STARTED|Overall Study||184
9037310|NCT03312231|10098491|FG001|STARTED|Overall Study||176
9037311|NCT03312231|10098492|FG002|STARTED|Overall Study||181
9037312|NCT03312231|10098493|FG003|STARTED|Overall Study||89
9037313|NCT03312231|10098494|FG004|STARTED|Overall Study||90
9037314|NCT03312231|10098490|FG000|COMPLETED|Overall Study||181
9037315|NCT03312231|10098491|FG001|COMPLETED|Overall Study||165
9037316|NCT03312231|10098492|FG002|COMPLETED|Overall Study||177
9037317|NCT03312231|10098493|FG003|COMPLETED|Overall Study||86
9037318|NCT03312231|10098494|FG004|COMPLETED|Overall Study||89
9037319|NCT03312231|10098490|FG000|NOT COMPLETED|Overall Study||3
9037320|NCT03312231|10098491|FG001|NOT COMPLETED|Overall Study||11
9037321|NCT03312231|10098492|FG002|NOT COMPLETED|Overall Study||4
9037322|NCT03312231|10098493|FG003|NOT COMPLETED|Overall Study||3
9037323|NCT03312231|10098494|FG004|NOT COMPLETED|Overall Study||1
9037324|NCT03312348|10098506|FG000|STARTED|Overall Study||30
9037325|NCT03312348|10098506|FG000|COMPLETED|Overall Study||30
9037326|NCT03312348|10098506|FG000|NOT COMPLETED|Overall Study||0
9037327|NCT03312517|10098510|FG000|STARTED|Overall Study||2
9037328|NCT03312517|10098511|FG001|STARTED|Overall Study||2
9037329|NCT03312517|10098512|FG002|STARTED|Overall Study||2
9037330|NCT03312517|10098513|FG003|STARTED|Overall Study||2
9037331|NCT03312517|10098514|FG004|STARTED|Overall Study||2
9037332|NCT03312517|10098515|FG005|STARTED|Overall Study||2
9037333|NCT03312517|10098510|FG000|COMPLETED|Overall Study||2
9037334|NCT03312517|10098511|FG001|COMPLETED|Overall Study||2
9037335|NCT03312517|10098512|FG002|COMPLETED|Overall Study||2
9037336|NCT03312517|10098513|FG003|COMPLETED|Overall Study||2
9037337|NCT03312517|10098514|FG004|COMPLETED|Overall Study||2
9037338|NCT03312517|10098515|FG005|COMPLETED|Overall Study||2
9037339|NCT03312517|10098510|FG000|NOT COMPLETED|Overall Study||0
9037340|NCT03312517|10098511|FG001|NOT COMPLETED|Overall Study||0
9037341|NCT03312517|10098512|FG002|NOT COMPLETED|Overall Study||0
9037342|NCT03312517|10098513|FG003|NOT COMPLETED|Overall Study||0
9037343|NCT03312517|10098514|FG004|NOT COMPLETED|Overall Study||0
9037344|NCT03312517|10098515|FG005|NOT COMPLETED|Overall Study||0
9037345|NCT03312543|10098525|FG000|STARTED|Before Treatment (Screening to Baseline)||61
9037346|NCT03312543|10098526|FG001|STARTED|Before Treatment (Screening to Baseline)||63
9037347|NCT03312543|10098525|FG000|COMPLETED|Before Treatment (Screening to Baseline)||60
9037348|NCT03312543|10098526|FG001|COMPLETED|Before Treatment (Screening to Baseline)||59
9037349|NCT03312543|10098525|FG000|NOT COMPLETED|Before Treatment (Screening to Baseline)||1
9037350|NCT03312543|10098526|FG001|NOT COMPLETED|Before Treatment (Screening to Baseline)||4
9037351|NCT03312543|10098525|FG000|STARTED|Treatment (Baseline to Week 12)||60
9037352|NCT03312543|10098526|FG001|STARTED|Treatment (Baseline to Week 12)||59
9037353|NCT03312543|10098525|FG000|COMPLETED|Treatment (Baseline to Week 12)||56
9037354|NCT03312543|10098526|FG001|COMPLETED|Treatment (Baseline to Week 12)||54
9037355|NCT03312543|10098525|FG000|NOT COMPLETED|Treatment (Baseline to Week 12)||4
9037356|NCT03312543|10098526|FG001|NOT COMPLETED|Treatment (Baseline to Week 12)||5
9037357|NCT03312543|10098525|FG000|STARTED|Regression (Week 12 to Week 24)||56
9037358|NCT03312543|10098526|FG001|STARTED|Regression (Week 12 to Week 24)||54
9037359|NCT03312543|10098525|FG000|COMPLETED|Regression (Week 12 to Week 24)||55
8922529|NCT02233101|9982913|FG000|NOT COMPLETED|Overall Study||12
8922530|NCT02233101|9982914|FG001|NOT COMPLETED|Overall Study||1
8922531|NCT02233296|9982922|FG000|STARTED|Overall Study||16
8922532|NCT02233296|9982923|FG001|STARTED|Overall Study||14
8922533|NCT02233296|9982922|FG000|COMPLETED|Overall Study||16
8922534|NCT02233296|9982923|FG001|COMPLETED|Overall Study||14
8922535|NCT02233296|9982922|FG000|NOT COMPLETED|Overall Study||0
8922536|NCT02233296|9982923|FG001|NOT COMPLETED|Overall Study||0
8922537|NCT02233309|9982933|FG000|STARTED|Overall Study||36
8922538|NCT02233309|9982933|FG000|COMPLETED|Overall Study||31
8922539|NCT02233309|9982933|FG000|NOT COMPLETED|Overall Study||5
8922540|NCT02233413|9982939|FG000|STARTED|Overall Study||35
8922541|NCT02233413|9982940|FG001|STARTED|Overall Study||33
8922542|NCT02233413|9982939|FG000|COMPLETED|Overall Study||24
8922543|NCT02233413|9982940|FG001|COMPLETED|Overall Study||19
8922544|NCT02233413|9982939|FG000|NOT COMPLETED|Overall Study||11
8922545|NCT02233413|9982940|FG001|NOT COMPLETED|Overall Study||14
8922546|NCT02233478|9982946|FG000|STARTED|First Intervention (1 Day)||3
8922547|NCT02233478|9982947|FG001|STARTED|First Intervention (1 Day)||3
8922548|NCT02233478|9982948|FG002|STARTED|First Intervention (1 Day)||3
8922549|NCT02233478|9982949|FG003|STARTED|First Intervention (1 Day)||3
8922550|NCT02233478|9982950|FG004|STARTED|First Intervention (1 Day)||3
8922551|NCT02233478|9982951|FG005|STARTED|First Intervention (1 Day)||3
8922552|NCT02233478|9982946|FG000|COMPLETED|First Intervention (1 Day)||3
8922553|NCT02233478|9982947|FG001|COMPLETED|First Intervention (1 Day)||3
8922554|NCT02233478|9982948|FG002|COMPLETED|First Intervention (1 Day)||3
8922555|NCT02233478|9982949|FG003|COMPLETED|First Intervention (1 Day)||3
8922556|NCT02233478|9982950|FG004|COMPLETED|First Intervention (1 Day)||3
8922557|NCT02233478|9982951|FG005|COMPLETED|First Intervention (1 Day)||3
8922558|NCT02233478|9982946|FG000|NOT COMPLETED|First Intervention (1 Day)||0
8922559|NCT02233478|9982947|FG001|NOT COMPLETED|First Intervention (1 Day)||0
8922560|NCT02233478|9982948|FG002|NOT COMPLETED|First Intervention (1 Day)||0
8922561|NCT02233478|9982949|FG003|NOT COMPLETED|First Intervention (1 Day)||0
8922562|NCT02233478|9982950|FG004|NOT COMPLETED|First Intervention (1 Day)||0
8922563|NCT02233478|9982951|FG005|NOT COMPLETED|First Intervention (1 Day)||0
8922564|NCT02233478|9982946|FG000|STARTED|Washout (7 Days)||3
8922565|NCT02233478|9982947|FG001|STARTED|Washout (7 Days)||3
8922566|NCT02233478|9982948|FG002|STARTED|Washout (7 Days)||3
8922567|NCT02233478|9982949|FG003|STARTED|Washout (7 Days)||3
8922568|NCT02233478|9982950|FG004|STARTED|Washout (7 Days)||3
8922569|NCT02233478|9982951|FG005|STARTED|Washout (7 Days)||3
8922570|NCT02233478|9982946|FG000|COMPLETED|Washout (7 Days)||3
8922571|NCT02233478|9982947|FG001|COMPLETED|Washout (7 Days)||3
8922572|NCT02233478|9982948|FG002|COMPLETED|Washout (7 Days)||3
8922573|NCT02233478|9982949|FG003|COMPLETED|Washout (7 Days)||3
8922574|NCT02233478|9982950|FG004|COMPLETED|Washout (7 Days)||3
8922575|NCT02233478|9982951|FG005|COMPLETED|Washout (7 Days)||3
8922576|NCT02233478|9982946|FG000|NOT COMPLETED|Washout (7 Days)||0
8922577|NCT02233478|9982947|FG001|NOT COMPLETED|Washout (7 Days)||0
8922578|NCT02233478|9982948|FG002|NOT COMPLETED|Washout (7 Days)||0
8922579|NCT02233478|9982949|FG003|NOT COMPLETED|Washout (7 Days)||0
8922580|NCT02233478|9982950|FG004|NOT COMPLETED|Washout (7 Days)||0
8922581|NCT02233478|9982951|FG005|NOT COMPLETED|Washout (7 Days)||0
8922582|NCT02233478|9982946|FG000|STARTED|Second Intervention (1 Day)||3
8922583|NCT02233478|9982947|FG001|STARTED|Second Intervention (1 Day)||3
8922584|NCT02233478|9982948|FG002|STARTED|Second Intervention (1 Day)||3
8922585|NCT02233478|9982949|FG003|STARTED|Second Intervention (1 Day)||3
8922586|NCT02233478|9982950|FG004|STARTED|Second Intervention (1 Day)||3
8922587|NCT02233478|9982951|FG005|STARTED|Second Intervention (1 Day)||3
8922588|NCT02233478|9982946|FG000|COMPLETED|Second Intervention (1 Day)||3
8922589|NCT02233478|9982947|FG001|COMPLETED|Second Intervention (1 Day)||3
8922590|NCT02233478|9982948|FG002|COMPLETED|Second Intervention (1 Day)||3
8922591|NCT02233478|9982949|FG003|COMPLETED|Second Intervention (1 Day)||3
8922592|NCT02233478|9982950|FG004|COMPLETED|Second Intervention (1 Day)||3
8922593|NCT02233478|9982951|FG005|COMPLETED|Second Intervention (1 Day)||3
8922594|NCT02233478|9982946|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
8922595|NCT02233478|9982947|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
8922596|NCT02233478|9982948|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
8922597|NCT02233478|9982949|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
8922598|NCT02233478|9982950|FG004|NOT COMPLETED|Second Intervention (1 Day)||0
8922599|NCT02233478|9982951|FG005|NOT COMPLETED|Second Intervention (1 Day)||0
8922600|NCT02233478|9982946|FG000|STARTED|Washout (7 Days)||3
8922601|NCT02233478|9982947|FG001|STARTED|Washout (7 Days)||3
8922602|NCT02233478|9982948|FG002|STARTED|Washout (7 Days)||3
8922603|NCT02233478|9982949|FG003|STARTED|Washout (7 Days)||3
8922604|NCT02233478|9982950|FG004|STARTED|Washout (7 Days)||3
8922605|NCT02233478|9982951|FG005|STARTED|Washout (7 Days)||3
8922606|NCT02233478|9982946|FG000|COMPLETED|Washout (7 Days)||3
8922607|NCT02233478|9982947|FG001|COMPLETED|Washout (7 Days)||3
8922608|NCT02233478|9982948|FG002|COMPLETED|Washout (7 Days)||3
8922609|NCT02233478|9982949|FG003|COMPLETED|Washout (7 Days)||3
8922610|NCT02233478|9982950|FG004|COMPLETED|Washout (7 Days)||3
8922611|NCT02233478|9982951|FG005|COMPLETED|Washout (7 Days)||3
8922612|NCT02233478|9982946|FG000|NOT COMPLETED|Washout (7 Days)||0
8922613|NCT02233478|9982947|FG001|NOT COMPLETED|Washout (7 Days)||0
8922614|NCT02233478|9982948|FG002|NOT COMPLETED|Washout (7 Days)||0
8922615|NCT02233478|9982949|FG003|NOT COMPLETED|Washout (7 Days)||0
8922616|NCT02233478|9982950|FG004|NOT COMPLETED|Washout (7 Days)||0
8922617|NCT02233478|9982951|FG005|NOT COMPLETED|Washout (7 Days)||0
8922618|NCT02233478|9982946|FG000|STARTED|Third Intervention (1 Day)||3
8922619|NCT02233478|9982947|FG001|STARTED|Third Intervention (1 Day)||3
8922620|NCT02233478|9982948|FG002|STARTED|Third Intervention (1 Day)||3
8922621|NCT02233478|9982949|FG003|STARTED|Third Intervention (1 Day)||3
8922622|NCT02233478|9982950|FG004|STARTED|Third Intervention (1 Day)||3
8922623|NCT02233478|9982951|FG005|STARTED|Third Intervention (1 Day)||3
8922624|NCT02233478|9982946|FG000|COMPLETED|Third Intervention (1 Day)||3
8922625|NCT02233478|9982947|FG001|COMPLETED|Third Intervention (1 Day)||3
8922626|NCT02233478|9982948|FG002|COMPLETED|Third Intervention (1 Day)||3
8922627|NCT02233478|9982949|FG003|COMPLETED|Third Intervention (1 Day)||3
8922628|NCT02233478|9982950|FG004|COMPLETED|Third Intervention (1 Day)||3
8922629|NCT02233478|9982951|FG005|COMPLETED|Third Intervention (1 Day)||3
8922630|NCT02233478|9982946|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
8922631|NCT02233478|9982947|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
8922632|NCT02233478|9982948|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
8922633|NCT02233478|9982949|FG003|NOT COMPLETED|Third Intervention (1 Day)||0
8922634|NCT02233478|9982950|FG004|NOT COMPLETED|Third Intervention (1 Day)||0
8922635|NCT02233478|9982951|FG005|NOT COMPLETED|Third Intervention (1 Day)||0
8922636|NCT02233517|9982961|FG000|STARTED|Overall Study||19
8922637|NCT02233517|9982962|FG001|STARTED|Overall Study||17
8922638|NCT02233517|9982961|FG000|COMPLETED|Overall Study||12
8922639|NCT02233517|9982962|FG001|COMPLETED|Overall Study||13
8922640|NCT02233517|9982961|FG000|NOT COMPLETED|Overall Study||7
8922641|NCT02233517|9982962|FG001|NOT COMPLETED|Overall Study||4
8922642|NCT02233530|9982968|FG000|STARTED|Overall Study||8
8922643|NCT02233530|9982968|FG000|COMPLETED|Overall Study||8
8922644|NCT02233530|9982968|FG000|NOT COMPLETED|Overall Study||0
8922645|NCT02233543|9982972|FG000|STARTED|Period 1||22
8922646|NCT02233543|9982973|FG001|STARTED|Period 1||16
8922647|NCT02233543|9982972|FG000|COMPLETED|Period 1||19
8922648|NCT02233543|9982973|FG001|COMPLETED|Period 1||13
8922649|NCT02233543|9982972|FG000|NOT COMPLETED|Period 1||3
8922650|NCT02233543|9982973|FG001|NOT COMPLETED|Period 1||3
8922651|NCT02233543|9982972|FG000|STARTED|Period 2||19
8922652|NCT02233543|9982973|FG001|STARTED|Period 2||13
8922653|NCT02233543|9982972|FG000|COMPLETED|Period 2|1 participant erroneously received QVA149 during both periods.|17
8922654|NCT02233543|9982973|FG001|COMPLETED|Period 2||12
8922655|NCT02233543|9982972|FG000|NOT COMPLETED|Period 2||2
8922656|NCT02233543|9982973|FG001|NOT COMPLETED|Period 2||1
8922657|NCT02233647|9982979|FG000|STARTED|Overall Study||11
8922658|NCT02233647|9982979|FG000|0 mg Cocaine With 0 mg Phendimetrazine|Overall Study||11
8922659|NCT02233647|9982979|FG000|10 mg Cocaine With 0 mg Phendimetrazine|Overall Study||11
8922660|NCT02233647|9982979|FG000|20 mg Cocaine With 0 mg Phendimetrazine|Overall Study||10
8922661|NCT02233647|9982979|FG000|40 mg Cocaine With 0 mg Phendimetrazine|Overall Study||10
8922662|NCT02233647|9982979|FG000|80 mg Cocaine With 0 mg Phendimetrazine|Overall Study||10
8922663|NCT02233647|9982979|FG000|0 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
8922664|NCT02233647|9982979|FG000|10 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
8922665|NCT02233647|9982979|FG000|20 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
8922666|NCT02233647|9982979|FG000|40 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
8922667|NCT02233647|9982979|FG000|80 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
8922668|NCT02233647|9982979|FG000|0 mg Cocaine With 140 mg Phendimetrazine|Overall Study||10
8922669|NCT02233647|9982979|FG000|10 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
8922670|NCT02233647|9982979|FG000|20 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
8922671|NCT02233647|9982979|FG000|40 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
8922672|NCT02233647|9982979|FG000|80 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
8922673|NCT02233647|9982979|FG000|0 mg Cocaine With 210 mg Phendimetrazine|Overall Study||10
8922674|NCT02233647|9982979|FG000|10 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
8922675|NCT02233647|9982979|FG000|20 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
8922676|NCT02233647|9982979|FG000|40 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
8922677|NCT02233647|9982979|FG000|80 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
8922678|NCT02233647|9982979|FG000|COMPLETED|Overall Study||10
8922679|NCT02233647|9982979|FG000|NOT COMPLETED|Overall Study||1
8922680|NCT02233738|9982985|FG000|STARTED|Overall Study||93
8922681|NCT02233738|9982986|FG001|STARTED|Overall Study||91
8922682|NCT02233738|9982985|FG000|1 Month Follow-Up|Overall Study||89
8922683|NCT02233738|9982986|FG001|1 Month Follow-Up|Overall Study||82
8922684|NCT02233738|9982985|FG000|3 Month Follow-Up|Overall Study||87
8922685|NCT02233738|9982986|FG001|3 Month Follow-Up|Overall Study||77
8922686|NCT02233738|9982985|FG000|6 Month Follow-Up|Overall Study||85
8922687|NCT02233738|9982986|FG001|6 Month Follow-Up|Overall Study||75
8922688|NCT02233738|9982985|FG000|COMPLETED|Overall Study||85
8922689|NCT02233738|9982986|FG001|COMPLETED|Overall Study||75
8922690|NCT02233738|9982985|FG000|NOT COMPLETED|Overall Study||8
8922691|NCT02233738|9982986|FG001|NOT COMPLETED|Overall Study||16
8922692|NCT02233751|9983156|FG000|STARTED|Overall Study||6
8922693|NCT02233751|9983157|FG001|STARTED|Overall Study||6
8922694|NCT02233751|9983156|FG000|COMPLETED|Overall Study||6
8922695|NCT02233751|9983157|FG001|COMPLETED|Overall Study||6
8922696|NCT02233751|9983156|FG000|NOT COMPLETED|Overall Study||0
8922697|NCT02233751|9983157|FG001|NOT COMPLETED|Overall Study||0
8922698|NCT02233803|9983163|FG000|STARTED|Treatment Period 1 (4-Wks)||100
8922699|NCT02233803|9983164|FG001|STARTED|Treatment Period 1 (4-Wks)||99
8922700|NCT02233803|9983163|FG000|COMPLETED|Treatment Period 1 (4-Wks)||97
8922701|NCT02233803|9983164|FG001|COMPLETED|Treatment Period 1 (4-Wks)||95
8922702|NCT02233803|9983163|FG000|NOT COMPLETED|Treatment Period 1 (4-Wks)||3
8922703|NCT02233803|9983164|FG001|NOT COMPLETED|Treatment Period 1 (4-Wks)||4
8922704|NCT02233803|9983163|FG000|STARTED|Washout Period (4-Wks)||97
8922705|NCT02233803|9983164|FG001|STARTED|Washout Period (4-Wks)||95
8922706|NCT02233803|9983163|FG000|COMPLETED|Washout Period (4-Wks)||95
8922707|NCT02233803|9983164|FG001|COMPLETED|Washout Period (4-Wks)||93
8922708|NCT02233803|9983163|FG000|NOT COMPLETED|Washout Period (4-Wks)||2
8922709|NCT02233803|9983164|FG001|NOT COMPLETED|Washout Period (4-Wks)||2
8922710|NCT02233803|9983163|FG000|STARTED|Treatment Period 2 (4-Wks)||95
8922711|NCT02233803|9983164|FG001|STARTED|Treatment Period 2 (4-Wks)||93
8922712|NCT02233803|9983163|FG000|COMPLETED|Treatment Period 2 (4-Wks)||93
8922713|NCT02233803|9983164|FG001|COMPLETED|Treatment Period 2 (4-Wks)||91
8922714|NCT02233803|9983163|FG000|NOT COMPLETED|Treatment Period 2 (4-Wks)||2
8922715|NCT02233803|9983164|FG001|NOT COMPLETED|Treatment Period 2 (4-Wks)||2
8922716|NCT02233842|9983172|FG000|STARTED|Questionnaire 1 Version 1||5
8922717|NCT02233842|9983172|FG000|COMPLETED|Questionnaire 1 Version 1||5
8922718|NCT02233842|9983172|FG000|NOT COMPLETED|Questionnaire 1 Version 1||0
8922719|NCT02233842|9983172|FG000|STARTED|Questionnaire 1 Version 2||5
8922720|NCT02233842|9983172|FG000|COMPLETED|Questionnaire 1 Version 2||5
8922721|NCT02233842|9983172|FG000|NOT COMPLETED|Questionnaire 1 Version 2||0
8922722|NCT02233842|9983172|FG000|STARTED|Questionnaire 2 Version 1||5
8922723|NCT02233842|9983172|FG000|COMPLETED|Questionnaire 2 Version 1||5
8922724|NCT02233842|9983172|FG000|NOT COMPLETED|Questionnaire 2 Version 1||0
8922725|NCT02233842|9983172|FG000|STARTED|Questionnaire 2 Version 2||5
8922726|NCT02233842|9983172|FG000|COMPLETED|Questionnaire 2 Version 2||5
8922727|NCT02233842|9983172|FG000|NOT COMPLETED|Questionnaire 2 Version 2||0
8922728|NCT02233842|9983172|FG000|STARTED|Questionnaire 3 Version 1||5
8922729|NCT02233842|9983172|FG000|COMPLETED|Questionnaire 3 Version 1||5
8922730|NCT02233842|9983172|FG000|NOT COMPLETED|Questionnaire 3 Version 1||0
8922731|NCT02233842|9983172|FG000|STARTED|Questionnaire 3 Version 2||5
8922732|NCT02233842|9983172|FG000|COMPLETED|Questionnaire 3 Version 2||5
8922733|NCT02233842|9983172|FG000|NOT COMPLETED|Questionnaire 3 Version 2||0
8922734|NCT02233946|9983179|FG000|STARTED|Baseline|Allocated to and received the intervention|628
8922735|NCT02233946|9983180|FG001|STARTED|Baseline|Allocated to and received usual care|243
8922736|NCT02233946|9983179|FG000|COMPLETED|Baseline|Completed baseline assessment|626
8922737|NCT02233946|9983180|FG001|COMPLETED|Baseline|Completed baseline assessment|243
8922738|NCT02233946|9983179|FG000|NOT COMPLETED|Baseline||2
8922739|NCT02233946|9983180|FG001|NOT COMPLETED|Baseline||0
8922740|NCT02233946|9983179|FG000|STARTED|Immediate Post-visit Questionnaire||626
8922741|NCT02233946|9983180|FG001|STARTED|Immediate Post-visit Questionnaire||243
8922742|NCT02233946|9983179|FG000|COMPLETED|Immediate Post-visit Questionnaire||624
8922743|NCT02233946|9983180|FG001|COMPLETED|Immediate Post-visit Questionnaire||243
8922744|NCT02233946|9983179|FG000|NOT COMPLETED|Immediate Post-visit Questionnaire||2
8922745|NCT02233946|9983180|FG001|NOT COMPLETED|Immediate Post-visit Questionnaire||0
8922746|NCT02233946|9983179|FG000|STARTED|3-months Follow-up||624
8922747|NCT02233946|9983180|FG001|STARTED|3-months Follow-up||243
8922748|NCT02233946|9983179|FG000|COMPLETED|3-months Follow-up||571
8922749|NCT02233946|9983180|FG001|COMPLETED|3-months Follow-up||214
8922750|NCT02233946|9983179|FG000|NOT COMPLETED|3-months Follow-up||53
8922751|NCT02233946|9983180|FG001|NOT COMPLETED|3-months Follow-up||29
8922752|NCT02233946|9983179|FG000|STARTED|6-months Follow-up||571
8922753|NCT02233946|9983180|FG001|STARTED|6-months Follow-up||214
8922754|NCT02233946|9983179|FG000|COMPLETED|6-months Follow-up||550
8922755|NCT02233946|9983180|FG001|COMPLETED|6-months Follow-up||212
8922756|NCT02233946|9983179|FG000|NOT COMPLETED|6-months Follow-up||21
8922757|NCT02233946|9983180|FG001|NOT COMPLETED|6-months Follow-up||2
8922758|NCT02233946|9983179|FG000|STARTED|9-month Follow-up||550
8922759|NCT02233946|9983180|FG001|STARTED|9-month Follow-up||212
8922760|NCT02233946|9983179|FG000|COMPLETED|9-month Follow-up||530
8922761|NCT02233946|9983180|FG001|COMPLETED|9-month Follow-up||201
8922762|NCT02233946|9983179|FG000|NOT COMPLETED|9-month Follow-up||20
8922763|NCT02233946|9983180|FG001|NOT COMPLETED|9-month Follow-up||11
8922764|NCT02233946|9983179|FG000|STARTED|12-month Follow-up||530
8922765|NCT02233946|9983180|FG001|STARTED|12-month Follow-up||201
8922766|NCT02233946|9983179|FG000|COMPLETED|12-month Follow-up||502
8922767|NCT02233946|9983180|FG001|COMPLETED|12-month Follow-up||190
8922768|NCT02233946|9983179|FG000|NOT COMPLETED|12-month Follow-up||28
8922769|NCT02233946|9983180|FG001|NOT COMPLETED|12-month Follow-up||11
8922770|NCT02233985|9983188|FG000|STARTED|Overall Study||33
8922771|NCT02233985|9983189|FG001|STARTED|Overall Study||31
8922772|NCT02233985|9983188|FG000|COMPLETED|Overall Study||33
8922773|NCT02233985|9983189|FG001|COMPLETED|Overall Study||31
8922774|NCT02233985|9983188|FG000|NOT COMPLETED|Overall Study||0
8922775|NCT02233985|9983189|FG001|NOT COMPLETED|Overall Study||0
8922776|NCT02233998|9983200|FG000|STARTED|Overall Study||53
8922777|NCT02233998|9983201|FG001|STARTED|Overall Study||52
8922778|NCT02233998|9983202|FG002|STARTED|Overall Study||53
8922779|NCT02233998|9983200|FG000|COMPLETED|Overall Study||53
8922780|NCT02233998|9983201|FG001|COMPLETED|Overall Study||52
8922781|NCT02233998|9983202|FG002|COMPLETED|Overall Study||53
8922782|NCT02233998|9983200|FG000|NOT COMPLETED|Overall Study||0
8922783|NCT02233998|9983201|FG001|NOT COMPLETED|Overall Study||0
8922784|NCT02233998|9983202|FG002|NOT COMPLETED|Overall Study||0
8922785|NCT02234063|9983212|FG000|STARTED|Overall Study||1795
8922786|NCT02234063|9983213|FG001|STARTED|Overall Study||255
8922787|NCT02234063|9983212|FG000|COMPLETED|Overall Study||1540
8922788|NCT02234063|9983213|FG001|COMPLETED|Overall Study||212
8922789|NCT02234063|9983212|FG000|NOT COMPLETED|Overall Study||255
8922790|NCT02234063|9983213|FG001|NOT COMPLETED|Overall Study||43
8922791|NCT02234115|9983224|FG000|STARTED|Overall Study||137
8922792|NCT02234115|9983224|FG000|ITT|Overall Study||137
8922793|NCT02234115|9983224|FG000|PP|Overall Study||124
8922794|NCT02234115|9983224|FG000|PK Subgroup|Overall Study||31
8922795|NCT02234115|9983224|FG000|COMPLETED|Overall Study||122
8922796|NCT02234115|9983224|FG000|NOT COMPLETED|Overall Study||15
9037360|NCT03312543|10098526|FG001|COMPLETED|Regression (Week 12 to Week 24)||52
9037361|NCT03312543|10098525|FG000|NOT COMPLETED|Regression (Week 12 to Week 24)||1
9037362|NCT03312543|10098526|FG001|NOT COMPLETED|Regression (Week 12 to Week 24)||2
9037363|NCT03312595|10098532|FG000|STARTED|Overall Study||30
9037364|NCT03312595|10098532|FG000|COMPLETED|Overall Study||24
9037365|NCT03312595|10098532|FG000|NOT COMPLETED|Overall Study||6
9037366|NCT03312933|10098536|FG000|STARTED|Overall Study||100
9037367|NCT03312933|10098536|FG000|COMPLETED|Overall Study||46
9037368|NCT03312933|10098536|FG000|NOT COMPLETED|Overall Study||54
9037369|NCT03313037|10098542|FG000|STARTED|Overall Study||222
9037370|NCT03313037|10098543|FG001|STARTED|Overall Study||222
9037371|NCT03313037|10098542|FG000|Safety Population|Overall Study||221
9037372|NCT03313037|10098543|FG001|Safety Population|Overall Study||222
9037373|NCT03313037|10098542|FG000|Evaluable Immunogenicity Population(EIP)|Overall Study||210
9037374|NCT03313037|10098543|FG001|Evaluable Immunogenicity Population(EIP)|Overall Study||208
9037375|NCT03313037|10098542|FG000|COMPLETED|Overall Study||202
9037376|NCT03313037|10098543|FG001|COMPLETED|Overall Study||202
9037377|NCT03313037|10098542|FG000|NOT COMPLETED|Overall Study||20
9037378|NCT03313037|10098543|FG001|NOT COMPLETED|Overall Study||20
9037379|NCT03313050|10098553|FG000|STARTED|Stage 1: 6 Months||34
9037380|NCT03313050|10098554|FG001|STARTED|Stage 1: 6 Months||32
9037381|NCT03313050|10098555|FG002|STARTED|Stage 1: 6 Months||0
9037382|NCT03313050|10098556|FG003|STARTED|Stage 1: 6 Months||0
9037383|NCT03313050|10098553|FG000|Vaccinated|Stage 1: 6 Months||34
9037384|NCT03313050|10098554|FG001|Vaccinated|Stage 1: 6 Months||32
9037385|NCT03313050|10098555|FG002|Vaccinated|Stage 1: 6 Months||0
9037386|NCT03313050|10098556|FG003|Vaccinated|Stage 1: 6 Months||0
9037387|NCT03313050|10098553|FG000|COMPLETED|Stage 1: 6 Months||34
9037388|NCT03313050|10098554|FG001|COMPLETED|Stage 1: 6 Months||32
9037389|NCT03313050|10098555|FG002|COMPLETED|Stage 1: 6 Months||0
9037390|NCT03313050|10098556|FG003|COMPLETED|Stage 1: 6 Months||0
9037391|NCT03313050|10098553|FG000|NOT COMPLETED|Stage 1: 6 Months||0
9037392|NCT03313050|10098554|FG001|NOT COMPLETED|Stage 1: 6 Months||0
9037393|NCT03313050|10098555|FG002|NOT COMPLETED|Stage 1: 6 Months||0
9037394|NCT03313050|10098556|FG003|NOT COMPLETED|Stage 1: 6 Months||0
9037395|NCT03313050|10098553|FG000|STARTED|Stage 2: 12 Months|Stage 1 participants did not continue in Stage 2.|0
9037396|NCT03313050|10098554|FG001|STARTED|Stage 2: 12 Months|Stage 1 participants did not continue in Stage 2.|0
9037397|NCT03313050|10098555|FG002|STARTED|Stage 2: 12 Months|After Stage 1 safety was acceptable then Stage 2 followed with newer participants.|221
9037398|NCT03313050|10098556|FG003|STARTED|Stage 2: 12 Months|After Stage 1 safety was acceptable then Stage 2 followed with newer participants.|224
9037399|NCT03313050|10098553|FG000|Vaccinated|Stage 2: 12 Months||0
9037400|NCT03313050|10098554|FG001|Vaccinated|Stage 2: 12 Months||0
9037401|NCT03313050|10098555|FG002|Vaccinated|Stage 2: 12 Months||221
9037402|NCT03313050|10098556|FG003|Vaccinated|Stage 2: 12 Months||223
9037403|NCT03313050|10098553|FG000|COMPLETED|Stage 2: 12 Months||0
9037404|NCT03313050|10098554|FG001|COMPLETED|Stage 2: 12 Months||0
9037405|NCT03313050|10098555|FG002|COMPLETED|Stage 2: 12 Months||210
9037406|NCT03313050|10098556|FG003|COMPLETED|Stage 2: 12 Months||204
9037407|NCT03313050|10098553|FG000|NOT COMPLETED|Stage 2: 12 Months||0
9037408|NCT03313050|10098554|FG001|NOT COMPLETED|Stage 2: 12 Months||0
9037409|NCT03313050|10098555|FG002|NOT COMPLETED|Stage 2: 12 Months||11
9037410|NCT03313050|10098556|FG003|NOT COMPLETED|Stage 2: 12 Months||20
9037411|NCT03313076|10098570|FG000|STARTED|Overall Study||7
9037412|NCT03313076|10098571|FG001|STARTED|Overall Study||6
9037413|NCT03313076|10098572|FG002|STARTED|Overall Study||6
9037414|NCT03313076|10098573|FG003|STARTED|Overall Study||5
9037415|NCT03313076|10098570|FG000|COMPLETED|Overall Study||5
9037416|NCT03313076|10098571|FG001|COMPLETED|Overall Study||4
9037417|NCT03313076|10098572|FG002|COMPLETED|Overall Study||4
9037418|NCT03313076|10098573|FG003|COMPLETED|Overall Study||3
9037419|NCT03313076|10098570|FG000|NOT COMPLETED|Overall Study||2
9037420|NCT03313076|10098571|FG001|NOT COMPLETED|Overall Study||2
9037421|NCT03313076|10098572|FG002|NOT COMPLETED|Overall Study||2
9037422|NCT03313076|10098573|FG003|NOT COMPLETED|Overall Study||2
9037423|NCT03313310|10098591|FG000|STARTED|Phase 2||51
9037424|NCT03313310|10098592|FG001|STARTED|Phase 2|Phase 2 participants did not participate in Phase 3.|0
9037425|NCT03313310|10098591|FG000|COMPLETED|Phase 2||47
9037426|NCT03313310|10098592|FG001|COMPLETED|Phase 2|Phase 2 participants did not participate in Phase 3.|0
9037427|NCT03313310|10098591|FG000|NOT COMPLETED|Phase 2||4
9037428|NCT03313310|10098592|FG001|NOT COMPLETED|Phase 2||0
9037429|NCT03313310|10098591|FG000|STARTED|Phase 3|Phase 3 participants did not participate in Phase 2.|0
9037430|NCT03313310|10098592|FG001|STARTED|Phase 3||41
9037431|NCT03313310|10098591|FG000|COMPLETED|Phase 3|Phase 3 participants did not participate in Phase 2.|0
9037432|NCT03313310|10098592|FG001|COMPLETED|Phase 3||40
8922797|NCT02234128|9983231|FG000|STARTED|Overall Study||35
8922798|NCT02234128|9983232|FG001|STARTED|Overall Study||31
8922799|NCT02234128|9983233|FG002|STARTED|Overall Study||52
8922800|NCT02234128|9983231|FG000|COMPLETED|Overall Study||30
8922801|NCT02234128|9983232|FG001|COMPLETED|Overall Study||29
8922802|NCT02234128|9983233|FG002|COMPLETED|Overall Study||48
8922803|NCT02234128|9983231|FG000|NOT COMPLETED|Overall Study||5
8922804|NCT02234128|9983232|FG001|NOT COMPLETED|Overall Study||2
8922805|NCT02234128|9983233|FG002|NOT COMPLETED|Overall Study||4
8922806|NCT02234141|9983245|FG000|STARTED|Treatment Period (24 Weeks)||39
8922807|NCT02234141|9983246|FG001|STARTED|Treatment Period (24 Weeks)||38
8922808|NCT02234141|9983247|FG002|STARTED|Treatment Period (24 Weeks)||37
8922809|NCT02234141|9983248|FG003|STARTED|Treatment Period (24 Weeks)||37
8922810|NCT02234141|9983249|FG004|STARTED|Treatment Period (24 Weeks)||0
8922811|NCT02234141|9983250|FG005|STARTED|Treatment Period (24 Weeks)||0
8922812|NCT02234141|9983251|FG006|STARTED|Treatment Period (24 Weeks)||0
8922813|NCT02234141|9983245|FG000|COMPLETED|Treatment Period (24 Weeks)||35
8922814|NCT02234141|9983246|FG001|COMPLETED|Treatment Period (24 Weeks)||32
8922815|NCT02234141|9983247|FG002|COMPLETED|Treatment Period (24 Weeks)||35
8922816|NCT02234141|9983248|FG003|COMPLETED|Treatment Period (24 Weeks)||32
8922817|NCT02234141|9983249|FG004|COMPLETED|Treatment Period (24 Weeks)||0
8922818|NCT02234141|9983250|FG005|COMPLETED|Treatment Period (24 Weeks)||0
8922819|NCT02234141|9983251|FG006|COMPLETED|Treatment Period (24 Weeks)||0
8922820|NCT02234141|9983245|FG000|NOT COMPLETED|Treatment Period (24 Weeks)||4
8922821|NCT02234141|9983246|FG001|NOT COMPLETED|Treatment Period (24 Weeks)||6
8922822|NCT02234141|9983247|FG002|NOT COMPLETED|Treatment Period (24 Weeks)||2
8922823|NCT02234141|9983248|FG003|NOT COMPLETED|Treatment Period (24 Weeks)||5
8922824|NCT02234141|9983249|FG004|NOT COMPLETED|Treatment Period (24 Weeks)||0
8922825|NCT02234141|9983250|FG005|NOT COMPLETED|Treatment Period (24 Weeks)||0
8922826|NCT02234141|9983251|FG006|NOT COMPLETED|Treatment Period (24 Weeks)||0
8922827|NCT02234141|9983245|FG000|STARTED|Long-Term Treatment Period|2 participants who completed Period 1 did not continue into the Long-Term Treatment Phase.|33
8922828|NCT02234141|9983246|FG001|STARTED|Long-Term Treatment Period|1 participant who completed the Period 1 did not continue into the Long-Term Treatment Phase.|31
8922829|NCT02234141|9983247|FG002|STARTED|Long-Term Treatment Period|2 participants who completed Period 1 did not continue into the Long-Term Treatment Phase.|33
8922830|NCT02234141|9983248|FG003|STARTED|Long-Term Treatment Period|Participants were rerandomized to receive selonsertib during the Long-Term Treatment Phase.|0
8922831|NCT02234141|9983249|FG004|STARTED|Long-Term Treatment Period|The Placebo group was rerandomized to receive selonsertib during the Long-Term Treatment Phase.|10
8922832|NCT02234141|9983250|FG005|STARTED|Long-Term Treatment Period|The Placebo group was rerandomized to receive selonsertib during the Long-Term Treatment Phase.|12
8922833|NCT02234141|9983251|FG006|STARTED|Long-Term Treatment Period|The Placebo group was rerandomized to receive selonsertib during the Long-Term Treatment Phase.|10
8922834|NCT02234141|9983245|FG000|COMPLETED|Long-Term Treatment Period||0
8922835|NCT02234141|9983246|FG001|COMPLETED|Long-Term Treatment Period||0
8922836|NCT02234141|9983247|FG002|COMPLETED|Long-Term Treatment Period||0
8922837|NCT02234141|9983248|FG003|COMPLETED|Long-Term Treatment Period||0
8922838|NCT02234141|9983249|FG004|COMPLETED|Long-Term Treatment Period||0
8922839|NCT02234141|9983250|FG005|COMPLETED|Long-Term Treatment Period||0
8922840|NCT02234141|9983251|FG006|COMPLETED|Long-Term Treatment Period||0
8922841|NCT02234141|9983245|FG000|NOT COMPLETED|Long-Term Treatment Period||33
8922842|NCT02234141|9983246|FG001|NOT COMPLETED|Long-Term Treatment Period||31
8922843|NCT02234141|9983247|FG002|NOT COMPLETED|Long-Term Treatment Period||33
8922844|NCT02234141|9983248|FG003|NOT COMPLETED|Long-Term Treatment Period||0
8922845|NCT02234141|9983249|FG004|NOT COMPLETED|Long-Term Treatment Period||10
8922846|NCT02234141|9983250|FG005|NOT COMPLETED|Long-Term Treatment Period||12
8922847|NCT02234141|9983251|FG006|NOT COMPLETED|Long-Term Treatment Period||10
8922848|NCT02234180|9983262|FG000|STARTED|Overall Study||2
8922849|NCT02234180|9983263|FG001|STARTED|Overall Study||1
8922850|NCT02234180|9983262|FG000|COMPLETED|Overall Study||2
8922851|NCT02234180|9983263|FG001|COMPLETED|Overall Study||1
8922852|NCT02234180|9983262|FG000|NOT COMPLETED|Overall Study||0
8922853|NCT02234180|9983263|FG001|NOT COMPLETED|Overall Study||0
8922854|NCT02234284|9983269|FG000|STARTED|Overall Study||100
8922855|NCT02234284|9983270|FG001|STARTED|Overall Study||92
8922856|NCT02234284|9983269|FG000|COMPLETED|Overall Study||75
8922857|NCT02234284|9983270|FG001|COMPLETED|Overall Study||83
8922858|NCT02234284|9983269|FG000|NOT COMPLETED|Overall Study||25
8922859|NCT02234284|9983270|FG001|NOT COMPLETED|Overall Study||9
8922860|NCT02234362|9983280|FG000|STARTED|Overall Study||47
8922861|NCT02234362|9983280|FG000|Received at Least One Dose of Medication|Overall Study||27
8922862|NCT02234362|9983280|FG000|COMPLETED|Overall Study||21
8922863|NCT02234362|9983280|FG000|NOT COMPLETED|Overall Study||26
8922864|NCT02234427|9983284|FG000|STARTED|Overall Study||34
8922865|NCT02234427|9983284|FG000|COMPLETED|Overall Study|One individual withdrew after first visit|33
8922866|NCT02234427|9983284|FG000|NOT COMPLETED|Overall Study||1
8922867|NCT02234479|9983290|FG000|STARTED|Overall Study||16
8922868|NCT02234479|9983291|FG001|STARTED|Overall Study||18
8922869|NCT02234479|9983290|FG000|COMPLETED|Overall Study||15
8922870|NCT02234479|9983291|FG001|COMPLETED|Overall Study||15
8922871|NCT02234479|9983290|FG000|NOT COMPLETED|Overall Study||1
8922872|NCT02234479|9983291|FG001|NOT COMPLETED|Overall Study||3
8922873|NCT02234570|9983305|FG000|STARTED|Overall Study||8
8922874|NCT02234570|9983306|FG001|STARTED|Overall Study||8
8922875|NCT02234570|9983307|FG002|STARTED|Overall Study||8
8922876|NCT02234570|9983308|FG003|STARTED|Overall Study||8
8922877|NCT02234570|9983309|FG004|STARTED|Overall Study||8
8922878|NCT02234570|9983310|FG005|STARTED|Overall Study||8
8922879|NCT02234570|9983311|FG006|STARTED|Overall Study||8
8922880|NCT02234570|9983312|FG007|STARTED|Overall Study||14
8922881|NCT02234570|9983305|FG000|COMPLETED|Overall Study||8
8922882|NCT02234570|9983306|FG001|COMPLETED|Overall Study||8
8922883|NCT02234570|9983307|FG002|COMPLETED|Overall Study||8
8922884|NCT02234570|9983308|FG003|COMPLETED|Overall Study||8
8922885|NCT02234570|9983309|FG004|COMPLETED|Overall Study||8
8922886|NCT02234570|9983310|FG005|COMPLETED|Overall Study||8
8922887|NCT02234570|9983311|FG006|COMPLETED|Overall Study||8
8922888|NCT02234570|9983312|FG007|COMPLETED|Overall Study||14
8922889|NCT02234570|9983305|FG000|NOT COMPLETED|Overall Study||0
8922890|NCT02234570|9983306|FG001|NOT COMPLETED|Overall Study||0
8922891|NCT02234570|9983307|FG002|NOT COMPLETED|Overall Study||0
8922892|NCT02234570|9983308|FG003|NOT COMPLETED|Overall Study||0
8922893|NCT02234570|9983309|FG004|NOT COMPLETED|Overall Study||0
8922894|NCT02234570|9983310|FG005|NOT COMPLETED|Overall Study||0
8922895|NCT02234570|9983311|FG006|NOT COMPLETED|Overall Study||0
8922896|NCT02234570|9983312|FG007|NOT COMPLETED|Overall Study||0
8922897|NCT02234583|9983332|FG000|STARTED|Overall Study||847
8922898|NCT02234583|9983333|FG001|STARTED|Overall Study||1241
8922899|NCT02234583|9983332|FG000|COMPLETED|Overall Study||434
8922900|NCT02234583|9983333|FG001|COMPLETED|Overall Study||685
8922901|NCT02234583|9983332|FG000|NOT COMPLETED|Overall Study||413
8922902|NCT02234583|9983333|FG001|NOT COMPLETED|Overall Study||556
8922903|NCT02234596|9983345|FG000|STARTED|Overall Study||34
8922904|NCT02234596|9983345|FG000|COMPLETED|Overall Study||32
8922905|NCT02234596|9983345|FG000|NOT COMPLETED|Overall Study||2
8922906|NCT02234622|9983351|FG000|STARTED|Overall Study||108
8922907|NCT02234622|9983352|FG001|STARTED|Overall Study||104
8922908|NCT02234622|9983351|FG000|COMPLETED|Overall Study||65
8922909|NCT02234622|9983352|FG001|COMPLETED|Overall Study||68
8922910|NCT02234622|9983351|FG000|NOT COMPLETED|Overall Study||43
8922911|NCT02234622|9983352|FG001|NOT COMPLETED|Overall Study||36
8922912|NCT02234713|9983362|FG000|STARTED|Overall Study||31
8922913|NCT02234713|9983363|FG001|STARTED|Overall Study||32
8922914|NCT02234713|9983362|FG000|COMPLETED|Overall Study||25
8922915|NCT02234713|9983363|FG001|COMPLETED|Overall Study||27
8922916|NCT02234713|9983362|FG000|NOT COMPLETED|Overall Study||6
8922917|NCT02234713|9983363|FG001|NOT COMPLETED|Overall Study||5
8922918|NCT02234752|9983370|FG000|STARTED|Overall Study||3
8922919|NCT02234752|9983370|FG000|COMPLETED|Overall Study||2
8922920|NCT02234752|9983370|FG000|NOT COMPLETED|Overall Study||1
8922921|NCT02235064|9983377|FG000|STARTED|Overall Study||1
8922922|NCT02235064|9983378|FG001|STARTED|Overall Study||1
8922923|NCT02235064|9983377|FG000|COMPLETED|Overall Study||1
8922924|NCT02235064|9983378|FG001|COMPLETED|Overall Study||1
8922925|NCT02235064|9983377|FG000|NOT COMPLETED|Overall Study||0
8922926|NCT02235064|9983378|FG001|NOT COMPLETED|Overall Study||0
8922927|NCT02235077|9983388|FG000|STARTED|Overall Study||182
8922928|NCT02235077|9983389|FG001|STARTED|Overall Study||178
8922929|NCT02235077|9983388|FG000|COMPLETED|Overall Study||164
8922930|NCT02235077|9983389|FG001|COMPLETED|Overall Study||159
8922931|NCT02235077|9983388|FG000|NOT COMPLETED|Overall Study||18
8922932|NCT02235077|9983389|FG001|NOT COMPLETED|Overall Study||19
8922933|NCT02235285|9983395|FG000|STARTED|Overall Study||162
8922934|NCT02235285|9983395|FG000|COMPLETED|Overall Study||149
8922935|NCT02235285|9983395|FG000|NOT COMPLETED|Overall Study||13
8922936|NCT02235298|9983401|FG000|STARTED|Overall Study||50
8922937|NCT02235298|9983402|FG001|STARTED|Overall Study||50
8922938|NCT02235298|9983401|FG000|COMPLETED|Overall Study||42
8922939|NCT02235298|9983402|FG001|COMPLETED|Overall Study||42
8922940|NCT02235298|9983401|FG000|NOT COMPLETED|Overall Study||8
8922941|NCT02235298|9983402|FG001|NOT COMPLETED|Overall Study||8
8922942|NCT02235311|9983410|FG000|STARTED|Overall Study||1
8922943|NCT02235311|9983411|FG001|STARTED|Overall Study||2
8922944|NCT02235311|9983410|FG000|COMPLETED|Overall Study||1
8922945|NCT02235311|9983411|FG001|COMPLETED|Overall Study||0
8922946|NCT02235311|9983410|FG000|NOT COMPLETED|Overall Study||0
8922947|NCT02235311|9983411|FG001|NOT COMPLETED|Overall Study||2
8922948|NCT02235454|9983417|FG000|STARTED|Overall Study||57
8922949|NCT02235454|9983417|FG000|COMPLETED|Overall Study||55
8922950|NCT02235454|9983417|FG000|NOT COMPLETED|Overall Study||2
8922951|NCT02235493|9983421|FG000|STARTED|Overall Study||6
8922952|NCT02235493|9983421|FG000|COMPLETED|Overall Study||6
8922953|NCT02235493|9983421|FG000|NOT COMPLETED|Overall Study||0
8922954|NCT02235831|9983425|FG000|STARTED|Period 1, First 5 Days of Wear||4
8922955|NCT02235831|9983426|FG001|STARTED|Period 1, First 5 Days of Wear||4
8922956|NCT02235831|9983427|FG002|STARTED|Period 1, First 5 Days of Wear||4
8922957|NCT02235831|9983428|FG003|STARTED|Period 1, First 5 Days of Wear||4
8922958|NCT02235831|9983429|FG004|STARTED|Period 1, First 5 Days of Wear||4
8922959|NCT02235831|9983430|FG005|STARTED|Period 1, First 5 Days of Wear||4
8922960|NCT02235831|9983425|FG000|COMPLETED|Period 1, First 5 Days of Wear||4
8922961|NCT02235831|9983426|FG001|COMPLETED|Period 1, First 5 Days of Wear||4
8922962|NCT02235831|9983427|FG002|COMPLETED|Period 1, First 5 Days of Wear||4
8922963|NCT02235831|9983428|FG003|COMPLETED|Period 1, First 5 Days of Wear||4
8922964|NCT02235831|9983429|FG004|COMPLETED|Period 1, First 5 Days of Wear||4
8922965|NCT02235831|9983430|FG005|COMPLETED|Period 1, First 5 Days of Wear||4
8922966|NCT02235831|9983425|FG000|NOT COMPLETED|Period 1, First 5 Days of Wear||0
8922967|NCT02235831|9983426|FG001|NOT COMPLETED|Period 1, First 5 Days of Wear||0
8922968|NCT02235831|9983427|FG002|NOT COMPLETED|Period 1, First 5 Days of Wear||0
8922969|NCT02235831|9983428|FG003|NOT COMPLETED|Period 1, First 5 Days of Wear||0
8922970|NCT02235831|9983429|FG004|NOT COMPLETED|Period 1, First 5 Days of Wear||0
8922971|NCT02235831|9983430|FG005|NOT COMPLETED|Period 1, First 5 Days of Wear||0
8922972|NCT02235831|9983425|FG000|STARTED|Period 2, Second 5 Days of Wear||4
8922973|NCT02235831|9983426|FG001|STARTED|Period 2, Second 5 Days of Wear||4
8922974|NCT02235831|9983427|FG002|STARTED|Period 2, Second 5 Days of Wear||4
8922975|NCT02235831|9983428|FG003|STARTED|Period 2, Second 5 Days of Wear||4
8922976|NCT02235831|9983429|FG004|STARTED|Period 2, Second 5 Days of Wear||4
8922977|NCT02235831|9983430|FG005|STARTED|Period 2, Second 5 Days of Wear||4
8922978|NCT02235831|9983425|FG000|COMPLETED|Period 2, Second 5 Days of Wear||4
8922979|NCT02235831|9983426|FG001|COMPLETED|Period 2, Second 5 Days of Wear||4
8922980|NCT02235831|9983427|FG002|COMPLETED|Period 2, Second 5 Days of Wear||4
8922981|NCT02235831|9983428|FG003|COMPLETED|Period 2, Second 5 Days of Wear||4
8922982|NCT02235831|9983429|FG004|COMPLETED|Period 2, Second 5 Days of Wear||4
8922983|NCT02235831|9983430|FG005|COMPLETED|Period 2, Second 5 Days of Wear||4
8922984|NCT02235831|9983425|FG000|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
8922985|NCT02235831|9983426|FG001|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
8922986|NCT02235831|9983427|FG002|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
8922987|NCT02235831|9983428|FG003|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
8922988|NCT02235831|9983429|FG004|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
8922989|NCT02235831|9983430|FG005|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
8922990|NCT02235831|9983425|FG000|STARTED|Period 3, Third 5 Days of Wear||4
8922991|NCT02235831|9983426|FG001|STARTED|Period 3, Third 5 Days of Wear||4
8922992|NCT02235831|9983427|FG002|STARTED|Period 3, Third 5 Days of Wear||4
8922993|NCT02235831|9983428|FG003|STARTED|Period 3, Third 5 Days of Wear||4
8922994|NCT02235831|9983429|FG004|STARTED|Period 3, Third 5 Days of Wear||4
8922995|NCT02235831|9983430|FG005|STARTED|Period 3, Third 5 Days of Wear||4
8922996|NCT02235831|9983425|FG000|COMPLETED|Period 3, Third 5 Days of Wear||4
8922997|NCT02235831|9983426|FG001|COMPLETED|Period 3, Third 5 Days of Wear||4
8922998|NCT02235831|9983427|FG002|COMPLETED|Period 3, Third 5 Days of Wear||4
8922999|NCT02235831|9983428|FG003|COMPLETED|Period 3, Third 5 Days of Wear||4
8923000|NCT02235831|9983429|FG004|COMPLETED|Period 3, Third 5 Days of Wear||4
8923001|NCT02235831|9983430|FG005|COMPLETED|Period 3, Third 5 Days of Wear||4
8923002|NCT02235831|9983425|FG000|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
8923003|NCT02235831|9983426|FG001|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
8923004|NCT02235831|9983427|FG002|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
8923005|NCT02235831|9983428|FG003|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
8923006|NCT02235831|9983429|FG004|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
8923007|NCT02235831|9983430|FG005|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
8923008|NCT02235870|9983439|FG000|STARTED|Overall Study||198
8923009|NCT02235870|9983440|FG001|STARTED|Overall Study||189
8923010|NCT02235870|9983439|FG000|Completed Phase I (Week 24)|Overall Study||182
8923011|NCT02235870|9983440|FG001|Completed Phase I (Week 24)|Overall Study||179
8923012|NCT02235870|9983439|FG000|Crossover (Week 24)|Overall Study||170
8923013|NCT02235870|9983440|FG001|Crossover (Week 24)|Overall Study||138
8923014|NCT02235870|9983439|FG000|COMPLETED|Overall Study||160
8923015|NCT02235870|9983440|FG001|COMPLETED|Overall Study||128
8923016|NCT02235870|9983439|FG000|NOT COMPLETED|Overall Study||38
8923017|NCT02235870|9983440|FG001|NOT COMPLETED|Overall Study||61
8923018|NCT02235987|9983447|FG000|STARTED|Overall Study||20
8923019|NCT02235987|9983447|FG000|Received Octreotide|Overall Study||20
8923020|NCT02235987|9983447|FG000|Received 100 µg DG3173|Overall Study||20
8923021|NCT02235987|9983447|FG000|Received 300 µg DG3173|Overall Study||20
8923022|NCT02235987|9983447|FG000|Received 900 µg DG3173|Overall Study||19
8923023|NCT02235987|9983447|FG000|Received 1800 µg DG3173|Overall Study||19
8923024|NCT02235987|9983447|FG000|COMPLETED|Overall Study||19
8923025|NCT02235987|9983447|FG000|NOT COMPLETED|Overall Study||1
8923026|NCT02236130|9983462|FG000|STARTED|Overall Study||22
8923027|NCT02236130|9983463|FG001|STARTED|Overall Study||27
8923028|NCT02236130|9983462|FG000|COMPLETED|Overall Study||15
8923029|NCT02236130|9983463|FG001|COMPLETED|Overall Study||15
8923030|NCT02236130|9983462|FG000|NOT COMPLETED|Overall Study||7
8923031|NCT02236130|9983463|FG001|NOT COMPLETED|Overall Study||12
8923032|NCT02236338|9983471|FG000|STARTED|Overall Study||100
8923033|NCT02236338|9983472|FG001|STARTED|Overall Study||100
8923034|NCT02236338|9983471|FG000|COMPLETED|Overall Study||100
8923035|NCT02236338|9983472|FG001|COMPLETED|Overall Study||100
8923036|NCT02236338|9983471|FG000|NOT COMPLETED|Overall Study||0
8923037|NCT02236338|9983472|FG001|NOT COMPLETED|Overall Study||0
8923038|NCT02236520|9983482|FG000|STARTED|Overall Study||16
8923039|NCT02236520|9983483|FG001|STARTED|Overall Study||13
8923040|NCT02236520|9983484|FG002|STARTED|Overall Study||15
8923041|NCT02236520|9983485|FG003|STARTED|Overall Study||15
8923042|NCT02236520|9983482|FG000|COMPLETED|Overall Study||14
8923043|NCT02236520|9983483|FG001|COMPLETED|Overall Study||8
8923044|NCT02236520|9983484|FG002|COMPLETED|Overall Study||15
8923045|NCT02236520|9983485|FG003|COMPLETED|Overall Study||14
8923046|NCT02236520|9983482|FG000|NOT COMPLETED|Overall Study||2
8923047|NCT02236520|9983483|FG001|NOT COMPLETED|Overall Study||5
8923048|NCT02236520|9983484|FG002|NOT COMPLETED|Overall Study||0
8923049|NCT02236520|9983485|FG003|NOT COMPLETED|Overall Study||1
8923050|NCT02236559|9983497|FG000|STARTED|Overall Study||112
8923051|NCT02236559|9983498|FG001|STARTED|Overall Study||116
8923052|NCT02236559|9983497|FG000|COMPLETED|Overall Study||100
8923053|NCT02236559|9983498|FG001|COMPLETED|Overall Study||104
8923054|NCT02236559|9983497|FG000|NOT COMPLETED|Overall Study||12
8923055|NCT02236559|9983498|FG001|NOT COMPLETED|Overall Study||12
8923056|NCT02236598|9983506|FG000|STARTED|Overall Study||15
8923057|NCT02236598|9983507|FG001|STARTED|Overall Study||14
8923058|NCT02236598|9983506|FG000|COMPLETED|Overall Study||15
8923059|NCT02236598|9983507|FG001|COMPLETED|Overall Study||12
8923060|NCT02236598|9983506|FG000|NOT COMPLETED|Overall Study||0
8923061|NCT02236598|9983507|FG001|NOT COMPLETED|Overall Study||2
8923062|NCT02236611|9983515|FG000|STARTED|Overall Study||516
8923063|NCT02236611|9983516|FG001|STARTED|Overall Study||518
8923064|NCT02236611|9983515|FG000|COMPLETED|Overall Study||490
8923065|NCT02236611|9983516|FG001|COMPLETED|Overall Study||484
8923066|NCT02236611|9983515|FG000|NOT COMPLETED|Overall Study||26
8923067|NCT02236611|9983516|FG001|NOT COMPLETED|Overall Study||34
8923068|NCT02236767|9983522|FG000|STARTED|Overall Study||1
8923069|NCT02236767|9983522|FG000|COMPLETED|Overall Study||1
8923070|NCT02236767|9983522|FG000|NOT COMPLETED|Overall Study||0
8923071|NCT02236988|9983530|FG000|STARTED|Overall Study||16
8923072|NCT02236988|9983531|FG001|STARTED|Overall Study||16
8923073|NCT02236988|9983532|FG002|STARTED|Overall Study||18
8923074|NCT02236988|9983533|FG003|STARTED|Overall Study||30
8923075|NCT02236988|9983530|FG000|COMPLETED|Overall Study||16
8923076|NCT02236988|9983531|FG001|COMPLETED|Overall Study||16
8923077|NCT02236988|9983532|FG002|COMPLETED|Overall Study||18
8923078|NCT02236988|9983533|FG003|COMPLETED|Overall Study||27
8923079|NCT02236988|9983530|FG000|NOT COMPLETED|Overall Study||0
8923080|NCT02236988|9983531|FG001|NOT COMPLETED|Overall Study||0
8923081|NCT02236988|9983532|FG002|NOT COMPLETED|Overall Study||0
8923082|NCT02236988|9983533|FG003|NOT COMPLETED|Overall Study||3
8923083|NCT02237001|9983584|FG000|STARTED|Overall Study||30
8923084|NCT02237001|9983584|FG000|6 Month Follow-up|Overall Study||27
8923085|NCT02237001|9983584|FG000|12 Month Follow-up|Overall Study||21
8923086|NCT02237001|9983584|FG000|24 Month Follow-up|Overall Study||19
8923087|NCT02237001|9983584|FG000|COMPLETED|Overall Study||19
8923088|NCT02237001|9983584|FG000|NOT COMPLETED|Overall Study||11
8923089|NCT02237092|9983588|FG000|STARTED|Overall Study||196
8923090|NCT02237092|9983588|FG000|COMPLETED|Overall Study||196
8923091|NCT02237092|9983588|FG000|NOT COMPLETED|Overall Study||0
8923092|NCT02237118|9983605|FG000|STARTED|Overall Study||60
8923093|NCT02237118|9983606|FG001|STARTED|Overall Study||63
8923094|NCT02237118|9983605|FG000|COMPLETED|Overall Study||59
8923095|NCT02237118|9983606|FG001|COMPLETED|Overall Study||62
8923096|NCT02237118|9983605|FG000|NOT COMPLETED|Overall Study||1
8923097|NCT02237118|9983606|FG001|NOT COMPLETED|Overall Study||1
8923098|NCT02237157|9983620|FG000|STARTED|Gemcitabine, Local Delivery (Dose 1)||20
8923099|NCT02237157|9983621|FG001|STARTED|Gemcitabine, Local Delivery (Dose 1)||0
8923100|NCT02237157|9983622|FG002|STARTED|Gemcitabine, Local Delivery (Dose 1)||0
8923101|NCT02237157|9983623|FG003|STARTED|Gemcitabine, Local Delivery (Dose 1)||0
8923102|NCT02237157|9983620|FG000|COMPLETED|Gemcitabine, Local Delivery (Dose 1)||16
8923103|NCT02237157|9983621|FG001|COMPLETED|Gemcitabine, Local Delivery (Dose 1)||0
8923104|NCT02237157|9983622|FG002|COMPLETED|Gemcitabine, Local Delivery (Dose 1)||0
8923105|NCT02237157|9983623|FG003|COMPLETED|Gemcitabine, Local Delivery (Dose 1)||0
8923106|NCT02237157|9983620|FG000|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 1)||4
8923107|NCT02237157|9983621|FG001|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 1)||0
8923108|NCT02237157|9983622|FG002|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 1)||0
8923109|NCT02237157|9983623|FG003|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 1)||0
8923110|NCT02237157|9983620|FG000|STARTED|Gemcitabine, Local Delivery (Dose 2)||0
8923111|NCT02237157|9983621|FG001|STARTED|Gemcitabine, Local Delivery (Dose 2)||15
8923112|NCT02237157|9983622|FG002|STARTED|Gemcitabine, Local Delivery (Dose 2)||0
8923113|NCT02237157|9983623|FG003|STARTED|Gemcitabine, Local Delivery (Dose 2)||0
8923114|NCT02237157|9983620|FG000|COMPLETED|Gemcitabine, Local Delivery (Dose 2)||0
8923115|NCT02237157|9983621|FG001|COMPLETED|Gemcitabine, Local Delivery (Dose 2)||15
8923116|NCT02237157|9983622|FG002|COMPLETED|Gemcitabine, Local Delivery (Dose 2)||0
8923117|NCT02237157|9983623|FG003|COMPLETED|Gemcitabine, Local Delivery (Dose 2)||0
8923118|NCT02237157|9983620|FG000|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 2)||0
8923119|NCT02237157|9983621|FG001|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 2)||0
8923120|NCT02237157|9983622|FG002|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 2)||0
8923121|NCT02237157|9983623|FG003|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 2)||0
8923122|NCT02237157|9983620|FG000|STARTED|Gemcitabine, Local Delivery (Dose 3)||0
8923123|NCT02237157|9983621|FG001|STARTED|Gemcitabine, Local Delivery (Dose 3)||0
8923124|NCT02237157|9983622|FG002|STARTED|Gemcitabine, Local Delivery (Dose 3)||11
8923125|NCT02237157|9983623|FG003|STARTED|Gemcitabine, Local Delivery (Dose 3)||0
8923126|NCT02237157|9983620|FG000|COMPLETED|Gemcitabine, Local Delivery (Dose 3)||0
8923127|NCT02237157|9983621|FG001|COMPLETED|Gemcitabine, Local Delivery (Dose 3)||0
8923128|NCT02237157|9983622|FG002|COMPLETED|Gemcitabine, Local Delivery (Dose 3)||11
8923129|NCT02237157|9983623|FG003|COMPLETED|Gemcitabine, Local Delivery (Dose 3)||0
8923130|NCT02237157|9983620|FG000|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 3)||0
8923131|NCT02237157|9983621|FG001|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 3)||0
8923132|NCT02237157|9983622|FG002|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 3)||0
8923133|NCT02237157|9983623|FG003|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 3)||0
8923134|NCT02237157|9983620|FG000|STARTED|Gemcitabine, Local Delivery (Dose 4)||0
8923135|NCT02237157|9983621|FG001|STARTED|Gemcitabine, Local Delivery (Dose 4)||0
8923136|NCT02237157|9983622|FG002|STARTED|Gemcitabine, Local Delivery (Dose 4)||0
8923137|NCT02237157|9983623|FG003|STARTED|Gemcitabine, Local Delivery (Dose 4)||8
8923138|NCT02237157|9983620|FG000|COMPLETED|Gemcitabine, Local Delivery (Dose 4)||0
8923139|NCT02237157|9983621|FG001|COMPLETED|Gemcitabine, Local Delivery (Dose 4)||0
8923140|NCT02237157|9983622|FG002|COMPLETED|Gemcitabine, Local Delivery (Dose 4)||0
8923141|NCT02237157|9983623|FG003|COMPLETED|Gemcitabine, Local Delivery (Dose 4)||8
8923142|NCT02237157|9983620|FG000|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 4)||0
8923143|NCT02237157|9983621|FG001|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 4)||0
8923144|NCT02237157|9983622|FG002|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 4)||0
8923145|NCT02237157|9983623|FG003|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 4)||0
8923146|NCT02237196|9983634|FG000|STARTED|Overall Study||32
8923147|NCT02237196|9983635|FG001|STARTED|Overall Study||31
8923148|NCT02237196|9983636|FG002|STARTED|Overall Study||30
8923149|NCT02237196|9983637|FG003|STARTED|Overall Study||28
8923150|NCT02237196|9983634|FG000|COMPLETED|Overall Study||24
8923151|NCT02237196|9983635|FG001|COMPLETED|Overall Study||25
8923152|NCT02237196|9983636|FG002|COMPLETED|Overall Study||20
8923153|NCT02237196|9983637|FG003|COMPLETED|Overall Study||17
8923154|NCT02237196|9983634|FG000|NOT COMPLETED|Overall Study||8
8923155|NCT02237196|9983635|FG001|NOT COMPLETED|Overall Study||6
8923156|NCT02237196|9983636|FG002|NOT COMPLETED|Overall Study||10
8923157|NCT02237196|9983637|FG003|NOT COMPLETED|Overall Study||11
8923158|NCT02237417|9983650|FG000|STARTED|Overall Study||16
8923159|NCT02237417|9983651|FG001|STARTED|Overall Study||15
8923160|NCT02237417|9983652|FG002|STARTED|Overall Study||16
8923161|NCT02237417|9983650|FG000|COMPLETED|Overall Study||16
8923162|NCT02237417|9983651|FG001|COMPLETED|Overall Study||9
8923163|NCT02237417|9983652|FG002|COMPLETED|Overall Study||7
8923164|NCT02237417|9983650|FG000|NOT COMPLETED|Overall Study||0
8923165|NCT02237417|9983651|FG001|NOT COMPLETED|Overall Study||6
8923166|NCT02237417|9983652|FG002|NOT COMPLETED|Overall Study||9
8923167|NCT02237898|9983662|FG000|STARTED|Overall Study||12
8923168|NCT02237898|9983663|FG001|STARTED|Overall Study||14
8923169|NCT02237898|9983662|FG000|Completed 12 Weeks of CM|Overall Study||7
8923170|NCT02237898|9983663|FG001|Completed 12 Weeks of CM|Overall Study||2
8923171|NCT02237898|9983662|FG000|Completed 3 Month Follow-up|Overall Study||6
8923172|NCT02237898|9983663|FG001|Completed 3 Month Follow-up|Overall Study||6
8923173|NCT02237898|9983662|FG000|Completed 9 Month Follow-up|Overall Study||6
8923174|NCT02237898|9983663|FG001|Completed 9 Month Follow-up|Overall Study||7
8923175|NCT02237898|9983662|FG000|Completed 15 Month Follow-up|Overall Study||8
8923176|NCT02237898|9983663|FG001|Completed 15 Month Follow-up|Overall Study||8
8923177|NCT02237898|9983662|FG000|COMPLETED|Overall Study||5
8923178|NCT02237898|9983663|FG001|COMPLETED|Overall Study||2
8923179|NCT02237898|9983662|FG000|NOT COMPLETED|Overall Study||7
8923180|NCT02237898|9983663|FG001|NOT COMPLETED|Overall Study||12
8923181|NCT02237911|9983674|FG000|STARTED|Overall Study||96
8923182|NCT02237911|9983675|FG001|STARTED|Overall Study||96
8923183|NCT02237911|9983676|FG002|STARTED|Overall Study||48
8923184|NCT02237911|9983674|FG000|3 Months|Overall Study||90
8923185|NCT02237911|9983675|FG001|3 Months|Overall Study||87
8923186|NCT02237911|9983676|FG002|3 Months|Overall Study||44
8923187|NCT02237911|9983674|FG000|6 Months|Overall Study||89
8923188|NCT02237911|9983675|FG001|6 Months|Overall Study||88
8923189|NCT02237911|9983676|FG002|6 Months|Overall Study||45
8923190|NCT02237911|9983674|FG000|COMPLETED|Overall Study||89
8923191|NCT02237911|9983675|FG001|COMPLETED|Overall Study||88
8923192|NCT02237911|9983676|FG002|COMPLETED|Overall Study||45
8923193|NCT02237911|9983674|FG000|NOT COMPLETED|Overall Study||7
8923194|NCT02237911|9983675|FG001|NOT COMPLETED|Overall Study||8
8923195|NCT02237911|9983676|FG002|NOT COMPLETED|Overall Study||3
8923196|NCT02237950|9983686|FG000|STARTED|Overall Study||295
8923197|NCT02237950|9983687|FG001|STARTED|Overall Study||291
8923198|NCT02237950|9983686|FG000|COMPLETED|Overall Study||247
8923199|NCT02237950|9983687|FG001|COMPLETED|Overall Study||243
8923200|NCT02237950|9983686|FG000|NOT COMPLETED|Overall Study||48
8923201|NCT02237950|9983687|FG001|NOT COMPLETED|Overall Study||48
8923202|NCT02237989|9983695|FG000|STARTED|Overall Study||19
8805977|NCT01474512|9858118|FG000|STARTED|Post-Treatment Follow-Up||0
8805978|NCT01474512|9858119|FG001|STARTED|Post-Treatment Follow-Up||0
8805979|NCT01474512|9858120|FG002|STARTED|Post-Treatment Follow-Up||0
8805980|NCT01474512|9858121|FG003|STARTED|Post-Treatment Follow-Up||0
8805981|NCT01474512|9858122|FG004|STARTED|Post-Treatment Follow-Up||0
8805982|NCT01474512|9858123|FG005|STARTED|Post-Treatment Follow-Up||0
8805983|NCT01474512|9858124|FG006|STARTED|Post-Treatment Follow-Up||0
8805984|NCT01474512|9858125|FG007|STARTED|Post-Treatment Follow-Up||0
8805985|NCT01474512|9858126|FG008|STARTED|Post-Treatment Follow-Up||0
8805986|NCT01474512|9858127|FG009|STARTED|Post-Treatment Follow-Up||0
8805987|NCT01474512|9858128|FG010|STARTED|Post-Treatment Follow-Up||0
8805988|NCT01474512|9858129|FG011|STARTED|Post-Treatment Follow-Up||0
8805989|NCT01474512|9858130|FG012|STARTED|Post-Treatment Follow-Up||0
8805990|NCT01474512|9858131|FG013|STARTED|Post-Treatment Follow-Up||0
8805991|NCT01474512|9858132|FG014|STARTED|Post-Treatment Follow-Up|Includes participants who started the post treatment follow-up period.|18
8923203|NCT02237989|9983696|FG001|STARTED|Overall Study||20
8923204|NCT02237989|9983695|FG000|COMPLETED|Overall Study||19
8923205|NCT02237989|9983696|FG001|COMPLETED|Overall Study||20
8923206|NCT02237989|9983695|FG000|NOT COMPLETED|Overall Study||0
8923207|NCT02237989|9983696|FG001|NOT COMPLETED|Overall Study||0
8923208|NCT02238028|9983702|FG000|STARTED|Overall Study||14
8923209|NCT02238028|9983703|FG001|STARTED|Overall Study||14
8923210|NCT02238028|9983702|FG000|COMPLETED|Overall Study||12
8923211|NCT02238028|9983703|FG001|COMPLETED|Overall Study||12
8923212|NCT02238028|9983702|FG000|NOT COMPLETED|Overall Study||2
8923213|NCT02238028|9983703|FG001|NOT COMPLETED|Overall Study||2
8923214|NCT02238067|9983714|FG000|STARTED|Overall Study||196
8923215|NCT02238067|9983714|FG000|COMPLETED|Overall Study||151
8923216|NCT02238067|9983714|FG000|NOT COMPLETED|Overall Study||45
8923217|NCT02238080|9983718|FG000|STARTED|Overall Study||197
8923218|NCT02238080|9983718|FG000|COMPLETED|Overall Study||172
8923219|NCT02238080|9983718|FG000|NOT COMPLETED|Overall Study||25
8923220|NCT02238379|9983724|FG000|STARTED|Overall Study||12
8923221|NCT02238379|9983725|FG001|STARTED|Overall Study||14
8923222|NCT02238379|9983724|FG000|COMPLETED|Overall Study||11
8923223|NCT02238379|9983725|FG001|COMPLETED|Overall Study||14
8923224|NCT02238379|9983724|FG000|NOT COMPLETED|Overall Study||1
8923225|NCT02238379|9983725|FG001|NOT COMPLETED|Overall Study||0
8923226|NCT02238483|9983733|FG000|STARTED|Overall Study||108
8923227|NCT02238483|9983734|FG001|STARTED|Overall Study||105
8923228|NCT02238483|9983733|FG000|COMPLETED|Overall Study||93
8923229|NCT02238483|9983734|FG001|COMPLETED|Overall Study||91
8923230|NCT02238483|9983733|FG000|NOT COMPLETED|Overall Study||15
8923231|NCT02238483|9983734|FG001|NOT COMPLETED|Overall Study||14
8923232|NCT02238626|9983744|FG000|STARTED|Overall Study||17
8923233|NCT02238626|9983745|FG001|STARTED|Overall Study||34
8923234|NCT02238626|9983746|FG002|STARTED|Overall Study||8
8923235|NCT02238626|9983747|FG003|STARTED|Overall Study||11
8923236|NCT02238626|9983744|FG000|COMPLETED|Overall Study||12
8923237|NCT02238626|9983745|FG001|COMPLETED|Overall Study||20
8923238|NCT02238626|9983746|FG002|COMPLETED|Overall Study||5
8923239|NCT02238626|9983747|FG003|COMPLETED|Overall Study||4
8923240|NCT02238626|9983744|FG000|NOT COMPLETED|Overall Study||5
8923241|NCT02238626|9983745|FG001|NOT COMPLETED|Overall Study||14
8923242|NCT02238626|9983746|FG002|NOT COMPLETED|Overall Study||3
8923243|NCT02238626|9983747|FG003|NOT COMPLETED|Overall Study||7
8923244|NCT02238782|9983768|FG000|STARTED|Overall Study||12
8923245|NCT02238782|9983768|FG000|Subjects Treated|Overall Study||12
8923246|NCT02238782|9983768|FG000|COMPLETED|Overall Study||12
8923247|NCT02238782|9983768|FG000|NOT COMPLETED|Overall Study||0
8923248|NCT02238847|9983774|FG000|STARTED|Overall Study||59
8923249|NCT02238847|9983775|FG001|STARTED|Overall Study||60
8923250|NCT02238847|9983774|FG000|COMPLETED|Overall Study||37
8923251|NCT02238847|9983775|FG001|COMPLETED|Overall Study||36
8923252|NCT02238847|9983774|FG000|NOT COMPLETED|Overall Study||22
8923253|NCT02238847|9983775|FG001|NOT COMPLETED|Overall Study||24
8923254|NCT02238925|9983781|FG000|STARTED|Overall Study||26
8923255|NCT02238925|9983781|FG000|COMPLETED|Overall Study||1
8923256|NCT02238925|9983781|FG000|NOT COMPLETED|Overall Study||25
8923257|NCT02238977|9983787|FG000|STARTED|Overall Study||0
8923258|NCT02238977|9983788|FG001|STARTED|Overall Study||1
8923259|NCT02238977|9983787|FG000|COMPLETED|Overall Study||0
8923260|NCT02238977|9983788|FG001|COMPLETED|Overall Study||1
8923261|NCT02238977|9983787|FG000|NOT COMPLETED|Overall Study||0
8923262|NCT02238977|9983788|FG001|NOT COMPLETED|Overall Study||0
8923263|NCT02239094|9983794|FG000|STARTED|Overall Study||20
8923264|NCT02239094|9983794|FG000|COMPLETED|Overall Study||18
8923265|NCT02239094|9983794|FG000|NOT COMPLETED|Overall Study||2
8923266|NCT02239120|9983800|FG000|STARTED|Overall Study||2695
8923267|NCT02239120|9983801|FG001|STARTED|Overall Study||2695
8923268|NCT02239120|9983800|FG000|COMPLETED|Overall Study||2620
8923269|NCT02239120|9983801|FG001|COMPLETED|Overall Study||2623
8923270|NCT02239120|9983800|FG000|NOT COMPLETED|Overall Study||75
8923271|NCT02239120|9983801|FG001|NOT COMPLETED|Overall Study||72
8923272|NCT02239224|9983811|FG000|STARTED|Overall Study||3
8923273|NCT02239224|9983812|FG001|STARTED|Overall Study||6
8923274|NCT02239224|9983813|FG002|STARTED|Overall Study||6
8923275|NCT02239224|9983814|FG003|STARTED|Overall Study||5
8923276|NCT02239224|9983811|FG000|Received at Least One Dose of Study Drug|Overall Study||3
8923277|NCT02239224|9983812|FG001|Received at Least One Dose of Study Drug|Overall Study||6
8923278|NCT02239224|9983813|FG002|Received at Least One Dose of Study Drug|Overall Study||6
9037433|NCT03313310|10098591|FG000|NOT COMPLETED|Phase 3||0
9037434|NCT03313310|10098592|FG001|NOT COMPLETED|Phase 3||1
9037435|NCT03314233|10098598|FG000|STARTED|Overall Study|21 mothers provided informed consent for participation in the trial.|21
9037436|NCT03314233|10098598|FG000|COMPLETED|Overall Study|20 mothers who had provided informed consent met eligibility criteria at time of delivery.|20
9037437|NCT03314233|10098598|FG000|NOT COMPLETED|Overall Study||1
9037438|NCT03314519|10098604|FG000|STARTED|Overall Study||100
9037439|NCT03314519|10098605|FG001|STARTED|Overall Study||100
9037440|NCT03314519|10098604|FG000|COMPLETED|Overall Study||97
9037441|NCT03314519|10098605|FG001|COMPLETED|Overall Study||98
8923279|NCT02239224|9983814|FG003|Received at Least One Dose of Study Drug|Overall Study||5
8923280|NCT02239224|9983811|FG000|COMPLETED|Overall Study||3
8923281|NCT02239224|9983812|FG001|COMPLETED|Overall Study||6
8923282|NCT02239224|9983813|FG002|COMPLETED|Overall Study||3
8923283|NCT02239224|9983814|FG003|COMPLETED|Overall Study||4
8923284|NCT02239224|9983811|FG000|NOT COMPLETED|Overall Study||0
8923285|NCT02239224|9983812|FG001|NOT COMPLETED|Overall Study||0
8923286|NCT02239224|9983813|FG002|NOT COMPLETED|Overall Study||3
8923287|NCT02239224|9983814|FG003|NOT COMPLETED|Overall Study||1
8577184|NCT00157014|9610081|FG002|NOT COMPLETED|Overall Study||1
8577185|NCT00157014|9610082|FG003|NOT COMPLETED|Overall Study||1
8577186|NCT00157157|9610092|FG000|STARTED|Overall Study||55
8577187|NCT00157157|9610092|FG000|COMPLETED|Overall Study||44
8577188|NCT00157157|9610092|FG000|NOT COMPLETED|Overall Study||11
8577189|NCT00157196|9610103|FG000|STARTED|Overall Study||22
8577190|NCT00157196|9610103|FG000|COMPLETED|Overall Study||13
8577191|NCT00157196|9610103|FG000|NOT COMPLETED|Overall Study||9
8577192|NCT00157209|9610109|FG000|STARTED|Overall Study||88
8577193|NCT00157209|9610110|FG001|STARTED|Overall Study||83
8577194|NCT00157209|9610109|FG000|COMPLETED|Overall Study||78
8577195|NCT00157209|9610110|FG001|COMPLETED|Overall Study||83
8577196|NCT00157209|9610109|FG000|NOT COMPLETED|Overall Study||10
8577197|NCT00157209|9610110|FG001|NOT COMPLETED|Overall Study||0
8577198|NCT00157248|9610120|FG000|STARTED|Overall Study|Started: Participant completed previous trial on Dabigatran and took study drug of present trial.|98
8577199|NCT00157248|9610121|FG001|STARTED|Overall Study||89
8577200|NCT00157248|9610122|FG002|STARTED|Overall Study||50
8577201|NCT00157248|9610123|FG003|STARTED|Overall Study||124
8577202|NCT00157248|9610120|FG000|COMPLETED|Overall Study|Completed: Participant without premature discontinuation of study medication.|50
8577203|NCT00157248|9610121|FG001|COMPLETED|Overall Study||52
8577204|NCT00157248|9610122|FG002|COMPLETED|Overall Study||29
8577205|NCT00157248|9610123|FG003|COMPLETED|Overall Study||77
8577206|NCT00157248|9610120|FG000|NOT COMPLETED|Overall Study||48
8577207|NCT00157248|9610121|FG001|NOT COMPLETED|Overall Study||37
8577208|NCT00157248|9610122|FG002|NOT COMPLETED|Overall Study||21
8577209|NCT00157248|9610123|FG003|NOT COMPLETED|Overall Study||47
8577210|NCT00157573|9610137|FG000|STARTED|Overall Study||35
8577211|NCT00157573|9610138|FG001|STARTED|Overall Study||37
8577212|NCT00157573|9610137|FG000|COMPLETED|Overall Study||35
8577213|NCT00157573|9610138|FG001|COMPLETED|Overall Study||37
8577214|NCT00157573|9610137|FG000|NOT COMPLETED|Overall Study||0
8577215|NCT00157573|9610138|FG001|NOT COMPLETED|Overall Study||0
8577216|NCT00157755|9610145|FG000|STARTED|Overall Study||26
8577217|NCT00157755|9610146|FG001|STARTED|Overall Study||19
8577218|NCT00157755|9610147|FG002|STARTED|Overall Study||10
8577219|NCT00157755|9610148|FG003|STARTED|Overall Study||15
8577220|NCT00157755|9610149|FG004|STARTED|Overall Study||12
8577221|NCT00157755|9610150|FG005|STARTED|Overall Study||5
8577222|NCT00157755|9610145|FG000|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|24
8577223|NCT00157755|9610146|FG001|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|15
8577224|NCT00157755|9610147|FG002|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|3
8577225|NCT00157755|9610148|FG003|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|11
8577226|NCT00157755|9610149|FG004|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|10
8577227|NCT00157755|9610150|FG005|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|0
8577228|NCT00157755|9610145|FG000|NOT COMPLETED|Overall Study||2
8577229|NCT00157755|9610146|FG001|NOT COMPLETED|Overall Study||4
8577230|NCT00157755|9610147|FG002|NOT COMPLETED|Overall Study||7
8577231|NCT00157755|9610148|FG003|NOT COMPLETED|Overall Study||4
8577232|NCT00157755|9610149|FG004|NOT COMPLETED|Overall Study||2
8577233|NCT00157755|9610150|FG005|NOT COMPLETED|Overall Study||5
8577234|NCT00157820|9610159|FG000|STARTED|Randomized||118
8577235|NCT00157820|9610160|FG001|STARTED|Randomized||116
8577236|NCT00157820|9610161|FG002|STARTED|Randomized||120
8577237|NCT00157820|9610159|FG000|COMPLETED|Randomized||111
8577238|NCT00157820|9610160|FG001|COMPLETED|Randomized||111
8577239|NCT00157820|9610161|FG002|COMPLETED|Randomized||112
8577240|NCT00157820|9610159|FG000|NOT COMPLETED|Randomized||7
8577241|NCT00157820|9610160|FG001|NOT COMPLETED|Randomized||5
8577242|NCT00157820|9610161|FG002|NOT COMPLETED|Randomized||8
8577243|NCT00157820|9610159|FG000|STARTED|1st 8 Month||111
8577244|NCT00157820|9610160|FG001|STARTED|1st 8 Month||111
8577245|NCT00157820|9610161|FG002|STARTED|1st 8 Month||112
8577246|NCT00157820|9610159|FG000|COMPLETED|1st 8 Month||103
8577247|NCT00157820|9610160|FG001|COMPLETED|1st 8 Month||99
8577248|NCT00157820|9610161|FG002|COMPLETED|1st 8 Month||106
8577249|NCT00157820|9610159|FG000|NOT COMPLETED|1st 8 Month||8
8577250|NCT00157820|9610160|FG001|NOT COMPLETED|1st 8 Month||12
8577251|NCT00157820|9610161|FG002|NOT COMPLETED|1st 8 Month||6
8577252|NCT00157820|9610159|FG000|STARTED|1 Month Wash Out Period||103
8577253|NCT00157820|9610160|FG001|STARTED|1 Month Wash Out Period|2 patients had crossed over prematurely in SC sim period, that are now carried to DC true period|101
8577254|NCT00157820|9610161|FG002|STARTED|1 Month Wash Out Period|2 patients had crossed over prematurely in DC true period, that are now carried to SC sim period|108
8577255|NCT00157820|9610159|FG000|COMPLETED|1 Month Wash Out Period||103
8577256|NCT00157820|9610160|FG001|COMPLETED|1 Month Wash Out Period||101
8577257|NCT00157820|9610161|FG002|COMPLETED|1 Month Wash Out Period||108
8577258|NCT00157820|9610159|FG000|NOT COMPLETED|1 Month Wash Out Period||0
8577259|NCT00157820|9610160|FG001|NOT COMPLETED|1 Month Wash Out Period||0
8577260|NCT00157820|9610161|FG002|NOT COMPLETED|1 Month Wash Out Period||0
8577261|NCT00157820|9610159|FG000|STARTED|2nd 8 Months||103
8577262|NCT00157820|9610160|FG001|STARTED|2nd 8 Months||101
8577263|NCT00157820|9610161|FG002|STARTED|2nd 8 Months||108
8577264|NCT00157820|9610159|FG000|COMPLETED|2nd 8 Months||98
8577265|NCT00157820|9610160|FG001|COMPLETED|2nd 8 Months||88
8577266|NCT00157820|9610161|FG002|COMPLETED|2nd 8 Months||94
8577267|NCT00157820|9610159|FG000|NOT COMPLETED|2nd 8 Months||5
8577268|NCT00157820|9610160|FG001|NOT COMPLETED|2nd 8 Months||13
8577269|NCT00157820|9610161|FG002|NOT COMPLETED|2nd 8 Months||14
8577270|NCT00157950|9610172|FG000|STARTED|Overall Study||117
8577271|NCT00157950|9610173|FG001|STARTED|Overall Study||59
8577272|NCT00157950|9610172|FG000|Vaccinated at Dose 1|Overall Study||117
8577273|NCT00157950|9610173|FG001|Vaccinated at Dose 1|Overall Study||59
8577274|NCT00157950|9610172|FG000|Vaccinated at Dose 2|Overall Study||117
8577275|NCT00157950|9610173|FG001|Vaccinated at Dose 2|Overall Study||59
8577276|NCT00157950|9610172|FG000|Vaccinated at Dose 3|Overall Study||116
8577277|NCT00157950|9610173|FG001|Vaccinated at Dose 3|Overall Study||59
8577278|NCT00157950|9610172|FG000|COMPLETED|Overall Study||116
8577279|NCT00157950|9610173|FG001|COMPLETED|Overall Study||59
8577280|NCT00157950|9610172|FG000|NOT COMPLETED|Overall Study||1
8577281|NCT00157950|9610173|FG001|NOT COMPLETED|Overall Study||0
8577282|NCT00158054|9610181|FG000|STARTED|Overall Study||80
8577283|NCT00158054|9610182|FG001|STARTED|Overall Study||77
8577284|NCT00158054|9610181|FG000|COMPLETED|Overall Study||70
8577285|NCT00158054|9610182|FG001|COMPLETED|Overall Study||74
8577286|NCT00158054|9610181|FG000|NOT COMPLETED|Overall Study||10
8577287|NCT00158054|9610182|FG001|NOT COMPLETED|Overall Study||3
8577288|NCT00158184|9610190|FG000|STARTED|Overall Study||16
8577289|NCT00158184|9610191|FG001|STARTED|Overall Study||11
8577290|NCT00158184|9610190|FG000|COMPLETED|Overall Study||10
8577291|NCT00158184|9610191|FG001|COMPLETED|Overall Study||9
8577292|NCT00158184|9610190|FG000|NOT COMPLETED|Overall Study||6
8577293|NCT00158184|9610191|FG001|NOT COMPLETED|Overall Study||2
8577294|NCT00158197|9610203|FG000|STARTED|Overall Study||32
8577295|NCT00158197|9610204|FG001|STARTED|Overall Study||30
8577296|NCT00158197|9610205|FG002|STARTED|Overall Study||28
8577297|NCT00158197|9610206|FG003|STARTED|Overall Study||29
8577298|NCT00158197|9610203|FG000|COMPLETED|Overall Study||32
8577299|NCT00158197|9610204|FG001|COMPLETED|Overall Study||30
8577300|NCT00158197|9610205|FG002|COMPLETED|Overall Study||28
8577301|NCT00158197|9610206|FG003|COMPLETED|Overall Study||29
8577302|NCT00158197|9610203|FG000|NOT COMPLETED|Overall Study||0
8577303|NCT00158197|9610204|FG001|NOT COMPLETED|Overall Study||0
8577304|NCT00158197|9610205|FG002|NOT COMPLETED|Overall Study||0
8577305|NCT00158197|9610206|FG003|NOT COMPLETED|Overall Study||0
8577306|NCT00158223|9610218|FG000|STARTED|Overall Study||28
8577307|NCT00158223|9610219|FG001|STARTED|Overall Study||25
8577308|NCT00158223|9610218|FG000|COMPLETED|Overall Study||23
8577309|NCT00158223|9610219|FG001|COMPLETED|Overall Study||22
8577310|NCT00158223|9610218|FG000|NOT COMPLETED|Overall Study||5
8577311|NCT00158223|9610219|FG001|NOT COMPLETED|Overall Study||3
8577312|NCT00158249|9610227|FG000|STARTED|Overall Study||11
8577313|NCT00158249|9610228|FG001|STARTED|Overall Study||10
8577314|NCT00158249|9610227|FG000|COMPLETED|Overall Study||9
8577315|NCT00158249|9610228|FG001|COMPLETED|Overall Study||10
8577316|NCT00158249|9610227|FG000|NOT COMPLETED|Overall Study||2
8577317|NCT00158249|9610228|FG001|NOT COMPLETED|Overall Study||0
8577318|NCT00158262|9610236|FG000|STARTED|Overall Study||21
8577319|NCT00158262|9610237|FG001|STARTED|Overall Study||22
8577320|NCT00158262|9610236|FG000|COMPLETED|Overall Study||20
8577321|NCT00158262|9610237|FG001|COMPLETED|Overall Study||21
8577322|NCT00158262|9610236|FG000|NOT COMPLETED|Overall Study||1
8577323|NCT00158262|9610237|FG001|NOT COMPLETED|Overall Study||1
8577324|NCT00158379|9610243|FG000|STARTED|Overall Study||105
8577325|NCT00158379|9610243|FG000|COMPLETED|Overall Study||105
8577326|NCT00158379|9610243|FG000|NOT COMPLETED|Overall Study||0
8577327|NCT00158600|9610249|FG000|STARTED|Overall Study||60
8577328|NCT00158600|9610250|FG001|STARTED|Overall Study||30
8577329|NCT00158600|9610249|FG000|COMPLETED|Overall Study||55
8577330|NCT00158600|9610250|FG001|COMPLETED|Overall Study||26
8577331|NCT00158600|9610249|FG000|NOT COMPLETED|Overall Study||5
8577332|NCT00158600|9610250|FG001|NOT COMPLETED|Overall Study||4
8577333|NCT00158743|9610259|FG000|STARTED|Overall Study||24
8577334|NCT00158743|9610260|FG001|STARTED|Overall Study||27
8577335|NCT00158743|9610259|FG000|COMPLETED|Overall Study||15
8577336|NCT00158743|9610260|FG001|COMPLETED|Overall Study||20
8577337|NCT00158743|9610259|FG000|NOT COMPLETED|Overall Study||9
8577338|NCT00158743|9610260|FG001|NOT COMPLETED|Overall Study||7
8577339|NCT00158756|9610271|FG000|STARTED|Overall Study||80
8577340|NCT00158756|9610272|FG001|STARTED|Overall Study||25
8577341|NCT00158756|9610273|FG002|STARTED|Overall Study||81
8577342|NCT00158756|9610274|FG003|STARTED|Overall Study||23
8577343|NCT00158756|9610275|FG004|STARTED|Overall Study||99
8577344|NCT00158756|9610271|FG000|COMPLETED|Overall Study||75
8577345|NCT00158756|9610272|FG001|COMPLETED|Overall Study||25
8577346|NCT00158756|9610273|FG002|COMPLETED|Overall Study||73
8577347|NCT00158756|9610274|FG003|COMPLETED|Overall Study||22
8577348|NCT00158756|9610275|FG004|COMPLETED|Overall Study||96
8577349|NCT00158756|9610271|FG000|NOT COMPLETED|Overall Study||5
8577350|NCT00158756|9610272|FG001|NOT COMPLETED|Overall Study||0
8577351|NCT00158756|9610273|FG002|NOT COMPLETED|Overall Study||8
8577352|NCT00158756|9610274|FG003|NOT COMPLETED|Overall Study||1
8577353|NCT00158756|9610275|FG004|NOT COMPLETED|Overall Study||3
8577354|NCT00158860|9610289|FG000|STARTED|Overall Study||128
8577355|NCT00158860|9610290|FG001|STARTED|Overall Study||255
8577356|NCT00158860|9610289|FG000|COMPLETED|Overall Study||93
8577357|NCT00158860|9610290|FG001|COMPLETED|Overall Study||184
8577358|NCT00158860|9610289|FG000|NOT COMPLETED|Overall Study||35
8577359|NCT00158860|9610290|FG001|NOT COMPLETED|Overall Study||71
8577360|NCT00158925|9610297|FG000|STARTED|Overall Study|96 subjects were implanted or attempted with the study lead|96
8577361|NCT00158925|9610297|FG000|COMPLETED|Overall Study||84
8577362|NCT00158925|9610297|FG000|NOT COMPLETED|Overall Study||12
8577363|NCT00159250|9610303|FG000|STARTED|Overall Study||2
8577364|NCT00159250|9610304|FG001|STARTED|Overall Study||5
8577365|NCT00159250|9610303|FG000|COMPLETED|Overall Study||2
8577366|NCT00159250|9610304|FG001|COMPLETED|Overall Study||5
8577367|NCT00159250|9610303|FG000|NOT COMPLETED|Overall Study||0
8577368|NCT00159250|9610304|FG001|NOT COMPLETED|Overall Study||0
8577369|NCT00159263|9610310|FG000|STARTED|First Intervention||1
8577370|NCT00159263|9610311|FG001|STARTED|First Intervention||1
8577371|NCT00159263|9610312|FG002|STARTED|First Intervention||2
8577372|NCT00159263|9610313|FG003|STARTED|First Intervention||2
8577373|NCT00159263|9610314|FG004|STARTED|First Intervention||2
8577374|NCT00159263|9610315|FG005|STARTED|First Intervention||2
8577375|NCT00159263|9610310|FG000|COMPLETED|First Intervention||1
8577376|NCT00159263|9610311|FG001|COMPLETED|First Intervention||1
8577377|NCT00159263|9610312|FG002|COMPLETED|First Intervention||2
8577378|NCT00159263|9610313|FG003|COMPLETED|First Intervention||2
8577379|NCT00159263|9610314|FG004|COMPLETED|First Intervention||2
8577380|NCT00159263|9610315|FG005|COMPLETED|First Intervention||2
8577381|NCT00159263|9610310|FG000|NOT COMPLETED|First Intervention||0
8577382|NCT00159263|9610311|FG001|NOT COMPLETED|First Intervention||0
8577383|NCT00159263|9610312|FG002|NOT COMPLETED|First Intervention||0
8577384|NCT00159263|9610313|FG003|NOT COMPLETED|First Intervention||0
8577385|NCT00159263|9610314|FG004|NOT COMPLETED|First Intervention||0
8577386|NCT00159263|9610315|FG005|NOT COMPLETED|First Intervention||0
8577387|NCT00159263|9610310|FG000|STARTED|Washout||1
8577388|NCT00159263|9610311|FG001|STARTED|Washout||1
8577389|NCT00159263|9610312|FG002|STARTED|Washout||2
8577390|NCT00159263|9610313|FG003|STARTED|Washout||2
8577391|NCT00159263|9610314|FG004|STARTED|Washout||2
8577392|NCT00159263|9610315|FG005|STARTED|Washout||2
8577393|NCT00159263|9610310|FG000|COMPLETED|Washout||1
8577394|NCT00159263|9610311|FG001|COMPLETED|Washout||1
8577395|NCT00159263|9610312|FG002|COMPLETED|Washout||2
8577396|NCT00159263|9610313|FG003|COMPLETED|Washout||2
8577397|NCT00159263|9610314|FG004|COMPLETED|Washout||2
8577398|NCT00159263|9610315|FG005|COMPLETED|Washout||2
8577399|NCT00159263|9610310|FG000|NOT COMPLETED|Washout||0
8577400|NCT00159263|9610311|FG001|NOT COMPLETED|Washout||0
8577401|NCT00159263|9610312|FG002|NOT COMPLETED|Washout||0
8577402|NCT00159263|9610313|FG003|NOT COMPLETED|Washout||0
8577403|NCT00159263|9610314|FG004|NOT COMPLETED|Washout||0
8577404|NCT00159263|9610315|FG005|NOT COMPLETED|Washout||0
8577405|NCT00159263|9610310|FG000|STARTED|Second Intervention||1
8577406|NCT00159263|9610311|FG001|STARTED|Second Intervention||1
8577407|NCT00159263|9610312|FG002|STARTED|Second Intervention||2
8577408|NCT00159263|9610313|FG003|STARTED|Second Intervention||2
8577409|NCT00159263|9610314|FG004|STARTED|Second Intervention||2
8577410|NCT00159263|9610315|FG005|STARTED|Second Intervention||2
8577411|NCT00159263|9610310|FG000|COMPLETED|Second Intervention||1
8577412|NCT00159263|9610311|FG001|COMPLETED|Second Intervention||1
8577413|NCT00159263|9610312|FG002|COMPLETED|Second Intervention||2
8577414|NCT00159263|9610313|FG003|COMPLETED|Second Intervention||2
8577415|NCT00159263|9610314|FG004|COMPLETED|Second Intervention||2
8577416|NCT00159263|9610315|FG005|COMPLETED|Second Intervention||2
8577417|NCT00159263|9610310|FG000|NOT COMPLETED|Second Intervention||0
8577418|NCT00159263|9610311|FG001|NOT COMPLETED|Second Intervention||0
8577419|NCT00159263|9610312|FG002|NOT COMPLETED|Second Intervention||0
8577420|NCT00159263|9610313|FG003|NOT COMPLETED|Second Intervention||0
8577421|NCT00159263|9610314|FG004|NOT COMPLETED|Second Intervention||0
8577422|NCT00159263|9610315|FG005|NOT COMPLETED|Second Intervention||0
8577423|NCT00159263|9610310|FG000|STARTED|Washout||1
8577424|NCT00159263|9610311|FG001|STARTED|Washout||1
8577425|NCT00159263|9610312|FG002|STARTED|Washout||2
8577426|NCT00159263|9610313|FG003|STARTED|Washout||2
8577427|NCT00159263|9610314|FG004|STARTED|Washout||2
8577428|NCT00159263|9610315|FG005|STARTED|Washout||2
8577429|NCT00159263|9610310|FG000|COMPLETED|Washout||1
8577430|NCT00159263|9610311|FG001|COMPLETED|Washout||1
8577431|NCT00159263|9610312|FG002|COMPLETED|Washout||2
8577432|NCT00159263|9610313|FG003|COMPLETED|Washout||2
8577433|NCT00159263|9610314|FG004|COMPLETED|Washout||2
8577434|NCT00159263|9610315|FG005|COMPLETED|Washout||2
8577435|NCT00159263|9610310|FG000|NOT COMPLETED|Washout||0
8577436|NCT00159263|9610311|FG001|NOT COMPLETED|Washout||0
8577437|NCT00159263|9610312|FG002|NOT COMPLETED|Washout||0
8577438|NCT00159263|9610313|FG003|NOT COMPLETED|Washout||0
8577439|NCT00159263|9610314|FG004|NOT COMPLETED|Washout||0
8577440|NCT00159263|9610315|FG005|NOT COMPLETED|Washout||0
8577441|NCT00159263|9610310|FG000|STARTED|Third Intervention||1
8577442|NCT00159263|9610311|FG001|STARTED|Third Intervention||1
8577443|NCT00159263|9610312|FG002|STARTED|Third Intervention||2
8577444|NCT00159263|9610313|FG003|STARTED|Third Intervention||2
8577445|NCT00159263|9610314|FG004|STARTED|Third Intervention||2
8577446|NCT00159263|9610315|FG005|STARTED|Third Intervention||2
8577447|NCT00159263|9610310|FG000|COMPLETED|Third Intervention||1
8577448|NCT00159263|9610311|FG001|COMPLETED|Third Intervention||1
8577449|NCT00159263|9610312|FG002|COMPLETED|Third Intervention||2
8577450|NCT00159263|9610313|FG003|COMPLETED|Third Intervention||2
8577451|NCT00159263|9610314|FG004|COMPLETED|Third Intervention||2
8577452|NCT00159263|9610315|FG005|COMPLETED|Third Intervention||2
8577453|NCT00159263|9610310|FG000|NOT COMPLETED|Third Intervention||0
8577454|NCT00159263|9610311|FG001|NOT COMPLETED|Third Intervention||0
8577455|NCT00159263|9610312|FG002|NOT COMPLETED|Third Intervention||0
8577456|NCT00159263|9610313|FG003|NOT COMPLETED|Third Intervention||0
8577457|NCT00159263|9610314|FG004|NOT COMPLETED|Third Intervention||0
8577458|NCT00159263|9610315|FG005|NOT COMPLETED|Third Intervention||0
8577459|NCT00159263|9610310|FG000|STARTED|Washout||1
8577460|NCT00159263|9610311|FG001|STARTED|Washout||1
8577461|NCT00159263|9610312|FG002|STARTED|Washout||2
8577462|NCT00159263|9610313|FG003|STARTED|Washout||2
8577463|NCT00159263|9610314|FG004|STARTED|Washout||2
8577464|NCT00159263|9610315|FG005|STARTED|Washout||2
8577465|NCT00159263|9610310|FG000|COMPLETED|Washout||1
8577466|NCT00159263|9610311|FG001|COMPLETED|Washout||1
8577467|NCT00159263|9610312|FG002|COMPLETED|Washout||2
8577468|NCT00159263|9610313|FG003|COMPLETED|Washout||2
8577469|NCT00159263|9610314|FG004|COMPLETED|Washout||2
8577470|NCT00159263|9610315|FG005|COMPLETED|Washout||2
8577471|NCT00159263|9610310|FG000|NOT COMPLETED|Washout||0
8577472|NCT00159263|9610311|FG001|NOT COMPLETED|Washout||0
8577473|NCT00159263|9610312|FG002|NOT COMPLETED|Washout||0
8577474|NCT00159263|9610313|FG003|NOT COMPLETED|Washout||0
8577475|NCT00159263|9610314|FG004|NOT COMPLETED|Washout||0
8577476|NCT00159263|9610315|FG005|NOT COMPLETED|Washout||0
8577477|NCT00159263|9610310|FG000|STARTED|Fourth Intervention||1
8577478|NCT00159263|9610311|FG001|STARTED|Fourth Intervention||1
8577479|NCT00159263|9610312|FG002|STARTED|Fourth Intervention||2
8577480|NCT00159263|9610313|FG003|STARTED|Fourth Intervention||2
8577481|NCT00159263|9610314|FG004|STARTED|Fourth Intervention||2
8577482|NCT00159263|9610315|FG005|STARTED|Fourth Intervention||2
8577483|NCT00159263|9610310|FG000|COMPLETED|Fourth Intervention||1
8577484|NCT00159263|9610311|FG001|COMPLETED|Fourth Intervention||1
8577485|NCT00159263|9610312|FG002|COMPLETED|Fourth Intervention||2
8577486|NCT00159263|9610313|FG003|COMPLETED|Fourth Intervention||2
8577487|NCT00159263|9610314|FG004|COMPLETED|Fourth Intervention||2
8577488|NCT00159263|9610315|FG005|COMPLETED|Fourth Intervention||2
8577489|NCT00159263|9610310|FG000|NOT COMPLETED|Fourth Intervention||0
8577490|NCT00159263|9610311|FG001|NOT COMPLETED|Fourth Intervention||0
8577491|NCT00159263|9610312|FG002|NOT COMPLETED|Fourth Intervention||0
8577492|NCT00159263|9610313|FG003|NOT COMPLETED|Fourth Intervention||0
8577493|NCT00159263|9610314|FG004|NOT COMPLETED|Fourth Intervention||0
8577494|NCT00159263|9610315|FG005|NOT COMPLETED|Fourth Intervention||0
8577495|NCT00159263|9610310|FG000|STARTED|Washout||1
8577496|NCT00159263|9610311|FG001|STARTED|Washout||1
8577497|NCT00159263|9610312|FG002|STARTED|Washout||2
8577498|NCT00159263|9610313|FG003|STARTED|Washout||2
8577499|NCT00159263|9610314|FG004|STARTED|Washout||2
8577500|NCT00159263|9610315|FG005|STARTED|Washout||2
8577501|NCT00159263|9610310|FG000|COMPLETED|Washout||1
8577502|NCT00159263|9610311|FG001|COMPLETED|Washout||1
8577503|NCT00159263|9610312|FG002|COMPLETED|Washout||2
8577504|NCT00159263|9610313|FG003|COMPLETED|Washout||2
8577505|NCT00159263|9610314|FG004|COMPLETED|Washout||2
8577506|NCT00159263|9610315|FG005|COMPLETED|Washout||2
8577507|NCT00159263|9610310|FG000|NOT COMPLETED|Washout||0
8577508|NCT00159263|9610311|FG001|NOT COMPLETED|Washout||0
8577509|NCT00159263|9610312|FG002|NOT COMPLETED|Washout||0
8577510|NCT00159263|9610313|FG003|NOT COMPLETED|Washout||0
8577511|NCT00159263|9610314|FG004|NOT COMPLETED|Washout||0
8577512|NCT00159263|9610315|FG005|NOT COMPLETED|Washout||0
8577513|NCT00159263|9610310|FG000|STARTED|Fifth Intervention||1
8577514|NCT00159263|9610311|FG001|STARTED|Fifth Intervention||1
8577515|NCT00159263|9610312|FG002|STARTED|Fifth Intervention||2
8577516|NCT00159263|9610313|FG003|STARTED|Fifth Intervention||2
8577517|NCT00159263|9610314|FG004|STARTED|Fifth Intervention||2
8577518|NCT00159263|9610315|FG005|STARTED|Fifth Intervention||2
8577519|NCT00159263|9610310|FG000|COMPLETED|Fifth Intervention||1
8577520|NCT00159263|9610311|FG001|COMPLETED|Fifth Intervention||1
8577521|NCT00159263|9610312|FG002|COMPLETED|Fifth Intervention||2
8577522|NCT00159263|9610313|FG003|COMPLETED|Fifth Intervention||2
8577523|NCT00159263|9610314|FG004|COMPLETED|Fifth Intervention||2
8577524|NCT00159263|9610315|FG005|COMPLETED|Fifth Intervention||2
8577525|NCT00159263|9610310|FG000|NOT COMPLETED|Fifth Intervention||0
8577526|NCT00159263|9610311|FG001|NOT COMPLETED|Fifth Intervention||0
8577527|NCT00159263|9610312|FG002|NOT COMPLETED|Fifth Intervention||0
8577528|NCT00159263|9610313|FG003|NOT COMPLETED|Fifth Intervention||0
8577529|NCT00159263|9610314|FG004|NOT COMPLETED|Fifth Intervention||0
8691195|NCT00853658|9736426|FG002|STARTED|Overall Study||2354
8691196|NCT00853658|9736424|FG000|Full Analysis Set (FAS)|Overall Study||2340
8691197|NCT00853658|9736425|FG001|Full Analysis Set (FAS)|Overall Study||2340
8691198|NCT00853658|9736426|FG002|Full Analysis Set (FAS)|Overall Study||2336
8691199|NCT00853658|9736424|FG000|Safety Set|Overall Study||2347
8691200|NCT00853658|9736425|FG001|Safety Set|Overall Study||2348
8691201|NCT00853658|9736426|FG002|Safety Set|Overall Study||2345
8691202|NCT00853658|9736424|FG000|COMPLETED|Overall Study||1567
8691203|NCT00853658|9736425|FG001|COMPLETED|Overall Study||1524
8691204|NCT00853658|9736426|FG002|COMPLETED|Overall Study||1539
8691205|NCT00853658|9736424|FG000|NOT COMPLETED|Overall Study||787
8691206|NCT00853658|9736425|FG001|NOT COMPLETED|Overall Study||832
8691207|NCT00853658|9736426|FG002|NOT COMPLETED|Overall Study||815
8691208|NCT00853671|9736434|FG000|STARTED|Overall Study||50
8691209|NCT00853671|9736434|FG000|COMPLETED|Overall Study||50
8691210|NCT00853671|9736434|FG000|NOT COMPLETED|Overall Study||0
8691211|NCT00853723|9736441|FG000|STARTED|Overall Study||35
8691212|NCT00853723|9736442|FG001|STARTED|Overall Study||35
8691213|NCT00853723|9736443|FG002|STARTED|Overall Study||35
8691214|NCT00853723|9736441|FG000|COMPLETED|Overall Study||29
8691215|NCT00853723|9736442|FG001|COMPLETED|Overall Study||28
8691216|NCT00853723|9736443|FG002|COMPLETED|Overall Study||33
8691217|NCT00853723|9736441|FG000|NOT COMPLETED|Overall Study||6
8691218|NCT00853723|9736442|FG001|NOT COMPLETED|Overall Study||7
8691219|NCT00853723|9736443|FG002|NOT COMPLETED|Overall Study||2
8691220|NCT00853749|9736456|FG000|STARTED|Overall Study||50
8691221|NCT00853749|9736457|FG001|STARTED|Overall Study||39
8691222|NCT00853749|9736456|FG000|Vaccinated|Overall Study||50
8691223|NCT00853749|9736457|FG001|Vaccinated|Overall Study||39
8691224|NCT00853749|9736456|FG000|COMPLETED|Overall Study||50
8691225|NCT00853749|9736457|FG001|COMPLETED|Overall Study||38
8691226|NCT00853749|9736456|FG000|NOT COMPLETED|Overall Study||0
8691227|NCT00853749|9736457|FG001|NOT COMPLETED|Overall Study||1
8691228|NCT00853762|9736467|FG000|STARTED|Overall Study||16
8691229|NCT00853762|9736468|FG001|STARTED|Overall Study||19
8691230|NCT00853762|9736469|FG002|STARTED|Overall Study||17
8691231|NCT00853762|9736470|FG003|STARTED|Overall Study||22
8691232|NCT00853762|9736467|FG000|COMPLETED|Overall Study||0
8691233|NCT00853762|9736468|FG001|COMPLETED|Overall Study||0
8691234|NCT00853762|9736469|FG002|COMPLETED|Overall Study||0
8691235|NCT00853762|9736470|FG003|COMPLETED|Overall Study||0
8691236|NCT00853762|9736467|FG000|NOT COMPLETED|Overall Study||16
8691237|NCT00853762|9736468|FG001|NOT COMPLETED|Overall Study||19
8691238|NCT00853762|9736469|FG002|NOT COMPLETED|Overall Study||17
8691239|NCT00853762|9736470|FG003|NOT COMPLETED|Overall Study||22
8691240|NCT00853827|9736482|FG000|STARTED|Single Blind Period (1 Week)|Enrolled patients in single blind|652
8691241|NCT00853827|9736483|FG001|STARTED|Single Blind Period (1 Week)|This arm was only used in double blind period|0
8691242|NCT00853827|9736482|FG000|COMPLETED|Single Blind Period (1 Week)|Completed patients in single blind period|613
8691243|NCT00853827|9736483|FG001|COMPLETED|Single Blind Period (1 Week)||0
8691244|NCT00853827|9736482|FG000|NOT COMPLETED|Single Blind Period (1 Week)||39
8691245|NCT00853827|9736483|FG001|NOT COMPLETED|Single Blind Period (1 Week)||0
8691246|NCT00853827|9736482|FG000|STARTED|Double Blind Period (103 Weeks)|"Started indicates number of patients in randomized set, full analysis set (FAS) and safety set."|305
8691247|NCT00853827|9736483|FG001|STARTED|Double Blind Period (103 Weeks)||308
8691248|NCT00853827|9736482|FG000|Modified Full Analysis Set (mFAS)|Double Blind Period (103 Weeks)||225
8691249|NCT00853827|9736483|FG001|Modified Full Analysis Set (mFAS)|Double Blind Period (103 Weeks)||233
8691250|NCT00853827|9736482|FG000|COMPLETED|Double Blind Period (103 Weeks)||201
8691251|NCT00853827|9736483|FG001|COMPLETED|Double Blind Period (103 Weeks)||199
8691252|NCT00853827|9736482|FG000|NOT COMPLETED|Double Blind Period (103 Weeks)||104
8691253|NCT00853827|9736483|FG001|NOT COMPLETED|Double Blind Period (103 Weeks)||109
8805992|NCT01474512|9858133|FG015|STARTED|Post-Treatment Follow-Up|Includes participants who started the post treatment follow-up period.|25
8805993|NCT01474512|9858134|FG016|STARTED|Post-Treatment Follow-Up|Includes participants who started the post treatment follow-up period.|700
8805994|NCT01474512|9858135|FG017|STARTED|Post-Treatment Follow-Up|Includes participants who started the post treatment follow-up period.|285
8805995|NCT01474512|9858118|FG000|COMPLETED|Post-Treatment Follow-Up||0
8805996|NCT01474512|9858119|FG001|COMPLETED|Post-Treatment Follow-Up||0
8805997|NCT01474512|9858120|FG002|COMPLETED|Post-Treatment Follow-Up||0
8805998|NCT01474512|9858121|FG003|COMPLETED|Post-Treatment Follow-Up||0
8805999|NCT01474512|9858122|FG004|COMPLETED|Post-Treatment Follow-Up||0
8806000|NCT01474512|9858123|FG005|COMPLETED|Post-Treatment Follow-Up||0
8806001|NCT01474512|9858124|FG006|COMPLETED|Post-Treatment Follow-Up||0
8806002|NCT01474512|9858125|FG007|COMPLETED|Post-Treatment Follow-Up||0
8806003|NCT01474512|9858126|FG008|COMPLETED|Post-Treatment Follow-Up||0
8806004|NCT01474512|9858127|FG009|COMPLETED|Post-Treatment Follow-Up||0
8806005|NCT01474512|9858128|FG010|COMPLETED|Post-Treatment Follow-Up||0
8806006|NCT01474512|9858129|FG011|COMPLETED|Post-Treatment Follow-Up||0
8806007|NCT01474512|9858130|FG012|COMPLETED|Post-Treatment Follow-Up||0
8806008|NCT01474512|9858131|FG013|COMPLETED|Post-Treatment Follow-Up||0
8806009|NCT01474512|9858132|FG014|COMPLETED|Post-Treatment Follow-Up||0
8806010|NCT01474512|9858133|FG015|COMPLETED|Post-Treatment Follow-Up||17
8806011|NCT01474512|9858134|FG016|COMPLETED|Post-Treatment Follow-Up||544
8806012|NCT01474512|9858135|FG017|COMPLETED|Post-Treatment Follow-Up||239
8806013|NCT01474512|9858118|FG000|NOT COMPLETED|Post-Treatment Follow-Up||0
8806014|NCT01474512|9858119|FG001|NOT COMPLETED|Post-Treatment Follow-Up||0
8806015|NCT01474512|9858120|FG002|NOT COMPLETED|Post-Treatment Follow-Up||0
8806016|NCT01474512|9858121|FG003|NOT COMPLETED|Post-Treatment Follow-Up||0
8806017|NCT01474512|9858122|FG004|NOT COMPLETED|Post-Treatment Follow-Up||0
8806018|NCT01474512|9858123|FG005|NOT COMPLETED|Post-Treatment Follow-Up||0
8806019|NCT01474512|9858124|FG006|NOT COMPLETED|Post-Treatment Follow-Up||0
8806020|NCT01474512|9858125|FG007|NOT COMPLETED|Post-Treatment Follow-Up||0
8806021|NCT01474512|9858126|FG008|NOT COMPLETED|Post-Treatment Follow-Up||0
8806022|NCT01474512|9858127|FG009|NOT COMPLETED|Post-Treatment Follow-Up||0
8806023|NCT01474512|9858128|FG010|NOT COMPLETED|Post-Treatment Follow-Up||0
8806024|NCT01474512|9858129|FG011|NOT COMPLETED|Post-Treatment Follow-Up||0
8806025|NCT01474512|9858130|FG012|NOT COMPLETED|Post-Treatment Follow-Up||0
8806026|NCT01474512|9858131|FG013|NOT COMPLETED|Post-Treatment Follow-Up||0
8806027|NCT01474512|9858132|FG014|NOT COMPLETED|Post-Treatment Follow-Up||18
8806028|NCT01474512|9858133|FG015|NOT COMPLETED|Post-Treatment Follow-Up||8
8806029|NCT01474512|9858134|FG016|NOT COMPLETED|Post-Treatment Follow-Up||156
8806030|NCT01474512|9858135|FG017|NOT COMPLETED|Post-Treatment Follow-Up||46
8806031|NCT01474538|9858167|FG000|STARTED|Treatment Period 1||60
8806032|NCT01474538|9858168|FG001|STARTED|Treatment Period 1||62
8806033|NCT01474538|9858167|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1||60
8806034|NCT01474538|9858168|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1||62
8806035|NCT01474538|9858167|FG000|COMPLETED|Treatment Period 1||57
8806036|NCT01474538|9858168|FG001|COMPLETED|Treatment Period 1||58
8806037|NCT01474538|9858167|FG000|NOT COMPLETED|Treatment Period 1||3
8806038|NCT01474538|9858168|FG001|NOT COMPLETED|Treatment Period 1||4
8806039|NCT01474538|9858167|FG000|STARTED|Treatment Period 2||57
8806040|NCT01474538|9858168|FG001|STARTED|Treatment Period 2||58
8806041|NCT01474538|9858167|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 2||57
8806042|NCT01474538|9858168|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 2||58
8806043|NCT01474538|9858167|FG000|COMPLETED|Treatment Period 2||51
8806044|NCT01474538|9858168|FG001|COMPLETED|Treatment Period 2||56
8806045|NCT01474538|9858167|FG000|NOT COMPLETED|Treatment Period 2||6
8806046|NCT01474538|9858168|FG001|NOT COMPLETED|Treatment Period 2||2
8806047|NCT01474551|9858174|FG000|STARTED|Overall Study||2
8806048|NCT01474551|9858174|FG000|COMPLETED|Overall Study||1
8806049|NCT01474551|9858174|FG000|NOT COMPLETED|Overall Study||1
8806050|NCT01474590|9858180|FG000|STARTED|Overall Study||133
8806051|NCT01474590|9858181|FG001|STARTED|Overall Study||133
8806052|NCT01474590|9858180|FG000|COMPLETED|Overall Study||105
8806053|NCT01474590|9858181|FG001|COMPLETED|Overall Study||116
8806054|NCT01474590|9858180|FG000|NOT COMPLETED|Overall Study||28
8806055|NCT01474590|9858181|FG001|NOT COMPLETED|Overall Study||17
8806056|NCT01474681|9858189|FG000|STARTED|Overall Study||1
8806057|NCT01474681|9858190|FG001|STARTED|Overall Study||8
8806058|NCT01474681|9858191|FG002|STARTED|Overall Study||3
8806059|NCT01474681|9858192|FG003|STARTED|Overall Study||15
8806060|NCT01474681|9858189|FG000|COMPLETED|Overall Study||1
8806061|NCT01474681|9858190|FG001|COMPLETED|Overall Study||5
8806062|NCT01474681|9858191|FG002|COMPLETED|Overall Study||1
8806063|NCT01474681|9858192|FG003|COMPLETED|Overall Study||9
8806064|NCT01474681|9858189|FG000|NOT COMPLETED|Overall Study||0
8806065|NCT01474681|9858190|FG001|NOT COMPLETED|Overall Study||3
8806066|NCT01474681|9858191|FG002|NOT COMPLETED|Overall Study||2
8806067|NCT01474681|9858192|FG003|NOT COMPLETED|Overall Study||6
8806068|NCT01474746|9858208|FG000|STARTED|Overall Study||30
8806069|NCT01474746|9858209|FG001|STARTED|Overall Study||27
8806070|NCT01474746|9858208|FG000|COMPLETED|Overall Study||27
8806071|NCT01474746|9858209|FG001|COMPLETED|Overall Study||25
8806072|NCT01474746|9858208|FG000|NOT COMPLETED|Overall Study||3
8806073|NCT01474746|9858209|FG001|NOT COMPLETED|Overall Study||2
8923288|NCT02239263|9983824|FG000|STARTED|Overall Study||40
8806074|NCT01474772|9858217|FG000|STARTED|Period 1|STARTED=treated. In Period 1 a participant discontinued due to an AE and later died due to the AE.|101
8806075|NCT01474772|9858218|FG001|STARTED|Period 1|STARTED=treated|102
8806076|NCT01474772|9858217|FG000|COMPLETED|Period 1||89
8806077|NCT01474772|9858218|FG001|COMPLETED|Period 1||99
8806078|NCT01474772|9858217|FG000|NOT COMPLETED|Period 1||12
8806079|NCT01474772|9858218|FG001|NOT COMPLETED|Period 1||3
8806080|NCT01474772|9858217|FG000|STARTED|Washout||89
8806081|NCT01474772|9858218|FG001|STARTED|Washout||99
8806082|NCT01474772|9858217|FG000|COMPLETED|Washout||86
8806083|NCT01474772|9858218|FG001|COMPLETED|Washout||97
8806084|NCT01474772|9858217|FG000|NOT COMPLETED|Washout||3
8806085|NCT01474772|9858218|FG001|NOT COMPLETED|Washout||2
8806086|NCT01474772|9858217|FG000|STARTED|Period 2||86
8806087|NCT01474772|9858218|FG001|STARTED|Period 2||97
8806088|NCT01474772|9858217|FG000|COMPLETED|Period 2||77
8806089|NCT01474772|9858218|FG001|COMPLETED|Period 2||87
8806090|NCT01474772|9858217|FG000|NOT COMPLETED|Period 2||9
8806091|NCT01474772|9858218|FG001|NOT COMPLETED|Period 2||10
8806092|NCT01474772|9858217|FG000|STARTED|Follow-up||77
8806093|NCT01474772|9858218|FG001|STARTED|Follow-up||87
8806094|NCT01474772|9858217|FG000|COMPLETED|Follow-up||77
8806095|NCT01474772|9858218|FG001|COMPLETED|Follow-up||86
8806096|NCT01474772|9858217|FG000|NOT COMPLETED|Follow-up||0
8806097|NCT01474772|9858218|FG001|NOT COMPLETED|Follow-up||1
8806098|NCT01474863|9858227|FG000|STARTED|Overall Study||26
8806099|NCT01474863|9858228|FG001|STARTED|Overall Study||22
8806100|NCT01474863|9858229|FG002|STARTED|Overall Study||24
8806101|NCT01474863|9858227|FG000|COMPLETED|Overall Study||26
8806102|NCT01474863|9858228|FG001|COMPLETED|Overall Study||22
8806103|NCT01474863|9858229|FG002|COMPLETED|Overall Study||24
8806104|NCT01474863|9858227|FG000|NOT COMPLETED|Overall Study||0
8806105|NCT01474863|9858228|FG001|NOT COMPLETED|Overall Study||0
8806106|NCT01474863|9858229|FG002|NOT COMPLETED|Overall Study||0
8806107|NCT01474876|9858240|FG000|STARTED|Overall Study||403
8806108|NCT01474876|9858241|FG001|STARTED|Overall Study||151
8806109|NCT01474876|9858242|FG002|STARTED|Overall Study||1
8806110|NCT01474876|9858240|FG000|COMPLETED|Overall Study||337
8806111|NCT01474876|9858241|FG001|COMPLETED|Overall Study||128
8806112|NCT01474876|9858242|FG002|COMPLETED|Overall Study||1
8806113|NCT01474876|9858240|FG000|NOT COMPLETED|Overall Study||66
8806114|NCT01474876|9858241|FG001|NOT COMPLETED|Overall Study||23
8806115|NCT01474876|9858242|FG002|NOT COMPLETED|Overall Study||0
8806116|NCT01474915|9858250|FG000|STARTED|Overall Study||60
8806117|NCT01474915|9858251|FG001|STARTED|Overall Study||61
8806118|NCT01474915|9858250|FG000|COMPLETED|Overall Study||50
8806119|NCT01474915|9858251|FG001|COMPLETED|Overall Study||51
8806120|NCT01474915|9858250|FG000|NOT COMPLETED|Overall Study||10
8806121|NCT01474915|9858251|FG001|NOT COMPLETED|Overall Study||10
8806122|NCT01474993|9858260|FG000|STARTED|Overall Study||15
8806123|NCT01474993|9858261|FG001|STARTED|Overall Study||29
8806124|NCT01474993|9858260|FG000|COMPLETED|Overall Study||14
8806125|NCT01474993|9858261|FG001|COMPLETED|Overall Study||26
8806126|NCT01474993|9858260|FG000|NOT COMPLETED|Overall Study||1
8806127|NCT01474993|9858261|FG001|NOT COMPLETED|Overall Study||3
8806128|NCT01475071|9858269|FG000|STARTED|Overall Study||100
8806129|NCT01475071|9858269|FG000|COMPLETED|Overall Study||92
8806130|NCT01475071|9858269|FG000|NOT COMPLETED|Overall Study||8
8806131|NCT01475097|9858277|FG000|STARTED|Overall Study||128
8806132|NCT01475097|9858278|FG001|STARTED|Overall Study||127
8806133|NCT01475097|9858277|FG000|COMPLETED|Overall Study||127
8806134|NCT01475097|9858278|FG001|COMPLETED|Overall Study||126
8806135|NCT01475097|9858277|FG000|NOT COMPLETED|Overall Study||1
8806136|NCT01475097|9858278|FG001|NOT COMPLETED|Overall Study||1
8806137|NCT01475136|9858288|FG000|STARTED|Overall Study||7
8806138|NCT01475136|9858289|FG001|STARTED|Overall Study||9
8806139|NCT01475136|9858290|FG002|STARTED|Overall Study||9
8806140|NCT01475136|9858291|FG003|STARTED|Overall Study||12
8806141|NCT01475136|9858288|FG000|Received 1 Dose of Study Drug|Overall Study||7
8806142|NCT01475136|9858289|FG001|Received 1 Dose of Study Drug|Overall Study||6
8806143|NCT01475136|9858290|FG002|Received 1 Dose of Study Drug|Overall Study||6
8806144|NCT01475136|9858291|FG003|Received 1 Dose of Study Drug|Overall Study||7
8806145|NCT01475136|9858288|FG000|COMPLETED|Overall Study||6
8806146|NCT01475136|9858289|FG001|COMPLETED|Overall Study||6
8806147|NCT01475136|9858290|FG002|COMPLETED|Overall Study||6
8806148|NCT01475136|9858291|FG003|COMPLETED|Overall Study||7
8806149|NCT01475136|9858288|FG000|NOT COMPLETED|Overall Study||1
8806150|NCT01475136|9858289|FG001|NOT COMPLETED|Overall Study||3
8806151|NCT01475136|9858290|FG002|NOT COMPLETED|Overall Study||3
8806152|NCT01475136|9858291|FG003|NOT COMPLETED|Overall Study||5
8806153|NCT01475162|9858301|FG000|STARTED|Overall Study||14
8806154|NCT01475162|9858301|FG000|COMPLETED|Overall Study||0
8806155|NCT01475162|9858301|FG000|NOT COMPLETED|Overall Study||14
8806156|NCT01475175|9858306|FG000|STARTED|Overall Study||12
8806157|NCT01475175|9858306|FG000|COMPLETED|Overall Study||12
8806158|NCT01475175|9858306|FG000|NOT COMPLETED|Overall Study||0
8806159|NCT01475214|9858313|FG000|STARTED|Overall Study||84
8806160|NCT01475214|9858314|FG001|STARTED|Overall Study||79
8806161|NCT01475214|9858315|FG002|STARTED|Overall Study||81
8806162|NCT01475214|9858313|FG000|COMPLETED|Overall Study||79
8806163|NCT01475214|9858314|FG001|COMPLETED|Overall Study||75
8806164|NCT01475214|9858315|FG002|COMPLETED|Overall Study||79
8806165|NCT01475214|9858313|FG000|NOT COMPLETED|Overall Study||5
8806166|NCT01475214|9858314|FG001|NOT COMPLETED|Overall Study||4
8806167|NCT01475214|9858315|FG002|NOT COMPLETED|Overall Study||2
8806168|NCT01475253|9858327|FG000|STARTED|Randomized, Blinded Study||47
8806169|NCT01475253|9858328|FG001|STARTED|Randomized, Blinded Study||46
8806170|NCT01475253|9858329|FG002|STARTED|Randomized, Blinded Study||11
8806171|NCT01475253|9858330|FG003|STARTED|Randomized, Blinded Study||0
8806172|NCT01475253|9858327|FG000|COMPLETED|Randomized, Blinded Study||45
8806173|NCT01475253|9858328|FG001|COMPLETED|Randomized, Blinded Study||45
8806174|NCT01475253|9858329|FG002|COMPLETED|Randomized, Blinded Study||11
8806175|NCT01475253|9858330|FG003|COMPLETED|Randomized, Blinded Study||0
8806176|NCT01475253|9858327|FG000|NOT COMPLETED|Randomized, Blinded Study||2
8806177|NCT01475253|9858328|FG001|NOT COMPLETED|Randomized, Blinded Study||1
8806178|NCT01475253|9858329|FG002|NOT COMPLETED|Randomized, Blinded Study||0
8806179|NCT01475253|9858330|FG003|NOT COMPLETED|Randomized, Blinded Study||0
8806180|NCT01475253|9858327|FG000|STARTED|Open Label Extension||0
8806181|NCT01475253|9858328|FG001|STARTED|Open Label Extension||0
8806182|NCT01475253|9858329|FG002|STARTED|Open Label Extension||0
8806183|NCT01475253|9858330|FG003|STARTED|Open Label Extension||56
8806184|NCT01475253|9858327|FG000|COMPLETED|Open Label Extension||0
8806185|NCT01475253|9858328|FG001|COMPLETED|Open Label Extension||0
8806186|NCT01475253|9858329|FG002|COMPLETED|Open Label Extension||0
8806187|NCT01475253|9858330|FG003|COMPLETED|Open Label Extension||56
8806188|NCT01475253|9858327|FG000|NOT COMPLETED|Open Label Extension||0
8806189|NCT01475253|9858328|FG001|NOT COMPLETED|Open Label Extension||0
8806190|NCT01475253|9858329|FG002|NOT COMPLETED|Open Label Extension||0
8806191|NCT01475253|9858330|FG003|NOT COMPLETED|Open Label Extension||0
8806192|NCT01475305|9858340|FG000|STARTED|Overall Study||4
8806193|NCT01475305|9858341|FG001|STARTED|Overall Study||3
8806194|NCT01475305|9858340|FG000|End of Quarantine, Day 15|Overall Study||4
8806195|NCT01475305|9858341|FG001|End of Quarantine, Day 15|Overall Study||3
8806196|NCT01475305|9858340|FG000|COMPLETED|Overall Study||4
8806197|NCT01475305|9858341|FG001|COMPLETED|Overall Study||3
8806198|NCT01475305|9858340|FG000|NOT COMPLETED|Overall Study||0
8806199|NCT01475305|9858341|FG001|NOT COMPLETED|Overall Study||0
8806200|NCT01475331|9858350|FG000|STARTED|Overall Study||23
8806201|NCT01475331|9858351|FG001|STARTED|Overall Study||23
8806202|NCT01475331|9858350|FG000|COMPLETED|Overall Study||18
8806203|NCT01475331|9858351|FG001|COMPLETED|Overall Study||21
8806204|NCT01475331|9858350|FG000|NOT COMPLETED|Overall Study||5
8806205|NCT01475331|9858351|FG001|NOT COMPLETED|Overall Study||2
8806206|NCT01475370|9858360|FG000|STARTED|Overall Study||3
8806207|NCT01475370|9858361|FG001|STARTED|Overall Study||3
8806208|NCT01475370|9858362|FG002|STARTED|Overall Study||3
8806209|NCT01475370|9858360|FG000|COMPLETED|Overall Study||0
8806210|NCT01475370|9858361|FG001|COMPLETED|Overall Study||0
8806211|NCT01475370|9858362|FG002|COMPLETED|Overall Study||0
8806212|NCT01475370|9858360|FG000|NOT COMPLETED|Overall Study||3
8806213|NCT01475370|9858361|FG001|NOT COMPLETED|Overall Study||3
8806214|NCT01475370|9858362|FG002|NOT COMPLETED|Overall Study||3
8806215|NCT01475461|9858376|FG000|STARTED|Run-in Period||376
8806216|NCT01475461|9858377|FG001|STARTED|Run-in Period||0
8806217|NCT01475461|9858378|FG002|STARTED|Run-in Period||0
8806218|NCT01475461|9858379|FG003|STARTED|Run-in Period||0
8806219|NCT01475461|9858380|FG004|STARTED|Run-in Period||0
8806220|NCT01475461|9858381|FG005|STARTED|Run-in Period||0
8806221|NCT01475461|9858382|FG006|STARTED|Run-in Period||0
8806222|NCT01475461|9858376|FG000|COMPLETED|Run-in Period||335
8806223|NCT01475461|9858377|FG001|COMPLETED|Run-in Period||0
8806224|NCT01475461|9858378|FG002|COMPLETED|Run-in Period||0
8806225|NCT01475461|9858379|FG003|COMPLETED|Run-in Period||0
8806226|NCT01475461|9858380|FG004|COMPLETED|Run-in Period||0
8806227|NCT01475461|9858381|FG005|COMPLETED|Run-in Period||0
8806228|NCT01475461|9858382|FG006|COMPLETED|Run-in Period||0
8806229|NCT01475461|9858376|FG000|NOT COMPLETED|Run-in Period||41
8806230|NCT01475461|9858377|FG001|NOT COMPLETED|Run-in Period||0
8806231|NCT01475461|9858378|FG002|NOT COMPLETED|Run-in Period||0
8806232|NCT01475461|9858379|FG003|NOT COMPLETED|Run-in Period||0
8806233|NCT01475461|9858380|FG004|NOT COMPLETED|Run-in Period||0
8806234|NCT01475461|9858381|FG005|NOT COMPLETED|Run-in Period||0
8806235|NCT01475461|9858382|FG006|NOT COMPLETED|Run-in Period||0
8806236|NCT01475461|9858376|FG000|STARTED|Treatment Period||0
8806237|NCT01475461|9858377|FG001|STARTED|Treatment Period||57
8806238|NCT01475461|9858378|FG002|STARTED|Treatment Period||57
8806239|NCT01475461|9858379|FG003|STARTED|Treatment Period||54
8806240|NCT01475461|9858380|FG004|STARTED|Treatment Period||56
8806241|NCT01475461|9858381|FG005|STARTED|Treatment Period||56
8806242|NCT01475461|9858382|FG006|STARTED|Treatment Period||55
8806243|NCT01475461|9858376|FG000|COMPLETED|Treatment Period||0
8806244|NCT01475461|9858377|FG001|COMPLETED|Treatment Period||48
8806245|NCT01475461|9858378|FG002|COMPLETED|Treatment Period||53
8806246|NCT01475461|9858379|FG003|COMPLETED|Treatment Period||46
8806247|NCT01475461|9858380|FG004|COMPLETED|Treatment Period||52
8806248|NCT01475461|9858381|FG005|COMPLETED|Treatment Period||51
8806249|NCT01475461|9858382|FG006|COMPLETED|Treatment Period||53
8806250|NCT01475461|9858376|FG000|NOT COMPLETED|Treatment Period||0
8806251|NCT01475461|9858377|FG001|NOT COMPLETED|Treatment Period||9
8806252|NCT01475461|9858378|FG002|NOT COMPLETED|Treatment Period||4
8806253|NCT01475461|9858379|FG003|NOT COMPLETED|Treatment Period||8
8806254|NCT01475461|9858380|FG004|NOT COMPLETED|Treatment Period||4
8806255|NCT01475461|9858381|FG005|NOT COMPLETED|Treatment Period||5
8806256|NCT01475461|9858382|FG006|NOT COMPLETED|Treatment Period||2
8806257|NCT01475474|9858415|FG000|STARTED|Baseline Period - 4 Weeks||97
8806258|NCT01475474|9858415|FG000|COMPLETED|Baseline Period - 4 Weeks||91
8806259|NCT01475474|9858415|FG000|NOT COMPLETED|Baseline Period - 4 Weeks||6
8806260|NCT01475474|9858415|FG000|STARTED|Treatment Period - 12 Weeks||91
8806261|NCT01475474|9858415|FG000|COMPLETED|Treatment Period - 12 Weeks||73
8806262|NCT01475474|9858415|FG000|NOT COMPLETED|Treatment Period - 12 Weeks||18
8806263|NCT01475474|9858415|FG000|STARTED|Return to Baseline Period - 4 Weeks||73
8806264|NCT01475474|9858415|FG000|COMPLETED|Return to Baseline Period - 4 Weeks||71
8806265|NCT01475474|9858415|FG000|NOT COMPLETED|Return to Baseline Period - 4 Weeks||2
8806266|NCT01475487|9858422|FG000|STARTED|Overall Study||25
8806267|NCT01475487|9858423|FG001|STARTED|Overall Study||25
8806268|NCT01475487|9858422|FG000|COMPLETED|Overall Study||23
8806269|NCT01475487|9858423|FG001|COMPLETED|Overall Study||24
8806270|NCT01475487|9858422|FG000|NOT COMPLETED|Overall Study||2
8806271|NCT01475487|9858423|FG001|NOT COMPLETED|Overall Study||1
8806272|NCT01475513|9858431|FG000|STARTED|Overall Study||20
8806273|NCT01475513|9858432|FG001|STARTED|Overall Study||26
8806274|NCT01475513|9858431|FG000|COMPLETED|Overall Study||17
8806275|NCT01475513|9858432|FG001|COMPLETED|Overall Study||16
8806276|NCT01475513|9858431|FG000|NOT COMPLETED|Overall Study||3
8806277|NCT01475513|9858432|FG001|NOT COMPLETED|Overall Study||10
8806278|NCT01475643|9858442|FG000|STARTED|Overall Study|53 included in Intent-to-treat (ITT) population, due to no post-treatment assessment.|54
8806279|NCT01475643|9858443|FG001|STARTED|Overall Study|52 included in Intent-to-treat (ITT) population, due to no post-treatment assessment.|53
8806280|NCT01475643|9858442|FG000|COMPLETED|Overall Study||40
8806281|NCT01475643|9858443|FG001|COMPLETED|Overall Study||43
8806282|NCT01475643|9858442|FG000|NOT COMPLETED|Overall Study||14
8806283|NCT01475643|9858443|FG001|NOT COMPLETED|Overall Study||10
8806284|NCT01475721|9858451|FG000|STARTED|Overall Study||5834
8806285|NCT01475721|9858452|FG001|STARTED|Overall Study||5845
8806286|NCT01475721|9858451|FG000|COMPLETED|Overall Study||5823
8806287|NCT01475721|9858452|FG001|COMPLETED|Overall Study||5831
8806288|NCT01475721|9858451|FG000|NOT COMPLETED|Overall Study||11
8806289|NCT01475721|9858452|FG001|NOT COMPLETED|Overall Study||14
8806290|NCT01475734|9858460|FG000|STARTED|Overall Study||22
8806291|NCT01475734|9858461|FG001|STARTED|Overall Study||22
8806292|NCT01475734|9858460|FG000|COMPLETED|Overall Study||20
8806293|NCT01475734|9858461|FG001|COMPLETED|Overall Study||21
8806294|NCT01475734|9858460|FG000|NOT COMPLETED|Overall Study||2
8806295|NCT01475734|9858461|FG001|NOT COMPLETED|Overall Study||1
8806296|NCT01475825|9858471|FG000|STARTED|Overall Study||104
8806297|NCT01475825|9858472|FG001|STARTED|Overall Study||51
8806298|NCT01475825|9858473|FG002|STARTED|Overall Study||102
8806299|NCT01475825|9858474|FG003|STARTED|Overall Study||52
8806300|NCT01475825|9858471|FG000|Randomized and Treated|Overall Study||104
8806301|NCT01475825|9858472|FG001|Randomized and Treated|Overall Study||51
8806302|NCT01475825|9858473|FG002|Randomized and Treated|Overall Study||102
8806303|NCT01475825|9858474|FG003|Randomized and Treated|Overall Study||52
8806304|NCT01475825|9858471|FG000|Completed Blinded Treatment Period|Overall Study||60
8806305|NCT01475825|9858472|FG001|Completed Blinded Treatment Period|Overall Study||42
8806306|NCT01475825|9858473|FG002|Completed Blinded Treatment Period|Overall Study||59
8806307|NCT01475825|9858474|FG003|Completed Blinded Treatment Period|Overall Study||40
8806308|NCT01475825|9858471|FG000|Entered Open-Label Continuation|Overall Study||45
8806309|NCT01475825|9858472|FG001|Entered Open-Label Continuation|Overall Study||31
8806310|NCT01475825|9858473|FG002|Entered Open-Label Continuation|Overall Study||44
8806311|NCT01475825|9858474|FG003|Entered Open-Label Continuation|Overall Study||29
8806312|NCT01475825|9858471|FG000|Completed Open-Label Continuation|Overall Study||37
8806313|NCT01475825|9858472|FG001|Completed Open-Label Continuation|Overall Study||19
8806314|NCT01475825|9858473|FG002|Completed Open-Label Continuation|Overall Study||38
8806315|NCT01475825|9858474|FG003|Completed Open-Label Continuation|Overall Study||22
8806316|NCT01475825|9858471|FG000|COMPLETED|Overall Study||37
8806317|NCT01475825|9858472|FG001|COMPLETED|Overall Study||19
8806318|NCT01475825|9858473|FG002|COMPLETED|Overall Study||38
8806319|NCT01475825|9858474|FG003|COMPLETED|Overall Study||22
8806320|NCT01475825|9858471|FG000|NOT COMPLETED|Overall Study||67
8806321|NCT01475825|9858472|FG001|NOT COMPLETED|Overall Study||32
8806322|NCT01475825|9858473|FG002|NOT COMPLETED|Overall Study||64
8806323|NCT01475825|9858474|FG003|NOT COMPLETED|Overall Study||30
8806324|NCT01475838|9858486|FG000|STARTED|Randomized Phase||293
8806325|NCT01475838|9858487|FG001|STARTED|Randomized Phase||145
8806326|NCT01475838|9858486|FG000|COMPLETED|Randomized Phase||263
8806327|NCT01475838|9858487|FG001|COMPLETED|Randomized Phase||109
8806328|NCT01475838|9858486|FG000|NOT COMPLETED|Randomized Phase||30
8806329|NCT01475838|9858487|FG001|NOT COMPLETED|Randomized Phase||36
8806330|NCT01475838|9858486|FG000|STARTED|Extension Phase||42
8806331|NCT01475838|9858487|FG001|STARTED|Extension Phase||20
8806332|NCT01475838|9858486|FG000|COMPLETED|Extension Phase||41
8806333|NCT01475838|9858487|FG001|COMPLETED|Extension Phase||20
8806334|NCT01475838|9858486|FG000|NOT COMPLETED|Extension Phase||1
8806335|NCT01475838|9858487|FG001|NOT COMPLETED|Extension Phase||0
8806336|NCT01475851|9858496|FG000|STARTED|Overall Study||13
8806337|NCT01475851|9858497|FG001|STARTED|Overall Study||21
8806338|NCT01475851|9858496|FG000|COMPLETED|Overall Study||12
8806339|NCT01475851|9858497|FG001|COMPLETED|Overall Study||21
8806340|NCT01475851|9858496|FG000|NOT COMPLETED|Overall Study||1
8806341|NCT01475851|9858497|FG001|NOT COMPLETED|Overall Study||0
8806342|NCT01475955|9858508|FG000|STARTED|Overall Study||48
8806343|NCT01475955|9858509|FG001|STARTED|Overall Study||48
8806344|NCT01475955|9858510|FG002|STARTED|Overall Study||47
8806345|NCT01475955|9858511|FG003|STARTED|Overall Study||46
8806346|NCT01475955|9858512|FG004|STARTED|Overall Study||46
8806347|NCT01475955|9858508|FG000|COMPLETED|Overall Study||47
8806348|NCT01475955|9858509|FG001|COMPLETED|Overall Study||48
8806349|NCT01475955|9858510|FG002|COMPLETED|Overall Study||44
8806350|NCT01475955|9858511|FG003|COMPLETED|Overall Study||46
8806351|NCT01475955|9858512|FG004|COMPLETED|Overall Study||46
8806352|NCT01475955|9858508|FG000|NOT COMPLETED|Overall Study||1
8806353|NCT01475955|9858509|FG001|NOT COMPLETED|Overall Study||0
8806354|NCT01475955|9858510|FG002|NOT COMPLETED|Overall Study||3
8806355|NCT01475955|9858511|FG003|NOT COMPLETED|Overall Study||0
8806356|NCT01475955|9858512|FG004|NOT COMPLETED|Overall Study||0
8806357|NCT01476202|9858546|FG000|STARTED|Overall Study||40
8806358|NCT01476202|9858547|FG001|STARTED|Overall Study||40
8806359|NCT01476202|9858548|FG002|STARTED|Overall Study||40
8806360|NCT01476202|9858546|FG000|COMPLETED|Overall Study||40
8806361|NCT01476202|9858547|FG001|COMPLETED|Overall Study||40
8806362|NCT01476202|9858548|FG002|COMPLETED|Overall Study||40
8806363|NCT01476202|9858546|FG000|NOT COMPLETED|Overall Study||0
8806364|NCT01476202|9858547|FG001|NOT COMPLETED|Overall Study||0
8806365|NCT01476202|9858548|FG002|NOT COMPLETED|Overall Study||0
8806366|NCT01476267|9858559|FG000|STARTED|Overall Study||6
8806367|NCT01476267|9858559|FG000|COMPLETED|Overall Study||6
8806368|NCT01476267|9858559|FG000|NOT COMPLETED|Overall Study||0
8806369|NCT01476345|9858563|FG000|STARTED|Period 1||40
8806370|NCT01476345|9858564|FG001|STARTED|Period 1||40
8806371|NCT01476345|9858563|FG000|Received at Least 1 Dose of Study Drug|Period 1||40
8806372|NCT01476345|9858564|FG001|Received at Least 1 Dose of Study Drug|Period 1||40
8806373|NCT01476345|9858563|FG000|COMPLETED|Period 1||40
8806374|NCT01476345|9858564|FG001|COMPLETED|Period 1||40
8806375|NCT01476345|9858563|FG000|NOT COMPLETED|Period 1||0
8806376|NCT01476345|9858564|FG001|NOT COMPLETED|Period 1||0
8806377|NCT01476345|9858563|FG000|STARTED|Period 2||40
8806378|NCT01476345|9858564|FG001|STARTED|Period 2||40
8806379|NCT01476345|9858563|FG000|COMPLETED|Period 2|1 did not enter Period 3 due to participant's decision.|40
8806380|NCT01476345|9858564|FG001|COMPLETED|Period 2|1 did not enter Period 3 due to participant's decision.|40
8806381|NCT01476345|9858563|FG000|NOT COMPLETED|Period 2||0
8806382|NCT01476345|9858564|FG001|NOT COMPLETED|Period 2||0
8806383|NCT01476345|9858563|FG000|STARTED|Period 3||39
8806384|NCT01476345|9858564|FG001|STARTED|Period 3||39
8806385|NCT01476345|9858563|FG000|COMPLETED|Period 3||39
8806386|NCT01476345|9858564|FG001|COMPLETED|Period 3||39
8806387|NCT01476345|9858563|FG000|NOT COMPLETED|Period 3||0
8806388|NCT01476345|9858564|FG001|NOT COMPLETED|Period 3||0
8806389|NCT01476345|9858563|FG000|STARTED|Period 4||39
8806390|NCT01476345|9858564|FG001|STARTED|Period 4||39
8806391|NCT01476345|9858563|FG000|COMPLETED|Period 4||39
8806392|NCT01476345|9858564|FG001|COMPLETED|Period 4||39
8806393|NCT01476345|9858563|FG000|NOT COMPLETED|Period 4||0
8806394|NCT01476345|9858564|FG001|NOT COMPLETED|Period 4||0
8806395|NCT01476449|9858572|FG000|STARTED|Overall Study||10
8806396|NCT01476449|9858573|FG001|STARTED|Overall Study||10
8806397|NCT01476449|9858572|FG000|COMPLETED|Overall Study||8
8806398|NCT01476449|9858573|FG001|COMPLETED|Overall Study||8
8806399|NCT01476449|9858572|FG000|NOT COMPLETED|Overall Study||2
8806400|NCT01476449|9858573|FG001|NOT COMPLETED|Overall Study||2
8806401|NCT01476475|9858581|FG000|STARTED|Overall Study||161
8806402|NCT01476475|9858582|FG001|STARTED|Overall Study||162
8806403|NCT01476475|9858581|FG000|COMPLETED|Overall Study||150
8806404|NCT01476475|9858582|FG001|COMPLETED|Overall Study||159
8806405|NCT01476475|9858581|FG000|NOT COMPLETED|Overall Study||11
8806406|NCT01476475|9858582|FG001|NOT COMPLETED|Overall Study||3
8806407|NCT01476644|9858589|FG000|STARTED|Overall Study||161
8806408|NCT01476644|9858589|FG000|COMPLETED|Overall Study||122
8806409|NCT01476644|9858589|FG000|NOT COMPLETED|Overall Study||39
8806410|NCT01476696|9858594|FG000|STARTED|Overall Study||15
8806411|NCT01476696|9858595|FG001|STARTED|Overall Study||9
8806412|NCT01476696|9858596|FG002|STARTED|Overall Study||9
8806413|NCT01476696|9858594|FG000|Received at Least 1 Dose of Study Drug|Overall Study||15
8806414|NCT01476696|9858595|FG001|Received at Least 1 Dose of Study Drug|Overall Study||9
8806415|NCT01476696|9858596|FG002|Received at Least 1 Dose of Study Drug|Overall Study||9
8806416|NCT01476696|9858594|FG000|COMPLETED|Overall Study||12
8806417|NCT01476696|9858595|FG001|COMPLETED|Overall Study||8
8806418|NCT01476696|9858596|FG002|COMPLETED|Overall Study||9
8806419|NCT01476696|9858594|FG000|NOT COMPLETED|Overall Study||3
8806420|NCT01476696|9858595|FG001|NOT COMPLETED|Overall Study||1
8806421|NCT01476696|9858596|FG002|NOT COMPLETED|Overall Study||0
8806422|NCT01476722|9858609|FG000|STARTED|Overall Study||125
8806423|NCT01476722|9858609|FG000|COMPLETED|Overall Study||124
8806424|NCT01476722|9858609|FG000|NOT COMPLETED|Overall Study||1
8806425|NCT01476748|9858616|FG000|STARTED|Overall Study||5
8806426|NCT01476748|9858617|FG001|STARTED|Overall Study||5
8806427|NCT01476748|9858618|FG002|STARTED|Overall Study||5
8806428|NCT01476748|9858616|FG000|COMPLETED|Overall Study||5
8806429|NCT01476748|9858617|FG001|COMPLETED|Overall Study||5
8806430|NCT01476748|9858618|FG002|COMPLETED|Overall Study||5
8806431|NCT01476748|9858616|FG000|NOT COMPLETED|Overall Study||0
8806432|NCT01476748|9858617|FG001|NOT COMPLETED|Overall Study||0
8806433|NCT01476748|9858618|FG002|NOT COMPLETED|Overall Study||0
8806434|NCT01477320|9858628|FG000|STARTED|Overall Study||62
8806435|NCT01477320|9858629|FG001|STARTED|Overall Study||62
8806436|NCT01477320|9858628|FG000|COMPLETED|Overall Study||55
8806437|NCT01477320|9858629|FG001|COMPLETED|Overall Study||47
8806438|NCT01477320|9858628|FG000|NOT COMPLETED|Overall Study||7
8806439|NCT01477320|9858629|FG001|NOT COMPLETED|Overall Study||15
8806440|NCT01477333|9858635|FG000|STARTED|Overall Study||18
8806441|NCT01477333|9858635|FG000|COMPLETED|Overall Study||15
8806442|NCT01477333|9858635|FG000|NOT COMPLETED|Overall Study||3
8806443|NCT01477450|9858646|FG000|STARTED|Overall Study||10
8806444|NCT01477450|9858647|FG001|STARTED|Overall Study||10
8806445|NCT01477450|9858648|FG002|STARTED|Overall Study||10
8806446|NCT01477450|9858646|FG000|COMPLETED|Overall Study||10
8806447|NCT01477450|9858647|FG001|COMPLETED|Overall Study||10
8806448|NCT01477450|9858648|FG002|COMPLETED|Overall Study||10
8806449|NCT01477450|9858646|FG000|NOT COMPLETED|Overall Study||0
8806450|NCT01477450|9858647|FG001|NOT COMPLETED|Overall Study||0
8806451|NCT01477450|9858648|FG002|NOT COMPLETED|Overall Study||0
8806452|NCT01477463|9858658|FG000|STARTED|Overall Study||18
8806453|NCT01477463|9858659|FG001|STARTED|Overall Study||6
8806454|NCT01477463|9858658|FG000|COMPLETED|Overall Study||18
8806455|NCT01477463|9858659|FG001|COMPLETED|Overall Study||6
8806456|NCT01477463|9858658|FG000|NOT COMPLETED|Overall Study||0
8806457|NCT01477463|9858659|FG001|NOT COMPLETED|Overall Study||0
8806458|NCT01477567|9858674|FG000|STARTED|Overall Study||5
8806459|NCT01477567|9858675|FG001|STARTED|Overall Study||6
8806460|NCT01477567|9858676|FG002|STARTED|Overall Study||6
8806461|NCT01477567|9858677|FG003|STARTED|Overall Study||6
8806462|NCT01477567|9858678|FG004|STARTED|Overall Study||6
8806463|NCT01477567|9858679|FG005|STARTED|Overall Study||5
8806464|NCT01477567|9858680|FG006|STARTED|Overall Study||6
8806465|NCT01477567|9858674|FG000|Received at Least 1 Dose of Study Drug|Overall Study||5
8806466|NCT01477567|9858675|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
8806467|NCT01477567|9858676|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
8806468|NCT01477567|9858677|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
8806469|NCT01477567|9858678|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6
8806470|NCT01477567|9858679|FG005|Received at Least 1 Dose of Study Drug|Overall Study||5
8806471|NCT01477567|9858680|FG006|Received at Least 1 Dose of Study Drug|Overall Study||6
8806472|NCT01477567|9858674|FG000|COMPLETED|Overall Study||5
8806473|NCT01477567|9858675|FG001|COMPLETED|Overall Study||6
8806474|NCT01477567|9858676|FG002|COMPLETED|Overall Study||6
8806475|NCT01477567|9858677|FG003|COMPLETED|Overall Study||6
8806476|NCT01477567|9858678|FG004|COMPLETED|Overall Study||6
8806477|NCT01477567|9858679|FG005|COMPLETED|Overall Study||5
8806478|NCT01477567|9858680|FG006|COMPLETED|Overall Study||6
8806479|NCT01477567|9858674|FG000|NOT COMPLETED|Overall Study||0
8806480|NCT01477567|9858675|FG001|NOT COMPLETED|Overall Study||0
8806481|NCT01477567|9858676|FG002|NOT COMPLETED|Overall Study||0
8806482|NCT01477567|9858677|FG003|NOT COMPLETED|Overall Study||0
8806483|NCT01477567|9858678|FG004|NOT COMPLETED|Overall Study||0
8806484|NCT01477567|9858679|FG005|NOT COMPLETED|Overall Study||0
8806485|NCT01477567|9858680|FG006|NOT COMPLETED|Overall Study||0
8806486|NCT01477710|9858701|FG000|STARTED|Overall Study||30
8806487|NCT01477710|9858701|FG000|COMPLETED|Overall Study||30
8806488|NCT01477710|9858701|FG000|NOT COMPLETED|Overall Study||0
8806489|NCT01477749|9858709|FG000|STARTED|Overall Study||47
8806490|NCT01477749|9858709|FG000|COMPLETED|Overall Study||43
8806491|NCT01477749|9858709|FG000|NOT COMPLETED|Overall Study||4
8806492|NCT01477762|9858717|FG000|STARTED|Overall Study||25
8806493|NCT01477762|9858718|FG001|STARTED|Overall Study||33
8806494|NCT01477762|9858719|FG002|STARTED|Overall Study||20
8806495|NCT01477762|9858720|FG003|STARTED|Overall Study||13
8806496|NCT01477762|9858717|FG000|COMPLETED|Overall Study||16
8806497|NCT01477762|9858718|FG001|COMPLETED|Overall Study||20
8806498|NCT01477762|9858719|FG002|COMPLETED|Overall Study||16
8806499|NCT01477762|9858720|FG003|COMPLETED|Overall Study||11
8806500|NCT01477762|9858717|FG000|NOT COMPLETED|Overall Study||9
8806501|NCT01477762|9858718|FG001|NOT COMPLETED|Overall Study||13
8806502|NCT01477762|9858719|FG002|NOT COMPLETED|Overall Study||4
8806503|NCT01477762|9858720|FG003|NOT COMPLETED|Overall Study||2
8806504|NCT01477853|9858733|FG000|STARTED|Phase A||55
8806505|NCT01477853|9858734|FG001|STARTED|Phase A||56
8806506|NCT01477853|9858735|FG002|STARTED|Phase A||55
8806507|NCT01477853|9858733|FG000|COMPLETED|Phase A||12
8806508|NCT01477853|9858734|FG001|COMPLETED|Phase A||11
8806509|NCT01477853|9858735|FG002|COMPLETED|Phase A||11
8806510|NCT01477853|9858733|FG000|NOT COMPLETED|Phase A||43
9037442|NCT03314519|10098604|FG000|NOT COMPLETED|Overall Study||3
9037443|NCT03314519|10098605|FG001|NOT COMPLETED|Overall Study||2
9037444|NCT03314662|10098614|FG000|STARTED|Overall Study||889
9037445|NCT03314662|10098615|FG001|STARTED|Overall Study||445
9037446|NCT03314662|10098616|FG002|STARTED|Overall Study||444
9037447|NCT03314662|10098614|FG000|Treated|Overall Study||888
9037448|NCT03314662|10098615|FG001|Treated|Overall Study||444
9037449|NCT03314662|10098616|FG002|Treated|Overall Study||444
9037450|NCT03314662|10098614|FG000|COMPLETED|Overall Study||881
9037451|NCT03314662|10098615|FG001|COMPLETED|Overall Study||440
9037452|NCT03314662|10098616|FG002|COMPLETED|Overall Study||439
9037453|NCT03314662|10098614|FG000|NOT COMPLETED|Overall Study||8
8806511|NCT01477853|9858734|FG001|NOT COMPLETED|Phase A||45
8806512|NCT01477853|9858735|FG002|NOT COMPLETED|Phase A||44
8806513|NCT01477853|9858733|FG000|STARTED|Phase B||12
8806514|NCT01477853|9858734|FG001|STARTED|Phase B||11
8806515|NCT01477853|9858735|FG002|STARTED|Phase B||11
8577813|NCT00162266|9610686|FG001|Completed Day 1 to Day 181|Double-Blind Period||80
8577814|NCT00162266|9610687|FG002|Completed Day 1 to Day 181|Double-Blind Period||78
8577815|NCT00162266|9610688|FG003|Completed Day 1 to Day 181|Double-Blind Period||0
8577816|NCT00162266|9610685|FG000|COMPLETED|Double-Blind Period||90
8577817|NCT00162266|9610686|FG001|COMPLETED|Double-Blind Period||74
8577818|NCT00162266|9610687|FG002|COMPLETED|Double-Blind Period||71
8577819|NCT00162266|9610688|FG003|COMPLETED|Double-Blind Period||0
8577820|NCT00162266|9610685|FG000|NOT COMPLETED|Double-Blind Period||25
8577821|NCT00162266|9610686|FG001|NOT COMPLETED|Double-Blind Period||31
8577822|NCT00162266|9610687|FG002|NOT COMPLETED|Double-Blind Period||48
8577823|NCT00162266|9610688|FG003|NOT COMPLETED|Double-Blind Period||0
8577824|NCT00162266|9610685|FG000|STARTED|Open-Label Period||0
8577825|NCT00162266|9610686|FG001|STARTED|Open-Label Period||0
8577826|NCT00162266|9610687|FG002|STARTED|Open-Label Period||0
8577827|NCT00162266|9610688|FG003|STARTED|Open-Label Period||219
8577828|NCT00162266|9610685|FG000|COMPLETED|Open-Label Period||0
8577829|NCT00162266|9610686|FG001|COMPLETED|Open-Label Period||0
8577830|NCT00162266|9610687|FG002|COMPLETED|Open-Label Period||0
8577831|NCT00162266|9610688|FG003|COMPLETED|Open-Label Period||82
8577832|NCT00162266|9610685|FG000|NOT COMPLETED|Open-Label Period||0
8577833|NCT00162266|9610686|FG001|NOT COMPLETED|Open-Label Period||0
8577834|NCT00162266|9610687|FG002|NOT COMPLETED|Open-Label Period||0
8577835|NCT00162266|9610688|FG003|NOT COMPLETED|Open-Label Period||137
8577836|NCT00162981|9610742|FG000|STARTED|Overall Study||32
8577837|NCT00162981|9610743|FG001|STARTED|Overall Study||36
8577838|NCT00162981|9610742|FG000|COMPLETED|Overall Study||28
8577839|NCT00162981|9610743|FG001|COMPLETED|Overall Study||30
8577840|NCT00162981|9610742|FG000|NOT COMPLETED|Overall Study||4
8577841|NCT00162981|9610743|FG001|NOT COMPLETED|Overall Study||6
8577842|NCT00163020|9610751|FG000|STARTED|Overall Study|Twins = 160 Triplets = 56|216
8577843|NCT00163020|9610752|FG001|STARTED|Overall Study|Twins = 80 Triplets = 25|105
8577844|NCT00163020|9610751|FG000|COMPLETED|Overall Study|Twins = 160 Triplets = 56|216
8577845|NCT00163020|9610752|FG001|COMPLETED|Overall Study|Twins = 78 Triplets = 25|103
8577846|NCT00163020|9610751|FG000|NOT COMPLETED|Overall Study||0
8577847|NCT00163020|9610752|FG001|NOT COMPLETED|Overall Study||2
8577848|NCT00163189|9610760|FG000|STARTED|Overall Study||98
8577849|NCT00163189|9610760|FG000|COMPLETED|Overall Study||35
8577850|NCT00163189|9610760|FG000|NOT COMPLETED|Overall Study||63
8577851|NCT00163215|9610764|FG000|STARTED|Overall Study||46
8577852|NCT00163215|9610764|FG000|COMPLETED|Overall Study||31
8577853|NCT00163215|9610764|FG000|NOT COMPLETED|Overall Study||15
8577854|NCT00163293|9610771|FG000|STARTED|Overall Study||79
8577855|NCT00163293|9610772|FG001|STARTED|Overall Study||76
8577856|NCT00163293|9610773|FG002|STARTED|Overall Study||85
8577857|NCT00163293|9610771|FG000|COMPLETED|Overall Study||66
8577858|NCT00163293|9610772|FG001|COMPLETED|Overall Study||69
8577859|NCT00163293|9610773|FG002|COMPLETED|Overall Study||66
8577860|NCT00163293|9610771|FG000|NOT COMPLETED|Overall Study||13
8577861|NCT00163293|9610772|FG001|NOT COMPLETED|Overall Study||7
8577862|NCT00163293|9610773|FG002|NOT COMPLETED|Overall Study||19
8577863|NCT00163657|9610784|FG000|STARTED|Overall Study||80
8577864|NCT00163657|9610785|FG001|STARTED|Overall Study||79
8577865|NCT00163657|9610786|FG002|STARTED|Overall Study||153
8577866|NCT00163657|9610784|FG000|COMPLETED|Overall Study||60
8577867|NCT00163657|9610785|FG001|COMPLETED|Overall Study||56
8577868|NCT00163657|9610786|FG002|COMPLETED|Overall Study||116
8577869|NCT00163657|9610784|FG000|NOT COMPLETED|Overall Study||20
8577870|NCT00163657|9610785|FG001|NOT COMPLETED|Overall Study||23
8577871|NCT00163657|9610786|FG002|NOT COMPLETED|Overall Study||37
8577872|NCT00165646|9610797|FG000|STARTED|Overall Study||93
8577873|NCT00165646|9610798|FG001|STARTED|Overall Study||93
8577874|NCT00165646|9610799|FG002|STARTED|Overall Study||102
8577875|NCT00165646|9610797|FG000|COMPLETED|Overall Study||88
8577876|NCT00165646|9610798|FG001|COMPLETED|Overall Study||88
8577877|NCT00165646|9610799|FG002|COMPLETED|Overall Study||98
8577878|NCT00165646|9610797|FG000|NOT COMPLETED|Overall Study||5
8577879|NCT00165646|9610798|FG001|NOT COMPLETED|Overall Study||5
8577880|NCT00165646|9610799|FG002|NOT COMPLETED|Overall Study||4
8577881|NCT00165672|9610809|FG000|STARTED|Overall Study||13
8577882|NCT00165672|9610810|FG001|STARTED|Overall Study||13
8577883|NCT00165672|9610809|FG000|COMPLETED|Overall Study||13
8577884|NCT00165672|9610810|FG001|COMPLETED|Overall Study||12
8577885|NCT00165672|9610809|FG000|NOT COMPLETED|Overall Study||0
8577886|NCT00165672|9610810|FG001|NOT COMPLETED|Overall Study||1
8577887|NCT00165698|9610818|FG000|STARTED|Overall Study||120
8577888|NCT00165698|9610819|FG001|STARTED|Overall Study||120
8577889|NCT00165698|9610818|FG000|COMPLETED|Overall Study||112
8577890|NCT00165698|9610819|FG001|COMPLETED|Overall Study||105
8577891|NCT00165698|9610818|FG000|NOT COMPLETED|Overall Study||8
8577892|NCT00165698|9610819|FG001|NOT COMPLETED|Overall Study||15
8577893|NCT00165776|9610829|FG000|STARTED|Overall Study||35
8577894|NCT00165776|9610830|FG001|STARTED|Overall Study||34
8577895|NCT00165776|9610831|FG002|STARTED|Overall Study||33
8577896|NCT00165776|9610832|FG003|STARTED|Overall Study||31
8577897|NCT00165776|9610829|FG000|COMPLETED|Overall Study||31
8577898|NCT00165776|9610830|FG001|COMPLETED|Overall Study||33
8577899|NCT00165776|9610831|FG002|COMPLETED|Overall Study||31
8577900|NCT00165776|9610832|FG003|COMPLETED|Overall Study||29
8577901|NCT00165776|9610829|FG000|NOT COMPLETED|Overall Study||4
8577902|NCT00165776|9610830|FG001|NOT COMPLETED|Overall Study||1
8577903|NCT00165776|9610831|FG002|NOT COMPLETED|Overall Study||2
8577926|NCT00165958|9610871|FG001|COMPLETED|Overall Study||19
8577927|NCT00165958|9610870|FG000|NOT COMPLETED|Overall Study||1
8577928|NCT00165958|9610871|FG001|NOT COMPLETED|Overall Study||2
8577929|NCT00165984|9610877|FG000|STARTED|Overall Study||165
8577930|NCT00165984|9610877|FG000|COMPLETED|Overall Study||150
8577931|NCT00165984|9610877|FG000|NOT COMPLETED|Overall Study||15
8577932|NCT00166036|9610886|FG000|STARTED|Overall Study||17
8577933|NCT00166036|9610887|FG001|STARTED|Overall Study||19
8577934|NCT00166036|9610886|FG000|COMPLETED|Overall Study||17
8577935|NCT00166036|9610887|FG001|COMPLETED|Overall Study||19
8577936|NCT00166036|9610886|FG000|NOT COMPLETED|Overall Study||0
8577937|NCT00166036|9610887|FG001|NOT COMPLETED|Overall Study||0
8577938|NCT00166114|9610896|FG000|STARTED|Overall Study||21
8577939|NCT00166114|9610897|FG001|STARTED|Overall Study||19
8577940|NCT00166114|9610896|FG000|COMPLETED|Overall Study||7
8577941|NCT00166114|9610897|FG001|COMPLETED|Overall Study||13
8577942|NCT00166114|9610896|FG000|NOT COMPLETED|Overall Study||14
8577943|NCT00166114|9610897|FG001|NOT COMPLETED|Overall Study||6
8577944|NCT00166166|9610905|FG000|STARTED|Overall Study||103
8577945|NCT00166166|9610906|FG001|STARTED|Overall Study||71
8577946|NCT00166166|9610905|FG000|COMPLETED|Overall Study||103
8577947|NCT00166166|9610906|FG001|COMPLETED|Overall Study||71
8577948|NCT00166166|9610905|FG000|NOT COMPLETED|Overall Study||0
8577949|NCT00166166|9610906|FG001|NOT COMPLETED|Overall Study||0
8577950|NCT00166205|9610925|FG000|STARTED|Overall Study||276
8577951|NCT00166205|9610925|FG000|Intervention - SAGB Surgery|Overall Study||276
8577952|NCT00166205|9610925|FG000|COMPLETED|Overall Study||228
8577953|NCT00166205|9610925|FG000|NOT COMPLETED|Overall Study||48
8577954|NCT00166296|9610931|FG000|STARTED|Overall Study|Randomized patients|67
8577955|NCT00166296|9610932|FG001|STARTED|Overall Study|Randomized patients|66
8577956|NCT00166296|9610931|FG000|ANALYZED|Overall Study|Patients who did receive at least the first dose of study medications, included in the analysis|66
8577957|NCT00166296|9610932|FG001|ANALYZED|Overall Study|Patients who did receive at least the first dose of study medications, included in the analysis|63
8577958|NCT00166296|9610931|FG000|COMPLETED|Overall Study|Patients who completed both trial medication and interferon+ribavirin treatment for 12 weeks|60
8577959|NCT00166296|9610932|FG001|COMPLETED|Overall Study|Patients who completed both trial medication and interferon+ribavirin treatment for 12 weeks|57
8577960|NCT00166296|9610931|FG000|NOT COMPLETED|Overall Study||7
8577961|NCT00166296|9610932|FG001|NOT COMPLETED|Overall Study||9
8577962|NCT00166361|9610940|FG000|STARTED|Overall Study||14
8577963|NCT00166361|9610941|FG001|STARTED|Overall Study||10
8577964|NCT00166361|9610940|FG000|COMPLETED|Overall Study||14
8577965|NCT00166361|9610941|FG001|COMPLETED|Overall Study||10
8577966|NCT00166361|9610940|FG000|NOT COMPLETED|Overall Study||0
8577967|NCT00166361|9610941|FG001|NOT COMPLETED|Overall Study||0
8577968|NCT00166439|9610947|FG000|STARTED|Overall Study||50
8577969|NCT00166439|9610947|FG000|COMPLETED|Overall Study||45
8577970|NCT00166439|9610947|FG000|NOT COMPLETED|Overall Study||5
8577971|NCT00166517|9610953|FG000|STARTED|Overall Study||115
8577972|NCT00166517|9610954|FG001|STARTED|Overall Study||63
8577973|NCT00166517|9610953|FG000|Vaccinated at Visit 1|Overall Study||115
8577974|NCT00166517|9610954|FG001|Vaccinated at Visit 1|Overall Study||63
8577975|NCT00166517|9610953|FG000|Vaccinated at Visit 2|Overall Study||112
8577976|NCT00166517|9610954|FG001|Vaccinated at Visit 2|Overall Study||61
8577977|NCT00166517|9610953|FG000|Vaccinated at Visit 3|Overall Study||110
8577978|NCT00166517|9610954|FG001|Vaccinated at Visit 3|Overall Study||61
8577979|NCT00166517|9610953|FG000|COMPLETED|Overall Study||110
8577980|NCT00166517|9610954|FG001|COMPLETED|Overall Study||61
8577981|NCT00166517|9610953|FG000|NOT COMPLETED|Overall Study||5
8577982|NCT00166517|9610954|FG001|NOT COMPLETED|Overall Study||2
8577983|NCT00166712|9610962|FG000|STARTED|Overall Study|Consented:Randomized-Group 1. Given MMF prior to surgery, Alemtuzumab & TAC (Prograf) day of surgery|24
8577984|NCT00166712|9610963|FG001|STARTED|Overall Study|Consented: Randomized-Group 2. Given Sirolimus & MMF prior to surgery, Alemtuzumab day of surgery.|16
8577985|NCT00166712|9610962|FG000|Phase 1|Overall Study|Evaluated for rejection at 6months post-transplant|22
8577986|NCT00166712|9610963|FG001|Phase 1|Overall Study|Evaluated at 6 month post-transplant to potentially be weaned off Sirolimus.|12
8577987|NCT00166712|9610962|FG000|Phase 2a|Overall Study|Subjects who remained on Prograf at 6mo post-transplant.|19
8577988|NCT00166712|9610963|FG001|Phase 2a|Overall Study|Subject who remained on Sirolimus at 6 months post-transplant.|12
8577989|NCT00166712|9610962|FG000|Phase 2b|Overall Study|Subjects converted to Sirolimus post-transplant.|3
8577990|NCT00166712|9610963|FG001|Phase 2b|Overall Study|Subjects weaned off Sirolimus|0
8577991|NCT00166712|9610962|FG000|Phase 3|Overall Study|Subjects from Phase 2b who were weaned off Sirolimus @ 12 months post-transplant.|0
8577992|NCT00166712|9610963|FG001|Phase 3|Overall Study|# weaned off Sirolimus at 12 months post-transplant.|0
8577993|NCT00166712|9610962|FG000|COMPLETED|Overall Study|Completed study participation.|22
8577994|NCT00166712|9610963|FG001|COMPLETED|Overall Study|Completed study participation.|11
8577995|NCT00166712|9610962|FG000|NOT COMPLETED|Overall Study||2
8577996|NCT00166712|9610963|FG001|NOT COMPLETED|Overall Study||5
8577997|NCT00167102|9610975|FG000|STARTED|Overall Study||23
8577998|NCT00167102|9610976|FG001|STARTED|Overall Study||22
8577999|NCT00167102|9610975|FG000|COMPLETED|Overall Study||23
8578000|NCT00167102|9610976|FG001|COMPLETED|Overall Study||22
8578001|NCT00167102|9610975|FG000|NOT COMPLETED|Overall Study||0
8578002|NCT00167102|9610976|FG001|NOT COMPLETED|Overall Study||0
8578003|NCT00167180|9610986|FG000|STARTED|Overall Study||0
8578004|NCT00167180|9610987|FG001|STARTED|Overall Study||57
8578005|NCT00167180|9610986|FG000|COMPLETED|Overall Study||0
8578006|NCT00167180|9610987|FG001|COMPLETED|Overall Study||57
8578007|NCT00167180|9610986|FG000|NOT COMPLETED|Overall Study||0
8578008|NCT00167180|9610987|FG001|NOT COMPLETED|Overall Study||0
8578009|NCT00167206|9610993|FG000|STARTED|Overall Study||16
8578010|NCT00167206|9610993|FG000|COMPLETED|Overall Study||16
8578011|NCT00167206|9610993|FG000|NOT COMPLETED|Overall Study||0
8578012|NCT00167245|9610999|FG000|STARTED|Overall Study||83
8578013|NCT00167245|9611000|FG001|STARTED|Overall Study||87
8578014|NCT00167245|9610999|FG000|COMPLETED|Overall Study||54
8578015|NCT00167245|9611000|FG001|COMPLETED|Overall Study||46
8578016|NCT00167245|9610999|FG000|NOT COMPLETED|Overall Study||29
8578017|NCT00167245|9611000|FG001|NOT COMPLETED|Overall Study||41
8578018|NCT00167310|9611011|FG000|STARTED|Overall Study||29
8578019|NCT00167310|9611012|FG001|STARTED|Overall Study||28
8578020|NCT00167310|9611011|FG000|COMPLETED|Overall Study||21
8578021|NCT00167310|9611012|FG001|COMPLETED|Overall Study||18
8578022|NCT00167310|9611011|FG000|NOT COMPLETED|Overall Study||8
8578023|NCT00167310|9611012|FG001|NOT COMPLETED|Overall Study||10
8578024|NCT00167388|9611022|FG000|STARTED|Overall Study||5
8578025|NCT00167388|9611023|FG001|STARTED|Overall Study||5
8578026|NCT00167388|9611024|FG002|STARTED|Overall Study||6
8578027|NCT00167388|9611025|FG003|STARTED|Overall Study||6
8578028|NCT00167388|9611022|FG000|Completed Doppler Study|Overall Study||5
8578029|NCT00167388|9611023|FG001|Completed Doppler Study|Overall Study||5
8578030|NCT00167388|9611024|FG002|Completed Doppler Study|Overall Study||6
8578031|NCT00167388|9611025|FG003|Completed Doppler Study|Overall Study||6
8578032|NCT00167388|9611022|FG000|COMPLETED|Overall Study||5
8578033|NCT00167388|9611023|FG001|COMPLETED|Overall Study||5
8578034|NCT00167388|9611024|FG002|COMPLETED|Overall Study||6
8578035|NCT00167388|9611025|FG003|COMPLETED|Overall Study||6
8578036|NCT00167388|9611022|FG000|NOT COMPLETED|Overall Study||0
8578037|NCT00167388|9611023|FG001|NOT COMPLETED|Overall Study||0
8578038|NCT00167388|9611024|FG002|NOT COMPLETED|Overall Study||0
8578039|NCT00167388|9611025|FG003|NOT COMPLETED|Overall Study||0
8578040|NCT00167414|9611033|FG000|STARTED|Overall Study||49
8578041|NCT00167414|9611033|FG000|COMPLETED|Overall Study||39
8578042|NCT00167414|9611033|FG000|NOT COMPLETED|Overall Study||10
8578043|NCT00167544|9611039|FG000|STARTED|Overall Study||31
8578044|NCT00167544|9611040|FG001|STARTED|Overall Study||33
8578045|NCT00167544|9611039|FG000|COMPLETED|Overall Study||30
8578046|NCT00167544|9611040|FG001|COMPLETED|Overall Study||33
8578047|NCT00167544|9611039|FG000|NOT COMPLETED|Overall Study||1
8578048|NCT00167544|9611040|FG001|NOT COMPLETED|Overall Study||0
8578049|NCT00167661|9611046|FG000|STARTED|Overall Study||33
8578050|NCT00167661|9611046|FG000|COMPLETED|Overall Study||33
8578051|NCT00167661|9611046|FG000|NOT COMPLETED|Overall Study||0
8578052|NCT00167778|9611050|FG000|STARTED|Overall Study||11
8578053|NCT00167778|9611050|FG000|COMPLETED|Overall Study||10
8578054|NCT00167778|9611050|FG000|NOT COMPLETED|Overall Study||1
8578055|NCT00167934|9611057|FG000|STARTED|Overall Study||82
8578056|NCT00167934|9611058|FG001|STARTED|Overall Study||82
8578057|NCT00167934|9611057|FG000|COMPLETED|Overall Study||82
8578058|NCT00167934|9611058|FG001|COMPLETED|Overall Study||82
8578059|NCT00167934|9611057|FG000|NOT COMPLETED|Overall Study||0
8578060|NCT00167934|9611058|FG001|NOT COMPLETED|Overall Study||0
8578061|NCT00168038|9611064|FG000|STARTED|Overall Study||57
8578062|NCT00168038|9611064|FG000|COMPLETED|Overall Study||55
8578063|NCT00168038|9611064|FG000|NOT COMPLETED|Overall Study||2
8578064|NCT00168064|9611070|FG000|STARTED|Overall Study|128 participants received PG formulation|130
8578065|NCT00168064|9611071|FG001|STARTED|Overall Study|127 participants received AP formulation|130
8578066|NCT00168064|9611070|FG000|COMPLETED|Overall Study||81
8578067|NCT00168064|9611071|FG001|COMPLETED|Overall Study||86
8578068|NCT00168064|9611070|FG000|NOT COMPLETED|Overall Study||49
8578069|NCT00168064|9611071|FG001|NOT COMPLETED|Overall Study||44
8578070|NCT00168103|9611082|FG000|STARTED|Overall Study||40
8578071|NCT00168103|9611083|FG001|STARTED|Overall Study||43
8578072|NCT00168103|9611084|FG002|STARTED|Overall Study||42
8578073|NCT00168103|9611085|FG003|STARTED|Overall Study||1
8578074|NCT00168103|9611082|FG000|COMPLETED|Overall Study|1 randomized subject received open-label rescue medication before receiving randomized treatment.|38
8578075|NCT00168103|9611083|FG001|COMPLETED|Overall Study||38
8578076|NCT00168103|9611084|FG002|COMPLETED|Overall Study||41
8578077|NCT00168103|9611085|FG003|COMPLETED|Overall Study||1
8578078|NCT00168103|9611082|FG000|NOT COMPLETED|Overall Study||2
8578079|NCT00168103|9611083|FG001|NOT COMPLETED|Overall Study||5
8578080|NCT00168103|9611084|FG002|NOT COMPLETED|Overall Study||1
8578081|NCT00168103|9611085|FG003|NOT COMPLETED|Overall Study||0
8578082|NCT00168298|9611096|FG000|STARTED|Double-Blind Period||226
8578083|NCT00168298|9611097|FG001|STARTED|Double-Blind Period||218
8578084|NCT00168298|9611098|FG002|STARTED|Double-Blind Period||224
8578085|NCT00168298|9611096|FG000|COMPLETED|Double-Blind Period||214
8578086|NCT00168298|9611097|FG001|COMPLETED|Double-Blind Period||206
8578087|NCT00168298|9611098|FG002|COMPLETED|Double-Blind Period||209
8578088|NCT00168298|9611096|FG000|NOT COMPLETED|Double-Blind Period||12
8578089|NCT00168298|9611097|FG001|NOT COMPLETED|Double-Blind Period||12
8578090|NCT00168298|9611098|FG002|NOT COMPLETED|Double-Blind Period||15
8578091|NCT00168298|9611096|FG000|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|179
8578092|NCT00168298|9611097|FG001|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|173
8578093|NCT00168298|9611098|FG002|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|168
8578094|NCT00168298|9611096|FG000|COMPLETED|Open-Label Period||172
8578095|NCT00168298|9611097|FG001|COMPLETED|Open-Label Period||168
8578096|NCT00168298|9611098|FG002|COMPLETED|Open-Label Period||160
8578097|NCT00168298|9611096|FG000|NOT COMPLETED|Open-Label Period||7
8578098|NCT00168298|9611097|FG001|NOT COMPLETED|Open-Label Period||5
8578099|NCT00168298|9611098|FG002|NOT COMPLETED|Open-Label Period||8
8578100|NCT00168311|9611108|FG000|STARTED|Overall Study||12
8578101|NCT00168311|9611109|FG001|STARTED|Overall Study||10
8578102|NCT00168311|9611108|FG000|COMPLETED|Overall Study||12
8578103|NCT00168311|9611109|FG001|COMPLETED|Overall Study||8
8578104|NCT00168311|9611108|FG000|NOT COMPLETED|Overall Study||0
8578105|NCT00168311|9611109|FG001|NOT COMPLETED|Overall Study||2
8578106|NCT00168324|9611118|FG000|STARTED|Double-Blind Period||201
8578107|NCT00168324|9611119|FG001|STARTED|Double-Blind Period||196
8578108|NCT00168324|9611120|FG002|STARTED|Double-Blind Period||202
8578109|NCT00168324|9611118|FG000|COMPLETED|Double-Blind Period||189
8578110|NCT00168324|9611119|FG001|COMPLETED|Double-Blind Period||189
8578111|NCT00168324|9611120|FG002|COMPLETED|Double-Blind Period||189
8578112|NCT00168324|9611118|FG000|NOT COMPLETED|Double-Blind Period||12
8578113|NCT00168324|9611119|FG001|NOT COMPLETED|Double-Blind Period||7
8578114|NCT00168324|9611120|FG002|NOT COMPLETED|Double-Blind Period||13
8578115|NCT00168324|9611118|FG000|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|164
8578116|NCT00168324|9611119|FG001|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|155
8578117|NCT00168324|9611120|FG002|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|158
8578118|NCT00168324|9611118|FG000|COMPLETED|Open-Label Period||160
8578119|NCT00168324|9611119|FG001|COMPLETED|Open-Label Period||147
8578120|NCT00168324|9611120|FG002|COMPLETED|Open-Label Period||152
8578121|NCT00168324|9611118|FG000|NOT COMPLETED|Open-Label Period||4
8578122|NCT00168324|9611119|FG001|NOT COMPLETED|Open-Label Period||8
8578123|NCT00168324|9611120|FG002|NOT COMPLETED|Open-Label Period||6
8578124|NCT00168337|9611131|FG000|STARTED|Overall Study||188
8578125|NCT00168337|9611132|FG001|STARTED|Overall Study||181
8578126|NCT00168337|9611133|FG002|STARTED|Overall Study||185
8578127|NCT00168337|9611131|FG000|COMPLETED|Overall Study||118
8578128|NCT00168337|9611132|FG001|COMPLETED|Overall Study||112
8578129|NCT00168337|9611133|FG002|COMPLETED|Overall Study||82
8578130|NCT00168337|9611131|FG000|NOT COMPLETED|Overall Study||70
8578131|NCT00168337|9611132|FG001|NOT COMPLETED|Overall Study||69
8578132|NCT00168337|9611133|FG002|NOT COMPLETED|Overall Study||103
8578133|NCT00168389|9611144|FG000|STARTED|Overall Study||163
8578134|NCT00168389|9611145|FG001|STARTED|Overall Study||166
8578135|NCT00168389|9611146|FG002|STARTED|Overall Study||165
8578136|NCT00168389|9611144|FG000|COMPLETED|Overall Study||107
8578137|NCT00168389|9611145|FG001|COMPLETED|Overall Study||118
8578138|NCT00168389|9611146|FG002|COMPLETED|Overall Study||70
8578139|NCT00168389|9611144|FG000|NOT COMPLETED|Overall Study||56
8578140|NCT00168389|9611145|FG001|NOT COMPLETED|Overall Study||48
8578141|NCT00168389|9611146|FG002|NOT COMPLETED|Overall Study||95
8578142|NCT00168428|9611156|FG000|STARTED|Double-Blind Phase (DB)||347
8578143|NCT00168428|9611157|FG001|STARTED|Double-Blind Phase (DB)||358
8578144|NCT00168428|9611156|FG000|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|311
8578145|NCT00168428|9611157|FG001|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|334
8578146|NCT00168428|9611156|FG000|NOT COMPLETED|Double-Blind Phase (DB)||36
8578147|NCT00168428|9611157|FG001|NOT COMPLETED|Double-Blind Phase (DB)||24
8578148|NCT00168428|9611156|FG000|STARTED|Open-Label Phase (OL)|Number of DB Botulinum toxin type A patients who rolled into OL phase|305
8578149|NCT00168428|9611157|FG001|STARTED|Open-Label Phase (OL)|Number of DB Placebo patients who rolled into OL phase|329
8578150|NCT00168428|9611156|FG000|COMPLETED|Open-Label Phase (OL)||261
8578151|NCT00168428|9611157|FG001|COMPLETED|Open-Label Phase (OL)||261
8578152|NCT00168428|9611156|FG000|NOT COMPLETED|Open-Label Phase (OL)||44
8578153|NCT00168428|9611157|FG001|NOT COMPLETED|Open-Label Phase (OL)||68
8578154|NCT00168454|9611169|FG000|STARTED|Overall Study||44
8578155|NCT00168454|9611170|FG001|STARTED|Overall Study||57
8578156|NCT00168454|9611171|FG002|STARTED|Overall Study||54
8578157|NCT00168454|9611172|FG003|STARTED|Overall Study||49
8578158|NCT00168454|9611173|FG004|STARTED|Overall Study||53
8578159|NCT00168454|9611174|FG005|STARTED|Overall Study||56
8578160|NCT00168454|9611169|FG000|COMPLETED|Overall Study||37
8578161|NCT00168454|9611170|FG001|COMPLETED|Overall Study||50
8578162|NCT00168454|9611171|FG002|COMPLETED|Overall Study||48
8578163|NCT00168454|9611172|FG003|COMPLETED|Overall Study||40
8578164|NCT00168454|9611173|FG004|COMPLETED|Overall Study||47
8578165|NCT00168454|9611174|FG005|COMPLETED|Overall Study||50
8578166|NCT00168454|9611169|FG000|NOT COMPLETED|Overall Study||7
8578167|NCT00168454|9611170|FG001|NOT COMPLETED|Overall Study||7
8578168|NCT00168454|9611171|FG002|NOT COMPLETED|Overall Study||6
8578169|NCT00168454|9611172|FG003|NOT COMPLETED|Overall Study||9
8578170|NCT00168454|9611173|FG004|NOT COMPLETED|Overall Study||6
8578171|NCT00168454|9611174|FG005|NOT COMPLETED|Overall Study||6
8578172|NCT00168805|9611191|FG000|STARTED|Overall Study||679
8578173|NCT00168805|9611192|FG001|STARTED|Overall Study||703
8578174|NCT00168805|9611193|FG002|STARTED|Overall Study||694
8578175|NCT00168805|9611191|FG000|COMPLETED|Overall Study||608
8578176|NCT00168805|9611192|FG001|COMPLETED|Overall Study||625
8578177|NCT00168805|9611193|FG002|COMPLETED|Overall Study||616
8578178|NCT00168805|9611191|FG000|NOT COMPLETED|Overall Study||71
8578179|NCT00168805|9611192|FG001|NOT COMPLETED|Overall Study||78
8578180|NCT00168805|9611193|FG002|NOT COMPLETED|Overall Study||78
8578181|NCT00168805|9611191|FG000|STARTED|Treatment||679
8578182|NCT00168805|9611192|FG001|STARTED|Treatment||703
8578183|NCT00168805|9611193|FG002|STARTED|Treatment||694
8578184|NCT00168805|9611191|FG000|COMPLETED|Treatment||630
8578185|NCT00168805|9611192|FG001|COMPLETED|Treatment||647
8578186|NCT00168805|9611193|FG002|COMPLETED|Treatment||632
8578187|NCT00168805|9611191|FG000|NOT COMPLETED|Treatment||49
8578188|NCT00168805|9611192|FG001|NOT COMPLETED|Treatment||56
8578189|NCT00168805|9611193|FG002|NOT COMPLETED|Treatment||62
8578190|NCT00168818|9611204|FG000|STARTED|Overall Study||1146
8578191|NCT00168818|9611205|FG001|STARTED|Overall Study||1163
8578192|NCT00168818|9611206|FG002|STARTED|Overall Study||1154
8578193|NCT00168818|9611204|FG000|COMPLETED|Overall Study||1029
8578194|NCT00168818|9611205|FG001|COMPLETED|Overall Study||1054
8578195|NCT00168818|9611206|FG002|COMPLETED|Overall Study||1030
8578196|NCT00168818|9611204|FG000|NOT COMPLETED|Overall Study||117
8578197|NCT00168818|9611205|FG001|NOT COMPLETED|Overall Study||109
8578198|NCT00168818|9611206|FG002|NOT COMPLETED|Overall Study||124
8578199|NCT00168818|9611204|FG000|STARTED|Treatment||1146
8578200|NCT00168818|9611205|FG001|STARTED|Treatment||1163
8578201|NCT00168818|9611206|FG002|STARTED|Treatment||1154
8578202|NCT00168818|9611204|FG000|COMPLETED|Treatment||1013
8578203|NCT00168818|9611205|FG001|COMPLETED|Treatment||1012
8578204|NCT00168818|9611206|FG002|COMPLETED|Treatment||1021
8578205|NCT00168818|9611204|FG000|NOT COMPLETED|Treatment||133
8578206|NCT00168818|9611205|FG001|NOT COMPLETED|Treatment||151
8578207|NCT00168818|9611206|FG002|NOT COMPLETED|Treatment||133
8578208|NCT00168831|9611217|FG000|STARTED|Overall Study||338
8578209|NCT00168831|9611218|FG001|STARTED|Overall Study||335
8578210|NCT00168831|9611219|FG002|STARTED|Overall Study||334
8578211|NCT00168831|9611217|FG000|COMPLETED|Overall Study||278
8578212|NCT00168831|9611218|FG001|COMPLETED|Overall Study||254
8578213|NCT00168831|9611219|FG002|COMPLETED|Overall Study||220
8578214|NCT00168831|9611217|FG000|NOT COMPLETED|Overall Study||60
8578215|NCT00168831|9611218|FG001|NOT COMPLETED|Overall Study||81
8578216|NCT00168831|9611219|FG002|NOT COMPLETED|Overall Study||114
8578217|NCT00168844|9611230|FG000|STARTED|Overall Study||332
8578218|NCT00168844|9611231|FG001|STARTED|Overall Study||332
8578219|NCT00168844|9611232|FG002|STARTED|Overall Study||319
8578220|NCT00168844|9611230|FG000|COMPLETED|Overall Study||277
8578221|NCT00168844|9611231|FG001|COMPLETED|Overall Study||277
8578222|NCT00168844|9611232|FG002|COMPLETED|Overall Study||228
8578223|NCT00168844|9611230|FG000|NOT COMPLETED|Overall Study||55
8578224|NCT00168844|9611231|FG001|NOT COMPLETED|Overall Study||55
8578225|NCT00168844|9611232|FG002|NOT COMPLETED|Overall Study||91
8578226|NCT00169104|9611242|FG000|STARTED|Overall Study||13
8578227|NCT00169104|9611243|FG001|STARTED|Overall Study||10
8578228|NCT00169104|9611242|FG000|COMPLETED|Overall Study||11
8578229|NCT00169104|9611243|FG001|COMPLETED|Overall Study||8
8578230|NCT00169104|9611242|FG000|NOT COMPLETED|Overall Study||2
8578231|NCT00169104|9611243|FG001|NOT COMPLETED|Overall Study||2
8578232|NCT00169442|9611256|FG000|STARTED|Overall Study||119
8578233|NCT00169442|9611257|FG001|STARTED|Overall Study||124
8578234|NCT00169442|9611258|FG002|STARTED|Overall Study||167
8578235|NCT00169442|9611259|FG003|STARTED|Overall Study||250
8578236|NCT00169442|9611260|FG004|STARTED|Overall Study||42
8578237|NCT00169442|9611261|FG005|STARTED|Overall Study||43
8578238|NCT00169442|9611256|FG000|COMPLETED|Overall Study||119
8578239|NCT00169442|9611257|FG001|COMPLETED|Overall Study||123
8578240|NCT00169442|9611258|FG002|COMPLETED|Overall Study||166
8578241|NCT00169442|9611259|FG003|COMPLETED|Overall Study||250
8578242|NCT00169442|9611260|FG004|COMPLETED|Overall Study||41
8578243|NCT00169442|9611261|FG005|COMPLETED|Overall Study||41
8578244|NCT00169442|9611256|FG000|NOT COMPLETED|Overall Study||0
8578245|NCT00169442|9611257|FG001|NOT COMPLETED|Overall Study||1
8578246|NCT00169442|9611258|FG002|NOT COMPLETED|Overall Study||1
8578247|NCT00169442|9611259|FG003|NOT COMPLETED|Overall Study||0
8578248|NCT00169442|9611260|FG004|NOT COMPLETED|Overall Study||1
8578249|NCT00169442|9611261|FG005|NOT COMPLETED|Overall Study||2
8578250|NCT00170157|9611277|FG000|STARTED|Treatment Period 1 Initial Randomization||54
8578251|NCT00170157|9611278|FG001|STARTED|Treatment Period 1 Initial Randomization||58
8578252|NCT00170157|9611277|FG000|COMPLETED|Treatment Period 1 Initial Randomization||54
8578253|NCT00170157|9611278|FG001|COMPLETED|Treatment Period 1 Initial Randomization||58
8578254|NCT00170157|9611277|FG000|NOT COMPLETED|Treatment Period 1 Initial Randomization||0
8578255|NCT00170157|9611278|FG001|NOT COMPLETED|Treatment Period 1 Initial Randomization||0
8578256|NCT00170157|9611277|FG000|STARTED|Washout Period of 14 Days|Participants initially randomized to this arm were not eligible for crossover.|0
8578257|NCT00170157|9611278|FG001|STARTED|Washout Period of 14 Days||58
8578258|NCT00170157|9611277|FG000|COMPLETED|Washout Period of 14 Days||0
8578259|NCT00170157|9611278|FG001|COMPLETED|Washout Period of 14 Days||41
8578260|NCT00170157|9611277|FG000|NOT COMPLETED|Washout Period of 14 Days||0
8578261|NCT00170157|9611278|FG001|NOT COMPLETED|Washout Period of 14 Days||17
8578262|NCT00170157|9611277|FG000|STARTED|Treatment Period 2 Crossover|Participants initially randomized to this arm were not eligible for crossover.|0
8578263|NCT00170157|9611278|FG001|STARTED|Treatment Period 2 Crossover||41
8578264|NCT00170157|9611277|FG000|COMPLETED|Treatment Period 2 Crossover||0
8578265|NCT00170157|9611278|FG001|COMPLETED|Treatment Period 2 Crossover||41
8578266|NCT00170157|9611277|FG000|NOT COMPLETED|Treatment Period 2 Crossover||0
8578267|NCT00170157|9611278|FG001|NOT COMPLETED|Treatment Period 2 Crossover||0
8578268|NCT00170625|9611284|FG000|STARTED|Overall Study||26
8578269|NCT00170625|9611284|FG000|COMPLETED|Overall Study||26
8578270|NCT00170625|9611284|FG000|NOT COMPLETED|Overall Study||0
8578271|NCT00170846|9611291|FG000|STARTED|Overall Study||123
8578272|NCT00170846|9611292|FG001|STARTED|Overall Study||127
8578273|NCT00170846|9611293|FG002|STARTED|Overall Study||144
8578274|NCT00170846|9611291|FG000|COMPLETED|Overall Study||112
8578275|NCT00170846|9611292|FG001|COMPLETED|Overall Study||108
8578276|NCT00170846|9611293|FG002|COMPLETED|Overall Study||131
8578277|NCT00170846|9611291|FG000|NOT COMPLETED|Overall Study||11
8578278|NCT00170846|9611292|FG001|NOT COMPLETED|Overall Study||19
8578279|NCT00170846|9611293|FG002|NOT COMPLETED|Overall Study||13
8578280|NCT00170950|9611303|FG000|STARTED|Overall Study||5744
8578281|NCT00170950|9611304|FG001|STARTED|Overall Study||5762
8578282|NCT00170950|9611303|FG000|COMPLETED|Overall Study||4859
8578283|NCT00170950|9611304|FG001|COMPLETED|Overall Study||4852
8578284|NCT00170950|9611303|FG000|NOT COMPLETED|Overall Study||885
8578285|NCT00170950|9611304|FG001|NOT COMPLETED|Overall Study||910
8578286|NCT00171054|9611312|FG000|STARTED|Overall Study||63
8578287|NCT00171054|9611313|FG001|STARTED|Overall Study||62
8578288|NCT00171054|9611312|FG000|COMPLETED|Overall Study||53
8578289|NCT00171054|9611313|FG001|COMPLETED|Overall Study||50
8578290|NCT00171054|9611312|FG000|NOT COMPLETED|Overall Study||10
8578291|NCT00171054|9611313|FG001|NOT COMPLETED|Overall Study||12
8578292|NCT00171158|9611319|FG000|STARTED|Core Study||260
8578293|NCT00171158|9611319|FG000|COMPLETED|Core Study||21
8578294|NCT00171158|9611319|FG000|NOT COMPLETED|Core Study||239
8578295|NCT00171158|9611319|FG000|STARTED|E2 Extension||8
8578296|NCT00171158|9611319|FG000|COMPLETED|E2 Extension||1
8578297|NCT00171158|9611319|FG000|NOT COMPLETED|E2 Extension||7
8578298|NCT00171210|9611325|FG000|STARTED|Overall Study||259
8578299|NCT00171210|9611326|FG001|STARTED|Overall Study||296
8578300|NCT00171210|9611325|FG000|STARTED EXTENSION STUDY|Overall Study||259
8578301|NCT00171210|9611326|FG001|STARTED EXTENSION STUDY|Overall Study||247
8578302|NCT00171210|9611325|FG000|COMPLETED|Overall Study||190
8578303|NCT00171210|9611326|FG001|COMPLETED|Overall Study||181
8578304|NCT00171210|9611325|FG000|NOT COMPLETED|Overall Study||69
8578305|NCT00171210|9611326|FG001|NOT COMPLETED|Overall Study||115
8578306|NCT00171223|9611335|FG000|STARTED|Overall Study||152
8578307|NCT00171223|9611336|FG001|STARTED|Overall Study||188
8578308|NCT00171223|9611337|FG002|STARTED|Overall Study||192
8578309|NCT00171223|9611335|FG000|COMPLETED|Overall Study||12
8578310|NCT00171223|9611336|FG001|COMPLETED|Overall Study||47
8578311|NCT00171223|9611337|FG002|COMPLETED|Overall Study||22
8578312|NCT00171223|9611335|FG000|NOT COMPLETED|Overall Study||140
8578313|NCT00171223|9611336|FG001|NOT COMPLETED|Overall Study||141
8578314|NCT00171223|9611337|FG002|NOT COMPLETED|Overall Study||170
8578315|NCT00171249|9611343|FG000|STARTED|Overall Study||77
8578316|NCT00171249|9611344|FG001|STARTED|Overall Study||5
8578317|NCT00171249|9611345|FG002|STARTED|Overall Study||5
8578318|NCT00171249|9611346|FG003|STARTED|Overall Study||158
8578319|NCT00171249|9611347|FG004|STARTED|Overall Study||3
8578320|NCT00171249|9611348|FG005|STARTED|Overall Study||43
8578321|NCT00171249|9611349|FG006|STARTED|Overall Study||2
8578322|NCT00171249|9611343|FG000|Completed Part 1|Overall Study||50
8578323|NCT00171249|9611344|FG001|Completed Part 1|Overall Study||0
8578324|NCT00171249|9611345|FG002|Completed Part 1|Overall Study||1
8578325|NCT00171249|9611346|FG003|Completed Part 1|Overall Study||125
8578326|NCT00171249|9611347|FG004|Completed Part 1|Overall Study||2
8578327|NCT00171249|9611348|FG005|Completed Part 1|Overall Study||6
8578328|NCT00171249|9611349|FG006|Completed Part 1|Overall Study||0
8578329|NCT00171249|9611343|FG000|COMPLETED|Overall Study||1
8578330|NCT00171249|9611344|FG001|COMPLETED|Overall Study||0
8578331|NCT00171249|9611345|FG002|COMPLETED|Overall Study||0
8578332|NCT00171249|9611346|FG003|COMPLETED|Overall Study||6
8578333|NCT00171249|9611347|FG004|COMPLETED|Overall Study||0
8578334|NCT00171249|9611348|FG005|COMPLETED|Overall Study||0
8578335|NCT00171249|9611349|FG006|COMPLETED|Overall Study||0
8578336|NCT00171249|9611343|FG000|NOT COMPLETED|Overall Study||76
8578337|NCT00171249|9611344|FG001|NOT COMPLETED|Overall Study||5
8578338|NCT00171249|9611345|FG002|NOT COMPLETED|Overall Study||5
8578339|NCT00171249|9611346|FG003|NOT COMPLETED|Overall Study||152
8578340|NCT00171249|9611347|FG004|NOT COMPLETED|Overall Study||3
8578341|NCT00171249|9611348|FG005|NOT COMPLETED|Overall Study||43
8578342|NCT00171249|9611349|FG006|NOT COMPLETED|Overall Study||2
8578343|NCT00171301|9611360|FG000|STARTED|Overall Study||162
8578344|NCT00171301|9611361|FG001|STARTED|Overall Study|2 participants in this group never received deferasirox.|71
8578345|NCT00171301|9611360|FG000|Received Deferasirox|Overall Study||162
8578346|NCT00171301|9611361|FG001|Received Deferasirox|Overall Study||69
8578347|NCT00171301|9611360|FG000|COMPLETED|Overall Study||154
8578348|NCT00171301|9611361|FG001|COMPLETED|Overall Study||62
8578349|NCT00171301|9611360|FG000|NOT COMPLETED|Overall Study||8
8578350|NCT00171301|9611361|FG001|NOT COMPLETED|Overall Study||9
8578351|NCT00171314|9611370|FG000|STARTED|Overall Study|2 patients in each arm were randomized but not treated.|263
8578352|NCT00171314|9611371|FG001|STARTED|Overall Study||264
8578353|NCT00171314|9611370|FG000|Safety Population|Overall Study|"Treatment Actually Received = 251 from upfront Arm and 3 from delayed Arm"|254
8578354|NCT00171314|9611371|FG001|Safety Population|Overall Study|"Treatment Actually Received = 10 from upfront Arm and 259 from delayed Arm"|269
8578355|NCT00171314|9611370|FG000|COMPLETED|Overall Study||172
8578356|NCT00171314|9611371|FG001|COMPLETED|Overall Study||186
8578357|NCT00171314|9611370|FG000|NOT COMPLETED|Overall Study||91
8578358|NCT00171314|9611371|FG001|NOT COMPLETED|Overall Study||78
8578359|NCT00171340|9611379|FG000|STARTED|Overall Study||532
8578360|NCT00171340|9611380|FG001|STARTED|Overall Study||533
8578361|NCT00171340|9611379|FG000|COMPLETED|Overall Study||408
8578362|NCT00171340|9611380|FG001|COMPLETED|Overall Study||398
8578363|NCT00171340|9611379|FG000|NOT COMPLETED|Overall Study||124
8578364|NCT00171340|9611380|FG001|NOT COMPLETED|Overall Study||135
8578365|NCT00171704|9611390|FG000|STARTED|Overall Study||133
8578366|NCT00171704|9611391|FG001|STARTED|Overall Study||130
8578367|NCT00171704|9611390|FG000|COMPLETED|Overall Study||89
8578368|NCT00171704|9611391|FG001|COMPLETED|Overall Study||81
8578369|NCT00171704|9611390|FG000|NOT COMPLETED|Overall Study||44
8578370|NCT00171704|9611391|FG001|NOT COMPLETED|Overall Study||49
8578371|NCT00171730|9611397|FG000|STARTED|Overall Study||30
8578372|NCT00171730|9611397|FG000|COMPLETED|Overall Study||15
8578373|NCT00171730|9611397|FG000|NOT COMPLETED|Overall Study||15
8578374|NCT00171834|9611414|FG000|STARTED|Overall Study||6
8578375|NCT00171834|9611415|FG001|STARTED|Overall Study||12
8578376|NCT00171834|9611416|FG002|STARTED|Overall Study||12
8578377|NCT00171834|9611417|FG003|STARTED|Overall Study||12
8578378|NCT00171834|9611418|FG004|STARTED|Overall Study||8
8578379|NCT00171834|9611419|FG005|STARTED|Overall Study||35
8578380|NCT00171834|9611420|FG006|STARTED|Overall Study||4
8578381|NCT00171834|9611414|FG000|Completed 6 Cycles of Treatment|Overall Study||0
8578382|NCT00171834|9611415|FG001|Completed 6 Cycles of Treatment|Overall Study||0
8578383|NCT00171834|9611416|FG002|Completed 6 Cycles of Treatment|Overall Study||1
8578384|NCT00171834|9611417|FG003|Completed 6 Cycles of Treatment|Overall Study||0
8578385|NCT00171834|9611418|FG004|Completed 6 Cycles of Treatment|Overall Study||2
8578386|NCT00171834|9611419|FG005|Completed 6 Cycles of Treatment|Overall Study||1
8578387|NCT00171834|9611420|FG006|Completed 6 Cycles of Treatment|Overall Study||0
8578388|NCT00171834|9611414|FG000|COMPLETED|Overall Study||0
8578389|NCT00171834|9611415|FG001|COMPLETED|Overall Study||0
8578390|NCT00171834|9611416|FG002|COMPLETED|Overall Study||0
8578391|NCT00171834|9611417|FG003|COMPLETED|Overall Study||0
8578392|NCT00171834|9611418|FG004|COMPLETED|Overall Study||0
8578393|NCT00171834|9611419|FG005|COMPLETED|Overall Study||0
8578394|NCT00171834|9611420|FG006|COMPLETED|Overall Study||0
8578395|NCT00171834|9611414|FG000|NOT COMPLETED|Overall Study||6
8578396|NCT00171834|9611415|FG001|NOT COMPLETED|Overall Study||12
8578397|NCT00171834|9611416|FG002|NOT COMPLETED|Overall Study||12
8578398|NCT00171834|9611417|FG003|NOT COMPLETED|Overall Study||12
8578399|NCT00171834|9611418|FG004|NOT COMPLETED|Overall Study||8
8578400|NCT00171834|9611419|FG005|NOT COMPLETED|Overall Study||35
8578401|NCT00171834|9611420|FG006|NOT COMPLETED|Overall Study||4
8578402|NCT00171873|9611452|FG000|STARTED|Overall Study||42
8578403|NCT00171873|9611453|FG001|STARTED|Overall Study||43
8578404|NCT00171873|9611452|FG000|COMPLETED|Overall Study||33
8578405|NCT00171873|9611453|FG001|COMPLETED|Overall Study||40
8578406|NCT00171873|9611452|FG000|NOT COMPLETED|Overall Study||9
8578407|NCT00171873|9611453|FG001|NOT COMPLETED|Overall Study||3
8578408|NCT00171925|9611461|FG000|STARTED|Overall Study||72
8578409|NCT00171925|9611462|FG001|STARTED|Overall Study||71
8578410|NCT00171925|9611461|FG000|COMPLETED|Overall Study||42
8578411|NCT00171925|9611462|FG001|COMPLETED|Overall Study||40
8578412|NCT00171925|9611461|FG000|NOT COMPLETED|Overall Study||30
8578413|NCT00171925|9611462|FG001|NOT COMPLETED|Overall Study||31
8578414|NCT00171951|9611468|FG000|STARTED|Overall Study||19
8578415|NCT00171951|9611468|FG000|COMPLETED|Overall Study||3
8578416|NCT00171951|9611468|FG000|NOT COMPLETED|Overall Study||16
8578417|NCT00172042|9611477|FG000|STARTED|Overall Study||226
8578418|NCT00172042|9611478|FG001|STARTED|Overall Study||211
8578419|NCT00172042|9611477|FG000|COMPLETED|Overall Study||68
8578420|NCT00172042|9611478|FG001|COMPLETED|Overall Study||86
8578421|NCT00172042|9611477|FG000|NOT COMPLETED|Overall Study||158
8578422|NCT00172042|9611478|FG001|NOT COMPLETED|Overall Study||125
8578423|NCT00172185|9611488|FG000|STARTED|Overall Study||6
8578424|NCT00172185|9611489|FG001|STARTED|Overall Study||7
8578425|NCT00172185|9611490|FG002|STARTED|Overall Study||25
8578426|NCT00172185|9611491|FG003|STARTED|Overall Study||27
8578427|NCT00172185|9611488|FG000|COMPLETED|Overall Study||6
8578428|NCT00172185|9611489|FG001|COMPLETED|Overall Study||5
8578429|NCT00172185|9611490|FG002|COMPLETED|Overall Study||20
8578430|NCT00172185|9611491|FG003|COMPLETED|Overall Study||23
8578431|NCT00172185|9611488|FG000|NOT COMPLETED|Overall Study||0
8578432|NCT00172185|9611489|FG001|NOT COMPLETED|Overall Study||2
8578433|NCT00172185|9611490|FG002|NOT COMPLETED|Overall Study||5
8578434|NCT00172185|9611491|FG003|NOT COMPLETED|Overall Study||4
8578435|NCT00174187|9611507|FG000|STARTED|Period 1 (up to 3 Years)||15
8578436|NCT00174187|9611508|FG001|STARTED|Period 1 (up to 3 Years)||15
8578437|NCT00174187|9611509|FG002|STARTED|Period 1 (up to 3 Years)||0
8578438|NCT00174187|9611507|FG000|COMPLETED|Period 1 (up to 3 Years)||15
8578439|NCT00174187|9611508|FG001|COMPLETED|Period 1 (up to 3 Years)||11
8578440|NCT00174187|9611509|FG002|COMPLETED|Period 1 (up to 3 Years)||0
8578441|NCT00174187|9611507|FG000|NOT COMPLETED|Period 1 (up to 3 Years)||0
8578442|NCT00174187|9611508|FG001|NOT COMPLETED|Period 1 (up to 3 Years)||4
8578443|NCT00174187|9611509|FG002|NOT COMPLETED|Period 1 (up to 3 Years)||0
8578444|NCT00174187|9611507|FG000|STARTED|Between Period 1 and Period 2||0
8578445|NCT00174187|9611508|FG001|STARTED|Between Period 1 and Period 2||0
8578446|NCT00174187|9611509|FG002|STARTED|Between Period 1 and Period 2||26
8578447|NCT00174187|9611507|FG000|Consented|Between Period 1 and Period 2||0
8578448|NCT00174187|9611508|FG001|Consented|Between Period 1 and Period 2||0
8578449|NCT00174187|9611509|FG002|Consented|Between Period 1 and Period 2||24
8578450|NCT00174187|9611507|FG000|COMPLETED|Between Period 1 and Period 2||0
8578451|NCT00174187|9611508|FG001|COMPLETED|Between Period 1 and Period 2||0
8578452|NCT00174187|9611509|FG002|COMPLETED|Between Period 1 and Period 2||21
8578453|NCT00174187|9611507|FG000|NOT COMPLETED|Between Period 1 and Period 2||0
8578454|NCT00174187|9611508|FG001|NOT COMPLETED|Between Period 1 and Period 2||0
8578455|NCT00174187|9611509|FG002|NOT COMPLETED|Between Period 1 and Period 2||5
8578456|NCT00174187|9611507|FG000|STARTED|Period 2 (After 3 Years)||0
8578457|NCT00174187|9611508|FG001|STARTED|Period 2 (After 3 Years)||0
8578458|NCT00174187|9611509|FG002|STARTED|Period 2 (After 3 Years)||21
8578459|NCT00174187|9611507|FG000|COMPLETED|Period 2 (After 3 Years)||0
8578460|NCT00174187|9611508|FG001|COMPLETED|Period 2 (After 3 Years)||0
8578461|NCT00174187|9611509|FG002|COMPLETED|Period 2 (After 3 Years)||13
8578462|NCT00174187|9611507|FG000|NOT COMPLETED|Period 2 (After 3 Years)||0
8578463|NCT00174187|9611508|FG001|NOT COMPLETED|Period 2 (After 3 Years)||0
8578464|NCT00174187|9611509|FG002|NOT COMPLETED|Period 2 (After 3 Years)||8
8578465|NCT00174252|9611517|FG000|STARTED|Overall Study||57
8578466|NCT00174252|9611517|FG000|COMPLETED|Overall Study||55
8578467|NCT00174252|9611517|FG000|NOT COMPLETED|Overall Study||2
8578468|NCT00174291|9611525|FG000|STARTED|Overall Study||11
8578469|NCT00174291|9611526|FG001|STARTED|Overall Study||10
8578470|NCT00174291|9611525|FG000|COMPLETED|Overall Study||6
8578471|NCT00174291|9611526|FG001|COMPLETED|Overall Study||4
8578472|NCT00174291|9611525|FG000|NOT COMPLETED|Overall Study||5
8578473|NCT00174291|9611526|FG001|NOT COMPLETED|Overall Study||6
8578474|NCT00174382|9611532|FG000|STARTED|Overall Study|148 are summarized below: 1 subject entered the study but was lost to follow up.|149
8578475|NCT00174382|9611532|FG000|COMPLETED|Overall Study||116
8578476|NCT00174382|9611532|FG000|NOT COMPLETED|Overall Study||33
8578477|NCT00174447|9611536|FG000|STARTED|Overall Study||43
8578478|NCT00174447|9611536|FG000|COMPLETED|Overall Study||5
8578479|NCT00174447|9611536|FG000|NOT COMPLETED|Overall Study||38
8578480|NCT00174460|9611542|FG000|STARTED|Overall Study||18
8578481|NCT00174460|9611543|FG001|STARTED|Overall Study||15
8578482|NCT00174460|9611542|FG000|Received Study Treatment|Overall Study||18
8578483|NCT00174460|9611543|FG001|Received Study Treatment|Overall Study||14
8578484|NCT00174460|9611542|FG000|COMPLETED|Overall Study||18
8578485|NCT00174460|9611543|FG001|COMPLETED|Overall Study||14
8578486|NCT00174460|9611542|FG000|NOT COMPLETED|Overall Study||0
8578487|NCT00174460|9611543|FG001|NOT COMPLETED|Overall Study||1
8578488|NCT00174785|9611552|FG000|STARTED|Overall Study|randomized patients; among them, 10 patients did not receive any study drug in the dronedarone group|2301
8578489|NCT00174785|9611553|FG001|STARTED|Overall Study|randomized patients; among them, 14 patients did not receive any study drug in the placebo group|2327
8578490|NCT00174785|9611552|FG000|COMPLETED|Overall Study|completed study drug|1605
8578491|NCT00174785|9611553|FG001|COMPLETED|Overall Study|completed study drug|1611
8578492|NCT00174785|9611552|FG000|NOT COMPLETED|Overall Study||696
8578493|NCT00174785|9611553|FG001|NOT COMPLETED|Overall Study||716
8578494|NCT00174915|9611564|FG000|STARTED|Overall Study||267
8578495|NCT00174915|9611565|FG001|STARTED|Overall Study||269
8578496|NCT00174915|9611566|FG002|STARTED|Overall Study||134
8578497|NCT00174915|9611567|FG003|STARTED|Overall Study||268
8578498|NCT00174915|9611568|FG004|STARTED|Overall Study||134
8578499|NCT00174915|9611564|FG000|COMPLETED|Overall Study||174
8578500|NCT00174915|9611565|FG001|COMPLETED|Overall Study||200
8578501|NCT00174915|9611566|FG002|COMPLETED|Overall Study||86
8578502|NCT00174915|9611567|FG003|COMPLETED|Overall Study||211
8578503|NCT00174915|9611568|FG004|COMPLETED|Overall Study||101
8578504|NCT00174915|9611564|FG000|NOT COMPLETED|Overall Study||93
8578505|NCT00174915|9611565|FG001|NOT COMPLETED|Overall Study||69
8578506|NCT00174915|9611566|FG002|NOT COMPLETED|Overall Study||48
8578507|NCT00174915|9611567|FG003|NOT COMPLETED|Overall Study||57
8578508|NCT00174915|9611568|FG004|NOT COMPLETED|Overall Study||33
8578509|NCT00174941|9611583|FG000|STARTED|Overall Study|Subjects started on febuxostat 80mg. Number of subjects based on Final Stable Dose after titration.|8
8578510|NCT00174941|9611584|FG001|STARTED|Overall Study|Subjects started on febuxostat 80mg. Number of subjects based on Final Stable Dose after titration.|79
8578511|NCT00174941|9611585|FG002|STARTED|Overall Study|Subjects started on febuxostat 80mg. Number of subjects based on Final Stable Dose after titration.|29
8578512|NCT00174941|9611586|FG003|STARTED|Overall Study||116
8578513|NCT00174941|9611583|FG000|COMPLETED|Overall Study||6
8578514|NCT00174941|9611584|FG001|COMPLETED|Overall Study||41
8578515|NCT00174941|9611585|FG002|COMPLETED|Overall Study||11
8578516|NCT00174941|9611586|FG003|COMPLETED|Overall Study||58
8578517|NCT00174941|9611583|FG000|NOT COMPLETED|Overall Study||2
8578518|NCT00174941|9611584|FG001|NOT COMPLETED|Overall Study||38
8578519|NCT00174941|9611585|FG002|NOT COMPLETED|Overall Study||18
8578520|NCT00174941|9611586|FG003|NOT COMPLETED|Overall Study||58
8578521|NCT00174954|9611596|FG000|STARTED|Overall Study||32
8578522|NCT00174954|9611596|FG000|COMPLETED|Overall Study||28
8578523|NCT00174954|9611596|FG000|NOT COMPLETED|Overall Study||4
8578524|NCT00174967|9611604|FG000|STARTED|Overall Study||37
8578525|NCT00174967|9611605|FG001|STARTED|Overall Study||40
8578526|NCT00174967|9611606|FG002|STARTED|Overall Study||38
8578527|NCT00174967|9611607|FG003|STARTED|Overall Study||38
8578528|NCT00174967|9611604|FG000|COMPLETED|Overall Study||36
8578529|NCT00174967|9611605|FG001|COMPLETED|Overall Study||37
8578530|NCT00174967|9611606|FG002|COMPLETED|Overall Study||36
8578531|NCT00174967|9611607|FG003|COMPLETED|Overall Study||36
8578532|NCT00174967|9611604|FG000|NOT COMPLETED|Overall Study||1
8693786|NCT00868530|9739337|FG000|STARTED|Overall Study||53
8693787|NCT00868530|9739337|FG000|COMPLETED|Overall Study||49
8693788|NCT00868530|9739337|FG000|NOT COMPLETED|Overall Study||4
8693789|NCT00868608|9739344|FG000|STARTED|Overall Study||72
8693790|NCT00868608|9739345|FG001|STARTED|Overall Study||4
8693791|NCT00868608|9739346|FG002|STARTED|Overall Study||5
8693792|NCT00868608|9739344|FG000|COMPLETED|Overall Study||49
8693793|NCT00868608|9739345|FG001|COMPLETED|Overall Study||1
8693794|NCT00868608|9739346|FG002|COMPLETED|Overall Study||0
8693795|NCT00868608|9739344|FG000|NOT COMPLETED|Overall Study||23
8693796|NCT00868608|9739345|FG001|NOT COMPLETED|Overall Study||3
8693797|NCT00868608|9739346|FG002|NOT COMPLETED|Overall Study||5
8693798|NCT00868699|9739357|FG000|STARTED|Overall Study||170
8693799|NCT00868699|9739358|FG001|STARTED|Overall Study||169
8693800|NCT00868699|9739359|FG002|STARTED|Overall Study||166
8693801|NCT00868699|9739357|FG000|Intent-to-Treat Population|Overall Study||162
8693802|NCT00868699|9739358|FG001|Intent-to-Treat Population|Overall Study||162
8693803|NCT00868699|9739359|FG002|Intent-to-Treat Population|Overall Study||161
8693804|NCT00868699|9739357|FG000|Safety Population|Overall Study||168
8693805|NCT00868699|9739358|FG001|Safety Population|Overall Study||167
8693806|NCT00868699|9739359|FG002|Safety Population|Overall Study||164
8693807|NCT00868699|9739357|FG000|COMPLETED|Overall Study||127
8693808|NCT00868699|9739358|FG001|COMPLETED|Overall Study||124
8693809|NCT00868699|9739359|FG002|COMPLETED|Overall Study||123
8693810|NCT00868699|9739357|FG000|NOT COMPLETED|Overall Study||43
8693811|NCT00868699|9739358|FG001|NOT COMPLETED|Overall Study||45
8693812|NCT00868699|9739359|FG002|NOT COMPLETED|Overall Study||43
8693813|NCT00868712|9739370|FG000|STARTED|Overall Study||31
8693814|NCT00868712|9739371|FG001|STARTED|Overall Study||11
8693815|NCT00868712|9739372|FG002|STARTED|Overall Study||28
8693816|NCT00868712|9739370|FG000|COMPLETED|Overall Study||31
8693817|NCT00868712|9739371|FG001|COMPLETED|Overall Study||11
8693818|NCT00868712|9739372|FG002|COMPLETED|Overall Study||28
8693819|NCT00868712|9739370|FG000|NOT COMPLETED|Overall Study||0
8693820|NCT00868712|9739371|FG001|NOT COMPLETED|Overall Study||0
8693821|NCT00868712|9739372|FG002|NOT COMPLETED|Overall Study||0
8693822|NCT00868751|9739380|FG000|STARTED|Overall Study||1
8693823|NCT00868751|9739380|FG000|COMPLETED|Overall Study||0
8693824|NCT00868751|9739380|FG000|NOT COMPLETED|Overall Study||1
8693825|NCT00868790|9739384|FG000|STARTED|Period 1||11
8693826|NCT00868790|9739385|FG001|STARTED|Period 1||8
8693827|NCT00868790|9739386|FG002|STARTED|Period 1||4
8693828|NCT00868790|9739387|FG003|STARTED|Period 1||4
8693829|NCT00868790|9739388|FG004|STARTED|Period 1||19
8693830|NCT00868790|9739389|FG005|STARTED|Period 1||3
8693831|NCT00868790|9739390|FG006|STARTED|Period 1||4
8693832|NCT00868790|9739391|FG007|STARTED|Period 1||20
8693833|NCT00868790|9739392|FG008|STARTED|Period 1||11
8693834|NCT00868790|9739393|FG009|STARTED|Period 1||3
8693835|NCT00868790|9739394|FG010|STARTED|Period 1||9
8693836|NCT00868790|9739395|FG011|STARTED|Period 1||4
8693837|NCT00868790|9739396|FG012|STARTED|Period 1||7
8693838|NCT00868790|9739397|FG013|STARTED|Period 1||11
8693839|NCT00868790|9739384|FG000|COMPLETED|Period 1||9
8693840|NCT00868790|9739385|FG001|COMPLETED|Period 1||7
8693841|NCT00868790|9739386|FG002|COMPLETED|Period 1||4
8693842|NCT00868790|9739387|FG003|COMPLETED|Period 1||4
8693843|NCT00868790|9739388|FG004|COMPLETED|Period 1||18
8693844|NCT00868790|9739389|FG005|COMPLETED|Period 1||2
8693845|NCT00868790|9739390|FG006|COMPLETED|Period 1||4
8693846|NCT00868790|9739391|FG007|COMPLETED|Period 1||17
8693847|NCT00868790|9739392|FG008|COMPLETED|Period 1||10
8693848|NCT00868790|9739393|FG009|COMPLETED|Period 1||3
8693849|NCT00868790|9739394|FG010|COMPLETED|Period 1||9
8693850|NCT00868790|9739395|FG011|COMPLETED|Period 1||4
8693851|NCT00868790|9739396|FG012|COMPLETED|Period 1||7
8693852|NCT00868790|9739397|FG013|COMPLETED|Period 1||9
8693853|NCT00868790|9739384|FG000|NOT COMPLETED|Period 1||2
8693854|NCT00868790|9739385|FG001|NOT COMPLETED|Period 1||1
8693855|NCT00868790|9739386|FG002|NOT COMPLETED|Period 1||0
8693856|NCT00868790|9739387|FG003|NOT COMPLETED|Period 1||0
8693857|NCT00868790|9739388|FG004|NOT COMPLETED|Period 1||1
8693858|NCT00868790|9739389|FG005|NOT COMPLETED|Period 1||1
8693859|NCT00868790|9739390|FG006|NOT COMPLETED|Period 1||0
8693860|NCT00868790|9739391|FG007|NOT COMPLETED|Period 1||3
8693861|NCT00868790|9739392|FG008|NOT COMPLETED|Period 1||1
8693862|NCT00868790|9739393|FG009|NOT COMPLETED|Period 1||0
8693863|NCT00868790|9739394|FG010|NOT COMPLETED|Period 1||0
8693864|NCT00868790|9739395|FG011|NOT COMPLETED|Period 1||0
8693865|NCT00868790|9739396|FG012|NOT COMPLETED|Period 1||0
8693866|NCT00868790|9739397|FG013|NOT COMPLETED|Period 1||2
8693867|NCT00868790|9739384|FG000|STARTED|Period 2||9
8693868|NCT00868790|9739385|FG001|STARTED|Period 2||7
8693869|NCT00868790|9739386|FG002|STARTED|Period 2||4
8693870|NCT00868790|9739387|FG003|STARTED|Period 2||4
8693871|NCT00868790|9739388|FG004|STARTED|Period 2||18
8693872|NCT00868790|9739389|FG005|STARTED|Period 2||2
8693873|NCT00868790|9739390|FG006|STARTED|Period 2||4
8693874|NCT00868790|9739391|FG007|STARTED|Period 2||17
8693875|NCT00868790|9739392|FG008|STARTED|Period 2||10
8693876|NCT00868790|9739393|FG009|STARTED|Period 2||3
8693877|NCT00868790|9739394|FG010|STARTED|Period 2||9
8693878|NCT00868790|9739395|FG011|STARTED|Period 2||4
8693879|NCT00868790|9739396|FG012|STARTED|Period 2||7
8693880|NCT00868790|9739397|FG013|STARTED|Period 2||9
8693881|NCT00868790|9739384|FG000|COMPLETED|Period 2||9
8693882|NCT00868790|9739385|FG001|COMPLETED|Period 2||6
8693883|NCT00868790|9739386|FG002|COMPLETED|Period 2||4
8693884|NCT00868790|9739387|FG003|COMPLETED|Period 2||4
8693885|NCT00868790|9739388|FG004|COMPLETED|Period 2||18
8693886|NCT00868790|9739389|FG005|COMPLETED|Period 2||1
8693887|NCT00868790|9739390|FG006|COMPLETED|Period 2||4
8693888|NCT00868790|9739391|FG007|COMPLETED|Period 2||17
8693889|NCT00868790|9739392|FG008|COMPLETED|Period 2||8
8693890|NCT00868790|9739393|FG009|COMPLETED|Period 2||3
8693891|NCT00868790|9739394|FG010|COMPLETED|Period 2||9
8693892|NCT00868790|9739395|FG011|COMPLETED|Period 2||4
8693893|NCT00868790|9739396|FG012|COMPLETED|Period 2||7
8693894|NCT00868790|9739397|FG013|COMPLETED|Period 2||8
8693895|NCT00868790|9739384|FG000|NOT COMPLETED|Period 2||0
8693896|NCT00868790|9739385|FG001|NOT COMPLETED|Period 2||1
8693897|NCT00868790|9739386|FG002|NOT COMPLETED|Period 2||0
8693898|NCT00868790|9739387|FG003|NOT COMPLETED|Period 2||0
8693899|NCT00868790|9739388|FG004|NOT COMPLETED|Period 2||0
8693900|NCT00868790|9739389|FG005|NOT COMPLETED|Period 2||1
8693901|NCT00868790|9739390|FG006|NOT COMPLETED|Period 2||0
8693902|NCT00868790|9739391|FG007|NOT COMPLETED|Period 2||0
8693903|NCT00868790|9739392|FG008|NOT COMPLETED|Period 2||2
8693904|NCT00868790|9739393|FG009|NOT COMPLETED|Period 2||0
8693905|NCT00868790|9739394|FG010|NOT COMPLETED|Period 2||0
8693906|NCT00868790|9739395|FG011|NOT COMPLETED|Period 2||0
8693907|NCT00868790|9739396|FG012|NOT COMPLETED|Period 2||0
8693908|NCT00868790|9739397|FG013|NOT COMPLETED|Period 2||1
8693909|NCT00868790|9739384|FG000|STARTED|Period 3||9
8693910|NCT00868790|9739385|FG001|STARTED|Period 3||6
8693911|NCT00868790|9739386|FG002|STARTED|Period 3||4
8693912|NCT00868790|9739387|FG003|STARTED|Period 3||4
8693913|NCT00868790|9739388|FG004|STARTED|Period 3||18
8693914|NCT00868790|9739389|FG005|STARTED|Period 3||1
8693915|NCT00868790|9739390|FG006|STARTED|Period 3||4
8693916|NCT00868790|9739391|FG007|STARTED|Period 3||17
8693917|NCT00868790|9739392|FG008|STARTED|Period 3||8
8693918|NCT00868790|9739393|FG009|STARTED|Period 3||3
8693919|NCT00868790|9739394|FG010|STARTED|Period 3||9
8693920|NCT00868790|9739395|FG011|STARTED|Period 3||4
8693921|NCT00868790|9739396|FG012|STARTED|Period 3||7
8693922|NCT00868790|9739397|FG013|STARTED|Period 3||8
8693923|NCT00868790|9739384|FG000|COMPLETED|Period 3||9
8693924|NCT00868790|9739385|FG001|COMPLETED|Period 3||6
8693925|NCT00868790|9739386|FG002|COMPLETED|Period 3||4
8693926|NCT00868790|9739387|FG003|COMPLETED|Period 3||3
8693927|NCT00868790|9739388|FG004|COMPLETED|Period 3||18
8693928|NCT00868790|9739389|FG005|COMPLETED|Period 3||1
8693929|NCT00868790|9739390|FG006|COMPLETED|Period 3||4
8693930|NCT00868790|9739391|FG007|COMPLETED|Period 3||17
8693931|NCT00868790|9739392|FG008|COMPLETED|Period 3||8
8693932|NCT00868790|9739393|FG009|COMPLETED|Period 3||2
8693933|NCT00868790|9739394|FG010|COMPLETED|Period 3||8
8693934|NCT00868790|9739395|FG011|COMPLETED|Period 3||4
8693935|NCT00868790|9739396|FG012|COMPLETED|Period 3||7
8693936|NCT00868790|9739397|FG013|COMPLETED|Period 3||8
8693937|NCT00868790|9739384|FG000|NOT COMPLETED|Period 3||0
8693938|NCT00868790|9739385|FG001|NOT COMPLETED|Period 3||0
8693939|NCT00868790|9739386|FG002|NOT COMPLETED|Period 3||0
8693940|NCT00868790|9739387|FG003|NOT COMPLETED|Period 3||1
8693941|NCT00868790|9739388|FG004|NOT COMPLETED|Period 3||0
8693942|NCT00868790|9739389|FG005|NOT COMPLETED|Period 3||0
8693943|NCT00868790|9739390|FG006|NOT COMPLETED|Period 3||0
8693944|NCT00868790|9739391|FG007|NOT COMPLETED|Period 3||0
8693945|NCT00868790|9739392|FG008|NOT COMPLETED|Period 3||0
8693946|NCT00868790|9739393|FG009|NOT COMPLETED|Period 3||1
8693947|NCT00868790|9739394|FG010|NOT COMPLETED|Period 3||1
8693948|NCT00868790|9739395|FG011|NOT COMPLETED|Period 3||0
8693949|NCT00868790|9739396|FG012|NOT COMPLETED|Period 3||0
8693950|NCT00868790|9739397|FG013|NOT COMPLETED|Period 3||0
8693951|NCT00868790|9739384|FG000|STARTED|Period 4||9
8693952|NCT00868790|9739385|FG001|STARTED|Period 4||6
8693953|NCT00868790|9739386|FG002|STARTED|Period 4||4
8693954|NCT00868790|9739387|FG003|STARTED|Period 4||3
8693955|NCT00868790|9739388|FG004|STARTED|Period 4||18
8693956|NCT00868790|9739389|FG005|STARTED|Period 4||1
8693957|NCT00868790|9739390|FG006|STARTED|Period 4||4
8693958|NCT00868790|9739391|FG007|STARTED|Period 4||17
8693959|NCT00868790|9739392|FG008|STARTED|Period 4||8
8693960|NCT00868790|9739393|FG009|STARTED|Period 4||2
8693961|NCT00868790|9739394|FG010|STARTED|Period 4||8
8693962|NCT00868790|9739395|FG011|STARTED|Period 4||4
8693963|NCT00868790|9739396|FG012|STARTED|Period 4||7
8693964|NCT00868790|9739397|FG013|STARTED|Period 4||8
8693965|NCT00868790|9739384|FG000|COMPLETED|Period 4||7
8693966|NCT00868790|9739385|FG001|COMPLETED|Period 4||6
8693967|NCT00868790|9739386|FG002|COMPLETED|Period 4|One non-completion due to abnormal alanine aminotransferase/aspartate aminotransferase (ALT/AST)|3
8693968|NCT00868790|9739387|FG003|COMPLETED|Period 4||3
8693969|NCT00868790|9739388|FG004|COMPLETED|Period 4||18
8693970|NCT00868790|9739389|FG005|COMPLETED|Period 4||1
8693971|NCT00868790|9739390|FG006|COMPLETED|Period 4||4
8693972|NCT00868790|9739391|FG007|COMPLETED|Period 4||14
8693973|NCT00868790|9739392|FG008|COMPLETED|Period 4||6
8693974|NCT00868790|9739393|FG009|COMPLETED|Period 4||2
8693975|NCT00868790|9739394|FG010|COMPLETED|Period 4||5
8693976|NCT00868790|9739395|FG011|COMPLETED|Period 4||3
8693977|NCT00868790|9739396|FG012|COMPLETED|Period 4||6
8693978|NCT00868790|9739397|FG013|COMPLETED|Period 4||7
8693979|NCT00868790|9739384|FG000|NOT COMPLETED|Period 4||2
8693980|NCT00868790|9739385|FG001|NOT COMPLETED|Period 4||0
8693981|NCT00868790|9739386|FG002|NOT COMPLETED|Period 4||1
8693982|NCT00868790|9739387|FG003|NOT COMPLETED|Period 4||0
8693983|NCT00868790|9739388|FG004|NOT COMPLETED|Period 4||0
8693984|NCT00868790|9739389|FG005|NOT COMPLETED|Period 4||0
8693985|NCT00868790|9739390|FG006|NOT COMPLETED|Period 4||0
8693986|NCT00868790|9739391|FG007|NOT COMPLETED|Period 4||3
8693987|NCT00868790|9739392|FG008|NOT COMPLETED|Period 4||2
8693988|NCT00868790|9739393|FG009|NOT COMPLETED|Period 4||0
8693989|NCT00868790|9739394|FG010|NOT COMPLETED|Period 4||3
8693990|NCT00868790|9739395|FG011|NOT COMPLETED|Period 4||1
8693991|NCT00868790|9739396|FG012|NOT COMPLETED|Period 4||1
8693992|NCT00868790|9739397|FG013|NOT COMPLETED|Period 4||1
8693993|NCT00868790|9739384|FG000|STARTED|Post-study||7
8693994|NCT00868790|9739385|FG001|STARTED|Post-study||6
8693995|NCT00868790|9739386|FG002|STARTED|Post-study||3
8693996|NCT00868790|9739387|FG003|STARTED|Post-study||3
8693997|NCT00868790|9739388|FG004|STARTED|Post-study||18
8693998|NCT00868790|9739389|FG005|STARTED|Post-study||1
8693999|NCT00868790|9739390|FG006|STARTED|Post-study||4
8694000|NCT00868790|9739391|FG007|STARTED|Post-study||14
8694001|NCT00868790|9739392|FG008|STARTED|Post-study||6
8694002|NCT00868790|9739393|FG009|STARTED|Post-study||2
8694003|NCT00868790|9739394|FG010|STARTED|Post-study||5
8694004|NCT00868790|9739395|FG011|STARTED|Post-study||3
8694005|NCT00868790|9739396|FG012|STARTED|Post-study||6
8694006|NCT00868790|9739397|FG013|STARTED|Post-study||7
8694007|NCT00868790|9739384|FG000|COMPLETED|Post-study||7
8694008|NCT00868790|9739385|FG001|COMPLETED|Post-study||6
8694009|NCT00868790|9739386|FG002|COMPLETED|Post-study||3
8694010|NCT00868790|9739387|FG003|COMPLETED|Post-study||3
8694011|NCT00868790|9739388|FG004|COMPLETED|Post-study||17
8694012|NCT00868790|9739389|FG005|COMPLETED|Post-study||1
8694013|NCT00868790|9739390|FG006|COMPLETED|Post-study||4
8694014|NCT00868790|9739391|FG007|COMPLETED|Post-study||12
8694015|NCT00868790|9739392|FG008|COMPLETED|Post-study||6
8694016|NCT00868790|9739393|FG009|COMPLETED|Post-study||1
8694017|NCT00868790|9739394|FG010|COMPLETED|Post-study||5
8694018|NCT00868790|9739395|FG011|COMPLETED|Post-study||3
8694019|NCT00868790|9739396|FG012|COMPLETED|Post-study||6
8694020|NCT00868790|9739397|FG013|COMPLETED|Post-study||7
8694021|NCT00868790|9739384|FG000|NOT COMPLETED|Post-study||0
8694022|NCT00868790|9739385|FG001|NOT COMPLETED|Post-study||0
8694023|NCT00868790|9739386|FG002|NOT COMPLETED|Post-study||0
8694024|NCT00868790|9739387|FG003|NOT COMPLETED|Post-study||0
8694025|NCT00868790|9739388|FG004|NOT COMPLETED|Post-study||1
8694026|NCT00868790|9739389|FG005|NOT COMPLETED|Post-study||0
8694027|NCT00868790|9739390|FG006|NOT COMPLETED|Post-study||0
8694028|NCT00868790|9739391|FG007|NOT COMPLETED|Post-study||2
8694029|NCT00868790|9739392|FG008|NOT COMPLETED|Post-study||0
8694030|NCT00868790|9739393|FG009|NOT COMPLETED|Post-study||1
8694031|NCT00868790|9739394|FG010|NOT COMPLETED|Post-study||0
8694032|NCT00868790|9739395|FG011|NOT COMPLETED|Post-study||0
8694033|NCT00868790|9739396|FG012|NOT COMPLETED|Post-study||0
8694034|NCT00868790|9739397|FG013|NOT COMPLETED|Post-study||0
8694035|NCT00868959|9739413|FG000|STARTED|Overall Study|817 represents total number of subjects who provided informed consent.|817
8694036|NCT00868959|9739413|FG000|COMPLETED|Overall Study||559
8694037|NCT00868959|9739413|FG000|NOT COMPLETED|Overall Study||258
8694038|NCT00869024|9739419|FG000|STARTED|Overall Study||16
8694039|NCT00869024|9739420|FG001|STARTED|Overall Study|One patient intent to treat, did not receive study product|9
8694040|NCT00869024|9739419|FG000|COMPLETED|Overall Study||14
8694041|NCT00869024|9739420|FG001|COMPLETED|Overall Study||4
8694042|NCT00869024|9739419|FG000|NOT COMPLETED|Overall Study||2
8694043|NCT00869024|9739420|FG001|NOT COMPLETED|Overall Study||5
8694044|NCT00869050|9739426|FG000|STARTED|Overall Study||41
8694045|NCT00869050|9739426|FG000|COMPLETED|Overall Study||38
8694046|NCT00869050|9739426|FG000|NOT COMPLETED|Overall Study||3
8694047|NCT00869089|9739430|FG000|STARTED|Overall Study||5
8694048|NCT00869089|9739430|FG000|COMPLETED|Overall Study||2
8694049|NCT00869089|9739430|FG000|NOT COMPLETED|Overall Study||3
8694050|NCT00869141|9739436|FG000|STARTED|Overall Study||26
8694051|NCT00869141|9739437|FG001|STARTED|Overall Study||26
8694052|NCT00869141|9739436|FG000|COMPLETED|Overall Study||26
8694053|NCT00869141|9739437|FG001|COMPLETED|Overall Study||26
8694054|NCT00869141|9739436|FG000|NOT COMPLETED|Overall Study||0
8694055|NCT00869141|9739437|FG001|NOT COMPLETED|Overall Study||0
8694056|NCT00869167|9739447|FG000|STARTED|Overall Study||2
8694057|NCT00869167|9739448|FG001|STARTED|Overall Study||1
8694058|NCT00869167|9739447|FG000|COMPLETED|Overall Study||2
8694059|NCT00869167|9739448|FG001|COMPLETED|Overall Study||0
8694060|NCT00869167|9739447|FG000|NOT COMPLETED|Overall Study||0
8694061|NCT00869167|9739448|FG001|NOT COMPLETED|Overall Study||1
8694062|NCT00869206|9739458|FG000|STARTED|Overall Study||911
8694063|NCT00869206|9739459|FG001|STARTED|Overall Study||911
8694064|NCT00869206|9739458|FG000|COMPLETED|Overall Study||882
8694065|NCT00869206|9739459|FG001|COMPLETED|Overall Study||884
8694066|NCT00869206|9739458|FG000|NOT COMPLETED|Overall Study||29
8694067|NCT00869206|9739459|FG001|NOT COMPLETED|Overall Study||27
8694068|NCT00869323|9739471|FG000|STARTED|Induction Therapy||3
8694069|NCT00869323|9739471|FG000|COMPLETED|Induction Therapy||3
8694070|NCT00869323|9739471|FG000|NOT COMPLETED|Induction Therapy||0
8694071|NCT00869323|9739471|FG000|STARTED|Maintenance Therapy|One participant removed from study after completing induction therapy due to progressive disease.|2
8694072|NCT00869323|9739471|FG000|COMPLETED|Maintenance Therapy||1
8694073|NCT00869323|9739471|FG000|NOT COMPLETED|Maintenance Therapy||1
8694074|NCT00869349|9739477|FG000|STARTED|Overall Study||39
8694075|NCT00869349|9739478|FG001|STARTED|Overall Study||40
8694076|NCT00869349|9739477|FG000|COMPLETED|Overall Study||32
8694077|NCT00869349|9739478|FG001|COMPLETED|Overall Study||36
8694078|NCT00869349|9739477|FG000|NOT COMPLETED|Overall Study||7
8694079|NCT00869349|9739478|FG001|NOT COMPLETED|Overall Study||4
8694080|NCT00869362|9739486|FG000|STARTED|Overall Study||15
8694081|NCT00869362|9739487|FG001|STARTED|Overall Study||16
8694082|NCT00869362|9739486|FG000|COMPLETED|Overall Study||14
8694083|NCT00869362|9739487|FG001|COMPLETED|Overall Study||11
8694084|NCT00869362|9739486|FG000|NOT COMPLETED|Overall Study||1
8694085|NCT00869362|9739487|FG001|NOT COMPLETED|Overall Study||5
8694086|NCT00869375|9739496|FG000|STARTED|Overall Study||3
8694087|NCT00869375|9739497|FG001|STARTED|Overall Study||3
8694088|NCT00869375|9739496|FG000|COMPLETED|Overall Study||3
8694089|NCT00869375|9739497|FG001|COMPLETED|Overall Study||3
8694090|NCT00869375|9739496|FG000|NOT COMPLETED|Overall Study||0
8694091|NCT00869375|9739497|FG001|NOT COMPLETED|Overall Study||0
8694092|NCT00869401|9739508|FG000|STARTED|Overall Study||3
8694093|NCT00869401|9739509|FG001|STARTED|Overall Study||3
8694094|NCT00869401|9739510|FG002|STARTED|Overall Study||7
8694095|NCT00869401|9739511|FG003|STARTED|Overall Study||138
8694096|NCT00869401|9739512|FG004|STARTED|Overall Study||66
8694097|NCT00869401|9739508|FG000|COMPLETED|Overall Study||3
8694098|NCT00869401|9739509|FG001|COMPLETED|Overall Study||3
8694099|NCT00869401|9739510|FG002|COMPLETED|Overall Study||7
8694100|NCT00869401|9739511|FG003|COMPLETED|Overall Study||133
8694101|NCT00869401|9739512|FG004|COMPLETED|Overall Study||63
8694102|NCT00869401|9739508|FG000|NOT COMPLETED|Overall Study||0
8694103|NCT00869401|9739509|FG001|NOT COMPLETED|Overall Study||0
8694104|NCT00869401|9739510|FG002|NOT COMPLETED|Overall Study||0
8694105|NCT00869401|9739511|FG003|NOT COMPLETED|Overall Study||5
8694106|NCT00869401|9739512|FG004|NOT COMPLETED|Overall Study||3
8694107|NCT00869440|9739528|FG000|STARTED|Overall Study||25
8694108|NCT00869440|9739529|FG001|STARTED|Overall Study||25
8694109|NCT00869440|9739530|FG002|STARTED|Overall Study||25
8694110|NCT00869440|9739531|FG003|STARTED|Overall Study||25
8694111|NCT00869440|9739528|FG000|COMPLETED|Overall Study||23
8694112|NCT00869440|9739529|FG001|COMPLETED|Overall Study||24
8694113|NCT00869440|9739530|FG002|COMPLETED|Overall Study||25
8694114|NCT00869440|9739531|FG003|COMPLETED|Overall Study||25
8694115|NCT00869440|9739528|FG000|NOT COMPLETED|Overall Study||2
8694116|NCT00869440|9739529|FG001|NOT COMPLETED|Overall Study||1
8694117|NCT00869440|9739530|FG002|NOT COMPLETED|Overall Study||0
8694118|NCT00869440|9739531|FG003|NOT COMPLETED|Overall Study||0
8694119|NCT00869518|9739543|FG000|STARTED|Overall Study||6
8694120|NCT00869518|9739544|FG001|STARTED|Overall Study||6
8694121|NCT00869518|9739543|FG000|COMPLETED|Overall Study||5
8694122|NCT00869518|9739544|FG001|COMPLETED|Overall Study||5
8694123|NCT00869518|9739543|FG000|NOT COMPLETED|Overall Study||1
8694124|NCT00869518|9739544|FG001|NOT COMPLETED|Overall Study||1
8694125|NCT00869557|9739552|FG000|STARTED|Randomized Phase||48
8694126|NCT00869557|9739553|FG001|STARTED|Randomized Phase||23
8694127|NCT00869557|9739552|FG000|COMPLETED|Randomized Phase||45
8694128|NCT00869557|9739553|FG001|COMPLETED|Randomized Phase||21
8694129|NCT00869557|9739552|FG000|NOT COMPLETED|Randomized Phase||3
8694130|NCT00869557|9739553|FG001|NOT COMPLETED|Randomized Phase||2
8694131|NCT00869557|9739552|FG000|STARTED|Extension Phase||45
8694132|NCT00869557|9739553|FG001|STARTED|Extension Phase|Seven participants completing randomized Atripla treatment did not enter open-label extension phase.|14
8694133|NCT00869557|9739552|FG000|COMPLETED|Extension Phase||35
8694134|NCT00869557|9739553|FG001|COMPLETED|Extension Phase||11
8694135|NCT00869557|9739552|FG000|NOT COMPLETED|Extension Phase||10
8694136|NCT00869557|9739553|FG001|NOT COMPLETED|Extension Phase||3
8694137|NCT00869609|9739562|FG000|STARTED|Overall Study||31
8694138|NCT00869609|9739563|FG001|STARTED|Overall Study||29
8694139|NCT00869609|9739562|FG000|COMPLETED|Overall Study||25
8694140|NCT00869609|9739563|FG001|COMPLETED|Overall Study||26
8694141|NCT00869609|9739562|FG000|NOT COMPLETED|Overall Study||6
8694142|NCT00869609|9739563|FG001|NOT COMPLETED|Overall Study||3
8694143|NCT00869622|9739571|FG000|STARTED|Overall Study||40
8694144|NCT00869622|9739572|FG001|STARTED|Overall Study||40
8694145|NCT00869622|9739571|FG000|COMPLETED|Overall Study||27
8694146|NCT00869622|9739572|FG001|COMPLETED|Overall Study||26
8694147|NCT00869622|9739571|FG000|NOT COMPLETED|Overall Study||13
8694148|NCT00869622|9739572|FG001|NOT COMPLETED|Overall Study||14
8694149|NCT00869778|9739582|FG000|STARTED|Overall Study||120
8694150|NCT00869778|9739583|FG001|STARTED|Overall Study||120
8694151|NCT00869778|9739584|FG002|STARTED|Overall Study||120
8694152|NCT00869778|9739582|FG000|COMPLETED|Overall Study||108
8694153|NCT00869778|9739583|FG001|COMPLETED|Overall Study||113
8694154|NCT00869778|9739584|FG002|COMPLETED|Overall Study||110
8694155|NCT00869778|9739582|FG000|NOT COMPLETED|Overall Study||12
8694156|NCT00869778|9739583|FG001|NOT COMPLETED|Overall Study||7
8694157|NCT00869778|9739584|FG002|NOT COMPLETED|Overall Study||10
8694158|NCT00869791|9739595|FG000|STARTED|Period 1 Treatment for 7 Days||14
8694159|NCT00869791|9739596|FG001|STARTED|Period 1 Treatment for 7 Days||13
8694160|NCT00869791|9739595|FG000|COMPLETED|Period 1 Treatment for 7 Days||14
8694161|NCT00869791|9739596|FG001|COMPLETED|Period 1 Treatment for 7 Days||13
8694162|NCT00869791|9739595|FG000|NOT COMPLETED|Period 1 Treatment for 7 Days||0
8694163|NCT00869791|9739596|FG001|NOT COMPLETED|Period 1 Treatment for 7 Days||0
8694164|NCT00869791|9739595|FG000|STARTED|Period 2 Treatment for 7 Days||14
8694165|NCT00869791|9739596|FG001|STARTED|Period 2 Treatment for 7 Days||13
